id|nct_id|result_group_id|ctgov_group_code|title|period|description|count
3159644|NCT01857882|3886619|FG000|STARTED|Overall Study||21
3159645|NCT01857882|3886620|FG001|STARTED|Overall Study||20
3159646|NCT01857882|3886619|FG000|COMPLETED|Overall Study||21
3159647|NCT01857882|3886620|FG001|COMPLETED|Overall Study||20
3159648|NCT01857882|3886619|FG000|NOT COMPLETED|Overall Study||0
3159649|NCT01857882|3886620|FG001|NOT COMPLETED|Overall Study||0
3159650|NCT01857973|3886626|FG000|STARTED|Overall Study||78
3159651|NCT01857973|3886626|FG000|Exploratory A Phase|Overall Study||9
3159652|NCT01857973|3886626|FG000|Xploratory B Phase|Overall Study||9
3159653|NCT01857973|3886626|FG000|Phase 1|Overall Study||17
3159654|NCT01857973|3886626|FG000|Phase 2|Overall Study||14
3159655|NCT01857973|3886626|FG000|Phase 3|Overall Study||10
3159656|NCT01857973|3886626|FG000|Phase 4|Overall Study||10
3159657|NCT01857973|3886626|FG000|Phase 6|Overall Study||4
3159658|NCT01857973|3886626|FG000|Phase 7|Overall Study||4
3159659|NCT01857973|3886626|FG000|COMPLETED|Overall Study||73
3159660|NCT01857973|3886626|FG000|NOT COMPLETED|Overall Study||5
3159661|NCT01857986|3886632|FG000|STARTED|Overall Study||39
3159662|NCT01857986|3886633|FG001|STARTED|Overall Study||37
3159663|NCT01857986|3886632|FG000|COMPLETED|Overall Study||34
3159664|NCT01857986|3886633|FG001|COMPLETED|Overall Study||30
3159665|NCT01857986|3886632|FG000|NOT COMPLETED|Overall Study||5
3159666|NCT01857986|3886633|FG001|NOT COMPLETED|Overall Study||7
3159667|NCT01858194|3886641|FG000|STARTED|Overall Study||8
3159668|NCT01858194|3886642|FG001|STARTED|Overall Study||9
3159669|NCT01858194|3886641|FG000|COMPLETED|Overall Study|All patients in Control arm completed.|8
3159670|NCT01858194|3886642|FG001|COMPLETED|Overall Study||7
3159671|NCT01858194|3886641|FG000|NOT COMPLETED|Overall Study||0
3159672|NCT01858194|3886642|FG001|NOT COMPLETED|Overall Study||2
3159673|NCT01858363|3886652|FG000|STARTED|Overall Study||222
3159674|NCT01858363|3886653|FG001|STARTED|Overall Study||72
3159675|NCT01858363|3886652|FG000|Pre-discharge Visit|Overall Study||219
3159676|NCT01858363|3886653|FG001|Pre-discharge Visit|Overall Study||72
3159677|NCT01858363|3886652|FG000|1-month Visit|Overall Study||214
3159678|NCT01858363|3886653|FG001|1-month Visit|Overall Study||68
3159679|NCT01858363|3886652|FG000|6-month Visit|Overall Study||208
3159680|NCT01858363|3886653|FG001|6-month Visit|Overall Study||64
3159681|NCT01858363|3886652|FG000|12-month Vist|Overall Study||205
3159682|NCT01858363|3886653|FG001|12-month Vist|Overall Study||61
3159683|NCT01858363|3886652|FG000|24-month Visit|Overall Study||184
3159684|NCT01858363|3886653|FG001|24-month Visit|Overall Study||58
3159685|NCT01858363|3886652|FG000|36-month Visit|Overall Study||169
3159686|NCT01858363|3886653|FG001|36-month Visit|Overall Study||53
3159687|NCT01858363|3886652|FG000|48-month Visit|Overall Study||157
3159688|NCT01858363|3886653|FG001|48-month Visit|Overall Study||53
3159689|NCT01858363|3886652|FG000|COMPLETED|Overall Study||146
3159690|NCT01858363|3886653|FG001|COMPLETED|Overall Study||46
3159691|NCT01858363|3886652|FG000|NOT COMPLETED|Overall Study||76
3159692|NCT01858363|3886653|FG001|NOT COMPLETED|Overall Study||26
3159693|NCT01858376|3886659|FG000|STARTED|Overall Study||24
3159694|NCT01858376|3886659|FG000|COMPLETED|Overall Study||20
3159695|NCT01858376|3886659|FG000|NOT COMPLETED|Overall Study||4
3159696|NCT01858389|3886665|FG000|STARTED|Overall Study|Enrolled|16
3159697|NCT01858389|3886666|FG001|STARTED|Overall Study|Enrolled|25
3159698|NCT01858389|3886665|FG000|Received Treatment|Overall Study||16
3159699|NCT01858389|3886666|FG001|Received Treatment|Overall Study||22
3159700|NCT01858389|3886665|FG000|COMPLETED|Overall Study||0
3159701|NCT01858389|3886666|FG001|COMPLETED|Overall Study||0
3159702|NCT01858389|3886665|FG000|NOT COMPLETED|Overall Study||16
3159703|NCT01858389|3886666|FG001|NOT COMPLETED|Overall Study||25
3159704|NCT01858428|3886676|FG000|STARTED|Overall Study|EverCross™ Balloon Catheter now a product of Medtronic|100
3159705|NCT01858428|3886677|FG001|STARTED|Overall Study||200
3159706|NCT01858428|3886676|FG000|COMPLETED|Overall Study||99
3159707|NCT01858428|3886677|FG001|COMPLETED|Overall Study||190
3159708|NCT01858428|3886676|FG000|NOT COMPLETED|Overall Study||1
3159709|NCT01858428|3886677|FG001|NOT COMPLETED|Overall Study||10
3159710|NCT01858532|3886687|FG000|STARTED|Overall Study||1325
3159711|NCT01858532|3886688|FG001|STARTED|Overall Study||1323
3159712|NCT01858532|3886689|FG002|STARTED|Overall Study||509
3159713|NCT01858532|3886690|FG003|STARTED|Overall Study||511
3159714|NCT01858532|3886687|FG000|COMPLETED|Overall Study||1144
3159715|NCT01858532|3886688|FG001|COMPLETED|Overall Study||1131
3159716|NCT01858532|3886689|FG002|COMPLETED|Overall Study||411
3159717|NCT01858532|3886690|FG003|COMPLETED|Overall Study||418
3159718|NCT01858532|3886687|FG000|NOT COMPLETED|Overall Study||181
3159719|NCT01858532|3886688|FG001|NOT COMPLETED|Overall Study||192
3159720|NCT01858532|3886689|FG002|NOT COMPLETED|Overall Study||98
3159721|NCT01858532|3886690|FG003|NOT COMPLETED|Overall Study||93
3159722|NCT01858545|3886702|FG000|STARTED|Overall Study||27
3159723|NCT01858545|3886703|FG001|STARTED|Overall Study||29
3159724|NCT01858545|3886702|FG000|COMPLETED|Overall Study||23
3159725|NCT01858545|3886703|FG001|COMPLETED|Overall Study||23
3159726|NCT01858545|3886702|FG000|NOT COMPLETED|Overall Study||4
3159727|NCT01858545|3886703|FG001|NOT COMPLETED|Overall Study||6
3159728|NCT01858558|3886711|FG000|STARTED|Overall Study||70
3159729|NCT01858558|3886712|FG001|STARTED|Overall Study||31
3159730|NCT01858558|3886711|FG000|COMPLETED|Overall Study||61
3159731|NCT01858558|3886712|FG001|COMPLETED|Overall Study||29
3159732|NCT01858558|3886711|FG000|NOT COMPLETED|Overall Study||9
3159733|NCT01858558|3886712|FG001|NOT COMPLETED|Overall Study||2
3159734|NCT01858636|3886718|FG000|STARTED|Overall Study|Subjects consented|235
3159735|NCT01858636|3886718|FG000|Device Deployment|Overall Study||211
3159736|NCT01858636|3886718|FG000|COMPLETED|Overall Study||207
3159737|NCT01858636|3886718|FG000|NOT COMPLETED|Overall Study||28
3159738|NCT01858701|3886723|FG000|STARTED|Period 1, First 30 Days of Wear||20
3159739|NCT01858701|3886724|FG001|STARTED|Period 1, First 30 Days of Wear||20
3159740|NCT01858701|3886723|FG000|COMPLETED|Period 1, First 30 Days of Wear||20
3159741|NCT01858701|3886724|FG001|COMPLETED|Period 1, First 30 Days of Wear||19
3159742|NCT01858701|3886723|FG000|NOT COMPLETED|Period 1, First 30 Days of Wear||0
3159743|NCT01858701|3886724|FG001|NOT COMPLETED|Period 1, First 30 Days of Wear||1
3159744|NCT01858701|3886723|FG000|STARTED|Washout Period, 1-13 Days||20
3159745|NCT01858701|3886724|FG001|STARTED|Washout Period, 1-13 Days||19
3159746|NCT01858701|3886723|FG000|COMPLETED|Washout Period, 1-13 Days||18
3159747|NCT01858701|3886724|FG001|COMPLETED|Washout Period, 1-13 Days||17
3159748|NCT01858701|3886723|FG000|NOT COMPLETED|Washout Period, 1-13 Days||2
3159749|NCT01858701|3886724|FG001|NOT COMPLETED|Washout Period, 1-13 Days||2
3159750|NCT01858701|3886723|FG000|STARTED|Period 2, Second 30 Days of Wear||18
3159751|NCT01858701|3886724|FG001|STARTED|Period 2, Second 30 Days of Wear||17
3159752|NCT01858701|3886723|FG000|COMPLETED|Period 2, Second 30 Days of Wear||18
3159753|NCT01858701|3886724|FG001|COMPLETED|Period 2, Second 30 Days of Wear||16
3159754|NCT01858701|3886723|FG000|NOT COMPLETED|Period 2, Second 30 Days of Wear||0
3159755|NCT01858701|3886724|FG001|NOT COMPLETED|Period 2, Second 30 Days of Wear||1
3159756|NCT01858753|3886732|FG000|STARTED|Overall Study||5
3159757|NCT01858753|3886733|FG001|STARTED|Overall Study||0
3159758|NCT01858753|3886732|FG000|COMPLETED|Overall Study||0
3159759|NCT01858753|3886733|FG001|COMPLETED|Overall Study||0
3159760|NCT01858753|3886732|FG000|NOT COMPLETED|Overall Study||5
3159761|NCT01858753|3886733|FG001|NOT COMPLETED|Overall Study||0
3159762|NCT01858766|3886758|FG000|STARTED|Overall Study||27
3159763|NCT01858766|3886759|FG001|STARTED|Overall Study||28
3159764|NCT01858766|3886760|FG002|STARTED|Overall Study||11
3159765|NCT01858766|3886761|FG003|STARTED|Overall Study||10
3159766|NCT01858766|3886762|FG004|STARTED|Overall Study||27
3159767|NCT01858766|3886763|FG005|STARTED|Overall Study||28
3159768|NCT01858766|3886764|FG006|STARTED|Overall Study||7
3159769|NCT01858766|3886765|FG007|STARTED|Overall Study||7
3159770|NCT01858766|3886766|FG008|STARTED|Overall Study||1
3159771|NCT01858766|3886767|FG009|STARTED|Overall Study||4
3159772|NCT01858766|3886768|FG010|STARTED|Overall Study||5
3159773|NCT01858766|3886769|FG011|STARTED|Overall Study||30
3159774|NCT01858766|3886770|FG012|STARTED|Overall Study||30
3159775|NCT01858766|3886771|FG013|STARTED|Overall Study||29
3159776|NCT01858766|3886772|FG014|STARTED|Overall Study||31
3159777|NCT01858766|3886773|FG015|STARTED|Overall Study||26
3159778|NCT01858766|3886774|FG016|STARTED|Overall Study||25
3159779|NCT01858766|3886775|FG017|STARTED|Overall Study||27
3159780|NCT01858766|3886776|FG018|STARTED|Overall Study||26
3159781|NCT01858766|3886758|FG000|COMPLETED|Overall Study||26
3159782|NCT01858766|3886759|FG001|COMPLETED|Overall Study||28
3159783|NCT01858766|3886760|FG002|COMPLETED|Overall Study||10
3159784|NCT01858766|3886761|FG003|COMPLETED|Overall Study||10
3159785|NCT01858766|3886762|FG004|COMPLETED|Overall Study||26
3159786|NCT01858766|3886763|FG005|COMPLETED|Overall Study||24
3159787|NCT01858766|3886764|FG006|COMPLETED|Overall Study||7
3159788|NCT01858766|3886765|FG007|COMPLETED|Overall Study||5
3159789|NCT01858766|3886766|FG008|COMPLETED|Overall Study||1
3159790|NCT01858766|3886767|FG009|COMPLETED|Overall Study||4
3159791|NCT01858766|3886768|FG010|COMPLETED|Overall Study||5
3159792|NCT01858766|3886769|FG011|COMPLETED|Overall Study||25
3159793|NCT01858766|3886770|FG012|COMPLETED|Overall Study||25
3159794|NCT01858766|3886771|FG013|COMPLETED|Overall Study||26
3159795|NCT01858766|3886772|FG014|COMPLETED|Overall Study||23
3159796|NCT01858766|3886773|FG015|COMPLETED|Overall Study||20
3159797|NCT01858766|3886774|FG016|COMPLETED|Overall Study||22
3159798|NCT01858766|3886775|FG017|COMPLETED|Overall Study||23
3159799|NCT01858766|3886776|FG018|COMPLETED|Overall Study||22
3159800|NCT01858766|3886758|FG000|NOT COMPLETED|Overall Study||1
3159801|NCT01858766|3886759|FG001|NOT COMPLETED|Overall Study||0
3159802|NCT01858766|3886760|FG002|NOT COMPLETED|Overall Study||1
3159803|NCT01858766|3886761|FG003|NOT COMPLETED|Overall Study||0
3159804|NCT01858766|3886762|FG004|NOT COMPLETED|Overall Study||1
3159805|NCT01858766|3886763|FG005|NOT COMPLETED|Overall Study||4
3159806|NCT01858766|3886764|FG006|NOT COMPLETED|Overall Study||0
3159807|NCT01858766|3886765|FG007|NOT COMPLETED|Overall Study||2
3159808|NCT01858766|3886766|FG008|NOT COMPLETED|Overall Study||0
3159809|NCT01858766|3886767|FG009|NOT COMPLETED|Overall Study||0
3159810|NCT01858766|3886768|FG010|NOT COMPLETED|Overall Study||0
3159811|NCT01858766|3886769|FG011|NOT COMPLETED|Overall Study||5
3159812|NCT01858766|3886770|FG012|NOT COMPLETED|Overall Study||5
3159813|NCT01858766|3886771|FG013|NOT COMPLETED|Overall Study||3
3159814|NCT01858766|3886772|FG014|NOT COMPLETED|Overall Study||8
3159815|NCT01858766|3886773|FG015|NOT COMPLETED|Overall Study||6
3159816|NCT01858766|3886774|FG016|NOT COMPLETED|Overall Study||3
3159817|NCT01858766|3886775|FG017|NOT COMPLETED|Overall Study||4
3159818|NCT01858766|3886776|FG018|NOT COMPLETED|Overall Study||4
3159819|NCT01859013|3886811|FG000|STARTED|Overall Study||16
3159820|NCT01859013|3886812|FG001|STARTED|Overall Study||14
3159821|NCT01859013|3886811|FG000|COMPLETED|Overall Study||12
3159822|NCT01859013|3886812|FG001|COMPLETED|Overall Study||9
3159823|NCT01859013|3886811|FG000|NOT COMPLETED|Overall Study||4
3159824|NCT01859013|3886812|FG001|NOT COMPLETED|Overall Study||5
3159825|NCT01859078|3886818|FG000|STARTED|Overall Study||28
3159826|NCT01859078|3886818|FG000|COMPLETED|Overall Study||28
3159827|NCT01859078|3886818|FG000|NOT COMPLETED|Overall Study||0
3159828|NCT01859143|3886826|FG000|STARTED|Overall Study||240
3159829|NCT01859143|3886827|FG001|STARTED|Overall Study|One participant in this group received trivalent influenza vaccine on Day 1.|60
3159830|NCT01859143|3886826|FG000|COMPLETED|Overall Study||238
3159831|NCT01859143|3886827|FG001|COMPLETED|Overall Study||60
3159832|NCT01859143|3886826|FG000|NOT COMPLETED|Overall Study||2
3159833|NCT01859143|3886827|FG001|NOT COMPLETED|Overall Study||0
3159834|NCT01859195|3886836|FG000|STARTED|Overall Study||24
3159835|NCT01859195|3886837|FG001|STARTED|Overall Study||12
3159836|NCT01859195|3886836|FG000|COMPLETED|Overall Study||24
3159837|NCT01859195|3886837|FG001|COMPLETED|Overall Study||12
3159838|NCT01859195|3886836|FG000|NOT COMPLETED|Overall Study||0
3159839|NCT01859195|3886837|FG001|NOT COMPLETED|Overall Study||0
3159840|NCT01859247|3886853|FG000|STARTED|Overall Study||1
3159841|NCT01859247|3886854|FG001|STARTED|Overall Study||1
3159842|NCT01859247|3886855|FG002|STARTED|Overall Study||1
3159843|NCT01859247|3886856|FG003|STARTED|Overall Study||1
3159844|NCT01859247|3886857|FG004|STARTED|Overall Study||1
3159845|NCT01859247|3886858|FG005|STARTED|Overall Study||1
3159846|NCT01859247|3886859|FG006|STARTED|Overall Study||1
3159847|NCT01859247|3886860|FG007|STARTED|Overall Study||1
3159848|NCT01859247|3886853|FG000|COMPLETED|Overall Study||1
3159849|NCT01859247|3886854|FG001|COMPLETED|Overall Study||1
3159850|NCT01859247|3886855|FG002|COMPLETED|Overall Study||1
3159851|NCT01859247|3886856|FG003|COMPLETED|Overall Study||1
3159852|NCT01859247|3886857|FG004|COMPLETED|Overall Study||1
3159853|NCT01859247|3886858|FG005|COMPLETED|Overall Study||1
3159854|NCT01859247|3886859|FG006|COMPLETED|Overall Study||1
3159855|NCT01859247|3886860|FG007|COMPLETED|Overall Study||1
3159856|NCT01859247|3886853|FG000|NOT COMPLETED|Overall Study||0
3159857|NCT01859247|3886854|FG001|NOT COMPLETED|Overall Study||0
3159858|NCT01859247|3886855|FG002|NOT COMPLETED|Overall Study||0
3159859|NCT01859247|3886856|FG003|NOT COMPLETED|Overall Study||0
3159860|NCT01859247|3886857|FG004|NOT COMPLETED|Overall Study||0
3159861|NCT01859247|3886858|FG005|NOT COMPLETED|Overall Study||0
3159862|NCT01859247|3886859|FG006|NOT COMPLETED|Overall Study||0
3159863|NCT01859247|3886860|FG007|NOT COMPLETED|Overall Study||0
3159864|NCT01859312|3886879|FG000|STARTED|Overall Study||8
3159865|NCT01859312|3886879|FG000|COMPLETED|Overall Study|Based on medication & supply accountability, one participant was found to be partially non-compliant|8
3159866|NCT01859312|3886879|FG000|NOT COMPLETED|Overall Study||0
3159867|NCT01859325|3886886|FG000|STARTED|Overall Study||15
3159868|NCT01859325|3886887|FG001|STARTED|Overall Study||16
3159869|NCT01859325|3886888|FG002|STARTED|Overall Study||2
3159870|NCT01859325|3886886|FG000|COMPLETED|Overall Study||12
3159871|NCT01859325|3886887|FG001|COMPLETED|Overall Study||12
3159872|NCT01859325|3886888|FG002|COMPLETED|Overall Study||2
3159873|NCT01859325|3886886|FG000|NOT COMPLETED|Overall Study||3
3159874|NCT01859325|3886887|FG001|NOT COMPLETED|Overall Study||4
3159875|NCT01859325|3886888|FG002|NOT COMPLETED|Overall Study||0
3159876|NCT01859390|3886896|FG000|STARTED|Overall Study||36
3159877|NCT01859390|3886897|FG001|STARTED|Overall Study||37
3159878|NCT01859390|3886896|FG000|Withdrawals|Overall Study||2
3159879|NCT01859390|3886897|FG001|Withdrawals|Overall Study||2
3159880|NCT01859390|3886896|FG000|COMPLETED|Overall Study||35
3159881|NCT01859390|3886897|FG001|COMPLETED|Overall Study||30
3159882|NCT01859390|3886896|FG000|NOT COMPLETED|Overall Study||1
3159883|NCT01859390|3886897|FG001|NOT COMPLETED|Overall Study||7
3159884|NCT01859403|3886905|FG000|STARTED|Primary Endpoint Measure||21
3159885|NCT01859403|3886906|FG001|STARTED|Primary Endpoint Measure||30
3159886|NCT01859403|3886905|FG000|COMPLETED|Primary Endpoint Measure||20
3159887|NCT01859403|3886906|FG001|COMPLETED|Primary Endpoint Measure||26
3159888|NCT01859403|3886905|FG000|NOT COMPLETED|Primary Endpoint Measure||1
3159889|NCT01859403|3886906|FG001|NOT COMPLETED|Primary Endpoint Measure||4
3159890|NCT01859403|3886905|FG000|STARTED|Secondary Endpoint Measure||20
3159891|NCT01859403|3886906|FG001|STARTED|Secondary Endpoint Measure||26
3271819|NCT02676882|4007120|FG000|STARTED|Overall Study||13
3271820|NCT02676882|4007121|FG001|STARTED|Overall Study||7
3271821|NCT02676882|4007120|FG000|Evaluable|Overall Study||11
3271822|NCT02676882|4007121|FG001|Evaluable|Overall Study||6
3271823|NCT02676882|4007120|FG000|COMPLETED|Overall Study||10
3271824|NCT02676882|4007121|FG001|COMPLETED|Overall Study||5
3271825|NCT02676882|4007120|FG000|NOT COMPLETED|Overall Study||3
3271826|NCT02676882|4007121|FG001|NOT COMPLETED|Overall Study||2
3271827|NCT02676895|4007130|FG000|STARTED|Overall Study||22
3271828|NCT02676895|4007131|FG001|STARTED|Overall Study||26
3271829|NCT02676895|4007132|FG002|STARTED|Overall Study||24
3271830|NCT02676895|4007130|FG000|COMPLETED|Overall Study||20
3271831|NCT02676895|4007131|FG001|COMPLETED|Overall Study||23
3271832|NCT02676895|4007132|FG002|COMPLETED|Overall Study||21
3271833|NCT02676895|4007130|FG000|NOT COMPLETED|Overall Study||2
3271834|NCT02676895|4007131|FG001|NOT COMPLETED|Overall Study||3
3271835|NCT02676895|4007132|FG002|NOT COMPLETED|Overall Study||3
3271836|NCT02677116|4007150|FG000|STARTED|Overall Study||10
3271837|NCT02677116|4007151|FG001|STARTED|Overall Study||11
3159892|NCT01859403|3886905|FG000|COMPLETED|Secondary Endpoint Measure||14
3159893|NCT01859403|3886906|FG001|COMPLETED|Secondary Endpoint Measure||18
3271838|NCT02677116|4007152|FG002|STARTED|Overall Study||9
3271839|NCT02677116|4007153|FG003|STARTED|Overall Study||10
3271840|NCT02677116|4007154|FG004|STARTED|Overall Study||1
3159894|NCT01859403|3886905|FG000|NOT COMPLETED|Secondary Endpoint Measure||6
3159895|NCT01859403|3886906|FG001|NOT COMPLETED|Secondary Endpoint Measure||8
3159896|NCT01859494|3886912|FG000|STARTED|Overall Study||219
3159897|NCT01859494|3886912|FG000|COMPLETED|Overall Study||218
3159898|NCT01859494|3886912|FG000|NOT COMPLETED|Overall Study||1
3159899|NCT01859507|3886916|FG000|STARTED|Overall Study||32
3159900|NCT01859507|3886916|FG000|COMPLETED|Overall Study||28
3159901|NCT01859507|3886916|FG000|NOT COMPLETED|Overall Study||4
3159902|NCT01859598|3886921|FG000|STARTED|Visit 2 at 3 Months|At visit 1, patients remained at baseline, N=18995|18995
3159903|NCT01859598|3886921|FG000|COMPLETED|Visit 2 at 3 Months||17253
3159904|NCT01859598|3886921|FG000|NOT COMPLETED|Visit 2 at 3 Months||1742
3159905|NCT01859598|3886921|FG000|STARTED|Visit 3 at 6 Months||17253
3159906|NCT01859598|3886921|FG000|COMPLETED|Visit 3 at 6 Months|Loss to follow-up, N=1517; Come back at visit 3, N=605;|16341
3159907|NCT01859598|3886921|FG000|NOT COMPLETED|Visit 3 at 6 Months||912
3159908|NCT01859611|3886927|FG000|STARTED|Overall Study||51
3159909|NCT01859611|3886927|FG000|COMPLETED|Overall Study||43
3159910|NCT01859611|3886927|FG000|NOT COMPLETED|Overall Study||8
3159911|NCT01859637|3886931|FG000|STARTED|Overall Study||6
3159912|NCT01859637|3886931|FG000|COMPLETED|Overall Study||6
3159913|NCT01859637|3886931|FG000|NOT COMPLETED|Overall Study||0
3159914|NCT01859702|3886935|FG000|STARTED|Overall Study||36
3159915|NCT01859702|3886935|FG000|COMPLETED|Overall Study||31
3159916|NCT01859702|3886935|FG000|NOT COMPLETED|Overall Study||5
3159917|NCT01859715|3886942|FG000|STARTED|Overall Study||141
3159918|NCT01859715|3886943|FG001|STARTED|Overall Study||91
3159919|NCT01859715|3886944|FG002|STARTED|Overall Study||116
3159920|NCT01859715|3886942|FG000|COMPLETED|Overall Study||125
3159921|NCT01859715|3886943|FG001|COMPLETED|Overall Study||83
3159922|NCT01859715|3886944|FG002|COMPLETED|Overall Study||93
3159923|NCT01859715|3886942|FG000|NOT COMPLETED|Overall Study||16
3159924|NCT01859715|3886943|FG001|NOT COMPLETED|Overall Study||8
3159925|NCT01859715|3886944|FG002|NOT COMPLETED|Overall Study||23
3159926|NCT01859741|3886962|FG000|STARTED|Overall Study||3
3159927|NCT01859741|3886963|FG001|STARTED|Overall Study||3
3159928|NCT01859741|3886964|FG002|STARTED|Overall Study||6
3159929|NCT01859741|3886965|FG003|STARTED|Overall Study||3
3159930|NCT01859741|3886966|FG004|STARTED|Overall Study||6
3159931|NCT01859741|3886967|FG005|STARTED|Overall Study||6
3159932|NCT01859741|3886968|FG006|STARTED|Overall Study||72
3159933|NCT01859741|3886969|FG007|STARTED|Overall Study||73
3159934|NCT01859741|3886962|FG000|COMPLETED|Overall Study||0
3159935|NCT01859741|3886963|FG001|COMPLETED|Overall Study||0
3159936|NCT01859741|3886964|FG002|COMPLETED|Overall Study||0
3159937|NCT01859741|3886965|FG003|COMPLETED|Overall Study||0
3159938|NCT01859741|3886966|FG004|COMPLETED|Overall Study||0
3159939|NCT01859741|3886967|FG005|COMPLETED|Overall Study||0
3159940|NCT01859741|3886968|FG006|COMPLETED|Overall Study||2
3159941|NCT01859741|3886969|FG007|COMPLETED|Overall Study||3
3159942|NCT01859741|3886962|FG000|NOT COMPLETED|Overall Study||3
3159943|NCT01859741|3886963|FG001|NOT COMPLETED|Overall Study||3
3159944|NCT01859741|3886964|FG002|NOT COMPLETED|Overall Study||6
3159945|NCT01859741|3886965|FG003|NOT COMPLETED|Overall Study||3
3159946|NCT01859741|3886966|FG004|NOT COMPLETED|Overall Study||6
3159947|NCT01859741|3886967|FG005|NOT COMPLETED|Overall Study||6
3159948|NCT01859741|3886968|FG006|NOT COMPLETED|Overall Study||70
3159949|NCT01859741|3886969|FG007|NOT COMPLETED|Overall Study||70
3159950|NCT01859793|3886989|FG000|STARTED|First Intervention (8 Weeks)||20
3159951|NCT01859793|3886990|FG001|STARTED|First Intervention (8 Weeks)||18
3159952|NCT01859793|3886989|FG000|COMPLETED|First Intervention (8 Weeks)||15
3159953|NCT01859793|3886990|FG001|COMPLETED|First Intervention (8 Weeks)||17
3159954|NCT01859793|3886989|FG000|NOT COMPLETED|First Intervention (8 Weeks)||5
3159955|NCT01859793|3886990|FG001|NOT COMPLETED|First Intervention (8 Weeks)||1
3159956|NCT01859793|3886989|FG000|STARTED|Washout Period (4 Weeks)||15
3159957|NCT01859793|3886990|FG001|STARTED|Washout Period (4 Weeks)||17
3159958|NCT01859793|3886989|FG000|COMPLETED|Washout Period (4 Weeks)||14
3159959|NCT01859793|3886990|FG001|COMPLETED|Washout Period (4 Weeks)||16
3159960|NCT01859793|3886989|FG000|NOT COMPLETED|Washout Period (4 Weeks)||1
3159961|NCT01859793|3886990|FG001|NOT COMPLETED|Washout Period (4 Weeks)||1
3159962|NCT01859793|3886989|FG000|STARTED|2nd Intervention Period||14
3159963|NCT01859793|3886990|FG001|STARTED|2nd Intervention Period||16
3159964|NCT01859793|3886989|FG000|COMPLETED|2nd Intervention Period||14
3159965|NCT01859793|3886990|FG001|COMPLETED|2nd Intervention Period||16
3159966|NCT01859793|3886989|FG000|NOT COMPLETED|2nd Intervention Period||0
3159967|NCT01859793|3886990|FG001|NOT COMPLETED|2nd Intervention Period||0
3159968|NCT01859923|3887000|FG000|STARTED|Overall Study||7
3159969|NCT01859923|3887001|FG001|STARTED|Overall Study||6
3159970|NCT01859923|3887002|FG002|STARTED|Overall Study||12
3159971|NCT01859923|3887003|FG003|STARTED|Overall Study||12
3159972|NCT01859923|3887000|FG000|COMPLETED|Overall Study||7
3159973|NCT01859923|3887001|FG001|COMPLETED|Overall Study||6
3159974|NCT01859923|3887002|FG002|COMPLETED|Overall Study||11
3159975|NCT01859923|3887003|FG003|COMPLETED|Overall Study||11
3159976|NCT01859923|3887000|FG000|NOT COMPLETED|Overall Study||0
3159977|NCT01859923|3887001|FG001|NOT COMPLETED|Overall Study||0
3159978|NCT01859923|3887002|FG002|NOT COMPLETED|Overall Study||1
3159979|NCT01859923|3887003|FG003|NOT COMPLETED|Overall Study||1
3159980|NCT01859949|3887018|FG000|STARTED|Overall Study|Treated participants|29
3159981|NCT01859949|3887019|FG001|STARTED|Overall Study|Treated participants|32
3159982|NCT01859949|3887018|FG000|COMPLETED|Overall Study||15
3159983|NCT01859949|3887019|FG001|COMPLETED|Overall Study||15
3159984|NCT01859949|3887018|FG000|NOT COMPLETED|Overall Study||14
3159985|NCT01859949|3887019|FG001|NOT COMPLETED|Overall Study||17
3159986|NCT01859988|3887031|FG000|STARTED|Overall Study||63
3159987|NCT01859988|3887032|FG001|STARTED|Overall Study||64
3159988|NCT01859988|3887033|FG002|STARTED|Overall Study||62
3159989|NCT01859988|3887034|FG003|STARTED|Overall Study||65
3159990|NCT01859988|3887035|FG004|STARTED|Overall Study||65
3159991|NCT01859988|3887036|FG005|STARTED|Overall Study||61
3159992|NCT01859988|3887031|FG000|Treated|Overall Study||63
3159993|NCT01859988|3887032|FG001|Treated|Overall Study||64
3159994|NCT01859988|3887033|FG002|Treated|Overall Study||61
3159995|NCT01859988|3887034|FG003|Treated|Overall Study||65
3159996|NCT01859988|3887035|FG004|Treated|Overall Study||65
3159997|NCT01859988|3887036|FG005|Treated|Overall Study||61
3159998|NCT01859988|3887031|FG000|COMPLETED|Overall Study||52
3159999|NCT01859988|3887032|FG001|COMPLETED|Overall Study||52
3160000|NCT01859988|3887033|FG002|COMPLETED|Overall Study||34
3160001|NCT01859988|3887034|FG003|COMPLETED|Overall Study||55
3160002|NCT01859988|3887035|FG004|COMPLETED|Overall Study||42
3160003|NCT01859988|3887036|FG005|COMPLETED|Overall Study||42
3160004|NCT01859988|3887031|FG000|NOT COMPLETED|Overall Study||11
3160005|NCT01859988|3887032|FG001|NOT COMPLETED|Overall Study||12
3160006|NCT01859988|3887033|FG002|NOT COMPLETED|Overall Study||28
3160007|NCT01859988|3887034|FG003|NOT COMPLETED|Overall Study||10
3160008|NCT01859988|3887035|FG004|NOT COMPLETED|Overall Study||23
3160009|NCT01859988|3887036|FG005|NOT COMPLETED|Overall Study||19
3160010|NCT01860079|3887052|FG000|STARTED|Overall Study||384
3160011|NCT01860079|3887053|FG001|STARTED|Overall Study||385
3160012|NCT01860079|3887052|FG000|COMPLETED|Overall Study||370
3160013|NCT01860079|3887053|FG001|COMPLETED|Overall Study||363
3160014|NCT01860079|3887052|FG000|NOT COMPLETED|Overall Study||14
3160015|NCT01860079|3887053|FG001|NOT COMPLETED|Overall Study||22
3160016|NCT01860170|3887062|FG000|STARTED|Overall Study||3
3160017|NCT01860170|3887063|FG001|STARTED|Overall Study||3
3160018|NCT01860170|3887064|FG002|STARTED|Overall Study||22
3160019|NCT01860170|3887062|FG000|COMPLETED|Overall Study||3
3160020|NCT01860170|3887063|FG001|COMPLETED|Overall Study||3
3160021|NCT01860170|3887064|FG002|COMPLETED|Overall Study||22
3160022|NCT01860170|3887062|FG000|NOT COMPLETED|Overall Study||0
3160023|NCT01860170|3887063|FG001|NOT COMPLETED|Overall Study||0
3160024|NCT01860170|3887064|FG002|NOT COMPLETED|Overall Study||0
3160025|NCT01860287|3887075|FG000|STARTED|Overall Study||18
3160026|NCT01860287|3887076|FG001|STARTED|Overall Study||15
3160027|NCT01860287|3887077|FG002|STARTED|Overall Study||15
3160028|NCT01860287|3887075|FG000|COMPLETED|Overall Study||18
3160029|NCT01860287|3887076|FG001|COMPLETED|Overall Study||15
3160030|NCT01860287|3887077|FG002|COMPLETED|Overall Study||15
3160031|NCT01860287|3887075|FG000|NOT COMPLETED|Overall Study||0
3160032|NCT01860287|3887076|FG001|NOT COMPLETED|Overall Study||0
3160033|NCT01860287|3887077|FG002|NOT COMPLETED|Overall Study||0
3160034|NCT01860521|3887087|FG000|STARTED|Overall Study|September 2011|52
3160035|NCT01860521|3887088|FG001|STARTED|Overall Study|September 2011|52
3160036|NCT01860521|3887087|FG000|COMPLETED|Overall Study|June 2013|52
3160037|NCT01860521|3887088|FG001|COMPLETED|Overall Study|June 2013|52
3160038|NCT01860521|3887087|FG000|NOT COMPLETED|Overall Study||0
3160039|NCT01860521|3887088|FG001|NOT COMPLETED|Overall Study||0
3160040|NCT01860534|3887096|FG000|STARTED|ROP #1||14
3160041|NCT01860534|3887097|FG001|STARTED|ROP #1||14
3160042|NCT01860534|3887096|FG000|COMPLETED|ROP #1||14
3160043|NCT01860534|3887097|FG001|COMPLETED|ROP #1||13
3160044|NCT01860534|3887096|FG000|NOT COMPLETED|ROP #1||0
3160045|NCT01860534|3887097|FG001|NOT COMPLETED|ROP #1||1
3160046|NCT01860534|3887096|FG000|STARTED|ROP #2||14
3160047|NCT01860534|3887097|FG001|STARTED|ROP #2||13
3160048|NCT01860534|3887096|FG000|COMPLETED|ROP #2||13
3160049|NCT01860534|3887097|FG001|COMPLETED|ROP #2||13
3160050|NCT01860534|3887096|FG000|NOT COMPLETED|ROP #2||1
3160051|NCT01860534|3887097|FG001|NOT COMPLETED|ROP #2||0
3160052|NCT01860573|3887107|FG000|STARTED|Overall Study||83
3160053|NCT01860573|3887108|FG001|STARTED|Overall Study||85
3160054|NCT01860573|3887107|FG000|COMPLETED|Overall Study||83
3160055|NCT01860573|3887108|FG001|COMPLETED|Overall Study||85
3160056|NCT01860573|3887107|FG000|NOT COMPLETED|Overall Study||0
3160057|NCT01860573|3887108|FG001|NOT COMPLETED|Overall Study||0
3160058|NCT01860586|3887114|FG000|STARTED|Overall Study||20
3160059|NCT01860586|3887114|FG000|COMPLETED|Overall Study||20
3160060|NCT01860586|3887114|FG000|NOT COMPLETED|Overall Study||0
3160061|NCT01860651|3887121|FG000|STARTED|Overall Study||56
3160062|NCT01860651|3887122|FG001|STARTED|Overall Study||47
3160063|NCT01860651|3887121|FG000|COMPLETED|Overall Study||31
3160064|NCT01860651|3887122|FG001|COMPLETED|Overall Study||39
3160065|NCT01860651|3887121|FG000|NOT COMPLETED|Overall Study||25
3160066|NCT01860651|3887122|FG001|NOT COMPLETED|Overall Study||8
3160067|NCT01860677|3887134|FG000|STARTED|First Intervention (1 Day)||8
3160068|NCT01860677|3887135|FG001|STARTED|First Intervention (1 Day)||0
3160069|NCT01860677|3887134|FG000|COMPLETED|First Intervention (1 Day)||8
3160070|NCT01860677|3887135|FG001|COMPLETED|First Intervention (1 Day)||0
3160071|NCT01860677|3887134|FG000|NOT COMPLETED|First Intervention (1 Day)||0
3160072|NCT01860677|3887135|FG001|NOT COMPLETED|First Intervention (1 Day)||0
3160073|NCT01860677|3887134|FG000|STARTED|Second Intervention (1 Day)||8
3160074|NCT01860677|3887135|FG001|STARTED|Second Intervention (1 Day)||0
3160075|NCT01860677|3887134|FG000|COMPLETED|Second Intervention (1 Day)||1
3160076|NCT01860677|3887135|FG001|COMPLETED|Second Intervention (1 Day)||0
3160077|NCT01860677|3887134|FG000|NOT COMPLETED|Second Intervention (1 Day)||7
3160078|NCT01860677|3887135|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
3160079|NCT01860703|3887142|FG000|STARTED|Overall Study||13
3160080|NCT01860703|3887143|FG001|STARTED|Overall Study||13
3160081|NCT01860703|3887144|FG002|STARTED|Overall Study||12
3160082|NCT01860703|3887145|FG003|STARTED|Overall Study||12
3160083|NCT01860703|3887142|FG000|COMPLETED|Overall Study||11
3160084|NCT01860703|3887143|FG001|COMPLETED|Overall Study||8
3160085|NCT01860703|3887144|FG002|COMPLETED|Overall Study||11
3160086|NCT01860703|3887145|FG003|COMPLETED|Overall Study||10
3160087|NCT01860703|3887142|FG000|NOT COMPLETED|Overall Study||2
3160088|NCT01860703|3887143|FG001|NOT COMPLETED|Overall Study||5
3160089|NCT01860703|3887144|FG002|NOT COMPLETED|Overall Study||1
3160090|NCT01860703|3887145|FG003|NOT COMPLETED|Overall Study||2
3160091|NCT01860807|3887163|FG000|STARTED|Overall Study||64
3160092|NCT01860807|3887164|FG001|STARTED|Overall Study||61
3160093|NCT01860807|3887163|FG000|COMPLETED|Overall Study||34
3160094|NCT01860807|3887164|FG001|COMPLETED|Overall Study||32
3160095|NCT01860807|3887163|FG000|NOT COMPLETED|Overall Study||30
3160096|NCT01860807|3887164|FG001|NOT COMPLETED|Overall Study||29
3160097|NCT01860846|3887170|FG000|STARTED|Overall Study||106
3160098|NCT01860846|3887170|FG000|Month 1|Overall Study||97
3160099|NCT01860846|3887170|FG000|Month 2|Overall Study||83
3160100|NCT01860846|3887170|FG000|Month 4|Overall Study||82
3160101|NCT01860846|3887170|FG000|Month 6|Overall Study||85
3160102|NCT01860846|3887170|FG000|Month 12|Overall Study||73
3160103|NCT01860846|3887170|FG000|COMPLETED|Overall Study||73
3160104|NCT01860846|3887170|FG000|NOT COMPLETED|Overall Study||33
3160105|NCT01860950|3887180|FG000|STARTED|Overall Study||14
3160106|NCT01860950|3887181|FG001|STARTED|Overall Study||15
3160107|NCT01860950|3887182|FG002|STARTED|Overall Study||10
3160108|NCT01860950|3887183|FG003|STARTED|Overall Study||13
3160109|NCT01860950|3887184|FG004|STARTED|Overall Study||14
3160110|NCT01860950|3887185|FG005|STARTED|Overall Study||13
3160111|NCT01860950|3887180|FG000|COMPLETED|Overall Study||14
3160112|NCT01860950|3887181|FG001|COMPLETED|Overall Study||15
3160113|NCT01860950|3887182|FG002|COMPLETED|Overall Study||10
3160114|NCT01860950|3887183|FG003|COMPLETED|Overall Study||13
3160115|NCT01860950|3887184|FG004|COMPLETED|Overall Study||14
3160116|NCT01860950|3887185|FG005|COMPLETED|Overall Study||13
3160117|NCT01860950|3887180|FG000|NOT COMPLETED|Overall Study||0
3160118|NCT01860950|3887181|FG001|NOT COMPLETED|Overall Study||0
3160119|NCT01860950|3887182|FG002|NOT COMPLETED|Overall Study||0
3160120|NCT01860950|3887183|FG003|NOT COMPLETED|Overall Study||0
3160121|NCT01860950|3887184|FG004|NOT COMPLETED|Overall Study||0
3160122|NCT01860950|3887185|FG005|NOT COMPLETED|Overall Study||0
3160123|NCT01860976|3887202|FG000|STARTED|Blinded Treatment||213
3160124|NCT01860976|3887203|FG001|STARTED|Blinded Treatment||211
3160125|NCT01860976|3887202|FG000|COMPLETED|Blinded Treatment||125
3160126|NCT01860976|3887203|FG001|COMPLETED|Blinded Treatment||98
3160127|NCT01860976|3887202|FG000|NOT COMPLETED|Blinded Treatment||88
3160128|NCT01860976|3887203|FG001|NOT COMPLETED|Blinded Treatment||113
3160129|NCT01860976|3887202|FG000|STARTED|Open-Label||197
3160130|NCT01860976|3887203|FG001|STARTED|Open-Label||185
3160131|NCT01860976|3887202|FG000|COMPLETED|Open-Label||123
3160132|NCT01860976|3887203|FG001|COMPLETED|Open-Label||121
3160133|NCT01860976|3887202|FG000|NOT COMPLETED|Open-Label||74
3160134|NCT01860976|3887203|FG001|NOT COMPLETED|Open-Label||64
3160135|NCT01860976|3887202|FG000|STARTED|Long Term Extension||113
3160136|NCT01860976|3887203|FG001|STARTED|Long Term Extension||115
3160137|NCT01860976|3887202|FG000|COMPLETED|Long Term Extension||0
3160138|NCT01860976|3887203|FG001|COMPLETED|Long Term Extension||8
3160139|NCT01860976|3887202|FG000|NOT COMPLETED|Long Term Extension||113
3160140|NCT01860976|3887203|FG001|NOT COMPLETED|Long Term Extension||107
3160141|NCT01860989|3887209|FG000|STARTED|Overall Study||11
3160142|NCT01860989|3887209|FG000|COMPLETED|Overall Study||6
3160143|NCT01860989|3887209|FG000|NOT COMPLETED|Overall Study||5
3160144|NCT01861002|3887213|FG000|STARTED|Overall Study||15
3160145|NCT01861002|3887213|FG000|COMPLETED|Overall Study||14
3160146|NCT01861002|3887213|FG000|NOT COMPLETED|Overall Study||1
3160147|NCT01861028|3887221|FG000|STARTED|Overall Study||44
3160148|NCT01861028|3887221|FG000|COMPLETED|Overall Study||44
3160149|NCT01861028|3887221|FG000|NOT COMPLETED|Overall Study||0
3160150|NCT01861054|3887228|FG000|STARTED|Overall Study||18
3160151|NCT01861054|3887229|FG001|STARTED|Overall Study||2
3160152|NCT01861054|3887228|FG000|Safety Population|Overall Study||18
3160153|NCT01861054|3887229|FG001|Safety Population|Overall Study||2
3160154|NCT01861054|3887228|FG000|PK Population|Overall Study||4
3160155|NCT01861054|3887229|FG001|PK Population|Overall Study||2
3160156|NCT01861054|3887228|FG000|COMPLETED|Overall Study||18
3160157|NCT01861054|3887229|FG001|COMPLETED|Overall Study||2
3160158|NCT01861054|3887228|FG000|NOT COMPLETED|Overall Study||0
3160159|NCT01861054|3887229|FG001|NOT COMPLETED|Overall Study||0
3160160|NCT01861301|3887238|FG000|STARTED|Overall Study||18
3160161|NCT01861301|3887238|FG000|COMPLETED|Overall Study||18
3160162|NCT01861301|3887238|FG000|NOT COMPLETED|Overall Study||0
3160163|NCT01861457|3887245|FG000|STARTED|Overall Study||20
3160164|NCT01861457|3887246|FG001|STARTED|Overall Study||19
3160165|NCT01861457|3887245|FG000|COMPLETED|Overall Study||20
3160166|NCT01861457|3887246|FG001|COMPLETED|Overall Study||19
3160167|NCT01861457|3887245|FG000|NOT COMPLETED|Overall Study||0
3160168|NCT01861457|3887246|FG001|NOT COMPLETED|Overall Study||0
3160169|NCT01861522|3887254|FG000|STARTED|Overall Study||240
3160170|NCT01861522|3887255|FG001|STARTED|Overall Study|One subject who did not receive any study drug was excluded from the FAS and the Safety Analysis Set|232
3160171|NCT01861522|3887254|FG000|COMPLETED|Overall Study||237
3160172|NCT01861522|3887255|FG001|COMPLETED|Overall Study||232
3160173|NCT01861522|3887254|FG000|NOT COMPLETED|Overall Study||3
3160174|NCT01861522|3887255|FG001|NOT COMPLETED|Overall Study||0
3160175|NCT01861574|3887265|FG000|STARTED|Overall Study||28
3160176|NCT01861574|3887266|FG001|STARTED|Overall Study||25
3160177|NCT01861574|3887267|FG002|STARTED|Overall Study||27
3160178|NCT01861574|3887268|FG003|STARTED|Overall Study||28
3160179|NCT01861574|3887265|FG000|COMPLETED|Overall Study||28
3160180|NCT01861574|3887266|FG001|COMPLETED|Overall Study||25
3160181|NCT01861574|3887267|FG002|COMPLETED|Overall Study||27
3160182|NCT01861574|3887268|FG003|COMPLETED|Overall Study||28
3160183|NCT01861574|3887265|FG000|NOT COMPLETED|Overall Study||0
3160184|NCT01861574|3887266|FG001|NOT COMPLETED|Overall Study||0
3160185|NCT01861574|3887267|FG002|NOT COMPLETED|Overall Study||0
3160186|NCT01861574|3887268|FG003|NOT COMPLETED|Overall Study||0
3160187|NCT01861587|3887283|FG000|STARTED|Overall Study||14
3160188|NCT01861587|3887284|FG001|STARTED|Overall Study||13
3160189|NCT01861587|3887283|FG000|COMPLETED|Overall Study||14
3160190|NCT01861587|3887284|FG001|COMPLETED|Overall Study||13
3160191|NCT01861587|3887283|FG000|NOT COMPLETED|Overall Study||0
3160192|NCT01861587|3887284|FG001|NOT COMPLETED|Overall Study||0
3160193|NCT01861665|3887296|FG000|STARTED|Overall Study||10
3160194|NCT01861665|3887297|FG001|STARTED|Overall Study||17
3160195|NCT01861665|3887296|FG000|COMPLETED|Overall Study||10
3160196|NCT01861665|3887297|FG001|COMPLETED|Overall Study||17
3160197|NCT01861665|3887296|FG000|NOT COMPLETED|Overall Study||0
3160198|NCT01861665|3887297|FG001|NOT COMPLETED|Overall Study||0
3160199|NCT01861704|3887305|FG000|STARTED|Overall Study||70
3160200|NCT01861704|3887306|FG001|STARTED|Overall Study||107
3160201|NCT01861704|3887305|FG000|COMPLETED|Overall Study||67
3160202|NCT01861704|3887306|FG001|COMPLETED|Overall Study||104
3160203|NCT01861704|3887305|FG000|NOT COMPLETED|Overall Study||3
3160204|NCT01861704|3887306|FG001|NOT COMPLETED|Overall Study||3
3160205|NCT01861756|3887314|FG000|STARTED|Overall Study||101
3160206|NCT01861756|3887315|FG001|STARTED|Overall Study||103
3160207|NCT01861756|3887314|FG000|COMPLETED|Overall Study||88
3160208|NCT01861756|3887315|FG001|COMPLETED|Overall Study||85
3160209|NCT01861756|3887314|FG000|NOT COMPLETED|Overall Study||13
3160210|NCT01861756|3887315|FG001|NOT COMPLETED|Overall Study||18
3160211|NCT01861925|3887324|FG000|STARTED|Overall Study||34
3160212|NCT01861925|3887325|FG001|STARTED|Overall Study||8
3160213|NCT01861925|3887326|FG002|STARTED|Overall Study||8
3160214|NCT01861925|3887324|FG000|COMPLETED|Overall Study||34
3160215|NCT01861925|3887325|FG001|COMPLETED|Overall Study||8
3160216|NCT01861925|3887326|FG002|COMPLETED|Overall Study||8
3160217|NCT01861925|3887324|FG000|NOT COMPLETED|Overall Study||0
3160218|NCT01861925|3887325|FG001|NOT COMPLETED|Overall Study||0
3160219|NCT01861925|3887326|FG002|NOT COMPLETED|Overall Study||0
3160220|NCT01862029|3887335|FG000|STARTED|Overall Study||9
3271841|NCT02677116|4007155|FG005|STARTED|Overall Study||13
3271842|NCT02677116|4007156|FG006|STARTED|Overall Study||6
3271843|NCT02677116|4007157|FG007|STARTED|Overall Study||4
3271844|NCT02677116|4007158|FG008|STARTED|Overall Study||4
3271845|NCT02677116|4007150|FG000|Cycle 1 Olaratumab Alone|Overall Study||10
3271846|NCT02677116|4007151|FG001|Cycle 1 Olaratumab Alone|Overall Study||11
3271847|NCT02677116|4007152|FG002|Cycle 1 Olaratumab Alone|Overall Study||9
3047428|NCT01201967|3767342|FG000|STARTED|Overall Study||92
3047429|NCT01201967|3767343|FG001|STARTED|Overall Study||91
3047430|NCT01201967|3767342|FG000|COMPLETED|Overall Study||86
3047431|NCT01201967|3767343|FG001|COMPLETED|Overall Study||86
3047432|NCT01201967|3767342|FG000|NOT COMPLETED|Overall Study||6
3047433|NCT01201967|3767343|FG001|NOT COMPLETED|Overall Study||5
3047434|NCT01202071|3767350|FG000|STARTED|Overall Study||6
3047435|NCT01202071|3767351|FG001|STARTED|Overall Study||6
3047436|NCT01202071|3767352|FG002|STARTED|Overall Study||6
3047437|NCT01202071|3767353|FG003|STARTED|Overall Study||6
3047438|NCT01202071|3767350|FG000|COMPLETED|Overall Study||6
3047439|NCT01202071|3767351|FG001|COMPLETED|Overall Study||6
3047440|NCT01202071|3767352|FG002|COMPLETED|Overall Study||6
3047441|NCT01202071|3767353|FG003|COMPLETED|Overall Study||6
3047442|NCT01202071|3767350|FG000|NOT COMPLETED|Overall Study||0
3047443|NCT01202071|3767351|FG001|NOT COMPLETED|Overall Study||0
3047444|NCT01202071|3767352|FG002|NOT COMPLETED|Overall Study||0
3047445|NCT01202071|3767353|FG003|NOT COMPLETED|Overall Study||0
3047446|NCT01202162|3767365|FG000|STARTED|Overall Study||43
3047447|NCT01202162|3767366|FG001|STARTED|Overall Study||42
3047448|NCT01202162|3767365|FG000|COMPLETED|Overall Study|40 completed the intraoperative through discharge phase of the study.|40
3047449|NCT01202162|3767366|FG001|COMPLETED|Overall Study|40 completed the intraoperative through discharge phase of the study.|40
3047450|NCT01202162|3767365|FG000|NOT COMPLETED|Overall Study||3
3047451|NCT01202162|3767366|FG001|NOT COMPLETED|Overall Study||2
3047452|NCT01202175|3767374|FG000|STARTED|Overall Study||50
3047453|NCT01202175|3767374|FG000|Nebivolol|Overall Study||25
3047454|NCT01202175|3767374|FG000|Pacebo|Overall Study||25
3160221|NCT01862029|3887335|FG000|COMPLETED|Overall Study||8
3160222|NCT01862029|3887335|FG000|NOT COMPLETED|Overall Study||1
3160223|NCT01862133|3887340|FG000|STARTED|Overall Study||105
3160224|NCT01862133|3887341|FG001|STARTED|Overall Study||31
3047455|NCT01202175|3767374|FG000|COMPLETED|Overall Study||45
3047456|NCT01202175|3767374|FG000|NOT COMPLETED|Overall Study||5
3047457|NCT01202188|3767384|FG000|STARTED|Overall Study||475
3047458|NCT01202188|3767385|FG001|STARTED|Overall Study||477
3047459|NCT01202188|3767386|FG002|STARTED|Overall Study||475
3047460|NCT01202188|3767387|FG003|STARTED|Overall Study||483
3047461|NCT01202188|3767388|FG004|STARTED|Overall Study||234
3047462|NCT01202188|3767384|FG000|Safety Set; Received Study Drug|Overall Study||474
3047463|NCT01202188|3767385|FG001|Safety Set; Received Study Drug|Overall Study||476
3047464|NCT01202188|3767386|FG002|Safety Set; Received Study Drug|Overall Study||473
3047465|NCT01202188|3767387|FG003|Safety Set; Received Study Drug|Overall Study||480
3047466|NCT01202188|3767388|FG004|Safety Set; Received Study Drug|Overall Study||232
3047467|NCT01202188|3767384|FG000|COMPLETED|Overall Study||437
3047468|NCT01202188|3767385|FG001|COMPLETED|Overall Study||421
3271848|NCT02677116|4007153|FG003|Cycle 1 Olaratumab Alone|Overall Study||10
3271849|NCT02677116|4007154|FG004|Cycle 1 Olaratumab Alone|Overall Study||1
3271850|NCT02677116|4007155|FG005|Cycle 1 Olaratumab Alone|Overall Study||13
3271851|NCT02677116|4007156|FG006|Cycle 1 Olaratumab Alone|Overall Study||6
3271852|NCT02677116|4007157|FG007|Cycle 1 Olaratumab Alone|Overall Study||4
3271853|NCT02677116|4007158|FG008|Cycle 1 Olaratumab Alone|Overall Study||4
3271854|NCT02677116|4007150|FG000|Progressive Disease|Overall Study||7
3271855|NCT02677116|4007151|FG001|Progressive Disease|Overall Study||7
3271856|NCT02677116|4007152|FG002|Progressive Disease|Overall Study||6
3047469|NCT01202188|3767386|FG002|COMPLETED|Overall Study||422
3047470|NCT01202188|3767387|FG003|COMPLETED|Overall Study||441
3047471|NCT01202188|3767388|FG004|COMPLETED|Overall Study||189
3047472|NCT01202188|3767384|FG000|NOT COMPLETED|Overall Study||38
3047473|NCT01202188|3767385|FG001|NOT COMPLETED|Overall Study||56
3047474|NCT01202188|3767386|FG002|NOT COMPLETED|Overall Study||53
3047475|NCT01202188|3767387|FG003|NOT COMPLETED|Overall Study||42
3047476|NCT01202188|3767388|FG004|NOT COMPLETED|Overall Study||45
3047477|NCT01202227|3767406|FG000|STARTED|Overall Study|Treated|103
3047478|NCT01202227|3767406|FG000|COMPLETED|Overall Study||84
3047479|NCT01202227|3767406|FG000|NOT COMPLETED|Overall Study||19
3047480|NCT01202253|3767410|FG000|STARTED|Overall Study||50
3047481|NCT01202253|3767410|FG000|COMPLETED|Overall Study||50
3047482|NCT01202253|3767410|FG000|NOT COMPLETED|Overall Study||0
3047483|NCT01202279|3767416|FG000|STARTED|Overall Study||591
3047484|NCT01202279|3767417|FG001|STARTED|Overall Study||588
3047485|NCT01202279|3767416|FG000|COMPLETED|Overall Study||554
3047486|NCT01202279|3767417|FG001|COMPLETED|Overall Study||561
3047487|NCT01202279|3767416|FG000|NOT COMPLETED|Overall Study||37
3047488|NCT01202279|3767417|FG001|NOT COMPLETED|Overall Study||27
3047489|NCT01202409|3767423|FG000|STARTED|Overall Study||19
3047490|NCT01202409|3767423|FG000|COMPLETED|Overall Study||11
3047491|NCT01202409|3767423|FG000|NOT COMPLETED|Overall Study||8
3047492|NCT01202565|3767427|FG000|STARTED|Overall Study||506
3047493|NCT01202565|3767427|FG000|Full Analysis Set|Overall Study|Participants with a signed informed consent and any available data regarding adalimumab treatment.|501
3047494|NCT01202565|3767427|FG000|COMPLETED|Overall Study|Indicates participants who completed the Month 12 visit|439
3047495|NCT01202565|3767427|FG000|NOT COMPLETED|Overall Study||67
3271857|NCT02677116|4007153|FG003|Progressive Disease|Overall Study||7
3271858|NCT02677116|4007154|FG004|Progressive Disease|Overall Study||0
3271859|NCT02677116|4007155|FG005|Progressive Disease|Overall Study||9
3271860|NCT02677116|4007156|FG006|Progressive Disease|Overall Study||2
3271861|NCT02677116|4007157|FG007|Progressive Disease|Overall Study||2
3271862|NCT02677116|4007158|FG008|Progressive Disease|Overall Study||2
3271863|NCT02677116|4007150|FG000|COMPLETED|Overall Study||7
3271864|NCT02677116|4007151|FG001|COMPLETED|Overall Study||7
3271865|NCT02677116|4007152|FG002|COMPLETED|Overall Study||6
3271866|NCT02677116|4007153|FG003|COMPLETED|Overall Study||7
3271867|NCT02677116|4007154|FG004|COMPLETED|Overall Study||0
3271868|NCT02677116|4007155|FG005|COMPLETED|Overall Study||9
3271869|NCT02677116|4007156|FG006|COMPLETED|Overall Study||2
3271870|NCT02677116|4007157|FG007|COMPLETED|Overall Study||2
3271871|NCT02677116|4007158|FG008|COMPLETED|Overall Study||2
3047496|NCT01202578|3767431|FG000|STARTED|Overall Study||53
3047497|NCT01202578|3767431|FG000|COMPLETED|Overall Study||53
3047498|NCT01202578|3767431|FG000|NOT COMPLETED|Overall Study||0
3047499|NCT01202591|3767441|FG000|STARTED|Overall Study||5
3047500|NCT01202591|3767442|FG001|STARTED|Overall Study||5
3047501|NCT01202591|3767443|FG002|STARTED|Overall Study||12
3047502|NCT01202591|3767444|FG003|STARTED|Overall Study||9
3047503|NCT01202591|3767445|FG004|STARTED|Overall Study||5
3047504|NCT01202591|3767446|FG005|STARTED|Overall Study||4
3047505|NCT01202591|3767441|FG000|COMPLETED|Overall Study||0
3047506|NCT01202591|3767442|FG001|COMPLETED|Overall Study||0
3047507|NCT01202591|3767443|FG002|COMPLETED|Overall Study||1
3047508|NCT01202591|3767444|FG003|COMPLETED|Overall Study||2
3047509|NCT01202591|3767445|FG004|COMPLETED|Overall Study||0
3047510|NCT01202591|3767446|FG005|COMPLETED|Overall Study||0
3047511|NCT01202591|3767441|FG000|NOT COMPLETED|Overall Study||5
3047512|NCT01202591|3767442|FG001|NOT COMPLETED|Overall Study||5
3047513|NCT01202591|3767443|FG002|NOT COMPLETED|Overall Study||11
3047514|NCT01202591|3767444|FG003|NOT COMPLETED|Overall Study||7
3271872|NCT02677116|4007150|FG000|NOT COMPLETED|Overall Study||3
3271873|NCT02677116|4007151|FG001|NOT COMPLETED|Overall Study||4
3271874|NCT02677116|4007152|FG002|NOT COMPLETED|Overall Study||3
3271875|NCT02677116|4007153|FG003|NOT COMPLETED|Overall Study||3
3271876|NCT02677116|4007154|FG004|NOT COMPLETED|Overall Study||1
3271877|NCT02677116|4007155|FG005|NOT COMPLETED|Overall Study||4
3271878|NCT02677116|4007156|FG006|NOT COMPLETED|Overall Study||4
3271879|NCT02677116|4007157|FG007|NOT COMPLETED|Overall Study||2
3271880|NCT02677116|4007158|FG008|NOT COMPLETED|Overall Study||2
3271881|NCT02677220|4007201|FG000|STARTED|Overall Study||1
3271882|NCT02677220|4007201|FG000|COMPLETED|Overall Study||0
3271883|NCT02677220|4007201|FG000|NOT COMPLETED|Overall Study||1
3271884|NCT02677324|4007206|FG000|STARTED|Overall Study||33
3271885|NCT02677324|4007206|FG000|COMPLETED|Overall Study||21
3271886|NCT02677324|4007206|FG000|NOT COMPLETED|Overall Study||12
3271887|NCT02677428|4007214|FG000|STARTED|Overall Study||63
3271888|NCT02677428|4007215|FG001|STARTED|Overall Study||55
3271889|NCT02677428|4007214|FG000|COMPLETED|Overall Study||63
3271890|NCT02677428|4007215|FG001|COMPLETED|Overall Study||55
3271891|NCT02677428|4007214|FG000|NOT COMPLETED|Overall Study||0
3271892|NCT02677428|4007215|FG001|NOT COMPLETED|Overall Study||0
3047515|NCT01202591|3767445|FG004|NOT COMPLETED|Overall Study||5
3047516|NCT01202591|3767446|FG005|NOT COMPLETED|Overall Study||4
3047517|NCT01202643|3767462|FG000|STARTED|Period 1||6
3047518|NCT01202643|3767463|FG001|STARTED|Period 1||6
3047519|NCT01202643|3767462|FG000|COMPLETED|Period 1||6
3047520|NCT01202643|3767463|FG001|COMPLETED|Period 1||6
3047521|NCT01202643|3767462|FG000|NOT COMPLETED|Period 1||0
3047522|NCT01202643|3767463|FG001|NOT COMPLETED|Period 1||0
3047523|NCT01202643|3767462|FG000|STARTED|Crossover Cycle|One patient became pregnant following Period 1, Only one non-pregnant chose to cycle again|1
3047524|NCT01202643|3767463|FG001|STARTED|Crossover Cycle|Three patients became pregnant after Period 1, 1 patient chose not to cycle again|2
3047525|NCT01202643|3767462|FG000|COMPLETED|Crossover Cycle||1
3047526|NCT01202643|3767463|FG001|COMPLETED|Crossover Cycle||2
3047527|NCT01202643|3767462|FG000|NOT COMPLETED|Crossover Cycle||0
3047528|NCT01202643|3767463|FG001|NOT COMPLETED|Crossover Cycle||0
3160225|NCT01862133|3887340|FG000|Returned During 6 mo Study|Overall Study||92
3160226|NCT01862133|3887341|FG001|Returned During 6 mo Study|Overall Study||31
3160227|NCT01862133|3887340|FG000|COMPLETED|Overall Study|All 105 patients recorded preferences; 92 (88%) returned to the study clinic during the 6 mo. study|105
3160228|NCT01862133|3887341|FG001|COMPLETED|Overall Study||31
3160229|NCT01862133|3887340|FG000|NOT COMPLETED|Overall Study||0
3160230|NCT01862133|3887341|FG001|NOT COMPLETED|Overall Study||0
3160231|NCT01862159|3887347|FG000|STARTED|Overall Study||25038
3160232|NCT01862159|3887347|FG000|COMPLETED|Overall Study||25038
3160233|NCT01862159|3887347|FG000|NOT COMPLETED|Overall Study||0
3160234|NCT01862250|3887351|FG000|STARTED|Overall Study||12
3160235|NCT01862250|3887351|FG000|COMPLETED|Overall Study||8
3160236|NCT01862250|3887351|FG000|NOT COMPLETED|Overall Study||4
3160237|NCT01862328|3887362|FG000|STARTED|Overall Study||4
3160238|NCT01862328|3887363|FG001|STARTED|Overall Study||18
3160239|NCT01862328|3887364|FG002|STARTED|Overall Study||6
3160240|NCT01862328|3887365|FG003|STARTED|Overall Study||7
3160241|NCT01862328|3887366|FG004|STARTED|Overall Study||12
3160242|NCT01862328|3887367|FG005|STARTED|Overall Study||7
3160243|NCT01862328|3887368|FG006|STARTED|Overall Study||10
3160244|NCT01862328|3887362|FG000|COMPLETED|Overall Study||0
3160245|NCT01862328|3887363|FG001|COMPLETED|Overall Study||0
3160246|NCT01862328|3887364|FG002|COMPLETED|Overall Study||0
3160247|NCT01862328|3887365|FG003|COMPLETED|Overall Study||0
3160248|NCT01862328|3887366|FG004|COMPLETED|Overall Study||0
3160249|NCT01862328|3887367|FG005|COMPLETED|Overall Study||0
3160250|NCT01862328|3887368|FG006|COMPLETED|Overall Study||0
3160251|NCT01862328|3887362|FG000|NOT COMPLETED|Overall Study||4
3160252|NCT01862328|3887363|FG001|NOT COMPLETED|Overall Study||18
3160253|NCT01862328|3887364|FG002|NOT COMPLETED|Overall Study||6
3160254|NCT01862328|3887365|FG003|NOT COMPLETED|Overall Study||7
3160255|NCT01862328|3887366|FG004|NOT COMPLETED|Overall Study||12
3160256|NCT01862328|3887367|FG005|NOT COMPLETED|Overall Study||7
3160257|NCT01862328|3887368|FG006|NOT COMPLETED|Overall Study||10
3160258|NCT01862419|3887392|FG000|STARTED|Overall Study||1201
3160259|NCT01862419|3887393|FG001|STARTED|Overall Study||1192
3160260|NCT01862419|3887392|FG000|COMPLETED|Overall Study||1201
3160261|NCT01862419|3887393|FG001|COMPLETED|Overall Study||1192
3160262|NCT01862419|3887392|FG000|NOT COMPLETED|Overall Study||0
3160263|NCT01862419|3887393|FG001|NOT COMPLETED|Overall Study||0
3160264|NCT01862484|3887401|FG000|STARTED|Overall Study||15
3160265|NCT01862484|3887402|FG001|STARTED|Overall Study||14
3160266|NCT01862484|3887401|FG000|COMPLETED|Overall Study||13
3160267|NCT01862484|3887402|FG001|COMPLETED|Overall Study||6
3160268|NCT01862484|3887401|FG000|NOT COMPLETED|Overall Study||2
3160269|NCT01862484|3887402|FG001|NOT COMPLETED|Overall Study||8
3160270|NCT01862536|3887410|FG000|STARTED|Overall Study||13
3160271|NCT01862536|3887411|FG001|STARTED|Overall Study||23
3160272|NCT01862536|3887410|FG000|COMPLETED|Overall Study||10
3160273|NCT01862536|3887411|FG001|COMPLETED|Overall Study||16
3160274|NCT01862536|3887410|FG000|NOT COMPLETED|Overall Study||3
3160275|NCT01862536|3887411|FG001|NOT COMPLETED|Overall Study||7
3160276|NCT01862614|3887419|FG000|STARTED|First Appointment.|Received articaine injection at first appointment.|40
3160277|NCT01862614|3887420|FG001|STARTED|First Appointment.|Received buffered articaine at first appointment.|40
3160278|NCT01862614|3887419|FG000|COMPLETED|First Appointment.||40
3160279|NCT01862614|3887420|FG001|COMPLETED|First Appointment.||40
3271893|NCT02677493|4007224|FG000|STARTED|Overall Study||1197
3271894|NCT02677493|4007225|FG001|STARTED|Overall Study||298
3271895|NCT02677493|4007226|FG002|STARTED|Overall Study||299
3271896|NCT02677493|4007224|FG000|COMPLETED|Overall Study||1186
3047529|NCT01202656|3767471|FG000|STARTED|Cycle 1|Results reported In Barad et al 2014 are combined from both G-CSF studies|67
3047530|NCT01202656|3767472|FG001|STARTED|Cycle 1|Results reported In Barad et al 2014 are combined from both G-CSF studies|62
3047531|NCT01202656|3767471|FG000|COMPLETED|Cycle 1||67
3047532|NCT01202656|3767472|FG001|COMPLETED|Cycle 1||62
3047533|NCT01202656|3767471|FG000|NOT COMPLETED|Cycle 1||0
3047534|NCT01202656|3767472|FG001|NOT COMPLETED|Cycle 1||0
3047535|NCT01202656|3767471|FG000|STARTED|CrossoverCycle|16 ongoing pregnancies were not eligible for crossover, others chose to not have another IVF cycle|18
3047536|NCT01202656|3767472|FG001|STARTED|CrossoverCycle|14 ongoing pregnancies were not eligible for crossover, others chose to not have another IVF cycle|14
3047537|NCT01202656|3767471|FG000|COMPLETED|CrossoverCycle||18
3047538|NCT01202656|3767472|FG001|COMPLETED|CrossoverCycle||14
3047539|NCT01202656|3767471|FG000|NOT COMPLETED|CrossoverCycle||0
3047540|NCT01202656|3767472|FG001|NOT COMPLETED|CrossoverCycle||0
3047541|NCT01202721|3767482|FG000|STARTED|Overall Study||18
3047542|NCT01202721|3767483|FG001|STARTED|Overall Study||26
3047543|NCT01202721|3767484|FG002|STARTED|Overall Study||14
3047544|NCT01202721|3767485|FG003|STARTED|Overall Study||27
3047545|NCT01202721|3767482|FG000|COMPLETED|Overall Study||18
3047546|NCT01202721|3767483|FG001|COMPLETED|Overall Study||26
3047547|NCT01202721|3767484|FG002|COMPLETED|Overall Study||14
3047548|NCT01202721|3767485|FG003|COMPLETED|Overall Study||27
3047549|NCT01202721|3767482|FG000|NOT COMPLETED|Overall Study||0
3047550|NCT01202721|3767483|FG001|NOT COMPLETED|Overall Study||0
3047551|NCT01202721|3767484|FG002|NOT COMPLETED|Overall Study||0
3047552|NCT01202721|3767485|FG003|NOT COMPLETED|Overall Study||0
3047553|NCT01202747|3767497|FG000|STARTED|Overall Study||50
3047554|NCT01202747|3767497|FG000|COMPLETED|Overall Study|One subject did not return for the 4 Week visit due to inconvenience.|49
3047555|NCT01202747|3767497|FG000|NOT COMPLETED|Overall Study||1
3047556|NCT01202760|3767504|FG000|STARTED|Overall Study||379
3047557|NCT01202760|3767505|FG001|STARTED|Overall Study||374
3047558|NCT01202760|3767506|FG002|STARTED|Overall Study||251
3047559|NCT01202760|3767504|FG000|Received at Least One Dose of Study Drug|Overall Study||379
3047560|NCT01202760|3767505|FG001|Received at Least One Dose of Study Drug|Overall Study||371
3047561|NCT01202760|3767506|FG002|Received at Least One Dose of Study Drug|Overall Study||250
3047562|NCT01202760|3767504|FG000|COMPLETED|Overall Study||332
3047563|NCT01202760|3767505|FG001|COMPLETED|Overall Study||322
3047564|NCT01202760|3767506|FG002|COMPLETED|Overall Study||216
3047565|NCT01202760|3767504|FG000|NOT COMPLETED|Overall Study||47
3047566|NCT01202760|3767505|FG001|NOT COMPLETED|Overall Study||52
3047567|NCT01202760|3767506|FG002|NOT COMPLETED|Overall Study||35
3047568|NCT01202773|3767529|FG000|STARTED|Overall Study||153
3047569|NCT01202773|3767530|FG001|STARTED|Overall Study||148
3047570|NCT01202773|3767531|FG002|STARTED|Overall Study||155
3047571|NCT01202773|3767529|FG000|Received at Least 1 Dose of Study Drug|Overall Study||153
3047572|NCT01202773|3767530|FG001|Received at Least 1 Dose of Study Drug|Overall Study||147
3047573|NCT01202773|3767531|FG002|Received at Least 1 Dose of Study Drug|Overall Study||154
3047574|NCT01202773|3767529|FG000|Week 16 NR|Overall Study||23
3047575|NCT01202773|3767530|FG001|Week 16 NR|Overall Study||33
3047576|NCT01202773|3767531|FG002|Week 16 NR|Overall Study||37
3047577|NCT01202773|3767529|FG000|Post-Treatment Follow-Up Population|Overall Study||46
3047578|NCT01202773|3767530|FG001|Post-Treatment Follow-Up Population|Overall Study||36
3047579|NCT01202773|3767531|FG002|Post-Treatment Follow-Up Population|Overall Study||51
3047580|NCT01202773|3767529|FG000|COMPLETED|Overall Study|Those who completed 24-week treatment period including both Week 16 responders and NR.|96
3047581|NCT01202773|3767530|FG001|COMPLETED|Overall Study|Those who completed 24-week treatment period including both Week 16 responders and NR.|105
3047582|NCT01202773|3767531|FG002|COMPLETED|Overall Study|Those who completed 24-week treatment period including both Week 16 responders and NR.|100
3047583|NCT01202773|3767529|FG000|NOT COMPLETED|Overall Study||57
3047584|NCT01202773|3767530|FG001|NOT COMPLETED|Overall Study||43
3047585|NCT01202773|3767531|FG002|NOT COMPLETED|Overall Study||55
3047586|NCT01202877|3767552|FG000|STARTED|Overall Study||6
3047587|NCT01202877|3767553|FG001|STARTED|Overall Study||8
3047588|NCT01202877|3767554|FG002|STARTED|Overall Study||40
3271897|NCT02677493|4007225|FG001|COMPLETED|Overall Study||296
3271898|NCT02677493|4007226|FG002|COMPLETED|Overall Study||296
3271899|NCT02677493|4007224|FG000|NOT COMPLETED|Overall Study||11
3271900|NCT02677493|4007225|FG001|NOT COMPLETED|Overall Study||2
3271901|NCT02677493|4007226|FG002|NOT COMPLETED|Overall Study||3
3271902|NCT02677623|4007241|FG000|STARTED|Overall Study||33
3271903|NCT02677623|4007242|FG001|STARTED|Overall Study||32
3271904|NCT02677623|4007243|FG002|STARTED|Overall Study||32
3271905|NCT02677623|4007244|FG003|STARTED|Overall Study||33
3047589|NCT01202877|3767552|FG000|COMPLETED|Overall Study||6
3047590|NCT01202877|3767553|FG001|COMPLETED|Overall Study||7
3047591|NCT01202877|3767554|FG002|COMPLETED|Overall Study||34
3047592|NCT01202877|3767552|FG000|NOT COMPLETED|Overall Study||0
3047593|NCT01202877|3767553|FG001|NOT COMPLETED|Overall Study||1
3047594|NCT01202877|3767554|FG002|NOT COMPLETED|Overall Study||6
3047595|NCT01202903|3767564|FG000|STARTED|Overall Study||308
3047596|NCT01202903|3767565|FG001|STARTED|Overall Study||308
3047597|NCT01202903|3767564|FG000|Full Analysis Set|Overall Study||306
3047598|NCT01202903|3767565|FG001|Full Analysis Set|Overall Study||302
3047599|NCT01202903|3767564|FG000|Safety Set*|Overall Study||310
3047600|NCT01202903|3767565|FG001|Safety Set*|Overall Study||299
3047601|NCT01202903|3767564|FG000|COMPLETED|Overall Study||297
3271906|NCT02677623|4007241|FG000|COMPLETED|Overall Study||33
3047602|NCT01202903|3767565|FG001|COMPLETED|Overall Study||292
3271907|NCT02677623|4007242|FG001|COMPLETED|Overall Study||32
3271908|NCT02677623|4007243|FG002|COMPLETED|Overall Study||32
3271909|NCT02677623|4007244|FG003|COMPLETED|Overall Study||33
3271910|NCT02677623|4007241|FG000|NOT COMPLETED|Overall Study||0
3271911|NCT02677623|4007242|FG001|NOT COMPLETED|Overall Study||0
3271912|NCT02677623|4007243|FG002|NOT COMPLETED|Overall Study||0
3271913|NCT02677623|4007244|FG003|NOT COMPLETED|Overall Study||0
3271914|NCT02677701|4007256|FG000|STARTED|Overall Study||62
3271915|NCT02677701|4007257|FG001|STARTED|Overall Study||57
3271916|NCT02677701|4007256|FG000|Treated|Overall Study||61
3271917|NCT02677701|4007257|FG001|Treated|Overall Study||54
3271918|NCT02677701|4007256|FG000|COMPLETED|Overall Study||56
3271919|NCT02677701|4007257|FG001|COMPLETED|Overall Study||52
3271920|NCT02677701|4007256|FG000|NOT COMPLETED|Overall Study||6
3271921|NCT02677701|4007257|FG001|NOT COMPLETED|Overall Study||5
3271922|NCT02677714|4007265|FG000|STARTED|Overall Study||12
3271923|NCT02677714|4007266|FG001|STARTED|Overall Study||2
3271924|NCT02677714|4007265|FG000|COMPLETED|Overall Study||10
3271925|NCT02677714|4007266|FG001|COMPLETED|Overall Study||2
3271926|NCT02677714|4007265|FG000|NOT COMPLETED|Overall Study||2
3271927|NCT02677714|4007266|FG001|NOT COMPLETED|Overall Study||0
3271928|NCT02677740|4007274|FG000|STARTED|Overall Study||7
3271929|NCT02677740|4007275|FG001|STARTED|Overall Study||1
3271930|NCT02677740|4007274|FG000|COMPLETED|Overall Study||7
3271931|NCT02677740|4007275|FG001|COMPLETED|Overall Study||1
3271932|NCT02677740|4007274|FG000|NOT COMPLETED|Overall Study||0
3271933|NCT02677740|4007275|FG001|NOT COMPLETED|Overall Study||0
3271934|NCT02677753|4007283|FG000|STARTED|Overall Study||37
3271935|NCT02677753|4007284|FG001|STARTED|Overall Study||38
3271936|NCT02677753|4007283|FG000|COMPLETED|Overall Study||36
3271937|NCT02677753|4007284|FG001|COMPLETED|Overall Study||38
3271938|NCT02677753|4007283|FG000|NOT COMPLETED|Overall Study||1
3271939|NCT02677753|4007284|FG001|NOT COMPLETED|Overall Study||0
3047603|NCT01202903|3767564|FG000|NOT COMPLETED|Overall Study||11
3047604|NCT01202903|3767565|FG001|NOT COMPLETED|Overall Study||16
3047605|NCT01202955|3767573|FG000|STARTED|Period 1: 10 Days||9
3047606|NCT01202955|3767574|FG001|STARTED|Period 1: 10 Days||10
3047607|NCT01202955|3767573|FG000|COMPLETED|Period 1: 10 Days||9
3047608|NCT01202955|3767574|FG001|COMPLETED|Period 1: 10 Days||8
3047609|NCT01202955|3767573|FG000|NOT COMPLETED|Period 1: 10 Days||0
3047610|NCT01202955|3767574|FG001|NOT COMPLETED|Period 1: 10 Days||2
3271940|NCT02677766|4007292|FG000|STARTED|Overall Study||20
3047611|NCT01202955|3767573|FG000|STARTED|Period 2: 7 Days (Wash-Out)||9
3047612|NCT01202955|3767574|FG001|STARTED|Period 2: 7 Days (Wash-Out)||8
3047613|NCT01202955|3767573|FG000|COMPLETED|Period 2: 7 Days (Wash-Out)||9
3047614|NCT01202955|3767574|FG001|COMPLETED|Period 2: 7 Days (Wash-Out)||8
3047615|NCT01202955|3767573|FG000|NOT COMPLETED|Period 2: 7 Days (Wash-Out)||0
3047616|NCT01202955|3767574|FG001|NOT COMPLETED|Period 2: 7 Days (Wash-Out)||0
3047617|NCT01202955|3767573|FG000|STARTED|Period 3: 10 Days||9
3047618|NCT01202955|3767574|FG001|STARTED|Period 3: 10 Days||8
3047619|NCT01202955|3767573|FG000|COMPLETED|Period 3: 10 Days||9
3047620|NCT01202955|3767574|FG001|COMPLETED|Period 3: 10 Days||8
3047621|NCT01202955|3767573|FG000|NOT COMPLETED|Period 3: 10 Days||0
3047622|NCT01202955|3767574|FG001|NOT COMPLETED|Period 3: 10 Days||0
3047623|NCT01202994|3767580|FG000|STARTED|Overall Study||27
3047624|NCT01202994|3767580|FG000|COMPLETED|Overall Study||27
3047625|NCT01202994|3767580|FG000|NOT COMPLETED|Overall Study||0
3047626|NCT01203046|3767587|FG000|STARTED|Overall Study||28
3047627|NCT01203046|3767588|FG001|STARTED|Overall Study||28
3047628|NCT01203046|3767587|FG000|COMPLETED|Overall Study||28
3047629|NCT01203046|3767588|FG001|COMPLETED|Overall Study||28
3047630|NCT01203046|3767587|FG000|NOT COMPLETED|Overall Study||0
3047631|NCT01203046|3767588|FG001|NOT COMPLETED|Overall Study||0
3047632|NCT01203072|3767601|FG000|STARTED|Overall Study||105
3047633|NCT01203072|3767602|FG001|STARTED|Overall Study||106
3160280|NCT01862614|3887419|FG000|NOT COMPLETED|First Appointment.||0
3160281|NCT01862614|3887420|FG001|NOT COMPLETED|First Appointment.||0
3160282|NCT01862614|3887419|FG000|STARTED|2 Week Washout Period.||40
3160283|NCT01862614|3887420|FG001|STARTED|2 Week Washout Period.||40
3160284|NCT01862614|3887419|FG000|COMPLETED|2 Week Washout Period.||40
3160285|NCT01862614|3887420|FG001|COMPLETED|2 Week Washout Period.||40
3160286|NCT01862614|3887419|FG000|NOT COMPLETED|2 Week Washout Period.||0
3160287|NCT01862614|3887420|FG001|NOT COMPLETED|2 Week Washout Period.||0
3160288|NCT01862614|3887419|FG000|STARTED|Second Appointment.|Received buffered articaine at second appointment.|40
3160289|NCT01862614|3887420|FG001|STARTED|Second Appointment.|Received articaine at second appointment.|40
3160290|NCT01862614|3887419|FG000|COMPLETED|Second Appointment.||40
3160291|NCT01862614|3887420|FG001|COMPLETED|Second Appointment.||40
3160292|NCT01862614|3887419|FG000|NOT COMPLETED|Second Appointment.||0
3160293|NCT01862614|3887420|FG001|NOT COMPLETED|Second Appointment.||0
3160294|NCT01862640|3887430|FG000|STARTED|Overall Study||20
3160295|NCT01862640|3887431|FG001|STARTED|Overall Study||137
3160296|NCT01862640|3887432|FG002|STARTED|Overall Study||140
3160297|NCT01862640|3887433|FG003|STARTED|Overall Study||136
3160298|NCT01862640|3887430|FG000|COMPLETED|Overall Study||13
3160299|NCT01862640|3887431|FG001|COMPLETED|Overall Study||121
3160300|NCT01862640|3887432|FG002|COMPLETED|Overall Study||122
3160301|NCT01862640|3887433|FG003|COMPLETED|Overall Study||121
3271941|NCT02677766|4007293|FG001|STARTED|Overall Study||20
3271942|NCT02677766|4007292|FG000|COMPLETED|Overall Study||15
3271943|NCT02677766|4007293|FG001|COMPLETED|Overall Study||17
3047634|NCT01203072|3767603|FG002|STARTED|Overall Study||104
3047635|NCT01203072|3767604|FG003|STARTED|Overall Study||106
3047636|NCT01203072|3767605|FG004|STARTED|Overall Study||102
3047637|NCT01203072|3767601|FG000|COMPLETED|Overall Study||95
3047638|NCT01203072|3767602|FG001|COMPLETED|Overall Study||100
3047639|NCT01203072|3767603|FG002|COMPLETED|Overall Study||101
3047640|NCT01203072|3767604|FG003|COMPLETED|Overall Study||100
3047641|NCT01203072|3767605|FG004|COMPLETED|Overall Study||96
3047642|NCT01203072|3767601|FG000|NOT COMPLETED|Overall Study||10
3047643|NCT01203072|3767602|FG001|NOT COMPLETED|Overall Study||6
3047644|NCT01203072|3767603|FG002|NOT COMPLETED|Overall Study||3
3047645|NCT01203072|3767604|FG003|NOT COMPLETED|Overall Study||6
3047646|NCT01203072|3767605|FG004|NOT COMPLETED|Overall Study||6
3383438|NCT01545050|4118465|FG000|STARTED|Overall Study||18
3383439|NCT01545050|4118466|FG001|STARTED|Overall Study||9
3383440|NCT01545050|4118467|FG002|STARTED|Overall Study||9
3383441|NCT01545050|4118468|FG003|STARTED|Overall Study||18
3383442|NCT01545050|4118469|FG004|STARTED|Overall Study||18
3383443|NCT01545050|4118465|FG000|COMPLETED|Overall Study||11
3383444|NCT01545050|4118466|FG001|COMPLETED|Overall Study||4
3383445|NCT01545050|4118467|FG002|COMPLETED|Overall Study||4
3383446|NCT01545050|4118468|FG003|COMPLETED|Overall Study||6
2935251|NCT00611026|3646960|FG000|STARTED|Randomized to Double-blind Treatment||480
2935252|NCT00611026|3646961|FG001|STARTED|Randomized to Double-blind Treatment||974
2935253|NCT00611026|3646962|FG002|STARTED|Randomized to Double-blind Treatment||963
2935254|NCT00611026|3646960|FG000|COMPLETED|Randomized to Double-blind Treatment||478
2935255|NCT00611026|3646961|FG001|COMPLETED|Randomized to Double-blind Treatment||973
2935256|NCT00611026|3646962|FG002|COMPLETED|Randomized to Double-blind Treatment||960
2935257|NCT00611026|3646960|FG000|NOT COMPLETED|Randomized to Double-blind Treatment||2
2935258|NCT00611026|3646961|FG001|NOT COMPLETED|Randomized to Double-blind Treatment||1
2935259|NCT00611026|3646962|FG002|NOT COMPLETED|Randomized to Double-blind Treatment||3
2935260|NCT00611026|3646960|FG000|STARTED|Double-blind Treatment Period||478
2935261|NCT00611026|3646961|FG001|STARTED|Double-blind Treatment Period||973
2935262|NCT00611026|3646962|FG002|STARTED|Double-blind Treatment Period||960
2935263|NCT00611026|3646960|FG000|COMPLETED|Double-blind Treatment Period||431
2935264|NCT00611026|3646961|FG001|COMPLETED|Double-blind Treatment Period||885
2935265|NCT00611026|3646962|FG002|COMPLETED|Double-blind Treatment Period||862
2935266|NCT00611026|3646960|FG000|NOT COMPLETED|Double-blind Treatment Period||47
2935267|NCT00611026|3646961|FG001|NOT COMPLETED|Double-blind Treatment Period||88
2935268|NCT00611026|3646962|FG002|NOT COMPLETED|Double-blind Treatment Period||98
2935269|NCT00611130|3646974|FG000|STARTED|Overall Study||92
2935270|NCT00611130|3646975|FG001|STARTED|Overall Study||94
2935271|NCT00611130|3646974|FG000|Completed 12 Week Treatment Phase|Overall Study||61
2935272|NCT00611130|3646975|FG001|Completed 12 Week Treatment Phase|Overall Study||64
2935273|NCT00611130|3646974|FG000|COMPLETED|Overall Study||43
2935274|NCT00611130|3646975|FG001|COMPLETED|Overall Study||47
2935275|NCT00611130|3646974|FG000|NOT COMPLETED|Overall Study||49
2935276|NCT00611130|3646975|FG001|NOT COMPLETED|Overall Study||47
2935277|NCT00611247|3646984|FG000|STARTED|Overall Study||5
2935278|NCT00611247|3646985|FG001|STARTED|Overall Study||31
2935279|NCT00611247|3646984|FG000|COMPLETED|Overall Study||3
2935280|NCT00611247|3646985|FG001|COMPLETED|Overall Study||10
2935281|NCT00611247|3646984|FG000|NOT COMPLETED|Overall Study||2
2935282|NCT00611247|3646985|FG001|NOT COMPLETED|Overall Study||21
2935283|NCT00611325|3646994|FG000|STARTED|Overall Study||28
2935284|NCT00611325|3646995|FG001|STARTED|Overall Study||28
2935285|NCT00611325|3646994|FG000|COMPLETED|Overall Study||28
2935286|NCT00611325|3646995|FG001|COMPLETED|Overall Study||28
2935287|NCT00611325|3646994|FG000|NOT COMPLETED|Overall Study||0
2935288|NCT00611325|3646995|FG001|NOT COMPLETED|Overall Study||0
2935289|NCT00611351|3647001|FG000|STARTED|Overall Study||5
2935290|NCT00611351|3647001|FG000|COMPLETED|Overall Study||3
2935291|NCT00611351|3647001|FG000|NOT COMPLETED|Overall Study||2
2935292|NCT00611403|3647007|FG000|STARTED|Treatment Phase||68
2935293|NCT00611403|3647008|FG001|STARTED|Treatment Phase||69
2935294|NCT00611403|3647007|FG000|COMPLETED|Treatment Phase||62
2935295|NCT00611403|3647008|FG001|COMPLETED|Treatment Phase||58
2935296|NCT00611403|3647007|FG000|NOT COMPLETED|Treatment Phase||6
2935297|NCT00611403|3647008|FG001|NOT COMPLETED|Treatment Phase||11
2935298|NCT00611403|3647007|FG000|STARTED|Post Treatment Extension Phase|26 of 68 pts who received RESTASIS® in the Treatment Phase entered the Post Treatment Ext. Phase|26
2935299|NCT00611403|3647008|FG001|STARTED|Post Treatment Extension Phase|25 of 69 pts who received ENDURA® in the Treatment Phase entered the Post Treatment Extension Phase|25
2935300|NCT00611403|3647007|FG000|COMPLETED|Post Treatment Extension Phase||22
2935301|NCT00611403|3647008|FG001|COMPLETED|Post Treatment Extension Phase||24
2935302|NCT00611403|3647007|FG000|NOT COMPLETED|Post Treatment Extension Phase||4
3047647|NCT01203098|3767620|FG000|STARTED|Overall Study||89
3047648|NCT01203098|3767621|FG001|STARTED|Overall Study||86
3047649|NCT01203098|3767622|FG002|STARTED|Overall Study||89
3047650|NCT01203098|3767620|FG000|Safety Analysis Dataset|Overall Study||89
3047651|NCT01203098|3767621|FG001|Safety Analysis Dataset|Overall Study||85
3383447|NCT01545050|4118469|FG004|COMPLETED|Overall Study||9
3383448|NCT01545050|4118465|FG000|NOT COMPLETED|Overall Study||7
3383449|NCT01545050|4118466|FG001|NOT COMPLETED|Overall Study||5
3383450|NCT01545050|4118467|FG002|NOT COMPLETED|Overall Study||5
3383451|NCT01545050|4118468|FG003|NOT COMPLETED|Overall Study||12
3383452|NCT01545050|4118469|FG004|NOT COMPLETED|Overall Study||9
3383453|NCT01550302|4118487|FG000|STARTED|Overall Study||5
3383454|NCT01550302|4118488|FG001|STARTED|Overall Study||5
3383455|NCT01550302|4118487|FG000|COMPLETED|Overall Study||5
3383456|NCT01550302|4118488|FG001|COMPLETED|Overall Study||5
3383457|NCT01550302|4118487|FG000|NOT COMPLETED|Overall Study||0
3383458|NCT01550302|4118488|FG001|NOT COMPLETED|Overall Study||0
3385773|NCT03589976|4121137|FG000|STARTED|Overall Study||35
3385774|NCT03589976|4121138|FG001|STARTED|Overall Study||12
3385775|NCT03589976|4121137|FG000|COMPLETED|Overall Study||16
3385776|NCT03589976|4121138|FG001|COMPLETED|Overall Study||6
3385777|NCT03589976|4121137|FG000|NOT COMPLETED|Overall Study||19
3385778|NCT03589976|4121138|FG001|NOT COMPLETED|Overall Study||6
3385779|NCT03517449|4121146|FG000|STARTED|Overall Study||411
3385780|NCT03517449|4121147|FG001|STARTED|Overall Study||416
3385781|NCT03517449|4121146|FG000|Treated|Overall Study||406
2911380|NCT00483704|3621079|FG000|STARTED|Randomization||644
2911381|NCT00483704|3621080|FG001|STARTED|Randomization||645
2911382|NCT00483704|3621081|FG002|STARTED|Randomization||646
2911383|NCT00483704|3621079|FG000|COMPLETED|Randomization||573
2911384|NCT00483704|3621080|FG001|COMPLETED|Randomization||549
2911385|NCT00483704|3621081|FG002|COMPLETED|Randomization||555
2911386|NCT00483704|3621079|FG000|NOT COMPLETED|Randomization||71
2911387|NCT00483704|3621080|FG001|NOT COMPLETED|Randomization||96
2911388|NCT00483704|3621081|FG002|NOT COMPLETED|Randomization||91
2911389|NCT00483704|3621079|FG000|STARTED|Treatment||573
2911390|NCT00483704|3621080|FG001|STARTED|Treatment||549
2911391|NCT00483704|3621081|FG002|STARTED|Treatment||555
2911392|NCT00483704|3621079|FG000|COMPLETED|Treatment||444
2911393|NCT00483704|3621080|FG001|COMPLETED|Treatment||420
2911394|NCT00483704|3621081|FG002|COMPLETED|Treatment||399
2911395|NCT00483704|3621079|FG000|NOT COMPLETED|Treatment||129
2911396|NCT00483704|3621080|FG001|NOT COMPLETED|Treatment||129
2911397|NCT00483704|3621081|FG002|NOT COMPLETED|Treatment||156
2911398|NCT00483717|3621094|FG000|STARTED|Overall Study||87
2911399|NCT00483717|3621095|FG001|STARTED|Overall Study||86
2911400|NCT00483717|3621094|FG000|COMPLETED|Overall Study||63
2911401|NCT00483717|3621095|FG001|COMPLETED|Overall Study||65
2911402|NCT00483717|3621094|FG000|NOT COMPLETED|Overall Study||24
2911403|NCT00483717|3621095|FG001|NOT COMPLETED|Overall Study||21
2911404|NCT00483756|3621104|FG000|STARTED|Overall Study||110
2911405|NCT00483756|3621105|FG001|STARTED|Overall Study||110
2911406|NCT00483756|3621106|FG002|STARTED|Overall Study||111
2911407|NCT00483756|3621104|FG000|Treated|Overall Study||109
2911408|NCT00483756|3621105|FG001|Treated|Overall Study||106
2911409|NCT00483756|3621106|FG002|Treated|Overall Study||107
2911410|NCT00483756|3621104|FG000|COMPLETED|Overall Study||77
2911411|NCT00483756|3621105|FG001|COMPLETED|Overall Study||60
2911412|NCT00483756|3621106|FG002|COMPLETED|Overall Study||59
2911413|NCT00483756|3621104|FG000|NOT COMPLETED|Overall Study||33
2911414|NCT00483756|3621105|FG001|NOT COMPLETED|Overall Study||50
2911415|NCT00483756|3621106|FG002|NOT COMPLETED|Overall Study||52
2911416|NCT00483938|3621121|FG000|STARTED|Overall Study||41
2911417|NCT00483938|3621122|FG001|STARTED|Overall Study||43
2911418|NCT00483938|3621123|FG002|STARTED|Overall Study||30
2911419|NCT00483938|3621124|FG003|STARTED|Overall Study||31
2911420|NCT00483938|3621125|FG004|STARTED|Overall Study||25
2911421|NCT00483938|3621126|FG005|STARTED|Overall Study||26
2911422|NCT00483938|3621127|FG006|STARTED|Overall Study||40
2911423|NCT00483938|3621121|FG000|COMPLETED|Overall Study||36
2911424|NCT00483938|3621122|FG001|COMPLETED|Overall Study||24
2911425|NCT00483938|3621123|FG002|COMPLETED|Overall Study||30
2911426|NCT00483938|3621124|FG003|COMPLETED|Overall Study||25
2911427|NCT00483938|3621125|FG004|COMPLETED|Overall Study||23
2935303|NCT00611403|3647008|FG001|NOT COMPLETED|Post Treatment Extension Phase||1
2935304|NCT00611442|3647016|FG000|STARTED|Overall Study||95
2935305|NCT00611442|3647017|FG001|STARTED|Overall Study||96
2935306|NCT00611442|3647016|FG000|COMPLETED|Overall Study||94
2935307|NCT00611442|3647017|FG001|COMPLETED|Overall Study||94
2935308|NCT00611442|3647016|FG000|NOT COMPLETED|Overall Study||1
2935309|NCT00611442|3647017|FG001|NOT COMPLETED|Overall Study||2
2935310|NCT00611455|3647025|FG000|STARTED|DB Treatment Period (24 Weeks)||134
2935311|NCT00611455|3647026|FG001|STARTED|DB Treatment Period (24 Weeks)||131
2935312|NCT00611455|3647027|FG002|STARTED|DB Treatment Period (24 Weeks)||0
2935313|NCT00611455|3647025|FG000|COMPLETED|DB Treatment Period (24 Weeks)||121
2935314|NCT00611455|3647026|FG001|COMPLETED|DB Treatment Period (24 Weeks)||117
2935315|NCT00611455|3647027|FG002|COMPLETED|DB Treatment Period (24 Weeks)||0
2935316|NCT00611455|3647025|FG000|NOT COMPLETED|DB Treatment Period (24 Weeks)||13
2911428|NCT00483938|3621126|FG005|COMPLETED|Overall Study||18
2911429|NCT00483938|3621127|FG006|COMPLETED|Overall Study||0
2911430|NCT00483938|3621121|FG000|NOT COMPLETED|Overall Study||5
2911431|NCT00483938|3621122|FG001|NOT COMPLETED|Overall Study||19
2911432|NCT00483938|3621123|FG002|NOT COMPLETED|Overall Study||0
2935317|NCT00611455|3647026|FG001|NOT COMPLETED|DB Treatment Period (24 Weeks)||14
3038345|NCT01153815|3757772|FG001|STARTED|Overall Study||87
3385782|NCT03517449|4121147|FG001|Treated|Overall Study||388
3385783|NCT03517449|4121146|FG000|COMPLETED|Overall Study||0
3385784|NCT03517449|4121147|FG001|COMPLETED|Overall Study||0
3385785|NCT03517449|4121146|FG000|NOT COMPLETED|Overall Study||411
3385786|NCT03517449|4121147|FG001|NOT COMPLETED|Overall Study||416
3385787|NCT03490227|4121153|FG000|STARTED|Overall Study||10
3385788|NCT03490227|4121153|FG000|COMPLETED|Overall Study||10
3385789|NCT03490227|4121153|FG000|NOT COMPLETED|Overall Study||0
3385790|NCT03401190|4121162|FG000|STARTED|Overall Study||8
3383459|NCT01555021|4118496|FG000|STARTED|Overall Study||2
3383460|NCT01555021|4118497|FG001|STARTED|Overall Study||2
3383461|NCT01555021|4118496|FG000|COMPLETED|Overall Study|One treatment as usual subject completed 1 month, 3 month, and 6 month follow up visits|1
3383462|NCT01555021|4118497|FG001|COMPLETED|Overall Study|None of the AGT subjects competed month 1, month 3, or month 6 follow up visits.|0
3383463|NCT01555021|4118496|FG000|NOT COMPLETED|Overall Study||1
3383464|NCT01555021|4118497|FG001|NOT COMPLETED|Overall Study||2
3383465|NCT01561430|4118513|FG000|STARTED|Overall Study||9
3383466|NCT01561430|4118514|FG001|STARTED|Overall Study||23
3383467|NCT01561430|4118515|FG002|STARTED|Overall Study||18
3383468|NCT01561430|4118516|FG003|STARTED|Overall Study||20
3383469|NCT01561430|4118513|FG000|Received at Least One Dose of Study Drug|Overall Study||9
3383470|NCT01561430|4118514|FG001|Received at Least One Dose of Study Drug|Overall Study||23
3383471|NCT01561430|4118515|FG002|Received at Least One Dose of Study Drug|Overall Study||18
3383472|NCT01561430|4118516|FG003|Received at Least One Dose of Study Drug|Overall Study||20
3383473|NCT01561430|4118513|FG000|COMPLETED|Overall Study||8
3383474|NCT01561430|4118514|FG001|COMPLETED|Overall Study||8
3383475|NCT01561430|4118515|FG002|COMPLETED|Overall Study||1
3383476|NCT01561430|4118516|FG003|COMPLETED|Overall Study||7
3383477|NCT01561430|4118513|FG000|NOT COMPLETED|Overall Study||1
3383478|NCT01561430|4118514|FG001|NOT COMPLETED|Overall Study||15
3383479|NCT01561430|4118515|FG002|NOT COMPLETED|Overall Study||17
3383480|NCT01561430|4118516|FG003|NOT COMPLETED|Overall Study||13
3383481|NCT01580813|4118527|FG000|STARTED|Overall Study||4
3383482|NCT01580813|4118528|FG001|STARTED|Overall Study||3
3383483|NCT01580813|4118527|FG000|Completed First Intervention|Overall Study||4
3383484|NCT01580813|4118528|FG001|Completed First Intervention|Overall Study||3
3383485|NCT01580813|4118527|FG000|Completed 1 Week Washout|Overall Study||4
3383486|NCT01580813|4118528|FG001|Completed 1 Week Washout|Overall Study||3
3383487|NCT01580813|4118527|FG000|Started Second Intervention|Overall Study||4
3383488|NCT01580813|4118528|FG001|Started Second Intervention|Overall Study||3
3383489|NCT01580813|4118527|FG000|COMPLETED|Overall Study||4
3383490|NCT01580813|4118528|FG001|COMPLETED|Overall Study||3
3383491|NCT01580813|4118527|FG000|NOT COMPLETED|Overall Study||0
3383492|NCT01580813|4118528|FG001|NOT COMPLETED|Overall Study||0
3383493|NCT01595009|4118536|FG000|STARTED|Core||126
3383494|NCT01595009|4118537|FG001|STARTED|Core||120
3383495|NCT01595009|4118538|FG002|STARTED|Core||0
3383496|NCT01595009|4118539|FG003|STARTED|Core||0
3383497|NCT01595009|4118536|FG000|COMPLETED|Core||0
3383498|NCT01595009|4118537|FG001|COMPLETED|Core||0
3383499|NCT01595009|4118538|FG002|COMPLETED|Core||0
3383500|NCT01595009|4118539|FG003|COMPLETED|Core||0
2935318|NCT00611455|3647027|FG002|NOT COMPLETED|DB Treatment Period (24 Weeks)||0
2935319|NCT00611455|3647025|FG000|STARTED|OL Treatment Period (120 Weeks)||0
2935320|NCT00611455|3647026|FG001|STARTED|OL Treatment Period (120 Weeks)|118 participants received OFA during the DB Period; 113 received placebo during the DB Period.|231
2935321|NCT00611455|3647027|FG002|STARTED|OL Treatment Period (120 Weeks)||0
2935322|NCT00611455|3647025|FG000|COMPLETED|OL Treatment Period (120 Weeks)||0
2935323|NCT00611455|3647026|FG001|COMPLETED|OL Treatment Period (120 Weeks)||52
2935324|NCT00611455|3647027|FG002|COMPLETED|OL Treatment Period (120 Weeks)||0
2935325|NCT00611455|3647025|FG000|NOT COMPLETED|OL Treatment Period (120 Weeks)||0
2935326|NCT00611455|3647026|FG001|NOT COMPLETED|OL Treatment Period (120 Weeks)||179
2935327|NCT00611455|3647027|FG002|NOT COMPLETED|OL Treatment Period (120 Weeks)||0
2935328|NCT00611455|3647025|FG000|STARTED|Follow-up Period (Approximately 2 Years)||0
2935329|NCT00611455|3647026|FG001|STARTED|Follow-up Period (Approximately 2 Years)||0
2935330|NCT00611455|3647027|FG002|STARTED|Follow-up Period (Approximately 2 Years)|These participants received at least one infusion of placebo or ofatumumab.|260
2935331|NCT00611455|3647025|FG000|COMPLETED|Follow-up Period (Approximately 2 Years)||0
2935332|NCT00611455|3647026|FG001|COMPLETED|Follow-up Period (Approximately 2 Years)||0
2935333|NCT00611455|3647027|FG002|COMPLETED|Follow-up Period (Approximately 2 Years)||49
2935334|NCT00611455|3647025|FG000|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||0
2935335|NCT00611455|3647026|FG001|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||0
2935336|NCT00611455|3647027|FG002|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||211
2935337|NCT00611468|3647037|FG000|STARTED|Overall Study||3
2935338|NCT00611468|3647038|FG001|STARTED|Overall Study||7
2935339|NCT00611468|3647039|FG002|STARTED|Overall Study||6
2935340|NCT00611468|3647040|FG003|STARTED|Overall Study||13
2935341|NCT00611468|3647037|FG000|COMPLETED|Overall Study||3
2935342|NCT00611468|3647038|FG001|COMPLETED|Overall Study|One subject did not complete Cycle 1 of treatment and was replaced.|6
2935343|NCT00611468|3647039|FG002|COMPLETED|Overall Study||6
2935344|NCT00611468|3647040|FG003|COMPLETED|Overall Study||13
2935345|NCT00611468|3647037|FG000|NOT COMPLETED|Overall Study||0
2935346|NCT00611468|3647038|FG001|NOT COMPLETED|Overall Study||1
2935347|NCT00611468|3647039|FG002|NOT COMPLETED|Overall Study||0
2935348|NCT00611468|3647040|FG003|NOT COMPLETED|Overall Study||0
2935349|NCT00611533|3647044|FG000|STARTED|First Intervention (6 Weeks)||8
2935350|NCT00611533|3647045|FG001|STARTED|First Intervention (6 Weeks)||8
2935351|NCT00611533|3647044|FG000|COMPLETED|First Intervention (6 Weeks)||8
2935352|NCT00611533|3647045|FG001|COMPLETED|First Intervention (6 Weeks)||6
2935353|NCT00611533|3647044|FG000|NOT COMPLETED|First Intervention (6 Weeks)||0
2935354|NCT00611533|3647045|FG001|NOT COMPLETED|First Intervention (6 Weeks)||2
2935355|NCT00611533|3647044|FG000|STARTED|Second Intervention (6 Weeks)||8
2935356|NCT00611533|3647045|FG001|STARTED|Second Intervention (6 Weeks)||6
3383501|NCT01595009|4118536|FG000|NOT COMPLETED|Core||126
3047652|NCT01203098|3767622|FG002|Safety Analysis Dataset|Overall Study||87
3047653|NCT01203098|3767620|FG000|COMPLETED|Overall Study||83
3047654|NCT01203098|3767621|FG001|COMPLETED|Overall Study||82
3047655|NCT01203098|3767622|FG002|COMPLETED|Overall Study||78
3047656|NCT01203098|3767620|FG000|NOT COMPLETED|Overall Study||6
3047657|NCT01203098|3767621|FG001|NOT COMPLETED|Overall Study||4
3047658|NCT01203098|3767622|FG002|NOT COMPLETED|Overall Study||11
3047659|NCT01203189|3767633|FG000|STARTED|First 4 Weeks Treatment||10
3047660|NCT01203189|3767634|FG001|STARTED|First 4 Weeks Treatment||10
3047661|NCT01203189|3767635|FG002|STARTED|First 4 Weeks Treatment||3
3047662|NCT01203189|3767633|FG000|COMPLETED|First 4 Weeks Treatment||8
3047663|NCT01203189|3767634|FG001|COMPLETED|First 4 Weeks Treatment||8
3047664|NCT01203189|3767635|FG002|COMPLETED|First 4 Weeks Treatment||3
3047665|NCT01203189|3767633|FG000|NOT COMPLETED|First 4 Weeks Treatment||2
3047666|NCT01203189|3767634|FG001|NOT COMPLETED|First 4 Weeks Treatment||2
3047667|NCT01203189|3767635|FG002|NOT COMPLETED|First 4 Weeks Treatment||0
3047668|NCT01203189|3767633|FG000|STARTED|Cross Over Period 4 Weeks Treatment||0
3047669|NCT01203189|3767634|FG001|STARTED|Cross Over Period 4 Weeks Treatment||0
3047670|NCT01203189|3767635|FG002|STARTED|Cross Over Period 4 Weeks Treatment||3
3047671|NCT01203189|3767633|FG000|COMPLETED|Cross Over Period 4 Weeks Treatment||0
3047672|NCT01203189|3767634|FG001|COMPLETED|Cross Over Period 4 Weeks Treatment||0
3271944|NCT02677766|4007292|FG000|NOT COMPLETED|Overall Study||5
3271945|NCT02677766|4007293|FG001|NOT COMPLETED|Overall Study||3
3271946|NCT02677779|4007301|FG000|STARTED|Overall Study||10
3271947|NCT02677779|4007302|FG001|STARTED|Overall Study||10
3271948|NCT02677779|4007301|FG000|COMPLETED|Overall Study||10
3271949|NCT02677779|4007302|FG001|COMPLETED|Overall Study||10
3271950|NCT02677779|4007301|FG000|NOT COMPLETED|Overall Study||0
3271951|NCT02677779|4007302|FG001|NOT COMPLETED|Overall Study||0
3271952|NCT02677844|4007310|FG000|STARTED|Period 1||5
3271953|NCT02677844|4007311|FG001|STARTED|Period 1||5
3271954|NCT02677844|4007312|FG002|STARTED|Period 1||5
3271955|NCT02677844|4007313|FG003|STARTED|Period 1||5
3271956|NCT02677844|4007314|FG004|STARTED|Period 1||0
3271957|NCT02677844|4007315|FG005|STARTED|Period 1||0
3271958|NCT02677844|4007316|FG006|STARTED|Period 1||0
3271959|NCT02677844|4007310|FG000|COMPLETED|Period 1||5
3271960|NCT02677844|4007311|FG001|COMPLETED|Period 1||5
3271961|NCT02677844|4007312|FG002|COMPLETED|Period 1||5
3271962|NCT02677844|4007313|FG003|COMPLETED|Period 1||5
3271963|NCT02677844|4007314|FG004|COMPLETED|Period 1||0
3271964|NCT02677844|4007315|FG005|COMPLETED|Period 1||0
3271965|NCT02677844|4007316|FG006|COMPLETED|Period 1||0
3271966|NCT02677844|4007310|FG000|NOT COMPLETED|Period 1||0
3271967|NCT02677844|4007311|FG001|NOT COMPLETED|Period 1||0
3271968|NCT02677844|4007312|FG002|NOT COMPLETED|Period 1||0
3271969|NCT02677844|4007313|FG003|NOT COMPLETED|Period 1||0
3271970|NCT02677844|4007314|FG004|NOT COMPLETED|Period 1||0
3271971|NCT02677844|4007315|FG005|NOT COMPLETED|Period 1||0
3271972|NCT02677844|4007316|FG006|NOT COMPLETED|Period 1||0
3271973|NCT02677844|4007310|FG000|STARTED|Period 2||5
3271974|NCT02677844|4007311|FG001|STARTED|Period 2||5
3271975|NCT02677844|4007312|FG002|STARTED|Period 2||5
3271976|NCT02677844|4007313|FG003|STARTED|Period 2||5
3271977|NCT02677844|4007314|FG004|STARTED|Period 2||0
3271978|NCT02677844|4007315|FG005|STARTED|Period 2||0
3271979|NCT02677844|4007316|FG006|STARTED|Period 2||0
3271980|NCT02677844|4007310|FG000|COMPLETED|Period 2||5
3271981|NCT02677844|4007311|FG001|COMPLETED|Period 2||5
3271982|NCT02677844|4007312|FG002|COMPLETED|Period 2||5
3271983|NCT02677844|4007313|FG003|COMPLETED|Period 2||5
3271984|NCT02677844|4007314|FG004|COMPLETED|Period 2||0
3271985|NCT02677844|4007315|FG005|COMPLETED|Period 2||0
3271986|NCT02677844|4007316|FG006|COMPLETED|Period 2||0
3271987|NCT02677844|4007310|FG000|NOT COMPLETED|Period 2||0
3271988|NCT02677844|4007311|FG001|NOT COMPLETED|Period 2||0
3271989|NCT02677844|4007312|FG002|NOT COMPLETED|Period 2||0
3271990|NCT02677844|4007313|FG003|NOT COMPLETED|Period 2||0
3271991|NCT02677844|4007314|FG004|NOT COMPLETED|Period 2||0
3271992|NCT02677844|4007315|FG005|NOT COMPLETED|Period 2||0
3271993|NCT02677844|4007316|FG006|NOT COMPLETED|Period 2||0
3047673|NCT01203189|3767635|FG002|COMPLETED|Cross Over Period 4 Weeks Treatment||3
3047674|NCT01203189|3767633|FG000|NOT COMPLETED|Cross Over Period 4 Weeks Treatment||0
3047675|NCT01203189|3767634|FG001|NOT COMPLETED|Cross Over Period 4 Weeks Treatment||0
3047676|NCT01203189|3767635|FG002|NOT COMPLETED|Cross Over Period 4 Weeks Treatment||0
3047677|NCT01203319|3767646|FG000|STARTED|Overall Study||434
3047678|NCT01203319|3767647|FG001|STARTED|Overall Study||435
3047679|NCT01203319|3767648|FG002|STARTED|Overall Study||222
3047680|NCT01203319|3767646|FG000|COMPLETED|Overall Study||428
3047681|NCT01203319|3767647|FG001|COMPLETED|Overall Study||426
3047682|NCT01203319|3767648|FG002|COMPLETED|Overall Study||217
3047683|NCT01203319|3767646|FG000|NOT COMPLETED|Overall Study||6
3047684|NCT01203319|3767647|FG001|NOT COMPLETED|Overall Study||9
3047685|NCT01203319|3767648|FG002|NOT COMPLETED|Overall Study||5
3047686|NCT01203644|3767658|FG000|STARTED|Overall Study||26
3271994|NCT02677844|4007310|FG000|STARTED|Period 3||5
3271995|NCT02677844|4007311|FG001|STARTED|Period 3||5
3271996|NCT02677844|4007312|FG002|STARTED|Period 3||5
3271997|NCT02677844|4007313|FG003|STARTED|Period 3||5
3271998|NCT02677844|4007314|FG004|STARTED|Period 3||0
3271999|NCT02677844|4007315|FG005|STARTED|Period 3||0
3272000|NCT02677844|4007316|FG006|STARTED|Period 3||0
3272001|NCT02677844|4007310|FG000|COMPLETED|Period 3||5
3383502|NCT01595009|4118537|FG001|NOT COMPLETED|Core||120
3383503|NCT01595009|4118538|FG002|NOT COMPLETED|Core||0
2911433|NCT00483938|3621124|FG003|NOT COMPLETED|Overall Study||6
2911434|NCT00483938|3621125|FG004|NOT COMPLETED|Overall Study||2
2911435|NCT00483938|3621126|FG005|NOT COMPLETED|Overall Study||8
2911436|NCT00483938|3621127|FG006|NOT COMPLETED|Overall Study||40
2911437|NCT00484094|3621146|FG000|STARTED|Overall Study||209
2911438|NCT00484094|3621146|FG000|COMPLETED|Overall Study||167
2911439|NCT00484094|3621146|FG000|NOT COMPLETED|Overall Study||42
3272002|NCT02677844|4007311|FG001|COMPLETED|Period 3||5
3272003|NCT02677844|4007312|FG002|COMPLETED|Period 3||5
3272004|NCT02677844|4007313|FG003|COMPLETED|Period 3||4
3272005|NCT02677844|4007314|FG004|COMPLETED|Period 3||0
3272006|NCT02677844|4007315|FG005|COMPLETED|Period 3||0
3272007|NCT02677844|4007316|FG006|COMPLETED|Period 3||0
3272008|NCT02677844|4007310|FG000|NOT COMPLETED|Period 3||0
3272009|NCT02677844|4007311|FG001|NOT COMPLETED|Period 3||0
3272010|NCT02677844|4007312|FG002|NOT COMPLETED|Period 3||0
3272011|NCT02677844|4007313|FG003|NOT COMPLETED|Period 3||1
3272012|NCT02677844|4007314|FG004|NOT COMPLETED|Period 3||0
3272013|NCT02677844|4007315|FG005|NOT COMPLETED|Period 3||0
3272014|NCT02677844|4007316|FG006|NOT COMPLETED|Period 3||0
3272015|NCT02677844|4007310|FG000|STARTED|Period 4||5
3272016|NCT02677844|4007311|FG001|STARTED|Period 4||5
3272017|NCT02677844|4007312|FG002|STARTED|Period 4||5
3272018|NCT02677844|4007313|FG003|STARTED|Period 4||4
3272019|NCT02677844|4007314|FG004|STARTED|Period 4||0
3272020|NCT02677844|4007315|FG005|STARTED|Period 4||0
3272021|NCT02677844|4007316|FG006|STARTED|Period 4||0
3272022|NCT02677844|4007310|FG000|COMPLETED|Period 4||5
3272023|NCT02677844|4007311|FG001|COMPLETED|Period 4||5
3272024|NCT02677844|4007312|FG002|COMPLETED|Period 4||5
3272025|NCT02677844|4007313|FG003|COMPLETED|Period 4||4
3272026|NCT02677844|4007314|FG004|COMPLETED|Period 4||0
3272027|NCT02677844|4007315|FG005|COMPLETED|Period 4||0
3272028|NCT02677844|4007316|FG006|COMPLETED|Period 4||0
3272029|NCT02677844|4007310|FG000|NOT COMPLETED|Period 4||0
3272030|NCT02677844|4007311|FG001|NOT COMPLETED|Period 4||0
3272031|NCT02677844|4007312|FG002|NOT COMPLETED|Period 4||0
3272032|NCT02677844|4007313|FG003|NOT COMPLETED|Period 4||0
3272033|NCT02677844|4007314|FG004|NOT COMPLETED|Period 4||0
3272034|NCT02677844|4007315|FG005|NOT COMPLETED|Period 4||0
3272035|NCT02677844|4007316|FG006|NOT COMPLETED|Period 4||0
3272036|NCT02677844|4007310|FG000|STARTED|Period 4 (DDI)||0
3272037|NCT02677844|4007311|FG001|STARTED|Period 4 (DDI)||0
3272038|NCT02677844|4007312|FG002|STARTED|Period 4 (DDI)||0
3272039|NCT02677844|4007313|FG003|STARTED|Period 4 (DDI)||0
3272040|NCT02677844|4007314|FG004|STARTED|Period 4 (DDI)||7
3272041|NCT02677844|4007315|FG005|STARTED|Period 4 (DDI)||4
3272042|NCT02677844|4007316|FG006|STARTED|Period 4 (DDI)||4
3272043|NCT02677844|4007310|FG000|COMPLETED|Period 4 (DDI)||0
3272044|NCT02677844|4007311|FG001|COMPLETED|Period 4 (DDI)||0
3272045|NCT02677844|4007312|FG002|COMPLETED|Period 4 (DDI)||0
3272046|NCT02677844|4007313|FG003|COMPLETED|Period 4 (DDI)||0
3272047|NCT02677844|4007314|FG004|COMPLETED|Period 4 (DDI)||7
3272048|NCT02677844|4007315|FG005|COMPLETED|Period 4 (DDI)||4
3272049|NCT02677844|4007316|FG006|COMPLETED|Period 4 (DDI)||4
3272050|NCT02677844|4007310|FG000|NOT COMPLETED|Period 4 (DDI)||0
3272051|NCT02677844|4007311|FG001|NOT COMPLETED|Period 4 (DDI)||0
3272052|NCT02677844|4007312|FG002|NOT COMPLETED|Period 4 (DDI)||0
3272053|NCT02677844|4007313|FG003|NOT COMPLETED|Period 4 (DDI)||0
3272054|NCT02677844|4007314|FG004|NOT COMPLETED|Period 4 (DDI)||0
3272055|NCT02677844|4007315|FG005|NOT COMPLETED|Period 4 (DDI)||0
3272056|NCT02677844|4007316|FG006|NOT COMPLETED|Period 4 (DDI)||0
3272057|NCT02677844|4007310|FG000|STARTED|Period 5||0
3272058|NCT02677844|4007311|FG001|STARTED|Period 5||0
3272059|NCT02677844|4007312|FG002|STARTED|Period 5||0
3272060|NCT02677844|4007313|FG003|STARTED|Period 5||0
3272061|NCT02677844|4007314|FG004|STARTED|Period 5||7
3272062|NCT02677844|4007315|FG005|STARTED|Period 5||4
3272063|NCT02677844|4007316|FG006|STARTED|Period 5||4
3272064|NCT02677844|4007310|FG000|COMPLETED|Period 5||0
2911440|NCT00484159|3621153|FG000|STARTED|Overall Study||50
2911441|NCT00484159|3621154|FG001|STARTED|Overall Study||50
2911442|NCT00484159|3621155|FG002|STARTED|Overall Study||51
3272065|NCT02677844|4007311|FG001|COMPLETED|Period 5||0
3272066|NCT02677844|4007312|FG002|COMPLETED|Period 5||0
3272067|NCT02677844|4007313|FG003|COMPLETED|Period 5||0
3272068|NCT02677844|4007314|FG004|COMPLETED|Period 5||7
3272069|NCT02677844|4007315|FG005|COMPLETED|Period 5||4
3272070|NCT02677844|4007316|FG006|COMPLETED|Period 5||4
3272071|NCT02677844|4007310|FG000|NOT COMPLETED|Period 5||0
3272072|NCT02677844|4007311|FG001|NOT COMPLETED|Period 5||0
3272073|NCT02677844|4007312|FG002|NOT COMPLETED|Period 5||0
3272074|NCT02677844|4007313|FG003|NOT COMPLETED|Period 5||0
3272075|NCT02677844|4007314|FG004|NOT COMPLETED|Period 5||0
3272076|NCT02677844|4007315|FG005|NOT COMPLETED|Period 5||0
3272077|NCT02677844|4007316|FG006|NOT COMPLETED|Period 5||0
3272078|NCT02677844|4007310|FG000|STARTED|Period 6||0
3272079|NCT02677844|4007311|FG001|STARTED|Period 6||0
3272080|NCT02677844|4007312|FG002|STARTED|Period 6||0
3272081|NCT02677844|4007313|FG003|STARTED|Period 6||0
3272082|NCT02677844|4007314|FG004|STARTED|Period 6||7
3272083|NCT02677844|4007315|FG005|STARTED|Period 6||4
3272084|NCT02677844|4007316|FG006|STARTED|Period 6||4
3272085|NCT02677844|4007310|FG000|COMPLETED|Period 6||0
3272086|NCT02677844|4007311|FG001|COMPLETED|Period 6||0
3272087|NCT02677844|4007312|FG002|COMPLETED|Period 6||0
3383504|NCT01595009|4118539|FG003|NOT COMPLETED|Core||0
3047687|NCT01203644|3767659|FG001|STARTED|Overall Study||50
3047688|NCT01203644|3767658|FG000|COMPLETED|Overall Study||26
3047689|NCT01203644|3767659|FG001|COMPLETED|Overall Study||50
3047690|NCT01203644|3767658|FG000|NOT COMPLETED|Overall Study||0
3047691|NCT01203644|3767659|FG001|NOT COMPLETED|Overall Study||0
3047692|NCT01203774|3767668|FG000|STARTED|Overall Study||21
3047693|NCT01203774|3767669|FG001|STARTED|Overall Study||10
3047694|NCT01203774|3767668|FG000|COMPLETED|Overall Study||21
3047695|NCT01203774|3767669|FG001|COMPLETED|Overall Study||10
3047696|NCT01203774|3767668|FG000|NOT COMPLETED|Overall Study||0
3047697|NCT01203774|3767669|FG001|NOT COMPLETED|Overall Study||0
3272088|NCT02677844|4007313|FG003|COMPLETED|Period 6||0
3272089|NCT02677844|4007314|FG004|COMPLETED|Period 6||7
3272090|NCT02677844|4007315|FG005|COMPLETED|Period 6||4
3272091|NCT02677844|4007316|FG006|COMPLETED|Period 6||4
3272092|NCT02677844|4007310|FG000|NOT COMPLETED|Period 6||0
3272093|NCT02677844|4007311|FG001|NOT COMPLETED|Period 6||0
3272094|NCT02677844|4007312|FG002|NOT COMPLETED|Period 6||0
3272095|NCT02677844|4007313|FG003|NOT COMPLETED|Period 6||0
3272096|NCT02677844|4007314|FG004|NOT COMPLETED|Period 6||0
3272097|NCT02677844|4007315|FG005|NOT COMPLETED|Period 6||0
3272098|NCT02677844|4007316|FG006|NOT COMPLETED|Period 6||0
3272099|NCT02677844|4007310|FG000|STARTED|Period 7||0
3272100|NCT02677844|4007311|FG001|STARTED|Period 7||0
3272101|NCT02677844|4007312|FG002|STARTED|Period 7||0
3272102|NCT02677844|4007313|FG003|STARTED|Period 7||0
3272103|NCT02677844|4007314|FG004|STARTED|Period 7||7
3272104|NCT02677844|4007315|FG005|STARTED|Period 7||4
3272105|NCT02677844|4007316|FG006|STARTED|Period 7||4
3272106|NCT02677844|4007310|FG000|COMPLETED|Period 7||0
3272107|NCT02677844|4007311|FG001|COMPLETED|Period 7||0
3272108|NCT02677844|4007312|FG002|COMPLETED|Period 7||0
3272109|NCT02677844|4007313|FG003|COMPLETED|Period 7||0
3272110|NCT02677844|4007314|FG004|COMPLETED|Period 7||7
3272111|NCT02677844|4007315|FG005|COMPLETED|Period 7||4
3272112|NCT02677844|4007316|FG006|COMPLETED|Period 7||4
3272113|NCT02677844|4007310|FG000|NOT COMPLETED|Period 7||0
3272114|NCT02677844|4007311|FG001|NOT COMPLETED|Period 7||0
3272115|NCT02677844|4007312|FG002|NOT COMPLETED|Period 7||0
3272116|NCT02677844|4007313|FG003|NOT COMPLETED|Period 7||0
3272117|NCT02677844|4007314|FG004|NOT COMPLETED|Period 7||0
3272118|NCT02677844|4007315|FG005|NOT COMPLETED|Period 7||0
3272119|NCT02677844|4007316|FG006|NOT COMPLETED|Period 7||0
3272120|NCT02678000|4007340|FG000|STARTED|PART 1||7
3272121|NCT02678000|4007341|FG001|STARTED|PART 1||4
3272122|NCT02678000|4007342|FG002|STARTED|PART 1||0
3272123|NCT02678000|4007343|FG003|STARTED|PART 1||0
3272124|NCT02678000|4007344|FG004|STARTED|PART 1||0
3272125|NCT02678000|4007340|FG000|COMPLETED|PART 1||7
3272126|NCT02678000|4007341|FG001|COMPLETED|PART 1||4
3272127|NCT02678000|4007342|FG002|COMPLETED|PART 1||0
3272128|NCT02678000|4007343|FG003|COMPLETED|PART 1||0
3272129|NCT02678000|4007344|FG004|COMPLETED|PART 1||0
3272130|NCT02678000|4007340|FG000|NOT COMPLETED|PART 1||0
3272131|NCT02678000|4007341|FG001|NOT COMPLETED|PART 1||0
3272132|NCT02678000|4007342|FG002|NOT COMPLETED|PART 1||0
3272133|NCT02678000|4007343|FG003|NOT COMPLETED|PART 1||0
3272134|NCT02678000|4007344|FG004|NOT COMPLETED|PART 1||0
3272135|NCT02678000|4007340|FG000|STARTED|PART 2||0
3272136|NCT02678000|4007341|FG001|STARTED|PART 2||0
3272137|NCT02678000|4007342|FG002|STARTED|PART 2||28
3272138|NCT02678000|4007343|FG003|STARTED|PART 2||27
3272139|NCT02678000|4007344|FG004|STARTED|PART 2||18
3272140|NCT02678000|4007340|FG000|COMPLETED|PART 2||0
3272141|NCT02678000|4007341|FG001|COMPLETED|PART 2||0
3272142|NCT02678000|4007342|FG002|COMPLETED|PART 2||25
3272143|NCT02678000|4007343|FG003|COMPLETED|PART 2||26
3272144|NCT02678000|4007344|FG004|COMPLETED|PART 2||18
3272145|NCT02678000|4007340|FG000|NOT COMPLETED|PART 2||0
3272146|NCT02678000|4007341|FG001|NOT COMPLETED|PART 2||0
3272147|NCT02678000|4007342|FG002|NOT COMPLETED|PART 2||3
3272148|NCT02678000|4007343|FG003|NOT COMPLETED|PART 2||1
3272149|NCT02678000|4007344|FG004|NOT COMPLETED|PART 2||0
3047698|NCT01203787|3767677|FG000|STARTED|Overall Study||63
3047699|NCT01203787|3767678|FG001|STARTED|Overall Study||57
3272150|NCT02678039|4007371|FG000|STARTED|Overall Study||53
3272151|NCT02678039|4007372|FG001|STARTED|Overall Study||47
3272152|NCT02678039|4007371|FG000|COMPLETED|Overall Study||53
3272153|NCT02678039|4007372|FG001|COMPLETED|Overall Study||47
3272154|NCT02678039|4007371|FG000|NOT COMPLETED|Overall Study||0
3272155|NCT02678039|4007372|FG001|NOT COMPLETED|Overall Study||0
3272156|NCT02678247|4007380|FG000|STARTED|First Intervention (7 Weeks)||15
3272157|NCT02678247|4007381|FG001|STARTED|First Intervention (7 Weeks)||15
3272158|NCT02678247|4007380|FG000|COMPLETED|First Intervention (7 Weeks)||13
3272159|NCT02678247|4007381|FG001|COMPLETED|First Intervention (7 Weeks)||11
3272160|NCT02678247|4007380|FG000|NOT COMPLETED|First Intervention (7 Weeks)||2
3272161|NCT02678247|4007381|FG001|NOT COMPLETED|First Intervention (7 Weeks)||4
3272162|NCT02678247|4007380|FG000|STARTED|Second Intervention (7 Weeks)|One subject crossed over despite not completing all data collection time points for the preceding socket.|14
3272163|NCT02678247|4007381|FG001|STARTED|Second Intervention (7 Weeks)||11
3272164|NCT02678247|4007380|FG000|COMPLETED|Second Intervention (7 Weeks)||10
3272165|NCT02678247|4007381|FG001|COMPLETED|Second Intervention (7 Weeks)||9
3272166|NCT02678247|4007380|FG000|NOT COMPLETED|Second Intervention (7 Weeks)||4
3272167|NCT02678247|4007381|FG001|NOT COMPLETED|Second Intervention (7 Weeks)||2
3383505|NCT01595009|4118536|FG000|STARTED|Extension||0
3383506|NCT01595009|4118537|FG001|STARTED|Extension||0
3383507|NCT01595009|4118538|FG002|STARTED|Extension||4
3383508|NCT01595009|4118539|FG003|STARTED|Extension||11
3383509|NCT01595009|4118536|FG000|COMPLETED|Extension||0
3383510|NCT01595009|4118537|FG001|COMPLETED|Extension||0
2911443|NCT00484159|3621153|FG000|COMPLETED|Overall Study||49
2911444|NCT00484159|3621154|FG001|COMPLETED|Overall Study||49
2911445|NCT00484159|3621155|FG002|COMPLETED|Overall Study||51
2911446|NCT00484159|3621153|FG000|NOT COMPLETED|Overall Study||1
2911447|NCT00484159|3621154|FG001|NOT COMPLETED|Overall Study||1
2911448|NCT00484159|3621155|FG002|NOT COMPLETED|Overall Study||0
2911449|NCT00484185|3621163|FG000|STARTED|Overall Study||183
2911450|NCT00484185|3621163|FG000|Treated|Overall Study||178
2911451|NCT00484185|3621163|FG000|COMPLETED|Overall Study||112
2911452|NCT00484185|3621163|FG000|NOT COMPLETED|Overall Study||71
2911453|NCT00484198|3621171|FG000|STARTED|Overall Study||137
2911454|NCT00484198|3621172|FG001|STARTED|Overall Study||274
2911455|NCT00484198|3621173|FG002|STARTED|Overall Study||750
2911456|NCT00484198|3621174|FG003|STARTED|Overall Study||751
2911457|NCT00484198|3621171|FG000|COMPLETED|Overall Study||96
2911458|NCT00484198|3621172|FG001|COMPLETED|Overall Study||208
2911459|NCT00484198|3621173|FG002|COMPLETED|Overall Study||599
2911460|NCT00484198|3621174|FG003|COMPLETED|Overall Study||579
2911461|NCT00484198|3621171|FG000|NOT COMPLETED|Overall Study||41
2911462|NCT00484198|3621172|FG001|NOT COMPLETED|Overall Study||66
2911463|NCT00484198|3621173|FG002|NOT COMPLETED|Overall Study||151
2911464|NCT00484198|3621174|FG003|NOT COMPLETED|Overall Study||172
3272168|NCT02678286|4007394|FG000|STARTED|Treatment Phase (48 Hours Post-Dose 1)||110
3272169|NCT02678286|4007395|FG001|STARTED|Treatment Phase (48 Hours Post-Dose 1)||109
3272170|NCT02678286|4007394|FG000|COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||108
3272171|NCT02678286|4007395|FG001|COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||107
3272172|NCT02678286|4007394|FG000|NOT COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||2
3272173|NCT02678286|4007395|FG001|NOT COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||2
3272174|NCT02678286|4007394|FG000|STARTED|Study Overall (28 Day Follow-Up)||110
3272175|NCT02678286|4007395|FG001|STARTED|Study Overall (28 Day Follow-Up)||109
3272176|NCT02678286|4007394|FG000|COMPLETED|Study Overall (28 Day Follow-Up)||104
3272177|NCT02678286|4007395|FG001|COMPLETED|Study Overall (28 Day Follow-Up)||105
3272178|NCT02678286|4007394|FG000|NOT COMPLETED|Study Overall (28 Day Follow-Up)||6
3272179|NCT02678286|4007395|FG001|NOT COMPLETED|Study Overall (28 Day Follow-Up)||4
3272180|NCT02678390|4007403|FG000|STARTED|Control (5 Days)||10
3272181|NCT02678390|4007404|FG001|STARTED|Control (5 Days)||10
3272182|NCT02678390|4007403|FG000|COMPLETED|Control (5 Days)||10
3272183|NCT02678390|4007404|FG001|COMPLETED|Control (5 Days)||10
3272184|NCT02678390|4007403|FG000|NOT COMPLETED|Control (5 Days)||0
3272185|NCT02678390|4007404|FG001|NOT COMPLETED|Control (5 Days)||0
3272186|NCT02678390|4007403|FG000|STARTED|MCT (5 Days)||10
3272187|NCT02678390|4007404|FG001|STARTED|MCT (5 Days)||10
3272188|NCT02678390|4007403|FG000|COMPLETED|MCT (5 Days)||10
3272189|NCT02678390|4007404|FG001|COMPLETED|MCT (5 Days)||10
3272190|NCT02678390|4007403|FG000|NOT COMPLETED|MCT (5 Days)||0
3272191|NCT02678390|4007404|FG001|NOT COMPLETED|MCT (5 Days)||0
3272192|NCT02678390|4007403|FG000|STARTED|AE (1 Day)||10
3272193|NCT02678390|4007404|FG001|STARTED|AE (1 Day)||10
3272194|NCT02678390|4007403|FG000|COMPLETED|AE (1 Day)||10
3272195|NCT02678390|4007404|FG001|COMPLETED|AE (1 Day)||9
3047700|NCT01203787|3767677|FG000|COMPLETED|Overall Study||32
3047701|NCT01203787|3767678|FG001|COMPLETED|Overall Study||30
3047702|NCT01203787|3767677|FG000|NOT COMPLETED|Overall Study||31
3272196|NCT02678390|4007403|FG000|NOT COMPLETED|AE (1 Day)||0
3272197|NCT02678390|4007404|FG001|NOT COMPLETED|AE (1 Day)||1
3272198|NCT02678390|4007403|FG000|STARTED|MCT + AE (5 Days)||10
3272199|NCT02678390|4007404|FG001|STARTED|MCT + AE (5 Days)||9
3272200|NCT02678390|4007403|FG000|COMPLETED|MCT + AE (5 Days)||10
3272201|NCT02678390|4007404|FG001|COMPLETED|MCT + AE (5 Days)||9
3272202|NCT02678390|4007403|FG000|NOT COMPLETED|MCT + AE (5 Days)||0
3272203|NCT02678390|4007404|FG001|NOT COMPLETED|MCT + AE (5 Days)||0
3272204|NCT02678416|4007412|FG000|STARTED|Part 1||12
3047703|NCT01203787|3767678|FG001|NOT COMPLETED|Overall Study||27
3047704|NCT01203826|3767688|FG000|STARTED|Overall Study|Dose cohorts are per assigned dose in ENB-006-09. Results presented are for Study ENB-008-10 only.|6
3272205|NCT02678416|4007412|FG000|Safety Population|Part 1||12
3272206|NCT02678416|4007412|FG000|Modified Intent to Treat (mITT)|Part 1||12
3272207|NCT02678416|4007412|FG000|Per Protocol Population|Part 1||8
3272208|NCT02678416|4007412|FG000|COMPLETED|Part 1||11
3272209|NCT02678416|4007412|FG000|NOT COMPLETED|Part 1||1
3272210|NCT02678416|4007412|FG000|STARTED|Part 2|Part 2 enrolled all new participants|67
3272211|NCT02678416|4007412|FG000|Treated (Safety Population)|Part 2||66
3272212|NCT02678416|4007412|FG000|Modified Intent to Treat Population|Part 2||66
3272213|NCT02678416|4007412|FG000|Pharmacokinetic Population|Part 2||65
2911465|NCT00484289|3621192|FG000|STARTED|Long Term Phase||13
3272214|NCT02678416|4007412|FG000|Per Protocol Population|Part 2||64
3272215|NCT02678416|4007412|FG000|COMPLETED|Part 2||64
3272216|NCT02678416|4007412|FG000|NOT COMPLETED|Part 2||3
3272217|NCT02678442|4007432|FG000|STARTED|First Intervention||25
3272218|NCT02678442|4007433|FG001|STARTED|First Intervention||25
3272219|NCT02678442|4007432|FG000|COMPLETED|First Intervention||25
3272220|NCT02678442|4007433|FG001|COMPLETED|First Intervention||25
3383511|NCT01595009|4118538|FG002|COMPLETED|Extension||0
3383512|NCT01595009|4118539|FG003|COMPLETED|Extension||0
3383513|NCT01595009|4118536|FG000|NOT COMPLETED|Extension||0
3383514|NCT01595009|4118537|FG001|NOT COMPLETED|Extension||0
3383515|NCT01595009|4118538|FG002|NOT COMPLETED|Extension||4
3383516|NCT01595009|4118539|FG003|NOT COMPLETED|Extension||11
3385791|NCT03401190|4121163|FG001|STARTED|Overall Study||6
3385792|NCT03401190|4121164|FG002|STARTED|Overall Study||7
3385793|NCT03401190|4121162|FG000|COMPLETED|Overall Study||8
2935357|NCT00611533|3647044|FG000|COMPLETED|Second Intervention (6 Weeks)||8
2935358|NCT00611533|3647045|FG001|COMPLETED|Second Intervention (6 Weeks)||4
2935359|NCT00611533|3647044|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||0
2935360|NCT00611533|3647045|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||2
2935361|NCT00611559|3647055|FG000|STARTED|Overall Study||111
2935362|NCT00611559|3647056|FG001|STARTED|Overall Study||115
2935363|NCT00611559|3647057|FG002|STARTED|Overall Study||57
2935364|NCT00611559|3647055|FG000|COMPLETED|Overall Study||110
2935365|NCT00611559|3647056|FG001|COMPLETED|Overall Study||114
2935366|NCT00611559|3647057|FG002|COMPLETED|Overall Study||56
2935367|NCT00611559|3647055|FG000|NOT COMPLETED|Overall Study||1
2935368|NCT00611559|3647056|FG001|NOT COMPLETED|Overall Study||1
2935369|NCT00611559|3647057|FG002|NOT COMPLETED|Overall Study||1
2935370|NCT00611624|3647065|FG000|STARTED|Overall Study||28
2935371|NCT00611624|3647065|FG000|COMPLETED|Overall Study||28
2935372|NCT00611624|3647065|FG000|NOT COMPLETED|Overall Study||0
2935373|NCT00611715|3647072|FG000|STARTED|Overall Study||42
2935374|NCT00611715|3647073|FG001|STARTED|Overall Study||6
2935375|NCT00611715|3647072|FG000|COMPLETED|Overall Study|"2 pts in Arm 1 remain on-tx. They are not accounted for in off-tx reasonor completed data fields"|1
2935376|NCT00611715|3647073|FG001|COMPLETED|Overall Study||0
2935377|NCT00611715|3647072|FG000|NOT COMPLETED|Overall Study||41
2935378|NCT00611715|3647073|FG001|NOT COMPLETED|Overall Study||6
2935379|NCT00611767|3647087|FG000|STARTED|Overall Study||49
2935380|NCT00611767|3647088|FG001|STARTED|Overall Study||24
2935381|NCT00611767|3647087|FG000|Thiopental Test Day|Overall Study||3
2935382|NCT00611767|3647088|FG001|Thiopental Test Day|Overall Study||1
2935383|NCT00611767|3647087|FG000|Placebo Test Day|Overall Study||6
2935384|NCT00611767|3647088|FG001|Placebo Test Day|Overall Study||1
2935385|NCT00611767|3647087|FG000|COMPLETED|Overall Study||40
2935386|NCT00611767|3647088|FG001|COMPLETED|Overall Study||22
2935387|NCT00611767|3647087|FG000|NOT COMPLETED|Overall Study||9
2935388|NCT00611767|3647088|FG001|NOT COMPLETED|Overall Study||2
2935389|NCT00611806|3647096|FG000|STARTED|Overall Study||94
2935390|NCT00611806|3647097|FG001|STARTED|Overall Study||46
2935391|NCT00611806|3647096|FG000|COMPLETED|Overall Study||78
2935392|NCT00611806|3647097|FG001|COMPLETED|Overall Study||43
2935393|NCT00611806|3647096|FG000|NOT COMPLETED|Overall Study||16
2935394|NCT00611806|3647097|FG001|NOT COMPLETED|Overall Study||3
3047705|NCT01203826|3767689|FG001|STARTED|Overall Study|Dose cohorts are per assigned dose in ENB-006-09. Results presented are for Study ENB-008-10 only.|6
3047706|NCT01203826|3767688|FG000|COMPLETED|Overall Study||6
3047707|NCT01203826|3767689|FG001|COMPLETED|Overall Study||6
3047708|NCT01203826|3767688|FG000|NOT COMPLETED|Overall Study||0
3047709|NCT01203826|3767689|FG001|NOT COMPLETED|Overall Study||0
3272221|NCT02678442|4007432|FG000|NOT COMPLETED|First Intervention||0
3272222|NCT02678442|4007433|FG001|NOT COMPLETED|First Intervention||0
3272223|NCT02678442|4007432|FG000|STARTED|Second Intervention||25
3272224|NCT02678442|4007433|FG001|STARTED|Second Intervention||25
3272225|NCT02678442|4007432|FG000|COMPLETED|Second Intervention||23
3272226|NCT02678442|4007433|FG001|COMPLETED|Second Intervention||23
3272227|NCT02678442|4007432|FG000|NOT COMPLETED|Second Intervention||2
3272228|NCT02678442|4007433|FG001|NOT COMPLETED|Second Intervention||2
3272229|NCT02678676|4007441|FG000|STARTED|Overall Study||1820
3272230|NCT02678676|4007442|FG001|STARTED|Overall Study||1779
3272231|NCT02678676|4007441|FG000|COMPLETED|Overall Study||932
3272232|NCT02678676|4007442|FG001|COMPLETED|Overall Study||907
3272233|NCT02678676|4007441|FG000|NOT COMPLETED|Overall Study||888
3272234|NCT02678676|4007442|FG001|NOT COMPLETED|Overall Study||872
3272235|NCT02678923|4007450|FG000|STARTED|Overall Study||59
3272236|NCT02678923|4007451|FG001|STARTED|Overall Study||67
3272237|NCT02678923|4007450|FG000|Received at Least 1 Dose of Study Drug|Overall Study||58
3272238|NCT02678923|4007451|FG001|Received at Least 1 Dose of Study Drug|Overall Study||64
3272239|NCT02678923|4007450|FG000|mITT Population|Overall Study||52
3272240|NCT02678923|4007451|FG001|mITT Population|Overall Study||61
3272241|NCT02678923|4007450|FG000|COMPLETED|Overall Study||53
3272242|NCT02678923|4007451|FG001|COMPLETED|Overall Study||62
3272243|NCT02678923|4007450|FG000|NOT COMPLETED|Overall Study||6
3272244|NCT02678923|4007451|FG001|NOT COMPLETED|Overall Study||5
3272245|NCT02679079|4007460|FG000|STARTED|Overall Study||33
3385794|NCT03401190|4121163|FG001|COMPLETED|Overall Study||4
3272246|NCT02679079|4007461|FG001|STARTED|Overall Study||32
3272247|NCT02679079|4007462|FG002|STARTED|Overall Study||33
3272248|NCT02679079|4007460|FG000|ITT Analysis Set|Overall Study||31
3272249|NCT02679079|4007461|FG001|ITT Analysis Set|Overall Study||32
3272250|NCT02679079|4007462|FG002|ITT Analysis Set|Overall Study||32
3272251|NCT02679079|4007460|FG000|COMPLETED|Overall Study||29
3272252|NCT02679079|4007461|FG001|COMPLETED|Overall Study||30
3272253|NCT02679079|4007462|FG002|COMPLETED|Overall Study||31
3272254|NCT02679079|4007460|FG000|NOT COMPLETED|Overall Study||4
3272255|NCT02679079|4007461|FG001|NOT COMPLETED|Overall Study||2
3272256|NCT02679079|4007462|FG002|NOT COMPLETED|Overall Study||2
3272257|NCT02679222|4007470|FG000|STARTED|Overall Study||10
3272258|NCT02679222|4007470|FG000|COMPLETED|Overall Study||9
3385795|NCT03401190|4121164|FG002|COMPLETED|Overall Study||7
3383517|NCT01620944|4118556|FG000|STARTED|Overall Study||2
3383518|NCT01620944|4118557|FG001|STARTED|Overall Study||1
3383519|NCT01620944|4118556|FG000|COMPLETED|Overall Study||0
3383520|NCT01620944|4118557|FG001|COMPLETED|Overall Study||0
3383521|NCT01620944|4118556|FG000|NOT COMPLETED|Overall Study||2
3383522|NCT01620944|4118557|FG001|NOT COMPLETED|Overall Study||1
3383523|NCT01627561|4118565|FG000|STARTED|Overall Study||74
3383524|NCT01627561|4118566|FG001|STARTED|Overall Study||74
2911466|NCT00484289|3621193|FG001|STARTED|Long Term Phase||178
2911467|NCT00484289|3621194|FG002|STARTED|Long Term Phase||26
2911468|NCT00484289|3621192|FG000|COMPLETED|Long Term Phase|Completed participants entered postmarketing phase.|10
2911469|NCT00484289|3621193|FG001|COMPLETED|Long Term Phase|Completed participants entered postmarketing phase.|142
2911470|NCT00484289|3621194|FG002|COMPLETED|Long Term Phase|Completed participants entered postmarketing phase.|10
2911471|NCT00484289|3621192|FG000|NOT COMPLETED|Long Term Phase||3
2911472|NCT00484289|3621193|FG001|NOT COMPLETED|Long Term Phase||36
2911473|NCT00484289|3621194|FG002|NOT COMPLETED|Long Term Phase||16
2911474|NCT00484289|3621192|FG000|STARTED|Post Marketing Phase||10
2911475|NCT00484289|3621193|FG001|STARTED|Post Marketing Phase||142
2911476|NCT00484289|3621194|FG002|STARTED|Post Marketing Phase||10
2911477|NCT00484289|3621192|FG000|COMPLETED|Post Marketing Phase||10
2911478|NCT00484289|3621193|FG001|COMPLETED|Post Marketing Phase||141
2911479|NCT00484289|3621194|FG002|COMPLETED|Post Marketing Phase||10
2911480|NCT00484289|3621192|FG000|NOT COMPLETED|Post Marketing Phase||0
2911481|NCT00484289|3621193|FG001|NOT COMPLETED|Post Marketing Phase||1
2911482|NCT00484289|3621194|FG002|NOT COMPLETED|Post Marketing Phase||0
2911483|NCT00484315|3621205|FG000|STARTED|12-Month Clinical Follow-up||942
2911484|NCT00484315|3621206|FG001|STARTED|12-Month Clinical Follow-up||320
2911485|NCT00484315|3621205|FG000|COMPLETED|12-Month Clinical Follow-up||914
2911486|NCT00484315|3621206|FG001|COMPLETED|12-Month Clinical Follow-up||311
2911487|NCT00484315|3621205|FG000|NOT COMPLETED|12-Month Clinical Follow-up||28
2911488|NCT00484315|3621206|FG001|NOT COMPLETED|12-Month Clinical Follow-up||9
2911489|NCT00484315|3621205|FG000|STARTED|9-Month Angiographic Follow-up||256
2911490|NCT00484315|3621206|FG001|STARTED|9-Month Angiographic Follow-up||74
2911491|NCT00484315|3621205|FG000|COMPLETED|9-Month Angiographic Follow-up||228
2911492|NCT00484315|3621206|FG001|COMPLETED|9-Month Angiographic Follow-up||61
2911493|NCT00484315|3621205|FG000|NOT COMPLETED|9-Month Angiographic Follow-up||28
2911494|NCT00484315|3621206|FG001|NOT COMPLETED|9-Month Angiographic Follow-up||13
2911495|NCT00484354|3621214|FG000|STARTED|Overall Study||64
2911496|NCT00484354|3621215|FG001|STARTED|Overall Study||59
2911497|NCT00484354|3621214|FG000|COMPLETED|Overall Study||63
2911498|NCT00484354|3621215|FG001|COMPLETED|Overall Study||57
2911499|NCT00484354|3621214|FG000|NOT COMPLETED|Overall Study||1
2911500|NCT00484354|3621215|FG001|NOT COMPLETED|Overall Study||2
2911501|NCT00484393|3621223|FG000|STARTED|Overall Study||4
2911502|NCT00484393|3621224|FG001|STARTED|Overall Study||3
2911503|NCT00484393|3621223|FG000|COMPLETED|Overall Study||4
2911504|NCT00484393|3621224|FG001|COMPLETED|Overall Study||3
2911505|NCT00484393|3621223|FG000|NOT COMPLETED|Overall Study||0
2911506|NCT00484393|3621224|FG001|NOT COMPLETED|Overall Study||0
2911507|NCT00484679|3621230|FG000|STARTED|Overall Study||18
2911508|NCT00484679|3621230|FG000|COMPLETED|Overall Study||15
2911509|NCT00484679|3621230|FG000|NOT COMPLETED|Overall Study||3
2911510|NCT00484874|3621234|FG000|STARTED|Overall Study||12
2911511|NCT00484874|3621234|FG000|COMPLETED|Overall Study||12
2911512|NCT00484874|3621234|FG000|NOT COMPLETED|Overall Study||0
2911513|NCT00484939|3621243|FG000|STARTED|Overall Study||140
2911514|NCT00484939|3621244|FG001|STARTED|Overall Study||140
2911515|NCT00484939|3621243|FG000|COMPLETED|Overall Study||0
2911516|NCT00484939|3621244|FG001|COMPLETED|Overall Study||0
2911517|NCT00484939|3621243|FG000|NOT COMPLETED|Overall Study||140
2911518|NCT00484939|3621244|FG001|NOT COMPLETED|Overall Study||140
2911519|NCT00485069|3621252|FG000|STARTED|Overall Study||65
2911520|NCT00485069|3621253|FG001|STARTED|Overall Study||58
2911521|NCT00485069|3621252|FG000|COMPLETED|Overall Study||47
2911522|NCT00485069|3621253|FG001|COMPLETED|Overall Study||46
2911523|NCT00485069|3621252|FG000|NOT COMPLETED|Overall Study||18
3272259|NCT02679222|4007470|FG000|NOT COMPLETED|Overall Study||1
3272260|NCT02679235|4007482|FG000|STARTED|Overall Study||15
2911524|NCT00485069|3621253|FG001|NOT COMPLETED|Overall Study||12
2911525|NCT00485134|3621274|FG000|STARTED|Overall Study||12
2911526|NCT00485134|3621275|FG001|STARTED|Overall Study||12
2911527|NCT00485134|3621276|FG002|STARTED|Overall Study||12
2911528|NCT00485134|3621277|FG003|STARTED|Overall Study||8
2911529|NCT00485134|3621278|FG004|STARTED|Overall Study||10
2911530|NCT00485134|3621279|FG005|STARTED|Overall Study||7
2911531|NCT00485134|3621280|FG006|STARTED|Overall Study||31
2935395|NCT00611858|3647103|FG000|STARTED|Overall Study||13
2935396|NCT00611858|3647103|FG000|COMPLETED|Overall Study||9
2935397|NCT00611858|3647103|FG000|NOT COMPLETED|Overall Study||4
2935398|NCT00611884|3647113|FG000|STARTED|Overall Study||61
2935399|NCT00611884|3647114|FG001|STARTED|Overall Study||60
2935400|NCT00611884|3647115|FG002|STARTED|Overall Study||62
2935401|NCT00611884|3647116|FG003|STARTED|Overall Study||62
2935402|NCT00611884|3647113|FG000|Exposed|Overall Study|Three subjects withdrew prior to exposure to trial drug|58
2935403|NCT00611884|3647114|FG001|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|59
2935404|NCT00611884|3647115|FG002|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|61
3383525|NCT01627561|4118565|FG000|COMPLETED|Overall Study||73
3383526|NCT01627561|4118566|FG001|COMPLETED|Overall Study||71
3383527|NCT01627561|4118565|FG000|NOT COMPLETED|Overall Study||1
3383528|NCT01627561|4118566|FG001|NOT COMPLETED|Overall Study||3
3385796|NCT03401190|4121162|FG000|NOT COMPLETED|Overall Study||0
3385797|NCT03401190|4121163|FG001|NOT COMPLETED|Overall Study||2
3385798|NCT03401190|4121164|FG002|NOT COMPLETED|Overall Study||0
3385799|NCT03392753|4121178|FG000|STARTED|Overall Study||83
3385800|NCT03392753|4121179|FG001|STARTED|Overall Study||84
3385801|NCT03392753|4121178|FG000|COMPLETED|Overall Study||47
3385802|NCT03392753|4121179|FG001|COMPLETED|Overall Study||50
3385803|NCT03392753|4121178|FG000|NOT COMPLETED|Overall Study||36
3385804|NCT03392753|4121179|FG001|NOT COMPLETED|Overall Study||34
3385805|NCT03212963|4121185|FG000|STARTED|Overall Study||16
2911532|NCT00485134|3621281|FG007|STARTED|Overall Study||21
3272261|NCT02679235|4007482|FG000|COMPLETED|Overall Study||11
3272262|NCT02679235|4007482|FG000|NOT COMPLETED|Overall Study||4
3272263|NCT02679274|4007488|FG000|STARTED|Overall Study||2
3272264|NCT02679274|4007489|FG001|STARTED|Overall Study||1
3272265|NCT02679274|4007488|FG000|COMPLETED|Overall Study||1
3272266|NCT02679274|4007489|FG001|COMPLETED|Overall Study||1
3272267|NCT02679274|4007488|FG000|NOT COMPLETED|Overall Study||1
3272268|NCT02679274|4007489|FG001|NOT COMPLETED|Overall Study||0
3272269|NCT02679287|4007497|FG000|STARTED|Period 1: Randomization-Study Session 1||47
3272270|NCT02679287|4007498|FG001|STARTED|Period 1: Randomization-Study Session 1||46
3272271|NCT02679287|4007497|FG000|COMPLETED|Period 1: Randomization-Study Session 1||43
3272272|NCT02679287|4007498|FG001|COMPLETED|Period 1: Randomization-Study Session 1||40
3272273|NCT02679287|4007497|FG000|NOT COMPLETED|Period 1: Randomization-Study Session 1||4
3272274|NCT02679287|4007498|FG001|NOT COMPLETED|Period 1: Randomization-Study Session 1||6
3272275|NCT02679287|4007497|FG000|STARTED|Period 2||43
3272276|NCT02679287|4007498|FG001|STARTED|Period 2||40
3272277|NCT02679287|4007497|FG000|COMPLETED|Period 2||40
3272278|NCT02679287|4007498|FG001|COMPLETED|Period 2||40
3272279|NCT02679287|4007497|FG000|NOT COMPLETED|Period 2||3
3272280|NCT02679287|4007498|FG001|NOT COMPLETED|Period 2||0
3272281|NCT02679287|4007497|FG000|STARTED|Period 3||40
3272282|NCT02679287|4007498|FG001|STARTED|Period 3||40
3272283|NCT02679287|4007497|FG000|COMPLETED|Period 3||40
3272284|NCT02679287|4007498|FG001|COMPLETED|Period 3||39
3272285|NCT02679287|4007497|FG000|NOT COMPLETED|Period 3||0
3272286|NCT02679287|4007498|FG001|NOT COMPLETED|Period 3||1
3272287|NCT02679287|4007497|FG000|STARTED|Phase 4||40
3272288|NCT02679287|4007498|FG001|STARTED|Phase 4||39
3272289|NCT02679287|4007497|FG000|COMPLETED|Phase 4||40
3272290|NCT02679287|4007498|FG001|COMPLETED|Phase 4||39
3272291|NCT02679287|4007497|FG000|NOT COMPLETED|Phase 4||0
3272292|NCT02679287|4007498|FG001|NOT COMPLETED|Phase 4||0
3272293|NCT02679469|4007510|FG000|STARTED|Overall Study||7
3272294|NCT02679469|4007510|FG000|COMPLETED|Overall Study||7
3272295|NCT02679469|4007510|FG000|NOT COMPLETED|Overall Study||0
3272296|NCT02679573|4007516|FG000|STARTED|Overall Study||431
3272297|NCT02679573|4007517|FG001|STARTED|Overall Study||428
3272298|NCT02679573|4007516|FG000|COMPLETED|Overall Study||394
3272299|NCT02679573|4007517|FG001|COMPLETED|Overall Study||389
3272300|NCT02679573|4007516|FG000|NOT COMPLETED|Overall Study||37
3272301|NCT02679573|4007517|FG001|NOT COMPLETED|Overall Study||39
3272302|NCT02679690|4007523|FG000|STARTED|Overall Study||10
3272303|NCT02679690|4007523|FG000|COMPLETED|Overall Study||9
3272304|NCT02679690|4007523|FG000|NOT COMPLETED|Overall Study||1
3272305|NCT02679729|4007538|FG000|STARTED|Overall Study||6
3272306|NCT02679729|4007539|FG001|STARTED|Overall Study||7
3272307|NCT02679729|4007540|FG002|STARTED|Overall Study||6
3272308|NCT02679729|4007541|FG003|STARTED|Overall Study||6
3272309|NCT02679729|4007542|FG004|STARTED|Overall Study||6
3272310|NCT02679729|4007543|FG005|STARTED|Overall Study||6
3272311|NCT02679729|4007544|FG006|STARTED|Overall Study||6
3272312|NCT02679729|4007545|FG007|STARTED|Overall Study||14
3272313|NCT02679729|4007546|FG008|STARTED|Overall Study||6
3272314|NCT02679729|4007538|FG000|COMPLETED|Overall Study||6
3272315|NCT02679729|4007539|FG001|COMPLETED|Overall Study||5
3272316|NCT02679729|4007540|FG002|COMPLETED|Overall Study||6
3272317|NCT02679729|4007541|FG003|COMPLETED|Overall Study||6
3272318|NCT02679729|4007542|FG004|COMPLETED|Overall Study||5
3272319|NCT02679729|4007543|FG005|COMPLETED|Overall Study||6
3272320|NCT02679729|4007544|FG006|COMPLETED|Overall Study||5
3272321|NCT02679729|4007545|FG007|COMPLETED|Overall Study||14
3272322|NCT02679729|4007546|FG008|COMPLETED|Overall Study||6
3272323|NCT02679729|4007538|FG000|NOT COMPLETED|Overall Study||0
3272324|NCT02679729|4007539|FG001|NOT COMPLETED|Overall Study||2
3272325|NCT02679729|4007540|FG002|NOT COMPLETED|Overall Study||0
3272326|NCT02679729|4007541|FG003|NOT COMPLETED|Overall Study||0
3272327|NCT02679729|4007542|FG004|NOT COMPLETED|Overall Study||1
3272328|NCT02679729|4007543|FG005|NOT COMPLETED|Overall Study||0
3272329|NCT02679729|4007544|FG006|NOT COMPLETED|Overall Study||1
3272330|NCT02679729|4007545|FG007|NOT COMPLETED|Overall Study||0
3272331|NCT02679729|4007546|FG008|NOT COMPLETED|Overall Study||0
3272332|NCT02679755|4007580|FG000|STARTED|Overall Study||100
3272333|NCT02679755|4007581|FG001|STARTED|Overall Study||152
3272334|NCT02679755|4007580|FG000|COMPLETED|Overall Study||66
3272335|NCT02679755|4007581|FG001|COMPLETED|Overall Study||47
3272336|NCT02679755|4007580|FG000|NOT COMPLETED|Overall Study||34
3272337|NCT02679755|4007581|FG001|NOT COMPLETED|Overall Study||105
3272338|NCT02679807|4007592|FG000|STARTED|Overall Study||165
3385806|NCT03212963|4121185|FG000|COMPLETED|Overall Study||16
3383529|NCT01629511|4118576|FG000|STARTED|Overall Study||4
3383530|NCT01629511|4118577|FG001|STARTED|Overall Study||0
3383531|NCT01629511|4118578|FG002|STARTED|Overall Study||8
3383532|NCT01629511|4118579|FG003|STARTED|Overall Study||3
3383533|NCT01629511|4118576|FG000|COMPLETED|Overall Study||4
3383534|NCT01629511|4118577|FG001|COMPLETED|Overall Study||0
3383535|NCT01629511|4118578|FG002|COMPLETED|Overall Study||8
3272339|NCT02679807|4007593|FG001|STARTED|Overall Study||169
3272340|NCT02679807|4007592|FG000|COMPLETED|Overall Study||143
3272341|NCT02679807|4007593|FG001|COMPLETED|Overall Study||153
3272342|NCT02679807|4007592|FG000|NOT COMPLETED|Overall Study||22
3272343|NCT02679807|4007593|FG001|NOT COMPLETED|Overall Study||16
3272344|NCT02679911|4007599|FG000|STARTED|Overall Study|Intra-individual study|20
3272345|NCT02679911|4007599|FG000|COMPLETED|Overall Study||20
3272346|NCT02679911|4007599|FG000|NOT COMPLETED|Overall Study||0
3272347|NCT02679976|4007604|FG000|STARTED|Overall Study||30
3272348|NCT02679976|4007604|FG000|Hyperopes|Overall Study||16
3272349|NCT02679976|4007604|FG000|Myopes|Overall Study||14
3272350|NCT02679976|4007604|FG000|COMPLETED|Overall Study||30
3272351|NCT02679976|4007604|FG000|NOT COMPLETED|Overall Study||0
3272352|NCT02680002|4007615|FG000|STARTED|Overall Study||71
3272353|NCT02680002|4007616|FG001|STARTED|Overall Study||70
3272354|NCT02680002|4007617|FG002|STARTED|Overall Study||70
3272355|NCT02680002|4007618|FG003|STARTED|Overall Study||71
3272356|NCT02680002|4007619|FG004|STARTED|Overall Study||70
3272357|NCT02680002|4007620|FG005|STARTED|Overall Study||70
3272358|NCT02680002|4007615|FG000|Day 0 (Dose 1)|Overall Study||70
3272359|NCT02680002|4007616|FG001|Day 0 (Dose 1)|Overall Study||70
3272360|NCT02680002|4007617|FG002|Day 0 (Dose 1)|Overall Study||70
3272361|NCT02680002|4007618|FG003|Day 0 (Dose 1)|Overall Study||71
3272362|NCT02680002|4007619|FG004|Day 0 (Dose 1)|Overall Study||70
3272363|NCT02680002|4007620|FG005|Day 0 (Dose 1)|Overall Study||68
3272364|NCT02680002|4007615|FG000|Day 21 (Dose 2)|Overall Study||63
3272365|NCT02680002|4007616|FG001|Day 21 (Dose 2)|Overall Study||68
3272366|NCT02680002|4007617|FG002|Day 21 (Dose 2)|Overall Study||65
3272367|NCT02680002|4007618|FG003|Day 21 (Dose 2)|Overall Study||69
3272368|NCT02680002|4007619|FG004|Day 21 (Dose 2)|Overall Study||65
3272369|NCT02680002|4007620|FG005|Day 21 (Dose 2)|Overall Study||63
3272370|NCT02680002|4007615|FG000|Day 201|Overall Study||58
3272371|NCT02680002|4007616|FG001|Day 201|Overall Study||66
3272372|NCT02680002|4007617|FG002|Day 201|Overall Study||60
3272373|NCT02680002|4007618|FG003|Day 201|Overall Study||67
3272374|NCT02680002|4007619|FG004|Day 201|Overall Study||59
3272375|NCT02680002|4007620|FG005|Day 201|Overall Study||61
3272376|NCT02680002|4007615|FG000|COMPLETED|Overall Study||58
3272377|NCT02680002|4007616|FG001|COMPLETED|Overall Study||66
3272378|NCT02680002|4007617|FG002|COMPLETED|Overall Study||60
3272379|NCT02680002|4007618|FG003|COMPLETED|Overall Study||67
3272380|NCT02680002|4007619|FG004|COMPLETED|Overall Study||59
3272381|NCT02680002|4007620|FG005|COMPLETED|Overall Study||61
3272382|NCT02680002|4007615|FG000|NOT COMPLETED|Overall Study||13
3272383|NCT02680002|4007616|FG001|NOT COMPLETED|Overall Study||4
3272384|NCT02680002|4007617|FG002|NOT COMPLETED|Overall Study||10
3272385|NCT02680002|4007618|FG003|NOT COMPLETED|Overall Study||4
3272386|NCT02680002|4007619|FG004|NOT COMPLETED|Overall Study||11
3272387|NCT02680002|4007620|FG005|NOT COMPLETED|Overall Study||9
3272388|NCT02680041|4007637|FG000|STARTED|Overall Study||221
3272389|NCT02680041|4007637|FG000|Received 18F-fluciclovine|Overall Study||213
3272390|NCT02680041|4007637|FG000|COMPLETED|Overall Study||211
3272391|NCT02680041|4007637|FG000|NOT COMPLETED|Overall Study||10
3272392|NCT02680054|4007642|FG000|STARTED|Overall Study||38
3272393|NCT02680054|4007642|FG000|COMPLETED|Overall Study||27
3272394|NCT02680054|4007642|FG000|NOT COMPLETED|Overall Study||11
3272395|NCT02680145|4007651|FG000|STARTED|Overall Study||58
3272396|NCT02680145|4007651|FG000|COMPLETED|Overall Study||47
3272397|NCT02680145|4007651|FG000|NOT COMPLETED|Overall Study||11
3272398|NCT02680158|4007655|FG000|STARTED|Overall Study||8
3272399|NCT02680158|4007656|FG001|STARTED|Overall Study||8
3272400|NCT02680158|4007657|FG002|STARTED|Overall Study||8
3272401|NCT02680158|4007658|FG003|STARTED|Overall Study||8
3272402|NCT02680158|4007659|FG004|STARTED|Overall Study||8
3272403|NCT02680158|4007660|FG005|STARTED|Overall Study||8
3272404|NCT02680158|4007655|FG000|COMPLETED|Overall Study||8
3272405|NCT02680158|4007656|FG001|COMPLETED|Overall Study||8
3272406|NCT02680158|4007657|FG002|COMPLETED|Overall Study||8
3272407|NCT02680158|4007658|FG003|COMPLETED|Overall Study||8
3272408|NCT02680158|4007659|FG004|COMPLETED|Overall Study||8
3272409|NCT02680158|4007660|FG005|COMPLETED|Overall Study||8
3272410|NCT02680158|4007655|FG000|NOT COMPLETED|Overall Study||0
3272411|NCT02680158|4007656|FG001|NOT COMPLETED|Overall Study||0
3272412|NCT02680158|4007657|FG002|NOT COMPLETED|Overall Study||0
3272413|NCT02680158|4007658|FG003|NOT COMPLETED|Overall Study||0
3272414|NCT02680158|4007659|FG004|NOT COMPLETED|Overall Study||0
3272415|NCT02680158|4007660|FG005|NOT COMPLETED|Overall Study||0
3272416|NCT02680301|4007670|FG000|STARTED|Overall Study||22
3272417|NCT02680301|4007671|FG001|STARTED|Overall Study||18
3272418|NCT02680301|4007670|FG000|COMPLETED|Overall Study||22
3272419|NCT02680301|4007671|FG001|COMPLETED|Overall Study||17
3272420|NCT02680301|4007670|FG000|NOT COMPLETED|Overall Study||0
3272421|NCT02680301|4007671|FG001|NOT COMPLETED|Overall Study||1
3383536|NCT01629511|4118579|FG003|COMPLETED|Overall Study||3
3383537|NCT01629511|4118576|FG000|NOT COMPLETED|Overall Study||0
3383538|NCT01629511|4118577|FG001|NOT COMPLETED|Overall Study||0
3272422|NCT02680314|4007680|FG000|STARTED|Overall Study||120
3272423|NCT02680314|4007681|FG001|STARTED|Overall Study||123
3272424|NCT02680314|4007680|FG000|COMPLETED|Overall Study||120
3383539|NCT01629511|4118578|FG002|NOT COMPLETED|Overall Study||0
3383540|NCT01629511|4118579|FG003|NOT COMPLETED|Overall Study||0
3385807|NCT03212963|4121185|FG000|NOT COMPLETED|Overall Study||0
3385808|NCT03135262|4121194|FG000|STARTED|Overall Study||9
3385809|NCT03135262|4121195|FG001|STARTED|Overall Study||6
3385810|NCT03135262|4121196|FG002|STARTED|Overall Study||7
3385811|NCT03135262|4121197|FG003|STARTED|Overall Study||6
3385812|NCT03135262|4121198|FG004|STARTED|Overall Study||1
3385813|NCT03135262|4121194|FG000|COMPLETED|Overall Study|The study was terminated after escalation phase. The planned expansion phase did not take place due to the early termination.|0
3385814|NCT03135262|4121195|FG001|COMPLETED|Overall Study|The study was terminated after escalation phase. The planned expansion phase did not take place due to the early termination.|0
2911533|NCT00485134|3621274|FG000|COMPLETED|Overall Study||11
2911534|NCT00485134|3621275|FG001|COMPLETED|Overall Study||10
2911535|NCT00485134|3621276|FG002|COMPLETED|Overall Study||9
2911536|NCT00485134|3621277|FG003|COMPLETED|Overall Study||7
2911537|NCT00485134|3621278|FG004|COMPLETED|Overall Study||7
2911538|NCT00485134|3621279|FG005|COMPLETED|Overall Study||3
2911539|NCT00485134|3621280|FG006|COMPLETED|Overall Study||28
2911540|NCT00485134|3621281|FG007|COMPLETED|Overall Study||20
2911541|NCT00485134|3621274|FG000|NOT COMPLETED|Overall Study||1
2911542|NCT00485134|3621275|FG001|NOT COMPLETED|Overall Study||2
2911543|NCT00485134|3621276|FG002|NOT COMPLETED|Overall Study||3
2911544|NCT00485134|3621277|FG003|NOT COMPLETED|Overall Study||1
2911545|NCT00485134|3621278|FG004|NOT COMPLETED|Overall Study||3
2911546|NCT00485134|3621279|FG005|NOT COMPLETED|Overall Study||4
2911547|NCT00485134|3621280|FG006|NOT COMPLETED|Overall Study||3
2911548|NCT00485134|3621281|FG007|NOT COMPLETED|Overall Study||1
2911549|NCT00485173|3621295|FG000|STARTED|Overall Study||224
2911550|NCT00485173|3621296|FG001|STARTED|Overall Study||486
2911551|NCT00485173|3621295|FG000|COMPLETED|Overall Study|The number of completed participants is reported the number of subjects who had any 24-month data.|188
2911552|NCT00485173|3621296|FG001|COMPLETED|Overall Study|The number of completed participants is reported the number of subjects who had any 24-month data.|422
2911553|NCT00485173|3621295|FG000|NOT COMPLETED|Overall Study||36
2911554|NCT00485173|3621296|FG001|NOT COMPLETED|Overall Study||64
2911555|NCT00485264|3621308|FG000|STARTED|Overall Study||71
2911556|NCT00485264|3621309|FG001|STARTED|Overall Study||16
2911557|NCT00485264|3621310|FG002|STARTED|Overall Study||18
2911558|NCT00485264|3621311|FG003|STARTED|Overall Study||21
2935405|NCT00611884|3647116|FG003|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|61
2935406|NCT00611884|3647113|FG000|COMPLETED|Overall Study||52
2935407|NCT00611884|3647114|FG001|COMPLETED|Overall Study||51
2935408|NCT00611884|3647115|FG002|COMPLETED|Overall Study||58
2935409|NCT00611884|3647116|FG003|COMPLETED|Overall Study||56
2935410|NCT00611884|3647113|FG000|NOT COMPLETED|Overall Study||9
2935411|NCT00611884|3647114|FG001|NOT COMPLETED|Overall Study||9
2935412|NCT00611884|3647115|FG002|NOT COMPLETED|Overall Study||4
2935413|NCT00611884|3647116|FG003|NOT COMPLETED|Overall Study||6
2935414|NCT00611897|3647126|FG000|STARTED|Day 1: Initial Treatment||8
2935415|NCT00611897|3647127|FG001|STARTED|Day 1: Initial Treatment||8
2935416|NCT00611897|3647126|FG000|COMPLETED|Day 1: Initial Treatment||8
2935417|NCT00611897|3647127|FG001|COMPLETED|Day 1: Initial Treatment||8
2935418|NCT00611897|3647126|FG000|NOT COMPLETED|Day 1: Initial Treatment||0
2935419|NCT00611897|3647127|FG001|NOT COMPLETED|Day 1: Initial Treatment||0
2935420|NCT00611897|3647126|FG000|STARTED|Day 2: Crossover Treatment||8
2935421|NCT00611897|3647127|FG001|STARTED|Day 2: Crossover Treatment||8
2935422|NCT00611897|3647126|FG000|COMPLETED|Day 2: Crossover Treatment||8
2935423|NCT00611897|3647127|FG001|COMPLETED|Day 2: Crossover Treatment||8
2935424|NCT00611897|3647126|FG000|NOT COMPLETED|Day 2: Crossover Treatment||0
2935425|NCT00611897|3647127|FG001|NOT COMPLETED|Day 2: Crossover Treatment||0
2935426|NCT00611923|3647137|FG000|STARTED|Overall Study||12
3272425|NCT02680314|4007681|FG001|COMPLETED|Overall Study||123
3272426|NCT02680314|4007680|FG000|NOT COMPLETED|Overall Study||0
3272427|NCT02680314|4007681|FG001|NOT COMPLETED|Overall Study||0
3272428|NCT02680457|4007687|FG000|STARTED|Initial Intervention||6
3272429|NCT02680457|4007688|FG001|STARTED|Initial Intervention||6
3272430|NCT02680457|4007687|FG000|COMPLETED|Initial Intervention||6
3272431|NCT02680457|4007688|FG001|COMPLETED|Initial Intervention||6
3272432|NCT02680457|4007687|FG000|NOT COMPLETED|Initial Intervention||0
3272433|NCT02680457|4007688|FG001|NOT COMPLETED|Initial Intervention||0
3272434|NCT02680457|4007687|FG000|STARTED|Washout Period||6
3272435|NCT02680457|4007688|FG001|STARTED|Washout Period||6
3272436|NCT02680457|4007687|FG000|COMPLETED|Washout Period||6
3272437|NCT02680457|4007688|FG001|COMPLETED|Washout Period||6
3272438|NCT02680457|4007687|FG000|NOT COMPLETED|Washout Period||0
3272439|NCT02680457|4007688|FG001|NOT COMPLETED|Washout Period||0
3272440|NCT02680457|4007687|FG000|STARTED|Cross-over Intervention||6
3272441|NCT02680457|4007688|FG001|STARTED|Cross-over Intervention||6
3272442|NCT02680457|4007687|FG000|COMPLETED|Cross-over Intervention||6
3272443|NCT02680457|4007688|FG001|COMPLETED|Cross-over Intervention||6
3272444|NCT02680457|4007687|FG000|NOT COMPLETED|Cross-over Intervention||0
3272445|NCT02680457|4007688|FG001|NOT COMPLETED|Cross-over Intervention||0
3272446|NCT02680639|4007694|FG000|STARTED|Screening Period||10
3272447|NCT02680639|4007695|FG001|STARTED|Screening Period||0
3383541|NCT01652534|4118591|FG000|STARTED|Overall Study||2
3383542|NCT01652534|4118592|FG001|STARTED|Overall Study||1
3383543|NCT01652534|4118591|FG000|COMPLETED|Overall Study||1
3383544|NCT01652534|4118592|FG001|COMPLETED|Overall Study||1
3383545|NCT01652534|4118591|FG000|NOT COMPLETED|Overall Study||1
3383546|NCT01652534|4118592|FG001|NOT COMPLETED|Overall Study||0
3383547|NCT01701583|4118600|FG000|STARTED|Overall Study||7
3383548|NCT01701583|4118601|FG001|STARTED|Overall Study||3
3383549|NCT01701583|4118600|FG000|COMPLETED|Overall Study||5
3383550|NCT01701583|4118601|FG001|COMPLETED|Overall Study||3
3383551|NCT01701583|4118600|FG000|NOT COMPLETED|Overall Study||2
3383552|NCT01701583|4118601|FG001|NOT COMPLETED|Overall Study||0
3383553|NCT01714817|4118610|FG000|STARTED|Year 1 Period||203
3383554|NCT01714817|4118611|FG001|STARTED|Year 1 Period||203
3383555|NCT01714817|4118610|FG000|Treated|Year 1 Period||202
3383556|NCT01714817|4118611|FG001|Treated|Year 1 Period||203
3383557|NCT01714817|4118610|FG000|COMPLETED|Year 1 Period|Completed = continued study through Year 1|155
3383558|NCT01714817|4118611|FG001|COMPLETED|Year 1 Period|Completed = continued study through Year 1|161
3383559|NCT01714817|4118610|FG000|NOT COMPLETED|Year 1 Period||48
3383560|NCT01714817|4118611|FG001|NOT COMPLETED|Year 1 Period||42
3383561|NCT01714817|4118610|FG000|STARTED|Year 2 Period|Started = Completed Year 1|155
3383562|NCT01714817|4118611|FG001|STARTED|Year 2 Period|Started = Completed Year 1|161
3383563|NCT01714817|4118610|FG000|COMPLETED|Year 2 Period|Completed = Continued study through Year 2|129
3383564|NCT01714817|4118611|FG001|COMPLETED|Year 2 Period|Completed = Continued study through Year 2|123
3383565|NCT01714817|4118610|FG000|NOT COMPLETED|Year 2 Period||26
3383566|NCT01714817|4118611|FG001|NOT COMPLETED|Year 2 Period||38
3383567|NCT01714817|4118610|FG000|STARTED|Long-Term Extension (LTE) Period|Started = Completed Year 2|129
3383568|NCT01714817|4118611|FG001|STARTED|Long-Term Extension (LTE) Period|Started = Completed Year 2|123
3383569|NCT01714817|4118610|FG000|COMPLETED|Long-Term Extension (LTE) Period|Completed = Continued study through LTE|62
3383570|NCT01714817|4118611|FG001|COMPLETED|Long-Term Extension (LTE) Period|Completed = Continued study through LTE|53
3383571|NCT01714817|4118610|FG000|NOT COMPLETED|Long-Term Extension (LTE) Period||67
3383572|NCT01714817|4118611|FG001|NOT COMPLETED|Long-Term Extension (LTE) Period||70
3383573|NCT01755689|4118624|FG000|STARTED|Overall Study||259
3383574|NCT01755689|4118625|FG001|STARTED|Overall Study||259
3383575|NCT01755689|4118626|FG002|STARTED|Overall Study||261
3383576|NCT01755689|4118627|FG003|STARTED|Overall Study||260
3383577|NCT01755689|4118628|FG004|STARTED|Overall Study||261
3383578|NCT01755689|4118624|FG000|COMPLETED|Overall Study||256
3383579|NCT01755689|4118625|FG001|COMPLETED|Overall Study||254
3383580|NCT01755689|4118626|FG002|COMPLETED|Overall Study||255
3383581|NCT01755689|4118627|FG003|COMPLETED|Overall Study||254
3383582|NCT01755689|4118628|FG004|COMPLETED|Overall Study||255
3383583|NCT01755689|4118624|FG000|NOT COMPLETED|Overall Study||3
3383584|NCT01755689|4118625|FG001|NOT COMPLETED|Overall Study||5
3383585|NCT01755689|4118626|FG002|NOT COMPLETED|Overall Study||6
3383586|NCT01755689|4118627|FG003|NOT COMPLETED|Overall Study||6
3383587|NCT01755689|4118628|FG004|NOT COMPLETED|Overall Study||6
3383588|NCT01762761|4118650|FG000|STARTED|Overall Study||51
3383589|NCT01762761|4118651|FG001|STARTED|Overall Study||104
3383590|NCT01762761|4118650|FG000|COMPLETED|Overall Study||12
3383591|NCT01762761|4118651|FG001|COMPLETED|Overall Study||39
3383592|NCT01762761|4118650|FG000|NOT COMPLETED|Overall Study||39
3383593|NCT01762761|4118651|FG001|NOT COMPLETED|Overall Study||65
3385815|NCT03135262|4121196|FG002|COMPLETED|Overall Study|The study was terminated after escalation phase. The planned expansion phase did not take place due to the early termination.|0
2935427|NCT00611923|3647138|FG001|STARTED|Overall Study||13
2935428|NCT00611923|3647137|FG000|COMPLETED|Overall Study||10
2935429|NCT00611923|3647138|FG001|COMPLETED|Overall Study||11
2935430|NCT00611923|3647137|FG000|NOT COMPLETED|Overall Study||2
2935431|NCT00611923|3647138|FG001|NOT COMPLETED|Overall Study||2
2935432|NCT00611975|3647148|FG000|STARTED|Overall Study||45
2935433|NCT00611975|3647149|FG001|STARTED|Overall Study||38
2935434|NCT00611975|3647148|FG000|COMPLETED|Overall Study||40
2935435|NCT00611975|3647149|FG001|COMPLETED|Overall Study||30
2935436|NCT00611975|3647148|FG000|NOT COMPLETED|Overall Study||5
2935437|NCT00611975|3647149|FG001|NOT COMPLETED|Overall Study||8
2935438|NCT00612040|3647158|FG000|STARTED|Overall Study||60
2935439|NCT00612040|3647159|FG001|STARTED|Overall Study||59
2935440|NCT00612040|3647160|FG002|STARTED|Overall Study||59
2935441|NCT00612040|3647158|FG000|Exposed|Overall Study||60
2935442|NCT00612040|3647159|FG001|Exposed|Overall Study||59
2935443|NCT00612040|3647160|FG002|Exposed|Overall Study||59
2935444|NCT00612040|3647158|FG000|COMPLETED|Overall Study||55
2935445|NCT00612040|3647159|FG001|COMPLETED|Overall Study||52
2935446|NCT00612040|3647160|FG002|COMPLETED|Overall Study||52
2935447|NCT00612040|3647158|FG000|NOT COMPLETED|Overall Study||5
2935448|NCT00612040|3647159|FG001|NOT COMPLETED|Overall Study||7
2935449|NCT00612040|3647160|FG002|NOT COMPLETED|Overall Study||7
2935450|NCT00612066|3647168|FG000|STARTED|Overall Study||2
2935451|NCT00612066|3647168|FG000|COMPLETED|Overall Study||1
2935452|NCT00612066|3647168|FG000|NOT COMPLETED|Overall Study||1
2935453|NCT00612105|3647174|FG000|STARTED|Period Title 1: 6-Week Titration Phase||125
2935454|NCT00612105|3647175|FG001|STARTED|Period Title 1: 6-Week Titration Phase||62
2935455|NCT00612105|3647174|FG000|COMPLETED|Period Title 1: 6-Week Titration Phase||89
2935456|NCT00612105|3647175|FG001|COMPLETED|Period Title 1: 6-Week Titration Phase||57
2935457|NCT00612105|3647174|FG000|NOT COMPLETED|Period Title 1: 6-Week Titration Phase||36
2935458|NCT00612105|3647175|FG001|NOT COMPLETED|Period Title 1: 6-Week Titration Phase||5
2935459|NCT00612105|3647174|FG000|STARTED|Period Title 2: 4-Week Maintenance Phase||89
2935460|NCT00612105|3647175|FG001|STARTED|Period Title 2: 4-Week Maintenance Phase||57
2935461|NCT00612105|3647174|FG000|COMPLETED|Period Title 2: 4-Week Maintenance Phase||78
2935462|NCT00612105|3647175|FG001|COMPLETED|Period Title 2: 4-Week Maintenance Phase||55
2935463|NCT00612105|3647174|FG000|NOT COMPLETED|Period Title 2: 4-Week Maintenance Phase||11
2935464|NCT00612105|3647175|FG001|NOT COMPLETED|Period Title 2: 4-Week Maintenance Phase||2
2935465|NCT00612105|3647174|FG000|STARTED|Period Title 3: 3-Week Taper Phase|Includes participants who discontinued during the titration phase and entered taper phase.|86
2935466|NCT00612105|3647175|FG001|STARTED|Period Title 3: 3-Week Taper Phase|Includes participants who discontinued during the titration phase and entered taper phase.|58
2935467|NCT00612105|3647174|FG000|COMPLETED|Period Title 3: 3-Week Taper Phase||85
2935468|NCT00612105|3647175|FG001|COMPLETED|Period Title 3: 3-Week Taper Phase||58
2935469|NCT00612105|3647174|FG000|NOT COMPLETED|Period Title 3: 3-Week Taper Phase||1
2935470|NCT00612105|3647175|FG001|NOT COMPLETED|Period Title 3: 3-Week Taper Phase||0
2935471|NCT00612222|3647181|FG000|STARTED|Overall Study||4
2935472|NCT00612222|3647181|FG000|COMPLETED|Overall Study||4
2935473|NCT00612222|3647181|FG000|NOT COMPLETED|Overall Study||0
2935474|NCT00612235|3647189|FG000|STARTED|Overall Study||20
2935475|NCT00612235|3647190|FG001|STARTED|Overall Study||20
2935476|NCT00612235|3647191|FG002|STARTED|Overall Study||20
2935477|NCT00612235|3647192|FG003|STARTED|Overall Study||20
2935478|NCT00612235|3647189|FG000|COMPLETED|Overall Study||20
2935479|NCT00612235|3647190|FG001|COMPLETED|Overall Study||20
2935480|NCT00612235|3647191|FG002|COMPLETED|Overall Study||20
2935481|NCT00612235|3647192|FG003|COMPLETED|Overall Study||20
2935482|NCT00612235|3647189|FG000|NOT COMPLETED|Overall Study||0
2935483|NCT00612235|3647190|FG001|NOT COMPLETED|Overall Study||0
2935484|NCT00612235|3647191|FG002|NOT COMPLETED|Overall Study||0
2935485|NCT00612235|3647192|FG003|NOT COMPLETED|Overall Study||0
2935486|NCT00612313|3647205|FG000|STARTED|Overall Study||69
2935487|NCT00612313|3647206|FG001|STARTED|Overall Study||75
2935488|NCT00612313|3647205|FG000|COMPLETED|Overall Study||52
2935489|NCT00612313|3647206|FG001|COMPLETED|Overall Study||62
2935490|NCT00612313|3647205|FG000|NOT COMPLETED|Overall Study||17
2935491|NCT00612313|3647206|FG001|NOT COMPLETED|Overall Study||13
2935492|NCT00612339|3647218|FG000|STARTED|Overall Study||41
2935493|NCT00612339|3647218|FG000|COMPLETED|Overall Study||41
2935494|NCT00612339|3647218|FG000|NOT COMPLETED|Overall Study||0
2935495|NCT00612352|3647224|FG000|STARTED|Overall Study||65
2935496|NCT00612352|3647225|FG001|STARTED|Overall Study||115
2935497|NCT00612352|3647224|FG000|40%mg & 100%mg|Overall Study||1
2935498|NCT00612352|3647225|FG001|40%mg & 100%mg|Overall Study||1
2935499|NCT00612352|3647224|FG000|Placebo & 100%mg|Overall Study||1
2935500|NCT00612352|3647225|FG001|Placebo & 100%mg|Overall Study||0
2935501|NCT00612352|3647224|FG000|100%mg|Overall Study||2
2935502|NCT00612352|3647225|FG001|100%mg|Overall Study||1
2935503|NCT00612352|3647224|FG000|40%mg|Overall Study||1
2935504|NCT00612352|3647225|FG001|40%mg|Overall Study||0
2935505|NCT00612352|3647224|FG000|Placebo|Overall Study||4
2935506|NCT00612352|3647225|FG001|Placebo|Overall Study||4
2935507|NCT00612352|3647224|FG000|COMPLETED|Overall Study||56
2935508|NCT00612352|3647225|FG001|COMPLETED|Overall Study||109
2935509|NCT00612352|3647224|FG000|NOT COMPLETED|Overall Study||9
2935510|NCT00612352|3647225|FG001|NOT COMPLETED|Overall Study||6
2935511|NCT00612430|3647233|FG000|STARTED|Overall Study||32
2935512|NCT00612430|3647234|FG001|STARTED|Overall Study||27
2935513|NCT00612430|3647233|FG000|COMPLETED|Overall Study||32
2935514|NCT00612430|3647234|FG001|COMPLETED|Overall Study||27
2935515|NCT00612430|3647233|FG000|NOT COMPLETED|Overall Study||0
2935516|NCT00612430|3647234|FG001|NOT COMPLETED|Overall Study||0
2935517|NCT00612456|3647245|FG000|STARTED|Overall Study||27
2935518|NCT00612456|3647246|FG001|STARTED|Overall Study||27
2935519|NCT00612456|3647247|FG002|STARTED|Overall Study||16
2935520|NCT00612456|3647245|FG000|COMPLETED|Overall Study||25
2935521|NCT00612456|3647246|FG001|COMPLETED|Overall Study||25
2935522|NCT00612456|3647247|FG002|COMPLETED|Overall Study||16
2935523|NCT00612456|3647245|FG000|NOT COMPLETED|Overall Study||2
2935524|NCT00612456|3647246|FG001|NOT COMPLETED|Overall Study||2
2935525|NCT00612456|3647247|FG002|NOT COMPLETED|Overall Study||0
2935526|NCT00612508|3647259|FG000|STARTED|Overall Study||7
2935527|NCT00612508|3647260|FG001|STARTED|Overall Study||7
2935528|NCT00612508|3647259|FG000|COMPLETED|Overall Study|5 desogen users returned for the 84 day biopsy|4
2935529|NCT00612508|3647260|FG001|COMPLETED|Overall Study|6 nuvaring users returned for the 84 day biopsy|3
2935530|NCT00612508|3647259|FG000|NOT COMPLETED|Overall Study||3
2935531|NCT00612508|3647260|FG001|NOT COMPLETED|Overall Study||4
2935532|NCT00612534|3647272|FG000|STARTED|Overall Study||24
2935533|NCT00612534|3647273|FG001|STARTED|Overall Study||26
2935534|NCT00612534|3647274|FG002|STARTED|Overall Study||20
2935535|NCT00612534|3647275|FG003|STARTED|Overall Study||24
2935536|NCT00612534|3647272|FG000|COMPLETED|Overall Study||11
2935537|NCT00612534|3647273|FG001|COMPLETED|Overall Study||9
2935538|NCT00612534|3647274|FG002|COMPLETED|Overall Study||13
2935539|NCT00612534|3647275|FG003|COMPLETED|Overall Study||7
2935540|NCT00612534|3647272|FG000|NOT COMPLETED|Overall Study||13
2935541|NCT00612534|3647273|FG001|NOT COMPLETED|Overall Study||17
2935542|NCT00612534|3647274|FG002|NOT COMPLETED|Overall Study||7
2935543|NCT00612534|3647275|FG003|NOT COMPLETED|Overall Study||17
2935544|NCT00612560|3647289|FG000|STARTED|Overall Study||7
2935545|NCT00612560|3647290|FG001|STARTED|Overall Study||7
2935546|NCT00612560|3647291|FG002|STARTED|Overall Study||8
2935547|NCT00612560|3647292|FG003|STARTED|Overall Study||6
2935548|NCT00612560|3647289|FG000|COMPLETED|Overall Study||7
2935549|NCT00612560|3647290|FG001|COMPLETED|Overall Study||7
2935550|NCT00612560|3647291|FG002|COMPLETED|Overall Study||8
2935551|NCT00612560|3647292|FG003|COMPLETED|Overall Study||6
2935552|NCT00612560|3647289|FG000|NOT COMPLETED|Overall Study||0
2935553|NCT00612560|3647290|FG001|NOT COMPLETED|Overall Study||0
2935554|NCT00612560|3647291|FG002|NOT COMPLETED|Overall Study||0
2935555|NCT00612560|3647292|FG003|NOT COMPLETED|Overall Study||0
2935556|NCT00612573|3647306|FG000|STARTED|Overall Study||64
2935557|NCT00612573|3647307|FG001|STARTED|Overall Study||65
2935558|NCT00612573|3647308|FG002|STARTED|Overall Study||61
2935559|NCT00612573|3647309|FG003|STARTED|Overall Study||67
2935560|NCT00612573|3647306|FG000|COMPLETED|Overall Study||52
2935561|NCT00612573|3647307|FG001|COMPLETED|Overall Study||51
2935562|NCT00612573|3647308|FG002|COMPLETED|Overall Study||52
2935563|NCT00612573|3647309|FG003|COMPLETED|Overall Study||54
2935564|NCT00612573|3647306|FG000|NOT COMPLETED|Overall Study||12
2935565|NCT00612573|3647307|FG001|NOT COMPLETED|Overall Study||14
2935566|NCT00612573|3647308|FG002|NOT COMPLETED|Overall Study||9
2935567|NCT00612573|3647309|FG003|NOT COMPLETED|Overall Study||13
2935568|NCT00612586|3647321|FG000|STARTED|Overall Study||58
2935569|NCT00612586|3647322|FG001|STARTED|Overall Study||59
3272448|NCT02680639|4007696|FG002|STARTED|Screening Period||0
3272449|NCT02680639|4007694|FG000|COMPLETED|Screening Period||3
3272450|NCT02680639|4007695|FG001|COMPLETED|Screening Period||0
3272451|NCT02680639|4007696|FG002|COMPLETED|Screening Period||0
3272452|NCT02680639|4007694|FG000|NOT COMPLETED|Screening Period||7
3272453|NCT02680639|4007695|FG001|NOT COMPLETED|Screening Period||0
3272454|NCT02680639|4007696|FG002|NOT COMPLETED|Screening Period||0
3272455|NCT02680639|4007694|FG000|STARTED|High Frequency Oscillation (HFO) Therapy||0
3272456|NCT02680639|4007695|FG001|STARTED|High Frequency Oscillation (HFO) Therapy||2
3272457|NCT02680639|4007696|FG002|STARTED|High Frequency Oscillation (HFO) Therapy||1
3272458|NCT02680639|4007694|FG000|COMPLETED|High Frequency Oscillation (HFO) Therapy||0
3272459|NCT02680639|4007695|FG001|COMPLETED|High Frequency Oscillation (HFO) Therapy||2
3272460|NCT02680639|4007696|FG002|COMPLETED|High Frequency Oscillation (HFO) Therapy||1
3272461|NCT02680639|4007694|FG000|NOT COMPLETED|High Frequency Oscillation (HFO) Therapy||0
3272462|NCT02680639|4007695|FG001|NOT COMPLETED|High Frequency Oscillation (HFO) Therapy||0
3272463|NCT02680639|4007696|FG002|NOT COMPLETED|High Frequency Oscillation (HFO) Therapy||0
3272464|NCT02680665|4007706|FG000|STARTED|Overall Study||120
3272465|NCT02680665|4007706|FG000|COMPLETED|Overall Study||115
3272466|NCT02680665|4007706|FG000|NOT COMPLETED|Overall Study||5
3272467|NCT02680756|4007712|FG000|STARTED|Overall Study||125
3272468|NCT02680756|4007713|FG001|STARTED|Overall Study||125
3272469|NCT02680756|4007712|FG000|Received Treatment|Overall Study||127
3272470|NCT02680756|4007713|FG001|Received Treatment|Overall Study||120
3272471|NCT02680756|4007712|FG000|COMPLETED|Overall Study||93
3272472|NCT02680756|4007713|FG001|COMPLETED|Overall Study||106
3272473|NCT02680756|4007712|FG000|NOT COMPLETED|Overall Study||32
3272474|NCT02680756|4007713|FG001|NOT COMPLETED|Overall Study||19
3272475|NCT02680834|4007721|FG000|STARTED|Overall Study||26
3272476|NCT02680834|4007722|FG001|STARTED|Overall Study||30
3272477|NCT02680834|4007721|FG000|COMPLETED|Overall Study||15
3272478|NCT02680834|4007722|FG001|COMPLETED|Overall Study||27
3272479|NCT02680834|4007721|FG000|NOT COMPLETED|Overall Study||11
3272480|NCT02680834|4007722|FG001|NOT COMPLETED|Overall Study||3
3272481|NCT02680847|4007731|FG000|STARTED|Overall Study||16
3272482|NCT02680847|4007732|FG001|STARTED|Overall Study||9
3272483|NCT02680847|4007733|FG002|STARTED|Overall Study||7
3272484|NCT02680847|4007731|FG000|COMPLETED|Overall Study||11
3272485|NCT02680847|4007732|FG001|COMPLETED|Overall Study||6
3272486|NCT02680847|4007733|FG002|COMPLETED|Overall Study||4
3272487|NCT02680847|4007731|FG000|NOT COMPLETED|Overall Study||5
3272488|NCT02680847|4007732|FG001|NOT COMPLETED|Overall Study||3
3272489|NCT02680847|4007733|FG002|NOT COMPLETED|Overall Study||3
3272490|NCT02681094|4007744|FG000|STARTED|1 -Modified Enrolled Participants Set||293
3272491|NCT02681094|4007745|FG001|STARTED|1 -Modified Enrolled Participants Set|A participant was randomized but did not receive treatment|294
3272492|NCT02681094|4007746|FG002|STARTED|1 -Modified Enrolled Participants Set|A participant was randomized but did not receive treatment|296
3272493|NCT02681094|4007744|FG000|Participants Completed Treatment Period|1 -Modified Enrolled Participants Set||273
3272494|NCT02681094|4007745|FG001|Participants Completed Treatment Period|1 -Modified Enrolled Participants Set||276
3272495|NCT02681094|4007746|FG002|Participants Completed Treatment Period|1 -Modified Enrolled Participants Set||283
3272496|NCT02681094|4007744|FG000|COMPLETED|1 -Modified Enrolled Participants Set||256
3272497|NCT02681094|4007745|FG001|COMPLETED|1 -Modified Enrolled Participants Set||255
3272498|NCT02681094|4007746|FG002|COMPLETED|1 -Modified Enrolled Participants Set||243
3272499|NCT02681094|4007744|FG000|NOT COMPLETED|1 -Modified Enrolled Participants Set||37
3272500|NCT02681094|4007745|FG001|NOT COMPLETED|1 -Modified Enrolled Participants Set||39
2935570|NCT00612586|3647321|FG000|Received at Least 1 Dose|Overall Study||57
2935571|NCT00612586|3647322|FG001|Received at Least 1 Dose|Overall Study||58
2935572|NCT00612586|3647321|FG000|COMPLETED|Overall Study||15
2935573|NCT00612586|3647322|FG001|COMPLETED|Overall Study||18
2935574|NCT00612586|3647321|FG000|NOT COMPLETED|Overall Study||43
2935575|NCT00612586|3647322|FG001|NOT COMPLETED|Overall Study||41
2935576|NCT00612690|3647331|FG000|STARTED|Overall Study||275
2935577|NCT00612690|3647332|FG001|STARTED|Overall Study||207
2935578|NCT00612690|3647331|FG000|COMPLETED|Overall Study||160
2935579|NCT00612690|3647332|FG001|COMPLETED|Overall Study||89
2935580|NCT00612690|3647331|FG000|NOT COMPLETED|Overall Study||115
2935581|NCT00612690|3647332|FG001|NOT COMPLETED|Overall Study||118
2935582|NCT00612716|3647340|FG000|STARTED|Overall Study||6
2935583|NCT00612716|3647340|FG000|COMPLETED|Overall Study||6
2935584|NCT00612716|3647340|FG000|NOT COMPLETED|Overall Study||0
2935585|NCT00612768|3647344|FG000|STARTED|Overall Study||50
2935586|NCT00612768|3647344|FG000|COMPLETED|Overall Study||50
2935587|NCT00612768|3647344|FG000|NOT COMPLETED|Overall Study||0
2935588|NCT00612807|3647371|FG000|STARTED|Overall Study||14
2935589|NCT00612807|3647372|FG001|STARTED|Overall Study||28
2935590|NCT00612807|3647371|FG000|COMPLETED|Overall Study||12
3272501|NCT02681094|4007746|FG002|NOT COMPLETED|1 -Modified Enrolled Participants Set||53
3272502|NCT02681094|4007744|FG000|STARTED|2 - Enrolled Participants Set|Population was used for the sensitivity analysis to assess the robustness of the treatment effect.|301
3272503|NCT02681094|4007745|FG001|STARTED|2 - Enrolled Participants Set|Population was used for the sensitivity analysis to assess the robustness of the treatment effect.|302
3272504|NCT02681094|4007746|FG002|STARTED|2 - Enrolled Participants Set|Population was used for the sensitivity analysis to assess the robustness of the treatment effect.|302
3272505|NCT02681094|4007744|FG000|Participants Completed Treatment Period|2 - Enrolled Participants Set||281
3272506|NCT02681094|4007745|FG001|Participants Completed Treatment Period|2 - Enrolled Participants Set|A participant was randomized but did not receive treatment due to screen failure.|284
3272507|NCT02681094|4007746|FG002|Participants Completed Treatment Period|2 - Enrolled Participants Set|A participant was randomized but did not receive treatment due to screen failure.|289
3272508|NCT02681094|4007744|FG000|COMPLETED|2 - Enrolled Participants Set||261
3272509|NCT02681094|4007745|FG001|COMPLETED|2 - Enrolled Participants Set||261
3272510|NCT02681094|4007746|FG002|COMPLETED|2 - Enrolled Participants Set||248
3272511|NCT02681094|4007744|FG000|NOT COMPLETED|2 - Enrolled Participants Set||40
3272512|NCT02681094|4007745|FG001|NOT COMPLETED|2 - Enrolled Participants Set||41
3272513|NCT02681094|4007746|FG002|NOT COMPLETED|2 - Enrolled Participants Set||54
3272514|NCT02681172|4007755|FG000|STARTED|Overall Study||218
3272515|NCT02681172|4007755|FG000|Safety Analysis Set|Overall Study||205
3272516|NCT02681172|4007755|FG000|Full Analysis Set|Overall Study||205
3272517|NCT02681172|4007755|FG000|Per Protocol Set|Overall Study||205
3272518|NCT02681172|4007755|FG000|COMPLETED|Overall Study||205
3272519|NCT02681172|4007755|FG000|NOT COMPLETED|Overall Study||13
3272520|NCT02681458|4007761|FG000|STARTED|Overall Study||718
3272521|NCT02681458|4007762|FG001|STARTED|Overall Study||718
3272522|NCT02681458|4007761|FG000|COMPLETED|Overall Study||73
3272523|NCT02681458|4007762|FG001|COMPLETED|Overall Study||62
3272524|NCT02681458|4007761|FG000|NOT COMPLETED|Overall Study||645
3272525|NCT02681458|4007762|FG001|NOT COMPLETED|Overall Study||656
3272526|NCT02681510|4007768|FG000|STARTED|Overall Study||36
3272527|NCT02681510|4007768|FG000|COMPLETED|Overall Study||26
3272528|NCT02681510|4007768|FG000|NOT COMPLETED|Overall Study||10
3272529|NCT02681523|4007772|FG000|STARTED|Overall Study||8
3272530|NCT02681523|4007772|FG000|COMPLETED|Overall Study||6
3272531|NCT02681523|4007772|FG000|NOT COMPLETED|Overall Study||2
3272532|NCT02681614|4007776|FG000|STARTED|Overall Study||5
3272533|NCT02681614|4007776|FG000|COMPLETED|Overall Study||5
3272534|NCT02681614|4007776|FG000|NOT COMPLETED|Overall Study||0
3272535|NCT02681757|4007783|FG000|STARTED|Overall Study||47
3272536|NCT02681757|4007784|FG001|STARTED|Overall Study||49
3272537|NCT02681757|4007783|FG000|COMPLETED|Overall Study||47
3272538|NCT02681757|4007784|FG001|COMPLETED|Overall Study||49
3272539|NCT02681757|4007783|FG000|NOT COMPLETED|Overall Study||0
3272540|NCT02681757|4007784|FG001|NOT COMPLETED|Overall Study||0
3272541|NCT02681809|4007793|FG000|STARTED|Overall Study||20
3272542|NCT02681809|4007794|FG001|STARTED|Overall Study||19
3272543|NCT02681809|4007795|FG002|STARTED|Overall Study||9
3272544|NCT02681809|4007793|FG000|COMPLETED|Overall Study||15
3272545|NCT02681809|4007794|FG001|COMPLETED|Overall Study||15
3272546|NCT02681809|4007795|FG002|COMPLETED|Overall Study||8
3272547|NCT02681809|4007793|FG000|NOT COMPLETED|Overall Study||5
3272548|NCT02681809|4007794|FG001|NOT COMPLETED|Overall Study||4
3272549|NCT02681809|4007795|FG002|NOT COMPLETED|Overall Study||1
3272550|NCT02682030|4007805|FG000|STARTED|Overall Study||1
3272551|NCT02682030|4007806|FG001|STARTED|Overall Study||4
3272552|NCT02682030|4007805|FG000|COMPLETED|Overall Study||0
3272553|NCT02682030|4007806|FG001|COMPLETED|Overall Study||2
3272554|NCT02682030|4007805|FG000|NOT COMPLETED|Overall Study||1
3272555|NCT02682030|4007806|FG001|NOT COMPLETED|Overall Study||2
3272556|NCT02682056|4007813|FG000|STARTED|Overall Study||15
3272557|NCT02682056|4007813|FG000|COMPLETED|Overall Study||15
3272558|NCT02682056|4007813|FG000|NOT COMPLETED|Overall Study||0
3272559|NCT02682069|4007821|FG000|STARTED|Overall Study||30
3272560|NCT02682069|4007821|FG000|COMPLETED|Overall Study||30
3272561|NCT02682069|4007821|FG000|NOT COMPLETED|Overall Study||0
3272562|NCT02682264|4007827|FG000|STARTED|Overall Study||317
3272563|NCT02682264|4007828|FG001|STARTED|Overall Study||290
3272564|NCT02682264|4007827|FG000|COMPLETED|Overall Study||179
3272565|NCT02682264|4007828|FG001|COMPLETED|Overall Study||168
3272566|NCT02682264|4007827|FG000|NOT COMPLETED|Overall Study||138
2935591|NCT00612807|3647372|FG001|COMPLETED|Overall Study||28
2935592|NCT00612807|3647371|FG000|NOT COMPLETED|Overall Study||2
2935593|NCT00612807|3647372|FG001|NOT COMPLETED|Overall Study||0
2935594|NCT00612924|3647380|FG000|STARTED|Overall Study||101
2935595|NCT00612924|3647381|FG001|STARTED|Overall Study||94
2935596|NCT00612924|3647380|FG000|COMPLETED|Overall Study||94
2935597|NCT00612924|3647381|FG001|COMPLETED|Overall Study||85
2935598|NCT00612924|3647380|FG000|NOT COMPLETED|Overall Study||7
2935599|NCT00612924|3647381|FG001|NOT COMPLETED|Overall Study||9
2935600|NCT00613015|3647394|FG000|STARTED|Overall Study||13
2935601|NCT00613015|3647395|FG001|STARTED|Overall Study||12
2935602|NCT00613015|3647396|FG002|STARTED|Overall Study||26
2935603|NCT00613015|3647397|FG003|STARTED|Overall Study||24
2935604|NCT00613015|3647398|FG004|STARTED|Overall Study||15
2935605|NCT00613015|3647399|FG005|STARTED|Overall Study||19
3272567|NCT02682264|4007828|FG001|NOT COMPLETED|Overall Study||122
3272568|NCT02682381|4007837|FG000|STARTED|Overall Study||24
3272569|NCT02682381|4007838|FG001|STARTED|Overall Study||26
3272570|NCT02682381|4007839|FG002|STARTED|Overall Study||9
3272571|NCT02682381|4007837|FG000|COMPLETED|Overall Study||24
3272572|NCT02682381|4007838|FG001|COMPLETED|Overall Study||26
3272573|NCT02682381|4007839|FG002|COMPLETED|Overall Study||9
3272574|NCT02682381|4007837|FG000|NOT COMPLETED|Overall Study||0
3272575|NCT02682381|4007838|FG001|NOT COMPLETED|Overall Study||0
3272576|NCT02682381|4007839|FG002|NOT COMPLETED|Overall Study||0
3272577|NCT02682420|4007847|FG000|STARTED|Overall Study||100
3272578|NCT02682420|4007847|FG000|COMPLETED|Overall Study|Note: 63 participants completed the 6-month visit. The study was discontinued prematurely due to company acquisition and therefore, many participants did not complete their 12-month visit.|63
3272579|NCT02682420|4007847|FG000|NOT COMPLETED|Overall Study||37
3272580|NCT02682498|4007860|FG000|STARTED|Overall Study||18
3272581|NCT02682498|4007861|FG001|STARTED|Overall Study||20
3272582|NCT02682498|4007860|FG000|COMPLETED|Overall Study||18
3272583|NCT02682498|4007861|FG001|COMPLETED|Overall Study||20
3272584|NCT02682498|4007860|FG000|NOT COMPLETED|Overall Study||0
3272585|NCT02682498|4007861|FG001|NOT COMPLETED|Overall Study||0
3272586|NCT02682563|4007870|FG000|STARTED|Overall Study||24
3272587|NCT02682563|4007871|FG001|STARTED|Overall Study||20
3272588|NCT02682563|4007870|FG000|COMPLETED|Overall Study||24
3272589|NCT02682563|4007871|FG001|COMPLETED|Overall Study||20
3272590|NCT02682563|4007870|FG000|NOT COMPLETED|Overall Study||0
3272591|NCT02682563|4007871|FG001|NOT COMPLETED|Overall Study||0
3272592|NCT02682602|4007879|FG000|STARTED|Pre-operative Diseased & Normal Hips||11
3272593|NCT02682602|4007880|FG001|STARTED|Pre-operative Diseased & Normal Hips||10
3272594|NCT02682602|4007879|FG000|COMPLETED|Pre-operative Diseased & Normal Hips||10
3272595|NCT02682602|4007880|FG001|COMPLETED|Pre-operative Diseased & Normal Hips||10
3272596|NCT02682602|4007879|FG000|NOT COMPLETED|Pre-operative Diseased & Normal Hips||1
3272597|NCT02682602|4007880|FG001|NOT COMPLETED|Pre-operative Diseased & Normal Hips||0
3272598|NCT02682602|4007879|FG000|STARTED|Post-operative Fluoroscopy for Implanted||10
3272599|NCT02682602|4007880|FG001|STARTED|Post-operative Fluoroscopy for Implanted||0
3272600|NCT02682602|4007879|FG000|COMPLETED|Post-operative Fluoroscopy for Implanted||7
3272601|NCT02682602|4007880|FG001|COMPLETED|Post-operative Fluoroscopy for Implanted|Nonimplanted subjects were not analyzed again for the second period, because this would be redundant|0
3272602|NCT02682602|4007879|FG000|NOT COMPLETED|Post-operative Fluoroscopy for Implanted||3
3272603|NCT02682602|4007880|FG001|NOT COMPLETED|Post-operative Fluoroscopy for Implanted||0
3272604|NCT02682784|4007894|FG000|STARTED|Overall Study||40
3272605|NCT02682784|4007895|FG001|STARTED|Overall Study||37
3272606|NCT02682784|4007896|FG002|STARTED|Overall Study||29
3272607|NCT02682784|4007897|FG003|STARTED|Overall Study||32
3272608|NCT02682784|4007894|FG000|COMPLETED|Overall Study||39
3272609|NCT02682784|4007895|FG001|COMPLETED|Overall Study||35
3272610|NCT02682784|4007896|FG002|COMPLETED|Overall Study||27
3272611|NCT02682784|4007897|FG003|COMPLETED|Overall Study||29
3272612|NCT02682784|4007894|FG000|NOT COMPLETED|Overall Study||1
3272613|NCT02682784|4007895|FG001|NOT COMPLETED|Overall Study||2
3272614|NCT02682784|4007896|FG002|NOT COMPLETED|Overall Study||2
3272615|NCT02682784|4007897|FG003|NOT COMPLETED|Overall Study||3
3272616|NCT02682823|4007912|FG000|STARTED|Overall Study||17
3272617|NCT02682823|4007913|FG001|STARTED|Overall Study||19
3272618|NCT02682823|4007914|FG002|STARTED|Overall Study||19
3272619|NCT02682823|4007915|FG003|STARTED|Overall Study||17
3272620|NCT02682823|4007916|FG004|STARTED|Overall Study||19
3272621|NCT02682823|4007912|FG000|Safety Population|Overall Study|All CGs who administered at least one dose of study drug.|17
3272622|NCT02682823|4007913|FG001|Safety Population|Overall Study|All HCPs who administered at least one dose of study drug.|19
3272623|NCT02682823|4007914|FG002|Safety Population|Overall Study|All participants who received at least one dose of study drug.|18
3272624|NCT02682823|4007915|FG003|Safety Population|Overall Study|All participants who received at least one dose of study drug.|17
3272625|NCT02682823|4007916|FG004|Safety Population|Overall Study|All participants who received at least one dose of study drug.|19
3272626|NCT02682823|4007912|FG000|COMPLETED|Overall Study||17
3272627|NCT02682823|4007913|FG001|COMPLETED|Overall Study||18
3272628|NCT02682823|4007914|FG002|COMPLETED|Overall Study||18
3272629|NCT02682823|4007915|FG003|COMPLETED|Overall Study||16
3272630|NCT02682823|4007916|FG004|COMPLETED|Overall Study||18
3272631|NCT02682823|4007912|FG000|NOT COMPLETED|Overall Study||0
2935606|NCT00613015|3647394|FG000|COMPLETED|Overall Study||13
2935607|NCT00613015|3647395|FG001|COMPLETED|Overall Study|One participant did not complete the one-week follow-up visit.|11
2935608|NCT00613015|3647396|FG002|COMPLETED|Overall Study|Three participants did not complete one-week follow-up visit.|23
2935609|NCT00613015|3647397|FG003|COMPLETED|Overall Study|Three participants did not complete one-week follow-up visit.|21
2935610|NCT00613015|3647398|FG004|COMPLETED|Overall Study|Two participants did not complete one-week follow-up visit.|13
2935611|NCT00613015|3647399|FG005|COMPLETED|Overall Study|Three participants did not complete one-week follow-up visit.|16
2935612|NCT00613015|3647394|FG000|NOT COMPLETED|Overall Study||0
2935613|NCT00613015|3647395|FG001|NOT COMPLETED|Overall Study||1
2935614|NCT00613015|3647396|FG002|NOT COMPLETED|Overall Study||3
2935615|NCT00613015|3647397|FG003|NOT COMPLETED|Overall Study||3
3272632|NCT02682823|4007913|FG001|NOT COMPLETED|Overall Study||1
3272633|NCT02682823|4007914|FG002|NOT COMPLETED|Overall Study||1
3272634|NCT02682823|4007915|FG003|NOT COMPLETED|Overall Study||1
3272635|NCT02682823|4007916|FG004|NOT COMPLETED|Overall Study||1
3272636|NCT02683083|4007928|FG000|STARTED|Overall Study||9
3272637|NCT02683083|4007928|FG000|COMPLETED|Overall Study||9
3272638|NCT02683083|4007928|FG000|NOT COMPLETED|Overall Study||0
3272639|NCT02683109|4007934|FG000|STARTED|Overall Study||110
3272640|NCT02683109|4007935|FG001|STARTED|Overall Study||111
3272641|NCT02683109|4007934|FG000|COMPLETED|Overall Study||109
3272642|NCT02683109|4007935|FG001|COMPLETED|Overall Study||111
3272643|NCT02683109|4007934|FG000|NOT COMPLETED|Overall Study||1
3272644|NCT02683109|4007935|FG001|NOT COMPLETED|Overall Study||0
3272645|NCT02683161|4007942|FG000|STARTED|Overall Study||5
3272646|NCT02683161|4007942|FG000|COMPLETED|Overall Study||5
3272647|NCT02683161|4007942|FG000|NOT COMPLETED|Overall Study||0
3272648|NCT02683174|4007946|FG000|STARTED|Overall Study||86
3272649|NCT02683174|4007946|FG000|COMPLETED|Overall Study||86
3272650|NCT02683174|4007946|FG000|NOT COMPLETED|Overall Study||0
3272651|NCT02683187|4007951|FG000|STARTED|Overall Study||40
3272652|NCT02683187|4007951|FG000|COMPLETED|Overall Study||32
3272653|NCT02683187|4007951|FG000|NOT COMPLETED|Overall Study||8
3272654|NCT02683421|4007963|FG000|STARTED|Overall Study||5
3272655|NCT02683421|4007964|FG001|STARTED|Overall Study||4
3272656|NCT02683421|4007965|FG002|STARTED|Overall Study||4
3272657|NCT02683421|4007966|FG003|STARTED|Overall Study||5
3272658|NCT02683421|4007963|FG000|COMPLETED|Overall Study||5
3272659|NCT02683421|4007964|FG001|COMPLETED|Overall Study||4
3272660|NCT02683421|4007965|FG002|COMPLETED|Overall Study||4
3272661|NCT02683421|4007966|FG003|COMPLETED|Overall Study||5
3272662|NCT02683421|4007963|FG000|NOT COMPLETED|Overall Study||0
3272663|NCT02683421|4007964|FG001|NOT COMPLETED|Overall Study||0
3272664|NCT02683421|4007965|FG002|NOT COMPLETED|Overall Study||0
3272665|NCT02683421|4007966|FG003|NOT COMPLETED|Overall Study||0
3272666|NCT02683525|4007976|FG000|STARTED|Overall Study||37
3272667|NCT02683525|4007976|FG000|COMPLETED|Overall Study||29
3272668|NCT02683525|4007976|FG000|NOT COMPLETED|Overall Study||8
3272669|NCT02683577|4007983|FG000|STARTED|Overall Study||8
3272670|NCT02683577|4007984|FG001|STARTED|Overall Study||8
3272671|NCT02683577|4007985|FG002|STARTED|Overall Study||8
3272672|NCT02683577|4007983|FG000|COMPLETED|Overall Study||8
3272673|NCT02683577|4007984|FG001|COMPLETED|Overall Study||8
3272674|NCT02683577|4007985|FG002|COMPLETED|Overall Study||8
3272675|NCT02683577|4007983|FG000|NOT COMPLETED|Overall Study||0
3272676|NCT02683577|4007984|FG001|NOT COMPLETED|Overall Study||0
3272677|NCT02683577|4007985|FG002|NOT COMPLETED|Overall Study||0
3272678|NCT02683668|4007995|FG000|STARTED|Period 1||44
3272679|NCT02683668|4007996|FG001|STARTED|Period 1||0
3272680|NCT02683668|4007997|FG002|STARTED|Period 1||0
3272681|NCT02683668|4007995|FG000|COMPLETED|Period 1||44
3272682|NCT02683668|4007996|FG001|COMPLETED|Period 1||0
3272683|NCT02683668|4007997|FG002|COMPLETED|Period 1||0
3272684|NCT02683668|4007995|FG000|NOT COMPLETED|Period 1||0
3272685|NCT02683668|4007996|FG001|NOT COMPLETED|Period 1||0
3272686|NCT02683668|4007997|FG002|NOT COMPLETED|Period 1||0
3272687|NCT02683668|4007995|FG000|STARTED|Period 2||0
3272688|NCT02683668|4007996|FG001|STARTED|Period 2||44
3272689|NCT02683668|4007997|FG002|STARTED|Period 2||0
3272690|NCT02683668|4007995|FG000|COMPLETED|Period 2||0
3272691|NCT02683668|4007996|FG001|COMPLETED|Period 2||43
3272692|NCT02683668|4007997|FG002|COMPLETED|Period 2||0
3272693|NCT02683668|4007995|FG000|NOT COMPLETED|Period 2||0
3272694|NCT02683668|4007996|FG001|NOT COMPLETED|Period 2||1
3272695|NCT02683668|4007997|FG002|NOT COMPLETED|Period 2||0
3272696|NCT02683668|4007995|FG000|STARTED|Period 3||0
3272697|NCT02683668|4007996|FG001|STARTED|Period 3||0
3272698|NCT02683668|4007997|FG002|STARTED|Period 3||43
3272699|NCT02683668|4007995|FG000|COMPLETED|Period 3||0
3272700|NCT02683668|4007996|FG001|COMPLETED|Period 3||0
3272701|NCT02683668|4007997|FG002|COMPLETED|Period 3||43
3272702|NCT02683668|4007995|FG000|NOT COMPLETED|Period 3||0
3272703|NCT02683668|4007996|FG001|NOT COMPLETED|Period 3||0
3272704|NCT02683668|4007997|FG002|NOT COMPLETED|Period 3||0
3272705|NCT02683707|4008005|FG000|STARTED|Overall Study||105
3272706|NCT02683707|4008006|FG001|STARTED|Overall Study||107
3272707|NCT02683707|4008005|FG000|COMPLETED|Overall Study||105
3272708|NCT02683707|4008006|FG001|COMPLETED|Overall Study||107
3272709|NCT02683707|4008005|FG000|NOT COMPLETED|Overall Study||0
3272710|NCT02683707|4008006|FG001|NOT COMPLETED|Overall Study||0
3272711|NCT02683746|4008014|FG000|STARTED|Overall Study||154
3272712|NCT02683746|4008015|FG001|STARTED|Overall Study||154
3272713|NCT02683746|4008014|FG000|COMPLETED|Overall Study||138
3272714|NCT02683746|4008015|FG001|COMPLETED|Overall Study||140
3272715|NCT02683746|4008014|FG000|NOT COMPLETED|Overall Study||16
3272716|NCT02683746|4008015|FG001|NOT COMPLETED|Overall Study||14
3272717|NCT02683772|4008021|FG000|STARTED|Overall Study||15
2935616|NCT00613015|3647398|FG004|NOT COMPLETED|Overall Study||2
2935617|NCT00613015|3647399|FG005|NOT COMPLETED|Overall Study||3
2935618|NCT00613028|3647415|FG000|STARTED|Overall Study||10
2935619|NCT00613028|3647416|FG001|STARTED|Overall Study||13
2935620|NCT00613028|3647415|FG000|COMPLETED|Overall Study||10
2935621|NCT00613028|3647416|FG001|COMPLETED|Overall Study||12
3272718|NCT02683772|4008022|FG001|STARTED|Overall Study||23
3272719|NCT02683772|4008021|FG000|COMPLETED|Overall Study||15
3272720|NCT02683772|4008022|FG001|COMPLETED|Overall Study||23
3272721|NCT02683772|4008021|FG000|NOT COMPLETED|Overall Study||0
3272722|NCT02683772|4008022|FG001|NOT COMPLETED|Overall Study||0
3272723|NCT02683785|4008034|FG000|STARTED|Overall Study||22
3272724|NCT02683785|4008035|FG001|STARTED|Overall Study||22
3272725|NCT02683785|4008034|FG000|COMPLETED|Overall Study||21
3272726|NCT02683785|4008035|FG001|COMPLETED|Overall Study||18
3272727|NCT02683785|4008034|FG000|NOT COMPLETED|Overall Study||1
3272728|NCT02683785|4008035|FG001|NOT COMPLETED|Overall Study||4
3272729|NCT02683876|4008045|FG000|STARTED|Overall Study||17
3272730|NCT02683876|4008046|FG001|STARTED|Overall Study||22
3272731|NCT02683876|4008045|FG000|COMPLETED|Overall Study||15
3272732|NCT02683876|4008046|FG001|COMPLETED|Overall Study||22
3272733|NCT02683876|4008045|FG000|NOT COMPLETED|Overall Study||2
3272734|NCT02683876|4008046|FG001|NOT COMPLETED|Overall Study||0
3316269|NCT03108157|4049515|FG000|COMPLETED|Overall Study||161
3316270|NCT03108157|4049516|FG001|COMPLETED|Overall Study||172
3316271|NCT03108157|4049515|FG000|NOT COMPLETED|Overall Study||15
3316272|NCT03108157|4049516|FG001|NOT COMPLETED|Overall Study||4
3316273|NCT03108469|4049525|FG000|STARTED|Overall Study||15
3316274|NCT03108469|4049526|FG001|STARTED|Overall Study||15
3316275|NCT03108469|4049525|FG000|COMPLETED|Overall Study||11
3316276|NCT03108469|4049526|FG001|COMPLETED|Overall Study||11
3316277|NCT03108469|4049525|FG000|NOT COMPLETED|Overall Study||4
3316278|NCT03108469|4049526|FG001|NOT COMPLETED|Overall Study||4
3316279|NCT03108482|4049536|FG000|STARTED|Overall Study||183
3316280|NCT03108482|4049537|FG001|STARTED|Overall Study||183
3316281|NCT03108482|4049538|FG002|STARTED|Overall Study||182
3316282|NCT03108482|4049539|FG003|STARTED|Overall Study||89
3316283|NCT03108482|4049536|FG000|COMPLETED|Overall Study||183
3316284|NCT03108482|4049537|FG001|COMPLETED|Overall Study||179
3316285|NCT03108482|4049538|FG002|COMPLETED|Overall Study||180
3316286|NCT03108482|4049539|FG003|COMPLETED|Overall Study||86
3316287|NCT03108482|4049536|FG000|NOT COMPLETED|Overall Study||0
3316288|NCT03108482|4049537|FG001|NOT COMPLETED|Overall Study||4
3316289|NCT03108482|4049538|FG002|NOT COMPLETED|Overall Study||2
3316290|NCT03108482|4049539|FG003|NOT COMPLETED|Overall Study||3
3316291|NCT03108521|4049551|FG000|STARTED|Overall Study||83
3316292|NCT03108521|4049552|FG001|STARTED|Overall Study||36
3316293|NCT03108521|4049551|FG000|COMPLETED|Overall Study||71
3316294|NCT03108521|4049552|FG001|COMPLETED|Overall Study||36
3316295|NCT03108521|4049551|FG000|NOT COMPLETED|Overall Study||12
3316296|NCT03108521|4049552|FG001|NOT COMPLETED|Overall Study||0
3316297|NCT03108924|4049566|FG000|STARTED|Overall Study||6
3316298|NCT03108924|4049567|FG001|STARTED|Overall Study||6
3316299|NCT03108924|4049568|FG002|STARTED|Overall Study||6
3316300|NCT03108924|4049569|FG003|STARTED|Overall Study||6
3316301|NCT03108924|4049566|FG000|COMPLETED|Overall Study||6
3316302|NCT03108924|4049567|FG001|COMPLETED|Overall Study||6
3316303|NCT03108924|4049568|FG002|COMPLETED|Overall Study||6
3316304|NCT03108924|4049569|FG003|COMPLETED|Overall Study||6
3316305|NCT03108924|4049566|FG000|NOT COMPLETED|Overall Study||0
3316306|NCT03108924|4049567|FG001|NOT COMPLETED|Overall Study||0
3316307|NCT03108924|4049568|FG002|NOT COMPLETED|Overall Study||0
3316308|NCT03108924|4049569|FG003|NOT COMPLETED|Overall Study||0
3316309|NCT03109015|4049590|FG000|STARTED|Overall Study||4
3316310|NCT03109015|4049591|FG001|STARTED|Overall Study||3
3316311|NCT03109015|4049590|FG000|COMPLETED|Overall Study||4
3316312|NCT03109015|4049591|FG001|COMPLETED|Overall Study||3
3316313|NCT03109015|4049590|FG000|NOT COMPLETED|Overall Study||0
3316314|NCT03109015|4049591|FG001|NOT COMPLETED|Overall Study||0
3316315|NCT03109184|4049599|FG000|STARTED|Overall Study||60
3316316|NCT03109184|4049600|FG001|STARTED|Overall Study||59
3316317|NCT03109184|4049599|FG000|COMPLETED|Overall Study||53
3316318|NCT03109184|4049600|FG001|COMPLETED|Overall Study||52
3316319|NCT03109184|4049599|FG000|NOT COMPLETED|Overall Study||7
3316320|NCT03109184|4049600|FG001|NOT COMPLETED|Overall Study||7
3316321|NCT03109769|4049608|FG000|STARTED|Overall Study||22
3316322|NCT03109769|4049609|FG001|STARTED|Overall Study||22
3316323|NCT03109769|4049608|FG000|COMPLETED|Overall Study||22
3316324|NCT03109769|4049609|FG001|COMPLETED|Overall Study||22
3316325|NCT03109769|4049608|FG000|NOT COMPLETED|Overall Study||0
3316326|NCT03109769|4049609|FG001|NOT COMPLETED|Overall Study||0
3316327|NCT03109951|4049615|FG000|STARTED|Overall Study||187
3316328|NCT03109951|4049615|FG000|COMPLETED|Overall Study||187
3316329|NCT03109951|4049615|FG000|NOT COMPLETED|Overall Study||0
3316330|NCT03110003|4049621|FG000|STARTED|Overall Study||21
3316331|NCT03110003|4049622|FG001|STARTED|Overall Study||24
3316332|NCT03110003|4049621|FG000|COMPLETED|Overall Study||21
3316333|NCT03110003|4049622|FG001|COMPLETED|Overall Study||24
3316334|NCT03110003|4049621|FG000|NOT COMPLETED|Overall Study||0
3316335|NCT03110003|4049622|FG001|NOT COMPLETED|Overall Study||0
3316336|NCT03110029|4049630|FG000|STARTED|Overall Study||7
3316337|NCT03110029|4049631|FG001|STARTED|Overall Study||6
3316338|NCT03110029|4049630|FG000|COMPLETED|Overall Study||6
3316339|NCT03110029|4049631|FG001|COMPLETED|Overall Study||5
2935622|NCT00613028|3647415|FG000|NOT COMPLETED|Overall Study||0
2935623|NCT00613028|3647416|FG001|NOT COMPLETED|Overall Study||1
3034286|NCT01131676|3753345|FG002|Final Vital Status (VS) Available|Discontinuation From Study (Treated Set)||2327
3034287|NCT01131676|3753343|FG000|COMPLETED|Discontinuation From Study (Treated Set)|Completed the trial or died|2266
3034288|NCT01131676|3753344|FG001|COMPLETED|Discontinuation From Study (Treated Set)|Completed the trial or died|2264
3034289|NCT01131676|3753345|FG002|COMPLETED|Discontinuation From Study (Treated Set)|Completed the trial or died|2279
3034290|NCT01131676|3753343|FG000|NOT COMPLETED|Discontinuation From Study (Treated Set)||67
3034291|NCT01131676|3753344|FG001|NOT COMPLETED|Discontinuation From Study (Treated Set)||81
3034292|NCT01131676|3753345|FG002|NOT COMPLETED|Discontinuation From Study (Treated Set)||63
3034293|NCT01132118|3753356|FG000|STARTED|First Intervention (8 Weeks)||15
3034294|NCT01132118|3753357|FG001|STARTED|First Intervention (8 Weeks)||15
3034295|NCT01132118|3753356|FG000|COMPLETED|First Intervention (8 Weeks)||12
3034296|NCT01132118|3753357|FG001|COMPLETED|First Intervention (8 Weeks)||12
3034297|NCT01132118|3753356|FG000|NOT COMPLETED|First Intervention (8 Weeks)||3
3034298|NCT01132118|3753357|FG001|NOT COMPLETED|First Intervention (8 Weeks)||3
3034299|NCT01132118|3753356|FG000|STARTED|Second Intervention (8 Weeks)||12
3034300|NCT01132118|3753357|FG001|STARTED|Second Intervention (8 Weeks)||12
3034301|NCT01132118|3753356|FG000|COMPLETED|Second Intervention (8 Weeks)||12
3034302|NCT01132118|3753357|FG001|COMPLETED|Second Intervention (8 Weeks)||11
3034303|NCT01132118|3753356|FG000|NOT COMPLETED|Second Intervention (8 Weeks)||0
3034304|NCT01132118|3753357|FG001|NOT COMPLETED|Second Intervention (8 Weeks)||1
3034305|NCT01132144|3753365|FG000|STARTED|Overall Study||79
3034306|NCT01132144|3753366|FG001|STARTED|Overall Study||79
3034307|NCT01132144|3753365|FG000|COMPLETED|Overall Study||79
3034308|NCT01132144|3753366|FG001|COMPLETED|Overall Study||79
3034309|NCT01132144|3753365|FG000|NOT COMPLETED|Overall Study||0
3034310|NCT01132144|3753366|FG001|NOT COMPLETED|Overall Study||0
3034311|NCT01132313|3753386|FG000|STARTED|Overall Study||17
3034312|NCT01132313|3753387|FG001|STARTED|Overall Study||17
3034313|NCT01132313|3753388|FG002|STARTED|Overall Study||81
3034314|NCT01132313|3753389|FG003|STARTED|Overall Study||80
3034315|NCT01132313|3753390|FG004|STARTED|Overall Study||79
3034316|NCT01132313|3753391|FG005|STARTED|Overall Study||79
3034317|NCT01132313|3753392|FG006|STARTED|Overall Study||49
3034318|NCT01132313|3753393|FG007|STARTED|Overall Study||32
3034319|NCT01132313|3753394|FG008|STARTED|Overall Study||26
3034320|NCT01132313|3753395|FG009|STARTED|Overall Study||25
3034321|NCT01132313|3753396|FG010|STARTED|Overall Study||1
3034322|NCT01132313|3753397|FG011|STARTED|Overall Study||2
3034323|NCT01132313|3753386|FG000|COMPLETED|Overall Study||14
3034324|NCT01132313|3753387|FG001|COMPLETED|Overall Study||17
3034325|NCT01132313|3753388|FG002|COMPLETED|Overall Study||61
3034326|NCT01132313|3753389|FG003|COMPLETED|Overall Study||48
3034327|NCT01132313|3753390|FG004|COMPLETED|Overall Study||34
3034328|NCT01132313|3753391|FG005|COMPLETED|Overall Study||54
3034329|NCT01132313|3753392|FG006|COMPLETED|Overall Study||19
3034330|NCT01132313|3753393|FG007|COMPLETED|Overall Study||24
3034331|NCT01132313|3753394|FG008|COMPLETED|Overall Study||5
3034332|NCT01132313|3753395|FG009|COMPLETED|Overall Study||5
3034333|NCT01132313|3753396|FG010|COMPLETED|Overall Study||0
3034334|NCT01132313|3753397|FG011|COMPLETED|Overall Study||2
3034335|NCT01132313|3753386|FG000|NOT COMPLETED|Overall Study||3
3034336|NCT01132313|3753387|FG001|NOT COMPLETED|Overall Study||0
3034337|NCT01132313|3753388|FG002|NOT COMPLETED|Overall Study||20
3034338|NCT01132313|3753389|FG003|NOT COMPLETED|Overall Study||32
3034339|NCT01132313|3753390|FG004|NOT COMPLETED|Overall Study||45
3034340|NCT01132313|3753391|FG005|NOT COMPLETED|Overall Study||25
3034341|NCT01132313|3753392|FG006|NOT COMPLETED|Overall Study||30
3034342|NCT01132313|3753393|FG007|NOT COMPLETED|Overall Study||8
3034343|NCT01132313|3753394|FG008|NOT COMPLETED|Overall Study||21
3034344|NCT01132313|3753395|FG009|NOT COMPLETED|Overall Study||20
3034345|NCT01132313|3753396|FG010|NOT COMPLETED|Overall Study||1
3034346|NCT01132313|3753397|FG011|NOT COMPLETED|Overall Study||0
3034347|NCT01132326|3753428|FG000|STARTED|Overall Study||350
3034348|NCT01132326|3753428|FG000|COMPLETED|Overall Study||132
3034349|NCT01132326|3753428|FG000|NOT COMPLETED|Overall Study||218
3034350|NCT01132378|3753432|FG000|STARTED|Overall Study||40
3034351|NCT01132378|3753432|FG000|COMPLETED|Overall Study||40
3034352|NCT01132378|3753432|FG000|NOT COMPLETED|Overall Study||0
3034353|NCT01132482|3753439|FG000|STARTED|Overall Study||13
3034354|NCT01132482|3753440|FG001|STARTED|Overall Study||6
3034355|NCT01132482|3753439|FG000|COMPLETED|Overall Study||12
3034356|NCT01132482|3753440|FG001|COMPLETED|Overall Study||6
3034357|NCT01132482|3753439|FG000|NOT COMPLETED|Overall Study||1
3034358|NCT01132482|3753440|FG001|NOT COMPLETED|Overall Study||0
3034359|NCT01132495|3753450|FG000|STARTED|Overall Study||447
3034360|NCT01132495|3753451|FG001|STARTED|Overall Study||441
3034361|NCT01132495|3753452|FG002|STARTED|Overall Study||166
3034362|NCT01132495|3753453|FG003|STARTED|Overall Study||116
3034363|NCT01132495|3753450|FG000|COMPLETED|Overall Study||407
3034364|NCT01132495|3753451|FG001|COMPLETED|Overall Study||403
3034365|NCT01132495|3753452|FG002|COMPLETED|Overall Study||146
3034366|NCT01132495|3753453|FG003|COMPLETED|Overall Study||104
3034367|NCT01132495|3753450|FG000|NOT COMPLETED|Overall Study||40
3034368|NCT01132495|3753451|FG001|NOT COMPLETED|Overall Study||38
3034369|NCT01132495|3753452|FG002|NOT COMPLETED|Overall Study||20
3034370|NCT01132495|3753453|FG003|NOT COMPLETED|Overall Study||12
2935624|NCT00613080|3647422|FG000|STARTED|Overall Study||79
2935625|NCT00613080|3647422|FG000|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|68
2935626|NCT00613080|3647422|FG000|NOT COMPLETED|Overall Study||11
2935627|NCT00613106|3647428|FG000|STARTED|Overall Study||132
2935628|NCT00613106|3647429|FG001|STARTED|Overall Study||47
2935629|NCT00613106|3647428|FG000|COMPLETED|Overall Study||112
2935630|NCT00613106|3647429|FG001|COMPLETED|Overall Study||38
2935631|NCT00613106|3647428|FG000|NOT COMPLETED|Overall Study||20
2935632|NCT00613106|3647429|FG001|NOT COMPLETED|Overall Study||9
2935633|NCT00613171|3647435|FG000|STARTED|Overall Study||27
2935634|NCT00613171|3647435|FG000|COMPLETED|Overall Study||13
2935635|NCT00613171|3647435|FG000|NOT COMPLETED|Overall Study||14
2935636|NCT00613301|3647440|FG000|STARTED|Overall Study||416
2935637|NCT00613301|3647440|FG000|COMPLETED|Overall Study||188
2935638|NCT00613301|3647440|FG000|NOT COMPLETED|Overall Study||228
2935639|NCT00613314|3647445|FG000|STARTED|Overall Study||15268
2935640|NCT00613314|3647445|FG000|COMPLETED|Overall Study||15113
2935641|NCT00613314|3647445|FG000|NOT COMPLETED|Overall Study||155
2935642|NCT00613327|3647449|FG000|STARTED|Overall Study||345
2935643|NCT00613327|3647449|FG000|COMPLETED|Overall Study||244
2935644|NCT00613327|3647449|FG000|NOT COMPLETED|Overall Study||101
2935645|NCT00613366|3647455|FG000|STARTED|Overall Study||20
2935646|NCT00613366|3647456|FG001|STARTED|Overall Study||20
3272735|NCT02683928|4008056|FG000|STARTED|Overall Study||48
3272736|NCT02683928|4008057|FG001|STARTED|Overall Study||16
3272737|NCT02683928|4008056|FG000|COMPLETED|Overall Study||26
3272738|NCT02683928|4008057|FG001|COMPLETED|Overall Study||8
3272739|NCT02683928|4008056|FG000|NOT COMPLETED|Overall Study||22
3272740|NCT02683928|4008057|FG001|NOT COMPLETED|Overall Study||8
3272741|NCT02683941|4008065|FG000|STARTED|Double-blind Phase||51
3272742|NCT02683941|4008066|FG001|STARTED|Double-blind Phase||26
3272743|NCT02683941|4008065|FG000|COMPLETED|Double-blind Phase||41
3272744|NCT02683941|4008066|FG001|COMPLETED|Double-blind Phase||21
3272745|NCT02683941|4008065|FG000|NOT COMPLETED|Double-blind Phase||10
3272746|NCT02683941|4008066|FG001|NOT COMPLETED|Double-blind Phase||5
3272747|NCT02683941|4008065|FG000|STARTED|Open-label Treatment Phase||21
3272748|NCT02683941|4008066|FG001|STARTED|Open-label Treatment Phase||19
3272749|NCT02683941|4008065|FG000|COMPLETED|Open-label Treatment Phase||1
3272750|NCT02683941|4008066|FG001|COMPLETED|Open-label Treatment Phase||6
3272751|NCT02683941|4008065|FG000|NOT COMPLETED|Open-label Treatment Phase||20
3272752|NCT02683941|4008066|FG001|NOT COMPLETED|Open-label Treatment Phase||13
3272753|NCT02683941|4008065|FG000|STARTED|Open-label Follow-up Phase||18
3272754|NCT02683941|4008066|FG001|STARTED|Open-label Follow-up Phase||8
3272755|NCT02683941|4008065|FG000|COMPLETED|Open-label Follow-up Phase||0
3272756|NCT02683941|4008066|FG001|COMPLETED|Open-label Follow-up Phase||0
3272757|NCT02683941|4008065|FG000|NOT COMPLETED|Open-label Follow-up Phase||18
3272758|NCT02683941|4008066|FG001|NOT COMPLETED|Open-label Follow-up Phase||8
3272759|NCT02683954|4008078|FG000|STARTED|Overall Study||30
3272760|NCT02683954|4008079|FG001|STARTED|Overall Study||30
3272761|NCT02683954|4008078|FG000|COMPLETED|Overall Study||30
3272762|NCT02683954|4008079|FG001|COMPLETED|Overall Study||30
3272763|NCT02683954|4008078|FG000|NOT COMPLETED|Overall Study||0
3272764|NCT02683954|4008079|FG001|NOT COMPLETED|Overall Study||0
3272765|NCT02684097|4008087|FG000|STARTED|Overall Study||15
3272766|NCT02684097|4008088|FG001|STARTED|Overall Study||7
3272767|NCT02684097|4008087|FG000|COMPLETED|Overall Study||2
3272768|NCT02684097|4008088|FG001|COMPLETED|Overall Study||1
3272769|NCT02684097|4008087|FG000|NOT COMPLETED|Overall Study||13
3272770|NCT02684097|4008088|FG001|NOT COMPLETED|Overall Study||6
3272771|NCT02684136|4008094|FG000|STARTED|First Intervention (9 Nights)||5
3272772|NCT02684136|4008095|FG001|STARTED|First Intervention (9 Nights)||5
3272773|NCT02684136|4008094|FG000|COMPLETED|First Intervention (9 Nights)||5
3272774|NCT02684136|4008095|FG001|COMPLETED|First Intervention (9 Nights)||5
3272775|NCT02684136|4008094|FG000|NOT COMPLETED|First Intervention (9 Nights)||0
3272776|NCT02684136|4008095|FG001|NOT COMPLETED|First Intervention (9 Nights)||0
3272777|NCT02684136|4008094|FG000|STARTED|Washout (7 Days)||5
3272778|NCT02684136|4008095|FG001|STARTED|Washout (7 Days)||5
3272779|NCT02684136|4008094|FG000|COMPLETED|Washout (7 Days)||5
3272780|NCT02684136|4008095|FG001|COMPLETED|Washout (7 Days)||5
3272781|NCT02684136|4008094|FG000|NOT COMPLETED|Washout (7 Days)||0
3272782|NCT02684136|4008095|FG001|NOT COMPLETED|Washout (7 Days)||0
3272783|NCT02684136|4008094|FG000|STARTED|Second Intervention (9 Nights)||5
3272784|NCT02684136|4008095|FG001|STARTED|Second Intervention (9 Nights)||5
3272785|NCT02684136|4008094|FG000|COMPLETED|Second Intervention (9 Nights)||5
3272786|NCT02684136|4008095|FG001|COMPLETED|Second Intervention (9 Nights)||5
3272787|NCT02684136|4008094|FG000|NOT COMPLETED|Second Intervention (9 Nights)||0
3272788|NCT02684136|4008095|FG001|NOT COMPLETED|Second Intervention (9 Nights)||0
3272789|NCT02684188|4008103|FG000|STARTED|Overall Study||77
3272790|NCT02684188|4008104|FG001|STARTED|Overall Study||50
3272791|NCT02684188|4008103|FG000|COMPLETED|Overall Study||75
3272792|NCT02684188|4008104|FG001|COMPLETED|Overall Study||47
3272793|NCT02684188|4008103|FG000|NOT COMPLETED|Overall Study||2
3272794|NCT02684188|4008104|FG001|NOT COMPLETED|Overall Study||3
3272795|NCT02684279|4008113|FG000|STARTED|Overall Study||528
3272796|NCT02684279|4008113|FG000|COMPLETED|Overall Study||249
3272797|NCT02684279|4008113|FG000|NOT COMPLETED|Overall Study||279
3272798|NCT02684344|4008119|FG000|STARTED|Overall Study||1
2935647|NCT00613366|3647455|FG000|COMPLETED|Overall Study||17
2935648|NCT00613366|3647456|FG001|COMPLETED|Overall Study||18
2935649|NCT00613366|3647455|FG000|NOT COMPLETED|Overall Study||3
2935650|NCT00613366|3647456|FG001|NOT COMPLETED|Overall Study||2
2935651|NCT00613379|3647465|FG000|STARTED|Overall Study||10
2935652|NCT00613379|3647466|FG001|STARTED|Overall Study||10
2935653|NCT00613379|3647467|FG002|STARTED|Overall Study||11
2935654|NCT00613379|3647465|FG000|COMPLETED|Overall Study||10
2935655|NCT00613379|3647466|FG001|COMPLETED|Overall Study||10
2935656|NCT00613379|3647467|FG002|COMPLETED|Overall Study||11
2935657|NCT00613379|3647465|FG000|NOT COMPLETED|Overall Study||0
2935658|NCT00613379|3647466|FG001|NOT COMPLETED|Overall Study||0
2935659|NCT00613379|3647467|FG002|NOT COMPLETED|Overall Study||0
2935660|NCT00613405|3647477|FG000|STARTED|Overall Study||45
2935661|NCT00613405|3647478|FG001|STARTED|Overall Study||42
2935662|NCT00613405|3647477|FG000|COMPLETED|Overall Study||45
2935663|NCT00613405|3647478|FG001|COMPLETED|Overall Study||42
2935664|NCT00613405|3647477|FG000|NOT COMPLETED|Overall Study||0
2935665|NCT00613405|3647478|FG001|NOT COMPLETED|Overall Study||0
2935666|NCT00613509|3647486|FG000|STARTED|Cycle 1||11
2935667|NCT00613509|3647487|FG001|STARTED|Cycle 1||12
2935668|NCT00613509|3647486|FG000|COMPLETED|Cycle 1|Completion of Cycle 1. 9 participants were deemed evaluable|6
2935669|NCT00613509|3647487|FG001|COMPLETED|Cycle 1|Completion of Cycle 1. 12 participants were deemed evaluable|4
2935670|NCT00613509|3647486|FG000|NOT COMPLETED|Cycle 1||5
2935671|NCT00613509|3647487|FG001|NOT COMPLETED|Cycle 1||8
2935672|NCT00613509|3647486|FG000|STARTED|Cycle 2 (Group 2 = Crossover)||11
2935673|NCT00613509|3647487|FG001|STARTED|Cycle 2 (Group 2 = Crossover)||4
2935674|NCT00613509|3647486|FG000|COMPLETED|Cycle 2 (Group 2 = Crossover)||11
2935675|NCT00613509|3647487|FG001|COMPLETED|Cycle 2 (Group 2 = Crossover)||4
2935676|NCT00613509|3647486|FG000|NOT COMPLETED|Cycle 2 (Group 2 = Crossover)||0
2935677|NCT00613509|3647487|FG001|NOT COMPLETED|Cycle 2 (Group 2 = Crossover)||0
2935678|NCT00613574|3647493|FG000|STARTED|Overall Study||407
2935679|NCT00613574|3647493|FG000|COMPLETED|Overall Study||401
2935680|NCT00613574|3647493|FG000|NOT COMPLETED|Overall Study||6
2935681|NCT00613626|3647500|FG000|STARTED|Overall Study||33
2935682|NCT00613626|3647501|FG001|STARTED|Overall Study||34
2935683|NCT00613626|3647502|FG002|STARTED|Overall Study|These participants provided the toxicity data to determine if ZD6474+Etopiside+Cisplatin was safe.|7
2935684|NCT00613626|3647500|FG000|1st Dose ZD6474|Overall Study||33
2935685|NCT00613626|3647501|FG001|1st Dose ZD6474|Overall Study||34
2935686|NCT00613626|3647502|FG002|1st Dose ZD6474|Overall Study||7
2935687|NCT00613626|3647500|FG000|COMPLETED|Overall Study||33
2935688|NCT00613626|3647501|FG001|COMPLETED|Overall Study||33
2935689|NCT00613626|3647502|FG002|COMPLETED|Overall Study||7
2935690|NCT00613626|3647500|FG000|NOT COMPLETED|Overall Study||0
2935691|NCT00613626|3647501|FG001|NOT COMPLETED|Overall Study||1
2935692|NCT00613626|3647502|FG002|NOT COMPLETED|Overall Study||0
2935693|NCT00613821|3647511|FG000|STARTED|Overall Study||40
2935694|NCT00613821|3647512|FG001|STARTED|Overall Study||40
2935695|NCT00613821|3647511|FG000|COMPLETED|Overall Study||38
2935696|NCT00613821|3647512|FG001|COMPLETED|Overall Study||39
2935697|NCT00613821|3647511|FG000|NOT COMPLETED|Overall Study||2
2935698|NCT00613821|3647512|FG001|NOT COMPLETED|Overall Study||1
2935699|NCT00613834|3647520|FG000|STARTED|Overall Study||29
2935700|NCT00613834|3647521|FG001|STARTED|Overall Study||29
2935701|NCT00613834|3647520|FG000|COMPLETED|Overall Study||29
2935702|NCT00613834|3647521|FG001|COMPLETED|Overall Study||26
2935703|NCT00613834|3647520|FG000|NOT COMPLETED|Overall Study||0
2935704|NCT00613834|3647521|FG001|NOT COMPLETED|Overall Study||3
2935705|NCT00613925|3647531|FG000|STARTED|Overall Study||37
2935706|NCT00613925|3647532|FG001|STARTED|Overall Study||33
2935707|NCT00613925|3647531|FG000|COMPLETED|Overall Study||37
2935708|NCT00613925|3647532|FG001|COMPLETED|Overall Study||32
2935709|NCT00613925|3647531|FG000|NOT COMPLETED|Overall Study||0
2935710|NCT00613925|3647532|FG001|NOT COMPLETED|Overall Study||1
2935711|NCT00613938|3647542|FG000|STARTED|Overall Study||69
2935712|NCT00613938|3647543|FG001|STARTED|Overall Study||275
2935713|NCT00613938|3647544|FG002|STARTED|Overall Study||278
2935714|NCT00613938|3647545|FG003|STARTED|Overall Study|one patient did not have a valid baseline score therefore excluded from above|279
2935715|NCT00613938|3647542|FG000|COMPLETED|Overall Study||49
2935716|NCT00613938|3647543|FG001|COMPLETED|Overall Study||247
2935717|NCT00613938|3647544|FG002|COMPLETED|Overall Study||255
2935718|NCT00613938|3647545|FG003|COMPLETED|Overall Study||253
2935719|NCT00613938|3647542|FG000|NOT COMPLETED|Overall Study||20
2935720|NCT00613938|3647543|FG001|NOT COMPLETED|Overall Study||28
2935721|NCT00613938|3647544|FG002|NOT COMPLETED|Overall Study||23
2935722|NCT00613938|3647545|FG003|NOT COMPLETED|Overall Study||26
2935723|NCT00613951|3647558|FG000|STARTED|Overall Study||61
2935724|NCT00613951|3647559|FG001|STARTED|Overall Study||59
2935725|NCT00613951|3647560|FG002|STARTED|Overall Study||62
2935726|NCT00613951|3647558|FG000|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|60
2935727|NCT00613951|3647559|FG001|Exposed|Overall Study||59
2935728|NCT00613951|3647560|FG002|Exposed|Overall Study||62
2935729|NCT00613951|3647558|FG000|COMPLETED|Overall Study||54
2935730|NCT00613951|3647559|FG001|COMPLETED|Overall Study||54
2935731|NCT00613951|3647560|FG002|COMPLETED|Overall Study||57
2935732|NCT00613951|3647558|FG000|NOT COMPLETED|Overall Study||7
2935733|NCT00613951|3647559|FG001|NOT COMPLETED|Overall Study||5
2935734|NCT00613951|3647560|FG002|NOT COMPLETED|Overall Study||5
2935735|NCT00614055|3647574|FG000|STARTED|Overall Study||59
2935736|NCT00614055|3647575|FG001|STARTED|Overall Study||59
2935737|NCT00614055|3647576|FG002|STARTED|Overall Study||60
2935738|NCT00614055|3647574|FG000|Exposed|Overall Study||59
2935739|NCT00614055|3647575|FG001|Exposed|Overall Study||59
2935740|NCT00614055|3647576|FG002|Exposed|Overall Study||60
2935741|NCT00614055|3647574|FG000|COMPLETED|Overall Study||55
2935742|NCT00614055|3647575|FG001|COMPLETED|Overall Study||53
2935743|NCT00614055|3647576|FG002|COMPLETED|Overall Study||55
2935744|NCT00614055|3647574|FG000|NOT COMPLETED|Overall Study||4
2935745|NCT00614055|3647575|FG001|NOT COMPLETED|Overall Study||6
2935746|NCT00614055|3647576|FG002|NOT COMPLETED|Overall Study||5
2935747|NCT00614120|3647591|FG000|STARTED|Overall Study|Randomised|231
2935748|NCT00614120|3647592|FG001|STARTED|Overall Study|Randomised|233
2935749|NCT00614120|3647593|FG002|STARTED|Overall Study|Randomised|234
2935750|NCT00614120|3647594|FG003|STARTED|Overall Study|Randomised|231
2935751|NCT00614120|3647591|FG000|Exposed to Study Drug|Overall Study||231
2935752|NCT00614120|3647592|FG001|Exposed to Study Drug|Overall Study||233
2935753|NCT00614120|3647593|FG002|Exposed to Study Drug|Overall Study|Subject withdrew before exposure to study products, and thus not included in full analysis set.|233
2935754|NCT00614120|3647594|FG003|Exposed to Study Drug|Overall Study||231
2935755|NCT00614120|3647591|FG000|COMPLETED|Overall Study||202
2935756|NCT00614120|3647592|FG001|COMPLETED|Overall Study||187
2935757|NCT00614120|3647593|FG002|COMPLETED|Overall Study||175
2935758|NCT00614120|3647594|FG003|COMPLETED|Overall Study||215
2935759|NCT00614120|3647591|FG000|NOT COMPLETED|Overall Study||29
2935760|NCT00614120|3647592|FG001|NOT COMPLETED|Overall Study||46
2935761|NCT00614120|3647593|FG002|NOT COMPLETED|Overall Study||59
2935762|NCT00614120|3647594|FG003|NOT COMPLETED|Overall Study||16
2935763|NCT00614198|3647606|FG000|STARTED|Stage 1||38
2935764|NCT00614198|3647607|FG001|STARTED|Stage 1||34
2935765|NCT00614198|3647606|FG000|COMPLETED|Stage 1||26
2935766|NCT00614198|3647607|FG001|COMPLETED|Stage 1||29
2935767|NCT00614198|3647606|FG000|NOT COMPLETED|Stage 1||12
2935768|NCT00614198|3647607|FG001|NOT COMPLETED|Stage 1||5
2935769|NCT00614198|3647606|FG000|STARTED|Stage 2||26
2935770|NCT00614198|3647607|FG001|STARTED|Stage 2|Reallocated to gluten- and casein-free dietary intervention|29
2935771|NCT00614198|3647606|FG000|COMPLETED|Stage 2||18
2935772|NCT00614198|3647607|FG001|COMPLETED|Stage 2||17
2935773|NCT00614198|3647606|FG000|NOT COMPLETED|Stage 2||8
2935774|NCT00614198|3647607|FG001|NOT COMPLETED|Stage 2||12
2935775|NCT00614315|3647613|FG000|STARTED|Overall Study||30
2935776|NCT00614315|3647613|FG000|COMPLETED|Overall Study||30
2935777|NCT00614315|3647613|FG000|NOT COMPLETED|Overall Study||0
2935778|NCT00614380|3647621|FG000|STARTED|Overall Study||564
2935779|NCT00614380|3647622|FG001|STARTED|Overall Study||206
2935780|NCT00614380|3647623|FG002|STARTED|Overall Study||25
2935781|NCT00614380|3647624|FG003|STARTED|Overall Study||181
2935782|NCT00614380|3647621|FG000|COMPLETED|Overall Study||529
2935783|NCT00614380|3647622|FG001|COMPLETED|Overall Study||198
2935784|NCT00614380|3647623|FG002|COMPLETED|Overall Study||24
2935785|NCT00614380|3647624|FG003|COMPLETED|Overall Study||179
3272799|NCT02684344|4008120|FG001|STARTED|Overall Study||4
3272800|NCT02684344|4008119|FG000|COMPLETED|Overall Study||1
3272801|NCT02684344|4008120|FG001|COMPLETED|Overall Study||3
3272802|NCT02684344|4008119|FG000|NOT COMPLETED|Overall Study||0
3272803|NCT02684344|4008120|FG001|NOT COMPLETED|Overall Study||1
3272804|NCT02684357|4008129|FG000|STARTED|Part A||98
3272805|NCT02684357|4008130|FG001|STARTED|Part A||99
3272806|NCT02684357|4008131|FG002|STARTED|Part A||294
3272807|NCT02684357|4008132|FG003|STARTED|Part A||0
3272808|NCT02684357|4008133|FG004|STARTED|Part A||0
3272809|NCT02684357|4008134|FG005|STARTED|Part A||0
3272810|NCT02684357|4008129|FG000|COMPLETED|Part A||94
3272811|NCT02684357|4008130|FG001|COMPLETED|Part A||96
3272812|NCT02684357|4008131|FG002|COMPLETED|Part A||292
3272813|NCT02684357|4008132|FG003|COMPLETED|Part A||0
3272814|NCT02684357|4008133|FG004|COMPLETED|Part A||0
3272815|NCT02684357|4008134|FG005|COMPLETED|Part A||0
3272816|NCT02684357|4008129|FG000|NOT COMPLETED|Part A||4
3272817|NCT02684357|4008130|FG001|NOT COMPLETED|Part A||3
3272818|NCT02684357|4008131|FG002|NOT COMPLETED|Part A||2
3272819|NCT02684357|4008132|FG003|NOT COMPLETED|Part A||0
3272820|NCT02684357|4008133|FG004|NOT COMPLETED|Part A||0
3272821|NCT02684357|4008134|FG005|NOT COMPLETED|Part A||0
3272822|NCT02684357|4008129|FG000|STARTED|Part B||0
3272823|NCT02684357|4008130|FG001|STARTED|Part B||0
3272824|NCT02684357|4008131|FG002|STARTED|Part B||0
3272825|NCT02684357|4008132|FG003|STARTED|Part B|Participants who received placebo in Part A received risankizumab in Part B|94
3272826|NCT02684357|4008133|FG004|STARTED|Part B|2 participants who received ustekinumab in Part A did not receive a dose of study drug in Part B.|94
3272827|NCT02684357|4008134|FG005|STARTED|Part B|1 participant who received risankizumab in Part A did not receive a dose of study drug in Part B|291
3272828|NCT02684357|4008129|FG000|COMPLETED|Part B||0
3272829|NCT02684357|4008130|FG001|COMPLETED|Part B||0
3272830|NCT02684357|4008131|FG002|COMPLETED|Part B||0
3272831|NCT02684357|4008132|FG003|COMPLETED|Part B||91
3272832|NCT02684357|4008133|FG004|COMPLETED|Part B||90
3272833|NCT02684357|4008134|FG005|COMPLETED|Part B||278
3272834|NCT02684357|4008129|FG000|NOT COMPLETED|Part B||0
3272835|NCT02684357|4008130|FG001|NOT COMPLETED|Part B||0
3272836|NCT02684357|4008131|FG002|NOT COMPLETED|Part B||0
3272837|NCT02684357|4008132|FG003|NOT COMPLETED|Part B||3
3272838|NCT02684357|4008133|FG004|NOT COMPLETED|Part B||4
3272839|NCT02684357|4008134|FG005|NOT COMPLETED|Part B||13
3272840|NCT02684370|4008150|FG000|STARTED|Part A||102
3272841|NCT02684370|4008151|FG001|STARTED|Part A||100
2935786|NCT00614380|3647621|FG000|NOT COMPLETED|Overall Study||35
2935787|NCT00614380|3647622|FG001|NOT COMPLETED|Overall Study||8
2935788|NCT00614380|3647623|FG002|NOT COMPLETED|Overall Study||1
2935789|NCT00614380|3647624|FG003|NOT COMPLETED|Overall Study||2
2935790|NCT00614393|3647644|FG000|STARTED|Overall Study||180
2935791|NCT00614393|3647645|FG001|STARTED|Overall Study||8
2935792|NCT00614393|3647646|FG002|STARTED|Overall Study||10
2935793|NCT00614393|3647647|FG003|STARTED|Overall Study||180
2935794|NCT00614393|3647648|FG004|STARTED|Overall Study||180
2935795|NCT00614393|3647644|FG000|Treated|Overall Study||180
2935796|NCT00614393|3647645|FG001|Treated|Overall Study||8
2935797|NCT00614393|3647646|FG002|Treated|Overall Study||10
2935798|NCT00614393|3647647|FG003|Treated|Overall Study||180
2935799|NCT00614393|3647648|FG004|Treated|Overall Study||178
2935800|NCT00614393|3647644|FG000|COMPLETED|Overall Study||0
2935801|NCT00614393|3647645|FG001|COMPLETED|Overall Study||0
2935802|NCT00614393|3647646|FG002|COMPLETED|Overall Study||0
2935803|NCT00614393|3647647|FG003|COMPLETED|Overall Study||0
2935804|NCT00614393|3647648|FG004|COMPLETED|Overall Study||0
2935805|NCT00614393|3647644|FG000|NOT COMPLETED|Overall Study||180
2935806|NCT00614393|3647645|FG001|NOT COMPLETED|Overall Study||8
2935807|NCT00614393|3647646|FG002|NOT COMPLETED|Overall Study||10
2935808|NCT00614393|3647647|FG003|NOT COMPLETED|Overall Study||180
2935809|NCT00614393|3647648|FG004|NOT COMPLETED|Overall Study||180
2935810|NCT00614406|3647662|FG000|STARTED|Overall Study||7
2935811|NCT00614406|3647663|FG001|STARTED|Overall Study||4
2935812|NCT00614406|3647662|FG000|COMPLETED|Overall Study||7
2935813|NCT00614406|3647663|FG001|COMPLETED|Overall Study||4
2935814|NCT00614406|3647662|FG000|NOT COMPLETED|Overall Study||0
2935815|NCT00614406|3647663|FG001|NOT COMPLETED|Overall Study||0
2935816|NCT00614432|3647671|FG000|STARTED|Overall Study||4
2935817|NCT00614432|3647672|FG001|STARTED|Overall Study||6
2935818|NCT00614432|3647671|FG000|COMPLETED|Overall Study||4
2935819|NCT00614432|3647672|FG001|COMPLETED|Overall Study||6
2935820|NCT00614432|3647671|FG000|NOT COMPLETED|Overall Study||0
2935821|NCT00614432|3647672|FG001|NOT COMPLETED|Overall Study||0
2935822|NCT00614445|3647680|FG000|STARTED|Overall Study||140
2935823|NCT00614445|3647681|FG001|STARTED|Overall Study||140
2935824|NCT00614445|3647680|FG000|COMPLETED|Overall Study||112
2935825|NCT00614445|3647681|FG001|COMPLETED|Overall Study||91
2935826|NCT00614445|3647680|FG000|NOT COMPLETED|Overall Study||28
2935827|NCT00614445|3647681|FG001|NOT COMPLETED|Overall Study||49
2935828|NCT00614458|3647687|FG000|STARTED|Overall Study||6
2935829|NCT00614458|3647687|FG000|COMPLETED|Overall Study||6
2935830|NCT00614458|3647687|FG000|NOT COMPLETED|Overall Study||0
2935831|NCT00614484|3647691|FG000|STARTED|Overall Study||28
2935832|NCT00614484|3647691|FG000|COMPLETED|Overall Study||28
2935833|NCT00614484|3647691|FG000|NOT COMPLETED|Overall Study||0
2935834|NCT00614523|3647698|FG000|STARTED|Overall Study||83
2935835|NCT00614523|3647699|FG001|STARTED|Overall Study||167
2935836|NCT00614523|3647698|FG000|COMPLETED|Overall Study||20
2935837|NCT00614523|3647699|FG001|COMPLETED|Overall Study||36
2935838|NCT00614523|3647698|FG000|NOT COMPLETED|Overall Study||63
2935839|NCT00614523|3647699|FG001|NOT COMPLETED|Overall Study||131
2935840|NCT00614575|3647705|FG000|STARTED|Overall Study|The number of patients enrolled.|1089
2935841|NCT00614575|3647705|FG000|COMPLETED|Overall Study||861
2935842|NCT00614575|3647705|FG000|NOT COMPLETED|Overall Study||228
2935843|NCT00614614|3647711|FG000|STARTED|Primary Vaccination Phase||1272
2935844|NCT00614614|3647712|FG001|STARTED|Primary Vaccination Phase||282
2935845|NCT00614614|3647713|FG002|STARTED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
2935846|NCT00614614|3647714|FG003|STARTED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
2935847|NCT00614614|3647715|FG004|STARTED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
2935848|NCT00614614|3647711|FG000|COMPLETED|Primary Vaccination Phase||1182
2935849|NCT00614614|3647712|FG001|COMPLETED|Primary Vaccination Phase||265
2935850|NCT00614614|3647713|FG002|COMPLETED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
2935851|NCT00614614|3647714|FG003|COMPLETED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
2935852|NCT00614614|3647715|FG004|COMPLETED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
2935853|NCT00614614|3647711|FG000|NOT COMPLETED|Primary Vaccination Phase||90
2935854|NCT00614614|3647712|FG001|NOT COMPLETED|Primary Vaccination Phase||17
3272842|NCT02684370|4008152|FG002|STARTED|Part A||304
3272843|NCT02684370|4008153|FG003|STARTED|Part A||0
3272844|NCT02684370|4008154|FG004|STARTED|Part A||0
3272845|NCT02684370|4008155|FG005|STARTED|Part A||0
3272846|NCT02684370|4008150|FG000|COMPLETED|Part A||98
3272847|NCT02684370|4008151|FG001|COMPLETED|Part A||99
3272848|NCT02684370|4008152|FG002|COMPLETED|Part A||299
2935855|NCT00614614|3647713|FG002|NOT COMPLETED|Primary Vaccination Phase||0
2935856|NCT00614614|3647714|FG003|NOT COMPLETED|Primary Vaccination Phase||0
2935857|NCT00614614|3647715|FG004|NOT COMPLETED|Primary Vaccination Phase||0
2935858|NCT00614614|3647711|FG000|STARTED|Booster Vaccination Phase|Menhibrix 1 Group was re-randomized to Nimenrix 1,Menhibrix 2 and Nimenrix 2 Groups in booster phase|0
2935859|NCT00614614|3647712|FG001|STARTED|Booster Vaccination Phase||233
2935860|NCT00614614|3647713|FG002|STARTED|Booster Vaccination Phase||432
2935861|NCT00614614|3647714|FG003|STARTED|Booster Vaccination Phase||229
3272849|NCT02684370|4008153|FG003|COMPLETED|Part A||0
2935862|NCT00614614|3647715|FG004|STARTED|Booster Vaccination Phase||409
2935863|NCT00614614|3647711|FG000|COMPLETED|Booster Vaccination Phase|Menhibrix 1 Group was re-randomized to Nimenrix 1,Menhibrix 2 and Nimenrix 2 Groups in booster phase|0
2935864|NCT00614614|3647712|FG001|COMPLETED|Booster Vaccination Phase||227
2935865|NCT00614614|3647713|FG002|COMPLETED|Booster Vaccination Phase||405
2935866|NCT00614614|3647714|FG003|COMPLETED|Booster Vaccination Phase||210
2935867|NCT00614614|3647715|FG004|COMPLETED|Booster Vaccination Phase||396
2935868|NCT00614614|3647711|FG000|NOT COMPLETED|Booster Vaccination Phase||0
2935869|NCT00614614|3647712|FG001|NOT COMPLETED|Booster Vaccination Phase||6
2935870|NCT00614614|3647713|FG002|NOT COMPLETED|Booster Vaccination Phase||27
2935871|NCT00614614|3647714|FG003|NOT COMPLETED|Booster Vaccination Phase||19
2935872|NCT00614614|3647715|FG004|NOT COMPLETED|Booster Vaccination Phase||13
2935873|NCT00614744|3647732|FG000|STARTED|Overall Study||83
3272850|NCT02684370|4008154|FG004|COMPLETED|Part A||0
3272851|NCT02684370|4008155|FG005|COMPLETED|Part A||0
3272852|NCT02684370|4008150|FG000|NOT COMPLETED|Part A||4
3272853|NCT02684370|4008151|FG001|NOT COMPLETED|Part A||1
3272854|NCT02684370|4008152|FG002|NOT COMPLETED|Part A||5
3272855|NCT02684370|4008153|FG003|NOT COMPLETED|Part A||0
3272856|NCT02684370|4008154|FG004|NOT COMPLETED|Part A||0
3272857|NCT02684370|4008155|FG005|NOT COMPLETED|Part A||0
3272858|NCT02684370|4008150|FG000|STARTED|Part B||0
3272859|NCT02684370|4008151|FG001|STARTED|Part B||0
3272860|NCT02684370|4008152|FG002|STARTED|Part B||0
3272861|NCT02684370|4008153|FG003|STARTED|Part B|1 participant who received placebo in Part A did not receive a dose of study drug in Part B|97
3272862|NCT02684370|4008154|FG004|STARTED|Part B|Participants who received ustekinumab in Part A received ustekinumab in Part B|99
3272863|NCT02684370|4008155|FG005|STARTED|Part B|2 participants who received risankizumab in Part A did not receive a dose of study drug in Part B|297
3272864|NCT02684370|4008150|FG000|COMPLETED|Part B||0
3272865|NCT02684370|4008151|FG001|COMPLETED|Part B||0
3272866|NCT02684370|4008152|FG002|COMPLETED|Part B||0
3272867|NCT02684370|4008153|FG003|COMPLETED|Part B||95
3272868|NCT02684370|4008154|FG004|COMPLETED|Part B||94
3272869|NCT02684370|4008155|FG005|COMPLETED|Part B||289
3272870|NCT02684370|4008150|FG000|NOT COMPLETED|Part B||0
3272871|NCT02684370|4008151|FG001|NOT COMPLETED|Part B||0
3272872|NCT02684370|4008152|FG002|NOT COMPLETED|Part B||0
3272873|NCT02684370|4008153|FG003|NOT COMPLETED|Part B||2
3272874|NCT02684370|4008154|FG004|NOT COMPLETED|Part B||5
3272875|NCT02684370|4008155|FG005|NOT COMPLETED|Part B||8
3272876|NCT02684396|4008175|FG000|STARTED|Overall Study||6
3272877|NCT02684396|4008176|FG001|STARTED|Overall Study||6
3272878|NCT02684396|4008177|FG002|STARTED|Overall Study||6
3272879|NCT02684396|4008178|FG003|STARTED|Overall Study||6
3272880|NCT02684396|4008179|FG004|STARTED|Overall Study||5
3272881|NCT02684396|4008180|FG005|STARTED|Overall Study||10
3272882|NCT02684396|4008175|FG000|COMPLETED|Overall Study||6
3272883|NCT02684396|4008176|FG001|COMPLETED|Overall Study||6
3272884|NCT02684396|4008177|FG002|COMPLETED|Overall Study||6
3272885|NCT02684396|4008178|FG003|COMPLETED|Overall Study||6
3272886|NCT02684396|4008179|FG004|COMPLETED|Overall Study||5
3272887|NCT02684396|4008180|FG005|COMPLETED|Overall Study||10
3272888|NCT02684396|4008175|FG000|NOT COMPLETED|Overall Study||0
3272889|NCT02684396|4008176|FG001|NOT COMPLETED|Overall Study||0
3272890|NCT02684396|4008177|FG002|NOT COMPLETED|Overall Study||0
3272891|NCT02684396|4008178|FG003|NOT COMPLETED|Overall Study||0
3272892|NCT02684396|4008179|FG004|NOT COMPLETED|Overall Study||0
3272893|NCT02684396|4008180|FG005|NOT COMPLETED|Overall Study||0
3272894|NCT02684435|4008194|FG000|STARTED|Overall Study||63
3272895|NCT02684435|4008194|FG000|COMPLETED|Overall Study||63
3272896|NCT02684435|4008194|FG000|NOT COMPLETED|Overall Study||0
3272897|NCT02684591|4008200|FG000|STARTED|Overall Study||25
3272898|NCT02684591|4008201|FG001|STARTED|Overall Study||25
3272899|NCT02684591|4008200|FG000|COMPLETED|Overall Study||24
3272900|NCT02684591|4008201|FG001|COMPLETED|Overall Study||22
3272901|NCT02684591|4008200|FG000|NOT COMPLETED|Overall Study||1
3272902|NCT02684591|4008201|FG001|NOT COMPLETED|Overall Study||3
3272903|NCT02684604|4008209|FG000|STARTED|Overall Study||44
3272904|NCT02684604|4008210|FG001|STARTED|Overall Study||44
2935874|NCT00614744|3647733|FG001|STARTED|Overall Study||85
3272905|NCT02684604|4008209|FG000|COMPLETED|Overall Study||44
3272906|NCT02684604|4008210|FG001|COMPLETED|Overall Study||44
3272907|NCT02684604|4008209|FG000|NOT COMPLETED|Overall Study||0
3272908|NCT02684604|4008210|FG001|NOT COMPLETED|Overall Study||0
3272909|NCT02684617|4008219|FG000|STARTED|Overall Study||18
3272910|NCT02684617|4008220|FG001|STARTED|Overall Study||17
3272911|NCT02684617|4008221|FG002|STARTED|Overall Study||40
3272912|NCT02684617|4008219|FG000|Treated|Overall Study||17
3272913|NCT02684617|4008220|FG001|Treated|Overall Study||17
3272914|NCT02684617|4008221|FG002|Treated|Overall Study||38
3272915|NCT02684617|4008219|FG000|COMPLETED|Overall Study||0
3272916|NCT02684617|4008220|FG001|COMPLETED|Overall Study||0
3272917|NCT02684617|4008221|FG002|COMPLETED|Overall Study||0
3272918|NCT02684617|4008219|FG000|NOT COMPLETED|Overall Study||18
3272919|NCT02684617|4008220|FG001|NOT COMPLETED|Overall Study||17
3272920|NCT02684617|4008221|FG002|NOT COMPLETED|Overall Study||40
3272921|NCT02684630|4008231|FG000|STARTED|Overall Study||65
3272922|NCT02684630|4008232|FG001|STARTED|Overall Study||63
3272923|NCT02684630|4008231|FG000|COMPLETED|Overall Study||60
3272924|NCT02684630|4008232|FG001|COMPLETED|Overall Study||60
3272925|NCT02684630|4008231|FG000|NOT COMPLETED|Overall Study||5
3272926|NCT02684630|4008232|FG001|NOT COMPLETED|Overall Study||3
2935875|NCT00614744|3647732|FG000|COMPLETED|Overall Study||78
2935876|NCT00614744|3647733|FG001|COMPLETED|Overall Study||79
2935877|NCT00614744|3647732|FG000|NOT COMPLETED|Overall Study||5
2935878|NCT00614744|3647733|FG001|NOT COMPLETED|Overall Study||6
2935879|NCT00614822|3647739|FG000|STARTED|Overall Study||50
2935880|NCT00614822|3647739|FG000|COMPLETED|Overall Study||47
2935881|NCT00614822|3647739|FG000|NOT COMPLETED|Overall Study||3
2935882|NCT00614874|3647744|FG000|STARTED|Overall Study||16
2935883|NCT00614874|3647744|FG000|COMPLETED|Overall Study||14
2935884|NCT00614874|3647744|FG000|NOT COMPLETED|Overall Study||2
2935885|NCT00614913|3647748|FG000|STARTED|Overall Study||76
2935886|NCT00614913|3647748|FG000|COMPLETED|Overall Study||76
2935887|NCT00614913|3647748|FG000|NOT COMPLETED|Overall Study||0
2935888|NCT00614926|3647754|FG000|STARTED|Overall Study||25
2935889|NCT00614926|3647755|FG001|STARTED|Overall Study||7
2935890|NCT00614926|3647754|FG000|COMPLETED|Overall Study||21
2935891|NCT00614926|3647755|FG001|COMPLETED|Overall Study||7
3272927|NCT02684851|4008242|FG000|STARTED|Overall Study||42
3272928|NCT02684851|4008243|FG001|STARTED|Overall Study||45
3272929|NCT02684851|4008242|FG000|COMPLETED|Overall Study||42
3272930|NCT02684851|4008243|FG001|COMPLETED|Overall Study||45
3272931|NCT02684851|4008242|FG000|NOT COMPLETED|Overall Study||0
3272932|NCT02684851|4008243|FG001|NOT COMPLETED|Overall Study||0
3272933|NCT02684942|4008251|FG000|STARTED|Overall Study||7
3272934|NCT02684942|4008252|FG001|STARTED|Overall Study||7
3272935|NCT02684942|4008253|FG002|STARTED|Overall Study||7
3272936|NCT02684942|4008254|FG003|STARTED|Overall Study||7
3272937|NCT02684942|4008255|FG004|STARTED|Overall Study||6
3272938|NCT02684942|4008256|FG005|STARTED|Overall Study||6
3272939|NCT02684942|4008251|FG000|COMPLETED|Overall Study||7
3272940|NCT02684942|4008252|FG001|COMPLETED|Overall Study||7
3272941|NCT02684942|4008253|FG002|COMPLETED|Overall Study||7
3272942|NCT02684942|4008254|FG003|COMPLETED|Overall Study||7
3272943|NCT02684942|4008255|FG004|COMPLETED|Overall Study||6
3272944|NCT02684942|4008256|FG005|COMPLETED|Overall Study||6
3272945|NCT02684942|4008251|FG000|NOT COMPLETED|Overall Study||0
3272946|NCT02684942|4008252|FG001|NOT COMPLETED|Overall Study||0
3272947|NCT02684942|4008253|FG002|NOT COMPLETED|Overall Study||0
3272948|NCT02684942|4008254|FG003|NOT COMPLETED|Overall Study||0
3272949|NCT02684942|4008255|FG004|NOT COMPLETED|Overall Study||0
3272950|NCT02684942|4008256|FG005|NOT COMPLETED|Overall Study||0
3272951|NCT02684981|4008270|FG000|STARTED|Overall Study||4100
3272952|NCT02684981|4008271|FG001|STARTED|Overall Study||3179
3272953|NCT02684981|4008272|FG002|STARTED|Overall Study||2186
3272954|NCT02684981|4008270|FG000|COMPLETED|Overall Study||3860
3272955|NCT02684981|4008271|FG001|COMPLETED|Overall Study||2969
3272956|NCT02684981|4008272|FG002|COMPLETED|Overall Study||2059
3272957|NCT02684981|4008270|FG000|NOT COMPLETED|Overall Study||240
3272958|NCT02684981|4008271|FG001|NOT COMPLETED|Overall Study||210
3272959|NCT02684981|4008272|FG002|NOT COMPLETED|Overall Study||127
3272960|NCT02685007|4008286|FG000|STARTED|Overall Study||131
3272961|NCT02685007|4008286|FG000|COMPLETED|Overall Study||131
3272962|NCT02685007|4008286|FG000|NOT COMPLETED|Overall Study||0
3272963|NCT02685033|4008292|FG000|STARTED|Overall Study||70
3272964|NCT02685033|4008293|FG001|STARTED|Overall Study||10
3272965|NCT02685033|4008292|FG000|COMPLETED|Overall Study||67
3272966|NCT02685033|4008293|FG001|COMPLETED|Overall Study||8
3272967|NCT02685033|4008292|FG000|NOT COMPLETED|Overall Study||3
3272968|NCT02685033|4008293|FG001|NOT COMPLETED|Overall Study||2
3272969|NCT02685072|4008301|FG000|STARTED|Treatment Period||33
3272970|NCT02685072|4008302|FG001|STARTED|Treatment Period||31
3272971|NCT02685072|4008301|FG000|Completed Week 2 Visit|Treatment Period||23
3272972|NCT02685072|4008302|FG001|Completed Week 2 Visit|Treatment Period||26
3272973|NCT02685072|4008301|FG000|Completed Week 3 Visit|Treatment Period||20
3272974|NCT02685072|4008302|FG001|Completed Week 3 Visit|Treatment Period||23
3272975|NCT02685072|4008301|FG000|Completed Week 4 Visit|Treatment Period||19
3272976|NCT02685072|4008302|FG001|Completed Week 4 Visit|Treatment Period||23
3272977|NCT02685072|4008301|FG000|Completed Week 5 Visit|Treatment Period||19
3272978|NCT02685072|4008302|FG001|Completed Week 5 Visit|Treatment Period||22
3272979|NCT02685072|4008301|FG000|Completed Week 6 Visit|Treatment Period||18
3272980|NCT02685072|4008302|FG001|Completed Week 6 Visit|Treatment Period||19
3272981|NCT02685072|4008301|FG000|Completed Week 7 Visit|Treatment Period||17
3272982|NCT02685072|4008302|FG001|Completed Week 7 Visit|Treatment Period||18
3272983|NCT02685072|4008301|FG000|Completed Week 8 Visit|Treatment Period||20
3272984|NCT02685072|4008302|FG001|Completed Week 8 Visit|Treatment Period|Week 8 data were collected at the 1-month follow-up for 1 participant|22
3272985|NCT02685072|4008301|FG000|COMPLETED|Treatment Period||20
3272986|NCT02685072|4008302|FG001|COMPLETED|Treatment Period||22
3272987|NCT02685072|4008301|FG000|NOT COMPLETED|Treatment Period||13
3272988|NCT02685072|4008302|FG001|NOT COMPLETED|Treatment Period||9
3272989|NCT02685072|4008301|FG000|STARTED|1-Month Follow-Up||20
3272990|NCT02685072|4008302|FG001|STARTED|1-Month Follow-Up||22
3272991|NCT02685072|4008301|FG000|COMPLETED|1-Month Follow-Up||19
3272992|NCT02685072|4008302|FG001|COMPLETED|1-Month Follow-Up||22
3272993|NCT02685072|4008301|FG000|NOT COMPLETED|1-Month Follow-Up||1
3272994|NCT02685072|4008302|FG001|NOT COMPLETED|1-Month Follow-Up||0
2935892|NCT00614926|3647754|FG000|NOT COMPLETED|Overall Study||4
2935893|NCT00614926|3647755|FG001|NOT COMPLETED|Overall Study||0
3272995|NCT02685072|4008301|FG000|STARTED|3-Month Follow-Up||19
3272996|NCT02685072|4008302|FG001|STARTED|3-Month Follow-Up||22
3272997|NCT02685072|4008301|FG000|COMPLETED|3-Month Follow-Up||19
2935894|NCT00614939|3647763|FG000|STARTED|Overall Study|Randomized and treated|85
2935895|NCT00614939|3647764|FG001|STARTED|Overall Study|Randomized and treated|85
2935896|NCT00614939|3647763|FG000|COMPLETED|Overall Study|Completed 52 weeks of treatment|50
2935897|NCT00614939|3647764|FG001|COMPLETED|Overall Study|Completed 52 weeks of treatment|42
2935898|NCT00614939|3647763|FG000|NOT COMPLETED|Overall Study||35
2935899|NCT00614939|3647764|FG001|NOT COMPLETED|Overall Study||43
2935900|NCT00614991|3647776|FG000|STARTED|Overall Study||8
2935901|NCT00614991|3647777|FG001|STARTED|Overall Study||9
2935902|NCT00614991|3647778|FG002|STARTED|Overall Study||7
3272998|NCT02685072|4008302|FG001|COMPLETED|3-Month Follow-Up||22
3272999|NCT02685072|4008301|FG000|NOT COMPLETED|3-Month Follow-Up||0
3273000|NCT02685072|4008302|FG001|NOT COMPLETED|3-Month Follow-Up||0
3273001|NCT02685267|4008311|FG000|STARTED|Overall Study||5
3273002|NCT02685267|4008312|FG001|STARTED|Overall Study||4
3273003|NCT02685267|4008311|FG000|COMPLETED|Overall Study||5
3273004|NCT02685267|4008312|FG001|COMPLETED|Overall Study||4
3273005|NCT02685267|4008311|FG000|NOT COMPLETED|Overall Study||0
3273006|NCT02685267|4008312|FG001|NOT COMPLETED|Overall Study||0
3273007|NCT02685293|4008318|FG000|STARTED|Treatment Period 1||1
3273008|NCT02685293|4008319|FG001|STARTED|Treatment Period 1||3
3273009|NCT02685293|4008318|FG000|COMPLETED|Treatment Period 1||1
3273010|NCT02685293|4008319|FG001|COMPLETED|Treatment Period 1||3
3273011|NCT02685293|4008318|FG000|NOT COMPLETED|Treatment Period 1||0
3273012|NCT02685293|4008319|FG001|NOT COMPLETED|Treatment Period 1||0
3273013|NCT02685293|4008318|FG000|STARTED|Washout Period||1
3273014|NCT02685293|4008319|FG001|STARTED|Washout Period||3
3273015|NCT02685293|4008318|FG000|COMPLETED|Washout Period||1
3273016|NCT02685293|4008319|FG001|COMPLETED|Washout Period||3
3273017|NCT02685293|4008318|FG000|NOT COMPLETED|Washout Period||0
3273018|NCT02685293|4008319|FG001|NOT COMPLETED|Washout Period||0
3273019|NCT02685293|4008318|FG000|STARTED|Treatment Period 2||1
3273020|NCT02685293|4008319|FG001|STARTED|Treatment Period 2||3
3273021|NCT02685293|4008318|FG000|COMPLETED|Treatment Period 2||1
3273022|NCT02685293|4008319|FG001|COMPLETED|Treatment Period 2||3
3273023|NCT02685293|4008318|FG000|NOT COMPLETED|Treatment Period 2||0
3273024|NCT02685293|4008319|FG001|NOT COMPLETED|Treatment Period 2||0
3273025|NCT02685436|4008325|FG000|STARTED|Overall Study|the overall studied group|52
3273026|NCT02685436|4008325|FG000|COMPLETED|Overall Study|GERD positive patients by either combined MII-pH or esophageal biopsy|38
3273027|NCT02685436|4008325|FG000|NOT COMPLETED|Overall Study||14
3273028|NCT02685488|4008331|FG000|STARTED|Overall Study||12
3273029|NCT02685488|4008332|FG001|STARTED|Overall Study||14
3273030|NCT02685488|4008331|FG000|COMPLETED|Overall Study||12
3273031|NCT02685488|4008332|FG001|COMPLETED|Overall Study||13
3273032|NCT02685488|4008331|FG000|NOT COMPLETED|Overall Study||0
3273033|NCT02685488|4008332|FG001|NOT COMPLETED|Overall Study||1
3273034|NCT02685566|4008338|FG000|STARTED|First Reading Session||50
3273035|NCT02685566|4008339|FG001|STARTED|First Reading Session||50
3273036|NCT02685566|4008338|FG000|COMPLETED|First Reading Session||50
3273037|NCT02685566|4008339|FG001|COMPLETED|First Reading Session||50
3273038|NCT02685566|4008338|FG000|NOT COMPLETED|First Reading Session||0
3273039|NCT02685566|4008339|FG001|NOT COMPLETED|First Reading Session||0
3273040|NCT02685566|4008338|FG000|STARTED|4 Week Memory Washout Period||50
3273041|NCT02685566|4008339|FG001|STARTED|4 Week Memory Washout Period||50
3273042|NCT02685566|4008338|FG000|COMPLETED|4 Week Memory Washout Period||50
3273043|NCT02685566|4008339|FG001|COMPLETED|4 Week Memory Washout Period||50
3273044|NCT02685566|4008338|FG000|NOT COMPLETED|4 Week Memory Washout Period||0
3273045|NCT02685566|4008339|FG001|NOT COMPLETED|4 Week Memory Washout Period||0
3273046|NCT02685566|4008338|FG000|STARTED|Second Reading Session||50
3273047|NCT02685566|4008339|FG001|STARTED|Second Reading Session||50
3273048|NCT02685566|4008338|FG000|COMPLETED|Second Reading Session||50
3273049|NCT02685566|4008339|FG001|COMPLETED|Second Reading Session||50
3273050|NCT02685566|4008338|FG000|NOT COMPLETED|Second Reading Session||0
3273051|NCT02685566|4008339|FG001|NOT COMPLETED|Second Reading Session||0
3273052|NCT02685826|4008350|FG000|STARTED|Overall Study||25
3273053|NCT02685826|4008351|FG001|STARTED|Overall Study||10
3273054|NCT02685826|4008352|FG002|STARTED|Overall Study||21
3273055|NCT02685826|4008350|FG000|COMPLETED|Overall Study||0
3273056|NCT02685826|4008351|FG001|COMPLETED|Overall Study||0
3273057|NCT02685826|4008352|FG002|COMPLETED|Overall Study||0
3273058|NCT02685826|4008350|FG000|NOT COMPLETED|Overall Study||25
3273059|NCT02685826|4008351|FG001|NOT COMPLETED|Overall Study||10
3273060|NCT02685826|4008352|FG002|NOT COMPLETED|Overall Study||21
3273061|NCT02685956|4008362|FG000|STARTED|Overall Study||317
3273062|NCT02685956|4008363|FG001|STARTED|Overall Study||1978
3273063|NCT02685956|4008362|FG000|COMPLETED|Overall Study||317
3273064|NCT02685956|4008363|FG001|COMPLETED|Overall Study||1978
3273065|NCT02685956|4008362|FG000|NOT COMPLETED|Overall Study||0
3273066|NCT02685956|4008363|FG001|NOT COMPLETED|Overall Study||0
3273067|NCT02685995|4008373|FG000|STARTED|Overall Study||50
3273068|NCT02685995|4008374|FG001|STARTED|Overall Study||50
3273069|NCT02685995|4008373|FG000|COMPLETED|Overall Study||49
3273070|NCT02685995|4008374|FG001|COMPLETED|Overall Study||49
3273071|NCT02685995|4008373|FG000|NOT COMPLETED|Overall Study||1
3273072|NCT02685995|4008374|FG001|NOT COMPLETED|Overall Study||1
3273073|NCT02686034|4008382|FG000|STARTED|Run-In Period 1||142
3273074|NCT02686034|4008383|FG001|STARTED|Run-In Period 1||143
3273075|NCT02686034|4008382|FG000|COMPLETED|Run-In Period 1||122
3273076|NCT02686034|4008383|FG001|COMPLETED|Run-In Period 1||126
2935903|NCT00614991|3647779|FG003|STARTED|Overall Study||7
2935904|NCT00614991|3647780|FG004|STARTED|Overall Study||7
2935905|NCT00614991|3647781|FG005|STARTED|Overall Study||6
2935906|NCT00614991|3647776|FG000|COMPLETED|Overall Study||5
2935907|NCT00614991|3647777|FG001|COMPLETED|Overall Study||6
2935908|NCT00614991|3647778|FG002|COMPLETED|Overall Study||7
2935909|NCT00614991|3647779|FG003|COMPLETED|Overall Study||7
2935910|NCT00614991|3647780|FG004|COMPLETED|Overall Study||6
2935911|NCT00614991|3647781|FG005|COMPLETED|Overall Study||6
2935912|NCT00614991|3647776|FG000|NOT COMPLETED|Overall Study||3
2935913|NCT00614991|3647777|FG001|NOT COMPLETED|Overall Study||3
2935914|NCT00614991|3647778|FG002|NOT COMPLETED|Overall Study||0
2935915|NCT00614991|3647779|FG003|NOT COMPLETED|Overall Study||0
2935916|NCT00614991|3647780|FG004|NOT COMPLETED|Overall Study||1
2935917|NCT00614991|3647781|FG005|NOT COMPLETED|Overall Study||0
2935918|NCT00615017|3647806|FG000|STARTED|Overall Study|Patients received treatment|8
2935919|NCT00615017|3647807|FG001|STARTED|Overall Study|Patients received treatment|9
2935920|NCT00615017|3647808|FG002|STARTED|Overall Study|Patients received treatment|12
2935921|NCT00615017|3647809|FG003|STARTED|Overall Study|Patients received treatment|10
2935922|NCT00615017|3647810|FG004|STARTED|Overall Study|Patients received treatment|8
2935923|NCT00615017|3647811|FG005|STARTED|Overall Study|Patients received treatment|23
2935924|NCT00615017|3647806|FG000|COMPLETED|Overall Study|Patient completed the study drug|8
2935925|NCT00615017|3647807|FG001|COMPLETED|Overall Study|Patient completed the study drug|8
2935926|NCT00615017|3647808|FG002|COMPLETED|Overall Study|Patient completed the study drug|7
2935927|NCT00615017|3647809|FG003|COMPLETED|Overall Study|Patient completed the study drug|9
2935928|NCT00615017|3647810|FG004|COMPLETED|Overall Study|Patient completed the study drug|7
2935929|NCT00615017|3647811|FG005|COMPLETED|Overall Study|Patient completed the study drug|20
3273077|NCT02686034|4008382|FG000|NOT COMPLETED|Run-In Period 1||20
3273078|NCT02686034|4008383|FG001|NOT COMPLETED|Run-In Period 1||17
3273079|NCT02686034|4008382|FG000|STARTED|Randomized Controlled Period 2||122
3273080|NCT02686034|4008383|FG001|STARTED|Randomized Controlled Period 2||126
3273081|NCT02686034|4008382|FG000|COMPLETED|Randomized Controlled Period 2||117
3273082|NCT02686034|4008383|FG001|COMPLETED|Randomized Controlled Period 2||122
3273083|NCT02686034|4008382|FG000|NOT COMPLETED|Randomized Controlled Period 2||5
3273084|NCT02686034|4008383|FG001|NOT COMPLETED|Randomized Controlled Period 2||4
3273085|NCT02686034|4008382|FG000|STARTED|Open Label Period 3||117
3273086|NCT02686034|4008383|FG001|STARTED|Open Label Period 3||122
3273087|NCT02686034|4008382|FG000|COMPLETED|Open Label Period 3||117
3273088|NCT02686034|4008383|FG001|COMPLETED|Open Label Period 3||121
3273089|NCT02686034|4008382|FG000|NOT COMPLETED|Open Label Period 3||0
3273090|NCT02686034|4008383|FG001|NOT COMPLETED|Open Label Period 3||1
3273091|NCT02686138|4008391|FG000|STARTED|Overall Study||293
3273092|NCT02686138|4008392|FG001|STARTED|Overall Study||300
3273093|NCT02686138|4008391|FG000|COMPLETED|Overall Study||219
3273094|NCT02686138|4008392|FG001|COMPLETED|Overall Study||235
3273095|NCT02686138|4008391|FG000|NOT COMPLETED|Overall Study||74
3273096|NCT02686138|4008392|FG001|NOT COMPLETED|Overall Study||65
3273097|NCT02686164|4008398|FG000|STARTED|Overall Study||30
3273098|NCT02686164|4008398|FG000|COMPLETED|Overall Study||27
3273099|NCT02686164|4008398|FG000|NOT COMPLETED|Overall Study||3
3273100|NCT02686437|4008407|FG000|STARTED|Overall Study||16
3273101|NCT02686437|4008408|FG001|STARTED|Overall Study||20
3273102|NCT02686437|4008407|FG000|COMPLETED|Overall Study||13
3273103|NCT02686437|4008408|FG001|COMPLETED|Overall Study||12
3273104|NCT02686437|4008407|FG000|NOT COMPLETED|Overall Study||3
3273105|NCT02686437|4008408|FG001|NOT COMPLETED|Overall Study||8
3273106|NCT02687035|4008414|FG000|STARTED|Overall Study||1822
3273107|NCT02687035|4008414|FG000|COMPLETED|Overall Study||1638
3273108|NCT02687035|4008414|FG000|NOT COMPLETED|Overall Study||184
3273109|NCT02687126|4008418|FG000|STARTED|Data Collection||106
3273110|NCT02687126|4008418|FG000|COMPLETED|Data Collection||106
3273111|NCT02687126|4008418|FG000|NOT COMPLETED|Data Collection||0
3273112|NCT02687126|4008418|FG000|STARTED|Data Analysis||106
3273113|NCT02687126|4008418|FG000|COMPLETED|Data Analysis||106
3273114|NCT02687126|4008418|FG000|NOT COMPLETED|Data Analysis||0
3273115|NCT02687139|4008425|FG000|STARTED|Overall Study||34
3273116|NCT02687139|4008425|FG000|COMPLETED|Overall Study||34
3273117|NCT02687139|4008425|FG000|NOT COMPLETED|Overall Study||0
3273118|NCT02687191|4008435|FG000|STARTED|Overall Study||3
3273119|NCT02687191|4008436|FG001|STARTED|Overall Study||3
3273120|NCT02687191|4008437|FG002|STARTED|Overall Study||3
3273121|NCT02687191|4008438|FG003|STARTED|Overall Study||6
3273122|NCT02687191|4008439|FG004|STARTED|Overall Study||3
3273123|NCT02687191|4008440|FG005|STARTED|Overall Study||3
3273124|NCT02687191|4008435|FG000|COMPLETED|Overall Study||3
3273125|NCT02687191|4008436|FG001|COMPLETED|Overall Study||2
3273126|NCT02687191|4008437|FG002|COMPLETED|Overall Study||2
3273127|NCT02687191|4008438|FG003|COMPLETED|Overall Study||5
3273128|NCT02687191|4008439|FG004|COMPLETED|Overall Study||2
3273129|NCT02687191|4008440|FG005|COMPLETED|Overall Study||2
3273130|NCT02687191|4008435|FG000|NOT COMPLETED|Overall Study||0
3273131|NCT02687191|4008436|FG001|NOT COMPLETED|Overall Study||1
3273132|NCT02687191|4008437|FG002|NOT COMPLETED|Overall Study||1
3273133|NCT02687191|4008438|FG003|NOT COMPLETED|Overall Study||1
3273134|NCT02687191|4008439|FG004|NOT COMPLETED|Overall Study||1
3273135|NCT02687191|4008440|FG005|NOT COMPLETED|Overall Study||1
3273136|NCT02687217|4008456|FG000|STARTED|Overall Study||30
3273137|NCT02687217|4008457|FG001|STARTED|Overall Study||30
3273138|NCT02687217|4008456|FG000|COMPLETED|Overall Study||30
2935930|NCT00615017|3647806|FG000|NOT COMPLETED|Overall Study||0
2935931|NCT00615017|3647807|FG001|NOT COMPLETED|Overall Study||1
2935932|NCT00615017|3647808|FG002|NOT COMPLETED|Overall Study||5
2935933|NCT00615017|3647809|FG003|NOT COMPLETED|Overall Study||1
2935934|NCT00615017|3647810|FG004|NOT COMPLETED|Overall Study||1
2935935|NCT00615017|3647811|FG005|NOT COMPLETED|Overall Study||3
2935936|NCT00615030|3647825|FG000|STARTED|Period I||9
2935937|NCT00615030|3647826|FG001|STARTED|Period I||8
2935938|NCT00615030|3647827|FG002|STARTED|Period I||9
2935939|NCT00615030|3647828|FG003|STARTED|Period I||8
2935940|NCT00615030|3647829|FG004|STARTED|Period I||9
2935941|NCT00615030|3647830|FG005|STARTED|Period I|1 randomized patient in this sequence dropped out before exposure to study drug in Period I.|6
2935942|NCT00615030|3647831|FG006|STARTED|Period I||7
2935943|NCT00615030|3647832|FG007|STARTED|Period I||7
2935944|NCT00615030|3647833|FG008|STARTED|Period I||9
2935945|NCT00615030|3647834|FG009|STARTED|Period I||8
2935946|NCT00615030|3647835|FG010|STARTED|Period I||8
2935947|NCT00615030|3647836|FG011|STARTED|Period I||7
2935948|NCT00615030|3647825|FG000|COMPLETED|Period I||8
2935949|NCT00615030|3647826|FG001|COMPLETED|Period I||8
2935950|NCT00615030|3647827|FG002|COMPLETED|Period I||9
2935951|NCT00615030|3647828|FG003|COMPLETED|Period I||8
2935952|NCT00615030|3647829|FG004|COMPLETED|Period I||8
2935953|NCT00615030|3647830|FG005|COMPLETED|Period I||5
2935954|NCT00615030|3647831|FG006|COMPLETED|Period I||7
2935955|NCT00615030|3647832|FG007|COMPLETED|Period I||7
2935956|NCT00615030|3647833|FG008|COMPLETED|Period I||8
2935957|NCT00615030|3647834|FG009|COMPLETED|Period I||8
2935958|NCT00615030|3647835|FG010|COMPLETED|Period I||7
2935959|NCT00615030|3647836|FG011|COMPLETED|Period I||6
2935960|NCT00615030|3647825|FG000|NOT COMPLETED|Period I||1
3273139|NCT02687217|4008457|FG001|COMPLETED|Overall Study||30
3273140|NCT02687217|4008456|FG000|NOT COMPLETED|Overall Study||0
3273141|NCT02687217|4008457|FG001|NOT COMPLETED|Overall Study||0
3273142|NCT02687412|4008465|FG000|STARTED|Overall Study||50
3273143|NCT02687412|4008466|FG001|STARTED|Overall Study||57
3273144|NCT02687412|4008465|FG000|COMPLETED|Overall Study||50
3273145|NCT02687412|4008466|FG001|COMPLETED|Overall Study||57
3273146|NCT02687412|4008465|FG000|NOT COMPLETED|Overall Study||0
3273147|NCT02687412|4008466|FG001|NOT COMPLETED|Overall Study||0
3273148|NCT02687451|4008478|FG000|STARTED|Overall Study||6
3273149|NCT02687451|4008479|FG001|STARTED|Overall Study||5
3273150|NCT02687451|4008480|FG002|STARTED|Overall Study||5
3273151|NCT02687451|4008481|FG003|STARTED|Overall Study||5
3273152|NCT02687451|4008482|FG004|STARTED|Overall Study||4
3273153|NCT02687451|4008483|FG005|STARTED|Overall Study||3
3273154|NCT02687451|4008478|FG000|COMPLETED|Overall Study||5
3273155|NCT02687451|4008479|FG001|COMPLETED|Overall Study||5
3273156|NCT02687451|4008480|FG002|COMPLETED|Overall Study||5
3273157|NCT02687451|4008481|FG003|COMPLETED|Overall Study||5
3273158|NCT02687451|4008482|FG004|COMPLETED|Overall Study||4
3273159|NCT02687451|4008483|FG005|COMPLETED|Overall Study||2
3273160|NCT02687451|4008478|FG000|NOT COMPLETED|Overall Study||1
3273161|NCT02687451|4008479|FG001|NOT COMPLETED|Overall Study||0
3273162|NCT02687451|4008480|FG002|NOT COMPLETED|Overall Study||0
3273163|NCT02687451|4008481|FG003|NOT COMPLETED|Overall Study||0
3273164|NCT02687451|4008482|FG004|NOT COMPLETED|Overall Study||0
3273165|NCT02687451|4008483|FG005|NOT COMPLETED|Overall Study||1
3273166|NCT02687529|4008501|FG000|STARTED|Overall Study||34
3273167|NCT02687529|4008502|FG001|STARTED|Overall Study||32
3273168|NCT02687529|4008501|FG000|COMPLETED|Overall Study||34
3273169|NCT02687529|4008502|FG001|COMPLETED|Overall Study||32
3273170|NCT02687529|4008501|FG000|NOT COMPLETED|Overall Study||0
3273171|NCT02687529|4008502|FG001|NOT COMPLETED|Overall Study||0
3273172|NCT02687542|4008513|FG000|STARTED|Overall Study||23
3273173|NCT02687542|4008514|FG001|STARTED|Overall Study||13
3273174|NCT02687542|4008515|FG002|STARTED|Overall Study||15
3273175|NCT02687542|4008516|FG003|STARTED|Overall Study||13
3273176|NCT02687542|4008517|FG004|STARTED|Overall Study||44
3273177|NCT02687542|4008513|FG000|COMPLETED|Overall Study||15
3273178|NCT02687542|4008514|FG001|COMPLETED|Overall Study||1
3273179|NCT02687542|4008515|FG002|COMPLETED|Overall Study||1
3273180|NCT02687542|4008516|FG003|COMPLETED|Overall Study||3
3273181|NCT02687542|4008517|FG004|COMPLETED|Overall Study||24
3273182|NCT02687542|4008513|FG000|NOT COMPLETED|Overall Study||8
3273183|NCT02687542|4008514|FG001|NOT COMPLETED|Overall Study||12
3273184|NCT02687542|4008515|FG002|NOT COMPLETED|Overall Study||14
3273185|NCT02687542|4008516|FG003|NOT COMPLETED|Overall Study||10
3273186|NCT02687542|4008517|FG004|NOT COMPLETED|Overall Study||20
3273187|NCT02687711|4008529|FG000|STARTED|Overall Study||544
3273188|NCT02687711|4008529|FG000|COMPLETED|Overall Study||332
3273189|NCT02687711|4008529|FG000|NOT COMPLETED|Overall Study||212
3273190|NCT02687815|4008535|FG000|STARTED|Overall Study||96
3273191|NCT02687815|4008536|FG001|STARTED|Overall Study||96
2935961|NCT00615030|3647826|FG001|NOT COMPLETED|Period I||0
2935962|NCT00615030|3647827|FG002|NOT COMPLETED|Period I||0
3273192|NCT02687815|4008535|FG000|COMPLETED|Overall Study||92
3273193|NCT02687815|4008536|FG001|COMPLETED|Overall Study||88
3273194|NCT02687815|4008535|FG000|NOT COMPLETED|Overall Study||4
3273195|NCT02687815|4008536|FG001|NOT COMPLETED|Overall Study||8
3273196|NCT02687919|4008544|FG000|STARTED|Overall Study||16
3273197|NCT02687919|4008545|FG001|STARTED|Overall Study||15
3273198|NCT02687919|4008544|FG000|COMPLETED|Overall Study||8
3273199|NCT02687919|4008545|FG001|COMPLETED|Overall Study||9
2935963|NCT00615030|3647828|FG003|NOT COMPLETED|Period I||0
2935964|NCT00615030|3647829|FG004|NOT COMPLETED|Period I||1
2935965|NCT00615030|3647830|FG005|NOT COMPLETED|Period I||1
2935966|NCT00615030|3647831|FG006|NOT COMPLETED|Period I||0
2935967|NCT00615030|3647832|FG007|NOT COMPLETED|Period I||0
3273200|NCT02687919|4008544|FG000|NOT COMPLETED|Overall Study||8
3273201|NCT02687919|4008545|FG001|NOT COMPLETED|Overall Study||6
3273202|NCT02688153|4008553|FG000|STARTED|Overall Study||62
3273203|NCT02688153|4008554|FG001|STARTED|Overall Study||58
3273204|NCT02688153|4008553|FG000|Final Randomized Arm/Group|Overall Study||59
3273205|NCT02688153|4008554|FG001|Final Randomized Arm/Group|Overall Study||61
3273206|NCT02688153|4008553|FG000|COMPLETED|Overall Study||47
3273207|NCT02688153|4008554|FG001|COMPLETED|Overall Study||51
3273208|NCT02688153|4008553|FG000|NOT COMPLETED|Overall Study||15
3273209|NCT02688153|4008554|FG001|NOT COMPLETED|Overall Study||7
3273210|NCT02688192|4008563|FG000|STARTED|Overall Study||25
3273211|NCT02688192|4008564|FG001|STARTED|Overall Study||24
3273212|NCT02688192|4008563|FG000|COMPLETED|Overall Study||13
3273213|NCT02688192|4008564|FG001|COMPLETED|Overall Study||19
3273214|NCT02688192|4008563|FG000|NOT COMPLETED|Overall Study||12
3273215|NCT02688192|4008564|FG001|NOT COMPLETED|Overall Study||5
3273216|NCT02688218|4008573|FG000|STARTED|First Exercise Intervention (2 Hours)||24
3273217|NCT02688218|4008574|FG001|STARTED|First Exercise Intervention (2 Hours)||6
3273218|NCT02688218|4008573|FG000|COMPLETED|First Exercise Intervention (2 Hours)||24
3273219|NCT02688218|4008574|FG001|COMPLETED|First Exercise Intervention (2 Hours)||6
3273220|NCT02688218|4008573|FG000|NOT COMPLETED|First Exercise Intervention (2 Hours)||0
3273221|NCT02688218|4008574|FG001|NOT COMPLETED|First Exercise Intervention (2 Hours)||0
3273222|NCT02688218|4008573|FG000|STARTED|Washout (30 Minutes)||24
3273223|NCT02688218|4008574|FG001|STARTED|Washout (30 Minutes)||6
3273224|NCT02688218|4008573|FG000|COMPLETED|Washout (30 Minutes)||24
3273225|NCT02688218|4008574|FG001|COMPLETED|Washout (30 Minutes)||6
3273226|NCT02688218|4008573|FG000|NOT COMPLETED|Washout (30 Minutes)||0
3273227|NCT02688218|4008574|FG001|NOT COMPLETED|Washout (30 Minutes)||0
3273228|NCT02688218|4008573|FG000|STARTED|Second Exercise Intervention (2 Hours)||24
3273229|NCT02688218|4008574|FG001|STARTED|Second Exercise Intervention (2 Hours)||6
3273230|NCT02688218|4008573|FG000|COMPLETED|Second Exercise Intervention (2 Hours)||24
3273231|NCT02688218|4008574|FG001|COMPLETED|Second Exercise Intervention (2 Hours)||6
3273232|NCT02688218|4008573|FG000|NOT COMPLETED|Second Exercise Intervention (2 Hours)||0
3273233|NCT02688218|4008574|FG001|NOT COMPLETED|Second Exercise Intervention (2 Hours)||0
3273234|NCT02688387|4008584|FG000|STARTED|Part 1, Period 1 (up to 6 Days)||3
3273235|NCT02688387|4008585|FG001|STARTED|Part 1, Period 1 (up to 6 Days)||3
3273236|NCT02688387|4008586|FG002|STARTED|Part 1, Period 1 (up to 6 Days)||4
3273237|NCT02688387|4008587|FG003|STARTED|Part 1, Period 1 (up to 6 Days)||3
3273238|NCT02688387|4008588|FG004|STARTED|Part 1, Period 1 (up to 6 Days)||3
3273239|NCT02688387|4008589|FG005|STARTED|Part 1, Period 1 (up to 6 Days)||2
3273240|NCT02688387|4008590|FG006|STARTED|Part 1, Period 1 (up to 6 Days)||2
3273241|NCT02688387|4008591|FG007|STARTED|Part 1, Period 1 (up to 6 Days)||2
3273242|NCT02688387|4008592|FG008|STARTED|Part 1, Period 1 (up to 6 Days)||2
3273243|NCT02688387|4008593|FG009|STARTED|Part 1, Period 1 (up to 6 Days)||2
3273244|NCT02688387|4008594|FG010|STARTED|Part 1, Period 1 (up to 6 Days)||0
3273245|NCT02688387|4008595|FG011|STARTED|Part 1, Period 1 (up to 6 Days)||0
3273246|NCT02688387|4008596|FG012|STARTED|Part 1, Period 1 (up to 6 Days)||0
3273247|NCT02688387|4008597|FG013|STARTED|Part 1, Period 1 (up to 6 Days)||0
3273248|NCT02688387|4008598|FG014|STARTED|Part 1, Period 1 (up to 6 Days)||0
3273249|NCT02688387|4008599|FG015|STARTED|Part 1, Period 1 (up to 6 Days)||0
3273250|NCT02688387|4008600|FG016|STARTED|Part 1, Period 1 (up to 6 Days)||0
3273251|NCT02688387|4008601|FG017|STARTED|Part 1, Period 1 (up to 6 Days)||0
3273252|NCT02688387|4008602|FG018|STARTED|Part 1, Period 1 (up to 6 Days)||0
3273253|NCT02688387|4008603|FG019|STARTED|Part 1, Period 1 (up to 6 Days)||0
3273254|NCT02688387|4008604|FG020|STARTED|Part 1, Period 1 (up to 6 Days)||0
3273255|NCT02688387|4008605|FG021|STARTED|Part 1, Period 1 (up to 6 Days)||0
3273256|NCT02688387|4008584|FG000|COMPLETED|Part 1, Period 1 (up to 6 Days)||3
3273257|NCT02688387|4008585|FG001|COMPLETED|Part 1, Period 1 (up to 6 Days)||3
3273258|NCT02688387|4008586|FG002|COMPLETED|Part 1, Period 1 (up to 6 Days)||3
3273259|NCT02688387|4008587|FG003|COMPLETED|Part 1, Period 1 (up to 6 Days)||2
3273260|NCT02688387|4008588|FG004|COMPLETED|Part 1, Period 1 (up to 6 Days)||3
3273261|NCT02688387|4008589|FG005|COMPLETED|Part 1, Period 1 (up to 6 Days)||2
3273262|NCT02688387|4008590|FG006|COMPLETED|Part 1, Period 1 (up to 6 Days)||2
3273263|NCT02688387|4008591|FG007|COMPLETED|Part 1, Period 1 (up to 6 Days)||2
3273264|NCT02688387|4008592|FG008|COMPLETED|Part 1, Period 1 (up to 6 Days)||2
3273265|NCT02688387|4008593|FG009|COMPLETED|Part 1, Period 1 (up to 6 Days)||2
3273266|NCT02688387|4008594|FG010|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
3273267|NCT02688387|4008595|FG011|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
3273268|NCT02688387|4008596|FG012|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
3273269|NCT02688387|4008597|FG013|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
3273270|NCT02688387|4008598|FG014|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
3273271|NCT02688387|4008599|FG015|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
3273272|NCT02688387|4008600|FG016|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
3273273|NCT02688387|4008601|FG017|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
3273274|NCT02688387|4008602|FG018|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
3273275|NCT02688387|4008603|FG019|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
3273276|NCT02688387|4008604|FG020|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
3273277|NCT02688387|4008605|FG021|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
3273278|NCT02688387|4008584|FG000|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
3273279|NCT02688387|4008585|FG001|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
2935968|NCT00615030|3647833|FG008|NOT COMPLETED|Period I||1
2935969|NCT00615030|3647834|FG009|NOT COMPLETED|Period I||0
2935970|NCT00615030|3647835|FG010|NOT COMPLETED|Period I||1
2935971|NCT00615030|3647836|FG011|NOT COMPLETED|Period I||1
2935972|NCT00615030|3647825|FG000|STARTED|Period II||8
2935973|NCT00615030|3647826|FG001|STARTED|Period II||8
2935974|NCT00615030|3647827|FG002|STARTED|Period II||9
2935975|NCT00615030|3647828|FG003|STARTED|Period II||8
2935976|NCT00615030|3647829|FG004|STARTED|Period II||8
2935977|NCT00615030|3647830|FG005|STARTED|Period II||5
2935978|NCT00615030|3647831|FG006|STARTED|Period II||7
2935979|NCT00615030|3647832|FG007|STARTED|Period II||7
2935980|NCT00615030|3647833|FG008|STARTED|Period II||8
2935981|NCT00615030|3647834|FG009|STARTED|Period II||8
2935982|NCT00615030|3647835|FG010|STARTED|Period II||7
2935983|NCT00615030|3647836|FG011|STARTED|Period II||6
2935984|NCT00615030|3647825|FG000|COMPLETED|Period II||8
2935985|NCT00615030|3647826|FG001|COMPLETED|Period II||8
2935986|NCT00615030|3647827|FG002|COMPLETED|Period II||8
2935987|NCT00615030|3647828|FG003|COMPLETED|Period II||7
2935988|NCT00615030|3647829|FG004|COMPLETED|Period II||8
2935989|NCT00615030|3647830|FG005|COMPLETED|Period II||5
2935990|NCT00615030|3647831|FG006|COMPLETED|Period II||6
2935991|NCT00615030|3647832|FG007|COMPLETED|Period II||7
2935992|NCT00615030|3647833|FG008|COMPLETED|Period II||7
2935993|NCT00615030|3647834|FG009|COMPLETED|Period II||8
2935994|NCT00615030|3647835|FG010|COMPLETED|Period II||7
2935995|NCT00615030|3647836|FG011|COMPLETED|Period II||6
2935996|NCT00615030|3647825|FG000|NOT COMPLETED|Period II||0
2935997|NCT00615030|3647826|FG001|NOT COMPLETED|Period II||0
2935998|NCT00615030|3647827|FG002|NOT COMPLETED|Period II||1
2935999|NCT00615030|3647828|FG003|NOT COMPLETED|Period II||1
2936000|NCT00615030|3647829|FG004|NOT COMPLETED|Period II||0
2936001|NCT00615030|3647830|FG005|NOT COMPLETED|Period II||0
2936002|NCT00615030|3647831|FG006|NOT COMPLETED|Period II||1
2936003|NCT00615030|3647832|FG007|NOT COMPLETED|Period II||0
2936004|NCT00615030|3647833|FG008|NOT COMPLETED|Period II||1
2936005|NCT00615030|3647834|FG009|NOT COMPLETED|Period II||0
2936006|NCT00615030|3647835|FG010|NOT COMPLETED|Period II||0
2936007|NCT00615030|3647836|FG011|NOT COMPLETED|Period II||0
2936008|NCT00615030|3647825|FG000|STARTED|Period III||8
2936009|NCT00615030|3647826|FG001|STARTED|Period III||8
2936010|NCT00615030|3647827|FG002|STARTED|Period III||8
2936011|NCT00615030|3647828|FG003|STARTED|Period III||7
2936012|NCT00615030|3647829|FG004|STARTED|Period III||8
2936013|NCT00615030|3647830|FG005|STARTED|Period III||5
2936014|NCT00615030|3647831|FG006|STARTED|Period III||6
2936015|NCT00615030|3647832|FG007|STARTED|Period III||7
2936016|NCT00615030|3647833|FG008|STARTED|Period III||7
2936017|NCT00615030|3647834|FG009|STARTED|Period III||8
2936018|NCT00615030|3647835|FG010|STARTED|Period III||7
2936019|NCT00615030|3647836|FG011|STARTED|Period III||6
3273280|NCT02688387|4008586|FG002|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||1
3273281|NCT02688387|4008587|FG003|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||1
3273282|NCT02688387|4008588|FG004|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
3273283|NCT02688387|4008589|FG005|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
3273284|NCT02688387|4008590|FG006|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
3273285|NCT02688387|4008591|FG007|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
3273286|NCT02688387|4008592|FG008|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
3273287|NCT02688387|4008593|FG009|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
3273288|NCT02688387|4008594|FG010|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
3273289|NCT02688387|4008595|FG011|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
3273290|NCT02688387|4008596|FG012|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
3273291|NCT02688387|4008597|FG013|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
3273292|NCT02688387|4008598|FG014|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
3273293|NCT02688387|4008599|FG015|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
3273294|NCT02688387|4008600|FG016|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
3273295|NCT02688387|4008601|FG017|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
3273296|NCT02688387|4008602|FG018|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
3273297|NCT02688387|4008603|FG019|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
3273298|NCT02688387|4008604|FG020|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
3273299|NCT02688387|4008605|FG021|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
3273300|NCT02688387|4008584|FG000|STARTED|Part 1, Washout Period 1 (7 Days)||3
3273301|NCT02688387|4008585|FG001|STARTED|Part 1, Washout Period 1 (7 Days)||3
2936020|NCT00615030|3647825|FG000|COMPLETED|Period III||7
2936021|NCT00615030|3647826|FG001|COMPLETED|Period III||8
2936022|NCT00615030|3647827|FG002|COMPLETED|Period III||8
2936023|NCT00615030|3647828|FG003|COMPLETED|Period III||6
2936024|NCT00615030|3647829|FG004|COMPLETED|Period III||8
2936025|NCT00615030|3647830|FG005|COMPLETED|Period III||5
2936026|NCT00615030|3647831|FG006|COMPLETED|Period III||6
2936027|NCT00615030|3647832|FG007|COMPLETED|Period III||7
2936028|NCT00615030|3647833|FG008|COMPLETED|Period III||7
2936029|NCT00615030|3647834|FG009|COMPLETED|Period III||8
2936030|NCT00615030|3647835|FG010|COMPLETED|Period III||7
2936031|NCT00615030|3647836|FG011|COMPLETED|Period III||6
2936032|NCT00615030|3647825|FG000|NOT COMPLETED|Period III||1
2936033|NCT00615030|3647826|FG001|NOT COMPLETED|Period III||0
2936034|NCT00615030|3647827|FG002|NOT COMPLETED|Period III||0
2936035|NCT00615030|3647828|FG003|NOT COMPLETED|Period III||1
2936036|NCT00615030|3647829|FG004|NOT COMPLETED|Period III||0
2936037|NCT00615030|3647830|FG005|NOT COMPLETED|Period III||0
2936038|NCT00615030|3647831|FG006|NOT COMPLETED|Period III||0
2936039|NCT00615030|3647832|FG007|NOT COMPLETED|Period III||0
3273302|NCT02688387|4008586|FG002|STARTED|Part 1, Washout Period 1 (7 Days)||3
3273303|NCT02688387|4008587|FG003|STARTED|Part 1, Washout Period 1 (7 Days)||2
3273304|NCT02688387|4008588|FG004|STARTED|Part 1, Washout Period 1 (7 Days)||3
3273305|NCT02688387|4008589|FG005|STARTED|Part 1, Washout Period 1 (7 Days)||2
3273306|NCT02688387|4008590|FG006|STARTED|Part 1, Washout Period 1 (7 Days)||2
3273307|NCT02688387|4008591|FG007|STARTED|Part 1, Washout Period 1 (7 Days)||2
3273308|NCT02688387|4008592|FG008|STARTED|Part 1, Washout Period 1 (7 Days)||2
3273309|NCT02688387|4008593|FG009|STARTED|Part 1, Washout Period 1 (7 Days)||2
3273310|NCT02688387|4008594|FG010|STARTED|Part 1, Washout Period 1 (7 Days)||0
3273311|NCT02688387|4008595|FG011|STARTED|Part 1, Washout Period 1 (7 Days)||0
3273312|NCT02688387|4008596|FG012|STARTED|Part 1, Washout Period 1 (7 Days)||0
3273313|NCT02688387|4008597|FG013|STARTED|Part 1, Washout Period 1 (7 Days)||0
3273314|NCT02688387|4008598|FG014|STARTED|Part 1, Washout Period 1 (7 Days)||0
3273315|NCT02688387|4008599|FG015|STARTED|Part 1, Washout Period 1 (7 Days)||0
3273316|NCT02688387|4008600|FG016|STARTED|Part 1, Washout Period 1 (7 Days)||0
3273317|NCT02688387|4008601|FG017|STARTED|Part 1, Washout Period 1 (7 Days)||0
3273318|NCT02688387|4008602|FG018|STARTED|Part 1, Washout Period 1 (7 Days)||0
3273319|NCT02688387|4008603|FG019|STARTED|Part 1, Washout Period 1 (7 Days)||0
3273320|NCT02688387|4008604|FG020|STARTED|Part 1, Washout Period 1 (7 Days)||0
3273321|NCT02688387|4008605|FG021|STARTED|Part 1, Washout Period 1 (7 Days)||0
3273322|NCT02688387|4008584|FG000|COMPLETED|Part 1, Washout Period 1 (7 Days)||3
3273323|NCT02688387|4008585|FG001|COMPLETED|Part 1, Washout Period 1 (7 Days)||2
3273324|NCT02688387|4008586|FG002|COMPLETED|Part 1, Washout Period 1 (7 Days)||3
3273325|NCT02688387|4008587|FG003|COMPLETED|Part 1, Washout Period 1 (7 Days)||2
3273326|NCT02688387|4008588|FG004|COMPLETED|Part 1, Washout Period 1 (7 Days)||3
3273327|NCT02688387|4008589|FG005|COMPLETED|Part 1, Washout Period 1 (7 Days)||2
3273328|NCT02688387|4008590|FG006|COMPLETED|Part 1, Washout Period 1 (7 Days)||2
3273329|NCT02688387|4008591|FG007|COMPLETED|Part 1, Washout Period 1 (7 Days)||2
3273330|NCT02688387|4008592|FG008|COMPLETED|Part 1, Washout Period 1 (7 Days)||2
3273331|NCT02688387|4008593|FG009|COMPLETED|Part 1, Washout Period 1 (7 Days)||2
3273332|NCT02688387|4008594|FG010|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
3273333|NCT02688387|4008595|FG011|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
3273334|NCT02688387|4008596|FG012|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
3273335|NCT02688387|4008597|FG013|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
3273336|NCT02688387|4008598|FG014|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
3273337|NCT02688387|4008599|FG015|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
3273338|NCT02688387|4008600|FG016|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
3273339|NCT02688387|4008601|FG017|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
3273340|NCT02688387|4008602|FG018|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
3273341|NCT02688387|4008603|FG019|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
3273342|NCT02688387|4008604|FG020|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
3273343|NCT02688387|4008605|FG021|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
3273344|NCT02688387|4008584|FG000|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
3273345|NCT02688387|4008585|FG001|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||1
3273346|NCT02688387|4008586|FG002|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
3273347|NCT02688387|4008587|FG003|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
3273348|NCT02688387|4008588|FG004|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
3273349|NCT02688387|4008589|FG005|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
3273350|NCT02688387|4008590|FG006|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
3273351|NCT02688387|4008591|FG007|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
3273352|NCT02688387|4008592|FG008|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
3273353|NCT02688387|4008593|FG009|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
3273354|NCT02688387|4008594|FG010|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
3273355|NCT02688387|4008595|FG011|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
3273356|NCT02688387|4008596|FG012|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
3273357|NCT02688387|4008597|FG013|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
3273358|NCT02688387|4008598|FG014|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
3273359|NCT02688387|4008599|FG015|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
3273360|NCT02688387|4008600|FG016|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
3273361|NCT02688387|4008601|FG017|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
3273362|NCT02688387|4008602|FG018|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
3273363|NCT02688387|4008603|FG019|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
3273364|NCT02688387|4008604|FG020|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
3273365|NCT02688387|4008605|FG021|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
3273366|NCT02688387|4008584|FG000|STARTED|Part 1, Period 2 (up to 6 Days)||3
3273367|NCT02688387|4008585|FG001|STARTED|Part 1, Period 2 (up to 6 Days)||2
3273368|NCT02688387|4008586|FG002|STARTED|Part 1, Period 2 (up to 6 Days)||3
3273369|NCT02688387|4008587|FG003|STARTED|Part 1, Period 2 (up to 6 Days)||2
3273370|NCT02688387|4008588|FG004|STARTED|Part 1, Period 2 (up to 6 Days)||3
3273371|NCT02688387|4008589|FG005|STARTED|Part 1, Period 2 (up to 6 Days)||2
3273372|NCT02688387|4008590|FG006|STARTED|Part 1, Period 2 (up to 6 Days)||2
2936040|NCT00615030|3647833|FG008|NOT COMPLETED|Period III||0
2936041|NCT00615030|3647834|FG009|NOT COMPLETED|Period III||0
2936042|NCT00615030|3647835|FG010|NOT COMPLETED|Period III||0
2936043|NCT00615030|3647836|FG011|NOT COMPLETED|Period III||0
2936044|NCT00615056|3647854|FG000|STARTED|Overall Study||49
2936045|NCT00615056|3647855|FG001|STARTED|Overall Study||51
2936046|NCT00615056|3647856|FG002|STARTED|Overall Study||36
2936047|NCT00615056|3647857|FG003|STARTED|Overall Study||35
2936048|NCT00615056|3647854|FG000|Treated|Overall Study||46
2936049|NCT00615056|3647855|FG001|Treated|Overall Study||51
2936050|NCT00615056|3647856|FG002|Treated|Overall Study||36
2936051|NCT00615056|3647857|FG003|Treated|Overall Study||35
2936052|NCT00615056|3647854|FG000|COMPLETED|Overall Study||0
2936053|NCT00615056|3647855|FG001|COMPLETED|Overall Study||0
2936054|NCT00615056|3647856|FG002|COMPLETED|Overall Study||0
2936055|NCT00615056|3647857|FG003|COMPLETED|Overall Study||0
2936056|NCT00615056|3647854|FG000|NOT COMPLETED|Overall Study||49
2936057|NCT00615056|3647855|FG001|NOT COMPLETED|Overall Study||51
2936058|NCT00615056|3647856|FG002|NOT COMPLETED|Overall Study||36
2936059|NCT00615056|3647857|FG003|NOT COMPLETED|Overall Study||35
2936060|NCT00615069|3647867|FG000|STARTED|Overall Study||35
2936061|NCT00615069|3647867|FG000|COMPLETED|Overall Study||19
2936062|NCT00615069|3647867|FG000|NOT COMPLETED|Overall Study||16
2936063|NCT00615108|3647871|FG000|STARTED|Overall Study||3148
2936064|NCT00615108|3647871|FG000|COMPLETED|Overall Study||2641
2936065|NCT00615108|3647871|FG000|NOT COMPLETED|Overall Study||507
2936066|NCT00615199|3647881|FG000|STARTED|Overall Study||34
2936067|NCT00615199|3647882|FG001|STARTED|Overall Study||36
2936068|NCT00615199|3647883|FG002|STARTED|Overall Study||34
2936069|NCT00615199|3647884|FG003|STARTED|Overall Study||35
2936070|NCT00615199|3647881|FG000|COMPLETED|Overall Study||26
3273373|NCT02688387|4008591|FG007|STARTED|Part 1, Period 2 (up to 6 Days)||2
3273374|NCT02688387|4008592|FG008|STARTED|Part 1, Period 2 (up to 6 Days)||2
3273375|NCT02688387|4008593|FG009|STARTED|Part 1, Period 2 (up to 6 Days)||2
3273376|NCT02688387|4008594|FG010|STARTED|Part 1, Period 2 (up to 6 Days)||0
2936071|NCT00615199|3647882|FG001|COMPLETED|Overall Study||34
2936072|NCT00615199|3647883|FG002|COMPLETED|Overall Study||33
2936073|NCT00615199|3647884|FG003|COMPLETED|Overall Study||33
2936074|NCT00615199|3647881|FG000|NOT COMPLETED|Overall Study||8
2936075|NCT00615199|3647882|FG001|NOT COMPLETED|Overall Study||2
2936076|NCT00615199|3647883|FG002|NOT COMPLETED|Overall Study||1
2936077|NCT00615199|3647884|FG003|NOT COMPLETED|Overall Study||2
2936078|NCT00615264|3647896|FG000|STARTED|Overall Study||225
2936079|NCT00615264|3647897|FG001|STARTED|Overall Study||232
2936080|NCT00615264|3647896|FG000|Received at Least One Dose (ITT)|Overall Study||225
2936081|NCT00615264|3647897|FG001|Received at Least One Dose (ITT)|Overall Study||231
2936082|NCT00615264|3647896|FG000|ITT Patients Who Met Inc/Excl (MITT)|Overall Study||209
2936083|NCT00615264|3647897|FG001|ITT Patients Who Met Inc/Excl (MITT)|Overall Study||213
2936084|NCT00615264|3647896|FG000|COMPLETED|Overall Study||175
2936085|NCT00615264|3647897|FG001|COMPLETED|Overall Study||180
2936086|NCT00615264|3647896|FG000|NOT COMPLETED|Overall Study||50
2936087|NCT00615264|3647897|FG001|NOT COMPLETED|Overall Study||52
2936088|NCT00615290|3647903|FG000|STARTED|Overall Study||42
2936089|NCT00615290|3647903|FG000|COMPLETED|Overall Study||34
2936090|NCT00615290|3647903|FG000|NOT COMPLETED|Overall Study||8
2936091|NCT00615420|3647909|FG000|STARTED|Overall Study||54
2936092|NCT00615420|3647910|FG001|STARTED|Overall Study||52
2936093|NCT00615420|3647909|FG000|COMPLETED|Overall Study||23
2936094|NCT00615420|3647910|FG001|COMPLETED|Overall Study||25
2936095|NCT00615420|3647909|FG000|NOT COMPLETED|Overall Study||31
2936096|NCT00615420|3647910|FG001|NOT COMPLETED|Overall Study||27
2936097|NCT00615433|3647920|FG000|STARTED|Overall Study||120
2936098|NCT00615433|3647921|FG001|STARTED|Overall Study||119
2936099|NCT00615433|3647922|FG002|STARTED|Overall Study||123
2936100|NCT00615433|3647923|FG003|STARTED|Overall Study||116
2936101|NCT00615433|3647920|FG000|COMPLETED|Overall Study||77
2936102|NCT00615433|3647921|FG001|COMPLETED|Overall Study||66
2936103|NCT00615433|3647922|FG002|COMPLETED|Overall Study||84
2936104|NCT00615433|3647923|FG003|COMPLETED|Overall Study||71
2936105|NCT00615433|3647920|FG000|NOT COMPLETED|Overall Study||43
2936106|NCT00615433|3647921|FG001|NOT COMPLETED|Overall Study||53
2936107|NCT00615433|3647922|FG002|NOT COMPLETED|Overall Study||39
2936108|NCT00615433|3647923|FG003|NOT COMPLETED|Overall Study||45
2936109|NCT00615459|3647934|FG000|STARTED|Period I||41
2936110|NCT00615459|3647935|FG001|STARTED|Period I|1 randomized patient of this sequence was never exposed to drug. Hence, dropped out before Period I.|41
2936111|NCT00615459|3647936|FG002|STARTED|Period I|1 randomized patient of this sequence was never exposed to drug. Hence, dropped out before Period I.|42
2936112|NCT00615459|3647937|FG003|STARTED|Period I||43
2936113|NCT00615459|3647934|FG000|COMPLETED|Period I||37
2936114|NCT00615459|3647935|FG001|COMPLETED|Period I||40
2936115|NCT00615459|3647936|FG002|COMPLETED|Period I||40
3273377|NCT02688387|4008595|FG011|STARTED|Part 1, Period 2 (up to 6 Days)||0
2936116|NCT00615459|3647937|FG003|COMPLETED|Period I||42
2936117|NCT00615459|3647934|FG000|NOT COMPLETED|Period I||4
2936118|NCT00615459|3647935|FG001|NOT COMPLETED|Period I||1
2936119|NCT00615459|3647936|FG002|NOT COMPLETED|Period I||2
2936120|NCT00615459|3647937|FG003|NOT COMPLETED|Period I||1
2936121|NCT00615459|3647934|FG000|STARTED|Period II||37
2936122|NCT00615459|3647935|FG001|STARTED|Period II||40
2936123|NCT00615459|3647936|FG002|STARTED|Period II||40
2936124|NCT00615459|3647937|FG003|STARTED|Period II||42
2936125|NCT00615459|3647934|FG000|COMPLETED|Period II||36
2936126|NCT00615459|3647935|FG001|COMPLETED|Period II||40
2936127|NCT00615459|3647936|FG002|COMPLETED|Period II||40
2936128|NCT00615459|3647937|FG003|COMPLETED|Period II||41
2936129|NCT00615459|3647934|FG000|NOT COMPLETED|Period II||1
2936130|NCT00615459|3647935|FG001|NOT COMPLETED|Period II||0
2936131|NCT00615459|3647936|FG002|NOT COMPLETED|Period II||0
2936132|NCT00615459|3647937|FG003|NOT COMPLETED|Period II||1
2936133|NCT00615459|3647934|FG000|STARTED|Period III||36
2936134|NCT00615459|3647935|FG001|STARTED|Period III||40
2936135|NCT00615459|3647936|FG002|STARTED|Period III||40
2936136|NCT00615459|3647937|FG003|STARTED|Period III||41
2936137|NCT00615459|3647934|FG000|COMPLETED|Period III||36
2936138|NCT00615459|3647935|FG001|COMPLETED|Period III||37
2936139|NCT00615459|3647936|FG002|COMPLETED|Period III||39
2936140|NCT00615459|3647937|FG003|COMPLETED|Period III||41
2936141|NCT00615459|3647934|FG000|NOT COMPLETED|Period III||0
2936142|NCT00615459|3647935|FG001|NOT COMPLETED|Period III||3
2936143|NCT00615459|3647936|FG002|NOT COMPLETED|Period III||1
2936144|NCT00615459|3647937|FG003|NOT COMPLETED|Period III||0
2936145|NCT00615472|3647949|FG000|STARTED|Overall Study||30
2936146|NCT00615472|3647950|FG001|STARTED|Overall Study||28
2936147|NCT00615472|3647949|FG000|COMPLETED|Overall Study||30
2936148|NCT00615472|3647950|FG001|COMPLETED|Overall Study||28
2936149|NCT00615472|3647949|FG000|NOT COMPLETED|Overall Study||0
2936150|NCT00615472|3647950|FG001|NOT COMPLETED|Overall Study||0
2936151|NCT00615550|3647958|FG000|STARTED|Overall Study||229
2936152|NCT00615550|3647959|FG001|STARTED|Overall Study||236
2936153|NCT00615550|3647958|FG000|COMPLETED|Overall Study||223
2936154|NCT00615550|3647959|FG001|COMPLETED|Overall Study||235
2936155|NCT00615550|3647958|FG000|NOT COMPLETED|Overall Study||6
2936156|NCT00615550|3647959|FG001|NOT COMPLETED|Overall Study||1
2936157|NCT00615589|3647965|FG000|STARTED|Overall Study||22
2936158|NCT00615589|3647965|FG000|COMPLETED|Overall Study||22
2936159|NCT00615589|3647965|FG000|NOT COMPLETED|Overall Study||0
2936160|NCT00615719|3647970|FG000|STARTED|Overall Study||35
2936161|NCT00615719|3647970|FG000|COMPLETED|Overall Study||30
2936162|NCT00615719|3647970|FG000|NOT COMPLETED|Overall Study||5
2936163|NCT00615784|3647974|FG000|STARTED|Overall Study||24
2936164|NCT00615784|3647974|FG000|COMPLETED|Overall Study||24
2936165|NCT00615784|3647974|FG000|NOT COMPLETED|Overall Study||0
2936166|NCT00615836|3647982|FG000|STARTED|Part I of Core Study (FE992026 CS29)||163
2936167|NCT00615836|3647983|FG001|STARTED|Part I of Core Study (FE992026 CS29)||158
2936168|NCT00615836|3647984|FG002|STARTED|Part I of Core Study (FE992026 CS29)||158
2936169|NCT00615836|3647985|FG003|STARTED|Part I of Core Study (FE992026 CS29)||160
2936170|NCT00615836|3647986|FG004|STARTED|Part I of Core Study (FE992026 CS29)||160
2936171|NCT00615836|3647982|FG000|Intent-to-treat Population|Part I of Core Study (FE992026 CS29)|Received at least 1 dose of study drug and provided at least 1 primary efficacy measure.|155
2936172|NCT00615836|3647983|FG001|Intent-to-treat Population|Part I of Core Study (FE992026 CS29)|Received at least 1 dose of study drug and provided at least 1 primary efficacy measure.|152
3273378|NCT02688387|4008596|FG012|STARTED|Part 1, Period 2 (up to 6 Days)||0
3273379|NCT02688387|4008597|FG013|STARTED|Part 1, Period 2 (up to 6 Days)||0
3273380|NCT02688387|4008598|FG014|STARTED|Part 1, Period 2 (up to 6 Days)||0
3273381|NCT02688387|4008599|FG015|STARTED|Part 1, Period 2 (up to 6 Days)||0
3273382|NCT02688387|4008600|FG016|STARTED|Part 1, Period 2 (up to 6 Days)||0
3273383|NCT02688387|4008601|FG017|STARTED|Part 1, Period 2 (up to 6 Days)||0
3273384|NCT02688387|4008602|FG018|STARTED|Part 1, Period 2 (up to 6 Days)||0
3273385|NCT02688387|4008603|FG019|STARTED|Part 1, Period 2 (up to 6 Days)||0
2936173|NCT00615836|3647984|FG002|Intent-to-treat Population|Part I of Core Study (FE992026 CS29)|Received at least 1 dose of study drug and provided at least 1 primary efficacy measure.|148
2936174|NCT00615836|3647985|FG003|Intent-to-treat Population|Part I of Core Study (FE992026 CS29)|Received at least 1 dose of study drug and provided at least 1 primary efficacy measure.|146
2936175|NCT00615836|3647986|FG004|Intent-to-treat Population|Part I of Core Study (FE992026 CS29)|Received at least 1 dose of study drug and provided at least 1 primary efficacy measure.|156
3273386|NCT02688387|4008604|FG020|STARTED|Part 1, Period 2 (up to 6 Days)||0
2936176|NCT00615836|3647982|FG000|COMPLETED|Part I of Core Study (FE992026 CS29)||144
2936177|NCT00615836|3647983|FG001|COMPLETED|Part I of Core Study (FE992026 CS29)||148
2936178|NCT00615836|3647984|FG002|COMPLETED|Part I of Core Study (FE992026 CS29)||138
2936179|NCT00615836|3647985|FG003|COMPLETED|Part I of Core Study (FE992026 CS29)||135
2936180|NCT00615836|3647986|FG004|COMPLETED|Part I of Core Study (FE992026 CS29)||145
2936181|NCT00615836|3647982|FG000|NOT COMPLETED|Part I of Core Study (FE992026 CS29)||19
2936182|NCT00615836|3647983|FG001|NOT COMPLETED|Part I of Core Study (FE992026 CS29)||10
2936183|NCT00615836|3647984|FG002|NOT COMPLETED|Part I of Core Study (FE992026 CS29)||20
2936184|NCT00615836|3647985|FG003|NOT COMPLETED|Part I of Core Study (FE992026 CS29)||25
2936185|NCT00615836|3647986|FG004|NOT COMPLETED|Part I of Core Study (FE992026 CS29)||15
2936186|NCT00615836|3647982|FG000|STARTED|Extension Study (FE992026 CS31)||141
2936187|NCT00615836|3647983|FG001|STARTED|Extension Study (FE992026 CS31)||144
2936188|NCT00615836|3647984|FG002|STARTED|Extension Study (FE992026 CS31)||132
2936189|NCT00615836|3647985|FG003|STARTED|Extension Study (FE992026 CS31)||137
2936190|NCT00615836|3647986|FG004|STARTED|Extension Study (FE992026 CS31)||0
2936191|NCT00615836|3647982|FG000|COMPLETED|Extension Study (FE992026 CS31)||0
2936192|NCT00615836|3647983|FG001|COMPLETED|Extension Study (FE992026 CS31)||58
2936193|NCT00615836|3647984|FG002|COMPLETED|Extension Study (FE992026 CS31)||59
2936194|NCT00615836|3647985|FG003|COMPLETED|Extension Study (FE992026 CS31)||53
2936195|NCT00615836|3647986|FG004|COMPLETED|Extension Study (FE992026 CS31)||0
2936196|NCT00615836|3647982|FG000|NOT COMPLETED|Extension Study (FE992026 CS31)||141
2936197|NCT00615836|3647983|FG001|NOT COMPLETED|Extension Study (FE992026 CS31)||86
2936198|NCT00615836|3647984|FG002|NOT COMPLETED|Extension Study (FE992026 CS31)||73
2936199|NCT00615836|3647985|FG003|NOT COMPLETED|Extension Study (FE992026 CS31)||84
2936200|NCT00615836|3647986|FG004|NOT COMPLETED|Extension Study (FE992026 CS31)||0
2936201|NCT00615901|3648002|FG000|STARTED|Overall Study||38
2936202|NCT00615901|3648002|FG000|COMPLETED|Overall Study||29
2936203|NCT00615901|3648002|FG000|NOT COMPLETED|Overall Study||9
2936204|NCT00615914|3648006|FG000|STARTED|Overall Study|The number of patients enrolled|1645
2936205|NCT00615914|3648006|FG000|COMPLETED|Overall Study||1008
2936206|NCT00615914|3648006|FG000|NOT COMPLETED|Overall Study||637
3273387|NCT02688387|4008605|FG021|STARTED|Part 1, Period 2 (up to 6 Days)||0
3273388|NCT02688387|4008584|FG000|COMPLETED|Part 1, Period 2 (up to 6 Days)||3
3273389|NCT02688387|4008585|FG001|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
3273390|NCT02688387|4008586|FG002|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
3273391|NCT02688387|4008587|FG003|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
3273392|NCT02688387|4008588|FG004|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
3273393|NCT02688387|4008589|FG005|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
3273394|NCT02688387|4008590|FG006|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
3273395|NCT02688387|4008591|FG007|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
3273396|NCT02688387|4008592|FG008|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
3273397|NCT02688387|4008593|FG009|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
3273398|NCT02688387|4008594|FG010|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
3273399|NCT02688387|4008595|FG011|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
3273400|NCT02688387|4008596|FG012|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
3273401|NCT02688387|4008597|FG013|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
3273402|NCT02688387|4008598|FG014|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
3273403|NCT02688387|4008599|FG015|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
3273404|NCT02688387|4008600|FG016|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
3273405|NCT02688387|4008601|FG017|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
3273406|NCT02688387|4008602|FG018|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
3273407|NCT02688387|4008603|FG019|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
3273408|NCT02688387|4008604|FG020|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
3273409|NCT02688387|4008605|FG021|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
3273410|NCT02688387|4008584|FG000|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
3273411|NCT02688387|4008585|FG001|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
3273412|NCT02688387|4008586|FG002|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||1
3273413|NCT02688387|4008587|FG003|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
3273414|NCT02688387|4008588|FG004|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||1
3273415|NCT02688387|4008589|FG005|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
3273416|NCT02688387|4008590|FG006|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
3273417|NCT02688387|4008591|FG007|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
3273418|NCT02688387|4008592|FG008|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
3273419|NCT02688387|4008593|FG009|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
3273420|NCT02688387|4008594|FG010|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
3273421|NCT02688387|4008595|FG011|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
3273422|NCT02688387|4008596|FG012|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
3273423|NCT02688387|4008597|FG013|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
3273424|NCT02688387|4008598|FG014|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
3273425|NCT02688387|4008599|FG015|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
3273426|NCT02688387|4008600|FG016|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
3273427|NCT02688387|4008601|FG017|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
3273428|NCT02688387|4008602|FG018|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
3273429|NCT02688387|4008603|FG019|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
3273430|NCT02688387|4008604|FG020|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
3273431|NCT02688387|4008605|FG021|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
3273432|NCT02688387|4008584|FG000|STARTED|Part 1, Washout Period 2 (7 Days)||3
3273433|NCT02688387|4008585|FG001|STARTED|Part 1, Washout Period 2 (7 Days)||2
3273434|NCT02688387|4008586|FG002|STARTED|Part 1, Washout Period 2 (7 Days)||2
3273435|NCT02688387|4008587|FG003|STARTED|Part 1, Washout Period 2 (7 Days)||2
3273436|NCT02688387|4008588|FG004|STARTED|Part 1, Washout Period 2 (7 Days)||2
3273437|NCT02688387|4008589|FG005|STARTED|Part 1, Washout Period 2 (7 Days)||2
3273438|NCT02688387|4008590|FG006|STARTED|Part 1, Washout Period 2 (7 Days)||2
3273439|NCT02688387|4008591|FG007|STARTED|Part 1, Washout Period 2 (7 Days)||2
3273440|NCT02688387|4008592|FG008|STARTED|Part 1, Washout Period 2 (7 Days)||2
3273441|NCT02688387|4008593|FG009|STARTED|Part 1, Washout Period 2 (7 Days)||2
3273442|NCT02688387|4008594|FG010|STARTED|Part 1, Washout Period 2 (7 Days)||0
3273443|NCT02688387|4008595|FG011|STARTED|Part 1, Washout Period 2 (7 Days)||0
3273444|NCT02688387|4008596|FG012|STARTED|Part 1, Washout Period 2 (7 Days)||0
3273445|NCT02688387|4008597|FG013|STARTED|Part 1, Washout Period 2 (7 Days)||0
3273446|NCT02688387|4008598|FG014|STARTED|Part 1, Washout Period 2 (7 Days)||0
3273447|NCT02688387|4008599|FG015|STARTED|Part 1, Washout Period 2 (7 Days)||0
3273448|NCT02688387|4008600|FG016|STARTED|Part 1, Washout Period 2 (7 Days)||0
3273449|NCT02688387|4008601|FG017|STARTED|Part 1, Washout Period 2 (7 Days)||0
3273450|NCT02688387|4008602|FG018|STARTED|Part 1, Washout Period 2 (7 Days)||0
3273451|NCT02688387|4008603|FG019|STARTED|Part 1, Washout Period 2 (7 Days)||0
3273452|NCT02688387|4008604|FG020|STARTED|Part 1, Washout Period 2 (7 Days)||0
3273453|NCT02688387|4008605|FG021|STARTED|Part 1, Washout Period 2 (7 Days)||0
3273454|NCT02688387|4008584|FG000|COMPLETED|Part 1, Washout Period 2 (7 Days)||3
3273455|NCT02688387|4008585|FG001|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
2936207|NCT00615927|3648013|FG000|STARTED|Overall Study||32
2936208|NCT00615927|3648014|FG001|STARTED|Overall Study||32
2936209|NCT00615927|3648013|FG000|COMPLETED|Overall Study||32
2936210|NCT00615927|3648014|FG001|COMPLETED|Overall Study||32
3273456|NCT02688387|4008586|FG002|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
3273457|NCT02688387|4008587|FG003|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
3273458|NCT02688387|4008588|FG004|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
3273459|NCT02688387|4008589|FG005|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
3273460|NCT02688387|4008590|FG006|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
3273461|NCT02688387|4008591|FG007|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
3273462|NCT02688387|4008592|FG008|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
3273463|NCT02688387|4008593|FG009|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
3273464|NCT02688387|4008594|FG010|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
3273465|NCT02688387|4008595|FG011|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
3273466|NCT02688387|4008596|FG012|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
3273467|NCT02688387|4008597|FG013|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
3273468|NCT02688387|4008598|FG014|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
3273469|NCT02688387|4008599|FG015|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
3273470|NCT02688387|4008600|FG016|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
3273471|NCT02688387|4008601|FG017|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
3273472|NCT02688387|4008602|FG018|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
3273473|NCT02688387|4008603|FG019|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
3273474|NCT02688387|4008604|FG020|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
3273475|NCT02688387|4008605|FG021|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
3273476|NCT02688387|4008584|FG000|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
3273477|NCT02688387|4008585|FG001|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
3273478|NCT02688387|4008586|FG002|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
3273479|NCT02688387|4008587|FG003|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
3273480|NCT02688387|4008588|FG004|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
3273481|NCT02688387|4008589|FG005|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
3273482|NCT02688387|4008590|FG006|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
3273483|NCT02688387|4008591|FG007|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
3273484|NCT02688387|4008592|FG008|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
3273485|NCT02688387|4008593|FG009|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
3273486|NCT02688387|4008594|FG010|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
3273487|NCT02688387|4008595|FG011|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
3273488|NCT02688387|4008596|FG012|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
3273489|NCT02688387|4008597|FG013|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
3273490|NCT02688387|4008598|FG014|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
3273491|NCT02688387|4008599|FG015|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
3273492|NCT02688387|4008600|FG016|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
3273493|NCT02688387|4008601|FG017|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
3273494|NCT02688387|4008602|FG018|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
3273495|NCT02688387|4008603|FG019|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
3273496|NCT02688387|4008604|FG020|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
3273497|NCT02688387|4008605|FG021|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
3273498|NCT02688387|4008584|FG000|STARTED|Part 1, Period 3 (up to 6 Days)||3
3273499|NCT02688387|4008585|FG001|STARTED|Part 1, Period 3 (up to 6 Days)||2
3273500|NCT02688387|4008586|FG002|STARTED|Part 1, Period 3 (up to 6 Days)||2
3273501|NCT02688387|4008587|FG003|STARTED|Part 1, Period 3 (up to 6 Days)||2
3273502|NCT02688387|4008588|FG004|STARTED|Part 1, Period 3 (up to 6 Days)||2
3273503|NCT02688387|4008589|FG005|STARTED|Part 1, Period 3 (up to 6 Days)||2
3273504|NCT02688387|4008590|FG006|STARTED|Part 1, Period 3 (up to 6 Days)||2
3273505|NCT02688387|4008591|FG007|STARTED|Part 1, Period 3 (up to 6 Days)||2
3273506|NCT02688387|4008592|FG008|STARTED|Part 1, Period 3 (up to 6 Days)||2
3273507|NCT02688387|4008593|FG009|STARTED|Part 1, Period 3 (up to 6 Days)||2
3273508|NCT02688387|4008594|FG010|STARTED|Part 1, Period 3 (up to 6 Days)||0
3273509|NCT02688387|4008595|FG011|STARTED|Part 1, Period 3 (up to 6 Days)||0
3273510|NCT02688387|4008596|FG012|STARTED|Part 1, Period 3 (up to 6 Days)||0
3273511|NCT02688387|4008597|FG013|STARTED|Part 1, Period 3 (up to 6 Days)||0
3273512|NCT02688387|4008598|FG014|STARTED|Part 1, Period 3 (up to 6 Days)||0
3273513|NCT02688387|4008599|FG015|STARTED|Part 1, Period 3 (up to 6 Days)||0
3273514|NCT02688387|4008600|FG016|STARTED|Part 1, Period 3 (up to 6 Days)||0
3273515|NCT02688387|4008601|FG017|STARTED|Part 1, Period 3 (up to 6 Days)||0
3273516|NCT02688387|4008602|FG018|STARTED|Part 1, Period 3 (up to 6 Days)||0
3273517|NCT02688387|4008603|FG019|STARTED|Part 1, Period 3 (up to 6 Days)||0
3273518|NCT02688387|4008604|FG020|STARTED|Part 1, Period 3 (up to 6 Days)||0
3273519|NCT02688387|4008605|FG021|STARTED|Part 1, Period 3 (up to 6 Days)||0
3273520|NCT02688387|4008584|FG000|COMPLETED|Part 1, Period 3 (up to 6 Days)||3
3273521|NCT02688387|4008585|FG001|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
3273522|NCT02688387|4008586|FG002|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
3273523|NCT02688387|4008587|FG003|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
3273524|NCT02688387|4008588|FG004|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
3273525|NCT02688387|4008589|FG005|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
3273526|NCT02688387|4008590|FG006|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
3273527|NCT02688387|4008591|FG007|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
3273528|NCT02688387|4008592|FG008|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
2936211|NCT00615927|3648013|FG000|NOT COMPLETED|Overall Study||0
2936212|NCT00615927|3648014|FG001|NOT COMPLETED|Overall Study||0
2936213|NCT00615992|3648020|FG000|STARTED|Overall Study||754
2936214|NCT00615992|3648020|FG000|COMPLETED|Overall Study||687
2936215|NCT00615992|3648020|FG000|NOT COMPLETED|Overall Study||67
2936216|NCT00616018|3648024|FG000|STARTED|Overall Study||27
2936217|NCT00616018|3648024|FG000|COMPLETED|Overall Study||24
2936218|NCT00616018|3648024|FG000|NOT COMPLETED|Overall Study||3
2936219|NCT00616109|3648029|FG000|STARTED|Overall Study||16
2936220|NCT00616109|3648029|FG000|COMPLETED|Overall Study||16
2936221|NCT00616109|3648029|FG000|NOT COMPLETED|Overall Study||0
2936222|NCT00616122|3648034|FG000|STARTED|Overall Study||4
2936223|NCT00616122|3648035|FG001|STARTED|Overall Study||7
2936224|NCT00616122|3648036|FG002|STARTED|Overall Study||10
2936225|NCT00616122|3648037|FG003|STARTED|Overall Study||11
2936226|NCT00616122|3648034|FG000|COMPLETED|Overall Study||4
2936227|NCT00616122|3648035|FG001|COMPLETED|Overall Study||7
2936228|NCT00616122|3648036|FG002|COMPLETED|Overall Study||10
2936229|NCT00616122|3648037|FG003|COMPLETED|Overall Study||0
2936230|NCT00616122|3648034|FG000|NOT COMPLETED|Overall Study||0
3273529|NCT02688387|4008593|FG009|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
3273530|NCT02688387|4008594|FG010|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
3273531|NCT02688387|4008595|FG011|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
3273532|NCT02688387|4008596|FG012|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
3273533|NCT02688387|4008597|FG013|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
3273534|NCT02688387|4008598|FG014|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
3273535|NCT02688387|4008599|FG015|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
3273536|NCT02688387|4008600|FG016|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
3273537|NCT02688387|4008601|FG017|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
3273538|NCT02688387|4008602|FG018|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
3273539|NCT02688387|4008603|FG019|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
3273540|NCT02688387|4008604|FG020|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
3273541|NCT02688387|4008605|FG021|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
3273542|NCT02688387|4008584|FG000|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
3273543|NCT02688387|4008585|FG001|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
3273544|NCT02688387|4008586|FG002|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
3273545|NCT02688387|4008587|FG003|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
3273546|NCT02688387|4008588|FG004|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
3273547|NCT02688387|4008589|FG005|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
3273548|NCT02688387|4008590|FG006|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
3273549|NCT02688387|4008591|FG007|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
3273550|NCT02688387|4008592|FG008|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
3273551|NCT02688387|4008593|FG009|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
3273552|NCT02688387|4008594|FG010|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
3273553|NCT02688387|4008595|FG011|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
3273554|NCT02688387|4008596|FG012|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
3273555|NCT02688387|4008597|FG013|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
3273556|NCT02688387|4008598|FG014|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
3273557|NCT02688387|4008599|FG015|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
3273558|NCT02688387|4008600|FG016|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
3273559|NCT02688387|4008601|FG017|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
3273560|NCT02688387|4008602|FG018|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
3273561|NCT02688387|4008603|FG019|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
3273562|NCT02688387|4008604|FG020|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
3273563|NCT02688387|4008605|FG021|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
3273564|NCT02688387|4008584|FG000|STARTED|Part 1, Washout Period 3 (7 Days)||3
3273565|NCT02688387|4008585|FG001|STARTED|Part 1, Washout Period 3 (7 Days)||2
3273566|NCT02688387|4008586|FG002|STARTED|Part 1, Washout Period 3 (7 Days)||2
3273567|NCT02688387|4008587|FG003|STARTED|Part 1, Washout Period 3 (7 Days)||2
3273568|NCT02688387|4008588|FG004|STARTED|Part 1, Washout Period 3 (7 Days)||2
3273569|NCT02688387|4008589|FG005|STARTED|Part 1, Washout Period 3 (7 Days)||2
3273570|NCT02688387|4008590|FG006|STARTED|Part 1, Washout Period 3 (7 Days)||2
3273571|NCT02688387|4008591|FG007|STARTED|Part 1, Washout Period 3 (7 Days)||2
3273572|NCT02688387|4008592|FG008|STARTED|Part 1, Washout Period 3 (7 Days)||2
3273573|NCT02688387|4008593|FG009|STARTED|Part 1, Washout Period 3 (7 Days)||2
3273574|NCT02688387|4008594|FG010|STARTED|Part 1, Washout Period 3 (7 Days)||0
3273575|NCT02688387|4008595|FG011|STARTED|Part 1, Washout Period 3 (7 Days)||0
3273576|NCT02688387|4008596|FG012|STARTED|Part 1, Washout Period 3 (7 Days)||0
3273577|NCT02688387|4008597|FG013|STARTED|Part 1, Washout Period 3 (7 Days)||0
3273578|NCT02688387|4008598|FG014|STARTED|Part 1, Washout Period 3 (7 Days)||0
3273579|NCT02688387|4008599|FG015|STARTED|Part 1, Washout Period 3 (7 Days)||0
3273580|NCT02688387|4008600|FG016|STARTED|Part 1, Washout Period 3 (7 Days)||0
3273581|NCT02688387|4008601|FG017|STARTED|Part 1, Washout Period 3 (7 Days)||0
3273582|NCT02688387|4008602|FG018|STARTED|Part 1, Washout Period 3 (7 Days)||0
3273583|NCT02688387|4008603|FG019|STARTED|Part 1, Washout Period 3 (7 Days)||0
3273584|NCT02688387|4008604|FG020|STARTED|Part 1, Washout Period 3 (7 Days)||0
3273585|NCT02688387|4008605|FG021|STARTED|Part 1, Washout Period 3 (7 Days)||0
3273586|NCT02688387|4008584|FG000|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
3273587|NCT02688387|4008585|FG001|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
3273588|NCT02688387|4008586|FG002|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
3273589|NCT02688387|4008587|FG003|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
2936231|NCT00616122|3648035|FG001|NOT COMPLETED|Overall Study||0
2936232|NCT00616122|3648036|FG002|NOT COMPLETED|Overall Study||0
2936233|NCT00616122|3648037|FG003|NOT COMPLETED|Overall Study||11
2936234|NCT00616200|3648044|FG000|STARTED|Two Week Standard Diet||17
2936235|NCT00616200|3648044|FG000|COMPLETED|Two Week Standard Diet||16
2936236|NCT00616200|3648044|FG000|NOT COMPLETED|Two Week Standard Diet||1
2936237|NCT00616200|3648044|FG000|STARTED|Four Week Very Low Carbohydrate Diet||16
3273590|NCT02688387|4008588|FG004|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
3273591|NCT02688387|4008589|FG005|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
3273592|NCT02688387|4008590|FG006|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
3273593|NCT02688387|4008591|FG007|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
3273594|NCT02688387|4008592|FG008|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
3273595|NCT02688387|4008593|FG009|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
3273596|NCT02688387|4008594|FG010|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
3273597|NCT02688387|4008595|FG011|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
3273598|NCT02688387|4008596|FG012|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
3273599|NCT02688387|4008597|FG013|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
3273600|NCT02688387|4008598|FG014|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
3273601|NCT02688387|4008599|FG015|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
3273602|NCT02688387|4008600|FG016|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
3273603|NCT02688387|4008601|FG017|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
3273604|NCT02688387|4008602|FG018|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
3273605|NCT02688387|4008603|FG019|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
3273606|NCT02688387|4008604|FG020|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
3273607|NCT02688387|4008605|FG021|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
3273608|NCT02688387|4008584|FG000|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||1
3273609|NCT02688387|4008585|FG001|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
3273610|NCT02688387|4008586|FG002|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
3273611|NCT02688387|4008587|FG003|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
3273612|NCT02688387|4008588|FG004|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
3273613|NCT02688387|4008589|FG005|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
3273614|NCT02688387|4008590|FG006|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
3273615|NCT02688387|4008591|FG007|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
3273616|NCT02688387|4008592|FG008|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
3273617|NCT02688387|4008593|FG009|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
3273618|NCT02688387|4008594|FG010|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
3273619|NCT02688387|4008595|FG011|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
3273620|NCT02688387|4008596|FG012|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
3273621|NCT02688387|4008597|FG013|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
3273622|NCT02688387|4008598|FG014|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
3273623|NCT02688387|4008599|FG015|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
3273624|NCT02688387|4008600|FG016|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
3273625|NCT02688387|4008601|FG017|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
3273626|NCT02688387|4008602|FG018|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
3273627|NCT02688387|4008603|FG019|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
3273628|NCT02688387|4008604|FG020|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
3273629|NCT02688387|4008605|FG021|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
3273630|NCT02688387|4008584|FG000|STARTED|Part 1, Period 4 (up to 6 Days)||2
3273631|NCT02688387|4008585|FG001|STARTED|Part 1, Period 4 (up to 6 Days)||2
3273632|NCT02688387|4008586|FG002|STARTED|Part 1, Period 4 (up to 6 Days)||2
3273633|NCT02688387|4008587|FG003|STARTED|Part 1, Period 4 (up to 6 Days)||2
3273634|NCT02688387|4008588|FG004|STARTED|Part 1, Period 4 (up to 6 Days)||2
3273635|NCT02688387|4008589|FG005|STARTED|Part 1, Period 4 (up to 6 Days)||2
3273636|NCT02688387|4008590|FG006|STARTED|Part 1, Period 4 (up to 6 Days)||2
3273637|NCT02688387|4008591|FG007|STARTED|Part 1, Period 4 (up to 6 Days)||2
3273638|NCT02688387|4008592|FG008|STARTED|Part 1, Period 4 (up to 6 Days)||2
3273639|NCT02688387|4008593|FG009|STARTED|Part 1, Period 4 (up to 6 Days)||2
3273640|NCT02688387|4008594|FG010|STARTED|Part 1, Period 4 (up to 6 Days)||0
3273641|NCT02688387|4008595|FG011|STARTED|Part 1, Period 4 (up to 6 Days)||0
3273642|NCT02688387|4008596|FG012|STARTED|Part 1, Period 4 (up to 6 Days)||0
3273643|NCT02688387|4008597|FG013|STARTED|Part 1, Period 4 (up to 6 Days)||0
3273644|NCT02688387|4008598|FG014|STARTED|Part 1, Period 4 (up to 6 Days)||0
3273645|NCT02688387|4008599|FG015|STARTED|Part 1, Period 4 (up to 6 Days)||0
3273646|NCT02688387|4008600|FG016|STARTED|Part 1, Period 4 (up to 6 Days)||0
3273647|NCT02688387|4008601|FG017|STARTED|Part 1, Period 4 (up to 6 Days)||0
3273648|NCT02688387|4008602|FG018|STARTED|Part 1, Period 4 (up to 6 Days)||0
3273649|NCT02688387|4008603|FG019|STARTED|Part 1, Period 4 (up to 6 Days)||0
3273650|NCT02688387|4008604|FG020|STARTED|Part 1, Period 4 (up to 6 Days)||0
3273651|NCT02688387|4008605|FG021|STARTED|Part 1, Period 4 (up to 6 Days)||0
3273652|NCT02688387|4008584|FG000|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
3273653|NCT02688387|4008585|FG001|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
3273654|NCT02688387|4008586|FG002|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
3273655|NCT02688387|4008587|FG003|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
3273656|NCT02688387|4008588|FG004|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
3273657|NCT02688387|4008589|FG005|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
3273658|NCT02688387|4008590|FG006|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
3273659|NCT02688387|4008591|FG007|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
3273660|NCT02688387|4008592|FG008|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
3273661|NCT02688387|4008593|FG009|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
3034371|NCT01132508|3753464|FG000|STARTED|Overall Study||33
2936238|NCT00616200|3648044|FG000|COMPLETED|Four Week Very Low Carbohydrate Diet||13
2936239|NCT00616200|3648044|FG000|NOT COMPLETED|Four Week Very Low Carbohydrate Diet||3
2936240|NCT00616239|3648048|FG000|STARTED|Overall Study||20
2936241|NCT00616239|3648048|FG000|COMPLETED|Overall Study||18
2936242|NCT00616239|3648048|FG000|NOT COMPLETED|Overall Study||2
2936243|NCT00616421|3648055|FG000|STARTED|Overall Study||359
2936244|NCT00616421|3648056|FG001|STARTED|Overall Study||1278
2936245|NCT00616421|3648057|FG002|STARTED|Overall Study||1270
2936246|NCT00616421|3648055|FG000|COMPLETED|Overall Study||333
2936247|NCT00616421|3648056|FG001|COMPLETED|Overall Study||1240
2936248|NCT00616421|3648057|FG002|COMPLETED|Overall Study||1229
2936249|NCT00616421|3648055|FG000|NOT COMPLETED|Overall Study||26
2936250|NCT00616421|3648056|FG001|NOT COMPLETED|Overall Study||38
2936251|NCT00616421|3648057|FG002|NOT COMPLETED|Overall Study||41
2936252|NCT00616434|3648081|FG000|STARTED|Overall Study||62
2936253|NCT00616434|3648082|FG001|STARTED|Overall Study||61
2936254|NCT00616434|3648081|FG000|COMPLETED|Overall Study||56
2936255|NCT00616434|3648082|FG001|COMPLETED|Overall Study||53
2936256|NCT00616434|3648081|FG000|NOT COMPLETED|Overall Study||6
2936257|NCT00616434|3648082|FG001|NOT COMPLETED|Overall Study||8
2936258|NCT00616629|3648093|FG000|STARTED|Overall Study|Two patients never received study drug|13
2936259|NCT00616629|3648094|FG001|STARTED|Overall Study|Two patients never received study drug|14
3047710|NCT01203852|3767695|FG000|STARTED|Metoprolol 8 Weeks|This is the total number of subjects for both groups.|839
3047711|NCT01203852|3767695|FG000|COMPLETED|Metoprolol 8 Weeks||369
3047712|NCT01203852|3767695|FG000|NOT COMPLETED|Metoprolol 8 Weeks||470
3273662|NCT02688387|4008594|FG010|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
3273663|NCT02688387|4008595|FG011|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
3273664|NCT02688387|4008596|FG012|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
3273665|NCT02688387|4008597|FG013|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
3273666|NCT02688387|4008598|FG014|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
3273667|NCT02688387|4008599|FG015|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
3273668|NCT02688387|4008600|FG016|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
3273669|NCT02688387|4008601|FG017|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
3273670|NCT02688387|4008602|FG018|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
3273671|NCT02688387|4008603|FG019|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
3273672|NCT02688387|4008604|FG020|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
3273673|NCT02688387|4008605|FG021|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
3273674|NCT02688387|4008584|FG000|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
3273675|NCT02688387|4008585|FG001|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
3273676|NCT02688387|4008586|FG002|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
3273677|NCT02688387|4008587|FG003|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
3273678|NCT02688387|4008588|FG004|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
3273679|NCT02688387|4008589|FG005|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
3273680|NCT02688387|4008590|FG006|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
3273681|NCT02688387|4008591|FG007|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
3273682|NCT02688387|4008592|FG008|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
3273683|NCT02688387|4008593|FG009|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
3273684|NCT02688387|4008594|FG010|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
3273685|NCT02688387|4008595|FG011|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
3273686|NCT02688387|4008596|FG012|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
3273687|NCT02688387|4008597|FG013|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
3273688|NCT02688387|4008598|FG014|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
3273689|NCT02688387|4008599|FG015|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
3273690|NCT02688387|4008600|FG016|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
3273691|NCT02688387|4008601|FG017|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
3273692|NCT02688387|4008602|FG018|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
3273693|NCT02688387|4008603|FG019|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
3273694|NCT02688387|4008604|FG020|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
3273695|NCT02688387|4008605|FG021|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
3273696|NCT02688387|4008584|FG000|STARTED|Part 1, Washout Period 4 (7 Days)||2
3273697|NCT02688387|4008585|FG001|STARTED|Part 1, Washout Period 4 (7 Days)||2
3273698|NCT02688387|4008586|FG002|STARTED|Part 1, Washout Period 4 (7 Days)||2
3273699|NCT02688387|4008587|FG003|STARTED|Part 1, Washout Period 4 (7 Days)||2
3273700|NCT02688387|4008588|FG004|STARTED|Part 1, Washout Period 4 (7 Days)||2
3273701|NCT02688387|4008589|FG005|STARTED|Part 1, Washout Period 4 (7 Days)||2
3273702|NCT02688387|4008590|FG006|STARTED|Part 1, Washout Period 4 (7 Days)||2
3273703|NCT02688387|4008591|FG007|STARTED|Part 1, Washout Period 4 (7 Days)||2
3273704|NCT02688387|4008592|FG008|STARTED|Part 1, Washout Period 4 (7 Days)||2
3273705|NCT02688387|4008593|FG009|STARTED|Part 1, Washout Period 4 (7 Days)||2
3273706|NCT02688387|4008594|FG010|STARTED|Part 1, Washout Period 4 (7 Days)||0
3273707|NCT02688387|4008595|FG011|STARTED|Part 1, Washout Period 4 (7 Days)||0
3273708|NCT02688387|4008596|FG012|STARTED|Part 1, Washout Period 4 (7 Days)||0
3273709|NCT02688387|4008597|FG013|STARTED|Part 1, Washout Period 4 (7 Days)||0
3273710|NCT02688387|4008598|FG014|STARTED|Part 1, Washout Period 4 (7 Days)||0
3273711|NCT02688387|4008599|FG015|STARTED|Part 1, Washout Period 4 (7 Days)||0
3273712|NCT02688387|4008600|FG016|STARTED|Part 1, Washout Period 4 (7 Days)||0
3273713|NCT02688387|4008601|FG017|STARTED|Part 1, Washout Period 4 (7 Days)||0
2936260|NCT00616629|3648095|FG002|STARTED|Overall Study|One patient never received study drug|14
2936261|NCT00616629|3648096|FG003|STARTED|Overall Study||2
2936262|NCT00616629|3648097|FG004|STARTED|Overall Study||12
2936263|NCT00616629|3648093|FG000|COMPLETED|Overall Study||11
2936264|NCT00616629|3648094|FG001|COMPLETED|Overall Study||12
2936265|NCT00616629|3648095|FG002|COMPLETED|Overall Study||13
2936266|NCT00616629|3648096|FG003|COMPLETED|Overall Study||2
2936267|NCT00616629|3648097|FG004|COMPLETED|Overall Study||12
3273714|NCT02688387|4008602|FG018|STARTED|Part 1, Washout Period 4 (7 Days)||0
3273715|NCT02688387|4008603|FG019|STARTED|Part 1, Washout Period 4 (7 Days)||0
3273716|NCT02688387|4008604|FG020|STARTED|Part 1, Washout Period 4 (7 Days)||0
3273717|NCT02688387|4008605|FG021|STARTED|Part 1, Washout Period 4 (7 Days)||0
3273718|NCT02688387|4008584|FG000|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
3273719|NCT02688387|4008585|FG001|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
3273720|NCT02688387|4008586|FG002|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
3273721|NCT02688387|4008587|FG003|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
3273722|NCT02688387|4008588|FG004|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
3273723|NCT02688387|4008589|FG005|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
3273724|NCT02688387|4008590|FG006|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
3273725|NCT02688387|4008591|FG007|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
3273726|NCT02688387|4008592|FG008|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
3273727|NCT02688387|4008593|FG009|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
3273728|NCT02688387|4008594|FG010|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
3273729|NCT02688387|4008595|FG011|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
3273730|NCT02688387|4008596|FG012|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
3273731|NCT02688387|4008597|FG013|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
3273732|NCT02688387|4008598|FG014|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
3273733|NCT02688387|4008599|FG015|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
3273734|NCT02688387|4008600|FG016|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
3273735|NCT02688387|4008601|FG017|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
3273736|NCT02688387|4008602|FG018|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
3273737|NCT02688387|4008603|FG019|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
3273738|NCT02688387|4008604|FG020|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
3273739|NCT02688387|4008605|FG021|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
3273740|NCT02688387|4008584|FG000|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
3273741|NCT02688387|4008585|FG001|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
3273742|NCT02688387|4008586|FG002|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
3273743|NCT02688387|4008587|FG003|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
3273744|NCT02688387|4008588|FG004|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
3273745|NCT02688387|4008589|FG005|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
3273746|NCT02688387|4008590|FG006|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
3273747|NCT02688387|4008591|FG007|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
3273748|NCT02688387|4008592|FG008|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
3273749|NCT02688387|4008593|FG009|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
3273750|NCT02688387|4008594|FG010|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
3273751|NCT02688387|4008595|FG011|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
3273752|NCT02688387|4008596|FG012|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
3273753|NCT02688387|4008597|FG013|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
3273754|NCT02688387|4008598|FG014|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
3273755|NCT02688387|4008599|FG015|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
3273756|NCT02688387|4008600|FG016|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
3273757|NCT02688387|4008601|FG017|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
3273758|NCT02688387|4008602|FG018|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
3273759|NCT02688387|4008603|FG019|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
3273760|NCT02688387|4008604|FG020|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
3273761|NCT02688387|4008605|FG021|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
3273762|NCT02688387|4008584|FG000|STARTED|Part 1, Period 5 (up to 6 Days)||2
3273763|NCT02688387|4008585|FG001|STARTED|Part 1, Period 5 (up to 6 Days)||2
3273764|NCT02688387|4008586|FG002|STARTED|Part 1, Period 5 (up to 6 Days)||2
3273765|NCT02688387|4008587|FG003|STARTED|Part 1, Period 5 (up to 6 Days)||2
3273766|NCT02688387|4008588|FG004|STARTED|Part 1, Period 5 (up to 6 Days)||2
3273767|NCT02688387|4008589|FG005|STARTED|Part 1, Period 5 (up to 6 Days)||2
3273768|NCT02688387|4008590|FG006|STARTED|Part 1, Period 5 (up to 6 Days)||2
3273769|NCT02688387|4008591|FG007|STARTED|Part 1, Period 5 (up to 6 Days)||2
3273770|NCT02688387|4008592|FG008|STARTED|Part 1, Period 5 (up to 6 Days)||2
3273771|NCT02688387|4008593|FG009|STARTED|Part 1, Period 5 (up to 6 Days)||2
3273772|NCT02688387|4008594|FG010|STARTED|Part 1, Period 5 (up to 6 Days)||0
3273773|NCT02688387|4008595|FG011|STARTED|Part 1, Period 5 (up to 6 Days)||0
3273774|NCT02688387|4008596|FG012|STARTED|Part 1, Period 5 (up to 6 Days)||0
3273775|NCT02688387|4008597|FG013|STARTED|Part 1, Period 5 (up to 6 Days)||0
3273776|NCT02688387|4008598|FG014|STARTED|Part 1, Period 5 (up to 6 Days)||0
3273777|NCT02688387|4008599|FG015|STARTED|Part 1, Period 5 (up to 6 Days)||0
3273778|NCT02688387|4008600|FG016|STARTED|Part 1, Period 5 (up to 6 Days)||0
3273779|NCT02688387|4008601|FG017|STARTED|Part 1, Period 5 (up to 6 Days)||0
3273780|NCT02688387|4008602|FG018|STARTED|Part 1, Period 5 (up to 6 Days)||0
3273781|NCT02688387|4008603|FG019|STARTED|Part 1, Period 5 (up to 6 Days)||0
3273782|NCT02688387|4008604|FG020|STARTED|Part 1, Period 5 (up to 6 Days)||0
3273783|NCT02688387|4008605|FG021|STARTED|Part 1, Period 5 (up to 6 Days)||0
3273784|NCT02688387|4008584|FG000|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
3273785|NCT02688387|4008585|FG001|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
2936268|NCT00616629|3648093|FG000|NOT COMPLETED|Overall Study||2
2936269|NCT00616629|3648094|FG001|NOT COMPLETED|Overall Study||2
2936270|NCT00616629|3648095|FG002|NOT COMPLETED|Overall Study||1
2936271|NCT00616629|3648096|FG003|NOT COMPLETED|Overall Study||0
2936272|NCT00616629|3648097|FG004|NOT COMPLETED|Overall Study||0
2936273|NCT00616655|3648112|FG000|STARTED|Overall Study||152
2936274|NCT00616655|3648113|FG001|STARTED|Overall Study||153
2936275|NCT00616655|3648114|FG002|STARTED|Overall Study||151
2936276|NCT00616655|3648112|FG000|COMPLETED|Overall Study||117
2936277|NCT00616655|3648113|FG001|COMPLETED|Overall Study||112
2936278|NCT00616655|3648114|FG002|COMPLETED|Overall Study||103
2936279|NCT00616655|3648112|FG000|NOT COMPLETED|Overall Study||35
2936280|NCT00616655|3648113|FG001|NOT COMPLETED|Overall Study||41
3273786|NCT02688387|4008586|FG002|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
3273787|NCT02688387|4008587|FG003|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
3273788|NCT02688387|4008588|FG004|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
3273789|NCT02688387|4008589|FG005|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
3273790|NCT02688387|4008590|FG006|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
3273791|NCT02688387|4008591|FG007|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
3273792|NCT02688387|4008592|FG008|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
3273793|NCT02688387|4008593|FG009|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
3273794|NCT02688387|4008594|FG010|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
3273795|NCT02688387|4008595|FG011|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
3273796|NCT02688387|4008596|FG012|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
3273797|NCT02688387|4008597|FG013|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
3273798|NCT02688387|4008598|FG014|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
3273799|NCT02688387|4008599|FG015|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
3273800|NCT02688387|4008600|FG016|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
3273801|NCT02688387|4008601|FG017|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
3273802|NCT02688387|4008602|FG018|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
3273803|NCT02688387|4008603|FG019|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
3273804|NCT02688387|4008604|FG020|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
3273805|NCT02688387|4008605|FG021|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
3273806|NCT02688387|4008584|FG000|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
3273807|NCT02688387|4008585|FG001|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
3273808|NCT02688387|4008586|FG002|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
3273809|NCT02688387|4008587|FG003|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
3273810|NCT02688387|4008588|FG004|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
3273811|NCT02688387|4008589|FG005|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
3273812|NCT02688387|4008590|FG006|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
3273813|NCT02688387|4008591|FG007|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
3273814|NCT02688387|4008592|FG008|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
3273815|NCT02688387|4008593|FG009|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
3273816|NCT02688387|4008594|FG010|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
3273817|NCT02688387|4008595|FG011|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
3273818|NCT02688387|4008596|FG012|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
3273819|NCT02688387|4008597|FG013|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
3273820|NCT02688387|4008598|FG014|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
3273821|NCT02688387|4008599|FG015|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
3273822|NCT02688387|4008600|FG016|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
3273823|NCT02688387|4008601|FG017|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
3273824|NCT02688387|4008602|FG018|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
3273825|NCT02688387|4008603|FG019|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
3273826|NCT02688387|4008604|FG020|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
3273827|NCT02688387|4008605|FG021|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
3273828|NCT02688387|4008584|FG000|STARTED|Part 2, Period 1 (up to 6 Days)||0
3273829|NCT02688387|4008585|FG001|STARTED|Part 2, Period 1 (up to 6 Days)||0
3273830|NCT02688387|4008586|FG002|STARTED|Part 2, Period 1 (up to 6 Days)||0
3273831|NCT02688387|4008587|FG003|STARTED|Part 2, Period 1 (up to 6 Days)||0
3273832|NCT02688387|4008588|FG004|STARTED|Part 2, Period 1 (up to 6 Days)||0
3273833|NCT02688387|4008589|FG005|STARTED|Part 2, Period 1 (up to 6 Days)||0
3273834|NCT02688387|4008590|FG006|STARTED|Part 2, Period 1 (up to 6 Days)||0
3273835|NCT02688387|4008591|FG007|STARTED|Part 2, Period 1 (up to 6 Days)||0
3273836|NCT02688387|4008592|FG008|STARTED|Part 2, Period 1 (up to 6 Days)||0
3273837|NCT02688387|4008593|FG009|STARTED|Part 2, Period 1 (up to 6 Days)||0
3273838|NCT02688387|4008594|FG010|STARTED|Part 2, Period 1 (up to 6 Days)||6
3273839|NCT02688387|4008595|FG011|STARTED|Part 2, Period 1 (up to 6 Days)||5
3273840|NCT02688387|4008596|FG012|STARTED|Part 2, Period 1 (up to 6 Days)||5
3273841|NCT02688387|4008597|FG013|STARTED|Part 2, Period 1 (up to 6 Days)||5
3273842|NCT02688387|4008598|FG014|STARTED|Part 2, Period 1 (up to 6 Days)||0
3273843|NCT02688387|4008599|FG015|STARTED|Part 2, Period 1 (up to 6 Days)||0
3273844|NCT02688387|4008600|FG016|STARTED|Part 2, Period 1 (up to 6 Days)||0
3273845|NCT02688387|4008601|FG017|STARTED|Part 2, Period 1 (up to 6 Days)||0
3273846|NCT02688387|4008602|FG018|STARTED|Part 2, Period 1 (up to 6 Days)||0
3273847|NCT02688387|4008603|FG019|STARTED|Part 2, Period 1 (up to 6 Days)||0
3273848|NCT02688387|4008604|FG020|STARTED|Part 2, Period 1 (up to 6 Days)||0
3273849|NCT02688387|4008605|FG021|STARTED|Part 2, Period 1 (up to 6 Days)||0
3273850|NCT02688387|4008584|FG000|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
3273851|NCT02688387|4008585|FG001|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
3273852|NCT02688387|4008586|FG002|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
2936281|NCT00616655|3648114|FG002|NOT COMPLETED|Overall Study||48
2936282|NCT00616772|3648124|FG000|STARTED|Overall Study||340
2936283|NCT00616772|3648125|FG001|STARTED|Overall Study||342
2936284|NCT00616772|3648124|FG000|Treated|Overall Study||337
2936285|NCT00616772|3648125|FG001|Treated|Overall Study||339
2936286|NCT00616772|3648124|FG000|COMPLETED|Overall Study||225
2936287|NCT00616772|3648125|FG001|COMPLETED|Overall Study||240
2936288|NCT00616772|3648124|FG000|NOT COMPLETED|Overall Study||115
2936289|NCT00616772|3648125|FG001|NOT COMPLETED|Overall Study||102
2936290|NCT00616902|3648133|FG000|STARTED|Overall Study||6
2936291|NCT00616902|3648134|FG001|STARTED|Overall Study||6
2936292|NCT00616902|3648133|FG000|COMPLETED|Overall Study||0
2936293|NCT00616902|3648134|FG001|COMPLETED|Overall Study||0
2936294|NCT00616902|3648133|FG000|NOT COMPLETED|Overall Study||6
2936295|NCT00616902|3648134|FG001|NOT COMPLETED|Overall Study||6
2936296|NCT00616928|3648144|FG000|STARTED|Overall Study||2304
2936297|NCT00616928|3648145|FG001|STARTED|Overall Study||768
2936298|NCT00616928|3648146|FG002|STARTED|Overall Study||1118
2936299|NCT00616928|3648147|FG003|STARTED|Overall Study||371
2936300|NCT00616928|3648144|FG000|COMPLETED|Overall Study||2242
2936301|NCT00616928|3648145|FG001|COMPLETED|Overall Study||750
2936302|NCT00616928|3648146|FG002|COMPLETED|Overall Study||1101
2936303|NCT00616928|3648147|FG003|COMPLETED|Overall Study||364
2936304|NCT00616928|3648144|FG000|NOT COMPLETED|Overall Study||62
2936305|NCT00616928|3648145|FG001|NOT COMPLETED|Overall Study||18
2936306|NCT00616928|3648146|FG002|NOT COMPLETED|Overall Study||17
2936307|NCT00616928|3648147|FG003|NOT COMPLETED|Overall Study||7
2936308|NCT00616941|3648172|FG000|STARTED|Overall Study||4
2936309|NCT00616941|3648173|FG001|STARTED|Overall Study||13
2936310|NCT00616941|3648174|FG002|STARTED|Overall Study||11
2936311|NCT00616941|3648172|FG000|COMPLETED|Overall Study||3
2936312|NCT00616941|3648173|FG001|COMPLETED|Overall Study||8
2936313|NCT00616941|3648174|FG002|COMPLETED|Overall Study||5
2936314|NCT00616941|3648172|FG000|NOT COMPLETED|Overall Study||1
2936315|NCT00616941|3648173|FG001|NOT COMPLETED|Overall Study||5
2936316|NCT00616941|3648174|FG002|NOT COMPLETED|Overall Study||6
2936317|NCT00617058|3648185|FG000|STARTED|Overall Study||1
2936318|NCT00617058|3648186|FG001|STARTED|Overall Study||0
2936319|NCT00617058|3648187|FG002|STARTED|Overall Study||0
2936320|NCT00617058|3648185|FG000|COMPLETED|Overall Study||1
2936321|NCT00617058|3648186|FG001|COMPLETED|Overall Study||0
2936322|NCT00617058|3648187|FG002|COMPLETED|Overall Study||0
2936323|NCT00617058|3648185|FG000|NOT COMPLETED|Overall Study||0
2936324|NCT00617058|3648186|FG001|NOT COMPLETED|Overall Study||0
2936325|NCT00617058|3648187|FG002|NOT COMPLETED|Overall Study||0
2936326|NCT00617084|3648197|FG000|STARTED|Overall Study||1140
2936327|NCT00617084|3648198|FG001|STARTED|Overall Study||1152
2936328|NCT00617084|3648197|FG000|COMPLETED|Overall Study||1119
3273853|NCT02688387|4008587|FG003|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
3273854|NCT02688387|4008588|FG004|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
3273855|NCT02688387|4008589|FG005|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
3273856|NCT02688387|4008590|FG006|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
3273857|NCT02688387|4008591|FG007|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
3273858|NCT02688387|4008592|FG008|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
3273859|NCT02688387|4008593|FG009|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
3273860|NCT02688387|4008594|FG010|COMPLETED|Part 2, Period 1 (up to 6 Days)||5
3273861|NCT02688387|4008595|FG011|COMPLETED|Part 2, Period 1 (up to 6 Days)||5
3273862|NCT02688387|4008596|FG012|COMPLETED|Part 2, Period 1 (up to 6 Days)||5
3273863|NCT02688387|4008597|FG013|COMPLETED|Part 2, Period 1 (up to 6 Days)||5
3273864|NCT02688387|4008598|FG014|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
3273865|NCT02688387|4008599|FG015|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
3273866|NCT02688387|4008600|FG016|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
3273867|NCT02688387|4008601|FG017|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
3273868|NCT02688387|4008602|FG018|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
3273869|NCT02688387|4008603|FG019|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
3273870|NCT02688387|4008604|FG020|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
3273871|NCT02688387|4008605|FG021|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
3273872|NCT02688387|4008584|FG000|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
3273873|NCT02688387|4008585|FG001|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
3273874|NCT02688387|4008586|FG002|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
3273875|NCT02688387|4008587|FG003|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
3273876|NCT02688387|4008588|FG004|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
3273877|NCT02688387|4008589|FG005|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
3273878|NCT02688387|4008590|FG006|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
3273879|NCT02688387|4008591|FG007|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
3273880|NCT02688387|4008592|FG008|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
3273881|NCT02688387|4008593|FG009|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
3273882|NCT02688387|4008594|FG010|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||1
3273883|NCT02688387|4008595|FG011|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
2936329|NCT00617084|3648198|FG001|COMPLETED|Overall Study||1126
2936330|NCT00617084|3648197|FG000|NOT COMPLETED|Overall Study||21
2936331|NCT00617084|3648198|FG001|NOT COMPLETED|Overall Study||26
2936332|NCT00617097|3648206|FG000|STARTED|Overall Study||25
2936333|NCT00617097|3648207|FG001|STARTED|Overall Study||25
2936334|NCT00617097|3648206|FG000|COMPLETED|Overall Study||25
2936335|NCT00617097|3648207|FG001|COMPLETED|Overall Study||25
2936336|NCT00617097|3648206|FG000|NOT COMPLETED|Overall Study||0
2936337|NCT00617097|3648207|FG001|NOT COMPLETED|Overall Study||0
2936338|NCT00617123|3648217|FG000|STARTED|Referral Screening Period||137
2936339|NCT00617123|3648218|FG001|STARTED|Referral Screening Period||121
3273884|NCT02688387|4008596|FG012|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
3273885|NCT02688387|4008597|FG013|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
3273886|NCT02688387|4008598|FG014|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
3273887|NCT02688387|4008599|FG015|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
2936340|NCT00617123|3648217|FG000|COMPLETED|Referral Screening Period||98
2936341|NCT00617123|3648218|FG001|COMPLETED|Referral Screening Period||95
2936342|NCT00617123|3648217|FG000|NOT COMPLETED|Referral Screening Period||39
2936343|NCT00617123|3648218|FG001|NOT COMPLETED|Referral Screening Period||26
2936344|NCT00617123|3648217|FG000|STARTED|Study Treatment Period||98
2936345|NCT00617123|3648218|FG001|STARTED|Study Treatment Period||95
2936346|NCT00617123|3648217|FG000|Treated|Study Treatment Period|1 participant was not treated|97
2936347|NCT00617123|3648218|FG001|Treated|Study Treatment Period||95
2936348|NCT00617123|3648217|FG000|COMPLETED|Study Treatment Period||81
2936349|NCT00617123|3648218|FG001|COMPLETED|Study Treatment Period||79
2936350|NCT00617123|3648217|FG000|NOT COMPLETED|Study Treatment Period||17
2936351|NCT00617123|3648218|FG001|NOT COMPLETED|Study Treatment Period||16
2936352|NCT00617175|3648226|FG000|STARTED|Overall Study||954
2936353|NCT00617175|3648227|FG001|STARTED|Overall Study||948
2936354|NCT00617175|3648226|FG000|COMPLETED|Overall Study||954
2936355|NCT00617175|3648227|FG001|COMPLETED|Overall Study||948
2936356|NCT00617175|3648226|FG000|NOT COMPLETED|Overall Study||0
2936357|NCT00617175|3648227|FG001|NOT COMPLETED|Overall Study||0
2936358|NCT00617188|3648233|FG000|STARTED|Overall Study||26
2936359|NCT00617188|3648233|FG000|COMPLETED|Overall Study||26
2936360|NCT00617188|3648233|FG000|NOT COMPLETED|Overall Study||0
2936361|NCT00617201|3648239|FG000|STARTED|Overall Study||25
2936362|NCT00617201|3648240|FG001|STARTED|Overall Study||25
2936363|NCT00617201|3648239|FG000|COMPLETED|Overall Study||16
2936364|NCT00617201|3648240|FG001|COMPLETED|Overall Study||12
2936365|NCT00617201|3648239|FG000|NOT COMPLETED|Overall Study||9
2936366|NCT00617201|3648240|FG001|NOT COMPLETED|Overall Study||13
2936367|NCT00617240|3648250|FG000|STARTED|Overall Study||5
2936368|NCT00617240|3648251|FG001|STARTED|Overall Study||4
2936369|NCT00617240|3648250|FG000|COMPLETED|Overall Study||4
2936370|NCT00617240|3648251|FG001|COMPLETED|Overall Study||4
2936371|NCT00617240|3648250|FG000|NOT COMPLETED|Overall Study||1
2936372|NCT00617240|3648251|FG001|NOT COMPLETED|Overall Study||0
2936373|NCT00617279|3648259|FG000|STARTED|Overall Study||14
2936374|NCT00617279|3648260|FG001|STARTED|Overall Study||17
2936375|NCT00617279|3648259|FG000|COMPLETED|Overall Study||0
2936376|NCT00617279|3648260|FG001|COMPLETED|Overall Study||0
2936377|NCT00617279|3648259|FG000|NOT COMPLETED|Overall Study||14
2936378|NCT00617279|3648260|FG001|NOT COMPLETED|Overall Study||17
2936379|NCT00617305|3648269|FG000|STARTED|Overall Study||33
2936380|NCT00617305|3648270|FG001|STARTED|Overall Study||4
2936381|NCT00617305|3648271|FG002|STARTED|Overall Study||1
2936382|NCT00617305|3648269|FG000|Completed 24-week Primary Analysis|Overall Study||31
2936383|NCT00617305|3648270|FG001|Completed 24-week Primary Analysis|Overall Study||4
2936384|NCT00617305|3648271|FG002|Completed 24-week Primary Analysis|Overall Study||0
2936385|NCT00617305|3648269|FG000|COMPLETED|Overall Study||25
2936386|NCT00617305|3648270|FG001|COMPLETED|Overall Study||4
2936387|NCT00617305|3648271|FG002|COMPLETED|Overall Study||0
2936388|NCT00617305|3648269|FG000|NOT COMPLETED|Overall Study||8
2936389|NCT00617305|3648270|FG001|NOT COMPLETED|Overall Study||0
2936390|NCT00617305|3648271|FG002|NOT COMPLETED|Overall Study||1
2936391|NCT00617344|3648285|FG000|STARTED|Overall Study||104
2936392|NCT00617344|3648286|FG001|STARTED|Overall Study||103
2936393|NCT00617344|3648287|FG002|STARTED|Overall Study||53
2936394|NCT00617344|3648285|FG000|Received Vaccination 1|Overall Study||104
2936395|NCT00617344|3648286|FG001|Received Vaccination 1|Overall Study||103
2936396|NCT00617344|3648287|FG002|Received Vaccination 1|Overall Study||53
2936397|NCT00617344|3648285|FG000|Received Vaccination 2|Overall Study||86
2936398|NCT00617344|3648286|FG001|Received Vaccination 2|Overall Study||85
2936399|NCT00617344|3648287|FG002|Received Vaccination 2|Overall Study||46
2936400|NCT00617344|3648285|FG000|Received Vaccination 3|Overall Study||79
2936401|NCT00617344|3648286|FG001|Received Vaccination 3|Overall Study||81
2936402|NCT00617344|3648287|FG002|Received Vaccination 3|Overall Study||45
2936403|NCT00617344|3648285|FG000|COMPLETED|Overall Study||79
2936404|NCT00617344|3648286|FG001|COMPLETED|Overall Study||81
2936405|NCT00617344|3648287|FG002|COMPLETED|Overall Study||45
2936406|NCT00617344|3648285|FG000|NOT COMPLETED|Overall Study||25
2936407|NCT00617344|3648286|FG001|NOT COMPLETED|Overall Study||22
2936408|NCT00617344|3648287|FG002|NOT COMPLETED|Overall Study||8
2936409|NCT00617357|3648295|FG000|STARTED|Overall Study|83 subjects enrolled, 80 subjects received Strattice reinforcement of hernia repair|83
2936410|NCT00617357|3648295|FG000|COMPLETED|Overall Study|67 subjects completed study; 7 completed early, 60 completed 24 month visit|67
2936411|NCT00617357|3648295|FG000|NOT COMPLETED|Overall Study||16
2936412|NCT00617396|3648300|FG000|STARTED|Overall Study||25
2936413|NCT00617396|3648300|FG000|COMPLETED|Overall Study||25
2936414|NCT00617396|3648300|FG000|NOT COMPLETED|Overall Study||0
2936415|NCT00617409|3648307|FG000|STARTED|Overall Study||18
2936416|NCT00617409|3648308|FG001|STARTED|Overall Study||20
2936417|NCT00617409|3648309|FG002|STARTED|Overall Study||31
2936418|NCT00617409|3648307|FG000|COMPLETED|Overall Study||2
2936419|NCT00617409|3648308|FG001|COMPLETED|Overall Study||2
2936420|NCT00617409|3648309|FG002|COMPLETED|Overall Study||4
2936421|NCT00617409|3648307|FG000|NOT COMPLETED|Overall Study||16
2936422|NCT00617409|3648308|FG001|NOT COMPLETED|Overall Study||18
2936423|NCT00617409|3648309|FG002|NOT COMPLETED|Overall Study||27
2936424|NCT00617461|3648318|FG000|STARTED|First Treatment Intervention Period|2 par. (1 withdrawal due to inv. discretion, 1 withdrawal by subject) did not take study drug.|52
2936425|NCT00617461|3648319|FG001|STARTED|First Treatment Intervention Period||44
2936426|NCT00617461|3648318|FG000|COMPLETED|First Treatment Intervention Period||42
2936427|NCT00617461|3648319|FG001|COMPLETED|First Treatment Intervention Period||41
2936428|NCT00617461|3648318|FG000|NOT COMPLETED|First Treatment Intervention Period||10
2936429|NCT00617461|3648319|FG001|NOT COMPLETED|First Treatment Intervention Period||3
2936430|NCT00617461|3648318|FG000|STARTED|4-Day Crossover Period||42
2936431|NCT00617461|3648319|FG001|STARTED|4-Day Crossover Period|One 3600:1200 participant skipped the Crossover period, going directly to second Treatment Period.|40
2936432|NCT00617461|3648318|FG000|COMPLETED|4-Day Crossover Period||41
2936433|NCT00617461|3648319|FG001|COMPLETED|4-Day Crossover Period||40
2936434|NCT00617461|3648318|FG000|NOT COMPLETED|4-Day Crossover Period||1
2936435|NCT00617461|3648319|FG001|NOT COMPLETED|4-Day Crossover Period||0
3273888|NCT02688387|4008600|FG016|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
3273889|NCT02688387|4008601|FG017|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
3273890|NCT02688387|4008602|FG018|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
3273891|NCT02688387|4008603|FG019|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
3273892|NCT02688387|4008604|FG020|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
3273893|NCT02688387|4008605|FG021|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
3273894|NCT02688387|4008584|FG000|STARTED|Part 2, Washout Period 1 (10 Days)||0
3273895|NCT02688387|4008585|FG001|STARTED|Part 2, Washout Period 1 (10 Days)||0
3273896|NCT02688387|4008586|FG002|STARTED|Part 2, Washout Period 1 (10 Days)||0
3273897|NCT02688387|4008587|FG003|STARTED|Part 2, Washout Period 1 (10 Days)||0
3273898|NCT02688387|4008588|FG004|STARTED|Part 2, Washout Period 1 (10 Days)||0
3273899|NCT02688387|4008589|FG005|STARTED|Part 2, Washout Period 1 (10 Days)||0
3273900|NCT02688387|4008590|FG006|STARTED|Part 2, Washout Period 1 (10 Days)||0
3273901|NCT02688387|4008591|FG007|STARTED|Part 2, Washout Period 1 (10 Days)||0
3273902|NCT02688387|4008592|FG008|STARTED|Part 2, Washout Period 1 (10 Days)||0
3273903|NCT02688387|4008593|FG009|STARTED|Part 2, Washout Period 1 (10 Days)||0
3273904|NCT02688387|4008594|FG010|STARTED|Part 2, Washout Period 1 (10 Days)||5
3273905|NCT02688387|4008595|FG011|STARTED|Part 2, Washout Period 1 (10 Days)||5
3273906|NCT02688387|4008596|FG012|STARTED|Part 2, Washout Period 1 (10 Days)||5
3273907|NCT02688387|4008597|FG013|STARTED|Part 2, Washout Period 1 (10 Days)||5
3273908|NCT02688387|4008598|FG014|STARTED|Part 2, Washout Period 1 (10 Days)||0
3273909|NCT02688387|4008599|FG015|STARTED|Part 2, Washout Period 1 (10 Days)||0
3273910|NCT02688387|4008600|FG016|STARTED|Part 2, Washout Period 1 (10 Days)||0
3273911|NCT02688387|4008601|FG017|STARTED|Part 2, Washout Period 1 (10 Days)||0
3273912|NCT02688387|4008602|FG018|STARTED|Part 2, Washout Period 1 (10 Days)||0
3273913|NCT02688387|4008603|FG019|STARTED|Part 2, Washout Period 1 (10 Days)||0
3273914|NCT02688387|4008604|FG020|STARTED|Part 2, Washout Period 1 (10 Days)||0
3273915|NCT02688387|4008605|FG021|STARTED|Part 2, Washout Period 1 (10 Days)||0
3273916|NCT02688387|4008584|FG000|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
3273917|NCT02688387|4008585|FG001|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
3273918|NCT02688387|4008586|FG002|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
3273919|NCT02688387|4008587|FG003|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
3273920|NCT02688387|4008588|FG004|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
3273921|NCT02688387|4008589|FG005|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
3273922|NCT02688387|4008590|FG006|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
3273923|NCT02688387|4008591|FG007|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
3273924|NCT02688387|4008592|FG008|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
3273925|NCT02688387|4008593|FG009|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
3273926|NCT02688387|4008594|FG010|COMPLETED|Part 2, Washout Period 1 (10 Days)||5
3273927|NCT02688387|4008595|FG011|COMPLETED|Part 2, Washout Period 1 (10 Days)||5
3273928|NCT02688387|4008596|FG012|COMPLETED|Part 2, Washout Period 1 (10 Days)||5
3273929|NCT02688387|4008597|FG013|COMPLETED|Part 2, Washout Period 1 (10 Days)||5
3273930|NCT02688387|4008598|FG014|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
3273931|NCT02688387|4008599|FG015|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
3273932|NCT02688387|4008600|FG016|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
3273933|NCT02688387|4008601|FG017|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
3273934|NCT02688387|4008602|FG018|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
3273935|NCT02688387|4008603|FG019|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
3273936|NCT02688387|4008604|FG020|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
3273937|NCT02688387|4008605|FG021|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
3273938|NCT02688387|4008584|FG000|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
3273939|NCT02688387|4008585|FG001|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
3273940|NCT02688387|4008586|FG002|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
3273941|NCT02688387|4008587|FG003|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
3273942|NCT02688387|4008588|FG004|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
3273943|NCT02688387|4008589|FG005|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
3273944|NCT02688387|4008590|FG006|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
3273945|NCT02688387|4008591|FG007|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
3273946|NCT02688387|4008592|FG008|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
3273947|NCT02688387|4008593|FG009|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
3273948|NCT02688387|4008594|FG010|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
2936436|NCT00617461|3648318|FG000|STARTED|Second Treatment Intervention Period||41
2936437|NCT00617461|3648319|FG001|STARTED|Second Treatment Intervention Period||41
2936438|NCT00617461|3648318|FG000|COMPLETED|Second Treatment Intervention Period||41
2936439|NCT00617461|3648319|FG001|COMPLETED|Second Treatment Intervention Period||37
2936440|NCT00617461|3648318|FG000|NOT COMPLETED|Second Treatment Intervention Period||0
2936441|NCT00617461|3648319|FG001|NOT COMPLETED|Second Treatment Intervention Period||4
2936442|NCT00617461|3648318|FG000|STARTED|6-Day Down-Titration Period||41
2936443|NCT00617461|3648319|FG001|STARTED|6-Day Down-Titration Period||37
2936444|NCT00617461|3648318|FG000|COMPLETED|6-Day Down-Titration Period||39
2936445|NCT00617461|3648319|FG001|COMPLETED|6-Day Down-Titration Period||35
2936446|NCT00617461|3648318|FG000|NOT COMPLETED|6-Day Down-Titration Period||2
2936447|NCT00617461|3648319|FG001|NOT COMPLETED|6-Day Down-Titration Period||2
2936448|NCT00617539|3648341|FG000|STARTED|Overall Study||30
2936449|NCT00617539|3648341|FG000|COMPLETED|Overall Study||30
2936450|NCT00617539|3648341|FG000|NOT COMPLETED|Overall Study||0
2936451|NCT00617591|3648346|FG000|STARTED|Overall Study||57
2936452|NCT00617591|3648346|FG000|COMPLETED|Overall Study||47
2936453|NCT00617591|3648346|FG000|NOT COMPLETED|Overall Study||10
2936454|NCT00617604|3648353|FG000|STARTED|Overall Study||110
2936455|NCT00617604|3648354|FG001|STARTED|Overall Study||108
2936456|NCT00617604|3648353|FG000|Received Treatment|Overall Study||107
2936457|NCT00617604|3648354|FG001|Received Treatment|Overall Study||105
2936458|NCT00617604|3648353|FG000|Completed 12 Weeks of Treatment|Overall Study||89
2936459|NCT00617604|3648354|FG001|Completed 12 Weeks of Treatment|Overall Study||83
2936460|NCT00617604|3648353|FG000|COMPLETED|Overall Study|Completed Month 6 assessment|92
2936461|NCT00617604|3648354|FG001|COMPLETED|Overall Study|Completed Month 6 assessment|88
2936462|NCT00617604|3648353|FG000|NOT COMPLETED|Overall Study||18
2936463|NCT00617604|3648354|FG001|NOT COMPLETED|Overall Study||20
2936464|NCT00617669|3648362|FG000|STARTED|Overall Study||524
2936465|NCT00617669|3648363|FG001|STARTED|Overall Study||528
2936466|NCT00617669|3648362|FG000|Patients Who Received IP|Overall Study||522
2936467|NCT00617669|3648363|FG001|Patients Who Received IP|Overall Study||525
2936468|NCT00617669|3648362|FG000|COMPLETED|Overall Study|Patients receiving ZD4054 10 mg at data cut-off|94
2936469|NCT00617669|3648363|FG001|COMPLETED|Overall Study|Patients receiving placebo at data cut-off|77
2936470|NCT00617669|3648362|FG000|NOT COMPLETED|Overall Study||430
2936471|NCT00617669|3648363|FG001|NOT COMPLETED|Overall Study||451
2936472|NCT00617734|3648371|FG000|STARTED|Overall Study||49
2936473|NCT00617734|3648372|FG001|STARTED|Overall Study||48
2936474|NCT00617734|3648371|FG000|Received at Least 1 Dose of Study Drug|Overall Study||47
2936475|NCT00617734|3648372|FG001|Received at Least 1 Dose of Study Drug|Overall Study||44
2936476|NCT00617734|3648371|FG000|COMPLETED|Overall Study||41
2936477|NCT00617734|3648372|FG001|COMPLETED|Overall Study||42
2936478|NCT00617734|3648371|FG000|NOT COMPLETED|Overall Study||8
2936479|NCT00617734|3648372|FG001|NOT COMPLETED|Overall Study||6
2936480|NCT00617773|3648378|FG000|STARTED|Overall Study||31
2936481|NCT00617773|3648378|FG000|COMPLETED|Overall Study|Patients COMPLETED were evaluated as having no disease progression at the end of cycle 3.|7
2936482|NCT00617773|3648378|FG000|NOT COMPLETED|Overall Study||24
2936483|NCT00617851|3648386|FG000|STARTED|Overall Study||430
2936484|NCT00617851|3648387|FG001|STARTED|Overall Study||431
2936485|NCT00617851|3648388|FG002|STARTED|Overall Study||429
2936486|NCT00617851|3648389|FG003|STARTED|Overall Study||217
2936487|NCT00617851|3648386|FG000|COMPLETED|Overall Study||383
2936488|NCT00617851|3648387|FG001|COMPLETED|Overall Study||391
2936489|NCT00617851|3648388|FG002|COMPLETED|Overall Study||384
2936490|NCT00617851|3648389|FG003|COMPLETED|Overall Study||192
2936491|NCT00617851|3648386|FG000|NOT COMPLETED|Overall Study||47
2936492|NCT00617851|3648387|FG001|NOT COMPLETED|Overall Study||40
2936493|NCT00617851|3648388|FG002|NOT COMPLETED|Overall Study||45
2936494|NCT00617851|3648389|FG003|NOT COMPLETED|Overall Study||25
2936495|NCT00617890|3648413|FG000|STARTED|Overall Study||35
2936496|NCT00617890|3648414|FG001|STARTED|Overall Study||33
2936497|NCT00617890|3648415|FG002|STARTED|Overall Study||35
2936498|NCT00617890|3648416|FG003|STARTED|Overall Study||116
2936499|NCT00617890|3648413|FG000|Received Treatment|Overall Study||34
2936500|NCT00617890|3648414|FG001|Received Treatment|Overall Study||33
2936501|NCT00617890|3648415|FG002|Received Treatment|Overall Study||34
2936502|NCT00617890|3648416|FG003|Received Treatment|Overall Study||115
2936503|NCT00617890|3648413|FG000|COMPLETED|Overall Study||4
2936504|NCT00617890|3648414|FG001|COMPLETED|Overall Study||5
2936505|NCT00617890|3648415|FG002|COMPLETED|Overall Study||0
2936506|NCT00617890|3648416|FG003|COMPLETED|Overall Study||1
2936507|NCT00617890|3648413|FG000|NOT COMPLETED|Overall Study||31
2936508|NCT00617890|3648414|FG001|NOT COMPLETED|Overall Study||28
2936509|NCT00617890|3648415|FG002|NOT COMPLETED|Overall Study||35
2936510|NCT00617890|3648416|FG003|NOT COMPLETED|Overall Study||115
2936511|NCT00617903|3648431|FG000|STARTED|Overall Study||41
2936512|NCT00617903|3648432|FG001|STARTED|Overall Study||42
2936513|NCT00617903|3648431|FG000|COMPLETED|Overall Study||38
2936514|NCT00617903|3648432|FG001|COMPLETED|Overall Study||35
2936515|NCT00617903|3648431|FG000|NOT COMPLETED|Overall Study||3
2936516|NCT00617903|3648432|FG001|NOT COMPLETED|Overall Study||7
2936517|NCT00617929|3648438|FG000|STARTED|Overall Study||12
2936518|NCT00617929|3648438|FG000|COMPLETED|Overall Study||11
2936519|NCT00617929|3648438|FG000|NOT COMPLETED|Overall Study||1
2936520|NCT00617942|3648444|FG000|STARTED|Overall Study||37
2936521|NCT00617942|3648445|FG001|STARTED|Overall Study||23
2936522|NCT00617942|3648444|FG000|COMPLETED|Overall Study||29
2936523|NCT00617942|3648445|FG001|COMPLETED|Overall Study||19
2936524|NCT00617942|3648444|FG000|NOT COMPLETED|Overall Study||8
2936525|NCT00617942|3648445|FG001|NOT COMPLETED|Overall Study||4
2936526|NCT00617981|3648459|FG000|STARTED|Overall Study||354
2936527|NCT00617981|3648460|FG001|STARTED|Overall Study||347
2936528|NCT00617981|3648459|FG000|COMPLETED|Overall Study||244
2936529|NCT00617981|3648460|FG001|COMPLETED|Overall Study||245
2936530|NCT00617981|3648459|FG000|NOT COMPLETED|Overall Study||110
2936531|NCT00617981|3648460|FG001|NOT COMPLETED|Overall Study||102
2936532|NCT00618072|3648469|FG000|STARTED|Overall Study||16
2936533|NCT00618072|3648470|FG001|STARTED|Overall Study||15
2936534|NCT00618072|3648471|FG002|STARTED|Overall Study||15
3273949|NCT02688387|4008595|FG011|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
3273950|NCT02688387|4008596|FG012|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
3273951|NCT02688387|4008597|FG013|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
3273952|NCT02688387|4008598|FG014|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
3273953|NCT02688387|4008599|FG015|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
3273954|NCT02688387|4008600|FG016|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
3273955|NCT02688387|4008601|FG017|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
3273956|NCT02688387|4008602|FG018|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
3273957|NCT02688387|4008603|FG019|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
3273958|NCT02688387|4008604|FG020|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
3273959|NCT02688387|4008605|FG021|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
3273960|NCT02688387|4008584|FG000|STARTED|Part 2, Period 2 (up to 6 Days)||0
3273961|NCT02688387|4008585|FG001|STARTED|Part 2, Period 2 (up to 6 Days)||0
3273962|NCT02688387|4008586|FG002|STARTED|Part 2, Period 2 (up to 6 Days)||0
3273963|NCT02688387|4008587|FG003|STARTED|Part 2, Period 2 (up to 6 Days)||0
3273964|NCT02688387|4008588|FG004|STARTED|Part 2, Period 2 (up to 6 Days)||0
3273965|NCT02688387|4008589|FG005|STARTED|Part 2, Period 2 (up to 6 Days)||0
3273966|NCT02688387|4008590|FG006|STARTED|Part 2, Period 2 (up to 6 Days)||0
3273967|NCT02688387|4008591|FG007|STARTED|Part 2, Period 2 (up to 6 Days)||0
3273968|NCT02688387|4008592|FG008|STARTED|Part 2, Period 2 (up to 6 Days)||0
3273969|NCT02688387|4008593|FG009|STARTED|Part 2, Period 2 (up to 6 Days)||0
3273970|NCT02688387|4008594|FG010|STARTED|Part 2, Period 2 (up to 6 Days)||5
3273971|NCT02688387|4008595|FG011|STARTED|Part 2, Period 2 (up to 6 Days)||5
3273972|NCT02688387|4008596|FG012|STARTED|Part 2, Period 2 (up to 6 Days)||5
3273973|NCT02688387|4008597|FG013|STARTED|Part 2, Period 2 (up to 6 Days)||5
3273974|NCT02688387|4008598|FG014|STARTED|Part 2, Period 2 (up to 6 Days)||0
3273975|NCT02688387|4008599|FG015|STARTED|Part 2, Period 2 (up to 6 Days)||0
3273976|NCT02688387|4008600|FG016|STARTED|Part 2, Period 2 (up to 6 Days)||0
3273977|NCT02688387|4008601|FG017|STARTED|Part 2, Period 2 (up to 6 Days)||0
3273978|NCT02688387|4008602|FG018|STARTED|Part 2, Period 2 (up to 6 Days)||0
3273979|NCT02688387|4008603|FG019|STARTED|Part 2, Period 2 (up to 6 Days)||0
3273980|NCT02688387|4008604|FG020|STARTED|Part 2, Period 2 (up to 6 Days)||0
3273981|NCT02688387|4008605|FG021|STARTED|Part 2, Period 2 (up to 6 Days)||0
3273982|NCT02688387|4008584|FG000|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
3273983|NCT02688387|4008585|FG001|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
3273984|NCT02688387|4008586|FG002|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
3273985|NCT02688387|4008587|FG003|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
3273986|NCT02688387|4008588|FG004|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
3273987|NCT02688387|4008589|FG005|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
3273988|NCT02688387|4008590|FG006|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
3273989|NCT02688387|4008591|FG007|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
3273990|NCT02688387|4008592|FG008|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
3273991|NCT02688387|4008593|FG009|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
3273992|NCT02688387|4008594|FG010|COMPLETED|Part 2, Period 2 (up to 6 Days)||5
3273993|NCT02688387|4008595|FG011|COMPLETED|Part 2, Period 2 (up to 6 Days)||5
3273994|NCT02688387|4008596|FG012|COMPLETED|Part 2, Period 2 (up to 6 Days)||5
3273995|NCT02688387|4008597|FG013|COMPLETED|Part 2, Period 2 (up to 6 Days)||5
3273996|NCT02688387|4008598|FG014|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
3273997|NCT02688387|4008599|FG015|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
3273998|NCT02688387|4008600|FG016|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
3273999|NCT02688387|4008601|FG017|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
3274000|NCT02688387|4008602|FG018|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
3274001|NCT02688387|4008603|FG019|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
3274002|NCT02688387|4008604|FG020|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
3274003|NCT02688387|4008605|FG021|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
3274004|NCT02688387|4008584|FG000|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
3274005|NCT02688387|4008585|FG001|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
3274006|NCT02688387|4008586|FG002|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
3274007|NCT02688387|4008587|FG003|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
3274008|NCT02688387|4008588|FG004|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
3274009|NCT02688387|4008589|FG005|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
3274010|NCT02688387|4008590|FG006|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
3274011|NCT02688387|4008591|FG007|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
3274012|NCT02688387|4008592|FG008|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
3274013|NCT02688387|4008593|FG009|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
2936535|NCT00618072|3648469|FG000|COMPLETED|Overall Study||14
2936536|NCT00618072|3648470|FG001|COMPLETED|Overall Study||14
2936537|NCT00618072|3648471|FG002|COMPLETED|Overall Study||11
2936538|NCT00618072|3648469|FG000|NOT COMPLETED|Overall Study||2
2936539|NCT00618072|3648470|FG001|NOT COMPLETED|Overall Study||1
2936540|NCT00618072|3648471|FG002|NOT COMPLETED|Overall Study||4
3034372|NCT01132508|3753464|FG000|Treated at Baseline|Overall Study||33
3034373|NCT01132508|3753464|FG000|6 Weeks|Overall Study||33
3034374|NCT01132508|3753464|FG000|12 Weeks|Overall Study||33
3034375|NCT01132508|3753464|FG000|26 Weeks|Overall Study||33
3034376|NCT01132508|3753464|FG000|52 Weeks|Overall Study||30
3034377|NCT01132508|3753464|FG000|78 Weeks|Overall Study||28
3034378|NCT01132508|3753464|FG000|104 Weeks|Overall Study||27
3034379|NCT01132508|3753464|FG000|COMPLETED|Overall Study||24
3034380|NCT01132508|3753464|FG000|NOT COMPLETED|Overall Study||9
3034381|NCT01132547|3753470|FG000|STARTED|Overall Study||9
3034382|NCT01132547|3753471|FG001|STARTED|Overall Study||13
3034383|NCT01132547|3753470|FG000|COMPLETED|Overall Study||5
3034384|NCT01132547|3753471|FG001|COMPLETED|Overall Study||12
3034385|NCT01132547|3753470|FG000|NOT COMPLETED|Overall Study||4
3034386|NCT01132547|3753471|FG001|NOT COMPLETED|Overall Study||1
3034387|NCT01132612|3753480|FG000|STARTED|Overall Study||46
3034388|NCT01132612|3753481|FG001|STARTED|Overall Study||42
3034389|NCT01132612|3753482|FG002|STARTED|Overall Study||187
3274014|NCT02688387|4008594|FG010|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
3274015|NCT02688387|4008595|FG011|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
3274016|NCT02688387|4008596|FG012|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
3274017|NCT02688387|4008597|FG013|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
3274018|NCT02688387|4008598|FG014|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
3274019|NCT02688387|4008599|FG015|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
3274020|NCT02688387|4008600|FG016|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
3274021|NCT02688387|4008601|FG017|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
3274022|NCT02688387|4008602|FG018|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
3274023|NCT02688387|4008603|FG019|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
3274024|NCT02688387|4008604|FG020|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
3274025|NCT02688387|4008605|FG021|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
3274026|NCT02688387|4008584|FG000|STARTED|Part 2, Washout Period 2 (10 Days)||0
3274027|NCT02688387|4008585|FG001|STARTED|Part 2, Washout Period 2 (10 Days)||0
3274028|NCT02688387|4008586|FG002|STARTED|Part 2, Washout Period 2 (10 Days)||0
3274029|NCT02688387|4008587|FG003|STARTED|Part 2, Washout Period 2 (10 Days)||0
3274030|NCT02688387|4008588|FG004|STARTED|Part 2, Washout Period 2 (10 Days)||0
3274031|NCT02688387|4008589|FG005|STARTED|Part 2, Washout Period 2 (10 Days)||0
3274032|NCT02688387|4008590|FG006|STARTED|Part 2, Washout Period 2 (10 Days)||0
3274033|NCT02688387|4008591|FG007|STARTED|Part 2, Washout Period 2 (10 Days)||0
3274034|NCT02688387|4008592|FG008|STARTED|Part 2, Washout Period 2 (10 Days)||0
3274035|NCT02688387|4008593|FG009|STARTED|Part 2, Washout Period 2 (10 Days)||0
3274036|NCT02688387|4008594|FG010|STARTED|Part 2, Washout Period 2 (10 Days)||5
3274037|NCT02688387|4008595|FG011|STARTED|Part 2, Washout Period 2 (10 Days)||5
3274038|NCT02688387|4008596|FG012|STARTED|Part 2, Washout Period 2 (10 Days)||5
3274039|NCT02688387|4008597|FG013|STARTED|Part 2, Washout Period 2 (10 Days)||5
3274040|NCT02688387|4008598|FG014|STARTED|Part 2, Washout Period 2 (10 Days)||0
3274041|NCT02688387|4008599|FG015|STARTED|Part 2, Washout Period 2 (10 Days)||0
3274042|NCT02688387|4008600|FG016|STARTED|Part 2, Washout Period 2 (10 Days)||0
3274043|NCT02688387|4008601|FG017|STARTED|Part 2, Washout Period 2 (10 Days)||0
3274044|NCT02688387|4008602|FG018|STARTED|Part 2, Washout Period 2 (10 Days)||0
3274045|NCT02688387|4008603|FG019|STARTED|Part 2, Washout Period 2 (10 Days)||0
3274046|NCT02688387|4008604|FG020|STARTED|Part 2, Washout Period 2 (10 Days)||0
3274047|NCT02688387|4008605|FG021|STARTED|Part 2, Washout Period 2 (10 Days)||0
3274048|NCT02688387|4008584|FG000|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
3274049|NCT02688387|4008585|FG001|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
3274050|NCT02688387|4008586|FG002|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
3274051|NCT02688387|4008587|FG003|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
3274052|NCT02688387|4008588|FG004|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
3274053|NCT02688387|4008589|FG005|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
3274054|NCT02688387|4008590|FG006|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
3274055|NCT02688387|4008591|FG007|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
3274056|NCT02688387|4008592|FG008|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
3274057|NCT02688387|4008593|FG009|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
3274058|NCT02688387|4008594|FG010|COMPLETED|Part 2, Washout Period 2 (10 Days)||5
3274059|NCT02688387|4008595|FG011|COMPLETED|Part 2, Washout Period 2 (10 Days)||5
3274060|NCT02688387|4008596|FG012|COMPLETED|Part 2, Washout Period 2 (10 Days)||5
3274061|NCT02688387|4008597|FG013|COMPLETED|Part 2, Washout Period 2 (10 Days)||5
3274062|NCT02688387|4008598|FG014|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
3274063|NCT02688387|4008599|FG015|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
3274064|NCT02688387|4008600|FG016|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
3274065|NCT02688387|4008601|FG017|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
3034390|NCT01132612|3753480|FG000|COMPLETED|Overall Study||6
3034391|NCT01132612|3753481|FG001|COMPLETED|Overall Study||7
3034392|NCT01132612|3753482|FG002|COMPLETED|Overall Study||17
3034393|NCT01132612|3753480|FG000|NOT COMPLETED|Overall Study||40
3034394|NCT01132612|3753481|FG001|NOT COMPLETED|Overall Study||35
3034395|NCT01132612|3753482|FG002|NOT COMPLETED|Overall Study||170
3034396|NCT01132651|3753492|FG000|STARTED|Overall Study||4
2936541|NCT00618332|3648481|FG000|STARTED|Overall Study||20
2936542|NCT00618332|3648482|FG001|STARTED|Overall Study||20
2936543|NCT00618332|3648481|FG000|COMPLETED|Overall Study||20
2936544|NCT00618332|3648482|FG001|COMPLETED|Overall Study||20
2936545|NCT00618332|3648481|FG000|NOT COMPLETED|Overall Study||0
2936546|NCT00618332|3648482|FG001|NOT COMPLETED|Overall Study||0
2936547|NCT00618371|3648488|FG000|STARTED|Overall Study||12
2936548|NCT00618371|3648488|FG000|COMPLETED|Overall Study||10
2936549|NCT00618371|3648488|FG000|NOT COMPLETED|Overall Study||2
2936550|NCT00618410|3648493|FG000|STARTED|First Intervention||7
2936551|NCT00618410|3648494|FG001|STARTED|First Intervention||6
2936552|NCT00618410|3648493|FG000|COMPLETED|First Intervention||7
2936553|NCT00618410|3648494|FG001|COMPLETED|First Intervention||6
2936554|NCT00618410|3648493|FG000|NOT COMPLETED|First Intervention||0
2936555|NCT00618410|3648494|FG001|NOT COMPLETED|First Intervention||0
2936556|NCT00618410|3648493|FG000|STARTED|Washout Period (2 Weeks)||7
2936557|NCT00618410|3648494|FG001|STARTED|Washout Period (2 Weeks)||6
2936558|NCT00618410|3648493|FG000|COMPLETED|Washout Period (2 Weeks)||7
2936559|NCT00618410|3648494|FG001|COMPLETED|Washout Period (2 Weeks)||5
2936560|NCT00618410|3648493|FG000|NOT COMPLETED|Washout Period (2 Weeks)||0
2936561|NCT00618410|3648494|FG001|NOT COMPLETED|Washout Period (2 Weeks)||1
2936562|NCT00618410|3648493|FG000|STARTED|Second Intervention||7
2936563|NCT00618410|3648494|FG001|STARTED|Second Intervention||5
2936564|NCT00618410|3648493|FG000|COMPLETED|Second Intervention||7
2936565|NCT00618410|3648494|FG001|COMPLETED|Second Intervention||5
2936566|NCT00618410|3648493|FG000|NOT COMPLETED|Second Intervention||0
2936567|NCT00618410|3648494|FG001|NOT COMPLETED|Second Intervention||0
2936568|NCT00618436|3648502|FG000|STARTED|Overall Study||34
2936569|NCT00618436|3648503|FG001|STARTED|Overall Study||18
2936570|NCT00618436|3648502|FG000|COMPLETED|Overall Study||34
2936571|NCT00618436|3648503|FG001|COMPLETED|Overall Study||18
2936572|NCT00618436|3648502|FG000|NOT COMPLETED|Overall Study||0
2936573|NCT00618436|3648503|FG001|NOT COMPLETED|Overall Study||0
2936574|NCT00618449|3648511|FG000|STARTED|Overall Study||679
2936575|NCT00618449|3648512|FG001|STARTED|Overall Study||668
2936576|NCT00618449|3648511|FG000|1-month, Post-treatment|Overall Study||666
2936577|NCT00618449|3648512|FG001|1-month, Post-treatment|Overall Study||656
2936578|NCT00618449|3648511|FG000|1-year, Post-treatment|Overall Study||581
2936579|NCT00618449|3648512|FG001|1-year, Post-treatment|Overall Study||558
2936580|NCT00618449|3648511|FG000|COMPLETED|Overall Study||581
2936581|NCT00618449|3648512|FG001|COMPLETED|Overall Study||558
3047713|NCT01203852|3767695|FG000|STARTED|Washout 2 Weeks|Some study subjects did not proceed to the washout phase after the first intervention.|328
3047714|NCT01203852|3767695|FG000|COMPLETED|Washout 2 Weeks||282
3047715|NCT01203852|3767695|FG000|NOT COMPLETED|Washout 2 Weeks||46
2936582|NCT00618449|3648511|FG000|NOT COMPLETED|Overall Study||98
2936583|NCT00618449|3648512|FG001|NOT COMPLETED|Overall Study||110
2936584|NCT00618514|3648520|FG000|STARTED|Overall Study||36
2936585|NCT00618514|3648521|FG001|STARTED|Overall Study||38
2936586|NCT00618514|3648522|FG002|STARTED|Overall Study||16
2936587|NCT00618514|3648520|FG000|COMPLETED|Overall Study||25
2936588|NCT00618514|3648521|FG001|COMPLETED|Overall Study||26
2936589|NCT00618514|3648522|FG002|COMPLETED|Overall Study||12
2936590|NCT00618514|3648520|FG000|NOT COMPLETED|Overall Study||11
2936591|NCT00618514|3648521|FG001|NOT COMPLETED|Overall Study||12
2936592|NCT00618514|3648522|FG002|NOT COMPLETED|Overall Study||4
2936593|NCT00618540|3648528|FG000|STARTED|Overall Study||1
2936594|NCT00618540|3648528|FG000|COMPLETED|Overall Study||1
2936595|NCT00618540|3648528|FG000|NOT COMPLETED|Overall Study||0
2936596|NCT00618618|3648537|FG000|STARTED|Overall Study||24
2936597|NCT00618618|3648538|FG001|STARTED|Overall Study||14
2936598|NCT00618618|3648539|FG002|STARTED|Overall Study||21
2936599|NCT00618618|3648540|FG003|STARTED|Overall Study||14
3047716|NCT01203852|3767695|FG000|STARTED|Chlorthalidone 8 Weeks|Subjects were allowed to enter the study at Chlorthalidone without completing Metoprolol.|328
3047717|NCT01203852|3767695|FG000|Continued From Metoprolol|Chlorthalidone 8 Weeks||282
3047718|NCT01203852|3767695|FG000|COMPLETED|Chlorthalidone 8 Weeks||328
3047719|NCT01203852|3767695|FG000|NOT COMPLETED|Chlorthalidone 8 Weeks||0
3047720|NCT01203878|3767705|FG000|STARTED|Overall Study||9
3047721|NCT01203878|3767706|FG001|STARTED|Overall Study||9
2936600|NCT00618618|3648537|FG000|Received Treatment|Overall Study||24
2936601|NCT00618618|3648538|FG001|Received Treatment|Overall Study||13
2936602|NCT00618618|3648539|FG002|Received Treatment|Overall Study||20
2936603|NCT00618618|3648540|FG003|Received Treatment|Overall Study||14
2936604|NCT00618618|3648537|FG000|COMPLETED|Overall Study||20
2936605|NCT00618618|3648538|FG001|COMPLETED|Overall Study||11
3047722|NCT01203878|3767707|FG002|STARTED|Overall Study||3
2936606|NCT00618618|3648539|FG002|COMPLETED|Overall Study||18
2936607|NCT00618618|3648540|FG003|COMPLETED|Overall Study||13
2936608|NCT00618618|3648537|FG000|NOT COMPLETED|Overall Study||4
2936609|NCT00618618|3648538|FG001|NOT COMPLETED|Overall Study||3
2936610|NCT00618618|3648539|FG002|NOT COMPLETED|Overall Study||3
2936611|NCT00618618|3648540|FG003|NOT COMPLETED|Overall Study||1
2936612|NCT00618722|3648555|FG000|STARTED|Overall Study||21
2936613|NCT00618722|3648556|FG001|STARTED|Overall Study||20
2936614|NCT00618722|3648557|FG002|STARTED|Overall Study||22
2936615|NCT00618722|3648558|FG003|STARTED|Overall Study||22
2936616|NCT00618722|3648555|FG000|Received Treatment|Overall Study||20
2936617|NCT00618722|3648556|FG001|Received Treatment|Overall Study||20
2936618|NCT00618722|3648557|FG002|Received Treatment|Overall Study||22
2936619|NCT00618722|3648558|FG003|Received Treatment|Overall Study||22
2936620|NCT00618722|3648555|FG000|COMPLETED|Overall Study||18
2936621|NCT00618722|3648556|FG001|COMPLETED|Overall Study||18
2936622|NCT00618722|3648557|FG002|COMPLETED|Overall Study||19
2936623|NCT00618722|3648558|FG003|COMPLETED|Overall Study||18
2936624|NCT00618722|3648555|FG000|NOT COMPLETED|Overall Study||3
2936625|NCT00618722|3648556|FG001|NOT COMPLETED|Overall Study||2
2936626|NCT00618722|3648557|FG002|NOT COMPLETED|Overall Study||3
2936627|NCT00618722|3648558|FG003|NOT COMPLETED|Overall Study||4
2936628|NCT00618748|3648571|FG000|STARTED|Overall Study||56
2936629|NCT00618748|3648572|FG001|STARTED|Overall Study||25
2936630|NCT00618748|3648573|FG002|STARTED|Overall Study||20
2936631|NCT00618748|3648571|FG000|COMPLETED|Overall Study||45
2936632|NCT00618748|3648572|FG001|COMPLETED|Overall Study||20
2936633|NCT00618748|3648573|FG002|COMPLETED|Overall Study||6
2936634|NCT00618748|3648571|FG000|NOT COMPLETED|Overall Study||11
2936635|NCT00618748|3648572|FG001|NOT COMPLETED|Overall Study||5
2936636|NCT00618748|3648573|FG002|NOT COMPLETED|Overall Study||14
2936637|NCT00618774|3648583|FG000|STARTED|Overall Study||211
2936638|NCT00618774|3648584|FG001|STARTED|Overall Study||48
2936639|NCT00618774|3648583|FG000|COMPLETED|Overall Study||205
2936640|NCT00618774|3648584|FG001|COMPLETED|Overall Study||45
2936641|NCT00618774|3648583|FG000|NOT COMPLETED|Overall Study||6
2936642|NCT00618774|3648584|FG001|NOT COMPLETED|Overall Study||3
2936643|NCT00618787|3648592|FG000|STARTED|Overall Study||22
2936644|NCT00618787|3648593|FG001|STARTED|Overall Study||23
2936645|NCT00618787|3648592|FG000|COMPLETED|Overall Study||19
2936646|NCT00618787|3648593|FG001|COMPLETED|Overall Study||21
3274066|NCT02688387|4008602|FG018|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
3316340|NCT03110029|4049630|FG000|NOT COMPLETED|Overall Study||1
2936647|NCT00618787|3648592|FG000|NOT COMPLETED|Overall Study||3
2936648|NCT00618787|3648593|FG001|NOT COMPLETED|Overall Study||2
2936649|NCT00618813|3648599|FG000|STARTED|Overall Study||35
2936650|NCT00618813|3648599|FG000|Completed Enrollment - Week 12 Treatment|Overall Study|Patients that complete this segment of protocol therapy are evaluated for outcome measure.|35
2936651|NCT00618813|3648599|FG000|Completed Week 13 to Week 22 Treatment|Overall Study|Patients that complete this segment of protocol therapy are evaluated for outcome measure.|34
2936652|NCT00618813|3648599|FG000|Completed Week 23 to Week 28 Therapy|Overall Study|Patients that complete this segment of protocol therapy are evaluated for outcome measure.|34
2936653|NCT00618813|3648599|FG000|Completed Week 29 to Week 37 Therapy|Overall Study|Patients that complete this segment of protocol therapy are evaluated for outcome measure.|33
2936654|NCT00618813|3648599|FG000|COMPLETED|Overall Study||31
2936655|NCT00618813|3648599|FG000|NOT COMPLETED|Overall Study||4
2936656|NCT00618826|3648603|FG000|STARTED|Overall Study||14
2936657|NCT00618826|3648603|FG000|COMPLETED|Overall Study||13
2936658|NCT00618826|3648603|FG000|NOT COMPLETED|Overall Study||1
2936659|NCT00618839|3648608|FG000|STARTED|Overall Study||15
2936660|NCT00618839|3648608|FG000|COMPLETED|Overall Study||15
2936661|NCT00618839|3648608|FG000|NOT COMPLETED|Overall Study||0
2936662|NCT00618917|3648618|FG000|STARTED|Overall Study||4
2936663|NCT00618917|3648619|FG001|STARTED|Overall Study||3
2936664|NCT00618917|3648620|FG002|STARTED|Overall Study||11
2936665|NCT00618917|3648618|FG000|COMPLETED|Overall Study||3
2936666|NCT00618917|3648619|FG001|COMPLETED|Overall Study||3
2936667|NCT00618917|3648620|FG002|COMPLETED|Overall Study||11
2936668|NCT00618917|3648618|FG000|NOT COMPLETED|Overall Study||1
2936669|NCT00618917|3648619|FG001|NOT COMPLETED|Overall Study||0
2936670|NCT00618917|3648620|FG002|NOT COMPLETED|Overall Study||0
2936671|NCT00618956|3648630|FG000|STARTED|Overall Study||111
2936672|NCT00618956|3648631|FG001|STARTED|Overall Study||210
2936673|NCT00618956|3648630|FG000|COMPLETED|Overall Study||86
2936674|NCT00618956|3648631|FG001|COMPLETED|Overall Study||160
2936675|NCT00618956|3648630|FG000|NOT COMPLETED|Overall Study||25
2936676|NCT00618956|3648631|FG001|NOT COMPLETED|Overall Study||50
2936677|NCT00618982|3648643|FG000|STARTED|Overall Study||83
2936678|NCT00618982|3648643|FG000|COMPLETED|Overall Study||33
2936679|NCT00618982|3648643|FG000|NOT COMPLETED|Overall Study||50
2936680|NCT00618995|3648650|FG000|STARTED|Period 1||6
2936681|NCT00618995|3648651|FG001|STARTED|Period 1||7
2936682|NCT00618995|3648652|FG002|STARTED|Period 1||7
2936683|NCT00618995|3648653|FG003|STARTED|Period 1||6
2936684|NCT00618995|3648650|FG000|COMPLETED|Period 1||6
2936685|NCT00618995|3648651|FG001|COMPLETED|Period 1||6
2936686|NCT00618995|3648652|FG002|COMPLETED|Period 1||5
2936687|NCT00618995|3648653|FG003|COMPLETED|Period 1||6
2936688|NCT00618995|3648650|FG000|NOT COMPLETED|Period 1||0
2936689|NCT00618995|3648651|FG001|NOT COMPLETED|Period 1||1
2936690|NCT00618995|3648652|FG002|NOT COMPLETED|Period 1||2
2936691|NCT00618995|3648653|FG003|NOT COMPLETED|Period 1||0
2936692|NCT00618995|3648650|FG000|STARTED|Period 2||6
2936693|NCT00618995|3648651|FG001|STARTED|Period 2||6
2936694|NCT00618995|3648652|FG002|STARTED|Period 2||5
2936695|NCT00618995|3648653|FG003|STARTED|Period 2||6
2936696|NCT00618995|3648650|FG000|COMPLETED|Period 2||6
2936697|NCT00618995|3648651|FG001|COMPLETED|Period 2||6
2936698|NCT00618995|3648652|FG002|COMPLETED|Period 2||4
2936699|NCT00618995|3648653|FG003|COMPLETED|Period 2||6
2936700|NCT00618995|3648650|FG000|NOT COMPLETED|Period 2||0
2936701|NCT00618995|3648651|FG001|NOT COMPLETED|Period 2||0
2936702|NCT00618995|3648652|FG002|NOT COMPLETED|Period 2||1
2936703|NCT00618995|3648653|FG003|NOT COMPLETED|Period 2||0
2936704|NCT00618995|3648650|FG000|STARTED|Period 3||6
2936705|NCT00618995|3648651|FG001|STARTED|Period 3||6
2936706|NCT00618995|3648652|FG002|STARTED|Period 3||4
2936707|NCT00618995|3648653|FG003|STARTED|Period 3||6
2936708|NCT00618995|3648650|FG000|COMPLETED|Period 3||6
2936709|NCT00618995|3648651|FG001|COMPLETED|Period 3||6
2936710|NCT00618995|3648652|FG002|COMPLETED|Period 3||4
2936711|NCT00618995|3648653|FG003|COMPLETED|Period 3||6
2936712|NCT00618995|3648650|FG000|NOT COMPLETED|Period 3||0
3274067|NCT02688387|4008603|FG019|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
3274068|NCT02688387|4008604|FG020|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
3274069|NCT02688387|4008605|FG021|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
2936713|NCT00618995|3648651|FG001|NOT COMPLETED|Period 3||0
2936714|NCT00618995|3648652|FG002|NOT COMPLETED|Period 3||0
2936715|NCT00618995|3648653|FG003|NOT COMPLETED|Period 3||0
2936716|NCT00618995|3648650|FG000|STARTED|Period 4||6
2936717|NCT00618995|3648651|FG001|STARTED|Period 4||6
2936718|NCT00618995|3648652|FG002|STARTED|Period 4||4
2936719|NCT00618995|3648653|FG003|STARTED|Period 4||6
2936720|NCT00618995|3648650|FG000|COMPLETED|Period 4||5
2936721|NCT00618995|3648651|FG001|COMPLETED|Period 4||6
2936722|NCT00618995|3648652|FG002|COMPLETED|Period 4||4
2936723|NCT00618995|3648653|FG003|COMPLETED|Period 4||6
2936724|NCT00618995|3648650|FG000|NOT COMPLETED|Period 4||1
2936725|NCT00618995|3648651|FG001|NOT COMPLETED|Period 4||0
2936726|NCT00618995|3648652|FG002|NOT COMPLETED|Period 4||0
2936727|NCT00618995|3648653|FG003|NOT COMPLETED|Period 4||0
2936728|NCT00619060|3648663|FG000|STARTED|Overall Study||10
2936729|NCT00619060|3648664|FG001|STARTED|Overall Study||12
2936730|NCT00619060|3648663|FG000|COMPLETED|Overall Study||10
2936731|NCT00619060|3648664|FG001|COMPLETED|Overall Study||12
2936732|NCT00619060|3648663|FG000|NOT COMPLETED|Overall Study||0
2936733|NCT00619060|3648664|FG001|NOT COMPLETED|Overall Study||0
2936734|NCT00619073|3648672|FG000|STARTED|First Intervention - 60 Days||8
2936735|NCT00619073|3648673|FG001|STARTED|First Intervention - 60 Days||8
2936736|NCT00619073|3648672|FG000|COMPLETED|First Intervention - 60 Days||8
2936737|NCT00619073|3648673|FG001|COMPLETED|First Intervention - 60 Days||8
2936738|NCT00619073|3648672|FG000|NOT COMPLETED|First Intervention - 60 Days||0
2936739|NCT00619073|3648673|FG001|NOT COMPLETED|First Intervention - 60 Days||0
2936740|NCT00619073|3648672|FG000|STARTED|Washout Period (30 Days)||8
2936741|NCT00619073|3648673|FG001|STARTED|Washout Period (30 Days)||8
2936742|NCT00619073|3648672|FG000|COMPLETED|Washout Period (30 Days)||8
2936743|NCT00619073|3648673|FG001|COMPLETED|Washout Period (30 Days)||8
2936744|NCT00619073|3648672|FG000|NOT COMPLETED|Washout Period (30 Days)||0
2936745|NCT00619073|3648673|FG001|NOT COMPLETED|Washout Period (30 Days)||0
2936746|NCT00619073|3648672|FG000|STARTED|Second Intervention - 60 Days||8
2936747|NCT00619073|3648673|FG001|STARTED|Second Intervention - 60 Days||8
2936748|NCT00619073|3648672|FG000|COMPLETED|Second Intervention - 60 Days||8
2936749|NCT00619073|3648673|FG001|COMPLETED|Second Intervention - 60 Days||8
2936750|NCT00619073|3648672|FG000|NOT COMPLETED|Second Intervention - 60 Days||0
2936751|NCT00619073|3648673|FG001|NOT COMPLETED|Second Intervention - 60 Days||0
2936752|NCT00619099|3648681|FG000|STARTED|Overall Study|All randomized subjects|44
2936753|NCT00619099|3648682|FG001|STARTED|Overall Study|All randomized subjects|23
2936754|NCT00619099|3648681|FG000|Received at Least 2 Cycles of Treatment|Overall Study|Subjects included in the Modified Intent to Treat Population|43
2936755|NCT00619099|3648682|FG001|Received at Least 2 Cycles of Treatment|Overall Study|Subjects included in the Modified Intent to Treat Population|22
3274070|NCT02688387|4008584|FG000|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
3274071|NCT02688387|4008585|FG001|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
3274072|NCT02688387|4008586|FG002|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
3274073|NCT02688387|4008587|FG003|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
3274074|NCT02688387|4008588|FG004|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
3274075|NCT02688387|4008589|FG005|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
3274076|NCT02688387|4008590|FG006|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
3274077|NCT02688387|4008591|FG007|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
3274078|NCT02688387|4008592|FG008|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
3274079|NCT02688387|4008593|FG009|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
3274080|NCT02688387|4008594|FG010|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
3274081|NCT02688387|4008595|FG011|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
3274082|NCT02688387|4008596|FG012|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
3274083|NCT02688387|4008597|FG013|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
3274084|NCT02688387|4008598|FG014|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
3274085|NCT02688387|4008599|FG015|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
3274086|NCT02688387|4008600|FG016|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
3274087|NCT02688387|4008601|FG017|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
3274088|NCT02688387|4008602|FG018|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
3274089|NCT02688387|4008603|FG019|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
3274090|NCT02688387|4008604|FG020|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
3274091|NCT02688387|4008605|FG021|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
3274092|NCT02688387|4008584|FG000|STARTED|Part 2, Period 3 (up to 6 Days)||0
3274093|NCT02688387|4008585|FG001|STARTED|Part 2, Period 3 (up to 6 Days)||0
3274094|NCT02688387|4008586|FG002|STARTED|Part 2, Period 3 (up to 6 Days)||0
3274095|NCT02688387|4008587|FG003|STARTED|Part 2, Period 3 (up to 6 Days)||0
3274096|NCT02688387|4008588|FG004|STARTED|Part 2, Period 3 (up to 6 Days)||0
3274097|NCT02688387|4008589|FG005|STARTED|Part 2, Period 3 (up to 6 Days)||0
3274098|NCT02688387|4008590|FG006|STARTED|Part 2, Period 3 (up to 6 Days)||0
2936756|NCT00619099|3648681|FG000|COMPLETED|Overall Study||11
2936757|NCT00619099|3648682|FG001|COMPLETED|Overall Study||4
2936758|NCT00619099|3648681|FG000|NOT COMPLETED|Overall Study||33
2936759|NCT00619099|3648682|FG001|NOT COMPLETED|Overall Study||19
2936760|NCT00619112|3648690|FG000|STARTED|Overall Study||40
2936761|NCT00619112|3648691|FG001|STARTED|Overall Study||20
2936762|NCT00619112|3648690|FG000|COMPLETED|Overall Study|Data from patient who didn't complete study was still included in the final analysis.|39
2936763|NCT00619112|3648691|FG001|COMPLETED|Overall Study|Data from patients who didn't complete study was still included in the final analysis.|18
2936764|NCT00619112|3648690|FG000|NOT COMPLETED|Overall Study||1
2936765|NCT00619112|3648691|FG001|NOT COMPLETED|Overall Study||2
2936766|NCT00619177|3648700|FG000|STARTED|Overall Study|treated set = 3569 (treated with Movalis)|3569
2936767|NCT00619177|3648700|FG000|COMPLETED|Overall Study|"Due to some missing termination information, the number of completed may be larger than 3061."|3061
2936768|NCT00619177|3648700|FG000|NOT COMPLETED|Overall Study||508
3274099|NCT02688387|4008591|FG007|STARTED|Part 2, Period 3 (up to 6 Days)||0
3274100|NCT02688387|4008592|FG008|STARTED|Part 2, Period 3 (up to 6 Days)||0
3274101|NCT02688387|4008593|FG009|STARTED|Part 2, Period 3 (up to 6 Days)||0
2936769|NCT00619190|3648706|FG000|STARTED|Overall Study||21
2936770|NCT00619190|3648707|FG001|STARTED|Overall Study||9
2936771|NCT00619190|3648706|FG000|COMPLETED|Overall Study||20
2936772|NCT00619190|3648707|FG001|COMPLETED|Overall Study||9
2936773|NCT00619190|3648706|FG000|NOT COMPLETED|Overall Study||1
2936774|NCT00619190|3648707|FG001|NOT COMPLETED|Overall Study||0
2936775|NCT00619229|3648715|FG000|STARTED|Overall Study||18
2936776|NCT00619229|3648716|FG001|STARTED|Overall Study||18
2936777|NCT00619229|3648715|FG000|Full Analysis Set (FAS)|Overall Study||16
2936778|NCT00619229|3648716|FG001|Full Analysis Set (FAS)|Overall Study||17
2936779|NCT00619229|3648715|FG000|COMPLETED|Overall Study||14
2936780|NCT00619229|3648716|FG001|COMPLETED|Overall Study||16
2936781|NCT00619229|3648715|FG000|NOT COMPLETED|Overall Study||4
2936782|NCT00619229|3648716|FG001|NOT COMPLETED|Overall Study||2
2936783|NCT00619255|3648724|FG000|STARTED|Overall Study||59
2936784|NCT00619255|3648725|FG001|STARTED|Overall Study||61
2936785|NCT00619255|3648724|FG000|COMPLETED|Overall Study||57
2936786|NCT00619255|3648725|FG001|COMPLETED|Overall Study||61
2936787|NCT00619255|3648724|FG000|NOT COMPLETED|Overall Study||2
2936788|NCT00619255|3648725|FG001|NOT COMPLETED|Overall Study||0
2936789|NCT00619307|3648733|FG000|STARTED|Overall Study||60
2936790|NCT00619307|3648734|FG001|STARTED|Overall Study||57
2936791|NCT00619307|3648733|FG000|COMPLETED|Overall Study||56
2936792|NCT00619307|3648734|FG001|COMPLETED|Overall Study||53
2936793|NCT00619307|3648733|FG000|NOT COMPLETED|Overall Study||4
2936794|NCT00619307|3648734|FG001|NOT COMPLETED|Overall Study||4
2936795|NCT00619359|3648742|FG000|STARTED|Overall Study||1147
2936796|NCT00619359|3648743|FG001|STARTED|Overall Study||1175
2936797|NCT00619359|3648742|FG000|COMPLETED|Overall Study||1080
2936798|NCT00619359|3648743|FG001|COMPLETED|Overall Study||1094
2936799|NCT00619359|3648742|FG000|NOT COMPLETED|Overall Study||67
2936800|NCT00619359|3648743|FG001|NOT COMPLETED|Overall Study||81
2936801|NCT00619385|3648752|FG000|STARTED|Overall Study||7
2936802|NCT00619385|3648753|FG001|STARTED|Overall Study||8
3047723|NCT01203878|3767705|FG000|COMPLETED|Overall Study||9
3047724|NCT01203878|3767706|FG001|COMPLETED|Overall Study||9
3047725|NCT01203878|3767707|FG002|COMPLETED|Overall Study||0
3047726|NCT01203878|3767705|FG000|NOT COMPLETED|Overall Study||0
3047727|NCT01203878|3767706|FG001|NOT COMPLETED|Overall Study||0
3047728|NCT01203878|3767707|FG002|NOT COMPLETED|Overall Study||3
2936803|NCT00619385|3648754|FG002|STARTED|Overall Study||10
2936804|NCT00619385|3648752|FG000|COMPLETED|Overall Study||6
2936805|NCT00619385|3648753|FG001|COMPLETED|Overall Study||6
2936806|NCT00619385|3648754|FG002|COMPLETED|Overall Study||6
3047729|NCT01203917|3767714|FG000|STARTED|Overall Study|106 patients were EGFR M+ patients and 1 patient was EGFR M+I|107
3274102|NCT02688387|4008594|FG010|STARTED|Part 2, Period 3 (up to 6 Days)||5
3274103|NCT02688387|4008595|FG011|STARTED|Part 2, Period 3 (up to 6 Days)||5
3274104|NCT02688387|4008596|FG012|STARTED|Part 2, Period 3 (up to 6 Days)||5
3274105|NCT02688387|4008597|FG013|STARTED|Part 2, Period 3 (up to 6 Days)||5
3274106|NCT02688387|4008598|FG014|STARTED|Part 2, Period 3 (up to 6 Days)||0
3274107|NCT02688387|4008599|FG015|STARTED|Part 2, Period 3 (up to 6 Days)||0
3274108|NCT02688387|4008600|FG016|STARTED|Part 2, Period 3 (up to 6 Days)||0
3274109|NCT02688387|4008601|FG017|STARTED|Part 2, Period 3 (up to 6 Days)||0
3274110|NCT02688387|4008602|FG018|STARTED|Part 2, Period 3 (up to 6 Days)||0
3274111|NCT02688387|4008603|FG019|STARTED|Part 2, Period 3 (up to 6 Days)||0
3274112|NCT02688387|4008604|FG020|STARTED|Part 2, Period 3 (up to 6 Days)||0
3274113|NCT02688387|4008605|FG021|STARTED|Part 2, Period 3 (up to 6 Days)||0
3274114|NCT02688387|4008584|FG000|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
3274115|NCT02688387|4008585|FG001|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
3274116|NCT02688387|4008586|FG002|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
3274117|NCT02688387|4008587|FG003|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
3274118|NCT02688387|4008588|FG004|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
3274119|NCT02688387|4008589|FG005|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
3274120|NCT02688387|4008590|FG006|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
3274121|NCT02688387|4008591|FG007|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
3274122|NCT02688387|4008592|FG008|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
3274123|NCT02688387|4008593|FG009|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
3274124|NCT02688387|4008594|FG010|COMPLETED|Part 2, Period 3 (up to 6 Days)||5
3274125|NCT02688387|4008595|FG011|COMPLETED|Part 2, Period 3 (up to 6 Days)||5
2936807|NCT00619385|3648752|FG000|NOT COMPLETED|Overall Study||1
2936808|NCT00619385|3648753|FG001|NOT COMPLETED|Overall Study||2
2936809|NCT00619385|3648754|FG002|NOT COMPLETED|Overall Study||4
3274126|NCT02688387|4008596|FG012|COMPLETED|Part 2, Period 3 (up to 6 Days)||5
3274127|NCT02688387|4008597|FG013|COMPLETED|Part 2, Period 3 (up to 6 Days)||5
3274128|NCT02688387|4008598|FG014|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
3274129|NCT02688387|4008599|FG015|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
3274130|NCT02688387|4008600|FG016|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
3274131|NCT02688387|4008601|FG017|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
3274132|NCT02688387|4008602|FG018|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
3274133|NCT02688387|4008603|FG019|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
3274134|NCT02688387|4008604|FG020|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
3274135|NCT02688387|4008605|FG021|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
3274136|NCT02688387|4008584|FG000|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
3274137|NCT02688387|4008585|FG001|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
3274138|NCT02688387|4008586|FG002|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
3274139|NCT02688387|4008587|FG003|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
3274140|NCT02688387|4008588|FG004|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
3274141|NCT02688387|4008589|FG005|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
3274142|NCT02688387|4008590|FG006|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
3274143|NCT02688387|4008591|FG007|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
3274144|NCT02688387|4008592|FG008|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
3274145|NCT02688387|4008593|FG009|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
3274146|NCT02688387|4008594|FG010|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
3274147|NCT02688387|4008595|FG011|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
3274148|NCT02688387|4008596|FG012|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
3274149|NCT02688387|4008597|FG013|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
3274150|NCT02688387|4008598|FG014|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
3274151|NCT02688387|4008599|FG015|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
3274152|NCT02688387|4008600|FG016|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
3274153|NCT02688387|4008601|FG017|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
3274154|NCT02688387|4008602|FG018|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
3274155|NCT02688387|4008603|FG019|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
3274156|NCT02688387|4008604|FG020|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
3274157|NCT02688387|4008605|FG021|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
3274158|NCT02688387|4008584|FG000|STARTED|Part 2, Washout Period 3 (10 Days)||0
3274159|NCT02688387|4008585|FG001|STARTED|Part 2, Washout Period 3 (10 Days)||0
3274160|NCT02688387|4008586|FG002|STARTED|Part 2, Washout Period 3 (10 Days)||0
3274161|NCT02688387|4008587|FG003|STARTED|Part 2, Washout Period 3 (10 Days)||0
3274162|NCT02688387|4008588|FG004|STARTED|Part 2, Washout Period 3 (10 Days)||0
3274163|NCT02688387|4008589|FG005|STARTED|Part 2, Washout Period 3 (10 Days)||0
3274164|NCT02688387|4008590|FG006|STARTED|Part 2, Washout Period 3 (10 Days)||0
3274165|NCT02688387|4008591|FG007|STARTED|Part 2, Washout Period 3 (10 Days)||0
3274166|NCT02688387|4008592|FG008|STARTED|Part 2, Washout Period 3 (10 Days)||0
3274167|NCT02688387|4008593|FG009|STARTED|Part 2, Washout Period 3 (10 Days)||0
3274168|NCT02688387|4008594|FG010|STARTED|Part 2, Washout Period 3 (10 Days)||5
3274169|NCT02688387|4008595|FG011|STARTED|Part 2, Washout Period 3 (10 Days)||5
3274170|NCT02688387|4008596|FG012|STARTED|Part 2, Washout Period 3 (10 Days)||5
3274171|NCT02688387|4008597|FG013|STARTED|Part 2, Washout Period 3 (10 Days)||5
3274172|NCT02688387|4008598|FG014|STARTED|Part 2, Washout Period 3 (10 Days)||0
3274173|NCT02688387|4008599|FG015|STARTED|Part 2, Washout Period 3 (10 Days)||0
3274174|NCT02688387|4008600|FG016|STARTED|Part 2, Washout Period 3 (10 Days)||0
3274175|NCT02688387|4008601|FG017|STARTED|Part 2, Washout Period 3 (10 Days)||0
3274176|NCT02688387|4008602|FG018|STARTED|Part 2, Washout Period 3 (10 Days)||0
3274177|NCT02688387|4008603|FG019|STARTED|Part 2, Washout Period 3 (10 Days)||0
3274178|NCT02688387|4008604|FG020|STARTED|Part 2, Washout Period 3 (10 Days)||0
3274179|NCT02688387|4008605|FG021|STARTED|Part 2, Washout Period 3 (10 Days)||0
3274180|NCT02688387|4008584|FG000|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
3274181|NCT02688387|4008585|FG001|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
3274182|NCT02688387|4008586|FG002|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
3274183|NCT02688387|4008587|FG003|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
3274184|NCT02688387|4008588|FG004|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
3274185|NCT02688387|4008589|FG005|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
3274186|NCT02688387|4008590|FG006|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
3274187|NCT02688387|4008591|FG007|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
3274188|NCT02688387|4008592|FG008|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
3274189|NCT02688387|4008593|FG009|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
3274190|NCT02688387|4008594|FG010|COMPLETED|Part 2, Washout Period 3 (10 Days)||5
3274191|NCT02688387|4008595|FG011|COMPLETED|Part 2, Washout Period 3 (10 Days)||5
3274192|NCT02688387|4008596|FG012|COMPLETED|Part 2, Washout Period 3 (10 Days)||5
3274193|NCT02688387|4008597|FG013|COMPLETED|Part 2, Washout Period 3 (10 Days)||5
3274194|NCT02688387|4008598|FG014|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
3274195|NCT02688387|4008599|FG015|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
3274196|NCT02688387|4008600|FG016|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
3274197|NCT02688387|4008601|FG017|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
3274198|NCT02688387|4008602|FG018|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
3274199|NCT02688387|4008603|FG019|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
3274200|NCT02688387|4008604|FG020|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
3274201|NCT02688387|4008605|FG021|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
3274202|NCT02688387|4008584|FG000|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
2936810|NCT00619476|3648769|FG000|STARTED|Overall Study||95
2936811|NCT00619476|3648770|FG001|STARTED|Overall Study||107
2936812|NCT00619476|3648771|FG002|STARTED|Overall Study||84
2936813|NCT00619476|3648772|FG003|STARTED|Overall Study||90
2936814|NCT00619476|3648769|FG000|Intent-to-Treat Population|Overall Study||95
2936815|NCT00619476|3648770|FG001|Intent-to-Treat Population|Overall Study||107
2936816|NCT00619476|3648771|FG002|Intent-to-Treat Population|Overall Study||82
2936817|NCT00619476|3648772|FG003|Intent-to-Treat Population|Overall Study||87
2936818|NCT00619476|3648769|FG000|Safety Population|Overall Study||95
2936819|NCT00619476|3648770|FG001|Safety Population|Overall Study||107
2936820|NCT00619476|3648771|FG002|Safety Population|Overall Study||82
2936821|NCT00619476|3648772|FG003|Safety Population|Overall Study||87
2936822|NCT00619476|3648769|FG000|COMPLETED|Overall Study||64
2936823|NCT00619476|3648770|FG001|COMPLETED|Overall Study||85
2936824|NCT00619476|3648771|FG002|COMPLETED|Overall Study||60
2936825|NCT00619476|3648772|FG003|COMPLETED|Overall Study||56
2936826|NCT00619476|3648769|FG000|NOT COMPLETED|Overall Study||31
2936827|NCT00619476|3648770|FG001|NOT COMPLETED|Overall Study||22
2936828|NCT00619476|3648771|FG002|NOT COMPLETED|Overall Study||24
2936829|NCT00619476|3648772|FG003|NOT COMPLETED|Overall Study||34
2936830|NCT00619489|3648784|FG000|STARTED|Overall Study||37
2936831|NCT00619489|3648785|FG001|STARTED|Overall Study||35
2936832|NCT00619489|3648784|FG000|COMPLETED|Overall Study||14
2936833|NCT00619489|3648785|FG001|COMPLETED|Overall Study||1
2936834|NCT00619489|3648784|FG000|NOT COMPLETED|Overall Study||23
2936835|NCT00619489|3648785|FG001|NOT COMPLETED|Overall Study||34
2936836|NCT00619502|3648793|FG000|STARTED|Overall Study||130
2936837|NCT00619502|3648794|FG001|STARTED|Overall Study||124
2936838|NCT00619502|3648793|FG000|COMPLETED|Overall Study||122
2936839|NCT00619502|3648794|FG001|COMPLETED|Overall Study||114
2936840|NCT00619502|3648793|FG000|NOT COMPLETED|Overall Study||8
2936841|NCT00619502|3648794|FG001|NOT COMPLETED|Overall Study||10
2936842|NCT00619619|3648810|FG000|STARTED|Overall Study||6
2936843|NCT00619619|3648811|FG001|STARTED|Overall Study||7
2936844|NCT00619619|3648812|FG002|STARTED|Overall Study||9
2936845|NCT00619619|3648813|FG003|STARTED|Overall Study||7
2936846|NCT00619619|3648814|FG004|STARTED|Overall Study||7
2936847|NCT00619619|3648815|FG005|STARTED|Overall Study||7
2936848|NCT00619619|3648816|FG006|STARTED|Overall Study||8
2936849|NCT00619619|3648817|FG007|STARTED|Overall Study||8
2936850|NCT00619619|3648810|FG000|Entered the Extension Study|Overall Study|Extension study: 3151A6-2001 (NCT00669110)|6
2936851|NCT00619619|3648811|FG001|Entered the Extension Study|Overall Study||5
2936852|NCT00619619|3648812|FG002|Entered the Extension Study|Overall Study||8
2936853|NCT00619619|3648813|FG003|Entered the Extension Study|Overall Study||3
2936854|NCT00619619|3648814|FG004|Entered the Extension Study|Overall Study||7
2936855|NCT00619619|3648815|FG005|Entered the Extension Study|Overall Study||6
2936856|NCT00619619|3648816|FG006|Entered the Extension Study|Overall Study||6
2936857|NCT00619619|3648817|FG007|Entered the Extension Study|Overall Study||7
2936858|NCT00619619|3648810|FG000|COMPLETED|Overall Study|Completed=conclusion of Test Article (treatment) phase for all treatment groups in 3151A6-2000.|6
2936859|NCT00619619|3648811|FG001|COMPLETED|Overall Study||7
2936860|NCT00619619|3648812|FG002|COMPLETED|Overall Study||8
2936861|NCT00619619|3648813|FG003|COMPLETED|Overall Study||6
2936862|NCT00619619|3648814|FG004|COMPLETED|Overall Study||5
2936863|NCT00619619|3648815|FG005|COMPLETED|Overall Study||7
2936864|NCT00619619|3648816|FG006|COMPLETED|Overall Study||7
2936865|NCT00619619|3648817|FG007|COMPLETED|Overall Study||5
2936866|NCT00619619|3648810|FG000|NOT COMPLETED|Overall Study||0
2936867|NCT00619619|3648811|FG001|NOT COMPLETED|Overall Study||0
2936868|NCT00619619|3648812|FG002|NOT COMPLETED|Overall Study||1
2936869|NCT00619619|3648813|FG003|NOT COMPLETED|Overall Study||1
2936870|NCT00619619|3648814|FG004|NOT COMPLETED|Overall Study||2
2936871|NCT00619619|3648815|FG005|NOT COMPLETED|Overall Study||0
2936872|NCT00619619|3648816|FG006|NOT COMPLETED|Overall Study||1
2936873|NCT00619619|3648817|FG007|NOT COMPLETED|Overall Study||3
2936874|NCT00619645|3648838|FG000|STARTED|Overall Study||8
2936875|NCT00619645|3648838|FG000|COMPLETED|Overall Study||7
2936876|NCT00619645|3648838|FG000|NOT COMPLETED|Overall Study||1
2936877|NCT00619684|3648842|FG000|STARTED|Overall Study||18
2936878|NCT00619684|3648842|FG000|COMPLETED|Overall Study||18
2936879|NCT00619684|3648842|FG000|NOT COMPLETED|Overall Study||0
2936880|NCT00619723|3648848|FG000|STARTED|Overall Study||63
2936881|NCT00619723|3648849|FG001|STARTED|Overall Study||67
2936882|NCT00619723|3648848|FG000|COMPLETED|Overall Study||61
2936883|NCT00619723|3648849|FG001|COMPLETED|Overall Study||61
2936884|NCT00619723|3648848|FG000|NOT COMPLETED|Overall Study||2
2936885|NCT00619723|3648849|FG001|NOT COMPLETED|Overall Study||6
2936886|NCT00619762|3648855|FG000|STARTED|Overall Study|(29 breasts) First patient implanted 10/23/2007|17
2936887|NCT00619762|3648855|FG000|COMPLETED|Overall Study|(25 breasts) last patient visit 11/09/2009|14
2936888|NCT00619762|3648855|FG000|NOT COMPLETED|Overall Study||3
2936889|NCT00619801|3648862|FG000|STARTED|Overall Study||59
2936890|NCT00619801|3648863|FG001|STARTED|Overall Study||114
2936891|NCT00619801|3648862|FG000|Safety Population|Overall Study||59
2936892|NCT00619801|3648863|FG001|Safety Population|Overall Study||114
2936893|NCT00619801|3648862|FG000|COMPLETED|Overall Study||58
2936894|NCT00619801|3648863|FG001|COMPLETED|Overall Study||111
2936895|NCT00619801|3648862|FG000|NOT COMPLETED|Overall Study||1
2936896|NCT00619801|3648863|FG001|NOT COMPLETED|Overall Study||3
2936897|NCT00619827|3648871|FG000|STARTED|Overall Study||45
2936898|NCT00619827|3648872|FG001|STARTED|Overall Study||44
2936899|NCT00619827|3648871|FG000|COMPLETED|Overall Study||42
2936900|NCT00619827|3648872|FG001|COMPLETED|Overall Study||40
2936901|NCT00619827|3648871|FG000|NOT COMPLETED|Overall Study||3
2936902|NCT00619827|3648872|FG001|NOT COMPLETED|Overall Study||4
2936903|NCT00619866|3648881|FG000|STARTED|Weeks 1 - 12||52
2936904|NCT00619866|3648882|FG001|STARTED|Weeks 1 - 12||51
2936905|NCT00619866|3648883|FG002|STARTED|Weeks 1 - 12||52
2936906|NCT00619866|3648884|FG003|STARTED|Weeks 1 - 12||0
2936907|NCT00619866|3648885|FG004|STARTED|Weeks 1 - 12||0
2936908|NCT00619866|3648881|FG000|COMPLETED|Weeks 1 - 12||38
2936909|NCT00619866|3648882|FG001|COMPLETED|Weeks 1 - 12||45
2936910|NCT00619866|3648883|FG002|COMPLETED|Weeks 1 - 12||42
2936911|NCT00619866|3648884|FG003|COMPLETED|Weeks 1 - 12||0
2936912|NCT00619866|3648885|FG004|COMPLETED|Weeks 1 - 12||0
2936913|NCT00619866|3648881|FG000|NOT COMPLETED|Weeks 1 - 12||14
2936914|NCT00619866|3648882|FG001|NOT COMPLETED|Weeks 1 - 12||6
2936915|NCT00619866|3648883|FG002|NOT COMPLETED|Weeks 1 - 12||10
2936916|NCT00619866|3648884|FG003|NOT COMPLETED|Weeks 1 - 12||0
3274203|NCT02688387|4008585|FG001|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
3274204|NCT02688387|4008586|FG002|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
3274205|NCT02688387|4008587|FG003|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
3274206|NCT02688387|4008588|FG004|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
3274207|NCT02688387|4008589|FG005|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
3274208|NCT02688387|4008590|FG006|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
3274209|NCT02688387|4008591|FG007|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
3274210|NCT02688387|4008592|FG008|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
3274211|NCT02688387|4008593|FG009|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
3274212|NCT02688387|4008594|FG010|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
3274213|NCT02688387|4008595|FG011|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
3274214|NCT02688387|4008596|FG012|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
3274215|NCT02688387|4008597|FG013|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
3274216|NCT02688387|4008598|FG014|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
3274217|NCT02688387|4008599|FG015|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
3274218|NCT02688387|4008600|FG016|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
3274219|NCT02688387|4008601|FG017|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
3274220|NCT02688387|4008602|FG018|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
3274221|NCT02688387|4008603|FG019|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
3274222|NCT02688387|4008604|FG020|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
3274223|NCT02688387|4008605|FG021|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
3274224|NCT02688387|4008584|FG000|STARTED|Part 2, Period 4 (up to 6 Days)||0
3274225|NCT02688387|4008585|FG001|STARTED|Part 2, Period 4 (up to 6 Days)||0
3274226|NCT02688387|4008586|FG002|STARTED|Part 2, Period 4 (up to 6 Days)||0
3274227|NCT02688387|4008587|FG003|STARTED|Part 2, Period 4 (up to 6 Days)||0
3274228|NCT02688387|4008588|FG004|STARTED|Part 2, Period 4 (up to 6 Days)||0
3274229|NCT02688387|4008589|FG005|STARTED|Part 2, Period 4 (up to 6 Days)||0
3274230|NCT02688387|4008590|FG006|STARTED|Part 2, Period 4 (up to 6 Days)||0
3274231|NCT02688387|4008591|FG007|STARTED|Part 2, Period 4 (up to 6 Days)||0
3274232|NCT02688387|4008592|FG008|STARTED|Part 2, Period 4 (up to 6 Days)||0
3274233|NCT02688387|4008593|FG009|STARTED|Part 2, Period 4 (up to 6 Days)||0
3274234|NCT02688387|4008594|FG010|STARTED|Part 2, Period 4 (up to 6 Days)||5
3274235|NCT02688387|4008595|FG011|STARTED|Part 2, Period 4 (up to 6 Days)||5
3274236|NCT02688387|4008596|FG012|STARTED|Part 2, Period 4 (up to 6 Days)||5
3274237|NCT02688387|4008597|FG013|STARTED|Part 2, Period 4 (up to 6 Days)||5
3274238|NCT02688387|4008598|FG014|STARTED|Part 2, Period 4 (up to 6 Days)||0
3274239|NCT02688387|4008599|FG015|STARTED|Part 2, Period 4 (up to 6 Days)||0
3274240|NCT02688387|4008600|FG016|STARTED|Part 2, Period 4 (up to 6 Days)||0
3274241|NCT02688387|4008601|FG017|STARTED|Part 2, Period 4 (up to 6 Days)||0
3274242|NCT02688387|4008602|FG018|STARTED|Part 2, Period 4 (up to 6 Days)||0
3274243|NCT02688387|4008603|FG019|STARTED|Part 2, Period 4 (up to 6 Days)||0
3274244|NCT02688387|4008604|FG020|STARTED|Part 2, Period 4 (up to 6 Days)||0
3274245|NCT02688387|4008605|FG021|STARTED|Part 2, Period 4 (up to 6 Days)||0
3274246|NCT02688387|4008584|FG000|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
3274247|NCT02688387|4008585|FG001|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
3274248|NCT02688387|4008586|FG002|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
3274249|NCT02688387|4008587|FG003|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
3274250|NCT02688387|4008588|FG004|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
3274251|NCT02688387|4008589|FG005|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
3274252|NCT02688387|4008590|FG006|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
3274253|NCT02688387|4008591|FG007|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
3274254|NCT02688387|4008592|FG008|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
3274255|NCT02688387|4008593|FG009|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
3274256|NCT02688387|4008594|FG010|COMPLETED|Part 2, Period 4 (up to 6 Days)||5
3274257|NCT02688387|4008595|FG011|COMPLETED|Part 2, Period 4 (up to 6 Days)||5
3274258|NCT02688387|4008596|FG012|COMPLETED|Part 2, Period 4 (up to 6 Days)||5
3274259|NCT02688387|4008597|FG013|COMPLETED|Part 2, Period 4 (up to 6 Days)||5
3274260|NCT02688387|4008598|FG014|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
3274261|NCT02688387|4008599|FG015|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
2936917|NCT00619866|3648885|FG004|NOT COMPLETED|Weeks 1 - 12||0
2936918|NCT00619866|3648881|FG000|STARTED|Weeks 13 - 24||0
2936919|NCT00619866|3648882|FG001|STARTED|Weeks 13 - 24||45
2936920|NCT00619866|3648883|FG002|STARTED|Weeks 13 - 24||42
2936921|NCT00619866|3648884|FG003|STARTED|Weeks 13 - 24||18
2936922|NCT00619866|3648885|FG004|STARTED|Weeks 13 - 24||20
3274262|NCT02688387|4008600|FG016|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
3274263|NCT02688387|4008601|FG017|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
3274264|NCT02688387|4008602|FG018|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
3274265|NCT02688387|4008603|FG019|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
3274266|NCT02688387|4008604|FG020|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
3274267|NCT02688387|4008605|FG021|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
3274268|NCT02688387|4008584|FG000|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
3274269|NCT02688387|4008585|FG001|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
3274270|NCT02688387|4008586|FG002|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
3274271|NCT02688387|4008587|FG003|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
3274272|NCT02688387|4008588|FG004|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
3274273|NCT02688387|4008589|FG005|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
3274274|NCT02688387|4008590|FG006|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
3274275|NCT02688387|4008591|FG007|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
3274276|NCT02688387|4008592|FG008|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
3274277|NCT02688387|4008593|FG009|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
3274278|NCT02688387|4008594|FG010|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
3274279|NCT02688387|4008595|FG011|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
3274280|NCT02688387|4008596|FG012|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
3274281|NCT02688387|4008597|FG013|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
3274282|NCT02688387|4008598|FG014|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
3274283|NCT02688387|4008599|FG015|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
3274284|NCT02688387|4008600|FG016|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
3274285|NCT02688387|4008601|FG017|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
3274286|NCT02688387|4008602|FG018|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
3274287|NCT02688387|4008603|FG019|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
3274288|NCT02688387|4008604|FG020|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
3274289|NCT02688387|4008605|FG021|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
3274290|NCT02688387|4008584|FG000|STARTED|Part 3A, Period 1 (up to 6 Days)||0
3274291|NCT02688387|4008585|FG001|STARTED|Part 3A, Period 1 (up to 6 Days)||0
3274292|NCT02688387|4008586|FG002|STARTED|Part 3A, Period 1 (up to 6 Days)||0
3274293|NCT02688387|4008587|FG003|STARTED|Part 3A, Period 1 (up to 6 Days)||0
3274294|NCT02688387|4008588|FG004|STARTED|Part 3A, Period 1 (up to 6 Days)||0
3274295|NCT02688387|4008589|FG005|STARTED|Part 3A, Period 1 (up to 6 Days)||0
3274296|NCT02688387|4008590|FG006|STARTED|Part 3A, Period 1 (up to 6 Days)||0
3274297|NCT02688387|4008591|FG007|STARTED|Part 3A, Period 1 (up to 6 Days)||0
3274298|NCT02688387|4008592|FG008|STARTED|Part 3A, Period 1 (up to 6 Days)||0
3274299|NCT02688387|4008593|FG009|STARTED|Part 3A, Period 1 (up to 6 Days)||0
3274300|NCT02688387|4008594|FG010|STARTED|Part 3A, Period 1 (up to 6 Days)||0
3274301|NCT02688387|4008595|FG011|STARTED|Part 3A, Period 1 (up to 6 Days)||0
3274302|NCT02688387|4008596|FG012|STARTED|Part 3A, Period 1 (up to 6 Days)||0
3274303|NCT02688387|4008597|FG013|STARTED|Part 3A, Period 1 (up to 6 Days)||0
3274304|NCT02688387|4008598|FG014|STARTED|Part 3A, Period 1 (up to 6 Days)||9
3274305|NCT02688387|4008599|FG015|STARTED|Part 3A, Period 1 (up to 6 Days)||8
3274306|NCT02688387|4008600|FG016|STARTED|Part 3A, Period 1 (up to 6 Days)||8
3274307|NCT02688387|4008601|FG017|STARTED|Part 3A, Period 1 (up to 6 Days)||8
3274308|NCT02688387|4008602|FG018|STARTED|Part 3A, Period 1 (up to 6 Days)||0
3274309|NCT02688387|4008603|FG019|STARTED|Part 3A, Period 1 (up to 6 Days)||0
3274310|NCT02688387|4008604|FG020|STARTED|Part 3A, Period 1 (up to 6 Days)||0
3274311|NCT02688387|4008605|FG021|STARTED|Part 3A, Period 1 (up to 6 Days)||0
3274312|NCT02688387|4008584|FG000|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
3274313|NCT02688387|4008585|FG001|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
3274314|NCT02688387|4008586|FG002|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
3274315|NCT02688387|4008587|FG003|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
3274316|NCT02688387|4008588|FG004|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
3274317|NCT02688387|4008589|FG005|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
3274318|NCT02688387|4008590|FG006|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
3274319|NCT02688387|4008591|FG007|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
3274320|NCT02688387|4008592|FG008|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
3274321|NCT02688387|4008593|FG009|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
3274322|NCT02688387|4008594|FG010|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
3274323|NCT02688387|4008595|FG011|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
3274324|NCT02688387|4008596|FG012|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
3274325|NCT02688387|4008597|FG013|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
3274326|NCT02688387|4008598|FG014|COMPLETED|Part 3A, Period 1 (up to 6 Days)||8
3274327|NCT02688387|4008599|FG015|COMPLETED|Part 3A, Period 1 (up to 6 Days)||8
3274328|NCT02688387|4008600|FG016|COMPLETED|Part 3A, Period 1 (up to 6 Days)||8
3274329|NCT02688387|4008601|FG017|COMPLETED|Part 3A, Period 1 (up to 6 Days)||8
3274330|NCT02688387|4008602|FG018|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
3274331|NCT02688387|4008603|FG019|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
3274332|NCT02688387|4008604|FG020|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
3274333|NCT02688387|4008605|FG021|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
2936923|NCT00619866|3648881|FG000|COMPLETED|Weeks 13 - 24||0
2936924|NCT00619866|3648882|FG001|COMPLETED|Weeks 13 - 24||38
2936925|NCT00619866|3648883|FG002|COMPLETED|Weeks 13 - 24||37
2936926|NCT00619866|3648884|FG003|COMPLETED|Weeks 13 - 24||14
2936927|NCT00619866|3648885|FG004|COMPLETED|Weeks 13 - 24||18
2936928|NCT00619866|3648881|FG000|NOT COMPLETED|Weeks 13 - 24||0
2936929|NCT00619866|3648882|FG001|NOT COMPLETED|Weeks 13 - 24||7
2936930|NCT00619866|3648883|FG002|NOT COMPLETED|Weeks 13 - 24||5
3274334|NCT02688387|4008584|FG000|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
3274335|NCT02688387|4008585|FG001|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
3274336|NCT02688387|4008586|FG002|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
3274337|NCT02688387|4008587|FG003|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
3274338|NCT02688387|4008588|FG004|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
3274339|NCT02688387|4008589|FG005|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
3274340|NCT02688387|4008590|FG006|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
3274341|NCT02688387|4008591|FG007|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
3274342|NCT02688387|4008592|FG008|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
3274343|NCT02688387|4008593|FG009|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
3274344|NCT02688387|4008594|FG010|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
3274345|NCT02688387|4008595|FG011|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
3274346|NCT02688387|4008596|FG012|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
3274347|NCT02688387|4008597|FG013|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
3274348|NCT02688387|4008598|FG014|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||1
3274349|NCT02688387|4008599|FG015|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
3274350|NCT02688387|4008600|FG016|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
3274351|NCT02688387|4008601|FG017|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
3274352|NCT02688387|4008602|FG018|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
3274353|NCT02688387|4008603|FG019|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
3274354|NCT02688387|4008604|FG020|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
3274355|NCT02688387|4008605|FG021|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
3274356|NCT02688387|4008584|FG000|STARTED|Part 3A, Washout Period 1 (10 Days)||0
3274357|NCT02688387|4008585|FG001|STARTED|Part 3A, Washout Period 1 (10 Days)||0
3274358|NCT02688387|4008586|FG002|STARTED|Part 3A, Washout Period 1 (10 Days)||0
3274359|NCT02688387|4008587|FG003|STARTED|Part 3A, Washout Period 1 (10 Days)||0
3274360|NCT02688387|4008588|FG004|STARTED|Part 3A, Washout Period 1 (10 Days)||0
3274361|NCT02688387|4008589|FG005|STARTED|Part 3A, Washout Period 1 (10 Days)||0
3274362|NCT02688387|4008590|FG006|STARTED|Part 3A, Washout Period 1 (10 Days)||0
3274363|NCT02688387|4008591|FG007|STARTED|Part 3A, Washout Period 1 (10 Days)||0
3274364|NCT02688387|4008592|FG008|STARTED|Part 3A, Washout Period 1 (10 Days)||0
3274365|NCT02688387|4008593|FG009|STARTED|Part 3A, Washout Period 1 (10 Days)||0
3274366|NCT02688387|4008594|FG010|STARTED|Part 3A, Washout Period 1 (10 Days)||0
3274367|NCT02688387|4008595|FG011|STARTED|Part 3A, Washout Period 1 (10 Days)||0
3274368|NCT02688387|4008596|FG012|STARTED|Part 3A, Washout Period 1 (10 Days)||0
3274369|NCT02688387|4008597|FG013|STARTED|Part 3A, Washout Period 1 (10 Days)||0
3274370|NCT02688387|4008598|FG014|STARTED|Part 3A, Washout Period 1 (10 Days)||8
3274371|NCT02688387|4008599|FG015|STARTED|Part 3A, Washout Period 1 (10 Days)||8
3274372|NCT02688387|4008600|FG016|STARTED|Part 3A, Washout Period 1 (10 Days)||8
3274373|NCT02688387|4008601|FG017|STARTED|Part 3A, Washout Period 1 (10 Days)||8
3274374|NCT02688387|4008602|FG018|STARTED|Part 3A, Washout Period 1 (10 Days)||0
3274375|NCT02688387|4008603|FG019|STARTED|Part 3A, Washout Period 1 (10 Days)||0
3274376|NCT02688387|4008604|FG020|STARTED|Part 3A, Washout Period 1 (10 Days)||0
3274377|NCT02688387|4008605|FG021|STARTED|Part 3A, Washout Period 1 (10 Days)||0
3274378|NCT02688387|4008584|FG000|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
3274379|NCT02688387|4008585|FG001|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
3274380|NCT02688387|4008586|FG002|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
3274381|NCT02688387|4008587|FG003|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
3274382|NCT02688387|4008588|FG004|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
3274383|NCT02688387|4008589|FG005|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
3274384|NCT02688387|4008590|FG006|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
3274385|NCT02688387|4008591|FG007|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
3274386|NCT02688387|4008592|FG008|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
3274387|NCT02688387|4008593|FG009|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
3274388|NCT02688387|4008594|FG010|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
3274389|NCT02688387|4008595|FG011|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
3274390|NCT02688387|4008596|FG012|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
3274391|NCT02688387|4008597|FG013|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
3274392|NCT02688387|4008598|FG014|COMPLETED|Part 3A, Washout Period 1 (10 Days)||8
3274393|NCT02688387|4008599|FG015|COMPLETED|Part 3A, Washout Period 1 (10 Days)||8
3274394|NCT02688387|4008600|FG016|COMPLETED|Part 3A, Washout Period 1 (10 Days)||8
3274395|NCT02688387|4008601|FG017|COMPLETED|Part 3A, Washout Period 1 (10 Days)||8
3274396|NCT02688387|4008602|FG018|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
3274397|NCT02688387|4008603|FG019|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
3274398|NCT02688387|4008604|FG020|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
3274399|NCT02688387|4008605|FG021|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
3274400|NCT02688387|4008584|FG000|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
2936931|NCT00619866|3648884|FG003|NOT COMPLETED|Weeks 13 - 24||4
2936932|NCT00619866|3648885|FG004|NOT COMPLETED|Weeks 13 - 24||2
2936933|NCT00619892|3648899|FG000|STARTED|Overall Study||13
2936934|NCT00619892|3648900|FG001|STARTED|Overall Study||13
2936935|NCT00619892|3648899|FG000|COMPLETED|Overall Study||10
2936936|NCT00619892|3648900|FG001|COMPLETED|Overall Study||11
2936937|NCT00619892|3648899|FG000|NOT COMPLETED|Overall Study||3
3274401|NCT02688387|4008585|FG001|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
3274402|NCT02688387|4008586|FG002|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
3274403|NCT02688387|4008587|FG003|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
3274404|NCT02688387|4008588|FG004|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
3274405|NCT02688387|4008589|FG005|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
3274406|NCT02688387|4008590|FG006|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
2936938|NCT00619892|3648900|FG001|NOT COMPLETED|Overall Study||2
2936939|NCT00619918|3648910|FG000|STARTED|Overall Study||230
2936940|NCT00619918|3648911|FG001|STARTED|Overall Study||217
2936941|NCT00619918|3648910|FG000|COMPLETED|Overall Study||210
2936942|NCT00619918|3648911|FG001|COMPLETED|Overall Study||195
2936943|NCT00619918|3648910|FG000|NOT COMPLETED|Overall Study||20
2936944|NCT00619918|3648911|FG001|NOT COMPLETED|Overall Study||22
2936945|NCT00619957|3648919|FG000|STARTED|Month 24 Double-Blind||93
2936946|NCT00619957|3648920|FG001|STARTED|Month 24 Double-Blind||192
2936947|NCT00619957|3648919|FG000|Intent to Treat (ITT Population)|Month 24 Double-Blind||93
2936948|NCT00619957|3648920|FG001|Intent to Treat (ITT Population)|Month 24 Double-Blind|One subject did not take any study medication.|191
2936949|NCT00619957|3648919|FG000|COMPLETED|Month 24 Double-Blind||75
2936950|NCT00619957|3648920|FG001|COMPLETED|Month 24 Double-Blind||175
2936951|NCT00619957|3648919|FG000|NOT COMPLETED|Month 24 Double-Blind||18
2936952|NCT00619957|3648920|FG001|NOT COMPLETED|Month 24 Double-Blind||17
2936953|NCT00619957|3648919|FG000|STARTED|Month 48 Open-Label||67
2936954|NCT00619957|3648920|FG001|STARTED|Month 48 Open-Label||151
2936955|NCT00619957|3648919|FG000|COMPLETED|Month 48 Open-Label||55
2936956|NCT00619957|3648920|FG001|COMPLETED|Month 48 Open-Label||134
2936957|NCT00619957|3648919|FG000|NOT COMPLETED|Month 48 Open-Label||12
2936958|NCT00619957|3648920|FG001|NOT COMPLETED|Month 48 Open-Label||17
2936959|NCT00619970|3648931|FG000|STARTED|Overall Study||40
2936960|NCT00619970|3648932|FG001|STARTED|Overall Study||49
2936961|NCT00619970|3648933|FG002|STARTED|Overall Study||26
2936962|NCT00619970|3648931|FG000|COMPLETED|Overall Study||40
2936963|NCT00619970|3648932|FG001|COMPLETED|Overall Study||46
2936964|NCT00619970|3648933|FG002|COMPLETED|Overall Study||24
2936965|NCT00619970|3648931|FG000|NOT COMPLETED|Overall Study||0
2936966|NCT00619970|3648932|FG001|NOT COMPLETED|Overall Study||3
2936967|NCT00619970|3648933|FG002|NOT COMPLETED|Overall Study||2
2936968|NCT00619983|3648947|FG000|STARTED|Test Drug Alone||5
2936969|NCT00619983|3648948|FG001|STARTED|Test Drug Alone||5
2936970|NCT00619983|3648949|FG002|STARTED|Test Drug Alone||6
2936971|NCT00619983|3648950|FG003|STARTED|Test Drug Alone||6
2936972|NCT00619983|3648947|FG000|COMPLETED|Test Drug Alone||3
2936973|NCT00619983|3648948|FG001|COMPLETED|Test Drug Alone||4
2936974|NCT00619983|3648949|FG002|COMPLETED|Test Drug Alone||4
2936975|NCT00619983|3648950|FG003|COMPLETED|Test Drug Alone||3
2936976|NCT00619983|3648947|FG000|NOT COMPLETED|Test Drug Alone||2
2936977|NCT00619983|3648948|FG001|NOT COMPLETED|Test Drug Alone||1
2936978|NCT00619983|3648949|FG002|NOT COMPLETED|Test Drug Alone||2
2936979|NCT00619983|3648950|FG003|NOT COMPLETED|Test Drug Alone||3
2936980|NCT00619983|3648947|FG000|STARTED|Test Drug Plus Gabapentin||3
2936981|NCT00619983|3648948|FG001|STARTED|Test Drug Plus Gabapentin||4
2936982|NCT00619983|3648949|FG002|STARTED|Test Drug Plus Gabapentin||4
2936983|NCT00619983|3648950|FG003|STARTED|Test Drug Plus Gabapentin||3
2936984|NCT00619983|3648947|FG000|COMPLETED|Test Drug Plus Gabapentin||3
2936985|NCT00619983|3648948|FG001|COMPLETED|Test Drug Plus Gabapentin||4
2936986|NCT00619983|3648949|FG002|COMPLETED|Test Drug Plus Gabapentin||4
2936987|NCT00619983|3648950|FG003|COMPLETED|Test Drug Plus Gabapentin||3
2936988|NCT00619983|3648947|FG000|NOT COMPLETED|Test Drug Plus Gabapentin||0
2936989|NCT00619983|3648948|FG001|NOT COMPLETED|Test Drug Plus Gabapentin||0
2936990|NCT00619983|3648949|FG002|NOT COMPLETED|Test Drug Plus Gabapentin||0
2936991|NCT00619983|3648950|FG003|NOT COMPLETED|Test Drug Plus Gabapentin||0
2936992|NCT00619983|3648947|FG000|STARTED|Gabapentin Alone||3
2936993|NCT00619983|3648948|FG001|STARTED|Gabapentin Alone||4
2936994|NCT00619983|3648949|FG002|STARTED|Gabapentin Alone||4
2936995|NCT00619983|3648950|FG003|STARTED|Gabapentin Alone||3
2936996|NCT00619983|3648947|FG000|COMPLETED|Gabapentin Alone||3
2936997|NCT00619983|3648948|FG001|COMPLETED|Gabapentin Alone||4
2936998|NCT00619983|3648949|FG002|COMPLETED|Gabapentin Alone||4
2936999|NCT00619983|3648950|FG003|COMPLETED|Gabapentin Alone||3
2937000|NCT00619983|3648947|FG000|NOT COMPLETED|Gabapentin Alone||0
2937001|NCT00619983|3648948|FG001|NOT COMPLETED|Gabapentin Alone||0
2937002|NCT00619983|3648949|FG002|NOT COMPLETED|Gabapentin Alone||0
2937003|NCT00619983|3648950|FG003|NOT COMPLETED|Gabapentin Alone||0
2937004|NCT00620022|3648960|FG000|STARTED|Treatment Period 1||46
2937005|NCT00620022|3648961|FG001|STARTED|Treatment Period 1|Of 44 randomized patients, 1 patient discontinued before receiving any study treatment.|43
2937006|NCT00620022|3648960|FG000|COMPLETED|Treatment Period 1||41
2937007|NCT00620022|3648961|FG001|COMPLETED|Treatment Period 1||37
2937008|NCT00620022|3648960|FG000|NOT COMPLETED|Treatment Period 1||5
2937009|NCT00620022|3648961|FG001|NOT COMPLETED|Treatment Period 1||6
2937010|NCT00620022|3648960|FG000|STARTED|Treatment Period 2||41
2937011|NCT00620022|3648961|FG001|STARTED|Treatment Period 2||37
2937012|NCT00620022|3648960|FG000|COMPLETED|Treatment Period 2||39
2937013|NCT00620022|3648961|FG001|COMPLETED|Treatment Period 2||35
2937014|NCT00620022|3648960|FG000|NOT COMPLETED|Treatment Period 2||2
2937015|NCT00620022|3648961|FG001|NOT COMPLETED|Treatment Period 2||2
2937016|NCT00620061|3648967|FG000|STARTED|Overall Study||439
2937017|NCT00620061|3648967|FG000|COMPLETED|Overall Study||286
2937018|NCT00620061|3648967|FG000|NOT COMPLETED|Overall Study||153
2937019|NCT00620074|3648972|FG000|STARTED|Overall Study||6
2937020|NCT00620074|3648972|FG000|COMPLETED|Overall Study||5
2937021|NCT00620074|3648972|FG000|NOT COMPLETED|Overall Study||1
2937022|NCT00620113|3648980|FG000|STARTED|Overall Study||73
2937023|NCT00620113|3648981|FG001|STARTED|Overall Study||74
2937024|NCT00620113|3648982|FG002|STARTED|Overall Study|Includes 1 participant who also received 50 mg dose by accident during study.|71
2937025|NCT00620113|3648983|FG003|STARTED|Overall Study||69
2937026|NCT00620113|3648980|FG000|Efficacy/Safety Population|Overall Study||73
2937027|NCT00620113|3648981|FG001|Efficacy/Safety Population|Overall Study||74
2937028|NCT00620113|3648982|FG002|Efficacy/Safety Population|Overall Study||70
2937029|NCT00620113|3648983|FG003|Efficacy/Safety Population|Overall Study||69
2937030|NCT00620113|3648980|FG000|COMPLETED|Overall Study||60
2937031|NCT00620113|3648981|FG001|COMPLETED|Overall Study||67
2937032|NCT00620113|3648982|FG002|COMPLETED|Overall Study|Includes 1 participant who also received 50 mg dose by accident during study.|66
2937033|NCT00620113|3648983|FG003|COMPLETED|Overall Study||59
2937034|NCT00620113|3648980|FG000|NOT COMPLETED|Overall Study||13
2937035|NCT00620113|3648981|FG001|NOT COMPLETED|Overall Study||7
2937036|NCT00620113|3648982|FG002|NOT COMPLETED|Overall Study||5
2937037|NCT00620113|3648983|FG003|NOT COMPLETED|Overall Study||10
2937038|NCT00620126|3648995|FG000|STARTED|Overall Study||25
2937039|NCT00620126|3648996|FG001|STARTED|Overall Study||22
2937040|NCT00620126|3648995|FG000|COMPLETED|Overall Study||14
2937041|NCT00620126|3648996|FG001|COMPLETED|Overall Study||17
2937042|NCT00620126|3648995|FG000|NOT COMPLETED|Overall Study||11
2937043|NCT00620126|3648996|FG001|NOT COMPLETED|Overall Study||5
2937044|NCT00620191|3649004|FG000|STARTED|Overall Study||40
2937045|NCT00620191|3649005|FG001|STARTED|Overall Study||40
2937046|NCT00620191|3649004|FG000|3 Month Follow-up|Overall Study||39
2937047|NCT00620191|3649005|FG001|3 Month Follow-up|Overall Study||39
2937048|NCT00620191|3649004|FG000|6 Month Follow-up|Overall Study||38
2937049|NCT00620191|3649005|FG001|6 Month Follow-up|Overall Study||36
3274407|NCT02688387|4008591|FG007|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
3274408|NCT02688387|4008592|FG008|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
3274409|NCT02688387|4008593|FG009|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
3274410|NCT02688387|4008594|FG010|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
3274411|NCT02688387|4008595|FG011|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
3274412|NCT02688387|4008596|FG012|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
3274413|NCT02688387|4008597|FG013|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
3274414|NCT02688387|4008598|FG014|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
3274415|NCT02688387|4008599|FG015|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
3274416|NCT02688387|4008600|FG016|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
3274417|NCT02688387|4008601|FG017|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
3274418|NCT02688387|4008602|FG018|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
3274419|NCT02688387|4008603|FG019|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
3274420|NCT02688387|4008604|FG020|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
3274421|NCT02688387|4008605|FG021|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
3274422|NCT02688387|4008584|FG000|STARTED|Part 3A, Period 2 (up to 6 Days)||0
3274423|NCT02688387|4008585|FG001|STARTED|Part 3A, Period 2 (up to 6 Days)||0
3274424|NCT02688387|4008586|FG002|STARTED|Part 3A, Period 2 (up to 6 Days)||0
3274425|NCT02688387|4008587|FG003|STARTED|Part 3A, Period 2 (up to 6 Days)||0
3274426|NCT02688387|4008588|FG004|STARTED|Part 3A, Period 2 (up to 6 Days)||0
3274427|NCT02688387|4008589|FG005|STARTED|Part 3A, Period 2 (up to 6 Days)||0
3274428|NCT02688387|4008590|FG006|STARTED|Part 3A, Period 2 (up to 6 Days)||0
3274429|NCT02688387|4008591|FG007|STARTED|Part 3A, Period 2 (up to 6 Days)||0
3274430|NCT02688387|4008592|FG008|STARTED|Part 3A, Period 2 (up to 6 Days)||0
3274431|NCT02688387|4008593|FG009|STARTED|Part 3A, Period 2 (up to 6 Days)||0
3274432|NCT02688387|4008594|FG010|STARTED|Part 3A, Period 2 (up to 6 Days)||0
3274433|NCT02688387|4008595|FG011|STARTED|Part 3A, Period 2 (up to 6 Days)||0
3274434|NCT02688387|4008596|FG012|STARTED|Part 3A, Period 2 (up to 6 Days)||0
3274435|NCT02688387|4008597|FG013|STARTED|Part 3A, Period 2 (up to 6 Days)||0
3274436|NCT02688387|4008598|FG014|STARTED|Part 3A, Period 2 (up to 6 Days)||8
3274437|NCT02688387|4008599|FG015|STARTED|Part 3A, Period 2 (up to 6 Days)||8
3274438|NCT02688387|4008600|FG016|STARTED|Part 3A, Period 2 (up to 6 Days)||8
3274439|NCT02688387|4008601|FG017|STARTED|Part 3A, Period 2 (up to 6 Days)||8
3274440|NCT02688387|4008602|FG018|STARTED|Part 3A, Period 2 (up to 6 Days)||0
3274441|NCT02688387|4008603|FG019|STARTED|Part 3A, Period 2 (up to 6 Days)||0
3274442|NCT02688387|4008604|FG020|STARTED|Part 3A, Period 2 (up to 6 Days)||0
3274443|NCT02688387|4008605|FG021|STARTED|Part 3A, Period 2 (up to 6 Days)||0
3274444|NCT02688387|4008584|FG000|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
3274445|NCT02688387|4008585|FG001|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
3274446|NCT02688387|4008586|FG002|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
3274447|NCT02688387|4008587|FG003|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
3274448|NCT02688387|4008588|FG004|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
3274449|NCT02688387|4008589|FG005|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
3274450|NCT02688387|4008590|FG006|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
2937050|NCT00620191|3649004|FG000|9 Month Follow-up|Overall Study||37
2937051|NCT00620191|3649005|FG001|9 Month Follow-up|Overall Study||34
2937052|NCT00620191|3649004|FG000|COMPLETED|Overall Study|12 month follow-up|33
2937053|NCT00620191|3649005|FG001|COMPLETED|Overall Study|12 month follow-up|32
2937054|NCT00620191|3649004|FG000|NOT COMPLETED|Overall Study||7
2937055|NCT00620191|3649005|FG001|NOT COMPLETED|Overall Study||8
2937056|NCT00620282|3649019|FG000|STARTED|Overall Study||16
2937057|NCT00620282|3649020|FG001|STARTED|Overall Study||16
2937058|NCT00620282|3649021|FG002|STARTED|Overall Study||17
2937059|NCT00620282|3649019|FG000|COMPLETED|Overall Study||16
2937060|NCT00620282|3649020|FG001|COMPLETED|Overall Study||14
2937061|NCT00620282|3649021|FG002|COMPLETED|Overall Study||16
2937062|NCT00620282|3649019|FG000|NOT COMPLETED|Overall Study||0
2937063|NCT00620282|3649020|FG001|NOT COMPLETED|Overall Study||2
2937064|NCT00620282|3649021|FG002|NOT COMPLETED|Overall Study||1
2937065|NCT00620321|3649031|FG000|STARTED|Overall Study||8
2937066|NCT00620321|3649032|FG001|STARTED|Overall Study||16
2937067|NCT00620321|3649031|FG000|Received at Least 1 Dose of Study Drug|Overall Study||8
2937068|NCT00620321|3649032|FG001|Received at Least 1 Dose of Study Drug|Overall Study||16
2937069|NCT00620321|3649031|FG000|COMPLETED|Overall Study||0
2937070|NCT00620321|3649032|FG001|COMPLETED|Overall Study||0
2937071|NCT00620321|3649031|FG000|NOT COMPLETED|Overall Study||8
2937072|NCT00620321|3649032|FG001|NOT COMPLETED|Overall Study||16
2937073|NCT00620373|3649038|FG000|STARTED|Overall Study||969
2937074|NCT00620373|3649038|FG000|COMPLETED|Overall Study||936
2937075|NCT00620373|3649038|FG000|NOT COMPLETED|Overall Study||33
2937076|NCT00620425|3649045|FG000|STARTED|Overall Study||18
2937077|NCT00620425|3649045|FG000|COMPLETED|Overall Study||18
2937078|NCT00620425|3649045|FG000|NOT COMPLETED|Overall Study||0
3274451|NCT02688387|4008591|FG007|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
3274452|NCT02688387|4008592|FG008|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
3274453|NCT02688387|4008593|FG009|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
3274454|NCT02688387|4008594|FG010|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
3274455|NCT02688387|4008595|FG011|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
3274456|NCT02688387|4008596|FG012|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
3274457|NCT02688387|4008597|FG013|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
3274458|NCT02688387|4008598|FG014|COMPLETED|Part 3A, Period 2 (up to 6 Days)||8
3274459|NCT02688387|4008599|FG015|COMPLETED|Part 3A, Period 2 (up to 6 Days)||8
3274460|NCT02688387|4008600|FG016|COMPLETED|Part 3A, Period 2 (up to 6 Days)||8
3274461|NCT02688387|4008601|FG017|COMPLETED|Part 3A, Period 2 (up to 6 Days)||8
3274462|NCT02688387|4008602|FG018|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
3274463|NCT02688387|4008603|FG019|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
3274464|NCT02688387|4008604|FG020|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
3274465|NCT02688387|4008605|FG021|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
3274466|NCT02688387|4008584|FG000|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
3274467|NCT02688387|4008585|FG001|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
3274468|NCT02688387|4008586|FG002|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
3274469|NCT02688387|4008587|FG003|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
3274470|NCT02688387|4008588|FG004|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
3274471|NCT02688387|4008589|FG005|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
3274472|NCT02688387|4008590|FG006|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
3274473|NCT02688387|4008591|FG007|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
3274474|NCT02688387|4008592|FG008|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
3274475|NCT02688387|4008593|FG009|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
3274476|NCT02688387|4008594|FG010|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
3274477|NCT02688387|4008595|FG011|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
3274478|NCT02688387|4008596|FG012|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
3274479|NCT02688387|4008597|FG013|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
3274480|NCT02688387|4008598|FG014|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
3274481|NCT02688387|4008599|FG015|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
3274482|NCT02688387|4008600|FG016|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
3274483|NCT02688387|4008601|FG017|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
3274484|NCT02688387|4008602|FG018|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
3274485|NCT02688387|4008603|FG019|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
3274486|NCT02688387|4008604|FG020|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
3274487|NCT02688387|4008605|FG021|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
3274488|NCT02688387|4008584|FG000|STARTED|Part 3A, Washout Period 2 (10 Days)||0
3274489|NCT02688387|4008585|FG001|STARTED|Part 3A, Washout Period 2 (10 Days)||0
3274490|NCT02688387|4008586|FG002|STARTED|Part 3A, Washout Period 2 (10 Days)||0
3274491|NCT02688387|4008587|FG003|STARTED|Part 3A, Washout Period 2 (10 Days)||0
3274492|NCT02688387|4008588|FG004|STARTED|Part 3A, Washout Period 2 (10 Days)||0
3274493|NCT02688387|4008589|FG005|STARTED|Part 3A, Washout Period 2 (10 Days)||0
3274494|NCT02688387|4008590|FG006|STARTED|Part 3A, Washout Period 2 (10 Days)||0
3274495|NCT02688387|4008591|FG007|STARTED|Part 3A, Washout Period 2 (10 Days)||0
3274496|NCT02688387|4008592|FG008|STARTED|Part 3A, Washout Period 2 (10 Days)||0
3274497|NCT02688387|4008593|FG009|STARTED|Part 3A, Washout Period 2 (10 Days)||0
3274498|NCT02688387|4008594|FG010|STARTED|Part 3A, Washout Period 2 (10 Days)||0
3274499|NCT02688387|4008595|FG011|STARTED|Part 3A, Washout Period 2 (10 Days)||0
3274500|NCT02688387|4008596|FG012|STARTED|Part 3A, Washout Period 2 (10 Days)||0
2937079|NCT00620503|3649056|FG000|STARTED|Screening (up to 21 Days)||2
2937080|NCT00620503|3649057|FG001|STARTED|Screening (up to 21 Days)||2
2937081|NCT00620503|3649058|FG002|STARTED|Screening (up to 21 Days)||2
2937082|NCT00620503|3649059|FG003|STARTED|Screening (up to 21 Days)||2
2937083|NCT00620503|3649060|FG004|STARTED|Screening (up to 21 Days)||2
2937084|NCT00620503|3649061|FG005|STARTED|Screening (up to 21 Days)||2
2937085|NCT00620503|3649056|FG000|COMPLETED|Screening (up to 21 Days)||2
2937086|NCT00620503|3649057|FG001|COMPLETED|Screening (up to 21 Days)||2
2937087|NCT00620503|3649058|FG002|COMPLETED|Screening (up to 21 Days)||2
2937088|NCT00620503|3649059|FG003|COMPLETED|Screening (up to 21 Days)||2
2937089|NCT00620503|3649060|FG004|COMPLETED|Screening (up to 21 Days)||2
2937090|NCT00620503|3649061|FG005|COMPLETED|Screening (up to 21 Days)||2
2937091|NCT00620503|3649056|FG000|NOT COMPLETED|Screening (up to 21 Days)||0
3274501|NCT02688387|4008597|FG013|STARTED|Part 3A, Washout Period 2 (10 Days)||0
3274502|NCT02688387|4008598|FG014|STARTED|Part 3A, Washout Period 2 (10 Days)||8
3274503|NCT02688387|4008599|FG015|STARTED|Part 3A, Washout Period 2 (10 Days)||8
3274504|NCT02688387|4008600|FG016|STARTED|Part 3A, Washout Period 2 (10 Days)||8
3274505|NCT02688387|4008601|FG017|STARTED|Part 3A, Washout Period 2 (10 Days)||8
3274506|NCT02688387|4008602|FG018|STARTED|Part 3A, Washout Period 2 (10 Days)||0
3274507|NCT02688387|4008603|FG019|STARTED|Part 3A, Washout Period 2 (10 Days)||0
3274508|NCT02688387|4008604|FG020|STARTED|Part 3A, Washout Period 2 (10 Days)||0
3274509|NCT02688387|4008605|FG021|STARTED|Part 3A, Washout Period 2 (10 Days)||0
3274510|NCT02688387|4008584|FG000|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
3274511|NCT02688387|4008585|FG001|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
3274512|NCT02688387|4008586|FG002|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
3274513|NCT02688387|4008587|FG003|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
3274514|NCT02688387|4008588|FG004|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
3274515|NCT02688387|4008589|FG005|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
3274516|NCT02688387|4008590|FG006|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
3274517|NCT02688387|4008591|FG007|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
3274518|NCT02688387|4008592|FG008|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
3274519|NCT02688387|4008593|FG009|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
3274520|NCT02688387|4008594|FG010|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
3274521|NCT02688387|4008595|FG011|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
3274522|NCT02688387|4008596|FG012|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
3274523|NCT02688387|4008597|FG013|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
3274524|NCT02688387|4008598|FG014|COMPLETED|Part 3A, Washout Period 2 (10 Days)||8
3274525|NCT02688387|4008599|FG015|COMPLETED|Part 3A, Washout Period 2 (10 Days)||8
3274526|NCT02688387|4008600|FG016|COMPLETED|Part 3A, Washout Period 2 (10 Days)||8
3274527|NCT02688387|4008601|FG017|COMPLETED|Part 3A, Washout Period 2 (10 Days)||8
3274528|NCT02688387|4008602|FG018|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
3274529|NCT02688387|4008603|FG019|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
3274530|NCT02688387|4008604|FG020|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
3274531|NCT02688387|4008605|FG021|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
3274532|NCT02688387|4008584|FG000|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
3274533|NCT02688387|4008585|FG001|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
3274534|NCT02688387|4008586|FG002|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
3274535|NCT02688387|4008587|FG003|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
3274536|NCT02688387|4008588|FG004|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
3274537|NCT02688387|4008589|FG005|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
3274538|NCT02688387|4008590|FG006|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
3274539|NCT02688387|4008591|FG007|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
3274540|NCT02688387|4008592|FG008|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
3274541|NCT02688387|4008593|FG009|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
3274542|NCT02688387|4008594|FG010|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
3274543|NCT02688387|4008595|FG011|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
3274544|NCT02688387|4008596|FG012|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
3274545|NCT02688387|4008597|FG013|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
3274546|NCT02688387|4008598|FG014|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
3274547|NCT02688387|4008599|FG015|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
3274548|NCT02688387|4008600|FG016|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
3274549|NCT02688387|4008601|FG017|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
3274550|NCT02688387|4008602|FG018|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
3274551|NCT02688387|4008603|FG019|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
3274552|NCT02688387|4008604|FG020|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
3274553|NCT02688387|4008605|FG021|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
3274554|NCT02688387|4008584|FG000|STARTED|Part 3A, Period 3 (up to 6 Days)||0
3274555|NCT02688387|4008585|FG001|STARTED|Part 3A, Period 3 (up to 6 Days)||0
3274556|NCT02688387|4008586|FG002|STARTED|Part 3A, Period 3 (up to 6 Days)||0
3274557|NCT02688387|4008587|FG003|STARTED|Part 3A, Period 3 (up to 6 Days)||0
3274558|NCT02688387|4008588|FG004|STARTED|Part 3A, Period 3 (up to 6 Days)||0
3274559|NCT02688387|4008589|FG005|STARTED|Part 3A, Period 3 (up to 6 Days)||0
3274560|NCT02688387|4008590|FG006|STARTED|Part 3A, Period 3 (up to 6 Days)||0
3274561|NCT02688387|4008591|FG007|STARTED|Part 3A, Period 3 (up to 6 Days)||0
3274562|NCT02688387|4008592|FG008|STARTED|Part 3A, Period 3 (up to 6 Days)||0
2937092|NCT00620503|3649057|FG001|NOT COMPLETED|Screening (up to 21 Days)||0
2937093|NCT00620503|3649058|FG002|NOT COMPLETED|Screening (up to 21 Days)||0
2937094|NCT00620503|3649059|FG003|NOT COMPLETED|Screening (up to 21 Days)||0
2937095|NCT00620503|3649060|FG004|NOT COMPLETED|Screening (up to 21 Days)||0
2937096|NCT00620503|3649061|FG005|NOT COMPLETED|Screening (up to 21 Days)||0
2937097|NCT00620503|3649056|FG000|STARTED|Treatment Period 1 (TP1) (7days)||2
2937098|NCT00620503|3649057|FG001|STARTED|Treatment Period 1 (TP1) (7days)||2
2937099|NCT00620503|3649058|FG002|STARTED|Treatment Period 1 (TP1) (7days)||2
2937100|NCT00620503|3649059|FG003|STARTED|Treatment Period 1 (TP1) (7days)||2
2937101|NCT00620503|3649060|FG004|STARTED|Treatment Period 1 (TP1) (7days)||2
2937102|NCT00620503|3649061|FG005|STARTED|Treatment Period 1 (TP1) (7days)||2
2937103|NCT00620503|3649056|FG000|COMPLETED|Treatment Period 1 (TP1) (7days)||2
2937104|NCT00620503|3649057|FG001|COMPLETED|Treatment Period 1 (TP1) (7days)||2
2937105|NCT00620503|3649058|FG002|COMPLETED|Treatment Period 1 (TP1) (7days)||2
2937106|NCT00620503|3649059|FG003|COMPLETED|Treatment Period 1 (TP1) (7days)||2
2937107|NCT00620503|3649060|FG004|COMPLETED|Treatment Period 1 (TP1) (7days)||2
2937108|NCT00620503|3649061|FG005|COMPLETED|Treatment Period 1 (TP1) (7days)||2
2937109|NCT00620503|3649056|FG000|NOT COMPLETED|Treatment Period 1 (TP1) (7days)||0
2937110|NCT00620503|3649057|FG001|NOT COMPLETED|Treatment Period 1 (TP1) (7days)||0
2937111|NCT00620503|3649058|FG002|NOT COMPLETED|Treatment Period 1 (TP1) (7days)||0
2937112|NCT00620503|3649059|FG003|NOT COMPLETED|Treatment Period 1 (TP1) (7days)||0
2937113|NCT00620503|3649060|FG004|NOT COMPLETED|Treatment Period 1 (TP1) (7days)||0
2937114|NCT00620503|3649061|FG005|NOT COMPLETED|Treatment Period 1 (TP1) (7days)||0
2937115|NCT00620503|3649056|FG000|STARTED|Washout (at Least 1 Day)||2
2937116|NCT00620503|3649057|FG001|STARTED|Washout (at Least 1 Day)||2
2937117|NCT00620503|3649058|FG002|STARTED|Washout (at Least 1 Day)||2
2937118|NCT00620503|3649059|FG003|STARTED|Washout (at Least 1 Day)||2
2937119|NCT00620503|3649060|FG004|STARTED|Washout (at Least 1 Day)||2
2937120|NCT00620503|3649061|FG005|STARTED|Washout (at Least 1 Day)||2
2937121|NCT00620503|3649056|FG000|COMPLETED|Washout (at Least 1 Day)||2
2937122|NCT00620503|3649057|FG001|COMPLETED|Washout (at Least 1 Day)||2
2937123|NCT00620503|3649058|FG002|COMPLETED|Washout (at Least 1 Day)||2
2937124|NCT00620503|3649059|FG003|COMPLETED|Washout (at Least 1 Day)||2
2937125|NCT00620503|3649060|FG004|COMPLETED|Washout (at Least 1 Day)||2
2937126|NCT00620503|3649061|FG005|COMPLETED|Washout (at Least 1 Day)||2
2937127|NCT00620503|3649056|FG000|NOT COMPLETED|Washout (at Least 1 Day)||0
2937128|NCT00620503|3649057|FG001|NOT COMPLETED|Washout (at Least 1 Day)||0
2937129|NCT00620503|3649058|FG002|NOT COMPLETED|Washout (at Least 1 Day)||0
2937130|NCT00620503|3649059|FG003|NOT COMPLETED|Washout (at Least 1 Day)||0
2937131|NCT00620503|3649060|FG004|NOT COMPLETED|Washout (at Least 1 Day)||0
2937132|NCT00620503|3649061|FG005|NOT COMPLETED|Washout (at Least 1 Day)||0
2937133|NCT00620503|3649056|FG000|STARTED|Treatment Period 2 (TP2) (7days)||2
2937134|NCT00620503|3649057|FG001|STARTED|Treatment Period 2 (TP2) (7days)||2
2937135|NCT00620503|3649058|FG002|STARTED|Treatment Period 2 (TP2) (7days)||2
2937136|NCT00620503|3649059|FG003|STARTED|Treatment Period 2 (TP2) (7days)||2
2937137|NCT00620503|3649060|FG004|STARTED|Treatment Period 2 (TP2) (7days)||2
2937138|NCT00620503|3649061|FG005|STARTED|Treatment Period 2 (TP2) (7days)||2
2937139|NCT00620503|3649056|FG000|COMPLETED|Treatment Period 2 (TP2) (7days)||2
2937140|NCT00620503|3649057|FG001|COMPLETED|Treatment Period 2 (TP2) (7days)||2
2937141|NCT00620503|3649058|FG002|COMPLETED|Treatment Period 2 (TP2) (7days)||2
2937142|NCT00620503|3649059|FG003|COMPLETED|Treatment Period 2 (TP2) (7days)||2
2937143|NCT00620503|3649060|FG004|COMPLETED|Treatment Period 2 (TP2) (7days)||2
2937144|NCT00620503|3649061|FG005|COMPLETED|Treatment Period 2 (TP2) (7days)||2
2937145|NCT00620503|3649056|FG000|NOT COMPLETED|Treatment Period 2 (TP2) (7days)||0
2937146|NCT00620503|3649057|FG001|NOT COMPLETED|Treatment Period 2 (TP2) (7days)||0
2937147|NCT00620503|3649058|FG002|NOT COMPLETED|Treatment Period 2 (TP2) (7days)||0
2937148|NCT00620503|3649059|FG003|NOT COMPLETED|Treatment Period 2 (TP2) (7days)||0
2937149|NCT00620503|3649060|FG004|NOT COMPLETED|Treatment Period 2 (TP2) (7days)||0
2937150|NCT00620503|3649061|FG005|NOT COMPLETED|Treatment Period 2 (TP2) (7days)||0
2937151|NCT00620503|3649056|FG000|STARTED|Washout (at Least 1 Day)||2
2937152|NCT00620503|3649057|FG001|STARTED|Washout (at Least 1 Day)||2
2937153|NCT00620503|3649058|FG002|STARTED|Washout (at Least 1 Day)||2
2937154|NCT00620503|3649059|FG003|STARTED|Washout (at Least 1 Day)||2
2937155|NCT00620503|3649060|FG004|STARTED|Washout (at Least 1 Day)||2
2937156|NCT00620503|3649061|FG005|STARTED|Washout (at Least 1 Day)||2
2937157|NCT00620503|3649056|FG000|COMPLETED|Washout (at Least 1 Day)||2
2937158|NCT00620503|3649057|FG001|COMPLETED|Washout (at Least 1 Day)||2
2937159|NCT00620503|3649058|FG002|COMPLETED|Washout (at Least 1 Day)||2
2937160|NCT00620503|3649059|FG003|COMPLETED|Washout (at Least 1 Day)||2
2937161|NCT00620503|3649060|FG004|COMPLETED|Washout (at Least 1 Day)||2
2937162|NCT00620503|3649061|FG005|COMPLETED|Washout (at Least 1 Day)||2
2937163|NCT00620503|3649056|FG000|NOT COMPLETED|Washout (at Least 1 Day)||0
2937164|NCT00620503|3649057|FG001|NOT COMPLETED|Washout (at Least 1 Day)||0
2937165|NCT00620503|3649058|FG002|NOT COMPLETED|Washout (at Least 1 Day)||0
2937166|NCT00620503|3649059|FG003|NOT COMPLETED|Washout (at Least 1 Day)||0
2937167|NCT00620503|3649060|FG004|NOT COMPLETED|Washout (at Least 1 Day)||0
2937168|NCT00620503|3649061|FG005|NOT COMPLETED|Washout (at Least 1 Day)||0
2937169|NCT00620503|3649056|FG000|STARTED|Treatment Period 3 (TP3) (7 Days)||2
2937170|NCT00620503|3649057|FG001|STARTED|Treatment Period 3 (TP3) (7 Days)||2
2937171|NCT00620503|3649058|FG002|STARTED|Treatment Period 3 (TP3) (7 Days)||2
2937172|NCT00620503|3649059|FG003|STARTED|Treatment Period 3 (TP3) (7 Days)||2
2937173|NCT00620503|3649060|FG004|STARTED|Treatment Period 3 (TP3) (7 Days)||2
2937174|NCT00620503|3649061|FG005|STARTED|Treatment Period 3 (TP3) (7 Days)||2
3274563|NCT02688387|4008593|FG009|STARTED|Part 3A, Period 3 (up to 6 Days)||0
3274564|NCT02688387|4008594|FG010|STARTED|Part 3A, Period 3 (up to 6 Days)||0
3274565|NCT02688387|4008595|FG011|STARTED|Part 3A, Period 3 (up to 6 Days)||0
3274566|NCT02688387|4008596|FG012|STARTED|Part 3A, Period 3 (up to 6 Days)||0
3274567|NCT02688387|4008597|FG013|STARTED|Part 3A, Period 3 (up to 6 Days)||0
3274568|NCT02688387|4008598|FG014|STARTED|Part 3A, Period 3 (up to 6 Days)||8
3274569|NCT02688387|4008599|FG015|STARTED|Part 3A, Period 3 (up to 6 Days)||8
3274570|NCT02688387|4008600|FG016|STARTED|Part 3A, Period 3 (up to 6 Days)||8
3274571|NCT02688387|4008601|FG017|STARTED|Part 3A, Period 3 (up to 6 Days)||8
3274572|NCT02688387|4008602|FG018|STARTED|Part 3A, Period 3 (up to 6 Days)||0
3274573|NCT02688387|4008603|FG019|STARTED|Part 3A, Period 3 (up to 6 Days)||0
3274574|NCT02688387|4008604|FG020|STARTED|Part 3A, Period 3 (up to 6 Days)||0
3274575|NCT02688387|4008605|FG021|STARTED|Part 3A, Period 3 (up to 6 Days)||0
3274576|NCT02688387|4008584|FG000|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
3274577|NCT02688387|4008585|FG001|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
3274578|NCT02688387|4008586|FG002|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
3274579|NCT02688387|4008587|FG003|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
3274580|NCT02688387|4008588|FG004|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
3274581|NCT02688387|4008589|FG005|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
3274582|NCT02688387|4008590|FG006|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
3274583|NCT02688387|4008591|FG007|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
3274584|NCT02688387|4008592|FG008|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
3274585|NCT02688387|4008593|FG009|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
3274586|NCT02688387|4008594|FG010|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
3274587|NCT02688387|4008595|FG011|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
3274588|NCT02688387|4008596|FG012|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
3274589|NCT02688387|4008597|FG013|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
3274590|NCT02688387|4008598|FG014|COMPLETED|Part 3A, Period 3 (up to 6 Days)||8
3274591|NCT02688387|4008599|FG015|COMPLETED|Part 3A, Period 3 (up to 6 Days)||8
3274592|NCT02688387|4008600|FG016|COMPLETED|Part 3A, Period 3 (up to 6 Days)||8
3274593|NCT02688387|4008601|FG017|COMPLETED|Part 3A, Period 3 (up to 6 Days)||8
3274594|NCT02688387|4008602|FG018|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
3274595|NCT02688387|4008603|FG019|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
3274596|NCT02688387|4008604|FG020|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
3274597|NCT02688387|4008605|FG021|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
3274598|NCT02688387|4008584|FG000|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
3274599|NCT02688387|4008585|FG001|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
3274600|NCT02688387|4008586|FG002|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
3274601|NCT02688387|4008587|FG003|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
3274602|NCT02688387|4008588|FG004|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
3274603|NCT02688387|4008589|FG005|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
3274604|NCT02688387|4008590|FG006|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
3274605|NCT02688387|4008591|FG007|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
3274606|NCT02688387|4008592|FG008|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
3274607|NCT02688387|4008593|FG009|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
3274608|NCT02688387|4008594|FG010|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
3274609|NCT02688387|4008595|FG011|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
3274610|NCT02688387|4008596|FG012|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
3274611|NCT02688387|4008597|FG013|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
3274612|NCT02688387|4008598|FG014|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
3274613|NCT02688387|4008599|FG015|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
3274614|NCT02688387|4008600|FG016|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
3274615|NCT02688387|4008601|FG017|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
3274616|NCT02688387|4008602|FG018|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
3274617|NCT02688387|4008603|FG019|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
3274618|NCT02688387|4008604|FG020|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
3274619|NCT02688387|4008605|FG021|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
3274620|NCT02688387|4008584|FG000|STARTED|Part 3A, Washout Period 3 (10 Days)||0
3274621|NCT02688387|4008585|FG001|STARTED|Part 3A, Washout Period 3 (10 Days)||0
3274622|NCT02688387|4008586|FG002|STARTED|Part 3A, Washout Period 3 (10 Days)||0
3274623|NCT02688387|4008587|FG003|STARTED|Part 3A, Washout Period 3 (10 Days)||0
3274624|NCT02688387|4008588|FG004|STARTED|Part 3A, Washout Period 3 (10 Days)||0
3274625|NCT02688387|4008589|FG005|STARTED|Part 3A, Washout Period 3 (10 Days)||0
3274626|NCT02688387|4008590|FG006|STARTED|Part 3A, Washout Period 3 (10 Days)||0
3274627|NCT02688387|4008591|FG007|STARTED|Part 3A, Washout Period 3 (10 Days)||0
3274628|NCT02688387|4008592|FG008|STARTED|Part 3A, Washout Period 3 (10 Days)||0
3274629|NCT02688387|4008593|FG009|STARTED|Part 3A, Washout Period 3 (10 Days)||0
3274630|NCT02688387|4008594|FG010|STARTED|Part 3A, Washout Period 3 (10 Days)||0
3274631|NCT02688387|4008595|FG011|STARTED|Part 3A, Washout Period 3 (10 Days)||0
3274632|NCT02688387|4008596|FG012|STARTED|Part 3A, Washout Period 3 (10 Days)||0
3274633|NCT02688387|4008597|FG013|STARTED|Part 3A, Washout Period 3 (10 Days)||0
3274634|NCT02688387|4008598|FG014|STARTED|Part 3A, Washout Period 3 (10 Days)||8
3274635|NCT02688387|4008599|FG015|STARTED|Part 3A, Washout Period 3 (10 Days)||8
3274636|NCT02688387|4008600|FG016|STARTED|Part 3A, Washout Period 3 (10 Days)||8
3274637|NCT02688387|4008601|FG017|STARTED|Part 3A, Washout Period 3 (10 Days)||8
2937175|NCT00620503|3649056|FG000|COMPLETED|Treatment Period 3 (TP3) (7 Days)||2
2937176|NCT00620503|3649057|FG001|COMPLETED|Treatment Period 3 (TP3) (7 Days)||2
3274638|NCT02688387|4008602|FG018|STARTED|Part 3A, Washout Period 3 (10 Days)||0
3274639|NCT02688387|4008603|FG019|STARTED|Part 3A, Washout Period 3 (10 Days)||0
3274640|NCT02688387|4008604|FG020|STARTED|Part 3A, Washout Period 3 (10 Days)||0
3274641|NCT02688387|4008605|FG021|STARTED|Part 3A, Washout Period 3 (10 Days)||0
3274642|NCT02688387|4008584|FG000|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
3274643|NCT02688387|4008585|FG001|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
3274644|NCT02688387|4008586|FG002|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
3274645|NCT02688387|4008587|FG003|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
3274646|NCT02688387|4008588|FG004|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
3274647|NCT02688387|4008589|FG005|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
3274648|NCT02688387|4008590|FG006|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
3274649|NCT02688387|4008591|FG007|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
3274650|NCT02688387|4008592|FG008|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
3274651|NCT02688387|4008593|FG009|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
3274652|NCT02688387|4008594|FG010|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
3274653|NCT02688387|4008595|FG011|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
3274654|NCT02688387|4008596|FG012|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
3274655|NCT02688387|4008597|FG013|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
3274656|NCT02688387|4008598|FG014|COMPLETED|Part 3A, Washout Period 3 (10 Days)||8
3274657|NCT02688387|4008599|FG015|COMPLETED|Part 3A, Washout Period 3 (10 Days)||8
3274658|NCT02688387|4008600|FG016|COMPLETED|Part 3A, Washout Period 3 (10 Days)||8
3274659|NCT02688387|4008601|FG017|COMPLETED|Part 3A, Washout Period 3 (10 Days)||8
3274660|NCT02688387|4008602|FG018|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
3274661|NCT02688387|4008603|FG019|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
3274662|NCT02688387|4008604|FG020|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
3274663|NCT02688387|4008605|FG021|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
3274664|NCT02688387|4008584|FG000|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
3274665|NCT02688387|4008585|FG001|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
3274666|NCT02688387|4008586|FG002|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
3274667|NCT02688387|4008587|FG003|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
3274668|NCT02688387|4008588|FG004|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
3274669|NCT02688387|4008589|FG005|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
3274670|NCT02688387|4008590|FG006|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
3274671|NCT02688387|4008591|FG007|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
3274672|NCT02688387|4008592|FG008|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
3274673|NCT02688387|4008593|FG009|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
3274674|NCT02688387|4008594|FG010|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
3274675|NCT02688387|4008595|FG011|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
3274676|NCT02688387|4008596|FG012|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
3274677|NCT02688387|4008597|FG013|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
3274678|NCT02688387|4008598|FG014|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
3274679|NCT02688387|4008599|FG015|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
3274680|NCT02688387|4008600|FG016|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
3274681|NCT02688387|4008601|FG017|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
3274682|NCT02688387|4008602|FG018|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
3274683|NCT02688387|4008603|FG019|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
3274684|NCT02688387|4008604|FG020|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
3274685|NCT02688387|4008605|FG021|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
3274686|NCT02688387|4008584|FG000|STARTED|Part 3A, Period 4 (up to 6 Days)||0
3274687|NCT02688387|4008585|FG001|STARTED|Part 3A, Period 4 (up to 6 Days)||0
3274688|NCT02688387|4008586|FG002|STARTED|Part 3A, Period 4 (up to 6 Days)||0
3274689|NCT02688387|4008587|FG003|STARTED|Part 3A, Period 4 (up to 6 Days)||0
3274690|NCT02688387|4008588|FG004|STARTED|Part 3A, Period 4 (up to 6 Days)||0
3274691|NCT02688387|4008589|FG005|STARTED|Part 3A, Period 4 (up to 6 Days)||0
3274692|NCT02688387|4008590|FG006|STARTED|Part 3A, Period 4 (up to 6 Days)||0
3274693|NCT02688387|4008591|FG007|STARTED|Part 3A, Period 4 (up to 6 Days)||0
3274694|NCT02688387|4008592|FG008|STARTED|Part 3A, Period 4 (up to 6 Days)||0
3274695|NCT02688387|4008593|FG009|STARTED|Part 3A, Period 4 (up to 6 Days)||0
3274696|NCT02688387|4008594|FG010|STARTED|Part 3A, Period 4 (up to 6 Days)||0
3274697|NCT02688387|4008595|FG011|STARTED|Part 3A, Period 4 (up to 6 Days)||0
3274698|NCT02688387|4008596|FG012|STARTED|Part 3A, Period 4 (up to 6 Days)||0
3274699|NCT02688387|4008597|FG013|STARTED|Part 3A, Period 4 (up to 6 Days)||0
3274700|NCT02688387|4008598|FG014|STARTED|Part 3A, Period 4 (up to 6 Days)||8
3274701|NCT02688387|4008599|FG015|STARTED|Part 3A, Period 4 (up to 6 Days)||8
3274702|NCT02688387|4008600|FG016|STARTED|Part 3A, Period 4 (up to 6 Days)||8
3274703|NCT02688387|4008601|FG017|STARTED|Part 3A, Period 4 (up to 6 Days)||8
3274704|NCT02688387|4008602|FG018|STARTED|Part 3A, Period 4 (up to 6 Days)||0
3274705|NCT02688387|4008603|FG019|STARTED|Part 3A, Period 4 (up to 6 Days)||0
3274706|NCT02688387|4008604|FG020|STARTED|Part 3A, Period 4 (up to 6 Days)||0
3274707|NCT02688387|4008605|FG021|STARTED|Part 3A, Period 4 (up to 6 Days)||0
3274708|NCT02688387|4008584|FG000|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
3274709|NCT02688387|4008585|FG001|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
3274710|NCT02688387|4008586|FG002|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
3274711|NCT02688387|4008587|FG003|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
2937177|NCT00620503|3649058|FG002|COMPLETED|Treatment Period 3 (TP3) (7 Days)||2
2937178|NCT00620503|3649059|FG003|COMPLETED|Treatment Period 3 (TP3) (7 Days)||2
2937179|NCT00620503|3649060|FG004|COMPLETED|Treatment Period 3 (TP3) (7 Days)||2
2937180|NCT00620503|3649061|FG005|COMPLETED|Treatment Period 3 (TP3) (7 Days)||2
2937181|NCT00620503|3649056|FG000|NOT COMPLETED|Treatment Period 3 (TP3) (7 Days)||0
2937182|NCT00620503|3649057|FG001|NOT COMPLETED|Treatment Period 3 (TP3) (7 Days)||0
2937183|NCT00620503|3649058|FG002|NOT COMPLETED|Treatment Period 3 (TP3) (7 Days)||0
2937184|NCT00620503|3649059|FG003|NOT COMPLETED|Treatment Period 3 (TP3) (7 Days)||0
2937185|NCT00620503|3649060|FG004|NOT COMPLETED|Treatment Period 3 (TP3) (7 Days)||0
2937186|NCT00620503|3649061|FG005|NOT COMPLETED|Treatment Period 3 (TP3) (7 Days)||0
2937187|NCT00620503|3649056|FG000|STARTED|Follow-up (up to 14 Days)||2
2937188|NCT00620503|3649057|FG001|STARTED|Follow-up (up to 14 Days)||2
2937189|NCT00620503|3649058|FG002|STARTED|Follow-up (up to 14 Days)||2
2937190|NCT00620503|3649059|FG003|STARTED|Follow-up (up to 14 Days)||2
3274712|NCT02688387|4008588|FG004|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
3274713|NCT02688387|4008589|FG005|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
3274714|NCT02688387|4008590|FG006|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
3274715|NCT02688387|4008591|FG007|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
3274716|NCT02688387|4008592|FG008|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
3274717|NCT02688387|4008593|FG009|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
3274718|NCT02688387|4008594|FG010|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
3274719|NCT02688387|4008595|FG011|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
3274720|NCT02688387|4008596|FG012|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
3274721|NCT02688387|4008597|FG013|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
3274722|NCT02688387|4008598|FG014|COMPLETED|Part 3A, Period 4 (up to 6 Days)||8
3274723|NCT02688387|4008599|FG015|COMPLETED|Part 3A, Period 4 (up to 6 Days)||8
3274724|NCT02688387|4008600|FG016|COMPLETED|Part 3A, Period 4 (up to 6 Days)||8
3274725|NCT02688387|4008601|FG017|COMPLETED|Part 3A, Period 4 (up to 6 Days)||8
3274726|NCT02688387|4008602|FG018|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
3274727|NCT02688387|4008603|FG019|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
3274728|NCT02688387|4008604|FG020|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
3274729|NCT02688387|4008605|FG021|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
3274730|NCT02688387|4008584|FG000|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
3274731|NCT02688387|4008585|FG001|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
3274732|NCT02688387|4008586|FG002|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
3274733|NCT02688387|4008587|FG003|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
3274734|NCT02688387|4008588|FG004|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
3274735|NCT02688387|4008589|FG005|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
3274736|NCT02688387|4008590|FG006|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
3274737|NCT02688387|4008591|FG007|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
3274738|NCT02688387|4008592|FG008|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
3274739|NCT02688387|4008593|FG009|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
3274740|NCT02688387|4008594|FG010|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
3274741|NCT02688387|4008595|FG011|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
3274742|NCT02688387|4008596|FG012|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
3274743|NCT02688387|4008597|FG013|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
3274744|NCT02688387|4008598|FG014|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
3274745|NCT02688387|4008599|FG015|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
3274746|NCT02688387|4008600|FG016|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
3274747|NCT02688387|4008601|FG017|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
3274748|NCT02688387|4008602|FG018|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
3274749|NCT02688387|4008603|FG019|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
3274750|NCT02688387|4008604|FG020|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
3274751|NCT02688387|4008605|FG021|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
3274752|NCT02688387|4008584|FG000|STARTED|Part 3B, Period 1 (up to 6 Days)||0
3274753|NCT02688387|4008585|FG001|STARTED|Part 3B, Period 1 (up to 6 Days)||0
3274754|NCT02688387|4008586|FG002|STARTED|Part 3B, Period 1 (up to 6 Days)||0
3274755|NCT02688387|4008587|FG003|STARTED|Part 3B, Period 1 (up to 6 Days)||0
3274756|NCT02688387|4008588|FG004|STARTED|Part 3B, Period 1 (up to 6 Days)||0
3274757|NCT02688387|4008589|FG005|STARTED|Part 3B, Period 1 (up to 6 Days)||0
3274758|NCT02688387|4008590|FG006|STARTED|Part 3B, Period 1 (up to 6 Days)||0
3274759|NCT02688387|4008591|FG007|STARTED|Part 3B, Period 1 (up to 6 Days)||0
3274760|NCT02688387|4008592|FG008|STARTED|Part 3B, Period 1 (up to 6 Days)||0
3274761|NCT02688387|4008593|FG009|STARTED|Part 3B, Period 1 (up to 6 Days)||0
3274762|NCT02688387|4008594|FG010|STARTED|Part 3B, Period 1 (up to 6 Days)||0
3274763|NCT02688387|4008595|FG011|STARTED|Part 3B, Period 1 (up to 6 Days)||0
3274764|NCT02688387|4008596|FG012|STARTED|Part 3B, Period 1 (up to 6 Days)||0
3274765|NCT02688387|4008597|FG013|STARTED|Part 3B, Period 1 (up to 6 Days)||0
3274766|NCT02688387|4008598|FG014|STARTED|Part 3B, Period 1 (up to 6 Days)||0
3274767|NCT02688387|4008599|FG015|STARTED|Part 3B, Period 1 (up to 6 Days)||0
3274768|NCT02688387|4008600|FG016|STARTED|Part 3B, Period 1 (up to 6 Days)||0
3274769|NCT02688387|4008601|FG017|STARTED|Part 3B, Period 1 (up to 6 Days)||0
3274770|NCT02688387|4008602|FG018|STARTED|Part 3B, Period 1 (up to 6 Days)||8
3274771|NCT02688387|4008603|FG019|STARTED|Part 3B, Period 1 (up to 6 Days)||8
3274772|NCT02688387|4008604|FG020|STARTED|Part 3B, Period 1 (up to 6 Days)||8
3274773|NCT02688387|4008605|FG021|STARTED|Part 3B, Period 1 (up to 6 Days)||8
3274774|NCT02688387|4008584|FG000|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
2937191|NCT00620503|3649060|FG004|STARTED|Follow-up (up to 14 Days)||2
2937192|NCT00620503|3649061|FG005|STARTED|Follow-up (up to 14 Days)||2
2937193|NCT00620503|3649056|FG000|COMPLETED|Follow-up (up to 14 Days)||2
2937194|NCT00620503|3649057|FG001|COMPLETED|Follow-up (up to 14 Days)||2
2937195|NCT00620503|3649058|FG002|COMPLETED|Follow-up (up to 14 Days)||2
2937196|NCT00620503|3649059|FG003|COMPLETED|Follow-up (up to 14 Days)||2
2937197|NCT00620503|3649060|FG004|COMPLETED|Follow-up (up to 14 Days)||2
2937198|NCT00620503|3649061|FG005|COMPLETED|Follow-up (up to 14 Days)||2
2937199|NCT00620503|3649056|FG000|NOT COMPLETED|Follow-up (up to 14 Days)||0
2937200|NCT00620503|3649057|FG001|NOT COMPLETED|Follow-up (up to 14 Days)||0
2937201|NCT00620503|3649058|FG002|NOT COMPLETED|Follow-up (up to 14 Days)||0
2937202|NCT00620503|3649059|FG003|NOT COMPLETED|Follow-up (up to 14 Days)||0
3274775|NCT02688387|4008585|FG001|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
3274776|NCT02688387|4008586|FG002|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
3274777|NCT02688387|4008587|FG003|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
3274778|NCT02688387|4008588|FG004|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
3274779|NCT02688387|4008589|FG005|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
3274780|NCT02688387|4008590|FG006|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
3274781|NCT02688387|4008591|FG007|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
3274782|NCT02688387|4008592|FG008|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
3274783|NCT02688387|4008593|FG009|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
3274784|NCT02688387|4008594|FG010|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
3274785|NCT02688387|4008595|FG011|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
3274786|NCT02688387|4008596|FG012|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
3274787|NCT02688387|4008597|FG013|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
3274788|NCT02688387|4008598|FG014|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
3274789|NCT02688387|4008599|FG015|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
3274790|NCT02688387|4008600|FG016|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
3274791|NCT02688387|4008601|FG017|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
3274792|NCT02688387|4008602|FG018|COMPLETED|Part 3B, Period 1 (up to 6 Days)||8
3274793|NCT02688387|4008603|FG019|COMPLETED|Part 3B, Period 1 (up to 6 Days)||8
3274794|NCT02688387|4008604|FG020|COMPLETED|Part 3B, Period 1 (up to 6 Days)||8
3274795|NCT02688387|4008605|FG021|COMPLETED|Part 3B, Period 1 (up to 6 Days)||8
3274796|NCT02688387|4008584|FG000|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
3274797|NCT02688387|4008585|FG001|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
3274798|NCT02688387|4008586|FG002|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
3274799|NCT02688387|4008587|FG003|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
3274800|NCT02688387|4008588|FG004|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
3274801|NCT02688387|4008589|FG005|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
3274802|NCT02688387|4008590|FG006|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
3274803|NCT02688387|4008591|FG007|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
3274804|NCT02688387|4008592|FG008|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
3274805|NCT02688387|4008593|FG009|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
3274806|NCT02688387|4008594|FG010|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
3274807|NCT02688387|4008595|FG011|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
3274808|NCT02688387|4008596|FG012|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
3274809|NCT02688387|4008597|FG013|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
3274810|NCT02688387|4008598|FG014|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
3274811|NCT02688387|4008599|FG015|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
3274812|NCT02688387|4008600|FG016|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
3274813|NCT02688387|4008601|FG017|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
3274814|NCT02688387|4008602|FG018|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
3274815|NCT02688387|4008603|FG019|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
3274816|NCT02688387|4008604|FG020|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
3274817|NCT02688387|4008605|FG021|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
3274818|NCT02688387|4008584|FG000|STARTED|Part 3B, Washout Period 1 (10 Days)||0
3274819|NCT02688387|4008585|FG001|STARTED|Part 3B, Washout Period 1 (10 Days)||0
3274820|NCT02688387|4008586|FG002|STARTED|Part 3B, Washout Period 1 (10 Days)||0
3274821|NCT02688387|4008587|FG003|STARTED|Part 3B, Washout Period 1 (10 Days)||0
3274822|NCT02688387|4008588|FG004|STARTED|Part 3B, Washout Period 1 (10 Days)||0
3274823|NCT02688387|4008589|FG005|STARTED|Part 3B, Washout Period 1 (10 Days)||0
3274824|NCT02688387|4008590|FG006|STARTED|Part 3B, Washout Period 1 (10 Days)||0
3274825|NCT02688387|4008591|FG007|STARTED|Part 3B, Washout Period 1 (10 Days)||0
3274826|NCT02688387|4008592|FG008|STARTED|Part 3B, Washout Period 1 (10 Days)||0
3274827|NCT02688387|4008593|FG009|STARTED|Part 3B, Washout Period 1 (10 Days)||0
3274828|NCT02688387|4008594|FG010|STARTED|Part 3B, Washout Period 1 (10 Days)||0
3274829|NCT02688387|4008595|FG011|STARTED|Part 3B, Washout Period 1 (10 Days)||0
3274830|NCT02688387|4008596|FG012|STARTED|Part 3B, Washout Period 1 (10 Days)||0
3274831|NCT02688387|4008597|FG013|STARTED|Part 3B, Washout Period 1 (10 Days)||0
3274832|NCT02688387|4008598|FG014|STARTED|Part 3B, Washout Period 1 (10 Days)||0
3274833|NCT02688387|4008599|FG015|STARTED|Part 3B, Washout Period 1 (10 Days)||0
3274834|NCT02688387|4008600|FG016|STARTED|Part 3B, Washout Period 1 (10 Days)||0
3274835|NCT02688387|4008601|FG017|STARTED|Part 3B, Washout Period 1 (10 Days)||0
3274836|NCT02688387|4008602|FG018|STARTED|Part 3B, Washout Period 1 (10 Days)||8
3274837|NCT02688387|4008603|FG019|STARTED|Part 3B, Washout Period 1 (10 Days)||8
3274838|NCT02688387|4008604|FG020|STARTED|Part 3B, Washout Period 1 (10 Days)||8
2937203|NCT00620503|3649060|FG004|NOT COMPLETED|Follow-up (up to 14 Days)||0
2937204|NCT00620503|3649061|FG005|NOT COMPLETED|Follow-up (up to 14 Days)||0
2937205|NCT00620542|3649071|FG000|STARTED|Part A (Run-in - 2 Weeks)|Of 1167 randomized, N=783 received treatment.|1167
2937206|NCT00620542|3649072|FG001|STARTED|Part A (Run-in - 2 Weeks)|Of 1166 randomized, N=795 received treatment.|1166
2937207|NCT00620542|3649073|FG002|STARTED|Part A (Run-in - 2 Weeks)||0
2937208|NCT00620542|3649074|FG003|STARTED|Part A (Run-in - 2 Weeks)||0
2937209|NCT00620542|3649071|FG000|Received Treatment|Part A (Run-in - 2 Weeks)||783
2937210|NCT00620542|3649072|FG001|Received Treatment|Part A (Run-in - 2 Weeks)||795
2937211|NCT00620542|3649073|FG002|Received Treatment|Part A (Run-in - 2 Weeks)||0
2937212|NCT00620542|3649074|FG003|Received Treatment|Part A (Run-in - 2 Weeks)||0
2937213|NCT00620542|3649071|FG000|COMPLETED|Part A (Run-in - 2 Weeks)||695
2937214|NCT00620542|3649072|FG001|COMPLETED|Part A (Run-in - 2 Weeks)||690
2937215|NCT00620542|3649073|FG002|COMPLETED|Part A (Run-in - 2 Weeks)||0
2937216|NCT00620542|3649074|FG003|COMPLETED|Part A (Run-in - 2 Weeks)||0
2937217|NCT00620542|3649071|FG000|NOT COMPLETED|Part A (Run-in - 2 Weeks)||472
2937218|NCT00620542|3649072|FG001|NOT COMPLETED|Part A (Run-in - 2 Weeks)||476
2937219|NCT00620542|3649073|FG002|NOT COMPLETED|Part A (Run-in - 2 Weeks)||0
2937220|NCT00620542|3649074|FG003|NOT COMPLETED|Part A (Run-in - 2 Weeks)||0
2937221|NCT00620542|3649071|FG000|STARTED|Part B (2 Year Core Study)||0
2937222|NCT00620542|3649072|FG001|STARTED|Part B (2 Year Core Study)||0
2937223|NCT00620542|3649073|FG002|STARTED|Part B (2 Year Core Study)|Of 694 patients randomized, N=691 received treatment.|694
2937224|NCT00620542|3649074|FG003|STARTED|Part B (2 Year Core Study)|Of 691 patients randomized, N=689 received treatment.|691
2937225|NCT00620542|3649071|FG000|Received Treatment|Part B (2 Year Core Study)||0
2937226|NCT00620542|3649072|FG001|Received Treatment|Part B (2 Year Core Study)||0
3274839|NCT02688387|4008605|FG021|STARTED|Part 3B, Washout Period 1 (10 Days)||8
3274840|NCT02688387|4008584|FG000|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
3274841|NCT02688387|4008585|FG001|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
3274842|NCT02688387|4008586|FG002|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
3274843|NCT02688387|4008587|FG003|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
3274844|NCT02688387|4008588|FG004|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
3274845|NCT02688387|4008589|FG005|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
3274846|NCT02688387|4008590|FG006|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
3274847|NCT02688387|4008591|FG007|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
3274848|NCT02688387|4008592|FG008|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
3274849|NCT02688387|4008593|FG009|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
3274850|NCT02688387|4008594|FG010|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
3274851|NCT02688387|4008595|FG011|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
3274852|NCT02688387|4008596|FG012|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
3274853|NCT02688387|4008597|FG013|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
3274854|NCT02688387|4008598|FG014|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
3274855|NCT02688387|4008599|FG015|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
3274856|NCT02688387|4008600|FG016|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
3274857|NCT02688387|4008601|FG017|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
3274858|NCT02688387|4008602|FG018|COMPLETED|Part 3B, Washout Period 1 (10 Days)||8
3274859|NCT02688387|4008603|FG019|COMPLETED|Part 3B, Washout Period 1 (10 Days)||8
3274860|NCT02688387|4008604|FG020|COMPLETED|Part 3B, Washout Period 1 (10 Days)||8
3274861|NCT02688387|4008605|FG021|COMPLETED|Part 3B, Washout Period 1 (10 Days)||8
3274862|NCT02688387|4008584|FG000|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
3274863|NCT02688387|4008585|FG001|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
3274864|NCT02688387|4008586|FG002|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
3274865|NCT02688387|4008587|FG003|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
3274866|NCT02688387|4008588|FG004|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
3274867|NCT02688387|4008589|FG005|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
3274868|NCT02688387|4008590|FG006|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
3274869|NCT02688387|4008591|FG007|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
3274870|NCT02688387|4008592|FG008|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
3274871|NCT02688387|4008593|FG009|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
3274872|NCT02688387|4008594|FG010|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
3274873|NCT02688387|4008595|FG011|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
3274874|NCT02688387|4008596|FG012|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
3274875|NCT02688387|4008597|FG013|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
3274876|NCT02688387|4008598|FG014|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
3274877|NCT02688387|4008599|FG015|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
3274878|NCT02688387|4008600|FG016|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
3274879|NCT02688387|4008601|FG017|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
3274880|NCT02688387|4008602|FG018|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
3274881|NCT02688387|4008603|FG019|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
3274882|NCT02688387|4008604|FG020|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
3274883|NCT02688387|4008605|FG021|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
3274884|NCT02688387|4008584|FG000|STARTED|Part 3B, Period 2 (up to 6 Days)||0
3274885|NCT02688387|4008585|FG001|STARTED|Part 3B, Period 2 (up to 6 Days)||0
3274886|NCT02688387|4008586|FG002|STARTED|Part 3B, Period 2 (up to 6 Days)||0
3274887|NCT02688387|4008587|FG003|STARTED|Part 3B, Period 2 (up to 6 Days)||0
3274888|NCT02688387|4008588|FG004|STARTED|Part 3B, Period 2 (up to 6 Days)||0
2937227|NCT00620542|3649073|FG002|Received Treatment|Part B (2 Year Core Study)||691
2937228|NCT00620542|3649074|FG003|Received Treatment|Part B (2 Year Core Study)||689
2937229|NCT00620542|3649071|FG000|Intent-to-treat Population|Part B (2 Year Core Study)||0
2937230|NCT00620542|3649072|FG001|Intent-to-treat Population|Part B (2 Year Core Study)||0
2937231|NCT00620542|3649073|FG002|Intent-to-treat Population|Part B (2 Year Core Study)|Patients who received treatment and had a baseline and end of study (Week 104) IVUS|520
2937232|NCT00620542|3649074|FG003|Intent-to-treat Population|Part B (2 Year Core Study)|Patients who received treatment and had a baseline and end of study (Week 104) IVUS|519
2937233|NCT00620542|3649071|FG000|COMPLETED|Part B (2 Year Core Study)||0
2937234|NCT00620542|3649072|FG001|COMPLETED|Part B (2 Year Core Study)||0
2937235|NCT00620542|3649073|FG002|COMPLETED|Part B (2 Year Core Study)||546
2937236|NCT00620542|3649074|FG003|COMPLETED|Part B (2 Year Core Study)||547
2937237|NCT00620542|3649071|FG000|NOT COMPLETED|Part B (2 Year Core Study)||0
2937238|NCT00620542|3649072|FG001|NOT COMPLETED|Part B (2 Year Core Study)||0
2937239|NCT00620542|3649073|FG002|NOT COMPLETED|Part B (2 Year Core Study)||148
2937240|NCT00620542|3649074|FG003|NOT COMPLETED|Part B (2 Year Core Study)||144
2937241|NCT00620555|3649082|FG000|STARTED|Overall Study||65
2937242|NCT00620555|3649082|FG000|COMPLETED|Overall Study||44
2937243|NCT00620555|3649082|FG000|NOT COMPLETED|Overall Study||21
2937244|NCT00620659|3649086|FG000|STARTED|Treatment Period 1||21
2937245|NCT00620659|3649087|FG001|STARTED|Treatment Period 1||21
2937246|NCT00620659|3649088|FG002|STARTED|Treatment Period 1||21
2937247|NCT00620659|3649089|FG003|STARTED|Treatment Period 1||21
2937248|NCT00620659|3649090|FG004|STARTED|Treatment Period 1||21
2937249|NCT00620659|3649091|FG005|STARTED|Treatment Period 1||20
2937250|NCT00620659|3649086|FG000|COMPLETED|Treatment Period 1||18
2937251|NCT00620659|3649087|FG001|COMPLETED|Treatment Period 1||21
2937252|NCT00620659|3649088|FG002|COMPLETED|Treatment Period 1||20
2937253|NCT00620659|3649089|FG003|COMPLETED|Treatment Period 1|1 patient discontinued from MK0249, but continued in following periods, & completed the study|18
2937254|NCT00620659|3649090|FG004|COMPLETED|Treatment Period 1||20
2937255|NCT00620659|3649091|FG005|COMPLETED|Treatment Period 1||20
2937256|NCT00620659|3649086|FG000|NOT COMPLETED|Treatment Period 1||3
2937257|NCT00620659|3649087|FG001|NOT COMPLETED|Treatment Period 1||0
2937258|NCT00620659|3649088|FG002|NOT COMPLETED|Treatment Period 1||1
2937259|NCT00620659|3649089|FG003|NOT COMPLETED|Treatment Period 1||3
2937260|NCT00620659|3649090|FG004|NOT COMPLETED|Treatment Period 1||1
2937261|NCT00620659|3649091|FG005|NOT COMPLETED|Treatment Period 1||0
2937262|NCT00620659|3649086|FG000|STARTED|Placebo Washout Period 1||18
2937263|NCT00620659|3649087|FG001|STARTED|Placebo Washout Period 1||21
2937264|NCT00620659|3649088|FG002|STARTED|Placebo Washout Period 1||20
2937265|NCT00620659|3649089|FG003|STARTED|Placebo Washout Period 1||19
2937266|NCT00620659|3649090|FG004|STARTED|Placebo Washout Period 1||20
2937267|NCT00620659|3649091|FG005|STARTED|Placebo Washout Period 1||20
2937268|NCT00620659|3649086|FG000|COMPLETED|Placebo Washout Period 1||18
2937269|NCT00620659|3649087|FG001|COMPLETED|Placebo Washout Period 1||21
2937270|NCT00620659|3649088|FG002|COMPLETED|Placebo Washout Period 1||20
2937271|NCT00620659|3649089|FG003|COMPLETED|Placebo Washout Period 1||18
2937272|NCT00620659|3649090|FG004|COMPLETED|Placebo Washout Period 1||20
2937273|NCT00620659|3649091|FG005|COMPLETED|Placebo Washout Period 1||20
2937274|NCT00620659|3649086|FG000|NOT COMPLETED|Placebo Washout Period 1||0
2937275|NCT00620659|3649087|FG001|NOT COMPLETED|Placebo Washout Period 1||0
2937276|NCT00620659|3649088|FG002|NOT COMPLETED|Placebo Washout Period 1||0
2937277|NCT00620659|3649089|FG003|NOT COMPLETED|Placebo Washout Period 1||1
2937278|NCT00620659|3649090|FG004|NOT COMPLETED|Placebo Washout Period 1||0
2937279|NCT00620659|3649091|FG005|NOT COMPLETED|Placebo Washout Period 1||0
2937280|NCT00620659|3649086|FG000|STARTED|Treatment Period 2||18
2937281|NCT00620659|3649087|FG001|STARTED|Treatment Period 2||21
3274889|NCT02688387|4008589|FG005|STARTED|Part 3B, Period 2 (up to 6 Days)||0
3274890|NCT02688387|4008590|FG006|STARTED|Part 3B, Period 2 (up to 6 Days)||0
3274891|NCT02688387|4008591|FG007|STARTED|Part 3B, Period 2 (up to 6 Days)||0
3274892|NCT02688387|4008592|FG008|STARTED|Part 3B, Period 2 (up to 6 Days)||0
3274893|NCT02688387|4008593|FG009|STARTED|Part 3B, Period 2 (up to 6 Days)||0
3274894|NCT02688387|4008594|FG010|STARTED|Part 3B, Period 2 (up to 6 Days)||0
3274895|NCT02688387|4008595|FG011|STARTED|Part 3B, Period 2 (up to 6 Days)||0
3274896|NCT02688387|4008596|FG012|STARTED|Part 3B, Period 2 (up to 6 Days)||0
3274897|NCT02688387|4008597|FG013|STARTED|Part 3B, Period 2 (up to 6 Days)||0
3274898|NCT02688387|4008598|FG014|STARTED|Part 3B, Period 2 (up to 6 Days)||0
3274899|NCT02688387|4008599|FG015|STARTED|Part 3B, Period 2 (up to 6 Days)||0
3274900|NCT02688387|4008600|FG016|STARTED|Part 3B, Period 2 (up to 6 Days)||0
3274901|NCT02688387|4008601|FG017|STARTED|Part 3B, Period 2 (up to 6 Days)||0
3274902|NCT02688387|4008602|FG018|STARTED|Part 3B, Period 2 (up to 6 Days)||8
3274903|NCT02688387|4008603|FG019|STARTED|Part 3B, Period 2 (up to 6 Days)||8
3274904|NCT02688387|4008604|FG020|STARTED|Part 3B, Period 2 (up to 6 Days)||8
3274905|NCT02688387|4008605|FG021|STARTED|Part 3B, Period 2 (up to 6 Days)||8
3274906|NCT02688387|4008584|FG000|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
3274907|NCT02688387|4008585|FG001|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
3274908|NCT02688387|4008586|FG002|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
3274909|NCT02688387|4008587|FG003|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
2937282|NCT00620659|3649088|FG002|STARTED|Treatment Period 2||20
2937283|NCT00620659|3649089|FG003|STARTED|Treatment Period 2||18
2937284|NCT00620659|3649090|FG004|STARTED|Treatment Period 2||20
2937285|NCT00620659|3649091|FG005|STARTED|Treatment Period 2||20
3274910|NCT02688387|4008588|FG004|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
2937286|NCT00620659|3649086|FG000|COMPLETED|Treatment Period 2||18
2937287|NCT00620659|3649087|FG001|COMPLETED|Treatment Period 2||18
2937288|NCT00620659|3649088|FG002|COMPLETED|Treatment Period 2||19
2937289|NCT00620659|3649089|FG003|COMPLETED|Treatment Period 2||18
2937290|NCT00620659|3649090|FG004|COMPLETED|Treatment Period 2||15
2937291|NCT00620659|3649091|FG005|COMPLETED|Treatment Period 2||20
2937292|NCT00620659|3649086|FG000|NOT COMPLETED|Treatment Period 2||0
2937293|NCT00620659|3649087|FG001|NOT COMPLETED|Treatment Period 2||3
2937294|NCT00620659|3649088|FG002|NOT COMPLETED|Treatment Period 2||1
2937295|NCT00620659|3649089|FG003|NOT COMPLETED|Treatment Period 2||0
2937296|NCT00620659|3649090|FG004|NOT COMPLETED|Treatment Period 2||5
2937297|NCT00620659|3649091|FG005|NOT COMPLETED|Treatment Period 2||0
2937298|NCT00620659|3649086|FG000|STARTED|Placebo Washout Period 2||18
2937299|NCT00620659|3649087|FG001|STARTED|Placebo Washout Period 2||18
2937300|NCT00620659|3649088|FG002|STARTED|Placebo Washout Period 2||19
3274911|NCT02688387|4008589|FG005|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
3274912|NCT02688387|4008590|FG006|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
3274913|NCT02688387|4008591|FG007|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
3274914|NCT02688387|4008592|FG008|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
3274915|NCT02688387|4008593|FG009|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
3274916|NCT02688387|4008594|FG010|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
3274917|NCT02688387|4008595|FG011|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
3274918|NCT02688387|4008596|FG012|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
3274919|NCT02688387|4008597|FG013|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
3274920|NCT02688387|4008598|FG014|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
3274921|NCT02688387|4008599|FG015|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
3274922|NCT02688387|4008600|FG016|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
3274923|NCT02688387|4008601|FG017|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
3274924|NCT02688387|4008602|FG018|COMPLETED|Part 3B, Period 2 (up to 6 Days)||8
3274925|NCT02688387|4008603|FG019|COMPLETED|Part 3B, Period 2 (up to 6 Days)||8
3274926|NCT02688387|4008604|FG020|COMPLETED|Part 3B, Period 2 (up to 6 Days)||8
3274927|NCT02688387|4008605|FG021|COMPLETED|Part 3B, Period 2 (up to 6 Days)||8
3274928|NCT02688387|4008584|FG000|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
3274929|NCT02688387|4008585|FG001|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
3274930|NCT02688387|4008586|FG002|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
3274931|NCT02688387|4008587|FG003|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
3274932|NCT02688387|4008588|FG004|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
3274933|NCT02688387|4008589|FG005|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
3274934|NCT02688387|4008590|FG006|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
3274935|NCT02688387|4008591|FG007|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
3274936|NCT02688387|4008592|FG008|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
3274937|NCT02688387|4008593|FG009|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
3274938|NCT02688387|4008594|FG010|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
3274939|NCT02688387|4008595|FG011|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
3274940|NCT02688387|4008596|FG012|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
3274941|NCT02688387|4008597|FG013|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
3274942|NCT02688387|4008598|FG014|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
3274943|NCT02688387|4008599|FG015|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
3274944|NCT02688387|4008600|FG016|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
3274945|NCT02688387|4008601|FG017|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
3274946|NCT02688387|4008602|FG018|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
3274947|NCT02688387|4008603|FG019|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
3274948|NCT02688387|4008604|FG020|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
3274949|NCT02688387|4008605|FG021|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
3274950|NCT02688387|4008584|FG000|STARTED|Part 3B, Washout Period 2 (10 Days)||0
3274951|NCT02688387|4008585|FG001|STARTED|Part 3B, Washout Period 2 (10 Days)||0
3274952|NCT02688387|4008586|FG002|STARTED|Part 3B, Washout Period 2 (10 Days)||0
3274953|NCT02688387|4008587|FG003|STARTED|Part 3B, Washout Period 2 (10 Days)||0
3274954|NCT02688387|4008588|FG004|STARTED|Part 3B, Washout Period 2 (10 Days)||0
3274955|NCT02688387|4008589|FG005|STARTED|Part 3B, Washout Period 2 (10 Days)||0
3274956|NCT02688387|4008590|FG006|STARTED|Part 3B, Washout Period 2 (10 Days)||0
3274957|NCT02688387|4008591|FG007|STARTED|Part 3B, Washout Period 2 (10 Days)||0
3274958|NCT02688387|4008592|FG008|STARTED|Part 3B, Washout Period 2 (10 Days)||0
3274959|NCT02688387|4008593|FG009|STARTED|Part 3B, Washout Period 2 (10 Days)||0
3274960|NCT02688387|4008594|FG010|STARTED|Part 3B, Washout Period 2 (10 Days)||0
3274961|NCT02688387|4008595|FG011|STARTED|Part 3B, Washout Period 2 (10 Days)||0
3274962|NCT02688387|4008596|FG012|STARTED|Part 3B, Washout Period 2 (10 Days)||0
3274963|NCT02688387|4008597|FG013|STARTED|Part 3B, Washout Period 2 (10 Days)||0
3274964|NCT02688387|4008598|FG014|STARTED|Part 3B, Washout Period 2 (10 Days)||0
3274965|NCT02688387|4008599|FG015|STARTED|Part 3B, Washout Period 2 (10 Days)||0
3274966|NCT02688387|4008600|FG016|STARTED|Part 3B, Washout Period 2 (10 Days)||0
3274967|NCT02688387|4008601|FG017|STARTED|Part 3B, Washout Period 2 (10 Days)||0
3274968|NCT02688387|4008602|FG018|STARTED|Part 3B, Washout Period 2 (10 Days)||8
2937301|NCT00620659|3649089|FG003|STARTED|Placebo Washout Period 2||18
2937302|NCT00620659|3649090|FG004|STARTED|Placebo Washout Period 2||15
2937303|NCT00620659|3649091|FG005|STARTED|Placebo Washout Period 2||20
2937304|NCT00620659|3649086|FG000|COMPLETED|Placebo Washout Period 2||16
2937305|NCT00620659|3649087|FG001|COMPLETED|Placebo Washout Period 2||18
2937306|NCT00620659|3649088|FG002|COMPLETED|Placebo Washout Period 2||19
3136751|NCT01714804|3862003|FG000|NOT COMPLETED|Overall Study||1
3274969|NCT02688387|4008603|FG019|STARTED|Part 3B, Washout Period 2 (10 Days)||8
3274970|NCT02688387|4008604|FG020|STARTED|Part 3B, Washout Period 2 (10 Days)||8
3274971|NCT02688387|4008605|FG021|STARTED|Part 3B, Washout Period 2 (10 Days)||8
3274972|NCT02688387|4008584|FG000|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
3274973|NCT02688387|4008585|FG001|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
3274974|NCT02688387|4008586|FG002|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
3274975|NCT02688387|4008587|FG003|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
3274976|NCT02688387|4008588|FG004|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
3274977|NCT02688387|4008589|FG005|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
3274978|NCT02688387|4008590|FG006|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
3274979|NCT02688387|4008591|FG007|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
3274980|NCT02688387|4008592|FG008|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
3274981|NCT02688387|4008593|FG009|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
3274982|NCT02688387|4008594|FG010|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
3274983|NCT02688387|4008595|FG011|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
3274984|NCT02688387|4008596|FG012|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
3274985|NCT02688387|4008597|FG013|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
3274986|NCT02688387|4008598|FG014|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
3274987|NCT02688387|4008599|FG015|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
3274988|NCT02688387|4008600|FG016|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
3274989|NCT02688387|4008601|FG017|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
3274990|NCT02688387|4008602|FG018|COMPLETED|Part 3B, Washout Period 2 (10 Days)||8
3274991|NCT02688387|4008603|FG019|COMPLETED|Part 3B, Washout Period 2 (10 Days)||8
3274992|NCT02688387|4008604|FG020|COMPLETED|Part 3B, Washout Period 2 (10 Days)||8
3274993|NCT02688387|4008605|FG021|COMPLETED|Part 3B, Washout Period 2 (10 Days)||8
3274994|NCT02688387|4008584|FG000|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
3274995|NCT02688387|4008585|FG001|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
3274996|NCT02688387|4008586|FG002|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
3274997|NCT02688387|4008587|FG003|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
3274998|NCT02688387|4008588|FG004|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
3274999|NCT02688387|4008589|FG005|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
3275000|NCT02688387|4008590|FG006|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
3275001|NCT02688387|4008591|FG007|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
3275002|NCT02688387|4008592|FG008|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
3275003|NCT02688387|4008593|FG009|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
3275004|NCT02688387|4008594|FG010|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
3275005|NCT02688387|4008595|FG011|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
3275006|NCT02688387|4008596|FG012|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
3275007|NCT02688387|4008597|FG013|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
3275008|NCT02688387|4008598|FG014|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
3275009|NCT02688387|4008599|FG015|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
3275010|NCT02688387|4008600|FG016|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
3275011|NCT02688387|4008601|FG017|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
3275012|NCT02688387|4008602|FG018|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
3275013|NCT02688387|4008603|FG019|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
3275014|NCT02688387|4008604|FG020|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
3275015|NCT02688387|4008605|FG021|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
3275016|NCT02688387|4008584|FG000|STARTED|Part 3B, Period 3 (up to 6 Days)||0
3275017|NCT02688387|4008585|FG001|STARTED|Part 3B, Period 3 (up to 6 Days)||0
3275018|NCT02688387|4008586|FG002|STARTED|Part 3B, Period 3 (up to 6 Days)||0
3275019|NCT02688387|4008587|FG003|STARTED|Part 3B, Period 3 (up to 6 Days)||0
3275020|NCT02688387|4008588|FG004|STARTED|Part 3B, Period 3 (up to 6 Days)||0
3275021|NCT02688387|4008589|FG005|STARTED|Part 3B, Period 3 (up to 6 Days)||0
3275022|NCT02688387|4008590|FG006|STARTED|Part 3B, Period 3 (up to 6 Days)||0
3275023|NCT02688387|4008591|FG007|STARTED|Part 3B, Period 3 (up to 6 Days)||0
3275024|NCT02688387|4008592|FG008|STARTED|Part 3B, Period 3 (up to 6 Days)||0
3275025|NCT02688387|4008593|FG009|STARTED|Part 3B, Period 3 (up to 6 Days)||0
3275026|NCT02688387|4008594|FG010|STARTED|Part 3B, Period 3 (up to 6 Days)||0
3275027|NCT02688387|4008595|FG011|STARTED|Part 3B, Period 3 (up to 6 Days)||0
3275028|NCT02688387|4008596|FG012|STARTED|Part 3B, Period 3 (up to 6 Days)||0
3275029|NCT02688387|4008597|FG013|STARTED|Part 3B, Period 3 (up to 6 Days)||0
3275030|NCT02688387|4008598|FG014|STARTED|Part 3B, Period 3 (up to 6 Days)||0
3275031|NCT02688387|4008599|FG015|STARTED|Part 3B, Period 3 (up to 6 Days)||0
3275032|NCT02688387|4008600|FG016|STARTED|Part 3B, Period 3 (up to 6 Days)||0
3275033|NCT02688387|4008601|FG017|STARTED|Part 3B, Period 3 (up to 6 Days)||0
3275034|NCT02688387|4008602|FG018|STARTED|Part 3B, Period 3 (up to 6 Days)||8
3275035|NCT02688387|4008603|FG019|STARTED|Part 3B, Period 3 (up to 6 Days)||8
3275036|NCT02688387|4008604|FG020|STARTED|Part 3B, Period 3 (up to 6 Days)||8
3275037|NCT02688387|4008605|FG021|STARTED|Part 3B, Period 3 (up to 6 Days)||8
3275038|NCT02688387|4008584|FG000|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
3275039|NCT02688387|4008585|FG001|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
3275040|NCT02688387|4008586|FG002|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
3275041|NCT02688387|4008587|FG003|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
2937307|NCT00620659|3649089|FG003|COMPLETED|Placebo Washout Period 2||18
2937308|NCT00620659|3649090|FG004|COMPLETED|Placebo Washout Period 2||15
2937309|NCT00620659|3649091|FG005|COMPLETED|Placebo Washout Period 2||20
2937310|NCT00620659|3649086|FG000|NOT COMPLETED|Placebo Washout Period 2||2
3275042|NCT02688387|4008588|FG004|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
3275043|NCT02688387|4008589|FG005|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
3275044|NCT02688387|4008590|FG006|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
3275045|NCT02688387|4008591|FG007|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
3275046|NCT02688387|4008592|FG008|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
3275047|NCT02688387|4008593|FG009|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
3275048|NCT02688387|4008594|FG010|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
3275049|NCT02688387|4008595|FG011|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
3275050|NCT02688387|4008596|FG012|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
3275051|NCT02688387|4008597|FG013|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
3275052|NCT02688387|4008598|FG014|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
3275053|NCT02688387|4008599|FG015|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
3275054|NCT02688387|4008600|FG016|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
3275055|NCT02688387|4008601|FG017|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
3275056|NCT02688387|4008602|FG018|COMPLETED|Part 3B, Period 3 (up to 6 Days)||8
3275057|NCT02688387|4008603|FG019|COMPLETED|Part 3B, Period 3 (up to 6 Days)||8
3275058|NCT02688387|4008604|FG020|COMPLETED|Part 3B, Period 3 (up to 6 Days)||7
3275059|NCT02688387|4008605|FG021|COMPLETED|Part 3B, Period 3 (up to 6 Days)||8
3275060|NCT02688387|4008584|FG000|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
3275061|NCT02688387|4008585|FG001|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
3275062|NCT02688387|4008586|FG002|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
3275063|NCT02688387|4008587|FG003|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
3275064|NCT02688387|4008588|FG004|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
3275065|NCT02688387|4008589|FG005|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
3275066|NCT02688387|4008590|FG006|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
3275067|NCT02688387|4008591|FG007|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
3275068|NCT02688387|4008592|FG008|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
3275069|NCT02688387|4008593|FG009|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
3275070|NCT02688387|4008594|FG010|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
3275071|NCT02688387|4008595|FG011|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
3275072|NCT02688387|4008596|FG012|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
3275073|NCT02688387|4008597|FG013|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
3275074|NCT02688387|4008598|FG014|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
3275075|NCT02688387|4008599|FG015|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
3275076|NCT02688387|4008600|FG016|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
3275077|NCT02688387|4008601|FG017|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
3275078|NCT02688387|4008602|FG018|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
3275079|NCT02688387|4008603|FG019|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
3275080|NCT02688387|4008604|FG020|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||1
3275081|NCT02688387|4008605|FG021|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
3275082|NCT02688387|4008584|FG000|STARTED|Part 3B, Washout Period 3 (10 Days)||0
3275083|NCT02688387|4008585|FG001|STARTED|Part 3B, Washout Period 3 (10 Days)||0
3275084|NCT02688387|4008586|FG002|STARTED|Part 3B, Washout Period 3 (10 Days)||0
3275085|NCT02688387|4008587|FG003|STARTED|Part 3B, Washout Period 3 (10 Days)||0
3275086|NCT02688387|4008588|FG004|STARTED|Part 3B, Washout Period 3 (10 Days)||0
3275087|NCT02688387|4008589|FG005|STARTED|Part 3B, Washout Period 3 (10 Days)||0
3275088|NCT02688387|4008590|FG006|STARTED|Part 3B, Washout Period 3 (10 Days)||0
3275089|NCT02688387|4008591|FG007|STARTED|Part 3B, Washout Period 3 (10 Days)||0
3275090|NCT02688387|4008592|FG008|STARTED|Part 3B, Washout Period 3 (10 Days)||0
3275091|NCT02688387|4008593|FG009|STARTED|Part 3B, Washout Period 3 (10 Days)||0
3275092|NCT02688387|4008594|FG010|STARTED|Part 3B, Washout Period 3 (10 Days)||0
3275093|NCT02688387|4008595|FG011|STARTED|Part 3B, Washout Period 3 (10 Days)||0
3275094|NCT02688387|4008596|FG012|STARTED|Part 3B, Washout Period 3 (10 Days)||0
3275095|NCT02688387|4008597|FG013|STARTED|Part 3B, Washout Period 3 (10 Days)||0
3275096|NCT02688387|4008598|FG014|STARTED|Part 3B, Washout Period 3 (10 Days)||0
3275097|NCT02688387|4008599|FG015|STARTED|Part 3B, Washout Period 3 (10 Days)||0
3275098|NCT02688387|4008600|FG016|STARTED|Part 3B, Washout Period 3 (10 Days)||0
3275099|NCT02688387|4008601|FG017|STARTED|Part 3B, Washout Period 3 (10 Days)||0
3275100|NCT02688387|4008602|FG018|STARTED|Part 3B, Washout Period 3 (10 Days)||8
3275101|NCT02688387|4008603|FG019|STARTED|Part 3B, Washout Period 3 (10 Days)||8
3275102|NCT02688387|4008604|FG020|STARTED|Part 3B, Washout Period 3 (10 Days)||7
3275103|NCT02688387|4008605|FG021|STARTED|Part 3B, Washout Period 3 (10 Days)||8
3275104|NCT02688387|4008584|FG000|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
3275105|NCT02688387|4008585|FG001|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
3275106|NCT02688387|4008586|FG002|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
3275107|NCT02688387|4008587|FG003|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
3275108|NCT02688387|4008588|FG004|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
3275109|NCT02688387|4008589|FG005|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
3275110|NCT02688387|4008590|FG006|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
3275111|NCT02688387|4008591|FG007|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
3275112|NCT02688387|4008592|FG008|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
3275113|NCT02688387|4008593|FG009|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
3275114|NCT02688387|4008594|FG010|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
3275115|NCT02688387|4008595|FG011|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
3275116|NCT02688387|4008596|FG012|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
3275117|NCT02688387|4008597|FG013|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
3275118|NCT02688387|4008598|FG014|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
2937311|NCT00620659|3649087|FG001|NOT COMPLETED|Placebo Washout Period 2||0
2937312|NCT00620659|3649088|FG002|NOT COMPLETED|Placebo Washout Period 2||0
2937313|NCT00620659|3649089|FG003|NOT COMPLETED|Placebo Washout Period 2||0
2937314|NCT00620659|3649090|FG004|NOT COMPLETED|Placebo Washout Period 2||0
2937315|NCT00620659|3649091|FG005|NOT COMPLETED|Placebo Washout Period 2||0
2937316|NCT00620659|3649086|FG000|STARTED|Treatment Period 3||16
3275119|NCT02688387|4008599|FG015|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
3275120|NCT02688387|4008600|FG016|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
3275121|NCT02688387|4008601|FG017|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
2937317|NCT00620659|3649087|FG001|STARTED|Treatment Period 3||18
2937318|NCT00620659|3649088|FG002|STARTED|Treatment Period 3||19
2937319|NCT00620659|3649089|FG003|STARTED|Treatment Period 3||18
2937320|NCT00620659|3649090|FG004|STARTED|Treatment Period 3||15
2937321|NCT00620659|3649091|FG005|STARTED|Treatment Period 3||20
2937322|NCT00620659|3649086|FG000|COMPLETED|Treatment Period 3||16
2937323|NCT00620659|3649087|FG001|COMPLETED|Treatment Period 3||16
2937324|NCT00620659|3649088|FG002|COMPLETED|Treatment Period 3||19
2937325|NCT00620659|3649089|FG003|COMPLETED|Treatment Period 3||17
2937326|NCT00620659|3649090|FG004|COMPLETED|Treatment Period 3||15
2937327|NCT00620659|3649091|FG005|COMPLETED|Treatment Period 3||20
2937328|NCT00620659|3649086|FG000|NOT COMPLETED|Treatment Period 3||0
2937329|NCT00620659|3649087|FG001|NOT COMPLETED|Treatment Period 3||2
2937330|NCT00620659|3649088|FG002|NOT COMPLETED|Treatment Period 3||0
2937331|NCT00620659|3649089|FG003|NOT COMPLETED|Treatment Period 3||1
2937332|NCT00620659|3649090|FG004|NOT COMPLETED|Treatment Period 3||0
2937333|NCT00620659|3649091|FG005|NOT COMPLETED|Treatment Period 3||0
2937334|NCT00620698|3649104|FG000|STARTED|Overall Study||89
2937335|NCT00620698|3649104|FG000|COMPLETED|Overall Study||60
2937336|NCT00620698|3649104|FG000|NOT COMPLETED|Overall Study||29
2937337|NCT00620711|3649108|FG000|STARTED|Overall Study||4
2937338|NCT00620711|3649108|FG000|COMPLETED|Overall Study||4
2937339|NCT00620711|3649108|FG000|NOT COMPLETED|Overall Study||0
2937340|NCT00620750|3649112|FG000|STARTED|Overall Study||65
2937341|NCT00620750|3649112|FG000|COMPLETED|Overall Study||40
2937342|NCT00620750|3649112|FG000|NOT COMPLETED|Overall Study||25
2937343|NCT00620763|3649116|FG000|STARTED|Period: First Intervention||10
2937344|NCT00620763|3649117|FG001|STARTED|Period: First Intervention||12
2937345|NCT00620763|3649116|FG000|COMPLETED|Period: First Intervention||10
2937346|NCT00620763|3649117|FG001|COMPLETED|Period: First Intervention||7
2937347|NCT00620763|3649116|FG000|NOT COMPLETED|Period: First Intervention||0
2937348|NCT00620763|3649117|FG001|NOT COMPLETED|Period: First Intervention||5
2937349|NCT00620763|3649116|FG000|STARTED|Period: Washout Period of 1 Week||10
2937350|NCT00620763|3649117|FG001|STARTED|Period: Washout Period of 1 Week||7
2937351|NCT00620763|3649116|FG000|COMPLETED|Period: Washout Period of 1 Week||10
2937352|NCT00620763|3649117|FG001|COMPLETED|Period: Washout Period of 1 Week||7
2937353|NCT00620763|3649116|FG000|NOT COMPLETED|Period: Washout Period of 1 Week||0
2937354|NCT00620763|3649117|FG001|NOT COMPLETED|Period: Washout Period of 1 Week||0
2937355|NCT00620763|3649116|FG000|STARTED|Period: Second Intervention||10
3275122|NCT02688387|4008602|FG018|COMPLETED|Part 3B, Washout Period 3 (10 Days)||7
3275123|NCT02688387|4008603|FG019|COMPLETED|Part 3B, Washout Period 3 (10 Days)||7
3275124|NCT02688387|4008604|FG020|COMPLETED|Part 3B, Washout Period 3 (10 Days)||6
3275125|NCT02688387|4008605|FG021|COMPLETED|Part 3B, Washout Period 3 (10 Days)||8
3275126|NCT02688387|4008584|FG000|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
3275127|NCT02688387|4008585|FG001|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
2937356|NCT00620763|3649117|FG001|STARTED|Period: Second Intervention||7
2937357|NCT00620763|3649116|FG000|COMPLETED|Period: Second Intervention||9
2937358|NCT00620763|3649117|FG001|COMPLETED|Period: Second Intervention||7
2937359|NCT00620763|3649116|FG000|NOT COMPLETED|Period: Second Intervention||1
2937360|NCT00620763|3649117|FG001|NOT COMPLETED|Period: Second Intervention||0
2937361|NCT00620776|3649125|FG000|STARTED|Overall Study|29 patients (of the 77 that were randomly assigned to add on CBT) consented to this option.|29
2937362|NCT00620776|3649126|FG001|STARTED|Overall Study|All 40 patients that were randomly assigned to not be offered CBT consented to this option.|40
2937363|NCT00620776|3649125|FG000|Received at Least One Session/Dose|Overall Study|26 out of 29 that consented to the combined treatment option received at least one session of CBT.|26
2937364|NCT00620776|3649126|FG001|Received at Least One Session/Dose|Overall Study|35 out of 40 that consented to receive medication alone received at least one dose of medication.|35
2937365|NCT00620776|3649125|FG000|COMPLETED|Overall Study|17 out of 26 attended the week 24 (last) assessment.|17
2937366|NCT00620776|3649126|FG001|COMPLETED|Overall Study|24 out of 35 attended the week 24 (last) assessment.|24
2937367|NCT00620776|3649125|FG000|NOT COMPLETED|Overall Study||12
2937368|NCT00620776|3649126|FG001|NOT COMPLETED|Overall Study||16
2937369|NCT00620815|3649135|FG000|STARTED|Overall Study||199
2937370|NCT00620815|3649136|FG001|STARTED|Overall Study||203
3275128|NCT02688387|4008586|FG002|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
3275129|NCT02688387|4008587|FG003|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
3275130|NCT02688387|4008588|FG004|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
3275131|NCT02688387|4008589|FG005|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
3275132|NCT02688387|4008590|FG006|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
3275133|NCT02688387|4008591|FG007|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
3275134|NCT02688387|4008592|FG008|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
3275135|NCT02688387|4008593|FG009|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
3275136|NCT02688387|4008594|FG010|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
3275137|NCT02688387|4008595|FG011|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
3275138|NCT02688387|4008596|FG012|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
3275139|NCT02688387|4008597|FG013|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
3275140|NCT02688387|4008598|FG014|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
3275141|NCT02688387|4008599|FG015|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
3275142|NCT02688387|4008600|FG016|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
3275143|NCT02688387|4008601|FG017|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
3275144|NCT02688387|4008602|FG018|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||1
3275145|NCT02688387|4008603|FG019|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||1
3275146|NCT02688387|4008604|FG020|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||1
3275147|NCT02688387|4008605|FG021|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
3275148|NCT02688387|4008584|FG000|STARTED|Part 3B, Period 4 (up to 6 Days)||0
3275149|NCT02688387|4008585|FG001|STARTED|Part 3B, Period 4 (up to 6 Days)||0
3275150|NCT02688387|4008586|FG002|STARTED|Part 3B, Period 4 (up to 6 Days)||0
3275151|NCT02688387|4008587|FG003|STARTED|Part 3B, Period 4 (up to 6 Days)||0
3275152|NCT02688387|4008588|FG004|STARTED|Part 3B, Period 4 (up to 6 Days)||0
3275153|NCT02688387|4008589|FG005|STARTED|Part 3B, Period 4 (up to 6 Days)||0
3275154|NCT02688387|4008590|FG006|STARTED|Part 3B, Period 4 (up to 6 Days)||0
3275155|NCT02688387|4008591|FG007|STARTED|Part 3B, Period 4 (up to 6 Days)||0
3275156|NCT02688387|4008592|FG008|STARTED|Part 3B, Period 4 (up to 6 Days)||0
3275157|NCT02688387|4008593|FG009|STARTED|Part 3B, Period 4 (up to 6 Days)||0
3275158|NCT02688387|4008594|FG010|STARTED|Part 3B, Period 4 (up to 6 Days)||0
3275159|NCT02688387|4008595|FG011|STARTED|Part 3B, Period 4 (up to 6 Days)||0
3275160|NCT02688387|4008596|FG012|STARTED|Part 3B, Period 4 (up to 6 Days)||0
3275161|NCT02688387|4008597|FG013|STARTED|Part 3B, Period 4 (up to 6 Days)||0
3275162|NCT02688387|4008598|FG014|STARTED|Part 3B, Period 4 (up to 6 Days)||0
2937371|NCT00620815|3649137|FG002|STARTED|Overall Study||199
2937372|NCT00620815|3649135|FG000|COMPLETED|Overall Study||195
2937373|NCT00620815|3649136|FG001|COMPLETED|Overall Study||192
2937374|NCT00620815|3649137|FG002|COMPLETED|Overall Study||192
2937375|NCT00620815|3649135|FG000|NOT COMPLETED|Overall Study||4
2937376|NCT00620815|3649136|FG001|NOT COMPLETED|Overall Study||11
2937377|NCT00620815|3649137|FG002|NOT COMPLETED|Overall Study||7
2937378|NCT00620828|3649163|FG000|STARTED|Overall Study||32
2937379|NCT00620828|3649164|FG001|STARTED|Overall Study||35
2937380|NCT00620828|3649163|FG000|Number of Subjects Enrolled = 67|Overall Study||32
2937381|NCT00620828|3649164|FG001|Number of Subjects Enrolled = 67|Overall Study||35
2937382|NCT00620828|3649163|FG000|COMPLETED|Overall Study||32
2937383|NCT00620828|3649164|FG001|COMPLETED|Overall Study||35
2937384|NCT00620828|3649163|FG000|NOT COMPLETED|Overall Study||0
2937385|NCT00620828|3649164|FG001|NOT COMPLETED|Overall Study||0
2937386|NCT00620854|3649176|FG000|STARTED|Period 1||4
2937387|NCT00620854|3649177|FG001|STARTED|Period 1||4
2937388|NCT00620854|3649178|FG002|STARTED|Period 1||4
2937389|NCT00620854|3649179|FG003|STARTED|Period 1||4
2937390|NCT00620854|3649180|FG004|STARTED|Period 1||4
2937391|NCT00620854|3649181|FG005|STARTED|Period 1||4
2937392|NCT00620854|3649176|FG000|COMPLETED|Period 1||4
2937393|NCT00620854|3649177|FG001|COMPLETED|Period 1||4
2937394|NCT00620854|3649178|FG002|COMPLETED|Period 1||4
2937395|NCT00620854|3649179|FG003|COMPLETED|Period 1||4
2937396|NCT00620854|3649180|FG004|COMPLETED|Period 1||4
2937397|NCT00620854|3649181|FG005|COMPLETED|Period 1||4
2937398|NCT00620854|3649176|FG000|NOT COMPLETED|Period 1||0
3275163|NCT02688387|4008599|FG015|STARTED|Part 3B, Period 4 (up to 6 Days)||0
3275164|NCT02688387|4008600|FG016|STARTED|Part 3B, Period 4 (up to 6 Days)||0
3275165|NCT02688387|4008601|FG017|STARTED|Part 3B, Period 4 (up to 6 Days)||0
3275166|NCT02688387|4008602|FG018|STARTED|Part 3B, Period 4 (up to 6 Days)||7
3275167|NCT02688387|4008603|FG019|STARTED|Part 3B, Period 4 (up to 6 Days)||7
3275168|NCT02688387|4008604|FG020|STARTED|Part 3B, Period 4 (up to 6 Days)||6
3275169|NCT02688387|4008605|FG021|STARTED|Part 3B, Period 4 (up to 6 Days)||8
3275170|NCT02688387|4008584|FG000|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
3275171|NCT02688387|4008585|FG001|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
3275172|NCT02688387|4008586|FG002|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
3275173|NCT02688387|4008587|FG003|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
3275174|NCT02688387|4008588|FG004|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
3275175|NCT02688387|4008589|FG005|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
3275176|NCT02688387|4008590|FG006|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
3275177|NCT02688387|4008591|FG007|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
3275178|NCT02688387|4008592|FG008|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
3275179|NCT02688387|4008593|FG009|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
3275180|NCT02688387|4008594|FG010|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
3275181|NCT02688387|4008595|FG011|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
2937399|NCT00620854|3649177|FG001|NOT COMPLETED|Period 1||0
2937400|NCT00620854|3649178|FG002|NOT COMPLETED|Period 1||0
2937401|NCT00620854|3649179|FG003|NOT COMPLETED|Period 1||0
2937402|NCT00620854|3649180|FG004|NOT COMPLETED|Period 1||0
2937403|NCT00620854|3649181|FG005|NOT COMPLETED|Period 1||0
2937404|NCT00620854|3649176|FG000|STARTED|Washout 1||4
2937405|NCT00620854|3649177|FG001|STARTED|Washout 1||4
2937406|NCT00620854|3649178|FG002|STARTED|Washout 1||4
2937407|NCT00620854|3649179|FG003|STARTED|Washout 1||4
2937408|NCT00620854|3649180|FG004|STARTED|Washout 1||4
2937409|NCT00620854|3649181|FG005|STARTED|Washout 1||4
2937410|NCT00620854|3649176|FG000|COMPLETED|Washout 1||4
2937411|NCT00620854|3649177|FG001|COMPLETED|Washout 1||4
2937412|NCT00620854|3649178|FG002|COMPLETED|Washout 1||3
2937413|NCT00620854|3649179|FG003|COMPLETED|Washout 1||3
2937414|NCT00620854|3649180|FG004|COMPLETED|Washout 1||4
2937415|NCT00620854|3649181|FG005|COMPLETED|Washout 1||4
2937416|NCT00620854|3649176|FG000|NOT COMPLETED|Washout 1||0
2937417|NCT00620854|3649177|FG001|NOT COMPLETED|Washout 1||0
2937418|NCT00620854|3649178|FG002|NOT COMPLETED|Washout 1||1
2937419|NCT00620854|3649179|FG003|NOT COMPLETED|Washout 1||1
2937420|NCT00620854|3649180|FG004|NOT COMPLETED|Washout 1||0
2937421|NCT00620854|3649181|FG005|NOT COMPLETED|Washout 1||0
2937422|NCT00620854|3649176|FG000|STARTED|Period 2||4
2937423|NCT00620854|3649177|FG001|STARTED|Period 2||4
2937424|NCT00620854|3649178|FG002|STARTED|Period 2||3
2937425|NCT00620854|3649179|FG003|STARTED|Period 2||3
2937426|NCT00620854|3649180|FG004|STARTED|Period 2||4
2937427|NCT00620854|3649181|FG005|STARTED|Period 2||4
2937428|NCT00620854|3649176|FG000|COMPLETED|Period 2||4
2937429|NCT00620854|3649177|FG001|COMPLETED|Period 2||4
2937430|NCT00620854|3649178|FG002|COMPLETED|Period 2||3
2937431|NCT00620854|3649179|FG003|COMPLETED|Period 2||3
2937432|NCT00620854|3649180|FG004|COMPLETED|Period 2||4
2937433|NCT00620854|3649181|FG005|COMPLETED|Period 2||4
2937434|NCT00620854|3649176|FG000|NOT COMPLETED|Period 2||0
2937435|NCT00620854|3649177|FG001|NOT COMPLETED|Period 2||0
2937436|NCT00620854|3649178|FG002|NOT COMPLETED|Period 2||0
2937437|NCT00620854|3649179|FG003|NOT COMPLETED|Period 2||0
2937438|NCT00620854|3649180|FG004|NOT COMPLETED|Period 2||0
2937439|NCT00620854|3649181|FG005|NOT COMPLETED|Period 2||0
2937440|NCT00620854|3649176|FG000|STARTED|Washout 2||4
2937441|NCT00620854|3649177|FG001|STARTED|Washout 2||4
2937442|NCT00620854|3649178|FG002|STARTED|Washout 2||3
2937443|NCT00620854|3649179|FG003|STARTED|Washout 2||3
2937444|NCT00620854|3649180|FG004|STARTED|Washout 2||4
2937445|NCT00620854|3649181|FG005|STARTED|Washout 2||4
2937446|NCT00620854|3649176|FG000|COMPLETED|Washout 2||4
2937447|NCT00620854|3649177|FG001|COMPLETED|Washout 2||4
2937448|NCT00620854|3649178|FG002|COMPLETED|Washout 2||3
2937449|NCT00620854|3649179|FG003|COMPLETED|Washout 2||3
2937450|NCT00620854|3649180|FG004|COMPLETED|Washout 2||4
2937451|NCT00620854|3649181|FG005|COMPLETED|Washout 2||4
2937452|NCT00620854|3649176|FG000|NOT COMPLETED|Washout 2||0
2937453|NCT00620854|3649177|FG001|NOT COMPLETED|Washout 2||0
2937454|NCT00620854|3649178|FG002|NOT COMPLETED|Washout 2||0
2937455|NCT00620854|3649179|FG003|NOT COMPLETED|Washout 2||0
2937456|NCT00620854|3649180|FG004|NOT COMPLETED|Washout 2||0
2937457|NCT00620854|3649181|FG005|NOT COMPLETED|Washout 2||0
2937458|NCT00620854|3649176|FG000|STARTED|Period 3||4
2937459|NCT00620854|3649177|FG001|STARTED|Period 3||4
2937460|NCT00620854|3649178|FG002|STARTED|Period 3||3
2937461|NCT00620854|3649179|FG003|STARTED|Period 3||3
2937462|NCT00620854|3649180|FG004|STARTED|Period 3||4
2937463|NCT00620854|3649181|FG005|STARTED|Period 3||4
2937464|NCT00620854|3649176|FG000|COMPLETED|Period 3||4
2937465|NCT00620854|3649177|FG001|COMPLETED|Period 3||4
2937466|NCT00620854|3649178|FG002|COMPLETED|Period 3||3
2937467|NCT00620854|3649179|FG003|COMPLETED|Period 3||3
2937468|NCT00620854|3649180|FG004|COMPLETED|Period 3||4
2937469|NCT00620854|3649181|FG005|COMPLETED|Period 3||4
2937470|NCT00620854|3649176|FG000|NOT COMPLETED|Period 3||0
2937471|NCT00620854|3649177|FG001|NOT COMPLETED|Period 3||0
2937472|NCT00620854|3649178|FG002|NOT COMPLETED|Period 3||0
2937473|NCT00620854|3649179|FG003|NOT COMPLETED|Period 3||0
2937474|NCT00620854|3649180|FG004|NOT COMPLETED|Period 3||0
2937475|NCT00620854|3649181|FG005|NOT COMPLETED|Period 3||0
2937476|NCT00620945|3649192|FG000|STARTED|Overall Study|Total number in the study|87
2937477|NCT00620945|3649192|FG000|COMPLETED|Overall Study||87
2937478|NCT00620945|3649192|FG000|NOT COMPLETED|Overall Study||0
2937479|NCT00621023|3649196|FG000|STARTED|Overall Study||6
2937480|NCT00621023|3649196|FG000|COMPLETED|Overall Study|Completed is defined as 5 years of follow up.|0
2937481|NCT00621023|3649196|FG000|NOT COMPLETED|Overall Study||6
3275182|NCT02688387|4008596|FG012|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
3275183|NCT02688387|4008597|FG013|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
3275184|NCT02688387|4008598|FG014|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
3275185|NCT02688387|4008599|FG015|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
3275186|NCT02688387|4008600|FG016|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
3275187|NCT02688387|4008601|FG017|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
3275188|NCT02688387|4008602|FG018|COMPLETED|Part 3B, Period 4 (up to 6 Days)||7
2937482|NCT00621049|3649202|FG000|STARTED|Adjuvant Treatment||55
2937483|NCT00621049|3649203|FG001|STARTED|Adjuvant Treatment||57
2937484|NCT00621049|3649202|FG000|COMPLETED|Adjuvant Treatment||52
2937485|NCT00621049|3649203|FG001|COMPLETED|Adjuvant Treatment||47
2937486|NCT00621049|3649202|FG000|NOT COMPLETED|Adjuvant Treatment||3
2937487|NCT00621049|3649203|FG001|NOT COMPLETED|Adjuvant Treatment||10
2937488|NCT00621049|3649202|FG000|STARTED|Maintenance Treatment|3 patients came off study between the end of adjuvant therapy and the start of maintenance|49
3034397|NCT01132651|3753493|FG001|STARTED|Overall Study||5
2937489|NCT00621049|3649203|FG001|STARTED|Maintenance Treatment|Per protocol, only the Docetaxel/Carboplatin/Bevacizumab/Erlotinib arm enters maintenance therapy|0
2937490|NCT00621049|3649202|FG000|COMPLETED|Maintenance Treatment||34
2937491|NCT00621049|3649203|FG001|COMPLETED|Maintenance Treatment||0
2937492|NCT00621049|3649202|FG000|NOT COMPLETED|Maintenance Treatment||15
2937493|NCT00621049|3649203|FG001|NOT COMPLETED|Maintenance Treatment||0
2937494|NCT00621140|3649211|FG000|STARTED|Overall Study|number who started treatment|167
2937495|NCT00621140|3649212|FG001|STARTED|Overall Study|number who started treatment|336
2937496|NCT00621140|3649211|FG000|COMPLETED|Overall Study|number who completed treatment|152
2937497|NCT00621140|3649212|FG001|COMPLETED|Overall Study|number who completed treatment|318
2937498|NCT00621140|3649211|FG000|NOT COMPLETED|Overall Study||15
2937499|NCT00621140|3649212|FG001|NOT COMPLETED|Overall Study||18
2937500|NCT00621153|3649220|FG000|STARTED|Overall Study|randomised|117
2937501|NCT00621153|3649221|FG001|STARTED|Overall Study|randomised|116
2937502|NCT00621153|3649220|FG000|Discontinued|Overall Study||20
2937503|NCT00621153|3649221|FG001|Discontinued|Overall Study||15
2937504|NCT00621153|3649220|FG000|COMPLETED|Overall Study|completed|97
2937505|NCT00621153|3649221|FG001|COMPLETED|Overall Study|completed|101
2937506|NCT00621153|3649220|FG000|NOT COMPLETED|Overall Study||20
2937507|NCT00621153|3649221|FG001|NOT COMPLETED|Overall Study||15
2937508|NCT00621179|3649231|FG000|STARTED|Overall Study||12
2937509|NCT00621179|3649232|FG001|STARTED|Overall Study||8
3275189|NCT02688387|4008603|FG019|COMPLETED|Part 3B, Period 4 (up to 6 Days)||7
3275190|NCT02688387|4008604|FG020|COMPLETED|Part 3B, Period 4 (up to 6 Days)||6
3275191|NCT02688387|4008605|FG021|COMPLETED|Part 3B, Period 4 (up to 6 Days)||8
2937510|NCT00621179|3649233|FG002|STARTED|Overall Study||7
2937511|NCT00621179|3649234|FG003|STARTED|Overall Study||10
2937512|NCT00621179|3649231|FG000|COMPLETED|Overall Study||12
2937513|NCT00621179|3649232|FG001|COMPLETED|Overall Study||8
2937514|NCT00621179|3649233|FG002|COMPLETED|Overall Study||6
2937515|NCT00621179|3649234|FG003|COMPLETED|Overall Study||9
2937516|NCT00621179|3649231|FG000|NOT COMPLETED|Overall Study||0
2937517|NCT00621179|3649232|FG001|NOT COMPLETED|Overall Study||0
2937518|NCT00621179|3649233|FG002|NOT COMPLETED|Overall Study||1
2937519|NCT00621179|3649234|FG003|NOT COMPLETED|Overall Study||1
2937520|NCT00621192|3649248|FG000|STARTED|Overall Study||39
2937521|NCT00621192|3649249|FG001|STARTED|Overall Study||103
2937522|NCT00621192|3649250|FG002|STARTED|Overall Study||31
2937523|NCT00621192|3649251|FG003|STARTED|Overall Study||27
2937524|NCT00621192|3649248|FG000|Safety Population|Overall Study||39
2937525|NCT00621192|3649249|FG001|Safety Population|Overall Study||103
2937526|NCT00621192|3649250|FG002|Safety Population|Overall Study||31
2937527|NCT00621192|3649251|FG003|Safety Population|Overall Study||27
2937528|NCT00621192|3649248|FG000|Efficacy Population|Overall Study||39
2937529|NCT00621192|3649249|FG001|Efficacy Population|Overall Study||101
2937530|NCT00621192|3649250|FG002|Efficacy Population|Overall Study||28
2937531|NCT00621192|3649251|FG003|Efficacy Population|Overall Study||27
2937532|NCT00621192|3649248|FG000|COMPLETED|Overall Study||35
2937533|NCT00621192|3649249|FG001|COMPLETED|Overall Study||94
2937534|NCT00621192|3649250|FG002|COMPLETED|Overall Study||26
2937535|NCT00621192|3649251|FG003|COMPLETED|Overall Study||24
2937536|NCT00621192|3649248|FG000|NOT COMPLETED|Overall Study||4
2937537|NCT00621192|3649249|FG001|NOT COMPLETED|Overall Study||9
2937538|NCT00621192|3649250|FG002|NOT COMPLETED|Overall Study||5
2937539|NCT00621192|3649251|FG003|NOT COMPLETED|Overall Study||3
2937540|NCT00621244|3649265|FG000|STARTED|Overall Study||86
2937541|NCT00621244|3649266|FG001|STARTED|Overall Study||34
2937542|NCT00621244|3649267|FG002|STARTED|Overall Study||33
2937543|NCT00621244|3649268|FG003|STARTED|Overall Study||23
2937544|NCT00621244|3649265|FG000|COMPLETED|Overall Study||0
2937545|NCT00621244|3649266|FG001|COMPLETED|Overall Study||0
2937546|NCT00621244|3649267|FG002|COMPLETED|Overall Study||0
2937547|NCT00621244|3649268|FG003|COMPLETED|Overall Study||0
3275192|NCT02688387|4008584|FG000|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
3275193|NCT02688387|4008585|FG001|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
3275194|NCT02688387|4008586|FG002|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
3275195|NCT02688387|4008587|FG003|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
3275196|NCT02688387|4008588|FG004|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
3275197|NCT02688387|4008589|FG005|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
3275198|NCT02688387|4008590|FG006|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
3275199|NCT02688387|4008591|FG007|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
3275200|NCT02688387|4008592|FG008|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
3275201|NCT02688387|4008593|FG009|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
3275202|NCT02688387|4008594|FG010|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
3275203|NCT02688387|4008595|FG011|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
3275204|NCT02688387|4008596|FG012|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
3275205|NCT02688387|4008597|FG013|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
3275206|NCT02688387|4008598|FG014|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
3275207|NCT02688387|4008599|FG015|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
3275208|NCT02688387|4008600|FG016|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
2937548|NCT00621244|3649265|FG000|NOT COMPLETED|Overall Study||86
2937549|NCT00621244|3649266|FG001|NOT COMPLETED|Overall Study||34
3275209|NCT02688387|4008601|FG017|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
3275210|NCT02688387|4008602|FG018|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
3275211|NCT02688387|4008603|FG019|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
2937550|NCT00621244|3649267|FG002|NOT COMPLETED|Overall Study||33
2937551|NCT00621244|3649268|FG003|NOT COMPLETED|Overall Study||23
2937552|NCT00621257|3649347|FG000|STARTED|Overall Study||24
2937553|NCT00621257|3649348|FG001|STARTED|Overall Study||24
2937554|NCT00621257|3649349|FG002|STARTED|Overall Study||23
2937555|NCT00621257|3649350|FG003|STARTED|Overall Study||32
2937556|NCT00621257|3649351|FG004|STARTED|Overall Study||31
2937557|NCT00621257|3649347|FG000|COMPLETED|Overall Study||20
2937558|NCT00621257|3649348|FG001|COMPLETED|Overall Study||21
2937559|NCT00621257|3649349|FG002|COMPLETED|Overall Study||20
2937560|NCT00621257|3649350|FG003|COMPLETED|Overall Study||26
2937561|NCT00621257|3649351|FG004|COMPLETED|Overall Study||22
2937562|NCT00621257|3649347|FG000|NOT COMPLETED|Overall Study||4
2937563|NCT00621257|3649348|FG001|NOT COMPLETED|Overall Study||3
3275212|NCT02688387|4008604|FG020|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
3275213|NCT02688387|4008605|FG021|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
3275214|NCT02688556|4008653|FG000|STARTED|Overall Study||372
3275215|NCT02688556|4008654|FG001|STARTED|Overall Study||373
3275216|NCT02688556|4008653|FG000|COMPLETED|Overall Study||347
3275217|NCT02688556|4008654|FG001|COMPLETED|Overall Study||361
3275218|NCT02688556|4008653|FG000|NOT COMPLETED|Overall Study||25
3275219|NCT02688556|4008654|FG001|NOT COMPLETED|Overall Study||12
3275220|NCT02688621|4008662|FG000|STARTED|Overall Study||212
3275221|NCT02688621|4008663|FG001|STARTED|Overall Study||206
3275222|NCT02688621|4008662|FG000|COMPLETED|Overall Study||172
3275223|NCT02688621|4008663|FG001|COMPLETED|Overall Study||188
3275224|NCT02688621|4008662|FG000|NOT COMPLETED|Overall Study||40
3275225|NCT02688621|4008663|FG001|NOT COMPLETED|Overall Study||18
3275226|NCT02688764|4008674|FG000|STARTED|Overall Study||66
3275227|NCT02688764|4008675|FG001|STARTED|Overall Study||19
3275228|NCT02688764|4008674|FG000|Treated in Stage 1|Overall Study||66
3275229|NCT02688764|4008675|FG001|Treated in Stage 1|Overall Study||19
3275230|NCT02688764|4008674|FG000|Treated in Stage 2|Overall Study||43
3275231|NCT02688764|4008675|FG001|Treated in Stage 2|Overall Study||8
3275232|NCT02688764|4008674|FG000|COMPLETED|Overall Study||26
3275233|NCT02688764|4008675|FG001|COMPLETED|Overall Study||2
3275234|NCT02688764|4008674|FG000|NOT COMPLETED|Overall Study||40
3275235|NCT02688764|4008675|FG001|NOT COMPLETED|Overall Study||17
3275236|NCT02688829|4008684|FG000|STARTED|Overall Study||21
3275237|NCT02688829|4008684|FG000|COMPLETED|Overall Study||19
3275238|NCT02688829|4008684|FG000|NOT COMPLETED|Overall Study||2
3275239|NCT02688842|4008688|FG000|STARTED|Overall Study||38
3275240|NCT02688842|4008688|FG000|COMPLETED|Overall Study||38
3275241|NCT02688842|4008688|FG000|NOT COMPLETED|Overall Study||0
3275242|NCT02688868|4008692|FG000|STARTED|Overall Study||38
3275243|NCT02688868|4008692|FG000|COMPLETED|Overall Study||34
3275244|NCT02688868|4008692|FG000|NOT COMPLETED|Overall Study||4
3275245|NCT02688933|4008698|FG000|STARTED|Overall Study||320
3275246|NCT02688933|4008699|FG001|STARTED|Overall Study||318
3275247|NCT02688933|4008698|FG000|COMPLETED|Overall Study||291
3275248|NCT02688933|4008699|FG001|COMPLETED|Overall Study||281
3275249|NCT02688933|4008698|FG000|NOT COMPLETED|Overall Study||29
3275250|NCT02688933|4008699|FG001|NOT COMPLETED|Overall Study||37
3275251|NCT02689063|4008709|FG000|STARTED|Overall Study||75
3275252|NCT02689063|4008710|FG001|STARTED|Overall Study||75
3275253|NCT02689063|4008711|FG002|STARTED|Overall Study||76
3275254|NCT02689063|4008712|FG003|STARTED|Overall Study||50
3275255|NCT02689063|4008709|FG000|COMPLETED|Overall Study||75
3275256|NCT02689063|4008710|FG001|COMPLETED|Overall Study||73
3275257|NCT02689063|4008711|FG002|COMPLETED|Overall Study||73
3275258|NCT02689063|4008712|FG003|COMPLETED|Overall Study||50
3275259|NCT02689063|4008709|FG000|NOT COMPLETED|Overall Study||0
3275260|NCT02689063|4008710|FG001|NOT COMPLETED|Overall Study||2
3275261|NCT02689063|4008711|FG002|NOT COMPLETED|Overall Study||3
3275262|NCT02689063|4008712|FG003|NOT COMPLETED|Overall Study||0
3275263|NCT02689076|4008725|FG000|STARTED|Overall Study||268
3275264|NCT02689076|4008726|FG001|STARTED|Overall Study||337
3275265|NCT02689076|4008727|FG002|STARTED|Overall Study||191
3275266|NCT02689076|4008725|FG000|COMPLETED|Overall Study||87
3275267|NCT02689076|4008726|FG001|COMPLETED|Overall Study||115
3275268|NCT02689076|4008727|FG002|COMPLETED|Overall Study||191
3275269|NCT02689076|4008725|FG000|NOT COMPLETED|Overall Study||181
3275270|NCT02689076|4008726|FG001|NOT COMPLETED|Overall Study||222
3275271|NCT02689076|4008727|FG002|NOT COMPLETED|Overall Study||0
3275272|NCT02689154|4008735|FG000|STARTED|Overall Study||18
3275273|NCT02689154|4008735|FG000|COMPLETED|Overall Study||18
3275274|NCT02689154|4008735|FG000|NOT COMPLETED|Overall Study||0
3275275|NCT02689206|4008744|FG000|STARTED|Overall Study||20
3275276|NCT02689206|4008745|FG001|STARTED|Overall Study||20
3275277|NCT02689206|4008746|FG002|STARTED|Overall Study||20
3275278|NCT02689206|4008747|FG003|STARTED|Overall Study||21
3275279|NCT02689206|4008748|FG004|STARTED|Overall Study||22
3275280|NCT02689206|4008744|FG000|COMPLETED|Overall Study||17
3275281|NCT02689206|4008745|FG001|COMPLETED|Overall Study||19
3275282|NCT02689206|4008746|FG002|COMPLETED|Overall Study||16
3275283|NCT02689206|4008747|FG003|COMPLETED|Overall Study||17
3275284|NCT02689206|4008748|FG004|COMPLETED|Overall Study||14
3275285|NCT02689206|4008744|FG000|NOT COMPLETED|Overall Study||3
2937564|NCT00621257|3649349|FG002|NOT COMPLETED|Overall Study||3
2937565|NCT00621257|3649350|FG003|NOT COMPLETED|Overall Study||6
3275286|NCT02689206|4008745|FG001|NOT COMPLETED|Overall Study||1
3275287|NCT02689206|4008746|FG002|NOT COMPLETED|Overall Study||4
3275288|NCT02689206|4008747|FG003|NOT COMPLETED|Overall Study||4
2937566|NCT00621257|3649351|FG004|NOT COMPLETED|Overall Study||9
2937567|NCT00621296|3649363|FG000|STARTED|Overall Study||15
2937568|NCT00621296|3649363|FG000|COMPLETED|Overall Study||1
2937569|NCT00621296|3649363|FG000|NOT COMPLETED|Overall Study||14
2937570|NCT00621309|3649367|FG000|STARTED|Overall Study||6
2937571|NCT00621309|3649368|FG001|STARTED|Overall Study||4
2937572|NCT00621309|3649369|FG002|STARTED|Overall Study||5
2937573|NCT00621309|3649370|FG003|STARTED|Overall Study||6
2937574|NCT00621309|3649371|FG004|STARTED|Overall Study||4
2937575|NCT00621309|3649372|FG005|STARTED|Overall Study||4
2937576|NCT00621309|3649367|FG000|COMPLETED|Overall Study||4
2937577|NCT00621309|3649368|FG001|COMPLETED|Overall Study||4
2937578|NCT00621309|3649369|FG002|COMPLETED|Overall Study||4
2937579|NCT00621309|3649370|FG003|COMPLETED|Overall Study||5
2937580|NCT00621309|3649371|FG004|COMPLETED|Overall Study||3
2937581|NCT00621309|3649372|FG005|COMPLETED|Overall Study||3
2937582|NCT00621309|3649367|FG000|NOT COMPLETED|Overall Study||2
2937583|NCT00621309|3649368|FG001|NOT COMPLETED|Overall Study||0
2937584|NCT00621309|3649369|FG002|NOT COMPLETED|Overall Study||1
2937585|NCT00621309|3649370|FG003|NOT COMPLETED|Overall Study||1
2937586|NCT00621309|3649371|FG004|NOT COMPLETED|Overall Study||1
2937587|NCT00621309|3649372|FG005|NOT COMPLETED|Overall Study||1
2937588|NCT00621322|3649384|FG000|STARTED|Overall Study||10
2937589|NCT00621322|3649385|FG001|STARTED|Overall Study||10
2937590|NCT00621322|3649386|FG002|STARTED|Overall Study||40
2937591|NCT00621322|3649387|FG003|STARTED|Overall Study||40
2937592|NCT00621322|3649388|FG004|STARTED|Overall Study||40
2937593|NCT00621322|3649389|FG005|STARTED|Overall Study||40
2937594|NCT00621322|3649384|FG000|COMPLETED|Overall Study||9
2937595|NCT00621322|3649385|FG001|COMPLETED|Overall Study||10
2937596|NCT00621322|3649386|FG002|COMPLETED|Overall Study||38
2937597|NCT00621322|3649387|FG003|COMPLETED|Overall Study||37
2937598|NCT00621322|3649388|FG004|COMPLETED|Overall Study||39
2937599|NCT00621322|3649389|FG005|COMPLETED|Overall Study||36
2937600|NCT00621322|3649384|FG000|NOT COMPLETED|Overall Study||1
2937601|NCT00621322|3649385|FG001|NOT COMPLETED|Overall Study||0
2937602|NCT00621322|3649386|FG002|NOT COMPLETED|Overall Study||2
2937603|NCT00621322|3649387|FG003|NOT COMPLETED|Overall Study||3
2937604|NCT00621322|3649388|FG004|NOT COMPLETED|Overall Study||1
2937605|NCT00621322|3649389|FG005|NOT COMPLETED|Overall Study||4
2937606|NCT00621348|3649406|FG000|STARTED|Overall Study||58
2937607|NCT00621348|3649407|FG001|STARTED|Overall Study||53
2937608|NCT00621348|3649408|FG002|STARTED|Overall Study||56
2937609|NCT00621348|3649406|FG000|COMPLETED|Overall Study||58
2937610|NCT00621348|3649407|FG001|COMPLETED|Overall Study||53
2937611|NCT00621348|3649408|FG002|COMPLETED|Overall Study||56
2937612|NCT00621348|3649406|FG000|NOT COMPLETED|Overall Study||0
2937613|NCT00621348|3649407|FG001|NOT COMPLETED|Overall Study||0
2937614|NCT00621348|3649408|FG002|NOT COMPLETED|Overall Study||0
2937615|NCT00621504|3649418|FG000|STARTED|Overall Study||299
2937616|NCT00621504|3649419|FG001|STARTED|Overall Study||307
2937617|NCT00621504|3649418|FG000|COMPLETED|Overall Study||273
2937618|NCT00621504|3649419|FG001|COMPLETED|Overall Study||282
2937619|NCT00621504|3649418|FG000|NOT COMPLETED|Overall Study||26
2937620|NCT00621504|3649419|FG001|NOT COMPLETED|Overall Study||25
3275289|NCT02689206|4008748|FG004|NOT COMPLETED|Overall Study||8
3275290|NCT02689219|4008766|FG000|STARTED|Overall Study||11
3275291|NCT02689219|4008767|FG001|STARTED|Overall Study||7
3275292|NCT02689219|4008766|FG000|COMPLETED|Overall Study||0
3275293|NCT02689219|4008767|FG001|COMPLETED|Overall Study||0
3275294|NCT02689219|4008766|FG000|NOT COMPLETED|Overall Study||11
3275295|NCT02689219|4008767|FG001|NOT COMPLETED|Overall Study||7
3275296|NCT02689492|4008773|FG000|STARTED|Overall Study||401
3275297|NCT02689492|4008773|FG000|COMPLETED|Overall Study||315
3275298|NCT02689492|4008773|FG000|NOT COMPLETED|Overall Study||86
3275299|NCT02689804|4008782|FG000|STARTED|Overall Study||18
3275300|NCT02689804|4008783|FG001|STARTED|Overall Study||16
3275301|NCT02689804|4008782|FG000|COMPLETED|Overall Study||16
3275302|NCT02689804|4008783|FG001|COMPLETED|Overall Study||16
3275303|NCT02689804|4008782|FG000|NOT COMPLETED|Overall Study||2
3275304|NCT02689804|4008783|FG001|NOT COMPLETED|Overall Study||0
3275305|NCT02689973|4008796|FG000|STARTED|Overall Study||311
3275306|NCT02689973|4008797|FG001|STARTED|Overall Study||270
3275307|NCT02689973|4008798|FG002|STARTED|Overall Study||351
3275308|NCT02689973|4008799|FG003|STARTED|Overall Study||285
3275309|NCT02689973|4008796|FG000|COMPLETED|Overall Study||257
3275310|NCT02689973|4008797|FG001|COMPLETED|Overall Study||221
3275311|NCT02689973|4008798|FG002|COMPLETED|Overall Study||279
3275312|NCT02689973|4008799|FG003|COMPLETED|Overall Study||232
3275313|NCT02689973|4008796|FG000|NOT COMPLETED|Overall Study||54
3275314|NCT02689973|4008797|FG001|NOT COMPLETED|Overall Study||49
3275315|NCT02689973|4008798|FG002|NOT COMPLETED|Overall Study||72
3275316|NCT02689973|4008799|FG003|NOT COMPLETED|Overall Study||53
3275317|NCT02690168|4008810|FG000|STARTED|Overall Study||6
3275318|NCT02690168|4008810|FG000|COMPLETED|Overall Study||6
3275319|NCT02690168|4008810|FG000|NOT COMPLETED|Overall Study||0
3275320|NCT02690181|4008821|FG000|STARTED|Overall Study||14
2937621|NCT00621517|3649427|FG000|STARTED|Overall Study||29
2937622|NCT00621517|3649428|FG001|STARTED|Overall Study||31
2937623|NCT00621517|3649427|FG000|COMPLETED|Overall Study||22
2937624|NCT00621517|3649428|FG001|COMPLETED|Overall Study||24
2937625|NCT00621517|3649427|FG000|NOT COMPLETED|Overall Study||7
3275321|NCT02690181|4008822|FG001|STARTED|Overall Study||14
3275322|NCT02690181|4008823|FG002|STARTED|Overall Study||15
2937626|NCT00621517|3649428|FG001|NOT COMPLETED|Overall Study||7
2937627|NCT00621530|3649436|FG000|STARTED|Overall Study||30
2937628|NCT00621530|3649437|FG001|STARTED|Overall Study||32
2937629|NCT00621530|3649436|FG000|COMPLETED|Overall Study||28
2937630|NCT00621530|3649437|FG001|COMPLETED|Overall Study||29
2937631|NCT00621530|3649436|FG000|NOT COMPLETED|Overall Study||2
3275323|NCT02690181|4008824|FG003|STARTED|Overall Study||10
3275324|NCT02690181|4008825|FG004|STARTED|Overall Study||6
3275325|NCT02690181|4008826|FG005|STARTED|Overall Study||21
3275326|NCT02690181|4008821|FG000|COMPLETED|Overall Study||14
3275327|NCT02690181|4008822|FG001|COMPLETED|Overall Study||14
2937632|NCT00621530|3649437|FG001|NOT COMPLETED|Overall Study||3
2937633|NCT00621543|3649446|FG000|STARTED|Overall Study||120
2937634|NCT00621543|3649446|FG000|COMPLETED|Overall Study||97
2937635|NCT00621543|3649446|FG000|NOT COMPLETED|Overall Study||23
2937636|NCT00621582|3649450|FG000|STARTED|Overall Study||4918
2937637|NCT00621582|3649450|FG000|COMPLETED|Overall Study||4812
2937638|NCT00621582|3649450|FG000|NOT COMPLETED|Overall Study||106
2937639|NCT00621621|3649457|FG000|STARTED|Overall Study|Date of Post- Approval Study protocol approval|105
2937640|NCT00621621|3649458|FG001|STARTED|Overall Study||705
2937641|NCT00621621|3649457|FG000|COMPLETED|Overall Study|Treated with the experimental catheter|75
2937642|NCT00621621|3649458|FG001|COMPLETED|Overall Study||705
2937643|NCT00621621|3649457|FG000|NOT COMPLETED|Overall Study||30
2937644|NCT00621621|3649458|FG001|NOT COMPLETED|Overall Study||0
2937645|NCT00621686|3649468|FG000|STARTED|Overall Study||19
2937646|NCT00621686|3649469|FG001|STARTED|Overall Study||35
2937647|NCT00621686|3649468|FG000|COMPLETED|Overall Study||19
2937648|NCT00621686|3649469|FG001|COMPLETED|Overall Study||35
2937649|NCT00621686|3649468|FG000|NOT COMPLETED|Overall Study||0
2937650|NCT00621686|3649469|FG001|NOT COMPLETED|Overall Study||0
2937651|NCT00621751|3649478|FG000|STARTED|Overall Study||35
2937652|NCT00621751|3649479|FG001|STARTED|Overall Study||35
2937653|NCT00621751|3649478|FG000|COMPLETED|Overall Study||35
2937654|NCT00621751|3649479|FG001|COMPLETED|Overall Study||34
2937655|NCT00621751|3649478|FG000|NOT COMPLETED|Overall Study||0
2937656|NCT00621751|3649479|FG001|NOT COMPLETED|Overall Study||1
2937657|NCT00621764|3649489|FG000|STARTED|Overall Study||50
2937658|NCT00621764|3649490|FG001|STARTED|Overall Study||50
2937659|NCT00621764|3649491|FG002|STARTED|Overall Study||101
2937660|NCT00621764|3649492|FG003|STARTED|Overall Study||99
2937661|NCT00621764|3649489|FG000|COMPLETED|Overall Study||50
2937662|NCT00621764|3649490|FG001|COMPLETED|Overall Study||50
2937663|NCT00621764|3649491|FG002|COMPLETED|Overall Study||101
2937664|NCT00621764|3649492|FG003|COMPLETED|Overall Study||98
2937665|NCT00621764|3649489|FG000|NOT COMPLETED|Overall Study||0
2937666|NCT00621764|3649490|FG001|NOT COMPLETED|Overall Study||0
2937667|NCT00621764|3649491|FG002|NOT COMPLETED|Overall Study||0
2937668|NCT00621764|3649492|FG003|NOT COMPLETED|Overall Study||1
2937669|NCT00621777|3649505|FG000|STARTED|Open Phase||203
2937670|NCT00621777|3649506|FG001|STARTED|Open Phase|During this open label phase, all study participants received varenicline|0
2937671|NCT00621777|3649505|FG000|COMPLETED|Open Phase||87
2937672|NCT00621777|3649506|FG001|COMPLETED|Open Phase||0
2937673|NCT00621777|3649505|FG000|NOT COMPLETED|Open Phase||116
2937674|NCT00621777|3649506|FG001|NOT COMPLETED|Open Phase||0
2937675|NCT00621777|3649505|FG000|STARTED|Randomized Phase|87 open phase participants were continuously abstinent for at least 14 days and were randomized|40
2937676|NCT00621777|3649506|FG001|STARTED|Randomized Phase||47
2937677|NCT00621777|3649505|FG000|COMPLETED|Randomized Phase||33
2937678|NCT00621777|3649506|FG001|COMPLETED|Randomized Phase||28
2937679|NCT00621777|3649505|FG000|NOT COMPLETED|Randomized Phase||7
2937680|NCT00621777|3649506|FG001|NOT COMPLETED|Randomized Phase||19
2937681|NCT00621842|3649514|FG000|STARTED|Overall Study||57
2937682|NCT00621842|3649514|FG000|COMPLETED|Overall Study||38
2937683|NCT00621842|3649514|FG000|NOT COMPLETED|Overall Study||19
2937684|NCT00621855|3649523|FG000|STARTED|Overall Study|Started means randomised to treatment|372
2937685|NCT00621855|3649524|FG001|STARTED|Overall Study|Started means randomised to treatment|371
2937686|NCT00621855|3649525|FG002|STARTED|Overall Study|Started means randomised to treatment|411
2937687|NCT00621855|3649526|FG003|STARTED|Overall Study|Started means randomised to treatment|351
2937688|NCT00621855|3649527|FG004|STARTED|Overall Study|Started means randomised to treatment|373
2937689|NCT00621855|3649523|FG000|COMPLETED|Overall Study|Completed means completed treatment|296
2937690|NCT00621855|3649524|FG001|COMPLETED|Overall Study|Completed means completed treatment|310
2937691|NCT00621855|3649525|FG002|COMPLETED|Overall Study|Completed means completed treatment|330
2937692|NCT00621855|3649526|FG003|COMPLETED|Overall Study|Completed means completed treatment|284
2937693|NCT00621855|3649527|FG004|COMPLETED|Overall Study|Completed means completed treatment|318
2937694|NCT00621855|3649523|FG000|NOT COMPLETED|Overall Study||76
2937695|NCT00621855|3649524|FG001|NOT COMPLETED|Overall Study||61
2937696|NCT00621855|3649525|FG002|NOT COMPLETED|Overall Study||81
2937697|NCT00621855|3649526|FG003|NOT COMPLETED|Overall Study||67
2937698|NCT00621855|3649527|FG004|NOT COMPLETED|Overall Study||55
2937699|NCT00621933|3649539|FG000|STARTED|Overall Study||399
2937700|NCT00621933|3649539|FG000|COMPLETED|Overall Study||399
2937701|NCT00621933|3649539|FG000|NOT COMPLETED|Overall Study||0
2937702|NCT00621946|3649545|FG000|STARTED|Overall Study||13
2937703|NCT00621946|3649546|FG001|STARTED|Overall Study||13
2937704|NCT00621946|3649545|FG000|COMPLETED|Overall Study||13
2937705|NCT00621946|3649546|FG001|COMPLETED|Overall Study||12
2937706|NCT00621946|3649545|FG000|NOT COMPLETED|Overall Study||0
2937707|NCT00621946|3649546|FG001|NOT COMPLETED|Overall Study||1
2937708|NCT00621959|3649555|FG000|STARTED|Overall Study|In all 791 subjects have been screened and 596 have been randomized|295
2937709|NCT00621959|3649556|FG001|STARTED|Overall Study||301
2937710|NCT00621959|3649555|FG000|COMPLETED|Overall Study||288
2937711|NCT00621959|3649556|FG001|COMPLETED|Overall Study||292
2937712|NCT00621959|3649555|FG000|NOT COMPLETED|Overall Study||7
2937713|NCT00621959|3649556|FG001|NOT COMPLETED|Overall Study||9
2937714|NCT00621985|3649562|FG000|STARTED|Hydrocortisone Admission||5
2937715|NCT00621985|3649562|FG000|COMPLETED|Hydrocortisone Admission||5
2937716|NCT00621985|3649562|FG000|NOT COMPLETED|Hydrocortisone Admission||0
2937717|NCT00621985|3649562|FG000|STARTED|Dexamethasone Admission||5
2937718|NCT00621985|3649562|FG000|COMPLETED|Dexamethasone Admission||4
2937719|NCT00621985|3649562|FG000|NOT COMPLETED|Dexamethasone Admission||1
2937720|NCT00622180|3649568|FG000|STARTED|Overall Study||6
2937721|NCT00622180|3649569|FG001|STARTED|Overall Study||7
2937722|NCT00622180|3649568|FG000|COMPLETED|Overall Study||5
2937723|NCT00622180|3649569|FG001|COMPLETED|Overall Study||5
2937724|NCT00622180|3649568|FG000|NOT COMPLETED|Overall Study||1
2937725|NCT00622180|3649569|FG001|NOT COMPLETED|Overall Study||2
2937726|NCT00622284|3649577|FG000|STARTED|Overall Study|Number who started treatment. One patient in the Linagliptin group was randomized but not treated.|776
2937727|NCT00622284|3649578|FG001|STARTED|Overall Study|Number who started treatment.|775
2937728|NCT00622284|3649577|FG000|COMPLETED|Overall Study|Number who completed treatment.|587
2937729|NCT00622284|3649578|FG001|COMPLETED|Overall Study|Number who completed treatment.|604
2937730|NCT00622284|3649577|FG000|NOT COMPLETED|Overall Study||189
2937731|NCT00622284|3649578|FG001|NOT COMPLETED|Overall Study||171
2937732|NCT00622336|3649584|FG000|STARTED|Treatment Phase||330
2937733|NCT00622336|3649584|FG000|Safety Population|Treatment Phase||330
2937734|NCT00622336|3649584|FG000|COMPLETED|Treatment Phase|Completed = those who completed the treatment phase and were ongoing in the extension study|21
2937735|NCT00622336|3649584|FG000|NOT COMPLETED|Treatment Phase||309
2937736|NCT00622336|3649584|FG000|STARTED|Extension Phase||21
2937737|NCT00622336|3649584|FG000|COMPLETED|Extension Phase||0
2937738|NCT00622336|3649584|FG000|NOT COMPLETED|Extension Phase||21
3034398|NCT01132651|3753492|FG000|COMPLETED|Overall Study||3
3034399|NCT01132651|3753493|FG001|COMPLETED|Overall Study||4
3034400|NCT01132651|3753492|FG000|NOT COMPLETED|Overall Study||1
3034401|NCT01132651|3753493|FG001|NOT COMPLETED|Overall Study||1
3034402|NCT01132664|3753504|FG000|STARTED|Phase lb||5
3034403|NCT01132664|3753505|FG001|STARTED|Phase lb||12
3034404|NCT01132664|3753506|FG002|STARTED|Phase lb||0
3275328|NCT02690181|4008823|FG002|COMPLETED|Overall Study||15
3275329|NCT02690181|4008824|FG003|COMPLETED|Overall Study||10
3275330|NCT02690181|4008825|FG004|COMPLETED|Overall Study||6
3034405|NCT01132664|3753507|FG003|STARTED|Phase lb||0
3034406|NCT01132664|3753508|FG004|STARTED|Phase lb||0
3034407|NCT01132664|3753504|FG000|COMPLETED|Phase lb||0
3034408|NCT01132664|3753505|FG001|COMPLETED|Phase lb||0
3034409|NCT01132664|3753506|FG002|COMPLETED|Phase lb||0
3034410|NCT01132664|3753507|FG003|COMPLETED|Phase lb||0
3034411|NCT01132664|3753508|FG004|COMPLETED|Phase lb||0
3034412|NCT01132664|3753504|FG000|NOT COMPLETED|Phase lb||5
3034413|NCT01132664|3753505|FG001|NOT COMPLETED|Phase lb||12
3034414|NCT01132664|3753506|FG002|NOT COMPLETED|Phase lb||0
3275331|NCT02690181|4008826|FG005|COMPLETED|Overall Study||21
3275332|NCT02690181|4008821|FG000|NOT COMPLETED|Overall Study||0
3275333|NCT02690181|4008822|FG001|NOT COMPLETED|Overall Study||0
3275334|NCT02690181|4008823|FG002|NOT COMPLETED|Overall Study||0
3275335|NCT02690181|4008824|FG003|NOT COMPLETED|Overall Study||0
3275336|NCT02690181|4008825|FG004|NOT COMPLETED|Overall Study||0
3275337|NCT02690181|4008826|FG005|NOT COMPLETED|Overall Study||0
3275338|NCT02690194|4008843|FG000|STARTED|Overall Study||17
3275339|NCT02690194|4008844|FG001|STARTED|Overall Study||18
3275340|NCT02690194|4008845|FG002|STARTED|Overall Study||19
3275341|NCT02690194|4008843|FG000|COMPLETED|Overall Study||16
3275342|NCT02690194|4008844|FG001|COMPLETED|Overall Study||14
3275343|NCT02690194|4008845|FG002|COMPLETED|Overall Study||19
3275344|NCT02690194|4008843|FG000|NOT COMPLETED|Overall Study||1
3275345|NCT02690194|4008844|FG001|NOT COMPLETED|Overall Study||4
3275346|NCT02690194|4008845|FG002|NOT COMPLETED|Overall Study||0
3275347|NCT02690207|4008853|FG000|STARTED|Overall Study||8687
3275348|NCT02690207|4008853|FG000|COMPLETED|Overall Study||8434
3275349|NCT02690207|4008853|FG000|NOT COMPLETED|Overall Study||253
3275350|NCT02690558|4008857|FG000|STARTED|Overall Study||39
3275351|NCT02690558|4008857|FG000|COMPLETED|Overall Study||39
3275352|NCT02690558|4008857|FG000|NOT COMPLETED|Overall Study||0
3275353|NCT02690649|4008863|FG000|STARTED|Overall Study||80
3275354|NCT02690649|4008864|FG001|STARTED|Overall Study||80
3275355|NCT02690649|4008863|FG000|COMPLETED|Overall Study||79
3275356|NCT02690649|4008864|FG001|COMPLETED|Overall Study||76
3275357|NCT02690649|4008863|FG000|NOT COMPLETED|Overall Study||1
3275358|NCT02690649|4008864|FG001|NOT COMPLETED|Overall Study||4
3275359|NCT02690701|4008874|FG000|STARTED|Treatment Period 1||46
3275360|NCT02690701|4008875|FG001|STARTED|Treatment Period 1||45
3275361|NCT02690701|4008874|FG000|COMPLETED|Treatment Period 1||44
3275362|NCT02690701|4008875|FG001|COMPLETED|Treatment Period 1||42
3275363|NCT02690701|4008874|FG000|NOT COMPLETED|Treatment Period 1||2
3275364|NCT02690701|4008875|FG001|NOT COMPLETED|Treatment Period 1||3
3275365|NCT02690701|4008874|FG000|STARTED|Treatment Period 2|Completed Treatment Period 1 and continued to Treatment Period 2|44
3275366|NCT02690701|4008875|FG001|STARTED|Treatment Period 2||42
2937739|NCT00622388|3649590|FG000|STARTED|Overall Study||81
2937740|NCT00622388|3649590|FG000|COMPLETED|Overall Study||9
2937741|NCT00622388|3649590|FG000|NOT COMPLETED|Overall Study||72
2937742|NCT00622401|3649598|FG000|STARTED|Overall Study||6
2937743|NCT00622401|3649599|FG001|STARTED|Overall Study||2
2937744|NCT00622401|3649600|FG002|STARTED|Overall Study|Never Opened|0
2937745|NCT00622401|3649598|FG000|COMPLETED|Overall Study||3
2937746|NCT00622401|3649599|FG001|COMPLETED|Overall Study||0
2937747|NCT00622401|3649600|FG002|COMPLETED|Overall Study||0
2937748|NCT00622401|3649598|FG000|NOT COMPLETED|Overall Study||3
2937749|NCT00622401|3649599|FG001|NOT COMPLETED|Overall Study||2
2937750|NCT00622401|3649600|FG002|NOT COMPLETED|Overall Study||0
2937751|NCT00622427|3649609|FG000|STARTED|Overall Study||16
2937752|NCT00622427|3649610|FG001|STARTED|Overall Study||16
2937753|NCT00622427|3649609|FG000|COMPLETED|Overall Study|each subject received 2 weeks of Ramelteon, then 2 weeks of placebo after a two week wash out period|16
2937754|NCT00622427|3649610|FG001|COMPLETED|Overall Study|each subject received 2 weeks of placebo, then 2 weeks of Ramelteon after a two week wash out period|16
3275367|NCT02690701|4008874|FG000|COMPLETED|Treatment Period 2|Completed Treatment Period 2|41
3275368|NCT02690701|4008875|FG001|COMPLETED|Treatment Period 2||37
3275369|NCT02690701|4008874|FG000|NOT COMPLETED|Treatment Period 2||3
3275370|NCT02690701|4008875|FG001|NOT COMPLETED|Treatment Period 2||5
2937755|NCT00622427|3649609|FG000|NOT COMPLETED|Overall Study||0
2937756|NCT00622427|3649610|FG001|NOT COMPLETED|Overall Study||0
2937757|NCT00622440|3649620|FG000|STARTED|Baseline - Week 12 (Treatment)||35
2937758|NCT00622440|3649621|FG001|STARTED|Baseline - Week 12 (Treatment)||35
2937759|NCT00622440|3649620|FG000|COMPLETED|Baseline - Week 12 (Treatment)||31
2937760|NCT00622440|3649621|FG001|COMPLETED|Baseline - Week 12 (Treatment)||34
2937761|NCT00622440|3649620|FG000|NOT COMPLETED|Baseline - Week 12 (Treatment)||4
2937762|NCT00622440|3649621|FG001|NOT COMPLETED|Baseline - Week 12 (Treatment)||1
2937763|NCT00622440|3649620|FG000|STARTED|Week 12 - Week 48 (Treatment)||31
2937764|NCT00622440|3649621|FG001|STARTED|Week 12 - Week 48 (Treatment)||34
2937765|NCT00622440|3649620|FG000|COMPLETED|Week 12 - Week 48 (Treatment)||28
2937766|NCT00622440|3649621|FG001|COMPLETED|Week 12 - Week 48 (Treatment)||28
2937767|NCT00622440|3649620|FG000|NOT COMPLETED|Week 12 - Week 48 (Treatment)||3
2937768|NCT00622440|3649621|FG001|NOT COMPLETED|Week 12 - Week 48 (Treatment)||6
2937769|NCT00622440|3649620|FG000|STARTED|Week 60 (Post-treatment Follow-up Visit)||28
2937770|NCT00622440|3649621|FG001|STARTED|Week 60 (Post-treatment Follow-up Visit)||28
2937771|NCT00622440|3649620|FG000|COMPLETED|Week 60 (Post-treatment Follow-up Visit)||28
2937772|NCT00622440|3649621|FG001|COMPLETED|Week 60 (Post-treatment Follow-up Visit)||27
2937773|NCT00622440|3649620|FG000|NOT COMPLETED|Week 60 (Post-treatment Follow-up Visit)||0
2937774|NCT00622440|3649621|FG001|NOT COMPLETED|Week 60 (Post-treatment Follow-up Visit)||1
2937775|NCT00622466|3649627|FG000|STARTED|Overall Study||20
2937776|NCT00622466|3649627|FG000|COMPLETED|Overall Study||16
2937777|NCT00622466|3649627|FG000|NOT COMPLETED|Overall Study||4
2937778|NCT00622505|3649633|FG000|STARTED|Overall Study||79
2937779|NCT00622505|3649634|FG001|STARTED|Overall Study||42
2937780|NCT00622505|3649633|FG000|COMPLETED|Overall Study||50
2937781|NCT00622505|3649634|FG001|COMPLETED|Overall Study||19
2937782|NCT00622505|3649633|FG000|NOT COMPLETED|Overall Study||29
2937783|NCT00622505|3649634|FG001|NOT COMPLETED|Overall Study||23
2937784|NCT00622518|3649642|FG000|STARTED|Overall Study||59
2937785|NCT00622518|3649643|FG001|STARTED|Overall Study||60
2937786|NCT00622518|3649642|FG000|COMPLETED|Overall Study||59
2937787|NCT00622518|3649643|FG001|COMPLETED|Overall Study||60
2937788|NCT00622518|3649642|FG000|NOT COMPLETED|Overall Study||0
2937789|NCT00622518|3649643|FG001|NOT COMPLETED|Overall Study||0
2937790|NCT00622544|3649649|FG000|STARTED|Overall Study||44
2937791|NCT00622544|3649649|FG000|COMPLETED|Overall Study|35|35
2937792|NCT00622544|3649649|FG000|NOT COMPLETED|Overall Study||9
2937793|NCT00622635|3649653|FG000|STARTED|Treatment Period 1||13
2937794|NCT00622635|3649654|FG001|STARTED|Treatment Period 1||11
2937795|NCT00622635|3649655|FG002|STARTED|Treatment Period 1||11
2937796|NCT00622635|3649656|FG003|STARTED|Treatment Period 1||13
2937797|NCT00622635|3649657|FG004|STARTED|Treatment Period 1||10
2937798|NCT00622635|3649658|FG005|STARTED|Treatment Period 1||10
2937799|NCT00622635|3649653|FG000|COMPLETED|Treatment Period 1||13
2937800|NCT00622635|3649654|FG001|COMPLETED|Treatment Period 1||10
2937801|NCT00622635|3649655|FG002|COMPLETED|Treatment Period 1||10
2937802|NCT00622635|3649656|FG003|COMPLETED|Treatment Period 1||13
2937803|NCT00622635|3649657|FG004|COMPLETED|Treatment Period 1||9
2937804|NCT00622635|3649658|FG005|COMPLETED|Treatment Period 1||10
2937805|NCT00622635|3649653|FG000|NOT COMPLETED|Treatment Period 1||0
2937806|NCT00622635|3649654|FG001|NOT COMPLETED|Treatment Period 1||1
2937807|NCT00622635|3649655|FG002|NOT COMPLETED|Treatment Period 1||1
2937808|NCT00622635|3649656|FG003|NOT COMPLETED|Treatment Period 1||0
2937809|NCT00622635|3649657|FG004|NOT COMPLETED|Treatment Period 1||1
2937810|NCT00622635|3649658|FG005|NOT COMPLETED|Treatment Period 1||0
2937811|NCT00622635|3649653|FG000|STARTED|Treatment Period 2||13
2937812|NCT00622635|3649654|FG001|STARTED|Treatment Period 2||10
2937813|NCT00622635|3649655|FG002|STARTED|Treatment Period 2||10
2937814|NCT00622635|3649656|FG003|STARTED|Treatment Period 2||13
2937815|NCT00622635|3649657|FG004|STARTED|Treatment Period 2||9
2937816|NCT00622635|3649658|FG005|STARTED|Treatment Period 2||10
2937817|NCT00622635|3649653|FG000|COMPLETED|Treatment Period 2||12
2937818|NCT00622635|3649654|FG001|COMPLETED|Treatment Period 2||10
2937819|NCT00622635|3649655|FG002|COMPLETED|Treatment Period 2||10
2937820|NCT00622635|3649656|FG003|COMPLETED|Treatment Period 2||13
2937821|NCT00622635|3649657|FG004|COMPLETED|Treatment Period 2||9
2937822|NCT00622635|3649658|FG005|COMPLETED|Treatment Period 2||10
2937823|NCT00622635|3649653|FG000|NOT COMPLETED|Treatment Period 2||1
2937824|NCT00622635|3649654|FG001|NOT COMPLETED|Treatment Period 2||0
3275371|NCT02690714|4008882|FG000|STARTED|Segment 1: Single-dose Day -4 to Day 0||9
3275372|NCT02690714|4008882|FG000|COMPLETED|Segment 1: Single-dose Day -4 to Day 0|Six participants skipped Segment 1 as they had PK data from Phase 1 study 2002C005G.|9
3275373|NCT02690714|4008882|FG000|NOT COMPLETED|Segment 1: Single-dose Day -4 to Day 0||0
3275374|NCT02690714|4008882|FG000|STARTED|Segment 2: Multi-dose Day 0 to Week 12||15
3275375|NCT02690714|4008882|FG000|COMPLETED|Segment 2: Multi-dose Day 0 to Week 12||15
3275376|NCT02690714|4008882|FG000|NOT COMPLETED|Segment 2: Multi-dose Day 0 to Week 12||0
3275377|NCT02690714|4008882|FG000|STARTED|Segment 3: Extended Treatment Wks 12-48||15
3275378|NCT02690714|4008882|FG000|COMPLETED|Segment 3: Extended Treatment Wks 12-48||15
3275379|NCT02690714|4008882|FG000|NOT COMPLETED|Segment 3: Extended Treatment Wks 12-48||0
3275380|NCT02690714|4008882|FG000|STARTED|Post-Wk 48: Safety Week 48 to EoS Visit|3 subjects from Norway did not go past 48 weeks|12
3275381|NCT02690714|4008882|FG000|COMPLETED|Post-Wk 48: Safety Week 48 to EoS Visit||10
3275382|NCT02690714|4008882|FG000|NOT COMPLETED|Post-Wk 48: Safety Week 48 to EoS Visit||2
3275383|NCT02690727|4008890|FG000|STARTED|Overall Study||9
3275384|NCT02690727|4008891|FG001|STARTED|Overall Study||9
3275385|NCT02690727|4008890|FG000|COMPLETED|Overall Study||7
3275386|NCT02690727|4008891|FG001|COMPLETED|Overall Study||7
3275387|NCT02690727|4008890|FG000|NOT COMPLETED|Overall Study||2
3275388|NCT02690727|4008891|FG001|NOT COMPLETED|Overall Study||2
3275389|NCT02690935|4008901|FG000|STARTED|Overall Study|Count of participants|51
3275390|NCT02690935|4008902|FG001|STARTED|Overall Study|Count of participants|51
3275391|NCT02690935|4008901|FG000|COMPLETED|Overall Study|Count of participants|51
3275392|NCT02690935|4008902|FG001|COMPLETED|Overall Study|Count of participants|51
3275393|NCT02690935|4008901|FG000|NOT COMPLETED|Overall Study||0
3275394|NCT02690935|4008902|FG001|NOT COMPLETED|Overall Study||0
3275395|NCT02690948|4008910|FG000|STARTED|Overall Study||9
3275396|NCT02690948|4008911|FG001|STARTED|Overall Study||7
3275397|NCT02690948|4008910|FG000|COMPLETED|Overall Study||9
3275398|NCT02690948|4008911|FG001|COMPLETED|Overall Study||7
3275399|NCT02690948|4008910|FG000|NOT COMPLETED|Overall Study||0
3275400|NCT02690948|4008911|FG001|NOT COMPLETED|Overall Study||0
3275401|NCT02690974|4008917|FG000|STARTED|Overall Study||302
3275402|NCT02690974|4008917|FG000|COMPLETED|Overall Study||262
3275403|NCT02690974|4008917|FG000|NOT COMPLETED|Overall Study||40
3275404|NCT02691143|4008923|FG000|STARTED|Overall Study||27
3275405|NCT02691143|4008924|FG001|STARTED|Overall Study||23
3275406|NCT02691143|4008923|FG000|COMPLETED|Overall Study||27
3275407|NCT02691143|4008924|FG001|COMPLETED|Overall Study||23
3275408|NCT02691143|4008923|FG000|NOT COMPLETED|Overall Study||0
3275409|NCT02691143|4008924|FG001|NOT COMPLETED|Overall Study||0
3275410|NCT02691247|4008933|FG000|STARTED|Overall Study||40
3275411|NCT02691247|4008934|FG001|STARTED|Overall Study||24
3275412|NCT02691247|4008935|FG002|STARTED|Overall Study||46
3275413|NCT02691247|4008933|FG000|COMPLETED|Overall Study||37
3275414|NCT02691247|4008934|FG001|COMPLETED|Overall Study||22
3275415|NCT02691247|4008935|FG002|COMPLETED|Overall Study||43
3275416|NCT02691247|4008933|FG000|NOT COMPLETED|Overall Study||3
3275417|NCT02691247|4008934|FG001|NOT COMPLETED|Overall Study||2
3275418|NCT02691247|4008935|FG002|NOT COMPLETED|Overall Study||3
3275419|NCT02691260|4008947|FG000|STARTED|Overall Study||26
3275420|NCT02691260|4008948|FG001|STARTED|Overall Study||26
3275421|NCT02691260|4008949|FG002|STARTED|Overall Study||27
3275422|NCT02691260|4008950|FG003|STARTED|Overall Study||26
3275423|NCT02691260|4008947|FG000|COMPLETED|Overall Study||24
3275424|NCT02691260|4008948|FG001|COMPLETED|Overall Study||24
3275425|NCT02691260|4008949|FG002|COMPLETED|Overall Study||25
3275426|NCT02691260|4008950|FG003|COMPLETED|Overall Study||23
3275427|NCT02691260|4008947|FG000|NOT COMPLETED|Overall Study||2
3275428|NCT02691260|4008948|FG001|NOT COMPLETED|Overall Study||2
3275429|NCT02691260|4008949|FG002|NOT COMPLETED|Overall Study||2
3275430|NCT02691260|4008950|FG003|NOT COMPLETED|Overall Study||3
3275431|NCT02691416|4008962|FG000|STARTED|Overall Study||30
3275432|NCT02691416|4008963|FG001|STARTED|Overall Study||30
3275433|NCT02691416|4008962|FG000|COMPLETED|Overall Study||30
3275434|NCT02691416|4008963|FG001|COMPLETED|Overall Study||30
3275435|NCT02691416|4008962|FG000|NOT COMPLETED|Overall Study||0
3275436|NCT02691416|4008963|FG001|NOT COMPLETED|Overall Study||0
3275437|NCT02691455|4008975|FG000|STARTED|Overall Study||23
3275438|NCT02691455|4008976|FG001|STARTED|Overall Study||22
3275439|NCT02691455|4008975|FG000|Randomized|Overall Study||23
3275440|NCT02691455|4008976|FG001|Randomized|Overall Study||22
3275441|NCT02691455|4008975|FG000|Received Assigned Intervention|Overall Study||22
3275442|NCT02691455|4008976|FG001|Received Assigned Intervention|Overall Study||20
3275443|NCT02691455|4008975|FG000|Week 1 Follow up|Overall Study||22
3275444|NCT02691455|4008976|FG001|Week 1 Follow up|Overall Study||19
3275445|NCT02691455|4008975|FG000|Month 1 Follow up|Overall Study||22
3275446|NCT02691455|4008976|FG001|Month 1 Follow up|Overall Study||18
3275447|NCT02691455|4008975|FG000|Month 3 Follow up|Overall Study||21
3275448|NCT02691455|4008976|FG001|Month 3 Follow up|Overall Study||18
3275449|NCT02691455|4008975|FG000|Month 6 Follow up|Overall Study||19
3275450|NCT02691455|4008976|FG001|Month 6 Follow up|Overall Study||19
2937825|NCT00622635|3649655|FG002|NOT COMPLETED|Treatment Period 2||0
2937826|NCT00622635|3649656|FG003|NOT COMPLETED|Treatment Period 2||0
3275451|NCT02691455|4008975|FG000|Month 12 Follow up|Overall Study||16
3275452|NCT02691455|4008976|FG001|Month 12 Follow up|Overall Study||16
3275453|NCT02691455|4008975|FG000|Year 2 Follow up|Overall Study||6
3275454|NCT02691455|4008976|FG001|Year 2 Follow up|Overall Study||9
3275455|NCT02691455|4008975|FG000|Year 3 Follow up|Overall Study||7
3275456|NCT02691455|4008976|FG001|Year 3 Follow up|Overall Study||5
3275457|NCT02691455|4008975|FG000|COMPLETED|Overall Study||7
3275458|NCT02691455|4008976|FG001|COMPLETED|Overall Study||5
3275459|NCT02691455|4008975|FG000|NOT COMPLETED|Overall Study||16
3275460|NCT02691455|4008976|FG001|NOT COMPLETED|Overall Study||17
3275461|NCT02691468|4008984|FG000|STARTED|Overall Study||54
3275462|NCT02691468|4008985|FG001|STARTED|Overall Study||54
3275463|NCT02691468|4008984|FG000|COMPLETED|Overall Study||48
3275464|NCT02691468|4008985|FG001|COMPLETED|Overall Study||52
3275465|NCT02691468|4008984|FG000|NOT COMPLETED|Overall Study||6
3275466|NCT02691468|4008985|FG001|NOT COMPLETED|Overall Study||2
3275467|NCT02691494|4008994|FG000|STARTED|Treatment Period||94
3275468|NCT02691494|4008995|FG001|STARTED|Treatment Period||95
3275469|NCT02691494|4008996|FG002|STARTED|Treatment Period||189
3275470|NCT02691494|4008994|FG000|COMPLETED|Treatment Period|completed treatment period|72
3275471|NCT02691494|4008995|FG001|COMPLETED|Treatment Period|completed treatment period|69
3275472|NCT02691494|4008996|FG002|COMPLETED|Treatment Period|completed treatment period|148
3275473|NCT02691494|4008994|FG000|NOT COMPLETED|Treatment Period||22
3275474|NCT02691494|4008995|FG001|NOT COMPLETED|Treatment Period||26
3275475|NCT02691494|4008996|FG002|NOT COMPLETED|Treatment Period||41
3275476|NCT02691494|4008994|FG000|STARTED|Post-Treatment Follow-Up Period||14
3275477|NCT02691494|4008995|FG001|STARTED|Post-Treatment Follow-Up Period||25
3275478|NCT02691494|4008996|FG002|STARTED|Post-Treatment Follow-Up Period||59
3275479|NCT02691494|4008994|FG000|COMPLETED|Post-Treatment Follow-Up Period||9
3275480|NCT02691494|4008995|FG001|COMPLETED|Post-Treatment Follow-Up Period||18
3275481|NCT02691494|4008996|FG002|COMPLETED|Post-Treatment Follow-Up Period||42
3275482|NCT02691494|4008994|FG000|NOT COMPLETED|Post-Treatment Follow-Up Period||5
3275483|NCT02691494|4008995|FG001|NOT COMPLETED|Post-Treatment Follow-Up Period||7
3275484|NCT02691494|4008996|FG002|NOT COMPLETED|Post-Treatment Follow-Up Period||17
3275485|NCT02691507|4009006|FG000|STARTED|Overall Study||40
3275486|NCT02691507|4009007|FG001|STARTED|Overall Study||13
3275487|NCT02691507|4009006|FG000|COMPLETED|Overall Study||40
3275488|NCT02691507|4009007|FG001|COMPLETED|Overall Study||12
3275489|NCT02691507|4009006|FG000|NOT COMPLETED|Overall Study||0
3275490|NCT02691507|4009007|FG001|NOT COMPLETED|Overall Study||1
3275491|NCT02691572|4009015|FG000|STARTED|Overall Study||40
3275492|NCT02691572|4009016|FG001|STARTED|Overall Study||40
3275493|NCT02691572|4009015|FG000|COMPLETED|Overall Study||39
3275494|NCT02691572|4009016|FG001|COMPLETED|Overall Study||39
3275495|NCT02691572|4009015|FG000|NOT COMPLETED|Overall Study||1
3275496|NCT02691572|4009016|FG001|NOT COMPLETED|Overall Study||1
3275497|NCT02691702|4009033|FG000|STARTED|Overall Study||10
3275498|NCT02691702|4009034|FG001|STARTED|Overall Study||11
3275499|NCT02691702|4009035|FG002|STARTED|Overall Study||8
3275500|NCT02691702|4009036|FG003|STARTED|Overall Study||8
3275501|NCT02691702|4009037|FG004|STARTED|Overall Study||8
3275502|NCT02691702|4009038|FG005|STARTED|Overall Study||8
3275503|NCT02691702|4009039|FG006|STARTED|Overall Study||8
3275504|NCT02691702|4009040|FG007|STARTED|Overall Study||12
3275505|NCT02691702|4009041|FG008|STARTED|Overall Study||8
3275506|NCT02691702|4009042|FG009|STARTED|Overall Study||8
3275507|NCT02691702|4009043|FG010|STARTED|Overall Study||8
3275508|NCT02691702|4009033|FG000|COMPLETED|Overall Study||8
3275509|NCT02691702|4009034|FG001|COMPLETED|Overall Study||10
3275510|NCT02691702|4009035|FG002|COMPLETED|Overall Study||7
3275511|NCT02691702|4009036|FG003|COMPLETED|Overall Study||8
3275512|NCT02691702|4009037|FG004|COMPLETED|Overall Study||8
3275513|NCT02691702|4009038|FG005|COMPLETED|Overall Study||5
3275514|NCT02691702|4009039|FG006|COMPLETED|Overall Study||5
3275515|NCT02691702|4009040|FG007|COMPLETED|Overall Study||12
3275516|NCT02691702|4009041|FG008|COMPLETED|Overall Study||6
3275517|NCT02691702|4009042|FG009|COMPLETED|Overall Study||6
3275518|NCT02691702|4009043|FG010|COMPLETED|Overall Study||6
3275519|NCT02691702|4009033|FG000|NOT COMPLETED|Overall Study||2
3275520|NCT02691702|4009034|FG001|NOT COMPLETED|Overall Study||1
3275521|NCT02691702|4009035|FG002|NOT COMPLETED|Overall Study||1
3275522|NCT02691702|4009036|FG003|NOT COMPLETED|Overall Study||0
3275523|NCT02691702|4009037|FG004|NOT COMPLETED|Overall Study||0
3275524|NCT02691702|4009038|FG005|NOT COMPLETED|Overall Study||3
3275525|NCT02691702|4009039|FG006|NOT COMPLETED|Overall Study||3
3275526|NCT02691702|4009040|FG007|NOT COMPLETED|Overall Study||0
3275527|NCT02691702|4009041|FG008|NOT COMPLETED|Overall Study||2
3275528|NCT02691702|4009042|FG009|NOT COMPLETED|Overall Study||2
3275529|NCT02691702|4009043|FG010|NOT COMPLETED|Overall Study||2
3275530|NCT02691741|4009077|FG000|STARTED|Overall Study||94
3275531|NCT02691741|4009078|FG001|STARTED|Overall Study||94
2937827|NCT00622635|3649657|FG004|NOT COMPLETED|Treatment Period 2||0
3275532|NCT02691741|4009077|FG000|All-Implanted Analysis Set|Overall Study||93
3275533|NCT02691741|4009078|FG001|All-Implanted Analysis Set|Overall Study||89
3275534|NCT02691741|4009077|FG000|Best-Case Analysis Set|Overall Study||86
3275535|NCT02691741|4009078|FG001|Best-Case Analysis Set|Overall Study||85
3275536|NCT02691741|4009077|FG000|Safety Analysis Set|Overall Study||93
3275537|NCT02691741|4009078|FG001|Safety Analysis Set|Overall Study||89
3275538|NCT02691741|4009077|FG000|COMPLETED|Overall Study||93
3275539|NCT02691741|4009078|FG001|COMPLETED|Overall Study||87
3275540|NCT02691741|4009077|FG000|NOT COMPLETED|Overall Study||1
3275541|NCT02691741|4009078|FG001|NOT COMPLETED|Overall Study||7
2937828|NCT00622635|3649658|FG005|NOT COMPLETED|Treatment Period 2||0
2937829|NCT00622635|3649653|FG000|STARTED|Treatment Period 3||12
2937830|NCT00622635|3649654|FG001|STARTED|Treatment Period 3||10
2937831|NCT00622635|3649655|FG002|STARTED|Treatment Period 3||10
2937832|NCT00622635|3649656|FG003|STARTED|Treatment Period 3||13
2937833|NCT00622635|3649657|FG004|STARTED|Treatment Period 3||9
2937834|NCT00622635|3649658|FG005|STARTED|Treatment Period 3||10
2937835|NCT00622635|3649653|FG000|COMPLETED|Treatment Period 3||12
2937836|NCT00622635|3649654|FG001|COMPLETED|Treatment Period 3||10
3275542|NCT02691936|4009091|FG000|STARTED|Overall Study||35
3275543|NCT02691936|4009092|FG001|STARTED|Overall Study||34
3275544|NCT02691936|4009091|FG000|COMPLETED|Overall Study||33
3275545|NCT02691936|4009092|FG001|COMPLETED|Overall Study||29
3275546|NCT02691936|4009091|FG000|NOT COMPLETED|Overall Study||2
3275547|NCT02691936|4009092|FG001|NOT COMPLETED|Overall Study||5
3275548|NCT02691962|4009098|FG000|STARTED|Overall Study||75
3275549|NCT02691962|4009098|FG000|COMPLETED|Overall Study||59
3275550|NCT02691962|4009098|FG000|NOT COMPLETED|Overall Study||16
3275551|NCT02692040|4009120|FG000|STARTED|Overall Study||10
3275552|NCT02692040|4009121|FG001|STARTED|Overall Study||4
3275553|NCT02692040|4009122|FG002|STARTED|Overall Study||5
3275554|NCT02692040|4009123|FG003|STARTED|Overall Study||5
3275555|NCT02692040|4009124|FG004|STARTED|Overall Study||4
3275556|NCT02692040|4009125|FG005|STARTED|Overall Study||5
3275557|NCT02692040|4009126|FG006|STARTED|Overall Study||5
3275558|NCT02692040|4009127|FG007|STARTED|Overall Study||5
3275559|NCT02692040|4009128|FG008|STARTED|Overall Study||5
3275560|NCT02692040|4009129|FG009|STARTED|Overall Study||4
3275561|NCT02692040|4009130|FG010|STARTED|Overall Study||5
3275562|NCT02692040|4009131|FG011|STARTED|Overall Study||5
3275563|NCT02692040|4009132|FG012|STARTED|Overall Study||6
3275564|NCT02692040|4009133|FG013|STARTED|Overall Study||6
3275565|NCT02692040|4009134|FG014|STARTED|Overall Study||6
3275566|NCT02692040|4009135|FG015|STARTED|Overall Study||6
3275567|NCT02692040|4009136|FG016|STARTED|Overall Study||4
3275568|NCT02692040|4009120|FG000|COMPLETED|Overall Study||10
3275569|NCT02692040|4009121|FG001|COMPLETED|Overall Study||4
3275570|NCT02692040|4009122|FG002|COMPLETED|Overall Study||5
3275571|NCT02692040|4009123|FG003|COMPLETED|Overall Study||5
3275572|NCT02692040|4009124|FG004|COMPLETED|Overall Study||4
3275573|NCT02692040|4009125|FG005|COMPLETED|Overall Study||5
3275574|NCT02692040|4009126|FG006|COMPLETED|Overall Study||5
3275575|NCT02692040|4009127|FG007|COMPLETED|Overall Study||5
3275576|NCT02692040|4009128|FG008|COMPLETED|Overall Study||5
3275577|NCT02692040|4009129|FG009|COMPLETED|Overall Study||4
3275578|NCT02692040|4009130|FG010|COMPLETED|Overall Study||5
3275579|NCT02692040|4009131|FG011|COMPLETED|Overall Study||5
3275580|NCT02692040|4009132|FG012|COMPLETED|Overall Study||5
3275581|NCT02692040|4009133|FG013|COMPLETED|Overall Study||3
3275582|NCT02692040|4009134|FG014|COMPLETED|Overall Study||5
3275583|NCT02692040|4009135|FG015|COMPLETED|Overall Study||5
3275584|NCT02692040|4009136|FG016|COMPLETED|Overall Study||4
3275585|NCT02692040|4009120|FG000|NOT COMPLETED|Overall Study||0
3275586|NCT02692040|4009121|FG001|NOT COMPLETED|Overall Study||0
3275587|NCT02692040|4009122|FG002|NOT COMPLETED|Overall Study||0
3275588|NCT02692040|4009123|FG003|NOT COMPLETED|Overall Study||0
3275589|NCT02692040|4009124|FG004|NOT COMPLETED|Overall Study||0
3275590|NCT02692040|4009125|FG005|NOT COMPLETED|Overall Study||0
3275591|NCT02692040|4009126|FG006|NOT COMPLETED|Overall Study||0
3275592|NCT02692040|4009127|FG007|NOT COMPLETED|Overall Study||0
3275593|NCT02692040|4009128|FG008|NOT COMPLETED|Overall Study||0
3275594|NCT02692040|4009129|FG009|NOT COMPLETED|Overall Study||0
3275595|NCT02692040|4009130|FG010|NOT COMPLETED|Overall Study||0
3275596|NCT02692040|4009131|FG011|NOT COMPLETED|Overall Study||0
3275597|NCT02692040|4009132|FG012|NOT COMPLETED|Overall Study||1
3275598|NCT02692040|4009133|FG013|NOT COMPLETED|Overall Study||3
3275599|NCT02692040|4009134|FG014|NOT COMPLETED|Overall Study||1
3275600|NCT02692040|4009135|FG015|NOT COMPLETED|Overall Study||1
3275601|NCT02692040|4009136|FG016|NOT COMPLETED|Overall Study||0
3275602|NCT02692209|4009213|FG000|STARTED|Overall Study||298
3275603|NCT02692209|4009213|FG000|COMPLETED|Overall Study||298
3275604|NCT02692209|4009213|FG000|NOT COMPLETED|Overall Study||0
3275605|NCT02692235|4009221|FG000|STARTED|Overall Study||14
3275606|NCT02692235|4009222|FG001|STARTED|Overall Study||14
3275607|NCT02692235|4009221|FG000|COMPLETED|Overall Study||11
3275608|NCT02692235|4009222|FG001|COMPLETED|Overall Study||11
3275609|NCT02692235|4009221|FG000|NOT COMPLETED|Overall Study||3
3275610|NCT02692235|4009222|FG001|NOT COMPLETED|Overall Study||3
2937837|NCT00622635|3649655|FG002|COMPLETED|Treatment Period 3||10
2937838|NCT00622635|3649656|FG003|COMPLETED|Treatment Period 3||10
3275611|NCT02692391|4009230|FG000|STARTED|Overall Study||24
3275612|NCT02692391|4009231|FG001|STARTED|Overall Study||18
3275613|NCT02692391|4009230|FG000|COMPLETED|Overall Study||24
3275614|NCT02692391|4009231|FG001|COMPLETED|Overall Study||18
3275615|NCT02692391|4009230|FG000|NOT COMPLETED|Overall Study||0
3275616|NCT02692391|4009231|FG001|NOT COMPLETED|Overall Study||0
3275617|NCT02692417|4009239|FG000|STARTED|Overall Study||9
3275618|NCT02692417|4009240|FG001|STARTED|Overall Study||7
3275619|NCT02692417|4009239|FG000|COMPLETED|Overall Study||3
2937839|NCT00622635|3649657|FG004|COMPLETED|Treatment Period 3||9
2937840|NCT00622635|3649658|FG005|COMPLETED|Treatment Period 3||10
2937841|NCT00622635|3649653|FG000|NOT COMPLETED|Treatment Period 3||0
2937842|NCT00622635|3649654|FG001|NOT COMPLETED|Treatment Period 3||0
2937843|NCT00622635|3649655|FG002|NOT COMPLETED|Treatment Period 3||0
2937844|NCT00622635|3649656|FG003|NOT COMPLETED|Treatment Period 3||3
2937845|NCT00622635|3649657|FG004|NOT COMPLETED|Treatment Period 3||0
2937846|NCT00622635|3649658|FG005|NOT COMPLETED|Treatment Period 3||0
2937847|NCT00622700|3649669|FG000|STARTED|Core Treatment Period||197
2937848|NCT00622700|3649670|FG001|STARTED|Core Treatment Period||205
2937849|NCT00622700|3649671|FG002|STARTED|Core Treatment Period||216
2937850|NCT00622700|3649672|FG003|STARTED|Core Treatment Period||0
2937851|NCT00622700|3649673|FG004|STARTED|Core Treatment Period||0
2937852|NCT00622700|3649674|FG005|STARTED|Core Treatment Period||0
2937853|NCT00622700|3649675|FG006|STARTED|Core Treatment Period||0
2937854|NCT00622700|3649669|FG000|Treated|Core Treatment Period||197
2937855|NCT00622700|3649670|FG001|Treated|Core Treatment Period||203
2937856|NCT00622700|3649671|FG002|Treated|Core Treatment Period||214
2937857|NCT00622700|3649672|FG003|Treated|Core Treatment Period||0
2937858|NCT00622700|3649673|FG004|Treated|Core Treatment Period||0
2937859|NCT00622700|3649674|FG005|Treated|Core Treatment Period||0
2937860|NCT00622700|3649675|FG006|Treated|Core Treatment Period||0
2937861|NCT00622700|3649669|FG000|COMPLETED|Core Treatment Period||141
2937862|NCT00622700|3649670|FG001|COMPLETED|Core Treatment Period||150
2937863|NCT00622700|3649671|FG002|COMPLETED|Core Treatment Period||163
2937864|NCT00622700|3649672|FG003|COMPLETED|Core Treatment Period||0
2937865|NCT00622700|3649673|FG004|COMPLETED|Core Treatment Period||0
2937866|NCT00622700|3649674|FG005|COMPLETED|Core Treatment Period||0
2937867|NCT00622700|3649675|FG006|COMPLETED|Core Treatment Period||0
2937868|NCT00622700|3649669|FG000|NOT COMPLETED|Core Treatment Period||56
2937869|NCT00622700|3649670|FG001|NOT COMPLETED|Core Treatment Period||55
2937870|NCT00622700|3649671|FG002|NOT COMPLETED|Core Treatment Period||53
2937871|NCT00622700|3649672|FG003|NOT COMPLETED|Core Treatment Period||0
2937872|NCT00622700|3649673|FG004|NOT COMPLETED|Core Treatment Period||0
2937873|NCT00622700|3649674|FG005|NOT COMPLETED|Core Treatment Period||0
2937874|NCT00622700|3649675|FG006|NOT COMPLETED|Core Treatment Period||0
2937875|NCT00622700|3649669|FG000|STARTED|Extension Treatment Period|Participants were re-randomized in a 1:1 ratio to either teriflunomide 7 mg or 14 mg treatment arm.|0
2937876|NCT00622700|3649670|FG001|STARTED|Extension Treatment Period||0
2937877|NCT00622700|3649671|FG002|STARTED|Extension Treatment Period||0
2937878|NCT00622700|3649672|FG003|STARTED|Extension Treatment Period|10 participants completed core treatment period but did not enter in extension treatment period.|64
2937879|NCT00622700|3649673|FG004|STARTED|Extension Treatment Period|8 participants completed core treatment period but did not enter in extension treatment period.|142
2937880|NCT00622700|3649674|FG005|STARTED|Extension Treatment Period|10 participants completed core treatment period but did not enter in extension treatment period.|67
2937881|NCT00622700|3649675|FG006|STARTED|Extension Treatment Period|13 participants completed core treatment period but did not enter in extension treatment period.|150
2937882|NCT00622700|3649669|FG000|COMPLETED|Extension Treatment Period||0
2937883|NCT00622700|3649670|FG001|COMPLETED|Extension Treatment Period||0
2937884|NCT00622700|3649671|FG002|COMPLETED|Extension Treatment Period||0
2937885|NCT00622700|3649672|FG003|COMPLETED|Extension Treatment Period||43
2937886|NCT00622700|3649673|FG004|COMPLETED|Extension Treatment Period||103
2937887|NCT00622700|3649674|FG005|COMPLETED|Extension Treatment Period||50
2937888|NCT00622700|3649675|FG006|COMPLETED|Extension Treatment Period||120
2937889|NCT00622700|3649669|FG000|NOT COMPLETED|Extension Treatment Period||0
2937890|NCT00622700|3649670|FG001|NOT COMPLETED|Extension Treatment Period||0
2937891|NCT00622700|3649671|FG002|NOT COMPLETED|Extension Treatment Period||0
2937892|NCT00622700|3649672|FG003|NOT COMPLETED|Extension Treatment Period||21
2937893|NCT00622700|3649673|FG004|NOT COMPLETED|Extension Treatment Period||39
2937894|NCT00622700|3649674|FG005|NOT COMPLETED|Extension Treatment Period||17
2937895|NCT00622700|3649675|FG006|NOT COMPLETED|Extension Treatment Period||30
2937896|NCT00622713|3649692|FG000|STARTED|Overall Study||228
2937897|NCT00622713|3649692|FG000|Exposed to Study Drug|Overall Study||226
2937898|NCT00622713|3649692|FG000|Intent to Treat (ITT) Population|Overall Study||218
2937899|NCT00622713|3649692|FG000|COMPLETED|Overall Study||169
2937900|NCT00622713|3649692|FG000|NOT COMPLETED|Overall Study||59
2937901|NCT00622726|3649698|FG000|STARTED|March, 2008 to August, 2010||75
2937902|NCT00622726|3649699|FG001|STARTED|March, 2008 to August, 2010||75
2937903|NCT00622726|3649698|FG000|COMPLETED|March, 2008 to August, 2010|All infants were extremely immature with multiple neonatal intensive care unit complications.|70
2937904|NCT00622726|3649699|FG001|COMPLETED|March, 2008 to August, 2010|All infants were extremely immature with multiple neonatal intensive care unit complications.|73
2937905|NCT00622726|3649698|FG000|NOT COMPLETED|March, 2008 to August, 2010||5
2937906|NCT00622726|3649699|FG001|NOT COMPLETED|March, 2008 to August, 2010||2
2937907|NCT00622726|3649698|FG000|STARTED|August, 2010 to April, 2013||70
2937908|NCT00622726|3649699|FG001|STARTED|August, 2010 to April, 2013||73
2937909|NCT00622726|3649698|FG000|COMPLETED|August, 2010 to April, 2013||69
2937910|NCT00622726|3649699|FG001|COMPLETED|August, 2010 to April, 2013||68
2937911|NCT00622726|3649698|FG000|NOT COMPLETED|August, 2010 to April, 2013||1
2937912|NCT00622726|3649699|FG001|NOT COMPLETED|August, 2010 to April, 2013||5
2937913|NCT00622739|3649711|FG000|STARTED|Overall Study||13
2937914|NCT00622739|3649712|FG001|STARTED|Overall Study||15
2937915|NCT00622739|3649711|FG000|COMPLETED|Overall Study||11
2937916|NCT00622739|3649712|FG001|COMPLETED|Overall Study||9
2937917|NCT00622739|3649711|FG000|NOT COMPLETED|Overall Study||2
2937918|NCT00622739|3649712|FG001|NOT COMPLETED|Overall Study||6
2937919|NCT00622869|3649723|FG000|STARTED|Overall Study||245
2937920|NCT00622869|3649724|FG001|STARTED|Overall Study||231
2937921|NCT00622869|3649725|FG002|STARTED|Overall Study||243
2937922|NCT00622869|3649723|FG000|COMPLETED|Overall Study||202
2937923|NCT00622869|3649724|FG001|COMPLETED|Overall Study||174
2937924|NCT00622869|3649725|FG002|COMPLETED|Overall Study||204
2937925|NCT00622869|3649723|FG000|NOT COMPLETED|Overall Study||43
2937926|NCT00622869|3649724|FG001|NOT COMPLETED|Overall Study||57
2937927|NCT00622869|3649725|FG002|NOT COMPLETED|Overall Study||39
2937928|NCT00622895|3649733|FG000|STARTED|Overall Study||3
2937929|NCT00622895|3649733|FG000|COMPLETED|Overall Study||3
2937930|NCT00622895|3649733|FG000|NOT COMPLETED|Overall Study||0
2937931|NCT00622908|3649742|FG000|STARTED|Overall Study|Intent to treat population|137
2937932|NCT00622908|3649743|FG001|STARTED|Overall Study|Intent to treat population|132
2937933|NCT00622908|3649742|FG000|COMPLETED|Overall Study||134
2937934|NCT00622908|3649743|FG001|COMPLETED|Overall Study||122
2937935|NCT00622908|3649742|FG000|NOT COMPLETED|Overall Study||3
2937936|NCT00622908|3649743|FG001|NOT COMPLETED|Overall Study||10
2937937|NCT00623012|3649749|FG000|STARTED|Overall Study||2
2937938|NCT00623012|3649749|FG000|COMPLETED|Overall Study||2
2937939|NCT00623012|3649749|FG000|NOT COMPLETED|Overall Study||0
2937940|NCT00623103|3649755|FG000|STARTED|Overall Study||295
2937941|NCT00623103|3649756|FG001|STARTED|Overall Study||288
2937942|NCT00623103|3649755|FG000|Safety Set: Received Study Drug|Overall Study|One randomized participant did not receive study drug and was not included in the Safety set.|294
2937943|NCT00623103|3649756|FG001|Safety Set: Received Study Drug|Overall Study||288
2937944|NCT00623103|3649755|FG000|COMPLETED|Overall Study||184
2937945|NCT00623103|3649756|FG001|COMPLETED|Overall Study||175
2937946|NCT00623103|3649755|FG000|NOT COMPLETED|Overall Study||111
2937947|NCT00623103|3649756|FG001|NOT COMPLETED|Overall Study||113
2937948|NCT00623181|3649764|FG000|STARTED|Overall Study||56
2937949|NCT00623181|3649765|FG001|STARTED|Overall Study||54
2937950|NCT00623181|3649764|FG000|COMPLETED|Overall Study||56
2937951|NCT00623181|3649765|FG001|COMPLETED|Overall Study||54
2937952|NCT00623181|3649764|FG000|NOT COMPLETED|Overall Study||0
2937953|NCT00623181|3649765|FG001|NOT COMPLETED|Overall Study||0
2937954|NCT00623194|3649775|FG000|STARTED|Overall Study||146
2937955|NCT00623194|3649775|FG000|COMPLETED|Overall Study||141
2937956|NCT00623194|3649775|FG000|NOT COMPLETED|Overall Study||5
2937957|NCT00623233|3649779|FG000|STARTED|Overall Study||52
2937958|NCT00623233|3649779|FG000|COMPLETED|Overall Study|Included those who discontinued due to PD or death and those who achieved complete response (CR).|28
2937959|NCT00623233|3649779|FG000|NOT COMPLETED|Overall Study||24
2937960|NCT00623363|3649785|FG000|STARTED|Overall Study||7
2937961|NCT00623363|3649786|FG001|STARTED|Overall Study||20
2937962|NCT00623363|3649785|FG000|COMPLETED|Overall Study||5
2937963|NCT00623363|3649786|FG001|COMPLETED|Overall Study||18
2937964|NCT00623363|3649785|FG000|NOT COMPLETED|Overall Study||2
2937965|NCT00623363|3649786|FG001|NOT COMPLETED|Overall Study||2
2937966|NCT00623428|3649795|FG000|STARTED|Treatment Period||95
2937967|NCT00623428|3649796|FG001|STARTED|Treatment Period||93
2937968|NCT00623428|3649795|FG000|COMPLETED|Treatment Period|Patients who completed 24 weeks of treatment|95
2937969|NCT00623428|3649796|FG001|COMPLETED|Treatment Period|Patients who completed 48 weeks of treatment|66
3275620|NCT02692417|4009240|FG001|COMPLETED|Overall Study||6
3275621|NCT02692417|4009239|FG000|NOT COMPLETED|Overall Study||6
3275622|NCT02692417|4009240|FG001|NOT COMPLETED|Overall Study||1
3275623|NCT02692482|4009248|FG000|STARTED|Overall Study||177
3275624|NCT02692482|4009249|FG001|STARTED|Overall Study||182
3275625|NCT02692482|4009248|FG000|COMPLETED|Overall Study||174
3275626|NCT02692482|4009249|FG001|COMPLETED|Overall Study||178
3275627|NCT02692482|4009248|FG000|NOT COMPLETED|Overall Study||3
3275628|NCT02692482|4009249|FG001|NOT COMPLETED|Overall Study||4
3275629|NCT02692495|4009258|FG000|STARTED|Overall Study||12
3275630|NCT02692495|4009259|FG001|STARTED|Overall Study||4
3275631|NCT02692495|4009258|FG000|COMPLETED|Overall Study||12
3275632|NCT02692495|4009259|FG001|COMPLETED|Overall Study||4
3275633|NCT02692495|4009258|FG000|NOT COMPLETED|Overall Study||0
3275634|NCT02692495|4009259|FG001|NOT COMPLETED|Overall Study||0
3275635|NCT02692560|4009271|FG000|STARTED|Overall Study||29
3275636|NCT02692560|4009272|FG001|STARTED|Overall Study||31
3275637|NCT02692560|4009271|FG000|COMPLETED|Overall Study||29
3275638|NCT02692560|4009272|FG001|COMPLETED|Overall Study||25
3275639|NCT02692560|4009271|FG000|NOT COMPLETED|Overall Study||0
3275640|NCT02692560|4009272|FG001|NOT COMPLETED|Overall Study||6
3275641|NCT02692586|4009278|FG000|STARTED|Overall Study||106
3275642|NCT02692586|4009278|FG000|COMPLETED|Overall Study||103
3275643|NCT02692586|4009278|FG000|NOT COMPLETED|Overall Study||3
3275644|NCT02692703|4009282|FG000|STARTED|Overall Study||100
3275645|NCT02692703|4009282|FG000|COMPLETED|Overall Study||98
3275646|NCT02692703|4009282|FG000|NOT COMPLETED|Overall Study||2
3316341|NCT03110029|4049631|FG001|NOT COMPLETED|Overall Study||1
3316342|NCT03110185|4049639|FG000|STARTED|Overall Study||27
3316343|NCT03110185|4049640|FG001|STARTED|Overall Study||64
3316344|NCT03110185|4049639|FG000|COMPLETED|Overall Study||17
3316345|NCT03110185|4049640|FG001|COMPLETED|Overall Study||33
3316346|NCT03110185|4049639|FG000|NOT COMPLETED|Overall Study||10
3316347|NCT03110185|4049640|FG001|NOT COMPLETED|Overall Study||31
3316348|NCT03110458|4049652|FG000|STARTED|Overall Study||37
2937970|NCT00623428|3649795|FG000|NOT COMPLETED|Treatment Period||0
2937971|NCT00623428|3649796|FG001|NOT COMPLETED|Treatment Period||27
2937972|NCT00623428|3649795|FG000|STARTED|Follow-up Period||95
2937973|NCT00623428|3649796|FG001|STARTED|Follow-up Period||93
2937974|NCT00623428|3649795|FG000|COMPLETED|Follow-up Period|Patients who had an HCV RNA sample at 48 weeks of follow-up|66
2937975|NCT00623428|3649796|FG001|COMPLETED|Follow-up Period|Patients who had an HCV RNA sample at 24 weeks of follow-up|78
2937976|NCT00623428|3649795|FG000|NOT COMPLETED|Follow-up Period||29
2937977|NCT00623428|3649796|FG001|NOT COMPLETED|Follow-up Period||15
2937978|NCT00623441|3649802|FG000|STARTED|Overall Study||8314
2937979|NCT00623441|3649802|FG000|COMPLETED|Overall Study|12 months follow-up compliance was 94.2%|8314
2937980|NCT00623441|3649802|FG000|NOT COMPLETED|Overall Study||0
2937981|NCT00623467|3649806|FG000|STARTED|Overall Study||343
2937982|NCT00623467|3649806|FG000|COMPLETED|Overall Study||336
2937983|NCT00623467|3649806|FG000|NOT COMPLETED|Overall Study||7
2937984|NCT00623480|3649814|FG000|STARTED|Overall Study||42
2937985|NCT00623480|3649815|FG001|STARTED|Overall Study||42
2937986|NCT00623480|3649814|FG000|COMPLETED|Overall Study||35
2937987|NCT00623480|3649815|FG001|COMPLETED|Overall Study||35
2937988|NCT00623480|3649814|FG000|NOT COMPLETED|Overall Study||7
2937989|NCT00623480|3649815|FG001|NOT COMPLETED|Overall Study||7
2937990|NCT00623506|3649823|FG000|STARTED|Overall Study||15
2937991|NCT00623506|3649824|FG001|STARTED|Overall Study||15
2937992|NCT00623506|3649823|FG000|Week 4|Overall Study||11
2937993|NCT00623506|3649824|FG001|Week 4|Overall Study||11
2937994|NCT00623506|3649823|FG000|COMPLETED|Overall Study||11
2937995|NCT00623506|3649824|FG001|COMPLETED|Overall Study||11
2937996|NCT00623506|3649823|FG000|NOT COMPLETED|Overall Study||4
2937997|NCT00623506|3649824|FG001|NOT COMPLETED|Overall Study||4
2937998|NCT00623545|3649830|FG000|STARTED|Overall Study||28
2937999|NCT00623545|3649830|FG000|COMPLETED|Overall Study||18
2938000|NCT00623545|3649830|FG000|NOT COMPLETED|Overall Study||10
2938001|NCT00623597|3649837|FG000|STARTED|Overall Study||5
2938002|NCT00623597|3649838|FG001|STARTED|Overall Study||13
2938003|NCT00623597|3649837|FG000|COMPLETED|Overall Study||4
2938004|NCT00623597|3649838|FG001|COMPLETED|Overall Study||13
2938005|NCT00623597|3649837|FG000|NOT COMPLETED|Overall Study||1
2938006|NCT00623597|3649838|FG001|NOT COMPLETED|Overall Study||0
2938007|NCT00623623|3649848|FG000|STARTED|Overall Study||950
2938008|NCT00623623|3649849|FG001|STARTED|Overall Study||949
2938009|NCT00623623|3649848|FG000|COMPLETED|Overall Study||949
2938010|NCT00623623|3649849|FG001|COMPLETED|Overall Study||948
2938011|NCT00623623|3649848|FG000|NOT COMPLETED|Overall Study||1
2938012|NCT00623623|3649849|FG001|NOT COMPLETED|Overall Study||1
2938013|NCT00623636|3649857|FG000|STARTED|Double Blind||452
2938014|NCT00623636|3649858|FG001|STARTED|Double Blind||450
2938015|NCT00623636|3649857|FG000|COMPLETED|Double Blind||419
2938016|NCT00623636|3649858|FG001|COMPLETED|Double Blind||422
2938017|NCT00623636|3649857|FG000|NOT COMPLETED|Double Blind||33
2938018|NCT00623636|3649858|FG001|NOT COMPLETED|Double Blind||28
2938019|NCT00623636|3649857|FG000|STARTED|Open Label|Eligible double-blind placebo patients received MAP0004 in the open-label period.|0
2938020|NCT00623636|3649858|FG001|STARTED|Open Label|Includes eligible Placebo and MAP0004 patients from the double-blind period.|675
2938021|NCT00623636|3649857|FG000|COMPLETED|Open Label||0
2938022|NCT00623636|3649858|FG001|COMPLETED|Open Label||263
2938023|NCT00623636|3649857|FG000|NOT COMPLETED|Open Label||0
2938024|NCT00623636|3649858|FG001|NOT COMPLETED|Open Label||412
2938025|NCT00623714|3649865|FG000|STARTED|Period 1||6
2938026|NCT00623714|3649866|FG001|STARTED|Period 1||7
2938027|NCT00623714|3649865|FG000|COMPLETED|Period 1||6
2938028|NCT00623714|3649866|FG001|COMPLETED|Period 1||7
2938029|NCT00623714|3649865|FG000|NOT COMPLETED|Period 1||0
2938030|NCT00623714|3649866|FG001|NOT COMPLETED|Period 1||0
2938031|NCT00623714|3649865|FG000|STARTED|Period 2||6
2938032|NCT00623714|3649866|FG001|STARTED|Period 2||7
2938033|NCT00623714|3649865|FG000|COMPLETED|Period 2||6
2938034|NCT00623714|3649866|FG001|COMPLETED|Period 2||7
2938035|NCT00623714|3649865|FG000|NOT COMPLETED|Period 2||0
2938036|NCT00623714|3649866|FG001|NOT COMPLETED|Period 2||0
2938037|NCT00623727|3649874|FG000|STARTED|Double Blind (DB)|only 67 participants are applicable for baseline characteristic evaluation|70
2938038|NCT00623727|3649875|FG001|STARTED|Double Blind (DB)|only 72 participants are applicable for baseline characteristic evaluation|73
2938039|NCT00623727|3649874|FG000|Participants Received Treatment|Double Blind (DB)||67
2938040|NCT00623727|3649875|FG001|Participants Received Treatment|Double Blind (DB)||72
2938041|NCT00623727|3649874|FG000|COMPLETED|Double Blind (DB)||34
2938042|NCT00623727|3649875|FG001|COMPLETED|Double Blind (DB)||41
2938043|NCT00623727|3649874|FG000|NOT COMPLETED|Double Blind (DB)||36
2938044|NCT00623727|3649875|FG001|NOT COMPLETED|Double Blind (DB)||32
2938045|NCT00623727|3649874|FG000|STARTED|Open Label Follow-up||0
2938046|NCT00623727|3649875|FG001|STARTED|Open Label Follow-up|13 Participants from each group after DB period terminated entered open label follow up.|26
2938047|NCT00623727|3649874|FG000|COMPLETED|Open Label Follow-up||0
2938048|NCT00623727|3649875|FG001|COMPLETED|Open Label Follow-up||18
2938049|NCT00623727|3649874|FG000|NOT COMPLETED|Open Label Follow-up||0
2938050|NCT00623727|3649875|FG001|NOT COMPLETED|Open Label Follow-up||8
2938051|NCT00623727|3649874|FG000|STARTED|Open Label Extension Period|10 participants of each group entered open-label extension period after completion of DB study|20
2938052|NCT00623727|3649875|FG001|STARTED|Open Label Extension Period||0
2938053|NCT00623727|3649874|FG000|COMPLETED|Open Label Extension Period||20
2938054|NCT00623727|3649875|FG001|COMPLETED|Open Label Extension Period||0
2938055|NCT00623727|3649874|FG000|NOT COMPLETED|Open Label Extension Period||0
2938056|NCT00623727|3649875|FG001|NOT COMPLETED|Open Label Extension Period||0
2938057|NCT00623766|3649885|FG000|STARTED|Induction Phase (Day 1 to Week 24)|Participants who received treatment|51
2938058|NCT00623766|3649886|FG001|STARTED|Induction Phase (Day 1 to Week 24)|Participants who received treatment|21
2938059|NCT00623766|3649885|FG000|COMPLETED|Induction Phase (Day 1 to Week 24)|4 patients completed Induction but did not enter Maintenance; they were only followed up with scans.|15
2938060|NCT00623766|3649886|FG001|COMPLETED|Induction Phase (Day 1 to Week 24)|3 patients completed Induction but did not enter Maintenance; they were only followed up with scans.|5
2938061|NCT00623766|3649885|FG000|NOT COMPLETED|Induction Phase (Day 1 to Week 24)||36
2938062|NCT00623766|3649886|FG001|NOT COMPLETED|Induction Phase (Day 1 to Week 24)||16
2938063|NCT00623766|3649885|FG000|STARTED|Maintenance Phase (Week 24 to Year 2)||11
2938064|NCT00623766|3649886|FG001|STARTED|Maintenance Phase (Week 24 to Year 2)||2
2938065|NCT00623766|3649885|FG000|COMPLETED|Maintenance Phase (Week 24 to Year 2)|Inadvertently not noted as discontinued (disease progression); data collection error at site closure|1
2938066|NCT00623766|3649886|FG001|COMPLETED|Maintenance Phase (Week 24 to Year 2)||0
2938067|NCT00623766|3649885|FG000|NOT COMPLETED|Maintenance Phase (Week 24 to Year 2)||10
2938068|NCT00623766|3649886|FG001|NOT COMPLETED|Maintenance Phase (Week 24 to Year 2)||2
2938069|NCT00623779|3649899|FG000|STARTED|Overall Study||41
2938070|NCT00623779|3649900|FG001|STARTED|Overall Study||42
3047730|NCT01203917|3767714|FG000|COMPLETED|Overall Study|Patients on-going study at data cut-off(of which 49 were still on study treatment).|71
3275647|NCT02692716|4009288|FG000|STARTED|Overall Study||1591
3275648|NCT02692716|4009289|FG001|STARTED|Overall Study||1592
2938071|NCT00623779|3649901|FG002|STARTED|Overall Study||45
2938072|NCT00623779|3649899|FG000|COMPLETED|Overall Study||38
2938073|NCT00623779|3649900|FG001|COMPLETED|Overall Study||39
2938074|NCT00623779|3649901|FG002|COMPLETED|Overall Study||44
2938075|NCT00623779|3649899|FG000|NOT COMPLETED|Overall Study||3
3275649|NCT02692716|4009288|FG000|Full Analysis Set (FAS)|Overall Study||1591
3275650|NCT02692716|4009289|FG001|Full Analysis Set (FAS)|Overall Study||1592
3275651|NCT02692716|4009288|FG000|Exposed|Overall Study||1591
3275652|NCT02692716|4009289|FG001|Exposed|Overall Study||1591
3275653|NCT02692716|4009288|FG000|COMPLETED|Overall Study||1586
3275654|NCT02692716|4009289|FG001|COMPLETED|Overall Study||1586
3275655|NCT02692716|4009288|FG000|NOT COMPLETED|Overall Study||5
3275656|NCT02692716|4009289|FG001|NOT COMPLETED|Overall Study||6
3275657|NCT02692755|4009295|FG000|STARTED|Overall Study||35
3275658|NCT02692755|4009295|FG000|COMPLETED|Overall Study||35
3275659|NCT02692755|4009295|FG000|NOT COMPLETED|Overall Study||0
3275660|NCT02692859|4009302|FG000|STARTED|Overall Study||996
3275661|NCT02692859|4009303|FG001|STARTED|Overall Study||996
3275662|NCT02692859|4009302|FG000|COMPLETED|Overall Study||912
3275663|NCT02692859|4009303|FG001|COMPLETED|Overall Study||901
3275664|NCT02692859|4009302|FG000|NOT COMPLETED|Overall Study||84
3275665|NCT02692859|4009303|FG001|NOT COMPLETED|Overall Study||95
3275666|NCT02693106|4009309|FG000|STARTED|Overall Study||13
3275667|NCT02693106|4009309|FG000|COMPLETED|Overall Study||10
3275668|NCT02693106|4009309|FG000|NOT COMPLETED|Overall Study||3
3275669|NCT02693119|4009321|FG000|STARTED|Double-Blind Period||8
3275670|NCT02693119|4009322|FG001|STARTED|Double-Blind Period||4
3275671|NCT02693119|4009321|FG000|COMPLETED|Double-Blind Period||8
3275672|NCT02693119|4009322|FG001|COMPLETED|Double-Blind Period||4
3275673|NCT02693119|4009321|FG000|NOT COMPLETED|Double-Blind Period||0
3275674|NCT02693119|4009322|FG001|NOT COMPLETED|Double-Blind Period||0
3275675|NCT02693119|4009321|FG000|STARTED|Open-Label Period||8
3275676|NCT02693119|4009322|FG001|STARTED|Open-Label Period||4
3275677|NCT02693119|4009321|FG000|COMPLETED|Open-Label Period||8
3275678|NCT02693119|4009322|FG001|COMPLETED|Open-Label Period||3
3275679|NCT02693119|4009321|FG000|NOT COMPLETED|Open-Label Period||0
3275680|NCT02693119|4009322|FG001|NOT COMPLETED|Open-Label Period||1
3275681|NCT02693132|4009361|FG000|STARTED|Overall Study||17
3275682|NCT02693132|4009362|FG001|STARTED|Overall Study||17
3275683|NCT02693132|4009363|FG002|STARTED|Overall Study||18
3275684|NCT02693132|4009361|FG000|COMPLETED|Overall Study||16
3275685|NCT02693132|4009362|FG001|COMPLETED|Overall Study||16
3275686|NCT02693132|4009363|FG002|COMPLETED|Overall Study||17
3275687|NCT02693132|4009361|FG000|NOT COMPLETED|Overall Study||1
3275688|NCT02693132|4009362|FG001|NOT COMPLETED|Overall Study||1
3275689|NCT02693132|4009363|FG002|NOT COMPLETED|Overall Study||1
3275690|NCT02693262|4009371|FG000|STARTED|Overall Study||4
3275691|NCT02693262|4009372|FG001|STARTED|Overall Study||5
3275692|NCT02693262|4009371|FG000|COMPLETED|Overall Study||4
3275693|NCT02693262|4009372|FG001|COMPLETED|Overall Study||5
3275694|NCT02693262|4009371|FG000|NOT COMPLETED|Overall Study||0
3275695|NCT02693262|4009372|FG001|NOT COMPLETED|Overall Study||0
3275696|NCT02693418|4009383|FG000|STARTED|Overall Study||22
3275697|NCT02693418|4009384|FG001|STARTED|Overall Study||21
3275698|NCT02693418|4009385|FG002|STARTED|Overall Study||21
3275699|NCT02693418|4009386|FG003|STARTED|Overall Study||20
3275700|NCT02693418|4009387|FG004|STARTED|Overall Study||21
3275701|NCT02693418|4009383|FG000|COMPLETED|Overall Study||21
3275702|NCT02693418|4009384|FG001|COMPLETED|Overall Study||19
3275703|NCT02693418|4009385|FG002|COMPLETED|Overall Study||19
3275704|NCT02693418|4009386|FG003|COMPLETED|Overall Study||20
3275705|NCT02693418|4009387|FG004|COMPLETED|Overall Study||21
3275706|NCT02693418|4009383|FG000|NOT COMPLETED|Overall Study||1
3275707|NCT02693418|4009384|FG001|NOT COMPLETED|Overall Study||2
3275708|NCT02693418|4009385|FG002|NOT COMPLETED|Overall Study||2
2938076|NCT00623779|3649900|FG001|NOT COMPLETED|Overall Study||3
2938077|NCT00623779|3649901|FG002|NOT COMPLETED|Overall Study||1
2938078|NCT00623805|3649911|FG000|STARTED|Overall Study||62
2938079|NCT00623805|3649912|FG001|STARTED|Overall Study||61
2938080|NCT00623805|3649911|FG000|COMPLETED|Overall Study||42
2938081|NCT00623805|3649912|FG001|COMPLETED|Overall Study||39
2938082|NCT00623805|3649911|FG000|NOT COMPLETED|Overall Study||20
2938083|NCT00623805|3649912|FG001|NOT COMPLETED|Overall Study||22
2938084|NCT00623831|3649920|FG000|STARTED|Overall Study||13
2938085|NCT00623831|3649921|FG001|STARTED|Overall Study||4
2938086|NCT00623831|3649920|FG000|COMPLETED|Overall Study||12
2938087|NCT00623831|3649921|FG001|COMPLETED|Overall Study||3
2938088|NCT00623831|3649920|FG000|NOT COMPLETED|Overall Study||1
2938089|NCT00623831|3649921|FG001|NOT COMPLETED|Overall Study||1
2938090|NCT00623935|3649930|FG000|STARTED|Overall Study||56
2938091|NCT00623935|3649930|FG000|COMPLETED|Overall Study||54
2938092|NCT00623935|3649930|FG000|NOT COMPLETED|Overall Study||2
2938093|NCT00624013|3649936|FG000|STARTED|Overall Study||44
2938094|NCT00624013|3649937|FG001|STARTED|Overall Study||45
2938095|NCT00624013|3649936|FG000|COMPLETED|Overall Study||36
2938096|NCT00624013|3649937|FG001|COMPLETED|Overall Study||39
2938097|NCT00624013|3649936|FG000|NOT COMPLETED|Overall Study||8
2938098|NCT00624013|3649937|FG001|NOT COMPLETED|Overall Study||6
2938099|NCT00624052|3649949|FG000|STARTED|Overall Study||219
2938100|NCT00624052|3649950|FG001|STARTED|Overall Study||436
2938101|NCT00624052|3649951|FG002|STARTED|Overall Study||91
2938102|NCT00624052|3649952|FG003|STARTED|Overall Study||92
2938103|NCT00624052|3649949|FG000|COMPLETED|Overall Study||204
2938104|NCT00624052|3649950|FG001|COMPLETED|Overall Study||422
2938105|NCT00624052|3649951|FG002|COMPLETED|Overall Study||88
2938106|NCT00624052|3649952|FG003|COMPLETED|Overall Study||88
2938107|NCT00624052|3649949|FG000|NOT COMPLETED|Overall Study||15
2938108|NCT00624052|3649950|FG001|NOT COMPLETED|Overall Study||14
2938109|NCT00624052|3649951|FG002|NOT COMPLETED|Overall Study||3
2938110|NCT00624052|3649952|FG003|NOT COMPLETED|Overall Study||4
2938111|NCT00624065|3649968|FG000|STARTED|Overall Study||216
2938112|NCT00624065|3649969|FG001|STARTED|Overall Study||216
2938113|NCT00624065|3649968|FG000|COMPLETED|Overall Study||197
3275709|NCT02693418|4009386|FG003|NOT COMPLETED|Overall Study||0
3275710|NCT02693418|4009387|FG004|NOT COMPLETED|Overall Study||0
3275711|NCT02693691|4009399|FG000|STARTED|Primary Endpoint Analysis (First 12M)||234
3275712|NCT02693691|4009399|FG000|COMPLETED|Primary Endpoint Analysis (First 12M)||184
3275713|NCT02693691|4009399|FG000|NOT COMPLETED|Primary Endpoint Analysis (First 12M)||50
3275714|NCT02693691|4009399|FG000|STARTED|Extended Follow-Up (Until Last pt 12M)||184
3275715|NCT02693691|4009399|FG000|COMPLETED|Extended Follow-Up (Until Last pt 12M)||160
3275716|NCT02693691|4009399|FG000|NOT COMPLETED|Extended Follow-Up (Until Last pt 12M)||24
3275717|NCT02693704|4009407|FG000|STARTED|Overall Study||10
3275718|NCT02693704|4009408|FG001|STARTED|Overall Study||10
3275719|NCT02693704|4009409|FG002|STARTED|Overall Study||10
3275720|NCT02693704|4009410|FG003|STARTED|Overall Study||10
3275721|NCT02693704|4009407|FG000|COMPLETED|Overall Study||10
3275722|NCT02693704|4009408|FG001|COMPLETED|Overall Study||10
3275723|NCT02693704|4009409|FG002|COMPLETED|Overall Study||10
3275724|NCT02693704|4009410|FG003|COMPLETED|Overall Study||10
3275725|NCT02693704|4009407|FG000|NOT COMPLETED|Overall Study||0
3275726|NCT02693704|4009408|FG001|NOT COMPLETED|Overall Study||0
3275727|NCT02693704|4009409|FG002|NOT COMPLETED|Overall Study||0
3275728|NCT02693704|4009410|FG003|NOT COMPLETED|Overall Study||0
3275729|NCT02693834|4009420|FG000|STARTED|Baseline Measurement|10 were randomized to PLS AFO first week group (2 dropped out at baseline)|12
3275730|NCT02693834|4009421|FG001|STARTED|Baseline Measurement|11 participants were assigned to DA AFO first group|11
3275731|NCT02693834|4009420|FG000|COMPLETED|Baseline Measurement|10 particiapnts completed wearing PLS AFO during the first week and 10 during the second week|10
3275732|NCT02693834|4009421|FG001|COMPLETED|Baseline Measurement|10 particiapnts completed wearing DA AFO during the first week and 10 the second week (1 was lost)|11
3275733|NCT02693834|4009420|FG000|NOT COMPLETED|Baseline Measurement||2
3275734|NCT02693834|4009421|FG001|NOT COMPLETED|Baseline Measurement||0
3275735|NCT02693834|4009420|FG000|STARTED|Week 1 Practice|During the first week of practice, 10 participants were assigned to PLS AFO group|10
3275736|NCT02693834|4009421|FG001|STARTED|Week 1 Practice|During the first week of practice, 11 participants were assigned to DAAFO group|11
3275737|NCT02693834|4009420|FG000|COMPLETED|Week 1 Practice||10
3275738|NCT02693834|4009421|FG001|COMPLETED|Week 1 Practice||11
3275739|NCT02693834|4009420|FG000|NOT COMPLETED|Week 1 Practice||0
3275740|NCT02693834|4009421|FG001|NOT COMPLETED|Week 1 Practice||0
3275741|NCT02693834|4009420|FG000|STARTED|Week 2 Practice||10
3275742|NCT02693834|4009421|FG001|STARTED|Week 2 Practice||11
3275743|NCT02693834|4009420|FG000|COMPLETED|Week 2 Practice||10
3275744|NCT02693834|4009421|FG001|COMPLETED|Week 2 Practice||10
3275745|NCT02693834|4009420|FG000|NOT COMPLETED|Week 2 Practice||0
3275746|NCT02693834|4009421|FG001|NOT COMPLETED|Week 2 Practice||1
3275747|NCT02694029|4009429|FG000|STARTED|Overall Study||5
3275748|NCT02694029|4009430|FG001|STARTED|Overall Study||5
3275749|NCT02694029|4009429|FG000|First Intervention|Overall Study||5
3275750|NCT02694029|4009430|FG001|First Intervention|Overall Study||5
3275751|NCT02694029|4009429|FG000|Second Intervention|Overall Study||5
3275752|NCT02694029|4009430|FG001|Second Intervention|Overall Study||5
2938114|NCT00624065|3649969|FG001|COMPLETED|Overall Study||192
2938115|NCT00624065|3649968|FG000|NOT COMPLETED|Overall Study||19
2938116|NCT00624065|3649969|FG001|NOT COMPLETED|Overall Study||24
2938117|NCT00624195|3649977|FG000|STARTED|Overall Study||29
2938118|NCT00624195|3649978|FG001|STARTED|Overall Study||30
2938119|NCT00624195|3649977|FG000|COMPLETED|Overall Study||26
2938120|NCT00624195|3649978|FG001|COMPLETED|Overall Study||23
2938121|NCT00624195|3649977|FG000|NOT COMPLETED|Overall Study||3
3275753|NCT02694029|4009429|FG000|COMPLETED|Overall Study||5
3275754|NCT02694029|4009430|FG001|COMPLETED|Overall Study||5
3275755|NCT02694029|4009429|FG000|NOT COMPLETED|Overall Study||0
3275756|NCT02694029|4009430|FG001|NOT COMPLETED|Overall Study||0
3275757|NCT02694185|4009442|FG000|STARTED|Overall Study||476
3275758|NCT02694185|4009443|FG001|STARTED|Overall Study||4793
3275759|NCT02694185|4009442|FG000|COMPLETED|Overall Study||431
3275760|NCT02694185|4009443|FG001|COMPLETED|Overall Study||4793
3275761|NCT02694185|4009442|FG000|NOT COMPLETED|Overall Study||45
3275762|NCT02694185|4009443|FG001|NOT COMPLETED|Overall Study||0
3275763|NCT02694198|4009449|FG000|STARTED|Overall Study||135
3275764|NCT02694198|4009449|FG000|COMPLETED|Overall Study||135
3275765|NCT02694198|4009449|FG000|NOT COMPLETED|Overall Study||0
3275766|NCT02694315|4009453|FG000|STARTED|Overall Study||200
3275767|NCT02694315|4009453|FG000|COMPLETED|Overall Study||200
3275768|NCT02694315|4009453|FG000|NOT COMPLETED|Overall Study||0
3275769|NCT02694328|4009459|FG000|STARTED|Overall Study||276
3275770|NCT02694328|4009460|FG001|STARTED|Overall Study||274
3275771|NCT02694328|4009459|FG000|COMPLETED|Overall Study||176
3275772|NCT02694328|4009460|FG001|COMPLETED|Overall Study||176
3275773|NCT02694328|4009459|FG000|NOT COMPLETED|Overall Study||100
3275774|NCT02694328|4009460|FG001|NOT COMPLETED|Overall Study||98
3275775|NCT02694445|4009466|FG000|STARTED|Overall Study||3098
3275776|NCT02694445|4009466|FG000|COMPLETED|Overall Study||3046
3275777|NCT02694445|4009466|FG000|NOT COMPLETED|Overall Study||52
3275778|NCT02694523|4009472|FG000|STARTED|Part A||304
3275779|NCT02694523|4009473|FG001|STARTED|Part A||301
3275780|NCT02694523|4009474|FG002|STARTED|Part A||0
3275781|NCT02694523|4009475|FG003|STARTED|Part A||0
3275782|NCT02694523|4009476|FG004|STARTED|Part A||0
3275783|NCT02694523|4009477|FG005|STARTED|Part A||0
3275784|NCT02694523|4009478|FG006|STARTED|Part A||0
3275785|NCT02694523|4009472|FG000|COMPLETED|Part A||291
3275786|NCT02694523|4009473|FG001|COMPLETED|Part A||294
3275787|NCT02694523|4009474|FG002|COMPLETED|Part A||0
3275788|NCT02694523|4009475|FG003|COMPLETED|Part A||0
3275789|NCT02694523|4009476|FG004|COMPLETED|Part A||0
3275790|NCT02694523|4009477|FG005|COMPLETED|Part A||0
3275791|NCT02694523|4009478|FG006|COMPLETED|Part A||0
3275792|NCT02694523|4009472|FG000|NOT COMPLETED|Part A||13
3275793|NCT02694523|4009473|FG001|NOT COMPLETED|Part A||7
3275794|NCT02694523|4009474|FG002|NOT COMPLETED|Part A||0
3275795|NCT02694523|4009475|FG003|NOT COMPLETED|Part A||0
3275796|NCT02694523|4009476|FG004|NOT COMPLETED|Part A||0
3275797|NCT02694523|4009477|FG005|NOT COMPLETED|Part A||0
3275798|NCT02694523|4009478|FG006|NOT COMPLETED|Part A||0
3275799|NCT02694523|4009472|FG000|STARTED|Part B||0
3275800|NCT02694523|4009473|FG001|STARTED|Part B||0
3275801|NCT02694523|4009474|FG002|STARTED|Part B|Participants who received risankizumab in Part A continued to received risankizumab in Part B|294
3275802|NCT02694523|4009475|FG003|STARTED|Part B|Adalimumab responders in Part A continued to received adalimumab in Part B|144
3275803|NCT02694523|4009476|FG004|STARTED|Part B|Adalimumab nonresponders in Part A switched to risankizumab in Part B|38
3275804|NCT02694523|4009477|FG005|STARTED|Part B|Adalimumab inadequate responders in Part A, rerandomized to adalimumab in Part B|56
3275805|NCT02694523|4009478|FG006|STARTED|Part B|Adalimumab inadequate responders in Part A, rerandomized to risankizumab in Part B|53
3275806|NCT02694523|4009472|FG000|COMPLETED|Part B||0
3275807|NCT02694523|4009473|FG001|COMPLETED|Part B||0
3275808|NCT02694523|4009474|FG002|COMPLETED|Part B||274
3275809|NCT02694523|4009475|FG003|COMPLETED|Part B||140
3275810|NCT02694523|4009476|FG004|COMPLETED|Part B||34
3275811|NCT02694523|4009477|FG005|COMPLETED|Part B||51
3275812|NCT02694523|4009478|FG006|COMPLETED|Part B||51
3275813|NCT02694523|4009472|FG000|NOT COMPLETED|Part B||0
3275814|NCT02694523|4009473|FG001|NOT COMPLETED|Part B||0
3275815|NCT02694523|4009474|FG002|NOT COMPLETED|Part B||20
3275816|NCT02694523|4009475|FG003|NOT COMPLETED|Part B||4
3275817|NCT02694523|4009476|FG004|NOT COMPLETED|Part B||4
3275818|NCT02694523|4009477|FG005|NOT COMPLETED|Part B||5
3275819|NCT02694523|4009478|FG006|NOT COMPLETED|Part B||2
3275820|NCT02694536|4009490|FG000|STARTED|Overall Study||80
3275821|NCT02694536|4009490|FG000|COMPLETED|Overall Study||0
3275822|NCT02694536|4009490|FG000|NOT COMPLETED|Overall Study||80
3275823|NCT02694549|4009494|FG000|STARTED|Overall Study||12
3275824|NCT02694549|4009494|FG000|COMPLETED|Overall Study||10
3275825|NCT02694549|4009494|FG000|NOT COMPLETED|Overall Study||2
3275826|NCT02694562|4009498|FG000|STARTED|Overall Study||20
3275827|NCT02694562|4009498|FG000|COMPLETED|Overall Study||2
3275828|NCT02694562|4009498|FG000|NOT COMPLETED|Overall Study||18
3275829|NCT02694601|4009502|FG000|STARTED|Overall Study||10
3275830|NCT02694601|4009502|FG000|COMPLETED|Overall Study||10
3275831|NCT02694601|4009502|FG000|NOT COMPLETED|Overall Study||0
3275832|NCT02694718|4009506|FG000|STARTED|Overall Study||60
3275833|NCT02694718|4009506|FG000|COMPLETED|Overall Study||58
3275834|NCT02694718|4009506|FG000|NOT COMPLETED|Overall Study||2
3275835|NCT02694744|4009512|FG000|STARTED|Overall Study||57
3275836|NCT02694744|4009513|FG001|STARTED|Overall Study||57
3275837|NCT02694744|4009512|FG000|Safety Population|Overall Study||57
3275838|NCT02694744|4009513|FG001|Safety Population|Overall Study||56
3275839|NCT02694744|4009512|FG000|ITT|Overall Study||57
3275840|NCT02694744|4009513|FG001|ITT|Overall Study||55
2938122|NCT00624195|3649978|FG001|NOT COMPLETED|Overall Study||7
2938123|NCT00624221|3649986|FG000|STARTED|Overall Study||20
2938124|NCT00624221|3649987|FG001|STARTED|Overall Study||20
2938125|NCT00624221|3649986|FG000|COMPLETED|Overall Study||20
2938126|NCT00624221|3649987|FG001|COMPLETED|Overall Study||20
2938127|NCT00624221|3649986|FG000|NOT COMPLETED|Overall Study||0
2938128|NCT00624221|3649987|FG001|NOT COMPLETED|Overall Study||0
2938129|NCT00624234|3649999|FG000|STARTED|Overall Study||8
2938130|NCT00624234|3650000|FG001|STARTED|Overall Study||9
3275841|NCT02694744|4009512|FG000|COMPLETED|Overall Study||51
3275842|NCT02694744|4009513|FG001|COMPLETED|Overall Study||52
3275843|NCT02694744|4009512|FG000|NOT COMPLETED|Overall Study||6
3275844|NCT02694744|4009513|FG001|NOT COMPLETED|Overall Study||5
3275845|NCT02694835|4009523|FG000|STARTED|Overall Study||41
3275846|NCT02694835|4009524|FG001|STARTED|Overall Study||39
3275847|NCT02694835|4009523|FG000|COMPLETED|Overall Study||41
3275848|NCT02694835|4009524|FG001|COMPLETED|Overall Study||39
3275849|NCT02694835|4009523|FG000|NOT COMPLETED|Overall Study||0
3275850|NCT02694835|4009524|FG001|NOT COMPLETED|Overall Study||0
3275851|NCT02694978|4009532|FG000|STARTED|Overall Study||1006
3275852|NCT02694978|4009533|FG001|STARTED|Overall Study||1008
3275853|NCT02694978|4009532|FG000|Received at Least 1 Dose of Study Drug|Overall Study||997
3275854|NCT02694978|4009533|FG001|Received at Least 1 Dose of Study Drug|Overall Study||1000
3275855|NCT02694978|4009532|FG000|COMPLETED|Overall Study||935
3275856|NCT02694978|4009533|FG001|COMPLETED|Overall Study||948
3275857|NCT02694978|4009532|FG000|NOT COMPLETED|Overall Study||71
3275858|NCT02694978|4009533|FG001|NOT COMPLETED|Overall Study||60
3275859|NCT02695290|4009539|FG000|STARTED|Overall Study||1
3275860|NCT02695290|4009539|FG000|COMPLETED|Overall Study||1
3275861|NCT02695290|4009539|FG000|NOT COMPLETED|Overall Study||0
3275862|NCT02695329|4009545|FG000|STARTED|Overall Study||50
3275863|NCT02695329|4009546|FG001|STARTED|Overall Study||50
3275864|NCT02695329|4009545|FG000|COMPLETED|Overall Study||45
3275865|NCT02695329|4009546|FG001|COMPLETED|Overall Study||45
3275866|NCT02695329|4009545|FG000|NOT COMPLETED|Overall Study||5
3275867|NCT02695329|4009546|FG001|NOT COMPLETED|Overall Study||5
3275868|NCT02695420|4009556|FG000|STARTED|Overall Study||21
3275869|NCT02695420|4009557|FG001|STARTED|Overall Study||21
3275870|NCT02695420|4009558|FG002|STARTED|Overall Study||19
3275871|NCT02695420|4009559|FG003|STARTED|Overall Study||20
3275872|NCT02695420|4009556|FG000|COMPLETED|Overall Study||21
3275873|NCT02695420|4009557|FG001|COMPLETED|Overall Study||20
3275874|NCT02695420|4009558|FG002|COMPLETED|Overall Study||19
3275875|NCT02695420|4009559|FG003|COMPLETED|Overall Study||20
3275876|NCT02695420|4009556|FG000|NOT COMPLETED|Overall Study||0
3275877|NCT02695420|4009557|FG001|NOT COMPLETED|Overall Study||1
3275878|NCT02695420|4009558|FG002|NOT COMPLETED|Overall Study||0
3275879|NCT02695420|4009559|FG003|NOT COMPLETED|Overall Study||0
3275880|NCT02695446|4009572|FG000|STARTED|Overall Study||12
3275881|NCT02695446|4009572|FG000|COMPLETED|Overall Study||12
3275882|NCT02695446|4009572|FG000|NOT COMPLETED|Overall Study||0
3275883|NCT02695524|4009578|FG000|STARTED|Overall Study||30
3275884|NCT02695524|4009579|FG001|STARTED|Overall Study||30
3275885|NCT02695524|4009578|FG000|COMPLETED|Overall Study||27
3275886|NCT02695524|4009579|FG001|COMPLETED|Overall Study||27
3275887|NCT02695524|4009578|FG000|NOT COMPLETED|Overall Study||3
3275888|NCT02695524|4009579|FG001|NOT COMPLETED|Overall Study||3
3275889|NCT02695537|4009585|FG000|STARTED|Overall Study||89
3275890|NCT02695537|4009585|FG000|COMPLETED|Overall Study||51
3275891|NCT02695537|4009585|FG000|NOT COMPLETED|Overall Study||38
3275892|NCT02695628|4009589|FG000|STARTED|Overall Study||5
3275893|NCT02695628|4009589|FG000|COMPLETED|Overall Study||4
3275894|NCT02695628|4009589|FG000|NOT COMPLETED|Overall Study||1
3275895|NCT02695719|4009595|FG000|STARTED|Overall Study||74
3275896|NCT02695719|4009596|FG001|STARTED|Overall Study||82
3275897|NCT02695719|4009595|FG000|COMPLETED|Overall Study||71
3275898|NCT02695719|4009596|FG001|COMPLETED|Overall Study||72
3275899|NCT02695719|4009595|FG000|NOT COMPLETED|Overall Study||3
3275900|NCT02695719|4009596|FG001|NOT COMPLETED|Overall Study||10
3275901|NCT02696031|4009605|FG000|STARTED|Week 24||185
3275902|NCT02696031|4009606|FG001|STARTED|Week 24||184
3275903|NCT02696031|4009607|FG002|STARTED|Week 24||186
3275904|NCT02696031|4009605|FG000|COMPLETED|Week 24||175
3275905|NCT02696031|4009606|FG001|COMPLETED|Week 24||177
3275906|NCT02696031|4009607|FG002|COMPLETED|Week 24||175
3275907|NCT02696031|4009605|FG000|NOT COMPLETED|Week 24||10
3275908|NCT02696031|4009606|FG001|NOT COMPLETED|Week 24||7
3275909|NCT02696031|4009607|FG002|NOT COMPLETED|Week 24||11
3275910|NCT02696031|4009605|FG000|STARTED|Week 52||185
3275911|NCT02696031|4009606|FG001|STARTED|Week 52||184
3275912|NCT02696031|4009607|FG002|STARTED|Week 52||186
3275913|NCT02696031|4009605|FG000|COMPLETED|Week 52||156
3275914|NCT02696031|4009606|FG001|COMPLETED|Week 52||165
3275915|NCT02696031|4009607|FG002|COMPLETED|Week 52||160
3275916|NCT02696031|4009605|FG000|NOT COMPLETED|Week 52||29
3275917|NCT02696031|4009606|FG001|NOT COMPLETED|Week 52||19
3275918|NCT02696031|4009607|FG002|NOT COMPLETED|Week 52||26
3275919|NCT02696070|4009618|FG000|STARTED|Overall Study||8
3275920|NCT02696070|4009619|FG001|STARTED|Overall Study||14
3275921|NCT02696070|4009618|FG000|COMPLETED|Overall Study||7
2938131|NCT00624234|3650001|FG002|STARTED|Overall Study||26
2938132|NCT00624234|3650002|FG003|STARTED|Overall Study||14
3275922|NCT02696070|4009619|FG001|COMPLETED|Overall Study||12
3275923|NCT02696070|4009618|FG000|NOT COMPLETED|Overall Study||1
3275924|NCT02696070|4009619|FG001|NOT COMPLETED|Overall Study||2
2938133|NCT00624234|3650003|FG004|STARTED|Overall Study||18
2938134|NCT00624234|3650004|FG005|STARTED|Overall Study||14
2938135|NCT00624234|3649999|FG000|COMPLETED|Overall Study||8
2938136|NCT00624234|3650000|FG001|COMPLETED|Overall Study||9
2938137|NCT00624234|3650001|FG002|COMPLETED|Overall Study||26
2938138|NCT00624234|3650002|FG003|COMPLETED|Overall Study||14
2938139|NCT00624234|3650003|FG004|COMPLETED|Overall Study||18
2938140|NCT00624234|3650004|FG005|COMPLETED|Overall Study||14
2938141|NCT00624234|3649999|FG000|NOT COMPLETED|Overall Study||0
2938142|NCT00624234|3650000|FG001|NOT COMPLETED|Overall Study||0
2938143|NCT00624234|3650001|FG002|NOT COMPLETED|Overall Study||0
2938144|NCT00624234|3650002|FG003|NOT COMPLETED|Overall Study||0
2938145|NCT00624234|3650003|FG004|NOT COMPLETED|Overall Study||0
2938146|NCT00624234|3650004|FG005|NOT COMPLETED|Overall Study||0
2938147|NCT00624286|3650020|FG000|STARTED|Overall Study||211
2938148|NCT00624286|3650021|FG001|STARTED|Overall Study||205
2938149|NCT00624286|3650020|FG000|COMPLETED|Overall Study||186
2938150|NCT00624286|3650021|FG001|COMPLETED|Overall Study||178
2938151|NCT00624286|3650020|FG000|NOT COMPLETED|Overall Study||25
2938152|NCT00624286|3650021|FG001|NOT COMPLETED|Overall Study||27
2938153|NCT00624338|3650030|FG000|STARTED|Overall Study||159
2938154|NCT00624338|3650031|FG001|STARTED|Overall Study||145
2938155|NCT00624338|3650032|FG002|STARTED|Overall Study||157
2938156|NCT00624338|3650030|FG000|Treated|Overall Study||157
2938157|NCT00624338|3650031|FG001|Treated|Overall Study||144
2938158|NCT00624338|3650032|FG002|Treated|Overall Study||154
2938159|NCT00624338|3650030|FG000|COMPLETED|Overall Study||112
2938160|NCT00624338|3650031|FG001|COMPLETED|Overall Study||62
2938161|NCT00624338|3650032|FG002|COMPLETED|Overall Study||111
2938162|NCT00624338|3650030|FG000|NOT COMPLETED|Overall Study||47
2938163|NCT00624338|3650031|FG001|NOT COMPLETED|Overall Study||83
2938164|NCT00624338|3650032|FG002|NOT COMPLETED|Overall Study||46
2938165|NCT00624377|3650040|FG000|STARTED|Overall Study||2031
2938166|NCT00624377|3650040|FG000|COMPLETED|Overall Study||1387
2938167|NCT00624377|3650040|FG000|NOT COMPLETED|Overall Study||644
2938168|NCT00624416|3650044|FG000|STARTED|Overall Study||10
2938169|NCT00624416|3650044|FG000|COMPLETED|Overall Study||10
2938170|NCT00624416|3650044|FG000|NOT COMPLETED|Overall Study||0
2938171|NCT00624442|3650053|FG000|STARTED|Overall Study||8
2938172|NCT00624442|3650054|FG001|STARTED|Overall Study||9
2938173|NCT00624442|3650055|FG002|STARTED|Overall Study||10
2938174|NCT00624442|3650056|FG003|STARTED|Overall Study||8
2938175|NCT00624442|3650057|FG004|STARTED|Overall Study||10
2938176|NCT00624442|3650053|FG000|COMPLETED|Overall Study||8
2938177|NCT00624442|3650054|FG001|COMPLETED|Overall Study|One patient was discontinued after inadvertant overdose.|8
2938178|NCT00624442|3650055|FG002|COMPLETED|Overall Study|Two patients discontinued after meeting termination criteria during dosing.|8
2938179|NCT00624442|3650056|FG003|COMPLETED|Overall Study||8
2938180|NCT00624442|3650057|FG004|COMPLETED|Overall Study|Two patients discontinued after meeting termination criteria during dosing.|8
2938181|NCT00624442|3650053|FG000|NOT COMPLETED|Overall Study||0
2938182|NCT00624442|3650054|FG001|NOT COMPLETED|Overall Study||1
2938183|NCT00624442|3650055|FG002|NOT COMPLETED|Overall Study||2
3275925|NCT02696083|4009625|FG000|STARTED|Overall Study||19
3275926|NCT02696083|4009625|FG000|COMPLETED|Overall Study||13
3275927|NCT02696083|4009625|FG000|NOT COMPLETED|Overall Study||6
2938184|NCT00624442|3650056|FG003|NOT COMPLETED|Overall Study||0
2938185|NCT00624442|3650057|FG004|NOT COMPLETED|Overall Study||2
2938186|NCT00624468|3650092|FG000|STARTED|Double-blind Period||17
3275928|NCT02696200|4009636|FG000|STARTED|Overall Study||32
3275929|NCT02696200|4009637|FG001|STARTED|Overall Study||30
3275930|NCT02696200|4009636|FG000|COMPLETED|Overall Study||32
2938187|NCT00624468|3650093|FG001|STARTED|Double-blind Period||17
2938188|NCT00624468|3650094|FG002|STARTED|Double-blind Period||0
2938189|NCT00624468|3650095|FG003|STARTED|Double-blind Period||0
3275931|NCT02696200|4009637|FG001|COMPLETED|Overall Study||30
2938190|NCT00624468|3650092|FG000|COMPLETED|Double-blind Period||3
2938191|NCT00624468|3650093|FG001|COMPLETED|Double-blind Period||4
2938192|NCT00624468|3650094|FG002|COMPLETED|Double-blind Period||0
2938193|NCT00624468|3650095|FG003|COMPLETED|Double-blind Period||0
2938194|NCT00624468|3650092|FG000|NOT COMPLETED|Double-blind Period||14
2938195|NCT00624468|3650093|FG001|NOT COMPLETED|Double-blind Period||13
2938196|NCT00624468|3650094|FG002|NOT COMPLETED|Double-blind Period||0
2938197|NCT00624468|3650095|FG003|NOT COMPLETED|Double-blind Period||0
2938198|NCT00624468|3650092|FG000|STARTED|Safety Follow-up (SFU) Period||0
2938199|NCT00624468|3650093|FG001|STARTED|Safety Follow-up (SFU) Period||0
2938200|NCT00624468|3650094|FG002|STARTED|Safety Follow-up (SFU) Period||13
2938201|NCT00624468|3650095|FG003|STARTED|Safety Follow-up (SFU) Period||14
2938202|NCT00624468|3650092|FG000|COMPLETED|Safety Follow-up (SFU) Period||0
2938203|NCT00624468|3650093|FG001|COMPLETED|Safety Follow-up (SFU) Period||0
2938204|NCT00624468|3650094|FG002|COMPLETED|Safety Follow-up (SFU) Period||11
2938205|NCT00624468|3650095|FG003|COMPLETED|Safety Follow-up (SFU) Period||11
2938206|NCT00624468|3650092|FG000|NOT COMPLETED|Safety Follow-up (SFU) Period||0
2938207|NCT00624468|3650093|FG001|NOT COMPLETED|Safety Follow-up (SFU) Period||0
2938208|NCT00624468|3650094|FG002|NOT COMPLETED|Safety Follow-up (SFU) Period||2
2938209|NCT00624468|3650095|FG003|NOT COMPLETED|Safety Follow-up (SFU) Period||3
2938210|NCT00624520|3650105|FG000|STARTED|Overall Study||56
2938211|NCT00624520|3650106|FG001|STARTED|Overall Study||47
2938212|NCT00624520|3650105|FG000|COMPLETED|Overall Study||44
2938213|NCT00624520|3650106|FG001|COMPLETED|Overall Study||39
2938214|NCT00624520|3650105|FG000|NOT COMPLETED|Overall Study||12
2938215|NCT00624520|3650106|FG001|NOT COMPLETED|Overall Study||8
2938216|NCT00624559|3650116|FG000|STARTED|Overall Study|Celebrex 1st: 3days baseline(100mmol), 7days high(350mmol) followed by 7days low(20mmol) sodium/day|3
2938217|NCT00624559|3650117|FG001|STARTED|Overall Study|Celebrex 1st: 3days baseline(100mmol), 7days low(20mmol) followed by 7days high(350mmol) sodium/day|3
2938218|NCT00624559|3650118|FG002|STARTED|Overall Study|Placebo 1st: 3days baseline(100mmol), 7days low(20mmol) followed by 7days high(350mmol) sodium/day|3
2938219|NCT00624559|3650119|FG003|STARTED|Overall Study|Placebo 1st: 3days baseline(100mmol), 7days high(350mmol) followed by 7days low(20mmol) sodium/day|3
2938220|NCT00624559|3650116|FG000|COMPLETED|Overall Study||3
2938221|NCT00624559|3650117|FG001|COMPLETED|Overall Study||3
2938222|NCT00624559|3650118|FG002|COMPLETED|Overall Study||3
2938223|NCT00624559|3650119|FG003|COMPLETED|Overall Study||3
2938224|NCT00624559|3650116|FG000|NOT COMPLETED|Overall Study||0
2938225|NCT00624559|3650117|FG001|NOT COMPLETED|Overall Study||0
2938226|NCT00624559|3650118|FG002|NOT COMPLETED|Overall Study||0
2938227|NCT00624559|3650119|FG003|NOT COMPLETED|Overall Study||0
2938228|NCT00624585|3650129|FG000|STARTED|Overall Study||18
2938229|NCT00624585|3650129|FG000|COMPLETED|Overall Study||6
2938230|NCT00624585|3650129|FG000|NOT COMPLETED|Overall Study||12
2938231|NCT00624780|3650139|FG000|STARTED|Treatment Optimization (Up to Week 12)||154
2938232|NCT00624780|3650140|FG001|STARTED|Treatment Optimization (Up to Week 12)||52
2938233|NCT00624780|3650141|FG002|STARTED|Treatment Optimization (Up to Week 12)||154
2938234|NCT00624780|3650142|FG003|STARTED|Treatment Optimization (Up to Week 12)||52
2938235|NCT00624780|3650143|FG004|STARTED|Treatment Optimization (Up to Week 12)||153
2938236|NCT00624780|3650144|FG005|STARTED|Treatment Optimization (Up to Week 12)||50
2938237|NCT00624780|3650139|FG000|COMPLETED|Treatment Optimization (Up to Week 12)||121
2938238|NCT00624780|3650140|FG001|COMPLETED|Treatment Optimization (Up to Week 12)||39
2938239|NCT00624780|3650141|FG002|COMPLETED|Treatment Optimization (Up to Week 12)||112
2938240|NCT00624780|3650142|FG003|COMPLETED|Treatment Optimization (Up to Week 12)||38
2938241|NCT00624780|3650143|FG004|COMPLETED|Treatment Optimization (Up to Week 12)||114
2938242|NCT00624780|3650144|FG005|COMPLETED|Treatment Optimization (Up to Week 12)||39
2938243|NCT00624780|3650139|FG000|NOT COMPLETED|Treatment Optimization (Up to Week 12)||33
2938244|NCT00624780|3650140|FG001|NOT COMPLETED|Treatment Optimization (Up to Week 12)||13
2938245|NCT00624780|3650141|FG002|NOT COMPLETED|Treatment Optimization (Up to Week 12)||42
2938246|NCT00624780|3650142|FG003|NOT COMPLETED|Treatment Optimization (Up to Week 12)||14
2938247|NCT00624780|3650143|FG004|NOT COMPLETED|Treatment Optimization (Up to Week 12)||39
2938248|NCT00624780|3650144|FG005|NOT COMPLETED|Treatment Optimization (Up to Week 12)||11
2938249|NCT00624780|3650139|FG000|STARTED|Fixed Dosing (Week 13 to Week 24)||121
2938250|NCT00624780|3650140|FG001|STARTED|Fixed Dosing (Week 13 to Week 24)||39
2938251|NCT00624780|3650141|FG002|STARTED|Fixed Dosing (Week 13 to Week 24)||112
2938252|NCT00624780|3650142|FG003|STARTED|Fixed Dosing (Week 13 to Week 24)||38
2938253|NCT00624780|3650143|FG004|STARTED|Fixed Dosing (Week 13 to Week 24)||114
2938254|NCT00624780|3650144|FG005|STARTED|Fixed Dosing (Week 13 to Week 24)||39
2938255|NCT00624780|3650139|FG000|COMPLETED|Fixed Dosing (Week 13 to Week 24)||106
2938256|NCT00624780|3650140|FG001|COMPLETED|Fixed Dosing (Week 13 to Week 24)||28
3275932|NCT02696200|4009636|FG000|NOT COMPLETED|Overall Study||0
3275933|NCT02696200|4009637|FG001|NOT COMPLETED|Overall Study||0
3275934|NCT02696291|4009645|FG000|STARTED|Overall Study||5
3275935|NCT02696291|4009646|FG001|STARTED|Overall Study||2
3275936|NCT02696291|4009645|FG000|COMPLETED|Overall Study||5
3275937|NCT02696291|4009646|FG001|COMPLETED|Overall Study||2
2938257|NCT00624780|3650141|FG002|COMPLETED|Fixed Dosing (Week 13 to Week 24)||94
2938258|NCT00624780|3650142|FG003|COMPLETED|Fixed Dosing (Week 13 to Week 24)||27
2938259|NCT00624780|3650143|FG004|COMPLETED|Fixed Dosing (Week 13 to Week 24)||95
2938260|NCT00624780|3650144|FG005|COMPLETED|Fixed Dosing (Week 13 to Week 24)||30
2938261|NCT00624780|3650139|FG000|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||15
2938262|NCT00624780|3650140|FG001|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||11
2938263|NCT00624780|3650141|FG002|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||18
2938264|NCT00624780|3650142|FG003|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||11
2938265|NCT00624780|3650143|FG004|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||19
2938266|NCT00624780|3650144|FG005|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||9
2938267|NCT00624780|3650139|FG000|STARTED|Treatment Discontinuation (Week 25)||106
2938268|NCT00624780|3650140|FG001|STARTED|Treatment Discontinuation (Week 25)||28
2938269|NCT00624780|3650141|FG002|STARTED|Treatment Discontinuation (Week 25)||94
2938270|NCT00624780|3650142|FG003|STARTED|Treatment Discontinuation (Week 25)||27
2938271|NCT00624780|3650143|FG004|STARTED|Treatment Discontinuation (Week 25)||95
2938272|NCT00624780|3650144|FG005|STARTED|Treatment Discontinuation (Week 25)||30
2938273|NCT00624780|3650139|FG000|COMPLETED|Treatment Discontinuation (Week 25)||104
2938274|NCT00624780|3650140|FG001|COMPLETED|Treatment Discontinuation (Week 25)||28
2938275|NCT00624780|3650141|FG002|COMPLETED|Treatment Discontinuation (Week 25)||91
2938276|NCT00624780|3650142|FG003|COMPLETED|Treatment Discontinuation (Week 25)||26
2938277|NCT00624780|3650143|FG004|COMPLETED|Treatment Discontinuation (Week 25)||95
2938278|NCT00624780|3650144|FG005|COMPLETED|Treatment Discontinuation (Week 25)||29
3275938|NCT02696291|4009645|FG000|NOT COMPLETED|Overall Study||0
3275939|NCT02696291|4009646|FG001|NOT COMPLETED|Overall Study||0
2938279|NCT00624780|3650139|FG000|NOT COMPLETED|Treatment Discontinuation (Week 25)||2
2938280|NCT00624780|3650140|FG001|NOT COMPLETED|Treatment Discontinuation (Week 25)||0
2938281|NCT00624780|3650141|FG002|NOT COMPLETED|Treatment Discontinuation (Week 25)||3
3275940|NCT02696317|4009652|FG000|STARTED|Habitual, 10 Days of Wear||42
3275941|NCT02696317|4009653|FG001|STARTED|Habitual, 10 Days of Wear||40
3275942|NCT02696317|4009652|FG000|COMPLETED|Habitual, 10 Days of Wear||40
3275943|NCT02696317|4009653|FG001|COMPLETED|Habitual, 10 Days of Wear||36
3275944|NCT02696317|4009652|FG000|NOT COMPLETED|Habitual, 10 Days of Wear||2
3275945|NCT02696317|4009653|FG001|NOT COMPLETED|Habitual, 10 Days of Wear||4
3275946|NCT02696317|4009652|FG000|STARTED|Period 1, 10 Days of Wear||40
3275947|NCT02696317|4009653|FG001|STARTED|Period 1, 10 Days of Wear||36
3275948|NCT02696317|4009652|FG000|COMPLETED|Period 1, 10 Days of Wear||40
3275949|NCT02696317|4009653|FG001|COMPLETED|Period 1, 10 Days of Wear||36
3275950|NCT02696317|4009652|FG000|NOT COMPLETED|Period 1, 10 Days of Wear||0
3275951|NCT02696317|4009653|FG001|NOT COMPLETED|Period 1, 10 Days of Wear||0
2938282|NCT00624780|3650142|FG003|NOT COMPLETED|Treatment Discontinuation (Week 25)||1
2938283|NCT00624780|3650143|FG004|NOT COMPLETED|Treatment Discontinuation (Week 25)||0
2938284|NCT00624780|3650144|FG005|NOT COMPLETED|Treatment Discontinuation (Week 25)||1
2938285|NCT00624780|3650139|FG000|STARTED|Follow-up (Week 26)||104
2938286|NCT00624780|3650140|FG001|STARTED|Follow-up (Week 26)||28
2938287|NCT00624780|3650141|FG002|STARTED|Follow-up (Week 26)||91
2938288|NCT00624780|3650142|FG003|STARTED|Follow-up (Week 26)||26
2938289|NCT00624780|3650143|FG004|STARTED|Follow-up (Week 26)||95
2938290|NCT00624780|3650144|FG005|STARTED|Follow-up (Week 26)||29
2938291|NCT00624780|3650139|FG000|COMPLETED|Follow-up (Week 26)||102
2938292|NCT00624780|3650140|FG001|COMPLETED|Follow-up (Week 26)||27
2938293|NCT00624780|3650141|FG002|COMPLETED|Follow-up (Week 26)||89
2938294|NCT00624780|3650142|FG003|COMPLETED|Follow-up (Week 26)||26
2938295|NCT00624780|3650143|FG004|COMPLETED|Follow-up (Week 26)||93
2938296|NCT00624780|3650144|FG005|COMPLETED|Follow-up (Week 26)||29
2938297|NCT00624780|3650139|FG000|NOT COMPLETED|Follow-up (Week 26)||2
2938298|NCT00624780|3650140|FG001|NOT COMPLETED|Follow-up (Week 26)||1
2938299|NCT00624780|3650141|FG002|NOT COMPLETED|Follow-up (Week 26)||2
2938300|NCT00624780|3650142|FG003|NOT COMPLETED|Follow-up (Week 26)||0
2938301|NCT00624780|3650143|FG004|NOT COMPLETED|Follow-up (Week 26)||2
2938302|NCT00624780|3650144|FG005|NOT COMPLETED|Follow-up (Week 26)||0
2938303|NCT00624806|3650163|FG000|STARTED|Overall Study||10
2938304|NCT00624806|3650164|FG001|STARTED|Overall Study||8
2938305|NCT00624806|3650163|FG000|COMPLETED|Overall Study||10
2938306|NCT00624806|3650164|FG001|COMPLETED|Overall Study||8
2938307|NCT00624806|3650163|FG000|NOT COMPLETED|Overall Study||0
2938308|NCT00624806|3650164|FG001|NOT COMPLETED|Overall Study||0
2938309|NCT00624819|3650174|FG000|STARTED|Follow-up Period: Year 1||391
2938310|NCT00624819|3650175|FG001|STARTED|Follow-up Period: Year 1||31
2938311|NCT00624819|3650176|FG002|STARTED|Follow-up Period: Year 1||102
2938312|NCT00624819|3650177|FG003|STARTED|Follow-up Period: Year 1||0
2938313|NCT00624819|3650174|FG000|COMPLETED|Follow-up Period: Year 1||391
2938314|NCT00624819|3650175|FG001|COMPLETED|Follow-up Period: Year 1||31
3275952|NCT02696317|4009652|FG000|STARTED|Period 2, 10 Days of Wear||40
2938315|NCT00624819|3650176|FG002|COMPLETED|Follow-up Period: Year 1||102
2938316|NCT00624819|3650177|FG003|COMPLETED|Follow-up Period: Year 1||0
2938317|NCT00624819|3650174|FG000|NOT COMPLETED|Follow-up Period: Year 1||0
2938318|NCT00624819|3650175|FG001|NOT COMPLETED|Follow-up Period: Year 1||0
2938319|NCT00624819|3650176|FG002|NOT COMPLETED|Follow-up Period: Year 1||0
2938320|NCT00624819|3650177|FG003|NOT COMPLETED|Follow-up Period: Year 1||0
2938321|NCT00624819|3650174|FG000|STARTED|Follow-up Period: Year 2||370
2938322|NCT00624819|3650175|FG001|STARTED|Follow-up Period: Year 2||31
2938323|NCT00624819|3650176|FG002|STARTED|Follow-up Period: Year 2||96
2938324|NCT00624819|3650177|FG003|STARTED|Follow-up Period: Year 2||0
2938325|NCT00624819|3650174|FG000|COMPLETED|Follow-up Period: Year 2||370
2938326|NCT00624819|3650175|FG001|COMPLETED|Follow-up Period: Year 2||31
2938327|NCT00624819|3650176|FG002|COMPLETED|Follow-up Period: Year 2||96
2938328|NCT00624819|3650177|FG003|COMPLETED|Follow-up Period: Year 2||0
2938329|NCT00624819|3650174|FG000|NOT COMPLETED|Follow-up Period: Year 2||0
2938330|NCT00624819|3650175|FG001|NOT COMPLETED|Follow-up Period: Year 2||0
2938331|NCT00624819|3650176|FG002|NOT COMPLETED|Follow-up Period: Year 2||0
2938332|NCT00624819|3650177|FG003|NOT COMPLETED|Follow-up Period: Year 2||0
2938333|NCT00624819|3650174|FG000|STARTED|Follow-up Period: Year 4||264
2938334|NCT00624819|3650175|FG001|STARTED|Follow-up Period: Year 4||20
2938335|NCT00624819|3650176|FG002|STARTED|Follow-up Period: Year 4||65
2938336|NCT00624819|3650177|FG003|STARTED|Follow-up Period: Year 4||100
2938337|NCT00624819|3650174|FG000|COMPLETED|Follow-up Period: Year 4||263
2938338|NCT00624819|3650175|FG001|COMPLETED|Follow-up Period: Year 4||19
2938339|NCT00624819|3650176|FG002|COMPLETED|Follow-up Period: Year 4||64
2938340|NCT00624819|3650177|FG003|COMPLETED|Follow-up Period: Year 4||100
2938341|NCT00624819|3650174|FG000|NOT COMPLETED|Follow-up Period: Year 4||1
2938342|NCT00624819|3650175|FG001|NOT COMPLETED|Follow-up Period: Year 4||1
2938343|NCT00624819|3650176|FG002|NOT COMPLETED|Follow-up Period: Year 4||1
2938344|NCT00624819|3650177|FG003|NOT COMPLETED|Follow-up Period: Year 4||0
2938345|NCT00624832|3650191|FG000|STARTED|Overall Study||18
3275953|NCT02696317|4009653|FG001|STARTED|Period 2, 10 Days of Wear||36
3275954|NCT02696317|4009652|FG000|COMPLETED|Period 2, 10 Days of Wear||39
2938346|NCT00624832|3650192|FG001|STARTED|Overall Study||16
2938347|NCT00624832|3650193|FG002|STARTED|Overall Study||10
2938348|NCT00624832|3650194|FG003|STARTED|Overall Study||16
2938349|NCT00624832|3650191|FG000|COMPLETED|Overall Study||16
2938350|NCT00624832|3650192|FG001|COMPLETED|Overall Study||15
2938351|NCT00624832|3650193|FG002|COMPLETED|Overall Study||10
2938352|NCT00624832|3650194|FG003|COMPLETED|Overall Study||15
2938353|NCT00624832|3650191|FG000|NOT COMPLETED|Overall Study||2
2938354|NCT00624832|3650192|FG001|NOT COMPLETED|Overall Study||1
2938355|NCT00624832|3650193|FG002|NOT COMPLETED|Overall Study||0
2938356|NCT00624832|3650194|FG003|NOT COMPLETED|Overall Study||1
2938357|NCT00624910|3650206|FG000|STARTED|Overall Study||28
2938358|NCT00624910|3650207|FG001|STARTED|Overall Study||15
2938359|NCT00624910|3650208|FG002|STARTED|Overall Study||11
2938360|NCT00624910|3650206|FG000|COMPLETED|Overall Study||28
2938361|NCT00624910|3650207|FG001|COMPLETED|Overall Study||15
2938362|NCT00624910|3650208|FG002|COMPLETED|Overall Study||11
2938363|NCT00624910|3650206|FG000|NOT COMPLETED|Overall Study||0
2938364|NCT00624910|3650207|FG001|NOT COMPLETED|Overall Study||0
2938365|NCT00624910|3650208|FG002|NOT COMPLETED|Overall Study||0
2938366|NCT00624923|3650218|FG000|STARTED|Overall Study||127
2938367|NCT00624923|3650219|FG001|STARTED|Overall Study||124
2938368|NCT00624923|3650218|FG000|COMPLETED|Overall Study||89
2938369|NCT00624923|3650219|FG001|COMPLETED|Overall Study||101
2938370|NCT00624923|3650218|FG000|NOT COMPLETED|Overall Study||38
2938371|NCT00624923|3650219|FG001|NOT COMPLETED|Overall Study||23
2938372|NCT00625131|3650229|FG000|STARTED|Overall Study||38
2938373|NCT00625131|3650230|FG001|STARTED|Overall Study||44
2938374|NCT00625131|3650231|FG002|STARTED|Overall Study|These participants were not included in any analyses.|5
2938375|NCT00625131|3650229|FG000|COMPLETED|Overall Study||34
2938376|NCT00625131|3650230|FG001|COMPLETED|Overall Study||42
2938377|NCT00625131|3650231|FG002|COMPLETED|Overall Study||0
2938378|NCT00625131|3650229|FG000|NOT COMPLETED|Overall Study||4
2938379|NCT00625131|3650230|FG001|NOT COMPLETED|Overall Study||2
2938380|NCT00625131|3650231|FG002|NOT COMPLETED|Overall Study||5
2938381|NCT00625183|3650237|FG000|STARTED|Overall Study||5
2938382|NCT00625183|3650237|FG000|COMPLETED|Overall Study||4
2938383|NCT00625183|3650237|FG000|NOT COMPLETED|Overall Study||1
2938384|NCT00625365|3650243|FG000|STARTED|Overall Study||1060
2938385|NCT00625365|3650243|FG000|COMPLETED|Overall Study|Participants who were analyzed for safety|1053
2938386|NCT00625365|3650243|FG000|NOT COMPLETED|Overall Study||7
2938387|NCT00625391|3650251|FG000|STARTED|Overall Study||44
2938388|NCT00625391|3650252|FG001|STARTED|Overall Study||47
2938389|NCT00625391|3650253|FG002|STARTED|Overall Study||42
2938390|NCT00625391|3650254|FG003|STARTED|Overall Study||38
2938391|NCT00625391|3650251|FG000|COMPLETED|Overall Study||37
2938392|NCT00625391|3650252|FG001|COMPLETED|Overall Study||39
2938393|NCT00625391|3650253|FG002|COMPLETED|Overall Study||37
2938394|NCT00625391|3650254|FG003|COMPLETED|Overall Study||37
2938395|NCT00625391|3650251|FG000|NOT COMPLETED|Overall Study||7
2938396|NCT00625391|3650252|FG001|NOT COMPLETED|Overall Study||8
2938397|NCT00625391|3650253|FG002|NOT COMPLETED|Overall Study||5
2938398|NCT00625391|3650254|FG003|NOT COMPLETED|Overall Study||1
2938399|NCT00625404|3650266|FG000|STARTED|Overall Study||1062
2938400|NCT00625404|3650267|FG001|STARTED|Overall Study||1058
2938401|NCT00625404|3650266|FG000|COMPLETED|Overall Study||855
2938402|NCT00625404|3650267|FG001|COMPLETED|Overall Study||885
2938403|NCT00625404|3650266|FG000|NOT COMPLETED|Overall Study||207
2938404|NCT00625404|3650267|FG001|NOT COMPLETED|Overall Study||173
2938405|NCT00625443|3650280|FG000|STARTED|Overall Study||12
2938406|NCT00625443|3650281|FG001|STARTED|Overall Study||26
2938407|NCT00625443|3650282|FG002|STARTED|Overall Study||15
2938408|NCT00625443|3650280|FG000|COMPLETED|Overall Study||10
2938409|NCT00625443|3650281|FG001|COMPLETED|Overall Study||15
2938410|NCT00625443|3650282|FG002|COMPLETED|Overall Study||10
2938411|NCT00625443|3650280|FG000|NOT COMPLETED|Overall Study||2
2938412|NCT00625443|3650281|FG001|NOT COMPLETED|Overall Study||11
2938413|NCT00625443|3650282|FG002|NOT COMPLETED|Overall Study||5
2938414|NCT00625729|3650293|FG000|STARTED|Overall Study||6
2938415|NCT00625729|3650293|FG000|COMPLETED|Overall Study||6
2938416|NCT00625729|3650293|FG000|NOT COMPLETED|Overall Study||0
2938417|NCT00625807|3650300|FG000|STARTED|Overall Study||22
2938418|NCT00625807|3650301|FG001|STARTED|Overall Study||28
2938419|NCT00625807|3650300|FG000|COMPLETED|Overall Study||20
2938420|NCT00625807|3650301|FG001|COMPLETED|Overall Study||20
2938421|NCT00625807|3650300|FG000|NOT COMPLETED|Overall Study||2
2938422|NCT00625807|3650301|FG001|NOT COMPLETED|Overall Study||8
2938423|NCT00625820|3650309|FG000|STARTED|Overall Study||17
2938424|NCT00625820|3650309|FG000|COMPLETED|Overall Study||16
2938425|NCT00625820|3650309|FG000|NOT COMPLETED|Overall Study||1
2938426|NCT00625846|3650318|FG000|STARTED|Overall Study||39
2938427|NCT00625846|3650319|FG001|STARTED|Overall Study||35
2938428|NCT00625846|3650320|FG002|STARTED|Overall Study||16
2938429|NCT00625846|3650321|FG003|STARTED|Overall Study||62
2938430|NCT00625846|3650318|FG000|COMPLETED|Overall Study||37
2938431|NCT00625846|3650319|FG001|COMPLETED|Overall Study||35
2938432|NCT00625846|3650320|FG002|COMPLETED|Overall Study||15
2938433|NCT00625846|3650321|FG003|COMPLETED|Overall Study||60
2938434|NCT00625846|3650318|FG000|NOT COMPLETED|Overall Study||2
2938435|NCT00625846|3650319|FG001|NOT COMPLETED|Overall Study||0
2938436|NCT00625846|3650320|FG002|NOT COMPLETED|Overall Study||1
2938437|NCT00625846|3650321|FG003|NOT COMPLETED|Overall Study||2
2938438|NCT00625872|3650337|FG000|STARTED|Overall Study||12
2938439|NCT00625872|3650338|FG001|STARTED|Overall Study||11
2938440|NCT00625872|3650337|FG000|Treated|Overall Study||12
2938441|NCT00625872|3650338|FG001|Treated|Overall Study||10
2938442|NCT00625872|3650337|FG000|COMPLETED|Overall Study||8
2938443|NCT00625872|3650338|FG001|COMPLETED|Overall Study||5
2938444|NCT00625872|3650337|FG000|NOT COMPLETED|Overall Study||4
2938445|NCT00625872|3650338|FG001|NOT COMPLETED|Overall Study||6
2938446|NCT00625989|3650344|FG000|STARTED|Overall Study||6
2938447|NCT00625989|3650345|FG001|STARTED|Overall Study||6
2938448|NCT00625989|3650344|FG000|COMPLETED|Overall Study||6
3275955|NCT02696317|4009653|FG001|COMPLETED|Period 2, 10 Days of Wear||36
3275956|NCT02696317|4009652|FG000|NOT COMPLETED|Period 2, 10 Days of Wear||1
3275957|NCT02696317|4009653|FG001|NOT COMPLETED|Period 2, 10 Days of Wear||0
2938449|NCT00625989|3650345|FG001|COMPLETED|Overall Study||6
2938450|NCT00625989|3650344|FG000|NOT COMPLETED|Overall Study||0
2938451|NCT00625989|3650345|FG001|NOT COMPLETED|Overall Study||0
2938452|NCT00626028|3650352|FG000|STARTED|Overall Study||68
2938453|NCT00626028|3650353|FG001|STARTED|Overall Study||68
2938454|NCT00626028|3650352|FG000|COMPLETED|Overall Study||62
2938455|NCT00626028|3650353|FG001|COMPLETED|Overall Study||59
2938456|NCT00626028|3650352|FG000|NOT COMPLETED|Overall Study||6
2938457|NCT00626028|3650353|FG001|NOT COMPLETED|Overall Study||9
2938458|NCT00626093|3650359|FG000|STARTED|Overall Study||77
2938459|NCT00626093|3650359|FG000|COMPLETED|Overall Study||54
2938460|NCT00626093|3650359|FG000|NOT COMPLETED|Overall Study||23
2938461|NCT00626197|3650366|FG000|STARTED|Overall Study||127
2938462|NCT00626197|3650367|FG001|STARTED|Overall Study||128
2938463|NCT00626197|3650368|FG002|STARTED|Overall Study||126
2938464|NCT00626197|3650366|FG000|COMPLETED|Overall Study||83
2938465|NCT00626197|3650367|FG001|COMPLETED|Overall Study||74
2938466|NCT00626197|3650368|FG002|COMPLETED|Overall Study||49
2938467|NCT00626197|3650366|FG000|NOT COMPLETED|Overall Study||44
2938468|NCT00626197|3650367|FG001|NOT COMPLETED|Overall Study||54
2938469|NCT00626197|3650368|FG002|NOT COMPLETED|Overall Study||77
2938470|NCT00626210|3650382|FG000|STARTED|Overall Study||2
2938471|NCT00626210|3650382|FG000|COMPLETED|Overall Study||2
2938472|NCT00626210|3650382|FG000|NOT COMPLETED|Overall Study||0
2938473|NCT00626275|3650386|FG000|STARTED|Part A - Treatment Period 1||7
2938474|NCT00626275|3650387|FG001|STARTED|Part A - Treatment Period 1||7
2938475|NCT00626275|3650388|FG002|STARTED|Part A - Treatment Period 1||7
3275958|NCT02696434|4009663|FG000|STARTED|Overall Study||50
3275959|NCT02696434|4009664|FG001|STARTED|Overall Study||51
3275960|NCT02696434|4009663|FG000|COMPLETED|Overall Study||28
3275961|NCT02696434|4009664|FG001|COMPLETED|Overall Study||33
3275962|NCT02696434|4009663|FG000|NOT COMPLETED|Overall Study||22
3275963|NCT02696434|4009664|FG001|NOT COMPLETED|Overall Study||18
3275964|NCT02696759|4009670|FG000|STARTED|Overall Study||16
3275965|NCT02696759|4009670|FG000|COMPLETED|Overall Study||12
3275966|NCT02696759|4009670|FG000|NOT COMPLETED|Overall Study||4
3275967|NCT02696785|4009678|FG000|STARTED|Blinded Treatment Period||87
3275968|NCT02696785|4009679|FG001|STARTED|Blinded Treatment Period||90
3275969|NCT02696785|4009680|FG002|STARTED|Blinded Treatment Period||83
3275970|NCT02696785|4009681|FG003|STARTED|Blinded Treatment Period||81
3275971|NCT02696785|4009678|FG000|Received at Least One Dose of Study Drug|Blinded Treatment Period||86
3275972|NCT02696785|4009679|FG001|Received at Least One Dose of Study Drug|Blinded Treatment Period||90
3275973|NCT02696785|4009680|FG002|Received at Least One Dose of Study Drug|Blinded Treatment Period||83
3275974|NCT02696785|4009681|FG003|Received at Least One Dose of Study Drug|Blinded Treatment Period||81
3275975|NCT02696785|4009678|FG000|COMPLETED|Blinded Treatment Period||86
3275976|NCT02696785|4009679|FG001|COMPLETED|Blinded Treatment Period||88
3275977|NCT02696785|4009680|FG002|COMPLETED|Blinded Treatment Period||79
3275978|NCT02696785|4009681|FG003|COMPLETED|Blinded Treatment Period||78
3275979|NCT02696785|4009678|FG000|NOT COMPLETED|Blinded Treatment Period||1
3275980|NCT02696785|4009679|FG001|NOT COMPLETED|Blinded Treatment Period||2
3275981|NCT02696785|4009680|FG002|NOT COMPLETED|Blinded Treatment Period||4
3275982|NCT02696785|4009681|FG003|NOT COMPLETED|Blinded Treatment Period||3
3275983|NCT02696785|4009678|FG000|STARTED|Washout Period|Washout period occurred only for Adalimumab group.|0
3275984|NCT02696785|4009679|FG001|STARTED|Washout Period||88
3275985|NCT02696785|4009680|FG002|STARTED|Washout Period|Washout period occurred only for Adalimumab group.|0
3275986|NCT02696785|4009681|FG003|STARTED|Washout Period|Washout period occurred only for Adalimumab group.|0
3275987|NCT02696785|4009678|FG000|COMPLETED|Washout Period||0
3275988|NCT02696785|4009679|FG001|COMPLETED|Washout Period||86
3275989|NCT02696785|4009680|FG002|COMPLETED|Washout Period||0
3275990|NCT02696785|4009681|FG003|COMPLETED|Washout Period||0
3275991|NCT02696785|4009678|FG000|NOT COMPLETED|Washout Period||0
3275992|NCT02696785|4009679|FG001|NOT COMPLETED|Washout Period||2
3275993|NCT02696785|4009680|FG002|NOT COMPLETED|Washout Period||0
3275994|NCT02696785|4009681|FG003|NOT COMPLETED|Washout Period||0
3275995|NCT02696785|4009678|FG000|STARTED|Extended Treatment Period||86
3275996|NCT02696785|4009679|FG001|STARTED|Extended Treatment Period||86
3275997|NCT02696785|4009680|FG002|STARTED|Extended Treatment Period||79
3275998|NCT02696785|4009681|FG003|STARTED|Extended Treatment Period||78
3275999|NCT02696785|4009678|FG000|COMPLETED|Extended Treatment Period||83
3276000|NCT02696785|4009679|FG001|COMPLETED|Extended Treatment Period||80
3276001|NCT02696785|4009680|FG002|COMPLETED|Extended Treatment Period||74
3276002|NCT02696785|4009681|FG003|COMPLETED|Extended Treatment Period||72
3276003|NCT02696785|4009678|FG000|NOT COMPLETED|Extended Treatment Period||3
3276004|NCT02696785|4009679|FG001|NOT COMPLETED|Extended Treatment Period||6
3276005|NCT02696785|4009680|FG002|NOT COMPLETED|Extended Treatment Period||5
3276006|NCT02696785|4009681|FG003|NOT COMPLETED|Extended Treatment Period||6
2938476|NCT00626275|3650389|FG003|STARTED|Part A - Treatment Period 1||8
2938477|NCT00626275|3650390|FG004|STARTED|Part A - Treatment Period 1||9
2938478|NCT00626275|3650391|FG005|STARTED|Part A - Treatment Period 1||8
2938479|NCT00626275|3650392|FG006|STARTED|Part A - Treatment Period 1||0
2938480|NCT00626275|3650393|FG007|STARTED|Part A - Treatment Period 1||0
2938481|NCT00626275|3650386|FG000|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||7
2938482|NCT00626275|3650387|FG001|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||7
2938483|NCT00626275|3650388|FG002|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||7
2938484|NCT00626275|3650389|FG003|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||8
2938485|NCT00626275|3650390|FG004|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||9
2938486|NCT00626275|3650391|FG005|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||8
2938487|NCT00626275|3650392|FG006|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||0
2938488|NCT00626275|3650393|FG007|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||0
2938489|NCT00626275|3650386|FG000|COMPLETED|Part A - Treatment Period 1||6
2938490|NCT00626275|3650387|FG001|COMPLETED|Part A - Treatment Period 1||7
2938491|NCT00626275|3650388|FG002|COMPLETED|Part A - Treatment Period 1||6
2938492|NCT00626275|3650389|FG003|COMPLETED|Part A - Treatment Period 1||8
2938493|NCT00626275|3650390|FG004|COMPLETED|Part A - Treatment Period 1||9
2938494|NCT00626275|3650391|FG005|COMPLETED|Part A - Treatment Period 1||8
2938495|NCT00626275|3650392|FG006|COMPLETED|Part A - Treatment Period 1||0
2938496|NCT00626275|3650393|FG007|COMPLETED|Part A - Treatment Period 1||0
2938497|NCT00626275|3650386|FG000|NOT COMPLETED|Part A - Treatment Period 1||1
2938498|NCT00626275|3650387|FG001|NOT COMPLETED|Part A - Treatment Period 1||0
2938499|NCT00626275|3650388|FG002|NOT COMPLETED|Part A - Treatment Period 1||1
2938500|NCT00626275|3650389|FG003|NOT COMPLETED|Part A - Treatment Period 1||0
2938501|NCT00626275|3650390|FG004|NOT COMPLETED|Part A - Treatment Period 1||0
2938502|NCT00626275|3650391|FG005|NOT COMPLETED|Part A - Treatment Period 1||0
2938503|NCT00626275|3650392|FG006|NOT COMPLETED|Part A - Treatment Period 1||0
2938504|NCT00626275|3650393|FG007|NOT COMPLETED|Part A - Treatment Period 1||0
2938505|NCT00626275|3650386|FG000|STARTED|Part A - Washout Period 1||6
2938506|NCT00626275|3650387|FG001|STARTED|Part A - Washout Period 1||7
2938507|NCT00626275|3650388|FG002|STARTED|Part A - Washout Period 1||6
2938508|NCT00626275|3650389|FG003|STARTED|Part A - Washout Period 1||8
2938509|NCT00626275|3650390|FG004|STARTED|Part A - Washout Period 1||9
2938510|NCT00626275|3650391|FG005|STARTED|Part A - Washout Period 1||8
2938511|NCT00626275|3650392|FG006|STARTED|Part A - Washout Period 1||0
2938512|NCT00626275|3650393|FG007|STARTED|Part A - Washout Period 1||0
2938513|NCT00626275|3650386|FG000|COMPLETED|Part A - Washout Period 1||6
2938514|NCT00626275|3650387|FG001|COMPLETED|Part A - Washout Period 1||7
2938515|NCT00626275|3650388|FG002|COMPLETED|Part A - Washout Period 1||6
2938516|NCT00626275|3650389|FG003|COMPLETED|Part A - Washout Period 1||8
2938517|NCT00626275|3650390|FG004|COMPLETED|Part A - Washout Period 1||9
2938518|NCT00626275|3650391|FG005|COMPLETED|Part A - Washout Period 1||8
2938519|NCT00626275|3650392|FG006|COMPLETED|Part A - Washout Period 1||0
2938520|NCT00626275|3650393|FG007|COMPLETED|Part A - Washout Period 1||0
2938521|NCT00626275|3650386|FG000|NOT COMPLETED|Part A - Washout Period 1||0
3276007|NCT02696785|4009678|FG000|STARTED|Follow-up Period|Participants who completed study were eligible to enroll RHBY & who didn't enroll entered Follow-Up.|1
3276008|NCT02696785|4009679|FG001|STARTED|Follow-up Period|Participants who completed study were eligible to enroll RHBY & who didn't enroll entered Follow-Up.|0
3276009|NCT02696785|4009680|FG002|STARTED|Follow-up Period|Participants who completed study were eligible to enroll RHBY & who didn't enroll entered Follow-Up.|24
2938522|NCT00626275|3650387|FG001|NOT COMPLETED|Part A - Washout Period 1||0
2938523|NCT00626275|3650388|FG002|NOT COMPLETED|Part A - Washout Period 1||0
2938524|NCT00626275|3650389|FG003|NOT COMPLETED|Part A - Washout Period 1||0
2938525|NCT00626275|3650390|FG004|NOT COMPLETED|Part A - Washout Period 1||0
2938526|NCT00626275|3650391|FG005|NOT COMPLETED|Part A - Washout Period 1||0
2938527|NCT00626275|3650392|FG006|NOT COMPLETED|Part A - Washout Period 1||0
2938528|NCT00626275|3650393|FG007|NOT COMPLETED|Part A - Washout Period 1||0
2938529|NCT00626275|3650386|FG000|STARTED|Part A - Treatment Period 2||6
2938530|NCT00626275|3650387|FG001|STARTED|Part A - Treatment Period 2||7
2938531|NCT00626275|3650388|FG002|STARTED|Part A - Treatment Period 2||6
2938532|NCT00626275|3650389|FG003|STARTED|Part A - Treatment Period 2||8
2938533|NCT00626275|3650390|FG004|STARTED|Part A - Treatment Period 2||9
2938534|NCT00626275|3650391|FG005|STARTED|Part A - Treatment Period 2||8
2938535|NCT00626275|3650392|FG006|STARTED|Part A - Treatment Period 2||0
3276010|NCT02696785|4009681|FG003|STARTED|Follow-up Period|Participants who completed study were eligible to enroll RHBY & who didn't enroll entered Follow-Up.|16
3276011|NCT02696785|4009678|FG000|COMPLETED|Follow-up Period||0
3276012|NCT02696785|4009679|FG001|COMPLETED|Follow-up Period||0
3276013|NCT02696785|4009680|FG002|COMPLETED|Follow-up Period||11
3276014|NCT02696785|4009681|FG003|COMPLETED|Follow-up Period||8
3276015|NCT02696785|4009678|FG000|NOT COMPLETED|Follow-up Period||1
3276016|NCT02696785|4009679|FG001|NOT COMPLETED|Follow-up Period||0
3276017|NCT02696785|4009680|FG002|NOT COMPLETED|Follow-up Period||13
3276018|NCT02696785|4009681|FG003|NOT COMPLETED|Follow-up Period||8
3276019|NCT02696798|4009712|FG000|STARTED|Blinded Treatment Dosing Period||104
3276020|NCT02696798|4009713|FG001|STARTED|Blinded Treatment Dosing Period||114
3276021|NCT02696798|4009714|FG002|STARTED|Blinded Treatment Dosing Period||98
3276022|NCT02696798|4009712|FG000|COMPLETED|Blinded Treatment Dosing Period||93
3276023|NCT02696798|4009713|FG001|COMPLETED|Blinded Treatment Dosing Period||99
3276024|NCT02696798|4009714|FG002|COMPLETED|Blinded Treatment Dosing Period||90
3276025|NCT02696798|4009712|FG000|NOT COMPLETED|Blinded Treatment Dosing Period||11
2938536|NCT00626275|3650393|FG007|STARTED|Part A - Treatment Period 2||0
2938537|NCT00626275|3650386|FG000|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||6
2938538|NCT00626275|3650387|FG001|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||7
2938539|NCT00626275|3650388|FG002|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||6
3276026|NCT02696798|4009713|FG001|NOT COMPLETED|Blinded Treatment Dosing Period||15
3276027|NCT02696798|4009714|FG002|NOT COMPLETED|Blinded Treatment Dosing Period||8
3276028|NCT02696798|4009712|FG000|STARTED|Extended Treatment Period||93
3276029|NCT02696798|4009713|FG001|STARTED|Extended Treatment Period|1 participant completed blinded treatment period and entered post-treatment followup period directly|98
3276030|NCT02696798|4009714|FG002|STARTED|Extended Treatment Period||90
3276031|NCT02696798|4009712|FG000|COMPLETED|Extended Treatment Period||81
3276032|NCT02696798|4009713|FG001|COMPLETED|Extended Treatment Period||89
3276033|NCT02696798|4009714|FG002|COMPLETED|Extended Treatment Period||80
3276034|NCT02696798|4009712|FG000|NOT COMPLETED|Extended Treatment Period||12
3276035|NCT02696798|4009713|FG001|NOT COMPLETED|Extended Treatment Period||9
3276036|NCT02696798|4009714|FG002|NOT COMPLETED|Extended Treatment Period||10
3276037|NCT02696798|4009712|FG000|STARTED|Post-treatment Follow-up Period|Participants who terminate RHBW early or who didn't enroll into RHBY entered Follow-Up Period.|5
3276038|NCT02696798|4009713|FG001|STARTED|Post-treatment Follow-up Period|Participants who terminate RHBW early or who didn't enroll into RHBY entered Follow-Up Period.|34
3276039|NCT02696798|4009714|FG002|STARTED|Post-treatment Follow-up Period|Participants who terminate RHBW early or who didn't enroll into RHBY entered Follow-Up Period.|22
3276040|NCT02696798|4009712|FG000|COMPLETED|Post-treatment Follow-up Period||0
3276041|NCT02696798|4009713|FG001|COMPLETED|Post-treatment Follow-up Period||8
3276042|NCT02696798|4009714|FG002|COMPLETED|Post-treatment Follow-up Period||3
3276043|NCT02696798|4009712|FG000|NOT COMPLETED|Post-treatment Follow-up Period||5
3276044|NCT02696798|4009713|FG001|NOT COMPLETED|Post-treatment Follow-up Period||26
3276045|NCT02696798|4009714|FG002|NOT COMPLETED|Post-treatment Follow-up Period||19
3276046|NCT02696850|4009738|FG000|STARTED|Overall Study||40
3276047|NCT02696850|4009739|FG001|STARTED|Overall Study||40
3276048|NCT02696850|4009738|FG000|COMPLETED|Overall Study||29
3276049|NCT02696850|4009739|FG001|COMPLETED|Overall Study||32
3276050|NCT02696850|4009738|FG000|NOT COMPLETED|Overall Study||11
3276051|NCT02696850|4009739|FG001|NOT COMPLETED|Overall Study||8
3276052|NCT02696902|4009748|FG000|STARTED|Overall Study||85
3276053|NCT02696902|4009749|FG001|STARTED|Overall Study||16
3276054|NCT02696902|4009750|FG002|STARTED|Overall Study||87
3276055|NCT02696902|4009748|FG000|Treated|Overall Study||83
3276056|NCT02696902|4009749|FG001|Treated|Overall Study||16
3276057|NCT02696902|4009750|FG002|Treated|Overall Study||85
3276058|NCT02696902|4009748|FG000|Intent-to-treat (ITT) Population|Overall Study||85
3276059|NCT02696902|4009749|FG001|Intent-to-treat (ITT) Population|Overall Study||16
3276060|NCT02696902|4009750|FG002|Intent-to-treat (ITT) Population|Overall Study||87
3276061|NCT02696902|4009748|FG000|As-treated Population|Overall Study||83
3276062|NCT02696902|4009749|FG001|As-treated Population|Overall Study||16
3276063|NCT02696902|4009750|FG002|As-treated Population|Overall Study||85
3276064|NCT02696902|4009748|FG000|Modified Intent-to-treat (mITT) Population|Overall Study||83
3276065|NCT02696902|4009749|FG001|Modified Intent-to-treat (mITT) Population|Overall Study||16
3276066|NCT02696902|4009750|FG002|Modified Intent-to-treat (mITT) Population|Overall Study||85
3276067|NCT02696902|4009748|FG000|COMPLETED|Overall Study||63
3276068|NCT02696902|4009749|FG001|COMPLETED|Overall Study||12
3276069|NCT02696902|4009750|FG002|COMPLETED|Overall Study||59
3276070|NCT02696902|4009748|FG000|NOT COMPLETED|Overall Study||22
3276071|NCT02696902|4009749|FG001|NOT COMPLETED|Overall Study||4
3276072|NCT02696902|4009750|FG002|NOT COMPLETED|Overall Study||28
3276073|NCT02696967|4009764|FG000|STARTED|Overall Study||4
3276074|NCT02696967|4009765|FG001|STARTED|Overall Study||6
3276075|NCT02696967|4009766|FG002|STARTED|Overall Study||6
3276076|NCT02696967|4009767|FG003|STARTED|Overall Study||10
3276077|NCT02696967|4009764|FG000|Pharmacokinetic (PK) Analysis Set|Overall Study||4
3276078|NCT02696967|4009765|FG001|Pharmacokinetic (PK) Analysis Set|Overall Study||6
3276079|NCT02696967|4009766|FG002|Pharmacokinetic (PK) Analysis Set|Overall Study||4
3276080|NCT02696967|4009767|FG003|Pharmacokinetic (PK) Analysis Set|Overall Study||0
3276081|NCT02696967|4009764|FG000|COMPLETED|Overall Study||4
3276082|NCT02696967|4009765|FG001|COMPLETED|Overall Study||6
3276083|NCT02696967|4009766|FG002|COMPLETED|Overall Study||6
3276084|NCT02696967|4009767|FG003|COMPLETED|Overall Study||10
3276085|NCT02696967|4009764|FG000|NOT COMPLETED|Overall Study||0
3276086|NCT02696967|4009765|FG001|NOT COMPLETED|Overall Study||0
3276087|NCT02696967|4009766|FG002|NOT COMPLETED|Overall Study||0
3276088|NCT02696967|4009767|FG003|NOT COMPLETED|Overall Study||0
3276089|NCT02697071|4009779|FG000|STARTED|Overall Study||18
3276090|NCT02697071|4009780|FG001|STARTED|Overall Study||16
3276091|NCT02697071|4009779|FG000|COMPLETED|Overall Study||18
3276092|NCT02697071|4009780|FG001|COMPLETED|Overall Study||16
3276093|NCT02697071|4009779|FG000|NOT COMPLETED|Overall Study||0
3276094|NCT02697071|4009780|FG001|NOT COMPLETED|Overall Study||0
3276095|NCT02697188|4009786|FG000|STARTED|TE Period 1 - 400 mg QD||12
3276096|NCT02697188|4009786|FG000|COMPLETED|TE Period 1 - 400 mg QD||12
3276097|NCT02697188|4009786|FG000|NOT COMPLETED|TE Period 1 - 400 mg QD||0
3276098|NCT02697188|4009786|FG000|STARTED|TU Period 2 - 200 mg QD||12
3276099|NCT02697188|4009786|FG000|COMPLETED|TU Period 2 - 200 mg QD||12
3276100|NCT02697188|4009786|FG000|NOT COMPLETED|TU Period 2 - 200 mg QD||0
3276101|NCT02697188|4009786|FG000|STARTED|TU Period 3 - 200 mg BID||12
2938540|NCT00626275|3650389|FG003|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||8
2938541|NCT00626275|3650390|FG004|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||9
2938542|NCT00626275|3650391|FG005|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||8
3034415|NCT01132664|3753507|FG003|NOT COMPLETED|Phase lb||0
3047731|NCT01203917|3767714|FG000|NOT COMPLETED|Overall Study||36
3047732|NCT01203930|3767720|FG000|STARTED|Overall Study||64
3276102|NCT02697188|4009786|FG000|COMPLETED|TU Period 3 - 200 mg BID||12
3047733|NCT01203930|3767721|FG001|STARTED|Overall Study||41
3047734|NCT01203930|3767720|FG000|COMPLETED|Overall Study|43 participants completed 12 cycles and were then eligible to enroll in the extension study (101-99)|43
3276103|NCT02697188|4009786|FG000|NOT COMPLETED|TU Period 3 - 200 mg BID||0
3276104|NCT02697188|4009786|FG000|STARTED|TU Period 4 - 400 BID||12
3276105|NCT02697188|4009786|FG000|COMPLETED|TU Period 4 - 400 BID||12
3276106|NCT02697188|4009786|FG000|NOT COMPLETED|TU Period 4 - 400 BID||0
3276107|NCT02697188|4009786|FG000|STARTED|TE Period 5 - 800 mg BID||12
3276108|NCT02697188|4009786|FG000|COMPLETED|TE Period 5 - 800 mg BID||12
3276109|NCT02697188|4009786|FG000|NOT COMPLETED|TE Period 5 - 800 mg BID||0
3276110|NCT02697214|4009798|FG000|STARTED|Overall Study||26
3276111|NCT02697214|4009799|FG001|STARTED|Overall Study||25
3276112|NCT02697214|4009800|FG002|STARTED|Overall Study||25
3276113|NCT02697214|4009801|FG003|STARTED|Overall Study||24
3276114|NCT02697214|4009802|FG004|STARTED|Overall Study||50
3276115|NCT02697214|4009803|FG005|STARTED|Overall Study||50
3276116|NCT02697214|4009798|FG000|Heart Rate at 2mph|Overall Study||26
3276117|NCT02697214|4009799|FG001|Heart Rate at 2mph|Overall Study||25
3276118|NCT02697214|4009800|FG002|Heart Rate at 2mph|Overall Study||25
3276119|NCT02697214|4009801|FG003|Heart Rate at 2mph|Overall Study||24
3276120|NCT02697214|4009802|FG004|Heart Rate at 2mph|Overall Study||50
3276121|NCT02697214|4009803|FG005|Heart Rate at 2mph|Overall Study||50
3276122|NCT02697214|4009798|FG000|Heart Rate at 3mph|Overall Study||26
3276123|NCT02697214|4009799|FG001|Heart Rate at 3mph|Overall Study||25
3276124|NCT02697214|4009800|FG002|Heart Rate at 3mph|Overall Study||25
3276125|NCT02697214|4009801|FG003|Heart Rate at 3mph|Overall Study||24
3276126|NCT02697214|4009802|FG004|Heart Rate at 3mph|Overall Study||50
3276127|NCT02697214|4009803|FG005|Heart Rate at 3mph|Overall Study||50
3276128|NCT02697214|4009798|FG000|Heart Rate at 4mph|Overall Study||26
3276129|NCT02697214|4009799|FG001|Heart Rate at 4mph|Overall Study||25
3276130|NCT02697214|4009800|FG002|Heart Rate at 4mph|Overall Study||25
3276131|NCT02697214|4009801|FG003|Heart Rate at 4mph|Overall Study||24
3276132|NCT02697214|4009802|FG004|Heart Rate at 4mph|Overall Study||50
3276133|NCT02697214|4009803|FG005|Heart Rate at 4mph|Overall Study||50
3276134|NCT02697214|4009798|FG000|Heart Rate at 6mph|Overall Study||26
3276135|NCT02697214|4009799|FG001|Heart Rate at 6mph|Overall Study||25
3276136|NCT02697214|4009800|FG002|Heart Rate at 6mph|Overall Study||25
3276137|NCT02697214|4009801|FG003|Heart Rate at 6mph|Overall Study||24
3276138|NCT02697214|4009802|FG004|Heart Rate at 6mph|Overall Study||50
3276139|NCT02697214|4009803|FG005|Heart Rate at 6mph|Overall Study||50
3276140|NCT02697214|4009798|FG000|COMPLETED|Overall Study||26
3276141|NCT02697214|4009799|FG001|COMPLETED|Overall Study||25
3276142|NCT02697214|4009800|FG002|COMPLETED|Overall Study||25
3276143|NCT02697214|4009801|FG003|COMPLETED|Overall Study||24
3276144|NCT02697214|4009802|FG004|COMPLETED|Overall Study||50
3276145|NCT02697214|4009803|FG005|COMPLETED|Overall Study||50
3276146|NCT02697214|4009798|FG000|NOT COMPLETED|Overall Study||0
3276147|NCT02697214|4009799|FG001|NOT COMPLETED|Overall Study||0
3276148|NCT02697214|4009800|FG002|NOT COMPLETED|Overall Study||0
3276149|NCT02697214|4009801|FG003|NOT COMPLETED|Overall Study||0
3276150|NCT02697214|4009802|FG004|NOT COMPLETED|Overall Study||0
3276151|NCT02697214|4009803|FG005|NOT COMPLETED|Overall Study||0
3276152|NCT02697240|4009813|FG000|STARTED|Overall Study||4
3276153|NCT02697240|4009813|FG000|COMPLETED|Overall Study||4
3276154|NCT02697240|4009813|FG000|NOT COMPLETED|Overall Study||0
3276155|NCT02697292|4009819|FG000|STARTED|Overall Study||9
3276156|NCT02697292|4009820|FG001|STARTED|Overall Study||8
3276157|NCT02697292|4009819|FG000|COMPLETED|Overall Study||9
3276158|NCT02697292|4009820|FG001|COMPLETED|Overall Study||8
3276159|NCT02697292|4009819|FG000|NOT COMPLETED|Overall Study||0
3276160|NCT02697292|4009820|FG001|NOT COMPLETED|Overall Study||0
3276161|NCT02697435|4009829|FG000|STARTED|Overall Study||25
3276162|NCT02697435|4009830|FG001|STARTED|Overall Study||30
3276163|NCT02697435|4009829|FG000|COMPLETED|Overall Study||24
3276164|NCT02697435|4009830|FG001|COMPLETED|Overall Study||26
3276165|NCT02697435|4009829|FG000|NOT COMPLETED|Overall Study||1
3276166|NCT02697435|4009830|FG001|NOT COMPLETED|Overall Study||4
3276167|NCT02697591|4009847|FG000|STARTED|Overall Study||4
3276168|NCT02697591|4009848|FG001|STARTED|Overall Study||4
3276169|NCT02697591|4009849|FG002|STARTED|Overall Study||4
3276170|NCT02697591|4009850|FG003|STARTED|Overall Study||3
3276171|NCT02697591|4009851|FG004|STARTED|Overall Study||15
3276172|NCT02697591|4009852|FG005|STARTED|Overall Study||18
3276173|NCT02697591|4009853|FG006|STARTED|Overall Study||16
3276174|NCT02697591|4009854|FG007|STARTED|Overall Study||4
3276175|NCT02697591|4009855|FG008|STARTED|Overall Study||10
3276176|NCT02697591|4009856|FG009|STARTED|Overall Study||22
3276177|NCT02697591|4009847|FG000|COMPLETED|Overall Study||0
3276178|NCT02697591|4009848|FG001|COMPLETED|Overall Study||0
3276179|NCT02697591|4009849|FG002|COMPLETED|Overall Study||1
3276180|NCT02697591|4009850|FG003|COMPLETED|Overall Study||0
3276181|NCT02697591|4009851|FG004|COMPLETED|Overall Study||2
3276182|NCT02697591|4009852|FG005|COMPLETED|Overall Study||2
2938543|NCT00626275|3650392|FG006|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||0
2938544|NCT00626275|3650393|FG007|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||0
2938545|NCT00626275|3650386|FG000|COMPLETED|Part A - Treatment Period 2||6
2938546|NCT00626275|3650387|FG001|COMPLETED|Part A - Treatment Period 2||7
2938547|NCT00626275|3650388|FG002|COMPLETED|Part A - Treatment Period 2||6
2938548|NCT00626275|3650389|FG003|COMPLETED|Part A - Treatment Period 2||8
2938549|NCT00626275|3650390|FG004|COMPLETED|Part A - Treatment Period 2||9
2938550|NCT00626275|3650391|FG005|COMPLETED|Part A - Treatment Period 2||8
2938551|NCT00626275|3650392|FG006|COMPLETED|Part A - Treatment Period 2||0
2938552|NCT00626275|3650393|FG007|COMPLETED|Part A - Treatment Period 2||0
2938553|NCT00626275|3650386|FG000|NOT COMPLETED|Part A - Treatment Period 2||0
2938554|NCT00626275|3650387|FG001|NOT COMPLETED|Part A - Treatment Period 2||0
2938555|NCT00626275|3650388|FG002|NOT COMPLETED|Part A - Treatment Period 2||0
2938556|NCT00626275|3650389|FG003|NOT COMPLETED|Part A - Treatment Period 2||0
2938557|NCT00626275|3650390|FG004|NOT COMPLETED|Part A - Treatment Period 2||0
3047735|NCT01203930|3767721|FG001|COMPLETED|Overall Study||0
3047736|NCT01203930|3767720|FG000|NOT COMPLETED|Overall Study||21
3047737|NCT01203930|3767721|FG001|NOT COMPLETED|Overall Study||41
3276183|NCT02697591|4009853|FG006|COMPLETED|Overall Study||0
3276184|NCT02697591|4009854|FG007|COMPLETED|Overall Study||1
3276185|NCT02697591|4009855|FG008|COMPLETED|Overall Study||1
3276186|NCT02697591|4009856|FG009|COMPLETED|Overall Study||2
3276187|NCT02697591|4009847|FG000|NOT COMPLETED|Overall Study||4
3276188|NCT02697591|4009848|FG001|NOT COMPLETED|Overall Study||4
3276189|NCT02697591|4009849|FG002|NOT COMPLETED|Overall Study||3
3276190|NCT02697591|4009850|FG003|NOT COMPLETED|Overall Study||3
3276191|NCT02697591|4009851|FG004|NOT COMPLETED|Overall Study||13
3276192|NCT02697591|4009852|FG005|NOT COMPLETED|Overall Study||16
3276193|NCT02697591|4009853|FG006|NOT COMPLETED|Overall Study||16
3276194|NCT02697591|4009854|FG007|NOT COMPLETED|Overall Study||3
3276195|NCT02697591|4009855|FG008|NOT COMPLETED|Overall Study||9
3276196|NCT02697591|4009856|FG009|NOT COMPLETED|Overall Study||20
3276197|NCT02697617|4009879|FG000|STARTED|Overall Study||9
3276198|NCT02697617|4009880|FG001|STARTED|Overall Study||9
3276199|NCT02697617|4009879|FG000|COMPLETED|Overall Study|15 completed both arms|8
3276200|NCT02697617|4009880|FG001|COMPLETED|Overall Study||7
3276201|NCT02697617|4009879|FG000|NOT COMPLETED|Overall Study||1
3276202|NCT02697617|4009880|FG001|NOT COMPLETED|Overall Study||2
3276203|NCT02697734|4009892|FG000|STARTED|Core Phase - up to Week 48||48
3276204|NCT02697734|4009893|FG001|STARTED|Core Phase - up to Week 48||25
3276205|NCT02697734|4009892|FG000|COMPLETED|Core Phase - up to Week 48||42
3276206|NCT02697734|4009893|FG001|COMPLETED|Core Phase - up to Week 48||23
3276207|NCT02697734|4009892|FG000|NOT COMPLETED|Core Phase - up to Week 48||6
3276208|NCT02697734|4009893|FG001|NOT COMPLETED|Core Phase - up to Week 48||2
3276209|NCT02697734|4009892|FG000|STARTED|Optional Extension Phase||38
3276210|NCT02697734|4009893|FG001|STARTED|Optional Extension Phase||22
3276211|NCT02697734|4009892|FG000|COMPLETED|Optional Extension Phase||33
3276212|NCT02697734|4009893|FG001|COMPLETED|Optional Extension Phase||20
3276213|NCT02697734|4009892|FG000|NOT COMPLETED|Optional Extension Phase||5
3276214|NCT02697734|4009893|FG001|NOT COMPLETED|Optional Extension Phase||2
3276215|NCT02697773|4009910|FG000|STARTED|Overall Study||233
3276216|NCT02697773|4009911|FG001|STARTED|Overall Study||232
3276217|NCT02697773|4009912|FG002|STARTED|Overall Study||233
3276218|NCT02697773|4009910|FG000|Treated|Overall Study||232
3276219|NCT02697773|4009911|FG001|Treated|Overall Study||231
3276220|NCT02697773|4009912|FG002|Treated|Overall Study||233
3276221|NCT02697773|4009910|FG000|COMPLETED|Overall Study||195
3276222|NCT02697773|4009911|FG001|COMPLETED|Overall Study||194
3276223|NCT02697773|4009912|FG002|COMPLETED|Overall Study||193
3276224|NCT02697773|4009910|FG000|NOT COMPLETED|Overall Study||38
3276225|NCT02697773|4009911|FG001|NOT COMPLETED|Overall Study||38
3276226|NCT02697773|4009912|FG002|NOT COMPLETED|Overall Study||40
3276227|NCT02697890|4009922|FG000|STARTED|Overall Study||14
3276228|NCT02697890|4009923|FG001|STARTED|Overall Study||14
3276229|NCT02697890|4009922|FG000|COMPLETED|Overall Study||14
3047738|NCT01203956|3767729|FG000|STARTED|First Two-week Period||15
3047739|NCT01203956|3767730|FG001|STARTED|First Two-week Period||13
3276230|NCT02697890|4009923|FG001|COMPLETED|Overall Study||14
3276231|NCT02697890|4009922|FG000|NOT COMPLETED|Overall Study||0
3276232|NCT02697890|4009923|FG001|NOT COMPLETED|Overall Study||0
3276233|NCT02697916|4009931|FG000|STARTED|Overall Study||7540
3276234|NCT02697916|4009932|FG001|STARTED|Overall Study||7536
3276235|NCT02697916|4009931|FG000|COMPLETED|Overall Study||6962
3276236|NCT02697916|4009932|FG001|COMPLETED|Overall Study||6828
3276237|NCT02697916|4009931|FG000|NOT COMPLETED|Overall Study||578
3276238|NCT02697916|4009932|FG001|NOT COMPLETED|Overall Study||708
3276239|NCT02698033|4009938|FG000|STARTED|Overall Study||7
3276240|NCT02698033|4009938|FG000|COMPLETED|Overall Study||6
3276241|NCT02698033|4009938|FG000|NOT COMPLETED|Overall Study||1
3276242|NCT02698176|4009945|FG000|STARTED|Overall Study||9
3276243|NCT02698176|4009946|FG001|STARTED|Overall Study||3
3276244|NCT02698176|4009947|FG002|STARTED|Overall Study||1
3276245|NCT02698176|4009948|FG003|STARTED|Overall Study|No participants were enrolled in Part B.|0
3276246|NCT02698176|4009945|FG000|COMPLETED|Overall Study||0
3276247|NCT02698176|4009946|FG001|COMPLETED|Overall Study||0
3276248|NCT02698176|4009947|FG002|COMPLETED|Overall Study||0
3276249|NCT02698176|4009948|FG003|COMPLETED|Overall Study||0
3276250|NCT02698176|4009945|FG000|NOT COMPLETED|Overall Study||9
2938558|NCT00626275|3650391|FG005|NOT COMPLETED|Part A - Treatment Period 2||0
2938559|NCT00626275|3650392|FG006|NOT COMPLETED|Part A - Treatment Period 2||0
2938560|NCT00626275|3650393|FG007|NOT COMPLETED|Part A - Treatment Period 2||0
2938561|NCT00626275|3650386|FG000|STARTED|Part A - Washout Period 2||6
2938562|NCT00626275|3650387|FG001|STARTED|Part A - Washout Period 2||7
2938563|NCT00626275|3650388|FG002|STARTED|Part A - Washout Period 2||6
2938564|NCT00626275|3650389|FG003|STARTED|Part A - Washout Period 2||8
2938565|NCT00626275|3650390|FG004|STARTED|Part A - Washout Period 2||9
2938566|NCT00626275|3650391|FG005|STARTED|Part A - Washout Period 2||8
2938567|NCT00626275|3650392|FG006|STARTED|Part A - Washout Period 2||0
2938568|NCT00626275|3650393|FG007|STARTED|Part A - Washout Period 2||0
2938569|NCT00626275|3650386|FG000|COMPLETED|Part A - Washout Period 2||6
2938570|NCT00626275|3650387|FG001|COMPLETED|Part A - Washout Period 2||7
2938571|NCT00626275|3650388|FG002|COMPLETED|Part A - Washout Period 2||6
2938572|NCT00626275|3650389|FG003|COMPLETED|Part A - Washout Period 2||8
2938573|NCT00626275|3650390|FG004|COMPLETED|Part A - Washout Period 2||9
2938574|NCT00626275|3650391|FG005|COMPLETED|Part A - Washout Period 2||8
2938575|NCT00626275|3650392|FG006|COMPLETED|Part A - Washout Period 2||0
2938576|NCT00626275|3650393|FG007|COMPLETED|Part A - Washout Period 2||0
2938577|NCT00626275|3650386|FG000|NOT COMPLETED|Part A - Washout Period 2||0
2938578|NCT00626275|3650387|FG001|NOT COMPLETED|Part A - Washout Period 2||0
2938579|NCT00626275|3650388|FG002|NOT COMPLETED|Part A - Washout Period 2||0
2938580|NCT00626275|3650389|FG003|NOT COMPLETED|Part A - Washout Period 2||0
2938581|NCT00626275|3650390|FG004|NOT COMPLETED|Part A - Washout Period 2||0
2938582|NCT00626275|3650391|FG005|NOT COMPLETED|Part A - Washout Period 2||0
2938583|NCT00626275|3650392|FG006|NOT COMPLETED|Part A - Washout Period 2||0
2938584|NCT00626275|3650393|FG007|NOT COMPLETED|Part A - Washout Period 2||0
2938585|NCT00626275|3650386|FG000|STARTED|Part A - Treatment Period 3||6
2938586|NCT00626275|3650387|FG001|STARTED|Part A - Treatment Period 3||7
2938587|NCT00626275|3650388|FG002|STARTED|Part A - Treatment Period 3||6
2938588|NCT00626275|3650389|FG003|STARTED|Part A - Treatment Period 3||8
2938589|NCT00626275|3650390|FG004|STARTED|Part A - Treatment Period 3||9
2938590|NCT00626275|3650391|FG005|STARTED|Part A - Treatment Period 3||8
2938591|NCT00626275|3650392|FG006|STARTED|Part A - Treatment Period 3||0
2938592|NCT00626275|3650393|FG007|STARTED|Part A - Treatment Period 3||0
2938593|NCT00626275|3650386|FG000|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||6
2938594|NCT00626275|3650387|FG001|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||7
2938595|NCT00626275|3650388|FG002|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||6
2938596|NCT00626275|3650389|FG003|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||8
2938597|NCT00626275|3650390|FG004|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||9
2938598|NCT00626275|3650391|FG005|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||8
2938599|NCT00626275|3650392|FG006|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||0
2938600|NCT00626275|3650393|FG007|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||0
2938601|NCT00626275|3650386|FG000|COMPLETED|Part A - Treatment Period 3||6
2938602|NCT00626275|3650387|FG001|COMPLETED|Part A - Treatment Period 3||7
2938603|NCT00626275|3650388|FG002|COMPLETED|Part A - Treatment Period 3||6
2938604|NCT00626275|3650389|FG003|COMPLETED|Part A - Treatment Period 3||8
2938605|NCT00626275|3650390|FG004|COMPLETED|Part A - Treatment Period 3||9
2938606|NCT00626275|3650391|FG005|COMPLETED|Part A - Treatment Period 3||8
2938607|NCT00626275|3650392|FG006|COMPLETED|Part A - Treatment Period 3||0
2938608|NCT00626275|3650393|FG007|COMPLETED|Part A - Treatment Period 3||0
2938609|NCT00626275|3650386|FG000|NOT COMPLETED|Part A - Treatment Period 3||0
2938610|NCT00626275|3650387|FG001|NOT COMPLETED|Part A - Treatment Period 3||0
2938611|NCT00626275|3650388|FG002|NOT COMPLETED|Part A - Treatment Period 3||0
2938612|NCT00626275|3650389|FG003|NOT COMPLETED|Part A - Treatment Period 3||0
2938613|NCT00626275|3650390|FG004|NOT COMPLETED|Part A - Treatment Period 3||0
2938614|NCT00626275|3650391|FG005|NOT COMPLETED|Part A - Treatment Period 3||0
2938615|NCT00626275|3650392|FG006|NOT COMPLETED|Part A - Treatment Period 3||0
2938616|NCT00626275|3650393|FG007|NOT COMPLETED|Part A - Treatment Period 3||0
2938617|NCT00626275|3650386|FG000|STARTED|Re-randomization Period for Part B||0
2938618|NCT00626275|3650387|FG001|STARTED|Re-randomization Period for Part B||0
2938619|NCT00626275|3650388|FG002|STARTED|Re-randomization Period for Part B||0
2938620|NCT00626275|3650389|FG003|STARTED|Re-randomization Period for Part B||0
2938621|NCT00626275|3650390|FG004|STARTED|Re-randomization Period for Part B||0
2938622|NCT00626275|3650391|FG005|STARTED|Re-randomization Period for Part B||0
2938623|NCT00626275|3650392|FG006|STARTED|Re-randomization Period for Part B||20
3276251|NCT02698176|4009946|FG001|NOT COMPLETED|Overall Study||3
3276252|NCT02698176|4009947|FG002|NOT COMPLETED|Overall Study||1
3276253|NCT02698176|4009948|FG003|NOT COMPLETED|Overall Study||0
2938624|NCT00626275|3650393|FG007|STARTED|Re-randomization Period for Part B||24
2938625|NCT00626275|3650386|FG000|COMPLETED|Re-randomization Period for Part B||0
2938626|NCT00626275|3650387|FG001|COMPLETED|Re-randomization Period for Part B||0
2938627|NCT00626275|3650388|FG002|COMPLETED|Re-randomization Period for Part B||0
2938628|NCT00626275|3650389|FG003|COMPLETED|Re-randomization Period for Part B||0
2938629|NCT00626275|3650390|FG004|COMPLETED|Re-randomization Period for Part B||0
2938630|NCT00626275|3650391|FG005|COMPLETED|Re-randomization Period for Part B||0
2938631|NCT00626275|3650392|FG006|COMPLETED|Re-randomization Period for Part B||20
2938632|NCT00626275|3650393|FG007|COMPLETED|Re-randomization Period for Part B||24
2938633|NCT00626275|3650386|FG000|NOT COMPLETED|Re-randomization Period for Part B||0
2938634|NCT00626275|3650387|FG001|NOT COMPLETED|Re-randomization Period for Part B||0
2938635|NCT00626275|3650388|FG002|NOT COMPLETED|Re-randomization Period for Part B||0
2938636|NCT00626275|3650389|FG003|NOT COMPLETED|Re-randomization Period for Part B||0
2938637|NCT00626275|3650390|FG004|NOT COMPLETED|Re-randomization Period for Part B||0
2938638|NCT00626275|3650391|FG005|NOT COMPLETED|Re-randomization Period for Part B||0
2938639|NCT00626275|3650392|FG006|NOT COMPLETED|Re-randomization Period for Part B||0
2938640|NCT00626275|3650393|FG007|NOT COMPLETED|Re-randomization Period for Part B||0
2938641|NCT00626275|3650386|FG000|STARTED|Part B||0
2938642|NCT00626275|3650387|FG001|STARTED|Part B||0
2938643|NCT00626275|3650388|FG002|STARTED|Part B||0
2938644|NCT00626275|3650389|FG003|STARTED|Part B||0
2938645|NCT00626275|3650390|FG004|STARTED|Part B||0
2938646|NCT00626275|3650391|FG005|STARTED|Part B||0
2938647|NCT00626275|3650392|FG006|STARTED|Part B||20
2938648|NCT00626275|3650393|FG007|STARTED|Part B||24
2938649|NCT00626275|3650386|FG000|COMPLETED|Part B||0
2938650|NCT00626275|3650387|FG001|COMPLETED|Part B||0
2938651|NCT00626275|3650388|FG002|COMPLETED|Part B||0
2938652|NCT00626275|3650389|FG003|COMPLETED|Part B||0
2938653|NCT00626275|3650390|FG004|COMPLETED|Part B||0
2938654|NCT00626275|3650391|FG005|COMPLETED|Part B||0
2938655|NCT00626275|3650392|FG006|COMPLETED|Part B||19
2938656|NCT00626275|3650393|FG007|COMPLETED|Part B||23
3047740|NCT01203956|3767729|FG000|COMPLETED|First Two-week Period|All participants continued to the second two-week period, whether or not they had evaluable results.|15
3136752|NCT01714804|3862004|FG001|NOT COMPLETED|Overall Study||0
3276254|NCT02698189|4009961|FG000|STARTED|Overall Study||3
3276255|NCT02698189|4009962|FG001|STARTED|Overall Study||6
3276256|NCT02698189|4009961|FG000|COMPLETED|Overall Study||0
3276257|NCT02698189|4009962|FG001|COMPLETED|Overall Study||0
3276258|NCT02698189|4009961|FG000|NOT COMPLETED|Overall Study||3
3276259|NCT02698189|4009962|FG001|NOT COMPLETED|Overall Study||6
3276260|NCT02698215|4009972|FG000|STARTED|Overall Study||83
3276261|NCT02698215|4009973|FG001|STARTED|Overall Study||82
3276262|NCT02698215|4009972|FG000|COMPLETED|Overall Study||55
3276263|NCT02698215|4009973|FG001|COMPLETED|Overall Study||64
3276264|NCT02698215|4009972|FG000|NOT COMPLETED|Overall Study||28
3276265|NCT02698215|4009973|FG001|NOT COMPLETED|Overall Study||18
3276266|NCT02698241|4009979|FG000|STARTED|Overall Study|Number of subjects enrolled the study|79
3276267|NCT02698241|4009979|FG000|Baseline & Programming|Overall Study|Number of subjects that passed screening and completed baseline and programming visit|66
3276268|NCT02698241|4009979|FG000|COMPLETED|Overall Study|Number of subjects completed the study (no early exit or death)|45
3276269|NCT02698241|4009979|FG000|NOT COMPLETED|Overall Study||34
3276270|NCT02698371|4009983|FG000|STARTED|All Participants Flow||38
3276271|NCT02698371|4009983|FG000|COMPLETED|All Participants Flow||35
3276272|NCT02698371|4009983|FG000|NOT COMPLETED|All Participants Flow||3
3276273|NCT02698371|4009983|FG000|STARTED|FBDC-SE (G1; Control) Arm/Group Flow|Each participant received one NCCLs restoration with FBDC-SE (G1control Arm/Group).|35
3276274|NCT02698371|4009983|FG000|COMPLETED|FBDC-SE (G1; Control) Arm/Group Flow||32
3276275|NCT02698371|4009983|FG000|NOT COMPLETED|FBDC-SE (G1; Control) Arm/Group Flow||3
3276276|NCT02698371|4009983|FG000|STARTED|FBDC-SE-EE (G2; Control ) Arm/Group Flow|Each participant received one NCCLs restoration with FBDC-SE-EE (G2 control Arm/group)|35
3276277|NCT02698371|4009983|FG000|COMPLETED|FBDC-SE-EE (G2; Control ) Arm/Group Flow||32
3276278|NCT02698371|4009983|FG000|NOT COMPLETED|FBDC-SE-EE (G2; Control ) Arm/Group Flow||3
3276279|NCT02698371|4009983|FG000|STARTED|FBU-ER (G3) Arm/Group Flow|Each participant received one NCCLs restoration with FBU-ER (G3 Arm/group)|35
3276280|NCT02698371|4009983|FG000|COMPLETED|FBU-ER (G3) Arm/Group Flow||32
3276281|NCT02698371|4009983|FG000|NOT COMPLETED|FBU-ER (G3) Arm/Group Flow||3
3276282|NCT02698371|4009983|FG000|STARTED|FBU-SE (G4) Arm/Group Flow|Each participant received one NCCLs restoration with FBU-SE (G4 Arm/group)|35
3276283|NCT02698371|4009983|FG000|COMPLETED|FBU-SE (G4) Arm/Group Flow||32
3276284|NCT02698371|4009983|FG000|NOT COMPLETED|FBU-SE (G4) Arm/Group Flow||3
3276285|NCT02698371|4009983|FG000|STARTED|ADU-ER (G5) Arm/Group Flow|Each participant received one NCCLs restoration with ADU-ER (G5 Arm/group)|35
3276286|NCT02698371|4009983|FG000|COMPLETED|ADU-ER (G5) Arm/Group Flow||32
3276287|NCT02698371|4009983|FG000|NOT COMPLETED|ADU-ER (G5) Arm/Group Flow||3
3276288|NCT02698371|4009983|FG000|STARTED|ADU-SE (G6) Arm/Group Flow|Each participant received one NCCLs restoration with ADU-SE (G6 Arm/group)|35
3276289|NCT02698371|4009983|FG000|COMPLETED|ADU-SE (G6) Arm/Group Flow||33
3276290|NCT02698371|4009983|FG000|NOT COMPLETED|ADU-SE (G6) Arm/Group Flow||2
3276291|NCT02698410|4009999|FG000|STARTED|Overall Study||40
3276292|NCT02698410|4009999|FG000|COMPLETED|Overall Study||36
3276293|NCT02698410|4009999|FG000|NOT COMPLETED|Overall Study||4
3276294|NCT02698423|4010005|FG000|STARTED|Overall Study||336
3276295|NCT02698423|4010006|FG001|STARTED|Overall Study||331
3276296|NCT02698423|4010005|FG000|COMPLETED|Overall Study||317
3276297|NCT02698423|4010006|FG001|COMPLETED|Overall Study||307
3276298|NCT02698423|4010005|FG000|NOT COMPLETED|Overall Study||19
3276299|NCT02698423|4010006|FG001|NOT COMPLETED|Overall Study||24
3276300|NCT02698436|4010016|FG000|STARTED|Overall Study||59
3276301|NCT02698436|4010017|FG001|STARTED|Overall Study||58
3276302|NCT02698436|4010016|FG000|COMPLETED|Overall Study||52
3276303|NCT02698436|4010017|FG001|COMPLETED|Overall Study||51
3276304|NCT02698436|4010016|FG000|NOT COMPLETED|Overall Study||7
2938657|NCT00626275|3650386|FG000|NOT COMPLETED|Part B||0
2938658|NCT00626275|3650387|FG001|NOT COMPLETED|Part B||0
2938659|NCT00626275|3650388|FG002|NOT COMPLETED|Part B||0
2938660|NCT00626275|3650389|FG003|NOT COMPLETED|Part B||0
2938661|NCT00626275|3650390|FG004|NOT COMPLETED|Part B||0
2938662|NCT00626275|3650391|FG005|NOT COMPLETED|Part B||0
2938663|NCT00626275|3650392|FG006|NOT COMPLETED|Part B||1
2938664|NCT00626275|3650393|FG007|NOT COMPLETED|Part B||1
2938665|NCT00626327|3650410|FG000|STARTED|Overall Study||504
3276305|NCT02698436|4010017|FG001|NOT COMPLETED|Overall Study||7
3276306|NCT02698475|4010023|FG000|STARTED|Main Study Period||44
3276307|NCT02698475|4010023|FG000|COMPLETED|Main Study Period||41
3276308|NCT02698475|4010023|FG000|NOT COMPLETED|Main Study Period||3
3276309|NCT02698475|4010023|FG000|STARTED|Long-Term Extension Period|13 participants did not enter the long-term extension period.|28
3276310|NCT02698475|4010023|FG000|COMPLETED|Long-Term Extension Period||0
3276311|NCT02698475|4010023|FG000|NOT COMPLETED|Long-Term Extension Period||28
3276312|NCT02698566|4010030|FG000|STARTED|Overall Study||35
3276313|NCT02698566|4010031|FG001|STARTED|Overall Study||3
3276314|NCT02698566|4010030|FG000|COMPLETED|Overall Study||35
3276315|NCT02698566|4010031|FG001|COMPLETED|Overall Study||3
3276316|NCT02698566|4010030|FG000|NOT COMPLETED|Overall Study||0
3276317|NCT02698566|4010031|FG001|NOT COMPLETED|Overall Study||0
3276318|NCT02698735|4010035|FG000|STARTED|Overall Study||5
3276319|NCT02698735|4010035|FG000|COMPLETED|Overall Study|There are only 18 out of 20 samples because one patient declined intradermal injection intervention.|5
3276320|NCT02698735|4010035|FG000|NOT COMPLETED|Overall Study||0
3276321|NCT02698787|4010047|FG000|STARTED|First Intervention (3 Months)||6
3276322|NCT02698787|4010048|FG001|STARTED|First Intervention (3 Months)||5
3276323|NCT02698787|4010047|FG000|COMPLETED|First Intervention (3 Months)||6
3276324|NCT02698787|4010048|FG001|COMPLETED|First Intervention (3 Months)||5
3276325|NCT02698787|4010047|FG000|NOT COMPLETED|First Intervention (3 Months)||0
3276326|NCT02698787|4010048|FG001|NOT COMPLETED|First Intervention (3 Months)||0
3276327|NCT02698787|4010047|FG000|STARTED|Second Intervention (3 Months)||6
3276328|NCT02698787|4010048|FG001|STARTED|Second Intervention (3 Months)||5
3276329|NCT02698787|4010047|FG000|COMPLETED|Second Intervention (3 Months)||6
3276330|NCT02698787|4010048|FG001|COMPLETED|Second Intervention (3 Months)||4
3276331|NCT02698787|4010047|FG000|NOT COMPLETED|Second Intervention (3 Months)||0
3276332|NCT02698787|4010048|FG001|NOT COMPLETED|Second Intervention (3 Months)||1
3276333|NCT02698800|4010055|FG000|STARTED|Overall Study||7
3276334|NCT02698800|4010056|FG001|STARTED|Overall Study||8
3276335|NCT02698800|4010055|FG000|COMPLETED|Overall Study||6
3276336|NCT02698800|4010056|FG001|COMPLETED|Overall Study||8
3276337|NCT02698800|4010055|FG000|NOT COMPLETED|Overall Study||1
3276338|NCT02698800|4010056|FG001|NOT COMPLETED|Overall Study||0
3276339|NCT02699099|4010065|FG000|STARTED|Overall Study||231
3276340|NCT02699099|4010066|FG001|STARTED|Overall Study||236
3276341|NCT02699099|4010067|FG002|STARTED|Overall Study||232
3276342|NCT02699099|4010065|FG000|COMPLETED|Overall Study||223
3276343|NCT02699099|4010066|FG001|COMPLETED|Overall Study||233
3276344|NCT02699099|4010067|FG002|COMPLETED|Overall Study||226
3276345|NCT02699099|4010065|FG000|NOT COMPLETED|Overall Study||8
3276346|NCT02699099|4010066|FG001|NOT COMPLETED|Overall Study||3
3276347|NCT02699099|4010067|FG002|NOT COMPLETED|Overall Study||6
3276348|NCT02699125|4010077|FG000|STARTED|Placebo||21
3276349|NCT02699125|4010078|FG001|STARTED|Placebo||20
3276350|NCT02699125|4010077|FG000|COMPLETED|Placebo||18
3276351|NCT02699125|4010078|FG001|COMPLETED|Placebo||16
3276352|NCT02699125|4010077|FG000|NOT COMPLETED|Placebo||3
3276353|NCT02699125|4010078|FG001|NOT COMPLETED|Placebo||4
3276354|NCT02699125|4010077|FG000|STARTED|First Intervention (6 Weeks).||18
3276355|NCT02699125|4010078|FG001|STARTED|First Intervention (6 Weeks).||16
3276356|NCT02699125|4010077|FG000|COMPLETED|First Intervention (6 Weeks).||18
3276357|NCT02699125|4010078|FG001|COMPLETED|First Intervention (6 Weeks).||16
3276358|NCT02699125|4010077|FG000|NOT COMPLETED|First Intervention (6 Weeks).||0
3276359|NCT02699125|4010078|FG001|NOT COMPLETED|First Intervention (6 Weeks).||0
3276360|NCT02699125|4010077|FG000|STARTED|Second Intervention (6 Weeks).||18
3276361|NCT02699125|4010078|FG001|STARTED|Second Intervention (6 Weeks).||16
3276362|NCT02699125|4010077|FG000|COMPLETED|Second Intervention (6 Weeks).||11
3276363|NCT02699125|4010078|FG001|COMPLETED|Second Intervention (6 Weeks).||14
3276364|NCT02699125|4010077|FG000|NOT COMPLETED|Second Intervention (6 Weeks).||7
3276365|NCT02699125|4010078|FG001|NOT COMPLETED|Second Intervention (6 Weeks).||2
3276366|NCT02699450|4010091|FG000|STARTED|Overall Study||90
3276367|NCT02699450|4010092|FG001|STARTED|Overall Study||55
3276368|NCT02699450|4010093|FG002|STARTED|Overall Study||82
3276369|NCT02699450|4010091|FG000|Received at Least One Dose of Study Drug|Overall Study||89
3276370|NCT02699450|4010092|FG001|Received at Least One Dose of Study Drug|Overall Study||55
3276371|NCT02699450|4010093|FG002|Received at Least One Dose of Study Drug|Overall Study||80
3276372|NCT02699450|4010091|FG000|Completed up to Week 24|Overall Study||81
3276373|NCT02699450|4010092|FG001|Completed up to Week 24|Overall Study||53
2938666|NCT00626327|3650411|FG001|STARTED|Overall Study||616
3276374|NCT02699450|4010093|FG002|Completed up to Week 24|Overall Study||73
3276375|NCT02699450|4010091|FG000|COMPLETED|Overall Study||75
3276376|NCT02699450|4010092|FG001|COMPLETED|Overall Study||50
3276377|NCT02699450|4010093|FG002|COMPLETED|Overall Study||67
3276378|NCT02699450|4010091|FG000|NOT COMPLETED|Overall Study||15
3276379|NCT02699450|4010092|FG001|NOT COMPLETED|Overall Study||5
3276380|NCT02699450|4010093|FG002|NOT COMPLETED|Overall Study||15
3276381|NCT02699463|4010104|FG000|STARTED|Overall Study||115
3276382|NCT02699463|4010105|FG001|STARTED|Overall Study||118
3276383|NCT02699463|4010104|FG000|COMPLETED|Overall Study||100
2938667|NCT00626327|3650412|FG002|STARTED|Overall Study||510
2938668|NCT00626327|3650410|FG000|COMPLETED|Overall Study||426
2938669|NCT00626327|3650411|FG001|COMPLETED|Overall Study||557
2938670|NCT00626327|3650412|FG002|COMPLETED|Overall Study||422
2938671|NCT00626327|3650410|FG000|NOT COMPLETED|Overall Study||78
2938672|NCT00626327|3650411|FG001|NOT COMPLETED|Overall Study||59
2938673|NCT00626327|3650412|FG002|NOT COMPLETED|Overall Study||88
3276384|NCT02699463|4010105|FG001|COMPLETED|Overall Study||109
3276385|NCT02699463|4010104|FG000|NOT COMPLETED|Overall Study||15
3276386|NCT02699463|4010105|FG001|NOT COMPLETED|Overall Study||9
3276387|NCT02699593|4010111|FG000|STARTED|Period 1||72
3276388|NCT02699593|4010112|FG001|STARTED|Period 1||69
3276389|NCT02699593|4010111|FG000|COMPLETED|Period 1||67
3276390|NCT02699593|4010112|FG001|COMPLETED|Period 1||62
3276391|NCT02699593|4010111|FG000|NOT COMPLETED|Period 1||5
3276392|NCT02699593|4010112|FG001|NOT COMPLETED|Period 1||7
3276393|NCT02699593|4010111|FG000|STARTED|Period 2||67
3047741|NCT01203956|3767730|FG001|COMPLETED|First Two-week Period|All participants continued to the second two-week period, whether or not they had evaluable results.|13
3047742|NCT01203956|3767729|FG000|NOT COMPLETED|First Two-week Period||0
3047743|NCT01203956|3767730|FG001|NOT COMPLETED|First Two-week Period||0
3047744|NCT01203956|3767729|FG000|STARTED|Second Two-week Period||15
3276394|NCT02699593|4010112|FG001|STARTED|Period 2||62
3276395|NCT02699593|4010111|FG000|COMPLETED|Period 2||65
3276396|NCT02699593|4010112|FG001|COMPLETED|Period 2||60
3276397|NCT02699593|4010111|FG000|NOT COMPLETED|Period 2||2
3276398|NCT02699593|4010112|FG001|NOT COMPLETED|Period 2||2
3276399|NCT02699632|4010118|FG000|STARTED|Overall Study||360
3276400|NCT02699632|4010118|FG000|COMPLETED|Overall Study||358
3276401|NCT02699632|4010118|FG000|NOT COMPLETED|Overall Study||2
3276402|NCT02699684|4010125|FG000|STARTED|Period 1, First 30 Days of Wear||37
3276403|NCT02699684|4010126|FG001|STARTED|Period 1, First 30 Days of Wear||38
3276404|NCT02699684|4010125|FG000|COMPLETED|Period 1, First 30 Days of Wear||37
3276405|NCT02699684|4010126|FG001|COMPLETED|Period 1, First 30 Days of Wear||38
3276406|NCT02699684|4010125|FG000|NOT COMPLETED|Period 1, First 30 Days of Wear||0
3276407|NCT02699684|4010126|FG001|NOT COMPLETED|Period 1, First 30 Days of Wear||0
3276408|NCT02699684|4010125|FG000|STARTED|Period 2, Second 30 Days of Wear||37
3276409|NCT02699684|4010126|FG001|STARTED|Period 2, Second 30 Days of Wear||38
3276410|NCT02699684|4010125|FG000|COMPLETED|Period 2, Second 30 Days of Wear||36
3276411|NCT02699684|4010126|FG001|COMPLETED|Period 2, Second 30 Days of Wear||38
3276412|NCT02699684|4010125|FG000|NOT COMPLETED|Period 2, Second 30 Days of Wear||1
3276413|NCT02699684|4010126|FG001|NOT COMPLETED|Period 2, Second 30 Days of Wear||0
3276414|NCT02699749|4010147|FG000|STARTED|Overall Study||3
3276415|NCT02699749|4010148|FG001|STARTED|Overall Study||3
3276416|NCT02699749|4010149|FG002|STARTED|Overall Study||16
3276417|NCT02699749|4010150|FG003|STARTED|Overall Study||3
3276418|NCT02699749|4010151|FG004|STARTED|Overall Study||3
3276419|NCT02699749|4010152|FG005|STARTED|Overall Study||9
3276420|NCT02699749|4010153|FG006|STARTED|Overall Study||6
3276421|NCT02699749|4010154|FG007|STARTED|Overall Study||6
3276422|NCT02699749|4010155|FG008|STARTED|Overall Study||6
3276423|NCT02699749|4010156|FG009|STARTED|Overall Study||6
3276424|NCT02699749|4010157|FG010|STARTED|Overall Study||6
3276425|NCT02699749|4010158|FG011|STARTED|Overall Study||4
3276426|NCT02699749|4010159|FG012|STARTED|Overall Study||3
3276427|NCT02699749|4010160|FG013|STARTED|Overall Study||6
3276428|NCT02699749|4010147|FG000|COMPLETED|Overall Study||0
3276429|NCT02699749|4010148|FG001|COMPLETED|Overall Study||0
3276430|NCT02699749|4010149|FG002|COMPLETED|Overall Study||0
3276431|NCT02699749|4010150|FG003|COMPLETED|Overall Study||0
3276432|NCT02699749|4010151|FG004|COMPLETED|Overall Study||0
3276433|NCT02699749|4010152|FG005|COMPLETED|Overall Study||0
3276434|NCT02699749|4010153|FG006|COMPLETED|Overall Study||0
3276435|NCT02699749|4010154|FG007|COMPLETED|Overall Study||0
3276436|NCT02699749|4010155|FG008|COMPLETED|Overall Study||0
3276437|NCT02699749|4010156|FG009|COMPLETED|Overall Study||0
3276438|NCT02699749|4010157|FG010|COMPLETED|Overall Study||0
3276439|NCT02699749|4010158|FG011|COMPLETED|Overall Study||0
3276440|NCT02699749|4010159|FG012|COMPLETED|Overall Study||0
3276441|NCT02699749|4010160|FG013|COMPLETED|Overall Study||0
3276442|NCT02699749|4010147|FG000|NOT COMPLETED|Overall Study||3
3276443|NCT02699749|4010148|FG001|NOT COMPLETED|Overall Study||3
3276444|NCT02699749|4010149|FG002|NOT COMPLETED|Overall Study||16
3276445|NCT02699749|4010150|FG003|NOT COMPLETED|Overall Study||3
3276446|NCT02699749|4010151|FG004|NOT COMPLETED|Overall Study||3
3276447|NCT02699749|4010152|FG005|NOT COMPLETED|Overall Study||9
3276448|NCT02699749|4010153|FG006|NOT COMPLETED|Overall Study||6
3276449|NCT02699749|4010154|FG007|NOT COMPLETED|Overall Study||6
3047745|NCT01203956|3767730|FG001|STARTED|Second Two-week Period||13
3276450|NCT02699749|4010155|FG008|NOT COMPLETED|Overall Study||6
3276451|NCT02699749|4010156|FG009|NOT COMPLETED|Overall Study||6
3276452|NCT02699749|4010157|FG010|NOT COMPLETED|Overall Study||6
3276453|NCT02699749|4010158|FG011|NOT COMPLETED|Overall Study||4
3276454|NCT02699749|4010159|FG012|NOT COMPLETED|Overall Study||3
3276455|NCT02699749|4010160|FG013|NOT COMPLETED|Overall Study||6
3276456|NCT02699866|4010190|FG000|STARTED|Overall Study|First study centre initiation.|46
3276457|NCT02699866|4010190|FG000|Included|Overall Study||41
3276458|NCT02699866|4010190|FG000|COMPLETED|Overall Study|Last study centre close-out.|38
3276459|NCT02699866|4010190|FG000|NOT COMPLETED|Overall Study||8
3276460|NCT02699892|4010194|FG000|STARTED|Overall Study||130
3276461|NCT02699892|4010194|FG000|COMPLETED|Overall Study||94
2938674|NCT00626340|3650428|FG000|STARTED|Overall Study||18
2938675|NCT00626340|3650428|FG000|COMPLETED|Overall Study||18
2938676|NCT00626340|3650428|FG000|NOT COMPLETED|Overall Study||0
2938677|NCT00626366|3650434|FG000|STARTED|Overall Study||9
2938678|NCT00626366|3650435|FG001|STARTED|Overall Study||9
2938679|NCT00626366|3650434|FG000|COMPLETED|Overall Study||9
2938680|NCT00626366|3650435|FG001|COMPLETED|Overall Study||9
2938681|NCT00626366|3650434|FG000|NOT COMPLETED|Overall Study||0
2938682|NCT00626366|3650435|FG001|NOT COMPLETED|Overall Study||0
2938683|NCT00626392|3650447|FG000|STARTED|Run-in Period||45
2938684|NCT00626392|3650448|FG001|STARTED|Run-in Period||44
2938685|NCT00626392|3650449|FG002|STARTED|Run-in Period||44
2938686|NCT00626392|3650450|FG003|STARTED|Run-in Period||44
2938687|NCT00626392|3650451|FG004|STARTED|Run-in Period||45
2938688|NCT00626392|3650452|FG005|STARTED|Run-in Period||45
2938689|NCT00626392|3650447|FG000|COMPLETED|Run-in Period||44
2938690|NCT00626392|3650448|FG001|COMPLETED|Run-in Period||43
2938691|NCT00626392|3650449|FG002|COMPLETED|Run-in Period||41
2938692|NCT00626392|3650450|FG003|COMPLETED|Run-in Period||43
2938693|NCT00626392|3650451|FG004|COMPLETED|Run-in Period||41
2938694|NCT00626392|3650452|FG005|COMPLETED|Run-in Period||44
2938695|NCT00626392|3650447|FG000|NOT COMPLETED|Run-in Period||1
2938696|NCT00626392|3650448|FG001|NOT COMPLETED|Run-in Period||1
2938697|NCT00626392|3650449|FG002|NOT COMPLETED|Run-in Period||3
2938698|NCT00626392|3650450|FG003|NOT COMPLETED|Run-in Period||1
3047746|NCT01203956|3767729|FG000|Attended Sleep Studies for 14 Nights|Second Two-week Period||15
3047747|NCT01203956|3767730|FG001|Attended Sleep Studies for 14 Nights|Second Two-week Period||13
3047748|NCT01203956|3767729|FG000|COMPLETED|Second Two-week Period|Completed with evaluable results, as assessed over both two-week study periods.|10
3276462|NCT02699892|4010194|FG000|NOT COMPLETED|Overall Study||36
3276463|NCT02699970|4010198|FG000|STARTED|Overall Study||399
3276464|NCT02699970|4010198|FG000|Intra-system|Overall Study||399
3276465|NCT02699970|4010198|FG000|Inter-system|Overall Study||399
3276466|NCT02699970|4010198|FG000|COMPLETED|Overall Study||399
3276467|NCT02699970|4010198|FG000|NOT COMPLETED|Overall Study||0
3276468|NCT02699983|4010205|FG000|STARTED|Overall Study||18
3047749|NCT01203956|3767730|FG001|COMPLETED|Second Two-week Period|Completed with evaluable results, as assessed over both two-week study periods.|7
3047750|NCT01203956|3767729|FG000|NOT COMPLETED|Second Two-week Period||5
3047751|NCT01203956|3767730|FG001|NOT COMPLETED|Second Two-week Period||6
3047752|NCT01204203|3767737|FG000|STARTED|Overall Study||8
3047753|NCT01204203|3767737|FG000|COMPLETED|Overall Study||8
3047754|NCT01204203|3767737|FG000|NOT COMPLETED|Overall Study||0
3047755|NCT01204255|3767741|FG000|STARTED|Overall Study||11
3047756|NCT01204255|3767741|FG000|COMPLETED|Overall Study||10
3047757|NCT01204255|3767741|FG000|NOT COMPLETED|Overall Study||1
3047758|NCT01204294|3767752|FG000|STARTED|Overall Study||82
3047759|NCT01204294|3767753|FG001|STARTED|Overall Study||66
3047760|NCT01204294|3767754|FG002|STARTED|Overall Study||74
3047761|NCT01204294|3767755|FG003|STARTED|Overall Study||143
3047762|NCT01204294|3767756|FG004|STARTED|Overall Study||85
3047763|NCT01204294|3767757|FG005|STARTED|Overall Study||63
3047764|NCT01204294|3767758|FG006|STARTED|Overall Study||61
3047765|NCT01204294|3767752|FG000|COMPLETED|Overall Study||79
3047766|NCT01204294|3767753|FG001|COMPLETED|Overall Study||58
3047767|NCT01204294|3767754|FG002|COMPLETED|Overall Study||69
3047768|NCT01204294|3767755|FG003|COMPLETED|Overall Study||132
3047769|NCT01204294|3767756|FG004|COMPLETED|Overall Study||83
3047770|NCT01204294|3767757|FG005|COMPLETED|Overall Study||58
3047771|NCT01204294|3767758|FG006|COMPLETED|Overall Study||59
3047772|NCT01204294|3767752|FG000|NOT COMPLETED|Overall Study||3
3047773|NCT01204294|3767753|FG001|NOT COMPLETED|Overall Study||8
3047774|NCT01204294|3767754|FG002|NOT COMPLETED|Overall Study||5
3047775|NCT01204294|3767755|FG003|NOT COMPLETED|Overall Study||11
3047776|NCT01204294|3767756|FG004|NOT COMPLETED|Overall Study||2
3047777|NCT01204294|3767757|FG005|NOT COMPLETED|Overall Study||5
3047778|NCT01204294|3767758|FG006|NOT COMPLETED|Overall Study||2
3047779|NCT01204398|3767774|FG000|STARTED|Overall Study|Entered and treated.|27
3047780|NCT01204398|3767774|FG000|COMPLETED|Overall Study|Completed trial medication.|26
3047781|NCT01204398|3767774|FG000|NOT COMPLETED|Overall Study||1
3047782|NCT01204658|3767782|FG000|STARTED|Primary Phase||146
3047783|NCT01204658|3767783|FG001|STARTED|Primary Phase||142
3047784|NCT01204658|3767784|FG002|STARTED|Primary Phase||145
3047785|NCT01204658|3767785|FG003|STARTED|Primary Phase||142
3047786|NCT01204658|3767782|FG000|COMPLETED|Primary Phase||146
3047787|NCT01204658|3767783|FG001|COMPLETED|Primary Phase||142
3047788|NCT01204658|3767784|FG002|COMPLETED|Primary Phase||144
3047789|NCT01204658|3767785|FG003|COMPLETED|Primary Phase||142
3047790|NCT01204658|3767782|FG000|NOT COMPLETED|Primary Phase||0
3047791|NCT01204658|3767783|FG001|NOT COMPLETED|Primary Phase||0
3047792|NCT01204658|3767784|FG002|NOT COMPLETED|Primary Phase||1
3047793|NCT01204658|3767785|FG003|NOT COMPLETED|Primary Phase||0
3047794|NCT01204658|3767782|FG000|STARTED|Booster Phase|Not all subjects completing the primary vaccination returned for the booster phase.|144
3047795|NCT01204658|3767783|FG001|STARTED|Booster Phase|Not all subjects completing the primary vaccination returned for the booster phase.|140
3136753|NCT01714921|3862012|FG000|STARTED|Overall Study||504
2938699|NCT00626392|3650451|FG004|NOT COMPLETED|Run-in Period||4
2938700|NCT00626392|3650452|FG005|NOT COMPLETED|Run-in Period||1
2938701|NCT00626392|3650447|FG000|STARTED|Coadministration Period||44
2938702|NCT00626392|3650448|FG001|STARTED|Coadministration Period||43
2938703|NCT00626392|3650449|FG002|STARTED|Coadministration Period||41
2938704|NCT00626392|3650450|FG003|STARTED|Coadministration Period||43
2938705|NCT00626392|3650451|FG004|STARTED|Coadministration Period||41
3047796|NCT01204658|3767784|FG002|STARTED|Booster Phase|Not all subjects completing the primary vaccination returned for the booster phase.|140
3047797|NCT01204658|3767785|FG003|STARTED|Booster Phase|Not all subjects completing the primary vaccination returned for the booster phase.|140
3047798|NCT01204658|3767782|FG000|COMPLETED|Booster Phase||144
3047799|NCT01204658|3767783|FG001|COMPLETED|Booster Phase||140
3047800|NCT01204658|3767784|FG002|COMPLETED|Booster Phase||140
3047801|NCT01204658|3767785|FG003|COMPLETED|Booster Phase||140
3047802|NCT01204658|3767782|FG000|NOT COMPLETED|Booster Phase||0
3047803|NCT01204658|3767783|FG001|NOT COMPLETED|Booster Phase||0
3047804|NCT01204658|3767784|FG002|NOT COMPLETED|Booster Phase||0
3047805|NCT01204658|3767785|FG003|NOT COMPLETED|Booster Phase||0
3047806|NCT01204671|3767803|FG000|STARTED|Overall Study||1012
3047807|NCT01204671|3767804|FG001|STARTED|Overall Study||1013
3047808|NCT01204671|3767805|FG002|STARTED|Overall Study||1011
3047809|NCT01204671|3767806|FG003|STARTED|Overall Study||1010
3160302|NCT01862640|3887430|FG000|NOT COMPLETED|Overall Study||7
3160303|NCT01862640|3887431|FG001|NOT COMPLETED|Overall Study||16
3160304|NCT01862640|3887432|FG002|NOT COMPLETED|Overall Study||18
3160305|NCT01862640|3887433|FG003|NOT COMPLETED|Overall Study||15
3160306|NCT01862796|3887445|FG000|STARTED|Overall Study||19
3160307|NCT01862796|3887446|FG001|STARTED|Overall Study||18
3160308|NCT01862796|3887447|FG002|STARTED|Overall Study||24
3160309|NCT01862796|3887445|FG000|COMPLETED|Overall Study||19
3160310|NCT01862796|3887446|FG001|COMPLETED|Overall Study||18
3160311|NCT01862796|3887447|FG002|COMPLETED|Overall Study||23
3160312|NCT01862796|3887445|FG000|NOT COMPLETED|Overall Study||0
3160313|NCT01862796|3887446|FG001|NOT COMPLETED|Overall Study||0
3160314|NCT01862796|3887447|FG002|NOT COMPLETED|Overall Study||1
3160315|NCT01862874|3887457|FG000|STARTED|Overall Study|Randomized participants|562
3160316|NCT01862874|3887458|FG001|STARTED|Overall Study|Randomized participants|562
3160317|NCT01862874|3887457|FG000|Vaccination 1|Overall Study||561
3160318|NCT01862874|3887458|FG001|Vaccination 1|Overall Study||562
3160319|NCT01862874|3887457|FG000|Vaccination 2|Overall Study||539
3160320|NCT01862874|3887458|FG001|Vaccination 2|Overall Study||542
3160321|NCT01862874|3887457|FG000|Vaccination 3|Overall Study||530
3160322|NCT01862874|3887458|FG001|Vaccination 3|Overall Study||532
3160323|NCT01862874|3887457|FG000|COMPLETED|Overall Study||483
3160324|NCT01862874|3887458|FG001|COMPLETED|Overall Study||485
3160325|NCT01862874|3887457|FG000|NOT COMPLETED|Overall Study||79
3160326|NCT01862874|3887458|FG001|NOT COMPLETED|Overall Study||77
3160327|NCT01862991|3887467|FG000|STARTED|Overall Study||24
3160328|NCT01862991|3887468|FG001|STARTED|Overall Study||28
3160329|NCT01862991|3887469|FG002|STARTED|Overall Study||28
3160330|NCT01862991|3887467|FG000|COMPLETED|Overall Study||21
3160331|NCT01862991|3887468|FG001|COMPLETED|Overall Study||27
3160332|NCT01862991|3887469|FG002|COMPLETED|Overall Study||27
3160333|NCT01862991|3887467|FG000|NOT COMPLETED|Overall Study||3
3160334|NCT01862991|3887468|FG001|NOT COMPLETED|Overall Study||1
3160335|NCT01862991|3887469|FG002|NOT COMPLETED|Overall Study||1
3160336|NCT01863017|3887479|FG000|STARTED|Overall Study||12
3160337|NCT01863017|3887480|FG001|STARTED|Overall Study||19
3160338|NCT01863017|3887479|FG000|Normal Weight Participants|Overall Study||5
3160339|NCT01863017|3887480|FG001|Normal Weight Participants|Overall Study||5
3160340|NCT01863017|3887479|FG000|Obese Participants|Overall Study||4
3160341|NCT01863017|3887480|FG001|Obese Participants|Overall Study||7
3160342|NCT01863017|3887479|FG000|Participants With PWS|Overall Study||3
3160343|NCT01863017|3887480|FG001|Participants With PWS|Overall Study||7
3160344|NCT01863017|3887479|FG000|COMPLETED|Overall Study||12
3160345|NCT01863017|3887480|FG001|COMPLETED|Overall Study||19
3160346|NCT01863017|3887479|FG000|NOT COMPLETED|Overall Study||0
3160347|NCT01863017|3887480|FG001|NOT COMPLETED|Overall Study||0
3160348|NCT01863030|3887486|FG000|STARTED|Baseline||31
3160349|NCT01863030|3887486|FG000|COMPLETED|Baseline||31
3160350|NCT01863030|3887486|FG000|NOT COMPLETED|Baseline||0
3160351|NCT01863030|3887486|FG000|STARTED|Follow up||31
3160352|NCT01863030|3887486|FG000|2 Weeks|Follow up||31
3160353|NCT01863030|3887486|FG000|3 Months|Follow up||28
3160354|NCT01863030|3887486|FG000|6 Months|Follow up||29
3160355|NCT01863030|3887486|FG000|12 Months|Follow up||26
3160356|NCT01863030|3887486|FG000|24 Months|Follow up||13
3160357|NCT01863030|3887486|FG000|COMPLETED|Follow up||13
3160358|NCT01863030|3887486|FG000|NOT COMPLETED|Follow up||18
3160359|NCT01863134|3887493|FG000|STARTED|Overall Study||72
3160360|NCT01863134|3887494|FG001|STARTED|Overall Study||68
3160361|NCT01863134|3887493|FG000|COMPLETED|Overall Study||72
3160362|NCT01863134|3887494|FG001|COMPLETED|Overall Study||68
3160363|NCT01863134|3887493|FG000|NOT COMPLETED|Overall Study||0
3160364|NCT01863134|3887494|FG001|NOT COMPLETED|Overall Study||0
3160365|NCT01863186|3887503|FG000|STARTED|Double-blind Phase|Original number of 230. One participant was randomly assigned into the study, but not dosed.|229
3160366|NCT01863186|3887504|FG001|STARTED|Double-blind Phase||222
3160367|NCT01863186|3887505|FG002|STARTED|Double-blind Phase||151
3160368|NCT01863186|3887506|FG003|STARTED|Double-blind Phase||0
3160369|NCT01863186|3887503|FG000|COMPLETED|Double-blind Phase||95
3160370|NCT01863186|3887504|FG001|COMPLETED|Double-blind Phase||88
3160371|NCT01863186|3887505|FG002|COMPLETED|Double-blind Phase||42
3160372|NCT01863186|3887506|FG003|COMPLETED|Double-blind Phase||0
3160373|NCT01863186|3887503|FG000|NOT COMPLETED|Double-blind Phase||134
3160374|NCT01863186|3887504|FG001|NOT COMPLETED|Double-blind Phase||134
2938706|NCT00626392|3650452|FG005|STARTED|Coadministration Period||44
3160375|NCT01863186|3887505|FG002|NOT COMPLETED|Double-blind Phase||109
3160376|NCT01863186|3887506|FG003|NOT COMPLETED|Double-blind Phase||0
3160377|NCT01863186|3887503|FG000|STARTED|Open-label Phase||0
3160378|NCT01863186|3887504|FG001|STARTED|Open-label Phase||0
3160379|NCT01863186|3887505|FG002|STARTED|Open-label Phase|No placebo group in the Open-label Phase.|0
3160380|NCT01863186|3887506|FG003|STARTED|Open-label Phase|36 from 2.4 mg group, 28 from 3.2mg group, and 19 from Placebo continued to the Open-label phase.|83
3160381|NCT01863186|3887503|FG000|COMPLETED|Open-label Phase||0
3160382|NCT01863186|3887504|FG001|COMPLETED|Open-label Phase||0
3160383|NCT01863186|3887505|FG002|COMPLETED|Open-label Phase||0
3160384|NCT01863186|3887506|FG003|COMPLETED|Open-label Phase||70
3160385|NCT01863186|3887503|FG000|NOT COMPLETED|Open-label Phase||0
3160386|NCT01863186|3887504|FG001|NOT COMPLETED|Open-label Phase||0
3160387|NCT01863186|3887505|FG002|NOT COMPLETED|Open-label Phase||0
3160388|NCT01863186|3887506|FG003|NOT COMPLETED|Open-label Phase||13
3160389|NCT01863368|3887517|FG000|STARTED|Phase I, Day 0 to Day 35||46
3160390|NCT01863368|3887518|FG001|STARTED|Phase I, Day 0 to Day 35||48
3160391|NCT01863368|3887517|FG000|Treated|Phase I, Day 0 to Day 35||46
3160392|NCT01863368|3887518|FG001|Treated|Phase I, Day 0 to Day 35||47
3160393|NCT01863368|3887517|FG000|COMPLETED|Phase I, Day 0 to Day 35||43
3160394|NCT01863368|3887518|FG001|COMPLETED|Phase I, Day 0 to Day 35||41
3160395|NCT01863368|3887517|FG000|NOT COMPLETED|Phase I, Day 0 to Day 35||3
3160396|NCT01863368|3887518|FG001|NOT COMPLETED|Phase I, Day 0 to Day 35||7
3160397|NCT01863368|3887517|FG000|STARTED|Phase II, Day 35 to Day 90||43
3160398|NCT01863368|3887518|FG001|STARTED|Phase II, Day 35 to Day 90||41
3160399|NCT01863368|3887517|FG000|COMPLETED|Phase II, Day 35 to Day 90||41
3160400|NCT01863368|3887518|FG001|COMPLETED|Phase II, Day 35 to Day 90||41
3160401|NCT01863368|3887517|FG000|NOT COMPLETED|Phase II, Day 35 to Day 90||2
3160402|NCT01863368|3887518|FG001|NOT COMPLETED|Phase II, Day 35 to Day 90||0
3160403|NCT01863433|3887525|FG000|STARTED|Overall Study||120
3160404|NCT01863433|3887525|FG000|COMPLETED|Overall Study|1 subject was withdrawn from the study due to evidence of substance abuse.|119
3276469|NCT02699983|4010206|FG001|STARTED|Overall Study||17
3276470|NCT02699983|4010205|FG000|COMPLETED|Overall Study||17
3276471|NCT02699983|4010206|FG001|COMPLETED|Overall Study||17
3276472|NCT02699983|4010205|FG000|NOT COMPLETED|Overall Study||1
3276473|NCT02699983|4010206|FG001|NOT COMPLETED|Overall Study||0
3276474|NCT02699996|4010218|FG000|STARTED|Overall Study||20
3276475|NCT02699996|4010219|FG001|STARTED|Overall Study||11
3276476|NCT02699996|4010218|FG000|COMPLETED|Overall Study||15
3276477|NCT02699996|4010219|FG001|COMPLETED|Overall Study||9
3276478|NCT02699996|4010218|FG000|NOT COMPLETED|Overall Study||5
3276479|NCT02699996|4010219|FG001|NOT COMPLETED|Overall Study||2
3276480|NCT02700165|4010226|FG000|STARTED|Overall Study||14
3276481|NCT02700165|4010226|FG000|COMPLETED|Overall Study||14
3276482|NCT02700165|4010226|FG000|NOT COMPLETED|Overall Study||0
3276483|NCT02700334|4010233|FG000|STARTED|Overall Study||12
3276484|NCT02700334|4010234|FG001|STARTED|Overall Study||12
3276485|NCT02700334|4010233|FG000|COMPLETED|Overall Study||12
3276486|NCT02700334|4010234|FG001|COMPLETED|Overall Study||12
3276487|NCT02700334|4010233|FG000|NOT COMPLETED|Overall Study||0
3276488|NCT02700334|4010234|FG001|NOT COMPLETED|Overall Study||0
3276489|NCT02700412|4010240|FG000|STARTED|Overall Study||80
3276490|NCT02700412|4010240|FG000|COMPLETED|Overall Study||47
3276491|NCT02700412|4010240|FG000|NOT COMPLETED|Overall Study||33
3276492|NCT02700425|4010246|FG000|STARTED|Overall Study||21
3276493|NCT02700425|4010247|FG001|STARTED|Overall Study||20
3276494|NCT02700425|4010246|FG000|COMPLETED|Overall Study||21
3276495|NCT02700425|4010247|FG001|COMPLETED|Overall Study|1 patient withdrew after randomization|19
3276496|NCT02700425|4010246|FG000|NOT COMPLETED|Overall Study||0
3276497|NCT02700425|4010247|FG001|NOT COMPLETED|Overall Study||1
3276498|NCT02700815|4010257|FG000|STARTED|Overall Study||75
3276499|NCT02700815|4010258|FG001|STARTED|Overall Study||223
3276500|NCT02700815|4010259|FG002|STARTED|Overall Study||223
3276501|NCT02700815|4010260|FG003|STARTED|Overall Study||225
3276502|NCT02700815|4010257|FG000|COMPLETED|Overall Study||74
3276503|NCT02700815|4010258|FG001|COMPLETED|Overall Study||216
3276504|NCT02700815|4010259|FG002|COMPLETED|Overall Study||219
3276505|NCT02700815|4010260|FG003|COMPLETED|Overall Study||218
3276506|NCT02700815|4010257|FG000|NOT COMPLETED|Overall Study||1
3276507|NCT02700815|4010258|FG001|NOT COMPLETED|Overall Study||7
3276508|NCT02700815|4010259|FG002|NOT COMPLETED|Overall Study||4
3276509|NCT02700815|4010260|FG003|NOT COMPLETED|Overall Study||7
3276510|NCT02700919|4010273|FG000|STARTED|Overall Study||94
3276511|NCT02700919|4010274|FG001|STARTED|Overall Study||97
3276512|NCT02700919|4010275|FG002|STARTED|Overall Study||91
3276513|NCT02700919|4010273|FG000|COMPLETED|Overall Study||82
3276514|NCT02700919|4010274|FG001|COMPLETED|Overall Study||85
3276515|NCT02700919|4010275|FG002|COMPLETED|Overall Study||87
3276516|NCT02700919|4010273|FG000|NOT COMPLETED|Overall Study||12
3276517|NCT02700919|4010274|FG001|NOT COMPLETED|Overall Study||12
3276518|NCT02700919|4010275|FG002|NOT COMPLETED|Overall Study||4
3276519|NCT02700945|4010285|FG000|STARTED|Overall Study||242
3276520|NCT02700945|4010286|FG001|STARTED|Overall Study||250
3276521|NCT02700945|4010285|FG000|COMPLETED|Overall Study||210
3276522|NCT02700945|4010286|FG001|COMPLETED|Overall Study||207
3276523|NCT02700945|4010285|FG000|NOT COMPLETED|Overall Study||32
3276524|NCT02700945|4010286|FG001|NOT COMPLETED|Overall Study||43
3276525|NCT02700984|4010294|FG000|STARTED|Overall Study||215
2938707|NCT00626392|3650447|FG000|COMPLETED|Coadministration Period||40
2938708|NCT00626392|3650448|FG001|COMPLETED|Coadministration Period||38
2938709|NCT00626392|3650449|FG002|COMPLETED|Coadministration Period||31
2938710|NCT00626392|3650450|FG003|COMPLETED|Coadministration Period||36
2938711|NCT00626392|3650451|FG004|COMPLETED|Coadministration Period||36
2938712|NCT00626392|3650452|FG005|COMPLETED|Coadministration Period||38
2938713|NCT00626392|3650447|FG000|NOT COMPLETED|Coadministration Period||4
2938714|NCT00626392|3650448|FG001|NOT COMPLETED|Coadministration Period||5
2938715|NCT00626392|3650449|FG002|NOT COMPLETED|Coadministration Period||10
3276526|NCT02700984|4010295|FG001|STARTED|Overall Study||67
3276527|NCT02700984|4010294|FG000|COMPLETED|Overall Study||200
3276528|NCT02700984|4010295|FG001|COMPLETED|Overall Study||53
3276529|NCT02700984|4010294|FG000|NOT COMPLETED|Overall Study||15
3276530|NCT02700984|4010295|FG001|NOT COMPLETED|Overall Study||14
3276531|NCT02700997|4010311|FG000|STARTED|Overall Study||17
3276532|NCT02700997|4010311|FG000|COMPLETED|Overall Study||15
3276533|NCT02700997|4010311|FG000|NOT COMPLETED|Overall Study||2
3276534|NCT02701049|4010318|FG000|STARTED|Overall Study|Patients who completed a follow-up survey|209
3276535|NCT02701049|4010319|FG001|STARTED|Overall Study|Patients who completed a follow-up survey|342
3276536|NCT02701049|4010320|FG002|STARTED|Overall Study|Patients who completed a follow-up survey|198
3276537|NCT02701049|4010318|FG000|COMPLETED|Overall Study|Total patients included in analysis|209
3276538|NCT02701049|4010319|FG001|COMPLETED|Overall Study|Total patients included in analysis|342
3276539|NCT02701049|4010320|FG002|COMPLETED|Overall Study|Total patients included in analysis|198
3276540|NCT02701049|4010318|FG000|NOT COMPLETED|Overall Study||0
3276541|NCT02701049|4010319|FG001|NOT COMPLETED|Overall Study||0
3276542|NCT02701049|4010320|FG002|NOT COMPLETED|Overall Study||0
3276543|NCT02701062|4010334|FG000|STARTED|Baseline||376
3276544|NCT02701062|4010335|FG001|STARTED|Baseline||186
3276545|NCT02701062|4010334|FG000|COMPLETED|Baseline||376
3276546|NCT02701062|4010335|FG001|COMPLETED|Baseline||186
3276547|NCT02701062|4010334|FG000|NOT COMPLETED|Baseline||0
3276548|NCT02701062|4010335|FG001|NOT COMPLETED|Baseline||0
3276549|NCT02701062|4010334|FG000|STARTED|Index Procedure||376
3276550|NCT02701062|4010335|FG001|STARTED|Index Procedure||186
3276551|NCT02701062|4010334|FG000|COMPLETED|Index Procedure||376
3276552|NCT02701062|4010335|FG001|COMPLETED|Index Procedure||186
3276553|NCT02701062|4010334|FG000|NOT COMPLETED|Index Procedure||0
3276554|NCT02701062|4010335|FG001|NOT COMPLETED|Index Procedure||0
3276555|NCT02701062|4010334|FG000|STARTED|Discharge||376
3276556|NCT02701062|4010335|FG001|STARTED|Discharge||186
3276557|NCT02701062|4010334|FG000|COMPLETED|Discharge||376
3276558|NCT02701062|4010335|FG001|COMPLETED|Discharge||186
3276559|NCT02701062|4010334|FG000|NOT COMPLETED|Discharge||0
3276560|NCT02701062|4010335|FG001|NOT COMPLETED|Discharge||0
3276561|NCT02701062|4010334|FG000|STARTED|30 Day Follow-up||376
3276562|NCT02701062|4010335|FG001|STARTED|30 Day Follow-up||186
3276563|NCT02701062|4010334|FG000|COMPLETED|30 Day Follow-up||366
3276564|NCT02701062|4010335|FG001|COMPLETED|30 Day Follow-up||183
3276565|NCT02701062|4010334|FG000|NOT COMPLETED|30 Day Follow-up||10
3276566|NCT02701062|4010335|FG001|NOT COMPLETED|30 Day Follow-up||3
3276567|NCT02701062|4010334|FG000|STARTED|90 Day Follow-up||366
3276568|NCT02701062|4010335|FG001|STARTED|90 Day Follow-up||183
3276569|NCT02701062|4010334|FG000|COMPLETED|90 Day Follow-up||308
3276570|NCT02701062|4010335|FG001|COMPLETED|90 Day Follow-up||72
3276571|NCT02701062|4010334|FG000|NOT COMPLETED|90 Day Follow-up||58
3276572|NCT02701062|4010335|FG001|NOT COMPLETED|90 Day Follow-up||111
3276573|NCT02701062|4010334|FG000|STARTED|365 Day Follow-up||308
3276574|NCT02701062|4010335|FG001|STARTED|365 Day Follow-up||72
3276575|NCT02701062|4010334|FG000|COMPLETED|365 Day Follow-up||294
3276576|NCT02701062|4010335|FG001|COMPLETED|365 Day Follow-up||69
3276577|NCT02701062|4010334|FG000|NOT COMPLETED|365 Day Follow-up||14
3276578|NCT02701062|4010335|FG001|NOT COMPLETED|365 Day Follow-up||3
3276579|NCT02701101|4010349|FG000|STARTED|Overall Study||189
3276580|NCT02701101|4010349|FG000|COMPLETED|Overall Study||189
3276581|NCT02701101|4010349|FG000|NOT COMPLETED|Overall Study||0
3276582|NCT02701192|4010354|FG000|STARTED|Overall Study||100
3276583|NCT02701192|4010354|FG000|COMPLETED|Overall Study||94
3276584|NCT02701192|4010354|FG000|NOT COMPLETED|Overall Study||6
3276585|NCT02701257|4010363|FG000|STARTED|Overall Study||6
3276586|NCT02701257|4010364|FG001|STARTED|Overall Study||6
3276587|NCT02701257|4010365|FG002|STARTED|Overall Study||0
3276588|NCT02701257|4010366|FG003|STARTED|Overall Study||4
3276589|NCT02701257|4010367|FG004|STARTED|Overall Study||4
3276590|NCT02701257|4010363|FG000|COMPLETED|Overall Study||6
3276591|NCT02701257|4010364|FG001|COMPLETED|Overall Study||3
3276592|NCT02701257|4010365|FG002|COMPLETED|Overall Study||0
3276593|NCT02701257|4010366|FG003|COMPLETED|Overall Study||3
3276594|NCT02701257|4010367|FG004|COMPLETED|Overall Study||1
3276595|NCT02701257|4010363|FG000|NOT COMPLETED|Overall Study||0
3276596|NCT02701257|4010364|FG001|NOT COMPLETED|Overall Study||3
3276597|NCT02701257|4010365|FG002|NOT COMPLETED|Overall Study||0
3276598|NCT02701257|4010366|FG003|NOT COMPLETED|Overall Study||1
3276599|NCT02701257|4010367|FG004|NOT COMPLETED|Overall Study||3
3316349|NCT03110458|4049653|FG001|STARTED|Overall Study||36
3316350|NCT03110458|4049654|FG002|STARTED|Overall Study||34
3316351|NCT03110458|4049652|FG000|COMPLETED|Overall Study||31
3316352|NCT03110458|4049653|FG001|COMPLETED|Overall Study||32
3316353|NCT03110458|4049654|FG002|COMPLETED|Overall Study||31
3316354|NCT03110458|4049652|FG000|NOT COMPLETED|Overall Study||6
3316355|NCT03110458|4049653|FG001|NOT COMPLETED|Overall Study||4
2938716|NCT00626392|3650450|FG003|NOT COMPLETED|Coadministration Period||7
2938717|NCT00626392|3650451|FG004|NOT COMPLETED|Coadministration Period||5
2938718|NCT00626392|3650452|FG005|NOT COMPLETED|Coadministration Period||6
2938719|NCT00626405|3650460|FG000|STARTED|Overall Study||43
2938720|NCT00626405|3650461|FG001|STARTED|Overall Study||52
2938721|NCT00626405|3650460|FG000|COMPLETED|Overall Study||42
2938722|NCT00626405|3650461|FG001|COMPLETED|Overall Study||51
2938723|NCT00626405|3650460|FG000|NOT COMPLETED|Overall Study||1
2938724|NCT00626405|3650461|FG001|NOT COMPLETED|Overall Study||1
2938725|NCT00626431|3650469|FG000|STARTED|Overall Study|Separate groups of subjects received Formulation A and B and data were not compared between groups.|151
2938726|NCT00626431|3650470|FG001|STARTED|Overall Study|Separate groups of subjects received Formulation A and B and data were not compared between groups.|159
2938727|NCT00626431|3650469|FG000|COMPLETED|Overall Study||134
2938728|NCT00626431|3650470|FG001|COMPLETED|Overall Study||114
2938729|NCT00626431|3650469|FG000|NOT COMPLETED|Overall Study||17
2938730|NCT00626431|3650470|FG001|NOT COMPLETED|Overall Study||45
2938731|NCT00626522|3650482|FG000|STARTED|Overall Study||121
2938732|NCT00626522|3650483|FG001|STARTED|Overall Study||120
2938733|NCT00626522|3650484|FG002|STARTED|Overall Study||125
2938734|NCT00626522|3650485|FG003|STARTED|Overall Study||76
2938735|NCT00626522|3650486|FG004|STARTED|Overall Study||65
2938736|NCT00626522|3650487|FG005|STARTED|Overall Study||59
2938737|NCT00626522|3650482|FG000|COMPLETED|Overall Study||115
2938738|NCT00626522|3650483|FG001|COMPLETED|Overall Study||113
2938739|NCT00626522|3650484|FG002|COMPLETED|Overall Study||117
2938740|NCT00626522|3650485|FG003|COMPLETED|Overall Study||74
2938741|NCT00626522|3650486|FG004|COMPLETED|Overall Study||58
2938742|NCT00626522|3650487|FG005|COMPLETED|Overall Study||57
2938743|NCT00626522|3650482|FG000|NOT COMPLETED|Overall Study||6
2938744|NCT00626522|3650483|FG001|NOT COMPLETED|Overall Study||7
2938745|NCT00626522|3650484|FG002|NOT COMPLETED|Overall Study||8
2938746|NCT00626522|3650485|FG003|NOT COMPLETED|Overall Study||2
2938747|NCT00626522|3650486|FG004|NOT COMPLETED|Overall Study||7
2938748|NCT00626522|3650487|FG005|NOT COMPLETED|Overall Study||2
2938749|NCT00626548|3650503|FG000|STARTED|Overall Study||705
2938750|NCT00626548|3650504|FG001|STARTED|Overall Study||716
2938751|NCT00626548|3650503|FG000|Patients Received Treatment|Overall Study||703
2938752|NCT00626548|3650504|FG001|Patients Received Treatment|Overall Study||712
2938753|NCT00626548|3650503|FG000|COMPLETED|Overall Study||0
2938754|NCT00626548|3650504|FG001|COMPLETED|Overall Study||0
2938755|NCT00626548|3650503|FG000|NOT COMPLETED|Overall Study||705
2938756|NCT00626548|3650504|FG001|NOT COMPLETED|Overall Study||716
2938757|NCT00626574|3650512|FG000|STARTED|Overall Study||2
2938758|NCT00626574|3650513|FG001|STARTED|Overall Study||1
2938759|NCT00626574|3650512|FG000|COMPLETED|Overall Study||2
2938760|NCT00626574|3650513|FG001|COMPLETED|Overall Study||1
2938761|NCT00626574|3650512|FG000|NOT COMPLETED|Overall Study||0
2938762|NCT00626574|3650513|FG001|NOT COMPLETED|Overall Study||0
2938763|NCT00626626|3650523|FG000|STARTED|Overall Study||5
2938764|NCT00626626|3650524|FG001|STARTED|Overall Study||3
2938765|NCT00626626|3650523|FG000|COMPLETED|Overall Study||5
2938766|NCT00626626|3650524|FG001|COMPLETED|Overall Study||3
2938767|NCT00626626|3650523|FG000|NOT COMPLETED|Overall Study||0
2938768|NCT00626626|3650524|FG001|NOT COMPLETED|Overall Study||0
2938769|NCT00626639|3650533|FG000|STARTED|Overall Study||2
3276600|NCT02701270|4010383|FG000|STARTED|First Intervention at Visit 1||2
3276601|NCT02701270|4010384|FG001|STARTED|First Intervention at Visit 1||3
3276602|NCT02701270|4010385|FG002|STARTED|First Intervention at Visit 1||3
2938770|NCT00626639|3650534|FG001|STARTED|Overall Study||3
2938771|NCT00626639|3650533|FG000|COMPLETED|Overall Study|Participants who received all 8 doses of investigational product.|0
2938772|NCT00626639|3650534|FG001|COMPLETED|Overall Study|Participants who received all 8 doses of investigational product.|1
2938773|NCT00626639|3650533|FG000|NOT COMPLETED|Overall Study||2
2938774|NCT00626639|3650534|FG001|NOT COMPLETED|Overall Study||2
2938775|NCT00626743|3650544|FG000|STARTED|Treatment Period 1||6
2938776|NCT00626743|3650545|FG001|STARTED|Treatment Period 1||7
3276603|NCT02701270|4010386|FG003|STARTED|First Intervention at Visit 1||3
3276604|NCT02701270|4010383|FG000|COMPLETED|First Intervention at Visit 1||2
3276605|NCT02701270|4010384|FG001|COMPLETED|First Intervention at Visit 1||3
3276606|NCT02701270|4010385|FG002|COMPLETED|First Intervention at Visit 1||3
3276607|NCT02701270|4010386|FG003|COMPLETED|First Intervention at Visit 1||3
3276608|NCT02701270|4010383|FG000|NOT COMPLETED|First Intervention at Visit 1||0
3276609|NCT02701270|4010384|FG001|NOT COMPLETED|First Intervention at Visit 1||0
3276610|NCT02701270|4010385|FG002|NOT COMPLETED|First Intervention at Visit 1||0
2938777|NCT00626743|3650544|FG000|COMPLETED|Treatment Period 1||6
2938778|NCT00626743|3650545|FG001|COMPLETED|Treatment Period 1||6
2938779|NCT00626743|3650544|FG000|NOT COMPLETED|Treatment Period 1||0
2938780|NCT00626743|3650545|FG001|NOT COMPLETED|Treatment Period 1||1
2938781|NCT00626743|3650544|FG000|STARTED|Wash-out Period of 6 Days||6
2938782|NCT00626743|3650545|FG001|STARTED|Wash-out Period of 6 Days||6
2938783|NCT00626743|3650544|FG000|COMPLETED|Wash-out Period of 6 Days||6
2938784|NCT00626743|3650545|FG001|COMPLETED|Wash-out Period of 6 Days||6
2938785|NCT00626743|3650544|FG000|NOT COMPLETED|Wash-out Period of 6 Days||0
2938786|NCT00626743|3650545|FG001|NOT COMPLETED|Wash-out Period of 6 Days||0
2938787|NCT00626743|3650544|FG000|STARTED|Treatment Period 2||6
2938788|NCT00626743|3650545|FG001|STARTED|Treatment Period 2||6
2938789|NCT00626743|3650544|FG000|COMPLETED|Treatment Period 2||6
3276611|NCT02701270|4010386|FG003|NOT COMPLETED|First Intervention at Visit 1||0
3276612|NCT02701270|4010383|FG000|STARTED|Second Intervention at Visit 2||2
3276613|NCT02701270|4010384|FG001|STARTED|Second Intervention at Visit 2||3
2938790|NCT00626743|3650545|FG001|COMPLETED|Treatment Period 2||6
2938791|NCT00626743|3650544|FG000|NOT COMPLETED|Treatment Period 2||0
2938792|NCT00626743|3650545|FG001|NOT COMPLETED|Treatment Period 2||0
2938793|NCT00626782|3650553|FG000|STARTED|Overall Study||12
2938794|NCT00626782|3650554|FG001|STARTED|Overall Study||12
2938795|NCT00626782|3650553|FG000|COMPLETED|Overall Study||12
2938796|NCT00626782|3650554|FG001|COMPLETED|Overall Study||12
2938797|NCT00626782|3650553|FG000|NOT COMPLETED|Overall Study||0
2938798|NCT00626782|3650554|FG001|NOT COMPLETED|Overall Study||0
2938799|NCT00626795|3650565|FG000|STARTED|Open-label TD1414 Cream TID Treatment||0
2938800|NCT00626795|3650566|FG001|STARTED|Open-label TD1414 Cream TID Treatment||65
2938801|NCT00626795|3650567|FG002|STARTED|Open-label TD1414 Cream TID Treatment||0
2938802|NCT00626795|3650565|FG000|COMPLETED|Open-label TD1414 Cream TID Treatment||0
2938803|NCT00626795|3650566|FG001|COMPLETED|Open-label TD1414 Cream TID Treatment||64
2938804|NCT00626795|3650567|FG002|COMPLETED|Open-label TD1414 Cream TID Treatment||0
2938805|NCT00626795|3650565|FG000|NOT COMPLETED|Open-label TD1414 Cream TID Treatment||0
2938806|NCT00626795|3650566|FG001|NOT COMPLETED|Open-label TD1414 Cream TID Treatment||1
2938807|NCT00626795|3650567|FG002|NOT COMPLETED|Open-label TD1414 Cream TID Treatment||0
2938808|NCT00626795|3650565|FG000|STARTED|Blinded Treatment||204
2938809|NCT00626795|3650566|FG001|STARTED|Blinded Treatment||205
2938810|NCT00626795|3650567|FG002|STARTED|Blinded Treatment||205
2938811|NCT00626795|3650565|FG000|COMPLETED|Blinded Treatment||194
2938812|NCT00626795|3650566|FG001|COMPLETED|Blinded Treatment||200
2938813|NCT00626795|3650567|FG002|COMPLETED|Blinded Treatment||196
2938814|NCT00626795|3650565|FG000|NOT COMPLETED|Blinded Treatment||10
2938815|NCT00626795|3650566|FG001|NOT COMPLETED|Blinded Treatment||5
2938816|NCT00626795|3650567|FG002|NOT COMPLETED|Blinded Treatment||9
2938817|NCT00626808|3650583|FG000|STARTED|Overall Study||254464
2938818|NCT00626808|3650584|FG001|STARTED|Overall Study||34316
2938819|NCT00626808|3650585|FG002|STARTED|Overall Study||30011
2938820|NCT00626808|3650586|FG003|STARTED|Overall Study||2906
2938821|NCT00626808|3650583|FG000|COMPLETED|Overall Study||254464
2938822|NCT00626808|3650584|FG001|COMPLETED|Overall Study||34316
2938823|NCT00626808|3650585|FG002|COMPLETED|Overall Study||30011
2938824|NCT00626808|3650586|FG003|COMPLETED|Overall Study||2906
2938825|NCT00626808|3650583|FG000|NOT COMPLETED|Overall Study||0
2938826|NCT00626808|3650584|FG001|NOT COMPLETED|Overall Study||0
2938827|NCT00626808|3650585|FG002|NOT COMPLETED|Overall Study||0
2938828|NCT00626808|3650586|FG003|NOT COMPLETED|Overall Study||0
2938829|NCT00626821|3650596|FG000|STARTED|Overall Study||3017
2938830|NCT00626821|3650596|FG000|Quality of Life|Overall Study|Attended both visit 1 and visit 2|2672
2938831|NCT00626821|3650596|FG000|COMPLETED|Overall Study||2796
2938832|NCT00626821|3650596|FG000|NOT COMPLETED|Overall Study||221
2938833|NCT00626886|3650602|FG000|STARTED|Overall Study||24
2938834|NCT00626886|3650603|FG001|STARTED|Overall Study||29
2938835|NCT00626886|3650602|FG000|COMPLETED|Overall Study||24
2938836|NCT00626886|3650603|FG001|COMPLETED|Overall Study||29
2938837|NCT00626886|3650602|FG000|NOT COMPLETED|Overall Study||0
2938838|NCT00626886|3650603|FG001|NOT COMPLETED|Overall Study||0
2938839|NCT00626912|3650611|FG000|STARTED|Overall Study||222
2938840|NCT00626912|3650612|FG001|STARTED|Overall Study||225
2938841|NCT00626912|3650611|FG000|COMPLETED|Overall Study||220
2938842|NCT00626912|3650612|FG001|COMPLETED|Overall Study||215
2938843|NCT00626912|3650611|FG000|NOT COMPLETED|Overall Study||2
2938844|NCT00626912|3650612|FG001|NOT COMPLETED|Overall Study||10
2938845|NCT00626925|3650620|FG000|STARTED|Overall Study||67
2938846|NCT00626925|3650621|FG001|STARTED|Overall Study||71
2938847|NCT00626925|3650620|FG000|COMPLETED|Overall Study||55
2938848|NCT00626925|3650621|FG001|COMPLETED|Overall Study||62
2938849|NCT00626925|3650620|FG000|NOT COMPLETED|Overall Study||12
2938850|NCT00626925|3650621|FG001|NOT COMPLETED|Overall Study||9
2938851|NCT00627016|3650643|FG000|STARTED|Overall Study||153
2938852|NCT00627016|3650644|FG001|STARTED|Overall Study||152
2938853|NCT00627016|3650643|FG000|COMPLETED|Overall Study||147
2938854|NCT00627016|3650644|FG001|COMPLETED|Overall Study||146
2938855|NCT00627016|3650643|FG000|NOT COMPLETED|Overall Study||6
3276614|NCT02701270|4010385|FG002|STARTED|Second Intervention at Visit 2||3
3276615|NCT02701270|4010386|FG003|STARTED|Second Intervention at Visit 2||3
3276616|NCT02701270|4010383|FG000|COMPLETED|Second Intervention at Visit 2||2
3276617|NCT02701270|4010384|FG001|COMPLETED|Second Intervention at Visit 2||3
3276618|NCT02701270|4010385|FG002|COMPLETED|Second Intervention at Visit 2||3
3276619|NCT02701270|4010386|FG003|COMPLETED|Second Intervention at Visit 2||3
2938856|NCT00627016|3650644|FG001|NOT COMPLETED|Overall Study||6
2938857|NCT00627042|3650650|FG000|STARTED|Overall Study||42
2938858|NCT00627042|3650650|FG000|Received at Least 1 Dose of Study Drug|Overall Study||42
2938859|NCT00627042|3650650|FG000|COMPLETED|Overall Study||40
2938860|NCT00627042|3650650|FG000|NOT COMPLETED|Overall Study||2
2938861|NCT00627094|3650656|FG000|STARTED|Overall Study||60
2938862|NCT00627094|3650657|FG001|STARTED|Overall Study||60
2938863|NCT00627094|3650656|FG000|COMPLETED|Overall Study||48
2938864|NCT00627094|3650657|FG001|COMPLETED|Overall Study||45
2938865|NCT00627094|3650656|FG000|NOT COMPLETED|Overall Study||12
2938866|NCT00627094|3650657|FG001|NOT COMPLETED|Overall Study||15
2938867|NCT00627367|3650667|FG000|STARTED|Overall Study||112
2938868|NCT00627367|3650668|FG001|STARTED|Overall Study||112
2938869|NCT00627367|3650667|FG000|COMPLETED|Overall Study||112
2938870|NCT00627367|3650668|FG001|COMPLETED|Overall Study||112
2938871|NCT00627367|3650667|FG000|NOT COMPLETED|Overall Study||0
2938872|NCT00627367|3650668|FG001|NOT COMPLETED|Overall Study||0
2938873|NCT00627393|3650677|FG000|STARTED|Intention-To-Treat Analysis||58
2938874|NCT00627393|3650678|FG001|STARTED|Intention-To-Treat Analysis||56
2938875|NCT00627393|3650677|FG000|COMPLETED|Intention-To-Treat Analysis||49
2938876|NCT00627393|3650678|FG001|COMPLETED|Intention-To-Treat Analysis||48
2938877|NCT00627393|3650677|FG000|NOT COMPLETED|Intention-To-Treat Analysis||9
2938878|NCT00627393|3650678|FG001|NOT COMPLETED|Intention-To-Treat Analysis||8
2938879|NCT00627393|3650677|FG000|STARTED|Per-Protocol Analysis||49
2938880|NCT00627393|3650678|FG001|STARTED|Per-Protocol Analysis||48
2938881|NCT00627393|3650677|FG000|COMPLETED|Per-Protocol Analysis||39
2938882|NCT00627393|3650678|FG001|COMPLETED|Per-Protocol Analysis||35
2938883|NCT00627393|3650677|FG000|NOT COMPLETED|Per-Protocol Analysis||10
2938884|NCT00627393|3650678|FG001|NOT COMPLETED|Per-Protocol Analysis||13
3034416|NCT01132664|3753508|FG004|NOT COMPLETED|Phase lb||0
3034417|NCT01132664|3753504|FG000|STARTED|Phase ll||0
3034418|NCT01132664|3753505|FG001|STARTED|Phase ll||0
3034419|NCT01132664|3753506|FG002|STARTED|Phase ll|Of the 50 patients, 8 were from phase lb & were eligible for inclusion in Phase II|50
3034420|NCT01132664|3753507|FG003|STARTED|Phase ll||0
3034421|NCT01132664|3753508|FG004|STARTED|Phase ll||0
3034422|NCT01132664|3753504|FG000|COMPLETED|Phase ll||0
3034423|NCT01132664|3753505|FG001|COMPLETED|Phase ll||0
3034424|NCT01132664|3753506|FG002|COMPLETED|Phase ll||0
3034425|NCT01132664|3753507|FG003|COMPLETED|Phase ll||0
3034426|NCT01132664|3753508|FG004|COMPLETED|Phase ll||0
3034427|NCT01132664|3753504|FG000|NOT COMPLETED|Phase ll||0
3034428|NCT01132664|3753505|FG001|NOT COMPLETED|Phase ll||0
3034429|NCT01132664|3753506|FG002|NOT COMPLETED|Phase ll||50
3034430|NCT01132664|3753507|FG003|NOT COMPLETED|Phase ll||0
3034431|NCT01132664|3753508|FG004|NOT COMPLETED|Phase ll||0
3034432|NCT01132664|3753504|FG000|STARTED|BM Cohort||0
3034433|NCT01132664|3753505|FG001|STARTED|BM Cohort||0
3034434|NCT01132664|3753506|FG002|STARTED|BM Cohort||0
3034435|NCT01132664|3753507|FG003|STARTED|BM Cohort||3
3034436|NCT01132664|3753508|FG004|STARTED|BM Cohort||6
3034437|NCT01132664|3753504|FG000|COMPLETED|BM Cohort||0
3034438|NCT01132664|3753505|FG001|COMPLETED|BM Cohort||0
3034439|NCT01132664|3753506|FG002|COMPLETED|BM Cohort||0
3034440|NCT01132664|3753507|FG003|COMPLETED|BM Cohort||0
3034441|NCT01132664|3753508|FG004|COMPLETED|BM Cohort||0
3034442|NCT01132664|3753504|FG000|NOT COMPLETED|BM Cohort||0
3034443|NCT01132664|3753505|FG001|NOT COMPLETED|BM Cohort||0
3034444|NCT01132664|3753506|FG002|NOT COMPLETED|BM Cohort||0
3034445|NCT01132664|3753507|FG003|NOT COMPLETED|BM Cohort||3
3034446|NCT01132664|3753508|FG004|NOT COMPLETED|BM Cohort||6
3034447|NCT01132690|3753522|FG000|STARTED|Overall Study||6
3034448|NCT01132690|3753523|FG001|STARTED|Overall Study||5
3034449|NCT01132690|3753522|FG000|COMPLETED|Overall Study||6
3034450|NCT01132690|3753523|FG001|COMPLETED|Overall Study||5
3034451|NCT01132690|3753522|FG000|NOT COMPLETED|Overall Study||0
3034452|NCT01132690|3753523|FG001|NOT COMPLETED|Overall Study||0
3034453|NCT01132755|3753529|FG000|STARTED|Overall Study||112
3034454|NCT01132755|3753529|FG000|COMPLETED|Overall Study||70
3034455|NCT01132755|3753529|FG000|NOT COMPLETED|Overall Study||42
3034456|NCT01132807|3753533|FG000|STARTED|Initial ABVD Treatment (2 Cycles)||15
3034457|NCT01132807|3753534|FG001|STARTED|Initial ABVD Treatment (2 Cycles)||135
3034458|NCT01132807|3753535|FG002|STARTED|Initial ABVD Treatment (2 Cycles)||14
3034459|NCT01132807|3753533|FG000|COMPLETED|Initial ABVD Treatment (2 Cycles)||0
3034460|NCT01132807|3753534|FG001|COMPLETED|Initial ABVD Treatment (2 Cycles)||135
3034461|NCT01132807|3753535|FG002|COMPLETED|Initial ABVD Treatment (2 Cycles)||14
3034462|NCT01132807|3753533|FG000|NOT COMPLETED|Initial ABVD Treatment (2 Cycles)||15
3034463|NCT01132807|3753534|FG001|NOT COMPLETED|Initial ABVD Treatment (2 Cycles)||0
3034464|NCT01132807|3753535|FG002|NOT COMPLETED|Initial ABVD Treatment (2 Cycles)||0
3034465|NCT01132807|3753533|FG000|STARTED|Post-Cycle 2 PET Assessment||0
3034466|NCT01132807|3753534|FG001|STARTED|Post-Cycle 2 PET Assessment||135
3034467|NCT01132807|3753535|FG002|STARTED|Post-Cycle 2 PET Assessment||14
3034468|NCT01132807|3753533|FG000|COMPLETED|Post-Cycle 2 PET Assessment||0
3034469|NCT01132807|3753534|FG001|COMPLETED|Post-Cycle 2 PET Assessment||135
3034470|NCT01132807|3753535|FG002|COMPLETED|Post-Cycle 2 PET Assessment||14
3034471|NCT01132807|3753533|FG000|NOT COMPLETED|Post-Cycle 2 PET Assessment||0
3034472|NCT01132807|3753534|FG001|NOT COMPLETED|Post-Cycle 2 PET Assessment||0
3276620|NCT02701270|4010383|FG000|NOT COMPLETED|Second Intervention at Visit 2||0
3276621|NCT02701270|4010384|FG001|NOT COMPLETED|Second Intervention at Visit 2||0
3276622|NCT02701270|4010385|FG002|NOT COMPLETED|Second Intervention at Visit 2||0
3276623|NCT02701270|4010386|FG003|NOT COMPLETED|Second Intervention at Visit 2||0
3276624|NCT02701270|4010383|FG000|STARTED|Third Intervention at Visit 3||2
3276625|NCT02701270|4010384|FG001|STARTED|Third Intervention at Visit 3||3
3276626|NCT02701270|4010385|FG002|STARTED|Third Intervention at Visit 3||3
3276627|NCT02701270|4010386|FG003|STARTED|Third Intervention at Visit 3||3
3276628|NCT02701270|4010383|FG000|COMPLETED|Third Intervention at Visit 3||2
3276629|NCT02701270|4010384|FG001|COMPLETED|Third Intervention at Visit 3||3
3276630|NCT02701270|4010385|FG002|COMPLETED|Third Intervention at Visit 3||3
3276631|NCT02701270|4010386|FG003|COMPLETED|Third Intervention at Visit 3||3
3276632|NCT02701270|4010383|FG000|NOT COMPLETED|Third Intervention at Visit 3||0
3276633|NCT02701270|4010384|FG001|NOT COMPLETED|Third Intervention at Visit 3||0
2938885|NCT00627406|3650690|FG000|STARTED|Overall Study||60
2938886|NCT00627406|3650691|FG001|STARTED|Overall Study||58
2938887|NCT00627406|3650692|FG002|STARTED|Overall Study||125
2938888|NCT00627406|3650693|FG003|STARTED|Overall Study||141
2938889|NCT00627406|3650690|FG000|COMPLETED|Overall Study||60
2938890|NCT00627406|3650691|FG001|COMPLETED|Overall Study||58
2938891|NCT00627406|3650692|FG002|COMPLETED|Overall Study||125
2938892|NCT00627406|3650693|FG003|COMPLETED|Overall Study||141
2938893|NCT00627406|3650690|FG000|NOT COMPLETED|Overall Study||0
2938894|NCT00627406|3650691|FG001|NOT COMPLETED|Overall Study||0
2938895|NCT00627406|3650692|FG002|NOT COMPLETED|Overall Study||0
2938896|NCT00627406|3650693|FG003|NOT COMPLETED|Overall Study||0
2938897|NCT00627445|3650705|FG000|STARTED|Overall Study||219
2938898|NCT00627445|3650706|FG001|STARTED|Overall Study||222
2938899|NCT00627445|3650705|FG000|Exposed to Study Drug|Overall Study||219
2938900|NCT00627445|3650706|FG001|Exposed to Study Drug|Overall Study||222
2938901|NCT00627445|3650705|FG000|COMPLETED|Overall Study||210
2938902|NCT00627445|3650706|FG001|COMPLETED|Overall Study||210
2938903|NCT00627445|3650705|FG000|NOT COMPLETED|Overall Study||9
2938904|NCT00627445|3650706|FG001|NOT COMPLETED|Overall Study||12
2938905|NCT00627458|3650717|FG000|STARTED|Overall Study||127
2938906|NCT00627458|3650718|FG001|STARTED|Overall Study||137
2938907|NCT00627458|3650719|FG002|STARTED|Overall Study||139
2938908|NCT00627458|3650717|FG000|COMPLETED|Overall Study||123
2938909|NCT00627458|3650718|FG001|COMPLETED|Overall Study||130
2938910|NCT00627458|3650719|FG002|COMPLETED|Overall Study||133
2938911|NCT00627458|3650717|FG000|NOT COMPLETED|Overall Study||4
2938912|NCT00627458|3650718|FG001|NOT COMPLETED|Overall Study||7
2938913|NCT00627458|3650719|FG002|NOT COMPLETED|Overall Study||6
2938914|NCT00627497|3650732|FG000|STARTED|Overall Study||14
2938915|NCT00627497|3650733|FG001|STARTED|Overall Study||12
2938916|NCT00627497|3650734|FG002|STARTED|Overall Study||4
2938917|NCT00627497|3650735|FG003|STARTED|Overall Study||2
2938918|NCT00627497|3650732|FG000|COMPLETED|Overall Study||13
2938919|NCT00627497|3650733|FG001|COMPLETED|Overall Study||11
2938920|NCT00627497|3650734|FG002|COMPLETED|Overall Study||4
2938921|NCT00627497|3650735|FG003|COMPLETED|Overall Study||2
2938922|NCT00627497|3650732|FG000|NOT COMPLETED|Overall Study||1
2938923|NCT00627497|3650733|FG001|NOT COMPLETED|Overall Study||1
2938924|NCT00627497|3650734|FG002|NOT COMPLETED|Overall Study||0
2938925|NCT00627497|3650735|FG003|NOT COMPLETED|Overall Study||0
2938926|NCT00627523|3650747|FG000|STARTED|Overall Study|22 assigned to Genotropin and 21 in Control; 1 did not take Genotropin, so considered as Control.|21
3276634|NCT02701270|4010385|FG002|NOT COMPLETED|Third Intervention at Visit 3||0
3276635|NCT02701270|4010386|FG003|NOT COMPLETED|Third Intervention at Visit 3||0
3276636|NCT02701270|4010383|FG000|STARTED|Fourth Intervention at Visit 4||2
3276637|NCT02701270|4010384|FG001|STARTED|Fourth Intervention at Visit 4||3
3276638|NCT02701270|4010385|FG002|STARTED|Fourth Intervention at Visit 4||3
3276639|NCT02701270|4010386|FG003|STARTED|Fourth Intervention at Visit 4||3
3276640|NCT02701270|4010383|FG000|COMPLETED|Fourth Intervention at Visit 4||2
3276641|NCT02701270|4010384|FG001|COMPLETED|Fourth Intervention at Visit 4||3
3276642|NCT02701270|4010385|FG002|COMPLETED|Fourth Intervention at Visit 4||3
3276643|NCT02701270|4010386|FG003|COMPLETED|Fourth Intervention at Visit 4||3
3276644|NCT02701270|4010383|FG000|NOT COMPLETED|Fourth Intervention at Visit 4||0
3276645|NCT02701270|4010384|FG001|NOT COMPLETED|Fourth Intervention at Visit 4||0
3276646|NCT02701270|4010385|FG002|NOT COMPLETED|Fourth Intervention at Visit 4||0
3276647|NCT02701270|4010386|FG003|NOT COMPLETED|Fourth Intervention at Visit 4||0
3276648|NCT02701296|4010399|FG000|STARTED|Overall Study||42
2938927|NCT00627523|3650748|FG001|STARTED|Overall Study||22
2938928|NCT00627523|3650747|FG000|COMPLETED|Overall Study||19
2938929|NCT00627523|3650748|FG001|COMPLETED|Overall Study||20
2938930|NCT00627523|3650747|FG000|NOT COMPLETED|Overall Study||2
2938931|NCT00627523|3650748|FG001|NOT COMPLETED|Overall Study||2
2938932|NCT00627679|3650754|FG000|STARTED|Overall Study||4
2938933|NCT00627679|3650755|FG001|STARTED|Overall Study||4
2938934|NCT00627679|3650756|FG002|STARTED|Overall Study||4
2938935|NCT00627679|3650757|FG003|STARTED|Overall Study||4
2938936|NCT00627679|3650754|FG000|COMPLETED|Overall Study||4
2938937|NCT00627679|3650755|FG001|COMPLETED|Overall Study||4
2938938|NCT00627679|3650756|FG002|COMPLETED|Overall Study||4
2938939|NCT00627679|3650757|FG003|COMPLETED|Overall Study||4
2938940|NCT00627679|3650754|FG000|NOT COMPLETED|Overall Study||0
2938941|NCT00627679|3650755|FG001|NOT COMPLETED|Overall Study||0
2938942|NCT00627679|3650756|FG002|NOT COMPLETED|Overall Study||0
2938943|NCT00627679|3650757|FG003|NOT COMPLETED|Overall Study||0
2938944|NCT00627705|3650769|FG000|STARTED|Overall Study||15
2938945|NCT00627705|3650770|FG001|STARTED|Overall Study||18
2938946|NCT00627705|3650769|FG000|COMPLETED|Overall Study||13
2938947|NCT00627705|3650770|FG001|COMPLETED|Overall Study||12
2938948|NCT00627705|3650769|FG000|NOT COMPLETED|Overall Study||2
2938949|NCT00627705|3650770|FG001|NOT COMPLETED|Overall Study||6
2938950|NCT00627861|3650776|FG000|STARTED|Overall Study||1
2938951|NCT00627861|3650776|FG000|COMPLETED|Overall Study||1
2938952|NCT00627861|3650776|FG000|NOT COMPLETED|Overall Study||0
2938953|NCT00627926|3650785|FG000|STARTED|Overall Study||361
2938954|NCT00627926|3650786|FG001|STARTED|Overall Study||364
2938955|NCT00627926|3650787|FG002|STARTED|Overall Study||363
2938956|NCT00627926|3650785|FG000|COMPLETED|Overall Study||202
2938957|NCT00627926|3650786|FG001|COMPLETED|Overall Study||260
2938958|NCT00627926|3650787|FG002|COMPLETED|Overall Study||268
2938959|NCT00627926|3650785|FG000|NOT COMPLETED|Overall Study||159
2938960|NCT00627926|3650786|FG001|NOT COMPLETED|Overall Study||104
2938961|NCT00627926|3650787|FG002|NOT COMPLETED|Overall Study||95
2938962|NCT00627978|3650797|FG000|STARTED|Overall Study||10
2938963|NCT00627978|3650798|FG001|STARTED|Overall Study||5
2938964|NCT00627978|3650797|FG000|COMPLETED|Overall Study||10
2938965|NCT00627978|3650798|FG001|COMPLETED|Overall Study||5
2938966|NCT00627978|3650797|FG000|NOT COMPLETED|Overall Study||0
2938967|NCT00627978|3650798|FG001|NOT COMPLETED|Overall Study||0
2938968|NCT00628030|3650806|FG000|STARTED|Baseline to Post-Assessment||92
2938969|NCT00628030|3650807|FG001|STARTED|Baseline to Post-Assessment||92
2938970|NCT00628030|3650806|FG000|COMPLETED|Baseline to Post-Assessment||59
2938971|NCT00628030|3650807|FG001|COMPLETED|Baseline to Post-Assessment||63
2938972|NCT00628030|3650806|FG000|NOT COMPLETED|Baseline to Post-Assessment||33
2938973|NCT00628030|3650807|FG001|NOT COMPLETED|Baseline to Post-Assessment||29
2938974|NCT00628030|3650806|FG000|STARTED|Post to 6 Month Follow-up||59
3276649|NCT02701296|4010400|FG001|STARTED|Overall Study||38
3276650|NCT02701296|4010399|FG000|COMPLETED|Overall Study||42
3276651|NCT02701296|4010400|FG001|COMPLETED|Overall Study|Data was incomplete for two participants their data was not included in the overall data analysis.|36
3276652|NCT02701296|4010399|FG000|NOT COMPLETED|Overall Study||0
3276653|NCT02701296|4010400|FG001|NOT COMPLETED|Overall Study||2
3276654|NCT02701361|4010409|FG000|STARTED|Overall Study||31
2938975|NCT00628030|3650807|FG001|STARTED|Post to 6 Month Follow-up||63
2938976|NCT00628030|3650806|FG000|COMPLETED|Post to 6 Month Follow-up||27
2938977|NCT00628030|3650807|FG001|COMPLETED|Post to 6 Month Follow-up||33
2938978|NCT00628030|3650806|FG000|NOT COMPLETED|Post to 6 Month Follow-up||32
2938979|NCT00628030|3650807|FG001|NOT COMPLETED|Post to 6 Month Follow-up||30
2938980|NCT00628108|3650815|FG000|STARTED|Overall Study||23
2938981|NCT00628108|3650816|FG001|STARTED|Overall Study|One subject was randomized to levocetirizine but received placebo.|46
2938982|NCT00628108|3650815|FG000|Safety Population|Overall Study||24
2938983|NCT00628108|3650816|FG001|Safety Population|Overall Study|Subjects in the Safety Population were analyzed as treated.|45
2938984|NCT00628108|3650815|FG000|COMPLETED|Overall Study||22
2938985|NCT00628108|3650816|FG001|COMPLETED|Overall Study||43
2938986|NCT00628108|3650815|FG000|NOT COMPLETED|Overall Study||1
2938987|NCT00628108|3650816|FG001|NOT COMPLETED|Overall Study||3
2938988|NCT00628134|3650822|FG000|STARTED|Overall Study||4
2938989|NCT00628134|3650823|FG001|STARTED|Overall Study||4
2938990|NCT00628134|3650822|FG000|COMPLETED|Overall Study||4
2938991|NCT00628134|3650823|FG001|COMPLETED|Overall Study||4
2938992|NCT00628134|3650822|FG000|NOT COMPLETED|Overall Study||0
2938993|NCT00628134|3650823|FG001|NOT COMPLETED|Overall Study||0
2938994|NCT00628147|3650831|FG000|STARTED|Overall Study||142
2938995|NCT00628147|3650832|FG001|STARTED|Overall Study||142
2938996|NCT00628147|3650831|FG000|COMPLETED|Overall Study||135
2938997|NCT00628147|3650832|FG001|COMPLETED|Overall Study||141
2938998|NCT00628147|3650831|FG000|NOT COMPLETED|Overall Study||7
2938999|NCT00628147|3650832|FG001|NOT COMPLETED|Overall Study||1
2939000|NCT00628212|3650842|FG000|STARTED|Overall Study||80
2939001|NCT00628212|3650843|FG001|STARTED|Overall Study||84
2939002|NCT00628212|3650844|FG002|STARTED|Overall Study||79
2939003|NCT00628212|3650845|FG003|STARTED|Overall Study||81
2939004|NCT00628212|3650842|FG000|COMPLETED|Overall Study||77
2939005|NCT00628212|3650843|FG001|COMPLETED|Overall Study||83
2939006|NCT00628212|3650844|FG002|COMPLETED|Overall Study||76
2939007|NCT00628212|3650845|FG003|COMPLETED|Overall Study||76
2939008|NCT00628212|3650842|FG000|NOT COMPLETED|Overall Study||3
2939009|NCT00628212|3650843|FG001|NOT COMPLETED|Overall Study||1
2939010|NCT00628212|3650844|FG002|NOT COMPLETED|Overall Study||3
2939011|NCT00628212|3650845|FG003|NOT COMPLETED|Overall Study||5
2939012|NCT00628251|3650858|FG000|STARTED|Randomised Part|Patients randomised|32
2939013|NCT00628251|3650859|FG001|STARTED|Randomised Part|Patients randomised|32
2939014|NCT00628251|3650860|FG002|STARTED|Randomised Part|Patients randomised|33
2939015|NCT00628251|3650858|FG000|COMPLETED|Randomised Part|Patients who received olaparib treatment|32
2939016|NCT00628251|3650859|FG001|COMPLETED|Randomised Part|Patients who received olaparib treatment|32
2939017|NCT00628251|3650860|FG002|COMPLETED|Randomised Part|1 of 33 patients did not receive Liposomal Doxorubicin. Patient voluntarily discontinued|32
2939018|NCT00628251|3650858|FG000|NOT COMPLETED|Randomised Part||0
2939019|NCT00628251|3650859|FG001|NOT COMPLETED|Randomised Part||0
2939020|NCT00628251|3650860|FG002|NOT COMPLETED|Randomised Part||1
2939021|NCT00628251|3650858|FG000|STARTED|Ongoing Initial Study Treatment at DCO|Patients who received treatment|32
2939022|NCT00628251|3650859|FG001|STARTED|Ongoing Initial Study Treatment at DCO|Patients who received treatment|32
2939023|NCT00628251|3650860|FG002|STARTED|Ongoing Initial Study Treatment at DCO|Patients who received Liposomal doxorubicin 50 mg/m2|32
2939024|NCT00628251|3650858|FG000|Discontinued Initial Study Treatment|Ongoing Initial Study Treatment at DCO||22
2939025|NCT00628251|3650859|FG001|Discontinued Initial Study Treatment|Ongoing Initial Study Treatment at DCO||20
3276655|NCT02701361|4010410|FG001|STARTED|Overall Study||31
2939026|NCT00628251|3650860|FG002|Discontinued Initial Study Treatment|Ongoing Initial Study Treatment at DCO||25
2939027|NCT00628251|3650858|FG000|Crossover to Olaparib|Ongoing Initial Study Treatment at DCO||0
2939028|NCT00628251|3650859|FG001|Crossover to Olaparib|Ongoing Initial Study Treatment at DCO||0
2939029|NCT00628251|3650860|FG002|Crossover to Olaparib|Ongoing Initial Study Treatment at DCO|Crossover dosage was 400 mg bd Olaparib|14
2939030|NCT00628251|3650858|FG000|Ongoing Crossover at DCO|Ongoing Initial Study Treatment at DCO||0
3034473|NCT01132807|3753535|FG002|NOT COMPLETED|Post-Cycle 2 PET Assessment||0
2939031|NCT00628251|3650859|FG001|Ongoing Crossover at DCO|Ongoing Initial Study Treatment at DCO||0
2939032|NCT00628251|3650860|FG002|Ongoing Crossover at DCO|Ongoing Initial Study Treatment at DCO||5
2939033|NCT00628251|3650858|FG000|Discontinued Crossover|Ongoing Initial Study Treatment at DCO||0
2939034|NCT00628251|3650859|FG001|Discontinued Crossover|Ongoing Initial Study Treatment at DCO||0
2939035|NCT00628251|3650860|FG002|Discontinued Crossover|Ongoing Initial Study Treatment at DCO||9
2939036|NCT00628251|3650858|FG000|COMPLETED|Ongoing Initial Study Treatment at DCO|Ongoing initial study treatment at primary data cut-off|10
2939037|NCT00628251|3650859|FG001|COMPLETED|Ongoing Initial Study Treatment at DCO|Ongoing initial study treatment at primary data cut-off|12
2939038|NCT00628251|3650860|FG002|COMPLETED|Ongoing Initial Study Treatment at DCO|Patients ongoing initial study treatment (Liposomal doxorubicin)|7
2939039|NCT00628251|3650858|FG000|NOT COMPLETED|Ongoing Initial Study Treatment at DCO||22
2939040|NCT00628251|3650859|FG001|NOT COMPLETED|Ongoing Initial Study Treatment at DCO||20
2939041|NCT00628251|3650860|FG002|NOT COMPLETED|Ongoing Initial Study Treatment at DCO||25
2939042|NCT00628355|3650872|FG000|STARTED|Overall Study||15
2939043|NCT00628355|3650873|FG001|STARTED|Overall Study||15
2939044|NCT00628355|3650872|FG000|COMPLETED|Overall Study||14
2939045|NCT00628355|3650873|FG001|COMPLETED|Overall Study||14
2939046|NCT00628355|3650872|FG000|NOT COMPLETED|Overall Study||1
2939047|NCT00628355|3650873|FG001|NOT COMPLETED|Overall Study||1
2939048|NCT00628394|3650884|FG000|STARTED|Overall Study||14
3276656|NCT02701361|4010411|FG002|STARTED|Overall Study||18
3276657|NCT02701361|4010409|FG000|COMPLETED|Overall Study||22
3276658|NCT02701361|4010410|FG001|COMPLETED|Overall Study||28
3276659|NCT02701361|4010411|FG002|COMPLETED|Overall Study||16
3276660|NCT02701361|4010409|FG000|NOT COMPLETED|Overall Study||9
3276661|NCT02701361|4010410|FG001|NOT COMPLETED|Overall Study||3
3276662|NCT02701361|4010411|FG002|NOT COMPLETED|Overall Study||2
3276663|NCT02701387|4010421|FG000|STARTED|Overall Study||7
3276664|NCT02701387|4010421|FG000|COMPLETED|Overall Study||7
3276665|NCT02701387|4010421|FG000|NOT COMPLETED|Overall Study||0
3276666|NCT02701400|4010428|FG000|STARTED|Overall Study||9
3276667|NCT02701400|4010429|FG001|STARTED|Overall Study||9
3276668|NCT02701400|4010428|FG000|COMPLETED|Overall Study||9
3276669|NCT02701400|4010429|FG001|COMPLETED|Overall Study||9
3276670|NCT02701400|4010428|FG000|NOT COMPLETED|Overall Study||0
3276671|NCT02701400|4010429|FG001|NOT COMPLETED|Overall Study||0
3276672|NCT02701413|4010438|FG000|STARTED|Overall Study||33
3276673|NCT02701413|4010439|FG001|STARTED|Overall Study||33
3276674|NCT02701413|4010438|FG000|COMPLETED|Overall Study||26
3276675|NCT02701413|4010439|FG001|COMPLETED|Overall Study||22
3276676|NCT02701413|4010438|FG000|NOT COMPLETED|Overall Study||7
3276677|NCT02701413|4010439|FG001|NOT COMPLETED|Overall Study||11
3276678|NCT02701582|4010447|FG000|STARTED|Overall Study||35
3276679|NCT02701582|4010448|FG001|STARTED|Overall Study||33
3276680|NCT02701582|4010447|FG000|COMPLETED|Overall Study||33
3276681|NCT02701582|4010448|FG001|COMPLETED|Overall Study||33
3276682|NCT02701582|4010447|FG000|NOT COMPLETED|Overall Study||2
3276683|NCT02701582|4010448|FG001|NOT COMPLETED|Overall Study||0
3276684|NCT02701634|4010458|FG000|STARTED|Overall Study||33
3276685|NCT02701634|4010459|FG001|STARTED|Overall Study||33
3276686|NCT02701634|4010458|FG000|COMPLETED|Overall Study||1
3276687|NCT02701634|4010459|FG001|COMPLETED|Overall Study||2
3276688|NCT02701634|4010458|FG000|NOT COMPLETED|Overall Study||32
3276689|NCT02701634|4010459|FG001|NOT COMPLETED|Overall Study||31
3276690|NCT02701647|4010469|FG000|STARTED|Overall Study||17
3276691|NCT02701647|4010470|FG001|STARTED|Overall Study||17
3276692|NCT02701647|4010471|FG002|STARTED|Overall Study||17
3276693|NCT02701647|4010469|FG000|COMPLETED|Overall Study||17
3276694|NCT02701647|4010470|FG001|COMPLETED|Overall Study||17
3276695|NCT02701647|4010471|FG002|COMPLETED|Overall Study|One participant from sham-TT withdraw due a back injury unrelated to study.|16
3276696|NCT02701647|4010469|FG000|NOT COMPLETED|Overall Study||0
3276697|NCT02701647|4010470|FG001|NOT COMPLETED|Overall Study||0
3276698|NCT02701647|4010471|FG002|NOT COMPLETED|Overall Study||1
3276699|NCT02701764|4010487|FG000|STARTED|Overall Study||21
3276700|NCT02701764|4010488|FG001|STARTED|Overall Study||22
3276701|NCT02701764|4010487|FG000|COMPLETED|Overall Study||21
3276702|NCT02701764|4010488|FG001|COMPLETED|Overall Study||21
3276703|NCT02701764|4010487|FG000|NOT COMPLETED|Overall Study||0
3276704|NCT02701764|4010488|FG001|NOT COMPLETED|Overall Study||1
3276705|NCT02701868|4010497|FG000|STARTED|Overall Study||21
3276706|NCT02701868|4010498|FG001|STARTED|Overall Study||75
3276707|NCT02701868|4010499|FG002|STARTED|Overall Study||75
3276708|NCT02701868|4010497|FG000|COMPLETED|Overall Study||21
3276709|NCT02701868|4010498|FG001|COMPLETED|Overall Study||75
3276710|NCT02701868|4010499|FG002|COMPLETED|Overall Study||75
3276711|NCT02701868|4010497|FG000|NOT COMPLETED|Overall Study||0
3276712|NCT02701868|4010498|FG001|NOT COMPLETED|Overall Study||0
3276713|NCT02701868|4010499|FG002|NOT COMPLETED|Overall Study||0
3276714|NCT02701985|4010510|FG000|STARTED|Overall Study||37
3276715|NCT02701985|4010511|FG001|STARTED|Overall Study||38
3276716|NCT02701985|4010510|FG000|COMPLETED|Overall Study||34
3276717|NCT02701985|4010511|FG001|COMPLETED|Overall Study||32
3276718|NCT02701985|4010510|FG000|NOT COMPLETED|Overall Study||3
3276719|NCT02701985|4010511|FG001|NOT COMPLETED|Overall Study||6
3276720|NCT02702011|4010522|FG000|STARTED|Overall Study|Started are the treated patients.|11
3276721|NCT02702011|4010523|FG001|STARTED|Overall Study|Started are the treated patients.|13
3276722|NCT02702011|4010524|FG002|STARTED|Overall Study|Started are the treated patients.|12
2939049|NCT00628394|3650885|FG001|STARTED|Overall Study||13
2939050|NCT00628394|3650886|FG002|STARTED|Overall Study||13
2939051|NCT00628394|3650887|FG003|STARTED|Overall Study||13
2939052|NCT00628394|3650884|FG000|COMPLETED|Overall Study||10
2939053|NCT00628394|3650885|FG001|COMPLETED|Overall Study||9
2939054|NCT00628394|3650886|FG002|COMPLETED|Overall Study||11
2939055|NCT00628394|3650887|FG003|COMPLETED|Overall Study||10
2939056|NCT00628394|3650884|FG000|NOT COMPLETED|Overall Study||4
2939057|NCT00628394|3650885|FG001|NOT COMPLETED|Overall Study||4
2939058|NCT00628394|3650886|FG002|NOT COMPLETED|Overall Study||2
2939059|NCT00628394|3650887|FG003|NOT COMPLETED|Overall Study||3
2939060|NCT00628407|3650897|FG000|STARTED|Overall Study||13
2939061|NCT00628407|3650897|FG000|COMPLETED|Overall Study||13
2939062|NCT00628407|3650897|FG000|NOT COMPLETED|Overall Study||0
2939063|NCT00628446|3650901|FG000|STARTED|Overall Study||45
2939064|NCT00628446|3650901|FG000|COMPLETED|Overall Study||38
2939065|NCT00628446|3650901|FG000|NOT COMPLETED|Overall Study||7
2939066|NCT00628498|3650906|FG000|STARTED|Overall Study||1206
2939067|NCT00628498|3650906|FG000|COMPLETED|Overall Study||1154
2939068|NCT00628498|3650906|FG000|NOT COMPLETED|Overall Study||52
2939069|NCT00628589|3650913|FG000|STARTED|Overall Study||115
2939070|NCT00628589|3650914|FG001|STARTED|Overall Study||116
2939071|NCT00628589|3650915|FG002|STARTED|Overall Study||113
2939072|NCT00628589|3650913|FG000|COMPLETED|Overall Study||114
2939073|NCT00628589|3650914|FG001|COMPLETED|Overall Study||114
2939074|NCT00628589|3650915|FG002|COMPLETED|Overall Study||110
2939075|NCT00628589|3650913|FG000|NOT COMPLETED|Overall Study||1
2939076|NCT00628589|3650914|FG001|NOT COMPLETED|Overall Study||2
2939077|NCT00628589|3650915|FG002|NOT COMPLETED|Overall Study||3
2939078|NCT00628628|3650925|FG000|STARTED|Overall Study||40
2939079|NCT00628628|3650926|FG001|STARTED|Overall Study||40
2939080|NCT00628628|3650925|FG000|COMPLETED|Overall Study||40
3276723|NCT02702011|4010525|FG003|STARTED|Overall Study|Started are the treated patients.|12
3276724|NCT02702011|4010522|FG000|COMPLETED|Overall Study||11
3276725|NCT02702011|4010523|FG001|COMPLETED|Overall Study||12
3276726|NCT02702011|4010524|FG002|COMPLETED|Overall Study||12
3276727|NCT02702011|4010525|FG003|COMPLETED|Overall Study||12
3276728|NCT02702011|4010522|FG000|NOT COMPLETED|Overall Study||0
3276729|NCT02702011|4010523|FG001|NOT COMPLETED|Overall Study||1
3276730|NCT02702011|4010524|FG002|NOT COMPLETED|Overall Study||0
3276731|NCT02702011|4010525|FG003|NOT COMPLETED|Overall Study||0
3276732|NCT02702193|4010537|FG000|STARTED|Baseline Assessment/Randomization||86
3276733|NCT02702193|4010538|FG001|STARTED|Baseline Assessment/Randomization||87
3276734|NCT02702193|4010537|FG000|COMPLETED|Baseline Assessment/Randomization||85
3276735|NCT02702193|4010538|FG001|COMPLETED|Baseline Assessment/Randomization||87
3276736|NCT02702193|4010537|FG000|NOT COMPLETED|Baseline Assessment/Randomization||1
3276737|NCT02702193|4010538|FG001|NOT COMPLETED|Baseline Assessment/Randomization||0
3276738|NCT02702193|4010537|FG000|STARTED|4 Month Follow up||86
3276739|NCT02702193|4010538|FG001|STARTED|4 Month Follow up||87
3276740|NCT02702193|4010537|FG000|COMPLETED|4 Month Follow up||68
3276741|NCT02702193|4010538|FG001|COMPLETED|4 Month Follow up||69
3276742|NCT02702193|4010537|FG000|NOT COMPLETED|4 Month Follow up||18
3276743|NCT02702193|4010538|FG001|NOT COMPLETED|4 Month Follow up||18
3276744|NCT02702193|4010537|FG000|STARTED|8 Month Follow up||86
3276745|NCT02702193|4010538|FG001|STARTED|8 Month Follow up||87
3276746|NCT02702193|4010537|FG000|COMPLETED|8 Month Follow up||71
3276747|NCT02702193|4010538|FG001|COMPLETED|8 Month Follow up||69
3276748|NCT02702193|4010537|FG000|NOT COMPLETED|8 Month Follow up||15
3276749|NCT02702193|4010538|FG001|NOT COMPLETED|8 Month Follow up||18
3276750|NCT02702193|4010537|FG000|STARTED|12 Month Follow up||86
3276751|NCT02702193|4010538|FG001|STARTED|12 Month Follow up||87
3276752|NCT02702193|4010537|FG000|COMPLETED|12 Month Follow up||69
3276753|NCT02702193|4010538|FG001|COMPLETED|12 Month Follow up||69
3276754|NCT02702193|4010537|FG000|NOT COMPLETED|12 Month Follow up||17
3276755|NCT02702193|4010538|FG001|NOT COMPLETED|12 Month Follow up||18
3276756|NCT02702388|4010546|FG000|STARTED|Overall Study||75
3276757|NCT02702388|4010547|FG001|STARTED|Overall Study||77
3276758|NCT02702388|4010546|FG000|COMPLETED|Overall Study||35
3276759|NCT02702388|4010547|FG001|COMPLETED|Overall Study||26
3276760|NCT02702388|4010546|FG000|NOT COMPLETED|Overall Study||40
3276761|NCT02702388|4010547|FG001|NOT COMPLETED|Overall Study||51
3276762|NCT02702401|4010564|FG000|STARTED|Overall Study||278
3276763|NCT02702401|4010565|FG001|STARTED|Overall Study||135
3276764|NCT02702401|4010564|FG000|Treated|Overall Study||278
3276765|NCT02702401|4010565|FG001|Treated|Overall Study||135
3276766|NCT02702401|4010564|FG000|COMPLETED|Overall Study||0
3276767|NCT02702401|4010565|FG001|COMPLETED|Overall Study||0
3276768|NCT02702401|4010564|FG000|NOT COMPLETED|Overall Study||278
3276769|NCT02702401|4010565|FG001|NOT COMPLETED|Overall Study||135
3276770|NCT02702518|4010573|FG000|STARTED|Overall Study||29
3276771|NCT02702518|4010574|FG001|STARTED|Overall Study||29
3276772|NCT02702518|4010573|FG000|COMPLETED|Overall Study||26
2939081|NCT00628628|3650926|FG001|COMPLETED|Overall Study||40
2939082|NCT00628628|3650925|FG000|NOT COMPLETED|Overall Study||0
2939083|NCT00628628|3650926|FG001|NOT COMPLETED|Overall Study||0
2939084|NCT00628758|3650934|FG000|STARTED|Overall Study||209
2939085|NCT00628758|3650935|FG001|STARTED|Overall Study||221
2939086|NCT00628758|3650934|FG000|COMPLETED|Overall Study||165
2939087|NCT00628758|3650935|FG001|COMPLETED|Overall Study||179
2939088|NCT00628758|3650934|FG000|NOT COMPLETED|Overall Study||44
2939089|NCT00628758|3650935|FG001|NOT COMPLETED|Overall Study||42
2939090|NCT00628862|3650946|FG000|STARTED|Overall Study|randomised patients|206
2939091|NCT00628862|3650947|FG001|STARTED|Overall Study|randomised patients|199
2939092|NCT00628862|3650948|FG002|STARTED|Overall Study|randomised patients|208
3276773|NCT02702518|4010574|FG001|COMPLETED|Overall Study||25
3276774|NCT02702518|4010573|FG000|NOT COMPLETED|Overall Study||3
3276775|NCT02702518|4010574|FG001|NOT COMPLETED|Overall Study||4
2939093|NCT00628862|3650946|FG000|COMPLETED|Overall Study|randomised patients|195
2939094|NCT00628862|3650947|FG001|COMPLETED|Overall Study|randomised patients|182
2939095|NCT00628862|3650948|FG002|COMPLETED|Overall Study|randomised patients|186
2939096|NCT00628862|3650946|FG000|NOT COMPLETED|Overall Study||11
2939097|NCT00628862|3650947|FG001|NOT COMPLETED|Overall Study||17
2939098|NCT00628862|3650948|FG002|NOT COMPLETED|Overall Study||22
2939099|NCT00628901|3650958|FG000|STARTED|Overall Study||30
2939100|NCT00628901|3650959|FG001|STARTED|Overall Study||30
2939101|NCT00628901|3650958|FG000|COMPLETED|Overall Study||27
2939102|NCT00628901|3650959|FG001|COMPLETED|Overall Study||29
2939103|NCT00628901|3650958|FG000|NOT COMPLETED|Overall Study||3
2939104|NCT00628901|3650959|FG001|NOT COMPLETED|Overall Study||1
2939105|NCT00628927|3650967|FG000|STARTED|Overall Study||183
2939106|NCT00628927|3650968|FG001|STARTED|Overall Study||30
2939107|NCT00628927|3650967|FG000|COMPLETED|Overall Study||175
2939108|NCT00628927|3650968|FG001|COMPLETED|Overall Study||30
2939109|NCT00628927|3650967|FG000|NOT COMPLETED|Overall Study||8
2939110|NCT00628927|3650968|FG001|NOT COMPLETED|Overall Study||0
2939111|NCT00629018|3650981|FG000|STARTED|Overall Study||55
2939112|NCT00629018|3650982|FG001|STARTED|Overall Study||55
2939113|NCT00629018|3650981|FG000|COMPLETED|Overall Study||55
2939114|NCT00629018|3650982|FG001|COMPLETED|Overall Study||55
2939115|NCT00629018|3650981|FG000|NOT COMPLETED|Overall Study||0
2939116|NCT00629018|3650982|FG001|NOT COMPLETED|Overall Study||0
2939117|NCT00629083|3650990|FG000|STARTED|Overall Study||228
2939118|NCT00629083|3650991|FG001|STARTED|Overall Study||117
2939119|NCT00629083|3650990|FG000|COMPLETED|Overall Study||200
2939120|NCT00629083|3650991|FG001|COMPLETED|Overall Study||103
2939121|NCT00629083|3650990|FG000|NOT COMPLETED|Overall Study||28
2939122|NCT00629083|3650991|FG001|NOT COMPLETED|Overall Study||14
2939123|NCT00629122|3651001|FG000|STARTED|First Period: Day 1- 3 (Sublingual)||2
2939124|NCT00629122|3651002|FG001|STARTED|First Period: Day 1- 3 (Sublingual)||3
2939125|NCT00629122|3651001|FG000|COMPLETED|First Period: Day 1- 3 (Sublingual)||2
2939126|NCT00629122|3651002|FG001|COMPLETED|First Period: Day 1- 3 (Sublingual)||3
2939127|NCT00629122|3651001|FG000|NOT COMPLETED|First Period: Day 1- 3 (Sublingual)||0
2939128|NCT00629122|3651002|FG001|NOT COMPLETED|First Period: Day 1- 3 (Sublingual)||0
2939129|NCT00629122|3651001|FG000|STARTED|Second Period: Day 3-5 (Washout)||2
2939130|NCT00629122|3651002|FG001|STARTED|Second Period: Day 3-5 (Washout)||3
2939131|NCT00629122|3651001|FG000|COMPLETED|Second Period: Day 3-5 (Washout)||2
2939132|NCT00629122|3651002|FG001|COMPLETED|Second Period: Day 3-5 (Washout)||3
2939133|NCT00629122|3651001|FG000|NOT COMPLETED|Second Period: Day 3-5 (Washout)||0
2939134|NCT00629122|3651002|FG001|NOT COMPLETED|Second Period: Day 3-5 (Washout)||0
2939135|NCT00629122|3651001|FG000|STARTED|Third Period: Day 6-8 (Oral)||2
2939136|NCT00629122|3651002|FG001|STARTED|Third Period: Day 6-8 (Oral)||3
2939137|NCT00629122|3651001|FG000|COMPLETED|Third Period: Day 6-8 (Oral)||2
2939138|NCT00629122|3651002|FG001|COMPLETED|Third Period: Day 6-8 (Oral)||3
2939139|NCT00629122|3651001|FG000|NOT COMPLETED|Third Period: Day 6-8 (Oral)||0
2939140|NCT00629122|3651002|FG001|NOT COMPLETED|Third Period: Day 6-8 (Oral)||0
2939141|NCT00629239|3651010|FG000|STARTED|Overall Study||34
2939142|NCT00629239|3651011|FG001|STARTED|Overall Study||32
2939143|NCT00629239|3651010|FG000|COMPLETED|Overall Study||26
2939144|NCT00629239|3651011|FG001|COMPLETED|Overall Study||28
2939145|NCT00629239|3651010|FG000|NOT COMPLETED|Overall Study||8
2939146|NCT00629239|3651011|FG001|NOT COMPLETED|Overall Study||4
2939147|NCT00629265|3651019|FG000|STARTED|Overall Study||116
2939148|NCT00629265|3651020|FG001|STARTED|Overall Study||54
2939149|NCT00629265|3651019|FG000|COMPLETED|Overall Study||84
2939150|NCT00629265|3651020|FG001|COMPLETED|Overall Study||34
2939151|NCT00629265|3651019|FG000|NOT COMPLETED|Overall Study||32
2939152|NCT00629265|3651020|FG001|NOT COMPLETED|Overall Study||20
2939153|NCT00629499|3651026|FG000|STARTED|Overall Study||63
2939154|NCT00629499|3651026|FG000|COMPLETED|Overall Study||63
2939155|NCT00629499|3651026|FG000|NOT COMPLETED|Overall Study||0
2939156|NCT00629525|3651030|FG000|STARTED|Overall Study||35
2939157|NCT00629525|3651030|FG000|COMPLETED|Overall Study||32
2939158|NCT00629525|3651030|FG000|NOT COMPLETED|Overall Study||3
2939159|NCT00629707|3651036|FG000|STARTED|Overall Study||10
2939160|NCT00629707|3651037|FG001|STARTED|Overall Study||10
2939161|NCT00629707|3651036|FG000|COMPLETED|Overall Study||10
2939162|NCT00629707|3651037|FG001|COMPLETED|Overall Study||8
2939163|NCT00629707|3651036|FG000|NOT COMPLETED|Overall Study||0
2939164|NCT00629707|3651037|FG001|NOT COMPLETED|Overall Study||2
2939165|NCT00629772|3651045|FG000|STARTED|First Intervention - Day 0 - Week 14||12
2939166|NCT00629772|3651046|FG001|STARTED|First Intervention - Day 0 - Week 14||12
2939167|NCT00629772|3651045|FG000|COMPLETED|First Intervention - Day 0 - Week 14||12
2939168|NCT00629772|3651046|FG001|COMPLETED|First Intervention - Day 0 - Week 14||12
2939169|NCT00629772|3651045|FG000|NOT COMPLETED|First Intervention - Day 0 - Week 14||0
2939170|NCT00629772|3651046|FG001|NOT COMPLETED|First Intervention - Day 0 - Week 14||0
2939171|NCT00629772|3651045|FG000|STARTED|Second Intervention Week 14 - Week 26|Patient withdrew at Week 14 and therefore never received infliximab.|12
2939172|NCT00629772|3651046|FG001|STARTED|Second Intervention Week 14 - Week 26||12
2939173|NCT00629772|3651045|FG000|COMPLETED|Second Intervention Week 14 - Week 26||11
2939174|NCT00629772|3651046|FG001|COMPLETED|Second Intervention Week 14 - Week 26||10
2939175|NCT00629772|3651045|FG000|NOT COMPLETED|Second Intervention Week 14 - Week 26||1
2939176|NCT00629772|3651046|FG001|NOT COMPLETED|Second Intervention Week 14 - Week 26||2
2939177|NCT00630032|3651055|FG000|STARTED|Overall Study||398
2939178|NCT00630032|3651056|FG001|STARTED|Overall Study||364
2939179|NCT00630032|3651055|FG000|COMPLETED|Overall Study||308
2939180|NCT00630032|3651056|FG001|COMPLETED|Overall Study||269
2939181|NCT00630032|3651055|FG000|NOT COMPLETED|Overall Study||90
3276776|NCT02702609|4010582|FG000|STARTED|Overall Study||24
3276777|NCT02702609|4010583|FG001|STARTED|Overall Study||21
3276778|NCT02702609|4010582|FG000|Implant Placement|Overall Study||23
3276779|NCT02702609|4010583|FG001|Implant Placement|Overall Study||21
3276780|NCT02702609|4010582|FG000|Crown Delivery|Overall Study||16
3276781|NCT02702609|4010583|FG001|Crown Delivery|Overall Study||18
3276782|NCT02702609|4010582|FG000|COMPLETED|Overall Study||15
3276783|NCT02702609|4010583|FG001|COMPLETED|Overall Study||17
3276784|NCT02702609|4010582|FG000|NOT COMPLETED|Overall Study||9
3276785|NCT02702609|4010583|FG001|NOT COMPLETED|Overall Study||4
3276786|NCT02702921|4010591|FG000|STARTED|Overall Study||98
3276787|NCT02702921|4010592|FG001|STARTED|Overall Study||103
3276788|NCT02702921|4010591|FG000|COMPLETED|Overall Study||84
3276789|NCT02702921|4010592|FG001|COMPLETED|Overall Study||95
3276790|NCT02702921|4010591|FG000|NOT COMPLETED|Overall Study||14
3276791|NCT02702921|4010592|FG001|NOT COMPLETED|Overall Study||8
3276792|NCT02702999|4010600|FG000|STARTED|Overall Study||102
3276793|NCT02702999|4010601|FG001|STARTED|Overall Study||104
3276794|NCT02702999|4010600|FG000|COMPLETED|Overall Study||102
3276795|NCT02702999|4010601|FG001|COMPLETED|Overall Study||104
3276796|NCT02702999|4010600|FG000|NOT COMPLETED|Overall Study||0
3276797|NCT02702999|4010601|FG001|NOT COMPLETED|Overall Study||0
3276798|NCT02703259|4010609|FG000|STARTED|24 Hours Postoperative Assessment||70
3276799|NCT02703259|4010610|FG001|STARTED|24 Hours Postoperative Assessment||67
3276800|NCT02703259|4010609|FG000|COMPLETED|24 Hours Postoperative Assessment||68
3276801|NCT02703259|4010610|FG001|COMPLETED|24 Hours Postoperative Assessment||61
3276802|NCT02703259|4010609|FG000|NOT COMPLETED|24 Hours Postoperative Assessment||2
3276803|NCT02703259|4010610|FG001|NOT COMPLETED|24 Hours Postoperative Assessment||6
3276804|NCT02703259|4010609|FG000|STARTED|2 Weeks Postoperative Assessment||68
3276805|NCT02703259|4010610|FG001|STARTED|2 Weeks Postoperative Assessment||61
3276806|NCT02703259|4010609|FG000|COMPLETED|2 Weeks Postoperative Assessment||58
3276807|NCT02703259|4010610|FG001|COMPLETED|2 Weeks Postoperative Assessment||51
3276808|NCT02703259|4010609|FG000|NOT COMPLETED|2 Weeks Postoperative Assessment||10
3276809|NCT02703259|4010610|FG001|NOT COMPLETED|2 Weeks Postoperative Assessment||10
3276810|NCT02703311|4010616|FG000|STARTED|Overall Study||11
3276811|NCT02703311|4010616|FG000|Implanted|Overall Study||11
3276812|NCT02703311|4010616|FG000|30 Day Follow-Up Completed|Overall Study||9
3276813|NCT02703311|4010616|FG000|COMPLETED|Overall Study||3
3276814|NCT02703311|4010616|FG000|NOT COMPLETED|Overall Study||8
3276815|NCT02703324|4010620|FG000|STARTED|Period One||5
3276816|NCT02703324|4010621|FG001|STARTED|Period One||5
3276817|NCT02703324|4010622|FG002|STARTED|Period One||5
3276818|NCT02703324|4010623|FG003|STARTED|Period One||5
3276819|NCT02703324|4010624|FG004|STARTED|Period One||5
3276820|NCT02703324|4010625|FG005|STARTED|Period One||5
3276821|NCT02703324|4010620|FG000|Received Study Drug|Period One||5
3276822|NCT02703324|4010621|FG001|Received Study Drug|Period One||5
3276823|NCT02703324|4010622|FG002|Received Study Drug|Period One||5
3276824|NCT02703324|4010623|FG003|Received Study Drug|Period One||5
3276825|NCT02703324|4010624|FG004|Received Study Drug|Period One||5
3276826|NCT02703324|4010625|FG005|Received Study Drug|Period One||5
3276827|NCT02703324|4010620|FG000|COMPLETED|Period One||5
3276828|NCT02703324|4010621|FG001|COMPLETED|Period One||5
3276829|NCT02703324|4010622|FG002|COMPLETED|Period One||5
3276830|NCT02703324|4010623|FG003|COMPLETED|Period One||5
3276831|NCT02703324|4010624|FG004|COMPLETED|Period One||5
3276832|NCT02703324|4010625|FG005|COMPLETED|Period One||5
3276833|NCT02703324|4010620|FG000|NOT COMPLETED|Period One||0
3276834|NCT02703324|4010621|FG001|NOT COMPLETED|Period One||0
3276835|NCT02703324|4010622|FG002|NOT COMPLETED|Period One||0
3276836|NCT02703324|4010623|FG003|NOT COMPLETED|Period One||0
3276837|NCT02703324|4010624|FG004|NOT COMPLETED|Period One||0
3276838|NCT02703324|4010625|FG005|NOT COMPLETED|Period One||0
3276839|NCT02703324|4010620|FG000|STARTED|Period Two||5
3276840|NCT02703324|4010621|FG001|STARTED|Period Two||5
3276841|NCT02703324|4010622|FG002|STARTED|Period Two||5
3276842|NCT02703324|4010623|FG003|STARTED|Period Two||5
3276843|NCT02703324|4010624|FG004|STARTED|Period Two||5
3276844|NCT02703324|4010625|FG005|STARTED|Period Two||5
3276845|NCT02703324|4010620|FG000|Received Study Drug|Period Two||5
3276846|NCT02703324|4010621|FG001|Received Study Drug|Period Two||5
3276847|NCT02703324|4010622|FG002|Received Study Drug|Period Two||5
3276848|NCT02703324|4010623|FG003|Received Study Drug|Period Two||5
3276849|NCT02703324|4010624|FG004|Received Study Drug|Period Two||5
3276850|NCT02703324|4010625|FG005|Received Study Drug|Period Two||5
3276851|NCT02703324|4010620|FG000|COMPLETED|Period Two||5
3276852|NCT02703324|4010621|FG001|COMPLETED|Period Two||5
3276853|NCT02703324|4010622|FG002|COMPLETED|Period Two||4
3276854|NCT02703324|4010623|FG003|COMPLETED|Period Two||5
2939182|NCT00630032|3651056|FG001|NOT COMPLETED|Overall Study||95
2939183|NCT00630058|3651064|FG000|STARTED|Overall Study||10
3276855|NCT02703324|4010624|FG004|COMPLETED|Period Two||5
3276856|NCT02703324|4010625|FG005|COMPLETED|Period Two||5
3276857|NCT02703324|4010620|FG000|NOT COMPLETED|Period Two||0
3276858|NCT02703324|4010621|FG001|NOT COMPLETED|Period Two||0
3276859|NCT02703324|4010622|FG002|NOT COMPLETED|Period Two||1
3276860|NCT02703324|4010623|FG003|NOT COMPLETED|Period Two||0
3276861|NCT02703324|4010624|FG004|NOT COMPLETED|Period Two||0
3276862|NCT02703324|4010625|FG005|NOT COMPLETED|Period Two||0
3276863|NCT02703324|4010620|FG000|STARTED|Period Three||5
3276864|NCT02703324|4010621|FG001|STARTED|Period Three||5
3276865|NCT02703324|4010622|FG002|STARTED|Period Three||4
3276866|NCT02703324|4010623|FG003|STARTED|Period Three||5
3276867|NCT02703324|4010624|FG004|STARTED|Period Three||5
3276868|NCT02703324|4010625|FG005|STARTED|Period Three||5
3276869|NCT02703324|4010620|FG000|Received Study Drug|Period Three||5
3276870|NCT02703324|4010621|FG001|Received Study Drug|Period Three||5
3276871|NCT02703324|4010622|FG002|Received Study Drug|Period Three||4
3276872|NCT02703324|4010623|FG003|Received Study Drug|Period Three||5
3276873|NCT02703324|4010624|FG004|Received Study Drug|Period Three||5
3276874|NCT02703324|4010625|FG005|Received Study Drug|Period Three||5
3276875|NCT02703324|4010620|FG000|COMPLETED|Period Three||5
3276876|NCT02703324|4010621|FG001|COMPLETED|Period Three|One participant discontinued after Period 3. Did not enter Period 4.|5
3276877|NCT02703324|4010622|FG002|COMPLETED|Period Three||4
3276878|NCT02703324|4010623|FG003|COMPLETED|Period Three||5
3276879|NCT02703324|4010624|FG004|COMPLETED|Period Three||5
3276880|NCT02703324|4010625|FG005|COMPLETED|Period Three||5
3276881|NCT02703324|4010620|FG000|NOT COMPLETED|Period Three||0
3276882|NCT02703324|4010621|FG001|NOT COMPLETED|Period Three||0
3276883|NCT02703324|4010622|FG002|NOT COMPLETED|Period Three||0
3276884|NCT02703324|4010623|FG003|NOT COMPLETED|Period Three||0
3276885|NCT02703324|4010624|FG004|NOT COMPLETED|Period Three||0
3276886|NCT02703324|4010625|FG005|NOT COMPLETED|Period Three||0
3276887|NCT02703324|4010620|FG000|STARTED|Period Four||5
3276888|NCT02703324|4010621|FG001|STARTED|Period Four|One participant discontinued after Period 3. Did not enter Period 4.|4
3276889|NCT02703324|4010622|FG002|STARTED|Period Four||4
3276890|NCT02703324|4010623|FG003|STARTED|Period Four||5
3276891|NCT02703324|4010624|FG004|STARTED|Period Four||5
3276892|NCT02703324|4010625|FG005|STARTED|Period Four||5
3276893|NCT02703324|4010620|FG000|Received Study Drug|Period Four||5
3276894|NCT02703324|4010621|FG001|Received Study Drug|Period Four||4
3276895|NCT02703324|4010622|FG002|Received Study Drug|Period Four||4
3276896|NCT02703324|4010623|FG003|Received Study Drug|Period Four||5
3276897|NCT02703324|4010624|FG004|Received Study Drug|Period Four||5
3276898|NCT02703324|4010625|FG005|Received Study Drug|Period Four||5
3276899|NCT02703324|4010620|FG000|COMPLETED|Period Four||5
3276900|NCT02703324|4010621|FG001|COMPLETED|Period Four||4
3276901|NCT02703324|4010622|FG002|COMPLETED|Period Four||4
3276902|NCT02703324|4010623|FG003|COMPLETED|Period Four||5
3276903|NCT02703324|4010624|FG004|COMPLETED|Period Four||5
3276904|NCT02703324|4010625|FG005|COMPLETED|Period Four||5
3276905|NCT02703324|4010620|FG000|NOT COMPLETED|Period Four||0
3276906|NCT02703324|4010621|FG001|NOT COMPLETED|Period Four||0
3276907|NCT02703324|4010622|FG002|NOT COMPLETED|Period Four||0
3276908|NCT02703324|4010623|FG003|NOT COMPLETED|Period Four||0
3276909|NCT02703324|4010624|FG004|NOT COMPLETED|Period Four||0
3276910|NCT02703324|4010625|FG005|NOT COMPLETED|Period Four||0
3276911|NCT02703337|4010634|FG000|STARTED|Period One (Part A)||5
3276912|NCT02703337|4010635|FG001|STARTED|Period One (Part A)||5
3276913|NCT02703337|4010636|FG002|STARTED|Period One (Part A)||5
3276914|NCT02703337|4010637|FG003|STARTED|Period One (Part A)||5
3276915|NCT02703337|4010638|FG004|STARTED|Period One (Part A)||5
3276916|NCT02703337|4010639|FG005|STARTED|Period One (Part A)||5
3276917|NCT02703337|4010640|FG006|STARTED|Period One (Part A)||0
3276918|NCT02703337|4010641|FG007|STARTED|Period One (Part A)||0
3276919|NCT02703337|4010634|FG000|Received Study Drug|Period One (Part A)||5
3276920|NCT02703337|4010635|FG001|Received Study Drug|Period One (Part A)||5
3276921|NCT02703337|4010636|FG002|Received Study Drug|Period One (Part A)||5
3276922|NCT02703337|4010637|FG003|Received Study Drug|Period One (Part A)||5
3276923|NCT02703337|4010638|FG004|Received Study Drug|Period One (Part A)||5
3276924|NCT02703337|4010639|FG005|Received Study Drug|Period One (Part A)||5
3276925|NCT02703337|4010640|FG006|Received Study Drug|Period One (Part A)||0
3276926|NCT02703337|4010641|FG007|Received Study Drug|Period One (Part A)||0
3276927|NCT02703337|4010634|FG000|COMPLETED|Period One (Part A)||5
3276928|NCT02703337|4010635|FG001|COMPLETED|Period One (Part A)||5
3276929|NCT02703337|4010636|FG002|COMPLETED|Period One (Part A)||5
3276930|NCT02703337|4010637|FG003|COMPLETED|Period One (Part A)||5
3276931|NCT02703337|4010638|FG004|COMPLETED|Period One (Part A)||4
3276932|NCT02703337|4010639|FG005|COMPLETED|Period One (Part A)||5
3276933|NCT02703337|4010640|FG006|COMPLETED|Period One (Part A)||0
3276934|NCT02703337|4010641|FG007|COMPLETED|Period One (Part A)||0
3276935|NCT02703337|4010634|FG000|NOT COMPLETED|Period One (Part A)||0
3276936|NCT02703337|4010635|FG001|NOT COMPLETED|Period One (Part A)||0
3276937|NCT02703337|4010636|FG002|NOT COMPLETED|Period One (Part A)||0
3276938|NCT02703337|4010637|FG003|NOT COMPLETED|Period One (Part A)||0
3276939|NCT02703337|4010638|FG004|NOT COMPLETED|Period One (Part A)||1
3276940|NCT02703337|4010639|FG005|NOT COMPLETED|Period One (Part A)||0
3276941|NCT02703337|4010640|FG006|NOT COMPLETED|Period One (Part A)||0
3276942|NCT02703337|4010641|FG007|NOT COMPLETED|Period One (Part A)||0
3276943|NCT02703337|4010634|FG000|STARTED|Period Two (Part A)||5
3276944|NCT02703337|4010635|FG001|STARTED|Period Two (Part A)||5
3276945|NCT02703337|4010636|FG002|STARTED|Period Two (Part A)||5
2939184|NCT00630058|3651065|FG001|STARTED|Overall Study||10
2939185|NCT00630058|3651064|FG000|COMPLETED|Overall Study||6
2939186|NCT00630058|3651065|FG001|COMPLETED|Overall Study||6
2939187|NCT00630058|3651064|FG000|NOT COMPLETED|Overall Study||4
2939188|NCT00630058|3651065|FG001|NOT COMPLETED|Overall Study||4
2939189|NCT00630253|3651074|FG000|STARTED|Overall Study||16
2939190|NCT00630253|3651075|FG001|STARTED|Overall Study||9
2939191|NCT00630253|3651076|FG002|STARTED|Overall Study||6
2939192|NCT00630253|3651074|FG000|COMPLETED|Overall Study||16
2939193|NCT00630253|3651075|FG001|COMPLETED|Overall Study||9
2939194|NCT00630253|3651076|FG002|COMPLETED|Overall Study||6
2939195|NCT00630253|3651074|FG000|NOT COMPLETED|Overall Study||0
2939196|NCT00630253|3651075|FG001|NOT COMPLETED|Overall Study||0
2939197|NCT00630253|3651076|FG002|NOT COMPLETED|Overall Study||0
2939198|NCT00630305|3651084|FG000|STARTED|Overall Study||37
2939199|NCT00630305|3651084|FG000|COMPLETED|Overall Study||35
2939200|NCT00630305|3651084|FG000|NOT COMPLETED|Overall Study||2
2939201|NCT00630331|3651100|FG000|STARTED|Overall Study||3828
2939202|NCT00630331|3651101|FG001|STARTED|Overall Study||3676
2939203|NCT00630331|3651102|FG002|STARTED|Overall Study||3900
3160405|NCT01863433|3887525|FG000|NOT COMPLETED|Overall Study||1
3160406|NCT01863498|3887531|FG000|STARTED|Overall Study||33
3160407|NCT01863498|3887532|FG001|STARTED|Overall Study||32
3160408|NCT01863498|3887531|FG000|COMPLETED|Overall Study||33
3160409|NCT01863498|3887532|FG001|COMPLETED|Overall Study||32
3160410|NCT01863498|3887531|FG000|NOT COMPLETED|Overall Study||0
3276946|NCT02703337|4010637|FG003|STARTED|Period Two (Part A)||5
3276947|NCT02703337|4010638|FG004|STARTED|Period Two (Part A)||4
3276948|NCT02703337|4010639|FG005|STARTED|Period Two (Part A)||5
3276949|NCT02703337|4010640|FG006|STARTED|Period Two (Part A)||0
3276950|NCT02703337|4010641|FG007|STARTED|Period Two (Part A)||0
3276951|NCT02703337|4010634|FG000|Received Study Drug|Period Two (Part A)||5
3276952|NCT02703337|4010635|FG001|Received Study Drug|Period Two (Part A)||5
3276953|NCT02703337|4010636|FG002|Received Study Drug|Period Two (Part A)||5
3276954|NCT02703337|4010637|FG003|Received Study Drug|Period Two (Part A)||5
3276955|NCT02703337|4010638|FG004|Received Study Drug|Period Two (Part A)||4
3276956|NCT02703337|4010639|FG005|Received Study Drug|Period Two (Part A)||5
3276957|NCT02703337|4010640|FG006|Received Study Drug|Period Two (Part A)||0
3276958|NCT02703337|4010641|FG007|Received Study Drug|Period Two (Part A)||0
3276959|NCT02703337|4010634|FG000|COMPLETED|Period Two (Part A)||5
3276960|NCT02703337|4010635|FG001|COMPLETED|Period Two (Part A)||5
3276961|NCT02703337|4010636|FG002|COMPLETED|Period Two (Part A)||5
3276962|NCT02703337|4010637|FG003|COMPLETED|Period Two (Part A)||5
3276963|NCT02703337|4010638|FG004|COMPLETED|Period Two (Part A)||4
3276964|NCT02703337|4010639|FG005|COMPLETED|Period Two (Part A)||5
3276965|NCT02703337|4010640|FG006|COMPLETED|Period Two (Part A)||0
3276966|NCT02703337|4010641|FG007|COMPLETED|Period Two (Part A)||0
3276967|NCT02703337|4010634|FG000|NOT COMPLETED|Period Two (Part A)||0
3276968|NCT02703337|4010635|FG001|NOT COMPLETED|Period Two (Part A)||0
3276969|NCT02703337|4010636|FG002|NOT COMPLETED|Period Two (Part A)||0
3276970|NCT02703337|4010637|FG003|NOT COMPLETED|Period Two (Part A)||0
3276971|NCT02703337|4010638|FG004|NOT COMPLETED|Period Two (Part A)||0
3276972|NCT02703337|4010639|FG005|NOT COMPLETED|Period Two (Part A)||0
3276973|NCT02703337|4010640|FG006|NOT COMPLETED|Period Two (Part A)||0
3276974|NCT02703337|4010641|FG007|NOT COMPLETED|Period Two (Part A)||0
3276975|NCT02703337|4010634|FG000|STARTED|Period Three (Part A)||5
3276976|NCT02703337|4010635|FG001|STARTED|Period Three (Part A)||5
3276977|NCT02703337|4010636|FG002|STARTED|Period Three (Part A)||5
3276978|NCT02703337|4010637|FG003|STARTED|Period Three (Part A)||5
3276979|NCT02703337|4010638|FG004|STARTED|Period Three (Part A)||4
3276980|NCT02703337|4010639|FG005|STARTED|Period Three (Part A)||5
3276981|NCT02703337|4010640|FG006|STARTED|Period Three (Part A)||0
3276982|NCT02703337|4010641|FG007|STARTED|Period Three (Part A)||0
3276983|NCT02703337|4010634|FG000|Received Study Drug|Period Three (Part A)||5
3276984|NCT02703337|4010635|FG001|Received Study Drug|Period Three (Part A)||5
3276985|NCT02703337|4010636|FG002|Received Study Drug|Period Three (Part A)||5
3276986|NCT02703337|4010637|FG003|Received Study Drug|Period Three (Part A)||5
3276987|NCT02703337|4010638|FG004|Received Study Drug|Period Three (Part A)||4
3276988|NCT02703337|4010639|FG005|Received Study Drug|Period Three (Part A)||5
3276989|NCT02703337|4010640|FG006|Received Study Drug|Period Three (Part A)||0
3276990|NCT02703337|4010641|FG007|Received Study Drug|Period Three (Part A)||0
3276991|NCT02703337|4010634|FG000|COMPLETED|Period Three (Part A)||5
3276992|NCT02703337|4010635|FG001|COMPLETED|Period Three (Part A)||5
3276993|NCT02703337|4010636|FG002|COMPLETED|Period Three (Part A)||5
3276994|NCT02703337|4010637|FG003|COMPLETED|Period Three (Part A)||5
3276995|NCT02703337|4010638|FG004|COMPLETED|Period Three (Part A)||4
3276996|NCT02703337|4010639|FG005|COMPLETED|Period Three (Part A)||5
3276997|NCT02703337|4010640|FG006|COMPLETED|Period Three (Part A)||0
2939204|NCT00630331|3651100|FG000|COMPLETED|Overall Study||3622
2939205|NCT00630331|3651101|FG001|COMPLETED|Overall Study||3510
2939206|NCT00630331|3651102|FG002|COMPLETED|Overall Study||3712
2939207|NCT00630331|3651100|FG000|NOT COMPLETED|Overall Study||206
2939208|NCT00630331|3651101|FG001|NOT COMPLETED|Overall Study||166
2939209|NCT00630331|3651102|FG002|NOT COMPLETED|Overall Study||188
2939210|NCT00630344|3651110|FG000|STARTED|Overall Study||36
2939211|NCT00630344|3651110|FG000|COMPLETED|Overall Study||0
2939212|NCT00630344|3651110|FG000|NOT COMPLETED|Overall Study||36
2939213|NCT00630396|3651115|FG000|STARTED|Overall Study||60
2939214|NCT00630396|3651115|FG000|COMPLETED|Overall Study||53
2939215|NCT00630396|3651115|FG000|NOT COMPLETED|Overall Study||7
2939216|NCT00630409|3651119|FG000|STARTED|Overall Study||5
3276998|NCT02703337|4010641|FG007|COMPLETED|Period Three (Part A)||0
3276999|NCT02703337|4010634|FG000|NOT COMPLETED|Period Three (Part A)||0
3277000|NCT02703337|4010635|FG001|NOT COMPLETED|Period Three (Part A)||0
3277001|NCT02703337|4010636|FG002|NOT COMPLETED|Period Three (Part A)||0
3277002|NCT02703337|4010637|FG003|NOT COMPLETED|Period Three (Part A)||0
3277003|NCT02703337|4010638|FG004|NOT COMPLETED|Period Three (Part A)||0
3277004|NCT02703337|4010639|FG005|NOT COMPLETED|Period Three (Part A)||0
3277005|NCT02703337|4010640|FG006|NOT COMPLETED|Period Three (Part A)||0
3277006|NCT02703337|4010641|FG007|NOT COMPLETED|Period Three (Part A)||0
3277007|NCT02703337|4010634|FG000|STARTED|Period Four (Part A)||5
3277008|NCT02703337|4010635|FG001|STARTED|Period Four (Part A)||5
3277009|NCT02703337|4010636|FG002|STARTED|Period Four (Part A)||5
3277010|NCT02703337|4010637|FG003|STARTED|Period Four (Part A)||5
3277011|NCT02703337|4010638|FG004|STARTED|Period Four (Part A)||4
3277012|NCT02703337|4010639|FG005|STARTED|Period Four (Part A)||5
3277013|NCT02703337|4010640|FG006|STARTED|Period Four (Part A)||0
3277014|NCT02703337|4010641|FG007|STARTED|Period Four (Part A)||0
3277015|NCT02703337|4010634|FG000|Received Study Drug|Period Four (Part A)||5
3277016|NCT02703337|4010635|FG001|Received Study Drug|Period Four (Part A)||5
3277017|NCT02703337|4010636|FG002|Received Study Drug|Period Four (Part A)||5
3277018|NCT02703337|4010637|FG003|Received Study Drug|Period Four (Part A)||5
3277019|NCT02703337|4010638|FG004|Received Study Drug|Period Four (Part A)||4
3277020|NCT02703337|4010639|FG005|Received Study Drug|Period Four (Part A)||5
3277021|NCT02703337|4010640|FG006|Received Study Drug|Period Four (Part A)||0
3277022|NCT02703337|4010641|FG007|Received Study Drug|Period Four (Part A)||0
3277023|NCT02703337|4010634|FG000|COMPLETED|Period Four (Part A)||5
3277024|NCT02703337|4010635|FG001|COMPLETED|Period Four (Part A)||5
3277025|NCT02703337|4010636|FG002|COMPLETED|Period Four (Part A)||5
3277026|NCT02703337|4010637|FG003|COMPLETED|Period Four (Part A)||5
3277027|NCT02703337|4010638|FG004|COMPLETED|Period Four (Part A)||4
3277028|NCT02703337|4010639|FG005|COMPLETED|Period Four (Part A)||5
3277029|NCT02703337|4010640|FG006|COMPLETED|Period Four (Part A)||0
3277030|NCT02703337|4010641|FG007|COMPLETED|Period Four (Part A)||0
3277031|NCT02703337|4010634|FG000|NOT COMPLETED|Period Four (Part A)||0
3277032|NCT02703337|4010635|FG001|NOT COMPLETED|Period Four (Part A)||0
3277033|NCT02703337|4010636|FG002|NOT COMPLETED|Period Four (Part A)||0
3277034|NCT02703337|4010637|FG003|NOT COMPLETED|Period Four (Part A)||0
3277035|NCT02703337|4010638|FG004|NOT COMPLETED|Period Four (Part A)||0
3277036|NCT02703337|4010639|FG005|NOT COMPLETED|Period Four (Part A)||0
3277037|NCT02703337|4010640|FG006|NOT COMPLETED|Period Four (Part A)||0
3277038|NCT02703337|4010641|FG007|NOT COMPLETED|Period Four (Part A)||0
3277039|NCT02703337|4010634|FG000|STARTED|Period Five (Part A)||5
3277040|NCT02703337|4010635|FG001|STARTED|Period Five (Part A)||5
3277041|NCT02703337|4010636|FG002|STARTED|Period Five (Part A)||5
3277042|NCT02703337|4010637|FG003|STARTED|Period Five (Part A)||5
3277043|NCT02703337|4010638|FG004|STARTED|Period Five (Part A)||4
3277044|NCT02703337|4010639|FG005|STARTED|Period Five (Part A)||5
3277045|NCT02703337|4010640|FG006|STARTED|Period Five (Part A)||0
3277046|NCT02703337|4010641|FG007|STARTED|Period Five (Part A)||0
3277047|NCT02703337|4010634|FG000|Received Study Drug|Period Five (Part A)||5
3277048|NCT02703337|4010635|FG001|Received Study Drug|Period Five (Part A)||5
3277049|NCT02703337|4010636|FG002|Received Study Drug|Period Five (Part A)||5
3277050|NCT02703337|4010637|FG003|Received Study Drug|Period Five (Part A)||5
3277051|NCT02703337|4010638|FG004|Received Study Drug|Period Five (Part A)||4
3277052|NCT02703337|4010639|FG005|Received Study Drug|Period Five (Part A)||5
3277053|NCT02703337|4010640|FG006|Received Study Drug|Period Five (Part A)||0
3277054|NCT02703337|4010641|FG007|Received Study Drug|Period Five (Part A)||0
3277055|NCT02703337|4010634|FG000|COMPLETED|Period Five (Part A)||5
3277056|NCT02703337|4010635|FG001|COMPLETED|Period Five (Part A)||5
3277057|NCT02703337|4010636|FG002|COMPLETED|Period Five (Part A)||5
3277058|NCT02703337|4010637|FG003|COMPLETED|Period Five (Part A)||5
3277059|NCT02703337|4010638|FG004|COMPLETED|Period Five (Part A)||4
3277060|NCT02703337|4010639|FG005|COMPLETED|Period Five (Part A)||5
3277061|NCT02703337|4010640|FG006|COMPLETED|Period Five (Part A)||0
3277062|NCT02703337|4010641|FG007|COMPLETED|Period Five (Part A)||0
3277063|NCT02703337|4010634|FG000|NOT COMPLETED|Period Five (Part A)||0
3277064|NCT02703337|4010635|FG001|NOT COMPLETED|Period Five (Part A)||0
3277065|NCT02703337|4010636|FG002|NOT COMPLETED|Period Five (Part A)||0
3277066|NCT02703337|4010637|FG003|NOT COMPLETED|Period Five (Part A)||0
3277067|NCT02703337|4010638|FG004|NOT COMPLETED|Period Five (Part A)||0
3277068|NCT02703337|4010639|FG005|NOT COMPLETED|Period Five (Part A)||0
3277069|NCT02703337|4010640|FG006|NOT COMPLETED|Period Five (Part A)||0
3277070|NCT02703337|4010641|FG007|NOT COMPLETED|Period Five (Part A)||0
3277071|NCT02703337|4010634|FG000|STARTED|Period Six (Part A)||5
3277072|NCT02703337|4010635|FG001|STARTED|Period Six (Part A)||5
3277073|NCT02703337|4010636|FG002|STARTED|Period Six (Part A)||5
3277074|NCT02703337|4010637|FG003|STARTED|Period Six (Part A)||5
3277075|NCT02703337|4010638|FG004|STARTED|Period Six (Part A)||4
3277076|NCT02703337|4010639|FG005|STARTED|Period Six (Part A)||5
3277077|NCT02703337|4010640|FG006|STARTED|Period Six (Part A)||0
2939217|NCT00630409|3651119|FG000|COMPLETED|Overall Study||4
2939218|NCT00630409|3651119|FG000|NOT COMPLETED|Overall Study||1
3277078|NCT02703337|4010641|FG007|STARTED|Period Six (Part A)||0
3277079|NCT02703337|4010634|FG000|Received Study Drug|Period Six (Part A)||5
3277080|NCT02703337|4010635|FG001|Received Study Drug|Period Six (Part A)||5
3277081|NCT02703337|4010636|FG002|Received Study Drug|Period Six (Part A)||5
3277082|NCT02703337|4010637|FG003|Received Study Drug|Period Six (Part A)||5
3277083|NCT02703337|4010638|FG004|Received Study Drug|Period Six (Part A)||4
3277084|NCT02703337|4010639|FG005|Received Study Drug|Period Six (Part A)||5
3277085|NCT02703337|4010640|FG006|Received Study Drug|Period Six (Part A)||0
3277086|NCT02703337|4010641|FG007|Received Study Drug|Period Six (Part A)||0
3277087|NCT02703337|4010634|FG000|COMPLETED|Period Six (Part A)||5
3277088|NCT02703337|4010635|FG001|COMPLETED|Period Six (Part A)||5
3277089|NCT02703337|4010636|FG002|COMPLETED|Period Six (Part A)||5
3277090|NCT02703337|4010637|FG003|COMPLETED|Period Six (Part A)||5
3277091|NCT02703337|4010638|FG004|COMPLETED|Period Six (Part A)||4
3277092|NCT02703337|4010639|FG005|COMPLETED|Period Six (Part A)||5
3277093|NCT02703337|4010640|FG006|COMPLETED|Period Six (Part A)||0
3277094|NCT02703337|4010641|FG007|COMPLETED|Period Six (Part A)||0
3277095|NCT02703337|4010634|FG000|NOT COMPLETED|Period Six (Part A)||0
3277096|NCT02703337|4010635|FG001|NOT COMPLETED|Period Six (Part A)||0
3277097|NCT02703337|4010636|FG002|NOT COMPLETED|Period Six (Part A)||0
3277098|NCT02703337|4010637|FG003|NOT COMPLETED|Period Six (Part A)||0
3277099|NCT02703337|4010638|FG004|NOT COMPLETED|Period Six (Part A)||0
3277100|NCT02703337|4010639|FG005|NOT COMPLETED|Period Six (Part A)||0
3277101|NCT02703337|4010640|FG006|NOT COMPLETED|Period Six (Part A)||0
3277102|NCT02703337|4010641|FG007|NOT COMPLETED|Period Six (Part A)||0
3277103|NCT02703337|4010634|FG000|STARTED|Part B||0
3277104|NCT02703337|4010635|FG001|STARTED|Part B||0
3277105|NCT02703337|4010636|FG002|STARTED|Part B||0
3277106|NCT02703337|4010637|FG003|STARTED|Part B||0
3277107|NCT02703337|4010638|FG004|STARTED|Part B||0
3277108|NCT02703337|4010639|FG005|STARTED|Part B||0
3277109|NCT02703337|4010640|FG006|STARTED|Part B||15
3277110|NCT02703337|4010641|FG007|STARTED|Part B||14
3277111|NCT02703337|4010634|FG000|Received Study Drug|Part B||0
3277112|NCT02703337|4010635|FG001|Received Study Drug|Part B||0
3277113|NCT02703337|4010636|FG002|Received Study Drug|Part B||0
3277114|NCT02703337|4010637|FG003|Received Study Drug|Part B||0
3277115|NCT02703337|4010638|FG004|Received Study Drug|Part B||0
3277116|NCT02703337|4010639|FG005|Received Study Drug|Part B||0
3277117|NCT02703337|4010640|FG006|Received Study Drug|Part B||15
3277118|NCT02703337|4010641|FG007|Received Study Drug|Part B||14
3277119|NCT02703337|4010634|FG000|COMPLETED|Part B||0
3277120|NCT02703337|4010635|FG001|COMPLETED|Part B||0
3277121|NCT02703337|4010636|FG002|COMPLETED|Part B||0
3277122|NCT02703337|4010637|FG003|COMPLETED|Part B||0
3277123|NCT02703337|4010638|FG004|COMPLETED|Part B||0
3277124|NCT02703337|4010639|FG005|COMPLETED|Part B||0
3277125|NCT02703337|4010640|FG006|COMPLETED|Part B||15
3277126|NCT02703337|4010641|FG007|COMPLETED|Part B||14
3277127|NCT02703337|4010634|FG000|NOT COMPLETED|Part B||0
3277128|NCT02703337|4010635|FG001|NOT COMPLETED|Part B||0
3277129|NCT02703337|4010636|FG002|NOT COMPLETED|Part B||0
3277130|NCT02703337|4010637|FG003|NOT COMPLETED|Part B||0
3277131|NCT02703337|4010638|FG004|NOT COMPLETED|Part B||0
3277132|NCT02703337|4010639|FG005|NOT COMPLETED|Part B||0
3277133|NCT02703337|4010640|FG006|NOT COMPLETED|Part B||0
3277134|NCT02703337|4010641|FG007|NOT COMPLETED|Part B||0
3277135|NCT02703350|4010659|FG000|STARTED|Period One (Part A)||5
3277136|NCT02703350|4010660|FG001|STARTED|Period One (Part A)||5
3277137|NCT02703350|4010661|FG002|STARTED|Period One (Part A)||5
3277138|NCT02703350|4010662|FG003|STARTED|Period One (Part A)||5
3277139|NCT02703350|4010663|FG004|STARTED|Period One (Part A)||5
3277140|NCT02703350|4010664|FG005|STARTED|Period One (Part A)||5
3277141|NCT02703350|4010665|FG006|STARTED|Period One (Part A)||0
3277142|NCT02703350|4010666|FG007|STARTED|Period One (Part A)||0
3277143|NCT02703350|4010659|FG000|Received Study Drug|Period One (Part A)||5
3277144|NCT02703350|4010660|FG001|Received Study Drug|Period One (Part A)||5
3277145|NCT02703350|4010661|FG002|Received Study Drug|Period One (Part A)||5
3277146|NCT02703350|4010662|FG003|Received Study Drug|Period One (Part A)||5
3277147|NCT02703350|4010663|FG004|Received Study Drug|Period One (Part A)||5
3277148|NCT02703350|4010664|FG005|Received Study Drug|Period One (Part A)||5
3277149|NCT02703350|4010665|FG006|Received Study Drug|Period One (Part A)||0
3277150|NCT02703350|4010666|FG007|Received Study Drug|Period One (Part A)||0
3277151|NCT02703350|4010659|FG000|COMPLETED|Period One (Part A)||5
3277152|NCT02703350|4010660|FG001|COMPLETED|Period One (Part A)||5
3277153|NCT02703350|4010661|FG002|COMPLETED|Period One (Part A)||5
3277154|NCT02703350|4010662|FG003|COMPLETED|Period One (Part A)||5
3277155|NCT02703350|4010663|FG004|COMPLETED|Period One (Part A)||5
3277156|NCT02703350|4010664|FG005|COMPLETED|Period One (Part A)||5
3277157|NCT02703350|4010665|FG006|COMPLETED|Period One (Part A)||0
3277158|NCT02703350|4010666|FG007|COMPLETED|Period One (Part A)||0
3277159|NCT02703350|4010659|FG000|NOT COMPLETED|Period One (Part A)||0
3277160|NCT02703350|4010660|FG001|NOT COMPLETED|Period One (Part A)||0
3277161|NCT02703350|4010661|FG002|NOT COMPLETED|Period One (Part A)||0
3277162|NCT02703350|4010662|FG003|NOT COMPLETED|Period One (Part A)||0
3277163|NCT02703350|4010663|FG004|NOT COMPLETED|Period One (Part A)||0
3277164|NCT02703350|4010664|FG005|NOT COMPLETED|Period One (Part A)||0
3277165|NCT02703350|4010665|FG006|NOT COMPLETED|Period One (Part A)||0
2939219|NCT00630539|3651128|FG000|STARTED|Overall Study||34
2939220|NCT00630539|3651129|FG001|STARTED|Overall Study||33
2939221|NCT00630539|3651130|FG002|STARTED|Overall Study||29
2939222|NCT00630539|3651131|FG003|STARTED|Overall Study||30
2939223|NCT00630539|3651128|FG000|COMPLETED|Overall Study||33
3160411|NCT01863498|3887532|FG001|NOT COMPLETED|Overall Study||0
3277166|NCT02703350|4010666|FG007|NOT COMPLETED|Period One (Part A)||0
3277167|NCT02703350|4010659|FG000|STARTED|Period Two (Part A)||5
3277168|NCT02703350|4010660|FG001|STARTED|Period Two (Part A)||5
3277169|NCT02703350|4010661|FG002|STARTED|Period Two (Part A)||5
3277170|NCT02703350|4010662|FG003|STARTED|Period Two (Part A)||5
3277171|NCT02703350|4010663|FG004|STARTED|Period Two (Part A)||5
3277172|NCT02703350|4010664|FG005|STARTED|Period Two (Part A)||5
3277173|NCT02703350|4010665|FG006|STARTED|Period Two (Part A)||0
3277174|NCT02703350|4010666|FG007|STARTED|Period Two (Part A)||0
3277175|NCT02703350|4010659|FG000|Received Study Drug|Period Two (Part A)||5
3277176|NCT02703350|4010660|FG001|Received Study Drug|Period Two (Part A)||5
3277177|NCT02703350|4010661|FG002|Received Study Drug|Period Two (Part A)||5
3277178|NCT02703350|4010662|FG003|Received Study Drug|Period Two (Part A)||5
3277179|NCT02703350|4010663|FG004|Received Study Drug|Period Two (Part A)||5
3277180|NCT02703350|4010664|FG005|Received Study Drug|Period Two (Part A)||5
3277181|NCT02703350|4010665|FG006|Received Study Drug|Period Two (Part A)||0
3277182|NCT02703350|4010666|FG007|Received Study Drug|Period Two (Part A)||0
3277183|NCT02703350|4010659|FG000|COMPLETED|Period Two (Part A)||5
3277184|NCT02703350|4010660|FG001|COMPLETED|Period Two (Part A)||5
3277185|NCT02703350|4010661|FG002|COMPLETED|Period Two (Part A)||5
3277186|NCT02703350|4010662|FG003|COMPLETED|Period Two (Part A)||5
3277187|NCT02703350|4010663|FG004|COMPLETED|Period Two (Part A)||5
3277188|NCT02703350|4010664|FG005|COMPLETED|Period Two (Part A)||5
3277189|NCT02703350|4010665|FG006|COMPLETED|Period Two (Part A)||0
3277190|NCT02703350|4010666|FG007|COMPLETED|Period Two (Part A)||0
3277191|NCT02703350|4010659|FG000|NOT COMPLETED|Period Two (Part A)||0
3277192|NCT02703350|4010660|FG001|NOT COMPLETED|Period Two (Part A)||0
3277193|NCT02703350|4010661|FG002|NOT COMPLETED|Period Two (Part A)||0
3277194|NCT02703350|4010662|FG003|NOT COMPLETED|Period Two (Part A)||0
3277195|NCT02703350|4010663|FG004|NOT COMPLETED|Period Two (Part A)||0
3277196|NCT02703350|4010664|FG005|NOT COMPLETED|Period Two (Part A)||0
3277197|NCT02703350|4010665|FG006|NOT COMPLETED|Period Two (Part A)||0
3277198|NCT02703350|4010666|FG007|NOT COMPLETED|Period Two (Part A)||0
3277199|NCT02703350|4010659|FG000|STARTED|Period Three (Part A)||5
3277200|NCT02703350|4010660|FG001|STARTED|Period Three (Part A)||5
3277201|NCT02703350|4010661|FG002|STARTED|Period Three (Part A)||5
3277202|NCT02703350|4010662|FG003|STARTED|Period Three (Part A)||5
3277203|NCT02703350|4010663|FG004|STARTED|Period Three (Part A)||5
3277204|NCT02703350|4010664|FG005|STARTED|Period Three (Part A)||5
3277205|NCT02703350|4010665|FG006|STARTED|Period Three (Part A)||0
3277206|NCT02703350|4010666|FG007|STARTED|Period Three (Part A)||0
3277207|NCT02703350|4010659|FG000|Received Study Drug|Period Three (Part A)||5
3277208|NCT02703350|4010660|FG001|Received Study Drug|Period Three (Part A)||5
3277209|NCT02703350|4010661|FG002|Received Study Drug|Period Three (Part A)||5
3277210|NCT02703350|4010662|FG003|Received Study Drug|Period Three (Part A)||5
3277211|NCT02703350|4010663|FG004|Received Study Drug|Period Three (Part A)||5
3277212|NCT02703350|4010664|FG005|Received Study Drug|Period Three (Part A)||5
3277213|NCT02703350|4010665|FG006|Received Study Drug|Period Three (Part A)||0
3277214|NCT02703350|4010666|FG007|Received Study Drug|Period Three (Part A)||0
3277215|NCT02703350|4010659|FG000|COMPLETED|Period Three (Part A)||5
3277216|NCT02703350|4010660|FG001|COMPLETED|Period Three (Part A)||5
3160412|NCT01863563|3887538|FG000|STARTED|Overall Study||100
3160413|NCT01863563|3887538|FG000|COMPLETED|Overall Study||100
3160414|NCT01863563|3887538|FG000|NOT COMPLETED|Overall Study||0
3160415|NCT01863667|3887544|FG000|STARTED|Overall Study||33
3277217|NCT02703350|4010661|FG002|COMPLETED|Period Three (Part A)||5
3277218|NCT02703350|4010662|FG003|COMPLETED|Period Three (Part A)||5
3277219|NCT02703350|4010663|FG004|COMPLETED|Period Three (Part A)||5
3277220|NCT02703350|4010664|FG005|COMPLETED|Period Three (Part A)||5
3277221|NCT02703350|4010665|FG006|COMPLETED|Period Three (Part A)||0
3277222|NCT02703350|4010666|FG007|COMPLETED|Period Three (Part A)||0
3277223|NCT02703350|4010659|FG000|NOT COMPLETED|Period Three (Part A)||0
3277224|NCT02703350|4010660|FG001|NOT COMPLETED|Period Three (Part A)||0
3277225|NCT02703350|4010661|FG002|NOT COMPLETED|Period Three (Part A)||0
3277226|NCT02703350|4010662|FG003|NOT COMPLETED|Period Three (Part A)||0
3277227|NCT02703350|4010663|FG004|NOT COMPLETED|Period Three (Part A)||0
3277228|NCT02703350|4010664|FG005|NOT COMPLETED|Period Three (Part A)||0
3277229|NCT02703350|4010665|FG006|NOT COMPLETED|Period Three (Part A)||0
3277230|NCT02703350|4010666|FG007|NOT COMPLETED|Period Three (Part A)||0
3277231|NCT02703350|4010659|FG000|STARTED|Period Four (Part A)||5
3277232|NCT02703350|4010660|FG001|STARTED|Period Four (Part A)||5
3277233|NCT02703350|4010661|FG002|STARTED|Period Four (Part A)||5
3277234|NCT02703350|4010662|FG003|STARTED|Period Four (Part A)||5
3277235|NCT02703350|4010663|FG004|STARTED|Period Four (Part A)||5
3277236|NCT02703350|4010664|FG005|STARTED|Period Four (Part A)||5
3277237|NCT02703350|4010665|FG006|STARTED|Period Four (Part A)||0
3277238|NCT02703350|4010666|FG007|STARTED|Period Four (Part A)||0
3277239|NCT02703350|4010659|FG000|Received Study Drug|Period Four (Part A)||5
3277240|NCT02703350|4010660|FG001|Received Study Drug|Period Four (Part A)||5
2939224|NCT00630539|3651129|FG001|COMPLETED|Overall Study||29
3160416|NCT01863667|3887545|FG001|STARTED|Overall Study||32
2939225|NCT00630539|3651130|FG002|COMPLETED|Overall Study||28
2939226|NCT00630539|3651131|FG003|COMPLETED|Overall Study||27
2939227|NCT00630539|3651128|FG000|NOT COMPLETED|Overall Study||1
2939228|NCT00630539|3651129|FG001|NOT COMPLETED|Overall Study||4
2939229|NCT00630539|3651130|FG002|NOT COMPLETED|Overall Study||1
2939230|NCT00630539|3651131|FG003|NOT COMPLETED|Overall Study||3
3160417|NCT01863667|3887544|FG000|COMPLETED|Overall Study||0
3160418|NCT01863667|3887545|FG001|COMPLETED|Overall Study||0
3277241|NCT02703350|4010661|FG002|Received Study Drug|Period Four (Part A)||5
3277242|NCT02703350|4010662|FG003|Received Study Drug|Period Four (Part A)||5
3277243|NCT02703350|4010663|FG004|Received Study Drug|Period Four (Part A)||5
3277244|NCT02703350|4010664|FG005|Received Study Drug|Period Four (Part A)||5
3277245|NCT02703350|4010665|FG006|Received Study Drug|Period Four (Part A)||0
3277246|NCT02703350|4010666|FG007|Received Study Drug|Period Four (Part A)||0
3277247|NCT02703350|4010659|FG000|COMPLETED|Period Four (Part A)||5
3277248|NCT02703350|4010660|FG001|COMPLETED|Period Four (Part A)||5
3277249|NCT02703350|4010661|FG002|COMPLETED|Period Four (Part A)||5
3277250|NCT02703350|4010662|FG003|COMPLETED|Period Four (Part A)||5
3277251|NCT02703350|4010663|FG004|COMPLETED|Period Four (Part A)||5
3277252|NCT02703350|4010664|FG005|COMPLETED|Period Four (Part A)||5
3277253|NCT02703350|4010665|FG006|COMPLETED|Period Four (Part A)||0
3277254|NCT02703350|4010666|FG007|COMPLETED|Period Four (Part A)||0
3277255|NCT02703350|4010659|FG000|NOT COMPLETED|Period Four (Part A)||0
3277256|NCT02703350|4010660|FG001|NOT COMPLETED|Period Four (Part A)||0
3277257|NCT02703350|4010661|FG002|NOT COMPLETED|Period Four (Part A)||0
3277258|NCT02703350|4010662|FG003|NOT COMPLETED|Period Four (Part A)||0
3277259|NCT02703350|4010663|FG004|NOT COMPLETED|Period Four (Part A)||0
3277260|NCT02703350|4010664|FG005|NOT COMPLETED|Period Four (Part A)||0
3277261|NCT02703350|4010665|FG006|NOT COMPLETED|Period Four (Part A)||0
3277262|NCT02703350|4010666|FG007|NOT COMPLETED|Period Four (Part A)||0
3277263|NCT02703350|4010659|FG000|STARTED|Period Five (Part A)||5
3277264|NCT02703350|4010660|FG001|STARTED|Period Five (Part A)||5
3277265|NCT02703350|4010661|FG002|STARTED|Period Five (Part A)||5
3277266|NCT02703350|4010662|FG003|STARTED|Period Five (Part A)||5
3277267|NCT02703350|4010663|FG004|STARTED|Period Five (Part A)||5
3277268|NCT02703350|4010664|FG005|STARTED|Period Five (Part A)||5
3277269|NCT02703350|4010665|FG006|STARTED|Period Five (Part A)||0
3277270|NCT02703350|4010666|FG007|STARTED|Period Five (Part A)||0
3277271|NCT02703350|4010659|FG000|Received Study Drug|Period Five (Part A)||5
3277272|NCT02703350|4010660|FG001|Received Study Drug|Period Five (Part A)||5
3277273|NCT02703350|4010661|FG002|Received Study Drug|Period Five (Part A)||5
3277274|NCT02703350|4010662|FG003|Received Study Drug|Period Five (Part A)||5
3277275|NCT02703350|4010663|FG004|Received Study Drug|Period Five (Part A)||5
3277276|NCT02703350|4010664|FG005|Received Study Drug|Period Five (Part A)||5
3277277|NCT02703350|4010665|FG006|Received Study Drug|Period Five (Part A)||0
3277278|NCT02703350|4010666|FG007|Received Study Drug|Period Five (Part A)||0
3277279|NCT02703350|4010659|FG000|COMPLETED|Period Five (Part A)||5
3277280|NCT02703350|4010660|FG001|COMPLETED|Period Five (Part A)||5
3277281|NCT02703350|4010661|FG002|COMPLETED|Period Five (Part A)||5
3277282|NCT02703350|4010662|FG003|COMPLETED|Period Five (Part A)||5
3277283|NCT02703350|4010663|FG004|COMPLETED|Period Five (Part A)||5
3277284|NCT02703350|4010664|FG005|COMPLETED|Period Five (Part A)||5
3277285|NCT02703350|4010665|FG006|COMPLETED|Period Five (Part A)||0
3277286|NCT02703350|4010666|FG007|COMPLETED|Period Five (Part A)||0
3277287|NCT02703350|4010659|FG000|NOT COMPLETED|Period Five (Part A)||0
3277288|NCT02703350|4010660|FG001|NOT COMPLETED|Period Five (Part A)||0
3277289|NCT02703350|4010661|FG002|NOT COMPLETED|Period Five (Part A)||0
3277290|NCT02703350|4010662|FG003|NOT COMPLETED|Period Five (Part A)||0
3277291|NCT02703350|4010663|FG004|NOT COMPLETED|Period Five (Part A)||0
3277292|NCT02703350|4010664|FG005|NOT COMPLETED|Period Five (Part A)||0
3277293|NCT02703350|4010665|FG006|NOT COMPLETED|Period Five (Part A)||0
3277294|NCT02703350|4010666|FG007|NOT COMPLETED|Period Five (Part A)||0
3277295|NCT02703350|4010659|FG000|STARTED|Period Six (Part A)||5
3277296|NCT02703350|4010660|FG001|STARTED|Period Six (Part A)||5
3277297|NCT02703350|4010661|FG002|STARTED|Period Six (Part A)||5
3277298|NCT02703350|4010662|FG003|STARTED|Period Six (Part A)||5
3277299|NCT02703350|4010663|FG004|STARTED|Period Six (Part A)||5
3277300|NCT02703350|4010664|FG005|STARTED|Period Six (Part A)||5
3277301|NCT02703350|4010665|FG006|STARTED|Period Six (Part A)||0
3277302|NCT02703350|4010666|FG007|STARTED|Period Six (Part A)||0
3277303|NCT02703350|4010659|FG000|Received Study Drug|Period Six (Part A)||5
3277304|NCT02703350|4010660|FG001|Received Study Drug|Period Six (Part A)||5
3277305|NCT02703350|4010661|FG002|Received Study Drug|Period Six (Part A)||5
3277306|NCT02703350|4010662|FG003|Received Study Drug|Period Six (Part A)||5
3277307|NCT02703350|4010663|FG004|Received Study Drug|Period Six (Part A)||5
3277308|NCT02703350|4010664|FG005|Received Study Drug|Period Six (Part A)||5
3277309|NCT02703350|4010665|FG006|Received Study Drug|Period Six (Part A)||0
3277310|NCT02703350|4010666|FG007|Received Study Drug|Period Six (Part A)||0
3277311|NCT02703350|4010659|FG000|COMPLETED|Period Six (Part A)||5
3277312|NCT02703350|4010660|FG001|COMPLETED|Period Six (Part A)||5
2939231|NCT00630734|3651151|FG000|STARTED|Overall Study||11
2939232|NCT00630734|3651152|FG001|STARTED|Overall Study||13
3160419|NCT01863667|3887544|FG000|NOT COMPLETED|Overall Study||33
3160420|NCT01863667|3887545|FG001|NOT COMPLETED|Overall Study||32
3277313|NCT02703350|4010661|FG002|COMPLETED|Period Six (Part A)||5
2939233|NCT00630734|3651153|FG002|STARTED|Overall Study||8
2939234|NCT00630734|3651151|FG000|COMPLETED|Overall Study||9
2939235|NCT00630734|3651152|FG001|COMPLETED|Overall Study||12
2939236|NCT00630734|3651153|FG002|COMPLETED|Overall Study||7
2939237|NCT00630734|3651151|FG000|NOT COMPLETED|Overall Study||2
2939238|NCT00630734|3651152|FG001|NOT COMPLETED|Overall Study||1
2939239|NCT00630734|3651153|FG002|NOT COMPLETED|Overall Study||1
2939240|NCT00630747|3651163|FG000|STARTED|Overall Study||94
2939241|NCT00630747|3651163|FG000|Participants Treated in Phase I of Study|Overall Study||94
2939242|NCT00630747|3651163|FG000|COMPLETED|Overall Study||85
2939243|NCT00630747|3651163|FG000|NOT COMPLETED|Overall Study||9
2939244|NCT00630786|3651170|FG000|STARTED|Overall Study|Includes 2 patients enrolled in Part 1 and 17 patients enrolled in Part 2.|19
2939245|NCT00630786|3651171|FG001|STARTED|Overall Study|Includes 3 patients enrolled in Part 1 and 22 patients enrolled in Part 2.|25
2939246|NCT00630786|3651172|FG002|STARTED|Overall Study|All patients were enrolled in Part 2.|9
2939247|NCT00630786|3651170|FG000|Received Study Medication|Overall Study||19
2939248|NCT00630786|3651171|FG001|Received Study Medication|Overall Study||25
2939249|NCT00630786|3651172|FG002|Received Study Medication|Overall Study||8
2939250|NCT00630786|3651170|FG000|COMPLETED|Overall Study|Completed study defined as participant death|18
2939251|NCT00630786|3651171|FG001|COMPLETED|Overall Study|Completed study defined as participant death|23
2939252|NCT00630786|3651172|FG002|COMPLETED|Overall Study|Completed study defined as participant death|7
2939253|NCT00630786|3651170|FG000|NOT COMPLETED|Overall Study||1
2939254|NCT00630786|3651171|FG001|NOT COMPLETED|Overall Study||2
2939255|NCT00630786|3651172|FG002|NOT COMPLETED|Overall Study||2
2939256|NCT00630812|3651180|FG000|STARTED|Randomisation to First Dose||192
2939257|NCT00630812|3651181|FG001|STARTED|Randomisation to First Dose||126
2939258|NCT00630812|3651180|FG000|COMPLETED|Randomisation to First Dose||184
2939259|NCT00630812|3651181|FG001|COMPLETED|Randomisation to First Dose||121
2939260|NCT00630812|3651180|FG000|NOT COMPLETED|Randomisation to First Dose||8
2939261|NCT00630812|3651181|FG001|NOT COMPLETED|Randomisation to First Dose||5
2939262|NCT00630812|3651180|FG000|STARTED|Double Blind Treatment Period||184
2939263|NCT00630812|3651181|FG001|STARTED|Double Blind Treatment Period||121
2939264|NCT00630812|3651180|FG000|COMPLETED|Double Blind Treatment Period||153
2939265|NCT00630812|3651181|FG001|COMPLETED|Double Blind Treatment Period||107
2939266|NCT00630812|3651180|FG000|NOT COMPLETED|Double Blind Treatment Period||31
2939267|NCT00630812|3651181|FG001|NOT COMPLETED|Double Blind Treatment Period||14
2939268|NCT00630825|3651191|FG000|STARTED|Overall Study||65
2939269|NCT00630825|3651192|FG001|STARTED|Overall Study||65
2939270|NCT00630825|3651193|FG002|STARTED|Overall Study||66
2939271|NCT00630825|3651194|FG003|STARTED|Overall Study||66
2939272|NCT00630825|3651191|FG000|Received at Least One Dose of Study Drug|Overall Study||65
2939273|NCT00630825|3651192|FG001|Received at Least One Dose of Study Drug|Overall Study||65
2939274|NCT00630825|3651193|FG002|Received at Least One Dose of Study Drug|Overall Study||66
2939275|NCT00630825|3651194|FG003|Received at Least One Dose of Study Drug|Overall Study||66
2939276|NCT00630825|3651191|FG000|COMPLETED|Overall Study||56
2939277|NCT00630825|3651192|FG001|COMPLETED|Overall Study||58
2939278|NCT00630825|3651193|FG002|COMPLETED|Overall Study||58
2939279|NCT00630825|3651194|FG003|COMPLETED|Overall Study||60
2939280|NCT00630825|3651191|FG000|NOT COMPLETED|Overall Study||9
3277314|NCT02703350|4010662|FG003|COMPLETED|Period Six (Part A)||5
3277315|NCT02703350|4010663|FG004|COMPLETED|Period Six (Part A)||5
3277316|NCT02703350|4010664|FG005|COMPLETED|Period Six (Part A)||5
3277317|NCT02703350|4010665|FG006|COMPLETED|Period Six (Part A)||0
3277318|NCT02703350|4010666|FG007|COMPLETED|Period Six (Part A)||0
3277319|NCT02703350|4010659|FG000|NOT COMPLETED|Period Six (Part A)||0
3277320|NCT02703350|4010660|FG001|NOT COMPLETED|Period Six (Part A)||0
3277321|NCT02703350|4010661|FG002|NOT COMPLETED|Period Six (Part A)||0
3277322|NCT02703350|4010662|FG003|NOT COMPLETED|Period Six (Part A)||0
3277323|NCT02703350|4010663|FG004|NOT COMPLETED|Period Six (Part A)||0
3277324|NCT02703350|4010664|FG005|NOT COMPLETED|Period Six (Part A)||0
3277325|NCT02703350|4010665|FG006|NOT COMPLETED|Period Six (Part A)||0
3277326|NCT02703350|4010666|FG007|NOT COMPLETED|Period Six (Part A)||0
3277327|NCT02703350|4010659|FG000|STARTED|Part B||0
3277328|NCT02703350|4010660|FG001|STARTED|Part B||0
3277329|NCT02703350|4010661|FG002|STARTED|Part B||0
3277330|NCT02703350|4010662|FG003|STARTED|Part B||0
3277331|NCT02703350|4010663|FG004|STARTED|Part B||0
3277332|NCT02703350|4010664|FG005|STARTED|Part B||0
3277333|NCT02703350|4010665|FG006|STARTED|Part B||15
3277334|NCT02703350|4010666|FG007|STARTED|Part B||15
3277335|NCT02703350|4010659|FG000|Received Study Drug|Part B||0
3277336|NCT02703350|4010660|FG001|Received Study Drug|Part B||0
3277337|NCT02703350|4010661|FG002|Received Study Drug|Part B||0
3277338|NCT02703350|4010662|FG003|Received Study Drug|Part B||0
3277339|NCT02703350|4010663|FG004|Received Study Drug|Part B||0
3277340|NCT02703350|4010664|FG005|Received Study Drug|Part B||0
3277341|NCT02703350|4010665|FG006|Received Study Drug|Part B||15
3277342|NCT02703350|4010666|FG007|Received Study Drug|Part B||15
3277343|NCT02703350|4010659|FG000|COMPLETED|Part B||0
3277344|NCT02703350|4010660|FG001|COMPLETED|Part B||0
3277345|NCT02703350|4010661|FG002|COMPLETED|Part B||0
3277346|NCT02703350|4010662|FG003|COMPLETED|Part B||0
3277347|NCT02703350|4010663|FG004|COMPLETED|Part B||0
3277348|NCT02703350|4010664|FG005|COMPLETED|Part B||0
3277349|NCT02703350|4010665|FG006|COMPLETED|Part B||15
3277350|NCT02703350|4010666|FG007|COMPLETED|Part B||15
3277351|NCT02703350|4010659|FG000|NOT COMPLETED|Part B||0
2939281|NCT00630825|3651192|FG001|NOT COMPLETED|Overall Study||7
2939282|NCT00630825|3651193|FG002|NOT COMPLETED|Overall Study||8
2939283|NCT00630825|3651194|FG003|NOT COMPLETED|Overall Study||6
2939284|NCT00630838|3651206|FG000|STARTED|Overall Study||32
2939285|NCT00630838|3651207|FG001|STARTED|Overall Study||30
2939286|NCT00630838|3651206|FG000|COMPLETED|Overall Study||32
2939287|NCT00630838|3651207|FG001|COMPLETED|Overall Study||28
2939288|NCT00630838|3651206|FG000|NOT COMPLETED|Overall Study||0
2939289|NCT00630838|3651207|FG001|NOT COMPLETED|Overall Study||2
2939290|NCT00630864|3651215|FG000|STARTED|Part 1 (up to Week 6)||21
2939291|NCT00630864|3651215|FG000|COMPLETED|Part 1 (up to Week 6)||20
2939292|NCT00630864|3651215|FG000|NOT COMPLETED|Part 1 (up to Week 6)||1
2939293|NCT00630864|3651215|FG000|STARTED|Part 2 (After Week 6 up to Month 12)||20
2939294|NCT00630864|3651215|FG000|COMPLETED|Part 2 (After Week 6 up to Month 12)||18
2939295|NCT00630864|3651215|FG000|NOT COMPLETED|Part 2 (After Week 6 up to Month 12)||2
2939296|NCT00630877|3651222|FG000|STARTED|Overall Study|For all arms, started means treated.|91
2939297|NCT00630877|3651223|FG001|STARTED|Overall Study||90
2939298|NCT00630877|3651224|FG002|STARTED|Overall Study||90
2939299|NCT00630877|3651222|FG000|COMPLETED|Overall Study||72
2939300|NCT00630877|3651223|FG001|COMPLETED|Overall Study||75
2939301|NCT00630877|3651224|FG002|COMPLETED|Overall Study||80
2939302|NCT00630877|3651222|FG000|NOT COMPLETED|Overall Study||19
2939303|NCT00630877|3651223|FG001|NOT COMPLETED|Overall Study||15
2939304|NCT00630877|3651224|FG002|NOT COMPLETED|Overall Study||10
2939305|NCT00630916|3651236|FG000|STARTED|Overall Study|Total patients enrolled (i.e. consented) to participate in the study.|756
2939306|NCT00630916|3651236|FG000|Study Cohort|Overall Study|Enrolled but did not receive device via physician decision, protocol violation, or lack of efficacy.|699
2939307|NCT00630916|3651236|FG000|COMPLETED|Overall Study|The number of patients that were active (i.e. not drop out) at the end of the study.|546
2939308|NCT00630916|3651236|FG000|NOT COMPLETED|Overall Study||210
2939309|NCT00630955|3651243|FG000|STARTED|Overall Study||34
2939310|NCT00630955|3651244|FG001|STARTED|Overall Study||37
2939311|NCT00630955|3651245|FG002|STARTED|Overall Study||40
2939312|NCT00630955|3651243|FG000|COMPLETED|Overall Study||31
2939313|NCT00630955|3651244|FG001|COMPLETED|Overall Study||31
2939314|NCT00630955|3651245|FG002|COMPLETED|Overall Study||28
2939315|NCT00630955|3651243|FG000|NOT COMPLETED|Overall Study||3
2939316|NCT00630955|3651244|FG001|NOT COMPLETED|Overall Study||6
2939317|NCT00630955|3651245|FG002|NOT COMPLETED|Overall Study||12
2939318|NCT00630994|3651253|FG000|STARTED|Overall Study||4
2939319|NCT00630994|3651253|FG000|COMPLETED|Overall Study||0
2939320|NCT00630994|3651253|FG000|NOT COMPLETED|Overall Study||4
2939321|NCT00631007|3651263|FG000|STARTED|Overall Study||60
2939322|NCT00631007|3651264|FG001|STARTED|Overall Study||61
2939323|NCT00631007|3651265|FG002|STARTED|Overall Study||63
2939324|NCT00631007|3651266|FG003|STARTED|Overall Study||62
2939325|NCT00631007|3651267|FG004|STARTED|Overall Study||60
2939326|NCT00631007|3651268|FG005|STARTED|Overall Study||61
2939327|NCT00631007|3651263|FG000|COMPLETED|Overall Study||49
2939328|NCT00631007|3651264|FG001|COMPLETED|Overall Study||50
2939329|NCT00631007|3651265|FG002|COMPLETED|Overall Study||53
2939330|NCT00631007|3651266|FG003|COMPLETED|Overall Study||53
2939331|NCT00631007|3651267|FG004|COMPLETED|Overall Study||48
2939332|NCT00631007|3651268|FG005|COMPLETED|Overall Study||46
2939333|NCT00631007|3651263|FG000|NOT COMPLETED|Overall Study||11
2939334|NCT00631007|3651264|FG001|NOT COMPLETED|Overall Study||11
2939335|NCT00631007|3651265|FG002|NOT COMPLETED|Overall Study||10
2939336|NCT00631007|3651266|FG003|NOT COMPLETED|Overall Study||9
2939337|NCT00631007|3651267|FG004|NOT COMPLETED|Overall Study||12
2939338|NCT00631007|3651268|FG005|NOT COMPLETED|Overall Study||15
2939339|NCT00631020|3651282|FG000|STARTED|Overall Study||34
2939340|NCT00631020|3651282|FG000|COMPLETED|Overall Study||26
2939341|NCT00631020|3651282|FG000|NOT COMPLETED|Overall Study||8
2939342|NCT00631163|3651286|FG000|STARTED|Number of Participants in Year 1||102
2939343|NCT00631163|3651286|FG000|COMPLETED|Number of Participants in Year 1||68
2939344|NCT00631163|3651286|FG000|NOT COMPLETED|Number of Participants in Year 1||34
2939345|NCT00631163|3651286|FG000|STARTED|Number of Participants in Year 2||57
2939346|NCT00631163|3651286|FG000|COMPLETED|Number of Participants in Year 2||52
2939347|NCT00631163|3651286|FG000|NOT COMPLETED|Number of Participants in Year 2||5
2939348|NCT00631189|3651301|FG000|STARTED|Initial Phase||668
2939349|NCT00631189|3651302|FG001|STARTED|Initial Phase||0
2939350|NCT00631189|3651303|FG002|STARTED|Initial Phase||0
2939351|NCT00631189|3651304|FG003|STARTED|Initial Phase||0
2939352|NCT00631189|3651301|FG000|COMPLETED|Initial Phase||317
2939353|NCT00631189|3651302|FG001|COMPLETED|Initial Phase||0
2939354|NCT00631189|3651303|FG002|COMPLETED|Initial Phase||0
2939355|NCT00631189|3651304|FG003|COMPLETED|Initial Phase||0
2939356|NCT00631189|3651301|FG000|NOT COMPLETED|Initial Phase||351
2939357|NCT00631189|3651302|FG001|NOT COMPLETED|Initial Phase||0
2939358|NCT00631189|3651303|FG002|NOT COMPLETED|Initial Phase||0
2939359|NCT00631189|3651304|FG003|NOT COMPLETED|Initial Phase||0
2939360|NCT00631189|3651301|FG000|STARTED|Treatment Phase||0
2939361|NCT00631189|3651302|FG001|STARTED|Treatment Phase||104
2939362|NCT00631189|3651303|FG002|STARTED|Treatment Phase||103
2939363|NCT00631189|3651304|FG003|STARTED|Treatment Phase||110
2939364|NCT00631189|3651301|FG000|COMPLETED|Treatment Phase||0
2939365|NCT00631189|3651302|FG001|COMPLETED|Treatment Phase||97
2939366|NCT00631189|3651303|FG002|COMPLETED|Treatment Phase||92
2939367|NCT00631189|3651304|FG003|COMPLETED|Treatment Phase||103
2939368|NCT00631189|3651301|FG000|NOT COMPLETED|Treatment Phase||0
2939369|NCT00631189|3651302|FG001|NOT COMPLETED|Treatment Phase||7
2939370|NCT00631189|3651303|FG002|NOT COMPLETED|Treatment Phase||11
2939371|NCT00631189|3651304|FG003|NOT COMPLETED|Treatment Phase||7
2939372|NCT00631319|3651316|FG000|STARTED|Conversion and Titration Phase||343
2939373|NCT00631319|3651317|FG001|STARTED|Conversion and Titration Phase|Per the study design, no patients received placebo during this phase.|0
2939374|NCT00631319|3651316|FG000|COMPLETED|Conversion and Titration Phase||200
2939375|NCT00631319|3651317|FG001|COMPLETED|Conversion and Titration Phase||0
2939376|NCT00631319|3651316|FG000|NOT COMPLETED|Conversion and Titration Phase||143
2939377|NCT00631319|3651317|FG001|NOT COMPLETED|Conversion and Titration Phase||0
2939378|NCT00631319|3651316|FG000|STARTED|Double-blind Phase||100
2939379|NCT00631319|3651317|FG001|STARTED|Double-blind Phase||100
2939380|NCT00631319|3651316|FG000|COMPLETED|Double-blind Phase||60
2939381|NCT00631319|3651317|FG001|COMPLETED|Double-blind Phase||65
2939382|NCT00631319|3651316|FG000|NOT COMPLETED|Double-blind Phase||40
2939383|NCT00631319|3651317|FG001|NOT COMPLETED|Double-blind Phase||35
2939384|NCT00631358|3651326|FG000|STARTED|Overall Study||50
2939385|NCT00631358|3651327|FG001|STARTED|Overall Study||47
2939386|NCT00631358|3651326|FG000|COMPLETED|Overall Study||44
2939387|NCT00631358|3651327|FG001|COMPLETED|Overall Study||45
2939388|NCT00631358|3651326|FG000|NOT COMPLETED|Overall Study||6
2939389|NCT00631358|3651327|FG001|NOT COMPLETED|Overall Study||2
2939390|NCT00631371|3651335|FG000|STARTED|Overall Study||400
2939391|NCT00631371|3651336|FG001|STARTED|Overall Study||391
2939392|NCT00631371|3651335|FG000|Treated|Overall Study||393
2939393|NCT00631371|3651336|FG001|Treated|Overall Study||391
2939394|NCT00631371|3651335|FG000|COMPLETED|Overall Study||0
2939395|NCT00631371|3651336|FG001|COMPLETED|Overall Study||0
2939396|NCT00631371|3651335|FG000|NOT COMPLETED|Overall Study||400
2939397|NCT00631371|3651336|FG001|NOT COMPLETED|Overall Study||391
2939398|NCT00631410|3651344|FG000|STARTED|Overall Study||6
2939399|NCT00631410|3651345|FG001|STARTED|Overall Study||6
2939400|NCT00631410|3651344|FG000|COMPLETED|Overall Study||0
2939401|NCT00631410|3651345|FG001|COMPLETED|Overall Study||0
2939402|NCT00631410|3651344|FG000|NOT COMPLETED|Overall Study||6
2939403|NCT00631410|3651345|FG001|NOT COMPLETED|Overall Study||6
2939404|NCT00631449|3651356|FG000|STARTED|Overall Study||15
2939405|NCT00631449|3651357|FG001|STARTED|Overall Study||15
2939406|NCT00631449|3651356|FG000|COMPLETED|Overall Study||15
2939407|NCT00631449|3651357|FG001|COMPLETED|Overall Study||15
2939408|NCT00631449|3651356|FG000|NOT COMPLETED|Overall Study||0
2939409|NCT00631449|3651357|FG001|NOT COMPLETED|Overall Study||0
2939410|NCT00631475|3651365|FG000|STARTED|Overall Study||128
2939411|NCT00631475|3651365|FG000|COMPLETED|Overall Study||83
2939412|NCT00631475|3651365|FG000|NOT COMPLETED|Overall Study||45
2939413|NCT00631488|3651372|FG000|STARTED|Overall Study||48
2939414|NCT00631488|3651373|FG001|STARTED|Overall Study||49
2939415|NCT00631488|3651374|FG002|STARTED|Overall Study||49
2939416|NCT00631488|3651372|FG000|Completed Post-Treatment Period|Overall Study||44
2939417|NCT00631488|3651373|FG001|Completed Post-Treatment Period|Overall Study||47
2939418|NCT00631488|3651374|FG002|Completed Post-Treatment Period|Overall Study||47
2939419|NCT00631488|3651372|FG000|COMPLETED|Overall Study||44
2939420|NCT00631488|3651373|FG001|COMPLETED|Overall Study||47
2939421|NCT00631488|3651374|FG002|COMPLETED|Overall Study||47
2939422|NCT00631488|3651372|FG000|NOT COMPLETED|Overall Study||4
2939423|NCT00631488|3651373|FG001|NOT COMPLETED|Overall Study||2
2939424|NCT00631488|3651374|FG002|NOT COMPLETED|Overall Study||2
2939425|NCT00631540|3651382|FG000|STARTED|Overall Study||100
2939426|NCT00631540|3651382|FG000|COMPLETED|Overall Study||86
2939427|NCT00631540|3651382|FG000|NOT COMPLETED|Overall Study||14
2939428|NCT00631566|3651389|FG000|STARTED|Overall Study||21
2939429|NCT00631566|3651390|FG001|STARTED|Overall Study||28
2939430|NCT00631566|3651391|FG002|STARTED|Overall Study||501
2939431|NCT00631566|3651389|FG000|COMPLETED|Overall Study||19
2939432|NCT00631566|3651390|FG001|COMPLETED|Overall Study||24
2939433|NCT00631566|3651391|FG002|COMPLETED|Overall Study||501
2939434|NCT00631566|3651389|FG000|NOT COMPLETED|Overall Study||2
2939435|NCT00631566|3651390|FG001|NOT COMPLETED|Overall Study||4
2939436|NCT00631566|3651391|FG002|NOT COMPLETED|Overall Study||0
2939437|NCT00631657|3651401|FG000|STARTED|6-Month Treatment Period||344
2939438|NCT00631657|3651402|FG001|STARTED|6-Month Treatment Period||0
2939439|NCT00631657|3651403|FG002|STARTED|6-Month Treatment Period||116
2939440|NCT00631657|3651401|FG000|Treated|6-Month Treatment Period|Two randomized participants were not treated during the 6-month Treatment Period.|342
2939441|NCT00631657|3651402|FG001|Treated|6-Month Treatment Period||0
2939442|NCT00631657|3651403|FG002|Treated|6-Month Treatment Period|One randomized participant was not treated during the 6-month Treatment Period.|115
2939443|NCT00631657|3651401|FG000|COMPLETED|6-Month Treatment Period||203
2939444|NCT00631657|3651402|FG001|COMPLETED|6-Month Treatment Period||0
2939445|NCT00631657|3651403|FG002|COMPLETED|6-Month Treatment Period||66
2939446|NCT00631657|3651401|FG000|NOT COMPLETED|6-Month Treatment Period||141
2939447|NCT00631657|3651402|FG001|NOT COMPLETED|6-Month Treatment Period||0
2939448|NCT00631657|3651403|FG002|NOT COMPLETED|6-Month Treatment Period||50
2939449|NCT00631657|3651401|FG000|STARTED|7-Day Discontinuation Period|One participant was radomized in the Discont. Period, without completing the Treatment Period.|67
2939450|NCT00631657|3651402|FG001|STARTED|7-Day Discontinuation Period||137
2939451|NCT00631657|3651403|FG002|STARTED|7-Day Discontinuation Period||66
2939452|NCT00631657|3651401|FG000|Treated|7-Day Discontinuation Period|One participant was not treated during the Discontinuation Period.|66
2939453|NCT00631657|3651402|FG001|Treated|7-Day Discontinuation Period|One participant was not treated during the Discontinuation Period.|136
2939454|NCT00631657|3651403|FG002|Treated|7-Day Discontinuation Period|One participant was not treated during the Discontinuation Period.|65
2939455|NCT00631657|3651401|FG000|COMPLETED|7-Day Discontinuation Period||65
2939456|NCT00631657|3651402|FG001|COMPLETED|7-Day Discontinuation Period||136
2939457|NCT00631657|3651403|FG002|COMPLETED|7-Day Discontinuation Period||65
2939458|NCT00631657|3651401|FG000|NOT COMPLETED|7-Day Discontinuation Period||2
2939459|NCT00631657|3651402|FG001|NOT COMPLETED|7-Day Discontinuation Period||1
2939460|NCT00631657|3651403|FG002|NOT COMPLETED|7-Day Discontinuation Period||1
2939461|NCT00631670|3651416|FG000|STARTED|Overall Study||21
2939462|NCT00631670|3651417|FG001|STARTED|Overall Study||0
2939463|NCT00631670|3651416|FG000|COMPLETED|Overall Study||21
2939464|NCT00631670|3651417|FG001|COMPLETED|Overall Study||0
2939465|NCT00631670|3651416|FG000|NOT COMPLETED|Overall Study||0
2939466|NCT00631670|3651417|FG001|NOT COMPLETED|Overall Study||0
2939467|NCT00631696|3651429|FG000|STARTED|Overall Study||112
2939468|NCT00631696|3651430|FG001|STARTED|Overall Study||110
2939469|NCT00631696|3651429|FG000|Received Study Treatment (Tx)|Overall Study||111
2939470|NCT00631696|3651430|FG001|Received Study Treatment (Tx)|Overall Study||109
2939471|NCT00631696|3651429|FG000|Ongoing at Database Release 18Oct2011|Overall Study|Completed Tx at time of database release 18Oct2011; included in all analyses.|2
2939472|NCT00631696|3651430|FG001|Ongoing at Database Release 18Oct2011|Overall Study||0
2939473|NCT00631696|3651429|FG000|COMPLETED|Overall Study|Completed study at time of database release 18Oct2011.|75
2939474|NCT00631696|3651430|FG001|COMPLETED|Overall Study|Completed study at time of database release 18Oct2011.|70
2939475|NCT00631696|3651429|FG000|NOT COMPLETED|Overall Study||37
2939476|NCT00631696|3651430|FG001|NOT COMPLETED|Overall Study||40
2939477|NCT00631748|3651438|FG000|STARTED|Overall Study||29
2939478|NCT00631748|3651439|FG001|STARTED|Overall Study||31
2939479|NCT00631748|3651438|FG000|COMPLETED|Overall Study|11 participants completed the double-blind portion of the study; 8 participants completed follow-up.|11
2939480|NCT00631748|3651439|FG001|COMPLETED|Overall Study|9 participants completed the double-blind portion of the study; 5 participants completed follow-up.|9
3277352|NCT02703350|4010660|FG001|NOT COMPLETED|Part B||0
3277353|NCT02703350|4010661|FG002|NOT COMPLETED|Part B||0
3277354|NCT02703350|4010662|FG003|NOT COMPLETED|Part B||0
3277355|NCT02703350|4010663|FG004|NOT COMPLETED|Part B||0
3277356|NCT02703350|4010664|FG005|NOT COMPLETED|Part B||0
3277357|NCT02703350|4010665|FG006|NOT COMPLETED|Part B||0
3277358|NCT02703350|4010666|FG007|NOT COMPLETED|Part B||0
3277359|NCT02703454|4010686|FG000|STARTED|Overall Study||24
3277360|NCT02703454|4010687|FG001|STARTED|Overall Study||27
2939481|NCT00631748|3651438|FG000|NOT COMPLETED|Overall Study||18
2939482|NCT00631748|3651439|FG001|NOT COMPLETED|Overall Study||22
2939483|NCT00631852|3651446|FG000|STARTED|Overall Study|Seventeen subjects were consented and 16 were considered enrolled and treated under the protocol. One was a screen fail.|16
2939484|NCT00631852|3651446|FG000|COMPLETED|Overall Study|2 patients were administratively withdrawn after treatment had been completed as they declined sharing of data after PI transfer.|16
2939485|NCT00631852|3651446|FG000|NOT COMPLETED|Overall Study||0
2939486|NCT00631917|3651452|FG000|STARTED|Overall Study||375
2939487|NCT00631917|3651453|FG001|STARTED|Overall Study||399
2939488|NCT00631917|3651452|FG000|COMPLETED|Overall Study||287
2939489|NCT00631917|3651453|FG001|COMPLETED|Overall Study||291
2939490|NCT00631917|3651452|FG000|NOT COMPLETED|Overall Study||88
2939491|NCT00631917|3651453|FG001|NOT COMPLETED|Overall Study||108
2939492|NCT00631969|3651461|FG000|STARTED|Overall Study||186
2939493|NCT00631969|3651462|FG001|STARTED|Overall Study||176
2939494|NCT00631969|3651461|FG000|Received Treatment|Overall Study|safety population|184
2939495|NCT00631969|3651462|FG001|Received Treatment|Overall Study|safety population|174
2939496|NCT00631969|3651461|FG000|COMPLETED|Overall Study||171
2939497|NCT00631969|3651462|FG001|COMPLETED|Overall Study||155
2939498|NCT00631969|3651461|FG000|NOT COMPLETED|Overall Study||15
2939499|NCT00631969|3651462|FG001|NOT COMPLETED|Overall Study||21
2939500|NCT00632021|3651472|FG000|STARTED|Overall Study||432
2939501|NCT00632021|3651473|FG001|STARTED|Overall Study||430
2939502|NCT00632021|3651472|FG000|COMPLETED|Overall Study||428
2939503|NCT00632021|3651473|FG001|COMPLETED|Overall Study||423
2939504|NCT00632021|3651472|FG000|NOT COMPLETED|Overall Study||4
2939505|NCT00632021|3651473|FG001|NOT COMPLETED|Overall Study||7
2939506|NCT00632099|3651482|FG000|STARTED|Overall Study||10
2939507|NCT00632099|3651483|FG001|STARTED|Overall Study||11
2939508|NCT00632099|3651482|FG000|COMPLETED|Overall Study||7
2939509|NCT00632099|3651483|FG001|COMPLETED|Overall Study||8
2939510|NCT00632099|3651482|FG000|NOT COMPLETED|Overall Study||3
2939511|NCT00632099|3651483|FG001|NOT COMPLETED|Overall Study||3
2939512|NCT00632125|3651489|FG000|STARTED|Overall Study|1,698 patients were enrolled but 3 patients did not receive any study medication.|1695
2939513|NCT00632125|3651489|FG000|COMPLETED|Overall Study||1393
2939514|NCT00632125|3651489|FG000|NOT COMPLETED|Overall Study||302
2939515|NCT00632203|3651495|FG000|STARTED|Overall Study||26
2939516|NCT00632203|3651496|FG001|STARTED|Overall Study||27
2939517|NCT00632203|3651495|FG000|COMPLETED|Overall Study||25
2939518|NCT00632203|3651496|FG001|COMPLETED|Overall Study||27
2939519|NCT00632203|3651495|FG000|NOT COMPLETED|Overall Study||1
2939520|NCT00632203|3651496|FG001|NOT COMPLETED|Overall Study||0
2939521|NCT00632229|3651504|FG000|STARTED|Overall Study||17
2939522|NCT00632229|3651505|FG001|STARTED|Overall Study||17
3277361|NCT02703454|4010686|FG000|Treated|Overall Study||23
2939523|NCT00632229|3651504|FG000|COMPLETED|Overall Study||11
2939524|NCT00632229|3651505|FG001|COMPLETED|Overall Study||11
2939525|NCT00632229|3651504|FG000|NOT COMPLETED|Overall Study||6
2939526|NCT00632229|3651505|FG001|NOT COMPLETED|Overall Study||6
2939527|NCT00632281|3651511|FG000|STARTED|Overall Study||38
2939528|NCT00632281|3651511|FG000|COMPLETED|Overall Study||38
2939529|NCT00632281|3651511|FG000|NOT COMPLETED|Overall Study||0
2939530|NCT00632359|3651515|FG000|STARTED|Overall Study||33
2939531|NCT00632359|3651515|FG000|COMPLETED|Overall Study||31
2939532|NCT00632359|3651515|FG000|NOT COMPLETED|Overall Study||2
2939533|NCT00632411|3651522|FG000|STARTED|Overall Study||649
2939534|NCT00632411|3651523|FG001|STARTED|Overall Study||649
2939535|NCT00632411|3651522|FG000|COMPLETED|Overall Study||489
2939536|NCT00632411|3651523|FG001|COMPLETED|Overall Study||473
2939537|NCT00632411|3651522|FG000|NOT COMPLETED|Overall Study||160
2939538|NCT00632411|3651523|FG001|NOT COMPLETED|Overall Study||176
2939539|NCT00632424|3651532|FG000|STARTED|Overall Study||18
2939540|NCT00632424|3651532|FG000|COMPLETED|Overall Study||0
2939541|NCT00632424|3651532|FG000|NOT COMPLETED|Overall Study||18
2939542|NCT00632463|3651549|FG000|STARTED|Overall Study||7
2939543|NCT00632463|3651550|FG001|STARTED|Overall Study||7
2939544|NCT00632463|3651551|FG002|STARTED|Overall Study||7
2939545|NCT00632463|3651549|FG000|COMPLETED|Overall Study||7
2939546|NCT00632463|3651550|FG001|COMPLETED|Overall Study||6
2939547|NCT00632463|3651551|FG002|COMPLETED|Overall Study||7
2939548|NCT00632463|3651549|FG000|NOT COMPLETED|Overall Study||0
3160421|NCT01863680|3887551|FG000|STARTED|Overall Study||178
3277362|NCT02703454|4010687|FG001|Treated|Overall Study||24
3277363|NCT02703454|4010686|FG000|COMPLETED|Overall Study||13
3277364|NCT02703454|4010687|FG001|COMPLETED|Overall Study||11
3277365|NCT02703454|4010686|FG000|NOT COMPLETED|Overall Study||11
3277366|NCT02703454|4010687|FG001|NOT COMPLETED|Overall Study||16
3277367|NCT02703467|4010696|FG000|STARTED|Overall Study||20
3160422|NCT01863680|3887551|FG000|Subjects Started COS Treatment|Overall Study||169
3160423|NCT01863680|3887551|FG000|Subjects Received hCG Injection|Overall Study||162
3160424|NCT01863680|3887551|FG000|Subjects Received Study Drug|Overall Study||149
3160425|NCT01863680|3887551|FG000|Subjects Who Have Undergone IVF/ET|Overall Study||123
3160426|NCT01863680|3887551|FG000|COMPLETED|Overall Study||121
3160427|NCT01863680|3887551|FG000|NOT COMPLETED|Overall Study||57
3277368|NCT02703467|4010697|FG001|STARTED|Overall Study||5
3277369|NCT02703467|4010698|FG002|STARTED|Overall Study||45
3277370|NCT02703467|4010696|FG000|COMPLETED|Overall Study||20
3277371|NCT02703467|4010697|FG001|COMPLETED|Overall Study||5
3277372|NCT02703467|4010698|FG002|COMPLETED|Overall Study||45
3277373|NCT02703467|4010696|FG000|NOT COMPLETED|Overall Study||0
3277374|NCT02703467|4010697|FG001|NOT COMPLETED|Overall Study||0
3277375|NCT02703467|4010698|FG002|NOT COMPLETED|Overall Study||0
3277376|NCT02703532|4010714|FG000|STARTED|Overall Study||21
3277377|NCT02703532|4010715|FG001|STARTED|Overall Study||11
3277378|NCT02703532|4010716|FG002|STARTED|Overall Study||21
3277379|NCT02703532|4010717|FG003|STARTED|Overall Study||11
3277380|NCT02703532|4010714|FG000|COMPLETED|Overall Study||19
3277381|NCT02703532|4010715|FG001|COMPLETED|Overall Study||10
3277382|NCT02703532|4010716|FG002|COMPLETED|Overall Study||19
3277383|NCT02703532|4010717|FG003|COMPLETED|Overall Study||10
3277384|NCT02703532|4010714|FG000|NOT COMPLETED|Overall Study||2
3277385|NCT02703532|4010715|FG001|NOT COMPLETED|Overall Study||1
3277386|NCT02703532|4010716|FG002|NOT COMPLETED|Overall Study||2
3277387|NCT02703532|4010717|FG003|NOT COMPLETED|Overall Study||1
3277388|NCT02703636|4010727|FG000|STARTED|Overall Study||118
3277389|NCT02703636|4010727|FG000|COMPLETED|Overall Study||102
3277390|NCT02703636|4010727|FG000|NOT COMPLETED|Overall Study||16
3277391|NCT02703779|4010733|FG000|STARTED|Overall Study||51
3160428|NCT01863732|3887559|FG000|STARTED|Overall Study||100
3160429|NCT01863732|3887560|FG001|STARTED|Overall Study||87
3160430|NCT01863732|3887561|FG002|STARTED|Overall Study||46
3160431|NCT01863732|3887562|FG003|STARTED|Overall Study||41
3277392|NCT02703779|4010734|FG001|STARTED|Overall Study||50
3277393|NCT02703779|4010733|FG000|COMPLETED|Overall Study||51
3277394|NCT02703779|4010734|FG001|COMPLETED|Overall Study||50
3277395|NCT02703779|4010733|FG000|NOT COMPLETED|Overall Study||0
3277396|NCT02703779|4010734|FG001|NOT COMPLETED|Overall Study||0
3277397|NCT02703909|4010744|FG000|STARTED|Overall Study||36
3277398|NCT02703909|4010745|FG001|STARTED|Overall Study||37
3277399|NCT02703909|4010746|FG002|STARTED|Overall Study||36
3277400|NCT02703909|4010747|FG003|STARTED|Overall Study||35
3277401|NCT02703909|4010744|FG000|COMPLETED|Overall Study||36
3277402|NCT02703909|4010745|FG001|COMPLETED|Overall Study||37
3277403|NCT02703909|4010746|FG002|COMPLETED|Overall Study||36
3277404|NCT02703909|4010747|FG003|COMPLETED|Overall Study||35
3277405|NCT02703909|4010744|FG000|NOT COMPLETED|Overall Study||0
3277406|NCT02703909|4010745|FG001|NOT COMPLETED|Overall Study||0
3277407|NCT02703909|4010746|FG002|NOT COMPLETED|Overall Study||0
3277408|NCT02703909|4010747|FG003|NOT COMPLETED|Overall Study||0
3277409|NCT02703948|4010759|FG000|STARTED|Overall Study||60
2939549|NCT00632463|3651550|FG001|NOT COMPLETED|Overall Study||1
2939550|NCT00632463|3651551|FG002|NOT COMPLETED|Overall Study||0
2939551|NCT00632489|3651562|FG000|STARTED|Overall Study||15
2939552|NCT00632489|3651563|FG001|STARTED|Overall Study||5
3160432|NCT01863732|3887559|FG000|COMPLETED|Overall Study||87
3160433|NCT01863732|3887560|FG001|COMPLETED|Overall Study||75
3160434|NCT01863732|3887561|FG002|COMPLETED|Overall Study||35
3277410|NCT02703948|4010759|FG000|COMPLETED|Overall Study||57
2939553|NCT00632489|3651564|FG002|STARTED|Overall Study||0
2939554|NCT00632489|3651562|FG000|COMPLETED|Overall Study|Pts remained on study until disease progression, intolerable toxicity or other reason to discontinue|0
2939555|NCT00632489|3651563|FG001|COMPLETED|Overall Study|Pts remained on study until disease progression, intolerable toxicity or other reason to discontinue|0
2939556|NCT00632489|3651564|FG002|COMPLETED|Overall Study|Pts remained on study until disease progression, intolerable toxicity or other reason to discontinue|0
2939557|NCT00632489|3651562|FG000|NOT COMPLETED|Overall Study||15
2939558|NCT00632489|3651563|FG001|NOT COMPLETED|Overall Study||5
2939559|NCT00632489|3651564|FG002|NOT COMPLETED|Overall Study||0
2939560|NCT00632502|3651574|FG000|STARTED|Overall Study||25
2939561|NCT00632502|3651575|FG001|STARTED|Overall Study||12
2939562|NCT00632502|3651574|FG000|Treated|Overall Study||22
2939563|NCT00632502|3651575|FG001|Treated|Overall Study||12
2939564|NCT00632502|3651574|FG000|Completed Treatment|Overall Study||19
2939565|NCT00632502|3651575|FG001|Completed Treatment|Overall Study||9
2939566|NCT00632502|3651574|FG000|COMPLETED|Overall Study||22
2939567|NCT00632502|3651575|FG001|COMPLETED|Overall Study||11
2939568|NCT00632502|3651574|FG000|NOT COMPLETED|Overall Study||3
2939569|NCT00632502|3651575|FG001|NOT COMPLETED|Overall Study||1
2939570|NCT00632541|3651582|FG000|STARTED|Overall Study|18 subjects were accrued to the study|18
2939571|NCT00632541|3651582|FG000|COMPLETED|Overall Study||11
2939572|NCT00632541|3651582|FG000|NOT COMPLETED|Overall Study||7
2939573|NCT00632619|3651588|FG000|STARTED|Overall Study|first cohort started 9/11/09 second cohort started 12/7/11|33
2939574|NCT00632619|3651589|FG001|STARTED|Overall Study|first cohort started 9/11/09 second cohort started 12/7/11|35
2939575|NCT00632619|3651588|FG000|COMPLETED|Overall Study|"st cohort completed follow up by 5/24/10~nd cohort completed follow up 7/18/11"|25
2939576|NCT00632619|3651589|FG001|COMPLETED|Overall Study|"st cohort completed follow up by 5/24/10~nd cohort completed follow up 7/18/11"|31
2939577|NCT00632619|3651588|FG000|NOT COMPLETED|Overall Study||8
2939578|NCT00632619|3651589|FG001|NOT COMPLETED|Overall Study||4
2939579|NCT00632632|3651597|FG000|STARTED|Overall Study||13
2939580|NCT00632632|3651598|FG001|STARTED|Overall Study||12
2939581|NCT00632632|3651597|FG000|COMPLETED|Overall Study||13
2939582|NCT00632632|3651598|FG001|COMPLETED|Overall Study||9
2939583|NCT00632632|3651597|FG000|NOT COMPLETED|Overall Study||0
2939584|NCT00632632|3651598|FG001|NOT COMPLETED|Overall Study||3
2939585|NCT00632736|3651604|FG000|STARTED|Overall Study||419
2939586|NCT00632736|3651604|FG000|COMPLETED|Overall Study||151
2939587|NCT00632736|3651604|FG000|NOT COMPLETED|Overall Study||268
2939588|NCT00632749|3651622|FG000|STARTED|Overall Study||4
2939589|NCT00632749|3651623|FG001|STARTED|Overall Study||5
2939590|NCT00632749|3651624|FG002|STARTED|Overall Study||3
2939591|NCT00632749|3651625|FG003|STARTED|Overall Study||4
2939592|NCT00632749|3651626|FG004|STARTED|Overall Study||7
2939593|NCT00632749|3651627|FG005|STARTED|Overall Study||8
2939594|NCT00632749|3651628|FG006|STARTED|Overall Study||5
2939595|NCT00632749|3651629|FG007|STARTED|Overall Study||4
2939596|NCT00632749|3651630|FG008|STARTED|Overall Study||5
2939597|NCT00632749|3651631|FG009|STARTED|Overall Study||3
2939598|NCT00632749|3651632|FG010|STARTED|Overall Study||7
2939599|NCT00632749|3651633|FG011|STARTED|Overall Study||4
2939600|NCT00632749|3651634|FG012|STARTED|Overall Study||3
2939601|NCT00632749|3651635|FG013|STARTED|Overall Study||6
2939602|NCT00632749|3651622|FG000|Treated|Overall Study||4
2939603|NCT00632749|3651623|FG001|Treated|Overall Study||3
2939604|NCT00632749|3651624|FG002|Treated|Overall Study||3
2939605|NCT00632749|3651625|FG003|Treated|Overall Study||4
2939606|NCT00632749|3651626|FG004|Treated|Overall Study||7
2939607|NCT00632749|3651627|FG005|Treated|Overall Study||7
2939608|NCT00632749|3651628|FG006|Treated|Overall Study||4
2939609|NCT00632749|3651629|FG007|Treated|Overall Study||4
2939610|NCT00632749|3651630|FG008|Treated|Overall Study||5
2939611|NCT00632749|3651631|FG009|Treated|Overall Study||3
2939612|NCT00632749|3651632|FG010|Treated|Overall Study||7
2939613|NCT00632749|3651633|FG011|Treated|Overall Study||4
2939614|NCT00632749|3651634|FG012|Treated|Overall Study||3
2939615|NCT00632749|3651635|FG013|Treated|Overall Study||6
2939616|NCT00632749|3651622|FG000|Not Treated|Overall Study||0
2939617|NCT00632749|3651623|FG001|Not Treated|Overall Study||2
2939618|NCT00632749|3651624|FG002|Not Treated|Overall Study||0
2939619|NCT00632749|3651625|FG003|Not Treated|Overall Study||0
2939620|NCT00632749|3651626|FG004|Not Treated|Overall Study||0
2939621|NCT00632749|3651627|FG005|Not Treated|Overall Study||1
2939622|NCT00632749|3651628|FG006|Not Treated|Overall Study||1
2939623|NCT00632749|3651629|FG007|Not Treated|Overall Study||0
2939624|NCT00632749|3651630|FG008|Not Treated|Overall Study||0
2939625|NCT00632749|3651631|FG009|Not Treated|Overall Study||0
2939626|NCT00632749|3651632|FG010|Not Treated|Overall Study||0
2939627|NCT00632749|3651633|FG011|Not Treated|Overall Study||0
2939628|NCT00632749|3651634|FG012|Not Treated|Overall Study||0
2939629|NCT00632749|3651635|FG013|Not Treated|Overall Study||0
2939630|NCT00632749|3651622|FG000|COMPLETED|Overall Study||0
2939631|NCT00632749|3651623|FG001|COMPLETED|Overall Study||0
2939632|NCT00632749|3651624|FG002|COMPLETED|Overall Study||0
2939633|NCT00632749|3651625|FG003|COMPLETED|Overall Study||0
2939634|NCT00632749|3651626|FG004|COMPLETED|Overall Study||0
2939635|NCT00632749|3651627|FG005|COMPLETED|Overall Study||0
2939636|NCT00632749|3651628|FG006|COMPLETED|Overall Study||0
2939637|NCT00632749|3651629|FG007|COMPLETED|Overall Study||0
2939638|NCT00632749|3651630|FG008|COMPLETED|Overall Study||0
2939639|NCT00632749|3651631|FG009|COMPLETED|Overall Study||0
2939640|NCT00632749|3651632|FG010|COMPLETED|Overall Study||0
2939641|NCT00632749|3651633|FG011|COMPLETED|Overall Study||0
2939642|NCT00632749|3651634|FG012|COMPLETED|Overall Study||0
2939643|NCT00632749|3651635|FG013|COMPLETED|Overall Study||0
2939644|NCT00632749|3651622|FG000|NOT COMPLETED|Overall Study||4
2939645|NCT00632749|3651623|FG001|NOT COMPLETED|Overall Study||5
2939646|NCT00632749|3651624|FG002|NOT COMPLETED|Overall Study||3
2939647|NCT00632749|3651625|FG003|NOT COMPLETED|Overall Study||4
2939648|NCT00632749|3651626|FG004|NOT COMPLETED|Overall Study||7
2939649|NCT00632749|3651627|FG005|NOT COMPLETED|Overall Study||8
2939650|NCT00632749|3651628|FG006|NOT COMPLETED|Overall Study||5
2939651|NCT00632749|3651629|FG007|NOT COMPLETED|Overall Study||4
2939652|NCT00632749|3651630|FG008|NOT COMPLETED|Overall Study||5
2939653|NCT00632749|3651631|FG009|NOT COMPLETED|Overall Study||3
2939654|NCT00632749|3651632|FG010|NOT COMPLETED|Overall Study||7
2939655|NCT00632749|3651633|FG011|NOT COMPLETED|Overall Study||4
2939656|NCT00632749|3651634|FG012|NOT COMPLETED|Overall Study||3
2939657|NCT00632749|3651635|FG013|NOT COMPLETED|Overall Study||6
2939658|NCT00632814|3651674|FG000|STARTED|Overall Study||11
2939659|NCT00632814|3651675|FG001|STARTED|Overall Study||13
2939660|NCT00632814|3651676|FG002|STARTED|Overall Study||8
2939661|NCT00632814|3651674|FG000|COMPLETED|Overall Study||11
2939662|NCT00632814|3651675|FG001|COMPLETED|Overall Study||13
2939663|NCT00632814|3651676|FG002|COMPLETED|Overall Study||8
2939664|NCT00632814|3651674|FG000|NOT COMPLETED|Overall Study||0
2939665|NCT00632814|3651675|FG001|NOT COMPLETED|Overall Study||0
2939666|NCT00632814|3651676|FG002|NOT COMPLETED|Overall Study||0
2939667|NCT00632827|3651684|FG000|STARTED|Overall Study||21
2939668|NCT00632827|3651684|FG000|Received GVD|Overall Study||21
2939669|NCT00632827|3651684|FG000|Received M-CHOP|Overall Study||18
2939670|NCT00632827|3651684|FG000|Evaluated Post Stem Cell Transplant|Overall Study||16
2939671|NCT00632827|3651684|FG000|COMPLETED|Overall Study||11
2939672|NCT00632827|3651684|FG000|NOT COMPLETED|Overall Study||10
2939673|NCT00632931|3651689|FG000|STARTED|Part 1, Period 1||13
2939674|NCT00632931|3651690|FG001|STARTED|Part 1, Period 1||12
2939675|NCT00632931|3651691|FG002|STARTED|Part 1, Period 1||0
2939676|NCT00632931|3651689|FG000|COMPLETED|Part 1, Period 1||11
3277411|NCT02703948|4010759|FG000|NOT COMPLETED|Overall Study||3
3277412|NCT02703987|4010765|FG000|STARTED|Visit 3 Intervention (1 Day)||14
3277413|NCT02703987|4010766|FG001|STARTED|Visit 3 Intervention (1 Day)||14
3277414|NCT02703987|4010765|FG000|COMPLETED|Visit 3 Intervention (1 Day)||13
3277415|NCT02703987|4010766|FG001|COMPLETED|Visit 3 Intervention (1 Day)||11
3277416|NCT02703987|4010765|FG000|NOT COMPLETED|Visit 3 Intervention (1 Day)||1
3277417|NCT02703987|4010766|FG001|NOT COMPLETED|Visit 3 Intervention (1 Day)||3
3277418|NCT02703987|4010765|FG000|STARTED|Washout (Minimum 5 Days)||13
3277419|NCT02703987|4010766|FG001|STARTED|Washout (Minimum 5 Days)||11
3277420|NCT02703987|4010765|FG000|COMPLETED|Washout (Minimum 5 Days)||13
3277421|NCT02703987|4010766|FG001|COMPLETED|Washout (Minimum 5 Days)||11
3277422|NCT02703987|4010765|FG000|NOT COMPLETED|Washout (Minimum 5 Days)||0
3277423|NCT02703987|4010766|FG001|NOT COMPLETED|Washout (Minimum 5 Days)||0
3277424|NCT02703987|4010765|FG000|STARTED|Visit 4 Intervention (1 Day)||13
3277425|NCT02703987|4010766|FG001|STARTED|Visit 4 Intervention (1 Day)||11
3277426|NCT02703987|4010765|FG000|COMPLETED|Visit 4 Intervention (1 Day)||12
3277427|NCT02703987|4010766|FG001|COMPLETED|Visit 4 Intervention (1 Day)||10
3277428|NCT02703987|4010765|FG000|NOT COMPLETED|Visit 4 Intervention (1 Day)||1
3277429|NCT02703987|4010766|FG001|NOT COMPLETED|Visit 4 Intervention (1 Day)||1
3277430|NCT02704091|4010774|FG000|STARTED|Overall Study||430
3277431|NCT02704091|4010775|FG001|STARTED|Overall Study||423
3277432|NCT02704091|4010774|FG000|COMPLETED|Overall Study||402
3277433|NCT02704091|4010775|FG001|COMPLETED|Overall Study||400
3277434|NCT02704091|4010774|FG000|NOT COMPLETED|Overall Study||28
3277435|NCT02704091|4010775|FG001|NOT COMPLETED|Overall Study||23
3277436|NCT02704104|4010781|FG000|STARTED|Overall Study||46
3277437|NCT02704104|4010781|FG000|COMPLETED|Overall Study||46
3277438|NCT02704104|4010781|FG000|NOT COMPLETED|Overall Study||0
3277439|NCT02704143|4010789|FG000|STARTED|Overall Study||63
3277440|NCT02704143|4010789|FG000|COMPLETED|Overall Study||53
3277441|NCT02704143|4010789|FG000|NOT COMPLETED|Overall Study||10
3277442|NCT02704156|4010795|FG000|STARTED|Overall Study||85
3277443|NCT02704156|4010796|FG001|STARTED|Overall Study||85
3277444|NCT02704156|4010795|FG000|COMPLETED|Overall Study||85
3277445|NCT02704156|4010796|FG001|COMPLETED|Overall Study||85
3277446|NCT02704156|4010795|FG000|NOT COMPLETED|Overall Study||0
3277447|NCT02704156|4010796|FG001|NOT COMPLETED|Overall Study||0
3277448|NCT02704689|4010802|FG000|STARTED|Overall Study||9
3277449|NCT02704689|4010802|FG000|COMPLETED|Overall Study||6
3277450|NCT02704689|4010802|FG000|NOT COMPLETED|Overall Study||3
3277451|NCT02704702|4010812|FG000|STARTED|Overall Study||6
3277452|NCT02704702|4010813|FG001|STARTED|Overall Study||6
3277453|NCT02704702|4010814|FG002|STARTED|Overall Study||6
3277454|NCT02704702|4010815|FG003|STARTED|Overall Study||6
3277455|NCT02704702|4010816|FG004|STARTED|Overall Study||6
3277456|NCT02704702|4010817|FG005|STARTED|Overall Study||6
3277457|NCT02704702|4010812|FG000|COMPLETED|Overall Study||5
3277458|NCT02704702|4010813|FG001|COMPLETED|Overall Study||6
3277459|NCT02704702|4010814|FG002|COMPLETED|Overall Study||6
3277460|NCT02704702|4010815|FG003|COMPLETED|Overall Study||5
2939677|NCT00632931|3651690|FG001|COMPLETED|Part 1, Period 1||12
2939678|NCT00632931|3651691|FG002|COMPLETED|Part 1, Period 1||0
2939679|NCT00632931|3651689|FG000|NOT COMPLETED|Part 1, Period 1||2
3277461|NCT02704702|4010816|FG004|COMPLETED|Overall Study||4
2939680|NCT00632931|3651690|FG001|NOT COMPLETED|Part 1, Period 1||0
2939681|NCT00632931|3651691|FG002|NOT COMPLETED|Part 1, Period 1||0
2939682|NCT00632931|3651689|FG000|STARTED|Part 1, Washout||11
2939683|NCT00632931|3651690|FG001|STARTED|Part 1, Washout||12
2939684|NCT00632931|3651691|FG002|STARTED|Part 1, Washout||0
3277462|NCT02704702|4010817|FG005|COMPLETED|Overall Study||4
3277463|NCT02704702|4010812|FG000|NOT COMPLETED|Overall Study||1
3277464|NCT02704702|4010813|FG001|NOT COMPLETED|Overall Study||0
3277465|NCT02704702|4010814|FG002|NOT COMPLETED|Overall Study||0
3277466|NCT02704702|4010815|FG003|NOT COMPLETED|Overall Study||1
3277467|NCT02704702|4010816|FG004|NOT COMPLETED|Overall Study||2
3277468|NCT02704702|4010817|FG005|NOT COMPLETED|Overall Study||2
3277469|NCT02705105|4010843|FG000|STARTED|Treatment||4
3277470|NCT02705105|4010844|FG001|STARTED|Treatment||110
3277471|NCT02705105|4010843|FG000|Subjects Who Were Replaced|Treatment||1
3277472|NCT02705105|4010844|FG001|Subjects Who Were Replaced|Treatment||0
3277473|NCT02705105|4010843|FG000|D/C From Treatment Phase|Treatment||4
3277474|NCT02705105|4010844|FG001|D/C From Treatment Phase|Treatment||107
3277475|NCT02705105|4010843|FG000|D/C From Follow-Up|Treatment||4
3277476|NCT02705105|4010844|FG001|D/C From Follow-Up|Treatment||110
3277477|NCT02705105|4010843|FG000|COMPLETED|Treatment||0
3277478|NCT02705105|4010844|FG001|COMPLETED|Treatment||1
3277479|NCT02705105|4010843|FG000|NOT COMPLETED|Treatment||4
3277480|NCT02705105|4010844|FG001|NOT COMPLETED|Treatment||109
3277481|NCT02705105|4010843|FG000|STARTED|Follow-Up||4
3277482|NCT02705105|4010844|FG001|STARTED|Follow-Up||110
3277483|NCT02705105|4010843|FG000|COMPLETED|Follow-Up||0
3277484|NCT02705105|4010844|FG001|COMPLETED|Follow-Up||0
3277485|NCT02705105|4010843|FG000|NOT COMPLETED|Follow-Up||4
3277486|NCT02705105|4010844|FG001|NOT COMPLETED|Follow-Up||110
3277487|NCT02705352|4010864|FG000|STARTED|Overall Study||1
3277488|NCT02705352|4010865|FG001|STARTED|Overall Study||0
3277489|NCT02705352|4010864|FG000|COMPLETED|Overall Study||1
3277490|NCT02705352|4010865|FG001|COMPLETED|Overall Study||0
3277491|NCT02705352|4010864|FG000|NOT COMPLETED|Overall Study||0
3277492|NCT02705352|4010865|FG001|NOT COMPLETED|Overall Study||0
3277493|NCT02705365|4010873|FG000|STARTED|Overall Study||400
3277494|NCT02705365|4010874|FG001|STARTED|Overall Study||800
3277495|NCT02705365|4010873|FG000|COMPLETED|Overall Study||400
3277496|NCT02705365|4010874|FG001|COMPLETED|Overall Study||800
3277497|NCT02705365|4010873|FG000|NOT COMPLETED|Overall Study||0
3277498|NCT02705365|4010874|FG001|NOT COMPLETED|Overall Study||0
3277499|NCT02705586|4010880|FG000|STARTED|Overall Study||13
3277500|NCT02705586|4010880|FG000|COMPLETED|Overall Study||5
3277501|NCT02705586|4010880|FG000|NOT COMPLETED|Overall Study||8
3277502|NCT02705625|4010887|FG000|STARTED|Overall Study||82
3277503|NCT02705625|4010888|FG001|STARTED|Overall Study||82
3277504|NCT02705625|4010889|FG002|STARTED|Overall Study||80
3277505|NCT02705625|4010887|FG000|COMPLETED|Overall Study||74
3277506|NCT02705625|4010888|FG001|COMPLETED|Overall Study||72
3277507|NCT02705625|4010889|FG002|COMPLETED|Overall Study||69
3277508|NCT02705625|4010887|FG000|NOT COMPLETED|Overall Study||8
3277509|NCT02705625|4010888|FG001|NOT COMPLETED|Overall Study||10
3277510|NCT02705625|4010889|FG002|NOT COMPLETED|Overall Study||11
3277511|NCT02705716|4010899|FG000|STARTED|Overall Study||72
3277512|NCT02705716|4010900|FG001|STARTED|Overall Study||70
3277513|NCT02705716|4010899|FG000|COMPLETED|Overall Study||68
3277514|NCT02705716|4010900|FG001|COMPLETED|Overall Study||68
3277515|NCT02705716|4010899|FG000|NOT COMPLETED|Overall Study||4
3277516|NCT02705716|4010900|FG001|NOT COMPLETED|Overall Study||2
3277517|NCT02705807|4010906|FG000|STARTED|Overall Study||10
3277518|NCT02705807|4010906|FG000|COMPLETED|Overall Study||10
3277519|NCT02705807|4010906|FG000|NOT COMPLETED|Overall Study||0
3277520|NCT02706041|4010912|FG000|STARTED|Overall Study||18
3277521|NCT02706041|4010913|FG001|STARTED|Overall Study||21
3277522|NCT02706041|4010912|FG000|Received Allocated Intervention|Overall Study||18
3277523|NCT02706041|4010913|FG001|Received Allocated Intervention|Overall Study||18
3277524|NCT02706041|4010912|FG000|COMPLETED|Overall Study||18
3277525|NCT02706041|4010913|FG001|COMPLETED|Overall Study||18
3277526|NCT02706041|4010912|FG000|NOT COMPLETED|Overall Study||0
3277527|NCT02706041|4010913|FG001|NOT COMPLETED|Overall Study||3
3277528|NCT02706249|4010921|FG000|STARTED|Overall Study||25
3277529|NCT02706249|4010922|FG001|STARTED|Overall Study||25
3277530|NCT02706249|4010921|FG000|COMPLETED|Overall Study||23
3277531|NCT02706249|4010922|FG001|COMPLETED|Overall Study||24
3277532|NCT02706249|4010921|FG000|NOT COMPLETED|Overall Study||2
3277533|NCT02706249|4010922|FG001|NOT COMPLETED|Overall Study||1
3277534|NCT02706327|4010933|FG000|STARTED|Overall Study||22
3277535|NCT02706327|4010934|FG001|STARTED|Overall Study||22
3277536|NCT02706327|4010935|FG002|STARTED|Overall Study||23
3277537|NCT02706327|4010933|FG000|COMPLETED|Overall Study||21
3277538|NCT02706327|4010934|FG001|COMPLETED|Overall Study||21
3277539|NCT02706327|4010935|FG002|COMPLETED|Overall Study||21
3277540|NCT02706327|4010933|FG000|NOT COMPLETED|Overall Study||1
3277541|NCT02706327|4010934|FG001|NOT COMPLETED|Overall Study||1
3277542|NCT02706327|4010935|FG002|NOT COMPLETED|Overall Study||2
3277543|NCT02706483|4010943|FG000|STARTED|Overall Study||2272
3277544|NCT02706483|4010943|FG000|COMPLETED|Overall Study||1842
3277545|NCT02706483|4010943|FG000|NOT COMPLETED|Overall Study||430
3277546|NCT02706717|4010949|FG000|STARTED|Overall Study||47
3277547|NCT02706717|4010950|FG001|STARTED|Overall Study|3 placebo participants never initiated study treatment.|46
3277548|NCT02706717|4010949|FG000|COMPLETED|Overall Study||46
2939685|NCT00632931|3651689|FG000|COMPLETED|Part 1, Washout||11
2939686|NCT00632931|3651690|FG001|COMPLETED|Part 1, Washout||12
2939687|NCT00632931|3651691|FG002|COMPLETED|Part 1, Washout||0
2939688|NCT00632931|3651689|FG000|NOT COMPLETED|Part 1, Washout||0
2939689|NCT00632931|3651690|FG001|NOT COMPLETED|Part 1, Washout||0
2939690|NCT00632931|3651691|FG002|NOT COMPLETED|Part 1, Washout||0
2939691|NCT00632931|3651689|FG000|STARTED|Part 1, Period 2||11
2939692|NCT00632931|3651690|FG001|STARTED|Part 1, Period 2||12
2939693|NCT00632931|3651691|FG002|STARTED|Part 1, Period 2||0
2939694|NCT00632931|3651689|FG000|COMPLETED|Part 1, Period 2||11
2939695|NCT00632931|3651690|FG001|COMPLETED|Part 1, Period 2||12
2939696|NCT00632931|3651691|FG002|COMPLETED|Part 1, Period 2||0
2939697|NCT00632931|3651689|FG000|NOT COMPLETED|Part 1, Period 2||0
2939698|NCT00632931|3651690|FG001|NOT COMPLETED|Part 1, Period 2||0
2939699|NCT00632931|3651691|FG002|NOT COMPLETED|Part 1, Period 2||0
2939700|NCT00632931|3651689|FG000|STARTED|Post-Part 1 Washout|1 patient who did not complete Period 1 was subsequently enrolled into Post Part 1|12
2939701|NCT00632931|3651690|FG001|STARTED|Post-Part 1 Washout||12
2939702|NCT00632931|3651691|FG002|STARTED|Post-Part 1 Washout||0
3277549|NCT02706717|4010950|FG001|COMPLETED|Overall Study||35
3277550|NCT02706717|4010949|FG000|NOT COMPLETED|Overall Study||1
3277551|NCT02706717|4010950|FG001|NOT COMPLETED|Overall Study||11
3277552|NCT02706834|4010967|FG000|STARTED|Overall Study||3
3277553|NCT02706834|4010968|FG001|STARTED|Overall Study||3
3277554|NCT02706834|4010969|FG002|STARTED|Overall Study||3
3277555|NCT02706834|4010970|FG003|STARTED|Overall Study||3
3277556|NCT02706834|4010971|FG004|STARTED|Overall Study||3
3277557|NCT02706834|4010972|FG005|STARTED|Overall Study||3
3277558|NCT02706834|4010973|FG006|STARTED|Overall Study||3
3277559|NCT02706834|4010974|FG007|STARTED|Overall Study||3
3277560|NCT02706834|4010975|FG008|STARTED|Overall Study||4
3277561|NCT02706834|4010976|FG009|STARTED|Overall Study||4
3277562|NCT02706834|4010977|FG010|STARTED|Overall Study||4
3277563|NCT02706834|4010967|FG000|COMPLETED|Overall Study|Completed = completed study drug|1
3277564|NCT02706834|4010968|FG001|COMPLETED|Overall Study||2
3277565|NCT02706834|4010969|FG002|COMPLETED|Overall Study||2
3277566|NCT02706834|4010970|FG003|COMPLETED|Overall Study||3
3277567|NCT02706834|4010971|FG004|COMPLETED|Overall Study||2
3277568|NCT02706834|4010972|FG005|COMPLETED|Overall Study||3
3277569|NCT02706834|4010973|FG006|COMPLETED|Overall Study||3
3277570|NCT02706834|4010974|FG007|COMPLETED|Overall Study||3
3277571|NCT02706834|4010975|FG008|COMPLETED|Overall Study||4
3277572|NCT02706834|4010976|FG009|COMPLETED|Overall Study||3
3277573|NCT02706834|4010977|FG010|COMPLETED|Overall Study||3
3277574|NCT02706834|4010967|FG000|NOT COMPLETED|Overall Study||2
3277575|NCT02706834|4010968|FG001|NOT COMPLETED|Overall Study||1
3277576|NCT02706834|4010969|FG002|NOT COMPLETED|Overall Study||1
3277577|NCT02706834|4010970|FG003|NOT COMPLETED|Overall Study||0
3277578|NCT02706834|4010971|FG004|NOT COMPLETED|Overall Study||1
3277579|NCT02706834|4010972|FG005|NOT COMPLETED|Overall Study||0
3277580|NCT02706834|4010973|FG006|NOT COMPLETED|Overall Study||0
3277581|NCT02706834|4010974|FG007|NOT COMPLETED|Overall Study||0
3277582|NCT02706834|4010975|FG008|NOT COMPLETED|Overall Study||0
3277583|NCT02706834|4010976|FG009|NOT COMPLETED|Overall Study||1
3277584|NCT02706834|4010977|FG010|NOT COMPLETED|Overall Study||1
3277585|NCT02706873|4011026|FG000|STARTED|Overall Study||315
3277586|NCT02706873|4011027|FG001|STARTED|Overall Study||55
3277587|NCT02706873|4011028|FG002|STARTED|Overall Study||317
3277588|NCT02706873|4011029|FG003|STARTED|Overall Study||315
3277589|NCT02706873|4011026|FG000|Received Study Drug|Overall Study||314
3277590|NCT02706873|4011027|FG001|Received Study Drug|Overall Study||55
3277591|NCT02706873|4011028|FG002|Received Study Drug|Overall Study||317
3277592|NCT02706873|4011029|FG003|Received Study Drug|Overall Study||314
3277593|NCT02706873|4011026|FG000|Global Analysis Population|Overall Study|Includes 28 participants in the Japan sub-study|314
3277594|NCT02706873|4011027|FG001|Global Analysis Population|Overall Study||0
3277595|NCT02706873|4011028|FG002|Global Analysis Population|Overall Study|Includes 27 participants in the Japan sub-study|317
3277596|NCT02706873|4011029|FG003|Global Analysis Population|Overall Study|Includes 28 participants in the Japan sub-study|314
3277597|NCT02706873|4011026|FG000|Japan Sub-study|Overall Study||28
3277598|NCT02706873|4011027|FG001|Japan Sub-study|Overall Study||55
3277599|NCT02706873|4011028|FG002|Japan Sub-study|Overall Study||27
3277600|NCT02706873|4011029|FG003|Japan Sub-study|Overall Study||28
3277601|NCT02706873|4011026|FG000|COMPLETED|Overall Study||268
3277602|NCT02706873|4011027|FG001|COMPLETED|Overall Study||51
3277603|NCT02706873|4011028|FG002|COMPLETED|Overall Study||290
3277604|NCT02706873|4011029|FG003|COMPLETED|Overall Study||282
3277605|NCT02706873|4011026|FG000|NOT COMPLETED|Overall Study||47
3277606|NCT02706873|4011027|FG001|NOT COMPLETED|Overall Study||4
3277607|NCT02706873|4011028|FG002|NOT COMPLETED|Overall Study||27
3277608|NCT02706873|4011029|FG003|NOT COMPLETED|Overall Study||33
3277609|NCT02706886|4011050|FG000|STARTED|Part A: SAD Period||8
3277610|NCT02706886|4011051|FG001|STARTED|Part A: SAD Period||6
3277611|NCT02706886|4011052|FG002|STARTED|Part A: SAD Period||6
3277612|NCT02706886|4011053|FG003|STARTED|Part A: SAD Period||6
3277613|NCT02706886|4011054|FG004|STARTED|Part A: SAD Period||6
2939703|NCT00632931|3651689|FG000|COMPLETED|Post-Part 1 Washout||12
2939704|NCT00632931|3651690|FG001|COMPLETED|Post-Part 1 Washout||12
2939705|NCT00632931|3651691|FG002|COMPLETED|Post-Part 1 Washout||0
2939706|NCT00632931|3651689|FG000|NOT COMPLETED|Post-Part 1 Washout||0
2939707|NCT00632931|3651690|FG001|NOT COMPLETED|Post-Part 1 Washout||0
2939708|NCT00632931|3651691|FG002|NOT COMPLETED|Post-Part 1 Washout||0
2939709|NCT00632931|3651689|FG000|STARTED|Part 2||0
2939710|NCT00632931|3651690|FG001|STARTED|Part 2||0
2939711|NCT00632931|3651691|FG002|STARTED|Part 2||24
2939712|NCT00632931|3651689|FG000|COMPLETED|Part 2||0
2939713|NCT00632931|3651690|FG001|COMPLETED|Part 2||0
2939714|NCT00632931|3651691|FG002|COMPLETED|Part 2||0
2939715|NCT00632931|3651689|FG000|NOT COMPLETED|Part 2||0
2939716|NCT00632931|3651690|FG001|NOT COMPLETED|Part 2||0
2939717|NCT00632931|3651691|FG002|NOT COMPLETED|Part 2||24
2939718|NCT00632970|3651698|FG000|STARTED|Overall Study||3
2939719|NCT00632970|3651699|FG001|STARTED|Overall Study||3
2939720|NCT00632970|3651698|FG000|COMPLETED|Overall Study||3
2939721|NCT00632970|3651699|FG001|COMPLETED|Overall Study||3
2939722|NCT00632970|3651698|FG000|NOT COMPLETED|Overall Study||0
2939723|NCT00632970|3651699|FG001|NOT COMPLETED|Overall Study||0
2939724|NCT00633009|3651708|FG000|STARTED|Overall Study||12
2939725|NCT00633009|3651709|FG001|STARTED|Overall Study||27
2939726|NCT00633009|3651710|FG002|STARTED|Overall Study||11
2939727|NCT00633009|3651708|FG000|COMPLETED|Overall Study||8
2939728|NCT00633009|3651709|FG001|COMPLETED|Overall Study||23
2939729|NCT00633009|3651710|FG002|COMPLETED|Overall Study||10
2939730|NCT00633009|3651708|FG000|NOT COMPLETED|Overall Study||4
2939731|NCT00633009|3651709|FG001|NOT COMPLETED|Overall Study||4
2939732|NCT00633009|3651710|FG002|NOT COMPLETED|Overall Study||1
2939733|NCT00633022|3651724|FG000|STARTED|Overall Study||34
2939734|NCT00633022|3651725|FG001|STARTED|Overall Study||33
2939735|NCT00633022|3651726|FG002|STARTED|Overall Study||32
2939736|NCT00633022|3651724|FG000|COMPLETED|Overall Study||33
2939737|NCT00633022|3651725|FG001|COMPLETED|Overall Study||32
2939738|NCT00633022|3651726|FG002|COMPLETED|Overall Study||27
2939739|NCT00633022|3651724|FG000|NOT COMPLETED|Overall Study||1
2939740|NCT00633022|3651725|FG001|NOT COMPLETED|Overall Study||1
2939741|NCT00633022|3651726|FG002|NOT COMPLETED|Overall Study||5
2939742|NCT00633074|3651736|FG000|STARTED|Overall Study||360
2939743|NCT00633074|3651737|FG001|STARTED|Overall Study||360
2939744|NCT00633074|3651736|FG000|COMPLETED|Overall Study||359
3277614|NCT02706886|4011055|FG005|STARTED|Part A: SAD Period||0
3277615|NCT02706886|4011056|FG006|STARTED|Part A: SAD Period||0
3277616|NCT02706886|4011057|FG007|STARTED|Part A: SAD Period||0
3277617|NCT02706886|4011058|FG008|STARTED|Part A: SAD Period||0
3277618|NCT02706886|4011050|FG000|COMPLETED|Part A: SAD Period||8
3277619|NCT02706886|4011051|FG001|COMPLETED|Part A: SAD Period||6
3277620|NCT02706886|4011052|FG002|COMPLETED|Part A: SAD Period||6
3277621|NCT02706886|4011053|FG003|COMPLETED|Part A: SAD Period||4
3277622|NCT02706886|4011054|FG004|COMPLETED|Part A: SAD Period||6
3277623|NCT02706886|4011055|FG005|COMPLETED|Part A: SAD Period||0
3277624|NCT02706886|4011056|FG006|COMPLETED|Part A: SAD Period||0
3277625|NCT02706886|4011057|FG007|COMPLETED|Part A: SAD Period||0
3277626|NCT02706886|4011058|FG008|COMPLETED|Part A: SAD Period||0
3277627|NCT02706886|4011050|FG000|NOT COMPLETED|Part A: SAD Period||0
3277628|NCT02706886|4011051|FG001|NOT COMPLETED|Part A: SAD Period||0
3277629|NCT02706886|4011052|FG002|NOT COMPLETED|Part A: SAD Period||0
3277630|NCT02706886|4011053|FG003|NOT COMPLETED|Part A: SAD Period||2
3277631|NCT02706886|4011054|FG004|NOT COMPLETED|Part A: SAD Period||0
3277632|NCT02706886|4011055|FG005|NOT COMPLETED|Part A: SAD Period||0
3277633|NCT02706886|4011056|FG006|NOT COMPLETED|Part A: SAD Period||0
3277634|NCT02706886|4011057|FG007|NOT COMPLETED|Part A: SAD Period||0
3277635|NCT02706886|4011058|FG008|NOT COMPLETED|Part A: SAD Period||0
3277636|NCT02706886|4011050|FG000|STARTED|Part B: MAD Study Days 1-85||0
3277637|NCT02706886|4011051|FG001|STARTED|Part B: MAD Study Days 1-85||0
3277638|NCT02706886|4011052|FG002|STARTED|Part B: MAD Study Days 1-85||0
3277639|NCT02706886|4011053|FG003|STARTED|Part B: MAD Study Days 1-85||0
3277640|NCT02706886|4011054|FG004|STARTED|Part B: MAD Study Days 1-85||0
3277641|NCT02706886|4011055|FG005|STARTED|Part B: MAD Study Days 1-85||3
3277642|NCT02706886|4011056|FG006|STARTED|Part B: MAD Study Days 1-85||7
3277643|NCT02706886|4011057|FG007|STARTED|Part B: MAD Study Days 1-85||7
3277644|NCT02706886|4011058|FG008|STARTED|Part B: MAD Study Days 1-85||3
3277645|NCT02706886|4011050|FG000|COMPLETED|Part B: MAD Study Days 1-85||0
3277646|NCT02706886|4011051|FG001|COMPLETED|Part B: MAD Study Days 1-85||0
3277647|NCT02706886|4011052|FG002|COMPLETED|Part B: MAD Study Days 1-85||0
3277648|NCT02706886|4011053|FG003|COMPLETED|Part B: MAD Study Days 1-85||0
3277649|NCT02706886|4011054|FG004|COMPLETED|Part B: MAD Study Days 1-85||0
3277650|NCT02706886|4011055|FG005|COMPLETED|Part B: MAD Study Days 1-85||3
3277651|NCT02706886|4011056|FG006|COMPLETED|Part B: MAD Study Days 1-85||7
3277652|NCT02706886|4011057|FG007|COMPLETED|Part B: MAD Study Days 1-85||7
3277653|NCT02706886|4011058|FG008|COMPLETED|Part B: MAD Study Days 1-85||3
3277654|NCT02706886|4011050|FG000|NOT COMPLETED|Part B: MAD Study Days 1-85||0
3277655|NCT02706886|4011051|FG001|NOT COMPLETED|Part B: MAD Study Days 1-85||0
3277656|NCT02706886|4011052|FG002|NOT COMPLETED|Part B: MAD Study Days 1-85||0
3277657|NCT02706886|4011053|FG003|NOT COMPLETED|Part B: MAD Study Days 1-85||0
3277658|NCT02706886|4011054|FG004|NOT COMPLETED|Part B: MAD Study Days 1-85||0
2939745|NCT00633074|3651737|FG001|COMPLETED|Overall Study||360
2939746|NCT00633074|3651736|FG000|NOT COMPLETED|Overall Study||1
2939747|NCT00633074|3651737|FG001|NOT COMPLETED|Overall Study||0
3034474|NCT01132820|3753543|FG000|STARTED|Overall Study||53
3277659|NCT02706886|4011055|FG005|NOT COMPLETED|Part B: MAD Study Days 1-85||0
3277660|NCT02706886|4011056|FG006|NOT COMPLETED|Part B: MAD Study Days 1-85||0
3277661|NCT02706886|4011057|FG007|NOT COMPLETED|Part B: MAD Study Days 1-85||0
2939748|NCT00633126|3651743|FG000|STARTED|Overall Study||9
2939749|NCT00633126|3651743|FG000|COMPLETED|Overall Study||8
2939750|NCT00633126|3651743|FG000|NOT COMPLETED|Overall Study||1
2939751|NCT00633139|3651750|FG000|STARTED|Overall Study||4
2939752|NCT00633139|3651751|FG001|STARTED|Overall Study||5
2939753|NCT00633139|3651752|FG002|STARTED|Overall Study||4
2939754|NCT00633139|3651750|FG000|COMPLETED|Overall Study||4
2939755|NCT00633139|3651751|FG001|COMPLETED|Overall Study||4
3277662|NCT02706886|4011058|FG008|NOT COMPLETED|Part B: MAD Study Days 1-85||0
3277663|NCT02706886|4011050|FG000|STARTED|Part B: MAD Study Day 85-End of Study||0
3277664|NCT02706886|4011051|FG001|STARTED|Part B: MAD Study Day 85-End of Study||0
3277665|NCT02706886|4011052|FG002|STARTED|Part B: MAD Study Day 85-End of Study||0
3277666|NCT02706886|4011053|FG003|STARTED|Part B: MAD Study Day 85-End of Study||0
3277667|NCT02706886|4011054|FG004|STARTED|Part B: MAD Study Day 85-End of Study||0
3277668|NCT02706886|4011055|FG005|STARTED|Part B: MAD Study Day 85-End of Study||0
3277669|NCT02706886|4011056|FG006|STARTED|Part B: MAD Study Day 85-End of Study|One participant from the Part B: MAD: Placebo arm crossed over to this lumasiran arm.|8
3277670|NCT02706886|4011057|FG007|STARTED|Part B: MAD Study Day 85-End of Study|One participant from the Part B: MAD: Placebo arm crossed over to this lumasiran arm.|8
3277671|NCT02706886|4011058|FG008|STARTED|Part B: MAD Study Day 85-End of Study|One participant from the Part B: MAD: Placebo arm crossed over to this lumasiran arm.|4
3277672|NCT02706886|4011050|FG000|COMPLETED|Part B: MAD Study Day 85-End of Study||0
3277673|NCT02706886|4011051|FG001|COMPLETED|Part B: MAD Study Day 85-End of Study||0
3277674|NCT02706886|4011052|FG002|COMPLETED|Part B: MAD Study Day 85-End of Study||0
3277675|NCT02706886|4011053|FG003|COMPLETED|Part B: MAD Study Day 85-End of Study||0
3277676|NCT02706886|4011054|FG004|COMPLETED|Part B: MAD Study Day 85-End of Study||0
3277677|NCT02706886|4011055|FG005|COMPLETED|Part B: MAD Study Day 85-End of Study||0
3277678|NCT02706886|4011056|FG006|COMPLETED|Part B: MAD Study Day 85-End of Study||8
3277679|NCT02706886|4011057|FG007|COMPLETED|Part B: MAD Study Day 85-End of Study||8
3277680|NCT02706886|4011058|FG008|COMPLETED|Part B: MAD Study Day 85-End of Study||4
3277681|NCT02706886|4011050|FG000|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0
3277682|NCT02706886|4011051|FG001|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0
3277683|NCT02706886|4011052|FG002|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0
3277684|NCT02706886|4011053|FG003|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0
3277685|NCT02706886|4011054|FG004|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0
3277686|NCT02706886|4011055|FG005|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0
3277687|NCT02706886|4011056|FG006|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0
3277688|NCT02706886|4011057|FG007|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0
3277689|NCT02706886|4011058|FG008|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0
3277690|NCT02706899|4011103|FG000|STARTED|Overall Study||13
3277691|NCT02706899|4011104|FG001|STARTED|Overall Study||6
3277692|NCT02706899|4011103|FG000|COMPLETED|Overall Study||0
3277693|NCT02706899|4011104|FG001|COMPLETED|Overall Study||0
3277694|NCT02706899|4011103|FG000|NOT COMPLETED|Overall Study||13
3277695|NCT02706899|4011104|FG001|NOT COMPLETED|Overall Study||6
3277696|NCT02706925|4011119|FG000|STARTED|Overall Study||16
3277697|NCT02706925|4011120|FG001|STARTED|Overall Study||6
3277698|NCT02706925|4011121|FG002|STARTED|Overall Study||6
3277699|NCT02706925|4011122|FG003|STARTED|Overall Study||6
3277700|NCT02706925|4011123|FG004|STARTED|Overall Study||6
3277701|NCT02706925|4011124|FG005|STARTED|Overall Study||5
3277702|NCT02706925|4011125|FG006|STARTED|Overall Study||6
3277703|NCT02706925|4011126|FG007|STARTED|Overall Study||6
3277704|NCT02706925|4011127|FG008|STARTED|Overall Study||6
3277705|NCT02706925|4011119|FG000|COMPLETED|Overall Study||16
3277706|NCT02706925|4011120|FG001|COMPLETED|Overall Study||6
3277707|NCT02706925|4011121|FG002|COMPLETED|Overall Study||6
3277708|NCT02706925|4011122|FG003|COMPLETED|Overall Study||6
3277709|NCT02706925|4011123|FG004|COMPLETED|Overall Study||6
3277710|NCT02706925|4011124|FG005|COMPLETED|Overall Study||5
3277711|NCT02706925|4011125|FG006|COMPLETED|Overall Study||6
3277712|NCT02706925|4011126|FG007|COMPLETED|Overall Study||6
3277713|NCT02706925|4011127|FG008|COMPLETED|Overall Study||6
3277714|NCT02706925|4011119|FG000|NOT COMPLETED|Overall Study||0
3277715|NCT02706925|4011120|FG001|NOT COMPLETED|Overall Study||0
3277716|NCT02706925|4011121|FG002|NOT COMPLETED|Overall Study||0
3277717|NCT02706925|4011122|FG003|NOT COMPLETED|Overall Study||0
3277718|NCT02706925|4011123|FG004|NOT COMPLETED|Overall Study||0
3277719|NCT02706925|4011124|FG005|NOT COMPLETED|Overall Study||0
3277720|NCT02706925|4011125|FG006|NOT COMPLETED|Overall Study||0
3277721|NCT02706925|4011126|FG007|NOT COMPLETED|Overall Study||0
3277722|NCT02706925|4011127|FG008|NOT COMPLETED|Overall Study||0
3277723|NCT02706938|4011157|FG000|STARTED|First Period, 6 Weeks||32
3277724|NCT02706938|4011158|FG001|STARTED|First Period, 6 Weeks||33
3277725|NCT02706938|4011157|FG000|COMPLETED|First Period, 6 Weeks||21
3277726|NCT02706938|4011158|FG001|COMPLETED|First Period, 6 Weeks||31
3277727|NCT02706938|4011157|FG000|NOT COMPLETED|First Period, 6 Weeks||11
3277728|NCT02706938|4011158|FG001|NOT COMPLETED|First Period, 6 Weeks||2
3277729|NCT02706938|4011157|FG000|STARTED|Second Period, 6 Weeks||21
3277730|NCT02706938|4011158|FG001|STARTED|Second Period, 6 Weeks||31
3277731|NCT02706938|4011157|FG000|COMPLETED|Second Period, 6 Weeks|Only data from 20 patients were finally analyzed because of missing data.|21
3316356|NCT03110458|4049654|FG002|NOT COMPLETED|Overall Study||3
2939756|NCT00633139|3651752|FG002|COMPLETED|Overall Study||3
2939757|NCT00633139|3651750|FG000|NOT COMPLETED|Overall Study||0
2939758|NCT00633139|3651751|FG001|NOT COMPLETED|Overall Study||1
2939759|NCT00633139|3651752|FG002|NOT COMPLETED|Overall Study||1
2939760|NCT00633152|3651762|FG000|STARTED|Overall Study||103
2939761|NCT00633152|3651763|FG001|STARTED|Overall Study||47
2939762|NCT00633152|3651762|FG000|MITT and Safety Population|Overall Study||98
2939763|NCT00633152|3651763|FG001|MITT and Safety Population|Overall Study||45
2939764|NCT00633152|3651762|FG000|Clinically Evaluable Population|Overall Study||86
2939765|NCT00633152|3651763|FG001|Clinically Evaluable Population|Overall Study||39
2939766|NCT00633152|3651762|FG000|COMPLETED|Overall Study||89
3277732|NCT02706938|4011158|FG001|COMPLETED|Second Period, 6 Weeks|Only data from 19 patients were finally analyzed because of missing data.|21
3277733|NCT02706938|4011157|FG000|NOT COMPLETED|Second Period, 6 Weeks||0
3277734|NCT02706938|4011158|FG001|NOT COMPLETED|Second Period, 6 Weeks||10
2939767|NCT00633152|3651763|FG001|COMPLETED|Overall Study||41
2939768|NCT00633152|3651762|FG000|NOT COMPLETED|Overall Study||14
2939769|NCT00633152|3651763|FG001|NOT COMPLETED|Overall Study||6
2939770|NCT00633217|3651773|FG000|STARTED|Overall Study||121
2939771|NCT00633217|3651774|FG001|STARTED|Overall Study||126
2939772|NCT00633217|3651773|FG000|COMPLETED|Overall Study||106
2939773|NCT00633217|3651774|FG001|COMPLETED|Overall Study||103
2939774|NCT00633217|3651773|FG000|NOT COMPLETED|Overall Study||15
2939775|NCT00633217|3651774|FG001|NOT COMPLETED|Overall Study||23
2939776|NCT00633243|3651782|FG000|STARTED|Overall Study||12
2939777|NCT00633243|3651783|FG001|STARTED|Overall Study||9
2939778|NCT00633243|3651782|FG000|COMPLETED|Overall Study||11
3277735|NCT02706951|4011168|FG000|STARTED|Overall Study||216
3277736|NCT02706951|4011169|FG001|STARTED|Overall Study||217
3277737|NCT02706951|4011170|FG002|STARTED|Overall Study||215
3277738|NCT02706951|4011168|FG000|COMPLETED|Overall Study||202
3277739|NCT02706951|4011169|FG001|COMPLETED|Overall Study||201
3277740|NCT02706951|4011170|FG002|COMPLETED|Overall Study||205
3277741|NCT02706951|4011168|FG000|NOT COMPLETED|Overall Study||14
3277742|NCT02706951|4011169|FG001|NOT COMPLETED|Overall Study||16
3277743|NCT02706951|4011170|FG002|NOT COMPLETED|Overall Study||10
3277744|NCT02707146|4011180|FG000|STARTED|Overall Study||359
3277745|NCT02707146|4011181|FG001|STARTED|Overall Study||391
3277746|NCT02707146|4011180|FG000|COMPLETED|Overall Study||359
3277747|NCT02707146|4011181|FG001|COMPLETED|Overall Study||388
3277748|NCT02707146|4011180|FG000|NOT COMPLETED|Overall Study||0
3277749|NCT02707146|4011181|FG001|NOT COMPLETED|Overall Study||3
3277750|NCT02707172|4011187|FG000|STARTED|1st Set of Experiment||28
3277751|NCT02707172|4011187|FG000|COMPLETED|1st Set of Experiment||28
3277752|NCT02707172|4011187|FG000|NOT COMPLETED|1st Set of Experiment||0
3277753|NCT02707172|4011187|FG000|STARTED|Wash Out||28
3277754|NCT02707172|4011187|FG000|COMPLETED|Wash Out||28
3277755|NCT02707172|4011187|FG000|NOT COMPLETED|Wash Out||0
3277756|NCT02707172|4011187|FG000|STARTED|2nd Set of Experiment||28
3277757|NCT02707172|4011187|FG000|COMPLETED|2nd Set of Experiment||28
3277758|NCT02707172|4011187|FG000|NOT COMPLETED|2nd Set of Experiment||0
3277759|NCT02707432|4011194|FG000|STARTED|Overall Study||72
3277760|NCT02707432|4011195|FG001|STARTED|Overall Study||71
3277761|NCT02707432|4011194|FG000|COMPLETED|Overall Study||57
3277762|NCT02707432|4011195|FG001|COMPLETED|Overall Study||51
3277763|NCT02707432|4011194|FG000|NOT COMPLETED|Overall Study||15
3277764|NCT02707432|4011195|FG001|NOT COMPLETED|Overall Study||20
3277765|NCT02707523|4011204|FG000|STARTED|Overall Study||16
3277766|NCT02707523|4011205|FG001|STARTED|Overall Study||16
3277767|NCT02707523|4011206|FG002|STARTED|Overall Study||16
3277768|NCT02707523|4011204|FG000|COMPLETED|Overall Study||16
3277769|NCT02707523|4011205|FG001|COMPLETED|Overall Study||16
3277770|NCT02707523|4011206|FG002|COMPLETED|Overall Study||16
3277771|NCT02707523|4011204|FG000|NOT COMPLETED|Overall Study||0
3277772|NCT02707523|4011205|FG001|NOT COMPLETED|Overall Study||0
3277773|NCT02707523|4011206|FG002|NOT COMPLETED|Overall Study||0
3277774|NCT02707601|4011216|FG000|STARTED|Overall Study||76
3277775|NCT02707601|4011217|FG001|STARTED|Overall Study||74
3277776|NCT02707601|4011216|FG000|COMPLETED|Overall Study||72
3277777|NCT02707601|4011217|FG001|COMPLETED|Overall Study||70
3277778|NCT02707601|4011216|FG000|NOT COMPLETED|Overall Study||4
3277779|NCT02707601|4011217|FG001|NOT COMPLETED|Overall Study||4
3277780|NCT02707640|4011229|FG000|STARTED|Overall Study||61
3277781|NCT02707640|4011230|FG001|STARTED|Overall Study||62
3277782|NCT02707640|4011229|FG000|COMPLETED|Overall Study||52
3277783|NCT02707640|4011230|FG001|COMPLETED|Overall Study||55
3277784|NCT02707640|4011229|FG000|NOT COMPLETED|Overall Study||9
3277785|NCT02707640|4011230|FG001|NOT COMPLETED|Overall Study||7
3277786|NCT02707757|4011238|FG000|STARTED|Overall Study||88
3277787|NCT02707757|4011239|FG001|STARTED|Overall Study||96
2939779|NCT00633243|3651783|FG001|COMPLETED|Overall Study||2
3277788|NCT02707757|4011238|FG000|COMPLETED|Overall Study||76
3277789|NCT02707757|4011239|FG001|COMPLETED|Overall Study||84
3277790|NCT02707757|4011238|FG000|NOT COMPLETED|Overall Study||12
3277791|NCT02707757|4011239|FG001|NOT COMPLETED|Overall Study||12
3277792|NCT02707770|4011247|FG000|STARTED|Overall Study||10
3277793|NCT02707770|4011248|FG001|STARTED|Overall Study||10
3277794|NCT02707770|4011247|FG000|COMPLETED|Overall Study|One patient withdrew from the study following consent, initial assessment and randomisation|9
3277795|NCT02707770|4011248|FG001|COMPLETED|Overall Study||10
3277796|NCT02707770|4011247|FG000|NOT COMPLETED|Overall Study||1
3277797|NCT02707770|4011248|FG001|NOT COMPLETED|Overall Study||0
3277798|NCT02707861|4011258|FG000|STARTED|Overall Study||41
3277799|NCT02707861|4011259|FG001|STARTED|Overall Study||38
2939780|NCT00633243|3651782|FG000|NOT COMPLETED|Overall Study||1
2939781|NCT00633243|3651783|FG001|NOT COMPLETED|Overall Study||7
2939782|NCT00633256|3651791|FG000|STARTED|Overall Study||12
2939783|NCT00633256|3651792|FG001|STARTED|Overall Study||13
2939784|NCT00633256|3651791|FG000|COMPLETED|Overall Study||8
2939785|NCT00633256|3651792|FG001|COMPLETED|Overall Study||10
2939786|NCT00633256|3651791|FG000|NOT COMPLETED|Overall Study||4
2939787|NCT00633256|3651792|FG001|NOT COMPLETED|Overall Study||3
2939788|NCT00633360|3651800|FG000|STARTED|Overall Study||16
2939789|NCT00633360|3651801|FG001|STARTED|Overall Study||16
2939790|NCT00633360|3651800|FG000|COMPLETED|Overall Study||12
2939791|NCT00633360|3651801|FG001|COMPLETED|Overall Study||13
2939792|NCT00633360|3651800|FG000|NOT COMPLETED|Overall Study||4
2939793|NCT00633360|3651801|FG001|NOT COMPLETED|Overall Study||3
2939794|NCT00633399|3651811|FG000|STARTED|Overall Study||71
2939795|NCT00633399|3651812|FG001|STARTED|Overall Study||68
2939796|NCT00633399|3651811|FG000|COMPLETED|Overall Study||49
2939797|NCT00633399|3651812|FG001|COMPLETED|Overall Study||53
2939798|NCT00633399|3651811|FG000|NOT COMPLETED|Overall Study||22
2939799|NCT00633399|3651812|FG001|NOT COMPLETED|Overall Study||15
2939800|NCT00633464|3651820|FG000|STARTED|Overall Study||40
2939801|NCT00633464|3651821|FG001|STARTED|Overall Study||39
2939802|NCT00633464|3651820|FG000|Treated|Overall Study||40
2939803|NCT00633464|3651821|FG001|Treated|Overall Study||37
2939804|NCT00633464|3651820|FG000|COMPLETED|Overall Study|Completed=Offstudy;major reasons:Disease progression-27,study drug toxicity-7,max clinical benefit-3|40
2939805|NCT00633464|3651821|FG001|COMPLETED|Overall Study|Completed=Offstudy;major reasons:Disease progression-25,study drug toxicity-4,subject request-3|37
2939806|NCT00633464|3651820|FG000|NOT COMPLETED|Overall Study||0
2939807|NCT00633464|3651821|FG001|NOT COMPLETED|Overall Study||2
2939808|NCT00633477|3651829|FG000|STARTED|Overall Study|Seven subjects were randomized, however, one was not treated.|7
2939809|NCT00633477|3651830|FG001|STARTED|Overall Study||11
2939810|NCT00633477|3651829|FG000|Randomized But Not Treated|Overall Study||1
2939811|NCT00633477|3651830|FG001|Randomized But Not Treated|Overall Study||0
2939812|NCT00633477|3651829|FG000|Prematurely Discontinued Study Drug|Overall Study||1
2939813|NCT00633477|3651830|FG001|Prematurely Discontinued Study Drug|Overall Study||0
2939814|NCT00633477|3651829|FG000|Completed Study Through Day 28|Overall Study||4
2939815|NCT00633477|3651830|FG001|Completed Study Through Day 28|Overall Study||8
2939816|NCT00633477|3651829|FG000|COMPLETED|Overall Study|Include all subjects who could be evaluated for 28-d survival.|5
2939817|NCT00633477|3651830|FG001|COMPLETED|Overall Study|Include all subjects who could be evaluated for 28-d survival.|11
2939818|NCT00633477|3651829|FG000|NOT COMPLETED|Overall Study||2
2939819|NCT00633477|3651830|FG001|NOT COMPLETED|Overall Study||0
2939820|NCT00633594|3651839|FG000|STARTED|Overall Study||5
2939821|NCT00633594|3651840|FG001|STARTED|Overall Study||8
2939822|NCT00633594|3651841|FG002|STARTED|Overall Study||26
2939823|NCT00633594|3651839|FG000|COMPLETED|Overall Study||5
2939824|NCT00633594|3651840|FG001|COMPLETED|Overall Study||3
2939825|NCT00633594|3651841|FG002|COMPLETED|Overall Study||16
3277800|NCT02707861|4011258|FG000|COMPLETED|Overall Study||0
3277801|NCT02707861|4011259|FG001|COMPLETED|Overall Study||0
3277802|NCT02707861|4011258|FG000|NOT COMPLETED|Overall Study||41
3277803|NCT02707861|4011259|FG001|NOT COMPLETED|Overall Study||38
3277804|NCT02707952|4011269|FG000|STARTED|Overall Study||129
3277805|NCT02707952|4011270|FG001|STARTED|Overall Study||53
3277806|NCT02707952|4011271|FG002|STARTED|Overall Study||103
3277807|NCT02707952|4011272|FG003|STARTED|Overall Study||10
3277808|NCT02707952|4011269|FG000|Participants Who Received Study Drug|Overall Study||129
3277809|NCT02707952|4011270|FG001|Participants Who Received Study Drug|Overall Study||52
3277810|NCT02707952|4011271|FG002|Participants Who Received Study Drug|Overall Study||103
3277811|NCT02707952|4011272|FG003|Participants Who Received Study Drug|Overall Study||10
3277812|NCT02707952|4011269|FG000|COMPLETED|Overall Study||127
3277813|NCT02707952|4011270|FG001|COMPLETED|Overall Study||52
3277814|NCT02707952|4011271|FG002|COMPLETED|Overall Study||101
3277815|NCT02707952|4011272|FG003|COMPLETED|Overall Study||10
3277816|NCT02707952|4011269|FG000|NOT COMPLETED|Overall Study||2
3277817|NCT02707952|4011270|FG001|NOT COMPLETED|Overall Study||1
3277818|NCT02707952|4011271|FG002|NOT COMPLETED|Overall Study||2
3277819|NCT02707952|4011272|FG003|NOT COMPLETED|Overall Study||0
3277820|NCT02707965|4011293|FG000|STARTED|Overall Study||3
3277821|NCT02707965|4011294|FG001|STARTED|Overall Study||2
3277822|NCT02707965|4011295|FG002|STARTED|Overall Study||4
3277823|NCT02707965|4011296|FG003|STARTED|Overall Study||0
3277824|NCT02707965|4011297|FG004|STARTED|Overall Study||2
3277825|NCT02707965|4011298|FG005|STARTED|Overall Study||1
3277826|NCT02707965|4011299|FG006|STARTED|Overall Study||0
3277827|NCT02707965|4011300|FG007|STARTED|Overall Study||3
3277828|NCT02707965|4011301|FG008|STARTED|Overall Study||1
3277829|NCT02707965|4011302|FG009|STARTED|Overall Study||0
3277830|NCT02707965|4011303|FG010|STARTED|Overall Study||1
3277831|NCT02707965|4011304|FG011|STARTED|Overall Study||0
3277832|NCT02707965|4011305|FG012|STARTED|Overall Study||0
3277833|NCT02707965|4011306|FG013|STARTED|Overall Study||2
3277834|NCT02707965|4011307|FG014|STARTED|Overall Study||2
3277835|NCT02707965|4011308|FG015|STARTED|Overall Study||0
3277836|NCT02707965|4011293|FG000|COMPLETED|Overall Study||2
3277837|NCT02707965|4011294|FG001|COMPLETED|Overall Study||1
3277838|NCT02707965|4011295|FG002|COMPLETED|Overall Study||3
3277839|NCT02707965|4011296|FG003|COMPLETED|Overall Study||0
3277840|NCT02707965|4011297|FG004|COMPLETED|Overall Study||2
2939826|NCT00633594|3651839|FG000|NOT COMPLETED|Overall Study||0
2939827|NCT00633594|3651840|FG001|NOT COMPLETED|Overall Study||5
2939828|NCT00633594|3651841|FG002|NOT COMPLETED|Overall Study||10
2939829|NCT00633750|3651852|FG000|STARTED|Overall Study||47
2939830|NCT00633750|3651852|FG000|COMPLETED|Overall Study||42
2939831|NCT00633750|3651852|FG000|NOT COMPLETED|Overall Study||5
2939832|NCT00633867|3651860|FG000|STARTED|Overall Study||60
2939833|NCT00633867|3651861|FG001|STARTED|Overall Study||60
2939834|NCT00633867|3651860|FG000|COMPLETED|Overall Study||60
2939835|NCT00633867|3651861|FG001|COMPLETED|Overall Study||60
2939836|NCT00633867|3651860|FG000|NOT COMPLETED|Overall Study||0
2939837|NCT00633867|3651861|FG001|NOT COMPLETED|Overall Study||0
2939838|NCT00633880|3651870|FG000|STARTED|Open Label Titration||181
3277841|NCT02707965|4011298|FG005|COMPLETED|Overall Study||1
3277842|NCT02707965|4011299|FG006|COMPLETED|Overall Study||0
3277843|NCT02707965|4011300|FG007|COMPLETED|Overall Study||0
3277844|NCT02707965|4011301|FG008|COMPLETED|Overall Study||1
3277845|NCT02707965|4011302|FG009|COMPLETED|Overall Study||0
3277846|NCT02707965|4011303|FG010|COMPLETED|Overall Study||1
3277847|NCT02707965|4011304|FG011|COMPLETED|Overall Study||0
3277848|NCT02707965|4011305|FG012|COMPLETED|Overall Study||0
3277849|NCT02707965|4011306|FG013|COMPLETED|Overall Study||2
3277850|NCT02707965|4011307|FG014|COMPLETED|Overall Study||0
3277851|NCT02707965|4011308|FG015|COMPLETED|Overall Study||0
3277852|NCT02707965|4011293|FG000|NOT COMPLETED|Overall Study||1
3277853|NCT02707965|4011294|FG001|NOT COMPLETED|Overall Study||1
3277854|NCT02707965|4011295|FG002|NOT COMPLETED|Overall Study||1
3277855|NCT02707965|4011296|FG003|NOT COMPLETED|Overall Study||0
3277856|NCT02707965|4011297|FG004|NOT COMPLETED|Overall Study||0
3277857|NCT02707965|4011298|FG005|NOT COMPLETED|Overall Study||0
3277858|NCT02707965|4011299|FG006|NOT COMPLETED|Overall Study||0
3277859|NCT02707965|4011300|FG007|NOT COMPLETED|Overall Study||3
3277860|NCT02707965|4011301|FG008|NOT COMPLETED|Overall Study||0
3277861|NCT02707965|4011302|FG009|NOT COMPLETED|Overall Study||0
3277862|NCT02707965|4011303|FG010|NOT COMPLETED|Overall Study||0
3277863|NCT02707965|4011304|FG011|NOT COMPLETED|Overall Study||0
3277864|NCT02707965|4011305|FG012|NOT COMPLETED|Overall Study||0
3277865|NCT02707965|4011306|FG013|NOT COMPLETED|Overall Study||0
3277866|NCT02707965|4011307|FG014|NOT COMPLETED|Overall Study||2
3277867|NCT02707965|4011308|FG015|NOT COMPLETED|Overall Study||0
3277868|NCT02707991|4011343|FG000|STARTED|Overall Study||33
3277869|NCT02707991|4011344|FG001|STARTED|Overall Study||35
3277870|NCT02707991|4011343|FG000|Day 60 Data Collectio|Overall Study||32
3277871|NCT02707991|4011344|FG001|Day 60 Data Collectio|Overall Study||34
3277872|NCT02707991|4011343|FG000|Month 6 Data Collection|Overall Study||32
3277873|NCT02707991|4011344|FG001|Month 6 Data Collection|Overall Study||34
3277874|NCT02707991|4011343|FG000|COMPLETED|Overall Study||32
3277875|NCT02707991|4011344|FG001|COMPLETED|Overall Study||34
3277876|NCT02707991|4011343|FG000|NOT COMPLETED|Overall Study||1
3277877|NCT02707991|4011344|FG001|NOT COMPLETED|Overall Study||1
3277878|NCT02708095|4011353|FG000|STARTED|Overall Study||105
3277879|NCT02708095|4011354|FG001|STARTED|Overall Study||105
3277880|NCT02708095|4011355|FG002|STARTED|Overall Study||104
3277881|NCT02708095|4011353|FG000|Received at Least 1 Dose of Study Drug|Overall Study||105
3277882|NCT02708095|4011354|FG001|Received at Least 1 Dose of Study Drug|Overall Study||105
3277883|NCT02708095|4011355|FG002|Received at Least 1 Dose of Study Drug|Overall Study||104
3277884|NCT02708095|4011353|FG000|COMPLETED|Overall Study||83
3277885|NCT02708095|4011354|FG001|COMPLETED|Overall Study||86
3277886|NCT02708095|4011355|FG002|COMPLETED|Overall Study||86
3277887|NCT02708095|4011353|FG000|NOT COMPLETED|Overall Study||22
3277888|NCT02708095|4011354|FG001|NOT COMPLETED|Overall Study||19
3277889|NCT02708095|4011355|FG002|NOT COMPLETED|Overall Study||18
3277890|NCT02708121|4011367|FG000|STARTED|Overall Study||35
3277891|NCT02708121|4011368|FG001|STARTED|Overall Study||31
3277892|NCT02708121|4011367|FG000|Provided Acceptability Data|Overall Study||20
3277893|NCT02708121|4011368|FG001|Provided Acceptability Data|Overall Study|This condition did not participate in acceptability survey|0
3277894|NCT02708121|4011367|FG000|Treatment Program Use Data Available|Overall Study||34
3277895|NCT02708121|4011368|FG001|Treatment Program Use Data Available|Overall Study||24
3277896|NCT02708121|4011367|FG000|6 Month In-Person Follow Up Data|Overall Study||22
3277897|NCT02708121|4011368|FG001|6 Month In-Person Follow Up Data|Overall Study||19
3277898|NCT02708121|4011367|FG000|6 Month Weight Data Via EHR|Overall Study||14
3277899|NCT02708121|4011368|FG001|6 Month Weight Data Via EHR|Overall Study||13
3277900|NCT02708121|4011367|FG000|COMPLETED|Overall Study||34
3277901|NCT02708121|4011368|FG001|COMPLETED|Overall Study||26
3277902|NCT02708121|4011367|FG000|NOT COMPLETED|Overall Study||1
3277903|NCT02708121|4011368|FG001|NOT COMPLETED|Overall Study||5
3277904|NCT02708186|4011376|FG000|STARTED|Overall Study||16
3277905|NCT02708186|4011377|FG001|STARTED|Overall Study||18
3277906|NCT02708186|4011376|FG000|COMPLETED|Overall Study||14
3277907|NCT02708186|4011377|FG001|COMPLETED|Overall Study||16
3277908|NCT02708186|4011376|FG000|NOT COMPLETED|Overall Study||2
2939839|NCT00633880|3651871|FG001|STARTED|Open Label Titration||0
2939840|NCT00633880|3651872|FG002|STARTED|Open Label Titration||0
2939841|NCT00633880|3651870|FG000|COMPLETED|Open Label Titration||101
2939842|NCT00633880|3651871|FG001|COMPLETED|Open Label Titration||0
3277909|NCT02708186|4011377|FG001|NOT COMPLETED|Overall Study||2
3277910|NCT02708212|4011385|FG000|STARTED|Overall Study||60
3277911|NCT02708212|4011386|FG001|STARTED|Overall Study||60
3277912|NCT02708212|4011385|FG000|COMPLETED|Overall Study||60
2939843|NCT00633880|3651872|FG002|COMPLETED|Open Label Titration||0
2939844|NCT00633880|3651870|FG000|NOT COMPLETED|Open Label Titration||80
2939845|NCT00633880|3651871|FG001|NOT COMPLETED|Open Label Titration||0
2939846|NCT00633880|3651872|FG002|NOT COMPLETED|Open Label Titration||0
2939847|NCT00633880|3651870|FG000|STARTED|Randomized Double Blind||0
2939848|NCT00633880|3651871|FG001|STARTED|Randomized Double Blind||50
2939849|NCT00633880|3651872|FG002|STARTED|Randomized Double Blind||51
2939850|NCT00633880|3651870|FG000|COMPLETED|Randomized Double Blind||0
2939851|NCT00633880|3651871|FG001|COMPLETED|Randomized Double Blind||50
2939852|NCT00633880|3651872|FG002|COMPLETED|Randomized Double Blind||51
2939853|NCT00633880|3651870|FG000|NOT COMPLETED|Randomized Double Blind||0
2939854|NCT00633880|3651871|FG001|NOT COMPLETED|Randomized Double Blind||0
2939855|NCT00633880|3651872|FG002|NOT COMPLETED|Randomized Double Blind||0
2939856|NCT00633893|3651882|FG000|STARTED|Overall Study||840
2939857|NCT00633893|3651883|FG001|STARTED|Overall Study|2 participants were randomized to 5 mg study drug but not treated.|813
2939858|NCT00633893|3651884|FG002|STARTED|Overall Study|3 participants were randomized to placebo but not treated.|829
3277913|NCT02708212|4011386|FG001|COMPLETED|Overall Study||60
3277914|NCT02708212|4011385|FG000|NOT COMPLETED|Overall Study||0
3277915|NCT02708212|4011386|FG001|NOT COMPLETED|Overall Study||0
3277916|NCT02708238|4011399|FG000|STARTED|Overall Study||60
3277917|NCT02708238|4011400|FG001|STARTED|Overall Study||60
3277918|NCT02708238|4011401|FG002|STARTED|Overall Study||60
3277919|NCT02708238|4011399|FG000|COMPLETED|Overall Study||60
3277920|NCT02708238|4011400|FG001|COMPLETED|Overall Study||59
3277921|NCT02708238|4011401|FG002|COMPLETED|Overall Study||57
3277922|NCT02708238|4011399|FG000|NOT COMPLETED|Overall Study||0
3277923|NCT02708238|4011400|FG001|NOT COMPLETED|Overall Study||1
3277924|NCT02708238|4011401|FG002|NOT COMPLETED|Overall Study||3
3277925|NCT02708277|4011411|FG000|STARTED|Overall Study||50
3277926|NCT02708277|4011412|FG001|STARTED|Overall Study||43
3277927|NCT02708277|4011411|FG000|COMPLETED|Overall Study||43
3277928|NCT02708277|4011412|FG001|COMPLETED|Overall Study||39
3277929|NCT02708277|4011411|FG000|NOT COMPLETED|Overall Study||7
3277930|NCT02708277|4011412|FG001|NOT COMPLETED|Overall Study||4
3277931|NCT02708290|4011420|FG000|STARTED|Overall Study||1009
3277932|NCT02708290|4011421|FG001|STARTED|Overall Study||1009
3277933|NCT02708290|4011420|FG000|COMPLETED|Overall Study||1009
3277934|NCT02708290|4011421|FG001|COMPLETED|Overall Study||1009
3277935|NCT02708290|4011420|FG000|NOT COMPLETED|Overall Study||0
3277936|NCT02708290|4011421|FG001|NOT COMPLETED|Overall Study||0
3277937|NCT02708355|4011430|FG000|STARTED|Overall Study||21
3277938|NCT02708355|4011431|FG001|STARTED|Overall Study||22
3277939|NCT02708355|4011432|FG002|STARTED|Overall Study||12
3277940|NCT02708355|4011430|FG000|COMPLETED|Overall Study||20
3277941|NCT02708355|4011431|FG001|COMPLETED|Overall Study||22
3277942|NCT02708355|4011432|FG002|COMPLETED|Overall Study||12
3277943|NCT02708355|4011430|FG000|NOT COMPLETED|Overall Study||1
3277944|NCT02708355|4011431|FG001|NOT COMPLETED|Overall Study||0
3277945|NCT02708355|4011432|FG002|NOT COMPLETED|Overall Study||0
3277946|NCT02708433|4011440|FG000|STARTED|First Intervention (Visit 1)||12
3277947|NCT02708433|4011441|FG001|STARTED|First Intervention (Visit 1)||11
3277948|NCT02708433|4011440|FG000|COMPLETED|First Intervention (Visit 1)||12
3277949|NCT02708433|4011441|FG001|COMPLETED|First Intervention (Visit 1)||11
3277950|NCT02708433|4011440|FG000|NOT COMPLETED|First Intervention (Visit 1)||0
3277951|NCT02708433|4011441|FG001|NOT COMPLETED|First Intervention (Visit 1)||0
3277952|NCT02708433|4011440|FG000|STARTED|Washout (at Least 1 Week)||12
3277953|NCT02708433|4011441|FG001|STARTED|Washout (at Least 1 Week)||11
3277954|NCT02708433|4011440|FG000|COMPLETED|Washout (at Least 1 Week)||12
3277955|NCT02708433|4011441|FG001|COMPLETED|Washout (at Least 1 Week)||11
3277956|NCT02708433|4011440|FG000|NOT COMPLETED|Washout (at Least 1 Week)||0
3277957|NCT02708433|4011441|FG001|NOT COMPLETED|Washout (at Least 1 Week)||0
3277958|NCT02708433|4011440|FG000|STARTED|Second Intervention (Visit 2)||12
3277959|NCT02708433|4011441|FG001|STARTED|Second Intervention (Visit 2)||11
3277960|NCT02708433|4011440|FG000|COMPLETED|Second Intervention (Visit 2)||12
3277961|NCT02708433|4011441|FG001|COMPLETED|Second Intervention (Visit 2)||11
3277962|NCT02708433|4011440|FG000|NOT COMPLETED|Second Intervention (Visit 2)||0
3277963|NCT02708433|4011441|FG001|NOT COMPLETED|Second Intervention (Visit 2)||0
3277964|NCT02708485|4011449|FG000|STARTED|Overall Study||3
3277965|NCT02708485|4011450|FG001|STARTED|Overall Study||12
3277966|NCT02708485|4011449|FG000|COMPLETED|Overall Study||0
3277967|NCT02708485|4011450|FG001|COMPLETED|Overall Study||10
3277968|NCT02708485|4011449|FG000|NOT COMPLETED|Overall Study||3
3277969|NCT02708485|4011450|FG001|NOT COMPLETED|Overall Study||2
3277970|NCT02708498|4011464|FG000|STARTED|Overall Study||42
3277971|NCT02708498|4011465|FG001|STARTED|Overall Study||40
3277972|NCT02708498|4011466|FG002|STARTED|Overall Study||152
3277973|NCT02708498|4011467|FG003|STARTED|Overall Study||156
3277974|NCT02708498|4011468|FG004|STARTED|Overall Study||363
3277975|NCT02708498|4011469|FG005|STARTED|Overall Study||330
3277976|NCT02708498|4011470|FG006|STARTED|Overall Study||20
3277977|NCT02708498|4011471|FG007|STARTED|Overall Study||48
3277978|NCT02708498|4011464|FG000|COMPLETED|Overall Study||22
3277979|NCT02708498|4011465|FG001|COMPLETED|Overall Study||21
3277980|NCT02708498|4011466|FG002|COMPLETED|Overall Study||90
3277981|NCT02708498|4011467|FG003|COMPLETED|Overall Study||105
2939859|NCT00633893|3651882|FG000|COMPLETED|Overall Study||726
2939860|NCT00633893|3651883|FG001|COMPLETED|Overall Study||684
2939861|NCT00633893|3651884|FG002|COMPLETED|Overall Study||641
2939862|NCT00633893|3651882|FG000|NOT COMPLETED|Overall Study||114
2939863|NCT00633893|3651883|FG001|NOT COMPLETED|Overall Study||129
2939864|NCT00633893|3651884|FG002|NOT COMPLETED|Overall Study||188
2939865|NCT00633919|3651894|FG000|STARTED|Overall Study||63
2939866|NCT00633919|3651895|FG001|STARTED|Overall Study||61
3277982|NCT02708498|4011468|FG004|COMPLETED|Overall Study||167
3277983|NCT02708498|4011469|FG005|COMPLETED|Overall Study||198
3277984|NCT02708498|4011470|FG006|COMPLETED|Overall Study||20
3277985|NCT02708498|4011471|FG007|COMPLETED|Overall Study||48
3277986|NCT02708498|4011464|FG000|NOT COMPLETED|Overall Study||20
3277987|NCT02708498|4011465|FG001|NOT COMPLETED|Overall Study||19
3277988|NCT02708498|4011466|FG002|NOT COMPLETED|Overall Study||62
3277989|NCT02708498|4011467|FG003|NOT COMPLETED|Overall Study||51
3277990|NCT02708498|4011468|FG004|NOT COMPLETED|Overall Study||196
3277991|NCT02708498|4011469|FG005|NOT COMPLETED|Overall Study||132
3277992|NCT02708498|4011470|FG006|NOT COMPLETED|Overall Study||0
3277993|NCT02708498|4011471|FG007|NOT COMPLETED|Overall Study||0
3277994|NCT02708524|4011491|FG000|STARTED|Overall Study||139
3277995|NCT02708524|4011492|FG001|STARTED|Overall Study||136
3277996|NCT02708524|4011493|FG002|STARTED|Overall Study||137
3277997|NCT02708524|4011494|FG003|STARTED|Overall Study||136
3277998|NCT02708524|4011491|FG000|COMPLETED|Overall Study||135
3277999|NCT02708524|4011492|FG001|COMPLETED|Overall Study||130
3278000|NCT02708524|4011493|FG002|COMPLETED|Overall Study||134
3278001|NCT02708524|4011494|FG003|COMPLETED|Overall Study||136
3278002|NCT02708524|4011491|FG000|NOT COMPLETED|Overall Study||4
3278003|NCT02708524|4011492|FG001|NOT COMPLETED|Overall Study||6
3278004|NCT02708524|4011493|FG002|NOT COMPLETED|Overall Study||3
3278005|NCT02708524|4011494|FG003|NOT COMPLETED|Overall Study||0
3278006|NCT02708641|4011504|FG000|STARTED|Overall Study||12
3278007|NCT02708641|4011504|FG000|COMPLETED|Overall Study||12
3278008|NCT02708641|4011504|FG000|NOT COMPLETED|Overall Study||0
3278009|NCT02708745|4011512|FG000|STARTED|Overall Study||91
3278010|NCT02708745|4011513|FG001|STARTED|Overall Study||69
3278011|NCT02708745|4011514|FG002|STARTED|Overall Study||204
3278012|NCT02708745|4011515|FG003|STARTED|Overall Study||198
3278013|NCT02708745|4011512|FG000|COMPLETED|Overall Study||91
3278014|NCT02708745|4011513|FG001|COMPLETED|Overall Study||65
3278015|NCT02708745|4011514|FG002|COMPLETED|Overall Study||121
3278016|NCT02708745|4011515|FG003|COMPLETED|Overall Study||116
3278017|NCT02708745|4011512|FG000|NOT COMPLETED|Overall Study||0
3278018|NCT02708745|4011513|FG001|NOT COMPLETED|Overall Study||4
3278019|NCT02708745|4011514|FG002|NOT COMPLETED|Overall Study||83
3278020|NCT02708745|4011515|FG003|NOT COMPLETED|Overall Study||82
3278021|NCT02708862|4011527|FG000|STARTED|Overall Study||26
3278022|NCT02708862|4011527|FG000|COMPLETED|Overall Study||26
3278023|NCT02708862|4011527|FG000|NOT COMPLETED|Overall Study||0
3278024|NCT02708966|4011536|FG000|STARTED|Overall Study||15
3278025|NCT02708966|4011537|FG001|STARTED|Overall Study||15
3278026|NCT02708966|4011536|FG000|COMPLETED|Overall Study||13
3278027|NCT02708966|4011537|FG001|COMPLETED|Overall Study||13
3278028|NCT02708966|4011536|FG000|NOT COMPLETED|Overall Study||2
3278029|NCT02708966|4011537|FG001|NOT COMPLETED|Overall Study||2
3278030|NCT02709005|4011545|FG000|STARTED|Overall Study||73
3278031|NCT02709005|4011546|FG001|STARTED|Overall Study||36
3278032|NCT02709005|4011545|FG000|COMPLETED|Overall Study||69
3278033|NCT02709005|4011546|FG001|COMPLETED|Overall Study||35
3278034|NCT02709005|4011545|FG000|NOT COMPLETED|Overall Study||4
3278035|NCT02709005|4011546|FG001|NOT COMPLETED|Overall Study||1
3278036|NCT02709018|4011554|FG000|STARTED|Overall Study||75
3278037|NCT02709018|4011555|FG001|STARTED|Overall Study||74
3278038|NCT02709018|4011554|FG000|COMPLETED|Overall Study||59
3278039|NCT02709018|4011555|FG001|COMPLETED|Overall Study||58
3278040|NCT02709018|4011554|FG000|NOT COMPLETED|Overall Study||16
3278041|NCT02709018|4011555|FG001|NOT COMPLETED|Overall Study||16
3278042|NCT02709096|4011565|FG000|STARTED|Overall Study||22
3278043|NCT02709096|4011566|FG001|STARTED|Overall Study||11
3278044|NCT02709096|4011565|FG000|COMPLETED|Overall Study||21
3278045|NCT02709096|4011566|FG001|COMPLETED|Overall Study||10
3278046|NCT02709096|4011565|FG000|NOT COMPLETED|Overall Study||1
3278047|NCT02709096|4011566|FG001|NOT COMPLETED|Overall Study||1
3278048|NCT02709109|4011576|FG000|STARTED|Treatment Period 1 (28 Days)||49
3278049|NCT02709109|4011577|FG001|STARTED|Treatment Period 1 (28 Days)||47
3278050|NCT02709109|4011578|FG002|STARTED|Treatment Period 1 (28 Days)||22
3278051|NCT02709109|4011579|FG003|STARTED|Treatment Period 1 (28 Days)||24
3278052|NCT02709109|4011576|FG000|COMPLETED|Treatment Period 1 (28 Days)||45
3278053|NCT02709109|4011577|FG001|COMPLETED|Treatment Period 1 (28 Days)||42
3278054|NCT02709109|4011578|FG002|COMPLETED|Treatment Period 1 (28 Days)||21
3278055|NCT02709109|4011579|FG003|COMPLETED|Treatment Period 1 (28 Days)||24
3278056|NCT02709109|4011576|FG000|NOT COMPLETED|Treatment Period 1 (28 Days)||4
3278057|NCT02709109|4011577|FG001|NOT COMPLETED|Treatment Period 1 (28 Days)||5
3278058|NCT02709109|4011578|FG002|NOT COMPLETED|Treatment Period 1 (28 Days)||1
3278059|NCT02709109|4011579|FG003|NOT COMPLETED|Treatment Period 1 (28 Days)||0
3278060|NCT02709109|4011576|FG000|STARTED|Washout Period (28 Days)||45
3278061|NCT02709109|4011577|FG001|STARTED|Washout Period (28 Days)||42
3278062|NCT02709109|4011578|FG002|STARTED|Washout Period (28 Days)||21
3278063|NCT02709109|4011579|FG003|STARTED|Washout Period (28 Days)||24
3278064|NCT02709109|4011576|FG000|COMPLETED|Washout Period (28 Days)||43
3278065|NCT02709109|4011577|FG001|COMPLETED|Washout Period (28 Days)||40
3278066|NCT02709109|4011578|FG002|COMPLETED|Washout Period (28 Days)||18
2939867|NCT00633919|3651894|FG000|COMPLETED|Overall Study||36
2939868|NCT00633919|3651895|FG001|COMPLETED|Overall Study||39
2939869|NCT00633919|3651894|FG000|NOT COMPLETED|Overall Study||27
2939870|NCT00633919|3651895|FG001|NOT COMPLETED|Overall Study||22
2939871|NCT00633932|3651904|FG000|STARTED|Overall Study|Randomised|191
2939872|NCT00633932|3651905|FG001|STARTED|Overall Study|Randomised|190
2939873|NCT00633932|3651906|FG002|STARTED|Overall Study|Randomised|191
2939874|NCT00633932|3651904|FG000|COMPLETED|Overall Study||179
3278067|NCT02709109|4011579|FG003|COMPLETED|Washout Period (28 Days)||24
3278068|NCT02709109|4011576|FG000|NOT COMPLETED|Washout Period (28 Days)||2
3278069|NCT02709109|4011577|FG001|NOT COMPLETED|Washout Period (28 Days)||2
3278070|NCT02709109|4011578|FG002|NOT COMPLETED|Washout Period (28 Days)||3
3278071|NCT02709109|4011579|FG003|NOT COMPLETED|Washout Period (28 Days)||0
3278072|NCT02709109|4011576|FG000|STARTED|Treatment Period 2 (28 Days)||43
3278073|NCT02709109|4011577|FG001|STARTED|Treatment Period 2 (28 Days)||40
3278074|NCT02709109|4011578|FG002|STARTED|Treatment Period 2 (28 Days)||18
3278075|NCT02709109|4011579|FG003|STARTED|Treatment Period 2 (28 Days)||24
3278076|NCT02709109|4011576|FG000|COMPLETED|Treatment Period 2 (28 Days)||41
3278077|NCT02709109|4011577|FG001|COMPLETED|Treatment Period 2 (28 Days)||36
3278078|NCT02709109|4011578|FG002|COMPLETED|Treatment Period 2 (28 Days)||15
3278079|NCT02709109|4011579|FG003|COMPLETED|Treatment Period 2 (28 Days)||24
3278080|NCT02709109|4011576|FG000|NOT COMPLETED|Treatment Period 2 (28 Days)||2
3278081|NCT02709109|4011577|FG001|NOT COMPLETED|Treatment Period 2 (28 Days)||4
3278082|NCT02709109|4011578|FG002|NOT COMPLETED|Treatment Period 2 (28 Days)||3
3278083|NCT02709109|4011579|FG003|NOT COMPLETED|Treatment Period 2 (28 Days)||0
3278084|NCT02709330|4011590|FG000|STARTED|Overall Study||50
3278085|NCT02709330|4011591|FG001|STARTED|Overall Study||10
3278086|NCT02709330|4011590|FG000|COMPLETED|Overall Study||37
3278087|NCT02709330|4011591|FG001|COMPLETED|Overall Study||10
3278088|NCT02709330|4011590|FG000|NOT COMPLETED|Overall Study||13
3278089|NCT02709330|4011591|FG001|NOT COMPLETED|Overall Study||0
3278090|NCT02709369|4011597|FG000|STARTED|Overall Study||300
3278091|NCT02709369|4011597|FG000|COMPLETED|Overall Study||273
3278092|NCT02709369|4011597|FG000|NOT COMPLETED|Overall Study||27
3278093|NCT02709486|4011604|FG000|STARTED|Overall Study||282
3278094|NCT02709486|4011605|FG001|STARTED|Overall Study||283
3278095|NCT02709486|4011606|FG002|STARTED|Overall Study||284
3278096|NCT02709486|4011604|FG000|COMPLETED|Overall Study||238
3278097|NCT02709486|4011605|FG001|COMPLETED|Overall Study||249
3278098|NCT02709486|4011606|FG002|COMPLETED|Overall Study||239
3278099|NCT02709486|4011604|FG000|NOT COMPLETED|Overall Study||44
3278100|NCT02709486|4011605|FG001|NOT COMPLETED|Overall Study||34
3278101|NCT02709486|4011606|FG002|NOT COMPLETED|Overall Study||45
3278102|NCT02709538|4011617|FG000|STARTED|Overall Study||400
3278103|NCT02709538|4011618|FG001|STARTED|Overall Study||100
3278104|NCT02709538|4011619|FG002|STARTED|Overall Study||101
3278105|NCT02709538|4011617|FG000|COMPLETED|Overall Study||287
3278106|NCT02709538|4011618|FG001|COMPLETED|Overall Study||72
3278107|NCT02709538|4011619|FG002|COMPLETED|Overall Study||81
3278108|NCT02709538|4011617|FG000|NOT COMPLETED|Overall Study||113
3278109|NCT02709538|4011618|FG001|NOT COMPLETED|Overall Study||28
3278110|NCT02709538|4011619|FG002|NOT COMPLETED|Overall Study||20
3278111|NCT02709577|4011629|FG000|STARTED|Overall Study||12
3278112|NCT02709577|4011630|FG001|STARTED|Overall Study||13
3278113|NCT02709577|4011631|FG002|STARTED|Overall Study||6
3278114|NCT02709577|4011632|FG003|STARTED|Overall Study||5
3278115|NCT02709577|4011629|FG000|COMPLETED|Overall Study||10
3278116|NCT02709577|4011630|FG001|COMPLETED|Overall Study||8
3278117|NCT02709577|4011631|FG002|COMPLETED|Overall Study||4
3278118|NCT02709577|4011632|FG003|COMPLETED|Overall Study||5
3278119|NCT02709577|4011629|FG000|NOT COMPLETED|Overall Study||2
3278120|NCT02709577|4011630|FG001|NOT COMPLETED|Overall Study||5
3278121|NCT02709577|4011631|FG002|NOT COMPLETED|Overall Study||2
3278122|NCT02709577|4011632|FG003|NOT COMPLETED|Overall Study||0
3278123|NCT02709694|4011643|FG000|STARTED|Overall Study||33
3278124|NCT02709694|4011643|FG000|Any Back Pain|Overall Study||19
3278125|NCT02709694|4011643|FG000|No Back Pain|Overall Study||14
3278126|NCT02709694|4011643|FG000|MRI Showing Presence of Sacroiliitis|Overall Study||4
3278127|NCT02709694|4011643|FG000|MRI Not Showing Sacroiliitis|Overall Study||29
3278128|NCT02709694|4011643|FG000|Classified as Having Inflammatory Back Pain by the ASAS Criteria|Overall Study||6
3278129|NCT02709694|4011643|FG000|Not Classified as Having Inflammatory Back Pain by the ASAS Criteria|Overall Study||25
3278130|NCT02709694|4011643|FG000|Having Bone Marrow Edema Seen in MRI|Overall Study||33
3278131|NCT02709694|4011643|FG000|Having Erosion (a Structural Lesion) Seen in MRI|Overall Study||33
3278132|NCT02709694|4011643|FG000|Having Fat Metaplasia Seen in MRI|Overall Study||33
3278133|NCT02709694|4011643|FG000|Having Backfill (Type of Structural Lesion) Seen in MRI|Overall Study||33
3278134|NCT02709694|4011643|FG000|Having Ankylosis Seen in MRI|Overall Study||33
3278135|NCT02709694|4011643|FG000|COMPLETED|Overall Study||33
3278136|NCT02709694|4011643|FG000|NOT COMPLETED|Overall Study||0
3278137|NCT02709746|4011662|FG000|STARTED|Phase A (Single-blind Treatment Period)||784
3278138|NCT02709746|4011663|FG001|STARTED|Phase A (Single-blind Treatment Period)||0
3278139|NCT02709746|4011664|FG002|STARTED|Phase A (Single-blind Treatment Period)||0
3278140|NCT02709746|4011665|FG003|STARTED|Phase A (Single-blind Treatment Period)||0
3278141|NCT02709746|4011666|FG004|STARTED|Phase A (Single-blind Treatment Period)||0
3278142|NCT02709746|4011662|FG000|COMPLETED|Phase A (Single-blind Treatment Period)||616
3278143|NCT02709746|4011663|FG001|COMPLETED|Phase A (Single-blind Treatment Period)||0
2939875|NCT00633932|3651905|FG001|COMPLETED|Overall Study||176
2939876|NCT00633932|3651906|FG002|COMPLETED|Overall Study||180
2939877|NCT00633932|3651904|FG000|NOT COMPLETED|Overall Study||12
2939878|NCT00633932|3651905|FG001|NOT COMPLETED|Overall Study||14
2939879|NCT00633932|3651906|FG002|NOT COMPLETED|Overall Study||11
3278144|NCT02709746|4011664|FG002|COMPLETED|Phase A (Single-blind Treatment Period)||0
3278145|NCT02709746|4011665|FG003|COMPLETED|Phase A (Single-blind Treatment Period)||0
3278146|NCT02709746|4011666|FG004|COMPLETED|Phase A (Single-blind Treatment Period)||0
3278147|NCT02709746|4011662|FG000|NOT COMPLETED|Phase A (Single-blind Treatment Period)||168
3278148|NCT02709746|4011663|FG001|NOT COMPLETED|Phase A (Single-blind Treatment Period)||0
3278149|NCT02709746|4011664|FG002|NOT COMPLETED|Phase A (Single-blind Treatment Period)||0
3278150|NCT02709746|4011665|FG003|NOT COMPLETED|Phase A (Single-blind Treatment Period)||0
3278151|NCT02709746|4011666|FG004|NOT COMPLETED|Phase A (Single-blind Treatment Period)||0
3278152|NCT02709746|4011662|FG000|STARTED|Phase B (Double-blind Treatment Period)||0
3278153|NCT02709746|4011663|FG001|STARTED|Phase B (Double-blind Treatment Period)||147
3278154|NCT02709746|4011664|FG002|STARTED|Phase B (Double-blind Treatment Period)||162
3278155|NCT02709746|4011665|FG003|STARTED|Phase B (Double-blind Treatment Period)||153
3278156|NCT02709746|4011666|FG004|STARTED|Phase B (Double-blind Treatment Period)||154
3278157|NCT02709746|4011662|FG000|COMPLETED|Phase B (Double-blind Treatment Period)||0
3278158|NCT02709746|4011663|FG001|COMPLETED|Phase B (Double-blind Treatment Period)||126
3278159|NCT02709746|4011664|FG002|COMPLETED|Phase B (Double-blind Treatment Period)||140
3278160|NCT02709746|4011665|FG003|COMPLETED|Phase B (Double-blind Treatment Period)||138
3278161|NCT02709746|4011666|FG004|COMPLETED|Phase B (Double-blind Treatment Period)||138
3278162|NCT02709746|4011662|FG000|NOT COMPLETED|Phase B (Double-blind Treatment Period)||0
3278163|NCT02709746|4011663|FG001|NOT COMPLETED|Phase B (Double-blind Treatment Period)||21
3278164|NCT02709746|4011664|FG002|NOT COMPLETED|Phase B (Double-blind Treatment Period)||22
3278165|NCT02709746|4011665|FG003|NOT COMPLETED|Phase B (Double-blind Treatment Period)||15
3278166|NCT02709746|4011666|FG004|NOT COMPLETED|Phase B (Double-blind Treatment Period)||16
3278167|NCT02709785|4011681|FG000|STARTED|Overall Study||24
3278168|NCT02709785|4011682|FG001|STARTED|Overall Study||28
3278169|NCT02709785|4011683|FG002|STARTED|Overall Study||28
3278170|NCT02709785|4011681|FG000|3 Weeks|Overall Study||23
3278171|NCT02709785|4011682|FG001|3 Weeks|Overall Study||27
3278172|NCT02709785|4011683|FG002|3 Weeks|Overall Study||27
3278173|NCT02709785|4011681|FG000|6 Weeks|Overall Study||23
3278174|NCT02709785|4011682|FG001|6 Weeks|Overall Study||26
3278175|NCT02709785|4011683|FG002|6 Weeks|Overall Study||27
3278176|NCT02709785|4011681|FG000|COMPLETED|Overall Study||23
3278177|NCT02709785|4011682|FG001|COMPLETED|Overall Study||26
3278178|NCT02709785|4011683|FG002|COMPLETED|Overall Study||27
3278179|NCT02709785|4011681|FG000|NOT COMPLETED|Overall Study||1
3278180|NCT02709785|4011682|FG001|NOT COMPLETED|Overall Study||2
3278181|NCT02709785|4011683|FG002|NOT COMPLETED|Overall Study||1
3278182|NCT02709889|4011699|FG000|STARTED|Overall Study||43
3278183|NCT02709889|4011700|FG001|STARTED|Overall Study||57
3278184|NCT02709889|4011701|FG002|STARTED|Overall Study||12
3278185|NCT02709889|4011702|FG003|STARTED|Overall Study||88
3278186|NCT02709889|4011699|FG000|Large Cell Neuroendocrine Carcinoma(NEC)|Overall Study||3
3278187|NCT02709889|4011700|FG001|Large Cell Neuroendocrine Carcinoma(NEC)|Overall Study||4
3278188|NCT02709889|4011701|FG002|Large Cell Neuroendocrine Carcinoma(NEC)|Overall Study||2
3278189|NCT02709889|4011702|FG003|Large Cell Neuroendocrine Carcinoma(NEC)|Overall Study||4
3278190|NCT02709889|4011699|FG000|Neuroendocrine Prostate Cancer|Overall Study||4
3278191|NCT02709889|4011700|FG001|Neuroendocrine Prostate Cancer|Overall Study||7
3278192|NCT02709889|4011701|FG002|Neuroendocrine Prostate Cancer|Overall Study||3
3278193|NCT02709889|4011702|FG003|Neuroendocrine Prostate Cancer|Overall Study||7
3278194|NCT02709889|4011699|FG000|Gastroenteropancreatic NEC|Overall Study||6
3278195|NCT02709889|4011700|FG001|Gastroenteropancreatic NEC|Overall Study||5
3278196|NCT02709889|4011701|FG002|Gastroenteropancreatic NEC|Overall Study||2
3278197|NCT02709889|4011702|FG003|Gastroenteropancreatic NEC|Overall Study||23
3278198|NCT02709889|4011699|FG000|Other NEC|Overall Study||11
3278199|NCT02709889|4011700|FG001|Other NEC|Overall Study||12
3278200|NCT02709889|4011701|FG002|Other NEC|Overall Study||1
3278201|NCT02709889|4011702|FG003|Other NEC|Overall Study||7
3278202|NCT02709889|4011699|FG000|Malignant Melanoma|Overall Study||3
3278203|NCT02709889|4011700|FG001|Malignant Melanoma|Overall Study||6
3278204|NCT02709889|4011701|FG002|Malignant Melanoma|Overall Study||0
3278205|NCT02709889|4011702|FG003|Malignant Melanoma|Overall Study||11
3278206|NCT02709889|4011699|FG000|Medullary Thyroid Cancer|Overall Study||3
3278207|NCT02709889|4011700|FG001|Medullary Thyroid Cancer|Overall Study||3
3278208|NCT02709889|4011701|FG002|Medullary Thyroid Cancer|Overall Study||0
3278209|NCT02709889|4011702|FG003|Medullary Thyroid Cancer|Overall Study||7
3278210|NCT02709889|4011699|FG000|Glioblastoma|Overall Study||4
3278211|NCT02709889|4011700|FG001|Glioblastoma|Overall Study||4
3278212|NCT02709889|4011701|FG002|Glioblastoma|Overall Study||1
3278213|NCT02709889|4011702|FG003|Glioblastoma|Overall Study||14
3278214|NCT02709889|4011699|FG000|Other Solid Tumors|Overall Study||9
3278215|NCT02709889|4011700|FG001|Other Solid Tumors|Overall Study||16
3278216|NCT02709889|4011701|FG002|Other Solid Tumors|Overall Study||3
3278217|NCT02709889|4011702|FG003|Other Solid Tumors|Overall Study||15
3278218|NCT02709889|4011699|FG000|COMPLETED|Overall Study||0
3278219|NCT02709889|4011700|FG001|COMPLETED|Overall Study||0
3278220|NCT02709889|4011701|FG002|COMPLETED|Overall Study||0
2939880|NCT00633945|3651914|FG000|STARTED|Overall Study||5
3278221|NCT02709889|4011702|FG003|COMPLETED|Overall Study||0
3278222|NCT02709889|4011699|FG000|NOT COMPLETED|Overall Study||43
3278223|NCT02709889|4011700|FG001|NOT COMPLETED|Overall Study||57
3278224|NCT02709889|4011701|FG002|NOT COMPLETED|Overall Study||12
3278225|NCT02709889|4011702|FG003|NOT COMPLETED|Overall Study||88
3278226|NCT02710045|4011750|FG000|STARTED|Overall Study||106
2939881|NCT00633945|3651914|FG000|COMPLETED|Overall Study||3
2939882|NCT00633945|3651914|FG000|NOT COMPLETED|Overall Study||2
2939883|NCT00633984|3651922|FG000|STARTED|Overall Study||87
2939884|NCT00633984|3651923|FG001|STARTED|Overall Study||82
2939885|NCT00633984|3651922|FG000|COMPLETED|Overall Study||78
2939886|NCT00633984|3651923|FG001|COMPLETED|Overall Study||69
2939887|NCT00633984|3651922|FG000|NOT COMPLETED|Overall Study||9
2939888|NCT00633984|3651923|FG001|NOT COMPLETED|Overall Study||13
2939889|NCT00634036|3651931|FG000|STARTED|Overall Study||12
2939890|NCT00634036|3651932|FG001|STARTED|Overall Study||11
2939891|NCT00634036|3651931|FG000|COMPLETED|Overall Study||10
2939892|NCT00634036|3651932|FG001|COMPLETED|Overall Study||9
2939893|NCT00634036|3651931|FG000|NOT COMPLETED|Overall Study||2
2939894|NCT00634036|3651932|FG001|NOT COMPLETED|Overall Study||2
2939895|NCT00634049|3651938|FG000|STARTED|Overall Study||149
2939896|NCT00634049|3651938|FG000|COMPLETED|Overall Study||146
2939897|NCT00634049|3651938|FG000|NOT COMPLETED|Overall Study||3
2939898|NCT00634088|3651975|FG000|STARTED|Time Period 1: Dose Level 1||6
2939899|NCT00634088|3651976|FG001|STARTED|Time Period 1: Dose Level 1||0
2939900|NCT00634088|3651977|FG002|STARTED|Time Period 1: Dose Level 1||0
2939901|NCT00634088|3651978|FG003|STARTED|Time Period 1: Dose Level 1||0
2939902|NCT00634088|3651975|FG000|COMPLETED|Time Period 1: Dose Level 1||0
2939903|NCT00634088|3651976|FG001|COMPLETED|Time Period 1: Dose Level 1||0
2939904|NCT00634088|3651977|FG002|COMPLETED|Time Period 1: Dose Level 1||0
2939905|NCT00634088|3651978|FG003|COMPLETED|Time Period 1: Dose Level 1||0
2939906|NCT00634088|3651975|FG000|NOT COMPLETED|Time Period 1: Dose Level 1||6
2939907|NCT00634088|3651976|FG001|NOT COMPLETED|Time Period 1: Dose Level 1||0
2939908|NCT00634088|3651977|FG002|NOT COMPLETED|Time Period 1: Dose Level 1||0
2939909|NCT00634088|3651978|FG003|NOT COMPLETED|Time Period 1: Dose Level 1||0
2939910|NCT00634088|3651975|FG000|STARTED|Time Period 2: Dose Level 2||0
2939911|NCT00634088|3651976|FG001|STARTED|Time Period 2: Dose Level 2||3
2939912|NCT00634088|3651977|FG002|STARTED|Time Period 2: Dose Level 2||0
2939913|NCT00634088|3651978|FG003|STARTED|Time Period 2: Dose Level 2||0
2939914|NCT00634088|3651975|FG000|COMPLETED|Time Period 2: Dose Level 2||0
2939915|NCT00634088|3651976|FG001|COMPLETED|Time Period 2: Dose Level 2||0
2939916|NCT00634088|3651977|FG002|COMPLETED|Time Period 2: Dose Level 2||0
2939917|NCT00634088|3651978|FG003|COMPLETED|Time Period 2: Dose Level 2||0
2939918|NCT00634088|3651975|FG000|NOT COMPLETED|Time Period 2: Dose Level 2||0
2939919|NCT00634088|3651976|FG001|NOT COMPLETED|Time Period 2: Dose Level 2||3
2939920|NCT00634088|3651977|FG002|NOT COMPLETED|Time Period 2: Dose Level 2||0
2939921|NCT00634088|3651978|FG003|NOT COMPLETED|Time Period 2: Dose Level 2||0
2939922|NCT00634088|3651975|FG000|STARTED|Time Period 3: Dose Level 3||0
2939923|NCT00634088|3651976|FG001|STARTED|Time Period 3: Dose Level 3||0
2939924|NCT00634088|3651977|FG002|STARTED|Time Period 3: Dose Level 3||1
2939925|NCT00634088|3651978|FG003|STARTED|Time Period 3: Dose Level 3||0
2939926|NCT00634088|3651975|FG000|COMPLETED|Time Period 3: Dose Level 3||0
2939927|NCT00634088|3651976|FG001|COMPLETED|Time Period 3: Dose Level 3||0
2939928|NCT00634088|3651977|FG002|COMPLETED|Time Period 3: Dose Level 3||0
2939929|NCT00634088|3651978|FG003|COMPLETED|Time Period 3: Dose Level 3||0
2939930|NCT00634088|3651975|FG000|NOT COMPLETED|Time Period 3: Dose Level 3||0
2939931|NCT00634088|3651976|FG001|NOT COMPLETED|Time Period 3: Dose Level 3||0
2939932|NCT00634088|3651977|FG002|NOT COMPLETED|Time Period 3: Dose Level 3||1
2939933|NCT00634088|3651978|FG003|NOT COMPLETED|Time Period 3: Dose Level 3||0
2939934|NCT00634088|3651975|FG000|STARTED|Time Period 4: Triplet Combination||0
2939935|NCT00634088|3651976|FG001|STARTED|Time Period 4: Triplet Combination||0
2939936|NCT00634088|3651977|FG002|STARTED|Time Period 4: Triplet Combination||0
2939937|NCT00634088|3651978|FG003|STARTED|Time Period 4: Triplet Combination||0
2939938|NCT00634088|3651975|FG000|COMPLETED|Time Period 4: Triplet Combination||0
2939939|NCT00634088|3651976|FG001|COMPLETED|Time Period 4: Triplet Combination||0
2939940|NCT00634088|3651977|FG002|COMPLETED|Time Period 4: Triplet Combination||0
2939941|NCT00634088|3651978|FG003|COMPLETED|Time Period 4: Triplet Combination||0
2939942|NCT00634088|3651975|FG000|NOT COMPLETED|Time Period 4: Triplet Combination||0
2939943|NCT00634088|3651976|FG001|NOT COMPLETED|Time Period 4: Triplet Combination||0
2939944|NCT00634088|3651977|FG002|NOT COMPLETED|Time Period 4: Triplet Combination||0
2939945|NCT00634088|3651978|FG003|NOT COMPLETED|Time Period 4: Triplet Combination||0
2939946|NCT00634101|3651990|FG000|STARTED|Overall Study||66
2939947|NCT00634101|3651991|FG001|STARTED|Overall Study||59
2939948|NCT00634101|3651990|FG000|COMPLETED|Overall Study||61
2939949|NCT00634101|3651991|FG001|COMPLETED|Overall Study||56
2939950|NCT00634101|3651990|FG000|NOT COMPLETED|Overall Study||5
2939951|NCT00634101|3651991|FG001|NOT COMPLETED|Overall Study||3
2939952|NCT00634114|3652000|FG000|STARTED|Overall Study|Randomised|188
2939953|NCT00634114|3652001|FG001|STARTED|Overall Study|Randomised|189
2939954|NCT00634114|3652002|FG002|STARTED|Overall Study|Randomised|187
2939955|NCT00634114|3652000|FG000|COMPLETED|Overall Study|Completed|160
2939956|NCT00634114|3652001|FG001|COMPLETED|Overall Study|Completed|154
2939957|NCT00634114|3652002|FG002|COMPLETED|Overall Study|Completed|148
2939958|NCT00634114|3652000|FG000|NOT COMPLETED|Overall Study||28
2939959|NCT00634114|3652001|FG001|NOT COMPLETED|Overall Study||35
2939960|NCT00634114|3652002|FG002|NOT COMPLETED|Overall Study||39
2939961|NCT00634166|3652012|FG000|STARTED|Overall Study||82
2939962|NCT00634166|3652013|FG001|STARTED|Overall Study||138
2939963|NCT00634166|3652012|FG000|COMPLETED|Overall Study||22
2939964|NCT00634166|3652013|FG001|COMPLETED|Overall Study||78
2939965|NCT00634166|3652012|FG000|NOT COMPLETED|Overall Study||60
2939966|NCT00634166|3652013|FG001|NOT COMPLETED|Overall Study||60
2939967|NCT00634179|3652019|FG000|STARTED|Phase I: Induction||19
2939968|NCT00634179|3652019|FG000|COMPLETED|Phase I: Induction||19
2939969|NCT00634179|3652019|FG000|NOT COMPLETED|Phase I: Induction||0
2939970|NCT00634179|3652019|FG000|STARTED|Phase II: Maintenance||30
2939971|NCT00634179|3652019|FG000|COMPLETED|Phase II: Maintenance||29
2939972|NCT00634179|3652019|FG000|NOT COMPLETED|Phase II: Maintenance||1
2939973|NCT00634244|3652029|FG000|STARTED|Overall Study||35
2939974|NCT00634244|3652030|FG001|STARTED|Overall Study||37
2939975|NCT00634244|3652031|FG002|STARTED|Overall Study||20
2939976|NCT00634244|3652029|FG000|Eligible and Treated|Overall Study||35
2939977|NCT00634244|3652030|FG001|Eligible and Treated|Overall Study||36
2939978|NCT00634244|3652031|FG002|Eligible and Treated|Overall Study||20
2939979|NCT00634244|3652029|FG000|COMPLETED|Overall Study||34
2939980|NCT00634244|3652030|FG001|COMPLETED|Overall Study||24
2939981|NCT00634244|3652031|FG002|COMPLETED|Overall Study||20
2939982|NCT00634244|3652029|FG000|NOT COMPLETED|Overall Study||1
2939983|NCT00634244|3652030|FG001|NOT COMPLETED|Overall Study||13
2939984|NCT00634244|3652031|FG002|NOT COMPLETED|Overall Study||0
2939985|NCT00634270|3652041|FG000|STARTED|Overall Study|February 12, 2008|49
2939986|NCT00634270|3652042|FG001|STARTED|Overall Study||13
2939987|NCT00634270|3652041|FG000|COMPLETED|Overall Study||46
2939988|NCT00634270|3652042|FG001|COMPLETED|Overall Study||12
2939989|NCT00634270|3652041|FG000|NOT COMPLETED|Overall Study||3
2939990|NCT00634270|3652042|FG001|NOT COMPLETED|Overall Study||1
2939991|NCT00634283|3652054|FG000|STARTED|Overall Study||6
2939992|NCT00634283|3652054|FG000|COMPLETED|Overall Study||6
2939993|NCT00634283|3652054|FG000|NOT COMPLETED|Overall Study||0
2939994|NCT00634504|3652062|FG000|STARTED|Overall Study||11
2939995|NCT00634504|3652063|FG001|STARTED|Overall Study||9
2939996|NCT00634504|3652062|FG000|COMPLETED|Overall Study||10
2939997|NCT00634504|3652063|FG001|COMPLETED|Overall Study||9
2939998|NCT00634504|3652062|FG000|NOT COMPLETED|Overall Study||1
2939999|NCT00634504|3652063|FG001|NOT COMPLETED|Overall Study||0
2940000|NCT00634543|3652071|FG000|STARTED|Overall Study||78
2940001|NCT00634543|3652072|FG001|STARTED|Overall Study||84
2940002|NCT00634543|3652071|FG000|Treated|Overall Study||76
2940003|NCT00634543|3652072|FG001|Treated|Overall Study||80
2940004|NCT00634543|3652071|FG000|COMPLETED|Overall Study||59
2940005|NCT00634543|3652072|FG001|COMPLETED|Overall Study||63
2940006|NCT00634543|3652071|FG000|NOT COMPLETED|Overall Study||19
2940007|NCT00634543|3652072|FG001|NOT COMPLETED|Overall Study||21
2940008|NCT00634569|3652080|FG000|STARTED|Overall Study||14
2940009|NCT00634569|3652081|FG001|STARTED|Overall Study||10
2940010|NCT00634569|3652080|FG000|COMPLETED|Overall Study||14
2940011|NCT00634569|3652081|FG001|COMPLETED|Overall Study||5
2940012|NCT00634569|3652080|FG000|NOT COMPLETED|Overall Study||0
2940013|NCT00634569|3652081|FG001|NOT COMPLETED|Overall Study||5
2940014|NCT00634621|3652087|FG000|STARTED|Overall Study||283
2940015|NCT00634621|3652087|FG000|COMPLETED|Overall Study||283
2940016|NCT00634621|3652087|FG000|NOT COMPLETED|Overall Study||0
2940017|NCT00634647|3652095|FG000|STARTED|Overall Study||24
2940018|NCT00634647|3652095|FG000|COMPLETED|Overall Study||17
2940019|NCT00634647|3652095|FG000|NOT COMPLETED|Overall Study||7
2940020|NCT00634751|3652103|FG000|STARTED|Phase I: 200mg Sorafenib+2DOC||9
2940021|NCT00634751|3652104|FG001|STARTED|Phase I: 200mg Sorafenib+2DOC||0
2940022|NCT00634751|3652105|FG002|STARTED|Phase I: 200mg Sorafenib+2DOC||0
2940023|NCT00634751|3652106|FG003|STARTED|Phase I: 200mg Sorafenib+2DOC||0
2940024|NCT00634751|3652103|FG000|COMPLETED|Phase I: 200mg Sorafenib+2DOC||8
2940025|NCT00634751|3652104|FG001|COMPLETED|Phase I: 200mg Sorafenib+2DOC||0
2940026|NCT00634751|3652105|FG002|COMPLETED|Phase I: 200mg Sorafenib+2DOC||0
2940027|NCT00634751|3652106|FG003|COMPLETED|Phase I: 200mg Sorafenib+2DOC||0
2940028|NCT00634751|3652103|FG000|NOT COMPLETED|Phase I: 200mg Sorafenib+2DOC||1
2940029|NCT00634751|3652104|FG001|NOT COMPLETED|Phase I: 200mg Sorafenib+2DOC||0
2940030|NCT00634751|3652105|FG002|NOT COMPLETED|Phase I: 200mg Sorafenib+2DOC||0
2940031|NCT00634751|3652106|FG003|NOT COMPLETED|Phase I: 200mg Sorafenib+2DOC||0
2940032|NCT00634751|3652103|FG000|STARTED|Phase I: 400mg Sorafenib BID+2DOC||0
2940033|NCT00634751|3652104|FG001|STARTED|Phase I: 400mg Sorafenib BID+2DOC||7
2940034|NCT00634751|3652105|FG002|STARTED|Phase I: 400mg Sorafenib BID+2DOC||0
2940035|NCT00634751|3652106|FG003|STARTED|Phase I: 400mg Sorafenib BID+2DOC||0
2940036|NCT00634751|3652103|FG000|COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0
2940037|NCT00634751|3652104|FG001|COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||6
2940038|NCT00634751|3652105|FG002|COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0
2940039|NCT00634751|3652106|FG003|COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0
2940040|NCT00634751|3652103|FG000|NOT COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0
2940041|NCT00634751|3652104|FG001|NOT COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||1
2940042|NCT00634751|3652105|FG002|NOT COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0
2940043|NCT00634751|3652106|FG003|NOT COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0
2940044|NCT00634751|3652103|FG000|STARTED|Pancreatic and Bilial Tract Cancer||0
2940045|NCT00634751|3652104|FG001|STARTED|Pancreatic and Bilial Tract Cancer||0
2940046|NCT00634751|3652105|FG002|STARTED|Pancreatic and Bilial Tract Cancer||24
2940047|NCT00634751|3652106|FG003|STARTED|Pancreatic and Bilial Tract Cancer||8
2940048|NCT00634751|3652103|FG000|COMPLETED|Pancreatic and Bilial Tract Cancer||0
2940049|NCT00634751|3652104|FG001|COMPLETED|Pancreatic and Bilial Tract Cancer||0
2940050|NCT00634751|3652105|FG002|COMPLETED|Pancreatic and Bilial Tract Cancer||23
2940051|NCT00634751|3652106|FG003|COMPLETED|Pancreatic and Bilial Tract Cancer||7
2940052|NCT00634751|3652103|FG000|NOT COMPLETED|Pancreatic and Bilial Tract Cancer||0
2940053|NCT00634751|3652104|FG001|NOT COMPLETED|Pancreatic and Bilial Tract Cancer||0
2940054|NCT00634751|3652105|FG002|NOT COMPLETED|Pancreatic and Bilial Tract Cancer||1
2940055|NCT00634751|3652106|FG003|NOT COMPLETED|Pancreatic and Bilial Tract Cancer||1
2940056|NCT00634803|3652119|FG000|STARTED|Overall Study||30
2940057|NCT00634803|3652120|FG001|STARTED|Overall Study||30
2940058|NCT00634803|3652121|FG002|STARTED|Overall Study||30
2940059|NCT00634803|3652119|FG000|Month 1|Overall Study||29
2940060|NCT00634803|3652120|FG001|Month 1|Overall Study||29
2940061|NCT00634803|3652121|FG002|Month 1|Overall Study||29
2940062|NCT00634803|3652119|FG000|Month 2|Overall Study||26
2940063|NCT00634803|3652120|FG001|Month 2|Overall Study||26
2940064|NCT00634803|3652121|FG002|Month 2|Overall Study||28
2940065|NCT00634803|3652119|FG000|Month 3|Overall Study||25
2940066|NCT00634803|3652120|FG001|Month 3|Overall Study||23
2940067|NCT00634803|3652121|FG002|Month 3|Overall Study||26
2940068|NCT00634803|3652119|FG000|COMPLETED|Overall Study||24
2940069|NCT00634803|3652120|FG001|COMPLETED|Overall Study||23
2940070|NCT00634803|3652121|FG002|COMPLETED|Overall Study||23
2940071|NCT00634803|3652119|FG000|NOT COMPLETED|Overall Study||6
2940072|NCT00634803|3652120|FG001|NOT COMPLETED|Overall Study||7
2940073|NCT00634803|3652121|FG002|NOT COMPLETED|Overall Study||7
2940074|NCT00634842|3652131|FG000|STARTED|Overall Study||122
2940075|NCT00634842|3652132|FG001|STARTED|Overall Study||122
2940076|NCT00634842|3652131|FG000|COMPLETED|Overall Study||107
2940077|NCT00634842|3652132|FG001|COMPLETED|Overall Study||104
2940078|NCT00634842|3652131|FG000|NOT COMPLETED|Overall Study||15
2940079|NCT00634842|3652132|FG001|NOT COMPLETED|Overall Study||18
2940080|NCT00634907|3652140|FG000|STARTED|Overall Study||131
2940081|NCT00634907|3652141|FG001|STARTED|Overall Study||132
2940082|NCT00634907|3652140|FG000|COMPLETED|Overall Study||114
2940083|NCT00634907|3652141|FG001|COMPLETED|Overall Study||115
2940084|NCT00634907|3652140|FG000|NOT COMPLETED|Overall Study||17
2940085|NCT00634907|3652141|FG001|NOT COMPLETED|Overall Study||17
2940086|NCT00634920|3652150|FG000|STARTED|Period 1 - Pre-Randomization||0
2940087|NCT00634920|3652151|FG001|STARTED|Period 1 - Pre-Randomization||0
2940088|NCT00634920|3652152|FG002|STARTED|Period 1 - Pre-Randomization|Total number of Enrolled patients|341
2940089|NCT00634920|3652150|FG000|COMPLETED|Period 1 - Pre-Randomization||0
2940090|NCT00634920|3652151|FG001|COMPLETED|Period 1 - Pre-Randomization||0
2940091|NCT00634920|3652152|FG002|COMPLETED|Period 1 - Pre-Randomization|Total number of patients who became randomized|204
2940092|NCT00634920|3652150|FG000|NOT COMPLETED|Period 1 - Pre-Randomization||0
2940093|NCT00634920|3652151|FG001|NOT COMPLETED|Period 1 - Pre-Randomization||0
2940094|NCT00634920|3652152|FG002|NOT COMPLETED|Period 1 - Pre-Randomization||137
2940095|NCT00634920|3652150|FG000|STARTED|Period 2 - Post-Randomization|2 patients randomized in this group did not receive at least one dose of study drug.|104
2940096|NCT00634920|3652151|FG001|STARTED|Period 2 - Post-Randomization||100
2940097|NCT00634920|3652152|FG002|STARTED|Period 2 - Post-Randomization|This group included patients who had renal TX but did not qualify for randomization at Visit 2.|0
2940098|NCT00634920|3652150|FG000|Full Analysis Set (FAS)|Period 2 - Post-Randomization||92
2940099|NCT00634920|3652151|FG001|Full Analysis Set (FAS)|Period 2 - Post-Randomization||90
2940100|NCT00634920|3652152|FG002|Full Analysis Set (FAS)|Period 2 - Post-Randomization||0
2940101|NCT00634920|3652150|FG000|COMPLETED|Period 2 - Post-Randomization||43
2940102|NCT00634920|3652151|FG001|COMPLETED|Period 2 - Post-Randomization||68
2940103|NCT00634920|3652152|FG002|COMPLETED|Period 2 - Post-Randomization||0
2940104|NCT00634920|3652150|FG000|NOT COMPLETED|Period 2 - Post-Randomization||61
2940105|NCT00634920|3652151|FG001|NOT COMPLETED|Period 2 - Post-Randomization||32
2940106|NCT00634920|3652152|FG002|NOT COMPLETED|Period 2 - Post-Randomization||0
2940107|NCT00634933|3652161|FG000|STARTED|Part A: Baseline to Week 24||74
2940108|NCT00634933|3652162|FG001|STARTED|Part A: Baseline to Week 24||75
2940109|NCT00634933|3652163|FG002|STARTED|Part A: Baseline to Week 24||73
2940110|NCT00634933|3652164|FG003|STARTED|Part A: Baseline to Week 24||0
2940111|NCT00634933|3652165|FG004|STARTED|Part A: Baseline to Week 24||0
2940112|NCT00634933|3652161|FG000|COMPLETED|Part A: Baseline to Week 24||63
2940113|NCT00634933|3652162|FG001|COMPLETED|Part A: Baseline to Week 24||57
2940114|NCT00634933|3652163|FG002|COMPLETED|Part A: Baseline to Week 24||55
2940115|NCT00634933|3652164|FG003|COMPLETED|Part A: Baseline to Week 24||0
2940116|NCT00634933|3652165|FG004|COMPLETED|Part A: Baseline to Week 24||0
2940117|NCT00634933|3652161|FG000|NOT COMPLETED|Part A: Baseline to Week 24||11
2940118|NCT00634933|3652162|FG001|NOT COMPLETED|Part A: Baseline to Week 24||18
2940119|NCT00634933|3652163|FG002|NOT COMPLETED|Part A: Baseline to Week 24||18
2940120|NCT00634933|3652164|FG003|NOT COMPLETED|Part A: Baseline to Week 24||0
2940121|NCT00634933|3652165|FG004|NOT COMPLETED|Part A: Baseline to Week 24||0
2940122|NCT00634933|3652161|FG000|STARTED|Between Part A and Part B||0
2940123|NCT00634933|3652162|FG001|STARTED|Between Part A and Part B||57
2940124|NCT00634933|3652163|FG002|STARTED|Between Part A and Part B||55
2940125|NCT00634933|3652164|FG003|STARTED|Between Part A and Part B||31
2940126|NCT00634933|3652165|FG004|STARTED|Between Part A and Part B||32
2940127|NCT00634933|3652161|FG000|COMPLETED|Between Part A and Part B||0
2940128|NCT00634933|3652162|FG001|COMPLETED|Between Part A and Part B||56
2940129|NCT00634933|3652163|FG002|COMPLETED|Between Part A and Part B||55
2940130|NCT00634933|3652164|FG003|COMPLETED|Between Part A and Part B||31
2940131|NCT00634933|3652165|FG004|COMPLETED|Between Part A and Part B||32
2940132|NCT00634933|3652161|FG000|NOT COMPLETED|Between Part A and Part B||0
2940133|NCT00634933|3652162|FG001|NOT COMPLETED|Between Part A and Part B||1
2940134|NCT00634933|3652163|FG002|NOT COMPLETED|Between Part A and Part B||0
2940135|NCT00634933|3652164|FG003|NOT COMPLETED|Between Part A and Part B||0
2940136|NCT00634933|3652165|FG004|NOT COMPLETED|Between Part A and Part B||0
2940137|NCT00634933|3652161|FG000|STARTED|Part B: Week 24 to Week 52||0
2940138|NCT00634933|3652162|FG001|STARTED|Part B: Week 24 to Week 52||56
2940139|NCT00634933|3652163|FG002|STARTED|Part B: Week 24 to Week 52||55
2940140|NCT00634933|3652164|FG003|STARTED|Part B: Week 24 to Week 52||31
2940141|NCT00634933|3652165|FG004|STARTED|Part B: Week 24 to Week 52||32
2940142|NCT00634933|3652161|FG000|COMPLETED|Part B: Week 24 to Week 52||0
2940143|NCT00634933|3652162|FG001|COMPLETED|Part B: Week 24 to Week 52||42
2940144|NCT00634933|3652163|FG002|COMPLETED|Part B: Week 24 to Week 52||33
2940145|NCT00634933|3652164|FG003|COMPLETED|Part B: Week 24 to Week 52||25
2940146|NCT00634933|3652165|FG004|COMPLETED|Part B: Week 24 to Week 52||22
2940147|NCT00634933|3652161|FG000|NOT COMPLETED|Part B: Week 24 to Week 52||0
2940148|NCT00634933|3652162|FG001|NOT COMPLETED|Part B: Week 24 to Week 52||14
2940149|NCT00634933|3652163|FG002|NOT COMPLETED|Part B: Week 24 to Week 52||22
2940150|NCT00634933|3652164|FG003|NOT COMPLETED|Part B: Week 24 to Week 52||6
2940151|NCT00634933|3652165|FG004|NOT COMPLETED|Part B: Week 24 to Week 52||10
2940152|NCT00635024|3652177|FG000|STARTED|Overall Study||1
2940153|NCT00635024|3652177|FG000|COMPLETED|Overall Study||0
2940154|NCT00635024|3652177|FG000|NOT COMPLETED|Overall Study||1
2940155|NCT00635050|3652181|FG000|STARTED|Overall Study|No patient received regimen B due to grade 3 toxicity in the third patient treated on regimen A.|32
2940156|NCT00635050|3652181|FG000|COMPLETED|Overall Study|Followup through 10 years planned.|31
2940157|NCT00635050|3652181|FG000|NOT COMPLETED|Overall Study||1
2940158|NCT00635089|3652188|FG000|STARTED|Overall Study||190
2940159|NCT00635089|3652188|FG000|Completed >/= 16 Weeks of Study|Overall Study||181
2940160|NCT00635089|3652188|FG000|COMPLETED|Overall Study|Participants who had not withdrawn at the time of study termination.|112
2940161|NCT00635089|3652188|FG000|NOT COMPLETED|Overall Study||78
2940162|NCT00635102|3652207|FG000|STARTED|Overall Study||27
2940163|NCT00635102|3652208|FG001|STARTED|Overall Study||30
2940164|NCT00635102|3652207|FG000|COMPLETED|Overall Study||20
2940165|NCT00635102|3652208|FG001|COMPLETED|Overall Study||22
2940166|NCT00635102|3652207|FG000|NOT COMPLETED|Overall Study||7
2940167|NCT00635102|3652208|FG001|NOT COMPLETED|Overall Study||8
2940168|NCT00635128|3652216|FG000|STARTED|Overall Study||351
2940169|NCT00635128|3652217|FG001|STARTED|Overall Study||64
2940170|NCT00635128|3652216|FG000|COMPLETED|Overall Study||351
2940171|NCT00635128|3652217|FG001|COMPLETED|Overall Study||64
2940172|NCT00635128|3652216|FG000|NOT COMPLETED|Overall Study||0
2940173|NCT00635128|3652217|FG001|NOT COMPLETED|Overall Study||0
2940174|NCT00635154|3652225|FG000|STARTED|Overall Study||54
2940175|NCT00635154|3652225|FG000|COMPLETED|Overall Study||21
2940176|NCT00635154|3652225|FG000|NOT COMPLETED|Overall Study||33
2940177|NCT00635219|3652236|FG000|STARTED|Overall Study||148
2940178|NCT00635219|3652237|FG001|STARTED|Overall Study||155
2940179|NCT00635219|3652238|FG002|STARTED|Overall Study||157
2940180|NCT00635219|3652239|FG003|STARTED|Overall Study||151
2940181|NCT00635219|3652240|FG004|STARTED|Overall Study||155
2940182|NCT00635219|3652236|FG000|COMPLETED|Overall Study||123
2940183|NCT00635219|3652237|FG001|COMPLETED|Overall Study||130
2940184|NCT00635219|3652238|FG002|COMPLETED|Overall Study||122
2940185|NCT00635219|3652239|FG003|COMPLETED|Overall Study||117
3278227|NCT02710045|4011751|FG001|STARTED|Overall Study||115
3278228|NCT02710045|4011752|FG002|STARTED|Overall Study||81
3278229|NCT02710045|4011750|FG000|COMPLETED|Overall Study||95
3278230|NCT02710045|4011751|FG001|COMPLETED|Overall Study||98
3278231|NCT02710045|4011752|FG002|COMPLETED|Overall Study||68
3278232|NCT02710045|4011750|FG000|NOT COMPLETED|Overall Study||11
3278233|NCT02710045|4011751|FG001|NOT COMPLETED|Overall Study||17
3278234|NCT02710045|4011752|FG002|NOT COMPLETED|Overall Study||13
3316357|NCT03110471|4049664|FG000|STARTED|Overall Study||30
3316358|NCT03110471|4049665|FG001|STARTED|Overall Study||30
3316359|NCT03110471|4049664|FG000|COMPLETED|Overall Study||30
3316360|NCT03110471|4049665|FG001|COMPLETED|Overall Study||30
3316361|NCT03110471|4049664|FG000|NOT COMPLETED|Overall Study||0
3316362|NCT03110471|4049665|FG001|NOT COMPLETED|Overall Study||0
3316363|NCT03110562|4049671|FG000|STARTED|Overall Study||195
3316364|NCT03110562|4049672|FG001|STARTED|Overall Study||207
3316365|NCT03110562|4049671|FG000|Treated|Overall Study||195
3316366|NCT03110562|4049672|FG001|Treated|Overall Study||204
2940186|NCT00635219|3652240|FG004|COMPLETED|Overall Study||113
2940187|NCT00635219|3652236|FG000|NOT COMPLETED|Overall Study||25
2940188|NCT00635219|3652237|FG001|NOT COMPLETED|Overall Study||25
2940189|NCT00635219|3652238|FG002|NOT COMPLETED|Overall Study||35
2940190|NCT00635219|3652239|FG003|NOT COMPLETED|Overall Study||34
2940191|NCT00635219|3652240|FG004|NOT COMPLETED|Overall Study||42
2940192|NCT00635232|3652257|FG000|STARTED|Overall Study||58
2940193|NCT00635232|3652258|FG001|STARTED|Overall Study||59
2940194|NCT00635232|3652259|FG002|STARTED|Overall Study||58
3316367|NCT03110562|4049671|FG000|COMPLETED|Overall Study||0
2940195|NCT00635232|3652260|FG003|STARTED|Overall Study||58
2940196|NCT00635232|3652261|FG004|STARTED|Overall Study||28
2940197|NCT00635232|3652257|FG000|COMPLETED|Overall Study||44
2940198|NCT00635232|3652258|FG001|COMPLETED|Overall Study||39
2940199|NCT00635232|3652259|FG002|COMPLETED|Overall Study||55
2940200|NCT00635232|3652260|FG003|COMPLETED|Overall Study||48
2940201|NCT00635232|3652261|FG004|COMPLETED|Overall Study||20
2940202|NCT00635232|3652257|FG000|NOT COMPLETED|Overall Study||14
2940203|NCT00635232|3652258|FG001|NOT COMPLETED|Overall Study||20
2940204|NCT00635232|3652259|FG002|NOT COMPLETED|Overall Study||3
2940205|NCT00635232|3652260|FG003|NOT COMPLETED|Overall Study||10
2940206|NCT00635232|3652261|FG004|NOT COMPLETED|Overall Study||8
2940207|NCT00635349|3652275|FG000|STARTED|Overall Study||73
2940208|NCT00635349|3652276|FG001|STARTED|Overall Study||67
2940209|NCT00635349|3652275|FG000|COMPLETED|Overall Study||29
2940210|NCT00635349|3652276|FG001|COMPLETED|Overall Study||19
2940211|NCT00635349|3652275|FG000|NOT COMPLETED|Overall Study||44
2940212|NCT00635349|3652276|FG001|NOT COMPLETED|Overall Study||48
2940213|NCT00635362|3652284|FG000|STARTED|Overall Study||22
2940214|NCT00635362|3652285|FG001|STARTED|Overall Study||20
2940215|NCT00635362|3652284|FG000|COMPLETED|Overall Study||9
2940216|NCT00635362|3652285|FG001|COMPLETED|Overall Study||12
2940217|NCT00635362|3652284|FG000|NOT COMPLETED|Overall Study||13
2940218|NCT00635362|3652285|FG001|NOT COMPLETED|Overall Study||8
2940219|NCT00635427|3652296|FG000|STARTED|Overall Study|12 participants were considered ITT population as 1 participant did not have type 1 Gaucher disease|13
2940220|NCT00635427|3652297|FG001|STARTED|Overall Study|11 participants were considered ITT population as 1 participant did not have type 1 Gaucher disease|12
2940221|NCT00635427|3652298|FG002|STARTED|Overall Study||16
2940222|NCT00635427|3652299|FG003|STARTED|Overall Study||16
2940223|NCT00635427|3652300|FG004|STARTED|Overall Study||38
2940224|NCT00635427|3652296|FG000|COMPLETED|Overall Study||1
2940225|NCT00635427|3652297|FG001|COMPLETED|Overall Study||6
2940226|NCT00635427|3652298|FG002|COMPLETED|Overall Study||5
2940227|NCT00635427|3652299|FG003|COMPLETED|Overall Study||7
2940228|NCT00635427|3652300|FG004|COMPLETED|Overall Study||30
2940229|NCT00635427|3652296|FG000|NOT COMPLETED|Overall Study||12
2940230|NCT00635427|3652297|FG001|NOT COMPLETED|Overall Study||6
2940231|NCT00635427|3652298|FG002|NOT COMPLETED|Overall Study||11
2940232|NCT00635427|3652299|FG003|NOT COMPLETED|Overall Study||9
2940233|NCT00635427|3652300|FG004|NOT COMPLETED|Overall Study||8
2940234|NCT00635453|3652312|FG000|STARTED|Overall Study||360
2940235|NCT00635453|3652313|FG001|STARTED|Overall Study||355
2940236|NCT00635453|3652312|FG000|6 Months Assessment|Overall Study||322
2940237|NCT00635453|3652313|FG001|6 Months Assessment|Overall Study||311
2940238|NCT00635453|3652312|FG000|12 Months Assessment|Overall Study||285
3278235|NCT02710071|4011762|FG000|STARTED|Placebo (2 Weeks).||21
3278236|NCT02710071|4011763|FG001|STARTED|Placebo (2 Weeks).||20
3278237|NCT02710071|4011762|FG000|COMPLETED|Placebo (2 Weeks).||21
3278238|NCT02710071|4011763|FG001|COMPLETED|Placebo (2 Weeks).||20
3278239|NCT02710071|4011762|FG000|NOT COMPLETED|Placebo (2 Weeks).||0
3278240|NCT02710071|4011763|FG001|NOT COMPLETED|Placebo (2 Weeks).||0
3278241|NCT02710071|4011762|FG000|STARTED|First Intervention (6 Weeks).||21
3278242|NCT02710071|4011763|FG001|STARTED|First Intervention (6 Weeks).||20
3278243|NCT02710071|4011762|FG000|COMPLETED|First Intervention (6 Weeks).||18
3278244|NCT02710071|4011763|FG001|COMPLETED|First Intervention (6 Weeks).||16
3278245|NCT02710071|4011762|FG000|NOT COMPLETED|First Intervention (6 Weeks).||3
3278246|NCT02710071|4011763|FG001|NOT COMPLETED|First Intervention (6 Weeks).||4
3278247|NCT02710071|4011762|FG000|STARTED|Second Intervention (6 Weeks).||18
3278248|NCT02710071|4011763|FG001|STARTED|Second Intervention (6 Weeks).||16
3278249|NCT02710071|4011762|FG000|COMPLETED|Second Intervention (6 Weeks).||17
3278250|NCT02710071|4011763|FG001|COMPLETED|Second Intervention (6 Weeks).||14
3278251|NCT02710071|4011762|FG000|NOT COMPLETED|Second Intervention (6 Weeks).||1
3278252|NCT02710071|4011763|FG001|NOT COMPLETED|Second Intervention (6 Weeks).||2
3278253|NCT02710136|4011772|FG000|STARTED|Study Enrollment||10
3278254|NCT02710136|4011773|FG001|STARTED|Study Enrollment||25
3278255|NCT02710136|4011772|FG000|COMPLETED|Study Enrollment||10
3278256|NCT02710136|4011773|FG001|COMPLETED|Study Enrollment||25
3278257|NCT02710136|4011772|FG000|NOT COMPLETED|Study Enrollment||0
3278258|NCT02710136|4011773|FG001|NOT COMPLETED|Study Enrollment||0
3278259|NCT02710136|4011772|FG000|STARTED|Phase 1a[Refer to Arm/Group Description]||10
3278260|NCT02710136|4011773|FG001|STARTED|Phase 1a[Refer to Arm/Group Description]||0
3278261|NCT02710136|4011772|FG000|COMPLETED|Phase 1a[Refer to Arm/Group Description]||9
3278262|NCT02710136|4011773|FG001|COMPLETED|Phase 1a[Refer to Arm/Group Description]||0
3278263|NCT02710136|4011772|FG000|NOT COMPLETED|Phase 1a[Refer to Arm/Group Description]||1
3278264|NCT02710136|4011773|FG001|NOT COMPLETED|Phase 1a[Refer to Arm/Group Description]||0
3278265|NCT02710136|4011772|FG000|STARTED|Phase 1b[Refer to Arm/Group Description]||4
2940239|NCT00635453|3652313|FG001|12 Months Assessment|Overall Study||260
2940240|NCT00635453|3652312|FG000|3 Years Assessment|Overall Study||246
2940241|NCT00635453|3652313|FG001|3 Years Assessment|Overall Study||204
2940242|NCT00635453|3652312|FG000|COMPLETED|Overall Study||206
2940243|NCT00635453|3652313|FG001|COMPLETED|Overall Study||181
2940244|NCT00635453|3652312|FG000|NOT COMPLETED|Overall Study||154
2940245|NCT00635453|3652313|FG001|NOT COMPLETED|Overall Study||174
2940246|NCT00635479|3652321|FG000|STARTED|Overall Study||55
2940247|NCT00635479|3652322|FG001|STARTED|Overall Study||60
2940248|NCT00635479|3652321|FG000|COMPLETED|Overall Study||49
2940249|NCT00635479|3652322|FG001|COMPLETED|Overall Study||42
2940250|NCT00635479|3652321|FG000|NOT COMPLETED|Overall Study||6
2940251|NCT00635479|3652322|FG001|NOT COMPLETED|Overall Study||18
2940252|NCT00635492|3652330|FG000|STARTED|Overall Study|This population consists of the analysis population.|1114
2940253|NCT00635492|3652331|FG001|STARTED|Overall Study|This population consists of the analysis population.|1274
2940254|NCT00635492|3652330|FG000|COMPLETED|Overall Study|This population consists of patients that completed the 24 month study.|835
2940255|NCT00635492|3652331|FG001|COMPLETED|Overall Study|This population consists of patients that completed the 24 month study.|992
2940256|NCT00635492|3652330|FG000|NOT COMPLETED|Overall Study||279
2940257|NCT00635492|3652331|FG001|NOT COMPLETED|Overall Study||282
2940258|NCT00635570|3652343|FG000|STARTED|Overall Study||136
2940259|NCT00635570|3652344|FG001|STARTED|Overall Study||137
2940260|NCT00635570|3652343|FG000|COMPLETED|Overall Study||121
2940261|NCT00635570|3652344|FG001|COMPLETED|Overall Study||126
2940262|NCT00635570|3652343|FG000|NOT COMPLETED|Overall Study||15
2940263|NCT00635570|3652344|FG001|NOT COMPLETED|Overall Study||11
2940264|NCT00635609|3652352|FG000|STARTED|Overall Study||48
2940265|NCT00635609|3652353|FG001|STARTED|Overall Study||45
2940266|NCT00635609|3652352|FG000|COMPLETED|Overall Study||41
2940267|NCT00635609|3652353|FG001|COMPLETED|Overall Study||42
2940268|NCT00635609|3652352|FG000|NOT COMPLETED|Overall Study||7
2940269|NCT00635609|3652353|FG001|NOT COMPLETED|Overall Study||3
2940270|NCT00635648|3652359|FG000|STARTED|Overall Study||63
2940271|NCT00635648|3652359|FG000|COMPLETED|Overall Study||26
2940272|NCT00635648|3652359|FG000|NOT COMPLETED|Overall Study||37
2940273|NCT00635661|3652363|FG000|STARTED|Overall Study||34
2940274|NCT00635661|3652363|FG000|COMPLETED|Overall Study||30
2940275|NCT00635661|3652363|FG000|NOT COMPLETED|Overall Study||4
2940276|NCT00635700|3652369|FG000|STARTED|Overall Study||24
2940277|NCT00635700|3652370|FG001|STARTED|Overall Study||27
2940278|NCT00635700|3652369|FG000|COMPLETED|Overall Study||9
2940279|NCT00635700|3652370|FG001|COMPLETED|Overall Study||13
2940280|NCT00635700|3652369|FG000|NOT COMPLETED|Overall Study||15
2940281|NCT00635700|3652370|FG001|NOT COMPLETED|Overall Study||14
2940282|NCT00635739|3652378|FG000|STARTED|Overall Study||42
3278266|NCT02710136|4011773|FG001|STARTED|Phase 1b[Refer to Arm/Group Description]||0
3278267|NCT02710136|4011772|FG000|COMPLETED|Phase 1b[Refer to Arm/Group Description]||4
3278268|NCT02710136|4011773|FG001|COMPLETED|Phase 1b[Refer to Arm/Group Description]||0
3278269|NCT02710136|4011772|FG000|NOT COMPLETED|Phase 1b[Refer to Arm/Group Description]||0
3278270|NCT02710136|4011773|FG001|NOT COMPLETED|Phase 1b[Refer to Arm/Group Description]||0
3278271|NCT02710136|4011772|FG000|STARTED|Phase 2 [Refer to Arm/Group Description]||0
3278272|NCT02710136|4011773|FG001|STARTED|Phase 2 [Refer to Arm/Group Description]||25
3278273|NCT02710136|4011772|FG000|COMPLETED|Phase 2 [Refer to Arm/Group Description]||0
3278274|NCT02710136|4011773|FG001|COMPLETED|Phase 2 [Refer to Arm/Group Description]||25
3278275|NCT02710136|4011772|FG000|NOT COMPLETED|Phase 2 [Refer to Arm/Group Description]||0
3278276|NCT02710136|4011773|FG001|NOT COMPLETED|Phase 2 [Refer to Arm/Group Description]||0
3278277|NCT02710214|4011782|FG000|STARTED|Overall Study||12
3278278|NCT02710214|4011783|FG001|STARTED|Overall Study||12
3278279|NCT02710214|4011782|FG000|COMPLETED|Overall Study||11
3278280|NCT02710214|4011783|FG001|COMPLETED|Overall Study||10
3278281|NCT02710214|4011782|FG000|NOT COMPLETED|Overall Study||1
3278282|NCT02710214|4011783|FG001|NOT COMPLETED|Overall Study||2
3278283|NCT02710240|4011789|FG000|STARTED|Overall Study||336
3278284|NCT02710240|4011789|FG000|COMPLETED|Overall Study||336
3278285|NCT02710240|4011789|FG000|NOT COMPLETED|Overall Study||0
3278286|NCT02710292|4011793|FG000|STARTED|Period 1, First 10 Days of Wear||47
3278287|NCT02710292|4011794|FG001|STARTED|Period 1, First 10 Days of Wear||52
3278288|NCT02710292|4011793|FG000|COMPLETED|Period 1, First 10 Days of Wear||46
3278289|NCT02710292|4011794|FG001|COMPLETED|Period 1, First 10 Days of Wear||49
3278290|NCT02710292|4011793|FG000|NOT COMPLETED|Period 1, First 10 Days of Wear||1
3278291|NCT02710292|4011794|FG001|NOT COMPLETED|Period 1, First 10 Days of Wear||3
3278292|NCT02710292|4011793|FG000|STARTED|Period 2, Second 10 Days of Wear||46
3278293|NCT02710292|4011794|FG001|STARTED|Period 2, Second 10 Days of Wear||49
3278294|NCT02710292|4011793|FG000|COMPLETED|Period 2, Second 10 Days of Wear||46
3278295|NCT02710292|4011794|FG001|COMPLETED|Period 2, Second 10 Days of Wear||49
3278296|NCT02710292|4011793|FG000|NOT COMPLETED|Period 2, Second 10 Days of Wear||0
3278297|NCT02710292|4011794|FG001|NOT COMPLETED|Period 2, Second 10 Days of Wear||0
3278298|NCT02710422|4011803|FG000|STARTED|Overall Study||12
3278299|NCT02710422|4011804|FG001|STARTED|Overall Study||12
3278300|NCT02710422|4011803|FG000|3 Month Visit|Overall Study||9
3278301|NCT02710422|4011804|FG001|3 Month Visit|Overall Study||11
3278302|NCT02710422|4011803|FG000|6 Month Visit|Overall Study||7
3278303|NCT02710422|4011804|FG001|6 Month Visit|Overall Study||8
3278304|NCT02710422|4011803|FG000|9 Month Visit|Overall Study||5
3278305|NCT02710422|4011804|FG001|9 Month Visit|Overall Study||5
3278306|NCT02710422|4011803|FG000|12 Month Visit|Overall Study||3
3278307|NCT02710422|4011804|FG001|12 Month Visit|Overall Study||3
3278308|NCT02710422|4011803|FG000|COMPLETED|Overall Study||3
3278309|NCT02710422|4011804|FG001|COMPLETED|Overall Study||3
2940283|NCT00635739|3652379|FG001|STARTED|Overall Study||38
2940284|NCT00635739|3652378|FG000|COMPLETED|Overall Study||39
2940285|NCT00635739|3652379|FG001|COMPLETED|Overall Study||36
2940286|NCT00635739|3652378|FG000|NOT COMPLETED|Overall Study||3
2940287|NCT00635739|3652379|FG001|NOT COMPLETED|Overall Study||2
2940288|NCT00635778|3652392|FG000|STARTED|Overall Study||1
2940289|NCT00635778|3652393|FG001|STARTED|Overall Study||3
2940290|NCT00635778|3652394|FG002|STARTED|Overall Study||3
2940291|NCT00635778|3652395|FG003|STARTED|Overall Study||8
2940292|NCT00635778|3652396|FG004|STARTED|Overall Study||8
2940293|NCT00635778|3652397|FG005|STARTED|Overall Study||21
2940294|NCT00635778|3652398|FG006|STARTED|Overall Study||6
2940295|NCT00635778|3652392|FG000|COMPLETED|Overall Study||0
2940296|NCT00635778|3652393|FG001|COMPLETED|Overall Study||0
2940297|NCT00635778|3652394|FG002|COMPLETED|Overall Study||0
2940298|NCT00635778|3652395|FG003|COMPLETED|Overall Study||0
2940299|NCT00635778|3652396|FG004|COMPLETED|Overall Study||0
2940300|NCT00635778|3652397|FG005|COMPLETED|Overall Study||0
2940301|NCT00635778|3652398|FG006|COMPLETED|Overall Study||0
2940302|NCT00635778|3652392|FG000|NOT COMPLETED|Overall Study||1
2940303|NCT00635778|3652393|FG001|NOT COMPLETED|Overall Study||3
2940304|NCT00635778|3652394|FG002|NOT COMPLETED|Overall Study||3
2940305|NCT00635778|3652395|FG003|NOT COMPLETED|Overall Study||8
2940306|NCT00635778|3652396|FG004|NOT COMPLETED|Overall Study||8
2940307|NCT00635778|3652397|FG005|NOT COMPLETED|Overall Study||21
2940308|NCT00635778|3652398|FG006|NOT COMPLETED|Overall Study||6
2940309|NCT00635804|3652423|FG000|STARTED|Overall Study||7
2940310|NCT00635804|3652424|FG001|STARTED|Overall Study||6
2940311|NCT00635804|3652425|FG002|STARTED|Overall Study||6
2940312|NCT00635804|3652426|FG003|STARTED|Overall Study||6
2940313|NCT00635804|3652427|FG004|STARTED|Overall Study||6
2940314|NCT00635804|3652428|FG005|STARTED|Overall Study||12
2940315|NCT00635804|3652429|FG006|STARTED|Overall Study||3
2940316|NCT00635804|3652430|FG007|STARTED|Overall Study||14
2940317|NCT00635804|3652423|FG000|COMPLETED|Overall Study||6
2940318|NCT00635804|3652424|FG001|COMPLETED|Overall Study||6
2940319|NCT00635804|3652425|FG002|COMPLETED|Overall Study||6
2940320|NCT00635804|3652426|FG003|COMPLETED|Overall Study||6
2940321|NCT00635804|3652427|FG004|COMPLETED|Overall Study||6
2940322|NCT00635804|3652428|FG005|COMPLETED|Overall Study||11
2940323|NCT00635804|3652429|FG006|COMPLETED|Overall Study||3
2940324|NCT00635804|3652430|FG007|COMPLETED|Overall Study||14
2940325|NCT00635804|3652423|FG000|NOT COMPLETED|Overall Study||1
2940326|NCT00635804|3652424|FG001|NOT COMPLETED|Overall Study||0
2940327|NCT00635804|3652425|FG002|NOT COMPLETED|Overall Study||0
2940328|NCT00635804|3652426|FG003|NOT COMPLETED|Overall Study||0
2940329|NCT00635804|3652427|FG004|NOT COMPLETED|Overall Study||0
2940330|NCT00635804|3652428|FG005|NOT COMPLETED|Overall Study||1
2940331|NCT00635804|3652429|FG006|NOT COMPLETED|Overall Study||0
2940332|NCT00635804|3652430|FG007|NOT COMPLETED|Overall Study||0
2940333|NCT00635817|3652455|FG000|STARTED|Overall Study||21
2940334|NCT00635817|3652456|FG001|STARTED|Overall Study||21
2940335|NCT00635817|3652457|FG002|STARTED|Overall Study||21
2940336|NCT00635817|3652458|FG003|STARTED|Overall Study||21
2940337|NCT00635817|3652455|FG000|COMPLETED|Overall Study||15
2940338|NCT00635817|3652456|FG001|COMPLETED|Overall Study||19
2940339|NCT00635817|3652457|FG002|COMPLETED|Overall Study||19
2940340|NCT00635817|3652458|FG003|COMPLETED|Overall Study||21
2940341|NCT00635817|3652455|FG000|NOT COMPLETED|Overall Study||6
2940342|NCT00635817|3652456|FG001|NOT COMPLETED|Overall Study||2
2940343|NCT00635817|3652457|FG002|NOT COMPLETED|Overall Study||2
2940344|NCT00635817|3652458|FG003|NOT COMPLETED|Overall Study||0
2940345|NCT00635830|3652472|FG000|STARTED|Overall Study||20
2940346|NCT00635830|3652473|FG001|STARTED|Overall Study||20
2940347|NCT00635830|3652472|FG000|COMPLETED|Overall Study||20
2940348|NCT00635830|3652473|FG001|COMPLETED|Overall Study||20
2940349|NCT00635830|3652472|FG000|NOT COMPLETED|Overall Study||0
2940350|NCT00635830|3652473|FG001|NOT COMPLETED|Overall Study||0
2940351|NCT00635999|3652482|FG000|STARTED|Overall Study||27
2940352|NCT00635999|3652483|FG001|STARTED|Overall Study||25
2940353|NCT00635999|3652484|FG002|STARTED|Overall Study||24
2940354|NCT00635999|3652482|FG000|COMPLETED|Overall Study||23
2940355|NCT00635999|3652483|FG001|COMPLETED|Overall Study||23
2940356|NCT00635999|3652484|FG002|COMPLETED|Overall Study||23
2940357|NCT00635999|3652482|FG000|NOT COMPLETED|Overall Study||4
2940358|NCT00635999|3652483|FG001|NOT COMPLETED|Overall Study||2
2940359|NCT00635999|3652484|FG002|NOT COMPLETED|Overall Study||1
2940360|NCT00636077|3652492|FG000|STARTED|Week 1||3
2940361|NCT00636077|3652493|FG001|STARTED|Week 1||3
2940362|NCT00636077|3652494|FG002|STARTED|Week 1||3
2940363|NCT00636077|3652495|FG003|STARTED|Week 1||3
2940364|NCT00636077|3652492|FG000|COMPLETED|Week 1||3
2940365|NCT00636077|3652493|FG001|COMPLETED|Week 1||3
2940366|NCT00636077|3652494|FG002|COMPLETED|Week 1||3
2940367|NCT00636077|3652495|FG003|COMPLETED|Week 1||3
2940368|NCT00636077|3652492|FG000|NOT COMPLETED|Week 1||0
2940369|NCT00636077|3652493|FG001|NOT COMPLETED|Week 1||0
2940370|NCT00636077|3652494|FG002|NOT COMPLETED|Week 1||0
2940371|NCT00636077|3652495|FG003|NOT COMPLETED|Week 1||0
2940372|NCT00636077|3652492|FG000|STARTED|Week 2||3
2940373|NCT00636077|3652493|FG001|STARTED|Week 2||3
2940374|NCT00636077|3652494|FG002|STARTED|Week 2||3
2940375|NCT00636077|3652495|FG003|STARTED|Week 2||3
2940376|NCT00636077|3652492|FG000|COMPLETED|Week 2||3
2940377|NCT00636077|3652493|FG001|COMPLETED|Week 2||3
2940378|NCT00636077|3652494|FG002|COMPLETED|Week 2||3
2940379|NCT00636077|3652495|FG003|COMPLETED|Week 2||3
2940380|NCT00636077|3652492|FG000|NOT COMPLETED|Week 2||0
2940381|NCT00636077|3652493|FG001|NOT COMPLETED|Week 2||0
2940382|NCT00636077|3652494|FG002|NOT COMPLETED|Week 2||0
2940383|NCT00636077|3652495|FG003|NOT COMPLETED|Week 2||0
2940384|NCT00636077|3652492|FG000|STARTED|Week 3||3
2940385|NCT00636077|3652493|FG001|STARTED|Week 3||3
2940386|NCT00636077|3652494|FG002|STARTED|Week 3||3
2940387|NCT00636077|3652495|FG003|STARTED|Week 3||3
2940388|NCT00636077|3652492|FG000|COMPLETED|Week 3||3
2940389|NCT00636077|3652493|FG001|COMPLETED|Week 3||3
3278310|NCT02710422|4011803|FG000|NOT COMPLETED|Overall Study||9
3278311|NCT02710422|4011804|FG001|NOT COMPLETED|Overall Study||9
3278312|NCT02710526|4011815|FG000|STARTED|Treatment Phase||28
3278313|NCT02710526|4011816|FG001|STARTED|Treatment Phase||20
3278314|NCT02710526|4011817|FG002|STARTED|Treatment Phase||18
3278315|NCT02710526|4011815|FG000|COMPLETED|Treatment Phase||22
3278316|NCT02710526|4011816|FG001|COMPLETED|Treatment Phase||16
3278317|NCT02710526|4011817|FG002|COMPLETED|Treatment Phase||12
3278318|NCT02710526|4011815|FG000|NOT COMPLETED|Treatment Phase||6
3278319|NCT02710526|4011816|FG001|NOT COMPLETED|Treatment Phase||4
3278320|NCT02710526|4011817|FG002|NOT COMPLETED|Treatment Phase||6
3278321|NCT02710526|4011815|FG000|STARTED|Safety Extension||15
3278322|NCT02710526|4011816|FG001|STARTED|Safety Extension||12
3278323|NCT02710526|4011817|FG002|STARTED|Safety Extension||0
3278324|NCT02710526|4011815|FG000|COMPLETED|Safety Extension||14
3278325|NCT02710526|4011816|FG001|COMPLETED|Safety Extension||12
3278326|NCT02710526|4011817|FG002|COMPLETED|Safety Extension||0
3278327|NCT02710526|4011815|FG000|NOT COMPLETED|Safety Extension||1
3278328|NCT02710526|4011816|FG001|NOT COMPLETED|Safety Extension||0
3278329|NCT02710526|4011817|FG002|NOT COMPLETED|Safety Extension||0
3278330|NCT02710591|4011839|FG000|STARTED|Overall Study||5
3278331|NCT02710591|4011840|FG001|STARTED|Overall Study||5
3278332|NCT02710591|4011841|FG002|STARTED|Overall Study||5
3278333|NCT02710591|4011842|FG003|STARTED|Overall Study||5
3278334|NCT02710591|4011839|FG000|COMPLETED|Overall Study||5
3278335|NCT02710591|4011840|FG001|COMPLETED|Overall Study||5
3278336|NCT02710591|4011841|FG002|COMPLETED|Overall Study||5
3278337|NCT02710591|4011842|FG003|COMPLETED|Overall Study||5
3278338|NCT02710591|4011839|FG000|NOT COMPLETED|Overall Study||0
3278339|NCT02710591|4011840|FG001|NOT COMPLETED|Overall Study||0
3278340|NCT02710591|4011841|FG002|NOT COMPLETED|Overall Study||0
3278341|NCT02710591|4011842|FG003|NOT COMPLETED|Overall Study||0
3278342|NCT02710630|4011857|FG000|STARTED|Period 1||7
3278343|NCT02710630|4011858|FG001|STARTED|Period 1||7
3278344|NCT02710630|4011859|FG002|STARTED|Period 1||7
3278345|NCT02710630|4011860|FG003|STARTED|Period 1||7
3278346|NCT02710630|4011861|FG004|STARTED|Period 1||7
3278347|NCT02710630|4011857|FG000|COMPLETED|Period 1||7
3278348|NCT02710630|4011858|FG001|COMPLETED|Period 1||7
3278349|NCT02710630|4011859|FG002|COMPLETED|Period 1||7
3278350|NCT02710630|4011860|FG003|COMPLETED|Period 1||7
3278351|NCT02710630|4011861|FG004|COMPLETED|Period 1||7
3278352|NCT02710630|4011857|FG000|NOT COMPLETED|Period 1||0
3278353|NCT02710630|4011858|FG001|NOT COMPLETED|Period 1||0
3278354|NCT02710630|4011859|FG002|NOT COMPLETED|Period 1||0
3278355|NCT02710630|4011860|FG003|NOT COMPLETED|Period 1||0
3278356|NCT02710630|4011861|FG004|NOT COMPLETED|Period 1||0
3278357|NCT02710630|4011857|FG000|STARTED|Period 2||7
3278358|NCT02710630|4011858|FG001|STARTED|Period 2||7
3278359|NCT02710630|4011859|FG002|STARTED|Period 2||7
3278360|NCT02710630|4011860|FG003|STARTED|Period 2||7
3278361|NCT02710630|4011861|FG004|STARTED|Period 2||7
3278362|NCT02710630|4011857|FG000|Not Treated|Period 2||1
3278363|NCT02710630|4011858|FG001|Not Treated|Period 2||0
3278364|NCT02710630|4011859|FG002|Not Treated|Period 2||0
3278365|NCT02710630|4011860|FG003|Not Treated|Period 2||0
3278366|NCT02710630|4011861|FG004|Not Treated|Period 2||0
3278367|NCT02710630|4011857|FG000|COMPLETED|Period 2||7
3278368|NCT02710630|4011858|FG001|COMPLETED|Period 2||7
3278369|NCT02710630|4011859|FG002|COMPLETED|Period 2||7
3278370|NCT02710630|4011860|FG003|COMPLETED|Period 2||7
3278371|NCT02710630|4011861|FG004|COMPLETED|Period 2||7
3278372|NCT02710630|4011857|FG000|NOT COMPLETED|Period 2||0
3278373|NCT02710630|4011858|FG001|NOT COMPLETED|Period 2||0
3278374|NCT02710630|4011859|FG002|NOT COMPLETED|Period 2||0
3278375|NCT02710630|4011860|FG003|NOT COMPLETED|Period 2||0
3278376|NCT02710630|4011861|FG004|NOT COMPLETED|Period 2||0
3278377|NCT02710630|4011857|FG000|STARTED|Period 3||7
3278378|NCT02710630|4011858|FG001|STARTED|Period 3||7
3278379|NCT02710630|4011859|FG002|STARTED|Period 3||7
3278380|NCT02710630|4011860|FG003|STARTED|Period 3||7
3278381|NCT02710630|4011861|FG004|STARTED|Period 3||7
3278382|NCT02710630|4011857|FG000|COMPLETED|Period 3||7
3278383|NCT02710630|4011858|FG001|COMPLETED|Period 3||7
3278384|NCT02710630|4011859|FG002|COMPLETED|Period 3||7
3278385|NCT02710630|4011860|FG003|COMPLETED|Period 3||7
3278386|NCT02710630|4011861|FG004|COMPLETED|Period 3||7
3278387|NCT02710630|4011857|FG000|NOT COMPLETED|Period 3||0
3278388|NCT02710630|4011858|FG001|NOT COMPLETED|Period 3||0
3278389|NCT02710630|4011859|FG002|NOT COMPLETED|Period 3||0
3278390|NCT02710630|4011860|FG003|NOT COMPLETED|Period 3||0
3278391|NCT02710630|4011861|FG004|NOT COMPLETED|Period 3||0
3278392|NCT02710630|4011857|FG000|STARTED|Period 4||7
3278393|NCT02710630|4011858|FG001|STARTED|Period 4||7
3278394|NCT02710630|4011859|FG002|STARTED|Period 4||7
3278395|NCT02710630|4011860|FG003|STARTED|Period 4||7
3278396|NCT02710630|4011861|FG004|STARTED|Period 4||7
3278397|NCT02710630|4011857|FG000|COMPLETED|Period 4||7
3278398|NCT02710630|4011858|FG001|COMPLETED|Period 4||7
3278399|NCT02710630|4011859|FG002|COMPLETED|Period 4||7
3278400|NCT02710630|4011860|FG003|COMPLETED|Period 4||7
3278401|NCT02710630|4011861|FG004|COMPLETED|Period 4||7
3278402|NCT02710630|4011857|FG000|NOT COMPLETED|Period 4||0
3278403|NCT02710630|4011858|FG001|NOT COMPLETED|Period 4||0
2940390|NCT00636077|3652494|FG002|COMPLETED|Week 3||3
2940391|NCT00636077|3652495|FG003|COMPLETED|Week 3||3
2940392|NCT00636077|3652492|FG000|NOT COMPLETED|Week 3||0
2940393|NCT00636077|3652493|FG001|NOT COMPLETED|Week 3||0
2940394|NCT00636077|3652494|FG002|NOT COMPLETED|Week 3||0
2940395|NCT00636077|3652495|FG003|NOT COMPLETED|Week 3||0
2940396|NCT00636077|3652492|FG000|STARTED|Week 4||3
2940397|NCT00636077|3652493|FG001|STARTED|Week 4||3
2940398|NCT00636077|3652494|FG002|STARTED|Week 4||3
2940399|NCT00636077|3652495|FG003|STARTED|Week 4||3
2940400|NCT00636077|3652492|FG000|COMPLETED|Week 4||3
2940401|NCT00636077|3652493|FG001|COMPLETED|Week 4||3
2940402|NCT00636077|3652494|FG002|COMPLETED|Week 4||3
2940403|NCT00636077|3652495|FG003|COMPLETED|Week 4||3
2940404|NCT00636077|3652492|FG000|NOT COMPLETED|Week 4||0
2940405|NCT00636077|3652493|FG001|NOT COMPLETED|Week 4||0
3278404|NCT02710630|4011859|FG002|NOT COMPLETED|Period 4||0
3278405|NCT02710630|4011860|FG003|NOT COMPLETED|Period 4||0
3278406|NCT02710630|4011861|FG004|NOT COMPLETED|Period 4||0
3278407|NCT02710630|4011857|FG000|STARTED|Period 5||7
3278408|NCT02710630|4011858|FG001|STARTED|Period 5||7
3278409|NCT02710630|4011859|FG002|STARTED|Period 5||7
3278410|NCT02710630|4011860|FG003|STARTED|Period 5||7
3278411|NCT02710630|4011861|FG004|STARTED|Period 5||7
3278412|NCT02710630|4011857|FG000|COMPLETED|Period 5||7
3278413|NCT02710630|4011858|FG001|COMPLETED|Period 5||7
3278414|NCT02710630|4011859|FG002|COMPLETED|Period 5||7
3278415|NCT02710630|4011860|FG003|COMPLETED|Period 5||7
3278416|NCT02710630|4011861|FG004|COMPLETED|Period 5||7
3278417|NCT02710630|4011857|FG000|NOT COMPLETED|Period 5||0
3278418|NCT02710630|4011858|FG001|NOT COMPLETED|Period 5||0
3278419|NCT02710630|4011859|FG002|NOT COMPLETED|Period 5||0
3278420|NCT02710630|4011860|FG003|NOT COMPLETED|Period 5||0
3278421|NCT02710630|4011861|FG004|NOT COMPLETED|Period 5||0
3278422|NCT02710630|4011857|FG000|STARTED|Period 6||7
3278423|NCT02710630|4011858|FG001|STARTED|Period 6||7
3278424|NCT02710630|4011859|FG002|STARTED|Period 6||7
3278425|NCT02710630|4011860|FG003|STARTED|Period 6||7
3278426|NCT02710630|4011861|FG004|STARTED|Period 6||7
3278427|NCT02710630|4011857|FG000|COMPLETED|Period 6||7
3278428|NCT02710630|4011858|FG001|COMPLETED|Period 6||7
3278429|NCT02710630|4011859|FG002|COMPLETED|Period 6||7
3278430|NCT02710630|4011860|FG003|COMPLETED|Period 6||7
3278431|NCT02710630|4011861|FG004|COMPLETED|Period 6||7
3278432|NCT02710630|4011857|FG000|NOT COMPLETED|Period 6||0
3278433|NCT02710630|4011858|FG001|NOT COMPLETED|Period 6||0
3278434|NCT02710630|4011859|FG002|NOT COMPLETED|Period 6||0
3278435|NCT02710630|4011860|FG003|NOT COMPLETED|Period 6||0
3278436|NCT02710630|4011861|FG004|NOT COMPLETED|Period 6||0
3278437|NCT02710669|4011878|FG000|STARTED|Overall Study||85
3278438|NCT02710669|4011879|FG001|STARTED|Overall Study||86
3278439|NCT02710669|4011880|FG002|STARTED|Overall Study||21
3278440|NCT02710669|4011878|FG000|COMPLETED|Overall Study||71
3278441|NCT02710669|4011879|FG001|COMPLETED|Overall Study||75
3278442|NCT02710669|4011880|FG002|COMPLETED|Overall Study||19
3278443|NCT02710669|4011878|FG000|NOT COMPLETED|Overall Study||14
3278444|NCT02710669|4011879|FG001|NOT COMPLETED|Overall Study||11
3278445|NCT02710669|4011880|FG002|NOT COMPLETED|Overall Study||2
3278446|NCT02710890|4011890|FG000|STARTED|Overall Study||48
3278447|NCT02710890|4011891|FG001|STARTED|Overall Study||55
3278448|NCT02710890|4011890|FG000|COMPLETED|Overall Study||48
3278449|NCT02710890|4011891|FG001|COMPLETED|Overall Study||55
3278450|NCT02710890|4011890|FG000|NOT COMPLETED|Overall Study||0
3278451|NCT02710890|4011891|FG001|NOT COMPLETED|Overall Study||0
3278452|NCT02710981|4011897|FG000|STARTED|6th Ovulation Induction Cycle (5 Days)||42
3278453|NCT02710981|4011898|FG001|STARTED|6th Ovulation Induction Cycle (5 Days)||0
3278454|NCT02710981|4011897|FG000|COMPLETED|6th Ovulation Induction Cycle (5 Days)||41
3278455|NCT02710981|4011898|FG001|COMPLETED|6th Ovulation Induction Cycle (5 Days)||0
3278456|NCT02710981|4011897|FG000|NOT COMPLETED|6th Ovulation Induction Cycle (5 Days)||1
3278457|NCT02710981|4011898|FG001|NOT COMPLETED|6th Ovulation Induction Cycle (5 Days)||0
3278458|NCT02710981|4011897|FG000|STARTED|7th Ovulation Induction Cycle (5 Days)||0
3278459|NCT02710981|4011898|FG001|STARTED|7th Ovulation Induction Cycle (5 Days)||41
3278460|NCT02710981|4011897|FG000|COMPLETED|7th Ovulation Induction Cycle (5 Days)||0
3278461|NCT02710981|4011898|FG001|COMPLETED|7th Ovulation Induction Cycle (5 Days)||36
3278462|NCT02710981|4011897|FG000|NOT COMPLETED|7th Ovulation Induction Cycle (5 Days)||0
3278463|NCT02710981|4011898|FG001|NOT COMPLETED|7th Ovulation Induction Cycle (5 Days)||5
3278464|NCT02711306|4011908|FG000|STARTED|Overall Study||18
2940406|NCT00636077|3652494|FG002|NOT COMPLETED|Week 4||0
2940407|NCT00636077|3652495|FG003|NOT COMPLETED|Week 4||0
2940408|NCT00636155|3652505|FG000|STARTED|Overall Study||20
2940409|NCT00636155|3652505|FG000|COMPLETED|Overall Study|Completed maximum 6 cycles of treatment|2
3278465|NCT02711306|4011909|FG001|STARTED|Overall Study||18
3278466|NCT02711306|4011908|FG000|COMPLETED|Overall Study||16
3278467|NCT02711306|4011909|FG001|COMPLETED|Overall Study||16
3278468|NCT02711306|4011908|FG000|NOT COMPLETED|Overall Study||2
3278469|NCT02711306|4011909|FG001|NOT COMPLETED|Overall Study||2
3278470|NCT02711345|4011925|FG000|STARTED|Overall Study||2
3278471|NCT02711345|4011926|FG001|STARTED|Overall Study||3
3278472|NCT02711345|4011927|FG002|STARTED|Overall Study||6
3278473|NCT02711345|4011928|FG003|STARTED|Overall Study||4
3278474|NCT02711345|4011929|FG004|STARTED|Overall Study||8
3278475|NCT02711345|4011930|FG005|STARTED|Overall Study||6
3278476|NCT02711345|4011931|FG006|STARTED|Overall Study||12
3278477|NCT02711345|4011932|FG007|STARTED|Overall Study||6
2940410|NCT00636155|3652505|FG000|NOT COMPLETED|Overall Study||18
2940411|NCT00636168|3652511|FG000|STARTED|Randomized to Study Drug||475
2940412|NCT00636168|3652512|FG001|STARTED|Randomized to Study Drug||476
2940413|NCT00636168|3652511|FG000|COMPLETED|Randomized to Study Drug||471
2940414|NCT00636168|3652512|FG001|COMPLETED|Randomized to Study Drug||474
2940415|NCT00636168|3652511|FG000|NOT COMPLETED|Randomized to Study Drug||4
3278478|NCT02711345|4011933|FG008|STARTED|Overall Study||6
3278479|NCT02711345|4011934|FG009|STARTED|Overall Study||12
3278480|NCT02711345|4011925|FG000|COMPLETED|Overall Study||0
3278481|NCT02711345|4011926|FG001|COMPLETED|Overall Study||0
3278482|NCT02711345|4011927|FG002|COMPLETED|Overall Study||0
3278483|NCT02711345|4011928|FG003|COMPLETED|Overall Study||0
3278484|NCT02711345|4011929|FG004|COMPLETED|Overall Study||0
3278485|NCT02711345|4011930|FG005|COMPLETED|Overall Study||0
3278486|NCT02711345|4011931|FG006|COMPLETED|Overall Study||0
3278487|NCT02711345|4011932|FG007|COMPLETED|Overall Study||0
3278488|NCT02711345|4011933|FG008|COMPLETED|Overall Study||0
3278489|NCT02711345|4011934|FG009|COMPLETED|Overall Study||0
3278490|NCT02711345|4011925|FG000|NOT COMPLETED|Overall Study||2
3278491|NCT02711345|4011926|FG001|NOT COMPLETED|Overall Study||3
3278492|NCT02711345|4011927|FG002|NOT COMPLETED|Overall Study||6
3278493|NCT02711345|4011928|FG003|NOT COMPLETED|Overall Study||4
3278494|NCT02711345|4011929|FG004|NOT COMPLETED|Overall Study||8
3278495|NCT02711345|4011930|FG005|NOT COMPLETED|Overall Study||6
3278496|NCT02711345|4011931|FG006|NOT COMPLETED|Overall Study||12
3278497|NCT02711345|4011932|FG007|NOT COMPLETED|Overall Study||6
3278498|NCT02711345|4011933|FG008|NOT COMPLETED|Overall Study||6
3278499|NCT02711345|4011934|FG009|NOT COMPLETED|Overall Study||12
3278500|NCT02711553|4011965|FG000|STARTED|Overall Study||106
3278501|NCT02711553|4011966|FG001|STARTED|Overall Study||52
3278502|NCT02711553|4011967|FG002|STARTED|Overall Study||102
3278503|NCT02711553|4011968|FG003|STARTED|Overall Study||49
3278504|NCT02711553|4011965|FG000|Received at Least 1 Dose of Study Drug|Overall Study||104
3278505|NCT02711553|4011966|FG001|Received at Least 1 Dose of Study Drug|Overall Study||52
3278506|NCT02711553|4011967|FG002|Received at Least 1 Dose of Study Drug|Overall Study||102
3278507|NCT02711553|4011968|FG003|Received at Least 1 Dose of Study Drug|Overall Study||48
3278508|NCT02711553|4011965|FG000|COMPLETED|Overall Study||100
3278509|NCT02711553|4011966|FG001|COMPLETED|Overall Study||47
3278510|NCT02711553|4011967|FG002|COMPLETED|Overall Study||92
3278511|NCT02711553|4011968|FG003|COMPLETED|Overall Study||45
3278512|NCT02711553|4011965|FG000|NOT COMPLETED|Overall Study||6
3278513|NCT02711553|4011966|FG001|NOT COMPLETED|Overall Study||5
3278514|NCT02711553|4011967|FG002|NOT COMPLETED|Overall Study||10
3278515|NCT02711553|4011968|FG003|NOT COMPLETED|Overall Study||4
3278516|NCT02711800|4011980|FG000|STARTED|Overall Study||9
3278517|NCT02711800|4011980|FG000|COMPLETED|Overall Study||7
3278518|NCT02711800|4011980|FG000|NOT COMPLETED|Overall Study||2
3278519|NCT02711839|4011986|FG000|STARTED|Overall Study||20
3278520|NCT02711839|4011987|FG001|STARTED|Overall Study||34
3278521|NCT02711839|4011986|FG000|COMPLETED|Overall Study||16
3278522|NCT02711839|4011987|FG001|COMPLETED|Overall Study||24
3278523|NCT02711839|4011986|FG000|NOT COMPLETED|Overall Study||4
3278524|NCT02711839|4011987|FG001|NOT COMPLETED|Overall Study||10
3278525|NCT02711956|4012008|FG000|STARTED|Overall Study||2
3278526|NCT02711956|4012009|FG001|STARTED|Overall Study||2
3278527|NCT02711956|4012010|FG002|STARTED|Overall Study||3
3278528|NCT02711956|4012011|FG003|STARTED|Overall Study||5
3278529|NCT02711956|4012012|FG004|STARTED|Overall Study||4
3278530|NCT02711956|4012013|FG005|STARTED|Overall Study||3
3278531|NCT02711956|4012014|FG006|STARTED|Overall Study||4
3278532|NCT02711956|4012015|FG007|STARTED|Overall Study||4
3278533|NCT02711956|4012016|FG008|STARTED|Overall Study||4
3278534|NCT02711956|4012017|FG009|STARTED|Overall Study||3
3278535|NCT02711956|4012018|FG010|STARTED|Overall Study||1
3278536|NCT02711956|4012019|FG011|STARTED|Overall Study||9
3278537|NCT02711956|4012020|FG012|STARTED|Overall Study||17
3278538|NCT02711956|4012021|FG013|STARTED|Overall Study||6
3278539|NCT02711956|4012022|FG014|STARTED|Overall Study||8
3278540|NCT02711956|4012008|FG000|COMPLETED|Overall Study||0
3278541|NCT02711956|4012009|FG001|COMPLETED|Overall Study||0
3278542|NCT02711956|4012010|FG002|COMPLETED|Overall Study||1
3278543|NCT02711956|4012011|FG003|COMPLETED|Overall Study||2
3278544|NCT02711956|4012012|FG004|COMPLETED|Overall Study||0
3278545|NCT02711956|4012013|FG005|COMPLETED|Overall Study||1
3278546|NCT02711956|4012014|FG006|COMPLETED|Overall Study||0
3278547|NCT02711956|4012015|FG007|COMPLETED|Overall Study||2
3278548|NCT02711956|4012016|FG008|COMPLETED|Overall Study||0
3278549|NCT02711956|4012017|FG009|COMPLETED|Overall Study||0
3278550|NCT02711956|4012018|FG010|COMPLETED|Overall Study||0
3278551|NCT02711956|4012019|FG011|COMPLETED|Overall Study||0
3278552|NCT02711956|4012020|FG012|COMPLETED|Overall Study||1
2940416|NCT00636168|3652512|FG001|NOT COMPLETED|Randomized to Study Drug||2
2940417|NCT00636168|3652511|FG000|STARTED|Treated With Study Drug||471
2940418|NCT00636168|3652512|FG001|STARTED|Treated With Study Drug||474
3278553|NCT02711956|4012021|FG013|COMPLETED|Overall Study||1
3278554|NCT02711956|4012022|FG014|COMPLETED|Overall Study||0
3278555|NCT02711956|4012008|FG000|NOT COMPLETED|Overall Study||2
3278556|NCT02711956|4012009|FG001|NOT COMPLETED|Overall Study||2
3278557|NCT02711956|4012010|FG002|NOT COMPLETED|Overall Study||2
3278558|NCT02711956|4012011|FG003|NOT COMPLETED|Overall Study||3
3278559|NCT02711956|4012012|FG004|NOT COMPLETED|Overall Study||4
3278560|NCT02711956|4012013|FG005|NOT COMPLETED|Overall Study||2
2940419|NCT00636168|3652511|FG000|COMPLETED|Treated With Study Drug||63
2940420|NCT00636168|3652512|FG001|COMPLETED|Treated With Study Drug||143
2940421|NCT00636168|3652511|FG000|NOT COMPLETED|Treated With Study Drug||408
2940422|NCT00636168|3652512|FG001|NOT COMPLETED|Treated With Study Drug||331
2940423|NCT00636168|3652511|FG000|STARTED|Long Term Follow-Up||141
2940424|NCT00636168|3652512|FG001|STARTED|Long Term Follow-Up||143
2940425|NCT00636168|3652511|FG000|COMPLETED|Long Term Follow-Up||130
2940426|NCT00636168|3652512|FG001|COMPLETED|Long Term Follow-Up||129
2940427|NCT00636168|3652511|FG000|NOT COMPLETED|Long Term Follow-Up||11
2940428|NCT00636168|3652512|FG001|NOT COMPLETED|Long Term Follow-Up||14
2940429|NCT00636181|3652521|FG000|STARTED|Overall Study||54
2940430|NCT00636181|3652522|FG001|STARTED|Overall Study||53
2940431|NCT00636181|3652523|FG002|STARTED|Overall Study||57
2940432|NCT00636181|3652521|FG000|COMPLETED|Overall Study||46
2940433|NCT00636181|3652522|FG001|COMPLETED|Overall Study||47
2940434|NCT00636181|3652523|FG002|COMPLETED|Overall Study||47
2940435|NCT00636181|3652521|FG000|NOT COMPLETED|Overall Study||8
2940436|NCT00636181|3652522|FG001|NOT COMPLETED|Overall Study||6
2940437|NCT00636181|3652523|FG002|NOT COMPLETED|Overall Study||10
2940438|NCT00636194|3652533|FG000|STARTED|Overall Study||175
2940439|NCT00636194|3652534|FG001|STARTED|Overall Study||175
2940440|NCT00636194|3652533|FG000|COMPLETED|Overall Study||172
3047810|NCT01204671|3767807|FG004|STARTED|Overall Study||610
3278561|NCT02711956|4012014|FG006|NOT COMPLETED|Overall Study||4
3278562|NCT02711956|4012015|FG007|NOT COMPLETED|Overall Study||2
3278563|NCT02711956|4012016|FG008|NOT COMPLETED|Overall Study||4
3278564|NCT02711956|4012017|FG009|NOT COMPLETED|Overall Study||3
3278565|NCT02711956|4012018|FG010|NOT COMPLETED|Overall Study||1
3278566|NCT02711956|4012019|FG011|NOT COMPLETED|Overall Study||9
3278567|NCT02711956|4012020|FG012|NOT COMPLETED|Overall Study||16
3278568|NCT02711956|4012021|FG013|NOT COMPLETED|Overall Study||5
3278569|NCT02711956|4012022|FG014|NOT COMPLETED|Overall Study||8
3278570|NCT02711995|4012063|FG000|STARTED|First Intervention (30 Days)||8
3278571|NCT02711995|4012063|FG000|COMPLETED|First Intervention (30 Days)||8
3278572|NCT02711995|4012063|FG000|NOT COMPLETED|First Intervention (30 Days)||0
3278573|NCT02711995|4012063|FG000|STARTED|Washout (90 Days)||8
3278574|NCT02711995|4012063|FG000|COMPLETED|Washout (90 Days)||7
3278575|NCT02711995|4012063|FG000|NOT COMPLETED|Washout (90 Days)||1
3278576|NCT02711995|4012063|FG000|STARTED|Second Intervention (30 Days)||7
3278577|NCT02711995|4012063|FG000|COMPLETED|Second Intervention (30 Days)||7
3278578|NCT02711995|4012063|FG000|NOT COMPLETED|Second Intervention (30 Days)||0
3278579|NCT02712008|4012072|FG000|STARTED|Baseline (Day 1) up to Week 12||50
3278580|NCT02712008|4012073|FG001|STARTED|Baseline (Day 1) up to Week 12||100
3278581|NCT02712008|4012074|FG002|STARTED|Baseline (Day 1) up to Week 12||152
3278582|NCT02712008|4012075|FG003|STARTED|Baseline (Day 1) up to Week 12||0
3278583|NCT02712008|4012076|FG004|STARTED|Baseline (Day 1) up to Week 12||0
3278584|NCT02712008|4012077|FG005|STARTED|Baseline (Day 1) up to Week 12||0
3278585|NCT02712008|4012078|FG006|STARTED|Baseline (Day 1) up to Week 12||0
3278586|NCT02712008|4012079|FG007|STARTED|Baseline (Day 1) up to Week 12||0
3278587|NCT02712008|4012072|FG000|COMPLETED|Baseline (Day 1) up to Week 12||46
3278588|NCT02712008|4012073|FG001|COMPLETED|Baseline (Day 1) up to Week 12||97
3278589|NCT02712008|4012074|FG002|COMPLETED|Baseline (Day 1) up to Week 12||148
3278590|NCT02712008|4012075|FG003|COMPLETED|Baseline (Day 1) up to Week 12||0
3278591|NCT02712008|4012076|FG004|COMPLETED|Baseline (Day 1) up to Week 12||0
3278592|NCT02712008|4012077|FG005|COMPLETED|Baseline (Day 1) up to Week 12||0
3278593|NCT02712008|4012078|FG006|COMPLETED|Baseline (Day 1) up to Week 12||0
3278594|NCT02712008|4012079|FG007|COMPLETED|Baseline (Day 1) up to Week 12||0
3278595|NCT02712008|4012072|FG000|NOT COMPLETED|Baseline (Day 1) up to Week 12||4
3278596|NCT02712008|4012073|FG001|NOT COMPLETED|Baseline (Day 1) up to Week 12||3
3278597|NCT02712008|4012074|FG002|NOT COMPLETED|Baseline (Day 1) up to Week 12||4
3278598|NCT02712008|4012075|FG003|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
3278599|NCT02712008|4012076|FG004|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
3278600|NCT02712008|4012077|FG005|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
3278601|NCT02712008|4012078|FG006|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
3278602|NCT02712008|4012079|FG007|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
3278603|NCT02712008|4012072|FG000|STARTED|From Week 12 up to Week 36|Out of 46 participants that completed Week 12, 45 re-randomized for treatment from Week 12 to 36|45
3278604|NCT02712008|4012073|FG001|STARTED|From Week 12 up to Week 36|Out of 97 participants that completed Week 12, 96 re-randomized to REGN910-3 (6:2mg) Q8 and Q12|0
3278605|NCT02712008|4012074|FG002|STARTED|From Week 12 up to Week 36|Out of 148 that completed Week 12,143 re-randomized to Aflibercept 2mg Q8, Q12, REGN910-3 (6:2mg) Q8|0
3278606|NCT02712008|4012075|FG003|STARTED|From Week 12 up to Week 36|Out of 96 that were re-randomized, 44 re-randomized from REGN910-3(6:2 mg)Q4 to REGN910-3(6:2 mg)Q8|44
3278607|NCT02712008|4012076|FG004|STARTED|From Week 12 up to Week 36|Out of 96 that were re-randomized, 52 re-randomized from REGN910-3(6:2 mg)Q4 to REGN910-3(6:2 mg)Q12|52
3278608|NCT02712008|4012077|FG005|STARTED|From Week 12 up to Week 36|Out of 143 that were re-randomized, 46 re-randomized from Aflibercept 2mg Q4 to Aflibercept 2mg Q8|46
2940441|NCT00636194|3652534|FG001|COMPLETED|Overall Study||175
2940442|NCT00636194|3652533|FG000|NOT COMPLETED|Overall Study||3
2940443|NCT00636194|3652534|FG001|NOT COMPLETED|Overall Study||0
2940444|NCT00636207|3652543|FG000|STARTED|Overall Study|One participant discontinued after completing Period 2. Doses in Periods 1 and 2 were Montelukast.|1
2940445|NCT00636207|3652544|FG001|STARTED|Overall Study|One participant withdrew consent after completing all study doses.|8
2940446|NCT00636207|3652545|FG002|STARTED|Overall Study||18
2940447|NCT00636207|3652546|FG003|STARTED|Overall Study||6
2940448|NCT00636207|3652547|FG004|STARTED|Overall Study|One participant withdrew consent after completing all study doses.|9
2940449|NCT00636207|3652548|FG005|STARTED|Overall Study||1
2940450|NCT00636207|3652549|FG006|STARTED|Overall Study||3
2940451|NCT00636207|3652543|FG000|COMPLETED|Overall Study||0
2940452|NCT00636207|3652544|FG001|COMPLETED|Overall Study||7
2940453|NCT00636207|3652545|FG002|COMPLETED|Overall Study||18
2940454|NCT00636207|3652546|FG003|COMPLETED|Overall Study||6
2940455|NCT00636207|3652547|FG004|COMPLETED|Overall Study||8
3278609|NCT02712008|4012078|FG006|STARTED|From Week 12 up to Week 36|Out of 143 that were re-randomized, 48 re-randomized from Aflibercept 2mg Q4 to Aflibercept 2mg Q12|48
3278610|NCT02712008|4012079|FG007|STARTED|From Week 12 up to Week 36|Out of 143 that were re-randomized, 49 re-randomized from Aflibercept 2mg Q4 to REGN910-3 (6:2mg) Q8|49
3278611|NCT02712008|4012072|FG000|COMPLETED|From Week 12 up to Week 36||44
3278612|NCT02712008|4012073|FG001|COMPLETED|From Week 12 up to Week 36||0
3278613|NCT02712008|4012074|FG002|COMPLETED|From Week 12 up to Week 36||0
3278614|NCT02712008|4012075|FG003|COMPLETED|From Week 12 up to Week 36||42
3278615|NCT02712008|4012076|FG004|COMPLETED|From Week 12 up to Week 36||50
3278616|NCT02712008|4012077|FG005|COMPLETED|From Week 12 up to Week 36||46
3278617|NCT02712008|4012078|FG006|COMPLETED|From Week 12 up to Week 36||43
3278618|NCT02712008|4012079|FG007|COMPLETED|From Week 12 up to Week 36||45
3278619|NCT02712008|4012072|FG000|NOT COMPLETED|From Week 12 up to Week 36||1
3278620|NCT02712008|4012073|FG001|NOT COMPLETED|From Week 12 up to Week 36||0
3278621|NCT02712008|4012074|FG002|NOT COMPLETED|From Week 12 up to Week 36||0
3278622|NCT02712008|4012075|FG003|NOT COMPLETED|From Week 12 up to Week 36||2
3278623|NCT02712008|4012076|FG004|NOT COMPLETED|From Week 12 up to Week 36||2
3278624|NCT02712008|4012077|FG005|NOT COMPLETED|From Week 12 up to Week 36||0
3278625|NCT02712008|4012078|FG006|NOT COMPLETED|From Week 12 up to Week 36||5
3278626|NCT02712008|4012079|FG007|NOT COMPLETED|From Week 12 up to Week 36||4
3278627|NCT02712047|4012093|FG000|STARTED|Treatment Period 1 (35 Days)||14
3278628|NCT02712047|4012094|FG001|STARTED|Treatment Period 1 (35 Days)||13
3278629|NCT02712047|4012093|FG000|COMPLETED|Treatment Period 1 (35 Days)||14
3278630|NCT02712047|4012094|FG001|COMPLETED|Treatment Period 1 (35 Days)||13
3278631|NCT02712047|4012093|FG000|NOT COMPLETED|Treatment Period 1 (35 Days)||0
3278632|NCT02712047|4012094|FG001|NOT COMPLETED|Treatment Period 1 (35 Days)||0
3278633|NCT02712047|4012093|FG000|STARTED|Washout Period (21 Days)||14
3278634|NCT02712047|4012094|FG001|STARTED|Washout Period (21 Days)||13
3278635|NCT02712047|4012093|FG000|COMPLETED|Washout Period (21 Days)||14
3278636|NCT02712047|4012094|FG001|COMPLETED|Washout Period (21 Days)||13
3278637|NCT02712047|4012093|FG000|NOT COMPLETED|Washout Period (21 Days)||0
3278638|NCT02712047|4012094|FG001|NOT COMPLETED|Washout Period (21 Days)||0
3278639|NCT02712047|4012093|FG000|STARTED|Treatment Period 2 (35 Days)||14
3278640|NCT02712047|4012094|FG001|STARTED|Treatment Period 2 (35 Days)||13
3278641|NCT02712047|4012093|FG000|COMPLETED|Treatment Period 2 (35 Days)||14
3278642|NCT02712047|4012094|FG001|COMPLETED|Treatment Period 2 (35 Days)||13
3278643|NCT02712047|4012093|FG000|NOT COMPLETED|Treatment Period 2 (35 Days)||0
3278644|NCT02712047|4012094|FG001|NOT COMPLETED|Treatment Period 2 (35 Days)||0
3278645|NCT02712099|4012102|FG000|STARTED|Overall Study||30
3278646|NCT02712099|4012103|FG001|STARTED|Overall Study||20
3278647|NCT02712099|4012102|FG000|COMPLETED|Overall Study||30
3278648|NCT02712099|4012103|FG001|COMPLETED|Overall Study||20
3278649|NCT02712099|4012102|FG000|NOT COMPLETED|Overall Study||0
3278650|NCT02712099|4012103|FG001|NOT COMPLETED|Overall Study||0
3278651|NCT02712320|4012109|FG000|STARTED|Overall Study||30
3278652|NCT02712320|4012109|FG000|COMPLETED|Overall Study||25
3278653|NCT02712320|4012109|FG000|NOT COMPLETED|Overall Study||5
3278654|NCT02712333|4012115|FG000|STARTED|First Period||34
3278655|NCT02712333|4012116|FG001|STARTED|First Period||26
3278656|NCT02712333|4012115|FG000|COMPLETED|First Period||31
3278657|NCT02712333|4012116|FG001|COMPLETED|First Period||24
3278658|NCT02712333|4012115|FG000|NOT COMPLETED|First Period||3
3278659|NCT02712333|4012116|FG001|NOT COMPLETED|First Period||2
3278660|NCT02712333|4012115|FG000|STARTED|Second Period||31
3278661|NCT02712333|4012116|FG001|STARTED|Second Period||24
3278662|NCT02712333|4012115|FG000|COMPLETED|Second Period||31
3278663|NCT02712333|4012116|FG001|COMPLETED|Second Period||24
3278664|NCT02712333|4012115|FG000|NOT COMPLETED|Second Period||0
3278665|NCT02712333|4012116|FG001|NOT COMPLETED|Second Period||0
3278666|NCT02712359|4012131|FG000|STARTED|Epoch 001: Persistence at Year 8||300
3278667|NCT02712359|4012132|FG001|STARTED|Epoch 001: Persistence at Year 8||300
3278668|NCT02712359|4012133|FG002|STARTED|Epoch 001: Persistence at Year 8||0
3278669|NCT02712359|4012134|FG003|STARTED|Epoch 001: Persistence at Year 8||0
3278670|NCT02712359|4012131|FG000|COMPLETED|Epoch 001: Persistence at Year 8||300
3278671|NCT02712359|4012132|FG001|COMPLETED|Epoch 001: Persistence at Year 8||300
3278672|NCT02712359|4012133|FG002|COMPLETED|Epoch 001: Persistence at Year 8||0
3278673|NCT02712359|4012134|FG003|COMPLETED|Epoch 001: Persistence at Year 8||0
3278674|NCT02712359|4012131|FG000|NOT COMPLETED|Epoch 001: Persistence at Year 8||0
2940456|NCT00636207|3652548|FG005|COMPLETED|Overall Study||1
2940457|NCT00636207|3652549|FG006|COMPLETED|Overall Study||3
2940458|NCT00636207|3652543|FG000|NOT COMPLETED|Overall Study||1
2940459|NCT00636207|3652544|FG001|NOT COMPLETED|Overall Study||1
3278675|NCT02712359|4012132|FG001|NOT COMPLETED|Epoch 001: Persistence at Year 8||0
3278676|NCT02712359|4012133|FG002|NOT COMPLETED|Epoch 001: Persistence at Year 8||0
3278677|NCT02712359|4012134|FG003|NOT COMPLETED|Epoch 001: Persistence at Year 8||0
2940460|NCT00636207|3652545|FG002|NOT COMPLETED|Overall Study||0
2940461|NCT00636207|3652546|FG003|NOT COMPLETED|Overall Study||0
2940462|NCT00636207|3652547|FG004|NOT COMPLETED|Overall Study||1
2940463|NCT00636207|3652548|FG005|NOT COMPLETED|Overall Study||0
2940464|NCT00636207|3652549|FG006|NOT COMPLETED|Overall Study||0
2940465|NCT00636220|3652570|FG000|STARTED|Overall Study||101
2940466|NCT00636220|3652570|FG000|COMPLETED|Overall Study||101
2940467|NCT00636220|3652570|FG000|NOT COMPLETED|Overall Study||0
2940468|NCT00636363|3652577|FG000|STARTED|Overall Study||178
2940469|NCT00636363|3652578|FG001|STARTED|Overall Study||176
2940470|NCT00636363|3652579|FG002|STARTED|Overall Study||181
2940471|NCT00636363|3652577|FG000|COMPLETED|Overall Study||165
2940472|NCT00636363|3652578|FG001|COMPLETED|Overall Study||156
2940473|NCT00636363|3652579|FG002|COMPLETED|Overall Study||163
2940474|NCT00636363|3652577|FG000|NOT COMPLETED|Overall Study||13
2940475|NCT00636363|3652578|FG001|NOT COMPLETED|Overall Study||20
2940476|NCT00636363|3652579|FG002|NOT COMPLETED|Overall Study||18
2940477|NCT00636389|3652587|FG000|STARTED|Period 1 - 1 Week||7
2940478|NCT00636389|3652588|FG001|STARTED|Period 1 - 1 Week||5
2940479|NCT00636389|3652587|FG000|COMPLETED|Period 1 - 1 Week||7
2940480|NCT00636389|3652588|FG001|COMPLETED|Period 1 - 1 Week||5
2940481|NCT00636389|3652587|FG000|NOT COMPLETED|Period 1 - 1 Week||0
2940482|NCT00636389|3652588|FG001|NOT COMPLETED|Period 1 - 1 Week||0
2940483|NCT00636389|3652587|FG000|STARTED|Period 2 - 1 Week||7
2940484|NCT00636389|3652588|FG001|STARTED|Period 2 - 1 Week||5
2940485|NCT00636389|3652587|FG000|COMPLETED|Period 2 - 1 Week||7
2940486|NCT00636389|3652588|FG001|COMPLETED|Period 2 - 1 Week||5
2940487|NCT00636389|3652587|FG000|NOT COMPLETED|Period 2 - 1 Week||0
2940488|NCT00636389|3652588|FG001|NOT COMPLETED|Period 2 - 1 Week||0
3278678|NCT02712359|4012131|FG000|STARTED|Epoch 002: Persistence at Year 10||0
3278679|NCT02712359|4012132|FG001|STARTED|Epoch 002: Persistence at Year 10||0
3278680|NCT02712359|4012133|FG002|STARTED|Epoch 002: Persistence at Year 10||299
3278681|NCT02712359|4012134|FG003|STARTED|Epoch 002: Persistence at Year 10||300
3278682|NCT02712359|4012131|FG000|COMPLETED|Epoch 002: Persistence at Year 10||0
3278683|NCT02712359|4012132|FG001|COMPLETED|Epoch 002: Persistence at Year 10||0
3278684|NCT02712359|4012133|FG002|COMPLETED|Epoch 002: Persistence at Year 10||299
3278685|NCT02712359|4012134|FG003|COMPLETED|Epoch 002: Persistence at Year 10||300
3278686|NCT02712359|4012131|FG000|NOT COMPLETED|Epoch 002: Persistence at Year 10||0
3278687|NCT02712359|4012132|FG001|NOT COMPLETED|Epoch 002: Persistence at Year 10||0
3278688|NCT02712359|4012133|FG002|NOT COMPLETED|Epoch 002: Persistence at Year 10||0
3278689|NCT02712359|4012134|FG003|NOT COMPLETED|Epoch 002: Persistence at Year 10||0
3278690|NCT02712398|4012144|FG000|STARTED|Overall Study||120
3278691|NCT02712398|4012144|FG000|COMPLETED|Overall Study||83
3278692|NCT02712398|4012144|FG000|NOT COMPLETED|Overall Study||37
3278693|NCT02712424|4012150|FG000|STARTED|Overall Study||315
3278694|NCT02712424|4012151|FG001|STARTED|Overall Study||310
3278695|NCT02712424|4012150|FG000|COMPLETED|Overall Study||281
3278696|NCT02712424|4012151|FG001|COMPLETED|Overall Study||278
3278697|NCT02712424|4012150|FG000|NOT COMPLETED|Overall Study||34
3278698|NCT02712424|4012151|FG001|NOT COMPLETED|Overall Study||32
3278699|NCT02712554|4012159|FG000|STARTED|Part A: Dose Selection Phase||12
3278700|NCT02712554|4012160|FG001|STARTED|Part A: Dose Selection Phase||0
3278701|NCT02712554|4012159|FG000|COMPLETED|Part A: Dose Selection Phase||12
3278702|NCT02712554|4012160|FG001|COMPLETED|Part A: Dose Selection Phase|Subjects who participated in Dose Selection Phase were not eligible to participate in Part B.|0
3278703|NCT02712554|4012159|FG000|NOT COMPLETED|Part A: Dose Selection Phase||0
3278704|NCT02712554|4012160|FG001|NOT COMPLETED|Part A: Dose Selection Phase||0
3278705|NCT02712554|4012159|FG000|STARTED|Part B: Qualification Phase||0
3278706|NCT02712554|4012160|FG001|STARTED|Part B: Qualification Phase||61
3278707|NCT02712554|4012159|FG000|COMPLETED|Part B: Qualification Phase||0
3278708|NCT02712554|4012160|FG001|COMPLETED|Part B: Qualification Phase||40
3278709|NCT02712554|4012159|FG000|NOT COMPLETED|Part B: Qualification Phase||0
3278710|NCT02712554|4012160|FG001|NOT COMPLETED|Part B: Qualification Phase||21
3278711|NCT02712554|4012159|FG000|STARTED|Part B: Treatment Phase||0
3278712|NCT02712554|4012160|FG001|STARTED|Part B: Treatment Phase||40
3278713|NCT02712554|4012159|FG000|COMPLETED|Part B: Treatment Phase||0
3278714|NCT02712554|4012160|FG001|COMPLETED|Part B: Treatment Phase||37
3278715|NCT02712554|4012159|FG000|NOT COMPLETED|Part B: Treatment Phase||0
3278716|NCT02712554|4012160|FG001|NOT COMPLETED|Part B: Treatment Phase||3
3278717|NCT02712788|4012185|FG000|STARTED|Overall Study||2
3278718|NCT02712788|4012186|FG001|STARTED|Overall Study||2
3278719|NCT02712788|4012185|FG000|COMPLETED|Overall Study||0
3278720|NCT02712788|4012186|FG001|COMPLETED|Overall Study||2
3278721|NCT02712788|4012185|FG000|NOT COMPLETED|Overall Study||2
3278722|NCT02712788|4012186|FG001|NOT COMPLETED|Overall Study||0
3278723|NCT02712983|4012201|FG000|STARTED|Treatment Phase||14
3278724|NCT02712983|4012202|FG001|STARTED|Treatment Phase||13
3278725|NCT02712983|4012203|FG002|STARTED|Treatment Phase||7
3278726|NCT02712983|4012204|FG003|STARTED|Treatment Phase||15
3278727|NCT02712983|4012205|FG004|STARTED|Treatment Phase||14
3278728|NCT02712983|4012206|FG005|STARTED|Treatment Phase||7
3278729|NCT02712983|4012207|FG006|STARTED|Treatment Phase||15
2940489|NCT00636441|3652601|FG000|STARTED|Overall Study||6
2940490|NCT00636441|3652602|FG001|STARTED|Overall Study||7
2940491|NCT00636441|3652603|FG002|STARTED|Overall Study||6
2940492|NCT00636441|3652604|FG003|STARTED|Overall Study||6
2940493|NCT00636441|3652605|FG004|STARTED|Overall Study||6
2940494|NCT00636441|3652606|FG005|STARTED|Overall Study||7
2940495|NCT00636441|3652607|FG006|STARTED|Overall Study||18
2940496|NCT00636441|3652601|FG000|Assigned Treatment|Overall Study||6
2940497|NCT00636441|3652602|FG001|Assigned Treatment|Overall Study||7
2940498|NCT00636441|3652603|FG002|Assigned Treatment|Overall Study||6
2940499|NCT00636441|3652604|FG003|Assigned Treatment|Overall Study||6
2940500|NCT00636441|3652605|FG004|Assigned Treatment|Overall Study||6
2940501|NCT00636441|3652606|FG005|Assigned Treatment|Overall Study||7
2940502|NCT00636441|3652607|FG006|Assigned Treatment|Overall Study|This is a late determined ineligibility.|1
2940503|NCT00636441|3652601|FG000|COMPLETED|Overall Study||6
2940504|NCT00636441|3652602|FG001|COMPLETED|Overall Study||6
2940505|NCT00636441|3652603|FG002|COMPLETED|Overall Study||5
2940506|NCT00636441|3652604|FG003|COMPLETED|Overall Study||6
2940507|NCT00636441|3652605|FG004|COMPLETED|Overall Study||6
2940508|NCT00636441|3652606|FG005|COMPLETED|Overall Study||6
2940509|NCT00636441|3652607|FG006|COMPLETED|Overall Study||0
2940510|NCT00636441|3652601|FG000|NOT COMPLETED|Overall Study||0
2940511|NCT00636441|3652602|FG001|NOT COMPLETED|Overall Study||1
2940512|NCT00636441|3652603|FG002|NOT COMPLETED|Overall Study||1
2940513|NCT00636441|3652604|FG003|NOT COMPLETED|Overall Study||0
2940514|NCT00636441|3652605|FG004|NOT COMPLETED|Overall Study||0
2940515|NCT00636441|3652606|FG005|NOT COMPLETED|Overall Study||1
2940516|NCT00636441|3652607|FG006|NOT COMPLETED|Overall Study||18
2940517|NCT00636506|3652618|FG000|STARTED|Overall Study||76
2940518|NCT00636506|3652618|FG000|COMPLETED|Overall Study||60
2940519|NCT00636506|3652618|FG000|NOT COMPLETED|Overall Study||16
2940520|NCT00636610|3652642|FG000|STARTED|Overall Study||98
2940521|NCT00636610|3652643|FG001|STARTED|Overall Study||101
2940522|NCT00636610|3652642|FG000|COMPLETED|Overall Study||6
2940523|NCT00636610|3652643|FG001|COMPLETED|Overall Study||18
2940524|NCT00636610|3652642|FG000|NOT COMPLETED|Overall Study||92
2940525|NCT00636610|3652643|FG001|NOT COMPLETED|Overall Study||83
2940526|NCT00636636|3652653|FG000|STARTED|Overall Study||221
2940527|NCT00636636|3652654|FG001|STARTED|Overall Study||231
2940528|NCT00636636|3652653|FG000|Safety & Efficacy of Gabapentin ER|Overall Study||186
2940529|NCT00636636|3652654|FG001|Safety & Efficacy of Gabapentin ER|Overall Study|1 patient randomized twice, not included in ITT, but completed medication and counted as completer|194
2940530|NCT00636636|3652653|FG000|379|Overall Study||186
3278730|NCT02712983|4012208|FG007|STARTED|Treatment Phase||15
3278731|NCT02712983|4012209|FG008|STARTED|Treatment Phase||7
3278732|NCT02712983|4012201|FG000|Pharmacokinetic Analysis Set|Treatment Phase||14
3278733|NCT02712983|4012202|FG001|Pharmacokinetic Analysis Set|Treatment Phase||13
3278734|NCT02712983|4012203|FG002|Pharmacokinetic Analysis Set|Treatment Phase||0
3278735|NCT02712983|4012204|FG003|Pharmacokinetic Analysis Set|Treatment Phase||15
3034475|NCT01132820|3753543|FG000|COMPLETED|Overall Study||48
3034476|NCT01132820|3753543|FG000|NOT COMPLETED|Overall Study||5
3278736|NCT02712983|4012205|FG004|Pharmacokinetic Analysis Set|Treatment Phase||14
3278737|NCT02712983|4012206|FG005|Pharmacokinetic Analysis Set|Treatment Phase||0
3278738|NCT02712983|4012207|FG006|Pharmacokinetic Analysis Set|Treatment Phase||15
3278739|NCT02712983|4012208|FG007|Pharmacokinetic Analysis Set|Treatment Phase||14
3278740|NCT02712983|4012209|FG008|Pharmacokinetic Analysis Set|Treatment Phase||0
3278741|NCT02712983|4012201|FG000|COMPLETED|Treatment Phase||9
3278742|NCT02712983|4012202|FG001|COMPLETED|Treatment Phase||12
3278743|NCT02712983|4012203|FG002|COMPLETED|Treatment Phase||6
3278744|NCT02712983|4012204|FG003|COMPLETED|Treatment Phase||7
3278745|NCT02712983|4012205|FG004|COMPLETED|Treatment Phase||10
3278746|NCT02712983|4012206|FG005|COMPLETED|Treatment Phase||7
3278747|NCT02712983|4012207|FG006|COMPLETED|Treatment Phase||6
3278748|NCT02712983|4012208|FG007|COMPLETED|Treatment Phase||6
3278749|NCT02712983|4012209|FG008|COMPLETED|Treatment Phase||5
3278750|NCT02712983|4012201|FG000|NOT COMPLETED|Treatment Phase||5
3278751|NCT02712983|4012202|FG001|NOT COMPLETED|Treatment Phase||1
3278752|NCT02712983|4012203|FG002|NOT COMPLETED|Treatment Phase||1
3278753|NCT02712983|4012204|FG003|NOT COMPLETED|Treatment Phase||8
3278754|NCT02712983|4012205|FG004|NOT COMPLETED|Treatment Phase||4
3278755|NCT02712983|4012206|FG005|NOT COMPLETED|Treatment Phase||0
3278756|NCT02712983|4012207|FG006|NOT COMPLETED|Treatment Phase||9
3278757|NCT02712983|4012208|FG007|NOT COMPLETED|Treatment Phase||9
3278758|NCT02712983|4012209|FG008|NOT COMPLETED|Treatment Phase||2
3278759|NCT02712983|4012201|FG000|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|0
3278760|NCT02712983|4012202|FG001|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|1
3278761|NCT02712983|4012203|FG002|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|0
3278762|NCT02712983|4012204|FG003|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|1
3278763|NCT02712983|4012205|FG004|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|2
3278764|NCT02712983|4012206|FG005|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|1
3278765|NCT02712983|4012207|FG006|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|2
3278766|NCT02712983|4012208|FG007|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|3
3278767|NCT02712983|4012209|FG008|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|0
3278768|NCT02712983|4012201|FG000|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
3278769|NCT02712983|4012202|FG001|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
3316368|NCT03110562|4049672|FG001|COMPLETED|Overall Study||0
2940531|NCT00636636|3652654|FG001|379|Overall Study|1 patient randomized twice, not included in ITT, but completed medication and counted as completer|194
2940532|NCT00636636|3652653|FG000|COMPLETED|Overall Study||185
2940533|NCT00636636|3652654|FG001|COMPLETED|Overall Study||192
2940534|NCT00636636|3652653|FG000|NOT COMPLETED|Overall Study||36
2940535|NCT00636636|3652654|FG001|NOT COMPLETED|Overall Study||39
2940536|NCT00636649|3652662|FG000|STARTED|Overall Study||20
2940537|NCT00636649|3652663|FG001|STARTED|Overall Study||20
2940538|NCT00636649|3652662|FG000|COMPLETED|Overall Study||20
2940539|NCT00636649|3652663|FG001|COMPLETED|Overall Study||20
2940540|NCT00636649|3652662|FG000|NOT COMPLETED|Overall Study||0
2940541|NCT00636649|3652663|FG001|NOT COMPLETED|Overall Study||0
2940542|NCT00636675|3652675|FG000|STARTED|Overall Study||951
2940543|NCT00636675|3652676|FG001|STARTED|Overall Study||775
2940544|NCT00636675|3652675|FG000|COMPLETED|Overall Study||811
2940545|NCT00636675|3652676|FG001|COMPLETED|Overall Study||734
3278770|NCT02712983|4012203|FG002|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
3278771|NCT02712983|4012204|FG003|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
3278772|NCT02712983|4012205|FG004|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
2940546|NCT00636675|3652675|FG000|NOT COMPLETED|Overall Study||140
2940547|NCT00636675|3652676|FG001|NOT COMPLETED|Overall Study||41
2940548|NCT00636701|3652684|FG000|STARTED|Overall Study||2
2940549|NCT00636701|3652685|FG001|STARTED|Overall Study||2
2940550|NCT00636701|3652684|FG000|COMPLETED|Overall Study||2
2940551|NCT00636701|3652685|FG001|COMPLETED|Overall Study||2
2940552|NCT00636701|3652684|FG000|NOT COMPLETED|Overall Study||0
2940553|NCT00636701|3652685|FG001|NOT COMPLETED|Overall Study||0
2940554|NCT00636792|3652691|FG000|STARTED|Overall Study||73
2940555|NCT00636792|3652691|FG000|COMPLETED|Overall Study||40
2940556|NCT00636792|3652691|FG000|NOT COMPLETED|Overall Study||33
2940557|NCT00636805|3652695|FG000|STARTED|Overall Study||63
2940558|NCT00636805|3652695|FG000|COMPLETED|Overall Study||63
2940559|NCT00636805|3652695|FG000|NOT COMPLETED|Overall Study||0
2940560|NCT00636818|3652699|FG000|STARTED|Overall Study||45
2940561|NCT00636818|3652699|FG000|Received at Least One Dose of Study Drug|Overall Study|One patient was lost to follow up and did not receive any study drug.|44
2940562|NCT00636818|3652699|FG000|COMPLETED|Overall Study||34
2940563|NCT00636818|3652699|FG000|NOT COMPLETED|Overall Study||11
2940564|NCT00636961|3652705|FG000|STARTED|Period 1||14
2940565|NCT00636961|3652706|FG001|STARTED|Period 1||13
2940566|NCT00636961|3652705|FG000|COMPLETED|Period 1||13
2940567|NCT00636961|3652706|FG001|COMPLETED|Period 1||12
2940568|NCT00636961|3652705|FG000|NOT COMPLETED|Period 1||1
2940569|NCT00636961|3652706|FG001|NOT COMPLETED|Period 1||1
2940570|NCT00636961|3652705|FG000|STARTED|Period 2||13
2940571|NCT00636961|3652706|FG001|STARTED|Period 2||12
2940572|NCT00636961|3652705|FG000|COMPLETED|Period 2||12
2940573|NCT00636961|3652706|FG001|COMPLETED|Period 2||12
2940574|NCT00636961|3652705|FG000|NOT COMPLETED|Period 2||1
2940575|NCT00636961|3652706|FG001|NOT COMPLETED|Period 2||0
2940576|NCT00636987|3652712|FG000|STARTED|Overall Study||297
2940577|NCT00636987|3652712|FG000|COMPLETED|Overall Study||108
2940578|NCT00636987|3652712|FG000|NOT COMPLETED|Overall Study||189
2940579|NCT00637000|3652722|FG000|STARTED|Overall Study|Randomized and treated|20
2940580|NCT00637000|3652723|FG001|STARTED|Overall Study|Randomized and treated|18
2940581|NCT00637000|3652722|FG000|Evaluable|Overall Study||18
2940582|NCT00637000|3652723|FG001|Evaluable|Overall Study||16
2940583|NCT00637000|3652722|FG000|COMPLETED|Overall Study||16
2940584|NCT00637000|3652723|FG001|COMPLETED|Overall Study||15
2940585|NCT00637000|3652722|FG000|NOT COMPLETED|Overall Study||4
2940586|NCT00637000|3652723|FG001|NOT COMPLETED|Overall Study||3
2940587|NCT00637156|3652731|FG000|STARTED|Overall Study||209
2940588|NCT00637156|3652732|FG001|STARTED|Overall Study||188
2940589|NCT00637156|3652731|FG000|COMPLETED|Overall Study||199
2940590|NCT00637156|3652732|FG001|COMPLETED|Overall Study||164
2940591|NCT00637156|3652731|FG000|NOT COMPLETED|Overall Study||10
2940592|NCT00637156|3652732|FG001|NOT COMPLETED|Overall Study||24
2940593|NCT00637195|3652740|FG000|STARTED|Overall Study||76
2940594|NCT00637195|3652741|FG001|STARTED|Overall Study||76
2940595|NCT00637195|3652740|FG000|COMPLETED|Overall Study||73
2940596|NCT00637195|3652741|FG001|COMPLETED|Overall Study||75
2940597|NCT00637195|3652740|FG000|NOT COMPLETED|Overall Study||3
2940598|NCT00637195|3652741|FG001|NOT COMPLETED|Overall Study||1
2940599|NCT00637247|3652749|FG000|STARTED|Overall Study||72
2940600|NCT00637247|3652750|FG001|STARTED|Overall Study||70
2940601|NCT00637247|3652749|FG000|COMPLETED|Overall Study||72
3160435|NCT01863732|3887562|FG003|COMPLETED|Overall Study||33
3160436|NCT01863732|3887559|FG000|NOT COMPLETED|Overall Study||13
3160437|NCT01863732|3887560|FG001|NOT COMPLETED|Overall Study||12
3278773|NCT02712983|4012206|FG005|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
3278774|NCT02712983|4012207|FG006|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
3278775|NCT02712983|4012208|FG007|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
3278776|NCT02712983|4012209|FG008|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
3278777|NCT02712983|4012201|FG000|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
3278778|NCT02712983|4012202|FG001|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||1
3278779|NCT02712983|4012203|FG002|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
3278780|NCT02712983|4012204|FG003|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||1
2940602|NCT00637247|3652750|FG001|COMPLETED|Overall Study||70
2940603|NCT00637247|3652749|FG000|NOT COMPLETED|Overall Study||0
2940604|NCT00637247|3652750|FG001|NOT COMPLETED|Overall Study||0
3278781|NCT02712983|4012205|FG004|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||2
3278782|NCT02712983|4012206|FG005|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||1
3160438|NCT01863732|3887561|FG002|NOT COMPLETED|Overall Study||11
3160439|NCT01863732|3887562|FG003|NOT COMPLETED|Overall Study||8
3160440|NCT01863758|3887571|FG000|STARTED|Pharmacokinetic Assessment||66
3160441|NCT01863758|3887571|FG000|COMPLETED|Pharmacokinetic Assessment||66
3160442|NCT01863758|3887571|FG000|NOT COMPLETED|Pharmacokinetic Assessment||0
3160443|NCT01863758|3887571|FG000|STARTED|Prophylactic Treatment-Phase I||66
3160444|NCT01863758|3887571|FG000|COMPLETED|Prophylactic Treatment-Phase I||66
3160445|NCT01863758|3887571|FG000|NOT COMPLETED|Prophylactic Treatment-Phase I||0
3160446|NCT01863758|3887571|FG000|STARTED|Prophylactic Treatment-Phase II||66
3160447|NCT01863758|3887571|FG000|COMPLETED|Prophylactic Treatment-Phase II||64
3160448|NCT01863758|3887571|FG000|NOT COMPLETED|Prophylactic Treatment-Phase II||2
3160449|NCT01863771|3887575|FG000|STARTED|Induction Phase||144
3160450|NCT01863771|3887576|FG001|STARTED|Induction Phase||0
3160451|NCT01863771|3887577|FG002|STARTED|Induction Phase||0
3160452|NCT01863771|3887578|FG003|STARTED|Induction Phase||0
2940605|NCT00637273|3652761|FG000|STARTED|Overall Study||170
2940606|NCT00637273|3652762|FG001|STARTED|Overall Study||172
2940607|NCT00637273|3652763|FG002|STARTED|Overall Study||172
2940608|NCT00637273|3652761|FG000|Intent to Treat (ITT)|Overall Study||160
2940609|NCT00637273|3652762|FG001|Intent to Treat (ITT)|Overall Study||166
2940610|NCT00637273|3652763|FG002|Intent to Treat (ITT)|Overall Study||165
2940611|NCT00637273|3652761|FG000|COMPLETED|Overall Study||127
2940612|NCT00637273|3652762|FG001|COMPLETED|Overall Study||144
2940613|NCT00637273|3652763|FG002|COMPLETED|Overall Study||131
2940614|NCT00637273|3652761|FG000|NOT COMPLETED|Overall Study||43
2940615|NCT00637273|3652762|FG001|NOT COMPLETED|Overall Study||28
2940616|NCT00637273|3652763|FG002|NOT COMPLETED|Overall Study||41
2940617|NCT00637299|3652773|FG000|STARTED|Overall Study||10
2940618|NCT00637299|3652774|FG001|STARTED|Overall Study||10
2940619|NCT00637299|3652773|FG000|COMPLETED|Overall Study||10
2940620|NCT00637299|3652774|FG001|COMPLETED|Overall Study||10
2940621|NCT00637299|3652773|FG000|NOT COMPLETED|Overall Study||0
2940622|NCT00637299|3652774|FG001|NOT COMPLETED|Overall Study||0
2940623|NCT00637377|3652784|FG000|STARTED|Overall Study||303
2940624|NCT00637377|3652785|FG001|STARTED|Overall Study||313
2940625|NCT00637377|3652786|FG002|STARTED|Overall Study||311
3160453|NCT01863771|3887575|FG000|COMPLETED|Induction Phase|Same participants who completed the induction phase participated in the maintenance phase.|123
3160454|NCT01863771|3887576|FG001|COMPLETED|Induction Phase||0
3160455|NCT01863771|3887577|FG002|COMPLETED|Induction Phase||0
3278783|NCT02712983|4012207|FG006|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||2
3278784|NCT02712983|4012208|FG007|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||3
3278785|NCT02712983|4012209|FG008|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
2940626|NCT00637377|3652787|FG003|STARTED|Overall Study||313
2940627|NCT00637377|3652784|FG000|Participants Received Treatment|Overall Study|safety population|291
2940628|NCT00637377|3652785|FG001|Participants Received Treatment|Overall Study|safety population|309
2940629|NCT00637377|3652786|FG002|Participants Received Treatment|Overall Study|safety population|297
2940630|NCT00637377|3652787|FG003|Participants Received Treatment|Overall Study|safety population|307
2940631|NCT00637377|3652784|FG000|Participants Treated (FAS)|Overall Study||291
2940632|NCT00637377|3652785|FG001|Participants Treated (FAS)|Overall Study||309
2940633|NCT00637377|3652786|FG002|Participants Treated (FAS)|Overall Study||296
2940634|NCT00637377|3652787|FG003|Participants Treated (FAS)|Overall Study||306
2940635|NCT00637377|3652784|FG000|COMPLETED|Overall Study||276
2940636|NCT00637377|3652785|FG001|COMPLETED|Overall Study||281
2940637|NCT00637377|3652786|FG002|COMPLETED|Overall Study||274
2940638|NCT00637377|3652787|FG003|COMPLETED|Overall Study||284
2940639|NCT00637377|3652784|FG000|NOT COMPLETED|Overall Study||27
2940640|NCT00637377|3652785|FG001|NOT COMPLETED|Overall Study||32
2940641|NCT00637377|3652786|FG002|NOT COMPLETED|Overall Study||37
2940642|NCT00637377|3652787|FG003|NOT COMPLETED|Overall Study||29
2940643|NCT00637494|3652799|FG000|STARTED|Overall Study||141
2940644|NCT00637494|3652800|FG001|STARTED|Overall Study||151
2940645|NCT00637494|3652799|FG000|COMPLETED|Overall Study||109
2940646|NCT00637494|3652800|FG001|COMPLETED|Overall Study||108
2940647|NCT00637494|3652799|FG000|NOT COMPLETED|Overall Study||32
3278786|NCT02712996|4012231|FG000|STARTED|First Intervention (Study Days 1-42)||8
3278787|NCT02712996|4012232|FG001|STARTED|First Intervention (Study Days 1-42)||9
3278788|NCT02712996|4012231|FG000|COMPLETED|First Intervention (Study Days 1-42)||8
3278789|NCT02712996|4012232|FG001|COMPLETED|First Intervention (Study Days 1-42)||9
3278790|NCT02712996|4012231|FG000|NOT COMPLETED|First Intervention (Study Days 1-42)||0
3278791|NCT02712996|4012232|FG001|NOT COMPLETED|First Intervention (Study Days 1-42)||0
3278792|NCT02712996|4012231|FG000|STARTED|Second Intervention (Study Days 43-84)||8
2940648|NCT00637494|3652800|FG001|NOT COMPLETED|Overall Study||43
2940649|NCT00637572|3652808|FG000|STARTED|Overall Study||32
2940650|NCT00637572|3652809|FG001|STARTED|Overall Study||31
2940651|NCT00637572|3652808|FG000|COMPLETED|Overall Study||29
2940652|NCT00637572|3652809|FG001|COMPLETED|Overall Study||24
2940653|NCT00637572|3652808|FG000|NOT COMPLETED|Overall Study||3
2940654|NCT00637572|3652809|FG001|NOT COMPLETED|Overall Study||7
2940655|NCT00637780|3652815|FG000|STARTED|Overall Study||2
2940656|NCT00637780|3652815|FG000|COMPLETED|Overall Study||2
2940657|NCT00637780|3652815|FG000|NOT COMPLETED|Overall Study||0
3160456|NCT01863771|3887578|FG003|COMPLETED|Induction Phase||0
2940658|NCT00637923|3652821|FG000|STARTED|Overall Study||75
2940659|NCT00637923|3652822|FG001|STARTED|Overall Study||37
2940660|NCT00637923|3652821|FG000|COMPLETED|Overall Study||45
2940661|NCT00637923|3652822|FG001|COMPLETED|Overall Study||18
2940662|NCT00637923|3652821|FG000|NOT COMPLETED|Overall Study||30
2940663|NCT00637923|3652822|FG001|NOT COMPLETED|Overall Study||19
2940664|NCT00638014|3652830|FG000|STARTED|Overall Study||23
2940665|NCT00638014|3652831|FG001|STARTED|Overall Study||28
2940666|NCT00638014|3652830|FG000|COMPLETED|Overall Study||23
2940667|NCT00638014|3652831|FG001|COMPLETED|Overall Study||28
2940668|NCT00638014|3652830|FG000|NOT COMPLETED|Overall Study||0
2940669|NCT00638014|3652831|FG001|NOT COMPLETED|Overall Study||0
2940670|NCT00638027|3652839|FG000|STARTED|Overall Study||11
2940671|NCT00638027|3652840|FG001|STARTED|Overall Study||10
2940672|NCT00638027|3652839|FG000|COMPLETED|Overall Study||11
2940673|NCT00638027|3652840|FG001|COMPLETED|Overall Study|all 10 included in analyses|8
2940674|NCT00638027|3652839|FG000|NOT COMPLETED|Overall Study||0
2940675|NCT00638027|3652840|FG001|NOT COMPLETED|Overall Study||2
2940676|NCT00638157|3652848|FG000|STARTED|Overall Study||12
2940677|NCT00638157|3652849|FG001|STARTED|Overall Study||12
2940678|NCT00638157|3652848|FG000|Treated|Overall Study||10
2940679|NCT00638157|3652849|FG001|Treated|Overall Study||12
2940680|NCT00638157|3652848|FG000|COMPLETED|Overall Study|4 subjects completed study drug in this arm|5
2940681|NCT00638157|3652849|FG001|COMPLETED|Overall Study|4 subjects completed study drug in this arm|8
2940682|NCT00638157|3652848|FG000|NOT COMPLETED|Overall Study||7
2940683|NCT00638157|3652849|FG001|NOT COMPLETED|Overall Study||4
3034477|NCT01132846|3753550|FG000|STARTED|Overall Study||122
3034478|NCT01132846|3753551|FG001|STARTED|Overall Study||119
3034479|NCT01132846|3753552|FG002|STARTED|Overall Study||119
3034480|NCT01132846|3753550|FG000|COMPLETED|Overall Study||106
3034481|NCT01132846|3753551|FG001|COMPLETED|Overall Study||101
3034482|NCT01132846|3753552|FG002|COMPLETED|Overall Study||108
3034483|NCT01132846|3753550|FG000|NOT COMPLETED|Overall Study||16
3034484|NCT01132846|3753551|FG001|NOT COMPLETED|Overall Study||18
3034485|NCT01132846|3753552|FG002|NOT COMPLETED|Overall Study||11
3034486|NCT01133067|3753562|FG000|STARTED|Overall Study||200
3034487|NCT01133067|3753562|FG000|COMPLETED|Overall Study||61
3034488|NCT01133067|3753562|FG000|NOT COMPLETED|Overall Study||139
3034489|NCT01133158|3753566|FG000|STARTED|Overall Study||60
3034490|NCT01133158|3753566|FG000|COMPLETED|Overall Study||43
3034491|NCT01133158|3753566|FG000|NOT COMPLETED|Overall Study||17
3034492|NCT01133171|3753575|FG000|STARTED|Overall Study||25
3034493|NCT01133171|3753576|FG001|STARTED|Overall Study||27
3034494|NCT01133171|3753577|FG002|STARTED|Overall Study||25
3034495|NCT01133171|3753575|FG000|COMPLETED|Overall Study||24
3034496|NCT01133171|3753576|FG001|COMPLETED|Overall Study||25
3034497|NCT01133171|3753577|FG002|COMPLETED|Overall Study||25
3034498|NCT01133171|3753575|FG000|NOT COMPLETED|Overall Study||1
3034499|NCT01133171|3753576|FG001|NOT COMPLETED|Overall Study||2
3034500|NCT01133171|3753577|FG002|NOT COMPLETED|Overall Study||0
3034501|NCT01133275|3753585|FG000|STARTED|Overall Study||28
3034502|NCT01133275|3753585|FG000|COMPLETED|Overall Study||26
3034503|NCT01133275|3753585|FG000|NOT COMPLETED|Overall Study||2
3034504|NCT01133379|3753592|FG000|STARTED|Overall Study||58
3034505|NCT01133379|3753593|FG001|STARTED|Overall Study||58
3034506|NCT01133379|3753594|FG002|STARTED|Overall Study||58
3034507|NCT01133379|3753592|FG000|COMPLETED|Overall Study||57
3034508|NCT01133379|3753593|FG001|COMPLETED|Overall Study||56
3034509|NCT01133379|3753594|FG002|COMPLETED|Overall Study||56
3034510|NCT01133379|3753592|FG000|NOT COMPLETED|Overall Study||1
3034511|NCT01133379|3753593|FG001|NOT COMPLETED|Overall Study||2
3034512|NCT01133379|3753594|FG002|NOT COMPLETED|Overall Study||2
3034513|NCT01133392|3753604|FG000|STARTED|First Intervention (1 Day )||20
3034514|NCT01133392|3753605|FG001|STARTED|First Intervention (1 Day )||18
3034515|NCT01133392|3753604|FG000|COMPLETED|First Intervention (1 Day )||20
3034516|NCT01133392|3753605|FG001|COMPLETED|First Intervention (1 Day )||18
3034517|NCT01133392|3753604|FG000|NOT COMPLETED|First Intervention (1 Day )||0
3034518|NCT01133392|3753605|FG001|NOT COMPLETED|First Intervention (1 Day )||0
3034519|NCT01133392|3753604|FG000|STARTED|Interval Between Dosing (4-7 Days)||20
3034520|NCT01133392|3753605|FG001|STARTED|Interval Between Dosing (4-7 Days)||18
3034521|NCT01133392|3753604|FG000|COMPLETED|Interval Between Dosing (4-7 Days)||20
3034522|NCT01133392|3753605|FG001|COMPLETED|Interval Between Dosing (4-7 Days)||17
3034523|NCT01133392|3753604|FG000|NOT COMPLETED|Interval Between Dosing (4-7 Days)||0
3034524|NCT01133392|3753605|FG001|NOT COMPLETED|Interval Between Dosing (4-7 Days)||1
3034525|NCT01133392|3753604|FG000|STARTED|Second Intervention (1 Day)||20
3034526|NCT01133392|3753605|FG001|STARTED|Second Intervention (1 Day)||17
3034527|NCT01133392|3753604|FG000|COMPLETED|Second Intervention (1 Day)||20
3034528|NCT01133392|3753605|FG001|COMPLETED|Second Intervention (1 Day)||17
3278793|NCT02712996|4012232|FG001|STARTED|Second Intervention (Study Days 43-84)||9
3278794|NCT02712996|4012231|FG000|COMPLETED|Second Intervention (Study Days 43-84)||8
3278795|NCT02712996|4012232|FG001|COMPLETED|Second Intervention (Study Days 43-84)||8
3278796|NCT02712996|4012231|FG000|NOT COMPLETED|Second Intervention (Study Days 43-84)||0
3034529|NCT01133392|3753604|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
3034530|NCT01133392|3753605|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
3278797|NCT02712996|4012232|FG001|NOT COMPLETED|Second Intervention (Study Days 43-84)||1
3278798|NCT02713178|4012243|FG000|STARTED|Overall Study||76
3034531|NCT01133392|3753604|FG000|STARTED|Interval Between Dosing (4-7 Days)||20
3278799|NCT02713178|4012244|FG001|STARTED|Overall Study||77
3278800|NCT02713178|4012245|FG002|STARTED|Overall Study||79
3278801|NCT02713178|4012243|FG000|COMPLETED|Overall Study||75
3278802|NCT02713178|4012244|FG001|COMPLETED|Overall Study||73
3278803|NCT02713178|4012245|FG002|COMPLETED|Overall Study||74
3278804|NCT02713178|4012243|FG000|NOT COMPLETED|Overall Study||1
3278805|NCT02713178|4012244|FG001|NOT COMPLETED|Overall Study||4
3278806|NCT02713178|4012245|FG002|NOT COMPLETED|Overall Study||5
3278807|NCT02713204|4012256|FG000|STARTED|Baseline (Day 1) up to Week 12||60
3278808|NCT02713204|4012257|FG001|STARTED|Baseline (Day 1) up to Week 12||122
3278809|NCT02713204|4012258|FG002|STARTED|Baseline (Day 1) up to Week 12||183
3278810|NCT02713204|4012259|FG003|STARTED|Baseline (Day 1) up to Week 12||0
3278811|NCT02713204|4012260|FG004|STARTED|Baseline (Day 1) up to Week 12||0
3278812|NCT02713204|4012261|FG005|STARTED|Baseline (Day 1) up to Week 12||0
3278813|NCT02713204|4012262|FG006|STARTED|Baseline (Day 1) up to Week 12||0
3278814|NCT02713204|4012263|FG007|STARTED|Baseline (Day 1) up to Week 12||0
3278815|NCT02713204|4012256|FG000|COMPLETED|Baseline (Day 1) up to Week 12||59
3278816|NCT02713204|4012257|FG001|COMPLETED|Baseline (Day 1) up to Week 12||121
3278817|NCT02713204|4012258|FG002|COMPLETED|Baseline (Day 1) up to Week 12||181
3278818|NCT02713204|4012259|FG003|COMPLETED|Baseline (Day 1) up to Week 12||0
2940684|NCT00638183|3652856|FG000|STARTED|Overall Study||385
2940685|NCT00638183|3652856|FG000|COMPLETED|Overall Study||266
3278819|NCT02713204|4012260|FG004|COMPLETED|Baseline (Day 1) up to Week 12||0
3278820|NCT02713204|4012261|FG005|COMPLETED|Baseline (Day 1) up to Week 12||0
3278821|NCT02713204|4012262|FG006|COMPLETED|Baseline (Day 1) up to Week 12||0
3278822|NCT02713204|4012263|FG007|COMPLETED|Baseline (Day 1) up to Week 12||0
3278823|NCT02713204|4012256|FG000|NOT COMPLETED|Baseline (Day 1) up to Week 12||1
3278824|NCT02713204|4012257|FG001|NOT COMPLETED|Baseline (Day 1) up to Week 12||1
3278825|NCT02713204|4012258|FG002|NOT COMPLETED|Baseline (Day 1) up to Week 12||2
3278826|NCT02713204|4012259|FG003|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
3278827|NCT02713204|4012260|FG004|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
3278828|NCT02713204|4012261|FG005|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
3278829|NCT02713204|4012262|FG006|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
3278830|NCT02713204|4012263|FG007|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
3278831|NCT02713204|4012256|FG000|STARTED|From Week 12 up to Week 36||58
3278832|NCT02713204|4012257|FG001|STARTED|From Week 12 up to Week 36||0
3278833|NCT02713204|4012258|FG002|STARTED|From Week 12 up to Week 36||0
3278834|NCT02713204|4012259|FG003|STARTED|From Week 12 up to Week 36||57
3278835|NCT02713204|4012260|FG004|STARTED|From Week 12 up to Week 36||62
3278836|NCT02713204|4012261|FG005|STARTED|From Week 12 up to Week 36||60
3278837|NCT02713204|4012262|FG006|STARTED|From Week 12 up to Week 36||62
3278838|NCT02713204|4012263|FG007|STARTED|From Week 12 up to Week 36||58
3278839|NCT02713204|4012256|FG000|COMPLETED|From Week 12 up to Week 36||57
3278840|NCT02713204|4012257|FG001|COMPLETED|From Week 12 up to Week 36||0
3278841|NCT02713204|4012258|FG002|COMPLETED|From Week 12 up to Week 36||0
3278842|NCT02713204|4012259|FG003|COMPLETED|From Week 12 up to Week 36||53
3278843|NCT02713204|4012260|FG004|COMPLETED|From Week 12 up to Week 36||60
3278844|NCT02713204|4012261|FG005|COMPLETED|From Week 12 up to Week 36||59
3278845|NCT02713204|4012262|FG006|COMPLETED|From Week 12 up to Week 36||60
3278846|NCT02713204|4012263|FG007|COMPLETED|From Week 12 up to Week 36||54
3278847|NCT02713204|4012256|FG000|NOT COMPLETED|From Week 12 up to Week 36||1
3278848|NCT02713204|4012257|FG001|NOT COMPLETED|From Week 12 up to Week 36||0
3278849|NCT02713204|4012258|FG002|NOT COMPLETED|From Week 12 up to Week 36||0
3278850|NCT02713204|4012259|FG003|NOT COMPLETED|From Week 12 up to Week 36||4
3278851|NCT02713204|4012260|FG004|NOT COMPLETED|From Week 12 up to Week 36||2
3278852|NCT02713204|4012261|FG005|NOT COMPLETED|From Week 12 up to Week 36||1
3278853|NCT02713204|4012262|FG006|NOT COMPLETED|From Week 12 up to Week 36||2
3278854|NCT02713204|4012263|FG007|NOT COMPLETED|From Week 12 up to Week 36||4
3278855|NCT02713230|4012283|FG000|STARTED|Overall Study||69
3278856|NCT02713230|4012284|FG001|STARTED|Overall Study||15
3278857|NCT02713230|4012285|FG002|STARTED|Overall Study||71
3278858|NCT02713230|4012283|FG000|COMPLETED|Overall Study||68
3278859|NCT02713230|4012284|FG001|COMPLETED|Overall Study||15
3278860|NCT02713230|4012285|FG002|COMPLETED|Overall Study||71
3278861|NCT02713230|4012283|FG000|NOT COMPLETED|Overall Study||1
3278862|NCT02713230|4012284|FG001|NOT COMPLETED|Overall Study||0
3278863|NCT02713230|4012285|FG002|NOT COMPLETED|Overall Study||0
3278864|NCT02713243|4012294|FG000|STARTED|Overall Study||10
3278865|NCT02713243|4012295|FG001|STARTED|Overall Study||10
3278866|NCT02713243|4012294|FG000|PD Analysis Set|Overall Study||9
3278867|NCT02713243|4012295|FG001|PD Analysis Set|Overall Study||10
3278868|NCT02713243|4012294|FG000|PK Analysis Set|Overall Study||8
3278869|NCT02713243|4012295|FG001|PK Analysis Set|Overall Study||9
3278870|NCT02713243|4012294|FG000|COMPLETED|Overall Study||9
3278871|NCT02713243|4012295|FG001|COMPLETED|Overall Study||8
3278872|NCT02713243|4012294|FG000|NOT COMPLETED|Overall Study||1
3278873|NCT02713243|4012295|FG001|NOT COMPLETED|Overall Study||2
3278874|NCT02713256|4012301|FG000|STARTED|Overall Study||15
3278875|NCT02713256|4012301|FG000|COMPLETED|Overall Study||15
3278876|NCT02713256|4012301|FG000|NOT COMPLETED|Overall Study||0
3278877|NCT02713425|4012305|FG000|STARTED|Overall Study||20
3278878|NCT02713425|4012305|FG000|COMPLETED|Overall Study||20
3278879|NCT02713425|4012305|FG000|NOT COMPLETED|Overall Study||0
3278880|NCT02713490|4012311|FG000|STARTED|Overall Study||71
3278881|NCT02713490|4012312|FG001|STARTED|Overall Study||69
2940686|NCT00638183|3652856|FG000|NOT COMPLETED|Overall Study||119
2940687|NCT00638235|3652869|FG000|STARTED|Overall Study||141
2940688|NCT00638235|3652870|FG001|STARTED|Overall Study||26
2940689|NCT00638235|3652871|FG002|STARTED|Overall Study||81
2940690|NCT00638235|3652872|FG003|STARTED|Overall Study||56
2940691|NCT00638235|3652873|FG004|STARTED|Overall Study||55
2940692|NCT00638235|3652874|FG005|STARTED|Overall Study||139
2940693|NCT00638235|3652875|FG006|STARTED|Overall Study||23
2940694|NCT00638235|3652876|FG007|STARTED|Overall Study||35
2940695|NCT00638235|3652877|FG008|STARTED|Overall Study||142
2940696|NCT00638235|3652869|FG000|COMPLETED|Overall Study||110
2940697|NCT00638235|3652870|FG001|COMPLETED|Overall Study||23
2940698|NCT00638235|3652871|FG002|COMPLETED|Overall Study|Ph-II ended before all subjects had 24M b/c Perigee next generation was already under trial P-III/IV|63
2940699|NCT00638235|3652872|FG003|COMPLETED|Overall Study||46
2940700|NCT00638235|3652873|FG004|COMPLETED|Overall Study||42
2940701|NCT00638235|3652874|FG005|COMPLETED|Overall Study||113
2940702|NCT00638235|3652875|FG006|COMPLETED|Overall Study||23
2940703|NCT00638235|3652876|FG007|COMPLETED|Overall Study|Ph-VI ended after 12M b/c next generation of Elevate Anterior was already under trial in Phase VII|34
2940704|NCT00638235|3652877|FG008|COMPLETED|Overall Study||124
2940705|NCT00638235|3652869|FG000|NOT COMPLETED|Overall Study||31
2940706|NCT00638235|3652870|FG001|NOT COMPLETED|Overall Study||3
2940707|NCT00638235|3652871|FG002|NOT COMPLETED|Overall Study||18
2940708|NCT00638235|3652872|FG003|NOT COMPLETED|Overall Study||10
2940709|NCT00638235|3652873|FG004|NOT COMPLETED|Overall Study||13
2940710|NCT00638235|3652874|FG005|NOT COMPLETED|Overall Study||26
2940711|NCT00638235|3652875|FG006|NOT COMPLETED|Overall Study||0
2940712|NCT00638235|3652876|FG007|NOT COMPLETED|Overall Study||1
2940713|NCT00638235|3652877|FG008|NOT COMPLETED|Overall Study||18
2940714|NCT00638274|3652906|FG000|STARTED|Overall Study||179
2940715|NCT00638274|3652907|FG001|STARTED|Overall Study||177
2940716|NCT00638274|3652906|FG000|COMPLETED|Overall Study||173
2940717|NCT00638274|3652907|FG001|COMPLETED|Overall Study||172
2940718|NCT00638274|3652906|FG000|NOT COMPLETED|Overall Study||6
2940719|NCT00638274|3652907|FG001|NOT COMPLETED|Overall Study||5
2940720|NCT00638365|3652916|FG000|STARTED|Overall Study||9
2940721|NCT00638365|3652917|FG001|STARTED|Overall Study||10
2940722|NCT00638365|3652918|FG002|STARTED|Overall Study||8
2940723|NCT00638365|3652916|FG000|COMPLETED|Overall Study||9
2940724|NCT00638365|3652917|FG001|COMPLETED|Overall Study||10
2940725|NCT00638365|3652918|FG002|COMPLETED|Overall Study||8
2940726|NCT00638365|3652916|FG000|NOT COMPLETED|Overall Study||0
2940727|NCT00638365|3652917|FG001|NOT COMPLETED|Overall Study||0
2940728|NCT00638365|3652918|FG002|NOT COMPLETED|Overall Study||0
2940729|NCT00638378|3652926|FG000|STARTED|Overall Study||22
2940730|NCT00638378|3652926|FG000|COMPLETED|Overall Study||0
2940731|NCT00638378|3652926|FG000|NOT COMPLETED|Overall Study||22
2940732|NCT00638404|3652932|FG000|STARTED|Overall Study||200
2940733|NCT00638404|3652933|FG001|STARTED|Overall Study||100
2940734|NCT00638404|3652932|FG000|COMPLETED|Overall Study||192
2940735|NCT00638404|3652933|FG001|COMPLETED|Overall Study||100
2940736|NCT00638404|3652932|FG000|NOT COMPLETED|Overall Study||8
2940737|NCT00638404|3652933|FG001|NOT COMPLETED|Overall Study||0
2940738|NCT00638443|3652943|FG000|STARTED|First Intervention||14
2940739|NCT00638443|3652944|FG001|STARTED|First Intervention||15
2940740|NCT00638443|3652943|FG000|COMPLETED|First Intervention||12
2940741|NCT00638443|3652944|FG001|COMPLETED|First Intervention||14
2940742|NCT00638443|3652943|FG000|NOT COMPLETED|First Intervention||2
2940743|NCT00638443|3652944|FG001|NOT COMPLETED|First Intervention||1
2940744|NCT00638443|3652943|FG000|STARTED|Washout||12
2940745|NCT00638443|3652944|FG001|STARTED|Washout||14
2940746|NCT00638443|3652943|FG000|COMPLETED|Washout||12
2940747|NCT00638443|3652944|FG001|COMPLETED|Washout||14
2940748|NCT00638443|3652943|FG000|NOT COMPLETED|Washout||0
2940749|NCT00638443|3652944|FG001|NOT COMPLETED|Washout||0
2940750|NCT00638443|3652943|FG000|STARTED|Second Intervention||12
2940751|NCT00638443|3652944|FG001|STARTED|Second Intervention||14
2940752|NCT00638443|3652943|FG000|COMPLETED|Second Intervention||12
2940753|NCT00638443|3652944|FG001|COMPLETED|Second Intervention||14
2940754|NCT00638443|3652943|FG000|NOT COMPLETED|Second Intervention||0
2940755|NCT00638443|3652944|FG001|NOT COMPLETED|Second Intervention||0
2940756|NCT00638456|3652954|FG000|STARTED|Overall Study||21
2940757|NCT00638456|3652955|FG001|STARTED|Overall Study||11
2940758|NCT00638456|3652954|FG000|COMPLETED|Overall Study||15
2940759|NCT00638456|3652955|FG001|COMPLETED|Overall Study||9
2940760|NCT00638456|3652954|FG000|NOT COMPLETED|Overall Study||6
2940761|NCT00638456|3652955|FG001|NOT COMPLETED|Overall Study||2
2940762|NCT00638508|3652963|FG000|STARTED|Overall Study||35
2940763|NCT00638508|3652964|FG001|STARTED|Overall Study||32
2940764|NCT00638508|3652963|FG000|COMPLETED|Overall Study||30
2940765|NCT00638508|3652964|FG001|COMPLETED|Overall Study||30
2940766|NCT00638508|3652963|FG000|NOT COMPLETED|Overall Study||5
2940767|NCT00638508|3652964|FG001|NOT COMPLETED|Overall Study||2
2940768|NCT00638651|3652974|FG000|STARTED|Overall Study||3
2940769|NCT00638651|3652974|FG000|COMPLETED|Overall Study||3
2940770|NCT00638651|3652974|FG000|NOT COMPLETED|Overall Study||0
2940771|NCT00638690|3652981|FG000|STARTED|Overall Study||797
2940772|NCT00638690|3652982|FG001|STARTED|Overall Study||398
2940773|NCT00638690|3652981|FG000|COMPLETED|Overall Study||116
2940774|NCT00638690|3652982|FG001|COMPLETED|Overall Study||56
2940775|NCT00638690|3652981|FG000|NOT COMPLETED|Overall Study||681
2940776|NCT00638690|3652982|FG001|NOT COMPLETED|Overall Study||342
2940777|NCT00638716|3652992|FG000|STARTED|Overall Study||50
2940778|NCT00638716|3652993|FG001|STARTED|Overall Study||52
2940779|NCT00638716|3652994|FG002|STARTED|Overall Study||58
2940780|NCT00638716|3652992|FG000|COMPLETED|Overall Study||43
2940781|NCT00638716|3652993|FG001|COMPLETED|Overall Study||37
2940782|NCT00638716|3652994|FG002|COMPLETED|Overall Study||46
2940783|NCT00638716|3652992|FG000|NOT COMPLETED|Overall Study||7
2940784|NCT00638716|3652993|FG001|NOT COMPLETED|Overall Study||15
2940785|NCT00638716|3652994|FG002|NOT COMPLETED|Overall Study||12
2940786|NCT00638820|3653002|FG000|STARTED|Overall Study||3
2940787|NCT00638820|3653002|FG000|COMPLETED|Overall Study||3
2940788|NCT00638820|3653002|FG000|NOT COMPLETED|Overall Study||0
2940789|NCT00638846|3653008|FG000|STARTED|Overall Study||137
2940790|NCT00638846|3653009|FG001|STARTED|Overall Study||139
2940791|NCT00638846|3653008|FG000|COMPLETED|Overall Study||133
2940792|NCT00638846|3653009|FG001|COMPLETED|Overall Study||133
2940793|NCT00638846|3653008|FG000|NOT COMPLETED|Overall Study||4
2940794|NCT00638846|3653009|FG001|NOT COMPLETED|Overall Study||6
2940795|NCT00638885|3653015|FG000|STARTED|Overall Study||142
2940796|NCT00638885|3653015|FG000|COMPLETED|Overall Study||142
2940797|NCT00638885|3653015|FG000|NOT COMPLETED|Overall Study||0
2940798|NCT00638924|3653019|FG000|STARTED|Overall Study||40
2940799|NCT00638924|3653019|FG000|2 Months|Overall Study||40
2940800|NCT00638924|3653019|FG000|COMPLETED|Overall Study||40
2940801|NCT00638924|3653019|FG000|NOT COMPLETED|Overall Study||0
2940802|NCT00638937|3653023|FG000|STARTED|Overall Study||37
2940803|NCT00638937|3653023|FG000|COMPLETED|Overall Study||37
2940804|NCT00638937|3653023|FG000|NOT COMPLETED|Overall Study||0
2940805|NCT00638963|3653031|FG000|STARTED|Overall Study|Received randomized treatment assignment|3
2940806|NCT00638963|3653032|FG001|STARTED|Overall Study|Received randomized treatment assignment|3
2940807|NCT00638963|3653031|FG000|COMPLETED|Overall Study|including follow-up at Week 38 & Week 52|2
2940808|NCT00638963|3653032|FG001|COMPLETED|Overall Study|including follow-up at Week 38 & Week 52|3
2940809|NCT00638963|3653031|FG000|NOT COMPLETED|Overall Study||1
2940810|NCT00638963|3653032|FG001|NOT COMPLETED|Overall Study||0
2940811|NCT00638989|3653041|FG000|STARTED|Overall Study||10
2940812|NCT00638989|3653042|FG001|STARTED|Overall Study||10
2940813|NCT00638989|3653043|FG002|STARTED|Overall Study||10
2940814|NCT00638989|3653041|FG000|COMPLETED|Overall Study||10
2940815|NCT00638989|3653042|FG001|COMPLETED|Overall Study||10
2940816|NCT00638989|3653043|FG002|COMPLETED|Overall Study||9
2940817|NCT00638989|3653041|FG000|NOT COMPLETED|Overall Study||0
2940818|NCT00638989|3653042|FG001|NOT COMPLETED|Overall Study||0
2940819|NCT00638989|3653043|FG002|NOT COMPLETED|Overall Study||1
2940820|NCT00639002|3653053|FG000|STARTED|Overall Study||13
2940821|NCT00639002|3653053|FG000|Received Ruxolitinib|Overall Study||13
2940822|NCT00639002|3653053|FG000|Received Ruxolitinib + Dexamethasone|Overall Study||7
2940823|NCT00639002|3653053|FG000|COMPLETED|Overall Study||0
3047811|NCT01204671|3767803|FG000|COMPLETED|Overall Study||998
3047812|NCT01204671|3767804|FG001|COMPLETED|Overall Study||998
3047813|NCT01204671|3767805|FG002|COMPLETED|Overall Study||998
3047814|NCT01204671|3767806|FG003|COMPLETED|Overall Study||997
3047815|NCT01204671|3767807|FG004|COMPLETED|Overall Study||606
3047816|NCT01204671|3767803|FG000|NOT COMPLETED|Overall Study||14
3047817|NCT01204671|3767804|FG001|NOT COMPLETED|Overall Study||15
3047818|NCT01204671|3767805|FG002|NOT COMPLETED|Overall Study||13
3047819|NCT01204671|3767806|FG003|NOT COMPLETED|Overall Study||13
3047820|NCT01204671|3767807|FG004|NOT COMPLETED|Overall Study||4
3047821|NCT01204697|3767825|FG000|STARTED|Overall Study||36
3047822|NCT01204697|3767826|FG001|STARTED|Overall Study||38
3047823|NCT01204697|3767825|FG000|Treated|Overall Study||36
3047824|NCT01204697|3767826|FG001|Treated|Overall Study||37
3047825|NCT01204697|3767825|FG000|COMPLETED|Overall Study||5
3047826|NCT01204697|3767826|FG001|COMPLETED|Overall Study||2
3047827|NCT01204697|3767825|FG000|NOT COMPLETED|Overall Study||31
3047828|NCT01204697|3767826|FG001|NOT COMPLETED|Overall Study||36
3047829|NCT01204710|3767834|FG000|STARTED|Randomization Treatment||63
3047830|NCT01204710|3767835|FG001|STARTED|Randomization Treatment||60
3047831|NCT01204710|3767834|FG000|Received ≥1 Dose of Study Drug|Randomization Treatment||62
3047832|NCT01204710|3767835|FG001|Received ≥1 Dose of Study Drug|Randomization Treatment||59
3047833|NCT01204710|3767834|FG000|COMPLETED|Randomization Treatment||49
3047834|NCT01204710|3767835|FG001|COMPLETED|Randomization Treatment||47
3047835|NCT01204710|3767834|FG000|NOT COMPLETED|Randomization Treatment||14
3047836|NCT01204710|3767835|FG001|NOT COMPLETED|Randomization Treatment||13
3047837|NCT01204710|3767834|FG000|STARTED|Optional Olaratumab Monotherapy|Olaratumab follow-on treatment was optional for participants in mitoxantrone group only who had PD.|0
3047838|NCT01204710|3767835|FG001|STARTED|Optional Olaratumab Monotherapy|Among 43 participants who experienced PD, 19 received olaratumab monotherapy.|19
3047839|NCT01204710|3767834|FG000|COMPLETED|Optional Olaratumab Monotherapy||0
3047840|NCT01204710|3767835|FG001|COMPLETED|Optional Olaratumab Monotherapy||16
3047841|NCT01204710|3767834|FG000|NOT COMPLETED|Optional Olaratumab Monotherapy||0
3047842|NCT01204710|3767835|FG001|NOT COMPLETED|Optional Olaratumab Monotherapy||3
3047843|NCT01204736|3767852|FG000|STARTED|Overall Study||4
3047844|NCT01204736|3767853|FG001|STARTED|Overall Study||5
3047845|NCT01204736|3767854|FG002|STARTED|Overall Study||3
3047846|NCT01204736|3767855|FG003|STARTED|Overall Study||2
3047847|NCT01204736|3767852|FG000|COMPLETED|Overall Study||4
3047848|NCT01204736|3767853|FG001|COMPLETED|Overall Study||5
3047849|NCT01204736|3767854|FG002|COMPLETED|Overall Study||3
3047850|NCT01204736|3767855|FG003|COMPLETED|Overall Study||2
3047851|NCT01204736|3767852|FG000|NOT COMPLETED|Overall Study||0
3047852|NCT01204736|3767853|FG001|NOT COMPLETED|Overall Study||0
3047853|NCT01204736|3767854|FG002|NOT COMPLETED|Overall Study||0
3047854|NCT01204736|3767855|FG003|NOT COMPLETED|Overall Study||0
3047855|NCT01204775|3767867|FG000|STARTED|Overall Study||4
3047856|NCT01204775|3767868|FG001|STARTED|Overall Study||4
3047857|NCT01204775|3767867|FG000|Double-blind Treatment Period|Overall Study||4
3047858|NCT01204775|3767868|FG001|Double-blind Treatment Period|Overall Study||4
3047859|NCT01204775|3767867|FG000|COMPLETED|Overall Study||3
3047860|NCT01204775|3767868|FG001|COMPLETED|Overall Study||3
3047861|NCT01204775|3767867|FG000|NOT COMPLETED|Overall Study||1
3047862|NCT01204775|3767868|FG001|NOT COMPLETED|Overall Study||1
3047863|NCT01204853|3767874|FG000|STARTED|Overall Study||2
3047864|NCT01204853|3767874|FG000|COMPLETED|Overall Study||2
3047865|NCT01204853|3767874|FG000|NOT COMPLETED|Overall Study||0
3047866|NCT01204905|3767878|FG000|STARTED|Overall Study||7
3047867|NCT01204905|3767878|FG000|COMPLETED|Overall Study||5
3047868|NCT01204905|3767878|FG000|NOT COMPLETED|Overall Study||2
3047869|NCT01204918|3767885|FG000|STARTED|Overall Study||25
3047870|NCT01204918|3767886|FG001|STARTED|Overall Study||39
3047871|NCT01204918|3767887|FG002|STARTED|Overall Study||40
3047872|NCT01204918|3767885|FG000|Stage 1 Begin|Overall Study||25
3047873|NCT01204918|3767886|FG001|Stage 1 Begin|Overall Study||39
3047874|NCT01204918|3767887|FG002|Stage 1 Begin|Overall Study||40
3047875|NCT01204918|3767885|FG000|Stage 1 End|Overall Study||22
3047876|NCT01204918|3767886|FG001|Stage 1 End|Overall Study||35
3047877|NCT01204918|3767887|FG002|Stage 1 End|Overall Study||36
3047878|NCT01204918|3767885|FG000|Stage 2 Begin|Overall Study||22
3047879|NCT01204918|3767886|FG001|Stage 2 Begin|Overall Study||35
3047880|NCT01204918|3767887|FG002|Stage 2 Begin|Overall Study||36
3047881|NCT01204918|3767885|FG000|Stage 2 End|Overall Study||21
3047882|NCT01204918|3767886|FG001|Stage 2 End|Overall Study||29
3047883|NCT01204918|3767887|FG002|Stage 2 End|Overall Study||35
3047884|NCT01204918|3767885|FG000|COMPLETED|Overall Study||21
3047885|NCT01204918|3767886|FG001|COMPLETED|Overall Study||29
3047886|NCT01204918|3767887|FG002|COMPLETED|Overall Study||35
3047887|NCT01204918|3767885|FG000|NOT COMPLETED|Overall Study||4
3047888|NCT01204918|3767886|FG001|NOT COMPLETED|Overall Study||10
3047889|NCT01204918|3767887|FG002|NOT COMPLETED|Overall Study||5
3047890|NCT01205035|3767897|FG000|STARTED|Overall Study||3
3047891|NCT01205035|3767898|FG001|STARTED|Overall Study||3
3047892|NCT01205035|3767897|FG000|COMPLETED|Overall Study||1
3047893|NCT01205035|3767898|FG001|COMPLETED|Overall Study||3
3047894|NCT01205035|3767897|FG000|NOT COMPLETED|Overall Study||2
3047895|NCT01205035|3767898|FG001|NOT COMPLETED|Overall Study||0
3047896|NCT01205126|3767906|FG000|STARTED|Titration Phase||130
3047897|NCT01205126|3767907|FG001|STARTED|Titration Phase||130
3047898|NCT01205126|3767906|FG000|COMPLETED|Titration Phase||107
3047899|NCT01205126|3767907|FG001|COMPLETED|Titration Phase||111
3047900|NCT01205126|3767906|FG000|NOT COMPLETED|Titration Phase||23
3047901|NCT01205126|3767907|FG001|NOT COMPLETED|Titration Phase||19
3047902|NCT01205126|3767906|FG000|STARTED|Between Titration & Maintenance Phase||107
3047903|NCT01205126|3767907|FG001|STARTED|Between Titration & Maintenance Phase||111
3047904|NCT01205126|3767906|FG000|COMPLETED|Between Titration & Maintenance Phase||107
3047905|NCT01205126|3767907|FG001|COMPLETED|Between Titration & Maintenance Phase||107
3047906|NCT01205126|3767906|FG000|NOT COMPLETED|Between Titration & Maintenance Phase||0
3047907|NCT01205126|3767907|FG001|NOT COMPLETED|Between Titration & Maintenance Phase||4
3047908|NCT01205126|3767906|FG000|STARTED|Maintenance Phase||107
3047909|NCT01205126|3767907|FG001|STARTED|Maintenance Phase||107
3047910|NCT01205126|3767906|FG000|COMPLETED|Maintenance Phase||70
3047911|NCT01205126|3767907|FG001|COMPLETED|Maintenance Phase||67
3047912|NCT01205126|3767906|FG000|NOT COMPLETED|Maintenance Phase||37
3047913|NCT01205126|3767907|FG001|NOT COMPLETED|Maintenance Phase||40
3047914|NCT01205152|3767913|FG000|STARTED|Overall Study||10
3047915|NCT01205152|3767913|FG000|COMPLETED|Overall Study||9
3047916|NCT01205152|3767913|FG000|NOT COMPLETED|Overall Study||1
3047917|NCT01205165|3767919|FG000|STARTED|Overall Study||104
3047918|NCT01205165|3767919|FG000|COMPLETED|Overall Study||102
3047919|NCT01205165|3767919|FG000|NOT COMPLETED|Overall Study||2
3047920|NCT01205230|3767926|FG000|STARTED|Overall Study||21
3047921|NCT01205230|3767927|FG001|STARTED|Overall Study||13
3047922|NCT01205230|3767926|FG000|Combination Therapy|Overall Study||21
3047923|NCT01205230|3767927|FG001|Combination Therapy|Overall Study||13
3047924|NCT01205230|3767926|FG000|COMPLETED|Overall Study||16
3047925|NCT01205230|3767927|FG001|COMPLETED|Overall Study||13
3047926|NCT01205230|3767926|FG000|NOT COMPLETED|Overall Study||5
3047927|NCT01205230|3767927|FG001|NOT COMPLETED|Overall Study||0
3047928|NCT01205269|3767938|FG000|STARTED|Period 1 - First Intervention||4
3047929|NCT01205269|3767939|FG001|STARTED|Period 1 - First Intervention||4
3047930|NCT01205269|3767940|FG002|STARTED|Period 1 - First Intervention||4
3047931|NCT01205269|3767941|FG003|STARTED|Period 1 - First Intervention||6
3047932|NCT01205269|3767942|FG004|STARTED|Period 1 - First Intervention||5
3047933|NCT01205269|3767943|FG005|STARTED|Period 1 - First Intervention||5
3047934|NCT01205269|3767938|FG000|COMPLETED|Period 1 - First Intervention||4
3047935|NCT01205269|3767939|FG001|COMPLETED|Period 1 - First Intervention||4
3047936|NCT01205269|3767940|FG002|COMPLETED|Period 1 - First Intervention||4
3047937|NCT01205269|3767941|FG003|COMPLETED|Period 1 - First Intervention||6
3047938|NCT01205269|3767942|FG004|COMPLETED|Period 1 - First Intervention||5
3047939|NCT01205269|3767943|FG005|COMPLETED|Period 1 - First Intervention||5
3047940|NCT01205269|3767938|FG000|NOT COMPLETED|Period 1 - First Intervention||0
3047941|NCT01205269|3767939|FG001|NOT COMPLETED|Period 1 - First Intervention||0
3047942|NCT01205269|3767940|FG002|NOT COMPLETED|Period 1 - First Intervention||0
3047943|NCT01205269|3767941|FG003|NOT COMPLETED|Period 1 - First Intervention||0
3047944|NCT01205269|3767942|FG004|NOT COMPLETED|Period 1 - First Intervention||0
3047945|NCT01205269|3767943|FG005|NOT COMPLETED|Period 1 - First Intervention||0
3047946|NCT01205269|3767938|FG000|STARTED|Period 2 - Washout||4
3047947|NCT01205269|3767939|FG001|STARTED|Period 2 - Washout||4
3047948|NCT01205269|3767940|FG002|STARTED|Period 2 - Washout||4
3047949|NCT01205269|3767941|FG003|STARTED|Period 2 - Washout||6
3047950|NCT01205269|3767942|FG004|STARTED|Period 2 - Washout||5
3278882|NCT02713490|4012311|FG000|COMPLETED|Overall Study||68
3278883|NCT02713490|4012312|FG001|COMPLETED|Overall Study||67
3278884|NCT02713490|4012311|FG000|NOT COMPLETED|Overall Study||3
3047951|NCT01205269|3767943|FG005|STARTED|Period 2 - Washout||5
3047952|NCT01205269|3767938|FG000|COMPLETED|Period 2 - Washout||4
3047953|NCT01205269|3767939|FG001|COMPLETED|Period 2 - Washout||4
3047954|NCT01205269|3767940|FG002|COMPLETED|Period 2 - Washout||4
3047955|NCT01205269|3767941|FG003|COMPLETED|Period 2 - Washout||6
3047956|NCT01205269|3767942|FG004|COMPLETED|Period 2 - Washout||5
3047957|NCT01205269|3767943|FG005|COMPLETED|Period 2 - Washout||5
3278885|NCT02713490|4012312|FG001|NOT COMPLETED|Overall Study||2
3278886|NCT02713529|4012325|FG000|STARTED|Overall Study||8
3278887|NCT02713529|4012326|FG001|STARTED|Overall Study||7
3278888|NCT02713529|4012327|FG002|STARTED|Overall Study||42
3278889|NCT02713529|4012328|FG003|STARTED|Overall Study||31
3278890|NCT02713529|4012329|FG004|STARTED|Overall Study||4
3278891|NCT02713529|4012330|FG005|STARTED|Overall Study||19
3278892|NCT02713529|4012331|FG006|STARTED|Overall Study||6
3278893|NCT02713529|4012325|FG000|COMPLETED|Overall Study||1
3278894|NCT02713529|4012326|FG001|COMPLETED|Overall Study||3
3278895|NCT02713529|4012327|FG002|COMPLETED|Overall Study||11
3278896|NCT02713529|4012328|FG003|COMPLETED|Overall Study||2
3278897|NCT02713529|4012329|FG004|COMPLETED|Overall Study||1
3278898|NCT02713529|4012330|FG005|COMPLETED|Overall Study||5
3278899|NCT02713529|4012331|FG006|COMPLETED|Overall Study||2
3278900|NCT02713529|4012325|FG000|NOT COMPLETED|Overall Study||7
3278901|NCT02713529|4012326|FG001|NOT COMPLETED|Overall Study||4
3278902|NCT02713529|4012327|FG002|NOT COMPLETED|Overall Study||31
3278903|NCT02713529|4012328|FG003|NOT COMPLETED|Overall Study||29
3278904|NCT02713529|4012329|FG004|NOT COMPLETED|Overall Study||3
3278905|NCT02713529|4012330|FG005|NOT COMPLETED|Overall Study||14
3278906|NCT02713529|4012331|FG006|NOT COMPLETED|Overall Study||4
3278907|NCT02713542|4012353|FG000|STARTED|Overall Study||60
3278908|NCT02713542|4012354|FG001|STARTED|Overall Study||30
3278909|NCT02713542|4012353|FG000|COMPLETED|Overall Study||42
3278910|NCT02713542|4012354|FG001|COMPLETED|Overall Study||24
3278911|NCT02713542|4012353|FG000|NOT COMPLETED|Overall Study||18
3278912|NCT02713542|4012354|FG001|NOT COMPLETED|Overall Study||6
3278913|NCT02713594|4012362|FG000|STARTED|Overall Study||952
3278914|NCT02713594|4012363|FG001|STARTED|Overall Study||948
3278915|NCT02713594|4012362|FG000|COMPLETED|Overall Study||562
3278916|NCT02713594|4012363|FG001|COMPLETED|Overall Study||552
3278917|NCT02713594|4012362|FG000|NOT COMPLETED|Overall Study||390
3278918|NCT02713594|4012363|FG001|NOT COMPLETED|Overall Study||396
3278919|NCT02713659|4012373|FG000|STARTED|Baseline||60
3278920|NCT02713659|4012374|FG001|STARTED|Baseline||60
3278921|NCT02713659|4012373|FG000|COMPLETED|Baseline||60
3278922|NCT02713659|4012374|FG001|COMPLETED|Baseline||60
3278923|NCT02713659|4012373|FG000|NOT COMPLETED|Baseline||0
3278924|NCT02713659|4012374|FG001|NOT COMPLETED|Baseline||0
3278925|NCT02713659|4012373|FG000|STARTED|6 Month Study Visit||60
3278926|NCT02713659|4012374|FG001|STARTED|6 Month Study Visit||60
3278927|NCT02713659|4012373|FG000|COMPLETED|6 Month Study Visit||53
3278928|NCT02713659|4012374|FG001|COMPLETED|6 Month Study Visit||47
3278929|NCT02713659|4012373|FG000|NOT COMPLETED|6 Month Study Visit||7
3278930|NCT02713659|4012374|FG001|NOT COMPLETED|6 Month Study Visit||13
3278931|NCT02713659|4012373|FG000|STARTED|12 Month Study Visit||57
3278932|NCT02713659|4012374|FG001|STARTED|12 Month Study Visit||55
3278933|NCT02713659|4012373|FG000|COMPLETED|12 Month Study Visit||54
3278934|NCT02713659|4012374|FG001|COMPLETED|12 Month Study Visit||52
3278935|NCT02713659|4012373|FG000|NOT COMPLETED|12 Month Study Visit||3
3278936|NCT02713659|4012374|FG001|NOT COMPLETED|12 Month Study Visit||3
3278937|NCT02713659|4012373|FG000|STARTED|18 Month Study Visit||58
3278938|NCT02713659|4012374|FG001|STARTED|18 Month Study Visit||53
3278939|NCT02713659|4012373|FG000|COMPLETED|18 Month Study Visit||50
3278940|NCT02713659|4012374|FG001|COMPLETED|18 Month Study Visit||50
3278941|NCT02713659|4012373|FG000|NOT COMPLETED|18 Month Study Visit||8
3278942|NCT02713659|4012374|FG001|NOT COMPLETED|18 Month Study Visit||3
3278943|NCT02713659|4012373|FG000|STARTED|24 Month Study Visit||57
3278944|NCT02713659|4012374|FG001|STARTED|24 Month Study Visit||52
3278945|NCT02713659|4012373|FG000|COMPLETED|24 Month Study Visit||49
3278946|NCT02713659|4012374|FG001|COMPLETED|24 Month Study Visit||44
3047958|NCT01205269|3767938|FG000|NOT COMPLETED|Period 2 - Washout||0
3047959|NCT01205269|3767939|FG001|NOT COMPLETED|Period 2 - Washout||0
3047960|NCT01205269|3767940|FG002|NOT COMPLETED|Period 2 - Washout||0
3278947|NCT02713659|4012373|FG000|NOT COMPLETED|24 Month Study Visit||8
3278948|NCT02713659|4012374|FG001|NOT COMPLETED|24 Month Study Visit||8
3047961|NCT01205269|3767941|FG003|NOT COMPLETED|Period 2 - Washout||0
3047962|NCT01205269|3767942|FG004|NOT COMPLETED|Period 2 - Washout||0
3047963|NCT01205269|3767943|FG005|NOT COMPLETED|Period 2 - Washout||0
3047964|NCT01205269|3767938|FG000|STARTED|Period 3 - Second Intervention||4
3047965|NCT01205269|3767939|FG001|STARTED|Period 3 - Second Intervention||4
3047966|NCT01205269|3767940|FG002|STARTED|Period 3 - Second Intervention||4
3047967|NCT01205269|3767941|FG003|STARTED|Period 3 - Second Intervention||6
3047968|NCT01205269|3767942|FG004|STARTED|Period 3 - Second Intervention||5
3047969|NCT01205269|3767943|FG005|STARTED|Period 3 - Second Intervention||5
3047970|NCT01205269|3767938|FG000|COMPLETED|Period 3 - Second Intervention||4
3047971|NCT01205269|3767939|FG001|COMPLETED|Period 3 - Second Intervention||4
3047972|NCT01205269|3767940|FG002|COMPLETED|Period 3 - Second Intervention||4
3047973|NCT01205269|3767941|FG003|COMPLETED|Period 3 - Second Intervention||6
3047974|NCT01205269|3767942|FG004|COMPLETED|Period 3 - Second Intervention||5
3047975|NCT01205269|3767943|FG005|COMPLETED|Period 3 - Second Intervention||5
3047976|NCT01205269|3767938|FG000|NOT COMPLETED|Period 3 - Second Intervention||0
3047977|NCT01205269|3767939|FG001|NOT COMPLETED|Period 3 - Second Intervention||0
3047978|NCT01205269|3767940|FG002|NOT COMPLETED|Period 3 - Second Intervention||0
3047979|NCT01205269|3767941|FG003|NOT COMPLETED|Period 3 - Second Intervention||0
3047980|NCT01205269|3767942|FG004|NOT COMPLETED|Period 3 - Second Intervention||0
3047981|NCT01205269|3767943|FG005|NOT COMPLETED|Period 3 - Second Intervention||0
3047982|NCT01205269|3767938|FG000|STARTED|Period 4 - Washout||4
3047983|NCT01205269|3767939|FG001|STARTED|Period 4 - Washout||4
3047984|NCT01205269|3767940|FG002|STARTED|Period 4 - Washout||4
3047985|NCT01205269|3767941|FG003|STARTED|Period 4 - Washout||6
3047986|NCT01205269|3767942|FG004|STARTED|Period 4 - Washout||5
3047987|NCT01205269|3767943|FG005|STARTED|Period 4 - Washout||5
3047988|NCT01205269|3767938|FG000|COMPLETED|Period 4 - Washout||4
3047989|NCT01205269|3767939|FG001|COMPLETED|Period 4 - Washout||4
3047990|NCT01205269|3767940|FG002|COMPLETED|Period 4 - Washout||4
3047991|NCT01205269|3767941|FG003|COMPLETED|Period 4 - Washout||5
3047992|NCT01205269|3767942|FG004|COMPLETED|Period 4 - Washout||5
3047993|NCT01205269|3767943|FG005|COMPLETED|Period 4 - Washout||5
3047994|NCT01205269|3767938|FG000|NOT COMPLETED|Period 4 - Washout||0
3047995|NCT01205269|3767939|FG001|NOT COMPLETED|Period 4 - Washout||0
3047996|NCT01205269|3767940|FG002|NOT COMPLETED|Period 4 - Washout||0
3047997|NCT01205269|3767941|FG003|NOT COMPLETED|Period 4 - Washout||1
3047998|NCT01205269|3767942|FG004|NOT COMPLETED|Period 4 - Washout||0
3047999|NCT01205269|3767943|FG005|NOT COMPLETED|Period 4 - Washout||0
3048000|NCT01205269|3767938|FG000|STARTED|Period 5 - Third Intervention||4
3048001|NCT01205269|3767939|FG001|STARTED|Period 5 - Third Intervention||4
3048002|NCT01205269|3767940|FG002|STARTED|Period 5 - Third Intervention||4
3048003|NCT01205269|3767941|FG003|STARTED|Period 5 - Third Intervention||5
3048004|NCT01205269|3767942|FG004|STARTED|Period 5 - Third Intervention||5
3048005|NCT01205269|3767943|FG005|STARTED|Period 5 - Third Intervention||5
3048006|NCT01205269|3767938|FG000|COMPLETED|Period 5 - Third Intervention||4
3048007|NCT01205269|3767939|FG001|COMPLETED|Period 5 - Third Intervention||4
3048008|NCT01205269|3767940|FG002|COMPLETED|Period 5 - Third Intervention||4
3048009|NCT01205269|3767941|FG003|COMPLETED|Period 5 - Third Intervention||5
3048010|NCT01205269|3767942|FG004|COMPLETED|Period 5 - Third Intervention||5
3048011|NCT01205269|3767943|FG005|COMPLETED|Period 5 - Third Intervention||5
3048012|NCT01205269|3767938|FG000|NOT COMPLETED|Period 5 - Third Intervention||0
3048013|NCT01205269|3767939|FG001|NOT COMPLETED|Period 5 - Third Intervention||0
3048014|NCT01205269|3767940|FG002|NOT COMPLETED|Period 5 - Third Intervention||0
3048015|NCT01205269|3767941|FG003|NOT COMPLETED|Period 5 - Third Intervention||0
3048016|NCT01205269|3767942|FG004|NOT COMPLETED|Period 5 - Third Intervention||0
3278949|NCT02713698|4012383|FG000|STARTED|Overall Study||20
3278950|NCT02713698|4012384|FG001|STARTED|Overall Study||20
3278951|NCT02713698|4012385|FG002|STARTED|Overall Study||20
3278952|NCT02713698|4012383|FG000|COMPLETED|Overall Study||20
3278953|NCT02713698|4012384|FG001|COMPLETED|Overall Study||20
3278954|NCT02713698|4012385|FG002|COMPLETED|Overall Study||20
3278955|NCT02713698|4012383|FG000|NOT COMPLETED|Overall Study||0
3278956|NCT02713698|4012384|FG001|NOT COMPLETED|Overall Study||0
3278957|NCT02713698|4012385|FG002|NOT COMPLETED|Overall Study||0
3278958|NCT02713711|4012393|FG000|STARTED|Overall Study||9
3278959|NCT02713711|4012394|FG001|STARTED|Overall Study||6
3278960|NCT02713711|4012395|FG002|STARTED|Overall Study||6
3278961|NCT02713711|4012396|FG003|STARTED|Overall Study||10
3278962|NCT02713711|4012393|FG000|COMPLETED|Overall Study||9
3278963|NCT02713711|4012394|FG001|COMPLETED|Overall Study||6
3278964|NCT02713711|4012395|FG002|COMPLETED|Overall Study||6
3278965|NCT02713711|4012396|FG003|COMPLETED|Overall Study||10
3278966|NCT02713711|4012393|FG000|NOT COMPLETED|Overall Study||0
3278967|NCT02713711|4012394|FG001|NOT COMPLETED|Overall Study||0
3278968|NCT02713711|4012395|FG002|NOT COMPLETED|Overall Study||0
3278969|NCT02713711|4012396|FG003|NOT COMPLETED|Overall Study||0
3278970|NCT02713789|4012412|FG000|STARTED|Overall Study||8
3278971|NCT02713789|4012413|FG001|STARTED|Overall Study||10
3278972|NCT02713789|4012414|FG002|STARTED|Overall Study||8
3278973|NCT02713789|4012412|FG000|COMPLETED|Overall Study||8
3278974|NCT02713789|4012413|FG001|COMPLETED|Overall Study||9
3278975|NCT02713789|4012414|FG002|COMPLETED|Overall Study||7
3278976|NCT02713789|4012412|FG000|NOT COMPLETED|Overall Study||0
3278977|NCT02713789|4012413|FG001|NOT COMPLETED|Overall Study||1
3278978|NCT02713789|4012414|FG002|NOT COMPLETED|Overall Study||1
3048017|NCT01205269|3767943|FG005|NOT COMPLETED|Period 5 - Third Intervention||0
3048018|NCT01205399|3767951|FG000|STARTED|Overall Study||78
3048019|NCT01205399|3767951|FG000|COMPLETED|Overall Study||78
3048020|NCT01205399|3767951|FG000|NOT COMPLETED|Overall Study||0
3048021|NCT01205438|3767958|FG000|STARTED|Overall Study||372
3048022|NCT01205438|3767959|FG001|STARTED|Overall Study||376
3048023|NCT01205438|3767960|FG002|STARTED|Overall Study||376
3048024|NCT01205438|3767958|FG000|Received At Least One Dose of Study Drug|Overall Study||371
3048025|NCT01205438|3767959|FG001|Received At Least One Dose of Study Drug|Overall Study||374
3048026|NCT01205438|3767960|FG002|Received At Least One Dose of Study Drug|Overall Study||376
3048027|NCT01205438|3767958|FG000|Participated in Follow Up|Overall Study||72
3048028|NCT01205438|3767959|FG001|Participated in Follow Up|Overall Study||78
3048029|NCT01205438|3767960|FG002|Participated in Follow Up|Overall Study||66
3278979|NCT02713828|4012424|FG000|STARTED|Overall Study||13
3278980|NCT02713828|4012425|FG001|STARTED|Overall Study||0
3278981|NCT02713828|4012424|FG000|COMPLETED|Overall Study||8
3278982|NCT02713828|4012425|FG001|COMPLETED|Overall Study||0
3278983|NCT02713828|4012424|FG000|NOT COMPLETED|Overall Study||5
3278984|NCT02713828|4012425|FG001|NOT COMPLETED|Overall Study||0
3278985|NCT02713867|4012432|FG000|STARTED|Randomization||180
3278986|NCT02713867|4012433|FG001|STARTED|Randomization||183
3278987|NCT02713867|4012432|FG000|COMPLETED|Randomization||178
3278988|NCT02713867|4012433|FG001|COMPLETED|Randomization||180
3278989|NCT02713867|4012432|FG000|NOT COMPLETED|Randomization||2
3278990|NCT02713867|4012433|FG001|NOT COMPLETED|Randomization||3
3278991|NCT02713867|4012432|FG000|STARTED|Treatment Period||178
3278992|NCT02713867|4012433|FG001|STARTED|Treatment Period||180
3278993|NCT02713867|4012432|FG000|COMPLETED|Treatment Period||31
3278994|NCT02713867|4012433|FG001|COMPLETED|Treatment Period||30
3278995|NCT02713867|4012432|FG000|NOT COMPLETED|Treatment Period||147
3278996|NCT02713867|4012433|FG001|NOT COMPLETED|Treatment Period||150
3278997|NCT02714062|4012442|FG000|STARTED|Overall Study||14
3278998|NCT02714062|4012443|FG001|STARTED|Overall Study||15
3278999|NCT02714062|4012444|FG002|STARTED|Overall Study||13
3279000|NCT02714062|4012442|FG000|COMPLETED|Overall Study||13
3279001|NCT02714062|4012443|FG001|COMPLETED|Overall Study||14
3279002|NCT02714062|4012444|FG002|COMPLETED|Overall Study||10
3279003|NCT02714062|4012442|FG000|NOT COMPLETED|Overall Study||1
3279004|NCT02714062|4012443|FG001|NOT COMPLETED|Overall Study||1
3279005|NCT02714062|4012444|FG002|NOT COMPLETED|Overall Study||3
3279006|NCT02714153|4012454|FG000|STARTED|Overall Study||23
3279007|NCT02714153|4012454|FG000|COMPLETED|Overall Study||22
3279008|NCT02714153|4012454|FG000|NOT COMPLETED|Overall Study||1
3279009|NCT02714283|4012460|FG000|STARTED|Overall Study||83589
3279010|NCT02714283|4012461|FG001|STARTED|Overall Study||6500
3279011|NCT02714283|4012460|FG000|COMPLETED|Overall Study||83589
3279012|NCT02714283|4012461|FG001|COMPLETED|Overall Study||6500
3279013|NCT02714283|4012460|FG000|NOT COMPLETED|Overall Study||0
3279014|NCT02714283|4012461|FG001|NOT COMPLETED|Overall Study||0
3279015|NCT02714400|4012471|FG000|STARTED|First Intervention (1 Day)||12
3279016|NCT02714400|4012472|FG001|STARTED|First Intervention (1 Day)||8
3279017|NCT02714400|4012471|FG000|COMPLETED|First Intervention (1 Day)||12
3279018|NCT02714400|4012472|FG001|COMPLETED|First Intervention (1 Day)||8
3279019|NCT02714400|4012471|FG000|NOT COMPLETED|First Intervention (1 Day)||0
3279020|NCT02714400|4012472|FG001|NOT COMPLETED|First Intervention (1 Day)||0
3279021|NCT02714400|4012471|FG000|STARTED|Washout (>4 Days)||12
3279022|NCT02714400|4012472|FG001|STARTED|Washout (>4 Days)||8
3279023|NCT02714400|4012471|FG000|COMPLETED|Washout (>4 Days)||12
3279024|NCT02714400|4012472|FG001|COMPLETED|Washout (>4 Days)||8
3279025|NCT02714400|4012471|FG000|NOT COMPLETED|Washout (>4 Days)||0
3279026|NCT02714400|4012472|FG001|NOT COMPLETED|Washout (>4 Days)||0
3279027|NCT02714400|4012471|FG000|STARTED|Second Intervention (1 Day)||12
3279028|NCT02714400|4012472|FG001|STARTED|Second Intervention (1 Day)||8
3279029|NCT02714400|4012471|FG000|COMPLETED|Second Intervention (1 Day)||12
3279030|NCT02714400|4012472|FG001|COMPLETED|Second Intervention (1 Day)||8
3279031|NCT02714400|4012471|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
3279032|NCT02714400|4012472|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
3279033|NCT02714426|4012480|FG000|STARTED|Overall Study||21
3279034|NCT02714426|4012481|FG001|STARTED|Overall Study||21
3279035|NCT02714426|4012480|FG000|COMPLETED|Overall Study||19
3279036|NCT02714426|4012481|FG001|COMPLETED|Overall Study||19
3279037|NCT02714426|4012480|FG000|NOT COMPLETED|Overall Study||2
3279038|NCT02714426|4012481|FG001|NOT COMPLETED|Overall Study||2
3279039|NCT02714504|4012489|FG000|STARTED|Overall Study||61
3279040|NCT02714504|4012490|FG001|STARTED|Overall Study||178
3279041|NCT02714504|4012489|FG000|COMPLETED|Overall Study||61
3279042|NCT02714504|4012490|FG001|COMPLETED|Overall Study||178
3279043|NCT02714504|4012489|FG000|NOT COMPLETED|Overall Study||0
3279044|NCT02714504|4012490|FG001|NOT COMPLETED|Overall Study||0
3279045|NCT02714569|4012507|FG000|STARTED|Part A First Intervention||3
3279046|NCT02714569|4012508|FG001|STARTED|Part A First Intervention||3
3279047|NCT02714569|4012509|FG002|STARTED|Part A First Intervention||3
3279048|NCT02714569|4012510|FG003|STARTED|Part A First Intervention||3
3279049|NCT02714569|4012511|FG004|STARTED|Part A First Intervention||3
3279050|NCT02714569|4012512|FG005|STARTED|Part A First Intervention||3
3279051|NCT02714569|4012513|FG006|STARTED|Part A First Intervention||0
3279052|NCT02714569|4012514|FG007|STARTED|Part A First Intervention||0
3279053|NCT02714569|4012515|FG008|STARTED|Part A First Intervention||0
3279054|NCT02714569|4012516|FG009|STARTED|Part A First Intervention||0
3048030|NCT01205438|3767958|FG000|COMPLETED|Overall Study||295
3048031|NCT01205438|3767959|FG001|COMPLETED|Overall Study||289
3048032|NCT01205438|3767960|FG002|COMPLETED|Overall Study||288
3048033|NCT01205438|3767958|FG000|NOT COMPLETED|Overall Study||77
3048034|NCT01205438|3767959|FG001|NOT COMPLETED|Overall Study||87
3048035|NCT01205438|3767960|FG002|NOT COMPLETED|Overall Study||88
3048036|NCT01205451|3767973|FG000|STARTED|Overall Study||53
3048037|NCT01205451|3767974|FG001|STARTED|Overall Study||56
3048038|NCT01205451|3767973|FG000|COMPLETED|Overall Study||47
3048039|NCT01205451|3767974|FG001|COMPLETED|Overall Study||46
3048040|NCT01205451|3767973|FG000|NOT COMPLETED|Overall Study||6
3048041|NCT01205451|3767974|FG001|NOT COMPLETED|Overall Study||10
3279055|NCT02714569|4012517|FG010|STARTED|Part A First Intervention||0
3279056|NCT02714569|4012507|FG000|Received at Least One Dose of Study Drug|Part A First Intervention||3
3279057|NCT02714569|4012508|FG001|Received at Least One Dose of Study Drug|Part A First Intervention||3
3279058|NCT02714569|4012509|FG002|Received at Least One Dose of Study Drug|Part A First Intervention||3
3279059|NCT02714569|4012510|FG003|Received at Least One Dose of Study Drug|Part A First Intervention||3
3279060|NCT02714569|4012511|FG004|Received at Least One Dose of Study Drug|Part A First Intervention||3
3279061|NCT02714569|4012512|FG005|Received at Least One Dose of Study Drug|Part A First Intervention||3
3279062|NCT02714569|4012513|FG006|Received at Least One Dose of Study Drug|Part A First Intervention||0
3279063|NCT02714569|4012514|FG007|Received at Least One Dose of Study Drug|Part A First Intervention||0
3279064|NCT02714569|4012515|FG008|Received at Least One Dose of Study Drug|Part A First Intervention||0
3279065|NCT02714569|4012516|FG009|Received at Least One Dose of Study Drug|Part A First Intervention||0
3279066|NCT02714569|4012517|FG010|Received at Least One Dose of Study Drug|Part A First Intervention||0
3279067|NCT02714569|4012507|FG000|COMPLETED|Part A First Intervention||3
3279068|NCT02714569|4012508|FG001|COMPLETED|Part A First Intervention||3
3279069|NCT02714569|4012509|FG002|COMPLETED|Part A First Intervention||3
3279070|NCT02714569|4012510|FG003|COMPLETED|Part A First Intervention||3
3279071|NCT02714569|4012511|FG004|COMPLETED|Part A First Intervention||3
3279072|NCT02714569|4012512|FG005|COMPLETED|Part A First Intervention||3
3279073|NCT02714569|4012513|FG006|COMPLETED|Part A First Intervention||0
3279074|NCT02714569|4012514|FG007|COMPLETED|Part A First Intervention||0
3279075|NCT02714569|4012515|FG008|COMPLETED|Part A First Intervention||0
3279076|NCT02714569|4012516|FG009|COMPLETED|Part A First Intervention||0
3279077|NCT02714569|4012517|FG010|COMPLETED|Part A First Intervention||0
3279078|NCT02714569|4012507|FG000|NOT COMPLETED|Part A First Intervention||0
3279079|NCT02714569|4012508|FG001|NOT COMPLETED|Part A First Intervention||0
3279080|NCT02714569|4012509|FG002|NOT COMPLETED|Part A First Intervention||0
3279081|NCT02714569|4012510|FG003|NOT COMPLETED|Part A First Intervention||0
3279082|NCT02714569|4012511|FG004|NOT COMPLETED|Part A First Intervention||0
3279083|NCT02714569|4012512|FG005|NOT COMPLETED|Part A First Intervention||0
3279084|NCT02714569|4012513|FG006|NOT COMPLETED|Part A First Intervention||0
3279085|NCT02714569|4012514|FG007|NOT COMPLETED|Part A First Intervention||0
3279086|NCT02714569|4012515|FG008|NOT COMPLETED|Part A First Intervention||0
3279087|NCT02714569|4012516|FG009|NOT COMPLETED|Part A First Intervention||0
3279088|NCT02714569|4012517|FG010|NOT COMPLETED|Part A First Intervention||0
3279089|NCT02714569|4012507|FG000|STARTED|Part A Second Intervention||3
3279090|NCT02714569|4012508|FG001|STARTED|Part A Second Intervention||3
3279091|NCT02714569|4012509|FG002|STARTED|Part A Second Intervention||3
3279092|NCT02714569|4012510|FG003|STARTED|Part A Second Intervention||3
3279093|NCT02714569|4012511|FG004|STARTED|Part A Second Intervention||3
3279094|NCT02714569|4012512|FG005|STARTED|Part A Second Intervention||3
3279095|NCT02714569|4012513|FG006|STARTED|Part A Second Intervention||0
3279096|NCT02714569|4012514|FG007|STARTED|Part A Second Intervention||0
3279097|NCT02714569|4012515|FG008|STARTED|Part A Second Intervention||0
3279098|NCT02714569|4012516|FG009|STARTED|Part A Second Intervention||0
3279099|NCT02714569|4012517|FG010|STARTED|Part A Second Intervention||0
3279100|NCT02714569|4012507|FG000|Received at Least One Dose of Study Drug|Part A Second Intervention||3
3279101|NCT02714569|4012508|FG001|Received at Least One Dose of Study Drug|Part A Second Intervention||2
3279102|NCT02714569|4012509|FG002|Received at Least One Dose of Study Drug|Part A Second Intervention||3
3279103|NCT02714569|4012510|FG003|Received at Least One Dose of Study Drug|Part A Second Intervention||3
3279104|NCT02714569|4012511|FG004|Received at Least One Dose of Study Drug|Part A Second Intervention||3
3279105|NCT02714569|4012512|FG005|Received at Least One Dose of Study Drug|Part A Second Intervention||3
3279106|NCT02714569|4012513|FG006|Received at Least One Dose of Study Drug|Part A Second Intervention||0
3279107|NCT02714569|4012514|FG007|Received at Least One Dose of Study Drug|Part A Second Intervention||0
3279108|NCT02714569|4012515|FG008|Received at Least One Dose of Study Drug|Part A Second Intervention||0
3279109|NCT02714569|4012516|FG009|Received at Least One Dose of Study Drug|Part A Second Intervention||0
3279110|NCT02714569|4012517|FG010|Received at Least One Dose of Study Drug|Part A Second Intervention||0
3279111|NCT02714569|4012507|FG000|COMPLETED|Part A Second Intervention||3
3279112|NCT02714569|4012508|FG001|COMPLETED|Part A Second Intervention||2
3279113|NCT02714569|4012509|FG002|COMPLETED|Part A Second Intervention||3
3279114|NCT02714569|4012510|FG003|COMPLETED|Part A Second Intervention||3
3279115|NCT02714569|4012511|FG004|COMPLETED|Part A Second Intervention||3
3048042|NCT01205503|3767982|FG000|STARTED|First Intervention (1st Cycle)||16
3048043|NCT01205503|3767983|FG001|STARTED|First Intervention (1st Cycle)||16
3048044|NCT01205503|3767982|FG000|COMPLETED|First Intervention (1st Cycle)||16
3048045|NCT01205503|3767983|FG001|COMPLETED|First Intervention (1st Cycle)||16
3048046|NCT01205503|3767982|FG000|NOT COMPLETED|First Intervention (1st Cycle)||0
3048047|NCT01205503|3767983|FG001|NOT COMPLETED|First Intervention (1st Cycle)||0
3048048|NCT01205503|3767982|FG000|STARTED|Second Intervention (2nd Cycle)||16
3048049|NCT01205503|3767983|FG001|STARTED|Second Intervention (2nd Cycle)||16
3048050|NCT01205503|3767982|FG000|COMPLETED|Second Intervention (2nd Cycle)||16
3048051|NCT01205503|3767983|FG001|COMPLETED|Second Intervention (2nd Cycle)||16
3048052|NCT01205503|3767982|FG000|NOT COMPLETED|Second Intervention (2nd Cycle)||0
3048053|NCT01205503|3767983|FG001|NOT COMPLETED|Second Intervention (2nd Cycle)||0
3048054|NCT01205529|3767989|FG000|STARTED|Overall Study||161
3279116|NCT02714569|4012512|FG005|COMPLETED|Part A Second Intervention||3
3279117|NCT02714569|4012513|FG006|COMPLETED|Part A Second Intervention||0
3279118|NCT02714569|4012514|FG007|COMPLETED|Part A Second Intervention||0
3279119|NCT02714569|4012515|FG008|COMPLETED|Part A Second Intervention||0
3279120|NCT02714569|4012516|FG009|COMPLETED|Part A Second Intervention||0
3279121|NCT02714569|4012517|FG010|COMPLETED|Part A Second Intervention||0
3279122|NCT02714569|4012507|FG000|NOT COMPLETED|Part A Second Intervention||0
3279123|NCT02714569|4012508|FG001|NOT COMPLETED|Part A Second Intervention||1
3279124|NCT02714569|4012509|FG002|NOT COMPLETED|Part A Second Intervention||0
3279125|NCT02714569|4012510|FG003|NOT COMPLETED|Part A Second Intervention||0
3279126|NCT02714569|4012511|FG004|NOT COMPLETED|Part A Second Intervention||0
3279127|NCT02714569|4012512|FG005|NOT COMPLETED|Part A Second Intervention||0
3279128|NCT02714569|4012513|FG006|NOT COMPLETED|Part A Second Intervention||0
3279129|NCT02714569|4012514|FG007|NOT COMPLETED|Part A Second Intervention||0
3279130|NCT02714569|4012515|FG008|NOT COMPLETED|Part A Second Intervention||0
3279131|NCT02714569|4012516|FG009|NOT COMPLETED|Part A Second Intervention||0
3279132|NCT02714569|4012517|FG010|NOT COMPLETED|Part A Second Intervention||0
3279133|NCT02714569|4012507|FG000|STARTED|Part A Third Intervention||3
3279134|NCT02714569|4012508|FG001|STARTED|Part A Third Intervention||2
3279135|NCT02714569|4012509|FG002|STARTED|Part A Third Intervention||3
3279136|NCT02714569|4012510|FG003|STARTED|Part A Third Intervention||3
3279137|NCT02714569|4012511|FG004|STARTED|Part A Third Intervention||3
3279138|NCT02714569|4012512|FG005|STARTED|Part A Third Intervention||3
3279139|NCT02714569|4012513|FG006|STARTED|Part A Third Intervention||0
3279140|NCT02714569|4012514|FG007|STARTED|Part A Third Intervention||0
3279141|NCT02714569|4012515|FG008|STARTED|Part A Third Intervention||0
3279142|NCT02714569|4012516|FG009|STARTED|Part A Third Intervention||0
3279143|NCT02714569|4012517|FG010|STARTED|Part A Third Intervention||0
3279144|NCT02714569|4012507|FG000|Received at Least One Dose of Study Drug|Part A Third Intervention||3
3279145|NCT02714569|4012508|FG001|Received at Least One Dose of Study Drug|Part A Third Intervention||2
3279146|NCT02714569|4012509|FG002|Received at Least One Dose of Study Drug|Part A Third Intervention||2
3279147|NCT02714569|4012510|FG003|Received at Least One Dose of Study Drug|Part A Third Intervention||2
3279148|NCT02714569|4012511|FG004|Received at Least One Dose of Study Drug|Part A Third Intervention||3
3279149|NCT02714569|4012512|FG005|Received at Least One Dose of Study Drug|Part A Third Intervention||3
3279150|NCT02714569|4012513|FG006|Received at Least One Dose of Study Drug|Part A Third Intervention||0
3279151|NCT02714569|4012514|FG007|Received at Least One Dose of Study Drug|Part A Third Intervention||0
3279152|NCT02714569|4012515|FG008|Received at Least One Dose of Study Drug|Part A Third Intervention||0
3279153|NCT02714569|4012516|FG009|Received at Least One Dose of Study Drug|Part A Third Intervention||0
3279154|NCT02714569|4012517|FG010|Received at Least One Dose of Study Drug|Part A Third Intervention||0
3279155|NCT02714569|4012507|FG000|COMPLETED|Part A Third Intervention||3
3279156|NCT02714569|4012508|FG001|COMPLETED|Part A Third Intervention||2
3279157|NCT02714569|4012509|FG002|COMPLETED|Part A Third Intervention||2
3279158|NCT02714569|4012510|FG003|COMPLETED|Part A Third Intervention||2
3279159|NCT02714569|4012511|FG004|COMPLETED|Part A Third Intervention||3
3279160|NCT02714569|4012512|FG005|COMPLETED|Part A Third Intervention||3
3279161|NCT02714569|4012513|FG006|COMPLETED|Part A Third Intervention||0
3279162|NCT02714569|4012514|FG007|COMPLETED|Part A Third Intervention||0
3279163|NCT02714569|4012515|FG008|COMPLETED|Part A Third Intervention||0
3279164|NCT02714569|4012516|FG009|COMPLETED|Part A Third Intervention||0
3279165|NCT02714569|4012517|FG010|COMPLETED|Part A Third Intervention||0
3279166|NCT02714569|4012507|FG000|NOT COMPLETED|Part A Third Intervention||0
3279167|NCT02714569|4012508|FG001|NOT COMPLETED|Part A Third Intervention||0
3279168|NCT02714569|4012509|FG002|NOT COMPLETED|Part A Third Intervention||1
3279169|NCT02714569|4012510|FG003|NOT COMPLETED|Part A Third Intervention||1
3279170|NCT02714569|4012511|FG004|NOT COMPLETED|Part A Third Intervention||0
3279171|NCT02714569|4012512|FG005|NOT COMPLETED|Part A Third Intervention||0
3279172|NCT02714569|4012513|FG006|NOT COMPLETED|Part A Third Intervention||0
3279173|NCT02714569|4012514|FG007|NOT COMPLETED|Part A Third Intervention||0
3279174|NCT02714569|4012515|FG008|NOT COMPLETED|Part A Third Intervention||0
3279175|NCT02714569|4012516|FG009|NOT COMPLETED|Part A Third Intervention||0
3279176|NCT02714569|4012517|FG010|NOT COMPLETED|Part A Third Intervention||0
3279177|NCT02714569|4012507|FG000|STARTED|Part A Fourth Intervention|An additional participant replaced a discontinued participant.|4
3279178|NCT02714569|4012508|FG001|STARTED|Part A Fourth Intervention||2
3279179|NCT02714569|4012509|FG002|STARTED|Part A Fourth Intervention|An additional participant replaced a discontinued participant.|3
3279180|NCT02714569|4012510|FG003|STARTED|Part A Fourth Intervention||2
3048055|NCT01205529|3767989|FG000|COMPLETED|Overall Study||106
3048056|NCT01205529|3767989|FG000|NOT COMPLETED|Overall Study||55
3048057|NCT01205568|3767993|FG000|STARTED|Overall Study|26 patients received only CB therapy, 39 patients received both CB and HPB therapy.|65
3048058|NCT01205568|3767994|FG001|STARTED|Overall Study|8 patients received only HPB therapy, 39 patients received both CB and HPB therapy.|47
3048059|NCT01205568|3767993|FG000|COMPLETED|Overall Study||65
3048060|NCT01205568|3767994|FG001|COMPLETED|Overall Study||47
3048061|NCT01205568|3767993|FG000|NOT COMPLETED|Overall Study||0
3048062|NCT01205568|3767994|FG001|NOT COMPLETED|Overall Study||0
3048063|NCT01205581|3768004|FG000|STARTED|Overall Study||14
3048064|NCT01205581|3768005|FG001|STARTED|Overall Study||13
3048065|NCT01205581|3768006|FG002|STARTED|Overall Study||8
3048066|NCT01205581|3768007|FG003|STARTED|Overall Study||9
3048067|NCT01205581|3768008|FG004|STARTED|Overall Study||20
3048068|NCT01205581|3768009|FG005|STARTED|Overall Study||20
3048069|NCT01205581|3768004|FG000|COMPLETED|Overall Study||13
3048070|NCT01205581|3768005|FG001|COMPLETED|Overall Study||13
3048071|NCT01205581|3768006|FG002|COMPLETED|Overall Study||8
3048072|NCT01205581|3768007|FG003|COMPLETED|Overall Study||9
3048073|NCT01205581|3768008|FG004|COMPLETED|Overall Study||20
3048074|NCT01205581|3768009|FG005|COMPLETED|Overall Study||20
3048075|NCT01205581|3768004|FG000|NOT COMPLETED|Overall Study||1
3048076|NCT01205581|3768005|FG001|NOT COMPLETED|Overall Study||0
3048077|NCT01205581|3768006|FG002|NOT COMPLETED|Overall Study||0
3048078|NCT01205581|3768007|FG003|NOT COMPLETED|Overall Study||0
3048079|NCT01205581|3768008|FG004|NOT COMPLETED|Overall Study||0
3048080|NCT01205581|3768009|FG005|NOT COMPLETED|Overall Study||0
3048081|NCT01205646|3768040|FG000|STARTED|Overall Study||11
3048082|NCT01205646|3768040|FG000|COMPLETED|Overall Study||11
3048083|NCT01205646|3768040|FG000|NOT COMPLETED|Overall Study||0
3048084|NCT01205685|3768044|FG000|STARTED|Overall Study||11
3048085|NCT01205685|3768044|FG000|COMPLETED|Overall Study||0
3048086|NCT01205685|3768044|FG000|NOT COMPLETED|Overall Study||11
3048087|NCT01205776|3768050|FG000|STARTED|Overall Study||948
3048088|NCT01205776|3768051|FG001|STARTED|Overall Study||957
3048089|NCT01205776|3768050|FG000|COMPLETED|Overall Study||884
3279181|NCT02714569|4012511|FG004|STARTED|Part A Fourth Intervention||3
3279182|NCT02714569|4012512|FG005|STARTED|Part A Fourth Intervention||3
3279183|NCT02714569|4012513|FG006|STARTED|Part A Fourth Intervention||0
3279184|NCT02714569|4012514|FG007|STARTED|Part A Fourth Intervention||0
3279185|NCT02714569|4012515|FG008|STARTED|Part A Fourth Intervention||0
3279186|NCT02714569|4012516|FG009|STARTED|Part A Fourth Intervention||0
3279187|NCT02714569|4012517|FG010|STARTED|Part A Fourth Intervention||0
3279188|NCT02714569|4012507|FG000|Received at Least One Dose of Study Drug|Part A Fourth Intervention||3
3279189|NCT02714569|4012508|FG001|Received at Least One Dose of Study Drug|Part A Fourth Intervention||2
3279190|NCT02714569|4012509|FG002|Received at Least One Dose of Study Drug|Part A Fourth Intervention||3
3279191|NCT02714569|4012510|FG003|Received at Least One Dose of Study Drug|Part A Fourth Intervention||2
3279192|NCT02714569|4012511|FG004|Received at Least One Dose of Study Drug|Part A Fourth Intervention||3
3279193|NCT02714569|4012512|FG005|Received at Least One Dose of Study Drug|Part A Fourth Intervention||2
3279194|NCT02714569|4012513|FG006|Received at Least One Dose of Study Drug|Part A Fourth Intervention||0
3279195|NCT02714569|4012514|FG007|Received at Least One Dose of Study Drug|Part A Fourth Intervention||0
3279196|NCT02714569|4012515|FG008|Received at Least One Dose of Study Drug|Part A Fourth Intervention||0
3279197|NCT02714569|4012516|FG009|Received at Least One Dose of Study Drug|Part A Fourth Intervention||0
3279198|NCT02714569|4012517|FG010|Received at Least One Dose of Study Drug|Part A Fourth Intervention||0
3279199|NCT02714569|4012507|FG000|COMPLETED|Part A Fourth Intervention||3
3279200|NCT02714569|4012508|FG001|COMPLETED|Part A Fourth Intervention||2
3279201|NCT02714569|4012509|FG002|COMPLETED|Part A Fourth Intervention||3
3279202|NCT02714569|4012510|FG003|COMPLETED|Part A Fourth Intervention||2
3279203|NCT02714569|4012511|FG004|COMPLETED|Part A Fourth Intervention||3
3279204|NCT02714569|4012512|FG005|COMPLETED|Part A Fourth Intervention||2
3279205|NCT02714569|4012513|FG006|COMPLETED|Part A Fourth Intervention||0
3279206|NCT02714569|4012514|FG007|COMPLETED|Part A Fourth Intervention||0
3279207|NCT02714569|4012515|FG008|COMPLETED|Part A Fourth Intervention||0
3279208|NCT02714569|4012516|FG009|COMPLETED|Part A Fourth Intervention||0
3279209|NCT02714569|4012517|FG010|COMPLETED|Part A Fourth Intervention||0
3279210|NCT02714569|4012507|FG000|NOT COMPLETED|Part A Fourth Intervention||1
3279211|NCT02714569|4012508|FG001|NOT COMPLETED|Part A Fourth Intervention||0
3279212|NCT02714569|4012509|FG002|NOT COMPLETED|Part A Fourth Intervention||0
3279213|NCT02714569|4012510|FG003|NOT COMPLETED|Part A Fourth Intervention||0
3279214|NCT02714569|4012511|FG004|NOT COMPLETED|Part A Fourth Intervention||0
3279215|NCT02714569|4012512|FG005|NOT COMPLETED|Part A Fourth Intervention||1
3279216|NCT02714569|4012513|FG006|NOT COMPLETED|Part A Fourth Intervention||0
3279217|NCT02714569|4012514|FG007|NOT COMPLETED|Part A Fourth Intervention||0
3279218|NCT02714569|4012515|FG008|NOT COMPLETED|Part A Fourth Intervention||0
3279219|NCT02714569|4012516|FG009|NOT COMPLETED|Part A Fourth Intervention||0
3279220|NCT02714569|4012517|FG010|NOT COMPLETED|Part A Fourth Intervention||0
3279221|NCT02714569|4012507|FG000|STARTED|Part B (Overall)|Part A participants completed period 4 and were not in part B.|0
3279222|NCT02714569|4012508|FG001|STARTED|Part B (Overall)|Part A participants completed period 4 and were not in part B.|0
3048090|NCT01205776|3768051|FG001|COMPLETED|Overall Study||862
3048091|NCT01205776|3768050|FG000|NOT COMPLETED|Overall Study||64
3048092|NCT01205776|3768051|FG001|NOT COMPLETED|Overall Study||95
3048093|NCT01205828|3768057|FG000|STARTED|Overall Study||16
3048094|NCT01205828|3768057|FG000|COMPLETED|Overall Study|Completed the first stage of the study, terminated as pre-planned due to lack of efficacy|16
3048095|NCT01205828|3768057|FG000|NOT COMPLETED|Overall Study||0
3048096|NCT01206062|3768064|FG000|STARTED|Overall Study||4678
3048097|NCT01206062|3768065|FG001|STARTED|Overall Study||4683
3048098|NCT01206062|3768064|FG000|COMPLETED|Overall Study||4678
3048099|NCT01206062|3768065|FG001|COMPLETED|Overall Study||4683
3048100|NCT01206062|3768064|FG000|NOT COMPLETED|Overall Study||0
3048101|NCT01206062|3768065|FG001|NOT COMPLETED|Overall Study||0
3048102|NCT01206140|3768075|FG000|STARTED|Overall Study||35
3048103|NCT01206140|3768076|FG001|STARTED|Overall Study||35
3048104|NCT01206140|3768075|FG000|COMPLETED|Overall Study||34
3048105|NCT01206140|3768076|FG001|COMPLETED|Overall Study||35
3048106|NCT01206140|3768075|FG000|NOT COMPLETED|Overall Study||1
3048107|NCT01206140|3768076|FG001|NOT COMPLETED|Overall Study||0
3048108|NCT01206166|3768084|FG000|STARTED|Overall Study||73
3048109|NCT01206166|3768085|FG001|STARTED|Overall Study||52
3048110|NCT01206166|3768084|FG000|COMPLETED|Overall Study||71
3048111|NCT01206166|3768085|FG001|COMPLETED|Overall Study||49
3048112|NCT01206166|3768084|FG000|NOT COMPLETED|Overall Study||2
3048113|NCT01206166|3768085|FG001|NOT COMPLETED|Overall Study||3
3048114|NCT01206322|3768096|FG000|STARTED|Overall Study||4
3048115|NCT01206322|3768097|FG001|STARTED|Overall Study||11
3048116|NCT01206322|3768098|FG002|STARTED|Overall Study||9
3279223|NCT02714569|4012509|FG002|STARTED|Part B (Overall)|Part A participants completed period 4 and were not in part B.|0
3279224|NCT02714569|4012510|FG003|STARTED|Part B (Overall)|Part A participants completed period 4 and were not in part B.|0
3279225|NCT02714569|4012511|FG004|STARTED|Part B (Overall)|Part A participants completed period 4 and were not in part B.|0
3279226|NCT02714569|4012512|FG005|STARTED|Part B (Overall)|Part A participants completed period 4 and were not in part B.|0
3279227|NCT02714569|4012513|FG006|STARTED|Part B (Overall)|Part B participants randomized to receive 5 mg of LY3202328 + atorvastatin/simvastatin.|8
3279228|NCT02714569|4012514|FG007|STARTED|Part B (Overall)|Part B participants randomized to receive 20 mg of LY3202328 + atorvastatin/simvastatin.|8
3279229|NCT02714569|4012515|FG008|STARTED|Part B (Overall)|Part B participants randomized to receive 100 mg of LY3202328 + atorvastatin/simvastatin.|8
3279230|NCT02714569|4012516|FG009|STARTED|Part B (Overall)|Part B participants randomized to receive 300 mg of LY3202328 + atorvastatin/simvastatin.|8
3279231|NCT02714569|4012517|FG010|STARTED|Part B (Overall)|Part B participants randomized to receive placebo instead of LY3202328 + atorvastatin/simvastatin.|8
3279232|NCT02714569|4012507|FG000|COMPLETED|Part B (Overall)||0
3279233|NCT02714569|4012508|FG001|COMPLETED|Part B (Overall)||0
3279234|NCT02714569|4012509|FG002|COMPLETED|Part B (Overall)||0
3279235|NCT02714569|4012510|FG003|COMPLETED|Part B (Overall)||0
3279236|NCT02714569|4012511|FG004|COMPLETED|Part B (Overall)||0
3279237|NCT02714569|4012512|FG005|COMPLETED|Part B (Overall)||0
3279238|NCT02714569|4012513|FG006|COMPLETED|Part B (Overall)||7
3279239|NCT02714569|4012514|FG007|COMPLETED|Part B (Overall)||7
3279240|NCT02714569|4012515|FG008|COMPLETED|Part B (Overall)||8
3279241|NCT02714569|4012516|FG009|COMPLETED|Part B (Overall)||6
3279242|NCT02714569|4012517|FG010|COMPLETED|Part B (Overall)||8
3279243|NCT02714569|4012507|FG000|NOT COMPLETED|Part B (Overall)||0
3279244|NCT02714569|4012508|FG001|NOT COMPLETED|Part B (Overall)||0
3279245|NCT02714569|4012509|FG002|NOT COMPLETED|Part B (Overall)||0
3279246|NCT02714569|4012510|FG003|NOT COMPLETED|Part B (Overall)||0
3279247|NCT02714569|4012511|FG004|NOT COMPLETED|Part B (Overall)||0
3279248|NCT02714569|4012512|FG005|NOT COMPLETED|Part B (Overall)||0
3279249|NCT02714569|4012513|FG006|NOT COMPLETED|Part B (Overall)||1
3279250|NCT02714569|4012514|FG007|NOT COMPLETED|Part B (Overall)||1
3279251|NCT02714569|4012515|FG008|NOT COMPLETED|Part B (Overall)||0
3279252|NCT02714569|4012516|FG009|NOT COMPLETED|Part B (Overall)||2
3279253|NCT02714569|4012517|FG010|NOT COMPLETED|Part B (Overall)||0
3279254|NCT02714595|4012579|FG000|STARTED|Overall Study||101
3279255|NCT02714595|4012580|FG001|STARTED|Overall Study||51
3279256|NCT02714595|4012579|FG000|Received Treatment|Overall Study||101
3279257|NCT02714595|4012580|FG001|Received Treatment|Overall Study||49
3279258|NCT02714595|4012579|FG000|Carbapenem-resistant Microbiological Intent-to-treat|Overall Study||80
3279259|NCT02714595|4012580|FG001|Carbapenem-resistant Microbiological Intent-to-treat|Overall Study||38
3279260|NCT02714595|4012579|FG000|COMPLETED|Overall Study||69
3279261|NCT02714595|4012580|FG001|COMPLETED|Overall Study||38
3279262|NCT02714595|4012579|FG000|NOT COMPLETED|Overall Study||32
3279263|NCT02714595|4012580|FG001|NOT COMPLETED|Overall Study||13
3279264|NCT02714868|4012606|FG000|STARTED|Overall Study||47
3279265|NCT02714868|4012607|FG001|STARTED|Overall Study||35
3279266|NCT02714868|4012606|FG000|COMPLETED|Overall Study||42
3279267|NCT02714868|4012607|FG001|COMPLETED|Overall Study||35
3279268|NCT02714868|4012606|FG000|NOT COMPLETED|Overall Study||5
3279269|NCT02714868|4012607|FG001|NOT COMPLETED|Overall Study||0
3279270|NCT02715076|4012620|FG000|STARTED|Overall Study||48
3279271|NCT02715076|4012621|FG001|STARTED|Overall Study||50
3279272|NCT02715076|4012622|FG002|STARTED|Overall Study||49
3279273|NCT02715076|4012623|FG003|STARTED|Overall Study||50
3279274|NCT02715076|4012624|FG004|STARTED|Overall Study||47
3279275|NCT02715076|4012625|FG005|STARTED|Overall Study||48
3279276|NCT02715076|4012620|FG000|COMPLETED|Overall Study||48
3279277|NCT02715076|4012621|FG001|COMPLETED|Overall Study||50
3048117|NCT01206322|3768099|FG003|STARTED|Overall Study||6
3048118|NCT01206322|3768096|FG000|COMPLETED|Overall Study||4
3048119|NCT01206322|3768097|FG001|COMPLETED|Overall Study||11
3048120|NCT01206322|3768098|FG002|COMPLETED|Overall Study||9
3048121|NCT01206322|3768099|FG003|COMPLETED|Overall Study||5
3048122|NCT01206322|3768096|FG000|NOT COMPLETED|Overall Study||0
3048123|NCT01206322|3768097|FG001|NOT COMPLETED|Overall Study||0
3048124|NCT01206322|3768098|FG002|NOT COMPLETED|Overall Study||0
3048125|NCT01206322|3768099|FG003|NOT COMPLETED|Overall Study||1
3048126|NCT01206387|3768111|FG000|STARTED|Overall Study||60
3048127|NCT01206387|3768112|FG001|STARTED|Overall Study||60
3048128|NCT01206387|3768111|FG000|COMPLETED|Overall Study||59
3048129|NCT01206387|3768112|FG001|COMPLETED|Overall Study||60
3048130|NCT01206387|3768111|FG000|NOT COMPLETED|Overall Study||1
3048131|NCT01206387|3768112|FG001|NOT COMPLETED|Overall Study||0
3048132|NCT01206452|3768120|FG000|STARTED|Overall Study||30
3048133|NCT01206452|3768121|FG001|STARTED|Overall Study||30
3048134|NCT01206452|3768120|FG000|COMPLETED|Overall Study||30
3048135|NCT01206452|3768121|FG001|COMPLETED|Overall Study||30
3048136|NCT01206452|3768120|FG000|NOT COMPLETED|Overall Study||0
3048137|NCT01206452|3768121|FG001|NOT COMPLETED|Overall Study||0
3048138|NCT01206465|3768127|FG000|STARTED|Overall Study||3
3048139|NCT01206465|3768128|FG001|STARTED|Overall Study||6
3048140|NCT01206465|3768129|FG002|STARTED|Overall Study||6
3048141|NCT01206465|3768130|FG003|STARTED|Overall Study||6
3048142|NCT01206465|3768131|FG004|STARTED|Overall Study||6
3048143|NCT01206465|3768127|FG000|COMPLETED|Overall Study||3
3048144|NCT01206465|3768128|FG001|COMPLETED|Overall Study||6
3048145|NCT01206465|3768129|FG002|COMPLETED|Overall Study||6
3048146|NCT01206465|3768130|FG003|COMPLETED|Overall Study||6
3048147|NCT01206465|3768131|FG004|COMPLETED|Overall Study||6
3048148|NCT01206465|3768127|FG000|NOT COMPLETED|Overall Study||0
3048149|NCT01206465|3768128|FG001|NOT COMPLETED|Overall Study||0
3048150|NCT01206465|3768129|FG002|NOT COMPLETED|Overall Study||0
3048151|NCT01206465|3768130|FG003|NOT COMPLETED|Overall Study||0
3048152|NCT01206465|3768131|FG004|NOT COMPLETED|Overall Study||0
3048153|NCT01206478|3768149|FG000|STARTED|Overall Study||9
3279278|NCT02715076|4012622|FG002|COMPLETED|Overall Study||49
3279279|NCT02715076|4012623|FG003|COMPLETED|Overall Study||50
3279280|NCT02715076|4012624|FG004|COMPLETED|Overall Study||47
3279281|NCT02715076|4012625|FG005|COMPLETED|Overall Study||48
3279282|NCT02715076|4012620|FG000|NOT COMPLETED|Overall Study||0
3279283|NCT02715076|4012621|FG001|NOT COMPLETED|Overall Study||0
3279284|NCT02715076|4012622|FG002|NOT COMPLETED|Overall Study||0
3279285|NCT02715076|4012623|FG003|NOT COMPLETED|Overall Study||0
3279286|NCT02715076|4012624|FG004|NOT COMPLETED|Overall Study||0
3279287|NCT02715076|4012625|FG005|NOT COMPLETED|Overall Study||0
3279288|NCT02715258|4012641|FG000|STARTED|Overall Study||140
3279289|NCT02715258|4012642|FG001|STARTED|Overall Study||70
3279290|NCT02715258|4012641|FG000|Intent to Treat/Safety Analysis|Overall Study||138
3279291|NCT02715258|4012642|FG001|Intent to Treat/Safety Analysis|Overall Study||69
3279292|NCT02715258|4012641|FG000|COMPLETED|Overall Study||124
3279293|NCT02715258|4012642|FG001|COMPLETED|Overall Study||64
3279294|NCT02715258|4012641|FG000|NOT COMPLETED|Overall Study||16
3279295|NCT02715258|4012642|FG001|NOT COMPLETED|Overall Study||6
3279296|NCT02715700|4012648|FG000|STARTED|Overall Study||14
3279297|NCT02715700|4012648|FG000|COMPLETED|Overall Study||14
3279298|NCT02715700|4012648|FG000|NOT COMPLETED|Overall Study||0
3279299|NCT02715726|4012658|FG000|STARTED|Overall Study|Randomized|208
3279300|NCT02715726|4012659|FG001|STARTED|Overall Study|Randomized|407
3279301|NCT02715726|4012658|FG000|Treated|Overall Study||207
3279302|NCT02715726|4012659|FG001|Treated|Overall Study||405
3279303|NCT02715726|4012658|FG000|Safety Population|Overall Study||206
3279304|NCT02715726|4012659|FG001|Safety Population|Overall Study||406
3279305|NCT02715726|4012658|FG000|COMPLETED|Overall Study||190
3279306|NCT02715726|4012659|FG001|COMPLETED|Overall Study||380
3279307|NCT02715726|4012658|FG000|NOT COMPLETED|Overall Study||18
3279308|NCT02715726|4012659|FG001|NOT COMPLETED|Overall Study||27
3279309|NCT02715804|4012667|FG000|STARTED|Overall Study||327
3279310|NCT02715804|4012668|FG001|STARTED|Overall Study||165
3279311|NCT02715804|4012667|FG000|Received at Least 1 Dose of Study Drug|Overall Study||323
3279312|NCT02715804|4012668|FG001|Received at Least 1 Dose of Study Drug|Overall Study||158
3279313|NCT02715804|4012667|FG000|Safety Population|Overall Study|3 participants randomized to AG but received PAG|325
3279314|NCT02715804|4012668|FG001|Safety Population|Overall Study|1 participant randomized to PAG but received AG|156
3279315|NCT02715804|4012667|FG000|COMPLETED|Overall Study||98
3279316|NCT02715804|4012668|FG001|COMPLETED|Overall Study||52
3279317|NCT02715804|4012667|FG000|NOT COMPLETED|Overall Study||229
3279318|NCT02715804|4012668|FG001|NOT COMPLETED|Overall Study||113
3279319|NCT02716194|4012677|FG000|STARTED|Period 1 - ADVATE||11
3279320|NCT02716194|4012678|FG001|STARTED|Period 1 - ADVATE||16
3279321|NCT02716194|4012679|FG002|STARTED|Period 1 - ADVATE||13
3048154|NCT01206478|3768150|FG001|STARTED|Overall Study||12
3048155|NCT01206478|3768149|FG000|COMPLETED|Overall Study||7
3048156|NCT01206478|3768150|FG001|COMPLETED|Overall Study||7
3048157|NCT01206478|3768149|FG000|NOT COMPLETED|Overall Study||2
3048158|NCT01206478|3768150|FG001|NOT COMPLETED|Overall Study||5
3048159|NCT01206582|3768158|FG000|STARTED|Overall Study||11
3048160|NCT01206582|3768159|FG001|STARTED|Overall Study||9
3048161|NCT01206582|3768158|FG000|COMPLETED|Overall Study||9
3048162|NCT01206582|3768159|FG001|COMPLETED|Overall Study||7
3279322|NCT02716194|4012677|FG000|COMPLETED|Period 1 - ADVATE||10
3279323|NCT02716194|4012678|FG001|COMPLETED|Period 1 - ADVATE||15
3279324|NCT02716194|4012679|FG002|COMPLETED|Period 1 - ADVATE||13
3279325|NCT02716194|4012677|FG000|NOT COMPLETED|Period 1 - ADVATE||1
3279326|NCT02716194|4012678|FG001|NOT COMPLETED|Period 1 - ADVATE||1
3048163|NCT01206582|3768158|FG000|NOT COMPLETED|Overall Study||2
3048164|NCT01206582|3768159|FG001|NOT COMPLETED|Overall Study||2
3048165|NCT01206595|3768167|FG000|STARTED|Overall Study||38
3048166|NCT01206595|3768168|FG001|STARTED|Overall Study||20
3048167|NCT01206595|3768167|FG000|COMPLETED|Overall Study||38
3048168|NCT01206595|3768168|FG001|COMPLETED|Overall Study||20
3048169|NCT01206595|3768167|FG000|NOT COMPLETED|Overall Study||0
3048170|NCT01206595|3768168|FG001|NOT COMPLETED|Overall Study||0
3048171|NCT01206608|3768178|FG000|STARTED|Overall Study||20
3048172|NCT01206608|3768179|FG001|STARTED|Overall Study||20
3048173|NCT01206608|3768178|FG000|COMPLETED|Overall Study||20
3048174|NCT01206608|3768179|FG001|COMPLETED|Overall Study||20
3048175|NCT01206608|3768178|FG000|NOT COMPLETED|Overall Study||0
3048176|NCT01206608|3768179|FG001|NOT COMPLETED|Overall Study||0
3048177|NCT01206660|3768187|FG000|STARTED|Overall Study||60
3048178|NCT01206660|3768188|FG001|STARTED|Overall Study||60
3048179|NCT01206660|3768187|FG000|COMPLETED|Overall Study||60
3279327|NCT02716194|4012679|FG002|NOT COMPLETED|Period 1 - ADVATE||0
3279328|NCT02716194|4012677|FG000|STARTED|Period 2 - BAX 826||10
3279329|NCT02716194|4012678|FG001|STARTED|Period 2 - BAX 826||15
3279330|NCT02716194|4012679|FG002|STARTED|Period 2 - BAX 826||13
3279331|NCT02716194|4012677|FG000|COMPLETED|Period 2 - BAX 826||10
3279332|NCT02716194|4012678|FG001|COMPLETED|Period 2 - BAX 826||15
3279333|NCT02716194|4012679|FG002|COMPLETED|Period 2 - BAX 826||13
3279334|NCT02716194|4012677|FG000|NOT COMPLETED|Period 2 - BAX 826||0
3279335|NCT02716194|4012678|FG001|NOT COMPLETED|Period 2 - BAX 826||0
3279336|NCT02716194|4012679|FG002|NOT COMPLETED|Period 2 - BAX 826||0
3279337|NCT02716298|4012700|FG000|STARTED|First Intervention (1 Month)||25
3279338|NCT02716298|4012701|FG001|STARTED|First Intervention (1 Month)||24
3279339|NCT02716298|4012700|FG000|COMPLETED|First Intervention (1 Month)||24
3279340|NCT02716298|4012701|FG001|COMPLETED|First Intervention (1 Month)||23
3279341|NCT02716298|4012700|FG000|NOT COMPLETED|First Intervention (1 Month)||1
3279342|NCT02716298|4012701|FG001|NOT COMPLETED|First Intervention (1 Month)||1
3279343|NCT02716298|4012700|FG000|STARTED|Second Intervention (1 Month)||24
3279344|NCT02716298|4012701|FG001|STARTED|Second Intervention (1 Month)||23
3279345|NCT02716298|4012700|FG000|COMPLETED|Second Intervention (1 Month)||24
3279346|NCT02716298|4012701|FG001|COMPLETED|Second Intervention (1 Month)||23
3279347|NCT02716298|4012700|FG000|NOT COMPLETED|Second Intervention (1 Month)||0
3279348|NCT02716298|4012701|FG001|NOT COMPLETED|Second Intervention (1 Month)||0
3279349|NCT02716324|4012714|FG000|STARTED|Overall Study||149
3279350|NCT02716324|4012715|FG001|STARTED|Overall Study||154
3279351|NCT02716324|4012714|FG000|COMPLETED|Overall Study||130
3279352|NCT02716324|4012715|FG001|COMPLETED|Overall Study||143
3279353|NCT02716324|4012714|FG000|NOT COMPLETED|Overall Study||19
3279354|NCT02716324|4012715|FG001|NOT COMPLETED|Overall Study||11
3279355|NCT02716506|4012721|FG000|STARTED|Overall Study||3515
3279356|NCT02716506|4012721|FG000|6 Months|Overall Study|Patients that completed the questionnaires six months after the operation.|2528
3279357|NCT02716506|4012721|FG000|2 Years|Overall Study|Patients that completed the questionnaires two years after the operation.|2351
3279358|NCT02716506|4012721|FG000|COMPLETED|Overall Study||2351
3279359|NCT02716506|4012721|FG000|NOT COMPLETED|Overall Study||1164
3279360|NCT02716584|4012727|FG000|STARTED|Overall Study||35
3279361|NCT02716584|4012728|FG001|STARTED|Overall Study||18
3279362|NCT02716584|4012727|FG000|COMPLETED|Overall Study||27
3279363|NCT02716584|4012728|FG001|COMPLETED|Overall Study||13
3279364|NCT02716584|4012727|FG000|NOT COMPLETED|Overall Study||8
3279365|NCT02716584|4012728|FG001|NOT COMPLETED|Overall Study||5
3279366|NCT02716714|4012736|FG000|STARTED|Overall Study||67
3279367|NCT02716714|4012737|FG001|STARTED|Overall Study||10
3279368|NCT02716714|4012736|FG000|COMPLETED|Overall Study||55
3279369|NCT02716714|4012737|FG001|COMPLETED|Overall Study||8
3279370|NCT02716714|4012736|FG000|NOT COMPLETED|Overall Study||12
3279371|NCT02716714|4012737|FG001|NOT COMPLETED|Overall Study||2
3279372|NCT02716727|4012749|FG000|STARTED|Overall Study||7
3279373|NCT02716727|4012750|FG001|STARTED|Overall Study||9
3279374|NCT02716727|4012749|FG000|COMPLETED|Overall Study||7
3279375|NCT02716727|4012750|FG001|COMPLETED|Overall Study||9
3279376|NCT02716727|4012749|FG000|NOT COMPLETED|Overall Study||0
3279377|NCT02716727|4012750|FG001|NOT COMPLETED|Overall Study||0
3279378|NCT02716779|4012759|FG000|STARTED|Monotherapy||14
3279379|NCT02716779|4012760|FG001|STARTED|Monotherapy||26
3279380|NCT02716779|4012761|FG002|STARTED|Monotherapy||27
3279381|NCT02716779|4012759|FG000|COMPLETED|Monotherapy||14
3279382|NCT02716779|4012760|FG001|COMPLETED|Monotherapy||25
3279383|NCT02716779|4012761|FG002|COMPLETED|Monotherapy||26
3279384|NCT02716779|4012759|FG000|NOT COMPLETED|Monotherapy||0
3279385|NCT02716779|4012760|FG001|NOT COMPLETED|Monotherapy||1
3279386|NCT02716779|4012761|FG002|NOT COMPLETED|Monotherapy||1
3279387|NCT02716779|4012759|FG000|STARTED|Combination Therapy||14
3279388|NCT02716779|4012760|FG001|STARTED|Combination Therapy||25
3279389|NCT02716779|4012761|FG002|STARTED|Combination Therapy||26
3279390|NCT02716779|4012759|FG000|COMPLETED|Combination Therapy||14
3279391|NCT02716779|4012760|FG001|COMPLETED|Combination Therapy||23
3279392|NCT02716779|4012761|FG002|COMPLETED|Combination Therapy||25
3279393|NCT02716779|4012759|FG000|NOT COMPLETED|Combination Therapy||0
3279394|NCT02716779|4012760|FG001|NOT COMPLETED|Combination Therapy||2
3279395|NCT02716779|4012761|FG002|NOT COMPLETED|Combination Therapy||1
3279396|NCT02716805|4012775|FG000|STARTED|Overall Study||6
3048180|NCT01206660|3768188|FG001|COMPLETED|Overall Study||60
3048181|NCT01206660|3768187|FG000|NOT COMPLETED|Overall Study||0
3048182|NCT01206660|3768188|FG001|NOT COMPLETED|Overall Study||0
3048183|NCT01206738|3768197|FG000|STARTED|Overall Study||63
3048184|NCT01206738|3768198|FG001|STARTED|Overall Study||74
3048185|NCT01206738|3768199|FG002|STARTED|Overall Study||61
3048186|NCT01206738|3768197|FG000|COMPLETED|Overall Study||40
3048187|NCT01206738|3768198|FG001|COMPLETED|Overall Study||49
3048188|NCT01206738|3768199|FG002|COMPLETED|Overall Study||42
3048189|NCT01206738|3768197|FG000|NOT COMPLETED|Overall Study||23
3048190|NCT01206738|3768198|FG001|NOT COMPLETED|Overall Study||25
3048191|NCT01206738|3768199|FG002|NOT COMPLETED|Overall Study||19
3048192|NCT01206764|3768209|FG000|STARTED|Overall Study||142
3048193|NCT01206764|3768209|FG000|COMPLETED|Overall Study||4
3048194|NCT01206764|3768209|FG000|NOT COMPLETED|Overall Study||138
3048195|NCT01206777|3768213|FG000|STARTED|Overall Study||52
3048196|NCT01206777|3768213|FG000|Discontinued Trial and Deemed Ineligible|Overall Study||2
3048197|NCT01206777|3768213|FG000|COMPLETED|Overall Study||50
3048198|NCT01206777|3768213|FG000|NOT COMPLETED|Overall Study||2
3048199|NCT01206816|3768224|FG000|STARTED|Overall Study|Started=Treated|3
3048200|NCT01206816|3768225|FG001|STARTED|Overall Study|Started=Treated|3
3048201|NCT01206816|3768226|FG002|STARTED|Overall Study|Started=Treated|20
3048202|NCT01206816|3768227|FG003|STARTED|Overall Study|Started=Treated|3
3048203|NCT01206816|3768228|FG004|STARTED|Overall Study|Started=Treated|3
3048204|NCT01206816|3768229|FG005|STARTED|Overall Study|Started=Treated|19
3048205|NCT01206816|3768230|FG006|STARTED|Overall Study|Started=Treated|6
3048206|NCT01206816|3768224|FG000|COMPLETED|Overall Study||0
3048207|NCT01206816|3768225|FG001|COMPLETED|Overall Study||0
3048208|NCT01206816|3768226|FG002|COMPLETED|Overall Study|1pt dist.due to 'Other AE' for vol& since 'other' from aftb.1pt 'PD' for vol& since,'DLT' from aftb|0
3048209|NCT01206816|3768227|FG003|COMPLETED|Overall Study|1pt discontinue (dist.)due to 'PD' for vol.& since, 'Other AE' from aftb|0
3048210|NCT01206816|3768228|FG004|COMPLETED|Overall Study||0
3048211|NCT01206816|3768229|FG005|COMPLETED|Overall Study|1pt dist. due to 'PD' for vol & since, 'Other AE' from aftb|0
3048212|NCT01206816|3768230|FG006|COMPLETED|Overall Study|1pt dist. due to 'other AE' & 1pt 'other' for vol & since,'PD' from aftb.|0
3048213|NCT01206816|3768224|FG000|NOT COMPLETED|Overall Study||3
3048214|NCT01206816|3768225|FG001|NOT COMPLETED|Overall Study||3
3048215|NCT01206816|3768226|FG002|NOT COMPLETED|Overall Study||20
3048216|NCT01206816|3768227|FG003|NOT COMPLETED|Overall Study||3
3048217|NCT01206816|3768228|FG004|NOT COMPLETED|Overall Study||3
3048218|NCT01206816|3768229|FG005|NOT COMPLETED|Overall Study||19
3048219|NCT01206816|3768230|FG006|NOT COMPLETED|Overall Study||6
3048220|NCT01207219|3768253|FG000|STARTED|Overall Study||45
3048221|NCT01207219|3768254|FG001|STARTED|Overall Study||40
3048222|NCT01207219|3768255|FG002|STARTED|Overall Study||39
3048223|NCT01207219|3768253|FG000|Included in ITT Analysis|Overall Study||40
3048224|NCT01207219|3768254|FG001|Included in ITT Analysis|Overall Study||37
3048225|NCT01207219|3768255|FG002|Included in ITT Analysis|Overall Study||38
3048226|NCT01207219|3768253|FG000|COMPLETED|Overall Study||34
3048227|NCT01207219|3768254|FG001|COMPLETED|Overall Study||29
3048228|NCT01207219|3768255|FG002|COMPLETED|Overall Study||32
3160457|NCT01863771|3887575|FG000|NOT COMPLETED|Induction Phase||21
3160458|NCT01863771|3887576|FG001|NOT COMPLETED|Induction Phase||0
3160459|NCT01863771|3887577|FG002|NOT COMPLETED|Induction Phase||0
3279397|NCT02716805|4012776|FG001|STARTED|Overall Study||0
3279398|NCT02716805|4012777|FG002|STARTED|Overall Study||0
3279399|NCT02716805|4012778|FG003|STARTED|Overall Study||0
3279400|NCT02716805|4012775|FG000|COMPLETED|Overall Study||4
3279401|NCT02716805|4012776|FG001|COMPLETED|Overall Study||0
3279402|NCT02716805|4012777|FG002|COMPLETED|Overall Study||0
3279403|NCT02716805|4012778|FG003|COMPLETED|Overall Study||0
3279404|NCT02716805|4012775|FG000|NOT COMPLETED|Overall Study||2
3279405|NCT02716805|4012776|FG001|NOT COMPLETED|Overall Study||0
3279406|NCT02716805|4012777|FG002|NOT COMPLETED|Overall Study||0
3279407|NCT02716805|4012778|FG003|NOT COMPLETED|Overall Study||0
3279408|NCT02716818|4012784|FG000|STARTED|Overall Study||61
3279409|NCT02716818|4012785|FG001|STARTED|Overall Study||61
3279410|NCT02716818|4012784|FG000|COMPLETED|Overall Study||58
3279411|NCT02716818|4012785|FG001|COMPLETED|Overall Study||59
3279412|NCT02716818|4012784|FG000|NOT COMPLETED|Overall Study||3
3279413|NCT02716818|4012785|FG001|NOT COMPLETED|Overall Study||2
3279414|NCT02716896|4012815|FG000|STARTED|Overall Study||1
3279415|NCT02716896|4012816|FG001|STARTED|Overall Study||1
3279416|NCT02716896|4012815|FG000|COMPLETED|Overall Study||1
3279417|NCT02716896|4012816|FG001|COMPLETED|Overall Study||0
3279418|NCT02716896|4012815|FG000|NOT COMPLETED|Overall Study||0
3279419|NCT02716896|4012816|FG001|NOT COMPLETED|Overall Study||1
3279420|NCT02716987|4012828|FG000|STARTED|Overall Study||4
3279421|NCT02716987|4012829|FG001|STARTED|Overall Study||2
3279422|NCT02716987|4012830|FG002|STARTED|Overall Study||5
3279423|NCT02716987|4012831|FG003|STARTED|Overall Study||2
3048229|NCT01207219|3768253|FG000|NOT COMPLETED|Overall Study||11
3279424|NCT02716987|4012832|FG004|STARTED|Overall Study||6
3279425|NCT02716987|4012833|FG005|STARTED|Overall Study||1
3279426|NCT02716987|4012828|FG000|COMPLETED|Overall Study||4
3279427|NCT02716987|4012829|FG001|COMPLETED|Overall Study||2
3279428|NCT02716987|4012830|FG002|COMPLETED|Overall Study||4
3279429|NCT02716987|4012831|FG003|COMPLETED|Overall Study||2
3279430|NCT02716987|4012832|FG004|COMPLETED|Overall Study||5
3279431|NCT02716987|4012833|FG005|COMPLETED|Overall Study||0
3279432|NCT02716987|4012828|FG000|NOT COMPLETED|Overall Study||0
3279433|NCT02716987|4012829|FG001|NOT COMPLETED|Overall Study||0
3048230|NCT01207219|3768254|FG001|NOT COMPLETED|Overall Study||11
3048231|NCT01207219|3768255|FG002|NOT COMPLETED|Overall Study||7
3133772|NCT01697579|3858715|FG003|STARTED|Optional Extension-Cycles 2-6|27 participants from this arm in Cycle 1 entered optional Cycles 2-6 at 3 mg/kg|0
3133773|NCT01697579|3858716|FG004|STARTED|Optional Extension-Cycles 2-6|21 participants from this arm in Cycle 1 entered optional Cycles 2-6 at 3 mg/kg|0
3133774|NCT01697579|3858717|FG005|STARTED|Optional Extension-Cycles 2-6|Enrollment in Cycles 2-6 was optional.|47
3133775|NCT01697579|3858718|FG006|STARTED|Optional Extension-Cycles 2-6|Enrollment in Cycles 2-6 was optional.|106
3133776|NCT01697579|3858712|FG000|COMPLETED|Optional Extension-Cycles 2-6||0
3133777|NCT01697579|3858713|FG001|COMPLETED|Optional Extension-Cycles 2-6||0
3133778|NCT01697579|3858714|FG002|COMPLETED|Optional Extension-Cycles 2-6||0
3133779|NCT01697579|3858715|FG003|COMPLETED|Optional Extension-Cycles 2-6||0
3133780|NCT01697579|3858716|FG004|COMPLETED|Optional Extension-Cycles 2-6||0
3133781|NCT01697579|3858717|FG005|COMPLETED|Optional Extension-Cycles 2-6||12
3133782|NCT01697579|3858718|FG006|COMPLETED|Optional Extension-Cycles 2-6||37
3133783|NCT01697579|3858712|FG000|NOT COMPLETED|Optional Extension-Cycles 2-6||0
3133784|NCT01697579|3858713|FG001|NOT COMPLETED|Optional Extension-Cycles 2-6||0
3133785|NCT01697579|3858714|FG002|NOT COMPLETED|Optional Extension-Cycles 2-6||0
3133786|NCT01697579|3858715|FG003|NOT COMPLETED|Optional Extension-Cycles 2-6||0
3133787|NCT01697579|3858716|FG004|NOT COMPLETED|Optional Extension-Cycles 2-6||0
3133788|NCT01697579|3858717|FG005|NOT COMPLETED|Optional Extension-Cycles 2-6||35
3133789|NCT01697579|3858718|FG006|NOT COMPLETED|Optional Extension-Cycles 2-6||69
3133790|NCT01697592|3858756|FG000|STARTED|Phase A (Up to 24 Weeks)||126
3133791|NCT01697592|3858757|FG001|STARTED|Phase A (Up to 24 Weeks)||65
3133792|NCT01697592|3858758|FG002|STARTED|Phase A (Up to 24 Weeks)||66
3133793|NCT01697592|3858759|FG003|STARTED|Phase A (Up to 24 Weeks)||65
3133794|NCT01697592|3858760|FG004|STARTED|Phase A (Up to 24 Weeks)||67
3133795|NCT01697592|3858761|FG005|STARTED|Phase A (Up to 24 Weeks)||63
3133796|NCT01697592|3858762|FG006|STARTED|Phase A (Up to 24 Weeks)||34
3133797|NCT01697592|3858763|FG007|STARTED|Phase A (Up to 24 Weeks)||33
3133798|NCT01697592|3858764|FG008|STARTED|Phase A (Up to 24 Weeks)||34
3133799|NCT01697592|3858765|FG009|STARTED|Phase A (Up to 24 Weeks)||32
3133800|NCT01697592|3858756|FG000|COMPLETED|Phase A (Up to 24 Weeks)||123
3133801|NCT01697592|3858757|FG001|COMPLETED|Phase A (Up to 24 Weeks)||62
3133802|NCT01697592|3858758|FG002|COMPLETED|Phase A (Up to 24 Weeks)||65
3133803|NCT01697592|3858759|FG003|COMPLETED|Phase A (Up to 24 Weeks)||63
3133804|NCT01697592|3858760|FG004|COMPLETED|Phase A (Up to 24 Weeks)||67
3133805|NCT01697592|3858761|FG005|COMPLETED|Phase A (Up to 24 Weeks)||62
3133806|NCT01697592|3858762|FG006|COMPLETED|Phase A (Up to 24 Weeks)||32
3133807|NCT01697592|3858763|FG007|COMPLETED|Phase A (Up to 24 Weeks)||33
3133808|NCT01697592|3858764|FG008|COMPLETED|Phase A (Up to 24 Weeks)||34
3133809|NCT01697592|3858765|FG009|COMPLETED|Phase A (Up to 24 Weeks)||30
3133810|NCT01697592|3858756|FG000|NOT COMPLETED|Phase A (Up to 24 Weeks)||3
3133811|NCT01697592|3858757|FG001|NOT COMPLETED|Phase A (Up to 24 Weeks)||3
3133812|NCT01697592|3858758|FG002|NOT COMPLETED|Phase A (Up to 24 Weeks)||1
3133813|NCT01697592|3858759|FG003|NOT COMPLETED|Phase A (Up to 24 Weeks)||2
3133814|NCT01697592|3858760|FG004|NOT COMPLETED|Phase A (Up to 24 Weeks)||0
3133815|NCT01697592|3858761|FG005|NOT COMPLETED|Phase A (Up to 24 Weeks)||1
3133816|NCT01697592|3858762|FG006|NOT COMPLETED|Phase A (Up to 24 Weeks)||2
3133817|NCT01697592|3858763|FG007|NOT COMPLETED|Phase A (Up to 24 Weeks)||0
3133818|NCT01697592|3858764|FG008|NOT COMPLETED|Phase A (Up to 24 Weeks)||0
3133819|NCT01697592|3858765|FG009|NOT COMPLETED|Phase A (Up to 24 Weeks)||2
3133820|NCT01697592|3858756|FG000|STARTED|Phase B (Week 25 to Week 52)||123
3133821|NCT01697592|3858757|FG001|STARTED|Phase B (Week 25 to Week 52)||62
3133822|NCT01697592|3858758|FG002|STARTED|Phase B (Week 25 to Week 52)||65
3133823|NCT01697592|3858759|FG003|STARTED|Phase B (Week 25 to Week 52)||63
3133824|NCT01697592|3858760|FG004|STARTED|Phase B (Week 25 to Week 52)||67
3133825|NCT01697592|3858761|FG005|STARTED|Phase B (Week 25 to Week 52)||62
3133826|NCT01697592|3858762|FG006|STARTED|Phase B (Week 25 to Week 52)||32
3133827|NCT01697592|3858763|FG007|STARTED|Phase B (Week 25 to Week 52)||33
3133828|NCT01697592|3858764|FG008|STARTED|Phase B (Week 25 to Week 52)||34
3133829|NCT01697592|3858765|FG009|STARTED|Phase B (Week 25 to Week 52)||30
3133830|NCT01697592|3858756|FG000|COMPLETED|Phase B (Week 25 to Week 52)||118
3133831|NCT01697592|3858757|FG001|COMPLETED|Phase B (Week 25 to Week 52)||61
3133832|NCT01697592|3858758|FG002|COMPLETED|Phase B (Week 25 to Week 52)||64
3133833|NCT01697592|3858759|FG003|COMPLETED|Phase B (Week 25 to Week 52)||60
3133834|NCT01697592|3858760|FG004|COMPLETED|Phase B (Week 25 to Week 52)||67
3279434|NCT02716987|4012830|FG002|NOT COMPLETED|Overall Study||1
3279435|NCT02716987|4012831|FG003|NOT COMPLETED|Overall Study||0
3279436|NCT02716987|4012832|FG004|NOT COMPLETED|Overall Study||1
3279437|NCT02716987|4012833|FG005|NOT COMPLETED|Overall Study||1
3279438|NCT02717195|4012862|FG000|STARTED|Prospective Confirmation (PC) Period||711
3133835|NCT01697592|3858761|FG005|COMPLETED|Phase B (Week 25 to Week 52)||60
3133836|NCT01697592|3858762|FG006|COMPLETED|Phase B (Week 25 to Week 52)||31
3133837|NCT01697592|3858763|FG007|COMPLETED|Phase B (Week 25 to Week 52)||32
3133838|NCT01697592|3858764|FG008|COMPLETED|Phase B (Week 25 to Week 52)||32
3133839|NCT01697592|3858765|FG009|COMPLETED|Phase B (Week 25 to Week 52)||30
3133840|NCT01697592|3858756|FG000|NOT COMPLETED|Phase B (Week 25 to Week 52)||5
3133841|NCT01697592|3858757|FG001|NOT COMPLETED|Phase B (Week 25 to Week 52)||1
3279439|NCT02717195|4012863|FG001|STARTED|Prospective Confirmation (PC) Period||387
3048232|NCT01207388|3768263|FG000|STARTED|Overall Study||116
3048233|NCT01207388|3768263|FG000|COMPLETED|Overall Study||48
3048234|NCT01207388|3768263|FG000|NOT COMPLETED|Overall Study||68
3048235|NCT01207401|3768277|FG000|STARTED|Overall Study||26
3048236|NCT01207401|3768278|FG001|STARTED|Overall Study||24
3048237|NCT01207401|3768277|FG000|COMPLETED|Overall Study||26
3048238|NCT01207401|3768278|FG001|COMPLETED|Overall Study||24
3048239|NCT01207401|3768277|FG000|NOT COMPLETED|Overall Study||0
3048240|NCT01207401|3768278|FG001|NOT COMPLETED|Overall Study||0
3048241|NCT01207414|3768286|FG000|STARTED|Overall Study|Includes 1 patient randomized in error.|241
3048242|NCT01207414|3768287|FG001|STARTED|Overall Study||260
3048243|NCT01207414|3768286|FG000|Safety Population: Received Study Drug|Overall Study||240
3048244|NCT01207414|3768287|FG001|Safety Population: Received Study Drug|Overall Study||260
3048245|NCT01207414|3768286|FG000|COMPLETED|Overall Study||168
3048246|NCT01207414|3768287|FG001|COMPLETED|Overall Study||178
3048247|NCT01207414|3768286|FG000|NOT COMPLETED|Overall Study||73
3048248|NCT01207414|3768287|FG001|NOT COMPLETED|Overall Study||82
3048249|NCT01207427|3768296|FG000|STARTED|Run-in Placebo Period||43
3048250|NCT01207427|3768297|FG001|STARTED|Run-in Placebo Period||45
3048251|NCT01207427|3768298|FG002|STARTED|Run-in Placebo Period||43
3048252|NCT01207427|3768296|FG000|COMPLETED|Run-in Placebo Period||43
3048253|NCT01207427|3768297|FG001|COMPLETED|Run-in Placebo Period||45
3048254|NCT01207427|3768298|FG002|COMPLETED|Run-in Placebo Period||43
3048255|NCT01207427|3768296|FG000|NOT COMPLETED|Run-in Placebo Period||0
3048256|NCT01207427|3768297|FG001|NOT COMPLETED|Run-in Placebo Period||0
3048257|NCT01207427|3768298|FG002|NOT COMPLETED|Run-in Placebo Period||0
3048258|NCT01207427|3768296|FG000|STARTED|Double-blind Treatment Period||43
3048259|NCT01207427|3768297|FG001|STARTED|Double-blind Treatment Period||45
3048260|NCT01207427|3768298|FG002|STARTED|Double-blind Treatment Period||43
3048261|NCT01207427|3768296|FG000|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||43
3048262|NCT01207427|3768297|FG001|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||45
3048263|NCT01207427|3768298|FG002|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||43
3048264|NCT01207427|3768296|FG000|COMPLETED|Double-blind Treatment Period||40
3048265|NCT01207427|3768297|FG001|COMPLETED|Double-blind Treatment Period||43
3048266|NCT01207427|3768298|FG002|COMPLETED|Double-blind Treatment Period||41
3048267|NCT01207427|3768296|FG000|NOT COMPLETED|Double-blind Treatment Period||3
3048268|NCT01207427|3768297|FG001|NOT COMPLETED|Double-blind Treatment Period||2
3048269|NCT01207427|3768298|FG002|NOT COMPLETED|Double-blind Treatment Period||2
3048270|NCT01207427|3768296|FG000|STARTED|Run-out Placebo Period||40
3048271|NCT01207427|3768297|FG001|STARTED|Run-out Placebo Period||43
3048272|NCT01207427|3768298|FG002|STARTED|Run-out Placebo Period||41
3048273|NCT01207427|3768296|FG000|COMPLETED|Run-out Placebo Period||40
3048274|NCT01207427|3768297|FG001|COMPLETED|Run-out Placebo Period||43
3048275|NCT01207427|3768298|FG002|COMPLETED|Run-out Placebo Period||41
3048276|NCT01207427|3768296|FG000|NOT COMPLETED|Run-out Placebo Period||0
3048277|NCT01207427|3768297|FG001|NOT COMPLETED|Run-out Placebo Period||0
3048278|NCT01207427|3768298|FG002|NOT COMPLETED|Run-out Placebo Period||0
3048279|NCT01207440|3768313|FG000|STARTED|Overall Study||203
3048280|NCT01207440|3768314|FG001|STARTED|Overall Study||64
3048281|NCT01207440|3768315|FG002|STARTED|Overall Study||65
3048282|NCT01207440|3768316|FG003|STARTED|Overall Study||18
3048283|NCT01207440|3768317|FG004|STARTED|Overall Study||48
3048284|NCT01207440|3768318|FG005|STARTED|Overall Study||46
3048285|NCT01207440|3768319|FG006|STARTED|Overall Study||5
3048286|NCT01207440|3768313|FG000|COMPLETED|Overall Study||0
3048287|NCT01207440|3768314|FG001|COMPLETED|Overall Study||0
3048288|NCT01207440|3768315|FG002|COMPLETED|Overall Study||0
3048289|NCT01207440|3768316|FG003|COMPLETED|Overall Study||0
3048290|NCT01207440|3768317|FG004|COMPLETED|Overall Study||0
3048291|NCT01207440|3768318|FG005|COMPLETED|Overall Study||0
3048292|NCT01207440|3768319|FG006|COMPLETED|Overall Study||0
3048293|NCT01207440|3768313|FG000|NOT COMPLETED|Overall Study||203
3048294|NCT01207440|3768314|FG001|NOT COMPLETED|Overall Study||64
3048295|NCT01207440|3768315|FG002|NOT COMPLETED|Overall Study||65
3048296|NCT01207440|3768316|FG003|NOT COMPLETED|Overall Study||18
3048297|NCT01207440|3768317|FG004|NOT COMPLETED|Overall Study||48
3048298|NCT01207440|3768318|FG005|NOT COMPLETED|Overall Study||46
3048299|NCT01207440|3768319|FG006|NOT COMPLETED|Overall Study||5
3048300|NCT01207453|3768343|FG000|STARTED|First Intervention||23
3048301|NCT01207453|3768344|FG001|STARTED|First Intervention||18
3048302|NCT01207453|3768343|FG000|COMPLETED|First Intervention||21
3048303|NCT01207453|3768344|FG001|COMPLETED|First Intervention||17
3048304|NCT01207453|3768343|FG000|NOT COMPLETED|First Intervention||2
3048305|NCT01207453|3768344|FG001|NOT COMPLETED|First Intervention||1
3048306|NCT01207453|3768343|FG000|STARTED|Washout||21
3048307|NCT01207453|3768344|FG001|STARTED|Washout||17
3048308|NCT01207453|3768343|FG000|COMPLETED|Washout||19
3048309|NCT01207453|3768344|FG001|COMPLETED|Washout||17
3048310|NCT01207453|3768343|FG000|NOT COMPLETED|Washout||2
3048311|NCT01207453|3768344|FG001|NOT COMPLETED|Washout||0
3048312|NCT01207453|3768343|FG000|STARTED|2nd Intervention||19
3048313|NCT01207453|3768344|FG001|STARTED|2nd Intervention||17
3048314|NCT01207453|3768343|FG000|COMPLETED|2nd Intervention||17
3048315|NCT01207453|3768344|FG001|COMPLETED|2nd Intervention||15
3048316|NCT01207453|3768343|FG000|NOT COMPLETED|2nd Intervention||2
3048317|NCT01207453|3768344|FG001|NOT COMPLETED|2nd Intervention||2
3048318|NCT01207466|3768353|FG000|STARTED|Period 1, One Week of Wear||46
3048319|NCT01207466|3768354|FG001|STARTED|Period 1, One Week of Wear||48
3048320|NCT01207466|3768353|FG000|COMPLETED|Period 1, One Week of Wear|One participant discontinued between Period 1 and Period 2 due to inclusion/exclusion criteria.|46
3048321|NCT01207466|3768354|FG001|COMPLETED|Period 1, One Week of Wear||48
3048322|NCT01207466|3768353|FG000|NOT COMPLETED|Period 1, One Week of Wear||0
3279440|NCT02717195|4012864|FG002|STARTED|Prospective Confirmation (PC) Period||0
3279441|NCT02717195|4012865|FG003|STARTED|Prospective Confirmation (PC) Period||0
3279442|NCT02717195|4012866|FG004|STARTED|Prospective Confirmation (PC) Period||0
3279443|NCT02717195|4012862|FG000|COMPLETED|Prospective Confirmation (PC) Period||421
3279444|NCT02717195|4012863|FG001|COMPLETED|Prospective Confirmation (PC) Period||276
3279445|NCT02717195|4012864|FG002|COMPLETED|Prospective Confirmation (PC) Period||0
3279446|NCT02717195|4012865|FG003|COMPLETED|Prospective Confirmation (PC) Period||0
3279447|NCT02717195|4012866|FG004|COMPLETED|Prospective Confirmation (PC) Period||0
3279448|NCT02717195|4012862|FG000|NOT COMPLETED|Prospective Confirmation (PC) Period||290
3279449|NCT02717195|4012863|FG001|NOT COMPLETED|Prospective Confirmation (PC) Period||111
3279450|NCT02717195|4012864|FG002|NOT COMPLETED|Prospective Confirmation (PC) Period||0
3279451|NCT02717195|4012865|FG003|NOT COMPLETED|Prospective Confirmation (PC) Period||0
3279452|NCT02717195|4012866|FG004|NOT COMPLETED|Prospective Confirmation (PC) Period||0
3279453|NCT02717195|4012862|FG000|STARTED|Double-blind Treatment (DBT) Period||0
3279454|NCT02717195|4012863|FG001|STARTED|Double-blind Treatment (DBT) Period||0
3279455|NCT02717195|4012864|FG002|STARTED|Double-blind Treatment (DBT) Period||235
3279456|NCT02717195|4012865|FG003|STARTED|Double-blind Treatment (DBT) Period||232
3279457|NCT02717195|4012866|FG004|STARTED|Double-blind Treatment (DBT) Period||230
3279458|NCT02717195|4012862|FG000|COMPLETED|Double-blind Treatment (DBT) Period||0
3279459|NCT02717195|4012863|FG001|COMPLETED|Double-blind Treatment (DBT) Period||0
3279460|NCT02717195|4012864|FG002|COMPLETED|Double-blind Treatment (DBT) Period||198
3279461|NCT02717195|4012865|FG003|COMPLETED|Double-blind Treatment (DBT) Period||188
3279462|NCT02717195|4012866|FG004|COMPLETED|Double-blind Treatment (DBT) Period||200
3279463|NCT02717195|4012862|FG000|NOT COMPLETED|Double-blind Treatment (DBT) Period||0
3279464|NCT02717195|4012863|FG001|NOT COMPLETED|Double-blind Treatment (DBT) Period||0
3279465|NCT02717195|4012864|FG002|NOT COMPLETED|Double-blind Treatment (DBT) Period||37
3279466|NCT02717195|4012865|FG003|NOT COMPLETED|Double-blind Treatment (DBT) Period||44
3279467|NCT02717195|4012866|FG004|NOT COMPLETED|Double-blind Treatment (DBT) Period||30
3279468|NCT02717273|4012881|FG000|STARTED|Overall Study||52
3279469|NCT02717273|4012882|FG001|STARTED|Overall Study||50
3279470|NCT02717273|4012881|FG000|COMPLETED|Overall Study||49
3279471|NCT02717273|4012882|FG001|COMPLETED|Overall Study||48
3279472|NCT02717273|4012881|FG000|NOT COMPLETED|Overall Study||3
3279473|NCT02717273|4012882|FG001|NOT COMPLETED|Overall Study||2
3279474|NCT02717494|4012891|FG000|STARTED|First Intervention (Step 1)||115
3279475|NCT02717494|4012892|FG001|STARTED|First Intervention (Step 1)||115
3279476|NCT02717494|4012893|FG002|STARTED|First Intervention (Step 1)||116
3279477|NCT02717494|4012891|FG000|Were Randomized to Step 2A (PPV-23)|First Intervention (Step 1)||0
3279478|NCT02717494|4012892|FG001|Were Randomized to Step 2A (PPV-23)|First Intervention (Step 1)||0
3279479|NCT02717494|4012893|FG002|Were Randomized to Step 2A (PPV-23)|First Intervention (Step 1)||53
3279480|NCT02717494|4012891|FG000|Were Randomized to Step 2B (PCV-10)|First Intervention (Step 1)||0
3279481|NCT02717494|4012892|FG001|Were Randomized to Step 2B (PCV-10)|First Intervention (Step 1)||0
3279482|NCT02717494|4012893|FG002|Were Randomized to Step 2B (PCV-10)|First Intervention (Step 1)||53
3279483|NCT02717494|4012891|FG000|Were Enrolled in Step 3 (PCV-10)|First Intervention (Step 1)||0
3279484|NCT02717494|4012892|FG001|Were Enrolled in Step 3 (PCV-10)|First Intervention (Step 1)||0
3279485|NCT02717494|4012893|FG002|Were Enrolled in Step 3 (PCV-10)|First Intervention (Step 1)||4
3279486|NCT02717494|4012891|FG000|COMPLETED|First Intervention (Step 1)||109
3279487|NCT02717494|4012892|FG001|COMPLETED|First Intervention (Step 1)||108
3279488|NCT02717494|4012893|FG002|COMPLETED|First Intervention (Step 1)||111
3279489|NCT02717494|4012891|FG000|NOT COMPLETED|First Intervention (Step 1)||6
3279490|NCT02717494|4012892|FG001|NOT COMPLETED|First Intervention (Step 1)||7
3279491|NCT02717494|4012893|FG002|NOT COMPLETED|First Intervention (Step 1)||5
3279492|NCT02717494|4012891|FG000|STARTED|Second Intervention (Step 2 or Step 3)|Only Step 1 placebo recipients were enrolled in Step 2.|0
3279493|NCT02717494|4012892|FG001|STARTED|Second Intervention (Step 2 or Step 3)|Only Step 1 placebo recipients were enrolled in Step 2.|0
3279494|NCT02717494|4012893|FG002|STARTED|Second Intervention (Step 2 or Step 3)|One participant who completed Step 1 did not enroll in Step 2.|110
3279495|NCT02717494|4012891|FG000|Completed Step 2A|Second Intervention (Step 2 or Step 3)||0
3279496|NCT02717494|4012892|FG001|Completed Step 2A|Second Intervention (Step 2 or Step 3)||0
3279497|NCT02717494|4012893|FG002|Completed Step 2A|Second Intervention (Step 2 or Step 3)||52
3279498|NCT02717494|4012891|FG000|Completed Step 2B|Second Intervention (Step 2 or Step 3)||0
3279499|NCT02717494|4012892|FG001|Completed Step 2B|Second Intervention (Step 2 or Step 3)||0
3279500|NCT02717494|4012893|FG002|Completed Step 2B|Second Intervention (Step 2 or Step 3)||50
3279501|NCT02717494|4012891|FG000|Completed Step 3|Second Intervention (Step 2 or Step 3)||0
3279502|NCT02717494|4012892|FG001|Completed Step 3|Second Intervention (Step 2 or Step 3)||0
3279503|NCT02717494|4012893|FG002|Completed Step 3|Second Intervention (Step 2 or Step 3)||4
3279504|NCT02717494|4012891|FG000|COMPLETED|Second Intervention (Step 2 or Step 3)||0
3279505|NCT02717494|4012892|FG001|COMPLETED|Second Intervention (Step 2 or Step 3)||0
3279506|NCT02717494|4012893|FG002|COMPLETED|Second Intervention (Step 2 or Step 3)||106
3279507|NCT02717494|4012891|FG000|NOT COMPLETED|Second Intervention (Step 2 or Step 3)||0
3048323|NCT01207466|3768354|FG001|NOT COMPLETED|Period 1, One Week of Wear||0
3048324|NCT01207466|3768353|FG000|STARTED|Period 2, One Week of Wear||45
3048325|NCT01207466|3768354|FG001|STARTED|Period 2, One Week of Wear||48
3048326|NCT01207466|3768353|FG000|COMPLETED|Period 2, One Week of Wear||45
3048327|NCT01207466|3768354|FG001|COMPLETED|Period 2, One Week of Wear||48
3048328|NCT01207466|3768353|FG000|NOT COMPLETED|Period 2, One Week of Wear||0
3048329|NCT01207466|3768354|FG001|NOT COMPLETED|Period 2, One Week of Wear||0
3048330|NCT01207570|3768362|FG000|STARTED|The First Stage (Before Crossover)||23
3048331|NCT01207570|3768363|FG001|STARTED|The First Stage (Before Crossover)||31
3048332|NCT01207570|3768362|FG000|COMPLETED|The First Stage (Before Crossover)||23
3048333|NCT01207570|3768363|FG001|COMPLETED|The First Stage (Before Crossover)||31
3048334|NCT01207570|3768362|FG000|NOT COMPLETED|The First Stage (Before Crossover)||0
3048335|NCT01207570|3768363|FG001|NOT COMPLETED|The First Stage (Before Crossover)||0
3048336|NCT01207570|3768362|FG000|STARTED|The Second Stage (After Crossover)||31
3048337|NCT01207570|3768363|FG001|STARTED|The Second Stage (After Crossover)||23
3048338|NCT01207570|3768362|FG000|COMPLETED|The Second Stage (After Crossover)||31
3048339|NCT01207570|3768363|FG001|COMPLETED|The Second Stage (After Crossover)||23
3048340|NCT01207570|3768362|FG000|NOT COMPLETED|The Second Stage (After Crossover)||0
3048341|NCT01207570|3768363|FG001|NOT COMPLETED|The Second Stage (After Crossover)||0
3048342|NCT01207583|3768374|FG000|STARTED|Overall Study||14
3048343|NCT01207583|3768375|FG001|STARTED|Overall Study||31
3048344|NCT01207583|3768376|FG002|STARTED|Overall Study||55
3048345|NCT01207583|3768374|FG000|Dose 1|Overall Study||14
3048346|NCT01207583|3768375|FG001|Dose 1|Overall Study||31
3048347|NCT01207583|3768376|FG002|Dose 1|Overall Study||55
3048348|NCT01207583|3768374|FG000|Dose 2|Overall Study||13
3048349|NCT01207583|3768375|FG001|Dose 2|Overall Study||29
3048350|NCT01207583|3768376|FG002|Dose 2|Overall Study||54
3048351|NCT01207583|3768374|FG000|Dose 3|Overall Study||13
3048352|NCT01207583|3768375|FG001|Dose 3|Overall Study||27
3048353|NCT01207583|3768376|FG002|Dose 3|Overall Study||0
3048354|NCT01207583|3768374|FG000|Dose 4|Overall Study||7
3048355|NCT01207583|3768375|FG001|Dose 4|Overall Study||0
3048356|NCT01207583|3768376|FG002|Dose 4|Overall Study||0
3048357|NCT01207583|3768374|FG000|COMPLETED|Overall Study||13
3048358|NCT01207583|3768375|FG001|COMPLETED|Overall Study||26
3048359|NCT01207583|3768376|FG002|COMPLETED|Overall Study||54
3048360|NCT01207583|3768374|FG000|NOT COMPLETED|Overall Study||1
3048361|NCT01207583|3768375|FG001|NOT COMPLETED|Overall Study||5
3048362|NCT01207583|3768376|FG002|NOT COMPLETED|Overall Study||1
3048363|NCT01207596|3768397|FG000|STARTED|Overall Study||30
3048364|NCT01207596|3768397|FG000|COMPLETED|Overall Study||21
3048365|NCT01207596|3768397|FG000|NOT COMPLETED|Overall Study||9
3048366|NCT01207648|3768401|FG000|STARTED|Overall Study||307
3048367|NCT01207648|3768401|FG000|COMPLETED|Overall Study||307
3048368|NCT01207648|3768401|FG000|NOT COMPLETED|Overall Study||0
3048369|NCT01207687|3768405|FG000|STARTED|Overall Study||14
3048370|NCT01207687|3768405|FG000|COMPLETED|Overall Study||12
3048371|NCT01207687|3768405|FG000|NOT COMPLETED|Overall Study||2
3048372|NCT01207752|3768417|FG000|STARTED|Overall Study||35
3048373|NCT01207752|3768418|FG001|STARTED|Overall Study||34
3048374|NCT01207752|3768417|FG000|COMPLETED|Overall Study||33
3048375|NCT01207752|3768418|FG001|COMPLETED|Overall Study||27
3048376|NCT01207752|3768417|FG000|NOT COMPLETED|Overall Study||2
3048377|NCT01207752|3768418|FG001|NOT COMPLETED|Overall Study||7
3048378|NCT01207765|3768424|FG000|STARTED|Overall Study||8
3048379|NCT01207765|3768424|FG000|COMPLETED|Overall Study||8
3048380|NCT01207765|3768424|FG000|NOT COMPLETED|Overall Study||0
3048381|NCT01207908|3768430|FG000|STARTED|Overall Study||22
3279508|NCT02717494|4012892|FG001|NOT COMPLETED|Second Intervention (Step 2 or Step 3)||0
3279509|NCT02717494|4012893|FG002|NOT COMPLETED|Second Intervention (Step 2 or Step 3)||4
3279510|NCT02717546|4012919|FG000|STARTED|Overall Study||32
3279511|NCT02717546|4012919|FG000|COMPLETED|Overall Study||20
3279512|NCT02717546|4012919|FG000|NOT COMPLETED|Overall Study||12
3279513|NCT02717754|4012929|FG000|STARTED|Overall Study||10
3279514|NCT02717754|4012930|FG001|STARTED|Overall Study||19
3279515|NCT02717754|4012931|FG002|STARTED|Overall Study||20
3279516|NCT02717754|4012932|FG003|STARTED|Overall Study||10
3279517|NCT02717754|4012933|FG004|STARTED|Overall Study||20
3279518|NCT02717754|4012934|FG005|STARTED|Overall Study||20
3279519|NCT02717754|4012929|FG000|COMPLETED|Overall Study||10
3279520|NCT02717754|4012930|FG001|COMPLETED|Overall Study||19
3279521|NCT02717754|4012931|FG002|COMPLETED|Overall Study||20
3279522|NCT02717754|4012932|FG003|COMPLETED|Overall Study||0
3279523|NCT02717754|4012933|FG004|COMPLETED|Overall Study||0
3279524|NCT02717754|4012934|FG005|COMPLETED|Overall Study||0
3279525|NCT02717754|4012929|FG000|NOT COMPLETED|Overall Study||0
3279526|NCT02717754|4012930|FG001|NOT COMPLETED|Overall Study||0
3279527|NCT02717754|4012931|FG002|NOT COMPLETED|Overall Study||0
3279528|NCT02717754|4012932|FG003|NOT COMPLETED|Overall Study||10
3279529|NCT02717754|4012933|FG004|NOT COMPLETED|Overall Study||20
3048382|NCT01207908|3768431|FG001|STARTED|Overall Study||22
3048383|NCT01207908|3768430|FG000|COMPLETED|Overall Study||17
3048384|NCT01207908|3768431|FG001|COMPLETED|Overall Study||21
3048385|NCT01207908|3768430|FG000|NOT COMPLETED|Overall Study||5
3048386|NCT01207908|3768431|FG001|NOT COMPLETED|Overall Study||1
3048387|NCT01207934|3768440|FG000|STARTED|Overall Study||6
3048388|NCT01207934|3768441|FG001|STARTED|Overall Study||6
3048389|NCT01207934|3768442|FG002|STARTED|Overall Study||6
3048390|NCT01207934|3768440|FG000|COMPLETED|Overall Study||6
3048391|NCT01207934|3768441|FG001|COMPLETED|Overall Study||6
3048392|NCT01207934|3768442|FG002|COMPLETED|Overall Study||6
3048393|NCT01207934|3768440|FG000|NOT COMPLETED|Overall Study||0
3048394|NCT01207934|3768441|FG001|NOT COMPLETED|Overall Study||0
3048395|NCT01207934|3768442|FG002|NOT COMPLETED|Overall Study||0
3048396|NCT01208038|3768450|FG000|STARTED|Overall Study||22
3048397|NCT01208038|3768450|FG000|COMPLETED|Overall Study|Patient withdrew before commencing study drug|21
3048398|NCT01208038|3768450|FG000|NOT COMPLETED|Overall Study||1
3048399|NCT01208051|3768459|FG000|STARTED|Total Enrollment||4
3048400|NCT01208051|3768460|FG001|STARTED|Total Enrollment||7
3048401|NCT01208051|3768461|FG002|STARTED|Total Enrollment||6
3160460|NCT01863771|3887578|FG003|NOT COMPLETED|Induction Phase||0
3160461|NCT01863771|3887575|FG000|STARTED|Maintenance Phase||0
3279530|NCT02717754|4012934|FG005|NOT COMPLETED|Overall Study||20
3048402|NCT01208051|3768462|FG003|STARTED|Total Enrollment||39
3048403|NCT01208051|3768463|FG004|STARTED|Total Enrollment||71
3048404|NCT01208051|3768459|FG000|COMPLETED|Total Enrollment||4
3048405|NCT01208051|3768460|FG001|COMPLETED|Total Enrollment||6
3048406|NCT01208051|3768461|FG002|COMPLETED|Total Enrollment||5
3048407|NCT01208051|3768462|FG003|COMPLETED|Total Enrollment||39
3048408|NCT01208051|3768463|FG004|COMPLETED|Total Enrollment||69
3048409|NCT01208051|3768459|FG000|NOT COMPLETED|Total Enrollment||0
3048410|NCT01208051|3768460|FG001|NOT COMPLETED|Total Enrollment||1
3048411|NCT01208051|3768461|FG002|NOT COMPLETED|Total Enrollment||1
3048412|NCT01208051|3768462|FG003|NOT COMPLETED|Total Enrollment||0
3048413|NCT01208051|3768463|FG004|NOT COMPLETED|Total Enrollment||2
3048414|NCT01208051|3768459|FG000|STARTED|Interim Futility Analysis||0
3048415|NCT01208051|3768460|FG001|STARTED|Interim Futility Analysis||0
3048416|NCT01208051|3768461|FG002|STARTED|Interim Futility Analysis||0
3048417|NCT01208051|3768462|FG003|STARTED|Interim Futility Analysis||39
3048418|NCT01208051|3768463|FG004|STARTED|Interim Futility Analysis||68
3048419|NCT01208051|3768459|FG000|COMPLETED|Interim Futility Analysis||0
3048420|NCT01208051|3768460|FG001|COMPLETED|Interim Futility Analysis||0
3048421|NCT01208051|3768461|FG002|COMPLETED|Interim Futility Analysis||0
3048422|NCT01208051|3768462|FG003|COMPLETED|Interim Futility Analysis||39
3048423|NCT01208051|3768463|FG004|COMPLETED|Interim Futility Analysis||68
3048424|NCT01208051|3768459|FG000|NOT COMPLETED|Interim Futility Analysis||0
3048425|NCT01208051|3768460|FG001|NOT COMPLETED|Interim Futility Analysis||0
3048426|NCT01208051|3768461|FG002|NOT COMPLETED|Interim Futility Analysis||0
3048427|NCT01208051|3768462|FG003|NOT COMPLETED|Interim Futility Analysis||0
3048428|NCT01208051|3768463|FG004|NOT COMPLETED|Interim Futility Analysis||0
3048429|NCT01208051|3768459|FG000|STARTED|After Crossover to Cediranib Only||0
3048430|NCT01208051|3768460|FG001|STARTED|After Crossover to Cediranib Only||0
3048431|NCT01208051|3768461|FG002|STARTED|After Crossover to Cediranib Only||0
3048432|NCT01208051|3768462|FG003|STARTED|After Crossover to Cediranib Only||39
3048433|NCT01208051|3768463|FG004|STARTED|After Crossover to Cediranib Only|One patient entered while futility analysis was ongoing.|69
3048434|NCT01208051|3768459|FG000|COMPLETED|After Crossover to Cediranib Only||0
3048435|NCT01208051|3768460|FG001|COMPLETED|After Crossover to Cediranib Only||0
3048436|NCT01208051|3768461|FG002|COMPLETED|After Crossover to Cediranib Only||0
3048437|NCT01208051|3768462|FG003|COMPLETED|After Crossover to Cediranib Only||39
3048438|NCT01208051|3768463|FG004|COMPLETED|After Crossover to Cediranib Only||69
3048439|NCT01208051|3768459|FG000|NOT COMPLETED|After Crossover to Cediranib Only||0
3048440|NCT01208051|3768460|FG001|NOT COMPLETED|After Crossover to Cediranib Only||0
3048441|NCT01208051|3768461|FG002|NOT COMPLETED|After Crossover to Cediranib Only||0
3048442|NCT01208051|3768462|FG003|NOT COMPLETED|After Crossover to Cediranib Only||0
3048443|NCT01208051|3768463|FG004|NOT COMPLETED|After Crossover to Cediranib Only||0
3048444|NCT01208103|3768479|FG000|STARTED|Overall Study||30
3048445|NCT01208103|3768479|FG000|COMPLETED|Overall Study||28
3048446|NCT01208103|3768479|FG000|NOT COMPLETED|Overall Study||2
3048447|NCT01208220|3768486|FG000|STARTED|Overall Study||1
3048448|NCT01208220|3768487|FG001|STARTED|Overall Study||1
3048449|NCT01208220|3768486|FG000|COMPLETED|Overall Study||1
3048450|NCT01208220|3768487|FG001|COMPLETED|Overall Study||1
3048451|NCT01208220|3768486|FG000|NOT COMPLETED|Overall Study||0
3048452|NCT01208220|3768487|FG001|NOT COMPLETED|Overall Study||0
3048453|NCT01208233|3768499|FG000|STARTED|Overall Study||11
3048454|NCT01208233|3768500|FG001|STARTED|Overall Study||9
3048455|NCT01208233|3768501|FG002|STARTED|Overall Study||11
3048456|NCT01208233|3768502|FG003|STARTED|Overall Study||10
3048457|NCT01208233|3768503|FG004|STARTED|Overall Study||70
3048458|NCT01208233|3768504|FG005|STARTED|Overall Study||67
3048459|NCT01208233|3768499|FG000|COMPLETED|Overall Study||6
3048460|NCT01208233|3768500|FG001|COMPLETED|Overall Study||6
3048461|NCT01208233|3768501|FG002|COMPLETED|Overall Study||7
3048462|NCT01208233|3768502|FG003|COMPLETED|Overall Study||9
3048463|NCT01208233|3768503|FG004|COMPLETED|Overall Study||46
3048464|NCT01208233|3768504|FG005|COMPLETED|Overall Study||46
3279531|NCT02718040|4012944|FG000|STARTED|Overall Study||30
3279532|NCT02718040|4012944|FG000|COMPLETED|Overall Study||30
3279533|NCT02718040|4012944|FG000|NOT COMPLETED|Overall Study||0
3279534|NCT02718118|4012950|FG000|STARTED|Overall Study||30
3279535|NCT02718118|4012951|FG001|STARTED|Overall Study||30
3048465|NCT01208233|3768499|FG000|NOT COMPLETED|Overall Study||5
3048466|NCT01208233|3768500|FG001|NOT COMPLETED|Overall Study||3
3160462|NCT01863771|3887576|FG001|STARTED|Maintenance Phase||32
3160463|NCT01863771|3887577|FG002|STARTED|Maintenance Phase||31
3048467|NCT01208233|3768501|FG002|NOT COMPLETED|Overall Study||4
3048468|NCT01208233|3768502|FG003|NOT COMPLETED|Overall Study||1
3048469|NCT01208233|3768503|FG004|NOT COMPLETED|Overall Study||24
3048470|NCT01208233|3768504|FG005|NOT COMPLETED|Overall Study||21
3048471|NCT01208324|3768528|FG000|STARTED|Pre-randomization of Patch||14
3048472|NCT01208324|3768529|FG001|STARTED|Pre-randomization of Patch||15
3048473|NCT01208324|3768530|FG002|STARTED|Pre-randomization of Patch||10
3048474|NCT01208324|3768531|FG003|STARTED|Pre-randomization of Patch||8
3048475|NCT01208324|3768528|FG000|Test Day 1|Pre-randomization of Patch||14
3048476|NCT01208324|3768529|FG001|Test Day 1|Pre-randomization of Patch||15
3048477|NCT01208324|3768530|FG002|Test Day 1|Pre-randomization of Patch||10
3048478|NCT01208324|3768531|FG003|Test Day 1|Pre-randomization of Patch||8
3048479|NCT01208324|3768528|FG000|Test Day 2|Pre-randomization of Patch||14
3048480|NCT01208324|3768529|FG001|Test Day 2|Pre-randomization of Patch||15
3048481|NCT01208324|3768530|FG002|Test Day 2|Pre-randomization of Patch||8
3048482|NCT01208324|3768531|FG003|Test Day 2|Pre-randomization of Patch||5
3048483|NCT01208324|3768528|FG000|COMPLETED|Pre-randomization of Patch||14
3048484|NCT01208324|3768529|FG001|COMPLETED|Pre-randomization of Patch||15
3048485|NCT01208324|3768530|FG002|COMPLETED|Pre-randomization of Patch||8
3048486|NCT01208324|3768531|FG003|COMPLETED|Pre-randomization of Patch||5
3048487|NCT01208324|3768528|FG000|NOT COMPLETED|Pre-randomization of Patch||0
3048488|NCT01208324|3768529|FG001|NOT COMPLETED|Pre-randomization of Patch||0
3048489|NCT01208324|3768530|FG002|NOT COMPLETED|Pre-randomization of Patch||2
3048490|NCT01208324|3768531|FG003|NOT COMPLETED|Pre-randomization of Patch||3
3048491|NCT01208324|3768528|FG000|STARTED|Post-randomization of Patch||14
3048492|NCT01208324|3768529|FG001|STARTED|Post-randomization of Patch||15
3048493|NCT01208324|3768530|FG002|STARTED|Post-randomization of Patch||8
3048494|NCT01208324|3768531|FG003|STARTED|Post-randomization of Patch||5
3048495|NCT01208324|3768528|FG000|Test Day 3|Post-randomization of Patch||13
3048496|NCT01208324|3768529|FG001|Test Day 3|Post-randomization of Patch||15
3048497|NCT01208324|3768530|FG002|Test Day 3|Post-randomization of Patch||8
3048498|NCT01208324|3768531|FG003|Test Day 3|Post-randomization of Patch||5
3048499|NCT01208324|3768528|FG000|Test Day 4|Post-randomization of Patch||13
3048500|NCT01208324|3768529|FG001|Test Day 4|Post-randomization of Patch||15
3048501|NCT01208324|3768530|FG002|Test Day 4|Post-randomization of Patch||8
3279536|NCT02718118|4012950|FG000|COMPLETED|Overall Study||28
3279537|NCT02718118|4012951|FG001|COMPLETED|Overall Study||29
3279538|NCT02718118|4012950|FG000|NOT COMPLETED|Overall Study||2
3279539|NCT02718118|4012951|FG001|NOT COMPLETED|Overall Study||1
3279540|NCT02718131|4012959|FG000|STARTED|Overall Study||5
3279541|NCT02718131|4012960|FG001|STARTED|Overall Study||0
3279542|NCT02718131|4012959|FG000|Completed 12 Months|Overall Study||2
3279543|NCT02718131|4012960|FG001|Completed 12 Months|Overall Study||0
3279544|NCT02718131|4012959|FG000|COMPLETED|Overall Study||2
3279545|NCT02718131|4012960|FG001|COMPLETED|Overall Study||0
3279546|NCT02718131|4012959|FG000|NOT COMPLETED|Overall Study||3
3279547|NCT02718131|4012960|FG001|NOT COMPLETED|Overall Study||0
3279548|NCT02718157|4012968|FG000|STARTED|Overall Study||771
3279549|NCT02718157|4012968|FG000|COMPLETED|Overall Study||609
3279550|NCT02718157|4012968|FG000|NOT COMPLETED|Overall Study||162
3279551|NCT02718248|4012972|FG000|STARTED|Overall Study||7
3279552|NCT02718248|4012972|FG000|COMPLETED|Overall Study||7
3279553|NCT02718248|4012972|FG000|NOT COMPLETED|Overall Study||0
3279554|NCT02718326|4012979|FG000|STARTED|Overall Study||133
3279555|NCT02718326|4012980|FG001|STARTED|Overall Study||135
3279556|NCT02718326|4012981|FG002|STARTED|Overall Study||134
3279557|NCT02718326|4012979|FG000|Completed Week 52|Overall Study||109
3279558|NCT02718326|4012980|FG001|Completed Week 52|Overall Study||122
3279559|NCT02718326|4012981|FG002|Completed Week 52|Overall Study||124
3279560|NCT02718326|4012979|FG000|COMPLETED|Overall Study||97
3279561|NCT02718326|4012980|FG001|COMPLETED|Overall Study||111
3279562|NCT02718326|4012981|FG002|COMPLETED|Overall Study||112
3279563|NCT02718326|4012979|FG000|NOT COMPLETED|Overall Study||36
3279564|NCT02718326|4012980|FG001|NOT COMPLETED|Overall Study||24
3279565|NCT02718326|4012981|FG002|NOT COMPLETED|Overall Study||22
3279566|NCT02718417|4012994|FG000|STARTED|Chemotherapy Phase (CP)||332
3279567|NCT02718417|4012995|FG001|STARTED|Chemotherapy Phase (CP)||331
3279568|NCT02718417|4012996|FG002|STARTED|Chemotherapy Phase (CP)||335
3279569|NCT02718417|4012994|FG000|Safety Population|Chemotherapy Phase (CP)||328
3279570|NCT02718417|4012995|FG001|Safety Population|Chemotherapy Phase (CP)||329
3279571|NCT02718417|4012996|FG002|Safety Population|Chemotherapy Phase (CP)||334
3279572|NCT02718417|4012994|FG000|COMPLETED|Chemotherapy Phase (CP)||280
3279573|NCT02718417|4012995|FG001|COMPLETED|Chemotherapy Phase (CP)||294
3279574|NCT02718417|4012996|FG002|COMPLETED|Chemotherapy Phase (CP)||289
3279575|NCT02718417|4012994|FG000|NOT COMPLETED|Chemotherapy Phase (CP)||52
3279576|NCT02718417|4012995|FG001|NOT COMPLETED|Chemotherapy Phase (CP)||37
3279577|NCT02718417|4012996|FG002|NOT COMPLETED|Chemotherapy Phase (CP)||46
3279578|NCT02718417|4012994|FG000|STARTED|Maintenance Phase (MP)|Included participants without evidence of disease progression at the end of Chemotherapy phase.|267
3279579|NCT02718417|4012995|FG001|STARTED|Maintenance Phase (MP)|Included participants without evidence of disease progression at the end of Chemotherapy phase.|288
3279580|NCT02718417|4012996|FG002|STARTED|Maintenance Phase (MP)|After completing CP, participants moved to observation phase. MP was not applicable for this arm.|0
3279581|NCT02718417|4012994|FG000|COMPLETED|Maintenance Phase (MP)||1
3279582|NCT02718417|4012995|FG001|COMPLETED|Maintenance Phase (MP)||1
3279583|NCT02718417|4012996|FG002|COMPLETED|Maintenance Phase (MP)||0
3048502|NCT01208324|3768531|FG003|Test Day 4|Post-randomization of Patch||5
3048503|NCT01208324|3768528|FG000|COMPLETED|Post-randomization of Patch||13
3048504|NCT01208324|3768529|FG001|COMPLETED|Post-randomization of Patch||15
3048505|NCT01208324|3768530|FG002|COMPLETED|Post-randomization of Patch||8
3048506|NCT01208324|3768531|FG003|COMPLETED|Post-randomization of Patch||5
3048507|NCT01208324|3768528|FG000|NOT COMPLETED|Post-randomization of Patch||1
3048508|NCT01208324|3768529|FG001|NOT COMPLETED|Post-randomization of Patch||0
3048509|NCT01208324|3768530|FG002|NOT COMPLETED|Post-randomization of Patch||0
3048510|NCT01208324|3768531|FG003|NOT COMPLETED|Post-randomization of Patch||0
3048511|NCT01208337|3768541|FG000|STARTED|Overall Study||23
3160464|NCT01863771|3887578|FG003|STARTED|Maintenance Phase||60
3160465|NCT01863771|3887575|FG000|COMPLETED|Maintenance Phase||0
3160466|NCT01863771|3887576|FG001|COMPLETED|Maintenance Phase||27
3279584|NCT02718417|4012994|FG000|NOT COMPLETED|Maintenance Phase (MP)||266
3279585|NCT02718417|4012995|FG001|NOT COMPLETED|Maintenance Phase (MP)||287
3279586|NCT02718417|4012996|FG002|NOT COMPLETED|Maintenance Phase (MP)||0
3279587|NCT02718417|4012994|FG000|STARTED|Observation Phase (OP)|After completing MP, participants moved to follow-up phase. OP was not applicable.|0
3279588|NCT02718417|4012995|FG001|STARTED|Observation Phase (OP)|After completing MP, participants moved to follow-up phase. OP was not applicable.|0
3279589|NCT02718417|4012996|FG002|STARTED|Observation Phase (OP)|Included participants without evidence of disease progression at the end of Chemotherapy phase.|284
3279590|NCT02718417|4012994|FG000|COMPLETED|Observation Phase (OP)||0
3279591|NCT02718417|4012995|FG001|COMPLETED|Observation Phase (OP)||0
3279592|NCT02718417|4012996|FG002|COMPLETED|Observation Phase (OP)||2
3279593|NCT02718417|4012994|FG000|NOT COMPLETED|Observation Phase (OP)||0
3279594|NCT02718417|4012995|FG001|NOT COMPLETED|Observation Phase (OP)||0
3279595|NCT02718417|4012996|FG002|NOT COMPLETED|Observation Phase (OP)||282
3279596|NCT02718417|4012994|FG000|STARTED|Follow-up Phase|Participants not completing MP could also start this phase.|238
3279597|NCT02718417|4012995|FG001|STARTED|Follow-up Phase|Participants not completing MP could also start this phase.|263
3279598|NCT02718417|4012996|FG002|STARTED|Follow-up Phase|Participants not completing OP could also start this phase.|39
3279599|NCT02718417|4012994|FG000|COMPLETED|Follow-up Phase||103
3279600|NCT02718417|4012995|FG001|COMPLETED|Follow-up Phase||91
3279601|NCT02718417|4012996|FG002|COMPLETED|Follow-up Phase||20
3279602|NCT02718417|4012994|FG000|NOT COMPLETED|Follow-up Phase||135
3279603|NCT02718417|4012995|FG001|NOT COMPLETED|Follow-up Phase||172
3279604|NCT02718417|4012996|FG002|NOT COMPLETED|Follow-up Phase||19
3279605|NCT02718417|4012994|FG000|STARTED|Long-term Follow-up Phase|Participants not completing follow-up phase could also start this phase.|139
3160467|NCT01863771|3887577|FG002|COMPLETED|Maintenance Phase||19
3160468|NCT01863771|3887578|FG003|COMPLETED|Maintenance Phase||17
3279606|NCT02718417|4012995|FG001|STARTED|Long-term Follow-up Phase|Participants not completing follow-up phase could also start this phase.|112
3279607|NCT02718417|4012996|FG002|STARTED|Long-term Follow-up Phase|Participants not completing follow-up could also start this phase.|135
3279608|NCT02718417|4012994|FG000|COMPLETED|Long-term Follow-up Phase||0
3279609|NCT02718417|4012995|FG001|COMPLETED|Long-term Follow-up Phase||0
3279610|NCT02718417|4012996|FG002|COMPLETED|Long-term Follow-up Phase||0
3279611|NCT02718417|4012994|FG000|NOT COMPLETED|Long-term Follow-up Phase||139
3279612|NCT02718417|4012995|FG001|NOT COMPLETED|Long-term Follow-up Phase||112
3279613|NCT02718417|4012996|FG002|NOT COMPLETED|Long-term Follow-up Phase||135
3279614|NCT02718625|4013013|FG000|STARTED|Overall Study||1
3279615|NCT02718625|4013014|FG001|STARTED|Overall Study||2
3279616|NCT02718625|4013013|FG000|COMPLETED|Overall Study||1
3279617|NCT02718625|4013014|FG001|COMPLETED|Overall Study||0
3279618|NCT02718625|4013013|FG000|NOT COMPLETED|Overall Study||0
3279619|NCT02718625|4013014|FG001|NOT COMPLETED|Overall Study||2
3279620|NCT02718898|4013022|FG000|STARTED|Blinded Treatment Period||74
3279621|NCT02718898|4013023|FG001|STARTED|Blinded Treatment Period||75
3279622|NCT02718898|4013024|FG002|STARTED|Blinded Treatment Period||0
3279623|NCT02718898|4013025|FG003|STARTED|Blinded Treatment Period||0
3279624|NCT02718898|4013026|FG004|STARTED|Blinded Treatment Period||0
3279625|NCT02718898|4013027|FG005|STARTED|Blinded Treatment Period||0
3279626|NCT02718898|4013028|FG006|STARTED|Blinded Treatment Period||0
3279627|NCT02718898|4013022|FG000|COMPLETED|Blinded Treatment Period||65
3279628|NCT02718898|4013023|FG001|COMPLETED|Blinded Treatment Period||74
3279629|NCT02718898|4013024|FG002|COMPLETED|Blinded Treatment Period||0
3279630|NCT02718898|4013025|FG003|COMPLETED|Blinded Treatment Period||0
3279631|NCT02718898|4013026|FG004|COMPLETED|Blinded Treatment Period||0
3279632|NCT02718898|4013027|FG005|COMPLETED|Blinded Treatment Period||0
3279633|NCT02718898|4013028|FG006|COMPLETED|Blinded Treatment Period||0
3279634|NCT02718898|4013022|FG000|NOT COMPLETED|Blinded Treatment Period||9
3279635|NCT02718898|4013023|FG001|NOT COMPLETED|Blinded Treatment Period||1
3279636|NCT02718898|4013024|FG002|NOT COMPLETED|Blinded Treatment Period||0
3279637|NCT02718898|4013025|FG003|NOT COMPLETED|Blinded Treatment Period||0
3279638|NCT02718898|4013026|FG004|NOT COMPLETED|Blinded Treatment Period||0
3279639|NCT02718898|4013027|FG005|NOT COMPLETED|Blinded Treatment Period||0
3279640|NCT02718898|4013028|FG006|NOT COMPLETED|Blinded Treatment Period||0
3279641|NCT02718898|4013022|FG000|STARTED|Open Label Treatment Period (OLTP)||0
3279642|NCT02718898|4013023|FG001|STARTED|Open Label Treatment Period (OLTP)||0
3279643|NCT02718898|4013024|FG002|STARTED|Open Label Treatment Period (OLTP)||65
3279644|NCT02718898|4013025|FG003|STARTED|Open Label Treatment Period (OLTP)||74
3279645|NCT02718898|4013026|FG004|STARTED|Open Label Treatment Period (OLTP)||0
3279646|NCT02718898|4013027|FG005|STARTED|Open Label Treatment Period (OLTP)||0
3279647|NCT02718898|4013028|FG006|STARTED|Open Label Treatment Period (OLTP)||0
3279648|NCT02718898|4013022|FG000|COMPLETED|Open Label Treatment Period (OLTP)||0
3279649|NCT02718898|4013023|FG001|COMPLETED|Open Label Treatment Period (OLTP)||0
3048512|NCT01208337|3768541|FG000|One-year Follow-up|Overall Study||23
3048513|NCT01208337|3768541|FG000|Five-year Follow-up|Overall Study||20
3048514|NCT01208337|3768541|FG000|COMPLETED|Overall Study||20
3048515|NCT01208337|3768541|FG000|NOT COMPLETED|Overall Study||3
3048516|NCT01208402|3768547|FG000|STARTED|Overall Study||31
3048517|NCT01208402|3768548|FG001|STARTED|Overall Study||28
3048518|NCT01208402|3768547|FG000|COMPLETED|Overall Study||30
3048519|NCT01208402|3768548|FG001|COMPLETED|Overall Study||28
3048520|NCT01208402|3768547|FG000|NOT COMPLETED|Overall Study||1
3048521|NCT01208402|3768548|FG001|NOT COMPLETED|Overall Study||0
3048522|NCT01208415|3768554|FG000|STARTED|Overall Study||40
3048523|NCT01208415|3768554|FG000|6 Months|Overall Study||37
3048524|NCT01208415|3768554|FG000|COMPLETED|Overall Study||0
3048525|NCT01208415|3768554|FG000|NOT COMPLETED|Overall Study||40
3048526|NCT01208870|3768560|FG000|STARTED|Overall Study|The same group was run as Pilot 1 Spring 2012 and Pilot 2 Summer 2013|46
3048527|NCT01208870|3768561|FG001|STARTED|Overall Study|The same group was run as Pilot 1 Spring 2012 and Pilot 2 Summer 2013.|44
3048528|NCT01208870|3768560|FG000|Pilot 1|Overall Study||20
3048529|NCT01208870|3768561|FG001|Pilot 1|Overall Study||22
3048530|NCT01208870|3768560|FG000|Pilot 2|Overall Study||26
3048531|NCT01208870|3768561|FG001|Pilot 2|Overall Study||22
3048532|NCT01208870|3768560|FG000|COMPLETED|Overall Study||44
3048533|NCT01208870|3768561|FG001|COMPLETED|Overall Study||36
3048534|NCT01208870|3768560|FG000|NOT COMPLETED|Overall Study||2
3048535|NCT01208870|3768561|FG001|NOT COMPLETED|Overall Study||8
3048536|NCT01208922|3768571|FG000|STARTED|Overall Study||420
3048537|NCT01208922|3768572|FG001|STARTED|Overall Study||415
3048538|NCT01208922|3768571|FG000|COMPLETED|Overall Study||409
3048539|NCT01208922|3768572|FG001|COMPLETED|Overall Study||405
3048540|NCT01208922|3768571|FG000|NOT COMPLETED|Overall Study||11
3048541|NCT01208922|3768572|FG001|NOT COMPLETED|Overall Study||10
3048542|NCT01208961|3768578|FG000|STARTED|Low-Fat Period I||27
3048543|NCT01208961|3768579|FG001|STARTED|Low-Fat Period I||27
3048544|NCT01208961|3768578|FG000|COMPLETED|Low-Fat Period I||27
3048545|NCT01208961|3768579|FG001|COMPLETED|Low-Fat Period I||27
3048546|NCT01208961|3768578|FG000|NOT COMPLETED|Low-Fat Period I||0
3048547|NCT01208961|3768579|FG001|NOT COMPLETED|Low-Fat Period I||0
3048548|NCT01208961|3768578|FG000|STARTED|Low-Fat Period II||26
3048549|NCT01208961|3768579|FG001|STARTED|Low-Fat Period II||27
3048550|NCT01208961|3768578|FG000|COMPLETED|Low-Fat Period II||26
3048551|NCT01208961|3768579|FG001|COMPLETED|Low-Fat Period II||27
3048552|NCT01208961|3768578|FG000|NOT COMPLETED|Low-Fat Period II||0
3048553|NCT01208961|3768579|FG001|NOT COMPLETED|Low-Fat Period II||0
3048554|NCT01208961|3768578|FG000|STARTED|High-Fat Period III||26
3048555|NCT01208961|3768579|FG001|STARTED|High-Fat Period III||26
3048556|NCT01208961|3768578|FG000|COMPLETED|High-Fat Period III||25
3048557|NCT01208961|3768579|FG001|COMPLETED|High-Fat Period III||26
3048558|NCT01208961|3768578|FG000|NOT COMPLETED|High-Fat Period III||1
3048559|NCT01208961|3768579|FG001|NOT COMPLETED|High-Fat Period III||0
3048560|NCT01208961|3768578|FG000|STARTED|High-Fat Period IV||25
3048561|NCT01208961|3768579|FG001|STARTED|High-Fat Period IV||26
3048562|NCT01208961|3768578|FG000|COMPLETED|High-Fat Period IV||25
3048563|NCT01208961|3768579|FG001|COMPLETED|High-Fat Period IV||26
3048564|NCT01208961|3768578|FG000|NOT COMPLETED|High-Fat Period IV||0
3048565|NCT01208961|3768579|FG001|NOT COMPLETED|High-Fat Period IV||0
3048566|NCT01209078|3768586|FG000|STARTED|Overall Study||57
3048567|NCT01209078|3768587|FG001|STARTED|Overall Study||27
3048568|NCT01209078|3768586|FG000|COMPLETED|Overall Study||41
3048569|NCT01209078|3768587|FG001|COMPLETED|Overall Study||24
3048570|NCT01209078|3768586|FG000|NOT COMPLETED|Overall Study||16
3048571|NCT01209078|3768587|FG001|NOT COMPLETED|Overall Study||3
3048572|NCT01209143|3768597|FG000|STARTED|Overall Study||24
3048573|NCT01209143|3768598|FG001|STARTED|Overall Study||28
3048574|NCT01209143|3768597|FG000|COMPLETED|Overall Study||5
3048575|NCT01209143|3768598|FG001|COMPLETED|Overall Study||8
3048576|NCT01209143|3768597|FG000|NOT COMPLETED|Overall Study||19
3048577|NCT01209143|3768598|FG001|NOT COMPLETED|Overall Study||20
3048578|NCT01209195|3768606|FG000|STARTED|Overall Study||7
3048579|NCT01209195|3768607|FG001|STARTED|Overall Study||3
3048580|NCT01209195|3768608|FG002|STARTED|Overall Study||6
3048581|NCT01209195|3768609|FG003|STARTED|Overall Study||6
3048582|NCT01209195|3768610|FG004|STARTED|Overall Study||6
3048583|NCT01209195|3768611|FG005|STARTED|Overall Study||13
3048584|NCT01209195|3768606|FG000|COMPLETED|Overall Study||7
3048585|NCT01209195|3768607|FG001|COMPLETED|Overall Study||3
3048586|NCT01209195|3768608|FG002|COMPLETED|Overall Study||6
3048587|NCT01209195|3768609|FG003|COMPLETED|Overall Study||6
3048588|NCT01209195|3768610|FG004|COMPLETED|Overall Study||6
3048589|NCT01209195|3768611|FG005|COMPLETED|Overall Study||13
3048590|NCT01209195|3768606|FG000|NOT COMPLETED|Overall Study||0
3048591|NCT01209195|3768607|FG001|NOT COMPLETED|Overall Study||0
3048592|NCT01209195|3768608|FG002|NOT COMPLETED|Overall Study||0
3048593|NCT01209195|3768609|FG003|NOT COMPLETED|Overall Study||0
3048594|NCT01209195|3768610|FG004|NOT COMPLETED|Overall Study||0
3048595|NCT01209195|3768611|FG005|NOT COMPLETED|Overall Study||0
3048596|NCT01209234|3768629|FG000|STARTED|Overall Study||1070
3048597|NCT01209234|3768630|FG001|STARTED|Overall Study||1070
3048598|NCT01209234|3768629|FG000|COMPLETED|Overall Study||1058
3048599|NCT01209234|3768630|FG001|COMPLETED|Overall Study||1063
3048600|NCT01209234|3768629|FG000|NOT COMPLETED|Overall Study||12
3279650|NCT02718898|4013024|FG002|COMPLETED|Open Label Treatment Period (OLTP)||62
3279651|NCT02718898|4013025|FG003|COMPLETED|Open Label Treatment Period (OLTP)||64
3279652|NCT02718898|4013026|FG004|COMPLETED|Open Label Treatment Period (OLTP)||0
3279653|NCT02718898|4013027|FG005|COMPLETED|Open Label Treatment Period (OLTP)||0
3279654|NCT02718898|4013028|FG006|COMPLETED|Open Label Treatment Period (OLTP)||0
3048601|NCT01209234|3768630|FG001|NOT COMPLETED|Overall Study||7
3048602|NCT01209260|3768638|FG000|STARTED|Overall Study||36
3048603|NCT01209260|3768639|FG001|STARTED|Overall Study||36
3048604|NCT01209260|3768638|FG000|COMPLETED|Overall Study||36
3048605|NCT01209260|3768639|FG001|COMPLETED|Overall Study||36
3048606|NCT01209260|3768638|FG000|NOT COMPLETED|Overall Study||0
3048607|NCT01209260|3768639|FG001|NOT COMPLETED|Overall Study||0
3048608|NCT01209286|3768650|FG000|STARTED|Overall Study||7
3048609|NCT01209286|3768651|FG001|STARTED|Overall Study||23
3048610|NCT01209286|3768652|FG002|STARTED|Overall Study||6
3048611|NCT01209286|3768650|FG000|COMPLETED|Overall Study||2
3048612|NCT01209286|3768651|FG001|COMPLETED|Overall Study||13
3048613|NCT01209286|3768652|FG002|COMPLETED|Overall Study||3
3048614|NCT01209286|3768650|FG000|NOT COMPLETED|Overall Study||5
3048615|NCT01209286|3768651|FG001|NOT COMPLETED|Overall Study||10
3048616|NCT01209286|3768652|FG002|NOT COMPLETED|Overall Study||3
3048617|NCT01209325|3768669|FG000|STARTED|Overall Study||149
3048618|NCT01209325|3768669|FG000|Eligible|Overall Study||145
3048619|NCT01209325|3768669|FG000|Received First Vaccine Injection|Overall Study||144
3048620|NCT01209325|3768669|FG000|Received Second Vaccine Injection|Overall Study||141
3048621|NCT01209325|3768669|FG000|Received Third Vaccine Infjection|Overall Study||138
3048622|NCT01209325|3768669|FG000|Returned After Week 28|Overall Study||124
3279655|NCT02718898|4013022|FG000|NOT COMPLETED|Open Label Treatment Period (OLTP)||0
3279656|NCT02718898|4013023|FG001|NOT COMPLETED|Open Label Treatment Period (OLTP)||0
3279657|NCT02718898|4013024|FG002|NOT COMPLETED|Open Label Treatment Period (OLTP)||3
3279658|NCT02718898|4013025|FG003|NOT COMPLETED|Open Label Treatment Period (OLTP)||10
3279659|NCT02718898|4013026|FG004|NOT COMPLETED|Open Label Treatment Period (OLTP)||0
3279660|NCT02718898|4013027|FG005|NOT COMPLETED|Open Label Treatment Period (OLTP)||0
3279661|NCT02718898|4013028|FG006|NOT COMPLETED|Open Label Treatment Period (OLTP)||0
3279662|NCT02718898|4013022|FG000|STARTED|Post Treatment Follow-up Period||0
3279663|NCT02718898|4013023|FG001|STARTED|Post Treatment Follow-up Period||0
3279664|NCT02718898|4013024|FG002|STARTED|Post Treatment Follow-up Period||0
3279665|NCT02718898|4013025|FG003|STARTED|Post Treatment Follow-up Period||0
3279666|NCT02718898|4013026|FG004|STARTED|Post Treatment Follow-up Period|One participant who discontinued from placebo blinded treatment had entered post-treatment follow-up|1
3279667|NCT02718898|4013027|FG005|STARTED|Post Treatment Follow-up Period||78
3279668|NCT02718898|4013028|FG006|STARTED|Post Treatment Follow-up Period||49
3279669|NCT02718898|4013022|FG000|COMPLETED|Post Treatment Follow-up Period||0
3279670|NCT02718898|4013023|FG001|COMPLETED|Post Treatment Follow-up Period||0
3279671|NCT02718898|4013024|FG002|COMPLETED|Post Treatment Follow-up Period||0
3279672|NCT02718898|4013025|FG003|COMPLETED|Post Treatment Follow-up Period||0
3279673|NCT02718898|4013026|FG004|COMPLETED|Post Treatment Follow-up Period||0
3279674|NCT02718898|4013027|FG005|COMPLETED|Post Treatment Follow-up Period||67
3279675|NCT02718898|4013028|FG006|COMPLETED|Post Treatment Follow-up Period||44
3279676|NCT02718898|4013022|FG000|NOT COMPLETED|Post Treatment Follow-up Period||0
3279677|NCT02718898|4013023|FG001|NOT COMPLETED|Post Treatment Follow-up Period||0
3279678|NCT02718898|4013024|FG002|NOT COMPLETED|Post Treatment Follow-up Period||0
3279679|NCT02718898|4013025|FG003|NOT COMPLETED|Post Treatment Follow-up Period||0
3279680|NCT02718898|4013026|FG004|NOT COMPLETED|Post Treatment Follow-up Period||1
3279681|NCT02718898|4013027|FG005|NOT COMPLETED|Post Treatment Follow-up Period||11
3279682|NCT02718898|4013028|FG006|NOT COMPLETED|Post Treatment Follow-up Period||5
3279683|NCT02718963|4013043|FG000|STARTED|Overall Study||10
3279684|NCT02718963|4013044|FG001|STARTED|Overall Study||10
3279685|NCT02718963|4013043|FG000|COMPLETED|Overall Study||9
3279686|NCT02718963|4013044|FG001|COMPLETED|Overall Study||9
3279687|NCT02718963|4013043|FG000|NOT COMPLETED|Overall Study||1
3279688|NCT02718963|4013044|FG001|NOT COMPLETED|Overall Study||1
3279689|NCT02719028|4013054|FG000|STARTED|Overall Study||30
3279690|NCT02719028|4013055|FG001|STARTED|Overall Study||30
3279691|NCT02719028|4013056|FG002|STARTED|Overall Study||30
3279692|NCT02719028|4013057|FG003|STARTED|Overall Study||30
3279693|NCT02719028|4013054|FG000|COMPLETED|Overall Study||28
3279694|NCT02719028|4013055|FG001|COMPLETED|Overall Study||28
3048623|NCT01209325|3768669|FG000|COMPLETED|Overall Study||106
3048624|NCT01209325|3768669|FG000|NOT COMPLETED|Overall Study||43
3048625|NCT01209442|3768695|FG000|STARTED|Overall Study||30
3048626|NCT01209442|3768695|FG000|COMPLETED|Overall Study||30
3048627|NCT01209442|3768695|FG000|NOT COMPLETED|Overall Study||0
3048628|NCT01209598|3768701|FG000|STARTED|Overall Study||30
3048629|NCT01209598|3768702|FG001|STARTED|Overall Study||60
3048630|NCT01209598|3768701|FG000|COMPLETED|Overall Study||29
3048631|NCT01209598|3768702|FG001|COMPLETED|Overall Study||60
3048632|NCT01209598|3768701|FG000|NOT COMPLETED|Overall Study||1
3048633|NCT01209598|3768702|FG001|NOT COMPLETED|Overall Study||0
3048634|NCT01209624|3768709|FG000|STARTED|Overall Study||902
3048635|NCT01209624|3768709|FG000|Per Protocol Population|Overall Study||469
3048636|NCT01209624|3768709|FG000|COMPLETED|Overall Study||576
3048637|NCT01209624|3768709|FG000|NOT COMPLETED|Overall Study||326
3048638|NCT01209689|3768715|FG000|STARTED|Overall Study||91
3048639|NCT01209689|3768716|FG001|STARTED|Overall Study||22
3048640|NCT01209689|3768715|FG000|COMPLETED|Overall Study||0
3048641|NCT01209689|3768716|FG001|COMPLETED|Overall Study||0
3048642|NCT01209689|3768715|FG000|NOT COMPLETED|Overall Study||91
3048643|NCT01209689|3768716|FG001|NOT COMPLETED|Overall Study||22
3048644|NCT01209702|3768724|FG000|STARTED|Overall Study||51
3048645|NCT01209702|3768725|FG001|STARTED|Overall Study||51
3048646|NCT01209702|3768726|FG002|STARTED|Overall Study||51
3048647|NCT01209702|3768727|FG003|STARTED|Overall Study||153
3048648|NCT01209702|3768724|FG000|Treated|Overall Study||51
3048649|NCT01209702|3768725|FG001|Treated|Overall Study||51
3048650|NCT01209702|3768726|FG002|Treated|Overall Study||51
3048651|NCT01209702|3768727|FG003|Treated|Overall Study||152
3048652|NCT01209702|3768724|FG000|Escape or Switched to Tocilizumab|Overall Study||51
3048653|NCT01209702|3768725|FG001|Escape or Switched to Tocilizumab|Overall Study||0
3048654|NCT01209702|3768726|FG002|Escape or Switched to Tocilizumab|Overall Study||6
3048655|NCT01209702|3768727|FG003|Escape or Switched to Tocilizumab|Overall Study||0
3048656|NCT01209702|3768724|FG000|Completed 12 Weeks Treatment|Overall Study||50
3048657|NCT01209702|3768725|FG001|Completed 12 Weeks Treatment|Overall Study||48
3048658|NCT01209702|3768726|FG002|Completed 12 Weeks Treatment|Overall Study||12
3048659|NCT01209702|3768727|FG003|Completed 12 Weeks Treatment|Overall Study||59
3048660|NCT01209702|3768724|FG000|Completed 24 Weeks Treatment|Overall Study||19
3048661|NCT01209702|3768725|FG001|Completed 24 Weeks Treatment|Overall Study||28
3048662|NCT01209702|3768726|FG002|Completed 24 Weeks Treatment|Overall Study||3
3048663|NCT01209702|3768727|FG003|Completed 24 Weeks Treatment|Overall Study||10
3048664|NCT01209702|3768724|FG000|COMPLETED|Overall Study||0
3048665|NCT01209702|3768725|FG001|COMPLETED|Overall Study||0
3048666|NCT01209702|3768726|FG002|COMPLETED|Overall Study||0
3048667|NCT01209702|3768727|FG003|COMPLETED|Overall Study||0
3048668|NCT01209702|3768724|FG000|NOT COMPLETED|Overall Study||51
3048669|NCT01209702|3768725|FG001|NOT COMPLETED|Overall Study||51
3048670|NCT01209702|3768726|FG002|NOT COMPLETED|Overall Study||51
3048671|NCT01209702|3768727|FG003|NOT COMPLETED|Overall Study||153
3048672|NCT01209780|3768750|FG000|STARTED|Overall Study||1042
3048673|NCT01209780|3768751|FG001|STARTED|Overall Study||485
3048674|NCT01209780|3768752|FG002|STARTED|Overall Study||48
3048675|NCT01209780|3768753|FG003|STARTED|Overall Study||817
3048676|NCT01209780|3768754|FG004|STARTED|Overall Study||412
3048677|NCT01209780|3768750|FG000|COMPLETED|Overall Study||1016
3048678|NCT01209780|3768751|FG001|COMPLETED|Overall Study||467
3048679|NCT01209780|3768752|FG002|COMPLETED|Overall Study||44
3048680|NCT01209780|3768753|FG003|COMPLETED|Overall Study||807
3048681|NCT01209780|3768754|FG004|COMPLETED|Overall Study||407
3048682|NCT01209780|3768750|FG000|NOT COMPLETED|Overall Study||26
3048683|NCT01209780|3768751|FG001|NOT COMPLETED|Overall Study||18
3048684|NCT01209780|3768752|FG002|NOT COMPLETED|Overall Study||4
3048685|NCT01209780|3768753|FG003|NOT COMPLETED|Overall Study||10
3048686|NCT01209780|3768754|FG004|NOT COMPLETED|Overall Study||5
3048687|NCT01209832|3768767|FG000|STARTED|Period 1||11
3048688|NCT01209832|3768767|FG000|Received At Least 1 Dose of Study Drug|Period 1||10
3048689|NCT01209832|3768767|FG000|COMPLETED|Period 1||10
3048690|NCT01209832|3768767|FG000|NOT COMPLETED|Period 1||1
3048691|NCT01209832|3768767|FG000|STARTED|Period 2||10
3048692|NCT01209832|3768767|FG000|COMPLETED|Period 2||9
3048693|NCT01209832|3768767|FG000|NOT COMPLETED|Period 2||1
3048694|NCT01209832|3768767|FG000|STARTED|Maintenance Period 1 (M1)|Five participants who completed Period 2 did not enroll into Maintenance Period.|4
3048695|NCT01209832|3768767|FG000|COMPLETED|Maintenance Period 1 (M1)||4
3048696|NCT01209832|3768767|FG000|NOT COMPLETED|Maintenance Period 1 (M1)||0
3048697|NCT01209832|3768767|FG000|STARTED|Maintenance Period 2 (M1)|One participant who completed maintenance period 1 did not enter maintenance period 2.|3
3048698|NCT01209832|3768767|FG000|COMPLETED|Maintenance Period 2 (M1)||3
3048699|NCT01209832|3768767|FG000|NOT COMPLETED|Maintenance Period 2 (M1)||0
3048700|NCT01209949|3768778|FG000|STARTED|Overall Study||30
3048701|NCT01209949|3768778|FG000|COMPLETED|Overall Study||27
3048702|NCT01209949|3768778|FG000|NOT COMPLETED|Overall Study||3
3048703|NCT01210001|3768785|FG000|STARTED|Overall Study||166
3048704|NCT01210001|3768786|FG001|STARTED|Overall Study||165
3048705|NCT01210001|3768787|FG002|STARTED|Overall Study||168
3048706|NCT01210001|3768785|FG000|COMPLETED|Overall Study||147
3048707|NCT01210001|3768786|FG001|COMPLETED|Overall Study||154
3048708|NCT01210001|3768787|FG002|COMPLETED|Overall Study||156
3048709|NCT01210001|3768785|FG000|NOT COMPLETED|Overall Study||19
3048710|NCT01210001|3768786|FG001|NOT COMPLETED|Overall Study||11
3048711|NCT01210001|3768787|FG002|NOT COMPLETED|Overall Study||12
3048712|NCT01210079|3768797|FG000|STARTED|Overall Study||10
3048713|NCT01210079|3768798|FG001|STARTED|Overall Study||16
3048714|NCT01210079|3768797|FG000|COMPLETED|Overall Study||10
3048715|NCT01210079|3768798|FG001|COMPLETED|Overall Study||16
3048716|NCT01210079|3768797|FG000|NOT COMPLETED|Overall Study||0
3048717|NCT01210079|3768798|FG001|NOT COMPLETED|Overall Study||0
3048718|NCT01210118|3768806|FG000|STARTED|Overall Study||45
3048719|NCT01210118|3768807|FG001|STARTED|Overall Study||47
3048720|NCT01210118|3768806|FG000|COMPLETED|Overall Study||42
3048721|NCT01210118|3768807|FG001|COMPLETED|Overall Study||42
3048722|NCT01210118|3768806|FG000|NOT COMPLETED|Overall Study||3
3048723|NCT01210118|3768807|FG001|NOT COMPLETED|Overall Study||5
3048724|NCT01210144|3768818|FG000|STARTED|Overall Study||13
3048725|NCT01210144|3768819|FG001|STARTED|Overall Study||11
3048726|NCT01210144|3768818|FG000|COMPLETED|Overall Study||10
3048727|NCT01210144|3768819|FG001|COMPLETED|Overall Study||11
3048728|NCT01210144|3768818|FG000|NOT COMPLETED|Overall Study||3
3048729|NCT01210144|3768819|FG001|NOT COMPLETED|Overall Study||0
3048730|NCT01210170|3768826|FG000|STARTED|Overall Study||22
3048731|NCT01210170|3768826|FG000|COMPLETED|Overall Study||15
3048732|NCT01210170|3768826|FG000|NOT COMPLETED|Overall Study||7
3048733|NCT01210222|3768847|FG000|STARTED|Overall Study||35
3048734|NCT01210222|3768847|FG000|COMPLETED|Overall Study||32
3048735|NCT01210222|3768847|FG000|NOT COMPLETED|Overall Study||3
3048736|NCT01210352|3768866|FG000|STARTED|Overall Study||6
3048737|NCT01210352|3768867|FG001|STARTED|Overall Study||6
3048738|NCT01210352|3768868|FG002|STARTED|Overall Study||7
3048739|NCT01210352|3768869|FG003|STARTED|Overall Study||7
3048740|NCT01210352|3768870|FG004|STARTED|Overall Study||6
3048741|NCT01210352|3768871|FG005|STARTED|Overall Study||6
3279695|NCT02719028|4013056|FG002|COMPLETED|Overall Study||24
3279696|NCT02719028|4013057|FG003|COMPLETED|Overall Study||20
3279697|NCT02719028|4013054|FG000|NOT COMPLETED|Overall Study||2
3279698|NCT02719028|4013055|FG001|NOT COMPLETED|Overall Study||2
3279699|NCT02719028|4013056|FG002|NOT COMPLETED|Overall Study||6
3279700|NCT02719028|4013057|FG003|NOT COMPLETED|Overall Study||10
3279701|NCT02719158|4013070|FG000|STARTED|Overall Study||38
3279702|NCT02719158|4013071|FG001|STARTED|Overall Study||38
3279703|NCT02719158|4013072|FG002|STARTED|Overall Study||19
3048742|NCT01210352|3768872|FG006|STARTED|Overall Study||7
3048743|NCT01210352|3768873|FG007|STARTED|Overall Study||10
3048744|NCT01210352|3768874|FG008|STARTED|Overall Study||6
3048745|NCT01210352|3768866|FG000|COMPLETED|Overall Study||6
3048746|NCT01210352|3768867|FG001|COMPLETED|Overall Study||6
3048747|NCT01210352|3768868|FG002|COMPLETED|Overall Study||5
3048748|NCT01210352|3768869|FG003|COMPLETED|Overall Study||7
3048749|NCT01210352|3768870|FG004|COMPLETED|Overall Study||6
3048750|NCT01210352|3768871|FG005|COMPLETED|Overall Study||6
3048751|NCT01210352|3768872|FG006|COMPLETED|Overall Study||5
3048752|NCT01210352|3768873|FG007|COMPLETED|Overall Study||7
3048753|NCT01210352|3768874|FG008|COMPLETED|Overall Study||2
3048754|NCT01210352|3768866|FG000|NOT COMPLETED|Overall Study||0
3048755|NCT01210352|3768867|FG001|NOT COMPLETED|Overall Study||0
3048756|NCT01210352|3768868|FG002|NOT COMPLETED|Overall Study||2
3048757|NCT01210352|3768869|FG003|NOT COMPLETED|Overall Study||0
3048758|NCT01210352|3768870|FG004|NOT COMPLETED|Overall Study||0
3048759|NCT01210352|3768871|FG005|NOT COMPLETED|Overall Study||0
3048760|NCT01210352|3768872|FG006|NOT COMPLETED|Overall Study||2
3048761|NCT01210352|3768873|FG007|NOT COMPLETED|Overall Study||3
3048762|NCT01210352|3768874|FG008|NOT COMPLETED|Overall Study||4
3048763|NCT01210443|3768979|FG000|STARTED|Overall Study||2
3048764|NCT01210443|3768979|FG000|COMPLETED|Overall Study||0
3048765|NCT01210443|3768979|FG000|NOT COMPLETED|Overall Study||2
3048766|NCT01210495|3768987|FG000|STARTED|Overall Study||15
3048767|NCT01210495|3768988|FG001|STARTED|Overall Study||7
3048768|NCT01210495|3768989|FG002|STARTED|Overall Study||134
3048769|NCT01210495|3768990|FG003|STARTED|Overall Study||68
3048770|NCT01210495|3768987|FG000|COMPLETED|Overall Study||0
3048771|NCT01210495|3768988|FG001|COMPLETED|Overall Study||0
3279704|NCT02719158|4013070|FG000|COMPLETED|Overall Study||38
3279705|NCT02719158|4013071|FG001|COMPLETED|Overall Study||38
3279706|NCT02719158|4013072|FG002|COMPLETED|Overall Study||18
3279707|NCT02719158|4013070|FG000|NOT COMPLETED|Overall Study||0
3279708|NCT02719158|4013071|FG001|NOT COMPLETED|Overall Study||0
3279709|NCT02719158|4013072|FG002|NOT COMPLETED|Overall Study||1
3279710|NCT02719171|4013085|FG000|STARTED|Overall Study||42
3279711|NCT02719171|4013086|FG001|STARTED|Overall Study||42
3279712|NCT02719171|4013087|FG002|STARTED|Overall Study||42
3279713|NCT02719171|4013088|FG003|STARTED|Overall Study||39
3279714|NCT02719171|4013089|FG004|STARTED|Overall Study||20
3279715|NCT02719171|4013085|FG000|COMPLETED|Overall Study||41
3279716|NCT02719171|4013086|FG001|COMPLETED|Overall Study||38
3279717|NCT02719171|4013087|FG002|COMPLETED|Overall Study||39
3279718|NCT02719171|4013088|FG003|COMPLETED|Overall Study||37
3279719|NCT02719171|4013089|FG004|COMPLETED|Overall Study||18
3279720|NCT02719171|4013085|FG000|NOT COMPLETED|Overall Study||1
3279721|NCT02719171|4013086|FG001|NOT COMPLETED|Overall Study||4
3279722|NCT02719171|4013087|FG002|NOT COMPLETED|Overall Study||3
3279723|NCT02719171|4013088|FG003|NOT COMPLETED|Overall Study||2
3279724|NCT02719171|4013089|FG004|NOT COMPLETED|Overall Study||2
3279725|NCT02719353|4013104|FG000|STARTED|First Intervention||7
3279726|NCT02719353|4013105|FG001|STARTED|First Intervention||7
3279727|NCT02719353|4013104|FG000|COMPLETED|First Intervention||7
3279728|NCT02719353|4013105|FG001|COMPLETED|First Intervention||6
3279729|NCT02719353|4013104|FG000|NOT COMPLETED|First Intervention||0
3048772|NCT01210495|3768989|FG002|COMPLETED|Overall Study||0
3048773|NCT01210495|3768990|FG003|COMPLETED|Overall Study||0
3048774|NCT01210495|3768987|FG000|NOT COMPLETED|Overall Study||15
3048775|NCT01210495|3768988|FG001|NOT COMPLETED|Overall Study||7
3048776|NCT01210495|3768989|FG002|NOT COMPLETED|Overall Study||134
3048777|NCT01210495|3768990|FG003|NOT COMPLETED|Overall Study||68
3048778|NCT01210560|3769002|FG000|STARTED|Intervention 1 (7 Days)||2
3048779|NCT01210560|3769003|FG001|STARTED|Intervention 1 (7 Days)||2
3048780|NCT01210560|3769004|FG002|STARTED|Intervention 1 (7 Days)||2
3279730|NCT02719353|4013105|FG001|NOT COMPLETED|First Intervention||1
3279731|NCT02719353|4013104|FG000|STARTED|Second Intervention||7
3048781|NCT01210560|3769005|FG003|STARTED|Intervention 1 (7 Days)||2
3048782|NCT01210560|3769006|FG004|STARTED|Intervention 1 (7 Days)||2
3048783|NCT01210560|3769007|FG005|STARTED|Intervention 1 (7 Days)||2
3048784|NCT01210560|3769008|FG006|STARTED|Intervention 1 (7 Days)||4
3048785|NCT01210560|3769009|FG007|STARTED|Intervention 1 (7 Days)||4
3048786|NCT01210560|3769010|FG008|STARTED|Intervention 1 (7 Days)||5
3048787|NCT01210560|3769002|FG000|COMPLETED|Intervention 1 (7 Days)||2
3048788|NCT01210560|3769003|FG001|COMPLETED|Intervention 1 (7 Days)||2
3048789|NCT01210560|3769004|FG002|COMPLETED|Intervention 1 (7 Days)||2
3048790|NCT01210560|3769005|FG003|COMPLETED|Intervention 1 (7 Days)||2
3048791|NCT01210560|3769006|FG004|COMPLETED|Intervention 1 (7 Days)||2
3048792|NCT01210560|3769007|FG005|COMPLETED|Intervention 1 (7 Days)||2
3048793|NCT01210560|3769008|FG006|COMPLETED|Intervention 1 (7 Days)||4
3048794|NCT01210560|3769009|FG007|COMPLETED|Intervention 1 (7 Days)||4
3048795|NCT01210560|3769010|FG008|COMPLETED|Intervention 1 (7 Days)||5
3279732|NCT02719353|4013105|FG001|STARTED|Second Intervention||6
3279733|NCT02719353|4013104|FG000|COMPLETED|Second Intervention||7
3279734|NCT02719353|4013105|FG001|COMPLETED|Second Intervention||6
3048796|NCT01210560|3769002|FG000|NOT COMPLETED|Intervention 1 (7 Days)||0
3048797|NCT01210560|3769003|FG001|NOT COMPLETED|Intervention 1 (7 Days)||0
3048798|NCT01210560|3769004|FG002|NOT COMPLETED|Intervention 1 (7 Days)||0
3048799|NCT01210560|3769005|FG003|NOT COMPLETED|Intervention 1 (7 Days)||0
3048800|NCT01210560|3769006|FG004|NOT COMPLETED|Intervention 1 (7 Days)||0
3048801|NCT01210560|3769007|FG005|NOT COMPLETED|Intervention 1 (7 Days)||0
3048802|NCT01210560|3769008|FG006|NOT COMPLETED|Intervention 1 (7 Days)||0
3048803|NCT01210560|3769009|FG007|NOT COMPLETED|Intervention 1 (7 Days)||0
3048804|NCT01210560|3769010|FG008|NOT COMPLETED|Intervention 1 (7 Days)||0
3048805|NCT01210560|3769002|FG000|STARTED|Intervention 2 (7 Days)||2
3048806|NCT01210560|3769003|FG001|STARTED|Intervention 2 (7 Days)||2
3048807|NCT01210560|3769004|FG002|STARTED|Intervention 2 (7 Days)||2
3048808|NCT01210560|3769005|FG003|STARTED|Intervention 2 (7 Days)||2
3048809|NCT01210560|3769006|FG004|STARTED|Intervention 2 (7 Days)||2
3048810|NCT01210560|3769007|FG005|STARTED|Intervention 2 (7 Days)||2
3048811|NCT01210560|3769008|FG006|STARTED|Intervention 2 (7 Days)||4
3048812|NCT01210560|3769009|FG007|STARTED|Intervention 2 (7 Days)||4
3048813|NCT01210560|3769010|FG008|STARTED|Intervention 2 (7 Days)||5
3048814|NCT01210560|3769002|FG000|COMPLETED|Intervention 2 (7 Days)||2
3048815|NCT01210560|3769003|FG001|COMPLETED|Intervention 2 (7 Days)||2
3048816|NCT01210560|3769004|FG002|COMPLETED|Intervention 2 (7 Days)||2
3048817|NCT01210560|3769005|FG003|COMPLETED|Intervention 2 (7 Days)||2
3048818|NCT01210560|3769006|FG004|COMPLETED|Intervention 2 (7 Days)||2
3048819|NCT01210560|3769007|FG005|COMPLETED|Intervention 2 (7 Days)||2
3048820|NCT01210560|3769008|FG006|COMPLETED|Intervention 2 (7 Days)||4
3048821|NCT01210560|3769009|FG007|COMPLETED|Intervention 2 (7 Days)||4
3048822|NCT01210560|3769010|FG008|COMPLETED|Intervention 2 (7 Days)||5
3048823|NCT01210560|3769002|FG000|NOT COMPLETED|Intervention 2 (7 Days)||0
3048824|NCT01210560|3769003|FG001|NOT COMPLETED|Intervention 2 (7 Days)||0
3048825|NCT01210560|3769004|FG002|NOT COMPLETED|Intervention 2 (7 Days)||0
3048826|NCT01210560|3769005|FG003|NOT COMPLETED|Intervention 2 (7 Days)||0
3048827|NCT01210560|3769006|FG004|NOT COMPLETED|Intervention 2 (7 Days)||0
3048828|NCT01210560|3769007|FG005|NOT COMPLETED|Intervention 2 (7 Days)||0
3279735|NCT02719353|4013104|FG000|NOT COMPLETED|Second Intervention||0
3279736|NCT02719353|4013105|FG001|NOT COMPLETED|Second Intervention||0
3279737|NCT02719366|4013112|FG000|STARTED|First Intervention||6
3279738|NCT02719366|4013113|FG001|STARTED|First Intervention||6
3279739|NCT02719366|4013112|FG000|COMPLETED|First Intervention||6
3279740|NCT02719366|4013113|FG001|COMPLETED|First Intervention||6
3279741|NCT02719366|4013112|FG000|NOT COMPLETED|First Intervention||0
3279742|NCT02719366|4013113|FG001|NOT COMPLETED|First Intervention||0
3279743|NCT02719366|4013112|FG000|STARTED|Second Intervention||6
3048829|NCT01210560|3769008|FG006|NOT COMPLETED|Intervention 2 (7 Days)||0
3048830|NCT01210560|3769009|FG007|NOT COMPLETED|Intervention 2 (7 Days)||0
3048831|NCT01210560|3769010|FG008|NOT COMPLETED|Intervention 2 (7 Days)||0
3048832|NCT01210560|3769002|FG000|STARTED|Intervention 3 (7 Days)||2
3048833|NCT01210560|3769003|FG001|STARTED|Intervention 3 (7 Days)||2
3048834|NCT01210560|3769004|FG002|STARTED|Intervention 3 (7 Days)||2
3048835|NCT01210560|3769005|FG003|STARTED|Intervention 3 (7 Days)||2
3048836|NCT01210560|3769006|FG004|STARTED|Intervention 3 (7 Days)||2
3048837|NCT01210560|3769007|FG005|STARTED|Intervention 3 (7 Days)||2
3279744|NCT02719366|4013113|FG001|STARTED|Second Intervention||6
3279745|NCT02719366|4013112|FG000|COMPLETED|Second Intervention||6
3279746|NCT02719366|4013113|FG001|COMPLETED|Second Intervention||6
3279747|NCT02719366|4013112|FG000|NOT COMPLETED|Second Intervention||0
3279748|NCT02719366|4013113|FG001|NOT COMPLETED|Second Intervention||0
3279749|NCT02719535|4013120|FG000|STARTED|Overall Study||59
3279750|NCT02719535|4013120|FG000|COMPLETED|Overall Study||37
3279751|NCT02719535|4013120|FG000|NOT COMPLETED|Overall Study||22
3279752|NCT02719639|4013124|FG000|STARTED|Overall Study||7443
3279753|NCT02719639|4013124|FG000|COMPLETED|Overall Study||7443
3279754|NCT02719639|4013124|FG000|NOT COMPLETED|Overall Study||0
3279755|NCT02719743|4013133|FG000|STARTED|Overall Study||38
3279756|NCT02719743|4013134|FG001|STARTED|Overall Study||37
3279757|NCT02719743|4013135|FG002|STARTED|Overall Study||38
3048838|NCT01210560|3769008|FG006|STARTED|Intervention 3 (7 Days)||4
3048839|NCT01210560|3769009|FG007|STARTED|Intervention 3 (7 Days)||4
3048840|NCT01210560|3769010|FG008|STARTED|Intervention 3 (7 Days)||5
3048841|NCT01210560|3769002|FG000|COMPLETED|Intervention 3 (7 Days)||2
3048842|NCT01210560|3769003|FG001|COMPLETED|Intervention 3 (7 Days)||2
3048843|NCT01210560|3769004|FG002|COMPLETED|Intervention 3 (7 Days)||2
3048844|NCT01210560|3769005|FG003|COMPLETED|Intervention 3 (7 Days)||2
3048845|NCT01210560|3769006|FG004|COMPLETED|Intervention 3 (7 Days)||2
3048846|NCT01210560|3769007|FG005|COMPLETED|Intervention 3 (7 Days)||2
3048847|NCT01210560|3769008|FG006|COMPLETED|Intervention 3 (7 Days)||4
3048848|NCT01210560|3769009|FG007|COMPLETED|Intervention 3 (7 Days)||4
3048849|NCT01210560|3769010|FG008|COMPLETED|Intervention 3 (7 Days)||5
3048850|NCT01210560|3769002|FG000|NOT COMPLETED|Intervention 3 (7 Days)||0
3048851|NCT01210560|3769003|FG001|NOT COMPLETED|Intervention 3 (7 Days)||0
3048852|NCT01210560|3769004|FG002|NOT COMPLETED|Intervention 3 (7 Days)||0
3048853|NCT01210560|3769005|FG003|NOT COMPLETED|Intervention 3 (7 Days)||0
3048854|NCT01210560|3769006|FG004|NOT COMPLETED|Intervention 3 (7 Days)||0
3048855|NCT01210560|3769007|FG005|NOT COMPLETED|Intervention 3 (7 Days)||0
3048856|NCT01210560|3769008|FG006|NOT COMPLETED|Intervention 3 (7 Days)||0
3048857|NCT01210560|3769009|FG007|NOT COMPLETED|Intervention 3 (7 Days)||0
3048858|NCT01210560|3769010|FG008|NOT COMPLETED|Intervention 3 (7 Days)||0
3048859|NCT01210651|3769025|FG000|STARTED|Overall Study|Number randomized to intervention, but not number who started intervention by attending 1st session.|20
3048860|NCT01210651|3769026|FG001|STARTED|Overall Study|Number randomized to intervention, but not number who started intervention by attending 1st session.|18
3048861|NCT01210651|3769025|FG000|Number Attending 1st Assigned Session|Overall Study||18
3279758|NCT02719743|4013136|FG003|STARTED|Overall Study||37
3279759|NCT02719743|4013137|FG004|STARTED|Overall Study||35
3279760|NCT02719743|4013133|FG000|COMPLETED|Overall Study||37
3279761|NCT02719743|4013134|FG001|COMPLETED|Overall Study||34
3279762|NCT02719743|4013135|FG002|COMPLETED|Overall Study||38
3279763|NCT02719743|4013136|FG003|COMPLETED|Overall Study||36
3279764|NCT02719743|4013137|FG004|COMPLETED|Overall Study||33
3279765|NCT02719743|4013133|FG000|NOT COMPLETED|Overall Study||1
3279766|NCT02719743|4013134|FG001|NOT COMPLETED|Overall Study||3
3279767|NCT02719743|4013135|FG002|NOT COMPLETED|Overall Study||0
3279768|NCT02719743|4013136|FG003|NOT COMPLETED|Overall Study||1
3279769|NCT02719743|4013137|FG004|NOT COMPLETED|Overall Study||2
3279770|NCT02719938|4013151|FG000|STARTED|Overall Study||30
3279771|NCT02719938|4013152|FG001|STARTED|Overall Study||32
3279772|NCT02719938|4013151|FG000|COMPLETED|Overall Study||26
3279773|NCT02719938|4013152|FG001|COMPLETED|Overall Study||31
3279774|NCT02719938|4013151|FG000|NOT COMPLETED|Overall Study||4
3279775|NCT02719938|4013152|FG001|NOT COMPLETED|Overall Study||1
3279776|NCT02720042|4013158|FG000|STARTED|Overall Study||84
3279777|NCT02720042|4013158|FG000|COMPLETED|Overall Study||69
3279778|NCT02720042|4013158|FG000|NOT COMPLETED|Overall Study||15
3279779|NCT02720081|4013164|FG000|STARTED|Overall Study||72
3279780|NCT02720081|4013165|FG001|STARTED|Overall Study||70
3279781|NCT02720081|4013164|FG000|Treated|Overall Study||70
3279782|NCT02720081|4013165|FG001|Treated|Overall Study||69
3279783|NCT02720081|4013164|FG000|COMPLETED|Overall Study||68
3279784|NCT02720081|4013165|FG001|COMPLETED|Overall Study||66
3279785|NCT02720081|4013164|FG000|NOT COMPLETED|Overall Study||4
3279786|NCT02720081|4013165|FG001|NOT COMPLETED|Overall Study||4
3279787|NCT02720107|4013171|FG000|STARTED|Overall Study||130
3279788|NCT02720107|4013171|FG000|COMPLETED|Overall Study||130
3279789|NCT02720107|4013171|FG000|NOT COMPLETED|Overall Study||0
3316369|NCT03110562|4049671|FG000|NOT COMPLETED|Overall Study||195
3316370|NCT03110562|4049672|FG001|NOT COMPLETED|Overall Study||207
3316371|NCT03110601|4049678|FG000|STARTED|Conventional SCS Parameters||25
3316372|NCT03110601|4049678|FG000|COMPLETED|Conventional SCS Parameters||24
3316373|NCT03110601|4049678|FG000|NOT COMPLETED|Conventional SCS Parameters||1
3316374|NCT03110601|4049678|FG000|STARTED|Washout Period||24
3316375|NCT03110601|4049678|FG000|COMPLETED|Washout Period||23
3316376|NCT03110601|4049678|FG000|NOT COMPLETED|Washout Period||1
3316377|NCT03110601|4049678|FG000|STARTED|Stimgenics SCS Parameters||23
3316378|NCT03110601|4049678|FG000|COMPLETED|Stimgenics SCS Parameters||20
3316379|NCT03110601|4049678|FG000|NOT COMPLETED|Stimgenics SCS Parameters||3
3316380|NCT03110692|4049687|FG000|STARTED|Overall Study||679
3316381|NCT03110692|4049688|FG001|STARTED|Overall Study||509
3316382|NCT03110692|4049687|FG000|COMPLETED|Overall Study||679
3316383|NCT03110692|4049688|FG001|COMPLETED|Overall Study||509
3316384|NCT03110692|4049687|FG000|NOT COMPLETED|Overall Study||0
3316385|NCT03110692|4049688|FG001|NOT COMPLETED|Overall Study||0
3316386|NCT03110770|4049699|FG000|STARTED|Overall Study||30
3316387|NCT03110770|4049700|FG001|STARTED|Overall Study||30
3316388|NCT03110770|4049701|FG002|STARTED|Overall Study||30
3316389|NCT03110770|4049702|FG003|STARTED|Overall Study||1170
3316390|NCT03110770|4049703|FG004|STARTED|Overall Study||1168
3316391|NCT03110770|4049699|FG000|Received First Product Administration|Overall Study||30
3316392|NCT03110770|4049700|FG001|Received First Product Administration|Overall Study||30
3316393|NCT03110770|4049701|FG002|Received First Product Administration|Overall Study||30
3316394|NCT03110770|4049702|FG003|Received First Product Administration|Overall Study||1162
3316395|NCT03110770|4049703|FG004|Received First Product Administration|Overall Study||1161
3316396|NCT03110770|4049699|FG000|Received Second Product Administration|Overall Study||30
3316397|NCT03110770|4049700|FG001|Received Second Product Administration|Overall Study||29
3316398|NCT03110770|4049701|FG002|Received Second Product Administration|Overall Study||29
3316399|NCT03110770|4049702|FG003|Received Second Product Administration|Overall Study||1126
3316400|NCT03110770|4049703|FG004|Received Second Product Administration|Overall Study||1127
3048862|NCT01210651|3769026|FG001|Number Attending 1st Assigned Session|Overall Study||12
3048863|NCT01210651|3769025|FG000|COMPLETED|Overall Study||15
3048864|NCT01210651|3769026|FG001|COMPLETED|Overall Study||10
3048865|NCT01210651|3769025|FG000|NOT COMPLETED|Overall Study||5
3048866|NCT01210651|3769026|FG001|NOT COMPLETED|Overall Study||8
3048867|NCT01210664|3769036|FG000|STARTED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||3
3048868|NCT01210664|3769037|FG001|STARTED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
3048869|NCT01210664|3769038|FG002|STARTED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
3048870|NCT01210664|3769039|FG003|STARTED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
3279790|NCT02720198|4013177|FG000|STARTED|Overall Study||29
3279791|NCT02720198|4013178|FG001|STARTED|Overall Study||31
3279792|NCT02720198|4013177|FG000|COMPLETED|Overall Study||29
3279793|NCT02720198|4013178|FG001|COMPLETED|Overall Study||30
3279794|NCT02720198|4013177|FG000|NOT COMPLETED|Overall Study||0
3279795|NCT02720198|4013178|FG001|NOT COMPLETED|Overall Study||1
3279796|NCT02720224|4013184|FG000|STARTED|Overall Study||6
3279797|NCT02720224|4013184|FG000|COMPLETED|Overall Study||6
3279798|NCT02720224|4013184|FG000|NOT COMPLETED|Overall Study||0
3279799|NCT02720484|4013188|FG000|STARTED|Treatment on Study||10
3279800|NCT02720484|4013188|FG000|Reached 1st Response/2 Cycles|Treatment on Study||7
3279801|NCT02720484|4013188|FG000|Treated Cycle 3|Treatment on Study||4
3279802|NCT02720484|4013188|FG000|COMPLETED|Treatment on Study||4
3279803|NCT02720484|4013188|FG000|NOT COMPLETED|Treatment on Study||6
3279804|NCT02720484|4013188|FG000|STARTED|Follow Up for 2 Years|All patients that receive at least one treatment on study go into follow up.|7
3279805|NCT02720484|4013188|FG000|COMPLETED|Follow Up for 2 Years||1
3279806|NCT02720484|4013188|FG000|NOT COMPLETED|Follow Up for 2 Years||6
3279807|NCT02720523|4013196|FG000|STARTED|Period 1: Placebo-controlled Period||49
3279808|NCT02720523|4013197|FG001|STARTED|Period 1: Placebo-controlled Period||49
3279809|NCT02720523|4013198|FG002|STARTED|Period 1: Placebo-controlled Period||49
3279810|NCT02720523|4013199|FG003|STARTED|Period 1: Placebo-controlled Period||50
3279811|NCT02720523|4013200|FG004|STARTED|Period 1: Placebo-controlled Period||0
3279812|NCT02720523|4013201|FG005|STARTED|Period 1: Placebo-controlled Period||0
3279813|NCT02720523|4013202|FG006|STARTED|Period 1: Placebo-controlled Period||0
3279814|NCT02720523|4013196|FG000|COMPLETED|Period 1: Placebo-controlled Period||47
3279815|NCT02720523|4013197|FG001|COMPLETED|Period 1: Placebo-controlled Period||49
3279816|NCT02720523|4013198|FG002|COMPLETED|Period 1: Placebo-controlled Period||47
3279817|NCT02720523|4013199|FG003|COMPLETED|Period 1: Placebo-controlled Period||44
3279818|NCT02720523|4013200|FG004|COMPLETED|Period 1: Placebo-controlled Period||0
3279819|NCT02720523|4013201|FG005|COMPLETED|Period 1: Placebo-controlled Period||0
3279820|NCT02720523|4013202|FG006|COMPLETED|Period 1: Placebo-controlled Period||0
3279821|NCT02720523|4013196|FG000|NOT COMPLETED|Period 1: Placebo-controlled Period||2
3279822|NCT02720523|4013197|FG001|NOT COMPLETED|Period 1: Placebo-controlled Period||0
3279823|NCT02720523|4013198|FG002|NOT COMPLETED|Period 1: Placebo-controlled Period||2
3279824|NCT02720523|4013199|FG003|NOT COMPLETED|Period 1: Placebo-controlled Period||6
3279825|NCT02720523|4013200|FG004|NOT COMPLETED|Period 1: Placebo-controlled Period||0
3279826|NCT02720523|4013201|FG005|NOT COMPLETED|Period 1: Placebo-controlled Period||0
3279827|NCT02720523|4013202|FG006|NOT COMPLETED|Period 1: Placebo-controlled Period||0
3279828|NCT02720523|4013196|FG000|STARTED|Period 2: Long-term Extension Period||0
3279829|NCT02720523|4013197|FG001|STARTED|Period 2: Long-term Extension Period||0
3279830|NCT02720523|4013198|FG002|STARTED|Period 2: Long-term Extension Period||0
3279831|NCT02720523|4013199|FG003|STARTED|Period 2: Long-term Extension Period||0
3279832|NCT02720523|4013200|FG004|STARTED|Period 2: Long-term Extension Period|Includes participants originally randomized to placebo and upadacitinib 7.5 mg|65
3279833|NCT02720523|4013201|FG005|STARTED|Period 2: Long-term Extension Period|Includes participants originally randomized to placebo and upadacitinib 15 mg|62
3279834|NCT02720523|4013202|FG006|STARTED|Period 2: Long-term Extension Period|Includes participants originally randomized to placebo and upadacitinib 30 mg|60
3279835|NCT02720523|4013196|FG000|COMPLETED|Period 2: Long-term Extension Period||0
3279836|NCT02720523|4013197|FG001|COMPLETED|Period 2: Long-term Extension Period||0
3279837|NCT02720523|4013198|FG002|COMPLETED|Period 2: Long-term Extension Period||0
3279838|NCT02720523|4013199|FG003|COMPLETED|Period 2: Long-term Extension Period||0
3279839|NCT02720523|4013200|FG004|COMPLETED|Period 2: Long-term Extension Period||0
3279840|NCT02720523|4013201|FG005|COMPLETED|Period 2: Long-term Extension Period||0
3279841|NCT02720523|4013202|FG006|COMPLETED|Period 2: Long-term Extension Period||0
3279842|NCT02720523|4013196|FG000|NOT COMPLETED|Period 2: Long-term Extension Period||0
3279843|NCT02720523|4013197|FG001|NOT COMPLETED|Period 2: Long-term Extension Period||0
3279844|NCT02720523|4013198|FG002|NOT COMPLETED|Period 2: Long-term Extension Period||0
3279845|NCT02720523|4013199|FG003|NOT COMPLETED|Period 2: Long-term Extension Period||0
3279846|NCT02720523|4013200|FG004|NOT COMPLETED|Period 2: Long-term Extension Period||65
3279847|NCT02720523|4013201|FG005|NOT COMPLETED|Period 2: Long-term Extension Period||62
3279848|NCT02720523|4013202|FG006|NOT COMPLETED|Period 2: Long-term Extension Period||60
3279849|NCT02720536|4013215|FG000|STARTED|Overall Study||53
3279850|NCT02720536|4013215|FG000|COMPLETED|Overall Study||34
3279851|NCT02720536|4013215|FG000|NOT COMPLETED|Overall Study||19
3279852|NCT02720627|4013225|FG000|STARTED|Overall Study||27
3279853|NCT02720627|4013225|FG000|COMPLETED|Overall Study||27
3279854|NCT02720627|4013225|FG000|NOT COMPLETED|Overall Study||0
3279855|NCT02720757|4013229|FG000|STARTED|Overall Study||132
3279856|NCT02720757|4013229|FG000|COMPLETED|Overall Study||114
3048871|NCT01210664|3769036|FG000|Received Study Treatment|Cohort 1: PolyTregs 0.05 x 10^8 Cells||3
3048872|NCT01210664|3769037|FG001|Received Study Treatment|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
3048873|NCT01210664|3769038|FG002|Received Study Treatment|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
3048874|NCT01210664|3769039|FG003|Received Study Treatment|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
3048875|NCT01210664|3769036|FG000|COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||3
3048876|NCT01210664|3769037|FG001|COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
3048877|NCT01210664|3769038|FG002|COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
3048878|NCT01210664|3769039|FG003|COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
3048879|NCT01210664|3769036|FG000|NOT COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
3048880|NCT01210664|3769037|FG001|NOT COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
3048881|NCT01210664|3769038|FG002|NOT COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
3048882|NCT01210664|3769039|FG003|NOT COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
3048883|NCT01210664|3769036|FG000|STARTED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
3048884|NCT01210664|3769037|FG001|STARTED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||3
3048885|NCT01210664|3769038|FG002|STARTED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
3048886|NCT01210664|3769039|FG003|STARTED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
3048887|NCT01210664|3769036|FG000|Received Study Treatment|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
3048888|NCT01210664|3769037|FG001|Received Study Treatment|Cohort 2: PolyTregs 0.4 x 10^8 Cells||3
3048889|NCT01210664|3769038|FG002|Received Study Treatment|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
3048890|NCT01210664|3769039|FG003|Received Study Treatment|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
3048891|NCT01210664|3769036|FG000|COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
3048892|NCT01210664|3769037|FG001|COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||3
3048893|NCT01210664|3769038|FG002|COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
3048894|NCT01210664|3769039|FG003|COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
3048895|NCT01210664|3769036|FG000|NOT COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
3048896|NCT01210664|3769037|FG001|NOT COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
3048897|NCT01210664|3769038|FG002|NOT COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
3048898|NCT01210664|3769039|FG003|NOT COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
3048899|NCT01210664|3769036|FG000|STARTED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
3048900|NCT01210664|3769037|FG001|STARTED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
3048901|NCT01210664|3769038|FG002|STARTED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||5
3048902|NCT01210664|3769039|FG003|STARTED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
3048903|NCT01210664|3769036|FG000|Received Study Treatment|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
3048904|NCT01210664|3769037|FG001|Received Study Treatment|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
3048905|NCT01210664|3769038|FG002|Received Study Treatment|Cohort 3: PolyTregs 3.2 x 10^8 Cells||4
3048906|NCT01210664|3769039|FG003|Received Study Treatment|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
3048907|NCT01210664|3769036|FG000|COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
3279857|NCT02720757|4013229|FG000|NOT COMPLETED|Overall Study||18
3279858|NCT02720952|4013233|FG000|STARTED|Overall Study||24
3279859|NCT02720952|4013233|FG000|COMPLETED|Overall Study||24
3279860|NCT02720952|4013233|FG000|NOT COMPLETED|Overall Study||0
3279861|NCT02721017|4013243|FG000|STARTED|Hospital Stay|Intraoperative Application of Cryoanalgesia started on Date of Surgery (DOS).|10
3279862|NCT02721017|4013244|FG001|STARTED|Hospital Stay|Thoracic Epidural placed on Date of Surgery (DOS).|10
3279863|NCT02721017|4013243|FG000|COMPLETED|Hospital Stay|Completed during the course of surgery.|10
3279864|NCT02721017|4013244|FG001|COMPLETED|Hospital Stay|Removal occurs prior to Hospital Discharge.|10
3279865|NCT02721017|4013243|FG000|NOT COMPLETED|Hospital Stay||0
3279866|NCT02721017|4013244|FG001|NOT COMPLETED|Hospital Stay||0
3279867|NCT02721017|4013243|FG000|STARTED|Participant Follow Up|Assessment of recovery at 2 weeks, 1 month, 3 month and 12 month intervals.|10
3279868|NCT02721017|4013244|FG001|STARTED|Participant Follow Up|Assessment of recovery at 2 weeks, 1 month, 3 month and 12 month intervals.|10
3279869|NCT02721017|4013243|FG000|COMPLETED|Participant Follow Up|12 months after Date of Surgery.|10
3279870|NCT02721017|4013244|FG001|COMPLETED|Participant Follow Up|12 months after Date of Surgery.|10
3279871|NCT02721017|4013243|FG000|NOT COMPLETED|Participant Follow Up||0
3279872|NCT02721017|4013244|FG001|NOT COMPLETED|Participant Follow Up||0
3279873|NCT02721147|4013255|FG000|STARTED|Overall Study||40
3279874|NCT02721147|4013256|FG001|STARTED|Overall Study||18
3279875|NCT02721147|4013257|FG002|STARTED|Overall Study||31
3279876|NCT02721147|4013255|FG000|COMPLETED|Overall Study||38
3279877|NCT02721147|4013256|FG001|COMPLETED|Overall Study||18
3279878|NCT02721147|4013257|FG002|COMPLETED|Overall Study||31
3279879|NCT02721147|4013255|FG000|NOT COMPLETED|Overall Study||2
3279880|NCT02721147|4013256|FG001|NOT COMPLETED|Overall Study||0
3279881|NCT02721147|4013257|FG002|NOT COMPLETED|Overall Study||0
3279882|NCT02721251|4013268|FG000|STARTED|Overall Study||14
3279883|NCT02721251|4013269|FG001|STARTED|Overall Study||16
3279884|NCT02721251|4013270|FG002|STARTED|Overall Study||17
3279885|NCT02721251|4013268|FG000|COMPLETED|Overall Study||4
3279886|NCT02721251|4013269|FG001|COMPLETED|Overall Study||7
3279887|NCT02721251|4013270|FG002|COMPLETED|Overall Study||6
3279888|NCT02721251|4013268|FG000|NOT COMPLETED|Overall Study||10
3279889|NCT02721251|4013269|FG001|NOT COMPLETED|Overall Study||9
3279890|NCT02721251|4013270|FG002|NOT COMPLETED|Overall Study||11
3279891|NCT02721355|4013281|FG000|STARTED|Overall Study||42
3279892|NCT02721355|4013282|FG001|STARTED|Overall Study||42
3279893|NCT02721355|4013281|FG000|COMPLETED|Overall Study||36
3279894|NCT02721355|4013282|FG001|COMPLETED|Overall Study||41
3048908|NCT01210664|3769037|FG001|COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
3048909|NCT01210664|3769038|FG002|COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||3
3048910|NCT01210664|3769039|FG003|COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
3048911|NCT01210664|3769036|FG000|NOT COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
3048912|NCT01210664|3769037|FG001|NOT COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
3048913|NCT01210664|3769038|FG002|NOT COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||2
3048914|NCT01210664|3769039|FG003|NOT COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
3048915|NCT01210664|3769036|FG000|STARTED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
3048916|NCT01210664|3769037|FG001|STARTED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
3048917|NCT01210664|3769038|FG002|STARTED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
3048918|NCT01210664|3769039|FG003|STARTED|Cohort 4: PolyTregs 26 x 10^8 Cells||5
3048919|NCT01210664|3769036|FG000|Received Study Treatment|Cohort 4: PolyTregs 26 x 10^8 Cells||0
3048920|NCT01210664|3769037|FG001|Received Study Treatment|Cohort 4: PolyTregs 26 x 10^8 Cells||0
3048921|NCT01210664|3769038|FG002|Received Study Treatment|Cohort 4: PolyTregs 26 x 10^8 Cells||0
3048922|NCT01210664|3769039|FG003|Received Study Treatment|Cohort 4: PolyTregs 26 x 10^8 Cells||4
3048923|NCT01210664|3769036|FG000|COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
3279895|NCT02721355|4013281|FG000|NOT COMPLETED|Overall Study||6
3279896|NCT02721355|4013282|FG001|NOT COMPLETED|Overall Study||1
3279897|NCT02721641|4013288|FG000|STARTED|Overall Study||69
3279898|NCT02721641|4013288|FG000|COMPLETED|Overall Study|In this continued access study, all participants were considered to have completed per protocol.|69
3279899|NCT02721641|4013288|FG000|NOT COMPLETED|Overall Study||0
3279900|NCT02721875|4013294|FG000|STARTED|Overall Study||1
3279901|NCT02721875|4013295|FG001|STARTED|Overall Study||0
3279902|NCT02721875|4013294|FG000|COMPLETED|Overall Study||0
3279903|NCT02721875|4013295|FG001|COMPLETED|Overall Study||0
3279904|NCT02721875|4013294|FG000|NOT COMPLETED|Overall Study||1
3279905|NCT02721875|4013295|FG001|NOT COMPLETED|Overall Study||0
3279906|NCT02721966|4013304|FG000|STARTED|Overall Study||167
3279907|NCT02721966|4013305|FG001|STARTED|Overall Study||165
3279908|NCT02721966|4013306|FG002|STARTED|Overall Study||81
3279909|NCT02721966|4013307|FG003|STARTED|Overall Study||80
3279910|NCT02721966|4013308|FG004|STARTED|Overall Study||5
3279911|NCT02721966|4013304|FG000|Completed Period 1 & Went to Period 2|Overall Study||162
3279912|NCT02721966|4013305|FG001|Completed Period 1 & Went to Period 2|Overall Study||153
3279913|NCT02721966|4013306|FG002|Completed Period 1 & Went to Period 2|Overall Study||81
3279914|NCT02721966|4013307|FG003|Completed Period 1 & Went to Period 2|Overall Study||80
3279915|NCT02721966|4013308|FG004|Completed Period 1 & Went to Period 2|Overall Study||0
3279916|NCT02721966|4013304|FG000|COMPLETED|Overall Study||138
3279917|NCT02721966|4013305|FG001|COMPLETED|Overall Study||142
3279918|NCT02721966|4013306|FG002|COMPLETED|Overall Study||72
3279919|NCT02721966|4013307|FG003|COMPLETED|Overall Study||73
3279920|NCT02721966|4013308|FG004|COMPLETED|Overall Study||0
3279921|NCT02721966|4013304|FG000|NOT COMPLETED|Overall Study||29
3279922|NCT02721966|4013305|FG001|NOT COMPLETED|Overall Study||23
3279923|NCT02721966|4013306|FG002|NOT COMPLETED|Overall Study||9
3279924|NCT02721966|4013307|FG003|NOT COMPLETED|Overall Study||7
3279925|NCT02721966|4013308|FG004|NOT COMPLETED|Overall Study||5
3279926|NCT02722044|4013316|FG000|STARTED|Overall Study||33
3279927|NCT02722044|4013316|FG000|COMPLETED|Overall Study||28
3279928|NCT02722044|4013316|FG000|NOT COMPLETED|Overall Study||5
3279929|NCT02722148|4013321|FG000|STARTED|Overall Study||24
3279930|NCT02722148|4013321|FG000|COMPLETED|Overall Study||19
3279931|NCT02722148|4013321|FG000|NOT COMPLETED|Overall Study||5
3279932|NCT02722239|4013327|FG000|STARTED|Overall Study||20
3279933|NCT02722239|4013328|FG001|STARTED|Overall Study||20
3279934|NCT02722239|4013327|FG000|First Intervention (1 Day)|Overall Study||20
3279935|NCT02722239|4013328|FG001|First Intervention (1 Day)|Overall Study||20
3279936|NCT02722239|4013327|FG000|Washout (7 Days)|Overall Study||20
3279937|NCT02722239|4013328|FG001|Washout (7 Days)|Overall Study||20
3279938|NCT02722239|4013327|FG000|Second Intervention (1 Day)|Overall Study||20
3279939|NCT02722239|4013328|FG001|Second Intervention (1 Day)|Overall Study||20
3279940|NCT02722239|4013327|FG000|COMPLETED|Overall Study||20
3279941|NCT02722239|4013328|FG001|COMPLETED|Overall Study||20
3279942|NCT02722239|4013327|FG000|NOT COMPLETED|Overall Study||0
3279943|NCT02722239|4013328|FG001|NOT COMPLETED|Overall Study||0
3279944|NCT02722278|4013337|FG000|STARTED|Overall Study||166
3279945|NCT02722278|4013338|FG001|STARTED|Overall Study||56
3279946|NCT02722278|4013337|FG000|COMPLETED|Overall Study||154
3279947|NCT02722278|4013338|FG001|COMPLETED|Overall Study||49
3279948|NCT02722278|4013337|FG000|NOT COMPLETED|Overall Study||12
3279949|NCT02722278|4013338|FG001|NOT COMPLETED|Overall Study||7
3279950|NCT02722304|4013351|FG000|STARTED|Overall Study||1
3279951|NCT02722304|4013352|FG001|STARTED|Overall Study||0
3279952|NCT02722304|4013353|FG002|STARTED|Overall Study||2
3279953|NCT02722304|4013354|FG003|STARTED|Overall Study||2
3279954|NCT02722304|4013355|FG004|STARTED|Overall Study||2
3279955|NCT02722304|4013351|FG000|Treated|Overall Study||1
3279956|NCT02722304|4013352|FG001|Treated|Overall Study||0
3279957|NCT02722304|4013353|FG002|Treated|Overall Study||1
3279958|NCT02722304|4013354|FG003|Treated|Overall Study||1
3279959|NCT02722304|4013355|FG004|Treated|Overall Study||2
3279960|NCT02722304|4013351|FG000|COMPLETED|Overall Study||0
3279961|NCT02722304|4013352|FG001|COMPLETED|Overall Study||0
3279962|NCT02722304|4013353|FG002|COMPLETED|Overall Study||0
3279963|NCT02722304|4013354|FG003|COMPLETED|Overall Study||0
3048924|NCT01210664|3769037|FG001|COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
3048925|NCT01210664|3769038|FG002|COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
3048926|NCT01210664|3769039|FG003|COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||4
3048927|NCT01210664|3769036|FG000|NOT COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
3048928|NCT01210664|3769037|FG001|NOT COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
3048929|NCT01210664|3769038|FG002|NOT COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
3048930|NCT01210664|3769039|FG003|NOT COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||1
3048931|NCT01210690|3769049|FG000|STARTED|Overall Study||101
3048932|NCT01210690|3769049|FG000|COMPLETED|Overall Study||75
3048933|NCT01210690|3769049|FG000|NOT COMPLETED|Overall Study||26
3048934|NCT01210716|3769054|FG000|STARTED|First TPE Procedure||20
3048935|NCT01210716|3769055|FG001|STARTED|First TPE Procedure||17
3048936|NCT01210716|3769054|FG000|COMPLETED|First TPE Procedure||18
3279964|NCT02722304|4013355|FG004|COMPLETED|Overall Study||0
3279965|NCT02722304|4013351|FG000|NOT COMPLETED|Overall Study||1
3279966|NCT02722304|4013352|FG001|NOT COMPLETED|Overall Study||0
3279967|NCT02722304|4013353|FG002|NOT COMPLETED|Overall Study||2
3279968|NCT02722304|4013354|FG003|NOT COMPLETED|Overall Study||2
3279969|NCT02722304|4013355|FG004|NOT COMPLETED|Overall Study||2
3279970|NCT02722330|4013369|FG000|STARTED|Overall Study||23
3279971|NCT02722330|4013369|FG000|COMPLETED|Overall Study||23
3279972|NCT02722330|4013369|FG000|NOT COMPLETED|Overall Study||0
3279973|NCT02722408|4013373|FG000|STARTED|Overall Study||8
3279974|NCT02722408|4013373|FG000|COMPLETED|Overall Study||8
3279975|NCT02722408|4013373|FG000|NOT COMPLETED|Overall Study||0
3279976|NCT02722499|4013382|FG000|STARTED|Overall Study||20
3279977|NCT02722499|4013383|FG001|STARTED|Overall Study||20
3279978|NCT02722499|4013384|FG002|STARTED|Overall Study||20
3279979|NCT02722499|4013382|FG000|COMPLETED|Overall Study||18
3279980|NCT02722499|4013383|FG001|COMPLETED|Overall Study||20
3279981|NCT02722499|4013384|FG002|COMPLETED|Overall Study||19
3279982|NCT02722499|4013382|FG000|NOT COMPLETED|Overall Study||2
3279983|NCT02722499|4013383|FG001|NOT COMPLETED|Overall Study||0
3279984|NCT02722499|4013384|FG002|NOT COMPLETED|Overall Study||1
3279985|NCT02722564|4013392|FG000|STARTED|Overall Study||55
3279986|NCT02722564|4013392|FG000|COMPLETED|Overall Study||55
3279987|NCT02722564|4013392|FG000|NOT COMPLETED|Overall Study||0
3279988|NCT02722577|4013396|FG000|STARTED|Overall Study||20
3279989|NCT02722577|4013396|FG000|COMPLETED|Overall Study||20
3279990|NCT02722577|4013396|FG000|NOT COMPLETED|Overall Study||0
3279991|NCT02722837|4013400|FG000|STARTED|Overall Study||119
3279992|NCT02722837|4013400|FG000|COMPLETED|Overall Study||119
3279993|NCT02722837|4013400|FG000|NOT COMPLETED|Overall Study||0
3279994|NCT02722863|4013404|FG000|STARTED|Overall Study||908
3279995|NCT02722863|4013404|FG000|COMPLETED|Overall Study||908
3279996|NCT02722863|4013404|FG000|NOT COMPLETED|Overall Study||0
3279997|NCT02722928|4013411|FG000|STARTED|Overall Study||49
3279998|NCT02722928|4013412|FG001|STARTED|Overall Study||51
3279999|NCT02722928|4013411|FG000|COMPLETED|Overall Study||39
3280000|NCT02722928|4013412|FG001|COMPLETED|Overall Study||31
3280001|NCT02722928|4013411|FG000|NOT COMPLETED|Overall Study||10
3280002|NCT02722928|4013412|FG001|NOT COMPLETED|Overall Study||20
3280003|NCT02722967|4013425|FG000|STARTED|Overall Study||22
3280004|NCT02722967|4013426|FG001|STARTED|Overall Study||12
3280005|NCT02722967|4013427|FG002|STARTED|Overall Study||15
3280006|NCT02722967|4013425|FG000|COMPLETED|Overall Study||17
3280007|NCT02722967|4013426|FG001|COMPLETED|Overall Study||10
3280008|NCT02722967|4013427|FG002|COMPLETED|Overall Study||11
3280009|NCT02722967|4013425|FG000|NOT COMPLETED|Overall Study||5
3280010|NCT02722967|4013426|FG001|NOT COMPLETED|Overall Study||2
3280011|NCT02722967|4013427|FG002|NOT COMPLETED|Overall Study||4
3280012|NCT02723006|4013438|FG000|STARTED|Overall Study||1
3280013|NCT02723006|4013439|FG001|STARTED|Overall Study||9
3280014|NCT02723006|4013440|FG002|STARTED|Overall Study||12
3280015|NCT02723006|4013438|FG000|COMPLETED|Overall Study||0
3280016|NCT02723006|4013439|FG001|COMPLETED|Overall Study||2
3280017|NCT02723006|4013440|FG002|COMPLETED|Overall Study||5
3280018|NCT02723006|4013438|FG000|NOT COMPLETED|Overall Study||1
3280019|NCT02723006|4013439|FG001|NOT COMPLETED|Overall Study||7
3280020|NCT02723006|4013440|FG002|NOT COMPLETED|Overall Study||7
3280021|NCT02723084|4013450|FG000|STARTED|Overall Study||90
3280022|NCT02723084|4013451|FG001|STARTED|Overall Study||46
3280023|NCT02723084|4013450|FG000|COMPLETED|Overall Study||86
3280024|NCT02723084|4013451|FG001|COMPLETED|Overall Study||45
3280025|NCT02723084|4013450|FG000|NOT COMPLETED|Overall Study||4
3280026|NCT02723084|4013451|FG001|NOT COMPLETED|Overall Study||1
3280027|NCT02723175|4013459|FG000|STARTED|Overall Study||8
3280028|NCT02723175|4013460|FG001|STARTED|Overall Study||7
3280029|NCT02723175|4013459|FG000|COMPLETED|Overall Study||4
3280030|NCT02723175|4013460|FG001|COMPLETED|Overall Study||4
3280031|NCT02723175|4013459|FG000|NOT COMPLETED|Overall Study||4
3280032|NCT02723175|4013460|FG001|NOT COMPLETED|Overall Study||3
3280033|NCT02723188|4013469|FG000|STARTED|Overall Study||15
3280034|NCT02723188|4013470|FG001|STARTED|Overall Study||15
3280035|NCT02723188|4013471|FG002|STARTED|Overall Study||15
3280036|NCT02723188|4013469|FG000|COMPLETED|Overall Study||14
3280037|NCT02723188|4013470|FG001|COMPLETED|Overall Study||15
3048937|NCT01210716|3769055|FG001|COMPLETED|First TPE Procedure||15
3280038|NCT02723188|4013471|FG002|COMPLETED|Overall Study||15
3280039|NCT02723188|4013469|FG000|NOT COMPLETED|Overall Study||1
3280040|NCT02723188|4013470|FG001|NOT COMPLETED|Overall Study||0
3048938|NCT01210716|3769054|FG000|NOT COMPLETED|First TPE Procedure||2
3280041|NCT02723188|4013471|FG002|NOT COMPLETED|Overall Study||0
3280042|NCT02723201|4013482|FG000|STARTED|First Intervention Period||11
3280043|NCT02723201|4013483|FG001|STARTED|First Intervention Period||7
3280044|NCT02723201|4013484|FG002|STARTED|First Intervention Period||7
3280045|NCT02723201|4013482|FG000|COMPLETED|First Intervention Period||11
3280046|NCT02723201|4013483|FG001|COMPLETED|First Intervention Period||7
3280047|NCT02723201|4013484|FG002|COMPLETED|First Intervention Period||7
3280048|NCT02723201|4013482|FG000|NOT COMPLETED|First Intervention Period||0
3280049|NCT02723201|4013483|FG001|NOT COMPLETED|First Intervention Period||0
3280050|NCT02723201|4013484|FG002|NOT COMPLETED|First Intervention Period||0
3280051|NCT02723201|4013482|FG000|STARTED|Washout Period 1||11
3280052|NCT02723201|4013483|FG001|STARTED|Washout Period 1||7
3280053|NCT02723201|4013484|FG002|STARTED|Washout Period 1||7
3280054|NCT02723201|4013482|FG000|COMPLETED|Washout Period 1||11
3280055|NCT02723201|4013483|FG001|COMPLETED|Washout Period 1||7
3280056|NCT02723201|4013484|FG002|COMPLETED|Washout Period 1||7
3280057|NCT02723201|4013482|FG000|NOT COMPLETED|Washout Period 1||0
3280058|NCT02723201|4013483|FG001|NOT COMPLETED|Washout Period 1||0
3280059|NCT02723201|4013484|FG002|NOT COMPLETED|Washout Period 1||0
3280060|NCT02723201|4013482|FG000|STARTED|Second Intervention Period||11
3280061|NCT02723201|4013483|FG001|STARTED|Second Intervention Period||7
3280062|NCT02723201|4013484|FG002|STARTED|Second Intervention Period||7
3280063|NCT02723201|4013482|FG000|COMPLETED|Second Intervention Period||9
3280064|NCT02723201|4013483|FG001|COMPLETED|Second Intervention Period||7
3280065|NCT02723201|4013484|FG002|COMPLETED|Second Intervention Period||7
3280066|NCT02723201|4013482|FG000|NOT COMPLETED|Second Intervention Period||2
3280067|NCT02723201|4013483|FG001|NOT COMPLETED|Second Intervention Period||0
3280068|NCT02723201|4013484|FG002|NOT COMPLETED|Second Intervention Period||0
3280069|NCT02723201|4013482|FG000|STARTED|Washout Period 2||9
3280070|NCT02723201|4013483|FG001|STARTED|Washout Period 2||0
3280071|NCT02723201|4013484|FG002|STARTED|Washout Period 2||0
3280072|NCT02723201|4013482|FG000|COMPLETED|Washout Period 2||9
3280073|NCT02723201|4013483|FG001|COMPLETED|Washout Period 2||0
3280074|NCT02723201|4013484|FG002|COMPLETED|Washout Period 2||0
3280075|NCT02723201|4013482|FG000|NOT COMPLETED|Washout Period 2||0
3280076|NCT02723201|4013483|FG001|NOT COMPLETED|Washout Period 2||0
3280077|NCT02723201|4013484|FG002|NOT COMPLETED|Washout Period 2||0
3280078|NCT02723201|4013482|FG000|STARTED|Third Intervention Period||9
3280079|NCT02723201|4013483|FG001|STARTED|Third Intervention Period||0
3280080|NCT02723201|4013484|FG002|STARTED|Third Intervention Period||0
3280081|NCT02723201|4013482|FG000|COMPLETED|Third Intervention Period||9
3280082|NCT02723201|4013483|FG001|COMPLETED|Third Intervention Period||0
3280083|NCT02723201|4013484|FG002|COMPLETED|Third Intervention Period||0
3280084|NCT02723201|4013482|FG000|NOT COMPLETED|Third Intervention Period||0
3280085|NCT02723201|4013483|FG001|NOT COMPLETED|Third Intervention Period||0
3280086|NCT02723201|4013484|FG002|NOT COMPLETED|Third Intervention Period||0
3280087|NCT02723201|4013482|FG000|STARTED|Washout Period 3||9
3280088|NCT02723201|4013483|FG001|STARTED|Washout Period 3||0
3280089|NCT02723201|4013484|FG002|STARTED|Washout Period 3||0
3280090|NCT02723201|4013482|FG000|COMPLETED|Washout Period 3||9
3280091|NCT02723201|4013483|FG001|COMPLETED|Washout Period 3||0
3280092|NCT02723201|4013484|FG002|COMPLETED|Washout Period 3||0
3280093|NCT02723201|4013482|FG000|NOT COMPLETED|Washout Period 3||0
3280094|NCT02723201|4013483|FG001|NOT COMPLETED|Washout Period 3||0
3280095|NCT02723201|4013484|FG002|NOT COMPLETED|Washout Period 3||0
3280096|NCT02723201|4013482|FG000|STARTED|Fourth Intervention Period||9
3280097|NCT02723201|4013483|FG001|STARTED|Fourth Intervention Period||0
3280098|NCT02723201|4013484|FG002|STARTED|Fourth Intervention Period||0
3280099|NCT02723201|4013482|FG000|COMPLETED|Fourth Intervention Period||9
3280100|NCT02723201|4013483|FG001|COMPLETED|Fourth Intervention Period||0
3280101|NCT02723201|4013484|FG002|COMPLETED|Fourth Intervention Period||0
3280102|NCT02723201|4013482|FG000|NOT COMPLETED|Fourth Intervention Period||0
3280103|NCT02723201|4013483|FG001|NOT COMPLETED|Fourth Intervention Period||0
3280104|NCT02723201|4013484|FG002|NOT COMPLETED|Fourth Intervention Period||0
3280105|NCT02723344|4013500|FG000|STARTED|Overall Study||15
3280106|NCT02723344|4013501|FG001|STARTED|Overall Study||16
3280107|NCT02723344|4013500|FG000|COMPLETED|Overall Study||15
3280108|NCT02723344|4013501|FG001|COMPLETED|Overall Study||12
3280109|NCT02723344|4013500|FG000|NOT COMPLETED|Overall Study||0
3280110|NCT02723344|4013501|FG001|NOT COMPLETED|Overall Study||4
3280111|NCT02723591|4013509|FG000|STARTED|Overall Study||300
3280112|NCT02723591|4013510|FG001|STARTED|Overall Study||299
3280113|NCT02723591|4013509|FG000|COMPLETED|Overall Study||204
3280114|NCT02723591|4013510|FG001|COMPLETED|Overall Study||198
3280115|NCT02723591|4013509|FG000|NOT COMPLETED|Overall Study||96
3280116|NCT02723591|4013510|FG001|NOT COMPLETED|Overall Study||101
3280117|NCT02723630|4013522|FG000|STARTED|Intervention Period 1||10
3280118|NCT02723630|4013523|FG001|STARTED|Intervention Period 1||10
3280119|NCT02723630|4013524|FG002|STARTED|Intervention Period 1||10
3280120|NCT02723630|4013525|FG003|STARTED|Intervention Period 1||10
3280121|NCT02723630|4013526|FG004|STARTED|Intervention Period 1||10
3280122|NCT02723630|4013527|FG005|STARTED|Intervention Period 1||10
3280123|NCT02723630|4013522|FG000|COMPLETED|Intervention Period 1||9
3280124|NCT02723630|4013523|FG001|COMPLETED|Intervention Period 1||10
3280125|NCT02723630|4013524|FG002|COMPLETED|Intervention Period 1||10
3048939|NCT01210716|3769055|FG001|NOT COMPLETED|First TPE Procedure||2
3048940|NCT01210716|3769054|FG000|STARTED|Second TPE Procedure||18
3048941|NCT01210716|3769055|FG001|STARTED|Second TPE Procedure||15
3048942|NCT01210716|3769054|FG000|COMPLETED|Second TPE Procedure||15
3048943|NCT01210716|3769055|FG001|COMPLETED|Second TPE Procedure||15
3048944|NCT01210716|3769054|FG000|NOT COMPLETED|Second TPE Procedure||3
3048945|NCT01210716|3769055|FG001|NOT COMPLETED|Second TPE Procedure||0
3048946|NCT01210807|3769063|FG000|STARTED|Overall Study||36
3048947|NCT01210807|3769064|FG001|STARTED|Overall Study||34
3048948|NCT01210807|3769063|FG000|COMPLETED|Overall Study||33
3048949|NCT01210807|3769064|FG001|COMPLETED|Overall Study||31
3048950|NCT01210807|3769063|FG000|NOT COMPLETED|Overall Study||3
3048951|NCT01210807|3769064|FG001|NOT COMPLETED|Overall Study||3
3048952|NCT01210820|3769072|FG000|STARTED|Overall Study||17
3048953|NCT01210820|3769073|FG001|STARTED|Overall Study||4
3048954|NCT01210820|3769072|FG000|COMPLETED|Overall Study||17
3280126|NCT02723630|4013525|FG003|COMPLETED|Intervention Period 1||10
3280127|NCT02723630|4013526|FG004|COMPLETED|Intervention Period 1||10
3280128|NCT02723630|4013527|FG005|COMPLETED|Intervention Period 1||10
3280129|NCT02723630|4013522|FG000|NOT COMPLETED|Intervention Period 1||1
3280130|NCT02723630|4013523|FG001|NOT COMPLETED|Intervention Period 1||0
3280131|NCT02723630|4013524|FG002|NOT COMPLETED|Intervention Period 1||0
3280132|NCT02723630|4013525|FG003|NOT COMPLETED|Intervention Period 1||0
3280133|NCT02723630|4013526|FG004|NOT COMPLETED|Intervention Period 1||0
3280134|NCT02723630|4013527|FG005|NOT COMPLETED|Intervention Period 1||0
3280135|NCT02723630|4013522|FG000|STARTED|Intervention Period 2||9
3280136|NCT02723630|4013523|FG001|STARTED|Intervention Period 2||10
3280137|NCT02723630|4013524|FG002|STARTED|Intervention Period 2||10
3280138|NCT02723630|4013525|FG003|STARTED|Intervention Period 2||10
3280139|NCT02723630|4013526|FG004|STARTED|Intervention Period 2||10
3280140|NCT02723630|4013527|FG005|STARTED|Intervention Period 2||10
3280141|NCT02723630|4013522|FG000|COMPLETED|Intervention Period 2||9
3280142|NCT02723630|4013523|FG001|COMPLETED|Intervention Period 2||10
3280143|NCT02723630|4013524|FG002|COMPLETED|Intervention Period 2||10
3280144|NCT02723630|4013525|FG003|COMPLETED|Intervention Period 2||10
3280145|NCT02723630|4013526|FG004|COMPLETED|Intervention Period 2||10
3280146|NCT02723630|4013527|FG005|COMPLETED|Intervention Period 2||10
3280147|NCT02723630|4013522|FG000|NOT COMPLETED|Intervention Period 2||0
3280148|NCT02723630|4013523|FG001|NOT COMPLETED|Intervention Period 2||0
3280149|NCT02723630|4013524|FG002|NOT COMPLETED|Intervention Period 2||0
3280150|NCT02723630|4013525|FG003|NOT COMPLETED|Intervention Period 2||0
3280151|NCT02723630|4013526|FG004|NOT COMPLETED|Intervention Period 2||0
3280152|NCT02723630|4013527|FG005|NOT COMPLETED|Intervention Period 2||0
3280153|NCT02723630|4013522|FG000|STARTED|Intervention Period 3||9
3280154|NCT02723630|4013523|FG001|STARTED|Intervention Period 3||10
3280155|NCT02723630|4013524|FG002|STARTED|Intervention Period 3||10
3280156|NCT02723630|4013525|FG003|STARTED|Intervention Period 3||10
3280157|NCT02723630|4013526|FG004|STARTED|Intervention Period 3||10
3280158|NCT02723630|4013527|FG005|STARTED|Intervention Period 3||10
3280159|NCT02723630|4013522|FG000|COMPLETED|Intervention Period 3||9
3280160|NCT02723630|4013523|FG001|COMPLETED|Intervention Period 3||9
3280161|NCT02723630|4013524|FG002|COMPLETED|Intervention Period 3||10
3280162|NCT02723630|4013525|FG003|COMPLETED|Intervention Period 3||10
3280163|NCT02723630|4013526|FG004|COMPLETED|Intervention Period 3||10
3280164|NCT02723630|4013527|FG005|COMPLETED|Intervention Period 3||10
3280165|NCT02723630|4013522|FG000|NOT COMPLETED|Intervention Period 3||0
3280166|NCT02723630|4013523|FG001|NOT COMPLETED|Intervention Period 3||1
3280167|NCT02723630|4013524|FG002|NOT COMPLETED|Intervention Period 3||0
3280168|NCT02723630|4013525|FG003|NOT COMPLETED|Intervention Period 3||0
3280169|NCT02723630|4013526|FG004|NOT COMPLETED|Intervention Period 3||0
3280170|NCT02723630|4013527|FG005|NOT COMPLETED|Intervention Period 3||0
3280171|NCT02723786|4013540|FG000|STARTED|Overall Study||7
3280172|NCT02723786|4013540|FG000|COMPLETED|Overall Study||6
3280173|NCT02723786|4013540|FG000|NOT COMPLETED|Overall Study||1
3280174|NCT02723916|4013546|FG000|STARTED|Overall Study||144
3280175|NCT02723916|4013547|FG001|STARTED|Overall Study||143
3280176|NCT02723916|4013546|FG000|COMPLETED|Overall Study||135
3280177|NCT02723916|4013547|FG001|COMPLETED|Overall Study||137
3280178|NCT02723916|4013546|FG000|NOT COMPLETED|Overall Study||9
3280179|NCT02723916|4013547|FG001|NOT COMPLETED|Overall Study||6
3280180|NCT02723929|4013555|FG000|STARTED|Overall Study||30
3280181|NCT02723929|4013556|FG001|STARTED|Overall Study||34
3280182|NCT02723929|4013555|FG000|COMPLETED|Overall Study||24
3280183|NCT02723929|4013556|FG001|COMPLETED|Overall Study||24
3280184|NCT02723929|4013555|FG000|NOT COMPLETED|Overall Study||6
3280185|NCT02723929|4013556|FG001|NOT COMPLETED|Overall Study||10
3280186|NCT02724020|4013567|FG000|STARTED|Overall Study||32
3280187|NCT02724020|4013568|FG001|STARTED|Overall Study||32
3280188|NCT02724020|4013569|FG002|STARTED|Overall Study||32
3280189|NCT02724020|4013567|FG000|Treated (Safety Analysis Set)|Overall Study||32
3048955|NCT01210820|3769073|FG001|COMPLETED|Overall Study||4
3048956|NCT01210820|3769072|FG000|NOT COMPLETED|Overall Study||0
3048957|NCT01210820|3769073|FG001|NOT COMPLETED|Overall Study||0
3048958|NCT01211106|3769081|FG000|STARTED|Overall Study||95
3048959|NCT01211106|3769082|FG001|STARTED|Overall Study||88
3048960|NCT01211106|3769081|FG000|COMPLETED|Overall Study||82
3048961|NCT01211106|3769082|FG001|COMPLETED|Overall Study||77
3280190|NCT02724020|4013568|FG001|Treated (Safety Analysis Set)|Overall Study||32
3280191|NCT02724020|4013569|FG002|Treated (Safety Analysis Set)|Overall Study||31
3048962|NCT01211106|3769081|FG000|NOT COMPLETED|Overall Study||13
3048963|NCT01211106|3769082|FG001|NOT COMPLETED|Overall Study||11
3048964|NCT01211145|3769094|FG000|STARTED|Overall Study||296
3048965|NCT01211145|3769095|FG001|STARTED|Overall Study||115
3048966|NCT01211145|3769096|FG002|STARTED|Overall Study||99
3048967|NCT01211145|3769097|FG003|STARTED|Overall Study||288
3048968|NCT01211145|3769094|FG000|COMPLETED|Overall Study|1 patient was not counted as completed or discontinued due to incomplete information (N=270-1=269).|270
3048969|NCT01211145|3769095|FG001|COMPLETED|Overall Study||98
3048970|NCT01211145|3769096|FG002|COMPLETED|Overall Study||86
3048971|NCT01211145|3769097|FG003|COMPLETED|Overall Study||268
3048972|NCT01211145|3769094|FG000|NOT COMPLETED|Overall Study||26
3048973|NCT01211145|3769095|FG001|NOT COMPLETED|Overall Study||17
3048974|NCT01211145|3769096|FG002|NOT COMPLETED|Overall Study||13
3048975|NCT01211145|3769097|FG003|NOT COMPLETED|Overall Study||20
3048976|NCT01211184|3769110|FG000|STARTED|Overall Study||20
3048977|NCT01211184|3769111|FG001|STARTED|Overall Study||20
3048978|NCT01211184|3769112|FG002|STARTED|Overall Study||20
3048979|NCT01211184|3769110|FG000|COMPLETED|Overall Study||20
3048980|NCT01211184|3769111|FG001|COMPLETED|Overall Study||18
3048981|NCT01211184|3769112|FG002|COMPLETED|Overall Study||19
3048982|NCT01211184|3769110|FG000|NOT COMPLETED|Overall Study||0
3048983|NCT01211184|3769111|FG001|NOT COMPLETED|Overall Study||2
3048984|NCT01211184|3769112|FG002|NOT COMPLETED|Overall Study||1
3048985|NCT01211197|3769123|FG000|STARTED|Treatment Period 1 (1 Day)||3
3048986|NCT01211197|3769124|FG001|STARTED|Treatment Period 1 (1 Day)||3
3048987|NCT01211197|3769125|FG002|STARTED|Treatment Period 1 (1 Day)||3
3048988|NCT01211197|3769126|FG003|STARTED|Treatment Period 1 (1 Day)||3
3048989|NCT01211197|3769127|FG004|STARTED|Treatment Period 1 (1 Day)||2
3048990|NCT01211197|3769128|FG005|STARTED|Treatment Period 1 (1 Day)||2
3048991|NCT01211197|3769123|FG000|COMPLETED|Treatment Period 1 (1 Day)||3
3048992|NCT01211197|3769124|FG001|COMPLETED|Treatment Period 1 (1 Day)||3
3048993|NCT01211197|3769125|FG002|COMPLETED|Treatment Period 1 (1 Day)||3
3048994|NCT01211197|3769126|FG003|COMPLETED|Treatment Period 1 (1 Day)||3
3048995|NCT01211197|3769127|FG004|COMPLETED|Treatment Period 1 (1 Day)||2
3048996|NCT01211197|3769128|FG005|COMPLETED|Treatment Period 1 (1 Day)||2
3048997|NCT01211197|3769123|FG000|NOT COMPLETED|Treatment Period 1 (1 Day)||0
3048998|NCT01211197|3769124|FG001|NOT COMPLETED|Treatment Period 1 (1 Day)||0
3048999|NCT01211197|3769125|FG002|NOT COMPLETED|Treatment Period 1 (1 Day)||0
3049000|NCT01211197|3769126|FG003|NOT COMPLETED|Treatment Period 1 (1 Day)||0
3049001|NCT01211197|3769127|FG004|NOT COMPLETED|Treatment Period 1 (1 Day)||0
3049002|NCT01211197|3769128|FG005|NOT COMPLETED|Treatment Period 1 (1 Day)||0
3049003|NCT01211197|3769123|FG000|STARTED|Washout Period 1 (7 Days)||3
3049004|NCT01211197|3769124|FG001|STARTED|Washout Period 1 (7 Days)||3
3280192|NCT02724020|4013567|FG000|COMPLETED|Overall Study||0
3280193|NCT02724020|4013568|FG001|COMPLETED|Overall Study||0
3280194|NCT02724020|4013569|FG002|COMPLETED|Overall Study||0
3280195|NCT02724020|4013567|FG000|NOT COMPLETED|Overall Study||32
3280196|NCT02724020|4013568|FG001|NOT COMPLETED|Overall Study||32
3280197|NCT02724020|4013569|FG002|NOT COMPLETED|Overall Study||32
3280198|NCT02724033|4013580|FG000|STARTED|Overall Study||11
3280199|NCT02724033|4013581|FG001|STARTED|Overall Study||14
3280200|NCT02724033|4013582|FG002|STARTED|Overall Study||12
3280201|NCT02724033|4013580|FG000|COMPLETED|Overall Study||11
3280202|NCT02724033|4013581|FG001|COMPLETED|Overall Study||14
3280203|NCT02724033|4013582|FG002|COMPLETED|Overall Study||12
3280204|NCT02724033|4013580|FG000|NOT COMPLETED|Overall Study||0
3280205|NCT02724033|4013581|FG001|NOT COMPLETED|Overall Study||0
3280206|NCT02724033|4013582|FG002|NOT COMPLETED|Overall Study||0
3280207|NCT02724111|4013592|FG000|STARTED|Overall Study||45
3280208|NCT02724111|4013593|FG001|STARTED|Overall Study||45
3280209|NCT02724111|4013592|FG000|COMPLETED|Overall Study||43
3280210|NCT02724111|4013593|FG001|COMPLETED|Overall Study||40
3280211|NCT02724111|4013592|FG000|NOT COMPLETED|Overall Study||2
3280212|NCT02724111|4013593|FG001|NOT COMPLETED|Overall Study||5
3280213|NCT02724423|4013599|FG000|STARTED|Overall Study||57
3280214|NCT02724423|4013599|FG000|COMPLETED|Overall Study||54
3280215|NCT02724423|4013599|FG000|NOT COMPLETED|Overall Study||3
3280216|NCT02724449|4013604|FG000|STARTED|Overall Study||16
3280217|NCT02724449|4013604|FG000|COMPLETED|Overall Study||16
3280218|NCT02724449|4013604|FG000|NOT COMPLETED|Overall Study||0
3280219|NCT02724462|4013610|FG000|STARTED|3 Month Follow-up Survey||1254
3280220|NCT02724462|4013611|FG001|STARTED|3 Month Follow-up Survey||1249
3280221|NCT02724462|4013610|FG000|COMPLETED|3 Month Follow-up Survey||1043
3280222|NCT02724462|4013611|FG001|COMPLETED|3 Month Follow-up Survey||1050
3280223|NCT02724462|4013610|FG000|NOT COMPLETED|3 Month Follow-up Survey||211
3280224|NCT02724462|4013611|FG001|NOT COMPLETED|3 Month Follow-up Survey||199
3280225|NCT02724462|4013610|FG000|STARTED|6 Month Follow-up Survey||1254
3280226|NCT02724462|4013611|FG001|STARTED|6 Month Follow-up Survey||1249
3280227|NCT02724462|4013610|FG000|COMPLETED|6 Month Follow-up Survey||1058
3280228|NCT02724462|4013611|FG001|COMPLETED|6 Month Follow-up Survey||1078
3280229|NCT02724462|4013610|FG000|NOT COMPLETED|6 Month Follow-up Survey||196
3280230|NCT02724462|4013611|FG001|NOT COMPLETED|6 Month Follow-up Survey||171
3280231|NCT02724462|4013610|FG000|STARTED|12 Month Follow-up Survey||1254
3280232|NCT02724462|4013611|FG001|STARTED|12 Month Follow-up Survey||1249
3280233|NCT02724462|4013610|FG000|COMPLETED|12 Month Follow-up Survey||1040
3280234|NCT02724462|4013611|FG001|COMPLETED|12 Month Follow-up Survey||1067
3280235|NCT02724462|4013610|FG000|NOT COMPLETED|12 Month Follow-up Survey||214
3049005|NCT01211197|3769125|FG002|STARTED|Washout Period 1 (7 Days)||3
3049006|NCT01211197|3769126|FG003|STARTED|Washout Period 1 (7 Days)||3
3280236|NCT02724462|4013611|FG001|NOT COMPLETED|12 Month Follow-up Survey||182
3280237|NCT02724592|4013619|FG000|STARTED|Overall Study||35
3280238|NCT02724592|4013620|FG001|STARTED|Overall Study||35
3280239|NCT02724592|4013619|FG000|COMPLETED|Overall Study||31
3280240|NCT02724592|4013620|FG001|COMPLETED|Overall Study||34
3280241|NCT02724592|4013619|FG000|NOT COMPLETED|Overall Study||4
3280242|NCT02724592|4013620|FG001|NOT COMPLETED|Overall Study||1
3280243|NCT02724644|4013628|FG000|STARTED|Overall Study||189
3280244|NCT02724644|4013629|FG001|STARTED|Overall Study||186
3280245|NCT02724644|4013628|FG000|COMPLETED|Overall Study||168
3280246|NCT02724644|4013629|FG001|COMPLETED|Overall Study||182
3280247|NCT02724644|4013628|FG000|NOT COMPLETED|Overall Study||21
3280248|NCT02724644|4013629|FG001|NOT COMPLETED|Overall Study||4
3280249|NCT02724787|4013635|FG000|STARTED|Overall Study||24
3280250|NCT02724787|4013635|FG000|COMPLETED|Overall Study|22 completed treatment. 20 participants returned for post-treatment assessment.|22
3280251|NCT02724787|4013635|FG000|NOT COMPLETED|Overall Study||2
3280252|NCT02724800|4013641|FG000|STARTED|Overall Study||32
3280253|NCT02724800|4013642|FG001|STARTED|Overall Study||31
3280254|NCT02724800|4013641|FG000|COMPLETED|Overall Study||15
3280255|NCT02724800|4013642|FG001|COMPLETED|Overall Study||22
3280256|NCT02724800|4013641|FG000|NOT COMPLETED|Overall Study||17
3280257|NCT02724800|4013642|FG001|NOT COMPLETED|Overall Study||9
3280258|NCT02724839|4013651|FG000|STARTED|Overall Study||13
3280259|NCT02724839|4013652|FG001|STARTED|Overall Study||12
3280260|NCT02724839|4013653|FG002|STARTED|Overall Study||11
3280261|NCT02724839|4013651|FG000|COMPLETED|Overall Study||12
3280262|NCT02724839|4013652|FG001|COMPLETED|Overall Study||8
3280263|NCT02724839|4013653|FG002|COMPLETED|Overall Study||6
3280264|NCT02724839|4013651|FG000|NOT COMPLETED|Overall Study||1
3280265|NCT02724839|4013652|FG001|NOT COMPLETED|Overall Study||4
3280266|NCT02724839|4013653|FG002|NOT COMPLETED|Overall Study||5
3280267|NCT02724878|4013668|FG000|STARTED|Overall Study||65
3280268|NCT02724878|4013668|FG000|Treated|Overall Study||60
3280269|NCT02724878|4013668|FG000|Responders|Overall Study||20
3280270|NCT02724878|4013668|FG000|COMPLETED|Overall Study||0
3280271|NCT02724878|4013668|FG000|NOT COMPLETED|Overall Study||65
3280272|NCT02724956|4013674|FG000|STARTED|Overall Study||27
3280273|NCT02724956|4013675|FG001|STARTED|Overall Study||26
3280274|NCT02724956|4013674|FG000|COMPLETED|Overall Study||26
3280275|NCT02724956|4013675|FG001|COMPLETED|Overall Study||24
3280276|NCT02724956|4013674|FG000|NOT COMPLETED|Overall Study||1
3280277|NCT02724956|4013675|FG001|NOT COMPLETED|Overall Study||2
3280278|NCT02725008|4013683|FG000|STARTED|Overall Study||46
3280279|NCT02725008|4013684|FG001|STARTED|Overall Study||51
3280280|NCT02725008|4013683|FG000|COMPLETED|Overall Study||37
3280281|NCT02725008|4013684|FG001|COMPLETED|Overall Study||39
3280282|NCT02725008|4013683|FG000|NOT COMPLETED|Overall Study||9
3280283|NCT02725008|4013684|FG001|NOT COMPLETED|Overall Study||12
3280284|NCT02725268|4013694|FG000|STARTED|Overall Study||90
3280285|NCT02725268|4013695|FG001|STARTED|Overall Study||90
3280286|NCT02725268|4013696|FG002|STARTED|Overall Study||41
3280287|NCT02725268|4013697|FG003|STARTED|Overall Study||20
3280288|NCT02725268|4013694|FG000|Started|Overall Study||90
3280289|NCT02725268|4013695|FG001|Started|Overall Study||90
3280290|NCT02725268|4013696|FG002|Started|Overall Study||41
3280291|NCT02725268|4013697|FG003|Started|Overall Study||20
3280292|NCT02725268|4013694|FG000|Completed|Overall Study||18
3280293|NCT02725268|4013695|FG001|Completed|Overall Study||20
3280294|NCT02725268|4013696|FG002|Completed|Overall Study||3
3280295|NCT02725268|4013697|FG003|Completed|Overall Study||2
3280296|NCT02725268|4013694|FG000|COMPLETED|Overall Study||18
3280297|NCT02725268|4013695|FG001|COMPLETED|Overall Study||20
3280298|NCT02725268|4013696|FG002|COMPLETED|Overall Study||3
3280299|NCT02725268|4013697|FG003|COMPLETED|Overall Study||2
3280300|NCT02725268|4013694|FG000|NOT COMPLETED|Overall Study||72
3280301|NCT02725268|4013695|FG001|NOT COMPLETED|Overall Study||70
3280302|NCT02725268|4013696|FG002|NOT COMPLETED|Overall Study||38
3280303|NCT02725268|4013697|FG003|NOT COMPLETED|Overall Study||18
3280304|NCT02725411|4013710|FG000|STARTED|Treatment Period (56 Weeks)||92
3280305|NCT02725411|4013711|FG001|STARTED|Treatment Period (56 Weeks)||93
3280306|NCT02725411|4013712|FG002|STARTED|Treatment Period (56 Weeks)||92
3280307|NCT02725411|4013710|FG000|Treated|Treatment Period (56 Weeks)||92
3280308|NCT02725411|4013711|FG001|Treated|Treatment Period (56 Weeks)||93
3280309|NCT02725411|4013712|FG002|Treated|Treatment Period (56 Weeks)||92
3280310|NCT02725411|4013710|FG000|COMPLETED|Treatment Period (56 Weeks)||62
3280311|NCT02725411|4013711|FG001|COMPLETED|Treatment Period (56 Weeks)||43
3280312|NCT02725411|4013712|FG002|COMPLETED|Treatment Period (56 Weeks)||43
3280313|NCT02725411|4013710|FG000|NOT COMPLETED|Treatment Period (56 Weeks)||30
3280314|NCT02725411|4013711|FG001|NOT COMPLETED|Treatment Period (56 Weeks)||50
3280315|NCT02725411|4013712|FG002|NOT COMPLETED|Treatment Period (56 Weeks)||49
3280316|NCT02725411|4013710|FG000|STARTED|Follow-up Period (24 Weeks)|All participants on either completion or discontinuation of treatment, entered follow up period.|92
3280317|NCT02725411|4013711|FG001|STARTED|Follow-up Period (24 Weeks)|All participants on either completion or discontinuation of treatment, entered follow up period.|93
3280318|NCT02725411|4013712|FG002|STARTED|Follow-up Period (24 Weeks)|All participants on either completion or discontinuation of treatment, entered follow up period.|92
3280319|NCT02725411|4013710|FG000|COMPLETED|Follow-up Period (24 Weeks)||88
3280320|NCT02725411|4013711|FG001|COMPLETED|Follow-up Period (24 Weeks)||82
3049007|NCT01211197|3769127|FG004|STARTED|Washout Period 1 (7 Days)||2
3049008|NCT01211197|3769128|FG005|STARTED|Washout Period 1 (7 Days)||2
3049009|NCT01211197|3769123|FG000|COMPLETED|Washout Period 1 (7 Days)||3
3049010|NCT01211197|3769124|FG001|COMPLETED|Washout Period 1 (7 Days)||3
3160469|NCT01863771|3887575|FG000|NOT COMPLETED|Maintenance Phase||0
3280321|NCT02725411|4013712|FG002|COMPLETED|Follow-up Period (24 Weeks)||87
3280322|NCT02725411|4013710|FG000|NOT COMPLETED|Follow-up Period (24 Weeks)||4
3280323|NCT02725411|4013711|FG001|NOT COMPLETED|Follow-up Period (24 Weeks)||11
3280324|NCT02725411|4013712|FG002|NOT COMPLETED|Follow-up Period (24 Weeks)||5
3280325|NCT02725476|4013722|FG000|STARTED|Overall Study||15
3280326|NCT02725476|4013723|FG001|STARTED|Overall Study||5
3280327|NCT02725476|4013722|FG000|COMPLETED|Overall Study||12
3280328|NCT02725476|4013723|FG001|COMPLETED|Overall Study||4
3280329|NCT02725476|4013722|FG000|NOT COMPLETED|Overall Study||3
3280330|NCT02725476|4013723|FG001|NOT COMPLETED|Overall Study||1
3280331|NCT02725515|4013731|FG000|STARTED|Overall Study||53
3280332|NCT02725515|4013732|FG001|STARTED|Overall Study||52
3280333|NCT02725515|4013731|FG000|COMPLETED|Overall Study||28
3280334|NCT02725515|4013732|FG001|COMPLETED|Overall Study||17
3280335|NCT02725515|4013731|FG000|NOT COMPLETED|Overall Study||25
3280336|NCT02725515|4013732|FG001|NOT COMPLETED|Overall Study||35
3280337|NCT02725645|4013738|FG000|STARTED|Overall Study||14
3280338|NCT02725645|4013738|FG000|COMPLETED|Overall Study||14
3280339|NCT02725645|4013738|FG000|NOT COMPLETED|Overall Study||0
3280340|NCT02725710|4013744|FG000|STARTED|Overall Study||48
3280341|NCT02725710|4013745|FG001|STARTED|Overall Study||47
3280342|NCT02725710|4013744|FG000|COMPLETED|Overall Study||47
3280343|NCT02725710|4013745|FG001|COMPLETED|Overall Study||47
3280344|NCT02725710|4013744|FG000|NOT COMPLETED|Overall Study||1
3280345|NCT02725710|4013745|FG001|NOT COMPLETED|Overall Study||0
3280346|NCT02725788|4013753|FG000|STARTED|Overall Study||123
3280347|NCT02725788|4013754|FG001|STARTED|Overall Study||124
3280348|NCT02725788|4013753|FG000|COMPLETED|Overall Study||122
3280349|NCT02725788|4013754|FG001|COMPLETED|Overall Study||122
3280350|NCT02725788|4013753|FG000|NOT COMPLETED|Overall Study||1
3280351|NCT02725788|4013754|FG001|NOT COMPLETED|Overall Study||2
3280352|NCT02725801|4013762|FG000|STARTED|Overall Study||8
3280353|NCT02725801|4013763|FG001|STARTED|Overall Study||12
3280354|NCT02725801|4013762|FG000|COMPLETED|Overall Study||8
3280355|NCT02725801|4013763|FG001|COMPLETED|Overall Study||12
3280356|NCT02725801|4013762|FG000|NOT COMPLETED|Overall Study||0
3280357|NCT02725801|4013763|FG001|NOT COMPLETED|Overall Study||0
3280358|NCT02725866|4013769|FG000|STARTED|Overall Study||216
3280359|NCT02725866|4013769|FG000|COMPLETED|Overall Study||202
3280360|NCT02725866|4013769|FG000|NOT COMPLETED|Overall Study||14
3280361|NCT02726022|4013773|FG000|STARTED|Overall Study||114
3280362|NCT02726022|4013773|FG000|COMPLETED|Overall Study||78
3280363|NCT02726022|4013773|FG000|NOT COMPLETED|Overall Study||36
3280364|NCT02726074|4013777|FG000|STARTED|Overall Study||106
3280365|NCT02726074|4013777|FG000|Treated|Overall Study||102
3280366|NCT02726074|4013777|FG000|COMPLETED|Overall Study||80
3280367|NCT02726074|4013777|FG000|NOT COMPLETED|Overall Study||26
3280368|NCT02726113|4013783|FG000|STARTED|Total Enrollment||28
3280369|NCT02726113|4013784|FG001|STARTED|Total Enrollment||22
3280370|NCT02726113|4013783|FG000|COMPLETED|Total Enrollment||24
3280371|NCT02726113|4013784|FG001|COMPLETED|Total Enrollment||19
3280372|NCT02726113|4013783|FG000|NOT COMPLETED|Total Enrollment||4
3280373|NCT02726113|4013784|FG001|NOT COMPLETED|Total Enrollment||3
3280374|NCT02726113|4013783|FG000|STARTED|Genomic Analysis||19
3280375|NCT02726113|4013784|FG001|STARTED|Genomic Analysis||14
3160470|NCT01863771|3887576|FG001|NOT COMPLETED|Maintenance Phase||5
3280376|NCT02726113|4013783|FG000|COMPLETED|Genomic Analysis||15
3280377|NCT02726113|4013784|FG001|COMPLETED|Genomic Analysis||12
3280378|NCT02726113|4013783|FG000|NOT COMPLETED|Genomic Analysis||4
3280379|NCT02726113|4013784|FG001|NOT COMPLETED|Genomic Analysis||2
3280380|NCT02726178|4013793|FG000|STARTED|Overall Study||28
3280381|NCT02726178|4013794|FG001|STARTED|Overall Study||28
3280382|NCT02726178|4013793|FG000|COMPLETED|Overall Study||28
3280383|NCT02726178|4013794|FG001|COMPLETED|Overall Study||28
3280384|NCT02726178|4013793|FG000|NOT COMPLETED|Overall Study||0
3280385|NCT02726178|4013794|FG001|NOT COMPLETED|Overall Study||0
3280386|NCT02726451|4013804|FG000|STARTED|Overall Study||10
3280387|NCT02726451|4013805|FG001|STARTED|Overall Study||10
3280388|NCT02726451|4013804|FG000|COMPLETED|Overall Study||10
3280389|NCT02726451|4013805|FG001|COMPLETED|Overall Study||10
3280390|NCT02726451|4013804|FG000|NOT COMPLETED|Overall Study||0
3280391|NCT02726451|4013805|FG001|NOT COMPLETED|Overall Study||0
3280392|NCT02726542|4013813|FG000|STARTED|Overall Study||13
3280393|NCT02726542|4013814|FG001|STARTED|Overall Study||11
3280394|NCT02726542|4013813|FG000|COMPLETED|Overall Study||10
3280395|NCT02726542|4013814|FG001|COMPLETED|Overall Study||10
3280396|NCT02726542|4013813|FG000|NOT COMPLETED|Overall Study||3
3280397|NCT02726542|4013814|FG001|NOT COMPLETED|Overall Study||1
3280398|NCT02726620|4013822|FG000|STARTED|Historic Cohort - Three Years||17463
3280399|NCT02726620|4013823|FG001|STARTED|Historic Cohort - Three Years||0
3280400|NCT02726620|4013822|FG000|MAP < 65 mmHg: Primary Analysis|Historic Cohort - Three Years||15624
3280401|NCT02726620|4013823|FG001|MAP < 65 mmHg: Primary Analysis|Historic Cohort - Three Years||0
3280402|NCT02726620|4013822|FG000|COMPLETED|Historic Cohort - Three Years||17463
3280403|NCT02726620|4013823|FG001|COMPLETED|Historic Cohort - Three Years||0
3280404|NCT02726620|4013822|FG000|NOT COMPLETED|Historic Cohort - Three Years||0
3049011|NCT01211197|3769125|FG002|COMPLETED|Washout Period 1 (7 Days)||2
3049012|NCT01211197|3769126|FG003|COMPLETED|Washout Period 1 (7 Days)||3
3049013|NCT01211197|3769127|FG004|COMPLETED|Washout Period 1 (7 Days)||2
3049014|NCT01211197|3769128|FG005|COMPLETED|Washout Period 1 (7 Days)||2
3049015|NCT01211197|3769123|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0
3049016|NCT01211197|3769124|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0
3049017|NCT01211197|3769125|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||1
3049018|NCT01211197|3769126|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||0
3280405|NCT02726620|4013823|FG001|NOT COMPLETED|Historic Cohort - Three Years||0
3280406|NCT02726620|4013822|FG000|STARTED|Month 1: Attending Randomization||0
3280407|NCT02726620|4013823|FG001|STARTED|Month 1: Attending Randomization||485
3280408|NCT02726620|4013822|FG000|MAP < 65 mmHg: Primary Analysis|Month 1: Attending Randomization||0
3280409|NCT02726620|4013823|FG001|MAP < 65 mmHg: Primary Analysis|Month 1: Attending Randomization||432
3280410|NCT02726620|4013822|FG000|Correct IOH Notifications|Month 1: Attending Randomization||0
3280411|NCT02726620|4013823|FG001|Correct IOH Notifications|Month 1: Attending Randomization||313
3280412|NCT02726620|4013822|FG000|COMPLETED|Month 1: Attending Randomization||0
3280413|NCT02726620|4013823|FG001|COMPLETED|Month 1: Attending Randomization||485
3280414|NCT02726620|4013822|FG000|NOT COMPLETED|Month 1: Attending Randomization||0
3280415|NCT02726620|4013823|FG001|NOT COMPLETED|Month 1: Attending Randomization||0
3280416|NCT02726620|4013822|FG000|STARTED|Months 2-3: In-room Providers Randomized||0
3280417|NCT02726620|4013823|FG001|STARTED|Months 2-3: In-room Providers Randomized||1253
3280418|NCT02726620|4013822|FG000|MAP < 65 mmHg: Primary Analysis|Months 2-3: In-room Providers Randomized||0
3280419|NCT02726620|4013823|FG001|MAP < 65 mmHg: Primary Analysis|Months 2-3: In-room Providers Randomized||1103
3280420|NCT02726620|4013822|FG000|Correct IOH Notifications|Months 2-3: In-room Providers Randomized||0
3280421|NCT02726620|4013823|FG001|Correct IOH Notifications|Months 2-3: In-room Providers Randomized||825
3280422|NCT02726620|4013822|FG000|COMPLETED|Months 2-3: In-room Providers Randomized||0
3280423|NCT02726620|4013823|FG001|COMPLETED|Months 2-3: In-room Providers Randomized||1253
3280424|NCT02726620|4013822|FG000|NOT COMPLETED|Months 2-3: In-room Providers Randomized||0
3280425|NCT02726620|4013823|FG001|NOT COMPLETED|Months 2-3: In-room Providers Randomized||0
3280426|NCT02726620|4013822|FG000|STARTED|Through End of Study: All Interventions||0
3280427|NCT02726620|4013823|FG001|STARTED|Through End of Study: All Interventions||3234
3280428|NCT02726620|4013822|FG000|MAP < 65 mmHg: Primary Analysis|Through End of Study: All Interventions||0
3280429|NCT02726620|4013823|FG001|MAP < 65 mmHg: Primary Analysis|Through End of Study: All Interventions||2793
3280430|NCT02726620|4013822|FG000|Correct IOH Notifications|Through End of Study: All Interventions||0
3280431|NCT02726620|4013823|FG001|Correct IOH Notifications|Through End of Study: All Interventions||2072
3280432|NCT02726620|4013822|FG000|COMPLETED|Through End of Study: All Interventions||0
3280433|NCT02726620|4013823|FG001|COMPLETED|Through End of Study: All Interventions||3234
3280434|NCT02726620|4013822|FG000|NOT COMPLETED|Through End of Study: All Interventions||0
3280435|NCT02726620|4013823|FG001|NOT COMPLETED|Through End of Study: All Interventions||0
3280436|NCT02726789|4013829|FG000|STARTED|Overall Study||5
3280437|NCT02726789|4013829|FG000|COMPLETED|Overall Study||5
3280438|NCT02726789|4013829|FG000|NOT COMPLETED|Overall Study||0
3280439|NCT02726945|4013837|FG000|STARTED|Overall Study||13
3280440|NCT02726945|4013838|FG001|STARTED|Overall Study||13
3280441|NCT02726945|4013839|FG002|STARTED|Overall Study||13
3280442|NCT02726945|4013837|FG000|COMPLETED|Overall Study||13
3280443|NCT02726945|4013838|FG001|COMPLETED|Overall Study||12
3280444|NCT02726945|4013839|FG002|COMPLETED|Overall Study||12
3280445|NCT02726945|4013837|FG000|NOT COMPLETED|Overall Study||0
3280446|NCT02726945|4013838|FG001|NOT COMPLETED|Overall Study||1
3280447|NCT02726945|4013839|FG002|NOT COMPLETED|Overall Study||1
3280448|NCT02726971|4013849|FG000|STARTED|Overall Study||70
3280449|NCT02726971|4013850|FG001|STARTED|Overall Study||71
3280450|NCT02726971|4013849|FG000|COMPLETED|Overall Study||59
3280451|NCT02726971|4013850|FG001|COMPLETED|Overall Study||62
3280452|NCT02726971|4013849|FG000|NOT COMPLETED|Overall Study||11
3280453|NCT02726971|4013850|FG001|NOT COMPLETED|Overall Study||9
3280454|NCT02727192|4013858|FG000|STARTED|Overall Study||54
3280455|NCT02727192|4013859|FG001|STARTED|Overall Study||54
3280456|NCT02727192|4013860|FG002|STARTED|Overall Study||1
3280457|NCT02727192|4013858|FG000|COMPLETED|Overall Study||53
3280458|NCT02727192|4013859|FG001|COMPLETED|Overall Study||54
3280459|NCT02727192|4013860|FG002|COMPLETED|Overall Study||1
3280460|NCT02727192|4013858|FG000|NOT COMPLETED|Overall Study||1
3280461|NCT02727192|4013859|FG001|NOT COMPLETED|Overall Study||0
3280462|NCT02727192|4013860|FG002|NOT COMPLETED|Overall Study||0
3280463|NCT02727322|4013869|FG000|STARTED|Overall Study||77
3280464|NCT02727322|4013870|FG001|STARTED|Overall Study||77
3280465|NCT02727322|4013869|FG000|COMPLETED|Overall Study||75
3280466|NCT02727322|4013870|FG001|COMPLETED|Overall Study||76
3280467|NCT02727322|4013869|FG000|NOT COMPLETED|Overall Study||2
3280468|NCT02727322|4013870|FG001|NOT COMPLETED|Overall Study||1
3280469|NCT02727660|4013883|FG000|STARTED|Overall Study||619
3280470|NCT02727660|4013884|FG001|STARTED|Overall Study||617
3280471|NCT02727660|4013885|FG002|STARTED|Overall Study||607
3280472|NCT02727660|4013883|FG000|COMPLETED|Overall Study||503
3280473|NCT02727660|4013884|FG001|COMPLETED|Overall Study||501
3049019|NCT01211197|3769127|FG004|NOT COMPLETED|Washout Period 1 (7 Days)||0
3280474|NCT02727660|4013885|FG002|COMPLETED|Overall Study||442
3280475|NCT02727660|4013883|FG000|NOT COMPLETED|Overall Study||116
3280476|NCT02727660|4013884|FG001|NOT COMPLETED|Overall Study||116
3049020|NCT01211197|3769128|FG005|NOT COMPLETED|Washout Period 1 (7 Days)||0
3049021|NCT01211197|3769123|FG000|STARTED|Treatment Period 2 (1 Day)||3
3049022|NCT01211197|3769124|FG001|STARTED|Treatment Period 2 (1 Day)||3
3049023|NCT01211197|3769125|FG002|STARTED|Treatment Period 2 (1 Day)||2
3049024|NCT01211197|3769126|FG003|STARTED|Treatment Period 2 (1 Day)||3
3049025|NCT01211197|3769127|FG004|STARTED|Treatment Period 2 (1 Day)||2
3049026|NCT01211197|3769128|FG005|STARTED|Treatment Period 2 (1 Day)||2
3049027|NCT01211197|3769123|FG000|COMPLETED|Treatment Period 2 (1 Day)||3
3049028|NCT01211197|3769124|FG001|COMPLETED|Treatment Period 2 (1 Day)||3
3049029|NCT01211197|3769125|FG002|COMPLETED|Treatment Period 2 (1 Day)||2
3049030|NCT01211197|3769126|FG003|COMPLETED|Treatment Period 2 (1 Day)||3
3049031|NCT01211197|3769127|FG004|COMPLETED|Treatment Period 2 (1 Day)||2
3049032|NCT01211197|3769128|FG005|COMPLETED|Treatment Period 2 (1 Day)||2
3280477|NCT02727660|4013885|FG002|NOT COMPLETED|Overall Study||165
3280478|NCT02727699|4013895|FG000|STARTED|Overall Study||91
3280479|NCT02727699|4013896|FG001|STARTED|Overall Study||94
3280480|NCT02727699|4013895|FG000|COMPLETED|Overall Study||82
3280481|NCT02727699|4013896|FG001|COMPLETED|Overall Study||89
3280482|NCT02727699|4013895|FG000|NOT COMPLETED|Overall Study||9
3280483|NCT02727699|4013896|FG001|NOT COMPLETED|Overall Study||5
3280484|NCT02727751|4013902|FG000|STARTED|Overall Study||312
3280485|NCT02727751|4013902|FG000|COMPLETED|Overall Study||262
3280486|NCT02727751|4013902|FG000|NOT COMPLETED|Overall Study||50
3280487|NCT02727777|4013909|FG000|STARTED|Overall Study||4
3280488|NCT02727777|4013910|FG001|STARTED|Overall Study||0
3280489|NCT02727777|4013911|FG002|STARTED|Overall Study||0
3280490|NCT02727777|4013909|FG000|COMPLETED|Overall Study||0
3280491|NCT02727777|4013910|FG001|COMPLETED|Overall Study||0
3280492|NCT02727777|4013911|FG002|COMPLETED|Overall Study||0
3280493|NCT02727777|4013909|FG000|NOT COMPLETED|Overall Study||4
3280494|NCT02727777|4013910|FG001|NOT COMPLETED|Overall Study||0
3280495|NCT02727777|4013911|FG002|NOT COMPLETED|Overall Study||0
3280496|NCT02727816|4013919|FG000|STARTED|Overall Study||35
3280497|NCT02727816|4013919|FG000|COMPLETED|Overall Study||35
3280498|NCT02727816|4013919|FG000|NOT COMPLETED|Overall Study||0
3280499|NCT02727842|4013939|FG000|STARTED|Overall Study||30
3280500|NCT02727842|4013939|FG000|COMPLETED|Overall Study||30
3280501|NCT02727842|4013939|FG000|NOT COMPLETED|Overall Study||0
3280502|NCT02727894|4013945|FG000|STARTED|Overall Study|March 2013|73
3280503|NCT02727894|4013946|FG001|STARTED|Overall Study|March 2013|192
3280504|NCT02727894|4013945|FG000|COMPLETED|Overall Study|September 2015|73
3280505|NCT02727894|4013946|FG001|COMPLETED|Overall Study|September 2015|192
3280506|NCT02727894|4013945|FG000|NOT COMPLETED|Overall Study||0
3280507|NCT02727894|4013946|FG001|NOT COMPLETED|Overall Study||0
3280508|NCT02728089|4013955|FG000|STARTED|Overall Study||115
3280509|NCT02728089|4013955|FG000|Treated|Overall Study||114
3280510|NCT02728089|4013955|FG000|COMPLETED|Overall Study||112
3280511|NCT02728089|4013955|FG000|NOT COMPLETED|Overall Study||3
3280512|NCT02728102|4013962|FG000|STARTED|Overall Study||68
3280513|NCT02728102|4013963|FG001|STARTED|Overall Study||37
3280514|NCT02728102|4013964|FG002|STARTED|Overall Study||35
3280515|NCT02728102|4013962|FG000|COMPLETED|Overall Study||67
3280516|NCT02728102|4013963|FG001|COMPLETED|Overall Study||35
3280517|NCT02728102|4013964|FG002|COMPLETED|Overall Study||33
3280518|NCT02728102|4013962|FG000|NOT COMPLETED|Overall Study||1
3280519|NCT02728102|4013963|FG001|NOT COMPLETED|Overall Study||2
3280520|NCT02728102|4013964|FG002|NOT COMPLETED|Overall Study||2
3280521|NCT02728206|4013971|FG000|STARTED|Overall Study||9
3280522|NCT02728206|4013971|FG000|COMPLETED|Overall Study||8
3280523|NCT02728206|4013971|FG000|NOT COMPLETED|Overall Study||1
3280524|NCT02728830|4013975|FG000|STARTED|Overall Study||39
3280525|NCT02728830|4013975|FG000|COMPLETED|Overall Study||15
3280526|NCT02728830|4013975|FG000|NOT COMPLETED|Overall Study||24
3280527|NCT02728895|4013981|FG000|STARTED|Overall Study||3
3280528|NCT02728895|4013982|FG001|STARTED|Overall Study||21
3280529|NCT02728895|4013981|FG000|COMPLETED|Overall Study||2
3280530|NCT02728895|4013982|FG001|COMPLETED|Overall Study||16
3280531|NCT02728895|4013981|FG000|NOT COMPLETED|Overall Study||1
3280532|NCT02728895|4013982|FG001|NOT COMPLETED|Overall Study||5
3280533|NCT02729025|4013990|FG000|STARTED|Overall Study||64
3280534|NCT02729025|4013991|FG001|STARTED|Overall Study||65
3280535|NCT02729025|4013990|FG000|COMPLETED|Overall Study||64
3280536|NCT02729025|4013991|FG001|COMPLETED|Overall Study||64
3280537|NCT02729025|4013990|FG000|NOT COMPLETED|Overall Study||0
3280538|NCT02729025|4013991|FG001|NOT COMPLETED|Overall Study||1
3280539|NCT02729038|4014001|FG000|STARTED|Part 1 (Up to 44 Days)||8
3280540|NCT02729038|4014002|FG001|STARTED|Part 1 (Up to 44 Days)||8
3280541|NCT02729038|4014003|FG002|STARTED|Part 1 (Up to 44 Days)||8
3280542|NCT02729038|4014004|FG003|STARTED|Part 1 (Up to 44 Days)||0
3280543|NCT02729038|4014001|FG000|COMPLETED|Part 1 (Up to 44 Days)||8
3280544|NCT02729038|4014002|FG001|COMPLETED|Part 1 (Up to 44 Days)||8
3280545|NCT02729038|4014003|FG002|COMPLETED|Part 1 (Up to 44 Days)||8
3049033|NCT01211197|3769123|FG000|NOT COMPLETED|Treatment Period 2 (1 Day)||0
3280546|NCT02729038|4014004|FG003|COMPLETED|Part 1 (Up to 44 Days)||0
3280547|NCT02729038|4014001|FG000|NOT COMPLETED|Part 1 (Up to 44 Days)||0
3280548|NCT02729038|4014002|FG001|NOT COMPLETED|Part 1 (Up to 44 Days)||0
3280549|NCT02729038|4014003|FG002|NOT COMPLETED|Part 1 (Up to 44 Days)||0
3280550|NCT02729038|4014004|FG003|NOT COMPLETED|Part 1 (Up to 44 Days)||0
3280551|NCT02729038|4014001|FG000|STARTED|Part 2 (Up to 50 Days)||0
3280552|NCT02729038|4014002|FG001|STARTED|Part 2 (Up to 50 Days)||0
3049034|NCT01211197|3769124|FG001|NOT COMPLETED|Treatment Period 2 (1 Day)||0
3049035|NCT01211197|3769125|FG002|NOT COMPLETED|Treatment Period 2 (1 Day)||0
3049036|NCT01211197|3769126|FG003|NOT COMPLETED|Treatment Period 2 (1 Day)||0
3049037|NCT01211197|3769127|FG004|NOT COMPLETED|Treatment Period 2 (1 Day)||0
3049038|NCT01211197|3769128|FG005|NOT COMPLETED|Treatment Period 2 (1 Day)||0
3049039|NCT01211197|3769123|FG000|STARTED|Washout Period 2 (7 Days)||3
3049040|NCT01211197|3769124|FG001|STARTED|Washout Period 2 (7 Days)||3
3049041|NCT01211197|3769125|FG002|STARTED|Washout Period 2 (7 Days)||2
3049042|NCT01211197|3769126|FG003|STARTED|Washout Period 2 (7 Days)||3
3049043|NCT01211197|3769127|FG004|STARTED|Washout Period 2 (7 Days)||2
3049044|NCT01211197|3769128|FG005|STARTED|Washout Period 2 (7 Days)||2
3049045|NCT01211197|3769123|FG000|COMPLETED|Washout Period 2 (7 Days)||2
3049046|NCT01211197|3769124|FG001|COMPLETED|Washout Period 2 (7 Days)||3
3049047|NCT01211197|3769125|FG002|COMPLETED|Washout Period 2 (7 Days)||2
3049048|NCT01211197|3769126|FG003|COMPLETED|Washout Period 2 (7 Days)||3
3049049|NCT01211197|3769127|FG004|COMPLETED|Washout Period 2 (7 Days)||2
3049050|NCT01211197|3769128|FG005|COMPLETED|Washout Period 2 (7 Days)||2
3049051|NCT01211197|3769123|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||1
3049052|NCT01211197|3769124|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0
3049053|NCT01211197|3769125|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0
3049054|NCT01211197|3769126|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||0
3049055|NCT01211197|3769127|FG004|NOT COMPLETED|Washout Period 2 (7 Days)||0
3049056|NCT01211197|3769128|FG005|NOT COMPLETED|Washout Period 2 (7 Days)||0
3049057|NCT01211197|3769123|FG000|STARTED|Treatment Period 3 (1 Day)||2
3049058|NCT01211197|3769124|FG001|STARTED|Treatment Period 3 (1 Day)||3
3049059|NCT01211197|3769125|FG002|STARTED|Treatment Period 3 (1 Day)||2
3049060|NCT01211197|3769126|FG003|STARTED|Treatment Period 3 (1 Day)||3
3049061|NCT01211197|3769127|FG004|STARTED|Treatment Period 3 (1 Day)||2
3049062|NCT01211197|3769128|FG005|STARTED|Treatment Period 3 (1 Day)||2
3049063|NCT01211197|3769123|FG000|COMPLETED|Treatment Period 3 (1 Day)||2
3049064|NCT01211197|3769124|FG001|COMPLETED|Treatment Period 3 (1 Day)||3
3049065|NCT01211197|3769125|FG002|COMPLETED|Treatment Period 3 (1 Day)||2
3049066|NCT01211197|3769126|FG003|COMPLETED|Treatment Period 3 (1 Day)||3
3049067|NCT01211197|3769127|FG004|COMPLETED|Treatment Period 3 (1 Day)||2
3049068|NCT01211197|3769128|FG005|COMPLETED|Treatment Period 3 (1 Day)||2
3049069|NCT01211197|3769123|FG000|NOT COMPLETED|Treatment Period 3 (1 Day)||0
3049070|NCT01211197|3769124|FG001|NOT COMPLETED|Treatment Period 3 (1 Day)||0
3049071|NCT01211197|3769125|FG002|NOT COMPLETED|Treatment Period 3 (1 Day)||0
3049072|NCT01211197|3769126|FG003|NOT COMPLETED|Treatment Period 3 (1 Day)||0
3049073|NCT01211197|3769127|FG004|NOT COMPLETED|Treatment Period 3 (1 Day)||0
3049074|NCT01211197|3769128|FG005|NOT COMPLETED|Treatment Period 3 (1 Day)||0
3049075|NCT01211262|3769138|FG000|STARTED|Overall Study||66
3049076|NCT01211262|3769139|FG001|STARTED|Overall Study||18
3049077|NCT01211262|3769138|FG000|COMPLETED|Overall Study||43
3049078|NCT01211262|3769139|FG001|COMPLETED|Overall Study||8
3049079|NCT01211262|3769138|FG000|NOT COMPLETED|Overall Study||23
3049080|NCT01211262|3769139|FG001|NOT COMPLETED|Overall Study||10
3049081|NCT01211288|3769150|FG000|STARTED|Overall Study||21
3049082|NCT01211288|3769151|FG001|STARTED|Overall Study||20
3049083|NCT01211288|3769150|FG000|COMPLETED|Overall Study||20
3049084|NCT01211288|3769151|FG001|COMPLETED|Overall Study||19
3049085|NCT01211288|3769150|FG000|NOT COMPLETED|Overall Study||1
3049086|NCT01211288|3769151|FG001|NOT COMPLETED|Overall Study||1
3049087|NCT01211340|3769161|FG000|STARTED|Overall Study||223
3049088|NCT01211340|3769162|FG001|STARTED|Overall Study||223
3049089|NCT01211340|3769161|FG000|COMPLETED|Overall Study||223
3049090|NCT01211340|3769162|FG001|COMPLETED|Overall Study||223
3049091|NCT01211340|3769161|FG000|NOT COMPLETED|Overall Study||0
3049092|NCT01211340|3769162|FG001|NOT COMPLETED|Overall Study||0
3049093|NCT01211483|3769172|FG000|STARTED|Phase 1b||7
3049094|NCT01211483|3769173|FG001|STARTED|Phase 1b||0
3049095|NCT01211483|3769174|FG002|STARTED|Phase 1b||0
3049096|NCT01211483|3769175|FG003|STARTED|Phase 1b||0
3049097|NCT01211483|3769172|FG000|COMPLETED|Phase 1b||0
3049098|NCT01211483|3769173|FG001|COMPLETED|Phase 1b||0
3049099|NCT01211483|3769174|FG002|COMPLETED|Phase 1b||0
3049100|NCT01211483|3769175|FG003|COMPLETED|Phase 1b||0
3049101|NCT01211483|3769172|FG000|NOT COMPLETED|Phase 1b||7
3049102|NCT01211483|3769173|FG001|NOT COMPLETED|Phase 1b||0
3049103|NCT01211483|3769174|FG002|NOT COMPLETED|Phase 1b||0
3049104|NCT01211483|3769175|FG003|NOT COMPLETED|Phase 1b||0
3049105|NCT01211483|3769172|FG000|STARTED|Phase 2||0
3049106|NCT01211483|3769173|FG001|STARTED|Phase 2|Participants entered only at Period 2.|72
3049107|NCT01211483|3769174|FG002|STARTED|Phase 2|Participants entered only at Period 2.|72
3049108|NCT01211483|3769175|FG003|STARTED|Phase 2|Participants entered only at Period 2.|71
3049109|NCT01211483|3769172|FG000|COMPLETED|Phase 2||0
3049110|NCT01211483|3769173|FG001|COMPLETED|Phase 2||0
3049111|NCT01211483|3769174|FG002|COMPLETED|Phase 2||0
3049112|NCT01211483|3769175|FG003|COMPLETED|Phase 2||0
3049113|NCT01211483|3769172|FG000|NOT COMPLETED|Phase 2||0
3049114|NCT01211483|3769173|FG001|NOT COMPLETED|Phase 2||72
3049115|NCT01211483|3769174|FG002|NOT COMPLETED|Phase 2||72
3049116|NCT01211483|3769175|FG003|NOT COMPLETED|Phase 2||71
3049117|NCT01211522|3769192|FG000|STARTED|Overall Study||192
3049118|NCT01211522|3769193|FG001|STARTED|Overall Study||190
3049119|NCT01211522|3769194|FG002|STARTED|Overall Study||184
3049120|NCT01211522|3769192|FG000|COMPLETED|Overall Study||189
3049121|NCT01211522|3769193|FG001|COMPLETED|Overall Study||183
3049122|NCT01211522|3769194|FG002|COMPLETED|Overall Study||179
3049123|NCT01211522|3769192|FG000|NOT COMPLETED|Overall Study||3
3049124|NCT01211522|3769193|FG001|NOT COMPLETED|Overall Study||7
3049125|NCT01211522|3769194|FG002|NOT COMPLETED|Overall Study||5
3049126|NCT01211535|3769204|FG000|STARTED|Overall Study||52
3049127|NCT01211535|3769205|FG001|STARTED|Overall Study||52
3049128|NCT01211535|3769204|FG000|COMPLETED|Overall Study||52
3049129|NCT01211535|3769205|FG001|COMPLETED|Overall Study||51
3049130|NCT01211535|3769204|FG000|NOT COMPLETED|Overall Study||0
3049131|NCT01211535|3769205|FG001|NOT COMPLETED|Overall Study||1
3049132|NCT01211600|3769213|FG000|STARTED|Overall Study||370
3049133|NCT01211600|3769214|FG001|STARTED|Overall Study||376
3049134|NCT01211600|3769213|FG000|COMPLETED|Overall Study||370
3049135|NCT01211600|3769214|FG001|COMPLETED|Overall Study||376
3049136|NCT01211600|3769213|FG000|NOT COMPLETED|Overall Study||0
3049137|NCT01211600|3769214|FG001|NOT COMPLETED|Overall Study||0
3049138|NCT01211613|3769225|FG000|STARTED|Overall Study||37
3049139|NCT01211613|3769226|FG001|STARTED|Overall Study||35
3049140|NCT01211613|3769227|FG002|STARTED|Overall Study||35
3049141|NCT01211613|3769225|FG000|COMPLETED|Overall Study||34
3049142|NCT01211613|3769226|FG001|COMPLETED|Overall Study||33
3049143|NCT01211613|3769227|FG002|COMPLETED|Overall Study||33
3049144|NCT01211613|3769225|FG000|NOT COMPLETED|Overall Study||3
3049145|NCT01211613|3769226|FG001|NOT COMPLETED|Overall Study||2
3049146|NCT01211613|3769227|FG002|NOT COMPLETED|Overall Study||2
3049147|NCT01211665|3769237|FG000|STARTED|Overall Study||2
3049148|NCT01211665|3769238|FG001|STARTED|Overall Study||1
3049149|NCT01211665|3769237|FG000|COMPLETED|Overall Study||0
3049150|NCT01211665|3769238|FG001|COMPLETED|Overall Study|completed treatment with study drug|1
3049151|NCT01211665|3769237|FG000|NOT COMPLETED|Overall Study||2
3280553|NCT02729038|4014003|FG002|STARTED|Part 2 (Up to 50 Days)||0
3280554|NCT02729038|4014004|FG003|STARTED|Part 2 (Up to 50 Days)||8
3280555|NCT02729038|4014001|FG000|COMPLETED|Part 2 (Up to 50 Days)||0
3280556|NCT02729038|4014002|FG001|COMPLETED|Part 2 (Up to 50 Days)||0
3280557|NCT02729038|4014003|FG002|COMPLETED|Part 2 (Up to 50 Days)||0
3280558|NCT02729038|4014004|FG003|COMPLETED|Part 2 (Up to 50 Days)||8
3280559|NCT02729038|4014001|FG000|NOT COMPLETED|Part 2 (Up to 50 Days)||0
3280560|NCT02729038|4014002|FG001|NOT COMPLETED|Part 2 (Up to 50 Days)||0
3280561|NCT02729038|4014003|FG002|NOT COMPLETED|Part 2 (Up to 50 Days)||0
3280562|NCT02729038|4014004|FG003|NOT COMPLETED|Part 2 (Up to 50 Days)||0
3280563|NCT02729051|4014023|FG000|STARTED|Overall Study||527
3280564|NCT02729051|4014024|FG001|STARTED|Overall Study||528
3280565|NCT02729051|4014023|FG000|COMPLETED|Overall Study||497
3280566|NCT02729051|4014024|FG001|COMPLETED|Overall Study||496
3280567|NCT02729051|4014023|FG000|NOT COMPLETED|Overall Study||30
3280568|NCT02729051|4014024|FG001|NOT COMPLETED|Overall Study||32
3280569|NCT02729194|4014030|FG000|STARTED|Overall Study||16
3280570|NCT02729194|4014030|FG000|COMPLETED|Overall Study||13
3280571|NCT02729194|4014030|FG000|NOT COMPLETED|Overall Study||3
3280572|NCT02729545|4014036|FG000|STARTED|Overall Study||30
3280573|NCT02729545|4014037|FG001|STARTED|Overall Study||30
3280574|NCT02729545|4014036|FG000|COMPLETED|Overall Study||27
3280575|NCT02729545|4014037|FG001|COMPLETED|Overall Study||25
3280576|NCT02729545|4014036|FG000|NOT COMPLETED|Overall Study||3
3280577|NCT02729545|4014037|FG001|NOT COMPLETED|Overall Study||5
3280578|NCT02729740|4014043|FG000|STARTED|Overall Study||995
3280579|NCT02729740|4014043|FG000|COMPLETED|Overall Study||864
3280580|NCT02729740|4014043|FG000|NOT COMPLETED|Overall Study||131
3280581|NCT02729753|4014049|FG000|STARTED|Overall Study|First patient enrolled April 2016|3
3280582|NCT02729753|4014050|FG001|STARTED|Overall Study|First patient enrolled April 2016|7
3280583|NCT02729753|4014049|FG000|COMPLETED|Overall Study|Study Complete on 30 Oct 2016|3
3280584|NCT02729753|4014050|FG001|COMPLETED|Overall Study|Study Complete on 30 Oct 2016|6
3280585|NCT02729753|4014049|FG000|NOT COMPLETED|Overall Study||0
3280586|NCT02729753|4014050|FG001|NOT COMPLETED|Overall Study||1
3280587|NCT02729831|4014063|FG000|STARTED|Baseline (Post Decision Aid, Pre-visit)||320
3280588|NCT02729831|4014064|FG001|STARTED|Baseline (Post Decision Aid, Pre-visit)||315
3280589|NCT02729831|4014065|FG002|STARTED|Baseline (Post Decision Aid, Pre-visit)||293
3280590|NCT02729831|4014066|FG003|STARTED|Baseline (Post Decision Aid, Pre-visit)||292
3280591|NCT02729831|4014063|FG000|COMPLETED|Baseline (Post Decision Aid, Pre-visit)||282
3280592|NCT02729831|4014064|FG001|COMPLETED|Baseline (Post Decision Aid, Pre-visit)||292
3280593|NCT02729831|4014065|FG002|COMPLETED|Baseline (Post Decision Aid, Pre-visit)||275
3280594|NCT02729831|4014066|FG003|COMPLETED|Baseline (Post Decision Aid, Pre-visit)||275
3280595|NCT02729831|4014063|FG000|NOT COMPLETED|Baseline (Post Decision Aid, Pre-visit)||38
3280596|NCT02729831|4014064|FG001|NOT COMPLETED|Baseline (Post Decision Aid, Pre-visit)||23
3280597|NCT02729831|4014065|FG002|NOT COMPLETED|Baseline (Post Decision Aid, Pre-visit)||18
3280598|NCT02729831|4014066|FG003|NOT COMPLETED|Baseline (Post Decision Aid, Pre-visit)||17
3280599|NCT02729831|4014063|FG000|STARTED|1 Week Post-visit||282
3280600|NCT02729831|4014064|FG001|STARTED|1 Week Post-visit||292
3280601|NCT02729831|4014065|FG002|STARTED|1 Week Post-visit||275
3280602|NCT02729831|4014066|FG003|STARTED|1 Week Post-visit||275
3280603|NCT02729831|4014063|FG000|COMPLETED|1 Week Post-visit||239
3049152|NCT01211665|3769238|FG001|NOT COMPLETED|Overall Study||0
3049153|NCT01211730|3769246|FG000|STARTED|Overall Study||82
3049154|NCT01211730|3769247|FG001|STARTED|Overall Study||82
3049155|NCT01211730|3769246|FG000|COMPLETED|Overall Study||82
3049156|NCT01211730|3769247|FG001|COMPLETED|Overall Study||82
3049157|NCT01211730|3769246|FG000|NOT COMPLETED|Overall Study||0
3049158|NCT01211730|3769247|FG001|NOT COMPLETED|Overall Study||0
3049159|NCT01211769|3769257|FG000|STARTED|Overall Study||20
3049160|NCT01211769|3769258|FG001|STARTED|Overall Study||20
3049161|NCT01211769|3769259|FG002|STARTED|Overall Study||20
3049162|NCT01211769|3769260|FG003|STARTED|Overall Study||20
3049163|NCT01211769|3769257|FG000|Participants/Group|Overall Study||20
3049164|NCT01211769|3769258|FG001|Participants/Group|Overall Study||20
3049165|NCT01211769|3769259|FG002|Participants/Group|Overall Study||20
3049166|NCT01211769|3769260|FG003|Participants/Group|Overall Study||20
3049167|NCT01211769|3769257|FG000|COMPLETED|Overall Study||11
3049168|NCT01211769|3769258|FG001|COMPLETED|Overall Study||10
3049169|NCT01211769|3769259|FG002|COMPLETED|Overall Study||12
3049170|NCT01211769|3769260|FG003|COMPLETED|Overall Study||9
3049171|NCT01211769|3769257|FG000|NOT COMPLETED|Overall Study||9
3049172|NCT01211769|3769258|FG001|NOT COMPLETED|Overall Study||10
3049173|NCT01211769|3769259|FG002|NOT COMPLETED|Overall Study||8
3049174|NCT01211769|3769260|FG003|NOT COMPLETED|Overall Study||11
3049175|NCT01211873|3769273|FG000|STARTED|Overall Study||245
3049176|NCT01211873|3769274|FG001|STARTED|Overall Study||119
3049177|NCT01211873|3769275|FG002|STARTED|Overall Study||38
3049178|NCT01211873|3769273|FG000|COMPLETED|Overall Study||240
3049179|NCT01211873|3769274|FG001|COMPLETED|Overall Study||117
3049180|NCT01211873|3769275|FG002|COMPLETED|Overall Study||36
3049181|NCT01211873|3769273|FG000|NOT COMPLETED|Overall Study||5
3049182|NCT01211873|3769274|FG001|NOT COMPLETED|Overall Study||2
3049183|NCT01211873|3769275|FG002|NOT COMPLETED|Overall Study||2
3049184|NCT01212094|3769287|FG000|STARTED|Year 1: Baseline Monitoring||43
3049185|NCT01212094|3769288|FG001|STARTED|Year 1: Baseline Monitoring||0
3049186|NCT01212094|3769289|FG002|STARTED|Year 1: Baseline Monitoring||0
3049187|NCT01212094|3769287|FG000|COMPLETED|Year 1: Baseline Monitoring||27
3049188|NCT01212094|3769288|FG001|COMPLETED|Year 1: Baseline Monitoring||0
3049189|NCT01212094|3769289|FG002|COMPLETED|Year 1: Baseline Monitoring||0
3049190|NCT01212094|3769287|FG000|NOT COMPLETED|Year 1: Baseline Monitoring||16
3049191|NCT01212094|3769288|FG001|NOT COMPLETED|Year 1: Baseline Monitoring||0
3049192|NCT01212094|3769289|FG002|NOT COMPLETED|Year 1: Baseline Monitoring||0
3049193|NCT01212094|3769287|FG000|STARTED|Years 2 & 3: Treatment Randomization||0
3049194|NCT01212094|3769288|FG001|STARTED|Years 2 & 3: Treatment Randomization||9
3049195|NCT01212094|3769289|FG002|STARTED|Years 2 & 3: Treatment Randomization||18
3049196|NCT01212094|3769287|FG000|COMPLETED|Years 2 & 3: Treatment Randomization||0
3049197|NCT01212094|3769288|FG001|COMPLETED|Years 2 & 3: Treatment Randomization||5
3049198|NCT01212094|3769289|FG002|COMPLETED|Years 2 & 3: Treatment Randomization||7
3049199|NCT01212094|3769287|FG000|NOT COMPLETED|Years 2 & 3: Treatment Randomization||0
3049200|NCT01212094|3769288|FG001|NOT COMPLETED|Years 2 & 3: Treatment Randomization||4
3049201|NCT01212094|3769289|FG002|NOT COMPLETED|Years 2 & 3: Treatment Randomization||11
3049202|NCT01212107|3769308|FG000|STARTED|Overall Study||3
3049203|NCT01212107|3769309|FG001|STARTED|Overall Study||3
3049204|NCT01212107|3769310|FG002|STARTED|Overall Study||6
3049205|NCT01212107|3769311|FG003|STARTED|Overall Study||3
3049206|NCT01212107|3769312|FG004|STARTED|Overall Study||3
3049207|NCT01212107|3769313|FG005|STARTED|Overall Study||3
3049208|NCT01212107|3769314|FG006|STARTED|Overall Study||3
3049209|NCT01212107|3769315|FG007|STARTED|Overall Study||3
3049210|NCT01212107|3769316|FG008|STARTED|Overall Study||3
3049211|NCT01212107|3769317|FG009|STARTED|Overall Study||3
3049212|NCT01212107|3769318|FG010|STARTED|Overall Study||3
3049213|NCT01212107|3769319|FG011|STARTED|Overall Study||58
3049214|NCT01212107|3769308|FG000|COMPLETED|Overall Study||2
3049215|NCT01212107|3769309|FG001|COMPLETED|Overall Study||2
3049216|NCT01212107|3769310|FG002|COMPLETED|Overall Study||3
3049217|NCT01212107|3769311|FG003|COMPLETED|Overall Study||3
3049218|NCT01212107|3769312|FG004|COMPLETED|Overall Study||2
3049219|NCT01212107|3769313|FG005|COMPLETED|Overall Study||2
3049220|NCT01212107|3769314|FG006|COMPLETED|Overall Study||3
3049221|NCT01212107|3769315|FG007|COMPLETED|Overall Study||2
3049222|NCT01212107|3769316|FG008|COMPLETED|Overall Study||1
3049223|NCT01212107|3769317|FG009|COMPLETED|Overall Study||1
3049224|NCT01212107|3769318|FG010|COMPLETED|Overall Study||2
3049225|NCT01212107|3769319|FG011|COMPLETED|Overall Study||26
3049226|NCT01212107|3769308|FG000|NOT COMPLETED|Overall Study||1
3049227|NCT01212107|3769309|FG001|NOT COMPLETED|Overall Study||1
3049228|NCT01212107|3769310|FG002|NOT COMPLETED|Overall Study||3
3049229|NCT01212107|3769311|FG003|NOT COMPLETED|Overall Study||0
3049230|NCT01212107|3769312|FG004|NOT COMPLETED|Overall Study||1
3049231|NCT01212107|3769313|FG005|NOT COMPLETED|Overall Study||1
3049232|NCT01212107|3769314|FG006|NOT COMPLETED|Overall Study||0
3280604|NCT02729831|4014064|FG001|COMPLETED|1 Week Post-visit||252
3280605|NCT02729831|4014065|FG002|COMPLETED|1 Week Post-visit||237
3049233|NCT01212107|3769315|FG007|NOT COMPLETED|Overall Study||1
3049234|NCT01212107|3769316|FG008|NOT COMPLETED|Overall Study||2
3049235|NCT01212107|3769317|FG009|NOT COMPLETED|Overall Study||2
3049236|NCT01212107|3769318|FG010|NOT COMPLETED|Overall Study||1
3049237|NCT01212107|3769319|FG011|NOT COMPLETED|Overall Study||32
3049238|NCT01212159|3769363|FG000|STARTED|Overall Study||26
3049239|NCT01212159|3769364|FG001|STARTED|Overall Study||44
3049240|NCT01212159|3769363|FG000|COMPLETED|Overall Study||14
3049241|NCT01212159|3769364|FG001|COMPLETED|Overall Study||32
3049242|NCT01212159|3769363|FG000|NOT COMPLETED|Overall Study||12
3049243|NCT01212159|3769364|FG001|NOT COMPLETED|Overall Study||12
3049244|NCT01212172|3769370|FG000|STARTED|Overall Study||10
3049245|NCT01212172|3769371|FG001|STARTED|Overall Study||10
3049246|NCT01212172|3769370|FG000|COMPLETED|Overall Study||9
3049247|NCT01212172|3769371|FG001|COMPLETED|Overall Study||9
3049248|NCT01212172|3769370|FG000|NOT COMPLETED|Overall Study||1
3049249|NCT01212172|3769371|FG001|NOT COMPLETED|Overall Study||1
3049250|NCT01212185|3769381|FG000|STARTED|Overall Study||6
3049251|NCT01212185|3769382|FG001|STARTED|Overall Study||8
3049252|NCT01212185|3769381|FG000|COMPLETED|Overall Study||4
3049253|NCT01212185|3769382|FG001|COMPLETED|Overall Study||7
3049254|NCT01212185|3769381|FG000|NOT COMPLETED|Overall Study||2
3049255|NCT01212185|3769382|FG001|NOT COMPLETED|Overall Study||1
3049256|NCT01212302|3769388|FG000|STARTED|Overall Study||504
3049257|NCT01212302|3769388|FG000|COMPLETED|Overall Study||504
3049258|NCT01212302|3769388|FG000|NOT COMPLETED|Overall Study||0
3049259|NCT01212445|3769395|FG000|STARTED|Overall Study||52
3049260|NCT01212445|3769396|FG001|STARTED|Overall Study||51
3049261|NCT01212445|3769397|FG002|STARTED|Overall Study||51
3049262|NCT01212445|3769395|FG000|COMPLETED|Overall Study||52
3049263|NCT01212445|3769396|FG001|COMPLETED|Overall Study||51
3049264|NCT01212445|3769397|FG002|COMPLETED|Overall Study||51
3049265|NCT01212445|3769395|FG000|NOT COMPLETED|Overall Study||0
3049266|NCT01212445|3769396|FG001|NOT COMPLETED|Overall Study||0
3049267|NCT01212445|3769397|FG002|NOT COMPLETED|Overall Study||0
3049268|NCT01212471|3769409|FG000|STARTED|Overall Study||141
3049269|NCT01212471|3769410|FG001|STARTED|Overall Study||140
3049270|NCT01212471|3769411|FG002|STARTED|Overall Study||139
3049271|NCT01212471|3769409|FG000|COMPLETED|Overall Study||139
3049272|NCT01212471|3769410|FG001|COMPLETED|Overall Study||137
3049273|NCT01212471|3769411|FG002|COMPLETED|Overall Study||132
3049274|NCT01212471|3769409|FG000|NOT COMPLETED|Overall Study||2
3049275|NCT01212471|3769410|FG001|NOT COMPLETED|Overall Study||3
3049276|NCT01212471|3769411|FG002|NOT COMPLETED|Overall Study||7
3049277|NCT01212484|3769419|FG000|STARTED|Carbidopa Titration Period (4 Weeks)||6
3049278|NCT01212484|3769420|FG001|STARTED|Carbidopa Titration Period (4 Weeks)||6
3049279|NCT01212484|3769419|FG000|COMPLETED|Carbidopa Titration Period (4 Weeks)||5
3049280|NCT01212484|3769420|FG001|COMPLETED|Carbidopa Titration Period (4 Weeks)||6
3049281|NCT01212484|3769419|FG000|NOT COMPLETED|Carbidopa Titration Period (4 Weeks)||1
3049282|NCT01212484|3769420|FG001|NOT COMPLETED|Carbidopa Titration Period (4 Weeks)||0
3049283|NCT01212484|3769419|FG000|STARTED|First Intervention (4 Weeks)||5
3049284|NCT01212484|3769420|FG001|STARTED|First Intervention (4 Weeks)||6
3049285|NCT01212484|3769419|FG000|COMPLETED|First Intervention (4 Weeks)||5
3049286|NCT01212484|3769420|FG001|COMPLETED|First Intervention (4 Weeks)||4
3049287|NCT01212484|3769419|FG000|NOT COMPLETED|First Intervention (4 Weeks)||0
3049288|NCT01212484|3769420|FG001|NOT COMPLETED|First Intervention (4 Weeks)||2
3049289|NCT01212484|3769419|FG000|STARTED|Second Intervention (4 Weeks)||5
3049290|NCT01212484|3769420|FG001|STARTED|Second Intervention (4 Weeks)||4
3049291|NCT01212484|3769419|FG000|COMPLETED|Second Intervention (4 Weeks)||5
3049292|NCT01212484|3769420|FG001|COMPLETED|Second Intervention (4 Weeks)||3
3049293|NCT01212484|3769419|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||0
3049294|NCT01212484|3769420|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||1
3049295|NCT01212588|3769428|FG000|STARTED|Overall Study||10
3049296|NCT01212588|3769429|FG001|STARTED|Overall Study||12
3049297|NCT01212588|3769428|FG000|COMPLETED|Overall Study||9
3049298|NCT01212588|3769429|FG001|COMPLETED|Overall Study||10
3049299|NCT01212588|3769428|FG000|NOT COMPLETED|Overall Study||1
3049300|NCT01212588|3769429|FG001|NOT COMPLETED|Overall Study||2
3049301|NCT01212627|3769435|FG000|STARTED|Overall Study||12
3049302|NCT01212627|3769435|FG000|COMPLETED|Overall Study||12
3049303|NCT01212627|3769435|FG000|NOT COMPLETED|Overall Study||0
3049304|NCT01212744|3769439|FG000|STARTED|Overall Study||16
3049305|NCT01212744|3769439|FG000|COMPLETED|Overall Study||15
3049306|NCT01212744|3769439|FG000|NOT COMPLETED|Overall Study||1
3049307|NCT01212757|3769448|FG000|STARTED|Placebo-controlled Phase (Week 0 - 24)||162
3049308|NCT01212757|3769449|FG001|STARTED|Placebo-controlled Phase (Week 0 - 24)||163
3049309|NCT01212757|3769450|FG002|STARTED|Placebo-controlled Phase (Week 0 - 24)||163
3049310|NCT01212757|3769451|FG003|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
3049311|NCT01212757|3769452|FG004|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
3049312|NCT01212757|3769453|FG005|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
3049313|NCT01212757|3769454|FG006|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
3049314|NCT01212757|3769455|FG007|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
3049315|NCT01212757|3769456|FG008|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
3049316|NCT01212757|3769448|FG000|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||159
3049317|NCT01212757|3769449|FG001|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||163
3049318|NCT01212757|3769450|FG002|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||162
3049319|NCT01212757|3769451|FG003|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
3049320|NCT01212757|3769452|FG004|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
3049321|NCT01212757|3769453|FG005|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
3049322|NCT01212757|3769454|FG006|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
3049323|NCT01212757|3769455|FG007|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
3049324|NCT01212757|3769456|FG008|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
3049325|NCT01212757|3769448|FG000|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||148
3049326|NCT01212757|3769449|FG001|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||151
3049327|NCT01212757|3769450|FG002|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||149
3049328|NCT01212757|3769451|FG003|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
3049329|NCT01212757|3769452|FG004|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
3049330|NCT01212757|3769453|FG005|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
3049331|NCT01212757|3769454|FG006|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
3049332|NCT01212757|3769455|FG007|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
3049333|NCT01212757|3769456|FG008|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
3049334|NCT01212757|3769448|FG000|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)|Two participants who escaped early did not complete Week 24|88
3049335|NCT01212757|3769449|FG001|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)|Three participants who escaped early did not complete Week 24|59
3049336|NCT01212757|3769450|FG002|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||64
3049337|NCT01212757|3769451|FG003|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
3049338|NCT01212757|3769452|FG004|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
3049339|NCT01212757|3769453|FG005|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
3049340|NCT01212757|3769454|FG006|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
3049341|NCT01212757|3769455|FG007|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
3049342|NCT01212757|3769456|FG008|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
3049343|NCT01212757|3769448|FG000|COMPLETED|Placebo-controlled Phase (Week 0 - 24)|Two participants who completed Week 24 did not enter the active treatment phase|143
3049344|NCT01212757|3769449|FG001|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||143
3049345|NCT01212757|3769450|FG002|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||142
3280606|NCT02729831|4014066|FG003|COMPLETED|1 Week Post-visit||239
3280607|NCT02729831|4014063|FG000|NOT COMPLETED|1 Week Post-visit||43
3280608|NCT02729831|4014064|FG001|NOT COMPLETED|1 Week Post-visit||40
3280609|NCT02729831|4014065|FG002|NOT COMPLETED|1 Week Post-visit||38
3280610|NCT02729831|4014066|FG003|NOT COMPLETED|1 Week Post-visit||36
3280611|NCT02729831|4014063|FG000|STARTED|6 Month Follow-up||282
3280612|NCT02729831|4014064|FG001|STARTED|6 Month Follow-up||292
3280613|NCT02729831|4014065|FG002|STARTED|6 Month Follow-up||275
3280614|NCT02729831|4014066|FG003|STARTED|6 Month Follow-up||275
3280615|NCT02729831|4014063|FG000|COMPLETED|6 Month Follow-up||227
3280616|NCT02729831|4014064|FG001|COMPLETED|6 Month Follow-up||238
3280617|NCT02729831|4014065|FG002|COMPLETED|6 Month Follow-up||227
3280618|NCT02729831|4014066|FG003|COMPLETED|6 Month Follow-up||232
3280619|NCT02729831|4014063|FG000|NOT COMPLETED|6 Month Follow-up||55
3280620|NCT02729831|4014064|FG001|NOT COMPLETED|6 Month Follow-up||54
3280621|NCT02729831|4014065|FG002|NOT COMPLETED|6 Month Follow-up||48
3280622|NCT02729831|4014066|FG003|NOT COMPLETED|6 Month Follow-up||43
3280623|NCT02729896|4014079|FG000|STARTED|Overall Study||3
3280624|NCT02729896|4014080|FG001|STARTED|Overall Study||10
3280625|NCT02729896|4014081|FG002|STARTED|Overall Study||23
3280626|NCT02729896|4014079|FG000|COMPLETED|Overall Study||1
3280627|NCT02729896|4014080|FG001|COMPLETED|Overall Study||1
3280628|NCT02729896|4014081|FG002|COMPLETED|Overall Study||1
3280629|NCT02729896|4014079|FG000|NOT COMPLETED|Overall Study||2
3280630|NCT02729896|4014080|FG001|NOT COMPLETED|Overall Study||9
3280631|NCT02729896|4014081|FG002|NOT COMPLETED|Overall Study||22
3280632|NCT02729909|4014092|FG000|STARTED|Overall Study||105
3280633|NCT02729909|4014093|FG001|STARTED|Overall Study||106
3280634|NCT02729909|4014092|FG000|COMPLETED|Overall Study||104
3280635|NCT02729909|4014093|FG001|COMPLETED|Overall Study||101
3280636|NCT02729909|4014092|FG000|NOT COMPLETED|Overall Study||1
3280637|NCT02729909|4014093|FG001|NOT COMPLETED|Overall Study||5
3280638|NCT02730130|4014099|FG000|STARTED|Overall Study||17
3280639|NCT02730130|4014099|FG000|COMPLETED|Overall Study||17
3280640|NCT02730130|4014099|FG000|NOT COMPLETED|Overall Study||0
3280641|NCT02730169|4014107|FG000|STARTED|Overall Study||67
3280642|NCT02730169|4014108|FG001|STARTED|Overall Study||66
3280643|NCT02730169|4014109|FG002|STARTED|Overall Study||67
3280644|NCT02730169|4014110|FG003|STARTED|Overall Study||71
3280645|NCT02730169|4014107|FG000|COMPLETED|Overall Study||53
3280646|NCT02730169|4014108|FG001|COMPLETED|Overall Study||45
3280647|NCT02730169|4014109|FG002|COMPLETED|Overall Study||50
3280648|NCT02730169|4014110|FG003|COMPLETED|Overall Study||55
3280649|NCT02730169|4014107|FG000|NOT COMPLETED|Overall Study||14
3280650|NCT02730169|4014108|FG001|NOT COMPLETED|Overall Study||21
3280651|NCT02730169|4014109|FG002|NOT COMPLETED|Overall Study||17
3280652|NCT02730169|4014110|FG003|NOT COMPLETED|Overall Study||16
3280653|NCT02730195|4014120|FG000|STARTED|Overall Study||9
3280654|NCT02730195|4014120|FG000|COMPLETED|Overall Study||8
3280655|NCT02730195|4014120|FG000|NOT COMPLETED|Overall Study||1
3316401|NCT03110770|4049699|FG000|Received Third Product Administration|Overall Study||29
3316402|NCT03110770|4049700|FG001|Received Third Product Administration|Overall Study||27
3316403|NCT03110770|4049701|FG002|Received Third Product Administration|Overall Study||28
3316404|NCT03110770|4049702|FG003|Received Third Product Administration|Overall Study||1107
3316405|NCT03110770|4049703|FG004|Received Third Product Administration|Overall Study||1107
3316406|NCT03110770|4049699|FG000|COMPLETED|Overall Study||24
3316407|NCT03110770|4049700|FG001|COMPLETED|Overall Study||30
3316408|NCT03110770|4049701|FG002|COMPLETED|Overall Study||28
3316409|NCT03110770|4049702|FG003|COMPLETED|Overall Study||1037
3316410|NCT03110770|4049703|FG004|COMPLETED|Overall Study||1045
3316411|NCT03110770|4049699|FG000|NOT COMPLETED|Overall Study||6
3316412|NCT03110770|4049700|FG001|NOT COMPLETED|Overall Study||0
3316413|NCT03110770|4049701|FG002|NOT COMPLETED|Overall Study||2
3316414|NCT03110770|4049702|FG003|NOT COMPLETED|Overall Study||133
3049346|NCT01212757|3769451|FG003|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
3049347|NCT01212757|3769452|FG004|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
3049348|NCT01212757|3769453|FG005|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
3049349|NCT01212757|3769454|FG006|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
3049350|NCT01212757|3769455|FG007|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
3049351|NCT01212757|3769456|FG008|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
3049352|NCT01212757|3769448|FG000|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||19
3049353|NCT01212757|3769449|FG001|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||20
3049354|NCT01212757|3769450|FG002|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||21
3049355|NCT01212757|3769451|FG003|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
3049356|NCT01212757|3769452|FG004|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
3049357|NCT01212757|3769453|FG005|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
3049358|NCT01212757|3769454|FG006|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
3049359|NCT01212757|3769455|FG007|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
3049360|NCT01212757|3769456|FG008|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
3049361|NCT01212757|3769448|FG000|STARTED|Active Treatment Phase (Weeks 24 - 52)||0
3049362|NCT01212757|3769449|FG001|STARTED|Active Treatment Phase (Weeks 24 - 52)|6 participants who completed Week 24 did not enter the Week 24-52 active treatment phase|137
3049363|NCT01212757|3769450|FG002|STARTED|Active Treatment Phase (Weeks 24 - 52)|8 participants who completed Week 24 did not enter the Week 24-52 active treatment phase|134
3049364|NCT01212757|3769451|FG003|STARTED|Active Treatment Phase (Weeks 24 - 52)||43
3049365|NCT01212757|3769452|FG004|STARTED|Active Treatment Phase (Weeks 24 - 52)||27
3049366|NCT01212757|3769453|FG005|STARTED|Active Treatment Phase (Weeks 24 - 52)|2 participants who EE and completed Week 24 did not enter the Week 24-52 active treatment phase|41
3280656|NCT02730208|4014126|FG000|STARTED|Overall Study||20
3280657|NCT02730208|4014127|FG001|STARTED|Overall Study||21
3280658|NCT02730208|4014126|FG000|COMPLETED|Overall Study||20
3280659|NCT02730208|4014127|FG001|COMPLETED|Overall Study||20
3280660|NCT02730208|4014126|FG000|NOT COMPLETED|Overall Study||0
3280661|NCT02730208|4014127|FG001|NOT COMPLETED|Overall Study||1
3280662|NCT02730234|4014133|FG000|STARTED|Overall Study||60
3280663|NCT02730234|4014133|FG000|COMPLETED|Overall Study|8 Deaths|52
3280664|NCT02730234|4014133|FG000|NOT COMPLETED|Overall Study||8
3280665|NCT02730247|4014137|FG000|STARTED|Overall Study||7
3280666|NCT02730247|4014137|FG000|COMPLETED|Overall Study||7
3280667|NCT02730247|4014137|FG000|NOT COMPLETED|Overall Study||0
3280668|NCT02730260|4014143|FG000|STARTED|Overall Study||258
3280669|NCT02730260|4014144|FG001|STARTED|Overall Study||260
3280670|NCT02730260|4014143|FG000|COMPLETED|Overall Study||176
3280671|NCT02730260|4014144|FG001|COMPLETED|Overall Study||185
3280672|NCT02730260|4014143|FG000|NOT COMPLETED|Overall Study||82
3280673|NCT02730260|4014144|FG001|NOT COMPLETED|Overall Study||75
3280674|NCT02730351|4014150|FG000|STARTED|Treatment Period 1 (2 Weeks)||37
3280675|NCT02730351|4014151|FG001|STARTED|Treatment Period 1 (2 Weeks)||37
3280676|NCT02730351|4014150|FG000|COMPLETED|Treatment Period 1 (2 Weeks)||36
3280677|NCT02730351|4014151|FG001|COMPLETED|Treatment Period 1 (2 Weeks)||37
3280678|NCT02730351|4014150|FG000|NOT COMPLETED|Treatment Period 1 (2 Weeks)||1
3280679|NCT02730351|4014151|FG001|NOT COMPLETED|Treatment Period 1 (2 Weeks)||0
3280680|NCT02730351|4014150|FG000|STARTED|Wash-out Period (2 Weeks)||36
3280681|NCT02730351|4014151|FG001|STARTED|Wash-out Period (2 Weeks)||37
3280682|NCT02730351|4014150|FG000|COMPLETED|Wash-out Period (2 Weeks)||35
3280683|NCT02730351|4014151|FG001|COMPLETED|Wash-out Period (2 Weeks)||36
3280684|NCT02730351|4014150|FG000|NOT COMPLETED|Wash-out Period (2 Weeks)||1
3280685|NCT02730351|4014151|FG001|NOT COMPLETED|Wash-out Period (2 Weeks)||1
3280686|NCT02730351|4014150|FG000|STARTED|Treatment Period 2 (2 Weeks)||35
3280687|NCT02730351|4014151|FG001|STARTED|Treatment Period 2 (2 Weeks)||36
3280688|NCT02730351|4014150|FG000|COMPLETED|Treatment Period 2 (2 Weeks)||33
3280689|NCT02730351|4014151|FG001|COMPLETED|Treatment Period 2 (2 Weeks)||36
3280690|NCT02730351|4014150|FG000|NOT COMPLETED|Treatment Period 2 (2 Weeks)||2
3280691|NCT02730351|4014151|FG001|NOT COMPLETED|Treatment Period 2 (2 Weeks)||0
3280692|NCT02730377|4014159|FG000|STARTED|Overall Study||996
3280693|NCT02730377|4014160|FG001|STARTED|Overall Study||995
3280694|NCT02730377|4014159|FG000|Treated|Overall Study||980
3280695|NCT02730377|4014160|FG001|Treated|Overall Study||984
3280696|NCT02730377|4014159|FG000|Full Analysis Set (FAS)|Overall Study||996
3280697|NCT02730377|4014160|FG001|Full Analysis Set (FAS)|Overall Study||995
3280698|NCT02730377|4014159|FG000|Safety Analysis Set (SAS)|Overall Study||980
3280699|NCT02730377|4014160|FG001|Safety Analysis Set (SAS)|Overall Study||984
3280700|NCT02730377|4014159|FG000|COMPLETED|Overall Study||446
3280701|NCT02730377|4014160|FG001|COMPLETED|Overall Study||362
3280702|NCT02730377|4014159|FG000|NOT COMPLETED|Overall Study||550
3280703|NCT02730377|4014160|FG001|NOT COMPLETED|Overall Study||633
3280704|NCT02730403|4014166|FG000|STARTED|Overall Study||211
3280705|NCT02730403|4014166|FG000|COMPLETED|Overall Study||157
3280706|NCT02730403|4014166|FG000|NOT COMPLETED|Overall Study||54
3280707|NCT02730455|4014174|FG000|STARTED|Overall Study||94
3280708|NCT02730455|4014175|FG001|STARTED|Overall Study||91
3280709|NCT02730455|4014176|FG002|STARTED|Overall Study||92
3280710|NCT02730455|4014174|FG000|Safety Population|Overall Study||91
3280711|NCT02730455|4014175|FG001|Safety Population|Overall Study||90
3280712|NCT02730455|4014176|FG002|Safety Population|Overall Study||89
3280713|NCT02730455|4014174|FG000|Participants Dosed|Overall Study||91
3280714|NCT02730455|4014175|FG001|Participants Dosed|Overall Study||88
3280715|NCT02730455|4014176|FG002|Participants Dosed|Overall Study||91
3280716|NCT02730455|4014174|FG000|Who Received Total Volume of Study Drug|Overall Study||90
3280717|NCT02730455|4014175|FG001|Who Received Total Volume of Study Drug|Overall Study||88
3280718|NCT02730455|4014176|FG002|Who Received Total Volume of Study Drug|Overall Study||89
3280719|NCT02730455|4014174|FG000|COMPLETED|Overall Study||81
3280720|NCT02730455|4014175|FG001|COMPLETED|Overall Study||77
3049367|NCT01212757|3769454|FG006|STARTED|Active Treatment Phase (Weeks 24 - 52)||28
3049368|NCT01212757|3769455|FG007|STARTED|Active Treatment Phase (Weeks 24 - 52)||0
3049369|NCT01212757|3769456|FG008|STARTED|Active Treatment Phase (Weeks 24 - 52)||0
3049370|NCT01212757|3769448|FG000|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
3049371|NCT01212757|3769449|FG001|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||125
3049372|NCT01212757|3769450|FG002|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||114
3049373|NCT01212757|3769451|FG003|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||35
3049374|NCT01212757|3769452|FG004|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||25
3049375|NCT01212757|3769453|FG005|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||34
3049376|NCT01212757|3769454|FG006|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||28
3049377|NCT01212757|3769455|FG007|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
3049378|NCT01212757|3769456|FG008|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
3049379|NCT01212757|3769448|FG000|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
3049380|NCT01212757|3769449|FG001|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||12
3049381|NCT01212757|3769450|FG002|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||20
3049382|NCT01212757|3769451|FG003|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||8
3049383|NCT01212757|3769452|FG004|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||2
3049384|NCT01212757|3769453|FG005|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||7
3049385|NCT01212757|3769454|FG006|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
3049386|NCT01212757|3769455|FG007|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
3049387|NCT01212757|3769456|FG008|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
3049388|NCT01212757|3769448|FG000|STARTED|Long-Term Safety Phase (Year 2)||0
3049389|NCT01212757|3769449|FG001|STARTED|Long-Term Safety Phase (Year 2)|6 participants who completed Week 52 did not enter the long-term safety phase|119
3049390|NCT01212757|3769450|FG002|STARTED|Long-Term Safety Phase (Year 2)|5 participants who completed Week 52 did not enter the long-term safety phase|109
3049391|NCT01212757|3769451|FG003|STARTED|Long-Term Safety Phase (Year 2)||0
3049392|NCT01212757|3769452|FG004|STARTED|Long-Term Safety Phase (Year 2)||0
3049393|NCT01212757|3769453|FG005|STARTED|Long-Term Safety Phase (Year 2)||0
3049394|NCT01212757|3769454|FG006|STARTED|Long-Term Safety Phase (Year 2)||0
3049395|NCT01212757|3769455|FG007|STARTED|Long-Term Safety Phase (Year 2)|Combined PBO-APR 20EE+XO;2 participants who completed Week 52 did not enter long-term safety phase|58
3049396|NCT01212757|3769456|FG008|STARTED|Long-Term Safety Phase (Year 2)|Combined PBO-APR 30EE+XO;2 participants who completed Week 52 did not enter long-term safety phase|60
3049397|NCT01212757|3769448|FG000|COMPLETED|Long-Term Safety Phase (Year 2)||0
3049398|NCT01212757|3769449|FG001|COMPLETED|Long-Term Safety Phase (Year 2)||107
3049399|NCT01212757|3769450|FG002|COMPLETED|Long-Term Safety Phase (Year 2)||95
3049400|NCT01212757|3769451|FG003|COMPLETED|Long-Term Safety Phase (Year 2)||0
3049401|NCT01212757|3769452|FG004|COMPLETED|Long-Term Safety Phase (Year 2)||0
3049402|NCT01212757|3769453|FG005|COMPLETED|Long-Term Safety Phase (Year 2)||0
3049403|NCT01212757|3769454|FG006|COMPLETED|Long-Term Safety Phase (Year 2)||0
3049404|NCT01212757|3769455|FG007|COMPLETED|Long-Term Safety Phase (Year 2)||48
3049405|NCT01212757|3769456|FG008|COMPLETED|Long-Term Safety Phase (Year 2)||51
3049406|NCT01212757|3769448|FG000|NOT COMPLETED|Long-Term Safety Phase (Year 2)||0
3049407|NCT01212757|3769449|FG001|NOT COMPLETED|Long-Term Safety Phase (Year 2)||12
3049408|NCT01212757|3769450|FG002|NOT COMPLETED|Long-Term Safety Phase (Year 2)||14
3049409|NCT01212757|3769451|FG003|NOT COMPLETED|Long-Term Safety Phase (Year 2)||0
3049410|NCT01212757|3769452|FG004|NOT COMPLETED|Long-Term Safety Phase (Year 2)||0
3049411|NCT01212757|3769453|FG005|NOT COMPLETED|Long-Term Safety Phase (Year 2)||0
3049412|NCT01212757|3769454|FG006|NOT COMPLETED|Long-Term Safety Phase (Year 2)||0
3049413|NCT01212757|3769455|FG007|NOT COMPLETED|Long-Term Safety Phase (Year 2)||10
3049414|NCT01212757|3769456|FG008|NOT COMPLETED|Long-Term Safety Phase (Year 2)||9
3049415|NCT01212757|3769448|FG000|STARTED|Long-Term Safety Phase (Year 3)||0
3049416|NCT01212757|3769449|FG001|STARTED|Long-Term Safety Phase (Year 3)||107
3049417|NCT01212757|3769450|FG002|STARTED|Long-Term Safety Phase (Year 3)||95
3049418|NCT01212757|3769451|FG003|STARTED|Long-Term Safety Phase (Year 3)||0
3049419|NCT01212757|3769452|FG004|STARTED|Long-Term Safety Phase (Year 3)||0
3049420|NCT01212757|3769453|FG005|STARTED|Long-Term Safety Phase (Year 3)||0
3049421|NCT01212757|3769454|FG006|STARTED|Long-Term Safety Phase (Year 3)||0
3049422|NCT01212757|3769455|FG007|STARTED|Long-Term Safety Phase (Year 3)||48
3049423|NCT01212757|3769456|FG008|STARTED|Long-Term Safety Phase (Year 3)||51
3049424|NCT01212757|3769448|FG000|COMPLETED|Long-Term Safety Phase (Year 3)||0
3049425|NCT01212757|3769449|FG001|COMPLETED|Long-Term Safety Phase (Year 3)||89
3049426|NCT01212757|3769450|FG002|COMPLETED|Long-Term Safety Phase (Year 3)||84
3049427|NCT01212757|3769451|FG003|COMPLETED|Long-Term Safety Phase (Year 3)||0
3049428|NCT01212757|3769452|FG004|COMPLETED|Long-Term Safety Phase (Year 3)||0
3049429|NCT01212757|3769453|FG005|COMPLETED|Long-Term Safety Phase (Year 3)||0
3049430|NCT01212757|3769454|FG006|COMPLETED|Long-Term Safety Phase (Year 3)||0
3049431|NCT01212757|3769455|FG007|COMPLETED|Long-Term Safety Phase (Year 3)||42
3049432|NCT01212757|3769456|FG008|COMPLETED|Long-Term Safety Phase (Year 3)||46
3280721|NCT02730455|4014176|FG002|COMPLETED|Overall Study||81
3280722|NCT02730455|4014174|FG000|NOT COMPLETED|Overall Study||13
3049433|NCT01212757|3769448|FG000|NOT COMPLETED|Long-Term Safety Phase (Year 3)||0
3049434|NCT01212757|3769449|FG001|NOT COMPLETED|Long-Term Safety Phase (Year 3)||18
3049435|NCT01212757|3769450|FG002|NOT COMPLETED|Long-Term Safety Phase (Year 3)||11
3049436|NCT01212757|3769451|FG003|NOT COMPLETED|Long-Term Safety Phase (Year 3)||0
3049437|NCT01212757|3769452|FG004|NOT COMPLETED|Long-Term Safety Phase (Year 3)||0
3049438|NCT01212757|3769453|FG005|NOT COMPLETED|Long-Term Safety Phase (Year 3)||0
3049439|NCT01212757|3769454|FG006|NOT COMPLETED|Long-Term Safety Phase (Year 3)||0
3049440|NCT01212757|3769455|FG007|NOT COMPLETED|Long-Term Safety Phase (Year 3)||6
3049441|NCT01212757|3769456|FG008|NOT COMPLETED|Long-Term Safety Phase (Year 3)||5
3049442|NCT01212757|3769448|FG000|STARTED|Long-Term Safety Phase (Year 4)||0
3049443|NCT01212757|3769449|FG001|STARTED|Long-Term Safety Phase (Year 4)||89
3049444|NCT01212757|3769450|FG002|STARTED|Long-Term Safety Phase (Year 4)||84
3049445|NCT01212757|3769451|FG003|STARTED|Long-Term Safety Phase (Year 4)||0
3049446|NCT01212757|3769452|FG004|STARTED|Long-Term Safety Phase (Year 4)||0
3049447|NCT01212757|3769453|FG005|STARTED|Long-Term Safety Phase (Year 4)||0
3049448|NCT01212757|3769454|FG006|STARTED|Long-Term Safety Phase (Year 4)||0
3049449|NCT01212757|3769455|FG007|STARTED|Long-Term Safety Phase (Year 4)|1 participant who completed Year 3 did not continue treatment in Year 4|41
3049450|NCT01212757|3769456|FG008|STARTED|Long-Term Safety Phase (Year 4)||46
3049451|NCT01212757|3769448|FG000|COMPLETED|Long-Term Safety Phase (Year 4)||0
3049452|NCT01212757|3769449|FG001|COMPLETED|Long-Term Safety Phase (Year 4)||80
3049453|NCT01212757|3769450|FG002|COMPLETED|Long-Term Safety Phase (Year 4)||77
3049454|NCT01212757|3769451|FG003|COMPLETED|Long-Term Safety Phase (Year 4)||0
3049455|NCT01212757|3769452|FG004|COMPLETED|Long-Term Safety Phase (Year 4)||0
3049456|NCT01212757|3769453|FG005|COMPLETED|Long-Term Safety Phase (Year 4)||0
3049457|NCT01212757|3769454|FG006|COMPLETED|Long-Term Safety Phase (Year 4)||0
3049458|NCT01212757|3769455|FG007|COMPLETED|Long-Term Safety Phase (Year 4)||37
3049459|NCT01212757|3769456|FG008|COMPLETED|Long-Term Safety Phase (Year 4)||39
3049460|NCT01212757|3769448|FG000|NOT COMPLETED|Long-Term Safety Phase (Year 4)||0
3049461|NCT01212757|3769449|FG001|NOT COMPLETED|Long-Term Safety Phase (Year 4)||9
3049462|NCT01212757|3769450|FG002|NOT COMPLETED|Long-Term Safety Phase (Year 4)||7
3280723|NCT02730455|4014175|FG001|NOT COMPLETED|Overall Study||14
3280724|NCT02730455|4014176|FG002|NOT COMPLETED|Overall Study||11
3280725|NCT02730598|4014186|FG000|STARTED|Overall Study||14
3280726|NCT02730598|4014187|FG001|STARTED|Overall Study||14
3280727|NCT02730598|4014186|FG000|COMPLETED|Overall Study||10
3280728|NCT02730598|4014187|FG001|COMPLETED|Overall Study||10
3280729|NCT02730598|4014186|FG000|NOT COMPLETED|Overall Study||4
3280730|NCT02730598|4014187|FG001|NOT COMPLETED|Overall Study||4
3280731|NCT02730663|4014193|FG000|STARTED|Overall Study||36
3280732|NCT02730663|4014193|FG000|COMPLETED|Overall Study||35
3280733|NCT02730663|4014193|FG000|NOT COMPLETED|Overall Study||1
3280734|NCT02730728|4014200|FG000|STARTED|Overall Study||53
3280735|NCT02730728|4014201|FG001|STARTED|Overall Study||53
3280736|NCT02730728|4014202|FG002|STARTED|Overall Study||53
3280737|NCT02730728|4014200|FG000|COMPLETED|Overall Study||53
3280738|NCT02730728|4014201|FG001|COMPLETED|Overall Study||51
3280739|NCT02730728|4014202|FG002|COMPLETED|Overall Study||52
3280740|NCT02730728|4014200|FG000|NOT COMPLETED|Overall Study||0
3280741|NCT02730728|4014201|FG001|NOT COMPLETED|Overall Study||2
3280742|NCT02730728|4014202|FG002|NOT COMPLETED|Overall Study||1
3280743|NCT02730819|4014210|FG000|STARTED|Overall Study||19
3280744|NCT02730819|4014210|FG000|Follow-up Week 2|Overall Study||15
3280745|NCT02730819|4014210|FG000|Follow-up Week 4|Overall Study||16
3280746|NCT02730819|4014210|FG000|Follow-up Week 8|Overall Study||14
3280747|NCT02730819|4014210|FG000|Follow-up Week 12|Overall Study||11
3280748|NCT02730819|4014210|FG000|Follow-up Week 16|Overall Study||11
3280749|NCT02730819|4014210|FG000|Follow-up Week 20|Overall Study||10
3280750|NCT02730819|4014210|FG000|COMPLETED|Overall Study||10
3280751|NCT02730819|4014210|FG000|NOT COMPLETED|Overall Study||9
3280752|NCT02730871|4014216|FG000|STARTED|Overall Study||67
3280753|NCT02730871|4014217|FG001|STARTED|Overall Study||67
3280754|NCT02730871|4014216|FG000|Full Analysis Set (FAS)|Overall Study||67
3280755|NCT02730871|4014217|FG001|Full Analysis Set (FAS)|Overall Study||67
3280756|NCT02730871|4014216|FG000|Safety Analysis Set|Overall Study||67
3280757|NCT02730871|4014217|FG001|Safety Analysis Set|Overall Study||67
3280758|NCT02730871|4014216|FG000|COMPLETED|Overall Study||61
3280759|NCT02730871|4014217|FG001|COMPLETED|Overall Study||67
3280760|NCT02730871|4014216|FG000|NOT COMPLETED|Overall Study||6
3280761|NCT02730871|4014217|FG001|NOT COMPLETED|Overall Study||0
3280762|NCT02730884|4014223|FG000|STARTED|Overall Study||3
3049463|NCT01212757|3769451|FG003|NOT COMPLETED|Long-Term Safety Phase (Year 4)||0
3049464|NCT01212757|3769452|FG004|NOT COMPLETED|Long-Term Safety Phase (Year 4)||0
3049465|NCT01212757|3769453|FG005|NOT COMPLETED|Long-Term Safety Phase (Year 4)||0
3049466|NCT01212757|3769454|FG006|NOT COMPLETED|Long-Term Safety Phase (Year 4)||0
3049467|NCT01212757|3769455|FG007|NOT COMPLETED|Long-Term Safety Phase (Year 4)||4
3049468|NCT01212757|3769456|FG008|NOT COMPLETED|Long-Term Safety Phase (Year 4)||7
3049469|NCT01212757|3769448|FG000|STARTED|Long-Term Safety Phase (Year 5)||0
3049470|NCT01212757|3769449|FG001|STARTED|Long-Term Safety Phase (Year 5)||80
3280763|NCT02730884|4014223|FG000|COMPLETED|Overall Study||3
3280764|NCT02730884|4014223|FG000|NOT COMPLETED|Overall Study||0
3280765|NCT02730962|4014229|FG000|STARTED|Overall Study||7
3049471|NCT01212757|3769450|FG002|STARTED|Long-Term Safety Phase (Year 5)||77
3280766|NCT02730962|4014230|FG001|STARTED|Overall Study||5
3280767|NCT02730962|4014229|FG000|COMPLETED|Overall Study||7
3049472|NCT01212757|3769451|FG003|STARTED|Long-Term Safety Phase (Year 5)||0
3049473|NCT01212757|3769452|FG004|STARTED|Long-Term Safety Phase (Year 5)||0
3049474|NCT01212757|3769453|FG005|STARTED|Long-Term Safety Phase (Year 5)||0
3049475|NCT01212757|3769454|FG006|STARTED|Long-Term Safety Phase (Year 5)||0
3049476|NCT01212757|3769455|FG007|STARTED|Long-Term Safety Phase (Year 5)|1 participant was only counted in year 5 but not in 4 year due to late APR dispensing|38
3049477|NCT01212757|3769456|FG008|STARTED|Long-Term Safety Phase (Year 5)||39
3049478|NCT01212757|3769448|FG000|COMPLETED|Long-Term Safety Phase (Year 5)||0
3049479|NCT01212757|3769449|FG001|COMPLETED|Long-Term Safety Phase (Year 5)||72
3049480|NCT01212757|3769450|FG002|COMPLETED|Long-Term Safety Phase (Year 5)||69
3049481|NCT01212757|3769451|FG003|COMPLETED|Long-Term Safety Phase (Year 5)||0
3049482|NCT01212757|3769452|FG004|COMPLETED|Long-Term Safety Phase (Year 5)||0
3049483|NCT01212757|3769453|FG005|COMPLETED|Long-Term Safety Phase (Year 5)||0
3049484|NCT01212757|3769454|FG006|COMPLETED|Long-Term Safety Phase (Year 5)||0
3049485|NCT01212757|3769455|FG007|COMPLETED|Long-Term Safety Phase (Year 5)||33
3049486|NCT01212757|3769456|FG008|COMPLETED|Long-Term Safety Phase (Year 5)||37
3049487|NCT01212757|3769448|FG000|NOT COMPLETED|Long-Term Safety Phase (Year 5)||0
3049488|NCT01212757|3769449|FG001|NOT COMPLETED|Long-Term Safety Phase (Year 5)||8
3049489|NCT01212757|3769450|FG002|NOT COMPLETED|Long-Term Safety Phase (Year 5)||8
3049490|NCT01212757|3769451|FG003|NOT COMPLETED|Long-Term Safety Phase (Year 5)||0
3049491|NCT01212757|3769452|FG004|NOT COMPLETED|Long-Term Safety Phase (Year 5)||0
3049492|NCT01212757|3769453|FG005|NOT COMPLETED|Long-Term Safety Phase (Year 5)||0
3049493|NCT01212757|3769454|FG006|NOT COMPLETED|Long-Term Safety Phase (Year 5)||0
3049494|NCT01212757|3769455|FG007|NOT COMPLETED|Long-Term Safety Phase (Year 5)||5
3049495|NCT01212757|3769456|FG008|NOT COMPLETED|Long-Term Safety Phase (Year 5)||2
3049496|NCT01212770|3769477|FG000|STARTED|Placebo-controlled Phase (Week 0 - 24)||169
3049497|NCT01212770|3769478|FG001|STARTED|Placebo-controlled Phase (Week 0 - 24)||169
3049498|NCT01212770|3769479|FG002|STARTED|Placebo-controlled Phase (Week 0 - 24)||167
3049499|NCT01212770|3769480|FG003|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
3049500|NCT01212770|3769481|FG004|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
3049501|NCT01212770|3769482|FG005|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
3049502|NCT01212770|3769483|FG006|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
3049503|NCT01212770|3769484|FG007|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
3049504|NCT01212770|3769485|FG008|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
3049505|NCT01212770|3769477|FG000|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||169
3049506|NCT01212770|3769478|FG001|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||169
3049507|NCT01212770|3769479|FG002|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||167
3049508|NCT01212770|3769480|FG003|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
3049509|NCT01212770|3769481|FG004|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
3049510|NCT01212770|3769482|FG005|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
3049511|NCT01212770|3769483|FG006|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
3049512|NCT01212770|3769484|FG007|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
3280768|NCT02730962|4014230|FG001|COMPLETED|Overall Study||5
3280769|NCT02730962|4014229|FG000|NOT COMPLETED|Overall Study||0
3280770|NCT02730962|4014230|FG001|NOT COMPLETED|Overall Study||0
3280771|NCT02730988|4014238|FG000|STARTED|Overall Study||47
3280772|NCT02730988|4014239|FG001|STARTED|Overall Study||49
3280773|NCT02730988|4014238|FG000|COMPLETED|Overall Study||43
3280774|NCT02730988|4014239|FG001|COMPLETED|Overall Study||39
3280775|NCT02730988|4014238|FG000|NOT COMPLETED|Overall Study||4
3280776|NCT02730988|4014239|FG001|NOT COMPLETED|Overall Study||10
3280777|NCT02731131|4014247|FG000|STARTED|Overall Study||6
3280778|NCT02731131|4014248|FG001|STARTED|Overall Study||6
3280779|NCT02731131|4014247|FG000|COMPLETED|Overall Study||6
3280780|NCT02731131|4014248|FG001|COMPLETED|Overall Study||4
3280781|NCT02731131|4014247|FG000|NOT COMPLETED|Overall Study||0
3280782|NCT02731131|4014248|FG001|NOT COMPLETED|Overall Study||2
3280783|NCT02731157|4014254|FG000|STARTED|First Standard RCE||4
3280784|NCT02731157|4014254|FG000|COMPLETED|First Standard RCE||4
3280785|NCT02731157|4014254|FG000|NOT COMPLETED|First Standard RCE||0
3280786|NCT02731157|4014254|FG000|STARTED|First Rejuvenated RCE||4
3280787|NCT02731157|4014254|FG000|COMPLETED|First Rejuvenated RCE||3
3280788|NCT02731157|4014254|FG000|NOT COMPLETED|First Rejuvenated RCE||1
3280789|NCT02731157|4014254|FG000|STARTED|Second Rejuvenated RCE||3
3280790|NCT02731157|4014254|FG000|COMPLETED|Second Rejuvenated RCE||3
3280791|NCT02731157|4014254|FG000|NOT COMPLETED|Second Rejuvenated RCE||0
3280792|NCT02731157|4014254|FG000|STARTED|Third Rejuvenated RCE||3
3280793|NCT02731157|4014254|FG000|COMPLETED|Third Rejuvenated RCE||3
3280794|NCT02731157|4014254|FG000|NOT COMPLETED|Third Rejuvenated RCE||0
3280795|NCT02731157|4014254|FG000|STARTED|Second Standard RCE||3
3280796|NCT02731157|4014254|FG000|COMPLETED|Second Standard RCE||3
3280797|NCT02731157|4014254|FG000|NOT COMPLETED|Second Standard RCE||0
3280798|NCT02731157|4014254|FG000|STARTED|Third Standard RCE||3
3280799|NCT02731157|4014254|FG000|COMPLETED|Third Standard RCE||3
3280800|NCT02731157|4014254|FG000|NOT COMPLETED|Third Standard RCE||0
3280801|NCT02731300|4014262|FG000|STARTED|Overall Study||15
3280802|NCT02731300|4014263|FG001|STARTED|Overall Study||7
3280803|NCT02731300|4014262|FG000|COMPLETED|Overall Study||15
3280804|NCT02731300|4014263|FG001|COMPLETED|Overall Study||7
3280805|NCT02731300|4014262|FG000|NOT COMPLETED|Overall Study||0
3280806|NCT02731300|4014263|FG001|NOT COMPLETED|Overall Study||0
3280807|NCT02731313|4014269|FG000|STARTED|Overall Study||367
3280808|NCT02731313|4014269|FG000|COMPLETED|Overall Study||367
3049513|NCT01212770|3769485|FG008|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
3049514|NCT01212770|3769477|FG000|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||156
3049515|NCT01212770|3769478|FG001|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||157
3049516|NCT01212770|3769479|FG002|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||156
3049517|NCT01212770|3769480|FG003|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
3049518|NCT01212770|3769481|FG004|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
3049519|NCT01212770|3769482|FG005|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
3049520|NCT01212770|3769483|FG006|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
3049521|NCT01212770|3769484|FG007|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
3049522|NCT01212770|3769485|FG008|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
3049523|NCT01212770|3769477|FG000|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)|1 participant who escaped early did not complete Week (Wk) 24|97
3049524|NCT01212770|3769478|FG001|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||76
3049525|NCT01212770|3769479|FG002|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)|1 participant who escaped early did not complete Week 24|53
3049526|NCT01212770|3769480|FG003|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
3049527|NCT01212770|3769481|FG004|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
3049528|NCT01212770|3769482|FG005|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
3049529|NCT01212770|3769483|FG006|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
3049530|NCT01212770|3769484|FG007|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
3049531|NCT01212770|3769485|FG008|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
3049532|NCT01212770|3769477|FG000|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||146
3049533|NCT01212770|3769478|FG001|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||147
3049534|NCT01212770|3769479|FG002|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||145
3049535|NCT01212770|3769480|FG003|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
3049536|NCT01212770|3769481|FG004|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
3049537|NCT01212770|3769482|FG005|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
3049538|NCT01212770|3769483|FG006|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
3049539|NCT01212770|3769484|FG007|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
3049540|NCT01212770|3769485|FG008|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
3049541|NCT01212770|3769477|FG000|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||23
3049542|NCT01212770|3769478|FG001|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||22
3049543|NCT01212770|3769479|FG002|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||22
3049544|NCT01212770|3769480|FG003|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
3049545|NCT01212770|3769481|FG004|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
3049546|NCT01212770|3769482|FG005|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
3049547|NCT01212770|3769483|FG006|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
3049548|NCT01212770|3769484|FG007|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
3049549|NCT01212770|3769485|FG008|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
3049550|NCT01212770|3769477|FG000|STARTED|Active Treatment Phase (Weeks 25 - 52)||0
3049551|NCT01212770|3769478|FG001|STARTED|Active Treatment Phase (Weeks 25 - 52)|8 participants who completed Week 24 did not enter the Week 24-52 active treatment phase|139
3049552|NCT01212770|3769479|FG002|STARTED|Active Treatment Phase (Weeks 25 - 52)|7 participants who completed Week 24 did not enter the Week 24-52 active treatment phase|138
3133842|NCT01697592|3858758|FG002|NOT COMPLETED|Phase B (Week 25 to Week 52)||1
3280809|NCT02731313|4014269|FG000|NOT COMPLETED|Overall Study||0
3280810|NCT02731469|4014284|FG000|STARTED|Overall Study||3
3280811|NCT02731469|4014285|FG001|STARTED|Overall Study||3
3280812|NCT02731469|4014286|FG002|STARTED|Overall Study||3
3280813|NCT02731469|4014287|FG003|STARTED|Overall Study||3
3280814|NCT02731469|4014288|FG004|STARTED|Overall Study||3
3280815|NCT02731469|4014289|FG005|STARTED|Overall Study||3
3280816|NCT02731469|4014290|FG006|STARTED|Overall Study||3
3280817|NCT02731469|4014291|FG007|STARTED|Overall Study||6
3280818|NCT02731469|4014292|FG008|STARTED|Overall Study||6
3280819|NCT02731469|4014293|FG009|STARTED|Overall Study||6
3280820|NCT02731469|4014294|FG010|STARTED|Overall Study||6
3280821|NCT02731469|4014284|FG000|COMPLETED|Overall Study||3
3280822|NCT02731469|4014285|FG001|COMPLETED|Overall Study||3
3280823|NCT02731469|4014286|FG002|COMPLETED|Overall Study||3
3280824|NCT02731469|4014287|FG003|COMPLETED|Overall Study||3
3280825|NCT02731469|4014288|FG004|COMPLETED|Overall Study||3
3280826|NCT02731469|4014289|FG005|COMPLETED|Overall Study||3
3280827|NCT02731469|4014290|FG006|COMPLETED|Overall Study||3
3280828|NCT02731469|4014291|FG007|COMPLETED|Overall Study||6
3280829|NCT02731469|4014292|FG008|COMPLETED|Overall Study||6
3280830|NCT02731469|4014293|FG009|COMPLETED|Overall Study||6
3280831|NCT02731469|4014294|FG010|COMPLETED|Overall Study||6
3280832|NCT02731469|4014284|FG000|NOT COMPLETED|Overall Study||0
3280833|NCT02731469|4014285|FG001|NOT COMPLETED|Overall Study||0
3280834|NCT02731469|4014286|FG002|NOT COMPLETED|Overall Study||0
3280835|NCT02731469|4014287|FG003|NOT COMPLETED|Overall Study||0
3280836|NCT02731469|4014288|FG004|NOT COMPLETED|Overall Study||0
3280837|NCT02731469|4014289|FG005|NOT COMPLETED|Overall Study||0
3280838|NCT02731469|4014290|FG006|NOT COMPLETED|Overall Study||0
3280839|NCT02731469|4014291|FG007|NOT COMPLETED|Overall Study||0
3280840|NCT02731469|4014292|FG008|NOT COMPLETED|Overall Study||0
3280841|NCT02731469|4014293|FG009|NOT COMPLETED|Overall Study||0
3280842|NCT02731469|4014294|FG010|NOT COMPLETED|Overall Study||0
3280843|NCT02731638|4014320|FG000|STARTED|Overall Study||35
3280844|NCT02731638|4014321|FG001|STARTED|Overall Study||35
3280845|NCT02731638|4014320|FG000|COMPLETED|Overall Study||29
3280846|NCT02731638|4014321|FG001|COMPLETED|Overall Study||26
3280847|NCT02731638|4014320|FG000|NOT COMPLETED|Overall Study||6
3280848|NCT02731638|4014321|FG001|NOT COMPLETED|Overall Study||9
3280849|NCT02731690|4014327|FG000|STARTED|Overall Study||42
3049553|NCT01212770|3769480|FG003|STARTED|Active Treatment Phase (Weeks 25 - 52)|3 participants who EE completed Week 24 did not enter the Week 24-52 active treatment phase|43
3049554|NCT01212770|3769481|FG004|STARTED|Active Treatment Phase (Weeks 25 - 52)||25
3049555|NCT01212770|3769482|FG005|STARTED|Active Treatment Phase (Weeks 25 - 52)|3 participants who EE completed Week 24 did not enter the Week 24-52 active treatment phase|47
3049556|NCT01212770|3769483|FG006|STARTED|Active Treatment Phase (Weeks 25 - 52)||25
3049557|NCT01212770|3769484|FG007|STARTED|Active Treatment Phase (Weeks 25 - 52)||0
3049558|NCT01212770|3769485|FG008|STARTED|Active Treatment Phase (Weeks 25 - 52)||0
3049559|NCT01212770|3769477|FG000|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
3049560|NCT01212770|3769478|FG001|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||120
3049561|NCT01212770|3769479|FG002|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||126
3049562|NCT01212770|3769480|FG003|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||32
3049563|NCT01212770|3769481|FG004|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||23
3049564|NCT01212770|3769482|FG005|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||44
3049565|NCT01212770|3769483|FG006|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||23
3049566|NCT01212770|3769484|FG007|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
3049567|NCT01212770|3769485|FG008|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
3049568|NCT01212770|3769477|FG000|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
3049569|NCT01212770|3769478|FG001|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||19
3049570|NCT01212770|3769479|FG002|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||12
3049571|NCT01212770|3769480|FG003|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||11
3049572|NCT01212770|3769481|FG004|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||2
3049573|NCT01212770|3769482|FG005|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||3
3049574|NCT01212770|3769483|FG006|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||2
3049575|NCT01212770|3769484|FG007|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
3049576|NCT01212770|3769485|FG008|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
3049577|NCT01212770|3769477|FG000|STARTED|Long-term Safety Phase (Year 2)||0
3049578|NCT01212770|3769478|FG001|STARTED|Long-term Safety Phase (Year 2)|9 participants who completed Week 52 did not enter the long-term safety phase (LTSP)|111
3049579|NCT01212770|3769479|FG002|STARTED|Long-term Safety Phase (Year 2)|5 participants who completed Week 52 did not enter the long-term safety phase|121
3280850|NCT02731690|4014327|FG000|COMPLETED|Overall Study||12
3280851|NCT02731690|4014327|FG000|NOT COMPLETED|Overall Study||30
3280852|NCT02731729|4014333|FG000|STARTED|Overall Study||10
3280853|NCT02731729|4014334|FG001|STARTED|Overall Study||10
3280854|NCT02731729|4014333|FG000|COMPLETED|Overall Study||1
3280855|NCT02731729|4014334|FG001|COMPLETED|Overall Study||2
3280856|NCT02731729|4014333|FG000|NOT COMPLETED|Overall Study||9
3280857|NCT02731729|4014334|FG001|NOT COMPLETED|Overall Study||8
3280858|NCT02731742|4014344|FG000|STARTED|Overall Study||3
3280859|NCT02731742|4014345|FG001|STARTED|Overall Study||3
3280860|NCT02731742|4014346|FG002|STARTED|Overall Study||6
3280861|NCT02731742|4014347|FG003|STARTED|Overall Study||2
3280862|NCT02731742|4014344|FG000|COMPLETED|Overall Study||0
3280863|NCT02731742|4014345|FG001|COMPLETED|Overall Study||0
3280864|NCT02731742|4014346|FG002|COMPLETED|Overall Study||0
3280865|NCT02731742|4014347|FG003|COMPLETED|Overall Study||0
3280866|NCT02731742|4014344|FG000|NOT COMPLETED|Overall Study||3
3280867|NCT02731742|4014345|FG001|NOT COMPLETED|Overall Study||3
3280868|NCT02731742|4014346|FG002|NOT COMPLETED|Overall Study||6
3280869|NCT02731742|4014347|FG003|NOT COMPLETED|Overall Study||2
3280870|NCT02731755|4014357|FG000|STARTED|First Intervention||8
3280871|NCT02731755|4014358|FG001|STARTED|First Intervention||10
3280872|NCT02731755|4014357|FG000|COMPLETED|First Intervention||8
3280873|NCT02731755|4014358|FG001|COMPLETED|First Intervention||8
3280874|NCT02731755|4014357|FG000|NOT COMPLETED|First Intervention||0
3280875|NCT02731755|4014358|FG001|NOT COMPLETED|First Intervention||2
3280876|NCT02731755|4014357|FG000|STARTED|Second Intervention||8
3280877|NCT02731755|4014358|FG001|STARTED|Second Intervention||8
3280878|NCT02731755|4014357|FG000|COMPLETED|Second Intervention||8
3280879|NCT02731755|4014358|FG001|COMPLETED|Second Intervention||8
3280880|NCT02731755|4014357|FG000|NOT COMPLETED|Second Intervention||0
3280881|NCT02731755|4014358|FG001|NOT COMPLETED|Second Intervention||0
3280882|NCT02731820|4014366|FG000|STARTED|Overall Study||20
3280883|NCT02731820|4014367|FG001|STARTED|Overall Study||20
3280884|NCT02731820|4014366|FG000|COMPLETED|Overall Study||17
3280885|NCT02731820|4014367|FG001|COMPLETED|Overall Study||18
3280886|NCT02731820|4014366|FG000|NOT COMPLETED|Overall Study||3
3280887|NCT02731820|4014367|FG001|NOT COMPLETED|Overall Study||2
3280888|NCT02731833|4014375|FG000|STARTED|Overall Study||111
3280889|NCT02731833|4014376|FG001|STARTED|Overall Study||111
3280890|NCT02731833|4014375|FG000|COMPLETED|Overall Study||111
3280891|NCT02731833|4014376|FG001|COMPLETED|Overall Study||111
3280892|NCT02731833|4014375|FG000|NOT COMPLETED|Overall Study||0
3280893|NCT02731833|4014376|FG001|NOT COMPLETED|Overall Study||0
3280894|NCT02732015|4014384|FG000|STARTED|Overall Study||9
3280895|NCT02732015|4014385|FG001|STARTED|Overall Study||27
3280896|NCT02732015|4014384|FG000|COMPLETED|Overall Study||9
3280897|NCT02732015|4014385|FG001|COMPLETED|Overall Study||26
3049580|NCT01212770|3769480|FG003|STARTED|Long-term Safety Phase (Year 2)||0
3049581|NCT01212770|3769481|FG004|STARTED|Long-term Safety Phase (Year 2)||0
3049582|NCT01212770|3769482|FG005|STARTED|Long-term Safety Phase (Year 2)||0
3049583|NCT01212770|3769483|FG006|STARTED|Long-term Safety Phase (Year 2)||0
3049584|NCT01212770|3769484|FG007|STARTED|Long-term Safety Phase (Year 2)|Patients from the PBO/APR 20 mg EE and XO are combined;5 patients finished Wk 52;no entry into LTSP|51
3049585|NCT01212770|3769485|FG008|STARTED|Long-term Safety Phase (Year 2)|Patients from the PBO/APR 30 mg EE and XO are combined;3 patients finished Wk 52;no entry into LTSP|64
3049586|NCT01212770|3769477|FG000|COMPLETED|Long-term Safety Phase (Year 2)||0
3049587|NCT01212770|3769478|FG001|COMPLETED|Long-term Safety Phase (Year 2)||88
3049588|NCT01212770|3769479|FG002|COMPLETED|Long-term Safety Phase (Year 2)||106
3049589|NCT01212770|3769480|FG003|COMPLETED|Long-term Safety Phase (Year 2)||0
3049590|NCT01212770|3769481|FG004|COMPLETED|Long-term Safety Phase (Year 2)||0
3049591|NCT01212770|3769482|FG005|COMPLETED|Long-term Safety Phase (Year 2)||0
3049592|NCT01212770|3769483|FG006|COMPLETED|Long-term Safety Phase (Year 2)||0
3049593|NCT01212770|3769484|FG007|COMPLETED|Long-term Safety Phase (Year 2)||42
3049594|NCT01212770|3769485|FG008|COMPLETED|Long-term Safety Phase (Year 2)||50
3049595|NCT01212770|3769477|FG000|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
3049596|NCT01212770|3769478|FG001|NOT COMPLETED|Long-term Safety Phase (Year 2)||23
3049597|NCT01212770|3769479|FG002|NOT COMPLETED|Long-term Safety Phase (Year 2)||15
3049598|NCT01212770|3769480|FG003|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
3049599|NCT01212770|3769481|FG004|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
3049600|NCT01212770|3769482|FG005|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
3049601|NCT01212770|3769483|FG006|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
3049602|NCT01212770|3769484|FG007|NOT COMPLETED|Long-term Safety Phase (Year 2)||9
3049603|NCT01212770|3769485|FG008|NOT COMPLETED|Long-term Safety Phase (Year 2)||14
3049604|NCT01212770|3769477|FG000|STARTED|Long-term Safety Phase (Year 3)||0
3049605|NCT01212770|3769478|FG001|STARTED|Long-term Safety Phase (Year 3)|1 participant who completed Year 2 did not continue treatment in Year 3|87
3049606|NCT01212770|3769479|FG002|STARTED|Long-term Safety Phase (Year 3)|1 participant who completed Year 2 did not continue treatment in Year 3|105
3049607|NCT01212770|3769480|FG003|STARTED|Long-term Safety Phase (Year 3)||0
3049608|NCT01212770|3769481|FG004|STARTED|Long-term Safety Phase (Year 3)||0
3049609|NCT01212770|3769482|FG005|STARTED|Long-term Safety Phase (Year 3)||0
3049610|NCT01212770|3769483|FG006|STARTED|Long-term Safety Phase (Year 3)||0
3049611|NCT01212770|3769484|FG007|STARTED|Long-term Safety Phase (Year 3)|The PBO/APR 20 mg EE and XO participants from week 24-52 are combined within the LTSP.|42
3049612|NCT01212770|3769485|FG008|STARTED|Long-term Safety Phase (Year 3)|Patients from the PBO/APR 30 mg EE and XO are combined;1 patient finished Wk 52;no entry into LTSP|49
3049613|NCT01212770|3769477|FG000|COMPLETED|Long-term Safety Phase (Year 3)||0
3049614|NCT01212770|3769478|FG001|COMPLETED|Long-term Safety Phase (Year 3)|1 participant missed due to APR dispensed late|76
3280898|NCT02732015|4014384|FG000|NOT COMPLETED|Overall Study||0
3280899|NCT02732015|4014385|FG001|NOT COMPLETED|Overall Study||1
3280900|NCT02732119|4014396|FG000|STARTED|Phase I||8
3280901|NCT02732119|4014397|FG001|STARTED|Phase I||10
3280902|NCT02732119|4014398|FG002|STARTED|Phase I||7
3280903|NCT02732119|4014399|FG003|STARTED|Phase I||0
3280904|NCT02732119|4014400|FG004|STARTED|Phase I||0
3280905|NCT02732119|4014396|FG000|COMPLETED|Phase I||0
3280906|NCT02732119|4014397|FG001|COMPLETED|Phase I||0
3280907|NCT02732119|4014398|FG002|COMPLETED|Phase I||0
3280908|NCT02732119|4014399|FG003|COMPLETED|Phase I||0
3280909|NCT02732119|4014400|FG004|COMPLETED|Phase I||0
3280910|NCT02732119|4014396|FG000|NOT COMPLETED|Phase I||8
3280911|NCT02732119|4014397|FG001|NOT COMPLETED|Phase I||10
3280912|NCT02732119|4014398|FG002|NOT COMPLETED|Phase I||7
3280913|NCT02732119|4014399|FG003|NOT COMPLETED|Phase I||0
3280914|NCT02732119|4014400|FG004|NOT COMPLETED|Phase I||0
3280915|NCT02732119|4014396|FG000|STARTED|Phase II||0
3280916|NCT02732119|4014397|FG001|STARTED|Phase II||0
3280917|NCT02732119|4014398|FG002|STARTED|Phase II||0
3280918|NCT02732119|4014399|FG003|STARTED|Phase II||46
3280919|NCT02732119|4014400|FG004|STARTED|Phase II||33
3280920|NCT02732119|4014396|FG000|Protocol Analysis Set|Phase II||0
3280921|NCT02732119|4014397|FG001|Protocol Analysis Set|Phase II||0
3280922|NCT02732119|4014398|FG002|Protocol Analysis Set|Phase II||0
3280923|NCT02732119|4014399|FG003|Protocol Analysis Set|Phase II||46
3280924|NCT02732119|4014400|FG004|Protocol Analysis Set|Phase II||32
3280925|NCT02732119|4014396|FG000|COMPLETED|Phase II||0
3280926|NCT02732119|4014397|FG001|COMPLETED|Phase II||0
3280927|NCT02732119|4014398|FG002|COMPLETED|Phase II||0
3280928|NCT02732119|4014399|FG003|COMPLETED|Phase II||0
3280929|NCT02732119|4014400|FG004|COMPLETED|Phase II||0
3280930|NCT02732119|4014396|FG000|NOT COMPLETED|Phase II||0
3280931|NCT02732119|4014397|FG001|NOT COMPLETED|Phase II||0
3280932|NCT02732119|4014398|FG002|NOT COMPLETED|Phase II||0
3280933|NCT02732119|4014399|FG003|NOT COMPLETED|Phase II||46
3280934|NCT02732119|4014400|FG004|NOT COMPLETED|Phase II||33
3280935|NCT02732145|4014416|FG000|STARTED|Overall Study||82
3280936|NCT02732145|4014417|FG001|STARTED|Overall Study||82
3280937|NCT02732145|4014418|FG002|STARTED|Overall Study||82
3280938|NCT02732145|4014419|FG003|STARTED|Overall Study||82
3280939|NCT02732145|4014416|FG000|COMPLETED|Overall Study||82
3280940|NCT02732145|4014417|FG001|COMPLETED|Overall Study||82
3280941|NCT02732145|4014418|FG002|COMPLETED|Overall Study||82
3280942|NCT02732145|4014419|FG003|COMPLETED|Overall Study||82
3280943|NCT02732145|4014416|FG000|NOT COMPLETED|Overall Study||0
3280944|NCT02732145|4014417|FG001|NOT COMPLETED|Overall Study||0
3049615|NCT01212770|3769479|FG002|COMPLETED|Long-term Safety Phase (Year 3)||94
3049616|NCT01212770|3769480|FG003|COMPLETED|Long-term Safety Phase (Year 3)||0
3280945|NCT02732145|4014418|FG002|NOT COMPLETED|Overall Study||0
3280946|NCT02732145|4014419|FG003|NOT COMPLETED|Overall Study||0
3280947|NCT02732210|4014451|FG000|STARTED|Overall Study||303
3280948|NCT02732210|4014452|FG001|STARTED|Overall Study||632
3280949|NCT02732210|4014451|FG000|COMPLETED|Overall Study||218
3280950|NCT02732210|4014452|FG001|COMPLETED|Overall Study||338
3280951|NCT02732210|4014451|FG000|NOT COMPLETED|Overall Study||85
3280952|NCT02732210|4014452|FG001|NOT COMPLETED|Overall Study||294
3280953|NCT02732366|4014460|FG000|STARTED|Overall Study||23
3280954|NCT02732366|4014461|FG001|STARTED|Overall Study||23
3280955|NCT02732366|4014460|FG000|Withdrawal by Participant|Overall Study||5
3280956|NCT02732366|4014461|FG001|Withdrawal by Participant|Overall Study||2
3280957|NCT02732366|4014460|FG000|COMPLETED|Overall Study||18
3280958|NCT02732366|4014461|FG001|COMPLETED|Overall Study||21
3280959|NCT02732366|4014460|FG000|NOT COMPLETED|Overall Study||5
3280960|NCT02732366|4014461|FG001|NOT COMPLETED|Overall Study||2
3280961|NCT02732561|4014472|FG000|STARTED|Overall Study||5
3280962|NCT02732561|4014473|FG001|STARTED|Overall Study||5
3280963|NCT02732561|4014472|FG000|COMPLETED|Overall Study||3
3280964|NCT02732561|4014473|FG001|COMPLETED|Overall Study||4
3280965|NCT02732561|4014472|FG000|NOT COMPLETED|Overall Study||2
3280966|NCT02732561|4014473|FG001|NOT COMPLETED|Overall Study||1
3280967|NCT02732587|4014479|FG000|STARTED|Overall Study||5
3280968|NCT02732587|4014479|FG000|COMPLETED|Overall Study||5
3280969|NCT02732587|4014479|FG000|NOT COMPLETED|Overall Study||0
3280970|NCT02732600|4014485|FG000|STARTED|Overall Study||3525
3280971|NCT02732600|4014486|FG001|STARTED|Overall Study||2091
3280972|NCT02732600|4014485|FG000|Sub-set of Sites Newly Delivering PS Services|Overall Study||899
3280973|NCT02732600|4014486|FG001|Sub-set of Sites Newly Delivering PS Services|Overall Study||1484
3280974|NCT02732600|4014485|FG000|Veteran Baseline Veteran (Sub-set of 23 Sites)|Overall Study||118
3280975|NCT02732600|4014486|FG001|Veteran Baseline Veteran (Sub-set of 23 Sites)|Overall Study||145
3280976|NCT02732600|4014485|FG000|Veteran 6-months (Sub-set 23 Sites)|Overall Study||70
3280977|NCT02732600|4014486|FG001|Veteran 6-months (Sub-set 23 Sites)|Overall Study||84
3280978|NCT02732600|4014485|FG000|Veteran 1-year (Sub-set 23 Sites)|Overall Study||54
3280979|NCT02732600|4014486|FG001|Veteran 1-year (Sub-set 23 Sites)|Overall Study||71
3280980|NCT02732600|4014485|FG000|Peer Specialist Responses at 6-months (All 25 Sites)|Overall Study||12
3280981|NCT02732600|4014486|FG001|Peer Specialist Responses at 6-months (All 25 Sites)|Overall Study||14
3280982|NCT02732600|4014485|FG000|Peer Specialist Responses at 1-year (All 25 Sites)|Overall Study||5
3280983|NCT02732600|4014486|FG001|Peer Specialist Responses at 1-year (All 25 Sites)|Overall Study||12
3280984|NCT02732600|4014485|FG000|Supervisor Responses 6-months (All 25 Sites)|Overall Study||10
3280985|NCT02732600|4014486|FG001|Supervisor Responses 6-months (All 25 Sites)|Overall Study||21
3280986|NCT02732600|4014485|FG000|Supervisor 1-year (All 25 Sites)|Overall Study||6
3280987|NCT02732600|4014486|FG001|Supervisor 1-year (All 25 Sites)|Overall Study||10
3280988|NCT02732600|4014485|FG000|COMPLETED|Overall Study||100
3280989|NCT02732600|4014486|FG001|COMPLETED|Overall Study||113
3280990|NCT02732600|4014485|FG000|NOT COMPLETED|Overall Study||3425
3280991|NCT02732600|4014486|FG001|NOT COMPLETED|Overall Study||1978
3280992|NCT02732639|4014493|FG000|STARTED|Overall Study||31
3280993|NCT02732639|4014493|FG000|COMPLETED|Overall Study||30
3280994|NCT02732639|4014493|FG000|NOT COMPLETED|Overall Study||1
3280995|NCT02732847|4014499|FG000|STARTED|Overall Study||75
3280996|NCT02732847|4014500|FG001|STARTED|Overall Study||74
3280997|NCT02732847|4014499|FG000|COMPLETED|Overall Study||33
3280998|NCT02732847|4014500|FG001|COMPLETED|Overall Study||32
3280999|NCT02732847|4014499|FG000|NOT COMPLETED|Overall Study||42
3281000|NCT02732847|4014500|FG001|NOT COMPLETED|Overall Study||42
3281001|NCT02732899|4014508|FG000|STARTED|Overall Study||10
3281002|NCT02732899|4014509|FG001|STARTED|Overall Study||10
3281003|NCT02732899|4014508|FG000|COMPLETED|Overall Study||10
3281004|NCT02732899|4014509|FG001|COMPLETED|Overall Study||10
3281005|NCT02732899|4014508|FG000|NOT COMPLETED|Overall Study||0
3281006|NCT02732899|4014509|FG001|NOT COMPLETED|Overall Study||0
3281007|NCT02732912|4014517|FG000|STARTED|Overall Study||97
3281008|NCT02732912|4014518|FG001|STARTED|Overall Study||109
3281009|NCT02732912|4014517|FG000|COMPLETED|Overall Study||87
3281010|NCT02732912|4014518|FG001|COMPLETED|Overall Study||91
3281011|NCT02732912|4014517|FG000|NOT COMPLETED|Overall Study||10
3281012|NCT02732912|4014518|FG001|NOT COMPLETED|Overall Study||18
3281013|NCT02732938|4014526|FG000|STARTED|Overall Study||4
3281014|NCT02732938|4014527|FG001|STARTED|Overall Study||18
3281015|NCT02732938|4014528|FG002|STARTED|Overall Study||0
3281016|NCT02732938|4014526|FG000|Received Treatment|Overall Study||4
3281017|NCT02732938|4014527|FG001|Received Treatment|Overall Study||17
3281018|NCT02732938|4014528|FG002|Received Treatment|Overall Study||0
3281019|NCT02732938|4014526|FG000|COMPLETED|Overall Study||0
3281020|NCT02732938|4014527|FG001|COMPLETED|Overall Study||0
3281021|NCT02732938|4014528|FG002|COMPLETED|Overall Study||0
3281022|NCT02732938|4014526|FG000|NOT COMPLETED|Overall Study||4
3281023|NCT02732938|4014527|FG001|NOT COMPLETED|Overall Study||18
3281024|NCT02732938|4014528|FG002|NOT COMPLETED|Overall Study||0
3281025|NCT02732951|4014538|FG000|STARTED|Overall Study||53
3281026|NCT02732951|4014539|FG001|STARTED|Overall Study||52
3281027|NCT02732951|4014538|FG000|COMPLETED|Overall Study||48
3281028|NCT02732951|4014539|FG001|COMPLETED|Overall Study||46
3281029|NCT02732951|4014538|FG000|NOT COMPLETED|Overall Study||5
3049617|NCT01212770|3769481|FG004|COMPLETED|Long-term Safety Phase (Year 3)||0
3049618|NCT01212770|3769482|FG005|COMPLETED|Long-term Safety Phase (Year 3)||0
3049619|NCT01212770|3769483|FG006|COMPLETED|Long-term Safety Phase (Year 3)||0
3049620|NCT01212770|3769484|FG007|COMPLETED|Long-term Safety Phase (Year 3)||35
3049621|NCT01212770|3769485|FG008|COMPLETED|Long-term Safety Phase (Year 3)||44
3049622|NCT01212770|3769477|FG000|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
3049623|NCT01212770|3769478|FG001|NOT COMPLETED|Long-term Safety Phase (Year 3)||11
3049624|NCT01212770|3769479|FG002|NOT COMPLETED|Long-term Safety Phase (Year 3)||11
3049625|NCT01212770|3769480|FG003|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
3049626|NCT01212770|3769481|FG004|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
3049627|NCT01212770|3769482|FG005|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
3049628|NCT01212770|3769483|FG006|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
3049629|NCT01212770|3769484|FG007|NOT COMPLETED|Long-term Safety Phase (Year 3)||7
3049630|NCT01212770|3769485|FG008|NOT COMPLETED|Long-term Safety Phase (Year 3)||5
3049631|NCT01212770|3769477|FG000|STARTED|Long-term Safety Phase (Year 4)||0
3049632|NCT01212770|3769478|FG001|STARTED|Long-term Safety Phase (Year 4)|1 participant was counted in Year 4 but not in year 3 due to late APR dispensing|77
3049633|NCT01212770|3769479|FG002|STARTED|Long-term Safety Phase (Year 4)||94
3049634|NCT01212770|3769480|FG003|STARTED|Long-term Safety Phase (Year 4)||0
3049635|NCT01212770|3769481|FG004|STARTED|Long-term Safety Phase (Year 4)||0
3049636|NCT01212770|3769482|FG005|STARTED|Long-term Safety Phase (Year 4)||0
3049637|NCT01212770|3769483|FG006|STARTED|Long-term Safety Phase (Year 4)||0
3049638|NCT01212770|3769484|FG007|STARTED|Long-term Safety Phase (Year 4)||35
3049639|NCT01212770|3769485|FG008|STARTED|Long-term Safety Phase (Year 4)||44
3049640|NCT01212770|3769477|FG000|COMPLETED|Long-term Safety Phase (Year 4)||0
3049641|NCT01212770|3769478|FG001|COMPLETED|Long-term Safety Phase (Year 4)||71
3049642|NCT01212770|3769479|FG002|COMPLETED|Long-term Safety Phase (Year 4)||83
3049643|NCT01212770|3769480|FG003|COMPLETED|Long-term Safety Phase (Year 4)||0
3049644|NCT01212770|3769481|FG004|COMPLETED|Long-term Safety Phase (Year 4)||0
3049645|NCT01212770|3769482|FG005|COMPLETED|Long-term Safety Phase (Year 4)||0
3049646|NCT01212770|3769483|FG006|COMPLETED|Long-term Safety Phase (Year 4)||0
3049647|NCT01212770|3769484|FG007|COMPLETED|Long-term Safety Phase (Year 4)||32
3049648|NCT01212770|3769485|FG008|COMPLETED|Long-term Safety Phase (Year 4)||42
3049649|NCT01212770|3769477|FG000|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
3049650|NCT01212770|3769478|FG001|NOT COMPLETED|Long-term Safety Phase (Year 4)||6
3049651|NCT01212770|3769479|FG002|NOT COMPLETED|Long-term Safety Phase (Year 4)||11
3049652|NCT01212770|3769480|FG003|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
3049653|NCT01212770|3769481|FG004|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
3049654|NCT01212770|3769482|FG005|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
3281030|NCT02732951|4014539|FG001|NOT COMPLETED|Overall Study||6
3281031|NCT02733367|4014545|FG000|STARTED|Overall Study||18
3281032|NCT02733367|4014545|FG000|COMPLETED|Overall Study||12
3281033|NCT02733367|4014545|FG000|NOT COMPLETED|Overall Study||6
3281034|NCT02733588|4014550|FG000|STARTED|Overall Study||7
3281035|NCT02733588|4014550|FG000|COMPLETED|Overall Study||7
3281036|NCT02733588|4014550|FG000|NOT COMPLETED|Overall Study||0
3281037|NCT02733627|4014558|FG000|STARTED|Overall Study||9
3281038|NCT02733627|4014559|FG001|STARTED|Overall Study||9
3281039|NCT02733627|4014560|FG002|STARTED|Overall Study||9
3281040|NCT02733627|4014561|FG003|STARTED|Overall Study||9
3281041|NCT02733627|4014558|FG000|COMPLETED|Overall Study||9
3281042|NCT02733627|4014559|FG001|COMPLETED|Overall Study||8
3281043|NCT02733627|4014560|FG002|COMPLETED|Overall Study||7
3281044|NCT02733627|4014561|FG003|COMPLETED|Overall Study||9
3281045|NCT02733627|4014558|FG000|NOT COMPLETED|Overall Study||0
3281046|NCT02733627|4014559|FG001|NOT COMPLETED|Overall Study||1
3281047|NCT02733627|4014560|FG002|NOT COMPLETED|Overall Study||2
3281048|NCT02733627|4014561|FG003|NOT COMPLETED|Overall Study||0
3281049|NCT02733653|4014571|FG000|STARTED|Overall Study||50
3281050|NCT02733653|4014571|FG000|COMPLETED|Overall Study||49
3281051|NCT02733653|4014571|FG000|NOT COMPLETED|Overall Study||1
3281052|NCT02733757|4014579|FG000|STARTED|Overall Study||20
3281053|NCT02733757|4014580|FG001|STARTED|Overall Study||20
3281054|NCT02733757|4014581|FG002|STARTED|Overall Study||20
3281055|NCT02733757|4014582|FG003|STARTED|Overall Study||20
3281056|NCT02733757|4014579|FG000|COMPLETED|Overall Study||20
3281057|NCT02733757|4014580|FG001|COMPLETED|Overall Study||20
3281058|NCT02733757|4014581|FG002|COMPLETED|Overall Study||20
3281059|NCT02733757|4014582|FG003|COMPLETED|Overall Study||20
3281060|NCT02733757|4014579|FG000|NOT COMPLETED|Overall Study||0
3281061|NCT02733757|4014580|FG001|NOT COMPLETED|Overall Study||0
3281062|NCT02733757|4014581|FG002|NOT COMPLETED|Overall Study||0
3281063|NCT02733757|4014582|FG003|NOT COMPLETED|Overall Study||0
3281064|NCT02733991|4014594|FG000|STARTED|Overall Study||76
3281065|NCT02733991|4014595|FG001|STARTED|Overall Study||77
3281066|NCT02733991|4014594|FG000|COMPLETED|Overall Study||75
3281067|NCT02733991|4014595|FG001|COMPLETED|Overall Study||72
3281068|NCT02733991|4014594|FG000|NOT COMPLETED|Overall Study||1
3281069|NCT02733991|4014595|FG001|NOT COMPLETED|Overall Study||5
3281070|NCT02734056|4014603|FG000|STARTED|Overall Study||50
3281071|NCT02734056|4014604|FG001|STARTED|Overall Study||50
3281072|NCT02734056|4014603|FG000|COMPLETED|Overall Study||50
3281073|NCT02734056|4014604|FG001|COMPLETED|Overall Study||49
3281074|NCT02734056|4014603|FG000|NOT COMPLETED|Overall Study||0
3281075|NCT02734056|4014604|FG001|NOT COMPLETED|Overall Study||1
3281076|NCT02734147|4014612|FG000|STARTED|Overall Study||12
3049655|NCT01212770|3769483|FG006|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
3049656|NCT01212770|3769484|FG007|NOT COMPLETED|Long-term Safety Phase (Year 4)||3
3049657|NCT01212770|3769485|FG008|NOT COMPLETED|Long-term Safety Phase (Year 4)||2
3049658|NCT01212770|3769477|FG000|STARTED|Long-term Safety Phase (Year 5)||0
3049659|NCT01212770|3769478|FG001|STARTED|Long-term Safety Phase (Year 5)|1 participant who completed Year 4 did not continue treatment in Year 5|70
3049660|NCT01212770|3769479|FG002|STARTED|Long-term Safety Phase (Year 5)||83
3049661|NCT01212770|3769480|FG003|STARTED|Long-term Safety Phase (Year 5)||0
3049662|NCT01212770|3769481|FG004|STARTED|Long-term Safety Phase (Year 5)||0
3049663|NCT01212770|3769482|FG005|STARTED|Long-term Safety Phase (Year 5)||0
3049664|NCT01212770|3769483|FG006|STARTED|Long-term Safety Phase (Year 5)||0
3281077|NCT02734147|4014613|FG001|STARTED|Overall Study||12
3281078|NCT02734147|4014612|FG000|COMPLETED|Overall Study||9
3281079|NCT02734147|4014613|FG001|COMPLETED|Overall Study||11
3281080|NCT02734147|4014612|FG000|NOT COMPLETED|Overall Study||3
3281081|NCT02734147|4014613|FG001|NOT COMPLETED|Overall Study||1
3281082|NCT02734212|4014621|FG000|STARTED|Overall Study||29
3281083|NCT02734212|4014622|FG001|STARTED|Overall Study||28
3281084|NCT02734212|4014621|FG000|COMPLETED|Overall Study||24
3281085|NCT02734212|4014622|FG001|COMPLETED|Overall Study||18
3281086|NCT02734212|4014621|FG000|NOT COMPLETED|Overall Study||5
3281087|NCT02734212|4014622|FG001|NOT COMPLETED|Overall Study||10
3281088|NCT02734238|4014631|FG000|STARTED|Overall Study||26
3281089|NCT02734238|4014632|FG001|STARTED|Overall Study||24
3281090|NCT02734238|4014631|FG000|COMPLETED|Overall Study||26
3281091|NCT02734238|4014632|FG001|COMPLETED|Overall Study||24
3281092|NCT02734238|4014631|FG000|NOT COMPLETED|Overall Study||0
3281093|NCT02734238|4014632|FG001|NOT COMPLETED|Overall Study||0
3281094|NCT02734355|4014640|FG000|STARTED|Overall Study||34
3281095|NCT02734355|4014641|FG001|STARTED|Overall Study||30
3281096|NCT02734355|4014640|FG000|COMPLETED|Overall Study||34
3281097|NCT02734355|4014641|FG001|COMPLETED|Overall Study||30
3281098|NCT02734355|4014640|FG000|NOT COMPLETED|Overall Study||0
3281099|NCT02734355|4014641|FG001|NOT COMPLETED|Overall Study||0
3281100|NCT02734433|4014649|FG000|STARTED|Overall Study||3
3281101|NCT02734433|4014650|FG001|STARTED|Overall Study||8
3281102|NCT02734433|4014649|FG000|COMPLETED|Overall Study||1
3281103|NCT02734433|4014650|FG001|COMPLETED|Overall Study||0
3281104|NCT02734433|4014649|FG000|NOT COMPLETED|Overall Study||2
3281105|NCT02734433|4014650|FG001|NOT COMPLETED|Overall Study||8
3281106|NCT02734498|4014659|FG000|STARTED|Overall Study||2
3281107|NCT02734498|4014660|FG001|STARTED|Overall Study||0
3281108|NCT02734498|4014661|FG002|STARTED|Overall Study||0
3281109|NCT02734498|4014659|FG000|COMPLETED|Overall Study||2
3281110|NCT02734498|4014660|FG001|COMPLETED|Overall Study||0
3281111|NCT02734498|4014661|FG002|COMPLETED|Overall Study||0
3281112|NCT02734498|4014659|FG000|NOT COMPLETED|Overall Study||0
3281113|NCT02734498|4014660|FG001|NOT COMPLETED|Overall Study||0
3281114|NCT02734498|4014661|FG002|NOT COMPLETED|Overall Study||0
3281115|NCT02734576|4014669|FG000|STARTED|Overall Study||10
3281116|NCT02734576|4014669|FG000|COMPLETED|Overall Study||10
3281117|NCT02734576|4014669|FG000|NOT COMPLETED|Overall Study||0
3281118|NCT02734667|4014675|FG000|STARTED|Overall Study||42
3281119|NCT02734667|4014676|FG001|STARTED|Overall Study||18
3281120|NCT02734667|4014675|FG000|COMPLETED|Overall Study||41
3281121|NCT02734667|4014676|FG001|COMPLETED|Overall Study||15
3281122|NCT02734667|4014675|FG000|NOT COMPLETED|Overall Study||1
3281123|NCT02734667|4014676|FG001|NOT COMPLETED|Overall Study||3
3281124|NCT02734693|4014685|FG000|STARTED|Overall Study||56
3281125|NCT02734693|4014686|FG001|STARTED|Overall Study||56
3281126|NCT02734693|4014687|FG002|STARTED|Overall Study||20
3281127|NCT02734693|4014685|FG000|COMPLETED|Overall Study||50
3281128|NCT02734693|4014686|FG001|COMPLETED|Overall Study||53
3281129|NCT02734693|4014687|FG002|COMPLETED|Overall Study||17
3281130|NCT02734693|4014685|FG000|NOT COMPLETED|Overall Study||6
3281131|NCT02734693|4014686|FG001|NOT COMPLETED|Overall Study||3
3281132|NCT02734693|4014687|FG002|NOT COMPLETED|Overall Study||3
3281133|NCT02734810|4014697|FG000|STARTED|Overall Study||15
3281134|NCT02734810|4014698|FG001|STARTED|Overall Study||0
3281135|NCT02734810|4014697|FG000|COMPLETED|Overall Study||13
3281136|NCT02734810|4014698|FG001|COMPLETED|Overall Study||0
3281137|NCT02734810|4014697|FG000|NOT COMPLETED|Overall Study||2
3281138|NCT02734810|4014698|FG001|NOT COMPLETED|Overall Study||0
3281139|NCT02734849|4014707|FG000|STARTED|Overall Study|One patient was randomized but never received study treatment and excluded from all analysis sets.|16
3281140|NCT02734849|4014708|FG001|STARTED|Overall Study||14
3281141|NCT02734849|4014709|FG002|STARTED|Overall Study||10
3281142|NCT02734849|4014707|FG000|COMPLETED|Overall Study||12
3281143|NCT02734849|4014708|FG001|COMPLETED|Overall Study||14
3281144|NCT02734849|4014709|FG002|COMPLETED|Overall Study||9
3281145|NCT02734849|4014707|FG000|NOT COMPLETED|Overall Study||4
3281146|NCT02734849|4014708|FG001|NOT COMPLETED|Overall Study||0
3281147|NCT02734849|4014709|FG002|NOT COMPLETED|Overall Study||1
3281148|NCT02734862|4014720|FG000|STARTED|Part A||35
3281149|NCT02734862|4014721|FG001|STARTED|Part A||36
3281150|NCT02734862|4014722|FG002|STARTED|Part A||36
3281151|NCT02734862|4014720|FG000|COMPLETED|Part A||23
3281152|NCT02734862|4014721|FG001|COMPLETED|Part A||28
3281153|NCT02734862|4014722|FG002|COMPLETED|Part A||22
3281154|NCT02734862|4014720|FG000|NOT COMPLETED|Part A||12
3281155|NCT02734862|4014721|FG001|NOT COMPLETED|Part A||8
3281156|NCT02734862|4014722|FG002|NOT COMPLETED|Part A||14
3281157|NCT02734862|4014720|FG000|STARTED|Part B||46
3049665|NCT01212770|3769484|FG007|STARTED|Long-term Safety Phase (Year 5)||32
3049666|NCT01212770|3769485|FG008|STARTED|Long-term Safety Phase (Year 5)||42
3049667|NCT01212770|3769477|FG000|COMPLETED|Long-term Safety Phase (Year 5)||0
3049668|NCT01212770|3769478|FG001|COMPLETED|Long-term Safety Phase (Year 5)||68
3049669|NCT01212770|3769479|FG002|COMPLETED|Long-term Safety Phase (Year 5)||72
3049670|NCT01212770|3769480|FG003|COMPLETED|Long-term Safety Phase (Year 5)||0
3049671|NCT01212770|3769481|FG004|COMPLETED|Long-term Safety Phase (Year 5)||0
3049672|NCT01212770|3769482|FG005|COMPLETED|Long-term Safety Phase (Year 5)||0
3049673|NCT01212770|3769483|FG006|COMPLETED|Long-term Safety Phase (Year 5)||0
3049674|NCT01212770|3769484|FG007|COMPLETED|Long-term Safety Phase (Year 5)||30
3049675|NCT01212770|3769485|FG008|COMPLETED|Long-term Safety Phase (Year 5)||41
3049676|NCT01212770|3769477|FG000|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
3049677|NCT01212770|3769478|FG001|NOT COMPLETED|Long-term Safety Phase (Year 5)||2
3049678|NCT01212770|3769479|FG002|NOT COMPLETED|Long-term Safety Phase (Year 5)||11
3049679|NCT01212770|3769480|FG003|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
3049680|NCT01212770|3769481|FG004|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
3049681|NCT01212770|3769482|FG005|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
3281158|NCT02734862|4014721|FG001|STARTED|Part B||21
3281159|NCT02734862|4014722|FG002|STARTED|Part B||33
3281160|NCT02734862|4014720|FG000|COMPLETED|Part B||33
3281161|NCT02734862|4014721|FG001|COMPLETED|Part B||14
3281162|NCT02734862|4014722|FG002|COMPLETED|Part B||28
3281163|NCT02734862|4014720|FG000|NOT COMPLETED|Part B||13
3281164|NCT02734862|4014721|FG001|NOT COMPLETED|Part B||7
3281165|NCT02734862|4014722|FG002|NOT COMPLETED|Part B||5
3281166|NCT02734953|4014731|FG000|STARTED|Overall Study||10
3281167|NCT02734953|4014731|FG000|COMPLETED|Overall Study||10
3281168|NCT02734953|4014731|FG000|NOT COMPLETED|Overall Study||0
3281169|NCT02734979|4014735|FG000|STARTED|Overall Study||1
3281170|NCT02734979|4014735|FG000|COMPLETED|Overall Study||1
3281171|NCT02734979|4014735|FG000|NOT COMPLETED|Overall Study||0
3281172|NCT02735044|4014749|FG000|STARTED|Overall Study||233
3281173|NCT02735044|4014750|FG001|STARTED|Overall Study||230
3281174|NCT02735044|4014749|FG000|Treated|Overall Study||233
3281175|NCT02735044|4014750|FG001|Treated|Overall Study||228
3281176|NCT02735044|4014749|FG000|COMPLETED|Overall Study||217
3281177|NCT02735044|4014750|FG001|COMPLETED|Overall Study||207
3281178|NCT02735044|4014749|FG000|NOT COMPLETED|Overall Study||16
3281179|NCT02735044|4014750|FG001|NOT COMPLETED|Overall Study||23
3281180|NCT02735096|4014756|FG000|STARTED|Overall Study||4
3281181|NCT02735096|4014756|FG000|COMPLETED|Overall Study||3
3281182|NCT02735096|4014756|FG000|NOT COMPLETED|Overall Study||1
3281183|NCT02735174|4014760|FG000|STARTED|Overall Study||21
3281184|NCT02735174|4014760|FG000|COMPLETED|Overall Study||21
3281185|NCT02735174|4014760|FG000|NOT COMPLETED|Overall Study||0
3281186|NCT02735187|4014766|FG000|STARTED|Overall Study||25
3281187|NCT02735187|4014767|FG001|STARTED|Overall Study||26
3281188|NCT02735187|4014766|FG000|COMPLETED|Overall Study||21
3281189|NCT02735187|4014767|FG001|COMPLETED|Overall Study||25
3281190|NCT02735187|4014766|FG000|NOT COMPLETED|Overall Study||4
3281191|NCT02735187|4014767|FG001|NOT COMPLETED|Overall Study||1
3281192|NCT02735200|4014781|FG000|STARTED|Overall Study||200
3281193|NCT02735200|4014782|FG001|STARTED|Overall Study||350
3281194|NCT02735200|4014781|FG000|COMPLETED|Overall Study||192
3281195|NCT02735200|4014782|FG001|COMPLETED|Overall Study||345
3281196|NCT02735200|4014781|FG000|NOT COMPLETED|Overall Study||8
3281197|NCT02735200|4014782|FG001|NOT COMPLETED|Overall Study||5
3281198|NCT02735382|4014792|FG000|STARTED|Overall Study||7481
3281199|NCT02735382|4014793|FG001|STARTED|Overall Study||7155
3281200|NCT02735382|4014794|FG002|STARTED|Overall Study||184
3281201|NCT02735382|4014795|FG003|STARTED|Overall Study||110
3281202|NCT02735382|4014792|FG000|COMPLETED|Overall Study||7481
3281203|NCT02735382|4014793|FG001|COMPLETED|Overall Study||7155
3281204|NCT02735382|4014794|FG002|COMPLETED|Overall Study||184
3281205|NCT02735382|4014795|FG003|COMPLETED|Overall Study||110
3281206|NCT02735382|4014792|FG000|NOT COMPLETED|Overall Study||0
3281207|NCT02735382|4014793|FG001|NOT COMPLETED|Overall Study||0
3281208|NCT02735382|4014794|FG002|NOT COMPLETED|Overall Study||0
3281209|NCT02735382|4014795|FG003|NOT COMPLETED|Overall Study||0
3281210|NCT02735421|4014805|FG000|STARTED|Overall Study||67
3281211|NCT02735421|4014805|FG000|COMPLETED|Overall Study||54
3281212|NCT02735421|4014805|FG000|NOT COMPLETED|Overall Study||13
3281213|NCT02735551|4014815|FG000|STARTED|Overall Study||3
3281214|NCT02735551|4014816|FG001|STARTED|Overall Study||0
3281215|NCT02735551|4014817|FG002|STARTED|Overall Study||0
3281216|NCT02735551|4014815|FG000|COMPLETED|Overall Study||3
3281217|NCT02735551|4014816|FG001|COMPLETED|Overall Study||0
3281218|NCT02735551|4014817|FG002|COMPLETED|Overall Study||0
3281219|NCT02735551|4014815|FG000|NOT COMPLETED|Overall Study||0
3281220|NCT02735551|4014816|FG001|NOT COMPLETED|Overall Study||0
3281221|NCT02735551|4014817|FG002|NOT COMPLETED|Overall Study||0
3281222|NCT02735577|4014825|FG000|STARTED|Disulfiram Treatment||7
3281223|NCT02735577|4014825|FG000|COMPLETED|Disulfiram Treatment||6
3281224|NCT02735577|4014825|FG000|NOT COMPLETED|Disulfiram Treatment||1
3281225|NCT02735577|4014825|FG000|STARTED|Optional 28 Days of Disulfiram Treatment||6
3281226|NCT02735577|4014825|FG000|COMPLETED|Optional 28 Days of Disulfiram Treatment||4
3281227|NCT02735577|4014825|FG000|NOT COMPLETED|Optional 28 Days of Disulfiram Treatment||2
3281228|NCT02735642|4014831|FG000|STARTED|Overall Study||1046
3281229|NCT02735642|4014832|FG001|STARTED|Overall Study||152
3281230|NCT02735642|4014831|FG000|COMPLETED|Overall Study||1046
3049682|NCT01212770|3769483|FG006|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
3049683|NCT01212770|3769484|FG007|NOT COMPLETED|Long-term Safety Phase (Year 5)||2
3049684|NCT01212770|3769485|FG008|NOT COMPLETED|Long-term Safety Phase (Year 5)||1
3049685|NCT01212874|3769509|FG000|STARTED|Overall Study||35
3049686|NCT01212874|3769510|FG001|STARTED|Overall Study||35
3049687|NCT01212874|3769509|FG000|Received Allocated Intervention|Overall Study||13
3049688|NCT01212874|3769510|FG001|Received Allocated Intervention|Overall Study||12
3049689|NCT01212874|3769509|FG000|COMPLETED|Overall Study||13
3049690|NCT01212874|3769510|FG001|COMPLETED|Overall Study||12
3049691|NCT01212874|3769509|FG000|NOT COMPLETED|Overall Study||22
3049692|NCT01212874|3769510|FG001|NOT COMPLETED|Overall Study||23
3049693|NCT01212900|3769518|FG000|STARTED|Overall Study||116
3049694|NCT01212900|3769519|FG001|STARTED|Overall Study||114
3049695|NCT01212900|3769518|FG000|COMPLETED|Overall Study||104
3049696|NCT01212900|3769519|FG001|COMPLETED|Overall Study||107
3049697|NCT01212900|3769518|FG000|NOT COMPLETED|Overall Study||12
3049698|NCT01212900|3769519|FG001|NOT COMPLETED|Overall Study||7
3049699|NCT01212952|3769528|FG000|STARTED|Overall Study||3
3049700|NCT01212952|3769529|FG001|STARTED|Overall Study||6
3049701|NCT01212952|3769530|FG002|STARTED|Overall Study||41
3049702|NCT01212952|3769528|FG000|COMPLETED|Overall Study||3
3049703|NCT01212952|3769529|FG001|COMPLETED|Overall Study||6
3049704|NCT01212952|3769530|FG002|COMPLETED|Overall Study||41
3049705|NCT01212952|3769528|FG000|NOT COMPLETED|Overall Study||0
3049706|NCT01212952|3769529|FG001|NOT COMPLETED|Overall Study||0
3049707|NCT01212952|3769530|FG002|NOT COMPLETED|Overall Study||0
3049708|NCT01212991|3769542|FG000|STARTED|Double-blind||872
3049709|NCT01212991|3769543|FG001|STARTED|Double-blind||845
3049710|NCT01212991|3769544|FG002|STARTED|Double-blind||0
3049711|NCT01212991|3769542|FG000|Safety Population|Double-blind||871
3049712|NCT01212991|3769543|FG001|Safety Population|Double-blind||844
3049713|NCT01212991|3769544|FG002|Safety Population|Double-blind||0
3049714|NCT01212991|3769542|FG000|COMPLETED|Double-blind||0
3049715|NCT01212991|3769543|FG001|COMPLETED|Double-blind||234
3049716|NCT01212991|3769544|FG002|COMPLETED|Double-blind||0
3049717|NCT01212991|3769542|FG000|NOT COMPLETED|Double-blind||872
3049718|NCT01212991|3769543|FG001|NOT COMPLETED|Double-blind||611
3049719|NCT01212991|3769544|FG002|NOT COMPLETED|Double-blind||0
3049720|NCT01212991|3769542|FG000|STARTED|Open-label||0
3049721|NCT01212991|3769543|FG001|STARTED|Open-label|participants were given the opportunity to receive open-label access to enzalutamide|0
3049722|NCT01212991|3769544|FG002|STARTED|Open-label|previous placebo treated participants were given the opportunity to receive enzalutamide|234
3049723|NCT01212991|3769542|FG000|COMPLETED|Open-label||0
3049724|NCT01212991|3769543|FG001|COMPLETED|Open-label||0
3049725|NCT01212991|3769544|FG002|COMPLETED|Open-label||0
3049726|NCT01212991|3769542|FG000|NOT COMPLETED|Open-label||0
3049727|NCT01212991|3769543|FG001|NOT COMPLETED|Open-label||0
3049728|NCT01212991|3769544|FG002|NOT COMPLETED|Open-label||234
3049729|NCT01213043|3769554|FG000|STARTED|Treatment Period 1||15
3049730|NCT01213043|3769555|FG001|STARTED|Treatment Period 1||15
3281231|NCT02735642|4014832|FG001|COMPLETED|Overall Study||152
3281232|NCT02735642|4014831|FG000|NOT COMPLETED|Overall Study||0
3281233|NCT02735642|4014832|FG001|NOT COMPLETED|Overall Study||0
3281234|NCT02735915|4014842|FG000|STARTED|Overall Study||70
3281235|NCT02735915|4014842|FG000|Vaccinated|Overall Study||62
3281236|NCT02735915|4014842|FG000|COMPLETED|Overall Study||59
3281237|NCT02735915|4014842|FG000|NOT COMPLETED|Overall Study||11
3281238|NCT02735980|4014851|FG000|STARTED|Overall Study||58
3281239|NCT02735980|4014852|FG001|STARTED|Overall Study||60
3281240|NCT02735980|4014853|FG002|STARTED|Overall Study||15
3281241|NCT02735980|4014851|FG000|Received at Least 1 Dose of Study Drug|Overall Study||56
3281242|NCT02735980|4014852|FG001|Received at Least 1 Dose of Study Drug|Overall Study||60
3281243|NCT02735980|4014853|FG002|Received at Least 1 Dose of Study Drug|Overall Study||15
3281244|NCT02735980|4014851|FG000|COMPLETED|Overall Study||48
3281245|NCT02735980|4014852|FG001|COMPLETED|Overall Study||49
3281246|NCT02735980|4014853|FG002|COMPLETED|Overall Study||14
3281247|NCT02735980|4014851|FG000|NOT COMPLETED|Overall Study||10
3281248|NCT02735980|4014852|FG001|NOT COMPLETED|Overall Study||11
3281249|NCT02735980|4014853|FG002|NOT COMPLETED|Overall Study||1
3281250|NCT02736175|4014868|FG000|STARTED|Overall Study||216
3281251|NCT02736175|4014869|FG001|STARTED|Overall Study||222
3281252|NCT02736175|4014868|FG000|COMPLETED|Overall Study||214
3281253|NCT02736175|4014869|FG001|COMPLETED|Overall Study||221
3281254|NCT02736175|4014868|FG000|NOT COMPLETED|Overall Study||2
3281255|NCT02736175|4014869|FG001|NOT COMPLETED|Overall Study||1
3281256|NCT02736188|4014875|FG000|STARTED|Overall Study||142
3281257|NCT02736188|4014875|FG000|COMPLETED|Overall Study||0
3281258|NCT02736188|4014875|FG000|NOT COMPLETED|Overall Study||142
3281259|NCT02736409|4014885|FG000|STARTED|Overall Study||23
3281260|NCT02736409|4014886|FG001|STARTED|Overall Study||25
3281261|NCT02736409|4014887|FG002|STARTED|Overall Study||106
3281262|NCT02736409|4014888|FG003|STARTED|Overall Study||65
3281263|NCT02736409|4014885|FG000|COMPLETED|Overall Study||19
3281264|NCT02736409|4014886|FG001|COMPLETED|Overall Study||22
3281265|NCT02736409|4014887|FG002|COMPLETED|Overall Study||80
3281266|NCT02736409|4014888|FG003|COMPLETED|Overall Study||53
3281267|NCT02736409|4014885|FG000|NOT COMPLETED|Overall Study||4
3281268|NCT02736409|4014886|FG001|NOT COMPLETED|Overall Study||3
3281269|NCT02736409|4014887|FG002|NOT COMPLETED|Overall Study||26
3281270|NCT02736409|4014888|FG003|NOT COMPLETED|Overall Study||12
3049731|NCT01213043|3769554|FG000|COMPLETED|Treatment Period 1||15
3049732|NCT01213043|3769555|FG001|COMPLETED|Treatment Period 1||15
3049733|NCT01213043|3769554|FG000|NOT COMPLETED|Treatment Period 1||0
3049734|NCT01213043|3769555|FG001|NOT COMPLETED|Treatment Period 1||0
3281271|NCT02736474|4014901|FG000|STARTED|Overall Study||11
3281272|NCT02736474|4014902|FG001|STARTED|Overall Study||11
3281273|NCT02736474|4014901|FG000|COMPLETED|Overall Study||11
3281274|NCT02736474|4014902|FG001|COMPLETED|Overall Study||10
3281275|NCT02736474|4014901|FG000|NOT COMPLETED|Overall Study||0
3281276|NCT02736474|4014902|FG001|NOT COMPLETED|Overall Study||1
3281277|NCT02736578|4014910|FG000|STARTED|Overall Study||6
3281278|NCT02736578|4014911|FG001|STARTED|Overall Study||2
3281279|NCT02736578|4014910|FG000|COMPLETED|Overall Study||5
3281280|NCT02736578|4014911|FG001|COMPLETED|Overall Study||2
3281281|NCT02736578|4014910|FG000|NOT COMPLETED|Overall Study||1
3281282|NCT02736578|4014911|FG001|NOT COMPLETED|Overall Study||0
3281283|NCT02736721|4014921|FG000|STARTED|Overall Study||41
3281284|NCT02736721|4014921|FG000|COMPLETED|Overall Study||25
3281285|NCT02736721|4014921|FG000|NOT COMPLETED|Overall Study||16
3281286|NCT02736825|4014927|FG000|STARTED|Overall Study||127
3281287|NCT02736825|4014928|FG001|STARTED|Overall Study||135
3281288|NCT02736825|4014927|FG000|COMPLETED|Overall Study||117
3281289|NCT02736825|4014928|FG001|COMPLETED|Overall Study||123
3281290|NCT02736825|4014927|FG000|NOT COMPLETED|Overall Study||10
3281291|NCT02736825|4014928|FG001|NOT COMPLETED|Overall Study||12
3281292|NCT02736890|4014937|FG000|STARTED|First 12 Weeks||5
3281293|NCT02736890|4014938|FG001|STARTED|First 12 Weeks||3
3281294|NCT02736890|4014937|FG000|COMPLETED|First 12 Weeks||5
3281295|NCT02736890|4014938|FG001|COMPLETED|First 12 Weeks||3
3281296|NCT02736890|4014937|FG000|NOT COMPLETED|First 12 Weeks||0
3281297|NCT02736890|4014938|FG001|NOT COMPLETED|First 12 Weeks||0
3281298|NCT02736890|4014937|FG000|STARTED|Crossover Next 12 Weeks||5
3281299|NCT02736890|4014938|FG001|STARTED|Crossover Next 12 Weeks||3
3281300|NCT02736890|4014937|FG000|COMPLETED|Crossover Next 12 Weeks||3
3281301|NCT02736890|4014938|FG001|COMPLETED|Crossover Next 12 Weeks||1
3281302|NCT02736890|4014937|FG000|NOT COMPLETED|Crossover Next 12 Weeks||2
3281303|NCT02736890|4014938|FG001|NOT COMPLETED|Crossover Next 12 Weeks||2
3281304|NCT02736955|4014947|FG000|STARTED|Overall Study||36
3281305|NCT02736955|4014948|FG001|STARTED|Overall Study||117
3281306|NCT02736955|4014949|FG002|STARTED|Overall Study||8
3281307|NCT02736955|4014947|FG000|COMPLETED|Overall Study||29
3281308|NCT02736955|4014948|FG001|COMPLETED|Overall Study||103
3281309|NCT02736955|4014949|FG002|COMPLETED|Overall Study||6
3281310|NCT02736955|4014947|FG000|NOT COMPLETED|Overall Study||7
3281311|NCT02736955|4014948|FG001|NOT COMPLETED|Overall Study||14
3281312|NCT02736955|4014949|FG002|NOT COMPLETED|Overall Study||2
3281313|NCT02737072|4014961|FG000|STARTED|Overall Study||3
3281314|NCT02737072|4014962|FG001|STARTED|Overall Study||3
3281315|NCT02737072|4014963|FG002|STARTED|Overall Study||3
3281316|NCT02737072|4014961|FG000|Received at Least One Dose of Drug|Overall Study||3
3281317|NCT02737072|4014962|FG001|Received at Least One Dose of Drug|Overall Study||3
3281318|NCT02737072|4014963|FG002|Received at Least One Dose of Drug|Overall Study||3
3281319|NCT02737072|4014961|FG000|COMPLETED|Overall Study||3
3281320|NCT02737072|4014962|FG001|COMPLETED|Overall Study||3
3281321|NCT02737072|4014963|FG002|COMPLETED|Overall Study||3
3281322|NCT02737072|4014961|FG000|NOT COMPLETED|Overall Study||0
3281323|NCT02737072|4014962|FG001|NOT COMPLETED|Overall Study||0
3281324|NCT02737072|4014963|FG002|NOT COMPLETED|Overall Study||0
3281325|NCT02737163|4014975|FG000|STARTED|Overall Study|114 encounter assessments were completed on 95 participants over 15 months|95
3281326|NCT02737163|4014975|FG000|COMPLETED|Overall Study||95
3281327|NCT02737163|4014975|FG000|NOT COMPLETED|Overall Study||0
3281328|NCT02737332|4014981|FG000|STARTED|Overall Study||29
3281329|NCT02737332|4014982|FG001|STARTED|Overall Study||24
3281330|NCT02737332|4014981|FG000|COMPLETED|Overall Study||28
3281331|NCT02737332|4014982|FG001|COMPLETED|Overall Study||23
3281332|NCT02737332|4014981|FG000|NOT COMPLETED|Overall Study||1
3281333|NCT02737332|4014982|FG001|NOT COMPLETED|Overall Study||1
3281334|NCT02737358|4014992|FG000|STARTED|Overall Study||55
3281335|NCT02737358|4014993|FG001|STARTED|Overall Study||59
3281336|NCT02737358|4014992|FG000|COMPLETED|Overall Study||46
3281337|NCT02737358|4014993|FG001|COMPLETED|Overall Study||44
3281338|NCT02737358|4014992|FG000|NOT COMPLETED|Overall Study||9
3281339|NCT02737358|4014993|FG001|NOT COMPLETED|Overall Study||15
3281340|NCT02737397|4014999|FG000|STARTED|Overall Study||13
3281341|NCT02737397|4014999|FG000|JMI-001|Overall Study||13
3281342|NCT02737397|4014999|FG000|SJP-304|Overall Study||12
3281343|NCT02737397|4014999|FG000|SJP-223|Overall Study||13
3281344|NCT02737397|4014999|FG000|Placebo|Overall Study||13
3281345|NCT02737397|4014999|FG000|COMPLETED|Overall Study||13
3281346|NCT02737397|4014999|FG000|NOT COMPLETED|Overall Study||0
3281347|NCT02737501|4015011|FG000|STARTED|Randomized Phase||137
3281348|NCT02737501|4015012|FG001|STARTED|Randomized Phase||138
3281349|NCT02737501|4015013|FG002|STARTED|Randomized Phase||0
3281350|NCT02737501|4015011|FG000|Safety Analysis Set|Randomized Phase||136
3281351|NCT02737501|4015012|FG001|Safety Analysis Set|Randomized Phase||137
3281352|NCT02737501|4015013|FG002|Safety Analysis Set|Randomized Phase||0
3281353|NCT02737501|4015011|FG000|COMPLETED|Randomized Phase||20
3281354|NCT02737501|4015012|FG001|COMPLETED|Randomized Phase||84
3281355|NCT02737501|4015013|FG002|COMPLETED|Randomized Phase||0
3281356|NCT02737501|4015011|FG000|NOT COMPLETED|Randomized Phase||117
3281357|NCT02737501|4015012|FG001|NOT COMPLETED|Randomized Phase||54
3049735|NCT01213043|3769554|FG000|STARTED|Washout Period||15
3049736|NCT01213043|3769555|FG001|STARTED|Washout Period||15
3049737|NCT01213043|3769554|FG000|COMPLETED|Washout Period||15
3049738|NCT01213043|3769555|FG001|COMPLETED|Washout Period||15
3049739|NCT01213043|3769554|FG000|NOT COMPLETED|Washout Period||0
3049740|NCT01213043|3769555|FG001|NOT COMPLETED|Washout Period||0
3049741|NCT01213043|3769554|FG000|STARTED|Treatment Period 2||15
3049742|NCT01213043|3769555|FG001|STARTED|Treatment Period 2||15
3049743|NCT01213043|3769554|FG000|COMPLETED|Treatment Period 2||15
3049744|NCT01213043|3769555|FG001|COMPLETED|Treatment Period 2||15
3049745|NCT01213043|3769554|FG000|NOT COMPLETED|Treatment Period 2||0
3049746|NCT01213043|3769555|FG001|NOT COMPLETED|Treatment Period 2||0
3049747|NCT01213043|3769554|FG000|STARTED|Follow-up||15
3049748|NCT01213043|3769555|FG001|STARTED|Follow-up||15
3049749|NCT01213043|3769554|FG000|COMPLETED|Follow-up||15
3281358|NCT02737501|4015013|FG002|NOT COMPLETED|Randomized Phase||0
3281359|NCT02737501|4015011|FG000|STARTED|Crossover Phase||0
3281360|NCT02737501|4015012|FG001|STARTED|Crossover Phase||0
3281361|NCT02737501|4015013|FG002|STARTED|Crossover Phase||65
3281362|NCT02737501|4015011|FG000|COMPLETED|Crossover Phase||0
3281363|NCT02737501|4015012|FG001|COMPLETED|Crossover Phase||0
3281364|NCT02737501|4015013|FG002|COMPLETED|Crossover Phase||10
3281365|NCT02737501|4015011|FG000|NOT COMPLETED|Crossover Phase||0
3281366|NCT02737501|4015012|FG001|NOT COMPLETED|Crossover Phase||0
3281367|NCT02737501|4015013|FG002|NOT COMPLETED|Crossover Phase||55
3281368|NCT02737592|4015021|FG000|STARTED|Overall Study||34
3281369|NCT02737592|4015021|FG000|COMPLETED|Overall Study||33
3281370|NCT02737592|4015021|FG000|NOT COMPLETED|Overall Study||1
3281371|NCT02737618|4015025|FG000|STARTED|Overall Study||43
3281372|NCT02737618|4015025|FG000|COMPLETED|Overall Study||34
3281373|NCT02737618|4015025|FG000|NOT COMPLETED|Overall Study||9
3281374|NCT02737631|4015029|FG000|STARTED|Overall Study||222
3281375|NCT02737631|4015029|FG000|COMPLETED|Overall Study||222
3281376|NCT02737631|4015029|FG000|NOT COMPLETED|Overall Study||0
3281377|NCT02737722|4015037|FG000|STARTED|Overall Study||8
3281378|NCT02737722|4015038|FG001|STARTED|Overall Study||8
3281379|NCT02737722|4015039|FG002|STARTED|Overall Study||8
3281380|NCT02737722|4015040|FG003|STARTED|Overall Study||6
3281381|NCT02737722|4015037|FG000|COMPLETED|Overall Study||8
3281382|NCT02737722|4015038|FG001|COMPLETED|Overall Study||8
3281383|NCT02737722|4015039|FG002|COMPLETED|Overall Study||7
3281384|NCT02737722|4015040|FG003|COMPLETED|Overall Study||6
3281385|NCT02737722|4015037|FG000|NOT COMPLETED|Overall Study||0
3281386|NCT02737722|4015038|FG001|NOT COMPLETED|Overall Study||0
3281387|NCT02737722|4015039|FG002|NOT COMPLETED|Overall Study||1
3281388|NCT02737722|4015040|FG003|NOT COMPLETED|Overall Study||0
3281389|NCT02737826|4015050|FG000|STARTED|Phase I - Buprenorphine Initiation||27
3281390|NCT02737826|4015051|FG001|STARTED|Phase I - Buprenorphine Initiation||0
3281391|NCT02737826|4015052|FG002|STARTED|Phase I - Buprenorphine Initiation||0
3281392|NCT02737826|4015050|FG000|COMPLETED|Phase I - Buprenorphine Initiation||27
3281393|NCT02737826|4015051|FG001|COMPLETED|Phase I - Buprenorphine Initiation||0
3281394|NCT02737826|4015052|FG002|COMPLETED|Phase I - Buprenorphine Initiation||0
3281395|NCT02737826|4015050|FG000|NOT COMPLETED|Phase I - Buprenorphine Initiation||0
3281396|NCT02737826|4015051|FG001|NOT COMPLETED|Phase I - Buprenorphine Initiation||0
3281397|NCT02737826|4015052|FG002|NOT COMPLETED|Phase I - Buprenorphine Initiation||0
3281398|NCT02737826|4015050|FG000|STARTED|Phase II - Randomization + Taper||0
3281399|NCT02737826|4015051|FG001|STARTED|Phase II - Randomization + Taper||13
3281400|NCT02737826|4015052|FG002|STARTED|Phase II - Randomization + Taper||14
3281401|NCT02737826|4015050|FG000|COMPLETED|Phase II - Randomization + Taper||0
3281402|NCT02737826|4015051|FG001|COMPLETED|Phase II - Randomization + Taper||1
3281403|NCT02737826|4015052|FG002|COMPLETED|Phase II - Randomization + Taper||0
3281404|NCT02737826|4015050|FG000|NOT COMPLETED|Phase II - Randomization + Taper||0
3281405|NCT02737826|4015051|FG001|NOT COMPLETED|Phase II - Randomization + Taper||12
3281406|NCT02737826|4015052|FG002|NOT COMPLETED|Phase II - Randomization + Taper||14
3281407|NCT02737852|4015061|FG000|STARTED|Overall Study||32
3281408|NCT02737852|4015061|FG000|COMPLETED|Overall Study||30
3281409|NCT02737852|4015061|FG000|NOT COMPLETED|Overall Study||2
3281410|NCT02737891|4015067|FG000|STARTED|Overall Study||30
3281411|NCT02737891|4015068|FG001|STARTED|Overall Study||30
3281412|NCT02737891|4015067|FG000|COMPLETED|Overall Study||30
3281413|NCT02737891|4015068|FG001|COMPLETED|Overall Study||28
3281414|NCT02737891|4015067|FG000|NOT COMPLETED|Overall Study||0
3281415|NCT02737891|4015068|FG001|NOT COMPLETED|Overall Study||2
3281416|NCT02737917|4015076|FG000|STARTED|Overall Study||103
3281417|NCT02737917|4015077|FG001|STARTED|Overall Study||103
3281418|NCT02737917|4015076|FG000|COMPLETED|Overall Study||100
3281419|NCT02737917|4015077|FG001|COMPLETED|Overall Study||100
3281420|NCT02737917|4015076|FG000|NOT COMPLETED|Overall Study||3
3281421|NCT02737917|4015077|FG001|NOT COMPLETED|Overall Study||3
3281422|NCT02737930|4015085|FG000|STARTED|Overall Study||5
3281423|NCT02737930|4015086|FG001|STARTED|Overall Study||7
3281424|NCT02737930|4015085|FG000|COMPLETED|Overall Study||5
3281425|NCT02737930|4015086|FG001|COMPLETED|Overall Study||6
3281426|NCT02737930|4015085|FG000|NOT COMPLETED|Overall Study||0
3281427|NCT02737930|4015086|FG001|NOT COMPLETED|Overall Study||1
3281428|NCT02738008|4015095|FG000|STARTED|Overall Study||1
3281429|NCT02738008|4015096|FG001|STARTED|Overall Study||6
3049750|NCT01213043|3769555|FG001|COMPLETED|Follow-up||15
3281430|NCT02738008|4015097|FG002|STARTED|Overall Study||5
3049751|NCT01213043|3769554|FG000|NOT COMPLETED|Follow-up||0
3049752|NCT01213043|3769555|FG001|NOT COMPLETED|Follow-up||0
3049753|NCT01213082|3769564|FG000|STARTED|Overall Study||12
3049754|NCT01213082|3769565|FG001|STARTED|Overall Study||11
3049755|NCT01213082|3769566|FG002|STARTED|Overall Study||11
3049756|NCT01213082|3769564|FG000|COMPLETED|Overall Study||6
3049757|NCT01213082|3769565|FG001|COMPLETED|Overall Study||4
3281431|NCT02738008|4015095|FG000|COMPLETED|Overall Study||0
3281432|NCT02738008|4015096|FG001|COMPLETED|Overall Study||0
3281433|NCT02738008|4015097|FG002|COMPLETED|Overall Study||0
3281434|NCT02738008|4015095|FG000|NOT COMPLETED|Overall Study||1
3281435|NCT02738008|4015096|FG001|NOT COMPLETED|Overall Study||6
3281436|NCT02738008|4015097|FG002|NOT COMPLETED|Overall Study||5
3316415|NCT03110770|4049703|FG004|NOT COMPLETED|Overall Study||123
3316416|NCT03111108|4049719|FG000|STARTED|Overall Study||53
3316417|NCT03111108|4049720|FG001|STARTED|Overall Study||64
3316418|NCT03111108|4049719|FG000|COMPLETED|Overall Study||52
3316419|NCT03111108|4049720|FG001|COMPLETED|Overall Study||63
3316420|NCT03111108|4049719|FG000|NOT COMPLETED|Overall Study||1
3316421|NCT03111108|4049720|FG001|NOT COMPLETED|Overall Study||1
3316422|NCT03111316|4049730|FG000|STARTED|Overall Study||26
3316423|NCT03111316|4049731|FG001|STARTED|Overall Study||24
3316424|NCT03111316|4049732|FG002|STARTED|Overall Study||25
3316425|NCT03111316|4049733|FG003|STARTED|Overall Study||25
3316426|NCT03111316|4049730|FG000|COMPLETED|Overall Study||26
3316427|NCT03111316|4049731|FG001|COMPLETED|Overall Study||24
3316428|NCT03111316|4049732|FG002|COMPLETED|Overall Study||25
3316429|NCT03111316|4049733|FG003|COMPLETED|Overall Study||25
3316430|NCT03111316|4049730|FG000|NOT COMPLETED|Overall Study||0
3316431|NCT03111316|4049731|FG001|NOT COMPLETED|Overall Study||0
3316432|NCT03111316|4049732|FG002|NOT COMPLETED|Overall Study||0
3316433|NCT03111316|4049733|FG003|NOT COMPLETED|Overall Study||0
3316434|NCT03111381|4049745|FG000|STARTED|Overall Study||46
3316435|NCT03111381|4049746|FG001|STARTED|Overall Study||48
3316436|NCT03111381|4049745|FG000|COMPLETED|Overall Study||46
3316437|NCT03111381|4049746|FG001|COMPLETED|Overall Study||48
3316438|NCT03111381|4049745|FG000|NOT COMPLETED|Overall Study||0
3316439|NCT03111381|4049746|FG001|NOT COMPLETED|Overall Study||0
3316440|NCT03111407|4049754|FG000|STARTED|Overall Study||45
3316441|NCT03111407|4049755|FG001|STARTED|Overall Study||27
3316442|NCT03111407|4049754|FG000|COMPLETED|Overall Study||44
3316443|NCT03111407|4049755|FG001|COMPLETED|Overall Study||26
3316444|NCT03111407|4049754|FG000|NOT COMPLETED|Overall Study||1
3316445|NCT03111407|4049755|FG001|NOT COMPLETED|Overall Study||1
3316446|NCT03111550|4049765|FG000|STARTED|Overall Study|First eye|77
3316447|NCT03111550|4049766|FG001|STARTED|Overall Study|First eye|73
3316448|NCT03111550|4049767|FG002|STARTED|Overall Study|First eye|79
3316449|NCT03111550|4049765|FG000|COMPLETED|Overall Study||73
3316450|NCT03111550|4049766|FG001|COMPLETED|Overall Study||71
3316451|NCT03111550|4049767|FG002|COMPLETED|Overall Study||76
3316452|NCT03111550|4049765|FG000|NOT COMPLETED|Overall Study||4
3316453|NCT03111550|4049766|FG001|NOT COMPLETED|Overall Study||2
3316454|NCT03111550|4049767|FG002|NOT COMPLETED|Overall Study||3
3316455|NCT03111628|4049775|FG000|STARTED|Overall Study||18
3316456|NCT03111628|4049775|FG000|COMPLETED|Overall Study||18
3316457|NCT03111628|4049775|FG000|NOT COMPLETED|Overall Study||0
3316458|NCT03111940|4049782|FG000|STARTED|Overall Study||21
3316459|NCT03111940|4049783|FG001|STARTED|Overall Study||14
3316460|NCT03111940|4049782|FG000|COMPLETED|Overall Study||21
3316461|NCT03111940|4049783|FG001|COMPLETED|Overall Study||14
3316462|NCT03111940|4049782|FG000|NOT COMPLETED|Overall Study||0
3316463|NCT03111940|4049783|FG001|NOT COMPLETED|Overall Study||0
3316464|NCT03112473|4049795|FG000|STARTED|Overall Study||30
3316465|NCT03112473|4049796|FG001|STARTED|Overall Study||30
3316466|NCT03112473|4049797|FG002|STARTED|Overall Study||30
3316467|NCT03112473|4049798|FG003|STARTED|Overall Study||30
3316468|NCT03112473|4049795|FG000|COMPLETED|Overall Study||30
3316469|NCT03112473|4049796|FG001|COMPLETED|Overall Study||30
3316470|NCT03112473|4049797|FG002|COMPLETED|Overall Study||30
3316471|NCT03112473|4049798|FG003|COMPLETED|Overall Study||30
3316472|NCT03112473|4049795|FG000|NOT COMPLETED|Overall Study||0
3316473|NCT03112473|4049796|FG001|NOT COMPLETED|Overall Study||0
3316474|NCT03112473|4049797|FG002|NOT COMPLETED|Overall Study||0
3316475|NCT03112473|4049798|FG003|NOT COMPLETED|Overall Study||0
3316476|NCT03112863|4049813|FG000|STARTED|Overall Study||21
3316477|NCT03112863|4049814|FG001|STARTED|Overall Study||23
3316478|NCT03112863|4049813|FG000|COMPLETED|Overall Study||21
3316479|NCT03112863|4049814|FG001|COMPLETED|Overall Study||23
3049758|NCT01213082|3769566|FG002|COMPLETED|Overall Study||6
3316480|NCT03112863|4049813|FG000|NOT COMPLETED|Overall Study||0
3316481|NCT03112863|4049814|FG001|NOT COMPLETED|Overall Study||0
3316482|NCT03112993|4049822|FG000|STARTED|Overall Study||19
3316483|NCT03112993|4049823|FG001|STARTED|Overall Study||21
3316484|NCT03112993|4049822|FG000|COMPLETED|Overall Study||19
3316485|NCT03112993|4049823|FG001|COMPLETED|Overall Study||21
3316486|NCT03112993|4049822|FG000|NOT COMPLETED|Overall Study||0
3316487|NCT03112993|4049823|FG001|NOT COMPLETED|Overall Study||0
3316488|NCT03113656|4049833|FG000|STARTED|Overall Study||9
3316489|NCT03113656|4049834|FG001|STARTED|Overall Study||7
3316490|NCT03113656|4049833|FG000|COMPLETED|Overall Study||9
3316491|NCT03113656|4049834|FG001|COMPLETED|Overall Study||7
3316492|NCT03113656|4049833|FG000|NOT COMPLETED|Overall Study||0
3316493|NCT03113656|4049834|FG001|NOT COMPLETED|Overall Study||0
3049759|NCT01213082|3769564|FG000|NOT COMPLETED|Overall Study||6
3049760|NCT01213082|3769565|FG001|NOT COMPLETED|Overall Study||7
3049761|NCT01213082|3769566|FG002|NOT COMPLETED|Overall Study||5
3049762|NCT01213173|3769576|FG000|STARTED|Overall Study|Patients who were randomized and received treatment|125
3049763|NCT01213173|3769577|FG001|STARTED|Overall Study|Patients who were randomized and received treatment|126
3049764|NCT01213173|3769576|FG000|Patients Included in Safety Population|Overall Study||139
3049765|NCT01213173|3769577|FG001|Patients Included in Safety Population|Overall Study||112
3049766|NCT01213173|3769576|FG000|Patients Included in ITT Population|Overall Study||116
3049767|NCT01213173|3769577|FG001|Patients Included in ITT Population|Overall Study||115
3049768|NCT01213173|3769576|FG000|Patients Included in PP Population|Overall Study||102
3049769|NCT01213173|3769577|FG001|Patients Included in PP Population|Overall Study||89
3049770|NCT01213173|3769576|FG000|COMPLETED|Overall Study|Patients who completed the study|113
3049771|NCT01213173|3769577|FG001|COMPLETED|Overall Study|Patients who completed the study|110
3049772|NCT01213173|3769576|FG000|NOT COMPLETED|Overall Study||12
3049773|NCT01213173|3769577|FG001|NOT COMPLETED|Overall Study||16
3049774|NCT01213199|3769583|FG000|STARTED|Overall Study||20
3049775|NCT01213199|3769583|FG000|COMPLETED|Overall Study||16
3049776|NCT01213199|3769583|FG000|NOT COMPLETED|Overall Study||4
3049777|NCT01213251|3769590|FG000|STARTED|Overall Study||40
3049778|NCT01213251|3769591|FG001|STARTED|Overall Study||41
3049779|NCT01213251|3769592|FG002|STARTED|Overall Study||45
3049780|NCT01213251|3769590|FG000|COMPLETED|Overall Study|Patients that had the 18-Month follow-up visit|34
3049781|NCT01213251|3769591|FG001|COMPLETED|Overall Study|Patients that had the 18-Month follow-up visit|37
3049782|NCT01213251|3769592|FG002|COMPLETED|Overall Study|Patients that had the 18-Month follow-up visit|34
3049783|NCT01213251|3769590|FG000|NOT COMPLETED|Overall Study||6
3049784|NCT01213251|3769591|FG001|NOT COMPLETED|Overall Study||4
3049785|NCT01213251|3769592|FG002|NOT COMPLETED|Overall Study||11
3049786|NCT01213264|3769608|FG000|STARTED|Overall Study||155
3049787|NCT01213264|3769609|FG001|STARTED|Overall Study||177
3049788|NCT01213264|3769610|FG002|STARTED|Overall Study||327
3049789|NCT01213264|3769608|FG000|COMPLETED|Overall Study||153
3049790|NCT01213264|3769609|FG001|COMPLETED|Overall Study||175
3049791|NCT01213264|3769610|FG002|COMPLETED|Overall Study||321
3281437|NCT02738086|4015107|FG000|STARTED|Overall Study||16
3281438|NCT02738086|4015108|FG001|STARTED|Overall Study||15
3281439|NCT02738086|4015107|FG000|COMPLETED|Overall Study||14
3281440|NCT02738086|4015108|FG001|COMPLETED|Overall Study||13
3281441|NCT02738086|4015107|FG000|NOT COMPLETED|Overall Study||2
3281442|NCT02738086|4015108|FG001|NOT COMPLETED|Overall Study||2
3281443|NCT02738138|4015119|FG000|STARTED|Overall Study||137
3281444|NCT02738138|4015120|FG001|STARTED|Overall Study||16
3281445|NCT02738138|4015119|FG000|COMPLETED|Overall Study||134
3281446|NCT02738138|4015120|FG001|COMPLETED|Overall Study||15
3281447|NCT02738138|4015119|FG000|NOT COMPLETED|Overall Study||3
3281448|NCT02738138|4015120|FG001|NOT COMPLETED|Overall Study||1
3281449|NCT02738151|4015127|FG000|STARTED|Overall Study||466
3281450|NCT02738151|4015128|FG001|STARTED|Overall Study||463
3281451|NCT02738151|4015127|FG000|Treated|Overall Study||462
3281452|NCT02738151|4015128|FG001|Treated|Overall Study||462
3281453|NCT02738151|4015127|FG000|COMPLETED|Overall Study||443
3281454|NCT02738151|4015128|FG001|COMPLETED|Overall Study||432
3281455|NCT02738151|4015127|FG000|NOT COMPLETED|Overall Study||23
3281456|NCT02738151|4015128|FG001|NOT COMPLETED|Overall Study||31
3281457|NCT02738203|4015136|FG000|STARTED|Overall Study||110
3281458|NCT02738203|4015137|FG001|STARTED|Overall Study||110
3281459|NCT02738203|4015136|FG000|COMPLETED|Overall Study||108
3281460|NCT02738203|4015137|FG001|COMPLETED|Overall Study||107
3281461|NCT02738203|4015136|FG000|NOT COMPLETED|Overall Study||2
3281462|NCT02738203|4015137|FG001|NOT COMPLETED|Overall Study||3
3281463|NCT02738255|4015145|FG000|STARTED|Overall Study||11
3281464|NCT02738255|4015146|FG001|STARTED|Overall Study||15
3281465|NCT02738255|4015145|FG000|COMPLETED|Overall Study||11
3281466|NCT02738255|4015146|FG001|COMPLETED|Overall Study||14
3281467|NCT02738255|4015145|FG000|NOT COMPLETED|Overall Study||0
3281468|NCT02738255|4015146|FG001|NOT COMPLETED|Overall Study||1
3281469|NCT02738333|4015159|FG000|STARTED|Overall Study||106
3281470|NCT02738333|4015160|FG001|STARTED|Overall Study||108
3281471|NCT02738333|4015161|FG002|STARTED|Overall Study||25
3281472|NCT02738333|4015159|FG000|COMPLETED|Overall Study||104
3281473|NCT02738333|4015160|FG001|COMPLETED|Overall Study||108
3281474|NCT02738333|4015161|FG002|COMPLETED|Overall Study||25
3281475|NCT02738333|4015159|FG000|NOT COMPLETED|Overall Study||2
3281476|NCT02738333|4015160|FG001|NOT COMPLETED|Overall Study||0
3281477|NCT02738333|4015161|FG002|NOT COMPLETED|Overall Study||0
3281478|NCT02738450|4015173|FG000|STARTED|Overall Study||6
3281479|NCT02738450|4015174|FG001|STARTED|Overall Study||6
3281480|NCT02738450|4015175|FG002|STARTED|Overall Study||4
3281481|NCT02738450|4015173|FG000|COMPLETED|Overall Study||6
3281482|NCT02738450|4015174|FG001|COMPLETED|Overall Study||4
3281483|NCT02738450|4015175|FG002|COMPLETED|Overall Study||4
3281484|NCT02738450|4015173|FG000|NOT COMPLETED|Overall Study||0
3281485|NCT02738450|4015174|FG001|NOT COMPLETED|Overall Study||2
3281486|NCT02738450|4015175|FG002|NOT COMPLETED|Overall Study||0
3281487|NCT02738580|4015186|FG000|STARTED|Overall Study|56 patients were assigned to this arms.|56
3281488|NCT02738580|4015187|FG001|STARTED|Overall Study||56
3281489|NCT02738580|4015186|FG000|COMPLETED|Overall Study|"3 cycles cancelled due to por response to stimullation.~1 cycle cancelled due to SAE."|52
3316494|NCT03113916|4049842|FG000|STARTED|Overall Study||99
3049792|NCT01213264|3769608|FG000|NOT COMPLETED|Overall Study||2
3049793|NCT01213264|3769609|FG001|NOT COMPLETED|Overall Study||2
3049794|NCT01213264|3769610|FG002|NOT COMPLETED|Overall Study||6
3049795|NCT01213316|3769621|FG000|STARTED|Overall Study|Participants in the initial and amendment cohorts|451
3133843|NCT01697592|3858759|FG003|NOT COMPLETED|Phase B (Week 25 to Week 52)||3
3281490|NCT02738580|4015187|FG001|COMPLETED|Overall Study|"2 cycles cancelled due to por response to stimullation~1 patient withdrawal~1 excluded"|52
3281491|NCT02738580|4015186|FG000|NOT COMPLETED|Overall Study||4
3281492|NCT02738580|4015187|FG001|NOT COMPLETED|Overall Study||4
3281493|NCT02738775|4015199|FG000|STARTED|Overall Study||8
3281494|NCT02738775|4015200|FG001|STARTED|Overall Study||8
3281495|NCT02738775|4015201|FG002|STARTED|Overall Study||8
3281496|NCT02738775|4015202|FG003|STARTED|Overall Study||9
3281497|NCT02738775|4015203|FG004|STARTED|Overall Study||8
3281498|NCT02738775|4015204|FG005|STARTED|Overall Study||8
3281499|NCT02738775|4015199|FG000|Initially Treated With Placebo|Overall Study||0
3281500|NCT02738775|4015200|FG001|Initially Treated With Placebo|Overall Study||0
3281501|NCT02738775|4015201|FG002|Initially Treated With Placebo|Overall Study||0
3281502|NCT02738775|4015202|FG003|Initially Treated With Placebo|Overall Study||1
3281503|NCT02738775|4015203|FG004|Initially Treated With Placebo|Overall Study||0
3281504|NCT02738775|4015204|FG005|Initially Treated With Placebo|Overall Study||0
3281505|NCT02738775|4015199|FG000|COMPLETED|Overall Study||8
3281506|NCT02738775|4015200|FG001|COMPLETED|Overall Study||6
3281507|NCT02738775|4015201|FG002|COMPLETED|Overall Study||8
3281508|NCT02738775|4015202|FG003|COMPLETED|Overall Study||8
3281509|NCT02738775|4015203|FG004|COMPLETED|Overall Study||8
3281510|NCT02738775|4015204|FG005|COMPLETED|Overall Study||7
3281511|NCT02738775|4015199|FG000|NOT COMPLETED|Overall Study||0
3281512|NCT02738775|4015200|FG001|NOT COMPLETED|Overall Study||2
3281513|NCT02738775|4015201|FG002|NOT COMPLETED|Overall Study||0
3281514|NCT02738775|4015202|FG003|NOT COMPLETED|Overall Study||1
3281515|NCT02738775|4015203|FG004|NOT COMPLETED|Overall Study||0
3281516|NCT02738775|4015204|FG005|NOT COMPLETED|Overall Study||1
3281517|NCT02738801|4015224|FG000|STARTED|Overall Study||6
3281518|NCT02738801|4015225|FG001|STARTED|Overall Study||17
3281519|NCT02738801|4015224|FG000|COMPLETED|Overall Study||5
3281520|NCT02738801|4015225|FG001|COMPLETED|Overall Study||15
3281521|NCT02738801|4015224|FG000|NOT COMPLETED|Overall Study||1
3281522|NCT02738801|4015225|FG001|NOT COMPLETED|Overall Study||2
3281523|NCT02738840|4015232|FG000|STARTED|Overall Study||56
3281524|NCT02738840|4015232|FG000|COMPLETED|Overall Study||48
3281525|NCT02738840|4015232|FG000|NOT COMPLETED|Overall Study||8
3281526|NCT02738853|4015236|FG000|STARTED|Baseline -30 Days||60
3281527|NCT02738853|4015236|FG000|COMPLETED|Baseline -30 Days||59
3281528|NCT02738853|4015236|FG000|NOT COMPLETED|Baseline -30 Days||1
3281529|NCT02738853|4015236|FG000|STARTED|30 Days- 6 Months||59
3281530|NCT02738853|4015236|FG000|COMPLETED|30 Days- 6 Months||57
3281531|NCT02738853|4015236|FG000|NOT COMPLETED|30 Days- 6 Months||2
3281532|NCT02738879|4015242|FG000|STARTED|Overall Study||374
3281533|NCT02738879|4015243|FG001|STARTED|Overall Study||372
3281534|NCT02738879|4015242|FG000|Treated|Overall Study||373
3281535|NCT02738879|4015243|FG001|Treated|Overall Study||370
3281536|NCT02738879|4015242|FG000|COMPLETED|Overall Study||361
3281537|NCT02738879|4015243|FG001|COMPLETED|Overall Study||347
3281538|NCT02738879|4015242|FG000|NOT COMPLETED|Overall Study||13
3281539|NCT02738879|4015243|FG001|NOT COMPLETED|Overall Study||25
3281540|NCT02739100|4015249|FG000|STARTED|Overall Study||13
3281541|NCT02739100|4015249|FG000|Triferic 2 Micromolar Via Hemodialysate|Overall Study||13
3281542|NCT02739100|4015249|FG000|Triferic 6.6 mg IV Predialyzer|Overall Study||13
3281543|NCT02739100|4015249|FG000|Triferic 6.6. mg IV Post-dialyzer|Overall Study||13
3281544|NCT02739100|4015249|FG000|COMPLETED|Overall Study||13
3281545|NCT02739100|4015249|FG000|NOT COMPLETED|Overall Study||0
3281546|NCT02739269|4015259|FG000|STARTED|Overall Study||100
3281547|NCT02739269|4015260|FG001|STARTED|Overall Study||100
3281548|NCT02739269|4015259|FG000|COMPLETED|Overall Study||93
3281549|NCT02739269|4015260|FG001|COMPLETED|Overall Study||96
3281550|NCT02739269|4015259|FG000|NOT COMPLETED|Overall Study||7
3281551|NCT02739269|4015260|FG001|NOT COMPLETED|Overall Study||4
3281552|NCT02739321|4015268|FG000|STARTED|Overall Study||23
3281553|NCT02739321|4015269|FG001|STARTED|Overall Study||22
3281554|NCT02739321|4015268|FG000|COMPLETED|Overall Study||20
3281555|NCT02739321|4015269|FG001|COMPLETED|Overall Study||18
3281556|NCT02739321|4015268|FG000|NOT COMPLETED|Overall Study||3
3281557|NCT02739321|4015269|FG001|NOT COMPLETED|Overall Study||4
3281558|NCT02739360|4015284|FG000|STARTED|Overall Study||3
3281559|NCT02739360|4015284|FG000|COMPLETED|Overall Study||0
3281560|NCT02739360|4015284|FG000|NOT COMPLETED|Overall Study||3
3281561|NCT02739594|4015290|FG000|STARTED|Overall Study||46
3281562|NCT02739594|4015291|FG001|STARTED|Overall Study||43
3281563|NCT02739594|4015290|FG000|Completed at Week 44|Overall Study||11
3281564|NCT02739594|4015291|FG001|Completed at Week 44|Overall Study||5
3281565|NCT02739594|4015290|FG000|Completed at Week 96|Overall Study||10
3281566|NCT02739594|4015291|FG001|Completed at Week 96|Overall Study||10
3281567|NCT02739594|4015290|FG000|COMPLETED|Overall Study|Includes all participants who reached the protocol-defined end of study (either Week 44 or 96).|21
3281568|NCT02739594|4015291|FG001|COMPLETED|Overall Study|Includes all participants who reached the protocol-defined end of study (either Week 44 or 96).|15
3281569|NCT02739594|4015290|FG000|NOT COMPLETED|Overall Study||25
3281570|NCT02739594|4015291|FG001|NOT COMPLETED|Overall Study||28
3049796|NCT01213316|3769621|FG000|Amendment Cohort: Prolonged Participants|Overall Study|Participants >=50 years of age in the initial cohort who accept an additional 48-week observation|48
3049797|NCT01213316|3769621|FG000|Amendment Cohort: Newly Enrolled|Overall Study|Participants >=50 years of age newly enrolled|179
3049798|NCT01213316|3769621|FG000|Discontinued Treatment Before 48 Weeks|Overall Study||67
3049799|NCT01213316|3769621|FG000|Initial Cohort|Overall Study|Participants >=18 years of age in the initial cohort|272
3049800|NCT01213316|3769621|FG000|COMPLETED|Overall Study||451
3049801|NCT01213316|3769621|FG000|NOT COMPLETED|Overall Study||0
3133844|NCT01697592|3858760|FG004|NOT COMPLETED|Phase B (Week 25 to Week 52)||0
3133845|NCT01697592|3858761|FG005|NOT COMPLETED|Phase B (Week 25 to Week 52)||2
3133846|NCT01697592|3858762|FG006|NOT COMPLETED|Phase B (Week 25 to Week 52)||1
3133847|NCT01697592|3858763|FG007|NOT COMPLETED|Phase B (Week 25 to Week 52)||1
3133848|NCT01697592|3858764|FG008|NOT COMPLETED|Phase B (Week 25 to Week 52)||2
3133849|NCT01697592|3858765|FG009|NOT COMPLETED|Phase B (Week 25 to Week 52)||0
3136754|NCT01714921|3862012|FG000|COMPLETED|Overall Study||311
3136755|NCT01714921|3862012|FG000|NOT COMPLETED|Overall Study||193
3281571|NCT02739698|4015300|FG000|STARTED|Overall Study||22
3281572|NCT02739698|4015301|FG001|STARTED|Overall Study||21
3281573|NCT02739698|4015300|FG000|COMPLETED|Overall Study||16
3281574|NCT02739698|4015301|FG001|COMPLETED|Overall Study||16
3281575|NCT02739698|4015300|FG000|NOT COMPLETED|Overall Study||6
3281576|NCT02739698|4015301|FG001|NOT COMPLETED|Overall Study||5
3281577|NCT02739789|4015309|FG000|STARTED|First fMRI Scan||9
3281578|NCT02739789|4015310|FG001|STARTED|First fMRI Scan||10
3281579|NCT02739789|4015309|FG000|COMPLETED|First fMRI Scan||9
3281580|NCT02739789|4015310|FG001|COMPLETED|First fMRI Scan||10
3281581|NCT02739789|4015309|FG000|NOT COMPLETED|First fMRI Scan||0
3281582|NCT02739789|4015310|FG001|NOT COMPLETED|First fMRI Scan||0
3281583|NCT02739789|4015309|FG000|STARTED|~1 Week Waiting Period||9
3281584|NCT02739789|4015310|FG001|STARTED|~1 Week Waiting Period||10
3281585|NCT02739789|4015309|FG000|COMPLETED|~1 Week Waiting Period||9
3281586|NCT02739789|4015310|FG001|COMPLETED|~1 Week Waiting Period||7
3281587|NCT02739789|4015309|FG000|NOT COMPLETED|~1 Week Waiting Period||0
3281588|NCT02739789|4015310|FG001|NOT COMPLETED|~1 Week Waiting Period||3
3281589|NCT02739789|4015309|FG000|STARTED|Second fMRI Scan||9
3281590|NCT02739789|4015310|FG001|STARTED|Second fMRI Scan||7
3281591|NCT02739789|4015309|FG000|COMPLETED|Second fMRI Scan||9
3281592|NCT02739789|4015310|FG001|COMPLETED|Second fMRI Scan||7
3281593|NCT02739789|4015309|FG000|NOT COMPLETED|Second fMRI Scan||0
3281594|NCT02739789|4015310|FG001|NOT COMPLETED|Second fMRI Scan||0
3281595|NCT02739828|4015316|FG000|STARTED|Overall Study||24
3281596|NCT02739828|4015316|FG000|COMPLETED|Overall Study||19
3281597|NCT02739828|4015316|FG000|NOT COMPLETED|Overall Study||5
3281598|NCT02739984|4015322|FG000|STARTED|Overall Study||143
3281599|NCT02739984|4015323|FG001|STARTED|Overall Study||281
3281600|NCT02739984|4015322|FG000|Received Study Drug|Overall Study||141
3281601|NCT02739984|4015323|FG001|Received Study Drug|Overall Study||280
3281602|NCT02739984|4015322|FG000|COMPLETED|Overall Study||138
3281603|NCT02739984|4015323|FG001|COMPLETED|Overall Study||279
3281604|NCT02739984|4015322|FG000|NOT COMPLETED|Overall Study||5
3281605|NCT02739984|4015323|FG001|NOT COMPLETED|Overall Study||2
3281606|NCT02739997|4015329|FG000|STARTED|Overall Study||100
3281607|NCT02739997|4015329|FG000|COMPLETED|Overall Study||98
3281608|NCT02739997|4015329|FG000|NOT COMPLETED|Overall Study||2
3281609|NCT02740049|4015333|FG000|STARTED|Overall Study||9
3281610|NCT02740049|4015333|FG000|COMPLETED|Overall Study||8
3281611|NCT02740049|4015333|FG000|NOT COMPLETED|Overall Study||1
3281612|NCT02740114|4015339|FG000|STARTED|Overall Study||54
3281613|NCT02740114|4015340|FG001|STARTED|Overall Study||48
3281614|NCT02740114|4015339|FG000|COMPLETED|Overall Study||54
3281615|NCT02740114|4015340|FG001|COMPLETED|Overall Study||48
3281616|NCT02740114|4015339|FG000|NOT COMPLETED|Overall Study||0
3281617|NCT02740114|4015340|FG001|NOT COMPLETED|Overall Study||0
3281618|NCT02740153|4015348|FG000|STARTED|Overall Study||101
3281619|NCT02740153|4015349|FG001|STARTED|Overall Study||86
3281620|NCT02740153|4015348|FG000|COMPLETED|Overall Study||101
3281621|NCT02740153|4015349|FG001|COMPLETED|Overall Study||86
3281622|NCT02740153|4015348|FG000|NOT COMPLETED|Overall Study||0
3281623|NCT02740153|4015349|FG001|NOT COMPLETED|Overall Study||0
3281624|NCT02740413|4015357|FG000|STARTED|Overall Study||86
3281625|NCT02740413|4015357|FG000|COMPLETED|Overall Study||86
3281626|NCT02740413|4015357|FG000|NOT COMPLETED|Overall Study||0
3281627|NCT02740478|4015365|FG000|STARTED|Overall Study|Volunteers recruited until quantity 20 completed the study|21
3281628|NCT02740478|4015365|FG000|COMPLETED|Overall Study|One volunteer was very high BMI and uncomfortable lying still during the recordings: test stopped.|20
3281629|NCT02740478|4015365|FG000|NOT COMPLETED|Overall Study||1
3281630|NCT02740504|4015369|FG000|STARTED|Overall Study||20
3281631|NCT02740504|4015369|FG000|COMPLETED|Overall Study||20
3281632|NCT02740504|4015369|FG000|NOT COMPLETED|Overall Study||0
3281633|NCT02740517|4015376|FG000|STARTED|Overall Study||19
3281634|NCT02740517|4015377|FG001|STARTED|Overall Study||11
3281635|NCT02740517|4015378|FG002|STARTED|Overall Study||18
3281636|NCT02740517|4015376|FG000|COMPLETED|Overall Study||19
3281637|NCT02740517|4015377|FG001|COMPLETED|Overall Study||11
3281638|NCT02740517|4015378|FG002|COMPLETED|Overall Study||18
3281639|NCT02740517|4015376|FG000|NOT COMPLETED|Overall Study||0
3281640|NCT02740517|4015377|FG001|NOT COMPLETED|Overall Study||0
3281641|NCT02740517|4015378|FG002|NOT COMPLETED|Overall Study||0
3281642|NCT02740543|4015388|FG000|STARTED|Overall Study||9
3049802|NCT01213472|3769629|FG000|STARTED|Overall Study||33
3049803|NCT01213472|3769629|FG000|COMPLETED|Overall Study||6
3049804|NCT01213472|3769629|FG000|NOT COMPLETED|Overall Study||27
3049805|NCT01213524|3769635|FG000|STARTED|Baseline|Total number who signed informed consent.|75
3049806|NCT01213524|3769635|FG000|COMPLETED|Baseline|Number of participants who continued in the study past baseline|68
3049807|NCT01213524|3769635|FG000|NOT COMPLETED|Baseline||7
3049808|NCT01213524|3769635|FG000|STARTED|Session 2||68
3049809|NCT01213524|3769635|FG000|COMPLETED|Session 2|Number who continued in the study to the next session|63
3049810|NCT01213524|3769635|FG000|NOT COMPLETED|Session 2||5
3281643|NCT02740543|4015389|FG001|STARTED|Overall Study||9
3281644|NCT02740543|4015388|FG000|COMPLETED|Overall Study||9
3281645|NCT02740543|4015389|FG001|COMPLETED|Overall Study||9
3281646|NCT02740543|4015388|FG000|NOT COMPLETED|Overall Study||0
3281647|NCT02740543|4015389|FG001|NOT COMPLETED|Overall Study||0
3281648|NCT02740582|4015397|FG000|STARTED|First Intervention||29
3281649|NCT02740582|4015398|FG001|STARTED|First Intervention||33
3281650|NCT02740582|4015397|FG000|COMPLETED|First Intervention||24
3281651|NCT02740582|4015398|FG001|COMPLETED|First Intervention||31
3281652|NCT02740582|4015397|FG000|NOT COMPLETED|First Intervention||5
3281653|NCT02740582|4015398|FG001|NOT COMPLETED|First Intervention||2
3281654|NCT02740582|4015397|FG000|STARTED|Washout||24
3281655|NCT02740582|4015398|FG001|STARTED|Washout||31
3281656|NCT02740582|4015397|FG000|COMPLETED|Washout||24
3281657|NCT02740582|4015398|FG001|COMPLETED|Washout||31
3281658|NCT02740582|4015397|FG000|NOT COMPLETED|Washout||0
3281659|NCT02740582|4015398|FG001|NOT COMPLETED|Washout||0
3281660|NCT02740582|4015397|FG000|STARTED|Second Intervention||24
3281661|NCT02740582|4015398|FG001|STARTED|Second Intervention||31
3281662|NCT02740582|4015397|FG000|COMPLETED|Second Intervention||23
3281663|NCT02740582|4015398|FG001|COMPLETED|Second Intervention||28
3281664|NCT02740582|4015397|FG000|NOT COMPLETED|Second Intervention||1
3281665|NCT02740582|4015398|FG001|NOT COMPLETED|Second Intervention||3
3281666|NCT02740660|4015406|FG000|STARTED|Overall Study||6
3281667|NCT02740660|4015407|FG001|STARTED|Overall Study||6
3281668|NCT02740660|4015406|FG000|COMPLETED|Overall Study||6
3281669|NCT02740660|4015407|FG001|COMPLETED|Overall Study||6
3281670|NCT02740660|4015406|FG000|NOT COMPLETED|Overall Study||0
3281671|NCT02740660|4015407|FG001|NOT COMPLETED|Overall Study||0
3281672|NCT02740920|4015413|FG000|STARTED|Overall Study||9
3281673|NCT02740920|4015413|FG000|COMPLETED|Overall Study||9
3281674|NCT02740920|4015413|FG000|NOT COMPLETED|Overall Study||0
3281675|NCT02741076|4015421|FG000|STARTED|Overall Study||13
3281676|NCT02741076|4015422|FG001|STARTED|Overall Study||12
3281677|NCT02741076|4015423|FG002|STARTED|Overall Study||3
3281678|NCT02741076|4015424|FG003|STARTED|Overall Study||4
3281679|NCT02741076|4015421|FG000|COMPLETED|Overall Study||10
3281680|NCT02741076|4015422|FG001|COMPLETED|Overall Study||7
3281681|NCT02741076|4015423|FG002|COMPLETED|Overall Study||1
3281682|NCT02741076|4015424|FG003|COMPLETED|Overall Study||2
3281683|NCT02741076|4015421|FG000|NOT COMPLETED|Overall Study||3
3281684|NCT02741076|4015422|FG001|NOT COMPLETED|Overall Study||5
3281685|NCT02741076|4015423|FG002|NOT COMPLETED|Overall Study||2
3281686|NCT02741076|4015424|FG003|NOT COMPLETED|Overall Study||2
3281687|NCT02741284|4015437|FG000|STARTED|Overall Study||57
3281688|NCT02741284|4015438|FG001|STARTED|Overall Study||57
3281689|NCT02741284|4015437|FG000|COMPLETED|Overall Study||51
3281690|NCT02741284|4015438|FG001|COMPLETED|Overall Study||48
3281691|NCT02741284|4015437|FG000|NOT COMPLETED|Overall Study||6
3281692|NCT02741284|4015438|FG001|NOT COMPLETED|Overall Study||9
3281693|NCT02741297|4015446|FG000|STARTED|Overall Study||73
3281694|NCT02741297|4015446|FG000|COMPLETED|Overall Study||59
3281695|NCT02741297|4015446|FG000|NOT COMPLETED|Overall Study||14
3281696|NCT02741310|4015452|FG000|STARTED|Overall Study||12
3281697|NCT02741310|4015453|FG001|STARTED|Overall Study||22
3281698|NCT02741310|4015452|FG000|COMPLETED|Overall Study||10
3281699|NCT02741310|4015453|FG001|COMPLETED|Overall Study||20
3281700|NCT02741310|4015452|FG000|NOT COMPLETED|Overall Study||2
3281701|NCT02741310|4015453|FG001|NOT COMPLETED|Overall Study||2
3281702|NCT02741518|4015469|FG000|STARTED|Overall Study||11
3281703|NCT02741518|4015470|FG001|STARTED|Overall Study||11
3281704|NCT02741518|4015469|FG000|COMPLETED|Overall Study||10
3281705|NCT02741518|4015470|FG001|COMPLETED|Overall Study||10
3281706|NCT02741518|4015469|FG000|NOT COMPLETED|Overall Study||1
3281707|NCT02741518|4015470|FG001|NOT COMPLETED|Overall Study||1
3281708|NCT02741596|4015478|FG000|STARTED|Overall Study||109
3281709|NCT02741596|4015479|FG001|STARTED|Overall Study||103
3281710|NCT02741596|4015478|FG000|COMPLETED|Overall Study||31
3281711|NCT02741596|4015479|FG001|COMPLETED|Overall Study||25
3281712|NCT02741596|4015478|FG000|NOT COMPLETED|Overall Study||78
3281713|NCT02741596|4015479|FG001|NOT COMPLETED|Overall Study||78
3281714|NCT02741635|4015485|FG000|STARTED|Overall Study||15
3281715|NCT02741635|4015485|FG000|COMPLETED|Overall Study||14
3281716|NCT02741635|4015485|FG000|NOT COMPLETED|Overall Study||1
3281717|NCT02741687|4015492|FG000|STARTED|Overall Study||36
3281718|NCT02741687|4015493|FG001|STARTED|Overall Study||44
3281719|NCT02741687|4015492|FG000|COMPLETED|Overall Study||36
3281720|NCT02741687|4015493|FG001|COMPLETED|Overall Study||44
3281721|NCT02741687|4015492|FG000|NOT COMPLETED|Overall Study||0
3281722|NCT02741687|4015493|FG001|NOT COMPLETED|Overall Study||0
3281723|NCT02741713|4015501|FG000|STARTED|Overall Study||20
3281724|NCT02741713|4015502|FG001|STARTED|Overall Study||20
3281725|NCT02741713|4015501|FG000|COMPLETED|Overall Study||18
3049811|NCT01213524|3769635|FG000|STARTED|Session 3||63
3049812|NCT01213524|3769635|FG000|COMPLETED|Session 3|Number who continued in study to next session|59
3049813|NCT01213524|3769635|FG000|NOT COMPLETED|Session 3||4
3049814|NCT01213524|3769635|FG000|STARTED|Session 4||59
3049815|NCT01213524|3769635|FG000|COMPLETED|Session 4|Number who continued in the study to the next session|56
3049816|NCT01213524|3769635|FG000|NOT COMPLETED|Session 4||3
3049817|NCT01213524|3769635|FG000|STARTED|Session 5||56
3049818|NCT01213524|3769635|FG000|COMPLETED|Session 5|Number who continued in the study to the next session|56
3049819|NCT01213524|3769635|FG000|NOT COMPLETED|Session 5||0
3049820|NCT01213524|3769635|FG000|STARTED|Session 6||56
3049821|NCT01213524|3769635|FG000|COMPLETED|Session 6|Number who continued in the study to the next session|56
3049822|NCT01213524|3769635|FG000|NOT COMPLETED|Session 6||0
3049823|NCT01213524|3769635|FG000|STARTED|Session 7||56
3049824|NCT01213524|3769635|FG000|COMPLETED|Session 7||56
3049825|NCT01213524|3769635|FG000|NOT COMPLETED|Session 7||0
3049826|NCT01213576|3769650|FG000|STARTED|Overall Study||18
3049827|NCT01213576|3769651|FG001|STARTED|Overall Study||17
3049828|NCT01213576|3769652|FG002|STARTED|Overall Study||18
3049829|NCT01213576|3769653|FG003|STARTED|Overall Study||17
3049830|NCT01213576|3769650|FG000|COMPLETED|Overall Study||15
3049831|NCT01213576|3769651|FG001|COMPLETED|Overall Study||13
3049832|NCT01213576|3769652|FG002|COMPLETED|Overall Study||13
3049833|NCT01213576|3769653|FG003|COMPLETED|Overall Study||13
3049834|NCT01213576|3769650|FG000|NOT COMPLETED|Overall Study||3
3049835|NCT01213576|3769651|FG001|NOT COMPLETED|Overall Study||4
3049836|NCT01213576|3769652|FG002|NOT COMPLETED|Overall Study||5
3049837|NCT01213576|3769653|FG003|NOT COMPLETED|Overall Study||4
3049838|NCT01213589|3769666|FG000|STARTED|Overall Study||50
3049839|NCT01213589|3769667|FG001|STARTED|Overall Study||24
3049840|NCT01213589|3769668|FG002|STARTED|Overall Study||26
3049841|NCT01213589|3769666|FG000|COMPLETED|Overall Study||37
3049842|NCT01213589|3769667|FG001|COMPLETED|Overall Study||19
3049843|NCT01213589|3769668|FG002|COMPLETED|Overall Study||18
3049844|NCT01213589|3769666|FG000|NOT COMPLETED|Overall Study||13
3049845|NCT01213589|3769667|FG001|NOT COMPLETED|Overall Study||5
3049846|NCT01213589|3769668|FG002|NOT COMPLETED|Overall Study||8
3049847|NCT01213706|3769676|FG000|STARTED|Sham WBPA||45
3049848|NCT01213706|3769676|FG000|COMPLETED|Sham WBPA||45
3049849|NCT01213706|3769676|FG000|NOT COMPLETED|Sham WBPA||0
3049850|NCT01213706|3769676|FG000|STARTED|Washout (1 Hour)||45
3049851|NCT01213706|3769676|FG000|COMPLETED|Washout (1 Hour)||45
3049852|NCT01213706|3769676|FG000|NOT COMPLETED|Washout (1 Hour)||0
3049853|NCT01213706|3769676|FG000|STARTED|WBPA||45
3049854|NCT01213706|3769676|FG000|COMPLETED|WBPA||45
3049855|NCT01213706|3769676|FG000|NOT COMPLETED|WBPA||0
3049856|NCT01213823|3769684|FG000|STARTED|Overall Study||69
3049857|NCT01213823|3769685|FG001|STARTED|Overall Study||467
3049858|NCT01213823|3769684|FG000|COMPLETED|Overall Study||69
3049859|NCT01213823|3769685|FG001|COMPLETED|Overall Study||467
3049860|NCT01213823|3769684|FG000|NOT COMPLETED|Overall Study||0
3049861|NCT01213823|3769685|FG001|NOT COMPLETED|Overall Study||0
3049862|NCT01213836|3769693|FG000|STARTED|Period 1, First Intervention||34
3049863|NCT01213836|3769694|FG001|STARTED|Period 1, First Intervention||32
3049864|NCT01213836|3769693|FG000|COMPLETED|Period 1, First Intervention||31
3049865|NCT01213836|3769694|FG001|COMPLETED|Period 1, First Intervention||29
3049866|NCT01213836|3769693|FG000|NOT COMPLETED|Period 1, First Intervention||3
3049867|NCT01213836|3769694|FG001|NOT COMPLETED|Period 1, First Intervention||3
3049868|NCT01213836|3769693|FG000|STARTED|Period 2, Second Intervention||31
3049869|NCT01213836|3769694|FG001|STARTED|Period 2, Second Intervention||29
3049870|NCT01213836|3769693|FG000|COMPLETED|Period 2, Second Intervention||31
3049871|NCT01213836|3769694|FG001|COMPLETED|Period 2, Second Intervention||29
3049872|NCT01213836|3769693|FG000|NOT COMPLETED|Period 2, Second Intervention||0
3049873|NCT01213836|3769694|FG001|NOT COMPLETED|Period 2, Second Intervention||0
3049874|NCT01213940|3769705|FG000|STARTED|Overall Study||14
3049875|NCT01213940|3769706|FG001|STARTED|Overall Study||6
3049876|NCT01213940|3769705|FG000|COMPLETED|Overall Study||14
3049877|NCT01213940|3769706|FG001|COMPLETED|Overall Study||6
3049878|NCT01213940|3769705|FG000|NOT COMPLETED|Overall Study||0
3049879|NCT01213940|3769706|FG001|NOT COMPLETED|Overall Study||0
3049880|NCT01213966|3769716|FG000|STARTED|Overall Study||20
3049881|NCT01213966|3769717|FG001|STARTED|Overall Study||20
3049882|NCT01213966|3769718|FG002|STARTED|Overall Study||20
3049883|NCT01213966|3769719|FG003|STARTED|Overall Study||21
3049884|NCT01213966|3769716|FG000|COMPLETED|Overall Study||19
3049885|NCT01213966|3769717|FG001|COMPLETED|Overall Study||20
3049886|NCT01213966|3769718|FG002|COMPLETED|Overall Study||17
3049887|NCT01213966|3769719|FG003|COMPLETED|Overall Study||20
3049888|NCT01213966|3769716|FG000|NOT COMPLETED|Overall Study||1
3049889|NCT01213966|3769717|FG001|NOT COMPLETED|Overall Study||0
3049890|NCT01213966|3769718|FG002|NOT COMPLETED|Overall Study||3
3049891|NCT01213966|3769719|FG003|NOT COMPLETED|Overall Study||1
3049892|NCT01214044|3769729|FG000|STARTED|Visit 1: Screening and Consent, Washout||31
3049893|NCT01214044|3769729|FG000|COMPLETED|Visit 1: Screening and Consent, Washout||19
3049894|NCT01214044|3769729|FG000|NOT COMPLETED|Visit 1: Screening and Consent, Washout||12
3049895|NCT01214044|3769729|FG000|STARTED|Visit 2: End Washout & Start Placebo||19
3049896|NCT01214044|3769729|FG000|COMPLETED|Visit 2: End Washout & Start Placebo|2 subjects dropped out during the placebo week (between study visits 2 & 3)|17
3049897|NCT01214044|3769729|FG000|NOT COMPLETED|Visit 2: End Washout & Start Placebo||2
3049898|NCT01214044|3769729|FG000|STARTED|Visits 3-5: Escitalopram 10 mg Daily||17
3049899|NCT01214044|3769729|FG000|COMPLETED|Visits 3-5: Escitalopram 10 mg Daily||14
3049900|NCT01214044|3769729|FG000|NOT COMPLETED|Visits 3-5: Escitalopram 10 mg Daily||3
3049901|NCT01214044|3769729|FG000|STARTED|Visits 6-11: Escitalopram 20 mg Daily||14
3049902|NCT01214044|3769729|FG000|COMPLETED|Visits 6-11: Escitalopram 20 mg Daily||10
3049903|NCT01214044|3769729|FG000|NOT COMPLETED|Visits 6-11: Escitalopram 20 mg Daily||4
3049904|NCT01214057|3769739|FG000|STARTED|Overall Study||12
3049905|NCT01214057|3769740|FG001|STARTED|Overall Study||11
3049906|NCT01214057|3769739|FG000|COMPLETED|Overall Study||12
3049907|NCT01214057|3769740|FG001|COMPLETED|Overall Study||11
3049908|NCT01214057|3769739|FG000|NOT COMPLETED|Overall Study||0
3049909|NCT01214057|3769740|FG001|NOT COMPLETED|Overall Study||0
3049910|NCT01214083|3769749|FG000|STARTED|Overall Study||31
3049911|NCT01214083|3769750|FG001|STARTED|Overall Study||33
3049912|NCT01214083|3769751|FG002|STARTED|Overall Study||31
3049913|NCT01214083|3769749|FG000|COMPLETED|Overall Study||19
3049914|NCT01214083|3769750|FG001|COMPLETED|Overall Study||23
3049915|NCT01214083|3769751|FG002|COMPLETED|Overall Study||21
3049916|NCT01214083|3769749|FG000|NOT COMPLETED|Overall Study||12
3049917|NCT01214083|3769750|FG001|NOT COMPLETED|Overall Study||10
3049918|NCT01214083|3769751|FG002|NOT COMPLETED|Overall Study||10
3049919|NCT01214109|3769759|FG000|STARTED|Overall Study||24
3049920|NCT01214109|3769760|FG001|STARTED|Overall Study||24
3049921|NCT01214109|3769761|FG002|STARTED|Overall Study||24
3049922|NCT01214109|3769762|FG003|STARTED|Overall Study||24
3049923|NCT01214109|3769759|FG000|COMPLETED|Overall Study||24
3049924|NCT01214109|3769760|FG001|COMPLETED|Overall Study||24
3049925|NCT01214109|3769761|FG002|COMPLETED|Overall Study||24
3049926|NCT01214109|3769762|FG003|COMPLETED|Overall Study||24
3049927|NCT01214109|3769759|FG000|NOT COMPLETED|Overall Study||0
3049928|NCT01214109|3769760|FG001|NOT COMPLETED|Overall Study||0
3049929|NCT01214109|3769761|FG002|NOT COMPLETED|Overall Study||0
3049930|NCT01214109|3769762|FG003|NOT COMPLETED|Overall Study||0
3049931|NCT01214161|3769777|FG000|STARTED|Overall Study||100
3049932|NCT01214161|3769778|FG001|STARTED|Overall Study||100
3049933|NCT01214161|3769777|FG000|COMPLETED|Overall Study||100
3049934|NCT01214161|3769778|FG001|COMPLETED|Overall Study||100
3049935|NCT01214161|3769777|FG000|NOT COMPLETED|Overall Study||0
3049936|NCT01214161|3769778|FG001|NOT COMPLETED|Overall Study||0
3049937|NCT01214174|3769789|FG000|STARTED|Overall Study||13
3049938|NCT01214174|3769790|FG001|STARTED|Overall Study||16
3049939|NCT01214174|3769791|FG002|STARTED|Overall Study||14
3049940|NCT01214174|3769789|FG000|COMPLETED|Overall Study||13
3049941|NCT01214174|3769790|FG001|COMPLETED|Overall Study||16
3049942|NCT01214174|3769791|FG002|COMPLETED|Overall Study||13
3049943|NCT01214174|3769789|FG000|NOT COMPLETED|Overall Study||0
3049944|NCT01214174|3769790|FG001|NOT COMPLETED|Overall Study||0
3049945|NCT01214174|3769791|FG002|NOT COMPLETED|Overall Study||1
3049946|NCT01214187|3769801|FG000|STARTED|Overall Study||29
3049947|NCT01214187|3769802|FG001|STARTED|Overall Study||29
3049948|NCT01214187|3769801|FG000|COMPLETED|Overall Study||22
3049949|NCT01214187|3769802|FG001|COMPLETED|Overall Study||23
3049950|NCT01214187|3769801|FG000|NOT COMPLETED|Overall Study||7
3049951|NCT01214187|3769802|FG001|NOT COMPLETED|Overall Study||6
3049952|NCT01214200|3769808|FG000|STARTED|Overall Study||20
3049953|NCT01214200|3769808|FG000|COMPLETED|Overall Study||9
3049954|NCT01214200|3769808|FG000|NOT COMPLETED|Overall Study||11
3049955|NCT01214239|3769816|FG000|STARTED|Overall Study|patients who were randomised and treated with placebo|99
3049956|NCT01214239|3769817|FG001|STARTED|Overall Study|patients who were randomised and treated with placebo. 1 patient was not treated then not included|200
3049957|NCT01214239|3769816|FG000|COMPLETED|Overall Study||87
3049958|NCT01214239|3769817|FG001|COMPLETED|Overall Study||182
3049959|NCT01214239|3769816|FG000|NOT COMPLETED|Overall Study||12
3049960|NCT01214239|3769817|FG001|NOT COMPLETED|Overall Study||18
3049961|NCT01214252|3769823|FG000|STARTED|Overall Study||425
3049962|NCT01214252|3769823|FG000|COMPLETED|Overall Study||343
3049963|NCT01214252|3769823|FG000|NOT COMPLETED|Overall Study||82
3049964|NCT01214317|3769830|FG000|STARTED|Overall Study||18
3049965|NCT01214317|3769831|FG001|STARTED|Overall Study||22
3049966|NCT01214317|3769830|FG000|COMPLETED|Overall Study||18
3049967|NCT01214317|3769831|FG001|COMPLETED|Overall Study||22
3049968|NCT01214317|3769830|FG000|NOT COMPLETED|Overall Study||0
3049969|NCT01214317|3769831|FG001|NOT COMPLETED|Overall Study||0
3049970|NCT01214330|3769839|FG000|STARTED|Overall Study||150
3049971|NCT01214330|3769839|FG000|COMPLETED|Overall Study||102
3049972|NCT01214330|3769839|FG000|NOT COMPLETED|Overall Study||48
3049973|NCT01214356|3769845|FG000|STARTED|Overall Study||27
3049974|NCT01214356|3769846|FG001|STARTED|Overall Study||27
3281726|NCT02741713|4015502|FG001|COMPLETED|Overall Study||19
3281727|NCT02741713|4015501|FG000|NOT COMPLETED|Overall Study||2
3281728|NCT02741713|4015502|FG001|NOT COMPLETED|Overall Study||1
3281729|NCT02742077|4015509|FG000|STARTED|Overall Study||20
3281730|NCT02742077|4015509|FG000|COMPLETED|Overall Study||20
3281731|NCT02742077|4015509|FG000|NOT COMPLETED|Overall Study||0
3281732|NCT02742103|4015515|FG000|STARTED|Overall Study||55
3281733|NCT02742103|4015516|FG001|STARTED|Overall Study||28
3049975|NCT01214356|3769845|FG000|COMPLETED|Overall Study||10
3049976|NCT01214356|3769846|FG001|COMPLETED|Overall Study||13
3049977|NCT01214356|3769845|FG000|NOT COMPLETED|Overall Study||17
3049978|NCT01214356|3769846|FG001|NOT COMPLETED|Overall Study||14
3049979|NCT01214395|3769852|FG000|STARTED|Overall Study||5
3049980|NCT01214395|3769852|FG000|COMPLETED|Overall Study||0
3281734|NCT02742103|4015515|FG000|COMPLETED|Overall Study||46
3049981|NCT01214395|3769852|FG000|NOT COMPLETED|Overall Study||5
3049982|NCT01214421|3769861|FG000|STARTED|Overall Study||557
3049983|NCT01214421|3769862|FG001|STARTED|Overall Study||314
3049984|NCT01214421|3769863|FG002|STARTED|Overall Study||181
3049985|NCT01214421|3769864|FG003|STARTED|Overall Study||31
3049986|NCT01214421|3769861|FG000|COMPLETED|Overall Study||507
3049987|NCT01214421|3769862|FG001|COMPLETED|Overall Study||256
3049988|NCT01214421|3769863|FG002|COMPLETED|Overall Study||143
3281735|NCT02742103|4015516|FG001|COMPLETED|Overall Study||23
3281736|NCT02742103|4015515|FG000|NOT COMPLETED|Overall Study||9
3281737|NCT02742103|4015516|FG001|NOT COMPLETED|Overall Study||5
3049989|NCT01214421|3769864|FG003|COMPLETED|Overall Study||22
3049990|NCT01214421|3769861|FG000|NOT COMPLETED|Overall Study||50
3049991|NCT01214421|3769862|FG001|NOT COMPLETED|Overall Study||58
3049992|NCT01214421|3769863|FG002|NOT COMPLETED|Overall Study||38
3049993|NCT01214421|3769864|FG003|NOT COMPLETED|Overall Study||9
3049994|NCT01214434|3769876|FG000|STARTED|Overall Study||15
3049995|NCT01214434|3769877|FG001|STARTED|Overall Study||27
3049996|NCT01214434|3769876|FG000|COMPLETED|Overall Study||11
3049997|NCT01214434|3769877|FG001|COMPLETED|Overall Study||25
3049998|NCT01214434|3769876|FG000|NOT COMPLETED|Overall Study||4
3049999|NCT01214434|3769877|FG001|NOT COMPLETED|Overall Study||2
3050000|NCT01214603|3769886|FG000|STARTED|Overall Study||7
3050001|NCT01214603|3769887|FG001|STARTED|Overall Study||6
3050002|NCT01214603|3769888|FG002|STARTED|Overall Study||7
3050003|NCT01214603|3769886|FG000|Received at Least 1 Dose of LY2090314|Overall Study||7
3050004|NCT01214603|3769887|FG001|Received at Least 1 Dose of LY2090314|Overall Study||6
3050005|NCT01214603|3769888|FG002|Received at Least 1 Dose of LY2090314|Overall Study||7
3050006|NCT01214603|3769886|FG000|COMPLETED|Overall Study||2
3050007|NCT01214603|3769887|FG001|COMPLETED|Overall Study||5
3050008|NCT01214603|3769888|FG002|COMPLETED|Overall Study||3
3050009|NCT01214603|3769886|FG000|NOT COMPLETED|Overall Study||5
3050010|NCT01214603|3769887|FG001|NOT COMPLETED|Overall Study||1
3050011|NCT01214603|3769888|FG002|NOT COMPLETED|Overall Study||4
3050012|NCT01214616|3769901|FG000|STARTED|Overall Study||3
3050013|NCT01214616|3769902|FG001|STARTED|Overall Study||5
3050014|NCT01214616|3769903|FG002|STARTED|Overall Study||3
3050015|NCT01214616|3769904|FG003|STARTED|Overall Study|Cohort 3 with afatinib/vinorelbine modification. Skipping vinorelbine allowed and not considered DLT|6
3050016|NCT01214616|3769901|FG000|COMPLETED|Overall Study||0
3281738|NCT02742129|4015524|FG000|STARTED|Phase 1||53
3281739|NCT02742129|4015525|FG001|STARTED|Phase 1||52
3281740|NCT02742129|4015524|FG000|COMPLETED|Phase 1||51
3281741|NCT02742129|4015525|FG001|COMPLETED|Phase 1||50
3281742|NCT02742129|4015524|FG000|NOT COMPLETED|Phase 1||2
3281743|NCT02742129|4015525|FG001|NOT COMPLETED|Phase 1||2
3281744|NCT02742129|4015524|FG000|STARTED|Phase 2||51
3281745|NCT02742129|4015525|FG001|STARTED|Phase 2||50
3281746|NCT02742129|4015524|FG000|COMPLETED|Phase 2||50
3281747|NCT02742129|4015525|FG001|COMPLETED|Phase 2||48
3281748|NCT02742129|4015524|FG000|NOT COMPLETED|Phase 2||1
3281749|NCT02742129|4015525|FG001|NOT COMPLETED|Phase 2||2
3281750|NCT02742441|4015536|FG000|STARTED|Overall Study||205
3281751|NCT02742441|4015537|FG001|STARTED|Overall Study||204
3281752|NCT02742441|4015536|FG000|COMPLETED|Overall Study||199
3281753|NCT02742441|4015537|FG001|COMPLETED|Overall Study||196
3281754|NCT02742441|4015536|FG000|NOT COMPLETED|Overall Study||6
3281755|NCT02742441|4015537|FG001|NOT COMPLETED|Overall Study||8
3281756|NCT02742519|4015545|FG000|STARTED|Part 1 Treatment Period 1 (8 Weeks)||8
3281757|NCT02742519|4015546|FG001|STARTED|Part 1 Treatment Period 1 (8 Weeks)||6
3281758|NCT02742519|4015547|FG002|STARTED|Part 1 Treatment Period 1 (8 Weeks)||0
3281759|NCT02742519|4015545|FG000|COMPLETED|Part 1 Treatment Period 1 (8 Weeks)||8
3281760|NCT02742519|4015546|FG001|COMPLETED|Part 1 Treatment Period 1 (8 Weeks)||6
3281761|NCT02742519|4015547|FG002|COMPLETED|Part 1 Treatment Period 1 (8 Weeks)||0
3281762|NCT02742519|4015545|FG000|NOT COMPLETED|Part 1 Treatment Period 1 (8 Weeks)||0
3281763|NCT02742519|4015546|FG001|NOT COMPLETED|Part 1 Treatment Period 1 (8 Weeks)||0
3281764|NCT02742519|4015547|FG002|NOT COMPLETED|Part 1 Treatment Period 1 (8 Weeks)||0
3281765|NCT02742519|4015545|FG000|STARTED|Part 1 Treatment Period 2 (8 Weeks)||8
3281766|NCT02742519|4015546|FG001|STARTED|Part 1 Treatment Period 2 (8 Weeks)||6
3281767|NCT02742519|4015547|FG002|STARTED|Part 1 Treatment Period 2 (8 Weeks)||0
3281768|NCT02742519|4015545|FG000|COMPLETED|Part 1 Treatment Period 2 (8 Weeks)||7
3281769|NCT02742519|4015546|FG001|COMPLETED|Part 1 Treatment Period 2 (8 Weeks)||5
3281770|NCT02742519|4015547|FG002|COMPLETED|Part 1 Treatment Period 2 (8 Weeks)||0
3281771|NCT02742519|4015545|FG000|NOT COMPLETED|Part 1 Treatment Period 2 (8 Weeks)||1
3281772|NCT02742519|4015546|FG001|NOT COMPLETED|Part 1 Treatment Period 2 (8 Weeks)||1
3281773|NCT02742519|4015547|FG002|NOT COMPLETED|Part 1 Treatment Period 2 (8 Weeks)||0
3281774|NCT02742519|4015545|FG000|STARTED|Part 2 Open Label Period (32 Weeks)||0
3281775|NCT02742519|4015546|FG001|STARTED|Part 2 Open Label Period (32 Weeks)||0
3281776|NCT02742519|4015547|FG002|STARTED|Part 2 Open Label Period (32 Weeks)|Of 12 participants who completed DB period, only 10 entered OL period & 2 opted for commercial drug.|10
3281777|NCT02742519|4015545|FG000|COMPLETED|Part 2 Open Label Period (32 Weeks)||0
3281778|NCT02742519|4015546|FG001|COMPLETED|Part 2 Open Label Period (32 Weeks)||0
3281779|NCT02742519|4015547|FG002|COMPLETED|Part 2 Open Label Period (32 Weeks)||0
3281780|NCT02742519|4015545|FG000|NOT COMPLETED|Part 2 Open Label Period (32 Weeks)||0
3050017|NCT01214616|3769902|FG001|COMPLETED|Overall Study||0
3050018|NCT01214616|3769903|FG002|COMPLETED|Overall Study||0
3050019|NCT01214616|3769904|FG003|COMPLETED|Overall Study||0
3050020|NCT01214616|3769901|FG000|NOT COMPLETED|Overall Study||3
3050021|NCT01214616|3769902|FG001|NOT COMPLETED|Overall Study||5
3050022|NCT01214616|3769903|FG002|NOT COMPLETED|Overall Study||3
3050023|NCT01214616|3769904|FG003|NOT COMPLETED|Overall Study||6
3050024|NCT01214629|3769933|FG000|STARTED|Overall Study||1
3050025|NCT01214629|3769934|FG001|STARTED|Overall Study||1
3050026|NCT01214629|3769935|FG002|STARTED|Overall Study||1
3050027|NCT01214629|3769936|FG003|STARTED|Overall Study||3
3050028|NCT01214629|3769937|FG004|STARTED|Overall Study||3
3050029|NCT01214629|3769938|FG005|STARTED|Overall Study||13
3050030|NCT01214629|3769939|FG006|STARTED|Overall Study||5
3050031|NCT01214629|3769940|FG007|STARTED|Overall Study||3
3050032|NCT01214629|3769941|FG008|STARTED|Overall Study||3
3050033|NCT01214629|3769942|FG009|STARTED|Overall Study||18
3050034|NCT01214629|3769943|FG010|STARTED|Overall Study||3
3050035|NCT01214629|3769933|FG000|Received at Least 1 Dose of Study Drug|Overall Study||1
3050036|NCT01214629|3769934|FG001|Received at Least 1 Dose of Study Drug|Overall Study||1
3050037|NCT01214629|3769935|FG002|Received at Least 1 Dose of Study Drug|Overall Study||1
3050038|NCT01214629|3769936|FG003|Received at Least 1 Dose of Study Drug|Overall Study||3
3050039|NCT01214629|3769937|FG004|Received at Least 1 Dose of Study Drug|Overall Study||3
3050040|NCT01214629|3769938|FG005|Received at Least 1 Dose of Study Drug|Overall Study||13
3050041|NCT01214629|3769939|FG006|Received at Least 1 Dose of Study Drug|Overall Study||5
3050042|NCT01214629|3769940|FG007|Received at Least 1 Dose of Study Drug|Overall Study||3
3050043|NCT01214629|3769941|FG008|Received at Least 1 Dose of Study Drug|Overall Study||3
3050044|NCT01214629|3769942|FG009|Received at Least 1 Dose of Study Drug|Overall Study||18
3050045|NCT01214629|3769943|FG010|Received at Least 1 Dose of Study Drug|Overall Study||3
3050046|NCT01214629|3769933|FG000|COMPLETED|Overall Study||0
3050047|NCT01214629|3769934|FG001|COMPLETED|Overall Study||0
3050048|NCT01214629|3769935|FG002|COMPLETED|Overall Study||1
3050049|NCT01214629|3769936|FG003|COMPLETED|Overall Study||1
3050050|NCT01214629|3769937|FG004|COMPLETED|Overall Study||1
3050051|NCT01214629|3769938|FG005|COMPLETED|Overall Study||9
3050052|NCT01214629|3769939|FG006|COMPLETED|Overall Study||4
3050053|NCT01214629|3769940|FG007|COMPLETED|Overall Study||2
3050054|NCT01214629|3769941|FG008|COMPLETED|Overall Study||2
3050055|NCT01214629|3769942|FG009|COMPLETED|Overall Study||11
3050056|NCT01214629|3769943|FG010|COMPLETED|Overall Study||1
3050057|NCT01214629|3769933|FG000|NOT COMPLETED|Overall Study||1
3050058|NCT01214629|3769934|FG001|NOT COMPLETED|Overall Study||1
3050059|NCT01214629|3769935|FG002|NOT COMPLETED|Overall Study||0
3050060|NCT01214629|3769936|FG003|NOT COMPLETED|Overall Study||2
3050061|NCT01214629|3769937|FG004|NOT COMPLETED|Overall Study||2
3050062|NCT01214629|3769938|FG005|NOT COMPLETED|Overall Study||4
3050063|NCT01214629|3769939|FG006|NOT COMPLETED|Overall Study||1
3050064|NCT01214629|3769940|FG007|NOT COMPLETED|Overall Study||1
3050065|NCT01214629|3769941|FG008|NOT COMPLETED|Overall Study||1
3050066|NCT01214629|3769942|FG009|NOT COMPLETED|Overall Study||7
3050067|NCT01214629|3769943|FG010|NOT COMPLETED|Overall Study||2
3050068|NCT01214642|3769993|FG000|STARTED|Overall Study||3
3050069|NCT01214642|3769994|FG001|STARTED|Overall Study||3
3050070|NCT01214642|3769995|FG002|STARTED|Overall Study||6
3050071|NCT01214642|3769996|FG003|STARTED|Overall Study||6
3050072|NCT01214642|3769997|FG004|STARTED|Overall Study||6
3050073|NCT01214642|3769998|FG005|STARTED|Overall Study||3
3050074|NCT01214642|3769999|FG006|STARTED|Overall Study||6
3050075|NCT01214642|3770000|FG007|STARTED|Overall Study||3
3050076|NCT01214642|3770001|FG008|STARTED|Overall Study|All participants who received 12 mg/m2/day on Days 1 and 5 plus PEG in Part A and Part B.|13
3050077|NCT01214642|3770002|FG009|STARTED|Overall Study||4
3050078|NCT01214642|3770003|FG010|STARTED|Overall Study||4
3050079|NCT01214642|3770004|FG011|STARTED|Overall Study||6
3050080|NCT01214642|3769993|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
3050081|NCT01214642|3769994|FG001|Received at Least 1 Dose of Study Drug|Overall Study||3
3050082|NCT01214642|3769995|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
3050083|NCT01214642|3769996|FG003|Received at Least 1 Dose of Study Drug|Overall Study||6
3050084|NCT01214642|3769997|FG004|Received at Least 1 Dose of Study Drug|Overall Study||6
3050085|NCT01214642|3769998|FG005|Received at Least 1 Dose of Study Drug|Overall Study||3
3050086|NCT01214642|3769999|FG006|Received at Least 1 Dose of Study Drug|Overall Study||6
3050087|NCT01214642|3770000|FG007|Received at Least 1 Dose of Study Drug|Overall Study||3
3050088|NCT01214642|3770001|FG008|Received at Least 1 Dose of Study Drug|Overall Study||13
3050089|NCT01214642|3770002|FG009|Received at Least 1 Dose of Study Drug|Overall Study||4
3050090|NCT01214642|3770003|FG010|Received at Least 1 Dose of Study Drug|Overall Study||4
3050091|NCT01214642|3770004|FG011|Received at Least 1 Dose of Study Drug|Overall Study||6
3050092|NCT01214642|3769993|FG000|Complete at Least 2 Cycles of Study Drug|Overall Study||3
3050093|NCT01214642|3769994|FG001|Complete at Least 2 Cycles of Study Drug|Overall Study||1
3050094|NCT01214642|3769995|FG002|Complete at Least 2 Cycles of Study Drug|Overall Study||5
3050095|NCT01214642|3769996|FG003|Complete at Least 2 Cycles of Study Drug|Overall Study||4
3050096|NCT01214642|3769997|FG004|Complete at Least 2 Cycles of Study Drug|Overall Study||6
3050097|NCT01214642|3769998|FG005|Complete at Least 2 Cycles of Study Drug|Overall Study||1
3050098|NCT01214642|3769999|FG006|Complete at Least 2 Cycles of Study Drug|Overall Study||6
3050099|NCT01214642|3770000|FG007|Complete at Least 2 Cycles of Study Drug|Overall Study||3
3050100|NCT01214642|3770001|FG008|Complete at Least 2 Cycles of Study Drug|Overall Study||12
3050101|NCT01214642|3770002|FG009|Complete at Least 2 Cycles of Study Drug|Overall Study||2
3050102|NCT01214642|3770003|FG010|Complete at Least 2 Cycles of Study Drug|Overall Study||2
3050103|NCT01214642|3770004|FG011|Complete at Least 2 Cycles of Study Drug|Overall Study||5
3050104|NCT01214642|3769993|FG000|COMPLETED|Overall Study||0
3050105|NCT01214642|3769994|FG001|COMPLETED|Overall Study||0
3050106|NCT01214642|3769995|FG002|COMPLETED|Overall Study||0
3050107|NCT01214642|3769996|FG003|COMPLETED|Overall Study||0
3050108|NCT01214642|3769997|FG004|COMPLETED|Overall Study||0
3050109|NCT01214642|3769998|FG005|COMPLETED|Overall Study||0
3050110|NCT01214642|3769999|FG006|COMPLETED|Overall Study||0
3050111|NCT01214642|3770000|FG007|COMPLETED|Overall Study||0
3050112|NCT01214642|3770001|FG008|COMPLETED|Overall Study||0
3050113|NCT01214642|3770002|FG009|COMPLETED|Overall Study||0
3050114|NCT01214642|3770003|FG010|COMPLETED|Overall Study||0
3050115|NCT01214642|3770004|FG011|COMPLETED|Overall Study||0
3050116|NCT01214642|3769993|FG000|NOT COMPLETED|Overall Study||3
3050117|NCT01214642|3769994|FG001|NOT COMPLETED|Overall Study||3
3050118|NCT01214642|3769995|FG002|NOT COMPLETED|Overall Study||6
3050119|NCT01214642|3769996|FG003|NOT COMPLETED|Overall Study||6
3050120|NCT01214642|3769997|FG004|NOT COMPLETED|Overall Study||6
3050121|NCT01214642|3769998|FG005|NOT COMPLETED|Overall Study||3
3050122|NCT01214642|3769999|FG006|NOT COMPLETED|Overall Study||6
3050123|NCT01214642|3770000|FG007|NOT COMPLETED|Overall Study||3
3050124|NCT01214642|3770001|FG008|NOT COMPLETED|Overall Study||13
3050125|NCT01214642|3770002|FG009|NOT COMPLETED|Overall Study||4
3050126|NCT01214642|3770003|FG010|NOT COMPLETED|Overall Study||4
3050127|NCT01214642|3770004|FG011|NOT COMPLETED|Overall Study||6
3050128|NCT01214655|3770050|FG000|STARTED|Part A|Total on Schedule A, dose days 1,2,3|10
3050129|NCT01214655|3770051|FG001|STARTED|Part A||0
3050130|NCT01214655|3770052|FG002|STARTED|Part A||0
3050131|NCT01214655|3770050|FG000|Received 2 mg Study Drug|Part A||3
3050132|NCT01214655|3770051|FG001|Received 2 mg Study Drug|Part A||0
3050133|NCT01214655|3770052|FG002|Received 2 mg Study Drug|Part A||0
3050134|NCT01214655|3770050|FG000|Escalated From 2 to 4 mg/m²/Day|Part A||3
3050135|NCT01214655|3770051|FG001|Escalated From 2 to 4 mg/m²/Day|Part A||0
3050136|NCT01214655|3770052|FG002|Escalated From 2 to 4 mg/m²/Day|Part A||0
3050137|NCT01214655|3770050|FG000|Joined 4 mg Group|Part A||1
3050138|NCT01214655|3770051|FG001|Joined 4 mg Group|Part A||0
3050139|NCT01214655|3770052|FG002|Joined 4 mg Group|Part A||0
3281781|NCT02742519|4015546|FG001|NOT COMPLETED|Part 2 Open Label Period (32 Weeks)||0
3281782|NCT02742519|4015547|FG002|NOT COMPLETED|Part 2 Open Label Period (32 Weeks)||10
3281783|NCT02742532|4015557|FG000|STARTED|Overall Study||31
3281784|NCT02742532|4015558|FG001|STARTED|Overall Study||32
3281785|NCT02742532|4015557|FG000|COMPLETED|Overall Study||28
3281786|NCT02742532|4015558|FG001|COMPLETED|Overall Study||31
3281787|NCT02742532|4015557|FG000|NOT COMPLETED|Overall Study||3
3281788|NCT02742532|4015558|FG001|NOT COMPLETED|Overall Study||1
3281789|NCT02742649|4015567|FG000|STARTED|Pre-Randomization Washout Period||55
3281790|NCT02742649|4015568|FG001|STARTED|Pre-Randomization Washout Period||0
3281791|NCT02742649|4015569|FG002|STARTED|Pre-Randomization Washout Period||0
3281792|NCT02742649|4015570|FG003|STARTED|Pre-Randomization Washout Period||0
3281793|NCT02742649|4015571|FG004|STARTED|Pre-Randomization Washout Period||0
3281794|NCT02742649|4015567|FG000|COMPLETED|Pre-Randomization Washout Period||50
3281795|NCT02742649|4015568|FG001|COMPLETED|Pre-Randomization Washout Period||0
3281796|NCT02742649|4015569|FG002|COMPLETED|Pre-Randomization Washout Period||0
3281797|NCT02742649|4015570|FG003|COMPLETED|Pre-Randomization Washout Period||0
3281798|NCT02742649|4015571|FG004|COMPLETED|Pre-Randomization Washout Period||0
3050140|NCT01214655|3770050|FG000|Escalated From 4 mg Study Drug|Part A||0
3050141|NCT01214655|3770051|FG001|Escalated From 4 mg Study Drug|Part A||0
3050142|NCT01214655|3770052|FG002|Escalated From 4 mg Study Drug|Part A||0
3050143|NCT01214655|3770050|FG000|Joined 5 mg Study Drug|Part A||2
3050144|NCT01214655|3770051|FG001|Joined 5 mg Study Drug|Part A||0
3050145|NCT01214655|3770052|FG002|Joined 5 mg Study Drug|Part A||0
3050146|NCT01214655|3770050|FG000|Escalated From 5 mg Study Drug|Part A||1
3050147|NCT01214655|3770051|FG001|Escalated From 5 mg Study Drug|Part A||0
3050148|NCT01214655|3770052|FG002|Escalated From 5 mg Study Drug|Part A||0
3050149|NCT01214655|3770050|FG000|Joined 6 mg Group|Part A||4
3050150|NCT01214655|3770051|FG001|Joined 6 mg Group|Part A||0
3050151|NCT01214655|3770052|FG002|Joined 6 mg Group|Part A||0
3281799|NCT02742649|4015567|FG000|NOT COMPLETED|Pre-Randomization Washout Period||5
3281800|NCT02742649|4015568|FG001|NOT COMPLETED|Pre-Randomization Washout Period||0
3281801|NCT02742649|4015569|FG002|NOT COMPLETED|Pre-Randomization Washout Period||0
3281802|NCT02742649|4015570|FG003|NOT COMPLETED|Pre-Randomization Washout Period||0
3281803|NCT02742649|4015571|FG004|NOT COMPLETED|Pre-Randomization Washout Period||0
3281804|NCT02742649|4015567|FG000|STARTED|Double-Blind Treatment Period||0
3281805|NCT02742649|4015568|FG001|STARTED|Double-Blind Treatment Period||17
3281806|NCT02742649|4015569|FG002|STARTED|Double-Blind Treatment Period||17
3281807|NCT02742649|4015570|FG003|STARTED|Double-Blind Treatment Period||16
3281808|NCT02742649|4015571|FG004|STARTED|Double-Blind Treatment Period||0
3281809|NCT02742649|4015567|FG000|COMPLETED|Double-Blind Treatment Period||0
3281810|NCT02742649|4015568|FG001|COMPLETED|Double-Blind Treatment Period||16
3281811|NCT02742649|4015569|FG002|COMPLETED|Double-Blind Treatment Period||17
3050152|NCT01214655|3770050|FG000|Received 6 mg Study Drug|Part A||5
3050153|NCT01214655|3770051|FG001|Received 6 mg Study Drug|Part A||0
3050154|NCT01214655|3770052|FG002|Received 6 mg Study Drug|Part A||0
3050155|NCT01214655|3770050|FG000|COMPLETED|Part A||2
3050156|NCT01214655|3770051|FG001|COMPLETED|Part A||0
3050157|NCT01214655|3770052|FG002|COMPLETED|Part A||0
3050158|NCT01214655|3770050|FG000|NOT COMPLETED|Part A||8
3050159|NCT01214655|3770051|FG001|NOT COMPLETED|Part A||0
3050160|NCT01214655|3770052|FG002|NOT COMPLETED|Part A||0
3050161|NCT01214655|3770050|FG000|STARTED|Part B|Part A participants did not enroll in Part B. Participants in A, B, C are considered Cohorts.|0
3050162|NCT01214655|3770051|FG001|STARTED|Part B|Total on Schedule B, dose days 1,5,9|15
3050163|NCT01214655|3770052|FG002|STARTED|Part B||0
3050164|NCT01214655|3770050|FG000|Received at Least 1 Dose of Study Drug|Part B||0
3050165|NCT01214655|3770051|FG001|Received at Least 1 Dose of Study Drug|Part B||15
3050166|NCT01214655|3770052|FG002|Received at Least 1 Dose of Study Drug|Part B||0
3050167|NCT01214655|3770050|FG000|Recieved 8 mg/m²/Day Study Drug|Part B||0
3050168|NCT01214655|3770051|FG001|Recieved 8 mg/m²/Day Study Drug|Part B||4
3050169|NCT01214655|3770052|FG002|Recieved 8 mg/m²/Day Study Drug|Part B||0
3050170|NCT01214655|3770050|FG000|Escalated From 8 to 10 mg/m²/Day|Part B||0
3050171|NCT01214655|3770051|FG001|Escalated From 8 to 10 mg/m²/Day|Part B||2
3050172|NCT01214655|3770052|FG002|Escalated From 8 to 10 mg/m²/Day|Part B||0
3050173|NCT01214655|3770050|FG000|Joined 10 mg/m²/Day Study D|Part B||0
3050174|NCT01214655|3770051|FG001|Joined 10 mg/m²/Day Study D|Part B||3
3050175|NCT01214655|3770052|FG002|Joined 10 mg/m²/Day Study D|Part B||0
3050176|NCT01214655|3770050|FG000|Escalated to 12 mg/m²/Day|Part B||0
3050177|NCT01214655|3770051|FG001|Escalated to 12 mg/m²/Day|Part B||2
3050178|NCT01214655|3770052|FG002|Escalated to 12 mg/m²/Day|Part B||0
3050179|NCT01214655|3770050|FG000|Joined 12 mg/m²/Day|Part B||0
3050180|NCT01214655|3770051|FG001|Joined 12 mg/m²/Day|Part B||5
3050181|NCT01214655|3770052|FG002|Joined 12 mg/m²/Day|Part B||0
3050182|NCT01214655|3770050|FG000|Escalated From 12 to 14 mg/m²/Day|Part B||0
3050183|NCT01214655|3770051|FG001|Escalated From 12 to 14 mg/m²/Day|Part B||1
3050184|NCT01214655|3770052|FG002|Escalated From 12 to 14 mg/m²/Day|Part B||0
3050185|NCT01214655|3770050|FG000|Joined 14 mg/m²/Day|Part B||0
3050186|NCT01214655|3770051|FG001|Joined 14 mg/m²/Day|Part B||3
3050187|NCT01214655|3770052|FG002|Joined 14 mg/m²/Day|Part B||0
3281812|NCT02742649|4015570|FG003|COMPLETED|Double-Blind Treatment Period||16
3281813|NCT02742649|4015571|FG004|COMPLETED|Double-Blind Treatment Period||0
3281814|NCT02742649|4015567|FG000|NOT COMPLETED|Double-Blind Treatment Period||0
3050188|NCT01214655|3770050|FG000|COMPLETED|Part B||0
3050189|NCT01214655|3770051|FG001|COMPLETED|Part B||2
3050190|NCT01214655|3770052|FG002|COMPLETED|Part B||0
3050191|NCT01214655|3770050|FG000|NOT COMPLETED|Part B||0
3050192|NCT01214655|3770051|FG001|NOT COMPLETED|Part B||13
3050193|NCT01214655|3770052|FG002|NOT COMPLETED|Part B||0
3050194|NCT01214655|3770050|FG000|STARTED|Part C||0
3050195|NCT01214655|3770051|FG001|STARTED|Part C||0
3050196|NCT01214655|3770052|FG002|STARTED|Part C|Total on Schedule C, dose days 1,2,3|8
3050197|NCT01214655|3770050|FG000|Received at Least 1 Dose of 5 mg/m²/Day|Part C||0
3050198|NCT01214655|3770051|FG001|Received at Least 1 Dose of 5 mg/m²/Day|Part C||0
3050199|NCT01214655|3770052|FG002|Received at Least 1 Dose of 5 mg/m²/Day|Part C||8
3050200|NCT01214655|3770050|FG000|COMPLETED|Part C||0
3050201|NCT01214655|3770051|FG001|COMPLETED|Part C||0
3050202|NCT01214655|3770052|FG002|COMPLETED|Part C||1
3050203|NCT01214655|3770050|FG000|NOT COMPLETED|Part C||0
3050204|NCT01214655|3770051|FG001|NOT COMPLETED|Part C||0
3050205|NCT01214655|3770052|FG002|NOT COMPLETED|Part C||7
3050206|NCT01214668|3770104|FG000|STARTED|Overall Study||4
3050207|NCT01214668|3770105|FG001|STARTED|Overall Study||3
3050208|NCT01214668|3770106|FG002|STARTED|Overall Study||6
3050209|NCT01214668|3770107|FG003|STARTED|Overall Study||6
3050210|NCT01214668|3770108|FG004|STARTED|Overall Study||6
3050211|NCT01214668|3770109|FG005|STARTED|Overall Study||6
3050212|NCT01214668|3770104|FG000|Received at Least One Dose of Study Drug|Overall Study||4
3050213|NCT01214668|3770105|FG001|Received at Least One Dose of Study Drug|Overall Study||3
3050214|NCT01214668|3770106|FG002|Received at Least One Dose of Study Drug|Overall Study||6
3050215|NCT01214668|3770107|FG003|Received at Least One Dose of Study Drug|Overall Study||6
3050216|NCT01214668|3770108|FG004|Received at Least One Dose of Study Drug|Overall Study||6
3050217|NCT01214668|3770109|FG005|Received at Least One Dose of Study Drug|Overall Study||6
3050218|NCT01214668|3770104|FG000|COMPLETED|Overall Study||0
3050219|NCT01214668|3770105|FG001|COMPLETED|Overall Study||0
3050220|NCT01214668|3770106|FG002|COMPLETED|Overall Study||0
3050221|NCT01214668|3770107|FG003|COMPLETED|Overall Study||0
3050222|NCT01214668|3770108|FG004|COMPLETED|Overall Study||0
3050223|NCT01214668|3770109|FG005|COMPLETED|Overall Study||0
3050224|NCT01214668|3770104|FG000|NOT COMPLETED|Overall Study||4
3050225|NCT01214668|3770105|FG001|NOT COMPLETED|Overall Study||3
3050226|NCT01214668|3770106|FG002|NOT COMPLETED|Overall Study||6
3050227|NCT01214668|3770107|FG003|NOT COMPLETED|Overall Study||6
3050228|NCT01214668|3770108|FG004|NOT COMPLETED|Overall Study||6
3050229|NCT01214668|3770109|FG005|NOT COMPLETED|Overall Study||6
3050230|NCT01214720|3770126|FG000|STARTED|Overall Study||306
3050231|NCT01214720|3770127|FG001|STARTED|Overall Study||301
3050232|NCT01214720|3770126|FG000|COMPLETED|Overall Study|Indicates patients who had died at the time of the data cut-off|221
3050233|NCT01214720|3770127|FG001|COMPLETED|Overall Study|Indicates patients who had died at the time of the data cut-off|233
3050234|NCT01214720|3770126|FG000|NOT COMPLETED|Overall Study||85
3050235|NCT01214720|3770127|FG001|NOT COMPLETED|Overall Study||68
3050236|NCT01214759|3770133|FG000|STARTED|Overall Study||103
3050237|NCT01214759|3770133|FG000|28 Days nPEP Completion|Overall Study||85
3050238|NCT01214759|3770133|FG000|COMPLETED|Overall Study||55
3050239|NCT01214759|3770133|FG000|NOT COMPLETED|Overall Study||48
3050240|NCT01214811|3770137|FG000|STARTED|Overall Study||27
3050241|NCT01214811|3770137|FG000|COMPLETED|Overall Study||24
3050242|NCT01214811|3770137|FG000|NOT COMPLETED|Overall Study||3
3050243|NCT01214824|3770141|FG000|STARTED|Overall Study||32
3050244|NCT01214824|3770141|FG000|COMPLETED|Overall Study||29
3050245|NCT01214824|3770141|FG000|NOT COMPLETED|Overall Study||3
3050246|NCT01214837|3770149|FG000|STARTED|Overall Study||249
3050247|NCT01214837|3770150|FG001|STARTED|Overall Study||256
3050248|NCT01214837|3770151|FG002|STARTED|Overall Study||246
3050249|NCT01214837|3770149|FG000|COMPLETED|Overall Study||195
3050250|NCT01214837|3770150|FG001|COMPLETED|Overall Study||192
3050251|NCT01214837|3770151|FG002|COMPLETED|Overall Study||184
3050252|NCT01214837|3770149|FG000|NOT COMPLETED|Overall Study||54
3050253|NCT01214837|3770150|FG001|NOT COMPLETED|Overall Study||64
3050254|NCT01214837|3770151|FG002|NOT COMPLETED|Overall Study||62
3050255|NCT01214850|3770163|FG000|STARTED|Overall Study||979
3050256|NCT01214850|3770164|FG001|STARTED|Overall Study||988
3050257|NCT01214850|3770165|FG002|STARTED|Overall Study||987
3050258|NCT01214850|3770163|FG000|COMPLETED|Overall Study||796
3050259|NCT01214850|3770164|FG001|COMPLETED|Overall Study||844
3050260|NCT01214850|3770165|FG002|COMPLETED|Overall Study||826
3050261|NCT01214850|3770163|FG000|NOT COMPLETED|Overall Study||183
3050262|NCT01214850|3770164|FG001|NOT COMPLETED|Overall Study||144
3050263|NCT01214850|3770165|FG002|NOT COMPLETED|Overall Study||161
3050264|NCT01214915|3770176|FG000|STARTED|Overall Study||53
3050265|NCT01214915|3770176|FG000|COMPLETED|Overall Study||42
3050266|NCT01214915|3770176|FG000|NOT COMPLETED|Overall Study||11
3050267|NCT01214980|3770182|FG000|STARTED|Overall Study||16
3050268|NCT01214980|3770183|FG001|STARTED|Overall Study||16
3050269|NCT01214980|3770182|FG000|COMPLETED|Overall Study||13
3050270|NCT01214980|3770183|FG001|COMPLETED|Overall Study||14
3050271|NCT01214980|3770182|FG000|NOT COMPLETED|Overall Study||3
3050272|NCT01214980|3770183|FG001|NOT COMPLETED|Overall Study||2
3050273|NCT01215032|3770189|FG000|STARTED|Overall Study||21
3050274|NCT01215032|3770189|FG000|COMPLETED|Overall Study||1
3050275|NCT01215032|3770189|FG000|NOT COMPLETED|Overall Study||20
3050276|NCT01215097|3770197|FG000|STARTED|Overall Study|Patients who are randomised and treated with placebo. 1 patient was not treated then not included.|100
3050277|NCT01215097|3770198|FG001|STARTED|Overall Study|Patients who are randomised and treated with linagliptin.|205
3050278|NCT01215097|3770197|FG000|COMPLETED|Overall Study||88
3050279|NCT01215097|3770198|FG001|COMPLETED|Overall Study||191
3050280|NCT01215097|3770197|FG000|NOT COMPLETED|Overall Study||12
3050281|NCT01215097|3770198|FG001|NOT COMPLETED|Overall Study||14
3050282|NCT01215110|3770209|FG000|STARTED|Overall Study||15
3050283|NCT01215110|3770210|FG001|STARTED|Overall Study||15
3050284|NCT01215110|3770211|FG002|STARTED|Overall Study||15
3050285|NCT01215110|3770212|FG003|STARTED|Overall Study||15
3050286|NCT01215110|3770213|FG004|STARTED|Overall Study||8
3050287|NCT01215110|3770209|FG000|COMPLETED|Overall Study||15
3050288|NCT01215110|3770210|FG001|COMPLETED|Overall Study||15
3050289|NCT01215110|3770211|FG002|COMPLETED|Overall Study||13
3050290|NCT01215110|3770212|FG003|COMPLETED|Overall Study||14
3050291|NCT01215110|3770213|FG004|COMPLETED|Overall Study||8
3050292|NCT01215110|3770209|FG000|NOT COMPLETED|Overall Study||0
3050293|NCT01215110|3770210|FG001|NOT COMPLETED|Overall Study||0
3050294|NCT01215110|3770211|FG002|NOT COMPLETED|Overall Study||2
3050295|NCT01215110|3770212|FG003|NOT COMPLETED|Overall Study||1
3050296|NCT01215110|3770213|FG004|NOT COMPLETED|Overall Study||0
3050297|NCT01215123|3770229|FG000|STARTED|Overall Study||28
3050298|NCT01215123|3770229|FG000|COMPLETED|Overall Study||28
3281815|NCT02742649|4015568|FG001|NOT COMPLETED|Double-Blind Treatment Period||1
3281816|NCT02742649|4015569|FG002|NOT COMPLETED|Double-Blind Treatment Period||0
3281817|NCT02742649|4015570|FG003|NOT COMPLETED|Double-Blind Treatment Period||0
3281818|NCT02742649|4015571|FG004|NOT COMPLETED|Double-Blind Treatment Period||0
3281819|NCT02742649|4015567|FG000|STARTED|Open-Label Period||0
3281820|NCT02742649|4015568|FG001|STARTED|Open-Label Period||0
3281821|NCT02742649|4015569|FG002|STARTED|Open-Label Period||0
3281822|NCT02742649|4015570|FG003|STARTED|Open-Label Period||0
3281823|NCT02742649|4015571|FG004|STARTED|Open-Label Period||49
3281824|NCT02742649|4015567|FG000|COMPLETED|Open-Label Period||0
3281825|NCT02742649|4015568|FG001|COMPLETED|Open-Label Period||0
3281826|NCT02742649|4015569|FG002|COMPLETED|Open-Label Period||0
3281827|NCT02742649|4015570|FG003|COMPLETED|Open-Label Period||0
3281828|NCT02742649|4015571|FG004|COMPLETED|Open-Label Period||48
3281829|NCT02742649|4015567|FG000|NOT COMPLETED|Open-Label Period||0
3281830|NCT02742649|4015568|FG001|NOT COMPLETED|Open-Label Period||0
3281831|NCT02742649|4015569|FG002|NOT COMPLETED|Open-Label Period||0
3050299|NCT01215123|3770229|FG000|NOT COMPLETED|Overall Study||0
3050300|NCT01215175|3770238|FG000|STARTED|Overall Study||30
3050301|NCT01215175|3770239|FG001|STARTED|Overall Study||30
3050302|NCT01215175|3770240|FG002|STARTED|Overall Study||33
3050303|NCT01215175|3770241|FG003|STARTED|Overall Study||29
3050304|NCT01215175|3770242|FG004|STARTED|Overall Study||28
3050305|NCT01215175|3770238|FG000|Treated|Overall Study||30
3050306|NCT01215175|3770239|FG001|Treated|Overall Study||30
3050307|NCT01215175|3770240|FG002|Treated|Overall Study||33
3050308|NCT01215175|3770241|FG003|Treated|Overall Study||29
3050309|NCT01215175|3770242|FG004|Treated|Overall Study||28
3050310|NCT01215175|3770238|FG000|COMPLETED|Overall Study||30
3050311|NCT01215175|3770239|FG001|COMPLETED|Overall Study||29
3050312|NCT01215175|3770240|FG002|COMPLETED|Overall Study||33
3050313|NCT01215175|3770241|FG003|COMPLETED|Overall Study||28
3050314|NCT01215175|3770242|FG004|COMPLETED|Overall Study||28
3050315|NCT01215175|3770238|FG000|NOT COMPLETED|Overall Study||0
3050316|NCT01215175|3770239|FG001|NOT COMPLETED|Overall Study||1
3050317|NCT01215175|3770240|FG002|NOT COMPLETED|Overall Study||0
3050318|NCT01215175|3770241|FG003|NOT COMPLETED|Overall Study||1
3050319|NCT01215175|3770242|FG004|NOT COMPLETED|Overall Study||0
3050320|NCT01215188|3770257|FG000|STARTED|Overall Study||378
3050321|NCT01215188|3770258|FG001|STARTED|Overall Study||386
3050322|NCT01215188|3770259|FG002|STARTED|Overall Study||378
3050323|NCT01215188|3770257|FG000|COMPLETED|Overall Study||320
3050324|NCT01215188|3770258|FG001|COMPLETED|Overall Study||327
3050325|NCT01215188|3770259|FG002|COMPLETED|Overall Study||326
3050326|NCT01215188|3770257|FG000|NOT COMPLETED|Overall Study||58
3050327|NCT01215188|3770258|FG001|NOT COMPLETED|Overall Study||59
3050328|NCT01215188|3770259|FG002|NOT COMPLETED|Overall Study||52
3050329|NCT01215227|3770273|FG000|STARTED|Overall Study||218
3050330|NCT01215227|3770274|FG001|STARTED|Overall Study||215
3050331|NCT01215227|3770275|FG002|STARTED|Overall Study||107
3050332|NCT01215227|3770276|FG003|STARTED|Overall Study||97
3050333|NCT01215227|3770277|FG004|STARTED|Overall Study||93
3050334|NCT01215227|3770278|FG005|STARTED|Overall Study||109
3050335|NCT01215227|3770273|FG000|Treated|Overall Study||218
3050336|NCT01215227|3770274|FG001|Treated|Overall Study||215
3050337|NCT01215227|3770275|FG002|Treated|Overall Study||106
3050338|NCT01215227|3770276|FG003|Treated|Overall Study||96
3050339|NCT01215227|3770277|FG004|Treated|Overall Study||93
3050340|NCT01215227|3770278|FG005|Treated|Overall Study||108
3050341|NCT01215227|3770273|FG000|COMPLETED|Overall Study||97
3050342|NCT01215227|3770274|FG001|COMPLETED|Overall Study||96
3050343|NCT01215227|3770275|FG002|COMPLETED|Overall Study||50
3050344|NCT01215227|3770276|FG003|COMPLETED|Overall Study||48
3050345|NCT01215227|3770277|FG004|COMPLETED|Overall Study||45
3050346|NCT01215227|3770278|FG005|COMPLETED|Overall Study||51
3050347|NCT01215227|3770273|FG000|NOT COMPLETED|Overall Study||121
3050348|NCT01215227|3770274|FG001|NOT COMPLETED|Overall Study||119
3050349|NCT01215227|3770275|FG002|NOT COMPLETED|Overall Study||57
3050350|NCT01215227|3770276|FG003|NOT COMPLETED|Overall Study||49
3050351|NCT01215227|3770277|FG004|NOT COMPLETED|Overall Study||48
3050352|NCT01215227|3770278|FG005|NOT COMPLETED|Overall Study||58
3050353|NCT01215240|3770294|FG000|STARTED|Overall Study||10
3050354|NCT01215240|3770295|FG001|STARTED|Overall Study||12
3050355|NCT01215240|3770294|FG000|COMPLETED|Overall Study||10
3050356|NCT01215240|3770295|FG001|COMPLETED|Overall Study||12
3050357|NCT01215240|3770294|FG000|NOT COMPLETED|Overall Study||0
3050358|NCT01215240|3770295|FG001|NOT COMPLETED|Overall Study||0
3050359|NCT01215253|3770303|FG000|STARTED|Overall Study||510
3050360|NCT01215253|3770304|FG001|STARTED|Overall Study||502
3050361|NCT01215253|3770303|FG000|COMPLETED|Overall Study||424
3050362|NCT01215253|3770304|FG001|COMPLETED|Overall Study||439
3050363|NCT01215253|3770303|FG000|NOT COMPLETED|Overall Study||86
3050364|NCT01215253|3770304|FG001|NOT COMPLETED|Overall Study||63
3050365|NCT01215279|3770313|FG000|STARTED|Overall Study||31
3050366|NCT01215279|3770314|FG001|STARTED|Overall Study||32
3050367|NCT01215279|3770313|FG000|COMPLETED|Overall Study||31
3050368|NCT01215279|3770314|FG001|COMPLETED|Overall Study||32
3050369|NCT01215279|3770313|FG000|NOT COMPLETED|Overall Study||0
3050370|NCT01215279|3770314|FG001|NOT COMPLETED|Overall Study||0
3050371|NCT01215292|3770325|FG000|STARTED|Overall Study||8
3050372|NCT01215292|3770326|FG001|STARTED|Overall Study||8
3050373|NCT01215292|3770327|FG002|STARTED|Overall Study||8
3050374|NCT01215292|3770328|FG003|STARTED|Overall Study||8
3050375|NCT01215292|3770329|FG004|STARTED|Overall Study||8
3050376|NCT01215292|3770325|FG000|COMPLETED|Overall Study||8
3050377|NCT01215292|3770326|FG001|COMPLETED|Overall Study||8
3050378|NCT01215292|3770327|FG002|COMPLETED|Overall Study||8
3050379|NCT01215292|3770328|FG003|COMPLETED|Overall Study||8
3050380|NCT01215292|3770329|FG004|COMPLETED|Overall Study||8
3050381|NCT01215292|3770325|FG000|NOT COMPLETED|Overall Study||0
3050382|NCT01215292|3770326|FG001|NOT COMPLETED|Overall Study||0
3050383|NCT01215292|3770327|FG002|NOT COMPLETED|Overall Study||0
3050384|NCT01215292|3770328|FG003|NOT COMPLETED|Overall Study||0
3050385|NCT01215292|3770329|FG004|NOT COMPLETED|Overall Study||0
3050386|NCT01215318|3770351|FG000|STARTED|Overall Study||20
3050387|NCT01215318|3770352|FG001|STARTED|Overall Study||24
3050388|NCT01215318|3770351|FG000|COMPLETED|Overall Study||20
3050389|NCT01215318|3770352|FG001|COMPLETED|Overall Study||24
3050390|NCT01215318|3770351|FG000|NOT COMPLETED|Overall Study||0
3050391|NCT01215318|3770352|FG001|NOT COMPLETED|Overall Study||0
3050392|NCT01215344|3770362|FG000|STARTED|Overall Study||33
3050393|NCT01215344|3770363|FG001|STARTED|Overall Study||3
3050394|NCT01215344|3770362|FG000|COMPLETED|Overall Study||23
3050395|NCT01215344|3770363|FG001|COMPLETED|Overall Study||3
3050396|NCT01215344|3770362|FG000|NOT COMPLETED|Overall Study||10
3050397|NCT01215344|3770363|FG001|NOT COMPLETED|Overall Study||0
3050398|NCT01215357|3770371|FG000|STARTED|Overall Study||34
3050399|NCT01215357|3770371|FG000|COMPLETED|Overall Study||22
3050400|NCT01215357|3770371|FG000|NOT COMPLETED|Overall Study||12
3050401|NCT01215422|3770379|FG000|STARTED|Overall Study||14
3050402|NCT01215422|3770380|FG001|STARTED|Overall Study||249
3050403|NCT01215422|3770381|FG002|STARTED|Overall Study||196
3050404|NCT01215422|3770382|FG003|STARTED|Overall Study||201
3050405|NCT01215422|3770379|FG000|COMPLETED|Overall Study||6
3050406|NCT01215422|3770380|FG001|COMPLETED|Overall Study||249
3050407|NCT01215422|3770381|FG002|COMPLETED|Overall Study||193
3050408|NCT01215422|3770382|FG003|COMPLETED|Overall Study||193
3050409|NCT01215422|3770379|FG000|NOT COMPLETED|Overall Study||8
3050410|NCT01215422|3770380|FG001|NOT COMPLETED|Overall Study||0
3050411|NCT01215422|3770381|FG002|NOT COMPLETED|Overall Study||3
3050412|NCT01215422|3770382|FG003|NOT COMPLETED|Overall Study||8
3050413|NCT01215435|3770406|FG000|STARTED|Overall Study||122
3050414|NCT01215435|3770407|FG001|STARTED|Overall Study||123
3050415|NCT01215435|3770406|FG000|COMPLETED|Overall Study||103
3050416|NCT01215435|3770407|FG001|COMPLETED|Overall Study||107
3050417|NCT01215435|3770406|FG000|NOT COMPLETED|Overall Study||19
3050418|NCT01215435|3770407|FG001|NOT COMPLETED|Overall Study||16
3050419|NCT01215513|3770413|FG000|STARTED|Overall Study|157 participants were allocated to treatment in CS42 main study (Intent-to-treat analysis set)|157
3050420|NCT01215513|3770413|FG000|CS42 and CS42A Safety Analysis Set|Overall Study|156 participants received at least 1 dose of degarelix|156
3050421|NCT01215513|3770413|FG000|CS42 and CS42A Full Analysis Set|Overall Study|155 participants received at least 1 dose of degarelix and had at least 1 efficacy assessment|155
3050422|NCT01215513|3770413|FG000|CS42A Safety Analysis Set|Overall Study|127 participants were enrolled in the extension study CS42A|127
3050423|NCT01215513|3770413|FG000|COMPLETED|Overall Study||112
3050424|NCT01215513|3770413|FG000|NOT COMPLETED|Overall Study||45
3050425|NCT01215643|3770423|FG000|STARTED|Overall Study||83
3050426|NCT01215643|3770424|FG001|STARTED|Overall Study||84
3050427|NCT01215643|3770425|FG002|STARTED|Overall Study||94
3050428|NCT01215643|3770426|FG003|STARTED|Overall Study||39
3050429|NCT01215643|3770427|FG004|STARTED|Overall Study||40
3050430|NCT01215643|3770423|FG000|COMPLETED|Overall Study||74
3050431|NCT01215643|3770424|FG001|COMPLETED|Overall Study||80
3050432|NCT01215643|3770425|FG002|COMPLETED|Overall Study||82
3050433|NCT01215643|3770426|FG003|COMPLETED|Overall Study||35
3050434|NCT01215643|3770427|FG004|COMPLETED|Overall Study||29
3050435|NCT01215643|3770423|FG000|NOT COMPLETED|Overall Study||9
3050436|NCT01215643|3770424|FG001|NOT COMPLETED|Overall Study||4
3050437|NCT01215643|3770425|FG002|NOT COMPLETED|Overall Study||12
3050438|NCT01215643|3770426|FG003|NOT COMPLETED|Overall Study||4
3050439|NCT01215643|3770427|FG004|NOT COMPLETED|Overall Study||11
3050440|NCT01215695|3770446|FG000|STARTED|Overall Study||70
3050441|NCT01215695|3770447|FG001|STARTED|Overall Study||70
3050442|NCT01215695|3770446|FG000|COMPLETED|Overall Study||70
3050443|NCT01215695|3770447|FG001|COMPLETED|Overall Study||70
3050444|NCT01215695|3770446|FG000|NOT COMPLETED|Overall Study||0
3050445|NCT01215695|3770447|FG001|NOT COMPLETED|Overall Study||0
3050446|NCT01215721|3770453|FG000|STARTED|Overall Study||40
3050447|NCT01215721|3770453|FG000|COMPLETED|Overall Study||38
3050448|NCT01215721|3770453|FG000|NOT COMPLETED|Overall Study||2
3050449|NCT01215734|3770459|FG000|STARTED|Overall Study||29
3050450|NCT01215734|3770460|FG001|STARTED|Overall Study||15
3050451|NCT01215734|3770459|FG000|COMPLETED|Overall Study||29
3050452|NCT01215734|3770460|FG001|COMPLETED|Overall Study||14
3050453|NCT01215734|3770459|FG000|NOT COMPLETED|Overall Study||0
3050454|NCT01215734|3770460|FG001|NOT COMPLETED|Overall Study||1
3050455|NCT01215786|3770469|FG000|STARTED|Overall Study||21
3050456|NCT01215786|3770470|FG001|STARTED|Overall Study||19
3050457|NCT01215786|3770471|FG002|STARTED|Overall Study||10
3050458|NCT01215786|3770469|FG000|COMPLETED|Overall Study||21
3050459|NCT01215786|3770470|FG001|COMPLETED|Overall Study||19
3050460|NCT01215786|3770471|FG002|COMPLETED|Overall Study||10
3050461|NCT01215786|3770469|FG000|NOT COMPLETED|Overall Study||0
3050462|NCT01215786|3770470|FG001|NOT COMPLETED|Overall Study||0
3050463|NCT01215786|3770471|FG002|NOT COMPLETED|Overall Study||0
3050464|NCT01215851|3770485|FG000|STARTED|Treatment Period||15
3050465|NCT01215851|3770486|FG001|STARTED|Treatment Period||15
3050466|NCT01215851|3770487|FG002|STARTED|Treatment Period||15
3050467|NCT01215851|3770488|FG003|STARTED|Treatment Period||15
3050468|NCT01215851|3770489|FG004|STARTED|Treatment Period||10
3050469|NCT01215851|3770490|FG005|STARTED|Treatment Period||15
3050470|NCT01215851|3770485|FG000|COMPLETED|Treatment Period||14
3050471|NCT01215851|3770486|FG001|COMPLETED|Treatment Period||14
3050472|NCT01215851|3770487|FG002|COMPLETED|Treatment Period||14
3050473|NCT01215851|3770488|FG003|COMPLETED|Treatment Period||12
3050474|NCT01215851|3770489|FG004|COMPLETED|Treatment Period||10
3050475|NCT01215851|3770490|FG005|COMPLETED|Treatment Period||14
3050476|NCT01215851|3770485|FG000|NOT COMPLETED|Treatment Period||1
3050477|NCT01215851|3770486|FG001|NOT COMPLETED|Treatment Period||1
3050478|NCT01215851|3770487|FG002|NOT COMPLETED|Treatment Period||1
3050479|NCT01215851|3770488|FG003|NOT COMPLETED|Treatment Period||3
3050480|NCT01215851|3770489|FG004|NOT COMPLETED|Treatment Period||0
3050481|NCT01215851|3770490|FG005|NOT COMPLETED|Treatment Period||1
3050482|NCT01215851|3770485|FG000|STARTED|Follow up Period||14
3050483|NCT01215851|3770486|FG001|STARTED|Follow up Period||14
3050484|NCT01215851|3770487|FG002|STARTED|Follow up Period||14
3050485|NCT01215851|3770488|FG003|STARTED|Follow up Period||12
3050486|NCT01215851|3770489|FG004|STARTED|Follow up Period||10
3050487|NCT01215851|3770490|FG005|STARTED|Follow up Period||14
3050488|NCT01215851|3770485|FG000|COMPLETED|Follow up Period||14
3050489|NCT01215851|3770486|FG001|COMPLETED|Follow up Period||14
3050490|NCT01215851|3770487|FG002|COMPLETED|Follow up Period||14
3050491|NCT01215851|3770488|FG003|COMPLETED|Follow up Period||12
3050492|NCT01215851|3770489|FG004|COMPLETED|Follow up Period||10
3050493|NCT01215851|3770490|FG005|COMPLETED|Follow up Period||13
3050494|NCT01215851|3770485|FG000|NOT COMPLETED|Follow up Period||0
3050495|NCT01215851|3770486|FG001|NOT COMPLETED|Follow up Period||0
3050496|NCT01215851|3770487|FG002|NOT COMPLETED|Follow up Period||0
3050497|NCT01215851|3770488|FG003|NOT COMPLETED|Follow up Period||0
3050498|NCT01215851|3770489|FG004|NOT COMPLETED|Follow up Period||0
3050499|NCT01215851|3770490|FG005|NOT COMPLETED|Follow up Period||1
3050500|NCT01215916|3770514|FG000|STARTED|Overall Study||1
3050501|NCT01215916|3770515|FG001|STARTED|Overall Study||5
3050502|NCT01215916|3770516|FG002|STARTED|Overall Study||3
3050503|NCT01215916|3770517|FG003|STARTED|Overall Study||6
3050504|NCT01215916|3770518|FG004|STARTED|Overall Study||6
3050505|NCT01215916|3770519|FG005|STARTED|Overall Study||4
3050506|NCT01215916|3770520|FG006|STARTED|Overall Study||9
3050507|NCT01215916|3770521|FG007|STARTED|Overall Study||3
3050508|NCT01215916|3770522|FG008|STARTED|Overall Study||2
3050509|NCT01215916|3770514|FG000|Received at Least 1 Dose of Either Drug|Overall Study||1
3050510|NCT01215916|3770515|FG001|Received at Least 1 Dose of Either Drug|Overall Study||5
3050511|NCT01215916|3770516|FG002|Received at Least 1 Dose of Either Drug|Overall Study||3
3050512|NCT01215916|3770517|FG003|Received at Least 1 Dose of Either Drug|Overall Study||6
3050513|NCT01215916|3770518|FG004|Received at Least 1 Dose of Either Drug|Overall Study||6
3050514|NCT01215916|3770519|FG005|Received at Least 1 Dose of Either Drug|Overall Study||4
3050515|NCT01215916|3770520|FG006|Received at Least 1 Dose of Either Drug|Overall Study||9
3050516|NCT01215916|3770521|FG007|Received at Least 1 Dose of Either Drug|Overall Study||3
3050517|NCT01215916|3770522|FG008|Received at Least 1 Dose of Either Drug|Overall Study||2
3050518|NCT01215916|3770514|FG000|COMPLETED|Overall Study||0
3050519|NCT01215916|3770515|FG001|COMPLETED|Overall Study||0
3050520|NCT01215916|3770516|FG002|COMPLETED|Overall Study||0
3050521|NCT01215916|3770517|FG003|COMPLETED|Overall Study||0
3050522|NCT01215916|3770518|FG004|COMPLETED|Overall Study||0
3050523|NCT01215916|3770519|FG005|COMPLETED|Overall Study||0
3050524|NCT01215916|3770520|FG006|COMPLETED|Overall Study||0
3050525|NCT01215916|3770521|FG007|COMPLETED|Overall Study||0
3050526|NCT01215916|3770522|FG008|COMPLETED|Overall Study||0
3160471|NCT01863771|3887577|FG002|NOT COMPLETED|Maintenance Phase||12
3160472|NCT01863771|3887578|FG003|NOT COMPLETED|Maintenance Phase||43
3171714|NCT01936623|3898889|FG001|NOT COMPLETED|Overall Study||5
3171715|NCT01936649|3898895|FG000|STARTED|Overall Study||63
3171716|NCT01936649|3898895|FG000|Treated|Overall Study||51
3281832|NCT02742649|4015570|FG003|NOT COMPLETED|Open-Label Period||0
3050527|NCT01215916|3770514|FG000|NOT COMPLETED|Overall Study||1
3050528|NCT01215916|3770515|FG001|NOT COMPLETED|Overall Study||5
3050529|NCT01215916|3770516|FG002|NOT COMPLETED|Overall Study||3
3050530|NCT01215916|3770517|FG003|NOT COMPLETED|Overall Study||6
3050531|NCT01215916|3770518|FG004|NOT COMPLETED|Overall Study||6
3050532|NCT01215916|3770519|FG005|NOT COMPLETED|Overall Study||4
3050533|NCT01215916|3770520|FG006|NOT COMPLETED|Overall Study||9
3050534|NCT01215916|3770521|FG007|NOT COMPLETED|Overall Study||3
3050535|NCT01215916|3770522|FG008|NOT COMPLETED|Overall Study||2
3050536|NCT01215929|3770548|FG000|STARTED|Overall Study||18
3050537|NCT01215929|3770549|FG001|STARTED|Overall Study||17
3050538|NCT01215929|3770548|FG000|COMPLETED|Overall Study||12
3050539|NCT01215929|3770549|FG001|COMPLETED|Overall Study||12
3050540|NCT01215929|3770548|FG000|NOT COMPLETED|Overall Study||6
3050541|NCT01215929|3770549|FG001|NOT COMPLETED|Overall Study||5
3050542|NCT01215942|3770557|FG000|STARTED|Treatment Period|Participants who discontinued treatment were followed in post-treatment follow-up.|414
3050543|NCT01215942|3770558|FG001|STARTED|Treatment Period|Participants who discontinued treatment were followed in post-treatment follow-up.|672
3050544|NCT01215942|3770557|FG000|COMPLETED|Treatment Period||0
3050545|NCT01215942|3770558|FG001|COMPLETED|Treatment Period||0
3050546|NCT01215942|3770557|FG000|NOT COMPLETED|Treatment Period||414
3050547|NCT01215942|3770558|FG001|NOT COMPLETED|Treatment Period||672
3050548|NCT01215942|3770557|FG000|STARTED|Post-Treatment Follow-Up Period|Not all participants who discontinued treatment entered post-treatment follow-up period.|368
3050549|NCT01215942|3770558|FG001|STARTED|Post-Treatment Follow-Up Period|Not all participants who discontinued treatment entered post-treatment follow-up period.|591
3050550|NCT01215942|3770557|FG000|COMPLETED|Post-Treatment Follow-Up Period||283
3050551|NCT01215942|3770558|FG001|COMPLETED|Post-Treatment Follow-Up Period||445
3050552|NCT01215942|3770557|FG000|NOT COMPLETED|Post-Treatment Follow-Up Period||85
3050553|NCT01215942|3770558|FG001|NOT COMPLETED|Post-Treatment Follow-Up Period||146
3050554|NCT01215955|3770579|FG000|STARTED|Overall Study||268
3050555|NCT01215955|3770580|FG001|STARTED|Overall Study||263
3050556|NCT01215955|3770581|FG002|STARTED|Overall Study|Three (3) participants from 1 site were excluded due to quality issues and validity of data.|292
3171717|NCT01936649|3898895|FG000|COMPLETED|Overall Study||50
3171718|NCT01936649|3898895|FG000|NOT COMPLETED|Overall Study||13
3171719|NCT01936662|3898901|FG000|STARTED|Overall Study||42
3171720|NCT01936662|3898902|FG001|STARTED|Overall Study||42
3171721|NCT01936662|3898901|FG000|COMPLETED|Overall Study||42
3171722|NCT01936662|3898902|FG001|COMPLETED|Overall Study||42
3171723|NCT01936662|3898901|FG000|NOT COMPLETED|Overall Study||0
3171724|NCT01936662|3898902|FG001|NOT COMPLETED|Overall Study||0
3281833|NCT02742649|4015571|FG004|NOT COMPLETED|Open-Label Period||1
3171725|NCT01936844|3898912|FG000|STARTED|Overall Study||15
3171726|NCT01936844|3898913|FG001|STARTED|Overall Study||15
3171727|NCT01936844|3898912|FG000|COMPLETED|Overall Study||9
3171728|NCT01936844|3898913|FG001|COMPLETED|Overall Study||8
3171729|NCT01936844|3898912|FG000|NOT COMPLETED|Overall Study||6
3050557|NCT01215955|3770582|FG003|STARTED|Overall Study|Two (2) participants from 1 site were excluded due to quality issues and validity of the data.|294
3050558|NCT01215955|3770579|FG000|Received at Least 1 Dose of Study Drug|Overall Study||267
3050559|NCT01215955|3770580|FG001|Received at Least 1 Dose of Study Drug|Overall Study||261
3050560|NCT01215955|3770581|FG002|Received at Least 1 Dose of Study Drug|Overall Study||288
3050561|NCT01215955|3770582|FG003|Received at Least 1 Dose of Study Drug|Overall Study||290
3050562|NCT01215955|3770579|FG000|COMPLETED|Overall Study||223
3050563|NCT01215955|3770580|FG001|COMPLETED|Overall Study||210
3050564|NCT01215955|3770581|FG002|COMPLETED|Overall Study||244
3050565|NCT01215955|3770582|FG003|COMPLETED|Overall Study||241
3050566|NCT01215955|3770579|FG000|NOT COMPLETED|Overall Study||45
3050567|NCT01215955|3770580|FG001|NOT COMPLETED|Overall Study||53
3050568|NCT01215955|3770581|FG002|NOT COMPLETED|Overall Study||48
3050569|NCT01215955|3770582|FG003|NOT COMPLETED|Overall Study||53
3050570|NCT01215968|3770597|FG000|STARTED|Overall Study||13
3050571|NCT01215968|3770598|FG001|STARTED|Overall Study||25
3050572|NCT01215968|3770597|FG000|Received at Least 1 Dose of Study Drug|Overall Study||13
3050573|NCT01215968|3770598|FG001|Received at Least 1 Dose of Study Drug|Overall Study|25 participants received placebo during Week 1.|24
3050574|NCT01215968|3770597|FG000|COMPLETED|Overall Study||11
3050575|NCT01215968|3770598|FG001|COMPLETED|Overall Study||18
3050576|NCT01215968|3770597|FG000|NOT COMPLETED|Overall Study||2
3050577|NCT01215968|3770598|FG001|NOT COMPLETED|Overall Study||7
3050578|NCT01215981|3770609|FG000|STARTED|Overall Study||35
3050579|NCT01215981|3770610|FG001|STARTED|Overall Study||33
3050580|NCT01215981|3770609|FG000|COMPLETED|Overall Study||33
3050581|NCT01215981|3770610|FG001|COMPLETED|Overall Study||32
3050582|NCT01215981|3770609|FG000|NOT COMPLETED|Overall Study||2
3050583|NCT01215981|3770610|FG001|NOT COMPLETED|Overall Study||1
3050584|NCT01216072|3770618|FG000|STARTED|Open-Label Core Period ( 6 Months)||790
3050585|NCT01216072|3770619|FG001|STARTED|Open-Label Core Period ( 6 Months)||263
3281834|NCT02742766|4015601|FG000|STARTED|Part 1 (Up to 8 Days)||20
3281835|NCT02742766|4015602|FG001|STARTED|Part 1 (Up to 8 Days)||6
3281836|NCT02742766|4015603|FG002|STARTED|Part 1 (Up to 8 Days)||6
3281837|NCT02742766|4015604|FG003|STARTED|Part 1 (Up to 8 Days)||6
3281838|NCT02742766|4015605|FG004|STARTED|Part 1 (Up to 8 Days)||6
3281839|NCT02742766|4015606|FG005|STARTED|Part 1 (Up to 8 Days)||6
3281840|NCT02742766|4015607|FG006|STARTED|Part 1 (Up to 8 Days)||6
3281841|NCT02742766|4015608|FG007|STARTED|Part 1 (Up to 8 Days)||6
3281842|NCT02742766|4015609|FG008|STARTED|Part 1 (Up to 8 Days)||6
3281843|NCT02742766|4015610|FG009|STARTED|Part 1 (Up to 8 Days)||0
3281844|NCT02742766|4015611|FG010|STARTED|Part 1 (Up to 8 Days)||6
3281845|NCT02742766|4015612|FG011|STARTED|Part 1 (Up to 8 Days)||6
3281846|NCT02742766|4015613|FG012|STARTED|Part 1 (Up to 8 Days)||0
3281847|NCT02742766|4015614|FG013|STARTED|Part 1 (Up to 8 Days)||0
3281848|NCT02742766|4015615|FG014|STARTED|Part 1 (Up to 8 Days)||0
3281849|NCT02742766|4015616|FG015|STARTED|Part 1 (Up to 8 Days)||0
3281850|NCT02742766|4015617|FG016|STARTED|Part 1 (Up to 8 Days)||0
3281851|NCT02742766|4015618|FG017|STARTED|Part 1 (Up to 8 Days)||0
3281852|NCT02742766|4015619|FG018|STARTED|Part 1 (Up to 8 Days)||0
3281853|NCT02742766|4015601|FG000|COMPLETED|Part 1 (Up to 8 Days)||20
3281854|NCT02742766|4015602|FG001|COMPLETED|Part 1 (Up to 8 Days)||6
3281855|NCT02742766|4015603|FG002|COMPLETED|Part 1 (Up to 8 Days)||6
3281856|NCT02742766|4015604|FG003|COMPLETED|Part 1 (Up to 8 Days)||6
3281857|NCT02742766|4015605|FG004|COMPLETED|Part 1 (Up to 8 Days)||6
3281858|NCT02742766|4015606|FG005|COMPLETED|Part 1 (Up to 8 Days)||6
3281859|NCT02742766|4015607|FG006|COMPLETED|Part 1 (Up to 8 Days)||6
3281860|NCT02742766|4015608|FG007|COMPLETED|Part 1 (Up to 8 Days)||6
3281861|NCT02742766|4015609|FG008|COMPLETED|Part 1 (Up to 8 Days)||6
3281862|NCT02742766|4015610|FG009|COMPLETED|Part 1 (Up to 8 Days)||0
3281863|NCT02742766|4015611|FG010|COMPLETED|Part 1 (Up to 8 Days)||6
3281864|NCT02742766|4015612|FG011|COMPLETED|Part 1 (Up to 8 Days)||6
3281865|NCT02742766|4015613|FG012|COMPLETED|Part 1 (Up to 8 Days)||0
3281866|NCT02742766|4015614|FG013|COMPLETED|Part 1 (Up to 8 Days)||0
3281867|NCT02742766|4015615|FG014|COMPLETED|Part 1 (Up to 8 Days)||0
3281868|NCT02742766|4015616|FG015|COMPLETED|Part 1 (Up to 8 Days)||0
3281869|NCT02742766|4015617|FG016|COMPLETED|Part 1 (Up to 8 Days)||0
3281870|NCT02742766|4015618|FG017|COMPLETED|Part 1 (Up to 8 Days)||0
3281871|NCT02742766|4015619|FG018|COMPLETED|Part 1 (Up to 8 Days)||0
3281872|NCT02742766|4015601|FG000|NOT COMPLETED|Part 1 (Up to 8 Days)||0
3281873|NCT02742766|4015602|FG001|NOT COMPLETED|Part 1 (Up to 8 Days)||0
3281874|NCT02742766|4015603|FG002|NOT COMPLETED|Part 1 (Up to 8 Days)||0
3281875|NCT02742766|4015604|FG003|NOT COMPLETED|Part 1 (Up to 8 Days)||0
3281876|NCT02742766|4015605|FG004|NOT COMPLETED|Part 1 (Up to 8 Days)||0
3281877|NCT02742766|4015606|FG005|NOT COMPLETED|Part 1 (Up to 8 Days)||0
3281878|NCT02742766|4015607|FG006|NOT COMPLETED|Part 1 (Up to 8 Days)||0
3281879|NCT02742766|4015608|FG007|NOT COMPLETED|Part 1 (Up to 8 Days)||0
3281880|NCT02742766|4015609|FG008|NOT COMPLETED|Part 1 (Up to 8 Days)||0
3281881|NCT02742766|4015610|FG009|NOT COMPLETED|Part 1 (Up to 8 Days)||0
3281882|NCT02742766|4015611|FG010|NOT COMPLETED|Part 1 (Up to 8 Days)||0
3281883|NCT02742766|4015612|FG011|NOT COMPLETED|Part 1 (Up to 8 Days)||0
3281884|NCT02742766|4015613|FG012|NOT COMPLETED|Part 1 (Up to 8 Days)||0
3281885|NCT02742766|4015614|FG013|NOT COMPLETED|Part 1 (Up to 8 Days)||0
3281886|NCT02742766|4015615|FG014|NOT COMPLETED|Part 1 (Up to 8 Days)||0
3281887|NCT02742766|4015616|FG015|NOT COMPLETED|Part 1 (Up to 8 Days)||0
3281888|NCT02742766|4015617|FG016|NOT COMPLETED|Part 1 (Up to 8 Days)||0
3050586|NCT01216072|3770618|FG000|Full Analysis Set|Open-Label Core Period ( 6 Months)|One patient was randomized in error and was not included in FAS.|789
3050587|NCT01216072|3770619|FG001|Full Analysis Set|Open-Label Core Period ( 6 Months)||263
3050588|NCT01216072|3770618|FG000|Safety Set|Open-Label Core Period ( 6 Months)||783
3050589|NCT01216072|3770619|FG001|Safety Set|Open-Label Core Period ( 6 Months)||245
3050590|NCT01216072|3770618|FG000|COMPLETED|Open-Label Core Period ( 6 Months)||714
3050591|NCT01216072|3770619|FG001|COMPLETED|Open-Label Core Period ( 6 Months)||229
3050592|NCT01216072|3770618|FG000|NOT COMPLETED|Open-Label Core Period ( 6 Months)||76
3050593|NCT01216072|3770619|FG001|NOT COMPLETED|Open-Label Core Period ( 6 Months)||34
3050594|NCT01216072|3770618|FG000|STARTED|Open-Label Extension Period (3 Months)||0
3050595|NCT01216072|3770619|FG001|STARTED|Open-Label Extension Period (3 Months)|Only DMT patients, who completed the core study, were eligible for fingolimod.|195
3050596|NCT01216072|3770618|FG000|Safety Set|Open-Label Extension Period (3 Months)||0
3050597|NCT01216072|3770619|FG001|Safety Set|Open-Label Extension Period (3 Months)||193
3050598|NCT01216072|3770618|FG000|COMPLETED|Open-Label Extension Period (3 Months)||0
3050599|NCT01216072|3770619|FG001|COMPLETED|Open-Label Extension Period (3 Months)||181
3050600|NCT01216072|3770618|FG000|NOT COMPLETED|Open-Label Extension Period (3 Months)||0
3050601|NCT01216072|3770619|FG001|NOT COMPLETED|Open-Label Extension Period (3 Months)||14
3050602|NCT01216163|3770631|FG000|STARTED|Overall Study||45
3050603|NCT01216163|3770632|FG001|STARTED|Overall Study||88
3050604|NCT01216163|3770633|FG002|STARTED|Overall Study||85
3050605|NCT01216163|3770631|FG000|COMPLETED|Overall Study||44
3050606|NCT01216163|3770632|FG001|COMPLETED|Overall Study||87
3050607|NCT01216163|3770633|FG002|COMPLETED|Overall Study||85
3050608|NCT01216163|3770631|FG000|NOT COMPLETED|Overall Study||1
3050609|NCT01216163|3770632|FG001|NOT COMPLETED|Overall Study||1
3050610|NCT01216163|3770633|FG002|NOT COMPLETED|Overall Study||0
3050611|NCT01216176|3770644|FG000|STARTED|Overall Study||12
3050612|NCT01216176|3770645|FG001|STARTED|Overall Study||39
3050613|NCT01216176|3770646|FG002|STARTED|Overall Study||20
3050614|NCT01216176|3770644|FG000|COMPLETED|Overall Study||12
3050615|NCT01216176|3770645|FG001|COMPLETED|Overall Study||31
3050616|NCT01216176|3770646|FG002|COMPLETED|Overall Study||19
3050617|NCT01216176|3770644|FG000|NOT COMPLETED|Overall Study||0
3050618|NCT01216176|3770645|FG001|NOT COMPLETED|Overall Study||8
3050619|NCT01216176|3770646|FG002|NOT COMPLETED|Overall Study||1
3050620|NCT01216189|3770657|FG000|STARTED|Overall Study||110
3050621|NCT01216189|3770658|FG001|STARTED|Overall Study||32
3050622|NCT01216189|3770657|FG000|COMPLETED|Overall Study||85
3050623|NCT01216189|3770658|FG001|COMPLETED|Overall Study||27
3050624|NCT01216189|3770657|FG000|NOT COMPLETED|Overall Study||25
3050625|NCT01216189|3770658|FG001|NOT COMPLETED|Overall Study||5
3050626|NCT01216202|3770666|FG000|STARTED|Overall Study||101
3050627|NCT01216202|3770667|FG001|STARTED|Overall Study||77
3050628|NCT01216202|3770666|FG000|Analysed at Baseline|Overall Study||93
3050629|NCT01216202|3770667|FG001|Analysed at Baseline|Overall Study||75
3050630|NCT01216202|3770666|FG000|Analysed After RT|Overall Study||79
3050631|NCT01216202|3770667|FG001|Analysed After RT|Overall Study||0
3050632|NCT01216202|3770666|FG000|COMPLETED|Overall Study||79
3050633|NCT01216202|3770667|FG001|COMPLETED|Overall Study||75
3050634|NCT01216202|3770666|FG000|NOT COMPLETED|Overall Study||22
3050635|NCT01216202|3770667|FG001|NOT COMPLETED|Overall Study||2
3050636|NCT01216241|3770677|FG000|STARTED|Overall Study|18 subjects randomized. All didn't receive study drug/placebo if they didn't have neutropenic fever|18
3050637|NCT01216241|3770678|FG001|STARTED|Overall Study|18 subjects randomized. All didn't receive study drug/placebo if they didn't have neutropenic fever|18
3050638|NCT01216241|3770677|FG000|COMPLETED|Overall Study|Reporter remains blinded so the 4 completed could have been either study drug or placebo.|18
3050639|NCT01216241|3770678|FG001|COMPLETED|Overall Study|Reporter remains blinded so the 4 completed could have been either study drug or placebo.|18
3050640|NCT01216241|3770677|FG000|NOT COMPLETED|Overall Study||0
3050641|NCT01216241|3770678|FG001|NOT COMPLETED|Overall Study||0
3050642|NCT01216319|3770684|FG000|STARTED|Overall Study||50
3050643|NCT01216319|3770684|FG000|COMPLETED|Overall Study||46
3050644|NCT01216319|3770684|FG000|NOT COMPLETED|Overall Study||4
3050645|NCT01216332|3770690|FG000|STARTED|Overall Study||34
3050646|NCT01216332|3770691|FG001|STARTED|Overall Study||16
3050647|NCT01216332|3770690|FG000|COMPLETED|Overall Study||30
3050648|NCT01216332|3770691|FG001|COMPLETED|Overall Study||16
3050649|NCT01216332|3770690|FG000|NOT COMPLETED|Overall Study||4
3050650|NCT01216332|3770691|FG001|NOT COMPLETED|Overall Study||0
3050651|NCT01216397|3770697|FG000|STARTED|Period 1||20
3050652|NCT01216397|3770698|FG001|STARTED|Period 1||20
3050653|NCT01216397|3770697|FG000|COMPLETED|Period 1||20
3050654|NCT01216397|3770698|FG001|COMPLETED|Period 1||20
3050655|NCT01216397|3770697|FG000|NOT COMPLETED|Period 1||0
3281889|NCT02742766|4015618|FG017|NOT COMPLETED|Part 1 (Up to 8 Days)||0
3281890|NCT02742766|4015619|FG018|NOT COMPLETED|Part 1 (Up to 8 Days)||0
3281891|NCT02742766|4015601|FG000|STARTED|Part 2 (Up to 22 Days)||0
3281892|NCT02742766|4015602|FG001|STARTED|Part 2 (Up to 22 Days)||0
3281893|NCT02742766|4015603|FG002|STARTED|Part 2 (Up to 22 Days)||0
3281894|NCT02742766|4015604|FG003|STARTED|Part 2 (Up to 22 Days)||0
3281895|NCT02742766|4015605|FG004|STARTED|Part 2 (Up to 22 Days)||0
3281896|NCT02742766|4015606|FG005|STARTED|Part 2 (Up to 22 Days)||0
3281897|NCT02742766|4015607|FG006|STARTED|Part 2 (Up to 22 Days)||0
3281898|NCT02742766|4015608|FG007|STARTED|Part 2 (Up to 22 Days)||0
3281899|NCT02742766|4015609|FG008|STARTED|Part 2 (Up to 22 Days)||0
3281900|NCT02742766|4015610|FG009|STARTED|Part 2 (Up to 22 Days)||0
3050656|NCT01216397|3770698|FG001|NOT COMPLETED|Period 1||0
3050657|NCT01216397|3770697|FG000|STARTED|Washout (35 Days)||20
3050658|NCT01216397|3770698|FG001|STARTED|Washout (35 Days)||20
3050659|NCT01216397|3770697|FG000|COMPLETED|Washout (35 Days)||20
3050660|NCT01216397|3770698|FG001|COMPLETED|Washout (35 Days)||20
3050661|NCT01216397|3770697|FG000|NOT COMPLETED|Washout (35 Days)||0
3050662|NCT01216397|3770698|FG001|NOT COMPLETED|Washout (35 Days)||0
3050663|NCT01216397|3770697|FG000|STARTED|Period 2||20
3050664|NCT01216397|3770698|FG001|STARTED|Period 2||20
3050665|NCT01216397|3770697|FG000|COMPLETED|Period 2||20
3050666|NCT01216397|3770698|FG001|COMPLETED|Period 2||20
3050667|NCT01216397|3770697|FG000|NOT COMPLETED|Period 2||0
3050668|NCT01216397|3770698|FG001|NOT COMPLETED|Period 2||0
3050669|NCT01216410|3770707|FG000|STARTED|Overall Study||103
3050670|NCT01216410|3770708|FG001|STARTED|Overall Study||100
3050671|NCT01216410|3770709|FG002|STARTED|Overall Study||103
3050672|NCT01216410|3770707|FG000|COMPLETED|Overall Study||101
3050673|NCT01216410|3770708|FG001|COMPLETED|Overall Study||99
3050674|NCT01216410|3770709|FG002|COMPLETED|Overall Study||100
3050675|NCT01216410|3770707|FG000|NOT COMPLETED|Overall Study||2
3050676|NCT01216410|3770708|FG001|NOT COMPLETED|Overall Study||1
3050677|NCT01216410|3770709|FG002|NOT COMPLETED|Overall Study||3
3050678|NCT01216683|3770720|FG000|STARTED|Induction||65
3050679|NCT01216683|3770721|FG001|STARTED|Induction||99
3050680|NCT01216683|3770722|FG002|STARTED|Induction||125
3050681|NCT01216683|3770720|FG000|Received Treatment and Assessed for Toxicities|Induction||65
3050682|NCT01216683|3770721|FG001|Received Treatment and Assessed for Toxicities|Induction||93
3050683|NCT01216683|3770722|FG002|Received Treatment and Assessed for Toxicities|Induction||122
3050684|NCT01216683|3770720|FG000|Eligible and Treated|Induction||59
3050685|NCT01216683|3770721|FG001|Eligible and Treated|Induction||85
3050686|NCT01216683|3770722|FG002|Eligible and Treated|Induction||114
3050687|NCT01216683|3770720|FG000|Included in the Primary Analysis of Complete Remission Rate During Induction Treatment|Induction||48
3050688|NCT01216683|3770721|FG001|Included in the Primary Analysis of Complete Remission Rate During Induction Treatment|Induction||85
3050689|NCT01216683|3770722|FG002|Included in the Primary Analysis of Complete Remission Rate During Induction Treatment|Induction||89
3050690|NCT01216683|3770720|FG000|COMPLETED|Induction||61
3050691|NCT01216683|3770721|FG001|COMPLETED|Induction||80
3050692|NCT01216683|3770722|FG002|COMPLETED|Induction||104
3050693|NCT01216683|3770720|FG000|NOT COMPLETED|Induction||4
3050694|NCT01216683|3770721|FG001|NOT COMPLETED|Induction||19
3050695|NCT01216683|3770722|FG002|NOT COMPLETED|Induction||21
3050696|NCT01216683|3770720|FG000|STARTED|Continuation||59
3050697|NCT01216683|3770721|FG001|STARTED|Continuation||71
3050698|NCT01216683|3770722|FG002|STARTED|Continuation||94
3050699|NCT01216683|3770720|FG000|Received Continuation Treatment|Continuation||59
3050700|NCT01216683|3770721|FG001|Received Continuation Treatment|Continuation||70
3050701|NCT01216683|3770722|FG002|Received Continuation Treatment|Continuation||89
3050702|NCT01216683|3770720|FG000|COMPLETED|Continuation||44
3050703|NCT01216683|3770721|FG001|COMPLETED|Continuation||56
3050704|NCT01216683|3770722|FG002|COMPLETED|Continuation||51
3050705|NCT01216683|3770720|FG000|NOT COMPLETED|Continuation||15
3050706|NCT01216683|3770721|FG001|NOT COMPLETED|Continuation||15
3050707|NCT01216683|3770722|FG002|NOT COMPLETED|Continuation||43
3050708|NCT01216735|3770745|FG000|STARTED|First Intervention (3 Weeks)||8
3050709|NCT01216735|3770746|FG001|STARTED|First Intervention (3 Weeks)||7
3050710|NCT01216735|3770745|FG000|COMPLETED|First Intervention (3 Weeks)||8
3050711|NCT01216735|3770746|FG001|COMPLETED|First Intervention (3 Weeks)||7
3050712|NCT01216735|3770745|FG000|NOT COMPLETED|First Intervention (3 Weeks)||0
3050713|NCT01216735|3770746|FG001|NOT COMPLETED|First Intervention (3 Weeks)||0
3050714|NCT01216735|3770745|FG000|STARTED|Washout (3 Weeks)||8
3050715|NCT01216735|3770746|FG001|STARTED|Washout (3 Weeks)||7
3050716|NCT01216735|3770745|FG000|COMPLETED|Washout (3 Weeks)||8
3050717|NCT01216735|3770746|FG001|COMPLETED|Washout (3 Weeks)||7
3050718|NCT01216735|3770745|FG000|NOT COMPLETED|Washout (3 Weeks)||0
3050719|NCT01216735|3770746|FG001|NOT COMPLETED|Washout (3 Weeks)||0
3050720|NCT01216735|3770745|FG000|STARTED|Second Intervention (3 Weeks)||8
3050721|NCT01216735|3770746|FG001|STARTED|Second Intervention (3 Weeks)||7
3050722|NCT01216735|3770745|FG000|COMPLETED|Second Intervention (3 Weeks)||8
3050723|NCT01216735|3770746|FG001|COMPLETED|Second Intervention (3 Weeks)||7
3050724|NCT01216735|3770745|FG000|NOT COMPLETED|Second Intervention (3 Weeks)||0
3050725|NCT01216735|3770746|FG001|NOT COMPLETED|Second Intervention (3 Weeks)||0
3050726|NCT01216748|3770752|FG000|STARTED|Overall Study||10
3050727|NCT01216748|3770752|FG000|Quiet Breathing|Overall Study||10
3050728|NCT01216748|3770752|FG000|Hypocapnic Hyperventilation|Overall Study||10
3050729|NCT01216748|3770752|FG000|Hypercapnic Hyperventilation|Overall Study||10
3050730|NCT01216748|3770752|FG000|Eucapnic Hyperventilation|Overall Study||10
3050731|NCT01216748|3770752|FG000|COMPLETED|Overall Study||10
3050732|NCT01216748|3770752|FG000|NOT COMPLETED|Overall Study||0
3050733|NCT01216761|3770756|FG000|STARTED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1421
3050734|NCT01216761|3770757|FG001|STARTED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1410
3050735|NCT01216761|3770758|FG002|STARTED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1379
3050736|NCT01216761|3770756|FG000|COMPLETED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1421
3050737|NCT01216761|3770757|FG001|COMPLETED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1410
3050738|NCT01216761|3770758|FG002|COMPLETED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1379
3050739|NCT01216761|3770756|FG000|NOT COMPLETED|Overall Study||0
3050740|NCT01216761|3770757|FG001|NOT COMPLETED|Overall Study||0
3050741|NCT01216761|3770758|FG002|NOT COMPLETED|Overall Study||0
3050742|NCT01216943|3770766|FG000|STARTED|Overall Study||126
3050743|NCT01216943|3770766|FG000|COMPLETED|Overall Study||113
3050744|NCT01216943|3770766|FG000|NOT COMPLETED|Overall Study||13
3050745|NCT01217073|3770776|FG000|STARTED|Base Period||113
3050746|NCT01217073|3770777|FG001|STARTED|Base Period||115
3050747|NCT01217073|3770778|FG002|STARTED|Base Period||114
3050748|NCT01217073|3770779|FG003|STARTED|Base Period||115
3050749|NCT01217073|3770780|FG004|STARTED|Base Period||114
3050750|NCT01217073|3770781|FG005|STARTED|Base Period||114
3050751|NCT01217073|3770782|FG006|STARTED|Base Period||0
3050752|NCT01217073|3770783|FG007|STARTED|Base Period||0
3050753|NCT01217073|3770776|FG000|COMPLETED|Base Period||106
3050754|NCT01217073|3770777|FG001|COMPLETED|Base Period||110
3281901|NCT02742766|4015611|FG010|STARTED|Part 2 (Up to 22 Days)||0
3281902|NCT02742766|4015612|FG011|STARTED|Part 2 (Up to 22 Days)||0
3281903|NCT02742766|4015613|FG012|STARTED|Part 2 (Up to 22 Days)||6
3281904|NCT02742766|4015614|FG013|STARTED|Part 2 (Up to 22 Days)||6
3281905|NCT02742766|4015615|FG014|STARTED|Part 2 (Up to 22 Days)||6
3281906|NCT02742766|4015616|FG015|STARTED|Part 2 (Up to 22 Days)||6
3281907|NCT02742766|4015617|FG016|STARTED|Part 2 (Up to 22 Days)||0
3281908|NCT02742766|4015618|FG017|STARTED|Part 2 (Up to 22 Days)||0
3281909|NCT02742766|4015619|FG018|STARTED|Part 2 (Up to 22 Days)||0
3281910|NCT02742766|4015601|FG000|COMPLETED|Part 2 (Up to 22 Days)||0
3281911|NCT02742766|4015602|FG001|COMPLETED|Part 2 (Up to 22 Days)||0
3281912|NCT02742766|4015603|FG002|COMPLETED|Part 2 (Up to 22 Days)||0
3281913|NCT02742766|4015604|FG003|COMPLETED|Part 2 (Up to 22 Days)||0
3281914|NCT02742766|4015605|FG004|COMPLETED|Part 2 (Up to 22 Days)||0
3281915|NCT02742766|4015606|FG005|COMPLETED|Part 2 (Up to 22 Days)||0
3281916|NCT02742766|4015607|FG006|COMPLETED|Part 2 (Up to 22 Days)||0
3281917|NCT02742766|4015608|FG007|COMPLETED|Part 2 (Up to 22 Days)||0
3281918|NCT02742766|4015609|FG008|COMPLETED|Part 2 (Up to 22 Days)||0
3281919|NCT02742766|4015610|FG009|COMPLETED|Part 2 (Up to 22 Days)||0
3281920|NCT02742766|4015611|FG010|COMPLETED|Part 2 (Up to 22 Days)||0
3281921|NCT02742766|4015612|FG011|COMPLETED|Part 2 (Up to 22 Days)||0
3281922|NCT02742766|4015613|FG012|COMPLETED|Part 2 (Up to 22 Days)||4
3281923|NCT02742766|4015614|FG013|COMPLETED|Part 2 (Up to 22 Days)||0
3281924|NCT02742766|4015615|FG014|COMPLETED|Part 2 (Up to 22 Days)||6
3281925|NCT02742766|4015616|FG015|COMPLETED|Part 2 (Up to 22 Days)|Day 4 study medication interrupted due to an AE and eventually withdrew from study on Day 5.|5
3281926|NCT02742766|4015617|FG016|COMPLETED|Part 2 (Up to 22 Days)||0
3281927|NCT02742766|4015618|FG017|COMPLETED|Part 2 (Up to 22 Days)||0
3281928|NCT02742766|4015619|FG018|COMPLETED|Part 2 (Up to 22 Days)||0
3281929|NCT02742766|4015601|FG000|NOT COMPLETED|Part 2 (Up to 22 Days)||0
3281930|NCT02742766|4015602|FG001|NOT COMPLETED|Part 2 (Up to 22 Days)||0
3281931|NCT02742766|4015603|FG002|NOT COMPLETED|Part 2 (Up to 22 Days)||0
3281932|NCT02742766|4015604|FG003|NOT COMPLETED|Part 2 (Up to 22 Days)||0
3281933|NCT02742766|4015605|FG004|NOT COMPLETED|Part 2 (Up to 22 Days)||0
3281934|NCT02742766|4015606|FG005|NOT COMPLETED|Part 2 (Up to 22 Days)||0
3281935|NCT02742766|4015607|FG006|NOT COMPLETED|Part 2 (Up to 22 Days)||0
3281936|NCT02742766|4015608|FG007|NOT COMPLETED|Part 2 (Up to 22 Days)||0
3281937|NCT02742766|4015609|FG008|NOT COMPLETED|Part 2 (Up to 22 Days)||0
3281938|NCT02742766|4015610|FG009|NOT COMPLETED|Part 2 (Up to 22 Days)||0
3281939|NCT02742766|4015611|FG010|NOT COMPLETED|Part 2 (Up to 22 Days)||0
3281940|NCT02742766|4015612|FG011|NOT COMPLETED|Part 2 (Up to 22 Days)||0
3281941|NCT02742766|4015613|FG012|NOT COMPLETED|Part 2 (Up to 22 Days)||2
3281942|NCT02742766|4015614|FG013|NOT COMPLETED|Part 2 (Up to 22 Days)||6
3281943|NCT02742766|4015615|FG014|NOT COMPLETED|Part 2 (Up to 22 Days)||0
3281944|NCT02742766|4015616|FG015|NOT COMPLETED|Part 2 (Up to 22 Days)||1
3281945|NCT02742766|4015617|FG016|NOT COMPLETED|Part 2 (Up to 22 Days)||0
3281946|NCT02742766|4015618|FG017|NOT COMPLETED|Part 2 (Up to 22 Days)||0
3281947|NCT02742766|4015619|FG018|NOT COMPLETED|Part 2 (Up to 22 Days)||0
3281948|NCT02742766|4015601|FG000|STARTED|Part 3 (Up to 36 Days)||0
3281949|NCT02742766|4015602|FG001|STARTED|Part 3 (Up to 36 Days)||0
3281950|NCT02742766|4015603|FG002|STARTED|Part 3 (Up to 36 Days)||0
3281951|NCT02742766|4015604|FG003|STARTED|Part 3 (Up to 36 Days)||0
3281952|NCT02742766|4015605|FG004|STARTED|Part 3 (Up to 36 Days)||0
3281953|NCT02742766|4015606|FG005|STARTED|Part 3 (Up to 36 Days)||0
3281954|NCT02742766|4015607|FG006|STARTED|Part 3 (Up to 36 Days)||0
3281955|NCT02742766|4015608|FG007|STARTED|Part 3 (Up to 36 Days)||0
3281956|NCT02742766|4015609|FG008|STARTED|Part 3 (Up to 36 Days)||0
3281957|NCT02742766|4015610|FG009|STARTED|Part 3 (Up to 36 Days)||0
3281958|NCT02742766|4015611|FG010|STARTED|Part 3 (Up to 36 Days)||0
3050755|NCT01217073|3770778|FG002|COMPLETED|Base Period||107
3050756|NCT01217073|3770779|FG003|COMPLETED|Base Period||113
3281959|NCT02742766|4015612|FG011|STARTED|Part 3 (Up to 36 Days)||0
3281960|NCT02742766|4015613|FG012|STARTED|Part 3 (Up to 36 Days)||0
3281961|NCT02742766|4015614|FG013|STARTED|Part 3 (Up to 36 Days)||0
3281962|NCT02742766|4015615|FG014|STARTED|Part 3 (Up to 36 Days)||0
3281963|NCT02742766|4015616|FG015|STARTED|Part 3 (Up to 36 Days)||0
3281964|NCT02742766|4015617|FG016|STARTED|Part 3 (Up to 36 Days)||0
3281965|NCT02742766|4015618|FG017|STARTED|Part 3 (Up to 36 Days)||0
3281966|NCT02742766|4015619|FG018|STARTED|Part 3 (Up to 36 Days)||0
3281967|NCT02742766|4015601|FG000|COMPLETED|Part 3 (Up to 36 Days)||0
3050757|NCT01217073|3770780|FG004|COMPLETED|Base Period||99
3050758|NCT01217073|3770781|FG005|COMPLETED|Base Period||105
3050759|NCT01217073|3770782|FG006|COMPLETED|Base Period||0
3050760|NCT01217073|3770783|FG007|COMPLETED|Base Period||0
3050761|NCT01217073|3770776|FG000|NOT COMPLETED|Base Period||7
3050762|NCT01217073|3770777|FG001|NOT COMPLETED|Base Period||5
3050763|NCT01217073|3770778|FG002|NOT COMPLETED|Base Period||7
3050764|NCT01217073|3770779|FG003|NOT COMPLETED|Base Period||2
3050765|NCT01217073|3770780|FG004|NOT COMPLETED|Base Period||15
3050766|NCT01217073|3770781|FG005|NOT COMPLETED|Base Period||9
3050767|NCT01217073|3770782|FG006|NOT COMPLETED|Base Period||0
3050768|NCT01217073|3770783|FG007|NOT COMPLETED|Base Period||0
3281968|NCT02742766|4015602|FG001|COMPLETED|Part 3 (Up to 36 Days)||0
3281969|NCT02742766|4015603|FG002|COMPLETED|Part 3 (Up to 36 Days)||0
3281970|NCT02742766|4015604|FG003|COMPLETED|Part 3 (Up to 36 Days)||0
3281971|NCT02742766|4015605|FG004|COMPLETED|Part 3 (Up to 36 Days)||0
3281972|NCT02742766|4015606|FG005|COMPLETED|Part 3 (Up to 36 Days)||0
3281973|NCT02742766|4015607|FG006|COMPLETED|Part 3 (Up to 36 Days)||0
3281974|NCT02742766|4015608|FG007|COMPLETED|Part 3 (Up to 36 Days)||0
3281975|NCT02742766|4015609|FG008|COMPLETED|Part 3 (Up to 36 Days)||0
3281976|NCT02742766|4015610|FG009|COMPLETED|Part 3 (Up to 36 Days)||0
3281977|NCT02742766|4015611|FG010|COMPLETED|Part 3 (Up to 36 Days)||0
3281978|NCT02742766|4015612|FG011|COMPLETED|Part 3 (Up to 36 Days)||0
3281979|NCT02742766|4015613|FG012|COMPLETED|Part 3 (Up to 36 Days)||0
3281980|NCT02742766|4015614|FG013|COMPLETED|Part 3 (Up to 36 Days)||0
3281981|NCT02742766|4015615|FG014|COMPLETED|Part 3 (Up to 36 Days)||0
3281982|NCT02742766|4015616|FG015|COMPLETED|Part 3 (Up to 36 Days)||0
3281983|NCT02742766|4015617|FG016|COMPLETED|Part 3 (Up to 36 Days)||0
3281984|NCT02742766|4015618|FG017|COMPLETED|Part 3 (Up to 36 Days)||0
3281985|NCT02742766|4015619|FG018|COMPLETED|Part 3 (Up to 36 Days)||0
3281986|NCT02742766|4015601|FG000|NOT COMPLETED|Part 3 (Up to 36 Days)||0
3281987|NCT02742766|4015602|FG001|NOT COMPLETED|Part 3 (Up to 36 Days)||0
3281988|NCT02742766|4015603|FG002|NOT COMPLETED|Part 3 (Up to 36 Days)||0
3281989|NCT02742766|4015604|FG003|NOT COMPLETED|Part 3 (Up to 36 Days)||0
3281990|NCT02742766|4015605|FG004|NOT COMPLETED|Part 3 (Up to 36 Days)||0
3281991|NCT02742766|4015606|FG005|NOT COMPLETED|Part 3 (Up to 36 Days)||0
3281992|NCT02742766|4015607|FG006|NOT COMPLETED|Part 3 (Up to 36 Days)||0
3281993|NCT02742766|4015608|FG007|NOT COMPLETED|Part 3 (Up to 36 Days)||0
3281994|NCT02742766|4015609|FG008|NOT COMPLETED|Part 3 (Up to 36 Days)||0
3281995|NCT02742766|4015610|FG009|NOT COMPLETED|Part 3 (Up to 36 Days)||0
3281996|NCT02742766|4015611|FG010|NOT COMPLETED|Part 3 (Up to 36 Days)||0
3281997|NCT02742766|4015612|FG011|NOT COMPLETED|Part 3 (Up to 36 Days)||0
3281998|NCT02742766|4015613|FG012|NOT COMPLETED|Part 3 (Up to 36 Days)||0
3281999|NCT02742766|4015614|FG013|NOT COMPLETED|Part 3 (Up to 36 Days)||0
3282000|NCT02742766|4015615|FG014|NOT COMPLETED|Part 3 (Up to 36 Days)||0
3282001|NCT02742766|4015616|FG015|NOT COMPLETED|Part 3 (Up to 36 Days)||0
3282002|NCT02742766|4015617|FG016|NOT COMPLETED|Part 3 (Up to 36 Days)||0
3282003|NCT02742766|4015618|FG017|NOT COMPLETED|Part 3 (Up to 36 Days)||0
3282004|NCT02742766|4015619|FG018|NOT COMPLETED|Part 3 (Up to 36 Days)||0
3282005|NCT02742818|4015681|FG000|STARTED|Overall Study||25
3282006|NCT02742818|4015682|FG001|STARTED|Overall Study||25
3282007|NCT02742818|4015681|FG000|COMPLETED|Overall Study||25
3282008|NCT02742818|4015682|FG001|COMPLETED|Overall Study||23
3282009|NCT02742818|4015681|FG000|NOT COMPLETED|Overall Study||0
3282010|NCT02742818|4015682|FG001|NOT COMPLETED|Overall Study||2
3282011|NCT02742987|4015692|FG000|STARTED|Overall Study||21
3282012|NCT02742987|4015693|FG001|STARTED|Overall Study||21
3282013|NCT02742987|4015692|FG000|COMPLETED|Overall Study||21
3282014|NCT02742987|4015693|FG001|COMPLETED|Overall Study||21
3282015|NCT02742987|4015692|FG000|NOT COMPLETED|Overall Study||0
3282016|NCT02742987|4015693|FG001|NOT COMPLETED|Overall Study||0
3282017|NCT02743078|4015699|FG000|STARTED|Overall Study||3
3282018|NCT02743078|4015699|FG000|Eligible Populaton|Overall Study||3
3282019|NCT02743078|4015699|FG000|Eligible With Six-month Follow-up Data|Overall Study||3
3282020|NCT02743078|4015699|FG000|COMPLETED|Overall Study||3
3282021|NCT02743078|4015699|FG000|NOT COMPLETED|Overall Study||0
3282022|NCT02743117|4015705|FG000|STARTED|Overall Study||60
3282023|NCT02743117|4015706|FG001|STARTED|Overall Study||241
3282024|NCT02743117|4015705|FG000|Treated|Overall Study||59
3282025|NCT02743117|4015706|FG001|Treated|Overall Study||241
3282026|NCT02743117|4015705|FG000|COMPLETED|Overall Study||59
3282027|NCT02743117|4015706|FG001|COMPLETED|Overall Study||240
3282028|NCT02743117|4015705|FG000|NOT COMPLETED|Overall Study||1
3282029|NCT02743117|4015706|FG001|NOT COMPLETED|Overall Study||1
3282030|NCT02743221|4015714|FG000|STARTED|Overall Study||77
3282031|NCT02743221|4015715|FG001|STARTED|Overall Study||77
3282032|NCT02743221|4015714|FG000|COMPLETED|Overall Study||21
3282033|NCT02743221|4015715|FG001|COMPLETED|Overall Study||17
3282034|NCT02743221|4015714|FG000|NOT COMPLETED|Overall Study||56
3282035|NCT02743221|4015715|FG001|NOT COMPLETED|Overall Study||60
3282036|NCT02743312|4015723|FG000|STARTED|Overall Study||3
3282037|NCT02743312|4015724|FG001|STARTED|Overall Study||2
3050769|NCT01217073|3770776|FG000|STARTED|Extension Period||0
3050770|NCT01217073|3770777|FG001|STARTED|Extension Period||0
3050771|NCT01217073|3770778|FG002|STARTED|Extension Period||0
3050772|NCT01217073|3770779|FG003|STARTED|Extension Period||0
3282038|NCT02743312|4015723|FG000|COMPLETED|Overall Study||3
3282039|NCT02743312|4015724|FG001|COMPLETED|Overall Study||2
3282040|NCT02743312|4015723|FG000|NOT COMPLETED|Overall Study||0
3282041|NCT02743312|4015724|FG001|NOT COMPLETED|Overall Study||0
3050773|NCT01217073|3770780|FG004|STARTED|Extension Period||0
3050774|NCT01217073|3770781|FG005|STARTED|Extension Period||0
3050775|NCT01217073|3770782|FG006|STARTED|Extension Period||405
3050776|NCT01217073|3770783|FG007|STARTED|Extension Period||80
3050777|NCT01217073|3770776|FG000|COMPLETED|Extension Period||0
3050778|NCT01217073|3770777|FG001|COMPLETED|Extension Period||0
3050779|NCT01217073|3770778|FG002|COMPLETED|Extension Period||0
3050780|NCT01217073|3770779|FG003|COMPLETED|Extension Period||0
3050781|NCT01217073|3770780|FG004|COMPLETED|Extension Period||0
3050782|NCT01217073|3770781|FG005|COMPLETED|Extension Period||0
3050783|NCT01217073|3770782|FG006|COMPLETED|Extension Period||314
3050784|NCT01217073|3770783|FG007|COMPLETED|Extension Period||60
3050785|NCT01217073|3770776|FG000|NOT COMPLETED|Extension Period||0
3050786|NCT01217073|3770777|FG001|NOT COMPLETED|Extension Period||0
3050787|NCT01217073|3770778|FG002|NOT COMPLETED|Extension Period||0
3050788|NCT01217073|3770779|FG003|NOT COMPLETED|Extension Period||0
3050789|NCT01217073|3770780|FG004|NOT COMPLETED|Extension Period||0
3050790|NCT01217073|3770781|FG005|NOT COMPLETED|Extension Period||0
3050791|NCT01217073|3770782|FG006|NOT COMPLETED|Extension Period||91
3050792|NCT01217073|3770783|FG007|NOT COMPLETED|Extension Period||20
3050793|NCT01217112|3770812|FG000|STARTED|Overall Study||11
3050794|NCT01217112|3770813|FG001|STARTED|Overall Study||12
3050795|NCT01217112|3770814|FG002|STARTED|Overall Study||13
3050796|NCT01217112|3770815|FG003|STARTED|Overall Study||12
3050797|NCT01217112|3770816|FG004|STARTED|Overall Study||14
3050798|NCT01217112|3770812|FG000|COMPLETED|Overall Study||11
3050799|NCT01217112|3770813|FG001|COMPLETED|Overall Study||10
3050800|NCT01217112|3770814|FG002|COMPLETED|Overall Study||12
3050801|NCT01217112|3770815|FG003|COMPLETED|Overall Study||10
3050802|NCT01217112|3770816|FG004|COMPLETED|Overall Study||13
3050803|NCT01217112|3770812|FG000|NOT COMPLETED|Overall Study||0
3050804|NCT01217112|3770813|FG001|NOT COMPLETED|Overall Study||2
3050805|NCT01217112|3770814|FG002|NOT COMPLETED|Overall Study||1
3050806|NCT01217112|3770815|FG003|NOT COMPLETED|Overall Study||2
3050807|NCT01217112|3770816|FG004|NOT COMPLETED|Overall Study||1
3050808|NCT01217190|3770830|FG000|STARTED|First Dosing||24
3050809|NCT01217190|3770831|FG001|STARTED|First Dosing||24
3050810|NCT01217190|3770830|FG000|COMPLETED|First Dosing||24
3050811|NCT01217190|3770831|FG001|COMPLETED|First Dosing||24
3050812|NCT01217190|3770830|FG000|NOT COMPLETED|First Dosing||0
3050813|NCT01217190|3770831|FG001|NOT COMPLETED|First Dosing||0
3050814|NCT01217190|3770830|FG000|STARTED|Second Dosing||24
3050815|NCT01217190|3770831|FG001|STARTED|Second Dosing||24
3050816|NCT01217190|3770830|FG000|COMPLETED|Second Dosing||24
3050817|NCT01217190|3770831|FG001|COMPLETED|Second Dosing|Two subjects withdrew for personal reasons (other than adverse event).|22
3050818|NCT01217190|3770830|FG000|NOT COMPLETED|Second Dosing||0
3050819|NCT01217190|3770831|FG001|NOT COMPLETED|Second Dosing||2
3050820|NCT01217229|3770840|FG000|STARTED|Overall Study||20
3050821|NCT01217229|3770840|FG000|COMPLETED|Overall Study||0
3050822|NCT01217229|3770840|FG000|NOT COMPLETED|Overall Study||20
3050823|NCT01217307|3770846|FG000|STARTED|Overall Study||191
3050824|NCT01217307|3770847|FG001|STARTED|Overall Study||189
3050825|NCT01217307|3770846|FG000|COMPLETED|Overall Study||191
3050826|NCT01217307|3770847|FG001|COMPLETED|Overall Study||188
3050827|NCT01217307|3770846|FG000|NOT COMPLETED|Overall Study||0
3050828|NCT01217307|3770847|FG001|NOT COMPLETED|Overall Study||1
3050829|NCT01217385|3770853|FG000|STARTED|Overall Study||60
3050830|NCT01217385|3770853|FG000|COMPLETED|Overall Study||34
3050831|NCT01217385|3770853|FG000|NOT COMPLETED|Overall Study||26
3050832|NCT01217411|3770865|FG000|STARTED|Overall Study||3
3050833|NCT01217411|3770866|FG001|STARTED|Overall Study||2
3050834|NCT01217411|3770865|FG000|5mg|Overall Study||3
3050835|NCT01217411|3770866|FG001|5mg|Overall Study||2
3050836|NCT01217411|3770865|FG000|10mg|Overall Study||0
3050837|NCT01217411|3770866|FG001|10mg|Overall Study||0
3050838|NCT01217411|3770865|FG000|20mg|Overall Study||0
3050839|NCT01217411|3770866|FG001|20mg|Overall Study||0
3050840|NCT01217411|3770865|FG000|COMPLETED|Overall Study||0
3050841|NCT01217411|3770866|FG001|COMPLETED|Overall Study||0
3050842|NCT01217411|3770865|FG000|NOT COMPLETED|Overall Study||3
3050843|NCT01217411|3770866|FG001|NOT COMPLETED|Overall Study||2
3050844|NCT01217437|3770876|FG000|STARTED|Overall Study||55
3050845|NCT01217437|3770877|FG001|STARTED|Overall Study||53
3050846|NCT01217437|3770876|FG000|COMPLETED|Overall Study||12
3050847|NCT01217437|3770877|FG001|COMPLETED|Overall Study||12
3050848|NCT01217437|3770876|FG000|NOT COMPLETED|Overall Study||43
3050849|NCT01217437|3770877|FG001|NOT COMPLETED|Overall Study||41
3050850|NCT01217463|3770885|FG000|STARTED|Overall Study||99
3050851|NCT01217463|3770886|FG001|STARTED|Overall Study||102
3050852|NCT01217463|3770885|FG000|COMPLETED|Overall Study||86
3050853|NCT01217463|3770886|FG001|COMPLETED|Overall Study||94
3050854|NCT01217463|3770885|FG000|NOT COMPLETED|Overall Study||13
3050855|NCT01217463|3770886|FG001|NOT COMPLETED|Overall Study||8
3050856|NCT01217476|3770896|FG000|STARTED|Overall Study||105
3050857|NCT01217476|3770897|FG001|STARTED|Overall Study||102
3050858|NCT01217476|3770896|FG000|COMPLETED|Overall Study||93
3050859|NCT01217476|3770897|FG001|COMPLETED|Overall Study||95
3050860|NCT01217476|3770896|FG000|NOT COMPLETED|Overall Study||12
3050861|NCT01217476|3770897|FG001|NOT COMPLETED|Overall Study||7
3050862|NCT01217515|3770906|FG000|STARTED|Overall Study||154
3050863|NCT01217515|3770907|FG001|STARTED|Overall Study||156
3050864|NCT01217515|3770908|FG002|STARTED|Overall Study||155
3050865|NCT01217515|3770906|FG000|COMPLETED|Overall Study||147
3050866|NCT01217515|3770907|FG001|COMPLETED|Overall Study||148
3050867|NCT01217515|3770908|FG002|COMPLETED|Overall Study||145
3050868|NCT01217515|3770906|FG000|NOT COMPLETED|Overall Study||7
3050869|NCT01217515|3770907|FG001|NOT COMPLETED|Overall Study||8
3050870|NCT01217515|3770908|FG002|NOT COMPLETED|Overall Study||10
3050871|NCT01217606|3770918|FG000|STARTED|Initial Treatment Phase||90
3050872|NCT01217606|3770919|FG001|STARTED|Initial Treatment Phase||95
3050873|NCT01217606|3770918|FG000|COMPLETED|Initial Treatment Phase||76
3050874|NCT01217606|3770919|FG001|COMPLETED|Initial Treatment Phase||83
3050875|NCT01217606|3770918|FG000|NOT COMPLETED|Initial Treatment Phase||14
3050876|NCT01217606|3770919|FG001|NOT COMPLETED|Initial Treatment Phase||12
3282042|NCT02743377|4015741|FG000|STARTED|Overall Study||9
3282043|NCT02743377|4015742|FG001|STARTED|Overall Study||6
3282044|NCT02743377|4015741|FG000|Brain PET With 11C Rolipram|Overall Study||8
3282045|NCT02743377|4015742|FG001|Brain PET With 11C Rolipram|Overall Study||3
3282046|NCT02743377|4015741|FG000|Whole Body PET Baseline With 11C Rolipra|Overall Study||5
3282047|NCT02743377|4015742|FG001|Whole Body PET Baseline With 11C Rolipra|Overall Study||4
3050877|NCT01217606|3770918|FG000|STARTED|9-Month Masked Extension||67
3050878|NCT01217606|3770919|FG001|STARTED|9-Month Masked Extension||73
3050879|NCT01217606|3770918|FG000|Not Enrolled in Masked Extension|9-Month Masked Extension||9
3050880|NCT01217606|3770919|FG001|Not Enrolled in Masked Extension|9-Month Masked Extension||10
3050881|NCT01217606|3770918|FG000|COMPLETED|9-Month Masked Extension||54
3050882|NCT01217606|3770919|FG001|COMPLETED|9-Month Masked Extension||62
3050883|NCT01217606|3770918|FG000|NOT COMPLETED|9-Month Masked Extension||13
3050884|NCT01217606|3770919|FG001|NOT COMPLETED|9-Month Masked Extension||11
3282048|NCT02743377|4015741|FG000|Whole Body PET Baseline & Blocked|Overall Study||0
3282049|NCT02743377|4015742|FG001|Whole Body PET Baseline & Blocked|Overall Study||2
3282050|NCT02743377|4015741|FG000|COMPLETED|Overall Study||7
3282051|NCT02743377|4015742|FG001|COMPLETED|Overall Study||6
3282052|NCT02743377|4015741|FG000|NOT COMPLETED|Overall Study||2
3282053|NCT02743377|4015742|FG001|NOT COMPLETED|Overall Study||0
3282054|NCT02743442|4015749|FG000|STARTED|Overall Study||8
3282055|NCT02743442|4015749|FG000|COMPLETED|Overall Study||8
3282056|NCT02743442|4015749|FG000|NOT COMPLETED|Overall Study||0
3282057|NCT02743494|4015755|FG000|STARTED|Pre-treatment Period||532
3282058|NCT02743494|4015756|FG001|STARTED|Pre-treatment Period||262
3282059|NCT02743494|4015755|FG000|COMPLETED|Pre-treatment Period||532
3282060|NCT02743494|4015756|FG001|COMPLETED|Pre-treatment Period||260
3282061|NCT02743494|4015755|FG000|NOT COMPLETED|Pre-treatment Period||0
3282062|NCT02743494|4015756|FG001|NOT COMPLETED|Pre-treatment Period||2
3282063|NCT02743494|4015755|FG000|STARTED|Treatment Period||532
3282064|NCT02743494|4015756|FG001|STARTED|Treatment Period||260
3282065|NCT02743494|4015755|FG000|COMPLETED|Treatment Period||31
3282066|NCT02743494|4015756|FG001|COMPLETED|Treatment Period||19
3282067|NCT02743494|4015755|FG000|NOT COMPLETED|Treatment Period||501
3282068|NCT02743494|4015756|FG001|NOT COMPLETED|Treatment Period||241
3282069|NCT02743520|4015762|FG000|STARTED|Overall Study||86
3282070|NCT02743520|4015762|FG000|COMPLETED|Overall Study||85
3282071|NCT02743520|4015762|FG000|NOT COMPLETED|Overall Study||1
3282072|NCT02743702|4015768|FG000|STARTED|Overall Study||11
3282073|NCT02743702|4015769|FG001|STARTED|Overall Study||10
3282074|NCT02743702|4015768|FG000|COMPLETED|Overall Study||11
3282075|NCT02743702|4015769|FG001|COMPLETED|Overall Study||10
3282076|NCT02743702|4015768|FG000|NOT COMPLETED|Overall Study||0
3282077|NCT02743702|4015769|FG001|NOT COMPLETED|Overall Study||0
3282078|NCT02743780|4015780|FG000|STARTED|Part 1 (3 Days)||6
3282079|NCT02743780|4015781|FG001|STARTED|Part 1 (3 Days)||6
3282080|NCT02743780|4015782|FG002|STARTED|Part 1 (3 Days)||6
3282081|NCT02743780|4015783|FG003|STARTED|Part 1 (3 Days)||6
3282082|NCT02743780|4015784|FG004|STARTED|Part 1 (3 Days)||8
3282083|NCT02743780|4015780|FG000|COMPLETED|Part 1 (3 Days)||6
3282084|NCT02743780|4015781|FG001|COMPLETED|Part 1 (3 Days)||6
3282085|NCT02743780|4015782|FG002|COMPLETED|Part 1 (3 Days)||6
3282086|NCT02743780|4015783|FG003|COMPLETED|Part 1 (3 Days)||6
3282087|NCT02743780|4015784|FG004|COMPLETED|Part 1 (3 Days)||8
3282088|NCT02743780|4015780|FG000|NOT COMPLETED|Part 1 (3 Days)||0
3282089|NCT02743780|4015781|FG001|NOT COMPLETED|Part 1 (3 Days)||0
3282090|NCT02743780|4015782|FG002|NOT COMPLETED|Part 1 (3 Days)||0
3282091|NCT02743780|4015783|FG003|NOT COMPLETED|Part 1 (3 Days)||0
3282092|NCT02743780|4015784|FG004|NOT COMPLETED|Part 1 (3 Days)||0
3282093|NCT02743780|4015780|FG000|STARTED|Part 2 (8 Days)||0
3282094|NCT02743780|4015781|FG001|STARTED|Part 2 (8 Days)||6
3282095|NCT02743780|4015782|FG002|STARTED|Part 2 (8 Days)||6
3282096|NCT02743780|4015783|FG003|STARTED|Part 2 (8 Days)||0
3282097|NCT02743780|4015784|FG004|STARTED|Part 2 (8 Days)||4
3282098|NCT02743780|4015780|FG000|COMPLETED|Part 2 (8 Days)||0
3282099|NCT02743780|4015781|FG001|COMPLETED|Part 2 (8 Days)||6
3282100|NCT02743780|4015782|FG002|COMPLETED|Part 2 (8 Days)||6
3282101|NCT02743780|4015783|FG003|COMPLETED|Part 2 (8 Days)||0
3282102|NCT02743780|4015784|FG004|COMPLETED|Part 2 (8 Days)||4
3282103|NCT02743780|4015780|FG000|NOT COMPLETED|Part 2 (8 Days)||0
3282104|NCT02743780|4015781|FG001|NOT COMPLETED|Part 2 (8 Days)||0
3282105|NCT02743780|4015782|FG002|NOT COMPLETED|Part 2 (8 Days)||0
3282106|NCT02743780|4015783|FG003|NOT COMPLETED|Part 2 (8 Days)||0
3282107|NCT02743780|4015784|FG004|NOT COMPLETED|Part 2 (8 Days)||0
3282108|NCT02743780|4015780|FG000|STARTED|Part 3 (7 Days)||0
3050885|NCT01217749|3770928|FG000|STARTED|Overall Study||27
3050886|NCT01217749|3770929|FG001|STARTED|Overall Study||20
3282109|NCT02743780|4015781|FG001|STARTED|Part 3 (7 Days)||0
3282110|NCT02743780|4015782|FG002|STARTED|Part 3 (7 Days)||25
3050887|NCT01217749|3770930|FG002|STARTED|Overall Study||24
3050888|NCT01217749|3770928|FG000|COMPLETED|Overall Study||24
3050889|NCT01217749|3770929|FG001|COMPLETED|Overall Study||17
3050890|NCT01217749|3770930|FG002|COMPLETED|Overall Study||22
3282111|NCT02743780|4015783|FG003|STARTED|Part 3 (7 Days)||0
3282112|NCT02743780|4015784|FG004|STARTED|Part 3 (7 Days)||25
3282113|NCT02743780|4015780|FG000|COMPLETED|Part 3 (7 Days)||0
3282114|NCT02743780|4015781|FG001|COMPLETED|Part 3 (7 Days)||0
3282115|NCT02743780|4015782|FG002|COMPLETED|Part 3 (7 Days)||24
3282116|NCT02743780|4015783|FG003|COMPLETED|Part 3 (7 Days)||0
3282117|NCT02743780|4015784|FG004|COMPLETED|Part 3 (7 Days)||25
3282118|NCT02743780|4015780|FG000|NOT COMPLETED|Part 3 (7 Days)||0
3282119|NCT02743780|4015781|FG001|NOT COMPLETED|Part 3 (7 Days)||0
3282120|NCT02743780|4015782|FG002|NOT COMPLETED|Part 3 (7 Days)||1
3282121|NCT02743780|4015783|FG003|NOT COMPLETED|Part 3 (7 Days)||0
3282122|NCT02743780|4015784|FG004|NOT COMPLETED|Part 3 (7 Days)||0
3282123|NCT02743793|4015806|FG000|STARTED|Overall Study||5
3282124|NCT02743793|4015807|FG001|STARTED|Overall Study||36
3282125|NCT02743793|4015806|FG000|COMPLETED|Overall Study||0
3282126|NCT02743793|4015807|FG001|COMPLETED|Overall Study||0
3282127|NCT02743793|4015806|FG000|NOT COMPLETED|Overall Study||5
3282128|NCT02743793|4015807|FG001|NOT COMPLETED|Overall Study||36
3282129|NCT02743936|4015814|FG000|STARTED|Overall Study||32
3282130|NCT02743936|4015815|FG001|STARTED|Overall Study||32
3282131|NCT02743936|4015814|FG000|COMPLETED|Overall Study||32
3282132|NCT02743936|4015815|FG001|COMPLETED|Overall Study||32
3282133|NCT02743936|4015814|FG000|NOT COMPLETED|Overall Study||0
3282134|NCT02743936|4015815|FG001|NOT COMPLETED|Overall Study||0
3282135|NCT02743949|4015824|FG000|STARTED|Overall Study||86
3282136|NCT02743949|4015825|FG001|STARTED|Overall Study||85
3282137|NCT02743949|4015826|FG002|STARTED|Overall Study||85
3282138|NCT02743949|4015824|FG000|COMPLETED|Overall Study||82
3282139|NCT02743949|4015825|FG001|COMPLETED|Overall Study||84
3282140|NCT02743949|4015826|FG002|COMPLETED|Overall Study||82
3282141|NCT02743949|4015824|FG000|NOT COMPLETED|Overall Study||4
3282142|NCT02743949|4015825|FG001|NOT COMPLETED|Overall Study||1
3282143|NCT02743949|4015826|FG002|NOT COMPLETED|Overall Study||3
3282144|NCT02743962|4015836|FG000|STARTED|Overall Study||5
3282145|NCT02743962|4015837|FG001|STARTED|Overall Study||5
3282146|NCT02743962|4015836|FG000|COMPLETED|Overall Study||4
3282147|NCT02743962|4015837|FG001|COMPLETED|Overall Study||5
3282148|NCT02743962|4015836|FG000|NOT COMPLETED|Overall Study||1
3282149|NCT02743962|4015837|FG001|NOT COMPLETED|Overall Study||0
3282150|NCT02744066|4015848|FG000|STARTED|Overall Study||25
3282151|NCT02744066|4015849|FG001|STARTED|Overall Study||30
3282152|NCT02744066|4015848|FG000|COMPLETED|Overall Study||25
3282153|NCT02744066|4015849|FG001|COMPLETED|Overall Study||25
3282154|NCT02744066|4015848|FG000|NOT COMPLETED|Overall Study||0
3282155|NCT02744066|4015849|FG001|NOT COMPLETED|Overall Study||5
3282156|NCT02744391|4015857|FG000|STARTED|Overall Study||47
3282157|NCT02744391|4015857|FG000|COMPLETED|Overall Study||33
3282158|NCT02744391|4015857|FG000|NOT COMPLETED|Overall Study||14
3282159|NCT02744534|4015861|FG000|STARTED|Overall Study||21
3282160|NCT02744534|4015861|FG000|COMPLETED|Overall Study||21
3282161|NCT02744534|4015861|FG000|NOT COMPLETED|Overall Study||0
3282162|NCT02744755|4015869|FG000|STARTED|Study Period 1||177
3282163|NCT02744755|4015870|FG001|STARTED|Study Period 1||176
3282164|NCT02744755|4015869|FG000|COMPLETED|Study Period 1||163
3282165|NCT02744755|4015870|FG001|COMPLETED|Study Period 1||168
3282166|NCT02744755|4015869|FG000|NOT COMPLETED|Study Period 1||14
3282167|NCT02744755|4015870|FG001|NOT COMPLETED|Study Period 1||8
3282168|NCT02744755|4015869|FG000|STARTED|Study Period 2||159
3282169|NCT02744755|4015870|FG001|STARTED|Study Period 2||166
3282170|NCT02744755|4015869|FG000|COMPLETED|Study Period 2||145
3282171|NCT02744755|4015870|FG001|COMPLETED|Study Period 2||158
3282172|NCT02744755|4015869|FG000|NOT COMPLETED|Study Period 2||14
3282173|NCT02744755|4015870|FG001|NOT COMPLETED|Study Period 2||8
3282174|NCT02744846|4015880|FG000|STARTED|5 Year Outcome Assessment||681739
3282175|NCT02744846|4015880|FG000|Excluded Ineligible Patients|5 Year Outcome Assessment|Includes lost to follow-up and patients that had not reached age 4 years by end of study period|319189
3282176|NCT02744846|4015880|FG000|COMPLETED|5 Year Outcome Assessment|Number of patients that meet eligibility criteria|362550
3282177|NCT02744846|4015880|FG000|NOT COMPLETED|5 Year Outcome Assessment||319189
3282178|NCT02744846|4015880|FG000|STARTED|10 Year Outcome Assessment||362550
3282179|NCT02744846|4015880|FG000|Exclude Ineligible Patients|10 Year Outcome Assessment|Loss to follow-up, patients not yet 9 years, or systems that only had data from 2009 to 2016 or less|305820
3282180|NCT02744846|4015880|FG000|COMPLETED|10 Year Outcome Assessment||56730
3282181|NCT02744846|4015880|FG000|NOT COMPLETED|10 Year Outcome Assessment||305820
3282182|NCT02744898|4015888|FG000|STARTED|Overall Study||23
3282183|NCT02744898|4015888|FG000|COMPLETED|Overall Study||19
3282184|NCT02744898|4015888|FG000|NOT COMPLETED|Overall Study||4
3282185|NCT02745080|4015894|FG000|STARTED|Overall Study||426
3050891|NCT01217749|3770928|FG000|NOT COMPLETED|Overall Study||3
3282186|NCT02745080|4015895|FG001|STARTED|Overall Study||427
3282187|NCT02745080|4015894|FG000|COMPLETED|Overall Study||371
3282188|NCT02745080|4015895|FG001|COMPLETED|Overall Study||338
3282189|NCT02745080|4015894|FG000|NOT COMPLETED|Overall Study||55
3282190|NCT02745080|4015895|FG001|NOT COMPLETED|Overall Study||89
3282191|NCT02745119|4015906|FG000|STARTED|Overall Study||145
3282192|NCT02745119|4015907|FG001|STARTED|Overall Study||274
3282193|NCT02745119|4015908|FG002|STARTED|Overall Study||146
3282194|NCT02745119|4015909|FG003|STARTED|Overall Study||277
3050892|NCT01217749|3770929|FG001|NOT COMPLETED|Overall Study||3
3050893|NCT01217749|3770930|FG002|NOT COMPLETED|Overall Study||2
3050894|NCT01217801|3770942|FG000|STARTED|Period 1||24
3050895|NCT01217801|3770943|FG001|STARTED|Period 1||24
3050896|NCT01217801|3770942|FG000|COMPLETED|Period 1||23
3050897|NCT01217801|3770943|FG001|COMPLETED|Period 1||22
3050898|NCT01217801|3770942|FG000|NOT COMPLETED|Period 1||1
3050899|NCT01217801|3770943|FG001|NOT COMPLETED|Period 1||2
3050900|NCT01217801|3770942|FG000|STARTED|Period 2||23
3050901|NCT01217801|3770943|FG001|STARTED|Period 2||22
3050902|NCT01217801|3770942|FG000|COMPLETED|Period 2||23
3050903|NCT01217801|3770943|FG001|COMPLETED|Period 2||22
3050904|NCT01217801|3770942|FG000|NOT COMPLETED|Period 2||0
3050905|NCT01217801|3770943|FG001|NOT COMPLETED|Period 2||0
3050906|NCT01217814|3770952|FG000|STARTED|Overall Study||4
3050907|NCT01217814|3770953|FG001|STARTED|Overall Study||5
3050908|NCT01217814|3770954|FG002|STARTED|Overall Study||7
3050909|NCT01217814|3770952|FG000|COMPLETED|Overall Study||3
3050910|NCT01217814|3770953|FG001|COMPLETED|Overall Study||4
3050911|NCT01217814|3770954|FG002|COMPLETED|Overall Study||6
3050912|NCT01217814|3770952|FG000|NOT COMPLETED|Overall Study||1
3050913|NCT01217814|3770953|FG001|NOT COMPLETED|Overall Study||1
3050914|NCT01217814|3770954|FG002|NOT COMPLETED|Overall Study||1
3050915|NCT01217827|3770965|FG000|STARTED|Overall Study||46
3050916|NCT01217827|3770966|FG001|STARTED|Overall Study||43
3050917|NCT01217827|3770965|FG000|COMPLETED|Overall Study||46
3050918|NCT01217827|3770966|FG001|COMPLETED|Overall Study||43
3050919|NCT01217827|3770965|FG000|NOT COMPLETED|Overall Study||0
3050920|NCT01217827|3770966|FG001|NOT COMPLETED|Overall Study||0
3050921|NCT01217840|3770974|FG000|STARTED|Overall Study||20
3050922|NCT01217840|3770975|FG001|STARTED|Overall Study||20
3050923|NCT01217840|3770974|FG000|COMPLETED|Overall Study||14
3050924|NCT01217840|3770975|FG001|COMPLETED|Overall Study||17
3050925|NCT01217840|3770974|FG000|NOT COMPLETED|Overall Study||6
3050926|NCT01217840|3770975|FG001|NOT COMPLETED|Overall Study||3
3133850|NCT01697696|3858803|FG000|STARTED|Overall Study||254
3133851|NCT01697696|3858804|FG001|STARTED|Overall Study||257
3133852|NCT01697696|3858803|FG000|Safety Set|Overall Study||251
3133853|NCT01697696|3858804|FG001|Safety Set|Overall Study|Safety set included a patient that was treated, but not randomized|256
3133854|NCT01697696|3858803|FG000|Full Analysis Set (FAS)|Overall Study||251
3133855|NCT01697696|3858804|FG001|Full Analysis Set (FAS)|Overall Study||255
3133856|NCT01697696|3858803|FG000|COMPLETED|Overall Study||207
3133857|NCT01697696|3858804|FG001|COMPLETED|Overall Study||210
3133858|NCT01697696|3858803|FG000|NOT COMPLETED|Overall Study||47
3133859|NCT01697696|3858804|FG001|NOT COMPLETED|Overall Study||47
3133860|NCT01697709|3858812|FG000|STARTED|Overall Study||64
3133861|NCT01697709|3858813|FG001|STARTED|Overall Study||66
3133862|NCT01697709|3858812|FG000|COMPLETED|Overall Study||34
3133863|NCT01697709|3858813|FG001|COMPLETED|Overall Study||38
3282195|NCT02745119|4015906|FG000|COMPLETED|Overall Study||0
3282196|NCT02745119|4015907|FG001|COMPLETED|Overall Study||0
3282197|NCT02745119|4015908|FG002|COMPLETED|Overall Study||0
3282198|NCT02745119|4015909|FG003|COMPLETED|Overall Study||0
3282199|NCT02745119|4015906|FG000|NOT COMPLETED|Overall Study||145
3282200|NCT02745119|4015907|FG001|NOT COMPLETED|Overall Study||274
3282201|NCT02745119|4015908|FG002|NOT COMPLETED|Overall Study||146
3282202|NCT02745119|4015909|FG003|NOT COMPLETED|Overall Study||277
3282203|NCT02745145|4015924|FG000|STARTED|Overall Study||10
3282204|NCT02745145|4015925|FG001|STARTED|Overall Study||5
3282205|NCT02745145|4015926|FG002|STARTED|Overall Study||9
3282206|NCT02745145|4015924|FG000|COMPLETED|Overall Study||0
3282207|NCT02745145|4015925|FG001|COMPLETED|Overall Study||0
3282208|NCT02745145|4015926|FG002|COMPLETED|Overall Study||0
3282209|NCT02745145|4015924|FG000|NOT COMPLETED|Overall Study||10
3282210|NCT02745145|4015925|FG001|NOT COMPLETED|Overall Study||5
3282211|NCT02745145|4015926|FG002|NOT COMPLETED|Overall Study||9
3282212|NCT02745353|4015936|FG000|STARTED|First Intervention (2 Weeks)||4
3282213|NCT02745353|4015937|FG001|STARTED|First Intervention (2 Weeks)||3
3282214|NCT02745353|4015936|FG000|COMPLETED|First Intervention (2 Weeks)||1
3282215|NCT02745353|4015937|FG001|COMPLETED|First Intervention (2 Weeks)||1
3282216|NCT02745353|4015936|FG000|NOT COMPLETED|First Intervention (2 Weeks)||3
3282217|NCT02745353|4015937|FG001|NOT COMPLETED|First Intervention (2 Weeks)||2
3282218|NCT02745353|4015936|FG000|STARTED|Washout (3 Days)||1
3282219|NCT02745353|4015937|FG001|STARTED|Washout (3 Days)||1
3282220|NCT02745353|4015936|FG000|COMPLETED|Washout (3 Days)||1
3282221|NCT02745353|4015937|FG001|COMPLETED|Washout (3 Days)||1
3282222|NCT02745353|4015936|FG000|NOT COMPLETED|Washout (3 Days)||0
3282223|NCT02745353|4015937|FG001|NOT COMPLETED|Washout (3 Days)||0
3282224|NCT02745353|4015936|FG000|STARTED|Second Intervention (2 Weeks)||1
3282225|NCT02745353|4015937|FG001|STARTED|Second Intervention (2 Weeks)||1
3282226|NCT02745353|4015936|FG000|COMPLETED|Second Intervention (2 Weeks)||1
3133864|NCT01697709|3858812|FG000|NOT COMPLETED|Overall Study||30
3133865|NCT01697709|3858813|FG001|NOT COMPLETED|Overall Study||28
3133866|NCT01697748|3858821|FG000|STARTED|Overall Study||329
3133867|NCT01697748|3858822|FG001|STARTED|Overall Study||328
3133868|NCT01697748|3858821|FG000|COMPLETED|Overall Study||271
3133869|NCT01697748|3858822|FG001|COMPLETED|Overall Study||260
3133870|NCT01697748|3858821|FG000|NOT COMPLETED|Overall Study||58
3282227|NCT02745353|4015937|FG001|COMPLETED|Second Intervention (2 Weeks)||0
3282228|NCT02745353|4015936|FG000|NOT COMPLETED|Second Intervention (2 Weeks)||0
3282229|NCT02745353|4015937|FG001|NOT COMPLETED|Second Intervention (2 Weeks)||1
3050927|NCT01217892|3770986|FG000|STARTED|Overall Study||100
3050928|NCT01217892|3770987|FG001|STARTED|Overall Study||100
3050929|NCT01217892|3770988|FG002|STARTED|Overall Study||99
3050930|NCT01217892|3770989|FG003|STARTED|Overall Study||101
3050931|NCT01217892|3770986|FG000|COMPLETED|Overall Study||93
3050932|NCT01217892|3770987|FG001|COMPLETED|Overall Study||94
3050933|NCT01217892|3770988|FG002|COMPLETED|Overall Study||90
3050934|NCT01217892|3770989|FG003|COMPLETED|Overall Study||93
3050935|NCT01217892|3770986|FG000|NOT COMPLETED|Overall Study||7
3050936|NCT01217892|3770987|FG001|NOT COMPLETED|Overall Study||6
3050937|NCT01217892|3770988|FG002|NOT COMPLETED|Overall Study||9
3050938|NCT01217892|3770989|FG003|NOT COMPLETED|Overall Study||8
3050939|NCT01217944|3771002|FG000|STARTED|Overall Study||106
3050940|NCT01217944|3771003|FG001|STARTED|Overall Study||116
3050941|NCT01217944|3771004|FG002|STARTED|Overall Study||55
3050942|NCT01217944|3771002|FG000|Completed 3 Months|Overall Study||105
3050943|NCT01217944|3771003|FG001|Completed 3 Months|Overall Study||116
3050944|NCT01217944|3771004|FG002|Completed 3 Months|Overall Study||55
3050945|NCT01217944|3771002|FG000|Completed 6 Months|Overall Study||103
3050946|NCT01217944|3771003|FG001|Completed 6 Months|Overall Study||116
3050947|NCT01217944|3771004|FG002|Completed 6 Months|Overall Study||55
3050948|NCT01217944|3771002|FG000|COMPLETED|Overall Study||100
3050949|NCT01217944|3771003|FG001|COMPLETED|Overall Study||112
3050950|NCT01217944|3771004|FG002|COMPLETED|Overall Study||55
3050951|NCT01217944|3771002|FG000|NOT COMPLETED|Overall Study||6
3050952|NCT01217944|3771003|FG001|NOT COMPLETED|Overall Study||4
3050953|NCT01217944|3771004|FG002|NOT COMPLETED|Overall Study||0
3050954|NCT01217957|3771019|FG000|STARTED|Phase 1||3
3050955|NCT01217957|3771020|FG001|STARTED|Phase 1||3
3050956|NCT01217957|3771021|FG002|STARTED|Phase 1||6
3050957|NCT01217957|3771022|FG003|STARTED|Phase 1||3
3050958|NCT01217957|3771023|FG004|STARTED|Phase 1||0
3050959|NCT01217957|3771019|FG000|COMPLETED|Phase 1||2
3050960|NCT01217957|3771020|FG001|COMPLETED|Phase 1||3
3050961|NCT01217957|3771021|FG002|COMPLETED|Phase 1||5
3050962|NCT01217957|3771022|FG003|COMPLETED|Phase 1||2
3050963|NCT01217957|3771023|FG004|COMPLETED|Phase 1||0
3050964|NCT01217957|3771019|FG000|NOT COMPLETED|Phase 1||1
3050965|NCT01217957|3771020|FG001|NOT COMPLETED|Phase 1||0
3050966|NCT01217957|3771021|FG002|NOT COMPLETED|Phase 1||1
3050967|NCT01217957|3771022|FG003|NOT COMPLETED|Phase 1||1
3050968|NCT01217957|3771023|FG004|NOT COMPLETED|Phase 1||0
3050969|NCT01217957|3771019|FG000|STARTED|Phase 2||0
3050970|NCT01217957|3771020|FG001|STARTED|Phase 2||0
3050971|NCT01217957|3771021|FG002|STARTED|Phase 2||0
3050972|NCT01217957|3771022|FG003|STARTED|Phase 2||0
3050973|NCT01217957|3771023|FG004|STARTED|Phase 2||50
3050974|NCT01217957|3771019|FG000|COMPLETED|Phase 2||0
3050975|NCT01217957|3771020|FG001|COMPLETED|Phase 2||0
3050976|NCT01217957|3771021|FG002|COMPLETED|Phase 2||0
3050977|NCT01217957|3771022|FG003|COMPLETED|Phase 2||0
3050978|NCT01217957|3771023|FG004|COMPLETED|Phase 2|Completed=Participants who are ongoing or who have died on study.|49
3050979|NCT01217957|3771019|FG000|NOT COMPLETED|Phase 2||0
3050980|NCT01217957|3771020|FG001|NOT COMPLETED|Phase 2||0
3050981|NCT01217957|3771021|FG002|NOT COMPLETED|Phase 2||0
3050982|NCT01217957|3771022|FG003|NOT COMPLETED|Phase 2||0
3050983|NCT01217957|3771023|FG004|NOT COMPLETED|Phase 2||1
3050984|NCT01218009|3771046|FG000|STARTED|Overall Study||166
3050985|NCT01218009|3771047|FG001|STARTED|Overall Study||165
3050986|NCT01218009|3771046|FG000|COMPLETED|Overall Study||0
3050987|NCT01218009|3771047|FG001|COMPLETED|Overall Study||0
3050988|NCT01218009|3771046|FG000|NOT COMPLETED|Overall Study||166
3050989|NCT01218009|3771047|FG001|NOT COMPLETED|Overall Study||165
3050990|NCT01218048|3771053|FG000|STARTED|Overall Study||40
3050991|NCT01218048|3771053|FG000|COMPLETED|Overall Study||40
3050992|NCT01218048|3771053|FG000|NOT COMPLETED|Overall Study||0
3050993|NCT01218087|3771060|FG000|STARTED|Overall Study||42
3050994|NCT01218087|3771061|FG001|STARTED|Overall Study||41
3050995|NCT01218087|3771060|FG000|COMPLETED|Overall Study||27
3050996|NCT01218087|3771061|FG001|COMPLETED|Overall Study||35
3050997|NCT01218087|3771060|FG000|NOT COMPLETED|Overall Study||15
3050998|NCT01218087|3771061|FG001|NOT COMPLETED|Overall Study||6
3050999|NCT01218100|3771071|FG000|STARTED|Overall Study||95
3051000|NCT01218100|3771072|FG001|STARTED|Overall Study||190
3051001|NCT01218100|3771073|FG002|STARTED|Overall Study||189
3051002|NCT01218100|3771074|FG003|STARTED|Overall Study||190
3051003|NCT01218100|3771071|FG000|COMPLETED|Overall Study||71
3051004|NCT01218100|3771072|FG001|COMPLETED|Overall Study||165
3051005|NCT01218100|3771073|FG002|COMPLETED|Overall Study||162
3051006|NCT01218100|3771074|FG003|COMPLETED|Overall Study||156
3051007|NCT01218100|3771071|FG000|NOT COMPLETED|Overall Study||24
3051008|NCT01218100|3771072|FG001|NOT COMPLETED|Overall Study||25
3051009|NCT01218100|3771073|FG002|NOT COMPLETED|Overall Study||27
3051010|NCT01218100|3771074|FG003|NOT COMPLETED|Overall Study||34
3051011|NCT01218113|3771087|FG000|STARTED|Overall Study||62
3051012|NCT01218113|3771088|FG001|STARTED|Overall Study||64
3051013|NCT01218113|3771089|FG002|STARTED|Overall Study||64
3051014|NCT01218113|3771087|FG000|COMPLETED|Overall Study||57
3051015|NCT01218113|3771088|FG001|COMPLETED|Overall Study||63
3051016|NCT01218113|3771089|FG002|COMPLETED|Overall Study||58
3051017|NCT01218113|3771087|FG000|NOT COMPLETED|Overall Study||5
3051018|NCT01218113|3771088|FG001|NOT COMPLETED|Overall Study||1
3051019|NCT01218113|3771089|FG002|NOT COMPLETED|Overall Study||6
3051020|NCT01218126|3771108|FG000|STARTED|Overall Study||153
3051021|NCT01218126|3771109|FG001|STARTED|Overall Study||149
3051022|NCT01218126|3771110|FG002|STARTED|Overall Study||151
3051023|NCT01218126|3771111|FG003|STARTED|Overall Study||149
3282230|NCT02745392|4015947|FG000|STARTED|Overall Study||91
3282231|NCT02745392|4015948|FG001|STARTED|Overall Study||90
3282232|NCT02745392|4015949|FG002|STARTED|Overall Study||92
3282233|NCT02745392|4015950|FG003|STARTED|Overall Study||92
3282234|NCT02745392|4015947|FG000|COMPLETED|Overall Study||91
3282235|NCT02745392|4015948|FG001|COMPLETED|Overall Study||89
3282236|NCT02745392|4015949|FG002|COMPLETED|Overall Study||92
3282237|NCT02745392|4015950|FG003|COMPLETED|Overall Study||92
3282238|NCT02745392|4015947|FG000|NOT COMPLETED|Overall Study||0
3282239|NCT02745392|4015948|FG001|NOT COMPLETED|Overall Study||1
3282240|NCT02745392|4015949|FG002|NOT COMPLETED|Overall Study||0
3282241|NCT02745392|4015950|FG003|NOT COMPLETED|Overall Study||0
3282242|NCT02745535|4015960|FG000|STARTED|Overall Study||77
3282243|NCT02745535|4015960|FG000|Sustained Virologic Repsonse|Overall Study|Sustained Virologic response measured 24 weeks after completing study medication|70
3282244|NCT02745535|4015960|FG000|COMPLETED|Overall Study|Completed 12 weeks of study medication per protocol|71
3282245|NCT02745535|4015960|FG000|NOT COMPLETED|Overall Study||6
3282246|NCT02745626|4015967|FG000|STARTED|Overall Study||24
3282247|NCT02745626|4015968|FG001|STARTED|Overall Study||22
3282248|NCT02745626|4015969|FG002|STARTED|Overall Study||22
3282249|NCT02745626|4015967|FG000|COMPLETED|Overall Study||21
3282250|NCT02745626|4015968|FG001|COMPLETED|Overall Study||16
3282251|NCT02745626|4015969|FG002|COMPLETED|Overall Study||19
3282252|NCT02745626|4015967|FG000|NOT COMPLETED|Overall Study||3
3282253|NCT02745626|4015968|FG001|NOT COMPLETED|Overall Study||6
3282254|NCT02745626|4015969|FG002|NOT COMPLETED|Overall Study||3
3282255|NCT02746107|4015977|FG000|STARTED|Overall Study||968
3282256|NCT02746107|4015977|FG000|2 Diagrams DA|Overall Study||482
3282257|NCT02746107|4015977|FG000|1 Diagram DA|Overall Study||486
3282258|NCT02746107|4015977|FG000|1year Risk Estimate|Overall Study||483
3282259|NCT02746107|4015977|FG000|5year Risk Estimate|Overall Study||485
3282260|NCT02746107|4015977|FG000|Target=Patient|Overall Study||486
3282261|NCT02746107|4015977|FG000|Target=Physician|Overall Study||482
3282262|NCT02746107|4015977|FG000|CHA2DS2-VASC Score = 1|Overall Study||195
3282263|NCT02746107|4015977|FG000|CHA2DS2-VASC Score = 2|Overall Study||189
3282264|NCT02746107|4015977|FG000|CHA2DS2-VASC Score = 3|Overall Study||195
3282265|NCT02746107|4015977|FG000|CHA2DS2-VASC Score = 4|Overall Study||197
3282266|NCT02746107|4015977|FG000|CHA2DS2-VASC Score = 5|Overall Study||192
3282267|NCT02746107|4015977|FG000|COMPLETED|Overall Study||968
3282268|NCT02746107|4015977|FG000|NOT COMPLETED|Overall Study||0
3282269|NCT02746406|4015992|FG000|STARTED|Overall Study||5
3282270|NCT02746406|4015992|FG000|COMPLETED|Overall Study||5
3282271|NCT02746406|4015992|FG000|NOT COMPLETED|Overall Study||0
3282272|NCT02746575|4015996|FG000|STARTED|Overall Study||70
3282273|NCT02746575|4015996|FG000|COMPLETED|Overall Study||20
3282274|NCT02746575|4015996|FG000|NOT COMPLETED|Overall Study||50
3282275|NCT02746627|4016003|FG000|STARTED|Overall Study||60
3282276|NCT02746627|4016004|FG001|STARTED|Overall Study||30
3282277|NCT02746627|4016005|FG002|STARTED|Overall Study||30
3282278|NCT02746627|4016003|FG000|COMPLETED|Overall Study||59
3282279|NCT02746627|4016004|FG001|COMPLETED|Overall Study||29
3282280|NCT02746627|4016005|FG002|COMPLETED|Overall Study||29
3282281|NCT02746627|4016003|FG000|NOT COMPLETED|Overall Study||1
3282282|NCT02746627|4016004|FG001|NOT COMPLETED|Overall Study||1
3282283|NCT02746627|4016005|FG002|NOT COMPLETED|Overall Study||1
3282284|NCT02746679|4016015|FG000|STARTED|Overall Study||80
3282285|NCT02746679|4016016|FG001|STARTED|Overall Study||81
3282286|NCT02746679|4016015|FG000|COMPLETED|Overall Study||76
3282287|NCT02746679|4016016|FG001|COMPLETED|Overall Study||75
3282288|NCT02746679|4016015|FG000|NOT COMPLETED|Overall Study||4
3282289|NCT02746679|4016016|FG001|NOT COMPLETED|Overall Study||6
3282290|NCT02746705|4016024|FG000|STARTED|Overall Study||17
3282291|NCT02746705|4016025|FG001|STARTED|Overall Study||14
3282292|NCT02746705|4016024|FG000|COMPLETED|Overall Study||15
3282293|NCT02746705|4016025|FG001|COMPLETED|Overall Study||12
3282294|NCT02746705|4016024|FG000|NOT COMPLETED|Overall Study||2
3282295|NCT02746705|4016025|FG001|NOT COMPLETED|Overall Study||2
3282296|NCT02746809|4016031|FG000|STARTED|Baseline- 30 Days||60
3282297|NCT02746809|4016031|FG000|COMPLETED|Baseline- 30 Days||59
3282298|NCT02746809|4016031|FG000|NOT COMPLETED|Baseline- 30 Days||1
3282299|NCT02746809|4016031|FG000|STARTED|Baseline-6 Months||59
3282300|NCT02746809|4016031|FG000|COMPLETED|Baseline-6 Months||54
3282301|NCT02746809|4016031|FG000|NOT COMPLETED|Baseline-6 Months||5
3282302|NCT02746874|4016039|FG000|STARTED|Overall Study||35
3282303|NCT02746874|4016040|FG001|STARTED|Overall Study||35
3282304|NCT02746874|4016039|FG000|COMPLETED|Overall Study||35
3282305|NCT02746874|4016040|FG001|COMPLETED|Overall Study||32
3282306|NCT02746874|4016039|FG000|NOT COMPLETED|Overall Study||0
3282307|NCT02746874|4016040|FG001|NOT COMPLETED|Overall Study||3
3282308|NCT02746991|4016048|FG000|STARTED|Overall Study||52
3282309|NCT02746991|4016049|FG001|STARTED|Overall Study||101
3282310|NCT02746991|4016048|FG000|COMPLETED|Overall Study||24
3282311|NCT02746991|4016049|FG001|COMPLETED|Overall Study||67
3282312|NCT02746991|4016048|FG000|NOT COMPLETED|Overall Study||28
3282313|NCT02746991|4016049|FG001|NOT COMPLETED|Overall Study||34
3282314|NCT02747004|4016060|FG000|STARTED|Overall Study||78
3282315|NCT02747004|4016061|FG001|STARTED|Overall Study||79
3282316|NCT02747004|4016062|FG002|STARTED|Overall Study||77
3282317|NCT02747004|4016060|FG000|Received at Least One Dose of Study Drug|Overall Study||78
3051024|NCT01218126|3771108|FG000|COMPLETED|Overall Study||129
3051025|NCT01218126|3771109|FG001|COMPLETED|Overall Study||127
3051026|NCT01218126|3771110|FG002|COMPLETED|Overall Study||127
3051027|NCT01218126|3771111|FG003|COMPLETED|Overall Study||114
3051028|NCT01218126|3771108|FG000|NOT COMPLETED|Overall Study||24
3051029|NCT01218126|3771109|FG001|NOT COMPLETED|Overall Study||22
3051030|NCT01218126|3771110|FG002|NOT COMPLETED|Overall Study||24
3051031|NCT01218126|3771111|FG003|NOT COMPLETED|Overall Study||35
3051032|NCT01218204|3771123|FG000|STARTED|Part A||6
3282318|NCT02747004|4016061|FG001|Received at Least One Dose of Study Drug|Overall Study||79
3282319|NCT02747004|4016062|FG002|Received at Least One Dose of Study Drug|Overall Study||77
3282320|NCT02747004|4016060|FG000|COMPLETED|Overall Study||21
3282321|NCT02747004|4016061|FG001|COMPLETED|Overall Study||30
3282322|NCT02747004|4016062|FG002|COMPLETED|Overall Study||30
3282323|NCT02747004|4016060|FG000|NOT COMPLETED|Overall Study||57
3282324|NCT02747004|4016061|FG001|NOT COMPLETED|Overall Study||49
3282325|NCT02747004|4016062|FG002|NOT COMPLETED|Overall Study||47
3282326|NCT02747043|4016072|FG000|STARTED|Overall Study||128
3282327|NCT02747043|4016073|FG001|STARTED|Overall Study||128
3282328|NCT02747043|4016072|FG000|Treated|Overall Study||128
3282329|NCT02747043|4016073|FG001|Treated|Overall Study||126
3282330|NCT02747043|4016072|FG000|COMPLETED|Overall Study||118
3282331|NCT02747043|4016073|FG001|COMPLETED|Overall Study||123
3282332|NCT02747043|4016072|FG000|NOT COMPLETED|Overall Study||10
3282333|NCT02747043|4016073|FG001|NOT COMPLETED|Overall Study||5
3282334|NCT02747108|4016081|FG000|STARTED|Overall Study||253
3282335|NCT02747108|4016082|FG001|STARTED|Overall Study||62
3282336|NCT02747108|4016081|FG000|COMPLETED|Overall Study||248
3282337|NCT02747108|4016082|FG001|COMPLETED|Overall Study||60
3282338|NCT02747108|4016081|FG000|NOT COMPLETED|Overall Study||5
3282339|NCT02747108|4016082|FG001|NOT COMPLETED|Overall Study||2
3282340|NCT02747186|4016095|FG000|STARTED|First Intervention||12
3282341|NCT02747186|4016096|FG001|STARTED|First Intervention||12
3282342|NCT02747186|4016095|FG000|COMPLETED|First Intervention||12
3282343|NCT02747186|4016096|FG001|COMPLETED|First Intervention||12
3282344|NCT02747186|4016095|FG000|NOT COMPLETED|First Intervention||0
3282345|NCT02747186|4016096|FG001|NOT COMPLETED|First Intervention||0
3282346|NCT02747186|4016095|FG000|STARTED|Washout (1 Week)||12
3282347|NCT02747186|4016096|FG001|STARTED|Washout (1 Week)||12
3282348|NCT02747186|4016095|FG000|COMPLETED|Washout (1 Week)||12
3282349|NCT02747186|4016096|FG001|COMPLETED|Washout (1 Week)||12
3282350|NCT02747186|4016095|FG000|NOT COMPLETED|Washout (1 Week)||0
3282351|NCT02747186|4016096|FG001|NOT COMPLETED|Washout (1 Week)||0
3282352|NCT02747186|4016095|FG000|STARTED|Second Intervention||12
3282353|NCT02747186|4016096|FG001|STARTED|Second Intervention||12
3282354|NCT02747186|4016095|FG000|COMPLETED|Second Intervention||12
3282355|NCT02747186|4016096|FG001|COMPLETED|Second Intervention||12
3282356|NCT02747186|4016095|FG000|NOT COMPLETED|Second Intervention||0
3282357|NCT02747186|4016096|FG001|NOT COMPLETED|Second Intervention||0
3282358|NCT02747238|4016104|FG000|STARTED|Overall Study||12
3282359|NCT02747238|4016105|FG001|STARTED|Overall Study||20
3282360|NCT02747238|4016104|FG000|COMPLETED|Overall Study||9
3282361|NCT02747238|4016105|FG001|COMPLETED|Overall Study||14
3282362|NCT02747238|4016104|FG000|NOT COMPLETED|Overall Study||3
3282363|NCT02747238|4016105|FG001|NOT COMPLETED|Overall Study||6
3282364|NCT02747420|4016113|FG000|STARTED|Overall Study||18
3282365|NCT02747420|4016114|FG001|STARTED|Overall Study||22
3282366|NCT02747420|4016113|FG000|COMPLETED|Overall Study||11
3282367|NCT02747420|4016114|FG001|COMPLETED|Overall Study||18
3282368|NCT02747420|4016113|FG000|NOT COMPLETED|Overall Study||7
3282369|NCT02747420|4016114|FG001|NOT COMPLETED|Overall Study||4
3282370|NCT02747433|4016122|FG000|STARTED|Overall Study||5
3282371|NCT02747433|4016123|FG001|STARTED|Overall Study||5
3282372|NCT02747433|4016122|FG000|COMPLETED|Overall Study||5
3282373|NCT02747433|4016123|FG001|COMPLETED|Overall Study||5
3282374|NCT02747433|4016122|FG000|NOT COMPLETED|Overall Study||0
3282375|NCT02747433|4016123|FG001|NOT COMPLETED|Overall Study||0
3282376|NCT02747615|4016134|FG000|STARTED|Overall Study||30
3282377|NCT02747615|4016135|FG001|STARTED|Overall Study||30
3282378|NCT02747615|4016134|FG000|COMPLETED|Overall Study||30
3282379|NCT02747615|4016135|FG001|COMPLETED|Overall Study||30
3282380|NCT02747615|4016134|FG000|NOT COMPLETED|Overall Study||0
3282381|NCT02747615|4016135|FG001|NOT COMPLETED|Overall Study||0
3282382|NCT02747628|4016144|FG000|STARTED|Overall Study||20
3282383|NCT02747628|4016145|FG001|STARTED|Overall Study||20
3282384|NCT02747628|4016146|FG002|STARTED|Overall Study||20
3282385|NCT02747628|4016144|FG000|COMPLETED|Overall Study||20
3282386|NCT02747628|4016145|FG001|COMPLETED|Overall Study||20
3282387|NCT02747628|4016146|FG002|COMPLETED|Overall Study||20
3282388|NCT02747628|4016144|FG000|NOT COMPLETED|Overall Study||0
3282389|NCT02747628|4016145|FG001|NOT COMPLETED|Overall Study||0
3282390|NCT02747628|4016146|FG002|NOT COMPLETED|Overall Study||0
3282391|NCT02747875|4016156|FG000|STARTED|Overall Study||12
3051033|NCT01218204|3771124|FG001|STARTED|Part A||0
3051034|NCT01218204|3771125|FG002|STARTED|Part A||0
3051035|NCT01218204|3771126|FG003|STARTED|Part A||0
3282392|NCT02747875|4016157|FG001|STARTED|Overall Study||14
3282393|NCT02747875|4016156|FG000|COMPLETED|Overall Study||11
3282394|NCT02747875|4016157|FG001|COMPLETED|Overall Study||13
3282395|NCT02747875|4016156|FG000|NOT COMPLETED|Overall Study||1
3282396|NCT02747875|4016157|FG001|NOT COMPLETED|Overall Study||1
3282397|NCT02747927|4016165|FG000|STARTED|Overall Study||6698
3282398|NCT02747927|4016166|FG001|STARTED|Overall Study||13401
3051036|NCT01218204|3771123|FG000|COMPLETED|Part A||6
3051037|NCT01218204|3771124|FG001|COMPLETED|Part A||0
3282399|NCT02747927|4016165|FG000|Treated: Safety Set|Overall Study||6687
3282400|NCT02747927|4016166|FG001|Treated: Safety Set|Overall Study||13380
3282401|NCT02747927|4016165|FG000|COMPLETED|Overall Study||6477
3282402|NCT02747927|4016166|FG001|COMPLETED|Overall Study||12943
3282403|NCT02747927|4016165|FG000|NOT COMPLETED|Overall Study||221
3282404|NCT02747927|4016166|FG001|NOT COMPLETED|Overall Study||458
3316495|NCT03113916|4049843|FG001|STARTED|Overall Study||96
3316496|NCT03113916|4049842|FG000|COMPLETED|Overall Study||88
3316497|NCT03113916|4049843|FG001|COMPLETED|Overall Study||84
3316498|NCT03113916|4049842|FG000|NOT COMPLETED|Overall Study||11
3316499|NCT03113916|4049843|FG001|NOT COMPLETED|Overall Study||12
3316500|NCT03114124|4049856|FG000|STARTED|Overall Study||15
3316501|NCT03114124|4049857|FG001|STARTED|Overall Study||15
3316502|NCT03114124|4049856|FG000|COMPLETED|Overall Study||15
3316503|NCT03114124|4049857|FG001|COMPLETED|Overall Study||15
3316504|NCT03114124|4049856|FG000|NOT COMPLETED|Overall Study||0
3316505|NCT03114124|4049857|FG001|NOT COMPLETED|Overall Study||0
3316506|NCT03114488|4049863|FG000|STARTED|Time Period 1||19
3316507|NCT03114488|4049864|FG001|STARTED|Time Period 1||22
3316508|NCT03114488|4049863|FG000|COMPLETED|Time Period 1||19
3316509|NCT03114488|4049864|FG001|COMPLETED|Time Period 1||22
3316510|NCT03114488|4049863|FG000|NOT COMPLETED|Time Period 1||0
3316511|NCT03114488|4049864|FG001|NOT COMPLETED|Time Period 1||0
3316512|NCT03114488|4049863|FG000|STARTED|Time Period 2||19
3316513|NCT03114488|4049864|FG001|STARTED|Time Period 2||22
3316514|NCT03114488|4049863|FG000|COMPLETED|Time Period 2||18
3316515|NCT03114488|4049864|FG001|COMPLETED|Time Period 2||19
3316516|NCT03114488|4049863|FG000|NOT COMPLETED|Time Period 2||1
3316517|NCT03114488|4049864|FG001|NOT COMPLETED|Time Period 2||3
3316518|NCT03114657|4049876|FG000|STARTED|Overall Study||399
3316519|NCT03114657|4049877|FG001|STARTED|Overall Study||407
3316520|NCT03114657|4049876|FG000|COMPLETED|Overall Study||0
3316521|NCT03114657|4049877|FG001|COMPLETED|Overall Study||0
3316522|NCT03114657|4049876|FG000|NOT COMPLETED|Overall Study||399
3316523|NCT03114657|4049877|FG001|NOT COMPLETED|Overall Study||407
3316524|NCT03114683|4049884|FG000|STARTED|Overall Study||96
3316525|NCT03114683|4049884|FG000|COMPLETED|Overall Study||52
3316526|NCT03114683|4049884|FG000|NOT COMPLETED|Overall Study||44
3316527|NCT03114969|4049897|FG000|STARTED|Overall Study||50
3316528|NCT03114969|4049898|FG001|STARTED|Overall Study||50
3316529|NCT03114969|4049899|FG002|STARTED|Overall Study||50
3316530|NCT03114969|4049900|FG003|STARTED|Overall Study||50
3316531|NCT03114969|4049901|FG004|STARTED|Overall Study||51
3316532|NCT03114969|4049902|FG005|STARTED|Overall Study||49
3316533|NCT03114969|4049903|FG006|STARTED|Overall Study||50
3316534|NCT03114969|4049904|FG007|STARTED|Overall Study||50
3316535|NCT03114969|4049905|FG008|STARTED|Overall Study||50
3316536|NCT03114969|4049897|FG000|COMPLETED|Overall Study||50
3316537|NCT03114969|4049898|FG001|COMPLETED|Overall Study||50
3316538|NCT03114969|4049899|FG002|COMPLETED|Overall Study||46
3316539|NCT03114969|4049900|FG003|COMPLETED|Overall Study||48
3316540|NCT03114969|4049901|FG004|COMPLETED|Overall Study||51
3316541|NCT03114969|4049902|FG005|COMPLETED|Overall Study||48
3316542|NCT03114969|4049903|FG006|COMPLETED|Overall Study||49
3316543|NCT03114969|4049904|FG007|COMPLETED|Overall Study||50
3316544|NCT03114969|4049905|FG008|COMPLETED|Overall Study||48
3316545|NCT03114969|4049897|FG000|NOT COMPLETED|Overall Study||0
3316546|NCT03114969|4049898|FG001|NOT COMPLETED|Overall Study||0
3316547|NCT03114969|4049899|FG002|NOT COMPLETED|Overall Study||4
3316548|NCT03114969|4049900|FG003|NOT COMPLETED|Overall Study||2
3316549|NCT03114969|4049901|FG004|NOT COMPLETED|Overall Study||0
3316550|NCT03114969|4049902|FG005|NOT COMPLETED|Overall Study||1
3316551|NCT03114969|4049903|FG006|NOT COMPLETED|Overall Study||1
3316552|NCT03114969|4049904|FG007|NOT COMPLETED|Overall Study||0
3316553|NCT03114969|4049905|FG008|NOT COMPLETED|Overall Study||2
3316554|NCT03114995|4049935|FG000|STARTED|Overall Study||31
3316555|NCT03114995|4049936|FG001|STARTED|Overall Study||31
3316556|NCT03114995|4049937|FG002|STARTED|Overall Study||78
3316557|NCT03114995|4049935|FG000|COMPLETED|Overall Study||30
3316558|NCT03114995|4049936|FG001|COMPLETED|Overall Study||30
3316559|NCT03114995|4049937|FG002|COMPLETED|Overall Study||78
3316560|NCT03114995|4049935|FG000|NOT COMPLETED|Overall Study||1
3316561|NCT03114995|4049936|FG001|NOT COMPLETED|Overall Study||1
3316562|NCT03114995|4049937|FG002|NOT COMPLETED|Overall Study||0
3316563|NCT03115112|4049947|FG000|STARTED|Overall Study||192
3316564|NCT03115112|4049948|FG001|STARTED|Overall Study||194
3316565|NCT03115112|4049947|FG000|Intention-to-treat|Overall Study||191
3316566|NCT03115112|4049948|FG001|Intention-to-treat|Overall Study||193
3051038|NCT01218204|3771125|FG002|COMPLETED|Part A||0
3316567|NCT03115112|4049947|FG000|COMPLETED|Overall Study||180
3316568|NCT03115112|4049948|FG001|COMPLETED|Overall Study||189
3316569|NCT03115112|4049947|FG000|NOT COMPLETED|Overall Study||12
3316570|NCT03115112|4049948|FG001|NOT COMPLETED|Overall Study||5
3316571|NCT03115177|4049958|FG000|STARTED|Overall Study||27
3316572|NCT03115177|4049959|FG001|STARTED|Overall Study||29
3316573|NCT03115177|4049958|FG000|COMPLETED|Overall Study||27
3316574|NCT03115177|4049959|FG001|COMPLETED|Overall Study||29
3316575|NCT03115177|4049958|FG000|NOT COMPLETED|Overall Study||0
3316576|NCT03115177|4049959|FG001|NOT COMPLETED|Overall Study||0
3316577|NCT03115411|4049965|FG000|STARTED|Overall Study||23
3316578|NCT03115411|4049965|FG000|COMPLETED|Overall Study||23
3316579|NCT03115411|4049965|FG000|NOT COMPLETED|Overall Study||0
3051039|NCT01218204|3771126|FG003|COMPLETED|Part A||0
3051040|NCT01218204|3771123|FG000|NOT COMPLETED|Part A||0
3051041|NCT01218204|3771124|FG001|NOT COMPLETED|Part A||0
3051042|NCT01218204|3771125|FG002|NOT COMPLETED|Part A||0
3051043|NCT01218204|3771126|FG003|NOT COMPLETED|Part A||0
3051044|NCT01218204|3771123|FG000|STARTED|Part B Washout||0
3051045|NCT01218204|3771124|FG001|STARTED|Part B Washout||281
3051046|NCT01218204|3771125|FG002|STARTED|Part B Washout||0
3051047|NCT01218204|3771126|FG003|STARTED|Part B Washout||0
3051048|NCT01218204|3771123|FG000|COMPLETED|Part B Washout||0
3051049|NCT01218204|3771124|FG001|COMPLETED|Part B Washout||136
3051050|NCT01218204|3771125|FG002|COMPLETED|Part B Washout||0
3051051|NCT01218204|3771126|FG003|COMPLETED|Part B Washout||0
3051052|NCT01218204|3771123|FG000|NOT COMPLETED|Part B Washout||0
3051053|NCT01218204|3771124|FG001|NOT COMPLETED|Part B Washout||145
3051054|NCT01218204|3771125|FG002|NOT COMPLETED|Part B Washout||0
3051055|NCT01218204|3771126|FG003|NOT COMPLETED|Part B Washout||0
3051056|NCT01218204|3771123|FG000|STARTED|Part B Run-in||0
3051057|NCT01218204|3771124|FG001|STARTED|Part B Run-in||0
3051058|NCT01218204|3771125|FG002|STARTED|Part B Run-in||89
3051059|NCT01218204|3771126|FG003|STARTED|Part B Run-in||0
3051060|NCT01218204|3771123|FG000|COMPLETED|Part B Run-in||0
3051061|NCT01218204|3771124|FG001|COMPLETED|Part B Run-in||0
3051062|NCT01218204|3771125|FG002|COMPLETED|Part B Run-in||83
3051063|NCT01218204|3771126|FG003|COMPLETED|Part B Run-in||0
3051064|NCT01218204|3771123|FG000|NOT COMPLETED|Part B Run-in||0
3051065|NCT01218204|3771124|FG001|NOT COMPLETED|Part B Run-in||0
3051066|NCT01218204|3771125|FG002|NOT COMPLETED|Part B Run-in||6
3051067|NCT01218204|3771126|FG003|NOT COMPLETED|Part B Run-in||0
3051068|NCT01218204|3771123|FG000|STARTED|Part B Pooled Treatment Arm||0
3051069|NCT01218204|3771124|FG001|STARTED|Part B Pooled Treatment Arm||0
3051070|NCT01218204|3771125|FG002|STARTED|Part B Pooled Treatment Arm||0
3051071|NCT01218204|3771126|FG003|STARTED|Part B Pooled Treatment Arm||130
3051072|NCT01218204|3771123|FG000|COMPLETED|Part B Pooled Treatment Arm||0
3051073|NCT01218204|3771124|FG001|COMPLETED|Part B Pooled Treatment Arm||0
3051074|NCT01218204|3771125|FG002|COMPLETED|Part B Pooled Treatment Arm||0
3051075|NCT01218204|3771126|FG003|COMPLETED|Part B Pooled Treatment Arm||127
3051076|NCT01218204|3771123|FG000|NOT COMPLETED|Part B Pooled Treatment Arm||0
3051077|NCT01218204|3771124|FG001|NOT COMPLETED|Part B Pooled Treatment Arm||0
3051078|NCT01218204|3771125|FG002|NOT COMPLETED|Part B Pooled Treatment Arm||0
3051079|NCT01218204|3771126|FG003|NOT COMPLETED|Part B Pooled Treatment Arm||3
3051080|NCT01218243|3771175|FG000|STARTED|Overall Study||50
3282405|NCT02748070|4016174|FG000|STARTED|Overall Study||41
3282406|NCT02748070|4016175|FG001|STARTED|Overall Study||40
3051081|NCT01218243|3771176|FG001|STARTED|Overall Study||50
3051082|NCT01218243|3771175|FG000|Treatment Completed|Overall Study||45
3051083|NCT01218243|3771176|FG001|Treatment Completed|Overall Study||42
3051084|NCT01218243|3771175|FG000|COMPLETED|Overall Study||41
3051085|NCT01218243|3771176|FG001|COMPLETED|Overall Study||36
3051086|NCT01218243|3771175|FG000|NOT COMPLETED|Overall Study||9
3051087|NCT01218243|3771176|FG001|NOT COMPLETED|Overall Study||14
3051088|NCT01218308|3771184|FG000|STARTED|Overall Study||2584
3051089|NCT01218308|3771185|FG001|STARTED|Overall Study||2584
3051090|NCT01218308|3771184|FG000|COMPLETED|Overall Study||2481
3051091|NCT01218308|3771185|FG001|COMPLETED|Overall Study||2464
3051092|NCT01218308|3771184|FG000|NOT COMPLETED|Overall Study||103
3051093|NCT01218308|3771185|FG001|NOT COMPLETED|Overall Study||120
3051094|NCT01218399|3771193|FG000|STARTED|Overall Study||5
3051095|NCT01218399|3771194|FG001|STARTED|Overall Study||5
3051096|NCT01218399|3771193|FG000|COMPLETED|Overall Study||5
3051097|NCT01218399|3771194|FG001|COMPLETED|Overall Study||5
3051098|NCT01218399|3771193|FG000|NOT COMPLETED|Overall Study||0
3051099|NCT01218399|3771194|FG001|NOT COMPLETED|Overall Study||0
3051100|NCT01218438|3771200|FG000|STARTED|Epoch 1||77
3051101|NCT01218438|3771200|FG000|COMPLETED|Epoch 1||74
3051102|NCT01218438|3771200|FG000|NOT COMPLETED|Epoch 1||3
3051103|NCT01218438|3771200|FG000|STARTED|Epoch 2||45
3051104|NCT01218438|3771200|FG000|COMPLETED|Epoch 2||45
3051105|NCT01218438|3771200|FG000|NOT COMPLETED|Epoch 2||0
3051106|NCT01218438|3771200|FG000|STARTED|Epoch 3||74
3051107|NCT01218438|3771200|FG000|COMPLETED|Epoch 3||70
3051108|NCT01218438|3771200|FG000|NOT COMPLETED|Epoch 3||4
3051109|NCT01218438|3771200|FG000|STARTED|Epoch 4||70
3051110|NCT01218438|3771200|FG000|COMPLETED|Epoch 4||67
3051111|NCT01218438|3771200|FG000|NOT COMPLETED|Epoch 4||3
3051112|NCT01218477|3771278|FG000|STARTED|Overall Study|Participants who received treatment|3
3051113|NCT01218477|3771279|FG001|STARTED|Overall Study|Participants who received treatment|8
3051114|NCT01218477|3771280|FG002|STARTED|Overall Study|Participants who received treatment|14
3051115|NCT01218477|3771281|FG003|STARTED|Overall Study|Participants who received treatment|2
3051116|NCT01218477|3771278|FG000|COMPLETED|Overall Study|Still receiving study drug|0
3051117|NCT01218477|3771279|FG001|COMPLETED|Overall Study|Still receiving study drug|0
3051118|NCT01218477|3771280|FG002|COMPLETED|Overall Study|Still receiving study drug|0
3051119|NCT01218477|3771281|FG003|COMPLETED|Overall Study|Still receiving study drug|0
3051120|NCT01218477|3771278|FG000|NOT COMPLETED|Overall Study||3
3051121|NCT01218477|3771279|FG001|NOT COMPLETED|Overall Study||8
3051122|NCT01218477|3771280|FG002|NOT COMPLETED|Overall Study||14
3051123|NCT01218477|3771281|FG003|NOT COMPLETED|Overall Study||2
3051124|NCT01218516|3771297|FG000|STARTED|Combination Therapy (up to 4.5 Months)||67
3051125|NCT01218516|3771298|FG001|STARTED|Combination Therapy (up to 4.5 Months)||63
3051126|NCT01218516|3771299|FG002|STARTED|Combination Therapy (up to 4.5 Months)||0
3051127|NCT01218516|3771300|FG003|STARTED|Combination Therapy (up to 4.5 Months)||0
3051128|NCT01218516|3771297|FG000|COMPLETED|Combination Therapy (up to 4.5 Months)||38
3051129|NCT01218516|3771298|FG001|COMPLETED|Combination Therapy (up to 4.5 Months)||28
3051130|NCT01218516|3771299|FG002|COMPLETED|Combination Therapy (up to 4.5 Months)||0
3051131|NCT01218516|3771300|FG003|COMPLETED|Combination Therapy (up to 4.5 Months)||0
3051132|NCT01218516|3771297|FG000|NOT COMPLETED|Combination Therapy (up to 4.5 Months)||29
3051133|NCT01218516|3771298|FG001|NOT COMPLETED|Combination Therapy (up to 4.5 Months)||35
3051134|NCT01218516|3771299|FG002|NOT COMPLETED|Combination Therapy (up to 4.5 Months)||0
3051135|NCT01218516|3771300|FG003|NOT COMPLETED|Combination Therapy (up to 4.5 Months)||0
3051136|NCT01218516|3771297|FG000|STARTED|Monotherapy (up to 23.5 Months)|This phase ended once all participants finished.|0
3051137|NCT01218516|3771298|FG001|STARTED|Monotherapy (up to 23.5 Months)|This phase ended once all participants finished.|0
3051138|NCT01218516|3771299|FG002|STARTED|Monotherapy (up to 23.5 Months)|Only eligible participants entered this phase of the study.|38
3160473|NCT01863849|3887588|FG000|STARTED|Overall Study||60
3160474|NCT01863849|3887589|FG001|STARTED|Overall Study||60
3160475|NCT01863849|3887588|FG000|COMPLETED|Overall Study||59
3160476|NCT01863849|3887589|FG001|COMPLETED|Overall Study||60
3160477|NCT01863849|3887588|FG000|NOT COMPLETED|Overall Study||1
3160478|NCT01863849|3887589|FG001|NOT COMPLETED|Overall Study||0
3160479|NCT01863953|3887599|FG000|STARTED|Overall Study||38
3282407|NCT02748070|4016174|FG000|Randomized and Treated|Overall Study||40
3282408|NCT02748070|4016175|FG001|Randomized and Treated|Overall Study||40
3282409|NCT02748070|4016174|FG000|COMPLETED|Overall Study||33
3282410|NCT02748070|4016175|FG001|COMPLETED|Overall Study||39
3282411|NCT02748070|4016174|FG000|NOT COMPLETED|Overall Study||8
3282412|NCT02748070|4016175|FG001|NOT COMPLETED|Overall Study||1
3282413|NCT02748096|4016183|FG000|STARTED|Overall Study||23
3282414|NCT02748096|4016184|FG001|STARTED|Overall Study||22
3282415|NCT02748096|4016183|FG000|COMPLETED|Overall Study||23
3282416|NCT02748096|4016184|FG001|COMPLETED|Overall Study||22
3282417|NCT02748096|4016183|FG000|NOT COMPLETED|Overall Study||0
3282418|NCT02748096|4016184|FG001|NOT COMPLETED|Overall Study||0
3282419|NCT02748213|4016192|FG000|STARTED|Overall Study||113
3282420|NCT02748213|4016193|FG001|STARTED|Overall Study||112
3282421|NCT02748213|4016192|FG000|Treated|Overall Study||112
3282422|NCT02748213|4016193|FG001|Treated|Overall Study||110
3282423|NCT02748213|4016192|FG000|COMPLETED|Overall Study|"*The reason Refused Treatment also includes those who did not cooperate or withdrew consent."|0
3282424|NCT02748213|4016193|FG001|COMPLETED|Overall Study||0
3282425|NCT02748213|4016192|FG000|NOT COMPLETED|Overall Study||113
3282426|NCT02748213|4016193|FG001|NOT COMPLETED|Overall Study||112
3282427|NCT02748317|4016199|FG000|STARTED|Overall Study||96
3282428|NCT02748317|4016199|FG000|COMPLETED|Overall Study||73
3282429|NCT02748317|4016199|FG000|NOT COMPLETED|Overall Study||23
3282430|NCT02748356|4016203|FG000|STARTED|Overall Study||7
3282431|NCT02748356|4016203|FG000|COMPLETED|Overall Study||6
3282432|NCT02748356|4016203|FG000|NOT COMPLETED|Overall Study||1
3282433|NCT02748512|4016209|FG000|STARTED|Overall Study||14
3282434|NCT02748512|4016210|FG001|STARTED|Overall Study||12
3282435|NCT02748512|4016209|FG000|COMPLETED|Overall Study||13
3282436|NCT02748512|4016210|FG001|COMPLETED|Overall Study||11
3282437|NCT02748512|4016209|FG000|NOT COMPLETED|Overall Study||1
3282438|NCT02748512|4016210|FG001|NOT COMPLETED|Overall Study||1
3282439|NCT02748525|4016216|FG000|STARTED|Overall Study||50
3282440|NCT02748525|4016216|FG000|Completed Study Intervention|Overall Study||50
3282441|NCT02748525|4016216|FG000|COMPLETED|Overall Study|Completed 6 months follow up|39
3282442|NCT02748525|4016216|FG000|NOT COMPLETED|Overall Study||11
3282443|NCT02748694|4016235|FG000|STARTED|Overall Study||10
3282444|NCT02748694|4016236|FG001|STARTED|Overall Study||6
3282445|NCT02748694|4016237|FG002|STARTED|Overall Study||6
3282446|NCT02748694|4016238|FG003|STARTED|Overall Study||6
3282447|NCT02748694|4016239|FG004|STARTED|Overall Study||6
3160480|NCT01863953|3887600|FG001|STARTED|Overall Study||36
3160481|NCT01863953|3887601|FG002|STARTED|Overall Study||38
3160482|NCT01863953|3887599|FG000|COMPLETED|Overall Study||38
3160483|NCT01863953|3887600|FG001|COMPLETED|Overall Study||36
3160484|NCT01863953|3887601|FG002|COMPLETED|Overall Study||37
3160485|NCT01863953|3887599|FG000|NOT COMPLETED|Overall Study||0
3160486|NCT01863953|3887600|FG001|NOT COMPLETED|Overall Study||0
3160487|NCT01863953|3887601|FG002|NOT COMPLETED|Overall Study||1
3160488|NCT01864005|3887611|FG000|STARTED|Overall Study||29
3160489|NCT01864005|3887612|FG001|STARTED|Overall Study||31
3160490|NCT01864005|3887611|FG000|COMPLETED|Overall Study||26
3160491|NCT01864005|3887612|FG001|COMPLETED|Overall Study||25
3160492|NCT01864005|3887611|FG000|NOT COMPLETED|Overall Study||3
3160493|NCT01864005|3887612|FG001|NOT COMPLETED|Overall Study||6
3160494|NCT01864148|3887623|FG000|STARTED|Overall Study||93
3160495|NCT01864148|3887624|FG001|STARTED|Overall Study||45
3160496|NCT01864148|3887625|FG002|STARTED|Overall Study||95
3160497|NCT01864148|3887626|FG003|STARTED|Overall Study||94
3160498|NCT01864148|3887627|FG004|STARTED|Overall Study||92
3160499|NCT01864148|3887623|FG000|Randomized and Dosed|Overall Study||93
3282448|NCT02748694|4016240|FG005|STARTED|Overall Study||6
3282449|NCT02748694|4016241|FG006|STARTED|Overall Study||8
3282450|NCT02748694|4016242|FG007|STARTED|Overall Study||6
3282451|NCT02748694|4016243|FG008|STARTED|Overall Study||6
3282452|NCT02748694|4016244|FG009|STARTED|Overall Study||6
3282453|NCT02748694|4016245|FG010|STARTED|Overall Study||6
3051139|NCT01218516|3771300|FG003|STARTED|Monotherapy (up to 23.5 Months)|Only eligible participants entered this phase of the study.|28
3051140|NCT01218516|3771297|FG000|Safety Analysis Set|Monotherapy (up to 23.5 Months)||0
3051141|NCT01218516|3771298|FG001|Safety Analysis Set|Monotherapy (up to 23.5 Months)||0
3051142|NCT01218516|3771299|FG002|Safety Analysis Set|Monotherapy (up to 23.5 Months)||35
3051143|NCT01218516|3771300|FG003|Safety Analysis Set|Monotherapy (up to 23.5 Months)|Three participants were randomized to placebo but actually received Farletuzumab.|31
3051144|NCT01218516|3771297|FG000|COMPLETED|Monotherapy (up to 23.5 Months)||0
3051145|NCT01218516|3771298|FG001|COMPLETED|Monotherapy (up to 23.5 Months)||0
3051146|NCT01218516|3771299|FG002|COMPLETED|Monotherapy (up to 23.5 Months)||38
3051147|NCT01218516|3771300|FG003|COMPLETED|Monotherapy (up to 23.5 Months)||28
3051148|NCT01218516|3771297|FG000|NOT COMPLETED|Monotherapy (up to 23.5 Months)||0
3051149|NCT01218516|3771298|FG001|NOT COMPLETED|Monotherapy (up to 23.5 Months)||0
3051150|NCT01218516|3771299|FG002|NOT COMPLETED|Monotherapy (up to 23.5 Months)||0
3051151|NCT01218516|3771300|FG003|NOT COMPLETED|Monotherapy (up to 23.5 Months)||0
3051152|NCT01218542|3771310|FG000|STARTED|Overall Study||22
3051153|NCT01218542|3771310|FG000|COMPLETED|Overall Study||13
3051154|NCT01218542|3771310|FG000|NOT COMPLETED|Overall Study||9
3051155|NCT01218594|3771315|FG000|STARTED|Overall Study||48
3051156|NCT01218594|3771315|FG000|COMPLETED|Overall Study||36
3051157|NCT01218594|3771315|FG000|NOT COMPLETED|Overall Study||12
3051158|NCT01218646|3771323|FG000|STARTED|Overall Study||225
3051159|NCT01218646|3771324|FG001|STARTED|Overall Study||225
3051160|NCT01218646|3771325|FG002|STARTED|Overall Study||225
3051161|NCT01218646|3771326|FG003|STARTED|Overall Study||64
3051162|NCT01218646|3771323|FG000|COMPLETED|Overall Study||224
3282454|NCT02748694|4016246|FG011|STARTED|Overall Study||9
3282455|NCT02748694|4016247|FG012|STARTED|Overall Study||9
3051163|NCT01218646|3771324|FG001|COMPLETED|Overall Study||225
3051164|NCT01218646|3771325|FG002|COMPLETED|Overall Study||223
3051165|NCT01218646|3771326|FG003|COMPLETED|Overall Study||63
3051166|NCT01218646|3771323|FG000|NOT COMPLETED|Overall Study||1
3051167|NCT01218646|3771324|FG001|NOT COMPLETED|Overall Study||0
3051168|NCT01218646|3771325|FG002|NOT COMPLETED|Overall Study||2
3051169|NCT01218646|3771326|FG003|NOT COMPLETED|Overall Study||1
3051170|NCT01218659|3771338|FG000|STARTED|18-Month Randomized Period||36
3051171|NCT01218659|3771339|FG001|STARTED|18-Month Randomized Period||24
3051172|NCT01218659|3771340|FG002|STARTED|18-Month Randomized Period|Zero participants are noted here because participants started in this group during the 12-month OLE.|0
3051173|NCT01218659|3771338|FG000|Safety Population|18-Month Randomized Period||36
3051174|NCT01218659|3771339|FG001|Safety Population|18-Month Randomized Period||21
3051175|NCT01218659|3771340|FG002|Safety Population|18-Month Randomized Period|Zero participants are noted here because participants started in this group during the 12-month OLE.|0
3051176|NCT01218659|3771338|FG000|COMPLETED|18-Month Randomized Period||34
3051177|NCT01218659|3771339|FG001|COMPLETED|18-Month Randomized Period||18
3051178|NCT01218659|3771340|FG002|COMPLETED|18-Month Randomized Period|Zero participants are noted here because participants started in this group during the 12-month OLE.|0
3051179|NCT01218659|3771338|FG000|NOT COMPLETED|18-Month Randomized Period||2
3051180|NCT01218659|3771339|FG001|NOT COMPLETED|18-Month Randomized Period||6
3051181|NCT01218659|3771340|FG002|NOT COMPLETED|18-Month Randomized Period||0
3051182|NCT01218659|3771338|FG000|STARTED|12-Month OLE|Zero participants are noted here because they were combined in the All Migalastat (0-30 mo.) group.|0
3051183|NCT01218659|3771339|FG001|STARTED|12-Month OLE|Zero participants are noted here because they were combined in the All Migalastat (0-30 mo.) group.|0
3051184|NCT01218659|3771340|FG002|STARTED|12-Month OLE|Fifty-two participants completed the 18-mo. randomized treatment period.|52
3051185|NCT01218659|3771338|FG000|Safety Population|12-Month OLE||0
3051186|NCT01218659|3771339|FG001|Safety Population|12-Month OLE||0
3051187|NCT01218659|3771340|FG002|Safety Population|12-Month OLE||51
3051188|NCT01218659|3771338|FG000|Modified Intent-to-Treat (mITT)|12-Month OLE|Zero participants are noted here because they were combined in the All Migalastat (0-30 mo.) group.|0
3051189|NCT01218659|3771339|FG001|Modified Intent-to-Treat (mITT)|12-Month OLE|Zero participants are noted here because they were combined in the All Migalastat (0-30 mo.) group.|0
3051190|NCT01218659|3771340|FG002|Modified Intent-to-Treat (mITT)|12-Month OLE||46
3051191|NCT01218659|3771338|FG000|COMPLETED|12-Month OLE|Zero participants are noted here because they were combined in the All Migalastat (0-30 mo.) group.|0
3051192|NCT01218659|3771339|FG001|COMPLETED|12-Month OLE|Zero participants are noted here because they were combined in the All Migalastat (0-30 mo.) group.|0
3051193|NCT01218659|3771340|FG002|COMPLETED|12-Month OLE||42
3051194|NCT01218659|3771338|FG000|NOT COMPLETED|12-Month OLE||0
3051195|NCT01218659|3771339|FG001|NOT COMPLETED|12-Month OLE||0
3051196|NCT01218659|3771340|FG002|NOT COMPLETED|12-Month OLE||10
3051197|NCT01218672|3771349|FG000|STARTED|Overall Study||139
3051198|NCT01218672|3771350|FG001|STARTED|Overall Study||142
3051199|NCT01218672|3771349|FG000|Treated|Overall Study||136
3051200|NCT01218672|3771350|FG001|Treated|Overall Study||133
3051201|NCT01218672|3771349|FG000|COMPLETED|Overall Study||128
3051202|NCT01218672|3771350|FG001|COMPLETED|Overall Study||121
3051203|NCT01218672|3771349|FG000|NOT COMPLETED|Overall Study||11
3051204|NCT01218672|3771350|FG001|NOT COMPLETED|Overall Study||21
3051205|NCT01218802|3771360|FG000|STARTED|Overall Study||72
3051206|NCT01218802|3771361|FG001|STARTED|Overall Study||75
3051207|NCT01218802|3771360|FG000|COMPLETED|Overall Study||62
3051208|NCT01218802|3771361|FG001|COMPLETED|Overall Study||57
3051209|NCT01218802|3771360|FG000|NOT COMPLETED|Overall Study||10
3051210|NCT01218802|3771361|FG001|NOT COMPLETED|Overall Study||18
3051211|NCT01218867|3771378|FG000|STARTED|Overall Study||1
3051212|NCT01218867|3771379|FG001|STARTED|Overall Study||1
3051213|NCT01218867|3771380|FG002|STARTED|Overall Study||3
3051214|NCT01218867|3771381|FG003|STARTED|Overall Study||1
3051215|NCT01218867|3771382|FG004|STARTED|Overall Study||1
3051216|NCT01218867|3771383|FG005|STARTED|Overall Study||1
3051217|NCT01218867|3771384|FG006|STARTED|Overall Study||4
3051218|NCT01218867|3771385|FG007|STARTED|Overall Study||3
3282456|NCT02748694|4016248|FG013|STARTED|Overall Study||8
3282457|NCT02748694|4016249|FG014|STARTED|Overall Study||16
3282458|NCT02748694|4016235|FG000|COMPLETED|Overall Study||10
3282459|NCT02748694|4016236|FG001|COMPLETED|Overall Study||6
3282460|NCT02748694|4016237|FG002|COMPLETED|Overall Study||6
3282461|NCT02748694|4016238|FG003|COMPLETED|Overall Study||6
3282462|NCT02748694|4016239|FG004|COMPLETED|Overall Study||6
3282463|NCT02748694|4016240|FG005|COMPLETED|Overall Study||6
3282464|NCT02748694|4016241|FG006|COMPLETED|Overall Study||8
3282465|NCT02748694|4016242|FG007|COMPLETED|Overall Study||6
3282466|NCT02748694|4016243|FG008|COMPLETED|Overall Study||6
3282467|NCT02748694|4016244|FG009|COMPLETED|Overall Study||6
3282468|NCT02748694|4016245|FG010|COMPLETED|Overall Study||6
3282469|NCT02748694|4016246|FG011|COMPLETED|Overall Study||9
3282470|NCT02748694|4016247|FG012|COMPLETED|Overall Study||9
3282471|NCT02748694|4016248|FG013|COMPLETED|Overall Study||8
3282472|NCT02748694|4016249|FG014|COMPLETED|Overall Study||14
3282473|NCT02748694|4016235|FG000|NOT COMPLETED|Overall Study||0
3282474|NCT02748694|4016236|FG001|NOT COMPLETED|Overall Study||0
3282475|NCT02748694|4016237|FG002|NOT COMPLETED|Overall Study||0
3282476|NCT02748694|4016238|FG003|NOT COMPLETED|Overall Study||0
3282477|NCT02748694|4016239|FG004|NOT COMPLETED|Overall Study||0
3282478|NCT02748694|4016240|FG005|NOT COMPLETED|Overall Study||0
3282479|NCT02748694|4016241|FG006|NOT COMPLETED|Overall Study||0
3282480|NCT02748694|4016242|FG007|NOT COMPLETED|Overall Study||0
3282481|NCT02748694|4016243|FG008|NOT COMPLETED|Overall Study||0
3282482|NCT02748694|4016244|FG009|NOT COMPLETED|Overall Study||0
3282483|NCT02748694|4016245|FG010|NOT COMPLETED|Overall Study||0
3282484|NCT02748694|4016246|FG011|NOT COMPLETED|Overall Study||0
3282485|NCT02748694|4016247|FG012|NOT COMPLETED|Overall Study||0
3282486|NCT02748694|4016248|FG013|NOT COMPLETED|Overall Study||0
3282487|NCT02748694|4016249|FG014|NOT COMPLETED|Overall Study||2
3282488|NCT02748785|4016309|FG000|STARTED|Visit 1- Visit 2||69
3282489|NCT02748785|4016310|FG001|STARTED|Visit 1- Visit 2||68
3282490|NCT02748785|4016311|FG002|STARTED|Visit 1- Visit 2||71
3282491|NCT02748785|4016312|FG003|STARTED|Visit 1- Visit 2||69
3282492|NCT02748785|4016309|FG000|COMPLETED|Visit 1- Visit 2||59
3282493|NCT02748785|4016310|FG001|COMPLETED|Visit 1- Visit 2||49
3282494|NCT02748785|4016311|FG002|COMPLETED|Visit 1- Visit 2||57
3282495|NCT02748785|4016312|FG003|COMPLETED|Visit 1- Visit 2||63
3282496|NCT02748785|4016309|FG000|NOT COMPLETED|Visit 1- Visit 2||10
3282497|NCT02748785|4016310|FG001|NOT COMPLETED|Visit 1- Visit 2||19
3282498|NCT02748785|4016311|FG002|NOT COMPLETED|Visit 1- Visit 2||14
3282499|NCT02748785|4016312|FG003|NOT COMPLETED|Visit 1- Visit 2||6
3282500|NCT02748785|4016309|FG000|STARTED|Visit 2-Visit 3||59
3282501|NCT02748785|4016310|FG001|STARTED|Visit 2-Visit 3||49
3282502|NCT02748785|4016311|FG002|STARTED|Visit 2-Visit 3||57
3282503|NCT02748785|4016312|FG003|STARTED|Visit 2-Visit 3||63
3282504|NCT02748785|4016309|FG000|COMPLETED|Visit 2-Visit 3||54
3282505|NCT02748785|4016310|FG001|COMPLETED|Visit 2-Visit 3||44
3282506|NCT02748785|4016311|FG002|COMPLETED|Visit 2-Visit 3||49
3282507|NCT02748785|4016312|FG003|COMPLETED|Visit 2-Visit 3||52
3282508|NCT02748785|4016309|FG000|NOT COMPLETED|Visit 2-Visit 3||5
3282509|NCT02748785|4016310|FG001|NOT COMPLETED|Visit 2-Visit 3||5
3282510|NCT02748785|4016311|FG002|NOT COMPLETED|Visit 2-Visit 3||8
3282511|NCT02748785|4016312|FG003|NOT COMPLETED|Visit 2-Visit 3||11
3282512|NCT02748785|4016309|FG000|STARTED|Visit 3- Visit 4||54
3282513|NCT02748785|4016310|FG001|STARTED|Visit 3- Visit 4||44
3282514|NCT02748785|4016311|FG002|STARTED|Visit 3- Visit 4||49
3282515|NCT02748785|4016312|FG003|STARTED|Visit 3- Visit 4||52
3282516|NCT02748785|4016309|FG000|COMPLETED|Visit 3- Visit 4||53
3282517|NCT02748785|4016310|FG001|COMPLETED|Visit 3- Visit 4||43
3282518|NCT02748785|4016311|FG002|COMPLETED|Visit 3- Visit 4||47
3282519|NCT02748785|4016312|FG003|COMPLETED|Visit 3- Visit 4||50
3282520|NCT02748785|4016309|FG000|NOT COMPLETED|Visit 3- Visit 4||1
3282521|NCT02748785|4016310|FG001|NOT COMPLETED|Visit 3- Visit 4||1
3282522|NCT02748785|4016311|FG002|NOT COMPLETED|Visit 3- Visit 4||2
3282523|NCT02748785|4016312|FG003|NOT COMPLETED|Visit 3- Visit 4||2
3282524|NCT02748863|4016325|FG000|STARTED|Treatment Period 1||72
3282525|NCT02748863|4016326|FG001|STARTED|Treatment Period 1||71
3282526|NCT02748863|4016327|FG002|STARTED|Treatment Period 1||71
3282527|NCT02748863|4016328|FG003|STARTED|Treatment Period 1|Not applicable for this period|0
3282528|NCT02748863|4016329|FG004|STARTED|Treatment Period 1|Not applicable for this period|0
3282529|NCT02748863|4016325|FG000|COMPLETED|Treatment Period 1||72
3282530|NCT02748863|4016326|FG001|COMPLETED|Treatment Period 1||69
3282531|NCT02748863|4016327|FG002|COMPLETED|Treatment Period 1||69
3282532|NCT02748863|4016328|FG003|COMPLETED|Treatment Period 1||0
3051219|NCT01218867|3771386|FG008|STARTED|Overall Study||3
3282533|NCT02748863|4016329|FG004|COMPLETED|Treatment Period 1||0
3282534|NCT02748863|4016325|FG000|NOT COMPLETED|Treatment Period 1||0
3282535|NCT02748863|4016326|FG001|NOT COMPLETED|Treatment Period 1||2
3282536|NCT02748863|4016327|FG002|NOT COMPLETED|Treatment Period 1||2
3282537|NCT02748863|4016328|FG003|NOT COMPLETED|Treatment Period 1||0
3051220|NCT01218867|3771387|FG009|STARTED|Overall Study||4
3051221|NCT01218867|3771388|FG010|STARTED|Overall Study||2
3051222|NCT01218867|3771378|FG000|COMPLETED|Overall Study||1
3051223|NCT01218867|3771379|FG001|COMPLETED|Overall Study||1
3051224|NCT01218867|3771380|FG002|COMPLETED|Overall Study||3
3051225|NCT01218867|3771381|FG003|COMPLETED|Overall Study||1
3051226|NCT01218867|3771382|FG004|COMPLETED|Overall Study||1
3051227|NCT01218867|3771383|FG005|COMPLETED|Overall Study||1
3051228|NCT01218867|3771384|FG006|COMPLETED|Overall Study||3
3051229|NCT01218867|3771385|FG007|COMPLETED|Overall Study||3
3051230|NCT01218867|3771386|FG008|COMPLETED|Overall Study||3
3051231|NCT01218867|3771387|FG009|COMPLETED|Overall Study||4
3051232|NCT01218867|3771388|FG010|COMPLETED|Overall Study||2
3051233|NCT01218867|3771378|FG000|NOT COMPLETED|Overall Study||0
3051234|NCT01218867|3771379|FG001|NOT COMPLETED|Overall Study||0
3051235|NCT01218867|3771380|FG002|NOT COMPLETED|Overall Study||0
3051236|NCT01218867|3771381|FG003|NOT COMPLETED|Overall Study||0
3051237|NCT01218867|3771382|FG004|NOT COMPLETED|Overall Study||0
3051238|NCT01218867|3771383|FG005|NOT COMPLETED|Overall Study||0
3051239|NCT01218867|3771384|FG006|NOT COMPLETED|Overall Study||1
3051240|NCT01218867|3771385|FG007|NOT COMPLETED|Overall Study||0
3051241|NCT01218867|3771386|FG008|NOT COMPLETED|Overall Study||0
3051242|NCT01218867|3771387|FG009|NOT COMPLETED|Overall Study||0
3051243|NCT01218867|3771388|FG010|NOT COMPLETED|Overall Study||0
3051244|NCT01218958|3771426|FG000|STARTED|Overall Study||210
3051245|NCT01218958|3771427|FG001|STARTED|Overall Study||205
3051246|NCT01218958|3771428|FG002|STARTED|Overall Study||209
3051247|NCT01218958|3771426|FG000|COMPLETED|Overall Study||126
3051248|NCT01218958|3771427|FG001|COMPLETED|Overall Study||124
3051249|NCT01218958|3771428|FG002|COMPLETED|Overall Study||128
3051250|NCT01218958|3771426|FG000|NOT COMPLETED|Overall Study||84
3051251|NCT01218958|3771427|FG001|NOT COMPLETED|Overall Study||81
3051252|NCT01218958|3771428|FG002|NOT COMPLETED|Overall Study||81
3051253|NCT01218971|3771438|FG000|STARTED|Overall Study||175
3051254|NCT01218971|3771439|FG001|STARTED|Overall Study||157
3051255|NCT01218971|3771438|FG000|COMPLETED|Overall Study||71
3051256|NCT01218971|3771439|FG001|COMPLETED|Overall Study||77
3051257|NCT01218971|3771438|FG000|NOT COMPLETED|Overall Study||104
3051258|NCT01218971|3771439|FG001|NOT COMPLETED|Overall Study||80
3051259|NCT01218984|3771452|FG000|STARTED|Overall Study||9
3051260|NCT01218984|3771453|FG001|STARTED|Overall Study||8
3051261|NCT01218984|3771454|FG002|STARTED|Overall Study||10
3051262|NCT01218984|3771452|FG000|COMPLETED|Overall Study||8
3051263|NCT01218984|3771453|FG001|COMPLETED|Overall Study||6
3051264|NCT01218984|3771454|FG002|COMPLETED|Overall Study||7
3051265|NCT01218984|3771452|FG000|NOT COMPLETED|Overall Study||1
3051266|NCT01218984|3771453|FG001|NOT COMPLETED|Overall Study||2
3051267|NCT01218984|3771454|FG002|NOT COMPLETED|Overall Study||3
3051268|NCT01218997|3771464|FG000|STARTED|Overall Study||371
3051269|NCT01218997|3771465|FG001|STARTED|Overall Study||65
3051270|NCT01218997|3771464|FG000|COMPLETED|Overall Study||126
3051271|NCT01218997|3771465|FG001|COMPLETED|Overall Study||24
3051272|NCT01218997|3771464|FG000|NOT COMPLETED|Overall Study||245
3051273|NCT01218997|3771465|FG001|NOT COMPLETED|Overall Study||41
3051274|NCT01219738|3771471|FG000|STARTED|Overall Study||20
3051275|NCT01219738|3771471|FG000|Budesonide 360|Overall Study||20
3051276|NCT01219738|3771471|FG000|Budesonide 720|Overall Study||20
3051277|NCT01219738|3771471|FG000|Budesonide 1440|Overall Study||20
3051278|NCT01219738|3771471|FG000|Budesonide 720- 4 Times|Overall Study||20
3051279|NCT01219738|3771471|FG000|COMPLETED|Overall Study||20
3051280|NCT01219738|3771471|FG000|NOT COMPLETED|Overall Study||0
3051281|NCT01219777|3771484|FG000|STARTED|Overall Study||9
3051282|NCT01219777|3771484|FG000|COMPLETED|Overall Study||9
3051283|NCT01219777|3771484|FG000|NOT COMPLETED|Overall Study||0
3051284|NCT01219855|3771494|FG000|STARTED|Overall Study||17
3051285|NCT01219855|3771495|FG001|STARTED|Overall Study||17
3051286|NCT01219855|3771496|FG002|STARTED|Overall Study||17
3051287|NCT01219855|3771497|FG003|STARTED|Overall Study||13
3051288|NCT01219855|3771498|FG004|STARTED|Overall Study||14
3051289|NCT01219855|3771494|FG000|COMPLETED|Overall Study||16
3051290|NCT01219855|3771495|FG001|COMPLETED|Overall Study||12
3051291|NCT01219855|3771496|FG002|COMPLETED|Overall Study||16
3051292|NCT01219855|3771497|FG003|COMPLETED|Overall Study||12
3051293|NCT01219855|3771498|FG004|COMPLETED|Overall Study||13
3051294|NCT01219855|3771494|FG000|NOT COMPLETED|Overall Study||1
3051295|NCT01219855|3771495|FG001|NOT COMPLETED|Overall Study||5
3051296|NCT01219855|3771496|FG002|NOT COMPLETED|Overall Study||1
3051297|NCT01219855|3771497|FG003|NOT COMPLETED|Overall Study||1
3051298|NCT01219855|3771498|FG004|NOT COMPLETED|Overall Study||1
3051299|NCT01219881|3771511|FG000|STARTED|Overall Study||38
3051300|NCT01219881|3771512|FG001|STARTED|Overall Study||37
3051301|NCT01219881|3771511|FG000|COMPLETED|Overall Study||34
3051302|NCT01219881|3771512|FG001|COMPLETED|Overall Study||32
3051303|NCT01219881|3771511|FG000|NOT COMPLETED|Overall Study||4
3051304|NCT01219881|3771512|FG001|NOT COMPLETED|Overall Study||5
3051305|NCT01219933|3771518|FG000|STARTED|Overall Study||68
3051306|NCT01219933|3771518|FG000|COMPLETED|Overall Study||30
3051307|NCT01219933|3771518|FG000|NOT COMPLETED|Overall Study||38
3051308|NCT01219959|3771525|FG000|STARTED|Overall Study||127
3051309|NCT01219959|3771526|FG001|STARTED|Overall Study||124
3051310|NCT01219959|3771525|FG000|COMPLETED|Overall Study||120
3051311|NCT01219959|3771526|FG001|COMPLETED|Overall Study||101
3051312|NCT01219959|3771525|FG000|NOT COMPLETED|Overall Study||7
3051313|NCT01219959|3771526|FG001|NOT COMPLETED|Overall Study||23
3051314|NCT01219985|3771532|FG000|STARTED|Overall Study||50
3051315|NCT01219985|3771532|FG000|COMPLETED|Overall Study||30
3051316|NCT01219985|3771532|FG000|NOT COMPLETED|Overall Study||20
3051317|NCT01220024|3771540|FG000|STARTED|Overall Study||25
3051318|NCT01220024|3771541|FG001|STARTED|Overall Study||25
3051319|NCT01220024|3771540|FG000|COMPLETED|Overall Study||24
3051320|NCT01220024|3771541|FG001|COMPLETED|Overall Study||24
3051321|NCT01220024|3771540|FG000|NOT COMPLETED|Overall Study||1
3051322|NCT01220024|3771541|FG001|NOT COMPLETED|Overall Study||1
3051323|NCT01220128|3771554|FG000|STARTED|Overall Study||15
3051324|NCT01220128|3771555|FG001|STARTED|Overall Study||7
3051325|NCT01220128|3771556|FG002|STARTED|Overall Study||9
3051326|NCT01220128|3771557|FG003|STARTED|Overall Study||6
3051327|NCT01220128|3771558|FG004|STARTED|Overall Study||11
3051328|NCT01220128|3771559|FG005|STARTED|Overall Study||4
3051329|NCT01220128|3771560|FG006|STARTED|Overall Study||8
3051330|NCT01220128|3771554|FG000|COMPLETED|Overall Study||11
3051331|NCT01220128|3771555|FG001|COMPLETED|Overall Study||6
3051332|NCT01220128|3771556|FG002|COMPLETED|Overall Study||6
3051333|NCT01220128|3771557|FG003|COMPLETED|Overall Study||6
3051334|NCT01220128|3771558|FG004|COMPLETED|Overall Study||11
3051335|NCT01220128|3771559|FG005|COMPLETED|Overall Study||4
3051336|NCT01220128|3771560|FG006|COMPLETED|Overall Study||3
3051337|NCT01220128|3771554|FG000|NOT COMPLETED|Overall Study||4
3051338|NCT01220128|3771555|FG001|NOT COMPLETED|Overall Study||1
3051339|NCT01220128|3771556|FG002|NOT COMPLETED|Overall Study||3
3051340|NCT01220128|3771557|FG003|NOT COMPLETED|Overall Study||0
3051341|NCT01220128|3771558|FG004|NOT COMPLETED|Overall Study||0
3051342|NCT01220128|3771559|FG005|NOT COMPLETED|Overall Study||0
3051343|NCT01220128|3771560|FG006|NOT COMPLETED|Overall Study||5
3160500|NCT01864148|3887624|FG001|Randomized and Dosed|Overall Study||45
3160501|NCT01864148|3887625|FG002|Randomized and Dosed|Overall Study||95
3160502|NCT01864148|3887626|FG003|Randomized and Dosed|Overall Study||93
3160503|NCT01864148|3887627|FG004|Randomized and Dosed|Overall Study||92
3160504|NCT01864148|3887623|FG000|COMPLETED|Overall Study||73
3160505|NCT01864148|3887624|FG001|COMPLETED|Overall Study||40
3051344|NCT01220167|3771580|FG000|STARTED|Period 1||6
3051345|NCT01220167|3771581|FG001|STARTED|Period 1||6
3051346|NCT01220167|3771582|FG002|STARTED|Period 1||6
3051347|NCT01220167|3771580|FG000|COMPLETED|Period 1||6
3051348|NCT01220167|3771581|FG001|COMPLETED|Period 1||6
3051349|NCT01220167|3771582|FG002|COMPLETED|Period 1||6
3051350|NCT01220167|3771580|FG000|NOT COMPLETED|Period 1||0
3051351|NCT01220167|3771581|FG001|NOT COMPLETED|Period 1||0
3051352|NCT01220167|3771582|FG002|NOT COMPLETED|Period 1||0
3051353|NCT01220167|3771580|FG000|STARTED|Period 2||6
3051354|NCT01220167|3771581|FG001|STARTED|Period 2||6
3051355|NCT01220167|3771582|FG002|STARTED|Period 2||6
3051356|NCT01220167|3771580|FG000|COMPLETED|Period 2||6
3051357|NCT01220167|3771581|FG001|COMPLETED|Period 2||6
3051358|NCT01220167|3771582|FG002|COMPLETED|Period 2||6
3051359|NCT01220167|3771580|FG000|NOT COMPLETED|Period 2||0
3051360|NCT01220167|3771581|FG001|NOT COMPLETED|Period 2||0
3051361|NCT01220167|3771582|FG002|NOT COMPLETED|Period 2||0
3051362|NCT01220167|3771580|FG000|STARTED|Period 3||6
3051363|NCT01220167|3771581|FG001|STARTED|Period 3||6
3051364|NCT01220167|3771582|FG002|STARTED|Period 3||6
3051365|NCT01220167|3771580|FG000|COMPLETED|Period 3||6
3051366|NCT01220167|3771581|FG001|COMPLETED|Period 3||5
3051367|NCT01220167|3771582|FG002|COMPLETED|Period 3||6
3160506|NCT01864148|3887625|FG002|COMPLETED|Overall Study||84
3160507|NCT01864148|3887626|FG003|COMPLETED|Overall Study||68
3160508|NCT01864148|3887627|FG004|COMPLETED|Overall Study||69
3160509|NCT01864148|3887623|FG000|NOT COMPLETED|Overall Study||20
3160510|NCT01864148|3887624|FG001|NOT COMPLETED|Overall Study||5
3160511|NCT01864148|3887625|FG002|NOT COMPLETED|Overall Study||11
3160512|NCT01864148|3887626|FG003|NOT COMPLETED|Overall Study||26
3160513|NCT01864148|3887627|FG004|NOT COMPLETED|Overall Study||23
3051368|NCT01220167|3771580|FG000|NOT COMPLETED|Period 3||0
3051369|NCT01220167|3771581|FG001|NOT COMPLETED|Period 3||1
3051370|NCT01220167|3771582|FG002|NOT COMPLETED|Period 3||0
3051371|NCT01220180|3771591|FG000|STARTED|Overall Study||4175
3051372|NCT01220180|3771591|FG000|Treated|Overall Study||4174
3051373|NCT01220180|3771591|FG000|COMPLETED|Overall Study||3968
3051374|NCT01220180|3771591|FG000|NOT COMPLETED|Overall Study||207
3051375|NCT01220297|3771597|FG000|STARTED|Overall Study||3
3051376|NCT01220297|3771597|FG000|COMPLETED|Overall Study||0
3051377|NCT01220297|3771597|FG000|NOT COMPLETED|Overall Study||3
3051378|NCT01220401|3771603|FG000|STARTED|Overall Study||21
3051379|NCT01220401|3771603|FG000|COMPLETED|Overall Study||18
3051380|NCT01220401|3771603|FG000|NOT COMPLETED|Overall Study||3
3051381|NCT01220414|3771609|FG000|STARTED|Overall Study||15
3051382|NCT01220414|3771610|FG001|STARTED|Overall Study||14
3051383|NCT01220414|3771611|FG002|STARTED|Overall Study||14
3051384|NCT01220414|3771612|FG003|STARTED|Overall Study||15
3051385|NCT01220414|3771609|FG000|COMPLETED|Overall Study||14
3051386|NCT01220414|3771610|FG001|COMPLETED|Overall Study||14
3160514|NCT01864174|3887646|FG000|STARTED|Double Blind Treatment - All Treated||283
3051387|NCT01220414|3771611|FG002|COMPLETED|Overall Study||14
3051388|NCT01220414|3771612|FG003|COMPLETED|Overall Study||14
3051389|NCT01220414|3771609|FG000|NOT COMPLETED|Overall Study||1
3051390|NCT01220414|3771610|FG001|NOT COMPLETED|Overall Study||0
3051391|NCT01220414|3771611|FG002|NOT COMPLETED|Overall Study||0
3051392|NCT01220414|3771612|FG003|NOT COMPLETED|Overall Study||1
3051393|NCT01220466|3771622|FG000|STARTED|Overall Study|19 eyes|11
3051394|NCT01220466|3771623|FG001|STARTED|Overall Study|108 eyes|56
3051395|NCT01220466|3771624|FG002|STARTED|Overall Study|16 eyes|10
3051396|NCT01220466|3771622|FG000|COMPLETED|Overall Study|19 eyes|11
3051397|NCT01220466|3771623|FG001|COMPLETED|Overall Study|108 eyes|56
3051398|NCT01220466|3771624|FG002|COMPLETED|Overall Study|16 eyes|10
3051399|NCT01220466|3771622|FG000|NOT COMPLETED|Overall Study||0
3051400|NCT01220466|3771623|FG001|NOT COMPLETED|Overall Study||0
3051401|NCT01220466|3771624|FG002|NOT COMPLETED|Overall Study||0
3051402|NCT01220557|3771634|FG000|STARTED|Overall Study||81
3051403|NCT01220557|3771635|FG001|STARTED|Overall Study||79
3051404|NCT01220557|3771634|FG000|COMPLETED|Overall Study|per protocol analysis including patients which participated in at least 6 out of 12 lessons.|75
3051405|NCT01220557|3771635|FG001|COMPLETED|Overall Study|per protocol analysis including patients which participated in at least 6 out of 12 lessons.|74
3051406|NCT01220557|3771634|FG000|NOT COMPLETED|Overall Study||6
3051407|NCT01220557|3771635|FG001|NOT COMPLETED|Overall Study||5
3051408|NCT01220609|3771641|FG000|STARTED|Overall Study||26
3051409|NCT01220609|3771641|FG000|COMPLETED|Overall Study|Eligible and treated patients|23
3051410|NCT01220609|3771641|FG000|NOT COMPLETED|Overall Study||3
3051411|NCT01220687|3771653|FG000|STARTED|Overall Study||16
3051412|NCT01220687|3771654|FG001|STARTED|Overall Study||15
3051413|NCT01220687|3771653|FG000|COMPLETED|Overall Study||14
3051414|NCT01220687|3771654|FG001|COMPLETED|Overall Study||14
3051415|NCT01220687|3771653|FG000|NOT COMPLETED|Overall Study||2
3051416|NCT01220687|3771654|FG001|NOT COMPLETED|Overall Study||1
3051417|NCT01220726|3771662|FG000|STARTED|Overall Study||15
3051418|NCT01220726|3771663|FG001|STARTED|Overall Study||15
3051419|NCT01220726|3771662|FG000|COMPLETED|Overall Study||15
3282538|NCT02748863|4016329|FG004|NOT COMPLETED|Treatment Period 1||0
3282539|NCT02748863|4016325|FG000|STARTED|Treatment Period 2||72
3282540|NCT02748863|4016326|FG001|STARTED|Treatment Period 2||69
3282541|NCT02748863|4016327|FG002|STARTED|Treatment Period 2||0
3282542|NCT02748863|4016328|FG003|STARTED|Treatment Period 2||34
3282543|NCT02748863|4016329|FG004|STARTED|Treatment Period 2||34
3282544|NCT02748863|4016325|FG000|COMPLETED|Treatment Period 2||67
3282545|NCT02748863|4016326|FG001|COMPLETED|Treatment Period 2||66
3051420|NCT01220726|3771663|FG001|COMPLETED|Overall Study||13
3160515|NCT01864174|3887647|FG001|STARTED|Double Blind Treatment - All Treated||285
3160516|NCT01864174|3887646|FG000|COMPLETED|Double Blind Treatment - All Treated||268
3160517|NCT01864174|3887647|FG001|COMPLETED|Double Blind Treatment - All Treated||271
3160518|NCT01864174|3887646|FG000|NOT COMPLETED|Double Blind Treatment - All Treated||15
3160519|NCT01864174|3887647|FG001|NOT COMPLETED|Double Blind Treatment - All Treated||14
3160520|NCT01864174|3887646|FG000|STARTED|Double Blind - Compliant Randomized||268
3160521|NCT01864174|3887647|FG001|STARTED|Double Blind - Compliant Randomized||271
3051421|NCT01220726|3771662|FG000|NOT COMPLETED|Overall Study||0
3051422|NCT01220726|3771663|FG001|NOT COMPLETED|Overall Study||2
3051423|NCT01220739|3771671|FG000|STARTED|Overall Study||7
3051424|NCT01220739|3771672|FG001|STARTED|Overall Study||5
3051425|NCT01220739|3771671|FG000|COMPLETED|Overall Study||7
3051426|NCT01220739|3771672|FG001|COMPLETED|Overall Study||5
3051427|NCT01220739|3771671|FG000|NOT COMPLETED|Overall Study||0
3051428|NCT01220739|3771672|FG001|NOT COMPLETED|Overall Study||0
3051429|NCT01220856|3771680|FG000|STARTED|Overall Study||6
3051430|NCT01220856|3771681|FG001|STARTED|Overall Study||3
3051431|NCT01220856|3771680|FG000|COMPLETED|Overall Study||2
3051432|NCT01220856|3771681|FG001|COMPLETED|Overall Study||0
3051433|NCT01220856|3771680|FG000|NOT COMPLETED|Overall Study||4
3051434|NCT01220856|3771681|FG001|NOT COMPLETED|Overall Study||3
3051435|NCT01220869|3771690|FG000|STARTED|Overall Study||110
3051436|NCT01220869|3771690|FG000|COMPLETED|Overall Study||104
3051437|NCT01220869|3771690|FG000|NOT COMPLETED|Overall Study||6
3051438|NCT01220973|3771694|FG000|STARTED|Overall Study||27
3051439|NCT01220973|3771694|FG000|COMPLETED|Overall Study||23
3051440|NCT01220973|3771694|FG000|NOT COMPLETED|Overall Study||4
3051441|NCT01220999|3771703|FG000|STARTED|Overall Study||2
3051442|NCT01220999|3771704|FG001|STARTED|Overall Study||4
3051443|NCT01220999|3771705|FG002|STARTED|Overall Study||5
3051444|NCT01220999|3771706|FG003|STARTED|Overall Study||3
3051445|NCT01220999|3771707|FG004|STARTED|Overall Study||5
3051446|NCT01220999|3771703|FG000|COMPLETED|Overall Study||2
3051447|NCT01220999|3771704|FG001|COMPLETED|Overall Study||4
3051448|NCT01220999|3771705|FG002|COMPLETED|Overall Study||4
3051449|NCT01220999|3771706|FG003|COMPLETED|Overall Study||3
3051450|NCT01220999|3771707|FG004|COMPLETED|Overall Study||5
3051451|NCT01220999|3771703|FG000|NOT COMPLETED|Overall Study||0
3051452|NCT01220999|3771704|FG001|NOT COMPLETED|Overall Study||0
3051453|NCT01220999|3771705|FG002|NOT COMPLETED|Overall Study||1
3051454|NCT01220999|3771706|FG003|NOT COMPLETED|Overall Study||0
3051455|NCT01220999|3771707|FG004|NOT COMPLETED|Overall Study||0
3051456|NCT01221090|3771723|FG000|STARTED|Overall Study||101
3051457|NCT01221090|3771724|FG001|STARTED|Overall Study||81
3051458|NCT01221090|3771725|FG002|STARTED|Overall Study||99
3051459|NCT01221090|3771726|FG003|STARTED|Overall Study||95
3051460|NCT01221090|3771723|FG000|COMPLETED|Overall Study||86
3051461|NCT01221090|3771724|FG001|COMPLETED|Overall Study||47
3051462|NCT01221090|3771725|FG002|COMPLETED|Overall Study||57
3051463|NCT01221090|3771726|FG003|COMPLETED|Overall Study||73
3051464|NCT01221090|3771723|FG000|NOT COMPLETED|Overall Study||15
3282546|NCT02748863|4016327|FG002|COMPLETED|Treatment Period 2||0
3282547|NCT02748863|4016328|FG003|COMPLETED|Treatment Period 2||32
3282548|NCT02748863|4016329|FG004|COMPLETED|Treatment Period 2||33
3051465|NCT01221090|3771724|FG001|NOT COMPLETED|Overall Study||34
3051466|NCT01221090|3771725|FG002|NOT COMPLETED|Overall Study||42
3051467|NCT01221090|3771726|FG003|NOT COMPLETED|Overall Study||22
3051468|NCT01221181|3771736|FG000|STARTED|Overall Study||6
3051469|NCT01221181|3771736|FG000|COMPLETED|Overall Study||5
3051470|NCT01221181|3771736|FG000|NOT COMPLETED|Overall Study||1
3051471|NCT01221194|3771742|FG000|STARTED|Overall Study||195
3160522|NCT01864174|3887646|FG000|COMPLETED|Double Blind - Compliant Randomized||245
3160523|NCT01864174|3887647|FG001|COMPLETED|Double Blind - Compliant Randomized||245
3160524|NCT01864174|3887646|FG000|NOT COMPLETED|Double Blind - Compliant Randomized||23
3160525|NCT01864174|3887647|FG001|NOT COMPLETED|Double Blind - Compliant Randomized||26
3160526|NCT01864174|3887646|FG000|STARTED|Off Treatment Follow-Up||9
3160527|NCT01864174|3887647|FG001|STARTED|Off Treatment Follow-Up||1
3160528|NCT01864174|3887646|FG000|COMPLETED|Off Treatment Follow-Up||6
3160529|NCT01864174|3887647|FG001|COMPLETED|Off Treatment Follow-Up||1
3160530|NCT01864174|3887646|FG000|NOT COMPLETED|Off Treatment Follow-Up||3
3160531|NCT01864174|3887647|FG001|NOT COMPLETED|Off Treatment Follow-Up||0
3160532|NCT01864200|3887655|FG000|STARTED|Overall Study||45
3160533|NCT01864200|3887656|FG001|STARTED|Overall Study||29
3051472|NCT01221194|3771743|FG001|STARTED|Overall Study||186
3051473|NCT01221194|3771742|FG000|COMPLETED|Overall Study||195
3051474|NCT01221194|3771743|FG001|COMPLETED|Overall Study||186
3160534|NCT01864200|3887655|FG000|COMPLETED|Overall Study||43
3160535|NCT01864200|3887656|FG001|COMPLETED|Overall Study||26
3160536|NCT01864200|3887655|FG000|NOT COMPLETED|Overall Study||2
3160537|NCT01864200|3887656|FG001|NOT COMPLETED|Overall Study||3
3160538|NCT01864291|3887662|FG000|STARTED|Overall Study||9
3160539|NCT01864291|3887662|FG000|COMPLETED|Overall Study|7/9 subjects had a minimum of one year followup since enrollment.|7
3160540|NCT01864291|3887662|FG000|NOT COMPLETED|Overall Study||2
3160541|NCT01864434|3887668|FG000|STARTED|Overall Study||25
3160542|NCT01864434|3887669|FG001|STARTED|Overall Study||25
3160543|NCT01864434|3887668|FG000|COMPLETED|Overall Study||25
3160544|NCT01864434|3887669|FG001|COMPLETED|Overall Study||25
3160545|NCT01864434|3887668|FG000|NOT COMPLETED|Overall Study||0
3160546|NCT01864434|3887669|FG001|NOT COMPLETED|Overall Study||0
3160547|NCT01864525|3887677|FG000|STARTED|Overall Study||10
3160548|NCT01864525|3887678|FG001|STARTED|Overall Study||7
3160549|NCT01864525|3887677|FG000|COMPLETED|Overall Study||9
3160550|NCT01864525|3887678|FG001|COMPLETED|Overall Study||7
3282549|NCT02748863|4016325|FG000|NOT COMPLETED|Treatment Period 2||5
3282550|NCT02748863|4016326|FG001|NOT COMPLETED|Treatment Period 2||3
3282551|NCT02748863|4016327|FG002|NOT COMPLETED|Treatment Period 2||0
3282552|NCT02748863|4016328|FG003|NOT COMPLETED|Treatment Period 2||2
3282553|NCT02748863|4016329|FG004|NOT COMPLETED|Treatment Period 2||1
3282554|NCT02748889|4016346|FG000|STARTED|Overall Study||0
3282555|NCT02748889|4016347|FG001|STARTED|Overall Study||1
3282556|NCT02748889|4016346|FG000|COMPLETED|Overall Study||0
3282557|NCT02748889|4016347|FG001|COMPLETED|Overall Study||1
3282558|NCT02748889|4016346|FG000|NOT COMPLETED|Overall Study||0
3282559|NCT02748889|4016347|FG001|NOT COMPLETED|Overall Study||0
3282560|NCT02748928|4016351|FG000|STARTED|Overall Study||62
3282561|NCT02748928|4016351|FG000|COMPLETED|Overall Study||62
3282562|NCT02748928|4016351|FG000|NOT COMPLETED|Overall Study||0
3282563|NCT02749201|4016356|FG000|STARTED|Overall Study||10
3282564|NCT02749201|4016356|FG000|COMPLETED|Overall Study||10
3282565|NCT02749201|4016356|FG000|NOT COMPLETED|Overall Study||0
3282566|NCT02749370|4016360|FG000|STARTED|Overall Study||80
3282567|NCT02749370|4016360|FG000|COMPLETED|Overall Study||66
3282568|NCT02749370|4016360|FG000|NOT COMPLETED|Overall Study||14
3282569|NCT02749721|4016364|FG000|STARTED|Screening||31
3282570|NCT02749721|4016364|FG000|COMPLETED|Screening||25
3282571|NCT02749721|4016364|FG000|NOT COMPLETED|Screening||6
3282572|NCT02749721|4016364|FG000|STARTED|8-week Open-Label Treatment Phase||25
3282573|NCT02749721|4016364|FG000|COMPLETED|8-week Open-Label Treatment Phase||22
3282574|NCT02749721|4016364|FG000|NOT COMPLETED|8-week Open-Label Treatment Phase||3
3282575|NCT02749799|4016370|FG000|STARTED|Overall Study||45
3282576|NCT02749799|4016370|FG000|COMPLETED|Overall Study||37
3282577|NCT02749799|4016370|FG000|NOT COMPLETED|Overall Study||8
3282578|NCT02749903|4016374|FG000|STARTED|Overall Study||46
3282579|NCT02749903|4016374|FG000|COMPLETED|Overall Study||46
3282580|NCT02749903|4016374|FG000|NOT COMPLETED|Overall Study||0
3282581|NCT02750267|4016380|FG000|STARTED|Overall Study||6
3282582|NCT02750267|4016381|FG001|STARTED|Overall Study||6
3282583|NCT02750267|4016380|FG000|COMPLETED|Overall Study||6
3282584|NCT02750267|4016381|FG001|COMPLETED|Overall Study||6
3282585|NCT02750267|4016380|FG000|NOT COMPLETED|Overall Study||0
3282586|NCT02750267|4016381|FG001|NOT COMPLETED|Overall Study||0
3282587|NCT02750306|4016391|FG000|STARTED|Overall Study||142
3282588|NCT02750306|4016392|FG001|STARTED|Overall Study||143
3051475|NCT01221194|3771742|FG000|NOT COMPLETED|Overall Study||0
3160551|NCT01864525|3887677|FG000|NOT COMPLETED|Overall Study||1
3160552|NCT01864525|3887678|FG001|NOT COMPLETED|Overall Study||0
3160553|NCT01864538|3887684|FG000|STARTED|Overall Study||11
3282589|NCT02750306|4016391|FG000|COMPLETED|Overall Study||136
3282590|NCT02750306|4016392|FG001|COMPLETED|Overall Study||141
3282591|NCT02750306|4016391|FG000|NOT COMPLETED|Overall Study||6
3282592|NCT02750306|4016392|FG001|NOT COMPLETED|Overall Study||2
3160554|NCT01864538|3887684|FG000|COMPLETED|Overall Study||0
3160555|NCT01864538|3887684|FG000|NOT COMPLETED|Overall Study||11
3160556|NCT01864564|3887690|FG000|STARTED|Overall Study||480
3160557|NCT01864564|3887691|FG001|STARTED|Overall Study||482
3160558|NCT01864564|3887690|FG000|COMPLETED|Overall Study||443
3160559|NCT01864564|3887691|FG001|COMPLETED|Overall Study||387
3160560|NCT01864564|3887690|FG000|NOT COMPLETED|Overall Study||37
3160561|NCT01864564|3887691|FG001|NOT COMPLETED|Overall Study||95
3160562|NCT01865084|3887700|FG000|STARTED|Double Blind Period (DB)||116
3160563|NCT01865084|3887701|FG001|STARTED|Double Blind Period (DB)||102
3160564|NCT01865084|3887702|FG002|STARTED|Double Blind Period (DB)||113
3160565|NCT01865084|3887700|FG000|Received at Least One Dose of Study Drug|Double Blind Period (DB)||116
3160566|NCT01865084|3887701|FG001|Received at Least One Dose of Study Drug|Double Blind Period (DB)||102
3160567|NCT01865084|3887702|FG002|Received at Least One Dose of Study Drug|Double Blind Period (DB)||112
3160568|NCT01865084|3887700|FG000|COMPLETED|Double Blind Period (DB)||111
3160569|NCT01865084|3887701|FG001|COMPLETED|Double Blind Period (DB)|One participant stopped therapy during the DB period but remained in the study for follow-up.|98
3160570|NCT01865084|3887702|FG002|COMPLETED|Double Blind Period (DB)||107
3160571|NCT01865084|3887700|FG000|NOT COMPLETED|Double Blind Period (DB)||5
3160572|NCT01865084|3887701|FG001|NOT COMPLETED|Double Blind Period (DB)||4
3160573|NCT01865084|3887702|FG002|NOT COMPLETED|Double Blind Period (DB)||6
3160574|NCT01865084|3887700|FG000|STARTED|Open Label Extension (OLE) Period|Participants who were on Placebo during the double blind period were assigned tadalafil during OLE.|0
3160575|NCT01865084|3887701|FG001|STARTED|Open Label Extension (OLE) Period|Participants who were on Placebo during the double blind period were assigned tadalafil during OLE.|150
3051476|NCT01221194|3771743|FG001|NOT COMPLETED|Overall Study||0
3051477|NCT01221207|3771752|FG000|STARTED|Overall Study||75
3051478|NCT01221207|3771753|FG001|STARTED|Overall Study||75
3051479|NCT01221207|3771754|FG002|STARTED|Overall Study||75
3051480|NCT01221207|3771752|FG000|COMPLETED|Overall Study||43
3051481|NCT01221207|3771753|FG001|COMPLETED|Overall Study||66
3051482|NCT01221207|3771754|FG002|COMPLETED|Overall Study||54
3051483|NCT01221207|3771752|FG000|NOT COMPLETED|Overall Study||32
3051484|NCT01221207|3771753|FG001|NOT COMPLETED|Overall Study||9
3051485|NCT01221207|3771754|FG002|NOT COMPLETED|Overall Study||21
3051486|NCT01221233|3771764|FG000|STARTED|Overall Study||18
3051487|NCT01221233|3771765|FG001|STARTED|Overall Study||20
3051488|NCT01221233|3771764|FG000|COMPLETED|Overall Study||15
3051489|NCT01221233|3771765|FG001|COMPLETED|Overall Study||19
3051490|NCT01221233|3771764|FG000|NOT COMPLETED|Overall Study||3
3051491|NCT01221233|3771765|FG001|NOT COMPLETED|Overall Study||1
3051492|NCT01221272|3771771|FG000|STARTED|Period 1||41
3051493|NCT01221272|3771772|FG001|STARTED|Period 1||40
3051494|NCT01221272|3771771|FG000|COMPLETED|Period 1||39
3051495|NCT01221272|3771772|FG001|COMPLETED|Period 1||38
3051496|NCT01221272|3771771|FG000|NOT COMPLETED|Period 1||2
3160576|NCT01865084|3887702|FG002|STARTED|Open Label Extension (OLE) Period|Participants who were on Placebo during the double blind period were assigned tadalafil during OLE.|165
3160577|NCT01865084|3887700|FG000|COMPLETED|Open Label Extension (OLE) Period||0
3160578|NCT01865084|3887701|FG001|COMPLETED|Open Label Extension (OLE) Period||139
3160579|NCT01865084|3887702|FG002|COMPLETED|Open Label Extension (OLE) Period||158
3160580|NCT01865084|3887700|FG000|NOT COMPLETED|Open Label Extension (OLE) Period||0
3160581|NCT01865084|3887701|FG001|NOT COMPLETED|Open Label Extension (OLE) Period||11
3160582|NCT01865084|3887702|FG002|NOT COMPLETED|Open Label Extension (OLE) Period||7
3160583|NCT01865448|3887716|FG000|STARTED|Overall Study||17
3051497|NCT01221272|3771772|FG001|NOT COMPLETED|Period 1||2
3051498|NCT01221272|3771771|FG000|STARTED|Period 2||39
3051499|NCT01221272|3771772|FG001|STARTED|Period 2|1 participant did not complete Period 1, but started and completed Period 2.|39
3051500|NCT01221272|3771771|FG000|COMPLETED|Period 2||39
3051501|NCT01221272|3771772|FG001|COMPLETED|Period 2||37
3051502|NCT01221272|3771771|FG000|NOT COMPLETED|Period 2||0
3051503|NCT01221272|3771772|FG001|NOT COMPLETED|Period 2||2
3051504|NCT01221285|3771781|FG000|STARTED|Overall Study||11
3051505|NCT01221285|3771781|FG000|COMPLETED|Overall Study||10
3051506|NCT01221285|3771781|FG000|NOT COMPLETED|Overall Study||1
3051507|NCT01221298|3771785|FG000|STARTED|Overall Study||11
3051508|NCT01221298|3771785|FG000|COMPLETED|Overall Study|The number of participants who completed study drug|11
3051509|NCT01221298|3771785|FG000|NOT COMPLETED|Overall Study||0
3282593|NCT02750332|4016398|FG000|STARTED|Treatment Period 1||10
3282594|NCT02750332|4016399|FG001|STARTED|Treatment Period 1||10
3282595|NCT02750332|4016398|FG000|COMPLETED|Treatment Period 1||10
3282596|NCT02750332|4016399|FG001|COMPLETED|Treatment Period 1||9
3282597|NCT02750332|4016398|FG000|NOT COMPLETED|Treatment Period 1||0
3282598|NCT02750332|4016399|FG001|NOT COMPLETED|Treatment Period 1||1
3282599|NCT02750332|4016398|FG000|STARTED|Treatment Period 2||10
3282600|NCT02750332|4016399|FG001|STARTED|Treatment Period 2||9
3282601|NCT02750332|4016398|FG000|COMPLETED|Treatment Period 2||10
3282602|NCT02750332|4016399|FG001|COMPLETED|Treatment Period 2||9
3282603|NCT02750332|4016398|FG000|NOT COMPLETED|Treatment Period 2||0
3282604|NCT02750332|4016399|FG001|NOT COMPLETED|Treatment Period 2||0
3282605|NCT02750345|4016405|FG000|STARTED|Intervention 1||4
3282606|NCT02750345|4016406|FG001|STARTED|Intervention 1||4
3282607|NCT02750345|4016407|FG002|STARTED|Intervention 1||4
3282608|NCT02750345|4016408|FG003|STARTED|Intervention 1||4
3282609|NCT02750345|4016409|FG004|STARTED|Intervention 1||4
3282610|NCT02750345|4016410|FG005|STARTED|Intervention 1||4
3051510|NCT01221311|3771791|FG000|STARTED|Overall Study||57
3160584|NCT01865448|3887717|FG001|STARTED|Overall Study||17
3160585|NCT01865448|3887716|FG000|COMPLETED|Overall Study||15
3160586|NCT01865448|3887717|FG001|COMPLETED|Overall Study||14
3160587|NCT01865448|3887716|FG000|NOT COMPLETED|Overall Study||2
3160588|NCT01865448|3887717|FG001|NOT COMPLETED|Overall Study||3
3160589|NCT01865487|3887730|FG000|STARTED|Overall Study||15
3160590|NCT01865487|3887731|FG001|STARTED|Overall Study||15
3160591|NCT01865487|3887732|FG002|STARTED|Overall Study||15
3160592|NCT01865487|3887733|FG003|STARTED|Overall Study||5
3160593|NCT01865487|3887734|FG004|STARTED|Overall Study||12
3051511|NCT01221311|3771792|FG001|STARTED|Overall Study||55
3051512|NCT01221311|3771791|FG000|COMPLETED|Overall Study||57
3051513|NCT01221311|3771792|FG001|COMPLETED|Overall Study||55
3051514|NCT01221311|3771791|FG000|NOT COMPLETED|Overall Study||0
3051515|NCT01221311|3771792|FG001|NOT COMPLETED|Overall Study||0
3051516|NCT01221350|3771800|FG000|STARTED|Overall Study||28
3051517|NCT01221350|3771801|FG001|STARTED|Overall Study||27
3051518|NCT01221350|3771800|FG000|Received Intervention|Overall Study||28
3051519|NCT01221350|3771801|FG001|Received Intervention|Overall Study||27
3051520|NCT01221350|3771800|FG000|Analysis Population|Overall Study||23
3051521|NCT01221350|3771801|FG001|Analysis Population|Overall Study||24
3051522|NCT01221350|3771800|FG000|COMPLETED|Overall Study||23
3051523|NCT01221350|3771801|FG001|COMPLETED|Overall Study||24
3051524|NCT01221350|3771800|FG000|NOT COMPLETED|Overall Study||5
3051525|NCT01221350|3771801|FG001|NOT COMPLETED|Overall Study||3
3051526|NCT01221363|3771811|FG000|STARTED|Overall Study||93
3051527|NCT01221363|3771812|FG001|STARTED|Overall Study||73
3051528|NCT01221363|3771811|FG000|COMPLETED|Overall Study||81
3051529|NCT01221363|3771812|FG001|COMPLETED|Overall Study||68
3051530|NCT01221363|3771811|FG000|NOT COMPLETED|Overall Study||12
3051531|NCT01221363|3771812|FG001|NOT COMPLETED|Overall Study||5
3051532|NCT01221441|3771820|FG000|STARTED|Overall Study||67
3051533|NCT01221441|3771821|FG001|STARTED|Overall Study||35
3051534|NCT01221441|3771820|FG000|COMPLETED|Overall Study||45
3051535|NCT01221441|3771821|FG001|COMPLETED|Overall Study||23
3051536|NCT01221441|3771820|FG000|NOT COMPLETED|Overall Study||22
3051537|NCT01221441|3771821|FG001|NOT COMPLETED|Overall Study||12
3051538|NCT01221597|3771829|FG000|STARTED|Overall Study||277
3051539|NCT01221597|3771830|FG001|STARTED|Overall Study||140
3051540|NCT01221597|3771829|FG000|COMPLETED|Overall Study||241
3051541|NCT01221597|3771830|FG001|COMPLETED|Overall Study||124
3051542|NCT01221597|3771829|FG000|NOT COMPLETED|Overall Study||36
3051543|NCT01221597|3771830|FG001|NOT COMPLETED|Overall Study||16
3051544|NCT01221623|3771839|FG000|STARTED|Overall Study||274
3282611|NCT02750345|4016405|FG000|COMPLETED|Intervention 1||4
3282612|NCT02750345|4016406|FG001|COMPLETED|Intervention 1||4
3282613|NCT02750345|4016407|FG002|COMPLETED|Intervention 1||4
3282614|NCT02750345|4016408|FG003|COMPLETED|Intervention 1||4
3282615|NCT02750345|4016409|FG004|COMPLETED|Intervention 1||3
3282616|NCT02750345|4016410|FG005|COMPLETED|Intervention 1||4
3282617|NCT02750345|4016405|FG000|NOT COMPLETED|Intervention 1||0
3282618|NCT02750345|4016406|FG001|NOT COMPLETED|Intervention 1||0
3282619|NCT02750345|4016407|FG002|NOT COMPLETED|Intervention 1||0
3282620|NCT02750345|4016408|FG003|NOT COMPLETED|Intervention 1||0
3282621|NCT02750345|4016409|FG004|NOT COMPLETED|Intervention 1||1
3282622|NCT02750345|4016410|FG005|NOT COMPLETED|Intervention 1||0
3282623|NCT02750345|4016405|FG000|STARTED|Intervention 2||4
3282624|NCT02750345|4016406|FG001|STARTED|Intervention 2||4
3282625|NCT02750345|4016407|FG002|STARTED|Intervention 2||4
3282626|NCT02750345|4016408|FG003|STARTED|Intervention 2||4
3282627|NCT02750345|4016409|FG004|STARTED|Intervention 2||3
3282628|NCT02750345|4016410|FG005|STARTED|Intervention 2||4
3282629|NCT02750345|4016405|FG000|COMPLETED|Intervention 2||4
3282630|NCT02750345|4016406|FG001|COMPLETED|Intervention 2||4
3282631|NCT02750345|4016407|FG002|COMPLETED|Intervention 2||4
3282632|NCT02750345|4016408|FG003|COMPLETED|Intervention 2||4
3282633|NCT02750345|4016409|FG004|COMPLETED|Intervention 2||3
3282634|NCT02750345|4016410|FG005|COMPLETED|Intervention 2||4
3282635|NCT02750345|4016405|FG000|NOT COMPLETED|Intervention 2||0
3282636|NCT02750345|4016406|FG001|NOT COMPLETED|Intervention 2||0
3282637|NCT02750345|4016407|FG002|NOT COMPLETED|Intervention 2||0
3282638|NCT02750345|4016408|FG003|NOT COMPLETED|Intervention 2||0
3282639|NCT02750345|4016409|FG004|NOT COMPLETED|Intervention 2||0
3282640|NCT02750345|4016410|FG005|NOT COMPLETED|Intervention 2||0
3282641|NCT02750345|4016405|FG000|STARTED|Intervention 3||4
3282642|NCT02750345|4016406|FG001|STARTED|Intervention 3||4
3282643|NCT02750345|4016407|FG002|STARTED|Intervention 3||4
3282644|NCT02750345|4016408|FG003|STARTED|Intervention 3||4
3282645|NCT02750345|4016409|FG004|STARTED|Intervention 3||3
3282646|NCT02750345|4016410|FG005|STARTED|Intervention 3||4
3282647|NCT02750345|4016405|FG000|COMPLETED|Intervention 3||4
3282648|NCT02750345|4016406|FG001|COMPLETED|Intervention 3||4
3282649|NCT02750345|4016407|FG002|COMPLETED|Intervention 3||4
3282650|NCT02750345|4016408|FG003|COMPLETED|Intervention 3||4
3282651|NCT02750345|4016409|FG004|COMPLETED|Intervention 3||3
3282652|NCT02750345|4016410|FG005|COMPLETED|Intervention 3||4
3282653|NCT02750345|4016405|FG000|NOT COMPLETED|Intervention 3||0
3282654|NCT02750345|4016406|FG001|NOT COMPLETED|Intervention 3||0
3282655|NCT02750345|4016407|FG002|NOT COMPLETED|Intervention 3||0
3282656|NCT02750345|4016408|FG003|NOT COMPLETED|Intervention 3||0
3282657|NCT02750345|4016409|FG004|NOT COMPLETED|Intervention 3||0
3051545|NCT01221623|3771840|FG001|STARTED|Overall Study||141
3282658|NCT02750345|4016410|FG005|NOT COMPLETED|Intervention 3||0
3051546|NCT01221623|3771839|FG000|COMPLETED|Overall Study||236
3051547|NCT01221623|3771840|FG001|COMPLETED|Overall Study||127
3051548|NCT01221623|3771839|FG000|NOT COMPLETED|Overall Study||38
3051549|NCT01221623|3771840|FG001|NOT COMPLETED|Overall Study||14
3051550|NCT01221727|3771848|FG000|STARTED|Overall Study|Number of subjects randomized into the study|21
3051551|NCT01221727|3771849|FG001|STARTED|Overall Study|Number of subjects randomized into the study|9
3051552|NCT01221727|3771848|FG000|Treated|Overall Study|Number of subjects received investigational product|19
3051553|NCT01221727|3771849|FG001|Treated|Overall Study|Number of subjects received investigational product|8
3051554|NCT01221727|3771848|FG000|COMPLETED|Overall Study||18
3051555|NCT01221727|3771849|FG001|COMPLETED|Overall Study||8
3051556|NCT01221727|3771848|FG000|NOT COMPLETED|Overall Study||3
3051557|NCT01221727|3771849|FG001|NOT COMPLETED|Overall Study||1
3051558|NCT01221753|3771861|FG000|STARTED|Overall Study||7
3051559|NCT01221753|3771861|FG000|COMPLETED|Overall Study||6
3051560|NCT01221753|3771861|FG000|NOT COMPLETED|Overall Study||1
3051561|NCT01221857|3771865|FG000|STARTED|Overall Study||12
3051562|NCT01221857|3771865|FG000|COMPLETED|Overall Study||12
3051563|NCT01221857|3771865|FG000|NOT COMPLETED|Overall Study||0
3051564|NCT01221948|3771873|FG000|STARTED|Overall Study||53
3051565|NCT01221948|3771873|FG000|COMPLETED|Overall Study||39
3051566|NCT01221948|3771873|FG000|NOT COMPLETED|Overall Study||14
3051567|NCT01222078|3771877|FG000|STARTED|Overall Study||1
3051568|NCT01222078|3771877|FG000|COMPLETED|Overall Study||0
3051569|NCT01222078|3771877|FG000|NOT COMPLETED|Overall Study||1
3051570|NCT01222091|3771882|FG000|STARTED|Overall Study||5
3160594|NCT01865487|3887735|FG005|STARTED|Overall Study||4
3160595|NCT01865487|3887736|FG006|STARTED|Overall Study||12
3160596|NCT01865487|3887737|FG007|STARTED|Overall Study||4
3282659|NCT02750410|4016422|FG000|STARTED|Double-Blind Treatment Period||39
3282660|NCT02750410|4016423|FG001|STARTED|Double-Blind Treatment Period||120
3282661|NCT02750410|4016422|FG000|Received at Least One Dose of Study Drug|Double-Blind Treatment Period||39
3282662|NCT02750410|4016423|FG001|Received at Least One Dose of Study Drug|Double-Blind Treatment Period||120
3282663|NCT02750410|4016422|FG000|COMPLETED|Double-Blind Treatment Period||37
3282664|NCT02750410|4016423|FG001|COMPLETED|Double-Blind Treatment Period||117
3282665|NCT02750410|4016422|FG000|NOT COMPLETED|Double-Blind Treatment Period||2
3282666|NCT02750410|4016423|FG001|NOT COMPLETED|Double-Blind Treatment Period||3
3282667|NCT02750410|4016422|FG000|STARTED|Open-Label Extension Period||37
3282668|NCT02750410|4016423|FG001|STARTED|Open-Label Extension Period||117
3282669|NCT02750410|4016422|FG000|COMPLETED|Open-Label Extension Period||31
3282670|NCT02750410|4016423|FG001|COMPLETED|Open-Label Extension Period||111
3282671|NCT02750410|4016422|FG000|NOT COMPLETED|Open-Label Extension Period||6
3282672|NCT02750410|4016423|FG001|NOT COMPLETED|Open-Label Extension Period||6
3282673|NCT02750501|4016433|FG000|STARTED|Overall Study||44
3282674|NCT02750501|4016433|FG000|Enrolled|Overall Study||44
3282675|NCT02750501|4016433|FG000|Treated|Overall Study||39
3282676|NCT02750501|4016433|FG000|COMPLETED|Overall Study||36
3282677|NCT02750501|4016433|FG000|NOT COMPLETED|Overall Study||8
3282678|NCT02750514|4016446|FG000|STARTED|Track 1||40
3282679|NCT02750514|4016447|FG001|STARTED|Track 1||4
3282680|NCT02750514|4016448|FG002|STARTED|Track 1||0
3282681|NCT02750514|4016449|FG003|STARTED|Track 1||3
3282682|NCT02750514|4016450|FG004|STARTED|Track 1||0
3282683|NCT02750514|4016446|FG000|COMPLETED|Track 1|3 participants were re-randomized to track 3 (2 part.) or track 5 (1 part.)|13
3282684|NCT02750514|4016447|FG001|COMPLETED|Track 1||2
3282685|NCT02750514|4016448|FG002|COMPLETED|Track 1||0
3282686|NCT02750514|4016449|FG003|COMPLETED|Track 1||1
3282687|NCT02750514|4016450|FG004|COMPLETED|Track 1||0
3282688|NCT02750514|4016446|FG000|NOT COMPLETED|Track 1||27
3282689|NCT02750514|4016447|FG001|NOT COMPLETED|Track 1||2
3282690|NCT02750514|4016448|FG002|NOT COMPLETED|Track 1||0
3282691|NCT02750514|4016449|FG003|NOT COMPLETED|Track 1||2
3282692|NCT02750514|4016450|FG004|NOT COMPLETED|Track 1||0
3282693|NCT02750514|4016446|FG000|STARTED|Track 2||9
3282694|NCT02750514|4016447|FG001|STARTED|Track 2||8
3282695|NCT02750514|4016448|FG002|STARTED|Track 2||2
3282696|NCT02750514|4016449|FG003|STARTED|Track 2||12
3282697|NCT02750514|4016450|FG004|STARTED|Track 2||0
3282698|NCT02750514|4016446|FG000|COMPLETED|Track 2|2 participants were re-randomized to track 3 (1 part.) or track 5 (1 part.)|3
3282699|NCT02750514|4016447|FG001|COMPLETED|Track 2||0
3282700|NCT02750514|4016448|FG002|COMPLETED|Track 2||0
3282701|NCT02750514|4016449|FG003|COMPLETED|Track 2|1 participant was re-randomized to track 5|5
3282702|NCT02750514|4016450|FG004|COMPLETED|Track 2||0
3282703|NCT02750514|4016446|FG000|NOT COMPLETED|Track 2||6
3282704|NCT02750514|4016447|FG001|NOT COMPLETED|Track 2||8
3282705|NCT02750514|4016448|FG002|NOT COMPLETED|Track 2||2
3282706|NCT02750514|4016449|FG003|NOT COMPLETED|Track 2||7
3282707|NCT02750514|4016450|FG004|NOT COMPLETED|Track 2||0
3282708|NCT02750514|4016446|FG000|STARTED|Track 3||0
3282709|NCT02750514|4016447|FG001|STARTED|Track 3|2 participants had prior treatment in track 1 (1 part.) or track 2 (1 part.)|41
3282710|NCT02750514|4016448|FG002|STARTED|Track 3|1 participant had prior treatment in track 3|16
3282711|NCT02750514|4016449|FG003|STARTED|Track 3|5 participants had prior treatment in track 1 (1 part.) or track 3 (4 part.)|18
3282712|NCT02750514|4016450|FG004|STARTED|Track 3||0
3282713|NCT02750514|4016446|FG000|COMPLETED|Track 3||0
3282714|NCT02750514|4016447|FG001|COMPLETED|Track 3|6 participants were re-randomized to track 3 (5 part.) or to track 5 (1 part.)|5
3282715|NCT02750514|4016448|FG002|COMPLETED|Track 3||1
3051571|NCT01222091|3771883|FG001|STARTED|Overall Study||5
3051572|NCT01222091|3771882|FG000|COMPLETED|Overall Study||5
3051573|NCT01222091|3771883|FG001|COMPLETED|Overall Study||5
3051574|NCT01222091|3771882|FG000|NOT COMPLETED|Overall Study||0
3051575|NCT01222091|3771883|FG001|NOT COMPLETED|Overall Study||0
3051576|NCT01222104|3771889|FG000|STARTED|Overall Study||634
3051577|NCT01222104|3771889|FG000|Angio-Seal Deployment Attempted|Overall Study||534
3051578|NCT01222104|3771889|FG000|Successful Deployment|Overall Study||529
3051579|NCT01222104|3771889|FG000|Successful Deployment and Hemostasis|Overall Study||524
3051580|NCT01222104|3771889|FG000|Completed 30-day Visit-Angio-Seal|Overall Study||497
3051581|NCT01222104|3771889|FG000|Completed 30-day Visit-No Angio-Seal|Overall Study||90
3051582|NCT01222104|3771889|FG000|COMPLETED|Overall Study||587
3051583|NCT01222104|3771889|FG000|NOT COMPLETED|Overall Study||47
3051584|NCT01222117|3771910|FG000|STARTED|Overall Study||20
3051585|NCT01222117|3771911|FG001|STARTED|Overall Study||20
3051586|NCT01222117|3771912|FG002|STARTED|Overall Study||22
3051587|NCT01222117|3771913|FG003|STARTED|Overall Study||20
3051588|NCT01222117|3771914|FG004|STARTED|Overall Study||9
3051589|NCT01222117|3771915|FG005|STARTED|Overall Study||10
3051590|NCT01222117|3771916|FG006|STARTED|Overall Study||13
3051591|NCT01222117|3771917|FG007|STARTED|Overall Study||12
3051592|NCT01222117|3771918|FG008|STARTED|Overall Study||23
3051593|NCT01222117|3771919|FG009|STARTED|Overall Study||19
3051594|NCT01222117|3771920|FG010|STARTED|Overall Study||6
3051595|NCT01222117|3771910|FG000|COMPLETED|Overall Study||17
3051596|NCT01222117|3771911|FG001|COMPLETED|Overall Study||19
3051597|NCT01222117|3771912|FG002|COMPLETED|Overall Study||22
3051598|NCT01222117|3771913|FG003|COMPLETED|Overall Study||19
3051599|NCT01222117|3771914|FG004|COMPLETED|Overall Study||8
3051600|NCT01222117|3771915|FG005|COMPLETED|Overall Study||9
3051601|NCT01222117|3771916|FG006|COMPLETED|Overall Study||13
3051602|NCT01222117|3771917|FG007|COMPLETED|Overall Study||12
3282716|NCT02750514|4016449|FG003|COMPLETED|Track 3|1 participant was re-randomized to track 5|2
3282717|NCT02750514|4016450|FG004|COMPLETED|Track 3||0
3282718|NCT02750514|4016446|FG000|NOT COMPLETED|Track 3||0
3282719|NCT02750514|4016447|FG001|NOT COMPLETED|Track 3||36
3282720|NCT02750514|4016448|FG002|NOT COMPLETED|Track 3||15
3282721|NCT02750514|4016449|FG003|NOT COMPLETED|Track 3||16
3282722|NCT02750514|4016450|FG004|NOT COMPLETED|Track 3||0
3282723|NCT02750514|4016446|FG000|STARTED|Track 4||0
3282724|NCT02750514|4016447|FG001|STARTED|Track 4||53
3282725|NCT02750514|4016448|FG002|STARTED|Track 4||0
3282726|NCT02750514|4016449|FG003|STARTED|Track 4||60
3282727|NCT02750514|4016450|FG004|STARTED|Track 4||0
3282728|NCT02750514|4016446|FG000|COMPLETED|Track 4||0
3282729|NCT02750514|4016447|FG001|COMPLETED|Track 4|1 participant was re-randomized to track 5|2
3282730|NCT02750514|4016448|FG002|COMPLETED|Track 4||0
3282731|NCT02750514|4016449|FG003|COMPLETED|Track 4||18
3282732|NCT02750514|4016450|FG004|COMPLETED|Track 4||0
3282733|NCT02750514|4016446|FG000|NOT COMPLETED|Track 4||0
3282734|NCT02750514|4016447|FG001|NOT COMPLETED|Track 4||51
3282735|NCT02750514|4016448|FG002|NOT COMPLETED|Track 4||0
3282736|NCT02750514|4016449|FG003|NOT COMPLETED|Track 4||42
3282737|NCT02750514|4016450|FG004|NOT COMPLETED|Track 4||0
3282738|NCT02750514|4016446|FG000|STARTED|Track 5||0
3282739|NCT02750514|4016447|FG001|STARTED|Track 5||0
3282740|NCT02750514|4016448|FG002|STARTED|Track 5||0
3282741|NCT02750514|4016449|FG003|STARTED|Track 5||0
3282742|NCT02750514|4016450|FG004|STARTED|Track 5|6 participants had prior treatment in track 1 (1 part.), 2 (2 part.), 3 (2 part.) or 4 (1 part.)|43
3282743|NCT02750514|4016446|FG000|COMPLETED|Track 5||0
3282744|NCT02750514|4016447|FG001|COMPLETED|Track 5||0
3282745|NCT02750514|4016448|FG002|COMPLETED|Track 5||0
3282746|NCT02750514|4016449|FG003|COMPLETED|Track 5||0
3282747|NCT02750514|4016450|FG004|COMPLETED|Track 5||0
3282748|NCT02750514|4016446|FG000|NOT COMPLETED|Track 5||0
3282749|NCT02750514|4016447|FG001|NOT COMPLETED|Track 5||0
3282750|NCT02750514|4016448|FG002|NOT COMPLETED|Track 5||0
3282751|NCT02750514|4016449|FG003|NOT COMPLETED|Track 5||0
3282752|NCT02750514|4016450|FG004|NOT COMPLETED|Track 5||43
3282753|NCT02750592|4016470|FG000|STARTED|Overall Study||30
3282754|NCT02750592|4016470|FG000|COMPLETED|Overall Study||25
3282755|NCT02750592|4016470|FG000|NOT COMPLETED|Overall Study||5
3282756|NCT02750618|4016474|FG000|STARTED|Overall Study||13
3282757|NCT02750618|4016474|FG000|Completed Week 40|Overall Study||13
3282758|NCT02750618|4016474|FG000|Completed Week 64|Overall Study||13
3282759|NCT02750618|4016474|FG000|COMPLETED|Overall Study||12
3282760|NCT02750618|4016474|FG000|NOT COMPLETED|Overall Study||1
3282761|NCT02750709|4016478|FG000|STARTED|Treatment Period 1||4
3282762|NCT02750709|4016479|FG001|STARTED|Treatment Period 1||4
3282763|NCT02750709|4016480|FG002|STARTED|Treatment Period 1||4
3282764|NCT02750709|4016481|FG003|STARTED|Treatment Period 1||4
3282765|NCT02750709|4016482|FG004|STARTED|Treatment Period 1||4
3051603|NCT01222117|3771918|FG008|COMPLETED|Overall Study||20
3051604|NCT01222117|3771919|FG009|COMPLETED|Overall Study||17
3051605|NCT01222117|3771920|FG010|COMPLETED|Overall Study||6
3051606|NCT01222117|3771910|FG000|NOT COMPLETED|Overall Study||3
3051607|NCT01222117|3771911|FG001|NOT COMPLETED|Overall Study||1
3051608|NCT01222117|3771912|FG002|NOT COMPLETED|Overall Study||0
3051609|NCT01222117|3771913|FG003|NOT COMPLETED|Overall Study||1
3051610|NCT01222117|3771914|FG004|NOT COMPLETED|Overall Study||1
3051611|NCT01222117|3771915|FG005|NOT COMPLETED|Overall Study||1
3051612|NCT01222117|3771916|FG006|NOT COMPLETED|Overall Study||0
3051613|NCT01222117|3771917|FG007|NOT COMPLETED|Overall Study||0
3282766|NCT02750709|4016483|FG005|STARTED|Treatment Period 1||4
3051614|NCT01222117|3771918|FG008|NOT COMPLETED|Overall Study||3
3051615|NCT01222117|3771919|FG009|NOT COMPLETED|Overall Study||2
3051616|NCT01222117|3771920|FG010|NOT COMPLETED|Overall Study||0
3051617|NCT01222195|3771944|FG000|STARTED|Overall Study||1
3051618|NCT01222195|3771944|FG000|COMPLETED|Overall Study||1
3051619|NCT01222195|3771944|FG000|NOT COMPLETED|Overall Study||0
3051620|NCT01222234|3771951|FG000|STARTED|Overall Study||15
3051621|NCT01222234|3771952|FG001|STARTED|Overall Study||17
3051622|NCT01222234|3771953|FG002|STARTED|Overall Study||24
3051623|NCT01222234|3771951|FG000|COMPLETED|Overall Study||15
3051624|NCT01222234|3771952|FG001|COMPLETED|Overall Study||15
3051625|NCT01222234|3771953|FG002|COMPLETED|Overall Study||22
3051626|NCT01222234|3771951|FG000|NOT COMPLETED|Overall Study||0
3051627|NCT01222234|3771952|FG001|NOT COMPLETED|Overall Study||2
3051628|NCT01222234|3771953|FG002|NOT COMPLETED|Overall Study||2
3051629|NCT01222260|3771962|FG000|STARTED|Overall Study||31
3051630|NCT01222260|3771962|FG000|COMPLETED|Overall Study||29
3051631|NCT01222260|3771962|FG000|NOT COMPLETED|Overall Study||2
3051632|NCT01222273|3771966|FG000|STARTED|Overall Study||7
3051633|NCT01222273|3771966|FG000|COMPLETED|Overall Study||7
3051634|NCT01222273|3771966|FG000|NOT COMPLETED|Overall Study||0
3051635|NCT01222286|3771972|FG000|STARTED|Overall Study||16
3282767|NCT02750709|4016478|FG000|COMPLETED|Treatment Period 1||4
3282768|NCT02750709|4016479|FG001|COMPLETED|Treatment Period 1||4
3282769|NCT02750709|4016480|FG002|COMPLETED|Treatment Period 1||4
3282770|NCT02750709|4016481|FG003|COMPLETED|Treatment Period 1||4
3282771|NCT02750709|4016482|FG004|COMPLETED|Treatment Period 1||4
3282772|NCT02750709|4016483|FG005|COMPLETED|Treatment Period 1||3
3282773|NCT02750709|4016478|FG000|NOT COMPLETED|Treatment Period 1||0
3282774|NCT02750709|4016479|FG001|NOT COMPLETED|Treatment Period 1||0
3282775|NCT02750709|4016480|FG002|NOT COMPLETED|Treatment Period 1||0
3282776|NCT02750709|4016481|FG003|NOT COMPLETED|Treatment Period 1||0
3282777|NCT02750709|4016482|FG004|NOT COMPLETED|Treatment Period 1||0
3282778|NCT02750709|4016483|FG005|NOT COMPLETED|Treatment Period 1||1
3282779|NCT02750709|4016478|FG000|STARTED|Treatment Period 2||4
3282780|NCT02750709|4016479|FG001|STARTED|Treatment Period 2||4
3282781|NCT02750709|4016480|FG002|STARTED|Treatment Period 2||4
3282782|NCT02750709|4016481|FG003|STARTED|Treatment Period 2||4
3282783|NCT02750709|4016482|FG004|STARTED|Treatment Period 2||4
3282784|NCT02750709|4016483|FG005|STARTED|Treatment Period 2||3
3282785|NCT02750709|4016478|FG000|COMPLETED|Treatment Period 2||4
3282786|NCT02750709|4016479|FG001|COMPLETED|Treatment Period 2||4
3282787|NCT02750709|4016480|FG002|COMPLETED|Treatment Period 2||4
3282788|NCT02750709|4016481|FG003|COMPLETED|Treatment Period 2||4
3282789|NCT02750709|4016482|FG004|COMPLETED|Treatment Period 2||4
3282790|NCT02750709|4016483|FG005|COMPLETED|Treatment Period 2||3
3282791|NCT02750709|4016478|FG000|NOT COMPLETED|Treatment Period 2||0
3282792|NCT02750709|4016479|FG001|NOT COMPLETED|Treatment Period 2||0
3282793|NCT02750709|4016480|FG002|NOT COMPLETED|Treatment Period 2||0
3282794|NCT02750709|4016481|FG003|NOT COMPLETED|Treatment Period 2||0
3282795|NCT02750709|4016482|FG004|NOT COMPLETED|Treatment Period 2||0
3282796|NCT02750709|4016483|FG005|NOT COMPLETED|Treatment Period 2||0
3282797|NCT02750709|4016478|FG000|STARTED|Treatment Period 3||4
3282798|NCT02750709|4016479|FG001|STARTED|Treatment Period 3||4
3282799|NCT02750709|4016480|FG002|STARTED|Treatment Period 3||4
3282800|NCT02750709|4016481|FG003|STARTED|Treatment Period 3||4
3282801|NCT02750709|4016482|FG004|STARTED|Treatment Period 3||4
3282802|NCT02750709|4016483|FG005|STARTED|Treatment Period 3||3
3282803|NCT02750709|4016478|FG000|COMPLETED|Treatment Period 3||4
3282804|NCT02750709|4016479|FG001|COMPLETED|Treatment Period 3||4
3282805|NCT02750709|4016480|FG002|COMPLETED|Treatment Period 3||4
3282806|NCT02750709|4016481|FG003|COMPLETED|Treatment Period 3||4
3282807|NCT02750709|4016482|FG004|COMPLETED|Treatment Period 3||4
3282808|NCT02750709|4016483|FG005|COMPLETED|Treatment Period 3||3
3282809|NCT02750709|4016478|FG000|NOT COMPLETED|Treatment Period 3||0
3282810|NCT02750709|4016479|FG001|NOT COMPLETED|Treatment Period 3||0
3282811|NCT02750709|4016480|FG002|NOT COMPLETED|Treatment Period 3||0
3282812|NCT02750709|4016481|FG003|NOT COMPLETED|Treatment Period 3||0
3282813|NCT02750709|4016482|FG004|NOT COMPLETED|Treatment Period 3||0
3282814|NCT02750709|4016483|FG005|NOT COMPLETED|Treatment Period 3||0
3282815|NCT02750761|4016497|FG000|STARTED|Overall Study||5
3282816|NCT02750761|4016498|FG001|STARTED|Overall Study||5
3282817|NCT02750761|4016499|FG002|STARTED|Overall Study||5
3282818|NCT02750761|4016500|FG003|STARTED|Overall Study||5
3282819|NCT02750761|4016501|FG004|STARTED|Overall Study||6
3282820|NCT02750761|4016502|FG005|STARTED|Overall Study||6
3282821|NCT02750761|4016497|FG000|COMPLETED|Overall Study||5
3282822|NCT02750761|4016498|FG001|COMPLETED|Overall Study||5
3282823|NCT02750761|4016499|FG002|COMPLETED|Overall Study||4
3282824|NCT02750761|4016500|FG003|COMPLETED|Overall Study||5
3282825|NCT02750761|4016501|FG004|COMPLETED|Overall Study||6
3282826|NCT02750761|4016502|FG005|COMPLETED|Overall Study||6
3282827|NCT02750761|4016497|FG000|NOT COMPLETED|Overall Study||0
3282828|NCT02750761|4016498|FG001|NOT COMPLETED|Overall Study||0
3282829|NCT02750761|4016499|FG002|NOT COMPLETED|Overall Study||1
3051636|NCT01222286|3771973|FG001|STARTED|Overall Study||14
3051637|NCT01222286|3771972|FG000|COMPLETED|Overall Study||16
3051638|NCT01222286|3771973|FG001|COMPLETED|Overall Study||14
3051639|NCT01222286|3771972|FG000|NOT COMPLETED|Overall Study||0
3051640|NCT01222286|3771973|FG001|NOT COMPLETED|Overall Study||0
3051641|NCT01222299|3771983|FG000|STARTED|Overall Study||21
3051642|NCT01222299|3771984|FG001|STARTED|Overall Study||23
3051643|NCT01222299|3771985|FG002|STARTED|Overall Study||22
3051644|NCT01222299|3771986|FG003|STARTED|Overall Study||23
3051645|NCT01222299|3771983|FG000|COMPLETED|Overall Study||21
3051646|NCT01222299|3771984|FG001|COMPLETED|Overall Study||21
3051647|NCT01222299|3771985|FG002|COMPLETED|Overall Study||20
3051648|NCT01222299|3771986|FG003|COMPLETED|Overall Study||18
3051649|NCT01222299|3771983|FG000|NOT COMPLETED|Overall Study||0
3051650|NCT01222299|3771984|FG001|NOT COMPLETED|Overall Study||2
3051651|NCT01222299|3771985|FG002|NOT COMPLETED|Overall Study||2
3051652|NCT01222299|3771986|FG003|NOT COMPLETED|Overall Study||5
3051653|NCT01222390|3771996|FG000|STARTED|Overall Study||12
3051654|NCT01222390|3771996|FG000|COMPLETED|Overall Study||12
3051655|NCT01222390|3771996|FG000|NOT COMPLETED|Overall Study||0
3051656|NCT01222403|3772002|FG000|STARTED|Overall Study||386
3051657|NCT01222403|3772003|FG001|STARTED|Overall Study||381
3051658|NCT01222403|3772002|FG000|COMPLETED|Overall Study||386
3051659|NCT01222403|3772003|FG001|COMPLETED|Overall Study||379
3051660|NCT01222403|3772002|FG000|NOT COMPLETED|Overall Study||0
3051661|NCT01222403|3772003|FG001|NOT COMPLETED|Overall Study||2
3051662|NCT01222416|3772011|FG000|STARTED|Overall Study||50
3051663|NCT01222416|3772012|FG001|STARTED|Overall Study||0
3051664|NCT01222416|3772011|FG000|COMPLETED|Overall Study||30
3051665|NCT01222416|3772012|FG001|COMPLETED|Overall Study||0
3051666|NCT01222416|3772011|FG000|NOT COMPLETED|Overall Study||20
3051667|NCT01222416|3772012|FG001|NOT COMPLETED|Overall Study||0
3051668|NCT01222494|3772021|FG000|STARTED|Overall Study||7
3051669|NCT01222494|3772022|FG001|STARTED|Overall Study||19
3051670|NCT01222494|3772023|FG002|STARTED|Overall Study||21
3051671|NCT01222494|3772021|FG000|COMPLETED|Overall Study||6
3051672|NCT01222494|3772022|FG001|COMPLETED|Overall Study||15
3051673|NCT01222494|3772023|FG002|COMPLETED|Overall Study||17
3051674|NCT01222494|3772021|FG000|NOT COMPLETED|Overall Study||1
3051675|NCT01222494|3772022|FG001|NOT COMPLETED|Overall Study||4
3051676|NCT01222494|3772023|FG002|NOT COMPLETED|Overall Study||4
3051677|NCT01222507|3772031|FG000|STARTED|Overall Study||62
3051678|NCT01222507|3772031|FG000|COMPLETED|Overall Study||60
3051679|NCT01222507|3772031|FG000|NOT COMPLETED|Overall Study||2
3051680|NCT01222520|3772037|FG000|STARTED|Open-label run-in Period||0
3051681|NCT01222520|3772038|FG001|STARTED|Open-label run-in Period||197
3051682|NCT01222520|3772037|FG000|COMPLETED|Open-label run-in Period||0
3051683|NCT01222520|3772038|FG001|COMPLETED|Open-label run-in Period||174
3282830|NCT02750761|4016500|FG003|NOT COMPLETED|Overall Study||0
3282831|NCT02750761|4016501|FG004|NOT COMPLETED|Overall Study||0
3282832|NCT02750761|4016502|FG005|NOT COMPLETED|Overall Study||0
3282833|NCT02750800|4016526|FG000|STARTED|Overall Study||412
3282834|NCT02750800|4016526|FG000|COMPLETED|Overall Study||314
3282835|NCT02750800|4016526|FG000|NOT COMPLETED|Overall Study||98
3282836|NCT02750813|4016544|FG000|STARTED|Period 1, First 14 Days of Wear||125
3282837|NCT02750813|4016545|FG001|STARTED|Period 1, First 14 Days of Wear||121
3282838|NCT02750813|4016544|FG000|COMPLETED|Period 1, First 14 Days of Wear||124
3282839|NCT02750813|4016545|FG001|COMPLETED|Period 1, First 14 Days of Wear||120
3282840|NCT02750813|4016544|FG000|NOT COMPLETED|Period 1, First 14 Days of Wear||1
3282841|NCT02750813|4016545|FG001|NOT COMPLETED|Period 1, First 14 Days of Wear||1
3282842|NCT02750813|4016544|FG000|STARTED|Period 2, Second 14 Days of Wear||124
3282843|NCT02750813|4016545|FG001|STARTED|Period 2, Second 14 Days of Wear||120
3282844|NCT02750813|4016544|FG000|COMPLETED|Period 2, Second 14 Days of Wear||124
3282845|NCT02750813|4016545|FG001|COMPLETED|Period 2, Second 14 Days of Wear||120
3282846|NCT02750813|4016544|FG000|NOT COMPLETED|Period 2, Second 14 Days of Wear||0
3282847|NCT02750813|4016545|FG001|NOT COMPLETED|Period 2, Second 14 Days of Wear||0
3282848|NCT02750930|4016552|FG000|STARTED|Overall Study||8
3282849|NCT02750930|4016552|FG000|COMPLETED|Overall Study||0
3282850|NCT02750930|4016552|FG000|NOT COMPLETED|Overall Study||8
3282851|NCT02750943|4016558|FG000|STARTED|Overall Study||125
3282852|NCT02750943|4016559|FG001|STARTED|Overall Study||128
3282853|NCT02750943|4016558|FG000|COMPLETED|Overall Study||119
3282854|NCT02750943|4016559|FG001|COMPLETED|Overall Study||119
3282855|NCT02750943|4016558|FG000|NOT COMPLETED|Overall Study||6
3282856|NCT02750943|4016559|FG001|NOT COMPLETED|Overall Study||9
3282857|NCT02751320|4016565|FG000|STARTED|Overall Study||45
3282858|NCT02751320|4016565|FG000|Received Test Product 1|Overall Study||29
3282859|NCT02751320|4016565|FG000|Received Test Prodcut 2|Overall Study||28
3282860|NCT02751320|4016565|FG000|Received Test Prodcut 3|Overall Study||28
3282861|NCT02751320|4016565|FG000|Received Reference Product 1|Overall Study||29
3282862|NCT02751320|4016565|FG000|Received Reference Product 2|Overall Study||28
3282863|NCT02751320|4016565|FG000|Received Reference Product 3|Overall Study||28
3282864|NCT02751320|4016565|FG000|COMPLETED|Overall Study||42
3282865|NCT02751320|4016565|FG000|NOT COMPLETED|Overall Study||3
3051684|NCT01222520|3772037|FG000|NOT COMPLETED|Open-label run-in Period||0
3051685|NCT01222520|3772038|FG001|NOT COMPLETED|Open-label run-in Period||23
3051686|NCT01222520|3772037|FG000|STARTED|Double-blind Period||87
3051687|NCT01222520|3772038|FG001|STARTED|Double-blind Period||87
3051688|NCT01222520|3772037|FG000|COMPLETED|Double-blind Period||86
3051689|NCT01222520|3772038|FG001|COMPLETED|Double-blind Period||85
3051690|NCT01222520|3772037|FG000|NOT COMPLETED|Double-blind Period||1
3051691|NCT01222520|3772038|FG001|NOT COMPLETED|Double-blind Period||2
3051692|NCT01222533|3772044|FG000|STARTED|Overall Study|Entered and treated.|154
3051693|NCT01222533|3772044|FG000|Received Placebo|Overall Study||147
3051694|NCT01222533|3772044|FG000|Received Tio R1.25|Overall Study||147
3051695|NCT01222533|3772044|FG000|Received Tio R2.5|Overall Study||145
3051696|NCT01222533|3772044|FG000|Received Tio R5|Overall Study||150
3051697|NCT01222533|3772044|FG000|Received Tio HH18|Overall Study||146
3051698|NCT01222533|3772044|FG000|COMPLETED|Overall Study|Completed planned observation time (week 21)|140
3051699|NCT01222533|3772044|FG000|NOT COMPLETED|Overall Study||14
3160597|NCT01865487|3887738|FG008|STARTED|Overall Study||12
3160598|NCT01865487|3887739|FG009|STARTED|Overall Study||4
3160599|NCT01865487|3887730|FG000|COMPLETED|Overall Study||15
3160600|NCT01865487|3887731|FG001|COMPLETED|Overall Study||15
3160601|NCT01865487|3887732|FG002|COMPLETED|Overall Study||15
3160602|NCT01865487|3887733|FG003|COMPLETED|Overall Study||4
3160603|NCT01865487|3887734|FG004|COMPLETED|Overall Study||11
3160604|NCT01865487|3887735|FG005|COMPLETED|Overall Study||4
3160605|NCT01865487|3887736|FG006|COMPLETED|Overall Study||11
3282866|NCT02751359|4016590|FG000|STARTED|Overall Study||18
3282867|NCT02751359|4016590|FG000|COMPLETED|Overall Study||17
3282868|NCT02751359|4016590|FG000|NOT COMPLETED|Overall Study||1
3282869|NCT02751385|4016600|FG000|STARTED|Period 1||2
3282870|NCT02751385|4016601|FG001|STARTED|Period 1||0
3282871|NCT02751385|4016600|FG000|COMPLETED|Period 1||2
3282872|NCT02751385|4016601|FG001|COMPLETED|Period 1||0
3282873|NCT02751385|4016600|FG000|NOT COMPLETED|Period 1||0
3282874|NCT02751385|4016601|FG001|NOT COMPLETED|Period 1||0
3282875|NCT02751385|4016600|FG000|STARTED|Period 2||0
3282876|NCT02751385|4016601|FG001|STARTED|Period 2||2
3282877|NCT02751385|4016600|FG000|COMPLETED|Period 2||0
3282878|NCT02751385|4016601|FG001|COMPLETED|Period 2||2
3282879|NCT02751385|4016600|FG000|NOT COMPLETED|Period 2||0
3282880|NCT02751385|4016601|FG001|NOT COMPLETED|Period 2||0
3282881|NCT02751424|4016618|FG000|STARTED|Part 1||6
3282882|NCT02751424|4016619|FG001|STARTED|Part 1||6
3282883|NCT02751424|4016620|FG002|STARTED|Part 1||6
3282884|NCT02751424|4016621|FG003|STARTED|Part 1||6
3282885|NCT02751424|4016622|FG004|STARTED|Part 1||6
3282886|NCT02751424|4016623|FG005|STARTED|Part 1||6
3282887|NCT02751424|4016624|FG006|STARTED|Part 1||12
3282888|NCT02751424|4016625|FG007|STARTED|Part 1||0
3282889|NCT02751424|4016626|FG008|STARTED|Part 1||0
3282890|NCT02751424|4016618|FG000|COMPLETED|Part 1||6
3282891|NCT02751424|4016619|FG001|COMPLETED|Part 1||6
3282892|NCT02751424|4016620|FG002|COMPLETED|Part 1||6
3282893|NCT02751424|4016621|FG003|COMPLETED|Part 1||6
3282894|NCT02751424|4016622|FG004|COMPLETED|Part 1||6
3282895|NCT02751424|4016623|FG005|COMPLETED|Part 1||6
3282896|NCT02751424|4016624|FG006|COMPLETED|Part 1||12
3282897|NCT02751424|4016625|FG007|COMPLETED|Part 1||0
3282898|NCT02751424|4016626|FG008|COMPLETED|Part 1||0
3282899|NCT02751424|4016618|FG000|NOT COMPLETED|Part 1||0
3282900|NCT02751424|4016619|FG001|NOT COMPLETED|Part 1||0
3282901|NCT02751424|4016620|FG002|NOT COMPLETED|Part 1||0
3282902|NCT02751424|4016621|FG003|NOT COMPLETED|Part 1||0
3282903|NCT02751424|4016622|FG004|NOT COMPLETED|Part 1||0
3282904|NCT02751424|4016623|FG005|NOT COMPLETED|Part 1||0
3282905|NCT02751424|4016624|FG006|NOT COMPLETED|Part 1||0
3282906|NCT02751424|4016625|FG007|NOT COMPLETED|Part 1||0
3282907|NCT02751424|4016626|FG008|NOT COMPLETED|Part 1||0
3282908|NCT02751424|4016618|FG000|STARTED|Part 2||0
3282909|NCT02751424|4016619|FG001|STARTED|Part 2||0
3282910|NCT02751424|4016620|FG002|STARTED|Part 2||0
3282911|NCT02751424|4016621|FG003|STARTED|Part 2||0
3282912|NCT02751424|4016622|FG004|STARTED|Part 2||0
3282913|NCT02751424|4016623|FG005|STARTED|Part 2||0
3282914|NCT02751424|4016624|FG006|STARTED|Part 2||0
3282915|NCT02751424|4016625|FG007|STARTED|Part 2||11
3282916|NCT02751424|4016626|FG008|STARTED|Part 2||3
3282917|NCT02751424|4016618|FG000|COMPLETED|Part 2||0
3282918|NCT02751424|4016619|FG001|COMPLETED|Part 2||0
3282919|NCT02751424|4016620|FG002|COMPLETED|Part 2||0
3282920|NCT02751424|4016621|FG003|COMPLETED|Part 2||0
3282921|NCT02751424|4016622|FG004|COMPLETED|Part 2||0
3282922|NCT02751424|4016623|FG005|COMPLETED|Part 2||0
3282923|NCT02751424|4016624|FG006|COMPLETED|Part 2||0
3282924|NCT02751424|4016625|FG007|COMPLETED|Part 2||6
3282925|NCT02751424|4016626|FG008|COMPLETED|Part 2||3
3282926|NCT02751424|4016618|FG000|NOT COMPLETED|Part 2||0
3282927|NCT02751424|4016619|FG001|NOT COMPLETED|Part 2||0
3282928|NCT02751424|4016620|FG002|NOT COMPLETED|Part 2||0
3282929|NCT02751424|4016621|FG003|NOT COMPLETED|Part 2||0
3051700|NCT01222572|3772056|FG000|STARTED|Overall Study||1
3051701|NCT01222572|3772057|FG001|STARTED|Overall Study||0
3051702|NCT01222572|3772058|FG002|STARTED|Overall Study||0
3051703|NCT01222572|3772056|FG000|COMPLETED|Overall Study||1
3051704|NCT01222572|3772057|FG001|COMPLETED|Overall Study||0
3051705|NCT01222572|3772058|FG002|COMPLETED|Overall Study||0
3160606|NCT01865487|3887737|FG007|COMPLETED|Overall Study||4
3282930|NCT02751424|4016622|FG004|NOT COMPLETED|Part 2||0
3282931|NCT02751424|4016623|FG005|NOT COMPLETED|Part 2||0
3282932|NCT02751424|4016624|FG006|NOT COMPLETED|Part 2||0
3282933|NCT02751424|4016625|FG007|NOT COMPLETED|Part 2||5
3282934|NCT02751424|4016626|FG008|NOT COMPLETED|Part 2||0
3282935|NCT02751450|4016651|FG000|STARTED|Overall Study||117
3282936|NCT02751450|4016652|FG001|STARTED|Overall Study||116
3282937|NCT02751450|4016651|FG000|COMPLETED|Overall Study||116
3282938|NCT02751450|4016652|FG001|COMPLETED|Overall Study||116
3282939|NCT02751450|4016651|FG000|NOT COMPLETED|Overall Study||1
3282940|NCT02751450|4016652|FG001|NOT COMPLETED|Overall Study||0
3282941|NCT02751580|4016660|FG000|STARTED|Overall Study||37
3282942|NCT02751580|4016660|FG000|COMPLETED|Overall Study||31
3160607|NCT01865487|3887738|FG008|COMPLETED|Overall Study||12
3160608|NCT01865487|3887739|FG009|COMPLETED|Overall Study||4
3160609|NCT01865487|3887730|FG000|NOT COMPLETED|Overall Study||0
3160610|NCT01865487|3887731|FG001|NOT COMPLETED|Overall Study||0
3160611|NCT01865487|3887732|FG002|NOT COMPLETED|Overall Study||0
3160612|NCT01865487|3887733|FG003|NOT COMPLETED|Overall Study||1
3160613|NCT01865487|3887734|FG004|NOT COMPLETED|Overall Study||1
3160614|NCT01865487|3887735|FG005|NOT COMPLETED|Overall Study||0
3160615|NCT01865487|3887736|FG006|NOT COMPLETED|Overall Study||1
3282943|NCT02751580|4016660|FG000|NOT COMPLETED|Overall Study||6
3282944|NCT02751827|4016667|FG000|STARTED|Overall Study||41
3282945|NCT02751827|4016668|FG001|STARTED|Overall Study||171
3282946|NCT02751827|4016669|FG002|STARTED|Overall Study||100
3282947|NCT02751827|4016667|FG000|COMPLETED|Overall Study||41
3282948|NCT02751827|4016668|FG001|COMPLETED|Overall Study||171
3051706|NCT01222572|3772056|FG000|NOT COMPLETED|Overall Study||0
3051707|NCT01222572|3772057|FG001|NOT COMPLETED|Overall Study||0
3051708|NCT01222572|3772058|FG002|NOT COMPLETED|Overall Study||0
3051709|NCT01222585|3772062|FG000|STARTED|Overall Study||24
3051710|NCT01222585|3772062|FG000|COMPLETED|Overall Study||24
3051711|NCT01222585|3772062|FG000|NOT COMPLETED|Overall Study||0
3282949|NCT02751827|4016669|FG002|COMPLETED|Overall Study||99
3282950|NCT02751827|4016667|FG000|NOT COMPLETED|Overall Study||0
3282951|NCT02751827|4016668|FG001|NOT COMPLETED|Overall Study||0
3282952|NCT02751827|4016669|FG002|NOT COMPLETED|Overall Study||1
3282953|NCT02751879|4016679|FG000|STARTED|Overall Study||157
3282954|NCT02751879|4016680|FG001|STARTED|Overall Study||71
3282955|NCT02751879|4016679|FG000|On Treatment at Study Completion|Overall Study||81
3282956|NCT02751879|4016680|FG001|On Treatment at Study Completion|Overall Study||41
3282957|NCT02751879|4016679|FG000|COMPLETED|Overall Study||157
3282958|NCT02751879|4016680|FG001|COMPLETED|Overall Study||71
3282959|NCT02751879|4016679|FG000|NOT COMPLETED|Overall Study||0
3282960|NCT02751879|4016680|FG001|NOT COMPLETED|Overall Study||0
3282961|NCT02751931|4016691|FG000|STARTED|Overall Study||56
3282962|NCT02751931|4016692|FG001|STARTED|Overall Study||35
3282963|NCT02751931|4016691|FG000|Treated|Overall Study||55
3282964|NCT02751931|4016692|FG001|Treated|Overall Study||31
3282965|NCT02751931|4016691|FG000|COMPLETED|Overall Study||43
3282966|NCT02751931|4016692|FG001|COMPLETED|Overall Study||27
3282967|NCT02751931|4016691|FG000|NOT COMPLETED|Overall Study||13
3282968|NCT02751931|4016692|FG001|NOT COMPLETED|Overall Study||8
3282969|NCT02751983|4016706|FG000|STARTED|Baseline and Randomization||35
3282970|NCT02751983|4016707|FG001|STARTED|Baseline and Randomization||35
3282971|NCT02751983|4016706|FG000|COMPLETED|Baseline and Randomization||35
3282972|NCT02751983|4016707|FG001|COMPLETED|Baseline and Randomization||35
3282973|NCT02751983|4016706|FG000|NOT COMPLETED|Baseline and Randomization||0
3282974|NCT02751983|4016707|FG001|NOT COMPLETED|Baseline and Randomization||0
3282975|NCT02751983|4016706|FG000|STARTED|Treatment||35
3282976|NCT02751983|4016707|FG001|STARTED|Treatment||35
3282977|NCT02751983|4016706|FG000|COMPLETED|Treatment||31
3282978|NCT02751983|4016707|FG001|COMPLETED|Treatment||35
3282979|NCT02751983|4016706|FG000|NOT COMPLETED|Treatment||4
3282980|NCT02751983|4016707|FG001|NOT COMPLETED|Treatment||0
3282981|NCT02751983|4016706|FG000|STARTED|Post-Treatment Assessment||35
3282982|NCT02751983|4016707|FG001|STARTED|Post-Treatment Assessment||0
3282983|NCT02751983|4016706|FG000|COMPLETED|Post-Treatment Assessment||30
3282984|NCT02751983|4016707|FG001|COMPLETED|Post-Treatment Assessment||0
3282985|NCT02751983|4016706|FG000|NOT COMPLETED|Post-Treatment Assessment||5
3282986|NCT02751983|4016707|FG001|NOT COMPLETED|Post-Treatment Assessment||0
3282987|NCT02751983|4016706|FG000|STARTED|One-Month Follow-Up Assessments||35
3282988|NCT02751983|4016707|FG001|STARTED|One-Month Follow-Up Assessments||35
3282989|NCT02751983|4016706|FG000|COMPLETED|One-Month Follow-Up Assessments||21
3282990|NCT02751983|4016707|FG001|COMPLETED|One-Month Follow-Up Assessments||23
3282991|NCT02751983|4016706|FG000|NOT COMPLETED|One-Month Follow-Up Assessments||14
3282992|NCT02751983|4016707|FG001|NOT COMPLETED|One-Month Follow-Up Assessments||12
3282993|NCT02751983|4016706|FG000|STARTED|Three-Month Follow-Up Assessments||35
3282994|NCT02751983|4016707|FG001|STARTED|Three-Month Follow-Up Assessments||35
3282995|NCT02751983|4016706|FG000|COMPLETED|Three-Month Follow-Up Assessments||23
3282996|NCT02751983|4016707|FG001|COMPLETED|Three-Month Follow-Up Assessments||19
3282997|NCT02751983|4016706|FG000|NOT COMPLETED|Three-Month Follow-Up Assessments||12
3282998|NCT02751983|4016707|FG001|NOT COMPLETED|Three-Month Follow-Up Assessments||16
3282999|NCT02752048|4016716|FG000|STARTED|Overall Study||11
3283000|NCT02752048|4016717|FG001|STARTED|Overall Study||12
3283001|NCT02752048|4016718|FG002|STARTED|Overall Study||13
3283002|NCT02752048|4016716|FG000|COMPLETED|Overall Study||11
3283003|NCT02752048|4016717|FG001|COMPLETED|Overall Study||12
3283004|NCT02752048|4016718|FG002|COMPLETED|Overall Study||10
3283005|NCT02752048|4016716|FG000|NOT COMPLETED|Overall Study||0
3283006|NCT02752048|4016717|FG001|NOT COMPLETED|Overall Study||0
3283007|NCT02752048|4016718|FG002|NOT COMPLETED|Overall Study||3
3051712|NCT01222689|3772066|FG000|STARTED|Overall Study||46
3051713|NCT01222689|3772066|FG000|COMPLETED|Overall Study||46
3051714|NCT01222689|3772066|FG000|NOT COMPLETED|Overall Study||0
3051715|NCT01222715|3772072|FG000|STARTED|Overall Study||44
3051716|NCT01222715|3772073|FG001|STARTED|Overall Study||43
3051717|NCT01222715|3772072|FG000|COMPLETED|Overall Study||8
3051718|NCT01222715|3772073|FG001|COMPLETED|Overall Study||16
3051719|NCT01222715|3772072|FG000|NOT COMPLETED|Overall Study||36
3283008|NCT02752074|4016728|FG000|STARTED|Overall Study||354
3051720|NCT01222715|3772073|FG001|NOT COMPLETED|Overall Study||27
3051721|NCT01222767|3772079|FG000|STARTED|Overall Study||17
3051722|NCT01222767|3772079|FG000|Received Treatment|Overall Study||16
3051723|NCT01222767|3772079|FG000|COMPLETED|Overall Study||0
3051724|NCT01222767|3772079|FG000|NOT COMPLETED|Overall Study||17
3051725|NCT01222832|3772085|FG000|STARTED|Overall Study||113
3051726|NCT01222832|3772086|FG001|STARTED|Overall Study||113
3051727|NCT01222832|3772085|FG000|COMPLETED|Overall Study||113
3160616|NCT01865487|3887737|FG007|NOT COMPLETED|Overall Study||0
3160617|NCT01865487|3887738|FG008|NOT COMPLETED|Overall Study||0
3160618|NCT01865487|3887739|FG009|NOT COMPLETED|Overall Study||0
3160619|NCT01865552|3887773|FG000|STARTED|Period 1||23
3160620|NCT01865552|3887774|FG001|STARTED|Period 1||23
3160621|NCT01865552|3887775|FG002|STARTED|Period 1||23
3160622|NCT01865552|3887776|FG003|STARTED|Period 1||23
3160623|NCT01865552|3887777|FG004|STARTED|Period 1||23
3160624|NCT01865552|3887778|FG005|STARTED|Period 1||23
3160625|NCT01865552|3887773|FG000|Discontinued From Period 1|Period 1||1
3160626|NCT01865552|3887774|FG001|Discontinued From Period 1|Period 1||0
3160627|NCT01865552|3887775|FG002|Discontinued From Period 1|Period 1||0
3160628|NCT01865552|3887776|FG003|Discontinued From Period 1|Period 1||1
3160629|NCT01865552|3887777|FG004|Discontinued From Period 1|Period 1||3
3160630|NCT01865552|3887778|FG005|Discontinued From Period 1|Period 1||1
3160631|NCT01865552|3887773|FG000|COMPLETED|Period 1||22
3051728|NCT01222832|3772086|FG001|COMPLETED|Overall Study||112
3051729|NCT01222832|3772085|FG000|NOT COMPLETED|Overall Study||0
3051730|NCT01222832|3772086|FG001|NOT COMPLETED|Overall Study||1
3051731|NCT01222884|3772094|FG000|STARTED|Overall Study||234
3051732|NCT01222884|3772095|FG001|STARTED|Overall Study||117
3051733|NCT01222884|3772094|FG000|COMPLETED|Overall Study||210
3051734|NCT01222884|3772095|FG001|COMPLETED|Overall Study||113
3051735|NCT01222884|3772094|FG000|NOT COMPLETED|Overall Study||24
3051736|NCT01222884|3772095|FG001|NOT COMPLETED|Overall Study||4
3160632|NCT01865552|3887774|FG001|COMPLETED|Period 1||23
3160633|NCT01865552|3887775|FG002|COMPLETED|Period 1||23
3160634|NCT01865552|3887776|FG003|COMPLETED|Period 1||22
3160635|NCT01865552|3887777|FG004|COMPLETED|Period 1||20
3160636|NCT01865552|3887778|FG005|COMPLETED|Period 1||22
3160637|NCT01865552|3887773|FG000|NOT COMPLETED|Period 1||1
3160638|NCT01865552|3887774|FG001|NOT COMPLETED|Period 1||0
3160639|NCT01865552|3887775|FG002|NOT COMPLETED|Period 1||0
3160640|NCT01865552|3887776|FG003|NOT COMPLETED|Period 1||1
3160641|NCT01865552|3887777|FG004|NOT COMPLETED|Period 1||3
3160642|NCT01865552|3887778|FG005|NOT COMPLETED|Period 1||1
3160643|NCT01865552|3887773|FG000|STARTED|Period 2||22
3160644|NCT01865552|3887774|FG001|STARTED|Period 2||23
3160645|NCT01865552|3887775|FG002|STARTED|Period 2||23
3160646|NCT01865552|3887776|FG003|STARTED|Period 2||22
3160647|NCT01865552|3887777|FG004|STARTED|Period 2||20
3051737|NCT01223027|3772103|FG000|STARTED|Overall Study||284
3051738|NCT01223027|3772104|FG001|STARTED|Overall Study||286
3051739|NCT01223027|3772103|FG000|COMPLETED|Overall Study|Completed = Ongoing at data cut-off of 25-Jan-2013|10
3051740|NCT01223027|3772104|FG001|COMPLETED|Overall Study|Completed = Ongoing at data cut-off of 25-Jan-2013|9
3051741|NCT01223027|3772103|FG000|NOT COMPLETED|Overall Study||274
3051742|NCT01223027|3772104|FG001|NOT COMPLETED|Overall Study||277
3160648|NCT01865552|3887778|FG005|STARTED|Period 2||22
3160649|NCT01865552|3887773|FG000|COMPLETED|Period 2||22
3160650|NCT01865552|3887774|FG001|COMPLETED|Period 2||23
3160651|NCT01865552|3887775|FG002|COMPLETED|Period 2||23
3160652|NCT01865552|3887776|FG003|COMPLETED|Period 2||22
3160653|NCT01865552|3887777|FG004|COMPLETED|Period 2||20
3160654|NCT01865552|3887778|FG005|COMPLETED|Period 2||22
3160655|NCT01865552|3887773|FG000|NOT COMPLETED|Period 2||0
3160656|NCT01865552|3887774|FG001|NOT COMPLETED|Period 2||0
3160657|NCT01865552|3887775|FG002|NOT COMPLETED|Period 2||0
3160658|NCT01865552|3887776|FG003|NOT COMPLETED|Period 2||0
3160659|NCT01865552|3887777|FG004|NOT COMPLETED|Period 2||0
3160660|NCT01865552|3887778|FG005|NOT COMPLETED|Period 2||0
3160661|NCT01865708|3887792|FG000|STARTED|Overall Study||10
3160662|NCT01865708|3887792|FG000|COMPLETED|Overall Study||10
3051743|NCT01223183|3772112|FG000|STARTED|Imaging Day 1||10
3051744|NCT01223183|3772113|FG001|STARTED|Imaging Day 1||10
3051745|NCT01223183|3772112|FG000|COMPLETED|Imaging Day 1||10
3160663|NCT01865708|3887792|FG000|NOT COMPLETED|Overall Study||0
3160664|NCT01865747|3887798|FG000|STARTED|Overall Study (ITT)||330
3160665|NCT01865747|3887799|FG001|STARTED|Overall Study (ITT)||328
3160666|NCT01865747|3887798|FG000|COMPLETED|Overall Study (ITT)|One subject randomized to everolimus arm received cabozantinib discontd due to clin. deterioration|132
3160667|NCT01865747|3887799|FG001|COMPLETED|Overall Study (ITT)|Five subjects were randomized but not treated|73
3160668|NCT01865747|3887798|FG000|NOT COMPLETED|Overall Study (ITT)||198
3160669|NCT01865747|3887799|FG001|NOT COMPLETED|Overall Study (ITT)||255
3051746|NCT01223183|3772113|FG001|COMPLETED|Imaging Day 1||9
3051747|NCT01223183|3772112|FG000|NOT COMPLETED|Imaging Day 1||0
3051748|NCT01223183|3772113|FG001|NOT COMPLETED|Imaging Day 1||1
3160670|NCT01865747|3887798|FG000|STARTED|Primary Intent to Treat (PITT)||187
3160671|NCT01865747|3887799|FG001|STARTED|Primary Intent to Treat (PITT)|Three subjects in the everolimus arm were randomized but not treated.|188
3160672|NCT01865747|3887798|FG000|COMPLETED|Primary Intent to Treat (PITT)||56
3160673|NCT01865747|3887799|FG001|COMPLETED|Primary Intent to Treat (PITT)||36
3160674|NCT01865747|3887798|FG000|NOT COMPLETED|Primary Intent to Treat (PITT)||131
3160675|NCT01865747|3887799|FG001|NOT COMPLETED|Primary Intent to Treat (PITT)||152
3160676|NCT01865812|3887805|FG000|STARTED|Overall Study||26
3283009|NCT02752074|4016729|FG001|STARTED|Overall Study||352
3283010|NCT02752074|4016728|FG000|Treated|Overall Study||353
3051749|NCT01223183|3772112|FG000|STARTED|Washout Period (5-24 Days)||10
3051750|NCT01223183|3772113|FG001|STARTED|Washout Period (5-24 Days)||9
3051751|NCT01223183|3772112|FG000|COMPLETED|Washout Period (5-24 Days)||8
3051752|NCT01223183|3772113|FG001|COMPLETED|Washout Period (5-24 Days)||9
3051753|NCT01223183|3772112|FG000|NOT COMPLETED|Washout Period (5-24 Days)||2
3051754|NCT01223183|3772113|FG001|NOT COMPLETED|Washout Period (5-24 Days)||0
3051755|NCT01223183|3772112|FG000|STARTED|Imaging Day 2||8
3051756|NCT01223183|3772113|FG001|STARTED|Imaging Day 2||9
3051757|NCT01223183|3772112|FG000|COMPLETED|Imaging Day 2||8
3051758|NCT01223183|3772113|FG001|COMPLETED|Imaging Day 2||9
3051759|NCT01223183|3772112|FG000|NOT COMPLETED|Imaging Day 2||0
3051760|NCT01223183|3772113|FG001|NOT COMPLETED|Imaging Day 2||0
3051761|NCT01223196|3772122|FG000|STARTED|Overall Study||13
3051762|NCT01223196|3772123|FG001|STARTED|Overall Study||11
3051763|NCT01223196|3772122|FG000|COMPLETED|Overall Study||9
3051764|NCT01223196|3772123|FG001|COMPLETED|Overall Study||11
3051765|NCT01223196|3772122|FG000|NOT COMPLETED|Overall Study||4
3051766|NCT01223196|3772123|FG001|NOT COMPLETED|Overall Study||0
3051767|NCT01223235|3772131|FG000|STARTED|Overall Study||22
3051768|NCT01223235|3772131|FG000|COMPLETED|Overall Study||21
3051769|NCT01223235|3772131|FG000|NOT COMPLETED|Overall Study||1
3051770|NCT01223352|3772137|FG000|STARTED|Overall Study||31
3051771|NCT01223352|3772138|FG001|STARTED|Overall Study||33
3051772|NCT01223352|3772137|FG000|COMPLETED|Overall Study||31
3051773|NCT01223352|3772138|FG001|COMPLETED|Overall Study||33
3051774|NCT01223352|3772137|FG000|NOT COMPLETED|Overall Study||0
3051775|NCT01223352|3772138|FG001|NOT COMPLETED|Overall Study||0
3051776|NCT01223365|3772150|FG000|STARTED|Open-label Titration Period||330
3051777|NCT01223365|3772150|FG000|Safety Analysis Set|Open-label Titration Period||329
3051778|NCT01223365|3772150|FG000|Achieved Stable Pain Relief|Open-label Titration Period||294
3051779|NCT01223365|3772150|FG000|COMPLETED|Open-label Titration Period||291
3051780|NCT01223365|3772150|FG000|NOT COMPLETED|Open-label Titration Period||39
3051781|NCT01223365|3772150|FG000|STARTED|Open-label Treatment Period||291
3051782|NCT01223365|3772150|FG000|COMPLETED|Open-label Treatment Period||189
3051783|NCT01223365|3772150|FG000|NOT COMPLETED|Open-label Treatment Period||102
3051784|NCT01223378|3772164|FG000|STARTED|Overall Study||82
3051785|NCT01223378|3772165|FG001|STARTED|Overall Study||85
3051786|NCT01223378|3772166|FG002|STARTED|Overall Study||83
3051787|NCT01223378|3772167|FG003|STARTED|Overall Study||81
3051788|NCT01223378|3772168|FG004|STARTED|Overall Study||82
3051789|NCT01223378|3772164|FG000|COMPLETED|Overall Study||76
3051790|NCT01223378|3772165|FG001|COMPLETED|Overall Study||81
3051791|NCT01223378|3772166|FG002|COMPLETED|Overall Study||80
3051792|NCT01223378|3772167|FG003|COMPLETED|Overall Study||80
3051793|NCT01223378|3772168|FG004|COMPLETED|Overall Study||79
3051794|NCT01223378|3772164|FG000|NOT COMPLETED|Overall Study||6
3051795|NCT01223378|3772165|FG001|NOT COMPLETED|Overall Study||4
3051796|NCT01223378|3772166|FG002|NOT COMPLETED|Overall Study||3
3051797|NCT01223378|3772167|FG003|NOT COMPLETED|Overall Study||1
3051798|NCT01223378|3772168|FG004|NOT COMPLETED|Overall Study||3
3133871|NCT01697748|3858822|FG001|NOT COMPLETED|Overall Study||68
3133872|NCT01697956|3858830|FG000|STARTED|Overall Study|enrolled and randomized|67
3133873|NCT01697956|3858831|FG001|STARTED|Overall Study|enrolled and randomized|32
3133874|NCT01697956|3858830|FG000|Per Protocol Population|Overall Study||66
3133875|NCT01697956|3858831|FG001|Per Protocol Population|Overall Study||31
3133876|NCT01697956|3858830|FG000|COMPLETED|Overall Study||66
3133877|NCT01697956|3858831|FG001|COMPLETED|Overall Study||31
3133878|NCT01697956|3858830|FG000|NOT COMPLETED|Overall Study||1
3133879|NCT01697956|3858831|FG001|NOT COMPLETED|Overall Study||1
3133880|NCT01697969|3858843|FG000|STARTED|Overall Study||13
3133881|NCT01697969|3858843|FG000|COMPLETED|Overall Study||10
3133882|NCT01697969|3858843|FG000|NOT COMPLETED|Overall Study||3
3133883|NCT01698008|3858850|FG000|STARTED|Overall Study||3
3133884|NCT01698008|3858851|FG001|STARTED|Overall Study||2
3133885|NCT01698008|3858850|FG000|COMPLETED|Overall Study||2
3133886|NCT01698008|3858851|FG001|COMPLETED|Overall Study||0
3133887|NCT01698008|3858850|FG000|NOT COMPLETED|Overall Study||1
3133888|NCT01698008|3858851|FG001|NOT COMPLETED|Overall Study||2
3133889|NCT01698268|3858859|FG000|STARTED|Overall Study||25
3133890|NCT01698268|3858860|FG001|STARTED|Overall Study||25
3133891|NCT01698268|3858859|FG000|COMPLETED|Overall Study||23
3133892|NCT01698268|3858860|FG001|COMPLETED|Overall Study||24
3133893|NCT01698268|3858859|FG000|NOT COMPLETED|Overall Study||2
3133894|NCT01698268|3858860|FG001|NOT COMPLETED|Overall Study||1
3133895|NCT01698320|3858868|FG000|STARTED|Run-In Period (Week -1 to Day 0)||364
3133896|NCT01698320|3858869|FG001|STARTED|Run-In Period (Week -1 to Day 0)||0
3133897|NCT01698320|3858870|FG002|STARTED|Run-In Period (Week -1 to Day 0)||0
3133898|NCT01698320|3858868|FG000|COMPLETED|Run-In Period (Week -1 to Day 0)||337
3133899|NCT01698320|3858869|FG001|COMPLETED|Run-In Period (Week -1 to Day 0)||0
3133900|NCT01698320|3858870|FG002|COMPLETED|Run-In Period (Week -1 to Day 0)||0
3133901|NCT01698320|3858868|FG000|NOT COMPLETED|Run-In Period (Week -1 to Day 0)||27
3133902|NCT01698320|3858869|FG001|NOT COMPLETED|Run-In Period (Week -1 to Day 0)||0
3133903|NCT01698320|3858870|FG002|NOT COMPLETED|Run-In Period (Week -1 to Day 0)||0
3133904|NCT01698320|3858868|FG000|STARTED|12-Week Double-Blind Period||0
3133905|NCT01698320|3858869|FG001|STARTED|12-Week Double-Blind Period||169
3051799|NCT01223404|3772180|FG000|STARTED|First Intervention (1 Day)||4
3051800|NCT01223404|3772181|FG001|STARTED|First Intervention (1 Day)||3
3051801|NCT01223404|3772182|FG002|STARTED|First Intervention (1 Day)||4
3051802|NCT01223404|3772183|FG003|STARTED|First Intervention (1 Day)||5
3051803|NCT01223404|3772184|FG004|STARTED|First Intervention (1 Day)||2
3051804|NCT01223404|3772185|FG005|STARTED|First Intervention (1 Day)||3
3051805|NCT01223404|3772180|FG000|COMPLETED|First Intervention (1 Day)||4
3051806|NCT01223404|3772181|FG001|COMPLETED|First Intervention (1 Day)||3
3051807|NCT01223404|3772182|FG002|COMPLETED|First Intervention (1 Day)||4
3283011|NCT02752074|4016729|FG001|Treated|Overall Study||352
3283012|NCT02752074|4016728|FG000|COMPLETED|Overall Study||198
3283013|NCT02752074|4016729|FG001|COMPLETED|Overall Study||209
3283014|NCT02752074|4016728|FG000|NOT COMPLETED|Overall Study||156
3283015|NCT02752074|4016729|FG001|NOT COMPLETED|Overall Study||143
3283016|NCT02752087|4016735|FG000|STARTED|Study Period 1||12
3283017|NCT02752087|4016736|FG001|STARTED|Study Period 1||12
3283018|NCT02752087|4016735|FG000|Received Study Drug|Study Period 1||12
3283019|NCT02752087|4016736|FG001|Received Study Drug|Study Period 1||12
3283020|NCT02752087|4016735|FG000|COMPLETED|Study Period 1||12
3283021|NCT02752087|4016736|FG001|COMPLETED|Study Period 1||12
3283022|NCT02752087|4016735|FG000|NOT COMPLETED|Study Period 1||0
3283023|NCT02752087|4016736|FG001|NOT COMPLETED|Study Period 1||0
3283024|NCT02752087|4016735|FG000|STARTED|Washout||12
3283025|NCT02752087|4016736|FG001|STARTED|Washout||12
3283026|NCT02752087|4016735|FG000|COMPLETED|Washout||11
3283027|NCT02752087|4016736|FG001|COMPLETED|Washout||12
3283028|NCT02752087|4016735|FG000|NOT COMPLETED|Washout||1
3283029|NCT02752087|4016736|FG001|NOT COMPLETED|Washout||0
3283030|NCT02752087|4016735|FG000|STARTED|Study Period 2||11
3283031|NCT02752087|4016736|FG001|STARTED|Study Period 2||12
3283032|NCT02752087|4016735|FG000|Received Study Drug|Study Period 2||11
3283033|NCT02752087|4016736|FG001|Received Study Drug|Study Period 2||12
3283034|NCT02752087|4016735|FG000|COMPLETED|Study Period 2||11
3283035|NCT02752087|4016736|FG001|COMPLETED|Study Period 2||12
3283036|NCT02752087|4016735|FG000|NOT COMPLETED|Study Period 2||0
3283037|NCT02752087|4016736|FG001|NOT COMPLETED|Study Period 2||0
3283038|NCT02752087|4016735|FG000|STARTED|Washout||11
3283039|NCT02752087|4016736|FG001|STARTED|Washout||12
3283040|NCT02752087|4016735|FG000|COMPLETED|Washout||11
3283041|NCT02752087|4016736|FG001|COMPLETED|Washout||12
3283042|NCT02752087|4016735|FG000|NOT COMPLETED|Washout||0
3283043|NCT02752087|4016736|FG001|NOT COMPLETED|Washout||0
3283044|NCT02752087|4016735|FG000|STARTED|Study Period 3||11
3283045|NCT02752087|4016736|FG001|STARTED|Study Period 3||12
3283046|NCT02752087|4016735|FG000|Received Study Drug|Study Period 3||11
3283047|NCT02752087|4016736|FG001|Received Study Drug|Study Period 3||12
3283048|NCT02752087|4016735|FG000|COMPLETED|Study Period 3||11
3283049|NCT02752087|4016736|FG001|COMPLETED|Study Period 3||12
3283050|NCT02752087|4016735|FG000|NOT COMPLETED|Study Period 3||0
3283051|NCT02752087|4016736|FG001|NOT COMPLETED|Study Period 3||0
3283052|NCT02752087|4016735|FG000|STARTED|Washout||11
3283053|NCT02752087|4016736|FG001|STARTED|Washout||12
3283054|NCT02752087|4016735|FG000|COMPLETED|Washout||11
3283055|NCT02752087|4016736|FG001|COMPLETED|Washout||12
3283056|NCT02752087|4016735|FG000|NOT COMPLETED|Washout||0
3283057|NCT02752087|4016736|FG001|NOT COMPLETED|Washout||0
3283058|NCT02752087|4016735|FG000|STARTED|Study Period 4||11
3283059|NCT02752087|4016736|FG001|STARTED|Study Period 4||12
3283060|NCT02752087|4016735|FG000|Received Study Drug|Study Period 4||11
3283061|NCT02752087|4016736|FG001|Received Study Drug|Study Period 4||12
3283062|NCT02752087|4016735|FG000|COMPLETED|Study Period 4||11
3283063|NCT02752087|4016736|FG001|COMPLETED|Study Period 4||12
3283064|NCT02752087|4016735|FG000|NOT COMPLETED|Study Period 4||0
3283065|NCT02752087|4016736|FG001|NOT COMPLETED|Study Period 4||0
3283066|NCT02752087|4016735|FG000|STARTED|Follow-up||11
3283067|NCT02752087|4016736|FG001|STARTED|Follow-up||12
3283068|NCT02752087|4016735|FG000|COMPLETED|Follow-up||11
3283069|NCT02752087|4016736|FG001|COMPLETED|Follow-up||12
3283070|NCT02752087|4016735|FG000|NOT COMPLETED|Follow-up||0
3283071|NCT02752087|4016736|FG001|NOT COMPLETED|Follow-up||0
3283072|NCT02752256|4016744|FG000|STARTED|Overall Study||35
3283073|NCT02752256|4016745|FG001|STARTED|Overall Study||41
3283074|NCT02752256|4016744|FG000|COMPLETED|Overall Study||35
3283075|NCT02752256|4016745|FG001|COMPLETED|Overall Study||41
3283076|NCT02752256|4016744|FG000|NOT COMPLETED|Overall Study||0
3283077|NCT02752256|4016745|FG001|NOT COMPLETED|Overall Study||0
3283078|NCT02752490|4016753|FG000|STARTED|Overall Study||409
3283079|NCT02752490|4016754|FG001|STARTED|Overall Study||435
3283080|NCT02752490|4016753|FG000|COMPLETED|Overall Study||409
3051808|NCT01223404|3772183|FG003|COMPLETED|First Intervention (1 Day)||4
3283081|NCT02752490|4016754|FG001|COMPLETED|Overall Study||435
3283082|NCT02752490|4016753|FG000|NOT COMPLETED|Overall Study||0
3283083|NCT02752490|4016754|FG001|NOT COMPLETED|Overall Study||0
3283084|NCT02752633|4016760|FG000|STARTED|Overall Study||9
3283085|NCT02752633|4016760|FG000|COMPLETED|Overall Study||8
3283086|NCT02752633|4016760|FG000|NOT COMPLETED|Overall Study||1
3283087|NCT02752776|4016767|FG000|STARTED|Overall Study||663
3283088|NCT02752776|4016768|FG001|STARTED|Overall Study||673
3283089|NCT02752776|4016769|FG002|STARTED|Overall Study||324
3283090|NCT02752776|4016767|FG000|COMPLETED|Overall Study||611
3283091|NCT02752776|4016768|FG001|COMPLETED|Overall Study||597
3283092|NCT02752776|4016769|FG002|COMPLETED|Overall Study||276
3283093|NCT02752776|4016767|FG000|NOT COMPLETED|Overall Study||52
3051809|NCT01223404|3772184|FG004|COMPLETED|First Intervention (1 Day)||2
3051810|NCT01223404|3772185|FG005|COMPLETED|First Intervention (1 Day)||3
3051811|NCT01223404|3772180|FG000|NOT COMPLETED|First Intervention (1 Day)||0
3051812|NCT01223404|3772181|FG001|NOT COMPLETED|First Intervention (1 Day)||0
3051813|NCT01223404|3772182|FG002|NOT COMPLETED|First Intervention (1 Day)||0
3051814|NCT01223404|3772183|FG003|NOT COMPLETED|First Intervention (1 Day)||1
3051815|NCT01223404|3772184|FG004|NOT COMPLETED|First Intervention (1 Day)||0
3051816|NCT01223404|3772185|FG005|NOT COMPLETED|First Intervention (1 Day)||0
3051817|NCT01223404|3772180|FG000|STARTED|Second Intervention (1 Day)||4
3051818|NCT01223404|3772181|FG001|STARTED|Second Intervention (1 Day)||3
3051819|NCT01223404|3772182|FG002|STARTED|Second Intervention (1 Day)||4
3051820|NCT01223404|3772183|FG003|STARTED|Second Intervention (1 Day)||4
3051821|NCT01223404|3772184|FG004|STARTED|Second Intervention (1 Day)||2
3051822|NCT01223404|3772185|FG005|STARTED|Second Intervention (1 Day)||3
3051823|NCT01223404|3772180|FG000|COMPLETED|Second Intervention (1 Day)||3
3051824|NCT01223404|3772181|FG001|COMPLETED|Second Intervention (1 Day)||3
3051825|NCT01223404|3772182|FG002|COMPLETED|Second Intervention (1 Day)||4
3051826|NCT01223404|3772183|FG003|COMPLETED|Second Intervention (1 Day)||4
3051827|NCT01223404|3772184|FG004|COMPLETED|Second Intervention (1 Day)||2
3051828|NCT01223404|3772185|FG005|COMPLETED|Second Intervention (1 Day)||3
3051829|NCT01223404|3772180|FG000|NOT COMPLETED|Second Intervention (1 Day)||1
3051830|NCT01223404|3772181|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
3051831|NCT01223404|3772182|FG002|NOT COMPLETED|Second Intervention (1 Day)||0
3051832|NCT01223404|3772183|FG003|NOT COMPLETED|Second Intervention (1 Day)||0
3051833|NCT01223404|3772184|FG004|NOT COMPLETED|Second Intervention (1 Day)||0
3051834|NCT01223404|3772185|FG005|NOT COMPLETED|Second Intervention (1 Day)||0
3051835|NCT01223404|3772180|FG000|STARTED|Third Intervention (1 Day)||3
3051836|NCT01223404|3772181|FG001|STARTED|Third Intervention (1 Day)||3
3051837|NCT01223404|3772182|FG002|STARTED|Third Intervention (1 Day)||4
3051838|NCT01223404|3772183|FG003|STARTED|Third Intervention (1 Day)||4
3051839|NCT01223404|3772184|FG004|STARTED|Third Intervention (1 Day)||2
3051840|NCT01223404|3772185|FG005|STARTED|Third Intervention (1 Day)||3
3051841|NCT01223404|3772180|FG000|COMPLETED|Third Intervention (1 Day)||3
3051842|NCT01223404|3772181|FG001|COMPLETED|Third Intervention (1 Day)||3
3051843|NCT01223404|3772182|FG002|COMPLETED|Third Intervention (1 Day)||4
3051844|NCT01223404|3772183|FG003|COMPLETED|Third Intervention (1 Day)||3
3051845|NCT01223404|3772184|FG004|COMPLETED|Third Intervention (1 Day)||2
3051846|NCT01223404|3772185|FG005|COMPLETED|Third Intervention (1 Day)||3
3051847|NCT01223404|3772180|FG000|NOT COMPLETED|Third Intervention (1 Day)||0
3051848|NCT01223404|3772181|FG001|NOT COMPLETED|Third Intervention (1 Day)||0
3051849|NCT01223404|3772182|FG002|NOT COMPLETED|Third Intervention (1 Day)||0
3051850|NCT01223404|3772183|FG003|NOT COMPLETED|Third Intervention (1 Day)||1
3051851|NCT01223404|3772184|FG004|NOT COMPLETED|Third Intervention (1 Day)||0
3051852|NCT01223404|3772185|FG005|NOT COMPLETED|Third Intervention (1 Day)||0
3051853|NCT01223469|3772203|FG000|STARTED|Overall Study||34
3051854|NCT01223469|3772204|FG001|STARTED|Overall Study||43
3051855|NCT01223469|3772203|FG000|COMPLETED|Overall Study||34
3051856|NCT01223469|3772204|FG001|COMPLETED|Overall Study||43
3051857|NCT01223469|3772203|FG000|NOT COMPLETED|Overall Study||0
3283094|NCT02752776|4016768|FG001|NOT COMPLETED|Overall Study||76
3283095|NCT02752776|4016769|FG002|NOT COMPLETED|Overall Study||48
3283096|NCT02752802|4016781|FG000|STARTED|Overall Study||48
3283097|NCT02752802|4016782|FG001|STARTED|Overall Study||48
3283098|NCT02752802|4016781|FG000|COMPLETED|Overall Study||47
3283099|NCT02752802|4016782|FG001|COMPLETED|Overall Study||48
3283100|NCT02752802|4016781|FG000|NOT COMPLETED|Overall Study||1
3283101|NCT02752802|4016782|FG001|NOT COMPLETED|Overall Study||0
3283102|NCT02752880|4016792|FG000|STARTED|Overall Study||23
3283103|NCT02752880|4016793|FG001|STARTED|Overall Study||23
3283104|NCT02752880|4016792|FG000|COMPLETED|Overall Study||21
3283105|NCT02752880|4016793|FG001|COMPLETED|Overall Study||20
3283106|NCT02752880|4016792|FG000|NOT COMPLETED|Overall Study||2
3283107|NCT02752880|4016793|FG001|NOT COMPLETED|Overall Study||3
3283108|NCT02752906|4016802|FG000|STARTED|Overall Study||403
3283109|NCT02752906|4016803|FG001|STARTED|Overall Study||407
3283110|NCT02752906|4016802|FG000|Vaccinated|Overall Study||402
3283111|NCT02752906|4016803|FG001|Vaccinated|Overall Study||407
3283112|NCT02752906|4016802|FG000|COMPLETED|Overall Study||396
3283113|NCT02752906|4016803|FG001|COMPLETED|Overall Study||402
3283114|NCT02752906|4016802|FG000|NOT COMPLETED|Overall Study||7
3283115|NCT02752906|4016803|FG001|NOT COMPLETED|Overall Study||5
3283116|NCT02752958|4016809|FG000|STARTED|Overall Study||75
3283117|NCT02752958|4016809|FG000|COMPLETED|Overall Study||66
3283118|NCT02752958|4016809|FG000|NOT COMPLETED|Overall Study||9
3283119|NCT02753075|4016818|FG000|STARTED|Overall Study||79
3283120|NCT02753075|4016819|FG001|STARTED|Overall Study||80
3283121|NCT02753075|4016820|FG002|STARTED|Overall Study||81
3283122|NCT02753075|4016818|FG000|COMPLETED|Overall Study||71
3051858|NCT01223469|3772204|FG001|NOT COMPLETED|Overall Study||0
3051859|NCT01223703|3772212|FG000|STARTED|Overall Study||67
3051860|NCT01223703|3772213|FG001|STARTED|Overall Study||66
3051861|NCT01223703|3772212|FG000|COMPLETED|Overall Study||67
3051862|NCT01223703|3772213|FG001|COMPLETED|Overall Study||66
3051863|NCT01223703|3772212|FG000|NOT COMPLETED|Overall Study||0
3051864|NCT01223703|3772213|FG001|NOT COMPLETED|Overall Study||0
3283123|NCT02753075|4016819|FG001|COMPLETED|Overall Study||77
3283124|NCT02753075|4016820|FG002|COMPLETED|Overall Study||78
3051865|NCT01223937|3772221|FG000|STARTED|Overall Study|Intent to treat population: randomized participants regardless if they were exposed to treatment.|131
3051866|NCT01223937|3772222|FG001|STARTED|Overall Study|Intent to treat population: randomized participants regardless if they were exposed to treatment.|137
3051867|NCT01223937|3772221|FG000|Full Analysis Set (FAS)|Overall Study|FAS: participants with at least one post-treatment efficacy assessment|128
3283125|NCT02753075|4016818|FG000|NOT COMPLETED|Overall Study||8
3283126|NCT02753075|4016819|FG001|NOT COMPLETED|Overall Study||3
3283127|NCT02753075|4016820|FG002|NOT COMPLETED|Overall Study||3
3283128|NCT02753400|4016831|FG000|STARTED|Overall Study||12
3283129|NCT02753400|4016832|FG001|STARTED|Overall Study||12
3283130|NCT02753400|4016831|FG000|COMPLETED|Overall Study||7
3283131|NCT02753400|4016832|FG001|COMPLETED|Overall Study||11
3283132|NCT02753400|4016831|FG000|NOT COMPLETED|Overall Study||5
3283133|NCT02753400|4016832|FG001|NOT COMPLETED|Overall Study||1
3283134|NCT02753413|4016840|FG000|STARTED|Overall Study||49
3283135|NCT02753413|4016841|FG001|STARTED|Overall Study||51
3283136|NCT02753413|4016840|FG000|COMPLETED|Overall Study||49
3283137|NCT02753413|4016841|FG001|COMPLETED|Overall Study||51
3283138|NCT02753413|4016840|FG000|NOT COMPLETED|Overall Study||0
3283139|NCT02753413|4016841|FG001|NOT COMPLETED|Overall Study||0
3283140|NCT02753595|4016849|FG000|STARTED|Overall Study||5
3283141|NCT02753595|4016850|FG001|STARTED|Overall Study||9
3283142|NCT02753595|4016849|FG000|COMPLETED|Overall Study||3
3283143|NCT02753595|4016850|FG001|COMPLETED|Overall Study||7
3283144|NCT02753595|4016849|FG000|NOT COMPLETED|Overall Study||2
3283145|NCT02753595|4016850|FG001|NOT COMPLETED|Overall Study||2
3283146|NCT02753699|4016858|FG000|STARTED|Overall Study||164
3283147|NCT02753699|4016859|FG001|STARTED|Overall Study||397
3283148|NCT02753699|4016860|FG002|STARTED|Overall Study||162
3283149|NCT02753699|4016858|FG000|COMPLETED|Overall Study||150
3283150|NCT02753699|4016859|FG001|COMPLETED|Overall Study||354
3283151|NCT02753699|4016860|FG002|COMPLETED|Overall Study||139
3283152|NCT02753699|4016858|FG000|NOT COMPLETED|Overall Study||14
3283153|NCT02753699|4016859|FG001|NOT COMPLETED|Overall Study||43
3283154|NCT02753699|4016860|FG002|NOT COMPLETED|Overall Study||23
3283155|NCT02753816|4016873|FG000|STARTED|Overall Study||7
3283156|NCT02753816|4016874|FG001|STARTED|Overall Study||11
3283157|NCT02753816|4016875|FG002|STARTED|Overall Study||7
3283158|NCT02753816|4016873|FG000|Tranexamic Acid|Overall Study||7
3283159|NCT02753816|4016874|FG001|Tranexamic Acid|Overall Study||0
3283160|NCT02753816|4016875|FG002|Tranexamic Acid|Overall Study||7
3283161|NCT02753816|4016873|FG000|Placebo|Overall Study||0
3283162|NCT02753816|4016874|FG001|Placebo|Overall Study||11
3283163|NCT02753816|4016875|FG002|Placebo|Overall Study||7
3283164|NCT02753816|4016873|FG000|COMPLETED|Overall Study||7
3283165|NCT02753816|4016874|FG001|COMPLETED|Overall Study||10
3283166|NCT02753816|4016875|FG002|COMPLETED|Overall Study||7
3283167|NCT02753816|4016873|FG000|NOT COMPLETED|Overall Study||0
3283168|NCT02753816|4016874|FG001|NOT COMPLETED|Overall Study||1
3283169|NCT02753816|4016875|FG002|NOT COMPLETED|Overall Study||0
3283170|NCT02753842|4016887|FG000|STARTED|First Follow-Up (Set of Condoms)||85
3283171|NCT02753842|4016888|FG001|STARTED|First Follow-Up (Set of Condoms)||84
3283172|NCT02753842|4016889|FG002|STARTED|First Follow-Up (Set of Condoms)||85
3283173|NCT02753842|4016890|FG003|STARTED|First Follow-Up (Set of Condoms)||83
3283174|NCT02753842|4016891|FG004|STARTED|First Follow-Up (Set of Condoms)||83
3283175|NCT02753842|4016892|FG005|STARTED|First Follow-Up (Set of Condoms)||84
3283176|NCT02753842|4016887|FG000|COMPLETED|First Follow-Up (Set of Condoms)||75
3283177|NCT02753842|4016888|FG001|COMPLETED|First Follow-Up (Set of Condoms)||76
3283178|NCT02753842|4016889|FG002|COMPLETED|First Follow-Up (Set of Condoms)||76
3283179|NCT02753842|4016890|FG003|COMPLETED|First Follow-Up (Set of Condoms)||81
3283180|NCT02753842|4016891|FG004|COMPLETED|First Follow-Up (Set of Condoms)||76
3283181|NCT02753842|4016892|FG005|COMPLETED|First Follow-Up (Set of Condoms)||79
3283182|NCT02753842|4016887|FG000|NOT COMPLETED|First Follow-Up (Set of Condoms)||10
3283183|NCT02753842|4016888|FG001|NOT COMPLETED|First Follow-Up (Set of Condoms)||8
3283184|NCT02753842|4016889|FG002|NOT COMPLETED|First Follow-Up (Set of Condoms)||9
3283185|NCT02753842|4016890|FG003|NOT COMPLETED|First Follow-Up (Set of Condoms)||2
3283186|NCT02753842|4016891|FG004|NOT COMPLETED|First Follow-Up (Set of Condoms)||7
3283187|NCT02753842|4016892|FG005|NOT COMPLETED|First Follow-Up (Set of Condoms)||5
3283188|NCT02753842|4016887|FG000|STARTED|Second Follow-Up (Set of Condoms)||75
3283189|NCT02753842|4016888|FG001|STARTED|Second Follow-Up (Set of Condoms)||76
3283190|NCT02753842|4016889|FG002|STARTED|Second Follow-Up (Set of Condoms)||76
3283191|NCT02753842|4016890|FG003|STARTED|Second Follow-Up (Set of Condoms)||81
3283192|NCT02753842|4016891|FG004|STARTED|Second Follow-Up (Set of Condoms)||76
3283193|NCT02753842|4016892|FG005|STARTED|Second Follow-Up (Set of Condoms)||79
3283194|NCT02753842|4016887|FG000|COMPLETED|Second Follow-Up (Set of Condoms)||71
3283195|NCT02753842|4016888|FG001|COMPLETED|Second Follow-Up (Set of Condoms)||71
3283196|NCT02753842|4016889|FG002|COMPLETED|Second Follow-Up (Set of Condoms)||71
3283197|NCT02753842|4016890|FG003|COMPLETED|Second Follow-Up (Set of Condoms)||76
3283198|NCT02753842|4016891|FG004|COMPLETED|Second Follow-Up (Set of Condoms)||75
3283199|NCT02753842|4016892|FG005|COMPLETED|Second Follow-Up (Set of Condoms)||72
3283200|NCT02753842|4016887|FG000|NOT COMPLETED|Second Follow-Up (Set of Condoms)||4
3283201|NCT02753842|4016888|FG001|NOT COMPLETED|Second Follow-Up (Set of Condoms)||5
3283202|NCT02753842|4016889|FG002|NOT COMPLETED|Second Follow-Up (Set of Condoms)||5
3283203|NCT02753842|4016890|FG003|NOT COMPLETED|Second Follow-Up (Set of Condoms)||5
3051868|NCT01223937|3772222|FG001|Full Analysis Set (FAS)|Overall Study|FAS: participants with at least one post-treatment efficacy assessment|133
3051869|NCT01223937|3772221|FG000|Safety Analysis Set (SAS)|Overall Study|SAS: participants with at least one post-treatment safety assessment|126
3051870|NCT01223937|3772222|FG001|Safety Analysis Set (SAS)|Overall Study|SAS: participants with at least one post-treatment safety assessment|135
3051871|NCT01223937|3772221|FG000|COMPLETED|Overall Study||114
3283204|NCT02753842|4016891|FG004|NOT COMPLETED|Second Follow-Up (Set of Condoms)||1
3283205|NCT02753842|4016892|FG005|NOT COMPLETED|Second Follow-Up (Set of Condoms)||7
3283206|NCT02753842|4016887|FG000|STARTED|Third Follow-Up (Set of Condoms)||71
3283207|NCT02753842|4016888|FG001|STARTED|Third Follow-Up (Set of Condoms)||71
3283208|NCT02753842|4016889|FG002|STARTED|Third Follow-Up (Set of Condoms)||71
3283209|NCT02753842|4016890|FG003|STARTED|Third Follow-Up (Set of Condoms)||76
3283210|NCT02753842|4016891|FG004|STARTED|Third Follow-Up (Set of Condoms)||75
3283211|NCT02753842|4016892|FG005|STARTED|Third Follow-Up (Set of Condoms)||72
3283212|NCT02753842|4016887|FG000|COMPLETED|Third Follow-Up (Set of Condoms)||65
3283213|NCT02753842|4016888|FG001|COMPLETED|Third Follow-Up (Set of Condoms)||66
3283214|NCT02753842|4016889|FG002|COMPLETED|Third Follow-Up (Set of Condoms)||68
3283215|NCT02753842|4016890|FG003|COMPLETED|Third Follow-Up (Set of Condoms)||70
3283216|NCT02753842|4016891|FG004|COMPLETED|Third Follow-Up (Set of Condoms)||71
3283217|NCT02753842|4016892|FG005|COMPLETED|Third Follow-Up (Set of Condoms)||69
3283218|NCT02753842|4016887|FG000|NOT COMPLETED|Third Follow-Up (Set of Condoms)||6
3283219|NCT02753842|4016888|FG001|NOT COMPLETED|Third Follow-Up (Set of Condoms)||5
3283220|NCT02753842|4016889|FG002|NOT COMPLETED|Third Follow-Up (Set of Condoms)||3
3283221|NCT02753842|4016890|FG003|NOT COMPLETED|Third Follow-Up (Set of Condoms)||6
3283222|NCT02753842|4016891|FG004|NOT COMPLETED|Third Follow-Up (Set of Condoms)||4
3283223|NCT02753842|4016892|FG005|NOT COMPLETED|Third Follow-Up (Set of Condoms)||3
3283224|NCT02753881|4016909|FG000|STARTED|Overall Study||10
3283225|NCT02753881|4016910|FG001|STARTED|Overall Study||10
3283226|NCT02753881|4016911|FG002|STARTED|Overall Study||10
3283227|NCT02753881|4016909|FG000|COMPLETED|Overall Study||10
3283228|NCT02753881|4016910|FG001|COMPLETED|Overall Study||10
3283229|NCT02753881|4016911|FG002|COMPLETED|Overall Study||10
3283230|NCT02753881|4016909|FG000|NOT COMPLETED|Overall Study||0
3283231|NCT02753881|4016910|FG001|NOT COMPLETED|Overall Study||0
3283232|NCT02753881|4016911|FG002|NOT COMPLETED|Overall Study||0
3283233|NCT02753920|4016921|FG000|STARTED|Overall Study||87
3283234|NCT02753920|4016922|FG001|STARTED|Overall Study||86
3283235|NCT02753920|4016921|FG000|COMPLETED|Overall Study||87
3283236|NCT02753920|4016922|FG001|COMPLETED|Overall Study||86
3283237|NCT02753920|4016921|FG000|NOT COMPLETED|Overall Study||0
3283238|NCT02753920|4016922|FG001|NOT COMPLETED|Overall Study||0
3283239|NCT02753946|4016934|FG000|STARTED|Overall Study||233
3283240|NCT02753946|4016935|FG001|STARTED|Overall Study||231
3283241|NCT02753946|4016934|FG000|COMPLETED|Overall Study||219
3283242|NCT02753946|4016935|FG001|COMPLETED|Overall Study||222
3283243|NCT02753946|4016934|FG000|NOT COMPLETED|Overall Study||14
3283244|NCT02753946|4016935|FG001|NOT COMPLETED|Overall Study||9
3283245|NCT02754310|4016943|FG000|STARTED|Overall Study||42
3283246|NCT02754310|4016944|FG001|STARTED|Overall Study||43
3283247|NCT02754310|4016943|FG000|COMPLETED|Overall Study||42
3283248|NCT02754310|4016944|FG001|COMPLETED|Overall Study||43
3283249|NCT02754310|4016943|FG000|NOT COMPLETED|Overall Study||0
3283250|NCT02754310|4016944|FG001|NOT COMPLETED|Overall Study||0
3283251|NCT02754427|4016952|FG000|STARTED|Overall Study||21
3283252|NCT02754427|4016953|FG001|STARTED|Overall Study||20
3283253|NCT02754427|4016952|FG000|COMPLETED|Overall Study||21
3283254|NCT02754427|4016953|FG001|COMPLETED|Overall Study||19
3283255|NCT02754427|4016952|FG000|NOT COMPLETED|Overall Study||0
3283256|NCT02754427|4016953|FG001|NOT COMPLETED|Overall Study||1
3283257|NCT02754440|4016963|FG000|STARTED|Overall Study||99
3283258|NCT02754440|4016964|FG001|STARTED|Overall Study||101
3283259|NCT02754440|4016965|FG002|STARTED|Overall Study||100
3283260|NCT02754440|4016966|FG003|STARTED|Overall Study||35
3283261|NCT02754440|4016963|FG000|COMPLETED|Overall Study||93
3283262|NCT02754440|4016964|FG001|COMPLETED|Overall Study||93
3283263|NCT02754440|4016965|FG002|COMPLETED|Overall Study||93
3283264|NCT02754440|4016966|FG003|COMPLETED|Overall Study||0
3283265|NCT02754440|4016963|FG000|NOT COMPLETED|Overall Study||6
3283266|NCT02754440|4016964|FG001|NOT COMPLETED|Overall Study||8
3283267|NCT02754440|4016965|FG002|NOT COMPLETED|Overall Study||7
3283268|NCT02754440|4016966|FG003|NOT COMPLETED|Overall Study||35
3283269|NCT02754492|4016979|FG000|STARTED|Overall Study||97
3283270|NCT02754492|4016980|FG001|STARTED|Overall Study||95
3283271|NCT02754492|4016981|FG002|STARTED|Overall Study||95
3283272|NCT02754492|4016982|FG003|STARTED|Overall Study||23
3283273|NCT02754492|4016979|FG000|COMPLETED|Overall Study||93
3283274|NCT02754492|4016980|FG001|COMPLETED|Overall Study||93
3283275|NCT02754492|4016981|FG002|COMPLETED|Overall Study||93
3283276|NCT02754492|4016982|FG003|COMPLETED|Overall Study||0
3283277|NCT02754492|4016979|FG000|NOT COMPLETED|Overall Study||4
3283278|NCT02754492|4016980|FG001|NOT COMPLETED|Overall Study||2
3283279|NCT02754492|4016981|FG002|NOT COMPLETED|Overall Study||2
3283280|NCT02754492|4016982|FG003|NOT COMPLETED|Overall Study||23
3283281|NCT02754518|4016991|FG000|STARTED|Overall Study||40
3283282|NCT02754518|4016991|FG000|COMPLETED|Overall Study||40
3283283|NCT02754518|4016991|FG000|NOT COMPLETED|Overall Study||0
3283284|NCT02754570|4016995|FG000|STARTED|Overall Study||27
3283285|NCT02754570|4016995|FG000|Visits 1 and 2 (PGA Only)|Overall Study||27
3051872|NCT01223937|3772222|FG001|COMPLETED|Overall Study||119
3051873|NCT01223937|3772221|FG000|NOT COMPLETED|Overall Study||17
3051874|NCT01223937|3772222|FG001|NOT COMPLETED|Overall Study||18
3051875|NCT01223963|3772228|FG000|STARTED|Overall Study|All subjects treated between May 1 2008 and Dec 31 2009 in selected clinics were to be asked.|93
3051876|NCT01223963|3772228|FG000|COMPLETED|Overall Study||93
3051877|NCT01223963|3772228|FG000|NOT COMPLETED|Overall Study||0
3051878|NCT01224015|3772236|FG000|STARTED|Overall Study||361
3051879|NCT01224015|3772237|FG001|STARTED|Overall Study||227
3051880|NCT01224015|3772238|FG002|STARTED|Overall Study||96
3051881|NCT01224015|3772236|FG000|COMPLETED|Overall Study||347
3051882|NCT01224015|3772237|FG001|COMPLETED|Overall Study||211
3051883|NCT01224015|3772238|FG002|COMPLETED|Overall Study||83
3051884|NCT01224015|3772236|FG000|NOT COMPLETED|Overall Study||14
3051885|NCT01224015|3772237|FG001|NOT COMPLETED|Overall Study||16
3051886|NCT01224015|3772238|FG002|NOT COMPLETED|Overall Study||13
3051887|NCT01224145|3772246|FG000|STARTED|Overall Study||10
3051888|NCT01224145|3772246|FG000|COMPLETED|Overall Study||10
3051889|NCT01224145|3772246|FG000|NOT COMPLETED|Overall Study||0
3051890|NCT01224158|3772253|FG000|STARTED|Overall Study||76
3051891|NCT01224158|3772254|FG001|STARTED|Overall Study||77
3051892|NCT01224158|3772253|FG000|COMPLETED|Overall Study||75
3051893|NCT01224158|3772254|FG001|COMPLETED|Overall Study||77
3051894|NCT01224158|3772253|FG000|NOT COMPLETED|Overall Study||1
3051895|NCT01224158|3772254|FG001|NOT COMPLETED|Overall Study||0
3051896|NCT01224171|3772262|FG000|STARTED|Overall Study||207
3051897|NCT01224171|3772263|FG001|STARTED|Overall Study||209
3051898|NCT01224171|3772262|FG000|TNFα Antagonist Failure Population|Overall Study|Previously failed (inadequate response, loss of response, or intolerance) TNFα antagonist therapy|157
3051899|NCT01224171|3772263|FG001|TNFα Antagonist Failure Population|Overall Study|Previously failed (inadequate response, loss of response, or intolerance) TNFα antagonist therapy|158
3051900|NCT01224171|3772262|FG000|COMPLETED|Overall Study|Completed study is defined as patients who completed the Week 10 assessments.|192
3051901|NCT01224171|3772263|FG001|COMPLETED|Overall Study|Completed study is defined as patients who completed the Week 10 assessments.|196
3051902|NCT01224171|3772262|FG000|NOT COMPLETED|Overall Study||15
3051903|NCT01224171|3772263|FG001|NOT COMPLETED|Overall Study||13
3051904|NCT01224210|3772269|FG000|STARTED|Overall Study||30
3051905|NCT01224210|3772269|FG000|COMPLETED|Overall Study||23
3051906|NCT01224210|3772269|FG000|NOT COMPLETED|Overall Study||7
3051907|NCT01224236|3772276|FG000|STARTED|Overall Study||76
3051908|NCT01224236|3772277|FG001|STARTED|Overall Study||74
3051909|NCT01224236|3772276|FG000|COMPLETED|Overall Study||75
3051910|NCT01224236|3772277|FG001|COMPLETED|Overall Study||73
3051911|NCT01224236|3772276|FG000|NOT COMPLETED|Overall Study||1
3051912|NCT01224236|3772277|FG001|NOT COMPLETED|Overall Study||1
3051913|NCT01224431|3772285|FG000|STARTED|Overall Study||30
3051914|NCT01224431|3772286|FG001|STARTED|Overall Study||30
3051915|NCT01224431|3772285|FG000|COMPLETED|Overall Study||30
3051916|NCT01224431|3772286|FG001|COMPLETED|Overall Study||25
3283286|NCT02754570|4016995|FG000|Visit 3 (PGA + Pilocarpine)|Overall Study||27
3283287|NCT02754570|4016995|FG000|COMPLETED|Overall Study||27
3283288|NCT02754570|4016995|FG000|NOT COMPLETED|Overall Study||0
3283289|NCT02754661|4017003|FG000|STARTED|Overall Study||160
3283290|NCT02754661|4017004|FG001|STARTED|Overall Study||160
3283291|NCT02754661|4017003|FG000|COMPLETED|Overall Study||145
3283292|NCT02754661|4017004|FG001|COMPLETED|Overall Study||141
3283293|NCT02754661|4017003|FG000|NOT COMPLETED|Overall Study||15
3283294|NCT02754661|4017004|FG001|NOT COMPLETED|Overall Study||19
3283295|NCT02754674|4017014|FG000|STARTED|Overall Study||34
3283296|NCT02754674|4017015|FG001|STARTED|Overall Study||33
3283297|NCT02754674|4017014|FG000|COMPLETED|Overall Study||28
3283298|NCT02754674|4017015|FG001|COMPLETED|Overall Study||26
3283299|NCT02754674|4017014|FG000|NOT COMPLETED|Overall Study||6
3283300|NCT02754674|4017015|FG001|NOT COMPLETED|Overall Study||7
3283301|NCT02755090|4017023|FG000|STARTED|Overall Study||19
3283302|NCT02755090|4017024|FG001|STARTED|Overall Study||20
3283303|NCT02755090|4017023|FG000|COMPLETED|Overall Study||18
3283304|NCT02755090|4017024|FG001|COMPLETED|Overall Study||20
3283305|NCT02755090|4017023|FG000|NOT COMPLETED|Overall Study||1
3283306|NCT02755090|4017024|FG001|NOT COMPLETED|Overall Study||0
3283307|NCT02755116|4017032|FG000|STARTED|Overall Study||74
3283308|NCT02755116|4017033|FG001|STARTED|Overall Study||70
3283309|NCT02755116|4017032|FG000|COMPLETED|Overall Study||71
3283310|NCT02755116|4017033|FG001|COMPLETED|Overall Study||69
3283311|NCT02755116|4017032|FG000|NOT COMPLETED|Overall Study||3
3283312|NCT02755116|4017033|FG001|NOT COMPLETED|Overall Study||1
3283313|NCT02755129|4017039|FG000|STARTED|Overall Study||15
3283314|NCT02755129|4017039|FG000|COMPLETED|Overall Study||15
3283315|NCT02755129|4017039|FG000|NOT COMPLETED|Overall Study||0
3283316|NCT02755285|4017046|FG000|STARTED|Overall Study||20
3283317|NCT02755285|4017046|FG000|COMPLETED|Overall Study||20
3283318|NCT02755285|4017046|FG000|NOT COMPLETED|Overall Study||0
3283319|NCT02755649|4017053|FG000|STARTED|Overall Study||108
3283320|NCT02755649|4017054|FG001|STARTED|Overall Study||107
3283321|NCT02755649|4017055|FG002|STARTED|Overall Study||110
3283322|NCT02755649|4017053|FG000|Completed Treatment (Week 16)|Overall Study||107
3283323|NCT02755649|4017054|FG001|Completed Treatment (Week 16)|Overall Study||106
3051917|NCT01224431|3772285|FG000|NOT COMPLETED|Overall Study||0
3283324|NCT02755649|4017055|FG002|Completed Treatment (Week 16)|Overall Study||109
3283325|NCT02755649|4017053|FG000|Completed Study (Week 28)|Overall Study||7
3283326|NCT02755649|4017054|FG001|Completed Study (Week 28)|Overall Study||8
3051918|NCT01224431|3772286|FG001|NOT COMPLETED|Overall Study||5
3051919|NCT01224444|3772294|FG000|STARTED|Overall Study||269
3051920|NCT01224444|3772294|FG000|COMPLETED|Overall Study||269
3051921|NCT01224444|3772294|FG000|NOT COMPLETED|Overall Study||0
3051922|NCT01224626|3772298|FG000|STARTED|Overall Study||42
3051923|NCT01224626|3772298|FG000|COMPLETED|Overall Study||41
3051924|NCT01224626|3772298|FG000|NOT COMPLETED|Overall Study||1
3051925|NCT01224639|3772310|FG000|STARTED|Overall Study||19
3051926|NCT01224639|3772311|FG001|STARTED|Overall Study||5
3051927|NCT01224639|3772312|FG002|STARTED|Overall Study||21
3283327|NCT02755649|4017055|FG002|Completed Study (Week 28)|Overall Study||8
3283328|NCT02755649|4017053|FG000|COMPLETED|Overall Study||7
3283329|NCT02755649|4017054|FG001|COMPLETED|Overall Study||8
3283330|NCT02755649|4017055|FG002|COMPLETED|Overall Study||8
3283331|NCT02755649|4017053|FG000|NOT COMPLETED|Overall Study||101
3283332|NCT02755649|4017054|FG001|NOT COMPLETED|Overall Study||99
3283333|NCT02755649|4017055|FG002|NOT COMPLETED|Overall Study||102
3283334|NCT02755805|4017065|FG000|STARTED|Overall Study||15
3283335|NCT02755805|4017066|FG001|STARTED|Overall Study||15
3283336|NCT02755805|4017065|FG000|COMPLETED|Overall Study||13
3283337|NCT02755805|4017066|FG001|COMPLETED|Overall Study||11
3283338|NCT02755805|4017065|FG000|NOT COMPLETED|Overall Study||2
3283339|NCT02755805|4017066|FG001|NOT COMPLETED|Overall Study||4
3283340|NCT02755818|4017076|FG000|STARTED|Overall Study||30
3283341|NCT02755818|4017077|FG001|STARTED|Overall Study||2
3283342|NCT02755818|4017078|FG002|STARTED|Overall Study||2
3283343|NCT02755818|4017079|FG003|STARTED|Overall Study||17
3283344|NCT02755818|4017076|FG000|COMPLETED|Overall Study||30
3283345|NCT02755818|4017077|FG001|COMPLETED|Overall Study||2
3283346|NCT02755818|4017078|FG002|COMPLETED|Overall Study||1
3283347|NCT02755818|4017079|FG003|COMPLETED|Overall Study||14
3283348|NCT02755818|4017076|FG000|NOT COMPLETED|Overall Study||0
3283349|NCT02755818|4017077|FG001|NOT COMPLETED|Overall Study||0
3283350|NCT02755818|4017078|FG002|NOT COMPLETED|Overall Study||1
3283351|NCT02755818|4017079|FG003|NOT COMPLETED|Overall Study||3
3283352|NCT02755831|4017093|FG000|STARTED|Overall Study||100
3283353|NCT02755831|4017094|FG001|STARTED|Overall Study||93
3283354|NCT02755831|4017093|FG000|COMPLETED|Overall Study||97
3283355|NCT02755831|4017094|FG001|COMPLETED|Overall Study||90
3283356|NCT02755831|4017093|FG000|NOT COMPLETED|Overall Study||3
3283357|NCT02755831|4017094|FG001|NOT COMPLETED|Overall Study||3
3283358|NCT02755935|4017100|FG000|STARTED|Overall Study||24
3283359|NCT02755935|4017100|FG000|COMPLETED|Overall Study||22
3283360|NCT02755935|4017100|FG000|NOT COMPLETED|Overall Study||2
3283361|NCT02756013|4017104|FG000|STARTED|Overall Study||3
3283362|NCT02756013|4017104|FG000|COMPLETED|Overall Study||1
3283363|NCT02756013|4017104|FG000|NOT COMPLETED|Overall Study||2
3283364|NCT02756078|4017108|FG000|STARTED|Period 1||85
3283365|NCT02756078|4017109|FG001|STARTED|Period 1||86
3283366|NCT02756078|4017108|FG000|COMPLETED|Period 1||76
3283367|NCT02756078|4017109|FG001|COMPLETED|Period 1||64
3283368|NCT02756078|4017108|FG000|NOT COMPLETED|Period 1||9
3283369|NCT02756078|4017109|FG001|NOT COMPLETED|Period 1||22
3283370|NCT02756078|4017108|FG000|STARTED|Period 2||76
3283371|NCT02756078|4017109|FG001|STARTED|Period 2||64
3283372|NCT02756078|4017108|FG000|COMPLETED|Period 2||70
3283373|NCT02756078|4017109|FG001|COMPLETED|Period 2||57
3283374|NCT02756078|4017108|FG000|NOT COMPLETED|Period 2||6
3283375|NCT02756078|4017109|FG001|NOT COMPLETED|Period 2||7
3283376|NCT02756182|4017115|FG000|STARTED|Overall Study||25
3283377|NCT02756182|4017115|FG000|COMPLETED|Overall Study||21
3283378|NCT02756182|4017115|FG000|NOT COMPLETED|Overall Study||4
3283379|NCT02756338|4017121|FG000|STARTED|Overall Study||77
3283380|NCT02756338|4017121|FG000|COMPLETED|Overall Study||72
3283381|NCT02756338|4017121|FG000|NOT COMPLETED|Overall Study||5
3283382|NCT02756351|4017127|FG000|STARTED|Overall Study||24
3283383|NCT02756351|4017128|FG001|STARTED|Overall Study||24
3283384|NCT02756351|4017127|FG000|COMPLETED|Overall Study||24
3283385|NCT02756351|4017128|FG001|COMPLETED|Overall Study||24
3283386|NCT02756351|4017127|FG000|NOT COMPLETED|Overall Study||0
3283387|NCT02756351|4017128|FG001|NOT COMPLETED|Overall Study||0
3283388|NCT02756364|4017137|FG000|STARTED|Overall Study||46
3283389|NCT02756364|4017138|FG001|STARTED|Overall Study||47
3283390|NCT02756364|4017139|FG002|STARTED|Overall Study||48
3283391|NCT02756364|4017137|FG000|Treated Participants|Overall Study||46
3283392|NCT02756364|4017138|FG001|Treated Participants|Overall Study||47
3283393|NCT02756364|4017139|FG002|Treated Participants|Overall Study||47
3283394|NCT02756364|4017137|FG000|COMPLETED|Overall Study||0
3283395|NCT02756364|4017138|FG001|COMPLETED|Overall Study||0
3283396|NCT02756364|4017139|FG002|COMPLETED|Overall Study||0
3283397|NCT02756364|4017137|FG000|NOT COMPLETED|Overall Study||46
3283398|NCT02756364|4017138|FG001|NOT COMPLETED|Overall Study||47
3283399|NCT02756364|4017139|FG002|NOT COMPLETED|Overall Study||48
3283400|NCT02756572|4017147|FG000|STARTED|Overall Study||30
3283401|NCT02756572|4017147|FG000|COMPLETED|Overall Study||30
3283402|NCT02756572|4017147|FG000|NOT COMPLETED|Overall Study||0
3283403|NCT02756611|4017156|FG000|STARTED|Overall Study||258
3283404|NCT02756611|4017156|FG000|COMPLETED|Overall Study||2
3283405|NCT02756611|4017156|FG000|NOT COMPLETED|Overall Study||256
3051928|NCT01224639|3772313|FG003|STARTED|Overall Study||3
3283406|NCT02756624|4017162|FG000|STARTED|Overall Study||343
3283407|NCT02756624|4017163|FG001|STARTED|Overall Study||173
3283408|NCT02756624|4017162|FG000|COMPLETED|Overall Study||327
3283409|NCT02756624|4017163|FG001|COMPLETED|Overall Study||166
3051929|NCT01224639|3772314|FG004|STARTED|Overall Study||21
3051930|NCT01224639|3772315|FG005|STARTED|Overall Study||4
3051931|NCT01224639|3772316|FG006|STARTED|Overall Study||18
3051932|NCT01224639|3772317|FG007|STARTED|Overall Study||5
3051933|NCT01224639|3772310|FG000|COMPLETED|Overall Study||19
3051934|NCT01224639|3772311|FG001|COMPLETED|Overall Study||5
3283410|NCT02756624|4017162|FG000|NOT COMPLETED|Overall Study||16
3283411|NCT02756624|4017163|FG001|NOT COMPLETED|Overall Study||7
3283412|NCT02756637|4017171|FG000|STARTED|Overall Study||317
3283413|NCT02756637|4017172|FG001|STARTED|Overall Study||317
3283414|NCT02756637|4017171|FG000|Eligible for SWOG 8710|Overall Study||307
3283415|NCT02756637|4017172|FG001|Eligible for SWOG 8710|Overall Study||307
3283416|NCT02756637|4017171|FG000|Had NLR Value|Overall Study||263
3283417|NCT02756637|4017172|FG001|Had NLR Value|Overall Study||263
3283418|NCT02756637|4017171|FG000|Completed Curative Treatment|Overall Study||230
3283419|NCT02756637|4017172|FG001|Completed Curative Treatment|Overall Study||0
3283420|NCT02756637|4017171|FG000|COMPLETED|Overall Study||230
3283421|NCT02756637|4017172|FG001|COMPLETED|Overall Study||263
3283422|NCT02756637|4017171|FG000|NOT COMPLETED|Overall Study||87
3283423|NCT02756637|4017172|FG001|NOT COMPLETED|Overall Study||54
3283424|NCT02756650|4017178|FG000|STARTED|Overall Study||8
3283425|NCT02756650|4017178|FG000|COMPLETED|Overall Study||6
3283426|NCT02756650|4017178|FG000|NOT COMPLETED|Overall Study||2
3283427|NCT02756689|4017184|FG000|STARTED|Overall Study||64
3283428|NCT02756689|4017185|FG001|STARTED|Overall Study||65
3283429|NCT02756689|4017184|FG000|COMPLETED|Overall Study||64
3283430|NCT02756689|4017185|FG001|COMPLETED|Overall Study||65
3283431|NCT02756689|4017184|FG000|NOT COMPLETED|Overall Study||0
3283432|NCT02756689|4017185|FG001|NOT COMPLETED|Overall Study||0
3283433|NCT02756819|4017225|FG000|STARTED|Overall Study||1945
3283434|NCT02756819|4017225|FG000|Per-protocol Set (PPS)|Overall Study|Participants who were enrolled, received Edarbi® therapy and did not have major protocol deviations.|1724
3283435|NCT02756819|4017225|FG000|Safety Analysis Set (SAS)|Overall Study|Participants who received at least one dose of Edarbi® therapy and had any follow-up data.|1934
3283436|NCT02756819|4017225|FG000|COMPLETED|Overall Study||1893
3283437|NCT02756819|4017225|FG000|NOT COMPLETED|Overall Study||52
3283438|NCT02756832|4017229|FG000|STARTED|Overall Study||1409
3283439|NCT02756832|4017229|FG000|Received Therapy|Overall Study||1393
3283440|NCT02756832|4017229|FG000|Included in Efficacy and Safety Analysis|Overall Study||1399
3283441|NCT02756832|4017229|FG000|COMPLETED|Overall Study||1356
3283442|NCT02756832|4017229|FG000|NOT COMPLETED|Overall Study||53
3283443|NCT02756910|4017233|FG000|STARTED|Overall Study||80
3283444|NCT02756910|4017233|FG000|COMPLETED|Overall Study||80
3283445|NCT02756910|4017233|FG000|NOT COMPLETED|Overall Study||0
3283446|NCT02756949|4017239|FG000|STARTED|Overall Study||181
3283447|NCT02756949|4017240|FG001|STARTED|Overall Study||172
3283448|NCT02756949|4017239|FG000|COMPLETED|Overall Study||181
3283449|NCT02756949|4017240|FG001|COMPLETED|Overall Study||164
3283450|NCT02756949|4017239|FG000|NOT COMPLETED|Overall Study||0
3283451|NCT02756949|4017240|FG001|NOT COMPLETED|Overall Study||8
3283452|NCT02757092|4017248|FG000|STARTED|Overall Study|Random assignment was to encode subjects from opaque envelopes and sealed, on the day of discharge|18
3283453|NCT02757092|4017249|FG001|STARTED|Overall Study|Random assignment was to encode subjects from opaque envelopes and sealed, on the day of discharge|18
3283454|NCT02757092|4017248|FG000|COMPLETED|Overall Study|All subjects completed the study|18
3283455|NCT02757092|4017249|FG001|COMPLETED|Overall Study|All subjects completed the study|18
3283456|NCT02757092|4017248|FG000|NOT COMPLETED|Overall Study||0
3283457|NCT02757092|4017249|FG001|NOT COMPLETED|Overall Study||0
3283458|NCT02757105|4017315|FG000|STARTED|Overall Study||75
3283459|NCT02757105|4017316|FG001|STARTED|Overall Study||52
3283460|NCT02757105|4017315|FG000|Treated|Overall Study||75
3283461|NCT02757105|4017316|FG001|Treated|Overall Study||51
3283462|NCT02757105|4017315|FG000|COMPLETED|Overall Study||63
3283463|NCT02757105|4017316|FG001|COMPLETED|Overall Study||41
3283464|NCT02757105|4017315|FG000|NOT COMPLETED|Overall Study||12
3283465|NCT02757105|4017316|FG001|NOT COMPLETED|Overall Study||11
3283466|NCT02757326|4017326|FG000|STARTED|Overall Study||3
3283467|NCT02757326|4017327|FG001|STARTED|Overall Study||4
3283468|NCT02757326|4017328|FG002|STARTED|Overall Study||6
3283469|NCT02757326|4017326|FG000|COMPLETED|Overall Study||3
3283470|NCT02757326|4017327|FG001|COMPLETED|Overall Study||4
3283471|NCT02757326|4017328|FG002|COMPLETED|Overall Study||6
3283472|NCT02757326|4017326|FG000|NOT COMPLETED|Overall Study||0
3283473|NCT02757326|4017327|FG001|NOT COMPLETED|Overall Study||0
3283474|NCT02757326|4017328|FG002|NOT COMPLETED|Overall Study||0
3283475|NCT02757352|4017343|FG000|STARTED|Double-Blind Period (Week 0 - Week 16)||105
3283476|NCT02757352|4017344|FG001|STARTED|Double-Blind Period (Week 0 - Week 16)||96
3283477|NCT02757352|4017345|FG002|STARTED|Double-Blind Period (Week 0 - Week 16)||102
3283478|NCT02757352|4017346|FG003|STARTED|Double-Blind Period (Week 0 - Week 16)||0
3283479|NCT02757352|4017347|FG004|STARTED|Double-Blind Period (Week 0 - Week 16)||0
3283480|NCT02757352|4017348|FG005|STARTED|Double-Blind Period (Week 0 - Week 16)||0
3283481|NCT02757352|4017349|FG006|STARTED|Double-Blind Period (Week 0 - Week 16)||0
3283482|NCT02757352|4017350|FG007|STARTED|Double-Blind Period (Week 0 - Week 16)||0
3283483|NCT02757352|4017351|FG008|STARTED|Double-Blind Period (Week 0 - Week 16)||0
3283484|NCT02757352|4017352|FG009|STARTED|Double-Blind Period (Week 0 - Week 16)||0
3051935|NCT01224639|3772312|FG002|COMPLETED|Overall Study||21
3283485|NCT02757352|4017343|FG000|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||104
3051936|NCT01224639|3772313|FG003|COMPLETED|Overall Study||3
3051937|NCT01224639|3772314|FG004|COMPLETED|Overall Study||19
3283486|NCT02757352|4017344|FG001|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||96
3283487|NCT02757352|4017345|FG002|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||102
3283488|NCT02757352|4017346|FG003|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||0
3283489|NCT02757352|4017347|FG004|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||0
3283490|NCT02757352|4017348|FG005|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||0
3283491|NCT02757352|4017349|FG006|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||0
3283492|NCT02757352|4017350|FG007|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||0
3283493|NCT02757352|4017351|FG008|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||0
3283494|NCT02757352|4017352|FG009|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||0
3283495|NCT02757352|4017343|FG000|COMPLETED|Double-Blind Period (Week 0 - Week 16)||97
3283496|NCT02757352|4017344|FG001|COMPLETED|Double-Blind Period (Week 0 - Week 16)||95
3283497|NCT02757352|4017345|FG002|COMPLETED|Double-Blind Period (Week 0 - Week 16)||98
3283498|NCT02757352|4017346|FG003|COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
3283499|NCT02757352|4017347|FG004|COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
3283500|NCT02757352|4017348|FG005|COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
3283501|NCT02757352|4017349|FG006|COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
3283502|NCT02757352|4017350|FG007|COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
3283503|NCT02757352|4017351|FG008|COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
3283504|NCT02757352|4017352|FG009|COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
3283505|NCT02757352|4017343|FG000|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||8
3283506|NCT02757352|4017344|FG001|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||1
3283507|NCT02757352|4017345|FG002|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||4
3283508|NCT02757352|4017346|FG003|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
3283509|NCT02757352|4017347|FG004|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
3283510|NCT02757352|4017348|FG005|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
3283511|NCT02757352|4017349|FG006|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
3283512|NCT02757352|4017350|FG007|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
3283513|NCT02757352|4017351|FG008|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
3283514|NCT02757352|4017352|FG009|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
3283515|NCT02757352|4017343|FG000|STARTED|Double-Blind Period (Week 16 - Week 52)||97
3283516|NCT02757352|4017344|FG001|STARTED|Double-Blind Period (Week 16 - Week 52)||95
3283517|NCT02757352|4017345|FG002|STARTED|Double-Blind Period (Week 16 - Week 52)||98
3283518|NCT02757352|4017346|FG003|STARTED|Double-Blind Period (Week 16 - Week 52)||0
3283519|NCT02757352|4017347|FG004|STARTED|Double-Blind Period (Week 16 - Week 52)||0
3283520|NCT02757352|4017348|FG005|STARTED|Double-Blind Period (Week 16 - Week 52)||0
3283521|NCT02757352|4017349|FG006|STARTED|Double-Blind Period (Week 16 - Week 52)||0
3283522|NCT02757352|4017350|FG007|STARTED|Double-Blind Period (Week 16 - Week 52)||0
3283523|NCT02757352|4017351|FG008|STARTED|Double-Blind Period (Week 16 - Week 52)||0
3283524|NCT02757352|4017352|FG009|STARTED|Double-Blind Period (Week 16 - Week 52)||0
3283525|NCT02757352|4017343|FG000|COMPLETED|Double-Blind Period (Week 16 - Week 52)||34
3283526|NCT02757352|4017344|FG001|COMPLETED|Double-Blind Period (Week 16 - Week 52)||52
3283527|NCT02757352|4017345|FG002|COMPLETED|Double-Blind Period (Week 16 - Week 52)||52
3283528|NCT02757352|4017346|FG003|COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
3283529|NCT02757352|4017347|FG004|COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
3283530|NCT02757352|4017348|FG005|COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
3283531|NCT02757352|4017349|FG006|COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
3283532|NCT02757352|4017350|FG007|COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
3283533|NCT02757352|4017351|FG008|COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
3283534|NCT02757352|4017352|FG009|COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
3283535|NCT02757352|4017343|FG000|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||63
3283536|NCT02757352|4017344|FG001|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||43
3283537|NCT02757352|4017345|FG002|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||46
3283538|NCT02757352|4017346|FG003|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
3283539|NCT02757352|4017347|FG004|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
3283540|NCT02757352|4017348|FG005|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
3283541|NCT02757352|4017349|FG006|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
3283542|NCT02757352|4017350|FG007|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
3283543|NCT02757352|4017351|FG008|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
3283544|NCT02757352|4017352|FG009|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
3283545|NCT02757352|4017343|FG000|STARTED|IR-Open Label Period (Week 16 - Week 52)|Participants continued with original assigned treatment without switching to open label ixeQ2W.|0
3283546|NCT02757352|4017344|FG001|STARTED|IR-Open Label Period (Week 16 - Week 52)|Participants continued with original assigned treatment without switching to open label ixeQ2W.|0
3283547|NCT02757352|4017345|FG002|STARTED|IR-Open Label Period (Week 16 - Week 52)|Participants continued with original assigned treatment without switching to open label ixeQ2W.|0
3283548|NCT02757352|4017346|FG003|STARTED|IR-Open Label Period (Week 16 - Week 52)|IR based on the investigator's opinion switched to ixekizumab open label 80 mg Q2W.|62
3283549|NCT02757352|4017347|FG004|STARTED|IR-Open Label Period (Week 16 - Week 52)|IR based on the investigator's opinion switched to ixekizumab open label 80 mg Q2W.|40
3051938|NCT01224639|3772315|FG005|COMPLETED|Overall Study||4
3051939|NCT01224639|3772316|FG006|COMPLETED|Overall Study||17
3051940|NCT01224639|3772317|FG007|COMPLETED|Overall Study||3
3051941|NCT01224639|3772310|FG000|NOT COMPLETED|Overall Study||0
3051942|NCT01224639|3772311|FG001|NOT COMPLETED|Overall Study||0
3051943|NCT01224639|3772312|FG002|NOT COMPLETED|Overall Study||0
3051944|NCT01224639|3772313|FG003|NOT COMPLETED|Overall Study||0
3051945|NCT01224639|3772314|FG004|NOT COMPLETED|Overall Study||2
3051946|NCT01224639|3772315|FG005|NOT COMPLETED|Overall Study||0
3051947|NCT01224639|3772316|FG006|NOT COMPLETED|Overall Study||1
3051948|NCT01224639|3772317|FG007|NOT COMPLETED|Overall Study||2
3051949|NCT01224678|3772337|FG000|STARTED|Overall Study||150
3051950|NCT01224678|3772338|FG001|STARTED|Overall Study||150
3051951|NCT01224678|3772337|FG000|COMPLETED|Overall Study||150
3051952|NCT01224678|3772338|FG001|COMPLETED|Overall Study||150
3051953|NCT01224678|3772337|FG000|NOT COMPLETED|Overall Study||0
3051954|NCT01224678|3772338|FG001|NOT COMPLETED|Overall Study||0
3051955|NCT01224782|3772344|FG000|STARTED|Overall Study||994
3051956|NCT01224782|3772344|FG000|COMPLETED|Overall Study||730
3051957|NCT01224782|3772344|FG000|NOT COMPLETED|Overall Study||264
3051958|NCT01224821|3772348|FG000|STARTED|Dosimetric and Therapeutic Treatment||47
3051959|NCT01224821|3772348|FG000|COMPLETED|Dosimetric and Therapeutic Treatment|This participant completed the study per Protocol Amendment 2.|1
3051960|NCT01224821|3772348|FG000|NOT COMPLETED|Dosimetric and Therapeutic Treatment||46
3051961|NCT01224821|3772348|FG000|STARTED|Long-Term Follow-Up|11/47 participants withdrawing from this study enrolled in the LTFU study for continued evaluation.|11
3051962|NCT01224821|3772348|FG000|COMPLETED|Long-Term Follow-Up||0
3051963|NCT01224821|3772348|FG000|NOT COMPLETED|Long-Term Follow-Up||11
3051964|NCT01224925|3772354|FG000|STARTED|Overall Study||37
3051965|NCT01224925|3772355|FG001|STARTED|Overall Study||33
3051966|NCT01224925|3772354|FG000|COMPLETED|Overall Study||34
3051967|NCT01224925|3772355|FG001|COMPLETED|Overall Study||31
3051968|NCT01224925|3772354|FG000|NOT COMPLETED|Overall Study||3
3051969|NCT01224925|3772355|FG001|NOT COMPLETED|Overall Study||2
3051970|NCT01225029|3772365|FG000|STARTED|Overall Study||32
3051971|NCT01225029|3772366|FG001|STARTED|Overall Study||32
3051972|NCT01225029|3772365|FG000|COMPLETED|Overall Study||32
3051973|NCT01225029|3772366|FG001|COMPLETED|Overall Study||32
3051974|NCT01225029|3772365|FG000|NOT COMPLETED|Overall Study||0
3051975|NCT01225029|3772366|FG001|NOT COMPLETED|Overall Study||0
3051976|NCT01225055|3772375|FG000|STARTED|Overall Study||20
3051977|NCT01225055|3772376|FG001|STARTED|Overall Study||20
3051978|NCT01225055|3772377|FG002|STARTED|Overall Study||21
3051979|NCT01225055|3772375|FG000|COMPLETED|Overall Study||20
3051980|NCT01225055|3772376|FG001|COMPLETED|Overall Study||18
3051981|NCT01225055|3772377|FG002|COMPLETED|Overall Study||18
3051982|NCT01225055|3772375|FG000|NOT COMPLETED|Overall Study||0
3051983|NCT01225055|3772376|FG001|NOT COMPLETED|Overall Study||2
3051984|NCT01225055|3772377|FG002|NOT COMPLETED|Overall Study||3
3051985|NCT01225068|3772387|FG000|STARTED|Overall Study||20
3051986|NCT01225068|3772388|FG001|STARTED|Overall Study||20
3051987|NCT01225068|3772387|FG000|COMPLETED|Overall Study||16
3051988|NCT01225068|3772388|FG001|COMPLETED|Overall Study||19
3051989|NCT01225068|3772387|FG000|NOT COMPLETED|Overall Study||4
3051990|NCT01225068|3772388|FG001|NOT COMPLETED|Overall Study||1
3051991|NCT01225146|3772396|FG000|STARTED|Overall Study||6
3051992|NCT01225146|3772397|FG001|STARTED|Overall Study||2
3051993|NCT01225146|3772396|FG000|COMPLETED|Overall Study||6
3051994|NCT01225146|3772397|FG001|COMPLETED|Overall Study||0
3051995|NCT01225146|3772396|FG000|NOT COMPLETED|Overall Study||0
3051996|NCT01225146|3772397|FG001|NOT COMPLETED|Overall Study||2
3051997|NCT01225159|3772407|FG000|STARTED|Overall Study||100
3051998|NCT01225159|3772408|FG001|STARTED|Overall Study||100
3051999|NCT01225159|3772407|FG000|COMPLETED|Overall Study||99
3160677|NCT01865812|3887805|FG000|COMPLETED|Overall Study||24
3160678|NCT01865812|3887805|FG000|NOT COMPLETED|Overall Study||2
3160679|NCT01866098|3887812|FG000|STARTED|Overall Study||51
3160680|NCT01866098|3887813|FG001|STARTED|Overall Study||47
3160681|NCT01866098|3887814|FG002|STARTED|Overall Study||46
3160682|NCT01866098|3887812|FG000|COMPLETED|Overall Study||32
3160683|NCT01866098|3887813|FG001|COMPLETED|Overall Study||20
3160684|NCT01866098|3887814|FG002|COMPLETED|Overall Study||25
3160685|NCT01866098|3887812|FG000|NOT COMPLETED|Overall Study||19
3160686|NCT01866098|3887813|FG001|NOT COMPLETED|Overall Study||27
3160687|NCT01866098|3887814|FG002|NOT COMPLETED|Overall Study||21
3160688|NCT01866150|3887822|FG000|STARTED|Overall Study||450
3160689|NCT01866150|3887822|FG000|COMPLETED|Overall Study||450
3160690|NCT01866150|3887822|FG000|NOT COMPLETED|Overall Study||0
3160691|NCT01866163|3887831|FG000|STARTED|Overall Study||323
3160692|NCT01866163|3887832|FG001|STARTED|Overall Study||103
3160693|NCT01866163|3887831|FG000|COMPLETED|Overall Study||313
3160694|NCT01866163|3887832|FG001|COMPLETED|Overall Study||99
3052000|NCT01225159|3772408|FG001|COMPLETED|Overall Study||100
3160695|NCT01866163|3887831|FG000|NOT COMPLETED|Overall Study||10
3160696|NCT01866163|3887832|FG001|NOT COMPLETED|Overall Study||4
3160697|NCT01866293|3887838|FG000|STARTED|Overall Study||11
3160698|NCT01866293|3887838|FG000|COMPLETED|Overall Study||9
3160699|NCT01866293|3887838|FG000|NOT COMPLETED|Overall Study||2
3160700|NCT01866306|3887849|FG000|STARTED|Overall Study||6
3160701|NCT01866306|3887850|FG001|STARTED|Overall Study||6
3160702|NCT01866306|3887851|FG002|STARTED|Overall Study||6
3160703|NCT01866306|3887852|FG003|STARTED|Overall Study||6
3052001|NCT01225159|3772407|FG000|NOT COMPLETED|Overall Study||1
3052002|NCT01225159|3772408|FG001|NOT COMPLETED|Overall Study||0
3052003|NCT01225172|3772416|FG000|STARTED|Overall Study||52
3052004|NCT01225172|3772417|FG001|STARTED|Overall Study||7
3052005|NCT01225172|3772416|FG000|COMPLETED|Overall Study||46
3052006|NCT01225172|3772417|FG001|COMPLETED|Overall Study||6
3052007|NCT01225172|3772416|FG000|NOT COMPLETED|Overall Study||6
3052008|NCT01225172|3772417|FG001|NOT COMPLETED|Overall Study||1
3052009|NCT01225211|3772433|FG000|STARTED|Overall Study||21
3160704|NCT01866306|3887853|FG004|STARTED|Overall Study||6
3160705|NCT01866306|3887854|FG005|STARTED|Overall Study||6
3160706|NCT01866306|3887855|FG006|STARTED|Overall Study||23
3160707|NCT01866306|3887849|FG000|COMPLETED|Overall Study||6
3160708|NCT01866306|3887850|FG001|COMPLETED|Overall Study||6
3160709|NCT01866306|3887851|FG002|COMPLETED|Overall Study||6
3160710|NCT01866306|3887852|FG003|COMPLETED|Overall Study||6
3160711|NCT01866306|3887853|FG004|COMPLETED|Overall Study||6
3160712|NCT01866306|3887854|FG005|COMPLETED|Overall Study||6
3160713|NCT01866306|3887855|FG006|COMPLETED|Overall Study||23
3052010|NCT01225211|3772434|FG001|STARTED|Overall Study||20
3052011|NCT01225211|3772435|FG002|STARTED|Overall Study||21
3052012|NCT01225211|3772436|FG003|STARTED|Overall Study||27
3052013|NCT01225211|3772437|FG004|STARTED|Overall Study||23
3052014|NCT01225211|3772438|FG005|STARTED|Overall Study||21
3052015|NCT01225211|3772439|FG006|STARTED|Overall Study||42
3052016|NCT01225211|3772440|FG007|STARTED|Overall Study||11
3052017|NCT01225211|3772441|FG008|STARTED|Overall Study||63
3052018|NCT01225211|3772442|FG009|STARTED|Overall Study||62
3052019|NCT01225211|3772433|FG000|COMPLETED|Overall Study||21
3052020|NCT01225211|3772434|FG001|COMPLETED|Overall Study||20
3052021|NCT01225211|3772435|FG002|COMPLETED|Overall Study||20
3052022|NCT01225211|3772436|FG003|COMPLETED|Overall Study||27
3052023|NCT01225211|3772437|FG004|COMPLETED|Overall Study||23
3052024|NCT01225211|3772438|FG005|COMPLETED|Overall Study||21
3052025|NCT01225211|3772439|FG006|COMPLETED|Overall Study||41
3052026|NCT01225211|3772440|FG007|COMPLETED|Overall Study||11
3052027|NCT01225211|3772441|FG008|COMPLETED|Overall Study||62
3052028|NCT01225211|3772442|FG009|COMPLETED|Overall Study||57
3052029|NCT01225211|3772433|FG000|NOT COMPLETED|Overall Study||0
3052030|NCT01225211|3772434|FG001|NOT COMPLETED|Overall Study||0
3052031|NCT01225211|3772435|FG002|NOT COMPLETED|Overall Study||1
3052032|NCT01225211|3772436|FG003|NOT COMPLETED|Overall Study||0
3052033|NCT01225211|3772437|FG004|NOT COMPLETED|Overall Study||0
3052034|NCT01225211|3772438|FG005|NOT COMPLETED|Overall Study||0
3052035|NCT01225211|3772439|FG006|NOT COMPLETED|Overall Study||1
3052036|NCT01225211|3772440|FG007|NOT COMPLETED|Overall Study||0
3052037|NCT01225211|3772441|FG008|NOT COMPLETED|Overall Study||1
3052038|NCT01225211|3772442|FG009|NOT COMPLETED|Overall Study||5
3052039|NCT01225250|3772501|FG000|STARTED|Overall Study||15
3052040|NCT01225250|3772502|FG001|STARTED|Overall Study||15
3052041|NCT01225250|3772501|FG000|COMPLETED|Overall Study||10
3052042|NCT01225250|3772502|FG001|COMPLETED|Overall Study||10
3052043|NCT01225250|3772501|FG000|NOT COMPLETED|Overall Study||5
3052044|NCT01225250|3772502|FG001|NOT COMPLETED|Overall Study||5
3052045|NCT01225263|3772510|FG000|STARTED|Weeks 1 to 12||28
3052046|NCT01225263|3772511|FG001|STARTED|Weeks 1 to 12||29
3052047|NCT01225263|3772510|FG000|COMPLETED|Weeks 1 to 12||28
3052048|NCT01225263|3772511|FG001|COMPLETED|Weeks 1 to 12||29
3052049|NCT01225263|3772510|FG000|NOT COMPLETED|Weeks 1 to 12||0
3052050|NCT01225263|3772511|FG001|NOT COMPLETED|Weeks 1 to 12||0
3160714|NCT01866306|3887849|FG000|NOT COMPLETED|Overall Study||0
3160715|NCT01866306|3887850|FG001|NOT COMPLETED|Overall Study||0
3160716|NCT01866306|3887851|FG002|NOT COMPLETED|Overall Study||0
3160717|NCT01866306|3887852|FG003|NOT COMPLETED|Overall Study||0
3283550|NCT02757352|4017348|FG005|STARTED|IR-Open Label Period (Week 16 - Week 52)|IR based on the investigator's opinion switched to ixekizumab open label 80 mg Q2W.|42
3283551|NCT02757352|4017349|FG006|STARTED|IR-Open Label Period (Week 16 - Week 52)||0
3283552|NCT02757352|4017350|FG007|STARTED|IR-Open Label Period (Week 16 - Week 52)||0
3283553|NCT02757352|4017351|FG008|STARTED|IR-Open Label Period (Week 16 - Week 52)||0
3283554|NCT02757352|4017352|FG009|STARTED|IR-Open Label Period (Week 16 - Week 52)||0
3283555|NCT02757352|4017343|FG000|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||0
3283556|NCT02757352|4017344|FG001|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||0
3283557|NCT02757352|4017345|FG002|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||0
3283558|NCT02757352|4017346|FG003|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||2
3283559|NCT02757352|4017347|FG004|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||0
3283560|NCT02757352|4017348|FG005|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||3
3283561|NCT02757352|4017349|FG006|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||0
3283562|NCT02757352|4017350|FG007|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||0
3283563|NCT02757352|4017351|FG008|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||0
3283564|NCT02757352|4017352|FG009|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||0
3316580|NCT03115476|4049972|FG000|STARTED|Main Trials (LP0084-119x)||407
3052051|NCT01225263|3772510|FG000|STARTED|Weeks 13 to 24||28
3052052|NCT01225263|3772511|FG001|STARTED|Weeks 13 to 24||29
3160718|NCT01866306|3887853|FG004|NOT COMPLETED|Overall Study||0
3160719|NCT01866306|3887854|FG005|NOT COMPLETED|Overall Study||0
3160720|NCT01866306|3887855|FG006|NOT COMPLETED|Overall Study||0
3160721|NCT01866319|3887874|FG000|STARTED|Overall Study||278
3283565|NCT02757352|4017343|FG000|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
3283566|NCT02757352|4017344|FG001|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
3283567|NCT02757352|4017345|FG002|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
3283568|NCT02757352|4017346|FG003|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||55
3283569|NCT02757352|4017347|FG004|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||37
3283570|NCT02757352|4017348|FG005|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||35
3283571|NCT02757352|4017349|FG006|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
3283572|NCT02757352|4017350|FG007|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
3052053|NCT01225263|3772510|FG000|COMPLETED|Weeks 13 to 24||24
3052054|NCT01225263|3772511|FG001|COMPLETED|Weeks 13 to 24||28
3052055|NCT01225263|3772510|FG000|NOT COMPLETED|Weeks 13 to 24||4
3052056|NCT01225263|3772511|FG001|NOT COMPLETED|Weeks 13 to 24||1
3052057|NCT01225289|3772520|FG000|STARTED|Overall Study||18
3052058|NCT01225289|3772521|FG001|STARTED|Overall Study||18
3052059|NCT01225289|3772520|FG000|COMPLETED|Overall Study||18
3052060|NCT01225289|3772521|FG001|COMPLETED|Overall Study||17
3052061|NCT01225289|3772520|FG000|NOT COMPLETED|Overall Study||0
3052062|NCT01225289|3772521|FG001|NOT COMPLETED|Overall Study||1
3052063|NCT01225354|3772527|FG000|STARTED|Overall Study||20
3052064|NCT01225354|3772527|FG000|COMPLETED|Overall Study||19
3052065|NCT01225354|3772527|FG000|NOT COMPLETED|Overall Study||1
3052066|NCT01225549|3772532|FG000|STARTED|Period 1 - First Treatment Period||1
3052067|NCT01225549|3772533|FG001|STARTED|Period 1 - First Treatment Period||4
3052068|NCT01225549|3772534|FG002|STARTED|Period 1 - First Treatment Period||3
3052069|NCT01225549|3772535|FG003|STARTED|Period 1 - First Treatment Period||1
3052070|NCT01225549|3772536|FG004|STARTED|Period 1 - First Treatment Period||1
3052071|NCT01225549|3772537|FG005|STARTED|Period 1 - First Treatment Period||1
3052072|NCT01225549|3772538|FG006|STARTED|Period 1 - First Treatment Period||3
3052073|NCT01225549|3772539|FG007|STARTED|Period 1 - First Treatment Period||1
3052074|NCT01225549|3772540|FG008|STARTED|Period 1 - First Treatment Period||4
3052075|NCT01225549|3772541|FG009|STARTED|Period 1 - First Treatment Period||1
3052076|NCT01225549|3772532|FG000|COMPLETED|Period 1 - First Treatment Period||1
3052077|NCT01225549|3772533|FG001|COMPLETED|Period 1 - First Treatment Period||4
3052078|NCT01225549|3772534|FG002|COMPLETED|Period 1 - First Treatment Period||3
3052079|NCT01225549|3772535|FG003|COMPLETED|Period 1 - First Treatment Period||1
3052080|NCT01225549|3772536|FG004|COMPLETED|Period 1 - First Treatment Period||1
3052081|NCT01225549|3772537|FG005|COMPLETED|Period 1 - First Treatment Period||1
3052082|NCT01225549|3772538|FG006|COMPLETED|Period 1 - First Treatment Period||3
3052083|NCT01225549|3772539|FG007|COMPLETED|Period 1 - First Treatment Period||1
3052084|NCT01225549|3772540|FG008|COMPLETED|Period 1 - First Treatment Period||4
3160722|NCT01866319|3887875|FG001|STARTED|Overall Study||279
3160723|NCT01866319|3887876|FG002|STARTED|Overall Study||277
3160724|NCT01866319|3887874|FG000|Treated|Overall Study||256
3160725|NCT01866319|3887875|FG001|Treated|Overall Study||278
3160726|NCT01866319|3887876|FG002|Treated|Overall Study||277
3052085|NCT01225549|3772541|FG009|COMPLETED|Period 1 - First Treatment Period||1
3052086|NCT01225549|3772532|FG000|NOT COMPLETED|Period 1 - First Treatment Period||0
3052087|NCT01225549|3772533|FG001|NOT COMPLETED|Period 1 - First Treatment Period||0
3052088|NCT01225549|3772534|FG002|NOT COMPLETED|Period 1 - First Treatment Period||0
3052089|NCT01225549|3772535|FG003|NOT COMPLETED|Period 1 - First Treatment Period||0
3052090|NCT01225549|3772536|FG004|NOT COMPLETED|Period 1 - First Treatment Period||0
3052091|NCT01225549|3772537|FG005|NOT COMPLETED|Period 1 - First Treatment Period||0
3052092|NCT01225549|3772538|FG006|NOT COMPLETED|Period 1 - First Treatment Period||0
3052093|NCT01225549|3772539|FG007|NOT COMPLETED|Period 1 - First Treatment Period||0
3052094|NCT01225549|3772540|FG008|NOT COMPLETED|Period 1 - First Treatment Period||0
3052095|NCT01225549|3772541|FG009|NOT COMPLETED|Period 1 - First Treatment Period||0
3052096|NCT01225549|3772532|FG000|STARTED|Period 2 - Washout||1
3052097|NCT01225549|3772533|FG001|STARTED|Period 2 - Washout||4
3052098|NCT01225549|3772534|FG002|STARTED|Period 2 - Washout||3
3052099|NCT01225549|3772535|FG003|STARTED|Period 2 - Washout||1
3052100|NCT01225549|3772536|FG004|STARTED|Period 2 - Washout||1
3052101|NCT01225549|3772537|FG005|STARTED|Period 2 - Washout||1
3052102|NCT01225549|3772538|FG006|STARTED|Period 2 - Washout||3
3052103|NCT01225549|3772539|FG007|STARTED|Period 2 - Washout||1
3052104|NCT01225549|3772540|FG008|STARTED|Period 2 - Washout||4
3052105|NCT01225549|3772541|FG009|STARTED|Period 2 - Washout||1
3052106|NCT01225549|3772532|FG000|COMPLETED|Period 2 - Washout||1
3052107|NCT01225549|3772533|FG001|COMPLETED|Period 2 - Washout||4
3052108|NCT01225549|3772534|FG002|COMPLETED|Period 2 - Washout||3
3052109|NCT01225549|3772535|FG003|COMPLETED|Period 2 - Washout||1
3052110|NCT01225549|3772536|FG004|COMPLETED|Period 2 - Washout||1
3052111|NCT01225549|3772537|FG005|COMPLETED|Period 2 - Washout||1
3052112|NCT01225549|3772538|FG006|COMPLETED|Period 2 - Washout||3
3052113|NCT01225549|3772539|FG007|COMPLETED|Period 2 - Washout||1
3052114|NCT01225549|3772540|FG008|COMPLETED|Period 2 - Washout||4
3052115|NCT01225549|3772541|FG009|COMPLETED|Period 2 - Washout||1
3052116|NCT01225549|3772532|FG000|NOT COMPLETED|Period 2 - Washout||0
3052117|NCT01225549|3772533|FG001|NOT COMPLETED|Period 2 - Washout||0
3052118|NCT01225549|3772534|FG002|NOT COMPLETED|Period 2 - Washout||0
3052119|NCT01225549|3772535|FG003|NOT COMPLETED|Period 2 - Washout||0
3052120|NCT01225549|3772536|FG004|NOT COMPLETED|Period 2 - Washout||0
3160727|NCT01866319|3887874|FG000|COMPLETED|Overall Study||71
3052121|NCT01225549|3772537|FG005|NOT COMPLETED|Period 2 - Washout||0
3052122|NCT01225549|3772538|FG006|NOT COMPLETED|Period 2 - Washout||0
3052123|NCT01225549|3772539|FG007|NOT COMPLETED|Period 2 - Washout||0
3052124|NCT01225549|3772540|FG008|NOT COMPLETED|Period 2 - Washout||0
3052125|NCT01225549|3772541|FG009|NOT COMPLETED|Period 2 - Washout||0
3052126|NCT01225549|3772532|FG000|STARTED|Period 3 - Second Treatment Period||1
3052127|NCT01225549|3772533|FG001|STARTED|Period 3 - Second Treatment Period||4
3052128|NCT01225549|3772534|FG002|STARTED|Period 3 - Second Treatment Period||3
3052129|NCT01225549|3772535|FG003|STARTED|Period 3 - Second Treatment Period||1
3052130|NCT01225549|3772536|FG004|STARTED|Period 3 - Second Treatment Period||1
3052131|NCT01225549|3772537|FG005|STARTED|Period 3 - Second Treatment Period||1
3052132|NCT01225549|3772538|FG006|STARTED|Period 3 - Second Treatment Period||3
3052133|NCT01225549|3772539|FG007|STARTED|Period 3 - Second Treatment Period||1
3052134|NCT01225549|3772540|FG008|STARTED|Period 3 - Second Treatment Period||4
3052135|NCT01225549|3772541|FG009|STARTED|Period 3 - Second Treatment Period||1
3052136|NCT01225549|3772532|FG000|COMPLETED|Period 3 - Second Treatment Period||1
3052137|NCT01225549|3772533|FG001|COMPLETED|Period 3 - Second Treatment Period||4
3052138|NCT01225549|3772534|FG002|COMPLETED|Period 3 - Second Treatment Period||3
3052139|NCT01225549|3772535|FG003|COMPLETED|Period 3 - Second Treatment Period||1
3052140|NCT01225549|3772536|FG004|COMPLETED|Period 3 - Second Treatment Period||1
3052141|NCT01225549|3772537|FG005|COMPLETED|Period 3 - Second Treatment Period||1
3052142|NCT01225549|3772538|FG006|COMPLETED|Period 3 - Second Treatment Period||3
3052143|NCT01225549|3772539|FG007|COMPLETED|Period 3 - Second Treatment Period||1
3052144|NCT01225549|3772540|FG008|COMPLETED|Period 3 - Second Treatment Period||4
3052145|NCT01225549|3772541|FG009|COMPLETED|Period 3 - Second Treatment Period||1
3052146|NCT01225549|3772532|FG000|NOT COMPLETED|Period 3 - Second Treatment Period||0
3052147|NCT01225549|3772533|FG001|NOT COMPLETED|Period 3 - Second Treatment Period||0
3052148|NCT01225549|3772534|FG002|NOT COMPLETED|Period 3 - Second Treatment Period||0
3052149|NCT01225549|3772535|FG003|NOT COMPLETED|Period 3 - Second Treatment Period||0
3052150|NCT01225549|3772536|FG004|NOT COMPLETED|Period 3 - Second Treatment Period||0
3052151|NCT01225549|3772537|FG005|NOT COMPLETED|Period 3 - Second Treatment Period||0
3052152|NCT01225549|3772538|FG006|NOT COMPLETED|Period 3 - Second Treatment Period||0
3052153|NCT01225549|3772539|FG007|NOT COMPLETED|Period 3 - Second Treatment Period||0
3052154|NCT01225549|3772540|FG008|NOT COMPLETED|Period 3 - Second Treatment Period||0
3052155|NCT01225549|3772541|FG009|NOT COMPLETED|Period 3 - Second Treatment Period||0
3052156|NCT01225549|3772532|FG000|STARTED|Period 4 - Washout||1
3052157|NCT01225549|3772533|FG001|STARTED|Period 4 - Washout||4
3052158|NCT01225549|3772534|FG002|STARTED|Period 4 - Washout||3
3052159|NCT01225549|3772535|FG003|STARTED|Period 4 - Washout||1
3052160|NCT01225549|3772536|FG004|STARTED|Period 4 - Washout||1
3052161|NCT01225549|3772537|FG005|STARTED|Period 4 - Washout||1
3052162|NCT01225549|3772538|FG006|STARTED|Period 4 - Washout||3
3052163|NCT01225549|3772539|FG007|STARTED|Period 4 - Washout||1
3052164|NCT01225549|3772540|FG008|STARTED|Period 4 - Washout||4
3052165|NCT01225549|3772541|FG009|STARTED|Period 4 - Washout||1
3052166|NCT01225549|3772532|FG000|COMPLETED|Period 4 - Washout||1
3052167|NCT01225549|3772533|FG001|COMPLETED|Period 4 - Washout||3
3052168|NCT01225549|3772534|FG002|COMPLETED|Period 4 - Washout||3
3052169|NCT01225549|3772535|FG003|COMPLETED|Period 4 - Washout||1
3052170|NCT01225549|3772536|FG004|COMPLETED|Period 4 - Washout||1
3052171|NCT01225549|3772537|FG005|COMPLETED|Period 4 - Washout||1
3052172|NCT01225549|3772538|FG006|COMPLETED|Period 4 - Washout||3
3052173|NCT01225549|3772539|FG007|COMPLETED|Period 4 - Washout||1
3052174|NCT01225549|3772540|FG008|COMPLETED|Period 4 - Washout||4
3052175|NCT01225549|3772541|FG009|COMPLETED|Period 4 - Washout||1
3052176|NCT01225549|3772532|FG000|NOT COMPLETED|Period 4 - Washout||0
3052177|NCT01225549|3772533|FG001|NOT COMPLETED|Period 4 - Washout||1
3052178|NCT01225549|3772534|FG002|NOT COMPLETED|Period 4 - Washout||0
3052179|NCT01225549|3772535|FG003|NOT COMPLETED|Period 4 - Washout||0
3052180|NCT01225549|3772536|FG004|NOT COMPLETED|Period 4 - Washout||0
3052181|NCT01225549|3772537|FG005|NOT COMPLETED|Period 4 - Washout||0
3052182|NCT01225549|3772538|FG006|NOT COMPLETED|Period 4 - Washout||0
3052183|NCT01225549|3772539|FG007|NOT COMPLETED|Period 4 - Washout||0
3052184|NCT01225549|3772540|FG008|NOT COMPLETED|Period 4 - Washout||0
3052185|NCT01225549|3772541|FG009|NOT COMPLETED|Period 4 - Washout||0
3052186|NCT01225549|3772532|FG000|STARTED|Period 5 - Third Treatment Period||1
3052187|NCT01225549|3772533|FG001|STARTED|Period 5 - Third Treatment Period||3
3052188|NCT01225549|3772534|FG002|STARTED|Period 5 - Third Treatment Period||3
3052189|NCT01225549|3772535|FG003|STARTED|Period 5 - Third Treatment Period||1
3052190|NCT01225549|3772536|FG004|STARTED|Period 5 - Third Treatment Period||1
3052191|NCT01225549|3772537|FG005|STARTED|Period 5 - Third Treatment Period||1
3052192|NCT01225549|3772538|FG006|STARTED|Period 5 - Third Treatment Period||3
3052193|NCT01225549|3772539|FG007|STARTED|Period 5 - Third Treatment Period||1
3052194|NCT01225549|3772540|FG008|STARTED|Period 5 - Third Treatment Period||4
3052195|NCT01225549|3772541|FG009|STARTED|Period 5 - Third Treatment Period||1
3052196|NCT01225549|3772532|FG000|COMPLETED|Period 5 - Third Treatment Period||1
3052197|NCT01225549|3772533|FG001|COMPLETED|Period 5 - Third Treatment Period||3
3052198|NCT01225549|3772534|FG002|COMPLETED|Period 5 - Third Treatment Period||3
3052199|NCT01225549|3772535|FG003|COMPLETED|Period 5 - Third Treatment Period||1
3052200|NCT01225549|3772536|FG004|COMPLETED|Period 5 - Third Treatment Period||1
3052201|NCT01225549|3772537|FG005|COMPLETED|Period 5 - Third Treatment Period||1
3052202|NCT01225549|3772538|FG006|COMPLETED|Period 5 - Third Treatment Period||3
3052203|NCT01225549|3772539|FG007|COMPLETED|Period 5 - Third Treatment Period||1
3052204|NCT01225549|3772540|FG008|COMPLETED|Period 5 - Third Treatment Period||4
3052205|NCT01225549|3772541|FG009|COMPLETED|Period 5 - Third Treatment Period||1
3052206|NCT01225549|3772532|FG000|NOT COMPLETED|Period 5 - Third Treatment Period||0
3052207|NCT01225549|3772533|FG001|NOT COMPLETED|Period 5 - Third Treatment Period||0
3052208|NCT01225549|3772534|FG002|NOT COMPLETED|Period 5 - Third Treatment Period||0
3052209|NCT01225549|3772535|FG003|NOT COMPLETED|Period 5 - Third Treatment Period||0
3052210|NCT01225549|3772536|FG004|NOT COMPLETED|Period 5 - Third Treatment Period||0
3052211|NCT01225549|3772537|FG005|NOT COMPLETED|Period 5 - Third Treatment Period||0
3052212|NCT01225549|3772538|FG006|NOT COMPLETED|Period 5 - Third Treatment Period||0
3052213|NCT01225549|3772539|FG007|NOT COMPLETED|Period 5 - Third Treatment Period||0
3052214|NCT01225549|3772540|FG008|NOT COMPLETED|Period 5 - Third Treatment Period||0
3283573|NCT02757352|4017351|FG008|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
3283574|NCT02757352|4017352|FG009|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
3283575|NCT02757352|4017343|FG000|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
3283576|NCT02757352|4017344|FG001|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
3283577|NCT02757352|4017345|FG002|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
3283578|NCT02757352|4017346|FG003|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||7
3283579|NCT02757352|4017347|FG004|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||3
3283580|NCT02757352|4017348|FG005|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||7
3283581|NCT02757352|4017349|FG006|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
3283582|NCT02757352|4017350|FG007|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
3283583|NCT02757352|4017351|FG008|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
3283584|NCT02757352|4017352|FG009|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
3283585|NCT02757352|4017343|FG000|STARTED|Follow-Up Period||0
3283586|NCT02757352|4017344|FG001|STARTED|Follow-Up Period||0
3283587|NCT02757352|4017345|FG002|STARTED|Follow-Up Period||0
3283588|NCT02757352|4017346|FG003|STARTED|Follow-Up Period|Participants who completed the study were eligible to enroll in RHBY or enter follow up period.|0
3283589|NCT02757352|4017347|FG004|STARTED|Follow-Up Period|Participants who completed the study were eligible to enroll in RHBY or enter follow up period.|0
3283590|NCT02757352|4017348|FG005|STARTED|Follow-Up Period|Participants who completed the study were eligible to enroll in RHBY or enter follow up period.|0
3283591|NCT02757352|4017349|FG006|STARTED|Follow-Up Period|Participants who completed the study were eligible to enroll in RHBY or enter follow up period.|3
3283592|NCT02757352|4017350|FG007|STARTED|Follow-Up Period|Participants who completed the study were eligible to enroll in RHBY or enter follow up period.|5
3283593|NCT02757352|4017351|FG008|STARTED|Follow-Up Period|Participants who completed the study were eligible to enroll in RHBY or enter follow up period.|28
3283594|NCT02757352|4017352|FG009|STARTED|Follow-Up Period||5
3283595|NCT02757352|4017343|FG000|COMPLETED|Follow-Up Period||0
3283596|NCT02757352|4017344|FG001|COMPLETED|Follow-Up Period||0
3283597|NCT02757352|4017345|FG002|COMPLETED|Follow-Up Period||0
3283598|NCT02757352|4017346|FG003|COMPLETED|Follow-Up Period||0
3283599|NCT02757352|4017347|FG004|COMPLETED|Follow-Up Period||0
3283600|NCT02757352|4017348|FG005|COMPLETED|Follow-Up Period||0
3283601|NCT02757352|4017349|FG006|COMPLETED|Follow-Up Period||2
3283602|NCT02757352|4017350|FG007|COMPLETED|Follow-Up Period||4
3283603|NCT02757352|4017351|FG008|COMPLETED|Follow-Up Period||18
3283604|NCT02757352|4017352|FG009|COMPLETED|Follow-Up Period||2
3283605|NCT02757352|4017343|FG000|NOT COMPLETED|Follow-Up Period||0
3283606|NCT02757352|4017344|FG001|NOT COMPLETED|Follow-Up Period||0
3283607|NCT02757352|4017345|FG002|NOT COMPLETED|Follow-Up Period||0
3283608|NCT02757352|4017346|FG003|NOT COMPLETED|Follow-Up Period||0
3283609|NCT02757352|4017347|FG004|NOT COMPLETED|Follow-Up Period||0
3283610|NCT02757352|4017348|FG005|NOT COMPLETED|Follow-Up Period||0
3283611|NCT02757352|4017349|FG006|NOT COMPLETED|Follow-Up Period||1
3283612|NCT02757352|4017350|FG007|NOT COMPLETED|Follow-Up Period||1
3283613|NCT02757352|4017351|FG008|NOT COMPLETED|Follow-Up Period||10
3283614|NCT02757352|4017352|FG009|NOT COMPLETED|Follow-Up Period||3
3316581|NCT03115476|4049973|FG001|STARTED|Main Trials (LP0084-119x)||418
3316582|NCT03115476|4049974|FG002|STARTED|Main Trials (LP0084-119x)||409
3316583|NCT03115476|4049972|FG000|COMPLETED|Main Trials (LP0084-119x)||407
3316584|NCT03115476|4049973|FG001|COMPLETED|Main Trials (LP0084-119x)||418
3052215|NCT01225549|3772541|FG009|NOT COMPLETED|Period 5 - Third Treatment Period||0
3052216|NCT01225549|3772532|FG000|STARTED|Period 6 - Washout||1
3052217|NCT01225549|3772533|FG001|STARTED|Period 6 - Washout||3
3052218|NCT01225549|3772534|FG002|STARTED|Period 6 - Washout||3
3052219|NCT01225549|3772535|FG003|STARTED|Period 6 - Washout||1
3052220|NCT01225549|3772536|FG004|STARTED|Period 6 - Washout||1
3052221|NCT01225549|3772537|FG005|STARTED|Period 6 - Washout||1
3052222|NCT01225549|3772538|FG006|STARTED|Period 6 - Washout||3
3052223|NCT01225549|3772539|FG007|STARTED|Period 6 - Washout||1
3052224|NCT01225549|3772540|FG008|STARTED|Period 6 - Washout||4
3052225|NCT01225549|3772541|FG009|STARTED|Period 6 - Washout||1
3052226|NCT01225549|3772532|FG000|COMPLETED|Period 6 - Washout||1
3052227|NCT01225549|3772533|FG001|COMPLETED|Period 6 - Washout||3
3052228|NCT01225549|3772534|FG002|COMPLETED|Period 6 - Washout||3
3052229|NCT01225549|3772535|FG003|COMPLETED|Period 6 - Washout||0
3052230|NCT01225549|3772536|FG004|COMPLETED|Period 6 - Washout||1
3052231|NCT01225549|3772537|FG005|COMPLETED|Period 6 - Washout||1
3052232|NCT01225549|3772538|FG006|COMPLETED|Period 6 - Washout||3
3052233|NCT01225549|3772539|FG007|COMPLETED|Period 6 - Washout||1
3052234|NCT01225549|3772540|FG008|COMPLETED|Period 6 - Washout||4
3052235|NCT01225549|3772541|FG009|COMPLETED|Period 6 - Washout||1
3052236|NCT01225549|3772532|FG000|NOT COMPLETED|Period 6 - Washout||0
3052237|NCT01225549|3772533|FG001|NOT COMPLETED|Period 6 - Washout||0
3052238|NCT01225549|3772534|FG002|NOT COMPLETED|Period 6 - Washout||0
3052239|NCT01225549|3772535|FG003|NOT COMPLETED|Period 6 - Washout||1
3052240|NCT01225549|3772536|FG004|NOT COMPLETED|Period 6 - Washout||0
3052241|NCT01225549|3772537|FG005|NOT COMPLETED|Period 6 - Washout||0
3052242|NCT01225549|3772538|FG006|NOT COMPLETED|Period 6 - Washout||0
3052243|NCT01225549|3772539|FG007|NOT COMPLETED|Period 6 - Washout||0
3052244|NCT01225549|3772540|FG008|NOT COMPLETED|Period 6 - Washout||0
3052245|NCT01225549|3772541|FG009|NOT COMPLETED|Period 6 - Washout||0
3052246|NCT01225549|3772532|FG000|STARTED|Period 7 - Fourth Treatment Period||1
3052247|NCT01225549|3772533|FG001|STARTED|Period 7 - Fourth Treatment Period||3
3052248|NCT01225549|3772534|FG002|STARTED|Period 7 - Fourth Treatment Period||3
3052249|NCT01225549|3772535|FG003|STARTED|Period 7 - Fourth Treatment Period||0
3052250|NCT01225549|3772536|FG004|STARTED|Period 7 - Fourth Treatment Period||1
3052251|NCT01225549|3772537|FG005|STARTED|Period 7 - Fourth Treatment Period||1
3052252|NCT01225549|3772538|FG006|STARTED|Period 7 - Fourth Treatment Period||3
3052253|NCT01225549|3772539|FG007|STARTED|Period 7 - Fourth Treatment Period||1
3052254|NCT01225549|3772540|FG008|STARTED|Period 7 - Fourth Treatment Period||4
3052255|NCT01225549|3772541|FG009|STARTED|Period 7 - Fourth Treatment Period||1
3052256|NCT01225549|3772532|FG000|COMPLETED|Period 7 - Fourth Treatment Period||1
3052257|NCT01225549|3772533|FG001|COMPLETED|Period 7 - Fourth Treatment Period||3
3052258|NCT01225549|3772534|FG002|COMPLETED|Period 7 - Fourth Treatment Period||3
3052259|NCT01225549|3772535|FG003|COMPLETED|Period 7 - Fourth Treatment Period||0
3052260|NCT01225549|3772536|FG004|COMPLETED|Period 7 - Fourth Treatment Period||1
3052261|NCT01225549|3772537|FG005|COMPLETED|Period 7 - Fourth Treatment Period||1
3052262|NCT01225549|3772538|FG006|COMPLETED|Period 7 - Fourth Treatment Period||3
3052263|NCT01225549|3772539|FG007|COMPLETED|Period 7 - Fourth Treatment Period||1
3052264|NCT01225549|3772540|FG008|COMPLETED|Period 7 - Fourth Treatment Period||4
3052265|NCT01225549|3772541|FG009|COMPLETED|Period 7 - Fourth Treatment Period||1
3052266|NCT01225549|3772532|FG000|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
3052267|NCT01225549|3772533|FG001|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
3052268|NCT01225549|3772534|FG002|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
3052269|NCT01225549|3772535|FG003|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
3052270|NCT01225549|3772536|FG004|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
3052271|NCT01225549|3772537|FG005|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
3052272|NCT01225549|3772538|FG006|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
3052273|NCT01225549|3772539|FG007|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
3052274|NCT01225549|3772540|FG008|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
3052275|NCT01225549|3772541|FG009|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
3052276|NCT01225562|3772554|FG000|STARTED|Overall Study||7050
3052277|NCT01225562|3772555|FG001|STARTED|Overall Study||7045
3052278|NCT01225562|3772556|FG002|STARTED|Overall Study||7067
3052279|NCT01225562|3772554|FG000|COMPLETED|Overall Study||6995
3052280|NCT01225562|3772555|FG001|COMPLETED|Overall Study||6989
3052281|NCT01225562|3772556|FG002|COMPLETED|Overall Study||7014
3052282|NCT01225562|3772554|FG000|NOT COMPLETED|Overall Study||55
3052283|NCT01225562|3772555|FG001|NOT COMPLETED|Overall Study||56
3052284|NCT01225562|3772556|FG002|NOT COMPLETED|Overall Study||53
3052285|NCT01225731|3772569|FG000|STARTED|Part 1||42
3052286|NCT01225731|3772570|FG001|STARTED|Part 1||92
3052287|NCT01225731|3772571|FG002|STARTED|Part 1||89
3052288|NCT01225731|3772572|FG003|STARTED|Part 1||86
3052289|NCT01225731|3772573|FG004|STARTED|Part 1||46
3283615|NCT02757430|4017383|FG000|STARTED|Overall Study||515
3283616|NCT02757430|4017383|FG000|Baseline Visits|Overall Study||503
3283617|NCT02757430|4017383|FG000|EP Mapping/Ablation Procedure|Overall Study||503
3283618|NCT02757430|4017383|FG000|COMPLETED|Overall Study|Subjects with pre-discharge visit were considered completed.|503
3283619|NCT02757430|4017383|FG000|NOT COMPLETED|Overall Study||12
3052290|NCT01225731|3772574|FG005|STARTED|Part 1||0
3052291|NCT01225731|3772575|FG006|STARTED|Part 1||0
3052292|NCT01225731|3772576|FG007|STARTED|Part 1||0
3052293|NCT01225731|3772577|FG008|STARTED|Part 1||0
3052294|NCT01225731|3772578|FG009|STARTED|Part 1||0
3052295|NCT01225731|3772579|FG010|STARTED|Part 1||0
3052296|NCT01225731|3772580|FG011|STARTED|Part 1||0
3052297|NCT01225731|3772581|FG012|STARTED|Part 1||0
3052298|NCT01225731|3772569|FG000|COMPLETED|Part 1||40
3052299|NCT01225731|3772570|FG001|COMPLETED|Part 1||87
3052300|NCT01225731|3772571|FG002|COMPLETED|Part 1||88
3052301|NCT01225731|3772572|FG003|COMPLETED|Part 1||84
3052302|NCT01225731|3772573|FG004|COMPLETED|Part 1||40
3052303|NCT01225731|3772574|FG005|COMPLETED|Part 1||0
3052304|NCT01225731|3772575|FG006|COMPLETED|Part 1||0
3052305|NCT01225731|3772576|FG007|COMPLETED|Part 1||0
3052306|NCT01225731|3772577|FG008|COMPLETED|Part 1||0
3052307|NCT01225731|3772578|FG009|COMPLETED|Part 1||0
3052308|NCT01225731|3772579|FG010|COMPLETED|Part 1||0
3052309|NCT01225731|3772580|FG011|COMPLETED|Part 1||0
3052310|NCT01225731|3772581|FG012|COMPLETED|Part 1||0
3052311|NCT01225731|3772569|FG000|NOT COMPLETED|Part 1||2
3052312|NCT01225731|3772570|FG001|NOT COMPLETED|Part 1||5
3052313|NCT01225731|3772571|FG002|NOT COMPLETED|Part 1||1
3052314|NCT01225731|3772572|FG003|NOT COMPLETED|Part 1||2
3052315|NCT01225731|3772573|FG004|NOT COMPLETED|Part 1||6
3052316|NCT01225731|3772574|FG005|NOT COMPLETED|Part 1||0
3052317|NCT01225731|3772575|FG006|NOT COMPLETED|Part 1||0
3052318|NCT01225731|3772576|FG007|NOT COMPLETED|Part 1||0
3052319|NCT01225731|3772577|FG008|NOT COMPLETED|Part 1||0
3052320|NCT01225731|3772578|FG009|NOT COMPLETED|Part 1||0
3052321|NCT01225731|3772579|FG010|NOT COMPLETED|Part 1||0
3052322|NCT01225731|3772580|FG011|NOT COMPLETED|Part 1||0
3052323|NCT01225731|3772581|FG012|NOT COMPLETED|Part 1||0
3052324|NCT01225731|3772569|FG000|STARTED|Part 2|Participants could progress into Part 2|0
3052325|NCT01225731|3772570|FG001|STARTED|Part 2|Participants could progress into Part 2|0
3052326|NCT01225731|3772571|FG002|STARTED|Part 2|Participants could progress into Part 2|0
3052327|NCT01225731|3772572|FG003|STARTED|Part 2|Participants could progress into Part 2|0
3052328|NCT01225731|3772573|FG004|STARTED|Part 2|Participants could progress into Part 2; no placebo was given in Part 2|0
3052329|NCT01225731|3772574|FG005|STARTED|Part 2|Participants were reassigned based on PASI score at Week 16|13
3052330|NCT01225731|3772575|FG006|STARTED|Part 2|Participants were reassigned based on PASI score at Week 16|94
3052331|NCT01225731|3772576|FG007|STARTED|Part 2|Participants were reassigned based on PASI score at Week 16|153
3052332|NCT01225731|3772577|FG008|STARTED|Part 2|Participants were reassigned based on PASI score at Week 16|79
3052333|NCT01225731|3772578|FG009|STARTED|Part 2||0
3052334|NCT01225731|3772579|FG010|STARTED|Part 2||0
3052335|NCT01225731|3772580|FG011|STARTED|Part 2||0
3052336|NCT01225731|3772581|FG012|STARTED|Part 2||0
3052337|NCT01225731|3772569|FG000|COMPLETED|Part 2||0
3052338|NCT01225731|3772570|FG001|COMPLETED|Part 2||0
3052339|NCT01225731|3772571|FG002|COMPLETED|Part 2||0
3052340|NCT01225731|3772572|FG003|COMPLETED|Part 2||0
3052341|NCT01225731|3772573|FG004|COMPLETED|Part 2||0
3052342|NCT01225731|3772574|FG005|COMPLETED|Part 2||10
3052343|NCT01225731|3772575|FG006|COMPLETED|Part 2||86
3052344|NCT01225731|3772576|FG007|COMPLETED|Part 2||128
3052345|NCT01225731|3772577|FG008|COMPLETED|Part 2||68
3052346|NCT01225731|3772578|FG009|COMPLETED|Part 2||0
3052347|NCT01225731|3772579|FG010|COMPLETED|Part 2||0
3052348|NCT01225731|3772580|FG011|COMPLETED|Part 2||0
3052349|NCT01225731|3772581|FG012|COMPLETED|Part 2||0
3052350|NCT01225731|3772569|FG000|NOT COMPLETED|Part 2||0
3052351|NCT01225731|3772570|FG001|NOT COMPLETED|Part 2||0
3052352|NCT01225731|3772571|FG002|NOT COMPLETED|Part 2||0
3052353|NCT01225731|3772572|FG003|NOT COMPLETED|Part 2||0
3052354|NCT01225731|3772573|FG004|NOT COMPLETED|Part 2||0
3052355|NCT01225731|3772574|FG005|NOT COMPLETED|Part 2||3
3052356|NCT01225731|3772575|FG006|NOT COMPLETED|Part 2||8
3052357|NCT01225731|3772576|FG007|NOT COMPLETED|Part 2||25
3052358|NCT01225731|3772577|FG008|NOT COMPLETED|Part 2||11
3052359|NCT01225731|3772578|FG009|NOT COMPLETED|Part 2||0
3052360|NCT01225731|3772579|FG010|NOT COMPLETED|Part 2||0
3052361|NCT01225731|3772580|FG011|NOT COMPLETED|Part 2||0
3052362|NCT01225731|3772581|FG012|NOT COMPLETED|Part 2||0
3052363|NCT01225731|3772569|FG000|STARTED|Part 3||0
3052364|NCT01225731|3772570|FG001|STARTED|Part 3||0
3052365|NCT01225731|3772571|FG002|STARTED|Part 3||0
3160728|NCT01866319|3887875|FG001|COMPLETED|Overall Study||101
3160729|NCT01866319|3887876|FG002|COMPLETED|Overall Study||97
3160730|NCT01866319|3887874|FG000|NOT COMPLETED|Overall Study||207
3283620|NCT02757625|4017400|FG000|STARTED|Overall Study||14
3283621|NCT02757625|4017401|FG001|STARTED|Overall Study||18
3283622|NCT02757625|4017402|FG002|STARTED|Overall Study||19
3283623|NCT02757625|4017403|FG003|STARTED|Overall Study||12
3283624|NCT02757625|4017400|FG000|COMPLETED|Overall Study||14
3283625|NCT02757625|4017401|FG001|COMPLETED|Overall Study||18
3160731|NCT01866319|3887875|FG001|NOT COMPLETED|Overall Study||178
3160732|NCT01866319|3887876|FG002|NOT COMPLETED|Overall Study||180
3160733|NCT01866410|3887884|FG000|STARTED|Overall Study||37
3160734|NCT01866410|3887884|FG000|COMPLETED|Overall Study||37
3160735|NCT01866410|3887884|FG000|NOT COMPLETED|Overall Study||0
3160736|NCT01866423|3887891|FG000|STARTED|Overall Study||4
3160737|NCT01866423|3887891|FG000|COMPLETED|Overall Study||0
3160738|NCT01866423|3887891|FG000|NOT COMPLETED|Overall Study||4
3160739|NCT01866592|3887895|FG000|STARTED|Overall Study||81
3052366|NCT01225731|3772572|FG003|STARTED|Part 3||0
3052367|NCT01225731|3772573|FG004|STARTED|Part 3||0
3052368|NCT01225731|3772574|FG005|STARTED|Part 3|Participants could enter the follow-up period|0
3133906|NCT01698320|3858870|FG002|STARTED|12-Week Double-Blind Period||168
3160740|NCT01866592|3887895|FG000|COMPLETED|Overall Study||58
3283626|NCT02757625|4017402|FG002|COMPLETED|Overall Study||17
3283627|NCT02757625|4017403|FG003|COMPLETED|Overall Study||12
3283628|NCT02757625|4017400|FG000|NOT COMPLETED|Overall Study||0
3283629|NCT02757625|4017401|FG001|NOT COMPLETED|Overall Study||0
3283630|NCT02757625|4017402|FG002|NOT COMPLETED|Overall Study||2
3283631|NCT02757625|4017403|FG003|NOT COMPLETED|Overall Study||0
3283632|NCT02757768|4017417|FG000|STARTED|Overall Study||356
3283633|NCT02757768|4017418|FG001|STARTED|Overall Study||359
3283634|NCT02757768|4017417|FG000|Treated|Overall Study||352
3283635|NCT02757768|4017418|FG001|Treated|Overall Study||354
3283636|NCT02757768|4017417|FG000|COMPLETED|Overall Study||323
3283637|NCT02757768|4017418|FG001|COMPLETED|Overall Study||331
3283638|NCT02757768|4017417|FG000|NOT COMPLETED|Overall Study||33
3283639|NCT02757768|4017418|FG001|NOT COMPLETED|Overall Study||28
3283640|NCT02757950|4017428|FG000|STARTED|Overall Study||1203
3283641|NCT02757950|4017429|FG001|STARTED|Overall Study||1259
3052369|NCT01225731|3772575|FG006|STARTED|Part 3|Participants could enter the follow-up period|0
3052370|NCT01225731|3772576|FG007|STARTED|Part 3|Participants could enter the follow-up period|0
3052371|NCT01225731|3772577|FG008|STARTED|Part 3|Participants could enter the follow-up period|0
3052372|NCT01225731|3772578|FG009|STARTED|Part 3|Not all participants entered follow-up|10
3052373|NCT01225731|3772579|FG010|STARTED|Part 3|Not all participants entered follow-up|86
3052374|NCT01225731|3772580|FG011|STARTED|Part 3|Not all participants entered follow-up|126
3052375|NCT01225731|3772581|FG012|STARTED|Part 3|Not all participants entered follow-up|67
3052376|NCT01225731|3772569|FG000|COMPLETED|Part 3||0
3052377|NCT01225731|3772570|FG001|COMPLETED|Part 3||0
3052378|NCT01225731|3772571|FG002|COMPLETED|Part 3||0
3052379|NCT01225731|3772572|FG003|COMPLETED|Part 3||0
3052380|NCT01225731|3772573|FG004|COMPLETED|Part 3||0
3052381|NCT01225731|3772574|FG005|COMPLETED|Part 3||0
3052382|NCT01225731|3772575|FG006|COMPLETED|Part 3||0
3052383|NCT01225731|3772576|FG007|COMPLETED|Part 3||0
3052384|NCT01225731|3772577|FG008|COMPLETED|Part 3||0
3052385|NCT01225731|3772578|FG009|COMPLETED|Part 3||10
3052386|NCT01225731|3772579|FG010|COMPLETED|Part 3||80
3052387|NCT01225731|3772580|FG011|COMPLETED|Part 3||116
3052388|NCT01225731|3772581|FG012|COMPLETED|Part 3||60
3052389|NCT01225731|3772569|FG000|NOT COMPLETED|Part 3||0
3052390|NCT01225731|3772570|FG001|NOT COMPLETED|Part 3||0
3052391|NCT01225731|3772571|FG002|NOT COMPLETED|Part 3||0
3052392|NCT01225731|3772572|FG003|NOT COMPLETED|Part 3||0
3052393|NCT01225731|3772573|FG004|NOT COMPLETED|Part 3||0
3052394|NCT01225731|3772574|FG005|NOT COMPLETED|Part 3||0
3052395|NCT01225731|3772575|FG006|NOT COMPLETED|Part 3||0
3052396|NCT01225731|3772576|FG007|NOT COMPLETED|Part 3||0
3052397|NCT01225731|3772577|FG008|NOT COMPLETED|Part 3||0
3052398|NCT01225731|3772578|FG009|NOT COMPLETED|Part 3||0
3052399|NCT01225731|3772579|FG010|NOT COMPLETED|Part 3||6
3052400|NCT01225731|3772580|FG011|NOT COMPLETED|Part 3||10
3052401|NCT01225731|3772581|FG012|NOT COMPLETED|Part 3||7
3052402|NCT01225822|3772615|FG000|STARTED|Overall Study||389
3052403|NCT01225822|3772616|FG001|STARTED|Overall Study||390
3052404|NCT01225822|3772617|FG002|STARTED|Overall Study||393
3052405|NCT01225822|3772618|FG003|STARTED|Overall Study||385
3052406|NCT01225822|3772619|FG004|STARTED|Overall Study||392
3052407|NCT01225822|3772615|FG000|COMPLETED|Overall Study||351
3052408|NCT01225822|3772616|FG001|COMPLETED|Overall Study||334
3052409|NCT01225822|3772617|FG002|COMPLETED|Overall Study||355
3052410|NCT01225822|3772618|FG003|COMPLETED|Overall Study||333
3052411|NCT01225822|3772619|FG004|COMPLETED|Overall Study||361
3052412|NCT01225822|3772615|FG000|NOT COMPLETED|Overall Study||38
3052413|NCT01225822|3772616|FG001|NOT COMPLETED|Overall Study||56
3052414|NCT01225822|3772617|FG002|NOT COMPLETED|Overall Study||38
3052415|NCT01225822|3772618|FG003|NOT COMPLETED|Overall Study||52
3052416|NCT01225822|3772619|FG004|NOT COMPLETED|Overall Study||31
3052417|NCT01225835|3772636|FG000|STARTED|Overall Study||62
3052418|NCT01225835|3772637|FG001|STARTED|Overall Study||62
3052419|NCT01225835|3772636|FG000|Per Protocol Population|Overall Study||48
3052420|NCT01225835|3772637|FG001|Per Protocol Population|Overall Study||58
3052421|NCT01225835|3772636|FG000|COMPLETED|Overall Study|hCG criterion met|55
3052422|NCT01225835|3772637|FG001|COMPLETED|Overall Study|hCG criterion met|59
3052423|NCT01225835|3772636|FG000|NOT COMPLETED|Overall Study||7
3052424|NCT01225835|3772637|FG001|NOT COMPLETED|Overall Study||3
3052425|NCT01225887|3772649|FG000|STARTED|Overall Study||37
3052426|NCT01225887|3772649|FG000|COMPLETED|Overall Study||32
3052427|NCT01225887|3772649|FG000|NOT COMPLETED|Overall Study||5
3052428|NCT01225926|3772655|FG000|STARTED|Overall Study||12
3052429|NCT01225926|3772656|FG001|STARTED|Overall Study||12
3052430|NCT01225926|3772655|FG000|COMPLETED|Overall Study||12
3052431|NCT01225926|3772656|FG001|COMPLETED|Overall Study||12
3052432|NCT01225926|3772655|FG000|NOT COMPLETED|Overall Study||0
3052433|NCT01225926|3772656|FG001|NOT COMPLETED|Overall Study||0
3052434|NCT01225952|3772665|FG000|STARTED|Overall Study||31
3052435|NCT01225952|3772666|FG001|STARTED|Overall Study||31
3052436|NCT01225952|3772667|FG002|STARTED|Overall Study||31
3052437|NCT01225952|3772665|FG000|COMPLETED|Overall Study||25
3052438|NCT01225952|3772666|FG001|COMPLETED|Overall Study||27
3052439|NCT01225952|3772667|FG002|COMPLETED|Overall Study||25
3052440|NCT01225952|3772665|FG000|NOT COMPLETED|Overall Study||6
3052441|NCT01225952|3772666|FG001|NOT COMPLETED|Overall Study||4
3052442|NCT01225952|3772667|FG002|NOT COMPLETED|Overall Study||6
3052443|NCT01225991|3772675|FG000|STARTED|Overall Study||18
3052444|NCT01225991|3772675|FG000|COMPLETED|Overall Study||12
3052445|NCT01225991|3772675|FG000|NOT COMPLETED|Overall Study||6
3052446|NCT01226043|3772681|FG000|STARTED|4-week Crossover Phase - Period 1||202
3052447|NCT01226043|3772682|FG001|STARTED|4-week Crossover Phase - Period 1||203
3052448|NCT01226043|3772683|FG002|STARTED|4-week Crossover Phase - Period 1||0
3052449|NCT01226043|3772684|FG003|STARTED|4-week Crossover Phase - Period 1||0
3052450|NCT01226043|3772681|FG000|TREATED|4-week Crossover Phase - Period 1||202
3052451|NCT01226043|3772682|FG001|TREATED|4-week Crossover Phase - Period 1||200
3052452|NCT01226043|3772683|FG002|TREATED|4-week Crossover Phase - Period 1||0
3052453|NCT01226043|3772684|FG003|TREATED|4-week Crossover Phase - Period 1||0
3052454|NCT01226043|3772681|FG000|COMPLETED|4-week Crossover Phase - Period 1||199
3052455|NCT01226043|3772682|FG001|COMPLETED|4-week Crossover Phase - Period 1||194
3052456|NCT01226043|3772683|FG002|COMPLETED|4-week Crossover Phase - Period 1||0
3052457|NCT01226043|3772684|FG003|COMPLETED|4-week Crossover Phase - Period 1||0
3052458|NCT01226043|3772681|FG000|NOT COMPLETED|4-week Crossover Phase - Period 1||3
3160741|NCT01866592|3887895|FG000|NOT COMPLETED|Overall Study||23
3160742|NCT01866826|3887899|FG000|STARTED|Phase I -Initial Randomization - 4 Weeks||23
3160743|NCT01866826|3887900|FG001|STARTED|Phase I -Initial Randomization - 4 Weeks||23
3160744|NCT01866826|3887899|FG000|COMPLETED|Phase I -Initial Randomization - 4 Weeks||22
3160745|NCT01866826|3887900|FG001|COMPLETED|Phase I -Initial Randomization - 4 Weeks||23
3160746|NCT01866826|3887899|FG000|NOT COMPLETED|Phase I -Initial Randomization - 4 Weeks||1
3160747|NCT01866826|3887900|FG001|NOT COMPLETED|Phase I -Initial Randomization - 4 Weeks||0
3160748|NCT01866826|3887899|FG000|STARTED|Wash-Out Period - 4 -6 Weeks||22
3160749|NCT01866826|3887900|FG001|STARTED|Wash-Out Period - 4 -6 Weeks||23
3160750|NCT01866826|3887899|FG000|COMPLETED|Wash-Out Period - 4 -6 Weeks||22
3160751|NCT01866826|3887900|FG001|COMPLETED|Wash-Out Period - 4 -6 Weeks||20
3160752|NCT01866826|3887899|FG000|NOT COMPLETED|Wash-Out Period - 4 -6 Weeks||0
3160753|NCT01866826|3887900|FG001|NOT COMPLETED|Wash-Out Period - 4 -6 Weeks||3
3160754|NCT01866826|3887899|FG000|STARTED|Second Intervention - 4 Weeks||22
3160755|NCT01866826|3887900|FG001|STARTED|Second Intervention - 4 Weeks||20
3052459|NCT01226043|3772682|FG001|NOT COMPLETED|4-week Crossover Phase - Period 1||9
3052460|NCT01226043|3772683|FG002|NOT COMPLETED|4-week Crossover Phase - Period 1||0
3052461|NCT01226043|3772684|FG003|NOT COMPLETED|4-week Crossover Phase - Period 1||0
3052462|NCT01226043|3772681|FG000|STARTED|4-week Crossover Phase - Period 2||199
3052463|NCT01226043|3772682|FG001|STARTED|4-week Crossover Phase - Period 2||194
3052464|NCT01226043|3772683|FG002|STARTED|4-week Crossover Phase - Period 2||0
3052465|NCT01226043|3772684|FG003|STARTED|4-week Crossover Phase - Period 2||0
3052466|NCT01226043|3772681|FG000|TREATED|4-week Crossover Phase - Period 2||199
3052467|NCT01226043|3772682|FG001|TREATED|4-week Crossover Phase - Period 2||194
3052468|NCT01226043|3772683|FG002|TREATED|4-week Crossover Phase - Period 2||0
3052469|NCT01226043|3772684|FG003|TREATED|4-week Crossover Phase - Period 2||0
3052470|NCT01226043|3772681|FG000|COMPLETED|4-week Crossover Phase - Period 2|28 patients were not re-randomized to the second phase of the study|195
3052471|NCT01226043|3772682|FG001|COMPLETED|4-week Crossover Phase - Period 2|22 patients were not re-randomized to the second phase of the study|188
3052472|NCT01226043|3772683|FG002|COMPLETED|4-week Crossover Phase - Period 2||0
3052473|NCT01226043|3772684|FG003|COMPLETED|4-week Crossover Phase - Period 2||0
3052474|NCT01226043|3772681|FG000|NOT COMPLETED|4-week Crossover Phase - Period 2||4
3052475|NCT01226043|3772682|FG001|NOT COMPLETED|4-week Crossover Phase - Period 2||6
3052476|NCT01226043|3772683|FG002|NOT COMPLETED|4-week Crossover Phase - Period 2||0
3052477|NCT01226043|3772684|FG003|NOT COMPLETED|4-week Crossover Phase - Period 2||0
3052478|NCT01226043|3772681|FG000|STARTED|6-week Re-randomization Phase||0
3052479|NCT01226043|3772682|FG001|STARTED|6-week Re-randomization Phase||0
3052480|NCT01226043|3772683|FG002|STARTED|6-week Re-randomization Phase||166
3052481|NCT01226043|3772684|FG003|STARTED|6-week Re-randomization Phase||167
3052482|NCT01226043|3772681|FG000|TREATED|6-week Re-randomization Phase||0
3052483|NCT01226043|3772682|FG001|TREATED|6-week Re-randomization Phase||0
3052484|NCT01226043|3772683|FG002|TREATED|6-week Re-randomization Phase||165
3052485|NCT01226043|3772684|FG003|TREATED|6-week Re-randomization Phase||165
3052486|NCT01226043|3772681|FG000|COMPLETED|6-week Re-randomization Phase||0
3052487|NCT01226043|3772682|FG001|COMPLETED|6-week Re-randomization Phase||0
3052488|NCT01226043|3772683|FG002|COMPLETED|6-week Re-randomization Phase||159
3052489|NCT01226043|3772684|FG003|COMPLETED|6-week Re-randomization Phase|3 patients did not enter the observational phase of the study|156
3052490|NCT01226043|3772681|FG000|NOT COMPLETED|6-week Re-randomization Phase||0
3052491|NCT01226043|3772682|FG001|NOT COMPLETED|6-week Re-randomization Phase||0
3052492|NCT01226043|3772683|FG002|NOT COMPLETED|6-week Re-randomization Phase||7
3052493|NCT01226043|3772684|FG003|NOT COMPLETED|6-week Re-randomization Phase||11
3052494|NCT01226043|3772681|FG000|STARTED|30-week Observational Phase||0
3052495|NCT01226043|3772682|FG001|STARTED|30-week Observational Phase||0
3052496|NCT01226043|3772683|FG002|STARTED|30-week Observational Phase||159
3052497|NCT01226043|3772684|FG003|STARTED|30-week Observational Phase||153
3052498|NCT01226043|3772681|FG000|TREATED|30-week Observational Phase||0
3052499|NCT01226043|3772682|FG001|TREATED|30-week Observational Phase||0
3052500|NCT01226043|3772683|FG002|TREATED|30-week Observational Phase||159
3052501|NCT01226043|3772684|FG003|TREATED|30-week Observational Phase||153
3052502|NCT01226043|3772681|FG000|COMPLETED|30-week Observational Phase||0
3052503|NCT01226043|3772682|FG001|COMPLETED|30-week Observational Phase||0
3052504|NCT01226043|3772683|FG002|COMPLETED|30-week Observational Phase||153
3052505|NCT01226043|3772684|FG003|COMPLETED|30-week Observational Phase||140
3052506|NCT01226043|3772681|FG000|NOT COMPLETED|30-week Observational Phase||0
3052507|NCT01226043|3772682|FG001|NOT COMPLETED|30-week Observational Phase||0
3052508|NCT01226043|3772683|FG002|NOT COMPLETED|30-week Observational Phase||6
3052509|NCT01226043|3772684|FG003|NOT COMPLETED|30-week Observational Phase||13
3052510|NCT01226095|3772714|FG000|STARTED|Overall Study||519
3052511|NCT01226095|3772714|FG000|COMPLETED|Overall Study||518
3052512|NCT01226095|3772714|FG000|NOT COMPLETED|Overall Study||1
3052513|NCT01226121|3772728|FG000|STARTED|Overall Study||13
3052514|NCT01226121|3772729|FG001|STARTED|Overall Study||11
3052515|NCT01226121|3772730|FG002|STARTED|Overall Study||13
3160756|NCT01866826|3887899|FG000|COMPLETED|Second Intervention - 4 Weeks||22
3160757|NCT01866826|3887900|FG001|COMPLETED|Second Intervention - 4 Weeks||20
3160758|NCT01866826|3887899|FG000|NOT COMPLETED|Second Intervention - 4 Weeks||0
3160759|NCT01866826|3887900|FG001|NOT COMPLETED|Second Intervention - 4 Weeks||0
3160760|NCT01866839|3887906|FG000|STARTED|Overall Study||40
3160761|NCT01866839|3887906|FG000|COMPLETED|Overall Study||30
3160762|NCT01866839|3887906|FG000|NOT COMPLETED|Overall Study||10
3283642|NCT02757950|4017428|FG000|COMPLETED|Overall Study||1199
3052516|NCT01226121|3772728|FG000|30 Day Evaluation|Overall Study||12
3052517|NCT01226121|3772729|FG001|30 Day Evaluation|Overall Study||11
3052518|NCT01226121|3772730|FG002|30 Day Evaluation|Overall Study||13
3052519|NCT01226121|3772728|FG000|COMPLETED|Overall Study||11
3052520|NCT01226121|3772729|FG001|COMPLETED|Overall Study||11
3052521|NCT01226121|3772730|FG002|COMPLETED|Overall Study||12
3052522|NCT01226121|3772728|FG000|NOT COMPLETED|Overall Study||2
3052523|NCT01226121|3772729|FG001|NOT COMPLETED|Overall Study||0
3052524|NCT01226121|3772730|FG002|NOT COMPLETED|Overall Study||1
3052525|NCT01226420|3772738|FG000|STARTED|Overall Study||6
3052526|NCT01226420|3772738|FG000|COMPLETED|Overall Study||6
3052527|NCT01226420|3772738|FG000|NOT COMPLETED|Overall Study||0
3052528|NCT01226459|3772744|FG000|STARTED|Overall Study||201
3052529|NCT01226459|3772745|FG001|STARTED|Overall Study||203
3052530|NCT01226459|3772744|FG000|COMPLETED|Overall Study||180
3052531|NCT01226459|3772745|FG001|COMPLETED|Overall Study||171
3052532|NCT01226459|3772744|FG000|NOT COMPLETED|Overall Study||21
3052533|NCT01226459|3772745|FG001|NOT COMPLETED|Overall Study||32
3052534|NCT01226472|3772751|FG000|STARTED|Overall Study||1
3052535|NCT01226472|3772751|FG000|COMPLETED|Overall Study||0
3052536|NCT01226472|3772751|FG000|NOT COMPLETED|Overall Study||1
3052537|NCT01226485|3772762|FG000|STARTED|Overall Study||3
3052538|NCT01226485|3772763|FG001|STARTED|Overall Study||6
3052539|NCT01226485|3772764|FG002|STARTED|Overall Study||3
3283643|NCT02757950|4017429|FG001|COMPLETED|Overall Study||1248
3283644|NCT02757950|4017428|FG000|NOT COMPLETED|Overall Study||4
3052540|NCT01226485|3772765|FG003|STARTED|Overall Study||6
3052541|NCT01226485|3772766|FG004|STARTED|Overall Study||7
3052542|NCT01226485|3772767|FG005|STARTED|Overall Study||19
3052543|NCT01226485|3772768|FG006|STARTED|Overall Study||40
3052544|NCT01226485|3772762|FG000|Received at Least One Dose of Drug|Overall Study||3
3052545|NCT01226485|3772763|FG001|Received at Least One Dose of Drug|Overall Study||6
3052546|NCT01226485|3772764|FG002|Received at Least One Dose of Drug|Overall Study||3
3052547|NCT01226485|3772765|FG003|Received at Least One Dose of Drug|Overall Study||6
3052548|NCT01226485|3772766|FG004|Received at Least One Dose of Drug|Overall Study||7
3052549|NCT01226485|3772767|FG005|Received at Least One Dose of Drug|Overall Study||19
3052550|NCT01226485|3772768|FG006|Received at Least One Dose of Drug|Overall Study||40
3052551|NCT01226485|3772762|FG000|COMPLETED|Overall Study||3
3052552|NCT01226485|3772763|FG001|COMPLETED|Overall Study||6
3052553|NCT01226485|3772764|FG002|COMPLETED|Overall Study||3
3052554|NCT01226485|3772765|FG003|COMPLETED|Overall Study||6
3052555|NCT01226485|3772766|FG004|COMPLETED|Overall Study||7
3052556|NCT01226485|3772767|FG005|COMPLETED|Overall Study||19
3052557|NCT01226485|3772768|FG006|COMPLETED|Overall Study||40
3052558|NCT01226485|3772762|FG000|NOT COMPLETED|Overall Study||0
3052559|NCT01226485|3772763|FG001|NOT COMPLETED|Overall Study||0
3052560|NCT01226485|3772764|FG002|NOT COMPLETED|Overall Study||0
3052561|NCT01226485|3772765|FG003|NOT COMPLETED|Overall Study||0
3052562|NCT01226485|3772766|FG004|NOT COMPLETED|Overall Study||0
3052563|NCT01226485|3772767|FG005|NOT COMPLETED|Overall Study||0
3052564|NCT01226485|3772768|FG006|NOT COMPLETED|Overall Study||0
3052565|NCT01226511|3772794|FG000|STARTED|Acute Treatment Period|Thirty-one (31) participants who discontinued acute treatment did not enter the taper period.|140
3052566|NCT01226511|3772795|FG001|STARTED|Acute Treatment Period|Twenty-six (26) participants who discontinued acute treatment did not enter the taper period.|141
3052567|NCT01226511|3772794|FG000|COMPLETED|Acute Treatment Period||108
3052568|NCT01226511|3772795|FG001|COMPLETED|Acute Treatment Period||110
3052569|NCT01226511|3772794|FG000|NOT COMPLETED|Acute Treatment Period||32
3052570|NCT01226511|3772795|FG001|NOT COMPLETED|Acute Treatment Period||31
3052571|NCT01226511|3772794|FG000|STARTED|Extension Treatment Period|Nineteen (19) participants who discontinued extension treatment did not enter the taper period.|108
3052572|NCT01226511|3772795|FG001|STARTED|Extension Treatment Period|Twenty-three (23) participants who discontinued extension treatment did not enter the taper period.|110
3052573|NCT01226511|3772794|FG000|COMPLETED|Extension Treatment Period|Thirty-nine (39) participants who completed extension treatment did not enter the taper period.|81
3052574|NCT01226511|3772795|FG001|COMPLETED|Extension Treatment Period|Thirty-five (35) participants who completed extension treatment did not enter the taper period.|83
3052575|NCT01226511|3772794|FG000|NOT COMPLETED|Extension Treatment Period||27
3052576|NCT01226511|3772795|FG001|NOT COMPLETED|Extension Treatment Period||27
3052577|NCT01226511|3772794|FG000|STARTED|Taper Period||51
3052578|NCT01226511|3772795|FG001|STARTED|Taper Period||57
3052579|NCT01226511|3772794|FG000|COMPLETED|Taper Period||46
3052580|NCT01226511|3772795|FG001|COMPLETED|Taper Period||54
3052581|NCT01226511|3772794|FG000|NOT COMPLETED|Taper Period||5
3052582|NCT01226511|3772795|FG001|NOT COMPLETED|Taper Period||3
3052583|NCT01226706|3772809|FG000|STARTED|Overall Study||10
3052584|NCT01226706|3772810|FG001|STARTED|Overall Study||11
3052585|NCT01226706|3772809|FG000|COMPLETED|Overall Study||10
3052586|NCT01226706|3772810|FG001|COMPLETED|Overall Study||11
3052587|NCT01226706|3772809|FG000|NOT COMPLETED|Overall Study||0
3052588|NCT01226706|3772810|FG001|NOT COMPLETED|Overall Study||0
3052589|NCT01226719|3772818|FG000|STARTED|Overall Study||15
3052590|NCT01226719|3772818|FG000|COMPLETED|Overall Study|Completed = patient is surgical candidate, underwent resection, received treatment to week 24.|2
3160763|NCT01866917|3887912|FG000|STARTED|Overall Study||17
3283645|NCT02757950|4017429|FG001|NOT COMPLETED|Overall Study||11
3052591|NCT01226719|3772818|FG000|NOT COMPLETED|Overall Study||13
3052592|NCT01226732|3772828|FG000|STARTED|Overall Study||3
3052593|NCT01226732|3772829|FG001|STARTED|Overall Study||3
3052594|NCT01226732|3772830|FG002|STARTED|Overall Study||3
3052595|NCT01226732|3772831|FG003|STARTED|Overall Study||5
3052596|NCT01226732|3772832|FG004|STARTED|Overall Study||3
3052597|NCT01226732|3772833|FG005|STARTED|Overall Study||6
3052598|NCT01226732|3772828|FG000|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
3052599|NCT01226732|3772829|FG001|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
3052600|NCT01226732|3772830|FG002|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
3052601|NCT01226732|3772831|FG003|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
3052602|NCT01226732|3772832|FG004|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
3052603|NCT01226732|3772833|FG005|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
3052604|NCT01226732|3772828|FG000|NOT COMPLETED|Overall Study||3
3052605|NCT01226732|3772829|FG001|NOT COMPLETED|Overall Study||3
3052606|NCT01226732|3772830|FG002|NOT COMPLETED|Overall Study||3
3052607|NCT01226732|3772831|FG003|NOT COMPLETED|Overall Study||5
3052608|NCT01226732|3772832|FG004|NOT COMPLETED|Overall Study||3
3160764|NCT01866917|3887913|FG001|STARTED|Overall Study||18
3160765|NCT01866917|3887912|FG000|COMPLETED|Overall Study||13
3160766|NCT01866917|3887913|FG001|COMPLETED|Overall Study||12
3160767|NCT01866917|3887912|FG000|NOT COMPLETED|Overall Study||4
3160768|NCT01866917|3887913|FG001|NOT COMPLETED|Overall Study||6
3160769|NCT01866943|3887921|FG000|STARTED|Overall Study||19
3160770|NCT01866943|3887922|FG001|STARTED|Overall Study||22
3283646|NCT02757963|4017436|FG000|STARTED|Overall Study||1658
3283647|NCT02757963|4017436|FG000|COMPLETED|Overall Study||561
3283648|NCT02757963|4017436|FG000|NOT COMPLETED|Overall Study||1097
3052609|NCT01226732|3772833|FG005|NOT COMPLETED|Overall Study||6
3052610|NCT01226745|3772855|FG000|STARTED|Overall Study||80
3052611|NCT01226745|3772856|FG001|STARTED|Overall Study||87
3052612|NCT01226745|3772857|FG002|STARTED|Overall Study||89
3052613|NCT01226745|3772858|FG003|STARTED|Overall Study||29
3052614|NCT01226745|3772859|FG004|STARTED|Overall Study||26
3052615|NCT01226745|3772860|FG005|STARTED|Overall Study||29
3283649|NCT02758119|4017453|FG000|STARTED|Overall Study||41
3283650|NCT02758119|4017454|FG001|STARTED|Overall Study||41
3283651|NCT02758119|4017453|FG000|COMPLETED|Overall Study||39
3283652|NCT02758119|4017454|FG001|COMPLETED|Overall Study||40
3283653|NCT02758119|4017453|FG000|NOT COMPLETED|Overall Study||2
3283654|NCT02758119|4017454|FG001|NOT COMPLETED|Overall Study||1
3283655|NCT02758171|4017464|FG000|STARTED|Treatment Period 1||28
3283656|NCT02758171|4017465|FG001|STARTED|Treatment Period 1||28
3283657|NCT02758171|4017464|FG000|COMPLETED|Treatment Period 1||28
3283658|NCT02758171|4017465|FG001|COMPLETED|Treatment Period 1||28
3283659|NCT02758171|4017464|FG000|NOT COMPLETED|Treatment Period 1||0
3283660|NCT02758171|4017465|FG001|NOT COMPLETED|Treatment Period 1||0
3283661|NCT02758171|4017464|FG000|STARTED|Wash-out||28
3283662|NCT02758171|4017465|FG001|STARTED|Wash-out||28
3283663|NCT02758171|4017464|FG000|COMPLETED|Wash-out||26
3283664|NCT02758171|4017465|FG001|COMPLETED|Wash-out||28
3283665|NCT02758171|4017464|FG000|NOT COMPLETED|Wash-out||2
3283666|NCT02758171|4017465|FG001|NOT COMPLETED|Wash-out||0
3283667|NCT02758171|4017464|FG000|STARTED|Treatment Period 2||26
3283668|NCT02758171|4017465|FG001|STARTED|Treatment Period 2||28
3283669|NCT02758171|4017464|FG000|COMPLETED|Treatment Period 2||26
3283670|NCT02758171|4017465|FG001|COMPLETED|Treatment Period 2||28
3283671|NCT02758171|4017464|FG000|NOT COMPLETED|Treatment Period 2||0
3283672|NCT02758171|4017465|FG001|NOT COMPLETED|Treatment Period 2||0
3283673|NCT02758210|4017471|FG000|STARTED|Overall Study||20
3283674|NCT02758210|4017471|FG000|COMPLETED|Overall Study||20
3283675|NCT02758210|4017471|FG000|NOT COMPLETED|Overall Study||0
3283676|NCT02758301|4017477|FG000|STARTED|Overall Study||104
3283677|NCT02758301|4017478|FG001|STARTED|Overall Study||8
3283678|NCT02758301|4017477|FG000|COMPLETED|Overall Study||70
3283679|NCT02758301|4017478|FG001|COMPLETED|Overall Study||0
3283680|NCT02758301|4017477|FG000|NOT COMPLETED|Overall Study||34
3052616|NCT01226745|3772855|FG000|COMPLETED|Overall Study||63
3052617|NCT01226745|3772856|FG001|COMPLETED|Overall Study||71
3052618|NCT01226745|3772857|FG002|COMPLETED|Overall Study||69
3052619|NCT01226745|3772858|FG003|COMPLETED|Overall Study||24
3052620|NCT01226745|3772859|FG004|COMPLETED|Overall Study||22
3052621|NCT01226745|3772860|FG005|COMPLETED|Overall Study||24
3052622|NCT01226745|3772855|FG000|NOT COMPLETED|Overall Study||17
3052623|NCT01226745|3772856|FG001|NOT COMPLETED|Overall Study||16
3052624|NCT01226745|3772857|FG002|NOT COMPLETED|Overall Study||20
3052625|NCT01226745|3772858|FG003|NOT COMPLETED|Overall Study||5
3052626|NCT01226745|3772859|FG004|NOT COMPLETED|Overall Study||4
3052627|NCT01226745|3772860|FG005|NOT COMPLETED|Overall Study||5
3052628|NCT01226914|3772877|FG000|STARTED|Overall Study||28
3052629|NCT01226914|3772878|FG001|STARTED|Overall Study||27
3160771|NCT01866943|3887921|FG000|COMPLETED|Overall Study|Unknown - the only spreadsheet available is de-identified and blinded.|0
3171730|NCT01936844|3898913|FG001|NOT COMPLETED|Overall Study||7
3283681|NCT02758301|4017478|FG001|NOT COMPLETED|Overall Study||8
3283682|NCT02758613|4017488|FG000|STARTED|Treatment||8
3283683|NCT02758613|4017489|FG001|STARTED|Treatment||8
3283684|NCT02758613|4017490|FG002|STARTED|Treatment||9
3052630|NCT01226914|3772877|FG000|COMPLETED|Overall Study||28
3052631|NCT01226914|3772878|FG001|COMPLETED|Overall Study||27
3052632|NCT01226914|3772877|FG000|NOT COMPLETED|Overall Study||0
3052633|NCT01226914|3772878|FG001|NOT COMPLETED|Overall Study||0
3052634|NCT01226979|3772884|FG000|STARTED|Overall Study||16
3052635|NCT01226979|3772884|FG000|COMPLETED|Overall Study||16
3052636|NCT01226979|3772884|FG000|NOT COMPLETED|Overall Study||0
3052637|NCT01227005|3772891|FG000|STARTED|Overall Study||55
3052638|NCT01227005|3772892|FG001|STARTED|Overall Study||52
3052639|NCT01227005|3772891|FG000|COMPLETED|Overall Study||50
3052640|NCT01227005|3772892|FG001|COMPLETED|Overall Study||51
3052641|NCT01227005|3772891|FG000|NOT COMPLETED|Overall Study||5
3052642|NCT01227005|3772892|FG001|NOT COMPLETED|Overall Study||1
3052643|NCT01227018|3772898|FG000|STARTED|Overall Study||15
3052644|NCT01227018|3772898|FG000|COMPLETED|Overall Study||0
3052645|NCT01227018|3772898|FG000|NOT COMPLETED|Overall Study||15
3052646|NCT01227044|3772904|FG000|STARTED|Overall Study||25
3052647|NCT01227044|3772905|FG001|STARTED|Overall Study||26
3052648|NCT01227044|3772904|FG000|COMPLETED|Overall Study||19
3052649|NCT01227044|3772905|FG001|COMPLETED|Overall Study||17
3052650|NCT01227044|3772904|FG000|NOT COMPLETED|Overall Study||6
3052651|NCT01227044|3772905|FG001|NOT COMPLETED|Overall Study||9
3052652|NCT01227057|3772913|FG000|STARTED|Overall Study||31
3052653|NCT01227057|3772914|FG001|STARTED|Overall Study||27
3052654|NCT01227057|3772913|FG000|COMPLETED|Overall Study||25
3052655|NCT01227057|3772914|FG001|COMPLETED|Overall Study||19
3052656|NCT01227057|3772913|FG000|NOT COMPLETED|Overall Study||6
3052657|NCT01227057|3772914|FG001|NOT COMPLETED|Overall Study||8
3052658|NCT01227252|3772925|FG000|STARTED|Overall Study||12
3052659|NCT01227252|3772926|FG001|STARTED|Overall Study||10
3052660|NCT01227252|3772927|FG002|STARTED|Overall Study||10
3052661|NCT01227252|3772928|FG003|STARTED|Overall Study||10
3052662|NCT01227252|3772925|FG000|Received at Least 1 Dose of Study Drug|Overall Study||12
3052663|NCT01227252|3772926|FG001|Received at Least 1 Dose of Study Drug|Overall Study||10
3052664|NCT01227252|3772927|FG002|Received at Least 1 Dose of Study Drug|Overall Study||10
3052665|NCT01227252|3772928|FG003|Received at Least 1 Dose of Study Drug|Overall Study||10
3052666|NCT01227252|3772925|FG000|COMPLETED|Overall Study||12
3052667|NCT01227252|3772926|FG001|COMPLETED|Overall Study||7
3052668|NCT01227252|3772927|FG002|COMPLETED|Overall Study||10
3052669|NCT01227252|3772928|FG003|COMPLETED|Overall Study||10
3052670|NCT01227252|3772925|FG000|NOT COMPLETED|Overall Study||0
3052671|NCT01227252|3772926|FG001|NOT COMPLETED|Overall Study||3
3052672|NCT01227252|3772927|FG002|NOT COMPLETED|Overall Study||0
3052673|NCT01227252|3772928|FG003|NOT COMPLETED|Overall Study||0
3052674|NCT01227265|3772944|FG000|STARTED|Overall Study||158
3052675|NCT01227265|3772945|FG001|STARTED|Overall Study||159
3052676|NCT01227265|3772946|FG002|STARTED|Overall Study||159
3052677|NCT01227265|3772944|FG000|Treated|Overall Study||157
3052678|NCT01227265|3772945|FG001|Treated|Overall Study||157
3052679|NCT01227265|3772946|FG002|Treated|Overall Study||159
3052680|NCT01227265|3772944|FG000|COMPLETED|Overall Study||139
3052681|NCT01227265|3772945|FG001|COMPLETED|Overall Study||139
3052682|NCT01227265|3772946|FG002|COMPLETED|Overall Study||145
3052683|NCT01227265|3772944|FG000|NOT COMPLETED|Overall Study||19
3052684|NCT01227265|3772945|FG001|NOT COMPLETED|Overall Study||20
3052685|NCT01227265|3772946|FG002|NOT COMPLETED|Overall Study||14
3052686|NCT01227278|3772956|FG000|STARTED|Overall Study||50
3052687|NCT01227278|3772957|FG001|STARTED|Overall Study||51
3052688|NCT01227278|3772956|FG000|COMPLETED|Overall Study||45
3052689|NCT01227278|3772957|FG001|COMPLETED|Overall Study||43
3052690|NCT01227278|3772956|FG000|NOT COMPLETED|Overall Study||5
3052691|NCT01227278|3772957|FG001|NOT COMPLETED|Overall Study||8
3052692|NCT01227382|3772963|FG000|STARTED|Overall Study||26
3052693|NCT01227382|3772963|FG000|COMPLETED|Overall Study||26
3052694|NCT01227382|3772963|FG000|NOT COMPLETED|Overall Study||0
3052695|NCT01227395|3772971|FG000|STARTED|Overall Study||391
3052696|NCT01227395|3772972|FG001|STARTED|Overall Study||85
3052697|NCT01227395|3772971|FG000|COMPLETED|Overall Study||391
3052698|NCT01227395|3772972|FG001|COMPLETED|Overall Study||84
3052699|NCT01227395|3772971|FG000|NOT COMPLETED|Overall Study||0
3052700|NCT01227395|3772972|FG001|NOT COMPLETED|Overall Study||1
3052701|NCT01227421|3773000|FG000|STARTED|Overall Study||201
3052702|NCT01227421|3773001|FG001|STARTED|Overall Study||212
3052703|NCT01227421|3773002|FG002|STARTED|Overall Study||211
3052704|NCT01227421|3773000|FG000|COMPLETED|Overall Study||190
3052705|NCT01227421|3773001|FG001|COMPLETED|Overall Study||194
3052706|NCT01227421|3773002|FG002|COMPLETED|Overall Study||201
3052707|NCT01227421|3773000|FG000|NOT COMPLETED|Overall Study||11
3052708|NCT01227421|3773001|FG001|NOT COMPLETED|Overall Study||18
3052709|NCT01227421|3773002|FG002|NOT COMPLETED|Overall Study||10
3052710|NCT01227434|3773012|FG000|STARTED|Overall Study||6
3052711|NCT01227434|3773013|FG001|STARTED|Overall Study||16
3052712|NCT01227434|3773012|FG000|COMPLETED|Overall Study||6
3052713|NCT01227434|3773013|FG001|COMPLETED|Overall Study||16
3052714|NCT01227434|3773012|FG000|NOT COMPLETED|Overall Study||0
3052715|NCT01227434|3773013|FG001|NOT COMPLETED|Overall Study||0
3052716|NCT01227512|3773022|FG000|STARTED|Overall Study||66
3052717|NCT01227512|3773023|FG001|STARTED|Overall Study||58
3052718|NCT01227512|3773022|FG000|COMPLETED|Overall Study||53
3052719|NCT01227512|3773023|FG001|COMPLETED|Overall Study||48
3052720|NCT01227512|3773022|FG000|NOT COMPLETED|Overall Study||13
3052721|NCT01227512|3773023|FG001|NOT COMPLETED|Overall Study||10
3052722|NCT01227551|3773031|FG000|STARTED|Overall Study||57
3052723|NCT01227551|3773031|FG000|COMPLETED|Overall Study||23
3052724|NCT01227551|3773031|FG000|NOT COMPLETED|Overall Study||34
3052725|NCT01227564|3773038|FG000|STARTED|Overall Study||22
3052726|NCT01227564|3773039|FG001|STARTED|Overall Study||20
3052727|NCT01227564|3773040|FG002|STARTED|Overall Study||21
3052728|NCT01227564|3773038|FG000|Treated|Overall Study||22
3052729|NCT01227564|3773039|FG001|Treated|Overall Study||20
3052730|NCT01227564|3773040|FG002|Treated|Overall Study||21
3052731|NCT01227564|3773038|FG000|Completed Treatment|Overall Study|1 participant discontinued treatment due to an adverse event (AE).|21
3052732|NCT01227564|3773039|FG001|Completed Treatment|Overall Study|2 participants discontinued treatment due to no longer willing to participate in study.|18
3052733|NCT01227564|3773040|FG002|Completed Treatment|Overall Study|1 participant stopped treatment due to lack of efficacy, 3 due to no longer willing to participate.|17
3052734|NCT01227564|3773038|FG000|COMPLETED|Overall Study|Completed study|18
3052735|NCT01227564|3773039|FG001|COMPLETED|Overall Study|Completed study|18
3052736|NCT01227564|3773040|FG002|COMPLETED|Overall Study|Completed study|15
3052737|NCT01227564|3773038|FG000|NOT COMPLETED|Overall Study||4
3052738|NCT01227564|3773039|FG001|NOT COMPLETED|Overall Study||2
3052739|NCT01227564|3773040|FG002|NOT COMPLETED|Overall Study||6
3052740|NCT01227577|3773050|FG000|STARTED|Overall Study||128
3052741|NCT01227577|3773050|FG000|COMPLETED|Overall Study||93
3052742|NCT01227577|3773050|FG000|NOT COMPLETED|Overall Study||35
3052743|NCT01227616|3773056|FG000|STARTED|Overall Study||196
3052744|NCT01227616|3773057|FG001|STARTED|Overall Study||97
3052745|NCT01227616|3773056|FG000|COMPLETED|Overall Study||142
3052746|NCT01227616|3773057|FG001|COMPLETED|Overall Study||74
3052747|NCT01227616|3773056|FG000|NOT COMPLETED|Overall Study||54
3052748|NCT01227616|3773057|FG001|NOT COMPLETED|Overall Study||23
3052749|NCT01227629|3773073|FG000|STARTED|Overall Study|Started: Participant was randomised and took at least one dose of randomised study medication|58
3052750|NCT01227629|3773074|FG001|STARTED|Overall Study||20
3052751|NCT01227629|3773075|FG002|STARTED|Overall Study||27
3052752|NCT01227629|3773076|FG003|STARTED|Overall Study||99
3052753|NCT01227629|3773077|FG004|STARTED|Overall Study||34
3052754|NCT01227629|3773078|FG005|STARTED|Overall Study||33
3052755|NCT01227629|3773079|FG006|STARTED|Overall Study||98
3052756|NCT01227629|3773080|FG007|STARTED|Overall Study||33
3052757|NCT01227629|3773081|FG008|STARTED|Overall Study||30
3052758|NCT01227629|3773082|FG009|STARTED|Overall Study||70
3052759|NCT01227629|3773073|FG000|COMPLETED|Overall Study|Completed: Participant without premature discontinuation in the randomised treatment period|56
3052760|NCT01227629|3773074|FG001|COMPLETED|Overall Study||18
3052761|NCT01227629|3773075|FG002|COMPLETED|Overall Study||26
3052762|NCT01227629|3773076|FG003|COMPLETED|Overall Study||91
3052763|NCT01227629|3773077|FG004|COMPLETED|Overall Study||32
3052764|NCT01227629|3773078|FG005|COMPLETED|Overall Study||32
3052765|NCT01227629|3773079|FG006|COMPLETED|Overall Study||90
3052766|NCT01227629|3773080|FG007|COMPLETED|Overall Study||27
3052767|NCT01227629|3773081|FG008|COMPLETED|Overall Study||24
3052768|NCT01227629|3773082|FG009|COMPLETED|Overall Study||68
3052769|NCT01227629|3773073|FG000|NOT COMPLETED|Overall Study||2
3052770|NCT01227629|3773074|FG001|NOT COMPLETED|Overall Study||2
3052771|NCT01227629|3773075|FG002|NOT COMPLETED|Overall Study||1
3052772|NCT01227629|3773076|FG003|NOT COMPLETED|Overall Study||8
3052773|NCT01227629|3773077|FG004|NOT COMPLETED|Overall Study||2
3052774|NCT01227629|3773078|FG005|NOT COMPLETED|Overall Study||1
3052775|NCT01227629|3773079|FG006|NOT COMPLETED|Overall Study||8
3052776|NCT01227629|3773080|FG007|NOT COMPLETED|Overall Study||6
3052777|NCT01227629|3773081|FG008|NOT COMPLETED|Overall Study||6
3052778|NCT01227629|3773082|FG009|NOT COMPLETED|Overall Study||2
3052779|NCT01227655|3773131|FG000|STARTED|Overall Study||129
3052780|NCT01227655|3773132|FG001|STARTED|Overall Study||154
3052781|NCT01227655|3773133|FG002|STARTED|Overall Study||144
3052782|NCT01227655|3773131|FG000|Safety Set|Overall Study||125
3052783|NCT01227655|3773132|FG001|Safety Set|Overall Study||150
3052784|NCT01227655|3773133|FG002|Safety Set|Overall Study||136
3052785|NCT01227655|3773131|FG000|Full Analysis Set|Overall Study||125
3052786|NCT01227655|3773132|FG001|Full Analysis Set|Overall Study||147
3052787|NCT01227655|3773133|FG002|Full Analysis Set|Overall Study||135
3052788|NCT01227655|3773131|FG000|COMPLETED|Overall Study||118
3052789|NCT01227655|3773132|FG001|COMPLETED|Overall Study||128
3052790|NCT01227655|3773133|FG002|COMPLETED|Overall Study||130
3283685|NCT02758613|4017491|FG003|STARTED|Treatment||8
3283686|NCT02758613|4017488|FG000|Received at Least One Dose of Study Drug|Treatment||8
3052791|NCT01227655|3773131|FG000|NOT COMPLETED|Overall Study||11
3052792|NCT01227655|3773132|FG001|NOT COMPLETED|Overall Study||26
3052793|NCT01227655|3773133|FG002|NOT COMPLETED|Overall Study||14
3052794|NCT01227668|3773143|FG000|STARTED|Phase 1 (Stabilization Phase)|Randomized|157
3052795|NCT01227668|3773144|FG001|STARTED|Phase 1 (Stabilization Phase)||0
3052796|NCT01227668|3773143|FG000|Received Treatment|Phase 1 (Stabilization Phase)||155
3052797|NCT01227668|3773144|FG001|Received Treatment|Phase 1 (Stabilization Phase)||0
3052798|NCT01227668|3773143|FG000|COMPLETED|Phase 1 (Stabilization Phase)||85
3052799|NCT01227668|3773144|FG001|COMPLETED|Phase 1 (Stabilization Phase)||0
3052800|NCT01227668|3773143|FG000|NOT COMPLETED|Phase 1 (Stabilization Phase)||72
3052801|NCT01227668|3773144|FG001|NOT COMPLETED|Phase 1 (Stabilization Phase)||0
3052802|NCT01227668|3773143|FG000|STARTED|Phase 2 (Randomization Phase)|Randomized|41
3052803|NCT01227668|3773144|FG001|STARTED|Phase 2 (Randomization Phase)|Randomized|44
3052804|NCT01227668|3773143|FG000|Received Treatment|Phase 2 (Randomization Phase)||39
3052805|NCT01227668|3773144|FG001|Received Treatment|Phase 2 (Randomization Phase)||43
3052806|NCT01227668|3773143|FG000|COMPLETED|Phase 2 (Randomization Phase)||22
3052807|NCT01227668|3773144|FG001|COMPLETED|Phase 2 (Randomization Phase)||19
3052808|NCT01227668|3773143|FG000|NOT COMPLETED|Phase 2 (Randomization Phase)||19
3052809|NCT01227668|3773144|FG001|NOT COMPLETED|Phase 2 (Randomization Phase)||25
3052810|NCT01227681|3773157|FG000|STARTED|Overall Study||4
3052811|NCT01227681|3773158|FG001|STARTED|Overall Study||0
3052812|NCT01227681|3773159|FG002|STARTED|Overall Study||0
3052813|NCT01227681|3773157|FG000|COMPLETED|Overall Study||4
3052814|NCT01227681|3773158|FG001|COMPLETED|Overall Study||0
3052815|NCT01227681|3773159|FG002|COMPLETED|Overall Study||0
3052816|NCT01227681|3773157|FG000|NOT COMPLETED|Overall Study||0
3052817|NCT01227681|3773158|FG001|NOT COMPLETED|Overall Study||0
3283687|NCT02758613|4017489|FG001|Received at Least One Dose of Study Drug|Treatment||8
3283688|NCT02758613|4017490|FG002|Received at Least One Dose of Study Drug|Treatment||9
3283689|NCT02758613|4017491|FG003|Received at Least One Dose of Study Drug|Treatment||8
3283690|NCT02758613|4017488|FG000|COMPLETED|Treatment||6
3283691|NCT02758613|4017489|FG001|COMPLETED|Treatment||8
3283692|NCT02758613|4017490|FG002|COMPLETED|Treatment||8
3283693|NCT02758613|4017491|FG003|COMPLETED|Treatment||8
3283694|NCT02758613|4017488|FG000|NOT COMPLETED|Treatment||2
3283695|NCT02758613|4017489|FG001|NOT COMPLETED|Treatment||0
3283696|NCT02758613|4017490|FG002|NOT COMPLETED|Treatment||1
3283697|NCT02758613|4017491|FG003|NOT COMPLETED|Treatment||0
3283698|NCT02758613|4017488|FG000|STARTED|Follow-up||6
3052818|NCT01227681|3773159|FG002|NOT COMPLETED|Overall Study||0
3052819|NCT01227707|3773163|FG000|STARTED|Overall Study||43
3052820|NCT01227707|3773163|FG000|COMPLETED|Overall Study||19
3052821|NCT01227707|3773163|FG000|NOT COMPLETED|Overall Study||24
3052822|NCT01227785|3773167|FG000|STARTED|Overall Study||120
3052823|NCT01227785|3773167|FG000|COMPLETED|Overall Study||108
3052824|NCT01227785|3773167|FG000|NOT COMPLETED|Overall Study||12
3052825|NCT01227824|3773180|FG000|STARTED|Double-blind Phase: 96 Weeks Duration||411
3052826|NCT01227824|3773181|FG001|STARTED|Double-blind Phase: 96 Weeks Duration||411
3052827|NCT01227824|3773182|FG002|STARTED|Double-blind Phase: 96 Weeks Duration||0
3052828|NCT01227824|3773180|FG000|COMPLETED|Double-blind Phase: 96 Weeks Duration||304
3052829|NCT01227824|3773181|FG001|COMPLETED|Double-blind Phase: 96 Weeks Duration||332
3052830|NCT01227824|3773182|FG002|COMPLETED|Double-blind Phase: 96 Weeks Duration||0
3052831|NCT01227824|3773180|FG000|NOT COMPLETED|Double-blind Phase: 96 Weeks Duration||107
3052832|NCT01227824|3773181|FG001|NOT COMPLETED|Double-blind Phase: 96 Weeks Duration||79
3052833|NCT01227824|3773182|FG002|NOT COMPLETED|Double-blind Phase: 96 Weeks Duration||0
3052834|NCT01227824|3773180|FG000|STARTED|Open-label Phase: Median of 1267 Days||0
3052835|NCT01227824|3773181|FG001|STARTED|Open-label Phase: Median of 1267 Days||0
3052836|NCT01227824|3773182|FG002|STARTED|Open-label Phase: Median of 1267 Days|338 participants continued into the Open-label phase on completing the Double-blind Phase|338
3052837|NCT01227824|3773180|FG000|COMPLETED|Open-label Phase: Median of 1267 Days||0
3052838|NCT01227824|3773181|FG001|COMPLETED|Open-label Phase: Median of 1267 Days||0
3052839|NCT01227824|3773182|FG002|COMPLETED|Open-label Phase: Median of 1267 Days||294
3052840|NCT01227824|3773180|FG000|NOT COMPLETED|Open-label Phase: Median of 1267 Days||0
3052841|NCT01227824|3773181|FG001|NOT COMPLETED|Open-label Phase: Median of 1267 Days||0
3052842|NCT01227824|3773182|FG002|NOT COMPLETED|Open-label Phase: Median of 1267 Days||44
3052843|NCT01227889|3773191|FG000|STARTED|Randomized Phase (RP)||187
3052844|NCT01227889|3773192|FG001|STARTED|Randomized Phase (RP)||63
3052845|NCT01227889|3773191|FG000|COMPLETED|Randomized Phase (RP)||0
3052846|NCT01227889|3773192|FG001|COMPLETED|Randomized Phase (RP)||0
3052847|NCT01227889|3773191|FG000|NOT COMPLETED|Randomized Phase (RP)||187
3052848|NCT01227889|3773192|FG001|NOT COMPLETED|Randomized Phase (RP)||63
3052849|NCT01227889|3773191|FG000|STARTED|Crossover Phase||0
3052850|NCT01227889|3773192|FG001|STARTED|Crossover Phase|As of the data cut on December 18, 2012, 36 of 63 participants crossed over from DTIC to GSK2118436.|37
3052851|NCT01227889|3773191|FG000|COMPLETED|Crossover Phase||0
3052852|NCT01227889|3773192|FG001|COMPLETED|Crossover Phase||0
3052853|NCT01227889|3773191|FG000|NOT COMPLETED|Crossover Phase||0
3052854|NCT01227889|3773192|FG001|NOT COMPLETED|Crossover Phase||37
3052855|NCT01227902|3773210|FG000|STARTED|Overall Study||56
3052856|NCT01227902|3773211|FG001|STARTED|Overall Study||51
3052857|NCT01227902|3773212|FG002|STARTED|Overall Study||44
3052858|NCT01227902|3773213|FG003|STARTED|Overall Study||52
3052859|NCT01227902|3773210|FG000|COMPLETED|Overall Study||38
3052860|NCT01227902|3773211|FG001|COMPLETED|Overall Study||38
3052861|NCT01227902|3773212|FG002|COMPLETED|Overall Study||25
3052862|NCT01227902|3773213|FG003|COMPLETED|Overall Study||42
3052863|NCT01227902|3773210|FG000|NOT COMPLETED|Overall Study||18
3283699|NCT02758613|4017489|FG001|STARTED|Follow-up||8
3283700|NCT02758613|4017490|FG002|STARTED|Follow-up||8
3052864|NCT01227902|3773211|FG001|NOT COMPLETED|Overall Study||13
3052865|NCT01227902|3773212|FG002|NOT COMPLETED|Overall Study||19
3052866|NCT01227902|3773213|FG003|NOT COMPLETED|Overall Study||10
3052867|NCT01227928|3773226|FG000|STARTED|Overall Study||72
3052868|NCT01227928|3773227|FG001|STARTED|Overall Study||73
3052869|NCT01227928|3773226|FG000|COMPLETED|Overall Study||50
3052870|NCT01227928|3773227|FG001|COMPLETED|Overall Study||56
3052871|NCT01227928|3773226|FG000|NOT COMPLETED|Overall Study||22
3052872|NCT01227928|3773227|FG001|NOT COMPLETED|Overall Study||17
3052873|NCT01227954|3773233|FG000|STARTED|Overall Study||113
3283701|NCT02758613|4017491|FG003|STARTED|Follow-up||8
3052874|NCT01227954|3773233|FG000|COMPLETED|Overall Study|Eligible subjects available for analysis|100
3052875|NCT01227954|3773233|FG000|NOT COMPLETED|Overall Study||13
3052876|NCT01227967|3773239|FG000|STARTED|Overall Study||314
3052877|NCT01227967|3773240|FG001|STARTED|Overall Study||316
3052878|NCT01227967|3773239|FG000|COMPLETED|Overall Study||298
3052879|NCT01227967|3773240|FG001|COMPLETED|Overall Study||303
3052880|NCT01227967|3773239|FG000|NOT COMPLETED|Overall Study||16
3052881|NCT01227967|3773240|FG001|NOT COMPLETED|Overall Study||13
3052882|NCT01227980|3773248|FG000|STARTED|Overall Study||40
3052883|NCT01227980|3773249|FG001|STARTED|Overall Study||30
3052884|NCT01227980|3773248|FG000|Scripts Challenge Sessions|Overall Study||26
3283702|NCT02758613|4017488|FG000|COMPLETED|Follow-up||6
3283703|NCT02758613|4017489|FG001|COMPLETED|Follow-up||8
3283704|NCT02758613|4017490|FG002|COMPLETED|Follow-up||8
3283705|NCT02758613|4017491|FG003|COMPLETED|Follow-up||8
3283706|NCT02758613|4017488|FG000|NOT COMPLETED|Follow-up||0
3283707|NCT02758613|4017489|FG001|NOT COMPLETED|Follow-up||0
3283708|NCT02758613|4017490|FG002|NOT COMPLETED|Follow-up||0
3283709|NCT02758613|4017491|FG003|NOT COMPLETED|Follow-up||0
3283710|NCT02758899|4017506|FG000|STARTED|Overall Study||11
3283711|NCT02758899|4017507|FG001|STARTED|Overall Study||10
3283712|NCT02758899|4017506|FG000|COMPLETED|Overall Study||9
3052885|NCT01227980|3773249|FG001|Scripts Challenge Sessions|Overall Study||25
3052886|NCT01227980|3773248|FG000|Measure Drug Level Concentration|Overall Study||10
3052887|NCT01227980|3773249|FG001|Measure Drug Level Concentration|Overall Study|No placebo subjects completed this milestone which measured active drug levels|0
3052888|NCT01227980|3773248|FG000|COMPLETED|Overall Study|Two subjects did not complete the scripts sessions but completed the remainder of the protocol|38
3052889|NCT01227980|3773249|FG001|COMPLETED|Overall Study||25
3052890|NCT01227980|3773248|FG000|NOT COMPLETED|Overall Study||2
3052891|NCT01227980|3773249|FG001|NOT COMPLETED|Overall Study||5
3052892|NCT01227993|3773255|FG000|STARTED|Overall Study||3
3052893|NCT01227993|3773255|FG000|COMPLETED|Overall Study||3
3052894|NCT01227993|3773255|FG000|NOT COMPLETED|Overall Study||0
3052895|NCT01228019|3773259|FG000|STARTED|Overall Study||1166
3052896|NCT01228019|3773259|FG000|COMPLETED|Overall Study||862
3283713|NCT02758899|4017507|FG001|COMPLETED|Overall Study||9
3283714|NCT02758899|4017506|FG000|NOT COMPLETED|Overall Study||2
3283715|NCT02758899|4017507|FG001|NOT COMPLETED|Overall Study||1
3052897|NCT01228019|3773259|FG000|NOT COMPLETED|Overall Study||304
3052898|NCT01228071|3773263|FG000|STARTED|Overall Study||34
3052899|NCT01228071|3773263|FG000|COMPLETED|Overall Study||32
3052900|NCT01228071|3773263|FG000|NOT COMPLETED|Overall Study||2
3052901|NCT01228084|3773267|FG000|STARTED|Overall Study||20
3052902|NCT01228084|3773267|FG000|COMPLETED|Overall Study||16
3052903|NCT01228084|3773267|FG000|NOT COMPLETED|Overall Study||4
3052904|NCT01228149|3773273|FG000|STARTED|Overall Study||32
3052905|NCT01228149|3773274|FG001|STARTED|Overall Study||30
3052906|NCT01228149|3773273|FG000|COMPLETED|Overall Study||27
3052907|NCT01228149|3773274|FG001|COMPLETED|Overall Study||26
3052908|NCT01228149|3773273|FG000|NOT COMPLETED|Overall Study||5
3052909|NCT01228149|3773274|FG001|NOT COMPLETED|Overall Study||4
3052910|NCT01228175|3773285|FG000|STARTED|Overall Study||119
3052911|NCT01228175|3773286|FG001|STARTED|Overall Study||99
3052912|NCT01228175|3773285|FG000|COMPLETED|Overall Study||53
3160772|NCT01866943|3887922|FG001|COMPLETED|Overall Study|Unknown - the only spreadsheet available is de-identified and blinded.|0
3160773|NCT01866943|3887921|FG000|NOT COMPLETED|Overall Study||19
3160774|NCT01866943|3887922|FG001|NOT COMPLETED|Overall Study||22
3160775|NCT01867008|3887931|FG000|STARTED|Overall Study||55
3160776|NCT01867008|3887931|FG000|COMPLETED|Overall Study||54
3160777|NCT01867008|3887931|FG000|NOT COMPLETED|Overall Study||1
3160778|NCT01867021|3887937|FG000|STARTED|Overall Study||1452
3160779|NCT01867021|3887938|FG001|STARTED|Overall Study||1450
3160780|NCT01867021|3887937|FG000|COMPLETED|Overall Study||1450
3160781|NCT01867021|3887938|FG001|COMPLETED|Overall Study||1440
3160782|NCT01867021|3887937|FG000|NOT COMPLETED|Overall Study||2
3052913|NCT01228175|3773286|FG001|COMPLETED|Overall Study||46
3052914|NCT01228175|3773285|FG000|NOT COMPLETED|Overall Study||66
3052915|NCT01228175|3773286|FG001|NOT COMPLETED|Overall Study||53
3052916|NCT01228318|3773294|FG000|STARTED|Overall Study||34
3052917|NCT01228318|3773295|FG001|STARTED|Overall Study||29
3052918|NCT01228318|3773294|FG000|COMPLETED|Overall Study||30
3052919|NCT01228318|3773295|FG001|COMPLETED|Overall Study||22
3052920|NCT01228318|3773294|FG000|NOT COMPLETED|Overall Study||4
3052921|NCT01228318|3773295|FG001|NOT COMPLETED|Overall Study||7
3052922|NCT01228435|3773303|FG000|STARTED|Overall Study||1
3052923|NCT01228435|3773304|FG001|STARTED|Overall Study||2
3052924|NCT01228435|3773303|FG000|COMPLETED|Overall Study||1
3052925|NCT01228435|3773304|FG001|COMPLETED|Overall Study||2
3052926|NCT01228435|3773303|FG000|NOT COMPLETED|Overall Study||0
3052927|NCT01228435|3773304|FG001|NOT COMPLETED|Overall Study||0
3160783|NCT01867021|3887938|FG001|NOT COMPLETED|Overall Study||10
3283716|NCT02759016|4017515|FG000|STARTED|Overall Study||4
3283717|NCT02759016|4017516|FG001|STARTED|Overall Study||3
3283718|NCT02759016|4017515|FG000|Treated With BI 836826 and Ibrutinib|Overall Study||3
3160784|NCT01867047|3887951|FG000|STARTED|Overall Study||31
3052928|NCT01228591|3773310|FG000|STARTED|Baseline||18
3052929|NCT01228591|3773311|FG001|STARTED|Baseline||18
3052930|NCT01228591|3773310|FG000|COMPLETED|Baseline||17
3052931|NCT01228591|3773311|FG001|COMPLETED|Baseline||16
3052932|NCT01228591|3773310|FG000|NOT COMPLETED|Baseline||1
3052933|NCT01228591|3773311|FG001|NOT COMPLETED|Baseline||2
3052934|NCT01228591|3773310|FG000|STARTED|1-Week Follow-Up||17
3052935|NCT01228591|3773311|FG001|STARTED|1-Week Follow-Up||16
3052936|NCT01228591|3773310|FG000|COMPLETED|1-Week Follow-Up||17
3052937|NCT01228591|3773311|FG001|COMPLETED|1-Week Follow-Up||16
3052938|NCT01228591|3773310|FG000|NOT COMPLETED|1-Week Follow-Up||0
3052939|NCT01228591|3773311|FG001|NOT COMPLETED|1-Week Follow-Up||0
3052940|NCT01228591|3773310|FG000|STARTED|Final Visit||17
3052941|NCT01228591|3773311|FG001|STARTED|Final Visit||16
3052942|NCT01228591|3773310|FG000|COMPLETED|Final Visit||17
3052943|NCT01228591|3773311|FG001|COMPLETED|Final Visit||16
3052944|NCT01228591|3773310|FG000|NOT COMPLETED|Final Visit||0
3052945|NCT01228591|3773311|FG001|NOT COMPLETED|Final Visit||0
3052946|NCT01228734|3773323|FG000|STARTED|Overall Study||193
3052947|NCT01228734|3773324|FG001|STARTED|Overall Study||204
3052948|NCT01228734|3773323|FG000|Modified Intent-to-treat Population|Overall Study||193
3052949|NCT01228734|3773324|FG001|Modified Intent-to-treat Population|Overall Study||200
3052950|NCT01228734|3773323|FG000|Modified Safety Population|Overall Study|One subject was randomized to FOLFOX-4 group but received cetuximab + FOLFOX-4 treatment instead|194
3052951|NCT01228734|3773324|FG001|Modified Safety Population|Overall Study||199
3052952|NCT01228734|3773323|FG000|COMPLETED|Overall Study||193
3052953|NCT01228734|3773324|FG001|COMPLETED|Overall Study||200
3052954|NCT01228734|3773323|FG000|NOT COMPLETED|Overall Study||0
3052955|NCT01228734|3773324|FG001|NOT COMPLETED|Overall Study||4
3052956|NCT01228747|3773332|FG000|STARTED|Overall Study||125
3052957|NCT01228747|3773333|FG001|STARTED|Overall Study||126
3052958|NCT01228747|3773332|FG000|COMPLETED|Overall Study||60
3052959|NCT01228747|3773333|FG001|COMPLETED|Overall Study||81
3052960|NCT01228747|3773332|FG000|NOT COMPLETED|Overall Study||65
3052961|NCT01228747|3773333|FG001|NOT COMPLETED|Overall Study||45
3052962|NCT01228903|3773341|FG000|STARTED|Overall Study||41
3052963|NCT01228903|3773342|FG001|STARTED|Overall Study||39
3052964|NCT01228903|3773341|FG000|COMPLETED|Overall Study||36
3052965|NCT01228903|3773342|FG001|COMPLETED|Overall Study||34
3052966|NCT01228903|3773341|FG000|NOT COMPLETED|Overall Study||5
3052967|NCT01228903|3773342|FG001|NOT COMPLETED|Overall Study||5
3052968|NCT01228929|3773351|FG000|STARTED|Nominal Condition||6
3052969|NCT01228929|3773352|FG001|STARTED|Nominal Condition||6
3052970|NCT01228929|3773353|FG002|STARTED|Nominal Condition||6
3052971|NCT01228929|3773351|FG000|COMPLETED|Nominal Condition||6
3052972|NCT01228929|3773352|FG001|COMPLETED|Nominal Condition||6
3052973|NCT01228929|3773353|FG002|COMPLETED|Nominal Condition||6
3052974|NCT01228929|3773351|FG000|NOT COMPLETED|Nominal Condition||0
3052975|NCT01228929|3773352|FG001|NOT COMPLETED|Nominal Condition||0
3052976|NCT01228929|3773353|FG002|NOT COMPLETED|Nominal Condition||0
3052977|NCT01228929|3773351|FG000|STARTED|Low Humidity Condition||6
3052978|NCT01228929|3773352|FG001|STARTED|Low Humidity Condition||6
3052979|NCT01228929|3773353|FG002|STARTED|Low Humidity Condition||6
3052980|NCT01228929|3773351|FG000|COMPLETED|Low Humidity Condition||6
3052981|NCT01228929|3773352|FG001|COMPLETED|Low Humidity Condition||6
3052982|NCT01228929|3773353|FG002|COMPLETED|Low Humidity Condition||6
3052983|NCT01228929|3773351|FG000|NOT COMPLETED|Low Humidity Condition||0
3052984|NCT01228929|3773352|FG001|NOT COMPLETED|Low Humidity Condition||0
3052985|NCT01228929|3773353|FG002|NOT COMPLETED|Low Humidity Condition||0
3052986|NCT01228929|3773351|FG000|STARTED|High Temperature Condition||6
3052987|NCT01228929|3773352|FG001|STARTED|High Temperature Condition||6
3052988|NCT01228929|3773353|FG002|STARTED|High Temperature Condition||6
3052989|NCT01228929|3773351|FG000|COMPLETED|High Temperature Condition||6
3052990|NCT01228929|3773352|FG001|COMPLETED|High Temperature Condition||6
3052991|NCT01228929|3773353|FG002|COMPLETED|High Temperature Condition||6
3052992|NCT01228929|3773351|FG000|NOT COMPLETED|High Temperature Condition||0
3052993|NCT01228929|3773352|FG001|NOT COMPLETED|High Temperature Condition||0
3052994|NCT01228929|3773353|FG002|NOT COMPLETED|High Temperature Condition||0
3052995|NCT01228968|3773361|FG000|STARTED|Overall Study||9
3052996|NCT01228968|3773361|FG000|COMPLETED|Overall Study||9
3052997|NCT01228968|3773361|FG000|NOT COMPLETED|Overall Study||0
3052998|NCT01229111|3773365|FG000|STARTED|Overall Study||14
3052999|NCT01229111|3773365|FG000|COMPLETED|Overall Study||13
3053000|NCT01229111|3773365|FG000|NOT COMPLETED|Overall Study||1
3053001|NCT01229150|3773373|FG000|STARTED|Overall Study||30
3053002|NCT01229150|3773374|FG001|STARTED|Overall Study||11
3053003|NCT01229150|3773375|FG002|STARTED|Overall Study||19
3053004|NCT01229150|3773376|FG003|STARTED|Overall Study||19
3053005|NCT01229150|3773373|FG000|COMPLETED|Overall Study||28
3053006|NCT01229150|3773374|FG001|COMPLETED|Overall Study||9
3053007|NCT01229150|3773375|FG002|COMPLETED|Overall Study||19
3053008|NCT01229150|3773376|FG003|COMPLETED|Overall Study||19
3053009|NCT01229150|3773373|FG000|NOT COMPLETED|Overall Study||2
3053010|NCT01229150|3773374|FG001|NOT COMPLETED|Overall Study||2
3053011|NCT01229150|3773375|FG002|NOT COMPLETED|Overall Study||0
3053012|NCT01229150|3773376|FG003|NOT COMPLETED|Overall Study||0
3053013|NCT01229176|3773398|FG000|STARTED|Overall Study||40
3053014|NCT01229176|3773399|FG001|STARTED|Overall Study||40
3053015|NCT01229176|3773400|FG002|STARTED|Overall Study||20
3053016|NCT01229176|3773401|FG003|STARTED|Overall Study||20
3053017|NCT01229176|3773402|FG004|STARTED|Overall Study||20
3053018|NCT01229176|3773403|FG005|STARTED|Overall Study||20
3053019|NCT01229176|3773404|FG006|STARTED|Overall Study||20
3053020|NCT01229176|3773405|FG007|STARTED|Overall Study||20
3053021|NCT01229176|3773398|FG000|COMPLETED|Overall Study||40
3053022|NCT01229176|3773399|FG001|COMPLETED|Overall Study||37
3160785|NCT01867047|3887952|FG001|STARTED|Overall Study||28
3160786|NCT01867047|3887951|FG000|COMPLETED|Overall Study||23
3160787|NCT01867047|3887952|FG001|COMPLETED|Overall Study||23
3160788|NCT01867047|3887951|FG000|NOT COMPLETED|Overall Study||8
3160789|NCT01867047|3887952|FG001|NOT COMPLETED|Overall Study||5
3160790|NCT01867086|3887962|FG000|STARTED|Overall Study||1
3053023|NCT01229176|3773400|FG002|COMPLETED|Overall Study||20
3053024|NCT01229176|3773401|FG003|COMPLETED|Overall Study||19
3053025|NCT01229176|3773402|FG004|COMPLETED|Overall Study||18
3053026|NCT01229176|3773403|FG005|COMPLETED|Overall Study||18
3053027|NCT01229176|3773404|FG006|COMPLETED|Overall Study||20
3053028|NCT01229176|3773405|FG007|COMPLETED|Overall Study||17
3053029|NCT01229176|3773398|FG000|NOT COMPLETED|Overall Study||0
3053030|NCT01229176|3773399|FG001|NOT COMPLETED|Overall Study||3
3053031|NCT01229176|3773400|FG002|NOT COMPLETED|Overall Study||0
3053032|NCT01229176|3773401|FG003|NOT COMPLETED|Overall Study||1
3053033|NCT01229176|3773402|FG004|NOT COMPLETED|Overall Study||2
3053034|NCT01229176|3773403|FG005|NOT COMPLETED|Overall Study||2
3053035|NCT01229176|3773404|FG006|NOT COMPLETED|Overall Study||0
3053036|NCT01229176|3773405|FG007|NOT COMPLETED|Overall Study||3
3053037|NCT01229228|3773428|FG000|STARTED|Overall Study||51
3053038|NCT01229228|3773429|FG001|STARTED|Overall Study||51
3053039|NCT01229228|3773430|FG002|STARTED|Overall Study||50
3053040|NCT01229228|3773431|FG003|STARTED|Overall Study||51
3053041|NCT01229228|3773432|FG004|STARTED|Overall Study||51
3053042|NCT01229228|3773428|FG000|COMPLETED|Overall Study||50
3053043|NCT01229228|3773429|FG001|COMPLETED|Overall Study||51
3053044|NCT01229228|3773430|FG002|COMPLETED|Overall Study||49
3053045|NCT01229228|3773431|FG003|COMPLETED|Overall Study||51
3053046|NCT01229228|3773432|FG004|COMPLETED|Overall Study||50
3053047|NCT01229228|3773428|FG000|NOT COMPLETED|Overall Study||1
3053048|NCT01229228|3773429|FG001|NOT COMPLETED|Overall Study||0
3053049|NCT01229228|3773430|FG002|NOT COMPLETED|Overall Study||1
3053050|NCT01229228|3773431|FG003|NOT COMPLETED|Overall Study||0
3053051|NCT01229228|3773432|FG004|NOT COMPLETED|Overall Study||1
3133907|NCT01698320|3858868|FG000|Safety Population|12-Week Double-Blind Period||0
3133908|NCT01698320|3858869|FG001|Safety Population|12-Week Double-Blind Period|One participant took both placebo and albuterol so is counted in both treatment groups for safety.|170
3133909|NCT01698320|3858870|FG002|Safety Population|12-Week Double-Blind Period||168
3133910|NCT01698320|3858868|FG000|COMPLETED|12-Week Double-Blind Period||0
3133911|NCT01698320|3858869|FG001|COMPLETED|12-Week Double-Blind Period||165
3133912|NCT01698320|3858870|FG002|COMPLETED|12-Week Double-Blind Period||156
3160791|NCT01867086|3887962|FG000|COMPLETED|Overall Study|"Completed means subject had been given all manufactured doses."|0
3160792|NCT01867086|3887962|FG000|NOT COMPLETED|Overall Study||1
3160793|NCT01867164|3887968|FG000|STARTED|Overall Study||81
3160794|NCT01867164|3887969|FG001|STARTED|Overall Study||79
3160795|NCT01867164|3887968|FG000|COMPLETED|Overall Study||81
3160796|NCT01867164|3887969|FG001|COMPLETED|Overall Study||79
3133913|NCT01698320|3858868|FG000|NOT COMPLETED|12-Week Double-Blind Period||0
3133914|NCT01698320|3858869|FG001|NOT COMPLETED|12-Week Double-Blind Period||4
3133915|NCT01698320|3858870|FG002|NOT COMPLETED|12-Week Double-Blind Period||12
3133916|NCT01698320|3858868|FG000|STARTED|40-Week Open-Label Period||0
3133917|NCT01698320|3858869|FG001|STARTED|40-Week Open-Label Period||165
3133918|NCT01698320|3858870|FG002|STARTED|40-Week Open-Label Period||156
3133919|NCT01698320|3858868|FG000|COMPLETED|40-Week Open-Label Period||0
3133920|NCT01698320|3858869|FG001|COMPLETED|40-Week Open-Label Period||146
3133921|NCT01698320|3858870|FG002|COMPLETED|40-Week Open-Label Period||146
3133922|NCT01698320|3858868|FG000|NOT COMPLETED|40-Week Open-Label Period||0
3133923|NCT01698320|3858869|FG001|NOT COMPLETED|40-Week Open-Label Period||19
3133924|NCT01698320|3858870|FG002|NOT COMPLETED|40-Week Open-Label Period||10
3133925|NCT01698333|3858878|FG000|STARTED|Overall Study||25
3133926|NCT01698333|3858878|FG000|COMPLETED|Overall Study||25
3133927|NCT01698333|3858878|FG000|NOT COMPLETED|Overall Study||0
3133928|NCT01698463|3858882|FG000|STARTED|Overall Study||11
3133929|NCT01698463|3858882|FG000|COMPLETED|Overall Study||11
3133930|NCT01698463|3858882|FG000|NOT COMPLETED|Overall Study||0
3133931|NCT01698502|3858888|FG000|STARTED|Overall Study||11
3133932|NCT01698502|3858889|FG001|STARTED|Overall Study||10
3133933|NCT01698502|3858888|FG000|COMPLETED|Overall Study||11
3133934|NCT01698502|3858889|FG001|COMPLETED|Overall Study||10
3133935|NCT01698502|3858888|FG000|NOT COMPLETED|Overall Study||0
3133936|NCT01698502|3858889|FG001|NOT COMPLETED|Overall Study||0
3133937|NCT01698528|3858897|FG000|STARTED|Overall Study||20
3133938|NCT01698528|3858898|FG001|STARTED|Overall Study||20
3160797|NCT01867164|3887968|FG000|NOT COMPLETED|Overall Study||0
3160798|NCT01867164|3887969|FG001|NOT COMPLETED|Overall Study||0
3160799|NCT01867216|3887982|FG000|STARTED|Overall Study||16
3160800|NCT01867216|3887983|FG001|STARTED|Overall Study||8
3160801|NCT01867216|3887984|FG002|STARTED|Overall Study||8
3133939|NCT01698528|3858897|FG000|COMPLETED|Overall Study||19
3133940|NCT01698528|3858898|FG001|COMPLETED|Overall Study||16
3133941|NCT01698528|3858897|FG000|NOT COMPLETED|Overall Study||1
3133942|NCT01698528|3858898|FG001|NOT COMPLETED|Overall Study||4
3133943|NCT01698554|3858908|FG000|STARTED|Overall Study||153
3133944|NCT01698554|3858909|FG001|STARTED|Overall Study||157
3133945|NCT01698554|3858910|FG002|STARTED|Overall Study||75
3133946|NCT01698554|3858911|FG003|STARTED|Overall Study||79
3133947|NCT01698554|3858908|FG000|COMPLETED|Overall Study||147
3133948|NCT01698554|3858909|FG001|COMPLETED|Overall Study||147
3160802|NCT01867216|3887985|FG003|STARTED|Overall Study||8
3053052|NCT01229254|3773447|FG000|STARTED|Overall Study||42
3053053|NCT01229254|3773448|FG001|STARTED|Overall Study||74
3053054|NCT01229254|3773449|FG002|STARTED|Overall Study||73
3053055|NCT01229254|3773447|FG000|COMPLETED|Overall Study||27
3053056|NCT01229254|3773448|FG001|COMPLETED|Overall Study||58
3053057|NCT01229254|3773449|FG002|COMPLETED|Overall Study||61
3053058|NCT01229254|3773447|FG000|NOT COMPLETED|Overall Study||15
3053059|NCT01229254|3773448|FG001|NOT COMPLETED|Overall Study||16
3053060|NCT01229254|3773449|FG002|NOT COMPLETED|Overall Study||12
3053061|NCT01229267|3773463|FG000|STARTED|Overall Study||189
3053062|NCT01229267|3773464|FG001|STARTED|Overall Study||184
3053063|NCT01229267|3773465|FG002|STARTED|Overall Study||187
3053064|NCT01229267|3773466|FG003|STARTED|Overall Study||106
3053065|NCT01229267|3773467|FG004|STARTED|Overall Study||564
3053066|NCT01229267|3773463|FG000|Received Vaccination 1|Overall Study||188
3053067|NCT01229267|3773464|FG001|Received Vaccination 1|Overall Study||180
3053068|NCT01229267|3773465|FG002|Received Vaccination 1|Overall Study||186
3053069|NCT01229267|3773466|FG003|Received Vaccination 1|Overall Study||104
3053070|NCT01229267|3773467|FG004|Received Vaccination 1|Overall Study||556
3053071|NCT01229267|3773463|FG000|Received Vaccination 2|Overall Study||171
3053072|NCT01229267|3773464|FG001|Received Vaccination 2|Overall Study||163
3053073|NCT01229267|3773465|FG002|Received Vaccination 2|Overall Study||168
3053074|NCT01229267|3773466|FG003|Received Vaccination 2|Overall Study||94
3053075|NCT01229267|3773467|FG004|Received Vaccination 2|Overall Study||511
3053076|NCT01229267|3773463|FG000|Received Vaccination 3|Overall Study||163
3053077|NCT01229267|3773464|FG001|Received Vaccination 3|Overall Study||155
3053078|NCT01229267|3773465|FG002|Received Vaccination 3|Overall Study||160
3053079|NCT01229267|3773466|FG003|Received Vaccination 3|Overall Study||89
3053080|NCT01229267|3773467|FG004|Received Vaccination 3|Overall Study||491
3053081|NCT01229267|3773463|FG000|Received Vaccination 4|Overall Study||155
3053082|NCT01229267|3773464|FG001|Received Vaccination 4|Overall Study||149
3053083|NCT01229267|3773465|FG002|Received Vaccination 4|Overall Study||149
3053084|NCT01229267|3773466|FG003|Received Vaccination 4|Overall Study||87
3053085|NCT01229267|3773467|FG004|Received Vaccination 4|Overall Study||477
3053086|NCT01229267|3773463|FG000|COMPLETED|Overall Study||108
3053087|NCT01229267|3773464|FG001|COMPLETED|Overall Study||102
3053088|NCT01229267|3773465|FG002|COMPLETED|Overall Study||101
3053089|NCT01229267|3773466|FG003|COMPLETED|Overall Study||71
3053090|NCT01229267|3773467|FG004|COMPLETED|Overall Study||344
3053091|NCT01229267|3773463|FG000|NOT COMPLETED|Overall Study||81
3053092|NCT01229267|3773464|FG001|NOT COMPLETED|Overall Study||82
3053093|NCT01229267|3773465|FG002|NOT COMPLETED|Overall Study||86
3053094|NCT01229267|3773466|FG003|NOT COMPLETED|Overall Study||35
3053095|NCT01229267|3773467|FG004|NOT COMPLETED|Overall Study||220
3053096|NCT01229371|3773478|FG000|STARTED|Overall Study||109
3053097|NCT01229371|3773479|FG001|STARTED|Overall Study||111
3053098|NCT01229371|3773480|FG002|STARTED|Overall Study||110
3053099|NCT01229371|3773481|FG003|STARTED|Overall Study||110
3053100|NCT01229371|3773478|FG000|COMPLETED|Overall Study||109
3053101|NCT01229371|3773479|FG001|COMPLETED|Overall Study||110
3053102|NCT01229371|3773480|FG002|COMPLETED|Overall Study||110
3053103|NCT01229371|3773481|FG003|COMPLETED|Overall Study||110
3053104|NCT01229371|3773478|FG000|NOT COMPLETED|Overall Study||0
3053105|NCT01229371|3773479|FG001|NOT COMPLETED|Overall Study||1
3053106|NCT01229371|3773480|FG002|NOT COMPLETED|Overall Study||0
3053107|NCT01229371|3773481|FG003|NOT COMPLETED|Overall Study||0
3053108|NCT01229397|3773493|FG000|STARTED|Overall Study||103
3053109|NCT01229397|3773494|FG001|STARTED|Overall Study||102
3053110|NCT01229397|3773493|FG000|COMPLETED|Overall Study||92
3053111|NCT01229397|3773494|FG001|COMPLETED|Overall Study||93
3053112|NCT01229397|3773493|FG000|NOT COMPLETED|Overall Study||11
3053113|NCT01229397|3773494|FG001|NOT COMPLETED|Overall Study||9
3053114|NCT01229410|3773506|FG000|STARTED|Overall Study||12
3053115|NCT01229410|3773507|FG001|STARTED|Overall Study||12
3053116|NCT01229410|3773506|FG000|COMPLETED|Overall Study||7
3053117|NCT01229410|3773507|FG001|COMPLETED|Overall Study||9
3053118|NCT01229410|3773506|FG000|NOT COMPLETED|Overall Study||5
3053119|NCT01229410|3773507|FG001|NOT COMPLETED|Overall Study||3
3053120|NCT01229423|3773513|FG000|STARTED|Overall Study||62
3053121|NCT01229423|3773513|FG000|COMPLETED|Overall Study||47
3053122|NCT01229423|3773513|FG000|NOT COMPLETED|Overall Study||15
3053123|NCT01229436|3773517|FG000|STARTED|Overall Study||254
3053124|NCT01229436|3773517|FG000|COMPLETED|Overall Study||249
3053125|NCT01229436|3773517|FG000|NOT COMPLETED|Overall Study||5
3053126|NCT01229449|3773526|FG000|STARTED|Overall Study||173
3053127|NCT01229449|3773527|FG001|STARTED|Overall Study||168
3053128|NCT01229449|3773528|FG002|STARTED|Overall Study||169
3053129|NCT01229449|3773529|FG003|STARTED|Overall Study||113
3053130|NCT01229449|3773530|FG004|STARTED|Overall Study||55
3053131|NCT01229449|3773526|FG000|COMPLETED|Overall Study||172
3053132|NCT01229449|3773527|FG001|COMPLETED|Overall Study||164
3053133|NCT01229449|3773528|FG002|COMPLETED|Overall Study||167
3053134|NCT01229449|3773529|FG003|COMPLETED|Overall Study||112
3053135|NCT01229449|3773530|FG004|COMPLETED|Overall Study||54
3053136|NCT01229449|3773526|FG000|NOT COMPLETED|Overall Study||1
3053137|NCT01229449|3773527|FG001|NOT COMPLETED|Overall Study||4
3053138|NCT01229449|3773528|FG002|NOT COMPLETED|Overall Study||2
3053139|NCT01229449|3773529|FG003|NOT COMPLETED|Overall Study||1
3053140|NCT01229449|3773530|FG004|NOT COMPLETED|Overall Study||1
3053141|NCT01229462|3773544|FG000|STARTED|Overall Study||120
3053142|NCT01229462|3773545|FG001|STARTED|Overall Study||118
3053143|NCT01229462|3773544|FG000|COMPLETED|Overall Study||115
3053144|NCT01229462|3773545|FG001|COMPLETED|Overall Study||109
3053145|NCT01229462|3773544|FG000|NOT COMPLETED|Overall Study||5
3053146|NCT01229462|3773545|FG001|NOT COMPLETED|Overall Study||9
3053147|NCT01229527|3773554|FG000|STARTED|Overall Study||30
3053148|NCT01229527|3773555|FG001|STARTED|Overall Study||30
3053149|NCT01229527|3773556|FG002|STARTED|Overall Study||30
3053150|NCT01229527|3773554|FG000|COMPLETED|Overall Study||30
3053151|NCT01229527|3773555|FG001|COMPLETED|Overall Study||30
3053152|NCT01229527|3773556|FG002|COMPLETED|Overall Study||30
3053153|NCT01229527|3773554|FG000|NOT COMPLETED|Overall Study||0
3053154|NCT01229527|3773555|FG001|NOT COMPLETED|Overall Study||0
3053155|NCT01229527|3773556|FG002|NOT COMPLETED|Overall Study||0
3053156|NCT01229722|3773566|FG000|STARTED|Overall Study||36
3053157|NCT01229722|3773567|FG001|STARTED|Overall Study||34
3053158|NCT01229722|3773566|FG000|COMPLETED|Overall Study||36
3053159|NCT01229722|3773567|FG001|COMPLETED|Overall Study||30
3053160|NCT01229722|3773566|FG000|NOT COMPLETED|Overall Study||0
3053161|NCT01229722|3773567|FG001|NOT COMPLETED|Overall Study||4
3053162|NCT01229735|3773579|FG000|STARTED|Overall Study||177
3053163|NCT01229735|3773580|FG001|STARTED|Overall Study||166
3053164|NCT01229735|3773579|FG000|COMPLETED|Overall Study||111
3053165|NCT01229735|3773580|FG001|COMPLETED|Overall Study||100
3053166|NCT01229735|3773579|FG000|NOT COMPLETED|Overall Study||66
3053167|NCT01229735|3773580|FG001|NOT COMPLETED|Overall Study||66
3053168|NCT01229891|3773591|FG000|STARTED|Overall Study||30
3053169|NCT01229891|3773592|FG001|STARTED|Overall Study||30
3053170|NCT01229891|3773593|FG002|STARTED|Overall Study||30
3053171|NCT01229891|3773591|FG000|COMPLETED|Overall Study||30
3053172|NCT01229891|3773592|FG001|COMPLETED|Overall Study||30
3053173|NCT01229891|3773593|FG002|COMPLETED|Overall Study||30
3053174|NCT01229891|3773591|FG000|NOT COMPLETED|Overall Study||0
3053175|NCT01229891|3773592|FG001|NOT COMPLETED|Overall Study||0
3053176|NCT01229891|3773593|FG002|NOT COMPLETED|Overall Study||0
3053177|NCT01229943|3773603|FG000|STARTED|Overall Study||75
3053178|NCT01229943|3773604|FG001|STARTED|Overall Study||75
3283719|NCT02759016|4017516|FG001|Treated With BI 836826 and Ibrutinib|Overall Study||3
3283720|NCT02759016|4017515|FG000|COMPLETED|Overall Study||0
3283721|NCT02759016|4017516|FG001|COMPLETED|Overall Study||0
3053179|NCT01229943|3773603|FG000|COMPLETED|Overall Study||57
3053180|NCT01229943|3773604|FG001|COMPLETED|Overall Study||58
3053181|NCT01229943|3773603|FG000|NOT COMPLETED|Overall Study||18
3053182|NCT01229943|3773604|FG001|NOT COMPLETED|Overall Study||17
3053183|NCT01230021|3773612|FG000|STARTED|Overall Study||6
3053184|NCT01230021|3773612|FG000|COMPLETED|Overall Study||6
3053185|NCT01230021|3773612|FG000|NOT COMPLETED|Overall Study||0
3053186|NCT01230060|3773616|FG000|STARTED|Overall Study||122
3053187|NCT01230060|3773616|FG000|COMPLETED|Overall Study||121
3053188|NCT01230060|3773616|FG000|NOT COMPLETED|Overall Study||1
3053189|NCT01230125|3773622|FG000|STARTED|Overall Study||207
3053190|NCT01230125|3773623|FG001|STARTED|Overall Study||104
3053191|NCT01230125|3773622|FG000|COMPLETED|Overall Study||134
3053192|NCT01230125|3773623|FG001|COMPLETED|Overall Study||54
3053193|NCT01230125|3773622|FG000|NOT COMPLETED|Overall Study||73
3053194|NCT01230125|3773623|FG001|NOT COMPLETED|Overall Study||50
3053195|NCT01230177|3773629|FG000|STARTED|Overall Study||3
3053196|NCT01230177|3773629|FG000|COMPLETED|Overall Study||3
3160803|NCT01867216|3887986|FG004|STARTED|Overall Study||9
3160804|NCT01867216|3887987|FG005|STARTED|Overall Study||8
3160805|NCT01867216|3887988|FG006|STARTED|Overall Study||9
3160806|NCT01867216|3887982|FG000|Received Study Drug|Overall Study||14
3160807|NCT01867216|3887983|FG001|Received Study Drug|Overall Study||8
3160808|NCT01867216|3887984|FG002|Received Study Drug|Overall Study||8
3160809|NCT01867216|3887985|FG003|Received Study Drug|Overall Study||8
3160810|NCT01867216|3887986|FG004|Received Study Drug|Overall Study||9
3160811|NCT01867216|3887987|FG005|Received Study Drug|Overall Study||8
3160812|NCT01867216|3887988|FG006|Received Study Drug|Overall Study||9
3160813|NCT01867216|3887982|FG000|COMPLETED|Overall Study||12
3160814|NCT01867216|3887983|FG001|COMPLETED|Overall Study||8
3160815|NCT01867216|3887984|FG002|COMPLETED|Overall Study||8
3160816|NCT01867216|3887985|FG003|COMPLETED|Overall Study||8
3160817|NCT01867216|3887986|FG004|COMPLETED|Overall Study||8
3160818|NCT01867216|3887987|FG005|COMPLETED|Overall Study||8
3160819|NCT01867216|3887988|FG006|COMPLETED|Overall Study||8
3160820|NCT01867216|3887982|FG000|NOT COMPLETED|Overall Study||4
3160821|NCT01867216|3887983|FG001|NOT COMPLETED|Overall Study||0
3160822|NCT01867216|3887984|FG002|NOT COMPLETED|Overall Study||0
3160823|NCT01867216|3887985|FG003|NOT COMPLETED|Overall Study||0
3283722|NCT02759016|4017515|FG000|NOT COMPLETED|Overall Study||4
3053197|NCT01230177|3773629|FG000|NOT COMPLETED|Overall Study||0
3053198|NCT01230424|3773635|FG000|STARTED|Overall Study||70
3053199|NCT01230424|3773636|FG001|STARTED|Overall Study||70
3053200|NCT01230424|3773635|FG000|COMPLETED|Overall Study||70
3053201|NCT01230424|3773636|FG001|COMPLETED|Overall Study||70
3053202|NCT01230424|3773635|FG000|NOT COMPLETED|Overall Study||0
3053203|NCT01230424|3773636|FG001|NOT COMPLETED|Overall Study||0
3053204|NCT01230502|3773648|FG000|STARTED|Overall Study||9
3160824|NCT01867216|3887986|FG004|NOT COMPLETED|Overall Study||1
3160825|NCT01867216|3887987|FG005|NOT COMPLETED|Overall Study||0
3160826|NCT01867216|3887988|FG006|NOT COMPLETED|Overall Study||1
3160827|NCT01867294|3888014|FG000|STARTED|Overall Study||9
3160828|NCT01867294|3888015|FG001|STARTED|Overall Study||10
3053205|NCT01230502|3773649|FG001|STARTED|Overall Study||0
3053206|NCT01230502|3773650|FG002|STARTED|Overall Study||0
3053207|NCT01230502|3773648|FG000|COMPLETED|Overall Study||9
3053208|NCT01230502|3773649|FG001|COMPLETED|Overall Study||0
3053209|NCT01230502|3773650|FG002|COMPLETED|Overall Study||0
3053210|NCT01230502|3773648|FG000|NOT COMPLETED|Overall Study||0
3053211|NCT01230502|3773649|FG001|NOT COMPLETED|Overall Study||0
3053212|NCT01230502|3773650|FG002|NOT COMPLETED|Overall Study||0
3053213|NCT01230554|3773661|FG000|STARTED|Overall Study||212
3053214|NCT01230554|3773661|FG000|COMPLETED|Overall Study||209
3053215|NCT01230554|3773661|FG000|NOT COMPLETED|Overall Study||3
3053216|NCT01230593|3773668|FG000|STARTED|Overall Study||50
3053217|NCT01230593|3773669|FG001|STARTED|Overall Study||50
3053218|NCT01230593|3773670|FG002|STARTED|Overall Study||50
3053219|NCT01230593|3773668|FG000|COMPLETED|Overall Study||35
3053220|NCT01230593|3773669|FG001|COMPLETED|Overall Study||32
3053221|NCT01230593|3773670|FG002|COMPLETED|Overall Study||38
3053222|NCT01230593|3773668|FG000|NOT COMPLETED|Overall Study||15
3053223|NCT01230593|3773669|FG001|NOT COMPLETED|Overall Study||18
3053224|NCT01230593|3773670|FG002|NOT COMPLETED|Overall Study||12
3053225|NCT01230710|3773678|FG000|STARTED|Overall Study||51
3053226|NCT01230710|3773678|FG000|COMPLETED|Overall Study||2
3053227|NCT01230710|3773678|FG000|NOT COMPLETED|Overall Study||49
3053228|NCT01230749|3773686|FG000|STARTED|Overall Study||22
3053229|NCT01230749|3773687|FG001|STARTED|Overall Study||22
3053230|NCT01230749|3773688|FG002|STARTED|Overall Study||23
3053231|NCT01230749|3773689|FG003|STARTED|Overall Study||22
3053232|NCT01230749|3773686|FG000|COMPLETED|Overall Study||22
3053233|NCT01230749|3773687|FG001|COMPLETED|Overall Study||20
3053234|NCT01230749|3773688|FG002|COMPLETED|Overall Study||21
3053235|NCT01230749|3773689|FG003|COMPLETED|Overall Study||20
3053236|NCT01230749|3773686|FG000|NOT COMPLETED|Overall Study||0
3053237|NCT01230749|3773687|FG001|NOT COMPLETED|Overall Study||2
3053238|NCT01230749|3773688|FG002|NOT COMPLETED|Overall Study||2
3053239|NCT01230749|3773689|FG003|NOT COMPLETED|Overall Study||2
3053240|NCT01230801|3773705|FG000|STARTED|Overall Study||3
3053241|NCT01230801|3773706|FG001|STARTED|Overall Study||3
3053242|NCT01230801|3773707|FG002|STARTED|Overall Study||16
3053243|NCT01230801|3773705|FG000|COMPLETED|Overall Study||3
3053244|NCT01230801|3773706|FG001|COMPLETED|Overall Study||3
3053245|NCT01230801|3773707|FG002|COMPLETED|Overall Study||15
3053246|NCT01230801|3773705|FG000|NOT COMPLETED|Overall Study||0
3053247|NCT01230801|3773706|FG001|NOT COMPLETED|Overall Study||0
3053248|NCT01230801|3773707|FG002|NOT COMPLETED|Overall Study||1
3053249|NCT01230814|3773720|FG000|STARTED|Overall Study||118
3053250|NCT01230814|3773721|FG001|STARTED|Overall Study||116
3053251|NCT01230814|3773720|FG000|COMPLETED|Overall Study||105
3053252|NCT01230814|3773721|FG001|COMPLETED|Overall Study||112
3053253|NCT01230814|3773720|FG000|NOT COMPLETED|Overall Study||13
3053254|NCT01230814|3773721|FG001|NOT COMPLETED|Overall Study||4
3053255|NCT01230827|3773731|FG000|STARTED|Overall Study||19
3053256|NCT01230827|3773732|FG001|STARTED|Overall Study||11
3053257|NCT01230827|3773733|FG002|STARTED|Overall Study||65
3053258|NCT01230827|3773734|FG003|STARTED|Overall Study||78
3053259|NCT01230827|3773731|FG000|COMPLETED|Overall Study||0
3053260|NCT01230827|3773732|FG001|COMPLETED|Overall Study||0
3053261|NCT01230827|3773733|FG002|COMPLETED|Overall Study||0
3053262|NCT01230827|3773734|FG003|COMPLETED|Overall Study||0
3053263|NCT01230827|3773731|FG000|NOT COMPLETED|Overall Study||19
3053264|NCT01230827|3773732|FG001|NOT COMPLETED|Overall Study||11
3053265|NCT01230827|3773733|FG002|NOT COMPLETED|Overall Study||65
3053266|NCT01230827|3773734|FG003|NOT COMPLETED|Overall Study||78
3053267|NCT01230892|3773744|FG000|STARTED|Overall Study||15
3053268|NCT01230892|3773745|FG001|STARTED|Overall Study||14
3053269|NCT01230892|3773744|FG000|COMPLETED|Overall Study||12
3053270|NCT01230892|3773745|FG001|COMPLETED|Overall Study||13
3053271|NCT01230892|3773744|FG000|NOT COMPLETED|Overall Study||3
3053272|NCT01230892|3773745|FG001|NOT COMPLETED|Overall Study||1
3053273|NCT01230931|3773753|FG000|STARTED|Overall Study||10
3053274|NCT01230931|3773754|FG001|STARTED|Overall Study||10
3053275|NCT01230931|3773753|FG000|COMPLETED|Overall Study||10
3053276|NCT01230931|3773754|FG001|COMPLETED|Overall Study||10
3053277|NCT01230931|3773753|FG000|NOT COMPLETED|Overall Study||0
3053278|NCT01230931|3773754|FG001|NOT COMPLETED|Overall Study||0
3053279|NCT01231230|3773761|FG000|STARTED|Overall Study||14
3053280|NCT01231230|3773761|FG000|Fluticasone|Overall Study||14
3053281|NCT01231230|3773761|FG000|Salmeterol|Overall Study||14
3053282|NCT01231230|3773761|FG000|Fluticasone/Salmeterol|Overall Study||14
3053283|NCT01231230|3773761|FG000|Placebo|Overall Study||14
3053284|NCT01231230|3773761|FG000|COMPLETED|Overall Study||14
3053285|NCT01231230|3773761|FG000|NOT COMPLETED|Overall Study||0
3053286|NCT01231321|3773771|FG000|STARTED|Overall Study||100
3053287|NCT01231321|3773771|FG000|COMPLETED|Overall Study||95
3053288|NCT01231321|3773771|FG000|NOT COMPLETED|Overall Study||5
3053289|NCT01231334|3773783|FG000|STARTED|Overall Study||145
3053290|NCT01231334|3773784|FG001|STARTED|Overall Study||141
3053291|NCT01231334|3773783|FG000|COMPLETED|Overall Study||126
3053292|NCT01231334|3773784|FG001|COMPLETED|Overall Study||120
3053293|NCT01231334|3773783|FG000|NOT COMPLETED|Overall Study||19
3053294|NCT01231334|3773784|FG001|NOT COMPLETED|Overall Study||21
3053295|NCT01231373|3773794|FG000|STARTED|Overall Study||59
3053296|NCT01231373|3773795|FG001|STARTED|Overall Study||58
3053297|NCT01231373|3773796|FG002|STARTED|Overall Study||60
3053298|NCT01231373|3773797|FG003|STARTED|Overall Study||58
3053299|NCT01231373|3773794|FG000|Patients Receiving Blinded Treatment|Overall Study||57
3053300|NCT01231373|3773795|FG001|Patients Receiving Blinded Treatment|Overall Study||57
3053301|NCT01231373|3773796|FG002|Patients Receiving Blinded Treatment|Overall Study||60
3053302|NCT01231373|3773797|FG003|Patients Receiving Blinded Treatment|Overall Study||58
3053303|NCT01231373|3773794|FG000|COMPLETED|Overall Study||56
3053304|NCT01231373|3773795|FG001|COMPLETED|Overall Study||57
3053305|NCT01231373|3773796|FG002|COMPLETED|Overall Study||60
3053306|NCT01231373|3773797|FG003|COMPLETED|Overall Study||57
3053307|NCT01231373|3773794|FG000|NOT COMPLETED|Overall Study||3
3053308|NCT01231373|3773795|FG001|NOT COMPLETED|Overall Study||1
3053309|NCT01231373|3773796|FG002|NOT COMPLETED|Overall Study||0
3053310|NCT01231373|3773797|FG003|NOT COMPLETED|Overall Study||1
3053311|NCT01231399|3773809|FG000|STARTED|Overall Study||6
3053312|NCT01231399|3773809|FG000|COMPLETED|Overall Study||6
3053313|NCT01231399|3773809|FG000|NOT COMPLETED|Overall Study||0
3053314|NCT01231412|3773817|FG000|STARTED|Overall Study||77
3053315|NCT01231412|3773818|FG001|STARTED|Overall Study||91
3053316|NCT01231412|3773819|FG002|STARTED|Overall Study||6
3053317|NCT01231412|3773817|FG000|COMPLETED|Overall Study||77
3053318|NCT01231412|3773818|FG001|COMPLETED|Overall Study||90
3053319|NCT01231412|3773819|FG002|COMPLETED|Overall Study||6
3160829|NCT01867294|3888016|FG002|STARTED|Overall Study||0
3160830|NCT01867294|3888017|FG003|STARTED|Overall Study||0
3160831|NCT01867294|3888014|FG000|COMPLETED|Overall Study||8
3160832|NCT01867294|3888015|FG001|COMPLETED|Overall Study||9
3160833|NCT01867294|3888016|FG002|COMPLETED|Overall Study||0
3160834|NCT01867294|3888017|FG003|COMPLETED|Overall Study||0
3160835|NCT01867294|3888014|FG000|NOT COMPLETED|Overall Study||1
3160836|NCT01867294|3888015|FG001|NOT COMPLETED|Overall Study||1
3160837|NCT01867294|3888016|FG002|NOT COMPLETED|Overall Study||0
3160838|NCT01867294|3888017|FG003|NOT COMPLETED|Overall Study||0
3160839|NCT01867307|3888027|FG000|STARTED|Overall Study|Started are the treated patients|18
3160840|NCT01867307|3888028|FG001|STARTED|Overall Study|Started are the treated patients|19
3160841|NCT01867307|3888027|FG000|COMPLETED|Overall Study||15
3160842|NCT01867307|3888028|FG001|COMPLETED|Overall Study||16
3160843|NCT01867307|3888027|FG000|NOT COMPLETED|Overall Study||3
3160844|NCT01867307|3888028|FG001|NOT COMPLETED|Overall Study||3
3160845|NCT01867424|3888036|FG000|STARTED|Overall Study||12
3160846|NCT01867424|3888037|FG001|STARTED|Overall Study||12
3160847|NCT01867424|3888036|FG000|COMPLETED|Overall Study||10
3160848|NCT01867424|3888037|FG001|COMPLETED|Overall Study||11
3160849|NCT01867424|3888036|FG000|NOT COMPLETED|Overall Study||2
3160850|NCT01867424|3888037|FG001|NOT COMPLETED|Overall Study||1
3160851|NCT01867515|3888046|FG000|STARTED|Overall Study||13
3160852|NCT01867515|3888047|FG001|STARTED|Overall Study||12
3160853|NCT01867515|3888048|FG002|STARTED|Overall Study||25
3160854|NCT01867515|3888046|FG000|COMPLETED|Overall Study||13
3283723|NCT02759016|4017516|FG001|NOT COMPLETED|Overall Study||3
3283724|NCT02759055|4017525|FG000|STARTED|Overall Study||12702
3053320|NCT01231412|3773817|FG000|NOT COMPLETED|Overall Study||0
3053321|NCT01231412|3773818|FG001|NOT COMPLETED|Overall Study||1
3053322|NCT01231412|3773819|FG002|NOT COMPLETED|Overall Study||0
3053323|NCT01231464|3773829|FG000|STARTED|Overall Study||182
3053324|NCT01231464|3773830|FG001|STARTED|Overall Study||183
3053325|NCT01231464|3773829|FG000|COMPLETED|Overall Study||177
3283725|NCT02759055|4017526|FG001|STARTED|Overall Study||8962
3283726|NCT02759055|4017525|FG000|COMPLETED|Overall Study||10775
3283727|NCT02759055|4017526|FG001|COMPLETED|Overall Study||7454
3283728|NCT02759055|4017525|FG000|NOT COMPLETED|Overall Study||1927
3053326|NCT01231464|3773830|FG001|COMPLETED|Overall Study||176
3053327|NCT01231464|3773829|FG000|NOT COMPLETED|Overall Study||5
3053328|NCT01231464|3773830|FG001|NOT COMPLETED|Overall Study||7
3053329|NCT01231503|3773846|FG000|STARTED|Overall Study||60
3053330|NCT01231503|3773847|FG001|STARTED|Overall Study||59
3053331|NCT01231503|3773848|FG002|STARTED|Overall Study||60
3053332|NCT01231503|3773849|FG003|STARTED|Overall Study||60
3053333|NCT01231503|3773850|FG004|STARTED|Overall Study||60
3053334|NCT01231503|3773851|FG005|STARTED|Overall Study||60
3053335|NCT01231503|3773852|FG006|STARTED|Overall Study||60
3053336|NCT01231503|3773853|FG007|STARTED|Overall Study||60
3053337|NCT01231503|3773846|FG000|COMPLETED|Overall Study||46
3053338|NCT01231503|3773847|FG001|COMPLETED|Overall Study||46
3053339|NCT01231503|3773848|FG002|COMPLETED|Overall Study||48
3053340|NCT01231503|3773849|FG003|COMPLETED|Overall Study||52
3053341|NCT01231503|3773850|FG004|COMPLETED|Overall Study||50
3053342|NCT01231503|3773851|FG005|COMPLETED|Overall Study||44
3053343|NCT01231503|3773852|FG006|COMPLETED|Overall Study||53
3053344|NCT01231503|3773853|FG007|COMPLETED|Overall Study||52
3053345|NCT01231503|3773846|FG000|NOT COMPLETED|Overall Study||14
3053346|NCT01231503|3773847|FG001|NOT COMPLETED|Overall Study||13
3053347|NCT01231503|3773848|FG002|NOT COMPLETED|Overall Study||12
3053348|NCT01231503|3773849|FG003|NOT COMPLETED|Overall Study||8
3053349|NCT01231503|3773850|FG004|NOT COMPLETED|Overall Study||10
3053350|NCT01231503|3773851|FG005|NOT COMPLETED|Overall Study||16
3053351|NCT01231503|3773852|FG006|NOT COMPLETED|Overall Study||7
3160855|NCT01867515|3888047|FG001|COMPLETED|Overall Study||11
3160856|NCT01867515|3888048|FG002|COMPLETED|Overall Study||14
3160857|NCT01867515|3888046|FG000|NOT COMPLETED|Overall Study||0
3160858|NCT01867515|3888047|FG001|NOT COMPLETED|Overall Study||1
3160859|NCT01867515|3888048|FG002|NOT COMPLETED|Overall Study||11
3160860|NCT01867580|3888058|FG000|STARTED|Overall Study||93
3053352|NCT01231503|3773853|FG007|NOT COMPLETED|Overall Study||8
3053353|NCT01231516|3773883|FG000|STARTED|48 Week Double-blind Phase||357
3053354|NCT01231516|3773884|FG001|STARTED|48 Week Double-blind Phase||362
3053355|NCT01231516|3773883|FG000|COMPLETED|48 Week Double-blind Phase||299
3053356|NCT01231516|3773884|FG001|COMPLETED|48 Week Double-blind Phase||283
3053357|NCT01231516|3773883|FG000|NOT COMPLETED|48 Week Double-blind Phase||58
3053358|NCT01231516|3773884|FG001|NOT COMPLETED|48 Week Double-blind Phase||79
3053359|NCT01231516|3773883|FG000|STARTED|Open-label Phase|4 participants completed the Double-blind Phase but did not enter the Open-label Phase.|295
3053360|NCT01231516|3773884|FG001|STARTED|Open-label Phase|256 participants completed the Double-blind Phase but did not enter the Open-label Phase.|27
3053361|NCT01231516|3773883|FG000|Ongoing at the Time of Analysis|Open-label Phase||282
3053362|NCT01231516|3773884|FG001|Ongoing at the Time of Analysis|Open-label Phase||23
3053363|NCT01231516|3773883|FG000|COMPLETED|Open-label Phase||0
3053364|NCT01231516|3773884|FG001|COMPLETED|Open-label Phase||1
3053365|NCT01231516|3773883|FG000|NOT COMPLETED|Open-label Phase||295
3053366|NCT01231516|3773884|FG001|NOT COMPLETED|Open-label Phase||26
3053367|NCT01231555|3773894|FG000|STARTED|Overall Study||8
3053368|NCT01231555|3773895|FG001|STARTED|Overall Study||7
3053369|NCT01231555|3773896|FG002|STARTED|Overall Study||8
3053370|NCT01231555|3773894|FG000|COMPLETED|Overall Study||0
3053371|NCT01231555|3773895|FG001|COMPLETED|Overall Study||0
3053372|NCT01231555|3773896|FG002|COMPLETED|Overall Study||0
3053373|NCT01231555|3773894|FG000|NOT COMPLETED|Overall Study||8
3053374|NCT01231555|3773895|FG001|NOT COMPLETED|Overall Study||7
3053375|NCT01231555|3773896|FG002|NOT COMPLETED|Overall Study||8
3053376|NCT01231581|3773906|FG000|STARTED|Overall Study||80
3160861|NCT01867580|3888059|FG001|STARTED|Overall Study||88
3160862|NCT01867580|3888058|FG000|COMPLETED|Overall Study||65
3160863|NCT01867580|3888059|FG001|COMPLETED|Overall Study||64
3160864|NCT01867580|3888058|FG000|NOT COMPLETED|Overall Study||28
3160865|NCT01867580|3888059|FG001|NOT COMPLETED|Overall Study||24
3160866|NCT01867632|3888067|FG000|STARTED|Overall Study||65
3160867|NCT01867632|3888068|FG001|STARTED|Overall Study||66
3160868|NCT01867632|3888067|FG000|COMPLETED|Overall Study||65
3160869|NCT01867632|3888068|FG001|COMPLETED|Overall Study||66
3053377|NCT01231581|3773907|FG001|STARTED|Overall Study||80
3053378|NCT01231581|3773906|FG000|Ongoing|Overall Study|Participant is continuing treatment with trametinib and gemcitabine under roll over study MEK114375.|1
3053379|NCT01231581|3773907|FG001|Ongoing|Overall Study||0
3053380|NCT01231581|3773906|FG000|COMPLETED|Overall Study||0
3053381|NCT01231581|3773907|FG001|COMPLETED|Overall Study||0
3053382|NCT01231581|3773906|FG000|NOT COMPLETED|Overall Study||80
3053383|NCT01231581|3773907|FG001|NOT COMPLETED|Overall Study||80
3053384|NCT01231607|3773918|FG000|STARTED|Overall Study||185
3053385|NCT01231607|3773919|FG001|STARTED|Overall Study||188
3053386|NCT01231607|3773920|FG002|STARTED|Overall Study||184
3053387|NCT01231607|3773921|FG003|STARTED|Overall Study||179
3053388|NCT01231607|3773922|FG004|STARTED|Overall Study||181
3283729|NCT02759055|4017526|FG001|NOT COMPLETED|Overall Study||1508
3283730|NCT02759120|4017534|FG000|STARTED|Overall Study||254
3283731|NCT02759120|4017535|FG001|STARTED|Overall Study||259
3283732|NCT02759120|4017534|FG000|COMPLETED|Overall Study||169
3053389|NCT01231607|3773918|FG000|COMPLETED|Overall Study||156
3053390|NCT01231607|3773919|FG001|COMPLETED|Overall Study||154
3053391|NCT01231607|3773920|FG002|COMPLETED|Overall Study||153
3053392|NCT01231607|3773921|FG003|COMPLETED|Overall Study||141
3053393|NCT01231607|3773922|FG004|COMPLETED|Overall Study||157
3053394|NCT01231607|3773918|FG000|NOT COMPLETED|Overall Study||29
3053395|NCT01231607|3773919|FG001|NOT COMPLETED|Overall Study||34
3053396|NCT01231607|3773920|FG002|NOT COMPLETED|Overall Study||31
3053397|NCT01231607|3773921|FG003|NOT COMPLETED|Overall Study||38
3053398|NCT01231607|3773922|FG004|NOT COMPLETED|Overall Study||24
3053399|NCT01231620|3773940|FG000|STARTED|Overall Study||201
3053400|NCT01231620|3773941|FG001|STARTED|Overall Study||209
3053401|NCT01231620|3773942|FG002|STARTED|Overall Study||205
3053402|NCT01231620|3773940|FG000|COMPLETED|Overall Study||175
3053403|NCT01231620|3773941|FG001|COMPLETED|Overall Study||178
3053404|NCT01231620|3773942|FG002|COMPLETED|Overall Study||166
3053405|NCT01231620|3773940|FG000|NOT COMPLETED|Overall Study||26
3053406|NCT01231620|3773941|FG001|NOT COMPLETED|Overall Study||31
3053407|NCT01231620|3773942|FG002|NOT COMPLETED|Overall Study||39
3053408|NCT01231633|3773952|FG000|STARTED|Overall Study||14
3053409|NCT01231633|3773953|FG001|STARTED|Overall Study||13
3053410|NCT01231633|3773952|FG000|COMPLETED|Overall Study||14
3053411|NCT01231633|3773953|FG001|COMPLETED|Overall Study||13
3160870|NCT01867632|3888067|FG000|NOT COMPLETED|Overall Study||0
3160871|NCT01867632|3888068|FG001|NOT COMPLETED|Overall Study||0
3160872|NCT01867658|3888074|FG000|STARTED|Overall Study||112
3160873|NCT01867658|3888074|FG000|COMPLETED|Overall Study||103
3283733|NCT02759120|4017535|FG001|COMPLETED|Overall Study||180
3283734|NCT02759120|4017534|FG000|NOT COMPLETED|Overall Study||85
3053412|NCT01231633|3773952|FG000|NOT COMPLETED|Overall Study||0
3053413|NCT01231633|3773953|FG001|NOT COMPLETED|Overall Study||0
3053414|NCT01231646|3773963|FG000|STARTED|Overall Study||28
3053415|NCT01231646|3773964|FG001|STARTED|Overall Study||10
3053416|NCT01231646|3773963|FG000|COMPLETED|Overall Study||28
3053417|NCT01231646|3773964|FG001|COMPLETED|Overall Study||10
3160874|NCT01867658|3888074|FG000|NOT COMPLETED|Overall Study||9
3160875|NCT01867671|3888080|FG000|STARTED|Overall Study||96
3160876|NCT01867671|3888081|FG001|STARTED|Overall Study||50
3160877|NCT01867671|3888080|FG000|COMPLETED|Overall Study||67
3160878|NCT01867671|3888081|FG001|COMPLETED|Overall Study||22
3160879|NCT01867671|3888080|FG000|NOT COMPLETED|Overall Study||29
3160880|NCT01867671|3888081|FG001|NOT COMPLETED|Overall Study||28
3160881|NCT01867710|3888091|FG000|STARTED|Overall Study||41
3160882|NCT01867710|3888092|FG001|STARTED|Overall Study||41
3160883|NCT01867710|3888093|FG002|STARTED|Overall Study||40
3160884|NCT01867710|3888094|FG003|STARTED|Overall Study||42
3160885|NCT01867710|3888091|FG000|Treated|Overall Study||41
3160886|NCT01867710|3888092|FG001|Treated|Overall Study||41
3160887|NCT01867710|3888093|FG002|Treated|Overall Study||39
3160888|NCT01867710|3888094|FG003|Treated|Overall Study||42
3160889|NCT01867710|3888091|FG000|COMPLETED|Overall Study||0
3160890|NCT01867710|3888092|FG001|COMPLETED|Overall Study||0
3160891|NCT01867710|3888093|FG002|COMPLETED|Overall Study||0
3053418|NCT01231646|3773963|FG000|NOT COMPLETED|Overall Study||0
3053419|NCT01231646|3773964|FG001|NOT COMPLETED|Overall Study||0
3053420|NCT01231659|3773970|FG000|STARTED|Overall Study||72
3053421|NCT01231659|3773970|FG000|Per Protocol (PP) Set|Overall Study||72
3053422|NCT01231659|3773970|FG000|Safety Set|Overall Study||72
3053423|NCT01231659|3773970|FG000|COMPLETED|Overall Study||0
3053424|NCT01231659|3773970|FG000|NOT COMPLETED|Overall Study||72
3053425|NCT01231841|3773974|FG000|STARTED|Overall Study||20
3053426|NCT01231841|3773974|FG000|COMPLETED|Overall Study||20
3053427|NCT01231841|3773974|FG000|NOT COMPLETED|Overall Study||0
3053428|NCT01231906|3773980|FG000|STARTED|Overall Study||319
3053429|NCT01231906|3773981|FG001|STARTED|Overall Study||323
3053430|NCT01231906|3773980|FG000|Received Therapy|Overall Study||308
3053431|NCT01231906|3773981|FG001|Received Therapy|Overall Study||318
3053432|NCT01231906|3773980|FG000|COMPLETED|Overall Study||198
3053433|NCT01231906|3773981|FG001|COMPLETED|Overall Study||222
3053434|NCT01231906|3773980|FG000|NOT COMPLETED|Overall Study||121
3053435|NCT01231906|3773981|FG001|NOT COMPLETED|Overall Study||101
3053436|NCT01231984|3773989|FG000|STARTED|Study Period 1||69
3053437|NCT01231984|3773990|FG001|STARTED|Study Period 1||70
3053438|NCT01231984|3773991|FG002|STARTED|Study Period 1||66
3053439|NCT01231984|3773992|FG003|STARTED|Study Period 1||69
3053440|NCT01231984|3773989|FG000|COMPLETED|Study Period 1||57
3053441|NCT01231984|3773990|FG001|COMPLETED|Study Period 1||63
3053442|NCT01231984|3773991|FG002|COMPLETED|Study Period 1||59
3053443|NCT01231984|3773992|FG003|COMPLETED|Study Period 1||60
3053444|NCT01231984|3773989|FG000|NOT COMPLETED|Study Period 1||12
3053445|NCT01231984|3773990|FG001|NOT COMPLETED|Study Period 1||7
3053446|NCT01231984|3773991|FG002|NOT COMPLETED|Study Period 1||7
3053447|NCT01231984|3773992|FG003|NOT COMPLETED|Study Period 1||9
3053448|NCT01231984|3773989|FG000|STARTED|Study Period 2||57
3053449|NCT01231984|3773990|FG001|STARTED|Study Period 2||63
3053450|NCT01231984|3773991|FG002|STARTED|Study Period 2||59
3053451|NCT01231984|3773992|FG003|STARTED|Study Period 2||60
3053452|NCT01231984|3773989|FG000|COMPLETED|Study Period 2||54
3053453|NCT01231984|3773990|FG001|COMPLETED|Study Period 2||61
3053454|NCT01231984|3773991|FG002|COMPLETED|Study Period 2||59
3053455|NCT01231984|3773992|FG003|COMPLETED|Study Period 2||56
3053456|NCT01231984|3773989|FG000|NOT COMPLETED|Study Period 2||3
3053457|NCT01231984|3773990|FG001|NOT COMPLETED|Study Period 2||2
3053458|NCT01231984|3773991|FG002|NOT COMPLETED|Study Period 2||0
3053459|NCT01231984|3773992|FG003|NOT COMPLETED|Study Period 2||4
3053460|NCT01232127|3774010|FG000|STARTED|Period 1: Days 1-10|Participants who received treatment.|25
3053461|NCT01232127|3774011|FG001|STARTED|Period 1: Days 1-10||0
3053462|NCT01232127|3774012|FG002|STARTED|Period 1: Days 1-10||0
3053463|NCT01232127|3774010|FG000|COMPLETED|Period 1: Days 1-10||24
3053464|NCT01232127|3774011|FG001|COMPLETED|Period 1: Days 1-10||0
3053465|NCT01232127|3774012|FG002|COMPLETED|Period 1: Days 1-10||0
3053466|NCT01232127|3774010|FG000|NOT COMPLETED|Period 1: Days 1-10||1
3053467|NCT01232127|3774011|FG001|NOT COMPLETED|Period 1: Days 1-10||0
3053468|NCT01232127|3774012|FG002|NOT COMPLETED|Period 1: Days 1-10||0
3053469|NCT01232127|3774010|FG000|STARTED|Period 2: Days 11-17||0
3053470|NCT01232127|3774011|FG001|STARTED|Period 2: Days 11-17|Participants who received treatment.|24
3053471|NCT01232127|3774012|FG002|STARTED|Period 2: Days 11-17||0
3053472|NCT01232127|3774010|FG000|COMPLETED|Period 2: Days 11-17||0
3053473|NCT01232127|3774011|FG001|COMPLETED|Period 2: Days 11-17||24
3053474|NCT01232127|3774012|FG002|COMPLETED|Period 2: Days 11-17||0
3053475|NCT01232127|3774010|FG000|NOT COMPLETED|Period 2: Days 11-17||0
3053476|NCT01232127|3774011|FG001|NOT COMPLETED|Period 2: Days 11-17||0
3053477|NCT01232127|3774012|FG002|NOT COMPLETED|Period 2: Days 11-17||0
3053478|NCT01232127|3774010|FG000|STARTED|Period 3: Days 18-24||0
3053479|NCT01232127|3774011|FG001|STARTED|Period 3: Days 18-24||0
3053480|NCT01232127|3774012|FG002|STARTED|Period 3: Days 18-24|Participants who received treatment.|24
3053481|NCT01232127|3774010|FG000|COMPLETED|Period 3: Days 18-24||0
3053482|NCT01232127|3774011|FG001|COMPLETED|Period 3: Days 18-24||0
3053483|NCT01232127|3774012|FG002|COMPLETED|Period 3: Days 18-24||24
3053484|NCT01232127|3774010|FG000|NOT COMPLETED|Period 3: Days 18-24||0
3053485|NCT01232127|3774011|FG001|NOT COMPLETED|Period 3: Days 18-24||0
3053486|NCT01232127|3774012|FG002|NOT COMPLETED|Period 3: Days 18-24||0
3053487|NCT01232205|3774026|FG000|STARTED|Overall Study||52
3053488|NCT01232205|3774027|FG001|STARTED|Overall Study||58
3053489|NCT01232205|3774026|FG000|COMPLETED|Overall Study||49
3053490|NCT01232205|3774027|FG001|COMPLETED|Overall Study||55
3160892|NCT01867710|3888094|FG003|COMPLETED|Overall Study||0
3160893|NCT01867710|3888091|FG000|NOT COMPLETED|Overall Study||41
3053491|NCT01232205|3774026|FG000|NOT COMPLETED|Overall Study||3
3053492|NCT01232205|3774027|FG001|NOT COMPLETED|Overall Study||3
3053493|NCT01232283|3774035|FG000|STARTED|Placebo Controlled Phase (Weeks 0-16)||275
3053494|NCT01232283|3774036|FG001|STARTED|Placebo Controlled Phase (Weeks 0-16)||138
3053495|NCT01232283|3774037|FG002|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
3053496|NCT01232283|3774038|FG003|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
3053497|NCT01232283|3774039|FG004|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
3160894|NCT01867710|3888092|FG001|NOT COMPLETED|Overall Study||41
3160895|NCT01867710|3888093|FG002|NOT COMPLETED|Overall Study||40
3160896|NCT01867710|3888094|FG003|NOT COMPLETED|Overall Study||42
3160897|NCT01868009|3888104|FG000|STARTED|Period 1 (5-9 Days)||143
3160898|NCT01868009|3888105|FG001|STARTED|Period 1 (5-9 Days)||144
3160899|NCT01868009|3888104|FG000|COMPLETED|Period 1 (5-9 Days)||143
3160900|NCT01868009|3888105|FG001|COMPLETED|Period 1 (5-9 Days)||142
3160901|NCT01868009|3888104|FG000|NOT COMPLETED|Period 1 (5-9 Days)||0
3160902|NCT01868009|3888105|FG001|NOT COMPLETED|Period 1 (5-9 Days)||2
3160903|NCT01868009|3888104|FG000|STARTED|Period 2 (5-9 Days)||143
3160904|NCT01868009|3888105|FG001|STARTED|Period 2 (5-9 Days)||142
3160905|NCT01868009|3888104|FG000|COMPLETED|Period 2 (5-9 Days)||141
3160906|NCT01868009|3888105|FG001|COMPLETED|Period 2 (5-9 Days)||142
3160907|NCT01868009|3888104|FG000|NOT COMPLETED|Period 2 (5-9 Days)||2
3160908|NCT01868009|3888105|FG001|NOT COMPLETED|Period 2 (5-9 Days)||0
3053498|NCT01232283|3774040|FG005|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
3053499|NCT01232283|3774041|FG006|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
3053500|NCT01232283|3774042|FG007|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
3053501|NCT01232283|3774043|FG008|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
3053502|NCT01232283|3774044|FG009|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
3053503|NCT01232283|3774035|FG000|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)|1 protocol violation occurred|272
3053504|NCT01232283|3774036|FG001|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)|1 protocol violation occurred|136
3053505|NCT01232283|3774037|FG002|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
3053506|NCT01232283|3774038|FG003|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
3053507|NCT01232283|3774039|FG004|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
3053508|NCT01232283|3774040|FG005|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
3053509|NCT01232283|3774041|FG006|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
3053510|NCT01232283|3774042|FG007|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
3053511|NCT01232283|3774043|FG008|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
3053512|NCT01232283|3774044|FG009|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
3053513|NCT01232283|3774035|FG000|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||239
3053514|NCT01232283|3774036|FG001|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||112
3053515|NCT01232283|3774037|FG002|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
3053516|NCT01232283|3774038|FG003|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
3053517|NCT01232283|3774039|FG004|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
3053518|NCT01232283|3774040|FG005|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
3053519|NCT01232283|3774041|FG006|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
3053520|NCT01232283|3774042|FG007|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
3053521|NCT01232283|3774043|FG008|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
3053522|NCT01232283|3774044|FG009|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
3053523|NCT01232283|3774035|FG000|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||36
3053524|NCT01232283|3774036|FG001|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||26
3053525|NCT01232283|3774037|FG002|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
3053526|NCT01232283|3774038|FG003|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
3053527|NCT01232283|3774039|FG004|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
3053528|NCT01232283|3774040|FG005|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
3053529|NCT01232283|3774041|FG006|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
3053530|NCT01232283|3774042|FG007|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
3053531|NCT01232283|3774043|FG008|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
3053532|NCT01232283|3774044|FG009|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
3053533|NCT01232283|3774035|FG000|STARTED|Maintenance Phase (Weeks16-32)||0
3053534|NCT01232283|3774036|FG001|STARTED|Maintenance Phase (Weeks16-32)||0
3053535|NCT01232283|3774037|FG002|STARTED|Maintenance Phase (Weeks16-32)|5 participants discontinued after Week 16 but prior to entry into the Maintenance Phase|234
3053536|NCT01232283|3774038|FG003|STARTED|Maintenance Phase (Weeks16-32)|4 participants discontinued after Week 16 but prior to entry into the Maintenance Phase|108
3053537|NCT01232283|3774039|FG004|STARTED|Maintenance Phase (Weeks16-32)||0
3053538|NCT01232283|3774040|FG005|STARTED|Maintenance Phase (Weeks16-32)||0
3053539|NCT01232283|3774041|FG006|STARTED|Maintenance Phase (Weeks16-32)||0
3053540|NCT01232283|3774042|FG007|STARTED|Maintenance Phase (Weeks16-32)||0
3053541|NCT01232283|3774043|FG008|STARTED|Maintenance Phase (Weeks16-32)||0
3053542|NCT01232283|3774044|FG009|STARTED|Maintenance Phase (Weeks16-32)||0
3053543|NCT01232283|3774035|FG000|COMPLETED|Maintenance Phase (Weeks16-32)||0
3053544|NCT01232283|3774036|FG001|COMPLETED|Maintenance Phase (Weeks16-32)||0
3053545|NCT01232283|3774037|FG002|COMPLETED|Maintenance Phase (Weeks16-32)||194
3053546|NCT01232283|3774038|FG003|COMPLETED|Maintenance Phase (Weeks16-32)||100
3053547|NCT01232283|3774039|FG004|COMPLETED|Maintenance Phase (Weeks16-32)||0
3053548|NCT01232283|3774040|FG005|COMPLETED|Maintenance Phase (Weeks16-32)||0
3053549|NCT01232283|3774041|FG006|COMPLETED|Maintenance Phase (Weeks16-32)||0
3053550|NCT01232283|3774042|FG007|COMPLETED|Maintenance Phase (Weeks16-32)||0
3053551|NCT01232283|3774043|FG008|COMPLETED|Maintenance Phase (Weeks16-32)||0
3053552|NCT01232283|3774044|FG009|COMPLETED|Maintenance Phase (Weeks16-32)||0
3053553|NCT01232283|3774035|FG000|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
3053554|NCT01232283|3774036|FG001|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
3053555|NCT01232283|3774037|FG002|NOT COMPLETED|Maintenance Phase (Weeks16-32)||40
3053556|NCT01232283|3774038|FG003|NOT COMPLETED|Maintenance Phase (Weeks16-32)||8
3053557|NCT01232283|3774039|FG004|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
3053558|NCT01232283|3774040|FG005|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
3053559|NCT01232283|3774041|FG006|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
3053560|NCT01232283|3774042|FG007|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
3053561|NCT01232283|3774043|FG008|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
3053562|NCT01232283|3774044|FG009|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
3053563|NCT01232283|3774035|FG000|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
3053564|NCT01232283|3774036|FG001|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
3053565|NCT01232283|3774037|FG002|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
3053566|NCT01232283|3774038|FG003|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
3053567|NCT01232283|3774039|FG004|STARTED|Randomized Withdrawal Phase(Weeks 32-52)|4 participants discontinued after Week 32 but prior to entry into the Randomized Withdrawal Phase|62
3053568|NCT01232283|3774040|FG005|STARTED|Randomized Withdrawal Phase(Weeks 32-52)|13 participants discontinued after Week 32 but prior to entry into the Randomized Withdrawal Phase|61
3053569|NCT01232283|3774041|FG006|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||58
3053570|NCT01232283|3774042|FG007|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||96
3053571|NCT01232283|3774043|FG008|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
3053572|NCT01232283|3774044|FG009|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
3053573|NCT01232283|3774035|FG000|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
3053574|NCT01232283|3774036|FG001|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
3053575|NCT01232283|3774037|FG002|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
3053576|NCT01232283|3774038|FG003|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
3053577|NCT01232283|3774039|FG004|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
3053578|NCT01232283|3774040|FG005|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
3053579|NCT01232283|3774041|FG006|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||28
3160909|NCT01868022|3888120|FG000|STARTED|Overall Study||3
3160910|NCT01868022|3888121|FG001|STARTED|Overall Study||3
3160911|NCT01868022|3888122|FG002|STARTED|Overall Study||14
3160912|NCT01868022|3888123|FG003|STARTED|Overall Study||3
3053580|NCT01232283|3774042|FG007|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||17
3053581|NCT01232283|3774043|FG008|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
3053582|NCT01232283|3774044|FG009|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
3053583|NCT01232283|3774035|FG000|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
3053584|NCT01232283|3774036|FG001|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
3053585|NCT01232283|3774037|FG002|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
3053586|NCT01232283|3774038|FG003|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
3053587|NCT01232283|3774039|FG004|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||50
3053588|NCT01232283|3774040|FG005|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||56
3283735|NCT02759120|4017535|FG001|NOT COMPLETED|Overall Study||79
3283736|NCT02759146|4017547|FG000|STARTED|Week 1-4||57
3160913|NCT01868022|3888124|FG004|STARTED|Overall Study||3
3160914|NCT01868022|3888125|FG005|STARTED|Overall Study||3
3160915|NCT01868022|3888126|FG006|STARTED|Overall Study||3
3053589|NCT01232283|3774041|FG006|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||41
3053590|NCT01232283|3774042|FG007|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||84
3053591|NCT01232283|3774043|FG008|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
3053592|NCT01232283|3774044|FG009|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
3053593|NCT01232283|3774035|FG000|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
3053594|NCT01232283|3774036|FG001|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
3160916|NCT01868022|3888127|FG007|STARTED|Overall Study||25
3160917|NCT01868022|3888128|FG008|STARTED|Overall Study||8
3160918|NCT01868022|3888120|FG000|COMPLETED|Overall Study||3
3160919|NCT01868022|3888121|FG001|COMPLETED|Overall Study||3
3160920|NCT01868022|3888122|FG002|COMPLETED|Overall Study||13
3160921|NCT01868022|3888123|FG003|COMPLETED|Overall Study||2
3160922|NCT01868022|3888124|FG004|COMPLETED|Overall Study||1
3160923|NCT01868022|3888125|FG005|COMPLETED|Overall Study||2
3160924|NCT01868022|3888126|FG006|COMPLETED|Overall Study||3
3160925|NCT01868022|3888127|FG007|COMPLETED|Overall Study||16
3160926|NCT01868022|3888128|FG008|COMPLETED|Overall Study||6
3160927|NCT01868022|3888120|FG000|NOT COMPLETED|Overall Study||0
3160928|NCT01868022|3888121|FG001|NOT COMPLETED|Overall Study||0
3160929|NCT01868022|3888122|FG002|NOT COMPLETED|Overall Study||1
3053595|NCT01232283|3774037|FG002|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
3053596|NCT01232283|3774038|FG003|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
3053597|NCT01232283|3774039|FG004|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||12
3160930|NCT01868022|3888123|FG003|NOT COMPLETED|Overall Study||1
3160931|NCT01868022|3888124|FG004|NOT COMPLETED|Overall Study||2
3160932|NCT01868022|3888125|FG005|NOT COMPLETED|Overall Study||1
3160933|NCT01868022|3888126|FG006|NOT COMPLETED|Overall Study||0
3053598|NCT01232283|3774040|FG005|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||5
3053599|NCT01232283|3774041|FG006|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||17
3053600|NCT01232283|3774042|FG007|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||12
3053601|NCT01232283|3774043|FG008|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
3053602|NCT01232283|3774044|FG009|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
3053603|NCT01232283|3774035|FG000|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
3053604|NCT01232283|3774036|FG001|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
3053605|NCT01232283|3774037|FG002|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
3053606|NCT01232283|3774038|FG003|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
3053607|NCT01232283|3774039|FG004|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
3053608|NCT01232283|3774040|FG005|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
3053609|NCT01232283|3774041|FG006|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
3053610|NCT01232283|3774042|FG007|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
3053611|NCT01232283|3774043|FG008|STARTED|Long-Term Extension Phase (Weeks 52-260)||137
3053612|NCT01232283|3774044|FG009|STARTED|Long-Term Extension Phase (Weeks 52-260)||80
3053613|NCT01232283|3774035|FG000|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
3053614|NCT01232283|3774036|FG001|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
3053615|NCT01232283|3774037|FG002|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
3053616|NCT01232283|3774038|FG003|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
3283737|NCT02759146|4017548|FG001|STARTED|Week 1-4||36
3283738|NCT02759146|4017549|FG002|STARTED|Week 1-4||33
3283739|NCT02759146|4017550|FG003|STARTED|Week 1-4|One control participant could continue without the other after baseline.|44
3283740|NCT02759146|4017551|FG004|STARTED|Week 1-4||49
3283741|NCT02759146|4017552|FG005|STARTED|Week 1-4||30
3283742|NCT02759146|4017553|FG006|STARTED|Week 1-4||27
3053617|NCT01232283|3774039|FG004|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
3053618|NCT01232283|3774040|FG005|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
3053619|NCT01232283|3774041|FG006|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
3053620|NCT01232283|3774042|FG007|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
3053621|NCT01232283|3774043|FG008|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||29
3053622|NCT01232283|3774044|FG009|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||19
3283743|NCT02759146|4017547|FG000|COMPLETED|Week 1-4||56
3283744|NCT02759146|4017548|FG001|COMPLETED|Week 1-4||34
3283745|NCT02759146|4017549|FG002|COMPLETED|Week 1-4||32
3283746|NCT02759146|4017550|FG003|COMPLETED|Week 1-4||44
3283747|NCT02759146|4017551|FG004|COMPLETED|Week 1-4||49
3283748|NCT02759146|4017552|FG005|COMPLETED|Week 1-4||29
3283749|NCT02759146|4017553|FG006|COMPLETED|Week 1-4||26
3283750|NCT02759146|4017547|FG000|NOT COMPLETED|Week 1-4||1
3283751|NCT02759146|4017548|FG001|NOT COMPLETED|Week 1-4||2
3283752|NCT02759146|4017549|FG002|NOT COMPLETED|Week 1-4||1
3283753|NCT02759146|4017550|FG003|NOT COMPLETED|Week 1-4||0
3053623|NCT01232283|3774035|FG000|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
3053624|NCT01232283|3774036|FG001|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
3053625|NCT01232283|3774037|FG002|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
3053626|NCT01232283|3774038|FG003|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
3053627|NCT01232283|3774039|FG004|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
3053628|NCT01232283|3774040|FG005|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
3053629|NCT01232283|3774041|FG006|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
3053630|NCT01232283|3774042|FG007|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
3053631|NCT01232283|3774043|FG008|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||108
3053632|NCT01232283|3774044|FG009|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||61
3053633|NCT01232296|3774068|FG000|STARTED|Overall Study||82
3053634|NCT01232296|3774069|FG001|STARTED|Overall Study||83
3053635|NCT01232296|3774068|FG000|Full Analysis Set|Overall Study||82
3053636|NCT01232296|3774069|FG001|Full Analysis Set|Overall Study||83
3053637|NCT01232296|3774068|FG000|Safety Set|Overall Study|The Safety Set includes all patients who received at least one dose of study medication|79
3053638|NCT01232296|3774069|FG001|Safety Set|Overall Study||83
3053639|NCT01232296|3774068|FG000|COMPLETED|Overall Study||0
3053640|NCT01232296|3774069|FG001|COMPLETED|Overall Study||0
3053641|NCT01232296|3774068|FG000|NOT COMPLETED|Overall Study||82
3053642|NCT01232296|3774069|FG001|NOT COMPLETED|Overall Study||83
3053643|NCT01232452|3774077|FG000|STARTED|Overall Study||87
3053644|NCT01232452|3774078|FG001|STARTED|Overall Study||85
3053645|NCT01232452|3774077|FG000|Received at Least One Dose of Study Drug|Overall Study||85
3053646|NCT01232452|3774078|FG001|Received at Least One Dose of Study Drug|Overall Study||81
3053647|NCT01232452|3774077|FG000|COMPLETED|Overall Study||48
3053648|NCT01232452|3774078|FG001|COMPLETED|Overall Study||46
3053649|NCT01232452|3774077|FG000|NOT COMPLETED|Overall Study||39
3053650|NCT01232452|3774078|FG001|NOT COMPLETED|Overall Study||39
3053651|NCT01232465|3774086|FG000|STARTED|Overall Study||337
3053652|NCT01232465|3774087|FG001|STARTED|Overall Study||402
3053653|NCT01232465|3774086|FG000|COMPLETED|Overall Study||337
3053654|NCT01232465|3774087|FG001|COMPLETED|Overall Study||402
3053655|NCT01232465|3774086|FG000|NOT COMPLETED|Overall Study||0
3053656|NCT01232465|3774087|FG001|NOT COMPLETED|Overall Study||0
3283754|NCT02759146|4017551|FG004|NOT COMPLETED|Week 1-4||0
3283755|NCT02759146|4017552|FG005|NOT COMPLETED|Week 1-4||1
3283756|NCT02759146|4017553|FG006|NOT COMPLETED|Week 1-4||1
3283757|NCT02759146|4017547|FG000|STARTED|Week 5-8||56
3283758|NCT02759146|4017548|FG001|STARTED|Week 5-8||34
3053657|NCT01232491|3774095|FG000|STARTED|Overall Study||306
3053658|NCT01232491|3774096|FG001|STARTED|Overall Study||305
3053659|NCT01232491|3774095|FG000|Exposed (Safety Analysis Set)|Overall Study|One subject withdrew prior to exposure to trial drug.|305
3053660|NCT01232491|3774096|FG001|Exposed (Safety Analysis Set)|Overall Study|Four subjects withdrew prior to exposure to trial drug.|301
3053661|NCT01232491|3774095|FG000|COMPLETED|Overall Study||246
3053662|NCT01232491|3774096|FG001|COMPLETED|Overall Study||242
3053663|NCT01232491|3774095|FG000|NOT COMPLETED|Overall Study||60
3053664|NCT01232491|3774096|FG001|NOT COMPLETED|Overall Study||63
3053665|NCT01232504|3774105|FG000|STARTED|Overall Study||68
3053666|NCT01232504|3774106|FG001|STARTED|Overall Study||69
3053667|NCT01232504|3774107|FG002|STARTED|Overall Study||69
3053668|NCT01232504|3774105|FG000|COMPLETED|Overall Study||59
3053669|NCT01232504|3774106|FG001|COMPLETED|Overall Study||67
3053670|NCT01232504|3774107|FG002|COMPLETED|Overall Study||61
3053671|NCT01232504|3774105|FG000|NOT COMPLETED|Overall Study||9
3053672|NCT01232504|3774106|FG001|NOT COMPLETED|Overall Study||2
3053673|NCT01232504|3774107|FG002|NOT COMPLETED|Overall Study||8
3053674|NCT01232556|3774125|FG000|STARTED|Overall Study||166
3160934|NCT01868022|3888127|FG007|NOT COMPLETED|Overall Study||9
3160935|NCT01868022|3888128|FG008|NOT COMPLETED|Overall Study||2
3160936|NCT01868035|3888154|FG000|STARTED|Overall Study||15
3160937|NCT01868035|3888154|FG000|COMPLETED|Overall Study|These participants completed 10 years of follow-up.|8
3160938|NCT01868035|3888154|FG000|NOT COMPLETED|Overall Study||7
3160939|NCT01868074|3888160|FG000|STARTED|Overall Study||36
3053675|NCT01232556|3774126|FG001|STARTED|Overall Study||172
3053676|NCT01232556|3774125|FG000|Treated|Overall Study|One subject in this arm received rituximab only and was excluded from the safety population.|165
2940824|NCT00639002|3653053|FG000|NOT COMPLETED|Overall Study||13
2940825|NCT00639093|3653060|FG000|STARTED|Overall Study|45|45
2940826|NCT00639093|3653061|FG001|STARTED|Overall Study|46|46
2940827|NCT00639093|3653060|FG000|COMPLETED|Overall Study|45|45
2940828|NCT00639093|3653061|FG001|COMPLETED|Overall Study|46|46
2940829|NCT00639093|3653060|FG000|NOT COMPLETED|Overall Study||0
3053677|NCT01232556|3774126|FG001|Treated|Overall Study||167
3053678|NCT01232556|3774125|FG000|COMPLETED|Overall Study||7
3053679|NCT01232556|3774126|FG001|COMPLETED|Overall Study||1
3053680|NCT01232556|3774125|FG000|NOT COMPLETED|Overall Study||159
3053681|NCT01232556|3774126|FG001|NOT COMPLETED|Overall Study||171
3053682|NCT01232569|3774134|FG000|STARTED|Double-blind Treatment Period||438
3053683|NCT01232569|3774135|FG001|STARTED|Double-blind Treatment Period||218
3053684|NCT01232569|3774136|FG002|STARTED|Double-blind Treatment Period|There were no participants in this reporting group in this period.|0
3053685|NCT01232569|3774137|FG003|STARTED|Double-blind Treatment Period|There were no participants in this reporting group in this period.|0
3053686|NCT01232569|3774134|FG000|COMPLETED|Double-blind Treatment Period||410
3053687|NCT01232569|3774135|FG001|COMPLETED|Double-blind Treatment Period||209
3053688|NCT01232569|3774136|FG002|COMPLETED|Double-blind Treatment Period||0
3053689|NCT01232569|3774137|FG003|COMPLETED|Double-blind Treatment Period||0
3053690|NCT01232569|3774134|FG000|NOT COMPLETED|Double-blind Treatment Period||28
3053691|NCT01232569|3774135|FG001|NOT COMPLETED|Double-blind Treatment Period||9
3053692|NCT01232569|3774136|FG002|NOT COMPLETED|Double-blind Treatment Period||0
3160940|NCT01868074|3888161|FG001|STARTED|Overall Study||36
2940830|NCT00639093|3653061|FG001|NOT COMPLETED|Overall Study||0
2940831|NCT00639158|3653069|FG000|STARTED|Overall Study|All randomized subjects were treated.|272
3053693|NCT01232569|3774137|FG003|NOT COMPLETED|Double-blind Treatment Period||0
3053694|NCT01232569|3774134|FG000|STARTED|Open-label Extension Period|There were no participants in this reporting group in this period.|0
3053695|NCT01232569|3774135|FG001|STARTED|Open-label Extension Period|There were no participants in this reporting group in this period.|0
3053696|NCT01232569|3774136|FG002|STARTED|Open-label Extension Period|Some participants who completed the double-blind period did not enter the open-label period.|230
3053697|NCT01232569|3774137|FG003|STARTED|Open-label Extension Period|Some participants who completed the double-blind period did not enter the open-label period.|227
3053698|NCT01232569|3774134|FG000|COMPLETED|Open-label Extension Period||0
3053699|NCT01232569|3774135|FG001|COMPLETED|Open-label Extension Period||0
3053700|NCT01232569|3774136|FG002|COMPLETED|Open-label Extension Period||203
3053701|NCT01232569|3774137|FG003|COMPLETED|Open-label Extension Period||200
3053702|NCT01232569|3774134|FG000|NOT COMPLETED|Open-label Extension Period||0
3053703|NCT01232569|3774135|FG001|NOT COMPLETED|Open-label Extension Period||0
3053704|NCT01232569|3774136|FG002|NOT COMPLETED|Open-label Extension Period||27
3053705|NCT01232569|3774137|FG003|NOT COMPLETED|Open-label Extension Period||27
3053706|NCT01232738|3774146|FG000|STARTED|Overall Study||36
3053707|NCT01232738|3774146|FG000|COMPLETED|Overall Study||23
3053708|NCT01232738|3774146|FG000|NOT COMPLETED|Overall Study||13
3053709|NCT01232790|3774154|FG000|STARTED|Randomization||14
3053710|NCT01232790|3774155|FG001|STARTED|Randomization||14
3053711|NCT01232790|3774154|FG000|COMPLETED|Randomization||12
3053712|NCT01232790|3774155|FG001|COMPLETED|Randomization||12
3053713|NCT01232790|3774154|FG000|NOT COMPLETED|Randomization||2
3053714|NCT01232790|3774155|FG001|NOT COMPLETED|Randomization||2
3053715|NCT01232790|3774154|FG000|STARTED|Initial Assessment||12
3053716|NCT01232790|3774155|FG001|STARTED|Initial Assessment||12
3053717|NCT01232790|3774154|FG000|COMPLETED|Initial Assessment||12
3053718|NCT01232790|3774155|FG001|COMPLETED|Initial Assessment||11
3053719|NCT01232790|3774154|FG000|NOT COMPLETED|Initial Assessment||0
3160941|NCT01868074|3888160|FG000|COMPLETED|Overall Study||29
3160942|NCT01868074|3888161|FG001|COMPLETED|Overall Study||32
3053720|NCT01232790|3774155|FG001|NOT COMPLETED|Initial Assessment||1
3053721|NCT01232790|3774154|FG000|STARTED|First Crossover||12
3053722|NCT01232790|3774155|FG001|STARTED|First Crossover||11
3053723|NCT01232790|3774154|FG000|COMPLETED|First Crossover||11
3053724|NCT01232790|3774155|FG001|COMPLETED|First Crossover||11
3053725|NCT01232790|3774154|FG000|NOT COMPLETED|First Crossover||1
3053726|NCT01232790|3774155|FG001|NOT COMPLETED|First Crossover||0
3053727|NCT01232790|3774154|FG000|STARTED|Second Crossover||11
3053728|NCT01232790|3774155|FG001|STARTED|Second Crossover||11
3053729|NCT01232790|3774154|FG000|COMPLETED|Second Crossover||10
3053730|NCT01232790|3774155|FG001|COMPLETED|Second Crossover||9
3053731|NCT01232790|3774154|FG000|NOT COMPLETED|Second Crossover||1
3053732|NCT01232790|3774155|FG001|NOT COMPLETED|Second Crossover||2
3053733|NCT01232829|3774171|FG000|STARTED|Overall Study||18
3053734|NCT01232829|3774171|FG000|COMPLETED|Overall Study||18
3053735|NCT01232829|3774171|FG000|NOT COMPLETED|Overall Study||0
3053736|NCT01232868|3774177|FG000|STARTED|Overall Study||22
3053737|NCT01232868|3774178|FG001|STARTED|Overall Study||44
3053738|NCT01232868|3774177|FG000|COMPLETED|Overall Study||20
3053739|NCT01232868|3774178|FG001|COMPLETED|Overall Study||40
3053740|NCT01232868|3774177|FG000|NOT COMPLETED|Overall Study||2
3053741|NCT01232868|3774178|FG001|NOT COMPLETED|Overall Study||4
3053742|NCT01232894|3774186|FG000|STARTED|Overall Study||60
3053743|NCT01232894|3774187|FG001|STARTED|Overall Study||30
3053744|NCT01232894|3774186|FG000|Received Study Drug|Overall Study||59
3053745|NCT01232894|3774187|FG001|Received Study Drug|Overall Study||28
3053746|NCT01232894|3774186|FG000|COMPLETED|Overall Study||48
3053747|NCT01232894|3774187|FG001|COMPLETED|Overall Study||22
3053748|NCT01232894|3774186|FG000|NOT COMPLETED|Overall Study||12
3053749|NCT01232894|3774187|FG001|NOT COMPLETED|Overall Study||8
3053750|NCT01232920|3774195|FG000|STARTED|Overall Study||41
3053751|NCT01232920|3774196|FG001|STARTED|Overall Study||39
3053752|NCT01232920|3774195|FG000|COMPLETED|Overall Study||35
3053753|NCT01232920|3774196|FG001|COMPLETED|Overall Study||32
3053754|NCT01232920|3774195|FG000|NOT COMPLETED|Overall Study||6
3053755|NCT01232920|3774196|FG001|NOT COMPLETED|Overall Study||7
3053756|NCT01232946|3774205|FG000|STARTED|Overall Study||9
3160943|NCT01868074|3888160|FG000|NOT COMPLETED|Overall Study||7
3160944|NCT01868074|3888161|FG001|NOT COMPLETED|Overall Study||4
3160945|NCT01868165|3888167|FG000|STARTED|Overall Study||337
3160946|NCT01868165|3888167|FG000|COMPLETED|Overall Study||292
3160947|NCT01868165|3888167|FG000|NOT COMPLETED|Overall Study||45
3160948|NCT01868243|3888173|FG000|STARTED|Overall Study||15
3160949|NCT01868243|3888174|FG001|STARTED|Overall Study||12
3160950|NCT01868243|3888173|FG000|COMPLETED|Overall Study||15
3053757|NCT01232946|3774206|FG001|STARTED|Overall Study||10
3053758|NCT01232946|3774207|FG002|STARTED|Overall Study||11
3053759|NCT01232946|3774205|FG000|COMPLETED|Overall Study||9
3053760|NCT01232946|3774206|FG001|COMPLETED|Overall Study|1 participant died unrelated to study|9
3053761|NCT01232946|3774207|FG002|COMPLETED|Overall Study|2 withdrew after baseline measurements|9
3053762|NCT01232946|3774205|FG000|NOT COMPLETED|Overall Study||0
3160951|NCT01868243|3888174|FG001|COMPLETED|Overall Study||11
3053763|NCT01232946|3774206|FG001|NOT COMPLETED|Overall Study||1
3053764|NCT01232946|3774207|FG002|NOT COMPLETED|Overall Study||2
3053765|NCT01233050|3774217|FG000|STARTED|Overall Study||400
3053766|NCT01233050|3774218|FG001|STARTED|Overall Study||402
3053767|NCT01233050|3774217|FG000|COMPLETED|Overall Study|8 participants were excluded after treatment administered due to inclusion/exclusion criteria|392
3053768|NCT01233050|3774218|FG001|COMPLETED|Overall Study|6 participants were excluded after treatment administered due to inclusion/exclusion criteria|396
3053769|NCT01233050|3774217|FG000|NOT COMPLETED|Overall Study||8
3053770|NCT01233050|3774218|FG001|NOT COMPLETED|Overall Study||6
3053771|NCT01233076|3774224|FG000|STARTED|Period 1, One Week||30
3053772|NCT01233076|3774225|FG001|STARTED|Period 1, One Week||30
3053773|NCT01233076|3774224|FG000|COMPLETED|Period 1, One Week||30
3053774|NCT01233076|3774225|FG001|COMPLETED|Period 1, One Week||30
3053775|NCT01233076|3774224|FG000|NOT COMPLETED|Period 1, One Week||0
3053776|NCT01233076|3774225|FG001|NOT COMPLETED|Period 1, One Week||0
3053777|NCT01233076|3774224|FG000|STARTED|Period 2, One Week||30
3053778|NCT01233076|3774225|FG001|STARTED|Period 2, One Week||30
3053779|NCT01233076|3774224|FG000|COMPLETED|Period 2, One Week||29
3053780|NCT01233076|3774225|FG001|COMPLETED|Period 2, One Week||30
3053781|NCT01233076|3774224|FG000|NOT COMPLETED|Period 2, One Week||1
3053782|NCT01233076|3774225|FG001|NOT COMPLETED|Period 2, One Week||0
3053783|NCT01233232|3774234|FG000|STARTED|Overall Study||29
3053784|NCT01233232|3774235|FG001|STARTED|Overall Study||30
3053785|NCT01233232|3774236|FG002|STARTED|Overall Study||28
3053786|NCT01233232|3774234|FG000|COMPLETED|Overall Study||28
3053787|NCT01233232|3774235|FG001|COMPLETED|Overall Study||30
3053788|NCT01233232|3774236|FG002|COMPLETED|Overall Study||28
3053789|NCT01233232|3774234|FG000|NOT COMPLETED|Overall Study||1
3053790|NCT01233232|3774235|FG001|NOT COMPLETED|Overall Study||0
3053791|NCT01233232|3774236|FG002|NOT COMPLETED|Overall Study||0
3053792|NCT01233258|3774249|FG000|STARTED|First Intervention (6 Months)||11
3053793|NCT01233258|3774250|FG001|STARTED|First Intervention (6 Months)||10
3053794|NCT01233258|3774251|FG002|STARTED|First Intervention (6 Months)||14
3053795|NCT01233258|3774252|FG003|STARTED|First Intervention (6 Months)||16
3160952|NCT01868243|3888173|FG000|NOT COMPLETED|Overall Study||0
3160953|NCT01868243|3888174|FG001|NOT COMPLETED|Overall Study||1
3160954|NCT01868334|3888184|FG000|STARTED|Year 1 RCCT Study||13186
3160955|NCT01868334|3888185|FG001|STARTED|Year 1 RCCT Study||17185
3053796|NCT01233258|3774253|FG004|STARTED|First Intervention (6 Months)||16
3053797|NCT01233258|3774254|FG005|STARTED|First Intervention (6 Months)||16
3053798|NCT01233258|3774249|FG000|Participants Received Treatment|First Intervention (6 Months)||11
3283759|NCT02759146|4017549|FG002|STARTED|Week 5-8||32
3283760|NCT02759146|4017550|FG003|STARTED|Week 5-8||44
3053799|NCT01233258|3774250|FG001|Participants Received Treatment|First Intervention (6 Months)||10
3053800|NCT01233258|3774251|FG002|Participants Received Treatment|First Intervention (6 Months)||13
3053801|NCT01233258|3774252|FG003|Participants Received Treatment|First Intervention (6 Months)||15
3053802|NCT01233258|3774253|FG004|Participants Received Treatment|First Intervention (6 Months)||16
3053803|NCT01233258|3774254|FG005|Participants Received Treatment|First Intervention (6 Months)||15
3053804|NCT01233258|3774249|FG000|COMPLETED|First Intervention (6 Months)||10
3053805|NCT01233258|3774250|FG001|COMPLETED|First Intervention (6 Months)||10
3053806|NCT01233258|3774251|FG002|COMPLETED|First Intervention (6 Months)||13
3053807|NCT01233258|3774252|FG003|COMPLETED|First Intervention (6 Months)||15
3053808|NCT01233258|3774253|FG004|COMPLETED|First Intervention (6 Months)||16
3053809|NCT01233258|3774254|FG005|COMPLETED|First Intervention (6 Months)||15
3053810|NCT01233258|3774249|FG000|NOT COMPLETED|First Intervention (6 Months)||1
3053811|NCT01233258|3774250|FG001|NOT COMPLETED|First Intervention (6 Months)||0
3053812|NCT01233258|3774251|FG002|NOT COMPLETED|First Intervention (6 Months)||1
3053813|NCT01233258|3774252|FG003|NOT COMPLETED|First Intervention (6 Months)||1
3053814|NCT01233258|3774253|FG004|NOT COMPLETED|First Intervention (6 Months)||0
3053815|NCT01233258|3774254|FG005|NOT COMPLETED|First Intervention (6 Months)||1
3053816|NCT01233258|3774249|FG000|STARTED|Washout (2-3 Days)||10
3053817|NCT01233258|3774250|FG001|STARTED|Washout (2-3 Days)||10
3053818|NCT01233258|3774251|FG002|STARTED|Washout (2-3 Days)||13
3053819|NCT01233258|3774252|FG003|STARTED|Washout (2-3 Days)||15
3053820|NCT01233258|3774253|FG004|STARTED|Washout (2-3 Days)||16
3053821|NCT01233258|3774254|FG005|STARTED|Washout (2-3 Days)||15
3053822|NCT01233258|3774249|FG000|COMPLETED|Washout (2-3 Days)||10
3053823|NCT01233258|3774250|FG001|COMPLETED|Washout (2-3 Days)||10
3053824|NCT01233258|3774251|FG002|COMPLETED|Washout (2-3 Days)||13
3053825|NCT01233258|3774252|FG003|COMPLETED|Washout (2-3 Days)||15
3053826|NCT01233258|3774253|FG004|COMPLETED|Washout (2-3 Days)||16
3053827|NCT01233258|3774254|FG005|COMPLETED|Washout (2-3 Days)||15
3053828|NCT01233258|3774249|FG000|NOT COMPLETED|Washout (2-3 Days)||0
3053829|NCT01233258|3774250|FG001|NOT COMPLETED|Washout (2-3 Days)||0
3053830|NCT01233258|3774251|FG002|NOT COMPLETED|Washout (2-3 Days)||0
3053831|NCT01233258|3774252|FG003|NOT COMPLETED|Washout (2-3 Days)||0
3053832|NCT01233258|3774253|FG004|NOT COMPLETED|Washout (2-3 Days)||0
3053833|NCT01233258|3774254|FG005|NOT COMPLETED|Washout (2-3 Days)||0
3053834|NCT01233258|3774249|FG000|STARTED|Second Intervention (6 Months)||10
3053835|NCT01233258|3774250|FG001|STARTED|Second Intervention (6 Months)||10
3053836|NCT01233258|3774251|FG002|STARTED|Second Intervention (6 Months)||13
3053837|NCT01233258|3774252|FG003|STARTED|Second Intervention (6 Months)||15
3053838|NCT01233258|3774253|FG004|STARTED|Second Intervention (6 Months)||16
3053839|NCT01233258|3774254|FG005|STARTED|Second Intervention (6 Months)||15
3053840|NCT01233258|3774249|FG000|COMPLETED|Second Intervention (6 Months)||10
3053841|NCT01233258|3774250|FG001|COMPLETED|Second Intervention (6 Months)||10
3053842|NCT01233258|3774251|FG002|COMPLETED|Second Intervention (6 Months)||13
3053843|NCT01233258|3774252|FG003|COMPLETED|Second Intervention (6 Months)||15
3053844|NCT01233258|3774253|FG004|COMPLETED|Second Intervention (6 Months)||16
3053845|NCT01233258|3774254|FG005|COMPLETED|Second Intervention (6 Months)||15
3053846|NCT01233258|3774249|FG000|NOT COMPLETED|Second Intervention (6 Months)||0
3053847|NCT01233258|3774250|FG001|NOT COMPLETED|Second Intervention (6 Months)||0
3053848|NCT01233258|3774251|FG002|NOT COMPLETED|Second Intervention (6 Months)||0
3053849|NCT01233258|3774252|FG003|NOT COMPLETED|Second Intervention (6 Months)||0
3053850|NCT01233258|3774253|FG004|NOT COMPLETED|Second Intervention (6 Months)||0
3053851|NCT01233258|3774254|FG005|NOT COMPLETED|Second Intervention (6 Months)||0
3053852|NCT01233284|3774269|FG000|STARTED|Period 1 (4 Weeks)||37
3053853|NCT01233284|3774270|FG001|STARTED|Period 1 (4 Weeks)||38
3053854|NCT01233284|3774271|FG002|STARTED|Period 1 (4 Weeks)||38
3053855|NCT01233284|3774272|FG003|STARTED|Period 1 (4 Weeks)||35
3053856|NCT01233284|3774273|FG004|STARTED|Period 1 (4 Weeks)||1
3053857|NCT01233284|3774269|FG000|COMPLETED|Period 1 (4 Weeks)||36
3053858|NCT01233284|3774270|FG001|COMPLETED|Period 1 (4 Weeks)||37
3053859|NCT01233284|3774271|FG002|COMPLETED|Period 1 (4 Weeks)||37
3053860|NCT01233284|3774272|FG003|COMPLETED|Period 1 (4 Weeks)||35
3053861|NCT01233284|3774273|FG004|COMPLETED|Period 1 (4 Weeks)||1
3053862|NCT01233284|3774269|FG000|NOT COMPLETED|Period 1 (4 Weeks)||1
3053863|NCT01233284|3774270|FG001|NOT COMPLETED|Period 1 (4 Weeks)||1
3053864|NCT01233284|3774271|FG002|NOT COMPLETED|Period 1 (4 Weeks)||1
3053865|NCT01233284|3774272|FG003|NOT COMPLETED|Period 1 (4 Weeks)||0
3053866|NCT01233284|3774273|FG004|NOT COMPLETED|Period 1 (4 Weeks)||0
3053867|NCT01233284|3774269|FG000|STARTED|Period 2 (4 Weeks)||36
3053868|NCT01233284|3774270|FG001|STARTED|Period 2 (4 Weeks)||37
3053869|NCT01233284|3774271|FG002|STARTED|Period 2 (4 Weeks)||37
3053870|NCT01233284|3774272|FG003|STARTED|Period 2 (4 Weeks)||35
3053871|NCT01233284|3774273|FG004|STARTED|Period 2 (4 Weeks)||1
3053872|NCT01233284|3774269|FG000|COMPLETED|Period 2 (4 Weeks)||36
3053873|NCT01233284|3774270|FG001|COMPLETED|Period 2 (4 Weeks)||37
3053874|NCT01233284|3774271|FG002|COMPLETED|Period 2 (4 Weeks)||36
3283761|NCT02759146|4017551|FG004|STARTED|Week 5-8||49
3283762|NCT02759146|4017552|FG005|STARTED|Week 5-8||29
3160956|NCT01868334|3888186|FG002|STARTED|Year 1 RCCT Study||19274
3160957|NCT01868334|3888187|FG003|STARTED|Year 1 RCCT Study||20904
3160958|NCT01868334|3888184|FG000|COMPLETED|Year 1 RCCT Study||13186
3160959|NCT01868334|3888185|FG001|COMPLETED|Year 1 RCCT Study||17185
3053875|NCT01233284|3774272|FG003|COMPLETED|Period 2 (4 Weeks)||35
3053876|NCT01233284|3774273|FG004|COMPLETED|Period 2 (4 Weeks)||1
3053877|NCT01233284|3774269|FG000|NOT COMPLETED|Period 2 (4 Weeks)||0
3053878|NCT01233284|3774270|FG001|NOT COMPLETED|Period 2 (4 Weeks)||0
3053879|NCT01233284|3774271|FG002|NOT COMPLETED|Period 2 (4 Weeks)||1
3053880|NCT01233284|3774272|FG003|NOT COMPLETED|Period 2 (4 Weeks)||0
3053881|NCT01233284|3774273|FG004|NOT COMPLETED|Period 2 (4 Weeks)||0
3053882|NCT01233284|3774269|FG000|STARTED|Period 3 (4 Weeks)||36
3053883|NCT01233284|3774270|FG001|STARTED|Period 3 (4 Weeks)||37
3053884|NCT01233284|3774271|FG002|STARTED|Period 3 (4 Weeks)||36
3053885|NCT01233284|3774272|FG003|STARTED|Period 3 (4 Weeks)||35
3053886|NCT01233284|3774273|FG004|STARTED|Period 3 (4 Weeks)||1
3053887|NCT01233284|3774269|FG000|COMPLETED|Period 3 (4 Weeks)||36
3053888|NCT01233284|3774270|FG001|COMPLETED|Period 3 (4 Weeks)||37
3053889|NCT01233284|3774271|FG002|COMPLETED|Period 3 (4 Weeks)||35
3053890|NCT01233284|3774272|FG003|COMPLETED|Period 3 (4 Weeks)||34
3053891|NCT01233284|3774273|FG004|COMPLETED|Period 3 (4 Weeks)||1
3053892|NCT01233284|3774269|FG000|NOT COMPLETED|Period 3 (4 Weeks)||0
3053893|NCT01233284|3774270|FG001|NOT COMPLETED|Period 3 (4 Weeks)||0
3053894|NCT01233284|3774271|FG002|NOT COMPLETED|Period 3 (4 Weeks)||1
3053895|NCT01233284|3774272|FG003|NOT COMPLETED|Period 3 (4 Weeks)||1
3053896|NCT01233284|3774273|FG004|NOT COMPLETED|Period 3 (4 Weeks)||0
3053897|NCT01233284|3774269|FG000|STARTED|Period 4 (4 Weeks)||36
3053898|NCT01233284|3774270|FG001|STARTED|Period 4 (4 Weeks)||37
3053899|NCT01233284|3774271|FG002|STARTED|Period 4 (4 Weeks)||35
3053900|NCT01233284|3774272|FG003|STARTED|Period 4 (4 Weeks)||34
3053901|NCT01233284|3774273|FG004|STARTED|Period 4 (4 Weeks)||1
3053902|NCT01233284|3774269|FG000|COMPLETED|Period 4 (4 Weeks)||36
3053903|NCT01233284|3774270|FG001|COMPLETED|Period 4 (4 Weeks)||36
3053904|NCT01233284|3774271|FG002|COMPLETED|Period 4 (4 Weeks)||35
3053905|NCT01233284|3774272|FG003|COMPLETED|Period 4 (4 Weeks)||33
3053906|NCT01233284|3774273|FG004|COMPLETED|Period 4 (4 Weeks)||1
3053907|NCT01233284|3774269|FG000|NOT COMPLETED|Period 4 (4 Weeks)||0
3053908|NCT01233284|3774270|FG001|NOT COMPLETED|Period 4 (4 Weeks)||1
3053909|NCT01233284|3774271|FG002|NOT COMPLETED|Period 4 (4 Weeks)||0
3053910|NCT01233284|3774272|FG003|NOT COMPLETED|Period 4 (4 Weeks)||1
3053911|NCT01233284|3774273|FG004|NOT COMPLETED|Period 4 (4 Weeks)||0
3053912|NCT01233518|3774283|FG000|STARTED|Overall Study||285
3053913|NCT01233518|3774283|FG000|COMPLETED|Overall Study||252
3053914|NCT01233518|3774283|FG000|NOT COMPLETED|Overall Study||33
3053915|NCT01233609|3774290|FG000|STARTED|Overall Study||46
3053916|NCT01233609|3774291|FG001|STARTED|Overall Study||44
3053917|NCT01233609|3774290|FG000|COMPLETED|Overall Study||37
3053918|NCT01233609|3774291|FG001|COMPLETED|Overall Study||42
3053919|NCT01233609|3774290|FG000|NOT COMPLETED|Overall Study||9
3053920|NCT01233609|3774291|FG001|NOT COMPLETED|Overall Study||2
3053921|NCT01233687|3774305|FG000|STARTED|Phase I RP2D AMG 102 + Erlotinib||7
3053922|NCT01233687|3774305|FG000|COMPLETED|Phase I RP2D AMG 102 + Erlotinib||7
3053923|NCT01233687|3774305|FG000|NOT COMPLETED|Phase I RP2D AMG 102 + Erlotinib||0
3053924|NCT01233687|3774305|FG000|STARTED|Phase II AMG 102 + Erlotinib|Includes 7 participants from Phase 1 part of study.|49
3053925|NCT01233687|3774305|FG000|Response-Evaluable|Phase II AMG 102 + Erlotinib||45
3053926|NCT01233687|3774305|FG000|COMPLETED|Phase II AMG 102 + Erlotinib||45
3053927|NCT01233687|3774305|FG000|NOT COMPLETED|Phase II AMG 102 + Erlotinib||4
3053928|NCT01233726|3774312|FG000|STARTED|Overall Study||53
3053929|NCT01233726|3774313|FG001|STARTED|Overall Study||53
3053930|NCT01233726|3774314|FG002|STARTED|Overall Study||53
3053931|NCT01233726|3774312|FG000|COMPLETED|Overall Study||52
3053932|NCT01233726|3774313|FG001|COMPLETED|Overall Study||53
3053933|NCT01233726|3774314|FG002|COMPLETED|Overall Study||52
3053934|NCT01233726|3774312|FG000|NOT COMPLETED|Overall Study||1
3053935|NCT01233726|3774313|FG001|NOT COMPLETED|Overall Study||0
3053936|NCT01233726|3774314|FG002|NOT COMPLETED|Overall Study||1
3053937|NCT01233817|3774325|FG000|STARTED|Overall Study||12
3053938|NCT01233817|3774325|FG000|COMPLETED|Overall Study||9
3053939|NCT01233817|3774325|FG000|NOT COMPLETED|Overall Study||3
3053940|NCT01233869|3774333|FG000|STARTED|Initial Treatment Period (24 Months)||58
3053941|NCT01233869|3774334|FG001|STARTED|Initial Treatment Period (24 Months)||31
3053942|NCT01233869|3774335|FG002|STARTED|Initial Treatment Period (24 Months)||24
3053943|NCT01233869|3774336|FG003|STARTED|Initial Treatment Period (24 Months)||56
3053944|NCT01233869|3774333|FG000|COMPLETED|Initial Treatment Period (24 Months)||34
3053945|NCT01233869|3774334|FG001|COMPLETED|Initial Treatment Period (24 Months)||3
3053946|NCT01233869|3774335|FG002|COMPLETED|Initial Treatment Period (24 Months)||22
3053947|NCT01233869|3774336|FG003|COMPLETED|Initial Treatment Period (24 Months)||34
3053948|NCT01233869|3774333|FG000|NOT COMPLETED|Initial Treatment Period (24 Months)||24
3053949|NCT01233869|3774334|FG001|NOT COMPLETED|Initial Treatment Period (24 Months)||28
3053950|NCT01233869|3774335|FG002|NOT COMPLETED|Initial Treatment Period (24 Months)||2
3053951|NCT01233869|3774336|FG003|NOT COMPLETED|Initial Treatment Period (24 Months)||22
3053952|NCT01233869|3774333|FG000|STARTED|Washout Period 30 Days||34
3053953|NCT01233869|3774334|FG001|STARTED|Washout Period 30 Days||3
3160960|NCT01868334|3888186|FG002|COMPLETED|Year 1 RCCT Study||19274
3160961|NCT01868334|3888187|FG003|COMPLETED|Year 1 RCCT Study||20904
3053954|NCT01233869|3774335|FG002|STARTED|Washout Period 30 Days||22
3053955|NCT01233869|3774336|FG003|STARTED|Washout Period 30 Days||34
3053956|NCT01233869|3774333|FG000|COMPLETED|Washout Period 30 Days||34
3053957|NCT01233869|3774334|FG001|COMPLETED|Washout Period 30 Days||3
3053958|NCT01233869|3774335|FG002|COMPLETED|Washout Period 30 Days||22
3053959|NCT01233869|3774336|FG003|COMPLETED|Washout Period 30 Days||34
3053960|NCT01233869|3774333|FG000|NOT COMPLETED|Washout Period 30 Days||0
3053961|NCT01233869|3774334|FG001|NOT COMPLETED|Washout Period 30 Days||0
3053962|NCT01233869|3774335|FG002|NOT COMPLETED|Washout Period 30 Days||0
3053963|NCT01233869|3774336|FG003|NOT COMPLETED|Washout Period 30 Days||0
3053964|NCT01233869|3774333|FG000|STARTED|Extended Treatment Period (46 Months)||34
3053965|NCT01233869|3774334|FG001|STARTED|Extended Treatment Period (46 Months)||3
3053966|NCT01233869|3774335|FG002|STARTED|Extended Treatment Period (46 Months)||22
3053967|NCT01233869|3774336|FG003|STARTED|Extended Treatment Period (46 Months)||34
3053968|NCT01233869|3774333|FG000|COMPLETED|Extended Treatment Period (46 Months)||20
3053969|NCT01233869|3774334|FG001|COMPLETED|Extended Treatment Period (46 Months)||0
3053970|NCT01233869|3774335|FG002|COMPLETED|Extended Treatment Period (46 Months)||17
3053971|NCT01233869|3774336|FG003|COMPLETED|Extended Treatment Period (46 Months)||18
3053972|NCT01233869|3774333|FG000|NOT COMPLETED|Extended Treatment Period (46 Months)||14
3053973|NCT01233869|3774334|FG001|NOT COMPLETED|Extended Treatment Period (46 Months)||3
3053974|NCT01233869|3774335|FG002|NOT COMPLETED|Extended Treatment Period (46 Months)||5
3053975|NCT01233869|3774336|FG003|NOT COMPLETED|Extended Treatment Period (46 Months)||16
3053976|NCT01233921|3774348|FG000|STARTED|Overall Study||3
3053977|NCT01233921|3774349|FG001|STARTED|Overall Study||3
3053978|NCT01233921|3774348|FG000|COMPLETED|Overall Study||3
3053979|NCT01233921|3774349|FG001|COMPLETED|Overall Study||3
3053980|NCT01233921|3774348|FG000|NOT COMPLETED|Overall Study||0
3053981|NCT01233921|3774349|FG001|NOT COMPLETED|Overall Study||0
3053982|NCT01233999|3774355|FG000|STARTED|Overall Study||10
3053983|NCT01233999|3774355|FG000|COMPLETED|Overall Study||8
3053984|NCT01233999|3774355|FG000|NOT COMPLETED|Overall Study||2
3053985|NCT01234207|3774359|FG000|STARTED|First Intervention||47
3053986|NCT01234207|3774360|FG001|STARTED|First Intervention||48
3053987|NCT01234207|3774359|FG000|COMPLETED|First Intervention||47
3053988|NCT01234207|3774360|FG001|COMPLETED|First Intervention||48
3053989|NCT01234207|3774359|FG000|NOT COMPLETED|First Intervention||0
3053990|NCT01234207|3774360|FG001|NOT COMPLETED|First Intervention||0
3053991|NCT01234207|3774359|FG000|STARTED|1-Week Washout Period||47
3053992|NCT01234207|3774360|FG001|STARTED|1-Week Washout Period||48
3053993|NCT01234207|3774359|FG000|COMPLETED|1-Week Washout Period||47
3053994|NCT01234207|3774360|FG001|COMPLETED|1-Week Washout Period||48
3053995|NCT01234207|3774359|FG000|NOT COMPLETED|1-Week Washout Period||0
3053996|NCT01234207|3774360|FG001|NOT COMPLETED|1-Week Washout Period||0
3053997|NCT01234207|3774359|FG000|STARTED|Second Intervention||47
3053998|NCT01234207|3774360|FG001|STARTED|Second Intervention||48
3053999|NCT01234207|3774359|FG000|COMPLETED|Second Intervention||47
3054000|NCT01234207|3774360|FG001|COMPLETED|Second Intervention||48
3054001|NCT01234207|3774359|FG000|NOT COMPLETED|Second Intervention||0
3054002|NCT01234207|3774360|FG001|NOT COMPLETED|Second Intervention||0
3054003|NCT01234337|3774370|FG000|STARTED|Overall Study||266
3054004|NCT01234337|3774371|FG001|STARTED|Overall Study||271
3054005|NCT01234337|3774370|FG000|Participants Received Treatment|Overall Study||260
3054006|NCT01234337|3774371|FG001|Participants Received Treatment|Overall Study||267
3054007|NCT01234337|3774370|FG000|COMPLETED|Overall Study||0
3054008|NCT01234337|3774371|FG001|COMPLETED|Overall Study||0
3054009|NCT01234337|3774370|FG000|NOT COMPLETED|Overall Study||266
3054010|NCT01234337|3774371|FG001|NOT COMPLETED|Overall Study||271
3054011|NCT01234350|3774379|FG000|STARTED|Overall Study||1000
3054012|NCT01234350|3774380|FG001|STARTED|Overall Study||493
3054013|NCT01234350|3774379|FG000|COMPLETED|Overall Study||313
3054014|NCT01234350|3774380|FG001|COMPLETED|Overall Study||226
3054015|NCT01234350|3774379|FG000|NOT COMPLETED|Overall Study||687
3054016|NCT01234350|3774380|FG001|NOT COMPLETED|Overall Study||267
3054017|NCT01234402|3774391|FG000|STARTED|Overall Study||52
3054018|NCT01234402|3774392|FG001|STARTED|Overall Study||51
3054019|NCT01234402|3774393|FG002|STARTED|Overall Study||50
3054020|NCT01234402|3774391|FG000|Received at Least One Dose of Study Drug|Overall Study||52
3054021|NCT01234402|3774392|FG001|Received at Least One Dose of Study Drug|Overall Study||49
3054022|NCT01234402|3774393|FG002|Received at Least One Dose of Study Drug|Overall Study||49
3054023|NCT01234402|3774391|FG000|Capecitabine Crossover to Ramucirumab|Overall Study||0
3054024|NCT01234402|3774392|FG001|Capecitabine Crossover to Ramucirumab|Overall Study||0
3054025|NCT01234402|3774393|FG002|Capecitabine Crossover to Ramucirumab|Overall Study||29
3054026|NCT01234402|3774391|FG000|Capecitabine Crossover to Icrucumab|Overall Study||0
3054027|NCT01234402|3774392|FG001|Capecitabine Crossover to Icrucumab|Overall Study||0
3054028|NCT01234402|3774393|FG002|Capecitabine Crossover to Icrucumab|Overall Study||1
3054029|NCT01234402|3774391|FG000|COMPLETED|Overall Study||51
3054030|NCT01234402|3774392|FG001|COMPLETED|Overall Study||45
3054031|NCT01234402|3774393|FG002|COMPLETED|Overall Study||42
3054032|NCT01234402|3774391|FG000|NOT COMPLETED|Overall Study||1
3054033|NCT01234402|3774392|FG001|NOT COMPLETED|Overall Study||6
3054034|NCT01234402|3774393|FG002|NOT COMPLETED|Overall Study||8
3054035|NCT01234467|3774403|FG000|STARTED|Overall Study||23
3054036|NCT01234467|3774403|FG000|COMPLETED|Overall Study||11
3054037|NCT01234467|3774403|FG000|NOT COMPLETED|Overall Study||12
3054038|NCT01234480|3774407|FG000|STARTED|Overall Study||5859
3054039|NCT01234480|3774407|FG000|COMPLETED|Overall Study||5416
3054040|NCT01234480|3774407|FG000|NOT COMPLETED|Overall Study||443
3054041|NCT01234649|3774416|FG000|STARTED|Overall Study||78
3054042|NCT01234649|3774417|FG001|STARTED|Overall Study||75
3054043|NCT01234649|3774416|FG000|COMPLETED|Overall Study||35
3054044|NCT01234649|3774417|FG001|COMPLETED|Overall Study||37
3054045|NCT01234649|3774416|FG000|NOT COMPLETED|Overall Study||43
3054046|NCT01234649|3774417|FG001|NOT COMPLETED|Overall Study||38
3054047|NCT01234675|3774423|FG000|STARTED|First Intervention (6 Weeks)||10
3054048|NCT01234675|3774424|FG001|STARTED|First Intervention (6 Weeks)||9
3054049|NCT01234675|3774423|FG000|COMPLETED|First Intervention (6 Weeks)||9
3054050|NCT01234675|3774424|FG001|COMPLETED|First Intervention (6 Weeks)||8
3054051|NCT01234675|3774423|FG000|NOT COMPLETED|First Intervention (6 Weeks)||1
3054052|NCT01234675|3774424|FG001|NOT COMPLETED|First Intervention (6 Weeks)||1
3054053|NCT01234675|3774423|FG000|STARTED|Second Intervention (6 Weeks)||9
3054054|NCT01234675|3774424|FG001|STARTED|Second Intervention (6 Weeks)||8
3054055|NCT01234675|3774423|FG000|COMPLETED|Second Intervention (6 Weeks)||7
3054056|NCT01234675|3774424|FG001|COMPLETED|Second Intervention (6 Weeks)||8
3054057|NCT01234675|3774423|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||2
3054058|NCT01234675|3774424|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||0
3054059|NCT01234714|3774430|FG000|STARTED|Overall Study||84
3054060|NCT01234714|3774430|FG000|COMPLETED|Overall Study||84
3054061|NCT01234714|3774430|FG000|NOT COMPLETED|Overall Study||0
3054062|NCT01234766|3774437|FG000|STARTED|Overall Study||39
3054063|NCT01234766|3774437|FG000|COMPLETED|Overall Study||35
3054064|NCT01234766|3774437|FG000|NOT COMPLETED|Overall Study||4
3054065|NCT01234831|3774443|FG000|STARTED|Overall Study||261
3054066|NCT01234831|3774444|FG001|STARTED|Overall Study||202
3054067|NCT01234831|3774443|FG000|COMPLETED|Overall Study||259
3054068|NCT01234831|3774444|FG001|COMPLETED|Overall Study||198
3054069|NCT01234831|3774443|FG000|NOT COMPLETED|Overall Study||2
3054070|NCT01234831|3774444|FG001|NOT COMPLETED|Overall Study||4
3054071|NCT01234870|3774451|FG000|STARTED|Overall Study||40
3054072|NCT01234870|3774451|FG000|COMPLETED|Overall Study||40
3054073|NCT01234870|3774451|FG000|NOT COMPLETED|Overall Study||0
3054074|NCT01234883|3774458|FG000|STARTED|Overall Study||51
3054075|NCT01234883|3774459|FG001|STARTED|Overall Study||49
3054076|NCT01234883|3774458|FG000|COMPLETED|Overall Study||41
3054077|NCT01234883|3774459|FG001|COMPLETED|Overall Study||36
3054078|NCT01234883|3774458|FG000|NOT COMPLETED|Overall Study||10
3054079|NCT01234883|3774459|FG001|NOT COMPLETED|Overall Study||13
3054080|NCT01234922|3774469|FG000|STARTED|Overall Study||1
3054081|NCT01234922|3774470|FG001|STARTED|Overall Study||1
3054082|NCT01234922|3774471|FG002|STARTED|Overall Study||2
3054083|NCT01234922|3774472|FG003|STARTED|Overall Study||2
3054084|NCT01234922|3774469|FG000|COMPLETED|Overall Study||1
3054085|NCT01234922|3774470|FG001|COMPLETED|Overall Study||1
3054086|NCT01234922|3774471|FG002|COMPLETED|Overall Study||2
3054087|NCT01234922|3774472|FG003|COMPLETED|Overall Study||2
3054088|NCT01234922|3774469|FG000|NOT COMPLETED|Overall Study||0
3054089|NCT01234922|3774470|FG001|NOT COMPLETED|Overall Study||0
3054090|NCT01234922|3774471|FG002|NOT COMPLETED|Overall Study||0
3054091|NCT01234922|3774472|FG003|NOT COMPLETED|Overall Study||0
3054092|NCT01235195|3774482|FG000|STARTED|First Intervention||15
3054093|NCT01235195|3774483|FG001|STARTED|First Intervention||15
3054094|NCT01235195|3774482|FG000|COMPLETED|First Intervention||15
3054095|NCT01235195|3774483|FG001|COMPLETED|First Intervention||15
3054096|NCT01235195|3774482|FG000|NOT COMPLETED|First Intervention||0
3054097|NCT01235195|3774483|FG001|NOT COMPLETED|First Intervention||0
3054098|NCT01235195|3774482|FG000|STARTED|Washout Period of At Least 8 Days||15
3054099|NCT01235195|3774483|FG001|STARTED|Washout Period of At Least 8 Days||15
3054100|NCT01235195|3774482|FG000|COMPLETED|Washout Period of At Least 8 Days||15
3054101|NCT01235195|3774483|FG001|COMPLETED|Washout Period of At Least 8 Days||15
3054102|NCT01235195|3774482|FG000|NOT COMPLETED|Washout Period of At Least 8 Days||0
3054103|NCT01235195|3774483|FG001|NOT COMPLETED|Washout Period of At Least 8 Days||0
3054104|NCT01235195|3774482|FG000|STARTED|Second Intervention||15
3054105|NCT01235195|3774483|FG001|STARTED|Second Intervention||15
3054106|NCT01235195|3774482|FG000|COMPLETED|Second Intervention||15
3054107|NCT01235195|3774483|FG001|COMPLETED|Second Intervention||15
3054108|NCT01235195|3774482|FG000|NOT COMPLETED|Second Intervention||0
3054109|NCT01235195|3774483|FG001|NOT COMPLETED|Second Intervention||0
3283763|NCT02759146|4017553|FG006|STARTED|Week 5-8||26
3283764|NCT02759146|4017547|FG000|COMPLETED|Week 5-8||46
3283765|NCT02759146|4017548|FG001|COMPLETED|Week 5-8||29
3283766|NCT02759146|4017549|FG002|COMPLETED|Week 5-8||22
3283767|NCT02759146|4017550|FG003|COMPLETED|Week 5-8||37
3054110|NCT01235234|3774492|FG000|STARTED|Overall Study||77
3054111|NCT01235234|3774493|FG001|STARTED|Overall Study||78
3054112|NCT01235234|3774494|FG002|STARTED|Overall Study||81
3054113|NCT01235234|3774492|FG000|COMPLETED|Overall Study||75
3054114|NCT01235234|3774493|FG001|COMPLETED|Overall Study||76
3054115|NCT01235234|3774494|FG002|COMPLETED|Overall Study||80
3054116|NCT01235234|3774492|FG000|NOT COMPLETED|Overall Study||2
3054117|NCT01235234|3774493|FG001|NOT COMPLETED|Overall Study||2
3054118|NCT01235234|3774494|FG002|NOT COMPLETED|Overall Study||1
3054119|NCT01235338|3774504|FG000|STARTED|Overall Study||42
3054120|NCT01235338|3774505|FG001|STARTED|Overall Study||38
3054121|NCT01235338|3774504|FG000|COMPLETED|Overall Study||31
3283768|NCT02759146|4017551|FG004|COMPLETED|Week 5-8||44
3283769|NCT02759146|4017552|FG005|COMPLETED|Week 5-8||23
3054122|NCT01235338|3774505|FG001|COMPLETED|Overall Study||33
3283770|NCT02759146|4017553|FG006|COMPLETED|Week 5-8||20
3283771|NCT02759146|4017547|FG000|NOT COMPLETED|Week 5-8||10
3283772|NCT02759146|4017548|FG001|NOT COMPLETED|Week 5-8||5
3283773|NCT02759146|4017549|FG002|NOT COMPLETED|Week 5-8||10
3283774|NCT02759146|4017550|FG003|NOT COMPLETED|Week 5-8||7
3283775|NCT02759146|4017551|FG004|NOT COMPLETED|Week 5-8||5
3283776|NCT02759146|4017552|FG005|NOT COMPLETED|Week 5-8||6
3283777|NCT02759146|4017553|FG006|NOT COMPLETED|Week 5-8||6
3283778|NCT02759185|4017573|FG000|STARTED|Overall Study||20
3283779|NCT02759185|4017574|FG001|STARTED|Overall Study||20
3283780|NCT02759185|4017575|FG002|STARTED|Overall Study||20
3283781|NCT02759185|4017576|FG003|STARTED|Overall Study||20
3283782|NCT02759185|4017573|FG000|COMPLETED|Overall Study||19
3283783|NCT02759185|4017574|FG001|COMPLETED|Overall Study||19
3283784|NCT02759185|4017575|FG002|COMPLETED|Overall Study||18
3054123|NCT01235338|3774504|FG000|NOT COMPLETED|Overall Study||11
3054124|NCT01235338|3774505|FG001|NOT COMPLETED|Overall Study||5
3054125|NCT01235351|3774515|FG000|STARTED|Initial Treatment With 75 mg and 150 mg||247
3054126|NCT01235351|3774516|FG001|STARTED|Initial Treatment With 75 mg and 150 mg||86
3054127|NCT01235351|3774515|FG000|COMPLETED|Initial Treatment With 75 mg and 150 mg|4 allocated to initial treatment included in primary analysis|237
3054128|NCT01235351|3774516|FG001|COMPLETED|Initial Treatment With 75 mg and 150 mg||82
3054129|NCT01235351|3774515|FG000|NOT COMPLETED|Initial Treatment With 75 mg and 150 mg||10
3054130|NCT01235351|3774516|FG001|NOT COMPLETED|Initial Treatment With 75 mg and 150 mg||4
3160962|NCT01868334|3888184|FG000|NOT COMPLETED|Year 1 RCCT Study||0
3160963|NCT01868334|3888185|FG001|NOT COMPLETED|Year 1 RCCT Study||0
3160964|NCT01868334|3888186|FG002|NOT COMPLETED|Year 1 RCCT Study||0
3160965|NCT01868334|3888187|FG003|NOT COMPLETED|Year 1 RCCT Study||0
3160966|NCT01868334|3888184|FG000|STARTED|Year 2 Pre-post Study|Reflects: control sites from Year 1 (N=8) and Year 1 Intervention sites who continued in Y2 (N=4)|22324
3160967|NCT01868334|3888185|FG001|STARTED|Year 2 Pre-post Study|Reflects: the six Year 1 Intervention sites who chose not to actively engage Year 2|8047
3160968|NCT01868334|3888186|FG002|STARTED|Year 2 Pre-post Study|Reflects: Year 1 Control sites who became active in the intervention during Year 2|20904
3160969|NCT01868334|3888187|FG003|STARTED|Year 2 Pre-post Study|Reflects: Year 1 Intervention sites who chose not to actively engage Year 2|19274
3160970|NCT01868334|3888184|FG000|COMPLETED|Year 2 Pre-post Study||22324
3160971|NCT01868334|3888185|FG001|COMPLETED|Year 2 Pre-post Study||8047
3160972|NCT01868334|3888186|FG002|COMPLETED|Year 2 Pre-post Study||20904
3160973|NCT01868334|3888187|FG003|COMPLETED|Year 2 Pre-post Study||19274
3160974|NCT01868334|3888184|FG000|NOT COMPLETED|Year 2 Pre-post Study||0
3160975|NCT01868334|3888185|FG001|NOT COMPLETED|Year 2 Pre-post Study||0
3160976|NCT01868334|3888186|FG002|NOT COMPLETED|Year 2 Pre-post Study||0
3160977|NCT01868334|3888187|FG003|NOT COMPLETED|Year 2 Pre-post Study||0
3283785|NCT02759185|4017576|FG003|COMPLETED|Overall Study||20
3283786|NCT02759185|4017573|FG000|NOT COMPLETED|Overall Study||1
3283787|NCT02759185|4017574|FG001|NOT COMPLETED|Overall Study||1
3054131|NCT01235351|3774515|FG000|STARTED|Treatment With Different Dose Sequences||233
3054132|NCT01235351|3774516|FG001|STARTED|Treatment With Different Dose Sequences||82
3054133|NCT01235351|3774515|FG000|75 mg First and Then 150 mg|Treatment With Different Dose Sequences||116
3054134|NCT01235351|3774516|FG001|75 mg First and Then 150 mg|Treatment With Different Dose Sequences||0
3054135|NCT01235351|3774515|FG000|150 mg First Then 75 mg|Treatment With Different Dose Sequences||117
3054136|NCT01235351|3774516|FG001|150 mg First Then 75 mg|Treatment With Different Dose Sequences||0
3054137|NCT01235351|3774515|FG000|225 mg First Then 300 mg|Treatment With Different Dose Sequences||0
3054138|NCT01235351|3774516|FG001|225 mg First Then 300 mg|Treatment With Different Dose Sequences||41
3054139|NCT01235351|3774515|FG000|300 mg First Then 225 mg|Treatment With Different Dose Sequences||0
3054140|NCT01235351|3774516|FG001|300 mg First Then 225 mg|Treatment With Different Dose Sequences||41
3054141|NCT01235351|3774515|FG000|COMPLETED|Treatment With Different Dose Sequences||233
3054142|NCT01235351|3774516|FG001|COMPLETED|Treatment With Different Dose Sequences||82
3054143|NCT01235351|3774515|FG000|NOT COMPLETED|Treatment With Different Dose Sequences||0
3054144|NCT01235351|3774516|FG001|NOT COMPLETED|Treatment With Different Dose Sequences||0
3054145|NCT01235377|3774528|FG000|STARTED|Overall Study||11
3054146|NCT01235377|3774529|FG001|STARTED|Overall Study||9
3054147|NCT01235377|3774528|FG000|COMPLETED|Overall Study||10
3054148|NCT01235377|3774529|FG001|COMPLETED|Overall Study||8
3054149|NCT01235377|3774528|FG000|NOT COMPLETED|Overall Study||1
3054150|NCT01235377|3774529|FG001|NOT COMPLETED|Overall Study||1
3054151|NCT01235403|3774535|FG000|STARTED|Overall Study||100
3054152|NCT01235403|3774535|FG000|COMPLETED|Overall Study||74
3054153|NCT01235403|3774535|FG000|NOT COMPLETED|Overall Study||26
3054154|NCT01235442|3774541|FG000|STARTED|Overall Study||297
3054155|NCT01235442|3774542|FG001|STARTED|Overall Study||295
3054156|NCT01235442|3774541|FG000|COMPLETED|Overall Study||253
3054157|NCT01235442|3774542|FG001|COMPLETED|Overall Study||251
3054158|NCT01235442|3774541|FG000|NOT COMPLETED|Overall Study||44
3054159|NCT01235442|3774542|FG001|NOT COMPLETED|Overall Study||44
3054160|NCT01235507|3774548|FG000|STARTED|Overall Study||71
3054161|NCT01235507|3774548|FG000|COMPLETED|Overall Study||69
3054162|NCT01235507|3774548|FG000|NOT COMPLETED|Overall Study||2
3133949|NCT01698554|3858910|FG002|COMPLETED|Overall Study||73
3133950|NCT01698554|3858911|FG003|COMPLETED|Overall Study||77
3133951|NCT01698554|3858908|FG000|NOT COMPLETED|Overall Study||6
3283788|NCT02759185|4017575|FG002|NOT COMPLETED|Overall Study||2
3283789|NCT02759185|4017576|FG003|NOT COMPLETED|Overall Study||0
3054163|NCT01235546|3774554|FG000|STARTED|Overall Study||994
3054164|NCT01235546|3774555|FG001|STARTED|Overall Study||1019
3054165|NCT01235546|3774554|FG000|COMPLETED|Overall Study||992
3054166|NCT01235546|3774555|FG001|COMPLETED|Overall Study||1018
3054167|NCT01235546|3774554|FG000|NOT COMPLETED|Overall Study||2
3054168|NCT01235546|3774555|FG001|NOT COMPLETED|Overall Study||1
3054169|NCT01235598|3774572|FG000|STARTED|Overall Study||13
3054170|NCT01235598|3774573|FG001|STARTED|Overall Study|One subject was randomized to the CZP Arm but never received an injection (due to pre-treatment AE)|28
3054171|NCT01235598|3774572|FG000|COMPLETED|Overall Study||12
3054172|NCT01235598|3774573|FG001|COMPLETED|Overall Study||24
3054173|NCT01235598|3774572|FG000|NOT COMPLETED|Overall Study||1
3054174|NCT01235598|3774573|FG001|NOT COMPLETED|Overall Study||4
3054175|NCT01235689|3774582|FG000|STARTED|Overall Study|Total randomized includes participants who randomized at Week 9 and earlier.|122
3054176|NCT01235689|3774583|FG001|STARTED|Overall Study|Total randomized includes participants who randomized at Week 9 and earlier.|122
3054177|NCT01235689|3774582|FG000|Early Randomized (Baseline to Week 9)|Overall Study||63
3054178|NCT01235689|3774583|FG001|Early Randomized (Baseline to Week 9)|Overall Study||69
3054179|NCT01235689|3774582|FG000|Randomized at Week 9|Overall Study||59
3054180|NCT01235689|3774583|FG001|Randomized at Week 9|Overall Study||53
3054181|NCT01235689|3774582|FG000|COMPLETED|Overall Study||93
3054182|NCT01235689|3774583|FG001|COMPLETED|Overall Study||90
3054183|NCT01235689|3774582|FG000|NOT COMPLETED|Overall Study||29
3054184|NCT01235689|3774583|FG001|NOT COMPLETED|Overall Study||32
3054185|NCT01235715|3774591|FG000|STARTED|Overall Study||98
3054186|NCT01235715|3774592|FG001|STARTED|Overall Study||102
3054187|NCT01235715|3774591|FG000|COMPLETED|Overall Study||98
3054188|NCT01235715|3774592|FG001|COMPLETED|Overall Study||100
3054189|NCT01235715|3774591|FG000|NOT COMPLETED|Overall Study||0
3054190|NCT01235715|3774592|FG001|NOT COMPLETED|Overall Study||2
3054191|NCT01235728|3774599|FG000|STARTED|Overall Study||3
3054192|NCT01235728|3774600|FG001|STARTED|Overall Study||3
3054193|NCT01235728|3774601|FG002|STARTED|Overall Study||3
3054194|NCT01235728|3774602|FG003|STARTED|Overall Study||3
3054195|NCT01235728|3774603|FG004|STARTED|Overall Study||3
3054196|NCT01235728|3774604|FG005|STARTED|Overall Study||3
3054197|NCT01235728|3774605|FG006|STARTED|Overall Study||3
3054198|NCT01235728|3774606|FG007|STARTED|Overall Study||3
3054199|NCT01235728|3774599|FG000|COMPLETED|Overall Study||3
3054200|NCT01235728|3774600|FG001|COMPLETED|Overall Study||3
3054201|NCT01235728|3774601|FG002|COMPLETED|Overall Study||3
3054202|NCT01235728|3774602|FG003|COMPLETED|Overall Study||2
3054203|NCT01235728|3774603|FG004|COMPLETED|Overall Study||3
3054204|NCT01235728|3774604|FG005|COMPLETED|Overall Study||3
3054205|NCT01235728|3774605|FG006|COMPLETED|Overall Study||3
3054206|NCT01235728|3774606|FG007|COMPLETED|Overall Study||3
3054207|NCT01235728|3774599|FG000|NOT COMPLETED|Overall Study||0
3054208|NCT01235728|3774600|FG001|NOT COMPLETED|Overall Study||0
3054209|NCT01235728|3774601|FG002|NOT COMPLETED|Overall Study||0
3054210|NCT01235728|3774602|FG003|NOT COMPLETED|Overall Study||1
3054211|NCT01235728|3774603|FG004|NOT COMPLETED|Overall Study||0
3054212|NCT01235728|3774604|FG005|NOT COMPLETED|Overall Study||0
3054213|NCT01235728|3774605|FG006|NOT COMPLETED|Overall Study||0
3054214|NCT01235728|3774606|FG007|NOT COMPLETED|Overall Study||0
3054215|NCT01235741|3774617|FG000|STARTED|Non-Randomized Low Calorie Diet Lead-In|6 Week LCD period. Those who lost >=2% of body weight were randomized to treatment.|213
3054216|NCT01235741|3774618|FG001|STARTED|Non-Randomized Low Calorie Diet Lead-In||0
3054217|NCT01235741|3774619|FG002|STARTED|Non-Randomized Low Calorie Diet Lead-In||0
3054218|NCT01235741|3774617|FG000|COMPLETED|Non-Randomized Low Calorie Diet Lead-In|Study terminated by Sponsor. 72 randomized to treatment at time study halted.|72
3054219|NCT01235741|3774618|FG001|COMPLETED|Non-Randomized Low Calorie Diet Lead-In||0
3054220|NCT01235741|3774619|FG002|COMPLETED|Non-Randomized Low Calorie Diet Lead-In||0
3054221|NCT01235741|3774617|FG000|NOT COMPLETED|Non-Randomized Low Calorie Diet Lead-In||141
3054222|NCT01235741|3774618|FG001|NOT COMPLETED|Non-Randomized Low Calorie Diet Lead-In||0
3054223|NCT01235741|3774619|FG002|NOT COMPLETED|Non-Randomized Low Calorie Diet Lead-In||0
3054224|NCT01235741|3774617|FG000|STARTED|Randomized to Treatment||0
3054225|NCT01235741|3774618|FG001|STARTED|Randomized to Treatment||36
3054226|NCT01235741|3774619|FG002|STARTED|Randomized to Treatment||36
3054227|NCT01235741|3774617|FG000|COMPLETED|Randomized to Treatment||0
3054228|NCT01235741|3774618|FG001|COMPLETED|Randomized to Treatment|Study terminated by Sponsor. Maximum exposure to study drug was 30 days.|0
3054229|NCT01235741|3774619|FG002|COMPLETED|Randomized to Treatment|Study terminated by Sponsor. Maximum exposure to study drug was 30 days.|0
3054230|NCT01235741|3774617|FG000|NOT COMPLETED|Randomized to Treatment||0
3054231|NCT01235741|3774618|FG001|NOT COMPLETED|Randomized to Treatment||36
3054232|NCT01235741|3774619|FG002|NOT COMPLETED|Randomized to Treatment||36
3054233|NCT01235741|3774617|FG000|STARTED|Follow-Up Post Treatment up to Month 6||0
3054234|NCT01235741|3774618|FG001|STARTED|Follow-Up Post Treatment up to Month 6|No treatment; those who had been treated with placebo (36) were followed up 6 Months post treatment.|36
3054235|NCT01235741|3774619|FG002|STARTED|Follow-Up Post Treatment up to Month 6|No treatment; those who had been treated with drug (36) were followed up 6 months post treatment.|36
3283790|NCT02759315|4017596|FG000|STARTED|Overall Study||69
3283791|NCT02759315|4017597|FG001|STARTED|Overall Study||29
3054236|NCT01235741|3774617|FG000|COMPLETED|Follow-Up Post Treatment up to Month 6||0
3054237|NCT01235741|3774618|FG001|COMPLETED|Follow-Up Post Treatment up to Month 6|9 participants did not complete the 6 month follow up period|27
3054238|NCT01235741|3774619|FG002|COMPLETED|Follow-Up Post Treatment up to Month 6|7 participants did not complete the 6 month follow up period|29
3054239|NCT01235741|3774617|FG000|NOT COMPLETED|Follow-Up Post Treatment up to Month 6||0
3054240|NCT01235741|3774618|FG001|NOT COMPLETED|Follow-Up Post Treatment up to Month 6||9
3054241|NCT01235741|3774619|FG002|NOT COMPLETED|Follow-Up Post Treatment up to Month 6||7
3054242|NCT01235793|3774631|FG000|STARTED|Overall Study||11
3054243|NCT01235793|3774631|FG000|COMPLETED|Overall Study||5
3054244|NCT01235793|3774631|FG000|NOT COMPLETED|Overall Study||6
3054245|NCT01235897|3774636|FG000|STARTED|Overall Study||16
3054246|NCT01235897|3774636|FG000|COMPLETED|Overall Study||16
3054247|NCT01235897|3774636|FG000|NOT COMPLETED|Overall Study||0
3054248|NCT01235910|3774641|FG000|STARTED|Overall Study||1
3054249|NCT01235910|3774641|FG000|COMPLETED|Overall Study||1
3054250|NCT01235910|3774641|FG000|NOT COMPLETED|Overall Study||0
3054251|NCT01235923|3774647|FG000|STARTED|Overall Study||10
3054252|NCT01235923|3774648|FG001|STARTED|Overall Study||10
3054253|NCT01235923|3774647|FG000|COMPLETED|Overall Study||10
3054254|NCT01235923|3774648|FG001|COMPLETED|Overall Study||10
3054255|NCT01235923|3774647|FG000|NOT COMPLETED|Overall Study||0
3054256|NCT01235923|3774648|FG001|NOT COMPLETED|Overall Study||0
3054257|NCT01235949|3774672|FG000|STARTED|Primary Phase||198
3054258|NCT01235949|3774673|FG001|STARTED|Primary Phase||198
3054259|NCT01235949|3774674|FG002|STARTED|Primary Phase||199
3054260|NCT01235949|3774675|FG003|STARTED|Primary Phase||71
3054261|NCT01235949|3774676|FG004|STARTED|Primary Phase||72
3054262|NCT01235949|3774677|FG005|STARTED|Primary Phase||74
3054263|NCT01235949|3774678|FG006|STARTED|Primary Phase||0
3054264|NCT01235949|3774679|FG007|STARTED|Primary Phase||0
3054265|NCT01235949|3774680|FG008|STARTED|Primary Phase||0
3054266|NCT01235949|3774681|FG009|STARTED|Primary Phase||0
3054267|NCT01235949|3774682|FG010|STARTED|Primary Phase||0
3054268|NCT01235949|3774683|FG011|STARTED|Primary Phase||0
3054269|NCT01235949|3774684|FG012|STARTED|Primary Phase||0
3054270|NCT01235949|3774685|FG013|STARTED|Primary Phase||0
3054271|NCT01235949|3774686|FG014|STARTED|Primary Phase||0
3054272|NCT01235949|3774687|FG015|STARTED|Primary Phase||0
3054273|NCT01235949|3774688|FG016|STARTED|Primary Phase||0
3054274|NCT01235949|3774689|FG017|STARTED|Primary Phase||0
3054275|NCT01235949|3774672|FG000|COMPLETED|Primary Phase|After Primary Phase completion, 7 subjects were not willing to participate in the Booster Phase|194
3054276|NCT01235949|3774673|FG001|COMPLETED|Primary Phase|After Primary Phase completion, 6 subjects were not willing to participate in the Booster Phase|195
3054277|NCT01235949|3774674|FG002|COMPLETED|Primary Phase|After Primary Phase completion, 6 subjects were not willing to participate in the Booster Phase|196
3054278|NCT01235949|3774675|FG003|COMPLETED|Primary Phase|After Primary Phase completion, 2 subjects were not willing to participate in the Booster Phase|69
3054279|NCT01235949|3774676|FG004|COMPLETED|Primary Phase|After Primary Phase completion, 3 subjects were not willing to participate in the Booster Phase|71
3054280|NCT01235949|3774677|FG005|COMPLETED|Primary Phase|After Primary Phase completion, all subjects were willing to participate in the Booster Phase|67
3054281|NCT01235949|3774678|FG006|COMPLETED|Primary Phase||0
3054282|NCT01235949|3774679|FG007|COMPLETED|Primary Phase||0
3054283|NCT01235949|3774680|FG008|COMPLETED|Primary Phase||0
3054284|NCT01235949|3774681|FG009|COMPLETED|Primary Phase||0
3054285|NCT01235949|3774682|FG010|COMPLETED|Primary Phase||0
3054286|NCT01235949|3774683|FG011|COMPLETED|Primary Phase||0
3054287|NCT01235949|3774684|FG012|COMPLETED|Primary Phase||0
3054288|NCT01235949|3774685|FG013|COMPLETED|Primary Phase||0
3054289|NCT01235949|3774686|FG014|COMPLETED|Primary Phase||0
3054290|NCT01235949|3774687|FG015|COMPLETED|Primary Phase||0
3054291|NCT01235949|3774688|FG016|COMPLETED|Primary Phase||0
3054292|NCT01235949|3774689|FG017|COMPLETED|Primary Phase||0
3054293|NCT01235949|3774672|FG000|NOT COMPLETED|Primary Phase||4
3054294|NCT01235949|3774673|FG001|NOT COMPLETED|Primary Phase||3
3054295|NCT01235949|3774674|FG002|NOT COMPLETED|Primary Phase||3
3054296|NCT01235949|3774675|FG003|NOT COMPLETED|Primary Phase||2
3054297|NCT01235949|3774676|FG004|NOT COMPLETED|Primary Phase||1
3054298|NCT01235949|3774677|FG005|NOT COMPLETED|Primary Phase||7
3054299|NCT01235949|3774678|FG006|NOT COMPLETED|Primary Phase||0
3054300|NCT01235949|3774679|FG007|NOT COMPLETED|Primary Phase||0
3054301|NCT01235949|3774680|FG008|NOT COMPLETED|Primary Phase||0
3054302|NCT01235949|3774681|FG009|NOT COMPLETED|Primary Phase||0
3054303|NCT01235949|3774682|FG010|NOT COMPLETED|Primary Phase||0
3054304|NCT01235949|3774683|FG011|NOT COMPLETED|Primary Phase||0
3054305|NCT01235949|3774684|FG012|NOT COMPLETED|Primary Phase||0
3054306|NCT01235949|3774685|FG013|NOT COMPLETED|Primary Phase||0
3054307|NCT01235949|3774686|FG014|NOT COMPLETED|Primary Phase||0
3054308|NCT01235949|3774687|FG015|NOT COMPLETED|Primary Phase||0
3054309|NCT01235949|3774688|FG016|NOT COMPLETED|Primary Phase||0
3054310|NCT01235949|3774689|FG017|NOT COMPLETED|Primary Phase||0
3054311|NCT01235949|3774672|FG000|STARTED|Booster Phase|re-randomized to diverse treatments (IIBU-IIBU, IIBU-DIBU and IIBU-NIBU Groups) in booster phase|0
3054312|NCT01235949|3774673|FG001|STARTED|Booster Phase|re-randomized to diverse treatments (DIBU-IIBU, DIBU-DIBU and DIBU-NIBU Groups) in booster phase|0
3054313|NCT01235949|3774674|FG002|STARTED|Booster Phase|re-randomized to diverse treatments (NIBU-IIBU, NIBU-DIBU and NIBU-NIBU Groups) in booster phase|0
3054314|NCT01235949|3774675|FG003|STARTED|Booster Phase|subjects re-randomized to IPARA-NPARA Group in booster phase|0
3054315|NCT01235949|3774676|FG004|STARTED|Booster Phase|subjects re-randomized to DPARA-IPARA Group in booster phase|0
3054316|NCT01235949|3774677|FG005|STARTED|Booster Phase|subjects re-randomized to NPARA-IPARA Group in booster phase|0
3054317|NCT01235949|3774678|FG006|STARTED|Booster Phase|1/3 of subjects from primary IIBU group re-randomized to receive diverse booster phase treatments|64
3054318|NCT01235949|3774679|FG007|STARTED|Booster Phase|1/3 of subjects from primary IIBU group re-randomized to receive diverse booster phase treatments|60
3054319|NCT01235949|3774680|FG008|STARTED|Booster Phase|1/3 of subjects from primary IIBU group re-randomized to receive diverse booster phase treatments|63
3054320|NCT01235949|3774681|FG009|STARTED|Booster Phase|1/3 of subjects from primary DIBU group re-randomized to receive diverse booster phase treatments|63
3054321|NCT01235949|3774682|FG010|STARTED|Booster Phase|1/3 of subjects from primary DIBU group re-randomized to receive diverse booster phase treatments|63
3054322|NCT01235949|3774683|FG011|STARTED|Booster Phase|1/3 of subjects from primary DIBU group re-randomized to receive diverse booster phase treatments|63
3054323|NCT01235949|3774684|FG012|STARTED|Booster Phase|1/3 of subjects from primary NIBU group re-randomized to receive diverse booster phase treatments|63
3054324|NCT01235949|3774685|FG013|STARTED|Booster Phase|1/3 of subjects from primary NIBU group re-randomized to receive diverse booster phase treatments|65
3054325|NCT01235949|3774686|FG014|STARTED|Booster Phase|1/3 of subjects from primary NIBU group re-randomized to receive diverse booster phase treatments|62
3054326|NCT01235949|3774687|FG015|STARTED|Booster Phase|subjects from the primary IPARA group continuing in booster phase with different treatment|67
3054327|NCT01235949|3774688|FG016|STARTED|Booster Phase|subjects from the primary DPARA group continuing in booster phase with different treatment|68
3054328|NCT01235949|3774689|FG017|STARTED|Booster Phase|subjects from the primary NPARA group continuing in booster phase with different treatment|67
3054329|NCT01235949|3774672|FG000|COMPLETED|Booster Phase||0
3054330|NCT01235949|3774673|FG001|COMPLETED|Booster Phase||0
3054331|NCT01235949|3774674|FG002|COMPLETED|Booster Phase||0
3054332|NCT01235949|3774675|FG003|COMPLETED|Booster Phase||0
3054333|NCT01235949|3774676|FG004|COMPLETED|Booster Phase||0
3054334|NCT01235949|3774677|FG005|COMPLETED|Booster Phase||0
3054335|NCT01235949|3774678|FG006|COMPLETED|Booster Phase||64
3054336|NCT01235949|3774679|FG007|COMPLETED|Booster Phase||59
3054337|NCT01235949|3774680|FG008|COMPLETED|Booster Phase||61
3054338|NCT01235949|3774681|FG009|COMPLETED|Booster Phase||62
3054339|NCT01235949|3774682|FG010|COMPLETED|Booster Phase||61
3054340|NCT01235949|3774683|FG011|COMPLETED|Booster Phase||60
3054341|NCT01235949|3774684|FG012|COMPLETED|Booster Phase||60
3054342|NCT01235949|3774685|FG013|COMPLETED|Booster Phase||65
3054343|NCT01235949|3774686|FG014|COMPLETED|Booster Phase||60
3054344|NCT01235949|3774687|FG015|COMPLETED|Booster Phase||66
3054345|NCT01235949|3774688|FG016|COMPLETED|Booster Phase||68
3054346|NCT01235949|3774689|FG017|COMPLETED|Booster Phase||65
3054347|NCT01235949|3774672|FG000|NOT COMPLETED|Booster Phase||0
3054348|NCT01235949|3774673|FG001|NOT COMPLETED|Booster Phase||0
3054349|NCT01235949|3774674|FG002|NOT COMPLETED|Booster Phase||0
3054350|NCT01235949|3774675|FG003|NOT COMPLETED|Booster Phase||0
3054351|NCT01235949|3774676|FG004|NOT COMPLETED|Booster Phase||0
3054352|NCT01235949|3774677|FG005|NOT COMPLETED|Booster Phase||0
3054353|NCT01235949|3774678|FG006|NOT COMPLETED|Booster Phase||0
3054354|NCT01235949|3774679|FG007|NOT COMPLETED|Booster Phase||1
3054355|NCT01235949|3774680|FG008|NOT COMPLETED|Booster Phase||2
3054356|NCT01235949|3774681|FG009|NOT COMPLETED|Booster Phase||1
3054357|NCT01235949|3774682|FG010|NOT COMPLETED|Booster Phase||2
3160978|NCT01868425|3888227|FG000|STARTED|Overall Study||55
3160979|NCT01868425|3888228|FG001|STARTED|Overall Study||57
3160980|NCT01868425|3888227|FG000|COMPLETED|Overall Study||55
3160981|NCT01868425|3888228|FG001|COMPLETED|Overall Study||57
3160982|NCT01868425|3888227|FG000|NOT COMPLETED|Overall Study||0
3160983|NCT01868425|3888228|FG001|NOT COMPLETED|Overall Study||0
3160984|NCT01868477|3888236|FG000|STARTED|Overall Study||12
3160985|NCT01868477|3888237|FG001|STARTED|Overall Study||11
3160986|NCT01868477|3888236|FG000|Switched to EPO+DFX|Overall Study||5
3054358|NCT01235949|3774683|FG011|NOT COMPLETED|Booster Phase||3
3054359|NCT01235949|3774684|FG012|NOT COMPLETED|Booster Phase||3
3054360|NCT01235949|3774685|FG013|NOT COMPLETED|Booster Phase||0
3054361|NCT01235949|3774686|FG014|NOT COMPLETED|Booster Phase||2
3054362|NCT01235949|3774687|FG015|NOT COMPLETED|Booster Phase||1
3054363|NCT01235949|3774688|FG016|NOT COMPLETED|Booster Phase||0
3160987|NCT01868477|3888237|FG001|Switched to EPO+DFX|Overall Study||0
3160988|NCT01868477|3888236|FG000|Not Switched to EPO+DFX|Overall Study||7
3160989|NCT01868477|3888237|FG001|Not Switched to EPO+DFX|Overall Study||0
3160990|NCT01868477|3888236|FG000|COMPLETED|Overall Study||8
3160991|NCT01868477|3888237|FG001|COMPLETED|Overall Study||6
3160992|NCT01868477|3888236|FG000|NOT COMPLETED|Overall Study||4
3160993|NCT01868477|3888237|FG001|NOT COMPLETED|Overall Study||5
3160994|NCT01868503|3888250|FG000|STARTED|Overall Study||7
3054364|NCT01235949|3774689|FG017|NOT COMPLETED|Booster Phase||2
3054365|NCT01235975|3774729|FG000|STARTED|Overall Study||274
3054366|NCT01235975|3774730|FG001|STARTED|Overall Study||95
3054367|NCT01235975|3774729|FG000|COMPLETED|Overall Study||257
3054368|NCT01235975|3774730|FG001|COMPLETED|Overall Study||88
3054369|NCT01235975|3774729|FG000|NOT COMPLETED|Overall Study||17
3054370|NCT01235975|3774730|FG001|NOT COMPLETED|Overall Study||7
3054371|NCT01236001|3774738|FG000|STARTED|Overall Study||105
3054372|NCT01236001|3774739|FG001|STARTED|Overall Study||87
3054373|NCT01236001|3774738|FG000|COMPLETED|Overall Study||87
3054374|NCT01236001|3774739|FG001|COMPLETED|Overall Study||65
3054375|NCT01236001|3774738|FG000|NOT COMPLETED|Overall Study||18
3054376|NCT01236001|3774739|FG001|NOT COMPLETED|Overall Study||22
3160995|NCT01868503|3888250|FG000|COMPLETED|Overall Study||5
3160996|NCT01868503|3888250|FG000|NOT COMPLETED|Overall Study||2
3054377|NCT01236053|3774768|FG000|STARTED|Overall Study||179138
3054378|NCT01236053|3774769|FG001|STARTED|Overall Study||1710950
3054379|NCT01236053|3774770|FG002|STARTED|Overall Study||1877
3054380|NCT01236053|3774771|FG003|STARTED|Overall Study||17853
3054381|NCT01236053|3774772|FG004|STARTED|Overall Study||212
3054382|NCT01236053|3774773|FG005|STARTED|Overall Study||2067
3054383|NCT01236053|3774774|FG006|STARTED|Overall Study||10855
3054384|NCT01236053|3774775|FG007|STARTED|Overall Study||102836
3054385|NCT01236053|3774776|FG008|STARTED|Overall Study||300
3054386|NCT01236053|3774777|FG009|STARTED|Overall Study||2935
3054387|NCT01236053|3774778|FG010|STARTED|Overall Study||19564
3054388|NCT01236053|3774779|FG011|STARTED|Overall Study||188924
3054389|NCT01236053|3774780|FG012|STARTED|Overall Study||148
3054390|NCT01236053|3774781|FG013|STARTED|Overall Study||1396
3054391|NCT01236053|3774782|FG014|STARTED|Overall Study||4600
3054392|NCT01236053|3774783|FG015|STARTED|Overall Study||43559
3054393|NCT01236053|3774784|FG016|STARTED|Overall Study||38
3054394|NCT01236053|3774785|FG017|STARTED|Overall Study||380
3054395|NCT01236053|3774786|FG018|STARTED|Overall Study||2155
3054396|NCT01236053|3774787|FG019|STARTED|Overall Study||20382
3054397|NCT01236053|3774788|FG020|STARTED|Overall Study||1272
3054398|NCT01236053|3774789|FG021|STARTED|Overall Study||12167
3054399|NCT01236053|3774768|FG000|COMPLETED|Overall Study||179138
3054400|NCT01236053|3774769|FG001|COMPLETED|Overall Study||1710950
3054401|NCT01236053|3774770|FG002|COMPLETED|Overall Study||1877
3054402|NCT01236053|3774771|FG003|COMPLETED|Overall Study||17853
3054403|NCT01236053|3774772|FG004|COMPLETED|Overall Study||212
3054404|NCT01236053|3774773|FG005|COMPLETED|Overall Study||2067
3054405|NCT01236053|3774774|FG006|COMPLETED|Overall Study||10855
3054406|NCT01236053|3774775|FG007|COMPLETED|Overall Study||102836
3054407|NCT01236053|3774776|FG008|COMPLETED|Overall Study||300
3054408|NCT01236053|3774777|FG009|COMPLETED|Overall Study||2935
3160997|NCT01868542|3888258|FG000|STARTED|Overall Study||23
3160998|NCT01868542|3888259|FG001|STARTED|Overall Study||23
3160999|NCT01868542|3888258|FG000|COMPLETED|Overall Study||23
3161000|NCT01868542|3888259|FG001|COMPLETED|Overall Study||21
3161001|NCT01868542|3888258|FG000|NOT COMPLETED|Overall Study||0
3054409|NCT01236053|3774778|FG010|COMPLETED|Overall Study||19564
3054410|NCT01236053|3774779|FG011|COMPLETED|Overall Study||188924
3054411|NCT01236053|3774780|FG012|COMPLETED|Overall Study||148
3054412|NCT01236053|3774781|FG013|COMPLETED|Overall Study||1396
3054413|NCT01236053|3774782|FG014|COMPLETED|Overall Study||4600
3054414|NCT01236053|3774783|FG015|COMPLETED|Overall Study||43559
3054415|NCT01236053|3774784|FG016|COMPLETED|Overall Study||38
3054416|NCT01236053|3774785|FG017|COMPLETED|Overall Study||380
3054417|NCT01236053|3774786|FG018|COMPLETED|Overall Study||2155
3054418|NCT01236053|3774787|FG019|COMPLETED|Overall Study||20382
3054419|NCT01236053|3774788|FG020|COMPLETED|Overall Study||1272
3054420|NCT01236053|3774789|FG021|COMPLETED|Overall Study||12167
3054421|NCT01236053|3774768|FG000|NOT COMPLETED|Overall Study||0
3054422|NCT01236053|3774769|FG001|NOT COMPLETED|Overall Study||0
3054423|NCT01236053|3774770|FG002|NOT COMPLETED|Overall Study||0
3054424|NCT01236053|3774771|FG003|NOT COMPLETED|Overall Study||0
3054425|NCT01236053|3774772|FG004|NOT COMPLETED|Overall Study||0
3054426|NCT01236053|3774773|FG005|NOT COMPLETED|Overall Study||0
3054427|NCT01236053|3774774|FG006|NOT COMPLETED|Overall Study||0
3054428|NCT01236053|3774775|FG007|NOT COMPLETED|Overall Study||0
3054429|NCT01236053|3774776|FG008|NOT COMPLETED|Overall Study||0
3054430|NCT01236053|3774777|FG009|NOT COMPLETED|Overall Study||0
3054431|NCT01236053|3774778|FG010|NOT COMPLETED|Overall Study||0
3054432|NCT01236053|3774779|FG011|NOT COMPLETED|Overall Study||0
3054433|NCT01236053|3774780|FG012|NOT COMPLETED|Overall Study||0
3054434|NCT01236053|3774781|FG013|NOT COMPLETED|Overall Study||0
3054435|NCT01236053|3774782|FG014|NOT COMPLETED|Overall Study||0
3054436|NCT01236053|3774783|FG015|NOT COMPLETED|Overall Study||0
3054437|NCT01236053|3774784|FG016|NOT COMPLETED|Overall Study||0
3054438|NCT01236053|3774785|FG017|NOT COMPLETED|Overall Study||0
3054439|NCT01236053|3774786|FG018|NOT COMPLETED|Overall Study||0
3054440|NCT01236053|3774787|FG019|NOT COMPLETED|Overall Study||0
3054441|NCT01236053|3774788|FG020|NOT COMPLETED|Overall Study||0
3054442|NCT01236053|3774789|FG021|NOT COMPLETED|Overall Study||0
3054443|NCT01236105|3774838|FG000|STARTED|Overall Study||21
3054444|NCT01236105|3774838|FG000|COMPLETED|Overall Study||21
3054445|NCT01236105|3774838|FG000|NOT COMPLETED|Overall Study||0
3054446|NCT01236118|3774849|FG000|STARTED|Overall Study||6
3054447|NCT01236118|3774850|FG001|STARTED|Overall Study||5
3054448|NCT01236118|3774851|FG002|STARTED|Overall Study||17
3054449|NCT01236118|3774849|FG000|COMPLETED|Overall Study||4
3054450|NCT01236118|3774850|FG001|COMPLETED|Overall Study||4
3054451|NCT01236118|3774851|FG002|COMPLETED|Overall Study||14
3054452|NCT01236118|3774849|FG000|NOT COMPLETED|Overall Study||2
3054453|NCT01236118|3774850|FG001|NOT COMPLETED|Overall Study||1
3054454|NCT01236118|3774851|FG002|NOT COMPLETED|Overall Study||3
3054455|NCT01236170|3774859|FG000|STARTED|Overall Study||497
3054456|NCT01236170|3774859|FG000|COMPLETED|Overall Study||482
3054457|NCT01236170|3774859|FG000|NOT COMPLETED|Overall Study||15
3054458|NCT01236196|3774865|FG000|STARTED|Overall Study||18
3054459|NCT01236196|3774866|FG001|STARTED|Overall Study||21
3054460|NCT01236196|3774865|FG000|COMPLETED|Overall Study||17
3054461|NCT01236196|3774866|FG001|COMPLETED|Overall Study||13
3054462|NCT01236196|3774865|FG000|NOT COMPLETED|Overall Study||1
3054463|NCT01236196|3774866|FG001|NOT COMPLETED|Overall Study||8
3054464|NCT01236300|3774872|FG000|STARTED|Overall Study||66
3161002|NCT01868542|3888259|FG001|NOT COMPLETED|Overall Study||2
3054465|NCT01236300|3774872|FG000|COMPLETED|Overall Study||66
3054466|NCT01236300|3774872|FG000|NOT COMPLETED|Overall Study||0
3054467|NCT01236326|3774879|FG000|STARTED|Overall Study||50
3054468|NCT01236326|3774880|FG001|STARTED|Overall Study||55
3054469|NCT01236326|3774879|FG000|COMPLETED|Overall Study||49
3054470|NCT01236326|3774880|FG001|COMPLETED|Overall Study||51
3054471|NCT01236326|3774879|FG000|NOT COMPLETED|Overall Study||1
3054472|NCT01236326|3774880|FG001|NOT COMPLETED|Overall Study||4
3054473|NCT01236339|3774888|FG000|STARTED|Overall Study||13
3054474|NCT01236339|3774889|FG001|STARTED|Overall Study||13
3054475|NCT01236339|3774888|FG000|LVP Crossover to TIPS|Overall Study||0
3054476|NCT01236339|3774889|FG001|LVP Crossover to TIPS|Overall Study|ONLY patients failing LVP and meeting crossover according to protocol definition|4
3054477|NCT01236339|3774888|FG000|COMPLETED|Overall Study||2
3054478|NCT01236339|3774889|FG001|COMPLETED|Overall Study||0
3054479|NCT01236339|3774888|FG000|NOT COMPLETED|Overall Study||11
3054480|NCT01236339|3774889|FG001|NOT COMPLETED|Overall Study||13
3054481|NCT01236352|3774907|FG000|STARTED|Overall Study||4
3054482|NCT01236352|3774908|FG001|STARTED|Overall Study||4
3054483|NCT01236352|3774909|FG002|STARTED|Overall Study||4
3054484|NCT01236352|3774910|FG003|STARTED|Overall Study||4
3054485|NCT01236352|3774911|FG004|STARTED|Overall Study||4
3054486|NCT01236352|3774912|FG005|STARTED|Overall Study||4
3054487|NCT01236352|3774913|FG006|STARTED|Overall Study||8
3054488|NCT01236352|3774914|FG007|STARTED|Overall Study||7
3054489|NCT01236352|3774915|FG008|STARTED|Overall Study||3
3054490|NCT01236352|3774916|FG009|STARTED|Overall Study||22
3054491|NCT01236352|3774917|FG010|STARTED|Overall Study||20
3054492|NCT01236352|3774907|FG000|COMPLETED|Overall Study||0
3054493|NCT01236352|3774908|FG001|COMPLETED|Overall Study||0
3054494|NCT01236352|3774909|FG002|COMPLETED|Overall Study||0
3054495|NCT01236352|3774910|FG003|COMPLETED|Overall Study||1
3054496|NCT01236352|3774911|FG004|COMPLETED|Overall Study||0
3054497|NCT01236352|3774912|FG005|COMPLETED|Overall Study||0
3054498|NCT01236352|3774913|FG006|COMPLETED|Overall Study||0
3054499|NCT01236352|3774914|FG007|COMPLETED|Overall Study||0
3054500|NCT01236352|3774915|FG008|COMPLETED|Overall Study||0
3054501|NCT01236352|3774916|FG009|COMPLETED|Overall Study||0
3054502|NCT01236352|3774917|FG010|COMPLETED|Overall Study||0
3054503|NCT01236352|3774907|FG000|NOT COMPLETED|Overall Study||4
3054504|NCT01236352|3774908|FG001|NOT COMPLETED|Overall Study||4
3054505|NCT01236352|3774909|FG002|NOT COMPLETED|Overall Study||4
3054506|NCT01236352|3774910|FG003|NOT COMPLETED|Overall Study||3
3054507|NCT01236352|3774911|FG004|NOT COMPLETED|Overall Study||4
3054508|NCT01236352|3774912|FG005|NOT COMPLETED|Overall Study||4
3054509|NCT01236352|3774913|FG006|NOT COMPLETED|Overall Study||8
3054510|NCT01236352|3774914|FG007|NOT COMPLETED|Overall Study||7
3054511|NCT01236352|3774915|FG008|NOT COMPLETED|Overall Study||3
3054512|NCT01236352|3774916|FG009|NOT COMPLETED|Overall Study||22
3054513|NCT01236352|3774917|FG010|NOT COMPLETED|Overall Study||20
3054514|NCT01236365|3774943|FG000|STARTED|Overall Study||21
3054515|NCT01236365|3774944|FG001|STARTED|Overall Study||21
3054516|NCT01236365|3774943|FG000|COMPLETED|Overall Study||19
3054517|NCT01236365|3774944|FG001|COMPLETED|Overall Study||19
3054518|NCT01236365|3774943|FG000|NOT COMPLETED|Overall Study||2
3054519|NCT01236365|3774944|FG001|NOT COMPLETED|Overall Study||2
3054520|NCT01236378|3774962|FG000|STARTED|Overall Study||24
3054521|NCT01236378|3774962|FG000|COMPLETED|Overall Study||24
3054522|NCT01236378|3774962|FG000|NOT COMPLETED|Overall Study||0
3054523|NCT01236391|3774966|FG000|STARTED|Overall Study|Participants who received study treatment|111
3054524|NCT01236391|3774966|FG000|COMPLETED|Overall Study|Participants who were on treatment or discontinued treatment due to disease progression or death|95
3054525|NCT01236391|3774966|FG000|NOT COMPLETED|Overall Study||16
3054526|NCT01236521|3774975|FG000|STARTED|Overall Study||131
3054527|NCT01236521|3774976|FG001|STARTED|Overall Study||130
3054528|NCT01236521|3774975|FG000|3-month Completed|Overall Study||122
3054529|NCT01236521|3774976|FG001|3-month Completed|Overall Study||119
3054530|NCT01236521|3774975|FG000|6-month Completed|Overall Study||122
3054531|NCT01236521|3774976|FG001|6-month Completed|Overall Study||116
3054532|NCT01236521|3774975|FG000|9-month Completed|Overall Study||115
3054533|NCT01236521|3774976|FG001|9-month Completed|Overall Study||101
3054534|NCT01236521|3774975|FG000|12-moth Completed|Overall Study||110
3054535|NCT01236521|3774976|FG001|12-moth Completed|Overall Study||105
3054536|NCT01236521|3774975|FG000|COMPLETED|Overall Study||110
3054537|NCT01236521|3774976|FG001|COMPLETED|Overall Study||105
3054538|NCT01236521|3774975|FG000|NOT COMPLETED|Overall Study||21
3054539|NCT01236521|3774976|FG001|NOT COMPLETED|Overall Study||25
3054540|NCT01236534|3774984|FG000|STARTED|Overall Study||11
3054541|NCT01236534|3774985|FG001|STARTED|Overall Study||10
3054542|NCT01236534|3774984|FG000|COMPLETED|Overall Study|2 subjects stopped treatment due to diarrhea, and 1 stopped treatment due to constipation.|8
3054543|NCT01236534|3774985|FG001|COMPLETED|Overall Study||10
3054544|NCT01236534|3774984|FG000|NOT COMPLETED|Overall Study||3
3054545|NCT01236534|3774985|FG001|NOT COMPLETED|Overall Study||0
3054546|NCT01236547|3774996|FG000|STARTED|Overall Study||11
3054547|NCT01236547|3774997|FG001|STARTED|Overall Study||11
3054548|NCT01236547|3774998|FG002|STARTED|Overall Study||12
3054549|NCT01236547|3774999|FG003|STARTED|Overall Study||42
3054550|NCT01236547|3775000|FG004|STARTED|Overall Study||47
3054551|NCT01236547|3774996|FG000|Eligible|Overall Study||11
3054552|NCT01236547|3774997|FG001|Eligible|Overall Study||10
3054553|NCT01236547|3774998|FG002|Eligible|Overall Study||11
3054554|NCT01236547|3774999|FG003|Eligible|Overall Study||36
3054555|NCT01236547|3775000|FG004|Eligible|Overall Study||35
3054556|NCT01236547|3774996|FG000|Eligible and Started Study Treatment|Overall Study||11
3054557|NCT01236547|3774997|FG001|Eligible and Started Study Treatment|Overall Study||10
3054558|NCT01236547|3774998|FG002|Eligible and Started Study Treatment|Overall Study||11
3054559|NCT01236547|3774999|FG003|Eligible and Started Study Treatment|Overall Study||36
3054560|NCT01236547|3775000|FG004|Eligible and Started Study Treatment|Overall Study||34
3054561|NCT01236547|3774996|FG000|Eligible and Response Assessed|Overall Study||0
3054562|NCT01236547|3774997|FG001|Eligible and Response Assessed|Overall Study||0
3054563|NCT01236547|3774998|FG002|Eligible and Response Assessed|Overall Study||0
3054564|NCT01236547|3774999|FG003|Eligible and Response Assessed|Overall Study||23
3054565|NCT01236547|3775000|FG004|Eligible and Response Assessed|Overall Study||27
3054566|NCT01236547|3774996|FG000|COMPLETED|Overall Study||11
3054567|NCT01236547|3774997|FG001|COMPLETED|Overall Study||10
3054568|NCT01236547|3774998|FG002|COMPLETED|Overall Study||11
3054569|NCT01236547|3774999|FG003|COMPLETED|Overall Study||36
3054570|NCT01236547|3775000|FG004|COMPLETED|Overall Study||35
3054571|NCT01236547|3774996|FG000|NOT COMPLETED|Overall Study||0
3054572|NCT01236547|3774997|FG001|NOT COMPLETED|Overall Study||1
3054573|NCT01236547|3774998|FG002|NOT COMPLETED|Overall Study||1
3054574|NCT01236547|3774999|FG003|NOT COMPLETED|Overall Study||6
3054575|NCT01236547|3775000|FG004|NOT COMPLETED|Overall Study||12
3054576|NCT01236560|3775019|FG000|STARTED|Overall Study||6
3054577|NCT01236560|3775020|FG001|STARTED|Overall Study||32
3054578|NCT01236560|3775021|FG002|STARTED|Overall Study||31
3054579|NCT01236560|3775022|FG003|STARTED|Overall Study||32
3054580|NCT01236560|3775023|FG004|STARTED|Overall Study||0
3054581|NCT01236560|3775024|FG005|STARTED|Overall Study||0
3054582|NCT01236560|3775019|FG000|COMPLETED|Overall Study||1
3054583|NCT01236560|3775020|FG001|COMPLETED|Overall Study||8
3054584|NCT01236560|3775021|FG002|COMPLETED|Overall Study||11
3054585|NCT01236560|3775022|FG003|COMPLETED|Overall Study||10
3054586|NCT01236560|3775023|FG004|COMPLETED|Overall Study||0
3054587|NCT01236560|3775024|FG005|COMPLETED|Overall Study||0
3054588|NCT01236560|3775019|FG000|NOT COMPLETED|Overall Study||5
3054589|NCT01236560|3775020|FG001|NOT COMPLETED|Overall Study||24
3054590|NCT01236560|3775021|FG002|NOT COMPLETED|Overall Study||20
3054591|NCT01236560|3775022|FG003|NOT COMPLETED|Overall Study||22
3054592|NCT01236560|3775023|FG004|NOT COMPLETED|Overall Study||0
3054593|NCT01236560|3775024|FG005|NOT COMPLETED|Overall Study||0
3054594|NCT01236573|3775045|FG000|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||1
3054595|NCT01236573|3775046|FG001|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||1
3054596|NCT01236573|3775047|FG002|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||6
3054597|NCT01236573|3775048|FG003|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||1
3054598|NCT01236573|3775049|FG004|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
3054599|NCT01236573|3775050|FG005|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
3054600|NCT01236573|3775051|FG006|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
3054601|NCT01236573|3775052|FG007|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
3161003|NCT01868594|3888267|FG000|STARTED|Overall Study||76
3161004|NCT01868594|3888268|FG001|STARTED|Overall Study||75
3161005|NCT01868594|3888267|FG000|COMPLETED|Overall Study||72
3161006|NCT01868594|3888268|FG001|COMPLETED|Overall Study||72
3161007|NCT01868594|3888267|FG000|NOT COMPLETED|Overall Study||4
3161008|NCT01868594|3888268|FG001|NOT COMPLETED|Overall Study||3
3161009|NCT01868633|3888278|FG000|STARTED|Overall Study||26
3161010|NCT01868633|3888279|FG001|STARTED|Overall Study||26
3161011|NCT01868633|3888278|FG000|COMPLETED|Overall Study||26
3054602|NCT01236573|3775053|FG008|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
3054603|NCT01236573|3775054|FG009|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
3054604|NCT01236573|3775055|FG010|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
3054605|NCT01236573|3775045|FG000|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||1
3054606|NCT01236573|3775046|FG001|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||1
3054607|NCT01236573|3775047|FG002|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||6
3054608|NCT01236573|3775048|FG003|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||1
3054609|NCT01236573|3775049|FG004|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
3054610|NCT01236573|3775050|FG005|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
3054611|NCT01236573|3775051|FG006|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
3054612|NCT01236573|3775052|FG007|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
3054613|NCT01236573|3775053|FG008|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
3054614|NCT01236573|3775054|FG009|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
3054615|NCT01236573|3775055|FG010|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
3054616|NCT01236573|3775045|FG000|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
3054617|NCT01236573|3775046|FG001|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
3054618|NCT01236573|3775047|FG002|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
3054619|NCT01236573|3775048|FG003|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
3054620|NCT01236573|3775049|FG004|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
3054621|NCT01236573|3775050|FG005|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
3054622|NCT01236573|3775051|FG006|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
3054623|NCT01236573|3775052|FG007|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
3054624|NCT01236573|3775053|FG008|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
3161012|NCT01868633|3888279|FG001|COMPLETED|Overall Study||26
3161013|NCT01868633|3888278|FG000|NOT COMPLETED|Overall Study||0
3161014|NCT01868633|3888279|FG001|NOT COMPLETED|Overall Study||0
3054625|NCT01236573|3775054|FG009|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
3054626|NCT01236573|3775055|FG010|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
3054627|NCT01236573|3775045|FG000|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||0
3054628|NCT01236573|3775046|FG001|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||0
3054629|NCT01236573|3775047|FG002|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||0
3054630|NCT01236573|3775048|FG003|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||0
3054631|NCT01236573|3775049|FG004|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||1
3054632|NCT01236573|3775050|FG005|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||4
3054633|NCT01236573|3775051|FG006|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||3
3054634|NCT01236573|3775052|FG007|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||3
3054635|NCT01236573|3775053|FG008|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||4
3054636|NCT01236573|3775054|FG009|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||4
3054637|NCT01236573|3775055|FG010|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||0
3054638|NCT01236573|3775045|FG000|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
3054639|NCT01236573|3775046|FG001|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
3054640|NCT01236573|3775047|FG002|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
3054641|NCT01236573|3775048|FG003|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
3054642|NCT01236573|3775049|FG004|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||1
3054643|NCT01236573|3775050|FG005|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||4
3054644|NCT01236573|3775051|FG006|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||2
3054645|NCT01236573|3775052|FG007|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||3
3054646|NCT01236573|3775053|FG008|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||2
3054647|NCT01236573|3775054|FG009|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||3
3054648|NCT01236573|3775055|FG010|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
3054649|NCT01236573|3775045|FG000|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
3054650|NCT01236573|3775046|FG001|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
3054651|NCT01236573|3775047|FG002|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
3054652|NCT01236573|3775048|FG003|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
3054653|NCT01236573|3775049|FG004|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
3054654|NCT01236573|3775050|FG005|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
3054655|NCT01236573|3775051|FG006|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||1
3054656|NCT01236573|3775052|FG007|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
3054657|NCT01236573|3775053|FG008|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||2
3054658|NCT01236573|3775054|FG009|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||1
3054659|NCT01236573|3775055|FG010|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
3054660|NCT01236573|3775045|FG000|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
3054661|NCT01236573|3775046|FG001|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
3054662|NCT01236573|3775047|FG002|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
3054663|NCT01236573|3775048|FG003|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
3054664|NCT01236573|3775049|FG004|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
3054665|NCT01236573|3775050|FG005|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
3054666|NCT01236573|3775051|FG006|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
3054667|NCT01236573|3775052|FG007|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
3283792|NCT02759315|4017598|FG002|STARTED|Overall Study||39
3283793|NCT02759315|4017599|FG003|STARTED|Overall Study||20
3283794|NCT02759315|4017600|FG004|STARTED|Overall Study||3
3283795|NCT02759315|4017596|FG000|COMPLETED|Overall Study||65
3283796|NCT02759315|4017597|FG001|COMPLETED|Overall Study||28
3283797|NCT02759315|4017598|FG002|COMPLETED|Overall Study||29
3283798|NCT02759315|4017599|FG003|COMPLETED|Overall Study||19
3283799|NCT02759315|4017600|FG004|COMPLETED|Overall Study||2
3054668|NCT01236573|3775053|FG008|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
3054669|NCT01236573|3775054|FG009|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
3054670|NCT01236573|3775055|FG010|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||6
3054671|NCT01236573|3775045|FG000|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
3054672|NCT01236573|3775046|FG001|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
3054673|NCT01236573|3775047|FG002|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
3054674|NCT01236573|3775048|FG003|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
3054675|NCT01236573|3775049|FG004|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
3054676|NCT01236573|3775050|FG005|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
3054677|NCT01236573|3775051|FG006|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
3054678|NCT01236573|3775052|FG007|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
3054679|NCT01236573|3775053|FG008|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
3054680|NCT01236573|3775054|FG009|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
3054681|NCT01236573|3775055|FG010|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||5
3054682|NCT01236573|3775045|FG000|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
3054683|NCT01236573|3775046|FG001|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
3054684|NCT01236573|3775047|FG002|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
3054685|NCT01236573|3775048|FG003|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
3054686|NCT01236573|3775049|FG004|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
3054687|NCT01236573|3775050|FG005|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
3054688|NCT01236573|3775051|FG006|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
3054689|NCT01236573|3775052|FG007|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
3283800|NCT02759315|4017596|FG000|NOT COMPLETED|Overall Study||4
3283801|NCT02759315|4017597|FG001|NOT COMPLETED|Overall Study||1
3054690|NCT01236573|3775053|FG008|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
3054691|NCT01236573|3775054|FG009|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
3054692|NCT01236573|3775055|FG010|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||1
3161015|NCT01868646|3888287|FG000|STARTED|Overall Study||76
3161016|NCT01868646|3888288|FG001|STARTED|Overall Study||72
3161017|NCT01868646|3888287|FG000|COMPLETED|Overall Study||73
3161018|NCT01868646|3888288|FG001|COMPLETED|Overall Study||67
3161019|NCT01868646|3888287|FG000|NOT COMPLETED|Overall Study||3
3161020|NCT01868646|3888288|FG001|NOT COMPLETED|Overall Study||5
3161021|NCT01868776|3888296|FG000|STARTED|Overall Study||50
3054693|NCT01236742|3775083|FG000|STARTED|Overall Study||18
3054694|NCT01236742|3775084|FG001|STARTED|Overall Study||19
3054695|NCT01236742|3775085|FG002|STARTED|Overall Study||16
3054696|NCT01236742|3775083|FG000|COMPLETED|Overall Study||15
3054697|NCT01236742|3775084|FG001|COMPLETED|Overall Study||16
3054698|NCT01236742|3775085|FG002|COMPLETED|Overall Study||13
3054699|NCT01236742|3775083|FG000|NOT COMPLETED|Overall Study||3
3161022|NCT01868776|3888297|FG001|STARTED|Overall Study||50
3161023|NCT01868776|3888296|FG000|COMPLETED|Overall Study||50
3161024|NCT01868776|3888297|FG001|COMPLETED|Overall Study||50
3161025|NCT01868776|3888296|FG000|NOT COMPLETED|Overall Study||0
3161026|NCT01868776|3888297|FG001|NOT COMPLETED|Overall Study||0
3161027|NCT01868789|3888305|FG000|STARTED|Overall Study||9
3054700|NCT01236742|3775084|FG001|NOT COMPLETED|Overall Study||3
3054701|NCT01236742|3775085|FG002|NOT COMPLETED|Overall Study||3
3054702|NCT01236755|3775093|FG000|STARTED|Spectacles Wearing Phase||91
3054703|NCT01236755|3775093|FG000|COMPLETED|Spectacles Wearing Phase||74
3054704|NCT01236755|3775093|FG000|NOT COMPLETED|Spectacles Wearing Phase||17
3054705|NCT01236755|3775093|FG000|STARTED|Orthokeratology Wearing Phase||74
3054706|NCT01236755|3775093|FG000|COMPLETED|Orthokeratology Wearing Phase||66
3054707|NCT01236755|3775093|FG000|NOT COMPLETED|Orthokeratology Wearing Phase||8
3054708|NCT01236768|3775100|FG000|STARTED|Overall Study||201
3054709|NCT01236768|3775101|FG001|STARTED|Overall Study||206
3054710|NCT01236768|3775100|FG000|COMPLETED|Overall Study||112
3054711|NCT01236768|3775101|FG001|COMPLETED|Overall Study||145
3054712|NCT01236768|3775100|FG000|NOT COMPLETED|Overall Study||89
3054713|NCT01236768|3775101|FG001|NOT COMPLETED|Overall Study||61
3054714|NCT01237041|3775113|FG000|STARTED|Overall Study||2
3054715|NCT01237041|3775114|FG001|STARTED|Overall Study||3
3054716|NCT01237041|3775115|FG002|STARTED|Overall Study||2
3054717|NCT01237041|3775116|FG003|STARTED|Overall Study||5
3054718|NCT01237041|3775117|FG004|STARTED|Overall Study||5
3054719|NCT01237041|3775113|FG000|COMPLETED|Overall Study||2
3054720|NCT01237041|3775114|FG001|COMPLETED|Overall Study||3
3054721|NCT01237041|3775115|FG002|COMPLETED|Overall Study||2
3054722|NCT01237041|3775116|FG003|COMPLETED|Overall Study||5
3054723|NCT01237041|3775117|FG004|COMPLETED|Overall Study||5
3054724|NCT01237041|3775113|FG000|NOT COMPLETED|Overall Study||0
3054725|NCT01237041|3775114|FG001|NOT COMPLETED|Overall Study||0
3054726|NCT01237041|3775115|FG002|NOT COMPLETED|Overall Study||0
3054727|NCT01237041|3775116|FG003|NOT COMPLETED|Overall Study||0
3054728|NCT01237041|3775117|FG004|NOT COMPLETED|Overall Study||0
3054729|NCT01237054|3775127|FG000|STARTED|Overall Study||31
3054730|NCT01237054|3775127|FG000|COMPLETED|Overall Study||30
3054731|NCT01237054|3775127|FG000|NOT COMPLETED|Overall Study||1
3054732|NCT01237080|3775136|FG000|STARTED|Overall Study||50
3054733|NCT01237080|3775137|FG001|STARTED|Overall Study||50
3054734|NCT01237080|3775136|FG000|COMPLETED|Overall Study||50
3054735|NCT01237080|3775137|FG001|COMPLETED|Overall Study||50
3161028|NCT01868789|3888306|FG001|STARTED|Overall Study||14
3161029|NCT01868789|3888305|FG000|COMPLETED|Overall Study||7
3161030|NCT01868789|3888306|FG001|COMPLETED|Overall Study||12
3161031|NCT01868789|3888305|FG000|NOT COMPLETED|Overall Study||2
3161032|NCT01868789|3888306|FG001|NOT COMPLETED|Overall Study||2
3161033|NCT01868893|3888312|FG000|STARTED|Overall Study||20
3161034|NCT01868893|3888312|FG000|COMPLETED|Overall Study||0
3161035|NCT01868893|3888312|FG000|NOT COMPLETED|Overall Study||20
3161036|NCT01868997|3888320|FG000|STARTED|Overall Study|randomized and treated|45
3161037|NCT01868997|3888321|FG001|STARTED|Overall Study|randomized and treated|42
3161038|NCT01868997|3888320|FG000|COMPLETED|Overall Study||38
3161039|NCT01868997|3888321|FG001|COMPLETED|Overall Study||36
3161040|NCT01868997|3888320|FG000|NOT COMPLETED|Overall Study||7
3161041|NCT01868997|3888321|FG001|NOT COMPLETED|Overall Study||6
3161042|NCT01869075|3888333|FG000|STARTED|Phase 0 (Baseline)|Phase 0 was the baseline phase. No intervention had been started.|0
3161043|NCT01869075|3888334|FG001|STARTED|Phase 0 (Baseline)||418
3161044|NCT01869075|3888335|FG002|STARTED|Phase 0 (Baseline)|Phase 0 was the baseline phase. No intervention had been started.|0
3161045|NCT01869075|3888336|FG003|STARTED|Phase 0 (Baseline)||416
3161046|NCT01869075|3888337|FG004|STARTED|Phase 0 (Baseline)|Phase 0 was the baseline phase. No intervention had been started.|0
3161047|NCT01869075|3888338|FG005|STARTED|Phase 0 (Baseline)||341
3161048|NCT01869075|3888333|FG000|COMPLETED|Phase 0 (Baseline)||0
3161049|NCT01869075|3888334|FG001|COMPLETED|Phase 0 (Baseline)||418
3161050|NCT01869075|3888335|FG002|COMPLETED|Phase 0 (Baseline)||0
3161051|NCT01869075|3888336|FG003|COMPLETED|Phase 0 (Baseline)||416
3161052|NCT01869075|3888337|FG004|COMPLETED|Phase 0 (Baseline)||0
3161053|NCT01869075|3888338|FG005|COMPLETED|Phase 0 (Baseline)||341
3161054|NCT01869075|3888333|FG000|NOT COMPLETED|Phase 0 (Baseline)||0
3161055|NCT01869075|3888334|FG001|NOT COMPLETED|Phase 0 (Baseline)||0
3161056|NCT01869075|3888335|FG002|NOT COMPLETED|Phase 0 (Baseline)||0
3161057|NCT01869075|3888336|FG003|NOT COMPLETED|Phase 0 (Baseline)||0
3161058|NCT01869075|3888337|FG004|NOT COMPLETED|Phase 0 (Baseline)||0
3161059|NCT01869075|3888338|FG005|NOT COMPLETED|Phase 0 (Baseline)||0
3161060|NCT01869075|3888333|FG000|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|45
3161061|NCT01869075|3888334|FG001|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|75
3161062|NCT01869075|3888335|FG002|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|45
3171731|NCT01936857|3898921|FG000|STARTED|Overall Study||141
3054736|NCT01237080|3775136|FG000|NOT COMPLETED|Overall Study||0
3054737|NCT01237080|3775137|FG001|NOT COMPLETED|Overall Study||0
3054738|NCT01237197|3775145|FG000|STARTED|Randomization Period||13
3054739|NCT01237197|3775146|FG001|STARTED|Randomization Period||13
3054740|NCT01237197|3775145|FG000|COMPLETED|Randomization Period||12
3054741|NCT01237197|3775146|FG001|COMPLETED|Randomization Period||10
3054742|NCT01237197|3775145|FG000|NOT COMPLETED|Randomization Period||1
3054743|NCT01237197|3775146|FG001|NOT COMPLETED|Randomization Period||3
3054744|NCT01237197|3775145|FG000|STARTED|Open Label Period||12
3054745|NCT01237197|3775146|FG001|STARTED|Open Label Period||10
3054746|NCT01237197|3775145|FG000|COMPLETED|Open Label Period||12
3054747|NCT01237197|3775146|FG001|COMPLETED|Open Label Period||10
3054748|NCT01237197|3775145|FG000|NOT COMPLETED|Open Label Period||0
3054749|NCT01237197|3775146|FG001|NOT COMPLETED|Open Label Period||0
3054750|NCT01237223|3775158|FG000|STARTED|Single Blind(Run-in Period, 4 Weeks)|All the patients enrolled to single blind period received only placebo treatment.|1342
3054751|NCT01237223|3775159|FG001|STARTED|Single Blind(Run-in Period, 4 Weeks)||0
3054752|NCT01237223|3775160|FG002|STARTED|Single Blind(Run-in Period, 4 Weeks)||0
3054753|NCT01237223|3775161|FG003|STARTED|Single Blind(Run-in Period, 4 Weeks)||0
3054754|NCT01237223|3775162|FG004|STARTED|Single Blind(Run-in Period, 4 Weeks)||0
3054755|NCT01237223|3775163|FG005|STARTED|Single Blind(Run-in Period, 4 Weeks)||0
3054756|NCT01237223|3775158|FG000|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||944
3054757|NCT01237223|3775159|FG001|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
3054758|NCT01237223|3775160|FG002|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
3054759|NCT01237223|3775161|FG003|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
3054760|NCT01237223|3775162|FG004|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
3054761|NCT01237223|3775163|FG005|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
3054762|NCT01237223|3775158|FG000|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||398
3054763|NCT01237223|3775159|FG001|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
3054764|NCT01237223|3775160|FG002|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
3054765|NCT01237223|3775161|FG003|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
3054766|NCT01237223|3775162|FG004|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
3283802|NCT02759315|4017598|FG002|NOT COMPLETED|Overall Study||10
3283803|NCT02759315|4017599|FG003|NOT COMPLETED|Overall Study||1
3283804|NCT02759315|4017600|FG004|NOT COMPLETED|Overall Study||1
3283805|NCT02759354|4017618|FG000|STARTED|Overall Study||192
3283806|NCT02759354|4017619|FG001|STARTED|Overall Study||190
3054767|NCT01237223|3775163|FG005|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
3054768|NCT01237223|3775158|FG000|STARTED|Double Blind (Treatment Period, 8 Weeks)||153
3054769|NCT01237223|3775159|FG001|STARTED|Double Blind (Treatment Period, 8 Weeks)||157
3054770|NCT01237223|3775160|FG002|STARTED|Double Blind (Treatment Period, 8 Weeks)||158
3054771|NCT01237223|3775161|FG003|STARTED|Double Blind (Treatment Period, 8 Weeks)||158
3054772|NCT01237223|3775162|FG004|STARTED|Double Blind (Treatment Period, 8 Weeks)||159
3054773|NCT01237223|3775163|FG005|STARTED|Double Blind (Treatment Period, 8 Weeks)||159
3054774|NCT01237223|3775158|FG000|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||120
3054775|NCT01237223|3775159|FG001|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||142
3054776|NCT01237223|3775160|FG002|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||143
3054777|NCT01237223|3775161|FG003|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||153
3054778|NCT01237223|3775162|FG004|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||155
3054779|NCT01237223|3775163|FG005|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||154
3054780|NCT01237223|3775158|FG000|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||33
3054781|NCT01237223|3775159|FG001|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||15
3054782|NCT01237223|3775160|FG002|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||15
3054783|NCT01237223|3775161|FG003|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||5
3054784|NCT01237223|3775162|FG004|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||4
3054785|NCT01237223|3775163|FG005|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||5
3054786|NCT01237301|3775181|FG000|STARTED|Overall Study||65
3054787|NCT01237301|3775182|FG001|STARTED|Overall Study||59
3054788|NCT01237301|3775181|FG000|COMPLETED|Overall Study||60
3054789|NCT01237301|3775182|FG001|COMPLETED|Overall Study||55
3054790|NCT01237301|3775181|FG000|NOT COMPLETED|Overall Study||5
3054791|NCT01237301|3775182|FG001|NOT COMPLETED|Overall Study||4
3054792|NCT01237327|3775192|FG000|STARTED|Overall Study||43
3054793|NCT01237327|3775193|FG001|STARTED|Overall Study||41
3054794|NCT01237327|3775192|FG000|Stopped Treatment in Core Study (D/C)|Overall Study|Continued in Extension Study for follow-up only; not treated with study medication.|22
3054795|NCT01237327|3775193|FG001|Stopped Treatment in Core Study (D/C)|Overall Study|Continued in Extension Study for follow-up only; not treated with study medication.|24
3054796|NCT01237327|3775192|FG000|Completed Treatment in Core Study|Overall Study|Completed 26 weeks of treatment in Core Study; continued in Extension Study for follow-up only.|3
3133952|NCT01698554|3858909|FG001|NOT COMPLETED|Overall Study||10
3054797|NCT01237327|3775193|FG001|Completed Treatment in Core Study|Overall Study|Completed 26 weeks of treatment in Core Study; continued in Extension Study for follow-up only.|2
3054798|NCT01237327|3775192|FG000|Continued Treatment in Extension Study|Overall Study||21
3054799|NCT01237327|3775193|FG001|Continued Treatment in Extension Study|Overall Study||17
3054800|NCT01237327|3775192|FG000|COMPLETED|Overall Study|On treatment at Extension Study cut-off date.|1
3054801|NCT01237327|3775193|FG001|COMPLETED|Overall Study|On treatment at Extension Study cut-off date.|1
3054802|NCT01237327|3775192|FG000|NOT COMPLETED|Overall Study||42
3054803|NCT01237327|3775193|FG001|NOT COMPLETED|Overall Study||40
3054804|NCT01237340|3775199|FG000|STARTED|Overall Study||59
3054805|NCT01237340|3775199|FG000|COMPLETED|Overall Study||19
3054806|NCT01237340|3775199|FG000|NOT COMPLETED|Overall Study||40
3054807|NCT01237353|3775206|FG000|STARTED|Overall Study||6
3054808|NCT01237353|3775206|FG000|COMPLETED|Overall Study||6
3054809|NCT01237353|3775206|FG000|NOT COMPLETED|Overall Study||0
3054810|NCT01237587|3775212|FG000|STARTED|Double Blind Treatment (Acute Phase)||91
3054811|NCT01237587|3775213|FG001|STARTED|Double Blind Treatment (Acute Phase)||93
3054812|NCT01237587|3775212|FG000|Received at Least One Dose of Study Drug|Double Blind Treatment (Acute Phase)||91
3054813|NCT01237587|3775213|FG001|Received at Least One Dose of Study Drug|Double Blind Treatment (Acute Phase)||93
3054814|NCT01237587|3775212|FG000|COMPLETED|Double Blind Treatment (Acute Phase)||74
3054815|NCT01237587|3775213|FG001|COMPLETED|Double Blind Treatment (Acute Phase)||75
3054816|NCT01237587|3775212|FG000|NOT COMPLETED|Double Blind Treatment (Acute Phase)||17
3054817|NCT01237587|3775213|FG001|NOT COMPLETED|Double Blind Treatment (Acute Phase)||18
3054818|NCT01237587|3775212|FG000|STARTED|Open Label Treatment (Extension Phase)||74
3054819|NCT01237587|3775213|FG001|STARTED|Open Label Treatment (Extension Phase)||75
3054820|NCT01237587|3775212|FG000|Received at Least One Dose of Study Drug|Open Label Treatment (Extension Phase)||74
3054821|NCT01237587|3775213|FG001|Received at Least One Dose of Study Drug|Open Label Treatment (Extension Phase)||75
3054822|NCT01237587|3775212|FG000|COMPLETED|Open Label Treatment (Extension Phase)||56
3054823|NCT01237587|3775213|FG001|COMPLETED|Open Label Treatment (Extension Phase)||50
3054824|NCT01237587|3775212|FG000|NOT COMPLETED|Open Label Treatment (Extension Phase)||18
3054825|NCT01237587|3775213|FG001|NOT COMPLETED|Open Label Treatment (Extension Phase)||25
3054826|NCT01237587|3775212|FG000|STARTED|Taper Phase|Participants who discontinued Acute or Extension phase had an option to enter tapering phase.|36
3054827|NCT01237587|3775213|FG001|STARTED|Taper Phase|Participants who discontinued Acute or Extension phase had an option to enter tapering phase.|44
3054828|NCT01237587|3775212|FG000|COMPLETED|Taper Phase||31
3054829|NCT01237587|3775213|FG001|COMPLETED|Taper Phase||34
3054830|NCT01237587|3775212|FG000|NOT COMPLETED|Taper Phase||5
3054831|NCT01237587|3775213|FG001|NOT COMPLETED|Taper Phase||10
3054832|NCT01237678|3775229|FG000|STARTED|Phase I - IMGN901+Carboplatin+Etoposide||33
3054833|NCT01237678|3775230|FG001|STARTED|Phase I - IMGN901+Carboplatin+Etoposide||0
3054834|NCT01237678|3775231|FG002|STARTED|Phase I - IMGN901+Carboplatin+Etoposide||0
3054835|NCT01237678|3775229|FG000|Received Intervention|Phase I - IMGN901+Carboplatin+Etoposide||33
3054836|NCT01237678|3775230|FG001|Received Intervention|Phase I - IMGN901+Carboplatin+Etoposide||0
3054837|NCT01237678|3775231|FG002|Received Intervention|Phase I - IMGN901+Carboplatin+Etoposide||0
3054838|NCT01237678|3775229|FG000|COMPLETED|Phase I - IMGN901+Carboplatin+Etoposide||0
3054839|NCT01237678|3775230|FG001|COMPLETED|Phase I - IMGN901+Carboplatin+Etoposide||0
3054840|NCT01237678|3775231|FG002|COMPLETED|Phase I - IMGN901+Carboplatin+Etoposide||0
3054841|NCT01237678|3775229|FG000|NOT COMPLETED|Phase I - IMGN901+Carboplatin+Etoposide||33
3054842|NCT01237678|3775230|FG001|NOT COMPLETED|Phase I - IMGN901+Carboplatin+Etoposide||0
3054843|NCT01237678|3775231|FG002|NOT COMPLETED|Phase I - IMGN901+Carboplatin+Etoposide||0
3054844|NCT01237678|3775229|FG000|STARTED|Phase II||0
3054845|NCT01237678|3775230|FG001|STARTED|Phase II|98 subjects were randomized, 94 subjects treated|98
3054846|NCT01237678|3775231|FG002|STARTED|Phase II|50 subjects were randomized, 47 subjects treated|50
3054847|NCT01237678|3775229|FG000|Received Intervention|Phase II||0
3054848|NCT01237678|3775230|FG001|Received Intervention|Phase II||94
3054849|NCT01237678|3775231|FG002|Received Intervention|Phase II||47
3054850|NCT01237678|3775229|FG000|COMPLETED|Phase II||0
3054851|NCT01237678|3775230|FG001|COMPLETED|Phase II||0
3054852|NCT01237678|3775231|FG002|COMPLETED|Phase II||0
3054853|NCT01237678|3775229|FG000|NOT COMPLETED|Phase II||0
3054854|NCT01237678|3775230|FG001|NOT COMPLETED|Phase II||98
3054855|NCT01237678|3775231|FG002|NOT COMPLETED|Phase II||50
3054856|NCT01237821|3775248|FG000|STARTED|Overall Study||32
3054857|NCT01237821|3775249|FG001|STARTED|Overall Study||34
3054858|NCT01237821|3775248|FG000|COMPLETED|Overall Study||26
3054859|NCT01237821|3775249|FG001|COMPLETED|Overall Study||34
3054860|NCT01237821|3775248|FG000|NOT COMPLETED|Overall Study||6
3054861|NCT01237821|3775249|FG001|NOT COMPLETED|Overall Study||0
3054862|NCT01237899|3775266|FG000|STARTED|First Dosing Period||1
3054863|NCT01237899|3775267|FG001|STARTED|First Dosing Period||3
3054864|NCT01237899|3775268|FG002|STARTED|First Dosing Period||4
3054865|NCT01237899|3775269|FG003|STARTED|First Dosing Period||3
3054866|NCT01237899|3775270|FG004|STARTED|First Dosing Period||2
3054867|NCT01237899|3775271|FG005|STARTED|First Dosing Period||4
3054868|NCT01237899|3775272|FG006|STARTED|First Dosing Period||1
3054869|NCT01237899|3775273|FG007|STARTED|First Dosing Period||3
3054870|NCT01237899|3775274|FG008|STARTED|First Dosing Period||4
3054871|NCT01237899|3775275|FG009|STARTED|First Dosing Period||3
3054872|NCT01237899|3775276|FG010|STARTED|First Dosing Period||4
3054873|NCT01237899|3775266|FG000|COMPLETED|First Dosing Period||1
3054874|NCT01237899|3775267|FG001|COMPLETED|First Dosing Period||3
3054875|NCT01237899|3775268|FG002|COMPLETED|First Dosing Period||4
3054876|NCT01237899|3775269|FG003|COMPLETED|First Dosing Period||3
3054877|NCT01237899|3775270|FG004|COMPLETED|First Dosing Period||2
3054878|NCT01237899|3775271|FG005|COMPLETED|First Dosing Period||4
3054879|NCT01237899|3775272|FG006|COMPLETED|First Dosing Period||1
3054880|NCT01237899|3775273|FG007|COMPLETED|First Dosing Period||3
3054881|NCT01237899|3775274|FG008|COMPLETED|First Dosing Period||4
3054882|NCT01237899|3775275|FG009|COMPLETED|First Dosing Period||3
3054883|NCT01237899|3775276|FG010|COMPLETED|First Dosing Period||4
3054884|NCT01237899|3775266|FG000|NOT COMPLETED|First Dosing Period||0
3054885|NCT01237899|3775267|FG001|NOT COMPLETED|First Dosing Period||0
3054886|NCT01237899|3775268|FG002|NOT COMPLETED|First Dosing Period||0
3054887|NCT01237899|3775269|FG003|NOT COMPLETED|First Dosing Period||0
3054888|NCT01237899|3775270|FG004|NOT COMPLETED|First Dosing Period||0
3054889|NCT01237899|3775271|FG005|NOT COMPLETED|First Dosing Period||0
3054890|NCT01237899|3775272|FG006|NOT COMPLETED|First Dosing Period||0
3054891|NCT01237899|3775273|FG007|NOT COMPLETED|First Dosing Period||0
3054892|NCT01237899|3775274|FG008|NOT COMPLETED|First Dosing Period||0
3054893|NCT01237899|3775275|FG009|NOT COMPLETED|First Dosing Period||0
3054894|NCT01237899|3775276|FG010|NOT COMPLETED|First Dosing Period||0
3054895|NCT01237899|3775266|FG000|STARTED|Washout Period of at Least 7 Days||1
3054896|NCT01237899|3775267|FG001|STARTED|Washout Period of at Least 7 Days||3
3054897|NCT01237899|3775268|FG002|STARTED|Washout Period of at Least 7 Days||4
3054898|NCT01237899|3775269|FG003|STARTED|Washout Period of at Least 7 Days||3
3054899|NCT01237899|3775270|FG004|STARTED|Washout Period of at Least 7 Days||2
3054900|NCT01237899|3775271|FG005|STARTED|Washout Period of at Least 7 Days||4
3054901|NCT01237899|3775272|FG006|STARTED|Washout Period of at Least 7 Days||1
3054902|NCT01237899|3775273|FG007|STARTED|Washout Period of at Least 7 Days||3
3054903|NCT01237899|3775274|FG008|STARTED|Washout Period of at Least 7 Days||4
3054904|NCT01237899|3775275|FG009|STARTED|Washout Period of at Least 7 Days||3
3054905|NCT01237899|3775276|FG010|STARTED|Washout Period of at Least 7 Days||4
3054906|NCT01237899|3775266|FG000|COMPLETED|Washout Period of at Least 7 Days||1
3054907|NCT01237899|3775267|FG001|COMPLETED|Washout Period of at Least 7 Days||3
3054908|NCT01237899|3775268|FG002|COMPLETED|Washout Period of at Least 7 Days||3
3054909|NCT01237899|3775269|FG003|COMPLETED|Washout Period of at Least 7 Days||3
3054910|NCT01237899|3775270|FG004|COMPLETED|Washout Period of at Least 7 Days||2
3054911|NCT01237899|3775271|FG005|COMPLETED|Washout Period of at Least 7 Days||4
3054912|NCT01237899|3775272|FG006|COMPLETED|Washout Period of at Least 7 Days||1
3054913|NCT01237899|3775273|FG007|COMPLETED|Washout Period of at Least 7 Days||3
3054914|NCT01237899|3775274|FG008|COMPLETED|Washout Period of at Least 7 Days||4
3054915|NCT01237899|3775275|FG009|COMPLETED|Washout Period of at Least 7 Days||3
3054916|NCT01237899|3775276|FG010|COMPLETED|Washout Period of at Least 7 Days||4
3054917|NCT01237899|3775266|FG000|NOT COMPLETED|Washout Period of at Least 7 Days||0
3054918|NCT01237899|3775267|FG001|NOT COMPLETED|Washout Period of at Least 7 Days||0
3054919|NCT01237899|3775268|FG002|NOT COMPLETED|Washout Period of at Least 7 Days||1
3054920|NCT01237899|3775269|FG003|NOT COMPLETED|Washout Period of at Least 7 Days||0
3054921|NCT01237899|3775270|FG004|NOT COMPLETED|Washout Period of at Least 7 Days||0
3054922|NCT01237899|3775271|FG005|NOT COMPLETED|Washout Period of at Least 7 Days||0
3054923|NCT01237899|3775272|FG006|NOT COMPLETED|Washout Period of at Least 7 Days||0
3054924|NCT01237899|3775273|FG007|NOT COMPLETED|Washout Period of at Least 7 Days||0
3054925|NCT01237899|3775274|FG008|NOT COMPLETED|Washout Period of at Least 7 Days||0
3054926|NCT01237899|3775275|FG009|NOT COMPLETED|Washout Period of at Least 7 Days||0
3054927|NCT01237899|3775276|FG010|NOT COMPLETED|Washout Period of at Least 7 Days||0
3054928|NCT01237899|3775266|FG000|STARTED|Second Dosing Period||1
3054929|NCT01237899|3775267|FG001|STARTED|Second Dosing Period||3
3054930|NCT01237899|3775268|FG002|STARTED|Second Dosing Period||3
3054931|NCT01237899|3775269|FG003|STARTED|Second Dosing Period||3
3283807|NCT02759354|4017620|FG002|STARTED|Overall Study||181
3283808|NCT02759354|4017621|FG003|STARTED|Overall Study||191
3283809|NCT02759354|4017618|FG000|COMPLETED|Overall Study||192
3283810|NCT02759354|4017619|FG001|COMPLETED|Overall Study||190
3161063|NCT01869075|3888336|FG003|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|75
3161064|NCT01869075|3888337|FG004|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|30
3161065|NCT01869075|3888338|FG005|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|90
3161066|NCT01869075|3888333|FG000|COMPLETED|Phase 1||45
3161067|NCT01869075|3888334|FG001|COMPLETED|Phase 1||75
3161068|NCT01869075|3888335|FG002|COMPLETED|Phase 1||45
3161069|NCT01869075|3888336|FG003|COMPLETED|Phase 1||75
3161070|NCT01869075|3888337|FG004|COMPLETED|Phase 1||30
3161071|NCT01869075|3888338|FG005|COMPLETED|Phase 1||90
3161072|NCT01869075|3888333|FG000|NOT COMPLETED|Phase 1||0
3161073|NCT01869075|3888334|FG001|NOT COMPLETED|Phase 1||0
3161074|NCT01869075|3888335|FG002|NOT COMPLETED|Phase 1||0
3161075|NCT01869075|3888336|FG003|NOT COMPLETED|Phase 1||0
3161076|NCT01869075|3888337|FG004|NOT COMPLETED|Phase 1||0
3161077|NCT01869075|3888338|FG005|NOT COMPLETED|Phase 1||0
3161078|NCT01869075|3888333|FG000|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|90
3161079|NCT01869075|3888334|FG001|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|30
3283811|NCT02759354|4017620|FG002|COMPLETED|Overall Study||181
3283812|NCT02759354|4017621|FG003|COMPLETED|Overall Study||191
3283813|NCT02759354|4017618|FG000|NOT COMPLETED|Overall Study||0
3054932|NCT01237899|3775270|FG004|STARTED|Second Dosing Period||2
3054933|NCT01237899|3775271|FG005|STARTED|Second Dosing Period||4
3054934|NCT01237899|3775272|FG006|STARTED|Second Dosing Period||1
3054935|NCT01237899|3775273|FG007|STARTED|Second Dosing Period||3
3054936|NCT01237899|3775274|FG008|STARTED|Second Dosing Period||4
3054937|NCT01237899|3775275|FG009|STARTED|Second Dosing Period||3
3054938|NCT01237899|3775276|FG010|STARTED|Second Dosing Period||4
3054939|NCT01237899|3775266|FG000|COMPLETED|Second Dosing Period||1
3054940|NCT01237899|3775267|FG001|COMPLETED|Second Dosing Period||3
3054941|NCT01237899|3775268|FG002|COMPLETED|Second Dosing Period||3
3054942|NCT01237899|3775269|FG003|COMPLETED|Second Dosing Period||3
3054943|NCT01237899|3775270|FG004|COMPLETED|Second Dosing Period||2
3283814|NCT02759354|4017619|FG001|NOT COMPLETED|Overall Study||0
3283815|NCT02759354|4017620|FG002|NOT COMPLETED|Overall Study||0
3283816|NCT02759354|4017621|FG003|NOT COMPLETED|Overall Study||0
3283817|NCT02759471|4017633|FG000|STARTED|Overall Study||54
3054944|NCT01237899|3775271|FG005|COMPLETED|Second Dosing Period||4
3054945|NCT01237899|3775272|FG006|COMPLETED|Second Dosing Period||1
3054946|NCT01237899|3775273|FG007|COMPLETED|Second Dosing Period||3
3054947|NCT01237899|3775274|FG008|COMPLETED|Second Dosing Period||4
3054948|NCT01237899|3775275|FG009|COMPLETED|Second Dosing Period||3
3054949|NCT01237899|3775276|FG010|COMPLETED|Second Dosing Period||4
3054950|NCT01237899|3775266|FG000|NOT COMPLETED|Second Dosing Period||0
3054951|NCT01237899|3775267|FG001|NOT COMPLETED|Second Dosing Period||0
3054952|NCT01237899|3775268|FG002|NOT COMPLETED|Second Dosing Period||0
3054953|NCT01237899|3775269|FG003|NOT COMPLETED|Second Dosing Period||0
3054954|NCT01237899|3775270|FG004|NOT COMPLETED|Second Dosing Period||0
3054955|NCT01237899|3775271|FG005|NOT COMPLETED|Second Dosing Period||0
3054956|NCT01237899|3775272|FG006|NOT COMPLETED|Second Dosing Period||0
3054957|NCT01237899|3775273|FG007|NOT COMPLETED|Second Dosing Period||0
3054958|NCT01237899|3775274|FG008|NOT COMPLETED|Second Dosing Period||0
3054959|NCT01237899|3775275|FG009|NOT COMPLETED|Second Dosing Period||0
3054960|NCT01237899|3775276|FG010|NOT COMPLETED|Second Dosing Period||0
3054961|NCT01237951|3775294|FG000|STARTED|Overall Study||75
3054962|NCT01237951|3775294|FG000|COMPLETED|Overall Study||74
3054963|NCT01237951|3775294|FG000|NOT COMPLETED|Overall Study||1
3054964|NCT01238120|3775302|FG000|STARTED|Overall Study||25
3054965|NCT01238120|3775303|FG001|STARTED|Overall Study||23
3054966|NCT01238120|3775304|FG002|STARTED|Overall Study||25
3054967|NCT01238120|3775305|FG003|STARTED|Overall Study||24
3054968|NCT01238120|3775302|FG000|Received Intervention and Completed Baseline Assessments|Overall Study||21
3054969|NCT01238120|3775303|FG001|Received Intervention and Completed Baseline Assessments|Overall Study||22
3054970|NCT01238120|3775304|FG002|Received Intervention and Completed Baseline Assessments|Overall Study||22
3054971|NCT01238120|3775305|FG003|Received Intervention and Completed Baseline Assessments|Overall Study||21
3054972|NCT01238120|3775302|FG000|COMPLETED|Overall Study||17
3283818|NCT02759471|4017633|FG000|COMPLETED|Overall Study||52
3283819|NCT02759471|4017633|FG000|NOT COMPLETED|Overall Study||2
3054973|NCT01238120|3775303|FG001|COMPLETED|Overall Study||22
3054974|NCT01238120|3775304|FG002|COMPLETED|Overall Study||21
3054975|NCT01238120|3775305|FG003|COMPLETED|Overall Study||18
3054976|NCT01238120|3775302|FG000|NOT COMPLETED|Overall Study||8
3054977|NCT01238120|3775303|FG001|NOT COMPLETED|Overall Study||1
3054978|NCT01238120|3775304|FG002|NOT COMPLETED|Overall Study||4
3054979|NCT01238120|3775305|FG003|NOT COMPLETED|Overall Study||6
3054980|NCT01238172|3775317|FG000|STARTED|Overall Study||237
3054981|NCT01238172|3775318|FG001|STARTED|Overall Study||241
3054982|NCT01238172|3775317|FG000|COMPLETED|Overall Study||226
3054983|NCT01238172|3775318|FG001|COMPLETED|Overall Study||217
3054984|NCT01238172|3775317|FG000|NOT COMPLETED|Overall Study||11
3054985|NCT01238172|3775318|FG001|NOT COMPLETED|Overall Study||24
3054986|NCT01238341|3775324|FG000|STARTED|Overall Study||7
3054987|NCT01238341|3775324|FG000|COMPLETED|Overall Study||7
3054988|NCT01238341|3775324|FG000|NOT COMPLETED|Overall Study||0
3054989|NCT01238471|3775330|FG000|STARTED|Overall Study||10
3054990|NCT01238471|3775331|FG001|STARTED|Overall Study||10
3054991|NCT01238471|3775330|FG000|COMPLETED|Overall Study||10
3054992|NCT01238471|3775331|FG001|COMPLETED|Overall Study||10
3054993|NCT01238471|3775330|FG000|NOT COMPLETED|Overall Study||0
3054994|NCT01238471|3775331|FG001|NOT COMPLETED|Overall Study||0
3054995|NCT01238536|3775339|FG000|STARTED|Overall Study||200
3054996|NCT01238536|3775340|FG001|STARTED|Overall Study||200
3054997|NCT01238536|3775339|FG000|COMPLETED|Overall Study||153
3054998|NCT01238536|3775340|FG001|COMPLETED|Overall Study||150
3054999|NCT01238536|3775339|FG000|NOT COMPLETED|Overall Study||47
3055000|NCT01238536|3775340|FG001|NOT COMPLETED|Overall Study||50
3055001|NCT01238549|3775348|FG000|STARTED|Overall Study||284
3055002|NCT01238549|3775348|FG000|COMPLETED|Overall Study||248
3055003|NCT01238549|3775348|FG000|NOT COMPLETED|Overall Study||36
3055004|NCT01238575|3775354|FG000|STARTED|Overall Study||30
3055005|NCT01238575|3775355|FG001|STARTED|Overall Study||32
3055006|NCT01238575|3775354|FG000|COMPLETED|Overall Study||26
3055007|NCT01238575|3775355|FG001|COMPLETED|Overall Study||28
3055008|NCT01238575|3775354|FG000|NOT COMPLETED|Overall Study||4
3055009|NCT01238575|3775355|FG001|NOT COMPLETED|Overall Study||4
3055010|NCT01238588|3775361|FG000|STARTED|Overall Study||12
3055011|NCT01238588|3775361|FG000|COMPLETED|Overall Study||9
3283820|NCT02759562|4017641|FG000|STARTED|Double-Blind Treatment Period (8 Weeks)||3
3055012|NCT01238588|3775361|FG000|NOT COMPLETED|Overall Study||3
3055013|NCT01238640|3775365|FG000|STARTED|Overall Study||84
3055014|NCT01238640|3775365|FG000|COMPLETED|Overall Study||84
3055015|NCT01238640|3775365|FG000|NOT COMPLETED|Overall Study||0
3055016|NCT01238822|3775373|FG000|STARTED|Overall Study||96
3055017|NCT01238822|3775373|FG000|Received Placebo|Overall Study||93
3055018|NCT01238822|3775373|FG000|Received Low Dosage|Overall Study||93
3055019|NCT01238822|3775373|FG000|Received Medium Dosage|Overall Study||93
3055020|NCT01238822|3775373|FG000|Received High Dosage|Overall Study||93
3055021|NCT01238822|3775373|FG000|COMPLETED|Overall Study||93
3055022|NCT01238822|3775373|FG000|NOT COMPLETED|Overall Study||3
3055023|NCT01238835|3775383|FG000|STARTED|Overall Study||218
3055024|NCT01238835|3775383|FG000|COMPLETED|Overall Study||82
3055025|NCT01238835|3775383|FG000|NOT COMPLETED|Overall Study||136
3055026|NCT01238848|3775389|FG000|STARTED|Overall Study||50
3055027|NCT01238848|3775390|FG001|STARTED|Overall Study||50
3055028|NCT01238848|3775389|FG000|COMPLETED|Overall Study||37
3055029|NCT01238848|3775390|FG001|COMPLETED|Overall Study||45
3055030|NCT01238848|3775389|FG000|NOT COMPLETED|Overall Study||13
3055031|NCT01238848|3775390|FG001|NOT COMPLETED|Overall Study||5
3055032|NCT01238861|3775402|FG000|STARTED|Overall Study||80
3055033|NCT01238861|3775403|FG001|STARTED|Overall Study||81
3055034|NCT01238861|3775404|FG002|STARTED|Overall Study||81
3055035|NCT01238861|3775405|FG003|STARTED|Overall Study||82
3055036|NCT01238861|3775406|FG004|STARTED|Overall Study||142
3055037|NCT01238861|3775407|FG005|STARTED|Overall Study||140
3055038|NCT01238861|3775402|FG000|COMPLETED|Overall Study||69
3055039|NCT01238861|3775403|FG001|COMPLETED|Overall Study||73
3055040|NCT01238861|3775404|FG002|COMPLETED|Overall Study||70
3055041|NCT01238861|3775405|FG003|COMPLETED|Overall Study||69
3055042|NCT01238861|3775406|FG004|COMPLETED|Overall Study||129
3055043|NCT01238861|3775407|FG005|COMPLETED|Overall Study||125
3055044|NCT01238861|3775402|FG000|NOT COMPLETED|Overall Study||11
3055045|NCT01238861|3775403|FG001|NOT COMPLETED|Overall Study||8
3055046|NCT01238861|3775404|FG002|NOT COMPLETED|Overall Study||11
3055047|NCT01238861|3775405|FG003|NOT COMPLETED|Overall Study||13
3055048|NCT01238861|3775406|FG004|NOT COMPLETED|Overall Study||13
3055049|NCT01238861|3775407|FG005|NOT COMPLETED|Overall Study||15
3055050|NCT01238900|3775428|FG000|STARTED|6 Months Post Stent Placement||23
3055051|NCT01238900|3775428|FG000|COMPLETED|6 Months Post Stent Placement||23
3055052|NCT01238900|3775428|FG000|NOT COMPLETED|6 Months Post Stent Placement||0
3055053|NCT01238900|3775428|FG000|STARTED|<12 Months Post Stent Removal||23
3055054|NCT01238900|3775428|FG000|COMPLETED|<12 Months Post Stent Removal||18
3055055|NCT01238900|3775428|FG000|NOT COMPLETED|<12 Months Post Stent Removal||5
3055056|NCT01238991|3775443|FG000|STARTED|Overall Study||7
3055057|NCT01238991|3775444|FG001|STARTED|Overall Study||3
3055058|NCT01238991|3775445|FG002|STARTED|Overall Study||11
3055059|NCT01238991|3775446|FG003|STARTED|Overall Study||6
3055060|NCT01238991|3775447|FG004|STARTED|Overall Study||5
3055061|NCT01238991|3775448|FG005|STARTED|Overall Study||2
3055062|NCT01238991|3775449|FG006|STARTED|Overall Study||8
3055063|NCT01238991|3775450|FG007|STARTED|Overall Study||5
3055064|NCT01238991|3775451|FG008|STARTED|Overall Study||4
3055065|NCT01238991|3775452|FG009|STARTED|Overall Study||2
3055066|NCT01238991|3775443|FG000|Received Treatment|Overall Study||7
3055067|NCT01238991|3775444|FG001|Received Treatment|Overall Study||3
3055068|NCT01238991|3775445|FG002|Received Treatment|Overall Study||11
3055069|NCT01238991|3775446|FG003|Received Treatment|Overall Study||6
3055070|NCT01238991|3775447|FG004|Received Treatment|Overall Study||5
3055071|NCT01238991|3775448|FG005|Received Treatment|Overall Study||2
3055072|NCT01238991|3775449|FG006|Received Treatment|Overall Study||8
3055073|NCT01238991|3775450|FG007|Received Treatment|Overall Study||5
3055074|NCT01238991|3775451|FG008|Received Treatment|Overall Study||4
3161080|NCT01869075|3888335|FG002|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|75
3161081|NCT01869075|3888336|FG003|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|45
3161082|NCT01869075|3888337|FG004|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|75
3161083|NCT01869075|3888338|FG005|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|45
3161084|NCT01869075|3888333|FG000|COMPLETED|Phase 2||90
3055075|NCT01238991|3775452|FG009|Received Treatment|Overall Study||2
3055076|NCT01238991|3775443|FG000|COMPLETED|Overall Study||5
3055077|NCT01238991|3775444|FG001|COMPLETED|Overall Study||3
3055078|NCT01238991|3775445|FG002|COMPLETED|Overall Study||5
3055079|NCT01238991|3775446|FG003|COMPLETED|Overall Study||4
3055080|NCT01238991|3775447|FG004|COMPLETED|Overall Study||3
3055081|NCT01238991|3775448|FG005|COMPLETED|Overall Study||2
3055082|NCT01238991|3775449|FG006|COMPLETED|Overall Study||0
3055083|NCT01238991|3775450|FG007|COMPLETED|Overall Study||0
3055084|NCT01238991|3775451|FG008|COMPLETED|Overall Study||0
3055085|NCT01238991|3775452|FG009|COMPLETED|Overall Study||0
3055086|NCT01238991|3775443|FG000|NOT COMPLETED|Overall Study||2
3055087|NCT01238991|3775444|FG001|NOT COMPLETED|Overall Study||0
3055088|NCT01238991|3775445|FG002|NOT COMPLETED|Overall Study||6
3055089|NCT01238991|3775446|FG003|NOT COMPLETED|Overall Study||2
3055090|NCT01238991|3775447|FG004|NOT COMPLETED|Overall Study||2
3055091|NCT01238991|3775448|FG005|NOT COMPLETED|Overall Study||0
3055092|NCT01238991|3775449|FG006|NOT COMPLETED|Overall Study||8
3055093|NCT01238991|3775450|FG007|NOT COMPLETED|Overall Study||5
3055094|NCT01238991|3775451|FG008|NOT COMPLETED|Overall Study||4
3055095|NCT01238991|3775452|FG009|NOT COMPLETED|Overall Study||2
3055096|NCT01239043|3775479|FG000|STARTED|Overall Study|For safety analysis number includes 1 participant randomized to Menactra who received Menomune.|36
3055097|NCT01239043|3775480|FG001|STARTED|Overall Study||103
3055098|NCT01239043|3775479|FG000|COMPLETED|Overall Study||34
3055099|NCT01239043|3775480|FG001|COMPLETED|Overall Study||102
3055100|NCT01239043|3775479|FG000|NOT COMPLETED|Overall Study||2
3055101|NCT01239043|3775480|FG001|NOT COMPLETED|Overall Study||1
3055102|NCT01239056|3775486|FG000|STARTED|Overall Study||20
3055103|NCT01239056|3775486|FG000|COMPLETED|Overall Study||20
3055104|NCT01239056|3775486|FG000|NOT COMPLETED|Overall Study||0
3055105|NCT01239121|3775494|FG000|STARTED|Overall Study||188
3055106|NCT01239121|3775495|FG001|STARTED|Overall Study||199
3055107|NCT01239121|3775496|FG002|STARTED|Overall Study||15
3055108|NCT01239121|3775494|FG000|COMPLETED|Overall Study||186
3055109|NCT01239121|3775495|FG001|COMPLETED|Overall Study||195
3055110|NCT01239121|3775496|FG002|COMPLETED|Overall Study||15
3055111|NCT01239121|3775494|FG000|NOT COMPLETED|Overall Study||2
3055112|NCT01239121|3775495|FG001|NOT COMPLETED|Overall Study||4
3055113|NCT01239121|3775496|FG002|NOT COMPLETED|Overall Study||0
3055114|NCT01239160|3775506|FG000|STARTED|Overall Study||114
3055115|NCT01239160|3775507|FG001|STARTED|Overall Study||114
3055116|NCT01239160|3775508|FG002|STARTED|Overall Study||10
3055117|NCT01239160|3775506|FG000|COMPLETED|Overall Study||89
3055118|NCT01239160|3775507|FG001|COMPLETED|Overall Study||95
3055119|NCT01239160|3775508|FG002|COMPLETED|Overall Study||0
3055120|NCT01239160|3775506|FG000|NOT COMPLETED|Overall Study||25
3055121|NCT01239160|3775507|FG001|NOT COMPLETED|Overall Study||19
3055122|NCT01239160|3775508|FG002|NOT COMPLETED|Overall Study||10
3055123|NCT01239212|3775514|FG000|STARTED|Overall Study||7
3055124|NCT01239212|3775514|FG000|COMPLETED|Overall Study||7
3055125|NCT01239212|3775514|FG000|NOT COMPLETED|Overall Study||0
3055126|NCT01239316|3775518|FG000|STARTED|Overall Study||12
3055127|NCT01239316|3775518|FG000|COMPLETED|Overall Study||0
3055128|NCT01239316|3775518|FG000|NOT COMPLETED|Overall Study||12
3055129|NCT01239342|3775524|FG000|STARTED|Overall Study||29
3055130|NCT01239342|3775525|FG001|STARTED|Overall Study||14
3055131|NCT01239342|3775524|FG000|COMPLETED|Overall Study||26
3055132|NCT01239342|3775525|FG001|COMPLETED|Overall Study||8
3055133|NCT01239342|3775524|FG000|NOT COMPLETED|Overall Study||3
3055134|NCT01239342|3775525|FG001|NOT COMPLETED|Overall Study||6
3055135|NCT01239355|3775531|FG000|STARTED|Overall Study||15
3055136|NCT01239355|3775531|FG000|COMPLETED|Overall Study||15
3055137|NCT01239355|3775531|FG000|NOT COMPLETED|Overall Study||0
3055138|NCT01239381|3775535|FG000|STARTED|Overall Study||92
3055139|NCT01239381|3775535|FG000|COMPLETED|Overall Study||90
3055140|NCT01239381|3775535|FG000|NOT COMPLETED|Overall Study||2
3055141|NCT01239394|3775540|FG000|STARTED|Overall Study||42
3055142|NCT01239394|3775540|FG000|COMPLETED|Overall Study||41
3055143|NCT01239394|3775540|FG000|NOT COMPLETED|Overall Study||1
3055144|NCT01239472|3775546|FG000|STARTED|Overall Study||15
3055145|NCT01239472|3775547|FG001|STARTED|Overall Study||15
3055146|NCT01239472|3775546|FG000|COMPLETED|Overall Study||10
3055147|NCT01239472|3775547|FG001|COMPLETED|Overall Study||12
3055148|NCT01239472|3775546|FG000|NOT COMPLETED|Overall Study||5
3055149|NCT01239472|3775547|FG001|NOT COMPLETED|Overall Study||3
3055150|NCT01239511|3775559|FG000|STARTED|Overall Study||47
3055151|NCT01239511|3775560|FG001|STARTED|Overall Study||45
3055152|NCT01239511|3775561|FG002|STARTED|Overall Study||47
3055153|NCT01239511|3775562|FG003|STARTED|Overall Study||47
3055154|NCT01239511|3775559|FG000|COMPLETED|Overall Study||46
3055155|NCT01239511|3775560|FG001|COMPLETED|Overall Study||40
3055156|NCT01239511|3775561|FG002|COMPLETED|Overall Study||43
3055157|NCT01239511|3775562|FG003|COMPLETED|Overall Study||38
3055158|NCT01239511|3775559|FG000|NOT COMPLETED|Overall Study||1
3055159|NCT01239511|3775560|FG001|NOT COMPLETED|Overall Study||5
3055160|NCT01239511|3775561|FG002|NOT COMPLETED|Overall Study||4
3055161|NCT01239511|3775562|FG003|NOT COMPLETED|Overall Study||9
3055162|NCT01239732|3775572|FG000|STARTED|Overall Study||1021
3055163|NCT01239732|3775572|FG000|COMPLETED|Overall Study||0
3055164|NCT01239732|3775572|FG000|NOT COMPLETED|Overall Study||1021
3055165|NCT01239745|3775576|FG000|STARTED|Overall Study||46
3055166|NCT01239745|3775576|FG000|COMPLETED|Overall Study||0
3055167|NCT01239745|3775576|FG000|NOT COMPLETED|Overall Study||46
3055168|NCT01239797|3775582|FG000|STARTED|Randomized Participants||321
3055169|NCT01239797|3775583|FG001|STARTED|Randomized Participants||325
3055170|NCT01239797|3775582|FG000|COMPLETED|Randomized Participants||319
3055171|NCT01239797|3775583|FG001|COMPLETED|Randomized Participants||316
3055172|NCT01239797|3775582|FG000|NOT COMPLETED|Randomized Participants||2
3055173|NCT01239797|3775583|FG001|NOT COMPLETED|Randomized Participants||9
3055174|NCT01239797|3775582|FG000|STARTED|Treated Participants|1 participant was randomized to treatment E-Ld but received treatment Ld|318
3055175|NCT01239797|3775583|FG001|STARTED|Treated Participants|1 participant was randomized to treatment E-Ld but received treatment Ld|317
3055176|NCT01239797|3775582|FG000|COMPLETED|Treated Participants|Completed = Still on Treatment|83
3055177|NCT01239797|3775583|FG001|COMPLETED|Treated Participants|Completed = Still on Treatment|43
3055178|NCT01239797|3775582|FG000|NOT COMPLETED|Treated Participants||235
3055179|NCT01239797|3775583|FG001|NOT COMPLETED|Treated Participants||274
3055180|NCT01239992|3775589|FG000|STARTED|Overall Study||12
3055181|NCT01239992|3775589|FG000|COMPLETED|Overall Study||10
3055182|NCT01239992|3775589|FG000|NOT COMPLETED|Overall Study||2
3055183|NCT01240122|3775593|FG000|STARTED|Overall Study||29
3055184|NCT01240122|3775593|FG000|COMPLETED|Overall Study||29
3055185|NCT01240122|3775593|FG000|NOT COMPLETED|Overall Study||0
3055186|NCT01240135|3775604|FG000|STARTED|Period One, 14 Days of Wear||44
3055187|NCT01240135|3775605|FG001|STARTED|Period One, 14 Days of Wear||45
3055188|NCT01240135|3775604|FG000|COMPLETED|Period One, 14 Days of Wear||44
3055189|NCT01240135|3775605|FG001|COMPLETED|Period One, 14 Days of Wear||45
3055190|NCT01240135|3775604|FG000|NOT COMPLETED|Period One, 14 Days of Wear||0
3055191|NCT01240135|3775605|FG001|NOT COMPLETED|Period One, 14 Days of Wear||0
3055192|NCT01240135|3775604|FG000|STARTED|Period Two, 14 Days of Wear||44
3055193|NCT01240135|3775605|FG001|STARTED|Period Two, 14 Days of Wear||45
3055194|NCT01240135|3775604|FG000|COMPLETED|Period Two, 14 Days of Wear||43
3055195|NCT01240135|3775605|FG001|COMPLETED|Period Two, 14 Days of Wear||43
3055196|NCT01240135|3775604|FG000|NOT COMPLETED|Period Two, 14 Days of Wear||1
3055197|NCT01240135|3775605|FG001|NOT COMPLETED|Period Two, 14 Days of Wear||2
3055198|NCT01240200|3775613|FG000|STARTED|12-week Crossover Phase - Period 1||25
3055199|NCT01240200|3775614|FG001|STARTED|12-week Crossover Phase - Period 1||24
3055200|NCT01240200|3775613|FG000|COMPLETED|12-week Crossover Phase - Period 1||23
3055201|NCT01240200|3775614|FG001|COMPLETED|12-week Crossover Phase - Period 1||23
3055202|NCT01240200|3775613|FG000|NOT COMPLETED|12-week Crossover Phase - Period 1||2
3055203|NCT01240200|3775614|FG001|NOT COMPLETED|12-week Crossover Phase - Period 1||1
3055204|NCT01240200|3775613|FG000|STARTED|12-week Crossover Phase - Period 2||23
3055205|NCT01240200|3775614|FG001|STARTED|12-week Crossover Phase - Period 2||23
3055206|NCT01240200|3775613|FG000|COMPLETED|12-week Crossover Phase - Period 2||23
3055207|NCT01240200|3775614|FG001|COMPLETED|12-week Crossover Phase - Period 2||23
3055208|NCT01240200|3775613|FG000|NOT COMPLETED|12-week Crossover Phase - Period 2||0
3055209|NCT01240200|3775614|FG001|NOT COMPLETED|12-week Crossover Phase - Period 2||0
3055210|NCT01240330|3775623|FG000|STARTED|Overall Study||33
3055211|NCT01240330|3775623|FG000|COMPLETED|Overall Study||33
3055212|NCT01240330|3775623|FG000|NOT COMPLETED|Overall Study||0
3055213|NCT01240356|3775629|FG000|STARTED|Overall Study||18
3055214|NCT01240356|3775630|FG001|STARTED|Overall Study||20
3055215|NCT01240356|3775629|FG000|COMPLETED|Overall Study||15
3055216|NCT01240356|3775630|FG001|COMPLETED|Overall Study||20
3055217|NCT01240356|3775629|FG000|NOT COMPLETED|Overall Study||3
3055218|NCT01240356|3775630|FG001|NOT COMPLETED|Overall Study||0
3055219|NCT01240382|3775641|FG000|STARTED|Overall Study||144
3055220|NCT01240382|3775642|FG001|STARTED|Overall Study||143
3055221|NCT01240382|3775641|FG000|COMPLETED|Overall Study||142
3055222|NCT01240382|3775642|FG001|COMPLETED|Overall Study||139
3055223|NCT01240382|3775641|FG000|NOT COMPLETED|Overall Study||2
3055224|NCT01240382|3775642|FG001|NOT COMPLETED|Overall Study||4
3055225|NCT01240551|3775650|FG000|STARTED|Overall Study||30
3055226|NCT01240551|3775651|FG001|STARTED|Overall Study||30
3055227|NCT01240551|3775650|FG000|COMPLETED|Overall Study||26
3055228|NCT01240551|3775651|FG001|COMPLETED|Overall Study||27
3055229|NCT01240551|3775650|FG000|NOT COMPLETED|Overall Study||4
3055230|NCT01240551|3775651|FG001|NOT COMPLETED|Overall Study||3
3055231|NCT01240590|3775662|FG000|STARTED|Phase I||0
3055232|NCT01240590|3775663|FG001|STARTED|Phase I||6
3055233|NCT01240590|3775664|FG002|STARTED|Phase I||3
3055234|NCT01240590|3775665|FG003|STARTED|Phase I||0
3055235|NCT01240590|3775666|FG004|STARTED|Phase I||0
3055236|NCT01240590|3775662|FG000|COMPLETED|Phase I||0
3055237|NCT01240590|3775663|FG001|COMPLETED|Phase I||6
3055238|NCT01240590|3775664|FG002|COMPLETED|Phase I||0
3055239|NCT01240590|3775665|FG003|COMPLETED|Phase I||0
3055240|NCT01240590|3775666|FG004|COMPLETED|Phase I||0
3055241|NCT01240590|3775662|FG000|NOT COMPLETED|Phase I||0
3055242|NCT01240590|3775663|FG001|NOT COMPLETED|Phase I||0
3055243|NCT01240590|3775664|FG002|NOT COMPLETED|Phase I||3
3055244|NCT01240590|3775665|FG003|NOT COMPLETED|Phase I||0
3161085|NCT01869075|3888334|FG001|COMPLETED|Phase 2||30
3161086|NCT01869075|3888335|FG002|COMPLETED|Phase 2||75
3161087|NCT01869075|3888336|FG003|COMPLETED|Phase 2||45
3161088|NCT01869075|3888337|FG004|COMPLETED|Phase 2||75
3161089|NCT01869075|3888338|FG005|COMPLETED|Phase 2||45
3161090|NCT01869075|3888333|FG000|NOT COMPLETED|Phase 2||0
3161091|NCT01869075|3888334|FG001|NOT COMPLETED|Phase 2||0
3161092|NCT01869075|3888335|FG002|NOT COMPLETED|Phase 2||0
3161093|NCT01869075|3888336|FG003|NOT COMPLETED|Phase 2||0
3161094|NCT01869075|3888337|FG004|NOT COMPLETED|Phase 2||0
3161095|NCT01869075|3888338|FG005|NOT COMPLETED|Phase 2||0
3161096|NCT01869192|3888354|FG000|STARTED|Preoperative Chemotherapy to Surgery||37
3055245|NCT01240590|3775666|FG004|NOT COMPLETED|Phase I||0
3055246|NCT01240590|3775662|FG000|STARTED|Phase II||0
3055247|NCT01240590|3775663|FG001|STARTED|Phase II||0
3055248|NCT01240590|3775664|FG002|STARTED|Phase II||0
3055249|NCT01240590|3775665|FG003|STARTED|Phase II||17
3055250|NCT01240590|3775666|FG004|STARTED|Phase II||1
3161097|NCT01869192|3888355|FG001|STARTED|Preoperative Chemotherapy to Surgery||35
3161098|NCT01869192|3888354|FG000|COMPLETED|Preoperative Chemotherapy to Surgery||35
3283821|NCT02759562|4017642|FG001|STARTED|Double-Blind Treatment Period (8 Weeks)||3
3283822|NCT02759562|4017641|FG000|COMPLETED|Double-Blind Treatment Period (8 Weeks)||3
3055251|NCT01240590|3775662|FG000|COMPLETED|Phase II||0
3055252|NCT01240590|3775663|FG001|COMPLETED|Phase II||0
3055253|NCT01240590|3775664|FG002|COMPLETED|Phase II||0
3055254|NCT01240590|3775665|FG003|COMPLETED|Phase II||15
3055255|NCT01240590|3775666|FG004|COMPLETED|Phase II||0
3055256|NCT01240590|3775662|FG000|NOT COMPLETED|Phase II||0
3055257|NCT01240590|3775663|FG001|NOT COMPLETED|Phase II||0
3161099|NCT01869192|3888355|FG001|COMPLETED|Preoperative Chemotherapy to Surgery|one never got treatment on study|34
3161100|NCT01869192|3888354|FG000|NOT COMPLETED|Preoperative Chemotherapy to Surgery||2
3161101|NCT01869192|3888355|FG001|NOT COMPLETED|Preoperative Chemotherapy to Surgery||1
3161102|NCT01869192|3888354|FG000|STARTED|Postoperative Chemotherapy|3 did not start postop chemotherapy|32
3161103|NCT01869192|3888355|FG001|STARTED|Postoperative Chemotherapy||33
3161104|NCT01869192|3888354|FG000|COMPLETED|Postoperative Chemotherapy||32
3161105|NCT01869192|3888355|FG001|COMPLETED|Postoperative Chemotherapy||31
3161106|NCT01869192|3888354|FG000|NOT COMPLETED|Postoperative Chemotherapy||0
3161107|NCT01869192|3888355|FG001|NOT COMPLETED|Postoperative Chemotherapy||2
3161108|NCT01869348|3888363|FG000|STARTED|Overall Study||20
3161109|NCT01869348|3888364|FG001|STARTED|Overall Study||20
3161110|NCT01869348|3888363|FG000|COMPLETED|Overall Study||19
3161111|NCT01869348|3888364|FG001|COMPLETED|Overall Study||19
3161112|NCT01869348|3888363|FG000|NOT COMPLETED|Overall Study||1
3161113|NCT01869348|3888364|FG001|NOT COMPLETED|Overall Study||1
3161114|NCT01869374|3888372|FG000|STARTED|Overall Study||9
3161115|NCT01869374|3888373|FG001|STARTED|Overall Study||9
3161116|NCT01869374|3888372|FG000|COMPLETED|Overall Study||9
3161117|NCT01869374|3888373|FG001|COMPLETED|Overall Study||8
3161118|NCT01869374|3888372|FG000|NOT COMPLETED|Overall Study||0
3161119|NCT01869374|3888373|FG001|NOT COMPLETED|Overall Study||1
3161120|NCT01869439|3888379|FG000|STARTED|Overall Study||40
3161121|NCT01869439|3888379|FG000|COMPLETED|Overall Study||40
3161122|NCT01869439|3888379|FG000|NOT COMPLETED|Overall Study||0
3161123|NCT01869634|3888385|FG000|STARTED|Overall Study||20
3161124|NCT01869634|3888386|FG001|STARTED|Overall Study||17
3161125|NCT01869634|3888385|FG000|COMPLETED|Overall Study||18
3161126|NCT01869634|3888386|FG001|COMPLETED|Overall Study||17
3161127|NCT01869634|3888385|FG000|NOT COMPLETED|Overall Study||2
3161128|NCT01869634|3888386|FG001|NOT COMPLETED|Overall Study||0
3161129|NCT01869647|3888395|FG000|STARTED|Overall Study||66
3161130|NCT01869647|3888396|FG001|STARTED|Overall Study||136
3161131|NCT01869647|3888397|FG002|STARTED|Overall Study||62
3161132|NCT01869647|3888395|FG000|COMPLETED|Overall Study||65
3161133|NCT01869647|3888396|FG001|COMPLETED|Overall Study||130
3161134|NCT01869647|3888397|FG002|COMPLETED|Overall Study||62
3161135|NCT01869647|3888395|FG000|NOT COMPLETED|Overall Study||1
3161136|NCT01869647|3888396|FG001|NOT COMPLETED|Overall Study||6
3161137|NCT01869647|3888397|FG002|NOT COMPLETED|Overall Study||0
3161138|NCT01869686|3888405|FG000|STARTED|Overall Study||12
3161139|NCT01869686|3888405|FG000|COMPLETED|Overall Study||12
3161140|NCT01869686|3888405|FG000|NOT COMPLETED|Overall Study||0
3161141|NCT01869699|3888411|FG000|STARTED|Overall Study||21
3161142|NCT01869699|3888412|FG001|STARTED|Overall Study||20
3161143|NCT01869699|3888411|FG000|COMPLETED|Overall Study||20
3161144|NCT01869699|3888412|FG001|COMPLETED|Overall Study||20
3161145|NCT01869699|3888411|FG000|NOT COMPLETED|Overall Study||1
3161146|NCT01869699|3888412|FG001|NOT COMPLETED|Overall Study||0
3161147|NCT01869725|3888418|FG000|STARTED|Overall Study||68
3161148|NCT01869725|3888418|FG000|COMPLETED|Overall Study||64
3055258|NCT01240590|3775664|FG002|NOT COMPLETED|Phase II||0
3055259|NCT01240590|3775665|FG003|NOT COMPLETED|Phase II||2
3055260|NCT01240590|3775666|FG004|NOT COMPLETED|Phase II||1
3055261|NCT01240746|3775695|FG000|STARTED|Overall Study||736
3055262|NCT01240746|3775696|FG001|STARTED|Overall Study||725
3055263|NCT01240746|3775697|FG002|STARTED|Overall Study||2902
3055264|NCT01240746|3775695|FG000|COMPLETED|Overall Study||677
3055265|NCT01240746|3775696|FG001|COMPLETED|Overall Study||677
3055266|NCT01240746|3775697|FG002|COMPLETED|Overall Study||2659
3055267|NCT01240746|3775695|FG000|NOT COMPLETED|Overall Study||59
3055268|NCT01240746|3775696|FG001|NOT COMPLETED|Overall Study||48
3055269|NCT01240746|3775697|FG002|NOT COMPLETED|Overall Study||243
3055270|NCT01240785|3775707|FG000|STARTED|Overall Study||111
3161149|NCT01869725|3888418|FG000|NOT COMPLETED|Overall Study||4
3161150|NCT01869764|3888424|FG000|STARTED|Overall Study||28
3161151|NCT01869764|3888425|FG001|STARTED|Overall Study||29
3161152|NCT01869764|3888424|FG000|COMPLETED|Overall Study||28
3161153|NCT01869764|3888425|FG001|COMPLETED|Overall Study||27
3161154|NCT01869764|3888424|FG000|NOT COMPLETED|Overall Study||0
3055271|NCT01240785|3775708|FG001|STARTED|Overall Study||110
3055272|NCT01240785|3775707|FG000|COMPLETED|Overall Study|110 women completed in the metformin arm and 107 women completed in the insulin arm.|110
3055273|NCT01240785|3775708|FG001|COMPLETED|Overall Study||107
3055274|NCT01240785|3775707|FG000|NOT COMPLETED|Overall Study||1
3055275|NCT01240785|3775708|FG001|NOT COMPLETED|Overall Study||3
3055276|NCT01240811|3775717|FG000|STARTED|Overall Study||8
3055277|NCT01240811|3775718|FG001|STARTED|Overall Study||17
3055278|NCT01240811|3775719|FG002|STARTED|Overall Study||17
3161155|NCT01869764|3888425|FG001|NOT COMPLETED|Overall Study||2
3161156|NCT01869777|3888431|FG000|STARTED|Overall Study||102
3161157|NCT01869777|3888431|FG000|COMPLETED|Overall Study||101
3161158|NCT01869777|3888431|FG000|NOT COMPLETED|Overall Study||1
3161159|NCT01869959|3888439|FG000|STARTED|Randomization Period||0
3161160|NCT01869959|3888440|FG001|STARTED|Randomization Period||0
3161161|NCT01869959|3888441|FG002|STARTED|Randomization Period||0
3161162|NCT01869959|3888442|FG003|STARTED|Randomization Period||0
3161163|NCT01869959|3888443|FG004|STARTED|Randomization Period||47
3161164|NCT01869959|3888439|FG000|COMPLETED|Randomization Period||0
3161165|NCT01869959|3888440|FG001|COMPLETED|Randomization Period||0
3161166|NCT01869959|3888441|FG002|COMPLETED|Randomization Period||0
3161167|NCT01869959|3888442|FG003|COMPLETED|Randomization Period||0
3161168|NCT01869959|3888443|FG004|COMPLETED|Randomization Period|One participant discontinued after randomization but did not receive study drug.|46
3161169|NCT01869959|3888439|FG000|NOT COMPLETED|Randomization Period||0
3161170|NCT01869959|3888440|FG001|NOT COMPLETED|Randomization Period||0
3161171|NCT01869959|3888441|FG002|NOT COMPLETED|Randomization Period||0
3161172|NCT01869959|3888442|FG003|NOT COMPLETED|Randomization Period||0
3161173|NCT01869959|3888443|FG004|NOT COMPLETED|Randomization Period||1
3161174|NCT01869959|3888439|FG000|STARTED|Treatment Period||11
3161175|NCT01869959|3888440|FG001|STARTED|Treatment Period||10
3161176|NCT01869959|3888441|FG002|STARTED|Treatment Period||15
3161177|NCT01869959|3888442|FG003|STARTED|Treatment Period||10
3161178|NCT01869959|3888443|FG004|STARTED|Treatment Period|Participants were randomized to treatment groups for the Treatment Period.|0
3161179|NCT01869959|3888439|FG000|Received at Least 1 Dose of Study Drug|Treatment Period||11
3161180|NCT01869959|3888440|FG001|Received at Least 1 Dose of Study Drug|Treatment Period||10
3161181|NCT01869959|3888441|FG002|Received at Least 1 Dose of Study Drug|Treatment Period||15
3161182|NCT01869959|3888442|FG003|Received at Least 1 Dose of Study Drug|Treatment Period||10
3161183|NCT01869959|3888443|FG004|Received at Least 1 Dose of Study Drug|Treatment Period||0
3055279|NCT01240811|3775717|FG000|COMPLETED|Overall Study||8
3055280|NCT01240811|3775718|FG001|COMPLETED|Overall Study||16
3055281|NCT01240811|3775719|FG002|COMPLETED|Overall Study||16
3055282|NCT01240811|3775717|FG000|NOT COMPLETED|Overall Study||0
3055283|NCT01240811|3775718|FG001|NOT COMPLETED|Overall Study||1
3055284|NCT01240811|3775719|FG002|NOT COMPLETED|Overall Study||1
3055285|NCT01240863|3775731|FG000|STARTED|Open-label Titration Period||391
3055286|NCT01240863|3775732|FG001|STARTED|Open-label Titration Period||0
3055287|NCT01240863|3775733|FG002|STARTED|Open-label Titration Period||0
3055288|NCT01240863|3775731|FG000|Safety Analysis Set|Open-label Titration Period||389
3055289|NCT01240863|3775732|FG001|Safety Analysis Set|Open-label Titration Period||0
3055290|NCT01240863|3775733|FG002|Safety Analysis Set|Open-label Titration Period||0
3055291|NCT01240863|3775731|FG000|COMPLETED|Open-label Titration Period||294
3055292|NCT01240863|3775732|FG001|COMPLETED|Open-label Titration Period||0
3055293|NCT01240863|3775733|FG002|COMPLETED|Open-label Titration Period||0
3055294|NCT01240863|3775731|FG000|NOT COMPLETED|Open-label Titration Period||97
3055295|NCT01240863|3775732|FG001|NOT COMPLETED|Open-label Titration Period||0
3055296|NCT01240863|3775733|FG002|NOT COMPLETED|Open-label Titration Period||0
3055297|NCT01240863|3775731|FG000|STARTED|Double-blind Treatment Period (12 Weeks)||0
3055298|NCT01240863|3775732|FG001|STARTED|Double-blind Treatment Period (12 Weeks)||148
3055299|NCT01240863|3775733|FG002|STARTED|Double-blind Treatment Period (12 Weeks)||146
3055300|NCT01240863|3775731|FG000|Full Analysis and Safety Analysis Sets|Double-blind Treatment Period (12 Weeks)||0
3055301|NCT01240863|3775732|FG001|Full Analysis and Safety Analysis Sets|Double-blind Treatment Period (12 Weeks)||147
3055302|NCT01240863|3775733|FG002|Full Analysis and Safety Analysis Sets|Double-blind Treatment Period (12 Weeks)||146
3055303|NCT01240863|3775731|FG000|COMPLETED|Double-blind Treatment Period (12 Weeks)||0
3055304|NCT01240863|3775732|FG001|COMPLETED|Double-blind Treatment Period (12 Weeks)||102
3055305|NCT01240863|3775733|FG002|COMPLETED|Double-blind Treatment Period (12 Weeks)||94
3055306|NCT01240863|3775731|FG000|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||0
3055307|NCT01240863|3775732|FG001|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||46
3055308|NCT01240863|3775733|FG002|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||52
3055309|NCT01240902|3775749|FG000|STARTED|Overall Study||500
3055310|NCT01240902|3775750|FG001|STARTED|Overall Study||156
3055311|NCT01240902|3775751|FG002|STARTED|Overall Study||395
3055312|NCT01240902|3775752|FG003|STARTED|Overall Study||402
3055313|NCT01240902|3775749|FG000|COMPLETED|Overall Study||289
3055314|NCT01240902|3775750|FG001|COMPLETED|Overall Study||77
3055315|NCT01240902|3775751|FG002|COMPLETED|Overall Study||295
3055316|NCT01240902|3775752|FG003|COMPLETED|Overall Study||237
3055317|NCT01240902|3775749|FG000|NOT COMPLETED|Overall Study||211
3055318|NCT01240902|3775750|FG001|NOT COMPLETED|Overall Study||79
3055319|NCT01240902|3775751|FG002|NOT COMPLETED|Overall Study||100
3055320|NCT01240902|3775752|FG003|NOT COMPLETED|Overall Study||165
3055321|NCT01240915|3775770|FG000|STARTED|Overall Study||2
3055322|NCT01240915|3775771|FG001|STARTED|Overall Study||3
3055323|NCT01240915|3775772|FG002|STARTED|Overall Study||2
3055324|NCT01240915|3775773|FG003|STARTED|Overall Study||4
3055325|NCT01240915|3775774|FG004|STARTED|Overall Study||6
3055326|NCT01240915|3775775|FG005|STARTED|Overall Study||23
3055327|NCT01240915|3775776|FG006|STARTED|Overall Study||25
3055328|NCT01240915|3775777|FG007|STARTED|Overall Study||19
3055329|NCT01240915|3775778|FG008|STARTED|Overall Study||21
3055330|NCT01240915|3775770|FG000|COMPLETED|Overall Study||0
3055331|NCT01240915|3775771|FG001|COMPLETED|Overall Study||2
3055332|NCT01240915|3775772|FG002|COMPLETED|Overall Study||2
3055333|NCT01240915|3775773|FG003|COMPLETED|Overall Study||1
3055334|NCT01240915|3775774|FG004|COMPLETED|Overall Study||2
3055335|NCT01240915|3775775|FG005|COMPLETED|Overall Study||13
3055336|NCT01240915|3775776|FG006|COMPLETED|Overall Study||17
3161184|NCT01869959|3888439|FG000|COMPLETED|Treatment Period||10
3283823|NCT02759562|4017642|FG001|COMPLETED|Double-Blind Treatment Period (8 Weeks)||3
3283824|NCT02759562|4017641|FG000|NOT COMPLETED|Double-Blind Treatment Period (8 Weeks)||0
3055337|NCT01240915|3775777|FG007|COMPLETED|Overall Study||15
3055338|NCT01240915|3775778|FG008|COMPLETED|Overall Study||13
3055339|NCT01240915|3775770|FG000|NOT COMPLETED|Overall Study||2
3055340|NCT01240915|3775771|FG001|NOT COMPLETED|Overall Study||1
3055341|NCT01240915|3775772|FG002|NOT COMPLETED|Overall Study||0
3055342|NCT01240915|3775773|FG003|NOT COMPLETED|Overall Study||3
3055343|NCT01240915|3775774|FG004|NOT COMPLETED|Overall Study||4
3055344|NCT01240915|3775775|FG005|NOT COMPLETED|Overall Study||10
3055345|NCT01240915|3775776|FG006|NOT COMPLETED|Overall Study||8
3055346|NCT01240915|3775777|FG007|NOT COMPLETED|Overall Study||4
3055347|NCT01240915|3775778|FG008|NOT COMPLETED|Overall Study||8
3055348|NCT01241240|3775802|FG000|STARTED|Overall Study||94
3055349|NCT01241240|3775803|FG001|STARTED|Overall Study||98
3055350|NCT01241240|3775802|FG000|COMPLETED|Overall Study||86
3055351|NCT01241240|3775803|FG001|COMPLETED|Overall Study||89
3055352|NCT01241240|3775802|FG000|NOT COMPLETED|Overall Study||8
3055353|NCT01241240|3775803|FG001|NOT COMPLETED|Overall Study||9
3055354|NCT01241292|3775811|FG000|STARTED|Overall Study||3
3055355|NCT01241292|3775812|FG001|STARTED|Overall Study||3
3055356|NCT01241292|3775811|FG000|Entered Treatment Period|Overall Study||3
3055357|NCT01241292|3775812|FG001|Entered Treatment Period|Overall Study||3
3055358|NCT01241292|3775811|FG000|COMPLETED|Overall Study|completed=treatment on-going|0
3055359|NCT01241292|3775812|FG001|COMPLETED|Overall Study|completed=treatment on-going|0
3055360|NCT01241292|3775811|FG000|NOT COMPLETED|Overall Study||3
3055361|NCT01241292|3775812|FG001|NOT COMPLETED|Overall Study||3
3055362|NCT01241318|3775824|FG000|STARTED|Overall Study|Women enrolled|19629
3055363|NCT01241318|3775825|FG001|STARTED|Overall Study|Women enrolled|20050
3055364|NCT01241318|3775824|FG000|Liveborn Infant|Overall Study|Infants|18510
3055365|NCT01241318|3775825|FG001|Liveborn Infant|Overall Study|Infants|19346
3055366|NCT01241318|3775824|FG000|COMPLETED|Overall Study|Infants|18450
3055367|NCT01241318|3775825|FG001|COMPLETED|Overall Study|Infants|19308
3055368|NCT01241318|3775824|FG000|NOT COMPLETED|Overall Study||1179
3055369|NCT01241318|3775825|FG001|NOT COMPLETED|Overall Study||742
3055370|NCT01241344|3775838|FG000|STARTED|Overall Study||14
3055371|NCT01241344|3775839|FG001|STARTED|Overall Study||16
3055372|NCT01241344|3775840|FG002|STARTED|Overall Study||18
3055373|NCT01241344|3775841|FG003|STARTED|Overall Study||4
3055374|NCT01241344|3775838|FG000|Randomized to Open-label|Overall Study||3
3055375|NCT01241344|3775839|FG001|Randomized to Open-label|Overall Study||4
3055376|NCT01241344|3775840|FG002|Randomized to Open-label|Overall Study||5
3055377|NCT01241344|3775841|FG003|Randomized to Open-label|Overall Study||0
3055378|NCT01241344|3775838|FG000|COMPLETED|Overall Study||9
3055379|NCT01241344|3775839|FG001|COMPLETED|Overall Study||7
3055380|NCT01241344|3775840|FG002|COMPLETED|Overall Study||9
3055381|NCT01241344|3775841|FG003|COMPLETED|Overall Study||2
3055382|NCT01241344|3775838|FG000|NOT COMPLETED|Overall Study||5
3055383|NCT01241344|3775839|FG001|NOT COMPLETED|Overall Study||9
3055384|NCT01241344|3775840|FG002|NOT COMPLETED|Overall Study||9
3055385|NCT01241344|3775841|FG003|NOT COMPLETED|Overall Study||2
3055386|NCT01241435|3775854|FG000|STARTED|Overall Study||12
3055387|NCT01241435|3775855|FG001|STARTED|Overall Study||8
3055388|NCT01241435|3775856|FG002|STARTED|Overall Study||8
3055389|NCT01241435|3775857|FG003|STARTED|Overall Study||8
3055390|NCT01241435|3775854|FG000|Received at Least 1 Dose of Study Drug|Overall Study||12
3055391|NCT01241435|3775855|FG001|Received at Least 1 Dose of Study Drug|Overall Study||8
3055392|NCT01241435|3775856|FG002|Received at Least 1 Dose of Study Drug|Overall Study||8
3055393|NCT01241435|3775857|FG003|Received at Least 1 Dose of Study Drug|Overall Study||8
3055394|NCT01241435|3775854|FG000|COMPLETED|Overall Study||12
3055395|NCT01241435|3775855|FG001|COMPLETED|Overall Study||8
3055396|NCT01241435|3775856|FG002|COMPLETED|Overall Study||8
3055397|NCT01241435|3775857|FG003|COMPLETED|Overall Study||8
3055398|NCT01241435|3775854|FG000|NOT COMPLETED|Overall Study||0
3055399|NCT01241435|3775855|FG001|NOT COMPLETED|Overall Study||0
3055400|NCT01241435|3775856|FG002|NOT COMPLETED|Overall Study||0
3055401|NCT01241435|3775857|FG003|NOT COMPLETED|Overall Study||0
3055402|NCT01241448|3775871|FG000|STARTED|Overall Study||66
3055403|NCT01241448|3775872|FG001|STARTED|Overall Study||65
3055404|NCT01241448|3775873|FG002|STARTED|Overall Study||66
3055405|NCT01241448|3775874|FG003|STARTED|Overall Study||66
3055406|NCT01241448|3775871|FG000|Intent-to-Treat Population (ITT)|Overall Study||63
3055407|NCT01241448|3775872|FG001|Intent-to-Treat Population (ITT)|Overall Study||63
3055408|NCT01241448|3775873|FG002|Intent-to-Treat Population (ITT)|Overall Study||64
3055409|NCT01241448|3775874|FG003|Intent-to-Treat Population (ITT)|Overall Study||64
3055410|NCT01241448|3775871|FG000|ITT With ≥1 Post-Baseline Measure|Overall Study||61
3055411|NCT01241448|3775872|FG001|ITT With ≥1 Post-Baseline Measure|Overall Study||61
3055412|NCT01241448|3775873|FG002|ITT With ≥1 Post-Baseline Measure|Overall Study||64
3055413|NCT01241448|3775874|FG003|ITT With ≥1 Post-Baseline Measure|Overall Study||62
3055414|NCT01241448|3775871|FG000|COMPLETED|Overall Study||29
3055415|NCT01241448|3775872|FG001|COMPLETED|Overall Study||36
3055416|NCT01241448|3775873|FG002|COMPLETED|Overall Study||43
3055417|NCT01241448|3775874|FG003|COMPLETED|Overall Study||43
3055418|NCT01241448|3775871|FG000|NOT COMPLETED|Overall Study||37
3055419|NCT01241448|3775872|FG001|NOT COMPLETED|Overall Study||29
3055420|NCT01241448|3775873|FG002|NOT COMPLETED|Overall Study||23
3055421|NCT01241448|3775874|FG003|NOT COMPLETED|Overall Study||23
3055422|NCT01241461|3775887|FG000|STARTED|Overall Study||3
3055423|NCT01241461|3775888|FG001|STARTED|Overall Study||6
3055424|NCT01241461|3775887|FG000|COMPLETED|Overall Study||0
3055425|NCT01241461|3775888|FG001|COMPLETED|Overall Study||0
3055426|NCT01241461|3775887|FG000|NOT COMPLETED|Overall Study||3
3055427|NCT01241461|3775888|FG001|NOT COMPLETED|Overall Study||6
3055428|NCT01241513|3775900|FG000|STARTED|Overall Study||10
3055429|NCT01241513|3775901|FG001|STARTED|Overall Study||9
3055430|NCT01241513|3775900|FG000|COMPLETED|Overall Study|Study has been completed|10
3055431|NCT01241513|3775901|FG001|COMPLETED|Overall Study||9
3161185|NCT01869959|3888440|FG001|COMPLETED|Treatment Period||8
3161186|NCT01869959|3888441|FG002|COMPLETED|Treatment Period||12
3161187|NCT01869959|3888442|FG003|COMPLETED|Treatment Period||8
3161188|NCT01869959|3888443|FG004|COMPLETED|Treatment Period||0
3161189|NCT01869959|3888439|FG000|NOT COMPLETED|Treatment Period||1
3161190|NCT01869959|3888440|FG001|NOT COMPLETED|Treatment Period||2
3161191|NCT01869959|3888441|FG002|NOT COMPLETED|Treatment Period||3
3161192|NCT01869959|3888442|FG003|NOT COMPLETED|Treatment Period||2
3161193|NCT01869959|3888443|FG004|NOT COMPLETED|Treatment Period||0
3161194|NCT01870076|3888457|FG000|STARTED|Overall Study||10
3161195|NCT01870076|3888458|FG001|STARTED|Overall Study||12
3161196|NCT01870076|3888459|FG002|STARTED|Overall Study||8
3161197|NCT01870076|3888460|FG003|STARTED|Overall Study||11
3161198|NCT01870076|3888457|FG000|COMPLETED|Overall Study||9
3161199|NCT01870076|3888458|FG001|COMPLETED|Overall Study||12
3161200|NCT01870076|3888459|FG002|COMPLETED|Overall Study||7
3161201|NCT01870076|3888460|FG003|COMPLETED|Overall Study||11
3161202|NCT01870076|3888457|FG000|NOT COMPLETED|Overall Study||1
3161203|NCT01870076|3888458|FG001|NOT COMPLETED|Overall Study||0
3161204|NCT01870076|3888459|FG002|NOT COMPLETED|Overall Study||1
3161205|NCT01870076|3888460|FG003|NOT COMPLETED|Overall Study||0
3161206|NCT01870297|3888477|FG000|STARTED|Overall Study||11
3161207|NCT01870297|3888478|FG001|STARTED|Overall Study||15
3161208|NCT01870297|3888479|FG002|STARTED|Overall Study||8
3161209|NCT01870297|3888480|FG003|STARTED|Overall Study||9
3161210|NCT01870297|3888481|FG004|STARTED|Overall Study||10
3161211|NCT01870297|3888482|FG005|STARTED|Overall Study||9
3161212|NCT01870297|3888483|FG006|STARTED|Overall Study||10
3161213|NCT01870297|3888477|FG000|COMPLETED|Overall Study||11
3161214|NCT01870297|3888478|FG001|COMPLETED|Overall Study||8
3161215|NCT01870297|3888479|FG002|COMPLETED|Overall Study||7
3161216|NCT01870297|3888480|FG003|COMPLETED|Overall Study||9
3161217|NCT01870297|3888481|FG004|COMPLETED|Overall Study||7
3161218|NCT01870297|3888482|FG005|COMPLETED|Overall Study||8
3161219|NCT01870297|3888483|FG006|COMPLETED|Overall Study||8
3161220|NCT01870297|3888477|FG000|NOT COMPLETED|Overall Study||0
3161221|NCT01870297|3888478|FG001|NOT COMPLETED|Overall Study||7
3161222|NCT01870297|3888479|FG002|NOT COMPLETED|Overall Study||1
3161223|NCT01870297|3888480|FG003|NOT COMPLETED|Overall Study||0
3161224|NCT01870297|3888481|FG004|NOT COMPLETED|Overall Study||3
3161225|NCT01870297|3888482|FG005|NOT COMPLETED|Overall Study||1
3161226|NCT01870297|3888483|FG006|NOT COMPLETED|Overall Study||2
3161227|NCT01870388|3888510|FG000|STARTED|Overall Study||8
3161228|NCT01870388|3888511|FG001|STARTED|Overall Study||8
3161229|NCT01870388|3888510|FG000|Received 1 Dose of Study Drug|Overall Study||8
3161230|NCT01870388|3888511|FG001|Received 1 Dose of Study Drug|Overall Study||8
3161231|NCT01870388|3888510|FG000|COMPLETED|Overall Study||8
3161232|NCT01870388|3888511|FG001|COMPLETED|Overall Study||8
3161233|NCT01870388|3888510|FG000|NOT COMPLETED|Overall Study||0
3161234|NCT01870388|3888511|FG001|NOT COMPLETED|Overall Study||0
3161235|NCT01870583|3888522|FG000|STARTED|Overall Study||467
3161236|NCT01870583|3888523|FG001|STARTED|Overall Study||474
3161237|NCT01870583|3888524|FG002|STARTED|Overall Study||463
3161238|NCT01870583|3888522|FG000|COMPLETED|Overall Study||456
3055432|NCT01241513|3775900|FG000|NOT COMPLETED|Overall Study||0
3055433|NCT01241513|3775901|FG001|NOT COMPLETED|Overall Study||0
3133953|NCT01698554|3858910|FG002|NOT COMPLETED|Overall Study||2
3133954|NCT01698554|3858911|FG003|NOT COMPLETED|Overall Study||2
3133955|NCT01698684|3858924|FG000|STARTED|Overall Study||145
3133956|NCT01698684|3858925|FG001|STARTED|Overall Study||147
3133957|NCT01698684|3858926|FG002|STARTED|Overall Study||148
3133958|NCT01698684|3858924|FG000|ITT Population|Overall Study||136
3133959|NCT01698684|3858925|FG001|ITT Population|Overall Study||139
3133960|NCT01698684|3858926|FG002|ITT Population|Overall Study||139
3133961|NCT01698684|3858924|FG000|Safety Population|Overall Study||143
3161239|NCT01870583|3888523|FG001|COMPLETED|Overall Study||456
3161240|NCT01870583|3888524|FG002|COMPLETED|Overall Study||455
3161241|NCT01870583|3888522|FG000|NOT COMPLETED|Overall Study||11
3161242|NCT01870583|3888523|FG001|NOT COMPLETED|Overall Study||18
3161243|NCT01870583|3888524|FG002|NOT COMPLETED|Overall Study||8
3161244|NCT01870596|3888534|FG000|STARTED|Overall Study||14
3161245|NCT01870596|3888535|FG001|STARTED|Overall Study||18
3161246|NCT01870596|3888534|FG000|COMPLETED|Overall Study||14
3161247|NCT01870596|3888535|FG001|COMPLETED|Overall Study||18
3161248|NCT01870596|3888534|FG000|NOT COMPLETED|Overall Study||0
3161249|NCT01870596|3888535|FG001|NOT COMPLETED|Overall Study||0
3161250|NCT01870726|3888548|FG000|STARTED|Overall Study||5
3161251|NCT01870726|3888549|FG001|STARTED|Overall Study||6
3161252|NCT01870726|3888550|FG002|STARTED|Overall Study||4
3133962|NCT01698684|3858925|FG001|Safety Population|Overall Study||146
3133963|NCT01698684|3858926|FG002|Safety Population|Overall Study||146
3133964|NCT01698684|3858924|FG000|COMPLETED|Overall Study||116
3161253|NCT01870726|3888551|FG003|STARTED|Overall Study||6
3161254|NCT01870726|3888552|FG004|STARTED|Overall Study||7
3161255|NCT01870726|3888553|FG005|STARTED|Overall Study||5
3161256|NCT01870726|3888554|FG006|STARTED|Overall Study||10
3161257|NCT01870726|3888548|FG000|COMPLETED|Overall Study||0
3161258|NCT01870726|3888549|FG001|COMPLETED|Overall Study||0
3161259|NCT01870726|3888550|FG002|COMPLETED|Overall Study||0
3161260|NCT01870726|3888551|FG003|COMPLETED|Overall Study||0
3161261|NCT01870726|3888552|FG004|COMPLETED|Overall Study||0
3161262|NCT01870726|3888553|FG005|COMPLETED|Overall Study||0
3161263|NCT01870726|3888554|FG006|COMPLETED|Overall Study||0
3161264|NCT01870726|3888548|FG000|NOT COMPLETED|Overall Study||5
3161265|NCT01870726|3888549|FG001|NOT COMPLETED|Overall Study||6
3161266|NCT01870726|3888550|FG002|NOT COMPLETED|Overall Study||4
3161267|NCT01870726|3888551|FG003|NOT COMPLETED|Overall Study||6
3161268|NCT01870726|3888552|FG004|NOT COMPLETED|Overall Study||7
3161269|NCT01870726|3888553|FG005|NOT COMPLETED|Overall Study||5
3161270|NCT01870726|3888554|FG006|NOT COMPLETED|Overall Study||10
3161271|NCT01870739|3888581|FG000|STARTED|Single Drug Treatment (12 Weeks)|"Start = Safety/Pharmacokinetic/Pharmacodynamic analysis set"|57
3161272|NCT01870739|3888582|FG001|STARTED|Single Drug Treatment (12 Weeks)||57
3055434|NCT01241539|3775906|FG000|STARTED|Period 1||7
3055435|NCT01241539|3775906|FG000|COMPLETED|Period 1||7
3055436|NCT01241539|3775906|FG000|NOT COMPLETED|Period 1||0
3055437|NCT01241539|3775906|FG000|STARTED|Period 2|After a wash-out phase of at least 6 weeks.|7
3055438|NCT01241539|3775906|FG000|COMPLETED|Period 2||7
3055439|NCT01241539|3775906|FG000|NOT COMPLETED|Period 2||0
3055440|NCT01241552|3775916|FG000|STARTED|Overall Study||242
3055441|NCT01241552|3775917|FG001|STARTED|Overall Study||403
3055442|NCT01241552|3775918|FG002|STARTED|Overall Study||403
3055443|NCT01241552|3775919|FG003|STARTED|Overall Study||404
3055444|NCT01241552|3775916|FG000|Treated|Overall Study||235
3055445|NCT01241552|3775917|FG001|Treated|Overall Study||392
3055446|NCT01241552|3775918|FG002|Treated|Overall Study||388
3055447|NCT01241552|3775919|FG003|Treated|Overall Study||397
3055448|NCT01241552|3775916|FG000|COMPLETED|Overall Study||201
3055449|NCT01241552|3775917|FG001|COMPLETED|Overall Study||340
3055450|NCT01241552|3775918|FG002|COMPLETED|Overall Study||343
3055451|NCT01241552|3775919|FG003|COMPLETED|Overall Study||340
3055452|NCT01241552|3775916|FG000|NOT COMPLETED|Overall Study||41
3055453|NCT01241552|3775917|FG001|NOT COMPLETED|Overall Study||63
3055454|NCT01241552|3775918|FG002|NOT COMPLETED|Overall Study||60
3055455|NCT01241552|3775919|FG003|NOT COMPLETED|Overall Study||64
3055456|NCT01241565|3775929|FG000|STARTED|Overall Study||50
3055457|NCT01241565|3775929|FG000|COMPLETED|Overall Study||50
3055458|NCT01241565|3775929|FG000|NOT COMPLETED|Overall Study||0
3055459|NCT01241591|3775938|FG000|STARTED|Overall Study||329
3055460|NCT01241591|3775939|FG001|STARTED|Overall Study||330
3055461|NCT01241591|3775940|FG002|STARTED|Overall Study||335
3055462|NCT01241591|3775941|FG003|STARTED|Overall Study||107
3055463|NCT01241591|3775938|FG000|COMPLETED|Overall Study||306
3055464|NCT01241591|3775939|FG001|COMPLETED|Overall Study||306
3055465|NCT01241591|3775940|FG002|COMPLETED|Overall Study||313
3055466|NCT01241591|3775941|FG003|COMPLETED|Overall Study||95
3055467|NCT01241591|3775938|FG000|NOT COMPLETED|Overall Study||23
3055468|NCT01241591|3775939|FG001|NOT COMPLETED|Overall Study||24
3055469|NCT01241591|3775940|FG002|NOT COMPLETED|Overall Study||22
3055470|NCT01241591|3775941|FG003|NOT COMPLETED|Overall Study||12
3055471|NCT01241604|3775951|FG000|STARTED|Screening Period||11
3055472|NCT01241604|3775952|FG001|STARTED|Screening Period||0
3055473|NCT01241604|3775953|FG002|STARTED|Screening Period||0
3055474|NCT01241604|3775951|FG000|COMPLETED|Screening Period||8
3055475|NCT01241604|3775952|FG001|COMPLETED|Screening Period||0
3055476|NCT01241604|3775953|FG002|COMPLETED|Screening Period||0
3055477|NCT01241604|3775951|FG000|NOT COMPLETED|Screening Period||3
3055478|NCT01241604|3775952|FG001|NOT COMPLETED|Screening Period||0
3055479|NCT01241604|3775953|FG002|NOT COMPLETED|Screening Period||0
3055480|NCT01241604|3775951|FG000|STARTED|Study Period||0
3055481|NCT01241604|3775952|FG001|STARTED|Study Period||5
3055482|NCT01241604|3775953|FG002|STARTED|Study Period||3
3055483|NCT01241604|3775951|FG000|COMPLETED|Study Period||0
3055484|NCT01241604|3775952|FG001|COMPLETED|Study Period||5
3055485|NCT01241604|3775953|FG002|COMPLETED|Study Period||3
3055486|NCT01241604|3775951|FG000|NOT COMPLETED|Study Period||0
3055487|NCT01241604|3775952|FG001|NOT COMPLETED|Study Period||0
3055488|NCT01241604|3775953|FG002|NOT COMPLETED|Study Period||0
3055489|NCT01241760|3775962|FG000|STARTED|Overall Study||371
3055490|NCT01241760|3775963|FG001|STARTED|Overall Study||369
3055491|NCT01241760|3775962|FG000|COMPLETED|Overall Study||337
3055492|NCT01241760|3775963|FG001|COMPLETED|Overall Study||329
3055493|NCT01241760|3775962|FG000|NOT COMPLETED|Overall Study||34
3055494|NCT01241760|3775963|FG001|NOT COMPLETED|Overall Study||40
3055495|NCT01241903|3775972|FG000|STARTED|Overall Study||27
3055496|NCT01241903|3775973|FG001|STARTED|Overall Study||27
3055497|NCT01241903|3775972|FG000|COMPLETED|Overall Study||26
3055498|NCT01241903|3775973|FG001|COMPLETED|Overall Study||27
3055499|NCT01241903|3775972|FG000|NOT COMPLETED|Overall Study||1
3055500|NCT01241903|3775973|FG001|NOT COMPLETED|Overall Study||0
3055501|NCT01241916|3775981|FG000|STARTED|Overall Study||35
3055502|NCT01241916|3775982|FG001|STARTED|Overall Study||31
3055503|NCT01241916|3775981|FG000|COMPLETED|Overall Study||28
3055504|NCT01241916|3775982|FG001|COMPLETED|Overall Study||21
3055505|NCT01241916|3775981|FG000|NOT COMPLETED|Overall Study||7
3055506|NCT01241916|3775982|FG001|NOT COMPLETED|Overall Study||10
3055507|NCT01242085|3775991|FG000|STARTED|Overall Study||30
3055508|NCT01242085|3775992|FG001|STARTED|Overall Study||33
3055509|NCT01242085|3775993|FG002|STARTED|Overall Study||1
3133965|NCT01698684|3858925|FG001|COMPLETED|Overall Study||124
3161273|NCT01870739|3888581|FG000|Initiation Dose Completed|Single Drug Treatment (12 Weeks)||57
3055510|NCT01242085|3775991|FG000|COMPLETED|Overall Study|8 patients did not undergo intervention since 4 had medical problems and 4 withdrew|22
3055511|NCT01242085|3775992|FG001|COMPLETED|Overall Study|7 patients did not receive allocated intervention since 5 had medical problems and 2 withdrew|26
3055512|NCT01242085|3775993|FG002|COMPLETED|Overall Study||1
3055513|NCT01242085|3775991|FG000|NOT COMPLETED|Overall Study||8
3055514|NCT01242085|3775992|FG001|NOT COMPLETED|Overall Study||7
3055515|NCT01242085|3775993|FG002|NOT COMPLETED|Overall Study||0
3055516|NCT01242111|3775999|FG000|STARTED|Overall Study||20
3055517|NCT01242111|3775999|FG000|COMPLETED|Overall Study||17
3055518|NCT01242111|3775999|FG000|NOT COMPLETED|Overall Study||3
3055519|NCT01242176|3776003|FG000|STARTED|First Intervention||12
3055520|NCT01242176|3776004|FG001|STARTED|First Intervention||12
3055521|NCT01242176|3776003|FG000|COMPLETED|First Intervention||12
3055522|NCT01242176|3776004|FG001|COMPLETED|First Intervention||12
3055523|NCT01242176|3776003|FG000|NOT COMPLETED|First Intervention||0
3055524|NCT01242176|3776004|FG001|NOT COMPLETED|First Intervention||0
3055525|NCT01242176|3776003|FG000|STARTED|Washout Period of 7 Days||12
3055526|NCT01242176|3776004|FG001|STARTED|Washout Period of 7 Days||12
3055527|NCT01242176|3776003|FG000|COMPLETED|Washout Period of 7 Days||11
3055528|NCT01242176|3776004|FG001|COMPLETED|Washout Period of 7 Days||10
3055529|NCT01242176|3776003|FG000|NOT COMPLETED|Washout Period of 7 Days||1
3055530|NCT01242176|3776004|FG001|NOT COMPLETED|Washout Period of 7 Days||2
3055531|NCT01242176|3776003|FG000|STARTED|Second Intervention||11
3055532|NCT01242176|3776004|FG001|STARTED|Second Intervention||10
3055533|NCT01242176|3776003|FG000|COMPLETED|Second Intervention||11
3055534|NCT01242176|3776004|FG001|COMPLETED|Second Intervention||10
3055535|NCT01242176|3776003|FG000|NOT COMPLETED|Second Intervention||0
3055536|NCT01242176|3776004|FG001|NOT COMPLETED|Second Intervention||0
3055537|NCT01242241|3776012|FG000|STARTED|Overall Study||40
3055538|NCT01242241|3776013|FG001|STARTED|Overall Study||40
3055539|NCT01242241|3776012|FG000|COMPLETED|Overall Study||40
3055540|NCT01242241|3776013|FG001|COMPLETED|Overall Study||40
3055541|NCT01242241|3776012|FG000|NOT COMPLETED|Overall Study||0
3055542|NCT01242241|3776013|FG001|NOT COMPLETED|Overall Study||0
3055543|NCT01242371|3776021|FG000|STARTED|Overall Study||33
3055544|NCT01242371|3776022|FG001|STARTED|Overall Study||32
3055545|NCT01242371|3776021|FG000|COMPLETED|Overall Study||31
3055546|NCT01242371|3776022|FG001|COMPLETED|Overall Study||27
3055547|NCT01242371|3776021|FG000|NOT COMPLETED|Overall Study||2
3055548|NCT01242371|3776022|FG001|NOT COMPLETED|Overall Study||5
3055549|NCT01242514|3776031|FG000|STARTED|Overall Study|Patients who received treatment|1343
3055550|NCT01242514|3776032|FG001|STARTED|Overall Study|Patients who received treatment|357
3055551|NCT01242514|3776033|FG002|STARTED|Overall Study|Patients who received treatment|212
3055552|NCT01242514|3776031|FG000|Enrolled But Did Not Receive Treatment|Overall Study|Other|3
3055553|NCT01242514|3776032|FG001|Enrolled But Did Not Receive Treatment|Overall Study||0
3055554|NCT01242514|3776033|FG002|Enrolled But Did Not Receive Treatment|Overall Study|Adverse event/other|2
3055555|NCT01242514|3776031|FG000|COMPLETED|Overall Study|Due to project closure.|0
3055556|NCT01242514|3776032|FG001|COMPLETED|Overall Study|Due to project closure.|0
3161274|NCT01870739|3888582|FG001|Initiation Dose Completed|Single Drug Treatment (12 Weeks)||56
3161275|NCT01870739|3888581|FG000|Maintenance Dose Started|Single Drug Treatment (12 Weeks)||57
3161276|NCT01870739|3888582|FG001|Maintenance Dose Started|Single Drug Treatment (12 Weeks)||56
3161277|NCT01870739|3888581|FG000|COMPLETED|Single Drug Treatment (12 Weeks)|"Completed indicates maintenance dose complete"|54
3161278|NCT01870739|3888582|FG001|COMPLETED|Single Drug Treatment (12 Weeks)||53
3161279|NCT01870739|3888581|FG000|NOT COMPLETED|Single Drug Treatment (12 Weeks)||3
3161280|NCT01870739|3888582|FG001|NOT COMPLETED|Single Drug Treatment (12 Weeks)||4
3161281|NCT01870739|3888581|FG000|STARTED|Add-on Period (40 Weeks)||54
3161282|NCT01870739|3888582|FG001|STARTED|Add-on Period (40 Weeks)||53
3055557|NCT01242514|3776033|FG002|COMPLETED|Overall Study|Due to project closure.|0
3055558|NCT01242514|3776031|FG000|NOT COMPLETED|Overall Study||1343
3055559|NCT01242514|3776032|FG001|NOT COMPLETED|Overall Study||357
3055560|NCT01242514|3776033|FG002|NOT COMPLETED|Overall Study||212
3055561|NCT01242527|3776045|FG000|STARTED|Overall Study||99
3055562|NCT01242527|3776046|FG001|STARTED|Overall Study||100
3055563|NCT01242527|3776047|FG002|STARTED|Overall Study||101
3055564|NCT01242527|3776048|FG003|STARTED|Overall Study||99
3055565|NCT01242527|3776045|FG000|COMPLETED|Overall Study||94
3161283|NCT01870739|3888581|FG000|COMPLETED|Add-on Period (40 Weeks)||51
3161284|NCT01870739|3888582|FG001|COMPLETED|Add-on Period (40 Weeks)||51
3161285|NCT01870739|3888581|FG000|NOT COMPLETED|Add-on Period (40 Weeks)||3
3161286|NCT01870739|3888582|FG001|NOT COMPLETED|Add-on Period (40 Weeks)||2
3161287|NCT01870778|3888600|FG000|STARTED|Overall Study||3274
3161288|NCT01870778|3888601|FG001|STARTED|Overall Study||3271
3161289|NCT01870778|3888600|FG000|Safety Set|Overall Study||3257
3161290|NCT01870778|3888601|FG001|Safety Set|Overall Study||3248
3161291|NCT01870778|3888600|FG000|Full Analysis Set|Overall Study||3274
3161292|NCT01870778|3888601|FG001|Full Analysis Set|Overall Study||3271
3161293|NCT01870778|3888600|FG000|Biomarker Analysis Set|Overall Study||521
3161294|NCT01870778|3888601|FG001|Biomarker Analysis Set|Overall Study||510
3161295|NCT01870778|3888600|FG000|COMPLETED|Overall Study||3266
3161296|NCT01870778|3888601|FG001|COMPLETED|Overall Study||3262
3161297|NCT01870778|3888600|FG000|NOT COMPLETED|Overall Study||8
3161298|NCT01870778|3888601|FG001|NOT COMPLETED|Overall Study||9
3161299|NCT01870843|3888607|FG000|STARTED|Overall Study||261
3161300|NCT01870843|3888607|FG000|COMPLETED|Overall Study||208
3161301|NCT01870843|3888607|FG000|NOT COMPLETED|Overall Study||53
3161302|NCT01870856|3888613|FG000|STARTED|Overall Study||25
3161303|NCT01870856|3888614|FG001|STARTED|Overall Study||27
3161304|NCT01870856|3888613|FG000|COMPLETED|Overall Study||25
3161305|NCT01870856|3888614|FG001|COMPLETED|Overall Study||27
3161306|NCT01870856|3888613|FG000|NOT COMPLETED|Overall Study||0
3161307|NCT01870856|3888614|FG001|NOT COMPLETED|Overall Study||0
3161308|NCT01870869|3888626|FG000|STARTED|Overall Study||288
3161309|NCT01870869|3888627|FG001|STARTED|Overall Study||206
3161310|NCT01870869|3888628|FG002|STARTED|Overall Study||1222
3161311|NCT01870869|3888629|FG003|STARTED|Overall Study||235
3161312|NCT01870869|3888626|FG000|COMPLETED|Overall Study||260
3161313|NCT01870869|3888627|FG001|COMPLETED|Overall Study||192
3161314|NCT01870869|3888628|FG002|COMPLETED|Overall Study||1092
3161315|NCT01870869|3888629|FG003|COMPLETED|Overall Study||205
3161316|NCT01870869|3888626|FG000|NOT COMPLETED|Overall Study||28
3161317|NCT01870869|3888627|FG001|NOT COMPLETED|Overall Study||14
3161318|NCT01870869|3888628|FG002|NOT COMPLETED|Overall Study||130
3161319|NCT01870869|3888629|FG003|NOT COMPLETED|Overall Study||30
3161320|NCT01870921|3888639|FG000|STARTED|Overall Study||2004
3161321|NCT01870921|3888639|FG000|COMPLETED|Overall Study||1914
3161322|NCT01870921|3888639|FG000|NOT COMPLETED|Overall Study||90
3161323|NCT01870973|3888645|FG000|STARTED|Overall Study||56
3161324|NCT01870973|3888646|FG001|STARTED|Overall Study||52
3161325|NCT01870973|3888645|FG000|COMPLETED|Overall Study||46
3161326|NCT01870973|3888646|FG001|COMPLETED|Overall Study||49
3161327|NCT01870973|3888645|FG000|NOT COMPLETED|Overall Study||10
3161328|NCT01870973|3888646|FG001|NOT COMPLETED|Overall Study||3
3161329|NCT01870999|3888655|FG000|STARTED|Overall Study||14
3161330|NCT01870999|3888656|FG001|STARTED|Overall Study||16
3161331|NCT01870999|3888657|FG002|STARTED|Overall Study||11
3161332|NCT01870999|3888655|FG000|Safety Population; Received Study Drug|Overall Study||14
3161333|NCT01870999|3888656|FG001|Safety Population; Received Study Drug|Overall Study||15
3161334|NCT01870999|3888657|FG002|Safety Population; Received Study Drug|Overall Study||10
3161335|NCT01870999|3888655|FG000|COMPLETED|Overall Study||10
3161336|NCT01870999|3888656|FG001|COMPLETED|Overall Study||8
3161337|NCT01870999|3888657|FG002|COMPLETED|Overall Study||4
3161338|NCT01870999|3888655|FG000|NOT COMPLETED|Overall Study||4
3161339|NCT01870999|3888656|FG001|NOT COMPLETED|Overall Study||8
3161340|NCT01870999|3888657|FG002|NOT COMPLETED|Overall Study||7
3161341|NCT01871077|3888665|FG000|STARTED|Overall Study||30
3055566|NCT01242527|3776046|FG001|COMPLETED|Overall Study||93
3055567|NCT01242527|3776047|FG002|COMPLETED|Overall Study||87
3055568|NCT01242527|3776048|FG003|COMPLETED|Overall Study||90
3055569|NCT01242527|3776045|FG000|NOT COMPLETED|Overall Study||5
3055570|NCT01242527|3776046|FG001|NOT COMPLETED|Overall Study||7
3055571|NCT01242527|3776047|FG002|NOT COMPLETED|Overall Study||14
3055572|NCT01242527|3776048|FG003|NOT COMPLETED|Overall Study||9
3055573|NCT01242644|3776061|FG000|STARTED|Overall Study||16
3055574|NCT01242644|3776062|FG001|STARTED|Overall Study||17
3055575|NCT01242644|3776063|FG002|STARTED|Overall Study||15
3055576|NCT01242644|3776061|FG000|COMPLETED|Overall Study||16
3055577|NCT01242644|3776062|FG001|COMPLETED|Overall Study||17
3055578|NCT01242644|3776063|FG002|COMPLETED|Overall Study||15
3055579|NCT01242644|3776061|FG000|NOT COMPLETED|Overall Study||0
3055580|NCT01242644|3776062|FG001|NOT COMPLETED|Overall Study||0
3055581|NCT01242644|3776063|FG002|NOT COMPLETED|Overall Study||0
3055582|NCT01242748|3776073|FG000|STARTED|Overall Study|Enrolled in CS35A, CS35A Full Analysis Set.|194
3055583|NCT01242748|3776074|FG001|STARTED|Overall Study||94
3055584|NCT01242748|3776073|FG000|CS35/CS35A Safety Analysis Set|Overall Study|Received at least 1 dose of trial drug during the main CS35 trial.|565
3055585|NCT01242748|3776074|FG001|CS35/CS35A Safety Analysis Set|Overall Study||283
3055586|NCT01242748|3776073|FG000|CS35/CS35A Full Analysis Set (FAS)|Overall Study|Received at least 1 dose of trial drug during CS35+had at least 1 efficacy assessment after dosing.|565
3055587|NCT01242748|3776074|FG001|CS35/CS35A Full Analysis Set (FAS)|Overall Study||282
3055588|NCT01242748|3776073|FG000|COMPLETED|Overall Study|These participants were ongoing when the trial was closed by the Sponsor.|156
3055589|NCT01242748|3776074|FG001|COMPLETED|Overall Study||80
3055590|NCT01242748|3776073|FG000|NOT COMPLETED|Overall Study||38
3055591|NCT01242748|3776074|FG001|NOT COMPLETED|Overall Study||14
3055592|NCT01242813|3776080|FG000|STARTED|Overall Study||20
3055593|NCT01242813|3776080|FG000|COMPLETED|Overall Study||18
3055594|NCT01242813|3776080|FG000|NOT COMPLETED|Overall Study||2
3055595|NCT01243112|3776084|FG000|STARTED|Overall Study||25
3055596|NCT01243112|3776084|FG000|COMPLETED|Overall Study||25
3055597|NCT01243112|3776084|FG000|NOT COMPLETED|Overall Study||0
3055598|NCT01243151|3776093|FG000|STARTED|Overall Study||12
3161342|NCT01871077|3888665|FG000|COMPLETED|Overall Study||30
3161343|NCT01871077|3888665|FG000|NOT COMPLETED|Overall Study||0
3161344|NCT01871090|3888671|FG000|STARTED|Overall Study||35
3161345|NCT01871090|3888672|FG001|STARTED|Overall Study||48
3161346|NCT01871090|3888671|FG000|COMPLETED|Overall Study||33
3161347|NCT01871090|3888672|FG001|COMPLETED|Overall Study||25
3161348|NCT01871090|3888671|FG000|NOT COMPLETED|Overall Study||2
3161349|NCT01871090|3888672|FG001|NOT COMPLETED|Overall Study||23
3161350|NCT01871142|3888678|FG000|STARTED|Overall Study||12
3161351|NCT01871142|3888678|FG000|Received Placebo + Normoixa|Overall Study||11
3161352|NCT01871142|3888678|FG000|Received Placebo + Hypoxia|Overall Study||12
3161353|NCT01871142|3888678|FG000|Received 1000mg Aes 103+ Hypoxia|Overall Study||11
3161354|NCT01871142|3888678|FG000|Received 3000mg Aes-103 + Hypoxia|Overall Study||12
3055599|NCT01243151|3776094|FG001|STARTED|Overall Study||14
3055600|NCT01243151|3776095|FG002|STARTED|Overall Study||14
3055601|NCT01243151|3776096|FG003|STARTED|Overall Study||14
3055602|NCT01243151|3776097|FG004|STARTED|Overall Study||14
3055603|NCT01243151|3776093|FG000|Treated|Overall Study||12
3055604|NCT01243151|3776094|FG001|Treated|Overall Study||14
3055605|NCT01243151|3776095|FG002|Treated|Overall Study||14
3055606|NCT01243151|3776096|FG003|Treated|Overall Study||13
3055607|NCT01243151|3776097|FG004|Treated|Overall Study||14
3055608|NCT01243151|3776093|FG000|COMPLETED|Overall Study||12
3055609|NCT01243151|3776094|FG001|COMPLETED|Overall Study||13
3055610|NCT01243151|3776095|FG002|COMPLETED|Overall Study||13
3055611|NCT01243151|3776096|FG003|COMPLETED|Overall Study||12
3055612|NCT01243151|3776097|FG004|COMPLETED|Overall Study||14
3055613|NCT01243151|3776093|FG000|NOT COMPLETED|Overall Study||0
3055614|NCT01243151|3776094|FG001|NOT COMPLETED|Overall Study||1
3055615|NCT01243151|3776095|FG002|NOT COMPLETED|Overall Study||1
3055616|NCT01243151|3776096|FG003|NOT COMPLETED|Overall Study||2
3055617|NCT01243151|3776097|FG004|NOT COMPLETED|Overall Study||0
3055618|NCT01243177|3776115|FG000|STARTED|Overall Study||444
3055619|NCT01243177|3776116|FG001|STARTED|Overall Study||442
3055620|NCT01243177|3776115|FG000|COMPLETED|Overall Study||266
3055621|NCT01243177|3776116|FG001|COMPLETED|Overall Study||264
3055622|NCT01243177|3776115|FG000|NOT COMPLETED|Overall Study||178
3055623|NCT01243177|3776116|FG001|NOT COMPLETED|Overall Study||178
3055624|NCT01243242|3776124|FG000|STARTED|Overall Study||60
3055625|NCT01243242|3776125|FG001|STARTED|Overall Study||60
3055626|NCT01243242|3776124|FG000|COMPLETED|Overall Study||57
3055627|NCT01243242|3776125|FG001|COMPLETED|Overall Study||56
3055628|NCT01243242|3776124|FG000|NOT COMPLETED|Overall Study||3
3055629|NCT01243242|3776125|FG001|NOT COMPLETED|Overall Study||4
3055630|NCT01243268|3776131|FG000|STARTED|Overall Study||674
3055631|NCT01243268|3776131|FG000|COMPLETED|Overall Study||610
3055632|NCT01243268|3776131|FG000|NOT COMPLETED|Overall Study||64
3055633|NCT01243294|3776135|FG000|STARTED|First Intervention (10 Days +/- 2 Days)||28
3055634|NCT01243294|3776136|FG001|STARTED|First Intervention (10 Days +/- 2 Days)||26
3055635|NCT01243294|3776135|FG000|COMPLETED|First Intervention (10 Days +/- 2 Days)||28
3055636|NCT01243294|3776136|FG001|COMPLETED|First Intervention (10 Days +/- 2 Days)||26
3055637|NCT01243294|3776135|FG000|NOT COMPLETED|First Intervention (10 Days +/- 2 Days)||0
3055638|NCT01243294|3776136|FG001|NOT COMPLETED|First Intervention (10 Days +/- 2 Days)||0
3055639|NCT01243294|3776135|FG000|STARTED|Second Intervention (10 Days +/- 2 Days)||28
3055640|NCT01243294|3776136|FG001|STARTED|Second Intervention (10 Days +/- 2 Days)||26
3055641|NCT01243294|3776135|FG000|COMPLETED|Second Intervention (10 Days +/- 2 Days)||28
3055642|NCT01243294|3776136|FG001|COMPLETED|Second Intervention (10 Days +/- 2 Days)||26
3055643|NCT01243294|3776135|FG000|NOT COMPLETED|Second Intervention (10 Days +/- 2 Days)||0
3055644|NCT01243294|3776136|FG001|NOT COMPLETED|Second Intervention (10 Days +/- 2 Days)||0
3055645|NCT01243320|3776142|FG000|STARTED|10ppm Oral Silver (3 Days)||36
3055646|NCT01243320|3776142|FG000|COMPLETED|10ppm Oral Silver (3 Days)||36
3055647|NCT01243320|3776142|FG000|NOT COMPLETED|10ppm Oral Silver (3 Days)||0
3055648|NCT01243320|3776142|FG000|STARTED|10ppm Oral Silver (7 Days)||36
3055649|NCT01243320|3776142|FG000|COMPLETED|10ppm Oral Silver (7 Days)||36
3055650|NCT01243320|3776142|FG000|NOT COMPLETED|10ppm Oral Silver (7 Days)||0
3055651|NCT01243320|3776142|FG000|STARTED|10ppm Oral Silver (14 Days)||36
3055652|NCT01243320|3776142|FG000|COMPLETED|10ppm Oral Silver (14 Days)||36
3055653|NCT01243320|3776142|FG000|NOT COMPLETED|10ppm Oral Silver (14 Days)||0
3055654|NCT01243320|3776142|FG000|STARTED|Washout (3 Days)||36
3055655|NCT01243320|3776142|FG000|COMPLETED|Washout (3 Days)||36
3055656|NCT01243320|3776142|FG000|NOT COMPLETED|Washout (3 Days)||0
3055657|NCT01243320|3776142|FG000|STARTED|32ppm Oral Silver (14 Days)||24
3055658|NCT01243320|3776142|FG000|COMPLETED|32ppm Oral Silver (14 Days)||24
3055659|NCT01243320|3776142|FG000|NOT COMPLETED|32ppm Oral Silver (14 Days)||0
3055660|NCT01243333|3776148|FG000|STARTED|Overall Study||26
3055661|NCT01243333|3776148|FG000|COMPLETED|Overall Study||18
3055662|NCT01243333|3776148|FG000|NOT COMPLETED|Overall Study||8
3055663|NCT01243411|3776152|FG000|STARTED|Overall Study||347
3055664|NCT01243411|3776152|FG000|COMPLETED|Overall Study||306
3055665|NCT01243411|3776152|FG000|NOT COMPLETED|Overall Study||41
3055666|NCT01243424|3776158|FG000|STARTED|Discontinuation From Study (Treated Set)||3028
3055667|NCT01243424|3776159|FG001|STARTED|Discontinuation From Study (Treated Set)||3014
3055668|NCT01243424|3776158|FG000|Patient Died (Other Cause Than CV Death)|Discontinuation From Study (Treated Set)||123
3055669|NCT01243424|3776159|FG001|Patient Died (Other Cause Than CV Death)|Discontinuation From Study (Treated Set)||146
3055670|NCT01243424|3776158|FG000|Treated|Discontinuation From Study (Treated Set)||3023
3055671|NCT01243424|3776159|FG001|Treated|Discontinuation From Study (Treated Set)||3010
3055672|NCT01243424|3776158|FG000|COMPLETED|Discontinuation From Study (Treated Set)||2899
3055673|NCT01243424|3776159|FG001|COMPLETED|Discontinuation From Study (Treated Set)||2895
3055674|NCT01243424|3776158|FG000|NOT COMPLETED|Discontinuation From Study (Treated Set)||129
3055675|NCT01243424|3776159|FG001|NOT COMPLETED|Discontinuation From Study (Treated Set)||119
3055676|NCT01243424|3776158|FG000|STARTED|Discontinuation From Treatment||3028
3055677|NCT01243424|3776159|FG001|STARTED|Discontinuation From Treatment||3014
3055678|NCT01243424|3776158|FG000|Treated|Discontinuation From Treatment||3023
3055679|NCT01243424|3776159|FG001|Treated|Discontinuation From Treatment||3010
3055680|NCT01243424|3776158|FG000|COMPLETED|Discontinuation From Treatment||1896
3055681|NCT01243424|3776159|FG001|COMPLETED|Discontinuation From Treatment||1832
3055682|NCT01243424|3776158|FG000|NOT COMPLETED|Discontinuation From Treatment||1132
3055683|NCT01243424|3776159|FG001|NOT COMPLETED|Discontinuation From Treatment||1182
3055684|NCT01243450|3776169|FG000|STARTED|Overall Study||401
3055685|NCT01243450|3776170|FG001|STARTED|Overall Study||135
3055686|NCT01243450|3776171|FG002|STARTED|Overall Study||404
3055687|NCT01243450|3776169|FG000|COMPLETED|Overall Study||318
3055688|NCT01243450|3776170|FG001|COMPLETED|Overall Study||110
3055689|NCT01243450|3776171|FG002|COMPLETED|Overall Study||337
3055690|NCT01243450|3776169|FG000|NOT COMPLETED|Overall Study||83
3055691|NCT01243450|3776170|FG001|NOT COMPLETED|Overall Study||25
3055692|NCT01243450|3776171|FG002|NOT COMPLETED|Overall Study||67
3055693|NCT01243567|3776181|FG000|STARTED|Overall Study||43
3055694|NCT01243567|3776182|FG001|STARTED|Overall Study||38
3055695|NCT01243567|3776181|FG000|COMPLETED|Overall Study||42
3055696|NCT01243567|3776182|FG001|COMPLETED|Overall Study||38
3055697|NCT01243567|3776181|FG000|NOT COMPLETED|Overall Study||1
3055698|NCT01243567|3776182|FG001|NOT COMPLETED|Overall Study||0
3055699|NCT01243580|3776190|FG000|STARTED|Overall Study||18
3055700|NCT01243580|3776191|FG001|STARTED|Overall Study||18
3055701|NCT01243580|3776190|FG000|COMPLETED|Overall Study||18
3055702|NCT01243580|3776191|FG001|COMPLETED|Overall Study||16
3055703|NCT01243580|3776190|FG000|NOT COMPLETED|Overall Study||0
3055704|NCT01243580|3776191|FG001|NOT COMPLETED|Overall Study||2
3055705|NCT01243593|3776201|FG000|STARTED|Overall Study||16
3055706|NCT01243593|3776202|FG001|STARTED|Overall Study||16
3055707|NCT01243593|3776201|FG000|COMPLETED|Overall Study||16
3055708|NCT01243593|3776202|FG001|COMPLETED|Overall Study||16
3055709|NCT01243593|3776201|FG000|NOT COMPLETED|Overall Study||0
3055710|NCT01243593|3776202|FG001|NOT COMPLETED|Overall Study||0
3055711|NCT01243619|3776208|FG000|STARTED|Overall Study||5
3055712|NCT01243619|3776208|FG000|COMPLETED|Overall Study|Patient enrollment is complete, data analysis is ongoing|5
3055713|NCT01243619|3776208|FG000|NOT COMPLETED|Overall Study||0
3055714|NCT01243671|3776212|FG000|STARTED|Overall Study||20
3055715|NCT01243671|3776212|FG000|Completed 24 Weeks of Treatment|Overall Study||18
3055716|NCT01243671|3776212|FG000|Completed 52 Weeks of Treatment|Overall Study||17
3055717|NCT01243671|3776212|FG000|COMPLETED|Overall Study|Completed 136 weeks of treatment.|15
3055718|NCT01243671|3776212|FG000|NOT COMPLETED|Overall Study||5
3055719|NCT01243762|3776223|FG000|STARTED|Part 1 (Dose Escalation/MTD)||4
3055720|NCT01243762|3776224|FG001|STARTED|Part 1 (Dose Escalation/MTD)||13
3055721|NCT01243762|3776225|FG002|STARTED|Part 1 (Dose Escalation/MTD)||3
3055722|NCT01243762|3776226|FG003|STARTED|Part 1 (Dose Escalation/MTD)||8
3055723|NCT01243762|3776227|FG004|STARTED|Part 1 (Dose Escalation/MTD)||10
3055724|NCT01243762|3776228|FG005|STARTED|Part 1 (Dose Escalation/MTD)||3
3055725|NCT01243762|3776229|FG006|STARTED|Part 1 (Dose Escalation/MTD)||0
3055726|NCT01243762|3776223|FG000|COMPLETED|Part 1 (Dose Escalation/MTD)|Entered Part 2 of Study|1
3055727|NCT01243762|3776224|FG001|COMPLETED|Part 1 (Dose Escalation/MTD)|Entered Part 2 of Study|5
3055728|NCT01243762|3776225|FG002|COMPLETED|Part 1 (Dose Escalation/MTD)||0
3055729|NCT01243762|3776226|FG003|COMPLETED|Part 1 (Dose Escalation/MTD)|Entered Part 2 of Study|2
3055730|NCT01243762|3776227|FG004|COMPLETED|Part 1 (Dose Escalation/MTD)|Entered Part 2 of Study|4
3055731|NCT01243762|3776228|FG005|COMPLETED|Part 1 (Dose Escalation/MTD)||0
3055732|NCT01243762|3776229|FG006|COMPLETED|Part 1 (Dose Escalation/MTD)||0
3055733|NCT01243762|3776223|FG000|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||3
3055734|NCT01243762|3776224|FG001|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||8
3055735|NCT01243762|3776225|FG002|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||3
3055736|NCT01243762|3776226|FG003|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||6
3055737|NCT01243762|3776227|FG004|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||6
3055738|NCT01243762|3776228|FG005|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||3
3055739|NCT01243762|3776229|FG006|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||0
3055740|NCT01243762|3776223|FG000|STARTED|Part 2 (Dose Confirmation/Efficacy)||1
3055741|NCT01243762|3776224|FG001|STARTED|Part 2 (Dose Confirmation/Efficacy)||5
3055742|NCT01243762|3776225|FG002|STARTED|Part 2 (Dose Confirmation/Efficacy)||0
3055743|NCT01243762|3776226|FG003|STARTED|Part 2 (Dose Confirmation/Efficacy)||2
3055744|NCT01243762|3776227|FG004|STARTED|Part 2 (Dose Confirmation/Efficacy)||4
3055745|NCT01243762|3776228|FG005|STARTED|Part 2 (Dose Confirmation/Efficacy)||0
3055746|NCT01243762|3776229|FG006|STARTED|Part 2 (Dose Confirmation/Efficacy)|New participants were enrolled in Part 2 of the study that did not participate in Part 1|6
3055747|NCT01243762|3776223|FG000|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
3055748|NCT01243762|3776224|FG001|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
3055749|NCT01243762|3776225|FG002|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
3055750|NCT01243762|3776226|FG003|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
3055751|NCT01243762|3776227|FG004|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
3055752|NCT01243762|3776228|FG005|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
3055753|NCT01243762|3776229|FG006|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
3055754|NCT01243762|3776223|FG000|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||1
3055755|NCT01243762|3776224|FG001|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||5
3055756|NCT01243762|3776225|FG002|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
3055757|NCT01243762|3776226|FG003|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||2
3055758|NCT01243762|3776227|FG004|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||4
3055759|NCT01243762|3776228|FG005|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
3055760|NCT01243762|3776229|FG006|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||6
3055761|NCT01243775|3776248|FG000|STARTED|Overall Study||33
3161355|NCT01871142|3888678|FG000|COMPLETED|Overall Study||11
3161356|NCT01871142|3888678|FG000|NOT COMPLETED|Overall Study||1
3161357|NCT01871285|3888694|FG000|STARTED|First Intervention (1 Day)||18
3161358|NCT01871285|3888695|FG001|STARTED|First Intervention (1 Day)||15
3161359|NCT01871285|3888696|FG002|STARTED|First Intervention (1 Day)||4
3161360|NCT01871285|3888697|FG003|STARTED|First Intervention (1 Day)||2
3161361|NCT01871285|3888694|FG000|COMPLETED|First Intervention (1 Day)||17
3161362|NCT01871285|3888695|FG001|COMPLETED|First Intervention (1 Day)||14
3055762|NCT01243775|3776248|FG000|COMPLETED|Overall Study||31
3055763|NCT01243775|3776248|FG000|NOT COMPLETED|Overall Study||2
3055764|NCT01243944|3776254|FG000|STARTED|Overall Study||110
3055765|NCT01243944|3776255|FG001|STARTED|Overall Study|One participant withdrew consent 5 days after randomization to BAT & wasn't treated while on study.|112
3055766|NCT01243944|3776254|FG000|Treated|Overall Study||110
3055767|NCT01243944|3776255|FG001|Treated|Overall Study||111
3055768|NCT01243944|3776254|FG000|Followed for Survival|Overall Study||22
3055769|NCT01243944|3776255|FG001|Followed for Survival|Overall Study||21
3055770|NCT01243944|3776254|FG000|COMPLETED|Overall Study||65
3055771|NCT01243944|3776255|FG001|COMPLETED|Overall Study|Study evaluation completion is reported for participants that were treated & those never treatment.|61
3055772|NCT01243944|3776254|FG000|NOT COMPLETED|Overall Study||45
3055773|NCT01243944|3776255|FG001|NOT COMPLETED|Overall Study||51
3055774|NCT01243957|3776262|FG000|STARTED|Overall Study||20
3055775|NCT01243957|3776262|FG000|COMPLETED|Overall Study||20
3055776|NCT01243957|3776262|FG000|NOT COMPLETED|Overall Study||0
3055777|NCT01244035|3776268|FG000|STARTED|Part 1: Period 1||5
3055778|NCT01244035|3776269|FG001|STARTED|Part 1: Period 1||5
3055779|NCT01244035|3776270|FG002|STARTED|Part 1: Period 1||6
3055780|NCT01244035|3776271|FG003|STARTED|Part 1: Period 1||5
3055781|NCT01244035|3776272|FG004|STARTED|Part 1: Period 1||5
3055782|NCT01244035|3776273|FG005|STARTED|Part 1: Period 1||5
3055783|NCT01244035|3776268|FG000|COMPLETED|Part 1: Period 1||4
3055784|NCT01244035|3776269|FG001|COMPLETED|Part 1: Period 1||3
3055785|NCT01244035|3776270|FG002|COMPLETED|Part 1: Period 1||4
3055786|NCT01244035|3776271|FG003|COMPLETED|Part 1: Period 1||5
3055787|NCT01244035|3776272|FG004|COMPLETED|Part 1: Period 1||4
3055788|NCT01244035|3776273|FG005|COMPLETED|Part 1: Period 1||3
3055789|NCT01244035|3776268|FG000|NOT COMPLETED|Part 1: Period 1||1
3055790|NCT01244035|3776269|FG001|NOT COMPLETED|Part 1: Period 1||2
3055791|NCT01244035|3776270|FG002|NOT COMPLETED|Part 1: Period 1||2
3161363|NCT01871285|3888696|FG002|COMPLETED|First Intervention (1 Day)||3
3161364|NCT01871285|3888697|FG003|COMPLETED|First Intervention (1 Day)||2
3161365|NCT01871285|3888694|FG000|NOT COMPLETED|First Intervention (1 Day)||1
3055792|NCT01244035|3776271|FG003|NOT COMPLETED|Part 1: Period 1||0
3055793|NCT01244035|3776272|FG004|NOT COMPLETED|Part 1: Period 1||1
3055794|NCT01244035|3776273|FG005|NOT COMPLETED|Part 1: Period 1||2
3055795|NCT01244035|3776268|FG000|STARTED|Part 1: Period 2||4
3055796|NCT01244035|3776269|FG001|STARTED|Part 1: Period 2||3
3055797|NCT01244035|3776270|FG002|STARTED|Part 1: Period 2||4
3055798|NCT01244035|3776271|FG003|STARTED|Part 1: Period 2||5
3055799|NCT01244035|3776272|FG004|STARTED|Part 1: Period 2||4
3055800|NCT01244035|3776273|FG005|STARTED|Part 1: Period 2||3
3055801|NCT01244035|3776268|FG000|COMPLETED|Part 1: Period 2||4
3055802|NCT01244035|3776269|FG001|COMPLETED|Part 1: Period 2||3
3055803|NCT01244035|3776270|FG002|COMPLETED|Part 1: Period 2||3
3055804|NCT01244035|3776271|FG003|COMPLETED|Part 1: Period 2||5
3055805|NCT01244035|3776272|FG004|COMPLETED|Part 1: Period 2||4
3055806|NCT01244035|3776273|FG005|COMPLETED|Part 1: Period 2||3
3055807|NCT01244035|3776268|FG000|NOT COMPLETED|Part 1: Period 2||0
3055808|NCT01244035|3776269|FG001|NOT COMPLETED|Part 1: Period 2||0
3055809|NCT01244035|3776270|FG002|NOT COMPLETED|Part 1: Period 2||1
3055810|NCT01244035|3776271|FG003|NOT COMPLETED|Part 1: Period 2||0
3055811|NCT01244035|3776272|FG004|NOT COMPLETED|Part 1: Period 2||0
3055812|NCT01244035|3776273|FG005|NOT COMPLETED|Part 1: Period 2||0
3055813|NCT01244035|3776268|FG000|STARTED|Part 1: Period 3||4
3055814|NCT01244035|3776269|FG001|STARTED|Part 1: Period 3||3
3055815|NCT01244035|3776270|FG002|STARTED|Part 1: Period 3||3
3055816|NCT01244035|3776271|FG003|STARTED|Part 1: Period 3||5
3055817|NCT01244035|3776272|FG004|STARTED|Part 1: Period 3||4
3055818|NCT01244035|3776273|FG005|STARTED|Part 1: Period 3||3
3055819|NCT01244035|3776268|FG000|COMPLETED|Part 1: Period 3||4
3055820|NCT01244035|3776269|FG001|COMPLETED|Part 1: Period 3||2
3055821|NCT01244035|3776270|FG002|COMPLETED|Part 1: Period 3||3
3055822|NCT01244035|3776271|FG003|COMPLETED|Part 1: Period 3||5
3055823|NCT01244035|3776272|FG004|COMPLETED|Part 1: Period 3||3
3055824|NCT01244035|3776273|FG005|COMPLETED|Part 1: Period 3||2
3055825|NCT01244035|3776268|FG000|NOT COMPLETED|Part 1: Period 3||0
3055826|NCT01244035|3776269|FG001|NOT COMPLETED|Part 1: Period 3||1
3055827|NCT01244035|3776270|FG002|NOT COMPLETED|Part 1: Period 3||0
3055828|NCT01244035|3776271|FG003|NOT COMPLETED|Part 1: Period 3||0
3055829|NCT01244035|3776272|FG004|NOT COMPLETED|Part 1: Period 3||1
3055830|NCT01244035|3776273|FG005|NOT COMPLETED|Part 1: Period 3||1
3055831|NCT01244061|3776295|FG000|STARTED|Overall Study||251
3055832|NCT01244061|3776296|FG001|STARTED|Overall Study||247
3055833|NCT01244061|3776295|FG000|COMPLETED|Overall Study||169
3055834|NCT01244061|3776296|FG001|COMPLETED|Overall Study||144
3055835|NCT01244061|3776295|FG000|NOT COMPLETED|Overall Study||82
3055836|NCT01244061|3776296|FG001|NOT COMPLETED|Overall Study||103
3055837|NCT01244126|3776305|FG000|STARTED|Overall Study||59
3161366|NCT01871285|3888695|FG001|NOT COMPLETED|First Intervention (1 Day)||1
3055838|NCT01244126|3776306|FG001|STARTED|Overall Study||55
3055839|NCT01244126|3776307|FG002|STARTED|Overall Study||57
3055840|NCT01244126|3776305|FG000|COMPLETED|Overall Study||56
3055841|NCT01244126|3776306|FG001|COMPLETED|Overall Study||52
3055842|NCT01244126|3776307|FG002|COMPLETED|Overall Study||48
3055843|NCT01244126|3776305|FG000|NOT COMPLETED|Overall Study||3
3055844|NCT01244126|3776306|FG001|NOT COMPLETED|Overall Study||3
3055845|NCT01244126|3776307|FG002|NOT COMPLETED|Overall Study||9
3055846|NCT01244191|3776317|FG000|STARTED|Overall Study||526
3055847|NCT01244191|3776318|FG001|STARTED|Overall Study||522
3055848|NCT01244191|3776317|FG000|Did Not Receive Treatment|Overall Study||6
3055849|NCT01244191|3776318|FG001|Did Not Receive Treatment|Overall Study||5
3055850|NCT01244191|3776317|FG000|COMPLETED|Overall Study||46
3055851|NCT01244191|3776318|FG001|COMPLETED|Overall Study||24
3055852|NCT01244191|3776317|FG000|NOT COMPLETED|Overall Study||480
3055853|NCT01244191|3776318|FG001|NOT COMPLETED|Overall Study||498
3055854|NCT01244243|3776324|FG000|STARTED|Overall Study||41
3055855|NCT01244243|3776324|FG000|COMPLETED|Overall Study||41
3161367|NCT01871285|3888696|FG002|NOT COMPLETED|First Intervention (1 Day)||1
3161368|NCT01871285|3888697|FG003|NOT COMPLETED|First Intervention (1 Day)||0
3161369|NCT01871285|3888694|FG000|STARTED|Second Intervention (1 Day)||17
3161370|NCT01871285|3888695|FG001|STARTED|Second Intervention (1 Day)||14
3161371|NCT01871285|3888696|FG002|STARTED|Second Intervention (1 Day)||3
3161372|NCT01871285|3888697|FG003|STARTED|Second Intervention (1 Day)||2
3161373|NCT01871285|3888694|FG000|COMPLETED|Second Intervention (1 Day)||17
3161374|NCT01871285|3888695|FG001|COMPLETED|Second Intervention (1 Day)||14
3161375|NCT01871285|3888696|FG002|COMPLETED|Second Intervention (1 Day)||3
3161376|NCT01871285|3888697|FG003|COMPLETED|Second Intervention (1 Day)||2
3161377|NCT01871285|3888694|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
3161378|NCT01871285|3888695|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
3161379|NCT01871285|3888696|FG002|NOT COMPLETED|Second Intervention (1 Day)||0
3161380|NCT01871285|3888697|FG003|NOT COMPLETED|Second Intervention (1 Day)||0
3161381|NCT01871402|3888709|FG000|STARTED|Overall Study||110
3161382|NCT01871402|3888710|FG001|STARTED|Overall Study||111
3161383|NCT01871402|3888709|FG000|COMPLETED|Overall Study||109
3161384|NCT01871402|3888710|FG001|COMPLETED|Overall Study||108
3161385|NCT01871402|3888709|FG000|NOT COMPLETED|Overall Study||1
3161386|NCT01871402|3888710|FG001|NOT COMPLETED|Overall Study||3
3161387|NCT01871441|3888716|FG000|STARTED|Overall Study||4
3161388|NCT01871441|3888716|FG000|COMPLETED|Overall Study||4
3161389|NCT01871441|3888716|FG000|NOT COMPLETED|Overall Study||0
3161390|NCT01871506|3888723|FG000|STARTED|Overall Study||150
3055856|NCT01244243|3776324|FG000|NOT COMPLETED|Overall Study||0
3055857|NCT01244412|3776328|FG000|STARTED|Overall Study||1
3055858|NCT01244412|3776328|FG000|COMPLETED|Overall Study||1
3055859|NCT01244412|3776328|FG000|NOT COMPLETED|Overall Study||0
3055860|NCT01244425|3776334|FG000|STARTED|Overall Study||35
3055861|NCT01244425|3776335|FG001|STARTED|Overall Study||35
3055862|NCT01244425|3776334|FG000|COMPLETED|Overall Study|Adverse Event: multi-organ failure (death)|32
3055863|NCT01244425|3776335|FG001|COMPLETED|Overall Study|Adverse Event: septic shock with multi-organ failure due to liver abscess (death)|32
3055864|NCT01244425|3776334|FG000|NOT COMPLETED|Overall Study||3
3055865|NCT01244425|3776335|FG001|NOT COMPLETED|Overall Study||3
3055866|NCT01244451|3776349|FG000|STARTED|Overall Study||49
3161391|NCT01871506|3888724|FG001|STARTED|Overall Study||153
3161392|NCT01871506|3888723|FG000|COMPLETED|Overall Study||150
3161393|NCT01871506|3888724|FG001|COMPLETED|Overall Study||153
3161394|NCT01871506|3888723|FG000|NOT COMPLETED|Overall Study||0
3161395|NCT01871506|3888724|FG001|NOT COMPLETED|Overall Study||0
3161396|NCT01871519|3888743|FG000|STARTED|Overall Study||350
3161397|NCT01871519|3888743|FG000|COMPLETED|Overall Study||260
3161398|NCT01871519|3888743|FG000|NOT COMPLETED|Overall Study||90
3161399|NCT01871532|3888750|FG000|STARTED|Overall Study||12
3161400|NCT01871532|3888751|FG001|STARTED|Overall Study||12
3161401|NCT01871532|3888750|FG000|Subjects Received hCG Treatment|Overall Study||11
3161402|NCT01871532|3888751|FG001|Subjects Received hCG Treatment|Overall Study||9
3161403|NCT01871532|3888750|FG000|COMPLETED|Overall Study||11
3161404|NCT01871532|3888751|FG001|COMPLETED|Overall Study||10
3161405|NCT01871532|3888750|FG000|NOT COMPLETED|Overall Study||1
3161406|NCT01871532|3888751|FG001|NOT COMPLETED|Overall Study||2
3171732|NCT01936857|3898922|FG001|STARTED|Overall Study||140
3171733|NCT01936857|3898921|FG000|COMPLETED|Overall Study||107
3171734|NCT01936857|3898922|FG001|COMPLETED|Overall Study||115
3171735|NCT01936857|3898921|FG000|NOT COMPLETED|Overall Study||34
3171736|NCT01936857|3898922|FG001|NOT COMPLETED|Overall Study||25
3171737|NCT01936870|3898928|FG000|STARTED|Overall Study||2492
3171738|NCT01936870|3898928|FG000|COMPLETED|Overall Study||2303
3171739|NCT01936870|3898928|FG000|NOT COMPLETED|Overall Study||189
3171740|NCT01936896|3898932|FG000|STARTED|Overall Study||10
3171741|NCT01936896|3898932|FG000|COMPLETED|Overall Study||10
3171742|NCT01936896|3898932|FG000|NOT COMPLETED|Overall Study||0
3171743|NCT01936909|3898939|FG000|STARTED|Overall Study||20
3171744|NCT01936909|3898940|FG001|STARTED|Overall Study||20
3171745|NCT01936909|3898941|FG002|STARTED|Overall Study||20
3171746|NCT01936909|3898939|FG000|COMPLETED|Overall Study||10
3171747|NCT01936909|3898940|FG001|COMPLETED|Overall Study||12
3055867|NCT01244451|3776349|FG000|COMPLETED|Overall Study||36
3055868|NCT01244451|3776349|FG000|NOT COMPLETED|Overall Study||13
3171748|NCT01936909|3898941|FG002|COMPLETED|Overall Study||14
3171749|NCT01936909|3898939|FG000|NOT COMPLETED|Overall Study||10
3161407|NCT01871545|3888759|FG000|STARTED|Overall Study||73
3161408|NCT01871545|3888760|FG001|STARTED|Overall Study||11
3161409|NCT01871545|3888759|FG000|COMPLETED|Overall Study||56
3161410|NCT01871545|3888760|FG001|COMPLETED|Overall Study||8
3161411|NCT01871545|3888759|FG000|NOT COMPLETED|Overall Study||17
3161412|NCT01871545|3888760|FG001|NOT COMPLETED|Overall Study||3
3161413|NCT01871558|3888771|FG000|STARTED|Overall Study||21
3161414|NCT01871558|3888772|FG001|STARTED|Overall Study||21
3161415|NCT01871558|3888771|FG000|COMPLETED|Overall Study||18
3161416|NCT01871558|3888772|FG001|COMPLETED|Overall Study||19
3161417|NCT01871558|3888771|FG000|NOT COMPLETED|Overall Study||3
3161418|NCT01871558|3888772|FG001|NOT COMPLETED|Overall Study||2
3161419|NCT01871805|3888784|FG000|STARTED|Phase I||7
3161420|NCT01871805|3888785|FG001|STARTED|Phase I||7
3161421|NCT01871805|3888786|FG002|STARTED|Phase I||13
3161422|NCT01871805|3888787|FG003|STARTED|Phase I||7
3161423|NCT01871805|3888788|FG004|STARTED|Phase I||13
3161424|NCT01871805|3888789|FG005|STARTED|Phase I||0
3161425|NCT01871805|3888784|FG000|COMPLETED|Phase I||0
3161426|NCT01871805|3888785|FG001|COMPLETED|Phase I||0
3161427|NCT01871805|3888786|FG002|COMPLETED|Phase I||0
3161428|NCT01871805|3888787|FG003|COMPLETED|Phase I||0
3161429|NCT01871805|3888788|FG004|COMPLETED|Phase I||0
3161430|NCT01871805|3888789|FG005|COMPLETED|Phase I||0
3161431|NCT01871805|3888784|FG000|NOT COMPLETED|Phase I||7
3161432|NCT01871805|3888785|FG001|NOT COMPLETED|Phase I||7
3161433|NCT01871805|3888786|FG002|NOT COMPLETED|Phase I||13
3161434|NCT01871805|3888787|FG003|NOT COMPLETED|Phase I||7
3161435|NCT01871805|3888788|FG004|NOT COMPLETED|Phase I||13
3161436|NCT01871805|3888789|FG005|NOT COMPLETED|Phase I||0
3161437|NCT01871805|3888784|FG000|STARTED|Phase II||0
3161438|NCT01871805|3888785|FG001|STARTED|Phase II||0
3161439|NCT01871805|3888786|FG002|STARTED|Phase II||0
3161440|NCT01871805|3888787|FG003|STARTED|Phase II||0
3161441|NCT01871805|3888788|FG004|STARTED|Phase II||0
3161442|NCT01871805|3888789|FG005|STARTED|Phase II||87
3161443|NCT01871805|3888784|FG000|COMPLETED|Phase II||0
3161444|NCT01871805|3888785|FG001|COMPLETED|Phase II||0
3161445|NCT01871805|3888786|FG002|COMPLETED|Phase II||0
3161446|NCT01871805|3888787|FG003|COMPLETED|Phase II||0
3161447|NCT01871805|3888788|FG004|COMPLETED|Phase II||0
3161448|NCT01871805|3888789|FG005|COMPLETED|Phase II||0
3161449|NCT01871805|3888784|FG000|NOT COMPLETED|Phase II||0
3161450|NCT01871805|3888785|FG001|NOT COMPLETED|Phase II||0
3161451|NCT01871805|3888786|FG002|NOT COMPLETED|Phase II||0
3161452|NCT01871805|3888787|FG003|NOT COMPLETED|Phase II||0
3161453|NCT01871805|3888788|FG004|NOT COMPLETED|Phase II||0
3161454|NCT01871805|3888789|FG005|NOT COMPLETED|Phase II||87
3283825|NCT02759562|4017642|FG001|NOT COMPLETED|Double-Blind Treatment Period (8 Weeks)||0
3283826|NCT02759562|4017641|FG000|STARTED|Open-Label Treatment Period||2
3161455|NCT01871870|3888820|FG000|STARTED|Overall Study||20
3161456|NCT01871870|3888820|FG000|COMPLETED|Overall Study||11
3161457|NCT01871870|3888820|FG000|NOT COMPLETED|Overall Study||9
3161458|NCT01872078|3888828|FG000|STARTED|Overall Study||16
3161459|NCT01872078|3888829|FG001|STARTED|Overall Study||15
3161460|NCT01872078|3888830|FG002|STARTED|Overall Study||17
3161461|NCT01872078|3888831|FG003|STARTED|Overall Study||17
3161462|NCT01872078|3888828|FG000|COMPLETED|Overall Study||16
3161463|NCT01872078|3888829|FG001|COMPLETED|Overall Study||15
3161464|NCT01872078|3888830|FG002|COMPLETED|Overall Study||14
3161465|NCT01872078|3888831|FG003|COMPLETED|Overall Study||15
3161466|NCT01872078|3888828|FG000|NOT COMPLETED|Overall Study||0
3161467|NCT01872078|3888829|FG001|NOT COMPLETED|Overall Study||0
3161468|NCT01872078|3888830|FG002|NOT COMPLETED|Overall Study||3
3161469|NCT01872078|3888831|FG003|NOT COMPLETED|Overall Study||2
3161470|NCT01872325|3888843|FG000|STARTED|Overall Study||689
3161471|NCT01872325|3888844|FG001|STARTED|Overall Study||387
3161472|NCT01872325|3888843|FG000|COMPLETED|Overall Study||689
3161473|NCT01872325|3888844|FG001|COMPLETED|Overall Study||387
3161474|NCT01872325|3888843|FG000|NOT COMPLETED|Overall Study||0
3161475|NCT01872325|3888844|FG001|NOT COMPLETED|Overall Study||0
3161476|NCT01872338|3888852|FG000|STARTED|Overall Study||66
3161477|NCT01872338|3888853|FG001|STARTED|Overall Study||69
3161478|NCT01872338|3888852|FG000|COMPLETED|Overall Study||46
3161479|NCT01872338|3888853|FG001|COMPLETED|Overall Study||69
3161480|NCT01872338|3888852|FG000|NOT COMPLETED|Overall Study||20
3161481|NCT01872338|3888853|FG001|NOT COMPLETED|Overall Study||0
3161482|NCT01872611|3888861|FG000|STARTED|Overall Study||301
3161483|NCT01872611|3888862|FG001|STARTED|Overall Study||304
3161484|NCT01872611|3888861|FG000|Randomized|Overall Study||301
3161485|NCT01872611|3888862|FG001|Randomized|Overall Study||304
3161486|NCT01872611|3888861|FG000|Treated (Safety Analysis Set)|Overall Study||293
3161487|NCT01872611|3888862|FG001|Treated (Safety Analysis Set)|Overall Study||295
3161488|NCT01872611|3888861|FG000|Full Analysis Set|Overall Study||289
3161489|NCT01872611|3888862|FG001|Full Analysis Set|Overall Study||293
3161490|NCT01872611|3888861|FG000|COMPLETED|Overall Study||277
3161491|NCT01872611|3888862|FG001|COMPLETED|Overall Study||292
3161492|NCT01872611|3888861|FG000|NOT COMPLETED|Overall Study||24
3161493|NCT01872611|3888862|FG001|NOT COMPLETED|Overall Study||12
3161494|NCT01872689|3888874|FG000|STARTED|Double-Blind/Placebo-Controlled Period||76
3161495|NCT01872689|3888875|FG001|STARTED|Double-Blind/Placebo-Controlled Period||78
3161496|NCT01872689|3888876|FG002|STARTED|Double-Blind/Placebo-Controlled Period||177
3161497|NCT01872689|3888877|FG003|STARTED|Double-Blind/Placebo-Controlled Period||174
3161498|NCT01872689|3888874|FG000|COMPLETED|Double-Blind/Placebo-Controlled Period||56
3161499|NCT01872689|3888875|FG001|COMPLETED|Double-Blind/Placebo-Controlled Period||58
3161500|NCT01872689|3888876|FG002|COMPLETED|Double-Blind/Placebo-Controlled Period||129
3161501|NCT01872689|3888877|FG003|COMPLETED|Double-Blind/Placebo-Controlled Period||136
3161502|NCT01872689|3888874|FG000|NOT COMPLETED|Double-Blind/Placebo-Controlled Period||20
3161503|NCT01872689|3888875|FG001|NOT COMPLETED|Double-Blind/Placebo-Controlled Period||20
3161504|NCT01872689|3888876|FG002|NOT COMPLETED|Double-Blind/Placebo-Controlled Period||48
3161505|NCT01872689|3888877|FG003|NOT COMPLETED|Double-Blind/Placebo-Controlled Period||38
3161506|NCT01872689|3888874|FG000|STARTED|Open-Label Period (Only For Monotherapy)|Of the 56 participants who completed Period 1, only 52 started Period 2.|52
3161507|NCT01872689|3888875|FG001|STARTED|Open-Label Period (Only For Monotherapy)|Of the 58 participants who completed Period 1, only 56 started Period 2.|56
3161508|NCT01872689|3888876|FG002|STARTED|Open-Label Period (Only For Monotherapy)|As per study design, Period 2 was not intended for this arm.|0
3161509|NCT01872689|3888877|FG003|STARTED|Open-Label Period (Only For Monotherapy)|As per study design, Period 2 was not intended for this arm.|0
3161510|NCT01872689|3888874|FG000|COMPLETED|Open-Label Period (Only For Monotherapy)||31
3161511|NCT01872689|3888875|FG001|COMPLETED|Open-Label Period (Only For Monotherapy)||33
3161512|NCT01872689|3888876|FG002|COMPLETED|Open-Label Period (Only For Monotherapy)||0
3161513|NCT01872689|3888877|FG003|COMPLETED|Open-Label Period (Only For Monotherapy)||0
3161514|NCT01872689|3888874|FG000|NOT COMPLETED|Open-Label Period (Only For Monotherapy)||21
3161515|NCT01872689|3888875|FG001|NOT COMPLETED|Open-Label Period (Only For Monotherapy)||23
3161516|NCT01872689|3888876|FG002|NOT COMPLETED|Open-Label Period (Only For Monotherapy)||0
3161517|NCT01872689|3888877|FG003|NOT COMPLETED|Open-Label Period (Only For Monotherapy)||0
3161518|NCT01872715|3888890|FG000|STARTED|Overall Study||24
3161519|NCT01872715|3888890|FG000|COMPLETED|Overall Study||20
3161520|NCT01872715|3888890|FG000|NOT COMPLETED|Overall Study||4
3161521|NCT01872819|3888904|FG000|STARTED|Overall Study||14
3161522|NCT01872819|3888904|FG000|COMPLETED|Overall Study||14
3161523|NCT01872819|3888904|FG000|NOT COMPLETED|Overall Study||0
3161524|NCT01872910|3888915|FG000|STARTED|Overall Study||30
3161525|NCT01872910|3888916|FG001|STARTED|Overall Study||31
3161526|NCT01872910|3888917|FG002|STARTED|Overall Study||30
3161527|NCT01872910|3888918|FG003|STARTED|Overall Study||15
3161528|NCT01872910|3888919|FG004|STARTED|Overall Study||15
3161529|NCT01872910|3888920|FG005|STARTED|Overall Study||3
3161530|NCT01872910|3888915|FG000|Received Any Study Drug|Overall Study||30
3161531|NCT01872910|3888916|FG001|Received Any Study Drug|Overall Study||31
3161532|NCT01872910|3888917|FG002|Received Any Study Drug|Overall Study||30
3161533|NCT01872910|3888918|FG003|Received Any Study Drug|Overall Study||15
3161534|NCT01872910|3888919|FG004|Received Any Study Drug|Overall Study||15
3161535|NCT01872910|3888920|FG005|Received Any Study Drug|Overall Study||3
3161536|NCT01872910|3888915|FG000|COMPLETED|Overall Study||28
3161537|NCT01872910|3888916|FG001|COMPLETED|Overall Study||31
3161538|NCT01872910|3888917|FG002|COMPLETED|Overall Study||28
3161539|NCT01872910|3888918|FG003|COMPLETED|Overall Study||15
3161540|NCT01872910|3888919|FG004|COMPLETED|Overall Study||15
3161541|NCT01872910|3888920|FG005|COMPLETED|Overall Study||3
3161542|NCT01872910|3888915|FG000|NOT COMPLETED|Overall Study||2
3161543|NCT01872910|3888916|FG001|NOT COMPLETED|Overall Study||0
3161544|NCT01872910|3888917|FG002|NOT COMPLETED|Overall Study||2
3161545|NCT01872910|3888918|FG003|NOT COMPLETED|Overall Study||0
3161546|NCT01872910|3888919|FG004|NOT COMPLETED|Overall Study||0
3161547|NCT01872910|3888920|FG005|NOT COMPLETED|Overall Study||0
3161548|NCT01873287|3888935|FG000|STARTED|Overall Study||2006
3161549|NCT01873287|3888936|FG001|STARTED|Overall Study||1057
3161550|NCT01873287|3888935|FG000|COMPLETED|Overall Study||1701
3161551|NCT01873287|3888936|FG001|COMPLETED|Overall Study||883
3161552|NCT01873287|3888935|FG000|NOT COMPLETED|Overall Study||305
3161553|NCT01873287|3888936|FG001|NOT COMPLETED|Overall Study||174
3161554|NCT01873417|3888944|FG000|STARTED|Overall Study||237
3161555|NCT01873417|3888944|FG000|Safety Population|Overall Study|Participants who received at least 1 dose of dimethyl fumarate (DMF), recorded in diary data.|233
3161556|NCT01873417|3888944|FG000|COMPLETED|Overall Study||202
3161557|NCT01873417|3888944|FG000|NOT COMPLETED|Overall Study||35
3161558|NCT01873495|3888948|FG000|STARTED|Overall Study||7
3161559|NCT01873495|3888948|FG000|COMPLETED|Overall Study||0
3161560|NCT01873495|3888948|FG000|NOT COMPLETED|Overall Study||7
3161561|NCT01873586|3888952|FG000|STARTED|Overall Study||29
3161562|NCT01873586|3888952|FG000|COMPLETED|Overall Study||26
3161563|NCT01873586|3888952|FG000|NOT COMPLETED|Overall Study||3
3161564|NCT01873729|3888959|FG000|STARTED|Overall Study||3
3161565|NCT01873729|3888959|FG000|COMPLETED|Overall Study||2
3161566|NCT01873729|3888959|FG000|NOT COMPLETED|Overall Study||1
3161567|NCT01873742|3888965|FG000|STARTED|Overall Study||165
3161568|NCT01873742|3888966|FG001|STARTED|Overall Study||163
3161569|NCT01873742|3888965|FG000|COMPLETED|Overall Study||97
3161570|NCT01873742|3888966|FG001|COMPLETED|Overall Study||87
3161571|NCT01873742|3888965|FG000|NOT COMPLETED|Overall Study||68
3161572|NCT01873742|3888966|FG001|NOT COMPLETED|Overall Study||76
3161573|NCT01873846|3888972|FG000|STARTED|Overall Study||400
3161574|NCT01873846|3888972|FG000|Eligble Participants Dispensed Lenses|Overall Study||396
3161575|NCT01873846|3888972|FG000|COMPLETED|Overall Study||388
3161576|NCT01873846|3888972|FG000|NOT COMPLETED|Overall Study||12
3161577|NCT01873859|3888978|FG000|STARTED|Overall Study||83
3161578|NCT01873859|3888979|FG001|STARTED|Overall Study||83
3161579|NCT01873859|3888978|FG000|COMPLETED|Overall Study||83
3161580|NCT01873859|3888979|FG001|COMPLETED|Overall Study||79
3161581|NCT01873859|3888978|FG000|NOT COMPLETED|Overall Study||0
3161582|NCT01873859|3888979|FG001|NOT COMPLETED|Overall Study||4
3161583|NCT01873950|3888986|FG000|STARTED|Period 1||5
3161584|NCT01873950|3888987|FG001|STARTED|Period 1||4
3161585|NCT01873950|3888988|FG002|STARTED|Period 1||5
3161586|NCT01873950|3888989|FG003|STARTED|Period 1||4
3161587|NCT01873950|3888990|FG004|STARTED|Period 1||4
3161588|NCT01873950|3888986|FG000|COMPLETED|Period 1||5
3161589|NCT01873950|3888987|FG001|COMPLETED|Period 1||4
3161590|NCT01873950|3888988|FG002|COMPLETED|Period 1||5
3161591|NCT01873950|3888989|FG003|COMPLETED|Period 1||4
3161592|NCT01873950|3888990|FG004|COMPLETED|Period 1||4
3161593|NCT01873950|3888986|FG000|NOT COMPLETED|Period 1||0
3161594|NCT01873950|3888987|FG001|NOT COMPLETED|Period 1||0
3161595|NCT01873950|3888988|FG002|NOT COMPLETED|Period 1||0
3161596|NCT01873950|3888989|FG003|NOT COMPLETED|Period 1||0
3161597|NCT01873950|3888990|FG004|NOT COMPLETED|Period 1||0
3161598|NCT01873950|3888986|FG000|STARTED|Period 2||5
3161599|NCT01873950|3888987|FG001|STARTED|Period 2||4
3161600|NCT01873950|3888988|FG002|STARTED|Period 2||4
3161601|NCT01873950|3888989|FG003|STARTED|Period 2||4
3161602|NCT01873950|3888990|FG004|STARTED|Period 2||5
3161603|NCT01873950|3888986|FG000|COMPLETED|Period 2||5
3161604|NCT01873950|3888987|FG001|COMPLETED|Period 2||4
3161605|NCT01873950|3888988|FG002|COMPLETED|Period 2||4
3161606|NCT01873950|3888989|FG003|COMPLETED|Period 2||4
3161607|NCT01873950|3888990|FG004|COMPLETED|Period 2||5
3161608|NCT01873950|3888986|FG000|NOT COMPLETED|Period 2||0
3161609|NCT01873950|3888987|FG001|NOT COMPLETED|Period 2||0
3161610|NCT01873950|3888988|FG002|NOT COMPLETED|Period 2||0
3161611|NCT01873950|3888989|FG003|NOT COMPLETED|Period 2||0
3161612|NCT01873950|3888990|FG004|NOT COMPLETED|Period 2||0
3161613|NCT01873950|3888986|FG000|STARTED|Period 3||4
3161614|NCT01873950|3888987|FG001|STARTED|Period 3||4
3161615|NCT01873950|3888988|FG002|STARTED|Period 3||5
3161616|NCT01873950|3888989|FG003|STARTED|Period 3||5
3161617|NCT01873950|3888990|FG004|STARTED|Period 3||4
3161618|NCT01873950|3888986|FG000|COMPLETED|Period 3||4
3161619|NCT01873950|3888987|FG001|COMPLETED|Period 3||4
3161620|NCT01873950|3888988|FG002|COMPLETED|Period 3||5
3161621|NCT01873950|3888989|FG003|COMPLETED|Period 3||5
3161622|NCT01873950|3888990|FG004|COMPLETED|Period 3||4
3161623|NCT01873950|3888986|FG000|NOT COMPLETED|Period 3||0
3161624|NCT01873950|3888987|FG001|NOT COMPLETED|Period 3||0
3161625|NCT01873950|3888988|FG002|NOT COMPLETED|Period 3||0
3161626|NCT01873950|3888989|FG003|NOT COMPLETED|Period 3||0
3161627|NCT01873950|3888990|FG004|NOT COMPLETED|Period 3||0
3161628|NCT01873950|3888986|FG000|STARTED|Period 4||4
3161629|NCT01873950|3888987|FG001|STARTED|Period 4||5
3161630|NCT01873950|3888988|FG002|STARTED|Period 4||4
3161631|NCT01873950|3888989|FG003|STARTED|Period 4||4
3161632|NCT01873950|3888990|FG004|STARTED|Period 4||5
3161633|NCT01873950|3888986|FG000|COMPLETED|Period 4||4
3161634|NCT01873950|3888987|FG001|COMPLETED|Period 4||5
3161635|NCT01873950|3888988|FG002|COMPLETED|Period 4||4
3161636|NCT01873950|3888989|FG003|COMPLETED|Period 4||4
3161637|NCT01873950|3888990|FG004|COMPLETED|Period 4||5
3161638|NCT01873950|3888986|FG000|NOT COMPLETED|Period 4||0
3161639|NCT01873950|3888987|FG001|NOT COMPLETED|Period 4||0
3161640|NCT01873950|3888988|FG002|NOT COMPLETED|Period 4||0
3161641|NCT01873950|3888989|FG003|NOT COMPLETED|Period 4||0
3161642|NCT01873950|3888990|FG004|NOT COMPLETED|Period 4||0
3161643|NCT01873950|3888986|FG000|STARTED|Period 5||4
3161644|NCT01873950|3888987|FG001|STARTED|Period 5||5
3161645|NCT01873950|3888988|FG002|STARTED|Period 5||4
3161646|NCT01873950|3888989|FG003|STARTED|Period 5||4
3161647|NCT01873950|3888990|FG004|STARTED|Period 5||4
3161648|NCT01873950|3888986|FG000|COMPLETED|Period 5||4
3161649|NCT01873950|3888987|FG001|COMPLETED|Period 5||5
3161650|NCT01873950|3888988|FG002|COMPLETED|Period 5||4
3161651|NCT01873950|3888989|FG003|COMPLETED|Period 5||3
3161652|NCT01873950|3888990|FG004|COMPLETED|Period 5||4
3161653|NCT01873950|3888986|FG000|NOT COMPLETED|Period 5||0
3161654|NCT01873950|3888987|FG001|NOT COMPLETED|Period 5||0
3161655|NCT01873950|3888988|FG002|NOT COMPLETED|Period 5||0
3161656|NCT01873950|3888989|FG003|NOT COMPLETED|Period 5||1
3161657|NCT01873950|3888990|FG004|NOT COMPLETED|Period 5||0
3161658|NCT01873989|3889006|FG000|STARTED|Overall Study||8
3161659|NCT01873989|3889007|FG001|STARTED|Overall Study||7
3161660|NCT01873989|3889006|FG000|COMPLETED|Overall Study||7
3161661|NCT01873989|3889007|FG001|COMPLETED|Overall Study||6
3161662|NCT01873989|3889006|FG000|NOT COMPLETED|Overall Study||1
3161663|NCT01873989|3889007|FG001|NOT COMPLETED|Overall Study||1
3161664|NCT01874054|3889013|FG000|STARTED|Overall Study||55
3161665|NCT01874054|3889013|FG000|Completed ≥2 Cycles of Combo Treatment|Overall Study||53
3161666|NCT01874054|3889013|FG000|Completed 16 Cycles of BV Treatment|Overall Study||17
3161667|NCT01874054|3889013|FG000|COMPLETED|Overall Study||0
3161668|NCT01874054|3889013|FG000|NOT COMPLETED|Overall Study||55
3161669|NCT01874119|3889017|FG000|STARTED|First Intervention (6 Days)||8
3161670|NCT01874119|3889018|FG001|STARTED|First Intervention (6 Days)||5
3161671|NCT01874119|3889017|FG000|COMPLETED|First Intervention (6 Days)||7
3161672|NCT01874119|3889018|FG001|COMPLETED|First Intervention (6 Days)||5
3161673|NCT01874119|3889017|FG000|NOT COMPLETED|First Intervention (6 Days)||1
3161674|NCT01874119|3889018|FG001|NOT COMPLETED|First Intervention (6 Days)||0
3161675|NCT01874119|3889017|FG000|STARTED|Washout (7 Days)||7
3161676|NCT01874119|3889018|FG001|STARTED|Washout (7 Days)||5
3161677|NCT01874119|3889017|FG000|COMPLETED|Washout (7 Days)||4
3161678|NCT01874119|3889018|FG001|COMPLETED|Washout (7 Days)||3
3161679|NCT01874119|3889017|FG000|NOT COMPLETED|Washout (7 Days)||3
3161680|NCT01874119|3889018|FG001|NOT COMPLETED|Washout (7 Days)||2
3161681|NCT01874119|3889017|FG000|STARTED|Second Intervention (6 Days)||4
3161682|NCT01874119|3889018|FG001|STARTED|Second Intervention (6 Days)||3
3161683|NCT01874119|3889017|FG000|COMPLETED|Second Intervention (6 Days)||4
3161684|NCT01874119|3889018|FG001|COMPLETED|Second Intervention (6 Days)||3
3161685|NCT01874119|3889017|FG000|NOT COMPLETED|Second Intervention (6 Days)||0
3161686|NCT01874119|3889018|FG001|NOT COMPLETED|Second Intervention (6 Days)||0
3161687|NCT01874132|3889027|FG000|STARTED|Overall Study||22
3161688|NCT01874132|3889028|FG001|STARTED|Overall Study||22
3161689|NCT01874132|3889029|FG002|STARTED|Overall Study||22
3161690|NCT01874132|3889027|FG000|COMPLETED|Overall Study||18
3161691|NCT01874132|3889028|FG001|COMPLETED|Overall Study||18
3161692|NCT01874132|3889029|FG002|COMPLETED|Overall Study||19
3161693|NCT01874132|3889027|FG000|NOT COMPLETED|Overall Study||4
3161694|NCT01874132|3889028|FG001|NOT COMPLETED|Overall Study||4
3161695|NCT01874132|3889029|FG002|NOT COMPLETED|Overall Study||3
3161696|NCT01874145|3889039|FG000|STARTED|Core Period||101
3161697|NCT01874145|3889040|FG001|STARTED|Core Period||108
3161698|NCT01874145|3889039|FG000|Full Analysis Set|Core Period||100
3161699|NCT01874145|3889040|FG001|Full Analysis Set|Core Period||108
3161700|NCT01874145|3889039|FG000|COMPLETED|Core Period||98
3161701|NCT01874145|3889040|FG001|COMPLETED|Core Period||101
3161702|NCT01874145|3889039|FG000|NOT COMPLETED|Core Period||3
3161703|NCT01874145|3889040|FG001|NOT COMPLETED|Core Period||7
3161704|NCT01874145|3889039|FG000|STARTED|Extension Period|Switchers|97
3161705|NCT01874145|3889040|FG001|STARTED|Extension Period|Non-Switchers|101
3161706|NCT01874145|3889039|FG000|Full Analysis Set|Extension Period||95
3161707|NCT01874145|3889040|FG001|Full Analysis Set|Extension Period||101
3161708|NCT01874145|3889039|FG000|COMPLETED|Extension Period||91
3161709|NCT01874145|3889040|FG001|COMPLETED|Extension Period||97
3161710|NCT01874145|3889039|FG000|NOT COMPLETED|Extension Period||6
3161711|NCT01874145|3889040|FG001|NOT COMPLETED|Extension Period||4
3161712|NCT01874262|3889052|FG000|STARTED|Overall Study||91
3161713|NCT01874262|3889053|FG001|STARTED|Overall Study||83
3161714|NCT01874262|3889052|FG000|Not Correctly Randomised|Overall Study||2
3161715|NCT01874262|3889053|FG001|Not Correctly Randomised|Overall Study||0
3161716|NCT01874262|3889052|FG000|Not Included Due to Tehnical Issues|Overall Study||3
3161717|NCT01874262|3889053|FG001|Not Included Due to Tehnical Issues|Overall Study||3
3161718|NCT01874262|3889052|FG000|COMPLETED|Overall Study||86
3161719|NCT01874262|3889053|FG001|COMPLETED|Overall Study||80
3161720|NCT01874262|3889052|FG000|NOT COMPLETED|Overall Study||5
3161721|NCT01874262|3889053|FG001|NOT COMPLETED|Overall Study||3
3161722|NCT01874275|3889061|FG000|STARTED|Overall Study||4
3161723|NCT01874275|3889062|FG001|STARTED|Overall Study||2
3161724|NCT01874275|3889061|FG000|COMPLETED|Overall Study||3
3161725|NCT01874275|3889062|FG001|COMPLETED|Overall Study||2
3161726|NCT01874275|3889061|FG000|NOT COMPLETED|Overall Study||1
3161727|NCT01874275|3889062|FG001|NOT COMPLETED|Overall Study||0
3161728|NCT01874288|3889079|FG000|STARTED|Overall Study||3
3161729|NCT01874288|3889080|FG001|STARTED|Overall Study||3
3161730|NCT01874288|3889081|FG002|STARTED|Overall Study||9
3161731|NCT01874288|3889082|FG003|STARTED|Overall Study||7
3161732|NCT01874288|3889083|FG004|STARTED|Overall Study||2
3161733|NCT01874288|3889079|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
3161734|NCT01874288|3889080|FG001|Received at Least 1 Dose of Study Drug|Overall Study||3
3161735|NCT01874288|3889081|FG002|Received at Least 1 Dose of Study Drug|Overall Study||9
3161736|NCT01874288|3889082|FG003|Received at Least 1 Dose of Study Drug|Overall Study||7
3161737|NCT01874288|3889083|FG004|Received at Least 1 Dose of Study Drug|Overall Study||2
3161738|NCT01874288|3889079|FG000|COMPLETED|Overall Study||0
3161739|NCT01874288|3889080|FG001|COMPLETED|Overall Study||3
3161740|NCT01874288|3889081|FG002|COMPLETED|Overall Study||4
3161741|NCT01874288|3889082|FG003|COMPLETED|Overall Study||0
3161742|NCT01874288|3889083|FG004|COMPLETED|Overall Study||0
3161743|NCT01874288|3889079|FG000|NOT COMPLETED|Overall Study||3
3161744|NCT01874288|3889080|FG001|NOT COMPLETED|Overall Study||0
3161745|NCT01874288|3889081|FG002|NOT COMPLETED|Overall Study||5
3161746|NCT01874288|3889082|FG003|NOT COMPLETED|Overall Study||7
3161747|NCT01874288|3889083|FG004|NOT COMPLETED|Overall Study||2
3161748|NCT01874340|3889100|FG000|STARTED|Overall Study||6
3161749|NCT01874340|3889101|FG001|STARTED|Overall Study||8
3161750|NCT01874340|3889102|FG002|STARTED|Overall Study||8
3161751|NCT01874340|3889103|FG003|STARTED|Overall Study||6
3161752|NCT01874340|3889100|FG000|COMPLETED|Overall Study||0
3161753|NCT01874340|3889101|FG001|COMPLETED|Overall Study||0
3161754|NCT01874340|3889102|FG002|COMPLETED|Overall Study||0
3161755|NCT01874340|3889103|FG003|COMPLETED|Overall Study||1
3161756|NCT01874340|3889100|FG000|NOT COMPLETED|Overall Study||6
3161757|NCT01874340|3889101|FG001|NOT COMPLETED|Overall Study||8
3161758|NCT01874340|3889102|FG002|NOT COMPLETED|Overall Study||8
3161759|NCT01874340|3889103|FG003|NOT COMPLETED|Overall Study||5
3161760|NCT01874392|3889113|FG000|STARTED|Overall Study||9
3161761|NCT01874392|3889113|FG000|COMPLETED|Overall Study||9
3161762|NCT01874392|3889113|FG000|NOT COMPLETED|Overall Study||0
3161763|NCT01874431|3889125|FG000|STARTED|Overall Study||96
3161764|NCT01874431|3889126|FG001|STARTED|Overall Study||92
3161765|NCT01874431|3889127|FG002|STARTED|Overall Study||100
3161766|NCT01874431|3889128|FG003|STARTED|Overall Study||98
3161767|NCT01874431|3889129|FG004|STARTED|Overall Study||98
3161768|NCT01874431|3889130|FG005|STARTED|Overall Study||125
3161769|NCT01874431|3889131|FG006|STARTED|Overall Study||120
3161770|NCT01874431|3889132|FG007|STARTED|Overall Study||94
3161771|NCT01874431|3889125|FG000|Participants Received Treatment|Overall Study||96
3161772|NCT01874431|3889126|FG001|Participants Received Treatment|Overall Study||92
3161773|NCT01874431|3889127|FG002|Participants Received Treatment|Overall Study||100
3161774|NCT01874431|3889128|FG003|Participants Received Treatment|Overall Study||97
3161775|NCT01874431|3889129|FG004|Participants Received Treatment|Overall Study||98
3161776|NCT01874431|3889130|FG005|Participants Received Treatment|Overall Study||125
3161777|NCT01874431|3889131|FG006|Participants Received Treatment|Overall Study||119
3161778|NCT01874431|3889132|FG007|Participants Received Treatment|Overall Study||94
3161779|NCT01874431|3889125|FG000|COMPLETED|Overall Study||90
3161780|NCT01874431|3889126|FG001|COMPLETED|Overall Study||87
3161781|NCT01874431|3889127|FG002|COMPLETED|Overall Study||90
3161782|NCT01874431|3889128|FG003|COMPLETED|Overall Study||91
3161783|NCT01874431|3889129|FG004|COMPLETED|Overall Study||90
3161784|NCT01874431|3889130|FG005|COMPLETED|Overall Study||114
3161785|NCT01874431|3889131|FG006|COMPLETED|Overall Study||112
3161786|NCT01874431|3889132|FG007|COMPLETED|Overall Study||90
3161787|NCT01874431|3889125|FG000|NOT COMPLETED|Overall Study||6
3161788|NCT01874431|3889126|FG001|NOT COMPLETED|Overall Study||5
3161789|NCT01874431|3889127|FG002|NOT COMPLETED|Overall Study||10
3161790|NCT01874431|3889128|FG003|NOT COMPLETED|Overall Study||7
3161791|NCT01874431|3889129|FG004|NOT COMPLETED|Overall Study||8
3161792|NCT01874431|3889130|FG005|NOT COMPLETED|Overall Study||11
3161793|NCT01874431|3889131|FG006|NOT COMPLETED|Overall Study||8
3161794|NCT01874431|3889132|FG007|NOT COMPLETED|Overall Study||4
3161795|NCT01874535|3889152|FG000|STARTED|Overall Study||207
3161796|NCT01874535|3889153|FG001|STARTED|Overall Study||201
3161797|NCT01874535|3889152|FG000|COMPLETED|Overall Study||152
3161798|NCT01874535|3889153|FG001|COMPLETED|Overall Study||157
3161799|NCT01874535|3889152|FG000|NOT COMPLETED|Overall Study||55
3161800|NCT01874535|3889153|FG001|NOT COMPLETED|Overall Study||44
3161801|NCT01874665|3889161|FG000|STARTED|Overall Study||30
3161802|NCT01874665|3889162|FG001|STARTED|Overall Study||15
3161803|NCT01874665|3889161|FG000|COMPLETED|Overall Study||0
3161804|NCT01874665|3889162|FG001|COMPLETED|Overall Study||0
3161805|NCT01874665|3889161|FG000|NOT COMPLETED|Overall Study||30
3161806|NCT01874665|3889162|FG001|NOT COMPLETED|Overall Study||15
3161807|NCT01874756|3889173|FG000|STARTED|Overall Study||29
3161808|NCT01874756|3889174|FG001|STARTED|Overall Study||10
3161809|NCT01874756|3889175|FG002|STARTED|Overall Study||29
3161810|NCT01874756|3889176|FG003|STARTED|Overall Study||27
3161811|NCT01874756|3889173|FG000|COMPLETED|Overall Study||28
3161812|NCT01874756|3889174|FG001|COMPLETED|Overall Study||10
3161813|NCT01874756|3889175|FG002|COMPLETED|Overall Study||27
3161814|NCT01874756|3889176|FG003|COMPLETED|Overall Study||21
3161815|NCT01874756|3889173|FG000|NOT COMPLETED|Overall Study||1
3161816|NCT01874756|3889174|FG001|NOT COMPLETED|Overall Study||0
3161817|NCT01874756|3889175|FG002|NOT COMPLETED|Overall Study||2
3161818|NCT01874756|3889176|FG003|NOT COMPLETED|Overall Study||6
3161819|NCT01874951|3889188|FG000|STARTED|Overall Study||6
3161820|NCT01874951|3889189|FG001|STARTED|Overall Study||6
3161821|NCT01874951|3889188|FG000|COMPLETED|Overall Study||6
3161822|NCT01874951|3889189|FG001|COMPLETED|Overall Study||6
3161823|NCT01874951|3889188|FG000|NOT COMPLETED|Overall Study||0
3161824|NCT01874951|3889189|FG001|NOT COMPLETED|Overall Study||0
3161825|NCT01875159|3889200|FG000|STARTED|Overall Study||45
3161826|NCT01875159|3889201|FG001|STARTED|Overall Study||53
3161827|NCT01875159|3889200|FG000|COMPLETED|Overall Study||42
3161828|NCT01875159|3889201|FG001|COMPLETED|Overall Study||53
3161829|NCT01875159|3889200|FG000|NOT COMPLETED|Overall Study||3
3161830|NCT01875159|3889201|FG001|NOT COMPLETED|Overall Study||0
3161831|NCT01875237|3889209|FG000|STARTED|Overall Study||2
3161832|NCT01875237|3889210|FG001|STARTED|Overall Study||1
3161833|NCT01875237|3889209|FG000|COMPLETED|Overall Study||0
3161834|NCT01875237|3889210|FG001|COMPLETED|Overall Study||1
3161835|NCT01875237|3889209|FG000|NOT COMPLETED|Overall Study||2
3161836|NCT01875237|3889210|FG001|NOT COMPLETED|Overall Study||0
3161837|NCT01875250|3889220|FG000|STARTED|Overall Study||19
3161838|NCT01875250|3889221|FG001|STARTED|Overall Study||19
3161839|NCT01875250|3889220|FG000|COMPLETED|Overall Study||17
3161840|NCT01875250|3889221|FG001|COMPLETED|Overall Study||19
3161841|NCT01875250|3889220|FG000|NOT COMPLETED|Overall Study||2
3161842|NCT01875250|3889221|FG001|NOT COMPLETED|Overall Study||0
3161843|NCT01875367|3889231|FG000|STARTED|Overall Study||81
3161844|NCT01875367|3889232|FG001|STARTED|Overall Study||85
3161845|NCT01875367|3889231|FG000|COMPLETED|Overall Study||76
3161846|NCT01875367|3889232|FG001|COMPLETED|Overall Study||83
3161847|NCT01875367|3889231|FG000|NOT COMPLETED|Overall Study||5
3161848|NCT01875367|3889232|FG001|NOT COMPLETED|Overall Study||2
3161849|NCT01875445|3889244|FG000|STARTED|Overall Study||19
3161850|NCT01875445|3889245|FG001|STARTED|Overall Study||19
3161851|NCT01875445|3889244|FG000|COMPLETED|Overall Study||12
3161852|NCT01875445|3889245|FG001|COMPLETED|Overall Study||19
3161853|NCT01875445|3889244|FG000|NOT COMPLETED|Overall Study||7
3161854|NCT01875445|3889245|FG001|NOT COMPLETED|Overall Study||0
3161855|NCT01875471|3889253|FG000|STARTED|Overall Study||137
3161856|NCT01875471|3889254|FG001|STARTED|Overall Study||138
3161857|NCT01875471|3889253|FG000|Completed Per Protocol|Overall Study||127
3161858|NCT01875471|3889254|FG001|Completed Per Protocol|Overall Study||123
3161859|NCT01875471|3889253|FG000|COMPLETED|Overall Study||136
3161860|NCT01875471|3889254|FG001|COMPLETED|Overall Study||137
3161861|NCT01875471|3889253|FG000|NOT COMPLETED|Overall Study||1
3161862|NCT01875471|3889254|FG001|NOT COMPLETED|Overall Study||1
3161863|NCT01875510|3889262|FG000|STARTED|Overall Study||40
3161864|NCT01875510|3889263|FG001|STARTED|Overall Study||40
3161865|NCT01875510|3889262|FG000|COMPLETED|Overall Study||40
3161866|NCT01875510|3889263|FG001|COMPLETED|Overall Study||40
3161867|NCT01875510|3889262|FG000|NOT COMPLETED|Overall Study||0
3161868|NCT01875510|3889263|FG001|NOT COMPLETED|Overall Study||0
3161869|NCT01875731|3889271|FG000|STARTED|Overall Study||34
3161870|NCT01875731|3889272|FG001|STARTED|Overall Study||32
3161871|NCT01875731|3889271|FG000|COMPLETED|Overall Study||33
3161872|NCT01875731|3889272|FG001|COMPLETED|Overall Study||32
3161873|NCT01875731|3889271|FG000|NOT COMPLETED|Overall Study||1
3161874|NCT01875731|3889272|FG001|NOT COMPLETED|Overall Study||0
3161875|NCT01875783|3889278|FG000|STARTED|Overall Study||385
3161876|NCT01875783|3889278|FG000|COMPLETED|Overall Study||385
3161877|NCT01875783|3889278|FG000|NOT COMPLETED|Overall Study||0
3161878|NCT01875848|3889286|FG000|STARTED|Overall Study|3 patients were enrolled in the Buprenorphine arm of the study|3
3161879|NCT01875848|3889287|FG001|STARTED|Overall Study|4 patients were enrolled in the opioid dose escalation arm of the study|4
3161880|NCT01875848|3889286|FG000|COMPLETED|Overall Study|1 patient completed the Buprenorphine arm of the study. 2 patients withdrew|1
3161881|NCT01875848|3889287|FG001|COMPLETED|Overall Study|4 patients completed the opioid dose escalation arm of the study|4
3161882|NCT01875848|3889286|FG000|NOT COMPLETED|Overall Study||2
3161883|NCT01875848|3889287|FG001|NOT COMPLETED|Overall Study||0
3161884|NCT01875861|3889295|FG000|STARTED|Pre-implementation||4779
3161885|NCT01875861|3889296|FG001|STARTED|Pre-implementation||3714
3161886|NCT01875861|3889295|FG000|COMPLETED|Pre-implementation||4779
3161887|NCT01875861|3889296|FG001|COMPLETED|Pre-implementation||3714
3161888|NCT01875861|3889295|FG000|NOT COMPLETED|Pre-implementation||0
3161889|NCT01875861|3889296|FG001|NOT COMPLETED|Pre-implementation||0
3161890|NCT01875861|3889295|FG000|STARTED|Implementation||4546
3161891|NCT01875861|3889296|FG001|STARTED|Implementation||3444
3161892|NCT01875861|3889295|FG000|COMPLETED|Implementation||4546
3161893|NCT01875861|3889296|FG001|COMPLETED|Implementation||3444
3161894|NCT01875861|3889295|FG000|NOT COMPLETED|Implementation||0
3161895|NCT01875861|3889296|FG001|NOT COMPLETED|Implementation||0
3161896|NCT01875861|3889295|FG000|STARTED|Sustainability||4306
3161897|NCT01875861|3889296|FG001|STARTED|Sustainability||3444
3161898|NCT01875861|3889295|FG000|COMPLETED|Sustainability||4306
3161899|NCT01875861|3889296|FG001|COMPLETED|Sustainability||3444
3161900|NCT01875861|3889295|FG000|NOT COMPLETED|Sustainability||0
3161901|NCT01875861|3889296|FG001|NOT COMPLETED|Sustainability||0
3161902|NCT01875874|3889303|FG000|STARTED|Overall Study||8
3161903|NCT01875874|3889303|FG000|COMPLETED|Overall Study||5
3161904|NCT01875874|3889303|FG000|NOT COMPLETED|Overall Study||3
3161905|NCT01875978|3889310|FG000|STARTED|Study 4weeks||20
3161906|NCT01875978|3889311|FG001|STARTED|Study 4weeks||20
3161907|NCT01875978|3889310|FG000|COMPLETED|Study 4weeks||20
3161908|NCT01875978|3889311|FG001|COMPLETED|Study 4weeks||20
3161909|NCT01875978|3889310|FG000|NOT COMPLETED|Study 4weeks||0
3161910|NCT01875978|3889311|FG001|NOT COMPLETED|Study 4weeks||0
3161911|NCT01875978|3889310|FG000|STARTED|Washout 2 Weeks ,Crossover Study 4 Weeks||20
3161912|NCT01875978|3889311|FG001|STARTED|Washout 2 Weeks ,Crossover Study 4 Weeks||20
3161913|NCT01875978|3889310|FG000|COMPLETED|Washout 2 Weeks ,Crossover Study 4 Weeks||20
3161914|NCT01875978|3889311|FG001|COMPLETED|Washout 2 Weeks ,Crossover Study 4 Weeks||20
3161915|NCT01875978|3889310|FG000|NOT COMPLETED|Washout 2 Weeks ,Crossover Study 4 Weeks||0
3161916|NCT01875978|3889311|FG001|NOT COMPLETED|Washout 2 Weeks ,Crossover Study 4 Weeks||0
3161917|NCT01875991|3889321|FG000|STARTED|Overall Study||108
3161918|NCT01875991|3889322|FG001|STARTED|Overall Study||109
3161919|NCT01875991|3889321|FG000|Received Etanercept in Period 1|Overall Study||108
3161920|NCT01875991|3889322|FG001|Received Etanercept in Period 1|Overall Study||108
3161921|NCT01875991|3889321|FG000|Received Etanercept in Period 2|Overall Study||102
3161922|NCT01875991|3889322|FG001|Received Etanercept in Period 2|Overall Study||103
3161923|NCT01875991|3889321|FG000|COMPLETED|Overall Study||101
3161924|NCT01875991|3889322|FG001|COMPLETED|Overall Study||103
3161925|NCT01875991|3889321|FG000|NOT COMPLETED|Overall Study||7
3161926|NCT01875991|3889322|FG001|NOT COMPLETED|Overall Study||6
3161927|NCT01876043|3889331|FG000|STARTED|Overall Study||24
3161928|NCT01876043|3889331|FG000|Interim Analysis Population|Overall Study||17
3161929|NCT01876043|3889331|FG000|COMPLETED|Overall Study||22
3161930|NCT01876043|3889331|FG000|NOT COMPLETED|Overall Study||2
3161931|NCT01876082|3889337|FG000|STARTED|Overall Study||48
3161932|NCT01876082|3889338|FG001|STARTED|Overall Study||24
3161933|NCT01876082|3889337|FG000|Safety Population|Overall Study||48
3161934|NCT01876082|3889338|FG001|Safety Population|Overall Study|2 patients did not start control treatment|22
3161935|NCT01876082|3889337|FG000|COMPLETED|Overall Study||46
3161936|NCT01876082|3889338|FG001|COMPLETED|Overall Study||20
3161937|NCT01876082|3889337|FG000|NOT COMPLETED|Overall Study||2
3161938|NCT01876082|3889338|FG001|NOT COMPLETED|Overall Study||4
3161939|NCT01876212|3889346|FG000|STARTED|Overall Study||9
3161940|NCT01876212|3889347|FG001|STARTED|Overall Study||6
3161941|NCT01876212|3889346|FG000|COMPLETED|Overall Study||9
3161942|NCT01876212|3889347|FG001|COMPLETED|Overall Study||6
3161943|NCT01876212|3889346|FG000|NOT COMPLETED|Overall Study||0
3161944|NCT01876212|3889347|FG001|NOT COMPLETED|Overall Study||0
3161945|NCT01876251|3889356|FG000|STARTED|Overall Study||15
3161946|NCT01876251|3889357|FG001|STARTED|Overall Study||3
3161947|NCT01876251|3889358|FG002|STARTED|Overall Study||11
3161948|NCT01876251|3889356|FG000|COMPLETED|Overall Study||0
3161949|NCT01876251|3889357|FG001|COMPLETED|Overall Study||0
3161950|NCT01876251|3889358|FG002|COMPLETED|Overall Study||0
3161951|NCT01876251|3889356|FG000|NOT COMPLETED|Overall Study||15
3161952|NCT01876251|3889357|FG001|NOT COMPLETED|Overall Study||3
3161953|NCT01876251|3889358|FG002|NOT COMPLETED|Overall Study||11
3161954|NCT01876329|3889370|FG000|STARTED|Overall Study||45
3161955|NCT01876329|3889371|FG001|STARTED|Overall Study||36
3161956|NCT01876329|3889372|FG002|STARTED|Overall Study||44
3161957|NCT01876329|3889370|FG000|COMPLETED|Overall Study||45
3161958|NCT01876329|3889371|FG001|COMPLETED|Overall Study||36
3161959|NCT01876329|3889372|FG002|COMPLETED|Overall Study||44
3161960|NCT01876329|3889370|FG000|NOT COMPLETED|Overall Study||0
3161961|NCT01876329|3889371|FG001|NOT COMPLETED|Overall Study||0
3161962|NCT01876329|3889372|FG002|NOT COMPLETED|Overall Study||0
3161963|NCT01876368|3889382|FG000|STARTED|Overall Study||188
3161964|NCT01876368|3889383|FG001|STARTED|Overall Study||188
3161965|NCT01876368|3889382|FG000|Full Analysis Set (FAS)|Overall Study||188
3161966|NCT01876368|3889383|FG001|Full Analysis Set (FAS)|Overall Study|One patient was not included in the SAF and FAS due to mis-randomization.|187
3161967|NCT01876368|3889382|FG000|Safety Set (SAF)|Overall Study||188
3161968|NCT01876368|3889383|FG001|Safety Set (SAF)|Overall Study||187
3161969|NCT01876368|3889382|FG000|COMPLETED|Overall Study||179
3161970|NCT01876368|3889383|FG001|COMPLETED|Overall Study||175
3161971|NCT01876368|3889382|FG000|NOT COMPLETED|Overall Study||9
3161972|NCT01876368|3889383|FG001|NOT COMPLETED|Overall Study||13
3161973|NCT01876381|3889389|FG000|STARTED|Overall Study||23
3161974|NCT01876381|3889389|FG000|COMPLETED|Overall Study||16
3161975|NCT01876381|3889389|FG000|NOT COMPLETED|Overall Study||7
3161976|NCT01876420|3889393|FG000|STARTED|Overall Study||60
3161977|NCT01876420|3889393|FG000|COMPLETED|Overall Study||59
3161978|NCT01876420|3889393|FG000|NOT COMPLETED|Overall Study||1
3161979|NCT01876446|3889399|FG000|STARTED|Overall Study||20
3161980|NCT01876446|3889400|FG001|STARTED|Overall Study||18
3161981|NCT01876446|3889399|FG000|COMPLETED|Overall Study||18
3161982|NCT01876446|3889400|FG001|COMPLETED|Overall Study||12
3161983|NCT01876446|3889399|FG000|NOT COMPLETED|Overall Study||2
3161984|NCT01876446|3889400|FG001|NOT COMPLETED|Overall Study||6
3161985|NCT01876485|3889408|FG000|STARTED|Overall Study||140
3161986|NCT01876485|3889409|FG001|STARTED|Overall Study||140
3161987|NCT01876485|3889408|FG000|Post-Intervention|Overall Study||125
3161988|NCT01876485|3889409|FG001|Post-Intervention|Overall Study||129
3161989|NCT01876485|3889408|FG000|Maintenance|Overall Study||116
3161990|NCT01876485|3889409|FG001|Maintenance|Overall Study||114
3161991|NCT01876485|3889408|FG000|COMPLETED|Overall Study||116
3161992|NCT01876485|3889409|FG001|COMPLETED|Overall Study||114
3161993|NCT01876485|3889408|FG000|NOT COMPLETED|Overall Study||24
3161994|NCT01876485|3889409|FG001|NOT COMPLETED|Overall Study||26
3161995|NCT01876511|3889418|FG000|STARTED|Overall Study||41
3161996|NCT01876511|3889419|FG001|STARTED|Overall Study||25
3161997|NCT01876511|3889420|FG002|STARTED|Overall Study||47
3161998|NCT01876511|3889418|FG000|Stages 1 and 2|Overall Study||24
3161999|NCT01876511|3889419|FG001|Stages 1 and 2|Overall Study||25
3162000|NCT01876511|3889420|FG002|Stages 1 and 2|Overall Study||21
3162001|NCT01876511|3889418|FG000|COMPLETED|Overall Study||18
3162002|NCT01876511|3889419|FG001|COMPLETED|Overall Study||0
3162003|NCT01876511|3889420|FG002|COMPLETED|Overall Study||16
3162004|NCT01876511|3889418|FG000|NOT COMPLETED|Overall Study||23
3162005|NCT01876511|3889419|FG001|NOT COMPLETED|Overall Study||25
3162006|NCT01876511|3889420|FG002|NOT COMPLETED|Overall Study||31
3162007|NCT01876706|3889430|FG000|STARTED|Overall Study||51
3162008|NCT01876706|3889430|FG000|1 Month|Overall Study||51
3162009|NCT01876706|3889430|FG000|3 Months|Overall Study||51
3162010|NCT01876706|3889430|FG000|6 Months|Overall Study||46
3162011|NCT01876706|3889430|FG000|12 Months|Overall Study||42
3162012|NCT01876706|3889430|FG000|24 Months|Overall Study||35
3162013|NCT01876706|3889430|FG000|36 Months|Overall Study||32
3162014|NCT01876706|3889430|FG000|48 Months|Overall Study||31
3162015|NCT01876706|3889430|FG000|60 Months|Overall Study||26
3162016|NCT01876706|3889430|FG000|COMPLETED|Overall Study||26
3162017|NCT01876706|3889430|FG000|NOT COMPLETED|Overall Study||25
3162018|NCT01876732|3889434|FG000|STARTED|Overall Study||132
3162019|NCT01876732|3889434|FG000|COMPLETED|Overall Study||57
3162020|NCT01876732|3889434|FG000|NOT COMPLETED|Overall Study||75
3162021|NCT01876784|3889441|FG000|STARTED|Overall Study||119
3162022|NCT01876784|3889442|FG001|STARTED|Overall Study||119
3162023|NCT01876784|3889441|FG000|Treated|Overall Study||117
3162024|NCT01876784|3889442|FG001|Treated|Overall Study||118
3162025|NCT01876784|3889441|FG000|COMPLETED|Overall Study||0
3162026|NCT01876784|3889442|FG001|COMPLETED|Overall Study||0
3162027|NCT01876784|3889441|FG000|NOT COMPLETED|Overall Study||119
3162028|NCT01876784|3889442|FG001|NOT COMPLETED|Overall Study||119
3162029|NCT01876810|3889448|FG000|STARTED|Overall Study||14
3162030|NCT01876810|3889449|FG001|STARTED|Overall Study||14
3162031|NCT01876810|3889448|FG000|COMPLETED|Overall Study||14
3162032|NCT01876810|3889449|FG001|COMPLETED|Overall Study||13
3162033|NCT01876810|3889448|FG000|NOT COMPLETED|Overall Study||0
3162034|NCT01876810|3889449|FG001|NOT COMPLETED|Overall Study||1
3162035|NCT01876823|3889458|FG000|STARTED|Overall Study||35
3162036|NCT01876823|3889458|FG000|COMPLETED|Overall Study||26
3162037|NCT01876823|3889458|FG000|NOT COMPLETED|Overall Study||9
3162038|NCT01876901|3889464|FG000|STARTED|Overall Study||65
3162039|NCT01876901|3889465|FG001|STARTED|Overall Study||59
3162040|NCT01876901|3889464|FG000|COMPLETED|Overall Study||48
3162041|NCT01876901|3889465|FG001|COMPLETED|Overall Study||52
3162042|NCT01876901|3889464|FG000|NOT COMPLETED|Overall Study||17
3162043|NCT01876901|3889465|FG001|NOT COMPLETED|Overall Study||7
3162044|NCT01876953|3889474|FG000|STARTED|Overall Study||17
3162045|NCT01876953|3889475|FG001|STARTED|Overall Study||3
3162046|NCT01876953|3889474|FG000|COMPLETED|Overall Study||17
3162047|NCT01876953|3889475|FG001|COMPLETED|Overall Study||3
3162048|NCT01876953|3889474|FG000|NOT COMPLETED|Overall Study||0
3162049|NCT01876953|3889475|FG001|NOT COMPLETED|Overall Study||0
3055869|NCT01244477|3776356|FG000|STARTED|Overall Study||38
3055870|NCT01244477|3776357|FG001|STARTED|Overall Study||23
3055871|NCT01244477|3776356|FG000|COMPLETED|Overall Study||18
3055872|NCT01244477|3776357|FG001|COMPLETED|Overall Study||20
3055873|NCT01244477|3776356|FG000|NOT COMPLETED|Overall Study||20
3055874|NCT01244477|3776357|FG001|NOT COMPLETED|Overall Study||3
3055875|NCT01244490|3776368|FG000|STARTED|Overall Study||111
3055876|NCT01244490|3776369|FG001|STARTED|Overall Study||115
3055877|NCT01244490|3776370|FG002|STARTED|Overall Study||112
3055878|NCT01244490|3776368|FG000|COMPLETED|Overall Study||92
3055879|NCT01244490|3776369|FG001|COMPLETED|Overall Study||91
3055880|NCT01244490|3776370|FG002|COMPLETED|Overall Study||89
3055881|NCT01244490|3776368|FG000|NOT COMPLETED|Overall Study||19
3055882|NCT01244490|3776369|FG001|NOT COMPLETED|Overall Study||24
3055883|NCT01244490|3776370|FG002|NOT COMPLETED|Overall Study||23
3055884|NCT01244503|3776378|FG000|STARTED|Overall Study||61
3055885|NCT01244503|3776378|FG000|COMPLETED|Overall Study||61
3055886|NCT01244503|3776378|FG000|NOT COMPLETED|Overall Study||0
3055887|NCT01244516|3776385|FG000|STARTED|Period 1 (Baseline to 1-week Visit)||170
3055888|NCT01244516|3776386|FG001|STARTED|Period 1 (Baseline to 1-week Visit)||177
3055889|NCT01244516|3776387|FG002|STARTED|Period 1 (Baseline to 1-week Visit)||173
3055890|NCT01244516|3776385|FG000|COMPLETED|Period 1 (Baseline to 1-week Visit)||166
3055891|NCT01244516|3776386|FG001|COMPLETED|Period 1 (Baseline to 1-week Visit)||171
3055892|NCT01244516|3776387|FG002|COMPLETED|Period 1 (Baseline to 1-week Visit)||170
3055893|NCT01244516|3776385|FG000|NOT COMPLETED|Period 1 (Baseline to 1-week Visit)||4
3055894|NCT01244516|3776386|FG001|NOT COMPLETED|Period 1 (Baseline to 1-week Visit)||6
3055895|NCT01244516|3776387|FG002|NOT COMPLETED|Period 1 (Baseline to 1-week Visit)||3
3055896|NCT01244516|3776385|FG000|STARTED|Period 2 (1-week to 2-week Visit)||166
3055897|NCT01244516|3776386|FG001|STARTED|Period 2 (1-week to 2-week Visit)||171
3055898|NCT01244516|3776387|FG002|STARTED|Period 2 (1-week to 2-week Visit)||170
3055899|NCT01244516|3776385|FG000|COMPLETED|Period 2 (1-week to 2-week Visit)||163
3055900|NCT01244516|3776386|FG001|COMPLETED|Period 2 (1-week to 2-week Visit)||170
3055901|NCT01244516|3776387|FG002|COMPLETED|Period 2 (1-week to 2-week Visit)||168
3055902|NCT01244516|3776385|FG000|NOT COMPLETED|Period 2 (1-week to 2-week Visit)||3
3055903|NCT01244516|3776386|FG001|NOT COMPLETED|Period 2 (1-week to 2-week Visit)||1
3055904|NCT01244516|3776387|FG002|NOT COMPLETED|Period 2 (1-week to 2-week Visit)||2
3055905|NCT01244529|3776396|FG000|STARTED|Overall Study||41
3055906|NCT01244529|3776396|FG000|COMPLETED|Overall Study||41
3055907|NCT01244529|3776396|FG000|NOT COMPLETED|Overall Study||0
3055908|NCT01244633|3776412|FG000|STARTED|Overall Study||18
3055909|NCT01244633|3776412|FG000|COMPLETED|Overall Study||15
3055910|NCT01244633|3776412|FG000|NOT COMPLETED|Overall Study||3
3055911|NCT01244711|3776416|FG000|STARTED|Overall Study||1
3055912|NCT01244711|3776416|FG000|COMPLETED|Overall Study||1
3055913|NCT01244711|3776416|FG000|NOT COMPLETED|Overall Study||0
3055914|NCT01244724|3776420|FG000|STARTED|Overall Study|Of these 15 returned for a week 2 visit and are included in the efficacy analysis.|17
3055915|NCT01244724|3776420|FG000|Week 2 Visit|Overall Study||15
3055916|NCT01244724|3776420|FG000|COMPLETED|Overall Study||9
3055917|NCT01244724|3776420|FG000|NOT COMPLETED|Overall Study||8
3055918|NCT01244893|3776424|FG000|STARTED|Baseline||22
3055919|NCT01244893|3776425|FG001|STARTED|Baseline||22
3055920|NCT01244893|3776424|FG000|COMPLETED|Baseline||22
3055921|NCT01244893|3776425|FG001|COMPLETED|Baseline||21
3055922|NCT01244893|3776424|FG000|NOT COMPLETED|Baseline||0
3055923|NCT01244893|3776425|FG001|NOT COMPLETED|Baseline||1
3055924|NCT01244893|3776424|FG000|STARTED|1-Week Follow Up||22
3055925|NCT01244893|3776425|FG001|STARTED|1-Week Follow Up||21
3055926|NCT01244893|3776424|FG000|COMPLETED|1-Week Follow Up||21
3055927|NCT01244893|3776425|FG001|COMPLETED|1-Week Follow Up||21
3055928|NCT01244893|3776424|FG000|NOT COMPLETED|1-Week Follow Up||1
3055929|NCT01244893|3776425|FG001|NOT COMPLETED|1-Week Follow Up||0
3055930|NCT01244893|3776424|FG000|STARTED|Final Visit||21
3055931|NCT01244893|3776425|FG001|STARTED|Final Visit||21
3055932|NCT01244893|3776424|FG000|COMPLETED|Final Visit||21
3055933|NCT01244893|3776425|FG001|COMPLETED|Final Visit||21
3055934|NCT01244893|3776424|FG000|NOT COMPLETED|Final Visit||0
3055935|NCT01244893|3776425|FG001|NOT COMPLETED|Final Visit||0
3055936|NCT01244906|3776436|FG000|STARTED|Overall Study||26
3055937|NCT01244906|3776436|FG000|COMPLETED|Overall Study||18
3055938|NCT01244906|3776436|FG000|NOT COMPLETED|Overall Study||8
3055939|NCT01244984|3776443|FG000|STARTED|Overall Study||60
3055940|NCT01244984|3776444|FG001|STARTED|Overall Study||93
3055941|NCT01244984|3776445|FG002|STARTED|Overall Study||90
3055942|NCT01244984|3776443|FG000|COMPLETED|Overall Study||55
3162050|NCT01876979|3889483|FG000|STARTED|Overall Study||2
3162051|NCT01876979|3889484|FG001|STARTED|Overall Study||3
3055943|NCT01244984|3776444|FG001|COMPLETED|Overall Study||79
3055944|NCT01244984|3776445|FG002|COMPLETED|Overall Study||86
3055945|NCT01244984|3776443|FG000|NOT COMPLETED|Overall Study||5
3055946|NCT01244984|3776444|FG001|NOT COMPLETED|Overall Study||14
3055947|NCT01244984|3776445|FG002|NOT COMPLETED|Overall Study||4
3055948|NCT01245049|3776456|FG000|STARTED|Overall Study||255
3055949|NCT01245049|3776457|FG001|STARTED|Overall Study||130
3055950|NCT01245049|3776456|FG000|COMPLETED|Overall Study||254
3055951|NCT01245049|3776457|FG001|COMPLETED|Overall Study||126
3055952|NCT01245049|3776456|FG000|NOT COMPLETED|Overall Study||1
3055953|NCT01245049|3776457|FG001|NOT COMPLETED|Overall Study||4
3055954|NCT01245062|3776465|FG000|STARTED|Randomization and Crossover Phase||214
3055955|NCT01245062|3776466|FG001|STARTED|Randomization and Crossover Phase||108
3055956|NCT01245062|3776467|FG002|STARTED|Randomization and Crossover Phase||0
3055957|NCT01245062|3776465|FG000|COMPLETED|Randomization and Crossover Phase||173
3055958|NCT01245062|3776466|FG001|COMPLETED|Randomization and Crossover Phase||77
3055959|NCT01245062|3776467|FG002|COMPLETED|Randomization and Crossover Phase||0
3055960|NCT01245062|3776465|FG000|NOT COMPLETED|Randomization and Crossover Phase||41
3055961|NCT01245062|3776466|FG001|NOT COMPLETED|Randomization and Crossover Phase||31
3055962|NCT01245062|3776467|FG002|NOT COMPLETED|Randomization and Crossover Phase||0
3055963|NCT01245062|3776465|FG000|STARTED|Cross-over Phase||0
3055964|NCT01245062|3776466|FG001|STARTED|Cross-over Phase||0
3055965|NCT01245062|3776467|FG002|STARTED|Cross-over Phase|As of the data cut on December 16, 2016, 70 of 108 participants crossed over from CT to trametinib.|70
3055966|NCT01245062|3776465|FG000|COMPLETED|Cross-over Phase||0
3055967|NCT01245062|3776466|FG001|COMPLETED|Cross-over Phase||0
3055968|NCT01245062|3776467|FG002|COMPLETED|Cross-over Phase||53
3055969|NCT01245062|3776465|FG000|NOT COMPLETED|Cross-over Phase||0
3055970|NCT01245062|3776466|FG001|NOT COMPLETED|Cross-over Phase||0
3055971|NCT01245062|3776467|FG002|NOT COMPLETED|Cross-over Phase||17
3055972|NCT01245101|3776477|FG000|STARTED|Period 1 (Treatment)||15
3055973|NCT01245101|3776478|FG001|STARTED|Period 1 (Treatment)||0
3055974|NCT01245101|3776477|FG000|COMPLETED|Period 1 (Treatment)||13
3055975|NCT01245101|3776478|FG001|COMPLETED|Period 1 (Treatment)||0
3055976|NCT01245101|3776477|FG000|NOT COMPLETED|Period 1 (Treatment)||2
3055977|NCT01245101|3776478|FG001|NOT COMPLETED|Period 1 (Treatment)||0
3055978|NCT01245101|3776477|FG000|STARTED|Period 2 (Washout)||13
3055979|NCT01245101|3776478|FG001|STARTED|Period 2 (Washout)||0
3055980|NCT01245101|3776477|FG000|COMPLETED|Period 2 (Washout)||12
3055981|NCT01245101|3776478|FG001|COMPLETED|Period 2 (Washout)||0
3055982|NCT01245101|3776477|FG000|NOT COMPLETED|Period 2 (Washout)||1
3055983|NCT01245101|3776478|FG001|NOT COMPLETED|Period 2 (Washout)||0
3055984|NCT01245101|3776477|FG000|STARTED|Period 3 (Treatment)||12
3055985|NCT01245101|3776478|FG001|STARTED|Period 3 (Treatment)||0
3055986|NCT01245101|3776477|FG000|COMPLETED|Period 3 (Treatment)||11
3055987|NCT01245101|3776478|FG001|COMPLETED|Period 3 (Treatment)||0
3055988|NCT01245101|3776477|FG000|NOT COMPLETED|Period 3 (Treatment)||1
3055989|NCT01245101|3776478|FG001|NOT COMPLETED|Period 3 (Treatment)||0
3055990|NCT01245140|3776486|FG000|STARTED|Overall Study||9
3055991|NCT01245140|3776487|FG001|STARTED|Overall Study||24
3055992|NCT01245140|3776486|FG000|COMPLETED|Overall Study||6
3055993|NCT01245140|3776487|FG001|COMPLETED|Overall Study||14
3055994|NCT01245140|3776486|FG000|NOT COMPLETED|Overall Study||3
3055995|NCT01245140|3776487|FG001|NOT COMPLETED|Overall Study||10
3055996|NCT01245270|3776495|FG000|STARTED|Overall Study|In a cross-over design, volunteers (n=8) were randomised and double blinded into two groups (n=4)|4
3055997|NCT01245270|3776496|FG001|STARTED|Overall Study|In a cross-over design, volunteers (n=8) were randomised and double blinded into two groups (n=4)|4
3055998|NCT01245270|3776495|FG000|COMPLETED|Overall Study|In a cross-over design, volunteers (n=8) were randomised and double blinded into two groups (n=4)|4
3055999|NCT01245270|3776496|FG001|COMPLETED|Overall Study|In a cross-over design, volunteers (n=8) were randomised and double blinded into two groups (n=4)|4
3056000|NCT01245270|3776495|FG000|NOT COMPLETED|Overall Study||0
3056001|NCT01245270|3776496|FG001|NOT COMPLETED|Overall Study||0
3056002|NCT01245283|3776507|FG000|STARTED|Overall Study||32
3056003|NCT01245283|3776508|FG001|STARTED|Overall Study||28
3056004|NCT01245283|3776509|FG002|STARTED|Overall Study||30
3056005|NCT01245283|3776507|FG000|COMPLETED|Overall Study||18
3056006|NCT01245283|3776508|FG001|COMPLETED|Overall Study||17
3056007|NCT01245283|3776509|FG002|COMPLETED|Overall Study||19
3056008|NCT01245283|3776507|FG000|NOT COMPLETED|Overall Study||14
3056009|NCT01245283|3776508|FG001|NOT COMPLETED|Overall Study||11
3056010|NCT01245283|3776509|FG002|NOT COMPLETED|Overall Study||11
3056011|NCT01245374|3776520|FG000|STARTED|Overall Study||103
3056012|NCT01245374|3776520|FG000|COMPLETED|Overall Study||99
3056013|NCT01245374|3776520|FG000|NOT COMPLETED|Overall Study||4
3056014|NCT01245387|3776525|FG000|STARTED|Overall Study||1001
3056015|NCT01245387|3776525|FG000|COMPLETED|Overall Study||188
3056016|NCT01245387|3776525|FG000|NOT COMPLETED|Overall Study||813
3056017|NCT01245413|3776529|FG000|STARTED|Sensura First,||16
3056018|NCT01245413|3776530|FG001|STARTED|Sensura First,||16
3056019|NCT01245413|3776529|FG000|COMPLETED|Sensura First,||16
3056020|NCT01245413|3776530|FG001|COMPLETED|Sensura First,||16
3056021|NCT01245413|3776529|FG000|NOT COMPLETED|Sensura First,||0
3056022|NCT01245413|3776530|FG001|NOT COMPLETED|Sensura First,||0
3056023|NCT01245413|3776529|FG000|STARTED|Athena First,||16
3056024|NCT01245413|3776530|FG001|STARTED|Athena First,||16
3056025|NCT01245413|3776529|FG000|COMPLETED|Athena First,||16
3162052|NCT01876979|3889483|FG000|COMPLETED|Overall Study||0
3162053|NCT01876979|3889484|FG001|COMPLETED|Overall Study||0
3162054|NCT01876979|3889483|FG000|NOT COMPLETED|Overall Study||2
3162055|NCT01876979|3889484|FG001|NOT COMPLETED|Overall Study||3
3162056|NCT01876992|3889492|FG000|STARTED|Overall Study||5
3056026|NCT01245413|3776530|FG001|COMPLETED|Athena First,||16
3056027|NCT01245413|3776529|FG000|NOT COMPLETED|Athena First,||0
3056028|NCT01245413|3776530|FG001|NOT COMPLETED|Athena First,||0
3056029|NCT01245439|3776536|FG000|STARTED|Overall Study||65
3056030|NCT01245439|3776536|FG000|COMPLETED|Overall Study||65
3056031|NCT01245439|3776536|FG000|NOT COMPLETED|Overall Study||0
3056032|NCT01245595|3776544|FG000|STARTED|Overall Study||72
3056033|NCT01245595|3776545|FG001|STARTED|Overall Study||72
3056034|NCT01245595|3776544|FG000|Completed Full Course of Study Drug|Overall Study||57
3056035|NCT01245595|3776545|FG001|Completed Full Course of Study Drug|Overall Study||61
3056036|NCT01245595|3776544|FG000|COMPLETED|Overall Study||72
3056037|NCT01245595|3776545|FG001|COMPLETED|Overall Study||72
3056038|NCT01245595|3776544|FG000|NOT COMPLETED|Overall Study||0
3056039|NCT01245595|3776545|FG001|NOT COMPLETED|Overall Study||0
3162057|NCT01876992|3889493|FG001|STARTED|Overall Study||5
3162058|NCT01876992|3889492|FG000|COMPLETED|Overall Study||5
3162059|NCT01876992|3889493|FG001|COMPLETED|Overall Study||5
3162060|NCT01876992|3889492|FG000|NOT COMPLETED|Overall Study||0
3162061|NCT01876992|3889493|FG001|NOT COMPLETED|Overall Study||0
3162062|NCT01877083|3889500|FG000|STARTED|Treatment Phase||25
3162063|NCT01877083|3889500|FG000|COMPLETED|Treatment Phase||5
3162064|NCT01877083|3889500|FG000|NOT COMPLETED|Treatment Phase||20
3162065|NCT01877083|3889500|FG000|STARTED|Extension Phase||5
3162066|NCT01877083|3889500|FG000|COMPLETED|Extension Phase||0
3162067|NCT01877083|3889500|FG000|NOT COMPLETED|Extension Phase||5
3162068|NCT01877148|3889506|FG000|STARTED|Overall Study||6
3162069|NCT01877148|3889507|FG001|STARTED|Overall Study||6
3162070|NCT01877148|3889506|FG000|COMPLETED|Overall Study||5
3162071|NCT01877148|3889507|FG001|COMPLETED|Overall Study||5
3162072|NCT01877148|3889506|FG000|NOT COMPLETED|Overall Study||1
3162073|NCT01877148|3889507|FG001|NOT COMPLETED|Overall Study||1
3162074|NCT01877161|3889513|FG000|STARTED|First Session of Stimulation||12
3162075|NCT01877161|3889513|FG000|COMPLETED|First Session of Stimulation||12
3162076|NCT01877161|3889513|FG000|NOT COMPLETED|First Session of Stimulation||0
3162077|NCT01877161|3889513|FG000|STARTED|Washout (at Least 3 Days)||12
3162078|NCT01877161|3889513|FG000|COMPLETED|Washout (at Least 3 Days)||12
3056040|NCT01245647|3776553|FG000|STARTED|Overall Study||7
3056041|NCT01245647|3776554|FG001|STARTED|Overall Study||12
3056042|NCT01245647|3776553|FG000|COMPLETED|Overall Study||7
3056043|NCT01245647|3776554|FG001|COMPLETED|Overall Study||8
3056044|NCT01245647|3776553|FG000|NOT COMPLETED|Overall Study||0
3056045|NCT01245647|3776554|FG001|NOT COMPLETED|Overall Study||4
3056046|NCT01245673|3776560|FG000|STARTED|Enrollment||28
3056047|NCT01245673|3776560|FG000|COMPLETED|Enrollment|One subject failed to meet screening criteria for the trial.|27
3056048|NCT01245673|3776560|FG000|NOT COMPLETED|Enrollment||1
3056049|NCT01245673|3776560|FG000|STARTED|Pre Transplant Vaccinations||27
3056050|NCT01245673|3776560|FG000|Pre Transplant Vaccinations 1-3|Pre Transplant Vaccinations||27
3056051|NCT01245673|3776560|FG000|COMPLETED|Pre Transplant Vaccinations||27
3056052|NCT01245673|3776560|FG000|NOT COMPLETED|Pre Transplant Vaccinations||0
3056053|NCT01245673|3776560|FG000|STARTED|Activated/Costimulated Autologous T Cell||27
3056054|NCT01245673|3776560|FG000|COMPLETED|Activated/Costimulated Autologous T Cell||27
3056055|NCT01245673|3776560|FG000|NOT COMPLETED|Activated/Costimulated Autologous T Cell||0
3283827|NCT02759562|4017642|FG001|STARTED|Open-Label Treatment Period||2
3283828|NCT02759562|4017641|FG000|COMPLETED|Open-Label Treatment Period||0
3283829|NCT02759562|4017642|FG001|COMPLETED|Open-Label Treatment Period||0
3283830|NCT02759562|4017641|FG000|NOT COMPLETED|Open-Label Treatment Period||2
3283831|NCT02759562|4017642|FG001|NOT COMPLETED|Open-Label Treatment Period||2
3283832|NCT02759575|4017649|FG000|STARTED|Overall Study||9
3283833|NCT02759575|4017649|FG000|COMPLETED|Overall Study||9
3056056|NCT01245673|3776560|FG000|STARTED|MAGE-A3, Hiltonol®, PVC After T Cells||27
3056057|NCT01245673|3776560|FG000|COMPLETED|MAGE-A3, Hiltonol®, PVC After T Cells||26
3056058|NCT01245673|3776560|FG000|NOT COMPLETED|MAGE-A3, Hiltonol®, PVC After T Cells||1
3056059|NCT01245673|3776560|FG000|STARTED|Start Lenalidomide||26
3056060|NCT01245673|3776560|FG000|COMPLETED|Start Lenalidomide||26
3056061|NCT01245673|3776560|FG000|NOT COMPLETED|Start Lenalidomide||0
3056062|NCT01245673|3776560|FG000|STARTED|Maintenance: MAGE-A3, PVC After T Cells||26
3056063|NCT01245673|3776560|FG000|COMPLETED|Maintenance: MAGE-A3, PVC After T Cells||26
3056064|NCT01245673|3776560|FG000|NOT COMPLETED|Maintenance: MAGE-A3, PVC After T Cells||0
3056065|NCT01245699|3776566|FG000|STARTED|Overall Study||61
3056066|NCT01245699|3776567|FG001|STARTED|Overall Study||54
3056067|NCT01245699|3776566|FG000|COMPLETED|Overall Study||52
3056068|NCT01245699|3776567|FG001|COMPLETED|Overall Study||49
3056069|NCT01245699|3776566|FG000|NOT COMPLETED|Overall Study||9
3056070|NCT01245699|3776567|FG001|NOT COMPLETED|Overall Study||5
3056071|NCT01245738|3776574|FG000|STARTED|Overall Study||514
3056072|NCT01245738|3776574|FG000|COMPLETED|Overall Study||474
3056073|NCT01245738|3776574|FG000|NOT COMPLETED|Overall Study||40
3162079|NCT01877161|3889513|FG000|NOT COMPLETED|Washout (at Least 3 Days)||0
3162080|NCT01877161|3889513|FG000|STARTED|Second Session of Stimulation||12
3162081|NCT01877161|3889513|FG000|COMPLETED|Second Session of Stimulation||12
3162082|NCT01877161|3889513|FG000|NOT COMPLETED|Second Session of Stimulation||0
3283834|NCT02759575|4017649|FG000|NOT COMPLETED|Overall Study||0
3162083|NCT01877161|3889513|FG000|STARTED|Washout (at Least 3 Days)||12
3162084|NCT01877161|3889513|FG000|COMPLETED|Washout (at Least 3 Days)||12
3162085|NCT01877161|3889513|FG000|NOT COMPLETED|Washout (at Least 3 Days)||0
3283835|NCT02759692|4017653|FG000|STARTED|Period 1||141
3283836|NCT02759692|4017654|FG001|STARTED|Period 1||142
3283837|NCT02759692|4017653|FG000|COMPLETED|Period 1||138
3056074|NCT01245751|3776582|FG000|STARTED|Part 1: Day 1 to Week 52 (1 Year)||201
3056075|NCT01245751|3776583|FG001|STARTED|Part 1: Day 1 to Week 52 (1 Year)||199
3056076|NCT01245751|3776584|FG002|STARTED|Part 1: Day 1 to Week 52 (1 Year)||100
3056077|NCT01245751|3776585|FG003|STARTED|Part 1: Day 1 to Week 52 (1 Year)||100
3056078|NCT01245751|3776582|FG000|Completed 42-day Postvaccination Period|Part 1: Day 1 to Week 52 (1 Year)||201
3056079|NCT01245751|3776583|FG001|Completed 42-day Postvaccination Period|Part 1: Day 1 to Week 52 (1 Year)||199
3056080|NCT01245751|3776584|FG002|Completed 42-day Postvaccination Period|Part 1: Day 1 to Week 52 (1 Year)||100
3056081|NCT01245751|3776585|FG003|Completed 42-day Postvaccination Period|Part 1: Day 1 to Week 52 (1 Year)||100
3056082|NCT01245751|3776582|FG000|COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||199
3056083|NCT01245751|3776583|FG001|COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||194
3056084|NCT01245751|3776584|FG002|COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||100
3056085|NCT01245751|3776585|FG003|COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||98
3056086|NCT01245751|3776582|FG000|NOT COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||2
3056087|NCT01245751|3776583|FG001|NOT COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||5
3056088|NCT01245751|3776584|FG002|NOT COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||0
3056089|NCT01245751|3776585|FG003|NOT COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||2
3056090|NCT01245751|3776582|FG000|STARTED|Part 2: Week 156 (3 Year) Visit|Enrollment in Part 2 was voluntary|161
3056091|NCT01245751|3776583|FG001|STARTED|Part 2: Week 156 (3 Year) Visit|Enrollment in Part 2 was voluntary|139
3056092|NCT01245751|3776584|FG002|STARTED|Part 2: Week 156 (3 Year) Visit|Part 2 was planned for Groups 1 and 2 only|0
3056093|NCT01245751|3776585|FG003|STARTED|Part 2: Week 156 (3 Year) Visit|Part 2 was planned for Groups 1 and 2 only|0
3056094|NCT01245751|3776582|FG000|COMPLETED|Part 2: Week 156 (3 Year) Visit||161
3056095|NCT01245751|3776583|FG001|COMPLETED|Part 2: Week 156 (3 Year) Visit||139
3056096|NCT01245751|3776584|FG002|COMPLETED|Part 2: Week 156 (3 Year) Visit||0
3056097|NCT01245751|3776585|FG003|COMPLETED|Part 2: Week 156 (3 Year) Visit||0
3056098|NCT01245751|3776582|FG000|NOT COMPLETED|Part 2: Week 156 (3 Year) Visit||0
3056099|NCT01245751|3776583|FG001|NOT COMPLETED|Part 2: Week 156 (3 Year) Visit||0
3056100|NCT01245751|3776584|FG002|NOT COMPLETED|Part 2: Week 156 (3 Year) Visit||0
3056101|NCT01245751|3776585|FG003|NOT COMPLETED|Part 2: Week 156 (3 Year) Visit||0
3056102|NCT01245764|3776600|FG000|STARTED|Study Phase A||80
3056103|NCT01245764|3776601|FG001|STARTED|Study Phase A||30
3056104|NCT01245764|3776602|FG002|STARTED|Study Phase A||120
3056105|NCT01245764|3776603|FG003|STARTED|Study Phase A||20
3056106|NCT01245764|3776600|FG000|Completed Vaccinations in Study Phase A|Study Phase A||77
3056107|NCT01245764|3776601|FG001|Completed Vaccinations in Study Phase A|Study Phase A||28
3056108|NCT01245764|3776602|FG002|Completed Vaccinations in Study Phase A|Study Phase A||117
3056109|NCT01245764|3776603|FG003|Completed Vaccinations in Study Phase A|Study Phase A||19
3056110|NCT01245764|3776600|FG000|COMPLETED|Study Phase A||71
3056111|NCT01245764|3776601|FG001|COMPLETED|Study Phase A||25
3056112|NCT01245764|3776602|FG002|COMPLETED|Study Phase A||110
3056113|NCT01245764|3776603|FG003|COMPLETED|Study Phase A||17
3056114|NCT01245764|3776600|FG000|NOT COMPLETED|Study Phase A||9
3056115|NCT01245764|3776601|FG001|NOT COMPLETED|Study Phase A||5
3056116|NCT01245764|3776602|FG002|NOT COMPLETED|Study Phase A||10
3056117|NCT01245764|3776603|FG003|NOT COMPLETED|Study Phase A||3
3056118|NCT01245764|3776600|FG000|STARTED|Study Phase B||0
3056119|NCT01245764|3776601|FG001|STARTED|Study Phase B||0
3056120|NCT01245764|3776602|FG002|STARTED|Study Phase B||0
3056121|NCT01245764|3776603|FG003|STARTED|Study Phase B||17
3056122|NCT01245764|3776600|FG000|Completed Vaccinations in Study Phase B|Study Phase B||0
3056123|NCT01245764|3776601|FG001|Completed Vaccinations in Study Phase B|Study Phase B||0
3056124|NCT01245764|3776602|FG002|Completed Vaccinations in Study Phase B|Study Phase B||0
3056125|NCT01245764|3776603|FG003|Completed Vaccinations in Study Phase B|Study Phase B||17
3056126|NCT01245764|3776600|FG000|COMPLETED|Study Phase B||0
3056127|NCT01245764|3776601|FG001|COMPLETED|Study Phase B||0
3056128|NCT01245764|3776602|FG002|COMPLETED|Study Phase B||0
3056129|NCT01245764|3776603|FG003|COMPLETED|Study Phase B||17
3056130|NCT01245764|3776600|FG000|NOT COMPLETED|Study Phase B||0
3056131|NCT01245764|3776601|FG001|NOT COMPLETED|Study Phase B||0
3056132|NCT01245764|3776602|FG002|NOT COMPLETED|Study Phase B||0
3056133|NCT01245764|3776603|FG003|NOT COMPLETED|Study Phase B||0
3056134|NCT01245972|3776624|FG000|STARTED|Overall Study||7
3056135|NCT01245972|3776625|FG001|STARTED|Overall Study||8
3056136|NCT01245972|3776626|FG002|STARTED|Overall Study||8
3056137|NCT01245972|3776624|FG000|COMPLETED|Overall Study||7
3056138|NCT01245972|3776625|FG001|COMPLETED|Overall Study||8
3056139|NCT01245972|3776626|FG002|COMPLETED|Overall Study||8
3056140|NCT01245972|3776624|FG000|NOT COMPLETED|Overall Study||0
3056141|NCT01245972|3776625|FG001|NOT COMPLETED|Overall Study||0
3283838|NCT02759692|4017654|FG001|COMPLETED|Period 1||140
3283839|NCT02759692|4017653|FG000|NOT COMPLETED|Period 1||3
3283840|NCT02759692|4017654|FG001|NOT COMPLETED|Period 1||2
3056142|NCT01245972|3776626|FG002|NOT COMPLETED|Overall Study||0
3056143|NCT01246050|3776636|FG000|STARTED|Overall Study||6
3133966|NCT01698684|3858926|FG002|COMPLETED|Overall Study||127
3283841|NCT02759692|4017653|FG000|STARTED|Period 2||138
3283842|NCT02759692|4017654|FG001|STARTED|Period 2||140
3056144|NCT01246050|3776637|FG001|STARTED|Overall Study|Control providers were other providers in the same Primary Care Clinic, not enrolled in the study|6
3056145|NCT01246050|3776636|FG000|COMPLETED|Overall Study||6
3056146|NCT01246050|3776637|FG001|COMPLETED|Overall Study|Control providers were other providers in the same Primary Care Clinic, not enrolled in the study|6
3056147|NCT01246050|3776636|FG000|NOT COMPLETED|Overall Study||0
3056148|NCT01246050|3776637|FG001|NOT COMPLETED|Overall Study||0
3056149|NCT01246063|3776649|FG000|STARTED|Overall Study||3
3056150|NCT01246063|3776650|FG001|STARTED|Overall Study||4
3056151|NCT01246063|3776651|FG002|STARTED|Overall Study||4
3056152|NCT01246063|3776652|FG003|STARTED|Overall Study||5
3056153|NCT01246063|3776653|FG004|STARTED|Overall Study||7
3056154|NCT01246063|3776654|FG005|STARTED|Overall Study||17
3056155|NCT01246063|3776649|FG000|COMPLETED|Overall Study||3
3056156|NCT01246063|3776650|FG001|COMPLETED|Overall Study||4
3056157|NCT01246063|3776651|FG002|COMPLETED|Overall Study||4
3056158|NCT01246063|3776652|FG003|COMPLETED|Overall Study||5
3056159|NCT01246063|3776653|FG004|COMPLETED|Overall Study||7
3056160|NCT01246063|3776654|FG005|COMPLETED|Overall Study||17
3056161|NCT01246063|3776649|FG000|NOT COMPLETED|Overall Study||0
3056162|NCT01246063|3776650|FG001|NOT COMPLETED|Overall Study||0
3056163|NCT01246063|3776651|FG002|NOT COMPLETED|Overall Study||0
3056164|NCT01246063|3776652|FG003|NOT COMPLETED|Overall Study||0
3056165|NCT01246063|3776653|FG004|NOT COMPLETED|Overall Study||0
3056166|NCT01246063|3776654|FG005|NOT COMPLETED|Overall Study||0
3056167|NCT01246076|3776672|FG000|STARTED|Overall Study||24
3056168|NCT01246076|3776672|FG000|COMPLETED|Overall Study||24
3056169|NCT01246076|3776672|FG000|NOT COMPLETED|Overall Study||0
3056170|NCT01246206|3776676|FG000|STARTED|Overall Study||21
3056171|NCT01246206|3776676|FG000|COMPLETED|Overall Study||20
3056172|NCT01246206|3776676|FG000|NOT COMPLETED|Overall Study||1
3056173|NCT01246258|3776680|FG000|STARTED|Overall Study||5
3056174|NCT01246258|3776680|FG000|COMPLETED|Overall Study||5
3056175|NCT01246258|3776680|FG000|NOT COMPLETED|Overall Study||0
3056176|NCT01246349|3776687|FG000|STARTED|Overall Study||20
3056177|NCT01246349|3776688|FG001|STARTED|Overall Study||20
3056178|NCT01246349|3776687|FG000|COMPLETED|Overall Study||20
3056179|NCT01246349|3776688|FG001|COMPLETED|Overall Study||20
3056180|NCT01246349|3776687|FG000|NOT COMPLETED|Overall Study||0
3056181|NCT01246349|3776688|FG001|NOT COMPLETED|Overall Study||0
3056182|NCT01246401|3776696|FG000|STARTED|Overall Study||66
3056183|NCT01246401|3776697|FG001|STARTED|Overall Study||27
3056184|NCT01246401|3776696|FG000|COMPLETED|Overall Study||66
3056185|NCT01246401|3776697|FG001|COMPLETED|Overall Study||27
3056186|NCT01246401|3776696|FG000|NOT COMPLETED|Overall Study||0
3056187|NCT01246401|3776697|FG001|NOT COMPLETED|Overall Study||0
3056188|NCT01246466|3776705|FG000|STARTED|Overall Study||24
3283843|NCT02759692|4017653|FG000|COMPLETED|Period 2||137
3283844|NCT02759692|4017654|FG001|COMPLETED|Period 2||139
3283845|NCT02759692|4017653|FG000|NOT COMPLETED|Period 2||1
3283846|NCT02759692|4017654|FG001|NOT COMPLETED|Period 2||1
3283847|NCT02759692|4017653|FG000|STARTED|Period 3||137
3283848|NCT02759692|4017654|FG001|STARTED|Period 3||139
3283849|NCT02759692|4017653|FG000|COMPLETED|Period 3||137
3283850|NCT02759692|4017654|FG001|COMPLETED|Period 3||139
3283851|NCT02759692|4017653|FG000|NOT COMPLETED|Period 3||0
3283852|NCT02759692|4017654|FG001|NOT COMPLETED|Period 3||0
3283853|NCT02759939|4017664|FG000|STARTED|Overall Study||1256
3283854|NCT02759939|4017665|FG001|STARTED|Overall Study||1143
3283855|NCT02759939|4017666|FG002|STARTED|Overall Study||1393
3283856|NCT02759939|4017667|FG003|STARTED|Overall Study||1246
3283857|NCT02759939|4017664|FG000|Analyzed at T1|Overall Study||1245
3283858|NCT02759939|4017665|FG001|Analyzed at T1|Overall Study||1141
3283859|NCT02759939|4017666|FG002|Analyzed at T1|Overall Study||1388
3283860|NCT02759939|4017667|FG003|Analyzed at T1|Overall Study||1244
3283861|NCT02759939|4017664|FG000|Eligible for T2 and T3|Overall Study||935
3283862|NCT02759939|4017665|FG001|Eligible for T2 and T3|Overall Study||962
3283863|NCT02759939|4017666|FG002|Eligible for T2 and T3|Overall Study||1022
3283864|NCT02759939|4017667|FG003|Eligible for T2 and T3|Overall Study||853
3283865|NCT02759939|4017664|FG000|Analyzed at T2 and/or T3|Overall Study||303
3283866|NCT02759939|4017665|FG001|Analyzed at T2 and/or T3|Overall Study||278
3283867|NCT02759939|4017666|FG002|Analyzed at T2 and/or T3|Overall Study||373
3283868|NCT02759939|4017667|FG003|Analyzed at T2 and/or T3|Overall Study||304
3283869|NCT02759939|4017664|FG000|Consented to T2 and T3|Overall Study||579
3056189|NCT01246466|3776705|FG000|COMPLETED|Overall Study||22
3056190|NCT01246466|3776705|FG000|NOT COMPLETED|Overall Study||2
3056191|NCT01246479|3776710|FG000|STARTED|Overall Study||23
3056192|NCT01246479|3776710|FG000|COMPLETED|Overall Study|primary endpoint at Month 12|18
3056193|NCT01246479|3776710|FG000|NOT COMPLETED|Overall Study||5
3056194|NCT01246583|3776718|FG000|STARTED|Overall Study||23
3056195|NCT01246583|3776719|FG001|STARTED|Overall Study||13
3056196|NCT01246583|3776720|FG002|STARTED|Overall Study||25
3056197|NCT01246583|3776721|FG003|STARTED|Overall Study||10
3056198|NCT01246583|3776718|FG000|COMPLETED|Overall Study||22
3056199|NCT01246583|3776719|FG001|COMPLETED|Overall Study||13
3056200|NCT01246583|3776720|FG002|COMPLETED|Overall Study||24
3056201|NCT01246583|3776721|FG003|COMPLETED|Overall Study||9
3283870|NCT02759939|4017665|FG001|Consented to T2 and T3|Overall Study||626
3283871|NCT02759939|4017666|FG002|Consented to T2 and T3|Overall Study||702
3283872|NCT02759939|4017667|FG003|Consented to T2 and T3|Overall Study||564
3283873|NCT02759939|4017664|FG000|COMPLETED|Overall Study||200
3283874|NCT02759939|4017665|FG001|COMPLETED|Overall Study||171
3056202|NCT01246583|3776718|FG000|NOT COMPLETED|Overall Study||1
3056203|NCT01246583|3776719|FG001|NOT COMPLETED|Overall Study||0
3056204|NCT01246583|3776720|FG002|NOT COMPLETED|Overall Study||1
3056205|NCT01246583|3776721|FG003|NOT COMPLETED|Overall Study||1
3056206|NCT01246713|3776732|FG000|STARTED|First Acetaminophen Dosing (1 Day)||6
3056207|NCT01246713|3776733|FG001|STARTED|First Acetaminophen Dosing (1 Day)||9
3056208|NCT01246713|3776732|FG000|COMPLETED|First Acetaminophen Dosing (1 Day)||6
3056209|NCT01246713|3776733|FG001|COMPLETED|First Acetaminophen Dosing (1 Day)||9
3056210|NCT01246713|3776732|FG000|NOT COMPLETED|First Acetaminophen Dosing (1 Day)||0
3056211|NCT01246713|3776733|FG001|NOT COMPLETED|First Acetaminophen Dosing (1 Day)||0
3056212|NCT01246713|3776732|FG000|STARTED|Washout (at Least 14 Days)||6
3056213|NCT01246713|3776733|FG001|STARTED|Washout (at Least 14 Days)||9
3056214|NCT01246713|3776732|FG000|COMPLETED|Washout (at Least 14 Days)||6
3056215|NCT01246713|3776733|FG001|COMPLETED|Washout (at Least 14 Days)||9
3056216|NCT01246713|3776732|FG000|NOT COMPLETED|Washout (at Least 14 Days)||0
3056217|NCT01246713|3776733|FG001|NOT COMPLETED|Washout (at Least 14 Days)||0
3056218|NCT01246713|3776732|FG000|STARTED|Second Acetaminophen Dosing (1 Day)||6
3056219|NCT01246713|3776733|FG001|STARTED|Second Acetaminophen Dosing (1 Day)||9
3056220|NCT01246713|3776732|FG000|COMPLETED|Second Acetaminophen Dosing (1 Day)||6
3056221|NCT01246713|3776733|FG001|COMPLETED|Second Acetaminophen Dosing (1 Day)||9
3056222|NCT01246713|3776732|FG000|NOT COMPLETED|Second Acetaminophen Dosing (1 Day)||0
3056223|NCT01246713|3776733|FG001|NOT COMPLETED|Second Acetaminophen Dosing (1 Day)||0
3056224|NCT01246791|3776739|FG000|STARTED|Overall Study||12
3056225|NCT01246791|3776739|FG000|COMPLETED|Overall Study||12
3056226|NCT01246791|3776739|FG000|NOT COMPLETED|Overall Study||0
3056227|NCT01246895|3776745|FG000|STARTED|Overall Study||37
3056228|NCT01246895|3776746|FG001|STARTED|Overall Study||30
3056229|NCT01246895|3776745|FG000|COMPLETED|Overall Study||34
3056230|NCT01246895|3776746|FG001|COMPLETED|Overall Study||26
3056231|NCT01246895|3776745|FG000|NOT COMPLETED|Overall Study||3
3056232|NCT01246895|3776746|FG001|NOT COMPLETED|Overall Study||4
3056233|NCT01246960|3776756|FG000|STARTED|Overall Study||84
3056234|NCT01246960|3776757|FG001|STARTED|Overall Study||84
3056235|NCT01246960|3776756|FG000|Received Any Quantity of Study Drug|Overall Study||82
3056236|NCT01246960|3776757|FG001|Received Any Quantity of Study Drug|Overall Study||80
3056237|NCT01246960|3776756|FG000|COMPLETED|Overall Study||78
3056238|NCT01246960|3776757|FG001|COMPLETED|Overall Study||80
3056239|NCT01246960|3776756|FG000|NOT COMPLETED|Overall Study||6
3056240|NCT01246960|3776757|FG001|NOT COMPLETED|Overall Study||4
3056241|NCT01246973|3776765|FG000|STARTED|Overall Study||344
3056242|NCT01246973|3776766|FG001|STARTED|Overall Study||342
3056243|NCT01246973|3776765|FG000|COMPLETED|Overall Study||283
3056244|NCT01246973|3776766|FG001|COMPLETED|Overall Study||295
3056245|NCT01246973|3776765|FG000|NOT COMPLETED|Overall Study||61
3056246|NCT01246973|3776766|FG001|NOT COMPLETED|Overall Study||47
3056247|NCT01246986|3776779|FG000|STARTED|Overall Study||37
3056248|NCT01246986|3776780|FG001|STARTED|Overall Study||72
3056249|NCT01246986|3776781|FG002|STARTED|Overall Study||40
3056250|NCT01246986|3776782|FG003|STARTED|Overall Study||3
3056251|NCT01246986|3776783|FG004|STARTED|Overall Study||44
3056252|NCT01246986|3776784|FG005|STARTED|Overall Study||3
3056253|NCT01246986|3776785|FG006|STARTED|Overall Study||5
3056254|NCT01246986|3776779|FG000|Received at Least 1 Dose of Study Drug|Overall Study||37
3056255|NCT01246986|3776780|FG001|Received at Least 1 Dose of Study Drug|Overall Study||72
3056256|NCT01246986|3776781|FG002|Received at Least 1 Dose of Study Drug|Overall Study||40
3056257|NCT01246986|3776782|FG003|Received at Least 1 Dose of Study Drug|Overall Study||3
3056258|NCT01246986|3776783|FG004|Received at Least 1 Dose of Study Drug|Overall Study||44
3056259|NCT01246986|3776784|FG005|Received at Least 1 Dose of Study Drug|Overall Study||3
3056260|NCT01246986|3776785|FG006|Received at Least 1 Dose of Study Drug|Overall Study||5
3056261|NCT01246986|3776779|FG000|COMPLETED|Overall Study||34
3056262|NCT01246986|3776780|FG001|COMPLETED|Overall Study||67
3056263|NCT01246986|3776781|FG002|COMPLETED|Overall Study||34
3056264|NCT01246986|3776782|FG003|COMPLETED|Overall Study||3
3056265|NCT01246986|3776783|FG004|COMPLETED|Overall Study||40
3056266|NCT01246986|3776784|FG005|COMPLETED|Overall Study||2
3056267|NCT01246986|3776785|FG006|COMPLETED|Overall Study||5
3056268|NCT01246986|3776779|FG000|NOT COMPLETED|Overall Study||3
3056269|NCT01246986|3776780|FG001|NOT COMPLETED|Overall Study||5
3056270|NCT01246986|3776781|FG002|NOT COMPLETED|Overall Study||6
3056271|NCT01246986|3776782|FG003|NOT COMPLETED|Overall Study||0
3056272|NCT01246986|3776783|FG004|NOT COMPLETED|Overall Study||4
3056273|NCT01246986|3776784|FG005|NOT COMPLETED|Overall Study||1
3056274|NCT01246986|3776785|FG006|NOT COMPLETED|Overall Study||0
3056275|NCT01246999|3776820|FG000|STARTED|Overall Study||11
3056276|NCT01246999|3776821|FG001|STARTED|Overall Study||4
3056277|NCT01246999|3776822|FG002|STARTED|Overall Study||2
3056278|NCT01246999|3776823|FG003|STARTED|Overall Study||17
3056279|NCT01246999|3776820|FG000|COMPLETED|Overall Study||11
3056280|NCT01246999|3776821|FG001|COMPLETED|Overall Study||3
3056281|NCT01246999|3776822|FG002|COMPLETED|Overall Study||2
3056282|NCT01246999|3776823|FG003|COMPLETED|Overall Study||15
3056283|NCT01246999|3776820|FG000|NOT COMPLETED|Overall Study||0
3056284|NCT01246999|3776821|FG001|NOT COMPLETED|Overall Study||1
3056285|NCT01246999|3776822|FG002|NOT COMPLETED|Overall Study||0
3056286|NCT01246999|3776823|FG003|NOT COMPLETED|Overall Study||2
3056287|NCT01247064|3776838|FG000|STARTED|Overall Study||31
3056288|NCT01247064|3776839|FG001|STARTED|Overall Study||31
3056289|NCT01247064|3776838|FG000|COMPLETED|Overall Study||31
3056290|NCT01247064|3776839|FG001|COMPLETED|Overall Study||31
3056291|NCT01247064|3776838|FG000|NOT COMPLETED|Overall Study||0
3056292|NCT01247064|3776839|FG001|NOT COMPLETED|Overall Study||0
3056293|NCT01247090|3776848|FG000|STARTED|Overall Study||4
3056294|NCT01247090|3776849|FG001|STARTED|Overall Study||4
3056295|NCT01247090|3776850|FG002|STARTED|Overall Study||4
3056296|NCT01247090|3776848|FG000|COMPLETED|Overall Study||3
3056297|NCT01247090|3776849|FG001|COMPLETED|Overall Study||3
3056298|NCT01247090|3776850|FG002|COMPLETED|Overall Study||4
3056299|NCT01247090|3776848|FG000|NOT COMPLETED|Overall Study||1
3162086|NCT01877161|3889513|FG000|STARTED|Third Session of Stimulation||12
3162087|NCT01877161|3889513|FG000|COMPLETED|Third Session of Stimulation||12
3056300|NCT01247090|3776849|FG001|NOT COMPLETED|Overall Study||1
3056301|NCT01247090|3776850|FG002|NOT COMPLETED|Overall Study||0
3056302|NCT01247220|3776860|FG000|STARTED|Overall Study||6
3056303|NCT01247220|3776861|FG001|STARTED|Overall Study||6
3056304|NCT01247220|3776860|FG000|COMPLETED|Overall Study||6
3056305|NCT01247220|3776861|FG001|COMPLETED|Overall Study||6
3056306|NCT01247220|3776860|FG000|NOT COMPLETED|Overall Study||0
3056307|NCT01247220|3776861|FG001|NOT COMPLETED|Overall Study||0
3056308|NCT01247272|3776869|FG000|STARTED|First Intervention||13
3056309|NCT01247272|3776870|FG001|STARTED|First Intervention||13
3056310|NCT01247272|3776869|FG000|COMPLETED|First Intervention||13
3056311|NCT01247272|3776870|FG001|COMPLETED|First Intervention||13
3056312|NCT01247272|3776869|FG000|NOT COMPLETED|First Intervention||0
3056313|NCT01247272|3776870|FG001|NOT COMPLETED|First Intervention||0
3056314|NCT01247272|3776869|FG000|STARTED|Washout of 28 Days||13
3056315|NCT01247272|3776870|FG001|STARTED|Washout of 28 Days||13
3056316|NCT01247272|3776869|FG000|COMPLETED|Washout of 28 Days||13
3056317|NCT01247272|3776870|FG001|COMPLETED|Washout of 28 Days||13
3056318|NCT01247272|3776869|FG000|NOT COMPLETED|Washout of 28 Days||0
3056319|NCT01247272|3776870|FG001|NOT COMPLETED|Washout of 28 Days||0
3056320|NCT01247272|3776869|FG000|STARTED|Second Intervention||13
3056321|NCT01247272|3776870|FG001|STARTED|Second Intervention||13
3056322|NCT01247272|3776869|FG000|COMPLETED|Second Intervention||13
3056323|NCT01247272|3776870|FG001|COMPLETED|Second Intervention||13
3056324|NCT01247272|3776869|FG000|NOT COMPLETED|Second Intervention||0
3056325|NCT01247272|3776870|FG001|NOT COMPLETED|Second Intervention||0
3056326|NCT01247285|3776878|FG000|STARTED|First Intervention||13
3056327|NCT01247285|3776879|FG001|STARTED|First Intervention||13
3056328|NCT01247285|3776878|FG000|COMPLETED|First Intervention||13
3056329|NCT01247285|3776879|FG001|COMPLETED|First Intervention||13
3056330|NCT01247285|3776878|FG000|NOT COMPLETED|First Intervention||0
3056331|NCT01247285|3776879|FG001|NOT COMPLETED|First Intervention||0
3056332|NCT01247285|3776878|FG000|STARTED|Washout of 28 Days||13
3056333|NCT01247285|3776879|FG001|STARTED|Washout of 28 Days||13
3056334|NCT01247285|3776878|FG000|COMPLETED|Washout of 28 Days||13
3056335|NCT01247285|3776879|FG001|COMPLETED|Washout of 28 Days||13
3056336|NCT01247285|3776878|FG000|NOT COMPLETED|Washout of 28 Days||0
3056337|NCT01247285|3776879|FG001|NOT COMPLETED|Washout of 28 Days||0
3056338|NCT01247285|3776878|FG000|STARTED|Second Intervention||13
3056339|NCT01247285|3776879|FG001|STARTED|Second Intervention||13
3056340|NCT01247285|3776878|FG000|COMPLETED|Second Intervention||13
3056341|NCT01247285|3776879|FG001|COMPLETED|Second Intervention||13
3056342|NCT01247285|3776878|FG000|NOT COMPLETED|Second Intervention||0
3056343|NCT01247285|3776879|FG001|NOT COMPLETED|Second Intervention||0
3056344|NCT01247298|3776885|FG000|STARTED|Overall Study||17
3056345|NCT01247298|3776885|FG000|COMPLETED|Overall Study||17
3056346|NCT01247298|3776885|FG000|NOT COMPLETED|Overall Study||0
3056347|NCT01247350|3776895|FG000|STARTED|Overall Study||6
3056348|NCT01247350|3776896|FG001|STARTED|Overall Study||6
3056349|NCT01247350|3776897|FG002|STARTED|Overall Study||6
3056350|NCT01247350|3776898|FG003|STARTED|Overall Study||7
3056351|NCT01247350|3776899|FG004|STARTED|Overall Study||9
3056352|NCT01247350|3776895|FG000|Received Multiple Doses of Study Drug|Overall Study||0
3056353|NCT01247350|3776896|FG001|Received Multiple Doses of Study Drug|Overall Study||0
3056354|NCT01247350|3776897|FG002|Received Multiple Doses of Study Drug|Overall Study||6
3056355|NCT01247350|3776898|FG003|Received Multiple Doses of Study Drug|Overall Study||6
3056356|NCT01247350|3776899|FG004|Received Multiple Doses of Study Drug|Overall Study||5
3056357|NCT01247350|3776895|FG000|COMPLETED|Overall Study||6
3056358|NCT01247350|3776896|FG001|COMPLETED|Overall Study||6
3056359|NCT01247350|3776897|FG002|COMPLETED|Overall Study||5
3056360|NCT01247350|3776898|FG003|COMPLETED|Overall Study||6
3056361|NCT01247350|3776899|FG004|COMPLETED|Overall Study||8
3056362|NCT01247350|3776895|FG000|NOT COMPLETED|Overall Study||0
3056363|NCT01247350|3776896|FG001|NOT COMPLETED|Overall Study||0
3056364|NCT01247350|3776897|FG002|NOT COMPLETED|Overall Study||1
3056365|NCT01247350|3776898|FG003|NOT COMPLETED|Overall Study||1
3056366|NCT01247350|3776899|FG004|NOT COMPLETED|Overall Study||1
3056367|NCT01247363|3776925|FG000|STARTED|Overall Study||20
3056368|NCT01247363|3776925|FG000|COMPLETED|Overall Study||20
3056369|NCT01247363|3776925|FG000|NOT COMPLETED|Overall Study||0
3133967|NCT01698684|3858924|FG000|NOT COMPLETED|Overall Study||29
3133968|NCT01698684|3858925|FG001|NOT COMPLETED|Overall Study||23
3133969|NCT01698684|3858926|FG002|NOT COMPLETED|Overall Study||21
3133970|NCT01698710|3858934|FG000|STARTED|Overall Study||5
3133971|NCT01698710|3858934|FG000|COMPLETED|Overall Study||5
3056370|NCT01247428|3776940|FG000|STARTED|Overall Study||30
3056371|NCT01247428|3776940|FG000|COMPLETED|Overall Study||30
3056372|NCT01247428|3776940|FG000|NOT COMPLETED|Overall Study||0
3056373|NCT01247571|3776944|FG000|STARTED|Overall Study||22
3056374|NCT01247571|3776944|FG000|COMPLETED|Overall Study||19
3056375|NCT01247571|3776944|FG000|NOT COMPLETED|Overall Study||3
3056376|NCT01247675|3776952|FG000|STARTED|Overall Study||10
3056377|NCT01247675|3776953|FG001|STARTED|Overall Study||10
3056378|NCT01247675|3776954|FG002|STARTED|Overall Study||9
3056379|NCT01247675|3776955|FG003|STARTED|Overall Study||8
3056380|NCT01247675|3776952|FG000|COMPLETED|Overall Study||8
3056381|NCT01247675|3776953|FG001|COMPLETED|Overall Study||8
3056382|NCT01247675|3776954|FG002|COMPLETED|Overall Study||9
3056383|NCT01247675|3776955|FG003|COMPLETED|Overall Study||8
3056384|NCT01247675|3776952|FG000|NOT COMPLETED|Overall Study||2
3162088|NCT01877161|3889513|FG000|NOT COMPLETED|Third Session of Stimulation||0
3162089|NCT01877187|3889521|FG000|STARTED|Overall Study|21 HCC, 18 non-HCC|39
3162090|NCT01877187|3889521|FG000|Completed 30 Day f/u|Overall Study|18 HCC, 17 non-HCC|35
3056385|NCT01247675|3776953|FG001|NOT COMPLETED|Overall Study||2
3056386|NCT01247675|3776954|FG002|NOT COMPLETED|Overall Study||0
3056387|NCT01247675|3776955|FG003|NOT COMPLETED|Overall Study||0
3056388|NCT01247922|3776967|FG000|STARTED|Overall Study||4
3056389|NCT01247922|3776967|FG000|Treated|Overall Study||4
3056390|NCT01247922|3776967|FG000|COMPLETED|Overall Study||0
3056391|NCT01247922|3776967|FG000|NOT COMPLETED|Overall Study||4
3056392|NCT01247974|3776973|FG000|STARTED|Overall Study||217
3056393|NCT01247974|3776974|FG001|STARTED|Overall Study||222
3056394|NCT01247974|3776973|FG000|COMPLETED|Overall Study||191
3056395|NCT01247974|3776974|FG001|COMPLETED|Overall Study||203
3056396|NCT01247974|3776973|FG000|NOT COMPLETED|Overall Study||26
3056397|NCT01247974|3776974|FG001|NOT COMPLETED|Overall Study||19
3056398|NCT01248013|3776980|FG000|STARTED|Overall Study||89
3056399|NCT01248013|3776980|FG000|Irritable Bowel Syndrome Hypnotherapy|Overall Study||75
3056400|NCT01248013|3776980|FG000|COMPLETED|Overall Study||75
3056401|NCT01248013|3776980|FG000|NOT COMPLETED|Overall Study||14
3056402|NCT01248065|3776986|FG000|STARTED|Overall Study||207
3056403|NCT01248065|3776987|FG001|STARTED|Overall Study||201
3056404|NCT01248065|3776986|FG000|COMPLETED|Overall Study|All 207 participants were included in the primary time-to-event analysis.|181
3056405|NCT01248065|3776987|FG001|COMPLETED|Overall Study|All 201 participants were included in the primary time-to-event analysis.|179
3056406|NCT01248065|3776986|FG000|NOT COMPLETED|Overall Study||26
3056407|NCT01248065|3776987|FG001|NOT COMPLETED|Overall Study||22
3056408|NCT01248104|3776995|FG000|STARTED|Overall Study||50
3056409|NCT01248104|3776996|FG001|STARTED|Overall Study||50
3056410|NCT01248104|3776995|FG000|COMPLETED|Overall Study||40
3056411|NCT01248104|3776996|FG001|COMPLETED|Overall Study||42
3056412|NCT01248104|3776995|FG000|NOT COMPLETED|Overall Study||10
3056413|NCT01248104|3776996|FG001|NOT COMPLETED|Overall Study||8
3056414|NCT01248221|3777004|FG000|STARTED|Overall Study||15
3056415|NCT01248221|3777005|FG001|STARTED|Overall Study||15
3056416|NCT01248221|3777004|FG000|COMPLETED|Overall Study||15
3056417|NCT01248221|3777005|FG001|COMPLETED|Overall Study||15
3056418|NCT01248221|3777004|FG000|NOT COMPLETED|Overall Study||0
3056419|NCT01248221|3777005|FG001|NOT COMPLETED|Overall Study||0
3056420|NCT01248364|3777017|FG000|STARTED|Overall Study||32
3056421|NCT01248364|3777018|FG001|STARTED|Overall Study||34
3056422|NCT01248364|3777019|FG002|STARTED|Overall Study||13
3056423|NCT01248364|3777020|FG003|STARTED|Overall Study||12
3056424|NCT01248364|3777017|FG000|Completed Acute Phase:Single Dose, Day 1|Overall Study||32
3056425|NCT01248364|3777018|FG001|Completed Acute Phase:Single Dose, Day 1|Overall Study||34
3056426|NCT01248364|3777019|FG002|Completed Acute Phase:Single Dose, Day 1|Overall Study||13
3056427|NCT01248364|3777020|FG003|Completed Acute Phase:Single Dose, Day 1|Overall Study||12
3056428|NCT01248364|3777017|FG000|Completed Chronic Phase:28-day Treatment|Overall Study||32
3056429|NCT01248364|3777018|FG001|Completed Chronic Phase:28-day Treatment|Overall Study||33
3056430|NCT01248364|3777019|FG002|Completed Chronic Phase:28-day Treatment|Overall Study||13
3056431|NCT01248364|3777020|FG003|Completed Chronic Phase:28-day Treatment|Overall Study||0
3056432|NCT01248364|3777017|FG000|COMPLETED|Overall Study||32
3056433|NCT01248364|3777018|FG001|COMPLETED|Overall Study||33
3056434|NCT01248364|3777019|FG002|COMPLETED|Overall Study||13
3162091|NCT01877187|3889521|FG000|Completed 90 Day f/u|Overall Study|11 HCC, 9 non-HCC|20
3162092|NCT01877187|3889521|FG000|COMPLETED|Overall Study|10 HCC, 7 non-HCC|17
3162093|NCT01877187|3889521|FG000|NOT COMPLETED|Overall Study||22
3162094|NCT01877239|3889528|FG000|STARTED|Overall Study||111
3162095|NCT01877239|3889528|FG000|Treated|Overall Study||76
3162096|NCT01877239|3889528|FG000|COMPLETED|Overall Study||61
3162097|NCT01877239|3889528|FG000|NOT COMPLETED|Overall Study||50
3162098|NCT01877265|3889532|FG000|STARTED|Treatment Period 1||3
3162099|NCT01877265|3889533|FG001|STARTED|Treatment Period 1||3
3056435|NCT01248364|3777020|FG003|COMPLETED|Overall Study||12
3056436|NCT01248364|3777017|FG000|NOT COMPLETED|Overall Study||0
3056437|NCT01248364|3777018|FG001|NOT COMPLETED|Overall Study||1
3056438|NCT01248364|3777019|FG002|NOT COMPLETED|Overall Study||0
3056439|NCT01248364|3777020|FG003|NOT COMPLETED|Overall Study||0
3056440|NCT01248416|3777033|FG000|STARTED|Overall Study||25
3056441|NCT01248416|3777034|FG001|STARTED|Overall Study||25
3056442|NCT01248416|3777035|FG002|STARTED|Overall Study||26
3162100|NCT01877265|3889534|FG002|STARTED|Treatment Period 1||3
3162101|NCT01877265|3889535|FG003|STARTED|Treatment Period 1||3
3056443|NCT01248416|3777033|FG000|COMPLETED|Overall Study||21
3056444|NCT01248416|3777034|FG001|COMPLETED|Overall Study||25
3056445|NCT01248416|3777035|FG002|COMPLETED|Overall Study||25
3056446|NCT01248416|3777033|FG000|NOT COMPLETED|Overall Study||4
3056447|NCT01248416|3777034|FG001|NOT COMPLETED|Overall Study||0
3056448|NCT01248416|3777035|FG002|NOT COMPLETED|Overall Study||1
3056449|NCT01248455|3777045|FG000|STARTED|Overall Study||9
3056450|NCT01248455|3777045|FG000|COMPLETED|Overall Study||8
3056451|NCT01248455|3777045|FG000|NOT COMPLETED|Overall Study||1
3056452|NCT01248468|3777052|FG000|STARTED|Overall Study||299
3056453|NCT01248468|3777053|FG001|STARTED|Overall Study||304
3056454|NCT01248468|3777054|FG002|STARTED|Overall Study||149
3056455|NCT01248468|3777052|FG000|Safety Population|Overall Study||266
3056456|NCT01248468|3777053|FG001|Safety Population|Overall Study||271
3056457|NCT01248468|3777054|FG002|Safety Population|Overall Study||133
3056458|NCT01248468|3777052|FG000|ITT Population|Overall Study||256
3056459|NCT01248468|3777053|FG001|ITT Population|Overall Study||261
3056460|NCT01248468|3777054|FG002|ITT Population|Overall Study||125
3283875|NCT02759939|4017666|FG002|COMPLETED|Overall Study||239
3283876|NCT02759939|4017667|FG003|COMPLETED|Overall Study||203
3283877|NCT02759939|4017664|FG000|NOT COMPLETED|Overall Study||1056
3283878|NCT02759939|4017665|FG001|NOT COMPLETED|Overall Study||972
3283879|NCT02759939|4017666|FG002|NOT COMPLETED|Overall Study||1154
3283880|NCT02759939|4017667|FG003|NOT COMPLETED|Overall Study||1043
3283881|NCT02760056|4017679|FG000|STARTED|Overall Study||10
3056461|NCT01248468|3777052|FG000|COMPLETED|Overall Study||284
3056462|NCT01248468|3777053|FG001|COMPLETED|Overall Study||290
3056463|NCT01248468|3777054|FG002|COMPLETED|Overall Study||145
3056464|NCT01248468|3777052|FG000|NOT COMPLETED|Overall Study||15
3056465|NCT01248468|3777053|FG001|NOT COMPLETED|Overall Study||14
3056466|NCT01248468|3777054|FG002|NOT COMPLETED|Overall Study||4
3056467|NCT01248585|3777064|FG000|STARTED|Overall Study||148
3056468|NCT01248585|3777065|FG001|STARTED|Overall Study||150
3056469|NCT01248585|3777064|FG000|COMPLETED|Overall Study||148
3056470|NCT01248585|3777065|FG001|COMPLETED|Overall Study||150
3056471|NCT01248585|3777064|FG000|NOT COMPLETED|Overall Study||0
3056472|NCT01248585|3777065|FG001|NOT COMPLETED|Overall Study||0
3056473|NCT01248715|3777073|FG000|STARTED|Overall Study||556
3056474|NCT01248715|3777074|FG001|STARTED|Overall Study||551
3056475|NCT01248715|3777073|FG000|COMPLETED|Overall Study||55
3056476|NCT01248715|3777074|FG001|COMPLETED|Overall Study||41
3056477|NCT01248715|3777073|FG000|NOT COMPLETED|Overall Study||501
3056478|NCT01248715|3777074|FG001|NOT COMPLETED|Overall Study||510
3056479|NCT01248728|3777082|FG000|STARTED|Overall Study||19
3056480|NCT01248728|3777083|FG001|STARTED|Overall Study||19
3056481|NCT01248728|3777082|FG000|COMPLETED|Overall Study||15
3056482|NCT01248728|3777083|FG001|COMPLETED|Overall Study||17
3056483|NCT01248728|3777082|FG000|NOT COMPLETED|Overall Study||4
3056484|NCT01248728|3777083|FG001|NOT COMPLETED|Overall Study||2
3056485|NCT01248741|3777091|FG000|STARTED|Overall Study||20
3056486|NCT01248741|3777091|FG000|COMPLETED|Overall Study||20
3056487|NCT01248741|3777091|FG000|NOT COMPLETED|Overall Study||0
3056488|NCT01248780|3777097|FG000|STARTED|Overall Study||132
3056489|NCT01248780|3777098|FG001|STARTED|Overall Study||132
3056490|NCT01248780|3777097|FG000|COMPLETED|Overall Study||123
3056491|NCT01248780|3777098|FG001|COMPLETED|Overall Study||117
3056492|NCT01248780|3777097|FG000|NOT COMPLETED|Overall Study||9
3056493|NCT01248780|3777098|FG001|NOT COMPLETED|Overall Study||15
3056494|NCT01248793|3777106|FG000|STARTED|Overall Study||105
3056495|NCT01248793|3777107|FG001|STARTED|Overall Study||108
3056496|NCT01248793|3777106|FG000|COMPLETED|Overall Study||101
3056497|NCT01248793|3777107|FG001|COMPLETED|Overall Study||102
3056498|NCT01248793|3777106|FG000|NOT COMPLETED|Overall Study||4
3056499|NCT01248793|3777107|FG001|NOT COMPLETED|Overall Study||6
3056500|NCT01248884|3777116|FG000|STARTED|Overall Study||240
3056501|NCT01248884|3777117|FG001|STARTED|Overall Study||242
3056502|NCT01248884|3777118|FG002|STARTED|Overall Study||239
3056503|NCT01248884|3777116|FG000|COMPLETED|Overall Study||238
3056504|NCT01248884|3777117|FG001|COMPLETED|Overall Study||239
3056505|NCT01248884|3777118|FG002|COMPLETED|Overall Study||238
3056506|NCT01248884|3777116|FG000|NOT COMPLETED|Overall Study||2
3056507|NCT01248884|3777117|FG001|NOT COMPLETED|Overall Study||3
3056508|NCT01248884|3777118|FG002|NOT COMPLETED|Overall Study||1
3056509|NCT01248936|3777128|FG000|STARTED|Overall Study||374
3056510|NCT01248936|3777128|FG000|COMPLETED|Overall Study||0
3056511|NCT01248936|3777128|FG000|NOT COMPLETED|Overall Study||374
3056512|NCT01248949|3777138|FG000|STARTED|Overall Study||42
3056513|NCT01248949|3777139|FG001|STARTED|Overall Study||16
3056514|NCT01248949|3777140|FG002|STARTED|Overall Study||38
3056515|NCT01248949|3777141|FG003|STARTED|Overall Study||13
3056516|NCT01248949|3777142|FG004|STARTED|Overall Study||7
3056517|NCT01248949|3777138|FG000|COMPLETED|Overall Study||9
3056518|NCT01248949|3777139|FG001|COMPLETED|Overall Study||3
3056519|NCT01248949|3777140|FG002|COMPLETED|Overall Study||1
3056520|NCT01248949|3777141|FG003|COMPLETED|Overall Study||3
3056521|NCT01248949|3777142|FG004|COMPLETED|Overall Study||3
3056522|NCT01248949|3777138|FG000|NOT COMPLETED|Overall Study||33
3056523|NCT01248949|3777139|FG001|NOT COMPLETED|Overall Study||13
3056524|NCT01248949|3777140|FG002|NOT COMPLETED|Overall Study||37
3056525|NCT01248949|3777141|FG003|NOT COMPLETED|Overall Study||10
3056526|NCT01248949|3777142|FG004|NOT COMPLETED|Overall Study||4
3283882|NCT02760056|4017680|FG001|STARTED|Overall Study||5
3283883|NCT02760056|4017679|FG000|COMPLETED|Overall Study||10
3056527|NCT01248962|3777156|FG000|STARTED|Overall Study||74
3056528|NCT01248962|3777157|FG001|STARTED|Overall Study||72
3056529|NCT01248962|3777156|FG000|COMPLETED|Overall Study||58
3056530|NCT01248962|3777157|FG001|COMPLETED|Overall Study||56
3056531|NCT01248962|3777156|FG000|NOT COMPLETED|Overall Study||16
3056532|NCT01248962|3777157|FG001|NOT COMPLETED|Overall Study||16
3056533|NCT01249027|3777164|FG000|STARTED|1 Year Clinical Follow up||2482
3056534|NCT01249027|3777164|FG000|COMPLETED|1 Year Clinical Follow up||2391
3056535|NCT01249027|3777164|FG000|NOT COMPLETED|1 Year Clinical Follow up||91
3056536|NCT01249027|3777164|FG000|STARTED|2 Years Clinical Follow up||2391
3056537|NCT01249027|3777164|FG000|COMPLETED|2 Years Clinical Follow up||2254
3056538|NCT01249027|3777164|FG000|NOT COMPLETED|2 Years Clinical Follow up||137
3056539|NCT01249027|3777164|FG000|STARTED|3 Years Clinical Follow up||2254
3056540|NCT01249027|3777164|FG000|COMPLETED|3 Years Clinical Follow up||2223
3056541|NCT01249027|3777164|FG000|NOT COMPLETED|3 Years Clinical Follow up||31
3056542|NCT01249027|3777164|FG000|STARTED|4 Years Clinical Follow up||2223
3056543|NCT01249027|3777164|FG000|COMPLETED|4 Years Clinical Follow up||2210
3056544|NCT01249027|3777164|FG000|NOT COMPLETED|4 Years Clinical Follow up||13
3056545|NCT01249027|3777164|FG000|STARTED|5 Years Clinical Follow up||2210
3056546|NCT01249027|3777164|FG000|COMPLETED|5 Years Clinical Follow up||2142
3056547|NCT01249027|3777164|FG000|NOT COMPLETED|5 Years Clinical Follow up||68
3056548|NCT01249092|3777168|FG000|STARTED|Overall Study||20
3056549|NCT01249092|3777168|FG000|COMPLETED|Overall Study||18
3056550|NCT01249092|3777168|FG000|NOT COMPLETED|Overall Study||2
3056551|NCT01249118|3777174|FG000|STARTED|First Intervention Period||2
3056552|NCT01249118|3777175|FG001|STARTED|First Intervention Period||6
3056553|NCT01249118|3777176|FG002|STARTED|First Intervention Period||5
3056554|NCT01249118|3777174|FG000|COMPLETED|First Intervention Period||2
3056555|NCT01249118|3777175|FG001|COMPLETED|First Intervention Period||6
3056556|NCT01249118|3777176|FG002|COMPLETED|First Intervention Period||5
3056557|NCT01249118|3777174|FG000|NOT COMPLETED|First Intervention Period||0
3056558|NCT01249118|3777175|FG001|NOT COMPLETED|First Intervention Period||0
3056559|NCT01249118|3777176|FG002|NOT COMPLETED|First Intervention Period||0
3056560|NCT01249118|3777174|FG000|STARTED|First Washout Period||2
3056561|NCT01249118|3777175|FG001|STARTED|First Washout Period||6
3056562|NCT01249118|3777176|FG002|STARTED|First Washout Period||5
3056563|NCT01249118|3777174|FG000|COMPLETED|First Washout Period||2
3056564|NCT01249118|3777175|FG001|COMPLETED|First Washout Period||5
3056565|NCT01249118|3777176|FG002|COMPLETED|First Washout Period||5
3056566|NCT01249118|3777174|FG000|NOT COMPLETED|First Washout Period||0
3056567|NCT01249118|3777175|FG001|NOT COMPLETED|First Washout Period||1
3056568|NCT01249118|3777176|FG002|NOT COMPLETED|First Washout Period||0
3056569|NCT01249118|3777174|FG000|STARTED|Second Intervention Period||2
3056570|NCT01249118|3777175|FG001|STARTED|Second Intervention Period||5
3056571|NCT01249118|3777176|FG002|STARTED|Second Intervention Period||5
3056572|NCT01249118|3777174|FG000|COMPLETED|Second Intervention Period||2
3056573|NCT01249118|3777175|FG001|COMPLETED|Second Intervention Period||5
3056574|NCT01249118|3777176|FG002|COMPLETED|Second Intervention Period||5
3056575|NCT01249118|3777174|FG000|NOT COMPLETED|Second Intervention Period||0
3056576|NCT01249118|3777175|FG001|NOT COMPLETED|Second Intervention Period||0
3056577|NCT01249118|3777176|FG002|NOT COMPLETED|Second Intervention Period||0
3056578|NCT01249118|3777174|FG000|STARTED|Second Washout Period||2
3056579|NCT01249118|3777175|FG001|STARTED|Second Washout Period||5
3056580|NCT01249118|3777176|FG002|STARTED|Second Washout Period||5
3056581|NCT01249118|3777174|FG000|COMPLETED|Second Washout Period||2
3056582|NCT01249118|3777175|FG001|COMPLETED|Second Washout Period||5
3056583|NCT01249118|3777176|FG002|COMPLETED|Second Washout Period||5
3056584|NCT01249118|3777174|FG000|NOT COMPLETED|Second Washout Period||0
3056585|NCT01249118|3777175|FG001|NOT COMPLETED|Second Washout Period||0
3056586|NCT01249118|3777176|FG002|NOT COMPLETED|Second Washout Period||0
3056587|NCT01249131|3777183|FG000|STARTED|First Intervention||3
3162102|NCT01877265|3889536|FG004|STARTED|Treatment Period 1||3
3162103|NCT01877265|3889537|FG005|STARTED|Treatment Period 1||3
3056588|NCT01249131|3777184|FG001|STARTED|First Intervention||3
3056589|NCT01249131|3777185|FG002|STARTED|First Intervention||4
3056590|NCT01249131|3777186|FG003|STARTED|First Intervention||3
3056591|NCT01249131|3777187|FG004|STARTED|First Intervention||3
3056592|NCT01249131|3777188|FG005|STARTED|First Intervention||4
3056593|NCT01249131|3777183|FG000|COMPLETED|First Intervention||3
3056594|NCT01249131|3777184|FG001|COMPLETED|First Intervention||3
3056595|NCT01249131|3777185|FG002|COMPLETED|First Intervention||4
3056596|NCT01249131|3777186|FG003|COMPLETED|First Intervention||3
3056597|NCT01249131|3777187|FG004|COMPLETED|First Intervention||3
3056598|NCT01249131|3777188|FG005|COMPLETED|First Intervention||4
3056599|NCT01249131|3777183|FG000|NOT COMPLETED|First Intervention||0
3056600|NCT01249131|3777184|FG001|NOT COMPLETED|First Intervention||0
3056601|NCT01249131|3777185|FG002|NOT COMPLETED|First Intervention||0
3056602|NCT01249131|3777186|FG003|NOT COMPLETED|First Intervention||0
3056603|NCT01249131|3777187|FG004|NOT COMPLETED|First Intervention||0
3056604|NCT01249131|3777188|FG005|NOT COMPLETED|First Intervention||0
3056605|NCT01249131|3777183|FG000|STARTED|Washout Period of 10 Days||3
3056606|NCT01249131|3777184|FG001|STARTED|Washout Period of 10 Days||3
3056607|NCT01249131|3777185|FG002|STARTED|Washout Period of 10 Days||4
3056608|NCT01249131|3777186|FG003|STARTED|Washout Period of 10 Days||3
3056609|NCT01249131|3777187|FG004|STARTED|Washout Period of 10 Days||3
3056610|NCT01249131|3777188|FG005|STARTED|Washout Period of 10 Days||4
3056611|NCT01249131|3777183|FG000|COMPLETED|Washout Period of 10 Days||3
3056612|NCT01249131|3777184|FG001|COMPLETED|Washout Period of 10 Days||3
3056613|NCT01249131|3777185|FG002|COMPLETED|Washout Period of 10 Days||4
3056614|NCT01249131|3777186|FG003|COMPLETED|Washout Period of 10 Days||3
3056615|NCT01249131|3777187|FG004|COMPLETED|Washout Period of 10 Days||2
3056616|NCT01249131|3777188|FG005|COMPLETED|Washout Period of 10 Days||4
3056617|NCT01249131|3777183|FG000|NOT COMPLETED|Washout Period of 10 Days||0
3056618|NCT01249131|3777184|FG001|NOT COMPLETED|Washout Period of 10 Days||0
3056619|NCT01249131|3777185|FG002|NOT COMPLETED|Washout Period of 10 Days||0
3056620|NCT01249131|3777186|FG003|NOT COMPLETED|Washout Period of 10 Days||0
3056621|NCT01249131|3777187|FG004|NOT COMPLETED|Washout Period of 10 Days||1
3056622|NCT01249131|3777188|FG005|NOT COMPLETED|Washout Period of 10 Days||0
3056623|NCT01249131|3777183|FG000|STARTED|Second Intervention||3
3056624|NCT01249131|3777184|FG001|STARTED|Second Intervention||3
3056625|NCT01249131|3777185|FG002|STARTED|Second Intervention||4
3056626|NCT01249131|3777186|FG003|STARTED|Second Intervention||3
3056627|NCT01249131|3777187|FG004|STARTED|Second Intervention||2
3056628|NCT01249131|3777188|FG005|STARTED|Second Intervention||4
3056629|NCT01249131|3777183|FG000|COMPLETED|Second Intervention||3
3056630|NCT01249131|3777184|FG001|COMPLETED|Second Intervention||3
3056631|NCT01249131|3777185|FG002|COMPLETED|Second Intervention||4
3056632|NCT01249131|3777186|FG003|COMPLETED|Second Intervention||3
3056633|NCT01249131|3777187|FG004|COMPLETED|Second Intervention||2
3056634|NCT01249131|3777188|FG005|COMPLETED|Second Intervention||4
3056635|NCT01249131|3777183|FG000|NOT COMPLETED|Second Intervention||0
3056636|NCT01249131|3777184|FG001|NOT COMPLETED|Second Intervention||0
3056637|NCT01249131|3777185|FG002|NOT COMPLETED|Second Intervention||0
3056638|NCT01249131|3777186|FG003|NOT COMPLETED|Second Intervention||0
3056639|NCT01249131|3777187|FG004|NOT COMPLETED|Second Intervention||0
3056640|NCT01249131|3777188|FG005|NOT COMPLETED|Second Intervention||0
3056641|NCT01249131|3777183|FG000|STARTED|Washout Period of 10 Days||3
3056642|NCT01249131|3777184|FG001|STARTED|Washout Period of 10 Days||3
3056643|NCT01249131|3777185|FG002|STARTED|Washout Period of 10 Days||4
3056644|NCT01249131|3777186|FG003|STARTED|Washout Period of 10 Days||3
3056645|NCT01249131|3777187|FG004|STARTED|Washout Period of 10 Days||2
3056646|NCT01249131|3777188|FG005|STARTED|Washout Period of 10 Days||4
3056647|NCT01249131|3777183|FG000|COMPLETED|Washout Period of 10 Days||3
3056648|NCT01249131|3777184|FG001|COMPLETED|Washout Period of 10 Days||3
3056649|NCT01249131|3777185|FG002|COMPLETED|Washout Period of 10 Days||4
3056650|NCT01249131|3777186|FG003|COMPLETED|Washout Period of 10 Days||3
3056651|NCT01249131|3777187|FG004|COMPLETED|Washout Period of 10 Days||2
3056652|NCT01249131|3777188|FG005|COMPLETED|Washout Period of 10 Days||4
3056653|NCT01249131|3777183|FG000|NOT COMPLETED|Washout Period of 10 Days||0
3056654|NCT01249131|3777184|FG001|NOT COMPLETED|Washout Period of 10 Days||0
3056655|NCT01249131|3777185|FG002|NOT COMPLETED|Washout Period of 10 Days||0
3056656|NCT01249131|3777186|FG003|NOT COMPLETED|Washout Period of 10 Days||0
3056657|NCT01249131|3777187|FG004|NOT COMPLETED|Washout Period of 10 Days||0
3056658|NCT01249131|3777188|FG005|NOT COMPLETED|Washout Period of 10 Days||0
3056659|NCT01249131|3777183|FG000|STARTED|Third Intervention||3
3056660|NCT01249131|3777184|FG001|STARTED|Third Intervention||3
3056661|NCT01249131|3777185|FG002|STARTED|Third Intervention||4
3056662|NCT01249131|3777186|FG003|STARTED|Third Intervention||3
3056663|NCT01249131|3777187|FG004|STARTED|Third Intervention||2
3056664|NCT01249131|3777188|FG005|STARTED|Third Intervention||4
3056665|NCT01249131|3777183|FG000|COMPLETED|Third Intervention||3
3056666|NCT01249131|3777184|FG001|COMPLETED|Third Intervention||3
3056667|NCT01249131|3777185|FG002|COMPLETED|Third Intervention||4
3056668|NCT01249131|3777186|FG003|COMPLETED|Third Intervention||3
3056669|NCT01249131|3777187|FG004|COMPLETED|Third Intervention||2
3056670|NCT01249131|3777188|FG005|COMPLETED|Third Intervention||4
3056671|NCT01249131|3777183|FG000|NOT COMPLETED|Third Intervention||0
3056672|NCT01249131|3777184|FG001|NOT COMPLETED|Third Intervention||0
3056673|NCT01249131|3777185|FG002|NOT COMPLETED|Third Intervention||0
3056674|NCT01249131|3777186|FG003|NOT COMPLETED|Third Intervention||0
3056675|NCT01249131|3777187|FG004|NOT COMPLETED|Third Intervention||0
3056676|NCT01249131|3777188|FG005|NOT COMPLETED|Third Intervention||0
3056677|NCT01249261|3777198|FG000|STARTED|Overall Study||30
3056678|NCT01249261|3777199|FG001|STARTED|Overall Study||31
3056679|NCT01249261|3777198|FG000|COMPLETED|Overall Study||29
3056680|NCT01249261|3777199|FG001|COMPLETED|Overall Study||31
3056681|NCT01249261|3777198|FG000|NOT COMPLETED|Overall Study||1
3056682|NCT01249261|3777199|FG001|NOT COMPLETED|Overall Study||0
3056683|NCT01249274|3777207|FG000|STARTED|Overall Study|all 25 were included in intention-to-treat and safety analyses|25
3056684|NCT01249274|3777208|FG001|STARTED|Overall Study|all 25 were included in intention-to-treat and safety analyses|25
3056685|NCT01249274|3777207|FG000|Completed Treatment|Overall Study||21
3056686|NCT01249274|3777208|FG001|Completed Treatment|Overall Study||19
3056687|NCT01249274|3777207|FG000|Completed Treatment & Post Trial Visit|Overall Study||20
3056688|NCT01249274|3777208|FG001|Completed Treatment & Post Trial Visit|Overall Study||17
3056689|NCT01249274|3777207|FG000|Completed Post Trial Visit But Not tx|Overall Study||1
3056690|NCT01249274|3777208|FG001|Completed Post Trial Visit But Not tx|Overall Study||2
3056691|NCT01249274|3777207|FG000|COMPLETED|Overall Study||21
3056692|NCT01249274|3777208|FG001|COMPLETED|Overall Study||19
3056693|NCT01249274|3777207|FG000|NOT COMPLETED|Overall Study||4
3056694|NCT01249274|3777208|FG001|NOT COMPLETED|Overall Study||6
3056695|NCT01249365|3777216|FG000|STARTED|Overall Study||199
3056696|NCT01249365|3777216|FG000|COMPLETED|Overall Study||198
3056697|NCT01249365|3777216|FG000|NOT COMPLETED|Overall Study||1
3056698|NCT01249404|3777223|FG000|STARTED|Overall Study||127
3056699|NCT01249404|3777224|FG001|STARTED|Overall Study||129
3056700|NCT01249404|3777225|FG002|STARTED|Overall Study||132
3056701|NCT01249404|3777223|FG000|COMPLETED|Overall Study||120
3056702|NCT01249404|3777224|FG001|COMPLETED|Overall Study||121
3056703|NCT01249404|3777225|FG002|COMPLETED|Overall Study||125
3056704|NCT01249404|3777223|FG000|NOT COMPLETED|Overall Study||7
3056705|NCT01249404|3777224|FG001|NOT COMPLETED|Overall Study||8
3056706|NCT01249404|3777225|FG002|NOT COMPLETED|Overall Study||7
3056707|NCT01249417|3777236|FG000|STARTED|Randomised Population||80
3056708|NCT01249417|3777237|FG001|STARTED|Randomised Population||80
3056709|NCT01249417|3777238|FG002|STARTED|Randomised Population||81
3056710|NCT01249417|3777236|FG000|Treated|Randomised Population||80
3056711|NCT01249417|3777237|FG001|Treated|Randomised Population||80
3056712|NCT01249417|3777238|FG002|Treated|Randomised Population||79
3056713|NCT01249417|3777236|FG000|COMPLETED|Randomised Population||79
3056714|NCT01249417|3777237|FG001|COMPLETED|Randomised Population||79
3056715|NCT01249417|3777238|FG002|COMPLETED|Randomised Population||77
3056716|NCT01249417|3777236|FG000|NOT COMPLETED|Randomised Population||1
3056717|NCT01249417|3777237|FG001|NOT COMPLETED|Randomised Population||1
3056718|NCT01249417|3777238|FG002|NOT COMPLETED|Randomised Population||4
3056719|NCT01249417|3777236|FG000|STARTED|Treatment Phase - ITT Population||79
3056720|NCT01249417|3777237|FG001|STARTED|Treatment Phase - ITT Population||79
3056721|NCT01249417|3777238|FG002|STARTED|Treatment Phase - ITT Population||77
3056722|NCT01249417|3777236|FG000|COMPLETED|Treatment Phase - ITT Population||78
3056723|NCT01249417|3777237|FG001|COMPLETED|Treatment Phase - ITT Population||75
3056724|NCT01249417|3777238|FG002|COMPLETED|Treatment Phase - ITT Population||73
3056725|NCT01249417|3777236|FG000|NOT COMPLETED|Treatment Phase - ITT Population||1
3056726|NCT01249417|3777237|FG001|NOT COMPLETED|Treatment Phase - ITT Population||4
3056727|NCT01249417|3777238|FG002|NOT COMPLETED|Treatment Phase - ITT Population||4
3056728|NCT01249625|3777248|FG000|STARTED|Overall Study||1374
3056729|NCT01249625|3777249|FG001|STARTED|Overall Study||1488
3056730|NCT01249625|3777248|FG000|COMPLETED|Overall Study||1374
3056731|NCT01249625|3777249|FG001|COMPLETED|Overall Study||1488
3056732|NCT01249625|3777248|FG000|NOT COMPLETED|Overall Study||0
3056733|NCT01249625|3777249|FG001|NOT COMPLETED|Overall Study||0
3056734|NCT01249651|3777255|FG000|STARTED|Overall Study|Enrolled|101
3056735|NCT01249651|3777255|FG000|COMPLETED|Overall Study|Completed the 8-week treatment period|94
3056736|NCT01249651|3777255|FG000|NOT COMPLETED|Overall Study||7
3056737|NCT01249664|3777261|FG000|STARTED|Overall Study||91
3056738|NCT01249664|3777262|FG001|STARTED|Overall Study||31
3056739|NCT01249664|3777261|FG000|Participants Received Treatment|Overall Study|Safety population|91
3056740|NCT01249664|3777262|FG001|Participants Received Treatment|Overall Study|Safety population|31
3056741|NCT01249664|3777261|FG000|Fulfilled Requirements of FAS Population|Overall Study|Full Analysis Set (FAS) population: Basis of efficacy evaluation|90
3056742|NCT01249664|3777262|FG001|Fulfilled Requirements of FAS Population|Overall Study|FAS population: Basis of efficacy evaluation|31
3056743|NCT01249664|3777261|FG000|Completed 24 Weeks Treatment|Overall Study|Withdrawal from treatment does not equal to withdrawal from study.|83
3056744|NCT01249664|3777262|FG001|Completed 24 Weeks Treatment|Overall Study|Withdrawal from treatment does not equal to withdrawal from study.|25
3056745|NCT01249664|3777261|FG000|Completed 48 Weeks Treatment|Overall Study||78
3056746|NCT01249664|3777262|FG001|Completed 48 Weeks Treatment|Overall Study||24
3056747|NCT01249664|3777261|FG000|COMPLETED|Overall Study|Completers of study visits up to week 48|85
3056748|NCT01249664|3777262|FG001|COMPLETED|Overall Study|Completers of study visits up to week 48|31
3056749|NCT01249664|3777261|FG000|NOT COMPLETED|Overall Study||6
3056750|NCT01249664|3777262|FG001|NOT COMPLETED|Overall Study||0
3056751|NCT01249833|3777272|FG000|STARTED|Overall Study||59
3056752|NCT01249833|3777273|FG001|STARTED|Overall Study||63
3056753|NCT01249833|3777272|FG000|COMPLETED|Overall Study||59
3056754|NCT01249833|3777273|FG001|COMPLETED|Overall Study||62
3056755|NCT01249833|3777272|FG000|NOT COMPLETED|Overall Study||0
3056756|NCT01249833|3777273|FG001|NOT COMPLETED|Overall Study||1
3056757|NCT01249872|3777285|FG000|STARTED|Overall Study||16
3056758|NCT01249872|3777286|FG001|STARTED|Overall Study||16
3056759|NCT01249872|3777287|FG002|STARTED|Overall Study||16
3056760|NCT01249872|3777288|FG003|STARTED|Overall Study||16
3056761|NCT01249872|3777289|FG004|STARTED|Overall Study||16
3056762|NCT01249872|3777290|FG005|STARTED|Overall Study||16
3056763|NCT01249872|3777285|FG000|COMPLETED|Overall Study||16
3056764|NCT01249872|3777286|FG001|COMPLETED|Overall Study||16
3056765|NCT01249872|3777287|FG002|COMPLETED|Overall Study||16
3056766|NCT01249872|3777288|FG003|COMPLETED|Overall Study||16
3056767|NCT01249872|3777289|FG004|COMPLETED|Overall Study||16
3056768|NCT01249872|3777290|FG005|COMPLETED|Overall Study||16
3056769|NCT01249872|3777285|FG000|NOT COMPLETED|Overall Study||0
3056770|NCT01249872|3777286|FG001|NOT COMPLETED|Overall Study||0
3056771|NCT01249872|3777287|FG002|NOT COMPLETED|Overall Study||0
3056772|NCT01249872|3777288|FG003|NOT COMPLETED|Overall Study||0
3056773|NCT01249872|3777289|FG004|NOT COMPLETED|Overall Study||0
3056774|NCT01249872|3777290|FG005|NOT COMPLETED|Overall Study||0
3056775|NCT01250002|3777314|FG000|STARTED|Overall Study||35
3056776|NCT01250002|3777315|FG001|STARTED|Overall Study||35
3056777|NCT01250002|3777314|FG000|COMPLETED|Overall Study||31
3056778|NCT01250002|3777315|FG001|COMPLETED|Overall Study||32
3056779|NCT01250002|3777314|FG000|NOT COMPLETED|Overall Study||4
3056780|NCT01250002|3777315|FG001|NOT COMPLETED|Overall Study||3
3056781|NCT01250054|3777321|FG000|STARTED|Period 1, One Week of Wear||8
3056782|NCT01250054|3777322|FG001|STARTED|Period 1, One Week of Wear|One subject did not wear Period 1 lenses due to power availability and proceeded to Period 2 lenses.|8
3056783|NCT01250054|3777321|FG000|COMPLETED|Period 1, One Week of Wear|One subject discontinued between Period 1 and Period 2 due to power availability.|8
3056784|NCT01250054|3777322|FG001|COMPLETED|Period 1, One Week of Wear|One subject discontinued between Period 1 and Period 2 due to noncompliance.|8
3056785|NCT01250054|3777321|FG000|NOT COMPLETED|Period 1, One Week of Wear||0
3056786|NCT01250054|3777322|FG001|NOT COMPLETED|Period 1, One Week of Wear||0
3056787|NCT01250054|3777321|FG000|STARTED|Period 2, One Week of Wear||7
3056788|NCT01250054|3777322|FG001|STARTED|Period 2, One Week of Wear||8
3056789|NCT01250054|3777321|FG000|COMPLETED|Period 2, One Week of Wear||6
3056790|NCT01250054|3777322|FG001|COMPLETED|Period 2, One Week of Wear||8
3056791|NCT01250054|3777321|FG000|NOT COMPLETED|Period 2, One Week of Wear||1
3056792|NCT01250054|3777322|FG001|NOT COMPLETED|Period 2, One Week of Wear||0
3056793|NCT01250119|3777328|FG000|STARTED|Diagnostic Phase||688
3056794|NCT01250119|3777329|FG001|STARTED|Diagnostic Phase||0
3056795|NCT01250119|3777328|FG000|COMPLETED|Diagnostic Phase|Completed refers to participants with both positive and negative EGFR mutation test result.|575
3056796|NCT01250119|3777329|FG001|COMPLETED|Diagnostic Phase||0
3056797|NCT01250119|3777328|FG000|NOT COMPLETED|Diagnostic Phase||113
3056798|NCT01250119|3777329|FG001|NOT COMPLETED|Diagnostic Phase||0
3056799|NCT01250119|3777328|FG000|STARTED|Treatment Phase||0
3056800|NCT01250119|3777329|FG001|STARTED|Treatment Phase|Out of 52 participants with positive EGFR mutation test result, only 41 participants were treated.|41
3056801|NCT01250119|3777328|FG000|COMPLETED|Treatment Phase||0
3056802|NCT01250119|3777329|FG001|COMPLETED|Treatment Phase||0
3056803|NCT01250119|3777328|FG000|NOT COMPLETED|Treatment Phase||0
3056804|NCT01250119|3777329|FG001|NOT COMPLETED|Treatment Phase||41
3056805|NCT01250145|3777338|FG000|STARTED|Overall Study||41
3056806|NCT01250145|3777339|FG001|STARTED|Overall Study||210
3056807|NCT01250145|3777338|FG000|COMPLETED|Overall Study||39
3056808|NCT01250145|3777339|FG001|COMPLETED|Overall Study||205
3056809|NCT01250145|3777338|FG000|NOT COMPLETED|Overall Study||2
3056810|NCT01250145|3777339|FG001|NOT COMPLETED|Overall Study||5
3056811|NCT01250171|3777362|FG000|STARTED|Overall Study||26
3056812|NCT01250171|3777363|FG001|STARTED|Overall Study||22
3056813|NCT01250171|3777364|FG002|STARTED|Overall Study||24
3056814|NCT01250171|3777362|FG000|COMPLETED|Overall Study||25
3056815|NCT01250171|3777363|FG001|COMPLETED|Overall Study||22
3056816|NCT01250171|3777364|FG002|COMPLETED|Overall Study||24
3056817|NCT01250171|3777362|FG000|NOT COMPLETED|Overall Study||1
3056818|NCT01250171|3777363|FG001|NOT COMPLETED|Overall Study||0
3056819|NCT01250171|3777364|FG002|NOT COMPLETED|Overall Study||0
3056820|NCT01250184|3777375|FG000|STARTED|Overall Study||43
3056821|NCT01250184|3777376|FG001|STARTED|Overall Study||41
3056822|NCT01250184|3777377|FG002|STARTED|Overall Study||43
3056823|NCT01250184|3777375|FG000|COMPLETED|Overall Study||43
3056824|NCT01250184|3777376|FG001|COMPLETED|Overall Study||41
3056825|NCT01250184|3777377|FG002|COMPLETED|Overall Study||43
3056826|NCT01250184|3777375|FG000|NOT COMPLETED|Overall Study||0
3056827|NCT01250184|3777376|FG001|NOT COMPLETED|Overall Study||0
3056828|NCT01250184|3777377|FG002|NOT COMPLETED|Overall Study||0
3056829|NCT01250210|3777388|FG000|STARTED|Overall Study||45
3056830|NCT01250210|3777389|FG001|STARTED|Overall Study||45
3056831|NCT01250210|3777390|FG002|STARTED|Overall Study||33
3056832|NCT01250210|3777388|FG000|COMPLETED|Overall Study||41
3056833|NCT01250210|3777389|FG001|COMPLETED|Overall Study||41
3056834|NCT01250210|3777390|FG002|COMPLETED|Overall Study||25
3056835|NCT01250210|3777388|FG000|NOT COMPLETED|Overall Study||4
3283884|NCT02760056|4017680|FG001|COMPLETED|Overall Study||5
3283885|NCT02760056|4017679|FG000|NOT COMPLETED|Overall Study||0
3283886|NCT02760056|4017680|FG001|NOT COMPLETED|Overall Study||0
3283887|NCT02760069|4017690|FG000|STARTED|Overall Study||40
3283888|NCT02760069|4017691|FG001|STARTED|Overall Study||41
3283889|NCT02760069|4017692|FG002|STARTED|Overall Study||41
3283890|NCT02760069|4017690|FG000|COMPLETED|Overall Study||40
3283891|NCT02760069|4017691|FG001|COMPLETED|Overall Study||40
3283892|NCT02760069|4017692|FG002|COMPLETED|Overall Study||40
3283893|NCT02760069|4017690|FG000|NOT COMPLETED|Overall Study||0
3056836|NCT01250210|3777389|FG001|NOT COMPLETED|Overall Study||4
3056837|NCT01250210|3777390|FG002|NOT COMPLETED|Overall Study||8
3056838|NCT01250379|3777400|FG000|STARTED|Overall Study||247
3056839|NCT01250379|3777401|FG001|STARTED|Overall Study||247
3056840|NCT01250379|3777400|FG000|COMPLETED|Overall Study|Participants under study follow-up as of Data Cutoff 30 April 2015 were considered as completers.|45
3056841|NCT01250379|3777401|FG001|COMPLETED|Overall Study|Participants under study follow-up as of Data Cutoff 30 April 2015 were considered as completers.|54
3056842|NCT01250379|3777400|FG000|NOT COMPLETED|Overall Study||202
3056843|NCT01250379|3777401|FG001|NOT COMPLETED|Overall Study||193
3056844|NCT01250418|3777409|FG000|STARTED|Overall Study||9
3056845|NCT01250418|3777410|FG001|STARTED|Overall Study||16
3283894|NCT02760069|4017691|FG001|NOT COMPLETED|Overall Study||1
3283895|NCT02760069|4017692|FG002|NOT COMPLETED|Overall Study||1
3283896|NCT02760264|4017704|FG000|STARTED|0.25 mg/kg/Day||12
3283897|NCT02760264|4017705|FG001|STARTED|0.25 mg/kg/Day||0
3283898|NCT02760264|4017706|FG002|STARTED|0.25 mg/kg/Day||0
3283899|NCT02760264|4017707|FG003|STARTED|0.25 mg/kg/Day||0
3056846|NCT01250418|3777409|FG000|COMPLETED|Overall Study||8
3056847|NCT01250418|3777410|FG001|COMPLETED|Overall Study||15
3056848|NCT01250418|3777409|FG000|NOT COMPLETED|Overall Study||1
3056849|NCT01250418|3777410|FG001|NOT COMPLETED|Overall Study||1
3056850|NCT01250509|3777418|FG000|STARTED|Overall Study||24
3056851|NCT01250509|3777419|FG001|STARTED|Overall Study||23
3056852|NCT01250509|3777418|FG000|COMPLETED|Overall Study||19
3056853|NCT01250509|3777419|FG001|COMPLETED|Overall Study||21
3056854|NCT01250509|3777418|FG000|NOT COMPLETED|Overall Study||5
3056855|NCT01250509|3777419|FG001|NOT COMPLETED|Overall Study||2
3056856|NCT01250717|3777427|FG000|STARTED|Overall Study||28
3056857|NCT01250717|3777427|FG000|COMPLETED|Overall Study||28
3056858|NCT01250717|3777427|FG000|NOT COMPLETED|Overall Study||0
3056859|NCT01250730|3777434|FG000|STARTED|Overall Study||6
3056860|NCT01250730|3777435|FG001|STARTED|Overall Study||6
3056861|NCT01250730|3777436|FG002|STARTED|Overall Study||6
3056862|NCT01250730|3777434|FG000|COMPLETED|Overall Study||6
3056863|NCT01250730|3777435|FG001|COMPLETED|Overall Study||6
3056864|NCT01250730|3777436|FG002|COMPLETED|Overall Study||6
3056865|NCT01250730|3777434|FG000|NOT COMPLETED|Overall Study||0
3056866|NCT01250730|3777435|FG001|NOT COMPLETED|Overall Study||0
3056867|NCT01250730|3777436|FG002|NOT COMPLETED|Overall Study||0
3056868|NCT01250756|3777446|FG000|STARTED|Infant Series||161
3056869|NCT01250756|3777447|FG001|STARTED|Infant Series||160
3056870|NCT01250756|3777446|FG000|Vaccinated Dose 1|Infant Series||159
3056871|NCT01250756|3777447|FG001|Vaccinated Dose 1|Infant Series||158
3056872|NCT01250756|3777446|FG000|Vaccinated Dose 2|Infant Series||147
3056873|NCT01250756|3777447|FG001|Vaccinated Dose 2|Infant Series||157
3056874|NCT01250756|3777446|FG000|Vaccinated Dose 3|Infant Series||133
3056875|NCT01250756|3777447|FG001|Vaccinated Dose 3|Infant Series||155
3056876|NCT01250756|3777446|FG000|COMPLETED|Infant Series||133
3056877|NCT01250756|3777447|FG001|COMPLETED|Infant Series||153
3056878|NCT01250756|3777446|FG000|NOT COMPLETED|Infant Series||28
3056879|NCT01250756|3777447|FG001|NOT COMPLETED|Infant Series||7
3056880|NCT01250756|3777446|FG000|STARTED|After Infant Series||133
3056881|NCT01250756|3777447|FG001|STARTED|After Infant Series||153
3056882|NCT01250756|3777446|FG000|COMPLETED|After Infant Series||122
3056883|NCT01250756|3777447|FG001|COMPLETED|After Infant Series||149
3056884|NCT01250756|3777446|FG000|NOT COMPLETED|After Infant Series||11
3056885|NCT01250756|3777447|FG001|NOT COMPLETED|After Infant Series||4
3162104|NCT01877265|3889532|FG000|Received at Least One Dose of Study Drug|Treatment Period 1||3
3162105|NCT01877265|3889533|FG001|Received at Least One Dose of Study Drug|Treatment Period 1||3
3162106|NCT01877265|3889534|FG002|Received at Least One Dose of Study Drug|Treatment Period 1||3
3162107|NCT01877265|3889535|FG003|Received at Least One Dose of Study Drug|Treatment Period 1||3
3056886|NCT01250756|3777446|FG000|STARTED|Toddler Dose||122
3056887|NCT01250756|3777447|FG001|STARTED|Toddler Dose||149
3056888|NCT01250756|3777446|FG000|COMPLETED|Toddler Dose||122
3056889|NCT01250756|3777447|FG001|COMPLETED|Toddler Dose||148
3056890|NCT01250756|3777446|FG000|NOT COMPLETED|Toddler Dose||0
3056891|NCT01250756|3777447|FG001|NOT COMPLETED|Toddler Dose||1
3056892|NCT01250756|3777446|FG000|STARTED|After Toddler Dose||0
3056893|NCT01250756|3777447|FG001|STARTED|After Toddler Dose||148
3056894|NCT01250756|3777446|FG000|COMPLETED|After Toddler Dose||0
3056895|NCT01250756|3777447|FG001|COMPLETED|After Toddler Dose||147
3056896|NCT01250756|3777446|FG000|NOT COMPLETED|After Toddler Dose||0
3056897|NCT01250756|3777447|FG001|NOT COMPLETED|After Toddler Dose||1
3056898|NCT01250769|3777463|FG000|STARTED|Overall Study||11
3056899|NCT01250769|3777464|FG001|STARTED|Overall Study||73
3056900|NCT01250769|3777465|FG002|STARTED|Overall Study||75
3056901|NCT01250769|3777466|FG003|STARTED|Overall Study||11
3056902|NCT01250769|3777463|FG000|Day 14|Overall Study||11
3056903|NCT01250769|3777464|FG001|Day 14|Overall Study||72
3056904|NCT01250769|3777465|FG002|Day 14|Overall Study||74
3056905|NCT01250769|3777466|FG003|Day 14|Overall Study||11
3056906|NCT01250769|3777463|FG000|COMPLETED|Overall Study||11
3056907|NCT01250769|3777464|FG001|COMPLETED|Overall Study||72
3056908|NCT01250769|3777465|FG002|COMPLETED|Overall Study||73
3056909|NCT01250769|3777466|FG003|COMPLETED|Overall Study||11
3056910|NCT01250769|3777463|FG000|NOT COMPLETED|Overall Study||0
3056911|NCT01250769|3777464|FG001|NOT COMPLETED|Overall Study||1
3056912|NCT01250769|3777465|FG002|NOT COMPLETED|Overall Study||2
3056913|NCT01250769|3777466|FG003|NOT COMPLETED|Overall Study||0
3056914|NCT01250834|3777476|FG000|STARTED|Overall Study||27
3056915|NCT01250834|3777476|FG000|COMPLETED|Overall Study||27
3056916|NCT01250834|3777476|FG000|NOT COMPLETED|Overall Study||0
3056917|NCT01250873|3777483|FG000|STARTED|Period 1: LY2216684 (Days 1-3)||20
3056918|NCT01250873|3777483|FG000|COMPLETED|Period 1: LY2216684 (Days 1-3)||18
3056919|NCT01250873|3777483|FG000|NOT COMPLETED|Period 1: LY2216684 (Days 1-3)||2
3056920|NCT01250873|3777483|FG000|STARTED|Period 2: Sertraline (Day 4, 5-10)||18
3056921|NCT01250873|3777483|FG000|COMPLETED|Period 2: Sertraline (Day 4, 5-10)||18
3056922|NCT01250873|3777483|FG000|NOT COMPLETED|Period 2: Sertraline (Day 4, 5-10)||0
3056923|NCT01250873|3777483|FG000|STARTED|Period 3:LY2216684+Sertraline(Days11-13)||18
3056924|NCT01250873|3777483|FG000|COMPLETED|Period 3:LY2216684+Sertraline(Days11-13)||17
3056925|NCT01250873|3777483|FG000|NOT COMPLETED|Period 3:LY2216684+Sertraline(Days11-13)||1
3056926|NCT01250899|3777491|FG000|STARTED|Overall Study||40
3056927|NCT01250899|3777492|FG001|STARTED|Overall Study||82
3056928|NCT01250899|3777491|FG000|COMPLETED|Overall Study||40
3056929|NCT01250899|3777492|FG001|COMPLETED|Overall Study||82
3056930|NCT01250899|3777491|FG000|NOT COMPLETED|Overall Study||0
3056931|NCT01250899|3777492|FG001|NOT COMPLETED|Overall Study||0
3056932|NCT01250925|3777499|FG000|STARTED|Overall Study||31
3056933|NCT01250925|3777500|FG001|STARTED|Overall Study||31
3056934|NCT01250925|3777501|FG002|STARTED|Overall Study||32
3056935|NCT01250925|3777499|FG000|COMPLETED|Overall Study||26
3056936|NCT01250925|3777500|FG001|COMPLETED|Overall Study||28
3056937|NCT01250925|3777501|FG002|COMPLETED|Overall Study||30
3283900|NCT02760264|4017704|FG000|COMPLETED|0.25 mg/kg/Day||12
3056938|NCT01250925|3777499|FG000|NOT COMPLETED|Overall Study||5
3056939|NCT01250925|3777500|FG001|NOT COMPLETED|Overall Study||3
3056940|NCT01250925|3777501|FG002|NOT COMPLETED|Overall Study||2
3056941|NCT01250977|3777511|FG000|STARTED|Overall Study||6
3056942|NCT01250977|3777512|FG001|STARTED|Overall Study||14
3056943|NCT01250977|3777511|FG000|COMPLETED|Overall Study||6
3056944|NCT01250977|3777512|FG001|COMPLETED|Overall Study||12
3056945|NCT01250977|3777511|FG000|NOT COMPLETED|Overall Study||0
3056946|NCT01250977|3777512|FG001|NOT COMPLETED|Overall Study||2
3056947|NCT01250990|3777520|FG000|STARTED|Overall Study||11
3056948|NCT01250990|3777521|FG001|STARTED|Overall Study||11
3056949|NCT01250990|3777520|FG000|COMPLETED|Overall Study||7
3056950|NCT01250990|3777521|FG001|COMPLETED|Overall Study||9
3056951|NCT01250990|3777520|FG000|NOT COMPLETED|Overall Study||4
3056952|NCT01250990|3777521|FG001|NOT COMPLETED|Overall Study||2
3056953|NCT01251042|3777529|FG000|STARTED|Overall Study||26
3056954|NCT01251042|3777530|FG001|STARTED|Overall Study||23
3056955|NCT01251042|3777529|FG000|COMPLETED|Overall Study||26
3056956|NCT01251042|3777530|FG001|COMPLETED|Overall Study||23
3056957|NCT01251042|3777529|FG000|NOT COMPLETED|Overall Study||0
3056958|NCT01251042|3777530|FG001|NOT COMPLETED|Overall Study||0
3056959|NCT01251146|3777538|FG000|STARTED|Overall Study||86
3056960|NCT01251146|3777539|FG001|STARTED|Overall Study||91
3056961|NCT01251146|3777538|FG000|COMPLETED|Overall Study||83
3056962|NCT01251146|3777539|FG001|COMPLETED|Overall Study||81
3056963|NCT01251146|3777538|FG000|NOT COMPLETED|Overall Study||3
3056964|NCT01251146|3777539|FG001|NOT COMPLETED|Overall Study||10
3056965|NCT01251276|3777547|FG000|STARTED|Overall Study|Not all Base Study completers enrolled in the Challenge Dose Study|96
3056966|NCT01251276|3777548|FG001|STARTED|Overall Study|Not all Base Study completers enrolled in the Challenge Dose Study|108
3056967|NCT01251276|3777547|FG000|Vaccinated|Overall Study||96
3162108|NCT01877265|3889536|FG004|Received at Least One Dose of Study Drug|Treatment Period 1||3
3162109|NCT01877265|3889537|FG005|Received at Least One Dose of Study Drug|Treatment Period 1||3
3162110|NCT01877265|3889532|FG000|COMPLETED|Treatment Period 1||3
3162111|NCT01877265|3889533|FG001|COMPLETED|Treatment Period 1||3
3162112|NCT01877265|3889534|FG002|COMPLETED|Treatment Period 1||2
3162113|NCT01877265|3889535|FG003|COMPLETED|Treatment Period 1||3
3162114|NCT01877265|3889536|FG004|COMPLETED|Treatment Period 1||3
3162115|NCT01877265|3889537|FG005|COMPLETED|Treatment Period 1||3
3162116|NCT01877265|3889532|FG000|NOT COMPLETED|Treatment Period 1||0
3162117|NCT01877265|3889533|FG001|NOT COMPLETED|Treatment Period 1||0
3162118|NCT01877265|3889534|FG002|NOT COMPLETED|Treatment Period 1||1
3162119|NCT01877265|3889535|FG003|NOT COMPLETED|Treatment Period 1||0
3162120|NCT01877265|3889536|FG004|NOT COMPLETED|Treatment Period 1||0
3056968|NCT01251276|3777548|FG001|Vaccinated|Overall Study||108
3056969|NCT01251276|3777547|FG000|COMPLETED|Overall Study||95
3056970|NCT01251276|3777548|FG001|COMPLETED|Overall Study||107
3056971|NCT01251276|3777547|FG000|NOT COMPLETED|Overall Study||1
3056972|NCT01251276|3777548|FG001|NOT COMPLETED|Overall Study||1
3056973|NCT01251315|3777560|FG000|STARTED|Overall Study||4
3056974|NCT01251315|3777561|FG001|STARTED|Overall Study||4
3056975|NCT01251315|3777562|FG002|STARTED|Overall Study||4
3056976|NCT01251315|3777563|FG003|STARTED|Overall Study||4
3056977|NCT01251315|3777564|FG004|STARTED|Overall Study||4
3056978|NCT01251315|3777565|FG005|STARTED|Overall Study||4
3056979|NCT01251315|3777560|FG000|COMPLETED|Overall Study||4
3056980|NCT01251315|3777561|FG001|COMPLETED|Overall Study||4
3056981|NCT01251315|3777562|FG002|COMPLETED|Overall Study||4
3056982|NCT01251315|3777563|FG003|COMPLETED|Overall Study||4
3056983|NCT01251315|3777564|FG004|COMPLETED|Overall Study||4
3056984|NCT01251315|3777565|FG005|COMPLETED|Overall Study||4
3056985|NCT01251315|3777560|FG000|NOT COMPLETED|Overall Study||0
3056986|NCT01251315|3777561|FG001|NOT COMPLETED|Overall Study||0
3056987|NCT01251315|3777562|FG002|NOT COMPLETED|Overall Study||0
3056988|NCT01251315|3777563|FG003|NOT COMPLETED|Overall Study||0
3056989|NCT01251315|3777564|FG004|NOT COMPLETED|Overall Study||0
3056990|NCT01251315|3777565|FG005|NOT COMPLETED|Overall Study||0
3056991|NCT01251354|3777583|FG000|STARTED|Overall Study||6
3056992|NCT01251354|3777583|FG000|COMPLETED|Overall Study||0
3056993|NCT01251354|3777583|FG000|NOT COMPLETED|Overall Study||6
3056994|NCT01251367|3777587|FG000|STARTED|Overall Study||345
3056995|NCT01251367|3777587|FG000|Cycle 1|Overall Study||345
3056996|NCT01251367|3777587|FG000|Cycle 2|Overall Study||297
3056997|NCT01251367|3777587|FG000|Cycle 3|Overall Study||224
3056998|NCT01251367|3777587|FG000|Cycle 4|Overall Study||139
3056999|NCT01251367|3777587|FG000|COMPLETED|Overall Study||269
3057000|NCT01251367|3777587|FG000|NOT COMPLETED|Overall Study||76
3057001|NCT01251380|3777591|FG000|STARTED|Overall Study|Safety population.|216
3057002|NCT01251380|3777591|FG000|Cycle 1|Overall Study||207
3057003|NCT01251380|3777591|FG000|Cycle 2|Overall Study||175
3162121|NCT01877265|3889537|FG005|NOT COMPLETED|Treatment Period 1||0
3162122|NCT01877265|3889532|FG000|STARTED|Washout Period 1 (at Least 14 Days)||3
3057004|NCT01251380|3777591|FG000|Cycle 3|Overall Study||86
3057005|NCT01251380|3777591|FG000|Cycle 4|Overall Study||11
3057006|NCT01251380|3777591|FG000|COMPLETED|Overall Study||194
3057007|NCT01251380|3777591|FG000|NOT COMPLETED|Overall Study||22
3057008|NCT01251393|3777602|FG000|STARTED|Overall Study||56
3057009|NCT01251393|3777603|FG001|STARTED|Overall Study||55
3057010|NCT01251393|3777602|FG000|COMPLETED|Overall Study||24
3057011|NCT01251393|3777603|FG001|COMPLETED|Overall Study||11
3057012|NCT01251393|3777602|FG000|NOT COMPLETED|Overall Study||32
3057013|NCT01251393|3777603|FG001|NOT COMPLETED|Overall Study||44
3057014|NCT01251536|3777612|FG000|STARTED|Overall Study||8
3057015|NCT01251536|3777613|FG001|STARTED|Overall Study||93
3057016|NCT01251536|3777614|FG002|STARTED|Overall Study||7
3057017|NCT01251536|3777612|FG000|COMPLETED|Overall Study||8
3057018|NCT01251536|3777613|FG001|COMPLETED|Overall Study||93
3057019|NCT01251536|3777614|FG002|COMPLETED|Overall Study||7
3057020|NCT01251536|3777612|FG000|NOT COMPLETED|Overall Study||0
3057021|NCT01251536|3777613|FG001|NOT COMPLETED|Overall Study||0
3057022|NCT01251536|3777614|FG002|NOT COMPLETED|Overall Study||0
3057023|NCT01251575|3777624|FG000|STARTED|Overall Study||77
3057024|NCT01251575|3777624|FG000|COMPLETED|Overall Study||76
3057025|NCT01251575|3777624|FG000|NOT COMPLETED|Overall Study||1
3057026|NCT01251588|3777632|FG000|STARTED|Overall Study||65
3057027|NCT01251588|3777633|FG001|STARTED|Overall Study||63
3057028|NCT01251588|3777632|FG000|COMPLETED|Overall Study||65
3057029|NCT01251588|3777633|FG001|COMPLETED|Overall Study||59
3057030|NCT01251588|3777632|FG000|NOT COMPLETED|Overall Study||0
3057031|NCT01251588|3777633|FG001|NOT COMPLETED|Overall Study||4
3057032|NCT01251614|3777644|FG000|STARTED|Overall Study||37
3057033|NCT01251614|3777645|FG001|STARTED|Overall Study||39
3057034|NCT01251614|3777646|FG002|STARTED|Overall Study||38
3057035|NCT01251614|3777644|FG000|Entered Period B|Overall Study|Only participants who were responders at Week 16 (Period A) entered the Treatment Withdrawal Phase|13
3057036|NCT01251614|3777645|FG001|Entered Period B|Overall Study|Only participants who were responders at Week 16 (Period A) entered the Treatment Withdrawal Phase|18
3057037|NCT01251614|3777646|FG002|Entered Period B|Overall Study|Only participants who were responders at Week 16 (Period A) entered the Treatment Withdrawal Phase|23
3057038|NCT01251614|3777644|FG000|Entered Period C|Overall Study|Only participants who experienced loss of disease control in Period B entered the Re-Treatment Phase|8
3057039|NCT01251614|3777645|FG001|Entered Period C|Overall Study|Only participants who experienced loss of disease control in Period B entered the Re-Treatment Phase|11
3057040|NCT01251614|3777646|FG002|Entered Period C|Overall Study|Only participants who experienced loss of disease control in Period B entered the Re-Treatment Phase|19
3057041|NCT01251614|3777644|FG000|Entered Period D|Overall Study|Long-Term Follow-Up Phase (52 Weeks)|36
3057042|NCT01251614|3777645|FG001|Entered Period D|Overall Study|Long-Term Follow-Up Phase (52 Weeks)|36
3057043|NCT01251614|3777646|FG002|Entered Period D|Overall Study|Long-Term Follow-Up Phase (52 Weeks)|36
3057044|NCT01251614|3777644|FG000|COMPLETED|Overall Study||34
3057045|NCT01251614|3777645|FG001|COMPLETED|Overall Study||26
3057046|NCT01251614|3777646|FG002|COMPLETED|Overall Study||30
3057047|NCT01251614|3777644|FG000|NOT COMPLETED|Overall Study||3
3057048|NCT01251614|3777645|FG001|NOT COMPLETED|Overall Study||13
3057049|NCT01251614|3777646|FG002|NOT COMPLETED|Overall Study||8
3057050|NCT01251653|3777673|FG000|STARTED|Overall Study||3
3057051|NCT01251653|3777674|FG001|STARTED|Overall Study||8
3057052|NCT01251653|3777675|FG002|STARTED|Overall Study||20
3057053|NCT01251653|3777676|FG003|STARTED|Overall Study||6
3057054|NCT01251653|3777677|FG004|STARTED|Overall Study||2
3057055|NCT01251653|3777678|FG005|STARTED|Overall Study||18
3057056|NCT01251653|3777679|FG006|STARTED|Overall Study||18
3057057|NCT01251653|3777680|FG007|STARTED|Overall Study||12
3057058|NCT01251653|3777681|FG008|STARTED|Overall Study||6
3057059|NCT01251653|3777673|FG000|COMPLETED|Overall Study||0
3057060|NCT01251653|3777674|FG001|COMPLETED|Overall Study||0
3057061|NCT01251653|3777675|FG002|COMPLETED|Overall Study||0
3057062|NCT01251653|3777676|FG003|COMPLETED|Overall Study||0
3057063|NCT01251653|3777677|FG004|COMPLETED|Overall Study||0
3057064|NCT01251653|3777678|FG005|COMPLETED|Overall Study||0
3057065|NCT01251653|3777679|FG006|COMPLETED|Overall Study||0
3057066|NCT01251653|3777680|FG007|COMPLETED|Overall Study||0
3057067|NCT01251653|3777681|FG008|COMPLETED|Overall Study||0
3057068|NCT01251653|3777673|FG000|NOT COMPLETED|Overall Study||3
3057069|NCT01251653|3777674|FG001|NOT COMPLETED|Overall Study||8
3057070|NCT01251653|3777675|FG002|NOT COMPLETED|Overall Study||20
3057071|NCT01251653|3777676|FG003|NOT COMPLETED|Overall Study||6
3057072|NCT01251653|3777677|FG004|NOT COMPLETED|Overall Study||2
3057073|NCT01251653|3777678|FG005|NOT COMPLETED|Overall Study||18
3057074|NCT01251653|3777679|FG006|NOT COMPLETED|Overall Study||18
3057075|NCT01251653|3777680|FG007|NOT COMPLETED|Overall Study||12
3057076|NCT01251653|3777681|FG008|NOT COMPLETED|Overall Study||6
3057077|NCT01251744|3777719|FG000|STARTED|Overall Study||77
3057078|NCT01251744|3777720|FG001|STARTED|Overall Study||78
3057079|NCT01251744|3777719|FG000|COMPLETED|Overall Study||76
3057080|NCT01251744|3777720|FG001|COMPLETED|Overall Study||78
3057081|NCT01251744|3777719|FG000|NOT COMPLETED|Overall Study||1
3057082|NCT01251744|3777720|FG001|NOT COMPLETED|Overall Study||0
3057083|NCT01251757|3777736|FG000|STARTED|Overall Study|Separate analyses were done for statin users and ACEI/ARB users. This is the combined N.|7255
3057084|NCT01251757|3777737|FG001|STARTED|Overall Study|Separate analyses were done for statin users and ACEI/ARB users. This is the combined N.|7247
3057085|NCT01251757|3777738|FG002|STARTED|Overall Study|Separate analyses were done for statin users and ACEI/ARB users. This is the combined N.|7250
3057086|NCT01251757|3777736|FG000|COMPLETED|Overall Study|mean (SD) duration of follow-up was 9.7 (2.3) mos, but we computed an adherence score for everyone.|7255
3057087|NCT01251757|3777737|FG001|COMPLETED|Overall Study|mean (SD) duration of follow-up was 9.6 (2.4) mos, but we computed an adherence score for everyone.|7247
3057088|NCT01251757|3777738|FG002|COMPLETED|Overall Study|mean (SD) duration of follow-up was 9.6 (2.5) mos, but we computed an adherence score for everyone.|7250
3057089|NCT01251757|3777736|FG000|NOT COMPLETED|Overall Study||0
3057090|NCT01251757|3777737|FG001|NOT COMPLETED|Overall Study||0
3057091|NCT01251757|3777738|FG002|NOT COMPLETED|Overall Study||0
3057092|NCT01251770|3777752|FG000|STARTED|Overall Study||42
3057093|NCT01251770|3777753|FG001|STARTED|Overall Study||36
3057094|NCT01251770|3777752|FG000|COMPLETED|Overall Study||29
3057095|NCT01251770|3777753|FG001|COMPLETED|Overall Study||29
3057096|NCT01251770|3777752|FG000|NOT COMPLETED|Overall Study||13
3057097|NCT01251770|3777753|FG001|NOT COMPLETED|Overall Study||7
3057098|NCT01251861|3777761|FG000|STARTED|Overall Study||54
3057099|NCT01251861|3777762|FG001|STARTED|Overall Study||54
3057100|NCT01251861|3777761|FG000|Pts Who Received Protocol Therapy|Overall Study||50
3057101|NCT01251861|3777762|FG001|Pts Who Received Protocol Therapy|Overall Study||53
3057102|NCT01251861|3777761|FG000|Pts w/ Follow-up PSA Lower Than Baseline|Overall Study||49
3162123|NCT01877265|3889533|FG001|STARTED|Washout Period 1 (at Least 14 Days)||3
3162124|NCT01877265|3889534|FG002|STARTED|Washout Period 1 (at Least 14 Days)||2
3162125|NCT01877265|3889535|FG003|STARTED|Washout Period 1 (at Least 14 Days)||3
3162126|NCT01877265|3889536|FG004|STARTED|Washout Period 1 (at Least 14 Days)||3
3162127|NCT01877265|3889537|FG005|STARTED|Washout Period 1 (at Least 14 Days)||3
3162128|NCT01877265|3889532|FG000|COMPLETED|Washout Period 1 (at Least 14 Days)||3
3162129|NCT01877265|3889533|FG001|COMPLETED|Washout Period 1 (at Least 14 Days)||3
3057103|NCT01251861|3777762|FG001|Pts w/ Follow-up PSA Lower Than Baseline|Overall Study||47
3057104|NCT01251861|3777761|FG000|Pts With PSA Response|Overall Study||44
3057105|NCT01251861|3777762|FG001|Pts With PSA Response|Overall Study||36
3057106|NCT01251861|3777761|FG000|COMPLETED|Overall Study||36
3057107|NCT01251861|3777762|FG001|COMPLETED|Overall Study||26
3057108|NCT01251861|3777761|FG000|NOT COMPLETED|Overall Study||18
3057109|NCT01251861|3777762|FG001|NOT COMPLETED|Overall Study||28
3057110|NCT01251887|3777771|FG000|STARTED|Overall Study||18
3057111|NCT01251887|3777772|FG001|STARTED|Overall Study||29
3057112|NCT01251887|3777773|FG002|STARTED|Overall Study||18
3057113|NCT01251887|3777771|FG000|COMPLETED|Overall Study||17
3057114|NCT01251887|3777772|FG001|COMPLETED|Overall Study||26
3057115|NCT01251887|3777773|FG002|COMPLETED|Overall Study||16
3057116|NCT01251887|3777771|FG000|NOT COMPLETED|Overall Study||1
3057117|NCT01251887|3777772|FG001|NOT COMPLETED|Overall Study||3
3057118|NCT01251887|3777773|FG002|NOT COMPLETED|Overall Study||2
3057119|NCT01251965|3777784|FG000|STARTED|Overall Study||4
3057120|NCT01251965|3777785|FG001|STARTED|Overall Study||5
3057121|NCT01251965|3777786|FG002|STARTED|Overall Study||18
3057122|NCT01251965|3777784|FG000|COMPLETED|Overall Study||3
3057123|NCT01251965|3777785|FG001|COMPLETED|Overall Study||3
3057124|NCT01251965|3777786|FG002|COMPLETED|Overall Study||7
3057125|NCT01251965|3777784|FG000|NOT COMPLETED|Overall Study||1
3057126|NCT01251965|3777785|FG001|NOT COMPLETED|Overall Study||2
3057127|NCT01251965|3777786|FG002|NOT COMPLETED|Overall Study||11
3057128|NCT01251978|3777797|FG000|STARTED|Overall Study||5
3057129|NCT01251978|3777798|FG001|STARTED|Overall Study||3
3057130|NCT01251978|3777797|FG000|COMPLETED|Overall Study||5
3057131|NCT01251978|3777798|FG001|COMPLETED|Overall Study||3
3057132|NCT01251978|3777797|FG000|NOT COMPLETED|Overall Study||0
3057133|NCT01251978|3777798|FG001|NOT COMPLETED|Overall Study||0
3057134|NCT01252095|3777806|FG000|STARTED|Overall Study||3
3057135|NCT01252095|3777807|FG001|STARTED|Overall Study||1
3057136|NCT01252095|3777806|FG000|COMPLETED|Overall Study||2
3057137|NCT01252095|3777807|FG001|COMPLETED|Overall Study||1
3057138|NCT01252095|3777806|FG000|NOT COMPLETED|Overall Study||1
3057139|NCT01252095|3777807|FG001|NOT COMPLETED|Overall Study||0
3057140|NCT01252134|3777813|FG000|STARTED|Period 1, 8 Hours||3
3057141|NCT01252134|3777814|FG001|STARTED|Period 1, 8 Hours||4
3057142|NCT01252134|3777815|FG002|STARTED|Period 1, 8 Hours||3
3057143|NCT01252134|3777816|FG003|STARTED|Period 1, 8 Hours||5
3057144|NCT01252134|3777817|FG004|STARTED|Period 1, 8 Hours||3
3057145|NCT01252134|3777818|FG005|STARTED|Period 1, 8 Hours||4
3057146|NCT01252134|3777813|FG000|COMPLETED|Period 1, 8 Hours||3
3057147|NCT01252134|3777814|FG001|COMPLETED|Period 1, 8 Hours||3
3057148|NCT01252134|3777815|FG002|COMPLETED|Period 1, 8 Hours||2
3057149|NCT01252134|3777816|FG003|COMPLETED|Period 1, 8 Hours||5
3057150|NCT01252134|3777817|FG004|COMPLETED|Period 1, 8 Hours||3
3057151|NCT01252134|3777818|FG005|COMPLETED|Period 1, 8 Hours||4
3057152|NCT01252134|3777813|FG000|NOT COMPLETED|Period 1, 8 Hours||0
3057153|NCT01252134|3777814|FG001|NOT COMPLETED|Period 1, 8 Hours||1
3057154|NCT01252134|3777815|FG002|NOT COMPLETED|Period 1, 8 Hours||1
3057155|NCT01252134|3777816|FG003|NOT COMPLETED|Period 1, 8 Hours||0
3057156|NCT01252134|3777817|FG004|NOT COMPLETED|Period 1, 8 Hours||0
3057157|NCT01252134|3777818|FG005|NOT COMPLETED|Period 1, 8 Hours||0
3057158|NCT01252134|3777813|FG000|STARTED|Period 2, 8 Hours||3
3057159|NCT01252134|3777814|FG001|STARTED|Period 2, 8 Hours||3
3057160|NCT01252134|3777815|FG002|STARTED|Period 2, 8 Hours||2
3057161|NCT01252134|3777816|FG003|STARTED|Period 2, 8 Hours||5
3057162|NCT01252134|3777817|FG004|STARTED|Period 2, 8 Hours||3
3057163|NCT01252134|3777818|FG005|STARTED|Period 2, 8 Hours||4
3057164|NCT01252134|3777813|FG000|COMPLETED|Period 2, 8 Hours||3
3057165|NCT01252134|3777814|FG001|COMPLETED|Period 2, 8 Hours||3
3057166|NCT01252134|3777815|FG002|COMPLETED|Period 2, 8 Hours||2
3057167|NCT01252134|3777816|FG003|COMPLETED|Period 2, 8 Hours||5
3057168|NCT01252134|3777817|FG004|COMPLETED|Period 2, 8 Hours||3
3057169|NCT01252134|3777818|FG005|COMPLETED|Period 2, 8 Hours||4
3057170|NCT01252134|3777813|FG000|NOT COMPLETED|Period 2, 8 Hours||0
3057171|NCT01252134|3777814|FG001|NOT COMPLETED|Period 2, 8 Hours||0
3057172|NCT01252134|3777815|FG002|NOT COMPLETED|Period 2, 8 Hours||0
3057173|NCT01252134|3777816|FG003|NOT COMPLETED|Period 2, 8 Hours||0
3057174|NCT01252134|3777817|FG004|NOT COMPLETED|Period 2, 8 Hours||0
3057175|NCT01252134|3777818|FG005|NOT COMPLETED|Period 2, 8 Hours||0
3057176|NCT01252134|3777813|FG000|STARTED|Period 3, 8 Hours||3
3057177|NCT01252134|3777814|FG001|STARTED|Period 3, 8 Hours||3
3057178|NCT01252134|3777815|FG002|STARTED|Period 3, 8 Hours||2
3057179|NCT01252134|3777816|FG003|STARTED|Period 3, 8 Hours||5
3057180|NCT01252134|3777817|FG004|STARTED|Period 3, 8 Hours||3
3057181|NCT01252134|3777818|FG005|STARTED|Period 3, 8 Hours||4
3057182|NCT01252134|3777813|FG000|COMPLETED|Period 3, 8 Hours||3
3057183|NCT01252134|3777814|FG001|COMPLETED|Period 3, 8 Hours||3
3057184|NCT01252134|3777815|FG002|COMPLETED|Period 3, 8 Hours||2
3057185|NCT01252134|3777816|FG003|COMPLETED|Period 3, 8 Hours||5
3057186|NCT01252134|3777817|FG004|COMPLETED|Period 3, 8 Hours||3
3057187|NCT01252134|3777818|FG005|COMPLETED|Period 3, 8 Hours||4
3057188|NCT01252134|3777813|FG000|NOT COMPLETED|Period 3, 8 Hours||0
3057189|NCT01252134|3777814|FG001|NOT COMPLETED|Period 3, 8 Hours||0
3057190|NCT01252134|3777815|FG002|NOT COMPLETED|Period 3, 8 Hours||0
3057191|NCT01252134|3777816|FG003|NOT COMPLETED|Period 3, 8 Hours||0
3057192|NCT01252134|3777817|FG004|NOT COMPLETED|Period 3, 8 Hours||0
3057193|NCT01252134|3777818|FG005|NOT COMPLETED|Period 3, 8 Hours||0
3057194|NCT01252147|3777826|FG000|STARTED|Overall Study||68
3057195|NCT01252147|3777826|FG000|COMPLETED|Overall Study||68
3057196|NCT01252147|3777826|FG000|NOT COMPLETED|Overall Study||0
3057197|NCT01252186|3777833|FG000|STARTED|Overall Study||87
3057198|NCT01252186|3777834|FG001|STARTED|Overall Study||91
3057199|NCT01252186|3777835|FG002|STARTED|Overall Study||87
3057200|NCT01252186|3777833|FG000|Received Study Drug|Overall Study||83
3057201|NCT01252186|3777834|FG001|Received Study Drug|Overall Study||89
3057202|NCT01252186|3777835|FG002|Received Study Drug|Overall Study||80
3057203|NCT01252186|3777833|FG000|COMPLETED|Overall Study||57
3057204|NCT01252186|3777834|FG001|COMPLETED|Overall Study||59
3057205|NCT01252186|3777835|FG002|COMPLETED|Overall Study||53
3057206|NCT01252186|3777833|FG000|NOT COMPLETED|Overall Study||30
3057207|NCT01252186|3777834|FG001|NOT COMPLETED|Overall Study||32
3057208|NCT01252186|3777835|FG002|NOT COMPLETED|Overall Study||34
3057209|NCT01252238|3777846|FG000|STARTED|Overall Study||8
3057210|NCT01252238|3777847|FG001|STARTED|Overall Study||8
3057211|NCT01252238|3777848|FG002|STARTED|Overall Study||8
3057212|NCT01252238|3777846|FG000|COMPLETED|Overall Study|sponsor terminated study|4
3057213|NCT01252238|3777847|FG001|COMPLETED|Overall Study|sponsor terminated study|4
3057214|NCT01252238|3777848|FG002|COMPLETED|Overall Study|sponsor terminated study|4
3057215|NCT01252238|3777846|FG000|NOT COMPLETED|Overall Study||4
3057216|NCT01252238|3777847|FG001|NOT COMPLETED|Overall Study||4
3057217|NCT01252238|3777848|FG002|NOT COMPLETED|Overall Study||4
3057218|NCT01252251|3777859|FG000|STARTED|Overall Study||14
3057219|NCT01252251|3777859|FG000|COMPLETED|Overall Study||13
3057220|NCT01252251|3777859|FG000|NOT COMPLETED|Overall Study||1
3057221|NCT01252277|3777863|FG000|STARTED|Overall Study||36
3057222|NCT01252277|3777863|FG000|COMPLETED|Overall Study||34
3057223|NCT01252277|3777863|FG000|NOT COMPLETED|Overall Study||2
3057224|NCT01252290|3777868|FG000|STARTED|Overall Study||35
3057225|NCT01252290|3777868|FG000|COMPLETED|Overall Study||34
3057226|NCT01252290|3777868|FG000|NOT COMPLETED|Overall Study||1
3057227|NCT01252355|3777875|FG000|STARTED|Overall Study|Randomized.|177
3057228|NCT01252355|3777876|FG001|STARTED|Overall Study|Randomized.|178
3057229|NCT01252355|3777877|FG002|STARTED|Overall Study|Randomized.|179
3057230|NCT01252355|3777875|FG000|Treated|Overall Study||175
3057231|NCT01252355|3777876|FG001|Treated|Overall Study||178
3057232|NCT01252355|3777877|FG002|Treated|Overall Study|One participant received teriflunomide 7 mg.|179
3057233|NCT01252355|3777875|FG000|COMPLETED|Overall Study||0
3057234|NCT01252355|3777876|FG001|COMPLETED|Overall Study||0
3057235|NCT01252355|3777877|FG002|COMPLETED|Overall Study||0
3057236|NCT01252355|3777875|FG000|NOT COMPLETED|Overall Study||177
3057237|NCT01252355|3777876|FG001|NOT COMPLETED|Overall Study||178
3057238|NCT01252355|3777877|FG002|NOT COMPLETED|Overall Study||179
3057239|NCT01252563|3777885|FG000|STARTED|Overall Study||13775
3057240|NCT01252563|3777885|FG000|COMPLETED|Overall Study||13343
3057241|NCT01252563|3777885|FG000|NOT COMPLETED|Overall Study||432
3057242|NCT01252667|3777926|FG000|STARTED|Overall Study||3
3057243|NCT01252667|3777927|FG001|STARTED|Overall Study||3
3057244|NCT01252667|3777928|FG002|STARTED|Overall Study||3
3057245|NCT01252667|3777929|FG003|STARTED|Overall Study||0
3057246|NCT01252667|3777930|FG004|STARTED|Overall Study||0
3057247|NCT01252667|3777931|FG005|STARTED|Overall Study||35
3057248|NCT01252667|3777926|FG000|COMPLETED|Overall Study||3
3057249|NCT01252667|3777927|FG001|COMPLETED|Overall Study||3
3057250|NCT01252667|3777928|FG002|COMPLETED|Overall Study||3
3057251|NCT01252667|3777929|FG003|COMPLETED|Overall Study||0
3057252|NCT01252667|3777930|FG004|COMPLETED|Overall Study||0
3057253|NCT01252667|3777931|FG005|COMPLETED|Overall Study||34
3057254|NCT01252667|3777926|FG000|NOT COMPLETED|Overall Study||0
3057255|NCT01252667|3777927|FG001|NOT COMPLETED|Overall Study||0
3057256|NCT01252667|3777928|FG002|NOT COMPLETED|Overall Study||0
3057257|NCT01252667|3777929|FG003|NOT COMPLETED|Overall Study||0
3057258|NCT01252667|3777930|FG004|NOT COMPLETED|Overall Study||0
3057259|NCT01252667|3777931|FG005|NOT COMPLETED|Overall Study||1
3057260|NCT01252732|3777947|FG000|STARTED|Overall Study|Randomized|509
3057261|NCT01252732|3777948|FG001|STARTED|Overall Study|Randomized|510
3057262|NCT01252732|3777947|FG000|Modified Intent to Treat Population|Overall Study||503
3057263|NCT01252732|3777948|FG001|Modified Intent to Treat Population|Overall Study||502
3057264|NCT01252732|3777947|FG000|COMPLETED|Overall Study||455
3057265|NCT01252732|3777948|FG001|COMPLETED|Overall Study||446
3057266|NCT01252732|3777947|FG000|NOT COMPLETED|Overall Study||54
3057267|NCT01252732|3777948|FG001|NOT COMPLETED|Overall Study||64
3057268|NCT01252745|3777957|FG000|STARTED|Overall Study||8
3057269|NCT01252745|3777958|FG001|STARTED|Overall Study||7
3057270|NCT01252745|3777959|FG002|STARTED|Overall Study||7
3057271|NCT01252745|3777957|FG000|COMPLETED|Overall Study||8
3057272|NCT01252745|3777958|FG001|COMPLETED|Overall Study||7
3057273|NCT01252745|3777959|FG002|COMPLETED|Overall Study||7
3057274|NCT01252745|3777957|FG000|NOT COMPLETED|Overall Study||0
3057275|NCT01252745|3777958|FG001|NOT COMPLETED|Overall Study||0
3057276|NCT01252745|3777959|FG002|NOT COMPLETED|Overall Study||0
3057277|NCT01252810|3777972|FG000|STARTED|Overall Study||142
3057278|NCT01252810|3777973|FG001|STARTED|Overall Study||142
3057279|NCT01252810|3777972|FG000|COMPLETED|Overall Study||128
3057280|NCT01252810|3777973|FG001|COMPLETED|Overall Study||139
3057281|NCT01252810|3777972|FG000|NOT COMPLETED|Overall Study||14
3057282|NCT01252810|3777973|FG001|NOT COMPLETED|Overall Study||3
3057283|NCT01252940|3777981|FG000|STARTED|Main Study Phase||321
3057284|NCT01252940|3777982|FG001|STARTED|Main Study Phase||161
3057285|NCT01252940|3777981|FG000|Completed 24 Weeks|Main Study Phase||0
3057286|NCT01252940|3777982|FG001|Completed 24 Weeks|Main Study Phase|152 participants switched regimens at Week 24.|153
3057287|NCT01252940|3777981|FG000|COMPLETED|Main Study Phase||295
3057288|NCT01252940|3777982|FG001|COMPLETED|Main Study Phase|Discontinuations after switch: withdrawal by subject, 2; adverse event, 1; protocol violation, 1.|149
3057289|NCT01252940|3777981|FG000|NOT COMPLETED|Main Study Phase||26
3057290|NCT01252940|3777982|FG001|NOT COMPLETED|Main Study Phase||12
3057291|NCT01252940|3777981|FG000|STARTED|Extension Phase|FTC/RPV/TDF group: 110 participants completing the main study continued in extension phase.|110
3057292|NCT01252940|3777982|FG001|STARTED|Extension Phase|SBR/Delayed Switch Group: 49 participants completing the main study continued in extension phase.|49
3057293|NCT01252940|3777981|FG000|COMPLETED|Extension Phase||100
3057294|NCT01252940|3777982|FG001|COMPLETED|Extension Phase||46
3057295|NCT01252940|3777981|FG000|NOT COMPLETED|Extension Phase||10
3057296|NCT01252940|3777982|FG001|NOT COMPLETED|Extension Phase||3
3057297|NCT01252953|3777991|FG000|STARTED|Overall Study||15225
3057298|NCT01252953|3777992|FG001|STARTED|Overall Study||15224
3057299|NCT01252953|3777991|FG000|COMPLETED|Overall Study||15187
3057300|NCT01252953|3777992|FG001|COMPLETED|Overall Study||15186
3057301|NCT01252953|3777991|FG000|NOT COMPLETED|Overall Study||38
3057302|NCT01252953|3777992|FG001|NOT COMPLETED|Overall Study||38
3057303|NCT01252966|3778001|FG000|STARTED|Overall Study||108
3057304|NCT01252966|3778002|FG001|STARTED|Overall Study||105
3057305|NCT01252966|3778001|FG000|COMPLETED|Overall Study||85
3057306|NCT01252966|3778002|FG001|COMPLETED|Overall Study||92
3057307|NCT01252966|3778001|FG000|NOT COMPLETED|Overall Study||23
3057308|NCT01252966|3778002|FG001|NOT COMPLETED|Overall Study||13
3057309|NCT01253018|3778012|FG000|STARTED|Overall Study||22
3057310|NCT01253018|3778013|FG001|STARTED|Overall Study||23
3057311|NCT01253018|3778012|FG000|COMPLETED|Overall Study||18
3057312|NCT01253018|3778013|FG001|COMPLETED|Overall Study||21
3057313|NCT01253018|3778012|FG000|NOT COMPLETED|Overall Study||4
3057314|NCT01253018|3778013|FG001|NOT COMPLETED|Overall Study||2
3057315|NCT01253044|3778022|FG000|STARTED|Overall Study||80
3057316|NCT01253044|3778023|FG001|STARTED|Overall Study||80
3057317|NCT01253044|3778022|FG000|COMPLETED|Overall Study||42
3057318|NCT01253044|3778023|FG001|COMPLETED|Overall Study||51
3057319|NCT01253044|3778022|FG000|NOT COMPLETED|Overall Study||38
3057320|NCT01253044|3778023|FG001|NOT COMPLETED|Overall Study||29
3057321|NCT01253070|3778029|FG000|STARTED|Overall Study||54
3057322|NCT01253070|3778029|FG000|COMPLETED|Overall Study||54
3057323|NCT01253070|3778029|FG000|NOT COMPLETED|Overall Study||0
3057324|NCT01253135|3778034|FG000|STARTED|Original Protocol||15
3162130|NCT01877265|3889534|FG002|COMPLETED|Washout Period 1 (at Least 14 Days)||2
3162131|NCT01877265|3889535|FG003|COMPLETED|Washout Period 1 (at Least 14 Days)||3
3162132|NCT01877265|3889536|FG004|COMPLETED|Washout Period 1 (at Least 14 Days)||3
3162133|NCT01877265|3889537|FG005|COMPLETED|Washout Period 1 (at Least 14 Days)||3
3162134|NCT01877265|3889532|FG000|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0
3162135|NCT01877265|3889533|FG001|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0
3162136|NCT01877265|3889534|FG002|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0
3162137|NCT01877265|3889535|FG003|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0
3057325|NCT01253135|3778034|FG000|COMPLETED|Original Protocol||0
3057326|NCT01253135|3778034|FG000|NOT COMPLETED|Original Protocol||15
3057327|NCT01253135|3778034|FG000|STARTED|Amended Protocol||25
3057328|NCT01253135|3778034|FG000|COMPLETED|Amended Protocol||24
3057329|NCT01253135|3778034|FG000|NOT COMPLETED|Amended Protocol||1
3057330|NCT01253148|3778042|FG000|STARTED|Overall Study||25
3057331|NCT01253148|3778042|FG000|COMPLETED|Overall Study||25
3162138|NCT01877265|3889536|FG004|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0
3162139|NCT01877265|3889537|FG005|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0
3162140|NCT01877265|3889532|FG000|STARTED|Treatment Period 2||3
3162141|NCT01877265|3889533|FG001|STARTED|Treatment Period 2||3
3162142|NCT01877265|3889534|FG002|STARTED|Treatment Period 2||2
3162143|NCT01877265|3889535|FG003|STARTED|Treatment Period 2||3
3057332|NCT01253148|3778042|FG000|NOT COMPLETED|Overall Study||0
3057333|NCT01253174|3778046|FG000|STARTED|Period 1||6
3057334|NCT01253174|3778047|FG001|STARTED|Period 1||10
3057335|NCT01253174|3778048|FG002|STARTED|Period 1||9
3057336|NCT01253174|3778049|FG003|STARTED|Period 1||7
3057337|NCT01253174|3778050|FG004|STARTED|Period 1||9
3057338|NCT01253174|3778051|FG005|STARTED|Period 1||7
3057339|NCT01253174|3778046|FG000|COMPLETED|Period 1||6
3057340|NCT01253174|3778047|FG001|COMPLETED|Period 1||9
3057341|NCT01253174|3778048|FG002|COMPLETED|Period 1||8
3057342|NCT01253174|3778049|FG003|COMPLETED|Period 1||7
3057343|NCT01253174|3778050|FG004|COMPLETED|Period 1||8
3057344|NCT01253174|3778051|FG005|COMPLETED|Period 1||7
3057345|NCT01253174|3778046|FG000|NOT COMPLETED|Period 1||0
3057346|NCT01253174|3778047|FG001|NOT COMPLETED|Period 1||1
3057347|NCT01253174|3778048|FG002|NOT COMPLETED|Period 1||1
3057348|NCT01253174|3778049|FG003|NOT COMPLETED|Period 1||0
3057349|NCT01253174|3778050|FG004|NOT COMPLETED|Period 1||1
3162144|NCT01877265|3889536|FG004|STARTED|Treatment Period 2||3
3162145|NCT01877265|3889537|FG005|STARTED|Treatment Period 2||3
3162146|NCT01877265|3889532|FG000|Received at Least One Dose of Study Drug|Treatment Period 2||3
3162147|NCT01877265|3889533|FG001|Received at Least One Dose of Study Drug|Treatment Period 2||3
3162148|NCT01877265|3889534|FG002|Received at Least One Dose of Study Drug|Treatment Period 2||2
3162149|NCT01877265|3889535|FG003|Received at Least One Dose of Study Drug|Treatment Period 2||3
3057350|NCT01253174|3778051|FG005|NOT COMPLETED|Period 1||0
3057351|NCT01253174|3778046|FG000|STARTED|Period 2||6
3057352|NCT01253174|3778047|FG001|STARTED|Period 2||9
3057353|NCT01253174|3778048|FG002|STARTED|Period 2||8
3057354|NCT01253174|3778049|FG003|STARTED|Period 2||7
3057355|NCT01253174|3778050|FG004|STARTED|Period 2||8
3057356|NCT01253174|3778051|FG005|STARTED|Period 2||7
3057357|NCT01253174|3778046|FG000|COMPLETED|Period 2||6
3057358|NCT01253174|3778047|FG001|COMPLETED|Period 2||9
3057359|NCT01253174|3778048|FG002|COMPLETED|Period 2||7
3057360|NCT01253174|3778049|FG003|COMPLETED|Period 2||7
3057361|NCT01253174|3778050|FG004|COMPLETED|Period 2||8
3057362|NCT01253174|3778051|FG005|COMPLETED|Period 2||7
3057363|NCT01253174|3778046|FG000|NOT COMPLETED|Period 2||0
3057364|NCT01253174|3778047|FG001|NOT COMPLETED|Period 2||0
3057365|NCT01253174|3778048|FG002|NOT COMPLETED|Period 2||1
3057366|NCT01253174|3778049|FG003|NOT COMPLETED|Period 2||0
3057367|NCT01253174|3778050|FG004|NOT COMPLETED|Period 2||0
3057368|NCT01253174|3778051|FG005|NOT COMPLETED|Period 2||0
3057369|NCT01253174|3778046|FG000|STARTED|Period 3||6
3057370|NCT01253174|3778047|FG001|STARTED|Period 3||9
3057371|NCT01253174|3778048|FG002|STARTED|Period 3||7
3057372|NCT01253174|3778049|FG003|STARTED|Period 3||7
3057373|NCT01253174|3778050|FG004|STARTED|Period 3||8
3057374|NCT01253174|3778051|FG005|STARTED|Period 3||7
3057375|NCT01253174|3778046|FG000|COMPLETED|Period 3||6
3057376|NCT01253174|3778047|FG001|COMPLETED|Period 3||8
3057377|NCT01253174|3778048|FG002|COMPLETED|Period 3||6
3162150|NCT01877265|3889536|FG004|Received at Least One Dose of Study Drug|Treatment Period 2||3
3162151|NCT01877265|3889537|FG005|Received at Least One Dose of Study Drug|Treatment Period 2||3
3162152|NCT01877265|3889532|FG000|COMPLETED|Treatment Period 2||3
3162153|NCT01877265|3889533|FG001|COMPLETED|Treatment Period 2||3
3162154|NCT01877265|3889534|FG002|COMPLETED|Treatment Period 2||2
3162155|NCT01877265|3889535|FG003|COMPLETED|Treatment Period 2||3
3162156|NCT01877265|3889536|FG004|COMPLETED|Treatment Period 2||3
3162157|NCT01877265|3889537|FG005|COMPLETED|Treatment Period 2||3
3162158|NCT01877265|3889532|FG000|NOT COMPLETED|Treatment Period 2||0
3162159|NCT01877265|3889533|FG001|NOT COMPLETED|Treatment Period 2||0
3162160|NCT01877265|3889534|FG002|NOT COMPLETED|Treatment Period 2||0
3162161|NCT01877265|3889535|FG003|NOT COMPLETED|Treatment Period 2||0
3162162|NCT01877265|3889536|FG004|NOT COMPLETED|Treatment Period 2||0
3162163|NCT01877265|3889537|FG005|NOT COMPLETED|Treatment Period 2||0
3162164|NCT01877265|3889532|FG000|STARTED|Washout Period 2 (at Least 14 Days)||3
3162165|NCT01877265|3889533|FG001|STARTED|Washout Period 2 (at Least 14 Days)||3
3162166|NCT01877265|3889534|FG002|STARTED|Washout Period 2 (at Least 14 Days)||2
3162167|NCT01877265|3889535|FG003|STARTED|Washout Period 2 (at Least 14 Days)||3
3057378|NCT01253174|3778049|FG003|COMPLETED|Period 3||7
3057379|NCT01253174|3778050|FG004|COMPLETED|Period 3||7
3057380|NCT01253174|3778051|FG005|COMPLETED|Period 3||7
3162168|NCT01877265|3889536|FG004|STARTED|Washout Period 2 (at Least 14 Days)||3
3162169|NCT01877265|3889537|FG005|STARTED|Washout Period 2 (at Least 14 Days)||3
3283901|NCT02760264|4017705|FG001|COMPLETED|0.25 mg/kg/Day||0
3283902|NCT02760264|4017706|FG002|COMPLETED|0.25 mg/kg/Day||0
3283903|NCT02760264|4017707|FG003|COMPLETED|0.25 mg/kg/Day||0
3057381|NCT01253174|3778046|FG000|NOT COMPLETED|Period 3||0
3057382|NCT01253174|3778047|FG001|NOT COMPLETED|Period 3||1
3057383|NCT01253174|3778048|FG002|NOT COMPLETED|Period 3||1
3057384|NCT01253174|3778049|FG003|NOT COMPLETED|Period 3||0
3057385|NCT01253174|3778050|FG004|NOT COMPLETED|Period 3||1
3057386|NCT01253174|3778051|FG005|NOT COMPLETED|Period 3||0
3133972|NCT01698710|3858934|FG000|NOT COMPLETED|Overall Study||0
3283904|NCT02760264|4017704|FG000|NOT COMPLETED|0.25 mg/kg/Day||0
3162170|NCT01877265|3889532|FG000|COMPLETED|Washout Period 2 (at Least 14 Days)||3
3162171|NCT01877265|3889533|FG001|COMPLETED|Washout Period 2 (at Least 14 Days)||3
3162172|NCT01877265|3889534|FG002|COMPLETED|Washout Period 2 (at Least 14 Days)||2
3162173|NCT01877265|3889535|FG003|COMPLETED|Washout Period 2 (at Least 14 Days)||3
3162174|NCT01877265|3889536|FG004|COMPLETED|Washout Period 2 (at Least 14 Days)||3
3162175|NCT01877265|3889537|FG005|COMPLETED|Washout Period 2 (at Least 14 Days)||2
3162176|NCT01877265|3889532|FG000|NOT COMPLETED|Washout Period 2 (at Least 14 Days)||0
3162177|NCT01877265|3889533|FG001|NOT COMPLETED|Washout Period 2 (at Least 14 Days)||0
3162178|NCT01877265|3889534|FG002|NOT COMPLETED|Washout Period 2 (at Least 14 Days)||0
3162179|NCT01877265|3889535|FG003|NOT COMPLETED|Washout Period 2 (at Least 14 Days)||0
3162180|NCT01877265|3889536|FG004|NOT COMPLETED|Washout Period 2 (at Least 14 Days)||0
3162181|NCT01877265|3889537|FG005|NOT COMPLETED|Washout Period 2 (at Least 14 Days)||1
3162182|NCT01877265|3889532|FG000|STARTED|Treatment Period 3||3
3162183|NCT01877265|3889533|FG001|STARTED|Treatment Period 3||3
3162184|NCT01877265|3889534|FG002|STARTED|Treatment Period 3||2
3162185|NCT01877265|3889535|FG003|STARTED|Treatment Period 3||3
3162186|NCT01877265|3889536|FG004|STARTED|Treatment Period 3||3
3162187|NCT01877265|3889537|FG005|STARTED|Treatment Period 3||2
3162188|NCT01877265|3889532|FG000|Received at Least One Dose of Study Drug|Treatment Period 3||3
3162189|NCT01877265|3889533|FG001|Received at Least One Dose of Study Drug|Treatment Period 3||3
3162190|NCT01877265|3889534|FG002|Received at Least One Dose of Study Drug|Treatment Period 3||2
3162191|NCT01877265|3889535|FG003|Received at Least One Dose of Study Drug|Treatment Period 3||3
3162192|NCT01877265|3889536|FG004|Received at Least One Dose of Study Drug|Treatment Period 3||3
3162193|NCT01877265|3889537|FG005|Received at Least One Dose of Study Drug|Treatment Period 3||2
3162194|NCT01877265|3889532|FG000|COMPLETED|Treatment Period 3||2
3162195|NCT01877265|3889533|FG001|COMPLETED|Treatment Period 3||3
3162196|NCT01877265|3889534|FG002|COMPLETED|Treatment Period 3||2
3162197|NCT01877265|3889535|FG003|COMPLETED|Treatment Period 3||3
3162198|NCT01877265|3889536|FG004|COMPLETED|Treatment Period 3||3
3162199|NCT01877265|3889537|FG005|COMPLETED|Treatment Period 3||2
3162200|NCT01877265|3889532|FG000|NOT COMPLETED|Treatment Period 3||1
3162201|NCT01877265|3889533|FG001|NOT COMPLETED|Treatment Period 3||0
3162202|NCT01877265|3889534|FG002|NOT COMPLETED|Treatment Period 3||0
3162203|NCT01877265|3889535|FG003|NOT COMPLETED|Treatment Period 3||0
3162204|NCT01877265|3889536|FG004|NOT COMPLETED|Treatment Period 3||0
3162205|NCT01877265|3889537|FG005|NOT COMPLETED|Treatment Period 3||0
3162206|NCT01877278|3889550|FG000|STARTED|Overall Study||33
3162207|NCT01877278|3889551|FG001|STARTED|Overall Study||33
3162208|NCT01877278|3889550|FG000|COMPLETED|Overall Study||30
3162209|NCT01877278|3889551|FG001|COMPLETED|Overall Study||30
3162210|NCT01877278|3889550|FG000|NOT COMPLETED|Overall Study||3
3162211|NCT01877278|3889551|FG001|NOT COMPLETED|Overall Study||3
3162212|NCT01877408|3889559|FG000|STARTED|Overall Study||50
3162213|NCT01877408|3889560|FG001|STARTED|Overall Study||100
3162214|NCT01877408|3889559|FG000|COMPLETED|Overall Study|Completed follow up visit 28 days after procedure|50
3162215|NCT01877408|3889560|FG001|COMPLETED|Overall Study|Completed follow up visit 28 days after procedure|98
3162216|NCT01877408|3889559|FG000|NOT COMPLETED|Overall Study||0
3162217|NCT01877408|3889560|FG001|NOT COMPLETED|Overall Study||2
3162218|NCT01877421|3889599|FG000|STARTED|Phase 1||2
3162219|NCT01877421|3889600|FG001|STARTED|Phase 1||1
3162220|NCT01877421|3889601|FG002|STARTED|Phase 1||4
3162221|NCT01877421|3889602|FG003|STARTED|Phase 1||2
3162222|NCT01877421|3889603|FG004|STARTED|Phase 1||4
3162223|NCT01877421|3889604|FG005|STARTED|Phase 1||2
3162224|NCT01877421|3889605|FG006|STARTED|Phase 1||4
3162225|NCT01877421|3889606|FG007|STARTED|Phase 1||2
3162226|NCT01877421|3889607|FG008|STARTED|Phase 1||7
3162227|NCT01877421|3889608|FG009|STARTED|Phase 1||3
3162228|NCT01877421|3889609|FG010|STARTED|Phase 1||7
3162229|NCT01877421|3889610|FG011|STARTED|Phase 1||3
3162230|NCT01877421|3889611|FG012|STARTED|Phase 1||7
3162231|NCT01877421|3889612|FG013|STARTED|Phase 1||3
3162232|NCT01877421|3889613|FG014|STARTED|Phase 1||7
3162233|NCT01877421|3889614|FG015|STARTED|Phase 1||3
3162234|NCT01877421|3889615|FG016|STARTED|Phase 1||7
3162235|NCT01877421|3889616|FG017|STARTED|Phase 1||3
3162236|NCT01877421|3889599|FG000|COMPLETED|Phase 1||2
3162237|NCT01877421|3889600|FG001|COMPLETED|Phase 1||1
3162238|NCT01877421|3889601|FG002|COMPLETED|Phase 1||4
3162239|NCT01877421|3889602|FG003|COMPLETED|Phase 1||2
3162240|NCT01877421|3889603|FG004|COMPLETED|Phase 1||4
3162241|NCT01877421|3889604|FG005|COMPLETED|Phase 1||2
3162242|NCT01877421|3889605|FG006|COMPLETED|Phase 1||4
3162243|NCT01877421|3889606|FG007|COMPLETED|Phase 1||2
3162244|NCT01877421|3889607|FG008|COMPLETED|Phase 1||7
3162245|NCT01877421|3889608|FG009|COMPLETED|Phase 1||3
3162246|NCT01877421|3889609|FG010|COMPLETED|Phase 1||7
3162247|NCT01877421|3889610|FG011|COMPLETED|Phase 1||3
3162248|NCT01877421|3889611|FG012|COMPLETED|Phase 1||7
3162249|NCT01877421|3889612|FG013|COMPLETED|Phase 1||3
3162250|NCT01877421|3889613|FG014|COMPLETED|Phase 1||7
3162251|NCT01877421|3889614|FG015|COMPLETED|Phase 1||3
3162252|NCT01877421|3889615|FG016|COMPLETED|Phase 1||7
3162253|NCT01877421|3889616|FG017|COMPLETED|Phase 1||3
3162254|NCT01877421|3889599|FG000|NOT COMPLETED|Phase 1||0
3162255|NCT01877421|3889600|FG001|NOT COMPLETED|Phase 1||0
3162256|NCT01877421|3889601|FG002|NOT COMPLETED|Phase 1||0
3162257|NCT01877421|3889602|FG003|NOT COMPLETED|Phase 1||0
3162258|NCT01877421|3889603|FG004|NOT COMPLETED|Phase 1||0
3162259|NCT01877421|3889604|FG005|NOT COMPLETED|Phase 1||0
3162260|NCT01877421|3889605|FG006|NOT COMPLETED|Phase 1||0
3057387|NCT01253187|3778060|FG000|STARTED|Period 1||7
3057388|NCT01253187|3778061|FG001|STARTED|Period 1||8
3057389|NCT01253187|3778062|FG002|STARTED|Period 1||7
3057390|NCT01253187|3778063|FG003|STARTED|Period 1||7
3057391|NCT01253187|3778064|FG004|STARTED|Period 1||9
3057392|NCT01253187|3778065|FG005|STARTED|Period 1||6
3057393|NCT01253187|3778060|FG000|COMPLETED|Period 1||7
3057394|NCT01253187|3778061|FG001|COMPLETED|Period 1||8
3057395|NCT01253187|3778062|FG002|COMPLETED|Period 1||7
3162261|NCT01877421|3889606|FG007|NOT COMPLETED|Phase 1||0
3162262|NCT01877421|3889607|FG008|NOT COMPLETED|Phase 1||0
3162263|NCT01877421|3889608|FG009|NOT COMPLETED|Phase 1||0
3162264|NCT01877421|3889609|FG010|NOT COMPLETED|Phase 1||0
3162265|NCT01877421|3889610|FG011|NOT COMPLETED|Phase 1||0
3162266|NCT01877421|3889611|FG012|NOT COMPLETED|Phase 1||0
3162267|NCT01877421|3889612|FG013|NOT COMPLETED|Phase 1||0
3162268|NCT01877421|3889613|FG014|NOT COMPLETED|Phase 1||0
3162269|NCT01877421|3889614|FG015|NOT COMPLETED|Phase 1||0
3162270|NCT01877421|3889615|FG016|NOT COMPLETED|Phase 1||0
3162271|NCT01877421|3889616|FG017|NOT COMPLETED|Phase 1||0
3162272|NCT01877421|3889599|FG000|STARTED|Phase 2||0
3162273|NCT01877421|3889600|FG001|STARTED|Phase 2||0
3162274|NCT01877421|3889601|FG002|STARTED|Phase 2||4
3162275|NCT01877421|3889602|FG003|STARTED|Phase 2||2
3162276|NCT01877421|3889603|FG004|STARTED|Phase 2||7
3162277|NCT01877421|3889604|FG005|STARTED|Phase 2||3
3162278|NCT01877421|3889605|FG006|STARTED|Phase 2||7
3162279|NCT01877421|3889606|FG007|STARTED|Phase 2||2
3162280|NCT01877421|3889607|FG008|STARTED|Phase 2||6
3162281|NCT01877421|3889608|FG009|STARTED|Phase 2||3
3162282|NCT01877421|3889609|FG010|STARTED|Phase 2||7
3057396|NCT01253187|3778063|FG003|COMPLETED|Period 1||7
3057397|NCT01253187|3778064|FG004|COMPLETED|Period 1||9
3057398|NCT01253187|3778065|FG005|COMPLETED|Period 1||6
3057399|NCT01253187|3778060|FG000|NOT COMPLETED|Period 1||0
3057400|NCT01253187|3778061|FG001|NOT COMPLETED|Period 1||0
3057401|NCT01253187|3778062|FG002|NOT COMPLETED|Period 1||0
3057402|NCT01253187|3778063|FG003|NOT COMPLETED|Period 1||0
3057403|NCT01253187|3778064|FG004|NOT COMPLETED|Period 1||0
3057404|NCT01253187|3778065|FG005|NOT COMPLETED|Period 1||0
3057405|NCT01253187|3778060|FG000|STARTED|Period 2||7
3057406|NCT01253187|3778061|FG001|STARTED|Period 2||8
3057407|NCT01253187|3778062|FG002|STARTED|Period 2||7
3057408|NCT01253187|3778063|FG003|STARTED|Period 2||7
3057409|NCT01253187|3778064|FG004|STARTED|Period 2||9
3057410|NCT01253187|3778065|FG005|STARTED|Period 2||6
3057411|NCT01253187|3778060|FG000|COMPLETED|Period 2||7
3057412|NCT01253187|3778061|FG001|COMPLETED|Period 2||8
3057413|NCT01253187|3778062|FG002|COMPLETED|Period 2||7
3057414|NCT01253187|3778063|FG003|COMPLETED|Period 2||7
3057415|NCT01253187|3778064|FG004|COMPLETED|Period 2||8
3057416|NCT01253187|3778065|FG005|COMPLETED|Period 2||6
3057417|NCT01253187|3778060|FG000|NOT COMPLETED|Period 2||0
3057418|NCT01253187|3778061|FG001|NOT COMPLETED|Period 2||0
3057419|NCT01253187|3778062|FG002|NOT COMPLETED|Period 2||0
3057420|NCT01253187|3778063|FG003|NOT COMPLETED|Period 2||0
3057421|NCT01253187|3778064|FG004|NOT COMPLETED|Period 2||1
3057422|NCT01253187|3778065|FG005|NOT COMPLETED|Period 2||0
3057423|NCT01253187|3778060|FG000|STARTED|Period 3||7
3057424|NCT01253187|3778061|FG001|STARTED|Period 3||8
3057425|NCT01253187|3778062|FG002|STARTED|Period 3||7
3057426|NCT01253187|3778063|FG003|STARTED|Period 3||7
3057427|NCT01253187|3778064|FG004|STARTED|Period 3||8
3057428|NCT01253187|3778065|FG005|STARTED|Period 3||6
3057429|NCT01253187|3778060|FG000|COMPLETED|Period 3||6
3057430|NCT01253187|3778061|FG001|COMPLETED|Period 3||7
3057431|NCT01253187|3778062|FG002|COMPLETED|Period 3||7
3057432|NCT01253187|3778063|FG003|COMPLETED|Period 3||7
3057433|NCT01253187|3778064|FG004|COMPLETED|Period 3||7
3057434|NCT01253187|3778065|FG005|COMPLETED|Period 3||6
3057435|NCT01253187|3778060|FG000|NOT COMPLETED|Period 3||1
3057436|NCT01253187|3778061|FG001|NOT COMPLETED|Period 3||1
3057437|NCT01253187|3778062|FG002|NOT COMPLETED|Period 3||0
3057438|NCT01253187|3778063|FG003|NOT COMPLETED|Period 3||0
3057439|NCT01253187|3778064|FG004|NOT COMPLETED|Period 3||1
3057440|NCT01253187|3778065|FG005|NOT COMPLETED|Period 3||0
3057441|NCT01253200|3778081|FG000|STARTED|Overall Study||125
3057442|NCT01253200|3778082|FG001|STARTED|Overall Study||125
3057443|NCT01253200|3778083|FG002|STARTED|Overall Study||30
3057444|NCT01253200|3778084|FG003|STARTED|Overall Study||17
3057445|NCT01253200|3778085|FG004|STARTED|Overall Study||5
3057446|NCT01253200|3778081|FG000|Procedure|Overall Study||109
3057447|NCT01253200|3778082|FG001|Procedure|Overall Study||111
3057448|NCT01253200|3778083|FG002|Procedure|Overall Study||28
3057449|NCT01253200|3778084|FG003|Procedure|Overall Study||12
3057450|NCT01253200|3778085|FG004|Procedure|Overall Study||0
3057451|NCT01253200|3778081|FG000|10 Day Follow-up|Overall Study||106
3057452|NCT01253200|3778082|FG001|10 Day Follow-up|Overall Study||111
3057453|NCT01253200|3778083|FG002|10 Day Follow-up|Overall Study||28
3057454|NCT01253200|3778084|FG003|10 Day Follow-up|Overall Study||12
3057455|NCT01253200|3778085|FG004|10 Day Follow-up|Overall Study||0
3057456|NCT01253200|3778081|FG000|3 Month Follow-up|Overall Study||104
3057457|NCT01253200|3778082|FG001|3 Month Follow-up|Overall Study||106
3057458|NCT01253200|3778083|FG002|3 Month Follow-up|Overall Study||28
3162283|NCT01877421|3889610|FG011|STARTED|Phase 2||3
3162284|NCT01877421|3889611|FG012|STARTED|Phase 2||7
3162285|NCT01877421|3889612|FG013|STARTED|Phase 2||3
3162286|NCT01877421|3889613|FG014|STARTED|Phase 2||7
3162287|NCT01877421|3889614|FG015|STARTED|Phase 2||3
3057459|NCT01253200|3778084|FG003|3 Month Follow-up|Overall Study||12
3057460|NCT01253200|3778085|FG004|3 Month Follow-up|Overall Study||0
3057461|NCT01253200|3778081|FG000|COMPLETED|Overall Study||104
3057462|NCT01253200|3778082|FG001|COMPLETED|Overall Study||106
3057463|NCT01253200|3778083|FG002|COMPLETED|Overall Study||28
3057464|NCT01253200|3778084|FG003|COMPLETED|Overall Study||12
3057465|NCT01253200|3778085|FG004|COMPLETED|Overall Study||0
3057466|NCT01253200|3778081|FG000|NOT COMPLETED|Overall Study||21
3057467|NCT01253200|3778082|FG001|NOT COMPLETED|Overall Study||19
3057468|NCT01253200|3778083|FG002|NOT COMPLETED|Overall Study||2
3057469|NCT01253200|3778084|FG003|NOT COMPLETED|Overall Study||5
3057470|NCT01253200|3778085|FG004|NOT COMPLETED|Overall Study||5
3057471|NCT01253226|3778099|FG000|STARTED|Overall Study||6
3057472|NCT01253226|3778100|FG001|STARTED|Overall Study||6
3057473|NCT01253226|3778101|FG002|STARTED|Overall Study||6
3057474|NCT01253226|3778102|FG003|STARTED|Overall Study||6
3057475|NCT01253226|3778103|FG004|STARTED|Overall Study||8
3057476|NCT01253226|3778099|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6
3162288|NCT01877421|3889615|FG016|STARTED|Phase 2||0
3162289|NCT01877421|3889616|FG017|STARTED|Phase 2||0
3162290|NCT01877421|3889599|FG000|COMPLETED|Phase 2||0
3162291|NCT01877421|3889600|FG001|COMPLETED|Phase 2||0
3162292|NCT01877421|3889601|FG002|COMPLETED|Phase 2||4
3162293|NCT01877421|3889602|FG003|COMPLETED|Phase 2||2
3162294|NCT01877421|3889603|FG004|COMPLETED|Phase 2||7
3162295|NCT01877421|3889604|FG005|COMPLETED|Phase 2||3
3162296|NCT01877421|3889605|FG006|COMPLETED|Phase 2||6
3162297|NCT01877421|3889606|FG007|COMPLETED|Phase 2||2
3162298|NCT01877421|3889607|FG008|COMPLETED|Phase 2||5
3162299|NCT01877421|3889608|FG009|COMPLETED|Phase 2||3
3057477|NCT01253226|3778100|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6
3057478|NCT01253226|3778101|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
3057479|NCT01253226|3778102|FG003|Received at Least 1 Dose of Study Drug|Overall Study||6
3057480|NCT01253226|3778103|FG004|Received at Least 1 Dose of Study Drug|Overall Study||8
3057481|NCT01253226|3778099|FG000|COMPLETED|Overall Study||6
3057482|NCT01253226|3778100|FG001|COMPLETED|Overall Study||5
3057483|NCT01253226|3778101|FG002|COMPLETED|Overall Study||5
3057484|NCT01253226|3778102|FG003|COMPLETED|Overall Study||5
3057485|NCT01253226|3778103|FG004|COMPLETED|Overall Study||6
3057486|NCT01253226|3778099|FG000|NOT COMPLETED|Overall Study||0
3057487|NCT01253226|3778100|FG001|NOT COMPLETED|Overall Study||1
3057488|NCT01253226|3778101|FG002|NOT COMPLETED|Overall Study||1
3057489|NCT01253226|3778102|FG003|NOT COMPLETED|Overall Study||1
3057490|NCT01253226|3778103|FG004|NOT COMPLETED|Overall Study||2
3283905|NCT02760264|4017705|FG001|NOT COMPLETED|0.25 mg/kg/Day||0
3283906|NCT02760264|4017706|FG002|NOT COMPLETED|0.25 mg/kg/Day||0
3283907|NCT02760264|4017707|FG003|NOT COMPLETED|0.25 mg/kg/Day||0
3283908|NCT02760264|4017704|FG000|STARTED|0.75 mg/kg/Day||0
3283909|NCT02760264|4017705|FG001|STARTED|0.75 mg/kg/Day||12
3283910|NCT02760264|4017706|FG002|STARTED|0.75 mg/kg/Day||0
3283911|NCT02760264|4017707|FG003|STARTED|0.75 mg/kg/Day||0
3283912|NCT02760264|4017704|FG000|COMPLETED|0.75 mg/kg/Day||0
3283913|NCT02760264|4017705|FG001|COMPLETED|0.75 mg/kg/Day||12
3283914|NCT02760264|4017706|FG002|COMPLETED|0.75 mg/kg/Day||0
3283915|NCT02760264|4017707|FG003|COMPLETED|0.75 mg/kg/Day||0
3283916|NCT02760264|4017704|FG000|NOT COMPLETED|0.75 mg/kg/Day||0
3057491|NCT01253265|3778120|FG000|STARTED|Overall Study||6
3057492|NCT01253265|3778121|FG001|STARTED|Overall Study||6
3057493|NCT01253265|3778122|FG002|STARTED|Overall Study||6
3057494|NCT01253265|3778123|FG003|STARTED|Overall Study||6
3057495|NCT01253265|3778124|FG004|STARTED|Overall Study||8
3057496|NCT01253265|3778120|FG000|COMPLETED|Overall Study||5
3057497|NCT01253265|3778121|FG001|COMPLETED|Overall Study||6
3057498|NCT01253265|3778122|FG002|COMPLETED|Overall Study||6
3057499|NCT01253265|3778123|FG003|COMPLETED|Overall Study||6
3057500|NCT01253265|3778124|FG004|COMPLETED|Overall Study||7
3057501|NCT01253265|3778120|FG000|NOT COMPLETED|Overall Study||1
3057502|NCT01253265|3778121|FG001|NOT COMPLETED|Overall Study||0
3057503|NCT01253265|3778122|FG002|NOT COMPLETED|Overall Study||0
3057504|NCT01253265|3778123|FG003|NOT COMPLETED|Overall Study||0
3057505|NCT01253265|3778124|FG004|NOT COMPLETED|Overall Study||1
3057506|NCT01253291|3778141|FG000|STARTED|Overall Study||6
3057507|NCT01253291|3778142|FG001|STARTED|Overall Study||6
3057508|NCT01253291|3778143|FG002|STARTED|Overall Study||4
3057509|NCT01253291|3778144|FG003|STARTED|Overall Study||5
3057510|NCT01253291|3778145|FG004|STARTED|Overall Study||5
3057511|NCT01253291|3778141|FG000|Received Study Drug During BCDL|Overall Study||6
3057512|NCT01253291|3778142|FG001|Received Study Drug During BCDL|Overall Study||6
3057513|NCT01253291|3778143|FG002|Received Study Drug During BCDL|Overall Study||4
3057514|NCT01253291|3778144|FG003|Received Study Drug During BCDL|Overall Study||5
3057515|NCT01253291|3778145|FG004|Received Study Drug During BCDL|Overall Study||5
3057516|NCT01253291|3778141|FG000|COMPLETED|Overall Study||2
3057517|NCT01253291|3778142|FG001|COMPLETED|Overall Study||4
3162300|NCT01877421|3889609|FG010|COMPLETED|Phase 2||5
3162301|NCT01877421|3889610|FG011|COMPLETED|Phase 2||3
3162302|NCT01877421|3889611|FG012|COMPLETED|Phase 2||6
3162303|NCT01877421|3889612|FG013|COMPLETED|Phase 2||3
3162304|NCT01877421|3889613|FG014|COMPLETED|Phase 2||7
3162305|NCT01877421|3889614|FG015|COMPLETED|Phase 2||2
3162306|NCT01877421|3889615|FG016|COMPLETED|Phase 2||0
3283917|NCT02760264|4017705|FG001|NOT COMPLETED|0.75 mg/kg/Day||0
3283918|NCT02760264|4017706|FG002|NOT COMPLETED|0.75 mg/kg/Day||0
3283919|NCT02760264|4017707|FG003|NOT COMPLETED|0.75 mg/kg/Day||0
3057518|NCT01253291|3778143|FG002|COMPLETED|Overall Study||4
3057519|NCT01253291|3778144|FG003|COMPLETED|Overall Study||5
3057520|NCT01253291|3778145|FG004|COMPLETED|Overall Study||3
3162307|NCT01877421|3889616|FG017|COMPLETED|Phase 2||0
3162308|NCT01877421|3889599|FG000|NOT COMPLETED|Phase 2||0
3162309|NCT01877421|3889600|FG001|NOT COMPLETED|Phase 2||0
3162310|NCT01877421|3889601|FG002|NOT COMPLETED|Phase 2||0
3162311|NCT01877421|3889602|FG003|NOT COMPLETED|Phase 2||0
3283920|NCT02760264|4017704|FG000|STARTED|2.0 mg/kg/Day||0
3057521|NCT01253291|3778141|FG000|NOT COMPLETED|Overall Study||4
3057522|NCT01253291|3778142|FG001|NOT COMPLETED|Overall Study||2
3057523|NCT01253291|3778143|FG002|NOT COMPLETED|Overall Study||0
3057524|NCT01253291|3778144|FG003|NOT COMPLETED|Overall Study||0
3057525|NCT01253291|3778145|FG004|NOT COMPLETED|Overall Study||2
3057526|NCT01253304|3778162|FG000|STARTED|Overall Study||11
3057527|NCT01253304|3778163|FG001|STARTED|Overall Study||6
3057528|NCT01253304|3778164|FG002|STARTED|Overall Study||6
3057529|NCT01253304|3778165|FG003|STARTED|Overall Study||3
3057530|NCT01253304|3778162|FG000|Received at Least 1 Dose of Study Drug|Overall Study||11
3057531|NCT01253304|3778163|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6
3057532|NCT01253304|3778164|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
3057533|NCT01253304|3778165|FG003|Received at Least 1 Dose of Study Drug|Overall Study||3
3057534|NCT01253304|3778162|FG000|COMPLETED|Overall Study||11
3057535|NCT01253304|3778163|FG001|COMPLETED|Overall Study||6
3057536|NCT01253304|3778164|FG002|COMPLETED|Overall Study||6
3057537|NCT01253304|3778165|FG003|COMPLETED|Overall Study||2
3057538|NCT01253304|3778162|FG000|NOT COMPLETED|Overall Study||0
3057539|NCT01253304|3778163|FG001|NOT COMPLETED|Overall Study||0
3057540|NCT01253304|3778164|FG002|NOT COMPLETED|Overall Study||0
3057541|NCT01253304|3778165|FG003|NOT COMPLETED|Overall Study||1
3057542|NCT01253317|3778175|FG000|STARTED|Overall Study||12
3057543|NCT01253317|3778175|FG000|COMPLETED|Overall Study||10
3057544|NCT01253317|3778175|FG000|NOT COMPLETED|Overall Study||2
3057545|NCT01253343|3778185|FG000|STARTED|Overall Study||9
3057546|NCT01253343|3778186|FG001|STARTED|Overall Study||8
3057547|NCT01253343|3778185|FG000|COMPLETED|Overall Study||9
3057548|NCT01253343|3778186|FG001|COMPLETED|Overall Study||8
3057549|NCT01253343|3778185|FG000|NOT COMPLETED|Overall Study||0
3057550|NCT01253343|3778186|FG001|NOT COMPLETED|Overall Study||0
3057551|NCT01253369|3778208|FG000|STARTED|Overall Study||33
3057552|NCT01253369|3778208|FG000|Evaluable|Overall Study|Evaluable pts were w/ measurable disease, min 1 cycle of trt rcvd and 1 on-trt disease assessment.|30
3057553|NCT01253369|3778208|FG000|COMPLETED|Overall Study|Since treatment duration was not fixed, patients were not considered to have completed treatment.|0
3283921|NCT02760264|4017705|FG001|STARTED|2.0 mg/kg/Day||0
3283922|NCT02760264|4017706|FG002|STARTED|2.0 mg/kg/Day||12
3057554|NCT01253369|3778208|FG000|NOT COMPLETED|Overall Study||33
3057555|NCT01253408|3778215|FG000|STARTED|Overall Study||10
3057556|NCT01253408|3778216|FG001|STARTED|Overall Study||13
3057557|NCT01253408|3778217|FG002|STARTED|Overall Study||13
3057558|NCT01253408|3778215|FG000|COMPLETED|Overall Study||10
3057559|NCT01253408|3778216|FG001|COMPLETED|Overall Study||12
3057560|NCT01253408|3778217|FG002|COMPLETED|Overall Study||13
3057561|NCT01253408|3778215|FG000|NOT COMPLETED|Overall Study||0
3057562|NCT01253408|3778216|FG001|NOT COMPLETED|Overall Study||1
3057563|NCT01253408|3778217|FG002|NOT COMPLETED|Overall Study||0
3057564|NCT01253421|3778229|FG000|STARTED|Assessment and Scheduling||159
3057565|NCT01253421|3778230|FG001|STARTED|Assessment and Scheduling|Arm has no participants until randomization.|0
3057566|NCT01253421|3778231|FG002|STARTED|Assessment and Scheduling|Arm has no participants until randomization.|0
3057567|NCT01253421|3778232|FG003|STARTED|Assessment and Scheduling|Arm has no participants until randomization.|0
3057568|NCT01253421|3778233|FG004|STARTED|Assessment and Scheduling|Arm has no participants until randomization.|0
3057569|NCT01253421|3778229|FG000|Eligible After Screening Visit|Assessment and Scheduling||85
3057570|NCT01253421|3778230|FG001|Eligible After Screening Visit|Assessment and Scheduling||0
3057571|NCT01253421|3778231|FG002|Eligible After Screening Visit|Assessment and Scheduling||0
3057572|NCT01253421|3778232|FG003|Eligible After Screening Visit|Assessment and Scheduling||0
3057573|NCT01253421|3778233|FG004|Eligible After Screening Visit|Assessment and Scheduling||0
3057574|NCT01253421|3778229|FG000|Returned for Drug+Scanning Visit|Assessment and Scheduling||60
3057575|NCT01253421|3778230|FG001|Returned for Drug+Scanning Visit|Assessment and Scheduling||0
3057576|NCT01253421|3778231|FG002|Returned for Drug+Scanning Visit|Assessment and Scheduling||0
3057577|NCT01253421|3778232|FG003|Returned for Drug+Scanning Visit|Assessment and Scheduling||0
3057578|NCT01253421|3778233|FG004|Returned for Drug+Scanning Visit|Assessment and Scheduling||0
3057579|NCT01253421|3778229|FG000|COMPLETED|Assessment and Scheduling||60
3057580|NCT01253421|3778230|FG001|COMPLETED|Assessment and Scheduling||0
3057581|NCT01253421|3778231|FG002|COMPLETED|Assessment and Scheduling||0
3057582|NCT01253421|3778232|FG003|COMPLETED|Assessment and Scheduling||0
3057583|NCT01253421|3778233|FG004|COMPLETED|Assessment and Scheduling||0
3057584|NCT01253421|3778229|FG000|NOT COMPLETED|Assessment and Scheduling||99
3057585|NCT01253421|3778230|FG001|NOT COMPLETED|Assessment and Scheduling||0
3057586|NCT01253421|3778231|FG002|NOT COMPLETED|Assessment and Scheduling||0
3057587|NCT01253421|3778232|FG003|NOT COMPLETED|Assessment and Scheduling||0
3057588|NCT01253421|3778233|FG004|NOT COMPLETED|Assessment and Scheduling||0
3133973|NCT01698775|3858940|FG000|STARTED|Phase A||107
3162312|NCT01877421|3889603|FG004|NOT COMPLETED|Phase 2||0
3283923|NCT02760264|4017707|FG003|STARTED|2.0 mg/kg/Day||0
3057589|NCT01253421|3778229|FG000|STARTED|Drug+Scanning Visit|Arm has no participants once randomization has occurred.|0
3057590|NCT01253421|3778230|FG001|STARTED|Drug+Scanning Visit||15
3057591|NCT01253421|3778231|FG002|STARTED|Drug+Scanning Visit||14
3057592|NCT01253421|3778232|FG003|STARTED|Drug+Scanning Visit||16
3057593|NCT01253421|3778233|FG004|STARTED|Drug+Scanning Visit||15
3057594|NCT01253421|3778229|FG000|Received Drug Challenge|Drug+Scanning Visit||0
3057595|NCT01253421|3778230|FG001|Received Drug Challenge|Drug+Scanning Visit||15
3162313|NCT01877421|3889604|FG005|NOT COMPLETED|Phase 2||0
3162314|NCT01877421|3889605|FG006|NOT COMPLETED|Phase 2||1
3162315|NCT01877421|3889606|FG007|NOT COMPLETED|Phase 2||0
3057596|NCT01253421|3778231|FG002|Received Drug Challenge|Drug+Scanning Visit||14
3057597|NCT01253421|3778232|FG003|Received Drug Challenge|Drug+Scanning Visit||16
3057598|NCT01253421|3778233|FG004|Received Drug Challenge|Drug+Scanning Visit||15
3057599|NCT01253421|3778229|FG000|COMPLETED|Drug+Scanning Visit||0
3057600|NCT01253421|3778230|FG001|COMPLETED|Drug+Scanning Visit||15
3057601|NCT01253421|3778231|FG002|COMPLETED|Drug+Scanning Visit||14
3057602|NCT01253421|3778232|FG003|COMPLETED|Drug+Scanning Visit||16
3057603|NCT01253421|3778233|FG004|COMPLETED|Drug+Scanning Visit||14
3057604|NCT01253421|3778229|FG000|NOT COMPLETED|Drug+Scanning Visit||0
3057605|NCT01253421|3778230|FG001|NOT COMPLETED|Drug+Scanning Visit||0
3057606|NCT01253421|3778231|FG002|NOT COMPLETED|Drug+Scanning Visit||0
3057607|NCT01253421|3778232|FG003|NOT COMPLETED|Drug+Scanning Visit||0
3057608|NCT01253421|3778233|FG004|NOT COMPLETED|Drug+Scanning Visit||1
3057609|NCT01253447|3778243|FG000|STARTED|Overall Study||19
3057610|NCT01253447|3778243|FG000|COMPLETED|Overall Study||17
3057611|NCT01253447|3778243|FG000|NOT COMPLETED|Overall Study||2
3057612|NCT01253460|3778248|FG000|STARTED|Overall Study||18
3057613|NCT01253460|3778248|FG000|COMPLETED|Overall Study||18
3057614|NCT01253460|3778248|FG000|NOT COMPLETED|Overall Study||0
3057615|NCT01253525|3778252|FG000|STARTED|Overall Study||6
3057616|NCT01253525|3778252|FG000|Received Any Quantity of Study Drug|Overall Study||6
3057617|NCT01253525|3778252|FG000|COMPLETED|Overall Study||6
3057618|NCT01253525|3778252|FG000|NOT COMPLETED|Overall Study||0
3057619|NCT01253564|3778256|FG000|STARTED|Overall Study||24
3057620|NCT01253564|3778256|FG000|COMPLETED|Overall Study||0
3057621|NCT01253564|3778256|FG000|NOT COMPLETED|Overall Study||24
3057622|NCT01253577|3778260|FG000|STARTED|Overall Study||105
3057623|NCT01253577|3778260|FG000|COMPLETED|Overall Study||102
3057624|NCT01253577|3778260|FG000|NOT COMPLETED|Overall Study||3
3057625|NCT01253642|3778266|FG000|STARTED|Overall Study||11
3057626|NCT01253642|3778266|FG000|COMPLETED|Overall Study||6
3057627|NCT01253642|3778266|FG000|NOT COMPLETED|Overall Study||5
3057628|NCT01253811|3778271|FG000|STARTED|Overall Study||6
3057629|NCT01253811|3778271|FG000|Exposed|Overall Study||6
3057630|NCT01253811|3778271|FG000|COMPLETED|Overall Study||5
3057631|NCT01253811|3778271|FG000|NOT COMPLETED|Overall Study||1
3057632|NCT01253824|3778277|FG000|STARTED|Overall Study||7
3057633|NCT01253824|3778278|FG001|STARTED|Overall Study||7
3057634|NCT01253824|3778277|FG000|COMPLETED|Overall Study||7
3057635|NCT01253824|3778278|FG001|COMPLETED|Overall Study||7
3057636|NCT01253824|3778277|FG000|NOT COMPLETED|Overall Study||0
3057637|NCT01253824|3778278|FG001|NOT COMPLETED|Overall Study||0
3057638|NCT01253902|3778287|FG000|STARTED|Overall Study||56
3057639|NCT01253902|3778288|FG001|STARTED|Overall Study||53
3057640|NCT01253902|3778289|FG002|STARTED|Overall Study||55
3057641|NCT01253902|3778287|FG000|COMPLETED|Overall Study||51
3057642|NCT01253902|3778288|FG001|COMPLETED|Overall Study||51
3057643|NCT01253902|3778289|FG002|COMPLETED|Overall Study||51
3057644|NCT01253902|3778287|FG000|NOT COMPLETED|Overall Study||5
3057645|NCT01253902|3778288|FG001|NOT COMPLETED|Overall Study||2
3057646|NCT01253902|3778289|FG002|NOT COMPLETED|Overall Study||4
3057647|NCT01253980|3778299|FG000|STARTED|Overall Study||35
3057648|NCT01253980|3778300|FG001|STARTED|Overall Study||39
3057649|NCT01253980|3778299|FG000|COMPLETED|Overall Study||35
3057650|NCT01253980|3778300|FG001|COMPLETED|Overall Study||39
3057651|NCT01253980|3778299|FG000|NOT COMPLETED|Overall Study||0
3057652|NCT01253980|3778300|FG001|NOT COMPLETED|Overall Study||0
3283924|NCT02760264|4017704|FG000|COMPLETED|2.0 mg/kg/Day||0
3283925|NCT02760264|4017705|FG001|COMPLETED|2.0 mg/kg/Day||0
3283926|NCT02760264|4017706|FG002|COMPLETED|2.0 mg/kg/Day||12
3283927|NCT02760264|4017707|FG003|COMPLETED|2.0 mg/kg/Day||0
3283928|NCT02760264|4017704|FG000|NOT COMPLETED|2.0 mg/kg/Day||0
3283929|NCT02760264|4017705|FG001|NOT COMPLETED|2.0 mg/kg/Day||0
3283930|NCT02760264|4017706|FG002|NOT COMPLETED|2.0 mg/kg/Day||0
3283931|NCT02760264|4017707|FG003|NOT COMPLETED|2.0 mg/kg/Day||0
3283932|NCT02760264|4017704|FG000|STARTED|6.0 mg/kg/Day||0
3283933|NCT02760264|4017705|FG001|STARTED|6.0 mg/kg/Day||0
3283934|NCT02760264|4017706|FG002|STARTED|6.0 mg/kg/Day||0
3283935|NCT02760264|4017707|FG003|STARTED|6.0 mg/kg/Day||12
3283936|NCT02760264|4017704|FG000|COMPLETED|6.0 mg/kg/Day||0
3283937|NCT02760264|4017705|FG001|COMPLETED|6.0 mg/kg/Day||0
3283938|NCT02760264|4017706|FG002|COMPLETED|6.0 mg/kg/Day||0
3283939|NCT02760264|4017707|FG003|COMPLETED|6.0 mg/kg/Day||12
3057653|NCT01254019|3778308|FG000|STARTED|Overall Study||61
3057654|NCT01254019|3778309|FG001|STARTED|Overall Study||125
3162316|NCT01877421|3889607|FG008|NOT COMPLETED|Phase 2||1
3283940|NCT02760264|4017704|FG000|NOT COMPLETED|6.0 mg/kg/Day||0
3283941|NCT02760264|4017705|FG001|NOT COMPLETED|6.0 mg/kg/Day||0
3283942|NCT02760264|4017706|FG002|NOT COMPLETED|6.0 mg/kg/Day||0
3283943|NCT02760264|4017707|FG003|NOT COMPLETED|6.0 mg/kg/Day||0
3283944|NCT02760277|4017722|FG000|STARTED|Vamorolone 0.25 mg/kg/Day||12
3283945|NCT02760277|4017723|FG001|STARTED|Vamorolone 0.25 mg/kg/Day||0
3283946|NCT02760277|4017724|FG002|STARTED|Vamorolone 0.25 mg/kg/Day||0
3283947|NCT02760277|4017725|FG003|STARTED|Vamorolone 0.25 mg/kg/Day||0
3283948|NCT02760277|4017722|FG000|COMPLETED|Vamorolone 0.25 mg/kg/Day||12
3283949|NCT02760277|4017723|FG001|COMPLETED|Vamorolone 0.25 mg/kg/Day||0
3283950|NCT02760277|4017724|FG002|COMPLETED|Vamorolone 0.25 mg/kg/Day||0
3283951|NCT02760277|4017725|FG003|COMPLETED|Vamorolone 0.25 mg/kg/Day||0
3283952|NCT02760277|4017722|FG000|NOT COMPLETED|Vamorolone 0.25 mg/kg/Day||0
3283953|NCT02760277|4017723|FG001|NOT COMPLETED|Vamorolone 0.25 mg/kg/Day||0
3283954|NCT02760277|4017724|FG002|NOT COMPLETED|Vamorolone 0.25 mg/kg/Day||0
3283955|NCT02760277|4017725|FG003|NOT COMPLETED|Vamorolone 0.25 mg/kg/Day||0
3283956|NCT02760277|4017722|FG000|STARTED|0.75 mg/kg/Day||0
3283957|NCT02760277|4017723|FG001|STARTED|0.75 mg/kg/Day||12
3283958|NCT02760277|4017724|FG002|STARTED|0.75 mg/kg/Day||0
3283959|NCT02760277|4017725|FG003|STARTED|0.75 mg/kg/Day||0
3283960|NCT02760277|4017722|FG000|COMPLETED|0.75 mg/kg/Day||0
3057655|NCT01254019|3778308|FG000|COMPLETED|Overall Study||60
3057656|NCT01254019|3778309|FG001|COMPLETED|Overall Study||121
3057657|NCT01254019|3778308|FG000|NOT COMPLETED|Overall Study||1
3057658|NCT01254019|3778309|FG001|NOT COMPLETED|Overall Study||4
3057659|NCT01254045|3778318|FG000|STARTED|First/Baseline (1 Day at Week 1 )|One completed all baseline measures including administration of placebo, but then lost to follow-up.|2
3057660|NCT01254045|3778319|FG001|STARTED|First/Baseline (1 Day at Week 1 )||2
3057661|NCT01254045|3778320|FG002|STARTED|First/Baseline (1 Day at Week 1 )||2
3057662|NCT01254045|3778321|FG003|STARTED|First/Baseline (1 Day at Week 1 )||1
3057663|NCT01254045|3778322|FG004|STARTED|First/Baseline (1 Day at Week 1 )||1
3057664|NCT01254045|3778323|FG005|STARTED|First/Baseline (1 Day at Week 1 )||1
3057665|NCT01254045|3778318|FG000|COMPLETED|First/Baseline (1 Day at Week 1 )||1
3057666|NCT01254045|3778319|FG001|COMPLETED|First/Baseline (1 Day at Week 1 )||2
3057667|NCT01254045|3778320|FG002|COMPLETED|First/Baseline (1 Day at Week 1 )||2
3057668|NCT01254045|3778321|FG003|COMPLETED|First/Baseline (1 Day at Week 1 )||1
3057669|NCT01254045|3778322|FG004|COMPLETED|First/Baseline (1 Day at Week 1 )||1
3057670|NCT01254045|3778323|FG005|COMPLETED|First/Baseline (1 Day at Week 1 )||1
3057671|NCT01254045|3778318|FG000|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||1
3057672|NCT01254045|3778319|FG001|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||0
3057673|NCT01254045|3778320|FG002|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||0
3057674|NCT01254045|3778321|FG003|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||0
3057675|NCT01254045|3778322|FG004|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||0
3057676|NCT01254045|3778323|FG005|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||0
3057677|NCT01254045|3778318|FG000|STARTED|Second/Time 2 (1 Day at Week 2)||1
3057678|NCT01254045|3778319|FG001|STARTED|Second/Time 2 (1 Day at Week 2)||2
3057679|NCT01254045|3778320|FG002|STARTED|Second/Time 2 (1 Day at Week 2)||2
3057680|NCT01254045|3778321|FG003|STARTED|Second/Time 2 (1 Day at Week 2)||1
3057681|NCT01254045|3778322|FG004|STARTED|Second/Time 2 (1 Day at Week 2)||1
3057682|NCT01254045|3778323|FG005|STARTED|Second/Time 2 (1 Day at Week 2)||1
3057683|NCT01254045|3778318|FG000|COMPLETED|Second/Time 2 (1 Day at Week 2)||1
3057684|NCT01254045|3778319|FG001|COMPLETED|Second/Time 2 (1 Day at Week 2)||2
3057685|NCT01254045|3778320|FG002|COMPLETED|Second/Time 2 (1 Day at Week 2)||2
3057686|NCT01254045|3778321|FG003|COMPLETED|Second/Time 2 (1 Day at Week 2)||1
3057687|NCT01254045|3778322|FG004|COMPLETED|Second/Time 2 (1 Day at Week 2)||1
3057688|NCT01254045|3778323|FG005|COMPLETED|Second/Time 2 (1 Day at Week 2)||1
3057689|NCT01254045|3778318|FG000|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
3057690|NCT01254045|3778319|FG001|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
3057691|NCT01254045|3778320|FG002|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
3057692|NCT01254045|3778321|FG003|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
3057693|NCT01254045|3778322|FG004|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
3057694|NCT01254045|3778323|FG005|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
3057695|NCT01254045|3778318|FG000|STARTED|Third/Time 3 (1 Day at Week 3)||1
3057696|NCT01254045|3778319|FG001|STARTED|Third/Time 3 (1 Day at Week 3)||2
3057697|NCT01254045|3778320|FG002|STARTED|Third/Time 3 (1 Day at Week 3)||2
3057698|NCT01254045|3778321|FG003|STARTED|Third/Time 3 (1 Day at Week 3)||1
3057699|NCT01254045|3778322|FG004|STARTED|Third/Time 3 (1 Day at Week 3)||1
3057700|NCT01254045|3778323|FG005|STARTED|Third/Time 3 (1 Day at Week 3)||1
3057701|NCT01254045|3778318|FG000|COMPLETED|Third/Time 3 (1 Day at Week 3)||1
3057702|NCT01254045|3778319|FG001|COMPLETED|Third/Time 3 (1 Day at Week 3)||2
3057703|NCT01254045|3778320|FG002|COMPLETED|Third/Time 3 (1 Day at Week 3)||2
3057704|NCT01254045|3778321|FG003|COMPLETED|Third/Time 3 (1 Day at Week 3)||1
3057705|NCT01254045|3778322|FG004|COMPLETED|Third/Time 3 (1 Day at Week 3)||1
3057706|NCT01254045|3778323|FG005|COMPLETED|Third/Time 3 (1 Day at Week 3)||1
3057707|NCT01254045|3778318|FG000|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
3057708|NCT01254045|3778319|FG001|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
3057709|NCT01254045|3778320|FG002|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
3057710|NCT01254045|3778321|FG003|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
3057711|NCT01254045|3778322|FG004|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
3057712|NCT01254045|3778323|FG005|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
3057713|NCT01254188|3778333|FG000|STARTED|Overall Study||421
3057714|NCT01254188|3778333|FG000|COMPLETED|Overall Study||328
3057715|NCT01254188|3778333|FG000|NOT COMPLETED|Overall Study||93
3057716|NCT01254214|3778339|FG000|STARTED|Overall Study||27
3057717|NCT01254214|3778340|FG001|STARTED|Overall Study||28
3057718|NCT01254214|3778339|FG000|COMPLETED|Overall Study||24
3057719|NCT01254214|3778340|FG001|COMPLETED|Overall Study||27
3057720|NCT01254214|3778339|FG000|NOT COMPLETED|Overall Study||3
3057721|NCT01254214|3778340|FG001|NOT COMPLETED|Overall Study||1
3057722|NCT01254227|3778346|FG000|STARTED|Overall Study||60
3057723|NCT01254227|3778346|FG000|Completion of 12 Months|Overall Study||39
3057724|NCT01254227|3778346|FG000|Completion of 24 Months|Overall Study||34
3057725|NCT01254227|3778346|FG000|COMPLETED|Overall Study||34
3057726|NCT01254227|3778346|FG000|NOT COMPLETED|Overall Study||26
3057727|NCT01254292|3778352|FG000|STARTED|Comparative Phase||282
3057728|NCT01254292|3778353|FG001|STARTED|Comparative Phase||285
3057729|NCT01254292|3778352|FG000|Participants Received Treatment|Comparative Phase|safety population|279
3057730|NCT01254292|3778353|FG001|Participants Received Treatment|Comparative Phase|safety population|281
3057731|NCT01254292|3778352|FG000|COMPLETED|Comparative Phase||227
3057732|NCT01254292|3778353|FG001|COMPLETED|Comparative Phase||204
3057733|NCT01254292|3778352|FG000|NOT COMPLETED|Comparative Phase||55
3057734|NCT01254292|3778353|FG001|NOT COMPLETED|Comparative Phase||81
3057735|NCT01254292|3778352|FG000|STARTED|LCS12 Extension Phase|A total of 200 participants elected to enter this optional Extension Phase.|200
3057736|NCT01254292|3778353|FG001|STARTED|LCS12 Extension Phase|Optional Extension Phase was for LCS12 group only.|0
3057737|NCT01254292|3778352|FG000|COMPLETED|LCS12 Extension Phase||163
3057738|NCT01254292|3778353|FG001|COMPLETED|LCS12 Extension Phase||0
3057739|NCT01254292|3778352|FG000|NOT COMPLETED|LCS12 Extension Phase||37
3057740|NCT01254292|3778353|FG001|NOT COMPLETED|LCS12 Extension Phase||0
3057741|NCT01254305|3778363|FG000|STARTED|Overall Study||93
3057742|NCT01254305|3778364|FG001|STARTED|Overall Study||90
3057743|NCT01254305|3778365|FG002|STARTED|Overall Study||79
3057744|NCT01254305|3778363|FG000|Safety Population|Overall Study||89
3057745|NCT01254305|3778364|FG001|Safety Population|Overall Study||85
3057746|NCT01254305|3778365|FG002|Safety Population|Overall Study||77
3057747|NCT01254305|3778363|FG000|COMPLETED|Overall Study||71
3057748|NCT01254305|3778364|FG001|COMPLETED|Overall Study||72
3057749|NCT01254305|3778365|FG002|COMPLETED|Overall Study||62
3162317|NCT01877421|3889608|FG009|NOT COMPLETED|Phase 2||0
3162318|NCT01877421|3889609|FG010|NOT COMPLETED|Phase 2||2
3162319|NCT01877421|3889610|FG011|NOT COMPLETED|Phase 2||0
3057750|NCT01254305|3778363|FG000|NOT COMPLETED|Overall Study||22
3057751|NCT01254305|3778364|FG001|NOT COMPLETED|Overall Study||18
3057752|NCT01254305|3778365|FG002|NOT COMPLETED|Overall Study||17
3057753|NCT01254318|3778376|FG000|STARTED|Overall Study|Alive at start of study|130
3057754|NCT01254318|3778376|FG000|COMPLETED|Overall Study|Alive at end of study|78
3057755|NCT01254318|3778376|FG000|NOT COMPLETED|Overall Study||52
3057756|NCT01254331|3778380|FG000|STARTED|Initial Phase||51
3057757|NCT01254331|3778380|FG000|COMPLETED|Initial Phase||46
3057758|NCT01254331|3778380|FG000|NOT COMPLETED|Initial Phase||5
3057759|NCT01254331|3778380|FG000|STARTED|Extension Phase|1 participant withdrew consent after completing initial phase and did not enter the extension phase|45
3057760|NCT01254331|3778380|FG000|COMPLETED|Extension Phase||41
3057761|NCT01254331|3778380|FG000|NOT COMPLETED|Extension Phase||4
3057762|NCT01254344|3778386|FG000|STARTED|Overall Study||299
3057763|NCT01254344|3778387|FG001|STARTED|Overall Study||300
3057764|NCT01254344|3778386|FG000|Treated|Overall Study||290
3057765|NCT01254344|3778387|FG001|Treated|Overall Study||297
3057766|NCT01254344|3778386|FG000|COMPLETED|Overall Study||286
3057767|NCT01254344|3778387|FG001|COMPLETED|Overall Study||281
3057768|NCT01254344|3778386|FG000|NOT COMPLETED|Overall Study||13
3057769|NCT01254344|3778387|FG001|NOT COMPLETED|Overall Study||19
3057770|NCT01254396|3778393|FG000|STARTED|First Intervention Period||6
3057771|NCT01254396|3778394|FG001|STARTED|First Intervention Period||6
3057772|NCT01254396|3778393|FG000|COMPLETED|First Intervention Period||6
3057773|NCT01254396|3778394|FG001|COMPLETED|First Intervention Period||6
3057774|NCT01254396|3778393|FG000|NOT COMPLETED|First Intervention Period||0
3057775|NCT01254396|3778394|FG001|NOT COMPLETED|First Intervention Period||0
3057776|NCT01254396|3778393|FG000|STARTED|Washout Period (at Least 1 Day)||6
3057777|NCT01254396|3778394|FG001|STARTED|Washout Period (at Least 1 Day)||6
3057778|NCT01254396|3778393|FG000|COMPLETED|Washout Period (at Least 1 Day)||6
3057779|NCT01254396|3778394|FG001|COMPLETED|Washout Period (at Least 1 Day)||6
3057780|NCT01254396|3778393|FG000|NOT COMPLETED|Washout Period (at Least 1 Day)||0
3057781|NCT01254396|3778394|FG001|NOT COMPLETED|Washout Period (at Least 1 Day)||0
3057782|NCT01254396|3778393|FG000|STARTED|Second Intervention Period||6
3057783|NCT01254396|3778394|FG001|STARTED|Second Intervention Period||6
3057784|NCT01254396|3778393|FG000|COMPLETED|Second Intervention Period||6
3057785|NCT01254396|3778394|FG001|COMPLETED|Second Intervention Period||6
3057786|NCT01254396|3778393|FG000|NOT COMPLETED|Second Intervention Period||0
3057787|NCT01254396|3778394|FG001|NOT COMPLETED|Second Intervention Period||0
3057788|NCT01254409|3778404|FG000|STARTED|Overall Study||6
3057789|NCT01254409|3778405|FG001|STARTED|Overall Study||6
3057790|NCT01254409|3778406|FG002|STARTED|Overall Study||5
3057791|NCT01254409|3778407|FG003|STARTED|Overall Study||4
3057792|NCT01254409|3778404|FG000|COMPLETED|Overall Study||6
3057793|NCT01254409|3778405|FG001|COMPLETED|Overall Study||5
3057794|NCT01254409|3778406|FG002|COMPLETED|Overall Study||5
3057795|NCT01254409|3778407|FG003|COMPLETED|Overall Study||4
3057796|NCT01254409|3778404|FG000|NOT COMPLETED|Overall Study||0
3057797|NCT01254409|3778405|FG001|NOT COMPLETED|Overall Study||1
3057798|NCT01254409|3778406|FG002|NOT COMPLETED|Overall Study||0
3057799|NCT01254409|3778407|FG003|NOT COMPLETED|Overall Study||0
3057800|NCT01254422|3778422|FG000|STARTED|Overall Study||199
3162320|NCT01877421|3889611|FG012|NOT COMPLETED|Phase 2||1
3162321|NCT01877421|3889612|FG013|NOT COMPLETED|Phase 2||0
3162322|NCT01877421|3889613|FG014|NOT COMPLETED|Phase 2||0
3162323|NCT01877421|3889614|FG015|NOT COMPLETED|Phase 2||1
3162324|NCT01877421|3889615|FG016|NOT COMPLETED|Phase 2||0
3162325|NCT01877421|3889616|FG017|NOT COMPLETED|Phase 2||0
3162326|NCT01877538|3889696|FG000|STARTED|Overall Study||7
3162327|NCT01877538|3889696|FG000|COMPLETED|Overall Study||7
3162328|NCT01877538|3889696|FG000|NOT COMPLETED|Overall Study||0
3162329|NCT01877551|3889702|FG000|STARTED|Overall Study||13
3162330|NCT01877551|3889703|FG001|STARTED|Overall Study||14
3162331|NCT01877551|3889702|FG000|COMPLETED|Overall Study||13
3283961|NCT02760277|4017723|FG001|COMPLETED|0.75 mg/kg/Day||12
3283962|NCT02760277|4017724|FG002|COMPLETED|0.75 mg/kg/Day||0
3283963|NCT02760277|4017725|FG003|COMPLETED|0.75 mg/kg/Day||0
3283964|NCT02760277|4017722|FG000|NOT COMPLETED|0.75 mg/kg/Day||0
3283965|NCT02760277|4017723|FG001|NOT COMPLETED|0.75 mg/kg/Day||0
3283966|NCT02760277|4017724|FG002|NOT COMPLETED|0.75 mg/kg/Day||0
3057801|NCT01254422|3778423|FG001|STARTED|Overall Study||51
3057802|NCT01254422|3778422|FG000|COMPLETED|Overall Study||196
3057803|NCT01254422|3778423|FG001|COMPLETED|Overall Study||50
3057804|NCT01254422|3778422|FG000|NOT COMPLETED|Overall Study||3
3057805|NCT01254422|3778423|FG001|NOT COMPLETED|Overall Study||1
3057806|NCT01254552|3778429|FG000|STARTED|Screening Visit||351
3057807|NCT01254552|3778429|FG000|COMPLETED|Screening Visit||348
3057808|NCT01254552|3778429|FG000|NOT COMPLETED|Screening Visit||3
3057809|NCT01254552|3778429|FG000|STARTED|Delayed-enhanced MRI With Dotarem||348
3057810|NCT01254552|3778429|FG000|COMPLETED|Delayed-enhanced MRI With Dotarem||328
3057811|NCT01254552|3778429|FG000|NOT COMPLETED|Delayed-enhanced MRI With Dotarem||20
3057812|NCT01254552|3778429|FG000|STARTED|CCTA With Xenetix 350||328
3057813|NCT01254552|3778429|FG000|COMPLETED|CCTA With Xenetix 350||322
3057814|NCT01254552|3778429|FG000|NOT COMPLETED|CCTA With Xenetix 350||6
3057815|NCT01254565|3778443|FG000|STARTED|Overall Study||5
3057816|NCT01254565|3778444|FG001|STARTED|Overall Study||7
3057817|NCT01254565|3778445|FG002|STARTED|Overall Study||21
3057818|NCT01254565|3778446|FG003|STARTED|Overall Study||21
3057819|NCT01254565|3778447|FG004|STARTED|Overall Study||16
3057820|NCT01254565|3778448|FG005|STARTED|Overall Study||17
3057821|NCT01254565|3778443|FG000|Received Treatment|Overall Study||4
3057822|NCT01254565|3778444|FG001|Received Treatment|Overall Study||6
3057823|NCT01254565|3778445|FG002|Received Treatment|Overall Study||21
3057824|NCT01254565|3778446|FG003|Received Treatment|Overall Study||21
3057825|NCT01254565|3778447|FG004|Received Treatment|Overall Study||13
3057826|NCT01254565|3778448|FG005|Received Treatment|Overall Study||13
3057827|NCT01254565|3778443|FG000|COMPLETED|Overall Study||4
3057828|NCT01254565|3778444|FG001|COMPLETED|Overall Study||6
3057829|NCT01254565|3778445|FG002|COMPLETED|Overall Study||21
3057830|NCT01254565|3778446|FG003|COMPLETED|Overall Study||20
3057831|NCT01254565|3778447|FG004|COMPLETED|Overall Study||12
3057832|NCT01254565|3778448|FG005|COMPLETED|Overall Study||13
3057833|NCT01254565|3778443|FG000|NOT COMPLETED|Overall Study||1
3057834|NCT01254565|3778444|FG001|NOT COMPLETED|Overall Study||1
3057835|NCT01254565|3778445|FG002|NOT COMPLETED|Overall Study||0
3057836|NCT01254565|3778446|FG003|NOT COMPLETED|Overall Study||1
3057837|NCT01254565|3778447|FG004|NOT COMPLETED|Overall Study||4
3057838|NCT01254565|3778448|FG005|NOT COMPLETED|Overall Study||4
3057839|NCT01254604|3778464|FG000|STARTED|Overall Study||95
3057840|NCT01254604|3778465|FG001|STARTED|Overall Study||95
3057841|NCT01254604|3778464|FG000|Treated|Overall Study|"The 2 out of 95 started who did not take study drug discontinued due to Withdrawal by Subject"|93
3057842|NCT01254604|3778465|FG001|Treated|Overall Study|"The 1 out of 95 started who did not take study drug discontinued due to Withdrawal by Subject"|94
3057843|NCT01254604|3778464|FG000|COMPLETED|Overall Study||87
3057844|NCT01254604|3778465|FG001|COMPLETED|Overall Study||86
3057845|NCT01254604|3778464|FG000|NOT COMPLETED|Overall Study||8
3057846|NCT01254604|3778465|FG001|NOT COMPLETED|Overall Study||9
3057847|NCT01254630|3778475|FG000|STARTED|Overall Study||1348
3057848|NCT01254630|3778476|FG001|STARTED|Overall Study||1288
3057849|NCT01254630|3778477|FG002|STARTED|Overall Study||1364
3057850|NCT01254630|3778478|FG003|STARTED|Overall Study||1285
3057851|NCT01254630|3778475|FG000|Received Vaccination 1|Overall Study||1328
3057852|NCT01254630|3778476|FG001|Received Vaccination 1|Overall Study||1277
3057853|NCT01254630|3778477|FG002|Received Vaccination 1|Overall Study||1350
3057854|NCT01254630|3778478|FG003|Received Vaccination 1|Overall Study||1275
3057855|NCT01254630|3778475|FG000|Received Vaccination 2|Overall Study||1255
3057856|NCT01254630|3778476|FG001|Received Vaccination 2|Overall Study||1217
3057857|NCT01254630|3778477|FG002|Received Vaccination 2|Overall Study||1286
3057858|NCT01254630|3778478|FG003|Received Vaccination 2|Overall Study||1226
3057859|NCT01254630|3778475|FG000|Received Vaccination 3|Overall Study||1198
3057860|NCT01254630|3778476|FG001|Received Vaccination 3|Overall Study||1178
3057861|NCT01254630|3778477|FG002|Received Vaccination 3|Overall Study||1247
3057862|NCT01254630|3778478|FG003|Received Vaccination 3|Overall Study||1194
3057863|NCT01254630|3778475|FG000|Received Vaccination 4|Overall Study||1155
3057864|NCT01254630|3778476|FG001|Received Vaccination 4|Overall Study||1145
3162332|NCT01877551|3889703|FG001|COMPLETED|Overall Study||13
3162333|NCT01877551|3889702|FG000|NOT COMPLETED|Overall Study||0
3162334|NCT01877551|3889703|FG001|NOT COMPLETED|Overall Study||1
3162335|NCT01877642|3889711|FG000|STARTED|Overall Study||4
3283967|NCT02760277|4017725|FG003|NOT COMPLETED|0.75 mg/kg/Day||0
3057865|NCT01254630|3778477|FG002|Received Vaccination 4|Overall Study||1212
3057866|NCT01254630|3778478|FG003|Received Vaccination 4|Overall Study||1160
3057867|NCT01254630|3778475|FG000|COMPLETED|Overall Study||546
3057868|NCT01254630|3778476|FG001|COMPLETED|Overall Study||0
3057869|NCT01254630|3778477|FG002|COMPLETED|Overall Study||552
3057870|NCT01254630|3778478|FG003|COMPLETED|Overall Study||0
3057871|NCT01254630|3778475|FG000|NOT COMPLETED|Overall Study||802
3057872|NCT01254630|3778476|FG001|NOT COMPLETED|Overall Study||1288
3057873|NCT01254630|3778477|FG002|NOT COMPLETED|Overall Study||812
3057874|NCT01254630|3778478|FG003|NOT COMPLETED|Overall Study||1285
3057875|NCT01254643|3778486|FG000|STARTED|Overall Study||100
3057876|NCT01254643|3778486|FG000|Vaccination 1|Overall Study||100
3057877|NCT01254643|3778486|FG000|Vaccination 2|Overall Study||99
3057878|NCT01254643|3778486|FG000|Vaccination 3|Overall Study||99
3057879|NCT01254643|3778486|FG000|COMPLETED|Overall Study||99
3057880|NCT01254643|3778486|FG000|NOT COMPLETED|Overall Study||1
3057881|NCT01254656|3778493|FG000|STARTED|Overall Study||47
3057882|NCT01254656|3778494|FG001|STARTED|Overall Study||43
3057883|NCT01254656|3778495|FG002|STARTED|Overall Study||18
3057884|NCT01254656|3778493|FG000|Treated|Overall Study||47
3057885|NCT01254656|3778494|FG001|Treated|Overall Study||43
3057886|NCT01254656|3778495|FG002|Treated|Overall Study||18
3057887|NCT01254656|3778493|FG000|COMPLETED|Overall Study||0
3057888|NCT01254656|3778494|FG001|COMPLETED|Overall Study||0
3057889|NCT01254656|3778495|FG002|COMPLETED|Overall Study||0
3057890|NCT01254656|3778493|FG000|NOT COMPLETED|Overall Study||47
3057891|NCT01254656|3778494|FG001|NOT COMPLETED|Overall Study||43
3057892|NCT01254656|3778495|FG002|NOT COMPLETED|Overall Study||18
3057893|NCT01254669|3778505|FG000|STARTED|Overall Study||100
3057894|NCT01254669|3778506|FG001|STARTED|Overall Study||100
3057895|NCT01254669|3778505|FG000|COMPLETED|Overall Study||97
3057896|NCT01254669|3778506|FG001|COMPLETED|Overall Study||96
3057897|NCT01254669|3778505|FG000|NOT COMPLETED|Overall Study||3
3057898|NCT01254669|3778506|FG001|NOT COMPLETED|Overall Study||4
3057899|NCT01254721|3778516|FG000|STARTED|Overall Study|Seroquel XR: 300mg|67
3057900|NCT01254721|3778517|FG001|STARTED|Overall Study|Seroquel XR: 300mg Lithium: 900mg|64
3057901|NCT01254721|3778516|FG000|COMPLETED|Overall Study||52
3057902|NCT01254721|3778517|FG001|COMPLETED|Overall Study||42
3057903|NCT01254721|3778516|FG000|NOT COMPLETED|Overall Study||15
3057904|NCT01254721|3778517|FG001|NOT COMPLETED|Overall Study||22
3057905|NCT01254747|3778527|FG000|STARTED|Overall Study||40
3057906|NCT01254747|3778528|FG001|STARTED|Overall Study||29
3057907|NCT01254747|3778529|FG002|STARTED|Overall Study||30
3057908|NCT01254747|3778530|FG003|STARTED|Overall Study||30
3057909|NCT01254747|3778527|FG000|COMPLETED|Overall Study||40
3057910|NCT01254747|3778528|FG001|COMPLETED|Overall Study||23
3162336|NCT01877642|3889712|FG001|STARTED|Overall Study||3
3162337|NCT01877642|3889713|FG002|STARTED|Overall Study||3
3162338|NCT01877642|3889714|FG003|STARTED|Overall Study||3
3162339|NCT01877642|3889715|FG004|STARTED|Overall Study||3
3162340|NCT01877642|3889716|FG005|STARTED|Overall Study||3
3162341|NCT01877642|3889717|FG006|STARTED|Overall Study||3
3057911|NCT01254747|3778529|FG002|COMPLETED|Overall Study||26
3057912|NCT01254747|3778530|FG003|COMPLETED|Overall Study||28
3057913|NCT01254747|3778527|FG000|NOT COMPLETED|Overall Study||0
3057914|NCT01254747|3778528|FG001|NOT COMPLETED|Overall Study||6
3057915|NCT01254747|3778529|FG002|NOT COMPLETED|Overall Study||4
3057916|NCT01254747|3778530|FG003|NOT COMPLETED|Overall Study||2
3057917|NCT01254760|3778540|FG000|STARTED|First Period, 5 Days of Wear||34
3057918|NCT01254760|3778541|FG001|STARTED|First Period, 5 Days of Wear||38
3057919|NCT01254760|3778540|FG000|COMPLETED|First Period, 5 Days of Wear||34
3057920|NCT01254760|3778541|FG001|COMPLETED|First Period, 5 Days of Wear||38
3057921|NCT01254760|3778540|FG000|NOT COMPLETED|First Period, 5 Days of Wear||0
3057922|NCT01254760|3778541|FG001|NOT COMPLETED|First Period, 5 Days of Wear||0
3057923|NCT01254760|3778540|FG000|STARTED|Second Period, 5 Days of Wear||34
3057924|NCT01254760|3778541|FG001|STARTED|Second Period, 5 Days of Wear||38
3057925|NCT01254760|3778540|FG000|COMPLETED|Second Period, 5 Days of Wear||34
3057926|NCT01254760|3778541|FG001|COMPLETED|Second Period, 5 Days of Wear||38
3057927|NCT01254760|3778540|FG000|NOT COMPLETED|Second Period, 5 Days of Wear||0
3057928|NCT01254760|3778541|FG001|NOT COMPLETED|Second Period, 5 Days of Wear||0
3057929|NCT01254851|3778550|FG000|STARTED|Overall Study||69
3057930|NCT01254851|3778551|FG001|STARTED|Overall Study||77
3057931|NCT01254851|3778550|FG000|COMPLETED|Overall Study||61
3057932|NCT01254851|3778551|FG001|COMPLETED|Overall Study||68
3057933|NCT01254851|3778550|FG000|NOT COMPLETED|Overall Study||8
3057934|NCT01254851|3778551|FG001|NOT COMPLETED|Overall Study||9
3057935|NCT01254877|3778560|FG000|STARTED|Overall Study||67
3057936|NCT01254877|3778561|FG001|STARTED|Overall Study||69
3057937|NCT01254877|3778562|FG002|STARTED|Overall Study||69
3057938|NCT01254877|3778560|FG000|COMPLETED|Overall Study||57
3057939|NCT01254877|3778561|FG001|COMPLETED|Overall Study||58
3057940|NCT01254877|3778562|FG002|COMPLETED|Overall Study||64
3057941|NCT01254877|3778560|FG000|NOT COMPLETED|Overall Study||10
3057942|NCT01254877|3778561|FG001|NOT COMPLETED|Overall Study||11
3057943|NCT01254877|3778562|FG002|NOT COMPLETED|Overall Study||5
3057944|NCT01254890|3778572|FG000|STARTED|Overall Study||3
3057945|NCT01254890|3778573|FG001|STARTED|Overall Study||57
3057946|NCT01254890|3778572|FG000|COMPLETED|Overall Study||2
3162342|NCT01877642|3889711|FG000|COMPLETED|Overall Study||4
3162343|NCT01877642|3889712|FG001|COMPLETED|Overall Study||3
3162344|NCT01877642|3889713|FG002|COMPLETED|Overall Study||3
3057947|NCT01254890|3778573|FG001|COMPLETED|Overall Study||47
3057948|NCT01254890|3778572|FG000|NOT COMPLETED|Overall Study||1
3057949|NCT01254890|3778573|FG001|NOT COMPLETED|Overall Study||10
3057950|NCT01255137|3778578|FG000|STARTED|Overall Study||13
3057951|NCT01255137|3778578|FG000|COMPLETED|Overall Study||13
3057952|NCT01255137|3778578|FG000|NOT COMPLETED|Overall Study||0
3057953|NCT01255163|3778584|FG000|STARTED|Overall Study||13
3057954|NCT01255163|3778585|FG001|STARTED|Overall Study||14
3057955|NCT01255163|3778584|FG000|COMPLETED|Overall Study||9
3057956|NCT01255163|3778585|FG001|COMPLETED|Overall Study||9
3057957|NCT01255163|3778584|FG000|NOT COMPLETED|Overall Study||4
3057958|NCT01255163|3778585|FG001|NOT COMPLETED|Overall Study||5
3057959|NCT01255306|3778595|FG000|STARTED|Overall Study||26
3057960|NCT01255306|3778596|FG001|STARTED|Overall Study||33
3057961|NCT01255306|3778595|FG000|COMPLETED|Overall Study||25
3057962|NCT01255306|3778596|FG001|COMPLETED|Overall Study||32
3057963|NCT01255306|3778595|FG000|NOT COMPLETED|Overall Study||1
3057964|NCT01255306|3778596|FG001|NOT COMPLETED|Overall Study||1
3057965|NCT01255423|3778607|FG000|STARTED|Overall Study||104
3057966|NCT01255423|3778608|FG001|STARTED|Overall Study||102
3057967|NCT01255423|3778607|FG000|COMPLETED|Overall Study||101
3057968|NCT01255423|3778608|FG001|COMPLETED|Overall Study||99
3057969|NCT01255423|3778607|FG000|NOT COMPLETED|Overall Study||3
3057970|NCT01255423|3778608|FG001|NOT COMPLETED|Overall Study||3
3057971|NCT01255436|3778616|FG000|STARTED|Overall Study|350 patients enrolled but 17 excluded because of missing baseline data.|333
3057972|NCT01255436|3778617|FG001|STARTED|Overall Study|350 patients enrolled but 21 excluded because of missing baseline data|329
3057973|NCT01255436|3778616|FG000|COMPLETED|Overall Study||151
3057974|NCT01255436|3778617|FG001|COMPLETED|Overall Study||135
3057975|NCT01255436|3778616|FG000|NOT COMPLETED|Overall Study||182
3057976|NCT01255436|3778617|FG001|NOT COMPLETED|Overall Study||194
3057977|NCT01255449|3778623|FG000|STARTED|Overall Study||26
3057978|NCT01255449|3778623|FG000|COMPLETED|Overall Study||26
3057979|NCT01255449|3778623|FG000|NOT COMPLETED|Overall Study||0
3057980|NCT01255592|3778630|FG000|STARTED|Overall Study||26
3057981|NCT01255592|3778631|FG001|STARTED|Overall Study||26
3057982|NCT01255592|3778630|FG000|COMPLETED|Overall Study||20
3057983|NCT01255592|3778631|FG001|COMPLETED|Overall Study||25
3057984|NCT01255592|3778630|FG000|NOT COMPLETED|Overall Study||6
3057985|NCT01255592|3778631|FG001|NOT COMPLETED|Overall Study||1
3057986|NCT01255631|3778640|FG000|STARTED|Overall Study||13
3057987|NCT01255631|3778641|FG001|STARTED|Overall Study||9
3057988|NCT01255631|3778640|FG000|COMPLETED|Overall Study|study terminated due to poor enrollment|4
3057989|NCT01255631|3778641|FG001|COMPLETED|Overall Study|study terminated due to poor enrollment|3
3057990|NCT01255631|3778640|FG000|NOT COMPLETED|Overall Study||9
3057991|NCT01255631|3778641|FG001|NOT COMPLETED|Overall Study||6
3057992|NCT01255670|3778649|FG000|STARTED|Overall Study||100
3057993|NCT01255670|3778650|FG001|STARTED|Overall Study||100
3057994|NCT01255670|3778649|FG000|COMPLETED|Overall Study||74
3057995|NCT01255670|3778650|FG001|COMPLETED|Overall Study||80
3057996|NCT01255670|3778649|FG000|NOT COMPLETED|Overall Study||26
3057997|NCT01255670|3778650|FG001|NOT COMPLETED|Overall Study||20
3057998|NCT01255722|3778659|FG000|STARTED|Overall Study||155
3057999|NCT01255722|3778660|FG001|STARTED|Overall Study||160
3058000|NCT01255722|3778661|FG002|STARTED|Overall Study||153
3058001|NCT01255722|3778659|FG000|COMPLETED|Overall Study||152
3058002|NCT01255722|3778660|FG001|COMPLETED|Overall Study||159
3058003|NCT01255722|3778661|FG002|COMPLETED|Overall Study||152
3058004|NCT01255722|3778659|FG000|NOT COMPLETED|Overall Study||3
3058005|NCT01255722|3778660|FG001|NOT COMPLETED|Overall Study||1
3058006|NCT01255722|3778661|FG002|NOT COMPLETED|Overall Study||1
3058007|NCT01255761|3778672|FG000|STARTED|Overall Study||369
3058008|NCT01255761|3778673|FG001|STARTED|Overall Study||367
3058009|NCT01255761|3778672|FG000|COMPLETED|Overall Study||187
3058010|NCT01255761|3778673|FG001|COMPLETED|Overall Study||192
3058011|NCT01255761|3778672|FG000|NOT COMPLETED|Overall Study||182
3058012|NCT01255761|3778673|FG001|NOT COMPLETED|Overall Study||175
3058013|NCT01255787|3778683|FG000|STARTED|Overall Study||152
3058014|NCT01255787|3778684|FG001|STARTED|Overall Study||144
3058015|NCT01255787|3778685|FG002|STARTED|Overall Study||150
3058016|NCT01255787|3778686|FG003|STARTED|Overall Study||154
3058017|NCT01255787|3778683|FG000|Treated|Overall Study||152
3058018|NCT01255787|3778684|FG001|Treated|Overall Study||144
3058019|NCT01255787|3778685|FG002|Treated|Overall Study||148
3058020|NCT01255787|3778686|FG003|Treated|Overall Study||150
3058021|NCT01255787|3778683|FG000|COMPLETED|Overall Study||136
3058022|NCT01255787|3778684|FG001|COMPLETED|Overall Study||127
3058023|NCT01255787|3778685|FG002|COMPLETED|Overall Study||132
3058024|NCT01255787|3778686|FG003|COMPLETED|Overall Study||132
3058025|NCT01255787|3778683|FG000|NOT COMPLETED|Overall Study||16
3058026|NCT01255787|3778684|FG001|NOT COMPLETED|Overall Study||17
3058027|NCT01255787|3778685|FG002|NOT COMPLETED|Overall Study||18
3058028|NCT01255787|3778686|FG003|NOT COMPLETED|Overall Study||22
3058029|NCT01255865|3778703|FG000|STARTED|Overall Study||1
3058030|NCT01255865|3778704|FG001|STARTED|Overall Study||10
3058031|NCT01255865|3778705|FG002|STARTED|Overall Study||10
3058032|NCT01255865|3778706|FG003|STARTED|Overall Study||30
3058033|NCT01255865|3778707|FG004|STARTED|Overall Study||20
3058034|NCT01255865|3778708|FG005|STARTED|Overall Study||20
3058035|NCT01255865|3778709|FG006|STARTED|Overall Study||20
3058036|NCT01255865|3778703|FG000|COMPLETED|Overall Study||1
3058037|NCT01255865|3778704|FG001|COMPLETED|Overall Study||10
3058038|NCT01255865|3778705|FG002|COMPLETED|Overall Study||10
3058039|NCT01255865|3778706|FG003|COMPLETED|Overall Study||30
3058040|NCT01255865|3778707|FG004|COMPLETED|Overall Study||20
3058041|NCT01255865|3778708|FG005|COMPLETED|Overall Study||20
3058042|NCT01255865|3778709|FG006|COMPLETED|Overall Study||20
3058043|NCT01255865|3778703|FG000|NOT COMPLETED|Overall Study||0
3058044|NCT01255865|3778704|FG001|NOT COMPLETED|Overall Study||0
3058045|NCT01255865|3778705|FG002|NOT COMPLETED|Overall Study||0
3058046|NCT01255865|3778706|FG003|NOT COMPLETED|Overall Study||0
3058047|NCT01255865|3778707|FG004|NOT COMPLETED|Overall Study||0
3058048|NCT01255865|3778708|FG005|NOT COMPLETED|Overall Study||0
3058049|NCT01255865|3778709|FG006|NOT COMPLETED|Overall Study||0
3058050|NCT01255904|3778727|FG000|STARTED|Overall Study||45
3058051|NCT01255904|3778728|FG001|STARTED|Overall Study||45
3058052|NCT01255904|3778727|FG000|COMPLETED|Overall Study||44
3058053|NCT01255904|3778728|FG001|COMPLETED|Overall Study||41
3162345|NCT01877642|3889714|FG003|COMPLETED|Overall Study||3
3162346|NCT01877642|3889715|FG004|COMPLETED|Overall Study||3
3162347|NCT01877642|3889716|FG005|COMPLETED|Overall Study||3
3162348|NCT01877642|3889717|FG006|COMPLETED|Overall Study||3
3058054|NCT01255904|3778727|FG000|NOT COMPLETED|Overall Study||1
3058055|NCT01255904|3778728|FG001|NOT COMPLETED|Overall Study||4
3058056|NCT01256008|3778737|FG000|STARTED|Overall Study||98
3058057|NCT01256008|3778738|FG001|STARTED|Overall Study||98
3058058|NCT01256008|3778739|FG002|STARTED|Overall Study||196
3058059|NCT01256008|3778737|FG000|COMPLETED|Overall Study||90
3058060|NCT01256008|3778738|FG001|COMPLETED|Overall Study||91
3058061|NCT01256008|3778739|FG002|COMPLETED|Overall Study||175
3058062|NCT01256008|3778737|FG000|NOT COMPLETED|Overall Study||8
3058063|NCT01256008|3778738|FG001|NOT COMPLETED|Overall Study||7
3058064|NCT01256008|3778739|FG002|NOT COMPLETED|Overall Study||21
3058065|NCT01256034|3778751|FG000|STARTED|Overall Study||25
3058066|NCT01256034|3778752|FG001|STARTED|Overall Study||25
3058067|NCT01256034|3778751|FG000|COMPLETED|Overall Study||0
3058068|NCT01256034|3778752|FG001|COMPLETED|Overall Study||0
3058069|NCT01256034|3778751|FG000|NOT COMPLETED|Overall Study||25
3058070|NCT01256034|3778752|FG001|NOT COMPLETED|Overall Study||25
3058071|NCT01256060|3778758|FG000|STARTED|Overall Study||3
3058072|NCT01256060|3778759|FG001|STARTED|Overall Study||3
3058073|NCT01256060|3778760|FG002|STARTED|Overall Study||3
3058074|NCT01256060|3778761|FG003|STARTED|Overall Study||6
3058075|NCT01256060|3778758|FG000|COMPLETED|Overall Study||3
3058076|NCT01256060|3778759|FG001|COMPLETED|Overall Study||2
3058077|NCT01256060|3778760|FG002|COMPLETED|Overall Study||3
3058078|NCT01256060|3778761|FG003|COMPLETED|Overall Study||6
3058079|NCT01256060|3778758|FG000|NOT COMPLETED|Overall Study||0
3058080|NCT01256060|3778759|FG001|NOT COMPLETED|Overall Study||1
3058081|NCT01256060|3778760|FG002|NOT COMPLETED|Overall Study||0
3058082|NCT01256060|3778761|FG003|NOT COMPLETED|Overall Study||0
3058083|NCT01256164|3778769|FG000|STARTED|Overall Study||47
3058084|NCT01256164|3778770|FG001|STARTED|Overall Study||23
3058085|NCT01256164|3778769|FG000|COMPLETED|Overall Study||47
3058086|NCT01256164|3778770|FG001|COMPLETED|Overall Study||23
3058087|NCT01256164|3778769|FG000|NOT COMPLETED|Overall Study||0
3058088|NCT01256164|3778770|FG001|NOT COMPLETED|Overall Study||0
3058089|NCT01256177|3778778|FG000|STARTED|Overall Study||148
3058090|NCT01256177|3778779|FG001|STARTED|Overall Study||148
3058091|NCT01256177|3778778|FG000|COMPLETED|Overall Study||98
3058092|NCT01256177|3778779|FG001|COMPLETED|Overall Study||111
3058093|NCT01256177|3778778|FG000|NOT COMPLETED|Overall Study||50
3058094|NCT01256177|3778779|FG001|NOT COMPLETED|Overall Study||37
3058095|NCT01256190|3778787|FG000|STARTED|Overall Study||39
3058096|NCT01256190|3778788|FG001|STARTED|Overall Study||17
3058097|NCT01256190|3778787|FG000|COMPLETED|Overall Study||37
3058098|NCT01256190|3778788|FG001|COMPLETED|Overall Study||17
3058099|NCT01256190|3778787|FG000|NOT COMPLETED|Overall Study||2
3058100|NCT01256190|3778788|FG001|NOT COMPLETED|Overall Study||0
3058101|NCT01256294|3778794|FG000|STARTED|Overall Study||36
3058102|NCT01256294|3778795|FG001|STARTED|Overall Study||35
3058103|NCT01256294|3778794|FG000|COMPLETED|Overall Study||32
3058104|NCT01256294|3778795|FG001|COMPLETED|Overall Study||33
3058105|NCT01256294|3778794|FG000|NOT COMPLETED|Overall Study||4
3058106|NCT01256294|3778795|FG001|NOT COMPLETED|Overall Study||2
3058107|NCT01256385|3778803|FG000|STARTED|Overall Study||43
3058108|NCT01256385|3778804|FG001|STARTED|Overall Study||43
3058109|NCT01256385|3778803|FG000|Crossover From Arm B to Arm A|Overall Study||0
3058110|NCT01256385|3778804|FG001|Crossover From Arm B to Arm A|Overall Study||15
3058111|NCT01256385|3778803|FG000|COMPLETED|Overall Study||40
3058112|NCT01256385|3778804|FG001|COMPLETED|Overall Study||40
3058113|NCT01256385|3778803|FG000|NOT COMPLETED|Overall Study||3
3058114|NCT01256385|3778804|FG001|NOT COMPLETED|Overall Study||3
3058115|NCT01256398|3778810|FG000|STARTED|Overall Study||66
3058116|NCT01256398|3778810|FG000|COMPLETED|Overall Study||65
3058117|NCT01256398|3778810|FG000|NOT COMPLETED|Overall Study||1
3058118|NCT01256411|3778818|FG000|STARTED|Extension by Maximum Treatment||139
3058119|NCT01256411|3778819|FG001|STARTED|Extension by Maximum Treatment||89
3058120|NCT01256411|3778820|FG002|STARTED|Extension by Maximum Treatment||109
3058121|NCT01256411|3778821|FG003|STARTED|Extension by Maximum Treatment||4
3058122|NCT01256411|3778822|FG004|STARTED|Extension by Maximum Treatment||0
3058123|NCT01256411|3778823|FG005|STARTED|Extension by Maximum Treatment||0
3058124|NCT01256411|3778818|FG000|Down Titrated to 100 mg|Extension by Maximum Treatment||12
3058125|NCT01256411|3778819|FG001|Down Titrated to 100 mg|Extension by Maximum Treatment||0
3058126|NCT01256411|3778820|FG002|Down Titrated to 100 mg|Extension by Maximum Treatment||0
3058127|NCT01256411|3778821|FG003|Down Titrated to 100 mg|Extension by Maximum Treatment||0
3058128|NCT01256411|3778822|FG004|Down Titrated to 100 mg|Extension by Maximum Treatment||0
3058129|NCT01256411|3778823|FG005|Down Titrated to 100 mg|Extension by Maximum Treatment||0
3058130|NCT01256411|3778818|FG000|COMPLETED|Extension by Maximum Treatment||132
3058131|NCT01256411|3778819|FG001|COMPLETED|Extension by Maximum Treatment||79
3058132|NCT01256411|3778820|FG002|COMPLETED|Extension by Maximum Treatment||105
3058133|NCT01256411|3778821|FG003|COMPLETED|Extension by Maximum Treatment||4
3058134|NCT01256411|3778822|FG004|COMPLETED|Extension by Maximum Treatment||0
3058135|NCT01256411|3778823|FG005|COMPLETED|Extension by Maximum Treatment||0
3058136|NCT01256411|3778818|FG000|NOT COMPLETED|Extension by Maximum Treatment||7
3058137|NCT01256411|3778819|FG001|NOT COMPLETED|Extension by Maximum Treatment||10
3058138|NCT01256411|3778820|FG002|NOT COMPLETED|Extension by Maximum Treatment||4
3058139|NCT01256411|3778821|FG003|NOT COMPLETED|Extension by Maximum Treatment||0
3058140|NCT01256411|3778822|FG004|NOT COMPLETED|Extension by Maximum Treatment||0
3058141|NCT01256411|3778823|FG005|NOT COMPLETED|Extension by Maximum Treatment||0
3058142|NCT01256411|3778818|FG000|STARTED|Extension by Mono or Combination Therapy||0
3058143|NCT01256411|3778819|FG001|STARTED|Extension by Mono or Combination Therapy||0
3058144|NCT01256411|3778820|FG002|STARTED|Extension by Mono or Combination Therapy||0
3058145|NCT01256411|3778821|FG003|STARTED|Extension by Mono or Combination Therapy||0
3058146|NCT01256411|3778822|FG004|STARTED|Extension by Mono or Combination Therapy||228
3058147|NCT01256411|3778823|FG005|STARTED|Extension by Mono or Combination Therapy||113
3058148|NCT01256411|3778818|FG000|COMPLETED|Extension by Mono or Combination Therapy||0
3058149|NCT01256411|3778819|FG001|COMPLETED|Extension by Mono or Combination Therapy||0
3058150|NCT01256411|3778820|FG002|COMPLETED|Extension by Mono or Combination Therapy||0
3058151|NCT01256411|3778821|FG003|COMPLETED|Extension by Mono or Combination Therapy||0
3058152|NCT01256411|3778822|FG004|COMPLETED|Extension by Mono or Combination Therapy||211
3058153|NCT01256411|3778823|FG005|COMPLETED|Extension by Mono or Combination Therapy||109
3058154|NCT01256411|3778818|FG000|NOT COMPLETED|Extension by Mono or Combination Therapy||0
3058155|NCT01256411|3778819|FG001|NOT COMPLETED|Extension by Mono or Combination Therapy||0
3058156|NCT01256411|3778820|FG002|NOT COMPLETED|Extension by Mono or Combination Therapy||0
3058157|NCT01256411|3778821|FG003|NOT COMPLETED|Extension by Mono or Combination Therapy||0
3058158|NCT01256411|3778822|FG004|NOT COMPLETED|Extension by Mono or Combination Therapy||17
3058159|NCT01256411|3778823|FG005|NOT COMPLETED|Extension by Mono or Combination Therapy||4
3058160|NCT01256424|3778841|FG000|STARTED|Overall Study||65
3058161|NCT01256424|3778842|FG001|STARTED|Overall Study||67
3058162|NCT01256424|3778843|FG002|STARTED|Overall Study||62
3058163|NCT01256424|3778844|FG003|STARTED|Overall Study||68
3058164|NCT01256424|3778841|FG000|COMPLETED|Overall Study||56
3058165|NCT01256424|3778842|FG001|COMPLETED|Overall Study||59
3058166|NCT01256424|3778843|FG002|COMPLETED|Overall Study||55
3058167|NCT01256424|3778844|FG003|COMPLETED|Overall Study||61
3058168|NCT01256424|3778841|FG000|NOT COMPLETED|Overall Study||9
3058169|NCT01256424|3778842|FG001|NOT COMPLETED|Overall Study||8
3058170|NCT01256424|3778843|FG002|NOT COMPLETED|Overall Study||7
3058171|NCT01256424|3778844|FG003|NOT COMPLETED|Overall Study||7
3058172|NCT01256450|3778857|FG000|STARTED|Open-label Titration||334
3058173|NCT01256450|3778858|FG001|STARTED|Open-label Titration||0
3058174|NCT01256450|3778859|FG002|STARTED|Open-label Titration||0
3058175|NCT01256450|3778857|FG000|COMPLETED|Open-label Titration||235
3058176|NCT01256450|3778858|FG001|COMPLETED|Open-label Titration||0
3058177|NCT01256450|3778859|FG002|COMPLETED|Open-label Titration||0
3058178|NCT01256450|3778857|FG000|NOT COMPLETED|Open-label Titration||99
3058179|NCT01256450|3778858|FG001|NOT COMPLETED|Open-label Titration||0
3058180|NCT01256450|3778859|FG002|NOT COMPLETED|Open-label Titration||0
3058181|NCT01256450|3778857|FG000|STARTED|Double-blind Treatment|All subjects completing OL titration in the previous period were randomized to a DB treatment.|0
3058182|NCT01256450|3778858|FG001|STARTED|Double-blind Treatment|Subjects were randomized to DB treatment after completing OL titration in the previous period.|117
3058183|NCT01256450|3778859|FG002|STARTED|Double-blind Treatment|Subjects were randomized to DB treatment after completing OL titration in the previous period.|118
3058184|NCT01256450|3778857|FG000|COMPLETED|Double-blind Treatment||0
3162349|NCT01877642|3889711|FG000|NOT COMPLETED|Overall Study||0
3162350|NCT01877642|3889712|FG001|NOT COMPLETED|Overall Study||0
3162351|NCT01877642|3889713|FG002|NOT COMPLETED|Overall Study||0
3162352|NCT01877642|3889714|FG003|NOT COMPLETED|Overall Study||0
3162353|NCT01877642|3889715|FG004|NOT COMPLETED|Overall Study||0
3162354|NCT01877642|3889716|FG005|NOT COMPLETED|Overall Study||0
3162355|NCT01877642|3889717|FG006|NOT COMPLETED|Overall Study||0
3162356|NCT01877668|3889731|FG000|STARTED|Overall Study|Received treatment|107
3058185|NCT01256450|3778858|FG001|COMPLETED|Double-blind Treatment||89
3058186|NCT01256450|3778859|FG002|COMPLETED|Double-blind Treatment||81
3058187|NCT01256450|3778857|FG000|NOT COMPLETED|Double-blind Treatment||0
3162357|NCT01877668|3889732|FG001|STARTED|Overall Study|Received treatment|104
3162358|NCT01877668|3889733|FG002|STARTED|Overall Study|Received treatment|106
3162359|NCT01877668|3889734|FG003|STARTED|Overall Study|Received treatment|52
3162360|NCT01877668|3889735|FG004|STARTED|Overall Study|Received treatment|53
3162361|NCT01877668|3889731|FG000|COMPLETED|Overall Study||96
3162362|NCT01877668|3889732|FG001|COMPLETED|Overall Study||96
3162363|NCT01877668|3889733|FG002|COMPLETED|Overall Study||94
3058188|NCT01256450|3778858|FG001|NOT COMPLETED|Double-blind Treatment||28
3058189|NCT01256450|3778859|FG002|NOT COMPLETED|Double-blind Treatment||37
3058190|NCT01256476|3778868|FG000|STARTED|Overall Study||164
3058191|NCT01256476|3778869|FG001|STARTED|Overall Study||164
3058192|NCT01256476|3778868|FG000|COMPLETED|Overall Study||158
3058193|NCT01256476|3778869|FG001|COMPLETED|Overall Study||157
3058194|NCT01256476|3778868|FG000|NOT COMPLETED|Overall Study||6
3058195|NCT01256476|3778869|FG001|NOT COMPLETED|Overall Study||7
3058196|NCT01256502|3778875|FG000|STARTED|Overall Study|Implanted with SERI during Stage I breast reconstruction surgery|139
3058197|NCT01256502|3778875|FG000|COMPLETED|Overall Study||129
3058198|NCT01256502|3778875|FG000|NOT COMPLETED|Overall Study||10
3058199|NCT01256567|3778884|FG000|STARTED|Overall Study||7
3058200|NCT01256567|3778884|FG000|Received at Least 1 Dose of Study Drug|Overall Study||7
3058201|NCT01256567|3778884|FG000|COMPLETED|Overall Study||6
3058202|NCT01256567|3778884|FG000|NOT COMPLETED|Overall Study||1
3058203|NCT01256593|3778889|FG000|STARTED|Overall Study||3827
3058204|NCT01256593|3778889|FG000|COMPLETED|Overall Study|Number of participants whose survey form were collected and included in analyses is shown.|3613
3058205|NCT01256593|3778889|FG000|NOT COMPLETED|Overall Study||214
3058206|NCT01256658|3778895|FG000|STARTED|Period 1||6817
3058207|NCT01256658|3778896|FG001|STARTED|Period 1||7258
3058208|NCT01256658|3778895|FG000|COMPLETED|Period 1||5897
3058209|NCT01256658|3778896|FG001|COMPLETED|Period 1||6510
3058210|NCT01256658|3778895|FG000|NOT COMPLETED|Period 1||920
3058211|NCT01256658|3778896|FG001|NOT COMPLETED|Period 1||748
3058212|NCT01256658|3778895|FG000|STARTED|Period 2 - Follow up Only - No Treatment|43 participants who completed period 1 did not enroll to continue on period 2|5854
3058213|NCT01256658|3778896|FG001|STARTED|Period 2 - Follow up Only - No Treatment|138 participants who completed period 1 did not enroll to continue on period 2|6372
3058214|NCT01256658|3778895|FG000|Lost to Follow up|Period 2 - Follow up Only - No Treatment||71
3058215|NCT01256658|3778896|FG001|Lost to Follow up|Period 2 - Follow up Only - No Treatment||77
3058216|NCT01256658|3778895|FG000|Death|Period 2 - Follow up Only - No Treatment||6
3058217|NCT01256658|3778896|FG001|Death|Period 2 - Follow up Only - No Treatment||8
3058218|NCT01256658|3778895|FG000|Study Termination|Period 2 - Follow up Only - No Treatment|43 participants who completed period 1 did not enroll to continue on period 2|5777
3058219|NCT01256658|3778896|FG001|Study Termination|Period 2 - Follow up Only - No Treatment|138 participants who completed period 1 did not enroll to continue on period 2|6287
3058220|NCT01256658|3778895|FG000|COMPLETED|Period 2 - Follow up Only - No Treatment||0
3058221|NCT01256658|3778896|FG001|COMPLETED|Period 2 - Follow up Only - No Treatment||0
3058222|NCT01256658|3778895|FG000|NOT COMPLETED|Period 2 - Follow up Only - No Treatment||5854
3058223|NCT01256658|3778896|FG001|NOT COMPLETED|Period 2 - Follow up Only - No Treatment||6372
3058224|NCT01256671|3778905|FG000|STARTED|Overall Study||530
3058225|NCT01256671|3778905|FG000|Safety Population|Overall Study||521
3058226|NCT01256671|3778905|FG000|COMPLETED|Overall Study||435
3058227|NCT01256671|3778905|FG000|NOT COMPLETED|Overall Study||95
3058228|NCT01256684|3778912|FG000|STARTED|Overall Study||81
3058229|NCT01256684|3778913|FG001|STARTED|Overall Study||87
3058230|NCT01256684|3778914|FG002|STARTED|Overall Study||87
3058231|NCT01256684|3778912|FG000|Safety Population|Overall Study||80
3058232|NCT01256684|3778913|FG001|Safety Population|Overall Study||86
3058233|NCT01256684|3778914|FG002|Safety Population|Overall Study||87
3058234|NCT01256684|3778912|FG000|ITT Population|Overall Study||77
3058235|NCT01256684|3778913|FG001|ITT Population|Overall Study||79
3058236|NCT01256684|3778914|FG002|ITT Population|Overall Study||81
3058237|NCT01256684|3778912|FG000|COMPLETED|Overall Study||72
3058238|NCT01256684|3778913|FG001|COMPLETED|Overall Study||74
3058239|NCT01256684|3778914|FG002|COMPLETED|Overall Study||76
3058240|NCT01256684|3778912|FG000|NOT COMPLETED|Overall Study||9
3058241|NCT01256684|3778913|FG001|NOT COMPLETED|Overall Study||13
3058242|NCT01256684|3778914|FG002|NOT COMPLETED|Overall Study||11
3058243|NCT01256788|3778925|FG000|STARTED|Overall Study||12
3058244|NCT01256788|3778926|FG001|STARTED|Overall Study||14
3058245|NCT01256788|3778927|FG002|STARTED|Overall Study||8
3058246|NCT01256788|3778925|FG000|COMPLETED|Overall Study||7
3058247|NCT01256788|3778926|FG001|COMPLETED|Overall Study||6
3058248|NCT01256788|3778927|FG002|COMPLETED|Overall Study||5
3058249|NCT01256788|3778925|FG000|NOT COMPLETED|Overall Study||5
3058250|NCT01256788|3778926|FG001|NOT COMPLETED|Overall Study||8
3058251|NCT01256788|3778927|FG002|NOT COMPLETED|Overall Study||3
3058252|NCT01256840|3778938|FG000|STARTED|Overall Study||30
3058253|NCT01256840|3778939|FG001|STARTED|Overall Study||16
3058254|NCT01256840|3778940|FG002|STARTED|Overall Study||25
3058255|NCT01256840|3778938|FG000|COMPLETED|Overall Study||30
3058256|NCT01256840|3778939|FG001|COMPLETED|Overall Study||16
3058257|NCT01256840|3778940|FG002|COMPLETED|Overall Study||25
3058258|NCT01256840|3778938|FG000|NOT COMPLETED|Overall Study||0
3058259|NCT01256840|3778939|FG001|NOT COMPLETED|Overall Study||0
3058260|NCT01256840|3778940|FG002|NOT COMPLETED|Overall Study||0
3058261|NCT01256879|3778948|FG000|STARTED|Overall Study|25 started in this cross-over study but only 24 completed|25
3058262|NCT01256879|3778948|FG000|CimTest-A|Overall Study|25 started this intervention but only 24 completed|25
3058263|NCT01256879|3778948|FG000|CimTest-B|Overall Study|24 started this intervention and 24 completed|24
3058264|NCT01256879|3778948|FG000|Sorbitol-free Cimetidine Solution|Overall Study|24 started this intervention and 24 completed|24
3058265|NCT01256879|3778948|FG000|Commercial Cimetidine Solution|Overall Study|24 started this intervention and 24 completed|24
3058266|NCT01256879|3778948|FG000|COMPLETED|Overall Study||24
3058267|NCT01256879|3778948|FG000|NOT COMPLETED|Overall Study||1
3058268|NCT01256918|3778958|FG000|STARTED|Overall Study||200
3058269|NCT01256918|3778958|FG000|Full Thickness Nuclear Crack Achieved|Overall Study||200
3058270|NCT01256918|3778958|FG000|COMPLETED|Overall Study||200
3058271|NCT01256918|3778958|FG000|NOT COMPLETED|Overall Study||0
3058272|NCT01256944|3778971|FG000|STARTED|Overall Study||70
3058273|NCT01256944|3778972|FG001|STARTED|Overall Study||220
3058274|NCT01256944|3778971|FG000|COMPLETED|Overall Study||70
3058275|NCT01256944|3778972|FG001|COMPLETED|Overall Study||220
3058276|NCT01256944|3778971|FG000|NOT COMPLETED|Overall Study||0
3058277|NCT01256944|3778972|FG001|NOT COMPLETED|Overall Study||0
3058278|NCT01256983|3778984|FG000|STARTED|Overall Study||15
3058279|NCT01256983|3778985|FG001|STARTED|Overall Study||15
3058280|NCT01256983|3778984|FG000|COMPLETED|Overall Study||14
3058281|NCT01256983|3778985|FG001|COMPLETED|Overall Study||12
3058282|NCT01256983|3778984|FG000|NOT COMPLETED|Overall Study||1
3058283|NCT01256983|3778985|FG001|NOT COMPLETED|Overall Study||3
3058284|NCT01257087|3778993|FG000|STARTED|Overall Study||18
3058285|NCT01257087|3778994|FG001|STARTED|Overall Study||17
3058286|NCT01257087|3778993|FG000|COMPLETED|Overall Study||18
3058287|NCT01257087|3778994|FG001|COMPLETED|Overall Study||17
3058288|NCT01257087|3778993|FG000|NOT COMPLETED|Overall Study||0
3058289|NCT01257087|3778994|FG001|NOT COMPLETED|Overall Study||0
3058290|NCT01257204|3779003|FG000|STARTED|Treatment Period (up to Week 24)||50
3058291|NCT01257204|3779004|FG001|STARTED|Treatment Period (up to Week 24)||50
3058292|NCT01257204|3779005|FG002|STARTED|Treatment Period (up to Week 24)||51
3058293|NCT01257204|3779003|FG000|COMPLETED|Treatment Period (up to Week 24)||45
3058294|NCT01257204|3779004|FG001|COMPLETED|Treatment Period (up to Week 24)||44
3058295|NCT01257204|3779005|FG002|COMPLETED|Treatment Period (up to Week 24)||42
3058296|NCT01257204|3779003|FG000|NOT COMPLETED|Treatment Period (up to Week 24)||5
3058297|NCT01257204|3779004|FG001|NOT COMPLETED|Treatment Period (up to Week 24)||6
3058298|NCT01257204|3779005|FG002|NOT COMPLETED|Treatment Period (up to Week 24)||9
3058299|NCT01257204|3779003|FG000|STARTED|Follow-up Period (up to Week 48)|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment.|49
3058300|NCT01257204|3779004|FG001|STARTED|Follow-up Period (up to Week 48)|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment.|47
3058301|NCT01257204|3779005|FG002|STARTED|Follow-up Period (up to Week 48)|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment.|49
3058302|NCT01257204|3779003|FG000|COMPLETED|Follow-up Period (up to Week 48)||48
3058303|NCT01257204|3779004|FG001|COMPLETED|Follow-up Period (up to Week 48)||41
3058304|NCT01257204|3779005|FG002|COMPLETED|Follow-up Period (up to Week 48)||39
3058305|NCT01257204|3779003|FG000|NOT COMPLETED|Follow-up Period (up to Week 48)||1
3058306|NCT01257204|3779004|FG001|NOT COMPLETED|Follow-up Period (up to Week 48)||6
3058307|NCT01257204|3779005|FG002|NOT COMPLETED|Follow-up Period (up to Week 48)||10
3058308|NCT01257217|3779027|FG000|STARTED|Overall Study||15
3058309|NCT01257217|3779028|FG001|STARTED|Overall Study||10
3058310|NCT01257217|3779027|FG000|COMPLETED|Overall Study||13
3058311|NCT01257217|3779028|FG001|COMPLETED|Overall Study||10
3283968|NCT02760277|4017722|FG000|STARTED|2.0 mg/kg/Day||0
3283969|NCT02760277|4017723|FG001|STARTED|2.0 mg/kg/Day||0
3283970|NCT02760277|4017724|FG002|STARTED|2.0 mg/kg/Day||12
3283971|NCT02760277|4017725|FG003|STARTED|2.0 mg/kg/Day||0
3283972|NCT02760277|4017722|FG000|COMPLETED|2.0 mg/kg/Day||0
3283973|NCT02760277|4017723|FG001|COMPLETED|2.0 mg/kg/Day||0
3283974|NCT02760277|4017724|FG002|COMPLETED|2.0 mg/kg/Day||12
3283975|NCT02760277|4017725|FG003|COMPLETED|2.0 mg/kg/Day||0
3283976|NCT02760277|4017722|FG000|NOT COMPLETED|2.0 mg/kg/Day||0
3283977|NCT02760277|4017723|FG001|NOT COMPLETED|2.0 mg/kg/Day||0
3283978|NCT02760277|4017724|FG002|NOT COMPLETED|2.0 mg/kg/Day||0
3058312|NCT01257217|3779027|FG000|NOT COMPLETED|Overall Study||2
3058313|NCT01257217|3779028|FG001|NOT COMPLETED|Overall Study||0
3058314|NCT01257230|3779041|FG000|STARTED|Overall Study||138
3058315|NCT01257230|3779042|FG001|STARTED|Overall Study||125
3058316|NCT01257230|3779043|FG002|STARTED|Overall Study||135
3058317|NCT01257230|3779041|FG000|COMPLETED|Overall Study||132
3058318|NCT01257230|3779042|FG001|COMPLETED|Overall Study||115
3058319|NCT01257230|3779043|FG002|COMPLETED|Overall Study||129
3058320|NCT01257230|3779041|FG000|NOT COMPLETED|Overall Study||6
3058321|NCT01257230|3779042|FG001|NOT COMPLETED|Overall Study||10
3058322|NCT01257230|3779043|FG002|NOT COMPLETED|Overall Study||6
3058323|NCT01257347|3779056|FG000|STARTED|Overall Study|Median patients per provider = 3; range 1-10 (35 patients)|12
3058324|NCT01257347|3779057|FG001|STARTED|Overall Study|Median patients per provider = 4; range 1-13 (65 patients)|12
3058325|NCT01257347|3779058|FG002|STARTED|Overall Study||35
3058326|NCT01257347|3779059|FG003|STARTED|Overall Study||65
3058327|NCT01257347|3779056|FG000|COMPLETED|Overall Study||12
3058328|NCT01257347|3779057|FG001|COMPLETED|Overall Study||12
3058329|NCT01257347|3779058|FG002|COMPLETED|Overall Study||35
3058330|NCT01257347|3779059|FG003|COMPLETED|Overall Study||65
3058331|NCT01257347|3779056|FG000|NOT COMPLETED|Overall Study||0
3058332|NCT01257347|3779057|FG001|NOT COMPLETED|Overall Study||0
3058333|NCT01257347|3779058|FG002|NOT COMPLETED|Overall Study||0
3283979|NCT02760277|4017725|FG003|NOT COMPLETED|2.0 mg/kg/Day||0
3283980|NCT02760277|4017722|FG000|STARTED|6.0 mg/kg/Day||0
3283981|NCT02760277|4017723|FG001|STARTED|6.0 mg/kg/Day||0
3283982|NCT02760277|4017724|FG002|STARTED|6.0 mg/kg/Day||0
3283983|NCT02760277|4017725|FG003|STARTED|6.0 mg/kg/Day||12
3283984|NCT02760277|4017722|FG000|COMPLETED|6.0 mg/kg/Day||0
3283985|NCT02760277|4017723|FG001|COMPLETED|6.0 mg/kg/Day||0
3058334|NCT01257347|3779059|FG003|NOT COMPLETED|Overall Study||0
3058335|NCT01257425|3779074|FG000|STARTED|Overall Study||52
3058336|NCT01257425|3779075|FG001|STARTED|Overall Study||51
3058337|NCT01257425|3779074|FG000|COMPLETED|Overall Study||46
3058338|NCT01257425|3779075|FG001|COMPLETED|Overall Study||45
3058339|NCT01257425|3779074|FG000|NOT COMPLETED|Overall Study||6
3058340|NCT01257425|3779075|FG001|NOT COMPLETED|Overall Study||6
3058341|NCT01257438|3779083|FG000|STARTED|Overall Study||132
3058342|NCT01257438|3779084|FG001|STARTED|Overall Study||143
3058343|NCT01257438|3779083|FG000|COMPLETED|Overall Study||102
3058344|NCT01257438|3779084|FG001|COMPLETED|Overall Study||97
3058345|NCT01257438|3779083|FG000|NOT COMPLETED|Overall Study||30
3058346|NCT01257438|3779084|FG001|NOT COMPLETED|Overall Study||46
3058347|NCT01257503|3779092|FG000|STARTED|Overall Study||133
3058348|NCT01257503|3779093|FG001|STARTED|Overall Study||130
3058349|NCT01257503|3779092|FG000|Returned Symptom Diaries|Overall Study||80
3058350|NCT01257503|3779093|FG001|Returned Symptom Diaries|Overall Study||83
3058351|NCT01257503|3779092|FG000|Returned Dosage Logbooks|Overall Study||75
3058352|NCT01257503|3779093|FG001|Returned Dosage Logbooks|Overall Study||80
3058353|NCT01257503|3779092|FG000|COMPLETED|Overall Study|Completed defined as participants who completed telephone follow-up at end of study period|125
3058354|NCT01257503|3779093|FG001|COMPLETED|Overall Study|Completed defined as participants who completed telephone follow-up at end of study period|119
3058355|NCT01257503|3779092|FG000|NOT COMPLETED|Overall Study||8
3058356|NCT01257503|3779093|FG001|NOT COMPLETED|Overall Study||11
3058357|NCT01257542|3779101|FG000|STARTED|Overall Study||55
3058358|NCT01257542|3779102|FG001|STARTED|Overall Study||52
3058359|NCT01257542|3779101|FG000|COMPLETED|Overall Study||52
3058360|NCT01257542|3779102|FG001|COMPLETED|Overall Study||45
3058361|NCT01257542|3779101|FG000|NOT COMPLETED|Overall Study||3
3058362|NCT01257542|3779102|FG001|NOT COMPLETED|Overall Study||7
3058363|NCT01257581|3779111|FG000|STARTED|Overall Study||22
3058364|NCT01257581|3779112|FG001|STARTED|Overall Study||21
3058365|NCT01257581|3779113|FG002|STARTED|Overall Study||17
3058366|NCT01257581|3779111|FG000|COMPLETED|Overall Study||17
3058367|NCT01257581|3779112|FG001|COMPLETED|Overall Study||18
3058368|NCT01257581|3779113|FG002|COMPLETED|Overall Study||11
3058369|NCT01257581|3779111|FG000|NOT COMPLETED|Overall Study||5
3058370|NCT01257581|3779112|FG001|NOT COMPLETED|Overall Study||3
3058371|NCT01257581|3779113|FG002|NOT COMPLETED|Overall Study||6
3058372|NCT01257698|3779123|FG000|STARTED|Overall Study||12
3058373|NCT01257698|3779124|FG001|STARTED|Overall Study||9
3058374|NCT01257698|3779123|FG000|COMPLETED|Overall Study||8
3058375|NCT01257698|3779124|FG001|COMPLETED|Overall Study||9
3058376|NCT01257698|3779123|FG000|NOT COMPLETED|Overall Study||4
3058377|NCT01257698|3779124|FG001|NOT COMPLETED|Overall Study||0
3058378|NCT01257737|3779132|FG000|STARTED|Overall Study||45
3058379|NCT01257737|3779133|FG001|STARTED|Overall Study||43
3058380|NCT01257737|3779132|FG000|COMPLETED|Overall Study||43
3058381|NCT01257737|3779133|FG001|COMPLETED|Overall Study||39
3058382|NCT01257737|3779132|FG000|NOT COMPLETED|Overall Study||2
3058383|NCT01257737|3779133|FG001|NOT COMPLETED|Overall Study||4
3058384|NCT01257750|3779140|FG000|STARTED|Overall Study||20
3058385|NCT01257750|3779140|FG000|COMPLETED|Overall Study||20
3058386|NCT01257750|3779140|FG000|NOT COMPLETED|Overall Study||0
3058387|NCT01257802|3779147|FG000|STARTED|Overall Study||6
3058388|NCT01257802|3779148|FG001|STARTED|Overall Study||8
3058389|NCT01257802|3779147|FG000|6 Month / 24 Week Visit|Overall Study||5
3058390|NCT01257802|3779148|FG001|6 Month / 24 Week Visit|Overall Study||2
3058391|NCT01257802|3779147|FG000|COMPLETED|Overall Study||5
3058392|NCT01257802|3779148|FG001|COMPLETED|Overall Study||2
3058393|NCT01257802|3779147|FG000|NOT COMPLETED|Overall Study||1
3058394|NCT01257802|3779148|FG001|NOT COMPLETED|Overall Study||6
3133974|NCT01698775|3858941|FG001|STARTED|Phase A||106
3133975|NCT01698775|3858940|FG000|COMPLETED|Phase A||98
3133976|NCT01698775|3858941|FG001|COMPLETED|Phase A||97
3133977|NCT01698775|3858940|FG000|NOT COMPLETED|Phase A||9
3133978|NCT01698775|3858941|FG001|NOT COMPLETED|Phase A||9
3133979|NCT01698775|3858940|FG000|STARTED|Phase B||98
3133980|NCT01698775|3858941|FG001|STARTED|Phase B||97
3133981|NCT01698775|3858940|FG000|COMPLETED|Phase B||84
3133982|NCT01698775|3858941|FG001|COMPLETED|Phase B||86
3133983|NCT01698775|3858940|FG000|NOT COMPLETED|Phase B||14
3133984|NCT01698775|3858941|FG001|NOT COMPLETED|Phase B||11
3133985|NCT01698801|3858951|FG000|STARTED|Treatment Phase||26
3133986|NCT01698801|3858951|FG000|COMPLETED|Treatment Phase|Completed includes participants who continued to receive study medication and treatment is ongoing.|15
3133987|NCT01698801|3858951|FG000|NOT COMPLETED|Treatment Phase||11
3133988|NCT01698801|3858951|FG000|STARTED|Follow Up Phase|11 participants did not complete the study and moved into the follow up phase lasting up to 5 years.|11
3133989|NCT01698801|3858951|FG000|COMPLETED|Follow Up Phase|Completed includes participants who remain in follow-up for up to 5 years from start of treatment|6
3133990|NCT01698801|3858951|FG000|NOT COMPLETED|Follow Up Phase||5
3133991|NCT01698814|3858958|FG000|STARTED|Overall Study||331
3133992|NCT01698814|3858959|FG001|STARTED|Overall Study||169
3133993|NCT01698814|3858958|FG000|COMPLETED|Overall Study||329
3133994|NCT01698814|3858959|FG001|COMPLETED|Overall Study||166
3133995|NCT01698814|3858958|FG000|NOT COMPLETED|Overall Study||2
3133996|NCT01698814|3858959|FG001|NOT COMPLETED|Overall Study||3
3133997|NCT01698879|3858968|FG000|STARTED|Overall Study||6
3133998|NCT01698879|3858969|FG001|STARTED|Overall Study||20
3133999|NCT01698879|3858970|FG002|STARTED|Overall Study||20
3134000|NCT01698879|3858968|FG000|COMPLETED|Overall Study||5
3058395|NCT01257880|3779157|FG000|STARTED|Overall Study||12
3058396|NCT01257880|3779158|FG001|STARTED|Overall Study||19
3058397|NCT01257880|3779157|FG000|COMPLETED|Overall Study||12
3058398|NCT01257880|3779158|FG001|COMPLETED|Overall Study||19
3058399|NCT01257880|3779157|FG000|NOT COMPLETED|Overall Study||0
3058400|NCT01257880|3779158|FG001|NOT COMPLETED|Overall Study||0
3058401|NCT01258049|3779166|FG000|STARTED|Overall Study||77
3058402|NCT01258049|3779167|FG001|STARTED|Overall Study||74
3058403|NCT01258049|3779166|FG000|COMPLETED|Overall Study||75
3058404|NCT01258049|3779167|FG001|COMPLETED|Overall Study||72
3058405|NCT01258049|3779166|FG000|NOT COMPLETED|Overall Study||2
3058406|NCT01258049|3779167|FG001|NOT COMPLETED|Overall Study||2
3283986|NCT02760277|4017724|FG002|COMPLETED|6.0 mg/kg/Day||0
3283987|NCT02760277|4017725|FG003|COMPLETED|6.0 mg/kg/Day||12
3283988|NCT02760277|4017722|FG000|NOT COMPLETED|6.0 mg/kg/Day||0
3283989|NCT02760277|4017723|FG001|NOT COMPLETED|6.0 mg/kg/Day||0
3283990|NCT02760277|4017724|FG002|NOT COMPLETED|6.0 mg/kg/Day||0
3283991|NCT02760277|4017725|FG003|NOT COMPLETED|6.0 mg/kg/Day||0
3283992|NCT02760368|4017738|FG000|STARTED|Overall Study||143
3283993|NCT02760368|4017739|FG001|STARTED|Overall Study||142
3058407|NCT01258075|3779175|FG000|STARTED|Overall Study||141
3058408|NCT01258075|3779176|FG001|STARTED|Overall Study||95
3058409|NCT01258075|3779175|FG000|COMPLETED|Overall Study||99
3058410|NCT01258075|3779176|FG001|COMPLETED|Overall Study||72
3058411|NCT01258075|3779175|FG000|NOT COMPLETED|Overall Study||42
3058412|NCT01258075|3779176|FG001|NOT COMPLETED|Overall Study||23
3058413|NCT01258101|3779186|FG000|STARTED|Overall Study||151
3058414|NCT01258101|3779187|FG001|STARTED|Overall Study||144
3058415|NCT01258101|3779188|FG002|STARTED|Overall Study||33
3058416|NCT01258101|3779189|FG003|STARTED|Overall Study||52
3058417|NCT01258101|3779186|FG000|Safety Analysis Population|Overall Study||144
3058418|NCT01258101|3779187|FG001|Safety Analysis Population|Overall Study||141
3058419|NCT01258101|3779188|FG002|Safety Analysis Population|Overall Study||30
3058420|NCT01258101|3779189|FG003|Safety Analysis Population|Overall Study||48
3058421|NCT01258101|3779186|FG000|Standard Analysis Population|Overall Study||115
3058422|NCT01258101|3779187|FG001|Standard Analysis Population|Overall Study||110
3058423|NCT01258101|3779188|FG002|Standard Analysis Population|Overall Study||21
3058424|NCT01258101|3779189|FG003|Standard Analysis Population|Overall Study||26
3058425|NCT01258101|3779186|FG000|COMPLETED|Overall Study||118
3058426|NCT01258101|3779187|FG001|COMPLETED|Overall Study||110
3058427|NCT01258101|3779188|FG002|COMPLETED|Overall Study||22
3058428|NCT01258101|3779189|FG003|COMPLETED|Overall Study||27
3058429|NCT01258101|3779186|FG000|NOT COMPLETED|Overall Study||33
3058430|NCT01258101|3779187|FG001|NOT COMPLETED|Overall Study||34
3058431|NCT01258101|3779188|FG002|NOT COMPLETED|Overall Study||11
3058432|NCT01258101|3779189|FG003|NOT COMPLETED|Overall Study||25
3058433|NCT01258153|3779202|FG000|STARTED|Overall Study||40
3058434|NCT01258153|3779203|FG001|STARTED|Overall Study||38
3058435|NCT01258153|3779204|FG002|STARTED|Overall Study||37
3058436|NCT01258153|3779202|FG000|COMPLETED|Overall Study||39
3058437|NCT01258153|3779203|FG001|COMPLETED|Overall Study||37
3058438|NCT01258153|3779204|FG002|COMPLETED|Overall Study||36
3058439|NCT01258153|3779202|FG000|NOT COMPLETED|Overall Study||1
3058440|NCT01258153|3779203|FG001|NOT COMPLETED|Overall Study||1
3058441|NCT01258153|3779204|FG002|NOT COMPLETED|Overall Study||1
3058442|NCT01258348|3779214|FG000|STARTED|Overall Study||1
3058443|NCT01258348|3779215|FG001|STARTED|Overall Study||5
3058444|NCT01258348|3779216|FG002|STARTED|Overall Study||3
3058445|NCT01258348|3779217|FG003|STARTED|Overall Study||6
3058446|NCT01258348|3779218|FG004|STARTED|Overall Study||6
3058447|NCT01258348|3779214|FG000|Received at Least 1 Dose of Study Drug|Overall Study||1
3058448|NCT01258348|3779215|FG001|Received at Least 1 Dose of Study Drug|Overall Study||5
3058449|NCT01258348|3779216|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3
3058450|NCT01258348|3779217|FG003|Received at Least 1 Dose of Study Drug|Overall Study||6
3058451|NCT01258348|3779218|FG004|Received at Least 1 Dose of Study Drug|Overall Study||6
3058452|NCT01258348|3779214|FG000|COMPLETED|Overall Study||0
3058453|NCT01258348|3779215|FG001|COMPLETED|Overall Study||0
3058454|NCT01258348|3779216|FG002|COMPLETED|Overall Study||0
3058455|NCT01258348|3779217|FG003|COMPLETED|Overall Study||0
3058456|NCT01258348|3779218|FG004|COMPLETED|Overall Study||0
3058457|NCT01258348|3779214|FG000|NOT COMPLETED|Overall Study||1
3058458|NCT01258348|3779215|FG001|NOT COMPLETED|Overall Study||5
3058459|NCT01258348|3779216|FG002|NOT COMPLETED|Overall Study||3
3058460|NCT01258348|3779217|FG003|NOT COMPLETED|Overall Study||6
3058461|NCT01258348|3779218|FG004|NOT COMPLETED|Overall Study||6
3058462|NCT01258374|3779232|FG000|STARTED|Overall Study||15
3058463|NCT01258374|3779232|FG000|COMPLETED|Overall Study||15
3058464|NCT01258374|3779232|FG000|NOT COMPLETED|Overall Study||0
3058465|NCT01258387|3779245|FG000|STARTED|Overall Study||6
3058466|NCT01258387|3779246|FG001|STARTED|Overall Study||6
3058467|NCT01258387|3779247|FG002|STARTED|Overall Study||6
3058468|NCT01258387|3779248|FG003|STARTED|Overall Study||6
3058469|NCT01258387|3779249|FG004|STARTED|Overall Study||6
3058470|NCT01258387|3779250|FG005|STARTED|Overall Study||6
3058471|NCT01258387|3779251|FG006|STARTED|Overall Study||4
3058472|NCT01258387|3779245|FG000|Patients Randomized to GGF2|Overall Study||4
3058473|NCT01258387|3779246|FG001|Patients Randomized to GGF2|Overall Study||4
3058474|NCT01258387|3779247|FG002|Patients Randomized to GGF2|Overall Study||4
3058475|NCT01258387|3779248|FG003|Patients Randomized to GGF2|Overall Study||4
3283994|NCT02760368|4017740|FG002|STARTED|Overall Study||143
3058476|NCT01258387|3779249|FG004|Patients Randomized to GGF2|Overall Study||4
3058477|NCT01258387|3779250|FG005|Patients Randomized to GGF2|Overall Study||4
3058478|NCT01258387|3779251|FG006|Patients Randomized to GGF2|Overall Study||3
3058479|NCT01258387|3779245|FG000|Patients Randomized to Placebo|Overall Study||2
3058480|NCT01258387|3779246|FG001|Patients Randomized to Placebo|Overall Study||2
3058481|NCT01258387|3779247|FG002|Patients Randomized to Placebo|Overall Study||2
3058482|NCT01258387|3779248|FG003|Patients Randomized to Placebo|Overall Study||2
3058483|NCT01258387|3779249|FG004|Patients Randomized to Placebo|Overall Study||2
3058484|NCT01258387|3779250|FG005|Patients Randomized to Placebo|Overall Study||2
3058485|NCT01258387|3779251|FG006|Patients Randomized to Placebo|Overall Study||1
3058486|NCT01258387|3779245|FG000|COMPLETED|Overall Study||6
3058487|NCT01258387|3779246|FG001|COMPLETED|Overall Study||6
3058488|NCT01258387|3779247|FG002|COMPLETED|Overall Study||6
3058489|NCT01258387|3779248|FG003|COMPLETED|Overall Study||6
3058490|NCT01258387|3779249|FG004|COMPLETED|Overall Study||6
3058491|NCT01258387|3779250|FG005|COMPLETED|Overall Study||6
3058492|NCT01258387|3779251|FG006|COMPLETED|Overall Study||4
3058493|NCT01258387|3779245|FG000|NOT COMPLETED|Overall Study||0
3058494|NCT01258387|3779246|FG001|NOT COMPLETED|Overall Study||0
3058495|NCT01258387|3779247|FG002|NOT COMPLETED|Overall Study||0
3058496|NCT01258387|3779248|FG003|NOT COMPLETED|Overall Study||0
3058497|NCT01258387|3779249|FG004|NOT COMPLETED|Overall Study||0
3058498|NCT01258387|3779250|FG005|NOT COMPLETED|Overall Study||0
3058499|NCT01258387|3779251|FG006|NOT COMPLETED|Overall Study||0
3058500|NCT01258504|3779269|FG000|STARTED|Bosentan Single Dose||13
3058501|NCT01258504|3779269|FG000|COMPLETED|Bosentan Single Dose||13
3058502|NCT01258504|3779269|FG000|NOT COMPLETED|Bosentan Single Dose||0
3058503|NCT01258504|3779269|FG000|STARTED|Bosentan Steady-state||13
3058504|NCT01258504|3779269|FG000|COMPLETED|Bosentan Steady-state||13
3058505|NCT01258504|3779269|FG000|NOT COMPLETED|Bosentan Steady-state||0
3058506|NCT01258504|3779269|FG000|STARTED|Bosentan and SJW||13
3058507|NCT01258504|3779269|FG000|COMPLETED|Bosentan and SJW||13
3058508|NCT01258504|3779269|FG000|NOT COMPLETED|Bosentan and SJW||0
3058509|NCT01258582|3779280|FG000|STARTED|Overall Study||830
3058510|NCT01258582|3779281|FG001|STARTED|Overall Study||821
3058511|NCT01258582|3779280|FG000|COMPLETED|Overall Study||548
3058512|NCT01258582|3779281|FG001|COMPLETED|Overall Study||563
3058513|NCT01258582|3779280|FG000|NOT COMPLETED|Overall Study||282
3058514|NCT01258582|3779281|FG001|NOT COMPLETED|Overall Study||258
3058515|NCT01258595|3779289|FG000|STARTED|Overall Study||148
3058516|NCT01258595|3779290|FG001|STARTED|Overall Study||152
3058517|NCT01258595|3779289|FG000|COMPLETED|Overall Study||147
3058518|NCT01258595|3779290|FG001|COMPLETED|Overall Study||151
3058519|NCT01258595|3779289|FG000|NOT COMPLETED|Overall Study||1
3058520|NCT01258595|3779290|FG001|NOT COMPLETED|Overall Study||1
3058521|NCT01258608|3779298|FG000|STARTED|Overall Study||51
3058522|NCT01258608|3779299|FG001|STARTED|Overall Study||50
3058523|NCT01258608|3779298|FG000|COMPLETED|Overall Study||30
3058524|NCT01258608|3779299|FG001|COMPLETED|Overall Study||31
3058525|NCT01258608|3779298|FG000|NOT COMPLETED|Overall Study||21
3058526|NCT01258608|3779299|FG001|NOT COMPLETED|Overall Study||19
3058527|NCT01258660|3779308|FG000|STARTED|Overall Study|randomized and received at least one dose of treatment|86
3058528|NCT01258660|3779309|FG001|STARTED|Overall Study|randomized and received at least one dose of treatment|86
3058529|NCT01258660|3779308|FG000|Received Treatment|Overall Study||79
3058530|NCT01258660|3779309|FG001|Received Treatment|Overall Study||82
3058531|NCT01258660|3779308|FG000|Completed Treatment|Overall Study||79
3058532|NCT01258660|3779309|FG001|Completed Treatment|Overall Study||81
3058533|NCT01258660|3779308|FG000|COMPLETED|Overall Study|completed and valid for primary analysis data set|75
3058534|NCT01258660|3779309|FG001|COMPLETED|Overall Study|completed and valid for primary analysis data set|75
3058535|NCT01258660|3779308|FG000|NOT COMPLETED|Overall Study||11
3058536|NCT01258660|3779309|FG001|NOT COMPLETED|Overall Study||11
3058537|NCT01258738|3779318|FG000|STARTED|Double-blind Period||111
3058538|NCT01258738|3779319|FG001|STARTED|Double-blind Period||114
3058539|NCT01258738|3779318|FG000|Treated|Double-blind Period||111
3058540|NCT01258738|3779319|FG001|Treated|Double-blind Period||113
3058541|NCT01258738|3779318|FG000|COMPLETED|Double-blind Period||102
3058542|NCT01258738|3779319|FG001|COMPLETED|Double-blind Period|Only 106 participants entered the open label period.|107
3058543|NCT01258738|3779318|FG000|NOT COMPLETED|Double-blind Period||9
3058544|NCT01258738|3779319|FG001|NOT COMPLETED|Double-blind Period||7
3058545|NCT01258738|3779318|FG000|STARTED|Open-label Period||102
3058546|NCT01258738|3779319|FG001|STARTED|Open-label Period||106
3058547|NCT01258738|3779318|FG000|COMPLETED|Open-label Period||85
3058548|NCT01258738|3779319|FG001|COMPLETED|Open-label Period||85
3058549|NCT01258738|3779318|FG000|NOT COMPLETED|Open-label Period||17
3058550|NCT01258738|3779319|FG001|NOT COMPLETED|Open-label Period||21
3058551|NCT01258790|3779327|FG000|STARTED|Overall Study||6
3058552|NCT01258790|3779328|FG001|STARTED|Overall Study||6
3058553|NCT01258790|3779327|FG000|COMPLETED|Overall Study||6
3058554|NCT01258790|3779328|FG001|COMPLETED|Overall Study||6
3058555|NCT01258790|3779327|FG000|NOT COMPLETED|Overall Study||0
3058556|NCT01258790|3779328|FG001|NOT COMPLETED|Overall Study||0
3058557|NCT01258855|3779336|FG000|STARTED|Overall Study||55
3058558|NCT01258855|3779337|FG001|STARTED|Overall Study||29
3058559|NCT01258855|3779336|FG000|COMPLETED|Overall Study||55
3058560|NCT01258855|3779337|FG001|COMPLETED|Overall Study||29
3058561|NCT01258855|3779336|FG000|NOT COMPLETED|Overall Study||0
3058562|NCT01258855|3779337|FG001|NOT COMPLETED|Overall Study||0
3058563|NCT01258985|3779345|FG000|STARTED|Overall Study||106
3058564|NCT01258985|3779346|FG001|STARTED|Overall Study||98
3058565|NCT01258985|3779345|FG000|COMPLETED|Overall Study||106
3058566|NCT01258985|3779346|FG001|COMPLETED|Overall Study||98
3058567|NCT01258985|3779345|FG000|NOT COMPLETED|Overall Study||0
3058568|NCT01258985|3779346|FG001|NOT COMPLETED|Overall Study||0
3058569|NCT01258998|3779352|FG000|STARTED|Overall Study||60
3058570|NCT01258998|3779352|FG000|COMPLETED|Overall Study||59
3058571|NCT01258998|3779352|FG000|NOT COMPLETED|Overall Study||1
3058572|NCT01259011|3779358|FG000|STARTED|Main Study Period|101 dyads (=202 individuals)|101
3058573|NCT01259011|3779359|FG001|STARTED|Main Study Period|109 dyads (=218 individuals)|109
3058574|NCT01259011|3779358|FG000|COMPLETED|Main Study Period||101
3058575|NCT01259011|3779359|FG001|COMPLETED|Main Study Period||109
3058576|NCT01259011|3779358|FG000|NOT COMPLETED|Main Study Period||0
3058577|NCT01259011|3779359|FG001|NOT COMPLETED|Main Study Period||0
3058578|NCT01259011|3779358|FG000|STARTED|After Patient Death|of 101 patient-surrogate dyads/pairs randomized, 17 surrogates of patients who died|17
3058579|NCT01259011|3779359|FG001|STARTED|After Patient Death|of 109 patient-surrogate dyads/pairs randomized, 28 surrogates of patients who died|28
3058580|NCT01259011|3779358|FG000|COMPLETED|After Patient Death||17
3058581|NCT01259011|3779359|FG001|COMPLETED|After Patient Death||28
3058582|NCT01259011|3779358|FG000|NOT COMPLETED|After Patient Death||0
3058583|NCT01259011|3779359|FG001|NOT COMPLETED|After Patient Death||0
3058584|NCT01259063|3779367|FG000|STARTED|Overall Study||33
3058585|NCT01259063|3779367|FG000|COMPLETED|Overall Study||33
3058586|NCT01259063|3779367|FG000|NOT COMPLETED|Overall Study||0
3058587|NCT01259089|3779371|FG000|STARTED|Reached First Response at 4 Weeks||3
3058588|NCT01259089|3779372|FG001|STARTED|Reached First Response at 4 Weeks||3
3162364|NCT01877668|3889734|FG003|COMPLETED|Overall Study||44
3162365|NCT01877668|3889735|FG004|COMPLETED|Overall Study||43
3058589|NCT01259089|3779373|FG002|STARTED|Reached First Response at 4 Weeks||3
3058590|NCT01259089|3779374|FG003|STARTED|Reached First Response at 4 Weeks||3
3058591|NCT01259089|3779375|FG004|STARTED|Reached First Response at 4 Weeks||6
3058592|NCT01259089|3779376|FG005|STARTED|Reached First Response at 4 Weeks||20
3058593|NCT01259089|3779371|FG000|Started Treatment on Study|Reached First Response at 4 Weeks||3
3058594|NCT01259089|3779372|FG001|Started Treatment on Study|Reached First Response at 4 Weeks||3
3058595|NCT01259089|3779373|FG002|Started Treatment on Study|Reached First Response at 4 Weeks||3
3058596|NCT01259089|3779374|FG003|Started Treatment on Study|Reached First Response at 4 Weeks||3
3058597|NCT01259089|3779375|FG004|Started Treatment on Study|Reached First Response at 4 Weeks||6
3058598|NCT01259089|3779376|FG005|Started Treatment on Study|Reached First Response at 4 Weeks||19
3058599|NCT01259089|3779371|FG000|Completed 4 Weeks of Treatment|Reached First Response at 4 Weeks||3
3058600|NCT01259089|3779372|FG001|Completed 4 Weeks of Treatment|Reached First Response at 4 Weeks||3
3058601|NCT01259089|3779373|FG002|Completed 4 Weeks of Treatment|Reached First Response at 4 Weeks||3
3058602|NCT01259089|3779374|FG003|Completed 4 Weeks of Treatment|Reached First Response at 4 Weeks||3
3058603|NCT01259089|3779375|FG004|Completed 4 Weeks of Treatment|Reached First Response at 4 Weeks||6
3058604|NCT01259089|3779376|FG005|Completed 4 Weeks of Treatment|Reached First Response at 4 Weeks||18
3058605|NCT01259089|3779371|FG000|COMPLETED|Reached First Response at 4 Weeks||3
3058606|NCT01259089|3779372|FG001|COMPLETED|Reached First Response at 4 Weeks||3
3058607|NCT01259089|3779373|FG002|COMPLETED|Reached First Response at 4 Weeks||3
3058608|NCT01259089|3779374|FG003|COMPLETED|Reached First Response at 4 Weeks||3
3058609|NCT01259089|3779375|FG004|COMPLETED|Reached First Response at 4 Weeks||6
3058610|NCT01259089|3779376|FG005|COMPLETED|Reached First Response at 4 Weeks||18
3058611|NCT01259089|3779371|FG000|NOT COMPLETED|Reached First Response at 4 Weeks||0
3058612|NCT01259089|3779372|FG001|NOT COMPLETED|Reached First Response at 4 Weeks||0
3058613|NCT01259089|3779373|FG002|NOT COMPLETED|Reached First Response at 4 Weeks||0
3058614|NCT01259089|3779374|FG003|NOT COMPLETED|Reached First Response at 4 Weeks||0
3058615|NCT01259089|3779375|FG004|NOT COMPLETED|Reached First Response at 4 Weeks||0
3058616|NCT01259089|3779376|FG005|NOT COMPLETED|Reached First Response at 4 Weeks||2
3058617|NCT01259089|3779371|FG000|STARTED|Confirmed Response at 8 Weeks||3
3058618|NCT01259089|3779372|FG001|STARTED|Confirmed Response at 8 Weeks||3
3058619|NCT01259089|3779373|FG002|STARTED|Confirmed Response at 8 Weeks||3
3058620|NCT01259089|3779374|FG003|STARTED|Confirmed Response at 8 Weeks||3
3058621|NCT01259089|3779375|FG004|STARTED|Confirmed Response at 8 Weeks||6
3058622|NCT01259089|3779376|FG005|STARTED|Confirmed Response at 8 Weeks||18
3058623|NCT01259089|3779371|FG000|COMPLETED|Confirmed Response at 8 Weeks||3
3058624|NCT01259089|3779372|FG001|COMPLETED|Confirmed Response at 8 Weeks||3
3058625|NCT01259089|3779373|FG002|COMPLETED|Confirmed Response at 8 Weeks||2
3058626|NCT01259089|3779374|FG003|COMPLETED|Confirmed Response at 8 Weeks||2
3058627|NCT01259089|3779375|FG004|COMPLETED|Confirmed Response at 8 Weeks||2
3058628|NCT01259089|3779376|FG005|COMPLETED|Confirmed Response at 8 Weeks||8
3058629|NCT01259089|3779371|FG000|NOT COMPLETED|Confirmed Response at 8 Weeks||0
3058630|NCT01259089|3779372|FG001|NOT COMPLETED|Confirmed Response at 8 Weeks||0
3058631|NCT01259089|3779373|FG002|NOT COMPLETED|Confirmed Response at 8 Weeks||1
3058632|NCT01259089|3779374|FG003|NOT COMPLETED|Confirmed Response at 8 Weeks||1
3058633|NCT01259089|3779375|FG004|NOT COMPLETED|Confirmed Response at 8 Weeks||4
3058634|NCT01259089|3779376|FG005|NOT COMPLETED|Confirmed Response at 8 Weeks||10
3058635|NCT01259089|3779371|FG000|STARTED|Continued Treatment After 8 Weeks||3
3162366|NCT01877668|3889731|FG000|NOT COMPLETED|Overall Study||11
3058636|NCT01259089|3779372|FG001|STARTED|Continued Treatment After 8 Weeks||3
3058637|NCT01259089|3779373|FG002|STARTED|Continued Treatment After 8 Weeks||2
3058638|NCT01259089|3779374|FG003|STARTED|Continued Treatment After 8 Weeks||2
3058639|NCT01259089|3779375|FG004|STARTED|Continued Treatment After 8 Weeks||2
3058640|NCT01259089|3779376|FG005|STARTED|Continued Treatment After 8 Weeks||8
3058641|NCT01259089|3779371|FG000|COMPLETED|Continued Treatment After 8 Weeks||1
3058642|NCT01259089|3779372|FG001|COMPLETED|Continued Treatment After 8 Weeks||2
3058643|NCT01259089|3779373|FG002|COMPLETED|Continued Treatment After 8 Weeks||1
3058644|NCT01259089|3779374|FG003|COMPLETED|Continued Treatment After 8 Weeks||1
3058645|NCT01259089|3779375|FG004|COMPLETED|Continued Treatment After 8 Weeks||0
3058646|NCT01259089|3779376|FG005|COMPLETED|Continued Treatment After 8 Weeks||7
3058647|NCT01259089|3779371|FG000|NOT COMPLETED|Continued Treatment After 8 Weeks||2
3058648|NCT01259089|3779372|FG001|NOT COMPLETED|Continued Treatment After 8 Weeks||1
3058649|NCT01259089|3779373|FG002|NOT COMPLETED|Continued Treatment After 8 Weeks||1
3058650|NCT01259089|3779374|FG003|NOT COMPLETED|Continued Treatment After 8 Weeks||1
3058651|NCT01259089|3779375|FG004|NOT COMPLETED|Continued Treatment After 8 Weeks||2
3058652|NCT01259089|3779376|FG005|NOT COMPLETED|Continued Treatment After 8 Weeks||1
3058653|NCT01259089|3779371|FG000|STARTED|Survival Follow up for Two Years||3
3058654|NCT01259089|3779372|FG001|STARTED|Survival Follow up for Two Years||3
3058655|NCT01259089|3779373|FG002|STARTED|Survival Follow up for Two Years||3
3058656|NCT01259089|3779374|FG003|STARTED|Survival Follow up for Two Years||3
3058657|NCT01259089|3779375|FG004|STARTED|Survival Follow up for Two Years||6
3058658|NCT01259089|3779376|FG005|STARTED|Survival Follow up for Two Years||19
3058659|NCT01259089|3779371|FG000|COMPLETED|Survival Follow up for Two Years||0
3058660|NCT01259089|3779372|FG001|COMPLETED|Survival Follow up for Two Years||1
3058661|NCT01259089|3779373|FG002|COMPLETED|Survival Follow up for Two Years||1
3058662|NCT01259089|3779374|FG003|COMPLETED|Survival Follow up for Two Years||0
3058663|NCT01259089|3779375|FG004|COMPLETED|Survival Follow up for Two Years||0
3058664|NCT01259089|3779376|FG005|COMPLETED|Survival Follow up for Two Years||0
3058665|NCT01259089|3779371|FG000|NOT COMPLETED|Survival Follow up for Two Years||3
3058666|NCT01259089|3779372|FG001|NOT COMPLETED|Survival Follow up for Two Years||2
3058667|NCT01259089|3779373|FG002|NOT COMPLETED|Survival Follow up for Two Years||2
3058668|NCT01259089|3779374|FG003|NOT COMPLETED|Survival Follow up for Two Years||3
3058669|NCT01259089|3779375|FG004|NOT COMPLETED|Survival Follow up for Two Years||6
3058670|NCT01259089|3779376|FG005|NOT COMPLETED|Survival Follow up for Two Years||19
3058671|NCT01259102|3779395|FG000|STARTED|Overall Study||13
3058672|NCT01259102|3779396|FG001|STARTED|Overall Study||14
3162367|NCT01877668|3889732|FG001|NOT COMPLETED|Overall Study||8
3162368|NCT01877668|3889733|FG002|NOT COMPLETED|Overall Study||12
3162369|NCT01877668|3889734|FG003|NOT COMPLETED|Overall Study||8
3162370|NCT01877668|3889735|FG004|NOT COMPLETED|Overall Study||10
3162371|NCT01877720|3889751|FG000|STARTED|Overall Study||8
3058673|NCT01259102|3779397|FG002|STARTED|Overall Study||15
3058674|NCT01259102|3779398|FG003|STARTED|Overall Study||14
3058675|NCT01259102|3779399|FG004|STARTED|Overall Study||14
3058676|NCT01259102|3779395|FG000|COMPLETED|Overall Study||12
3058677|NCT01259102|3779396|FG001|COMPLETED|Overall Study||14
3058678|NCT01259102|3779397|FG002|COMPLETED|Overall Study||13
3058679|NCT01259102|3779398|FG003|COMPLETED|Overall Study||12
3058680|NCT01259102|3779399|FG004|COMPLETED|Overall Study||13
3058681|NCT01259102|3779395|FG000|NOT COMPLETED|Overall Study||1
3058682|NCT01259102|3779396|FG001|NOT COMPLETED|Overall Study||0
3058683|NCT01259102|3779397|FG002|NOT COMPLETED|Overall Study||2
3058684|NCT01259102|3779398|FG003|NOT COMPLETED|Overall Study||2
3058685|NCT01259102|3779399|FG004|NOT COMPLETED|Overall Study||1
3058686|NCT01259115|3779411|FG000|STARTED|Period 1||10
3058687|NCT01259115|3779412|FG001|STARTED|Period 1||10
3058688|NCT01259115|3779411|FG000|COMPLETED|Period 1||7
3058689|NCT01259115|3779412|FG001|COMPLETED|Period 1||9
3058690|NCT01259115|3779411|FG000|NOT COMPLETED|Period 1||3
3058691|NCT01259115|3779412|FG001|NOT COMPLETED|Period 1||1
3058692|NCT01259115|3779411|FG000|STARTED|Period: Washout Period of 4 to 18 Days||7
3058693|NCT01259115|3779412|FG001|STARTED|Period: Washout Period of 4 to 18 Days||9
3058694|NCT01259115|3779411|FG000|COMPLETED|Period: Washout Period of 4 to 18 Days||7
3058695|NCT01259115|3779412|FG001|COMPLETED|Period: Washout Period of 4 to 18 Days||9
3058696|NCT01259115|3779411|FG000|NOT COMPLETED|Period: Washout Period of 4 to 18 Days||0
3058697|NCT01259115|3779412|FG001|NOT COMPLETED|Period: Washout Period of 4 to 18 Days||0
3058698|NCT01259115|3779411|FG000|STARTED|Period 2||7
3058699|NCT01259115|3779412|FG001|STARTED|Period 2||9
3058700|NCT01259115|3779411|FG000|COMPLETED|Period 2||6
3058701|NCT01259115|3779412|FG001|COMPLETED|Period 2||9
3058702|NCT01259115|3779411|FG000|NOT COMPLETED|Period 2||1
3058703|NCT01259115|3779412|FG001|NOT COMPLETED|Period 2||0
3058704|NCT01259128|3779425|FG000|STARTED|Overall Study||15
3058705|NCT01259128|3779426|FG001|STARTED|Overall Study||17
3058706|NCT01259128|3779425|FG000|COMPLETED|Overall Study||15
3058707|NCT01259128|3779426|FG001|COMPLETED|Overall Study||15
3058708|NCT01259128|3779425|FG000|NOT COMPLETED|Overall Study||0
3058709|NCT01259128|3779426|FG001|NOT COMPLETED|Overall Study||2
3058710|NCT01259245|3779434|FG000|STARTED|Overall Study||98
3058711|NCT01259245|3779435|FG001|STARTED|Overall Study||94
3058712|NCT01259245|3779434|FG000|COMPLETED|Overall Study|27 were lost to follow-up and 1 deceased|70
3058713|NCT01259245|3779435|FG001|COMPLETED|Overall Study|24 discontinued intervention and 2 deceased|68
3058714|NCT01259245|3779434|FG000|NOT COMPLETED|Overall Study||28
3058715|NCT01259245|3779435|FG001|NOT COMPLETED|Overall Study||26
3058716|NCT01259297|3779451|FG000|STARTED|Run-in Open Label Period (4-5 Weeks)||1335
3058717|NCT01259297|3779452|FG001|STARTED|Run-in Open Label Period (4-5 Weeks)||0
3058718|NCT01259297|3779453|FG002|STARTED|Run-in Open Label Period (4-5 Weeks)||1001
3058719|NCT01259297|3779454|FG003|STARTED|Run-in Open Label Period (4-5 Weeks)||0
3058720|NCT01259297|3779455|FG004|STARTED|Run-in Open Label Period (4-5 Weeks)||0
3058721|NCT01259297|3779456|FG005|STARTED|Run-in Open Label Period (4-5 Weeks)||0
3058722|NCT01259297|3779457|FG006|STARTED|Run-in Open Label Period (4-5 Weeks)||0
3058723|NCT01259297|3779458|FG007|STARTED|Run-in Open Label Period (4-5 Weeks)||0
3058724|NCT01259297|3779451|FG000|COMPLETED|Run-in Open Label Period (4-5 Weeks)||980
3058725|NCT01259297|3779452|FG001|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
3058726|NCT01259297|3779453|FG002|COMPLETED|Run-in Open Label Period (4-5 Weeks)||779
3058727|NCT01259297|3779454|FG003|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
3058728|NCT01259297|3779455|FG004|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
3058729|NCT01259297|3779456|FG005|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
3058730|NCT01259297|3779457|FG006|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
3058731|NCT01259297|3779458|FG007|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
3058732|NCT01259297|3779451|FG000|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||355
3058733|NCT01259297|3779452|FG001|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
3058734|NCT01259297|3779453|FG002|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||222
3058735|NCT01259297|3779454|FG003|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
3058736|NCT01259297|3779455|FG004|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
3058737|NCT01259297|3779456|FG005|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
3058738|NCT01259297|3779457|FG006|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
3058739|NCT01259297|3779458|FG007|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
3058740|NCT01259297|3779451|FG000|STARTED|Double Blind Randomized Period||244
3058741|NCT01259297|3779452|FG001|STARTED|Double Blind Randomized Period||232
3058742|NCT01259297|3779453|FG002|STARTED|Double Blind Randomized Period||189
3058743|NCT01259297|3779454|FG003|STARTED|Double Blind Randomized Period||195
3058744|NCT01259297|3779455|FG004|STARTED|Double Blind Randomized Period||251
3058745|NCT01259297|3779456|FG005|STARTED|Double Blind Randomized Period||253
3058746|NCT01259297|3779457|FG006|STARTED|Double Blind Randomized Period||196
3058747|NCT01259297|3779458|FG007|STARTED|Double Blind Randomized Period||199
3058748|NCT01259297|3779451|FG000|COMPLETED|Double Blind Randomized Period||242
3058749|NCT01259297|3779452|FG001|COMPLETED|Double Blind Randomized Period||229
3058750|NCT01259297|3779453|FG002|COMPLETED|Double Blind Randomized Period||188
3058751|NCT01259297|3779454|FG003|COMPLETED|Double Blind Randomized Period||191
3058752|NCT01259297|3779455|FG004|COMPLETED|Double Blind Randomized Period||247
3058753|NCT01259297|3779456|FG005|COMPLETED|Double Blind Randomized Period||245
3058754|NCT01259297|3779457|FG006|COMPLETED|Double Blind Randomized Period||190
3058755|NCT01259297|3779458|FG007|COMPLETED|Double Blind Randomized Period||196
3058756|NCT01259297|3779451|FG000|NOT COMPLETED|Double Blind Randomized Period||2
3058757|NCT01259297|3779452|FG001|NOT COMPLETED|Double Blind Randomized Period||3
3058758|NCT01259297|3779453|FG002|NOT COMPLETED|Double Blind Randomized Period||1
3058759|NCT01259297|3779454|FG003|NOT COMPLETED|Double Blind Randomized Period||4
3058760|NCT01259297|3779455|FG004|NOT COMPLETED|Double Blind Randomized Period||4
3058761|NCT01259297|3779456|FG005|NOT COMPLETED|Double Blind Randomized Period||8
3058762|NCT01259297|3779457|FG006|NOT COMPLETED|Double Blind Randomized Period||6
3058763|NCT01259297|3779458|FG007|NOT COMPLETED|Double Blind Randomized Period||3
3058764|NCT01259375|3779475|FG000|STARTED|Overall Study||24
3058765|NCT01259375|3779475|FG000|COMPLETED|Overall Study||23
3058766|NCT01259375|3779475|FG000|NOT COMPLETED|Overall Study||1
3058767|NCT01259388|3779483|FG000|STARTED|Overall Study||11
3058768|NCT01259388|3779484|FG001|STARTED|Overall Study||12
3058769|NCT01259388|3779483|FG000|COMPLETED|Overall Study||6
3058770|NCT01259388|3779484|FG001|COMPLETED|Overall Study||11
3058771|NCT01259388|3779483|FG000|NOT COMPLETED|Overall Study||5
3058772|NCT01259388|3779484|FG001|NOT COMPLETED|Overall Study||1
3058773|NCT01259401|3779492|FG000|STARTED|End of 4-week Intervention||21
3058774|NCT01259401|3779493|FG001|STARTED|End of 4-week Intervention||21
3058775|NCT01259401|3779492|FG000|COMPLETED|End of 4-week Intervention||21
3058776|NCT01259401|3779493|FG001|COMPLETED|End of 4-week Intervention||21
3058777|NCT01259401|3779492|FG000|NOT COMPLETED|End of 4-week Intervention||0
3058778|NCT01259401|3779493|FG001|NOT COMPLETED|End of 4-week Intervention||0
3058779|NCT01259401|3779492|FG000|STARTED|4-month Follow-up||21
3058780|NCT01259401|3779493|FG001|STARTED|4-month Follow-up||21
3058781|NCT01259401|3779492|FG000|COMPLETED|4-month Follow-up||21
3058782|NCT01259401|3779493|FG001|COMPLETED|4-month Follow-up||19
3058783|NCT01259401|3779492|FG000|NOT COMPLETED|4-month Follow-up||0
3058784|NCT01259401|3779493|FG001|NOT COMPLETED|4-month Follow-up||2
3058785|NCT01259427|3779501|FG000|STARTED|Overall Study||124
3162372|NCT01877720|3889752|FG001|STARTED|Overall Study||8
3162373|NCT01877720|3889751|FG000|1st Intervention|Overall Study||7
3162374|NCT01877720|3889752|FG001|1st Intervention|Overall Study||8
3162375|NCT01877720|3889751|FG000|2nd Intervention|Overall Study||7
3162376|NCT01877720|3889752|FG001|2nd Intervention|Overall Study||8
3162377|NCT01877720|3889751|FG000|COMPLETED|Overall Study||7
3162378|NCT01877720|3889752|FG001|COMPLETED|Overall Study||8
3162379|NCT01877720|3889751|FG000|NOT COMPLETED|Overall Study||1
3162380|NCT01877720|3889752|FG001|NOT COMPLETED|Overall Study||0
3162381|NCT01877915|3889760|FG000|STARTED|Overall Study||2507
3058786|NCT01259427|3779502|FG001|STARTED|Overall Study||124
3058787|NCT01259427|3779501|FG000|COMPLETED|Overall Study||106
3058788|NCT01259427|3779502|FG001|COMPLETED|Overall Study||110
3058789|NCT01259427|3779501|FG000|NOT COMPLETED|Overall Study||18
3058790|NCT01259427|3779502|FG001|NOT COMPLETED|Overall Study||14
3058791|NCT01259440|3779511|FG000|STARTED|Overall Study||13
3058792|NCT01259440|3779512|FG001|STARTED|Overall Study||10
3058793|NCT01259440|3779511|FG000|COMPLETED|Overall Study||13
3058794|NCT01259440|3779512|FG001|COMPLETED|Overall Study||10
3058795|NCT01259440|3779511|FG000|NOT COMPLETED|Overall Study||0
3058796|NCT01259440|3779512|FG001|NOT COMPLETED|Overall Study||0
3058797|NCT01259466|3779520|FG000|STARTED|Overall Study||27
3058798|NCT01259466|3779521|FG001|STARTED|Overall Study||27
3058799|NCT01259466|3779520|FG000|COMPLETED|Overall Study||26
3058800|NCT01259466|3779521|FG001|COMPLETED|Overall Study||18
3058801|NCT01259466|3779520|FG000|NOT COMPLETED|Overall Study||1
3058802|NCT01259466|3779521|FG001|NOT COMPLETED|Overall Study||9
3058803|NCT01259492|3779531|FG000|STARTED|Period 1 (9 Weeks)||181
3058804|NCT01259492|3779532|FG001|STARTED|Period 1 (9 Weeks)||182
3058805|NCT01259492|3779533|FG002|STARTED|Period 1 (9 Weeks)||181
3058806|NCT01259492|3779534|FG003|STARTED|Period 1 (9 Weeks)||181
3058807|NCT01259492|3779531|FG000|Full Analysis Set|Period 1 (9 Weeks)||174
3058808|NCT01259492|3779532|FG001|Full Analysis Set|Period 1 (9 Weeks)||175
3058809|NCT01259492|3779533|FG002|Full Analysis Set|Period 1 (9 Weeks)||179
3058810|NCT01259492|3779534|FG003|Full Analysis Set|Period 1 (9 Weeks)||172
3058811|NCT01259492|3779531|FG000|COMPLETED|Period 1 (9 Weeks)|"Completed indicates patients entered Period 2."|152
3058812|NCT01259492|3779532|FG001|COMPLETED|Period 1 (9 Weeks)|Completed = entered Period 2|141
3058813|NCT01259492|3779533|FG002|COMPLETED|Period 1 (9 Weeks)|Completed = entered Period 2|138
3058814|NCT01259492|3779534|FG003|COMPLETED|Period 1 (9 Weeks)|Completed = entered Period 2|153
3058815|NCT01259492|3779531|FG000|NOT COMPLETED|Period 1 (9 Weeks)||29
3058816|NCT01259492|3779532|FG001|NOT COMPLETED|Period 1 (9 Weeks)||41
3058817|NCT01259492|3779533|FG002|NOT COMPLETED|Period 1 (9 Weeks)||43
3058818|NCT01259492|3779534|FG003|NOT COMPLETED|Period 1 (9 Weeks)||28
3058819|NCT01259492|3779531|FG000|STARTED|Period 2 (Week 10 to Week 14)|Treatment arms including Placebo indicate patients belong to respective treatment arms in Period 1|152
3058820|NCT01259492|3779532|FG001|STARTED|Period 2 (Week 10 to Week 14)||141
3058821|NCT01259492|3779533|FG002|STARTED|Period 2 (Week 10 to Week 14)||138
3058822|NCT01259492|3779534|FG003|STARTED|Period 2 (Week 10 to Week 14)||153
3058823|NCT01259492|3779531|FG000|COMPLETED|Period 2 (Week 10 to Week 14)|Completed = entered Period 3|127
3058824|NCT01259492|3779532|FG001|COMPLETED|Period 2 (Week 10 to Week 14)|Completed = entered Period 3|123
3058825|NCT01259492|3779533|FG002|COMPLETED|Period 2 (Week 10 to Week 14)|Completed = entered Period 3|114
3058826|NCT01259492|3779534|FG003|COMPLETED|Period 2 (Week 10 to Week 14)|Completed = entered Period 3|125
3058827|NCT01259492|3779531|FG000|NOT COMPLETED|Period 2 (Week 10 to Week 14)||25
3058828|NCT01259492|3779532|FG001|NOT COMPLETED|Period 2 (Week 10 to Week 14)||18
3058829|NCT01259492|3779533|FG002|NOT COMPLETED|Period 2 (Week 10 to Week 14)||24
3058830|NCT01259492|3779534|FG003|NOT COMPLETED|Period 2 (Week 10 to Week 14)||28
3058831|NCT01259492|3779531|FG000|STARTED|Period 3 (Week 15 to End of Week 40)|In period 3, all 489 patients who completed period 2 were re-randomized to 4 arms.|114
3058832|NCT01259492|3779532|FG001|STARTED|Period 3 (Week 15 to End of Week 40)||132
3058833|NCT01259492|3779533|FG002|STARTED|Period 3 (Week 15 to End of Week 40)||120
3283995|NCT02760368|4017738|FG000|COMPLETED|Overall Study||130
3283996|NCT02760368|4017739|FG001|COMPLETED|Overall Study||134
3283997|NCT02760368|4017740|FG002|COMPLETED|Overall Study||132
3058834|NCT01259492|3779534|FG003|STARTED|Period 3 (Week 15 to End of Week 40)||123
3058835|NCT01259492|3779531|FG000|Full Analysis Set|Period 3 (Week 15 to End of Week 40)||110
3058836|NCT01259492|3779532|FG001|Full Analysis Set|Period 3 (Week 15 to End of Week 40)||128
3058837|NCT01259492|3779533|FG002|Full Analysis Set|Period 3 (Week 15 to End of Week 40)||114
3058838|NCT01259492|3779534|FG003|Full Analysis Set|Period 3 (Week 15 to End of Week 40)||115
3058839|NCT01259492|3779531|FG000|COMPLETED|Period 3 (Week 15 to End of Week 40)|completed study|60
3058840|NCT01259492|3779532|FG001|COMPLETED|Period 3 (Week 15 to End of Week 40)|completed study|63
3058841|NCT01259492|3779533|FG002|COMPLETED|Period 3 (Week 15 to End of Week 40)|completed study|70
3058842|NCT01259492|3779534|FG003|COMPLETED|Period 3 (Week 15 to End of Week 40)|completed study|42
3058843|NCT01259492|3779531|FG000|NOT COMPLETED|Period 3 (Week 15 to End of Week 40)||54
3058844|NCT01259492|3779532|FG001|NOT COMPLETED|Period 3 (Week 15 to End of Week 40)||69
3058845|NCT01259492|3779533|FG002|NOT COMPLETED|Period 3 (Week 15 to End of Week 40)||50
3058846|NCT01259492|3779534|FG003|NOT COMPLETED|Period 3 (Week 15 to End of Week 40)||81
3058847|NCT01259596|3779545|FG000|STARTED|Overall Study||70
3058848|NCT01259596|3779546|FG001|STARTED|Overall Study||71
3058849|NCT01259596|3779545|FG000|COMPLETED|Overall Study||66
3058850|NCT01259596|3779546|FG001|COMPLETED|Overall Study||65
3058851|NCT01259596|3779545|FG000|NOT COMPLETED|Overall Study||4
3058852|NCT01259596|3779546|FG001|NOT COMPLETED|Overall Study||6
3058853|NCT01259713|3779556|FG000|STARTED|Overall Study||237
3058854|NCT01259713|3779557|FG001|STARTED|Overall Study||118
3058855|NCT01259713|3779556|FG000|COMPLETED|Overall Study||142
3058856|NCT01259713|3779557|FG001|COMPLETED|Overall Study||77
3058857|NCT01259713|3779556|FG000|NOT COMPLETED|Overall Study||95
3058858|NCT01259713|3779557|FG001|NOT COMPLETED|Overall Study||41
3058859|NCT01259726|3779567|FG000|STARTED|Overall Study||43
3283998|NCT02760368|4017738|FG000|NOT COMPLETED|Overall Study||13
3283999|NCT02760368|4017739|FG001|NOT COMPLETED|Overall Study||8
3058860|NCT01259726|3779568|FG001|STARTED|Overall Study||41
3058861|NCT01259726|3779569|FG002|STARTED|Overall Study||43
3058862|NCT01259726|3779570|FG003|STARTED|Overall Study||41
3058863|NCT01259726|3779567|FG000|Treated|Overall Study||40
3058864|NCT01259726|3779568|FG001|Treated|Overall Study||37
3058865|NCT01259726|3779569|FG002|Treated|Overall Study||41
3162382|NCT01877915|3889761|FG001|STARTED|Overall Study||2515
3162383|NCT01877915|3889760|FG000|COMPLETED|Overall Study||2453
3162384|NCT01877915|3889761|FG001|COMPLETED|Overall Study||2447
3162385|NCT01877915|3889760|FG000|NOT COMPLETED|Overall Study||54
3162386|NCT01877915|3889761|FG001|NOT COMPLETED|Overall Study||68
3162387|NCT01877941|3889767|FG000|STARTED|Overall Study||39
3058866|NCT01259726|3779570|FG003|Treated|Overall Study||39
3058867|NCT01259726|3779567|FG000|COMPLETED|Overall Study||38
3058868|NCT01259726|3779568|FG001|COMPLETED|Overall Study||37
3058869|NCT01259726|3779569|FG002|COMPLETED|Overall Study||39
3058870|NCT01259726|3779570|FG003|COMPLETED|Overall Study||36
3058871|NCT01259726|3779567|FG000|NOT COMPLETED|Overall Study||5
3058872|NCT01259726|3779568|FG001|NOT COMPLETED|Overall Study||4
3058873|NCT01259726|3779569|FG002|NOT COMPLETED|Overall Study||4
3058874|NCT01259726|3779570|FG003|NOT COMPLETED|Overall Study||5
3058875|NCT01259856|3779582|FG000|STARTED|Overall Study||82
3058876|NCT01259856|3779583|FG001|STARTED|Overall Study||86
3058877|NCT01259856|3779582|FG000|COMPLETED|Overall Study||13
3162388|NCT01877941|3889767|FG000|COMPLETED|Overall Study||39
3162389|NCT01877941|3889767|FG000|NOT COMPLETED|Overall Study||0
3162390|NCT01878006|3889772|FG000|STARTED|Study Session 1||5
3058878|NCT01259856|3779583|FG001|COMPLETED|Overall Study||12
3058879|NCT01259856|3779582|FG000|NOT COMPLETED|Overall Study||69
3058880|NCT01259856|3779583|FG001|NOT COMPLETED|Overall Study||74
3058881|NCT01259869|3779589|FG000|STARTED|Overall Study||34
3058882|NCT01259869|3779589|FG000|COMPLETED|Overall Study||33
3058883|NCT01259869|3779589|FG000|NOT COMPLETED|Overall Study||1
3058884|NCT01260142|3779599|FG000|STARTED|Treatment Period 1||6
3058885|NCT01260142|3779600|FG001|STARTED|Treatment Period 1||6
3058886|NCT01260142|3779601|FG002|STARTED|Treatment Period 1||6
3058887|NCT01260142|3779602|FG003|STARTED|Treatment Period 1||6
3058888|NCT01260142|3779603|FG004|STARTED|Treatment Period 1||6
3058889|NCT01260142|3779604|FG005|STARTED|Treatment Period 1||6
3058890|NCT01260142|3779599|FG000|COMPLETED|Treatment Period 1||5
3058891|NCT01260142|3779600|FG001|COMPLETED|Treatment Period 1||5
3058892|NCT01260142|3779601|FG002|COMPLETED|Treatment Period 1||6
3162391|NCT01878006|3889773|FG001|STARTED|Study Session 1||5
3162392|NCT01878006|3889772|FG000|COMPLETED|Study Session 1||5
3162393|NCT01878006|3889773|FG001|COMPLETED|Study Session 1||5
3162394|NCT01878006|3889772|FG000|NOT COMPLETED|Study Session 1||0
3162395|NCT01878006|3889773|FG001|NOT COMPLETED|Study Session 1||0
3162396|NCT01878006|3889772|FG000|STARTED|Study Session 2||5
3162397|NCT01878006|3889773|FG001|STARTED|Study Session 2||5
3162398|NCT01878006|3889772|FG000|COMPLETED|Study Session 2||5
3162399|NCT01878006|3889773|FG001|COMPLETED|Study Session 2||5
3162400|NCT01878006|3889772|FG000|NOT COMPLETED|Study Session 2||0
3162401|NCT01878006|3889773|FG001|NOT COMPLETED|Study Session 2||0
3162402|NCT01878084|3889779|FG000|STARTED|Overall Study||9
3058893|NCT01260142|3779602|FG003|COMPLETED|Treatment Period 1||6
3058894|NCT01260142|3779603|FG004|COMPLETED|Treatment Period 1||4
3058895|NCT01260142|3779604|FG005|COMPLETED|Treatment Period 1||3
3058896|NCT01260142|3779599|FG000|NOT COMPLETED|Treatment Period 1||1
3058897|NCT01260142|3779600|FG001|NOT COMPLETED|Treatment Period 1||1
3058898|NCT01260142|3779601|FG002|NOT COMPLETED|Treatment Period 1||0
3058899|NCT01260142|3779602|FG003|NOT COMPLETED|Treatment Period 1||0
3058900|NCT01260142|3779603|FG004|NOT COMPLETED|Treatment Period 1||2
3058901|NCT01260142|3779604|FG005|NOT COMPLETED|Treatment Period 1||3
3058902|NCT01260142|3779599|FG000|STARTED|Treatment Period 2||5
3058903|NCT01260142|3779600|FG001|STARTED|Treatment Period 2||5
3058904|NCT01260142|3779601|FG002|STARTED|Treatment Period 2||6
3058905|NCT01260142|3779602|FG003|STARTED|Treatment Period 2||6
3058906|NCT01260142|3779603|FG004|STARTED|Treatment Period 2||4
3058907|NCT01260142|3779604|FG005|STARTED|Treatment Period 2||3
3058908|NCT01260142|3779599|FG000|COMPLETED|Treatment Period 2||5
3058909|NCT01260142|3779600|FG001|COMPLETED|Treatment Period 2||5
3058910|NCT01260142|3779601|FG002|COMPLETED|Treatment Period 2||6
3058911|NCT01260142|3779602|FG003|COMPLETED|Treatment Period 2||6
3058912|NCT01260142|3779603|FG004|COMPLETED|Treatment Period 2||4
3058913|NCT01260142|3779604|FG005|COMPLETED|Treatment Period 2||3
3058914|NCT01260142|3779599|FG000|NOT COMPLETED|Treatment Period 2||0
3058915|NCT01260142|3779600|FG001|NOT COMPLETED|Treatment Period 2||0
3058916|NCT01260142|3779601|FG002|NOT COMPLETED|Treatment Period 2||0
3058917|NCT01260142|3779602|FG003|NOT COMPLETED|Treatment Period 2||0
3058918|NCT01260142|3779603|FG004|NOT COMPLETED|Treatment Period 2||0
3058919|NCT01260142|3779604|FG005|NOT COMPLETED|Treatment Period 2||0
3058920|NCT01260181|3779624|FG000|STARTED|Overall Study||30
3058921|NCT01260181|3779624|FG000|COMPLETED|Overall Study||29
3058922|NCT01260181|3779624|FG000|NOT COMPLETED|Overall Study||1
3058923|NCT01260194|3779628|FG000|STARTED|Overall Study||4
3058924|NCT01260194|3779628|FG000|COMPLETED|Overall Study||3
3058925|NCT01260194|3779628|FG000|NOT COMPLETED|Overall Study||1
3058926|NCT01260272|3779634|FG000|STARTED|Overall Study||17
3058927|NCT01260272|3779635|FG001|STARTED|Overall Study||32
3058928|NCT01260272|3779634|FG000|COMPLETED|Overall Study||15
3058929|NCT01260272|3779635|FG001|COMPLETED|Overall Study||30
3162403|NCT01878084|3889779|FG000|Test(Received TAMP Bioglass) s|Overall Study||7
3058930|NCT01260272|3779634|FG000|NOT COMPLETED|Overall Study||2
3058931|NCT01260272|3779635|FG001|NOT COMPLETED|Overall Study||2
3058932|NCT01260311|3779643|FG000|STARTED|Overall Study||508
3058933|NCT01260311|3779643|FG000|COMPLETED|Overall Study||381
3058934|NCT01260311|3779643|FG000|NOT COMPLETED|Overall Study||127
3058935|NCT01260324|3779649|FG000|STARTED|Overall Study||1283
3058936|NCT01260324|3779650|FG001|STARTED|Overall Study||20000
3058937|NCT01260324|3779649|FG000|COMPLETED|Overall Study||1283
3058938|NCT01260324|3779650|FG001|COMPLETED|Overall Study||20000
3058939|NCT01260324|3779649|FG000|NOT COMPLETED|Overall Study||0
3058940|NCT01260324|3779650|FG001|NOT COMPLETED|Overall Study||0
3058941|NCT01260350|3779676|FG000|STARTED|Overall Study||10
3058942|NCT01260350|3779677|FG001|STARTED|Overall Study||9
3058943|NCT01260350|3779678|FG002|STARTED|Overall Study||10
3058944|NCT01260350|3779679|FG003|STARTED|Overall Study||11
3058945|NCT01260350|3779680|FG004|STARTED|Overall Study||10
3058946|NCT01260350|3779681|FG005|STARTED|Overall Study||10
3058947|NCT01260350|3779682|FG006|STARTED|Overall Study||10
3058948|NCT01260350|3779683|FG007|STARTED|Overall Study||25
3058949|NCT01260350|3779684|FG008|STARTED|Overall Study||25
3058950|NCT01260350|3779685|FG009|STARTED|Overall Study||25
3058951|NCT01260350|3779686|FG010|STARTED|Overall Study||10
3058952|NCT01260350|3779687|FG011|STARTED|Overall Study||9
3058953|NCT01260350|3779688|FG012|STARTED|Overall Study||25
3058954|NCT01260350|3779689|FG013|STARTED|Overall Study||10
3058955|NCT01260350|3779690|FG014|STARTED|Overall Study||25
3058956|NCT01260350|3779691|FG015|STARTED|Overall Study||10
3058957|NCT01260350|3779692|FG016|STARTED|Overall Study||9
3058958|NCT01260350|3779693|FG017|STARTED|Overall Study||10
3058959|NCT01260350|3779694|FG018|STARTED|Overall Study||0
3058960|NCT01260350|3779695|FG019|STARTED|Overall Study||14
3058961|NCT01260350|3779696|FG020|STARTED|Overall Study||25
3058962|NCT01260350|3779697|FG021|STARTED|Overall Study||0
3058963|NCT01260350|3779676|FG000|COMPLETED|Overall Study||10
3058964|NCT01260350|3779677|FG001|COMPLETED|Overall Study||9
3058965|NCT01260350|3779678|FG002|COMPLETED|Overall Study||10
3058966|NCT01260350|3779679|FG003|COMPLETED|Overall Study||11
3058967|NCT01260350|3779680|FG004|COMPLETED|Overall Study||10
3058968|NCT01260350|3779681|FG005|COMPLETED|Overall Study||10
3058969|NCT01260350|3779682|FG006|COMPLETED|Overall Study||10
3058970|NCT01260350|3779683|FG007|COMPLETED|Overall Study||25
3058971|NCT01260350|3779684|FG008|COMPLETED|Overall Study||24
3058972|NCT01260350|3779685|FG009|COMPLETED|Overall Study||25
3058973|NCT01260350|3779686|FG010|COMPLETED|Overall Study||10
3058974|NCT01260350|3779687|FG011|COMPLETED|Overall Study||9
3058975|NCT01260350|3779688|FG012|COMPLETED|Overall Study||25
3058976|NCT01260350|3779689|FG013|COMPLETED|Overall Study||10
3058977|NCT01260350|3779690|FG014|COMPLETED|Overall Study||25
3162404|NCT01878084|3889779|FG000|Control (Sockets Were Left Empty)|Overall Study||7
3162405|NCT01878084|3889779|FG000|COMPLETED|Overall Study||7
3162406|NCT01878084|3889779|FG000|NOT COMPLETED|Overall Study||2
3162407|NCT01878097|3889786|FG000|STARTED|Baseline|number of students in 13 intervention schools completing anonymous surveys with non missing data|10725
3162408|NCT01878097|3889787|FG001|STARTED|Baseline|number of students in 13 control schools completing anonymous surveys with non missing data|10081
3058978|NCT01260350|3779691|FG015|COMPLETED|Overall Study||10
3058979|NCT01260350|3779692|FG016|COMPLETED|Overall Study||9
3058980|NCT01260350|3779693|FG017|COMPLETED|Overall Study||9
3058981|NCT01260350|3779694|FG018|COMPLETED|Overall Study||0
3058982|NCT01260350|3779695|FG019|COMPLETED|Overall Study||14
3058983|NCT01260350|3779696|FG020|COMPLETED|Overall Study||22
3058984|NCT01260350|3779697|FG021|COMPLETED|Overall Study||0
3058985|NCT01260350|3779676|FG000|NOT COMPLETED|Overall Study||0
3058986|NCT01260350|3779677|FG001|NOT COMPLETED|Overall Study||0
3058987|NCT01260350|3779678|FG002|NOT COMPLETED|Overall Study||0
3058988|NCT01260350|3779679|FG003|NOT COMPLETED|Overall Study||0
3058989|NCT01260350|3779680|FG004|NOT COMPLETED|Overall Study||0
3058990|NCT01260350|3779681|FG005|NOT COMPLETED|Overall Study||0
3058991|NCT01260350|3779682|FG006|NOT COMPLETED|Overall Study||0
3058992|NCT01260350|3779683|FG007|NOT COMPLETED|Overall Study||0
3058993|NCT01260350|3779684|FG008|NOT COMPLETED|Overall Study||1
3058994|NCT01260350|3779685|FG009|NOT COMPLETED|Overall Study||0
3058995|NCT01260350|3779686|FG010|NOT COMPLETED|Overall Study||0
3058996|NCT01260350|3779687|FG011|NOT COMPLETED|Overall Study||0
3058997|NCT01260350|3779688|FG012|NOT COMPLETED|Overall Study||0
3058998|NCT01260350|3779689|FG013|NOT COMPLETED|Overall Study||0
3058999|NCT01260350|3779690|FG014|NOT COMPLETED|Overall Study||0
3059000|NCT01260350|3779691|FG015|NOT COMPLETED|Overall Study||0
3059001|NCT01260350|3779692|FG016|NOT COMPLETED|Overall Study||0
3059002|NCT01260350|3779693|FG017|NOT COMPLETED|Overall Study||1
3059003|NCT01260350|3779694|FG018|NOT COMPLETED|Overall Study||0
3059004|NCT01260350|3779695|FG019|NOT COMPLETED|Overall Study||0
3059005|NCT01260350|3779696|FG020|NOT COMPLETED|Overall Study||3
3059006|NCT01260350|3779697|FG021|NOT COMPLETED|Overall Study||0
3059007|NCT01260454|3779751|FG000|STARTED|Overall Study||6
3059008|NCT01260454|3779751|FG000|COMPLETED|Overall Study||6
3059009|NCT01260454|3779751|FG000|NOT COMPLETED|Overall Study||0
3059010|NCT01260467|3779755|FG000|STARTED|Overall Study||4
3059011|NCT01260467|3779755|FG000|COMPLETED|Overall Study||2
3059012|NCT01260467|3779755|FG000|NOT COMPLETED|Overall Study||2
3059013|NCT01260493|3779763|FG000|STARTED|Overall Study||92
3059014|NCT01260493|3779764|FG001|STARTED|Overall Study||89
3059015|NCT01260493|3779763|FG000|COMPLETED|Overall Study||76
3059016|NCT01260493|3779764|FG001|COMPLETED|Overall Study||85
3059017|NCT01260493|3779763|FG000|NOT COMPLETED|Overall Study||16
3059018|NCT01260493|3779764|FG001|NOT COMPLETED|Overall Study||4
3059019|NCT01260584|3779774|FG000|STARTED|Period 1||27
3059020|NCT01260584|3779775|FG001|STARTED|Period 1||28
3059021|NCT01260584|3779776|FG002|STARTED|Period 1||27
3059022|NCT01260584|3779777|FG003|STARTED|Period 1||28
3059023|NCT01260584|3779774|FG000|COMPLETED|Period 1||27
3059024|NCT01260584|3779775|FG001|COMPLETED|Period 1||28
3059025|NCT01260584|3779776|FG002|COMPLETED|Period 1||25
3059026|NCT01260584|3779777|FG003|COMPLETED|Period 1||27
3059027|NCT01260584|3779774|FG000|NOT COMPLETED|Period 1||0
3059028|NCT01260584|3779775|FG001|NOT COMPLETED|Period 1||0
3059029|NCT01260584|3779776|FG002|NOT COMPLETED|Period 1||2
3059030|NCT01260584|3779777|FG003|NOT COMPLETED|Period 1||1
3059031|NCT01260584|3779774|FG000|STARTED|Period 2||27
3059032|NCT01260584|3779775|FG001|STARTED|Period 2||28
3059033|NCT01260584|3779776|FG002|STARTED|Period 2||25
3059034|NCT01260584|3779777|FG003|STARTED|Period 2||27
3059035|NCT01260584|3779774|FG000|COMPLETED|Period 2||26
3284000|NCT02760368|4017740|FG002|NOT COMPLETED|Overall Study||11
3284001|NCT02760407|4017752|FG000|STARTED|Overall Study||479
3284002|NCT02760407|4017753|FG001|STARTED|Overall Study||464
3284003|NCT02760407|4017754|FG002|STARTED|Overall Study||462
3059036|NCT01260584|3779775|FG001|COMPLETED|Period 2||25
3059037|NCT01260584|3779776|FG002|COMPLETED|Period 2||20
3059038|NCT01260584|3779777|FG003|COMPLETED|Period 2||26
3059039|NCT01260584|3779774|FG000|NOT COMPLETED|Period 2||1
3059040|NCT01260584|3779775|FG001|NOT COMPLETED|Period 2||3
3059041|NCT01260584|3779776|FG002|NOT COMPLETED|Period 2||5
3059042|NCT01260584|3779777|FG003|NOT COMPLETED|Period 2||1
3059043|NCT01260649|3779789|FG000|STARTED|Overall Study||8
3059044|NCT01260649|3779790|FG001|STARTED|Overall Study||9
3059045|NCT01260649|3779789|FG000|COMPLETED|Overall Study||6
3059046|NCT01260649|3779790|FG001|COMPLETED|Overall Study||8
3059047|NCT01260649|3779789|FG000|NOT COMPLETED|Overall Study||2
3059048|NCT01260649|3779790|FG001|NOT COMPLETED|Overall Study||1
3059049|NCT01260662|3779799|FG000|STARTED|Overall Study||90
3059050|NCT01260662|3779800|FG001|STARTED|Overall Study||85
3059051|NCT01260662|3779801|FG002|STARTED|Overall Study||96
3059052|NCT01260662|3779799|FG000|COMPLETED|Overall Study||90
3059053|NCT01260662|3779800|FG001|COMPLETED|Overall Study||85
3059054|NCT01260662|3779801|FG002|COMPLETED|Overall Study||96
3059055|NCT01260662|3779799|FG000|NOT COMPLETED|Overall Study||0
3059056|NCT01260662|3779800|FG001|NOT COMPLETED|Overall Study||0
3059057|NCT01260662|3779801|FG002|NOT COMPLETED|Overall Study||0
3059058|NCT01260688|3779811|FG000|STARTED|Overall Study||11
3059059|NCT01260688|3779812|FG001|STARTED|Overall Study||11
3059060|NCT01260688|3779811|FG000|COMPLETED|Overall Study||11
3059061|NCT01260688|3779812|FG001|COMPLETED|Overall Study||11
3059062|NCT01260688|3779811|FG000|NOT COMPLETED|Overall Study||0
3059063|NCT01260688|3779812|FG001|NOT COMPLETED|Overall Study||0
3059064|NCT01260701|3779821|FG000|STARTED|Overall Study||75
3059065|NCT01260701|3779821|FG000|Eligible|Overall Study||71
3059066|NCT01260701|3779821|FG000|Eligible and Began Protocol Therapy|Overall Study||70
3059067|NCT01260701|3779821|FG000|COMPLETED|Overall Study||0
3059068|NCT01260701|3779821|FG000|NOT COMPLETED|Overall Study||75
3059069|NCT01260883|3779828|FG000|STARTED|Overall Study||22
3059070|NCT01260883|3779829|FG001|STARTED|Overall Study||11
3059071|NCT01260883|3779830|FG002|STARTED|Overall Study||18
3059072|NCT01260883|3779828|FG000|COMPLETED|Overall Study||22
3059073|NCT01260883|3779829|FG001|COMPLETED|Overall Study||11
3059074|NCT01260883|3779830|FG002|COMPLETED|Overall Study||18
3059075|NCT01260883|3779828|FG000|NOT COMPLETED|Overall Study||0
3059076|NCT01260883|3779829|FG001|NOT COMPLETED|Overall Study||0
3059077|NCT01260883|3779830|FG002|NOT COMPLETED|Overall Study||0
3059078|NCT01260896|3779861|FG000|STARTED|First Intervention||12
3059079|NCT01260896|3779862|FG001|STARTED|First Intervention||12
3059080|NCT01260896|3779861|FG000|COMPLETED|First Intervention||10
3059081|NCT01260896|3779862|FG001|COMPLETED|First Intervention||12
3059082|NCT01260896|3779861|FG000|NOT COMPLETED|First Intervention||2
3059083|NCT01260896|3779862|FG001|NOT COMPLETED|First Intervention||0
3059084|NCT01260896|3779861|FG000|STARTED|Washout of 7 Days||10
3059085|NCT01260896|3779862|FG001|STARTED|Washout of 7 Days||12
3059086|NCT01260896|3779861|FG000|COMPLETED|Washout of 7 Days||10
3059087|NCT01260896|3779862|FG001|COMPLETED|Washout of 7 Days||12
3059088|NCT01260896|3779861|FG000|NOT COMPLETED|Washout of 7 Days||0
3059089|NCT01260896|3779862|FG001|NOT COMPLETED|Washout of 7 Days||0
3059090|NCT01260896|3779861|FG000|STARTED|Second Intervention||10
3059091|NCT01260896|3779862|FG001|STARTED|Second Intervention||12
3059092|NCT01260896|3779861|FG000|COMPLETED|Second Intervention||10
3059093|NCT01260896|3779862|FG001|COMPLETED|Second Intervention||12
3059094|NCT01260896|3779861|FG000|NOT COMPLETED|Second Intervention||0
3059095|NCT01260896|3779862|FG001|NOT COMPLETED|Second Intervention||0
3059096|NCT01260922|3779870|FG000|STARTED|First Intervention||13
3059097|NCT01260922|3779871|FG001|STARTED|First Intervention||13
3059098|NCT01260922|3779870|FG000|COMPLETED|First Intervention||13
3284004|NCT02760407|4017755|FG003|STARTED|Overall Study||243
3059099|NCT01260922|3779871|FG001|COMPLETED|First Intervention||12
3059100|NCT01260922|3779870|FG000|NOT COMPLETED|First Intervention||0
3059101|NCT01260922|3779871|FG001|NOT COMPLETED|First Intervention||1
3059102|NCT01260922|3779870|FG000|STARTED|Washout of 28 Days||13
3059103|NCT01260922|3779871|FG001|STARTED|Washout of 28 Days||12
3284005|NCT02760407|4017752|FG000|COMPLETED|Overall Study||443
3059104|NCT01260922|3779870|FG000|COMPLETED|Washout of 28 Days||9
3059105|NCT01260922|3779871|FG001|COMPLETED|Washout of 28 Days||10
3059106|NCT01260922|3779870|FG000|NOT COMPLETED|Washout of 28 Days||4
3059107|NCT01260922|3779871|FG001|NOT COMPLETED|Washout of 28 Days||2
3059108|NCT01260922|3779870|FG000|STARTED|Second Intervention||9
3059109|NCT01260922|3779871|FG001|STARTED|Second Intervention||10
3059110|NCT01260922|3779870|FG000|COMPLETED|Second Intervention||9
3059111|NCT01260922|3779871|FG001|COMPLETED|Second Intervention||8
3059112|NCT01260922|3779870|FG000|NOT COMPLETED|Second Intervention||0
3059113|NCT01260922|3779871|FG001|NOT COMPLETED|Second Intervention||2
3059114|NCT01260948|3779879|FG000|STARTED|First Intervention||13
3059115|NCT01260948|3779880|FG001|STARTED|First Intervention||13
3059116|NCT01260948|3779879|FG000|COMPLETED|First Intervention||13
3059117|NCT01260948|3779880|FG001|COMPLETED|First Intervention||13
3059118|NCT01260948|3779879|FG000|NOT COMPLETED|First Intervention||0
3059119|NCT01260948|3779880|FG001|NOT COMPLETED|First Intervention||0
3059120|NCT01260948|3779879|FG000|STARTED|Washout of 28 Days||13
3059121|NCT01260948|3779880|FG001|STARTED|Washout of 28 Days||13
3059122|NCT01260948|3779879|FG000|COMPLETED|Washout of 28 Days||12
3059123|NCT01260948|3779880|FG001|COMPLETED|Washout of 28 Days||10
3059124|NCT01260948|3779879|FG000|NOT COMPLETED|Washout of 28 Days||1
3059125|NCT01260948|3779880|FG001|NOT COMPLETED|Washout of 28 Days||3
3059126|NCT01260948|3779879|FG000|STARTED|Second Intervention||12
3059127|NCT01260948|3779880|FG001|STARTED|Second Intervention||10
3059128|NCT01260948|3779879|FG000|COMPLETED|Second Intervention||12
3059129|NCT01260948|3779880|FG001|COMPLETED|Second Intervention||9
3059130|NCT01260948|3779879|FG000|NOT COMPLETED|Second Intervention||0
3059131|NCT01260948|3779880|FG001|NOT COMPLETED|Second Intervention||1
3059132|NCT01261000|3779886|FG000|STARTED|Overall Study||8
3059133|NCT01261000|3779886|FG000|COMPLETED|Overall Study||7
3059134|NCT01261000|3779886|FG000|NOT COMPLETED|Overall Study||1
3059135|NCT01261052|3779890|FG000|STARTED|FMPD/APD Intervention (33 Hours)||14
3059136|NCT01261052|3779890|FG000|COMPLETED|FMPD/APD Intervention (33 Hours)||14
3059137|NCT01261052|3779890|FG000|NOT COMPLETED|FMPD/APD Intervention (33 Hours)||0
3059138|NCT01261052|3779890|FG000|STARTED|APD Only Intervention (33 Hours)||14
3059139|NCT01261052|3779890|FG000|COMPLETED|APD Only Intervention (33 Hours)||14
3059140|NCT01261052|3779890|FG000|NOT COMPLETED|APD Only Intervention (33 Hours)||0
3059141|NCT01261325|3779898|FG000|STARTED|Overall Study||263
3059142|NCT01261325|3779899|FG001|STARTED|Overall Study||254
3059143|NCT01261325|3779900|FG002|STARTED|Overall Study||251
3059144|NCT01261325|3779898|FG000|COMPLETED|Overall Study||246
3059145|NCT01261325|3779899|FG001|COMPLETED|Overall Study||225
3059146|NCT01261325|3779900|FG002|COMPLETED|Overall Study||225
3059147|NCT01261325|3779898|FG000|NOT COMPLETED|Overall Study||17
3059148|NCT01261325|3779899|FG001|NOT COMPLETED|Overall Study||29
3059149|NCT01261325|3779900|FG002|NOT COMPLETED|Overall Study||26
3059150|NCT01261338|3779913|FG000|STARTED|Overall Study|One person in the olestra group started 4 months after the trial began.|14
3059151|NCT01261338|3779914|FG001|STARTED|Overall Study||14
3059152|NCT01261338|3779913|FG000|COMPLETED|Overall Study||11
3059153|NCT01261338|3779914|FG001|COMPLETED|Overall Study||12
3059154|NCT01261338|3779913|FG000|NOT COMPLETED|Overall Study||3
3059155|NCT01261338|3779914|FG001|NOT COMPLETED|Overall Study||2
3059156|NCT01261390|3779924|FG000|STARTED|Overall Study|15 of the 44 participants only had to complete a 6-month follow-up assessment.|44
3059157|NCT01261390|3779925|FG001|STARTED|Overall Study|15 of the 42 participants only had to complete a 6-month follow-up assessment.|42
3059158|NCT01261390|3779926|FG002|STARTED|Overall Study|16 of the 42 participants only had to complete a 6-month follow-up assessment.|42
3059159|NCT01261390|3779927|FG003|STARTED|Overall Study|15 of the 41 participants only had to complete a 6-month follow-up assessment.|41
3059160|NCT01261390|3779924|FG000|6-Month Visit|Overall Study|For 14 of the 30 participants in this arm, this was their final visit.|37
3059161|NCT01261390|3779925|FG001|6-Month Visit|Overall Study|For 12 of the 34 participants in this arm, this was their final visit.|34
3059162|NCT01261390|3779926|FG002|6-Month Visit|Overall Study|For 16 of the 34 participants in this arm, this was their final visit.|34
3059163|NCT01261390|3779927|FG003|6-Month Visit|Overall Study|For 14 of the 32 participants in this arm, this was their final visit.|32
3059164|NCT01261390|3779924|FG000|12-Month Visit|Overall Study||23
3059165|NCT01261390|3779925|FG001|12-Month Visit|Overall Study||21
3059166|NCT01261390|3779926|FG002|12-Month Visit|Overall Study||19
3059167|NCT01261390|3779927|FG003|12-Month Visit|Overall Study||19
3059168|NCT01261390|3779924|FG000|COMPLETED|Overall Study|14 of the 37 participants that completed the study in this arm were under the 6-Month protocol.|37
3059169|NCT01261390|3779925|FG001|COMPLETED|Overall Study|12 of the 33 participants that completed the study in this arm were under the 6-Month protocol.|33
3059170|NCT01261390|3779926|FG002|COMPLETED|Overall Study|16 of the 35 participants that completed the study in this arm were under the 6-Month protocol.|35
3059171|NCT01261390|3779927|FG003|COMPLETED|Overall Study|14 of the 33 participants that completed the study in this arm were under the 6-Month protocol.|33
3059172|NCT01261390|3779924|FG000|NOT COMPLETED|Overall Study||7
3059173|NCT01261390|3779925|FG001|NOT COMPLETED|Overall Study||9
3059174|NCT01261390|3779926|FG002|NOT COMPLETED|Overall Study||7
3059175|NCT01261390|3779927|FG003|NOT COMPLETED|Overall Study||8
3059176|NCT01261507|3779942|FG000|STARTED|Overall Study||15
3059177|NCT01261507|3779942|FG000|COMPLETED|Overall Study||15
3059178|NCT01261507|3779942|FG000|NOT COMPLETED|Overall Study||0
3059179|NCT01261559|3779951|FG000|STARTED|Overall Study||36
3059180|NCT01261559|3779952|FG001|STARTED|Overall Study||36
3059181|NCT01261559|3779951|FG000|COMPLETED|Overall Study||36
3059182|NCT01261559|3779952|FG001|COMPLETED|Overall Study||36
3059183|NCT01261559|3779951|FG000|NOT COMPLETED|Overall Study||0
3162409|NCT01878097|3889786|FG000|COMPLETED|Baseline|Anonymous surveys so only last year data provided as annual completed.|8228
3162410|NCT01878097|3889787|FG001|COMPLETED|Baseline|Anonymous surveys; sum of all completed surveys.|8281
3162411|NCT01878097|3889786|FG000|NOT COMPLETED|Baseline||2497
3162412|NCT01878097|3889787|FG001|NOT COMPLETED|Baseline||1800
3162413|NCT01878097|3889786|FG000|STARTED|Implementation Year 1||11742
3162414|NCT01878097|3889787|FG001|STARTED|Implementation Year 1||9866
3059184|NCT01261559|3779952|FG001|NOT COMPLETED|Overall Study||0
3059185|NCT01261611|3779962|FG000|STARTED|Treatment Cycle 1||156
3059186|NCT01261611|3779963|FG001|STARTED|Treatment Cycle 1||159
3059187|NCT01261611|3779964|FG002|STARTED|Treatment Cycle 1||54
3059188|NCT01261611|3779962|FG000|COMPLETED|Treatment Cycle 1||152
3059189|NCT01261611|3779963|FG001|COMPLETED|Treatment Cycle 1||156
3059190|NCT01261611|3779964|FG002|COMPLETED|Treatment Cycle 1||52
3059191|NCT01261611|3779962|FG000|NOT COMPLETED|Treatment Cycle 1||4
3059192|NCT01261611|3779963|FG001|NOT COMPLETED|Treatment Cycle 1||3
3059193|NCT01261611|3779964|FG002|NOT COMPLETED|Treatment Cycle 1||2
3059194|NCT01261611|3779962|FG000|STARTED|Treatment Cycle 2|All but 1 who completed DB period entered the open label period. This subject remained at Cycle 1.|359
3059195|NCT01261611|3779963|FG001|STARTED|Treatment Cycle 2||0
3059196|NCT01261611|3779964|FG002|STARTED|Treatment Cycle 2||0
3059197|NCT01261611|3779962|FG000|COMPLETED|Treatment Cycle 2||346
3059198|NCT01261611|3779963|FG001|COMPLETED|Treatment Cycle 2||0
3059199|NCT01261611|3779964|FG002|COMPLETED|Treatment Cycle 2||0
3059200|NCT01261611|3779962|FG000|NOT COMPLETED|Treatment Cycle 2||13
3059201|NCT01261611|3779963|FG001|NOT COMPLETED|Treatment Cycle 2||0
3162415|NCT01878097|3889786|FG000|COMPLETED|Implementation Year 1||8540
3162416|NCT01878097|3889787|FG001|COMPLETED|Implementation Year 1||7317
3162417|NCT01878097|3889786|FG000|NOT COMPLETED|Implementation Year 1||3202
3162418|NCT01878097|3889787|FG001|NOT COMPLETED|Implementation Year 1||2549
3162419|NCT01878097|3889786|FG000|STARTED|Implementation Year 2||11567
3162420|NCT01878097|3889787|FG001|STARTED|Implementation Year 2||9611
3162421|NCT01878097|3889786|FG000|COMPLETED|Implementation Year 2||8286
3162422|NCT01878097|3889787|FG001|COMPLETED|Implementation Year 2||6770
3162423|NCT01878097|3889786|FG000|NOT COMPLETED|Implementation Year 2||3281
3059202|NCT01261611|3779964|FG002|NOT COMPLETED|Treatment Cycle 2||0
3059203|NCT01261611|3779962|FG000|STARTED|Treatment Cycle 3||346
3059204|NCT01261611|3779963|FG001|STARTED|Treatment Cycle 3||0
3059205|NCT01261611|3779964|FG002|STARTED|Treatment Cycle 3||0
3059206|NCT01261611|3779962|FG000|COMPLETED|Treatment Cycle 3||316
3059207|NCT01261611|3779963|FG001|COMPLETED|Treatment Cycle 3||0
3059208|NCT01261611|3779964|FG002|COMPLETED|Treatment Cycle 3||0
3059209|NCT01261611|3779962|FG000|NOT COMPLETED|Treatment Cycle 3||30
3059210|NCT01261611|3779963|FG001|NOT COMPLETED|Treatment Cycle 3||0
3059211|NCT01261611|3779964|FG002|NOT COMPLETED|Treatment Cycle 3||0
3059212|NCT01261611|3779962|FG000|STARTED|Treatment Cycle 4||316
3059213|NCT01261611|3779963|FG001|STARTED|Treatment Cycle 4||0
3059214|NCT01261611|3779964|FG002|STARTED|Treatment Cycle 4||0
3059215|NCT01261611|3779962|FG000|COMPLETED|Treatment Cycle 4||220
3059216|NCT01261611|3779963|FG001|COMPLETED|Treatment Cycle 4||0
3059217|NCT01261611|3779964|FG002|COMPLETED|Treatment Cycle 4||0
3059218|NCT01261611|3779962|FG000|NOT COMPLETED|Treatment Cycle 4||96
3059219|NCT01261611|3779963|FG001|NOT COMPLETED|Treatment Cycle 4||0
3059220|NCT01261611|3779964|FG002|NOT COMPLETED|Treatment Cycle 4||0
3059221|NCT01261611|3779962|FG000|STARTED|Treatment Cycle 5||220
3059222|NCT01261611|3779963|FG001|STARTED|Treatment Cycle 5||0
3059223|NCT01261611|3779964|FG002|STARTED|Treatment Cycle 5||0
3059224|NCT01261611|3779962|FG000|COMPLETED|Treatment Cycle 5||217
3059225|NCT01261611|3779963|FG001|COMPLETED|Treatment Cycle 5||0
3059226|NCT01261611|3779964|FG002|COMPLETED|Treatment Cycle 5||0
3059227|NCT01261611|3779962|FG000|NOT COMPLETED|Treatment Cycle 5||3
3059228|NCT01261611|3779963|FG001|NOT COMPLETED|Treatment Cycle 5||0
3059229|NCT01261611|3779964|FG002|NOT COMPLETED|Treatment Cycle 5||0
3059230|NCT01261624|3779978|FG000|STARTED|Week 0 to Week 12||10
3059231|NCT01261624|3779979|FG001|STARTED|Week 0 to Week 12||6
3059232|NCT01261624|3779978|FG000|COMPLETED|Week 0 to Week 12||9
3059233|NCT01261624|3779979|FG001|COMPLETED|Week 0 to Week 12||3
3059234|NCT01261624|3779978|FG000|NOT COMPLETED|Week 0 to Week 12||1
3059235|NCT01261624|3779979|FG001|NOT COMPLETED|Week 0 to Week 12||3
3059236|NCT01261624|3779978|FG000|STARTED|Week 13 to Week 24|Of 9 pts from LDTC: 5 non-responders switched to HDTC; 4 pts responded, but 3 switched to HDTC|1
3059237|NCT01261624|3779979|FG001|STARTED|Week 13 to Week 24|Of 6 pts of HDTC: 3 non-responders went out of study, 3 continued. 8 swithched from LDTC to HDTC|11
3059238|NCT01261624|3779978|FG000|COMPLETED|Week 13 to Week 24||1
3059239|NCT01261624|3779979|FG001|COMPLETED|Week 13 to Week 24||10
3059240|NCT01261624|3779978|FG000|NOT COMPLETED|Week 13 to Week 24||0
3059241|NCT01261624|3779979|FG001|NOT COMPLETED|Week 13 to Week 24||1
3059242|NCT01261780|3779993|FG000|STARTED|Overall Study||7
3059243|NCT01261780|3779994|FG001|STARTED|Overall Study||7
3059244|NCT01261780|3779993|FG000|COMPLETED|Overall Study||5
3059245|NCT01261780|3779994|FG001|COMPLETED|Overall Study||5
3059246|NCT01261780|3779993|FG000|NOT COMPLETED|Overall Study||2
3059247|NCT01261780|3779994|FG001|NOT COMPLETED|Overall Study||2
3059248|NCT01261793|3780003|FG000|STARTED|Overall Study||263
3059249|NCT01261793|3780004|FG001|STARTED|Overall Study||262
3059250|NCT01261793|3780005|FG002|STARTED|Overall Study||266
3059251|NCT01261793|3780003|FG000|COMPLETED|Overall Study||178
3059252|NCT01261793|3780004|FG001|COMPLETED|Overall Study||171
3059253|NCT01261793|3780005|FG002|COMPLETED|Overall Study||184
3059254|NCT01261793|3780003|FG000|NOT COMPLETED|Overall Study||85
3059255|NCT01261793|3780004|FG001|NOT COMPLETED|Overall Study||91
3059256|NCT01261793|3780005|FG002|NOT COMPLETED|Overall Study||82
3059257|NCT01261819|3780015|FG000|STARTED|Overall Study||33
3059258|NCT01261819|3780016|FG001|STARTED|Overall Study||33
3059259|NCT01261819|3780015|FG000|COMPLETED|Overall Study||33
3059260|NCT01261819|3780016|FG001|COMPLETED|Overall Study||33
3059261|NCT01261819|3780015|FG000|NOT COMPLETED|Overall Study||0
3059262|NCT01261819|3780016|FG001|NOT COMPLETED|Overall Study||0
3059263|NCT01261975|3780022|FG000|STARTED|Overall Study|36 Participants 72 eyes started|36
3059264|NCT01261975|3780022|FG000|COMPLETED|Overall Study|35 Participants 70 eyes completed|35
3059265|NCT01261975|3780022|FG000|NOT COMPLETED|Overall Study||1
3059266|NCT01262027|3780029|FG000|STARTED|Overall Study||22
3059267|NCT01262027|3780029|FG000|COMPLETED|Overall Study||17
3059268|NCT01262027|3780029|FG000|NOT COMPLETED|Overall Study||5
3059269|NCT01262092|3780035|FG000|STARTED|Buprenorphine+Gabapentin/Plac Induction||16
3059270|NCT01262092|3780036|FG001|STARTED|Buprenorphine+Gabapentin/Plac Induction||14
3059271|NCT01262092|3780035|FG000|COMPLETED|Buprenorphine+Gabapentin/Plac Induction||13
3059272|NCT01262092|3780036|FG001|COMPLETED|Buprenorphine+Gabapentin/Plac Induction||13
3059273|NCT01262092|3780035|FG000|NOT COMPLETED|Buprenorphine+Gabapentin/Plac Induction||3
3059274|NCT01262092|3780036|FG001|NOT COMPLETED|Buprenorphine+Gabapentin/Plac Induction||1
3059275|NCT01262092|3780035|FG000|STARTED|Buprenorphine Taper|One left the study prior to starting the taper due to pharmacy error (started taper in wk 2)|12
3059276|NCT01262092|3780036|FG001|STARTED|Buprenorphine Taper||13
3059277|NCT01262092|3780035|FG000|COMPLETED|Buprenorphine Taper||11
3059278|NCT01262092|3780036|FG001|COMPLETED|Buprenorphine Taper||12
3059279|NCT01262092|3780035|FG000|NOT COMPLETED|Buprenorphine Taper||1
3059280|NCT01262092|3780036|FG001|NOT COMPLETED|Buprenorphine Taper||1
3059281|NCT01262092|3780035|FG000|STARTED|Gabapentin Taper|One participant dropped out after the buprenorphine taper but prior to the gabapentin taper|10
3059282|NCT01262092|3780036|FG001|STARTED|Gabapentin Taper|One participant dropped out after the buprenorphine taper but prior to the gabapentin taper|11
3059283|NCT01262092|3780035|FG000|COMPLETED|Gabapentin Taper||9
3059284|NCT01262092|3780036|FG001|COMPLETED|Gabapentin Taper||11
3059285|NCT01262092|3780035|FG000|NOT COMPLETED|Gabapentin Taper||1
3059286|NCT01262092|3780036|FG001|NOT COMPLETED|Gabapentin Taper||0
3059287|NCT01262105|3780044|FG000|STARTED|Overall Study||13
3059288|NCT01262105|3780045|FG001|STARTED|Overall Study||10
3059289|NCT01262105|3780044|FG000|COMPLETED|Overall Study||13
3059290|NCT01262105|3780045|FG001|COMPLETED|Overall Study||10
3059291|NCT01262105|3780044|FG000|NOT COMPLETED|Overall Study||0
3059292|NCT01262105|3780045|FG001|NOT COMPLETED|Overall Study||0
3059293|NCT01262118|3780053|FG000|STARTED|Baseline Assessment Period (3 Days)||36
3059294|NCT01262118|3780054|FG001|STARTED|Baseline Assessment Period (3 Days)||33
3059295|NCT01262118|3780053|FG000|COMPLETED|Baseline Assessment Period (3 Days)||36
3059296|NCT01262118|3780054|FG001|COMPLETED|Baseline Assessment Period (3 Days)||33
3059297|NCT01262118|3780053|FG000|NOT COMPLETED|Baseline Assessment Period (3 Days)||0
3162424|NCT01878097|3889787|FG001|NOT COMPLETED|Implementation Year 2||2841
3162425|NCT01878097|3889786|FG000|STARTED|Implementation Year 3||10540
3162426|NCT01878097|3889787|FG001|STARTED|Implementation Year 3||9750
3162427|NCT01878097|3889786|FG000|COMPLETED|Implementation Year 3||7046
3162428|NCT01878097|3889787|FG001|COMPLETED|Implementation Year 3||6770
3162429|NCT01878097|3889786|FG000|NOT COMPLETED|Implementation Year 3||3494
3059298|NCT01262118|3780054|FG001|NOT COMPLETED|Baseline Assessment Period (3 Days)||0
3059299|NCT01262118|3780053|FG000|STARTED|Treatment Period (6 Weeks)||36
3059300|NCT01262118|3780054|FG001|STARTED|Treatment Period (6 Weeks)||0
3059301|NCT01262118|3780053|FG000|COMPLETED|Treatment Period (6 Weeks)||36
3059302|NCT01262118|3780054|FG001|COMPLETED|Treatment Period (6 Weeks)||0
3059303|NCT01262118|3780053|FG000|NOT COMPLETED|Treatment Period (6 Weeks)||0
3162430|NCT01878097|3889787|FG001|NOT COMPLETED|Implementation Year 3||2980
3162431|NCT01878097|3889786|FG000|STARTED|Implementation Year 4||10585
3162432|NCT01878097|3889787|FG001|STARTED|Implementation Year 4||9614
3162433|NCT01878097|3889786|FG000|COMPLETED|Implementation Year 4||6981
3162434|NCT01878097|3889787|FG001|COMPLETED|Implementation Year 4||6607
3162435|NCT01878097|3889786|FG000|NOT COMPLETED|Implementation Year 4||3604
3162436|NCT01878097|3889787|FG001|NOT COMPLETED|Implementation Year 4||3007
3162437|NCT01878149|3889795|FG000|STARTED|Overall Study||21
3162438|NCT01878149|3889796|FG001|STARTED|Overall Study||17
3162439|NCT01878149|3889795|FG000|COMPLETED|Overall Study||19
3162440|NCT01878149|3889796|FG001|COMPLETED|Overall Study||15
3162441|NCT01878149|3889795|FG000|NOT COMPLETED|Overall Study||2
3162442|NCT01878149|3889796|FG001|NOT COMPLETED|Overall Study||2
3059304|NCT01262118|3780054|FG001|NOT COMPLETED|Treatment Period (6 Weeks)||0
3059305|NCT01262131|3780063|FG000|STARTED|Overall Study||5
3059306|NCT01262131|3780064|FG001|STARTED|Overall Study||4
3059307|NCT01262131|3780065|FG002|STARTED|Overall Study||4
3059308|NCT01262131|3780063|FG000|COMPLETED|Overall Study||5
3059309|NCT01262131|3780064|FG001|COMPLETED|Overall Study||4
3059310|NCT01262131|3780065|FG002|COMPLETED|Overall Study||4
3059311|NCT01262131|3780063|FG000|NOT COMPLETED|Overall Study||0
3059312|NCT01262131|3780064|FG001|NOT COMPLETED|Overall Study||0
3162443|NCT01878175|3889802|FG000|STARTED|Overall Study||15
3162444|NCT01878175|3889802|FG000|COMPLETED|Overall Study||13
3162445|NCT01878175|3889802|FG000|NOT COMPLETED|Overall Study||2
3059313|NCT01262131|3780065|FG002|NOT COMPLETED|Overall Study||0
3059314|NCT01262287|3780075|FG000|STARTED|Overall Study||20
3059315|NCT01262287|3780076|FG001|STARTED|Overall Study||19
3059316|NCT01262287|3780075|FG000|COMPLETED|Overall Study||18
3059317|NCT01262287|3780076|FG001|COMPLETED|Overall Study||18
3059318|NCT01262287|3780075|FG000|NOT COMPLETED|Overall Study||2
3059319|NCT01262287|3780076|FG001|NOT COMPLETED|Overall Study||1
3059320|NCT01262352|3780088|FG000|STARTED|Period 1||11
3059321|NCT01262352|3780089|FG001|STARTED|Period 1||10
3059322|NCT01262352|3780088|FG000|Dosed|Period 1||10
3059323|NCT01262352|3780089|FG001|Dosed|Period 1||10
3059324|NCT01262352|3780088|FG000|COMPLETED|Period 1||10
3059325|NCT01262352|3780089|FG001|COMPLETED|Period 1||10
3059326|NCT01262352|3780088|FG000|NOT COMPLETED|Period 1||1
3059327|NCT01262352|3780089|FG001|NOT COMPLETED|Period 1||0
3059328|NCT01262352|3780088|FG000|STARTED|Washout||10
3059329|NCT01262352|3780089|FG001|STARTED|Washout||10
3059330|NCT01262352|3780088|FG000|COMPLETED|Washout||9
3059331|NCT01262352|3780089|FG001|COMPLETED|Washout||8
3059332|NCT01262352|3780088|FG000|NOT COMPLETED|Washout||1
3059333|NCT01262352|3780089|FG001|NOT COMPLETED|Washout||2
3059334|NCT01262352|3780088|FG000|STARTED|Period 2||9
3059335|NCT01262352|3780089|FG001|STARTED|Period 2||8
3059336|NCT01262352|3780088|FG000|Dosed|Period 2||9
3059337|NCT01262352|3780089|FG001|Dosed|Period 2||8
3059338|NCT01262352|3780088|FG000|COMPLETED|Period 2||9
3059339|NCT01262352|3780089|FG001|COMPLETED|Period 2||8
3059340|NCT01262352|3780088|FG000|NOT COMPLETED|Period 2||0
3059341|NCT01262352|3780089|FG001|NOT COMPLETED|Period 2||0
3059342|NCT01262365|3780098|FG000|STARTED|Overall Study||266
3059343|NCT01262365|3780099|FG001|STARTED|Overall Study||262
3059344|NCT01262365|3780100|FG002|STARTED|Overall Study||265
3059345|NCT01262365|3780098|FG000|COMPLETED|Overall Study||176
3059346|NCT01262365|3780099|FG001|COMPLETED|Overall Study||181
3059347|NCT01262365|3780100|FG002|COMPLETED|Overall Study||171
3059348|NCT01262365|3780098|FG000|NOT COMPLETED|Overall Study||90
3059349|NCT01262365|3780099|FG001|NOT COMPLETED|Overall Study||81
3059350|NCT01262365|3780100|FG002|NOT COMPLETED|Overall Study||94
3059351|NCT01262456|3780111|FG000|STARTED|3-Month Double-Blind Period|Intent-to-Treat (ITT) population: randomized participants regardless of exposure to treatment|143
3059352|NCT01262456|3780112|FG001|STARTED|3-Month Double-Blind Period|ITT population: randomized participants regardless of exposure to treatment|123
3059353|NCT01262456|3780113|FG002|STARTED|3-Month Double-Blind Period|ITT population: randomized participants regardless of exposure to treatment|129
3059354|NCT01262456|3780111|FG000|Full Analysis Set (FAS)|3-Month Double-Blind Period|FAS: ITT with at least 1 post-treatment efficacy assessment. Analysis as randomized.|142
3059355|NCT01262456|3780112|FG001|Full Analysis Set (FAS)|3-Month Double-Blind Period|FAS: ITT with at least 1 post-treatment efficacy assessment. Analysis as randomized.|119
3059356|NCT01262456|3780113|FG002|Full Analysis Set (FAS)|3-Month Double-Blind Period|FAS: ITT with at least 1 post-treatment efficacy assessment. Analysis as randomized.|124
3059357|NCT01262456|3780111|FG000|Safety Analysis Set (SAS)|3-Month Double-Blind Period|SAS: received at least 1 dose and had at least 1 safety assessment. Analysis on actual treatment.|143
3059358|NCT01262456|3780112|FG001|Safety Analysis Set (SAS)|3-Month Double-Blind Period|SAS: received at least 1 dose and had at least 1 safety assessment. Analysis on actual treatment.|119
3059359|NCT01262456|3780113|FG002|Safety Analysis Set (SAS)|3-Month Double-Blind Period|SAS: received at least 1 dose and had at least 1 safety assessment. Analysis on actual treatment.|122
3059360|NCT01262456|3780111|FG000|COMPLETED|3-Month Double-Blind Period||124
3059361|NCT01262456|3780112|FG001|COMPLETED|3-Month Double-Blind Period||100
3059362|NCT01262456|3780113|FG002|COMPLETED|3-Month Double-Blind Period||103
3059363|NCT01262456|3780111|FG000|NOT COMPLETED|3-Month Double-Blind Period||19
3059364|NCT01262456|3780112|FG001|NOT COMPLETED|3-Month Double-Blind Period||23
3059365|NCT01262456|3780113|FG002|NOT COMPLETED|3-Month Double-Blind Period||26
3059366|NCT01262456|3780111|FG000|STARTED|1-Month Open-Label Extension Period||124
3059367|NCT01262456|3780112|FG001|STARTED|1-Month Open-Label Extension Period||100
3059368|NCT01262456|3780113|FG002|STARTED|1-Month Open-Label Extension Period||103
3059369|NCT01262456|3780111|FG000|Safety Analysis Set (SAS)|1-Month Open-Label Extension Period||124
3059370|NCT01262456|3780112|FG001|Safety Analysis Set (SAS)|1-Month Open-Label Extension Period||101
3059371|NCT01262456|3780113|FG002|Safety Analysis Set (SAS)|1-Month Open-Label Extension Period|1 subject was randomized to Desmopressin 75 μg but received 50 μg. Also true in Double-Blind Period|102
3059372|NCT01262456|3780111|FG000|COMPLETED|1-Month Open-Label Extension Period||120
3059373|NCT01262456|3780112|FG001|COMPLETED|1-Month Open-Label Extension Period||97
3059374|NCT01262456|3780113|FG002|COMPLETED|1-Month Open-Label Extension Period||98
3059375|NCT01262456|3780111|FG000|NOT COMPLETED|1-Month Open-Label Extension Period||4
3059376|NCT01262456|3780112|FG001|NOT COMPLETED|1-Month Open-Label Extension Period||3
3059377|NCT01262456|3780113|FG002|NOT COMPLETED|1-Month Open-Label Extension Period||5
3059378|NCT01262547|3780129|FG000|STARTED|Overall Study||3
3059379|NCT01262547|3780129|FG000|COMPLETED|Overall Study||3
3059380|NCT01262547|3780129|FG000|NOT COMPLETED|Overall Study||0
3059381|NCT01262560|3780141|FG000|STARTED|Overall Study||53
3059382|NCT01262560|3780142|FG001|STARTED|Overall Study||54
3059383|NCT01262560|3780143|FG002|STARTED|Overall Study||56
3059384|NCT01262560|3780141|FG000|COMPLETED|Overall Study|Randomized eligible patients who received protocol treatment.|53
3059385|NCT01262560|3780142|FG001|COMPLETED|Overall Study|Randomized eligible patients who received protocol treatment.|53
3059386|NCT01262560|3780143|FG002|COMPLETED|Overall Study|Randomized eligible patients who received protocol treatment.|54
3059387|NCT01262560|3780141|FG000|NOT COMPLETED|Overall Study||0
3059388|NCT01262560|3780142|FG001|NOT COMPLETED|Overall Study||1
3059389|NCT01262560|3780143|FG002|NOT COMPLETED|Overall Study||2
3059390|NCT01262573|3780153|FG000|STARTED|Overall Study||32
3059391|NCT01262573|3780154|FG001|STARTED|Overall Study||32
3059392|NCT01262573|3780153|FG000|COMPLETED|Overall Study||32
3059393|NCT01262573|3780154|FG001|COMPLETED|Overall Study||31
3059394|NCT01262573|3780153|FG000|NOT COMPLETED|Overall Study||0
3059395|NCT01262573|3780154|FG001|NOT COMPLETED|Overall Study||1
3059396|NCT01262599|3780162|FG000|STARTED|Overall Study||16
3059397|NCT01262599|3780163|FG001|STARTED|Overall Study||16
3059398|NCT01262599|3780162|FG000|COMPLETED|Overall Study||16
3059399|NCT01262599|3780163|FG001|COMPLETED|Overall Study||16
3059400|NCT01262599|3780162|FG000|NOT COMPLETED|Overall Study||0
3059401|NCT01262599|3780163|FG001|NOT COMPLETED|Overall Study||0
3059402|NCT01262638|3780175|FG000|STARTED|Overall Study||45
3059403|NCT01262638|3780176|FG001|STARTED|Overall Study||44
3059404|NCT01262638|3780177|FG002|STARTED|Overall Study||44
3059405|NCT01262638|3780178|FG003|STARTED|Overall Study||44
3059406|NCT01262638|3780175|FG000|COMPLETED|Overall Study||38
3059407|NCT01262638|3780176|FG001|COMPLETED|Overall Study||38
3059408|NCT01262638|3780177|FG002|COMPLETED|Overall Study||38
3059409|NCT01262638|3780178|FG003|COMPLETED|Overall Study||37
3059410|NCT01262638|3780175|FG000|NOT COMPLETED|Overall Study||7
3059411|NCT01262638|3780176|FG001|NOT COMPLETED|Overall Study||6
3059412|NCT01262638|3780177|FG002|NOT COMPLETED|Overall Study||6
3059413|NCT01262638|3780178|FG003|NOT COMPLETED|Overall Study||7
3059414|NCT01262651|3780193|FG000|STARTED|Overall Study||199
3059415|NCT01262651|3780194|FG001|STARTED|Overall Study||198
3059416|NCT01262651|3780193|FG000|Received at Least 1 Dose of Study Drug|Overall Study||199
3059417|NCT01262651|3780194|FG001|Received at Least 1 Dose of Study Drug|Overall Study||198
3059418|NCT01262651|3780193|FG000|Safety Population|Overall Study||199
3059419|NCT01262651|3780194|FG001|Safety Population|Overall Study||198
3059420|NCT01262651|3780193|FG000|ITT Population|Overall Study||199
3059421|NCT01262651|3780194|FG001|ITT Population|Overall Study||198
3059422|NCT01262651|3780193|FG000|COMPLETED|Overall Study||141
3059423|NCT01262651|3780194|FG001|COMPLETED|Overall Study||150
3059424|NCT01262651|3780193|FG000|NOT COMPLETED|Overall Study||58
3162446|NCT01878214|3889809|FG000|STARTED|Overall Study||223
3162447|NCT01878214|3889810|FG001|STARTED|Overall Study||219
3162448|NCT01878214|3889809|FG000|COMPLETED|Overall Study||170
3162449|NCT01878214|3889810|FG001|COMPLETED|Overall Study||175
3162450|NCT01878214|3889809|FG000|NOT COMPLETED|Overall Study||53
3162451|NCT01878214|3889810|FG001|NOT COMPLETED|Overall Study||44
3162452|NCT01878253|3889816|FG000|STARTED|Overall Study||95
3162453|NCT01878253|3889816|FG000|Pre-Operative|Overall Study||95
3162454|NCT01878253|3889816|FG000|6 Weeks|Overall Study||95
3162455|NCT01878253|3889816|FG000|6 Months|Overall Study||90
3162456|NCT01878253|3889816|FG000|1 Year|Overall Study||88
3162457|NCT01878253|3889816|FG000|2 Year|Overall Study||86
3162458|NCT01878253|3889816|FG000|COMPLETED|Overall Study||86
3162459|NCT01878253|3889816|FG000|NOT COMPLETED|Overall Study||9
3162460|NCT01878292|3889828|FG000|STARTED|Randomized||174
3162461|NCT01878292|3889829|FG001|STARTED|Randomized||175
3162462|NCT01878292|3889830|FG002|STARTED|Randomized||180
3162463|NCT01878292|3889828|FG000|COMPLETED|Randomized||171
3162464|NCT01878292|3889829|FG001|COMPLETED|Randomized||175
3162465|NCT01878292|3889830|FG002|COMPLETED|Randomized||180
3162466|NCT01878292|3889828|FG000|NOT COMPLETED|Randomized||3
3162467|NCT01878292|3889829|FG001|NOT COMPLETED|Randomized||0
3162468|NCT01878292|3889830|FG002|NOT COMPLETED|Randomized||0
3162469|NCT01878292|3889828|FG000|STARTED|Double-blind Treatment Period||171
3162470|NCT01878292|3889829|FG001|STARTED|Double-blind Treatment Period||175
3162471|NCT01878292|3889830|FG002|STARTED|Double-blind Treatment Period||180
3162472|NCT01878292|3889828|FG000|COMPLETED|Double-blind Treatment Period||142
3162473|NCT01878292|3889829|FG001|COMPLETED|Double-blind Treatment Period||149
3162474|NCT01878292|3889830|FG002|COMPLETED|Double-blind Treatment Period||161
3162475|NCT01878292|3889828|FG000|NOT COMPLETED|Double-blind Treatment Period||29
3162476|NCT01878292|3889829|FG001|NOT COMPLETED|Double-blind Treatment Period||26
3162477|NCT01878292|3889830|FG002|NOT COMPLETED|Double-blind Treatment Period||19
3162478|NCT01878292|3889828|FG000|STARTED|Double-blind Down-Taper Period||127
3162479|NCT01878292|3889829|FG001|STARTED|Double-blind Down-Taper Period||140
3162480|NCT01878292|3889830|FG002|STARTED|Double-blind Down-Taper Period||146
3162481|NCT01878292|3889828|FG000|COMPLETED|Double-blind Down-Taper Period||122
3162482|NCT01878292|3889829|FG001|COMPLETED|Double-blind Down-Taper Period||132
3162483|NCT01878292|3889830|FG002|COMPLETED|Double-blind Down-Taper Period||142
3162484|NCT01878292|3889828|FG000|NOT COMPLETED|Double-blind Down-Taper Period||5
3162485|NCT01878292|3889829|FG001|NOT COMPLETED|Double-blind Down-Taper Period||8
3162486|NCT01878292|3889830|FG002|NOT COMPLETED|Double-blind Down-Taper Period||4
3162487|NCT01878383|3889840|FG000|STARTED|Overall Study||50
3162488|NCT01878383|3889841|FG001|STARTED|Overall Study||12500
3162489|NCT01878383|3889840|FG000|COMPLETED|Overall Study||50
3162490|NCT01878383|3889841|FG001|COMPLETED|Overall Study||11001
3162491|NCT01878383|3889840|FG000|NOT COMPLETED|Overall Study||0
3059425|NCT01262651|3780194|FG001|NOT COMPLETED|Overall Study||48
3059426|NCT01262677|3780203|FG000|STARTED|Overall Study||100
3059427|NCT01262677|3780204|FG001|STARTED|Overall Study||113
3059428|NCT01262677|3780205|FG002|STARTED|Overall Study||110
3059429|NCT01262677|3780203|FG000|COMPLETED|Overall Study||91
3059430|NCT01262677|3780204|FG001|COMPLETED|Overall Study||98
3059431|NCT01262677|3780205|FG002|COMPLETED|Overall Study||98
3162492|NCT01878383|3889841|FG001|NOT COMPLETED|Overall Study||1499
3162493|NCT01878526|3889849|FG000|STARTED|Overall Study||40
3162494|NCT01878526|3889850|FG001|STARTED|Overall Study||40
3162495|NCT01878526|3889849|FG000|COMPLETED|Overall Study||37
3162496|NCT01878526|3889850|FG001|COMPLETED|Overall Study||38
3162497|NCT01878526|3889849|FG000|NOT COMPLETED|Overall Study||3
3059432|NCT01262677|3780203|FG000|NOT COMPLETED|Overall Study||9
3059433|NCT01262677|3780204|FG001|NOT COMPLETED|Overall Study||15
3059434|NCT01262677|3780205|FG002|NOT COMPLETED|Overall Study||12
3059435|NCT01262755|3780213|FG000|STARTED|Overall Study||450
3059436|NCT01262755|3780213|FG000|COMPLETED|Overall Study||450
3059437|NCT01262755|3780213|FG000|NOT COMPLETED|Overall Study||0
3059438|NCT01262820|3780217|FG000|STARTED|Overall Study||15
3059439|NCT01262820|3780217|FG000|COMPLETED|Overall Study||0
3059440|NCT01262820|3780217|FG000|NOT COMPLETED|Overall Study||15
3059441|NCT01262846|3780223|FG000|STARTED|Overall Study||95
3059442|NCT01262846|3780224|FG001|STARTED|Overall Study||100
3059443|NCT01262846|3780223|FG000|COMPLETED|Overall Study||93
3059444|NCT01262846|3780224|FG001|COMPLETED|Overall Study||97
3059445|NCT01262846|3780223|FG000|NOT COMPLETED|Overall Study||2
3059446|NCT01262846|3780224|FG001|NOT COMPLETED|Overall Study||3
3059447|NCT01262872|3780238|FG000|STARTED|Step 1||60
3059448|NCT01262872|3780239|FG001|STARTED|Step 1||60
3059449|NCT01262872|3780240|FG002|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
3059450|NCT01262872|3780241|FG003|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
3059451|NCT01262872|3780242|FG004|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
3059452|NCT01262872|3780243|FG005|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
3059453|NCT01262872|3780244|FG006|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
3059454|NCT01262872|3780245|FG007|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
3059455|NCT01262872|3780238|FG000|COMPLETED|Step 1||60
3059456|NCT01262872|3780239|FG001|COMPLETED|Step 1||60
3059457|NCT01262872|3780240|FG002|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
3059458|NCT01262872|3780241|FG003|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone|0
3162498|NCT01878526|3889850|FG001|NOT COMPLETED|Overall Study||2
3162499|NCT01878604|3889857|FG000|STARTED|Overall Study||5
3162500|NCT01878604|3889857|FG000|COMPLETED|Overall Study||5
3162501|NCT01878604|3889857|FG000|NOT COMPLETED|Overall Study||0
3162502|NCT01878656|3889864|FG000|STARTED|Overall Study||72
3162503|NCT01878656|3889865|FG001|STARTED|Overall Study||72
3162504|NCT01878656|3889864|FG000|COMPLETED|Overall Study||72
3162505|NCT01878656|3889865|FG001|COMPLETED|Overall Study||72
3162506|NCT01878656|3889864|FG000|NOT COMPLETED|Overall Study||0
3162507|NCT01878656|3889865|FG001|NOT COMPLETED|Overall Study||0
3162508|NCT01878799|3889873|FG000|STARTED|Overall Study||37
3162509|NCT01878799|3889874|FG001|STARTED|Overall Study||13
3059459|NCT01262872|3780242|FG004|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
3059460|NCT01262872|3780243|FG005|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
3059461|NCT01262872|3780244|FG006|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
3059462|NCT01262872|3780245|FG007|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
3059463|NCT01262872|3780238|FG000|NOT COMPLETED|Step 1||0
3059464|NCT01262872|3780239|FG001|NOT COMPLETED|Step 1||0
3059465|NCT01262872|3780240|FG002|NOT COMPLETED|Step 1||0
3059466|NCT01262872|3780241|FG003|NOT COMPLETED|Step 1||0
3059467|NCT01262872|3780242|FG004|NOT COMPLETED|Step 1||0
3059468|NCT01262872|3780243|FG005|NOT COMPLETED|Step 1||0
3059469|NCT01262872|3780244|FG006|NOT COMPLETED|Step 1||0
3059470|NCT01262872|3780245|FG007|NOT COMPLETED|Step 1||0
3059471|NCT01262872|3780238|FG000|STARTED|Step 2|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
3059472|NCT01262872|3780239|FG001|STARTED|Step 2|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
3059473|NCT01262872|3780240|FG002|STARTED|Step 2||200
3059474|NCT01262872|3780241|FG003|STARTED|Step 2||200
3059475|NCT01262872|3780242|FG004|STARTED|Step 2||200
3059476|NCT01262872|3780243|FG005|STARTED|Step 2||200
3059477|NCT01262872|3780244|FG006|STARTED|Step 2||200
3059478|NCT01262872|3780245|FG007|STARTED|Step 2||200
3059479|NCT01262872|3780238|FG000|COMPLETED|Step 2|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
3059480|NCT01262872|3780239|FG001|COMPLETED|Step 2|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
3059481|NCT01262872|3780240|FG002|COMPLETED|Step 2||191
3059482|NCT01262872|3780241|FG003|COMPLETED|Step 2||190
3059483|NCT01262872|3780242|FG004|COMPLETED|Step 2||195
3059484|NCT01262872|3780243|FG005|COMPLETED|Step 2||191
3059485|NCT01262872|3780244|FG006|COMPLETED|Step 2||191
3059486|NCT01262872|3780245|FG007|COMPLETED|Step 2||194
3059487|NCT01262872|3780238|FG000|NOT COMPLETED|Step 2||0
3059488|NCT01262872|3780239|FG001|NOT COMPLETED|Step 2||0
3059489|NCT01262872|3780240|FG002|NOT COMPLETED|Step 2||9
3059490|NCT01262872|3780241|FG003|NOT COMPLETED|Step 2||10
3162510|NCT01878799|3889873|FG000|COMPLETED|Overall Study||36
3059491|NCT01262872|3780242|FG004|NOT COMPLETED|Step 2||5
3059492|NCT01262872|3780243|FG005|NOT COMPLETED|Step 2||9
3059493|NCT01262872|3780244|FG006|NOT COMPLETED|Step 2||9
3059494|NCT01262872|3780245|FG007|NOT COMPLETED|Step 2||6
3059495|NCT01262898|3780283|FG000|STARTED|Overall Study||21
3059496|NCT01262898|3780284|FG001|STARTED|Overall Study||18
3059497|NCT01262898|3780285|FG002|STARTED|Overall Study||18
3059498|NCT01262898|3780286|FG003|STARTED|Overall Study||22
3059499|NCT01262898|3780283|FG000|COMPLETED|Overall Study||18
3059500|NCT01262898|3780284|FG001|COMPLETED|Overall Study||16
3059501|NCT01262898|3780285|FG002|COMPLETED|Overall Study||18
3059502|NCT01262898|3780286|FG003|COMPLETED|Overall Study||22
3059503|NCT01262898|3780283|FG000|NOT COMPLETED|Overall Study||3
3059504|NCT01262898|3780284|FG001|NOT COMPLETED|Overall Study||2
3059505|NCT01262898|3780285|FG002|NOT COMPLETED|Overall Study||0
3059506|NCT01262898|3780286|FG003|NOT COMPLETED|Overall Study||0
3059507|NCT01262976|3780305|FG000|STARTED|Up to Month 2||40
3059508|NCT01262976|3780306|FG001|STARTED|Up to Month 2||40
3059509|NCT01262976|3780307|FG002|STARTED|Up to Month 2||40
3059510|NCT01262976|3780308|FG003|STARTED|Up to Month 2||40
3059511|NCT01262976|3780309|FG004|STARTED|Up to Month 2||40
3059512|NCT01262976|3780310|FG005|STARTED|Up to Month 2||40
3059513|NCT01262976|3780305|FG000|COMPLETED|Up to Month 2||37
3059514|NCT01262976|3780306|FG001|COMPLETED|Up to Month 2||39
3059515|NCT01262976|3780307|FG002|COMPLETED|Up to Month 2||39
3059516|NCT01262976|3780308|FG003|COMPLETED|Up to Month 2||38
3059517|NCT01262976|3780309|FG004|COMPLETED|Up to Month 2||38
3059518|NCT01262976|3780310|FG005|COMPLETED|Up to Month 2||36
3059519|NCT01262976|3780305|FG000|NOT COMPLETED|Up to Month 2||3
3059520|NCT01262976|3780306|FG001|NOT COMPLETED|Up to Month 2||1
3162511|NCT01878799|3889874|FG001|COMPLETED|Overall Study||13
3162512|NCT01878799|3889873|FG000|NOT COMPLETED|Overall Study||1
3162513|NCT01878799|3889874|FG001|NOT COMPLETED|Overall Study||0
3162514|NCT01878812|3889882|FG000|STARTED|Overall Study||60
3162515|NCT01878812|3889883|FG001|STARTED|Overall Study||57
3162516|NCT01878812|3889882|FG000|COMPLETED|Overall Study||60
3162517|NCT01878812|3889883|FG001|COMPLETED|Overall Study||57
3162518|NCT01878812|3889882|FG000|NOT COMPLETED|Overall Study||0
3162519|NCT01878812|3889883|FG001|NOT COMPLETED|Overall Study||0
3171750|NCT01936909|3898940|FG001|NOT COMPLETED|Overall Study||8
3171751|NCT01936909|3898941|FG002|NOT COMPLETED|Overall Study||6
3171803|NCT01937299|3899007|FG000|COMPLETED|Overall Study||103
3171804|NCT01937299|3899008|FG001|COMPLETED|Overall Study||112
3171805|NCT01937299|3899007|FG000|NOT COMPLETED|Overall Study||14
3171806|NCT01937299|3899008|FG001|NOT COMPLETED|Overall Study||4
3171807|NCT01937312|3899017|FG000|STARTED|Overall Study||94
3171808|NCT01937312|3899018|FG001|STARTED|Overall Study||95
3171809|NCT01937312|3899017|FG000|Treated|Overall Study||93
3059521|NCT01262976|3780307|FG002|NOT COMPLETED|Up to Month 2||1
3059522|NCT01262976|3780308|FG003|NOT COMPLETED|Up to Month 2||2
3059523|NCT01262976|3780309|FG004|NOT COMPLETED|Up to Month 2||2
3059524|NCT01262976|3780310|FG005|NOT COMPLETED|Up to Month 2||4
3059525|NCT01262976|3780305|FG000|STARTED|Up to Month 7||40
3059526|NCT01262976|3780306|FG001|STARTED|Up to Month 7||40
3059527|NCT01262976|3780307|FG002|STARTED|Up to Month 7||40
3059528|NCT01262976|3780308|FG003|STARTED|Up to Month 7||40
3059529|NCT01262976|3780309|FG004|STARTED|Up to Month 7||40
3059530|NCT01262976|3780310|FG005|STARTED|Up to Month 7||40
3059531|NCT01262976|3780305|FG000|COMPLETED|Up to Month 7||35
3059532|NCT01262976|3780306|FG001|COMPLETED|Up to Month 7||40
3059533|NCT01262976|3780307|FG002|COMPLETED|Up to Month 7||34
3059534|NCT01262976|3780308|FG003|COMPLETED|Up to Month 7||34
3059535|NCT01262976|3780309|FG004|COMPLETED|Up to Month 7||38
3059536|NCT01262976|3780310|FG005|COMPLETED|Up to Month 7||36
3059537|NCT01262976|3780305|FG000|NOT COMPLETED|Up to Month 7||5
3059538|NCT01262976|3780306|FG001|NOT COMPLETED|Up to Month 7||0
3059539|NCT01262976|3780307|FG002|NOT COMPLETED|Up to Month 7||6
3059540|NCT01262976|3780308|FG003|NOT COMPLETED|Up to Month 7||6
3059541|NCT01262976|3780309|FG004|NOT COMPLETED|Up to Month 7||2
3059542|NCT01262976|3780310|FG005|NOT COMPLETED|Up to Month 7||4
3059543|NCT01262976|3780305|FG000|STARTED|Up to Year 1||40
3059544|NCT01262976|3780306|FG001|STARTED|Up to Year 1||40
3059545|NCT01262976|3780307|FG002|STARTED|Up to Year 1||40
3059546|NCT01262976|3780308|FG003|STARTED|Up to Year 1||40
3059547|NCT01262976|3780309|FG004|STARTED|Up to Year 1||40
3059548|NCT01262976|3780310|FG005|STARTED|Up to Year 1||40
3059549|NCT01262976|3780305|FG000|COMPLETED|Up to Year 1||31
3059550|NCT01262976|3780306|FG001|COMPLETED|Up to Year 1||39
3059551|NCT01262976|3780307|FG002|COMPLETED|Up to Year 1||37
3059552|NCT01262976|3780308|FG003|COMPLETED|Up to Year 1||36
3059553|NCT01262976|3780309|FG004|COMPLETED|Up to Year 1||29
3059554|NCT01262976|3780310|FG005|COMPLETED|Up to Year 1||31
3059555|NCT01262976|3780305|FG000|NOT COMPLETED|Up to Year 1||9
3059556|NCT01262976|3780306|FG001|NOT COMPLETED|Up to Year 1||1
3059557|NCT01262976|3780307|FG002|NOT COMPLETED|Up to Year 1||3
3059558|NCT01262976|3780308|FG003|NOT COMPLETED|Up to Year 1||4
3059559|NCT01262976|3780309|FG004|NOT COMPLETED|Up to Year 1||11
3059560|NCT01262976|3780310|FG005|NOT COMPLETED|Up to Year 1||9
3059561|NCT01262976|3780305|FG000|STARTED|Up to Year 2||40
3059562|NCT01262976|3780306|FG001|STARTED|Up to Year 2||40
3059563|NCT01262976|3780307|FG002|STARTED|Up to Year 2||40
3171810|NCT01937312|3899018|FG001|Treated|Overall Study||95
3171811|NCT01937312|3899017|FG000|COMPLETED|Overall Study||83
3171812|NCT01937312|3899018|FG001|COMPLETED|Overall Study||92
3059564|NCT01262976|3780308|FG003|STARTED|Up to Year 2||40
3059565|NCT01262976|3780309|FG004|STARTED|Up to Year 2||40
3059566|NCT01262976|3780310|FG005|STARTED|Up to Year 2||40
3059567|NCT01262976|3780305|FG000|COMPLETED|Up to Year 2||35
3059568|NCT01262976|3780306|FG001|COMPLETED|Up to Year 2||39
3059569|NCT01262976|3780307|FG002|COMPLETED|Up to Year 2||35
3059570|NCT01262976|3780308|FG003|COMPLETED|Up to Year 2||36
3059571|NCT01262976|3780309|FG004|COMPLETED|Up to Year 2||36
3059572|NCT01262976|3780310|FG005|COMPLETED|Up to Year 2||35
3059573|NCT01262976|3780305|FG000|NOT COMPLETED|Up to Year 2||5
3059574|NCT01262976|3780306|FG001|NOT COMPLETED|Up to Year 2||1
3059575|NCT01262976|3780307|FG002|NOT COMPLETED|Up to Year 2||5
3059576|NCT01262976|3780308|FG003|NOT COMPLETED|Up to Year 2||4
3059577|NCT01262976|3780309|FG004|NOT COMPLETED|Up to Year 2||4
3059578|NCT01262976|3780310|FG005|NOT COMPLETED|Up to Year 2||5
3059579|NCT01262976|3780305|FG000|STARTED|Up to Year 3||40
3059580|NCT01262976|3780306|FG001|STARTED|Up to Year 3||40
3059581|NCT01262976|3780307|FG002|STARTED|Up to Year 3||40
3059582|NCT01262976|3780308|FG003|STARTED|Up to Year 3||40
3059583|NCT01262976|3780309|FG004|STARTED|Up to Year 3||40
3059584|NCT01262976|3780310|FG005|STARTED|Up to Year 3||40
3059585|NCT01262976|3780305|FG000|COMPLETED|Up to Year 3||34
3059586|NCT01262976|3780306|FG001|COMPLETED|Up to Year 3||38
3059587|NCT01262976|3780307|FG002|COMPLETED|Up to Year 3||33
3059588|NCT01262976|3780308|FG003|COMPLETED|Up to Year 3||35
3059589|NCT01262976|3780309|FG004|COMPLETED|Up to Year 3||38
3059590|NCT01262976|3780310|FG005|COMPLETED|Up to Year 3||36
3059591|NCT01262976|3780305|FG000|NOT COMPLETED|Up to Year 3||6
3059592|NCT01262976|3780306|FG001|NOT COMPLETED|Up to Year 3||2
3059593|NCT01262976|3780307|FG002|NOT COMPLETED|Up to Year 3||7
3059594|NCT01262976|3780308|FG003|NOT COMPLETED|Up to Year 3||5
3059595|NCT01262976|3780309|FG004|NOT COMPLETED|Up to Year 3||2
3059596|NCT01262976|3780310|FG005|NOT COMPLETED|Up to Year 3||4
3059597|NCT01262989|3780325|FG000|STARTED|Period 1||20
3059598|NCT01262989|3780326|FG001|STARTED|Period 1||20
3059599|NCT01262989|3780325|FG000|COMPLETED|Period 1||19
3059600|NCT01262989|3780326|FG001|COMPLETED|Period 1||17
3059601|NCT01262989|3780325|FG000|NOT COMPLETED|Period 1||1
3059602|NCT01262989|3780326|FG001|NOT COMPLETED|Period 1||3
3059603|NCT01262989|3780325|FG000|STARTED|7-Day Washout Period||19
3059604|NCT01262989|3780326|FG001|STARTED|7-Day Washout Period||17
3059605|NCT01262989|3780325|FG000|COMPLETED|7-Day Washout Period||19
3059606|NCT01262989|3780326|FG001|COMPLETED|7-Day Washout Period||17
3059607|NCT01262989|3780325|FG000|NOT COMPLETED|7-Day Washout Period||0
3059608|NCT01262989|3780326|FG001|NOT COMPLETED|7-Day Washout Period||0
3059609|NCT01262989|3780325|FG000|STARTED|Period 2||19
3059610|NCT01262989|3780326|FG001|STARTED|Period 2||17
3059611|NCT01262989|3780325|FG000|COMPLETED|Period 2||19
2940832|NCT00639158|3653070|FG001|STARTED|Overall Study|1 subject was randomized but not treated because of an abnormal ECG that precluded treatment.|270
2940833|NCT00639158|3653069|FG000|COMPLETED|Overall Study|26 subjects prematurely discontinued treatment.|246
2940834|NCT00639158|3653070|FG001|COMPLETED|Overall Study|30 subjects prematurely discontinued treatment|240
3059612|NCT01262989|3780326|FG001|COMPLETED|Period 2||16
3059613|NCT01262989|3780325|FG000|NOT COMPLETED|Period 2||0
3059614|NCT01262989|3780326|FG001|NOT COMPLETED|Period 2||1
3059615|NCT01263015|3780334|FG000|STARTED|Double-blind Phase: 96 Weeks Duration||414
3059616|NCT01263015|3780335|FG001|STARTED|Double-blind Phase: 96 Weeks Duration||419
3059617|NCT01263015|3780334|FG000|COMPLETED|Double-blind Phase: 96 Weeks Duration||342
3059618|NCT01263015|3780335|FG001|COMPLETED|Double-blind Phase: 96 Weeks Duration||310
3059619|NCT01263015|3780334|FG000|NOT COMPLETED|Double-blind Phase: 96 Weeks Duration||72
3059620|NCT01263015|3780335|FG001|NOT COMPLETED|Double-blind Phase: 96 Weeks Duration||109
3059621|NCT01263015|3780334|FG000|STARTED|Open-label Phase: 48 Weeks Duration||341
3059622|NCT01263015|3780335|FG001|STARTED|Open-label Phase: 48 Weeks Duration||309
3162520|NCT01878825|3889891|FG000|STARTED|Overall Study||60
3162521|NCT01878825|3889892|FG001|STARTED|Overall Study||60
3162522|NCT01878825|3889891|FG000|COMPLETED|Overall Study||60
3162523|NCT01878825|3889892|FG001|COMPLETED|Overall Study||60
3162524|NCT01878825|3889891|FG000|NOT COMPLETED|Overall Study||0
3162525|NCT01878825|3889892|FG001|NOT COMPLETED|Overall Study||0
3162526|NCT01878890|3889911|FG000|STARTED|Overall Study||5
3162527|NCT01878890|3889912|FG001|STARTED|Overall Study||11
3162528|NCT01878890|3889913|FG002|STARTED|Overall Study||4
3162529|NCT01878890|3889914|FG003|STARTED|Overall Study||5
3162530|NCT01878890|3889911|FG000|COMPLETED|Overall Study||5
3162531|NCT01878890|3889912|FG001|COMPLETED|Overall Study||10
3162532|NCT01878890|3889913|FG002|COMPLETED|Overall Study||4
3162533|NCT01878890|3889914|FG003|COMPLETED|Overall Study||5
3162534|NCT01878890|3889911|FG000|NOT COMPLETED|Overall Study||0
3162535|NCT01878890|3889912|FG001|NOT COMPLETED|Overall Study||1
3162536|NCT01878890|3889913|FG002|NOT COMPLETED|Overall Study||0
3162537|NCT01878890|3889914|FG003|NOT COMPLETED|Overall Study||0
3162538|NCT01879059|3889925|FG000|STARTED|Overall Study||13
3059623|NCT01263015|3780334|FG000|COMPLETED|Open-label Phase: 48 Weeks Duration||317
3059624|NCT01263015|3780335|FG001|COMPLETED|Open-label Phase: 48 Weeks Duration||278
3059625|NCT01263015|3780334|FG000|NOT COMPLETED|Open-label Phase: 48 Weeks Duration||24
3059626|NCT01263015|3780335|FG001|NOT COMPLETED|Open-label Phase: 48 Weeks Duration||31
3059627|NCT01263054|3780343|FG000|STARTED|Overall Study||29
3059628|NCT01263054|3780344|FG001|STARTED|Overall Study||34
3162539|NCT01879059|3889925|FG000|COMPLETED|Overall Study||13
3059629|NCT01263054|3780343|FG000|COMPLETED|Overall Study||24
3059630|NCT01263054|3780344|FG001|COMPLETED|Overall Study||28
3059631|NCT01263054|3780343|FG000|NOT COMPLETED|Overall Study||5
3059632|NCT01263054|3780344|FG001|NOT COMPLETED|Overall Study||6
3059633|NCT01263093|3780352|FG000|STARTED|Period 1||24
3059634|NCT01263093|3780353|FG001|STARTED|Period 1||23
3059635|NCT01263093|3780352|FG000|COMPLETED|Period 1||24
3059636|NCT01263093|3780353|FG001|COMPLETED|Period 1||23
3162540|NCT01879059|3889925|FG000|NOT COMPLETED|Overall Study||0
3162541|NCT01879072|3889929|FG000|STARTED|Overall Study||1860
3162542|NCT01879072|3889929|FG000|COMPLETED|Overall Study||1709
3162543|NCT01879072|3889929|FG000|NOT COMPLETED|Overall Study||151
3162544|NCT01879176|3889935|FG000|STARTED|Overall Study||24
3162545|NCT01879176|3889936|FG001|STARTED|Overall Study||22
3162546|NCT01879176|3889935|FG000|COMPLETED|Overall Study||16
3162547|NCT01879176|3889936|FG001|COMPLETED|Overall Study||16
3162548|NCT01879176|3889935|FG000|NOT COMPLETED|Overall Study||8
3162549|NCT01879176|3889936|FG001|NOT COMPLETED|Overall Study||6
3162550|NCT01879319|3889944|FG000|STARTED|Overall Study||82
3162551|NCT01879319|3889945|FG001|STARTED|Overall Study||82
3162552|NCT01879319|3889944|FG000|Received Treatment|Overall Study||82
3162553|NCT01879319|3889945|FG001|Received Treatment|Overall Study||82
3162554|NCT01879319|3889944|FG000|COMPLETED|Overall Study||80
3162555|NCT01879319|3889945|FG001|COMPLETED|Overall Study||77
3059637|NCT01263093|3780352|FG000|NOT COMPLETED|Period 1||0
3059638|NCT01263093|3780353|FG001|NOT COMPLETED|Period 1||0
3059639|NCT01263093|3780352|FG000|STARTED|Washout||24
3059640|NCT01263093|3780353|FG001|STARTED|Washout||23
3059641|NCT01263093|3780352|FG000|COMPLETED|Washout||23
3059642|NCT01263093|3780353|FG001|COMPLETED|Washout||23
3059643|NCT01263093|3780352|FG000|NOT COMPLETED|Washout||1
3059644|NCT01263093|3780353|FG001|NOT COMPLETED|Washout||0
3059645|NCT01263093|3780352|FG000|STARTED|Period 2||23
3059646|NCT01263093|3780353|FG001|STARTED|Period 2||23
3059647|NCT01263093|3780352|FG000|COMPLETED|Period 2||22
3059648|NCT01263093|3780353|FG001|COMPLETED|Period 2||23
3059649|NCT01263093|3780352|FG000|NOT COMPLETED|Period 2||1
3059650|NCT01263093|3780353|FG001|NOT COMPLETED|Period 2||0
3059651|NCT01263106|3780360|FG000|STARTED|Period 1 (7 Days)||11
3059652|NCT01263106|3780361|FG001|STARTED|Period 1 (7 Days)||10
3059653|NCT01263106|3780360|FG000|COMPLETED|Period 1 (7 Days)|Period 1: 1 participant took theophylline alone but was not given LY + theophylline.|11
3059654|NCT01263106|3780361|FG001|COMPLETED|Period 1 (7 Days)|Period 1: 1 participant took LY + theophylline but was not given theophylline alone.|10
3059655|NCT01263106|3780360|FG000|NOT COMPLETED|Period 1 (7 Days)||0
3059656|NCT01263106|3780361|FG001|NOT COMPLETED|Period 1 (7 Days)||0
3059657|NCT01263106|3780360|FG000|STARTED|Washout (at Least 7 Days)||11
3059658|NCT01263106|3780361|FG001|STARTED|Washout (at Least 7 Days)||10
3059659|NCT01263106|3780360|FG000|COMPLETED|Washout (at Least 7 Days)||10
3059660|NCT01263106|3780361|FG001|COMPLETED|Washout (at Least 7 Days)||9
3059661|NCT01263106|3780360|FG000|NOT COMPLETED|Washout (at Least 7 Days)||1
3059662|NCT01263106|3780361|FG001|NOT COMPLETED|Washout (at Least 7 Days)||1
3059663|NCT01263106|3780360|FG000|STARTED|Period 2 (7 Days)||10
3059664|NCT01263106|3780361|FG001|STARTED|Period 2 (7 Days)||9
3059665|NCT01263106|3780360|FG000|COMPLETED|Period 2 (7 Days)||10
3059666|NCT01263106|3780361|FG001|COMPLETED|Period 2 (7 Days)||9
3059667|NCT01263106|3780360|FG000|NOT COMPLETED|Period 2 (7 Days)||0
3059668|NCT01263106|3780361|FG001|NOT COMPLETED|Period 2 (7 Days)||0
3059669|NCT01263119|3780370|FG000|STARTED|Period 1||18
3059670|NCT01263119|3780370|FG000|COMPLETED|Period 1||16
3059671|NCT01263119|3780370|FG000|NOT COMPLETED|Period 1||2
3059672|NCT01263119|3780370|FG000|STARTED|Period 2||16
3059673|NCT01263119|3780370|FG000|COMPLETED|Period 2||14
3059674|NCT01263119|3780370|FG000|NOT COMPLETED|Period 2||2
3059675|NCT01263132|3780380|FG000|STARTED|Overall Study||38
3059676|NCT01263132|3780381|FG001|STARTED|Overall Study||37
3059677|NCT01263132|3780380|FG000|COMPLETED|Overall Study||38
3059678|NCT01263132|3780381|FG001|COMPLETED|Overall Study||37
3059679|NCT01263132|3780380|FG000|NOT COMPLETED|Overall Study||0
3059680|NCT01263132|3780381|FG001|NOT COMPLETED|Overall Study||0
3059681|NCT01263197|3780389|FG000|STARTED|First Intervention (Period 1)||8
3059682|NCT01263197|3780390|FG001|STARTED|First Intervention (Period 1)||8
3059683|NCT01263197|3780391|FG002|STARTED|First Intervention (Period 1)||8
3059684|NCT01263197|3780392|FG003|STARTED|First Intervention (Period 1)||8
3059685|NCT01263197|3780393|FG004|STARTED|First Intervention (Period 1)||8
3059686|NCT01263197|3780394|FG005|STARTED|First Intervention (Period 1)||8
3059687|NCT01263197|3780389|FG000|COMPLETED|First Intervention (Period 1)||8
3059688|NCT01263197|3780390|FG001|COMPLETED|First Intervention (Period 1)||8
3059689|NCT01263197|3780391|FG002|COMPLETED|First Intervention (Period 1)||8
3059690|NCT01263197|3780392|FG003|COMPLETED|First Intervention (Period 1)||8
3059691|NCT01263197|3780393|FG004|COMPLETED|First Intervention (Period 1)||8
3059692|NCT01263197|3780394|FG005|COMPLETED|First Intervention (Period 1)||7
3059693|NCT01263197|3780389|FG000|NOT COMPLETED|First Intervention (Period 1)||0
3059694|NCT01263197|3780390|FG001|NOT COMPLETED|First Intervention (Period 1)||0
3059695|NCT01263197|3780391|FG002|NOT COMPLETED|First Intervention (Period 1)||0
3059696|NCT01263197|3780392|FG003|NOT COMPLETED|First Intervention (Period 1)||0
3162556|NCT01879319|3889944|FG000|NOT COMPLETED|Overall Study||2
3162557|NCT01879319|3889945|FG001|NOT COMPLETED|Overall Study||5
3162558|NCT01879332|3889954|FG000|STARTED|Overall Study||6
3162559|NCT01879332|3889955|FG001|STARTED|Overall Study||6
3162560|NCT01879332|3889956|FG002|STARTED|Overall Study||4
3059697|NCT01263197|3780393|FG004|NOT COMPLETED|First Intervention (Period 1)||0
3059698|NCT01263197|3780394|FG005|NOT COMPLETED|First Intervention (Period 1)||1
3162561|NCT01879332|3889954|FG000|COMPLETED|Overall Study||0
3162562|NCT01879332|3889955|FG001|COMPLETED|Overall Study||0
3162563|NCT01879332|3889956|FG002|COMPLETED|Overall Study||0
3162564|NCT01879332|3889954|FG000|NOT COMPLETED|Overall Study||6
3162565|NCT01879332|3889955|FG001|NOT COMPLETED|Overall Study||6
3162566|NCT01879332|3889956|FG002|NOT COMPLETED|Overall Study||4
3162567|NCT01879345|3889967|FG000|STARTED|Single-dose Period||6
3162568|NCT01879345|3889968|FG001|STARTED|Single-dose Period||6
3162569|NCT01879345|3889969|FG002|STARTED|Single-dose Period||6
3162570|NCT01879345|3889967|FG000|COMPLETED|Single-dose Period||6
3162571|NCT01879345|3889968|FG001|COMPLETED|Single-dose Period||6
3162572|NCT01879345|3889969|FG002|COMPLETED|Single-dose Period||6
3162573|NCT01879345|3889967|FG000|NOT COMPLETED|Single-dose Period||0
3162574|NCT01879345|3889968|FG001|NOT COMPLETED|Single-dose Period||0
3162575|NCT01879345|3889969|FG002|NOT COMPLETED|Single-dose Period||0
3162576|NCT01879345|3889967|FG000|STARTED|7-day Multiple-dose Period||6
3162577|NCT01879345|3889968|FG001|STARTED|7-day Multiple-dose Period||6
3162578|NCT01879345|3889969|FG002|STARTED|7-day Multiple-dose Period||6
3162579|NCT01879345|3889967|FG000|COMPLETED|7-day Multiple-dose Period||6
3162580|NCT01879345|3889968|FG001|COMPLETED|7-day Multiple-dose Period||6
3162581|NCT01879345|3889969|FG002|COMPLETED|7-day Multiple-dose Period||6
3059699|NCT01263197|3780389|FG000|STARTED|Washout Period 1||8
3059700|NCT01263197|3780390|FG001|STARTED|Washout Period 1||8
3059701|NCT01263197|3780391|FG002|STARTED|Washout Period 1||8
3059702|NCT01263197|3780392|FG003|STARTED|Washout Period 1||8
3059703|NCT01263197|3780393|FG004|STARTED|Washout Period 1||8
3059704|NCT01263197|3780394|FG005|STARTED|Washout Period 1||7
3059705|NCT01263197|3780389|FG000|COMPLETED|Washout Period 1||8
3059706|NCT01263197|3780390|FG001|COMPLETED|Washout Period 1||8
3059707|NCT01263197|3780391|FG002|COMPLETED|Washout Period 1||8
3059708|NCT01263197|3780392|FG003|COMPLETED|Washout Period 1||8
3059709|NCT01263197|3780393|FG004|COMPLETED|Washout Period 1||7
3059710|NCT01263197|3780394|FG005|COMPLETED|Washout Period 1||7
3059711|NCT01263197|3780389|FG000|NOT COMPLETED|Washout Period 1||0
3059712|NCT01263197|3780390|FG001|NOT COMPLETED|Washout Period 1||0
3059713|NCT01263197|3780391|FG002|NOT COMPLETED|Washout Period 1||0
3059714|NCT01263197|3780392|FG003|NOT COMPLETED|Washout Period 1||0
3059715|NCT01263197|3780393|FG004|NOT COMPLETED|Washout Period 1||1
3059716|NCT01263197|3780394|FG005|NOT COMPLETED|Washout Period 1||0
3059717|NCT01263197|3780389|FG000|STARTED|Second Intervention (Period 2)||8
3059718|NCT01263197|3780390|FG001|STARTED|Second Intervention (Period 2)||8
3059719|NCT01263197|3780391|FG002|STARTED|Second Intervention (Period 2)||8
3059720|NCT01263197|3780392|FG003|STARTED|Second Intervention (Period 2)||8
3059721|NCT01263197|3780393|FG004|STARTED|Second Intervention (Period 2)||7
3059722|NCT01263197|3780394|FG005|STARTED|Second Intervention (Period 2)||7
3059723|NCT01263197|3780389|FG000|COMPLETED|Second Intervention (Period 2)||8
3059724|NCT01263197|3780390|FG001|COMPLETED|Second Intervention (Period 2)||8
3059725|NCT01263197|3780391|FG002|COMPLETED|Second Intervention (Period 2)||8
3059726|NCT01263197|3780392|FG003|COMPLETED|Second Intervention (Period 2)||8
3059727|NCT01263197|3780393|FG004|COMPLETED|Second Intervention (Period 2)||7
3059728|NCT01263197|3780394|FG005|COMPLETED|Second Intervention (Period 2)||7
3059729|NCT01263197|3780389|FG000|NOT COMPLETED|Second Intervention (Period 2)||0
3059730|NCT01263197|3780390|FG001|NOT COMPLETED|Second Intervention (Period 2)||0
3059731|NCT01263197|3780391|FG002|NOT COMPLETED|Second Intervention (Period 2)||0
3059732|NCT01263197|3780392|FG003|NOT COMPLETED|Second Intervention (Period 2)||0
3059733|NCT01263197|3780393|FG004|NOT COMPLETED|Second Intervention (Period 2)||0
3059734|NCT01263197|3780394|FG005|NOT COMPLETED|Second Intervention (Period 2)||0
3059735|NCT01263197|3780389|FG000|STARTED|Washout Period 2||8
3059736|NCT01263197|3780390|FG001|STARTED|Washout Period 2||8
3059737|NCT01263197|3780391|FG002|STARTED|Washout Period 2||8
3059738|NCT01263197|3780392|FG003|STARTED|Washout Period 2||8
3059739|NCT01263197|3780393|FG004|STARTED|Washout Period 2||7
3059740|NCT01263197|3780394|FG005|STARTED|Washout Period 2||7
3059741|NCT01263197|3780389|FG000|COMPLETED|Washout Period 2||8
3059742|NCT01263197|3780390|FG001|COMPLETED|Washout Period 2||8
3059743|NCT01263197|3780391|FG002|COMPLETED|Washout Period 2||8
3059744|NCT01263197|3780392|FG003|COMPLETED|Washout Period 2||7
3059745|NCT01263197|3780393|FG004|COMPLETED|Washout Period 2||7
3059746|NCT01263197|3780394|FG005|COMPLETED|Washout Period 2||6
3059747|NCT01263197|3780389|FG000|NOT COMPLETED|Washout Period 2||0
3059748|NCT01263197|3780390|FG001|NOT COMPLETED|Washout Period 2||0
3059749|NCT01263197|3780391|FG002|NOT COMPLETED|Washout Period 2||0
3059750|NCT01263197|3780392|FG003|NOT COMPLETED|Washout Period 2||1
3059751|NCT01263197|3780393|FG004|NOT COMPLETED|Washout Period 2||0
3059752|NCT01263197|3780394|FG005|NOT COMPLETED|Washout Period 2||1
3059753|NCT01263197|3780389|FG000|STARTED|Third Intervention (Period 3)||8
3162582|NCT01879345|3889967|FG000|NOT COMPLETED|7-day Multiple-dose Period||0
3162583|NCT01879345|3889968|FG001|NOT COMPLETED|7-day Multiple-dose Period||0
3162584|NCT01879345|3889969|FG002|NOT COMPLETED|7-day Multiple-dose Period||0
3162585|NCT01879371|3889985|FG000|STARTED|Overall Study||6
3162586|NCT01879371|3889986|FG001|STARTED|Overall Study||6
3162587|NCT01879371|3889987|FG002|STARTED|Overall Study||6
3162588|NCT01879371|3889988|FG003|STARTED|Overall Study||6
3162589|NCT01879371|3889989|FG004|STARTED|Overall Study||6
3059754|NCT01263197|3780390|FG001|STARTED|Third Intervention (Period 3)||8
3059755|NCT01263197|3780391|FG002|STARTED|Third Intervention (Period 3)||8
3059756|NCT01263197|3780392|FG003|STARTED|Third Intervention (Period 3)||7
3059757|NCT01263197|3780393|FG004|STARTED|Third Intervention (Period 3)||7
3059758|NCT01263197|3780394|FG005|STARTED|Third Intervention (Period 3)||6
3059759|NCT01263197|3780389|FG000|COMPLETED|Third Intervention (Period 3)||8
3059760|NCT01263197|3780390|FG001|COMPLETED|Third Intervention (Period 3)||7
3059761|NCT01263197|3780391|FG002|COMPLETED|Third Intervention (Period 3)||8
3059762|NCT01263197|3780392|FG003|COMPLETED|Third Intervention (Period 3)||7
3059763|NCT01263197|3780393|FG004|COMPLETED|Third Intervention (Period 3)||7
3059764|NCT01263197|3780394|FG005|COMPLETED|Third Intervention (Period 3)||6
3059765|NCT01263197|3780389|FG000|NOT COMPLETED|Third Intervention (Period 3)||0
3059766|NCT01263197|3780390|FG001|NOT COMPLETED|Third Intervention (Period 3)||1
3059767|NCT01263197|3780391|FG002|NOT COMPLETED|Third Intervention (Period 3)||0
3059768|NCT01263197|3780392|FG003|NOT COMPLETED|Third Intervention (Period 3)||0
3059769|NCT01263197|3780393|FG004|NOT COMPLETED|Third Intervention (Period 3)||0
3162590|NCT01879371|3889990|FG005|STARTED|Overall Study||6
3162591|NCT01879371|3889985|FG000|COMPLETED|Overall Study||6
3162592|NCT01879371|3889986|FG001|COMPLETED|Overall Study||6
3162593|NCT01879371|3889987|FG002|COMPLETED|Overall Study||6
3162594|NCT01879371|3889988|FG003|COMPLETED|Overall Study||6
3162595|NCT01879371|3889989|FG004|COMPLETED|Overall Study||6
3162596|NCT01879371|3889990|FG005|COMPLETED|Overall Study||6
3162597|NCT01879371|3889985|FG000|NOT COMPLETED|Overall Study||0
3162598|NCT01879371|3889986|FG001|NOT COMPLETED|Overall Study||0
3162599|NCT01879371|3889987|FG002|NOT COMPLETED|Overall Study||0
3162600|NCT01879371|3889988|FG003|NOT COMPLETED|Overall Study||0
3162601|NCT01879371|3889989|FG004|NOT COMPLETED|Overall Study||0
3162602|NCT01879371|3889990|FG005|NOT COMPLETED|Overall Study||0
3162603|NCT01879410|3890000|FG000|STARTED|Overall Study||350
3162604|NCT01879410|3890001|FG001|STARTED|Overall Study||350
3162605|NCT01879410|3890000|FG000|Intent-to-Treat Population|Overall Study||349
3162606|NCT01879410|3890001|FG001|Intent-to-Treat Population|Overall Study||348
3162607|NCT01879410|3890000|FG000|COMPLETED|Overall Study||326
3059770|NCT01263197|3780394|FG005|NOT COMPLETED|Third Intervention (Period 3)||0
3134001|NCT01698879|3858969|FG001|COMPLETED|Overall Study||20
3134002|NCT01698879|3858970|FG002|COMPLETED|Overall Study||20
3134003|NCT01698879|3858968|FG000|NOT COMPLETED|Overall Study||1
3134004|NCT01698879|3858969|FG001|NOT COMPLETED|Overall Study||0
3134005|NCT01698879|3858970|FG002|NOT COMPLETED|Overall Study||0
3134006|NCT01698905|3858984|FG000|STARTED|Overall Study||163
3134007|NCT01698905|3858984|FG000|Still on Study Phase|Overall Study||0
3134008|NCT01698905|3858984|FG000|TFR Phase|Overall Study||126
3134009|NCT01698905|3858984|FG000|NTRI Phase|Overall Study||51
3134010|NCT01698905|3858984|FG000|NTCT Phase|Overall Study||26
3134011|NCT01698905|3858984|FG000|TFR-2 Phase|Overall Study||2
3134012|NCT01698905|3858984|FG000|NTRI-2 Phase|Overall Study||1
3134013|NCT01698905|3858984|FG000|NTCT-P Phase Phase|Overall Study||6
3134014|NCT01698905|3858984|FG000|COMPLETED|Overall Study||152
3134015|NCT01698905|3858984|FG000|NOT COMPLETED|Overall Study||11
3134016|NCT01699022|3858995|FG000|STARTED|Overall Study||17
3134017|NCT01699022|3858995|FG000|COMPLETED|Overall Study||14
3134018|NCT01699022|3858995|FG000|NOT COMPLETED|Overall Study||3
3134019|NCT01699087|3859000|FG000|STARTED|Overall Study||176
3134020|NCT01699087|3859000|FG000|Treated|Overall Study||161
3134021|NCT01699087|3859000|FG000|COMPLETED|Overall Study||152
3134022|NCT01699087|3859000|FG000|NOT COMPLETED|Overall Study||24
3134023|NCT01699178|3859007|FG000|STARTED|Overall Study||88
3134024|NCT01699178|3859008|FG001|STARTED|Overall Study||94
3134025|NCT01699178|3859007|FG000|COMPLETED|Overall Study||69
3134026|NCT01699178|3859008|FG001|COMPLETED|Overall Study||62
3134027|NCT01699178|3859007|FG000|NOT COMPLETED|Overall Study||19
3134028|NCT01699178|3859008|FG001|NOT COMPLETED|Overall Study||32
3134029|NCT01699373|3859016|FG000|STARTED|Overall Study||85
3134030|NCT01699373|3859017|FG001|STARTED|Overall Study||85
3134031|NCT01699373|3859016|FG000|COMPLETED|Overall Study||85
3134032|NCT01699373|3859017|FG001|COMPLETED|Overall Study||85
3134033|NCT01699373|3859016|FG000|NOT COMPLETED|Overall Study||0
3134034|NCT01699373|3859017|FG001|NOT COMPLETED|Overall Study||0
3134035|NCT01699503|3859025|FG000|STARTED|Overall Study||2008
3134036|NCT01699503|3859026|FG001|STARTED|Overall Study||1997
3134037|NCT01699503|3859025|FG000|Baseline|Overall Study||1723
3134038|NCT01699503|3859026|FG001|Baseline|Overall Study||1693
3134039|NCT01699503|3859025|FG000|1 Month Follow-up|Overall Study||998
3134040|NCT01699503|3859026|FG001|1 Month Follow-up|Overall Study||1022
3134041|NCT01699503|3859025|FG000|6 Month Follow-up|Overall Study||903
3134042|NCT01699503|3859026|FG001|6 Month Follow-up|Overall Study||893
3134043|NCT01699503|3859025|FG000|COMPLETED|Overall Study||1008
3134044|NCT01699503|3859026|FG001|COMPLETED|Overall Study||992
3134045|NCT01699503|3859025|FG000|NOT COMPLETED|Overall Study||1000
3134046|NCT01699503|3859026|FG001|NOT COMPLETED|Overall Study||1005
3134047|NCT01699542|3859034|FG000|STARTED|Overall Study||9
3134048|NCT01699542|3859035|FG001|STARTED|Overall Study||9
3134049|NCT01699542|3859034|FG000|COMPLETED|Overall Study||9
3162608|NCT01879410|3890001|FG001|COMPLETED|Overall Study||312
3162609|NCT01879410|3890000|FG000|NOT COMPLETED|Overall Study||24
3162610|NCT01879410|3890001|FG001|NOT COMPLETED|Overall Study||38
3162611|NCT01879540|3890007|FG000|STARTED|Overall Study||63
3162612|NCT01879540|3890007|FG000|COMPLETED|Overall Study||63
3162613|NCT01879540|3890007|FG000|NOT COMPLETED|Overall Study||0
3059771|NCT01263223|3780408|FG000|STARTED|Period 1||12
3059772|NCT01263223|3780409|FG001|STARTED|Period 1||12
3059773|NCT01263223|3780408|FG000|COMPLETED|Period 1||12
3059774|NCT01263223|3780409|FG001|COMPLETED|Period 1||12
3059775|NCT01263223|3780408|FG000|NOT COMPLETED|Period 1||0
3059776|NCT01263223|3780409|FG001|NOT COMPLETED|Period 1||0
3059777|NCT01263223|3780408|FG000|STARTED|3-Day Washout||12
3059778|NCT01263223|3780409|FG001|STARTED|3-Day Washout||12
3059779|NCT01263223|3780408|FG000|COMPLETED|3-Day Washout||12
3059780|NCT01263223|3780409|FG001|COMPLETED|3-Day Washout||12
3059781|NCT01263223|3780408|FG000|NOT COMPLETED|3-Day Washout||0
3059782|NCT01263223|3780409|FG001|NOT COMPLETED|3-Day Washout||0
3059783|NCT01263223|3780408|FG000|STARTED|Period 2||12
3059784|NCT01263223|3780409|FG001|STARTED|Period 2||12
3059785|NCT01263223|3780408|FG000|COMPLETED|Period 2||12
3059786|NCT01263223|3780409|FG001|COMPLETED|Period 2||11
3059787|NCT01263223|3780408|FG000|NOT COMPLETED|Period 2||0
3059788|NCT01263223|3780409|FG001|NOT COMPLETED|Period 2||1
3059789|NCT01263223|3780408|FG000|STARTED|Period 3||12
3059790|NCT01263223|3780409|FG001|STARTED|Period 3||11
3059791|NCT01263223|3780408|FG000|COMPLETED|Period 3||12
3059792|NCT01263223|3780409|FG001|COMPLETED|Period 3||11
3059793|NCT01263223|3780408|FG000|NOT COMPLETED|Period 3||0
3059794|NCT01263223|3780409|FG001|NOT COMPLETED|Period 3||0
3059795|NCT01263223|3780408|FG000|STARTED|7-day Follow-up||12
3059796|NCT01263223|3780409|FG001|STARTED|7-day Follow-up||11
3059797|NCT01263223|3780408|FG000|COMPLETED|7-day Follow-up|One participant who did not complete received Placebo in Period 3.|11
3059798|NCT01263223|3780409|FG001|COMPLETED|7-day Follow-up|One participant who did not complete received 36-mg LY2216684 in Period 3.|10
3059799|NCT01263223|3780408|FG000|NOT COMPLETED|7-day Follow-up||1
3059800|NCT01263223|3780409|FG001|NOT COMPLETED|7-day Follow-up||1
3059801|NCT01263301|3780420|FG000|STARTED|Overall Study||5
3059802|NCT01263301|3780421|FG001|STARTED|Overall Study||11
3059803|NCT01263301|3780420|FG000|COMPLETED|Overall Study||5
3059804|NCT01263301|3780421|FG001|COMPLETED|Overall Study||11
3162614|NCT01879553|3890013|FG000|STARTED|Overall Study||63
3162615|NCT01879553|3890014|FG001|STARTED|Overall Study||63
3162616|NCT01879553|3890013|FG000|COMPLETED|Overall Study||62
3162617|NCT01879553|3890014|FG001|COMPLETED|Overall Study||63
3162618|NCT01879553|3890013|FG000|NOT COMPLETED|Overall Study||1
3284006|NCT02760407|4017753|FG001|COMPLETED|Overall Study||421
3059805|NCT01263301|3780420|FG000|NOT COMPLETED|Overall Study||0
3059806|NCT01263301|3780421|FG001|NOT COMPLETED|Overall Study||0
3059807|NCT01263314|3780435|FG000|STARTED|Period 1||2
3059808|NCT01263314|3780436|FG001|STARTED|Period 1||2
3059809|NCT01263314|3780437|FG002|STARTED|Period 1||2
3059810|NCT01263314|3780438|FG003|STARTED|Period 1||2
3059811|NCT01263314|3780439|FG004|STARTED|Period 1||2
3059812|NCT01263314|3780440|FG005|STARTED|Period 1||2
3059813|NCT01263314|3780441|FG006|STARTED|Period 1||2
3059814|NCT01263314|3780442|FG007|STARTED|Period 1||2
3059815|NCT01263314|3780435|FG000|COMPLETED|Period 1||2
3059816|NCT01263314|3780436|FG001|COMPLETED|Period 1||2
3059817|NCT01263314|3780437|FG002|COMPLETED|Period 1||2
3059818|NCT01263314|3780438|FG003|COMPLETED|Period 1||2
3284007|NCT02760407|4017754|FG002|COMPLETED|Overall Study||412
3284008|NCT02760407|4017755|FG003|COMPLETED|Overall Study||207
3284009|NCT02760407|4017752|FG000|NOT COMPLETED|Overall Study||36
3284010|NCT02760407|4017753|FG001|NOT COMPLETED|Overall Study||43
3284011|NCT02760407|4017754|FG002|NOT COMPLETED|Overall Study||50
3284012|NCT02760407|4017755|FG003|NOT COMPLETED|Overall Study||36
3059819|NCT01263314|3780439|FG004|COMPLETED|Period 1||2
3059820|NCT01263314|3780440|FG005|COMPLETED|Period 1||2
3059821|NCT01263314|3780441|FG006|COMPLETED|Period 1||2
3059822|NCT01263314|3780442|FG007|COMPLETED|Period 1||2
3059823|NCT01263314|3780435|FG000|NOT COMPLETED|Period 1||0
3059824|NCT01263314|3780436|FG001|NOT COMPLETED|Period 1||0
3059825|NCT01263314|3780437|FG002|NOT COMPLETED|Period 1||0
3059826|NCT01263314|3780438|FG003|NOT COMPLETED|Period 1||0
3059827|NCT01263314|3780439|FG004|NOT COMPLETED|Period 1||0
3059828|NCT01263314|3780440|FG005|NOT COMPLETED|Period 1||0
3059829|NCT01263314|3780441|FG006|NOT COMPLETED|Period 1||0
3059830|NCT01263314|3780442|FG007|NOT COMPLETED|Period 1||0
3059831|NCT01263314|3780435|FG000|STARTED|Period 2||2
3059832|NCT01263314|3780436|FG001|STARTED|Period 2||2
3059833|NCT01263314|3780437|FG002|STARTED|Period 2||2
3059834|NCT01263314|3780438|FG003|STARTED|Period 2||2
3059835|NCT01263314|3780439|FG004|STARTED|Period 2||2
3059836|NCT01263314|3780440|FG005|STARTED|Period 2||2
3059837|NCT01263314|3780441|FG006|STARTED|Period 2||2
3059838|NCT01263314|3780442|FG007|STARTED|Period 2||2
3059839|NCT01263314|3780435|FG000|COMPLETED|Period 2||2
3059840|NCT01263314|3780436|FG001|COMPLETED|Period 2||2
3059841|NCT01263314|3780437|FG002|COMPLETED|Period 2||2
3059842|NCT01263314|3780438|FG003|COMPLETED|Period 2||2
3059843|NCT01263314|3780439|FG004|COMPLETED|Period 2||2
3059844|NCT01263314|3780440|FG005|COMPLETED|Period 2||2
3059845|NCT01263314|3780441|FG006|COMPLETED|Period 2||2
3059846|NCT01263314|3780442|FG007|COMPLETED|Period 2||2
3059847|NCT01263314|3780435|FG000|NOT COMPLETED|Period 2||0
3059848|NCT01263314|3780436|FG001|NOT COMPLETED|Period 2||0
3059849|NCT01263314|3780437|FG002|NOT COMPLETED|Period 2||0
3162619|NCT01879553|3890014|FG001|NOT COMPLETED|Overall Study||0
3162620|NCT01879579|3890023|FG000|STARTED|Overall Study||33
3162621|NCT01879579|3890024|FG001|STARTED|Overall Study||28
3162622|NCT01879579|3890023|FG000|COMPLETED|Overall Study||28
3284013|NCT02760433|4017771|FG000|STARTED|Overall Study||161
3162623|NCT01879579|3890024|FG001|COMPLETED|Overall Study||26
3162624|NCT01879579|3890023|FG000|NOT COMPLETED|Overall Study||5
3162625|NCT01879579|3890024|FG001|NOT COMPLETED|Overall Study||2
3162626|NCT01879618|3890033|FG000|STARTED|Overall Study||152
3162627|NCT01879618|3890033|FG000|COMPLETED|Overall Study||131
3162628|NCT01879618|3890033|FG000|NOT COMPLETED|Overall Study||21
3162629|NCT01879683|3890037|FG000|STARTED|Overall Study||10
3162630|NCT01879683|3890037|FG000|COMPLETED|Overall Study||9
3162631|NCT01879683|3890037|FG000|NOT COMPLETED|Overall Study||1
3284014|NCT02760433|4017772|FG001|STARTED|Overall Study||138
3284015|NCT02760433|4017773|FG002|STARTED|Overall Study||26
3059850|NCT01263314|3780438|FG003|NOT COMPLETED|Period 2||0
3059851|NCT01263314|3780439|FG004|NOT COMPLETED|Period 2||0
3059852|NCT01263314|3780440|FG005|NOT COMPLETED|Period 2||0
3059853|NCT01263314|3780441|FG006|NOT COMPLETED|Period 2||0
3059854|NCT01263314|3780442|FG007|NOT COMPLETED|Period 2||0
3059855|NCT01263314|3780435|FG000|STARTED|Period 3||2
3059856|NCT01263314|3780436|FG001|STARTED|Period 3||2
3059857|NCT01263314|3780437|FG002|STARTED|Period 3||2
3059858|NCT01263314|3780438|FG003|STARTED|Period 3||2
3059859|NCT01263314|3780439|FG004|STARTED|Period 3||2
3059860|NCT01263314|3780440|FG005|STARTED|Period 3||2
3059861|NCT01263314|3780441|FG006|STARTED|Period 3||2
3059862|NCT01263314|3780442|FG007|STARTED|Period 3||2
3059863|NCT01263314|3780435|FG000|COMPLETED|Period 3||2
3059864|NCT01263314|3780436|FG001|COMPLETED|Period 3||2
3059865|NCT01263314|3780437|FG002|COMPLETED|Period 3||2
3059866|NCT01263314|3780438|FG003|COMPLETED|Period 3||2
3059867|NCT01263314|3780439|FG004|COMPLETED|Period 3||2
3059868|NCT01263314|3780440|FG005|COMPLETED|Period 3||2
3059869|NCT01263314|3780441|FG006|COMPLETED|Period 3||2
3059870|NCT01263314|3780442|FG007|COMPLETED|Period 3||2
3059871|NCT01263314|3780435|FG000|NOT COMPLETED|Period 3||0
3059872|NCT01263314|3780436|FG001|NOT COMPLETED|Period 3||0
3059873|NCT01263314|3780437|FG002|NOT COMPLETED|Period 3||0
3059874|NCT01263314|3780438|FG003|NOT COMPLETED|Period 3||0
3059875|NCT01263314|3780439|FG004|NOT COMPLETED|Period 3||0
3059876|NCT01263314|3780440|FG005|NOT COMPLETED|Period 3||0
3059877|NCT01263314|3780441|FG006|NOT COMPLETED|Period 3||0
3059878|NCT01263314|3780442|FG007|NOT COMPLETED|Period 3||0
3059879|NCT01263444|3780466|FG000|STARTED|Overall Study||47
3059880|NCT01263444|3780466|FG000|COMPLETED|Overall Study||37
3059881|NCT01263444|3780466|FG000|NOT COMPLETED|Overall Study||10
3059882|NCT01263470|3780476|FG000|STARTED|Overall Study||75
3059883|NCT01263470|3780477|FG001|STARTED|Overall Study||79
3059884|NCT01263470|3780478|FG002|STARTED|Overall Study||84
3059885|NCT01263470|3780479|FG003|STARTED|Overall Study||80
3059886|NCT01263470|3780480|FG004|STARTED|Overall Study||79
3059887|NCT01263470|3780481|FG005|STARTED|Overall Study||83
3059888|NCT01263470|3780476|FG000|COMPLETED|Overall Study||73
3059889|NCT01263470|3780477|FG001|COMPLETED|Overall Study||74
3059890|NCT01263470|3780478|FG002|COMPLETED|Overall Study||80
3059891|NCT01263470|3780479|FG003|COMPLETED|Overall Study||77
3059892|NCT01263470|3780480|FG004|COMPLETED|Overall Study||76
3059893|NCT01263470|3780481|FG005|COMPLETED|Overall Study||78
3059894|NCT01263470|3780476|FG000|NOT COMPLETED|Overall Study||2
3059895|NCT01263470|3780477|FG001|NOT COMPLETED|Overall Study||5
3059896|NCT01263470|3780478|FG002|NOT COMPLETED|Overall Study||4
3059897|NCT01263470|3780479|FG003|NOT COMPLETED|Overall Study||3
3059898|NCT01263470|3780480|FG004|NOT COMPLETED|Overall Study||3
3059899|NCT01263470|3780481|FG005|NOT COMPLETED|Overall Study||5
3059900|NCT01263483|3780498|FG000|STARTED|Overall Study||75
3059901|NCT01263483|3780499|FG001|STARTED|Overall Study||76
3059902|NCT01263483|3780500|FG002|STARTED|Overall Study||79
3059903|NCT01263483|3780498|FG000|COMPLETED|Overall Study||68
3059904|NCT01263483|3780499|FG001|COMPLETED|Overall Study||74
3059905|NCT01263483|3780500|FG002|COMPLETED|Overall Study||74
3059906|NCT01263483|3780498|FG000|NOT COMPLETED|Overall Study||7
3059907|NCT01263483|3780499|FG001|NOT COMPLETED|Overall Study||2
3059908|NCT01263483|3780500|FG002|NOT COMPLETED|Overall Study||5
3059909|NCT01263496|3780513|FG000|STARTED|Enrolled - Long-Term Extension Study||72
3059910|NCT01263496|3780514|FG001|STARTED|Enrolled - Long-Term Extension Study||75
3059911|NCT01263496|3780515|FG002|STARTED|Enrolled - Long-Term Extension Study||72
3059912|NCT01263496|3780516|FG003|STARTED|Enrolled - Long-Term Extension Study||75
3059913|NCT01263496|3780517|FG004|STARTED|Enrolled - Long-Term Extension Study||74
3059914|NCT01263496|3780518|FG005|STARTED|Enrolled - Long-Term Extension Study||17
3059915|NCT01263496|3780519|FG006|STARTED|Enrolled - Long-Term Extension Study||17
3059916|NCT01263496|3780520|FG007|STARTED|Enrolled - Long-Term Extension Study||18
3059917|NCT01263496|3780521|FG008|STARTED|Enrolled - Long-Term Extension Study||18
3059918|NCT01263496|3780513|FG000|COMPLETED|Enrolled - Long-Term Extension Study||71
3059919|NCT01263496|3780514|FG001|COMPLETED|Enrolled - Long-Term Extension Study||75
3059920|NCT01263496|3780515|FG002|COMPLETED|Enrolled - Long-Term Extension Study||72
3059921|NCT01263496|3780516|FG003|COMPLETED|Enrolled - Long-Term Extension Study||74
3059922|NCT01263496|3780517|FG004|COMPLETED|Enrolled - Long-Term Extension Study||72
3059923|NCT01263496|3780518|FG005|COMPLETED|Enrolled - Long-Term Extension Study||17
3059924|NCT01263496|3780519|FG006|COMPLETED|Enrolled - Long-Term Extension Study||17
3059925|NCT01263496|3780520|FG007|COMPLETED|Enrolled - Long-Term Extension Study||18
3059926|NCT01263496|3780521|FG008|COMPLETED|Enrolled - Long-Term Extension Study||18
3162632|NCT01879722|3890051|FG000|STARTED|Overall Study||7
3162633|NCT01879722|3890052|FG001|STARTED|Overall Study||8
3162634|NCT01879722|3890053|FG002|STARTED|Overall Study||7
3059927|NCT01263496|3780513|FG000|NOT COMPLETED|Enrolled - Long-Term Extension Study||1
3059928|NCT01263496|3780514|FG001|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
3059929|NCT01263496|3780515|FG002|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
3059930|NCT01263496|3780516|FG003|NOT COMPLETED|Enrolled - Long-Term Extension Study||1
3059931|NCT01263496|3780517|FG004|NOT COMPLETED|Enrolled - Long-Term Extension Study||2
3059932|NCT01263496|3780518|FG005|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
3059933|NCT01263496|3780519|FG006|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
3059934|NCT01263496|3780520|FG007|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
3059935|NCT01263496|3780521|FG008|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
3059936|NCT01263496|3780513|FG000|STARTED|Entered - Long-Term Extension Study||71
3059937|NCT01263496|3780514|FG001|STARTED|Entered - Long-Term Extension Study|3 participants did not enter from previous period (1 voluntary withdraw; 2 did not meet criteria).|72
3059938|NCT01263496|3780515|FG002|STARTED|Entered - Long-Term Extension Study||72
3059939|NCT01263496|3780516|FG003|STARTED|Entered - Long-Term Extension Study||74
3059940|NCT01263496|3780517|FG004|STARTED|Entered - Long-Term Extension Study|1 participant did not enter from previous period (voluntary withdraw).|71
3059941|NCT01263496|3780518|FG005|STARTED|Entered - Long-Term Extension Study||17
3059942|NCT01263496|3780519|FG006|STARTED|Entered - Long-Term Extension Study||17
3059943|NCT01263496|3780520|FG007|STARTED|Entered - Long-Term Extension Study|1 participant did not enter from previous period (voluntary withdraw).|17
3059944|NCT01263496|3780521|FG008|STARTED|Entered - Long-Term Extension Study||18
3059945|NCT01263496|3780513|FG000|COMPLETED|Entered - Long-Term Extension Study||62
3059946|NCT01263496|3780514|FG001|COMPLETED|Entered - Long-Term Extension Study||59
3059947|NCT01263496|3780515|FG002|COMPLETED|Entered - Long-Term Extension Study||62
3059948|NCT01263496|3780516|FG003|COMPLETED|Entered - Long-Term Extension Study||68
3059949|NCT01263496|3780517|FG004|COMPLETED|Entered - Long-Term Extension Study||61
3059950|NCT01263496|3780518|FG005|COMPLETED|Entered - Long-Term Extension Study||16
3059951|NCT01263496|3780519|FG006|COMPLETED|Entered - Long-Term Extension Study||16
3059952|NCT01263496|3780520|FG007|COMPLETED|Entered - Long-Term Extension Study||16
3059953|NCT01263496|3780521|FG008|COMPLETED|Entered - Long-Term Extension Study||15
3059954|NCT01263496|3780513|FG000|NOT COMPLETED|Entered - Long-Term Extension Study||9
3059955|NCT01263496|3780514|FG001|NOT COMPLETED|Entered - Long-Term Extension Study||13
3059956|NCT01263496|3780515|FG002|NOT COMPLETED|Entered - Long-Term Extension Study||10
3059957|NCT01263496|3780516|FG003|NOT COMPLETED|Entered - Long-Term Extension Study||6
3059958|NCT01263496|3780517|FG004|NOT COMPLETED|Entered - Long-Term Extension Study||10
3059959|NCT01263496|3780518|FG005|NOT COMPLETED|Entered - Long-Term Extension Study||1
3059960|NCT01263496|3780519|FG006|NOT COMPLETED|Entered - Long-Term Extension Study||1
3059961|NCT01263496|3780520|FG007|NOT COMPLETED|Entered - Long-Term Extension Study||1
3059962|NCT01263496|3780521|FG008|NOT COMPLETED|Entered - Long-Term Extension Study||3
3059963|NCT01263509|3780535|FG000|STARTED|Enrolled - Long-Term Extension Study||61
3059964|NCT01263509|3780536|FG001|STARTED|Enrolled - Long-Term Extension Study||60
3059965|NCT01263509|3780537|FG002|STARTED|Enrolled - Long-Term Extension Study||32
3059966|NCT01263509|3780538|FG003|STARTED|Enrolled - Long-Term Extension Study||26
3059967|NCT01263509|3780535|FG000|COMPLETED|Enrolled - Long-Term Extension Study||61
3059968|NCT01263509|3780536|FG001|COMPLETED|Enrolled - Long-Term Extension Study||60
3059969|NCT01263509|3780537|FG002|COMPLETED|Enrolled - Long-Term Extension Study||32
3059970|NCT01263509|3780538|FG003|COMPLETED|Enrolled - Long-Term Extension Study||26
3059971|NCT01263509|3780535|FG000|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
3059972|NCT01263509|3780536|FG001|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
3059973|NCT01263509|3780537|FG002|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
3059974|NCT01263509|3780538|FG003|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
3059975|NCT01263509|3780535|FG000|STARTED|Entered - Long-Term Extension Study||61
3059976|NCT01263509|3780536|FG001|STARTED|Entered - Long-Term Extension Study||60
3059977|NCT01263509|3780537|FG002|STARTED|Entered - Long-Term Extension Study||32
3059978|NCT01263509|3780538|FG003|STARTED|Entered - Long-Term Extension Study||26
3059979|NCT01263509|3780535|FG000|COMPLETED|Entered - Long-Term Extension Study||53
3059980|NCT01263509|3780536|FG001|COMPLETED|Entered - Long-Term Extension Study||48
3059981|NCT01263509|3780537|FG002|COMPLETED|Entered - Long-Term Extension Study||27
3059982|NCT01263509|3780538|FG003|COMPLETED|Entered - Long-Term Extension Study||24
3059983|NCT01263509|3780535|FG000|NOT COMPLETED|Entered - Long-Term Extension Study||8
3059984|NCT01263509|3780536|FG001|NOT COMPLETED|Entered - Long-Term Extension Study||12
3059985|NCT01263509|3780537|FG002|NOT COMPLETED|Entered - Long-Term Extension Study||5
3059986|NCT01263509|3780538|FG003|NOT COMPLETED|Entered - Long-Term Extension Study||2
3059987|NCT01263561|3780546|FG000|STARTED|Overall Study||31
3059988|NCT01263561|3780547|FG001|STARTED|Overall Study||33
3059989|NCT01263561|3780546|FG000|COMPLETED|Overall Study||30
3059990|NCT01263561|3780547|FG001|COMPLETED|Overall Study||31
3059991|NCT01263561|3780546|FG000|NOT COMPLETED|Overall Study||1
3059992|NCT01263561|3780547|FG001|NOT COMPLETED|Overall Study||2
3059993|NCT01263639|3780555|FG000|STARTED|Overall Study||107
3059994|NCT01263639|3780556|FG001|STARTED|Overall Study||121
3059995|NCT01263639|3780555|FG000|COMPLETED|Overall Study||34
3059996|NCT01263639|3780556|FG001|COMPLETED|Overall Study||42
3059997|NCT01263639|3780555|FG000|NOT COMPLETED|Overall Study||73
3059998|NCT01263639|3780556|FG001|NOT COMPLETED|Overall Study||79
3059999|NCT01263665|3780562|FG000|STARTED|Overall Study||71
3060000|NCT01263665|3780562|FG000|COMPLETED|Overall Study||62
3060001|NCT01263665|3780562|FG000|NOT COMPLETED|Overall Study||9
3060002|NCT01263691|3780572|FG000|STARTED|Overall Study||18
3060003|NCT01263691|3780573|FG001|STARTED|Overall Study||18
3060004|NCT01263691|3780574|FG002|STARTED|Overall Study||17
3060005|NCT01263691|3780575|FG003|STARTED|Overall Study||19
3060006|NCT01263691|3780576|FG004|STARTED|Overall Study||18
3060007|NCT01263691|3780577|FG005|STARTED|Overall Study||15
3060008|NCT01263691|3780572|FG000|COMPLETED|Overall Study||15
3060009|NCT01263691|3780573|FG001|COMPLETED|Overall Study||18
3060010|NCT01263691|3780574|FG002|COMPLETED|Overall Study||16
3060011|NCT01263691|3780575|FG003|COMPLETED|Overall Study||18
3060012|NCT01263691|3780576|FG004|COMPLETED|Overall Study||18
3284016|NCT02760433|4017774|FG003|STARTED|Overall Study||32
3284017|NCT02760433|4017775|FG004|STARTED|Overall Study||11
3284018|NCT02760433|4017771|FG000|COMPLETED|Overall Study||134
3284019|NCT02760433|4017772|FG001|COMPLETED|Overall Study||128
3284020|NCT02760433|4017773|FG002|COMPLETED|Overall Study||25
3284021|NCT02760433|4017774|FG003|COMPLETED|Overall Study||30
3284022|NCT02760433|4017775|FG004|COMPLETED|Overall Study||1
3284023|NCT02760433|4017771|FG000|NOT COMPLETED|Overall Study||27
3284024|NCT02760433|4017772|FG001|NOT COMPLETED|Overall Study||10
3284025|NCT02760433|4017773|FG002|NOT COMPLETED|Overall Study||1
3284026|NCT02760433|4017774|FG003|NOT COMPLETED|Overall Study||2
3284027|NCT02760433|4017775|FG004|NOT COMPLETED|Overall Study||10
3060013|NCT01263691|3780577|FG005|COMPLETED|Overall Study||15
3060014|NCT01263691|3780572|FG000|NOT COMPLETED|Overall Study||3
3060015|NCT01263691|3780573|FG001|NOT COMPLETED|Overall Study||0
3060016|NCT01263691|3780574|FG002|NOT COMPLETED|Overall Study||1
3060017|NCT01263691|3780575|FG003|NOT COMPLETED|Overall Study||1
3060018|NCT01263691|3780576|FG004|NOT COMPLETED|Overall Study||0
3060019|NCT01263691|3780577|FG005|NOT COMPLETED|Overall Study||0
3060020|NCT01263704|3780612|FG000|STARTED|Overall Study||42
3060021|NCT01263704|3780612|FG000|COMPLETED|Overall Study||13
3060022|NCT01263704|3780612|FG000|NOT COMPLETED|Overall Study||29
3060023|NCT01263717|3780618|FG000|STARTED|Overall Study||28
3060024|NCT01263717|3780619|FG001|STARTED|Overall Study||26
3060025|NCT01263717|3780618|FG000|Baseline Visit|Overall Study||28
3060026|NCT01263717|3780619|FG001|Baseline Visit|Overall Study||22
3060027|NCT01263717|3780618|FG000|COMPLETED|Overall Study||23
3060028|NCT01263717|3780619|FG001|COMPLETED|Overall Study||20
3060029|NCT01263717|3780618|FG000|NOT COMPLETED|Overall Study||5
3060030|NCT01263717|3780619|FG001|NOT COMPLETED|Overall Study||6
3060031|NCT01263782|3780629|FG000|STARTED|Overall Study||6
3060032|NCT01263782|3780630|FG001|STARTED|Overall Study||6
3060033|NCT01263782|3780631|FG002|STARTED|Overall Study||6
3060034|NCT01263782|3780632|FG003|STARTED|Overall Study||6
3060035|NCT01263782|3780629|FG000|COMPLETED|Overall Study||6
3060036|NCT01263782|3780630|FG001|COMPLETED|Overall Study||6
3060037|NCT01263782|3780631|FG002|COMPLETED|Overall Study||3
3060038|NCT01263782|3780632|FG003|COMPLETED|Overall Study||5
3060039|NCT01263782|3780629|FG000|NOT COMPLETED|Overall Study||0
3060040|NCT01263782|3780630|FG001|NOT COMPLETED|Overall Study||0
3060041|NCT01263782|3780631|FG002|NOT COMPLETED|Overall Study||3
3060042|NCT01263782|3780632|FG003|NOT COMPLETED|Overall Study||1
3060043|NCT01263873|3780644|FG000|STARTED|Overall Study||30
3060044|NCT01263873|3780645|FG001|STARTED|Overall Study||30
3060045|NCT01263873|3780644|FG000|COMPLETED|Overall Study||29
3060046|NCT01263873|3780645|FG001|COMPLETED|Overall Study||29
3060047|NCT01263873|3780644|FG000|NOT COMPLETED|Overall Study||1
3060048|NCT01263873|3780645|FG001|NOT COMPLETED|Overall Study||1
3060049|NCT01263925|3780653|FG000|STARTED|Overall Study||276
3060050|NCT01263925|3780654|FG001|STARTED|Overall Study||285
3060051|NCT01263925|3780653|FG000|Full Analysis Set|Overall Study||269
3060052|NCT01263925|3780654|FG001|Full Analysis Set|Overall Study||272
3060053|NCT01263925|3780653|FG000|COMPLETED|Overall Study||225
3060054|NCT01263925|3780654|FG001|COMPLETED|Overall Study||233
3060055|NCT01263925|3780653|FG000|NOT COMPLETED|Overall Study||51
3060056|NCT01263925|3780654|FG001|NOT COMPLETED|Overall Study||52
3060057|NCT01263938|3780660|FG000|STARTED|Overall Study||5
3060058|NCT01263938|3780660|FG000|COMPLETED|Overall Study||5
3060059|NCT01263938|3780660|FG000|NOT COMPLETED|Overall Study||0
3284028|NCT02760654|4017794|FG000|STARTED|Overall Study||30
3060060|NCT01264016|3780665|FG000|STARTED|Overall Study||96
3060061|NCT01264016|3780665|FG000|COMPLETED|Overall Study||94
3060062|NCT01264016|3780665|FG000|NOT COMPLETED|Overall Study||2
3060063|NCT01264081|3780670|FG000|STARTED|Participants Screened||34
3060064|NCT01264081|3780670|FG000|COMPLETED|Participants Screened||4
3060065|NCT01264081|3780670|FG000|NOT COMPLETED|Participants Screened||30
3060066|NCT01264081|3780670|FG000|STARTED|Started Treatment||4
3060067|NCT01264081|3780670|FG000|COMPLETED|Started Treatment||2
3060068|NCT01264081|3780670|FG000|NOT COMPLETED|Started Treatment||2
3060069|NCT01264081|3780670|FG000|STARTED|Analysis||2
3060070|NCT01264081|3780670|FG000|COMPLETED|Analysis||2
3060071|NCT01264081|3780670|FG000|NOT COMPLETED|Analysis||0
3060072|NCT01264380|3780674|FG000|STARTED|Period A||8
3060073|NCT01264380|3780675|FG001|STARTED|Period A||8
3060074|NCT01264380|3780676|FG002|STARTED|Period A||0
3060075|NCT01264380|3780674|FG000|COMPLETED|Period A||8
3060076|NCT01264380|3780675|FG001|COMPLETED|Period A||8
3060077|NCT01264380|3780676|FG002|COMPLETED|Period A||0
3060078|NCT01264380|3780674|FG000|NOT COMPLETED|Period A||0
3060079|NCT01264380|3780675|FG001|NOT COMPLETED|Period A||0
3284029|NCT02760654|4017795|FG001|STARTED|Overall Study||30
3284030|NCT02760654|4017794|FG000|COMPLETED|Overall Study||23
3060080|NCT01264380|3780676|FG002|NOT COMPLETED|Period A||0
3060081|NCT01264380|3780674|FG000|STARTED|Period B||8
3060082|NCT01264380|3780675|FG001|STARTED|Period B||8
3060083|NCT01264380|3780676|FG002|STARTED|Period B||0
3060084|NCT01264380|3780674|FG000|COMPLETED|Period B||8
3060085|NCT01264380|3780675|FG001|COMPLETED|Period B||8
3060086|NCT01264380|3780676|FG002|COMPLETED|Period B||0
3060087|NCT01264380|3780674|FG000|NOT COMPLETED|Period B||0
3060088|NCT01264380|3780675|FG001|NOT COMPLETED|Period B||0
3060089|NCT01264380|3780676|FG002|NOT COMPLETED|Period B||0
3060090|NCT01264380|3780674|FG000|STARTED|Period C||0
3060091|NCT01264380|3780675|FG001|STARTED|Period C||0
3060092|NCT01264380|3780676|FG002|STARTED|Period C||16
3060093|NCT01264380|3780674|FG000|COMPLETED|Period C||0
3060094|NCT01264380|3780675|FG001|COMPLETED|Period C||0
3060095|NCT01264380|3780676|FG002|COMPLETED|Period C||2
3060096|NCT01264380|3780674|FG000|NOT COMPLETED|Period C||0
3060097|NCT01264380|3780675|FG001|NOT COMPLETED|Period C||0
3060098|NCT01264380|3780676|FG002|NOT COMPLETED|Period C||14
3060099|NCT01264419|3780684|FG000|STARTED|Overall Study||75
3060100|NCT01264419|3780684|FG000|COMPLETED|Overall Study||72
3060101|NCT01264419|3780684|FG000|NOT COMPLETED|Overall Study||3
3060102|NCT01264601|3780690|FG000|STARTED|Overall Study||17
3060103|NCT01264601|3780691|FG001|STARTED|Overall Study||14
3060104|NCT01264601|3780690|FG000|COMPLETED|Overall Study||17
3060105|NCT01264601|3780691|FG001|COMPLETED|Overall Study||14
3060106|NCT01264601|3780690|FG000|NOT COMPLETED|Overall Study||0
3060107|NCT01264601|3780691|FG001|NOT COMPLETED|Overall Study||0
3060108|NCT01264614|3780699|FG000|STARTED|Overall Study||13
3060109|NCT01264614|3780700|FG001|STARTED|Overall Study||9
3060110|NCT01264614|3780699|FG000|COMPLETED|Overall Study||12
3060111|NCT01264614|3780700|FG001|COMPLETED|Overall Study||7
3060112|NCT01264614|3780699|FG000|NOT COMPLETED|Overall Study||1
3060113|NCT01264614|3780700|FG001|NOT COMPLETED|Overall Study||2
3060114|NCT01264705|3780709|FG000|STARTED|Overall Study||3
3060115|NCT01264705|3780710|FG001|STARTED|Overall Study||3
3060116|NCT01264705|3780711|FG002|STARTED|Overall Study||41
3060117|NCT01264705|3780709|FG000|COMPLETED|Overall Study||3
3060118|NCT01264705|3780710|FG001|COMPLETED|Overall Study||3
3060119|NCT01264705|3780711|FG002|COMPLETED|Overall Study||41
3060120|NCT01264705|3780709|FG000|NOT COMPLETED|Overall Study||0
3060121|NCT01264705|3780710|FG001|NOT COMPLETED|Overall Study||0
3060122|NCT01264705|3780711|FG002|NOT COMPLETED|Overall Study||0
3060123|NCT01264718|3780724|FG000|STARTED|Overall Study||172
3060124|NCT01264718|3780725|FG001|STARTED|Overall Study||157
3060125|NCT01264718|3780724|FG000|COMPLETED|Overall Study||123
3060126|NCT01264718|3780725|FG001|COMPLETED|Overall Study||114
3060127|NCT01264718|3780724|FG000|NOT COMPLETED|Overall Study||49
3060128|NCT01264718|3780725|FG001|NOT COMPLETED|Overall Study||43
3060129|NCT01264770|3780737|FG000|STARTED|Overall Study|Patients who received treatment|54
3060130|NCT01264770|3780738|FG001|STARTED|Overall Study|Patients who received treatment|48
3060131|NCT01264770|3780739|FG002|STARTED|Overall Study|Patients who received treatment|57
3060132|NCT01264770|3780740|FG003|STARTED|Overall Study|Patients who received treatment|54
3060133|NCT01264770|3780741|FG004|STARTED|Overall Study|Patients who received treatment|27
3060134|NCT01264770|3780742|FG005|STARTED|Overall Study|Patients who received treatment|25
3060135|NCT01264770|3780737|FG000|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|2
3060136|NCT01264770|3780738|FG001|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|5
3060137|NCT01264770|3780739|FG002|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|2
3060138|NCT01264770|3780740|FG003|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|3
3060139|NCT01264770|3780741|FG004|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|2
3060140|NCT01264770|3780742|FG005|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|0
3060141|NCT01264770|3780737|FG000|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|36
3060142|NCT01264770|3780738|FG001|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|38
3060143|NCT01264770|3780739|FG002|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|41
3060144|NCT01264770|3780740|FG003|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|48
3060145|NCT01264770|3780741|FG004|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|19
3060146|NCT01264770|3780742|FG005|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|19
3060147|NCT01264770|3780737|FG000|NOT COMPLETED|Overall Study||18
3060148|NCT01264770|3780738|FG001|NOT COMPLETED|Overall Study||10
3060149|NCT01264770|3780739|FG002|NOT COMPLETED|Overall Study||16
3060150|NCT01264770|3780740|FG003|NOT COMPLETED|Overall Study||6
3060151|NCT01264770|3780741|FG004|NOT COMPLETED|Overall Study||8
3060152|NCT01264770|3780742|FG005|NOT COMPLETED|Overall Study||6
3060153|NCT01264887|3780762|FG000|STARTED|Overall Study||31
3060154|NCT01264887|3780762|FG000|COMPLETED|Overall Study||0
3060155|NCT01264887|3780762|FG000|NOT COMPLETED|Overall Study||31
3060156|NCT01264939|3780770|FG000|STARTED|Overall Study||84
3060157|NCT01264939|3780771|FG001|STARTED|Overall Study||252
3060158|NCT01264939|3780770|FG000|COMPLETED|Overall Study||66
3060159|NCT01264939|3780771|FG001|COMPLETED|Overall Study||224
3162635|NCT01879722|3890054|FG003|STARTED|Overall Study||8
3162636|NCT01879722|3890055|FG004|STARTED|Overall Study||8
3162637|NCT01879722|3890056|FG005|STARTED|Overall Study||9
3162638|NCT01879722|3890057|FG006|STARTED|Overall Study||8
3162639|NCT01879722|3890058|FG007|STARTED|Overall Study||8
3162640|NCT01879722|3890059|FG008|STARTED|Overall Study||8
3162641|NCT01879722|3890060|FG009|STARTED|Overall Study||6
3162642|NCT01879722|3890051|FG000|COMPLETED|Overall Study||7
3162643|NCT01879722|3890052|FG001|COMPLETED|Overall Study||7
3162644|NCT01879722|3890053|FG002|COMPLETED|Overall Study||7
3060160|NCT01264939|3780770|FG000|NOT COMPLETED|Overall Study||18
3060161|NCT01264939|3780771|FG001|NOT COMPLETED|Overall Study||28
3060162|NCT01264952|3780780|FG000|STARTED|Overall Study||6
3060163|NCT01264952|3780781|FG001|STARTED|Overall Study||2
3060164|NCT01264952|3780782|FG002|STARTED|Overall Study||8
3060165|NCT01264952|3780780|FG000|COMPLETED|Overall Study||6
3060166|NCT01264952|3780781|FG001|COMPLETED|Overall Study||2
3060167|NCT01264952|3780782|FG002|COMPLETED|Overall Study||8
3060168|NCT01264952|3780780|FG000|NOT COMPLETED|Overall Study||0
3060169|NCT01264952|3780781|FG001|NOT COMPLETED|Overall Study||0
3060170|NCT01264952|3780782|FG002|NOT COMPLETED|Overall Study||0
3060171|NCT01265056|3780792|FG000|STARTED|Initial Study Period||26
3060172|NCT01265056|3780793|FG001|STARTED|Initial Study Period||27
3060173|NCT01265056|3780792|FG000|COMPLETED|Initial Study Period||24
3060174|NCT01265056|3780793|FG001|COMPLETED|Initial Study Period||25
3060175|NCT01265056|3780792|FG000|NOT COMPLETED|Initial Study Period||2
3060176|NCT01265056|3780793|FG001|NOT COMPLETED|Initial Study Period||2
3060177|NCT01265056|3780792|FG000|STARTED|Follow up||26
3060178|NCT01265056|3780793|FG001|STARTED|Follow up||27
3060179|NCT01265056|3780792|FG000|COMPLETED|Follow up||19
3060180|NCT01265056|3780793|FG001|COMPLETED|Follow up||24
3060181|NCT01265056|3780792|FG000|NOT COMPLETED|Follow up||7
3060182|NCT01265056|3780793|FG001|NOT COMPLETED|Follow up||3
3060183|NCT01265394|3780799|FG000|STARTED|Overall Study||218
3060184|NCT01265394|3780799|FG000|COMPLETED|Overall Study||181
3060185|NCT01265394|3780799|FG000|NOT COMPLETED|Overall Study||37
3060186|NCT01265420|3780804|FG000|STARTED|Overall Study||7
3060187|NCT01265420|3780804|FG000|COMPLETED|Overall Study|One patient was seen at Day 10 but did not return for Day 30 evaluation|6
3060188|NCT01265420|3780804|FG000|NOT COMPLETED|Overall Study||1
3060189|NCT01265446|3780810|FG000|STARTED|Overall Study||125
3060190|NCT01265446|3780811|FG001|STARTED|Overall Study||125
3060191|NCT01265446|3780810|FG000|COMPLETED|Overall Study||124
3060192|NCT01265446|3780811|FG001|COMPLETED|Overall Study||125
3060193|NCT01265446|3780810|FG000|NOT COMPLETED|Overall Study||1
3060194|NCT01265446|3780811|FG001|NOT COMPLETED|Overall Study||0
3060195|NCT01265459|3780820|FG000|STARTED|Overall Study||23
3060196|NCT01265459|3780821|FG001|STARTED|Overall Study||23
3060197|NCT01265459|3780822|FG002|STARTED|Overall Study||22
3060198|NCT01265459|3780820|FG000|COMPLETED|Overall Study||23
3060199|NCT01265459|3780821|FG001|COMPLETED|Overall Study||23
3060200|NCT01265459|3780822|FG002|COMPLETED|Overall Study||20
3060201|NCT01265459|3780820|FG000|NOT COMPLETED|Overall Study||0
3060202|NCT01265459|3780821|FG001|NOT COMPLETED|Overall Study||0
3060203|NCT01265459|3780822|FG002|NOT COMPLETED|Overall Study||2
3060204|NCT01265498|3780844|FG000|STARTED|Overall Study||141
3060205|NCT01265498|3780845|FG001|STARTED|Overall Study||142
3060206|NCT01265498|3780844|FG000|Both Baseline and Week 72 Biopsy|Overall Study||102
3060207|NCT01265498|3780845|FG001|Both Baseline and Week 72 Biopsy|Overall Study||98
3060208|NCT01265498|3780844|FG000|COMPLETED|Overall Study||110
3060209|NCT01265498|3780845|FG001|COMPLETED|Overall Study||109
3060210|NCT01265498|3780844|FG000|NOT COMPLETED|Overall Study||31
3060211|NCT01265498|3780845|FG001|NOT COMPLETED|Overall Study||33
3060212|NCT01265511|3780853|FG000|STARTED|Overall Study||2
3060213|NCT01265511|3780854|FG001|STARTED|Overall Study||8
3060214|NCT01265511|3780853|FG000|COMPLETED|Overall Study||0
3060215|NCT01265511|3780854|FG001|COMPLETED|Overall Study||5
3060216|NCT01265511|3780853|FG000|NOT COMPLETED|Overall Study||2
3060217|NCT01265511|3780854|FG001|NOT COMPLETED|Overall Study||3
3060218|NCT01265524|3780862|FG000|STARTED|Overall Study||59
3060219|NCT01265524|3780863|FG001|STARTED|Overall Study||52
3060220|NCT01265524|3780862|FG000|COMPLETED|Overall Study||41
3060221|NCT01265524|3780863|FG001|COMPLETED|Overall Study||46
3060222|NCT01265524|3780862|FG000|NOT COMPLETED|Overall Study||18
3060223|NCT01265524|3780863|FG001|NOT COMPLETED|Overall Study||6
3060224|NCT01265537|3780871|FG000|STARTED|Overall Study||15
3060225|NCT01265537|3780872|FG001|STARTED|Overall Study||15
3060226|NCT01265537|3780871|FG000|COMPLETED|Overall Study||13
3060227|NCT01265537|3780872|FG001|COMPLETED|Overall Study||13
3060228|NCT01265537|3780871|FG000|NOT COMPLETED|Overall Study||2
3060229|NCT01265537|3780872|FG001|NOT COMPLETED|Overall Study||2
3060230|NCT01265550|3780882|FG000|STARTED|Pre Randomization||0
3060231|NCT01265550|3780883|FG001|STARTED|Pre Randomization||0
3060232|NCT01265550|3780884|FG002|STARTED|Pre Randomization||0
3162645|NCT01879722|3890054|FG003|COMPLETED|Overall Study||7
3060233|NCT01265550|3780885|FG003|STARTED|Pre Randomization||366
3060234|NCT01265550|3780882|FG000|COMPLETED|Pre Randomization||0
3060235|NCT01265550|3780883|FG001|COMPLETED|Pre Randomization||0
3060236|NCT01265550|3780884|FG002|COMPLETED|Pre Randomization||0
3162646|NCT01879722|3890055|FG004|COMPLETED|Overall Study||7
3162647|NCT01879722|3890056|FG005|COMPLETED|Overall Study||9
3162648|NCT01879722|3890057|FG006|COMPLETED|Overall Study||8
3162649|NCT01879722|3890058|FG007|COMPLETED|Overall Study||7
3162650|NCT01879722|3890059|FG008|COMPLETED|Overall Study||6
3060237|NCT01265550|3780885|FG003|COMPLETED|Pre Randomization||78
3060238|NCT01265550|3780882|FG000|NOT COMPLETED|Pre Randomization||0
3060239|NCT01265550|3780883|FG001|NOT COMPLETED|Pre Randomization||0
3162651|NCT01879722|3890060|FG009|COMPLETED|Overall Study||6
3162652|NCT01879722|3890051|FG000|NOT COMPLETED|Overall Study||0
3162653|NCT01879722|3890052|FG001|NOT COMPLETED|Overall Study||1
3162654|NCT01879722|3890053|FG002|NOT COMPLETED|Overall Study||0
3162655|NCT01879722|3890054|FG003|NOT COMPLETED|Overall Study||1
3162656|NCT01879722|3890055|FG004|NOT COMPLETED|Overall Study||1
3060240|NCT01265550|3780884|FG002|NOT COMPLETED|Pre Randomization||0
3060241|NCT01265550|3780885|FG003|NOT COMPLETED|Pre Randomization||288
3060242|NCT01265550|3780882|FG000|STARTED|Post Randomization||25
3060243|NCT01265550|3780883|FG001|STARTED|Post Randomization||27
3060244|NCT01265550|3780884|FG002|STARTED|Post Randomization||26
3060245|NCT01265550|3780885|FG003|STARTED|Post Randomization||0
3060246|NCT01265550|3780882|FG000|COMPLETED|Post Randomization||10
3060247|NCT01265550|3780883|FG001|COMPLETED|Post Randomization||19
3060248|NCT01265550|3780884|FG002|COMPLETED|Post Randomization||6
3060249|NCT01265550|3780885|FG003|COMPLETED|Post Randomization||0
3060250|NCT01265550|3780882|FG000|NOT COMPLETED|Post Randomization||15
3060251|NCT01265550|3780883|FG001|NOT COMPLETED|Post Randomization||8
3060252|NCT01265550|3780884|FG002|NOT COMPLETED|Post Randomization||20
3060253|NCT01265550|3780885|FG003|NOT COMPLETED|Post Randomization||0
3060254|NCT01265563|3780904|FG000|STARTED|Overall Study||16
3060255|NCT01265563|3780905|FG001|STARTED|Overall Study||13
3060256|NCT01265563|3780906|FG002|STARTED|Overall Study||17
3060257|NCT01265563|3780907|FG003|STARTED|Overall Study||16
3060258|NCT01265563|3780908|FG004|STARTED|Overall Study||16
3060259|NCT01265563|3780904|FG000|COMPLETED|Overall Study||16
3060260|NCT01265563|3780905|FG001|COMPLETED|Overall Study||12
3060261|NCT01265563|3780906|FG002|COMPLETED|Overall Study||16
3060262|NCT01265563|3780907|FG003|COMPLETED|Overall Study||16
3060263|NCT01265563|3780908|FG004|COMPLETED|Overall Study||14
3060264|NCT01265563|3780904|FG000|NOT COMPLETED|Overall Study||0
3060265|NCT01265563|3780905|FG001|NOT COMPLETED|Overall Study||1
3060266|NCT01265563|3780906|FG002|NOT COMPLETED|Overall Study||1
3060267|NCT01265563|3780907|FG003|NOT COMPLETED|Overall Study||0
3060268|NCT01265563|3780908|FG004|NOT COMPLETED|Overall Study||2
3060269|NCT01265615|3780929|FG000|STARTED|Overall Study||30
3060270|NCT01265615|3780930|FG001|STARTED|Overall Study||30
3060271|NCT01265615|3780931|FG002|STARTED|Overall Study||30
3060272|NCT01265615|3780932|FG003|STARTED|Overall Study||30
3060273|NCT01265615|3780929|FG000|COMPLETED|Overall Study||28
3060274|NCT01265615|3780930|FG001|COMPLETED|Overall Study||28
3060275|NCT01265615|3780931|FG002|COMPLETED|Overall Study||26
3060276|NCT01265615|3780932|FG003|COMPLETED|Overall Study||27
3060277|NCT01265615|3780929|FG000|NOT COMPLETED|Overall Study||2
3060278|NCT01265615|3780930|FG001|NOT COMPLETED|Overall Study||2
3060279|NCT01265615|3780931|FG002|NOT COMPLETED|Overall Study||4
3060280|NCT01265615|3780932|FG003|NOT COMPLETED|Overall Study||3
3060281|NCT01265667|3780944|FG000|STARTED|Overall Study||145
3060282|NCT01265667|3780945|FG001|STARTED|Overall Study||148
3060283|NCT01265667|3780944|FG000|COMPLETED|Overall Study||125
3060284|NCT01265667|3780945|FG001|COMPLETED|Overall Study||135
3060285|NCT01265667|3780944|FG000|NOT COMPLETED|Overall Study||20
3060286|NCT01265667|3780945|FG001|NOT COMPLETED|Overall Study||13
3060287|NCT01265719|3780953|FG000|STARTED|Overall Study||102
3060288|NCT01265719|3780954|FG001|STARTED|Overall Study||73
3060289|NCT01265719|3780953|FG000|COMPLETED|Overall Study||88
3060290|NCT01265719|3780954|FG001|COMPLETED|Overall Study||60
3060291|NCT01265719|3780953|FG000|NOT COMPLETED|Overall Study||14
3060292|NCT01265719|3780954|FG001|NOT COMPLETED|Overall Study||13
3060293|NCT01265797|3780962|FG000|STARTED|Run-in Month||34
3060294|NCT01265797|3780963|FG001|STARTED|Run-in Month||34
3060295|NCT01265797|3780962|FG000|COMPLETED|Run-in Month||34
3060296|NCT01265797|3780963|FG001|COMPLETED|Run-in Month||29
3060297|NCT01265797|3780962|FG000|NOT COMPLETED|Run-in Month||0
3060298|NCT01265797|3780963|FG001|NOT COMPLETED|Run-in Month||5
3060299|NCT01265797|3780962|FG000|STARTED|Blinded Month||34
3060300|NCT01265797|3780963|FG001|STARTED|Blinded Month||29
3060301|NCT01265797|3780962|FG000|COMPLETED|Blinded Month||24
3060302|NCT01265797|3780963|FG001|COMPLETED|Blinded Month||27
3060303|NCT01265797|3780962|FG000|NOT COMPLETED|Blinded Month||10
3060304|NCT01265797|3780963|FG001|NOT COMPLETED|Blinded Month||2
3060305|NCT01265797|3780962|FG000|STARTED|Open Label Month||24
3060306|NCT01265797|3780963|FG001|STARTED|Open Label Month||27
3060307|NCT01265797|3780962|FG000|COMPLETED|Open Label Month||24
3060308|NCT01265797|3780963|FG001|COMPLETED|Open Label Month||26
3060309|NCT01265797|3780962|FG000|NOT COMPLETED|Open Label Month||0
3060310|NCT01265797|3780963|FG001|NOT COMPLETED|Open Label Month||1
3060311|NCT01265823|3780971|FG000|STARTED|Overall Study||150
3060312|NCT01265823|3780971|FG000|COMPLETED|Overall Study||143
3060313|NCT01265823|3780971|FG000|NOT COMPLETED|Overall Study||7
3060314|NCT01265875|3780979|FG000|STARTED|Overall Study||12
3060315|NCT01265875|3780979|FG000|COMPLETED|Overall Study||11
3060316|NCT01265875|3780979|FG000|NOT COMPLETED|Overall Study||1
3060317|NCT01265953|3780986|FG000|STARTED|Overall Study||50
3060318|NCT01265953|3780987|FG001|STARTED|Overall Study||48
3060319|NCT01265953|3780986|FG000|COMPLETED|Overall Study||45
3060320|NCT01265953|3780987|FG001|COMPLETED|Overall Study||45
3162657|NCT01879722|3890056|FG005|NOT COMPLETED|Overall Study||0
3162658|NCT01879722|3890057|FG006|NOT COMPLETED|Overall Study||0
3060321|NCT01265953|3780986|FG000|NOT COMPLETED|Overall Study||5
3060322|NCT01265953|3780987|FG001|NOT COMPLETED|Overall Study||3
3060323|NCT01265966|3780996|FG000|STARTED|Overall Study||47
3060324|NCT01265966|3780997|FG001|STARTED|Overall Study||41
3060325|NCT01265966|3780998|FG002|STARTED|Overall Study||29
3060326|NCT01265966|3780996|FG000|Analyzed Separately|Overall Study|Patients taking inhaled or intranasal corticosteroids were analyzed separately.|3
3060327|NCT01265966|3780997|FG001|Analyzed Separately|Overall Study|Patients taking inhaled or intranasal corticosteroids were analyzed separately.|2
3060328|NCT01265966|3780998|FG002|Analyzed Separately|Overall Study|Patients taking inhaled or intranasal corticosteroids were analyzed separately.|2
3162659|NCT01879722|3890058|FG007|NOT COMPLETED|Overall Study||1
3162660|NCT01879722|3890059|FG008|NOT COMPLETED|Overall Study||2
3162661|NCT01879722|3890060|FG009|NOT COMPLETED|Overall Study||0
3060329|NCT01265966|3780996|FG000|COMPLETED|Overall Study||44
3060330|NCT01265966|3780997|FG001|COMPLETED|Overall Study||39
3060331|NCT01265966|3780998|FG002|COMPLETED|Overall Study||27
3060332|NCT01265966|3780996|FG000|NOT COMPLETED|Overall Study||3
3060333|NCT01265966|3780997|FG001|NOT COMPLETED|Overall Study||2
3060334|NCT01265966|3780998|FG002|NOT COMPLETED|Overall Study||2
3060335|NCT01265992|3781006|FG000|STARTED|Overall Study||50
3060336|NCT01265992|3781006|FG000|Received Treatment|Overall Study||49
3060337|NCT01265992|3781006|FG000|COMPLETED|Overall Study||41
3060338|NCT01265992|3781006|FG000|NOT COMPLETED|Overall Study||9
3060339|NCT01266018|3781010|FG000|STARTED|Overall Study||9
3060340|NCT01266018|3781011|FG001|STARTED|Overall Study||13
3162662|NCT01879735|3890087|FG000|STARTED|Overall Study||6
3162663|NCT01879735|3890088|FG001|STARTED|Overall Study||16
3162664|NCT01879735|3890087|FG000|COMPLETED|Overall Study||6
3162665|NCT01879735|3890088|FG001|COMPLETED|Overall Study||16
3162666|NCT01879735|3890087|FG000|NOT COMPLETED|Overall Study||0
3162667|NCT01879735|3890088|FG001|NOT COMPLETED|Overall Study||0
3162668|NCT01879800|3890096|FG000|STARTED|Overall Study||14
3162669|NCT01879800|3890097|FG001|STARTED|Overall Study||30
3162670|NCT01879800|3890096|FG000|COMPLETED|Overall Study||14
3162671|NCT01879800|3890097|FG001|COMPLETED|Overall Study||26
3162672|NCT01879800|3890096|FG000|NOT COMPLETED|Overall Study||0
3162673|NCT01879800|3890097|FG001|NOT COMPLETED|Overall Study||4
3060341|NCT01266018|3781010|FG000|COMPLETED|Overall Study|Defined as evaluable for the primary endpoint|8
3060342|NCT01266018|3781011|FG001|COMPLETED|Overall Study||12
3060343|NCT01266018|3781010|FG000|NOT COMPLETED|Overall Study||1
3060344|NCT01266018|3781011|FG001|NOT COMPLETED|Overall Study||1
3060345|NCT01266070|3781017|FG000|STARTED|Overall Study||6
3060346|NCT01266070|3781017|FG000|COMPLETED|Overall Study||2
3060347|NCT01266070|3781017|FG000|NOT COMPLETED|Overall Study||4
3060348|NCT01266122|3781023|FG000|STARTED|Overall Study||48
3060349|NCT01266122|3781024|FG001|STARTED|Overall Study||48
3060350|NCT01266122|3781023|FG000|COMPLETED|Overall Study||42
3060351|NCT01266122|3781024|FG001|COMPLETED|Overall Study||42
3060352|NCT01266122|3781023|FG000|NOT COMPLETED|Overall Study||6
3060353|NCT01266122|3781024|FG001|NOT COMPLETED|Overall Study||6
3060354|NCT01266148|3781032|FG000|STARTED|Overall Study||56
3060355|NCT01266148|3781033|FG001|STARTED|Overall Study||59
3060356|NCT01266148|3781032|FG000|COMPLETED|Overall Study||49
3060357|NCT01266148|3781033|FG001|COMPLETED|Overall Study||56
3060358|NCT01266148|3781032|FG000|NOT COMPLETED|Overall Study||7
3060359|NCT01266148|3781033|FG001|NOT COMPLETED|Overall Study||3
3060360|NCT01266161|3781041|FG000|STARTED|Overall Study||52
3060361|NCT01266161|3781042|FG001|STARTED|Overall Study||54
3060362|NCT01266161|3781041|FG000|COMPLETED|Overall Study||48
3060363|NCT01266161|3781042|FG001|COMPLETED|Overall Study||53
3060364|NCT01266161|3781041|FG000|NOT COMPLETED|Overall Study||4
3162674|NCT01879826|3890105|FG000|STARTED|Overall Study||41
3162675|NCT01879826|3890106|FG001|STARTED|Overall Study||40
3162676|NCT01879826|3890105|FG000|COMPLETED|Overall Study||41
3162677|NCT01879826|3890106|FG001|COMPLETED|Overall Study||40
3162678|NCT01879826|3890105|FG000|NOT COMPLETED|Overall Study||0
3162679|NCT01879826|3890106|FG001|NOT COMPLETED|Overall Study||0
3162680|NCT01879852|3890114|FG000|STARTED|Overall Study||14
3162681|NCT01879852|3890115|FG001|STARTED|Overall Study||13
3162682|NCT01879852|3890114|FG000|COMPLETED|Overall Study||12
3162683|NCT01879852|3890115|FG001|COMPLETED|Overall Study||13
3162684|NCT01879852|3890114|FG000|NOT COMPLETED|Overall Study||2
3162685|NCT01879852|3890115|FG001|NOT COMPLETED|Overall Study||0
3060365|NCT01266161|3781042|FG001|NOT COMPLETED|Overall Study||1
3162686|NCT01880047|3890125|FG000|STARTED|Weeks 0-2||17
3162687|NCT01880047|3890126|FG001|STARTED|Weeks 0-2||9
3162688|NCT01880047|3890127|FG002|STARTED|Weeks 0-2||5
3162689|NCT01880047|3890128|FG003|STARTED|Weeks 0-2||3
3162690|NCT01880047|3890125|FG000|COMPLETED|Weeks 0-2||17
3162691|NCT01880047|3890126|FG001|COMPLETED|Weeks 0-2||8
3162692|NCT01880047|3890127|FG002|COMPLETED|Weeks 0-2||4
3162693|NCT01880047|3890128|FG003|COMPLETED|Weeks 0-2||2
3162694|NCT01880047|3890125|FG000|NOT COMPLETED|Weeks 0-2||0
3162695|NCT01880047|3890126|FG001|NOT COMPLETED|Weeks 0-2||1
3162696|NCT01880047|3890127|FG002|NOT COMPLETED|Weeks 0-2||1
3162697|NCT01880047|3890128|FG003|NOT COMPLETED|Weeks 0-2||1
3162698|NCT01880047|3890125|FG000|STARTED|Weeks 3-4||17
3162699|NCT01880047|3890126|FG001|STARTED|Weeks 3-4||8
3162700|NCT01880047|3890127|FG002|STARTED|Weeks 3-4||4
3162701|NCT01880047|3890128|FG003|STARTED|Weeks 3-4||2
3162702|NCT01880047|3890125|FG000|COMPLETED|Weeks 3-4||17
3162703|NCT01880047|3890126|FG001|COMPLETED|Weeks 3-4||7
3162704|NCT01880047|3890127|FG002|COMPLETED|Weeks 3-4||4
3162705|NCT01880047|3890128|FG003|COMPLETED|Weeks 3-4||2
3162706|NCT01880047|3890125|FG000|NOT COMPLETED|Weeks 3-4||0
3162707|NCT01880047|3890126|FG001|NOT COMPLETED|Weeks 3-4||1
3162708|NCT01880047|3890127|FG002|NOT COMPLETED|Weeks 3-4||0
3162709|NCT01880047|3890128|FG003|NOT COMPLETED|Weeks 3-4||0
3162710|NCT01880047|3890125|FG000|STARTED|Weeks 5-8||17
3162711|NCT01880047|3890126|FG001|STARTED|Weeks 5-8||7
3162712|NCT01880047|3890127|FG002|STARTED|Weeks 5-8||4
3162713|NCT01880047|3890128|FG003|STARTED|Weeks 5-8||2
3162714|NCT01880047|3890125|FG000|COMPLETED|Weeks 5-8||15
3162715|NCT01880047|3890126|FG001|COMPLETED|Weeks 5-8||6
3162716|NCT01880047|3890127|FG002|COMPLETED|Weeks 5-8||4
3162717|NCT01880047|3890128|FG003|COMPLETED|Weeks 5-8||2
3060366|NCT01266265|3781050|FG000|STARTED|Overall Study||666
3060367|NCT01266265|3781051|FG001|STARTED|Overall Study||667
3060368|NCT01266265|3781050|FG000|COMPLETED|Overall Study||461
3060369|NCT01266265|3781051|FG001|COMPLETED|Overall Study||477
3060370|NCT01266265|3781050|FG000|NOT COMPLETED|Overall Study||205
3060371|NCT01266265|3781051|FG001|NOT COMPLETED|Overall Study||190
3060372|NCT01266291|3781057|FG000|STARTED|Overall Study||1
3060373|NCT01266291|3781057|FG000|COMPLETED|Overall Study||0
3060374|NCT01266291|3781057|FG000|NOT COMPLETED|Overall Study||1
3060375|NCT01266317|3781061|FG000|STARTED|Overall Study|One additional patient was a protocol violation post consent when autoantibodies returned positive|9
3060376|NCT01266317|3781061|FG000|COMPLETED|Overall Study||7
3060377|NCT01266317|3781061|FG000|NOT COMPLETED|Overall Study||2
3060378|NCT01266447|3781065|FG000|STARTED|Overall Study||27
3060379|NCT01266447|3781065|FG000|COMPLETED|Overall Study|Eligible and treated patients|27
3060380|NCT01266447|3781065|FG000|NOT COMPLETED|Overall Study||0
3060381|NCT01266460|3781069|FG000|STARTED|Overall Study||50
3060382|NCT01266460|3781069|FG000|COMPLETED|Overall Study||16
3060383|NCT01266460|3781069|FG000|NOT COMPLETED|Overall Study||34
3060384|NCT01266590|3781073|FG000|STARTED|Overall Study||30
3060385|NCT01266590|3781073|FG000|COMPLETED|Overall Study||24
3060386|NCT01266590|3781073|FG000|NOT COMPLETED|Overall Study||6
3060387|NCT01266603|3781080|FG000|STARTED|Overall Study||44
3060388|NCT01266603|3781080|FG000|MAGE-A3 Positive Tumor|Overall Study||18
3060389|NCT01266603|3781080|FG000|Patients Evaluable for Safety|Overall Study||17
3060390|NCT01266603|3781080|FG000|Patients Evaluable for Response|Overall Study||16
3060391|NCT01266603|3781080|FG000|Continued to Maintenance- MAGE-A3|Overall Study||4
3060392|NCT01266603|3781080|FG000|Maintenance Completion|Overall Study||2
3060393|NCT01266603|3781080|FG000|COMPLETED|Overall Study||2
3060394|NCT01266603|3781080|FG000|NOT COMPLETED|Overall Study||42
3060395|NCT01266642|3781086|FG000|STARTED|Overall Study||149
3060396|NCT01266642|3781087|FG001|STARTED|Overall Study||138
3060397|NCT01266642|3781086|FG000|COMPLETED|Overall Study||149
3060398|NCT01266642|3781087|FG001|COMPLETED|Overall Study||137
3060399|NCT01266642|3781086|FG000|NOT COMPLETED|Overall Study||0
3060400|NCT01266642|3781087|FG001|NOT COMPLETED|Overall Study||1
3060401|NCT01266850|3781098|FG000|STARTED|Overall Study||242
3060402|NCT01266850|3781099|FG001|STARTED|Overall Study||248
3060403|NCT01266850|3781100|FG002|STARTED|Overall Study||238
3060404|NCT01266850|3781101|FG003|STARTED|Overall Study||329
3060405|NCT01266850|3781102|FG004|STARTED|Overall Study||327
3060406|NCT01266850|3781098|FG000|Received Second Vaccine|Overall Study||231
3162718|NCT01880047|3890125|FG000|NOT COMPLETED|Weeks 5-8||2
3162719|NCT01880047|3890126|FG001|NOT COMPLETED|Weeks 5-8||1
3162720|NCT01880047|3890127|FG002|NOT COMPLETED|Weeks 5-8||0
3060407|NCT01266850|3781099|FG001|Received Second Vaccine|Overall Study||233
3060408|NCT01266850|3781100|FG002|Received Second Vaccine|Overall Study||227
3060409|NCT01266850|3781101|FG003|Received Second Vaccine|Overall Study||311
3060410|NCT01266850|3781102|FG004|Received Second Vaccine|Overall Study||307
3060411|NCT01266850|3781098|FG000|Received Third Vaccine|Overall Study||221
3060412|NCT01266850|3781099|FG001|Received Third Vaccine|Overall Study||221
3060413|NCT01266850|3781100|FG002|Received Third Vaccine|Overall Study||217
3060414|NCT01266850|3781101|FG003|Received Third Vaccine|Overall Study||0
3060415|NCT01266850|3781102|FG004|Received Third Vaccine|Overall Study||299
3060416|NCT01266850|3781098|FG000|COMPLETED|Overall Study||212
3060417|NCT01266850|3781099|FG001|COMPLETED|Overall Study||212
3060418|NCT01266850|3781100|FG002|COMPLETED|Overall Study||214
3060419|NCT01266850|3781101|FG003|COMPLETED|Overall Study||301
3060420|NCT01266850|3781102|FG004|COMPLETED|Overall Study||297
3060421|NCT01266850|3781098|FG000|NOT COMPLETED|Overall Study||30
3060422|NCT01266850|3781099|FG001|NOT COMPLETED|Overall Study||36
3060423|NCT01266850|3781100|FG002|NOT COMPLETED|Overall Study||24
3060424|NCT01266850|3781101|FG003|NOT COMPLETED|Overall Study||28
3060425|NCT01266850|3781102|FG004|NOT COMPLETED|Overall Study||30
3060426|NCT01266876|3781119|FG000|STARTED|Overall Study||15
3060427|NCT01266876|3781120|FG001|STARTED|Overall Study||15
3162721|NCT01880047|3890128|FG003|NOT COMPLETED|Weeks 5-8||0
3162722|NCT01880047|3890125|FG000|STARTED|Extension Phase - 18 Months|15 subjects went into extension phase, were followed for variable periods of time|15
3162723|NCT01880047|3890126|FG001|STARTED|Extension Phase - 18 Months|6 subjects went into extension phase, were followed for variable periods of time|6
3060428|NCT01266876|3781121|FG002|STARTED|Overall Study||16
3060429|NCT01266876|3781122|FG003|STARTED|Overall Study||15
3060430|NCT01266876|3781123|FG004|STARTED|Overall Study||16
3060431|NCT01266876|3781119|FG000|COMPLETED|Overall Study||15
3060432|NCT01266876|3781120|FG001|COMPLETED|Overall Study||15
3162724|NCT01880047|3890127|FG002|STARTED|Extension Phase - 18 Months|4 subjects went into extension phase, were followed for variable periods of time|4
3060433|NCT01266876|3781121|FG002|COMPLETED|Overall Study||16
3060434|NCT01266876|3781122|FG003|COMPLETED|Overall Study||14
3060435|NCT01266876|3781123|FG004|COMPLETED|Overall Study||16
3060436|NCT01266876|3781119|FG000|NOT COMPLETED|Overall Study||0
3060437|NCT01266876|3781120|FG001|NOT COMPLETED|Overall Study||0
3060438|NCT01266876|3781121|FG002|NOT COMPLETED|Overall Study||0
3060439|NCT01266876|3781122|FG003|NOT COMPLETED|Overall Study||1
3060440|NCT01266876|3781123|FG004|NOT COMPLETED|Overall Study||0
3060441|NCT01266902|3781137|FG000|STARTED|Period 1 (Main Study)||119
3060442|NCT01266902|3781138|FG001|STARTED|Period 1 (Main Study)||363
3060443|NCT01266902|3781139|FG002|STARTED|Period 1 (Main Study)||0
3060444|NCT01266902|3781137|FG000|COMPLETED|Period 1 (Main Study)||89
3060445|NCT01266902|3781138|FG001|COMPLETED|Period 1 (Main Study)||282
3060446|NCT01266902|3781139|FG002|COMPLETED|Period 1 (Main Study)||0
3060447|NCT01266902|3781137|FG000|NOT COMPLETED|Period 1 (Main Study)||30
3060448|NCT01266902|3781138|FG001|NOT COMPLETED|Period 1 (Main Study)||81
3060449|NCT01266902|3781139|FG002|NOT COMPLETED|Period 1 (Main Study)||0
3060450|NCT01266902|3781137|FG000|STARTED|Period 2 (After Protocol Amendment 3)||0
3060451|NCT01266902|3781138|FG001|STARTED|Period 2 (After Protocol Amendment 3)||0
3060452|NCT01266902|3781139|FG002|STARTED|Period 2 (After Protocol Amendment 3)||45
3060453|NCT01266902|3781137|FG000|COMPLETED|Period 2 (After Protocol Amendment 3)||0
3060454|NCT01266902|3781138|FG001|COMPLETED|Period 2 (After Protocol Amendment 3)||0
3060455|NCT01266902|3781139|FG002|COMPLETED|Period 2 (After Protocol Amendment 3)||37
3060456|NCT01266902|3781137|FG000|NOT COMPLETED|Period 2 (After Protocol Amendment 3)||0
3060457|NCT01266902|3781138|FG001|NOT COMPLETED|Period 2 (After Protocol Amendment 3)||0
3060458|NCT01266902|3781139|FG002|NOT COMPLETED|Period 2 (After Protocol Amendment 3)||8
3060459|NCT01266967|3781149|FG000|STARTED|Overall Study||89
3060460|NCT01266967|3781150|FG001|STARTED|Overall Study||83
3060461|NCT01266967|3781149|FG000|COMPLETED|Overall Study||0
3060462|NCT01266967|3781150|FG001|COMPLETED|Overall Study||0
3060463|NCT01266967|3781149|FG000|NOT COMPLETED|Overall Study||89
3060464|NCT01266967|3781150|FG001|NOT COMPLETED|Overall Study||83
3060465|NCT01266993|3781161|FG000|STARTED|Persistence Phase (Month 32-44)||199
3060466|NCT01266993|3781162|FG001|STARTED|Persistence Phase (Month 32-44)||72
3060467|NCT01266993|3781161|FG000|COMPLETED|Persistence Phase (Month 32-44)||199
3060468|NCT01266993|3781162|FG001|COMPLETED|Persistence Phase (Month 32-44)||72
3060469|NCT01266993|3781161|FG000|NOT COMPLETED|Persistence Phase (Month 32-44)||0
3060470|NCT01266993|3781162|FG001|NOT COMPLETED|Persistence Phase (Month 32-44)||0
3060471|NCT01266993|3781161|FG000|STARTED|Persistence Phase (Month 44-56)||193
3060472|NCT01266993|3781162|FG001|STARTED|Persistence Phase (Month 44-56)||68
3060473|NCT01266993|3781161|FG000|COMPLETED|Persistence Phase (Month 44-56)||193
3060474|NCT01266993|3781162|FG001|COMPLETED|Persistence Phase (Month 44-56)||68
3060475|NCT01266993|3781161|FG000|NOT COMPLETED|Persistence Phase (Month 44-56)||0
3060476|NCT01266993|3781162|FG001|NOT COMPLETED|Persistence Phase (Month 44-56)||0
3060477|NCT01266993|3781161|FG000|STARTED|Persistence Phase (Month 56-68)||193
3060478|NCT01266993|3781162|FG001|STARTED|Persistence Phase (Month 56-68)||67
3060479|NCT01266993|3781161|FG000|COMPLETED|Persistence Phase (Month 56-68)||193
3060480|NCT01266993|3781162|FG001|COMPLETED|Persistence Phase (Month 56-68)||67
3060481|NCT01266993|3781161|FG000|NOT COMPLETED|Persistence Phase (Month 56-68)||0
3162725|NCT01880047|3890128|FG003|STARTED|Extension Phase - 18 Months|2 subjects went into extension phase, were followed for variable periods of time|2
3162726|NCT01880047|3890125|FG000|COMPLETED|Extension Phase - 18 Months||6
3162727|NCT01880047|3890126|FG001|COMPLETED|Extension Phase - 18 Months||3
3162728|NCT01880047|3890127|FG002|COMPLETED|Extension Phase - 18 Months||3
3162729|NCT01880047|3890128|FG003|COMPLETED|Extension Phase - 18 Months||0
3162730|NCT01880047|3890125|FG000|NOT COMPLETED|Extension Phase - 18 Months||9
3162731|NCT01880047|3890126|FG001|NOT COMPLETED|Extension Phase - 18 Months||3
3162732|NCT01880047|3890127|FG002|NOT COMPLETED|Extension Phase - 18 Months||1
3162733|NCT01880047|3890128|FG003|NOT COMPLETED|Extension Phase - 18 Months||2
3162734|NCT01880073|3890145|FG000|STARTED|Overall Study||24
3162735|NCT01880073|3890145|FG000|COMPLETED|Overall Study||24
3162736|NCT01880073|3890145|FG000|NOT COMPLETED|Overall Study||0
3060482|NCT01266993|3781162|FG001|NOT COMPLETED|Persistence Phase (Month 56-68)||0
3060483|NCT01266993|3781161|FG000|STARTED|Booster Phase (Month 68-69)||179
3060484|NCT01266993|3781162|FG001|STARTED|Booster Phase (Month 68-69)||62
3060485|NCT01266993|3781161|FG000|COMPLETED|Booster Phase (Month 68-69)||174
3060486|NCT01266993|3781162|FG001|COMPLETED|Booster Phase (Month 68-69)||60
3060487|NCT01266993|3781161|FG000|NOT COMPLETED|Booster Phase (Month 68-69)||5
3060488|NCT01266993|3781162|FG001|NOT COMPLETED|Booster Phase (Month 68-69)||2
3060489|NCT01267019|3781171|FG000|STARTED|Overall Study||47
3060490|NCT01267019|3781172|FG001|STARTED|Overall Study||53
3060491|NCT01267019|3781173|FG002|STARTED|Overall Study||53
3060492|NCT01267019|3781171|FG000|COMPLETED|Overall Study||41
3060493|NCT01267019|3781172|FG001|COMPLETED|Overall Study||47
3060494|NCT01267019|3781173|FG002|COMPLETED|Overall Study||47
3060495|NCT01267019|3781171|FG000|NOT COMPLETED|Overall Study||6
3060496|NCT01267019|3781172|FG001|NOT COMPLETED|Overall Study||6
3060497|NCT01267019|3781173|FG002|NOT COMPLETED|Overall Study||6
3060498|NCT01267045|3781183|FG000|STARTED|2-month Outcomes||26
3060499|NCT01267045|3781184|FG001|STARTED|2-month Outcomes||29
3060500|NCT01267045|3781183|FG000|COMPLETED|2-month Outcomes||22
3060501|NCT01267045|3781184|FG001|COMPLETED|2-month Outcomes||26
3060502|NCT01267045|3781183|FG000|NOT COMPLETED|2-month Outcomes||4
3060503|NCT01267045|3781184|FG001|NOT COMPLETED|2-month Outcomes||3
3060504|NCT01267045|3781183|FG000|STARTED|6-month Outcome||22
3060505|NCT01267045|3781184|FG001|STARTED|6-month Outcome||26
3060506|NCT01267045|3781183|FG000|COMPLETED|6-month Outcome||22
3060507|NCT01267045|3781184|FG001|COMPLETED|6-month Outcome||23
3060508|NCT01267045|3781183|FG000|NOT COMPLETED|6-month Outcome||0
3060509|NCT01267045|3781184|FG001|NOT COMPLETED|6-month Outcome||3
3060510|NCT01267136|3781193|FG000|STARTED|Overall Study||42
3060511|NCT01267136|3781194|FG001|STARTED|Overall Study||42
3060512|NCT01267136|3781193|FG000|COMPLETED|Overall Study||38
3060513|NCT01267136|3781194|FG001|COMPLETED|Overall Study||36
3060514|NCT01267136|3781193|FG000|NOT COMPLETED|Overall Study||4
3060515|NCT01267136|3781194|FG001|NOT COMPLETED|Overall Study||6
3060516|NCT01267175|3781202|FG000|STARTED|Overall Study||31
3060517|NCT01267175|3781202|FG000|COMPLETED|Overall Study||29
3060518|NCT01267175|3781202|FG000|NOT COMPLETED|Overall Study||2
3060519|NCT01267201|3781206|FG000|STARTED|First Intervention Period||4
3060520|NCT01267201|3781207|FG001|STARTED|First Intervention Period||4
3060521|NCT01267201|3781208|FG002|STARTED|First Intervention Period||4
3060522|NCT01267201|3781209|FG003|STARTED|First Intervention Period||4
3060523|NCT01267201|3781210|FG004|STARTED|First Intervention Period||4
3060524|NCT01267201|3781211|FG005|STARTED|First Intervention Period||4
3060525|NCT01267201|3781206|FG000|COMPLETED|First Intervention Period||3
3060526|NCT01267201|3781207|FG001|COMPLETED|First Intervention Period||4
3060527|NCT01267201|3781208|FG002|COMPLETED|First Intervention Period||4
3060528|NCT01267201|3781209|FG003|COMPLETED|First Intervention Period||4
3060529|NCT01267201|3781210|FG004|COMPLETED|First Intervention Period||4
3060530|NCT01267201|3781211|FG005|COMPLETED|First Intervention Period||4
3060531|NCT01267201|3781206|FG000|NOT COMPLETED|First Intervention Period||1
3060532|NCT01267201|3781207|FG001|NOT COMPLETED|First Intervention Period||0
3060533|NCT01267201|3781208|FG002|NOT COMPLETED|First Intervention Period||0
3060534|NCT01267201|3781209|FG003|NOT COMPLETED|First Intervention Period||0
3060535|NCT01267201|3781210|FG004|NOT COMPLETED|First Intervention Period||0
3060536|NCT01267201|3781211|FG005|NOT COMPLETED|First Intervention Period||0
3060537|NCT01267201|3781206|FG000|STARTED|Washout Period (At Least 2 Days)||3
3060538|NCT01267201|3781207|FG001|STARTED|Washout Period (At Least 2 Days)||4
3060539|NCT01267201|3781208|FG002|STARTED|Washout Period (At Least 2 Days)||4
3060540|NCT01267201|3781209|FG003|STARTED|Washout Period (At Least 2 Days)||4
3060541|NCT01267201|3781210|FG004|STARTED|Washout Period (At Least 2 Days)||4
3060542|NCT01267201|3781211|FG005|STARTED|Washout Period (At Least 2 Days)||4
3060543|NCT01267201|3781206|FG000|COMPLETED|Washout Period (At Least 2 Days)||3
3060544|NCT01267201|3781207|FG001|COMPLETED|Washout Period (At Least 2 Days)||4
3162737|NCT01880086|3890151|FG000|STARTED|Overall Study||6
3162738|NCT01880086|3890152|FG001|STARTED|Overall Study||7
3060545|NCT01267201|3781208|FG002|COMPLETED|Washout Period (At Least 2 Days)||4
3060546|NCT01267201|3781209|FG003|COMPLETED|Washout Period (At Least 2 Days)||4
3060547|NCT01267201|3781210|FG004|COMPLETED|Washout Period (At Least 2 Days)||4
3060548|NCT01267201|3781211|FG005|COMPLETED|Washout Period (At Least 2 Days)||4
3060549|NCT01267201|3781206|FG000|NOT COMPLETED|Washout Period (At Least 2 Days)||0
3060550|NCT01267201|3781207|FG001|NOT COMPLETED|Washout Period (At Least 2 Days)||0
3060551|NCT01267201|3781208|FG002|NOT COMPLETED|Washout Period (At Least 2 Days)||0
3060552|NCT01267201|3781209|FG003|NOT COMPLETED|Washout Period (At Least 2 Days)||0
3060553|NCT01267201|3781210|FG004|NOT COMPLETED|Washout Period (At Least 2 Days)||0
3060554|NCT01267201|3781211|FG005|NOT COMPLETED|Washout Period (At Least 2 Days)||0
3060555|NCT01267201|3781206|FG000|STARTED|Second Intervention Period||3
3060556|NCT01267201|3781207|FG001|STARTED|Second Intervention Period||4
3060557|NCT01267201|3781208|FG002|STARTED|Second Intervention Period||4
3060558|NCT01267201|3781209|FG003|STARTED|Second Intervention Period||4
3060559|NCT01267201|3781210|FG004|STARTED|Second Intervention Period||4
3060560|NCT01267201|3781211|FG005|STARTED|Second Intervention Period||4
3060561|NCT01267201|3781206|FG000|COMPLETED|Second Intervention Period||3
3060562|NCT01267201|3781207|FG001|COMPLETED|Second Intervention Period||3
3060563|NCT01267201|3781208|FG002|COMPLETED|Second Intervention Period||4
3060564|NCT01267201|3781209|FG003|COMPLETED|Second Intervention Period||4
3060565|NCT01267201|3781210|FG004|COMPLETED|Second Intervention Period||4
3060566|NCT01267201|3781211|FG005|COMPLETED|Second Intervention Period||4
3060567|NCT01267201|3781206|FG000|NOT COMPLETED|Second Intervention Period||0
3060568|NCT01267201|3781207|FG001|NOT COMPLETED|Second Intervention Period||1
3060569|NCT01267201|3781208|FG002|NOT COMPLETED|Second Intervention Period||0
3060570|NCT01267201|3781209|FG003|NOT COMPLETED|Second Intervention Period||0
3060571|NCT01267201|3781210|FG004|NOT COMPLETED|Second Intervention Period||0
3060572|NCT01267201|3781211|FG005|NOT COMPLETED|Second Intervention Period||0
3060573|NCT01267201|3781206|FG000|STARTED|Washout Period (At Least 2 Days)||3
3060574|NCT01267201|3781207|FG001|STARTED|Washout Period (At Least 2 Days)||3
3060575|NCT01267201|3781208|FG002|STARTED|Washout Period (At Least 2 Days)||4
3060576|NCT01267201|3781209|FG003|STARTED|Washout Period (At Least 2 Days)||4
3060577|NCT01267201|3781210|FG004|STARTED|Washout Period (At Least 2 Days)||4
3060578|NCT01267201|3781211|FG005|STARTED|Washout Period (At Least 2 Days)||4
3060579|NCT01267201|3781206|FG000|COMPLETED|Washout Period (At Least 2 Days)||3
3060580|NCT01267201|3781207|FG001|COMPLETED|Washout Period (At Least 2 Days)||3
3060581|NCT01267201|3781208|FG002|COMPLETED|Washout Period (At Least 2 Days)||4
3060582|NCT01267201|3781209|FG003|COMPLETED|Washout Period (At Least 2 Days)||4
3060583|NCT01267201|3781210|FG004|COMPLETED|Washout Period (At Least 2 Days)||4
3060584|NCT01267201|3781211|FG005|COMPLETED|Washout Period (At Least 2 Days)||4
3060585|NCT01267201|3781206|FG000|NOT COMPLETED|Washout Period (At Least 2 Days)||0
3060586|NCT01267201|3781207|FG001|NOT COMPLETED|Washout Period (At Least 2 Days)||0
3060587|NCT01267201|3781208|FG002|NOT COMPLETED|Washout Period (At Least 2 Days)||0
3060588|NCT01267201|3781209|FG003|NOT COMPLETED|Washout Period (At Least 2 Days)||0
3060589|NCT01267201|3781210|FG004|NOT COMPLETED|Washout Period (At Least 2 Days)||0
3060590|NCT01267201|3781211|FG005|NOT COMPLETED|Washout Period (At Least 2 Days)||0
3060591|NCT01267201|3781206|FG000|STARTED|Third Intervention Period||3
3060592|NCT01267201|3781207|FG001|STARTED|Third Intervention Period||3
3060593|NCT01267201|3781208|FG002|STARTED|Third Intervention Period||4
3060594|NCT01267201|3781209|FG003|STARTED|Third Intervention Period||4
3060595|NCT01267201|3781210|FG004|STARTED|Third Intervention Period||4
3060596|NCT01267201|3781211|FG005|STARTED|Third Intervention Period||4
3060597|NCT01267201|3781206|FG000|COMPLETED|Third Intervention Period||3
3060598|NCT01267201|3781207|FG001|COMPLETED|Third Intervention Period||3
3060599|NCT01267201|3781208|FG002|COMPLETED|Third Intervention Period||4
3060600|NCT01267201|3781209|FG003|COMPLETED|Third Intervention Period||4
3060601|NCT01267201|3781210|FG004|COMPLETED|Third Intervention Period||4
3060602|NCT01267201|3781211|FG005|COMPLETED|Third Intervention Period||4
3060603|NCT01267201|3781206|FG000|NOT COMPLETED|Third Intervention Period||0
3060604|NCT01267201|3781207|FG001|NOT COMPLETED|Third Intervention Period||0
3060605|NCT01267201|3781208|FG002|NOT COMPLETED|Third Intervention Period||0
3060606|NCT01267201|3781209|FG003|NOT COMPLETED|Third Intervention Period||0
3060607|NCT01267201|3781210|FG004|NOT COMPLETED|Third Intervention Period||0
3060608|NCT01267201|3781211|FG005|NOT COMPLETED|Third Intervention Period||0
3060609|NCT01267227|3781223|FG000|STARTED|Overall Study||20
3060610|NCT01267227|3781224|FG001|STARTED|Overall Study||20
3060611|NCT01267227|3781225|FG002|STARTED|Overall Study||20
3060612|NCT01267227|3781226|FG003|STARTED|Overall Study||20
3060613|NCT01267227|3781223|FG000|COMPLETED|Overall Study||19
3060614|NCT01267227|3781224|FG001|COMPLETED|Overall Study||19
3060615|NCT01267227|3781225|FG002|COMPLETED|Overall Study||18
3060616|NCT01267227|3781226|FG003|COMPLETED|Overall Study||17
3060617|NCT01267227|3781223|FG000|NOT COMPLETED|Overall Study||1
3060618|NCT01267227|3781224|FG001|NOT COMPLETED|Overall Study||1
3060619|NCT01267227|3781225|FG002|NOT COMPLETED|Overall Study||2
3060620|NCT01267227|3781226|FG003|NOT COMPLETED|Overall Study||3
3060621|NCT01267240|3781240|FG000|STARTED|Overall Study||25
3060622|NCT01267240|3781240|FG000|COMPLETED|Overall Study||25
3060623|NCT01267240|3781240|FG000|NOT COMPLETED|Overall Study||0
3060624|NCT01267253|3781244|FG000|STARTED|Overall Study||31
3060625|NCT01267253|3781244|FG000|COMPLETED|Overall Study|Eligible and treated patients|28
3060626|NCT01267253|3781244|FG000|NOT COMPLETED|Overall Study||3
3060627|NCT01267266|3781248|FG000|STARTED|Enrollment Phase||33
3060628|NCT01267266|3781249|FG001|STARTED|Enrollment Phase||0
3060629|NCT01267266|3781248|FG000|COMPLETED|Enrollment Phase|Two patients signed consent but did not proceed to treatment.|31
3060630|NCT01267266|3781249|FG001|COMPLETED|Enrollment Phase||0
3060631|NCT01267266|3781248|FG000|NOT COMPLETED|Enrollment Phase||2
3060632|NCT01267266|3781249|FG001|NOT COMPLETED|Enrollment Phase||0
3060633|NCT01267266|3781248|FG000|STARTED|Lead-in Phase||31
3060634|NCT01267266|3781249|FG001|STARTED|Lead-in Phase||0
3060635|NCT01267266|3781248|FG000|COMPLETED|Lead-in Phase|12 patients had radiographic progression, 8 clinical progression, 2 toxicity, 1 withdrawal.|8
3060636|NCT01267266|3781249|FG001|COMPLETED|Lead-in Phase||0
3060637|NCT01267266|3781248|FG000|NOT COMPLETED|Lead-in Phase||23
3060638|NCT01267266|3781249|FG001|NOT COMPLETED|Lead-in Phase||0
3060639|NCT01267266|3781248|FG000|STARTED|Randomized Phase|3 of 8 patients randomized to saracatinib.|3
3060640|NCT01267266|3781249|FG001|STARTED|Randomized Phase|5 of 8 patients randomized to placebo.|5
3060641|NCT01267266|3781248|FG000|COMPLETED|Randomized Phase||3
3060642|NCT01267266|3781249|FG001|COMPLETED|Randomized Phase||5
3060643|NCT01267266|3781248|FG000|NOT COMPLETED|Randomized Phase||0
3060644|NCT01267266|3781249|FG001|NOT COMPLETED|Randomized Phase||0
3060645|NCT01267279|3781260|FG000|STARTED|Overall Study||24
3060646|NCT01267279|3781261|FG001|STARTED|Overall Study||27
3060647|NCT01267279|3781260|FG000|COMPLETED|Overall Study||22
3060648|NCT01267279|3781261|FG001|COMPLETED|Overall Study||21
3060649|NCT01267279|3781260|FG000|NOT COMPLETED|Overall Study||2
3060650|NCT01267279|3781261|FG001|NOT COMPLETED|Overall Study||6
3060651|NCT01267292|3781269|FG000|STARTED|Overall Study||24
3060652|NCT01267292|3781270|FG001|STARTED|Overall Study||26
3060653|NCT01267292|3781269|FG000|COMPLETED|Overall Study||20
3060654|NCT01267292|3781270|FG001|COMPLETED|Overall Study||20
3060655|NCT01267292|3781269|FG000|NOT COMPLETED|Overall Study||4
3060656|NCT01267292|3781270|FG001|NOT COMPLETED|Overall Study||6
3060657|NCT01267422|3781276|FG000|STARTED|Intravitreal rAAV2-ND4 Injection||5
3060658|NCT01267422|3781277|FG001|STARTED|Intravitreal rAAV2-ND4 Injection||4
3060659|NCT01267422|3781276|FG000|COMPLETED|Intravitreal rAAV2-ND4 Injection||5
3060660|NCT01267422|3781277|FG001|COMPLETED|Intravitreal rAAV2-ND4 Injection||4
3060661|NCT01267422|3781276|FG000|NOT COMPLETED|Intravitreal rAAV2-ND4 Injection||0
3060662|NCT01267422|3781277|FG001|NOT COMPLETED|Intravitreal rAAV2-ND4 Injection||0
3060663|NCT01267422|3781276|FG000|STARTED|Safety and Efficacy Study||5
3060664|NCT01267422|3781277|FG001|STARTED|Safety and Efficacy Study||4
3060665|NCT01267422|3781276|FG000|COMPLETED|Safety and Efficacy Study||5
3060666|NCT01267422|3781277|FG001|COMPLETED|Safety and Efficacy Study||4
3060667|NCT01267422|3781276|FG000|NOT COMPLETED|Safety and Efficacy Study||0
3060668|NCT01267422|3781277|FG001|NOT COMPLETED|Safety and Efficacy Study||0
3060669|NCT01267656|3781295|FG000|STARTED|Overall Study||83
3060670|NCT01267656|3781296|FG001|STARTED|Overall Study||83
3060671|NCT01267656|3781295|FG000|COMPLETED|Overall Study||82
3060672|NCT01267656|3781296|FG001|COMPLETED|Overall Study||82
3060673|NCT01267656|3781295|FG000|NOT COMPLETED|Overall Study||1
3060674|NCT01267656|3781296|FG001|NOT COMPLETED|Overall Study||1
3060675|NCT01267864|3781305|FG000|STARTED|Overall Study||110
3060676|NCT01267864|3781306|FG001|STARTED|Overall Study||110
3060677|NCT01267864|3781307|FG002|STARTED|Overall Study||110
3060678|NCT01267864|3781305|FG000|COMPLETED|Overall Study||110
3060679|NCT01267864|3781306|FG001|COMPLETED|Overall Study||110
3060680|NCT01267864|3781307|FG002|COMPLETED|Overall Study||110
3060681|NCT01267864|3781305|FG000|NOT COMPLETED|Overall Study||0
3060682|NCT01267864|3781306|FG001|NOT COMPLETED|Overall Study||0
3060683|NCT01267864|3781307|FG002|NOT COMPLETED|Overall Study||0
3060684|NCT01267929|3781317|FG000|STARTED|Overall Study||15
3060685|NCT01267929|3781318|FG001|STARTED|Overall Study||15
3060686|NCT01267929|3781317|FG000|COMPLETED|Overall Study||15
3060687|NCT01267929|3781318|FG001|COMPLETED|Overall Study||15
3060688|NCT01267929|3781317|FG000|NOT COMPLETED|Overall Study||0
3060689|NCT01267929|3781318|FG001|NOT COMPLETED|Overall Study||0
3060690|NCT01267955|3781324|FG000|STARTED|Stage 1 (6 Months)||20
3060691|NCT01267955|3781324|FG000|COMPLETED|Stage 1 (6 Months)||17
3060692|NCT01267955|3781324|FG000|NOT COMPLETED|Stage 1 (6 Months)||3
3060693|NCT01267955|3781324|FG000|STARTED|Stage 2 (6 Months)||45
3060694|NCT01267955|3781324|FG000|COMPLETED|Stage 2 (6 Months)||39
3060695|NCT01267955|3781324|FG000|NOT COMPLETED|Stage 2 (6 Months)||6
3060696|NCT01267994|3781328|FG000|STARTED|Overall Study|Declined to participate. n=1 Did not receive intervention due to infeciton, n=1|12
3060697|NCT01267994|3781328|FG000|COMPLETED|Overall Study|Excluded from analysis, could not reach first milestone (day 28) for efficacy assessment, n=2|10
3060698|NCT01267994|3781328|FG000|NOT COMPLETED|Overall Study||2
3060699|NCT01268046|3781337|FG000|STARTED|Overall Study||13
3060700|NCT01268046|3781338|FG001|STARTED|Overall Study||9
3060701|NCT01268046|3781339|FG002|STARTED|Overall Study||8
3060702|NCT01268046|3781340|FG003|STARTED|Overall Study||8
3060703|NCT01268046|3781337|FG000|COMPLETED|Overall Study||12
3060704|NCT01268046|3781338|FG001|COMPLETED|Overall Study||9
3060705|NCT01268046|3781339|FG002|COMPLETED|Overall Study||7
3060706|NCT01268046|3781340|FG003|COMPLETED|Overall Study||7
3060707|NCT01268046|3781337|FG000|NOT COMPLETED|Overall Study||1
3060708|NCT01268046|3781338|FG001|NOT COMPLETED|Overall Study||0
3060709|NCT01268046|3781339|FG002|NOT COMPLETED|Overall Study||1
3060710|NCT01268046|3781340|FG003|NOT COMPLETED|Overall Study||1
3060711|NCT01268059|3781354|FG000|STARTED|Overall Study||40
3060712|NCT01268059|3781355|FG001|STARTED|Overall Study|Arm applicable for both dose-determination (Phase 1b) and randomization phase (Phase 2) of study.|45
3060713|NCT01268059|3781356|FG002|STARTED|Overall Study||6
3060714|NCT01268059|3781357|FG003|STARTED|Overall Study||8
3060715|NCT01268059|3781354|FG000|COMPLETED|Overall Study|End of study defined as 14 months from the last participant enrolled, or sponsor stopped the study.|12
3060716|NCT01268059|3781355|FG001|COMPLETED|Overall Study|End of study defined as 14 months from the last participant enrolled, or sponsor stopped the study.|10
3060717|NCT01268059|3781356|FG002|COMPLETED|Overall Study|End of study defined as 14 months from the last participant enrolled, or sponsor stopped the study.|3
3060718|NCT01268059|3781357|FG003|COMPLETED|Overall Study|End of study defined as 14 months from the last participant enrolled, or sponsor stopped the study.|3
3060719|NCT01268059|3781354|FG000|NOT COMPLETED|Overall Study||28
3060720|NCT01268059|3781355|FG001|NOT COMPLETED|Overall Study||35
3060721|NCT01268059|3781356|FG002|NOT COMPLETED|Overall Study||3
3060722|NCT01268059|3781357|FG003|NOT COMPLETED|Overall Study||5
3060723|NCT01268098|3781372|FG000|STARTED|Overall Study||19
3060724|NCT01268098|3781373|FG001|STARTED|Overall Study||23
3060725|NCT01268098|3781372|FG000|COMPLETED|Overall Study||18
3060726|NCT01268098|3781373|FG001|COMPLETED|Overall Study||23
3060727|NCT01268098|3781372|FG000|NOT COMPLETED|Overall Study||1
3060728|NCT01268098|3781373|FG001|NOT COMPLETED|Overall Study||0
3060729|NCT01268111|3781381|FG000|STARTED|Overall Study||6
3060730|NCT01268111|3781382|FG001|STARTED|Overall Study||6
3060731|NCT01268111|3781381|FG000|COMPLETED|Overall Study||6
3060732|NCT01268111|3781382|FG001|COMPLETED|Overall Study||6
3060733|NCT01268111|3781381|FG000|NOT COMPLETED|Overall Study||0
3060734|NCT01268111|3781382|FG001|NOT COMPLETED|Overall Study||0
3060735|NCT01268150|3781388|FG000|STARTED|Treatment Phase||56
3060736|NCT01268150|3781388|FG000|COMPLETED|Treatment Phase||28
3060737|NCT01268150|3781388|FG000|NOT COMPLETED|Treatment Phase||28
3060738|NCT01268150|3781388|FG000|STARTED|Extension Phase|28 participants discontinued study drug in Treatment Phase so did not enter the Extension Phase|28
3060739|NCT01268150|3781388|FG000|Treatment Ongoing at Data Cutoff Date|Extension Phase||1
3060740|NCT01268150|3781388|FG000|COMPLETED|Extension Phase||1
3060741|NCT01268150|3781388|FG000|NOT COMPLETED|Extension Phase||27
3060742|NCT01268189|3781392|FG000|STARTED|Overall Study||20
3060743|NCT01268189|3781392|FG000|COMPLETED|Overall Study||17
3060744|NCT01268189|3781392|FG000|NOT COMPLETED|Overall Study||3
3060745|NCT01268267|3781398|FG000|STARTED|Overall Study||94
3060746|NCT01268267|3781398|FG000|COMPLETED|Overall Study||93
3060747|NCT01268267|3781398|FG000|NOT COMPLETED|Overall Study||1
3060748|NCT01268293|3781403|FG000|STARTED|Overall Study||9
3060749|NCT01268293|3781403|FG000|Completed Cycle 1|Overall Study||9
3060750|NCT01268293|3781403|FG000|COMPLETED|Overall Study||0
3162739|NCT01880086|3890151|FG000|COMPLETED|Overall Study||5
3162740|NCT01880086|3890152|FG001|COMPLETED|Overall Study||6
3162741|NCT01880086|3890151|FG000|NOT COMPLETED|Overall Study||1
3162742|NCT01880086|3890152|FG001|NOT COMPLETED|Overall Study||1
3162743|NCT01880099|3890161|FG000|STARTED|Overall Study||17
3162744|NCT01880099|3890162|FG001|STARTED|Overall Study||21
3060751|NCT01268293|3781403|FG000|NOT COMPLETED|Overall Study||9
3060752|NCT01268306|3781407|FG000|STARTED|Overall Study||8
3060753|NCT01268306|3781407|FG000|COMPLETED|Overall Study||7
3060754|NCT01268306|3781407|FG000|NOT COMPLETED|Overall Study||1
3060755|NCT01268488|3781411|FG000|STARTED|Overall Study||98
3060756|NCT01268488|3781411|FG000|COMPLETED|Overall Study||93
3060757|NCT01268488|3781411|FG000|NOT COMPLETED|Overall Study||5
3060758|NCT01268501|3781416|FG000|STARTED|Overall Study||96
3060759|NCT01268501|3781416|FG000|COMPLETED|Overall Study||87
3060760|NCT01268501|3781416|FG000|NOT COMPLETED|Overall Study||9
3060761|NCT01268514|3781420|FG000|STARTED|Overall Study||115
3060762|NCT01268514|3781420|FG000|Participants Who Received the Device|Overall Study||114
3060763|NCT01268514|3781420|FG000|COMPLETED|Overall Study||74
3060764|NCT01268514|3781420|FG000|NOT COMPLETED|Overall Study||41
3060765|NCT01268527|3781428|FG000|STARTED|Overall Study||15
3060766|NCT01268527|3781429|FG001|STARTED|Overall Study||15
3060767|NCT01268527|3781428|FG000|COMPLETED|Overall Study||15
3060768|NCT01268527|3781429|FG001|COMPLETED|Overall Study||15
3060769|NCT01268527|3781428|FG000|NOT COMPLETED|Overall Study||0
3060770|NCT01268527|3781429|FG001|NOT COMPLETED|Overall Study||0
3060771|NCT01268553|3781448|FG000|STARTED|Overall Study||6
3060772|NCT01268553|3781448|FG000|COMPLETED|Overall Study||6
3060773|NCT01268553|3781448|FG000|NOT COMPLETED|Overall Study||0
3060774|NCT01268566|3781452|FG000|STARTED|Overall Study||56
3060775|NCT01268566|3781452|FG000|COMPLETED|Overall Study||13
3060776|NCT01268566|3781452|FG000|NOT COMPLETED|Overall Study||43
3134050|NCT01699542|3859035|FG001|COMPLETED|Overall Study||9
3134051|NCT01699542|3859034|FG000|NOT COMPLETED|Overall Study||0
3134052|NCT01699542|3859035|FG001|NOT COMPLETED|Overall Study||0
3134053|NCT01699607|3859043|FG000|STARTED|Overall Study||6
3134054|NCT01699607|3859044|FG001|STARTED|Overall Study||4
3134055|NCT01699607|3859043|FG000|COMPLETED|Overall Study||6
3134056|NCT01699607|3859044|FG001|COMPLETED|Overall Study||4
3134057|NCT01699607|3859043|FG000|NOT COMPLETED|Overall Study||0
3134058|NCT01699607|3859044|FG001|NOT COMPLETED|Overall Study||0
3134059|NCT01699685|3859051|FG000|STARTED|Period 1||39
3134060|NCT01699685|3859052|FG001|STARTED|Period 1||39
3134061|NCT01699685|3859051|FG000|Safety Population|Period 1||39
3134062|NCT01699685|3859052|FG001|Safety Population|Period 1||38
3134063|NCT01699685|3859051|FG000|Full Analysis Population (FAS)|Period 1||38
3134064|NCT01699685|3859052|FG001|Full Analysis Population (FAS)|Period 1||38
3134065|NCT01699685|3859051|FG000|COMPLETED|Period 1||36
3134066|NCT01699685|3859052|FG001|COMPLETED|Period 1||36
3134067|NCT01699685|3859051|FG000|NOT COMPLETED|Period 1||3
3134068|NCT01699685|3859052|FG001|NOT COMPLETED|Period 1||3
3134069|NCT01699685|3859051|FG000|STARTED|Period 2||36
3134070|NCT01699685|3859052|FG001|STARTED|Period 2||36
3134071|NCT01699685|3859051|FG000|COMPLETED|Period 2||35
3134072|NCT01699685|3859052|FG001|COMPLETED|Period 2||36
3134073|NCT01699685|3859051|FG000|NOT COMPLETED|Period 2||1
3134074|NCT01699685|3859052|FG001|NOT COMPLETED|Period 2||0
3134075|NCT01699698|3859060|FG000|STARTED|Overall Study||44
3134076|NCT01699698|3859061|FG001|STARTED|Overall Study||61
3134077|NCT01699698|3859060|FG000|COMPLETED|Overall Study||42
3134078|NCT01699698|3859061|FG001|COMPLETED|Overall Study||56
3134079|NCT01699698|3859060|FG000|NOT COMPLETED|Overall Study||2
3134080|NCT01699698|3859061|FG001|NOT COMPLETED|Overall Study||5
3134081|NCT01699750|3859070|FG000|STARTED|Overall Study||34
3134082|NCT01699750|3859071|FG001|STARTED|Overall Study||36
3134083|NCT01699750|3859070|FG000|COMPLETED|Overall Study||34
3134084|NCT01699750|3859071|FG001|COMPLETED|Overall Study||33
3134085|NCT01699750|3859070|FG000|NOT COMPLETED|Overall Study||0
3134086|NCT01699750|3859071|FG001|NOT COMPLETED|Overall Study||3
3134087|NCT01699763|3859081|FG000|STARTED|Overall Study||112
3134088|NCT01699763|3859081|FG000|COMPLETED|Overall Study||112
3134089|NCT01699763|3859081|FG000|NOT COMPLETED|Overall Study||0
3134090|NCT01699789|3859087|FG000|STARTED|Overall Study|606 eligible clients enrolled and contacted by telephone for baseline or follow-up survey in RS arm|606
3134091|NCT01699789|3859088|FG001|STARTED|Overall Study|640 eligible clients enrolled and contacted by telephone for baseline or follow-up survey in CEP arm|640
3134092|NCT01699789|3859087|FG000|Baseline|Overall Study||492
3134093|NCT01699789|3859088|FG001|Baseline|Overall Study||489
3134094|NCT01699789|3859087|FG000|6-Month Follow-Up|Overall Study||380
3134095|NCT01699789|3859088|FG001|6-Month Follow-Up|Overall Study||379
3134096|NCT01699789|3859087|FG000|12-Month Follow-Up|Overall Study||364
3134097|NCT01699789|3859088|FG001|12-Month Follow-Up|Overall Study||369
3134098|NCT01699789|3859087|FG000|3-Year Follow-up|Overall Study||293
3134099|NCT01699789|3859088|FG001|3-Year Follow-up|Overall Study||307
3134100|NCT01699789|3859087|FG000|4-Year Follow-up|Overall Study||143
3134101|NCT01699789|3859088|FG001|4-Year Follow-up|Overall Study||140
3134102|NCT01699789|3859087|FG000|COMPLETED|Overall Study|Clients in 44 programs with completed at least 1 data point at baseline, 6, or 12 mo FUP analyzed|504
3134103|NCT01699789|3859088|FG001|COMPLETED|Overall Study|Clients in 46 programs with completed at least 1 data point at baseline, 6, or 12 mo FUP analyzed|514
3134104|NCT01699789|3859087|FG000|NOT COMPLETED|Overall Study||102
3162745|NCT01880099|3890163|FG002|STARTED|Overall Study||22
3162746|NCT01880099|3890161|FG000|COMPLETED|Overall Study||9
3162747|NCT01880099|3890162|FG001|COMPLETED|Overall Study||11
3162748|NCT01880099|3890163|FG002|COMPLETED|Overall Study||15
3162749|NCT01880099|3890161|FG000|NOT COMPLETED|Overall Study||8
3162750|NCT01880099|3890162|FG001|NOT COMPLETED|Overall Study||10
3162751|NCT01880099|3890163|FG002|NOT COMPLETED|Overall Study||7
3162752|NCT01880320|3890174|FG000|STARTED|Overall Study||217
3162753|NCT01880320|3890175|FG001|STARTED|Overall Study||217
3162754|NCT01880320|3890176|FG002|STARTED|Overall Study||69
3162755|NCT01880320|3890174|FG000|COMPLETED|Overall Study||197
3162756|NCT01880320|3890175|FG001|COMPLETED|Overall Study||192
3162757|NCT01880320|3890176|FG002|COMPLETED|Overall Study||61
3162758|NCT01880320|3890174|FG000|NOT COMPLETED|Overall Study||20
3162759|NCT01880320|3890175|FG001|NOT COMPLETED|Overall Study||25
3162760|NCT01880320|3890176|FG002|NOT COMPLETED|Overall Study||8
3162761|NCT01880424|3890186|FG000|STARTED|Overall Study||417
3162762|NCT01880424|3890187|FG001|STARTED|Overall Study||422
3060777|NCT01268644|3781456|FG000|STARTED|Baseline Period (Week 0)||8
3060778|NCT01268644|3781456|FG000|COMPLETED|Baseline Period (Week 0)||8
3060779|NCT01268644|3781456|FG000|NOT COMPLETED|Baseline Period (Week 0)||0
3060780|NCT01268644|3781456|FG000|STARTED|Phase A (Weeks 0-12) Leptin Therapy||8
3060781|NCT01268644|3781456|FG000|COMPLETED|Phase A (Weeks 0-12) Leptin Therapy||8
3060782|NCT01268644|3781456|FG000|NOT COMPLETED|Phase A (Weeks 0-12) Leptin Therapy||0
3060783|NCT01268644|3781456|FG000|STARTED|Phase B (Weeks 12-20) Leptin Therapy|One subject withdrew after 12 weeks .|7
3060784|NCT01268644|3781456|FG000|COMPLETED|Phase B (Weeks 12-20) Leptin Therapy||7
3060785|NCT01268644|3781456|FG000|NOT COMPLETED|Phase B (Weeks 12-20) Leptin Therapy||0
3060786|NCT01268644|3781456|FG000|STARTED|Phase C (Weeks 20-24) Off Leptin Therapy||7
3060787|NCT01268644|3781456|FG000|COMPLETED|Phase C (Weeks 20-24) Off Leptin Therapy||7
3060788|NCT01268644|3781456|FG000|NOT COMPLETED|Phase C (Weeks 20-24) Off Leptin Therapy||0
3060789|NCT01268683|3781463|FG000|STARTED|Overall Study||10
3060790|NCT01268683|3781463|FG000|COMPLETED|Overall Study||8
3060791|NCT01268683|3781463|FG000|NOT COMPLETED|Overall Study||2
3060792|NCT01268891|3781469|FG000|STARTED|Overall Study||66
3060793|NCT01268891|3781470|FG001|STARTED|Overall Study||66
3060794|NCT01268891|3781469|FG000|COMPLETED|Overall Study||58
3060795|NCT01268891|3781470|FG001|COMPLETED|Overall Study||58
3060796|NCT01268891|3781469|FG000|NOT COMPLETED|Overall Study||8
3060797|NCT01268891|3781470|FG001|NOT COMPLETED|Overall Study||8
3060798|NCT01268943|3781480|FG000|STARTED|Overall Study||6
3060799|NCT01268943|3781481|FG001|STARTED|Overall Study||3
3060800|NCT01268943|3781482|FG002|STARTED|Overall Study||3
3060801|NCT01268943|3781483|FG003|STARTED|Overall Study||6
3060802|NCT01268943|3781480|FG000|COMPLETED|Overall Study||6
3060803|NCT01268943|3781481|FG001|COMPLETED|Overall Study||3
3060804|NCT01268943|3781482|FG002|COMPLETED|Overall Study||3
3060805|NCT01268943|3781483|FG003|COMPLETED|Overall Study||6
3060806|NCT01268943|3781480|FG000|NOT COMPLETED|Overall Study||0
3060807|NCT01268943|3781481|FG001|NOT COMPLETED|Overall Study||0
3060808|NCT01268943|3781482|FG002|NOT COMPLETED|Overall Study||0
3060809|NCT01268943|3781483|FG003|NOT COMPLETED|Overall Study||0
3060810|NCT01269047|3781496|FG000|STARTED|Overall Study||13
3060811|NCT01269047|3781497|FG001|STARTED|Overall Study||13
3060812|NCT01269047|3781498|FG002|STARTED|Overall Study||11
3060813|NCT01269047|3781496|FG000|COMPLETED|Overall Study||12
3060814|NCT01269047|3781497|FG001|COMPLETED|Overall Study||11
3060815|NCT01269047|3781498|FG002|COMPLETED|Overall Study||10
3060816|NCT01269047|3781496|FG000|NOT COMPLETED|Overall Study||1
3060817|NCT01269047|3781497|FG001|NOT COMPLETED|Overall Study||2
3060818|NCT01269047|3781498|FG002|NOT COMPLETED|Overall Study||1
3060819|NCT01269125|3781511|FG000|STARTED|Overall Study||60
3060820|NCT01269125|3781512|FG001|STARTED|Overall Study||60
3060821|NCT01269125|3781513|FG002|STARTED|Overall Study||60
3060822|NCT01269125|3781511|FG000|COMPLETED|Overall Study|lost to follow up:4; OHSS: 2; premature luteinization: 1|53
3060823|NCT01269125|3781512|FG001|COMPLETED|Overall Study|OHSS:4; premature luteinization: 1|55
3060824|NCT01269125|3781513|FG002|COMPLETED|Overall Study||60
3060825|NCT01269125|3781511|FG000|NOT COMPLETED|Overall Study||7
3060826|NCT01269125|3781512|FG001|NOT COMPLETED|Overall Study||5
3060827|NCT01269125|3781513|FG002|NOT COMPLETED|Overall Study||0
3162763|NCT01880424|3890186|FG000|COMPLETED|Overall Study||384
3162764|NCT01880424|3890187|FG001|COMPLETED|Overall Study||367
3162765|NCT01880424|3890186|FG000|NOT COMPLETED|Overall Study||33
3162766|NCT01880424|3890187|FG001|NOT COMPLETED|Overall Study||55
3284031|NCT02760654|4017795|FG001|COMPLETED|Overall Study||24
3284032|NCT02760654|4017794|FG000|NOT COMPLETED|Overall Study||7
3284033|NCT02760654|4017795|FG001|NOT COMPLETED|Overall Study||6
3284034|NCT02760810|4017801|FG000|STARTED|Overall Study||30
3284035|NCT02760810|4017801|FG000|COMPLETED|Overall Study||29
3284036|NCT02760810|4017801|FG000|NOT COMPLETED|Overall Study||1
3284037|NCT02760862|4017807|FG000|STARTED|Overall Study||25
3284038|NCT02760862|4017808|FG001|STARTED|Overall Study||25
3284039|NCT02760862|4017807|FG000|COMPLETED|Overall Study||25
3284040|NCT02760862|4017808|FG001|COMPLETED|Overall Study||25
3284041|NCT02760862|4017807|FG000|NOT COMPLETED|Overall Study||0
3284042|NCT02760862|4017808|FG001|NOT COMPLETED|Overall Study||0
3284043|NCT02760927|4017814|FG000|STARTED|Overall Study||4
3284044|NCT02760927|4017814|FG000|COMPLETED|Overall Study||3
3284045|NCT02760927|4017814|FG000|NOT COMPLETED|Overall Study||1
3284046|NCT02761252|4017821|FG000|STARTED|Overall Study||143
3162767|NCT01880437|3890196|FG000|STARTED|Overall Study||15
3162768|NCT01880437|3890197|FG001|STARTED|Overall Study||4
3060828|NCT01269346|3781521|FG000|STARTED|Treatment Phase||52
3060829|NCT01269346|3781521|FG000|Completed 6 Cycles|Treatment Phase||45
3060830|NCT01269346|3781521|FG000|COMPLETED|Treatment Phase||43
3060831|NCT01269346|3781521|FG000|NOT COMPLETED|Treatment Phase||9
3060832|NCT01269346|3781521|FG000|STARTED|Extension Phase|Out of 52 participants randomized, only 43 continued into the Extension Phase of the study.|43
3060833|NCT01269346|3781521|FG000|COMPLETED|Extension Phase||0
3060834|NCT01269346|3781521|FG000|NOT COMPLETED|Extension Phase||43
3060835|NCT01269372|3781526|FG000|STARTED|Overall Study||30
3060836|NCT01269372|3781526|FG000|COMPLETED|Overall Study||30
3060837|NCT01269372|3781526|FG000|NOT COMPLETED|Overall Study||0
3060838|NCT01269385|3781535|FG000|STARTED|Overall Study||4
3060839|NCT01269385|3781536|FG001|STARTED|Overall Study||4
3060840|NCT01269385|3781537|FG002|STARTED|Overall Study||6
3060841|NCT01269385|3781538|FG003|STARTED|Overall Study||8
3060842|NCT01269385|3781535|FG000|COMPLETED|Overall Study||3
3060843|NCT01269385|3781536|FG001|COMPLETED|Overall Study||3
3060844|NCT01269385|3781537|FG002|COMPLETED|Overall Study||6
3060845|NCT01269385|3781538|FG003|COMPLETED|Overall Study||8
3060846|NCT01269385|3781535|FG000|NOT COMPLETED|Overall Study||1
3060847|NCT01269385|3781536|FG001|NOT COMPLETED|Overall Study||1
3060848|NCT01269385|3781537|FG002|NOT COMPLETED|Overall Study||0
3060849|NCT01269385|3781538|FG003|NOT COMPLETED|Overall Study||0
3060850|NCT01269710|3781548|FG000|STARTED|Overall Study||4
3060851|NCT01269710|3781548|FG000|Week 12|Overall Study||3
3060852|NCT01269710|3781548|FG000|Week 36|Overall Study||2
3060853|NCT01269710|3781548|FG000|COMPLETED|Overall Study|This refers to Week 52.|1
3060854|NCT01269710|3781548|FG000|NOT COMPLETED|Overall Study||3
3060855|NCT01269736|3781554|FG000|STARTED|Nurses' Knowledge Assessments|873 unique nurses were assessed at 9 hospitals at the initiation of the study.|1585
3060856|NCT01269736|3781555|FG001|STARTED|Nurses' Knowledge Assessments|866 unique nurses were assessed at 8 hospitals at the initiation of the study.|1428
3060857|NCT01269736|3781554|FG000|Baseline Assessment|Nurses' Knowledge Assessments|873 unique nurses, assessed at 9 hospitals.|873
3060858|NCT01269736|3781555|FG001|Baseline Assessment|Nurses' Knowledge Assessments|866 unique nurses, assessed at 8 hospitals.|866
3060859|NCT01269736|3781554|FG000|15 Months Assessment|Nurses' Knowledge Assessments|1108 unique nurses, assessed at 9 hospitals.|1108
3060860|NCT01269736|3781555|FG001|15 Months Assessment|Nurses' Knowledge Assessments|866 unique nurses, assessed at 8 hospitals.|782
3060861|NCT01269736|3781554|FG000|30 Months Assessment|Nurses' Knowledge Assessments|741 unique nurses, assessed at 8 hospitals.|741
3060862|NCT01269736|3781555|FG001|30 Months Assessment|Nurses' Knowledge Assessments|926 unique nurses, assessed at 8 hospitals.|926
3060863|NCT01269736|3781554|FG000|COMPLETED|Nurses' Knowledge Assessments|1585 unique nurses assessed overall (at any time point) by end of study.|1585
3060864|NCT01269736|3781555|FG001|COMPLETED|Nurses' Knowledge Assessments|1428 unique nurses assessed overall (at any time point) by end of study.|1428
3060865|NCT01269736|3781554|FG000|NOT COMPLETED|Nurses' Knowledge Assessments||0
3060866|NCT01269736|3781555|FG001|NOT COMPLETED|Nurses' Knowledge Assessments||0
3060867|NCT01269736|3781554|FG000|STARTED|Patient Quality of Care Assessments|915 unique patients were assessed at 9 hospitals at the initiation of the study.|2299
3060868|NCT01269736|3781555|FG001|STARTED|Patient Quality of Care Assessments|889 unique patients were assessed at 8 hospitals at the initiation of the study.|2288
3060869|NCT01269736|3781554|FG000|Baseline Assessment|Patient Quality of Care Assessments|915 unique patients, assessed at 9 hospitals.|915
3060870|NCT01269736|3781555|FG001|Baseline Assessment|Patient Quality of Care Assessments|889 unique patients, assessed at 8 hospitals.|889
3060871|NCT01269736|3781554|FG000|15 Months Assessment|Patient Quality of Care Assessments|687 unique patients, assessed at 8 hospitals.|687
3060872|NCT01269736|3781555|FG001|15 Months Assessment|Patient Quality of Care Assessments|773 unique patients, assessed at 8 hospitals.|773
3060873|NCT01269736|3781554|FG000|30 Months Assessment|Patient Quality of Care Assessments|697 unique patients, assessed at 8 hospitals.|697
3060874|NCT01269736|3781555|FG001|30 Months Assessment|Patient Quality of Care Assessments|626 unique patients, assessed at 7 hospitals.|626
3060875|NCT01269736|3781554|FG000|COMPLETED|Patient Quality of Care Assessments|2299 unique patients assessed overall (at any time point) by end of study.|2299
3060876|NCT01269736|3781555|FG001|COMPLETED|Patient Quality of Care Assessments|2288 unique patients assessed overall (at any time point) by end of study.|2288
3060877|NCT01269736|3781554|FG000|NOT COMPLETED|Patient Quality of Care Assessments||0
3060878|NCT01269736|3781555|FG001|NOT COMPLETED|Patient Quality of Care Assessments||0
3060879|NCT01269736|3781554|FG000|STARTED|Patient Outcomes (Hospital Admissions)|17352 unique patients were assessed at 7 hospitals at the initiation of the study.|52085
3060880|NCT01269736|3781555|FG001|STARTED|Patient Outcomes (Hospital Admissions)|16459 unique patients were assessed at 6 hospitals at the initiation of the study.|43799
3060881|NCT01269736|3781554|FG000|Baseline Assessment|Patient Outcomes (Hospital Admissions)|17352 unique patients, assessed at 7 hospitals.|17352
3060882|NCT01269736|3781555|FG001|Baseline Assessment|Patient Outcomes (Hospital Admissions)|16549 unique patients, assessed at 6 hospitals.|16549
3060883|NCT01269736|3781554|FG000|15 Months Assessment|Patient Outcomes (Hospital Admissions)|18031 unique patients, assessed at 7 hospitals.|18031
3060884|NCT01269736|3781555|FG001|15 Months Assessment|Patient Outcomes (Hospital Admissions)|14075 unique patients, assessed at 6 hospitals.|14075
3060885|NCT01269736|3781554|FG000|30 Months Assessment|Patient Outcomes (Hospital Admissions)|16702 unique patients, assessed at 7 hospitals.|16702
3060886|NCT01269736|3781555|FG001|30 Months Assessment|Patient Outcomes (Hospital Admissions)|13265 unique patients, assessed at 6 hospitals.|13265
3060887|NCT01269736|3781554|FG000|COMPLETED|Patient Outcomes (Hospital Admissions)|52085 unique patients assessed overall (at any time point) by end of study.|52085
3060888|NCT01269736|3781555|FG001|COMPLETED|Patient Outcomes (Hospital Admissions)|43799 unique patients assessed overall (at any time point) by end of study.|43799
3060889|NCT01269736|3781554|FG000|NOT COMPLETED|Patient Outcomes (Hospital Admissions)||0
3060890|NCT01269736|3781555|FG001|NOT COMPLETED|Patient Outcomes (Hospital Admissions)||0
3060891|NCT01269801|3781565|FG000|STARTED|Overall Study||74
3060892|NCT01269801|3781566|FG001|STARTED|Overall Study||80
3060893|NCT01269801|3781565|FG000|COMPLETED|Overall Study||74
3060894|NCT01269801|3781566|FG001|COMPLETED|Overall Study||77
3060895|NCT01269801|3781565|FG000|NOT COMPLETED|Overall Study||0
3060896|NCT01269801|3781566|FG001|NOT COMPLETED|Overall Study||3
3060897|NCT01269918|3781574|FG000|STARTED|Overall Study||71
3060898|NCT01269918|3781575|FG001|STARTED|Overall Study||71
3060899|NCT01269918|3781574|FG000|COMPLETED|Overall Study||71
3060900|NCT01269918|3781575|FG001|COMPLETED|Overall Study||68
3060901|NCT01269918|3781574|FG000|NOT COMPLETED|Overall Study||0
3060902|NCT01269918|3781575|FG001|NOT COMPLETED|Overall Study||3
3060903|NCT01270126|3781583|FG000|STARTED|Overall Study||12
3060904|NCT01270126|3781584|FG001|STARTED|Overall Study||10
3060905|NCT01270126|3781583|FG000|COMPLETED|Overall Study||12
3060906|NCT01270126|3781584|FG001|COMPLETED|Overall Study||10
3060907|NCT01270126|3781583|FG000|NOT COMPLETED|Overall Study||0
3060908|NCT01270126|3781584|FG001|NOT COMPLETED|Overall Study||0
3060909|NCT01270139|3781593|FG000|STARTED|Overall Study|Intention-to-treat population|60
3060910|NCT01270139|3781594|FG001|STARTED|Overall Study|Intention-to-treat population|60
3060911|NCT01270139|3781595|FG002|STARTED|Overall Study|Intention-to-treat population|60
3060912|NCT01270139|3781593|FG000|COMPLETED|Overall Study|Pre-treatment evaluable population|42
3060913|NCT01270139|3781594|FG001|COMPLETED|Overall Study|Pre-treatment evaluable population|34
3060914|NCT01270139|3781595|FG002|COMPLETED|Overall Study|Pre-treatment evaluable population|40
3060915|NCT01270139|3781593|FG000|NOT COMPLETED|Overall Study||18
3060916|NCT01270139|3781594|FG001|NOT COMPLETED|Overall Study||26
3060917|NCT01270139|3781595|FG002|NOT COMPLETED|Overall Study||20
3060918|NCT01270256|3781612|FG000|STARTED|Overall Study||21
3060919|NCT01270256|3781613|FG001|STARTED|Overall Study||20
3060920|NCT01270256|3781612|FG000|COMPLETED|Overall Study||20
3060921|NCT01270256|3781613|FG001|COMPLETED|Overall Study||20
3060922|NCT01270256|3781612|FG000|NOT COMPLETED|Overall Study||1
3060923|NCT01270256|3781613|FG001|NOT COMPLETED|Overall Study||0
3060924|NCT01270321|3781622|FG000|STARTED|Overall Study||19
3060925|NCT01270321|3781623|FG001|STARTED|Overall Study||11
3060926|NCT01270321|3781624|FG002|STARTED|Overall Study||12
3060927|NCT01270321|3781622|FG000|COMPLETED|Overall Study||9
3060928|NCT01270321|3781623|FG001|COMPLETED|Overall Study||1
3060929|NCT01270321|3781624|FG002|COMPLETED|Overall Study||3
3060930|NCT01270321|3781622|FG000|NOT COMPLETED|Overall Study||10
3060931|NCT01270321|3781623|FG001|NOT COMPLETED|Overall Study||10
3162769|NCT01880437|3890198|FG002|STARTED|Overall Study||19
3162770|NCT01880437|3890196|FG000|COMPLETED|Overall Study||0
3162771|NCT01880437|3890197|FG001|COMPLETED|Overall Study||0
3162772|NCT01880437|3890198|FG002|COMPLETED|Overall Study||0
3284047|NCT02761252|4017822|FG001|STARTED|Overall Study||140
3284048|NCT02761252|4017823|FG002|STARTED|Overall Study||137
3060932|NCT01270321|3781624|FG002|NOT COMPLETED|Overall Study||9
3060933|NCT01270464|3781635|FG000|STARTED|Overall Study||105
3060934|NCT01270464|3781636|FG001|STARTED|Overall Study||104
3060935|NCT01270464|3781637|FG002|STARTED|Overall Study||106
3060936|NCT01270464|3781635|FG000|Safety Analysis Set|Overall Study||105
3060937|NCT01270464|3781636|FG001|Safety Analysis Set|Overall Study||103
3060938|NCT01270464|3781637|FG002|Safety Analysis Set|Overall Study||103
3060939|NCT01270464|3781635|FG000|Full Analysis Set|Overall Study||105
3060940|NCT01270464|3781636|FG001|Full Analysis Set|Overall Study||103
3060941|NCT01270464|3781637|FG002|Full Analysis Set|Overall Study||103
3060942|NCT01270464|3781635|FG000|Pharmacokinetic Analysis Set|Overall Study||105
3060943|NCT01270464|3781636|FG001|Pharmacokinetic Analysis Set|Overall Study||103
3060944|NCT01270464|3781637|FG002|Pharmacokinetic Analysis Set|Overall Study||103
3060945|NCT01270464|3781635|FG000|COMPLETED|Overall Study||85
3060946|NCT01270464|3781636|FG001|COMPLETED|Overall Study||92
3060947|NCT01270464|3781637|FG002|COMPLETED|Overall Study||88
3060948|NCT01270464|3781635|FG000|NOT COMPLETED|Overall Study||20
3060949|NCT01270464|3781636|FG001|NOT COMPLETED|Overall Study||12
3060950|NCT01270464|3781637|FG002|NOT COMPLETED|Overall Study||18
3060951|NCT01270503|3781645|FG000|STARTED|Overall Study||538
3060952|NCT01270503|3781645|FG000|COMPLETED|Overall Study||537
3060953|NCT01270503|3781645|FG000|NOT COMPLETED|Overall Study||1
3060954|NCT01270516|3781654|FG000|STARTED|Overall Study||20
3060955|NCT01270516|3781655|FG001|STARTED|Overall Study||17
3284049|NCT02761252|4017821|FG000|COMPLETED|Overall Study||133
3284050|NCT02761252|4017822|FG001|COMPLETED|Overall Study||132
3284051|NCT02761252|4017823|FG002|COMPLETED|Overall Study||123
3060956|NCT01270516|3781656|FG002|STARTED|Overall Study||18
3060957|NCT01270516|3781657|FG003|STARTED|Overall Study||18
3060958|NCT01270516|3781654|FG000|COMPLETED|Overall Study||17
3060959|NCT01270516|3781655|FG001|COMPLETED|Overall Study||13
3060960|NCT01270516|3781656|FG002|COMPLETED|Overall Study||13
3060961|NCT01270516|3781657|FG003|COMPLETED|Overall Study||13
3060962|NCT01270516|3781654|FG000|NOT COMPLETED|Overall Study||3
3060963|NCT01270516|3781655|FG001|NOT COMPLETED|Overall Study||4
3060964|NCT01270516|3781656|FG002|NOT COMPLETED|Overall Study||5
3060965|NCT01270516|3781657|FG003|NOT COMPLETED|Overall Study||5
3060966|NCT01270529|3781670|FG000|STARTED|Overall Study||12
3060967|NCT01270529|3781671|FG001|STARTED|Overall Study||7
3162773|NCT01880437|3890196|FG000|NOT COMPLETED|Overall Study||15
3060968|NCT01270529|3781672|FG002|STARTED|Overall Study||25
3060969|NCT01270529|3781670|FG000|COMPLETED|Overall Study||12
3060970|NCT01270529|3781671|FG001|COMPLETED|Overall Study||7
3060971|NCT01270529|3781672|FG002|COMPLETED|Overall Study||25
3060972|NCT01270529|3781670|FG000|NOT COMPLETED|Overall Study||0
3060973|NCT01270529|3781671|FG001|NOT COMPLETED|Overall Study||0
3060974|NCT01270529|3781672|FG002|NOT COMPLETED|Overall Study||0
3060975|NCT01270542|3781682|FG000|STARTED|Overall Study||10
3060976|NCT01270542|3781683|FG001|STARTED|Overall Study||9
3060977|NCT01270542|3781682|FG000|COMPLETED|Overall Study||9
3060978|NCT01270542|3781683|FG001|COMPLETED|Overall Study||8
3060979|NCT01270542|3781682|FG000|NOT COMPLETED|Overall Study||1
3060980|NCT01270542|3781683|FG001|NOT COMPLETED|Overall Study||1
3060981|NCT01270555|3781689|FG000|STARTED|Overall Study||32
3060982|NCT01270555|3781689|FG000|COMPLETED|Overall Study||19
3060983|NCT01270555|3781689|FG000|NOT COMPLETED|Overall Study||13
3060984|NCT01270620|3781695|FG000|STARTED|Overall Study||50
3060985|NCT01270620|3781696|FG001|STARTED|Overall Study||50
3060986|NCT01270620|3781695|FG000|COMPLETED|Overall Study||49
3060987|NCT01270620|3781696|FG001|COMPLETED|Overall Study||47
3060988|NCT01270620|3781695|FG000|NOT COMPLETED|Overall Study||1
3060989|NCT01270620|3781696|FG001|NOT COMPLETED|Overall Study||3
3060990|NCT01270659|3781712|FG000|STARTED|Overall Study||6
3060991|NCT01270659|3781713|FG001|STARTED|Overall Study||25
3060992|NCT01270659|3781714|FG002|STARTED|Overall Study||4
3060993|NCT01270659|3781715|FG003|STARTED|Overall Study||25
3060994|NCT01270659|3781712|FG000|COMPLETED|Overall Study||6
3060995|NCT01270659|3781713|FG001|COMPLETED|Overall Study||25
3060996|NCT01270659|3781714|FG002|COMPLETED|Overall Study||4
3060997|NCT01270659|3781715|FG003|COMPLETED|Overall Study||25
3060998|NCT01270659|3781712|FG000|NOT COMPLETED|Overall Study||0
3060999|NCT01270659|3781713|FG001|NOT COMPLETED|Overall Study||0
3061000|NCT01270659|3781714|FG002|NOT COMPLETED|Overall Study||0
3061001|NCT01270659|3781715|FG003|NOT COMPLETED|Overall Study||0
3061002|NCT01270711|3781733|FG000|STARTED|Part 1: Compliance||7537
3061003|NCT01270711|3781734|FG001|STARTED|Part 1: Compliance||6580
3061004|NCT01270711|3781735|FG002|STARTED|Part 1: Compliance||326
3061005|NCT01270711|3781736|FG003|STARTED|Part 1: Compliance||5486
3061006|NCT01270711|3781737|FG004|STARTED|Part 1: Compliance||2024
3061007|NCT01270711|3781738|FG005|STARTED|Part 1: Compliance||0
3061008|NCT01270711|3781739|FG006|STARTED|Part 1: Compliance||0
3061009|NCT01270711|3781740|FG007|STARTED|Part 1: Compliance||0
3061010|NCT01270711|3781733|FG000|COMPLETED|Part 1: Compliance||7537
3061011|NCT01270711|3781734|FG001|COMPLETED|Part 1: Compliance||6580
3061012|NCT01270711|3781735|FG002|COMPLETED|Part 1: Compliance||326
3061013|NCT01270711|3781736|FG003|COMPLETED|Part 1: Compliance||5486
3061014|NCT01270711|3781737|FG004|COMPLETED|Part 1: Compliance||2024
3061015|NCT01270711|3781738|FG005|COMPLETED|Part 1: Compliance||0
3061016|NCT01270711|3781739|FG006|COMPLETED|Part 1: Compliance||0
3061017|NCT01270711|3781740|FG007|COMPLETED|Part 1: Compliance||0
3061018|NCT01270711|3781733|FG000|NOT COMPLETED|Part 1: Compliance||0
3061019|NCT01270711|3781734|FG001|NOT COMPLETED|Part 1: Compliance||0
3061020|NCT01270711|3781735|FG002|NOT COMPLETED|Part 1: Compliance||0
3061021|NCT01270711|3781736|FG003|NOT COMPLETED|Part 1: Compliance||0
3061022|NCT01270711|3781737|FG004|NOT COMPLETED|Part 1: Compliance||0
3061023|NCT01270711|3781738|FG005|NOT COMPLETED|Part 1: Compliance||0
3061024|NCT01270711|3781739|FG006|NOT COMPLETED|Part 1: Compliance||0
3061025|NCT01270711|3781740|FG007|NOT COMPLETED|Part 1: Compliance||0
3061026|NCT01270711|3781733|FG000|STARTED|Part 2: Effectiveness||0
3061027|NCT01270711|3781734|FG001|STARTED|Part 2: Effectiveness||0
3061028|NCT01270711|3781735|FG002|STARTED|Part 2: Effectiveness||0
3061029|NCT01270711|3781736|FG003|STARTED|Part 2: Effectiveness||0
3061030|NCT01270711|3781737|FG004|STARTED|Part 2: Effectiveness||0
3061031|NCT01270711|3781738|FG005|STARTED|Part 2: Effectiveness||11
3061032|NCT01270711|3781739|FG006|STARTED|Part 2: Effectiveness||2
3061033|NCT01270711|3781740|FG007|STARTED|Part 2: Effectiveness||48
3061034|NCT01270711|3781733|FG000|COMPLETED|Part 2: Effectiveness||0
3061035|NCT01270711|3781734|FG001|COMPLETED|Part 2: Effectiveness||0
3061036|NCT01270711|3781735|FG002|COMPLETED|Part 2: Effectiveness||0
3061037|NCT01270711|3781736|FG003|COMPLETED|Part 2: Effectiveness||0
3061038|NCT01270711|3781737|FG004|COMPLETED|Part 2: Effectiveness||0
3061039|NCT01270711|3781738|FG005|COMPLETED|Part 2: Effectiveness||11
3061040|NCT01270711|3781739|FG006|COMPLETED|Part 2: Effectiveness||2
3061041|NCT01270711|3781740|FG007|COMPLETED|Part 2: Effectiveness||48
3061042|NCT01270711|3781733|FG000|NOT COMPLETED|Part 2: Effectiveness||0
3061043|NCT01270711|3781734|FG001|NOT COMPLETED|Part 2: Effectiveness||0
3061044|NCT01270711|3781735|FG002|NOT COMPLETED|Part 2: Effectiveness||0
3061045|NCT01270711|3781736|FG003|NOT COMPLETED|Part 2: Effectiveness||0
3061046|NCT01270711|3781737|FG004|NOT COMPLETED|Part 2: Effectiveness||0
3061047|NCT01270711|3781738|FG005|NOT COMPLETED|Part 2: Effectiveness||0
3061048|NCT01270711|3781739|FG006|NOT COMPLETED|Part 2: Effectiveness||0
3061049|NCT01270711|3781740|FG007|NOT COMPLETED|Part 2: Effectiveness||0
3061050|NCT01270802|3781761|FG000|STARTED|Overall Study||15
3061051|NCT01270802|3781762|FG001|STARTED|Overall Study||15
3061052|NCT01270802|3781761|FG000|COMPLETED|Overall Study||13
3061053|NCT01270802|3781762|FG001|COMPLETED|Overall Study||14
3061054|NCT01270802|3781761|FG000|NOT COMPLETED|Overall Study||2
3061055|NCT01270802|3781762|FG001|NOT COMPLETED|Overall Study||1
3061056|NCT01270828|3781771|FG000|STARTED|Pregabalin CR SB||0
3061057|NCT01270828|3781772|FG001|STARTED|Pregabalin CR SB||0
3061058|NCT01270828|3781773|FG002|STARTED|Pregabalin CR SB||806
3061059|NCT01270828|3781771|FG000|COMPLETED|Pregabalin CR SB||0
3061060|NCT01270828|3781772|FG001|COMPLETED|Pregabalin CR SB||0
3061061|NCT01270828|3781773|FG002|COMPLETED|Pregabalin CR SB||660
3061062|NCT01270828|3781771|FG000|NOT COMPLETED|Pregabalin CR SB||0
3061063|NCT01270828|3781772|FG001|NOT COMPLETED|Pregabalin CR SB||0
3061064|NCT01270828|3781773|FG002|NOT COMPLETED|Pregabalin CR SB||146
3061065|NCT01270828|3781771|FG000|STARTED|Double Blind Phase||208
3061066|NCT01270828|3781772|FG001|STARTED|Double Blind Phase||205
3061067|NCT01270828|3781773|FG002|STARTED|Double Blind Phase||0
3284052|NCT02761252|4017821|FG000|NOT COMPLETED|Overall Study||10
3284053|NCT02761252|4017822|FG001|NOT COMPLETED|Overall Study||8
3284054|NCT02761252|4017823|FG002|NOT COMPLETED|Overall Study||14
3284055|NCT02761330|4017833|FG000|STARTED|Treatment Week 1||2
3284056|NCT02761330|4017834|FG001|STARTED|Treatment Week 1||3
3284057|NCT02761330|4017835|FG002|STARTED|Treatment Week 1||2
3284058|NCT02761330|4017836|FG003|STARTED|Treatment Week 1||3
3284059|NCT02761330|4017837|FG004|STARTED|Treatment Week 1||1
3284060|NCT02761330|4017838|FG005|STARTED|Treatment Week 1||3
3284061|NCT02761330|4017833|FG000|COMPLETED|Treatment Week 1||2
3284062|NCT02761330|4017834|FG001|COMPLETED|Treatment Week 1||3
3284063|NCT02761330|4017835|FG002|COMPLETED|Treatment Week 1||2
3284064|NCT02761330|4017836|FG003|COMPLETED|Treatment Week 1||2
3284065|NCT02761330|4017837|FG004|COMPLETED|Treatment Week 1||1
3284066|NCT02761330|4017838|FG005|COMPLETED|Treatment Week 1||2
3061068|NCT01270828|3781771|FG000|COMPLETED|Double Blind Phase||182
3061069|NCT01270828|3781772|FG001|COMPLETED|Double Blind Phase||160
3061070|NCT01270828|3781773|FG002|COMPLETED|Double Blind Phase||0
3284067|NCT02761330|4017833|FG000|NOT COMPLETED|Treatment Week 1||0
3284068|NCT02761330|4017834|FG001|NOT COMPLETED|Treatment Week 1||0
3284069|NCT02761330|4017835|FG002|NOT COMPLETED|Treatment Week 1||0
3284070|NCT02761330|4017836|FG003|NOT COMPLETED|Treatment Week 1||1
3061071|NCT01270828|3781771|FG000|NOT COMPLETED|Double Blind Phase||26
3061072|NCT01270828|3781772|FG001|NOT COMPLETED|Double Blind Phase||45
3061073|NCT01270828|3781773|FG002|NOT COMPLETED|Double Blind Phase||0
3061074|NCT01270841|3781785|FG000|STARTED|Overall Study||29
3061075|NCT01270841|3781786|FG001|STARTED|Overall Study||33
3061076|NCT01270841|3781787|FG002|STARTED|Overall Study||29
3061077|NCT01270841|3781788|FG003|STARTED|Overall Study||33
3061078|NCT01270841|3781785|FG000|COMPLETED|Overall Study||16
3061079|NCT01270841|3781786|FG001|COMPLETED|Overall Study||19
3061080|NCT01270841|3781787|FG002|COMPLETED|Overall Study||18
3061081|NCT01270841|3781788|FG003|COMPLETED|Overall Study||20
3061082|NCT01270841|3781785|FG000|NOT COMPLETED|Overall Study||13
3061083|NCT01270841|3781786|FG001|NOT COMPLETED|Overall Study||14
3061084|NCT01270841|3781787|FG002|NOT COMPLETED|Overall Study||11
3061085|NCT01270841|3781788|FG003|NOT COMPLETED|Overall Study||13
3061086|NCT01270867|3781800|FG000|STARTED|Overall Study||90
3061087|NCT01270867|3781801|FG001|STARTED|Overall Study||88
3061088|NCT01270867|3781800|FG000|COMPLETED|Overall Study||89
3061089|NCT01270867|3781801|FG001|COMPLETED|Overall Study||88
3061090|NCT01270867|3781800|FG000|NOT COMPLETED|Overall Study||1
3061091|NCT01270867|3781801|FG001|NOT COMPLETED|Overall Study||0
3061092|NCT01270880|3781807|FG000|STARTED|Overall Study||18
3061093|NCT01270880|3781807|FG000|COMPLETED|Overall Study||17
3061094|NCT01270880|3781807|FG000|NOT COMPLETED|Overall Study||1
3061095|NCT01270958|3781811|FG000|STARTED|Overall Study||60
3061096|NCT01270958|3781811|FG000|COMPLETED|Overall Study||56
3061097|NCT01270958|3781811|FG000|NOT COMPLETED|Overall Study||4
3061098|NCT01270971|3781817|FG000|STARTED|Overall Study||400
3061099|NCT01270971|3781818|FG001|STARTED|Overall Study||194
3061100|NCT01270971|3781817|FG000|COMPLETED|Overall Study||348
3061101|NCT01270971|3781818|FG001|COMPLETED|Overall Study||171
3061102|NCT01270971|3781817|FG000|NOT COMPLETED|Overall Study||52
3061103|NCT01270971|3781818|FG001|NOT COMPLETED|Overall Study||23
3061104|NCT01271010|3781824|FG000|STARTED|Overall Study||89
3061105|NCT01271010|3781824|FG000|COMPLETED|Overall Study||28
3061106|NCT01271010|3781824|FG000|NOT COMPLETED|Overall Study||61
3061107|NCT01271036|3781830|FG000|STARTED|Overall Study||62
3061108|NCT01271036|3781831|FG001|STARTED|Overall Study||62
3061109|NCT01271036|3781830|FG000|COMPLETED|Overall Study||62
3061110|NCT01271036|3781831|FG001|COMPLETED|Overall Study||62
3061111|NCT01271036|3781830|FG000|NOT COMPLETED|Overall Study||0
3061112|NCT01271036|3781831|FG001|NOT COMPLETED|Overall Study||0
3061113|NCT01271244|3781839|FG000|STARTED|Overall Study||18
3061114|NCT01271244|3781840|FG001|STARTED|Overall Study||8
3061115|NCT01271244|3781839|FG000|COMPLETED|Overall Study||11
3061116|NCT01271244|3781840|FG001|COMPLETED|Overall Study||5
3061117|NCT01271244|3781839|FG000|NOT COMPLETED|Overall Study||7
3061118|NCT01271244|3781840|FG001|NOT COMPLETED|Overall Study||3
3061119|NCT01271413|3781848|FG000|STARTED|Overall Study||37
3061120|NCT01271413|3781849|FG001|STARTED|Overall Study||36
3061121|NCT01271413|3781848|FG000|COMPLETED|Overall Study||28
3061122|NCT01271413|3781849|FG001|COMPLETED|Overall Study||28
3061123|NCT01271413|3781848|FG000|NOT COMPLETED|Overall Study||9
3061124|NCT01271413|3781849|FG001|NOT COMPLETED|Overall Study||8
3061125|NCT01271452|3781857|FG000|STARTED|Overall Study||112
3061126|NCT01271452|3781858|FG001|STARTED|Overall Study||112
3061127|NCT01271452|3781857|FG000|COMPLETED|Overall Study||105
3061128|NCT01271452|3781858|FG001|COMPLETED|Overall Study||104
3284071|NCT02761330|4017837|FG004|NOT COMPLETED|Treatment Week 1||0
3284072|NCT02761330|4017838|FG005|NOT COMPLETED|Treatment Week 1||1
3061129|NCT01271452|3781857|FG000|NOT COMPLETED|Overall Study||7
3061130|NCT01271452|3781858|FG001|NOT COMPLETED|Overall Study||8
3061131|NCT01271504|3781868|FG000|STARTED|Overall Study||7
3061132|NCT01271504|3781869|FG001|STARTED|Overall Study||8
3061133|NCT01271504|3781870|FG002|STARTED|Overall Study||44
3061134|NCT01271504|3781871|FG003|STARTED|Overall Study||43
3061135|NCT01271504|3781868|FG000|Treated|Overall Study||7
3061136|NCT01271504|3781869|FG001|Treated|Overall Study||7
3061137|NCT01271504|3781870|FG002|Treated|Overall Study||42
3061138|NCT01271504|3781871|FG003|Treated|Overall Study||42
3061139|NCT01271504|3781868|FG000|COMPLETED|Overall Study||0
3061140|NCT01271504|3781869|FG001|COMPLETED|Overall Study||0
3061141|NCT01271504|3781870|FG002|COMPLETED|Overall Study||0
3061142|NCT01271504|3781871|FG003|COMPLETED|Overall Study||0
3061143|NCT01271504|3781868|FG000|NOT COMPLETED|Overall Study||7
3061144|NCT01271504|3781869|FG001|NOT COMPLETED|Overall Study||8
3061145|NCT01271504|3781870|FG002|NOT COMPLETED|Overall Study||44
3061146|NCT01271504|3781871|FG003|NOT COMPLETED|Overall Study||43
3061147|NCT01271543|3781893|FG000|STARTED|Overall Study||30
3061148|NCT01271543|3781894|FG001|STARTED|Overall Study||30
3061149|NCT01271543|3781893|FG000|COMPLETED|Overall Study||29
3061150|NCT01271543|3781894|FG001|COMPLETED|Overall Study||29
3061151|NCT01271543|3781893|FG000|NOT COMPLETED|Overall Study||1
3061152|NCT01271543|3781894|FG001|NOT COMPLETED|Overall Study||1
3061153|NCT01271686|3781901|FG000|STARTED|Overall Study||16
3061154|NCT01271686|3781901|FG000|COMPLETED|Overall Study||16
3061155|NCT01271686|3781901|FG000|NOT COMPLETED|Overall Study||0
3061156|NCT01271712|3781907|FG000|STARTED|Double Blind Treatment||133
3061157|NCT01271712|3781908|FG001|STARTED|Double Blind Treatment||66
3061158|NCT01271712|3781907|FG000|Participants Received Treatment|Double Blind Treatment||132
3061159|NCT01271712|3781908|FG001|Participants Received Treatment|Double Blind Treatment||66
3061160|NCT01271712|3781907|FG000|COMPLETED|Double Blind Treatment|91 participants started open-label treatment with regorafenib|91
3061161|NCT01271712|3781908|FG001|COMPLETED|Double Blind Treatment|58 participants started open-label treatment with regorafenib|58
3061162|NCT01271712|3781907|FG000|NOT COMPLETED|Double Blind Treatment||42
3061163|NCT01271712|3781908|FG001|NOT COMPLETED|Double Blind Treatment||8
3061164|NCT01271712|3781907|FG000|STARTED|Open Label Treatment||91
3061165|NCT01271712|3781908|FG001|STARTED|Open Label Treatment||58
3061166|NCT01271712|3781907|FG000|COMPLETED|Open Label Treatment||0
3061167|NCT01271712|3781908|FG001|COMPLETED|Open Label Treatment||0
3061168|NCT01271712|3781907|FG000|NOT COMPLETED|Open Label Treatment||91
3061169|NCT01271712|3781908|FG001|NOT COMPLETED|Open Label Treatment||58
3061170|NCT01271712|3781907|FG000|STARTED|Safety Follow-up|All participants who discontinued study drug entered 30-day Safety Follow-up|118
3061171|NCT01271712|3781908|FG001|STARTED|Safety Follow-up|All participants who discontinued study drug entered 30-day Safety Follow-up|52
3061172|NCT01271712|3781907|FG000|COMPLETED|Safety Follow-up||97
3061173|NCT01271712|3781908|FG001|COMPLETED|Safety Follow-up||37
3061174|NCT01271712|3781907|FG000|NOT COMPLETED|Safety Follow-up||21
3061175|NCT01271712|3781908|FG001|NOT COMPLETED|Safety Follow-up||15
3061176|NCT01271712|3781907|FG000|STARTED|Survival Follow-up|All participants entered Survival Follow-up immediately after safety follow-up|100
3061177|NCT01271712|3781908|FG001|STARTED|Survival Follow-up|All participants entered Survival Follow-up immediately after safety follow-up|39
3061178|NCT01271712|3781907|FG000|COMPLETED|Survival Follow-up|85 participants died and completed survival follow-up.|85
3061179|NCT01271712|3781908|FG001|COMPLETED|Survival Follow-up|33 participants died and completed survival follow-up.|33
3061180|NCT01271712|3781907|FG000|NOT COMPLETED|Survival Follow-up||15
3061181|NCT01271712|3781908|FG001|NOT COMPLETED|Survival Follow-up||6
3061182|NCT01271725|3781917|FG000|STARTED|Part A|Started are the treated patients|74
3061183|NCT01271725|3781918|FG001|STARTED|Part A||0
3061184|NCT01271725|3781917|FG000|COMPLETED|Part A||39
3061185|NCT01271725|3781918|FG001|COMPLETED|Part A||0
3061186|NCT01271725|3781917|FG000|NOT COMPLETED|Part A||35
3061187|NCT01271725|3781918|FG001|NOT COMPLETED|Part A||0
3061188|NCT01271725|3781917|FG000|STARTED|Part B||0
3061189|NCT01271725|3781918|FG001|STARTED|Part B||39
3061190|NCT01271725|3781917|FG000|COMPLETED|Part B||0
3061191|NCT01271725|3781918|FG001|COMPLETED|Part B|Patient deemed to have completed the trial once they showed progressive disease according to RECIST|27
3061192|NCT01271725|3781917|FG000|NOT COMPLETED|Part B||0
3061193|NCT01271725|3781918|FG001|NOT COMPLETED|Part B||12
3061194|NCT01271803|3781930|FG000|STARTED|Overall Study||66
3061195|NCT01271803|3781931|FG001|STARTED|Overall Study||63
3061196|NCT01271803|3781932|FG002|STARTED|Overall Study||2
3061197|NCT01271803|3781930|FG000|COMPLETED|Overall Study||11
3061198|NCT01271803|3781931|FG001|COMPLETED|Overall Study||24
3061199|NCT01271803|3781932|FG002|COMPLETED|Overall Study||0
3061200|NCT01271803|3781930|FG000|NOT COMPLETED|Overall Study||55
3061201|NCT01271803|3781931|FG001|NOT COMPLETED|Overall Study||39
3061202|NCT01271803|3781932|FG002|NOT COMPLETED|Overall Study||2
3061203|NCT01271855|3781979|FG000|STARTED|Overall Study||48
3061204|NCT01271855|3781980|FG001|STARTED|Overall Study||52
3061205|NCT01271855|3781979|FG000|COMPLETED|Overall Study||48
3061206|NCT01271855|3781980|FG001|COMPLETED|Overall Study||52
3061207|NCT01271855|3781979|FG000|NOT COMPLETED|Overall Study||0
3061208|NCT01271855|3781980|FG001|NOT COMPLETED|Overall Study||0
3061209|NCT01271868|3781986|FG000|STARTED|Pharmacokinetic Study||9
3061210|NCT01271868|3781986|FG000|COMPLETED|Pharmacokinetic Study||9
3061211|NCT01271868|3781986|FG000|NOT COMPLETED|Pharmacokinetic Study||0
3061212|NCT01271868|3781986|FG000|STARTED|Treatment Study||9
3061213|NCT01271868|3781986|FG000|COMPLETED|Treatment Study||9
3061214|NCT01271868|3781986|FG000|NOT COMPLETED|Treatment Study||0
3061215|NCT01271907|3781995|FG000|STARTED|Overall Study||3
3061216|NCT01271907|3781996|FG001|STARTED|Overall Study||0
3061217|NCT01271907|3781997|FG002|STARTED|Overall Study||0
3061218|NCT01271907|3781995|FG000|COMPLETED|Overall Study||3
3061219|NCT01271907|3781996|FG001|COMPLETED|Overall Study||0
3061220|NCT01271907|3781997|FG002|COMPLETED|Overall Study||0
3061221|NCT01271907|3781995|FG000|NOT COMPLETED|Overall Study||0
3061222|NCT01271907|3781996|FG001|NOT COMPLETED|Overall Study||0
3061223|NCT01271907|3781997|FG002|NOT COMPLETED|Overall Study||0
3061224|NCT01271933|3782005|FG000|STARTED|Single-Blind Phase||441
3284073|NCT02761330|4017833|FG000|STARTED|Treatment Week 2||2
3284074|NCT02761330|4017834|FG001|STARTED|Treatment Week 2||3
3284075|NCT02761330|4017835|FG002|STARTED|Treatment Week 2||2
3162774|NCT01880437|3890197|FG001|NOT COMPLETED|Overall Study||4
3162775|NCT01880437|3890198|FG002|NOT COMPLETED|Overall Study||19
3162776|NCT01880515|3890210|FG000|STARTED|Overall Study||53
3162777|NCT01880515|3890211|FG001|STARTED|Overall Study||54
3162778|NCT01880515|3890210|FG000|COMPLETED|Overall Study||45
3162779|NCT01880515|3890211|FG001|COMPLETED|Overall Study||45
3061225|NCT01271933|3782006|FG001|STARTED|Single-Blind Phase||0
3061226|NCT01271933|3782007|FG002|STARTED|Single-Blind Phase||0
3061227|NCT01271933|3782005|FG000|COMPLETED|Single-Blind Phase||320
3061228|NCT01271933|3782006|FG001|COMPLETED|Single-Blind Phase||0
3061229|NCT01271933|3782007|FG002|COMPLETED|Single-Blind Phase||0
3061230|NCT01271933|3782005|FG000|NOT COMPLETED|Single-Blind Phase||121
3061231|NCT01271933|3782006|FG001|NOT COMPLETED|Single-Blind Phase||0
3061232|NCT01271933|3782007|FG002|NOT COMPLETED|Single-Blind Phase||0
3061233|NCT01271933|3782005|FG000|STARTED|Double-Blind Phase||0
3061234|NCT01271933|3782006|FG001|STARTED|Double-Blind Phase||63
3061235|NCT01271933|3782007|FG002|STARTED|Double-Blind Phase||59
3061236|NCT01271933|3782005|FG000|Treated|Double-Blind Phase||0
3061237|NCT01271933|3782006|FG001|Treated|Double-Blind Phase||63
3061238|NCT01271933|3782007|FG002|Treated|Double-Blind Phase||58
3061239|NCT01271933|3782005|FG000|COMPLETED|Double-Blind Phase||0
3061240|NCT01271933|3782006|FG001|COMPLETED|Double-Blind Phase||46
3061241|NCT01271933|3782007|FG002|COMPLETED|Double-Blind Phase||47
3061242|NCT01271933|3782005|FG000|NOT COMPLETED|Double-Blind Phase||0
3162780|NCT01880515|3890210|FG000|NOT COMPLETED|Overall Study||8
3162781|NCT01880515|3890211|FG001|NOT COMPLETED|Overall Study||9
3162782|NCT01880528|3890220|FG000|STARTED|Overall Study||12
3162783|NCT01880528|3890221|FG001|STARTED|Overall Study||11
3061243|NCT01271933|3782006|FG001|NOT COMPLETED|Double-Blind Phase||17
3061244|NCT01271933|3782007|FG002|NOT COMPLETED|Double-Blind Phase||12
3061245|NCT01271946|3782019|FG000|STARTED|Overall Study||346
3162784|NCT01880528|3890220|FG000|COMPLETED|Overall Study||11
3162785|NCT01880528|3890221|FG001|COMPLETED|Overall Study||10
3162786|NCT01880528|3890220|FG000|NOT COMPLETED|Overall Study||1
3061246|NCT01271946|3782020|FG001|STARTED|Overall Study||5
3061247|NCT01271946|3782019|FG000|COMPLETED|Overall Study||346
3061248|NCT01271946|3782020|FG001|COMPLETED|Overall Study||5
3061249|NCT01271946|3782019|FG000|NOT COMPLETED|Overall Study||0
3061250|NCT01271946|3782020|FG001|NOT COMPLETED|Overall Study||0
3061251|NCT01272011|3782043|FG000|STARTED|Overall Study||3
3061252|NCT01272011|3782044|FG001|STARTED|Overall Study||10
3061253|NCT01272011|3782045|FG002|STARTED|Overall Study||3
3061254|NCT01272011|3782043|FG000|COMPLETED|Overall Study||3
3061255|NCT01272011|3782044|FG001|COMPLETED|Overall Study||8
3061256|NCT01272011|3782045|FG002|COMPLETED|Overall Study||3
3061257|NCT01272011|3782043|FG000|NOT COMPLETED|Overall Study||0
3061258|NCT01272011|3782044|FG001|NOT COMPLETED|Overall Study||2
3061259|NCT01272011|3782045|FG002|NOT COMPLETED|Overall Study||0
3061260|NCT01272076|3782053|FG000|STARTED|Overall Study||52
3061261|NCT01272076|3782053|FG000|COMPLETED|Overall Study||52
3061262|NCT01272076|3782053|FG000|NOT COMPLETED|Overall Study||0
3061263|NCT01272180|3782061|FG000|STARTED|Overall Study||120
3061264|NCT01272180|3782062|FG001|STARTED|Overall Study||121
3061265|NCT01272180|3782063|FG002|STARTED|Overall Study||122
3061266|NCT01272180|3782064|FG003|STARTED|Overall Study||121
3061267|NCT01272180|3782061|FG000|COMPLETED|Overall Study||103
3061268|NCT01272180|3782062|FG001|COMPLETED|Overall Study||100
3061269|NCT01272180|3782063|FG002|COMPLETED|Overall Study||109
3061270|NCT01272180|3782064|FG003|COMPLETED|Overall Study||107
3061271|NCT01272180|3782061|FG000|NOT COMPLETED|Overall Study||17
3061272|NCT01272180|3782062|FG001|NOT COMPLETED|Overall Study||21
3061273|NCT01272180|3782063|FG002|NOT COMPLETED|Overall Study||13
3061274|NCT01272180|3782064|FG003|NOT COMPLETED|Overall Study||14
3061275|NCT01272193|3782080|FG000|STARTED|Overall Study||147
3061276|NCT01272193|3782081|FG001|STARTED|Overall Study||149
3061277|NCT01272193|3782080|FG000|COMPLETED|Overall Study||137
3061278|NCT01272193|3782081|FG001|COMPLETED|Overall Study||137
3061279|NCT01272193|3782080|FG000|NOT COMPLETED|Overall Study||10
3061280|NCT01272193|3782081|FG001|NOT COMPLETED|Overall Study||12
3061281|NCT01272219|3782091|FG000|STARTED|Main Period: Week 0 to Week 56||959
3061282|NCT01272219|3782092|FG001|STARTED|Main Period: Week 0 to Week 56|This arm is not considered for main period as these subjects belong to re-randomised period|0
3061283|NCT01272219|3782093|FG002|STARTED|Main Period: Week 0 to Week 56|This arm is not considered for main period as these subjects belong to re-randomised period|0
3162787|NCT01880528|3890221|FG001|NOT COMPLETED|Overall Study||1
3162788|NCT01880554|3890227|FG000|STARTED|Overall Study|Patients enrolled in the study|68
3061284|NCT01272219|3782094|FG003|STARTED|Main Period: Week 0 to Week 56||487
3061285|NCT01272219|3782095|FG004|STARTED|Main Period: Week 0 to Week 56||1528
3061286|NCT01272219|3782096|FG005|STARTED|Main Period: Week 0 to Week 56||757
3061287|NCT01272219|3782091|FG000|Exposed|Main Period: Week 0 to Week 56||957
3061288|NCT01272219|3782092|FG001|Exposed|Main Period: Week 0 to Week 56||0
3061289|NCT01272219|3782093|FG002|Exposed|Main Period: Week 0 to Week 56||0
3061290|NCT01272219|3782094|FG003|Exposed|Main Period: Week 0 to Week 56||487
3061291|NCT01272219|3782095|FG004|Exposed|Main Period: Week 0 to Week 56||1524
3061292|NCT01272219|3782096|FG005|Exposed|Main Period: Week 0 to Week 56||755
3061293|NCT01272219|3782091|FG000|COMPLETED|Main Period: Week 0 to Week 56||679
3061294|NCT01272219|3782092|FG001|COMPLETED|Main Period: Week 0 to Week 56||0
3061295|NCT01272219|3782093|FG002|COMPLETED|Main Period: Week 0 to Week 56||0
3061296|NCT01272219|3782094|FG003|COMPLETED|Main Period: Week 0 to Week 56||296
3061297|NCT01272219|3782095|FG004|COMPLETED|Main Period: Week 0 to Week 56||1110
3061298|NCT01272219|3782096|FG005|COMPLETED|Main Period: Week 0 to Week 56||505
3061299|NCT01272219|3782091|FG000|NOT COMPLETED|Main Period: Week 0 to Week 56||280
3061300|NCT01272219|3782092|FG001|NOT COMPLETED|Main Period: Week 0 to Week 56||0
3061301|NCT01272219|3782093|FG002|NOT COMPLETED|Main Period: Week 0 to Week 56||0
3061302|NCT01272219|3782094|FG003|NOT COMPLETED|Main Period: Week 0 to Week 56||191
3061303|NCT01272219|3782095|FG004|NOT COMPLETED|Main Period: Week 0 to Week 56||418
3061304|NCT01272219|3782096|FG005|NOT COMPLETED|Main Period: Week 0 to Week 56||252
3061305|NCT01272219|3782091|FG000|STARTED|Re-randomised Period: Week 56 to Week 68|This arm is not considered for re-randomised period as these subjects belong to main period|0
3061306|NCT01272219|3782092|FG001|STARTED|Re-randomised Period: Week 56 to Week 68|Incorrect stratification: In this period, overall 37 pre-diabetic subjects were included by error.|351
3061307|NCT01272219|3782093|FG002|STARTED|Re-randomised Period: Week 56 to Week 68|Incorrect stratification: In this period, overall 37 pre-diabetic subjects were included by error.|350
3061308|NCT01272219|3782094|FG003|STARTED|Re-randomised Period: Week 56 to Week 68|Incorrect stratification: In this period, overall 37 pre-diabetic subjects were included by error.|304
3061309|NCT01272219|3782095|FG004|STARTED|Re-randomised Period: Week 56 to Week 68|This arm is not considered for re-randomised period as these subjects belong to main period|0
3061310|NCT01272219|3782096|FG005|STARTED|Re-randomised Period: Week 56 to Week 68|This arm is not considered for re-randomised period as these subjects belong to main period|0
3061311|NCT01272219|3782091|FG000|COMPLETED|Re-randomised Period: Week 56 to Week 68||0
3061312|NCT01272219|3782092|FG001|COMPLETED|Re-randomised Period: Week 56 to Week 68||342
3061313|NCT01272219|3782093|FG002|COMPLETED|Re-randomised Period: Week 56 to Week 68||343
3061314|NCT01272219|3782094|FG003|COMPLETED|Re-randomised Period: Week 56 to Week 68||289
3061315|NCT01272219|3782095|FG004|COMPLETED|Re-randomised Period: Week 56 to Week 68||0
3061316|NCT01272219|3782096|FG005|COMPLETED|Re-randomised Period: Week 56 to Week 68||0
3061317|NCT01272219|3782091|FG000|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||0
3061318|NCT01272219|3782092|FG001|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||9
3061319|NCT01272219|3782093|FG002|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||7
3061320|NCT01272219|3782094|FG003|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||15
3061321|NCT01272219|3782095|FG004|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||0
3061322|NCT01272219|3782096|FG005|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||0
3061323|NCT01272219|3782091|FG000|STARTED|Main + Extension Period: Week 0-172|This arm is not considered for this period as these subjects belong to main period|0
3061324|NCT01272219|3782092|FG001|STARTED|Main + Extension Period: Week 0-172|This arm is not considered for this period as these subjects belong to re-randomised period|0
3061325|NCT01272219|3782093|FG002|STARTED|Main + Extension Period: Week 0-172|This arm is not considered for this period as these subjects belong to re-randomised period|0
3061326|NCT01272219|3782094|FG003|STARTED|Main + Extension Period: Week 0-172|This arm is not considered for this period as these subjects belong to main and re-randomised period|0
3061327|NCT01272219|3782095|FG004|STARTED|Main + Extension Period: Week 0-172|Incorrect stratification: In this period, overall 6 subjects with no pre-diabetes included by error.|1505
3061328|NCT01272219|3782096|FG005|STARTED|Main + Extension Period: Week 0-172|Incorrect stratification: In this period, overall 6 subjects with no pre-diabetes included by error.|749
3061329|NCT01272219|3782091|FG000|Exposed|Main + Extension Period: Week 0-172||0
3061330|NCT01272219|3782092|FG001|Exposed|Main + Extension Period: Week 0-172||0
3061331|NCT01272219|3782093|FG002|Exposed|Main + Extension Period: Week 0-172||0
3061332|NCT01272219|3782094|FG003|Exposed|Main + Extension Period: Week 0-172||0
3061333|NCT01272219|3782095|FG004|Exposed|Main + Extension Period: Week 0-172||1501
3061334|NCT01272219|3782096|FG005|Exposed|Main + Extension Period: Week 0-172||747
3061335|NCT01272219|3782091|FG000|COMPLETED|Main + Extension Period: Week 0-172||0
3061336|NCT01272219|3782092|FG001|COMPLETED|Main + Extension Period: Week 0-172||0
3061337|NCT01272219|3782093|FG002|COMPLETED|Main + Extension Period: Week 0-172||0
3061338|NCT01272219|3782094|FG003|COMPLETED|Main + Extension Period: Week 0-172||0
3061339|NCT01272219|3782095|FG004|COMPLETED|Main + Extension Period: Week 0-172||783
3061340|NCT01272219|3782096|FG005|COMPLETED|Main + Extension Period: Week 0-172||327
3061341|NCT01272219|3782091|FG000|NOT COMPLETED|Main + Extension Period: Week 0-172||0
3061342|NCT01272219|3782092|FG001|NOT COMPLETED|Main + Extension Period: Week 0-172||0
3061343|NCT01272219|3782093|FG002|NOT COMPLETED|Main + Extension Period: Week 0-172||0
3061344|NCT01272219|3782094|FG003|NOT COMPLETED|Main + Extension Period: Week 0-172||0
3061345|NCT01272219|3782095|FG004|NOT COMPLETED|Main + Extension Period: Week 0-172||722
3061346|NCT01272219|3782096|FG005|NOT COMPLETED|Main + Extension Period: Week 0-172||422
3061347|NCT01272232|3782112|FG000|STARTED|Weeks 0-56||423
3061348|NCT01272232|3782113|FG001|STARTED|Weeks 0-56||211
3061349|NCT01272232|3782114|FG002|STARTED|Weeks 0-56||212
3061350|NCT01272232|3782112|FG000|Exposed|Weeks 0-56|1 subject dropped out after randomisation and before exposure to trial drug.|422
3061351|NCT01272232|3782113|FG001|Exposed|Weeks 0-56|1 subject dropped out after randomisation and before exposure to trial drug.|210
3061352|NCT01272232|3782114|FG002|Exposed|Weeks 0-56||212
3061353|NCT01272232|3782112|FG000|COMPLETED|Weeks 0-56||324
3061354|NCT01272232|3782113|FG001|COMPLETED|Weeks 0-56||164
3061355|NCT01272232|3782114|FG002|COMPLETED|Weeks 0-56||140
3061356|NCT01272232|3782112|FG000|NOT COMPLETED|Weeks 0-56||99
3061357|NCT01272232|3782113|FG001|NOT COMPLETED|Weeks 0-56||47
3061358|NCT01272232|3782114|FG002|NOT COMPLETED|Weeks 0-56||72
3061359|NCT01272232|3782112|FG000|STARTED|Off Drug Follow-up Period (Weeks 56-68)||324
3061360|NCT01272232|3782113|FG001|STARTED|Off Drug Follow-up Period (Weeks 56-68)||164
3061361|NCT01272232|3782114|FG002|STARTED|Off Drug Follow-up Period (Weeks 56-68)||140
3061362|NCT01272232|3782112|FG000|COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||310
3061363|NCT01272232|3782113|FG001|COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||154
3061364|NCT01272232|3782114|FG002|COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||135
3061365|NCT01272232|3782112|FG000|NOT COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||14
3061366|NCT01272232|3782113|FG001|NOT COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||10
3061367|NCT01272232|3782114|FG002|NOT COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||5
3061368|NCT01272245|3782122|FG000|STARTED|Overall Study||36
3061369|NCT01272245|3782122|FG000|COMPLETED|Overall Study||36
3061370|NCT01272245|3782122|FG000|NOT COMPLETED|Overall Study||0
3061371|NCT01272284|3782126|FG000|STARTED|3-month Follow-up Visit||113
3061372|NCT01272284|3782126|FG000|COMPLETED|3-month Follow-up Visit||112
3061373|NCT01272284|3782126|FG000|NOT COMPLETED|3-month Follow-up Visit||1
3061374|NCT01272284|3782126|FG000|STARTED|6-month Follow-up Visit||112
3061375|NCT01272284|3782126|FG000|COMPLETED|6-month Follow-up Visit||109
3061376|NCT01272284|3782126|FG000|NOT COMPLETED|6-month Follow-up Visit||3
3061377|NCT01272284|3782126|FG000|STARTED|12-month Follow-up Visit||109
3061378|NCT01272284|3782126|FG000|COMPLETED|12-month Follow-up Visit||105
3061379|NCT01272284|3782126|FG000|NOT COMPLETED|12-month Follow-up Visit||4
3061380|NCT01272388|3782133|FG000|STARTED|Overall Study||1
3061381|NCT01272388|3782134|FG001|STARTED|Overall Study||0
3061382|NCT01272388|3782133|FG000|COMPLETED|Overall Study||1
3061383|NCT01272388|3782134|FG001|COMPLETED|Overall Study||0
3061384|NCT01272388|3782133|FG000|NOT COMPLETED|Overall Study||0
3061385|NCT01272388|3782134|FG001|NOT COMPLETED|Overall Study||0
3061386|NCT01272583|3782142|FG000|STARTED|Overall Study||8
3061387|NCT01272583|3782143|FG001|STARTED|Overall Study||8
3061388|NCT01272583|3782142|FG000|COMPLETED|Overall Study||8
3061389|NCT01272583|3782143|FG001|COMPLETED|Overall Study||8
3061390|NCT01272583|3782142|FG000|NOT COMPLETED|Overall Study||0
3061391|NCT01272583|3782143|FG001|NOT COMPLETED|Overall Study||0
3061392|NCT01272635|3782153|FG000|STARTED|Overall Study||153
3061393|NCT01272635|3782154|FG001|STARTED|Overall Study||154
3061394|NCT01272635|3782155|FG002|STARTED|Overall Study||148
3061395|NCT01272635|3782156|FG003|STARTED|Overall Study||152
3061396|NCT01272635|3782153|FG000|COMPLETED|Overall Study||122
3284076|NCT02761330|4017836|FG003|STARTED|Treatment Week 2|1 pt. in this group completed Week 1, but did not begin Week 2 due to withdraw.|1
3284077|NCT02761330|4017837|FG004|STARTED|Treatment Week 2||1
3284078|NCT02761330|4017838|FG005|STARTED|Treatment Week 2|1 pt. in this group completed Week 1, but did not begin Week 2 due to cancellation of treatment.|1
3284079|NCT02761330|4017833|FG000|COMPLETED|Treatment Week 2||2
3284080|NCT02761330|4017834|FG001|COMPLETED|Treatment Week 2||3
3284081|NCT02761330|4017835|FG002|COMPLETED|Treatment Week 2||2
3284082|NCT02761330|4017836|FG003|COMPLETED|Treatment Week 2||1
3284083|NCT02761330|4017837|FG004|COMPLETED|Treatment Week 2||1
3284084|NCT02761330|4017838|FG005|COMPLETED|Treatment Week 2||1
3061397|NCT01272635|3782154|FG001|COMPLETED|Overall Study||134
3061398|NCT01272635|3782155|FG002|COMPLETED|Overall Study||117
3061399|NCT01272635|3782156|FG003|COMPLETED|Overall Study||129
3061400|NCT01272635|3782153|FG000|NOT COMPLETED|Overall Study||31
3061401|NCT01272635|3782154|FG001|NOT COMPLETED|Overall Study||20
3061402|NCT01272635|3782155|FG002|NOT COMPLETED|Overall Study||31
3061403|NCT01272635|3782156|FG003|NOT COMPLETED|Overall Study||23
3061404|NCT01272661|3782167|FG000|STARTED|Overall Study||413
3061405|NCT01272661|3782168|FG001|STARTED|Overall Study||497
3061406|NCT01272661|3782169|FG002|STARTED|Overall Study||386
3061407|NCT01272661|3782167|FG000|COMPLETED|Overall Study||287
3061408|NCT01272661|3782168|FG001|COMPLETED|Overall Study||288
3061409|NCT01272661|3782169|FG002|COMPLETED|Overall Study||314
3061410|NCT01272661|3782167|FG000|NOT COMPLETED|Overall Study||126
3061411|NCT01272661|3782168|FG001|NOT COMPLETED|Overall Study||209
3061412|NCT01272661|3782169|FG002|NOT COMPLETED|Overall Study||72
3061413|NCT01272804|3782183|FG000|STARTED|Overall Study||9
3061414|NCT01272804|3782184|FG001|STARTED|Overall Study||9
3061415|NCT01272804|3782185|FG002|STARTED|Overall Study||9
3061416|NCT01272804|3782186|FG003|STARTED|Overall Study||9
3061417|NCT01272804|3782187|FG004|STARTED|Overall Study||9
3061418|NCT01272804|3782188|FG005|STARTED|Overall Study||16
3061419|NCT01272804|3782183|FG000|COMPLETED|Overall Study||8
3061420|NCT01272804|3782184|FG001|COMPLETED|Overall Study||9
3061421|NCT01272804|3782185|FG002|COMPLETED|Overall Study||9
3061422|NCT01272804|3782186|FG003|COMPLETED|Overall Study||9
3061423|NCT01272804|3782187|FG004|COMPLETED|Overall Study||7
3061424|NCT01272804|3782188|FG005|COMPLETED|Overall Study||15
3061425|NCT01272804|3782183|FG000|NOT COMPLETED|Overall Study||1
3061426|NCT01272804|3782184|FG001|NOT COMPLETED|Overall Study||0
3061427|NCT01272804|3782185|FG002|NOT COMPLETED|Overall Study||0
3061428|NCT01272804|3782186|FG003|NOT COMPLETED|Overall Study||0
3061429|NCT01272804|3782187|FG004|NOT COMPLETED|Overall Study||2
3061430|NCT01272804|3782188|FG005|NOT COMPLETED|Overall Study||1
3061431|NCT01272830|3782204|FG000|STARTED|Overall Study||25
3061432|NCT01272830|3782205|FG001|STARTED|Overall Study||26
3061433|NCT01272830|3782204|FG000|COMPLETED|Overall Study||17
3061434|NCT01272830|3782205|FG001|COMPLETED|Overall Study||21
3061435|NCT01272830|3782204|FG000|NOT COMPLETED|Overall Study||8
3061436|NCT01272830|3782205|FG001|NOT COMPLETED|Overall Study||5
3061437|NCT01272869|3782213|FG000|STARTED|Period 1 (14 Days)||10
3061438|NCT01272869|3782214|FG001|STARTED|Period 1 (14 Days)||10
3061439|NCT01272869|3782213|FG000|COMPLETED|Period 1 (14 Days)||10
3061440|NCT01272869|3782214|FG001|COMPLETED|Period 1 (14 Days)||10
3061441|NCT01272869|3782213|FG000|NOT COMPLETED|Period 1 (14 Days)||0
3061442|NCT01272869|3782214|FG001|NOT COMPLETED|Period 1 (14 Days)||0
3061443|NCT01272869|3782213|FG000|STARTED|Period 2 (14 Days)||10
3061444|NCT01272869|3782214|FG001|STARTED|Period 2 (14 Days)||10
3061445|NCT01272869|3782213|FG000|COMPLETED|Period 2 (14 Days)||9
3061446|NCT01272869|3782214|FG001|COMPLETED|Period 2 (14 Days)||10
3061447|NCT01272869|3782213|FG000|NOT COMPLETED|Period 2 (14 Days)||1
3061448|NCT01272869|3782214|FG001|NOT COMPLETED|Period 2 (14 Days)||0
3061449|NCT01272882|3782220|FG000|STARTED|Overall Study||13
3061450|NCT01272882|3782220|FG000|COMPLETED|Overall Study||13
3061451|NCT01272882|3782220|FG000|NOT COMPLETED|Overall Study||0
3061452|NCT01272908|3782224|FG000|STARTED|Initial Treatment Period||120
3061453|NCT01272908|3782224|FG000|COMPLETED|Initial Treatment Period||112
3061454|NCT01272908|3782224|FG000|NOT COMPLETED|Initial Treatment Period||8
3061455|NCT01272908|3782224|FG000|STARTED|Re-Treatment Period|Only participants with active disease as characterized by DAS-28 score ≥2.6 were included.|77
3061456|NCT01272908|3782224|FG000|COMPLETED|Re-Treatment Period||71
3061457|NCT01272908|3782224|FG000|NOT COMPLETED|Re-Treatment Period||6
3061458|NCT01272921|3782232|FG000|STARTED|Overall Study||71
3061459|NCT01272921|3782233|FG001|STARTED|Overall Study||71
3061460|NCT01272921|3782232|FG000|COMPLETED|Overall Study||69
3061461|NCT01272921|3782233|FG001|COMPLETED|Overall Study||70
3061462|NCT01272921|3782232|FG000|NOT COMPLETED|Overall Study||2
3061463|NCT01272921|3782233|FG001|NOT COMPLETED|Overall Study||1
3061464|NCT01272934|3782243|FG000|STARTED|Overall Study||102
3061465|NCT01272934|3782244|FG001|STARTED|Overall Study||103
3061466|NCT01272934|3782243|FG000|COMPLETED|Overall Study||102
3061467|NCT01272934|3782244|FG001|COMPLETED|Overall Study||101
3061468|NCT01272934|3782243|FG000|NOT COMPLETED|Overall Study||0
3061469|NCT01272934|3782244|FG001|NOT COMPLETED|Overall Study||2
3061470|NCT01272947|3782253|FG000|STARTED|Overall Study||104
3061471|NCT01272947|3782254|FG001|STARTED|Overall Study||100
3061472|NCT01272947|3782253|FG000|COMPLETED|Overall Study||102
3061473|NCT01272947|3782254|FG001|COMPLETED|Overall Study||98
3061474|NCT01272947|3782253|FG000|NOT COMPLETED|Overall Study||2
3061475|NCT01272947|3782254|FG001|NOT COMPLETED|Overall Study||2
3061476|NCT01272960|3782262|FG000|STARTED|Overall Study||14
3061477|NCT01272960|3782263|FG001|STARTED|Overall Study||15
3061478|NCT01272960|3782262|FG000|COMPLETED|Overall Study||14
3061479|NCT01272960|3782263|FG001|COMPLETED|Overall Study||15
3061480|NCT01272960|3782262|FG000|NOT COMPLETED|Overall Study||0
3061481|NCT01272960|3782263|FG001|NOT COMPLETED|Overall Study||0
3061482|NCT01272999|3782274|FG000|STARTED|Overall Study||357
3061483|NCT01272999|3782275|FG001|STARTED|Overall Study||34
3061484|NCT01272999|3782274|FG000|COMPLETED|Overall Study||357
3061485|NCT01272999|3782275|FG001|COMPLETED|Overall Study||34
3061486|NCT01272999|3782274|FG000|NOT COMPLETED|Overall Study||0
3061487|NCT01272999|3782275|FG001|NOT COMPLETED|Overall Study||0
3061488|NCT01273038|3782283|FG000|STARTED|First Intervention (14 Days)||10
3061489|NCT01273038|3782284|FG001|STARTED|First Intervention (14 Days)||10
3061490|NCT01273038|3782283|FG000|COMPLETED|First Intervention (14 Days)||10
3061491|NCT01273038|3782284|FG001|COMPLETED|First Intervention (14 Days)||10
3061492|NCT01273038|3782283|FG000|NOT COMPLETED|First Intervention (14 Days)||0
3061493|NCT01273038|3782284|FG001|NOT COMPLETED|First Intervention (14 Days)||0
3061494|NCT01273038|3782283|FG000|STARTED|Second Intervention (14 Days)||10
3061495|NCT01273038|3782284|FG001|STARTED|Second Intervention (14 Days)||10
3061496|NCT01273038|3782283|FG000|COMPLETED|Second Intervention (14 Days)||10
3061497|NCT01273038|3782284|FG001|COMPLETED|Second Intervention (14 Days)||8
3061498|NCT01273038|3782283|FG000|NOT COMPLETED|Second Intervention (14 Days)||0
3061499|NCT01273038|3782284|FG001|NOT COMPLETED|Second Intervention (14 Days)||2
3061500|NCT01273155|3782294|FG000|STARTED|Overall Study||14
3061501|NCT01273155|3782295|FG001|STARTED|Overall Study||12
3061502|NCT01273155|3782296|FG002|STARTED|Overall Study||18
3061503|NCT01273155|3782297|FG003|STARTED|Overall Study||5
3061504|NCT01273155|3782298|FG004|STARTED|Overall Study||5
3061505|NCT01273155|3782299|FG005|STARTED|Overall Study||10
3061506|NCT01273155|3782300|FG006|STARTED|Overall Study||8
3061507|NCT01273155|3782294|FG000|COMPLETED|Overall Study||12
3061508|NCT01273155|3782295|FG001|COMPLETED|Overall Study||8
3061509|NCT01273155|3782296|FG002|COMPLETED|Overall Study||6
3061510|NCT01273155|3782297|FG003|COMPLETED|Overall Study||4
3061511|NCT01273155|3782298|FG004|COMPLETED|Overall Study||3
3061512|NCT01273155|3782299|FG005|COMPLETED|Overall Study||5
3061513|NCT01273155|3782300|FG006|COMPLETED|Overall Study||2
3061514|NCT01273155|3782294|FG000|NOT COMPLETED|Overall Study||2
3061515|NCT01273155|3782295|FG001|NOT COMPLETED|Overall Study||4
3061516|NCT01273155|3782296|FG002|NOT COMPLETED|Overall Study||12
3061517|NCT01273155|3782297|FG003|NOT COMPLETED|Overall Study||1
3061518|NCT01273155|3782298|FG004|NOT COMPLETED|Overall Study||2
3061519|NCT01273155|3782299|FG005|NOT COMPLETED|Overall Study||5
3061520|NCT01273155|3782300|FG006|NOT COMPLETED|Overall Study||6
3061521|NCT01273181|3782327|FG000|STARTED|Phase I, Dose 1||3
3162789|NCT01880554|3890227|FG000|Population Eligible|Overall Study||58
3162790|NCT01880554|3890227|FG000|Population Eligible and Assessable|Overall Study||54
3162791|NCT01880554|3890227|FG000|COMPLETED|Overall Study|Patients eligible and assessable according to two-stage Simon's design (primary outcome)|52
3162792|NCT01880554|3890227|FG000|NOT COMPLETED|Overall Study||16
3162793|NCT01880593|3890234|FG000|STARTED|Overall Study||18
3162794|NCT01880593|3890235|FG001|STARTED|Overall Study||16
3162795|NCT01880593|3890234|FG000|COMPLETED|Overall Study||10
3162796|NCT01880593|3890235|FG001|COMPLETED|Overall Study||10
3061522|NCT01273181|3782328|FG001|STARTED|Phase I, Dose 1||0
3061523|NCT01273181|3782329|FG002|STARTED|Phase I, Dose 1||0
3061524|NCT01273181|3782330|FG003|STARTED|Phase I, Dose 1||0
3061525|NCT01273181|3782327|FG000|COMPLETED|Phase I, Dose 1||2
3061526|NCT01273181|3782328|FG001|COMPLETED|Phase I, Dose 1||0
3061527|NCT01273181|3782329|FG002|COMPLETED|Phase I, Dose 1||0
3061528|NCT01273181|3782330|FG003|COMPLETED|Phase I, Dose 1||0
3061529|NCT01273181|3782327|FG000|NOT COMPLETED|Phase I, Dose 1||1
3061530|NCT01273181|3782328|FG001|NOT COMPLETED|Phase I, Dose 1||0
3061531|NCT01273181|3782329|FG002|NOT COMPLETED|Phase I, Dose 1||0
3061532|NCT01273181|3782330|FG003|NOT COMPLETED|Phase I, Dose 1||0
3061533|NCT01273181|3782327|FG000|STARTED|Phase I, Dose 2||0
3061534|NCT01273181|3782328|FG001|STARTED|Phase I, Dose 2||3
3061535|NCT01273181|3782329|FG002|STARTED|Phase I, Dose 2||0
3061536|NCT01273181|3782330|FG003|STARTED|Phase I, Dose 2||0
3061537|NCT01273181|3782327|FG000|COMPLETED|Phase I, Dose 2||0
3061538|NCT01273181|3782328|FG001|COMPLETED|Phase I, Dose 2||2
3061539|NCT01273181|3782329|FG002|COMPLETED|Phase I, Dose 2||0
3061540|NCT01273181|3782330|FG003|COMPLETED|Phase I, Dose 2||0
3061541|NCT01273181|3782327|FG000|NOT COMPLETED|Phase I, Dose 2||0
3061542|NCT01273181|3782328|FG001|NOT COMPLETED|Phase I, Dose 2||1
3061543|NCT01273181|3782329|FG002|NOT COMPLETED|Phase I, Dose 2||0
3061544|NCT01273181|3782330|FG003|NOT COMPLETED|Phase I, Dose 2||0
3061545|NCT01273181|3782327|FG000|STARTED|Phase 2, Dose 1||0
3061546|NCT01273181|3782328|FG001|STARTED|Phase 2, Dose 1||0
3061547|NCT01273181|3782329|FG002|STARTED|Phase 2, Dose 1||2
3061548|NCT01273181|3782330|FG003|STARTED|Phase 2, Dose 1||0
3061549|NCT01273181|3782327|FG000|COMPLETED|Phase 2, Dose 1||0
3061550|NCT01273181|3782328|FG001|COMPLETED|Phase 2, Dose 1||0
3061551|NCT01273181|3782329|FG002|COMPLETED|Phase 2, Dose 1||1
3061552|NCT01273181|3782330|FG003|COMPLETED|Phase 2, Dose 1||0
3061553|NCT01273181|3782327|FG000|NOT COMPLETED|Phase 2, Dose 1||0
3061554|NCT01273181|3782328|FG001|NOT COMPLETED|Phase 2, Dose 1||0
3061555|NCT01273181|3782329|FG002|NOT COMPLETED|Phase 2, Dose 1||1
3061556|NCT01273181|3782330|FG003|NOT COMPLETED|Phase 2, Dose 1||0
3061557|NCT01273181|3782327|FG000|STARTED|Phase 2, Dose 2||0
3061558|NCT01273181|3782328|FG001|STARTED|Phase 2, Dose 2||0
3061559|NCT01273181|3782329|FG002|STARTED|Phase 2, Dose 2||0
3061560|NCT01273181|3782330|FG003|STARTED|Phase 2, Dose 2||1
3061561|NCT01273181|3782327|FG000|COMPLETED|Phase 2, Dose 2||0
3061562|NCT01273181|3782328|FG001|COMPLETED|Phase 2, Dose 2||0
3061563|NCT01273181|3782329|FG002|COMPLETED|Phase 2, Dose 2||0
3061564|NCT01273181|3782330|FG003|COMPLETED|Phase 2, Dose 2||0
3061565|NCT01273181|3782327|FG000|NOT COMPLETED|Phase 2, Dose 2||0
3061566|NCT01273181|3782328|FG001|NOT COMPLETED|Phase 2, Dose 2||0
3061567|NCT01273181|3782329|FG002|NOT COMPLETED|Phase 2, Dose 2||0
3061568|NCT01273181|3782330|FG003|NOT COMPLETED|Phase 2, Dose 2||1
3061569|NCT01273207|3782344|FG000|STARTED|Overall Study||7
3061570|NCT01273207|3782344|FG000|COMPLETED|Overall Study||2
3061571|NCT01273207|3782344|FG000|NOT COMPLETED|Overall Study||5
3061572|NCT01273519|3782351|FG000|STARTED|Overall Study||78
3061573|NCT01273519|3782352|FG001|STARTED|Overall Study||30
3061574|NCT01273519|3782353|FG002|STARTED|Overall Study||47
3061575|NCT01273519|3782351|FG000|COMPLETED|Overall Study||59
3061576|NCT01273519|3782352|FG001|COMPLETED|Overall Study||25
3061577|NCT01273519|3782353|FG002|COMPLETED|Overall Study||39
3061578|NCT01273519|3782351|FG000|NOT COMPLETED|Overall Study||19
3061579|NCT01273519|3782352|FG001|NOT COMPLETED|Overall Study||5
3061580|NCT01273519|3782353|FG002|NOT COMPLETED|Overall Study||8
3061581|NCT01273597|3782364|FG000|STARTED|Overall Study||60
3061582|NCT01273597|3782364|FG000|COMPLETED|Overall Study||52
3061583|NCT01273597|3782364|FG000|NOT COMPLETED|Overall Study||8
3162797|NCT01880593|3890234|FG000|NOT COMPLETED|Overall Study||8
3061584|NCT01273623|3782368|FG000|STARTED|Overall Study|met angiographic criteria|55
3061585|NCT01273623|3782368|FG000|COMPLETED|Overall Study|met IVUS criteria|26
3061586|NCT01273623|3782368|FG000|NOT COMPLETED|Overall Study||29
3061587|NCT01273766|3782377|FG000|STARTED|Overall Study||4
3061588|NCT01273766|3782378|FG001|STARTED|Overall Study||7
3061589|NCT01273766|3782379|FG002|STARTED|Overall Study||5
3061590|NCT01273766|3782377|FG000|COMPLETED|Overall Study||4
3061591|NCT01273766|3782378|FG001|COMPLETED|Overall Study||7
3061592|NCT01273766|3782379|FG002|COMPLETED|Overall Study||5
3061593|NCT01273766|3782377|FG000|NOT COMPLETED|Overall Study||0
3061594|NCT01273766|3782378|FG001|NOT COMPLETED|Overall Study||0
3061595|NCT01273766|3782379|FG002|NOT COMPLETED|Overall Study||0
3162798|NCT01880593|3890235|FG001|NOT COMPLETED|Overall Study||6
3162799|NCT01880697|3890243|FG000|STARTED|Overall Study||63
3162800|NCT01880697|3890244|FG001|STARTED|Overall Study||63
3162801|NCT01880697|3890243|FG000|COMPLETED|Overall Study||63
3162802|NCT01880697|3890244|FG001|COMPLETED|Overall Study||62
3162803|NCT01880697|3890243|FG000|NOT COMPLETED|Overall Study||0
3162804|NCT01880697|3890244|FG001|NOT COMPLETED|Overall Study||1
3162805|NCT01880723|3890252|FG000|STARTED|Overall Study||16
3162806|NCT01880723|3890253|FG001|STARTED|Overall Study||16
3061596|NCT01273805|3782388|FG000|STARTED|Overall Study||10
3061597|NCT01273805|3782389|FG001|STARTED|Overall Study||10
3061598|NCT01273805|3782388|FG000|COMPLETED|Overall Study||0
3061599|NCT01273805|3782389|FG001|COMPLETED|Overall Study||0
3061600|NCT01273805|3782388|FG000|NOT COMPLETED|Overall Study||10
3061601|NCT01273805|3782389|FG001|NOT COMPLETED|Overall Study||10
3061602|NCT01273818|3782398|FG000|STARTED|Overall Study||100
3061603|NCT01273818|3782399|FG001|STARTED|Overall Study||100
3061604|NCT01273818|3782400|FG002|STARTED|Overall Study||100
3061605|NCT01273818|3782398|FG000|COMPLETED|Overall Study||87
3061606|NCT01273818|3782399|FG001|COMPLETED|Overall Study||98
3061607|NCT01273818|3782400|FG002|COMPLETED|Overall Study||91
3061608|NCT01273818|3782398|FG000|NOT COMPLETED|Overall Study||13
3061609|NCT01273818|3782399|FG001|NOT COMPLETED|Overall Study||2
3061610|NCT01273818|3782400|FG002|NOT COMPLETED|Overall Study||9
3061611|NCT01273857|3782410|FG000|STARTED|Overall Study||7
3061612|NCT01273857|3782411|FG001|STARTED|Overall Study||7
3061613|NCT01273857|3782410|FG000|COMPLETED|Overall Study||7
3061614|NCT01273857|3782411|FG001|COMPLETED|Overall Study||7
3061615|NCT01273857|3782410|FG000|NOT COMPLETED|Overall Study||0
3061616|NCT01273857|3782411|FG001|NOT COMPLETED|Overall Study||0
3061617|NCT01273883|3782417|FG000|STARTED|First Intervention|Received at least 1 dose of study drug.|19
3061618|NCT01273883|3782418|FG001|STARTED|First Intervention|Received at least 1 dose of study drug.|19
3061619|NCT01273883|3782417|FG000|COMPLETED|First Intervention||17
3061620|NCT01273883|3782418|FG001|COMPLETED|First Intervention||18
3061621|NCT01273883|3782417|FG000|NOT COMPLETED|First Intervention||2
3061622|NCT01273883|3782418|FG001|NOT COMPLETED|First Intervention||1
3061623|NCT01273883|3782417|FG000|STARTED|Washout Period of 2 Weeks||17
3061624|NCT01273883|3782418|FG001|STARTED|Washout Period of 2 Weeks||18
3061625|NCT01273883|3782417|FG000|COMPLETED|Washout Period of 2 Weeks||17
3061626|NCT01273883|3782418|FG001|COMPLETED|Washout Period of 2 Weeks||18
3061627|NCT01273883|3782417|FG000|NOT COMPLETED|Washout Period of 2 Weeks||0
3061628|NCT01273883|3782418|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0
3061629|NCT01273883|3782417|FG000|STARTED|Second Intervention||17
3061630|NCT01273883|3782418|FG001|STARTED|Second Intervention||18
3061631|NCT01273883|3782417|FG000|COMPLETED|Second Intervention||15
3061632|NCT01273883|3782418|FG001|COMPLETED|Second Intervention||17
3061633|NCT01273883|3782417|FG000|NOT COMPLETED|Second Intervention||2
3061634|NCT01273883|3782418|FG001|NOT COMPLETED|Second Intervention||1
3061635|NCT01273896|3782424|FG000|STARTED|Overall Study||22
3061636|NCT01273896|3782424|FG000|COMPLETED|Overall Study||22
3061637|NCT01273896|3782424|FG000|NOT COMPLETED|Overall Study||0
3061638|NCT01274182|3782431|FG000|STARTED|Overall Study||133
3061639|NCT01274182|3782432|FG001|STARTED|Overall Study||87
3061640|NCT01274182|3782433|FG002|STARTED|Overall Study||92
3061641|NCT01274182|3782431|FG000|24 Weeks|Overall Study||123
3061642|NCT01274182|3782432|FG001|24 Weeks|Overall Study||83
3061643|NCT01274182|3782433|FG002|24 Weeks|Overall Study||84
3061644|NCT01274182|3782431|FG000|COMPLETED|Overall Study||112
3061645|NCT01274182|3782432|FG001|COMPLETED|Overall Study||69
3061646|NCT01274182|3782433|FG002|COMPLETED|Overall Study||80
3061647|NCT01274182|3782431|FG000|NOT COMPLETED|Overall Study||21
3061648|NCT01274182|3782432|FG001|NOT COMPLETED|Overall Study||18
3061649|NCT01274182|3782433|FG002|NOT COMPLETED|Overall Study||12
3061650|NCT01274338|3782451|FG000|STARTED|Overall Study||511
3061651|NCT01274338|3782452|FG001|STARTED|Overall Study||636
3061652|NCT01274338|3782453|FG002|STARTED|Overall Study||523
3061653|NCT01274338|3782454|FG003|STARTED|Overall Study||1
3061654|NCT01274338|3782455|FG004|STARTED|Overall Study||1
3061655|NCT01274338|3782456|FG005|STARTED|Overall Study||1
3061656|NCT01274338|3782451|FG000|Received Treatment|Overall Study||503
3061657|NCT01274338|3782452|FG001|Received Treatment|Overall Study||520
3061658|NCT01274338|3782453|FG002|Received Treatment|Overall Study||516
3061659|NCT01274338|3782454|FG003|Received Treatment|Overall Study||1
3061660|NCT01274338|3782455|FG004|Received Treatment|Overall Study||1
3061661|NCT01274338|3782456|FG005|Received Treatment|Overall Study||1
3061662|NCT01274338|3782451|FG000|Data Available for the FACT-G and FACT-BRM Analyses|Overall Study||110
3061663|NCT01274338|3782452|FG001|Data Available for the FACT-G and FACT-BRM Analyses|Overall Study||114
3061664|NCT01274338|3782453|FG002|Data Available for the FACT-G and FACT-BRM Analyses|Overall Study||97
3061665|NCT01274338|3782454|FG003|Data Available for the FACT-G and FACT-BRM Analyses|Overall Study||0
3061666|NCT01274338|3782455|FG004|Data Available for the FACT-G and FACT-BRM Analyses|Overall Study||0
3061667|NCT01274338|3782456|FG005|Data Available for the FACT-G and FACT-BRM Analyses|Overall Study||0
3061668|NCT01274338|3782451|FG000|Data Available for FACIT-D Analysis|Overall Study||109
3061669|NCT01274338|3782452|FG001|Data Available for FACIT-D Analysis|Overall Study||114
3061670|NCT01274338|3782453|FG002|Data Available for FACIT-D Analysis|Overall Study||97
3061671|NCT01274338|3782454|FG003|Data Available for FACIT-D Analysis|Overall Study||0
3162807|NCT01880723|3890252|FG000|COMPLETED|Overall Study||16
3162808|NCT01880723|3890253|FG001|COMPLETED|Overall Study||16
3162809|NCT01880723|3890252|FG000|NOT COMPLETED|Overall Study||0
3061672|NCT01274338|3782455|FG004|Data Available for FACIT-D Analysis|Overall Study||0
3061673|NCT01274338|3782456|FG005|Data Available for FACIT-D Analysis|Overall Study||0
3284085|NCT02761330|4017833|FG000|NOT COMPLETED|Treatment Week 2||0
3284086|NCT02761330|4017834|FG001|NOT COMPLETED|Treatment Week 2||0
3284087|NCT02761330|4017835|FG002|NOT COMPLETED|Treatment Week 2||0
3284088|NCT02761330|4017836|FG003|NOT COMPLETED|Treatment Week 2||0
3284089|NCT02761330|4017837|FG004|NOT COMPLETED|Treatment Week 2||0
3284090|NCT02761330|4017838|FG005|NOT COMPLETED|Treatment Week 2||0
3284091|NCT02761629|4017854|FG000|STARTED|Overall Study||90
3284092|NCT02761629|4017855|FG001|STARTED|Overall Study||90
3061674|NCT01274338|3782451|FG000|COMPLETED|Overall Study||108
3061675|NCT01274338|3782452|FG001|COMPLETED|Overall Study||182
3061676|NCT01274338|3782453|FG002|COMPLETED|Overall Study||198
3061677|NCT01274338|3782454|FG003|COMPLETED|Overall Study||0
3061678|NCT01274338|3782455|FG004|COMPLETED|Overall Study||0
3061679|NCT01274338|3782456|FG005|COMPLETED|Overall Study||1
3061680|NCT01274338|3782451|FG000|NOT COMPLETED|Overall Study||403
3061681|NCT01274338|3782452|FG001|NOT COMPLETED|Overall Study||454
3284093|NCT02761629|4017854|FG000|Treated|Overall Study||82
3284094|NCT02761629|4017855|FG001|Treated|Overall Study||86
3284095|NCT02761629|4017854|FG000|COMPLETED|Overall Study||63
3061682|NCT01274338|3782453|FG002|NOT COMPLETED|Overall Study||325
3061683|NCT01274338|3782454|FG003|NOT COMPLETED|Overall Study||1
3061684|NCT01274338|3782455|FG004|NOT COMPLETED|Overall Study||1
3061685|NCT01274338|3782456|FG005|NOT COMPLETED|Overall Study||0
3061686|NCT01274351|3782469|FG000|STARTED|Overall Study||112
3061687|NCT01274351|3782469|FG000|COMPLETED|Overall Study||92
3061688|NCT01274351|3782469|FG000|NOT COMPLETED|Overall Study||20
3061689|NCT01274520|3782475|FG000|STARTED|Overall Study||25
3061690|NCT01274520|3782476|FG001|STARTED|Overall Study||24
3061691|NCT01274520|3782475|FG000|COMPLETED|Overall Study||25
3061692|NCT01274520|3782476|FG001|COMPLETED|Overall Study||24
3061693|NCT01274520|3782475|FG000|NOT COMPLETED|Overall Study||0
3061694|NCT01274520|3782476|FG001|NOT COMPLETED|Overall Study||0
3061695|NCT01274585|3782487|FG000|STARTED|Overall Study||2
3061696|NCT01274585|3782488|FG001|STARTED|Overall Study||3
3061697|NCT01274585|3782487|FG000|COMPLETED|Overall Study||2
3061698|NCT01274585|3782488|FG001|COMPLETED|Overall Study||3
3061699|NCT01274585|3782487|FG000|NOT COMPLETED|Overall Study||0
3061700|NCT01274585|3782488|FG001|NOT COMPLETED|Overall Study||0
3061701|NCT01274637|3782496|FG000|STARTED|Overall Study||30
3061702|NCT01274637|3782497|FG001|STARTED|Overall Study||32
3061703|NCT01274637|3782496|FG000|COMPLETED|Overall Study||30
3061704|NCT01274637|3782497|FG001|COMPLETED|Overall Study||30
3061705|NCT01274637|3782496|FG000|NOT COMPLETED|Overall Study||0
3061706|NCT01274637|3782497|FG001|NOT COMPLETED|Overall Study||2
3061707|NCT01274715|3782503|FG000|STARTED|Overall Study||12
3061708|NCT01274715|3782503|FG000|Screened Out at Baseline|Overall Study||3
3061709|NCT01274715|3782503|FG000|COMPLETED|Overall Study||8
3061710|NCT01274715|3782503|FG000|NOT COMPLETED|Overall Study||4
3061711|NCT01274897|3782509|FG000|STARTED|Overall Study||297
3061712|NCT01274897|3782510|FG001|STARTED|Overall Study||153
3061713|NCT01274897|3782509|FG000|COMPLETED|Overall Study||297
3061714|NCT01274897|3782510|FG001|COMPLETED|Overall Study||153
3061715|NCT01274897|3782509|FG000|NOT COMPLETED|Overall Study||0
3061716|NCT01274897|3782510|FG001|NOT COMPLETED|Overall Study||0
3061717|NCT01275053|3782516|FG000|STARTED|Overall Study||12
3061718|NCT01275053|3782516|FG000|COMPLETED|Overall Study||12
3061719|NCT01275053|3782516|FG000|NOT COMPLETED|Overall Study||0
3061720|NCT01275066|3782523|FG000|STARTED|Overall Study||60
3061721|NCT01275066|3782524|FG001|STARTED|Overall Study||59
3061722|NCT01275066|3782525|FG002|STARTED|Overall Study||58
3061723|NCT01275066|3782523|FG000|Treated|Overall Study||59
3061724|NCT01275066|3782524|FG001|Treated|Overall Study||59
3061725|NCT01275066|3782525|FG002|Treated|Overall Study||58
3061726|NCT01275066|3782523|FG000|COMPLETED|Overall Study||59
3061727|NCT01275066|3782524|FG001|COMPLETED|Overall Study||59
3061728|NCT01275066|3782525|FG002|COMPLETED|Overall Study||57
3061729|NCT01275066|3782523|FG000|NOT COMPLETED|Overall Study||1
3162810|NCT01880723|3890253|FG001|NOT COMPLETED|Overall Study||0
3162811|NCT01880736|3890263|FG000|STARTED|Overall Study||114
3162812|NCT01880736|3890264|FG001|STARTED|Overall Study||115
3162813|NCT01880736|3890265|FG002|STARTED|Overall Study||115
3061730|NCT01275066|3782524|FG001|NOT COMPLETED|Overall Study||0
3061731|NCT01275066|3782525|FG002|NOT COMPLETED|Overall Study||1
3061732|NCT01275092|3782533|FG000|STARTED|Overall Study||164
3061733|NCT01275092|3782533|FG000|COMPLETED|Overall Study||164
3061734|NCT01275092|3782533|FG000|NOT COMPLETED|Overall Study||0
3061735|NCT01275131|3782541|FG000|STARTED|Period 1||11
3061736|NCT01275131|3782542|FG001|STARTED|Period 1||9
3061737|NCT01275131|3782543|FG002|STARTED|Period 1||13
3061738|NCT01275131|3782544|FG003|STARTED|Period 1||12
3061739|NCT01275131|3782541|FG000|Received at Least One Dose of Study Drug|Period 1||11
3061740|NCT01275131|3782542|FG001|Received at Least One Dose of Study Drug|Period 1||9
3061741|NCT01275131|3782543|FG002|Received at Least One Dose of Study Drug|Period 1||13
3162814|NCT01880736|3890266|FG003|STARTED|Overall Study||114
3162815|NCT01880736|3890263|FG000|COMPLETED|Overall Study||113
3162816|NCT01880736|3890264|FG001|COMPLETED|Overall Study||113
3284096|NCT02761629|4017855|FG001|COMPLETED|Overall Study||58
3284097|NCT02761629|4017854|FG000|NOT COMPLETED|Overall Study||27
3284098|NCT02761629|4017855|FG001|NOT COMPLETED|Overall Study||32
3284099|NCT02761642|4017861|FG000|STARTED|Overall Study||200
3284100|NCT02761642|4017861|FG000|Treated|Overall Study||197
3061742|NCT01275131|3782544|FG003|Received at Least One Dose of Study Drug|Period 1||12
3061743|NCT01275131|3782541|FG000|COMPLETED|Period 1||9
3061744|NCT01275131|3782542|FG001|COMPLETED|Period 1||9
3061745|NCT01275131|3782543|FG002|COMPLETED|Period 1||10
3061746|NCT01275131|3782544|FG003|COMPLETED|Period 1||10
3061747|NCT01275131|3782541|FG000|NOT COMPLETED|Period 1||2
3061748|NCT01275131|3782542|FG001|NOT COMPLETED|Period 1||0
3061749|NCT01275131|3782543|FG002|NOT COMPLETED|Period 1||3
3061750|NCT01275131|3782544|FG003|NOT COMPLETED|Period 1||2
3061751|NCT01275131|3782541|FG000|STARTED|5- to 14-Day Washout Period||9
3061752|NCT01275131|3782542|FG001|STARTED|5- to 14-Day Washout Period||9
3061753|NCT01275131|3782543|FG002|STARTED|5- to 14-Day Washout Period||10
3061754|NCT01275131|3782544|FG003|STARTED|5- to 14-Day Washout Period||10
3061755|NCT01275131|3782541|FG000|COMPLETED|5- to 14-Day Washout Period||9
3061756|NCT01275131|3782542|FG001|COMPLETED|5- to 14-Day Washout Period||9
3061757|NCT01275131|3782543|FG002|COMPLETED|5- to 14-Day Washout Period||10
3061758|NCT01275131|3782544|FG003|COMPLETED|5- to 14-Day Washout Period||10
3061759|NCT01275131|3782541|FG000|NOT COMPLETED|5- to 14-Day Washout Period||0
3061760|NCT01275131|3782542|FG001|NOT COMPLETED|5- to 14-Day Washout Period||0
3061761|NCT01275131|3782543|FG002|NOT COMPLETED|5- to 14-Day Washout Period||0
3061762|NCT01275131|3782544|FG003|NOT COMPLETED|5- to 14-Day Washout Period||0
3061763|NCT01275131|3782541|FG000|STARTED|Period 2 (Crossover)||9
3061764|NCT01275131|3782542|FG001|STARTED|Period 2 (Crossover)||9
3061765|NCT01275131|3782543|FG002|STARTED|Period 2 (Crossover)||10
3061766|NCT01275131|3782544|FG003|STARTED|Period 2 (Crossover)||10
3061767|NCT01275131|3782541|FG000|COMPLETED|Period 2 (Crossover)||8
3061768|NCT01275131|3782542|FG001|COMPLETED|Period 2 (Crossover)||8
3061769|NCT01275131|3782543|FG002|COMPLETED|Period 2 (Crossover)||9
3061770|NCT01275131|3782544|FG003|COMPLETED|Period 2 (Crossover)||8
3061771|NCT01275131|3782541|FG000|NOT COMPLETED|Period 2 (Crossover)||1
3061772|NCT01275131|3782542|FG001|NOT COMPLETED|Period 2 (Crossover)||1
3061773|NCT01275131|3782543|FG002|NOT COMPLETED|Period 2 (Crossover)||1
3061774|NCT01275131|3782544|FG003|NOT COMPLETED|Period 2 (Crossover)||2
3061775|NCT01275144|3782562|FG000|STARTED|First Intervention (6 Days)||14
3061776|NCT01275144|3782563|FG001|STARTED|First Intervention (6 Days)||14
3061777|NCT01275144|3782562|FG000|Received at Least 1 Dose of Study Drug|First Intervention (6 Days)||14
3061778|NCT01275144|3782563|FG001|Received at Least 1 Dose of Study Drug|First Intervention (6 Days)||14
3061779|NCT01275144|3782562|FG000|COMPLETED|First Intervention (6 Days)||14
3061780|NCT01275144|3782563|FG001|COMPLETED|First Intervention (6 Days)||14
3061781|NCT01275144|3782562|FG000|NOT COMPLETED|First Intervention (6 Days)||0
3061782|NCT01275144|3782563|FG001|NOT COMPLETED|First Intervention (6 Days)||0
3061783|NCT01275144|3782562|FG000|STARTED|Washout (7 Days)||14
3061784|NCT01275144|3782563|FG001|STARTED|Washout (7 Days)||14
3061785|NCT01275144|3782562|FG000|COMPLETED|Washout (7 Days)||14
3061786|NCT01275144|3782563|FG001|COMPLETED|Washout (7 Days)||14
3061787|NCT01275144|3782562|FG000|NOT COMPLETED|Washout (7 Days)||0
3061788|NCT01275144|3782563|FG001|NOT COMPLETED|Washout (7 Days)||0
3061789|NCT01275144|3782562|FG000|STARTED|Second Intervention (6 Days)||14
3061790|NCT01275144|3782563|FG001|STARTED|Second Intervention (6 Days)||14
3061791|NCT01275144|3782562|FG000|COMPLETED|Second Intervention (6 Days)||13
3061792|NCT01275144|3782563|FG001|COMPLETED|Second Intervention (6 Days)||14
3061793|NCT01275144|3782562|FG000|NOT COMPLETED|Second Intervention (6 Days)||1
3061794|NCT01275144|3782563|FG001|NOT COMPLETED|Second Intervention (6 Days)||0
3061795|NCT01275170|3782579|FG000|STARTED|Part 1: Period 1||7
3061796|NCT01275170|3782580|FG001|STARTED|Part 1: Period 1||6
3061797|NCT01275170|3782581|FG002|STARTED|Part 1: Period 1||6
3061798|NCT01275170|3782582|FG003|STARTED|Part 1: Period 1||6
3061799|NCT01275170|3782583|FG004|STARTED|Part 1: Period 1||6
3061800|NCT01275170|3782584|FG005|STARTED|Part 1: Period 1||6
3061801|NCT01275170|3782585|FG006|STARTED|Part 1: Period 1||6
3061802|NCT01275170|3782586|FG007|STARTED|Part 1: Period 1||6
3061803|NCT01275170|3782579|FG000|Treated|Part 1: Period 1||6
3061804|NCT01275170|3782580|FG001|Treated|Part 1: Period 1||6
3061805|NCT01275170|3782581|FG002|Treated|Part 1: Period 1||6
3061806|NCT01275170|3782582|FG003|Treated|Part 1: Period 1||6
3061807|NCT01275170|3782583|FG004|Treated|Part 1: Period 1||6
3061808|NCT01275170|3782584|FG005|Treated|Part 1: Period 1||6
3061809|NCT01275170|3782585|FG006|Treated|Part 1: Period 1||6
3061810|NCT01275170|3782586|FG007|Treated|Part 1: Period 1||6
3061811|NCT01275170|3782579|FG000|COMPLETED|Part 1: Period 1||6
3061812|NCT01275170|3782580|FG001|COMPLETED|Part 1: Period 1||6
3061813|NCT01275170|3782581|FG002|COMPLETED|Part 1: Period 1||6
3061814|NCT01275170|3782582|FG003|COMPLETED|Part 1: Period 1||6
3061815|NCT01275170|3782583|FG004|COMPLETED|Part 1: Period 1||6
3061816|NCT01275170|3782584|FG005|COMPLETED|Part 1: Period 1||6
3061817|NCT01275170|3782585|FG006|COMPLETED|Part 1: Period 1||6
3061818|NCT01275170|3782586|FG007|COMPLETED|Part 1: Period 1||6
3061819|NCT01275170|3782579|FG000|NOT COMPLETED|Part 1: Period 1||1
3061820|NCT01275170|3782580|FG001|NOT COMPLETED|Part 1: Period 1||0
3061821|NCT01275170|3782581|FG002|NOT COMPLETED|Part 1: Period 1||0
3061822|NCT01275170|3782582|FG003|NOT COMPLETED|Part 1: Period 1||0
3061823|NCT01275170|3782583|FG004|NOT COMPLETED|Part 1: Period 1||0
3061824|NCT01275170|3782584|FG005|NOT COMPLETED|Part 1: Period 1||0
3061825|NCT01275170|3782585|FG006|NOT COMPLETED|Part 1: Period 1||0
3061826|NCT01275170|3782586|FG007|NOT COMPLETED|Part 1: Period 1||0
3061827|NCT01275170|3782579|FG000|STARTED|Part 1: Period 2|Panel A participated in Part 1, Period 1 only.|0
3061828|NCT01275170|3782580|FG001|STARTED|Part 1: Period 2|Panel B participated in Part 1, Period 1 only.|0
3061829|NCT01275170|3782581|FG002|STARTED|Part 1: Period 2|Panel C participated in Part 1, Period 1 only.|0
3061830|NCT01275170|3782582|FG003|STARTED|Part 1: Period 2|Panel D participated in Part 1, Period 1 only.|0
3061831|NCT01275170|3782583|FG004|STARTED|Part 1: Period 2|Panel E participated in Part 1, Period 1 and Part 2, Period 1.|0
3061832|NCT01275170|3782584|FG005|STARTED|Part 1: Period 2|Panel E participated in Part 1, Period 1 and Part 2, Period 1.|0
3061833|NCT01275170|3782585|FG006|STARTED|Part 1: Period 2||6
3061834|NCT01275170|3782586|FG007|STARTED|Part 1: Period 2||6
3061835|NCT01275170|3782579|FG000|COMPLETED|Part 1: Period 2||0
3061836|NCT01275170|3782580|FG001|COMPLETED|Part 1: Period 2||0
3061837|NCT01275170|3782581|FG002|COMPLETED|Part 1: Period 2||0
3061838|NCT01275170|3782582|FG003|COMPLETED|Part 1: Period 2||0
3061839|NCT01275170|3782583|FG004|COMPLETED|Part 1: Period 2||0
3061840|NCT01275170|3782584|FG005|COMPLETED|Part 1: Period 2||0
3061841|NCT01275170|3782585|FG006|COMPLETED|Part 1: Period 2||6
3061842|NCT01275170|3782586|FG007|COMPLETED|Part 1: Period 2||6
3061843|NCT01275170|3782579|FG000|NOT COMPLETED|Part 1: Period 2||0
3061844|NCT01275170|3782580|FG001|NOT COMPLETED|Part 1: Period 2||0
3061845|NCT01275170|3782581|FG002|NOT COMPLETED|Part 1: Period 2||0
3061846|NCT01275170|3782582|FG003|NOT COMPLETED|Part 1: Period 2||0
3061847|NCT01275170|3782583|FG004|NOT COMPLETED|Part 1: Period 2||0
3061848|NCT01275170|3782584|FG005|NOT COMPLETED|Part 1: Period 2||0
3061849|NCT01275170|3782585|FG006|NOT COMPLETED|Part 1: Period 2||0
3061850|NCT01275170|3782586|FG007|NOT COMPLETED|Part 1: Period 2||0
3061851|NCT01275170|3782579|FG000|STARTED|Part 2: Period 1||0
3061852|NCT01275170|3782580|FG001|STARTED|Part 2: Period 1||0
3061853|NCT01275170|3782581|FG002|STARTED|Part 2: Period 1||0
3061854|NCT01275170|3782582|FG003|STARTED|Part 2: Period 1||0
3061855|NCT01275170|3782583|FG004|STARTED|Part 2: Period 1||6
3061856|NCT01275170|3782584|FG005|STARTED|Part 2: Period 1||6
3061857|NCT01275170|3782585|FG006|STARTED|Part 2: Period 1||6
3061858|NCT01275170|3782586|FG007|STARTED|Part 2: Period 1||6
3061859|NCT01275170|3782579|FG000|COMPLETED|Part 2: Period 1||0
3061860|NCT01275170|3782580|FG001|COMPLETED|Part 2: Period 1||0
3061861|NCT01275170|3782581|FG002|COMPLETED|Part 2: Period 1||0
3061862|NCT01275170|3782582|FG003|COMPLETED|Part 2: Period 1||0
3061863|NCT01275170|3782583|FG004|COMPLETED|Part 2: Period 1||6
3061864|NCT01275170|3782584|FG005|COMPLETED|Part 2: Period 1||6
3061865|NCT01275170|3782585|FG006|COMPLETED|Part 2: Period 1||6
3061866|NCT01275170|3782586|FG007|COMPLETED|Part 2: Period 1||6
3061867|NCT01275170|3782579|FG000|NOT COMPLETED|Part 2: Period 1||0
3061868|NCT01275170|3782580|FG001|NOT COMPLETED|Part 2: Period 1||0
3061869|NCT01275170|3782581|FG002|NOT COMPLETED|Part 2: Period 1||0
3061870|NCT01275170|3782582|FG003|NOT COMPLETED|Part 2: Period 1||0
3061871|NCT01275170|3782583|FG004|NOT COMPLETED|Part 2: Period 1||0
3061872|NCT01275170|3782584|FG005|NOT COMPLETED|Part 2: Period 1||0
3061873|NCT01275170|3782585|FG006|NOT COMPLETED|Part 2: Period 1||0
3061874|NCT01275170|3782586|FG007|NOT COMPLETED|Part 2: Period 1||0
3061875|NCT01275170|3782579|FG000|STARTED|Part 2: Period 2||0
3061876|NCT01275170|3782580|FG001|STARTED|Part 2: Period 2||0
3061877|NCT01275170|3782581|FG002|STARTED|Part 2: Period 2||0
3061878|NCT01275170|3782582|FG003|STARTED|Part 2: Period 2||0
3061879|NCT01275170|3782583|FG004|STARTED|Part 2: Period 2|Panel E participated in Part 1, Period 1 and Part 2, Period 1.|0
3061880|NCT01275170|3782584|FG005|STARTED|Part 2: Period 2|Panel F participated in Part 1, Period 1 and Part 2, Period 1.|0
3061881|NCT01275170|3782585|FG006|STARTED|Part 2: Period 2||6
3061882|NCT01275170|3782586|FG007|STARTED|Part 2: Period 2||6
3061883|NCT01275170|3782579|FG000|COMPLETED|Part 2: Period 2||0
3061884|NCT01275170|3782580|FG001|COMPLETED|Part 2: Period 2||0
3061885|NCT01275170|3782581|FG002|COMPLETED|Part 2: Period 2||0
3162817|NCT01880736|3890265|FG002|COMPLETED|Overall Study||114
3162818|NCT01880736|3890266|FG003|COMPLETED|Overall Study||108
3162819|NCT01880736|3890263|FG000|NOT COMPLETED|Overall Study||1
3162820|NCT01880736|3890264|FG001|NOT COMPLETED|Overall Study||2
3162821|NCT01880736|3890265|FG002|NOT COMPLETED|Overall Study||1
3162822|NCT01880736|3890266|FG003|NOT COMPLETED|Overall Study||6
3162823|NCT01880840|3890278|FG000|STARTED|Overall Study||95
3162824|NCT01880840|3890279|FG001|STARTED|Overall Study||96
3162825|NCT01880840|3890278|FG000|COMPLETED|Overall Study||87
3162826|NCT01880840|3890279|FG001|COMPLETED|Overall Study||91
3162827|NCT01880840|3890278|FG000|NOT COMPLETED|Overall Study||8
3162828|NCT01880840|3890279|FG001|NOT COMPLETED|Overall Study||5
3162829|NCT01881009|3890287|FG000|STARTED|Inpatient Safety Testing (22 Hours)||16
3162830|NCT01881009|3890288|FG001|STARTED|Inpatient Safety Testing (22 Hours)||0
3162831|NCT01881009|3890287|FG000|COMPLETED|Inpatient Safety Testing (22 Hours)||16
3162832|NCT01881009|3890288|FG001|COMPLETED|Inpatient Safety Testing (22 Hours)||0
3284101|NCT02761642|4017861|FG000|COMPLETED|Overall Study||130
3061886|NCT01275170|3782582|FG003|COMPLETED|Part 2: Period 2||0
3061887|NCT01275170|3782583|FG004|COMPLETED|Part 2: Period 2||0
3061888|NCT01275170|3782584|FG005|COMPLETED|Part 2: Period 2||0
3061889|NCT01275170|3782585|FG006|COMPLETED|Part 2: Period 2||6
3061890|NCT01275170|3782586|FG007|COMPLETED|Part 2: Period 2||6
3061891|NCT01275170|3782579|FG000|NOT COMPLETED|Part 2: Period 2||0
3162833|NCT01881009|3890287|FG000|NOT COMPLETED|Inpatient Safety Testing (22 Hours)||0
3162834|NCT01881009|3890288|FG001|NOT COMPLETED|Inpatient Safety Testing (22 Hours)||0
3162835|NCT01881009|3890287|FG000|STARTED|Summer Camp Session (6 Days)||0
3162836|NCT01881009|3890288|FG001|STARTED|Summer Camp Session (6 Days)||22
3284102|NCT02761642|4017861|FG000|NOT COMPLETED|Overall Study||70
3284103|NCT02761733|4017869|FG000|STARTED|Overall Study||60
3061892|NCT01275170|3782580|FG001|NOT COMPLETED|Part 2: Period 2||0
3061893|NCT01275170|3782581|FG002|NOT COMPLETED|Part 2: Period 2||0
3061894|NCT01275170|3782582|FG003|NOT COMPLETED|Part 2: Period 2||0
3061895|NCT01275170|3782583|FG004|NOT COMPLETED|Part 2: Period 2||0
3061896|NCT01275170|3782584|FG005|NOT COMPLETED|Part 2: Period 2||0
3061897|NCT01275170|3782585|FG006|NOT COMPLETED|Part 2: Period 2||0
3162837|NCT01881009|3890287|FG000|COMPLETED|Summer Camp Session (6 Days)||0
3162838|NCT01881009|3890288|FG001|COMPLETED|Summer Camp Session (6 Days)||21
3162839|NCT01881009|3890287|FG000|NOT COMPLETED|Summer Camp Session (6 Days)||0
3162840|NCT01881009|3890288|FG001|NOT COMPLETED|Summer Camp Session (6 Days)||1
3162841|NCT01881087|3890298|FG000|STARTED|Overall Study||60
3162842|NCT01881087|3890299|FG001|STARTED|Overall Study||61
3162843|NCT01881087|3890300|FG002|STARTED|Overall Study||62
3162844|NCT01881087|3890298|FG000|COMPLETED|Overall Study||59
3162845|NCT01881087|3890299|FG001|COMPLETED|Overall Study||61
3162846|NCT01881087|3890300|FG002|COMPLETED|Overall Study||60
3162847|NCT01881087|3890298|FG000|NOT COMPLETED|Overall Study||1
3162848|NCT01881087|3890299|FG001|NOT COMPLETED|Overall Study||0
3061898|NCT01275170|3782586|FG007|NOT COMPLETED|Part 2: Period 2||0
3061899|NCT01275196|3782621|FG000|STARTED|Overall Study||133
3061900|NCT01275196|3782622|FG001|STARTED|Overall Study||134
3061901|NCT01275196|3782621|FG000|Intended to Continue Into Extension|Overall Study||112
3061902|NCT01275196|3782622|FG001|Intended to Continue Into Extension|Overall Study||113
3061903|NCT01275196|3782621|FG000|COMPLETED|Overall Study||113
3061904|NCT01275196|3782622|FG001|COMPLETED|Overall Study||113
3061905|NCT01275196|3782621|FG000|NOT COMPLETED|Overall Study||20
3061906|NCT01275196|3782622|FG001|NOT COMPLETED|Overall Study||21
3061907|NCT01275222|3782636|FG000|STARTED|Phase l by Treatment||13
3061908|NCT01275222|3782637|FG001|STARTED|Phase l by Treatment||13
3061909|NCT01275222|3782638|FG002|STARTED|Phase l by Treatment||5
3162849|NCT01881087|3890300|FG002|NOT COMPLETED|Overall Study||2
3162850|NCT01881113|3890310|FG000|STARTED|Overall Study||51
3162851|NCT01881113|3890311|FG001|STARTED|Overall Study||50
3162852|NCT01881113|3890310|FG000|COMPLETED|Overall Study||43
3284104|NCT02761733|4017870|FG001|STARTED|Overall Study||60
3061910|NCT01275222|3782639|FG003|STARTED|Phase l by Treatment||11
3061911|NCT01275222|3782640|FG004|STARTED|Phase l by Treatment||0
3061912|NCT01275222|3782641|FG005|STARTED|Phase l by Treatment||0
3061913|NCT01275222|3782636|FG000|COMPLETED|Phase l by Treatment||0
3061914|NCT01275222|3782637|FG001|COMPLETED|Phase l by Treatment||0
3061915|NCT01275222|3782638|FG002|COMPLETED|Phase l by Treatment||0
3061916|NCT01275222|3782639|FG003|COMPLETED|Phase l by Treatment||0
3061917|NCT01275222|3782640|FG004|COMPLETED|Phase l by Treatment||0
3061918|NCT01275222|3782641|FG005|COMPLETED|Phase l by Treatment||0
3061919|NCT01275222|3782636|FG000|NOT COMPLETED|Phase l by Treatment||13
3061920|NCT01275222|3782637|FG001|NOT COMPLETED|Phase l by Treatment||13
3061921|NCT01275222|3782638|FG002|NOT COMPLETED|Phase l by Treatment||5
3061922|NCT01275222|3782639|FG003|NOT COMPLETED|Phase l by Treatment||11
3061923|NCT01275222|3782640|FG004|NOT COMPLETED|Phase l by Treatment||0
3061924|NCT01275222|3782641|FG005|NOT COMPLETED|Phase l by Treatment||0
3061925|NCT01275222|3782636|FG000|STARTED|Phase ll by Stratum||0
3061926|NCT01275222|3782637|FG001|STARTED|Phase ll by Stratum||0
3061927|NCT01275222|3782638|FG002|STARTED|Phase ll by Stratum||0
3061928|NCT01275222|3782639|FG003|STARTED|Phase ll by Stratum||0
3061929|NCT01275222|3782640|FG004|STARTED|Phase ll by Stratum||28
3061930|NCT01275222|3782641|FG005|STARTED|Phase ll by Stratum||47
3061931|NCT01275222|3782636|FG000|COMPLETED|Phase ll by Stratum||0
3061932|NCT01275222|3782637|FG001|COMPLETED|Phase ll by Stratum||0
3061933|NCT01275222|3782638|FG002|COMPLETED|Phase ll by Stratum||0
3061934|NCT01275222|3782639|FG003|COMPLETED|Phase ll by Stratum||0
3061935|NCT01275222|3782640|FG004|COMPLETED|Phase ll by Stratum||0
3061936|NCT01275222|3782641|FG005|COMPLETED|Phase ll by Stratum||1
3061937|NCT01275222|3782636|FG000|NOT COMPLETED|Phase ll by Stratum||0
3061938|NCT01275222|3782637|FG001|NOT COMPLETED|Phase ll by Stratum||0
3061939|NCT01275222|3782638|FG002|NOT COMPLETED|Phase ll by Stratum||0
3061940|NCT01275222|3782639|FG003|NOT COMPLETED|Phase ll by Stratum||0
3061941|NCT01275222|3782640|FG004|NOT COMPLETED|Phase ll by Stratum||28
3061942|NCT01275222|3782641|FG005|NOT COMPLETED|Phase ll by Stratum||46
3134105|NCT01699789|3859088|FG001|NOT COMPLETED|Overall Study||126
3134106|NCT01699815|3859098|FG000|STARTED|Overall Study||62
3134107|NCT01699815|3859099|FG001|STARTED|Overall Study||64
3134108|NCT01699815|3859098|FG000|COMPLETED|Overall Study||57
3134109|NCT01699815|3859099|FG001|COMPLETED|Overall Study||56
3134110|NCT01699815|3859098|FG000|NOT COMPLETED|Overall Study||5
3134111|NCT01699815|3859099|FG001|NOT COMPLETED|Overall Study||8
3134112|NCT01699867|3859105|FG000|STARTED|Overall Study||50
3134113|NCT01699867|3859105|FG000|COMPLETED|Overall Study||47
3134114|NCT01699867|3859105|FG000|NOT COMPLETED|Overall Study||3
3134115|NCT01700036|3859109|FG000|STARTED|Overall Study||40
3134116|NCT01700036|3859109|FG000|COMPLETED|Overall Study||40
3162853|NCT01881113|3890311|FG001|COMPLETED|Overall Study||44
3162854|NCT01881113|3890310|FG000|NOT COMPLETED|Overall Study||8
3162855|NCT01881113|3890311|FG001|NOT COMPLETED|Overall Study||6
3162856|NCT01881126|3890319|FG000|STARTED|Overall Study||47
3162857|NCT01881126|3890320|FG001|STARTED|Overall Study||46
3162858|NCT01881126|3890319|FG000|COMPLETED|Overall Study||46
3162859|NCT01881126|3890320|FG001|COMPLETED|Overall Study||44
3061943|NCT01275300|3782659|FG000|STARTED|1st Intervention (5 Days)||5
3162860|NCT01881126|3890319|FG000|NOT COMPLETED|Overall Study||1
3162861|NCT01881126|3890320|FG001|NOT COMPLETED|Overall Study||2
3162862|NCT01881230|3890329|FG000|STARTED|Overall Study||61
3162863|NCT01881230|3890330|FG001|STARTED|Overall Study||64
3162864|NCT01881230|3890331|FG002|STARTED|Overall Study||66
3162865|NCT01881230|3890329|FG000|Safety Population|Overall Study|Safety Population = randomized who received at least 1 dose of Investigational Product (IP)|60
3061944|NCT01275300|3782660|FG001|STARTED|1st Intervention (5 Days)||4
3061945|NCT01275300|3782659|FG000|COMPLETED|1st Intervention (5 Days)||5
3061946|NCT01275300|3782660|FG001|COMPLETED|1st Intervention (5 Days)||4
3061947|NCT01275300|3782659|FG000|NOT COMPLETED|1st Intervention (5 Days)||0
3061948|NCT01275300|3782660|FG001|NOT COMPLETED|1st Intervention (5 Days)||0
3061949|NCT01275300|3782659|FG000|STARTED|Washout (14 Days)||5
3061950|NCT01275300|3782660|FG001|STARTED|Washout (14 Days)||4
3061951|NCT01275300|3782659|FG000|COMPLETED|Washout (14 Days)||5
3061952|NCT01275300|3782660|FG001|COMPLETED|Washout (14 Days)||4
3061953|NCT01275300|3782659|FG000|NOT COMPLETED|Washout (14 Days)||0
3061954|NCT01275300|3782660|FG001|NOT COMPLETED|Washout (14 Days)||0
3162866|NCT01881230|3890330|FG001|Safety Population|Overall Study|Safety Population = randomized who received at least 1 dose of IP|64
3162867|NCT01881230|3890331|FG002|Safety Population|Overall Study|Safety Population = randomized who received at least 1 dose of IP|64
3162868|NCT01881230|3890329|FG000|Treatment Discontinued|Overall Study|Treatment Duration=PD, toxicity, radiation/removal of lesions, consent withdrawal, doctor decision|60
3162869|NCT01881230|3890330|FG001|Treatment Discontinued|Overall Study|Treatment Duration=PD, toxicity, radiation/removal of lesions, consent withdrawal, doctor decision|64
3162870|NCT01881230|3890331|FG002|Treatment Discontinued|Overall Study|Treatment Duration=PD, toxicity, radiation/removal of lesions, consent withdrawal, doctor decision|64
3162871|NCT01881230|3890329|FG000|COMPLETED|Overall Study|Not applicable according to the study design|0
3162872|NCT01881230|3890330|FG001|COMPLETED|Overall Study|Not applicable according to the study design|0
3162873|NCT01881230|3890331|FG002|COMPLETED|Overall Study|Not applicable according to the study design|0
3162874|NCT01881230|3890329|FG000|NOT COMPLETED|Overall Study||61
3162875|NCT01881230|3890330|FG001|NOT COMPLETED|Overall Study||64
3162876|NCT01881230|3890331|FG002|NOT COMPLETED|Overall Study||66
3162877|NCT01881373|3890342|FG000|STARTED|Baseline|Cross-sectional sample|1517
3061955|NCT01275300|3782659|FG000|STARTED|2nd Intervention(5 Days)||5
3061956|NCT01275300|3782660|FG001|STARTED|2nd Intervention(5 Days)||4
3061957|NCT01275300|3782659|FG000|COMPLETED|2nd Intervention(5 Days)||5
3061958|NCT01275300|3782660|FG001|COMPLETED|2nd Intervention(5 Days)||4
3061959|NCT01275300|3782659|FG000|NOT COMPLETED|2nd Intervention(5 Days)||0
3061960|NCT01275300|3782660|FG001|NOT COMPLETED|2nd Intervention(5 Days)||0
3061961|NCT01275300|3782659|FG000|STARTED|Washout (14 Days)||5
3061962|NCT01275300|3782660|FG001|STARTED|Washout (14 Days)||4
3061963|NCT01275300|3782659|FG000|COMPLETED|Washout (14 Days)||5
3061964|NCT01275300|3782660|FG001|COMPLETED|Washout (14 Days)||4
3061965|NCT01275300|3782659|FG000|NOT COMPLETED|Washout (14 Days)||0
3061966|NCT01275300|3782660|FG001|NOT COMPLETED|Washout (14 Days)||0
3061967|NCT01275300|3782659|FG000|STARTED|Phase 2: Open-label 6days)||5
3061968|NCT01275300|3782660|FG001|STARTED|Phase 2: Open-label 6days)||4
3061969|NCT01275300|3782659|FG000|COMPLETED|Phase 2: Open-label 6days)||5
3061970|NCT01275300|3782660|FG001|COMPLETED|Phase 2: Open-label 6days)||4
3061971|NCT01275300|3782659|FG000|NOT COMPLETED|Phase 2: Open-label 6days)||0
3061972|NCT01275300|3782660|FG001|NOT COMPLETED|Phase 2: Open-label 6days)||0
3061973|NCT01275313|3782668|FG000|STARTED|Overall Study||127
3061974|NCT01275313|3782669|FG001|STARTED|Overall Study||131
3061975|NCT01275313|3782668|FG000|COMPLETED|Overall Study||102
3061976|NCT01275313|3782669|FG001|COMPLETED|Overall Study||79
3061977|NCT01275313|3782668|FG000|NOT COMPLETED|Overall Study||25
3061978|NCT01275313|3782669|FG001|NOT COMPLETED|Overall Study||52
3061979|NCT01275339|3782679|FG000|STARTED|Overall Study||2
3061980|NCT01275339|3782680|FG001|STARTED|Overall Study||0
3061981|NCT01275339|3782681|FG002|STARTED|Overall Study||4
3061982|NCT01275339|3782682|FG003|STARTED|Overall Study||4
3061983|NCT01275339|3782679|FG000|COMPLETED|Overall Study||1
3061984|NCT01275339|3782680|FG001|COMPLETED|Overall Study||0
3061985|NCT01275339|3782681|FG002|COMPLETED|Overall Study||3
3061986|NCT01275339|3782682|FG003|COMPLETED|Overall Study||4
3061987|NCT01275339|3782679|FG000|NOT COMPLETED|Overall Study||1
3061988|NCT01275339|3782680|FG001|NOT COMPLETED|Overall Study||0
3061989|NCT01275339|3782681|FG002|NOT COMPLETED|Overall Study||1
3061990|NCT01275339|3782682|FG003|NOT COMPLETED|Overall Study||0
3061991|NCT01275365|3782696|FG000|STARTED|Overall Study||24
3061992|NCT01275365|3782697|FG001|STARTED|Overall Study||24
3061993|NCT01275365|3782698|FG002|STARTED|Overall Study||22
3061994|NCT01275365|3782699|FG003|STARTED|Overall Study||22
3061995|NCT01275365|3782696|FG000|COMPLETED|Overall Study||21
3061996|NCT01275365|3782697|FG001|COMPLETED|Overall Study||21
3061997|NCT01275365|3782698|FG002|COMPLETED|Overall Study||17
3061998|NCT01275365|3782699|FG003|COMPLETED|Overall Study||19
3061999|NCT01275365|3782696|FG000|NOT COMPLETED|Overall Study||3
3062000|NCT01275365|3782697|FG001|NOT COMPLETED|Overall Study||3
3062001|NCT01275365|3782698|FG002|NOT COMPLETED|Overall Study||5
3062002|NCT01275365|3782699|FG003|NOT COMPLETED|Overall Study||3
3062003|NCT01275430|3782709|FG000|STARTED|Overall Study||27
3062004|NCT01275430|3782709|FG000|COMPLETED|Overall Study||18
3062005|NCT01275430|3782709|FG000|NOT COMPLETED|Overall Study||9
3062006|NCT01275586|3782714|FG000|STARTED|Overall Study||6
3062007|NCT01275586|3782714|FG000|COMPLETED|Overall Study||3
3062008|NCT01275586|3782714|FG000|NOT COMPLETED|Overall Study||3
3062009|NCT01275625|3782718|FG000|STARTED|Overall Study||77
3062010|NCT01275625|3782718|FG000|Treated|Overall Study||77
3062011|NCT01275625|3782718|FG000|COMPLETED|Overall Study||64
3062012|NCT01275625|3782718|FG000|NOT COMPLETED|Overall Study||13
3062013|NCT01275664|3782722|FG000|STARTED|Overall Study||4
3062014|NCT01275664|3782722|FG000|COMPLETED|Overall Study||4
3062015|NCT01275664|3782722|FG000|NOT COMPLETED|Overall Study||0
3062016|NCT01275755|3782728|FG000|STARTED|Run-in Placebo Period||41
3062017|NCT01275755|3782729|FG001|STARTED|Run-in Placebo Period||40
3062018|NCT01275755|3782728|FG000|COMPLETED|Run-in Placebo Period||41
3062019|NCT01275755|3782729|FG001|COMPLETED|Run-in Placebo Period||40
3062020|NCT01275755|3782728|FG000|NOT COMPLETED|Run-in Placebo Period||0
3062021|NCT01275755|3782729|FG001|NOT COMPLETED|Run-in Placebo Period||0
3062022|NCT01275755|3782728|FG000|STARTED|Double-blind Treatment Period||41
3062023|NCT01275755|3782729|FG001|STARTED|Double-blind Treatment Period||40
3062024|NCT01275755|3782728|FG000|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||41
3062025|NCT01275755|3782729|FG001|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||40
3062026|NCT01275755|3782728|FG000|COMPLETED|Double-blind Treatment Period||39
3062027|NCT01275755|3782729|FG001|COMPLETED|Double-blind Treatment Period||37
3062028|NCT01275755|3782728|FG000|NOT COMPLETED|Double-blind Treatment Period||2
3062029|NCT01275755|3782729|FG001|NOT COMPLETED|Double-blind Treatment Period||3
3062030|NCT01275755|3782728|FG000|STARTED|Run-out Placebo Period||39
3062031|NCT01275755|3782729|FG001|STARTED|Run-out Placebo Period||37
3062032|NCT01275755|3782728|FG000|COMPLETED|Run-out Placebo Period||38
3062033|NCT01275755|3782729|FG001|COMPLETED|Run-out Placebo Period||37
3062034|NCT01275755|3782728|FG000|NOT COMPLETED|Run-out Placebo Period||1
3062035|NCT01275755|3782729|FG001|NOT COMPLETED|Run-out Placebo Period||0
3062036|NCT01275833|3782737|FG000|STARTED|Overall Study||1
3062037|NCT01275833|3782738|FG001|STARTED|Overall Study||1
3062038|NCT01275833|3782737|FG000|COMPLETED|Overall Study||0
3062039|NCT01275833|3782738|FG001|COMPLETED|Overall Study||0
3062040|NCT01275833|3782737|FG000|NOT COMPLETED|Overall Study||1
3062041|NCT01275833|3782738|FG001|NOT COMPLETED|Overall Study||1
3062042|NCT01276041|3782744|FG000|STARTED|Overall Study||70
3062043|NCT01276041|3782744|FG000|COMPLETED|Overall Study||67
3062044|NCT01276041|3782744|FG000|NOT COMPLETED|Overall Study||3
3062045|NCT01276106|3782752|FG000|STARTED|Overall Study||65
3062046|NCT01276106|3782753|FG001|STARTED|Overall Study||64
3062047|NCT01276106|3782754|FG002|STARTED|Overall Study||65
3062048|NCT01276106|3782755|FG003|STARTED|Overall Study||65
3062049|NCT01276106|3782752|FG000|COMPLETED|Overall Study||53
3062050|NCT01276106|3782753|FG001|COMPLETED|Overall Study||55
3062051|NCT01276106|3782754|FG002|COMPLETED|Overall Study||49
3062052|NCT01276106|3782755|FG003|COMPLETED|Overall Study||52
3062053|NCT01276106|3782752|FG000|NOT COMPLETED|Overall Study||12
3062054|NCT01276106|3782753|FG001|NOT COMPLETED|Overall Study||9
3062055|NCT01276106|3782754|FG002|NOT COMPLETED|Overall Study||16
3062056|NCT01276106|3782755|FG003|NOT COMPLETED|Overall Study||13
3062057|NCT01276171|3782768|FG000|STARTED|Overall Study||249
3062058|NCT01276171|3782769|FG001|STARTED|Overall Study||244
3062059|NCT01276171|3782770|FG002|STARTED|Overall Study||256
3062060|NCT01276171|3782768|FG000|COMPLETED|Overall Study||249
3062061|NCT01276171|3782769|FG001|COMPLETED|Overall Study||244
3062062|NCT01276171|3782770|FG002|COMPLETED|Overall Study||256
3062063|NCT01276171|3782768|FG000|NOT COMPLETED|Overall Study||0
3062064|NCT01276171|3782769|FG001|NOT COMPLETED|Overall Study||0
3062065|NCT01276171|3782770|FG002|NOT COMPLETED|Overall Study||0
3062066|NCT01276184|3782780|FG000|STARTED|Overall Study||13
3062067|NCT01276184|3782781|FG001|STARTED|Overall Study||9
3062068|NCT01276184|3782780|FG000|COMPLETED|Overall Study||13
3062069|NCT01276184|3782781|FG001|COMPLETED|Overall Study||9
3062070|NCT01276184|3782780|FG000|NOT COMPLETED|Overall Study||0
3062071|NCT01276184|3782781|FG001|NOT COMPLETED|Overall Study||0
3062072|NCT01276197|3782789|FG000|STARTED|Overall Study||308
3062073|NCT01276197|3782790|FG001|STARTED|Overall Study||310
3062074|NCT01276197|3782789|FG000|COMPLETED|Overall Study||200
3062075|NCT01276197|3782790|FG001|COMPLETED|Overall Study||200
3062076|NCT01276197|3782789|FG000|NOT COMPLETED|Overall Study||108
3062077|NCT01276197|3782790|FG001|NOT COMPLETED|Overall Study||110
3062078|NCT01276223|3782799|FG000|STARTED|Overall Study||78
3062079|NCT01276223|3782800|FG001|STARTED|Overall Study||107
3062080|NCT01276223|3782801|FG002|STARTED|Overall Study||104
3062081|NCT01276223|3782799|FG000|COMPLETED|Overall Study||67
3062082|NCT01276223|3782800|FG001|COMPLETED|Overall Study||103
3062083|NCT01276223|3782801|FG002|COMPLETED|Overall Study||101
3062084|NCT01276223|3782799|FG000|NOT COMPLETED|Overall Study||11
3062085|NCT01276223|3782800|FG001|NOT COMPLETED|Overall Study||4
3062086|NCT01276223|3782801|FG002|NOT COMPLETED|Overall Study||3
3062087|NCT01276236|3782808|FG000|STARTED|Overall Study||13
3062088|NCT01276236|3782808|FG000|Week 36 Visit|Overall Study||13
3062089|NCT01276236|3782808|FG000|Week 56 Visit|Overall Study||9
3062090|NCT01276236|3782808|FG000|Week 76 Visit|Overall Study||8
3062091|NCT01276236|3782808|FG000|COMPLETED|Overall Study||7
3062092|NCT01276236|3782808|FG000|NOT COMPLETED|Overall Study||6
3062093|NCT01276288|3782812|FG000|STARTED|Overall Study||7
3062094|NCT01276288|3782813|FG001|STARTED|Overall Study||6
3062095|NCT01276288|3782814|FG002|STARTED|Overall Study||5
3062096|NCT01276288|3782815|FG003|STARTED|Overall Study||5
3062097|NCT01276288|3782812|FG000|Received EMPA|Overall Study||6
3284105|NCT02761733|4017871|FG002|STARTED|Overall Study||60
3284106|NCT02761733|4017872|FG003|STARTED|Overall Study||60
3284107|NCT02761733|4017869|FG000|9/30/2014|Overall Study||53
3284108|NCT02761733|4017870|FG001|9/30/2014|Overall Study||56
3284109|NCT02761733|4017871|FG002|9/30/2014|Overall Study||48
3284110|NCT02761733|4017872|FG003|9/30/2014|Overall Study||55
3062098|NCT01276288|3782813|FG001|Received EMPA|Overall Study||5
3062099|NCT01276288|3782814|FG002|Received EMPA|Overall Study||5
3062100|NCT01276288|3782815|FG003|Received EMPA|Overall Study||5
3062101|NCT01276288|3782812|FG000|Received EMPA+HCT|Overall Study||5
3062102|NCT01276288|3782813|FG001|Received EMPA+HCT|Overall Study||5
3062103|NCT01276288|3782814|FG002|Received EMPA+HCT|Overall Study||0
3062104|NCT01276288|3782815|FG003|Received EMPA+HCT|Overall Study||0
3062105|NCT01276288|3782812|FG000|Received EMPA+TOR|Overall Study||0
3062106|NCT01276288|3782813|FG001|Received EMPA+TOR|Overall Study||0
3062107|NCT01276288|3782814|FG002|Received EMPA+TOR|Overall Study||5
3062108|NCT01276288|3782815|FG003|Received EMPA+TOR|Overall Study||5
3062109|NCT01276288|3782812|FG000|COMPLETED|Overall Study||5
3062110|NCT01276288|3782813|FG001|COMPLETED|Overall Study||5
3062111|NCT01276288|3782814|FG002|COMPLETED|Overall Study||5
3062112|NCT01276288|3782815|FG003|COMPLETED|Overall Study||5
3062113|NCT01276288|3782812|FG000|NOT COMPLETED|Overall Study||2
3062114|NCT01276288|3782813|FG001|NOT COMPLETED|Overall Study||1
3062115|NCT01276288|3782814|FG002|NOT COMPLETED|Overall Study||0
3062116|NCT01276288|3782815|FG003|NOT COMPLETED|Overall Study||0
3062117|NCT01276301|3782837|FG000|STARTED|First Intervention||8
3062118|NCT01276301|3782838|FG001|STARTED|First Intervention||8
3062119|NCT01276301|3782837|FG000|COMPLETED|First Intervention||8
3062120|NCT01276301|3782838|FG001|COMPLETED|First Intervention||8
3062121|NCT01276301|3782837|FG000|NOT COMPLETED|First Intervention||0
3062122|NCT01276301|3782838|FG001|NOT COMPLETED|First Intervention||0
3062123|NCT01276301|3782837|FG000|STARTED|Washout Period of 7 Days||8
3062124|NCT01276301|3782838|FG001|STARTED|Washout Period of 7 Days||8
3062125|NCT01276301|3782837|FG000|COMPLETED|Washout Period of 7 Days||8
3062126|NCT01276301|3782838|FG001|COMPLETED|Washout Period of 7 Days||8
3062127|NCT01276301|3782837|FG000|NOT COMPLETED|Washout Period of 7 Days||0
3062128|NCT01276301|3782838|FG001|NOT COMPLETED|Washout Period of 7 Days||0
3062129|NCT01276301|3782837|FG000|STARTED|Second Intervention||8
3062130|NCT01276301|3782838|FG001|STARTED|Second Intervention||8
3062131|NCT01276301|3782837|FG000|COMPLETED|Second Intervention||8
3062132|NCT01276301|3782838|FG001|COMPLETED|Second Intervention||8
3062133|NCT01276301|3782837|FG000|NOT COMPLETED|Second Intervention||0
3062134|NCT01276301|3782838|FG001|NOT COMPLETED|Second Intervention||0
3062135|NCT01276314|3782849|FG000|STARTED|Overall Study||48
3062136|NCT01276314|3782850|FG001|STARTED|Overall Study||43
3062137|NCT01276314|3782851|FG002|STARTED|Overall Study||22
3062138|NCT01276314|3782852|FG003|STARTED|Overall Study||22
3062139|NCT01276314|3782849|FG000|COMPLETED|Overall Study||38
3062140|NCT01276314|3782850|FG001|COMPLETED|Overall Study||33
3062141|NCT01276314|3782851|FG002|COMPLETED|Overall Study||18
3062142|NCT01276314|3782852|FG003|COMPLETED|Overall Study||17
3062143|NCT01276314|3782849|FG000|NOT COMPLETED|Overall Study||10
3062144|NCT01276314|3782850|FG001|NOT COMPLETED|Overall Study||10
3062145|NCT01276314|3782851|FG002|NOT COMPLETED|Overall Study||4
3062146|NCT01276314|3782852|FG003|NOT COMPLETED|Overall Study||5
3062147|NCT01276327|3782864|FG000|STARTED|Overall Study||32
3062148|NCT01276327|3782865|FG001|STARTED|Overall Study||32
3062149|NCT01276327|3782864|FG000|COMPLETED|Overall Study||30
3062150|NCT01276327|3782865|FG001|COMPLETED|Overall Study||29
3062151|NCT01276327|3782864|FG000|NOT COMPLETED|Overall Study||2
3062152|NCT01276327|3782865|FG001|NOT COMPLETED|Overall Study||3
3062153|NCT01276353|3782873|FG000|STARTED|Double-blind||22
3062154|NCT01276353|3782874|FG001|STARTED|Double-blind||23
3062155|NCT01276353|3782873|FG000|COMPLETED|Double-blind||19
3062156|NCT01276353|3782874|FG001|COMPLETED|Double-blind||23
3062157|NCT01276353|3782873|FG000|NOT COMPLETED|Double-blind||3
3062158|NCT01276353|3782874|FG001|NOT COMPLETED|Double-blind||0
3062159|NCT01276353|3782873|FG000|STARTED|Extension||19
3062160|NCT01276353|3782874|FG001|STARTED|Extension||23
3062161|NCT01276353|3782873|FG000|COMPLETED|Extension||12
3062162|NCT01276353|3782874|FG001|COMPLETED|Extension||14
3062163|NCT01276353|3782873|FG000|NOT COMPLETED|Extension||7
3062164|NCT01276353|3782874|FG001|NOT COMPLETED|Extension||9
3062165|NCT01276379|3782886|FG000|STARTED|Overall Study||221
3062166|NCT01276379|3782886|FG000|COMPLETED|Overall Study||181
3062167|NCT01276379|3782886|FG000|NOT COMPLETED|Overall Study||40
3062168|NCT01276457|3782894|FG000|STARTED|Core Study||142
3062169|NCT01276457|3782895|FG001|STARTED|Core Study||143
3062170|NCT01276457|3782894|FG000|COMPLETED|Core Study||129
3062171|NCT01276457|3782895|FG001|COMPLETED|Core Study||123
3062172|NCT01276457|3782894|FG000|NOT COMPLETED|Core Study||13
3062173|NCT01276457|3782895|FG001|NOT COMPLETED|Core Study||20
3062174|NCT01276457|3782894|FG000|STARTED|Extension Study||111
3062175|NCT01276457|3782895|FG001|STARTED|Extension Study||112
3062176|NCT01276457|3782894|FG000|COMPLETED|Extension Study||105
3062177|NCT01276457|3782895|FG001|COMPLETED|Extension Study||110
3062178|NCT01276457|3782894|FG000|NOT COMPLETED|Extension Study||6
3062179|NCT01276457|3782895|FG001|NOT COMPLETED|Extension Study||2
3062180|NCT01276509|3782905|FG000|STARTED|Overall Study||66
3062181|NCT01276509|3782906|FG001|STARTED|Overall Study||65
3062182|NCT01276509|3782907|FG002|STARTED|Overall Study||68
3062183|NCT01276509|3782908|FG003|STARTED|Overall Study||63
3062184|NCT01276509|3782905|FG000|COMPLETED|Overall Study||53
3062185|NCT01276509|3782906|FG001|COMPLETED|Overall Study||53
3062186|NCT01276509|3782907|FG002|COMPLETED|Overall Study||63
3062187|NCT01276509|3782908|FG003|COMPLETED|Overall Study||58
3062188|NCT01276509|3782905|FG000|NOT COMPLETED|Overall Study||13
3062189|NCT01276509|3782906|FG001|NOT COMPLETED|Overall Study||12
3062190|NCT01276509|3782907|FG002|NOT COMPLETED|Overall Study||5
3062191|NCT01276509|3782908|FG003|NOT COMPLETED|Overall Study||5
3062192|NCT01276535|3782918|FG000|STARTED|Overall Study||12
3062193|NCT01276535|3782918|FG000|COMPLETED|Overall Study||12
3062194|NCT01276535|3782918|FG000|NOT COMPLETED|Overall Study||0
3062195|NCT01276639|3782925|FG000|STARTED|Week 0 to 16||363
3062196|NCT01276639|3782926|FG001|STARTED|Week 0 to 16||361
3062197|NCT01276639|3782927|FG002|STARTED|Week 0 to 16||177
3062198|NCT01276639|3782928|FG003|STARTED|Week 0 to 16||0
3062199|NCT01276639|3782929|FG004|STARTED|Week 0 to 16||0
3062200|NCT01276639|3782925|FG000|Treated|Week 0 to 16||363
3062201|NCT01276639|3782926|FG001|Treated|Week 0 to 16||360
3062202|NCT01276639|3782927|FG002|Treated|Week 0 to 16||177
3062203|NCT01276639|3782928|FG003|Treated|Week 0 to 16||0
3062204|NCT01276639|3782929|FG004|Treated|Week 0 to 16||0
3062205|NCT01276639|3782925|FG000|COMPLETED|Week 0 to 16||313
3062206|NCT01276639|3782926|FG001|COMPLETED|Week 0 to 16||320
3062207|NCT01276639|3782927|FG002|COMPLETED|Week 0 to 16||132
3062208|NCT01276639|3782928|FG003|COMPLETED|Week 0 to 16||0
3062209|NCT01276639|3782929|FG004|COMPLETED|Week 0 to 16||0
3062210|NCT01276639|3782925|FG000|NOT COMPLETED|Week 0 to 16||50
3062211|NCT01276639|3782926|FG001|NOT COMPLETED|Week 0 to 16||41
3062212|NCT01276639|3782927|FG002|NOT COMPLETED|Week 0 to 16||45
3062213|NCT01276639|3782928|FG003|NOT COMPLETED|Week 0 to 16||0
3062214|NCT01276639|3782929|FG004|NOT COMPLETED|Week 0 to 16||0
3062215|NCT01276639|3782925|FG000|STARTED|Week 16 to 52||313
3062216|NCT01276639|3782926|FG001|STARTED|Week 16 to 52||320
3062217|NCT01276639|3782927|FG002|STARTED|Week 16 to 52||0
3062218|NCT01276639|3782928|FG003|STARTED|Week 16 to 52||66
3062219|NCT01276639|3782929|FG004|STARTED|Week 16 to 52||66
3062220|NCT01276639|3782925|FG000|COMPLETED|Week 16 to 52||186
3062221|NCT01276639|3782926|FG001|COMPLETED|Week 16 to 52||219
3062222|NCT01276639|3782927|FG002|COMPLETED|Week 16 to 52||0
3062223|NCT01276639|3782928|FG003|COMPLETED|Week 16 to 52||50
3062224|NCT01276639|3782929|FG004|COMPLETED|Week 16 to 52||45
3062225|NCT01276639|3782925|FG000|NOT COMPLETED|Week 16 to 52||127
3062226|NCT01276639|3782926|FG001|NOT COMPLETED|Week 16 to 52||101
3062227|NCT01276639|3782927|FG002|NOT COMPLETED|Week 16 to 52||0
3062228|NCT01276639|3782928|FG003|NOT COMPLETED|Week 16 to 52||16
3062229|NCT01276639|3782929|FG004|NOT COMPLETED|Week 16 to 52||21
3062230|NCT01276652|3782947|FG000|STARTED|Period 1: Randomization||9
3062231|NCT01276652|3782948|FG001|STARTED|Period 1: Randomization||8
3062232|NCT01276652|3782949|FG002|STARTED|Period 1: Randomization|No subjects were enrolled in this arm during Period 1.|0
3062233|NCT01276652|3782947|FG000|COMPLETED|Period 1: Randomization||9
3062234|NCT01276652|3782948|FG001|COMPLETED|Period 1: Randomization||8
3062235|NCT01276652|3782949|FG002|COMPLETED|Period 1: Randomization||0
3062236|NCT01276652|3782947|FG000|NOT COMPLETED|Period 1: Randomization||0
3062237|NCT01276652|3782948|FG001|NOT COMPLETED|Period 1: Randomization||0
3062238|NCT01276652|3782949|FG002|NOT COMPLETED|Period 1: Randomization||0
3062239|NCT01276652|3782947|FG000|STARTED|Period 2: Observational||9
3062240|NCT01276652|3782948|FG001|STARTED|Period 2: Observational||8
3062241|NCT01276652|3782949|FG002|STARTED|Period 2: Observational|Subjects were only enrolled in the Observational arm during Period 2.|5
3062242|NCT01276652|3782947|FG000|COMPLETED|Period 2: Observational||9
3284111|NCT02761733|4017869|FG000|3/31/2015|Overall Study||48
3284112|NCT02761733|4017870|FG001|3/31/2015|Overall Study||47
3284113|NCT02761733|4017871|FG002|3/31/2015|Overall Study||43
3284114|NCT02761733|4017872|FG003|3/31/2015|Overall Study||50
3284115|NCT02761733|4017869|FG000|9/30/2015|Overall Study||40
3284116|NCT02761733|4017870|FG001|9/30/2015|Overall Study||44
3284117|NCT02761733|4017871|FG002|9/30/2015|Overall Study||33
3284118|NCT02761733|4017872|FG003|9/30/2015|Overall Study||50
3284119|NCT02761733|4017869|FG000|COMPLETED|Overall Study||30
3284120|NCT02761733|4017870|FG001|COMPLETED|Overall Study||39
3284121|NCT02761733|4017871|FG002|COMPLETED|Overall Study||33
3284122|NCT02761733|4017872|FG003|COMPLETED|Overall Study||45
3062243|NCT01276652|3782948|FG001|COMPLETED|Period 2: Observational||8
3062244|NCT01276652|3782949|FG002|COMPLETED|Period 2: Observational||5
3062245|NCT01276652|3782947|FG000|NOT COMPLETED|Period 2: Observational||0
3062246|NCT01276652|3782948|FG001|NOT COMPLETED|Period 2: Observational||0
3062247|NCT01276652|3782949|FG002|NOT COMPLETED|Period 2: Observational||0
3062248|NCT01276756|3782964|FG000|STARTED|Overall Study||50
3062249|NCT01276756|3782965|FG001|STARTED|Overall Study||50
3062250|NCT01276756|3782964|FG000|COMPLETED|Overall Study||45
3062251|NCT01276756|3782965|FG001|COMPLETED|Overall Study||48
3062252|NCT01276756|3782964|FG000|NOT COMPLETED|Overall Study||5
3062253|NCT01276756|3782965|FG001|NOT COMPLETED|Overall Study||2
3062254|NCT01276821|3782973|FG000|STARTED|Overall Study||50
3062255|NCT01276821|3782974|FG001|STARTED|Overall Study||50
3062256|NCT01276821|3782973|FG000|COMPLETED|Overall Study||50
3062257|NCT01276821|3782974|FG001|COMPLETED|Overall Study||49
3062258|NCT01276821|3782973|FG000|NOT COMPLETED|Overall Study||0
3062259|NCT01276821|3782974|FG001|NOT COMPLETED|Overall Study||1
3062260|NCT01276847|3782983|FG000|STARTED|Overall Study||10
3284123|NCT02761733|4017869|FG000|NOT COMPLETED|Overall Study||30
3062261|NCT01276847|3782984|FG001|STARTED|Overall Study||10
3062262|NCT01276847|3782985|FG002|STARTED|Overall Study||20
3062263|NCT01276847|3782983|FG000|COMPLETED|Overall Study||9
3162878|NCT01881373|3890343|FG001|STARTED|Baseline|Cross-sectional sample|1491
3162879|NCT01881373|3890344|FG002|STARTED|Baseline|Cross-sectional sample|1321
3162880|NCT01881373|3890342|FG000|COMPLETED|Baseline|Cross-sectional sample|1517
3062264|NCT01276847|3782984|FG001|COMPLETED|Overall Study||10
3062265|NCT01276847|3782985|FG002|COMPLETED|Overall Study||20
3062266|NCT01276847|3782983|FG000|NOT COMPLETED|Overall Study||1
3162881|NCT01881373|3890343|FG001|COMPLETED|Baseline|Cross-sectional sample|1491
3162882|NCT01881373|3890344|FG002|COMPLETED|Baseline|Cross-sectional sample|1321
3162883|NCT01881373|3890342|FG000|NOT COMPLETED|Baseline||0
3162884|NCT01881373|3890343|FG001|NOT COMPLETED|Baseline||0
3062267|NCT01276847|3782984|FG001|NOT COMPLETED|Overall Study||0
3062268|NCT01276847|3782985|FG002|NOT COMPLETED|Overall Study||0
3062269|NCT01276860|3782994|FG000|STARTED|Overall Study||5
3062270|NCT01276860|3782995|FG001|STARTED|Overall Study||2
3062271|NCT01276860|3782994|FG000|COMPLETED|Overall Study||5
3062272|NCT01276860|3782995|FG001|COMPLETED|Overall Study||2
3062273|NCT01276860|3782994|FG000|NOT COMPLETED|Overall Study||0
3062274|NCT01276860|3782995|FG001|NOT COMPLETED|Overall Study||0
3062275|NCT01277042|3783003|FG000|STARTED|Overall Study||606
3062276|NCT01277042|3783004|FG001|STARTED|Overall Study||606
3062277|NCT01277042|3783003|FG000|COMPLETED|Overall Study||598
3062278|NCT01277042|3783004|FG001|COMPLETED|Overall Study||601
3062279|NCT01277042|3783003|FG000|NOT COMPLETED|Overall Study||8
3062280|NCT01277042|3783004|FG001|NOT COMPLETED|Overall Study||5
3062281|NCT01277081|3783013|FG000|STARTED|Overall Study||100
3062282|NCT01277081|3783014|FG001|STARTED|Overall Study||100
3062283|NCT01277081|3783013|FG000|COMPLETED|Overall Study||100
3062284|NCT01277081|3783014|FG001|COMPLETED|Overall Study||100
3062285|NCT01277081|3783013|FG000|NOT COMPLETED|Overall Study||0
3062286|NCT01277081|3783014|FG001|NOT COMPLETED|Overall Study||0
3062287|NCT01277159|3783025|FG000|STARTED|Overall Study||21
3062288|NCT01277159|3783026|FG001|STARTED|Overall Study||22
3062289|NCT01277159|3783027|FG002|STARTED|Overall Study||22
3062290|NCT01277159|3783028|FG003|STARTED|Overall Study||22
3062291|NCT01277159|3783029|FG004|STARTED|Overall Study||21
3062292|NCT01277159|3783025|FG000|COMPLETED|Overall Study||17
3062293|NCT01277159|3783026|FG001|COMPLETED|Overall Study||21
3062294|NCT01277159|3783027|FG002|COMPLETED|Overall Study||19
3062295|NCT01277159|3783028|FG003|COMPLETED|Overall Study||19
3062296|NCT01277159|3783029|FG004|COMPLETED|Overall Study||16
3062297|NCT01277159|3783025|FG000|NOT COMPLETED|Overall Study||4
3062298|NCT01277159|3783026|FG001|NOT COMPLETED|Overall Study||1
3062299|NCT01277159|3783027|FG002|NOT COMPLETED|Overall Study||3
3062300|NCT01277159|3783028|FG003|NOT COMPLETED|Overall Study||3
3062301|NCT01277159|3783029|FG004|NOT COMPLETED|Overall Study||5
3062302|NCT01277302|3783044|FG000|STARTED|7-Month Fixed Treatment Period||85
3062303|NCT01277302|3783045|FG001|STARTED|7-Month Fixed Treatment Period||86
3062304|NCT01277302|3783046|FG002|STARTED|7-Month Fixed Treatment Period||31
3062305|NCT01277302|3783044|FG000|COMPLETED|7-Month Fixed Treatment Period||85
3062306|NCT01277302|3783045|FG001|COMPLETED|7-Month Fixed Treatment Period||86
3062307|NCT01277302|3783046|FG002|COMPLETED|7-Month Fixed Treatment Period||19
3062308|NCT01277302|3783044|FG000|NOT COMPLETED|7-Month Fixed Treatment Period||0
3062309|NCT01277302|3783045|FG001|NOT COMPLETED|7-Month Fixed Treatment Period||0
3062310|NCT01277302|3783046|FG002|NOT COMPLETED|7-Month Fixed Treatment Period||12
3062311|NCT01277302|3783044|FG000|STARTED|8-Month Alternate Dose Regimen Period||85
3062312|NCT01277302|3783045|FG001|STARTED|8-Month Alternate Dose Regimen Period||86
3062313|NCT01277302|3783046|FG002|STARTED|8-Month Alternate Dose Regimen Period||19
3062314|NCT01277302|3783044|FG000|COMPLETED|8-Month Alternate Dose Regimen Period||80
3062315|NCT01277302|3783045|FG001|COMPLETED|8-Month Alternate Dose Regimen Period||82
3062316|NCT01277302|3783046|FG002|COMPLETED|8-Month Alternate Dose Regimen Period||13
3062317|NCT01277302|3783044|FG000|NOT COMPLETED|8-Month Alternate Dose Regimen Period||5
3062318|NCT01277302|3783045|FG001|NOT COMPLETED|8-Month Alternate Dose Regimen Period||4
3062319|NCT01277302|3783046|FG002|NOT COMPLETED|8-Month Alternate Dose Regimen Period||6
3062320|NCT01277341|3783058|FG000|STARTED|Overall Study||150
3062321|NCT01277341|3783059|FG001|STARTED|Overall Study||150
3062322|NCT01277341|3783060|FG002|STARTED|Overall Study||149
3062323|NCT01277341|3783061|FG003|STARTED|Overall Study||152
3062324|NCT01277341|3783058|FG000|COMPLETED|Overall Study||146
3062325|NCT01277341|3783059|FG001|COMPLETED|Overall Study||145
3062326|NCT01277341|3783060|FG002|COMPLETED|Overall Study||145
3062327|NCT01277341|3783061|FG003|COMPLETED|Overall Study||146
3062328|NCT01277341|3783058|FG000|NOT COMPLETED|Overall Study||4
3062329|NCT01277341|3783059|FG001|NOT COMPLETED|Overall Study||5
3062330|NCT01277341|3783060|FG002|NOT COMPLETED|Overall Study||4
3062331|NCT01277341|3783061|FG003|NOT COMPLETED|Overall Study||6
3062332|NCT01277354|3783073|FG000|STARTED|Overall Study||1
3062333|NCT01277354|3783074|FG001|STARTED|Overall Study||1
3062334|NCT01277354|3783073|FG000|COMPLETED|Overall Study||1
3062335|NCT01277354|3783074|FG001|COMPLETED|Overall Study||1
3062336|NCT01277354|3783073|FG000|NOT COMPLETED|Overall Study||0
3062337|NCT01277354|3783074|FG001|NOT COMPLETED|Overall Study||0
3062338|NCT01277510|3783082|FG000|STARTED|Double-blind Phase||21
3062339|NCT01277510|3783083|FG001|STARTED|Double-blind Phase||22
3162885|NCT01881373|3890344|FG002|NOT COMPLETED|Baseline||0
3162886|NCT01881373|3890342|FG000|STARTED|24 Months|Cross-sectional sample, independent of sample at baseline|1342
3062340|NCT01277510|3783082|FG000|Received Investigational Product|Double-blind Phase||21
3062341|NCT01277510|3783083|FG001|Received Investigational Product|Double-blind Phase||22
3062342|NCT01277510|3783082|FG000|COMPLETED|Double-blind Phase|Completed investigational product|8
3062343|NCT01277510|3783083|FG001|COMPLETED|Double-blind Phase|Completed investigational product|4
3062344|NCT01277510|3783082|FG000|NOT COMPLETED|Double-blind Phase||13
3062345|NCT01277510|3783083|FG001|NOT COMPLETED|Double-blind Phase||18
3062346|NCT01277510|3783082|FG000|STARTED|Open-label Phase||8
3062347|NCT01277510|3783083|FG001|STARTED|Open-label Phase||4
3062348|NCT01277510|3783082|FG000|Received Investigational Product|Open-label Phase||6
3062349|NCT01277510|3783083|FG001|Received Investigational Product|Open-label Phase||4
3062350|NCT01277510|3783082|FG000|COMPLETED|Open-label Phase|Completed investigational product|1
3062351|NCT01277510|3783083|FG001|COMPLETED|Open-label Phase|Completed investigational product|1
3062352|NCT01277510|3783082|FG000|NOT COMPLETED|Open-label Phase||7
3062353|NCT01277510|3783083|FG001|NOT COMPLETED|Open-label Phase||3
3062354|NCT01277523|3783094|FG000|STARTED|Overall Study||135
3062355|NCT01277523|3783095|FG001|STARTED|Overall Study||127
3062356|NCT01277523|3783096|FG002|STARTED|Overall Study||130
3062357|NCT01277523|3783094|FG000|COMPLETED|Overall Study||132
3062358|NCT01277523|3783095|FG001|COMPLETED|Overall Study||126
3062359|NCT01277523|3783096|FG002|COMPLETED|Overall Study||130
3062360|NCT01277523|3783094|FG000|NOT COMPLETED|Overall Study||3
3062361|NCT01277523|3783095|FG001|NOT COMPLETED|Overall Study||1
3062362|NCT01277523|3783096|FG002|NOT COMPLETED|Overall Study||0
3062363|NCT01277549|3783106|FG000|STARTED|Overall Study||41
3062364|NCT01277549|3783107|FG001|STARTED|Overall Study||29
3062365|NCT01277549|3783106|FG000|COMPLETED|Overall Study||15
3062366|NCT01277549|3783107|FG001|COMPLETED|Overall Study||15
3062367|NCT01277549|3783106|FG000|NOT COMPLETED|Overall Study||26
3062368|NCT01277549|3783107|FG001|NOT COMPLETED|Overall Study||14
3062369|NCT01277601|3783120|FG000|STARTED|Overall Study||188
3062370|NCT01277601|3783121|FG001|STARTED|Overall Study||187
3062371|NCT01277601|3783122|FG002|STARTED|Overall Study||190
3062372|NCT01277601|3783123|FG003|STARTED|Overall Study||186
3062373|NCT01277601|3783120|FG000|COMPLETED|Overall Study||151
3062374|NCT01277601|3783121|FG001|COMPLETED|Overall Study||139
3062375|NCT01277601|3783122|FG002|COMPLETED|Overall Study||163
3062376|NCT01277601|3783123|FG003|COMPLETED|Overall Study||150
3062377|NCT01277601|3783120|FG000|NOT COMPLETED|Overall Study||37
3062378|NCT01277601|3783121|FG001|NOT COMPLETED|Overall Study||48
3062379|NCT01277601|3783122|FG002|NOT COMPLETED|Overall Study||27
3062380|NCT01277601|3783123|FG003|NOT COMPLETED|Overall Study||36
3062381|NCT01277666|3783153|FG000|STARTED|Overall Study||203
3062382|NCT01277666|3783154|FG001|STARTED|Overall Study||203
3062383|NCT01277666|3783155|FG002|STARTED|Overall Study||202
3062384|NCT01277666|3783153|FG000|COMPLETED|Overall Study||158
3062385|NCT01277666|3783154|FG001|COMPLETED|Overall Study||144
3062386|NCT01277666|3783155|FG002|COMPLETED|Overall Study||153
3062387|NCT01277666|3783153|FG000|NOT COMPLETED|Overall Study||45
3062388|NCT01277666|3783154|FG001|NOT COMPLETED|Overall Study||59
3062389|NCT01277666|3783155|FG002|NOT COMPLETED|Overall Study||49
3062390|NCT01277718|3783163|FG000|STARTED|Period 1 - First Intervention||10
3062391|NCT01277718|3783164|FG001|STARTED|Period 1 - First Intervention||10
3062392|NCT01277718|3783163|FG000|COMPLETED|Period 1 - First Intervention||10
3062393|NCT01277718|3783164|FG001|COMPLETED|Period 1 - First Intervention||10
3062394|NCT01277718|3783163|FG000|NOT COMPLETED|Period 1 - First Intervention||0
3062395|NCT01277718|3783164|FG001|NOT COMPLETED|Period 1 - First Intervention||0
3062396|NCT01277718|3783163|FG000|STARTED|Washout Period of 13 Days||10
3062397|NCT01277718|3783164|FG001|STARTED|Washout Period of 13 Days||10
3062398|NCT01277718|3783163|FG000|COMPLETED|Washout Period of 13 Days||10
3062399|NCT01277718|3783164|FG001|COMPLETED|Washout Period of 13 Days||10
3062400|NCT01277718|3783163|FG000|NOT COMPLETED|Washout Period of 13 Days||0
3062401|NCT01277718|3783164|FG001|NOT COMPLETED|Washout Period of 13 Days||0
3062402|NCT01277718|3783163|FG000|STARTED|Period 2 - Second Intervention||10
3062403|NCT01277718|3783164|FG001|STARTED|Period 2 - Second Intervention||10
3062404|NCT01277718|3783163|FG000|COMPLETED|Period 2 - Second Intervention||10
3062405|NCT01277718|3783164|FG001|COMPLETED|Period 2 - Second Intervention||7
3062406|NCT01277718|3783163|FG000|NOT COMPLETED|Period 2 - Second Intervention||0
3062407|NCT01277718|3783164|FG001|NOT COMPLETED|Period 2 - Second Intervention||3
3062408|NCT01277718|3783163|FG000|STARTED|Washout Period of 13 Days||10
3062409|NCT01277718|3783164|FG001|STARTED|Washout Period of 13 Days||7
3062410|NCT01277718|3783163|FG000|COMPLETED|Washout Period of 13 Days||10
3062411|NCT01277718|3783164|FG001|COMPLETED|Washout Period of 13 Days||7
3062412|NCT01277718|3783163|FG000|NOT COMPLETED|Washout Period of 13 Days||0
3062413|NCT01277718|3783164|FG001|NOT COMPLETED|Washout Period of 13 Days||0
3062414|NCT01277718|3783163|FG000|STARTED|Period 3 - Third Intervention||10
3062415|NCT01277718|3783164|FG001|STARTED|Period 3 - Third Intervention||7
3062416|NCT01277718|3783163|FG000|COMPLETED|Period 3 - Third Intervention||10
3062417|NCT01277718|3783164|FG001|COMPLETED|Period 3 - Third Intervention||7
3062418|NCT01277718|3783163|FG000|NOT COMPLETED|Period 3 - Third Intervention||0
3062419|NCT01277718|3783164|FG001|NOT COMPLETED|Period 3 - Third Intervention||0
3062420|NCT01277744|3783172|FG000|STARTED|Overall Study||22
3062421|NCT01277744|3783172|FG000|COMPLETED|Overall Study||20
3062422|NCT01277744|3783172|FG000|NOT COMPLETED|Overall Study||2
3062423|NCT01277757|3783176|FG000|STARTED|Overall Study||30
3062424|NCT01277757|3783176|FG000|COMPLETED|Overall Study||28
3062425|NCT01277757|3783176|FG000|NOT COMPLETED|Overall Study||2
3062426|NCT01277783|3783180|FG000|STARTED|Overall Study||138
3062427|NCT01277783|3783180|FG000|COMPLETED|Overall Study||138
3062428|NCT01277783|3783180|FG000|NOT COMPLETED|Overall Study||0
3062429|NCT01277861|3783187|FG000|STARTED|Overall Study||51
3062430|NCT01277861|3783188|FG001|STARTED|Overall Study||49
3062431|NCT01277861|3783187|FG000|COMPLETED|Overall Study||49
3062432|NCT01277861|3783188|FG001|COMPLETED|Overall Study||47
3062433|NCT01277861|3783187|FG000|NOT COMPLETED|Overall Study||2
3062434|NCT01277861|3783188|FG001|NOT COMPLETED|Overall Study||2
3062435|NCT01277887|3783198|FG000|STARTED|Pre-Quit Treatment Phase||9
3062436|NCT01277887|3783199|FG001|STARTED|Pre-Quit Treatment Phase||10
3062437|NCT01277887|3783198|FG000|Entered Study|Pre-Quit Treatment Phase||7
3062438|NCT01277887|3783199|FG001|Entered Study|Pre-Quit Treatment Phase||10
3062439|NCT01277887|3783198|FG000|COMPLETED|Pre-Quit Treatment Phase||6
3062440|NCT01277887|3783199|FG001|COMPLETED|Pre-Quit Treatment Phase||10
3062441|NCT01277887|3783198|FG000|NOT COMPLETED|Pre-Quit Treatment Phase||3
3062442|NCT01277887|3783199|FG001|NOT COMPLETED|Pre-Quit Treatment Phase||0
3062443|NCT01277887|3783198|FG000|STARTED|Post-Quit Treatment Phase||6
3062444|NCT01277887|3783199|FG001|STARTED|Post-Quit Treatment Phase||10
3062445|NCT01277887|3783198|FG000|COMPLETED|Post-Quit Treatment Phase||3
3062446|NCT01277887|3783199|FG001|COMPLETED|Post-Quit Treatment Phase||5
3062447|NCT01277887|3783198|FG000|NOT COMPLETED|Post-Quit Treatment Phase||3
3062448|NCT01277887|3783199|FG001|NOT COMPLETED|Post-Quit Treatment Phase||5
3062449|NCT01278030|3783207|FG000|STARTED|Overall Study||43
3062450|NCT01278030|3783208|FG001|STARTED|Overall Study||35
3062451|NCT01278030|3783207|FG000|COMPLETED|Overall Study||35
3062452|NCT01278030|3783208|FG001|COMPLETED|Overall Study||31
3062453|NCT01278030|3783207|FG000|NOT COMPLETED|Overall Study||8
3062454|NCT01278030|3783208|FG001|NOT COMPLETED|Overall Study||4
3062455|NCT01278160|3783216|FG000|STARTED|Overall Study||89
3062456|NCT01278160|3783217|FG001|STARTED|Overall Study||90
3062457|NCT01278160|3783216|FG000|COMPLETED|Overall Study||84
3062458|NCT01278160|3783217|FG001|COMPLETED|Overall Study||84
3062459|NCT01278160|3783216|FG000|NOT COMPLETED|Overall Study||5
3062460|NCT01278160|3783217|FG001|NOT COMPLETED|Overall Study||6
3062461|NCT01278173|3783223|FG000|STARTED|Overall Study||65
3062462|NCT01278173|3783223|FG000|COMPLETED|Overall Study||38
3062463|NCT01278173|3783223|FG000|NOT COMPLETED|Overall Study||27
3062464|NCT01278303|3783227|FG000|STARTED|Overall Study||82
3062465|NCT01278303|3783227|FG000|COMPLETED|Overall Study||82
3062466|NCT01278303|3783227|FG000|NOT COMPLETED|Overall Study||0
3062467|NCT01278342|3783234|FG000|STARTED|Overall Study||7
3062468|NCT01278342|3783235|FG001|STARTED|Overall Study||31
3062469|NCT01278342|3783236|FG002|STARTED|Overall Study||32
3062470|NCT01278342|3783234|FG000|COMPLETED|Overall Study||3
3062471|NCT01278342|3783235|FG001|COMPLETED|Overall Study||30
3062472|NCT01278342|3783236|FG002|COMPLETED|Overall Study||32
3062473|NCT01278342|3783234|FG000|NOT COMPLETED|Overall Study||4
3062474|NCT01278342|3783235|FG001|NOT COMPLETED|Overall Study||1
3062475|NCT01278342|3783236|FG002|NOT COMPLETED|Overall Study||0
3062476|NCT01278394|3783244|FG000|STARTED|Overall Study||29
3062477|NCT01278394|3783244|FG000|COMPLETED|Overall Study||28
3062478|NCT01278394|3783244|FG000|NOT COMPLETED|Overall Study||1
3062479|NCT01278407|3783251|FG000|STARTED|Confirmatory Phase||46
3062480|NCT01278407|3783252|FG001|STARTED|Confirmatory Phase||47
3062481|NCT01278407|3783253|FG002|STARTED|Confirmatory Phase||49
3062482|NCT01278407|3783254|FG003|STARTED|Confirmatory Phase||0
3062483|NCT01278407|3783255|FG004|STARTED|Confirmatory Phase||0
3062484|NCT01278407|3783251|FG000|COMPLETED|Confirmatory Phase||37
3062485|NCT01278407|3783252|FG001|COMPLETED|Confirmatory Phase||31
3062486|NCT01278407|3783253|FG002|COMPLETED|Confirmatory Phase||43
3062487|NCT01278407|3783254|FG003|COMPLETED|Confirmatory Phase||0
3062488|NCT01278407|3783255|FG004|COMPLETED|Confirmatory Phase||0
3062489|NCT01278407|3783251|FG000|NOT COMPLETED|Confirmatory Phase||9
3062490|NCT01278407|3783252|FG001|NOT COMPLETED|Confirmatory Phase||16
3062491|NCT01278407|3783253|FG002|NOT COMPLETED|Confirmatory Phase||6
3062492|NCT01278407|3783254|FG003|NOT COMPLETED|Confirmatory Phase||0
3062493|NCT01278407|3783255|FG004|NOT COMPLETED|Confirmatory Phase||0
3062494|NCT01278407|3783251|FG000|STARTED|Extension Phase||0
3062495|NCT01278407|3783252|FG001|STARTED|Extension Phase||0
3062496|NCT01278407|3783253|FG002|STARTED|Extension Phase||0
3062497|NCT01278407|3783254|FG003|STARTED|Extension Phase||46
3062498|NCT01278407|3783255|FG004|STARTED|Extension Phase||96
3062499|NCT01278407|3783251|FG000|COMPLETED|Extension Phase||0
3062500|NCT01278407|3783252|FG001|COMPLETED|Extension Phase||0
3062501|NCT01278407|3783253|FG002|COMPLETED|Extension Phase||0
3062502|NCT01278407|3783254|FG003|COMPLETED|Extension Phase||34
3062503|NCT01278407|3783255|FG004|COMPLETED|Extension Phase||66
3062504|NCT01278407|3783251|FG000|NOT COMPLETED|Extension Phase||0
3062505|NCT01278407|3783252|FG001|NOT COMPLETED|Extension Phase||0
3062506|NCT01278407|3783253|FG002|NOT COMPLETED|Extension Phase||0
3062507|NCT01278407|3783254|FG003|NOT COMPLETED|Extension Phase||12
3062508|NCT01278407|3783255|FG004|NOT COMPLETED|Extension Phase||30
3062509|NCT01278485|3783265|FG000|STARTED|Overall Study||719
3062510|NCT01278485|3783265|FG000|COMPLETED|Overall Study||719
3062511|NCT01278485|3783265|FG000|NOT COMPLETED|Overall Study||0
3062512|NCT01278615|3783269|FG000|STARTED|Overall Study||16
3062513|NCT01278615|3783269|FG000|COMPLETED|Overall Study||14
3062514|NCT01278615|3783269|FG000|NOT COMPLETED|Overall Study||2
3062515|NCT01278745|3783275|FG000|STARTED|Overall Study||89
3062516|NCT01278745|3783276|FG001|STARTED|Overall Study||74
3062517|NCT01278745|3783277|FG002|STARTED|Overall Study||121
3062518|NCT01278745|3783278|FG003|STARTED|Overall Study||78
3062519|NCT01278745|3783275|FG000|COMPLETED|Overall Study||84
3062520|NCT01278745|3783276|FG001|COMPLETED|Overall Study||68
3062521|NCT01278745|3783277|FG002|COMPLETED|Overall Study||0
3062522|NCT01278745|3783278|FG003|COMPLETED|Overall Study||0
3062523|NCT01278745|3783275|FG000|NOT COMPLETED|Overall Study||5
3062524|NCT01278745|3783276|FG001|NOT COMPLETED|Overall Study||6
3062525|NCT01278745|3783277|FG002|NOT COMPLETED|Overall Study||121
3062526|NCT01278745|3783278|FG003|NOT COMPLETED|Overall Study||78
3062527|NCT01278797|3783286|FG000|STARTED|Period 1||14
3062528|NCT01278797|3783287|FG001|STARTED|Period 1||14
3062529|NCT01278797|3783286|FG000|COMPLETED|Period 1||13
3062530|NCT01278797|3783287|FG001|COMPLETED|Period 1||13
3062531|NCT01278797|3783286|FG000|NOT COMPLETED|Period 1||1
3062532|NCT01278797|3783287|FG001|NOT COMPLETED|Period 1||1
3062533|NCT01278797|3783286|FG000|STARTED|Washout Period of 21 Days||13
3062534|NCT01278797|3783287|FG001|STARTED|Washout Period of 21 Days||13
3062535|NCT01278797|3783286|FG000|COMPLETED|Washout Period of 21 Days||13
3062536|NCT01278797|3783287|FG001|COMPLETED|Washout Period of 21 Days||13
3062537|NCT01278797|3783286|FG000|NOT COMPLETED|Washout Period of 21 Days||0
3062538|NCT01278797|3783287|FG001|NOT COMPLETED|Washout Period of 21 Days||0
3062539|NCT01278797|3783286|FG000|STARTED|Period 2||13
3062540|NCT01278797|3783287|FG001|STARTED|Period 2||13
3062541|NCT01278797|3783286|FG000|COMPLETED|Period 2||13
3062542|NCT01278797|3783287|FG001|COMPLETED|Period 2||13
3062543|NCT01278797|3783286|FG000|NOT COMPLETED|Period 2||0
3062544|NCT01278797|3783287|FG001|NOT COMPLETED|Period 2||0
3062545|NCT01278862|3783295|FG000|STARTED|Overall Study||45
3062546|NCT01278862|3783296|FG001|STARTED|Overall Study||43
3062547|NCT01278862|3783295|FG000|COMPLETED|Overall Study||44
3062548|NCT01278862|3783296|FG001|COMPLETED|Overall Study||42
3062549|NCT01278862|3783295|FG000|NOT COMPLETED|Overall Study||1
3062550|NCT01278862|3783296|FG001|NOT COMPLETED|Overall Study||1
3062551|NCT01278927|3783306|FG000|STARTED|Overall Study||180
3062552|NCT01278927|3783307|FG001|STARTED|Overall Study||178
3284124|NCT02761733|4017870|FG001|NOT COMPLETED|Overall Study||21
3284125|NCT02761733|4017871|FG002|NOT COMPLETED|Overall Study||27
3284126|NCT02761733|4017872|FG003|NOT COMPLETED|Overall Study||15
3062553|NCT01278927|3783308|FG002|STARTED|Overall Study||178
3062554|NCT01278927|3783309|FG003|STARTED|Overall Study||175
3062555|NCT01278927|3783306|FG000|COMPLETED|Overall Study||180
3062556|NCT01278927|3783307|FG001|COMPLETED|Overall Study||178
3062557|NCT01278927|3783308|FG002|COMPLETED|Overall Study||178
3062558|NCT01278927|3783309|FG003|COMPLETED|Overall Study||175
3062559|NCT01278927|3783306|FG000|NOT COMPLETED|Overall Study||0
3062560|NCT01278927|3783307|FG001|NOT COMPLETED|Overall Study||0
3062561|NCT01278927|3783308|FG002|NOT COMPLETED|Overall Study||0
3062562|NCT01278927|3783309|FG003|NOT COMPLETED|Overall Study||0
3062563|NCT01278953|3783322|FG000|STARTED|Overall Study||155
3062564|NCT01278953|3783323|FG001|STARTED|Overall Study||145
3062565|NCT01278953|3783322|FG000|COMPLETED|Overall Study||146
3062566|NCT01278953|3783323|FG001|COMPLETED|Overall Study||134
3062567|NCT01278953|3783322|FG000|NOT COMPLETED|Overall Study||9
3062568|NCT01278953|3783323|FG001|NOT COMPLETED|Overall Study||11
3062569|NCT01279044|3783332|FG000|STARTED|PHASE 1 - Formative||59
3062570|NCT01279044|3783333|FG001|STARTED|PHASE 1 - Formative|Participants who participated in the formative phase did not participate in the RCT.|0
3062571|NCT01279044|3783334|FG002|STARTED|PHASE 1 - Formative|Participants who participated in the formative phase did not participate in the RCT.|0
3062572|NCT01279044|3783332|FG000|COMPLETED|PHASE 1 - Formative||59
3062573|NCT01279044|3783333|FG001|COMPLETED|PHASE 1 - Formative|Participants who participated in the formative phase did not participate in the RCT.|0
3062574|NCT01279044|3783334|FG002|COMPLETED|PHASE 1 - Formative|Participants who participated in the formative phase did not participate in the RCT.|0
3062575|NCT01279044|3783332|FG000|NOT COMPLETED|PHASE 1 - Formative||0
3062576|NCT01279044|3783333|FG001|NOT COMPLETED|PHASE 1 - Formative||0
3062577|NCT01279044|3783334|FG002|NOT COMPLETED|PHASE 1 - Formative||0
3062578|NCT01279044|3783332|FG000|STARTED|PHASE 2 - Randmonized Controlled Trial|Participants who participated in the RCT did not participate in the formative phase.|0
3062579|NCT01279044|3783333|FG001|STARTED|PHASE 2 - Randmonized Controlled Trial||162
3062580|NCT01279044|3783334|FG002|STARTED|PHASE 2 - Randmonized Controlled Trial||164
3062581|NCT01279044|3783332|FG000|COMPLETED|PHASE 2 - Randmonized Controlled Trial|Participants who participated in the RCT did not participate in the formative phase.|0
3062582|NCT01279044|3783333|FG001|COMPLETED|PHASE 2 - Randmonized Controlled Trial||151
3062583|NCT01279044|3783334|FG002|COMPLETED|PHASE 2 - Randmonized Controlled Trial||161
3062584|NCT01279044|3783332|FG000|NOT COMPLETED|PHASE 2 - Randmonized Controlled Trial||0
3062585|NCT01279044|3783333|FG001|NOT COMPLETED|PHASE 2 - Randmonized Controlled Trial||11
3062586|NCT01279044|3783334|FG002|NOT COMPLETED|PHASE 2 - Randmonized Controlled Trial||3
3062587|NCT01279057|3783343|FG000|STARTED|Overall Study||288
3062588|NCT01279057|3783344|FG001|STARTED|Overall Study||292
3062589|NCT01279057|3783345|FG002|STARTED|Overall Study||147
3062590|NCT01279057|3783343|FG000|Per-Protocol (PPP) Population|Overall Study||257
3062591|NCT01279057|3783344|FG001|Per-Protocol (PPP) Population|Overall Study||245
3062592|NCT01279057|3783345|FG002|Per-Protocol (PPP) Population|Overall Study||126
3062593|NCT01279057|3783343|FG000|Intent-to-Treat (ITT) Population|Overall Study||284
3062594|NCT01279057|3783344|FG001|Intent-to-Treat (ITT) Population|Overall Study||285
3062595|NCT01279057|3783345|FG002|Intent-to-Treat (ITT) Population|Overall Study||144
3062596|NCT01279057|3783343|FG000|COMPLETED|Overall Study||282
3062597|NCT01279057|3783344|FG001|COMPLETED|Overall Study||287
3062598|NCT01279057|3783345|FG002|COMPLETED|Overall Study||144
3062599|NCT01279057|3783343|FG000|NOT COMPLETED|Overall Study||6
3062600|NCT01279057|3783344|FG001|NOT COMPLETED|Overall Study||5
3062601|NCT01279057|3783345|FG002|NOT COMPLETED|Overall Study||3
3062602|NCT01279070|3783355|FG000|STARTED|Overall Study|34 outpatients were randomly assigned to 32 sessions of REPYFLEC.|34
3062603|NCT01279070|3783356|FG001|STARTED|Overall Study|28 outpatients were randomly assigned to 32 sessions of leisure group.|28
3062604|NCT01279070|3783355|FG000|COMPLETED|Overall Study|5 outpatients left the treatment up to 2 months after starting REPYFLEC.|29
3062605|NCT01279070|3783356|FG001|COMPLETED|Overall Study|4 outpatients left the leisure group up to 2 months after starting Leisure group.|24
3062606|NCT01279070|3783355|FG000|NOT COMPLETED|Overall Study||5
3062607|NCT01279070|3783356|FG001|NOT COMPLETED|Overall Study||4
3062608|NCT01279109|3783368|FG000|STARTED|Overall Study||68
3062609|NCT01279109|3783369|FG001|STARTED|Overall Study||67
3062610|NCT01279109|3783368|FG000|COMPLETED|Overall Study||55
3062611|NCT01279109|3783369|FG001|COMPLETED|Overall Study||55
3062612|NCT01279109|3783368|FG000|NOT COMPLETED|Overall Study||13
3062613|NCT01279109|3783369|FG001|NOT COMPLETED|Overall Study||12
3062614|NCT01279187|3783377|FG000|STARTED|Overall Study||14
3062615|NCT01279187|3783378|FG001|STARTED|Overall Study||13
3062616|NCT01279187|3783377|FG000|COMPLETED|Overall Study||14
3062617|NCT01279187|3783378|FG001|COMPLETED|Overall Study||13
3062618|NCT01279187|3783377|FG000|NOT COMPLETED|Overall Study||0
3062619|NCT01279187|3783378|FG001|NOT COMPLETED|Overall Study||0
3062620|NCT01279200|3783386|FG000|STARTED|Overall Study||10
3062621|NCT01279200|3783387|FG001|STARTED|Overall Study||11
3062622|NCT01279200|3783386|FG000|COMPLETED|Overall Study||8
3162887|NCT01881373|3890343|FG001|STARTED|24 Months|Cross-sectional sample, independent of sample at baseline|1295
3162888|NCT01881373|3890344|FG002|STARTED|24 Months|Cross-sectional sample, independent of sample at baseline|1405
3162889|NCT01881373|3890342|FG000|COMPLETED|24 Months|Cross-sectional sample, independent of sample at baseline|1342
3162890|NCT01881373|3890343|FG001|COMPLETED|24 Months|Cross-sectional sample, independent of sample at baseline|1295
3162891|NCT01881373|3890344|FG002|COMPLETED|24 Months|Cross-sectional sample, independent of sample at baseline|1405
3162892|NCT01881373|3890342|FG000|NOT COMPLETED|24 Months||0
3162893|NCT01881373|3890343|FG001|NOT COMPLETED|24 Months||0
3162894|NCT01881373|3890344|FG002|NOT COMPLETED|24 Months||0
3162895|NCT01881412|3890358|FG000|STARTED|Overall Study||59
3162896|NCT01881412|3890359|FG001|STARTED|Overall Study||59
3162897|NCT01881412|3890358|FG000|COMPLETED|Overall Study||49
3162898|NCT01881412|3890359|FG001|COMPLETED|Overall Study||57
3162899|NCT01881412|3890358|FG000|NOT COMPLETED|Overall Study||10
3162900|NCT01881412|3890359|FG001|NOT COMPLETED|Overall Study||2
3162901|NCT01881620|3890365|FG000|STARTED|Overall Study||109
3162902|NCT01881620|3890365|FG000|COMPLETED|Overall Study|Eligible patients with PET-CT scanner performed AND interpretation of 2 pairs of observors available|105
3062623|NCT01279200|3783387|FG001|COMPLETED|Overall Study||4
3062624|NCT01279200|3783386|FG000|NOT COMPLETED|Overall Study||2
3062625|NCT01279200|3783387|FG001|NOT COMPLETED|Overall Study||7
3062626|NCT01279265|3783395|FG000|STARTED|Overall Study||13
3062627|NCT01279265|3783396|FG001|STARTED|Overall Study||17
3062628|NCT01279265|3783395|FG000|COMPLETED|Overall Study||9
3062629|NCT01279265|3783396|FG001|COMPLETED|Overall Study||11
3062630|NCT01279265|3783395|FG000|NOT COMPLETED|Overall Study||4
3062631|NCT01279265|3783396|FG001|NOT COMPLETED|Overall Study||6
3062632|NCT01279317|3783404|FG000|STARTED|Period 1||6
3062633|NCT01279317|3783405|FG001|STARTED|Period 1||6
3062634|NCT01279317|3783404|FG000|COMPLETED|Period 1||6
3062635|NCT01279317|3783405|FG001|COMPLETED|Period 1||6
3062636|NCT01279317|3783404|FG000|NOT COMPLETED|Period 1||0
3062637|NCT01279317|3783405|FG001|NOT COMPLETED|Period 1||0
3062638|NCT01279317|3783404|FG000|STARTED|Washout||6
3062639|NCT01279317|3783405|FG001|STARTED|Washout||6
3062640|NCT01279317|3783404|FG000|COMPLETED|Washout||6
3062641|NCT01279317|3783405|FG001|COMPLETED|Washout||6
3062642|NCT01279317|3783404|FG000|NOT COMPLETED|Washout||0
3062643|NCT01279317|3783405|FG001|NOT COMPLETED|Washout||0
3062644|NCT01279317|3783404|FG000|STARTED|Period 2||6
3062645|NCT01279317|3783405|FG001|STARTED|Period 2||6
3062646|NCT01279317|3783404|FG000|COMPLETED|Period 2||6
3062647|NCT01279317|3783405|FG001|COMPLETED|Period 2||6
3062648|NCT01279317|3783404|FG000|NOT COMPLETED|Period 2||0
3062649|NCT01279317|3783405|FG001|NOT COMPLETED|Period 2||0
3062650|NCT01279343|3783412|FG000|STARTED|Overall Study||59
3062651|NCT01279343|3783413|FG001|STARTED|Overall Study||64
3062652|NCT01279343|3783412|FG000|COMPLETED|Overall Study||57
3062653|NCT01279343|3783413|FG001|COMPLETED|Overall Study||58
3062654|NCT01279343|3783412|FG000|NOT COMPLETED|Overall Study||2
3062655|NCT01279343|3783413|FG001|NOT COMPLETED|Overall Study||6
3062656|NCT01279447|3783421|FG000|STARTED|Overall Study||34
3062657|NCT01279447|3783422|FG001|STARTED|Overall Study||34
3062658|NCT01279447|3783421|FG000|COMPLETED|Overall Study||31
3062659|NCT01279447|3783422|FG001|COMPLETED|Overall Study||33
3062660|NCT01279447|3783421|FG000|NOT COMPLETED|Overall Study||3
3062661|NCT01279447|3783422|FG001|NOT COMPLETED|Overall Study||1
3062662|NCT01279486|3783428|FG000|STARTED|Overall Study||120
3062663|NCT01279486|3783428|FG000|COMPLETED|Overall Study|1 result questionnaire was not returned so 119 volunteers results were used for consumer accuracy.|119
3062664|NCT01279486|3783428|FG000|NOT COMPLETED|Overall Study||1
3162903|NCT01881620|3890365|FG000|NOT COMPLETED|Overall Study||4
3062665|NCT01279564|3783434|FG000|STARTED|Overall Study||40
3062666|NCT01279564|3783435|FG001|STARTED|Overall Study||32
3062667|NCT01279564|3783434|FG000|COMPLETED|Overall Study||40
3062668|NCT01279564|3783435|FG001|COMPLETED|Overall Study||32
3062669|NCT01279564|3783434|FG000|NOT COMPLETED|Overall Study||0
3062670|NCT01279564|3783435|FG001|NOT COMPLETED|Overall Study||0
3062671|NCT01279681|3783443|FG000|STARTED|Overall Study||15
3062672|NCT01279681|3783444|FG001|STARTED|Overall Study||17
3062673|NCT01279681|3783443|FG000|COMPLETED|Overall Study||0
3062674|NCT01279681|3783444|FG001|COMPLETED|Overall Study||0
3062675|NCT01279681|3783443|FG000|NOT COMPLETED|Overall Study||15
3062676|NCT01279681|3783444|FG001|NOT COMPLETED|Overall Study||17
3062677|NCT01279850|3783450|FG000|STARTED|Overall Study||891
3062678|NCT01279850|3783450|FG000|COMPLETED|Overall Study|Number of participants whose survey form were collected and included in analyses is shown.|800
3062679|NCT01279850|3783450|FG000|NOT COMPLETED|Overall Study||91
3062680|NCT01279954|3783456|FG000|STARTED|Overall Study||5
3062681|NCT01279954|3783457|FG001|STARTED|Overall Study||5
3062682|NCT01279954|3783456|FG000|COMPLETED|Overall Study||2
3062683|NCT01279954|3783457|FG001|COMPLETED|Overall Study||1
3062684|NCT01279954|3783456|FG000|NOT COMPLETED|Overall Study||3
3062685|NCT01279954|3783457|FG001|NOT COMPLETED|Overall Study||4
3062686|NCT01280058|3783468|FG000|STARTED|Overall Study||36
3062687|NCT01280058|3783469|FG001|STARTED|Overall Study||37
3062688|NCT01280058|3783468|FG000|COMPLETED|Overall Study||36
3062689|NCT01280058|3783469|FG001|COMPLETED|Overall Study||37
3062690|NCT01280058|3783468|FG000|NOT COMPLETED|Overall Study||0
3062691|NCT01280058|3783469|FG001|NOT COMPLETED|Overall Study||0
3062692|NCT01280110|3783479|FG000|STARTED|Overall Study||22
3062693|NCT01280110|3783480|FG001|STARTED|Overall Study||22
3062694|NCT01280110|3783479|FG000|COMPLETED|Overall Study||22
3062695|NCT01280110|3783480|FG001|COMPLETED|Overall Study||22
3062696|NCT01280110|3783479|FG000|NOT COMPLETED|Overall Study||0
3062697|NCT01280110|3783480|FG001|NOT COMPLETED|Overall Study||0
3062698|NCT01280123|3783491|FG000|STARTED|Overall Study||72
3062699|NCT01280123|3783492|FG001|STARTED|Overall Study||67
3062700|NCT01280123|3783493|FG002|STARTED|Overall Study||71
3062701|NCT01280123|3783491|FG000|COMPLETED|Overall Study||71
3062702|NCT01280123|3783492|FG001|COMPLETED|Overall Study||63
3062703|NCT01280123|3783493|FG002|COMPLETED|Overall Study||70
3062704|NCT01280123|3783491|FG000|NOT COMPLETED|Overall Study||1
3062705|NCT01280123|3783492|FG001|NOT COMPLETED|Overall Study||4
3062706|NCT01280123|3783493|FG002|NOT COMPLETED|Overall Study||1
3062707|NCT01280201|3783501|FG000|STARTED|Overall Study||44
3062708|NCT01280201|3783501|FG000|COMPLETED|Overall Study||44
3062709|NCT01280201|3783501|FG000|NOT COMPLETED|Overall Study||0
3062710|NCT01280266|3783507|FG000|STARTED|First Intervention (Week 1-4)||15
3062711|NCT01280266|3783508|FG001|STARTED|First Intervention (Week 1-4)||14
3062712|NCT01280266|3783507|FG000|COMPLETED|First Intervention (Week 1-4)||14
3062713|NCT01280266|3783508|FG001|COMPLETED|First Intervention (Week 1-4)||12
3062714|NCT01280266|3783507|FG000|NOT COMPLETED|First Intervention (Week 1-4)||1
3062715|NCT01280266|3783508|FG001|NOT COMPLETED|First Intervention (Week 1-4)||2
3062716|NCT01280266|3783507|FG000|STARTED|Washout Period (Week 4-5)||14
3062717|NCT01280266|3783508|FG001|STARTED|Washout Period (Week 4-5)||12
3062718|NCT01280266|3783507|FG000|COMPLETED|Washout Period (Week 4-5)||14
3062719|NCT01280266|3783508|FG001|COMPLETED|Washout Period (Week 4-5)||12
3062720|NCT01280266|3783507|FG000|NOT COMPLETED|Washout Period (Week 4-5)||0
3062721|NCT01280266|3783508|FG001|NOT COMPLETED|Washout Period (Week 4-5)||0
3062722|NCT01280266|3783507|FG000|STARTED|Second Intervention (Week 5-9)||14
3062723|NCT01280266|3783508|FG001|STARTED|Second Intervention (Week 5-9)||12
3062724|NCT01280266|3783507|FG000|COMPLETED|Second Intervention (Week 5-9)||14
3062725|NCT01280266|3783508|FG001|COMPLETED|Second Intervention (Week 5-9)||12
3062726|NCT01280266|3783507|FG000|NOT COMPLETED|Second Intervention (Week 5-9)||0
3062727|NCT01280266|3783508|FG001|NOT COMPLETED|Second Intervention (Week 5-9)||0
3062728|NCT01280357|3783518|FG000|STARTED|Overall Study||60
3062729|NCT01280357|3783518|FG000|COMPLETED|Overall Study||34
3062730|NCT01280357|3783518|FG000|NOT COMPLETED|Overall Study||26
3062731|NCT01280409|3783527|FG000|STARTED|Overall Study||59
3062732|NCT01280409|3783528|FG001|STARTED|Overall Study||55
3062733|NCT01280409|3783527|FG000|COMPLETED|Overall Study||43
3062734|NCT01280409|3783528|FG001|COMPLETED|Overall Study||36
3062735|NCT01280409|3783527|FG000|NOT COMPLETED|Overall Study||16
3062736|NCT01280409|3783528|FG001|NOT COMPLETED|Overall Study||19
3062737|NCT01280552|3783536|FG000|STARTED|Overall Study||81
3062738|NCT01280552|3783537|FG001|STARTED|Overall Study||43
3062739|NCT01280552|3783536|FG000|COMPLETED|Overall Study|Survival is still being assessed|75
3062740|NCT01280552|3783537|FG001|COMPLETED|Overall Study||42
3062741|NCT01280552|3783536|FG000|NOT COMPLETED|Overall Study||6
3062742|NCT01280552|3783537|FG001|NOT COMPLETED|Overall Study||1
3062743|NCT01280591|3783550|FG000|STARTED|Overall Study||203
3062744|NCT01280591|3783551|FG001|STARTED|Overall Study||204
3062745|NCT01280591|3783552|FG002|STARTED|Overall Study||203
3062746|NCT01280591|3783553|FG003|STARTED|Overall Study||102
3062747|NCT01280591|3783550|FG000|COMPLETED|Overall Study||203
3062748|NCT01280591|3783551|FG001|COMPLETED|Overall Study||204
3062749|NCT01280591|3783552|FG002|COMPLETED|Overall Study||203
3062750|NCT01280591|3783553|FG003|COMPLETED|Overall Study||99
3062751|NCT01280591|3783550|FG000|NOT COMPLETED|Overall Study||0
3062752|NCT01280591|3783551|FG001|NOT COMPLETED|Overall Study||0
3062753|NCT01280591|3783552|FG002|NOT COMPLETED|Overall Study||0
3062754|NCT01280591|3783553|FG003|NOT COMPLETED|Overall Study||3
3062755|NCT01280604|3783565|FG000|STARTED|Overall Study||33
3062756|NCT01280604|3783566|FG001|STARTED|Overall Study||33
3062757|NCT01280604|3783565|FG000|Subjects Meeting All Inclusion Criteria|Overall Study||25
3062758|NCT01280604|3783566|FG001|Subjects Meeting All Inclusion Criteria|Overall Study||29
3062759|NCT01280604|3783565|FG000|COMPLETED|Overall Study||24
3062760|NCT01280604|3783566|FG001|COMPLETED|Overall Study||28
3062761|NCT01280604|3783565|FG000|NOT COMPLETED|Overall Study||9
3062762|NCT01280604|3783566|FG001|NOT COMPLETED|Overall Study||5
3062763|NCT01280617|3783574|FG000|STARTED|Overall Study||23
3062764|NCT01280617|3783575|FG001|STARTED|Overall Study||21
3062765|NCT01280617|3783574|FG000|COMPLETED|Overall Study||23
3062766|NCT01280617|3783575|FG001|COMPLETED|Overall Study||20
3062767|NCT01280617|3783574|FG000|NOT COMPLETED|Overall Study||0
3062768|NCT01280617|3783575|FG001|NOT COMPLETED|Overall Study||1
3062769|NCT01280656|3783584|FG000|STARTED|Overall Study||62
3062770|NCT01280656|3783585|FG001|STARTED|Overall Study||312
3062771|NCT01280656|3783586|FG002|STARTED|Overall Study||286
3062772|NCT01280656|3783584|FG000|COMPLETED|Overall Study||59
3062773|NCT01280656|3783585|FG001|COMPLETED|Overall Study||265
3062774|NCT01280656|3783586|FG002|COMPLETED|Overall Study||223
3062775|NCT01280656|3783584|FG000|NOT COMPLETED|Overall Study||3
3062776|NCT01280656|3783585|FG001|NOT COMPLETED|Overall Study||47
3062777|NCT01280656|3783586|FG002|NOT COMPLETED|Overall Study||63
3062778|NCT01280695|3783599|FG000|STARTED|Overall Study||26
3062779|NCT01280695|3783600|FG001|STARTED|Overall Study||25
3062780|NCT01280695|3783601|FG002|STARTED|Overall Study||26
3062781|NCT01280695|3783602|FG003|STARTED|Overall Study||26
3062782|NCT01280695|3783603|FG004|STARTED|Overall Study||26
3062783|NCT01280695|3783599|FG000|COMPLETED|Overall Study||26
3062784|NCT01280695|3783600|FG001|COMPLETED|Overall Study||24
3062785|NCT01280695|3783601|FG002|COMPLETED|Overall Study||21
3062786|NCT01280695|3783602|FG003|COMPLETED|Overall Study||22
3062787|NCT01280695|3783603|FG004|COMPLETED|Overall Study||24
3062788|NCT01280695|3783599|FG000|NOT COMPLETED|Overall Study||0
3062789|NCT01280695|3783600|FG001|NOT COMPLETED|Overall Study||1
3062790|NCT01280695|3783601|FG002|NOT COMPLETED|Overall Study||5
3062791|NCT01280695|3783602|FG003|NOT COMPLETED|Overall Study||4
3062792|NCT01280695|3783603|FG004|NOT COMPLETED|Overall Study||2
3062793|NCT01280721|3783615|FG000|STARTED|Overall Study||135
3062794|NCT01280721|3783615|FG000|COMPLETED|Overall Study||113
3062795|NCT01280721|3783615|FG000|NOT COMPLETED|Overall Study||22
3284127|NCT02761915|4017888|FG000|STARTED|Overall Study||4
3284128|NCT02761915|4017889|FG001|STARTED|Overall Study||1
3284129|NCT02761915|4017890|FG002|STARTED|Overall Study||1
3062796|NCT01280812|3783633|FG000|STARTED|Overall Study||70
3062797|NCT01280812|3783634|FG001|STARTED|Overall Study||71
3062798|NCT01280812|3783635|FG002|STARTED|Overall Study||69
3062799|NCT01280812|3783633|FG000|COMPLETED|Overall Study||67
3062800|NCT01280812|3783634|FG001|COMPLETED|Overall Study||69
3062801|NCT01280812|3783635|FG002|COMPLETED|Overall Study||68
3062802|NCT01280812|3783633|FG000|NOT COMPLETED|Overall Study||3
3062803|NCT01280812|3783634|FG001|NOT COMPLETED|Overall Study||2
3062804|NCT01280812|3783635|FG002|NOT COMPLETED|Overall Study||1
3062805|NCT01280903|3783646|FG000|STARTED|Overall Study||91
3062806|NCT01280903|3783647|FG001|STARTED|Overall Study||91
3062807|NCT01280903|3783646|FG000|COMPLETED|Overall Study|91 participants analyzed per intention-to-treat|68
3062808|NCT01280903|3783647|FG001|COMPLETED|Overall Study|91 participants analyzed per intention-to-treat|75
3062809|NCT01280903|3783646|FG000|NOT COMPLETED|Overall Study||23
3062810|NCT01280903|3783647|FG001|NOT COMPLETED|Overall Study||16
3062811|NCT01280942|3783655|FG000|STARTED|Overall Study||10120
3062812|NCT01280942|3783656|FG001|STARTED|Overall Study||9911
3062813|NCT01280942|3783655|FG000|COMPLETED|Overall Study||10120
3062814|NCT01280942|3783656|FG001|COMPLETED|Overall Study||9911
3062815|NCT01280942|3783655|FG000|NOT COMPLETED|Overall Study||0
3062816|NCT01280942|3783656|FG001|NOT COMPLETED|Overall Study||0
3062817|NCT01280955|3783662|FG000|STARTED|Overall Study||30
3062818|NCT01280955|3783662|FG000|COMPLETED|Overall Study||27
3062819|NCT01280955|3783662|FG000|NOT COMPLETED|Overall Study||3
3062820|NCT01280968|3783670|FG000|STARTED|Overall Study||45
3062821|NCT01280968|3783671|FG001|STARTED|Overall Study||7
3062822|NCT01280968|3783670|FG000|COMPLETED|Overall Study||27
3062823|NCT01280968|3783671|FG001|COMPLETED|Overall Study||4
3062824|NCT01280968|3783670|FG000|NOT COMPLETED|Overall Study||18
3062825|NCT01280968|3783671|FG001|NOT COMPLETED|Overall Study||3
3062826|NCT01280981|3783678|FG000|STARTED|Overall Study||288
3062827|NCT01280981|3783678|FG000|Intent to Treat (ITT) Population|Overall Study|Participants who took drug during at least one menstrual cycle|260
3062828|NCT01280981|3783678|FG000|COMPLETED|Overall Study||196
3062829|NCT01280981|3783678|FG000|NOT COMPLETED|Overall Study||92
3062830|NCT01281007|3783684|FG000|STARTED|Overall Study||75
3062831|NCT01281007|3783685|FG001|STARTED|Overall Study||75
3062832|NCT01281007|3783684|FG000|COMPLETED|Overall Study||71
3062833|NCT01281007|3783685|FG001|COMPLETED|Overall Study||67
3062834|NCT01281007|3783684|FG000|NOT COMPLETED|Overall Study||4
3062835|NCT01281007|3783685|FG001|NOT COMPLETED|Overall Study||8
3062836|NCT01281137|3783693|FG000|STARTED|Baseline Population||25
3062837|NCT01281137|3783694|FG001|STARTED|Baseline Population||79
3062838|NCT01281137|3783693|FG000|COMPLETED|Baseline Population||25
3062839|NCT01281137|3783694|FG001|COMPLETED|Baseline Population||78
3062840|NCT01281137|3783693|FG000|NOT COMPLETED|Baseline Population||0
3062841|NCT01281137|3783694|FG001|NOT COMPLETED|Baseline Population||1
3062842|NCT01281137|3783693|FG000|STARTED|Analysis Population (Baseline)||25
3062843|NCT01281137|3783694|FG001|STARTED|Analysis Population (Baseline)||78
3062844|NCT01281137|3783693|FG000|COMPLETED|Analysis Population (Baseline)||21
3062845|NCT01281137|3783694|FG001|COMPLETED|Analysis Population (Baseline)||69
3062846|NCT01281137|3783693|FG000|NOT COMPLETED|Analysis Population (Baseline)||4
3062847|NCT01281137|3783694|FG001|NOT COMPLETED|Analysis Population (Baseline)||9
3062848|NCT01281137|3783693|FG000|STARTED|Analysis Population (9 Months)||21
3062849|NCT01281137|3783694|FG001|STARTED|Analysis Population (9 Months)||69
3062850|NCT01281137|3783693|FG000|COMPLETED|Analysis Population (9 Months)||21
3062851|NCT01281137|3783694|FG001|COMPLETED|Analysis Population (9 Months)||64
3062852|NCT01281137|3783693|FG000|NOT COMPLETED|Analysis Population (9 Months)||0
3062853|NCT01281137|3783694|FG001|NOT COMPLETED|Analysis Population (9 Months)||5
3062854|NCT01281137|3783693|FG000|STARTED|Analysis Population (10.5 Months)||21
3062855|NCT01281137|3783694|FG001|STARTED|Analysis Population (10.5 Months)||64
3284130|NCT02761915|4017891|FG003|STARTED|Overall Study||3
3284131|NCT02761915|4017892|FG004|STARTED|Overall Study||3
3284132|NCT02761915|4017893|FG005|STARTED|Overall Study||5
3284133|NCT02761915|4017888|FG000|Underwent Leukapheresis|Overall Study||4
3284134|NCT02761915|4017889|FG001|Underwent Leukapheresis|Overall Study||1
3062856|NCT01281137|3783693|FG000|COMPLETED|Analysis Population (10.5 Months)||20
3062857|NCT01281137|3783694|FG001|COMPLETED|Analysis Population (10.5 Months)||64
3062858|NCT01281137|3783693|FG000|NOT COMPLETED|Analysis Population (10.5 Months)||1
3062859|NCT01281137|3783694|FG001|NOT COMPLETED|Analysis Population (10.5 Months)||0
3062860|NCT01281137|3783693|FG000|STARTED|Analysis Population (12 Months)||20
3062861|NCT01281137|3783694|FG001|STARTED|Analysis Population (12 Months)||64
3062862|NCT01281137|3783693|FG000|COMPLETED|Analysis Population (12 Months)||19
3062863|NCT01281137|3783694|FG001|COMPLETED|Analysis Population (12 Months)||62
3062864|NCT01281137|3783693|FG000|NOT COMPLETED|Analysis Population (12 Months)||1
3062865|NCT01281137|3783694|FG001|NOT COMPLETED|Analysis Population (12 Months)||2
3134117|NCT01700036|3859109|FG000|NOT COMPLETED|Overall Study||0
3134118|NCT01700049|3859113|FG000|STARTED|Overall Study||28
3134119|NCT01700049|3859113|FG000|COMPLETED|Overall Study||27
3134120|NCT01700049|3859113|FG000|NOT COMPLETED|Overall Study||1
3134121|NCT01700140|3859121|FG000|STARTED|Overall Study||61
3134122|NCT01700140|3859122|FG001|STARTED|Overall Study||66
3134123|NCT01700140|3859123|FG002|STARTED|Overall Study||62
3134124|NCT01700140|3859121|FG000|COMPLETED|Overall Study||55
3134125|NCT01700140|3859122|FG001|COMPLETED|Overall Study||57
3134126|NCT01700140|3859123|FG002|COMPLETED|Overall Study||61
3134127|NCT01700140|3859121|FG000|NOT COMPLETED|Overall Study||6
3134128|NCT01700140|3859122|FG001|NOT COMPLETED|Overall Study||9
3134129|NCT01700140|3859123|FG002|NOT COMPLETED|Overall Study||1
3134130|NCT01700179|3859134|FG000|STARTED|Overall Study||8
3134131|NCT01700179|3859134|FG000|COMPLETED|Overall Study||6
3134132|NCT01700179|3859134|FG000|NOT COMPLETED|Overall Study||2
3134133|NCT01700192|3859140|FG000|STARTED|Overall Study||741
3134134|NCT01700192|3859141|FG001|STARTED|Overall Study||741
3134135|NCT01700192|3859140|FG000|Treated|Overall Study||740
3134136|NCT01700192|3859141|FG001|Treated|Overall Study||741
3134137|NCT01700192|3859140|FG000|All Participants as Treated (APaT)|Overall Study|Three participants randomized to receive placebo were given MK-8237 12 DU.|743
3134138|NCT01700192|3859141|FG001|All Participants as Treated (APaT)|Overall Study|Three participants randomized to receive placebo were given MK-8237 12 DU.|738
3134139|NCT01700192|3859140|FG000|COMPLETED|Overall Study||561
3134140|NCT01700192|3859141|FG001|COMPLETED|Overall Study||613
3134141|NCT01700192|3859140|FG000|NOT COMPLETED|Overall Study||180
3134142|NCT01700192|3859141|FG001|NOT COMPLETED|Overall Study||128
3134143|NCT01700205|3859149|FG000|STARTED|Overall Study|Mother-Infant Dyads|59
3134144|NCT01700205|3859150|FG001|STARTED|Overall Study|Mother-Infant Dyads|54
3284135|NCT02761915|4017890|FG002|Underwent Leukapheresis|Overall Study||1
3284136|NCT02761915|4017891|FG003|Underwent Leukapheresis|Overall Study||3
3284137|NCT02761915|4017892|FG004|Underwent Leukapheresis|Overall Study||3
3284138|NCT02761915|4017893|FG005|Underwent Leukapheresis|Overall Study||5
3284139|NCT02761915|4017888|FG000|Received Investigational Medicinal Product|Overall Study||4
3284140|NCT02761915|4017889|FG001|Received Investigational Medicinal Product|Overall Study||1
3284141|NCT02761915|4017890|FG002|Received Investigational Medicinal Product|Overall Study||1
3284142|NCT02761915|4017891|FG003|Received Investigational Medicinal Product|Overall Study||3
3284143|NCT02761915|4017892|FG004|Received Investigational Medicinal Product|Overall Study||3
3284144|NCT02761915|4017893|FG005|Received Investigational Medicinal Product|Overall Study||0
3284145|NCT02761915|4017888|FG000|COMPLETED|Overall Study||0
3134145|NCT01700205|3859149|FG000|COMPLETED|Overall Study|Mother-Infant Dyads|44
3134146|NCT01700205|3859150|FG001|COMPLETED|Overall Study|Mother-Infant Dyads|39
3134147|NCT01700205|3859149|FG000|NOT COMPLETED|Overall Study||15
3134148|NCT01700205|3859150|FG001|NOT COMPLETED|Overall Study||15
3134149|NCT01700335|3859156|FG000|STARTED|Overall Study||3
3134150|NCT01700335|3859157|FG001|STARTED|Overall Study||6
3134151|NCT01700335|3859156|FG000|COMPLETED|Overall Study||2
3134152|NCT01700335|3859157|FG001|COMPLETED|Overall Study||2
3134153|NCT01700335|3859156|FG000|NOT COMPLETED|Overall Study||1
3134154|NCT01700335|3859157|FG001|NOT COMPLETED|Overall Study||4
3134155|NCT01700387|3859166|FG000|STARTED|Overall Study||10
3134156|NCT01700387|3859167|FG001|STARTED|Overall Study||10
3134157|NCT01700387|3859166|FG000|COMPLETED|Overall Study||6
3134158|NCT01700387|3859167|FG001|COMPLETED|Overall Study||6
3134159|NCT01700387|3859166|FG000|NOT COMPLETED|Overall Study||4
3062866|NCT01281189|3783720|FG000|STARTED|Overall Study||468
3062867|NCT01281189|3783721|FG001|STARTED|Overall Study||474
3062868|NCT01281189|3783720|FG000|COMPLETED|Overall Study||321
3062869|NCT01281189|3783721|FG001|COMPLETED|Overall Study||331
3062870|NCT01281189|3783720|FG000|NOT COMPLETED|Overall Study||147
3062871|NCT01281189|3783721|FG001|NOT COMPLETED|Overall Study||143
3062872|NCT01281202|3783729|FG000|STARTED|Overall Study||103
3062873|NCT01281202|3783730|FG001|STARTED|Overall Study||104
3062874|NCT01281202|3783729|FG000|COMPLETED|Overall Study||75
3062875|NCT01281202|3783730|FG001|COMPLETED|Overall Study||68
3062876|NCT01281202|3783729|FG000|NOT COMPLETED|Overall Study||28
3062877|NCT01281202|3783730|FG001|NOT COMPLETED|Overall Study||36
3062878|NCT01281306|3783745|FG000|STARTED|Overall Study||144
3062879|NCT01281306|3783746|FG001|STARTED|Overall Study||145
3062880|NCT01281306|3783747|FG002|STARTED|Overall Study||141
3062881|NCT01281306|3783748|FG003|STARTED|Overall Study||134
3062882|NCT01281306|3783749|FG004|STARTED|Overall Study||143
3062883|NCT01281306|3783750|FG005|STARTED|Overall Study||142
3062884|NCT01281306|3783751|FG006|STARTED|Overall Study||58
3062885|NCT01281306|3783745|FG000|Full Analysis Set|Overall Study||143
3062886|NCT01281306|3783746|FG001|Full Analysis Set|Overall Study||145
3062887|NCT01281306|3783747|FG002|Full Analysis Set|Overall Study||141
3062888|NCT01281306|3783748|FG003|Full Analysis Set|Overall Study||133
3062889|NCT01281306|3783749|FG004|Full Analysis Set|Overall Study||143
3062890|NCT01281306|3783750|FG005|Full Analysis Set|Overall Study||142
3062891|NCT01281306|3783751|FG006|Full Analysis Set|Overall Study||58
3062892|NCT01281306|3783745|FG000|Safety Set|Overall Study||143
3284146|NCT02761915|4017889|FG001|COMPLETED|Overall Study||0
3284147|NCT02761915|4017890|FG002|COMPLETED|Overall Study||0
3062893|NCT01281306|3783746|FG001|Safety Set|Overall Study||145
3062894|NCT01281306|3783747|FG002|Safety Set|Overall Study||141
3062895|NCT01281306|3783748|FG003|Safety Set|Overall Study||133
3062896|NCT01281306|3783749|FG004|Safety Set|Overall Study||143
3062897|NCT01281306|3783750|FG005|Safety Set|Overall Study||142
3062898|NCT01281306|3783751|FG006|Safety Set|Overall Study||58
3062899|NCT01281306|3783745|FG000|Ambulatory Blood Pressure Monitoring Set|Overall Study||95
3062900|NCT01281306|3783746|FG001|Ambulatory Blood Pressure Monitoring Set|Overall Study||99
3062901|NCT01281306|3783747|FG002|Ambulatory Blood Pressure Monitoring Set|Overall Study||92
3062902|NCT01281306|3783748|FG003|Ambulatory Blood Pressure Monitoring Set|Overall Study||95
3062903|NCT01281306|3783749|FG004|Ambulatory Blood Pressure Monitoring Set|Overall Study||93
3062904|NCT01281306|3783750|FG005|Ambulatory Blood Pressure Monitoring Set|Overall Study||91
3062905|NCT01281306|3783751|FG006|Ambulatory Blood Pressure Monitoring Set|Overall Study||35
3062906|NCT01281306|3783745|FG000|COMPLETED|Overall Study||136
3062907|NCT01281306|3783746|FG001|COMPLETED|Overall Study||141
3062908|NCT01281306|3783747|FG002|COMPLETED|Overall Study||133
3062909|NCT01281306|3783748|FG003|COMPLETED|Overall Study||123
3062910|NCT01281306|3783749|FG004|COMPLETED|Overall Study||134
3062911|NCT01281306|3783750|FG005|COMPLETED|Overall Study||135
3062912|NCT01281306|3783751|FG006|COMPLETED|Overall Study||51
3062913|NCT01281306|3783745|FG000|NOT COMPLETED|Overall Study||8
3062914|NCT01281306|3783746|FG001|NOT COMPLETED|Overall Study||4
3062915|NCT01281306|3783747|FG002|NOT COMPLETED|Overall Study||8
3062916|NCT01281306|3783748|FG003|NOT COMPLETED|Overall Study||11
3062917|NCT01281306|3783749|FG004|NOT COMPLETED|Overall Study||9
3062918|NCT01281306|3783750|FG005|NOT COMPLETED|Overall Study||7
3062919|NCT01281306|3783751|FG006|NOT COMPLETED|Overall Study||7
3062920|NCT01281475|3783769|FG000|STARTED|Overall Study||33
3062921|NCT01281475|3783770|FG001|STARTED|Overall Study||34
3062922|NCT01281475|3783769|FG000|COMPLETED|Overall Study||29
3062923|NCT01281475|3783770|FG001|COMPLETED|Overall Study||26
3062924|NCT01281475|3783769|FG000|NOT COMPLETED|Overall Study||4
3062925|NCT01281475|3783770|FG001|NOT COMPLETED|Overall Study||8
3062926|NCT01281501|3783780|FG000|STARTED|Overall Study||44
3062927|NCT01281501|3783781|FG001|STARTED|Overall Study||43
3062928|NCT01281501|3783780|FG000|COMPLETED|Overall Study||44
3062929|NCT01281501|3783781|FG001|COMPLETED|Overall Study||43
3062930|NCT01281501|3783780|FG000|NOT COMPLETED|Overall Study||0
3062931|NCT01281501|3783781|FG001|NOT COMPLETED|Overall Study||0
3062932|NCT01281839|3783789|FG000|STARTED|Overall Study|Not including 1 participant was randomized to this group, but never received treatment.|260
3062933|NCT01281839|3783790|FG001|STARTED|Overall Study||133
3062934|NCT01281839|3783789|FG000|COMPLETED|Overall Study||250
3062935|NCT01281839|3783790|FG001|COMPLETED|Overall Study||119
3062936|NCT01281839|3783789|FG000|NOT COMPLETED|Overall Study||10
3062937|NCT01281839|3783790|FG001|NOT COMPLETED|Overall Study||14
3062938|NCT01281865|3783798|FG000|STARTED|Overall Study||12
3062939|NCT01281865|3783799|FG001|STARTED|Overall Study||2
3062940|NCT01281865|3783798|FG000|COMPLETED|Overall Study||9
3062941|NCT01281865|3783799|FG001|COMPLETED|Overall Study||1
3062942|NCT01281865|3783798|FG000|NOT COMPLETED|Overall Study||3
3062943|NCT01281865|3783799|FG001|NOT COMPLETED|Overall Study||1
3062944|NCT01281917|3783805|FG000|STARTED|Overall Study||40
3062945|NCT01281917|3783805|FG000|COMPLETED|Overall Study||39
3062946|NCT01281917|3783805|FG000|NOT COMPLETED|Overall Study||1
3062947|NCT01281956|3783809|FG000|STARTED|1st Intervention (3 Months)||5
3062948|NCT01281956|3783810|FG001|STARTED|1st Intervention (3 Months)||5
3062949|NCT01281956|3783809|FG000|COMPLETED|1st Intervention (3 Months)||5
3062950|NCT01281956|3783810|FG001|COMPLETED|1st Intervention (3 Months)||5
3062951|NCT01281956|3783809|FG000|NOT COMPLETED|1st Intervention (3 Months)||0
3062952|NCT01281956|3783810|FG001|NOT COMPLETED|1st Intervention (3 Months)||0
3062953|NCT01281956|3783809|FG000|STARTED|2nd Intervention (3 Months)||5
3062954|NCT01281956|3783810|FG001|STARTED|2nd Intervention (3 Months)||5
3062955|NCT01281956|3783809|FG000|COMPLETED|2nd Intervention (3 Months)||4
3062956|NCT01281956|3783810|FG001|COMPLETED|2nd Intervention (3 Months)||5
3062957|NCT01281956|3783809|FG000|NOT COMPLETED|2nd Intervention (3 Months)||1
3062958|NCT01281956|3783810|FG001|NOT COMPLETED|2nd Intervention (3 Months)||0
3062959|NCT01281969|3783821|FG000|STARTED|Overall Study||18
3062960|NCT01281969|3783822|FG001|STARTED|Overall Study||18
3062961|NCT01281969|3783823|FG002|STARTED|Overall Study||12
3062962|NCT01281969|3783821|FG000|COMPLETED|Overall Study||17
3062963|NCT01281969|3783822|FG001|COMPLETED|Overall Study||18
3062964|NCT01281969|3783823|FG002|COMPLETED|Overall Study||0
3062965|NCT01281969|3783821|FG000|NOT COMPLETED|Overall Study||1
3062966|NCT01281969|3783822|FG001|NOT COMPLETED|Overall Study||0
3062967|NCT01281969|3783823|FG002|NOT COMPLETED|Overall Study||12
3062968|NCT01282086|3783831|FG000|STARTED|Overall Study||1365
3062969|NCT01282086|3783831|FG000|COMPLETED|Overall Study||1365
3062970|NCT01282086|3783831|FG000|NOT COMPLETED|Overall Study||0
3062971|NCT01282138|3783838|FG000|STARTED|EEC||6
3062972|NCT01282138|3783839|FG001|STARTED|EEC||7
3062973|NCT01282138|3783838|FG000|COMPLETED|EEC||6
3062974|NCT01282138|3783839|FG001|COMPLETED|EEC||7
3062975|NCT01282138|3783838|FG000|NOT COMPLETED|EEC||0
3062976|NCT01282138|3783839|FG001|NOT COMPLETED|EEC||0
3062977|NCT01282138|3783838|FG000|STARTED|CAPT||6
3062978|NCT01282138|3783839|FG001|STARTED|CAPT||7
3062979|NCT01282138|3783838|FG000|COMPLETED|CAPT||6
3062980|NCT01282138|3783839|FG001|COMPLETED|CAPT||7
3062981|NCT01282138|3783838|FG000|NOT COMPLETED|CAPT||0
3162904|NCT01881737|3890369|FG000|STARTED|Overall Study|This is a pilot study|15
3162905|NCT01881737|3890369|FG000|Number Screened|Overall Study||15
3162906|NCT01881737|3890369|FG000|COMPLETED|Overall Study||10
3162907|NCT01881737|3890369|FG000|NOT COMPLETED|Overall Study||5
3162908|NCT01881750|3890377|FG000|STARTED|Overall Study||27
3162909|NCT01881750|3890378|FG001|STARTED|Overall Study||26
3062982|NCT01282138|3783839|FG001|NOT COMPLETED|CAPT||0
3062983|NCT01282164|3783847|FG000|STARTED|Overall Study||29
3062984|NCT01282164|3783848|FG001|STARTED|Overall Study||14
3062985|NCT01282164|3783847|FG000|COMPLETED|Overall Study||28
3062986|NCT01282164|3783848|FG001|COMPLETED|Overall Study||14
3062987|NCT01282164|3783847|FG000|NOT COMPLETED|Overall Study||1
3062988|NCT01282164|3783848|FG001|NOT COMPLETED|Overall Study||0
3062989|NCT01282203|3783862|FG000|STARTED|Overall Study||1122
3062990|NCT01282203|3783862|FG000|COMPLETED|Overall Study||1121
3062991|NCT01282203|3783862|FG000|NOT COMPLETED|Overall Study||1
3062992|NCT01282229|3783869|FG000|STARTED|Overall Study|59 Participants contributed 236 quadrants (59*4)|59
3062993|NCT01282229|3783869|FG000|COMPLETED|Overall Study|57 Participants contributed 228 quadrants (57*4)|57
3062994|NCT01282229|3783869|FG000|NOT COMPLETED|Overall Study||2
3062995|NCT01282242|3783889|FG000|STARTED|Overall Study||80
3062996|NCT01282242|3783890|FG001|STARTED|Overall Study||8
3062997|NCT01282242|3783889|FG000|COMPLETED|Overall Study||80
3062998|NCT01282242|3783890|FG001|COMPLETED|Overall Study||8
3062999|NCT01282242|3783889|FG000|NOT COMPLETED|Overall Study||0
3063000|NCT01282242|3783890|FG001|NOT COMPLETED|Overall Study||0
3063001|NCT01282294|3783896|FG000|STARTED|Overall Study||100
3063002|NCT01282294|3783896|FG000|Intra-operative|Overall Study||99
3063003|NCT01282294|3783896|FG000|Post-operative|Overall Study||99
3063004|NCT01282294|3783896|FG000|6 Weeks|Overall Study||95
3063005|NCT01282294|3783896|FG000|3 Months|Overall Study||95
3063006|NCT01282294|3783896|FG000|6 Months|Overall Study||94
3063007|NCT01282294|3783896|FG000|12 Months|Overall Study||86
3063008|NCT01282294|3783896|FG000|COMPLETED|Overall Study||81
3063009|NCT01282294|3783896|FG000|NOT COMPLETED|Overall Study||19
3063010|NCT01282372|3783900|FG000|STARTED|Overall Study||500
3063011|NCT01282372|3783900|FG000|COMPLETED|Overall Study||421
3063012|NCT01282372|3783900|FG000|NOT COMPLETED|Overall Study||79
3063013|NCT01282424|3783911|FG000|STARTED|Treatment Period (TP) (81 Months)||125
3063014|NCT01282424|3783911|FG000|Completed: Disease Progression|Treatment Period (TP) (81 Months)||70
3063015|NCT01282424|3783911|FG000|Completed: Death|Treatment Period (TP) (81 Months)||9
3063016|NCT01282424|3783911|FG000|COMPLETED|Treatment Period (TP) (81 Months)||79
3063017|NCT01282424|3783911|FG000|NOT COMPLETED|Treatment Period (TP) (81 Months)||46
3063018|NCT01282424|3783911|FG000|STARTED|Long-term Follow-up Period (5 Years)|Participants did not have to complete the TP in order to enter the Long-term Follow-up Period.|84
3063019|NCT01282424|3783911|FG000|COMPLETED|Long-term Follow-up Period (5 Years)||20
3063020|NCT01282424|3783911|FG000|NOT COMPLETED|Long-term Follow-up Period (5 Years)||64
3063021|NCT01282463|3783918|FG000|STARTED|Overall Study||49
3063022|NCT01282463|3783919|FG001|STARTED|Overall Study||49
3063023|NCT01282463|3783920|FG002|STARTED|Overall Study||50
3063024|NCT01282463|3783918|FG000|Received at Least 1 Dose of Study Drug|Overall Study||45
3063025|NCT01282463|3783919|FG001|Received at Least 1 Dose of Study Drug|Overall Study||46
3063026|NCT01282463|3783920|FG002|Received at Least 1 Dose of Study Drug|Overall Study||49
3063027|NCT01282463|3783918|FG000|COMPLETED|Overall Study||41
3063028|NCT01282463|3783919|FG001|COMPLETED|Overall Study||45
3063029|NCT01282463|3783920|FG002|COMPLETED|Overall Study||46
3063030|NCT01282463|3783918|FG000|NOT COMPLETED|Overall Study||8
3063031|NCT01282463|3783919|FG001|NOT COMPLETED|Overall Study||4
3063032|NCT01282463|3783920|FG002|NOT COMPLETED|Overall Study||4
3063033|NCT01282476|3783936|FG000|STARTED|Overall Study||18
3162910|NCT01881750|3890377|FG000|COMPLETED|Overall Study||25
3063034|NCT01282476|3783936|FG000|COMPLETED|Overall Study||7
3063035|NCT01282476|3783936|FG000|NOT COMPLETED|Overall Study||11
3063036|NCT01282710|3783940|FG000|STARTED|Overall Study||20
3063037|NCT01282710|3783940|FG000|COMPLETED|Overall Study||20
3063038|NCT01282710|3783940|FG000|NOT COMPLETED|Overall Study||0
3063039|NCT01282723|3783944|FG000|STARTED|Overall Study||20
3063040|NCT01282723|3783944|FG000|COMPLETED|Overall Study||20
3063041|NCT01282723|3783944|FG000|NOT COMPLETED|Overall Study||0
3063042|NCT01282801|3783950|FG000|STARTED|First Intervention||9
3063043|NCT01282801|3783951|FG001|STARTED|First Intervention||9
3063044|NCT01282801|3783950|FG000|COMPLETED|First Intervention||9
3063045|NCT01282801|3783951|FG001|COMPLETED|First Intervention||9
3063046|NCT01282801|3783950|FG000|NOT COMPLETED|First Intervention||0
3063047|NCT01282801|3783951|FG001|NOT COMPLETED|First Intervention||0
3063048|NCT01282801|3783950|FG000|STARTED|Washout of 7 Days||9
3063049|NCT01282801|3783951|FG001|STARTED|Washout of 7 Days||9
3063050|NCT01282801|3783950|FG000|COMPLETED|Washout of 7 Days||9
3063051|NCT01282801|3783951|FG001|COMPLETED|Washout of 7 Days||9
3063052|NCT01282801|3783950|FG000|NOT COMPLETED|Washout of 7 Days||0
3063053|NCT01282801|3783951|FG001|NOT COMPLETED|Washout of 7 Days||0
3063054|NCT01282801|3783950|FG000|STARTED|Second Intervention||9
3063055|NCT01282801|3783951|FG001|STARTED|Second Intervention||9
3063056|NCT01282801|3783950|FG000|COMPLETED|Second Intervention||9
3063057|NCT01282801|3783951|FG001|COMPLETED|Second Intervention||8
3063058|NCT01282801|3783950|FG000|NOT COMPLETED|Second Intervention||0
3063059|NCT01282801|3783951|FG001|NOT COMPLETED|Second Intervention||1
3063060|NCT01282814|3783959|FG000|STARTED|First Intervention||12
3063061|NCT01282814|3783960|FG001|STARTED|First Intervention||12
3063062|NCT01282814|3783959|FG000|COMPLETED|First Intervention||12
3063063|NCT01282814|3783960|FG001|COMPLETED|First Intervention||9
3063064|NCT01282814|3783959|FG000|NOT COMPLETED|First Intervention||0
3063065|NCT01282814|3783960|FG001|NOT COMPLETED|First Intervention||3
3063066|NCT01282814|3783959|FG000|STARTED|Washout of 7 Days||12
3063067|NCT01282814|3783960|FG001|STARTED|Washout of 7 Days||9
3063068|NCT01282814|3783959|FG000|COMPLETED|Washout of 7 Days||10
3063069|NCT01282814|3783960|FG001|COMPLETED|Washout of 7 Days||9
3063070|NCT01282814|3783959|FG000|NOT COMPLETED|Washout of 7 Days||2
3063071|NCT01282814|3783960|FG001|NOT COMPLETED|Washout of 7 Days||0
3063072|NCT01282814|3783959|FG000|STARTED|Second Intervention||10
3063073|NCT01282814|3783960|FG001|STARTED|Second Intervention||9
3063074|NCT01282814|3783959|FG000|COMPLETED|Second Intervention||10
3063075|NCT01282814|3783960|FG001|COMPLETED|Second Intervention||9
3063076|NCT01282814|3783959|FG000|NOT COMPLETED|Second Intervention||0
3063077|NCT01282814|3783960|FG001|NOT COMPLETED|Second Intervention||0
3063078|NCT01282866|3783966|FG000|STARTED|Overall Study||35
3063079|NCT01282866|3783966|FG000|COMPLETED|Overall Study||34
3063080|NCT01282866|3783966|FG000|NOT COMPLETED|Overall Study||1
3063081|NCT01283009|3783972|FG000|STARTED|Overall Study||287
3063082|NCT01283009|3783973|FG001|STARTED|Overall Study||297
3063083|NCT01283009|3783972|FG000|COMPLETED|Overall Study||169
3063084|NCT01283009|3783973|FG001|COMPLETED|Overall Study||180
3063085|NCT01283009|3783972|FG000|NOT COMPLETED|Overall Study||118
3063086|NCT01283009|3783973|FG001|NOT COMPLETED|Overall Study||117
3063087|NCT01283022|3783979|FG000|STARTED|Overall Study||24
3063088|NCT01283022|3783979|FG000|COMPLETED|Overall Study||24
3063089|NCT01283022|3783979|FG000|NOT COMPLETED|Overall Study||0
3063090|NCT01283035|3783984|FG000|STARTED|Overall Study||6
3063091|NCT01283035|3783984|FG000|COMPLETED|Overall Study||5
3063092|NCT01283035|3783984|FG000|NOT COMPLETED|Overall Study||1
3063093|NCT01283139|3783992|FG000|STARTED|Overall Study||108
3063094|NCT01283139|3783993|FG001|STARTED|Overall Study||108
3063095|NCT01283139|3783994|FG002|STARTED|Overall Study||109
3063096|NCT01283139|3783995|FG003|STARTED|Overall Study||107
3063097|NCT01283139|3783992|FG000|COMPLETED|Overall Study||91
3162911|NCT01881750|3890378|FG001|COMPLETED|Overall Study||22
3162912|NCT01881750|3890377|FG000|NOT COMPLETED|Overall Study||2
3063098|NCT01283139|3783993|FG001|COMPLETED|Overall Study||90
3063099|NCT01283139|3783994|FG002|COMPLETED|Overall Study||91
3063100|NCT01283139|3783995|FG003|COMPLETED|Overall Study||92
3063101|NCT01283139|3783992|FG000|NOT COMPLETED|Overall Study||17
3063102|NCT01283139|3783993|FG001|NOT COMPLETED|Overall Study||18
3063103|NCT01283139|3783994|FG002|NOT COMPLETED|Overall Study||18
3063104|NCT01283139|3783995|FG003|NOT COMPLETED|Overall Study||15
3063105|NCT01283152|3784007|FG000|STARTED|Overall Study||25
3063106|NCT01283152|3784008|FG001|STARTED|Overall Study||25
3063107|NCT01283152|3784007|FG000|ITT Population|Overall Study||25
3063108|NCT01283152|3784008|FG001|ITT Population|Overall Study||25
3063109|NCT01283152|3784007|FG000|Study Treatment Received|Overall Study||25
3063110|NCT01283152|3784008|FG001|Study Treatment Received|Overall Study||25
3063111|NCT01283152|3784007|FG000|24-hr HESA Attempted|Overall Study||25
3063112|NCT01283152|3784008|FG001|24-hr HESA Attempted|Overall Study||25
3063113|NCT01283152|3784007|FG000|COMPLETED|Overall Study||23
3063114|NCT01283152|3784008|FG001|COMPLETED|Overall Study||25
3063115|NCT01283152|3784007|FG000|NOT COMPLETED|Overall Study||2
3063116|NCT01283152|3784008|FG001|NOT COMPLETED|Overall Study||0
3063117|NCT01283282|3784014|FG000|STARTED|First Intervention (6 Weeks)||25
3063118|NCT01283282|3784015|FG001|STARTED|First Intervention (6 Weeks)||23
3063119|NCT01283282|3784014|FG000|COMPLETED|First Intervention (6 Weeks)||22
3063120|NCT01283282|3784015|FG001|COMPLETED|First Intervention (6 Weeks)||19
3162913|NCT01881750|3890378|FG001|NOT COMPLETED|Overall Study||4
3063121|NCT01283282|3784014|FG000|NOT COMPLETED|First Intervention (6 Weeks)||3
3063122|NCT01283282|3784015|FG001|NOT COMPLETED|First Intervention (6 Weeks)||4
3063123|NCT01283282|3784014|FG000|STARTED|Second Intervention (6 Weeks)||22
3063124|NCT01283282|3784015|FG001|STARTED|Second Intervention (6 Weeks)||19
3063125|NCT01283282|3784014|FG000|COMPLETED|Second Intervention (6 Weeks)||22
3063126|NCT01283282|3784015|FG001|COMPLETED|Second Intervention (6 Weeks)||19
3063127|NCT01283282|3784014|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||0
3063128|NCT01283282|3784015|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||0
3063129|NCT01283321|3784024|FG000|STARTED|Overall Study||10
3063130|NCT01283321|3784025|FG001|STARTED|Overall Study||10
3063131|NCT01283321|3784024|FG000|COMPLETED|Overall Study||10
3063132|NCT01283321|3784025|FG001|COMPLETED|Overall Study||10
3063133|NCT01283321|3784024|FG000|NOT COMPLETED|Overall Study||0
3063134|NCT01283321|3784025|FG001|NOT COMPLETED|Overall Study||0
3063135|NCT01283334|3784033|FG000|STARTED|Overall Study||20
3063136|NCT01283334|3784033|FG000|COMPLETED|Overall Study||13
3063137|NCT01283334|3784033|FG000|NOT COMPLETED|Overall Study||7
3063138|NCT01283386|3784041|FG000|STARTED|Overall Study||10
3063139|NCT01283386|3784042|FG001|STARTED|Overall Study||16
3063140|NCT01283386|3784041|FG000|COMPLETED|Overall Study||2
3063141|NCT01283386|3784042|FG001|COMPLETED|Overall Study||4
3063142|NCT01283386|3784041|FG000|NOT COMPLETED|Overall Study||8
3063143|NCT01283386|3784042|FG001|NOT COMPLETED|Overall Study||12
3063144|NCT01283464|3784050|FG000|STARTED|Overall Study||12
3063145|NCT01283464|3784051|FG001|STARTED|Overall Study||12
3063146|NCT01283464|3784050|FG000|COMPLETED|Overall Study||10
3063147|NCT01283464|3784051|FG001|COMPLETED|Overall Study||11
3063148|NCT01283464|3784050|FG000|NOT COMPLETED|Overall Study||2
3063149|NCT01283464|3784051|FG001|NOT COMPLETED|Overall Study||1
3063150|NCT01283516|3784066|FG000|STARTED|Overall Study|Started = Full Analysis Set and Safety Set|2
3063151|NCT01283516|3784067|FG001|STARTED|Overall Study||2
3063152|NCT01283516|3784068|FG002|STARTED|Overall Study||3
3063153|NCT01283516|3784069|FG003|STARTED|Overall Study||3
3063154|NCT01283516|3784070|FG004|STARTED|Overall Study||14
3063155|NCT01283516|3784071|FG005|STARTED|Overall Study||10
3063156|NCT01283516|3784072|FG006|STARTED|Overall Study||10
3063157|NCT01283516|3784073|FG007|STARTED|Overall Study||5
3063158|NCT01283516|3784074|FG008|STARTED|Overall Study||255
3063159|NCT01283516|3784066|FG000|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||2
3063160|NCT01283516|3784067|FG001|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||1
3063161|NCT01283516|3784068|FG002|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||2
3063162|NCT01283516|3784069|FG003|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||3
3063163|NCT01283516|3784070|FG004|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||12
3063164|NCT01283516|3784071|FG005|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||10
3063165|NCT01283516|3784072|FG006|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||9
3063166|NCT01283516|3784073|FG007|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||5
3063167|NCT01283516|3784074|FG008|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||246
3063168|NCT01283516|3784066|FG000|Dose-Determining Set (DDS)|Overall Study||2
3063169|NCT01283516|3784067|FG001|Dose-Determining Set (DDS)|Overall Study||1
3063170|NCT01283516|3784068|FG002|Dose-Determining Set (DDS)|Overall Study||3
3063171|NCT01283516|3784069|FG003|Dose-Determining Set (DDS)|Overall Study||3
3063172|NCT01283516|3784070|FG004|Dose-Determining Set (DDS)|Overall Study||14
3063173|NCT01283516|3784071|FG005|Dose-Determining Set (DDS)|Overall Study||8
3063174|NCT01283516|3784072|FG006|Dose-Determining Set (DDS)|Overall Study||10
3063175|NCT01283516|3784073|FG007|Dose-Determining Set (DDS)|Overall Study||5
3162914|NCT01881776|3890389|FG000|STARTED|Overall Study||24
3162915|NCT01881776|3890390|FG001|STARTED|Overall Study||24
3162916|NCT01881776|3890391|FG002|STARTED|Overall Study||22
3162917|NCT01881776|3890389|FG000|COMPLETED|Overall Study||23
3162918|NCT01881776|3890390|FG001|COMPLETED|Overall Study||20
3162919|NCT01881776|3890391|FG002|COMPLETED|Overall Study||20
3162920|NCT01881776|3890389|FG000|NOT COMPLETED|Overall Study||1
3063176|NCT01283516|3784074|FG008|Dose-Determining Set (DDS)|Overall Study||8
3063177|NCT01283516|3784066|FG000|Non-NSCLC|Overall Study||0
3063178|NCT01283516|3784067|FG001|Non-NSCLC|Overall Study||1
3063179|NCT01283516|3784068|FG002|Non-NSCLC|Overall Study||1
3063180|NCT01283516|3784069|FG003|Non-NSCLC|Overall Study||0
3063181|NCT01283516|3784070|FG004|Non-NSCLC|Overall Study||2
3063182|NCT01283516|3784071|FG005|Non-NSCLC|Overall Study||0
3063183|NCT01283516|3784072|FG006|Non-NSCLC|Overall Study||1
3063184|NCT01283516|3784073|FG007|Non-NSCLC|Overall Study||0
3063185|NCT01283516|3784074|FG008|Non-NSCLC|Overall Study|Small number of patients at 750 mg - non-NSCLC, assessment limited, not included in efficacy tables|9
3063186|NCT01283516|3784066|FG000|COMPLETED|Overall Study|Completed - see explanation in Recruitment Details.|0
3063187|NCT01283516|3784067|FG001|COMPLETED|Overall Study||0
3063188|NCT01283516|3784068|FG002|COMPLETED|Overall Study||0
3063189|NCT01283516|3784069|FG003|COMPLETED|Overall Study||0
3063190|NCT01283516|3784070|FG004|COMPLETED|Overall Study||0
3063191|NCT01283516|3784071|FG005|COMPLETED|Overall Study||0
3063192|NCT01283516|3784072|FG006|COMPLETED|Overall Study||0
3063193|NCT01283516|3784073|FG007|COMPLETED|Overall Study||0
3063194|NCT01283516|3784074|FG008|COMPLETED|Overall Study||0
3063195|NCT01283516|3784066|FG000|NOT COMPLETED|Overall Study||2
3162921|NCT01881776|3890390|FG001|NOT COMPLETED|Overall Study||4
3162922|NCT01881776|3890391|FG002|NOT COMPLETED|Overall Study||2
3162923|NCT01881789|3890405|FG000|STARTED|Overall Study||3
3162924|NCT01881789|3890406|FG001|STARTED|Overall Study||7
3162925|NCT01881789|3890407|FG002|STARTED|Overall Study||3
3063196|NCT01283516|3784067|FG001|NOT COMPLETED|Overall Study||2
3063197|NCT01283516|3784068|FG002|NOT COMPLETED|Overall Study||3
3063198|NCT01283516|3784069|FG003|NOT COMPLETED|Overall Study||3
3063199|NCT01283516|3784070|FG004|NOT COMPLETED|Overall Study||14
3063200|NCT01283516|3784071|FG005|NOT COMPLETED|Overall Study||10
3063201|NCT01283516|3784072|FG006|NOT COMPLETED|Overall Study||10
3063202|NCT01283516|3784073|FG007|NOT COMPLETED|Overall Study||5
3063203|NCT01283516|3784074|FG008|NOT COMPLETED|Overall Study||255
3063204|NCT01283542|3784102|FG000|STARTED|Main Phase||20
3063205|NCT01283542|3784102|FG000|Full Analysis Set (FAS)|Main Phase||20
3063206|NCT01283542|3784102|FG000|Safety Analysis Set|Main Phase||20
3063207|NCT01283542|3784102|FG000|COMPLETED|Main Phase||13
3063208|NCT01283542|3784102|FG000|NOT COMPLETED|Main Phase||7
3063209|NCT01283542|3784102|FG000|STARTED|Extension Phase||13
3063210|NCT01283542|3784102|FG000|Full Analysis Set (FAS)|Extension Phase||13
3063211|NCT01283542|3784102|FG000|Safety Analysis Set|Extension Phase||13
3063212|NCT01283542|3784102|FG000|COMPLETED|Extension Phase||10
3063213|NCT01283542|3784102|FG000|NOT COMPLETED|Extension Phase||3
3063214|NCT01283555|3784124|FG000|STARTED|First Intervention||13
3063215|NCT01283555|3784125|FG001|STARTED|First Intervention||12
3063216|NCT01283555|3784124|FG000|COMPLETED|First Intervention||13
3063217|NCT01283555|3784125|FG001|COMPLETED|First Intervention||12
3063218|NCT01283555|3784124|FG000|NOT COMPLETED|First Intervention||0
3063219|NCT01283555|3784125|FG001|NOT COMPLETED|First Intervention||0
3063220|NCT01283555|3784124|FG000|STARTED|Washout Period of at Least 21 Days||13
3063221|NCT01283555|3784125|FG001|STARTED|Washout Period of at Least 21 Days||12
3063222|NCT01283555|3784124|FG000|COMPLETED|Washout Period of at Least 21 Days||13
3063223|NCT01283555|3784125|FG001|COMPLETED|Washout Period of at Least 21 Days||12
3063224|NCT01283555|3784124|FG000|NOT COMPLETED|Washout Period of at Least 21 Days||0
3063225|NCT01283555|3784125|FG001|NOT COMPLETED|Washout Period of at Least 21 Days||0
3063226|NCT01283555|3784124|FG000|STARTED|Second Intervention||13
3063227|NCT01283555|3784125|FG001|STARTED|Second Intervention||12
3063228|NCT01283555|3784124|FG000|COMPLETED|Second Intervention||13
3063229|NCT01283555|3784125|FG001|COMPLETED|Second Intervention||12
3063230|NCT01283555|3784124|FG000|NOT COMPLETED|Second Intervention||0
3063231|NCT01283555|3784125|FG001|NOT COMPLETED|Second Intervention||0
3063232|NCT01283581|3784138|FG000|STARTED|Overall Study||81
3063233|NCT01283581|3784139|FG001|STARTED|Overall Study||77
3063234|NCT01283581|3784140|FG002|STARTED|Overall Study||98
3063235|NCT01283581|3784138|FG000|COMPLETED|Overall Study||69
3063236|NCT01283581|3784139|FG001|COMPLETED|Overall Study||63
3063237|NCT01283581|3784140|FG002|COMPLETED|Overall Study||78
3063238|NCT01283581|3784138|FG000|NOT COMPLETED|Overall Study||12
3063239|NCT01283581|3784139|FG001|NOT COMPLETED|Overall Study||14
3063240|NCT01283581|3784140|FG002|NOT COMPLETED|Overall Study||20
3063241|NCT01283971|3784153|FG000|STARTED|Overall Study||48
3063242|NCT01283971|3784154|FG001|STARTED|Overall Study||48
3063243|NCT01283971|3784153|FG000|Intent to Treat Population|Overall Study||46
3063244|NCT01283971|3784154|FG001|Intent to Treat Population|Overall Study||48
3063245|NCT01283971|3784153|FG000|COMPLETED|Overall Study||33
3063246|NCT01283971|3784154|FG001|COMPLETED|Overall Study||36
3063247|NCT01283971|3784153|FG000|NOT COMPLETED|Overall Study||15
3063248|NCT01283971|3784154|FG001|NOT COMPLETED|Overall Study||12
3063249|NCT01284062|3784164|FG000|STARTED|Overall Study||21
3063250|NCT01284062|3784165|FG001|STARTED|Overall Study||21
3063251|NCT01284062|3784166|FG002|STARTED|Overall Study||21
3063252|NCT01284062|3784167|FG003|STARTED|Overall Study||21
3063253|NCT01284062|3784164|FG000|COMPLETED|Overall Study||10
3063254|NCT01284062|3784165|FG001|COMPLETED|Overall Study||13
3063255|NCT01284062|3784166|FG002|COMPLETED|Overall Study||15
3063256|NCT01284062|3784167|FG003|COMPLETED|Overall Study||7
3063257|NCT01284062|3784164|FG000|NOT COMPLETED|Overall Study||11
3063258|NCT01284062|3784165|FG001|NOT COMPLETED|Overall Study||8
3063259|NCT01284062|3784166|FG002|NOT COMPLETED|Overall Study||6
3063260|NCT01284062|3784167|FG003|NOT COMPLETED|Overall Study||14
3063261|NCT01284114|3784180|FG000|STARTED|Overall Study||23
3063262|NCT01284114|3784180|FG000|COMPLETED|Overall Study||19
3063263|NCT01284114|3784180|FG000|NOT COMPLETED|Overall Study||4
3063264|NCT01284127|3784185|FG000|STARTED|Overall Study||38
3063265|NCT01284127|3784185|FG000|COMPLETED|Overall Study||31
3063266|NCT01284127|3784185|FG000|NOT COMPLETED|Overall Study||7
3063267|NCT01284140|3784191|FG000|STARTED|Randomization and Intervention||11
3063268|NCT01284140|3784192|FG001|STARTED|Randomization and Intervention||11
3063269|NCT01284140|3784191|FG000|COMPLETED|Randomization and Intervention||11
3063270|NCT01284140|3784192|FG001|COMPLETED|Randomization and Intervention||11
3063271|NCT01284140|3784191|FG000|NOT COMPLETED|Randomization and Intervention||0
3063272|NCT01284140|3784192|FG001|NOT COMPLETED|Randomization and Intervention||0
3063273|NCT01284140|3784191|FG000|STARTED|Subjects With Paired 24hr Collections||11
3063274|NCT01284140|3784192|FG001|STARTED|Subjects With Paired 24hr Collections||11
3063275|NCT01284140|3784191|FG000|COMPLETED|Subjects With Paired 24hr Collections||6
3063276|NCT01284140|3784192|FG001|COMPLETED|Subjects With Paired 24hr Collections||5
3063277|NCT01284140|3784191|FG000|NOT COMPLETED|Subjects With Paired 24hr Collections||5
3063278|NCT01284140|3784192|FG001|NOT COMPLETED|Subjects With Paired 24hr Collections||6
3063279|NCT01284244|3784200|FG000|STARTED|Overall Study||18
3063280|NCT01284244|3784201|FG001|STARTED|Overall Study||18
3063281|NCT01284244|3784200|FG000|COMPLETED|Overall Study||18
3063282|NCT01284244|3784201|FG001|COMPLETED|Overall Study||18
3063283|NCT01284244|3784200|FG000|NOT COMPLETED|Overall Study||0
3063284|NCT01284244|3784201|FG001|NOT COMPLETED|Overall Study||0
3063285|NCT01284296|3784207|FG000|STARTED|Overall Study||20
3063286|NCT01284296|3784207|FG000|COMPLETED|Overall Study||20
3063287|NCT01284296|3784207|FG000|NOT COMPLETED|Overall Study||0
3063288|NCT01284335|3784225|FG000|STARTED|Overall Study||25
3063289|NCT01284335|3784226|FG001|STARTED|Overall Study||33
3063290|NCT01284335|3784227|FG002|STARTED|Overall Study||5
3063291|NCT01284335|3784228|FG003|STARTED|Overall Study||5
3063292|NCT01284335|3784229|FG004|STARTED|Overall Study||24
3063293|NCT01284335|3784230|FG005|STARTED|Overall Study||26
3063294|NCT01284335|3784231|FG006|STARTED|Overall Study||19
3063295|NCT01284335|3784232|FG007|STARTED|Overall Study||6
3063296|NCT01284335|3784233|FG008|STARTED|Overall Study||4
3063297|NCT01284335|3784234|FG009|STARTED|Overall Study||14
3063298|NCT01284335|3784235|FG010|STARTED|Overall Study||45
3063299|NCT01284335|3784236|FG011|STARTED|Overall Study||16
3063300|NCT01284335|3784237|FG012|STARTED|Overall Study||12
3063301|NCT01284335|3784225|FG000|Received at Least One Dose of Study Drug|Overall Study||25
3063302|NCT01284335|3784226|FG001|Received at Least One Dose of Study Drug|Overall Study||33
3063303|NCT01284335|3784227|FG002|Received at Least One Dose of Study Drug|Overall Study||5
3063304|NCT01284335|3784228|FG003|Received at Least One Dose of Study Drug|Overall Study||5
3063305|NCT01284335|3784229|FG004|Received at Least One Dose of Study Drug|Overall Study||24
3063306|NCT01284335|3784230|FG005|Received at Least One Dose of Study Drug|Overall Study||26
3063307|NCT01284335|3784231|FG006|Received at Least One Dose of Study Drug|Overall Study||19
3063308|NCT01284335|3784232|FG007|Received at Least One Dose of Study Drug|Overall Study||6
3063309|NCT01284335|3784233|FG008|Received at Least One Dose of Study Drug|Overall Study||4
3063310|NCT01284335|3784234|FG009|Received at Least One Dose of Study Drug|Overall Study||14
3284148|NCT02761915|4017891|FG003|COMPLETED|Overall Study||0
3284149|NCT02761915|4017892|FG004|COMPLETED|Overall Study||0
3284150|NCT02761915|4017893|FG005|COMPLETED|Overall Study||0
3284151|NCT02761915|4017888|FG000|NOT COMPLETED|Overall Study||4
3284152|NCT02761915|4017889|FG001|NOT COMPLETED|Overall Study||1
3284153|NCT02761915|4017890|FG002|NOT COMPLETED|Overall Study||1
3284154|NCT02761915|4017891|FG003|NOT COMPLETED|Overall Study||3
3284155|NCT02761915|4017892|FG004|NOT COMPLETED|Overall Study||3
3284156|NCT02761915|4017893|FG005|NOT COMPLETED|Overall Study||5
3284157|NCT02761967|4017913|FG000|STARTED|Overall Study||70
3284158|NCT02761967|4017914|FG001|STARTED|Overall Study||70
3284159|NCT02761967|4017913|FG000|COMPLETED|Overall Study||65
3284160|NCT02761967|4017914|FG001|COMPLETED|Overall Study||64
3284161|NCT02761967|4017913|FG000|NOT COMPLETED|Overall Study||5
3284162|NCT02761967|4017914|FG001|NOT COMPLETED|Overall Study||6
3284163|NCT02761980|4017927|FG000|STARTED|Overall Study||29
3284164|NCT02761980|4017928|FG001|STARTED|Overall Study||87
3284165|NCT02761980|4017929|FG002|STARTED|Overall Study||87
3284166|NCT02761980|4017930|FG003|STARTED|Overall Study||87
3284167|NCT02761980|4017927|FG000|COMPLETED|Overall Study||25
3284168|NCT02761980|4017928|FG001|COMPLETED|Overall Study||80
3284169|NCT02761980|4017929|FG002|COMPLETED|Overall Study||81
3284170|NCT02761980|4017930|FG003|COMPLETED|Overall Study||81
3284171|NCT02761980|4017927|FG000|NOT COMPLETED|Overall Study||4
3284172|NCT02761980|4017928|FG001|NOT COMPLETED|Overall Study||7
3284173|NCT02761980|4017929|FG002|NOT COMPLETED|Overall Study||6
3284174|NCT02761980|4017930|FG003|NOT COMPLETED|Overall Study||6
3284175|NCT02761993|4017943|FG000|STARTED|Overall Study||52
3284176|NCT02761993|4017944|FG001|STARTED|Overall Study||49
3284177|NCT02761993|4017945|FG002|STARTED|Overall Study||50
3284178|NCT02761993|4017943|FG000|COMPLETED|Overall Study||50
3284179|NCT02761993|4017944|FG001|COMPLETED|Overall Study||43
3284180|NCT02761993|4017945|FG002|COMPLETED|Overall Study||46
3284181|NCT02761993|4017943|FG000|NOT COMPLETED|Overall Study||2
3162926|NCT01881789|3890408|FG003|STARTED|Overall Study||3
3162927|NCT01881789|3890409|FG004|STARTED|Overall Study||2
3162928|NCT01881789|3890410|FG005|STARTED|Overall Study||3
3162929|NCT01881789|3890405|FG000|COMPLETED|Overall Study||0
3162930|NCT01881789|3890406|FG001|COMPLETED|Overall Study||0
3162931|NCT01881789|3890407|FG002|COMPLETED|Overall Study||0
3063311|NCT01284335|3784235|FG010|Received at Least One Dose of Study Drug|Overall Study||45
3063312|NCT01284335|3784236|FG011|Received at Least One Dose of Study Drug|Overall Study||16
3063313|NCT01284335|3784237|FG012|Received at Least One Dose of Study Drug|Overall Study||12
3063314|NCT01284335|3784225|FG000|COMPLETED|Overall Study||25
3063315|NCT01284335|3784226|FG001|COMPLETED|Overall Study||33
3063316|NCT01284335|3784227|FG002|COMPLETED|Overall Study||5
3063317|NCT01284335|3784228|FG003|COMPLETED|Overall Study||5
3063318|NCT01284335|3784229|FG004|COMPLETED|Overall Study||24
3063319|NCT01284335|3784230|FG005|COMPLETED|Overall Study||26
3063320|NCT01284335|3784231|FG006|COMPLETED|Overall Study||19
3063321|NCT01284335|3784232|FG007|COMPLETED|Overall Study||6
3063322|NCT01284335|3784233|FG008|COMPLETED|Overall Study||4
3284182|NCT02761993|4017944|FG001|NOT COMPLETED|Overall Study||6
3284183|NCT02761993|4017945|FG002|NOT COMPLETED|Overall Study||4
3284184|NCT02762071|4017955|FG000|STARTED|Overall Study||54
3284185|NCT02762071|4017956|FG001|STARTED|Overall Study||54
3284186|NCT02762071|4017955|FG000|COMPLETED|Overall Study||54
3284187|NCT02762071|4017956|FG001|COMPLETED|Overall Study||54
3063323|NCT01284335|3784234|FG009|COMPLETED|Overall Study||14
3162932|NCT01881789|3890408|FG003|COMPLETED|Overall Study||0
3162933|NCT01881789|3890409|FG004|COMPLETED|Overall Study||0
3284188|NCT02762071|4017955|FG000|NOT COMPLETED|Overall Study||0
3063324|NCT01284335|3784235|FG010|COMPLETED|Overall Study||45
3063325|NCT01284335|3784236|FG011|COMPLETED|Overall Study||16
3063326|NCT01284335|3784237|FG012|COMPLETED|Overall Study||12
3063327|NCT01284335|3784225|FG000|NOT COMPLETED|Overall Study||0
3063328|NCT01284335|3784226|FG001|NOT COMPLETED|Overall Study||0
3063329|NCT01284335|3784227|FG002|NOT COMPLETED|Overall Study||0
3063330|NCT01284335|3784228|FG003|NOT COMPLETED|Overall Study||0
3063331|NCT01284335|3784229|FG004|NOT COMPLETED|Overall Study||0
3063332|NCT01284335|3784230|FG005|NOT COMPLETED|Overall Study||0
3063333|NCT01284335|3784231|FG006|NOT COMPLETED|Overall Study||0
3063334|NCT01284335|3784232|FG007|NOT COMPLETED|Overall Study||0
3063335|NCT01284335|3784233|FG008|NOT COMPLETED|Overall Study||0
3063336|NCT01284335|3784234|FG009|NOT COMPLETED|Overall Study||0
3063337|NCT01284335|3784235|FG010|NOT COMPLETED|Overall Study||0
3063338|NCT01284335|3784236|FG011|NOT COMPLETED|Overall Study||0
3063339|NCT01284335|3784237|FG012|NOT COMPLETED|Overall Study||0
3063340|NCT01284361|3784277|FG000|STARTED|Overall Study||91
3063341|NCT01284361|3784277|FG000|COMPLETED|Overall Study||82
3063342|NCT01284361|3784277|FG000|NOT COMPLETED|Overall Study||9
3063343|NCT01284426|3784284|FG000|STARTED|Overall Study||94
3063344|NCT01284426|3784284|FG000|COMPLETED|Overall Study||92
3063345|NCT01284426|3784284|FG000|NOT COMPLETED|Overall Study||2
3063346|NCT01284517|3784290|FG000|STARTED|Overall Study||180
3063347|NCT01284517|3784291|FG001|STARTED|Overall Study||176
3063348|NCT01284517|3784290|FG000|COMPLETED|Overall Study||148
3063349|NCT01284517|3784291|FG001|COMPLETED|Overall Study||140
3063350|NCT01284517|3784290|FG000|NOT COMPLETED|Overall Study||32
3063351|NCT01284517|3784291|FG001|NOT COMPLETED|Overall Study||36
3063352|NCT01284621|3784297|FG000|STARTED|First Intervention (8 Days)||3
3063353|NCT01284621|3784298|FG001|STARTED|First Intervention (8 Days)||4
3063354|NCT01284621|3784299|FG002|STARTED|First Intervention (8 Days)||4
3063355|NCT01284621|3784300|FG003|STARTED|First Intervention (8 Days)||4
3063356|NCT01284621|3784301|FG004|STARTED|First Intervention (8 Days)||4
3063357|NCT01284621|3784302|FG005|STARTED|First Intervention (8 Days)||4
3063358|NCT01284621|3784297|FG000|COMPLETED|First Intervention (8 Days)||3
3063359|NCT01284621|3784298|FG001|COMPLETED|First Intervention (8 Days)||4
3063360|NCT01284621|3784299|FG002|COMPLETED|First Intervention (8 Days)||4
3063361|NCT01284621|3784300|FG003|COMPLETED|First Intervention (8 Days)||4
3063362|NCT01284621|3784301|FG004|COMPLETED|First Intervention (8 Days)||4
3063363|NCT01284621|3784302|FG005|COMPLETED|First Intervention (8 Days)||4
3063364|NCT01284621|3784297|FG000|NOT COMPLETED|First Intervention (8 Days)||0
3063365|NCT01284621|3784298|FG001|NOT COMPLETED|First Intervention (8 Days)||0
3063366|NCT01284621|3784299|FG002|NOT COMPLETED|First Intervention (8 Days)||0
3063367|NCT01284621|3784300|FG003|NOT COMPLETED|First Intervention (8 Days)||0
3063368|NCT01284621|3784301|FG004|NOT COMPLETED|First Intervention (8 Days)||0
3063369|NCT01284621|3784302|FG005|NOT COMPLETED|First Intervention (8 Days)||0
3063370|NCT01284621|3784297|FG000|STARTED|Washout Period 1 (7 Days)||3
3063371|NCT01284621|3784298|FG001|STARTED|Washout Period 1 (7 Days)||4
3063372|NCT01284621|3784299|FG002|STARTED|Washout Period 1 (7 Days)||4
3063373|NCT01284621|3784300|FG003|STARTED|Washout Period 1 (7 Days)||4
3063374|NCT01284621|3784301|FG004|STARTED|Washout Period 1 (7 Days)||4
3063375|NCT01284621|3784302|FG005|STARTED|Washout Period 1 (7 Days)||4
3063376|NCT01284621|3784297|FG000|COMPLETED|Washout Period 1 (7 Days)||3
3063377|NCT01284621|3784298|FG001|COMPLETED|Washout Period 1 (7 Days)||4
3063378|NCT01284621|3784299|FG002|COMPLETED|Washout Period 1 (7 Days)||4
3063379|NCT01284621|3784300|FG003|COMPLETED|Washout Period 1 (7 Days)||4
3063380|NCT01284621|3784301|FG004|COMPLETED|Washout Period 1 (7 Days)||3
3063381|NCT01284621|3784302|FG005|COMPLETED|Washout Period 1 (7 Days)||4
3063382|NCT01284621|3784297|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0
3063383|NCT01284621|3784298|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0
3063384|NCT01284621|3784299|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||0
3063385|NCT01284621|3784300|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||0
3063386|NCT01284621|3784301|FG004|NOT COMPLETED|Washout Period 1 (7 Days)||1
3063387|NCT01284621|3784302|FG005|NOT COMPLETED|Washout Period 1 (7 Days)||0
3063388|NCT01284621|3784297|FG000|STARTED|Second Intervention (8 Days)||3
3063389|NCT01284621|3784298|FG001|STARTED|Second Intervention (8 Days)||4
3063390|NCT01284621|3784299|FG002|STARTED|Second Intervention (8 Days)||4
3063391|NCT01284621|3784300|FG003|STARTED|Second Intervention (8 Days)||4
3063392|NCT01284621|3784301|FG004|STARTED|Second Intervention (8 Days)||3
3063393|NCT01284621|3784302|FG005|STARTED|Second Intervention (8 Days)||4
3063394|NCT01284621|3784297|FG000|COMPLETED|Second Intervention (8 Days)||3
3063395|NCT01284621|3784298|FG001|COMPLETED|Second Intervention (8 Days)||4
3063396|NCT01284621|3784299|FG002|COMPLETED|Second Intervention (8 Days)||4
3063397|NCT01284621|3784300|FG003|COMPLETED|Second Intervention (8 Days)||4
3063398|NCT01284621|3784301|FG004|COMPLETED|Second Intervention (8 Days)||3
3063399|NCT01284621|3784302|FG005|COMPLETED|Second Intervention (8 Days)||4
3063400|NCT01284621|3784297|FG000|NOT COMPLETED|Second Intervention (8 Days)||0
3063401|NCT01284621|3784298|FG001|NOT COMPLETED|Second Intervention (8 Days)||0
3063402|NCT01284621|3784299|FG002|NOT COMPLETED|Second Intervention (8 Days)||0
3063403|NCT01284621|3784300|FG003|NOT COMPLETED|Second Intervention (8 Days)||0
3063404|NCT01284621|3784301|FG004|NOT COMPLETED|Second Intervention (8 Days)||0
3063405|NCT01284621|3784302|FG005|NOT COMPLETED|Second Intervention (8 Days)||0
3063406|NCT01284621|3784297|FG000|STARTED|Washout Period 2 (7 Days)||3
3063407|NCT01284621|3784298|FG001|STARTED|Washout Period 2 (7 Days)||4
3063408|NCT01284621|3784299|FG002|STARTED|Washout Period 2 (7 Days)||4
3063409|NCT01284621|3784300|FG003|STARTED|Washout Period 2 (7 Days)||4
3063410|NCT01284621|3784301|FG004|STARTED|Washout Period 2 (7 Days)||3
3063411|NCT01284621|3784302|FG005|STARTED|Washout Period 2 (7 Days)||4
3063412|NCT01284621|3784297|FG000|COMPLETED|Washout Period 2 (7 Days)||3
3063413|NCT01284621|3784298|FG001|COMPLETED|Washout Period 2 (7 Days)||4
3063414|NCT01284621|3784299|FG002|COMPLETED|Washout Period 2 (7 Days)||4
3063415|NCT01284621|3784300|FG003|COMPLETED|Washout Period 2 (7 Days)||4
3063416|NCT01284621|3784301|FG004|COMPLETED|Washout Period 2 (7 Days)||3
3063417|NCT01284621|3784302|FG005|COMPLETED|Washout Period 2 (7 Days)||4
3063418|NCT01284621|3784297|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||0
3063419|NCT01284621|3784298|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0
3063420|NCT01284621|3784299|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0
3063421|NCT01284621|3784300|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||0
3063422|NCT01284621|3784301|FG004|NOT COMPLETED|Washout Period 2 (7 Days)||0
3063423|NCT01284621|3784302|FG005|NOT COMPLETED|Washout Period 2 (7 Days)||0
3063424|NCT01284621|3784297|FG000|STARTED|Third Intervention (8 Days)||3
3063425|NCT01284621|3784298|FG001|STARTED|Third Intervention (8 Days)||4
3063426|NCT01284621|3784299|FG002|STARTED|Third Intervention (8 Days)||4
3063427|NCT01284621|3784300|FG003|STARTED|Third Intervention (8 Days)||4
3063428|NCT01284621|3784301|FG004|STARTED|Third Intervention (8 Days)||3
3063429|NCT01284621|3784302|FG005|STARTED|Third Intervention (8 Days)||4
3063430|NCT01284621|3784297|FG000|COMPLETED|Third Intervention (8 Days)||3
3063431|NCT01284621|3784298|FG001|COMPLETED|Third Intervention (8 Days)||4
3063432|NCT01284621|3784299|FG002|COMPLETED|Third Intervention (8 Days)||4
3063433|NCT01284621|3784300|FG003|COMPLETED|Third Intervention (8 Days)||4
3063434|NCT01284621|3784301|FG004|COMPLETED|Third Intervention (8 Days)||3
3063435|NCT01284621|3784302|FG005|COMPLETED|Third Intervention (8 Days)||4
3063436|NCT01284621|3784297|FG000|NOT COMPLETED|Third Intervention (8 Days)||0
3063437|NCT01284621|3784298|FG001|NOT COMPLETED|Third Intervention (8 Days)||0
3063438|NCT01284621|3784299|FG002|NOT COMPLETED|Third Intervention (8 Days)||0
3063439|NCT01284621|3784300|FG003|NOT COMPLETED|Third Intervention (8 Days)||0
3063440|NCT01284621|3784301|FG004|NOT COMPLETED|Third Intervention (8 Days)||0
3063441|NCT01284621|3784302|FG005|NOT COMPLETED|Third Intervention (8 Days)||0
3063442|NCT01284634|3784316|FG000|STARTED|Overall Study||7
3063443|NCT01284634|3784317|FG001|STARTED|Overall Study||6
3063444|NCT01284634|3784318|FG002|STARTED|Overall Study||7
3063445|NCT01284634|3784319|FG003|STARTED|Overall Study||5
3063446|NCT01284634|3784316|FG000|Received at Least 1 Dose of Study Drug|Overall Study||7
3063447|NCT01284634|3784317|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6
3063448|NCT01284634|3784318|FG002|Received at Least 1 Dose of Study Drug|Overall Study||7
3063449|NCT01284634|3784319|FG003|Received at Least 1 Dose of Study Drug|Overall Study||5
3063450|NCT01284634|3784316|FG000|Intent to Treat (ITT) Analysis Set|Overall Study||7
3063451|NCT01284634|3784317|FG001|Intent to Treat (ITT) Analysis Set|Overall Study||6
3063452|NCT01284634|3784318|FG002|Intent to Treat (ITT) Analysis Set|Overall Study||7
3063453|NCT01284634|3784319|FG003|Intent to Treat (ITT) Analysis Set|Overall Study||5
3063454|NCT01284634|3784316|FG000|COMPLETED|Overall Study||6
3063455|NCT01284634|3784317|FG001|COMPLETED|Overall Study||6
3162934|NCT01881789|3890410|FG005|COMPLETED|Overall Study||0
3162935|NCT01881789|3890405|FG000|NOT COMPLETED|Overall Study||3
3162936|NCT01881789|3890406|FG001|NOT COMPLETED|Overall Study||7
3162937|NCT01881789|3890407|FG002|NOT COMPLETED|Overall Study||3
3162938|NCT01881789|3890408|FG003|NOT COMPLETED|Overall Study||3
3063456|NCT01284634|3784318|FG002|COMPLETED|Overall Study||5
3063457|NCT01284634|3784319|FG003|COMPLETED|Overall Study||4
3063458|NCT01284634|3784316|FG000|NOT COMPLETED|Overall Study||1
3063459|NCT01284634|3784317|FG001|NOT COMPLETED|Overall Study||0
3063460|NCT01284634|3784318|FG002|NOT COMPLETED|Overall Study||2
3063461|NCT01284634|3784319|FG003|NOT COMPLETED|Overall Study||1
3063462|NCT01284959|3784332|FG000|STARTED|Overall Study||11
3063463|NCT01284959|3784333|FG001|STARTED|Overall Study||12
3063464|NCT01284959|3784334|FG002|STARTED|Overall Study||11
3063465|NCT01284959|3784332|FG000|COMPLETED|Overall Study||10
3063466|NCT01284959|3784333|FG001|COMPLETED|Overall Study||12
3063467|NCT01284959|3784334|FG002|COMPLETED|Overall Study||10
3063468|NCT01284959|3784332|FG000|NOT COMPLETED|Overall Study||1
3063469|NCT01284959|3784333|FG001|NOT COMPLETED|Overall Study||0
3063470|NCT01284959|3784334|FG002|NOT COMPLETED|Overall Study||1
3063471|NCT01285024|3784344|FG000|STARTED|Overall Study||49
3063472|NCT01285024|3784345|FG001|STARTED|Overall Study||60
3063473|NCT01285024|3784344|FG000|COMPLETED|Overall Study||49
3063474|NCT01285024|3784345|FG001|COMPLETED|Overall Study||60
3063475|NCT01285024|3784344|FG000|NOT COMPLETED|Overall Study||0
3063476|NCT01285024|3784345|FG001|NOT COMPLETED|Overall Study||0
3063477|NCT01285050|3784351|FG000|STARTED|Overall Study||20
3063478|NCT01285050|3784351|FG000|COMPLETED|Overall Study||19
3063479|NCT01285050|3784351|FG000|NOT COMPLETED|Overall Study||1
3063480|NCT01285076|3784356|FG000|STARTED|Overall Study||834
3063481|NCT01285076|3784356|FG000|COMPLETED|Overall Study||834
3063482|NCT01285076|3784356|FG000|NOT COMPLETED|Overall Study||0
3063483|NCT01285310|3784363|FG000|STARTED|Placebo Controlled Phase: Weeks 0-24||79
3063484|NCT01285310|3784364|FG001|STARTED|Placebo Controlled Phase: Weeks 0-24||82
3063485|NCT01285310|3784365|FG002|STARTED|Placebo Controlled Phase: Weeks 0-24||76
3063486|NCT01285310|3784366|FG003|STARTED|Placebo Controlled Phase: Weeks 0-24||0
3162939|NCT01881789|3890409|FG004|NOT COMPLETED|Overall Study||2
3063487|NCT01285310|3784367|FG004|STARTED|Placebo Controlled Phase: Weeks 0-24||0
3063488|NCT01285310|3784363|FG000|COMPLETED|Placebo Controlled Phase: Weeks 0-24|1 participant chose not to enter the active treatment phase|70
3063489|NCT01285310|3784364|FG001|COMPLETED|Placebo Controlled Phase: Weeks 0-24|Four participants chose not to enter the active treatment phase|67
3063490|NCT01285310|3784365|FG002|COMPLETED|Placebo Controlled Phase: Weeks 0-24|1 participant chose not to enter active treatment phase|61
3063491|NCT01285310|3784366|FG003|COMPLETED|Placebo Controlled Phase: Weeks 0-24||0
3063492|NCT01285310|3784367|FG004|COMPLETED|Placebo Controlled Phase: Weeks 0-24||0
3063493|NCT01285310|3784363|FG000|NOT COMPLETED|Placebo Controlled Phase: Weeks 0-24||9
3063494|NCT01285310|3784364|FG001|NOT COMPLETED|Placebo Controlled Phase: Weeks 0-24||15
3063495|NCT01285310|3784365|FG002|NOT COMPLETED|Placebo Controlled Phase: Weeks 0-24||15
3063496|NCT01285310|3784366|FG003|NOT COMPLETED|Placebo Controlled Phase: Weeks 0-24||0
3063497|NCT01285310|3784367|FG004|NOT COMPLETED|Placebo Controlled Phase: Weeks 0-24||0
3063498|NCT01285310|3784363|FG000|STARTED|Active Treatment Phase: Weeks 25-52||0
3063499|NCT01285310|3784364|FG001|STARTED|Active Treatment Phase: Weeks 25-52||63
3063500|NCT01285310|3784365|FG002|STARTED|Active Treatment Phase: Weeks 25-52||60
3063501|NCT01285310|3784366|FG003|STARTED|Active Treatment Phase: Weeks 25-52||27
3063502|NCT01285310|3784367|FG004|STARTED|Active Treatment Phase: Weeks 25-52||42
3063503|NCT01285310|3784363|FG000|COMPLETED|Active Treatment Phase: Weeks 25-52||0
3063504|NCT01285310|3784364|FG001|COMPLETED|Active Treatment Phase: Weeks 25-52||31
3063505|NCT01285310|3784365|FG002|COMPLETED|Active Treatment Phase: Weeks 25-52||34
3063506|NCT01285310|3784366|FG003|COMPLETED|Active Treatment Phase: Weeks 25-52||17
3063507|NCT01285310|3784367|FG004|COMPLETED|Active Treatment Phase: Weeks 25-52||23
3063508|NCT01285310|3784363|FG000|NOT COMPLETED|Active Treatment Phase: Weeks 25-52||0
3063509|NCT01285310|3784364|FG001|NOT COMPLETED|Active Treatment Phase: Weeks 25-52||32
3063510|NCT01285310|3784365|FG002|NOT COMPLETED|Active Treatment Phase: Weeks 25-52||26
3063511|NCT01285310|3784366|FG003|NOT COMPLETED|Active Treatment Phase: Weeks 25-52||10
3063512|NCT01285310|3784367|FG004|NOT COMPLETED|Active Treatment Phase: Weeks 25-52||19
3063513|NCT01285323|3784407|FG000|STARTED|Overall Study||232
3063514|NCT01285323|3784408|FG001|STARTED|Overall Study||232
3063515|NCT01285323|3784407|FG000|Full Analysis Set|Overall Study|Randomized participants who received at least 1 dose of study drug|232
3063516|NCT01285323|3784408|FG001|Full Analysis Set|Overall Study||232
3063517|NCT01285323|3784407|FG000|Safety Analysis Set|Overall Study|Participants who received at least 1 dose of study drug|232
3063518|NCT01285323|3784408|FG001|Safety Analysis Set|Overall Study||232
3063519|NCT01285323|3784407|FG000|COMPLETED|Overall Study||199
3063520|NCT01285323|3784408|FG001|COMPLETED|Overall Study||202
3063521|NCT01285323|3784407|FG000|NOT COMPLETED|Overall Study||33
3063522|NCT01285323|3784408|FG001|NOT COMPLETED|Overall Study||30
3063523|NCT01285349|3784417|FG000|STARTED|Overall Study||190
3063524|NCT01285349|3784418|FG001|STARTED|Overall Study||190
3063525|NCT01285349|3784419|FG002|STARTED|Overall Study||184
3063526|NCT01285349|3784417|FG000|COMPLETED|Overall Study||163
3063527|NCT01285349|3784418|FG001|COMPLETED|Overall Study||170
3063528|NCT01285349|3784419|FG002|COMPLETED|Overall Study||157
3063529|NCT01285349|3784417|FG000|NOT COMPLETED|Overall Study||27
3063530|NCT01285349|3784418|FG001|NOT COMPLETED|Overall Study||20
3063531|NCT01285349|3784419|FG002|NOT COMPLETED|Overall Study||27
3063532|NCT01285401|3784430|FG000|STARTED|Overall Study||115
3063533|NCT01285401|3784431|FG001|STARTED|Overall Study||117
3063534|NCT01285401|3784430|FG000|Treated|Overall Study||113
3063535|NCT01285401|3784431|FG001|Treated|Overall Study||116
3063536|NCT01285401|3784430|FG000|COMPLETED|Overall Study||98
3063537|NCT01285401|3784431|FG001|COMPLETED|Overall Study||88
3063538|NCT01285401|3784430|FG000|NOT COMPLETED|Overall Study||17
3063539|NCT01285401|3784431|FG001|NOT COMPLETED|Overall Study||29
3063540|NCT01285427|3784437|FG000|STARTED|Overall Study||300
3063541|NCT01285427|3784437|FG000|COMPLETED|Overall Study|One sample be discarded per FDA, sample drawn with heparin tube, not specified in protocol.|299
3063542|NCT01285427|3784437|FG000|NOT COMPLETED|Overall Study||1
3063543|NCT01285492|3784451|FG000|STARTED|Overall Study|All patients randomized to this group|121
3063544|NCT01285492|3784452|FG001|STARTED|Overall Study|All patients randomized to this group|39
3063545|NCT01285492|3784451|FG000|Safety Set (for Demographics)|Overall Study|All patients who took study drug; 2 patients did not|119
3063546|NCT01285492|3784452|FG001|Safety Set (for Demographics)|Overall Study|All patients who took study drug|39
3063547|NCT01285492|3784451|FG000|COMPLETED|Overall Study||104
3063548|NCT01285492|3784452|FG001|COMPLETED|Overall Study||38
3063549|NCT01285492|3784451|FG000|NOT COMPLETED|Overall Study||17
3063550|NCT01285492|3784452|FG001|NOT COMPLETED|Overall Study||1
3063551|NCT01285518|3784466|FG000|STARTED|Overall Study||10
3063552|NCT01285518|3784467|FG001|STARTED|Overall Study||10
3063553|NCT01285518|3784468|FG002|STARTED|Overall Study||10
3063554|NCT01285518|3784469|FG003|STARTED|Overall Study||10
3063555|NCT01285518|3784470|FG004|STARTED|Overall Study||10
3063556|NCT01285518|3784471|FG005|STARTED|Overall Study||10
3063557|NCT01285518|3784472|FG006|STARTED|Overall Study||10
3063558|NCT01285518|3784473|FG007|STARTED|Overall Study||14
3063559|NCT01285518|3784466|FG000|COMPLETED|Overall Study||10
3063560|NCT01285518|3784467|FG001|COMPLETED|Overall Study||10
3063561|NCT01285518|3784468|FG002|COMPLETED|Overall Study||10
3063562|NCT01285518|3784469|FG003|COMPLETED|Overall Study||10
3063563|NCT01285518|3784470|FG004|COMPLETED|Overall Study||10
3063564|NCT01285518|3784471|FG005|COMPLETED|Overall Study||9
3063565|NCT01285518|3784472|FG006|COMPLETED|Overall Study||10
3063566|NCT01285518|3784473|FG007|COMPLETED|Overall Study||14
3063567|NCT01285518|3784466|FG000|NOT COMPLETED|Overall Study||0
3063568|NCT01285518|3784467|FG001|NOT COMPLETED|Overall Study||0
3063569|NCT01285518|3784468|FG002|NOT COMPLETED|Overall Study||0
3063570|NCT01285518|3784469|FG003|NOT COMPLETED|Overall Study||0
3063571|NCT01285518|3784470|FG004|NOT COMPLETED|Overall Study||0
3063572|NCT01285518|3784471|FG005|NOT COMPLETED|Overall Study||1
3063573|NCT01285518|3784472|FG006|NOT COMPLETED|Overall Study||0
3063574|NCT01285518|3784473|FG007|NOT COMPLETED|Overall Study||0
3063575|NCT01285609|3784494|FG000|STARTED|Randomized|Represents participants randomized to this arm prior to 1st dose of chemotherapy treatment|479
3063576|NCT01285609|3784495|FG001|STARTED|Randomized|Represents participants randomized to this arm prior to 1st dose of chemotherapy treatment|477
3063577|NCT01285609|3784494|FG000|Treated With Chemotherapy (1st Dose)|Randomized||475
3063578|NCT01285609|3784495|FG001|Treated With Chemotherapy (1st Dose)|Randomized||473
3063579|NCT01285609|3784494|FG000|COMPLETED|Randomized||388
3063580|NCT01285609|3784495|FG001|COMPLETED|Randomized||361
3063581|NCT01285609|3784494|FG000|NOT COMPLETED|Randomized||91
3063582|NCT01285609|3784495|FG001|NOT COMPLETED|Randomized||116
3063583|NCT01285609|3784494|FG000|STARTED|Treated With Blinded Therapy||388
3063584|NCT01285609|3784495|FG001|STARTED|Treated With Blinded Therapy||361
3063585|NCT01285609|3784494|FG000|COMPLETED|Treated With Blinded Therapy||1
3063586|NCT01285609|3784495|FG001|COMPLETED|Treated With Blinded Therapy||2
3063587|NCT01285609|3784494|FG000|NOT COMPLETED|Treated With Blinded Therapy||387
3063588|NCT01285609|3784495|FG001|NOT COMPLETED|Treated With Blinded Therapy||359
3063589|NCT01285635|3784506|FG000|STARTED|First Intervention (2 Weeks)||13
3063590|NCT01285635|3784507|FG001|STARTED|First Intervention (2 Weeks)||11
3063591|NCT01285635|3784508|FG002|STARTED|First Intervention (2 Weeks)||11
3063592|NCT01285635|3784506|FG000|COMPLETED|First Intervention (2 Weeks)||13
3063593|NCT01285635|3784507|FG001|COMPLETED|First Intervention (2 Weeks)||11
3063594|NCT01285635|3784508|FG002|COMPLETED|First Intervention (2 Weeks)||11
3063595|NCT01285635|3784506|FG000|NOT COMPLETED|First Intervention (2 Weeks)||0
3063596|NCT01285635|3784507|FG001|NOT COMPLETED|First Intervention (2 Weeks)||0
3063597|NCT01285635|3784508|FG002|NOT COMPLETED|First Intervention (2 Weeks)||0
3063598|NCT01285635|3784506|FG000|STARTED|Second Intervention (10, 3 Week Cycles)||13
3063599|NCT01285635|3784507|FG001|STARTED|Second Intervention (10, 3 Week Cycles)||11
3063600|NCT01285635|3784508|FG002|STARTED|Second Intervention (10, 3 Week Cycles)||11
3063601|NCT01285635|3784506|FG000|COMPLETED|Second Intervention (10, 3 Week Cycles)||13
3063602|NCT01285635|3784507|FG001|COMPLETED|Second Intervention (10, 3 Week Cycles)||11
3063603|NCT01285635|3784508|FG002|COMPLETED|Second Intervention (10, 3 Week Cycles)||11
3063604|NCT01285635|3784506|FG000|NOT COMPLETED|Second Intervention (10, 3 Week Cycles)||0
3063605|NCT01285635|3784507|FG001|NOT COMPLETED|Second Intervention (10, 3 Week Cycles)||0
3063606|NCT01285635|3784508|FG002|NOT COMPLETED|Second Intervention (10, 3 Week Cycles)||0
3063607|NCT01285713|3784521|FG000|STARTED|Overall Study||42
3063608|NCT01285713|3784522|FG001|STARTED|Overall Study||41
3063609|NCT01285713|3784521|FG000|COMPLETED|Overall Study||42
3063610|NCT01285713|3784522|FG001|COMPLETED|Overall Study||41
3063611|NCT01285713|3784521|FG000|NOT COMPLETED|Overall Study||0
3063612|NCT01285713|3784522|FG001|NOT COMPLETED|Overall Study||0
3063613|NCT01285791|3784531|FG000|STARTED|Overall Study||11
3063614|NCT01285791|3784532|FG001|STARTED|Overall Study||15
3063615|NCT01285791|3784533|FG002|STARTED|Overall Study||13
3063616|NCT01285791|3784531|FG000|COMPLETED|Overall Study||11
3063617|NCT01285791|3784532|FG001|COMPLETED|Overall Study||15
3063618|NCT01285791|3784533|FG002|COMPLETED|Overall Study||13
3063619|NCT01285791|3784531|FG000|NOT COMPLETED|Overall Study||0
3063620|NCT01285791|3784532|FG001|NOT COMPLETED|Overall Study||0
3063621|NCT01285791|3784533|FG002|NOT COMPLETED|Overall Study||0
3063622|NCT01285843|3784543|FG000|STARTED|Overall Study||20
3063623|NCT01285843|3784544|FG001|STARTED|Overall Study||20
3063624|NCT01285843|3784543|FG000|COMPLETED|Overall Study||18
3063625|NCT01285843|3784544|FG001|COMPLETED|Overall Study||18
3063626|NCT01285843|3784543|FG000|NOT COMPLETED|Overall Study||2
3063627|NCT01285843|3784544|FG001|NOT COMPLETED|Overall Study||2
3063628|NCT01285908|3784550|FG000|STARTED|Baseline Measurement||6
3063629|NCT01285908|3784551|FG001|STARTED|Baseline Measurement||0
3063630|NCT01285908|3784552|FG002|STARTED|Baseline Measurement||0
3063631|NCT01285908|3784550|FG000|COMPLETED|Baseline Measurement||3
3063632|NCT01285908|3784551|FG001|COMPLETED|Baseline Measurement||0
3063633|NCT01285908|3784552|FG002|COMPLETED|Baseline Measurement||0
3063634|NCT01285908|3784550|FG000|NOT COMPLETED|Baseline Measurement||3
3063635|NCT01285908|3784551|FG001|NOT COMPLETED|Baseline Measurement||0
3063636|NCT01285908|3784552|FG002|NOT COMPLETED|Baseline Measurement||0
3063637|NCT01285908|3784550|FG000|STARTED|Treatment Crossover||0
3063638|NCT01285908|3784551|FG001|STARTED|Treatment Crossover|One subject in treatment crossover did not complete baseline testing as unable to complete tasks|2
3063639|NCT01285908|3784552|FG002|STARTED|Treatment Crossover||2
3063640|NCT01285908|3784550|FG000|COMPLETED|Treatment Crossover||0
3063641|NCT01285908|3784551|FG001|COMPLETED|Treatment Crossover||2
3063642|NCT01285908|3784552|FG002|COMPLETED|Treatment Crossover||2
3063643|NCT01285908|3784550|FG000|NOT COMPLETED|Treatment Crossover||0
3063644|NCT01285908|3784551|FG001|NOT COMPLETED|Treatment Crossover||0
3063645|NCT01285908|3784552|FG002|NOT COMPLETED|Treatment Crossover||0
3063646|NCT01285960|3784582|FG000|STARTED|Overall Study|2 subjects receiving fewer than 10 sonications were added to the 106 for safety population of 108|108
3063647|NCT01285960|3784582|FG000|COMPLETED|Overall Study|An additional 2 subjects receiving fewer than 10 sonications were included in the safety population|102
3063648|NCT01285960|3784582|FG000|NOT COMPLETED|Overall Study||6
3063649|NCT01286012|3784588|FG000|STARTED|Overall Study|2 patients randomized to SFP did not receive study drug.|54
3063650|NCT01286012|3784589|FG001|STARTED|Overall Study|3 patients randomized to placebo did not receive study drug.|54
3063651|NCT01286012|3784588|FG000|COMPLETED|Overall Study||41
3063652|NCT01286012|3784589|FG001|COMPLETED|Overall Study||40
3063653|NCT01286012|3784588|FG000|NOT COMPLETED|Overall Study||13
3063654|NCT01286012|3784589|FG001|NOT COMPLETED|Overall Study||14
3063655|NCT01286077|3784598|FG000|STARTED|Overall Study|One patient did not start treatment and was excluded from the Intent to Treat (ITT) population.|51
3063656|NCT01286077|3784599|FG001|STARTED|Overall Study|One patient did not have any post-baseline assessment and was excluded from the ITT population.|53
3063657|NCT01286077|3784598|FG000|COMPLETED|Overall Study||41
3063658|NCT01286077|3784599|FG001|COMPLETED|Overall Study||46
3063659|NCT01286077|3784598|FG000|NOT COMPLETED|Overall Study||10
3063660|NCT01286077|3784599|FG001|NOT COMPLETED|Overall Study||7
3063661|NCT01286129|3784607|FG000|STARTED|Overall Study||27
3063662|NCT01286129|3784608|FG001|STARTED|Overall Study||18
3063663|NCT01286129|3784607|FG000|COMPLETED|Overall Study||19
3063664|NCT01286129|3784608|FG001|COMPLETED|Overall Study||13
3063665|NCT01286129|3784607|FG000|NOT COMPLETED|Overall Study||8
3063666|NCT01286129|3784608|FG001|NOT COMPLETED|Overall Study||5
3063667|NCT01286168|3784616|FG000|STARTED|Overall Study||104
3063668|NCT01286168|3784616|FG000|COMPLETED|Overall Study||101
3063669|NCT01286168|3784616|FG000|NOT COMPLETED|Overall Study||3
3063670|NCT01286259|3784621|FG000|STARTED|Overall Study||16
3063671|NCT01286259|3784621|FG000|COMPLETED|Overall Study||16
3063672|NCT01286259|3784621|FG000|NOT COMPLETED|Overall Study||0
3063673|NCT01286311|3784627|FG000|STARTED|Overall Study|218 patients (of the 14 physician randomized to the intervention) started the study.|232
3063674|NCT01286311|3784628|FG001|STARTED|Overall Study|217 patients (of the 15 physician randomized to the intervention) started the study.|232
3063675|NCT01286311|3784627|FG000|COMPLETED|Overall Study|204 patients (of the 14 physician randomized to the intervention) completed the study.|218
3063676|NCT01286311|3784628|FG001|COMPLETED|Overall Study|217 patients (of the 15 physician randomized to the intervention) completed the study.|232
3063677|NCT01286311|3784627|FG000|NOT COMPLETED|Overall Study||14
3063678|NCT01286311|3784628|FG001|NOT COMPLETED|Overall Study||0
3063679|NCT01286324|3784636|FG000|STARTED|Overall Study||17
3063680|NCT01286324|3784637|FG001|STARTED|Overall Study||17
3063681|NCT01286324|3784636|FG000|COMPLETED|Overall Study||17
3063682|NCT01286324|3784637|FG001|COMPLETED|Overall Study||17
3063683|NCT01286324|3784636|FG000|NOT COMPLETED|Overall Study||0
3063684|NCT01286324|3784637|FG001|NOT COMPLETED|Overall Study||0
3063685|NCT01286402|3784645|FG000|STARTED|Overall Study||5
3063686|NCT01286402|3784646|FG001|STARTED|Overall Study||6
3063687|NCT01286402|3784645|FG000|COMPLETED|Overall Study||5
3063688|NCT01286402|3784646|FG001|COMPLETED|Overall Study||6
3063689|NCT01286402|3784645|FG000|NOT COMPLETED|Overall Study||0
3063690|NCT01286402|3784646|FG001|NOT COMPLETED|Overall Study||0
3063691|NCT01286441|3784656|FG000|STARTED|Overall Study||45
3063692|NCT01286441|3784657|FG001|STARTED|Overall Study||44
3063693|NCT01286441|3784658|FG002|STARTED|Overall Study||46
3063694|NCT01286441|3784659|FG003|STARTED|Overall Study||48
3063695|NCT01286441|3784656|FG000|COMPLETED|Overall Study||38
3063696|NCT01286441|3784657|FG001|COMPLETED|Overall Study||37
3063697|NCT01286441|3784658|FG002|COMPLETED|Overall Study||39
3063698|NCT01286441|3784659|FG003|COMPLETED|Overall Study||37
3063699|NCT01286441|3784656|FG000|NOT COMPLETED|Overall Study||7
3063700|NCT01286441|3784657|FG001|NOT COMPLETED|Overall Study||7
3063701|NCT01286441|3784658|FG002|NOT COMPLETED|Overall Study||7
3063702|NCT01286441|3784659|FG003|NOT COMPLETED|Overall Study||11
3063703|NCT01286454|3784669|FG000|STARTED|Part I- First Intervention Period||2
3063704|NCT01286454|3784670|FG001|STARTED|Part I- First Intervention Period||2
3063705|NCT01286454|3784671|FG002|STARTED|Part I- First Intervention Period||2
3063706|NCT01286454|3784672|FG003|STARTED|Part I- First Intervention Period||2
3063707|NCT01286454|3784673|FG004|STARTED|Part I- First Intervention Period||2
3063708|NCT01286454|3784674|FG005|STARTED|Part I- First Intervention Period||2
3063709|NCT01286454|3784675|FG006|STARTED|Part I- First Intervention Period||2
3063710|NCT01286454|3784676|FG007|STARTED|Part I- First Intervention Period||2
3063711|NCT01286454|3784677|FG008|STARTED|Part I- First Intervention Period||2
3063712|NCT01286454|3784678|FG009|STARTED|Part I- First Intervention Period||2
3063713|NCT01286454|3784679|FG010|STARTED|Part I- First Intervention Period||0
3063714|NCT01286454|3784669|FG000|COMPLETED|Part I- First Intervention Period||2
3063715|NCT01286454|3784670|FG001|COMPLETED|Part I- First Intervention Period||2
3063716|NCT01286454|3784671|FG002|COMPLETED|Part I- First Intervention Period||2
3063717|NCT01286454|3784672|FG003|COMPLETED|Part I- First Intervention Period||2
3063718|NCT01286454|3784673|FG004|COMPLETED|Part I- First Intervention Period||2
3063719|NCT01286454|3784674|FG005|COMPLETED|Part I- First Intervention Period||2
3063720|NCT01286454|3784675|FG006|COMPLETED|Part I- First Intervention Period||2
3063721|NCT01286454|3784676|FG007|COMPLETED|Part I- First Intervention Period||2
3063722|NCT01286454|3784677|FG008|COMPLETED|Part I- First Intervention Period||2
3063723|NCT01286454|3784678|FG009|COMPLETED|Part I- First Intervention Period||2
3063724|NCT01286454|3784679|FG010|COMPLETED|Part I- First Intervention Period||0
3063725|NCT01286454|3784669|FG000|NOT COMPLETED|Part I- First Intervention Period||0
3063726|NCT01286454|3784670|FG001|NOT COMPLETED|Part I- First Intervention Period||0
3063727|NCT01286454|3784671|FG002|NOT COMPLETED|Part I- First Intervention Period||0
3134160|NCT01700387|3859167|FG001|NOT COMPLETED|Overall Study||4
3063728|NCT01286454|3784672|FG003|NOT COMPLETED|Part I- First Intervention Period||0
3063729|NCT01286454|3784673|FG004|NOT COMPLETED|Part I- First Intervention Period||0
3063730|NCT01286454|3784674|FG005|NOT COMPLETED|Part I- First Intervention Period||0
3063731|NCT01286454|3784675|FG006|NOT COMPLETED|Part I- First Intervention Period||0
3063732|NCT01286454|3784676|FG007|NOT COMPLETED|Part I- First Intervention Period||0
3063733|NCT01286454|3784677|FG008|NOT COMPLETED|Part I- First Intervention Period||0
3063734|NCT01286454|3784678|FG009|NOT COMPLETED|Part I- First Intervention Period||0
3063735|NCT01286454|3784679|FG010|NOT COMPLETED|Part I- First Intervention Period||0
3063736|NCT01286454|3784669|FG000|STARTED|Washout Period (At Least 3 Days)||2
3063737|NCT01286454|3784670|FG001|STARTED|Washout Period (At Least 3 Days)||2
3063738|NCT01286454|3784671|FG002|STARTED|Washout Period (At Least 3 Days)||2
3063739|NCT01286454|3784672|FG003|STARTED|Washout Period (At Least 3 Days)||2
3063740|NCT01286454|3784673|FG004|STARTED|Washout Period (At Least 3 Days)||2
3063741|NCT01286454|3784674|FG005|STARTED|Washout Period (At Least 3 Days)||2
3063742|NCT01286454|3784675|FG006|STARTED|Washout Period (At Least 3 Days)||2
3063743|NCT01286454|3784676|FG007|STARTED|Washout Period (At Least 3 Days)||2
3063744|NCT01286454|3784677|FG008|STARTED|Washout Period (At Least 3 Days)||2
3063745|NCT01286454|3784678|FG009|STARTED|Washout Period (At Least 3 Days)||2
3063746|NCT01286454|3784679|FG010|STARTED|Washout Period (At Least 3 Days)||0
3063747|NCT01286454|3784669|FG000|COMPLETED|Washout Period (At Least 3 Days)||2
3063748|NCT01286454|3784670|FG001|COMPLETED|Washout Period (At Least 3 Days)||2
3063749|NCT01286454|3784671|FG002|COMPLETED|Washout Period (At Least 3 Days)||2
3063750|NCT01286454|3784672|FG003|COMPLETED|Washout Period (At Least 3 Days)||2
3063751|NCT01286454|3784673|FG004|COMPLETED|Washout Period (At Least 3 Days)||2
3063752|NCT01286454|3784674|FG005|COMPLETED|Washout Period (At Least 3 Days)||2
3063753|NCT01286454|3784675|FG006|COMPLETED|Washout Period (At Least 3 Days)||2
3063754|NCT01286454|3784676|FG007|COMPLETED|Washout Period (At Least 3 Days)||2
3063755|NCT01286454|3784677|FG008|COMPLETED|Washout Period (At Least 3 Days)||2
3063756|NCT01286454|3784678|FG009|COMPLETED|Washout Period (At Least 3 Days)||2
3063757|NCT01286454|3784679|FG010|COMPLETED|Washout Period (At Least 3 Days)||0
3063758|NCT01286454|3784669|FG000|NOT COMPLETED|Washout Period (At Least 3 Days)||0
3063759|NCT01286454|3784670|FG001|NOT COMPLETED|Washout Period (At Least 3 Days)||0
3063760|NCT01286454|3784671|FG002|NOT COMPLETED|Washout Period (At Least 3 Days)||0
3063761|NCT01286454|3784672|FG003|NOT COMPLETED|Washout Period (At Least 3 Days)||0
3063762|NCT01286454|3784673|FG004|NOT COMPLETED|Washout Period (At Least 3 Days)||0
3063763|NCT01286454|3784674|FG005|NOT COMPLETED|Washout Period (At Least 3 Days)||0
3063764|NCT01286454|3784675|FG006|NOT COMPLETED|Washout Period (At Least 3 Days)||0
3063765|NCT01286454|3784676|FG007|NOT COMPLETED|Washout Period (At Least 3 Days)||0
3063766|NCT01286454|3784677|FG008|NOT COMPLETED|Washout Period (At Least 3 Days)||0
3063767|NCT01286454|3784678|FG009|NOT COMPLETED|Washout Period (At Least 3 Days)||0
3063768|NCT01286454|3784679|FG010|NOT COMPLETED|Washout Period (At Least 3 Days)||0
3063769|NCT01286454|3784669|FG000|STARTED|Second Intervention Period||2
3063770|NCT01286454|3784670|FG001|STARTED|Second Intervention Period||2
3063771|NCT01286454|3784671|FG002|STARTED|Second Intervention Period||2
3063772|NCT01286454|3784672|FG003|STARTED|Second Intervention Period||2
3063773|NCT01286454|3784673|FG004|STARTED|Second Intervention Period||2
3063774|NCT01286454|3784674|FG005|STARTED|Second Intervention Period||2
3063775|NCT01286454|3784675|FG006|STARTED|Second Intervention Period||2
3063776|NCT01286454|3784676|FG007|STARTED|Second Intervention Period||2
3063777|NCT01286454|3784677|FG008|STARTED|Second Intervention Period||2
3063778|NCT01286454|3784678|FG009|STARTED|Second Intervention Period||2
3063779|NCT01286454|3784679|FG010|STARTED|Second Intervention Period||0
3063780|NCT01286454|3784669|FG000|COMPLETED|Second Intervention Period||2
3063781|NCT01286454|3784670|FG001|COMPLETED|Second Intervention Period||2
3063782|NCT01286454|3784671|FG002|COMPLETED|Second Intervention Period||2
3063783|NCT01286454|3784672|FG003|COMPLETED|Second Intervention Period||2
3063784|NCT01286454|3784673|FG004|COMPLETED|Second Intervention Period||2
3063785|NCT01286454|3784674|FG005|COMPLETED|Second Intervention Period||2
3063786|NCT01286454|3784675|FG006|COMPLETED|Second Intervention Period||2
3063787|NCT01286454|3784676|FG007|COMPLETED|Second Intervention Period||2
3063788|NCT01286454|3784677|FG008|COMPLETED|Second Intervention Period||2
3063789|NCT01286454|3784678|FG009|COMPLETED|Second Intervention Period||2
3063790|NCT01286454|3784679|FG010|COMPLETED|Second Intervention Period||0
3063791|NCT01286454|3784669|FG000|NOT COMPLETED|Second Intervention Period||0
3063792|NCT01286454|3784670|FG001|NOT COMPLETED|Second Intervention Period||0
3063793|NCT01286454|3784671|FG002|NOT COMPLETED|Second Intervention Period||0
3063794|NCT01286454|3784672|FG003|NOT COMPLETED|Second Intervention Period||0
3063795|NCT01286454|3784673|FG004|NOT COMPLETED|Second Intervention Period||0
3063796|NCT01286454|3784674|FG005|NOT COMPLETED|Second Intervention Period||0
3063797|NCT01286454|3784675|FG006|NOT COMPLETED|Second Intervention Period||0
3063798|NCT01286454|3784676|FG007|NOT COMPLETED|Second Intervention Period||0
3063799|NCT01286454|3784677|FG008|NOT COMPLETED|Second Intervention Period||0
3063800|NCT01286454|3784678|FG009|NOT COMPLETED|Second Intervention Period||0
3063801|NCT01286454|3784679|FG010|NOT COMPLETED|Second Intervention Period||0
3063802|NCT01286454|3784669|FG000|STARTED|Washout Period (At Least 3 Days)||2
3063803|NCT01286454|3784670|FG001|STARTED|Washout Period (At Least 3 Days)||2
3063804|NCT01286454|3784671|FG002|STARTED|Washout Period (At Least 3 Days)||2
3063805|NCT01286454|3784672|FG003|STARTED|Washout Period (At Least 3 Days)||2
3063806|NCT01286454|3784673|FG004|STARTED|Washout Period (At Least 3 Days)||2
3063807|NCT01286454|3784674|FG005|STARTED|Washout Period (At Least 3 Days)||2
3063808|NCT01286454|3784675|FG006|STARTED|Washout Period (At Least 3 Days)||2
3063809|NCT01286454|3784676|FG007|STARTED|Washout Period (At Least 3 Days)||2
3063810|NCT01286454|3784677|FG008|STARTED|Washout Period (At Least 3 Days)||2
3063811|NCT01286454|3784678|FG009|STARTED|Washout Period (At Least 3 Days)||2
3063812|NCT01286454|3784679|FG010|STARTED|Washout Period (At Least 3 Days)||0
3063813|NCT01286454|3784669|FG000|COMPLETED|Washout Period (At Least 3 Days)||2
3063814|NCT01286454|3784670|FG001|COMPLETED|Washout Period (At Least 3 Days)||2
3063815|NCT01286454|3784671|FG002|COMPLETED|Washout Period (At Least 3 Days)||2
3063816|NCT01286454|3784672|FG003|COMPLETED|Washout Period (At Least 3 Days)||2
3063817|NCT01286454|3784673|FG004|COMPLETED|Washout Period (At Least 3 Days)||2
3063818|NCT01286454|3784674|FG005|COMPLETED|Washout Period (At Least 3 Days)||2
3063819|NCT01286454|3784675|FG006|COMPLETED|Washout Period (At Least 3 Days)||2
3063820|NCT01286454|3784676|FG007|COMPLETED|Washout Period (At Least 3 Days)||2
3063821|NCT01286454|3784677|FG008|COMPLETED|Washout Period (At Least 3 Days)||2
3063822|NCT01286454|3784678|FG009|COMPLETED|Washout Period (At Least 3 Days)||2
3063823|NCT01286454|3784679|FG010|COMPLETED|Washout Period (At Least 3 Days)||0
3063824|NCT01286454|3784669|FG000|NOT COMPLETED|Washout Period (At Least 3 Days)||0
3063825|NCT01286454|3784670|FG001|NOT COMPLETED|Washout Period (At Least 3 Days)||0
3063826|NCT01286454|3784671|FG002|NOT COMPLETED|Washout Period (At Least 3 Days)||0
3063827|NCT01286454|3784672|FG003|NOT COMPLETED|Washout Period (At Least 3 Days)||0
3063828|NCT01286454|3784673|FG004|NOT COMPLETED|Washout Period (At Least 3 Days)||0
3063829|NCT01286454|3784674|FG005|NOT COMPLETED|Washout Period (At Least 3 Days)||0
3063830|NCT01286454|3784675|FG006|NOT COMPLETED|Washout Period (At Least 3 Days)||0
3063831|NCT01286454|3784676|FG007|NOT COMPLETED|Washout Period (At Least 3 Days)||0
3063832|NCT01286454|3784677|FG008|NOT COMPLETED|Washout Period (At Least 3 Days)||0
3063833|NCT01286454|3784678|FG009|NOT COMPLETED|Washout Period (At Least 3 Days)||0
3063834|NCT01286454|3784679|FG010|NOT COMPLETED|Washout Period (At Least 3 Days)||0
3063835|NCT01286454|3784669|FG000|STARTED|Third Intervention Period||2
3063836|NCT01286454|3784670|FG001|STARTED|Third Intervention Period||2
3162940|NCT01881789|3890410|FG005|NOT COMPLETED|Overall Study||3
3162941|NCT01881828|3890427|FG000|STARTED|Overall Study|23 excluded at randomization from enrollment|71
3162942|NCT01881828|3890428|FG001|STARTED|Overall Study|23 excluded from randomization from enrollment|69
3162943|NCT01881828|3890427|FG000|COMPLETED|Overall Study||71
3063837|NCT01286454|3784671|FG002|STARTED|Third Intervention Period||2
3063838|NCT01286454|3784672|FG003|STARTED|Third Intervention Period||2
3063839|NCT01286454|3784673|FG004|STARTED|Third Intervention Period||2
3063840|NCT01286454|3784674|FG005|STARTED|Third Intervention Period||2
3063841|NCT01286454|3784675|FG006|STARTED|Third Intervention Period||2
3063842|NCT01286454|3784676|FG007|STARTED|Third Intervention Period||2
3063843|NCT01286454|3784677|FG008|STARTED|Third Intervention Period||2
3063844|NCT01286454|3784678|FG009|STARTED|Third Intervention Period||2
3063845|NCT01286454|3784679|FG010|STARTED|Third Intervention Period||0
3063846|NCT01286454|3784669|FG000|COMPLETED|Third Intervention Period||2
3063847|NCT01286454|3784670|FG001|COMPLETED|Third Intervention Period||2
3063848|NCT01286454|3784671|FG002|COMPLETED|Third Intervention Period||2
3063849|NCT01286454|3784672|FG003|COMPLETED|Third Intervention Period||2
3063850|NCT01286454|3784673|FG004|COMPLETED|Third Intervention Period||2
3063851|NCT01286454|3784674|FG005|COMPLETED|Third Intervention Period||2
3063852|NCT01286454|3784675|FG006|COMPLETED|Third Intervention Period||2
3063853|NCT01286454|3784676|FG007|COMPLETED|Third Intervention Period||2
3063854|NCT01286454|3784677|FG008|COMPLETED|Third Intervention Period||2
3063855|NCT01286454|3784678|FG009|COMPLETED|Third Intervention Period||2
3063856|NCT01286454|3784679|FG010|COMPLETED|Third Intervention Period||0
3063857|NCT01286454|3784669|FG000|NOT COMPLETED|Third Intervention Period||0
3063858|NCT01286454|3784670|FG001|NOT COMPLETED|Third Intervention Period||0
3063859|NCT01286454|3784671|FG002|NOT COMPLETED|Third Intervention Period||0
3063860|NCT01286454|3784672|FG003|NOT COMPLETED|Third Intervention Period||0
3063861|NCT01286454|3784673|FG004|NOT COMPLETED|Third Intervention Period||0
3063862|NCT01286454|3784674|FG005|NOT COMPLETED|Third Intervention Period||0
3063863|NCT01286454|3784675|FG006|NOT COMPLETED|Third Intervention Period||0
3063864|NCT01286454|3784676|FG007|NOT COMPLETED|Third Intervention Period||0
3063865|NCT01286454|3784677|FG008|NOT COMPLETED|Third Intervention Period||0
3063866|NCT01286454|3784678|FG009|NOT COMPLETED|Third Intervention Period||0
3063867|NCT01286454|3784679|FG010|NOT COMPLETED|Third Intervention Period||0
3063868|NCT01286454|3784669|FG000|STARTED|Washout Period (At Least 3 Days)||2
3063869|NCT01286454|3784670|FG001|STARTED|Washout Period (At Least 3 Days)||2
3063870|NCT01286454|3784671|FG002|STARTED|Washout Period (At Least 3 Days)||2
3063871|NCT01286454|3784672|FG003|STARTED|Washout Period (At Least 3 Days)||2
3063872|NCT01286454|3784673|FG004|STARTED|Washout Period (At Least 3 Days)||2
3063873|NCT01286454|3784674|FG005|STARTED|Washout Period (At Least 3 Days)||2
3063874|NCT01286454|3784675|FG006|STARTED|Washout Period (At Least 3 Days)||2
3063875|NCT01286454|3784676|FG007|STARTED|Washout Period (At Least 3 Days)||2
3063876|NCT01286454|3784677|FG008|STARTED|Washout Period (At Least 3 Days)||2
3063877|NCT01286454|3784678|FG009|STARTED|Washout Period (At Least 3 Days)||2
3063878|NCT01286454|3784679|FG010|STARTED|Washout Period (At Least 3 Days)||0
3063879|NCT01286454|3784669|FG000|COMPLETED|Washout Period (At Least 3 Days)||2
3063880|NCT01286454|3784670|FG001|COMPLETED|Washout Period (At Least 3 Days)||2
3063881|NCT01286454|3784671|FG002|COMPLETED|Washout Period (At Least 3 Days)||2
3063882|NCT01286454|3784672|FG003|COMPLETED|Washout Period (At Least 3 Days)||2
3063883|NCT01286454|3784673|FG004|COMPLETED|Washout Period (At Least 3 Days)||2
3063884|NCT01286454|3784674|FG005|COMPLETED|Washout Period (At Least 3 Days)||2
3063885|NCT01286454|3784675|FG006|COMPLETED|Washout Period (At Least 3 Days)||2
3063886|NCT01286454|3784676|FG007|COMPLETED|Washout Period (At Least 3 Days)||2
3063887|NCT01286454|3784677|FG008|COMPLETED|Washout Period (At Least 3 Days)||2
3063888|NCT01286454|3784678|FG009|COMPLETED|Washout Period (At Least 3 Days)||2
3063889|NCT01286454|3784679|FG010|COMPLETED|Washout Period (At Least 3 Days)||0
3063890|NCT01286454|3784669|FG000|NOT COMPLETED|Washout Period (At Least 3 Days)||0
3063891|NCT01286454|3784670|FG001|NOT COMPLETED|Washout Period (At Least 3 Days)||0
3063892|NCT01286454|3784671|FG002|NOT COMPLETED|Washout Period (At Least 3 Days)||0
3063893|NCT01286454|3784672|FG003|NOT COMPLETED|Washout Period (At Least 3 Days)||0
3063894|NCT01286454|3784673|FG004|NOT COMPLETED|Washout Period (At Least 3 Days)||0
3063895|NCT01286454|3784674|FG005|NOT COMPLETED|Washout Period (At Least 3 Days)||0
3063896|NCT01286454|3784675|FG006|NOT COMPLETED|Washout Period (At Least 3 Days)||0
3063897|NCT01286454|3784676|FG007|NOT COMPLETED|Washout Period (At Least 3 Days)||0
3063898|NCT01286454|3784677|FG008|NOT COMPLETED|Washout Period (At Least 3 Days)||0
3063899|NCT01286454|3784678|FG009|NOT COMPLETED|Washout Period (At Least 3 Days)||0
3063900|NCT01286454|3784679|FG010|NOT COMPLETED|Washout Period (At Least 3 Days)||0
3063901|NCT01286454|3784669|FG000|STARTED|Fourth Intervention Period||2
3063902|NCT01286454|3784670|FG001|STARTED|Fourth Intervention Period||2
3063903|NCT01286454|3784671|FG002|STARTED|Fourth Intervention Period||2
3063904|NCT01286454|3784672|FG003|STARTED|Fourth Intervention Period||2
3063905|NCT01286454|3784673|FG004|STARTED|Fourth Intervention Period||2
3063906|NCT01286454|3784674|FG005|STARTED|Fourth Intervention Period||2
3063907|NCT01286454|3784675|FG006|STARTED|Fourth Intervention Period||2
3063908|NCT01286454|3784676|FG007|STARTED|Fourth Intervention Period||2
3063909|NCT01286454|3784677|FG008|STARTED|Fourth Intervention Period||2
3063910|NCT01286454|3784678|FG009|STARTED|Fourth Intervention Period||2
3063911|NCT01286454|3784679|FG010|STARTED|Fourth Intervention Period||0
3063912|NCT01286454|3784669|FG000|COMPLETED|Fourth Intervention Period||2
3063913|NCT01286454|3784670|FG001|COMPLETED|Fourth Intervention Period||2
3063914|NCT01286454|3784671|FG002|COMPLETED|Fourth Intervention Period||2
3063915|NCT01286454|3784672|FG003|COMPLETED|Fourth Intervention Period||2
3063916|NCT01286454|3784673|FG004|COMPLETED|Fourth Intervention Period||2
3063917|NCT01286454|3784674|FG005|COMPLETED|Fourth Intervention Period||2
3063918|NCT01286454|3784675|FG006|COMPLETED|Fourth Intervention Period||2
3063919|NCT01286454|3784676|FG007|COMPLETED|Fourth Intervention Period||2
3063920|NCT01286454|3784677|FG008|COMPLETED|Fourth Intervention Period||2
3063921|NCT01286454|3784678|FG009|COMPLETED|Fourth Intervention Period||2
3063922|NCT01286454|3784679|FG010|COMPLETED|Fourth Intervention Period||0
3063923|NCT01286454|3784669|FG000|NOT COMPLETED|Fourth Intervention Period||0
3063924|NCT01286454|3784670|FG001|NOT COMPLETED|Fourth Intervention Period||0
3063925|NCT01286454|3784671|FG002|NOT COMPLETED|Fourth Intervention Period||0
3063926|NCT01286454|3784672|FG003|NOT COMPLETED|Fourth Intervention Period||0
3063927|NCT01286454|3784673|FG004|NOT COMPLETED|Fourth Intervention Period||0
3063928|NCT01286454|3784674|FG005|NOT COMPLETED|Fourth Intervention Period||0
3063929|NCT01286454|3784675|FG006|NOT COMPLETED|Fourth Intervention Period||0
3063930|NCT01286454|3784676|FG007|NOT COMPLETED|Fourth Intervention Period||0
3063931|NCT01286454|3784677|FG008|NOT COMPLETED|Fourth Intervention Period||0
3063932|NCT01286454|3784678|FG009|NOT COMPLETED|Fourth Intervention Period||0
3063933|NCT01286454|3784679|FG010|NOT COMPLETED|Fourth Intervention Period||0
3063934|NCT01286454|3784669|FG000|STARTED|Washout Period (At Least 3 Days)||2
3063935|NCT01286454|3784670|FG001|STARTED|Washout Period (At Least 3 Days)||2
3063936|NCT01286454|3784671|FG002|STARTED|Washout Period (At Least 3 Days)||2
3063937|NCT01286454|3784672|FG003|STARTED|Washout Period (At Least 3 Days)||2
3063938|NCT01286454|3784673|FG004|STARTED|Washout Period (At Least 3 Days)||2
3063939|NCT01286454|3784674|FG005|STARTED|Washout Period (At Least 3 Days)||2
3063940|NCT01286454|3784675|FG006|STARTED|Washout Period (At Least 3 Days)||2
3063941|NCT01286454|3784676|FG007|STARTED|Washout Period (At Least 3 Days)||2
3063942|NCT01286454|3784677|FG008|STARTED|Washout Period (At Least 3 Days)||2
3063943|NCT01286454|3784678|FG009|STARTED|Washout Period (At Least 3 Days)||2
3063944|NCT01286454|3784679|FG010|STARTED|Washout Period (At Least 3 Days)||0
3063945|NCT01286454|3784669|FG000|COMPLETED|Washout Period (At Least 3 Days)||2
3063946|NCT01286454|3784670|FG001|COMPLETED|Washout Period (At Least 3 Days)||2
3063947|NCT01286454|3784671|FG002|COMPLETED|Washout Period (At Least 3 Days)||2
3063948|NCT01286454|3784672|FG003|COMPLETED|Washout Period (At Least 3 Days)||2
3063949|NCT01286454|3784673|FG004|COMPLETED|Washout Period (At Least 3 Days)||2
3063950|NCT01286454|3784674|FG005|COMPLETED|Washout Period (At Least 3 Days)||2
3063951|NCT01286454|3784675|FG006|COMPLETED|Washout Period (At Least 3 Days)||2
3063952|NCT01286454|3784676|FG007|COMPLETED|Washout Period (At Least 3 Days)||2
3063953|NCT01286454|3784677|FG008|COMPLETED|Washout Period (At Least 3 Days)||2
3063954|NCT01286454|3784678|FG009|COMPLETED|Washout Period (At Least 3 Days)||2
3063955|NCT01286454|3784679|FG010|COMPLETED|Washout Period (At Least 3 Days)||0
3063956|NCT01286454|3784669|FG000|NOT COMPLETED|Washout Period (At Least 3 Days)||0
3063957|NCT01286454|3784670|FG001|NOT COMPLETED|Washout Period (At Least 3 Days)||0
3063958|NCT01286454|3784671|FG002|NOT COMPLETED|Washout Period (At Least 3 Days)||0
3063959|NCT01286454|3784672|FG003|NOT COMPLETED|Washout Period (At Least 3 Days)||0
3063960|NCT01286454|3784673|FG004|NOT COMPLETED|Washout Period (At Least 3 Days)||0
3063961|NCT01286454|3784674|FG005|NOT COMPLETED|Washout Period (At Least 3 Days)||0
3063962|NCT01286454|3784675|FG006|NOT COMPLETED|Washout Period (At Least 3 Days)||0
3063963|NCT01286454|3784676|FG007|NOT COMPLETED|Washout Period (At Least 3 Days)||0
3063964|NCT01286454|3784677|FG008|NOT COMPLETED|Washout Period (At Least 3 Days)||0
3063965|NCT01286454|3784678|FG009|NOT COMPLETED|Washout Period (At Least 3 Days)||0
3063966|NCT01286454|3784679|FG010|NOT COMPLETED|Washout Period (At Least 3 Days)||0
3063967|NCT01286454|3784669|FG000|STARTED|Fifth Intervention Period||2
3063968|NCT01286454|3784670|FG001|STARTED|Fifth Intervention Period||2
3063969|NCT01286454|3784671|FG002|STARTED|Fifth Intervention Period||2
3063970|NCT01286454|3784672|FG003|STARTED|Fifth Intervention Period||2
3063971|NCT01286454|3784673|FG004|STARTED|Fifth Intervention Period||2
3063972|NCT01286454|3784674|FG005|STARTED|Fifth Intervention Period||2
3063973|NCT01286454|3784675|FG006|STARTED|Fifth Intervention Period||2
3063974|NCT01286454|3784676|FG007|STARTED|Fifth Intervention Period||2
3063975|NCT01286454|3784677|FG008|STARTED|Fifth Intervention Period||2
3063976|NCT01286454|3784678|FG009|STARTED|Fifth Intervention Period||2
3063977|NCT01286454|3784679|FG010|STARTED|Fifth Intervention Period||0
3063978|NCT01286454|3784669|FG000|COMPLETED|Fifth Intervention Period||2
3063979|NCT01286454|3784670|FG001|COMPLETED|Fifth Intervention Period||2
3063980|NCT01286454|3784671|FG002|COMPLETED|Fifth Intervention Period||2
3063981|NCT01286454|3784672|FG003|COMPLETED|Fifth Intervention Period||2
3284189|NCT02762071|4017956|FG001|NOT COMPLETED|Overall Study||0
3284190|NCT02762084|4017966|FG000|STARTED|Overall Study||6
3284191|NCT02762084|4017967|FG001|STARTED|Overall Study||6
3284192|NCT02762084|4017968|FG002|STARTED|Overall Study||5
3284193|NCT02762084|4017966|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6
3063982|NCT01286454|3784673|FG004|COMPLETED|Fifth Intervention Period||2
3063983|NCT01286454|3784674|FG005|COMPLETED|Fifth Intervention Period||2
3063984|NCT01286454|3784675|FG006|COMPLETED|Fifth Intervention Period||2
3063985|NCT01286454|3784676|FG007|COMPLETED|Fifth Intervention Period||2
3063986|NCT01286454|3784677|FG008|COMPLETED|Fifth Intervention Period||2
3063987|NCT01286454|3784678|FG009|COMPLETED|Fifth Intervention Period||2
3063988|NCT01286454|3784679|FG010|COMPLETED|Fifth Intervention Period||0
3063989|NCT01286454|3784669|FG000|NOT COMPLETED|Fifth Intervention Period||0
3063990|NCT01286454|3784670|FG001|NOT COMPLETED|Fifth Intervention Period||0
3063991|NCT01286454|3784671|FG002|NOT COMPLETED|Fifth Intervention Period||0
3063992|NCT01286454|3784672|FG003|NOT COMPLETED|Fifth Intervention Period||0
3063993|NCT01286454|3784673|FG004|NOT COMPLETED|Fifth Intervention Period||0
3063994|NCT01286454|3784674|FG005|NOT COMPLETED|Fifth Intervention Period||0
3063995|NCT01286454|3784675|FG006|NOT COMPLETED|Fifth Intervention Period||0
3063996|NCT01286454|3784676|FG007|NOT COMPLETED|Fifth Intervention Period||0
3063997|NCT01286454|3784677|FG008|NOT COMPLETED|Fifth Intervention Period||0
3063998|NCT01286454|3784678|FG009|NOT COMPLETED|Fifth Intervention Period||0
3063999|NCT01286454|3784679|FG010|NOT COMPLETED|Fifth Intervention Period||0
3064000|NCT01286454|3784669|FG000|STARTED|Washout Period (Approximately 2 Weeks)||2
3064001|NCT01286454|3784670|FG001|STARTED|Washout Period (Approximately 2 Weeks)||2
3064002|NCT01286454|3784671|FG002|STARTED|Washout Period (Approximately 2 Weeks)||2
3064003|NCT01286454|3784672|FG003|STARTED|Washout Period (Approximately 2 Weeks)||2
3064004|NCT01286454|3784673|FG004|STARTED|Washout Period (Approximately 2 Weeks)||2
3064005|NCT01286454|3784674|FG005|STARTED|Washout Period (Approximately 2 Weeks)||2
3064006|NCT01286454|3784675|FG006|STARTED|Washout Period (Approximately 2 Weeks)||2
3064007|NCT01286454|3784676|FG007|STARTED|Washout Period (Approximately 2 Weeks)||2
3064008|NCT01286454|3784677|FG008|STARTED|Washout Period (Approximately 2 Weeks)||2
3064009|NCT01286454|3784678|FG009|STARTED|Washout Period (Approximately 2 Weeks)||2
3064010|NCT01286454|3784679|FG010|STARTED|Washout Period (Approximately 2 Weeks)||0
3064011|NCT01286454|3784669|FG000|COMPLETED|Washout Period (Approximately 2 Weeks)||2
3064012|NCT01286454|3784670|FG001|COMPLETED|Washout Period (Approximately 2 Weeks)||2
3064013|NCT01286454|3784671|FG002|COMPLETED|Washout Period (Approximately 2 Weeks)||2
3064014|NCT01286454|3784672|FG003|COMPLETED|Washout Period (Approximately 2 Weeks)||2
3064015|NCT01286454|3784673|FG004|COMPLETED|Washout Period (Approximately 2 Weeks)||2
3064016|NCT01286454|3784674|FG005|COMPLETED|Washout Period (Approximately 2 Weeks)||2
3064017|NCT01286454|3784675|FG006|COMPLETED|Washout Period (Approximately 2 Weeks)||2
3064018|NCT01286454|3784676|FG007|COMPLETED|Washout Period (Approximately 2 Weeks)||2
3064019|NCT01286454|3784677|FG008|COMPLETED|Washout Period (Approximately 2 Weeks)||2
3064020|NCT01286454|3784678|FG009|COMPLETED|Washout Period (Approximately 2 Weeks)||2
3064021|NCT01286454|3784679|FG010|COMPLETED|Washout Period (Approximately 2 Weeks)||0
3064022|NCT01286454|3784669|FG000|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
3064023|NCT01286454|3784670|FG001|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
3064024|NCT01286454|3784671|FG002|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
3064025|NCT01286454|3784672|FG003|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
3064026|NCT01286454|3784673|FG004|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
3064027|NCT01286454|3784674|FG005|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
3064028|NCT01286454|3784675|FG006|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
3064029|NCT01286454|3784676|FG007|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
3064030|NCT01286454|3784677|FG008|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
3064031|NCT01286454|3784678|FG009|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
3284194|NCT02762084|4017967|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6
3064032|NCT01286454|3784679|FG010|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
3064033|NCT01286454|3784669|FG000|STARTED|Part II- Sixth Intervention Period||0
3064034|NCT01286454|3784670|FG001|STARTED|Part II- Sixth Intervention Period||0
3064035|NCT01286454|3784671|FG002|STARTED|Part II- Sixth Intervention Period||0
3064036|NCT01286454|3784672|FG003|STARTED|Part II- Sixth Intervention Period||0
3064037|NCT01286454|3784673|FG004|STARTED|Part II- Sixth Intervention Period||0
3064038|NCT01286454|3784674|FG005|STARTED|Part II- Sixth Intervention Period||0
3064039|NCT01286454|3784675|FG006|STARTED|Part II- Sixth Intervention Period||0
3064040|NCT01286454|3784676|FG007|STARTED|Part II- Sixth Intervention Period||0
3064041|NCT01286454|3784677|FG008|STARTED|Part II- Sixth Intervention Period||0
3064042|NCT01286454|3784678|FG009|STARTED|Part II- Sixth Intervention Period||0
3064043|NCT01286454|3784679|FG010|STARTED|Part II- Sixth Intervention Period||20
3064044|NCT01286454|3784669|FG000|COMPLETED|Part II- Sixth Intervention Period||0
3064045|NCT01286454|3784670|FG001|COMPLETED|Part II- Sixth Intervention Period||0
3064046|NCT01286454|3784671|FG002|COMPLETED|Part II- Sixth Intervention Period||0
3064047|NCT01286454|3784672|FG003|COMPLETED|Part II- Sixth Intervention Period||0
3064048|NCT01286454|3784673|FG004|COMPLETED|Part II- Sixth Intervention Period||0
3064049|NCT01286454|3784674|FG005|COMPLETED|Part II- Sixth Intervention Period||0
3064050|NCT01286454|3784675|FG006|COMPLETED|Part II- Sixth Intervention Period||0
3064051|NCT01286454|3784676|FG007|COMPLETED|Part II- Sixth Intervention Period||0
3064052|NCT01286454|3784677|FG008|COMPLETED|Part II- Sixth Intervention Period||0
3064053|NCT01286454|3784678|FG009|COMPLETED|Part II- Sixth Intervention Period||0
3064054|NCT01286454|3784679|FG010|COMPLETED|Part II- Sixth Intervention Period||20
3064055|NCT01286454|3784669|FG000|NOT COMPLETED|Part II- Sixth Intervention Period||0
3064056|NCT01286454|3784670|FG001|NOT COMPLETED|Part II- Sixth Intervention Period||0
3064057|NCT01286454|3784671|FG002|NOT COMPLETED|Part II- Sixth Intervention Period||0
3064058|NCT01286454|3784672|FG003|NOT COMPLETED|Part II- Sixth Intervention Period||0
3064059|NCT01286454|3784673|FG004|NOT COMPLETED|Part II- Sixth Intervention Period||0
3064060|NCT01286454|3784674|FG005|NOT COMPLETED|Part II- Sixth Intervention Period||0
3064061|NCT01286454|3784675|FG006|NOT COMPLETED|Part II- Sixth Intervention Period||0
3064062|NCT01286454|3784676|FG007|NOT COMPLETED|Part II- Sixth Intervention Period||0
3064063|NCT01286454|3784677|FG008|NOT COMPLETED|Part II- Sixth Intervention Period||0
3064064|NCT01286454|3784678|FG009|NOT COMPLETED|Part II- Sixth Intervention Period||0
3064065|NCT01286454|3784679|FG010|NOT COMPLETED|Part II- Sixth Intervention Period||0
3064066|NCT01286480|3784695|FG000|STARTED|Overall Study||32
3064067|NCT01286480|3784696|FG001|STARTED|Overall Study||34
3064068|NCT01286480|3784695|FG000|COMPLETED|Overall Study||27
3064069|NCT01286480|3784696|FG001|COMPLETED|Overall Study||31
3064070|NCT01286480|3784695|FG000|NOT COMPLETED|Overall Study||5
3064071|NCT01286480|3784696|FG001|NOT COMPLETED|Overall Study||3
3064072|NCT01286493|3784702|FG000|STARTED|Overall Study||33
3064073|NCT01286493|3784702|FG000|COMPLETED|Overall Study||30
3064074|NCT01286493|3784702|FG000|NOT COMPLETED|Overall Study||3
3064075|NCT01286558|3784708|FG000|STARTED|Overall Study||112
3064076|NCT01286558|3784709|FG001|STARTED|Overall Study||113
3064077|NCT01286558|3784708|FG000|COMPLETED|Overall Study||111
3064078|NCT01286558|3784709|FG001|COMPLETED|Overall Study||111
3064079|NCT01286558|3784708|FG000|NOT COMPLETED|Overall Study||1
3064080|NCT01286558|3784709|FG001|NOT COMPLETED|Overall Study||2
3064081|NCT01286740|3784715|FG000|STARTED|Overall Study||50
3064082|NCT01286740|3784715|FG000|Enrolled and Treated|Overall Study||49
3064083|NCT01286740|3784715|FG000|Week 12 (Primary Endpoint)|Overall Study||49
3064084|NCT01286740|3784715|FG000|COMPLETED|Overall Study||48
3064085|NCT01286740|3784715|FG000|NOT COMPLETED|Overall Study||2
3064086|NCT01286753|3784721|FG000|STARTED|Overall Study||26
3064087|NCT01286753|3784722|FG001|STARTED|Overall Study||25
3064088|NCT01286753|3784721|FG000|COMPLETED|Overall Study||0
3064089|NCT01286753|3784722|FG001|COMPLETED|Overall Study||0
3064090|NCT01286753|3784721|FG000|NOT COMPLETED|Overall Study||26
3064091|NCT01286753|3784722|FG001|NOT COMPLETED|Overall Study||25
3064092|NCT01286779|3784729|FG000|STARTED|Overall Study||115
3064093|NCT01286779|3784729|FG000|COMPLETED|Overall Study||96
3064094|NCT01286779|3784729|FG000|NOT COMPLETED|Overall Study||19
3064095|NCT01286805|3784745|FG000|STARTED|Overall Study||41
3064096|NCT01286805|3784746|FG001|STARTED|Overall Study||42
3064097|NCT01286805|3784745|FG000|COMPLETED|Overall Study||41
3064098|NCT01286805|3784746|FG001|COMPLETED|Overall Study||41
3064099|NCT01286805|3784745|FG000|NOT COMPLETED|Overall Study||0
3064100|NCT01286805|3784746|FG001|NOT COMPLETED|Overall Study||1
3064101|NCT01286818|3784752|FG000|STARTED|Overall Study||6
3064102|NCT01286818|3784752|FG000|Completed DLT Assessment Period|Overall Study||5
3064103|NCT01286818|3784752|FG000|COMPLETED|Overall Study||6
3064104|NCT01286818|3784752|FG000|NOT COMPLETED|Overall Study||0
3064105|NCT01286870|3784756|FG000|STARTED|Overall Study||11
3064106|NCT01286870|3784756|FG000|COMPLETED|Overall Study||11
3064107|NCT01286870|3784756|FG000|NOT COMPLETED|Overall Study||0
3064108|NCT01286987|3784775|FG000|STARTED|Part 1: Dose Escalation||3
3064109|NCT01286987|3784776|FG001|STARTED|Part 1: Dose Escalation||3
3064110|NCT01286987|3784777|FG002|STARTED|Part 1: Dose Escalation||3
3064111|NCT01286987|3784778|FG003|STARTED|Part 1: Dose Escalation||3
3284195|NCT02762084|4017968|FG002|Received at Least 1 Dose of Study Drug|Overall Study||5
3284196|NCT02762084|4017966|FG000|By Tumor Per Protocol Population (PP)|Overall Study||6
3284197|NCT02762084|4017967|FG001|By Tumor Per Protocol Population (PP)|Overall Study||6
3284198|NCT02762084|4017968|FG002|By Tumor Per Protocol Population (PP)|Overall Study||4
3064112|NCT01286987|3784779|FG004|STARTED|Part 1: Dose Escalation||3
3064113|NCT01286987|3784780|FG005|STARTED|Part 1: Dose Escalation||6
3064114|NCT01286987|3784781|FG006|STARTED|Part 1: Dose Escalation||6
3064115|NCT01286987|3784782|FG007|STARTED|Part 1: Dose Escalation||6
3064116|NCT01286987|3784783|FG008|STARTED|Part 1: Dose Escalation||6
3064117|NCT01286987|3784784|FG009|STARTED|Part 1: Dose Escalation||0
3064118|NCT01286987|3784785|FG010|STARTED|Part 1: Dose Escalation||0
3064119|NCT01286987|3784786|FG011|STARTED|Part 1: Dose Escalation||0
3064120|NCT01286987|3784787|FG012|STARTED|Part 1: Dose Escalation||0
3064121|NCT01286987|3784788|FG013|STARTED|Part 1: Dose Escalation||0
3064122|NCT01286987|3784789|FG014|STARTED|Part 1: Dose Escalation||0
3064123|NCT01286987|3784775|FG000|Colorectal Cancer|Part 1: Dose Escalation||1
3064124|NCT01286987|3784776|FG001|Colorectal Cancer|Part 1: Dose Escalation||0
3064125|NCT01286987|3784777|FG002|Colorectal Cancer|Part 1: Dose Escalation||1
3064126|NCT01286987|3784778|FG003|Colorectal Cancer|Part 1: Dose Escalation||0
3064127|NCT01286987|3784779|FG004|Colorectal Cancer|Part 1: Dose Escalation||0
3064128|NCT01286987|3784780|FG005|Colorectal Cancer|Part 1: Dose Escalation||0
3064129|NCT01286987|3784781|FG006|Colorectal Cancer|Part 1: Dose Escalation||0
3064130|NCT01286987|3784782|FG007|Colorectal Cancer|Part 1: Dose Escalation||0
3064131|NCT01286987|3784783|FG008|Colorectal Cancer|Part 1: Dose Escalation||0
3064132|NCT01286987|3784784|FG009|Colorectal Cancer|Part 1: Dose Escalation||0
3064133|NCT01286987|3784785|FG010|Colorectal Cancer|Part 1: Dose Escalation||0
3064134|NCT01286987|3784786|FG011|Colorectal Cancer|Part 1: Dose Escalation||0
3064135|NCT01286987|3784787|FG012|Colorectal Cancer|Part 1: Dose Escalation||0
3064136|NCT01286987|3784788|FG013|Colorectal Cancer|Part 1: Dose Escalation||0
3064137|NCT01286987|3784789|FG014|Colorectal Cancer|Part 1: Dose Escalation||0
3064138|NCT01286987|3784775|FG000|Prostate Cancer|Part 1: Dose Escalation||0
3064139|NCT01286987|3784776|FG001|Prostate Cancer|Part 1: Dose Escalation||0
3064140|NCT01286987|3784777|FG002|Prostate Cancer|Part 1: Dose Escalation||0
3064141|NCT01286987|3784778|FG003|Prostate Cancer|Part 1: Dose Escalation||0
3064142|NCT01286987|3784779|FG004|Prostate Cancer|Part 1: Dose Escalation||0
3064143|NCT01286987|3784780|FG005|Prostate Cancer|Part 1: Dose Escalation||1
3064144|NCT01286987|3784781|FG006|Prostate Cancer|Part 1: Dose Escalation||0
3064145|NCT01286987|3784782|FG007|Prostate Cancer|Part 1: Dose Escalation||0
3064146|NCT01286987|3784783|FG008|Prostate Cancer|Part 1: Dose Escalation||0
3064147|NCT01286987|3784784|FG009|Prostate Cancer|Part 1: Dose Escalation||0
3064148|NCT01286987|3784785|FG010|Prostate Cancer|Part 1: Dose Escalation||0
3064149|NCT01286987|3784786|FG011|Prostate Cancer|Part 1: Dose Escalation||0
3064150|NCT01286987|3784787|FG012|Prostate Cancer|Part 1: Dose Escalation||0
3064151|NCT01286987|3784788|FG013|Prostate Cancer|Part 1: Dose Escalation||0
3064152|NCT01286987|3784789|FG014|Prostate Cancer|Part 1: Dose Escalation||0
3064153|NCT01286987|3784775|FG000|Ewing Cancer|Part 1: Dose Escalation||0
3064154|NCT01286987|3784776|FG001|Ewing Cancer|Part 1: Dose Escalation||0
3064155|NCT01286987|3784777|FG002|Ewing Cancer|Part 1: Dose Escalation||0
3064156|NCT01286987|3784778|FG003|Ewing Cancer|Part 1: Dose Escalation||0
3064157|NCT01286987|3784779|FG004|Ewing Cancer|Part 1: Dose Escalation||0
3064158|NCT01286987|3784780|FG005|Ewing Cancer|Part 1: Dose Escalation||0
3064159|NCT01286987|3784781|FG006|Ewing Cancer|Part 1: Dose Escalation||0
3064160|NCT01286987|3784782|FG007|Ewing Cancer|Part 1: Dose Escalation||1
3064161|NCT01286987|3784783|FG008|Ewing Cancer|Part 1: Dose Escalation||1
3064162|NCT01286987|3784784|FG009|Ewing Cancer|Part 1: Dose Escalation||0
3064163|NCT01286987|3784785|FG010|Ewing Cancer|Part 1: Dose Escalation||0
3064164|NCT01286987|3784786|FG011|Ewing Cancer|Part 1: Dose Escalation||0
3064165|NCT01286987|3784787|FG012|Ewing Cancer|Part 1: Dose Escalation||0
3064166|NCT01286987|3784788|FG013|Ewing Cancer|Part 1: Dose Escalation||0
3064167|NCT01286987|3784789|FG014|Ewing Cancer|Part 1: Dose Escalation||0
3064168|NCT01286987|3784775|FG000|Pancreatic Cancer|Part 1: Dose Escalation||1
3064169|NCT01286987|3784776|FG001|Pancreatic Cancer|Part 1: Dose Escalation||2
3064170|NCT01286987|3784777|FG002|Pancreatic Cancer|Part 1: Dose Escalation||0
3064171|NCT01286987|3784778|FG003|Pancreatic Cancer|Part 1: Dose Escalation||0
3064172|NCT01286987|3784779|FG004|Pancreatic Cancer|Part 1: Dose Escalation||0
3064173|NCT01286987|3784780|FG005|Pancreatic Cancer|Part 1: Dose Escalation||0
3064174|NCT01286987|3784781|FG006|Pancreatic Cancer|Part 1: Dose Escalation||0
3064175|NCT01286987|3784782|FG007|Pancreatic Cancer|Part 1: Dose Escalation||0
3064176|NCT01286987|3784783|FG008|Pancreatic Cancer|Part 1: Dose Escalation||0
3064177|NCT01286987|3784784|FG009|Pancreatic Cancer|Part 1: Dose Escalation||0
3064178|NCT01286987|3784785|FG010|Pancreatic Cancer|Part 1: Dose Escalation||0
3064179|NCT01286987|3784786|FG011|Pancreatic Cancer|Part 1: Dose Escalation||0
3064180|NCT01286987|3784787|FG012|Pancreatic Cancer|Part 1: Dose Escalation||0
3064181|NCT01286987|3784788|FG013|Pancreatic Cancer|Part 1: Dose Escalation||0
3064182|NCT01286987|3784789|FG014|Pancreatic Cancer|Part 1: Dose Escalation||0
3064183|NCT01286987|3784775|FG000|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||1
3284199|NCT02762084|4017966|FG000|COMPLETED|Overall Study||5
3284200|NCT02762084|4017967|FG001|COMPLETED|Overall Study||6
3284201|NCT02762084|4017968|FG002|COMPLETED|Overall Study||4
3284202|NCT02762084|4017966|FG000|NOT COMPLETED|Overall Study||1
3284203|NCT02762084|4017967|FG001|NOT COMPLETED|Overall Study||0
3064184|NCT01286987|3784776|FG001|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||1
3064185|NCT01286987|3784777|FG002|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||2
3284204|NCT02762084|4017968|FG002|NOT COMPLETED|Overall Study||1
3284205|NCT02762331|4017980|FG000|STARTED|Overall Study||4
3064186|NCT01286987|3784778|FG003|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||3
3064187|NCT01286987|3784779|FG004|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||3
3064188|NCT01286987|3784780|FG005|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||4
3064189|NCT01286987|3784781|FG006|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||4
3064190|NCT01286987|3784782|FG007|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||3
3064191|NCT01286987|3784783|FG008|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||2
3064192|NCT01286987|3784784|FG009|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||0
3064193|NCT01286987|3784785|FG010|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||0
3064194|NCT01286987|3784786|FG011|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||0
3064195|NCT01286987|3784787|FG012|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||0
3064196|NCT01286987|3784788|FG013|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||0
3064197|NCT01286987|3784789|FG014|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||0
3064198|NCT01286987|3784775|FG000|Breast Cancer|Part 1: Dose Escalation||0
3064199|NCT01286987|3784776|FG001|Breast Cancer|Part 1: Dose Escalation||0
3064200|NCT01286987|3784777|FG002|Breast Cancer|Part 1: Dose Escalation||0
3064201|NCT01286987|3784778|FG003|Breast Cancer|Part 1: Dose Escalation||0
3064202|NCT01286987|3784779|FG004|Breast Cancer|Part 1: Dose Escalation||0
3064203|NCT01286987|3784780|FG005|Breast Cancer|Part 1: Dose Escalation||1
3064204|NCT01286987|3784781|FG006|Breast Cancer|Part 1: Dose Escalation||2
3064205|NCT01286987|3784782|FG007|Breast Cancer|Part 1: Dose Escalation||2
3064206|NCT01286987|3784783|FG008|Breast Cancer|Part 1: Dose Escalation||3
3064207|NCT01286987|3784784|FG009|Breast Cancer|Part 1: Dose Escalation||0
3064208|NCT01286987|3784785|FG010|Breast Cancer|Part 1: Dose Escalation||0
3064209|NCT01286987|3784786|FG011|Breast Cancer|Part 1: Dose Escalation||0
3064210|NCT01286987|3784787|FG012|Breast Cancer|Part 1: Dose Escalation||0
3064211|NCT01286987|3784788|FG013|Breast Cancer|Part 1: Dose Escalation||0
3064212|NCT01286987|3784789|FG014|Breast Cancer|Part 1: Dose Escalation||0
3064213|NCT01286987|3784775|FG000|COMPLETED|Part 1: Dose Escalation||0
3064214|NCT01286987|3784776|FG001|COMPLETED|Part 1: Dose Escalation||0
3064215|NCT01286987|3784777|FG002|COMPLETED|Part 1: Dose Escalation||0
3064216|NCT01286987|3784778|FG003|COMPLETED|Part 1: Dose Escalation||0
3064217|NCT01286987|3784779|FG004|COMPLETED|Part 1: Dose Escalation||0
3064218|NCT01286987|3784780|FG005|COMPLETED|Part 1: Dose Escalation||0
3064219|NCT01286987|3784781|FG006|COMPLETED|Part 1: Dose Escalation||1
3064220|NCT01286987|3784782|FG007|COMPLETED|Part 1: Dose Escalation||1
3064221|NCT01286987|3784783|FG008|COMPLETED|Part 1: Dose Escalation||0
3064222|NCT01286987|3784784|FG009|COMPLETED|Part 1: Dose Escalation||0
3064223|NCT01286987|3784785|FG010|COMPLETED|Part 1: Dose Escalation||0
3064224|NCT01286987|3784786|FG011|COMPLETED|Part 1: Dose Escalation||0
3064225|NCT01286987|3784787|FG012|COMPLETED|Part 1: Dose Escalation||0
3064226|NCT01286987|3784788|FG013|COMPLETED|Part 1: Dose Escalation||0
3064227|NCT01286987|3784789|FG014|COMPLETED|Part 1: Dose Escalation||0
3064228|NCT01286987|3784775|FG000|NOT COMPLETED|Part 1: Dose Escalation||3
3064229|NCT01286987|3784776|FG001|NOT COMPLETED|Part 1: Dose Escalation||3
3064230|NCT01286987|3784777|FG002|NOT COMPLETED|Part 1: Dose Escalation||3
3064231|NCT01286987|3784778|FG003|NOT COMPLETED|Part 1: Dose Escalation||3
3064232|NCT01286987|3784779|FG004|NOT COMPLETED|Part 1: Dose Escalation||3
3064233|NCT01286987|3784780|FG005|NOT COMPLETED|Part 1: Dose Escalation||6
3064234|NCT01286987|3784781|FG006|NOT COMPLETED|Part 1: Dose Escalation||5
3064235|NCT01286987|3784782|FG007|NOT COMPLETED|Part 1: Dose Escalation||5
3064236|NCT01286987|3784783|FG008|NOT COMPLETED|Part 1: Dose Escalation||6
3064237|NCT01286987|3784784|FG009|NOT COMPLETED|Part 1: Dose Escalation||0
3064238|NCT01286987|3784785|FG010|NOT COMPLETED|Part 1: Dose Escalation||0
3064239|NCT01286987|3784786|FG011|NOT COMPLETED|Part 1: Dose Escalation||0
3064240|NCT01286987|3784787|FG012|NOT COMPLETED|Part 1: Dose Escalation||0
3064241|NCT01286987|3784788|FG013|NOT COMPLETED|Part 1: Dose Escalation||0
3064242|NCT01286987|3784789|FG014|NOT COMPLETED|Part 1: Dose Escalation||0
3064243|NCT01286987|3784775|FG000|STARTED|Part 2: Dose Expansion||0
3064244|NCT01286987|3784776|FG001|STARTED|Part 2: Dose Expansion||0
3064245|NCT01286987|3784777|FG002|STARTED|Part 2: Dose Expansion||0
3064246|NCT01286987|3784778|FG003|STARTED|Part 2: Dose Expansion||0
3064247|NCT01286987|3784779|FG004|STARTED|Part 2: Dose Expansion||0
3064248|NCT01286987|3784780|FG005|STARTED|Part 2: Dose Expansion||0
3064249|NCT01286987|3784781|FG006|STARTED|Part 2: Dose Expansion||0
3064250|NCT01286987|3784782|FG007|STARTED|Part 2: Dose Expansion||0
3064251|NCT01286987|3784783|FG008|STARTED|Part 2: Dose Expansion||0
3064252|NCT01286987|3784784|FG009|STARTED|Part 2: Dose Expansion||12
3064253|NCT01286987|3784785|FG010|STARTED|Part 2: Dose Expansion||12
3064254|NCT01286987|3784786|FG011|STARTED|Part 2: Dose Expansion||11
3064255|NCT01286987|3784787|FG012|STARTED|Part 2: Dose Expansion||12
3064256|NCT01286987|3784788|FG013|STARTED|Part 2: Dose Expansion||24
3064257|NCT01286987|3784789|FG014|STARTED|Part 2: Dose Expansion||3
3064258|NCT01286987|3784775|FG000|Treated|Part 2: Dose Expansion||0
3064259|NCT01286987|3784776|FG001|Treated|Part 2: Dose Expansion||0
3064260|NCT01286987|3784777|FG002|Treated|Part 2: Dose Expansion||0
3064261|NCT01286987|3784778|FG003|Treated|Part 2: Dose Expansion||0
3064262|NCT01286987|3784779|FG004|Treated|Part 2: Dose Expansion||0
3064263|NCT01286987|3784780|FG005|Treated|Part 2: Dose Expansion||0
3064264|NCT01286987|3784781|FG006|Treated|Part 2: Dose Expansion||0
3064265|NCT01286987|3784782|FG007|Treated|Part 2: Dose Expansion||0
3064266|NCT01286987|3784783|FG008|Treated|Part 2: Dose Expansion||0
3064267|NCT01286987|3784784|FG009|Treated|Part 2: Dose Expansion||12
3064268|NCT01286987|3784785|FG010|Treated|Part 2: Dose Expansion||11
3064269|NCT01286987|3784786|FG011|Treated|Part 2: Dose Expansion||10
3064270|NCT01286987|3784787|FG012|Treated|Part 2: Dose Expansion||12
3064271|NCT01286987|3784788|FG013|Treated|Part 2: Dose Expansion||23
3064272|NCT01286987|3784789|FG014|Treated|Part 2: Dose Expansion||3
3064273|NCT01286987|3784775|FG000|COMPLETED|Part 2: Dose Expansion||0
3064274|NCT01286987|3784776|FG001|COMPLETED|Part 2: Dose Expansion||0
3064275|NCT01286987|3784777|FG002|COMPLETED|Part 2: Dose Expansion||0
3064276|NCT01286987|3784778|FG003|COMPLETED|Part 2: Dose Expansion||0
3064277|NCT01286987|3784779|FG004|COMPLETED|Part 2: Dose Expansion||0
3064278|NCT01286987|3784780|FG005|COMPLETED|Part 2: Dose Expansion||0
3064279|NCT01286987|3784781|FG006|COMPLETED|Part 2: Dose Expansion||0
3064280|NCT01286987|3784782|FG007|COMPLETED|Part 2: Dose Expansion||0
3064281|NCT01286987|3784783|FG008|COMPLETED|Part 2: Dose Expansion||0
3064282|NCT01286987|3784784|FG009|COMPLETED|Part 2: Dose Expansion||1
3064283|NCT01286987|3784785|FG010|COMPLETED|Part 2: Dose Expansion||2
3064284|NCT01286987|3784786|FG011|COMPLETED|Part 2: Dose Expansion||1
3064285|NCT01286987|3784787|FG012|COMPLETED|Part 2: Dose Expansion||0
3064286|NCT01286987|3784788|FG013|COMPLETED|Part 2: Dose Expansion||0
3064287|NCT01286987|3784789|FG014|COMPLETED|Part 2: Dose Expansion||1
3064288|NCT01286987|3784775|FG000|NOT COMPLETED|Part 2: Dose Expansion||0
3064289|NCT01286987|3784776|FG001|NOT COMPLETED|Part 2: Dose Expansion||0
3064290|NCT01286987|3784777|FG002|NOT COMPLETED|Part 2: Dose Expansion||0
3064291|NCT01286987|3784778|FG003|NOT COMPLETED|Part 2: Dose Expansion||0
3064292|NCT01286987|3784779|FG004|NOT COMPLETED|Part 2: Dose Expansion||0
3064293|NCT01286987|3784780|FG005|NOT COMPLETED|Part 2: Dose Expansion||0
3064294|NCT01286987|3784781|FG006|NOT COMPLETED|Part 2: Dose Expansion||0
3064295|NCT01286987|3784782|FG007|NOT COMPLETED|Part 2: Dose Expansion||0
3064296|NCT01286987|3784783|FG008|NOT COMPLETED|Part 2: Dose Expansion||0
3064297|NCT01286987|3784784|FG009|NOT COMPLETED|Part 2: Dose Expansion||11
3064298|NCT01286987|3784785|FG010|NOT COMPLETED|Part 2: Dose Expansion||10
3064299|NCT01286987|3784786|FG011|NOT COMPLETED|Part 2: Dose Expansion||10
3064300|NCT01286987|3784787|FG012|NOT COMPLETED|Part 2: Dose Expansion||12
3064301|NCT01286987|3784788|FG013|NOT COMPLETED|Part 2: Dose Expansion||24
3064302|NCT01286987|3784789|FG014|NOT COMPLETED|Part 2: Dose Expansion||2
3064303|NCT01287013|3784833|FG000|STARTED|Overall Study||32
3064304|NCT01287013|3784834|FG001|STARTED|Overall Study||34
3064305|NCT01287013|3784835|FG002|STARTED|Overall Study||21
3064306|NCT01287013|3784833|FG000|COMPLETED|Overall Study||29
3064307|NCT01287013|3784834|FG001|COMPLETED|Overall Study||29
3064308|NCT01287013|3784835|FG002|COMPLETED|Overall Study||0
3064309|NCT01287013|3784833|FG000|NOT COMPLETED|Overall Study||3
3064310|NCT01287013|3784834|FG001|NOT COMPLETED|Overall Study||5
3064311|NCT01287013|3784835|FG002|NOT COMPLETED|Overall Study||21
3064312|NCT01287039|3784845|FG000|STARTED|Overall Study||244
3064313|NCT01287039|3784846|FG001|STARTED|Overall Study||245
3064314|NCT01287039|3784845|FG000|COMPLETED|Overall Study||215
3064315|NCT01287039|3784846|FG001|COMPLETED|Overall Study||218
3064316|NCT01287039|3784845|FG000|NOT COMPLETED|Overall Study||29
3064317|NCT01287039|3784846|FG001|NOT COMPLETED|Overall Study||27
3064318|NCT01287065|3784852|FG000|STARTED|Treatment Period 1||4
3064319|NCT01287065|3784853|FG001|STARTED|Treatment Period 1||4
3064320|NCT01287065|3784854|FG002|STARTED|Treatment Period 1||4
3064321|NCT01287065|3784855|FG003|STARTED|Treatment Period 1||4
3064322|NCT01287065|3784856|FG004|STARTED|Treatment Period 1||5
3064323|NCT01287065|3784857|FG005|STARTED|Treatment Period 1||5
3064324|NCT01287065|3784852|FG000|COMPLETED|Treatment Period 1||4
3064325|NCT01287065|3784853|FG001|COMPLETED|Treatment Period 1||4
3064326|NCT01287065|3784854|FG002|COMPLETED|Treatment Period 1||4
3064327|NCT01287065|3784855|FG003|COMPLETED|Treatment Period 1||4
3064328|NCT01287065|3784856|FG004|COMPLETED|Treatment Period 1||4
3064329|NCT01287065|3784857|FG005|COMPLETED|Treatment Period 1||4
3064330|NCT01287065|3784852|FG000|NOT COMPLETED|Treatment Period 1||0
3064331|NCT01287065|3784853|FG001|NOT COMPLETED|Treatment Period 1||0
3064332|NCT01287065|3784854|FG002|NOT COMPLETED|Treatment Period 1||0
3064333|NCT01287065|3784855|FG003|NOT COMPLETED|Treatment Period 1||0
3064334|NCT01287065|3784856|FG004|NOT COMPLETED|Treatment Period 1||1
3064335|NCT01287065|3784857|FG005|NOT COMPLETED|Treatment Period 1||1
3064336|NCT01287065|3784852|FG000|STARTED|Washout Period 1||4
3064337|NCT01287065|3784853|FG001|STARTED|Washout Period 1||4
3064338|NCT01287065|3784854|FG002|STARTED|Washout Period 1||4
3064339|NCT01287065|3784855|FG003|STARTED|Washout Period 1||4
3064340|NCT01287065|3784856|FG004|STARTED|Washout Period 1||4
3064341|NCT01287065|3784857|FG005|STARTED|Washout Period 1||4
3064342|NCT01287065|3784852|FG000|COMPLETED|Washout Period 1||4
3064343|NCT01287065|3784853|FG001|COMPLETED|Washout Period 1||4
3064344|NCT01287065|3784854|FG002|COMPLETED|Washout Period 1||4
3064345|NCT01287065|3784855|FG003|COMPLETED|Washout Period 1||4
3064346|NCT01287065|3784856|FG004|COMPLETED|Washout Period 1||4
3064347|NCT01287065|3784857|FG005|COMPLETED|Washout Period 1||4
3064348|NCT01287065|3784852|FG000|NOT COMPLETED|Washout Period 1||0
3064349|NCT01287065|3784853|FG001|NOT COMPLETED|Washout Period 1||0
3064350|NCT01287065|3784854|FG002|NOT COMPLETED|Washout Period 1||0
3064351|NCT01287065|3784855|FG003|NOT COMPLETED|Washout Period 1||0
3064352|NCT01287065|3784856|FG004|NOT COMPLETED|Washout Period 1||0
3064353|NCT01287065|3784857|FG005|NOT COMPLETED|Washout Period 1||0
3064354|NCT01287065|3784852|FG000|STARTED|Treatment Period 2||4
3064355|NCT01287065|3784853|FG001|STARTED|Treatment Period 2||4
3064356|NCT01287065|3784854|FG002|STARTED|Treatment Period 2||4
3064357|NCT01287065|3784855|FG003|STARTED|Treatment Period 2||4
3064358|NCT01287065|3784856|FG004|STARTED|Treatment Period 2||4
3064359|NCT01287065|3784857|FG005|STARTED|Treatment Period 2||4
3064360|NCT01287065|3784852|FG000|COMPLETED|Treatment Period 2||4
3064361|NCT01287065|3784853|FG001|COMPLETED|Treatment Period 2||4
3064362|NCT01287065|3784854|FG002|COMPLETED|Treatment Period 2||4
3064363|NCT01287065|3784855|FG003|COMPLETED|Treatment Period 2||4
3064364|NCT01287065|3784856|FG004|COMPLETED|Treatment Period 2||4
3064365|NCT01287065|3784857|FG005|COMPLETED|Treatment Period 2||4
3064366|NCT01287065|3784852|FG000|NOT COMPLETED|Treatment Period 2||0
3064367|NCT01287065|3784853|FG001|NOT COMPLETED|Treatment Period 2||0
3064368|NCT01287065|3784854|FG002|NOT COMPLETED|Treatment Period 2||0
3064369|NCT01287065|3784855|FG003|NOT COMPLETED|Treatment Period 2||0
3064370|NCT01287065|3784856|FG004|NOT COMPLETED|Treatment Period 2||0
3064371|NCT01287065|3784857|FG005|NOT COMPLETED|Treatment Period 2||0
3064372|NCT01287065|3784852|FG000|STARTED|Washout Period 2||4
3064373|NCT01287065|3784853|FG001|STARTED|Washout Period 2||4
3064374|NCT01287065|3784854|FG002|STARTED|Washout Period 2||4
3064375|NCT01287065|3784855|FG003|STARTED|Washout Period 2||4
3064376|NCT01287065|3784856|FG004|STARTED|Washout Period 2||4
3064377|NCT01287065|3784857|FG005|STARTED|Washout Period 2||4
3064378|NCT01287065|3784852|FG000|COMPLETED|Washout Period 2||4
3064379|NCT01287065|3784853|FG001|COMPLETED|Washout Period 2||4
3064380|NCT01287065|3784854|FG002|COMPLETED|Washout Period 2||4
3064381|NCT01287065|3784855|FG003|COMPLETED|Washout Period 2||4
3064382|NCT01287065|3784856|FG004|COMPLETED|Washout Period 2||4
3064383|NCT01287065|3784857|FG005|COMPLETED|Washout Period 2||4
3064384|NCT01287065|3784852|FG000|NOT COMPLETED|Washout Period 2||0
3064385|NCT01287065|3784853|FG001|NOT COMPLETED|Washout Period 2||0
3064386|NCT01287065|3784854|FG002|NOT COMPLETED|Washout Period 2||0
3064387|NCT01287065|3784855|FG003|NOT COMPLETED|Washout Period 2||0
3064388|NCT01287065|3784856|FG004|NOT COMPLETED|Washout Period 2||0
3064389|NCT01287065|3784857|FG005|NOT COMPLETED|Washout Period 2||0
3064390|NCT01287065|3784852|FG000|STARTED|Treatment Period 3||4
3064391|NCT01287065|3784853|FG001|STARTED|Treatment Period 3||4
3064392|NCT01287065|3784854|FG002|STARTED|Treatment Period 3||4
3064393|NCT01287065|3784855|FG003|STARTED|Treatment Period 3||4
3064394|NCT01287065|3784856|FG004|STARTED|Treatment Period 3||4
3064395|NCT01287065|3784857|FG005|STARTED|Treatment Period 3||4
3064396|NCT01287065|3784852|FG000|COMPLETED|Treatment Period 3||4
3064397|NCT01287065|3784853|FG001|COMPLETED|Treatment Period 3||4
3064398|NCT01287065|3784854|FG002|COMPLETED|Treatment Period 3||4
3064399|NCT01287065|3784855|FG003|COMPLETED|Treatment Period 3||4
3064400|NCT01287065|3784856|FG004|COMPLETED|Treatment Period 3||4
3064401|NCT01287065|3784857|FG005|COMPLETED|Treatment Period 3||4
3064402|NCT01287065|3784852|FG000|NOT COMPLETED|Treatment Period 3||0
3064403|NCT01287065|3784853|FG001|NOT COMPLETED|Treatment Period 3||0
3064404|NCT01287065|3784854|FG002|NOT COMPLETED|Treatment Period 3||0
3064405|NCT01287065|3784855|FG003|NOT COMPLETED|Treatment Period 3||0
3064406|NCT01287065|3784856|FG004|NOT COMPLETED|Treatment Period 3||0
3064407|NCT01287065|3784857|FG005|NOT COMPLETED|Treatment Period 3||0
3064408|NCT01287078|3784867|FG000|STARTED|Overall Study||20
3064409|NCT01287078|3784868|FG001|STARTED|Overall Study||3
3064410|NCT01287078|3784867|FG000|COMPLETED|Overall Study||10
3064411|NCT01287078|3784868|FG001|COMPLETED|Overall Study||1
3064412|NCT01287078|3784867|FG000|NOT COMPLETED|Overall Study||10
3064413|NCT01287078|3784868|FG001|NOT COMPLETED|Overall Study||2
3064414|NCT01287104|3784878|FG000|STARTED|Overall Study||4
3064415|NCT01287104|3784879|FG001|STARTED|Overall Study||7
3064416|NCT01287104|3784880|FG002|STARTED|Overall Study||12
3064417|NCT01287104|3784881|FG003|STARTED|Overall Study||11
3064418|NCT01287104|3784878|FG000|COMPLETED|Overall Study||3
3064419|NCT01287104|3784879|FG001|COMPLETED|Overall Study||2
3064420|NCT01287104|3784880|FG002|COMPLETED|Overall Study||5
3064421|NCT01287104|3784881|FG003|COMPLETED|Overall Study||8
3064422|NCT01287104|3784878|FG000|NOT COMPLETED|Overall Study||1
3064423|NCT01287104|3784879|FG001|NOT COMPLETED|Overall Study||5
3064424|NCT01287104|3784880|FG002|NOT COMPLETED|Overall Study||7
3064425|NCT01287104|3784881|FG003|NOT COMPLETED|Overall Study||3
3064426|NCT01287117|3784902|FG000|STARTED|Overall Study||80
3064427|NCT01287117|3784903|FG001|STARTED|Overall Study||78
3064428|NCT01287117|3784904|FG002|STARTED|Overall Study||80
3064429|NCT01287117|3784905|FG003|STARTED|Overall Study||81
3064430|NCT01287117|3784902|FG000|Received Treatment|Overall Study||80
3064431|NCT01287117|3784903|FG001|Received Treatment|Overall Study||77
3064432|NCT01287117|3784904|FG002|Received Treatment|Overall Study||80
3064433|NCT01287117|3784905|FG003|Received Treatment|Overall Study||81
3064434|NCT01287117|3784902|FG000|COMPLETED|Overall Study||65
3064435|NCT01287117|3784903|FG001|COMPLETED|Overall Study||64
3064436|NCT01287117|3784904|FG002|COMPLETED|Overall Study||64
3064437|NCT01287117|3784905|FG003|COMPLETED|Overall Study||69
3064438|NCT01287117|3784902|FG000|NOT COMPLETED|Overall Study||15
3064439|NCT01287117|3784903|FG001|NOT COMPLETED|Overall Study||14
3064440|NCT01287117|3784904|FG002|NOT COMPLETED|Overall Study||16
3064441|NCT01287117|3784905|FG003|NOT COMPLETED|Overall Study||12
3064442|NCT01287195|3784915|FG000|STARTED|Overall Study||6
3064443|NCT01287195|3784915|FG000|COMPLETED|Overall Study||4
3064444|NCT01287195|3784915|FG000|NOT COMPLETED|Overall Study||2
3064445|NCT01287208|3784921|FG000|STARTED|Phase 1: Randomized Phase||52
3064446|NCT01287208|3784922|FG001|STARTED|Phase 1: Randomized Phase||52
3064447|NCT01287208|3784921|FG000|COMPLETED|Phase 1: Randomized Phase||50
3064448|NCT01287208|3784922|FG001|COMPLETED|Phase 1: Randomized Phase||49
3064449|NCT01287208|3784921|FG000|NOT COMPLETED|Phase 1: Randomized Phase||2
3064450|NCT01287208|3784922|FG001|NOT COMPLETED|Phase 1: Randomized Phase||3
3064451|NCT01287208|3784921|FG000|STARTED|Phase 2: Team Competition||50
3064452|NCT01287208|3784922|FG001|STARTED|Phase 2: Team Competition||49
3064453|NCT01287208|3784921|FG000|COMPLETED|Phase 2: Team Competition||50
3064454|NCT01287208|3784922|FG001|COMPLETED|Phase 2: Team Competition||49
3064455|NCT01287208|3784921|FG000|NOT COMPLETED|Phase 2: Team Competition||0
3064456|NCT01287208|3784922|FG001|NOT COMPLETED|Phase 2: Team Competition||0
3064457|NCT01287221|3784932|FG000|STARTED|Overall Study||50
3064458|NCT01287221|3784933|FG001|STARTED|Overall Study||50
3064459|NCT01287221|3784932|FG000|Completed 3 Months Follow-up|Overall Study||49
3064460|NCT01287221|3784933|FG001|Completed 3 Months Follow-up|Overall Study||50
3064461|NCT01287221|3784932|FG000|Completed 6 Months Follow-up|Overall Study||47
3064462|NCT01287221|3784933|FG001|Completed 6 Months Follow-up|Overall Study||43
3064463|NCT01287221|3784932|FG000|Completed 9 Months Follow-up|Overall Study||42
3064464|NCT01287221|3784933|FG001|Completed 9 Months Follow-up|Overall Study||40
3064465|NCT01287221|3784932|FG000|Completed 12 Months Follow-up|Overall Study||40
3064466|NCT01287221|3784933|FG001|Completed 12 Months Follow-up|Overall Study||39
3064467|NCT01287221|3784932|FG000|COMPLETED|Overall Study||46
3064468|NCT01287221|3784933|FG001|COMPLETED|Overall Study||45
3064469|NCT01287221|3784932|FG000|NOT COMPLETED|Overall Study||4
3064470|NCT01287221|3784933|FG001|NOT COMPLETED|Overall Study||5
3134161|NCT01700439|3859177|FG000|STARTED|Overall Study||889
3134162|NCT01700439|3859177|FG000|Study Valve Group|Overall Study|Received the Edwards INTUITY surgical aortic heart valve.|839
3134163|NCT01700439|3859177|FG000|Discharge|Overall Study||831
3134164|NCT01700439|3859177|FG000|3 Month|Overall Study||778
3134165|NCT01700439|3859177|FG000|1 Year|Overall Study||573
3134166|NCT01700439|3859177|FG000|2 Year|Overall Study||215
3134167|NCT01700439|3859177|FG000|COMPLETED|Overall Study||0
3134168|NCT01700439|3859177|FG000|NOT COMPLETED|Overall Study||889
3134169|NCT01700517|3859185|FG000|STARTED|Overall Study||40
3134170|NCT01700517|3859186|FG001|STARTED|Overall Study||40
3134171|NCT01700517|3859187|FG002|STARTED|Overall Study||40
3134172|NCT01700517|3859185|FG000|COMPLETED|Overall Study||40
3134173|NCT01700517|3859186|FG001|COMPLETED|Overall Study||40
3134174|NCT01700517|3859187|FG002|COMPLETED|Overall Study||40
3134175|NCT01700517|3859185|FG000|NOT COMPLETED|Overall Study||0
3134176|NCT01700517|3859186|FG001|NOT COMPLETED|Overall Study||0
3134177|NCT01700517|3859187|FG002|NOT COMPLETED|Overall Study||0
3134178|NCT01700530|3859198|FG000|STARTED|Overall Study||9
3134179|NCT01700530|3859199|FG001|STARTED|Overall Study||21
3134180|NCT01700530|3859200|FG002|STARTED|Overall Study||20
3134181|NCT01700530|3859198|FG000|COMPLETED|Overall Study||9
3134182|NCT01700530|3859199|FG001|COMPLETED|Overall Study||18
3134183|NCT01700530|3859200|FG002|COMPLETED|Overall Study||19
3134184|NCT01700530|3859198|FG000|NOT COMPLETED|Overall Study||0
3134185|NCT01700530|3859199|FG001|NOT COMPLETED|Overall Study||3
3134186|NCT01700530|3859200|FG002|NOT COMPLETED|Overall Study||1
3134187|NCT01700621|3859210|FG000|STARTED|Received Study Vaccines||240
3134188|NCT01700621|3859211|FG001|STARTED|Received Study Vaccines||240
3134189|NCT01700621|3859210|FG000|COMPLETED|Received Study Vaccines||240
3134190|NCT01700621|3859211|FG001|COMPLETED|Received Study Vaccines||240
3134191|NCT01700621|3859210|FG000|NOT COMPLETED|Received Study Vaccines||0
3134192|NCT01700621|3859211|FG001|NOT COMPLETED|Received Study Vaccines||0
3134193|NCT01700621|3859210|FG000|STARTED|Analyzed for Immunogenicity||240
3134194|NCT01700621|3859211|FG001|STARTED|Analyzed for Immunogenicity||240
3134195|NCT01700621|3859210|FG000|COMPLETED|Analyzed for Immunogenicity||227
3134196|NCT01700621|3859211|FG001|COMPLETED|Analyzed for Immunogenicity||233
3134197|NCT01700621|3859210|FG000|NOT COMPLETED|Analyzed for Immunogenicity||13
3134198|NCT01700621|3859211|FG001|NOT COMPLETED|Analyzed for Immunogenicity||7
3134199|NCT01700673|3859221|FG000|STARTED|Overall Study||1
3134200|NCT01700673|3859222|FG001|STARTED|Overall Study||23
3134201|NCT01700673|3859223|FG002|STARTED|Overall Study||1
3134202|NCT01700673|3859221|FG000|COMPLETED|Overall Study||1
3134203|NCT01700673|3859222|FG001|COMPLETED|Overall Study||17
3134204|NCT01700673|3859223|FG002|COMPLETED|Overall Study||1
3134205|NCT01700673|3859221|FG000|NOT COMPLETED|Overall Study||0
3134206|NCT01700673|3859222|FG001|NOT COMPLETED|Overall Study||6
3134207|NCT01700673|3859223|FG002|NOT COMPLETED|Overall Study||0
3134208|NCT01700725|3859235|FG000|STARTED|Overall Study||14
3134209|NCT01700725|3859236|FG001|STARTED|Overall Study||14
3134210|NCT01700725|3859237|FG002|STARTED|Overall Study||12
3134211|NCT01700725|3859235|FG000|COMPLETED|Overall Study||14
3134212|NCT01700725|3859236|FG001|COMPLETED|Overall Study||14
3134213|NCT01700725|3859237|FG002|COMPLETED|Overall Study||12
3162944|NCT01881828|3890428|FG001|COMPLETED|Overall Study||69
3162945|NCT01881828|3890427|FG000|NOT COMPLETED|Overall Study||0
3162946|NCT01881828|3890428|FG001|NOT COMPLETED|Overall Study||0
3162947|NCT01881867|3890436|FG000|STARTED|Overall Study||26
3162948|NCT01881867|3890437|FG001|STARTED|Overall Study||28
3134214|NCT01700725|3859235|FG000|NOT COMPLETED|Overall Study||0
3134215|NCT01700725|3859236|FG001|NOT COMPLETED|Overall Study||0
3134216|NCT01700725|3859237|FG002|NOT COMPLETED|Overall Study||0
3134217|NCT01700816|3859247|FG000|STARTED|Overall Study||21
3162949|NCT01881867|3890436|FG000|COMPLETED|Overall Study||14
3064471|NCT01287364|3784941|FG000|STARTED|Overall Study||94
3064472|NCT01287364|3784942|FG001|STARTED|Overall Study||91
3064473|NCT01287364|3784941|FG000|COMPLETED|Overall Study||85
3064474|NCT01287364|3784942|FG001|COMPLETED|Overall Study||81
3064475|NCT01287364|3784941|FG000|NOT COMPLETED|Overall Study||9
3064476|NCT01287364|3784942|FG001|NOT COMPLETED|Overall Study||10
3064477|NCT01287377|3784964|FG000|STARTED|Overall Study||80
3064478|NCT01287377|3784965|FG001|STARTED|Overall Study||81
3064479|NCT01287377|3784966|FG002|STARTED|Overall Study||82
3064480|NCT01287377|3784964|FG000|COMPLETED|Overall Study|Study Complete|80
3064481|NCT01287377|3784965|FG001|COMPLETED|Overall Study|Study Complete|81
3064482|NCT01287377|3784966|FG002|COMPLETED|Overall Study|Study Complete|82
3064483|NCT01287377|3784964|FG000|NOT COMPLETED|Overall Study||0
3064484|NCT01287377|3784965|FG001|NOT COMPLETED|Overall Study||0
3064485|NCT01287377|3784966|FG002|NOT COMPLETED|Overall Study||0
3064486|NCT01287403|3784974|FG000|STARTED|Diet Restriction (7 Days)||14
3064487|NCT01287403|3784974|FG000|COMPLETED|Diet Restriction (7 Days)||14
3064488|NCT01287403|3784974|FG000|NOT COMPLETED|Diet Restriction (7 Days)||0
3064489|NCT01287403|3784974|FG000|STARTED|1st Intervention (1 Day)||14
3064490|NCT01287403|3784974|FG000|COMPLETED|1st Intervention (1 Day)|"The adverse event was linked to the intake of refined wheat flour"|13
3064491|NCT01287403|3784974|FG000|NOT COMPLETED|1st Intervention (1 Day)||1
3064492|NCT01287403|3784974|FG000|STARTED|Washout 7 Days||13
3064493|NCT01287403|3784974|FG000|COMPLETED|Washout 7 Days||13
3064494|NCT01287403|3784974|FG000|NOT COMPLETED|Washout 7 Days||0
3064495|NCT01287403|3784974|FG000|STARTED|2nd Intervention (1 Day)||13
3064496|NCT01287403|3784974|FG000|COMPLETED|2nd Intervention (1 Day)||13
3064497|NCT01287403|3784974|FG000|NOT COMPLETED|2nd Intervention (1 Day)||0
3064498|NCT01287403|3784974|FG000|STARTED|Washout (7 Days)||13
3064499|NCT01287403|3784974|FG000|COMPLETED|Washout (7 Days)||13
3064500|NCT01287403|3784974|FG000|NOT COMPLETED|Washout (7 Days)||0
3064501|NCT01287403|3784974|FG000|STARTED|3rd Intervention (1 Day)||13
3064502|NCT01287403|3784974|FG000|COMPLETED|3rd Intervention (1 Day)||13
3064503|NCT01287403|3784974|FG000|NOT COMPLETED|3rd Intervention (1 Day)||0
3064504|NCT01287403|3784974|FG000|STARTED|Washout (7 Days)||13
3064505|NCT01287403|3784974|FG000|COMPLETED|Washout (7 Days)||13
3064506|NCT01287403|3784974|FG000|NOT COMPLETED|Washout (7 Days)||0
3064507|NCT01287403|3784974|FG000|STARTED|4th Intervention (1 Day)||13
3064508|NCT01287403|3784974|FG000|COMPLETED|4th Intervention (1 Day)||13
3064509|NCT01287403|3784974|FG000|NOT COMPLETED|4th Intervention (1 Day)||0
3064510|NCT01287403|3784974|FG000|STARTED|Washout (7 Days)||13
3064511|NCT01287403|3784974|FG000|COMPLETED|Washout (7 Days)||13
3064512|NCT01287403|3784974|FG000|NOT COMPLETED|Washout (7 Days)||0
3064513|NCT01287403|3784974|FG000|STARTED|5th Intervention (1 Day)||13
3064514|NCT01287403|3784974|FG000|COMPLETED|5th Intervention (1 Day)||13
3064515|NCT01287403|3784974|FG000|NOT COMPLETED|5th Intervention (1 Day)||0
3064516|NCT01287403|3784974|FG000|STARTED|Washout (7 Days)||13
3064517|NCT01287403|3784974|FG000|COMPLETED|Washout (7 Days)||13
3064518|NCT01287403|3784974|FG000|NOT COMPLETED|Washout (7 Days)||0
3064519|NCT01287403|3784974|FG000|STARTED|6th and Last Intervention (1 Day)||13
3064520|NCT01287403|3784974|FG000|COMPLETED|6th and Last Intervention (1 Day)||13
3064521|NCT01287403|3784974|FG000|NOT COMPLETED|6th and Last Intervention (1 Day)||0
3064522|NCT01287416|3784990|FG000|STARTED|Pre-post Training|number of people that were invited to participate based on eligibility and consent received|48
3064523|NCT01287416|3784991|FG001|STARTED|Pre-post Training|number of people that were invited to participate based on eligibility and consent received|48
3064524|NCT01287416|3784990|FG000|Training Workshop|Pre-post Training|number of people that showed up for the training session|31
3064525|NCT01287416|3784991|FG001|Training Workshop|Pre-post Training|number of people that showed up for the training session|24
3064526|NCT01287416|3784990|FG000|Post Training Questionnaire|Pre-post Training||26
3064527|NCT01287416|3784991|FG001|Post Training Questionnaire|Pre-post Training||23
3064528|NCT01287416|3784990|FG000|COMPLETED|Pre-post Training||26
3064529|NCT01287416|3784991|FG001|COMPLETED|Pre-post Training||23
3064530|NCT01287416|3784990|FG000|NOT COMPLETED|Pre-post Training||22
3064531|NCT01287416|3784991|FG001|NOT COMPLETED|Pre-post Training||25
3064532|NCT01287416|3784990|FG000|STARTED|6 Month Follow-up|all participants that had completed the baseline measure were invited to do the follow-up|31
3064533|NCT01287416|3784991|FG001|STARTED|6 Month Follow-up|all participants that had completed the baseline measure were invited to do the follow-up|24
3064534|NCT01287416|3784990|FG000|COMPLETED|6 Month Follow-up||28
3064535|NCT01287416|3784991|FG001|COMPLETED|6 Month Follow-up||22
3064536|NCT01287416|3784990|FG000|NOT COMPLETED|6 Month Follow-up||3
3064537|NCT01287416|3784991|FG001|NOT COMPLETED|6 Month Follow-up||2
3064538|NCT01287520|3785006|FG000|STARTED|Overall Study||3
3064539|NCT01287520|3785007|FG001|STARTED|Overall Study|One participant who received study drug but did not complete Cycle 1 was replaced.|7
3064540|NCT01287520|3785008|FG002|STARTED|Overall Study||5
3064541|NCT01287520|3785009|FG003|STARTED|Overall Study|One participant who received study drug but did not complete Cycle 1 was replaced.|7
3064542|NCT01287520|3785010|FG004|STARTED|Overall Study||3
3064543|NCT01287520|3785011|FG005|STARTED|Overall Study||4
3064544|NCT01287520|3785012|FG006|STARTED|Overall Study||2
3064545|NCT01287520|3785013|FG007|STARTED|Overall Study||5
3064546|NCT01287520|3785014|FG008|STARTED|Overall Study||5
3064547|NCT01287520|3785006|FG000|COMPLETED|Overall Study||0
3064548|NCT01287520|3785007|FG001|COMPLETED|Overall Study||0
3064549|NCT01287520|3785008|FG002|COMPLETED|Overall Study||0
3064550|NCT01287520|3785009|FG003|COMPLETED|Overall Study||0
3064551|NCT01287520|3785010|FG004|COMPLETED|Overall Study||0
3064552|NCT01287520|3785011|FG005|COMPLETED|Overall Study||0
3064553|NCT01287520|3785012|FG006|COMPLETED|Overall Study||0
3064554|NCT01287520|3785013|FG007|COMPLETED|Overall Study||0
3064555|NCT01287520|3785014|FG008|COMPLETED|Overall Study||0
3064556|NCT01287520|3785006|FG000|NOT COMPLETED|Overall Study||3
3064557|NCT01287520|3785007|FG001|NOT COMPLETED|Overall Study||7
3064558|NCT01287520|3785008|FG002|NOT COMPLETED|Overall Study||5
3064559|NCT01287520|3785009|FG003|NOT COMPLETED|Overall Study||7
3064560|NCT01287520|3785010|FG004|NOT COMPLETED|Overall Study||3
3064561|NCT01287520|3785011|FG005|NOT COMPLETED|Overall Study||4
3064562|NCT01287520|3785012|FG006|NOT COMPLETED|Overall Study||2
3064563|NCT01287520|3785013|FG007|NOT COMPLETED|Overall Study||5
3064564|NCT01287520|3785014|FG008|NOT COMPLETED|Overall Study||5
3064565|NCT01287611|3785065|FG000|STARTED|Overall Study||84
3064566|NCT01287611|3785066|FG001|STARTED|Overall Study||84
3064567|NCT01287611|3785065|FG000|The Number of Patients Who Underwent C/S|Overall Study||84
3064568|NCT01287611|3785066|FG001|The Number of Patients Who Underwent C/S|Overall Study||84
3064569|NCT01287611|3785065|FG000|COMPLETED|Overall Study||51
3064570|NCT01287611|3785066|FG001|COMPLETED|Overall Study||65
3064571|NCT01287611|3785065|FG000|NOT COMPLETED|Overall Study||33
3064572|NCT01287611|3785066|FG001|NOT COMPLETED|Overall Study||19
3064573|NCT01287754|3785076|FG000|STARTED|Overall Study||3
3064574|NCT01287754|3785077|FG001|STARTED|Overall Study||21
3064575|NCT01287754|3785076|FG000|COMPLETED|Overall Study||0
3064576|NCT01287754|3785077|FG001|COMPLETED|Overall Study||0
3064577|NCT01287754|3785076|FG000|NOT COMPLETED|Overall Study||3
3064578|NCT01287754|3785077|FG001|NOT COMPLETED|Overall Study||21
3064579|NCT01287832|3785085|FG000|STARTED|Overall Study||6
3064580|NCT01287832|3785086|FG001|STARTED|Overall Study||5
3064581|NCT01287832|3785085|FG000|COMPLETED|Overall Study||5
3064582|NCT01287832|3785086|FG001|COMPLETED|Overall Study||4
3064583|NCT01287832|3785085|FG000|NOT COMPLETED|Overall Study||1
3064584|NCT01287832|3785086|FG001|NOT COMPLETED|Overall Study||1
3064585|NCT01287897|3785096|FG000|STARTED|Overall Study||70
3064586|NCT01287897|3785097|FG001|STARTED|Overall Study||69
3064587|NCT01287897|3785098|FG002|STARTED|Overall Study||71
3064588|NCT01287897|3785099|FG003|STARTED|Overall Study|Enrollment was halted before reaching the planned sample size due to safety findings in NCT01405196.|40
3064589|NCT01287897|3785096|FG000|Treated|Overall Study||69
3064590|NCT01287897|3785097|FG001|Treated|Overall Study||67
3064591|NCT01287897|3785098|FG002|Treated|Overall Study||71
3064592|NCT01287897|3785099|FG003|Treated|Overall Study||40
3064593|NCT01287897|3785096|FG000|Completed Treatment Period|Overall Study||58
3064594|NCT01287897|3785097|FG001|Completed Treatment Period|Overall Study||52
3064595|NCT01287897|3785098|FG002|Completed Treatment Period|Overall Study||58
3064596|NCT01287897|3785099|FG003|Completed Treatment Period|Overall Study||29
3064597|NCT01287897|3785096|FG000|Completed Follow-up Period|Overall Study||3
3064598|NCT01287897|3785097|FG001|Completed Follow-up Period|Overall Study||8
3064599|NCT01287897|3785098|FG002|Completed Follow-up Period|Overall Study||3
3064600|NCT01287897|3785099|FG003|Completed Follow-up Period|Overall Study||4
3064601|NCT01287897|3785096|FG000|Enrolled in NCT01345318|Overall Study||56
3064602|NCT01287897|3785097|FG001|Enrolled in NCT01345318|Overall Study||50
3064603|NCT01287897|3785098|FG002|Enrolled in NCT01345318|Overall Study||56
3064604|NCT01287897|3785099|FG003|Enrolled in NCT01345318|Overall Study||29
3064605|NCT01287897|3785096|FG000|COMPLETED|Overall Study|Include participants who completed the follow-up period or enrolled in NCT01345318.|59
3064606|NCT01287897|3785097|FG001|COMPLETED|Overall Study|Include participants who completed the follow-up period or enrolled in NCT01345318.|58
3064607|NCT01287897|3785098|FG002|COMPLETED|Overall Study|Include participants who completed the follow-up period or enrolled in NCT01345318.|59
3064608|NCT01287897|3785099|FG003|COMPLETED|Overall Study|Include participants who completed the follow-up period or enrolled in NCT01345318.|33
3064609|NCT01287897|3785096|FG000|NOT COMPLETED|Overall Study||11
3064610|NCT01287897|3785097|FG001|NOT COMPLETED|Overall Study||11
3064611|NCT01287897|3785098|FG002|NOT COMPLETED|Overall Study||12
3064612|NCT01287897|3785099|FG003|NOT COMPLETED|Overall Study||7
3064613|NCT01288027|3785113|FG000|STARTED|Overall Study||16
3064614|NCT01288027|3785113|FG000|Full Analysis Set (FAS)|Overall Study|All participants who received at least 1 complete infusion of alglucosidase alfa.|16
3064615|NCT01288027|3785113|FG000|COMPLETED|Overall Study||16
3064616|NCT01288027|3785113|FG000|NOT COMPLETED|Overall Study||0
3064617|NCT01288053|3785117|FG000|STARTED|Overall Study||9
3064618|NCT01288053|3785117|FG000|COMPLETED|Overall Study||8
3064619|NCT01288053|3785117|FG000|NOT COMPLETED|Overall Study||1
3064620|NCT01288079|3785125|FG000|STARTED|Overall Study||37
3064621|NCT01288079|3785126|FG001|STARTED|Overall Study||36
3064622|NCT01288079|3785127|FG002|STARTED|Overall Study||37
3064623|NCT01288079|3785128|FG003|STARTED|Overall Study||35
3064624|NCT01288079|3785125|FG000|COMPLETED|Overall Study||17
3064625|NCT01288079|3785126|FG001|COMPLETED|Overall Study||9
3064626|NCT01288079|3785127|FG002|COMPLETED|Overall Study||18
3064627|NCT01288079|3785128|FG003|COMPLETED|Overall Study||18
3064628|NCT01288079|3785125|FG000|NOT COMPLETED|Overall Study||20
3064629|NCT01288079|3785126|FG001|NOT COMPLETED|Overall Study||27
3064630|NCT01288079|3785127|FG002|NOT COMPLETED|Overall Study||19
3064631|NCT01288079|3785128|FG003|NOT COMPLETED|Overall Study||17
3064632|NCT01288209|3785140|FG000|STARTED|Overall Study||53
3064633|NCT01288209|3785141|FG001|STARTED|Overall Study||53
3064634|NCT01288209|3785140|FG000|COMPLETED|Overall Study||51
3064635|NCT01288209|3785141|FG001|COMPLETED|Overall Study||50
3064636|NCT01288209|3785140|FG000|NOT COMPLETED|Overall Study||2
3064637|NCT01288209|3785141|FG001|NOT COMPLETED|Overall Study||3
3064638|NCT01288287|3785147|FG000|STARTED|Overall Study||149
3064639|NCT01288287|3785147|FG000|Safety Set|Overall Study||147
3064640|NCT01288287|3785147|FG000|Full Analysis Set|Overall Study||111
3064641|NCT01288287|3785147|FG000|COMPLETED|Overall Study||103
3064642|NCT01288287|3785147|FG000|NOT COMPLETED|Overall Study||46
3064643|NCT01288430|3785162|FG000|STARTED|Part 1||2
3064644|NCT01288430|3785163|FG001|STARTED|Part 1||3
3064645|NCT01288430|3785164|FG002|STARTED|Part 1||5
3064646|NCT01288430|3785165|FG003|STARTED|Part 1||7
3064647|NCT01288430|3785166|FG004|STARTED|Part 1||3
3064648|NCT01288430|3785167|FG005|STARTED|Part 1||6
3064649|NCT01288430|3785168|FG006|STARTED|Part 1||7
3064650|NCT01288430|3785169|FG007|STARTED|Part 1||0
3064651|NCT01288430|3785170|FG008|STARTED|Part 1||0
3064652|NCT01288430|3785171|FG009|STARTED|Part 1||0
3064653|NCT01288430|3785162|FG000|COMPLETED|Part 1||0
3064654|NCT01288430|3785163|FG001|COMPLETED|Part 1||0
3064655|NCT01288430|3785164|FG002|COMPLETED|Part 1||0
3064656|NCT01288430|3785165|FG003|COMPLETED|Part 1||0
3064657|NCT01288430|3785166|FG004|COMPLETED|Part 1||0
3064658|NCT01288430|3785167|FG005|COMPLETED|Part 1||0
3064659|NCT01288430|3785168|FG006|COMPLETED|Part 1||0
3064660|NCT01288430|3785169|FG007|COMPLETED|Part 1||0
3064661|NCT01288430|3785170|FG008|COMPLETED|Part 1||0
3064662|NCT01288430|3785171|FG009|COMPLETED|Part 1||0
3064663|NCT01288430|3785162|FG000|NOT COMPLETED|Part 1||2
3064664|NCT01288430|3785163|FG001|NOT COMPLETED|Part 1||3
3064665|NCT01288430|3785164|FG002|NOT COMPLETED|Part 1||5
3064666|NCT01288430|3785165|FG003|NOT COMPLETED|Part 1||7
3064667|NCT01288430|3785166|FG004|NOT COMPLETED|Part 1||3
3064668|NCT01288430|3785167|FG005|NOT COMPLETED|Part 1||6
3064669|NCT01288430|3785168|FG006|NOT COMPLETED|Part 1||7
3064670|NCT01288430|3785169|FG007|NOT COMPLETED|Part 1||0
3064671|NCT01288430|3785170|FG008|NOT COMPLETED|Part 1||0
3064672|NCT01288430|3785171|FG009|NOT COMPLETED|Part 1||0
3064673|NCT01288430|3785162|FG000|STARTED|Part 2||0
3064674|NCT01288430|3785163|FG001|STARTED|Part 2||0
3064675|NCT01288430|3785164|FG002|STARTED|Part 2||0
3064676|NCT01288430|3785165|FG003|STARTED|Part 2||0
3064677|NCT01288430|3785166|FG004|STARTED|Part 2||0
3064678|NCT01288430|3785167|FG005|STARTED|Part 2||0
3064679|NCT01288430|3785168|FG006|STARTED|Part 2||0
3064680|NCT01288430|3785169|FG007|STARTED|Part 2||12
3064681|NCT01288430|3785170|FG008|STARTED|Part 2||12
3064682|NCT01288430|3785171|FG009|STARTED|Part 2||3
3064683|NCT01288430|3785162|FG000|COMPLETED|Part 2||0
3064684|NCT01288430|3785163|FG001|COMPLETED|Part 2||0
3064685|NCT01288430|3785164|FG002|COMPLETED|Part 2||0
3064686|NCT01288430|3785165|FG003|COMPLETED|Part 2||0
3064687|NCT01288430|3785166|FG004|COMPLETED|Part 2||0
3064688|NCT01288430|3785167|FG005|COMPLETED|Part 2||0
3064689|NCT01288430|3785168|FG006|COMPLETED|Part 2||0
3064690|NCT01288430|3785169|FG007|COMPLETED|Part 2||0
3064691|NCT01288430|3785170|FG008|COMPLETED|Part 2||0
3064692|NCT01288430|3785171|FG009|COMPLETED|Part 2||0
3064693|NCT01288430|3785162|FG000|NOT COMPLETED|Part 2||0
3064694|NCT01288430|3785163|FG001|NOT COMPLETED|Part 2||0
3064695|NCT01288430|3785164|FG002|NOT COMPLETED|Part 2||0
3064696|NCT01288430|3785165|FG003|NOT COMPLETED|Part 2||0
3064697|NCT01288430|3785166|FG004|NOT COMPLETED|Part 2||0
3064698|NCT01288430|3785167|FG005|NOT COMPLETED|Part 2||0
3064699|NCT01288430|3785168|FG006|NOT COMPLETED|Part 2||0
3064700|NCT01288430|3785169|FG007|NOT COMPLETED|Part 2||12
3064701|NCT01288430|3785170|FG008|NOT COMPLETED|Part 2||12
3064702|NCT01288430|3785171|FG009|NOT COMPLETED|Part 2||3
3064703|NCT01288443|3785204|FG000|STARTED|Overall Study|Randomized|31
3064704|NCT01288443|3785205|FG001|STARTED|Overall Study|Randomized|30
3064705|NCT01288443|3785206|FG002|STARTED|Overall Study|Randomized|31
3064706|NCT01288443|3785207|FG003|STARTED|Overall Study|Randomized|31
3064707|NCT01288443|3785208|FG004|STARTED|Overall Study|Randomized|30
3064708|NCT01288443|3785209|FG005|STARTED|Overall Study|Randomized|30
3064709|NCT01288443|3785204|FG000|Treated|Overall Study||31
3064710|NCT01288443|3785205|FG001|Treated|Overall Study||30
3064711|NCT01288443|3785206|FG002|Treated|Overall Study||31
3064712|NCT01288443|3785207|FG003|Treated|Overall Study||31
3064713|NCT01288443|3785208|FG004|Treated|Overall Study||29
3064714|NCT01288443|3785209|FG005|Treated|Overall Study||30
3064715|NCT01288443|3785204|FG000|COMPLETED|Overall Study||31
3064716|NCT01288443|3785205|FG001|COMPLETED|Overall Study||29
3064717|NCT01288443|3785206|FG002|COMPLETED|Overall Study||30
3064718|NCT01288443|3785207|FG003|COMPLETED|Overall Study||27
3064719|NCT01288443|3785208|FG004|COMPLETED|Overall Study||23
3064720|NCT01288443|3785209|FG005|COMPLETED|Overall Study||25
3064721|NCT01288443|3785204|FG000|NOT COMPLETED|Overall Study||0
3064722|NCT01288443|3785205|FG001|NOT COMPLETED|Overall Study||1
3064723|NCT01288443|3785206|FG002|NOT COMPLETED|Overall Study||1
3064724|NCT01288443|3785207|FG003|NOT COMPLETED|Overall Study||4
3064725|NCT01288443|3785208|FG004|NOT COMPLETED|Overall Study||7
3064726|NCT01288443|3785209|FG005|NOT COMPLETED|Overall Study||5
3064727|NCT01288469|3785226|FG000|STARTED|Overall Study|Randomized|31
3064728|NCT01288469|3785227|FG001|STARTED|Overall Study|Randomized|31
3064729|NCT01288469|3785228|FG002|STARTED|Overall Study|Randomized|30
3064730|NCT01288469|3785226|FG000|Treated|Overall Study||31
3064731|NCT01288469|3785227|FG001|Treated|Overall Study||31
3064732|NCT01288469|3785228|FG002|Treated|Overall Study||30
3064733|NCT01288469|3785226|FG000|COMPLETED|Overall Study||24
3064734|NCT01288469|3785227|FG001|COMPLETED|Overall Study||28
3064735|NCT01288469|3785228|FG002|COMPLETED|Overall Study||28
3064736|NCT01288469|3785226|FG000|NOT COMPLETED|Overall Study||7
3064737|NCT01288469|3785227|FG001|NOT COMPLETED|Overall Study||3
3064738|NCT01288469|3785228|FG002|NOT COMPLETED|Overall Study||2
3064739|NCT01288521|3785238|FG000|STARTED|Overall Study||3
3064740|NCT01288521|3785239|FG001|STARTED|Overall Study||5
3064741|NCT01288521|3785238|FG000|COMPLETED|Overall Study||3
3064742|NCT01288521|3785239|FG001|COMPLETED|Overall Study||5
3064743|NCT01288521|3785238|FG000|NOT COMPLETED|Overall Study||0
3064744|NCT01288521|3785239|FG001|NOT COMPLETED|Overall Study||0
3064745|NCT01288534|3785245|FG000|STARTED|Overall Study||68
3064746|NCT01288534|3785245|FG000|COMPLETED|Overall Study||68
3064747|NCT01288534|3785245|FG000|NOT COMPLETED|Overall Study||0
3064748|NCT01288612|3785252|FG000|STARTED|Overall Study||150
3064749|NCT01288612|3785253|FG001|STARTED|Overall Study||151
3064750|NCT01288612|3785254|FG002|STARTED|Overall Study||158
3064751|NCT01288612|3785252|FG000|Contacted|Overall Study||139
3064752|NCT01288612|3785253|FG001|Contacted|Overall Study||135
3064753|NCT01288612|3785254|FG002|Contacted|Overall Study||138
3064754|NCT01288612|3785252|FG000|Agreed to Take Part|Overall Study||61
3064755|NCT01288612|3785253|FG001|Agreed to Take Part|Overall Study||72
3064756|NCT01288612|3785254|FG002|Agreed to Take Part|Overall Study||76
3064757|NCT01288612|3785252|FG000|COMPLETED|Overall Study||61
3064758|NCT01288612|3785253|FG001|COMPLETED|Overall Study||69
3064759|NCT01288612|3785254|FG002|COMPLETED|Overall Study||76
3064760|NCT01288612|3785252|FG000|NOT COMPLETED|Overall Study||89
3064761|NCT01288612|3785253|FG001|NOT COMPLETED|Overall Study||82
3064762|NCT01288612|3785254|FG002|NOT COMPLETED|Overall Study||82
3064763|NCT01288729|3785264|FG000|STARTED|Overall Study||10
3064764|NCT01288729|3785265|FG001|STARTED|Overall Study||10
3064765|NCT01288729|3785264|FG000|COMPLETED|Overall Study||9
3064766|NCT01288729|3785265|FG001|COMPLETED|Overall Study||10
3064767|NCT01288729|3785264|FG000|NOT COMPLETED|Overall Study||1
3064768|NCT01288729|3785265|FG001|NOT COMPLETED|Overall Study||0
3064769|NCT01288781|3785273|FG000|STARTED|Overall Study||11
3064770|NCT01288781|3785274|FG001|STARTED|Overall Study||12
3064771|NCT01288781|3785273|FG000|COMPLETED|Overall Study||11
3064772|NCT01288781|3785274|FG001|COMPLETED|Overall Study||12
3064773|NCT01288781|3785273|FG000|NOT COMPLETED|Overall Study||0
3064774|NCT01288781|3785274|FG001|NOT COMPLETED|Overall Study||0
3064775|NCT01288807|3785280|FG000|STARTED|Overall Study||8
3064776|NCT01288807|3785280|FG000|COMPLETED|Overall Study||8
3064777|NCT01288807|3785280|FG000|NOT COMPLETED|Overall Study||0
3064778|NCT01288833|3785286|FG000|STARTED|Overall Study||277
3064779|NCT01288833|3785287|FG001|STARTED|Overall Study||281
3064780|NCT01288833|3785286|FG000|COMPLETED|Overall Study||277
3064781|NCT01288833|3785287|FG001|COMPLETED|Overall Study||281
3064782|NCT01288833|3785286|FG000|NOT COMPLETED|Overall Study||0
3064783|NCT01288833|3785287|FG001|NOT COMPLETED|Overall Study||0
3064784|NCT01288859|3785293|FG000|STARTED|Free Then Encapsulated Curcumin (1 Day)||5
3064785|NCT01288859|3785294|FG001|STARTED|Free Then Encapsulated Curcumin (1 Day)||0
3064786|NCT01288859|3785295|FG002|STARTED|Free Then Encapsulated Curcumin (1 Day)||0
3064787|NCT01288859|3785296|FG003|STARTED|Free Then Encapsulated Curcumin (1 Day)||0
3064788|NCT01288859|3785297|FG004|STARTED|Free Then Encapsulated Curcumin (1 Day)||0
3064789|NCT01288859|3785298|FG005|STARTED|Free Then Encapsulated Curcumin (1 Day)||5
3064790|NCT01288859|3785293|FG000|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||5
3064791|NCT01288859|3785294|FG001|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
3064792|NCT01288859|3785295|FG002|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
3064793|NCT01288859|3785296|FG003|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
3064794|NCT01288859|3785297|FG004|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
3064795|NCT01288859|3785298|FG005|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||5
3064796|NCT01288859|3785293|FG000|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
3064797|NCT01288859|3785294|FG001|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
3064798|NCT01288859|3785295|FG002|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
3064799|NCT01288859|3785296|FG003|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
3064800|NCT01288859|3785297|FG004|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
3064801|NCT01288859|3785298|FG005|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
3064802|NCT01288859|3785293|FG000|STARTED|Washout Period of 1 Week||5
3064803|NCT01288859|3785294|FG001|STARTED|Washout Period of 1 Week||0
3064804|NCT01288859|3785295|FG002|STARTED|Washout Period of 1 Week||0
3064805|NCT01288859|3785296|FG003|STARTED|Washout Period of 1 Week||0
3064806|NCT01288859|3785297|FG004|STARTED|Washout Period of 1 Week||0
3064807|NCT01288859|3785298|FG005|STARTED|Washout Period of 1 Week||5
3064808|NCT01288859|3785293|FG000|COMPLETED|Washout Period of 1 Week||5
3064809|NCT01288859|3785294|FG001|COMPLETED|Washout Period of 1 Week||0
3064810|NCT01288859|3785295|FG002|COMPLETED|Washout Period of 1 Week||0
3064811|NCT01288859|3785296|FG003|COMPLETED|Washout Period of 1 Week||0
3064812|NCT01288859|3785297|FG004|COMPLETED|Washout Period of 1 Week||0
3064813|NCT01288859|3785298|FG005|COMPLETED|Washout Period of 1 Week||5
3064814|NCT01288859|3785293|FG000|NOT COMPLETED|Washout Period of 1 Week||0
3064815|NCT01288859|3785294|FG001|NOT COMPLETED|Washout Period of 1 Week||0
3064816|NCT01288859|3785295|FG002|NOT COMPLETED|Washout Period of 1 Week||0
3064817|NCT01288859|3785296|FG003|NOT COMPLETED|Washout Period of 1 Week||0
3064818|NCT01288859|3785297|FG004|NOT COMPLETED|Washout Period of 1 Week||0
3064819|NCT01288859|3785298|FG005|NOT COMPLETED|Washout Period of 1 Week||0
3064820|NCT01288859|3785293|FG000|STARTED|Encapsulated Then Free Curcumin (1 Day)||5
3064821|NCT01288859|3785294|FG001|STARTED|Encapsulated Then Free Curcumin (1 Day)||0
3064822|NCT01288859|3785295|FG002|STARTED|Encapsulated Then Free Curcumin (1 Day)||0
3064823|NCT01288859|3785296|FG003|STARTED|Encapsulated Then Free Curcumin (1 Day)||0
3064824|NCT01288859|3785297|FG004|STARTED|Encapsulated Then Free Curcumin (1 Day)||0
3064825|NCT01288859|3785298|FG005|STARTED|Encapsulated Then Free Curcumin (1 Day)||5
3064826|NCT01288859|3785293|FG000|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||5
3064827|NCT01288859|3785294|FG001|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
3064828|NCT01288859|3785295|FG002|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
3064829|NCT01288859|3785296|FG003|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
3064830|NCT01288859|3785297|FG004|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
3064831|NCT01288859|3785298|FG005|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||5
3064832|NCT01288859|3785293|FG000|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
3064833|NCT01288859|3785294|FG001|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
3064834|NCT01288859|3785295|FG002|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
3064835|NCT01288859|3785296|FG003|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
3064836|NCT01288859|3785297|FG004|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
3064837|NCT01288859|3785298|FG005|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
3064838|NCT01288859|3785293|FG000|STARTED|Washout Period of 1 Week||5
3064839|NCT01288859|3785294|FG001|STARTED|Washout Period of 1 Week||0
3064840|NCT01288859|3785295|FG002|STARTED|Washout Period of 1 Week||0
3064841|NCT01288859|3785296|FG003|STARTED|Washout Period of 1 Week||0
3064842|NCT01288859|3785297|FG004|STARTED|Washout Period of 1 Week||0
3064843|NCT01288859|3785298|FG005|STARTED|Washout Period of 1 Week||5
3064844|NCT01288859|3785293|FG000|COMPLETED|Washout Period of 1 Week||5
3064845|NCT01288859|3785294|FG001|COMPLETED|Washout Period of 1 Week||0
3064846|NCT01288859|3785295|FG002|COMPLETED|Washout Period of 1 Week||0
3064847|NCT01288859|3785296|FG003|COMPLETED|Washout Period of 1 Week||0
3064848|NCT01288859|3785297|FG004|COMPLETED|Washout Period of 1 Week||0
3064849|NCT01288859|3785298|FG005|COMPLETED|Washout Period of 1 Week||5
3064850|NCT01288859|3785293|FG000|NOT COMPLETED|Washout Period of 1 Week||0
3064851|NCT01288859|3785294|FG001|NOT COMPLETED|Washout Period of 1 Week||0
3064852|NCT01288859|3785295|FG002|NOT COMPLETED|Washout Period of 1 Week||0
3064853|NCT01288859|3785296|FG003|NOT COMPLETED|Washout Period of 1 Week||0
3064854|NCT01288859|3785297|FG004|NOT COMPLETED|Washout Period of 1 Week||0
3064855|NCT01288859|3785298|FG005|NOT COMPLETED|Washout Period of 1 Week||0
3064856|NCT01288859|3785293|FG000|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
3064857|NCT01288859|3785294|FG001|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||5
3064858|NCT01288859|3785295|FG002|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||5
3064859|NCT01288859|3785296|FG003|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
3064860|NCT01288859|3785297|FG004|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
3064861|NCT01288859|3785298|FG005|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
3064862|NCT01288859|3785293|FG000|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
3064863|NCT01288859|3785294|FG001|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||5
3064864|NCT01288859|3785295|FG002|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||5
3064865|NCT01288859|3785296|FG003|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
3064866|NCT01288859|3785297|FG004|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
3064867|NCT01288859|3785298|FG005|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
3064868|NCT01288859|3785293|FG000|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
3064869|NCT01288859|3785294|FG001|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
3064870|NCT01288859|3785295|FG002|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
3064871|NCT01288859|3785296|FG003|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
3064872|NCT01288859|3785297|FG004|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
3064873|NCT01288859|3785298|FG005|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
3064874|NCT01288859|3785293|FG000|STARTED|Washout Period of 1 Week||0
3064875|NCT01288859|3785294|FG001|STARTED|Washout Period of 1 Week||5
3064876|NCT01288859|3785295|FG002|STARTED|Washout Period of 1 Week||5
3064877|NCT01288859|3785296|FG003|STARTED|Washout Period of 1 Week||0
3064878|NCT01288859|3785297|FG004|STARTED|Washout Period of 1 Week||0
3064879|NCT01288859|3785298|FG005|STARTED|Washout Period of 1 Week||0
3064880|NCT01288859|3785293|FG000|COMPLETED|Washout Period of 1 Week||0
3064881|NCT01288859|3785294|FG001|COMPLETED|Washout Period of 1 Week||5
3064882|NCT01288859|3785295|FG002|COMPLETED|Washout Period of 1 Week||5
3064883|NCT01288859|3785296|FG003|COMPLETED|Washout Period of 1 Week||0
3064884|NCT01288859|3785297|FG004|COMPLETED|Washout Period of 1 Week||0
3064885|NCT01288859|3785298|FG005|COMPLETED|Washout Period of 1 Week||0
3064886|NCT01288859|3785293|FG000|NOT COMPLETED|Washout Period of 1 Week||0
3064887|NCT01288859|3785294|FG001|NOT COMPLETED|Washout Period of 1 Week||0
3064888|NCT01288859|3785295|FG002|NOT COMPLETED|Washout Period of 1 Week||0
3064889|NCT01288859|3785296|FG003|NOT COMPLETED|Washout Period of 1 Week||0
3064890|NCT01288859|3785297|FG004|NOT COMPLETED|Washout Period of 1 Week||0
3064891|NCT01288859|3785298|FG005|NOT COMPLETED|Washout Period of 1 Week||0
3064892|NCT01288859|3785293|FG000|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
3064893|NCT01288859|3785294|FG001|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||5
3064894|NCT01288859|3785295|FG002|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||5
3064895|NCT01288859|3785296|FG003|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
3064896|NCT01288859|3785297|FG004|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
3064897|NCT01288859|3785298|FG005|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
3064898|NCT01288859|3785293|FG000|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
3064899|NCT01288859|3785294|FG001|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||5
3064900|NCT01288859|3785295|FG002|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||5
3064901|NCT01288859|3785296|FG003|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
3064902|NCT01288859|3785297|FG004|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
3064903|NCT01288859|3785298|FG005|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
3064904|NCT01288859|3785293|FG000|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
3064905|NCT01288859|3785294|FG001|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
3064906|NCT01288859|3785295|FG002|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
3064907|NCT01288859|3785296|FG003|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
3064908|NCT01288859|3785297|FG004|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
3064909|NCT01288859|3785298|FG005|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
3064910|NCT01288859|3785293|FG000|STARTED|Washout Period of 1 Week||0
3064911|NCT01288859|3785294|FG001|STARTED|Washout Period of 1 Week||0
3064912|NCT01288859|3785295|FG002|STARTED|Washout Period of 1 Week||0
3064913|NCT01288859|3785296|FG003|STARTED|Washout Period of 1 Week||5
3064914|NCT01288859|3785297|FG004|STARTED|Washout Period of 1 Week||5
3064915|NCT01288859|3785298|FG005|STARTED|Washout Period of 1 Week||0
3064916|NCT01288859|3785293|FG000|COMPLETED|Washout Period of 1 Week||0
3064917|NCT01288859|3785294|FG001|COMPLETED|Washout Period of 1 Week||0
3064918|NCT01288859|3785295|FG002|COMPLETED|Washout Period of 1 Week||0
3064919|NCT01288859|3785296|FG003|COMPLETED|Washout Period of 1 Week||5
3064920|NCT01288859|3785297|FG004|COMPLETED|Washout Period of 1 Week||5
3064921|NCT01288859|3785298|FG005|COMPLETED|Washout Period of 1 Week||0
3064922|NCT01288859|3785293|FG000|NOT COMPLETED|Washout Period of 1 Week||0
3064923|NCT01288859|3785294|FG001|NOT COMPLETED|Washout Period of 1 Week||0
3064924|NCT01288859|3785295|FG002|NOT COMPLETED|Washout Period of 1 Week||0
3064925|NCT01288859|3785296|FG003|NOT COMPLETED|Washout Period of 1 Week||0
3064926|NCT01288859|3785297|FG004|NOT COMPLETED|Washout Period of 1 Week||0
3064927|NCT01288859|3785298|FG005|NOT COMPLETED|Washout Period of 1 Week||0
3064928|NCT01288859|3785293|FG000|STARTED|Enc Polyph. Then Control Cream (1 Day)||0
3064929|NCT01288859|3785294|FG001|STARTED|Enc Polyph. Then Control Cream (1 Day)||0
3064930|NCT01288859|3785295|FG002|STARTED|Enc Polyph. Then Control Cream (1 Day)||0
3064931|NCT01288859|3785296|FG003|STARTED|Enc Polyph. Then Control Cream (1 Day)||5
3064932|NCT01288859|3785297|FG004|STARTED|Enc Polyph. Then Control Cream (1 Day)||5
3064933|NCT01288859|3785298|FG005|STARTED|Enc Polyph. Then Control Cream (1 Day)||0
3064934|NCT01288859|3785293|FG000|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
3064935|NCT01288859|3785294|FG001|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
3064936|NCT01288859|3785295|FG002|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
3064937|NCT01288859|3785296|FG003|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||5
3064938|NCT01288859|3785297|FG004|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||5
3064939|NCT01288859|3785298|FG005|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
3064940|NCT01288859|3785293|FG000|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
3064941|NCT01288859|3785294|FG001|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
3064942|NCT01288859|3785295|FG002|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
3064943|NCT01288859|3785296|FG003|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
3064944|NCT01288859|3785297|FG004|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
3064945|NCT01288859|3785298|FG005|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
3064946|NCT01288859|3785293|FG000|STARTED|Washout Period of 1 Week||0
3064947|NCT01288859|3785294|FG001|STARTED|Washout Period of 1 Week||0
3064948|NCT01288859|3785295|FG002|STARTED|Washout Period of 1 Week||0
3064949|NCT01288859|3785296|FG003|STARTED|Washout Period of 1 Week||5
3064950|NCT01288859|3785297|FG004|STARTED|Washout Period of 1 Week||5
3064951|NCT01288859|3785298|FG005|STARTED|Washout Period of 1 Week||0
3064952|NCT01288859|3785293|FG000|COMPLETED|Washout Period of 1 Week||0
3064953|NCT01288859|3785294|FG001|COMPLETED|Washout Period of 1 Week||0
3064954|NCT01288859|3785295|FG002|COMPLETED|Washout Period of 1 Week||0
3064955|NCT01288859|3785296|FG003|COMPLETED|Washout Period of 1 Week||5
3064956|NCT01288859|3785297|FG004|COMPLETED|Washout Period of 1 Week||5
3064957|NCT01288859|3785298|FG005|COMPLETED|Washout Period of 1 Week||0
3064958|NCT01288859|3785293|FG000|NOT COMPLETED|Washout Period of 1 Week||0
3064959|NCT01288859|3785294|FG001|NOT COMPLETED|Washout Period of 1 Week||0
3064960|NCT01288859|3785295|FG002|NOT COMPLETED|Washout Period of 1 Week||0
3064961|NCT01288859|3785296|FG003|NOT COMPLETED|Washout Period of 1 Week||0
3064962|NCT01288859|3785297|FG004|NOT COMPLETED|Washout Period of 1 Week||0
3064963|NCT01288859|3785298|FG005|NOT COMPLETED|Washout Period of 1 Week||0
3064964|NCT01288859|3785293|FG000|STARTED|Control Cream Then Enc Polyph. (1 Day)||0
3064965|NCT01288859|3785294|FG001|STARTED|Control Cream Then Enc Polyph. (1 Day)||0
3064966|NCT01288859|3785295|FG002|STARTED|Control Cream Then Enc Polyph. (1 Day)||0
3064967|NCT01288859|3785296|FG003|STARTED|Control Cream Then Enc Polyph. (1 Day)||5
3064968|NCT01288859|3785297|FG004|STARTED|Control Cream Then Enc Polyph. (1 Day)||5
3064969|NCT01288859|3785298|FG005|STARTED|Control Cream Then Enc Polyph. (1 Day)||0
3064970|NCT01288859|3785293|FG000|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
3064971|NCT01288859|3785294|FG001|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
3064972|NCT01288859|3785295|FG002|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
3064973|NCT01288859|3785296|FG003|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||5
3064974|NCT01288859|3785297|FG004|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||5
3064975|NCT01288859|3785298|FG005|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
3064976|NCT01288859|3785293|FG000|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
3064977|NCT01288859|3785294|FG001|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
3064978|NCT01288859|3785295|FG002|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
3064979|NCT01288859|3785296|FG003|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
3064980|NCT01288859|3785297|FG004|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
3064981|NCT01288859|3785298|FG005|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
3064982|NCT01288911|3785320|FG000|STARTED|Double-blind Period||184
3064983|NCT01288911|3785321|FG001|STARTED|Double-blind Period||191
3064984|NCT01288911|3785320|FG000|Received Treatment|Double-blind Period||183
3064985|NCT01288911|3785321|FG001|Received Treatment|Double-blind Period||189
3064986|NCT01288911|3785320|FG000|COMPLETED|Double-blind Period|Indicates participants were still receiving treatment at the data cut-off date of 19 October 2014.|42
3064987|NCT01288911|3785321|FG001|COMPLETED|Double-blind Period|Indicates participants were still receiving treatment at the data cut-off date of 19 October 2014.|9
3064988|NCT01288911|3785320|FG000|NOT COMPLETED|Double-blind Period||142
3064989|NCT01288911|3785321|FG001|NOT COMPLETED|Double-blind Period||182
3064990|NCT01288911|3785320|FG000|STARTED|Open-label Period (All Enzalutamide)||42
3064991|NCT01288911|3785321|FG001|STARTED|Open-label Period (All Enzalutamide)||9
3064992|NCT01288911|3785320|FG000|Received Treatment|Open-label Period (All Enzalutamide)||42
3064993|NCT01288911|3785321|FG001|Received Treatment|Open-label Period (All Enzalutamide)||9
3064994|NCT01288911|3785320|FG000|COMPLETED|Open-label Period (All Enzalutamide)||0
3064995|NCT01288911|3785321|FG001|COMPLETED|Open-label Period (All Enzalutamide)||0
3064996|NCT01288911|3785320|FG000|NOT COMPLETED|Open-label Period (All Enzalutamide)||42
3064997|NCT01288911|3785321|FG001|NOT COMPLETED|Open-label Period (All Enzalutamide)||9
3064998|NCT01288937|3785332|FG000|STARTED|Overall Study||4
3064999|NCT01288937|3785333|FG001|STARTED|Overall Study||2
3065000|NCT01288937|3785332|FG000|COMPLETED|Overall Study||3
3065001|NCT01288937|3785333|FG001|COMPLETED|Overall Study||2
3065002|NCT01288937|3785332|FG000|NOT COMPLETED|Overall Study||1
3065003|NCT01288937|3785333|FG001|NOT COMPLETED|Overall Study||0
3065004|NCT01288976|3785342|FG000|STARTED|Overall Study||567
3065005|NCT01288976|3785343|FG001|STARTED|Overall Study||49
3065006|NCT01288976|3785344|FG002|STARTED|Overall Study||105
3065007|NCT01288976|3785342|FG000|COMPLETED|Overall Study||389
3065008|NCT01288976|3785343|FG001|COMPLETED|Overall Study||22
3065009|NCT01288976|3785344|FG002|COMPLETED|Overall Study||85
3065010|NCT01288976|3785342|FG000|NOT COMPLETED|Overall Study||178
3065011|NCT01288976|3785343|FG001|NOT COMPLETED|Overall Study||27
3065012|NCT01288976|3785344|FG002|NOT COMPLETED|Overall Study||20
3065013|NCT01288989|3785355|FG000|STARTED|Overall Study||6
3065014|NCT01288989|3785356|FG001|STARTED|Overall Study||3
3065015|NCT01288989|3785357|FG002|STARTED|Overall Study||3
3065016|NCT01288989|3785358|FG003|STARTED|Overall Study||11
3065017|NCT01288989|3785359|FG004|STARTED|Overall Study||21
3065018|NCT01288989|3785355|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6
3065019|NCT01288989|3785356|FG001|Received at Least 1 Dose of Study Drug|Overall Study||3
3065020|NCT01288989|3785357|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3
3065021|NCT01288989|3785358|FG003|Received at Least 1 Dose of Study Drug|Overall Study||11
3065022|NCT01288989|3785359|FG004|Received at Least 1 Dose of Study Drug|Overall Study||21
3065023|NCT01288989|3785355|FG000|COMPLETED|Overall Study||5
3065024|NCT01288989|3785356|FG001|COMPLETED|Overall Study||3
3065025|NCT01288989|3785357|FG002|COMPLETED|Overall Study||3
3065026|NCT01288989|3785358|FG003|COMPLETED|Overall Study||10
3065027|NCT01288989|3785359|FG004|COMPLETED|Overall Study||15
3065028|NCT01288989|3785355|FG000|NOT COMPLETED|Overall Study||1
3065029|NCT01288989|3785356|FG001|NOT COMPLETED|Overall Study||0
3065030|NCT01288989|3785357|FG002|NOT COMPLETED|Overall Study||0
3065031|NCT01288989|3785358|FG003|NOT COMPLETED|Overall Study||1
3065032|NCT01288989|3785359|FG004|NOT COMPLETED|Overall Study||6
3065033|NCT01289015|3785379|FG000|STARTED|Overall Study||571
3065034|NCT01289015|3785380|FG001|STARTED|Overall Study||284
3065035|NCT01289015|3785379|FG000|COMPLETED|Overall Study||472
3065036|NCT01289015|3785380|FG001|COMPLETED|Overall Study||230
3065037|NCT01289015|3785379|FG000|NOT COMPLETED|Overall Study||99
3065038|NCT01289015|3785380|FG001|NOT COMPLETED|Overall Study||54
3065039|NCT01289028|3785386|FG000|STARTED|Overall Study||125
3065040|NCT01289028|3785386|FG000|COMPLETED|Overall Study||42
3065041|NCT01289028|3785386|FG000|NOT COMPLETED|Overall Study||83
3065042|NCT01289041|3785392|FG000|STARTED|Overall Study||70
3065043|NCT01289041|3785392|FG000|COMPLETED|Overall Study||0
3065044|NCT01289041|3785392|FG000|NOT COMPLETED|Overall Study||70
3065045|NCT01289067|3785398|FG000|STARTED|Overall Study||13
3065046|NCT01289067|3785398|FG000|COMPLETED|Overall Study||13
3065047|NCT01289067|3785398|FG000|NOT COMPLETED|Overall Study||0
3065048|NCT01289080|3785404|FG000|STARTED|Overall Study||9
3065049|NCT01289080|3785405|FG001|STARTED|Overall Study||10
3065050|NCT01289080|3785404|FG000|COMPLETED|Overall Study||9
3065051|NCT01289080|3785405|FG001|COMPLETED|Overall Study||10
3065052|NCT01289080|3785404|FG000|NOT COMPLETED|Overall Study||0
3065053|NCT01289080|3785405|FG001|NOT COMPLETED|Overall Study||0
3065054|NCT01289119|3785418|FG000|STARTED|Overall Study||93
3065055|NCT01289119|3785419|FG001|STARTED|Overall Study||92
3065056|NCT01289119|3785420|FG002|STARTED|Overall Study||98
3065057|NCT01289119|3785421|FG003|STARTED|Overall Study||99
3065058|NCT01289119|3785422|FG004|STARTED|Overall Study||63
3065059|NCT01289119|3785423|FG005|STARTED|Overall Study||61
3065060|NCT01289119|3785418|FG000|Treated|Overall Study|Patients who took at least one dose of double-blind study drug.|92
3065061|NCT01289119|3785419|FG001|Treated|Overall Study||92
3065062|NCT01289119|3785420|FG002|Treated|Overall Study||98
3065063|NCT01289119|3785421|FG003|Treated|Overall Study||99
3065064|NCT01289119|3785422|FG004|Treated|Overall Study||63
3065065|NCT01289119|3785423|FG005|Treated|Overall Study||61
3065066|NCT01289119|3785418|FG000|COMPLETED|Overall Study||84
3065067|NCT01289119|3785419|FG001|COMPLETED|Overall Study||83
3065068|NCT01289119|3785420|FG002|COMPLETED|Overall Study||89
3065069|NCT01289119|3785421|FG003|COMPLETED|Overall Study||93
3065070|NCT01289119|3785422|FG004|COMPLETED|Overall Study||58
3065071|NCT01289119|3785423|FG005|COMPLETED|Overall Study||57
3065072|NCT01289119|3785418|FG000|NOT COMPLETED|Overall Study||9
3065073|NCT01289119|3785419|FG001|NOT COMPLETED|Overall Study||9
3065074|NCT01289119|3785420|FG002|NOT COMPLETED|Overall Study||9
3065075|NCT01289119|3785421|FG003|NOT COMPLETED|Overall Study||6
3065076|NCT01289119|3785422|FG004|NOT COMPLETED|Overall Study||5
3065077|NCT01289119|3785423|FG005|NOT COMPLETED|Overall Study||4
3065078|NCT01289210|3785437|FG000|STARTED|Overall Study||2
3065079|NCT01289210|3785437|FG000|COMPLETED|Overall Study||1
3065080|NCT01289210|3785437|FG000|NOT COMPLETED|Overall Study||1
3065081|NCT01289275|3785445|FG000|STARTED|Overall Study||317
3065082|NCT01289275|3785446|FG001|STARTED|Overall Study||320
3065083|NCT01289275|3785447|FG002|STARTED|Overall Study||317
3065084|NCT01289275|3785448|FG003|STARTED|Overall Study||316
3065085|NCT01289275|3785445|FG000|COMPLETED|Overall Study||317
3065086|NCT01289275|3785446|FG001|COMPLETED|Overall Study||320
3065087|NCT01289275|3785447|FG002|COMPLETED|Overall Study||317
3065088|NCT01289275|3785448|FG003|COMPLETED|Overall Study||316
3065089|NCT01289275|3785445|FG000|NOT COMPLETED|Overall Study||0
3065090|NCT01289275|3785446|FG001|NOT COMPLETED|Overall Study||0
3065091|NCT01289275|3785447|FG002|NOT COMPLETED|Overall Study||0
3065092|NCT01289275|3785448|FG003|NOT COMPLETED|Overall Study||0
3065093|NCT01289353|3785462|FG000|STARTED|Overall Study||92
3065094|NCT01289353|3785462|FG000|COMPLETED|Overall Study||90
3065095|NCT01289353|3785462|FG000|NOT COMPLETED|Overall Study||2
3065096|NCT01289392|3785469|FG000|STARTED|Overall Study||9
3065097|NCT01289392|3785470|FG001|STARTED|Overall Study||9
3065098|NCT01289392|3785471|FG002|STARTED|Overall Study||7
3065099|NCT01289392|3785469|FG000|COMPLETED|Overall Study||9
3065100|NCT01289392|3785470|FG001|COMPLETED|Overall Study||9
3065101|NCT01289392|3785471|FG002|COMPLETED|Overall Study||7
3065102|NCT01289392|3785469|FG000|NOT COMPLETED|Overall Study||0
3065103|NCT01289392|3785470|FG001|NOT COMPLETED|Overall Study||0
3065104|NCT01289392|3785471|FG002|NOT COMPLETED|Overall Study||0
3065105|NCT01289418|3785482|FG000|STARTED|Day 8 Survey||6525
3065106|NCT01289418|3785482|FG000|COMPLETED|Day 8 Survey||4307
3065107|NCT01289418|3785482|FG000|NOT COMPLETED|Day 8 Survey||2218
3065108|NCT01289418|3785482|FG000|STARTED|Day 29 Survey||6525
3065109|NCT01289418|3785482|FG000|COMPLETED|Day 29 Survey||4057
3065110|NCT01289418|3785482|FG000|NOT COMPLETED|Day 29 Survey||2468
3065111|NCT01289431|3785495|FG000|STARTED|Overall Study||34
3065112|NCT01289431|3785496|FG001|STARTED|Overall Study||34
3065113|NCT01289431|3785497|FG002|STARTED|Overall Study||34
3065114|NCT01289431|3785498|FG003|STARTED|Overall Study||33
3065115|NCT01289431|3785499|FG004|STARTED|Overall Study||34
3065116|NCT01289431|3785500|FG005|STARTED|Overall Study||33
3065117|NCT01289431|3785501|FG006|STARTED|Overall Study||34
3065118|NCT01289431|3785495|FG000|COMPLETED|Overall Study||29
3065119|NCT01289431|3785496|FG001|COMPLETED|Overall Study||32
3065120|NCT01289431|3785497|FG002|COMPLETED|Overall Study||30
3065121|NCT01289431|3785498|FG003|COMPLETED|Overall Study||28
3065122|NCT01289431|3785499|FG004|COMPLETED|Overall Study||32
3065123|NCT01289431|3785500|FG005|COMPLETED|Overall Study||31
3065124|NCT01289431|3785501|FG006|COMPLETED|Overall Study||33
3065125|NCT01289431|3785495|FG000|NOT COMPLETED|Overall Study||5
3065126|NCT01289431|3785496|FG001|NOT COMPLETED|Overall Study||2
3065127|NCT01289431|3785497|FG002|NOT COMPLETED|Overall Study||4
3065128|NCT01289431|3785498|FG003|NOT COMPLETED|Overall Study||5
3065129|NCT01289431|3785499|FG004|NOT COMPLETED|Overall Study||2
3065130|NCT01289431|3785500|FG005|NOT COMPLETED|Overall Study||2
3065131|NCT01289431|3785501|FG006|NOT COMPLETED|Overall Study||1
3065132|NCT01289457|3785520|FG000|STARTED|Overall Study||12
3065133|NCT01289457|3785521|FG001|STARTED|Overall Study||157
3065134|NCT01289457|3785522|FG002|STARTED|Overall Study||113
3065135|NCT01289457|3785520|FG000|COMPLETED|Overall Study||12
3065136|NCT01289457|3785521|FG001|COMPLETED|Overall Study||157
3065137|NCT01289457|3785522|FG002|COMPLETED|Overall Study||113
3065138|NCT01289457|3785520|FG000|NOT COMPLETED|Overall Study||0
3065139|NCT01289457|3785521|FG001|NOT COMPLETED|Overall Study||0
3065140|NCT01289457|3785522|FG002|NOT COMPLETED|Overall Study||0
3065141|NCT01289522|3785530|FG000|STARTED|Overall Study||54
3065142|NCT01289522|3785530|FG000|COMPLETED|Overall Study||43
3065143|NCT01289522|3785530|FG000|NOT COMPLETED|Overall Study||11
3065144|NCT01289548|3785537|FG000|STARTED|Overall Study|include both donors and recipients listed as milestones below|40
3065145|NCT01289548|3785538|FG001|STARTED|Overall Study|include both donors and recipients listed as milestones below|40
3065146|NCT01289548|3785539|FG002|STARTED|Overall Study|include both donors and recipients listed as milestones below|40
3065147|NCT01289548|3785537|FG000|Donors|Overall Study||20
3065148|NCT01289548|3785538|FG001|Donors|Overall Study||20
3065149|NCT01289548|3785539|FG002|Donors|Overall Study||20
3065150|NCT01289548|3785537|FG000|Recipients|Overall Study||20
3065151|NCT01289548|3785538|FG001|Recipients|Overall Study||20
3065152|NCT01289548|3785539|FG002|Recipients|Overall Study||20
3065153|NCT01289548|3785537|FG000|COMPLETED|Overall Study||40
3065154|NCT01289548|3785538|FG001|COMPLETED|Overall Study||40
3065155|NCT01289548|3785539|FG002|COMPLETED|Overall Study||40
3065156|NCT01289548|3785537|FG000|NOT COMPLETED|Overall Study||0
3065157|NCT01289548|3785538|FG001|NOT COMPLETED|Overall Study||0
3065158|NCT01289548|3785539|FG002|NOT COMPLETED|Overall Study||0
3065159|NCT01289574|3785550|FG000|STARTED|Overall Study||58
3065160|NCT01289574|3785551|FG001|STARTED|Overall Study||60
3065161|NCT01289574|3785552|FG002|STARTED|Overall Study||63
3065162|NCT01289574|3785550|FG000|COMPLETED|Overall Study||51
3065163|NCT01289574|3785551|FG001|COMPLETED|Overall Study||57
3065164|NCT01289574|3785552|FG002|COMPLETED|Overall Study||60
3065165|NCT01289574|3785550|FG000|NOT COMPLETED|Overall Study||7
3065166|NCT01289574|3785551|FG001|NOT COMPLETED|Overall Study||3
3065167|NCT01289574|3785552|FG002|NOT COMPLETED|Overall Study||3
3065168|NCT01289639|3785564|FG000|STARTED|Overall Study||5
3065169|NCT01289639|3785565|FG001|STARTED|Overall Study||6
3065170|NCT01289639|3785566|FG002|STARTED|Overall Study||0
3065171|NCT01289639|3785564|FG000|COMPLETED|Overall Study||4
3065172|NCT01289639|3785565|FG001|COMPLETED|Overall Study||6
3065173|NCT01289639|3785566|FG002|COMPLETED|Overall Study||0
3065174|NCT01289639|3785564|FG000|NOT COMPLETED|Overall Study||1
3065175|NCT01289639|3785565|FG001|NOT COMPLETED|Overall Study||0
3065176|NCT01289639|3785566|FG002|NOT COMPLETED|Overall Study||0
3065177|NCT01289665|3785576|FG000|STARTED|Overall Study||60
3065178|NCT01289665|3785577|FG001|STARTED|Overall Study||60
3065179|NCT01289665|3785576|FG000|COMPLETED|Overall Study||59
3065180|NCT01289665|3785577|FG001|COMPLETED|Overall Study||60
3065181|NCT01289665|3785576|FG000|NOT COMPLETED|Overall Study||1
3065182|NCT01289665|3785577|FG001|NOT COMPLETED|Overall Study||0
3065183|NCT01289678|3785583|FG000|STARTED|Overall Study||18
3065184|NCT01289678|3785583|FG000|COMPLETED|Overall Study||12
3065185|NCT01289678|3785583|FG000|NOT COMPLETED|Overall Study||6
3065186|NCT01289782|3785589|FG000|STARTED|Overall Study||264
3065187|NCT01289782|3785590|FG001|STARTED|Overall Study|Not including 1 participant was randomized to this group, but never received treatment.|130
3065188|NCT01289782|3785589|FG000|COMPLETED|Overall Study||239
3065189|NCT01289782|3785590|FG001|COMPLETED|Overall Study||118
3065190|NCT01289782|3785589|FG000|NOT COMPLETED|Overall Study||25
3065191|NCT01289782|3785590|FG001|NOT COMPLETED|Overall Study||12
3065192|NCT01289821|3785596|FG000|STARTED|Treatment Period||54
3065193|NCT01289821|3785596|FG000|Participants Received Regorafenib|Treatment Period||54
3065194|NCT01289821|3785596|FG000|COMPLETED|Treatment Period||0
3065195|NCT01289821|3785596|FG000|NOT COMPLETED|Treatment Period||54
3065196|NCT01289821|3785596|FG000|STARTED|Safety Follow-up Period||54
3065197|NCT01289821|3785596|FG000|COMPLETED|Safety Follow-up Period||49
3065198|NCT01289821|3785596|FG000|NOT COMPLETED|Safety Follow-up Period||5
3065199|NCT01289821|3785596|FG000|STARTED|Survival Follow-up Period||52
3065200|NCT01289821|3785596|FG000|COMPLETED|Survival Follow-up Period|34 participants died and completed survival follow-up period.|34
3065201|NCT01289821|3785596|FG000|NOT COMPLETED|Survival Follow-up Period||18
3065202|NCT01289847|3785600|FG000|STARTED|Overall Study||25
3065203|NCT01289847|3785600|FG000|COMPLETED|Overall Study||24
3065204|NCT01289847|3785600|FG000|NOT COMPLETED|Overall Study||1
3065205|NCT01289912|3785606|FG000|STARTED|Overall Study||32
3065206|NCT01289912|3785607|FG001|STARTED|Overall Study||15
3065207|NCT01289912|3785606|FG000|COMPLETED|Overall Study||29
3065208|NCT01289912|3785607|FG001|COMPLETED|Overall Study||13
3065209|NCT01289912|3785606|FG000|NOT COMPLETED|Overall Study||3
3065210|NCT01289912|3785607|FG001|NOT COMPLETED|Overall Study||2
3065211|NCT01289990|3785636|FG000|STARTED|Overall Study||224
3065212|NCT01289990|3785637|FG001|STARTED|Overall Study||224
3065213|NCT01289990|3785638|FG002|STARTED|Overall Study||228
3065214|NCT01289990|3785639|FG003|STARTED|Overall Study||223
3065215|NCT01289990|3785640|FG004|STARTED|Overall Study||165
3065216|NCT01289990|3785641|FG005|STARTED|Overall Study||168
3065217|NCT01289990|3785642|FG006|STARTED|Overall Study||166
3065218|NCT01289990|3785643|FG007|STARTED|Overall Study||217
3065219|NCT01289990|3785644|FG008|STARTED|Overall Study||214
3065220|NCT01289990|3785645|FG009|STARTED|Overall Study||207
3065221|NCT01289990|3785646|FG010|STARTED|Overall Study||226
3065222|NCT01289990|3785647|FG011|STARTED|Overall Study||218
3065223|NCT01289990|3785648|FG012|STARTED|Overall Study||225
3065224|NCT01289990|3785636|FG000|COMPLETED|Overall Study||147
3065225|NCT01289990|3785637|FG001|COMPLETED|Overall Study||143
3065226|NCT01289990|3785638|FG002|COMPLETED|Overall Study||119
3065227|NCT01289990|3785639|FG003|COMPLETED|Overall Study||136
3065228|NCT01289990|3785640|FG004|COMPLETED|Overall Study||93
3065229|NCT01289990|3785641|FG005|COMPLETED|Overall Study||94
3065230|NCT01289990|3785642|FG006|COMPLETED|Overall Study||78
3065231|NCT01289990|3785643|FG007|COMPLETED|Overall Study||162
3065232|NCT01289990|3785644|FG008|COMPLETED|Overall Study||139
3065233|NCT01289990|3785645|FG009|COMPLETED|Overall Study||121
3065234|NCT01289990|3785646|FG010|COMPLETED|Overall Study||150
3065235|NCT01289990|3785647|FG011|COMPLETED|Overall Study||150
3065236|NCT01289990|3785648|FG012|COMPLETED|Overall Study||127
3065237|NCT01289990|3785636|FG000|NOT COMPLETED|Overall Study||77
3065238|NCT01289990|3785637|FG001|NOT COMPLETED|Overall Study||81
3065239|NCT01289990|3785638|FG002|NOT COMPLETED|Overall Study||109
3065240|NCT01289990|3785639|FG003|NOT COMPLETED|Overall Study||87
3065241|NCT01289990|3785640|FG004|NOT COMPLETED|Overall Study||72
3065242|NCT01289990|3785641|FG005|NOT COMPLETED|Overall Study||74
3065243|NCT01289990|3785642|FG006|NOT COMPLETED|Overall Study||88
3065244|NCT01289990|3785643|FG007|NOT COMPLETED|Overall Study||55
3065245|NCT01289990|3785644|FG008|NOT COMPLETED|Overall Study||75
3065246|NCT01289990|3785645|FG009|NOT COMPLETED|Overall Study||86
3065247|NCT01289990|3785646|FG010|NOT COMPLETED|Overall Study||76
3065248|NCT01289990|3785647|FG011|NOT COMPLETED|Overall Study||68
3065249|NCT01289990|3785648|FG012|NOT COMPLETED|Overall Study||98
3065250|NCT01290029|3785676|FG000|STARTED|Overall Study||14
3065251|NCT01290029|3785676|FG000|Received Study Treatment|Overall Study||12
3065252|NCT01290029|3785676|FG000|COMPLETED|Overall Study||12
3065253|NCT01290029|3785676|FG000|NOT COMPLETED|Overall Study||2
3065254|NCT01290068|3785682|FG000|STARTED|Overall Study||108
3065255|NCT01290068|3785683|FG001|STARTED|Overall Study||100
3162950|NCT01881867|3890437|FG001|COMPLETED|Overall Study||15
3162951|NCT01881867|3890436|FG000|NOT COMPLETED|Overall Study||12
3162952|NCT01881867|3890437|FG001|NOT COMPLETED|Overall Study||13
3162953|NCT01882062|3890445|FG000|STARTED|Overall Study|16th of may 2013|10
3162954|NCT01882062|3890445|FG000|COMPLETED|Overall Study|18th of july 2013|10
3162955|NCT01882062|3890445|FG000|NOT COMPLETED|Overall Study||0
3162956|NCT01882088|3890449|FG000|STARTED|Overall Study|35 patients were provided with psyllium in 5.0 sachets, 3 sachets per day for 10 days|35
3162957|NCT01882088|3890449|FG000|COMPLETED|Overall Study||30
3065256|NCT01290068|3785682|FG000|Implanted|Overall Study||108
3065257|NCT01290068|3785683|FG001|Implanted|Overall Study||98
3065258|NCT01290068|3785682|FG000|COMPLETED|Overall Study||101
3065259|NCT01290068|3785683|FG001|COMPLETED|Overall Study||94
3065260|NCT01290068|3785682|FG000|NOT COMPLETED|Overall Study||7
3065261|NCT01290068|3785683|FG001|NOT COMPLETED|Overall Study||6
3065262|NCT01290094|3785689|FG000|STARTED|Overall Study||41
3065263|NCT01290094|3785689|FG000|COMPLETED|Overall Study||35
3065264|NCT01290094|3785689|FG000|NOT COMPLETED|Overall Study||6
3065265|NCT01290224|3785693|FG000|STARTED|Overall Study||10
3065266|NCT01290224|3785693|FG000|COMPLETED|Overall Study||5
3065267|NCT01290224|3785693|FG000|NOT COMPLETED|Overall Study||5
3065268|NCT01290237|3785701|FG000|STARTED|Overall Study||30
3065269|NCT01290237|3785702|FG001|STARTED|Overall Study||29
3065270|NCT01290237|3785701|FG000|COMPLETED|Overall Study||19
3162958|NCT01882088|3890449|FG000|NOT COMPLETED|Overall Study||5
3065271|NCT01290237|3785702|FG001|COMPLETED|Overall Study||27
3065272|NCT01290237|3785701|FG000|NOT COMPLETED|Overall Study||11
3065273|NCT01290237|3785702|FG001|NOT COMPLETED|Overall Study||2
3065274|NCT01290263|3785712|FG000|STARTED|Overall Study||11
3065275|NCT01290263|3785713|FG001|STARTED|Overall Study||3
3065276|NCT01290263|3785714|FG002|STARTED|Overall Study||7
3065277|NCT01290263|3785715|FG003|STARTED|Overall Study||27
3065278|NCT01290263|3785716|FG004|STARTED|Overall Study||37
3065279|NCT01290263|3785712|FG000|COMPLETED|Overall Study||0
3065280|NCT01290263|3785713|FG001|COMPLETED|Overall Study||0
3065281|NCT01290263|3785714|FG002|COMPLETED|Overall Study||0
3065282|NCT01290263|3785715|FG003|COMPLETED|Overall Study||0
3065283|NCT01290263|3785716|FG004|COMPLETED|Overall Study||0
3065284|NCT01290263|3785712|FG000|NOT COMPLETED|Overall Study||11
3065285|NCT01290263|3785713|FG001|NOT COMPLETED|Overall Study||3
3065286|NCT01290263|3785714|FG002|NOT COMPLETED|Overall Study||7
3065287|NCT01290263|3785715|FG003|NOT COMPLETED|Overall Study||27
3065288|NCT01290263|3785716|FG004|NOT COMPLETED|Overall Study||37
3065289|NCT01290315|3785728|FG000|STARTED|Overall Study||14
3065290|NCT01290315|3785729|FG001|STARTED|Overall Study||12
3065291|NCT01290315|3785730|FG002|STARTED|Overall Study||10
3065292|NCT01290315|3785731|FG003|STARTED|Overall Study||13
3065293|NCT01290315|3785728|FG000|COMPLETED|Overall Study||11
3065294|NCT01290315|3785729|FG001|COMPLETED|Overall Study||9
3065295|NCT01290315|3785730|FG002|COMPLETED|Overall Study||10
3065296|NCT01290315|3785731|FG003|COMPLETED|Overall Study||8
3065297|NCT01290315|3785728|FG000|NOT COMPLETED|Overall Study||3
3065298|NCT01290315|3785729|FG001|NOT COMPLETED|Overall Study||3
3065299|NCT01290315|3785730|FG002|NOT COMPLETED|Overall Study||0
3065300|NCT01290315|3785731|FG003|NOT COMPLETED|Overall Study||5
3065301|NCT01290341|3785742|FG000|STARTED|Overall Study||573
3065302|NCT01290341|3785743|FG001|STARTED|Overall Study||287
3065303|NCT01290341|3785742|FG000|COMPLETED|Overall Study||481
3065304|NCT01290341|3785743|FG001|COMPLETED|Overall Study||258
3065305|NCT01290341|3785742|FG000|NOT COMPLETED|Overall Study||92
3065306|NCT01290341|3785743|FG001|NOT COMPLETED|Overall Study||29
3065307|NCT01290445|3785752|FG000|STARTED|Overall Study||335
3065308|NCT01290445|3785753|FG001|STARTED|Overall Study||78412
3065309|NCT01290445|3785754|FG002|STARTED|Overall Study||806438
3065310|NCT01290445|3785752|FG000|COMPLETED|Overall Study||335
3065311|NCT01290445|3785753|FG001|COMPLETED|Overall Study||78412
3065312|NCT01290445|3785754|FG002|COMPLETED|Overall Study||806438
3065313|NCT01290445|3785752|FG000|NOT COMPLETED|Overall Study||0
3065314|NCT01290445|3785753|FG001|NOT COMPLETED|Overall Study||0
3065315|NCT01290445|3785754|FG002|NOT COMPLETED|Overall Study||0
3065316|NCT01290484|3785762|FG000|STARTED|Overall Study||7
3065317|NCT01290484|3785762|FG000|COMPLETED|Overall Study||7
3065318|NCT01290484|3785762|FG000|NOT COMPLETED|Overall Study||0
3065319|NCT01290523|3785766|FG000|STARTED|Overall Study||14
3065320|NCT01290523|3785766|FG000|COMPLETED|Overall Study||11
3065321|NCT01290523|3785766|FG000|NOT COMPLETED|Overall Study||3
3065322|NCT01290536|3785770|FG000|STARTED|Overall Study||42
3065323|NCT01290536|3785770|FG000|COMPLETED|Overall Study||42
3162959|NCT01882257|3890456|FG000|STARTED|Study Origination to Beginning Therapy||11
3065324|NCT01290536|3785770|FG000|NOT COMPLETED|Overall Study||0
3065325|NCT01290601|3785779|FG000|STARTED|Overall Study||46
3065326|NCT01290601|3785780|FG001|STARTED|Overall Study||24
3065327|NCT01290601|3785781|FG002|STARTED|Overall Study||0
3065328|NCT01290601|3785782|FG003|STARTED|Overall Study||0
3065329|NCT01290601|3785779|FG000|COMPLETED|Overall Study||35
3065330|NCT01290601|3785780|FG001|COMPLETED|Overall Study||19
3065331|NCT01290601|3785781|FG002|COMPLETED|Overall Study||0
3065332|NCT01290601|3785782|FG003|COMPLETED|Overall Study||0
3065333|NCT01290601|3785779|FG000|NOT COMPLETED|Overall Study||11
3065334|NCT01290601|3785780|FG001|NOT COMPLETED|Overall Study||5
3065335|NCT01290601|3785781|FG002|NOT COMPLETED|Overall Study||0
3065336|NCT01290601|3785782|FG003|NOT COMPLETED|Overall Study||0
3065337|NCT01290614|3785790|FG000|STARTED|Overall Study||1070
3065338|NCT01290614|3785791|FG001|STARTED|Overall Study||1129
3065339|NCT01290614|3785790|FG000|COMPLETED|Overall Study||518
3065340|NCT01290614|3785791|FG001|COMPLETED|Overall Study||1129
3065341|NCT01290614|3785790|FG000|NOT COMPLETED|Overall Study||552
3065342|NCT01290614|3785791|FG001|NOT COMPLETED|Overall Study||0
3065343|NCT01290627|3785800|FG000|STARTED|Overall Study||10
3065344|NCT01290627|3785801|FG001|STARTED|Overall Study||10
3065345|NCT01290627|3785802|FG002|STARTED|Overall Study||10
3065346|NCT01290627|3785800|FG000|COMPLETED|Overall Study||10
3065347|NCT01290627|3785801|FG001|COMPLETED|Overall Study||10
3065348|NCT01290627|3785802|FG002|COMPLETED|Overall Study||10
3065349|NCT01290627|3785800|FG000|NOT COMPLETED|Overall Study||0
3065350|NCT01290627|3785801|FG001|NOT COMPLETED|Overall Study||0
3065351|NCT01290627|3785802|FG002|NOT COMPLETED|Overall Study||0
3065352|NCT01290640|3785812|FG000|STARTED|Overall Study||12
3065353|NCT01290640|3785813|FG001|STARTED|Overall Study||10
3065354|NCT01290640|3785812|FG000|COMPLETED|Overall Study||12
3065355|NCT01290640|3785813|FG001|COMPLETED|Overall Study||10
3065356|NCT01290640|3785812|FG000|NOT COMPLETED|Overall Study||0
3065357|NCT01290640|3785813|FG001|NOT COMPLETED|Overall Study||0
3065358|NCT01290666|3785819|FG000|STARTED|Overall Study||93
3065359|NCT01290666|3785819|FG000|COMPLETED|Overall Study||55
3065360|NCT01290666|3785819|FG000|NOT COMPLETED|Overall Study||38
3065361|NCT01290679|3785825|FG000|STARTED|Overall Study|Not including 1 participant was randomized to this group, but never received treatment.|257
3065362|NCT01290679|3785826|FG001|STARTED|Overall Study|Not including 1 participant was randomized to this group, but never received treatment.|134
3065363|NCT01290679|3785825|FG000|COMPLETED|Overall Study||241
3065364|NCT01290679|3785826|FG001|COMPLETED|Overall Study||113
3065365|NCT01290679|3785825|FG000|NOT COMPLETED|Overall Study||16
3065366|NCT01290679|3785826|FG001|NOT COMPLETED|Overall Study||21
3162960|NCT01882257|3890457|FG001|STARTED|Study Origination to Beginning Therapy||40
3162961|NCT01882257|3890458|FG002|STARTED|Study Origination to Beginning Therapy||23
3171752|NCT01936948|3898953|FG000|STARTED|Overall Study||227
3065367|NCT01290731|3785832|FG000|STARTED|Overall Study||49
3065368|NCT01290731|3785832|FG000|COMPLETED|Overall Study||48
3065369|NCT01290731|3785832|FG000|NOT COMPLETED|Overall Study||1
3065370|NCT01290757|3785838|FG000|STARTED|Overall Study||90
3065371|NCT01290757|3785839|FG001|STARTED|Overall Study||90
3065372|NCT01290757|3785838|FG000|COMPLETED|Overall Study||88
3065373|NCT01290757|3785839|FG001|COMPLETED|Overall Study||88
3065374|NCT01290757|3785838|FG000|NOT COMPLETED|Overall Study||2
3065375|NCT01290757|3785839|FG001|NOT COMPLETED|Overall Study||2
3065376|NCT01290796|3785845|FG000|STARTED|Overall Study||153
3065377|NCT01290796|3785845|FG000|COMPLETED|Overall Study||123
3065378|NCT01290796|3785845|FG000|NOT COMPLETED|Overall Study||30
3065379|NCT01290874|3785851|FG000|STARTED|Overall Study||532
3065380|NCT01290874|3785852|FG001|STARTED|Overall Study||538
3065381|NCT01290874|3785851|FG000|COMPLETED|Overall Study||122
3065382|NCT01290874|3785852|FG001|COMPLETED|Overall Study||134
3065383|NCT01290874|3785851|FG000|NOT COMPLETED|Overall Study||410
3065384|NCT01290874|3785852|FG001|NOT COMPLETED|Overall Study||404
3065385|NCT01290887|3785861|FG000|STARTED|Overall Study||481
3065386|NCT01290887|3785862|FG001|STARTED|Overall Study||571
3065387|NCT01290887|3785861|FG000|Safety Analysis Set|Overall Study|One patient was enrolled but not treated.|480
3065388|NCT01290887|3785862|FG001|Safety Analysis Set|Overall Study||571
3065389|NCT01290887|3785861|FG000|COMPLETED|Overall Study|Completed study includes completion of the 104 week treatment phase and the 90-day follow-up.|15
3065390|NCT01290887|3785862|FG001|COMPLETED|Overall Study|Completed study includes completion of the 104 week treatment phase and the 90-day follow-up.|35
3065391|NCT01290887|3785861|FG000|NOT COMPLETED|Overall Study||466
3065392|NCT01290887|3785862|FG001|NOT COMPLETED|Overall Study||536
3065393|NCT01290913|3785868|FG000|STARTED|Overall Study||13
3065394|NCT01290913|3785868|FG000|COMPLETED|Overall Study||12
3065395|NCT01290913|3785868|FG000|NOT COMPLETED|Overall Study||1
3065396|NCT01290952|3785874|FG000|STARTED|Overall Study||204
3065397|NCT01290952|3785875|FG001|STARTED|Overall Study||207
3065398|NCT01290952|3785874|FG000|COMPLETED|Overall Study||192
3065399|NCT01290952|3785875|FG001|COMPLETED|Overall Study||193
3065400|NCT01290952|3785874|FG000|NOT COMPLETED|Overall Study||12
3065401|NCT01290952|3785875|FG001|NOT COMPLETED|Overall Study||14
3065402|NCT01290978|3785883|FG000|STARTED|Overall Study||22
3065403|NCT01290978|3785883|FG000|COMPLETED|Overall Study||22
3065404|NCT01290978|3785883|FG000|NOT COMPLETED|Overall Study||0
3065405|NCT01291017|3785888|FG000|STARTED|Overall Study||19
3065406|NCT01291017|3785888|FG000|COMPLETED|Overall Study||14
3065407|NCT01291017|3785888|FG000|NOT COMPLETED|Overall Study||5
3065408|NCT01291056|3785894|FG000|STARTED|Intervention One (Menstraution Day 3-7)||10
3065409|NCT01291056|3785895|FG001|STARTED|Intervention One (Menstraution Day 3-7)||10
3065410|NCT01291056|3785894|FG000|COMPLETED|Intervention One (Menstraution Day 3-7)||10
3065411|NCT01291056|3785895|FG001|COMPLETED|Intervention One (Menstraution Day 3-7)||10
3065412|NCT01291056|3785894|FG000|NOT COMPLETED|Intervention One (Menstraution Day 3-7)||0
3065413|NCT01291056|3785895|FG001|NOT COMPLETED|Intervention One (Menstraution Day 3-7)||0
3065414|NCT01291056|3785894|FG000|STARTED|Washout||10
3065415|NCT01291056|3785895|FG001|STARTED|Washout||10
3065416|NCT01291056|3785894|FG000|COMPLETED|Washout||10
3065417|NCT01291056|3785895|FG001|COMPLETED|Washout||10
3162962|NCT01882257|3890456|FG000|Started Therapy Using Device|Study Origination to Beginning Therapy||11
3162963|NCT01882257|3890457|FG001|Started Therapy Using Device|Study Origination to Beginning Therapy|Of the 40 who were given the device, 2 chose not to begin the actual therapy|38
3171753|NCT01936948|3898954|FG001|STARTED|Overall Study||231
3065418|NCT01291056|3785894|FG000|NOT COMPLETED|Washout||0
3065419|NCT01291056|3785895|FG001|NOT COMPLETED|Washout||0
3065420|NCT01291056|3785894|FG000|STARTED|Intervention Two (Menstration Days 3-7)||10
3065421|NCT01291056|3785895|FG001|STARTED|Intervention Two (Menstration Days 3-7)||10
3065422|NCT01291056|3785894|FG000|COMPLETED|Intervention Two (Menstration Days 3-7)||10
3065423|NCT01291056|3785895|FG001|COMPLETED|Intervention Two (Menstration Days 3-7)||10
3065424|NCT01291056|3785894|FG000|NOT COMPLETED|Intervention Two (Menstration Days 3-7)||0
3065425|NCT01291056|3785895|FG001|NOT COMPLETED|Intervention Two (Menstration Days 3-7)||0
3065426|NCT01291108|3785905|FG000|STARTED|Month 1 (Monotherapy)||65
3065427|NCT01291108|3785906|FG001|STARTED|Month 1 (Monotherapy)||0
3065428|NCT01291108|3785907|FG002|STARTED|Month 1 (Monotherapy)||0
3065429|NCT01291108|3785908|FG003|STARTED|Month 1 (Monotherapy)||60
3065430|NCT01291108|3785909|FG004|STARTED|Month 1 (Monotherapy)||0
3065431|NCT01291108|3785910|FG005|STARTED|Month 1 (Monotherapy)||0
3065432|NCT01291108|3785905|FG000|COMPLETED|Month 1 (Monotherapy)|All patients who completed Month 1 were randomized to adjunctive therapy for Month 2.|64
3065433|NCT01291108|3785906|FG001|COMPLETED|Month 1 (Monotherapy)||0
3065434|NCT01291108|3785907|FG002|COMPLETED|Month 1 (Monotherapy)||0
3065435|NCT01291108|3785908|FG003|COMPLETED|Month 1 (Monotherapy)|All patients who completed Month 1 were randomized to adjunctive therapy for Month 2.|60
3065436|NCT01291108|3785909|FG004|COMPLETED|Month 1 (Monotherapy)||0
3065437|NCT01291108|3785910|FG005|COMPLETED|Month 1 (Monotherapy)||0
3065438|NCT01291108|3785905|FG000|NOT COMPLETED|Month 1 (Monotherapy)||1
3065439|NCT01291108|3785906|FG001|NOT COMPLETED|Month 1 (Monotherapy)||0
3065440|NCT01291108|3785907|FG002|NOT COMPLETED|Month 1 (Monotherapy)||0
3065441|NCT01291108|3785908|FG003|NOT COMPLETED|Month 1 (Monotherapy)||0
3065442|NCT01291108|3785909|FG004|NOT COMPLETED|Month 1 (Monotherapy)||0
3065443|NCT01291108|3785910|FG005|NOT COMPLETED|Month 1 (Monotherapy)||0
3065444|NCT01291108|3785905|FG000|STARTED|Month 2 (Adjunctive Therapy)|All patients who completed Month 1 were randomized to adjunctive therapy for Month 2.|0
3065445|NCT01291108|3785906|FG001|STARTED|Month 2 (Adjunctive Therapy)||40
3065446|NCT01291108|3785907|FG002|STARTED|Month 2 (Adjunctive Therapy)||24
3065447|NCT01291108|3785908|FG003|STARTED|Month 2 (Adjunctive Therapy)|All patients who completed Month 1 were randomized to adjunctive therapy for Month 2.|0
3065448|NCT01291108|3785909|FG004|STARTED|Month 2 (Adjunctive Therapy)||34
3065449|NCT01291108|3785910|FG005|STARTED|Month 2 (Adjunctive Therapy)||26
3065450|NCT01291108|3785905|FG000|COMPLETED|Month 2 (Adjunctive Therapy)||0
3065451|NCT01291108|3785906|FG001|COMPLETED|Month 2 (Adjunctive Therapy)||38
3065452|NCT01291108|3785907|FG002|COMPLETED|Month 2 (Adjunctive Therapy)||24
3065453|NCT01291108|3785908|FG003|COMPLETED|Month 2 (Adjunctive Therapy)||0
3065454|NCT01291108|3785909|FG004|COMPLETED|Month 2 (Adjunctive Therapy)||34
3065455|NCT01291108|3785910|FG005|COMPLETED|Month 2 (Adjunctive Therapy)||25
3065456|NCT01291108|3785905|FG000|NOT COMPLETED|Month 2 (Adjunctive Therapy)||0
3065457|NCT01291108|3785906|FG001|NOT COMPLETED|Month 2 (Adjunctive Therapy)||2
3065458|NCT01291108|3785907|FG002|NOT COMPLETED|Month 2 (Adjunctive Therapy)||0
3065459|NCT01291108|3785908|FG003|NOT COMPLETED|Month 2 (Adjunctive Therapy)||0
3065460|NCT01291108|3785909|FG004|NOT COMPLETED|Month 2 (Adjunctive Therapy)||0
3065461|NCT01291108|3785910|FG005|NOT COMPLETED|Month 2 (Adjunctive Therapy)||1
3065462|NCT01291160|3785923|FG000|STARTED|Overall Study||66
3065463|NCT01291160|3785924|FG001|STARTED|Overall Study||64
3065464|NCT01291160|3785923|FG000|COMPLETED|Overall Study||48
3065465|NCT01291160|3785924|FG001|COMPLETED|Overall Study||48
3065466|NCT01291160|3785923|FG000|NOT COMPLETED|Overall Study||18
3065467|NCT01291160|3785924|FG001|NOT COMPLETED|Overall Study||16
3065468|NCT01291173|3785934|FG000|STARTED|Overall Study||64
3065469|NCT01291173|3785935|FG001|STARTED|Overall Study||66
3065470|NCT01291173|3785936|FG002|STARTED|Overall Study||65
3065471|NCT01291173|3785937|FG003|STARTED|Overall Study||65
3065472|NCT01291173|3785934|FG000|COMPLETED|Overall Study||47
3065473|NCT01291173|3785935|FG001|COMPLETED|Overall Study||51
3065474|NCT01291173|3785936|FG002|COMPLETED|Overall Study||52
3065475|NCT01291173|3785937|FG003|COMPLETED|Overall Study||52
3065476|NCT01291173|3785934|FG000|NOT COMPLETED|Overall Study||17
3065477|NCT01291173|3785935|FG001|NOT COMPLETED|Overall Study||15
3065478|NCT01291173|3785936|FG002|NOT COMPLETED|Overall Study||13
3065479|NCT01291173|3785937|FG003|NOT COMPLETED|Overall Study||13
3065480|NCT01291225|3785949|FG000|STARTED|Overall Study||151
3065481|NCT01291225|3785950|FG001|STARTED|Overall Study||160
3065482|NCT01291225|3785949|FG000|COMPLETED|Overall Study||66
3065483|NCT01291225|3785950|FG001|COMPLETED|Overall Study||121
3065484|NCT01291225|3785949|FG000|NOT COMPLETED|Overall Study||85
3065485|NCT01291225|3785950|FG001|NOT COMPLETED|Overall Study||39
3065486|NCT01291264|3785960|FG000|STARTED|Overall Study||260
3065487|NCT01291264|3785960|FG000|COMPLETED|Overall Study||260
3065488|NCT01291264|3785960|FG000|NOT COMPLETED|Overall Study||0
3065489|NCT01291277|3785966|FG000|STARTED|Overall Study||45
3065490|NCT01291277|3785967|FG001|STARTED|Overall Study||45
3065491|NCT01291277|3785966|FG000|COMPLETED|Overall Study||40
3065492|NCT01291277|3785967|FG001|COMPLETED|Overall Study||42
3065493|NCT01291277|3785966|FG000|NOT COMPLETED|Overall Study||5
3065494|NCT01291277|3785967|FG001|NOT COMPLETED|Overall Study||3
3065495|NCT01291498|3785973|FG000|STARTED|Overall Study||1
3065496|NCT01291498|3785973|FG000|COMPLETED|Overall Study||0
3065497|NCT01291498|3785973|FG000|NOT COMPLETED|Overall Study||1
3065498|NCT01291784|3785979|FG000|STARTED|Overall Study||1
3065499|NCT01291784|3785980|FG001|STARTED|Overall Study||1
3065500|NCT01291784|3785981|FG002|STARTED|Overall Study||1
3065501|NCT01291784|3785979|FG000|COMPLETED|Overall Study||1
3065502|NCT01291784|3785980|FG001|COMPLETED|Overall Study||0
3065503|NCT01291784|3785981|FG002|COMPLETED|Overall Study||1
3065504|NCT01291784|3785979|FG000|NOT COMPLETED|Overall Study||0
3065505|NCT01291784|3785980|FG001|NOT COMPLETED|Overall Study||1
3065506|NCT01291784|3785981|FG002|NOT COMPLETED|Overall Study||0
3065507|NCT01291836|3785989|FG000|STARTED|Overall Study||930
3065508|NCT01291836|3785990|FG001|STARTED|Overall Study||71
3065509|NCT01291836|3785989|FG000|COMPLETED|Overall Study||930
3065510|NCT01291836|3785990|FG001|COMPLETED|Overall Study||71
3065511|NCT01291836|3785989|FG000|NOT COMPLETED|Overall Study||0
3065512|NCT01291836|3785990|FG001|NOT COMPLETED|Overall Study||0
3065513|NCT01292005|3785998|FG000|STARTED|Overall Study||14
3065514|NCT01292005|3785999|FG001|STARTED|Overall Study||14
3065515|NCT01292005|3785998|FG000|COMPLETED|Overall Study||14
3065516|NCT01292005|3785999|FG001|COMPLETED|Overall Study||14
3065517|NCT01292005|3785998|FG000|NOT COMPLETED|Overall Study||0
3065518|NCT01292005|3785999|FG001|NOT COMPLETED|Overall Study||0
3065519|NCT01292057|3786007|FG000|STARTED|Overall Study||49
3065520|NCT01292057|3786008|FG001|STARTED|Overall Study||50
3065521|NCT01292057|3786007|FG000|COMPLETED|Overall Study||47
3065522|NCT01292057|3786008|FG001|COMPLETED|Overall Study||48
3065523|NCT01292057|3786007|FG000|NOT COMPLETED|Overall Study||2
3065524|NCT01292057|3786008|FG001|NOT COMPLETED|Overall Study||2
3065525|NCT01292135|3786016|FG000|STARTED|Overall Study||3
3065526|NCT01292135|3786017|FG001|STARTED|Overall Study||30
3065527|NCT01292135|3786016|FG000|COMPLETED|Overall Study||3
3065528|NCT01292135|3786017|FG001|COMPLETED|Overall Study||21
3065529|NCT01292135|3786016|FG000|NOT COMPLETED|Overall Study||0
3065530|NCT01292135|3786017|FG001|NOT COMPLETED|Overall Study||9
3065531|NCT01292187|3786027|FG000|STARTED|Overall Study||86
3065532|NCT01292187|3786028|FG001|STARTED|Overall Study||43
3065533|NCT01292187|3786027|FG000|COMPLETED|Overall Study||69
3065534|NCT01292187|3786028|FG001|COMPLETED|Overall Study||30
3065535|NCT01292187|3786027|FG000|NOT COMPLETED|Overall Study||17
3065536|NCT01292187|3786028|FG001|NOT COMPLETED|Overall Study||13
3065537|NCT01292226|3786035|FG000|STARTED|Overall Study||45
3065538|NCT01292226|3786035|FG000|COMPLETED|Overall Study||32
3065539|NCT01292226|3786035|FG000|NOT COMPLETED|Overall Study||13
3065540|NCT01292239|3786041|FG000|STARTED|Overall Study||123
3065541|NCT01292239|3786042|FG001|STARTED|Overall Study||60
3065542|NCT01292239|3786041|FG000|COMPLETED|Overall Study||119
3065543|NCT01292239|3786042|FG001|COMPLETED|Overall Study||53
3065544|NCT01292239|3786041|FG000|NOT COMPLETED|Overall Study||4
3065545|NCT01292239|3786042|FG001|NOT COMPLETED|Overall Study||7
3065546|NCT01292252|3786050|FG000|STARTED|Overall Study||21
3065547|NCT01292252|3786051|FG001|STARTED|Overall Study||15
3065548|NCT01292252|3786050|FG000|COMPLETED|Overall Study||21
3065549|NCT01292252|3786051|FG001|COMPLETED|Overall Study||14
3065550|NCT01292252|3786050|FG000|NOT COMPLETED|Overall Study||0
3065551|NCT01292252|3786051|FG001|NOT COMPLETED|Overall Study||1
3065552|NCT01292304|3786057|FG000|STARTED|Overall Study||10
3065553|NCT01292304|3786057|FG000|COMPLETED|Overall Study||10
3065554|NCT01292304|3786057|FG000|NOT COMPLETED|Overall Study||0
3065555|NCT01292447|3786063|FG000|STARTED|Overall Study||75
3065556|NCT01292447|3786064|FG001|STARTED|Overall Study||75
3065557|NCT01292447|3786063|FG000|COMPLETED|Overall Study||73
3065558|NCT01292447|3786064|FG001|COMPLETED|Overall Study||72
3065559|NCT01292447|3786063|FG000|NOT COMPLETED|Overall Study||2
3065560|NCT01292447|3786064|FG001|NOT COMPLETED|Overall Study||3
3065561|NCT01292473|3786074|FG000|STARTED|Overall Study||79
3065562|NCT01292473|3786075|FG001|STARTED|Overall Study||82
3065563|NCT01292473|3786076|FG002|STARTED|Overall Study||83
3065564|NCT01292473|3786077|FG003|STARTED|Overall Study||79
3065565|NCT01292473|3786074|FG000|COMPLETED|Overall Study||74
3065566|NCT01292473|3786075|FG001|COMPLETED|Overall Study||75
3065567|NCT01292473|3786076|FG002|COMPLETED|Overall Study||74
3065568|NCT01292473|3786077|FG003|COMPLETED|Overall Study||67
3065569|NCT01292473|3786074|FG000|NOT COMPLETED|Overall Study||5
3065570|NCT01292473|3786075|FG001|NOT COMPLETED|Overall Study||7
3065571|NCT01292473|3786076|FG002|NOT COMPLETED|Overall Study||9
3065572|NCT01292473|3786077|FG003|NOT COMPLETED|Overall Study||12
3134218|NCT01700816|3859248|FG001|STARTED|Overall Study||19
3134219|NCT01700816|3859247|FG000|COMPLETED|Overall Study||21
3134220|NCT01700816|3859248|FG001|COMPLETED|Overall Study||19
3134221|NCT01700816|3859247|FG000|NOT COMPLETED|Overall Study||0
3134222|NCT01700816|3859248|FG001|NOT COMPLETED|Overall Study||0
3134223|NCT01700829|3859256|FG000|STARTED|Overall Study||41
3134224|NCT01700829|3859257|FG001|STARTED|Overall Study||41
3065573|NCT01292486|3786091|FG000|STARTED|Overall Study||32
3065574|NCT01292486|3786091|FG000|COMPLETED|Overall Study||26
3065575|NCT01292486|3786091|FG000|NOT COMPLETED|Overall Study||6
3065576|NCT01292538|3786098|FG000|STARTED|Overall Study||35
3065577|NCT01292538|3786099|FG001|STARTED|Overall Study||32
3065578|NCT01292538|3786098|FG000|COMPLETED|Overall Study||35
3065579|NCT01292538|3786099|FG001|COMPLETED|Overall Study||32
3065580|NCT01292538|3786098|FG000|NOT COMPLETED|Overall Study||0
3065581|NCT01292538|3786099|FG001|NOT COMPLETED|Overall Study||0
3065582|NCT01292603|3786110|FG000|STARTED|Part 1: Pilot Dose Selection Period||16
3065583|NCT01292603|3786111|FG001|STARTED|Part 1: Pilot Dose Selection Period||17
3065584|NCT01292603|3786112|FG002|STARTED|Part 1: Pilot Dose Selection Period|1 participant received a dose of 1000mg of rituximab by oversight.|23
3065585|NCT01292603|3786113|FG003|STARTED|Part 1: Pilot Dose Selection Period|These participants were withdrawn prior to SC treatment.|8
3065586|NCT01292603|3786114|FG004|STARTED|Part 1: Pilot Dose Selection Period||0
3065587|NCT01292603|3786115|FG005|STARTED|Part 1: Pilot Dose Selection Period||0
3065588|NCT01292603|3786110|FG000|COMPLETED|Part 1: Pilot Dose Selection Period||16
3065589|NCT01292603|3786111|FG001|COMPLETED|Part 1: Pilot Dose Selection Period||17
3065590|NCT01292603|3786112|FG002|COMPLETED|Part 1: Pilot Dose Selection Period||23
3065591|NCT01292603|3786113|FG003|COMPLETED|Part 1: Pilot Dose Selection Period||0
3065592|NCT01292603|3786114|FG004|COMPLETED|Part 1: Pilot Dose Selection Period||0
3065593|NCT01292603|3786115|FG005|COMPLETED|Part 1: Pilot Dose Selection Period||0
3065594|NCT01292603|3786110|FG000|NOT COMPLETED|Part 1: Pilot Dose Selection Period||0
3065595|NCT01292603|3786111|FG001|NOT COMPLETED|Part 1: Pilot Dose Selection Period||0
3065596|NCT01292603|3786112|FG002|NOT COMPLETED|Part 1: Pilot Dose Selection Period||0
3065597|NCT01292603|3786113|FG003|NOT COMPLETED|Part 1: Pilot Dose Selection Period||8
3065598|NCT01292603|3786114|FG004|NOT COMPLETED|Part 1: Pilot Dose Selection Period||0
3065599|NCT01292603|3786115|FG005|NOT COMPLETED|Part 1: Pilot Dose Selection Period||0
3065600|NCT01292603|3786110|FG000|STARTED|Part 1: Regular Follow-Up Period||16
3065601|NCT01292603|3786111|FG001|STARTED|Part 1: Regular Follow-Up Period||17
3065602|NCT01292603|3786112|FG002|STARTED|Part 1: Regular Follow-Up Period||23
3065603|NCT01292603|3786113|FG003|STARTED|Part 1: Regular Follow-Up Period||8
3065604|NCT01292603|3786114|FG004|STARTED|Part 1: Regular Follow-Up Period||0
3065605|NCT01292603|3786115|FG005|STARTED|Part 1: Regular Follow-Up Period||0
3065606|NCT01292603|3786110|FG000|COMPLETED|Part 1: Regular Follow-Up Period|Participants withdrawn from regular follow-up who were still alive entered survival follow-up|10
3065607|NCT01292603|3786111|FG001|COMPLETED|Part 1: Regular Follow-Up Period|Participants withdrawn from regular follow-up who were still alive entered survival follow-up|10
3065608|NCT01292603|3786112|FG002|COMPLETED|Part 1: Regular Follow-Up Period|Participants withdrawn from regular follow-up who were still alive entered survival follow-up|17
3065609|NCT01292603|3786113|FG003|COMPLETED|Part 1: Regular Follow-Up Period||7
3065610|NCT01292603|3786114|FG004|COMPLETED|Part 1: Regular Follow-Up Period||0
3065611|NCT01292603|3786115|FG005|COMPLETED|Part 1: Regular Follow-Up Period||0
3065612|NCT01292603|3786110|FG000|NOT COMPLETED|Part 1: Regular Follow-Up Period||6
3065613|NCT01292603|3786111|FG001|NOT COMPLETED|Part 1: Regular Follow-Up Period||7
3065614|NCT01292603|3786112|FG002|NOT COMPLETED|Part 1: Regular Follow-Up Period||6
3065615|NCT01292603|3786113|FG003|NOT COMPLETED|Part 1: Regular Follow-Up Period||1
3065616|NCT01292603|3786114|FG004|NOT COMPLETED|Part 1: Regular Follow-Up Period||0
3065617|NCT01292603|3786115|FG005|NOT COMPLETED|Part 1: Regular Follow-Up Period||0
3065618|NCT01292603|3786110|FG000|STARTED|Part 2: Dose Confirmation Period||0
3065619|NCT01292603|3786111|FG001|STARTED|Part 2: Dose Confirmation Period||0
3065620|NCT01292603|3786112|FG002|STARTED|Part 2: Dose Confirmation Period||0
3065621|NCT01292603|3786113|FG003|STARTED|Part 2: Dose Confirmation Period||0
3065622|NCT01292603|3786114|FG004|STARTED|Part 2: Dose Confirmation Period||88
3065623|NCT01292603|3786115|FG005|STARTED|Part 2: Dose Confirmation Period||88
3065624|NCT01292603|3786110|FG000|COMPLETED|Part 2: Dose Confirmation Period||0
3065625|NCT01292603|3786111|FG001|COMPLETED|Part 2: Dose Confirmation Period||0
3065626|NCT01292603|3786112|FG002|COMPLETED|Part 2: Dose Confirmation Period||0
3065627|NCT01292603|3786113|FG003|COMPLETED|Part 2: Dose Confirmation Period||0
3065628|NCT01292603|3786114|FG004|COMPLETED|Part 2: Dose Confirmation Period||72
3065629|NCT01292603|3786115|FG005|COMPLETED|Part 2: Dose Confirmation Period||73
3065630|NCT01292603|3786110|FG000|NOT COMPLETED|Part 2: Dose Confirmation Period||0
3065631|NCT01292603|3786111|FG001|NOT COMPLETED|Part 2: Dose Confirmation Period||0
3065632|NCT01292603|3786112|FG002|NOT COMPLETED|Part 2: Dose Confirmation Period||0
3065633|NCT01292603|3786113|FG003|NOT COMPLETED|Part 2: Dose Confirmation Period||0
3065634|NCT01292603|3786114|FG004|NOT COMPLETED|Part 2: Dose Confirmation Period||16
3065635|NCT01292603|3786115|FG005|NOT COMPLETED|Part 2: Dose Confirmation Period||15
3065636|NCT01292603|3786110|FG000|STARTED|Part 2: Regular Follow-Up||0
3065637|NCT01292603|3786111|FG001|STARTED|Part 2: Regular Follow-Up||0
3065638|NCT01292603|3786112|FG002|STARTED|Part 2: Regular Follow-Up||0
3065639|NCT01292603|3786113|FG003|STARTED|Part 2: Regular Follow-Up||0
3065640|NCT01292603|3786114|FG004|STARTED|Part 2: Regular Follow-Up|Participants withdrawn from regular follow-up who were still alive entered survival follow-up|87
3065641|NCT01292603|3786115|FG005|STARTED|Part 2: Regular Follow-Up|Participants withdrawn from regular follow-up who were still alive entered survival follow-up|87
3065642|NCT01292603|3786110|FG000|COMPLETED|Part 2: Regular Follow-Up||0
3065643|NCT01292603|3786111|FG001|COMPLETED|Part 2: Regular Follow-Up||0
3065644|NCT01292603|3786112|FG002|COMPLETED|Part 2: Regular Follow-Up||0
3065645|NCT01292603|3786113|FG003|COMPLETED|Part 2: Regular Follow-Up||0
3065646|NCT01292603|3786114|FG004|COMPLETED|Part 2: Regular Follow-Up||68
3065647|NCT01292603|3786115|FG005|COMPLETED|Part 2: Regular Follow-Up||75
3065648|NCT01292603|3786110|FG000|NOT COMPLETED|Part 2: Regular Follow-Up||0
3065649|NCT01292603|3786111|FG001|NOT COMPLETED|Part 2: Regular Follow-Up||0
3065650|NCT01292603|3786112|FG002|NOT COMPLETED|Part 2: Regular Follow-Up||0
3065651|NCT01292603|3786113|FG003|NOT COMPLETED|Part 2: Regular Follow-Up||0
3065652|NCT01292603|3786114|FG004|NOT COMPLETED|Part 2: Regular Follow-Up||19
3065653|NCT01292603|3786115|FG005|NOT COMPLETED|Part 2: Regular Follow-Up||12
3065654|NCT01292603|3786110|FG000|STARTED|Overall Survival Status||16
3065655|NCT01292603|3786111|FG001|STARTED|Overall Survival Status||17
3065656|NCT01292603|3786112|FG002|STARTED|Overall Survival Status||23
3065657|NCT01292603|3786113|FG003|STARTED|Overall Survival Status||8
3065658|NCT01292603|3786114|FG004|STARTED|Overall Survival Status||88
3065659|NCT01292603|3786115|FG005|STARTED|Overall Survival Status||88
3065660|NCT01292603|3786110|FG000|COMPLETED|Overall Survival Status||13
3065661|NCT01292603|3786111|FG001|COMPLETED|Overall Survival Status||16
3065662|NCT01292603|3786112|FG002|COMPLETED|Overall Survival Status||20
3065663|NCT01292603|3786113|FG003|COMPLETED|Overall Survival Status||7
3065664|NCT01292603|3786114|FG004|COMPLETED|Overall Survival Status||72
3065665|NCT01292603|3786115|FG005|COMPLETED|Overall Survival Status||78
3065666|NCT01292603|3786110|FG000|NOT COMPLETED|Overall Survival Status||3
3065667|NCT01292603|3786111|FG001|NOT COMPLETED|Overall Survival Status||1
3065668|NCT01292603|3786112|FG002|NOT COMPLETED|Overall Survival Status||3
3065669|NCT01292603|3786113|FG003|NOT COMPLETED|Overall Survival Status||1
3065670|NCT01292603|3786114|FG004|NOT COMPLETED|Overall Survival Status||16
3065671|NCT01292603|3786115|FG005|NOT COMPLETED|Overall Survival Status||10
3065672|NCT01292629|3786136|FG000|STARTED|Overall Study||125
3065673|NCT01292629|3786136|FG000|COMPLETED|Overall Study||125
3065674|NCT01292629|3786136|FG000|NOT COMPLETED|Overall Study||0
3065675|NCT01292642|3786141|FG000|STARTED|Overall Study||12
3065676|NCT01292642|3786141|FG000|COMPLETED|Overall Study||7
3065677|NCT01292642|3786141|FG000|NOT COMPLETED|Overall Study||5
3065678|NCT01292746|3786149|FG000|STARTED|Overall Study||14
3065679|NCT01292746|3786149|FG000|COMPLETED|Overall Study||14
3065680|NCT01292746|3786149|FG000|NOT COMPLETED|Overall Study||0
3065681|NCT01292798|3786153|FG000|STARTED|Overall Study||43
3065682|NCT01292798|3786153|FG000|Persistent DME After 3 Months|Overall Study|Subjects with persistent DME after 3 monthly injections of 0.5 mg of ranibizumab|29
3065683|NCT01292798|3786153|FG000|COMPLETED|Overall Study||43
3065684|NCT01292798|3786153|FG000|NOT COMPLETED|Overall Study||0
3065685|NCT01292837|3786157|FG000|STARTED|Overall Study||13
3065686|NCT01292837|3786157|FG000|COMPLETED|Overall Study||11
3065687|NCT01292837|3786157|FG000|NOT COMPLETED|Overall Study||2
3065688|NCT01292876|3786161|FG000|STARTED|Overall Study||17
3065689|NCT01292876|3786161|FG000|COMPLETED|Overall Study||13
3065690|NCT01292876|3786161|FG000|NOT COMPLETED|Overall Study||4
3065691|NCT01292928|3786167|FG000|STARTED|Overall Study||299
3065692|NCT01292928|3786167|FG000|Completed 12-Month Clinical Follow-up|Overall Study||266
3065693|NCT01292928|3786167|FG000|COMPLETED|Overall Study||275
3065694|NCT01292928|3786167|FG000|NOT COMPLETED|Overall Study||24
3065695|NCT01293006|3786177|FG000|STARTED|Period 1||11
3065696|NCT01293006|3786178|FG001|STARTED|Period 1||2
3065697|NCT01293006|3786179|FG002|STARTED|Period 1||9
3065698|NCT01293006|3786180|FG003|STARTED|Period 1||3
3065699|NCT01293006|3786177|FG000|COMPLETED|Period 1||11
3065700|NCT01293006|3786178|FG001|COMPLETED|Period 1||2
3065701|NCT01293006|3786179|FG002|COMPLETED|Period 1||9
3065702|NCT01293006|3786180|FG003|COMPLETED|Period 1||3
3065703|NCT01293006|3786177|FG000|NOT COMPLETED|Period 1||0
3065704|NCT01293006|3786178|FG001|NOT COMPLETED|Period 1||0
3065705|NCT01293006|3786179|FG002|NOT COMPLETED|Period 1||0
3065706|NCT01293006|3786180|FG003|NOT COMPLETED|Period 1||0
3065707|NCT01293006|3786177|FG000|STARTED|Washout||11
3065708|NCT01293006|3786178|FG001|STARTED|Washout||2
3065709|NCT01293006|3786179|FG002|STARTED|Washout||9
3065710|NCT01293006|3786180|FG003|STARTED|Washout||3
3065711|NCT01293006|3786177|FG000|COMPLETED|Washout||11
3065712|NCT01293006|3786178|FG001|COMPLETED|Washout||2
3065713|NCT01293006|3786179|FG002|COMPLETED|Washout||9
3065714|NCT01293006|3786180|FG003|COMPLETED|Washout||3
3065715|NCT01293006|3786177|FG000|NOT COMPLETED|Washout||0
3065716|NCT01293006|3786178|FG001|NOT COMPLETED|Washout||0
3065717|NCT01293006|3786179|FG002|NOT COMPLETED|Washout||0
3065718|NCT01293006|3786180|FG003|NOT COMPLETED|Washout||0
3065719|NCT01293006|3786177|FG000|STARTED|Period 2||11
3065720|NCT01293006|3786178|FG001|STARTED|Period 2||2
3065721|NCT01293006|3786179|FG002|STARTED|Period 2||9
3065722|NCT01293006|3786180|FG003|STARTED|Period 2||3
3065723|NCT01293006|3786177|FG000|COMPLETED|Period 2||10
3065724|NCT01293006|3786178|FG001|COMPLETED|Period 2||2
3065725|NCT01293006|3786179|FG002|COMPLETED|Period 2||9
3065726|NCT01293006|3786180|FG003|COMPLETED|Period 2||3
3065727|NCT01293006|3786177|FG000|NOT COMPLETED|Period 2||1
3065728|NCT01293006|3786178|FG001|NOT COMPLETED|Period 2||0
3065729|NCT01293006|3786179|FG002|NOT COMPLETED|Period 2||0
3065730|NCT01293006|3786180|FG003|NOT COMPLETED|Period 2||0
3065731|NCT01293032|3786199|FG000|STARTED|Recurrence Score(RS)Assigned/Randomized||12
3065732|NCT01293032|3786200|FG001|STARTED|Recurrence Score(RS)Assigned/Randomized||17
3065733|NCT01293032|3786201|FG002|STARTED|Recurrence Score(RS)Assigned/Randomized||16
3065734|NCT01293032|3786202|FG003|STARTED|Recurrence Score(RS)Assigned/Randomized||14
3065735|NCT01293032|3786199|FG000|Assigned/Randomized to Arm|Recurrence Score(RS)Assigned/Randomized||12
3065736|NCT01293032|3786200|FG001|Assigned/Randomized to Arm|Recurrence Score(RS)Assigned/Randomized||17
3065737|NCT01293032|3786201|FG002|Assigned/Randomized to Arm|Recurrence Score(RS)Assigned/Randomized||16
3065738|NCT01293032|3786202|FG003|Assigned/Randomized to Arm|Recurrence Score(RS)Assigned/Randomized||14
3065739|NCT01293032|3786199|FG000|COMPLETED|Recurrence Score(RS)Assigned/Randomized||12
3065740|NCT01293032|3786200|FG001|COMPLETED|Recurrence Score(RS)Assigned/Randomized||17
3065741|NCT01293032|3786201|FG002|COMPLETED|Recurrence Score(RS)Assigned/Randomized|2/5 subjects who refused Arm 2(chemo) were treated with Arm 1(hormonal) and evaluable for response.|11
3065742|NCT01293032|3786202|FG003|COMPLETED|Recurrence Score(RS)Assigned/Randomized||14
3065743|NCT01293032|3786199|FG000|NOT COMPLETED|Recurrence Score(RS)Assigned/Randomized||0
3065744|NCT01293032|3786200|FG001|NOT COMPLETED|Recurrence Score(RS)Assigned/Randomized||0
3065745|NCT01293032|3786201|FG002|NOT COMPLETED|Recurrence Score(RS)Assigned/Randomized||5
3065746|NCT01293032|3786202|FG003|NOT COMPLETED|Recurrence Score(RS)Assigned/Randomized||0
3065747|NCT01293032|3786199|FG000|STARTED|Treatment||12
3065748|NCT01293032|3786200|FG001|STARTED|Treatment|2/5 subjects who refused Arm 2(chemo) were treated with Arm 1(hormonal) and evaluable for response.|19
3065749|NCT01293032|3786201|FG002|STARTED|Treatment||11
3065750|NCT01293032|3786202|FG003|STARTED|Treatment||14
3065751|NCT01293032|3786199|FG000|COMPLETED|Treatment||10
3162964|NCT01882257|3890458|FG002|Started Therapy Using Device|Study Origination to Beginning Therapy|Of the 23 who were given the device, 1 chose not to begin the actual therapy|22
3162965|NCT01882257|3890456|FG000|COMPLETED|Study Origination to Beginning Therapy||11
3162966|NCT01882257|3890457|FG001|COMPLETED|Study Origination to Beginning Therapy||38
3162967|NCT01882257|3890458|FG002|COMPLETED|Study Origination to Beginning Therapy||22
3162968|NCT01882257|3890456|FG000|NOT COMPLETED|Study Origination to Beginning Therapy||0
3162969|NCT01882257|3890457|FG001|NOT COMPLETED|Study Origination to Beginning Therapy||2
3162970|NCT01882257|3890458|FG002|NOT COMPLETED|Study Origination to Beginning Therapy||1
3162971|NCT01882257|3890456|FG000|STARTED|Therapy Portion of Study (12 Months)||11
3162972|NCT01882257|3890457|FG001|STARTED|Therapy Portion of Study (12 Months)||38
3162973|NCT01882257|3890458|FG002|STARTED|Therapy Portion of Study (12 Months)||22
3162974|NCT01882257|3890456|FG000|COMPLETED|Therapy Portion of Study (12 Months)||11
3162975|NCT01882257|3890457|FG001|COMPLETED|Therapy Portion of Study (12 Months)||27
3162976|NCT01882257|3890458|FG002|COMPLETED|Therapy Portion of Study (12 Months)||18
3162977|NCT01882257|3890456|FG000|NOT COMPLETED|Therapy Portion of Study (12 Months)||0
3162978|NCT01882257|3890457|FG001|NOT COMPLETED|Therapy Portion of Study (12 Months)||11
3162979|NCT01882257|3890458|FG002|NOT COMPLETED|Therapy Portion of Study (12 Months)||4
3162980|NCT01882413|3890465|FG000|STARTED|Overall Study||204
3162981|NCT01882413|3890465|FG000|COMPLETED|Overall Study||204
3162982|NCT01882413|3890465|FG000|NOT COMPLETED|Overall Study||0
3162983|NCT01882439|3890473|FG000|STARTED|Overall Study|Received treatment|131
3162984|NCT01882439|3890474|FG001|STARTED|Overall Study|Received treatment|132
3162985|NCT01882439|3890475|FG002|STARTED|Overall Study|Received treatment|66
3162986|NCT01882439|3890476|FG003|STARTED|Overall Study|Received treatment|65
3162987|NCT01882439|3890473|FG000|COMPLETED|Overall Study||122
3162988|NCT01882439|3890474|FG001|COMPLETED|Overall Study||111
3162989|NCT01882439|3890475|FG002|COMPLETED|Overall Study||56
3162990|NCT01882439|3890476|FG003|COMPLETED|Overall Study||56
3065752|NCT01293032|3786200|FG001|COMPLETED|Treatment||14
3065753|NCT01293032|3786201|FG002|COMPLETED|Treatment||10
3065754|NCT01293032|3786202|FG003|COMPLETED|Treatment||13
3065755|NCT01293032|3786199|FG000|NOT COMPLETED|Treatment||2
3065756|NCT01293032|3786200|FG001|NOT COMPLETED|Treatment||5
3065757|NCT01293032|3786201|FG002|NOT COMPLETED|Treatment||1
3065758|NCT01293032|3786202|FG003|NOT COMPLETED|Treatment||1
3065759|NCT01293084|3786209|FG000|STARTED|Overall Study||17
3065760|NCT01293084|3786209|FG000|COMPLETED|Overall Study||12
3065761|NCT01293084|3786209|FG000|NOT COMPLETED|Overall Study||5
3065762|NCT01293240|3786215|FG000|STARTED|Overall Study||117
3065763|NCT01293240|3786215|FG000|COMPLETED|Overall Study||115
3065764|NCT01293240|3786215|FG000|NOT COMPLETED|Overall Study||2
3065765|NCT01293396|3786219|FG000|STARTED|First Intervention||6
3065766|NCT01293396|3786220|FG001|STARTED|First Intervention||7
3065767|NCT01293396|3786221|FG002|STARTED|First Intervention||7
3065768|NCT01293396|3786219|FG000|COMPLETED|First Intervention||6
3065769|NCT01293396|3786220|FG001|COMPLETED|First Intervention||7
3065770|NCT01293396|3786221|FG002|COMPLETED|First Intervention||7
3065771|NCT01293396|3786219|FG000|NOT COMPLETED|First Intervention||0
3065772|NCT01293396|3786220|FG001|NOT COMPLETED|First Intervention||0
3065773|NCT01293396|3786221|FG002|NOT COMPLETED|First Intervention||0
3065774|NCT01293396|3786219|FG000|STARTED|Wash Out Period 1 (3 Days)||6
3065775|NCT01293396|3786220|FG001|STARTED|Wash Out Period 1 (3 Days)||7
3065776|NCT01293396|3786221|FG002|STARTED|Wash Out Period 1 (3 Days)||7
3065777|NCT01293396|3786219|FG000|COMPLETED|Wash Out Period 1 (3 Days)||6
3065778|NCT01293396|3786220|FG001|COMPLETED|Wash Out Period 1 (3 Days)||7
3065779|NCT01293396|3786221|FG002|COMPLETED|Wash Out Period 1 (3 Days)||7
3065780|NCT01293396|3786219|FG000|NOT COMPLETED|Wash Out Period 1 (3 Days)||0
3065781|NCT01293396|3786220|FG001|NOT COMPLETED|Wash Out Period 1 (3 Days)||0
3065782|NCT01293396|3786221|FG002|NOT COMPLETED|Wash Out Period 1 (3 Days)||0
3065783|NCT01293396|3786219|FG000|STARTED|Second Intervention||5
3065784|NCT01293396|3786220|FG001|STARTED|Second Intervention||5
3065785|NCT01293396|3786221|FG002|STARTED|Second Intervention||10
3065786|NCT01293396|3786219|FG000|COMPLETED|Second Intervention||5
3065787|NCT01293396|3786220|FG001|COMPLETED|Second Intervention||5
3065788|NCT01293396|3786221|FG002|COMPLETED|Second Intervention||10
3065789|NCT01293396|3786219|FG000|NOT COMPLETED|Second Intervention||0
3065790|NCT01293396|3786220|FG001|NOT COMPLETED|Second Intervention||0
3065791|NCT01293396|3786221|FG002|NOT COMPLETED|Second Intervention||0
3065792|NCT01293396|3786219|FG000|STARTED|Wash Out Period 2 (3 Days)||5
3065793|NCT01293396|3786220|FG001|STARTED|Wash Out Period 2 (3 Days)||5
3065794|NCT01293396|3786221|FG002|STARTED|Wash Out Period 2 (3 Days)||10
3065795|NCT01293396|3786219|FG000|COMPLETED|Wash Out Period 2 (3 Days)||5
3065796|NCT01293396|3786220|FG001|COMPLETED|Wash Out Period 2 (3 Days)||5
3065797|NCT01293396|3786221|FG002|COMPLETED|Wash Out Period 2 (3 Days)||10
3065798|NCT01293396|3786219|FG000|NOT COMPLETED|Wash Out Period 2 (3 Days)||0
3065799|NCT01293396|3786220|FG001|NOT COMPLETED|Wash Out Period 2 (3 Days)||0
3065800|NCT01293396|3786221|FG002|NOT COMPLETED|Wash Out Period 2 (3 Days)||0
3065801|NCT01293396|3786219|FG000|STARTED|Third Intervention||9
3065802|NCT01293396|3786220|FG001|STARTED|Third Intervention||8
3065803|NCT01293396|3786221|FG002|STARTED|Third Intervention||3
3065804|NCT01293396|3786219|FG000|COMPLETED|Third Intervention||9
3065805|NCT01293396|3786220|FG001|COMPLETED|Third Intervention||8
3065806|NCT01293396|3786221|FG002|COMPLETED|Third Intervention||3
3065807|NCT01293396|3786219|FG000|NOT COMPLETED|Third Intervention||0
3065808|NCT01293396|3786220|FG001|NOT COMPLETED|Third Intervention||0
3065809|NCT01293396|3786221|FG002|NOT COMPLETED|Third Intervention||0
3065810|NCT01293539|3786229|FG000|STARTED|Overall Study||10
3065811|NCT01293539|3786229|FG000|COMPLETED|Overall Study||9
3065812|NCT01293539|3786229|FG000|NOT COMPLETED|Overall Study||1
3065813|NCT01293682|3786233|FG000|STARTED|Overall Study||12
3065814|NCT01293682|3786233|FG000|COMPLETED|Overall Study||12
3065815|NCT01293682|3786233|FG000|NOT COMPLETED|Overall Study||0
3065816|NCT01293695|3786239|FG000|STARTED|Overall Study||93
3065817|NCT01293695|3786240|FG001|STARTED|Overall Study||94
3065818|NCT01293695|3786239|FG000|COMPLETED|Overall Study||78
3065819|NCT01293695|3786240|FG001|COMPLETED|Overall Study||87
3065820|NCT01293695|3786239|FG000|NOT COMPLETED|Overall Study||15
3065821|NCT01293695|3786240|FG001|NOT COMPLETED|Overall Study||7
3065822|NCT01293825|3786249|FG000|STARTED|Overall Study||30
3065823|NCT01293825|3786249|FG000|COMPLETED|Overall Study||20
3065824|NCT01293825|3786249|FG000|NOT COMPLETED|Overall Study||10
3065825|NCT01293968|3786255|FG000|STARTED|Overall Study||20
3065826|NCT01293968|3786256|FG001|STARTED|Overall Study||17
3065827|NCT01293968|3786255|FG000|COMPLETED|Overall Study||17
3065828|NCT01293968|3786256|FG001|COMPLETED|Overall Study||14
3065829|NCT01293968|3786255|FG000|NOT COMPLETED|Overall Study||3
3065830|NCT01293968|3786256|FG001|NOT COMPLETED|Overall Study||3
3065831|NCT01294098|3786265|FG000|STARTED|Overall Study||0
3065832|NCT01294098|3786266|FG001|STARTED|Overall Study||1
3065833|NCT01294098|3786267|FG002|STARTED|Overall Study||1
3065834|NCT01294098|3786265|FG000|COMPLETED|Overall Study||0
3065835|NCT01294098|3786266|FG001|COMPLETED|Overall Study||0
3065836|NCT01294098|3786267|FG002|COMPLETED|Overall Study||0
3065837|NCT01294098|3786265|FG000|NOT COMPLETED|Overall Study||0
3065838|NCT01294098|3786266|FG001|NOT COMPLETED|Overall Study||1
3065839|NCT01294098|3786267|FG002|NOT COMPLETED|Overall Study||1
3065840|NCT01294150|3786277|FG000|STARTED|Overall Study||140
3065841|NCT01294150|3786278|FG001|STARTED|Overall Study||66
3065842|NCT01294150|3786277|FG000|COMPLETED|Overall Study||138
3065843|NCT01294150|3786278|FG001|COMPLETED|Overall Study||64
3065844|NCT01294150|3786277|FG000|NOT COMPLETED|Overall Study||2
3065845|NCT01294150|3786278|FG001|NOT COMPLETED|Overall Study||2
3065846|NCT01294163|3786289|FG000|STARTED|Overall Study||178
3065847|NCT01294163|3786290|FG001|STARTED|Overall Study||165
3065848|NCT01294163|3786291|FG002|STARTED|Overall Study||166
3065849|NCT01294163|3786289|FG000|COMPLETED|Overall Study||177
3065850|NCT01294163|3786290|FG001|COMPLETED|Overall Study||165
3065851|NCT01294163|3786291|FG002|COMPLETED|Overall Study||163
3065852|NCT01294163|3786289|FG000|NOT COMPLETED|Overall Study||1
3065853|NCT01294163|3786290|FG001|NOT COMPLETED|Overall Study||0
3065854|NCT01294163|3786291|FG002|NOT COMPLETED|Overall Study||3
3065855|NCT01294228|3786298|FG000|STARTED|Overall Study||1001
3065856|NCT01294228|3786298|FG000|COMPLETED|Overall Study||1001
3065857|NCT01294228|3786298|FG000|NOT COMPLETED|Overall Study||0
3065858|NCT01294241|3786302|FG000|STARTED|Overall Study||10
3065859|NCT01294241|3786302|FG000|COMPLETED|Overall Study||10
3065860|NCT01294241|3786302|FG000|NOT COMPLETED|Overall Study||0
3065861|NCT01294267|3786308|FG000|STARTED|Overall Study||20
3065862|NCT01294267|3786308|FG000|COMPLETED|Overall Study||20
3065863|NCT01294267|3786308|FG000|NOT COMPLETED|Overall Study||0
3065864|NCT01294306|3786314|FG000|STARTED|Overall Study||45
3065865|NCT01294306|3786315|FG001|STARTED|Overall Study||35
3065866|NCT01294306|3786314|FG000|COMPLETED|Overall Study||45
3065867|NCT01294306|3786315|FG001|COMPLETED|Overall Study||35
3065868|NCT01294306|3786314|FG000|NOT COMPLETED|Overall Study||0
3065869|NCT01294306|3786315|FG001|NOT COMPLETED|Overall Study||0
3065870|NCT01294319|3786329|FG000|STARTED|Overall Study||4
3065871|NCT01294319|3786330|FG001|STARTED|Overall Study||6
3065872|NCT01294319|3786331|FG002|STARTED|Overall Study||5
3065873|NCT01294319|3786332|FG003|STARTED|Overall Study||5
3065874|NCT01294319|3786333|FG004|STARTED|Overall Study||5
3065875|NCT01294319|3786334|FG005|STARTED|Overall Study||4
3065876|NCT01294319|3786335|FG006|STARTED|Overall Study||5
3065877|NCT01294319|3786336|FG007|STARTED|Overall Study||5
3065878|NCT01294319|3786329|FG000|COMPLETED|Overall Study||4
3065879|NCT01294319|3786330|FG001|COMPLETED|Overall Study||6
3065880|NCT01294319|3786331|FG002|COMPLETED|Overall Study||5
3065881|NCT01294319|3786332|FG003|COMPLETED|Overall Study||5
3065882|NCT01294319|3786333|FG004|COMPLETED|Overall Study||5
3065883|NCT01294319|3786334|FG005|COMPLETED|Overall Study||4
3065884|NCT01294319|3786335|FG006|COMPLETED|Overall Study||5
3065885|NCT01294319|3786336|FG007|COMPLETED|Overall Study||5
3065886|NCT01294319|3786329|FG000|NOT COMPLETED|Overall Study||0
3065887|NCT01294319|3786330|FG001|NOT COMPLETED|Overall Study||0
3065888|NCT01294319|3786331|FG002|NOT COMPLETED|Overall Study||0
3065889|NCT01294319|3786332|FG003|NOT COMPLETED|Overall Study||0
3065890|NCT01294319|3786333|FG004|NOT COMPLETED|Overall Study||0
3065891|NCT01294319|3786334|FG005|NOT COMPLETED|Overall Study||0
3065892|NCT01294319|3786335|FG006|NOT COMPLETED|Overall Study||0
3065893|NCT01294319|3786336|FG007|NOT COMPLETED|Overall Study||0
3065894|NCT01294358|3786343|FG000|STARTED|Cohort 1: 5/11/11-11/9/11||4
3065895|NCT01294358|3786344|FG001|STARTED|Cohort 1: 5/11/11-11/9/11||0
3065896|NCT01294358|3786345|FG002|STARTED|Cohort 1: 5/11/11-11/9/11||0
3065897|NCT01294358|3786346|FG003|STARTED|Cohort 1: 5/11/11-11/9/11||0
3065898|NCT01294358|3786347|FG004|STARTED|Cohort 1: 5/11/11-11/9/11||0
3065899|NCT01294358|3786343|FG000|COMPLETED|Cohort 1: 5/11/11-11/9/11||4
3065900|NCT01294358|3786344|FG001|COMPLETED|Cohort 1: 5/11/11-11/9/11||0
3065901|NCT01294358|3786345|FG002|COMPLETED|Cohort 1: 5/11/11-11/9/11||0
3065902|NCT01294358|3786346|FG003|COMPLETED|Cohort 1: 5/11/11-11/9/11||0
3065903|NCT01294358|3786347|FG004|COMPLETED|Cohort 1: 5/11/11-11/9/11||0
3065904|NCT01294358|3786343|FG000|NOT COMPLETED|Cohort 1: 5/11/11-11/9/11||0
3065905|NCT01294358|3786344|FG001|NOT COMPLETED|Cohort 1: 5/11/11-11/9/11||0
3065906|NCT01294358|3786345|FG002|NOT COMPLETED|Cohort 1: 5/11/11-11/9/11||0
3065907|NCT01294358|3786346|FG003|NOT COMPLETED|Cohort 1: 5/11/11-11/9/11||0
3065908|NCT01294358|3786347|FG004|NOT COMPLETED|Cohort 1: 5/11/11-11/9/11||0
3065909|NCT01294358|3786343|FG000|STARTED|Cohort 2: 6/9/11-9/17/12||0
3065910|NCT01294358|3786344|FG001|STARTED|Cohort 2: 6/9/11-9/17/12|4 participants from 18mg move to 36mg and 2 additional participants were enrolled at this dose.|6
3065911|NCT01294358|3786345|FG002|STARTED|Cohort 2: 6/9/11-9/17/12||0
3065912|NCT01294358|3786346|FG003|STARTED|Cohort 2: 6/9/11-9/17/12||0
3065913|NCT01294358|3786347|FG004|STARTED|Cohort 2: 6/9/11-9/17/12||0
3065914|NCT01294358|3786343|FG000|COMPLETED|Cohort 2: 6/9/11-9/17/12||0
3065915|NCT01294358|3786344|FG001|COMPLETED|Cohort 2: 6/9/11-9/17/12||4
3065916|NCT01294358|3786345|FG002|COMPLETED|Cohort 2: 6/9/11-9/17/12||0
3065917|NCT01294358|3786346|FG003|COMPLETED|Cohort 2: 6/9/11-9/17/12||0
3065918|NCT01294358|3786347|FG004|COMPLETED|Cohort 2: 6/9/11-9/17/12||0
3065919|NCT01294358|3786343|FG000|NOT COMPLETED|Cohort 2: 6/9/11-9/17/12||0
3065920|NCT01294358|3786344|FG001|NOT COMPLETED|Cohort 2: 6/9/11-9/17/12||2
3065921|NCT01294358|3786345|FG002|NOT COMPLETED|Cohort 2: 6/9/11-9/17/12||0
3065922|NCT01294358|3786346|FG003|NOT COMPLETED|Cohort 2: 6/9/11-9/17/12||0
3065923|NCT01294358|3786347|FG004|NOT COMPLETED|Cohort 2: 6/9/11-9/17/12||0
3065924|NCT01294358|3786343|FG000|STARTED|Cohort 3: 12/1/11-10/6/12||0
3065925|NCT01294358|3786344|FG001|STARTED|Cohort 3: 12/1/11-10/6/12||0
3065926|NCT01294358|3786345|FG002|STARTED|Cohort 3: 12/1/11-10/6/12|4 participants from 36mg move to 72mg.|4
3065927|NCT01294358|3786346|FG003|STARTED|Cohort 3: 12/1/11-10/6/12||0
3065928|NCT01294358|3786347|FG004|STARTED|Cohort 3: 12/1/11-10/6/12||0
3065929|NCT01294358|3786343|FG000|COMPLETED|Cohort 3: 12/1/11-10/6/12||0
3065930|NCT01294358|3786344|FG001|COMPLETED|Cohort 3: 12/1/11-10/6/12||0
3065931|NCT01294358|3786345|FG002|COMPLETED|Cohort 3: 12/1/11-10/6/12||2
3065932|NCT01294358|3786346|FG003|COMPLETED|Cohort 3: 12/1/11-10/6/12||0
3065933|NCT01294358|3786347|FG004|COMPLETED|Cohort 3: 12/1/11-10/6/12||0
3065934|NCT01294358|3786343|FG000|NOT COMPLETED|Cohort 3: 12/1/11-10/6/12||0
3284206|NCT02762331|4017981|FG001|STARTED|Overall Study||2
3284207|NCT02762331|4017980|FG000|COMPLETED|Overall Study||4
3284208|NCT02762331|4017981|FG001|COMPLETED|Overall Study||2
3284209|NCT02762331|4017980|FG000|NOT COMPLETED|Overall Study||0
3065935|NCT01294358|3786344|FG001|NOT COMPLETED|Cohort 3: 12/1/11-10/6/12||0
3065936|NCT01294358|3786345|FG002|NOT COMPLETED|Cohort 3: 12/1/11-10/6/12||2
3065937|NCT01294358|3786346|FG003|NOT COMPLETED|Cohort 3: 12/1/11-10/6/12||0
3065938|NCT01294358|3786347|FG004|NOT COMPLETED|Cohort 3: 12/1/11-10/6/12||0
3065939|NCT01294358|3786343|FG000|STARTED|Cohort 4: 12/30/11-2/17/17||0
3065940|NCT01294358|3786344|FG001|STARTED|Cohort 4: 12/30/11-2/17/17||0
3065941|NCT01294358|3786345|FG002|STARTED|Cohort 4: 12/30/11-2/17/17||0
3065942|NCT01294358|3786346|FG003|STARTED|Cohort 4: 12/30/11-2/17/17|2 participants from 72mg move to 96mg.|2
3065943|NCT01294358|3786347|FG004|STARTED|Cohort 4: 12/30/11-2/17/17||0
3065944|NCT01294358|3786343|FG000|COMPLETED|Cohort 4: 12/30/11-2/17/17||0
3065945|NCT01294358|3786344|FG001|COMPLETED|Cohort 4: 12/30/11-2/17/17||0
3065946|NCT01294358|3786345|FG002|COMPLETED|Cohort 4: 12/30/11-2/17/17||0
3065947|NCT01294358|3786346|FG003|COMPLETED|Cohort 4: 12/30/11-2/17/17||1
3065948|NCT01294358|3786347|FG004|COMPLETED|Cohort 4: 12/30/11-2/17/17||0
3065949|NCT01294358|3786343|FG000|NOT COMPLETED|Cohort 4: 12/30/11-2/17/17||0
3065950|NCT01294358|3786344|FG001|NOT COMPLETED|Cohort 4: 12/30/11-2/17/17||0
3065951|NCT01294358|3786345|FG002|NOT COMPLETED|Cohort 4: 12/30/11-2/17/17||0
3065952|NCT01294358|3786346|FG003|NOT COMPLETED|Cohort 4: 12/30/11-2/17/17||1
3065953|NCT01294358|3786347|FG004|NOT COMPLETED|Cohort 4: 12/30/11-2/17/17||0
3065954|NCT01294358|3786343|FG000|STARTED|Cohort 5: 3/8/12-3/9/12||0
3065955|NCT01294358|3786344|FG001|STARTED|Cohort 5: 3/8/12-3/9/12||0
3065956|NCT01294358|3786345|FG002|STARTED|Cohort 5: 3/8/12-3/9/12||0
3065957|NCT01294358|3786346|FG003|STARTED|Cohort 5: 3/8/12-3/9/12||0
3284210|NCT02762331|4017981|FG001|NOT COMPLETED|Overall Study||0
3065958|NCT01294358|3786347|FG004|STARTED|Cohort 5: 3/8/12-3/9/12|1 participant from 96mg move to 115mg.|1
3065959|NCT01294358|3786343|FG000|COMPLETED|Cohort 5: 3/8/12-3/9/12||0
3065960|NCT01294358|3786344|FG001|COMPLETED|Cohort 5: 3/8/12-3/9/12||0
3065961|NCT01294358|3786345|FG002|COMPLETED|Cohort 5: 3/8/12-3/9/12||0
3065962|NCT01294358|3786346|FG003|COMPLETED|Cohort 5: 3/8/12-3/9/12||0
3065963|NCT01294358|3786347|FG004|COMPLETED|Cohort 5: 3/8/12-3/9/12||0
3065964|NCT01294358|3786343|FG000|NOT COMPLETED|Cohort 5: 3/8/12-3/9/12||0
3065965|NCT01294358|3786344|FG001|NOT COMPLETED|Cohort 5: 3/8/12-3/9/12||0
3065966|NCT01294358|3786345|FG002|NOT COMPLETED|Cohort 5: 3/8/12-3/9/12||0
3065967|NCT01294358|3786346|FG003|NOT COMPLETED|Cohort 5: 3/8/12-3/9/12||0
3065968|NCT01294358|3786347|FG004|NOT COMPLETED|Cohort 5: 3/8/12-3/9/12||1
3065969|NCT01294371|3786364|FG000|STARTED|Overall Study||391
3065970|NCT01294371|3786364|FG000|Treated|Overall Study||390
3065971|NCT01294371|3786364|FG000|COMPLETED|Overall Study||357
3065972|NCT01294371|3786364|FG000|NOT COMPLETED|Overall Study||34
3065973|NCT01294384|3786374|FG000|STARTED|Overall Study||101
3065974|NCT01294384|3786375|FG001|STARTED|Overall Study||100
3065975|NCT01294384|3786376|FG002|STARTED|Overall Study||104
3065976|NCT01294384|3786374|FG000|COMPLETED|Overall Study||97
3065977|NCT01294384|3786375|FG001|COMPLETED|Overall Study||94
3065978|NCT01294384|3786376|FG002|COMPLETED|Overall Study||95
3065979|NCT01294384|3786374|FG000|NOT COMPLETED|Overall Study||4
3065980|NCT01294384|3786375|FG001|NOT COMPLETED|Overall Study||6
3065981|NCT01294384|3786376|FG002|NOT COMPLETED|Overall Study||9
3065982|NCT01294397|3786384|FG000|STARTED|Overall Study||19
3065983|NCT01294397|3786384|FG000|COMPLETED|Overall Study||17
3065984|NCT01294397|3786384|FG000|NOT COMPLETED|Overall Study||2
3065985|NCT01294423|3786393|FG000|STARTED|Overall Study||86
3065986|NCT01294423|3786394|FG001|STARTED|Overall Study||88
3065987|NCT01294423|3786395|FG002|STARTED|Overall Study||87
3065988|NCT01294423|3786393|FG000|COMPLETED|Overall Study||81
3065989|NCT01294423|3786394|FG001|COMPLETED|Overall Study||79
3065990|NCT01294423|3786395|FG002|COMPLETED|Overall Study||79
3065991|NCT01294423|3786393|FG000|NOT COMPLETED|Overall Study||5
3065992|NCT01294423|3786394|FG001|NOT COMPLETED|Overall Study||9
3065993|NCT01294423|3786395|FG002|NOT COMPLETED|Overall Study||8
3065994|NCT01294436|3786405|FG000|STARTED|Overall Study||249
3065995|NCT01294436|3786406|FG001|STARTED|Overall Study||479
3065996|NCT01294436|3786405|FG000|COMPLETED|Overall Study||221
3065997|NCT01294436|3786406|FG001|COMPLETED|Overall Study||409
3065998|NCT01294436|3786405|FG000|NOT COMPLETED|Overall Study||28
3065999|NCT01294436|3786406|FG001|NOT COMPLETED|Overall Study||70
3066000|NCT01294449|3786414|FG000|STARTED|Overall Study||156
3066001|NCT01294449|3786415|FG001|STARTED|Overall Study||252
3066002|NCT01294449|3786414|FG000|Consent to Registry|Overall Study||149
3066003|NCT01294449|3786415|FG001|Consent to Registry|Overall Study||245
3066004|NCT01294449|3786414|FG000|COMPLETED|Overall Study||144
3066005|NCT01294449|3786415|FG001|COMPLETED|Overall Study||237
3066006|NCT01294449|3786414|FG000|NOT COMPLETED|Overall Study||12
3066007|NCT01294449|3786415|FG001|NOT COMPLETED|Overall Study||15
3066008|NCT01294462|3786423|FG000|STARTED|Overall Study||401
3066009|NCT01294462|3786424|FG001|STARTED|Overall Study||400
3066010|NCT01294462|3786423|FG000|Received Randomized Treatment|Overall Study||387
3066011|NCT01294462|3786424|FG001|Received Randomized Treatment|Overall Study||380
3066012|NCT01294462|3786423|FG000|COMPLETED|Overall Study||335
3066013|NCT01294462|3786424|FG001|COMPLETED|Overall Study||337
3066014|NCT01294462|3786423|FG000|NOT COMPLETED|Overall Study||66
3066015|NCT01294462|3786424|FG001|NOT COMPLETED|Overall Study||63
3066016|NCT01294514|3786430|FG000|STARTED|Overall Study||27
3066017|NCT01294514|3786430|FG000|COMPLETED|Overall Study||26
3066018|NCT01294514|3786430|FG000|NOT COMPLETED|Overall Study||1
3066019|NCT01294553|3786438|FG000|STARTED|Overall Study||982
3066020|NCT01294553|3786438|FG000|COMPLETED|Overall Study||713
3066021|NCT01294553|3786438|FG000|NOT COMPLETED|Overall Study||269
3066022|NCT01294579|3786443|FG000|STARTED|Overall Study||49
3066023|NCT01294579|3786443|FG000|COMPLETED|Overall Study||14
3066024|NCT01294579|3786443|FG000|NOT COMPLETED|Overall Study||35
3066025|NCT01294592|3786449|FG000|STARTED|Overall Study||369
3066026|NCT01294592|3786450|FG001|STARTED|Overall Study||373
3066027|NCT01294592|3786449|FG000|COMPLETED|Overall Study||292
3066028|NCT01294592|3786450|FG001|COMPLETED|Overall Study||300
3066029|NCT01294592|3786449|FG000|NOT COMPLETED|Overall Study||77
3066030|NCT01294592|3786450|FG001|NOT COMPLETED|Overall Study||73
3066031|NCT01294644|3786462|FG000|STARTED|Overall Study||121
3066032|NCT01294644|3786463|FG001|STARTED|Overall Study||122
3066033|NCT01294644|3786464|FG002|STARTED|Overall Study||117
3066034|NCT01294644|3786462|FG000|Received Treatment|Overall Study||118
3066035|NCT01294644|3786463|FG001|Received Treatment|Overall Study||122
3066036|NCT01294644|3786464|FG002|Received Treatment|Overall Study||114
3066037|NCT01294644|3786462|FG000|COMPLETED|Overall Study||111
3066038|NCT01294644|3786463|FG001|COMPLETED|Overall Study||112
3066039|NCT01294644|3786464|FG002|COMPLETED|Overall Study||103
3066040|NCT01294644|3786462|FG000|NOT COMPLETED|Overall Study||10
3066041|NCT01294644|3786463|FG001|NOT COMPLETED|Overall Study||10
3066042|NCT01294644|3786464|FG002|NOT COMPLETED|Overall Study||14
3066043|NCT01294683|3786474|FG000|STARTED|Precrossover (Periods I/II)||489
3066044|NCT01294683|3786475|FG001|STARTED|Precrossover (Periods I/II)||488
3066045|NCT01294683|3786474|FG000|Treated|Precrossover (Periods I/II)||486
3066046|NCT01294683|3786475|FG001|Treated|Precrossover (Periods I/II)||486
3066047|NCT01294683|3786474|FG000|COMPLETED|Precrossover (Periods I/II)||232
3066048|NCT01294683|3786475|FG001|COMPLETED|Precrossover (Periods I/II)||222
3066049|NCT01294683|3786474|FG000|NOT COMPLETED|Precrossover (Periods I/II)||257
3066050|NCT01294683|3786475|FG001|NOT COMPLETED|Precrossover (Periods I/II)||266
3066051|NCT01294683|3786474|FG000|STARTED|Post Crossover (Period III)||232
3066052|NCT01294683|3786475|FG001|STARTED|Post Crossover (Period III)||222
3066053|NCT01294683|3786474|FG000|COMPLETED|Post Crossover (Period III)||199
3066054|NCT01294683|3786475|FG001|COMPLETED|Post Crossover (Period III)||190
3066055|NCT01294683|3786474|FG000|NOT COMPLETED|Post Crossover (Period III)||33
3066056|NCT01294683|3786475|FG001|NOT COMPLETED|Post Crossover (Period III)||32
3066057|NCT01294709|3786487|FG000|STARTED|Period 1||31
3066058|NCT01294709|3786488|FG001|STARTED|Period 1||33
3066059|NCT01294709|3786487|FG000|COMPLETED|Period 1||30
3066060|NCT01294709|3786488|FG001|COMPLETED|Period 1||32
3066061|NCT01294709|3786487|FG000|NOT COMPLETED|Period 1||1
3066062|NCT01294709|3786488|FG001|NOT COMPLETED|Period 1||1
3066063|NCT01294709|3786487|FG000|STARTED|Washout Period||30
3066064|NCT01294709|3786488|FG001|STARTED|Washout Period||32
3066065|NCT01294709|3786487|FG000|COMPLETED|Washout Period||29
3066066|NCT01294709|3786488|FG001|COMPLETED|Washout Period||31
3066067|NCT01294709|3786487|FG000|NOT COMPLETED|Washout Period||1
3066068|NCT01294709|3786488|FG001|NOT COMPLETED|Washout Period||1
3066069|NCT01294709|3786487|FG000|STARTED|Period 2||29
3066070|NCT01294709|3786488|FG001|STARTED|Period 2||31
3066071|NCT01294709|3786487|FG000|COMPLETED|Period 2||28
3066072|NCT01294709|3786488|FG001|COMPLETED|Period 2||31
3066073|NCT01294709|3786487|FG000|NOT COMPLETED|Period 2||1
3066074|NCT01294709|3786488|FG001|NOT COMPLETED|Period 2||0
3066075|NCT01294748|3786501|FG000|STARTED|Overall Study||123
3066076|NCT01294748|3786502|FG001|STARTED|Overall Study||61
3066077|NCT01294748|3786501|FG000|COMPLETED|Overall Study|At 270 days|118
3066078|NCT01294748|3786502|FG001|COMPLETED|Overall Study|At 270 days|59
3066079|NCT01294748|3786501|FG000|NOT COMPLETED|Overall Study||5
3066080|NCT01294748|3786502|FG001|NOT COMPLETED|Overall Study||2
3066081|NCT01294787|3786508|FG000|STARTED|Period 1||12
3066082|NCT01294787|3786509|FG001|STARTED|Period 1||16
3066083|NCT01294787|3786510|FG002|STARTED|Period 1||14
3066084|NCT01294787|3786511|FG003|STARTED|Period 1||12
3066085|NCT01294787|3786512|FG004|STARTED|Period 1||16
3066086|NCT01294787|3786513|FG005|STARTED|Period 1|One randomized participant did not receive study drug|15
3066087|NCT01294787|3786508|FG000|COMPLETED|Period 1||12
3066088|NCT01294787|3786509|FG001|COMPLETED|Period 1||16
3066089|NCT01294787|3786510|FG002|COMPLETED|Period 1||13
3066090|NCT01294787|3786511|FG003|COMPLETED|Period 1||11
3066091|NCT01294787|3786512|FG004|COMPLETED|Period 1||14
3066092|NCT01294787|3786513|FG005|COMPLETED|Period 1||13
3066093|NCT01294787|3786508|FG000|NOT COMPLETED|Period 1||0
3066094|NCT01294787|3786509|FG001|NOT COMPLETED|Period 1||0
3066095|NCT01294787|3786510|FG002|NOT COMPLETED|Period 1||1
3066096|NCT01294787|3786511|FG003|NOT COMPLETED|Period 1||1
3066097|NCT01294787|3786512|FG004|NOT COMPLETED|Period 1||2
3066098|NCT01294787|3786513|FG005|NOT COMPLETED|Period 1||2
3066099|NCT01294787|3786508|FG000|STARTED|Period 2||12
3066100|NCT01294787|3786509|FG001|STARTED|Period 2||16
3066101|NCT01294787|3786510|FG002|STARTED|Period 2||13
3066102|NCT01294787|3786511|FG003|STARTED|Period 2||11
3066103|NCT01294787|3786512|FG004|STARTED|Period 2||14
3066104|NCT01294787|3786513|FG005|STARTED|Period 2||13
3066105|NCT01294787|3786508|FG000|COMPLETED|Period 2||12
3066106|NCT01294787|3786509|FG001|COMPLETED|Period 2||13
3066107|NCT01294787|3786510|FG002|COMPLETED|Period 2||13
3066108|NCT01294787|3786511|FG003|COMPLETED|Period 2||9
3066109|NCT01294787|3786512|FG004|COMPLETED|Period 2||14
3066110|NCT01294787|3786513|FG005|COMPLETED|Period 2||13
3066111|NCT01294787|3786508|FG000|NOT COMPLETED|Period 2||0
3066112|NCT01294787|3786509|FG001|NOT COMPLETED|Period 2||3
3066113|NCT01294787|3786510|FG002|NOT COMPLETED|Period 2||0
3066114|NCT01294787|3786511|FG003|NOT COMPLETED|Period 2||2
3066115|NCT01294787|3786512|FG004|NOT COMPLETED|Period 2||0
3066116|NCT01294787|3786513|FG005|NOT COMPLETED|Period 2||0
3066117|NCT01294787|3786508|FG000|STARTED|Period 3||12
3066118|NCT01294787|3786509|FG001|STARTED|Period 3||13
3066119|NCT01294787|3786510|FG002|STARTED|Period 3||13
3066120|NCT01294787|3786511|FG003|STARTED|Period 3||9
3066121|NCT01294787|3786512|FG004|STARTED|Period 3||14
3066122|NCT01294787|3786513|FG005|STARTED|Period 3||13
3066123|NCT01294787|3786508|FG000|COMPLETED|Period 3||12
3066124|NCT01294787|3786509|FG001|COMPLETED|Period 3||13
3066125|NCT01294787|3786510|FG002|COMPLETED|Period 3||13
3066126|NCT01294787|3786511|FG003|COMPLETED|Period 3||9
3066127|NCT01294787|3786512|FG004|COMPLETED|Period 3||13
3066128|NCT01294787|3786513|FG005|COMPLETED|Period 3||13
3066129|NCT01294787|3786508|FG000|NOT COMPLETED|Period 3||0
3066130|NCT01294787|3786509|FG001|NOT COMPLETED|Period 3||0
3066131|NCT01294787|3786510|FG002|NOT COMPLETED|Period 3||0
3066132|NCT01294787|3786511|FG003|NOT COMPLETED|Period 3||0
3066133|NCT01294787|3786512|FG004|NOT COMPLETED|Period 3||1
3066134|NCT01294787|3786513|FG005|NOT COMPLETED|Period 3||0
3066135|NCT01294800|3786528|FG000|STARTED|Overall Study||111
3066136|NCT01294800|3786529|FG001|STARTED|Overall Study||113
3066137|NCT01294800|3786530|FG002|STARTED|Overall Study||113
3066138|NCT01294800|3786531|FG003|STARTED|Overall Study||113
3066139|NCT01294800|3786528|FG000|COMPLETED|Overall Study||100
3066140|NCT01294800|3786529|FG001|COMPLETED|Overall Study||103
3066141|NCT01294800|3786530|FG002|COMPLETED|Overall Study||96
3066142|NCT01294800|3786531|FG003|COMPLETED|Overall Study||97
3066143|NCT01294800|3786528|FG000|NOT COMPLETED|Overall Study||11
3066144|NCT01294800|3786529|FG001|NOT COMPLETED|Overall Study||10
3066145|NCT01294800|3786530|FG002|NOT COMPLETED|Overall Study||17
3066146|NCT01294800|3786531|FG003|NOT COMPLETED|Overall Study||16
3066147|NCT01294917|3786541|FG000|STARTED|Overall Study||42
3066148|NCT01294917|3786541|FG000|Received Investigational MPS|Overall Study||36
3066149|NCT01294917|3786541|FG000|Received Clear Care|Overall Study||36
3066150|NCT01294917|3786541|FG000|Received OptiFree RepleniSH MPS|Overall Study||36
3066151|NCT01294917|3786541|FG000|COMPLETED|Overall Study||36
3066152|NCT01294917|3786541|FG000|NOT COMPLETED|Overall Study||6
3066153|NCT01295034|3786549|FG000|STARTED|Overall Study||32
3066154|NCT01295034|3786550|FG001|STARTED|Overall Study||30
3066155|NCT01295034|3786549|FG000|COMPLETED|Overall Study||27
3066156|NCT01295034|3786550|FG001|COMPLETED|Overall Study||25
3066157|NCT01295034|3786549|FG000|NOT COMPLETED|Overall Study||5
3066158|NCT01295034|3786550|FG001|NOT COMPLETED|Overall Study||5
3066159|NCT01295112|3786559|FG000|STARTED|Overall Study||35
3066160|NCT01295112|3786560|FG001|STARTED|Overall Study||33
3066161|NCT01295112|3786559|FG000|COMPLETED|Overall Study||35
3066162|NCT01295112|3786560|FG001|COMPLETED|Overall Study||33
3066163|NCT01295112|3786559|FG000|NOT COMPLETED|Overall Study||0
3066164|NCT01295112|3786560|FG001|NOT COMPLETED|Overall Study||0
3066165|NCT01295216|3786568|FG000|STARTED|Overall Study||316
3066166|NCT01295216|3786569|FG001|STARTED|Overall Study||321
3066167|NCT01295216|3786568|FG000|COMPLETED|Overall Study||266
3066168|NCT01295216|3786569|FG001|COMPLETED|Overall Study||287
3066169|NCT01295216|3786568|FG000|NOT COMPLETED|Overall Study||50
3066170|NCT01295216|3786569|FG001|NOT COMPLETED|Overall Study||34
3066171|NCT01295281|3786577|FG000|STARTED|First Intervention (7 Days)||53
3066172|NCT01295281|3786578|FG001|STARTED|First Intervention (7 Days)||52
3066173|NCT01295281|3786577|FG000|COMPLETED|First Intervention (7 Days)||53
3066174|NCT01295281|3786578|FG001|COMPLETED|First Intervention (7 Days)||51
3066175|NCT01295281|3786577|FG000|NOT COMPLETED|First Intervention (7 Days)||0
3066176|NCT01295281|3786578|FG001|NOT COMPLETED|First Intervention (7 Days)||1
3066177|NCT01295281|3786577|FG000|STARTED|Second Intervention (7days)||53
3066178|NCT01295281|3786578|FG001|STARTED|Second Intervention (7days)||51
3066179|NCT01295281|3786577|FG000|COMPLETED|Second Intervention (7days)||53
3066180|NCT01295281|3786578|FG001|COMPLETED|Second Intervention (7days)||51
3066181|NCT01295281|3786577|FG000|NOT COMPLETED|Second Intervention (7days)||0
3066182|NCT01295281|3786578|FG001|NOT COMPLETED|Second Intervention (7days)||0
3066183|NCT01295320|3786584|FG000|STARTED|Overall Study||129
3066184|NCT01295320|3786584|FG000|COMPLETED|Overall Study||119
3066185|NCT01295320|3786584|FG000|NOT COMPLETED|Overall Study||10
3066186|NCT01295515|3786588|FG000|STARTED|Overall Study||7
3066187|NCT01295515|3786588|FG000|COMPLETED|Overall Study||7
3066188|NCT01295515|3786588|FG000|NOT COMPLETED|Overall Study||0
3066189|NCT01295580|3786594|FG000|STARTED|Overall Study||174
3066190|NCT01295580|3786595|FG001|STARTED|Overall Study||175
3066191|NCT01295580|3786594|FG000|COMPLETED|Overall Study||164
3066192|NCT01295580|3786595|FG001|COMPLETED|Overall Study||167
3066193|NCT01295580|3786594|FG000|NOT COMPLETED|Overall Study||10
3066194|NCT01295580|3786595|FG001|NOT COMPLETED|Overall Study||8
3066195|NCT01295671|3786604|FG000|STARTED|Overall Study||67
3066196|NCT01295671|3786605|FG001|STARTED|Overall Study||67
3066197|NCT01295671|3786606|FG002|STARTED|Overall Study||69
3066198|NCT01295671|3786604|FG000|COMPLETED|Overall Study||60
3066199|NCT01295671|3786605|FG001|COMPLETED|Overall Study||60
3066200|NCT01295671|3786606|FG002|COMPLETED|Overall Study||66
3066201|NCT01295671|3786604|FG000|NOT COMPLETED|Overall Study||7
3066202|NCT01295671|3786605|FG001|NOT COMPLETED|Overall Study||7
3066203|NCT01295671|3786606|FG002|NOT COMPLETED|Overall Study||3
3066204|NCT01295710|3786616|FG000|STARTED|Overall Study|Randomized and treated|126
3066205|NCT01295710|3786617|FG001|STARTED|Overall Study|Randomized and treated|128
3066206|NCT01295710|3786616|FG000|COMPLETED|Overall Study||48
3066207|NCT01295710|3786617|FG001|COMPLETED|Overall Study||78
3066208|NCT01295710|3786616|FG000|NOT COMPLETED|Overall Study||78
3066209|NCT01295710|3786617|FG001|NOT COMPLETED|Overall Study||50
3066210|NCT01295814|3786625|FG000|STARTED|Overall Study||22
3066211|NCT01295814|3786626|FG001|STARTED|Overall Study||21
3066212|NCT01295814|3786625|FG000|COMPLETED|Overall Study||20
3066213|NCT01295814|3786626|FG001|COMPLETED|Overall Study||19
3066214|NCT01295814|3786625|FG000|NOT COMPLETED|Overall Study||2
3066215|NCT01295814|3786626|FG001|NOT COMPLETED|Overall Study||2
3066216|NCT01295827|3786644|FG000|STARTED|Overall Study||4
3066217|NCT01295827|3786645|FG001|STARTED|Overall Study||3
3066218|NCT01295827|3786646|FG002|STARTED|Overall Study||12
3066219|NCT01295827|3786647|FG003|STARTED|Overall Study||4
3066220|NCT01295827|3786648|FG004|STARTED|Overall Study||3
3066221|NCT01295827|3786649|FG005|STARTED|Overall Study||6
3066222|NCT01295827|3786650|FG006|STARTED|Overall Study||164
3066223|NCT01295827|3786651|FG007|STARTED|Overall Study||321
3066224|NCT01295827|3786652|FG008|STARTED|Overall Study||183
3066225|NCT01295827|3786653|FG009|STARTED|Overall Study||61
3066226|NCT01295827|3786654|FG010|STARTED|Overall Study||296
3066227|NCT01295827|3786655|FG011|STARTED|Overall Study||203
3066228|NCT01295827|3786656|FG012|STARTED|Overall Study||0
3066229|NCT01295827|3786657|FG013|STARTED|Overall Study||0
3066230|NCT01295827|3786658|FG014|STARTED|Overall Study||0
3066231|NCT01295827|3786644|FG000|Treated (All Treated Population)|Overall Study||4
3066232|NCT01295827|3786645|FG001|Treated (All Treated Population)|Overall Study||3
3066233|NCT01295827|3786646|FG002|Treated (All Treated Population)|Overall Study||10
3066234|NCT01295827|3786647|FG003|Treated (All Treated Population)|Overall Study||4
3066235|NCT01295827|3786648|FG004|Treated (All Treated Population)|Overall Study||3
3066236|NCT01295827|3786649|FG005|Treated (All Treated Population)|Overall Study||6
3066237|NCT01295827|3786650|FG006|Treated (All Treated Population)|Overall Study||162
3066238|NCT01295827|3786651|FG007|Treated (All Treated Population)|Overall Study||313
3066239|NCT01295827|3786652|FG008|Treated (All Treated Population)|Overall Study||180
3066240|NCT01295827|3786653|FG009|Treated (All Treated Population)|Overall Study||61
3066241|NCT01295827|3786654|FG010|Treated (All Treated Population)|Overall Study||287
3066242|NCT01295827|3786655|FG011|Treated (All Treated Population)|Overall Study||202
3066243|NCT01295827|3786656|FG012|Treated (All Treated Population)|Overall Study||0
3162991|NCT01882439|3890473|FG000|NOT COMPLETED|Overall Study||9
3162992|NCT01882439|3890474|FG001|NOT COMPLETED|Overall Study||21
3162993|NCT01882439|3890475|FG002|NOT COMPLETED|Overall Study||10
3162994|NCT01882439|3890476|FG003|NOT COMPLETED|Overall Study||9
3162995|NCT01882465|3890491|FG000|STARTED|Period 1||6
3066244|NCT01295827|3786657|FG013|Treated (All Treated Population)|Overall Study||0
3066245|NCT01295827|3786658|FG014|Treated (All Treated Population)|Overall Study||0
3066246|NCT01295827|3786644|FG000|COMPLETED|Overall Study||0
3066247|NCT01295827|3786645|FG001|COMPLETED|Overall Study||0
3066248|NCT01295827|3786646|FG002|COMPLETED|Overall Study||0
3066249|NCT01295827|3786647|FG003|COMPLETED|Overall Study||0
3066250|NCT01295827|3786648|FG004|COMPLETED|Overall Study||1
3066251|NCT01295827|3786649|FG005|COMPLETED|Overall Study||0
3066252|NCT01295827|3786650|FG006|COMPLETED|Overall Study||18
3066253|NCT01295827|3786651|FG007|COMPLETED|Overall Study||24
3066254|NCT01295827|3786652|FG008|COMPLETED|Overall Study||14
3066255|NCT01295827|3786653|FG009|COMPLETED|Overall Study||6
3066256|NCT01295827|3786654|FG010|COMPLETED|Overall Study||20
3066257|NCT01295827|3786655|FG011|COMPLETED|Overall Study||17
3066258|NCT01295827|3786656|FG012|COMPLETED|Overall Study||0
3066259|NCT01295827|3786657|FG013|COMPLETED|Overall Study||0
3066260|NCT01295827|3786658|FG014|COMPLETED|Overall Study||0
3066261|NCT01295827|3786644|FG000|NOT COMPLETED|Overall Study||4
3066262|NCT01295827|3786645|FG001|NOT COMPLETED|Overall Study||3
3066263|NCT01295827|3786646|FG002|NOT COMPLETED|Overall Study||12
3066264|NCT01295827|3786647|FG003|NOT COMPLETED|Overall Study||4
3066265|NCT01295827|3786648|FG004|NOT COMPLETED|Overall Study||2
3066266|NCT01295827|3786649|FG005|NOT COMPLETED|Overall Study||6
3066267|NCT01295827|3786650|FG006|NOT COMPLETED|Overall Study||146
3066268|NCT01295827|3786651|FG007|NOT COMPLETED|Overall Study||297
3066269|NCT01295827|3786652|FG008|NOT COMPLETED|Overall Study||169
3066270|NCT01295827|3786653|FG009|NOT COMPLETED|Overall Study||55
3066271|NCT01295827|3786654|FG010|NOT COMPLETED|Overall Study||276
3066272|NCT01295827|3786655|FG011|NOT COMPLETED|Overall Study||186
3066273|NCT01295827|3786656|FG012|NOT COMPLETED|Overall Study||0
3066274|NCT01295827|3786657|FG013|NOT COMPLETED|Overall Study||0
3066275|NCT01295827|3786658|FG014|NOT COMPLETED|Overall Study||0
3066276|NCT01295840|3786711|FG000|STARTED|Overall Study||51
3066277|NCT01295840|3786711|FG000|COMPLETED|Overall Study||50
3066278|NCT01295840|3786711|FG000|NOT COMPLETED|Overall Study||1
3066279|NCT01295879|3786717|FG000|STARTED|Overall Study||29
3066280|NCT01295879|3786717|FG000|COMPLETED|Overall Study||29
3066281|NCT01295879|3786717|FG000|NOT COMPLETED|Overall Study||0
3066282|NCT01295905|3786723|FG000|STARTED|Overall Study||60
3066283|NCT01295905|3786724|FG001|STARTED|Overall Study||30
3066284|NCT01295905|3786723|FG000|COMPLETED|Overall Study||58
3066285|NCT01295905|3786724|FG001|COMPLETED|Overall Study||30
3066286|NCT01295905|3786723|FG000|NOT COMPLETED|Overall Study||2
3066287|NCT01295905|3786724|FG001|NOT COMPLETED|Overall Study||0
3066288|NCT01296035|3786730|FG000|STARTED|Overall Study||8
3066289|NCT01296035|3786730|FG000|COMPLETED|Overall Study||7
3066290|NCT01296035|3786730|FG000|NOT COMPLETED|Overall Study||1
3066291|NCT01296152|3786734|FG000|STARTED|Overall Study||25
3066292|NCT01296152|3786734|FG000|COMPLETED|Overall Study||24
3066293|NCT01296152|3786734|FG000|NOT COMPLETED|Overall Study||1
3066294|NCT01296191|3786740|FG000|STARTED|Overall Study||60
3066295|NCT01296191|3786741|FG001|STARTED|Overall Study||60
3066296|NCT01296191|3786740|FG000|COMPLETED|Overall Study||57
3066297|NCT01296191|3786741|FG001|COMPLETED|Overall Study||59
3066298|NCT01296191|3786740|FG000|NOT COMPLETED|Overall Study||3
3066299|NCT01296191|3786741|FG001|NOT COMPLETED|Overall Study||1
3066300|NCT01296347|3786749|FG000|STARTED|Allocation||38
3066301|NCT01296347|3786750|FG001|STARTED|Allocation||39
3066302|NCT01296347|3786749|FG000|COMPLETED|Allocation||35
3066303|NCT01296347|3786750|FG001|COMPLETED|Allocation||35
3066304|NCT01296347|3786749|FG000|NOT COMPLETED|Allocation||3
3066305|NCT01296347|3786750|FG001|NOT COMPLETED|Allocation||4
3066306|NCT01296347|3786749|FG000|STARTED|6 Week Follow up||35
3066307|NCT01296347|3786750|FG001|STARTED|6 Week Follow up||35
3066308|NCT01296347|3786749|FG000|COMPLETED|6 Week Follow up||35
3066309|NCT01296347|3786750|FG001|COMPLETED|6 Week Follow up||34
3066310|NCT01296347|3786749|FG000|NOT COMPLETED|6 Week Follow up||0
3066311|NCT01296347|3786750|FG001|NOT COMPLETED|6 Week Follow up||1
3066312|NCT01296347|3786749|FG000|STARTED|3 Month Follow up||35
3066313|NCT01296347|3786750|FG001|STARTED|3 Month Follow up||34
3066314|NCT01296347|3786749|FG000|COMPLETED|3 Month Follow up||34
3066315|NCT01296347|3786750|FG001|COMPLETED|3 Month Follow up||33
3066316|NCT01296347|3786749|FG000|NOT COMPLETED|3 Month Follow up||1
3066317|NCT01296347|3786750|FG001|NOT COMPLETED|3 Month Follow up||1
3162996|NCT01882465|3890492|FG001|STARTED|Period 1||6
3066318|NCT01296347|3786749|FG000|STARTED|6 Month Follow up||34
3066319|NCT01296347|3786750|FG001|STARTED|6 Month Follow up||33
3066320|NCT01296347|3786749|FG000|COMPLETED|6 Month Follow up||32
3066321|NCT01296347|3786750|FG001|COMPLETED|6 Month Follow up||31
3066322|NCT01296347|3786749|FG000|NOT COMPLETED|6 Month Follow up||2
3066323|NCT01296347|3786750|FG001|NOT COMPLETED|6 Month Follow up||2
3066324|NCT01296347|3786749|FG000|STARTED|12 Month Follow up||32
3066325|NCT01296347|3786750|FG001|STARTED|12 Month Follow up||31
3066326|NCT01296347|3786749|FG000|COMPLETED|12 Month Follow up||28
3066327|NCT01296347|3786750|FG001|COMPLETED|12 Month Follow up||28
3066328|NCT01296347|3786749|FG000|NOT COMPLETED|12 Month Follow up||4
3066329|NCT01296347|3786750|FG001|NOT COMPLETED|12 Month Follow up||3
3066330|NCT01296360|3786761|FG000|STARTED|Overall Study||150
3066331|NCT01296360|3786762|FG001|STARTED|Overall Study||150
3066332|NCT01296360|3786761|FG000|Visit 2 (Month 12)|Overall Study|booster was administered|148
3066333|NCT01296360|3786762|FG001|Visit 2 (Month 12)|Overall Study||149
3066334|NCT01296360|3786761|FG000|Visit 2a (Month 13)|Overall Study|visit in Booster Group only: ~13 months after immunization in IC51-323 (i.e., 1 month post booster)|148
3066335|NCT01296360|3786762|FG001|Visit 2a (Month 13)|Overall Study||0
3066336|NCT01296360|3786761|FG000|COMPLETED|Overall Study||144
3066337|NCT01296360|3786762|FG001|COMPLETED|Overall Study||142
3066338|NCT01296360|3786761|FG000|NOT COMPLETED|Overall Study||6
3066339|NCT01296360|3786762|FG001|NOT COMPLETED|Overall Study||8
3066340|NCT01296412|3786770|FG000|STARTED|Overall Study||326
3066341|NCT01296412|3786771|FG001|STARTED|Overall Study||327
3066342|NCT01296412|3786770|FG000|COMPLETED|Overall Study||275
3066343|NCT01296412|3786771|FG001|COMPLETED|Overall Study||257
3066344|NCT01296412|3786770|FG000|NOT COMPLETED|Overall Study||51
3066345|NCT01296412|3786771|FG001|NOT COMPLETED|Overall Study||70
3066346|NCT01296542|3786779|FG000|STARTED|Overall Study||30
3066347|NCT01296542|3786780|FG001|STARTED|Overall Study||30
3066348|NCT01296542|3786779|FG000|COMPLETED|Overall Study||30
3066349|NCT01296542|3786780|FG001|COMPLETED|Overall Study||28
3066350|NCT01296542|3786779|FG000|NOT COMPLETED|Overall Study||0
3066351|NCT01296542|3786780|FG001|NOT COMPLETED|Overall Study||2
3066352|NCT01296568|3786786|FG000|STARTED|[^14C]LY2603618 Single Dose and Washout||3
3066353|NCT01296568|3786786|FG000|COMPLETED|[^14C]LY2603618 Single Dose and Washout||3
3066354|NCT01296568|3786786|FG000|NOT COMPLETED|[^14C]LY2603618 Single Dose and Washout||0
3066355|NCT01296568|3786786|FG000|STARTED|Continued Access Phase||3
3066356|NCT01296568|3786786|FG000|COMPLETED|Continued Access Phase|After study discontinuation participants assessed for disease progression (21-day safety follow-up).|0
3066357|NCT01296568|3786786|FG000|NOT COMPLETED|Continued Access Phase||3
3066358|NCT01296646|3786794|FG000|STARTED|Overall Study||40
3066359|NCT01296646|3786795|FG001|STARTED|Overall Study||40
3066360|NCT01296646|3786794|FG000|COMPLETED|Overall Study||29
3066361|NCT01296646|3786795|FG001|COMPLETED|Overall Study||29
3066362|NCT01296646|3786794|FG000|NOT COMPLETED|Overall Study||11
3066363|NCT01296646|3786795|FG001|NOT COMPLETED|Overall Study||11
3066364|NCT01296672|3786803|FG000|STARTED|Overall Study||306
3066365|NCT01296672|3786804|FG001|STARTED|Overall Study||77
3066366|NCT01296672|3786803|FG000|COMPLETED|Overall Study||233
3066367|NCT01296672|3786804|FG001|COMPLETED|Overall Study||59
3284211|NCT02762370|4017989|FG000|STARTED|Overall Study||18
3284212|NCT02762370|4017990|FG001|STARTED|Overall Study||15
3284213|NCT02762370|4017989|FG000|COMPLETED|Overall Study||17
3284214|NCT02762370|4017990|FG001|COMPLETED|Overall Study||15
3284215|NCT02762370|4017989|FG000|NOT COMPLETED|Overall Study||1
3284216|NCT02762370|4017990|FG001|NOT COMPLETED|Overall Study||0
3284217|NCT02762500|4018000|FG000|STARTED|Overall Study||62
3284218|NCT02762500|4018001|FG001|STARTED|Overall Study||62
3284219|NCT02762500|4018000|FG000|COMPLETED|Overall Study||60
3284220|NCT02762500|4018001|FG001|COMPLETED|Overall Study||59
3066368|NCT01296672|3786803|FG000|NOT COMPLETED|Overall Study||73
3066369|NCT01296672|3786804|FG001|NOT COMPLETED|Overall Study||18
3066370|NCT01296698|3786814|FG000|STARTED|Overall Study||244
3066371|NCT01296698|3786815|FG001|STARTED|Overall Study||13
3066372|NCT01296698|3786814|FG000|COMPLETED|Overall Study||0
3066373|NCT01296698|3786815|FG001|COMPLETED|Overall Study||0
3066374|NCT01296698|3786814|FG000|NOT COMPLETED|Overall Study||244
3066375|NCT01296698|3786815|FG001|NOT COMPLETED|Overall Study||13
3066376|NCT01296763|3786824|FG000|STARTED|Overall Study||7
3066377|NCT01296763|3786825|FG001|STARTED|Overall Study||5
3066378|NCT01296763|3786826|FG002|STARTED|Overall Study||6
3066379|NCT01296763|3786824|FG000|COMPLETED|Overall Study||7
3066380|NCT01296763|3786825|FG001|COMPLETED|Overall Study||5
3066381|NCT01296763|3786826|FG002|COMPLETED|Overall Study||6
3066382|NCT01296763|3786824|FG000|NOT COMPLETED|Overall Study||0
3066383|NCT01296763|3786825|FG001|NOT COMPLETED|Overall Study||0
3066384|NCT01296763|3786826|FG002|NOT COMPLETED|Overall Study||0
3066385|NCT01296815|3786836|FG000|STARTED|Overall Study||7
3066386|NCT01296815|3786837|FG001|STARTED|Overall Study||7
3066387|NCT01296815|3786836|FG000|COMPLETED|Overall Study||7
3066388|NCT01296815|3786837|FG001|COMPLETED|Overall Study||7
3066389|NCT01296815|3786836|FG000|NOT COMPLETED|Overall Study||0
3066390|NCT01296815|3786837|FG001|NOT COMPLETED|Overall Study||0
3066391|NCT01296841|3786845|FG000|STARTED|Overall Study||19
3066392|NCT01296841|3786846|FG001|STARTED|Overall Study||15
3066393|NCT01296841|3786845|FG000|COMPLETED|Overall Study||19
3066394|NCT01296841|3786846|FG001|COMPLETED|Overall Study||15
3066395|NCT01296841|3786845|FG000|NOT COMPLETED|Overall Study||0
3284221|NCT02762500|4018000|FG000|NOT COMPLETED|Overall Study||2
3066396|NCT01296841|3786846|FG001|NOT COMPLETED|Overall Study||0
3066397|NCT01296932|3786863|FG000|STARTED|Overall Study||3
3066398|NCT01296932|3786864|FG001|STARTED|Overall Study||3
3066399|NCT01296932|3786865|FG002|STARTED|Overall Study||6
3066400|NCT01296932|3786866|FG003|STARTED|Overall Study||6
3066401|NCT01296932|3786867|FG004|STARTED|Overall Study||3
3066402|NCT01296932|3786868|FG005|STARTED|Overall Study||3
3066403|NCT01296932|3786869|FG006|STARTED|Overall Study||6
3066404|NCT01296932|3786870|FG007|STARTED|Overall Study||3
3066405|NCT01296932|3786871|FG008|STARTED|Overall Study||4
3066406|NCT01296932|3786863|FG000|COMPLETED|Overall Study||0
3066407|NCT01296932|3786864|FG001|COMPLETED|Overall Study||0
3066408|NCT01296932|3786865|FG002|COMPLETED|Overall Study||0
3066409|NCT01296932|3786866|FG003|COMPLETED|Overall Study||0
3066410|NCT01296932|3786867|FG004|COMPLETED|Overall Study||0
3066411|NCT01296932|3786868|FG005|COMPLETED|Overall Study||0
3066412|NCT01296932|3786869|FG006|COMPLETED|Overall Study||0
3066413|NCT01296932|3786870|FG007|COMPLETED|Overall Study||1
3066414|NCT01296932|3786871|FG008|COMPLETED|Overall Study||0
3066415|NCT01296932|3786863|FG000|NOT COMPLETED|Overall Study||3
3284222|NCT02762500|4018001|FG001|NOT COMPLETED|Overall Study||3
3284223|NCT02762513|4018007|FG000|STARTED|Overall Study||28
3284224|NCT02762513|4018007|FG000|COMPLETED|Overall Study||28
3284225|NCT02762513|4018007|FG000|NOT COMPLETED|Overall Study||0
3284226|NCT02762565|4018011|FG000|STARTED|Overall Study||89
3284227|NCT02762565|4018011|FG000|COMPLETED|Overall Study||78
3284228|NCT02762565|4018011|FG000|NOT COMPLETED|Overall Study||11
3284229|NCT02762578|4018017|FG000|STARTED|Overall Study||361
3284230|NCT02762578|4018018|FG001|STARTED|Overall Study||182
3284231|NCT02762578|4018017|FG000|Exposed|Overall Study||360
3284232|NCT02762578|4018018|FG001|Exposed|Overall Study||181
3284233|NCT02762578|4018017|FG000|COMPLETED|Overall Study||346
3066416|NCT01296932|3786864|FG001|NOT COMPLETED|Overall Study||3
3066417|NCT01296932|3786865|FG002|NOT COMPLETED|Overall Study||6
3066418|NCT01296932|3786866|FG003|NOT COMPLETED|Overall Study||6
3066419|NCT01296932|3786867|FG004|NOT COMPLETED|Overall Study||3
3066420|NCT01296932|3786868|FG005|NOT COMPLETED|Overall Study||3
3066421|NCT01296932|3786869|FG006|NOT COMPLETED|Overall Study||6
3066422|NCT01296932|3786870|FG007|NOT COMPLETED|Overall Study||2
3066423|NCT01296932|3786871|FG008|NOT COMPLETED|Overall Study||4
3066424|NCT01297062|3786898|FG000|STARTED|Overall Study||15
3066425|NCT01297062|3786899|FG001|STARTED|Overall Study||14
3066426|NCT01297062|3786900|FG002|STARTED|Overall Study||14
3066427|NCT01297062|3786901|FG003|STARTED|Overall Study||14
3066428|NCT01297062|3786902|FG004|STARTED|Overall Study||15
3066429|NCT01297062|3786903|FG005|STARTED|Overall Study||14
3066430|NCT01297062|3786904|FG006|STARTED|Overall Study||8
3066431|NCT01297062|3786898|FG000|Intent to Treat (ITT)|Overall Study||15
3066432|NCT01297062|3786899|FG001|Intent to Treat (ITT)|Overall Study||14
3066433|NCT01297062|3786900|FG002|Intent to Treat (ITT)|Overall Study||14
3066434|NCT01297062|3786901|FG003|Intent to Treat (ITT)|Overall Study||14
3066435|NCT01297062|3786902|FG004|Intent to Treat (ITT)|Overall Study||15
3066436|NCT01297062|3786903|FG005|Intent to Treat (ITT)|Overall Study||14
3066437|NCT01297062|3786904|FG006|Intent to Treat (ITT)|Overall Study||0
3066438|NCT01297062|3786898|FG000|Evaluable Population|Overall Study||11
3066439|NCT01297062|3786899|FG001|Evaluable Population|Overall Study||12
3066440|NCT01297062|3786900|FG002|Evaluable Population|Overall Study||12
3066441|NCT01297062|3786901|FG003|Evaluable Population|Overall Study||13
3066442|NCT01297062|3786902|FG004|Evaluable Population|Overall Study||13
3066443|NCT01297062|3786903|FG005|Evaluable Population|Overall Study||13
3066444|NCT01297062|3786904|FG006|Evaluable Population|Overall Study||0
3066445|NCT01297062|3786898|FG000|COMPLETED|Overall Study||11
3066446|NCT01297062|3786899|FG001|COMPLETED|Overall Study||13
3066447|NCT01297062|3786900|FG002|COMPLETED|Overall Study||12
3066448|NCT01297062|3786901|FG003|COMPLETED|Overall Study||13
3066449|NCT01297062|3786902|FG004|COMPLETED|Overall Study||13
3066450|NCT01297062|3786903|FG005|COMPLETED|Overall Study||13
3066451|NCT01297062|3786904|FG006|COMPLETED|Overall Study||0
3066452|NCT01297062|3786898|FG000|NOT COMPLETED|Overall Study||4
3066453|NCT01297062|3786899|FG001|NOT COMPLETED|Overall Study||1
3066454|NCT01297062|3786900|FG002|NOT COMPLETED|Overall Study||2
3066455|NCT01297062|3786901|FG003|NOT COMPLETED|Overall Study||1
3066456|NCT01297062|3786902|FG004|NOT COMPLETED|Overall Study||2
3066457|NCT01297062|3786903|FG005|NOT COMPLETED|Overall Study||1
3066458|NCT01297062|3786904|FG006|NOT COMPLETED|Overall Study||8
3066459|NCT01297244|3786914|FG000|STARTED|Overall Study||90
3066460|NCT01297244|3786915|FG001|STARTED|Overall Study||15
3066461|NCT01297244|3786914|FG000|COMPLETED|Overall Study||55
3066462|NCT01297244|3786915|FG001|COMPLETED|Overall Study||9
3066463|NCT01297244|3786914|FG000|NOT COMPLETED|Overall Study||35
3066464|NCT01297244|3786915|FG001|NOT COMPLETED|Overall Study||6
3066465|NCT01297257|3786922|FG000|STARTED|Overall Study||7740
3284234|NCT02762578|4018018|FG001|COMPLETED|Overall Study||172
3284235|NCT02762578|4018017|FG000|NOT COMPLETED|Overall Study||15
3066466|NCT01297257|3786922|FG000|COMPLETED|Overall Study||7740
3066467|NCT01297257|3786922|FG000|NOT COMPLETED|Overall Study||0
3066468|NCT01297270|3786930|FG000|STARTED|Overall Study||262
3284236|NCT02762578|4018018|FG001|NOT COMPLETED|Overall Study||10
3066469|NCT01297270|3786931|FG001|STARTED|Overall Study||264
3066470|NCT01297270|3786932|FG002|STARTED|Overall Study||132
3066471|NCT01297270|3786930|FG000|COMPLETED|Overall Study||217
3066472|NCT01297270|3786931|FG001|COMPLETED|Overall Study||192
3066473|NCT01297270|3786932|FG002|COMPLETED|Overall Study||103
3066474|NCT01297270|3786930|FG000|NOT COMPLETED|Overall Study||45
3066475|NCT01297270|3786931|FG001|NOT COMPLETED|Overall Study||72
3066476|NCT01297270|3786932|FG002|NOT COMPLETED|Overall Study||29
3066477|NCT01297283|3786940|FG000|STARTED|Overall Study||195
3066478|NCT01297283|3786940|FG000|COMPLETED|Overall Study||176
3066479|NCT01297283|3786940|FG000|NOT COMPLETED|Overall Study||19
3066480|NCT01297309|3786944|FG000|STARTED|Overall Study||51
3066481|NCT01297309|3786944|FG000|Treated|Overall Study||49
3162997|NCT01882465|3890493|FG002|STARTED|Period 1||5
3162998|NCT01882465|3890494|FG003|STARTED|Period 1||6
3162999|NCT01882465|3890495|FG004|STARTED|Period 1||5
3163000|NCT01882465|3890496|FG005|STARTED|Period 1||5
3163001|NCT01882465|3890497|FG006|STARTED|Period 1||1
3163002|NCT01882465|3890491|FG000|COMPLETED|Period 1||6
3163003|NCT01882465|3890492|FG001|COMPLETED|Period 1||6
3163004|NCT01882465|3890493|FG002|COMPLETED|Period 1||5
3163005|NCT01882465|3890494|FG003|COMPLETED|Period 1||5
3163006|NCT01882465|3890495|FG004|COMPLETED|Period 1||5
3066482|NCT01297309|3786944|FG000|Started Extension Period|Overall Study||46
3066483|NCT01297309|3786944|FG000|COMPLETED|Overall Study||37
3066484|NCT01297309|3786944|FG000|NOT COMPLETED|Overall Study||14
3066485|NCT01297322|3786950|FG000|STARTED|Overall Study||142
3066486|NCT01297322|3786951|FG001|STARTED|Overall Study||278
3066487|NCT01297322|3786950|FG000|COMPLETED|Overall Study||141
3066488|NCT01297322|3786951|FG001|COMPLETED|Overall Study||274
3066489|NCT01297322|3786950|FG000|NOT COMPLETED|Overall Study||1
3066490|NCT01297322|3786951|FG001|NOT COMPLETED|Overall Study||4
3066491|NCT01297335|3786958|FG000|STARTED|Overall Study||10
3066492|NCT01297335|3786958|FG000|COMPLETED|Overall Study||10
3066493|NCT01297335|3786958|FG000|NOT COMPLETED|Overall Study||0
3066494|NCT01297348|3786966|FG000|STARTED|Overall Study||12281
3066495|NCT01297348|3786967|FG001|STARTED|Overall Study||586401
3066496|NCT01297348|3786966|FG000|COMPLETED|Overall Study||12281
3066497|NCT01297348|3786967|FG001|COMPLETED|Overall Study||586401
3066498|NCT01297348|3786966|FG000|NOT COMPLETED|Overall Study||0
3066499|NCT01297348|3786967|FG001|NOT COMPLETED|Overall Study||0
3066500|NCT01297465|3786976|FG000|STARTED|Overall Study||99
3066501|NCT01297465|3786977|FG001|STARTED|Overall Study||103
3066502|NCT01297465|3786976|FG000|COMPLETED|Overall Study||91
3066503|NCT01297465|3786977|FG001|COMPLETED|Overall Study||93
3066504|NCT01297465|3786976|FG000|NOT COMPLETED|Overall Study||8
3066505|NCT01297465|3786977|FG001|NOT COMPLETED|Overall Study||10
3066506|NCT01297491|3786985|FG000|STARTED|Overall Study||30
3066507|NCT01297491|3786986|FG001|STARTED|Overall Study||33
3066508|NCT01297491|3786985|FG000|COMPLETED|Overall Study||0
3066509|NCT01297491|3786986|FG001|COMPLETED|Overall Study||0
3066510|NCT01297491|3786985|FG000|NOT COMPLETED|Overall Study||30
3066511|NCT01297491|3786986|FG001|NOT COMPLETED|Overall Study||33
3066512|NCT01297504|3786992|FG000|STARTED|Overall Study||464
3066513|NCT01297504|3786992|FG000|Participants Studied|Overall Study|Six participants were eliminated due to invalid consent, previous palivizumab or no study visits|458
3066514|NCT01297504|3786992|FG000|COMPLETED|Overall Study||397
3066515|NCT01297504|3786992|FG000|NOT COMPLETED|Overall Study||67
3066516|NCT01297517|3787003|FG000|STARTED|Overall Study||214
3066517|NCT01297517|3787004|FG001|STARTED|Overall Study||226
3066518|NCT01297517|3787005|FG002|STARTED|Overall Study||220
3066519|NCT01297517|3787003|FG000|COMPLETED|Overall Study||187
3066520|NCT01297517|3787004|FG001|COMPLETED|Overall Study||214
3066521|NCT01297517|3787005|FG002|COMPLETED|Overall Study||193
3066522|NCT01297517|3787003|FG000|NOT COMPLETED|Overall Study||27
3066523|NCT01297517|3787004|FG001|NOT COMPLETED|Overall Study||12
3066524|NCT01297517|3787005|FG002|NOT COMPLETED|Overall Study||27
3066525|NCT01297595|3787013|FG000|STARTED|First Intervention Period||11
3066526|NCT01297595|3787014|FG001|STARTED|First Intervention Period||11
3066527|NCT01297595|3787013|FG000|COMPLETED|First Intervention Period||11
3066528|NCT01297595|3787014|FG001|COMPLETED|First Intervention Period||11
3066529|NCT01297595|3787013|FG000|NOT COMPLETED|First Intervention Period||0
3066530|NCT01297595|3787014|FG001|NOT COMPLETED|First Intervention Period||0
3066531|NCT01297595|3787013|FG000|STARTED|Washout Period (At Least 14 Days)||11
3066532|NCT01297595|3787014|FG001|STARTED|Washout Period (At Least 14 Days)||11
3066533|NCT01297595|3787013|FG000|COMPLETED|Washout Period (At Least 14 Days)||11
3066534|NCT01297595|3787014|FG001|COMPLETED|Washout Period (At Least 14 Days)||11
3066535|NCT01297595|3787013|FG000|NOT COMPLETED|Washout Period (At Least 14 Days)||0
3066536|NCT01297595|3787014|FG001|NOT COMPLETED|Washout Period (At Least 14 Days)||0
3066537|NCT01297595|3787013|FG000|STARTED|Second Intervention Period||11
3066538|NCT01297595|3787014|FG001|STARTED|Second Intervention Period||11
3066539|NCT01297595|3787013|FG000|COMPLETED|Second Intervention Period||11
3066540|NCT01297595|3787014|FG001|COMPLETED|Second Intervention Period||11
3066541|NCT01297595|3787013|FG000|NOT COMPLETED|Second Intervention Period||0
3066542|NCT01297595|3787014|FG001|NOT COMPLETED|Second Intervention Period||0
3066543|NCT01297920|3787023|FG000|STARTED|Overall Study||221
3066544|NCT01297920|3787024|FG001|STARTED|Overall Study||234
3066545|NCT01297920|3787025|FG002|STARTED|Overall Study||235
3066546|NCT01297920|3787023|FG000|COMPLETED|Overall Study||163
3066547|NCT01297920|3787024|FG001|COMPLETED|Overall Study||207
3066548|NCT01297920|3787025|FG002|COMPLETED|Overall Study||178
3163007|NCT01882465|3890496|FG005|COMPLETED|Period 1||5
3163008|NCT01882465|3890497|FG006|COMPLETED|Period 1||0
3163009|NCT01882465|3890491|FG000|NOT COMPLETED|Period 1||0
3066549|NCT01297920|3787023|FG000|NOT COMPLETED|Overall Study||58
3066550|NCT01297920|3787024|FG001|NOT COMPLETED|Overall Study||27
3066551|NCT01297920|3787025|FG002|NOT COMPLETED|Overall Study||57
3066552|NCT01297959|3787035|FG000|STARTED|Overall Study||261
3066553|NCT01297959|3787036|FG001|STARTED|Overall Study||242
3066554|NCT01297959|3787035|FG000|COMPLETED|Overall Study||241
3066555|NCT01297959|3787036|FG001|COMPLETED|Overall Study||226
3066556|NCT01297959|3787035|FG000|NOT COMPLETED|Overall Study||20
3066557|NCT01297959|3787036|FG001|NOT COMPLETED|Overall Study||16
3066558|NCT01297985|3787044|FG000|STARTED|Overall Study||212
3066559|NCT01297985|3787045|FG001|STARTED|Overall Study||216
3066560|NCT01297985|3787044|FG000|COMPLETED|Overall Study||157
3066561|NCT01297985|3787045|FG001|COMPLETED|Overall Study||163
3066562|NCT01297985|3787044|FG000|NOT COMPLETED|Overall Study||55
3066563|NCT01297985|3787045|FG001|NOT COMPLETED|Overall Study||53
3066564|NCT01298063|3787056|FG000|STARTED|Overall Study||8
3066565|NCT01298063|3787057|FG001|STARTED|Overall Study||3
3066566|NCT01298063|3787058|FG002|STARTED|Overall Study||8
3066567|NCT01298063|3787059|FG003|STARTED|Overall Study||8
3066568|NCT01298063|3787060|FG004|STARTED|Overall Study||8
3066569|NCT01298063|3787056|FG000|COMPLETED|Overall Study||8
3066570|NCT01298063|3787057|FG001|COMPLETED|Overall Study||3
3066571|NCT01298063|3787058|FG002|COMPLETED|Overall Study||8
3066572|NCT01298063|3787059|FG003|COMPLETED|Overall Study||8
3066573|NCT01298063|3787060|FG004|COMPLETED|Overall Study||8
3066574|NCT01298063|3787056|FG000|NOT COMPLETED|Overall Study||0
3066575|NCT01298063|3787057|FG001|NOT COMPLETED|Overall Study||0
3066576|NCT01298063|3787058|FG002|NOT COMPLETED|Overall Study||0
3066577|NCT01298063|3787059|FG003|NOT COMPLETED|Overall Study||0
3066578|NCT01298063|3787060|FG004|NOT COMPLETED|Overall Study||0
3066579|NCT01298128|3787075|FG000|STARTED|Overall Study||35
3066580|NCT01298128|3787076|FG001|STARTED|Overall Study||35
3066581|NCT01298128|3787075|FG000|COMPLETED|Overall Study||26
3066582|NCT01298128|3787076|FG001|COMPLETED|Overall Study||27
3066583|NCT01298128|3787075|FG000|NOT COMPLETED|Overall Study||9
3066584|NCT01298128|3787076|FG001|NOT COMPLETED|Overall Study||8
3066585|NCT01298141|3787082|FG000|STARTED|Overall Study||171
3066586|NCT01298141|3787082|FG000|Treated|Overall Study||167
3066587|NCT01298141|3787082|FG000|COMPLETED|Overall Study||140
3066588|NCT01298141|3787082|FG000|NOT COMPLETED|Overall Study||31
3066589|NCT01298167|3787088|FG000|STARTED|Overall Study||6
3066590|NCT01298167|3787089|FG001|STARTED|Overall Study||8
3066591|NCT01298167|3787088|FG000|COMPLETED|Overall Study||5
3066592|NCT01298167|3787089|FG001|COMPLETED|Overall Study||8
3066593|NCT01298167|3787088|FG000|NOT COMPLETED|Overall Study||1
3066594|NCT01298167|3787089|FG001|NOT COMPLETED|Overall Study||0
3066595|NCT01298193|3787095|FG000|STARTED|Observational Phase (First Cycle)||212
3066596|NCT01298193|3787095|FG000|COMPLETED|Observational Phase (First Cycle)|From these 185 completed patients, only 24 experiment emesis on Cycle 1 (NCR) (efficacy phase).|185
3066597|NCT01298193|3787095|FG000|NOT COMPLETED|Observational Phase (First Cycle)||27
3066598|NCT01298193|3787095|FG000|STARTED|Efficacy Phase (Second Cycle)||24
3066599|NCT01298193|3787095|FG000|COMPLETED|Efficacy Phase (Second Cycle)||23
3066600|NCT01298193|3787095|FG000|NOT COMPLETED|Efficacy Phase (Second Cycle)||1
3066601|NCT01298219|3787104|FG000|STARTED|Overall Study||219
3066602|NCT01298219|3787105|FG001|STARTED|Overall Study||220
3066603|NCT01298219|3787104|FG000|Intention to Treat (ITT)|Overall Study||219
3066604|NCT01298219|3787105|FG001|Intention to Treat (ITT)|Overall Study||220
3066605|NCT01298219|3787104|FG000|Safety Analysis Set|Overall Study||219
3066606|NCT01298219|3787105|FG001|Safety Analysis Set|Overall Study||220
3066607|NCT01298219|3787104|FG000|COMPLETED|Overall Study||169
3066608|NCT01298219|3787105|FG001|COMPLETED|Overall Study||184
3066609|NCT01298219|3787104|FG000|NOT COMPLETED|Overall Study||50
3066610|NCT01298219|3787105|FG001|NOT COMPLETED|Overall Study||36
3163010|NCT01882465|3890492|FG001|NOT COMPLETED|Period 1||0
3163011|NCT01882465|3890493|FG002|NOT COMPLETED|Period 1||0
3163012|NCT01882465|3890494|FG003|NOT COMPLETED|Period 1||1
3163013|NCT01882465|3890495|FG004|NOT COMPLETED|Period 1||0
3163014|NCT01882465|3890496|FG005|NOT COMPLETED|Period 1||0
3066611|NCT01298323|3787113|FG000|STARTED|Overall Study||102
3066612|NCT01298323|3787114|FG001|STARTED|Overall Study||103
3066613|NCT01298323|3787113|FG000|Ongoing|Overall Study||55
3066614|NCT01298323|3787114|FG001|Ongoing|Overall Study||55
3066615|NCT01298323|3787113|FG000|COMPLETED|Overall Study||16
3066616|NCT01298323|3787114|FG001|COMPLETED|Overall Study||15
3066617|NCT01298323|3787113|FG000|NOT COMPLETED|Overall Study||86
3066618|NCT01298323|3787114|FG001|NOT COMPLETED|Overall Study||88
3134225|NCT01700829|3859256|FG000|COMPLETED|Overall Study||40
3134226|NCT01700829|3859257|FG001|COMPLETED|Overall Study||40
3134227|NCT01700829|3859256|FG000|NOT COMPLETED|Overall Study||1
3134228|NCT01700829|3859257|FG001|NOT COMPLETED|Overall Study||1
3134229|NCT01700907|3859265|FG000|STARTED|Overall Study||10
3134230|NCT01700907|3859266|FG001|STARTED|Overall Study||10
3134231|NCT01700907|3859265|FG000|COMPLETED|Overall Study||10
3134232|NCT01700907|3859266|FG001|COMPLETED|Overall Study||10
3134233|NCT01700907|3859265|FG000|NOT COMPLETED|Overall Study||0
3163015|NCT01882465|3890497|FG006|NOT COMPLETED|Period 1||1
3134234|NCT01700907|3859266|FG001|NOT COMPLETED|Overall Study||0
3134235|NCT01700959|3859278|FG000|STARTED|Overall Study||89
3134236|NCT01700959|3859279|FG001|STARTED|Overall Study||88
3134237|NCT01700959|3859280|FG002|STARTED|Overall Study||105
3134238|NCT01700959|3859281|FG003|STARTED|Overall Study||105
3134239|NCT01700959|3859282|FG004|STARTED|Overall Study||96
3066619|NCT01298362|3787122|FG000|STARTED|Overall Study||124
3066620|NCT01298362|3787123|FG001|STARTED|Overall Study||166
3066621|NCT01298362|3787122|FG000|COMPLETED|Overall Study||86
3066622|NCT01298362|3787123|FG001|COMPLETED|Overall Study||123
3066623|NCT01298362|3787122|FG000|NOT COMPLETED|Overall Study||38
3066624|NCT01298362|3787123|FG001|NOT COMPLETED|Overall Study||43
3066625|NCT01298492|3787131|FG000|STARTED|Overall Study||268
3066626|NCT01298492|3787131|FG000|COMPLETED|Overall Study||149
3066627|NCT01298492|3787131|FG000|NOT COMPLETED|Overall Study||119
3066628|NCT01298518|3787138|FG000|STARTED|Overall Study||16
3066629|NCT01298518|3787139|FG001|STARTED|Overall Study||16
3066630|NCT01298518|3787140|FG002|STARTED|Overall Study||16
3066631|NCT01298518|3787138|FG000|COMPLETED|Overall Study||16
3066632|NCT01298518|3787139|FG001|COMPLETED|Overall Study||16
3066633|NCT01298518|3787140|FG002|COMPLETED|Overall Study||15
3066634|NCT01298518|3787138|FG000|NOT COMPLETED|Overall Study||0
3066635|NCT01298518|3787139|FG001|NOT COMPLETED|Overall Study||0
3066636|NCT01298518|3787140|FG002|NOT COMPLETED|Overall Study||1
3066637|NCT01298531|3787150|FG000|STARTED|Overall Study||42
3066638|NCT01298531|3787151|FG001|STARTED|Overall Study||48
3066639|NCT01298531|3787150|FG000|COMPLETED|Overall Study||33
3066640|NCT01298531|3787151|FG001|COMPLETED|Overall Study||41
3066641|NCT01298531|3787150|FG000|NOT COMPLETED|Overall Study||9
3066642|NCT01298531|3787151|FG001|NOT COMPLETED|Overall Study||7
3066643|NCT01298544|3787158|FG000|STARTED|Overall Study||335
3066644|NCT01298544|3787158|FG000|COMPLETED|Overall Study||335
3066645|NCT01298544|3787158|FG000|NOT COMPLETED|Overall Study||0
3066646|NCT01298570|3787166|FG000|STARTED|Overall Study||120
3066647|NCT01298570|3787167|FG001|STARTED|Overall Study||61
3066648|NCT01298570|3787166|FG000|COMPLETED|Overall Study||0
3066649|NCT01298570|3787167|FG001|COMPLETED|Overall Study||0
3066650|NCT01298570|3787166|FG000|NOT COMPLETED|Overall Study||120
3066651|NCT01298570|3787167|FG001|NOT COMPLETED|Overall Study||61
3066652|NCT01298596|3787175|FG000|STARTED|Overall Study||200
3066653|NCT01298596|3787176|FG001|STARTED|Overall Study||200
3066654|NCT01298596|3787175|FG000|COMPLETED|Overall Study||172
3066655|NCT01298596|3787176|FG001|COMPLETED|Overall Study||167
3066656|NCT01298596|3787175|FG000|NOT COMPLETED|Overall Study||28
3066657|NCT01298596|3787176|FG001|NOT COMPLETED|Overall Study||33
3066658|NCT01298648|3787182|FG000|STARTED|Overall Study||1716
3066659|NCT01298648|3787182|FG000|COMPLETED|Overall Study||1693
3066660|NCT01298648|3787182|FG000|NOT COMPLETED|Overall Study||23
3066661|NCT01298661|3787189|FG000|STARTED|Overall Study||33
3066662|NCT01298661|3787190|FG001|STARTED|Overall Study||24
3066663|NCT01298661|3787191|FG002|STARTED|Overall Study||34
3066664|NCT01298661|3787189|FG000|COMPLETED|Overall Study||31
3066665|NCT01298661|3787190|FG001|COMPLETED|Overall Study||24
3066666|NCT01298661|3787191|FG002|COMPLETED|Overall Study||32
3066667|NCT01298661|3787189|FG000|NOT COMPLETED|Overall Study||2
3066668|NCT01298661|3787190|FG001|NOT COMPLETED|Overall Study||0
3066669|NCT01298661|3787191|FG002|NOT COMPLETED|Overall Study||2
3066670|NCT01298700|3787202|FG000|STARTED|Overall Study||403
3066671|NCT01298700|3787203|FG001|STARTED|Overall Study||403
3066672|NCT01298700|3787202|FG000|Safety Population: Received Study Drug|Overall Study||400
3066673|NCT01298700|3787203|FG001|Safety Population: Received Study Drug|Overall Study||398
3066674|NCT01298700|3787202|FG000|COMPLETED|Overall Study||302
3066675|NCT01298700|3787203|FG001|COMPLETED|Overall Study||303
3066676|NCT01298700|3787202|FG000|NOT COMPLETED|Overall Study||101
3066677|NCT01298700|3787203|FG001|NOT COMPLETED|Overall Study||100
3066678|NCT01298752|3787211|FG000|STARTED|Overall Study||120
3066679|NCT01298752|3787212|FG001|STARTED|Overall Study||57
3066680|NCT01298752|3787211|FG000|COMPLETED|Overall Study||77
3066681|NCT01298752|3787212|FG001|COMPLETED|Overall Study||31
3066682|NCT01298752|3787211|FG000|NOT COMPLETED|Overall Study||43
3066683|NCT01298752|3787212|FG001|NOT COMPLETED|Overall Study||26
3066684|NCT01298765|3787218|FG000|STARTED|Titration Period||302
3066685|NCT01298765|3787218|FG000|COMPLETED|Titration Period||226
3066686|NCT01298765|3787218|FG000|NOT COMPLETED|Titration Period||76
3066687|NCT01298765|3787218|FG000|STARTED|Long-Term Treatment Period||226
3066688|NCT01298765|3787218|FG000|COMPLETED|Long-Term Treatment Period||127
3066689|NCT01298765|3787218|FG000|NOT COMPLETED|Long-Term Treatment Period||99
3066690|NCT01298778|3787224|FG000|STARTED|Overall Study||33
3066691|NCT01298778|3787225|FG001|STARTED|Overall Study||36
3066692|NCT01298778|3787224|FG000|COMPLETED|Overall Study||30
3066693|NCT01298778|3787225|FG001|COMPLETED|Overall Study||30
3066694|NCT01298778|3787224|FG000|NOT COMPLETED|Overall Study||3
3066695|NCT01298778|3787225|FG001|NOT COMPLETED|Overall Study||6
3066696|NCT01298999|3787235|FG000|STARTED|Overall Study||13
3066697|NCT01298999|3787236|FG001|STARTED|Overall Study||11
3066698|NCT01298999|3787235|FG000|COMPLETED|Overall Study||10
3066699|NCT01298999|3787236|FG001|COMPLETED|Overall Study||10
3066700|NCT01298999|3787235|FG000|NOT COMPLETED|Overall Study||3
3066701|NCT01298999|3787236|FG001|NOT COMPLETED|Overall Study||1
3066702|NCT01299025|3787244|FG000|STARTED|Overall Study||42
3066703|NCT01299025|3787245|FG001|STARTED|Overall Study||42
3066704|NCT01299025|3787244|FG000|COMPLETED|Overall Study||39
3066705|NCT01299025|3787245|FG001|COMPLETED|Overall Study||41
3066706|NCT01299025|3787244|FG000|NOT COMPLETED|Overall Study||3
3066707|NCT01299025|3787245|FG001|NOT COMPLETED|Overall Study||1
3066708|NCT01299038|3787253|FG000|STARTED|Overall Study|Consented|10
3066709|NCT01299038|3787254|FG001|STARTED|Overall Study|Consented|10
3066710|NCT01299038|3787253|FG000|COMPLETED|Overall Study|Evaluable|9
3066711|NCT01299038|3787254|FG001|COMPLETED|Overall Study|Evaluable|10
3066712|NCT01299038|3787253|FG000|NOT COMPLETED|Overall Study||1
3066713|NCT01299038|3787254|FG001|NOT COMPLETED|Overall Study||0
3066714|NCT01299077|3787260|FG000|STARTED|Overall Study||478
3066715|NCT01299077|3787260|FG000|COMPLETED|Overall Study||478
3066716|NCT01299077|3787260|FG000|NOT COMPLETED|Overall Study||0
3066717|NCT01299090|3787264|FG000|STARTED|Overall Study||49
3066718|NCT01299090|3787264|FG000|COMPLETED|Overall Study||49
3066719|NCT01299090|3787264|FG000|NOT COMPLETED|Overall Study||0
3066720|NCT01299103|3787271|FG000|STARTED|Overall Study||15
3066721|NCT01299103|3787272|FG001|STARTED|Overall Study||15
3066722|NCT01299103|3787273|FG002|STARTED|Overall Study||10
3066723|NCT01299103|3787271|FG000|COMPLETED|Overall Study||15
3066724|NCT01299103|3787272|FG001|COMPLETED|Overall Study||13
3066725|NCT01299103|3787273|FG002|COMPLETED|Overall Study||8
3066726|NCT01299103|3787271|FG000|NOT COMPLETED|Overall Study||0
3066727|NCT01299103|3787272|FG001|NOT COMPLETED|Overall Study||2
3066728|NCT01299103|3787273|FG002|NOT COMPLETED|Overall Study||2
3066729|NCT01299116|3787284|FG000|STARTED|Overall Study||522
3066730|NCT01299116|3787285|FG001|STARTED|Overall Study||177
3066731|NCT01299116|3787286|FG002|STARTED|Overall Study||195
3066732|NCT01299116|3787284|FG000|COMPLETED|Overall Study||457
3066733|NCT01299116|3787285|FG001|COMPLETED|Overall Study||168
3066734|NCT01299116|3787286|FG002|COMPLETED|Overall Study||184
3066735|NCT01299116|3787284|FG000|NOT COMPLETED|Overall Study||65
3066736|NCT01299116|3787285|FG001|NOT COMPLETED|Overall Study||9
3066737|NCT01299116|3787286|FG002|NOT COMPLETED|Overall Study||11
3066738|NCT01299272|3787297|FG000|STARTED|Acute Open-label (OL) Period||1249
3066739|NCT01299272|3787298|FG001|STARTED|Acute Open-label (OL) Period||0
3066740|NCT01299272|3787299|FG002|STARTED|Acute Open-label (OL) Period||0
3066741|NCT01299272|3787300|FG003|STARTED|Acute Open-label (OL) Period||0
3066742|NCT01299272|3787297|FG000|Entered Discontinuation (DC) Period|Acute Open-label (OL) Period|Participants who discontinued the Acute OL Period had the option to enter the DC Period.|271
3066743|NCT01299272|3787298|FG001|Entered Discontinuation (DC) Period|Acute Open-label (OL) Period||0
3066744|NCT01299272|3787299|FG002|Entered Discontinuation (DC) Period|Acute Open-label (OL) Period||0
3066745|NCT01299272|3787300|FG003|Entered Discontinuation (DC) Period|Acute Open-label (OL) Period||0
3066746|NCT01299272|3787297|FG000|COMPLETED|Acute Open-label (OL) Period|Participants who completed the Acute OL Period entered the Stabilization OL Period.|835
3066747|NCT01299272|3787298|FG001|COMPLETED|Acute Open-label (OL) Period||0
3284237|NCT02762799|4018028|FG000|STARTED|Overall Study||18
3284238|NCT02762799|4018029|FG001|STARTED|Overall Study||18
3284239|NCT02762799|4018030|FG002|STARTED|Overall Study||12
3284240|NCT02762799|4018031|FG003|STARTED|Overall Study||12
3284241|NCT02762799|4018028|FG000|COMPLETED|Overall Study||18
3066748|NCT01299272|3787299|FG002|COMPLETED|Acute Open-label (OL) Period||0
3066749|NCT01299272|3787300|FG003|COMPLETED|Acute Open-label (OL) Period||0
3066750|NCT01299272|3787297|FG000|NOT COMPLETED|Acute Open-label (OL) Period||414
3066751|NCT01299272|3787298|FG001|NOT COMPLETED|Acute Open-label (OL) Period||0
3066752|NCT01299272|3787299|FG002|NOT COMPLETED|Acute Open-label (OL) Period||0
3066753|NCT01299272|3787300|FG003|NOT COMPLETED|Acute Open-label (OL) Period||0
3066754|NCT01299272|3787297|FG000|STARTED|Stabilization Open-label (OL) Period||0
3066755|NCT01299272|3787298|FG001|STARTED|Stabilization Open-label (OL) Period||835
3066756|NCT01299272|3787299|FG002|STARTED|Stabilization Open-label (OL) Period||0
3066757|NCT01299272|3787300|FG003|STARTED|Stabilization Open-label (OL) Period||0
3066758|NCT01299272|3787297|FG000|Entered Discontinuation (DC) Period|Stabilization Open-label (OL) Period||0
3066759|NCT01299272|3787298|FG001|Entered Discontinuation (DC) Period|Stabilization Open-label (OL) Period|Participants who discontinued the Stabilization OL Period had the option to enter the DC Period.|164
3066760|NCT01299272|3787299|FG002|Entered Discontinuation (DC) Period|Stabilization Open-label (OL) Period||0
3066761|NCT01299272|3787300|FG003|Entered Discontinuation (DC) Period|Stabilization Open-label (OL) Period||0
3066762|NCT01299272|3787297|FG000|COMPLETED|Stabilization Open-label (OL) Period||0
3066763|NCT01299272|3787298|FG001|COMPLETED|Stabilization Open-label (OL) Period|Participants who completed the Stabilization OL Period were randomized to the DB Period.|586
3066764|NCT01299272|3787299|FG002|COMPLETED|Stabilization Open-label (OL) Period||0
3066765|NCT01299272|3787300|FG003|COMPLETED|Stabilization Open-label (OL) Period||0
3066766|NCT01299272|3787297|FG000|NOT COMPLETED|Stabilization Open-label (OL) Period||0
3066767|NCT01299272|3787298|FG001|NOT COMPLETED|Stabilization Open-label (OL) Period||249
3066768|NCT01299272|3787299|FG002|NOT COMPLETED|Stabilization Open-label (OL) Period||0
3066769|NCT01299272|3787300|FG003|NOT COMPLETED|Stabilization Open-label (OL) Period||0
3066770|NCT01299272|3787297|FG000|STARTED|Double-blind (DB) Randomized Period||0
3066771|NCT01299272|3787298|FG001|STARTED|Double-blind (DB) Randomized Period||0
3066772|NCT01299272|3787299|FG002|STARTED|Double-blind (DB) Randomized Period||294
3066773|NCT01299272|3787300|FG003|STARTED|Double-blind (DB) Randomized Period||292
3066774|NCT01299272|3787297|FG000|Entered Taper Discontinuation Period|Double-blind (DB) Randomized Period||0
3066775|NCT01299272|3787298|FG001|Entered Taper Discontinuation Period|Double-blind (DB) Randomized Period||0
3066776|NCT01299272|3787299|FG002|Entered Taper Discontinuation Period|Double-blind (DB) Randomized Period|Participants who completed or discontinued the DB Period were randomized to the taper DC Period.|129
3066777|NCT01299272|3787300|FG003|Entered Taper Discontinuation Period|Double-blind (DB) Randomized Period||0
3066778|NCT01299272|3787297|FG000|Entered Abrupt Discontinuation Period|Double-blind (DB) Randomized Period||0
3066779|NCT01299272|3787298|FG001|Entered Abrupt Discontinuation Period|Double-blind (DB) Randomized Period||0
3066780|NCT01299272|3787299|FG002|Entered Abrupt Discontinuation Period|Double-blind (DB) Randomized Period|Participants who completed or discontinued the DB Period were randomized to the abrupt DC Period.|132
3066781|NCT01299272|3787300|FG003|Entered Abrupt Discontinuation Period|Double-blind (DB) Randomized Period|Participants who completed or discontinued the DB Period entered the DC Period.|268
3066782|NCT01299272|3787297|FG000|COMPLETED|Double-blind (DB) Randomized Period||0
3066783|NCT01299272|3787298|FG001|COMPLETED|Double-blind (DB) Randomized Period||0
3066784|NCT01299272|3787299|FG002|COMPLETED|Double-blind (DB) Randomized Period||224
3066785|NCT01299272|3787300|FG003|COMPLETED|Double-blind (DB) Randomized Period||234
3066786|NCT01299272|3787297|FG000|NOT COMPLETED|Double-blind (DB) Randomized Period||0
3066787|NCT01299272|3787298|FG001|NOT COMPLETED|Double-blind (DB) Randomized Period||0
3066788|NCT01299272|3787299|FG002|NOT COMPLETED|Double-blind (DB) Randomized Period||70
3066789|NCT01299272|3787300|FG003|NOT COMPLETED|Double-blind (DB) Randomized Period||58
3066790|NCT01299285|3787314|FG000|STARTED|Overall Study||6
3066791|NCT01299285|3787314|FG000|COMPLETED|Overall Study||6
3066792|NCT01299285|3787314|FG000|NOT COMPLETED|Overall Study||0
3066793|NCT01299376|3787322|FG000|STARTED|Double-blind Treatment (Weeks 1 to 8)||141
3066794|NCT01299376|3787323|FG001|STARTED|Double-blind Treatment (Weeks 1 to 8)||145
3066795|NCT01299376|3787322|FG000|COMPLETED|Double-blind Treatment (Weeks 1 to 8)||134
3066796|NCT01299376|3787323|FG001|COMPLETED|Double-blind Treatment (Weeks 1 to 8)||133
3066797|NCT01299376|3787322|FG000|NOT COMPLETED|Double-blind Treatment (Weeks 1 to 8)||7
3066798|NCT01299376|3787323|FG001|NOT COMPLETED|Double-blind Treatment (Weeks 1 to 8)||12
3066799|NCT01299376|3787322|FG000|STARTED|Extension (Weeks 9 to 52)||134
3066800|NCT01299376|3787323|FG001|STARTED|Extension (Weeks 9 to 52)||133
3066801|NCT01299376|3787322|FG000|COMPLETED|Extension (Weeks 9 to 52)||124
3066802|NCT01299376|3787323|FG001|COMPLETED|Extension (Weeks 9 to 52)||118
3066803|NCT01299376|3787322|FG000|NOT COMPLETED|Extension (Weeks 9 to 52)||10
3066804|NCT01299376|3787323|FG001|NOT COMPLETED|Extension (Weeks 9 to 52)||15
3066805|NCT01299389|3787335|FG000|STARTED|Double-blind||164
3066806|NCT01299389|3787336|FG001|STARTED|Double-blind||159
3066807|NCT01299389|3787337|FG002|STARTED|Double-blind||0
3066808|NCT01299389|3787338|FG003|STARTED|Double-blind||0
3066809|NCT01299389|3787335|FG000|COMPLETED|Double-blind||55
3066810|NCT01299389|3787336|FG001|COMPLETED|Double-blind||95
3066811|NCT01299389|3787337|FG002|COMPLETED|Double-blind||0
3066812|NCT01299389|3787338|FG003|COMPLETED|Double-blind||0
3066813|NCT01299389|3787335|FG000|NOT COMPLETED|Double-blind||109
3066814|NCT01299389|3787336|FG001|NOT COMPLETED|Double-blind||64
3066815|NCT01299389|3787337|FG002|NOT COMPLETED|Double-blind||0
3066816|NCT01299389|3787338|FG003|NOT COMPLETED|Double-blind||0
3066817|NCT01299389|3787335|FG000|STARTED|Post-observational||0
3066818|NCT01299389|3787336|FG001|STARTED|Post-observational||0
3066819|NCT01299389|3787337|FG002|STARTED|Post-observational||156
3066820|NCT01299389|3787338|FG003|STARTED|Post-observational||155
3066821|NCT01299389|3787335|FG000|COMPLETED|Post-observational||0
3066822|NCT01299389|3787336|FG001|COMPLETED|Post-observational||0
3066823|NCT01299389|3787337|FG002|COMPLETED|Post-observational||144
3066824|NCT01299389|3787338|FG003|COMPLETED|Post-observational||149
3066825|NCT01299389|3787335|FG000|NOT COMPLETED|Post-observational||0
3066826|NCT01299389|3787336|FG001|NOT COMPLETED|Post-observational||0
3066827|NCT01299389|3787337|FG002|NOT COMPLETED|Post-observational||12
3066828|NCT01299389|3787338|FG003|NOT COMPLETED|Post-observational||6
3066829|NCT01299454|3787351|FG000|STARTED|Overall Study||8
3066830|NCT01299454|3787352|FG001|STARTED|Overall Study||8
3066831|NCT01299454|3787353|FG002|STARTED|Overall Study||6
3066832|NCT01299454|3787354|FG003|STARTED|Overall Study||23
3066833|NCT01299454|3787351|FG000|COMPLETED|Overall Study||8
3066834|NCT01299454|3787352|FG001|COMPLETED|Overall Study||8
3066835|NCT01299454|3787353|FG002|COMPLETED|Overall Study||6
3066836|NCT01299454|3787354|FG003|COMPLETED|Overall Study||23
3066837|NCT01299454|3787351|FG000|NOT COMPLETED|Overall Study||0
3066838|NCT01299454|3787352|FG001|NOT COMPLETED|Overall Study||0
3066839|NCT01299454|3787353|FG002|NOT COMPLETED|Overall Study||0
3066840|NCT01299454|3787354|FG003|NOT COMPLETED|Overall Study||0
3066841|NCT01299480|3787395|FG000|STARTED|Overall Study||427
3066842|NCT01299480|3787396|FG001|STARTED|Overall Study||430
3066843|NCT01299480|3787397|FG002|STARTED|Overall Study||427
3066844|NCT01299480|3787398|FG003|STARTED|Overall Study||286
3066845|NCT01299480|3787399|FG004|STARTED|Overall Study||143
3066846|NCT01299480|3787395|FG000|COMPLETED|Overall Study||385
3066847|NCT01299480|3787396|FG001|COMPLETED|Overall Study||395
3066848|NCT01299480|3787397|FG002|COMPLETED|Overall Study||386
3066849|NCT01299480|3787398|FG003|COMPLETED|Overall Study||261
3066850|NCT01299480|3787399|FG004|COMPLETED|Overall Study||123
3066851|NCT01299480|3787395|FG000|NOT COMPLETED|Overall Study||42
3066852|NCT01299480|3787396|FG001|NOT COMPLETED|Overall Study||35
3066853|NCT01299480|3787397|FG002|NOT COMPLETED|Overall Study||41
3066854|NCT01299480|3787398|FG003|NOT COMPLETED|Overall Study||25
3066855|NCT01299480|3787399|FG004|NOT COMPLETED|Overall Study||20
3066856|NCT01299571|3787412|FG000|STARTED|Overall Study||3977
3066857|NCT01299571|3787412|FG000|COMPLETED|Overall Study||3870
3066858|NCT01299571|3787412|FG000|NOT COMPLETED|Overall Study||107
3066859|NCT01299584|3787417|FG000|STARTED|Overall Study||775
3066860|NCT01299584|3787417|FG000|COMPLETED|Overall Study||766
3066861|NCT01299584|3787417|FG000|NOT COMPLETED|Overall Study||9
3066862|NCT01299610|3787424|FG000|STARTED|Overall Study||10
3066863|NCT01299610|3787425|FG001|STARTED|Overall Study||5
3066864|NCT01299610|3787426|FG002|STARTED|Overall Study||10
3066865|NCT01299610|3787424|FG000|COMPLETED|Overall Study||10
3066866|NCT01299610|3787425|FG001|COMPLETED|Overall Study||5
3284242|NCT02762799|4018029|FG001|COMPLETED|Overall Study||18
3284243|NCT02762799|4018030|FG002|COMPLETED|Overall Study||11
3284244|NCT02762799|4018031|FG003|COMPLETED|Overall Study||12
3066867|NCT01299610|3787426|FG002|COMPLETED|Overall Study||10
3066868|NCT01299610|3787424|FG000|NOT COMPLETED|Overall Study||0
3066869|NCT01299610|3787425|FG001|NOT COMPLETED|Overall Study||0
3066870|NCT01299610|3787426|FG002|NOT COMPLETED|Overall Study||0
3066871|NCT01299727|3787441|FG000|STARTED|Overall Study||4
3066872|NCT01299727|3787442|FG001|STARTED|Overall Study||4
3066873|NCT01299727|3787443|FG002|STARTED|Overall Study||4
3066874|NCT01299727|3787441|FG000|COMPLETED|Overall Study||0
3066875|NCT01299727|3787442|FG001|COMPLETED|Overall Study||0
3066876|NCT01299727|3787443|FG002|COMPLETED|Overall Study||0
3066877|NCT01299727|3787441|FG000|NOT COMPLETED|Overall Study||4
3066878|NCT01299727|3787442|FG001|NOT COMPLETED|Overall Study||4
3066879|NCT01299727|3787443|FG002|NOT COMPLETED|Overall Study||4
3066880|NCT01299766|3787453|FG000|STARTED|Overall Study||111
3066881|NCT01299766|3787454|FG001|STARTED|Overall Study||110
3066882|NCT01299766|3787453|FG000|COMPLETED|Overall Study||77
3066883|NCT01299766|3787454|FG001|COMPLETED|Overall Study||87
3066884|NCT01299766|3787453|FG000|NOT COMPLETED|Overall Study||34
3066885|NCT01299766|3787454|FG001|NOT COMPLETED|Overall Study||23
3066886|NCT01299805|3787462|FG000|STARTED|Overall Study||12
3066887|NCT01299805|3787463|FG001|STARTED|Overall Study||5
3066888|NCT01299805|3787462|FG000|COMPLETED|Overall Study||10
3066889|NCT01299805|3787463|FG001|COMPLETED|Overall Study||5
3284245|NCT02762799|4018028|FG000|NOT COMPLETED|Overall Study||0
3284246|NCT02762799|4018029|FG001|NOT COMPLETED|Overall Study||0
3284247|NCT02762799|4018030|FG002|NOT COMPLETED|Overall Study||1
3284248|NCT02762799|4018031|FG003|NOT COMPLETED|Overall Study||0
3284249|NCT02762877|4018045|FG000|STARTED|Overall Study||121
3284250|NCT02762877|4018046|FG001|STARTED|Overall Study||19
3066890|NCT01299805|3787462|FG000|NOT COMPLETED|Overall Study||2
3066891|NCT01299805|3787463|FG001|NOT COMPLETED|Overall Study||0
3066892|NCT01299896|3787471|FG000|STARTED|Overall Study||319
3066893|NCT01299896|3787472|FG001|STARTED|Overall Study||314
3066894|NCT01299896|3787471|FG000|COMPLETED|Overall Study||318
3066895|NCT01299896|3787472|FG001|COMPLETED|Overall Study||296
3284251|NCT02762877|4018045|FG000|COMPLETED|Overall Study||121
3284252|NCT02762877|4018046|FG001|COMPLETED|Overall Study||19
3284253|NCT02762877|4018045|FG000|NOT COMPLETED|Overall Study||0
3284254|NCT02762877|4018046|FG001|NOT COMPLETED|Overall Study||0
3284255|NCT02762994|4018057|FG000|STARTED|Overall Study||31
3284256|NCT02762994|4018058|FG001|STARTED|Overall Study||31
3066896|NCT01299896|3787471|FG000|NOT COMPLETED|Overall Study||1
3066897|NCT01299896|3787472|FG001|NOT COMPLETED|Overall Study||18
3066898|NCT01299909|3787481|FG000|STARTED|Overall Study||68
3066899|NCT01299909|3787482|FG001|STARTED|Overall Study||67
3066900|NCT01299909|3787483|FG002|STARTED|Overall Study||40
3066901|NCT01299909|3787481|FG000|COMPLETED|Overall Study||46
3066902|NCT01299909|3787482|FG001|COMPLETED|Overall Study||49
3066903|NCT01299909|3787483|FG002|COMPLETED|Overall Study||23
3066904|NCT01299909|3787481|FG000|NOT COMPLETED|Overall Study||22
3066905|NCT01299909|3787482|FG001|NOT COMPLETED|Overall Study||18
3066906|NCT01299909|3787483|FG002|NOT COMPLETED|Overall Study||17
3066907|NCT01299961|3787490|FG000|STARTED|Overall Study||25
3066908|NCT01299961|3787490|FG000|COMPLETED|Overall Study||19
3066909|NCT01299961|3787490|FG000|NOT COMPLETED|Overall Study||6
3066910|NCT01300052|3787496|FG000|STARTED|Overall Study||46
3066911|NCT01300052|3787497|FG001|STARTED|Overall Study||22
3066912|NCT01300052|3787496|FG000|COMPLETED|Overall Study||40
3066913|NCT01300052|3787497|FG001|COMPLETED|Overall Study||19
3066914|NCT01300052|3787496|FG000|NOT COMPLETED|Overall Study||6
3066915|NCT01300052|3787497|FG001|NOT COMPLETED|Overall Study||3
3066916|NCT01300065|3787505|FG000|STARTED|Overall Study||221
3066917|NCT01300065|3787506|FG001|STARTED|Overall Study||220
3066918|NCT01300065|3787505|FG000|COMPLETED|Overall Study||215
3066919|NCT01300065|3787506|FG001|COMPLETED|Overall Study||217
3066920|NCT01300065|3787505|FG000|NOT COMPLETED|Overall Study||6
3066921|NCT01300065|3787506|FG001|NOT COMPLETED|Overall Study||3
3066922|NCT01300234|3787514|FG000|STARTED|Overall Study||257
3066923|NCT01300234|3787515|FG001|STARTED|Overall Study||255
3066924|NCT01300234|3787514|FG000|COMPLETED|Overall Study||229
3066925|NCT01300234|3787515|FG001|COMPLETED|Overall Study||228
3066926|NCT01300234|3787514|FG000|NOT COMPLETED|Overall Study||28
3066927|NCT01300234|3787515|FG001|NOT COMPLETED|Overall Study||27
3066928|NCT01300247|3787534|FG000|STARTED|Overall Study||21
3066929|NCT01300247|3787535|FG001|STARTED|Overall Study||20
3066930|NCT01300247|3787534|FG000|COMPLETED|Overall Study||17
3284257|NCT02762994|4018059|FG002|STARTED|Overall Study||30
3284258|NCT02762994|4018060|FG003|STARTED|Overall Study||28
3284259|NCT02762994|4018057|FG000|COMPLETED|Overall Study||30
3284260|NCT02762994|4018058|FG001|COMPLETED|Overall Study||30
3284261|NCT02762994|4018059|FG002|COMPLETED|Overall Study||28
3284262|NCT02762994|4018060|FG003|COMPLETED|Overall Study||26
3284263|NCT02762994|4018057|FG000|NOT COMPLETED|Overall Study||1
3284264|NCT02762994|4018058|FG001|NOT COMPLETED|Overall Study||1
3066931|NCT01300247|3787535|FG001|COMPLETED|Overall Study||18
3066932|NCT01300247|3787534|FG000|NOT COMPLETED|Overall Study||4
3066933|NCT01300247|3787535|FG001|NOT COMPLETED|Overall Study||2
3284265|NCT02762994|4018059|FG002|NOT COMPLETED|Overall Study||2
3284266|NCT02762994|4018060|FG003|NOT COMPLETED|Overall Study||2
3284267|NCT02763046|4018077|FG000|STARTED|Overall Study||71
3284268|NCT02763046|4018078|FG001|STARTED|Overall Study||70
3284269|NCT02763046|4018079|FG002|STARTED|Overall Study||70
3284270|NCT02763046|4018077|FG000|COMPLETED|Overall Study||62
3284271|NCT02763046|4018078|FG001|COMPLETED|Overall Study||65
3284272|NCT02763046|4018079|FG002|COMPLETED|Overall Study||62
3284273|NCT02763046|4018077|FG000|NOT COMPLETED|Overall Study||9
3284274|NCT02763046|4018078|FG001|NOT COMPLETED|Overall Study||5
3284275|NCT02763046|4018079|FG002|NOT COMPLETED|Overall Study||8
3284276|NCT02763124|4018093|FG000|STARTED|Overall Study||18
3284277|NCT02763124|4018093|FG000|COMPLETED|Overall Study||18
3284278|NCT02763124|4018093|FG000|NOT COMPLETED|Overall Study||0
3284279|NCT02763189|4018099|FG000|STARTED|Overall Study||4
3284280|NCT02763189|4018100|FG001|STARTED|Overall Study||4
3284281|NCT02763189|4018099|FG000|COMPLETED|Overall Study||4
3284282|NCT02763189|4018100|FG001|COMPLETED|Overall Study||2
3284283|NCT02763189|4018099|FG000|NOT COMPLETED|Overall Study||0
3284284|NCT02763189|4018100|FG001|NOT COMPLETED|Overall Study||2
3284285|NCT02763215|4018106|FG000|STARTED|Overall Study||64
3284286|NCT02763215|4018106|FG000|COMPLETED|Overall Study||57
3284287|NCT02763215|4018106|FG000|NOT COMPLETED|Overall Study||7
3284288|NCT02763254|4018110|FG000|STARTED|Overall Study||1
3066934|NCT01300260|3787543|FG000|STARTED|Period 1 of Study: First Intervention||15
3066935|NCT01300260|3787544|FG001|STARTED|Period 1 of Study: First Intervention||17
3066936|NCT01300260|3787543|FG000|Received at Least 1 Dose of Study Drug|Period 1 of Study: First Intervention||15
3066937|NCT01300260|3787544|FG001|Received at Least 1 Dose of Study Drug|Period 1 of Study: First Intervention||17
3066938|NCT01300260|3787543|FG000|COMPLETED|Period 1 of Study: First Intervention||14
3066939|NCT01300260|3787544|FG001|COMPLETED|Period 1 of Study: First Intervention||16
3066940|NCT01300260|3787543|FG000|NOT COMPLETED|Period 1 of Study: First Intervention||1
3066941|NCT01300260|3787544|FG001|NOT COMPLETED|Period 1 of Study: First Intervention||1
3066942|NCT01300260|3787543|FG000|STARTED|Washout Period of at Least 28 Days||14
3066943|NCT01300260|3787544|FG001|STARTED|Washout Period of at Least 28 Days||16
3066944|NCT01300260|3787543|FG000|COMPLETED|Washout Period of at Least 28 Days||14
3066945|NCT01300260|3787544|FG001|COMPLETED|Washout Period of at Least 28 Days||16
3066946|NCT01300260|3787543|FG000|NOT COMPLETED|Washout Period of at Least 28 Days||0
3066947|NCT01300260|3787544|FG001|NOT COMPLETED|Washout Period of at Least 28 Days||0
3066948|NCT01300260|3787543|FG000|STARTED|Period 2 of Study: Second Intervention||14
3066949|NCT01300260|3787544|FG001|STARTED|Period 2 of Study: Second Intervention||16
3066950|NCT01300260|3787543|FG000|COMPLETED|Period 2 of Study: Second Intervention||14
3066951|NCT01300260|3787544|FG001|COMPLETED|Period 2 of Study: Second Intervention||15
3066952|NCT01300260|3787543|FG000|NOT COMPLETED|Period 2 of Study: Second Intervention||0
3066953|NCT01300260|3787544|FG001|NOT COMPLETED|Period 2 of Study: Second Intervention||1
3066954|NCT01300286|3787561|FG000|STARTED|Overall Study||23
3066955|NCT01300286|3787561|FG000|COMPLETED|Overall Study||22
3066956|NCT01300286|3787561|FG000|NOT COMPLETED|Overall Study||1
3066957|NCT01300338|3787568|FG000|STARTED|Overall Study||25
3066958|NCT01300338|3787569|FG001|STARTED|Overall Study||25
3066959|NCT01300338|3787568|FG000|COMPLETED|Overall Study||20
3066960|NCT01300338|3787569|FG001|COMPLETED|Overall Study||25
3066961|NCT01300338|3787568|FG000|NOT COMPLETED|Overall Study||5
3066962|NCT01300338|3787569|FG001|NOT COMPLETED|Overall Study||0
3066963|NCT01300351|3787577|FG000|STARTED|Overall Study||111
3066964|NCT01300351|3787578|FG001|STARTED|Overall Study||110
3066965|NCT01300351|3787577|FG000|Received Study Treatment|Overall Study||109
3066966|NCT01300351|3787578|FG001|Received Study Treatment|Overall Study||110
3066967|NCT01300351|3787577|FG000|COMPLETED|Overall Study||75
3066968|NCT01300351|3787578|FG001|COMPLETED|Overall Study||72
3066969|NCT01300351|3787577|FG000|NOT COMPLETED|Overall Study||36
3066970|NCT01300351|3787578|FG001|NOT COMPLETED|Overall Study||38
3066971|NCT01300455|3787586|FG000|STARTED|Period 1||13
3066972|NCT01300455|3787587|FG001|STARTED|Period 1||13
3066973|NCT01300455|3787586|FG000|COMPLETED|Period 1||13
3066974|NCT01300455|3787587|FG001|COMPLETED|Period 1||13
3066975|NCT01300455|3787586|FG000|NOT COMPLETED|Period 1||0
3066976|NCT01300455|3787587|FG001|NOT COMPLETED|Period 1||0
3066977|NCT01300455|3787586|FG000|STARTED|Washout||13
3066978|NCT01300455|3787587|FG001|STARTED|Washout||13
3066979|NCT01300455|3787586|FG000|COMPLETED|Washout||12
3066980|NCT01300455|3787587|FG001|COMPLETED|Washout||13
3066981|NCT01300455|3787586|FG000|NOT COMPLETED|Washout||1
3066982|NCT01300455|3787587|FG001|NOT COMPLETED|Washout||0
3066983|NCT01300455|3787586|FG000|STARTED|Period 2||12
3066984|NCT01300455|3787587|FG001|STARTED|Period 2||13
3066985|NCT01300455|3787586|FG000|COMPLETED|Period 2||12
3066986|NCT01300455|3787587|FG001|COMPLETED|Period 2||13
3066987|NCT01300455|3787586|FG000|NOT COMPLETED|Period 2||0
3066988|NCT01300455|3787587|FG001|NOT COMPLETED|Period 2||0
3066989|NCT01300546|3787595|FG000|STARTED|Overall Study||19
3066990|NCT01300546|3787596|FG001|STARTED|Overall Study||20
3066991|NCT01300546|3787595|FG000|COMPLETED|Overall Study||18
3066992|NCT01300546|3787596|FG001|COMPLETED|Overall Study||14
3066993|NCT01300546|3787595|FG000|NOT COMPLETED|Overall Study||1
3066994|NCT01300546|3787596|FG001|NOT COMPLETED|Overall Study||6
3066995|NCT01300559|3787604|FG000|STARTED|Overall Study||30
3066996|NCT01300559|3787605|FG001|STARTED|Overall Study||30
3066997|NCT01300559|3787604|FG000|COMPLETED|Overall Study||30
3284289|NCT02763254|4018110|FG000|COMPLETED|Overall Study||0
3066998|NCT01300559|3787605|FG001|COMPLETED|Overall Study||30
3066999|NCT01300559|3787604|FG000|NOT COMPLETED|Overall Study||0
3067000|NCT01300559|3787605|FG001|NOT COMPLETED|Overall Study||0
3067001|NCT01300572|3787611|FG000|STARTED|Overall Study||16
3067002|NCT01300572|3787611|FG000|COMPLETED|Overall Study||15
3067003|NCT01300572|3787611|FG000|NOT COMPLETED|Overall Study||1
3067004|NCT01300624|3787616|FG000|STARTED|Overall Study||11
3067005|NCT01300624|3787616|FG000|COMPLETED|Overall Study||11
3067006|NCT01300624|3787616|FG000|NOT COMPLETED|Overall Study||0
3067007|NCT01300650|3787621|FG000|STARTED|Overall Study||8
3067008|NCT01300650|3787621|FG000|COMPLETED|Overall Study||7
3067009|NCT01300650|3787621|FG000|NOT COMPLETED|Overall Study||1
3067010|NCT01300728|3787628|FG000|STARTED|Overall Study||26
3067011|NCT01300728|3787629|FG001|STARTED|Overall Study||26
3067012|NCT01300728|3787628|FG000|COMPLETED|Overall Study||24
3067013|NCT01300728|3787629|FG001|COMPLETED|Overall Study||25
3067014|NCT01300728|3787628|FG000|NOT COMPLETED|Overall Study||2
3067015|NCT01300728|3787629|FG001|NOT COMPLETED|Overall Study||1
3067016|NCT01300741|3787635|FG000|STARTED|Overall Study||75
3067017|NCT01300741|3787635|FG000|COMPLETED|Overall Study||72
3067018|NCT01300741|3787635|FG000|NOT COMPLETED|Overall Study||3
3067019|NCT01300767|3787641|FG000|STARTED|Overall Study||74
3067020|NCT01300767|3787641|FG000|COMPLETED|Overall Study||70
3067021|NCT01300767|3787641|FG000|NOT COMPLETED|Overall Study||4
3067022|NCT01300819|3787649|FG000|STARTED|Overall Study||125
3067023|NCT01300819|3787650|FG001|STARTED|Overall Study||224
3067024|NCT01300819|3787649|FG000|COMPLETED|Overall Study||103
3067025|NCT01300819|3787650|FG001|COMPLETED|Overall Study||180
3067026|NCT01300819|3787649|FG000|NOT COMPLETED|Overall Study||22
3067027|NCT01300819|3787650|FG001|NOT COMPLETED|Overall Study||44
3067028|NCT01300923|3787656|FG000|STARTED|Overall Study||12
3067029|NCT01300923|3787657|FG001|STARTED|Overall Study||2
3067030|NCT01300923|3787656|FG000|COMPLETED|Overall Study||12
3067031|NCT01300923|3787657|FG001|COMPLETED|Overall Study||0
3067032|NCT01300923|3787656|FG000|NOT COMPLETED|Overall Study||0
3067033|NCT01300923|3787657|FG001|NOT COMPLETED|Overall Study||2
3067034|NCT01300949|3787665|FG000|STARTED|Overall Study||154
3067035|NCT01300949|3787666|FG001|STARTED|Overall Study||125
3067036|NCT01300949|3787667|FG002|STARTED|Overall Study||35
3067037|NCT01300949|3787665|FG000|COMPLETED|Overall Study||154
3067038|NCT01300949|3787666|FG001|COMPLETED|Overall Study||125
3067039|NCT01300949|3787667|FG002|COMPLETED|Overall Study||35
3067040|NCT01300949|3787665|FG000|NOT COMPLETED|Overall Study||0
3067041|NCT01300949|3787666|FG001|NOT COMPLETED|Overall Study||0
3067042|NCT01300949|3787667|FG002|NOT COMPLETED|Overall Study||0
3067043|NCT01301001|3787675|FG000|STARTED|First Intervention||44
3067044|NCT01301001|3787676|FG001|STARTED|First Intervention||45
3067045|NCT01301001|3787675|FG000|COMPLETED|First Intervention||34
3067046|NCT01301001|3787676|FG001|COMPLETED|First Intervention||36
3067047|NCT01301001|3787675|FG000|NOT COMPLETED|First Intervention||10
3067048|NCT01301001|3787676|FG001|NOT COMPLETED|First Intervention||9
3067049|NCT01301001|3787675|FG000|STARTED|Washout (2 Weeks)||34
3067050|NCT01301001|3787676|FG001|STARTED|Washout (2 Weeks)||36
3067051|NCT01301001|3787675|FG000|COMPLETED|Washout (2 Weeks)||34
3067052|NCT01301001|3787676|FG001|COMPLETED|Washout (2 Weeks)||36
3067053|NCT01301001|3787675|FG000|NOT COMPLETED|Washout (2 Weeks)||0
3067054|NCT01301001|3787676|FG001|NOT COMPLETED|Washout (2 Weeks)||0
3067055|NCT01301001|3787675|FG000|STARTED|Second Intervention||34
3067056|NCT01301001|3787676|FG001|STARTED|Second Intervention||36
3067057|NCT01301001|3787675|FG000|COMPLETED|Second Intervention||30
3067058|NCT01301001|3787676|FG001|COMPLETED|Second Intervention||36
3067059|NCT01301001|3787675|FG000|NOT COMPLETED|Second Intervention||4
3067060|NCT01301001|3787676|FG001|NOT COMPLETED|Second Intervention||0
3067061|NCT01301027|3787685|FG000|STARTED|Overall Study||48
3067062|NCT01301027|3787686|FG001|STARTED|Overall Study||47
3067063|NCT01301027|3787685|FG000|COMPLETED|Overall Study||40
3067064|NCT01301027|3787686|FG001|COMPLETED|Overall Study||37
3067065|NCT01301027|3787685|FG000|NOT COMPLETED|Overall Study||8
3067066|NCT01301027|3787686|FG001|NOT COMPLETED|Overall Study||10
3067067|NCT01301066|3787694|FG000|STARTED|Overall Study||126
3067068|NCT01301066|3787695|FG001|STARTED|Overall Study||126
3067069|NCT01301066|3787694|FG000|COMPLETED|Overall Study||99
3067070|NCT01301066|3787695|FG001|COMPLETED|Overall Study||91
3067071|NCT01301066|3787694|FG000|NOT COMPLETED|Overall Study||27
3067072|NCT01301066|3787695|FG001|NOT COMPLETED|Overall Study||35
3067073|NCT01301079|3787703|FG000|STARTED|Overall Study||30
3067074|NCT01301079|3787704|FG001|STARTED|Overall Study||30
3067075|NCT01301079|3787703|FG000|COMPLETED|Overall Study||28
3067076|NCT01301079|3787704|FG001|COMPLETED|Overall Study||28
3067077|NCT01301079|3787703|FG000|NOT COMPLETED|Overall Study||2
3067078|NCT01301079|3787704|FG001|NOT COMPLETED|Overall Study||2
3067079|NCT01301092|3787717|FG000|STARTED|Overall Study||6
3067080|NCT01301092|3787718|FG001|STARTED|Overall Study||16
3067081|NCT01301092|3787719|FG002|STARTED|Overall Study||8
3067082|NCT01301092|3787717|FG000|COMPLETED|Overall Study||6
3067083|NCT01301092|3787718|FG001|COMPLETED|Overall Study||16
3067084|NCT01301092|3787719|FG002|COMPLETED|Overall Study||7
3067085|NCT01301092|3787717|FG000|NOT COMPLETED|Overall Study||0
3067086|NCT01301092|3787718|FG001|NOT COMPLETED|Overall Study||0
3067087|NCT01301092|3787719|FG002|NOT COMPLETED|Overall Study||1
3067088|NCT01301183|3787734|FG000|STARTED|Overall Study||38
3067089|NCT01301183|3787735|FG001|STARTED|Overall Study||37
3067090|NCT01301183|3787734|FG000|COMPLETED|Overall Study||12
3067091|NCT01301183|3787735|FG001|COMPLETED|Overall Study||21
3067092|NCT01301183|3787734|FG000|NOT COMPLETED|Overall Study||26
3067093|NCT01301183|3787735|FG001|NOT COMPLETED|Overall Study||16
3067094|NCT01301274|3787743|FG000|STARTED|Overall Study||34
3067095|NCT01301274|3787744|FG001|STARTED|Overall Study||32
3067096|NCT01301274|3787743|FG000|COMPLETED|Overall Study||32
3067097|NCT01301274|3787744|FG001|COMPLETED|Overall Study||31
3067098|NCT01301274|3787743|FG000|NOT COMPLETED|Overall Study||2
3067099|NCT01301274|3787744|FG001|NOT COMPLETED|Overall Study||1
3067100|NCT01301391|3787755|FG000|STARTED|Overall Study|On treatment until disease progression, patient withdrawal of consent, or unacceptable toxicity.|30
3067101|NCT01301391|3787755|FG000|COMPLETED|Overall Study||4
3067102|NCT01301391|3787755|FG000|NOT COMPLETED|Overall Study||26
3067103|NCT01301456|3787771|FG000|STARTED|Stage 1||15
3067104|NCT01301456|3787772|FG001|STARTED|Stage 1||5
3067105|NCT01301456|3787773|FG002|STARTED|Stage 1||6
3067106|NCT01301456|3787774|FG003|STARTED|Stage 1||6
3067107|NCT01301456|3787775|FG004|STARTED|Stage 1||7
3067108|NCT01301456|3787776|FG005|STARTED|Stage 1||5
3067109|NCT01301456|3787777|FG006|STARTED|Stage 1||8
3067110|NCT01301456|3787778|FG007|STARTED|Stage 1||0
3067111|NCT01301456|3787779|FG008|STARTED|Stage 1||0
3067112|NCT01301456|3787780|FG009|STARTED|Stage 1||0
3067113|NCT01301456|3787781|FG010|STARTED|Stage 1||0
3067114|NCT01301456|3787782|FG011|STARTED|Stage 1||0
3067115|NCT01301456|3787771|FG000|Received Treatment|Stage 1||15
3067116|NCT01301456|3787772|FG001|Received Treatment|Stage 1||5
3067117|NCT01301456|3787773|FG002|Received Treatment|Stage 1||6
3067118|NCT01301456|3787774|FG003|Received Treatment|Stage 1||6
3067119|NCT01301456|3787775|FG004|Received Treatment|Stage 1||7
3067120|NCT01301456|3787776|FG005|Received Treatment|Stage 1||5
3067121|NCT01301456|3787777|FG006|Received Treatment|Stage 1||7
3067122|NCT01301456|3787778|FG007|Received Treatment|Stage 1||0
3067123|NCT01301456|3787779|FG008|Received Treatment|Stage 1||0
3067124|NCT01301456|3787780|FG009|Received Treatment|Stage 1||0
3067125|NCT01301456|3787781|FG010|Received Treatment|Stage 1||0
3067126|NCT01301456|3787782|FG011|Received Treatment|Stage 1||0
3067127|NCT01301456|3787771|FG000|COMPLETED|Stage 1||15
3067128|NCT01301456|3787772|FG001|COMPLETED|Stage 1||5
3067129|NCT01301456|3787773|FG002|COMPLETED|Stage 1||5
3067130|NCT01301456|3787774|FG003|COMPLETED|Stage 1||6
3067131|NCT01301456|3787775|FG004|COMPLETED|Stage 1||6
3067132|NCT01301456|3787776|FG005|COMPLETED|Stage 1||5
3067133|NCT01301456|3787777|FG006|COMPLETED|Stage 1||7
3067134|NCT01301456|3787778|FG007|COMPLETED|Stage 1||0
3067135|NCT01301456|3787779|FG008|COMPLETED|Stage 1||0
3067136|NCT01301456|3787780|FG009|COMPLETED|Stage 1||0
3067137|NCT01301456|3787781|FG010|COMPLETED|Stage 1||0
3067138|NCT01301456|3787782|FG011|COMPLETED|Stage 1||0
3067139|NCT01301456|3787771|FG000|NOT COMPLETED|Stage 1||0
3067140|NCT01301456|3787772|FG001|NOT COMPLETED|Stage 1||0
3067141|NCT01301456|3787773|FG002|NOT COMPLETED|Stage 1||1
3067142|NCT01301456|3787774|FG003|NOT COMPLETED|Stage 1||0
3067143|NCT01301456|3787775|FG004|NOT COMPLETED|Stage 1||1
3067144|NCT01301456|3787776|FG005|NOT COMPLETED|Stage 1||0
3067145|NCT01301456|3787777|FG006|NOT COMPLETED|Stage 1||1
3067146|NCT01301456|3787778|FG007|NOT COMPLETED|Stage 1||0
3067147|NCT01301456|3787779|FG008|NOT COMPLETED|Stage 1||0
3067148|NCT01301456|3787780|FG009|NOT COMPLETED|Stage 1||0
3067149|NCT01301456|3787781|FG010|NOT COMPLETED|Stage 1||0
3067150|NCT01301456|3787782|FG011|NOT COMPLETED|Stage 1||0
3067151|NCT01301456|3787771|FG000|STARTED|Stage 2||0
3067152|NCT01301456|3787772|FG001|STARTED|Stage 2||0
3067153|NCT01301456|3787773|FG002|STARTED|Stage 2||0
3067154|NCT01301456|3787774|FG003|STARTED|Stage 2||0
3067155|NCT01301456|3787775|FG004|STARTED|Stage 2||0
3067156|NCT01301456|3787776|FG005|STARTED|Stage 2||0
3067157|NCT01301456|3787777|FG006|STARTED|Stage 2||0
3067158|NCT01301456|3787778|FG007|STARTED|Stage 2||7
3067159|NCT01301456|3787779|FG008|STARTED|Stage 2||5
3067160|NCT01301456|3787780|FG009|STARTED|Stage 2||7
3067161|NCT01301456|3787781|FG010|STARTED|Stage 2||7
3067162|NCT01301456|3787782|FG011|STARTED|Stage 2||6
3067163|NCT01301456|3787771|FG000|Received Treatment|Stage 2||0
3067164|NCT01301456|3787772|FG001|Received Treatment|Stage 2||0
3067165|NCT01301456|3787773|FG002|Received Treatment|Stage 2||0
3067166|NCT01301456|3787774|FG003|Received Treatment|Stage 2||0
3067167|NCT01301456|3787775|FG004|Received Treatment|Stage 2||0
3067168|NCT01301456|3787776|FG005|Received Treatment|Stage 2||0
3067169|NCT01301456|3787777|FG006|Received Treatment|Stage 2||0
3067170|NCT01301456|3787778|FG007|Received Treatment|Stage 2||7
3067171|NCT01301456|3787779|FG008|Received Treatment|Stage 2||5
3067172|NCT01301456|3787780|FG009|Received Treatment|Stage 2||7
3067173|NCT01301456|3787781|FG010|Received Treatment|Stage 2||7
3067174|NCT01301456|3787782|FG011|Received Treatment|Stage 2||6
3067175|NCT01301456|3787771|FG000|COMPLETED|Stage 2||0
3067176|NCT01301456|3787772|FG001|COMPLETED|Stage 2||0
3067177|NCT01301456|3787773|FG002|COMPLETED|Stage 2||0
3067178|NCT01301456|3787774|FG003|COMPLETED|Stage 2||0
3067179|NCT01301456|3787775|FG004|COMPLETED|Stage 2||0
3067180|NCT01301456|3787776|FG005|COMPLETED|Stage 2||0
3067181|NCT01301456|3787777|FG006|COMPLETED|Stage 2||0
3067182|NCT01301456|3787778|FG007|COMPLETED|Stage 2||7
3067183|NCT01301456|3787779|FG008|COMPLETED|Stage 2||5
3067184|NCT01301456|3787780|FG009|COMPLETED|Stage 2||7
3067185|NCT01301456|3787781|FG010|COMPLETED|Stage 2||6
3067186|NCT01301456|3787782|FG011|COMPLETED|Stage 2||6
3067187|NCT01301456|3787771|FG000|NOT COMPLETED|Stage 2||0
3067188|NCT01301456|3787772|FG001|NOT COMPLETED|Stage 2||0
3067189|NCT01301456|3787773|FG002|NOT COMPLETED|Stage 2||0
3067190|NCT01301456|3787774|FG003|NOT COMPLETED|Stage 2||0
3067191|NCT01301456|3787775|FG004|NOT COMPLETED|Stage 2||0
3067192|NCT01301456|3787776|FG005|NOT COMPLETED|Stage 2||0
3067193|NCT01301456|3787777|FG006|NOT COMPLETED|Stage 2||0
3067194|NCT01301456|3787778|FG007|NOT COMPLETED|Stage 2||0
3067195|NCT01301456|3787779|FG008|NOT COMPLETED|Stage 2||0
3067196|NCT01301456|3787780|FG009|NOT COMPLETED|Stage 2||0
3067197|NCT01301456|3787781|FG010|NOT COMPLETED|Stage 2||1
3067198|NCT01301456|3787782|FG011|NOT COMPLETED|Stage 2||0
3067199|NCT01301508|3787828|FG000|STARTED|Overall Study||21
3067200|NCT01301508|3787829|FG001|STARTED|Overall Study||25
3067201|NCT01301508|3787828|FG000|COMPLETED|Overall Study||20
3067202|NCT01301508|3787829|FG001|COMPLETED|Overall Study||22
3067203|NCT01301508|3787828|FG000|NOT COMPLETED|Overall Study||1
3067204|NCT01301508|3787829|FG001|NOT COMPLETED|Overall Study||3
3067205|NCT01301625|3787835|FG000|STARTED|Overall Study||78
3067206|NCT01301625|3787835|FG000|COMPLETED|Overall Study||43
3067207|NCT01301625|3787835|FG000|NOT COMPLETED|Overall Study||35
3067208|NCT01301729|3787839|FG000|STARTED|Overall Study||32
3067209|NCT01301729|3787839|FG000|COMPLETED|Overall Study||28
3067210|NCT01301729|3787839|FG000|NOT COMPLETED|Overall Study||4
3067211|NCT01301742|3787844|FG000|STARTED|First Intervention||9
3067212|NCT01301742|3787845|FG001|STARTED|First Intervention||9
3067213|NCT01301742|3787844|FG000|COMPLETED|First Intervention||9
3067214|NCT01301742|3787845|FG001|COMPLETED|First Intervention||9
3067215|NCT01301742|3787844|FG000|NOT COMPLETED|First Intervention||0
3067216|NCT01301742|3787845|FG001|NOT COMPLETED|First Intervention||0
3067217|NCT01301742|3787844|FG000|STARTED|Washout Period of at Least 7 Days||9
3067218|NCT01301742|3787845|FG001|STARTED|Washout Period of at Least 7 Days||9
3067219|NCT01301742|3787844|FG000|COMPLETED|Washout Period of at Least 7 Days||9
3067220|NCT01301742|3787845|FG001|COMPLETED|Washout Period of at Least 7 Days||9
3067221|NCT01301742|3787844|FG000|NOT COMPLETED|Washout Period of at Least 7 Days||0
3067222|NCT01301742|3787845|FG001|NOT COMPLETED|Washout Period of at Least 7 Days||0
3067223|NCT01301742|3787844|FG000|STARTED|Second Intervention||9
3067224|NCT01301742|3787845|FG001|STARTED|Second Intervention||9
3067225|NCT01301742|3787844|FG000|COMPLETED|Second Intervention||9
3067226|NCT01301742|3787845|FG001|COMPLETED|Second Intervention||9
3067227|NCT01301742|3787844|FG000|NOT COMPLETED|Second Intervention||0
3067228|NCT01301742|3787845|FG001|NOT COMPLETED|Second Intervention||0
3067229|NCT01301833|3787856|FG000|STARTED|Overall Study||212
3067230|NCT01301833|3787857|FG001|STARTED|Overall Study||80
3067231|NCT01301833|3787858|FG002|STARTED|Overall Study||95
3067232|NCT01301833|3787859|FG003|STARTED|Overall Study||75
3067233|NCT01301833|3787856|FG000|COMPLETED|Overall Study||197
3067234|NCT01301833|3787857|FG001|COMPLETED|Overall Study||72
3067235|NCT01301833|3787858|FG002|COMPLETED|Overall Study||88
3067236|NCT01301833|3787859|FG003|COMPLETED|Overall Study||68
3067237|NCT01301833|3787856|FG000|NOT COMPLETED|Overall Study||15
3067238|NCT01301833|3787857|FG001|NOT COMPLETED|Overall Study||8
3067239|NCT01301833|3787858|FG002|NOT COMPLETED|Overall Study||7
3067240|NCT01301833|3787859|FG003|NOT COMPLETED|Overall Study||7
3067241|NCT01301950|3787871|FG000|STARTED|Overall Study||15
3067242|NCT01301950|3787872|FG001|STARTED|Overall Study||15
3067243|NCT01301950|3787871|FG000|COMPLETED|Overall Study||15
3067244|NCT01301950|3787872|FG001|COMPLETED|Overall Study||14
3067245|NCT01301950|3787871|FG000|NOT COMPLETED|Overall Study||0
3067246|NCT01301950|3787872|FG001|NOT COMPLETED|Overall Study||1
3067247|NCT01302041|3787878|FG000|STARTED|Overall Study||67
3067248|NCT01302041|3787878|FG000|Treatment Received|Overall Study||67
3067249|NCT01302041|3787878|FG000|COMPLETED|Overall Study|Participants who discontinued treatment and completed the 30-day follow-up visit|27
3067250|NCT01302041|3787878|FG000|NOT COMPLETED|Overall Study||40
3067251|NCT01302054|3787883|FG000|STARTED|Tolterodine Open-Label Run-In Phase||990
3067252|NCT01302054|3787884|FG001|STARTED|Tolterodine Open-Label Run-In Phase||0
3067253|NCT01302054|3787885|FG002|STARTED|Tolterodine Open-Label Run-In Phase||0
3067254|NCT01302054|3787883|FG000|COMPLETED|Tolterodine Open-Label Run-In Phase||611
3067255|NCT01302054|3787884|FG001|COMPLETED|Tolterodine Open-Label Run-In Phase||0
3067256|NCT01302054|3787885|FG002|COMPLETED|Tolterodine Open-Label Run-In Phase||0
3067257|NCT01302054|3787883|FG000|NOT COMPLETED|Tolterodine Open-Label Run-In Phase||379
3067258|NCT01302054|3787884|FG001|NOT COMPLETED|Tolterodine Open-Label Run-In Phase||0
3067259|NCT01302054|3787885|FG002|NOT COMPLETED|Tolterodine Open-Label Run-In Phase||0
3067260|NCT01302054|3787883|FG000|STARTED|Between Open-Label and Double Blind||611
3067261|NCT01302054|3787884|FG001|STARTED|Between Open-Label and Double Blind||0
3067262|NCT01302054|3787885|FG002|STARTED|Between Open-Label and Double Blind||0
3067263|NCT01302054|3787883|FG000|COMPLETED|Between Open-Label and Double Blind||609
3067264|NCT01302054|3787884|FG001|COMPLETED|Between Open-Label and Double Blind||0
3067265|NCT01302054|3787885|FG002|COMPLETED|Between Open-Label and Double Blind||0
3067266|NCT01302054|3787883|FG000|NOT COMPLETED|Between Open-Label and Double Blind||2
3067267|NCT01302054|3787884|FG001|NOT COMPLETED|Between Open-Label and Double Blind||0
3067268|NCT01302054|3787885|FG002|NOT COMPLETED|Between Open-Label and Double Blind||0
3067269|NCT01302054|3787883|FG000|STARTED|Double-Blind Treatment Phase||0
3067270|NCT01302054|3787884|FG001|STARTED|Double-Blind Treatment Phase||308
3067271|NCT01302054|3787885|FG002|STARTED|Double-Blind Treatment Phase||301
3067272|NCT01302054|3787883|FG000|COMPLETED|Double-Blind Treatment Phase||0
3067273|NCT01302054|3787884|FG001|COMPLETED|Double-Blind Treatment Phase||281
3067274|NCT01302054|3787885|FG002|COMPLETED|Double-Blind Treatment Phase||255
3067275|NCT01302054|3787883|FG000|NOT COMPLETED|Double-Blind Treatment Phase||0
3067276|NCT01302054|3787884|FG001|NOT COMPLETED|Double-Blind Treatment Phase||27
3067277|NCT01302054|3787885|FG002|NOT COMPLETED|Double-Blind Treatment Phase||46
3067278|NCT01302067|3787897|FG000|STARTED|Overall Study||790
3067279|NCT01302067|3787898|FG001|STARTED|Overall Study||386
3067280|NCT01302067|3787899|FG002|STARTED|Overall Study||779
3067281|NCT01302067|3787897|FG000|COMPLETED|Overall Study||712
3067282|NCT01302067|3787898|FG001|COMPLETED|Overall Study||352
3067283|NCT01302067|3787899|FG002|COMPLETED|Overall Study||681
3067284|NCT01302067|3787897|FG000|NOT COMPLETED|Overall Study||78
3067285|NCT01302067|3787898|FG001|NOT COMPLETED|Overall Study||34
3067286|NCT01302067|3787899|FG002|NOT COMPLETED|Overall Study||98
3067287|NCT01302080|3787910|FG000|STARTED|Overall Study|Out of 696 participants, 1 participant started treatment with another antidepressant alone or along with psychotherapy.|696
3067288|NCT01302080|3787911|FG001|STARTED|Overall Study|Out of 245 participants, 2 participants started treatment with another antidepressant alone or along with psychotherapy.|245
3067289|NCT01302080|3787910|FG000|COMPLETED|Overall Study||330
3067290|NCT01302080|3787911|FG001|COMPLETED|Overall Study||102
3067291|NCT01302080|3787910|FG000|NOT COMPLETED|Overall Study||366
3067292|NCT01302080|3787911|FG001|NOT COMPLETED|Overall Study||143
3067293|NCT01302119|3787943|FG000|STARTED|Overall Study||399
3067294|NCT01302119|3787944|FG001|STARTED|Overall Study||205
3067295|NCT01302119|3787943|FG000|COMPLETED|Overall Study||349
3067296|NCT01302119|3787944|FG001|COMPLETED|Overall Study||177
3067297|NCT01302119|3787943|FG000|NOT COMPLETED|Overall Study||50
3067298|NCT01302119|3787944|FG001|NOT COMPLETED|Overall Study||28
3067299|NCT01302366|3787950|FG000|STARTED|Overall Study||20
3067300|NCT01302366|3787950|FG000|COMPLETED|Overall Study||15
3067301|NCT01302366|3787950|FG000|NOT COMPLETED|Overall Study||5
3067302|NCT01302379|3787958|FG000|STARTED|Overall Study||83
3067303|NCT01302379|3787959|FG001|STARTED|Overall Study||83
3067304|NCT01302379|3787960|FG002|STARTED|Overall Study||84
3067305|NCT01302379|3787961|FG003|STARTED|Overall Study||83
3067306|NCT01302379|3787958|FG000|COMPLETED|Overall Study||76
3067307|NCT01302379|3787959|FG001|COMPLETED|Overall Study||78
3067308|NCT01302379|3787960|FG002|COMPLETED|Overall Study||80
3067309|NCT01302379|3787961|FG003|COMPLETED|Overall Study||79
3067310|NCT01302379|3787958|FG000|NOT COMPLETED|Overall Study||7
3067311|NCT01302379|3787959|FG001|NOT COMPLETED|Overall Study||5
3067312|NCT01302379|3787960|FG002|NOT COMPLETED|Overall Study||4
3067313|NCT01302379|3787961|FG003|NOT COMPLETED|Overall Study||4
3067314|NCT01302392|3787971|FG000|STARTED|Overall Study||158
3067315|NCT01302392|3787972|FG001|STARTED|Overall Study||157
3067316|NCT01302392|3787971|FG000|Treated|Overall Study||153
3067317|NCT01302392|3787972|FG001|Treated|Overall Study||157
3067318|NCT01302392|3787971|FG000|COMPLETED|Overall Study||151
3067319|NCT01302392|3787972|FG001|COMPLETED|Overall Study||156
3067320|NCT01302392|3787971|FG000|NOT COMPLETED|Overall Study||7
3067321|NCT01302392|3787972|FG001|NOT COMPLETED|Overall Study||1
3067322|NCT01302418|3787978|FG000|STARTED|Overall Study||272
3067323|NCT01302418|3787978|FG000|COMPLETED|Overall Study||254
3067324|NCT01302418|3787978|FG000|NOT COMPLETED|Overall Study||18
3067325|NCT01302483|3787984|FG000|STARTED|Overall Study||30
3067326|NCT01302483|3787985|FG001|STARTED|Overall Study||15
3067327|NCT01302483|3787984|FG000|COMPLETED|Overall Study||30
3067328|NCT01302483|3787985|FG001|COMPLETED|Overall Study||15
3067329|NCT01302483|3787984|FG000|NOT COMPLETED|Overall Study||0
3067330|NCT01302483|3787985|FG001|NOT COMPLETED|Overall Study||0
3067331|NCT01302548|3787999|FG000|STARTED|Overall Study||14
3067332|NCT01302548|3788000|FG001|STARTED|Overall Study||19
3067333|NCT01302548|3787999|FG000|COMPLETED|Overall Study||12
3067334|NCT01302548|3788000|FG001|COMPLETED|Overall Study||18
3067335|NCT01302548|3787999|FG000|NOT COMPLETED|Overall Study||2
3067336|NCT01302548|3788000|FG001|NOT COMPLETED|Overall Study||1
3067337|NCT01302691|3788008|FG000|STARTED|Overall Study||164
3067338|NCT01302691|3788009|FG001|STARTED|Overall Study||163
3067339|NCT01302691|3788008|FG000|COMPLETED|Overall Study||154
3067340|NCT01302691|3788009|FG001|COMPLETED|Overall Study||157
3067341|NCT01302691|3788008|FG000|NOT COMPLETED|Overall Study||10
3067342|NCT01302691|3788009|FG001|NOT COMPLETED|Overall Study||6
3067343|NCT01302743|3788018|FG000|STARTED|Overall Study||7
3067344|NCT01302743|3788019|FG001|STARTED|Overall Study||8
3067345|NCT01302743|3788020|FG002|STARTED|Overall Study||10
3067346|NCT01302743|3788018|FG000|COMPLETED|Overall Study||6
3067347|NCT01302743|3788019|FG001|COMPLETED|Overall Study||7
3067348|NCT01302743|3788020|FG002|COMPLETED|Overall Study||8
3067349|NCT01302743|3788018|FG000|NOT COMPLETED|Overall Study||1
3067350|NCT01302743|3788019|FG001|NOT COMPLETED|Overall Study||1
3067351|NCT01302743|3788020|FG002|NOT COMPLETED|Overall Study||2
3067352|NCT01302808|3788032|FG000|STARTED|Overall Study||3
3067353|NCT01302808|3788033|FG001|STARTED|Overall Study||7
3067354|NCT01302808|3788034|FG002|STARTED|Overall Study||4
3067355|NCT01302808|3788035|FG003|STARTED|Overall Study||3
3067356|NCT01302808|3788032|FG000|COMPLETED|Overall Study||3
3067357|NCT01302808|3788033|FG001|COMPLETED|Overall Study||7
3067358|NCT01302808|3788034|FG002|COMPLETED|Overall Study||4
3067359|NCT01302808|3788035|FG003|COMPLETED|Overall Study||3
3067360|NCT01302808|3788032|FG000|NOT COMPLETED|Overall Study||0
3067361|NCT01302808|3788033|FG001|NOT COMPLETED|Overall Study||0
3067362|NCT01302808|3788034|FG002|NOT COMPLETED|Overall Study||0
3067363|NCT01302808|3788035|FG003|NOT COMPLETED|Overall Study||0
3067364|NCT01302834|3788049|FG000|STARTED|Overall Study||424
3067365|NCT01302834|3788050|FG001|STARTED|Overall Study||425
3067366|NCT01302834|3788049|FG000|Eligible|Overall Study||406
3067367|NCT01302834|3788050|FG001|Eligible|Overall Study||399
3067368|NCT01302834|3788049|FG000|Started Treatment|Overall Study||398
3067369|NCT01302834|3788050|FG001|Started Treatment|Overall Study||394
3067370|NCT01302834|3788049|FG000|AE Assessed 1 Month Post-treatment (PT)|Overall Study||369
3067371|NCT01302834|3788050|FG001|AE Assessed 1 Month Post-treatment (PT)|Overall Study||363
3067372|NCT01302834|3788049|FG000|AE Assessed 3 Months PT|Overall Study||359
3067373|NCT01302834|3788050|FG001|AE Assessed 3 Months PT|Overall Study||367
3067374|NCT01302834|3788049|FG000|AE Assessed 6 Months PT|Overall Study||361
3067375|NCT01302834|3788050|FG001|AE Assessed 6 Months PT|Overall Study||352
3067376|NCT01302834|3788049|FG000|AE Assessment 1 Year PT|Overall Study||360
3067377|NCT01302834|3788050|FG001|AE Assessment 1 Year PT|Overall Study||351
3067378|NCT01302834|3788049|FG000|AE Assessed 2 Years PT|Overall Study||311
3067379|NCT01302834|3788050|FG001|AE Assessed 2 Years PT|Overall Study||303
3067380|NCT01302834|3788049|FG000|AE Assessed 5 Years PT|Overall Study||92
3067381|NCT01302834|3788050|FG001|AE Assessed 5 Years PT|Overall Study||86
3067382|NCT01302834|3788049|FG000|Dental Health Assessed 1 Year PT|Overall Study||267
3067383|NCT01302834|3788050|FG001|Dental Health Assessed 1 Year PT|Overall Study||267
3067384|NCT01302834|3788049|FG000|Dental Health Assessed 2 Years PT|Overall Study||208
3067385|NCT01302834|3788050|FG001|Dental Health Assessed 2 Years PT|Overall Study||201
3067386|NCT01302834|3788049|FG000|Dental Health Assessed 5 Years PT|Overall Study||44
3067387|NCT01302834|3788050|FG001|Dental Health Assessed 5 Years PT|Overall Study||43
3067388|NCT01302834|3788049|FG000|Feeding Tube Assessed|Overall Study||368
3067389|NCT01302834|3788050|FG001|Feeding Tube Assessed|Overall Study||356
3067390|NCT01302834|3788049|FG000|Progressed|Overall Study||76
3067391|NCT01302834|3788050|FG001|Progressed|Overall Study||122
3067392|NCT01302834|3788049|FG000|COMPLETED|Overall Study||406
3067393|NCT01302834|3788050|FG001|COMPLETED|Overall Study||399
3067394|NCT01302834|3788049|FG000|NOT COMPLETED|Overall Study||18
3067395|NCT01302834|3788050|FG001|NOT COMPLETED|Overall Study||26
3067396|NCT01302860|3788056|FG000|STARTED|Overall Study||17
3067397|NCT01302860|3788056|FG000|COMPLETED|Overall Study||17
3067398|NCT01302860|3788056|FG000|NOT COMPLETED|Overall Study||0
3067399|NCT01302899|3788062|FG000|STARTED|Period 1 (Day 1 to End of Week 6)||4
3067400|NCT01302899|3788063|FG001|STARTED|Period 1 (Day 1 to End of Week 6)||4
3067401|NCT01302899|3788062|FG000|COMPLETED|Period 1 (Day 1 to End of Week 6)||4
3067402|NCT01302899|3788063|FG001|COMPLETED|Period 1 (Day 1 to End of Week 6)||4
3067403|NCT01302899|3788062|FG000|NOT COMPLETED|Period 1 (Day 1 to End of Week 6)||0
3067404|NCT01302899|3788063|FG001|NOT COMPLETED|Period 1 (Day 1 to End of Week 6)||0
3067405|NCT01302899|3788062|FG000|STARTED|Period 2 (Weeks 7 to 12)||4
3067406|NCT01302899|3788063|FG001|STARTED|Period 2 (Weeks 7 to 12)||4
3067407|NCT01302899|3788062|FG000|COMPLETED|Period 2 (Weeks 7 to 12)||3
3067408|NCT01302899|3788063|FG001|COMPLETED|Period 2 (Weeks 7 to 12)||3
3067409|NCT01302899|3788062|FG000|NOT COMPLETED|Period 2 (Weeks 7 to 12)||1
3067410|NCT01302899|3788063|FG001|NOT COMPLETED|Period 2 (Weeks 7 to 12)||1
3067411|NCT01302899|3788062|FG000|STARTED|Period 3 (Weeks 13 to 18)||3
3067412|NCT01302899|3788063|FG001|STARTED|Period 3 (Weeks 13 to 18)||3
3067413|NCT01302899|3788062|FG000|COMPLETED|Period 3 (Weeks 13 to 18)||3
3067414|NCT01302899|3788063|FG001|COMPLETED|Period 3 (Weeks 13 to 18)||3
3067415|NCT01302899|3788062|FG000|NOT COMPLETED|Period 3 (Weeks 13 to 18)||0
3067416|NCT01302899|3788063|FG001|NOT COMPLETED|Period 3 (Weeks 13 to 18)||0
3067417|NCT01302899|3788062|FG000|STARTED|Period 4 (Weeks 19 to 26)||3
3067418|NCT01302899|3788063|FG001|STARTED|Period 4 (Weeks 19 to 26)||3
3067419|NCT01302899|3788062|FG000|COMPLETED|Period 4 (Weeks 19 to 26)||3
3067420|NCT01302899|3788063|FG001|COMPLETED|Period 4 (Weeks 19 to 26)||3
3067421|NCT01302899|3788062|FG000|NOT COMPLETED|Period 4 (Weeks 19 to 26)||0
3067422|NCT01302899|3788063|FG001|NOT COMPLETED|Period 4 (Weeks 19 to 26)||0
3067423|NCT01302938|3788075|FG000|STARTED|Overall Study||12
3067424|NCT01302938|3788076|FG001|STARTED|Overall Study||6
3067425|NCT01302938|3788075|FG000|COMPLETED|Overall Study||10
3067426|NCT01302938|3788076|FG001|COMPLETED|Overall Study||6
3067427|NCT01302938|3788075|FG000|NOT COMPLETED|Overall Study||2
3067428|NCT01302938|3788076|FG001|NOT COMPLETED|Overall Study||0
3067429|NCT01302964|3788085|FG000|STARTED|Overall Study||20
3067430|NCT01302964|3788086|FG001|STARTED|Overall Study||10
3067431|NCT01302964|3788085|FG000|COMPLETED|Overall Study||19
3067432|NCT01302964|3788086|FG001|COMPLETED|Overall Study||10
3067433|NCT01302964|3788085|FG000|NOT COMPLETED|Overall Study||1
3067434|NCT01302964|3788086|FG001|NOT COMPLETED|Overall Study||0
3067435|NCT01303068|3788094|FG000|STARTED|Overall Study||6
3067436|NCT01303068|3788095|FG001|STARTED|Overall Study||6
3067437|NCT01303068|3788094|FG000|COMPLETED|Overall Study||6
3067438|NCT01303068|3788095|FG001|COMPLETED|Overall Study||6
3067439|NCT01303068|3788094|FG000|NOT COMPLETED|Overall Study||0
3067440|NCT01303068|3788095|FG001|NOT COMPLETED|Overall Study||0
3067441|NCT01303159|3788101|FG000|STARTED|Overall Study||29
3067442|NCT01303159|3788101|FG000|COMPLETED|Overall Study||6
3067443|NCT01303159|3788101|FG000|NOT COMPLETED|Overall Study||23
3067444|NCT01303172|3788107|FG000|STARTED|Overall Study||75
3067445|NCT01303172|3788108|FG001|STARTED|Overall Study||35
3067446|NCT01303172|3788107|FG000|COMPLETED|Overall Study||12
3067447|NCT01303172|3788108|FG001|COMPLETED|Overall Study||1
3067448|NCT01303172|3788107|FG000|NOT COMPLETED|Overall Study||63
3067449|NCT01303172|3788108|FG001|NOT COMPLETED|Overall Study||34
3067450|NCT01303224|3788119|FG000|STARTED|Overall Study|randomised, safety population, >= 1 dose of study medication|141
3067451|NCT01303224|3788120|FG001|STARTED|Overall Study|randomised, safety population, >= 1 dose of study medication|142
3067452|NCT01303224|3788121|FG002|STARTED|Overall Study|randomised, safety population, >= 1 dose of study medication|139
3067453|NCT01303224|3788122|FG003|STARTED|Overall Study|randomised, safety population, >= 1 dose of study medication|143
3067454|NCT01303224|3788119|FG000|Intention To Treat|Overall Study|subjects with at least 1 primary endpoint evaluation post randomisation|140
3067455|NCT01303224|3788120|FG001|Intention To Treat|Overall Study|subjects with at least 1 primary endpoint evaluation post randomisation|138
3067456|NCT01303224|3788121|FG002|Intention To Treat|Overall Study|subjects with at least 1 primary endpoint evaluation post randomisation|139
3067457|NCT01303224|3788122|FG003|Intention To Treat|Overall Study|subjects with at least 1 primary endpoint evaluation post randomisation|142
3067458|NCT01303224|3788119|FG000|COMPLETED|Overall Study||130
3067459|NCT01303224|3788120|FG001|COMPLETED|Overall Study||131
3067460|NCT01303224|3788121|FG002|COMPLETED|Overall Study||133
3067461|NCT01303224|3788122|FG003|COMPLETED|Overall Study||133
3067462|NCT01303224|3788119|FG000|NOT COMPLETED|Overall Study||11
3067463|NCT01303224|3788120|FG001|NOT COMPLETED|Overall Study||11
3067464|NCT01303224|3788121|FG002|NOT COMPLETED|Overall Study||6
3067465|NCT01303224|3788122|FG003|NOT COMPLETED|Overall Study||10
3067466|NCT01303380|3788132|FG000|STARTED|Overall Study||9
3067467|NCT01303380|3788132|FG000|COMPLETED|Overall Study||8
3067468|NCT01303380|3788132|FG000|NOT COMPLETED|Overall Study||1
3067469|NCT01303406|3788138|FG000|STARTED|Overall Study||13
3067470|NCT01303406|3788139|FG001|STARTED|Overall Study||16
3067471|NCT01303406|3788138|FG000|COMPLETED|Overall Study||13
3163016|NCT01882465|3890491|FG000|STARTED|Period 2||6
3163017|NCT01882465|3890492|FG001|STARTED|Period 2||6
3163018|NCT01882465|3890493|FG002|STARTED|Period 2||5
3067472|NCT01303406|3788139|FG001|COMPLETED|Overall Study||15
3067473|NCT01303406|3788138|FG000|NOT COMPLETED|Overall Study||0
3067474|NCT01303406|3788139|FG001|NOT COMPLETED|Overall Study||1
3067475|NCT01303419|3788145|FG000|STARTED|Overall Study|Subjects who met all Inclusion and none of the Exclusion criteria|224
3067476|NCT01303419|3788145|FG000|COMPLETED|Overall Study||128
3067477|NCT01303419|3788145|FG000|NOT COMPLETED|Overall Study||96
3067478|NCT01303445|3788149|FG000|STARTED|First Intervention (7 Days)||30
3067479|NCT01303445|3788150|FG001|STARTED|First Intervention (7 Days)||30
3067480|NCT01303445|3788149|FG000|COMPLETED|First Intervention (7 Days)||29
3067481|NCT01303445|3788150|FG001|COMPLETED|First Intervention (7 Days)||30
3067482|NCT01303445|3788149|FG000|NOT COMPLETED|First Intervention (7 Days)||1
3067483|NCT01303445|3788150|FG001|NOT COMPLETED|First Intervention (7 Days)||0
3067484|NCT01303445|3788149|FG000|STARTED|Second Intervention (7 Days)||29
3067485|NCT01303445|3788150|FG001|STARTED|Second Intervention (7 Days)||30
3067486|NCT01303445|3788149|FG000|COMPLETED|Second Intervention (7 Days)||28
3067487|NCT01303445|3788150|FG001|COMPLETED|Second Intervention (7 Days)||28
3067488|NCT01303445|3788149|FG000|NOT COMPLETED|Second Intervention (7 Days)||1
3067489|NCT01303445|3788150|FG001|NOT COMPLETED|Second Intervention (7 Days)||2
3067490|NCT01303445|3788149|FG000|STARTED|Washout (14 Days)||28
3067491|NCT01303445|3788150|FG001|STARTED|Washout (14 Days)||28
3067492|NCT01303445|3788149|FG000|COMPLETED|Washout (14 Days)||27
3067493|NCT01303445|3788150|FG001|COMPLETED|Washout (14 Days)||26
3067494|NCT01303445|3788149|FG000|NOT COMPLETED|Washout (14 Days)||1
3067495|NCT01303445|3788150|FG001|NOT COMPLETED|Washout (14 Days)||2
3067496|NCT01303445|3788149|FG000|STARTED|Third Intervention (7 Days)||27
3067497|NCT01303445|3788150|FG001|STARTED|Third Intervention (7 Days)||26
3067498|NCT01303445|3788149|FG000|COMPLETED|Third Intervention (7 Days)||27
3067499|NCT01303445|3788150|FG001|COMPLETED|Third Intervention (7 Days)||26
3067500|NCT01303445|3788149|FG000|NOT COMPLETED|Third Intervention (7 Days)||0
3067501|NCT01303445|3788150|FG001|NOT COMPLETED|Third Intervention (7 Days)||0
3067502|NCT01303445|3788149|FG000|STARTED|Fourth Intervention (7 Days)||27
3067503|NCT01303445|3788150|FG001|STARTED|Fourth Intervention (7 Days)||26
3067504|NCT01303445|3788149|FG000|COMPLETED|Fourth Intervention (7 Days)||26
3067505|NCT01303445|3788150|FG001|COMPLETED|Fourth Intervention (7 Days)||26
3067506|NCT01303445|3788149|FG000|NOT COMPLETED|Fourth Intervention (7 Days)||1
3067507|NCT01303445|3788150|FG001|NOT COMPLETED|Fourth Intervention (7 Days)||0
3067508|NCT01303445|3788149|FG000|STARTED|Follow-up Period (14 Days)||26
3067509|NCT01303445|3788150|FG001|STARTED|Follow-up Period (14 Days)||26
3067510|NCT01303445|3788149|FG000|COMPLETED|Follow-up Period (14 Days)||26
3067511|NCT01303445|3788150|FG001|COMPLETED|Follow-up Period (14 Days)||25
3067512|NCT01303445|3788149|FG000|NOT COMPLETED|Follow-up Period (14 Days)||0
3067513|NCT01303445|3788150|FG001|NOT COMPLETED|Follow-up Period (14 Days)||1
3067514|NCT01303510|3788162|FG000|STARTED|Overall Study||55
3067515|NCT01303510|3788163|FG001|STARTED|Overall Study||56
3067516|NCT01303510|3788162|FG000|COMPLETED|Overall Study||54
3067517|NCT01303510|3788163|FG001|COMPLETED|Overall Study||56
3067518|NCT01303510|3788162|FG000|NOT COMPLETED|Overall Study||1
3067519|NCT01303510|3788163|FG001|NOT COMPLETED|Overall Study||0
3067520|NCT01303627|3788171|FG000|STARTED|Overall Study||21
3067521|NCT01303627|3788172|FG001|STARTED|Overall Study||21
3067522|NCT01303627|3788171|FG000|COMPLETED|Overall Study||21
3067523|NCT01303627|3788172|FG001|COMPLETED|Overall Study|One patient excluded from the study because of the failure while performing uretero-renoscopy|20
3067524|NCT01303627|3788171|FG000|NOT COMPLETED|Overall Study||0
3163019|NCT01882465|3890494|FG003|STARTED|Period 2||5
3067525|NCT01303627|3788172|FG001|NOT COMPLETED|Overall Study||1
3067526|NCT01303744|3788182|FG000|STARTED|Overall Study||24
3067527|NCT01303744|3788183|FG001|STARTED|Overall Study||24
3067528|NCT01303744|3788184|FG002|STARTED|Overall Study||24
3067529|NCT01303744|3788185|FG003|STARTED|Overall Study||24
3067530|NCT01303744|3788182|FG000|COMPLETED|Overall Study||24
3067531|NCT01303744|3788183|FG001|COMPLETED|Overall Study||24
3067532|NCT01303744|3788184|FG002|COMPLETED|Overall Study||24
3067533|NCT01303744|3788185|FG003|COMPLETED|Overall Study||24
3067534|NCT01303744|3788182|FG000|NOT COMPLETED|Overall Study||0
3067535|NCT01303744|3788183|FG001|NOT COMPLETED|Overall Study||0
3067536|NCT01303744|3788184|FG002|NOT COMPLETED|Overall Study||0
3067537|NCT01303744|3788185|FG003|NOT COMPLETED|Overall Study||0
3134240|NCT01700959|3859283|FG005|STARTED|Overall Study||97
3134241|NCT01700959|3859278|FG000|COMPLETED|Overall Study||62
3134242|NCT01700959|3859279|FG001|COMPLETED|Overall Study||64
3134243|NCT01700959|3859280|FG002|COMPLETED|Overall Study||65
3134244|NCT01700959|3859281|FG003|COMPLETED|Overall Study||70
3134245|NCT01700959|3859282|FG004|COMPLETED|Overall Study||69
3134246|NCT01700959|3859283|FG005|COMPLETED|Overall Study||72
3134247|NCT01700959|3859278|FG000|NOT COMPLETED|Overall Study||27
3134248|NCT01700959|3859279|FG001|NOT COMPLETED|Overall Study||24
3134249|NCT01700959|3859280|FG002|NOT COMPLETED|Overall Study||40
3134250|NCT01700959|3859281|FG003|NOT COMPLETED|Overall Study||35
3134251|NCT01700959|3859282|FG004|NOT COMPLETED|Overall Study||27
3134252|NCT01700959|3859283|FG005|NOT COMPLETED|Overall Study||25
3134253|NCT01700985|3859301|FG000|STARTED|Overall Study||23
3134254|NCT01700985|3859302|FG001|STARTED|Overall Study||21
3134255|NCT01700985|3859301|FG000|COMPLETED|Overall Study||23
3134256|NCT01700985|3859302|FG001|COMPLETED|Overall Study||20
3134257|NCT01700985|3859301|FG000|NOT COMPLETED|Overall Study||0
3134258|NCT01700985|3859302|FG001|NOT COMPLETED|Overall Study||1
3134259|NCT01701011|3859311|FG000|STARTED|Overall Study||127
3134260|NCT01701011|3859312|FG001|STARTED|Overall Study||126
3134261|NCT01701011|3859313|FG002|STARTED|Overall Study||124
3134262|NCT01701011|3859311|FG000|COMPLETED|Overall Study||92
3134263|NCT01701011|3859312|FG001|COMPLETED|Overall Study||102
3134264|NCT01701011|3859313|FG002|COMPLETED|Overall Study||90
3134265|NCT01701011|3859311|FG000|NOT COMPLETED|Overall Study||35
3134266|NCT01701011|3859312|FG001|NOT COMPLETED|Overall Study||24
3134267|NCT01701011|3859313|FG002|NOT COMPLETED|Overall Study||34
3134268|NCT01701024|3859324|FG000|STARTED|Overall Study||253
3134269|NCT01701024|3859325|FG001|STARTED|Overall Study||245
3134270|NCT01701024|3859324|FG000|COMPLETED|Overall Study||243
3134271|NCT01701024|3859325|FG001|COMPLETED|Overall Study||236
3134272|NCT01701024|3859324|FG000|NOT COMPLETED|Overall Study||10
3134273|NCT01701024|3859325|FG001|NOT COMPLETED|Overall Study||9
3134274|NCT01701037|3859331|FG000|STARTED|Overall Study||13
3134275|NCT01701037|3859331|FG000|COMPLETED|Overall Study||13
3134276|NCT01701037|3859331|FG000|NOT COMPLETED|Overall Study||0
3134277|NCT01701063|3859339|FG000|STARTED|Overall Study||13
3134278|NCT01701063|3859340|FG001|STARTED|Overall Study||19
3134279|NCT01701063|3859341|FG002|STARTED|Overall Study||10
3134280|NCT01701063|3859339|FG000|COMPLETED|Overall Study||13
3134281|NCT01701063|3859340|FG001|COMPLETED|Overall Study||18
3134282|NCT01701063|3859341|FG002|COMPLETED|Overall Study||8
3134283|NCT01701063|3859339|FG000|NOT COMPLETED|Overall Study||0
3134284|NCT01701063|3859340|FG001|NOT COMPLETED|Overall Study||1
3134285|NCT01701063|3859341|FG002|NOT COMPLETED|Overall Study||2
3134286|NCT01701102|3859354|FG000|STARTED|Overall Study||22
3134287|NCT01701102|3859355|FG001|STARTED|Overall Study||6
3134288|NCT01701102|3859356|FG002|STARTED|Overall Study||10
3134289|NCT01701102|3859357|FG003|STARTED|Overall Study||18
3134290|NCT01701102|3859354|FG000|COMPLETED|Overall Study||22
3134291|NCT01701102|3859355|FG001|COMPLETED|Overall Study||6
3134292|NCT01701102|3859356|FG002|COMPLETED|Overall Study||10
3134293|NCT01701102|3859357|FG003|COMPLETED|Overall Study||18
3134294|NCT01701102|3859354|FG000|NOT COMPLETED|Overall Study||0
3134295|NCT01701102|3859355|FG001|NOT COMPLETED|Overall Study||0
3134296|NCT01701102|3859356|FG002|NOT COMPLETED|Overall Study||0
3134297|NCT01701102|3859357|FG003|NOT COMPLETED|Overall Study||0
3134298|NCT01701115|3859369|FG000|STARTED|Overall Study||77
3134299|NCT01701115|3859370|FG001|STARTED|Overall Study||77
3134300|NCT01701115|3859369|FG000|COMPLETED|Overall Study||75
3134301|NCT01701115|3859370|FG001|COMPLETED|Overall Study||77
3134302|NCT01701115|3859369|FG000|NOT COMPLETED|Overall Study||2
3134303|NCT01701115|3859370|FG001|NOT COMPLETED|Overall Study||0
3134304|NCT01701193|3859380|FG000|STARTED|Overall Study||18
3134305|NCT01701193|3859381|FG001|STARTED|Overall Study||19
3134306|NCT01701193|3859382|FG002|STARTED|Overall Study||5
3134307|NCT01701193|3859383|FG003|STARTED|Overall Study||5
3134308|NCT01701193|3859380|FG000|COMPLETED|Overall Study||15
3134309|NCT01701193|3859381|FG001|COMPLETED|Overall Study||17
3134310|NCT01701193|3859382|FG002|COMPLETED|Overall Study||4
3134311|NCT01701193|3859383|FG003|COMPLETED|Overall Study||3
3134312|NCT01701193|3859380|FG000|NOT COMPLETED|Overall Study||3
3134313|NCT01701193|3859381|FG001|NOT COMPLETED|Overall Study||2
3134314|NCT01701193|3859382|FG002|NOT COMPLETED|Overall Study||1
3134315|NCT01701193|3859383|FG003|NOT COMPLETED|Overall Study||2
3134316|NCT01701245|3859398|FG000|STARTED|Overall Study||49
3134317|NCT01701245|3859399|FG001|STARTED|Overall Study||48
3134318|NCT01701245|3859398|FG000|FAS Unmatched Data|Overall Study|1 patient protocol violation|48
3134319|NCT01701245|3859399|FG001|FAS Unmatched Data|Overall Study|3 patients protocol violation|45
3067538|NCT01303835|3788197|FG000|STARTED|Overall Study||54
3067539|NCT01303835|3788198|FG001|STARTED|Overall Study||56
3067540|NCT01303835|3788197|FG000|COMPLETED|Overall Study||35
3067541|NCT01303835|3788198|FG001|COMPLETED|Overall Study||31
3067542|NCT01303835|3788197|FG000|NOT COMPLETED|Overall Study||19
3067543|NCT01303835|3788198|FG001|NOT COMPLETED|Overall Study||25
3067544|NCT01303861|3788209|FG000|STARTED|Overall Study||109
3067545|NCT01303861|3788210|FG001|STARTED|Overall Study||50
3067546|NCT01303861|3788211|FG002|STARTED|Overall Study||55
3067547|NCT01303861|3788212|FG003|STARTED|Overall Study||113
3067548|NCT01303861|3788209|FG000|Finished Treatment Phase|Overall Study||71
3067549|NCT01303861|3788210|FG001|Finished Treatment Phase|Overall Study||34
3067550|NCT01303861|3788211|FG002|Finished Treatment Phase|Overall Study||39
3067551|NCT01303861|3788212|FG003|Finished Treatment Phase|Overall Study||72
3067552|NCT01303861|3788209|FG000|COMPLETED|Overall Study||51
3067553|NCT01303861|3788210|FG001|COMPLETED|Overall Study||25
3067554|NCT01303861|3788211|FG002|COMPLETED|Overall Study||19
3067555|NCT01303861|3788212|FG003|COMPLETED|Overall Study||54
3067556|NCT01303861|3788209|FG000|NOT COMPLETED|Overall Study||58
3067557|NCT01303861|3788210|FG001|NOT COMPLETED|Overall Study||25
3067558|NCT01303861|3788211|FG002|NOT COMPLETED|Overall Study||36
3067559|NCT01303861|3788212|FG003|NOT COMPLETED|Overall Study||59
3067560|NCT01303939|3788225|FG000|STARTED|Overall Study||22
3067561|NCT01303939|3788226|FG001|STARTED|Overall Study||15
3067562|NCT01303939|3788225|FG000|COMPLETED|Overall Study|Matched controls not found for comparisons. Only best matched glaucoma patients were included.|15
3067563|NCT01303939|3788226|FG001|COMPLETED|Overall Study||15
3067564|NCT01303939|3788225|FG000|NOT COMPLETED|Overall Study||7
3067565|NCT01303939|3788226|FG001|NOT COMPLETED|Overall Study||0
3067566|NCT01303965|3788236|FG000|STARTED|Overall Study||3
3067567|NCT01303965|3788237|FG001|STARTED|Overall Study||11
3067568|NCT01303965|3788236|FG000|COMPLETED|Overall Study||0
3067569|NCT01303965|3788237|FG001|COMPLETED|Overall Study||1
3067570|NCT01303965|3788236|FG000|NOT COMPLETED|Overall Study||3
3067571|NCT01303965|3788237|FG001|NOT COMPLETED|Overall Study||10
3067572|NCT01304082|3788243|FG000|STARTED|Overall Study||3
3067573|NCT01304082|3788244|FG001|STARTED|Overall Study||2
3067574|NCT01304082|3788245|FG002|STARTED|Overall Study||11
3067575|NCT01304082|3788246|FG003|STARTED|Overall Study||8
3067576|NCT01304082|3788247|FG004|STARTED|Overall Study||5
3067577|NCT01304082|3788243|FG000|First Intervention|Overall Study||3
3067578|NCT01304082|3788244|FG001|First Intervention|Overall Study||2
3067579|NCT01304082|3788245|FG002|First Intervention|Overall Study||11
3067580|NCT01304082|3788246|FG003|First Intervention|Overall Study||8
3067581|NCT01304082|3788247|FG004|First Intervention|Overall Study||5
3067582|NCT01304082|3788243|FG000|Second Intervention|Overall Study||3
3067583|NCT01304082|3788244|FG001|Second Intervention|Overall Study||2
3067584|NCT01304082|3788245|FG002|Second Intervention|Overall Study||11
3067585|NCT01304082|3788246|FG003|Second Intervention|Overall Study||8
3067586|NCT01304082|3788247|FG004|Second Intervention|Overall Study||5
3067587|NCT01304082|3788243|FG000|Third Intervention|Overall Study||3
3067588|NCT01304082|3788244|FG001|Third Intervention|Overall Study||2
3067589|NCT01304082|3788245|FG002|Third Intervention|Overall Study||11
3067590|NCT01304082|3788246|FG003|Third Intervention|Overall Study||8
3067591|NCT01304082|3788247|FG004|Third Intervention|Overall Study||5
3067592|NCT01304082|3788243|FG000|COMPLETED|Overall Study||3
3067593|NCT01304082|3788244|FG001|COMPLETED|Overall Study||2
3067594|NCT01304082|3788245|FG002|COMPLETED|Overall Study||11
3067595|NCT01304082|3788246|FG003|COMPLETED|Overall Study||8
3067596|NCT01304082|3788247|FG004|COMPLETED|Overall Study||5
3067597|NCT01304082|3788243|FG000|NOT COMPLETED|Overall Study||0
3067598|NCT01304082|3788244|FG001|NOT COMPLETED|Overall Study||0
3067599|NCT01304082|3788245|FG002|NOT COMPLETED|Overall Study||0
3067600|NCT01304082|3788246|FG003|NOT COMPLETED|Overall Study||0
3067601|NCT01304082|3788247|FG004|NOT COMPLETED|Overall Study||0
3067602|NCT01304147|3788255|FG000|STARTED|First Intervention (7days)||10
3067603|NCT01304147|3788256|FG001|STARTED|First Intervention (7days)||10
3067604|NCT01304147|3788255|FG000|COMPLETED|First Intervention (7days)||10
3067605|NCT01304147|3788256|FG001|COMPLETED|First Intervention (7days)||10
3067606|NCT01304147|3788255|FG000|NOT COMPLETED|First Intervention (7days)||0
3067607|NCT01304147|3788256|FG001|NOT COMPLETED|First Intervention (7days)||0
3067608|NCT01304147|3788255|FG000|STARTED|Washout (1 Day)||10
3067609|NCT01304147|3788256|FG001|STARTED|Washout (1 Day)||10
3067610|NCT01304147|3788255|FG000|COMPLETED|Washout (1 Day)||10
3067611|NCT01304147|3788256|FG001|COMPLETED|Washout (1 Day)||10
3067612|NCT01304147|3788255|FG000|NOT COMPLETED|Washout (1 Day)||0
3067613|NCT01304147|3788256|FG001|NOT COMPLETED|Washout (1 Day)||0
3067614|NCT01304147|3788255|FG000|STARTED|Second Intervention (7days)||10
3067615|NCT01304147|3788256|FG001|STARTED|Second Intervention (7days)||10
3067616|NCT01304147|3788255|FG000|COMPLETED|Second Intervention (7days)||9
3067617|NCT01304147|3788256|FG001|COMPLETED|Second Intervention (7days)||9
3067618|NCT01304147|3788255|FG000|NOT COMPLETED|Second Intervention (7days)||1
3067619|NCT01304147|3788256|FG001|NOT COMPLETED|Second Intervention (7days)||1
3067620|NCT01304238|3788272|FG000|STARTED|Overall Study||32
3067621|NCT01304238|3788273|FG001|STARTED|Overall Study||4
3067622|NCT01304238|3788274|FG002|STARTED|Overall Study||46
3067623|NCT01304238|3788275|FG003|STARTED|Overall Study||78
3067624|NCT01304238|3788276|FG004|STARTED|Overall Study||11
3067625|NCT01304238|3788277|FG005|STARTED|Overall Study||11
3067626|NCT01304238|3788278|FG006|STARTED|Overall Study||5
3067627|NCT01304238|3788279|FG007|STARTED|Overall Study||4
3067628|NCT01304238|3788280|FG008|STARTED|Overall Study||1
3067629|NCT01304238|3788281|FG009|STARTED|Overall Study||3
3067630|NCT01304238|3788272|FG000|COMPLETED|Overall Study||32
3067631|NCT01304238|3788273|FG001|COMPLETED|Overall Study||4
3067632|NCT01304238|3788274|FG002|COMPLETED|Overall Study||46
3067633|NCT01304238|3788275|FG003|COMPLETED|Overall Study||78
3067634|NCT01304238|3788276|FG004|COMPLETED|Overall Study||11
3067635|NCT01304238|3788277|FG005|COMPLETED|Overall Study||11
3067636|NCT01304238|3788278|FG006|COMPLETED|Overall Study||5
3067637|NCT01304238|3788279|FG007|COMPLETED|Overall Study||4
3067638|NCT01304238|3788280|FG008|COMPLETED|Overall Study||1
3067639|NCT01304238|3788281|FG009|COMPLETED|Overall Study||3
3067640|NCT01304238|3788272|FG000|NOT COMPLETED|Overall Study||0
3067641|NCT01304238|3788273|FG001|NOT COMPLETED|Overall Study||0
3067642|NCT01304238|3788274|FG002|NOT COMPLETED|Overall Study||0
3067643|NCT01304238|3788275|FG003|NOT COMPLETED|Overall Study||0
3067644|NCT01304238|3788276|FG004|NOT COMPLETED|Overall Study||0
3067645|NCT01304238|3788277|FG005|NOT COMPLETED|Overall Study||0
3067646|NCT01304238|3788278|FG006|NOT COMPLETED|Overall Study||0
3067647|NCT01304238|3788279|FG007|NOT COMPLETED|Overall Study||0
3067648|NCT01304238|3788280|FG008|NOT COMPLETED|Overall Study||0
3067649|NCT01304238|3788281|FG009|NOT COMPLETED|Overall Study||0
3067650|NCT01304277|3788303|FG000|STARTED|Screening (Replagal RB, Week 0- Week 2)||17
3067651|NCT01304277|3788303|FG000|COMPLETED|Screening (Replagal RB, Week 0- Week 2)||17
3067652|NCT01304277|3788303|FG000|NOT COMPLETED|Screening (Replagal RB, Week 0- Week 2)||0
3067653|NCT01304277|3788303|FG000|STARTED|Treatment (Replagal AF, Week 2- EOS)||17
3067654|NCT01304277|3788303|FG000|COMPLETED|Treatment (Replagal AF, Week 2- EOS)||17
3067655|NCT01304277|3788303|FG000|NOT COMPLETED|Treatment (Replagal AF, Week 2- EOS)||0
3067656|NCT01304329|3788310|FG000|STARTED|First Intervention (3 Days)||3
3067657|NCT01304329|3788311|FG001|STARTED|First Intervention (3 Days)||3
3067658|NCT01304329|3788312|FG002|STARTED|First Intervention (3 Days)||3
3067659|NCT01304329|3788313|FG003|STARTED|First Intervention (3 Days)||3
3067660|NCT01304329|3788314|FG004|STARTED|First Intervention (3 Days)||3
3067661|NCT01304329|3788315|FG005|STARTED|First Intervention (3 Days)||3
3067662|NCT01304329|3788310|FG000|COMPLETED|First Intervention (3 Days)||3
3067663|NCT01304329|3788311|FG001|COMPLETED|First Intervention (3 Days)||3
3067664|NCT01304329|3788312|FG002|COMPLETED|First Intervention (3 Days)||3
3067665|NCT01304329|3788313|FG003|COMPLETED|First Intervention (3 Days)||3
3067666|NCT01304329|3788314|FG004|COMPLETED|First Intervention (3 Days)||3
3067667|NCT01304329|3788315|FG005|COMPLETED|First Intervention (3 Days)||3
3067668|NCT01304329|3788310|FG000|NOT COMPLETED|First Intervention (3 Days)||0
3067669|NCT01304329|3788311|FG001|NOT COMPLETED|First Intervention (3 Days)||0
3067670|NCT01304329|3788312|FG002|NOT COMPLETED|First Intervention (3 Days)||0
3067671|NCT01304329|3788313|FG003|NOT COMPLETED|First Intervention (3 Days)||0
3067672|NCT01304329|3788314|FG004|NOT COMPLETED|First Intervention (3 Days)||0
3067673|NCT01304329|3788315|FG005|NOT COMPLETED|First Intervention (3 Days)||0
3067674|NCT01304329|3788310|FG000|STARTED|Second Intervention (3 Days)||3
3067675|NCT01304329|3788311|FG001|STARTED|Second Intervention (3 Days)||3
3067676|NCT01304329|3788312|FG002|STARTED|Second Intervention (3 Days)||3
3067677|NCT01304329|3788313|FG003|STARTED|Second Intervention (3 Days)||3
3067678|NCT01304329|3788314|FG004|STARTED|Second Intervention (3 Days)||3
3067679|NCT01304329|3788315|FG005|STARTED|Second Intervention (3 Days)||3
3067680|NCT01304329|3788310|FG000|COMPLETED|Second Intervention (3 Days)||3
3067681|NCT01304329|3788311|FG001|COMPLETED|Second Intervention (3 Days)||3
3067682|NCT01304329|3788312|FG002|COMPLETED|Second Intervention (3 Days)||3
3067683|NCT01304329|3788313|FG003|COMPLETED|Second Intervention (3 Days)||3
3067684|NCT01304329|3788314|FG004|COMPLETED|Second Intervention (3 Days)||3
3067685|NCT01304329|3788315|FG005|COMPLETED|Second Intervention (3 Days)||3
3067686|NCT01304329|3788310|FG000|NOT COMPLETED|Second Intervention (3 Days)||0
3067687|NCT01304329|3788311|FG001|NOT COMPLETED|Second Intervention (3 Days)||0
3067688|NCT01304329|3788312|FG002|NOT COMPLETED|Second Intervention (3 Days)||0
3067689|NCT01304329|3788313|FG003|NOT COMPLETED|Second Intervention (3 Days)||0
3067690|NCT01304329|3788314|FG004|NOT COMPLETED|Second Intervention (3 Days)||0
3067691|NCT01304329|3788315|FG005|NOT COMPLETED|Second Intervention (3 Days)||0
3067692|NCT01304329|3788310|FG000|STARTED|Third Intervention (3 Days)||3
3067693|NCT01304329|3788311|FG001|STARTED|Third Intervention (3 Days)||3
3067694|NCT01304329|3788312|FG002|STARTED|Third Intervention (3 Days)||3
3067695|NCT01304329|3788313|FG003|STARTED|Third Intervention (3 Days)||3
3067696|NCT01304329|3788314|FG004|STARTED|Third Intervention (3 Days)||3
3067697|NCT01304329|3788315|FG005|STARTED|Third Intervention (3 Days)||3
3067698|NCT01304329|3788310|FG000|COMPLETED|Third Intervention (3 Days)||3
3067699|NCT01304329|3788311|FG001|COMPLETED|Third Intervention (3 Days)||2
3067700|NCT01304329|3788312|FG002|COMPLETED|Third Intervention (3 Days)||3
3067701|NCT01304329|3788313|FG003|COMPLETED|Third Intervention (3 Days)||3
3067702|NCT01304329|3788314|FG004|COMPLETED|Third Intervention (3 Days)||3
3067703|NCT01304329|3788315|FG005|COMPLETED|Third Intervention (3 Days)||3
3067704|NCT01304329|3788310|FG000|NOT COMPLETED|Third Intervention (3 Days)||0
3067705|NCT01304329|3788311|FG001|NOT COMPLETED|Third Intervention (3 Days)||1
3067706|NCT01304329|3788312|FG002|NOT COMPLETED|Third Intervention (3 Days)||0
3067707|NCT01304329|3788313|FG003|NOT COMPLETED|Third Intervention (3 Days)||0
3067708|NCT01304329|3788314|FG004|NOT COMPLETED|Third Intervention (3 Days)||0
3067709|NCT01304329|3788315|FG005|NOT COMPLETED|Third Intervention (3 Days)||0
3067710|NCT01304407|3788323|FG000|STARTED|Overall Study||29
3067711|NCT01304407|3788323|FG000|COMPLETED|Overall Study||29
3067712|NCT01304407|3788323|FG000|NOT COMPLETED|Overall Study||0
3067713|NCT01304498|3788329|FG000|STARTED|Overall Study||300
3067714|NCT01304498|3788330|FG001|STARTED|Overall Study||300
3067715|NCT01304498|3788329|FG000|Received ≥1 Dose|Overall Study||300
3067716|NCT01304498|3788330|FG001|Received ≥1 Dose|Overall Study||300
3067717|NCT01304498|3788329|FG000|COMPLETED|Overall Study||294
3067718|NCT01304498|3788330|FG001|COMPLETED|Overall Study||295
3067719|NCT01304498|3788329|FG000|NOT COMPLETED|Overall Study||6
3067720|NCT01304498|3788330|FG001|NOT COMPLETED|Overall Study||5
3067721|NCT01304589|3788336|FG000|STARTED|Overall Study||31
3067722|NCT01304589|3788336|FG000|COMPLETED|Overall Study||18
3067723|NCT01304589|3788336|FG000|NOT COMPLETED|Overall Study||13
3067724|NCT01304641|3788343|FG000|STARTED|Overall Study||11470
3067725|NCT01304641|3788344|FG001|STARTED|Overall Study||20132
3067726|NCT01304641|3788343|FG000|COMPLETED|Overall Study||11470
3067727|NCT01304641|3788344|FG001|COMPLETED|Overall Study||20132
3067728|NCT01304641|3788343|FG000|NOT COMPLETED|Overall Study||0
3067729|NCT01304641|3788344|FG001|NOT COMPLETED|Overall Study||0
3067730|NCT01304693|3788355|FG000|STARTED|Overall Study||10
3067731|NCT01304693|3788356|FG001|STARTED|Overall Study||35
3067732|NCT01304693|3788357|FG002|STARTED|Overall Study||48
3067733|NCT01304693|3788358|FG003|STARTED|Overall Study||40
3067734|NCT01304693|3788359|FG004|STARTED|Overall Study||61
3067735|NCT01304693|3788355|FG000|COMPLETED|Overall Study||10
3067736|NCT01304693|3788356|FG001|COMPLETED|Overall Study||35
3067737|NCT01304693|3788357|FG002|COMPLETED|Overall Study||47
3067738|NCT01304693|3788358|FG003|COMPLETED|Overall Study||39
3067739|NCT01304693|3788359|FG004|COMPLETED|Overall Study||60
3067740|NCT01304693|3788355|FG000|NOT COMPLETED|Overall Study||0
3067741|NCT01304693|3788356|FG001|NOT COMPLETED|Overall Study||0
3067742|NCT01304693|3788357|FG002|NOT COMPLETED|Overall Study||1
3067743|NCT01304693|3788358|FG003|NOT COMPLETED|Overall Study||1
3067744|NCT01304693|3788359|FG004|NOT COMPLETED|Overall Study||1
3067745|NCT01304706|3788371|FG000|STARTED|Overall Study||121
3067746|NCT01304706|3788371|FG000|COMPLETED|Overall Study||104
3067747|NCT01304706|3788371|FG000|NOT COMPLETED|Overall Study||17
3067748|NCT01304940|3788377|FG000|STARTED|Overall Study||25
3067749|NCT01304940|3788378|FG001|STARTED|Overall Study||25
3067750|NCT01304940|3788377|FG000|Completed Study|Overall Study|recruitment ended when 25 participants completed study procedures|25
3067751|NCT01304940|3788378|FG001|Completed Study|Overall Study|recruitment ended when 25 participants completed study procedures|25
3067752|NCT01304940|3788377|FG000|COMPLETED|Overall Study|these participants met severity requirement and were included in study analyses|22
3067753|NCT01304940|3788378|FG001|COMPLETED|Overall Study||25
3067754|NCT01304940|3788377|FG000|NOT COMPLETED|Overall Study||3
3067755|NCT01304940|3788378|FG001|NOT COMPLETED|Overall Study||0
3067756|NCT01304966|3788384|FG000|STARTED|Overall Study||15
3067757|NCT01304966|3788384|FG000|COMPLETED|Overall Study||15
3067758|NCT01304966|3788384|FG000|NOT COMPLETED|Overall Study||0
3067759|NCT01305044|3788392|FG000|STARTED|Overall Study||32
3067760|NCT01305044|3788393|FG001|STARTED|Overall Study||31
3067761|NCT01305044|3788392|FG000|COMPLETED|Overall Study||29
3067762|NCT01305044|3788393|FG001|COMPLETED|Overall Study||25
3067763|NCT01305044|3788392|FG000|NOT COMPLETED|Overall Study||3
3067764|NCT01305044|3788393|FG001|NOT COMPLETED|Overall Study||6
3067765|NCT01305200|3788402|FG000|STARTED|Overall Study||111
3067766|NCT01305200|3788403|FG001|STARTED|Overall Study||112
3067767|NCT01305200|3788404|FG002|STARTED|Overall Study||3
3067768|NCT01305200|3788402|FG000|COMPLETED|Overall Study||82
3067769|NCT01305200|3788403|FG001|COMPLETED|Overall Study||81
3067770|NCT01305200|3788404|FG002|COMPLETED|Overall Study||0
3067771|NCT01305200|3788402|FG000|NOT COMPLETED|Overall Study||29
3067772|NCT01305200|3788403|FG001|NOT COMPLETED|Overall Study||31
3067773|NCT01305200|3788404|FG002|NOT COMPLETED|Overall Study||3
3067774|NCT01305213|3788412|FG000|STARTED|Overall Study||53
3067775|NCT01305213|3788413|FG001|STARTED|Overall Study||54
3067776|NCT01305213|3788412|FG000|COMPLETED|Overall Study||53
3067777|NCT01305213|3788413|FG001|COMPLETED|Overall Study||54
3067778|NCT01305213|3788412|FG000|NOT COMPLETED|Overall Study||0
3067779|NCT01305213|3788413|FG001|NOT COMPLETED|Overall Study||0
3067780|NCT01305239|3788422|FG000|STARTED|Overall Study||398
3067781|NCT01305239|3788422|FG000|Safety Set|Overall Study||397
3067782|NCT01305239|3788422|FG000|Intent to Treat Population|Overall Study||287
3067783|NCT01305239|3788422|FG000|COMPLETED|Overall Study||375
3067784|NCT01305239|3788422|FG000|NOT COMPLETED|Overall Study||23
3067785|NCT01305252|3788428|FG000|STARTED|Overall Study||10
3067786|NCT01305252|3788429|FG001|STARTED|Overall Study||11
3067787|NCT01305252|3788428|FG000|COMPLETED|Overall Study||9
3067788|NCT01305252|3788429|FG001|COMPLETED|Overall Study||11
3067789|NCT01305252|3788428|FG000|NOT COMPLETED|Overall Study||1
3067790|NCT01305252|3788429|FG001|NOT COMPLETED|Overall Study||0
3067791|NCT01305265|3788441|FG000|STARTED|Overall Study||71
3067792|NCT01305265|3788442|FG001|STARTED|Overall Study||70
3067793|NCT01305265|3788441|FG000|COMPLETED|Overall Study||69
3067794|NCT01305265|3788442|FG001|COMPLETED|Overall Study||64
3067795|NCT01305265|3788441|FG000|NOT COMPLETED|Overall Study||2
3067796|NCT01305265|3788442|FG001|NOT COMPLETED|Overall Study||6
3067797|NCT01305356|3788450|FG000|STARTED|Overall Study||132
3067798|NCT01305356|3788451|FG001|STARTED|Overall Study||167
3067799|NCT01305356|3788450|FG000|COMPLETED|Overall Study||132
3067800|NCT01305356|3788451|FG001|COMPLETED|Overall Study||167
3067801|NCT01305356|3788450|FG000|NOT COMPLETED|Overall Study||0
3067802|NCT01305356|3788451|FG001|NOT COMPLETED|Overall Study||0
3067803|NCT01305408|3788459|FG000|STARTED|Overall Study||199
3067804|NCT01305408|3788460|FG001|STARTED|Overall Study||200
3067805|NCT01305408|3788459|FG000|Safety Population|Overall Study|Treated participants. One participant was randomized but not treated.|198
3067806|NCT01305408|3788460|FG001|Safety Population|Overall Study|Treated participants.|200
3067807|NCT01305408|3788459|FG000|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|196
3067808|NCT01305408|3788460|FG001|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|197
3067809|NCT01305408|3788459|FG000|COMPLETED|Overall Study||167
3067810|NCT01305408|3788460|FG001|COMPLETED|Overall Study||169
3067811|NCT01305408|3788459|FG000|NOT COMPLETED|Overall Study||32
3067812|NCT01305408|3788460|FG001|NOT COMPLETED|Overall Study||31
3067813|NCT01305473|3788466|FG000|STARTED|Overall Study||90
3067814|NCT01305473|3788466|FG000|COMPLETED|Overall Study||90
3067815|NCT01305473|3788466|FG000|NOT COMPLETED|Overall Study||0
3067816|NCT01305564|3788470|FG000|STARTED|Overall Study||200
3067817|NCT01305564|3788470|FG000|COMPLETED|Overall Study||163
3067818|NCT01305564|3788470|FG000|NOT COMPLETED|Overall Study||37
3067819|NCT01305577|3788488|FG000|STARTED|Overall Study||120
3067820|NCT01305577|3788489|FG001|STARTED|Overall Study||121
3067821|NCT01305577|3788490|FG002|STARTED|Overall Study||122
3067822|NCT01305577|3788488|FG000|Received Treatment|Overall Study||119
3067823|NCT01305577|3788489|FG001|Received Treatment|Overall Study||121
3067824|NCT01305577|3788490|FG002|Received Treatment|Overall Study||122
3067825|NCT01305577|3788488|FG000|COMPLETED|Overall Study||107
3067826|NCT01305577|3788489|FG001|COMPLETED|Overall Study||110
3067827|NCT01305577|3788490|FG002|COMPLETED|Overall Study||112
3067828|NCT01305577|3788488|FG000|NOT COMPLETED|Overall Study||13
3067829|NCT01305577|3788489|FG001|NOT COMPLETED|Overall Study||11
3067830|NCT01305577|3788490|FG002|NOT COMPLETED|Overall Study||10
3067831|NCT01305655|3788498|FG000|STARTED|Overall Study|July 2008|47
3067832|NCT01305655|3788498|FG000|COMPLETED|Overall Study|December 31, 2014|47
3067833|NCT01305655|3788498|FG000|NOT COMPLETED|Overall Study||0
3067834|NCT01305772|3788504|FG000|STARTED|Overall Study||5
3067835|NCT01305772|3788505|FG001|STARTED|Overall Study||1
3067836|NCT01305772|3788504|FG000|Genomic Screening + Biopsy #1|Overall Study||5
3067837|NCT01305772|3788505|FG001|Genomic Screening + Biopsy #1|Overall Study||1
3067838|NCT01305772|3788504|FG000|Research PET/CT #1|Overall Study||5
3067839|NCT01305772|3788505|FG001|Research PET/CT #1|Overall Study||1
3067840|NCT01305772|3788504|FG000|Panitumumab Dose #1|Overall Study||5
3067841|NCT01305772|3788505|FG001|Panitumumab Dose #1|Overall Study||1
3067842|NCT01305772|3788504|FG000|Research PET/CT #2|Overall Study||5
3067843|NCT01305772|3788505|FG001|Research PET/CT #2|Overall Study||1
3067844|NCT01305772|3788504|FG000|Surgery/Biopsy #2|Overall Study|2nd research tissue sample not collected for 4 patients due to safety risk to subject.|1
3067845|NCT01305772|3788505|FG001|Surgery/Biopsy #2|Overall Study||1
3067846|NCT01305772|3788504|FG000|RT + Panitumumab Dose #2 / #3|Overall Study|RT and doses #2 and #3 of panitumumab administered to patients regardless of 2nd biopsy status.|5
3067847|NCT01305772|3788505|FG001|RT + Panitumumab Dose #2 / #3|Overall Study||1
3067848|NCT01305772|3788504|FG000|COMPLETED|Overall Study||5
3067849|NCT01305772|3788505|FG001|COMPLETED|Overall Study||1
3067850|NCT01305772|3788504|FG000|NOT COMPLETED|Overall Study||0
3067851|NCT01305772|3788505|FG001|NOT COMPLETED|Overall Study||0
3067852|NCT01305811|3788512|FG000|STARTED|Overall Study||52
3067853|NCT01305811|3788513|FG001|STARTED|Overall Study||52
3067854|NCT01305811|3788512|FG000|COMPLETED|Overall Study||44
3067855|NCT01305811|3788513|FG001|COMPLETED|Overall Study||41
3067856|NCT01305811|3788512|FG000|NOT COMPLETED|Overall Study||8
3067857|NCT01305811|3788513|FG001|NOT COMPLETED|Overall Study||11
3067858|NCT01305941|3788521|FG000|STARTED|Overall Study||32
3067859|NCT01305941|3788521|FG000|COMPLETED|Overall Study||22
3067860|NCT01305941|3788521|FG000|NOT COMPLETED|Overall Study||10
3067861|NCT01306032|3788531|FG000|STARTED|First Intervention||22
3067862|NCT01306032|3788532|FG001|STARTED|First Intervention|Not all participants on the Cyclophosphamide Alone Arm met eligibility criteria to crossover.|20
3067863|NCT01306032|3788533|FG002|STARTED|First Intervention||37
3067864|NCT01306032|3788534|FG003|STARTED|First Intervention|Not all participants on the Cyclophosphamide Alone Arm met eligibility criteria to crossover.|38
3067865|NCT01306032|3788535|FG004|STARTED|First Intervention||2
3067866|NCT01306032|3788536|FG005|STARTED|First Intervention||2
3067867|NCT01306032|3788531|FG000|COMPLETED|First Intervention||21
3067868|NCT01306032|3788532|FG001|COMPLETED|First Intervention||18
3067869|NCT01306032|3788533|FG002|COMPLETED|First Intervention||35
3067870|NCT01306032|3788534|FG003|COMPLETED|First Intervention||37
3067871|NCT01306032|3788535|FG004|COMPLETED|First Intervention||0
3067872|NCT01306032|3788536|FG005|COMPLETED|First Intervention||0
3067873|NCT01306032|3788531|FG000|NOT COMPLETED|First Intervention||1
3067874|NCT01306032|3788532|FG001|NOT COMPLETED|First Intervention||2
3067875|NCT01306032|3788533|FG002|NOT COMPLETED|First Intervention||2
3067876|NCT01306032|3788534|FG003|NOT COMPLETED|First Intervention||1
3067877|NCT01306032|3788535|FG004|NOT COMPLETED|First Intervention||2
3067878|NCT01306032|3788536|FG005|NOT COMPLETED|First Intervention||2
3067879|NCT01306032|3788531|FG000|STARTED|Disease Progression/Crossover||0
3067880|NCT01306032|3788532|FG001|STARTED|Disease Progression/Crossover||16
3067881|NCT01306032|3788533|FG002|STARTED|Disease Progression/Crossover||0
3067882|NCT01306032|3788534|FG003|STARTED|Disease Progression/Crossover||29
3067883|NCT01306032|3788535|FG004|STARTED|Disease Progression/Crossover||0
3067884|NCT01306032|3788536|FG005|STARTED|Disease Progression/Crossover||0
3067885|NCT01306032|3788531|FG000|COMPLETED|Disease Progression/Crossover||0
3067886|NCT01306032|3788532|FG001|COMPLETED|Disease Progression/Crossover||14
3067887|NCT01306032|3788533|FG002|COMPLETED|Disease Progression/Crossover||0
3067888|NCT01306032|3788534|FG003|COMPLETED|Disease Progression/Crossover||26
3067889|NCT01306032|3788535|FG004|COMPLETED|Disease Progression/Crossover||0
3067890|NCT01306032|3788536|FG005|COMPLETED|Disease Progression/Crossover||0
3067891|NCT01306032|3788531|FG000|NOT COMPLETED|Disease Progression/Crossover||0
3067892|NCT01306032|3788532|FG001|NOT COMPLETED|Disease Progression/Crossover||2
3067893|NCT01306032|3788533|FG002|NOT COMPLETED|Disease Progression/Crossover||0
3067894|NCT01306032|3788534|FG003|NOT COMPLETED|Disease Progression/Crossover||3
3067895|NCT01306032|3788535|FG004|NOT COMPLETED|Disease Progression/Crossover||0
3067896|NCT01306032|3788536|FG005|NOT COMPLETED|Disease Progression/Crossover||0
3067897|NCT01306058|3788562|FG000|STARTED|Overall Study||27
3163020|NCT01882465|3890495|FG004|STARTED|Period 2||5
3163021|NCT01882465|3890496|FG005|STARTED|Period 2||5
3163022|NCT01882465|3890497|FG006|STARTED|Period 2||0
3163023|NCT01882465|3890491|FG000|COMPLETED|Period 2||6
3163024|NCT01882465|3890492|FG001|COMPLETED|Period 2||6
3163025|NCT01882465|3890493|FG002|COMPLETED|Period 2||5
3163026|NCT01882465|3890494|FG003|COMPLETED|Period 2||5
3163027|NCT01882465|3890495|FG004|COMPLETED|Period 2||4
3163028|NCT01882465|3890496|FG005|COMPLETED|Period 2||5
3163029|NCT01882465|3890497|FG006|COMPLETED|Period 2||0
3163030|NCT01882465|3890491|FG000|NOT COMPLETED|Period 2||0
3067898|NCT01306058|3788562|FG000|COMPLETED|Overall Study||25
3067899|NCT01306058|3788562|FG000|NOT COMPLETED|Overall Study||2
3067900|NCT01306162|3788570|FG000|STARTED|Period 1||9
3067901|NCT01306162|3788571|FG001|STARTED|Period 1||9
3067902|NCT01306162|3788572|FG002|STARTED|Period 1||9
3067903|NCT01306162|3788573|FG003|STARTED|Period 1||9
3067904|NCT01306162|3788570|FG000|COMPLETED|Period 1||9
3067905|NCT01306162|3788571|FG001|COMPLETED|Period 1||9
3067906|NCT01306162|3788572|FG002|COMPLETED|Period 1||9
3067907|NCT01306162|3788573|FG003|COMPLETED|Period 1||8
3067908|NCT01306162|3788570|FG000|NOT COMPLETED|Period 1||0
3067909|NCT01306162|3788571|FG001|NOT COMPLETED|Period 1||0
3067910|NCT01306162|3788572|FG002|NOT COMPLETED|Period 1||0
3067911|NCT01306162|3788573|FG003|NOT COMPLETED|Period 1||1
3067912|NCT01306162|3788570|FG000|STARTED|Washout 1|Treatment A was followed by a washout period of at least 96 hours.|9
3067913|NCT01306162|3788571|FG001|STARTED|Washout 1|Treatment A was followed by a washout period of at least 96 hours.|9
3067914|NCT01306162|3788572|FG002|STARTED|Washout 1|No washout period. Treatment D followed directly after treatment B.|9
3067915|NCT01306162|3788573|FG003|STARTED|Washout 1|No washout period.Treatment E followed directly after treatment C.|8
3067916|NCT01306162|3788570|FG000|COMPLETED|Washout 1||9
3067917|NCT01306162|3788571|FG001|COMPLETED|Washout 1||8
3067918|NCT01306162|3788572|FG002|COMPLETED|Washout 1||9
3067919|NCT01306162|3788573|FG003|COMPLETED|Washout 1||8
3067920|NCT01306162|3788570|FG000|NOT COMPLETED|Washout 1||0
3067921|NCT01306162|3788571|FG001|NOT COMPLETED|Washout 1||1
3067922|NCT01306162|3788572|FG002|NOT COMPLETED|Washout 1||0
3067923|NCT01306162|3788573|FG003|NOT COMPLETED|Washout 1||0
3067924|NCT01306162|3788570|FG000|STARTED|Period 2|No washout phase after Period 2.|9
3067925|NCT01306162|3788571|FG001|STARTED|Period 2|No washout phase after Period 2.|8
3067926|NCT01306162|3788572|FG002|STARTED|Period 2|No washout phase after Period 2.|9
3067927|NCT01306162|3788573|FG003|STARTED|Period 2|No washout phase after Period 2.|8
3067928|NCT01306162|3788570|FG000|COMPLETED|Period 2||9
3067929|NCT01306162|3788571|FG001|COMPLETED|Period 2||8
3067930|NCT01306162|3788572|FG002|COMPLETED|Period 2||9
3067931|NCT01306162|3788573|FG003|COMPLETED|Period 2||8
3067932|NCT01306162|3788570|FG000|NOT COMPLETED|Period 2||0
3067933|NCT01306162|3788571|FG001|NOT COMPLETED|Period 2||0
3067934|NCT01306162|3788572|FG002|NOT COMPLETED|Period 2||0
3067935|NCT01306162|3788573|FG003|NOT COMPLETED|Period 2||0
3067936|NCT01306162|3788570|FG000|STARTED|Period 3||9
3067937|NCT01306162|3788571|FG001|STARTED|Period 3||8
3067938|NCT01306162|3788572|FG002|STARTED|Period 3||9
3067939|NCT01306162|3788573|FG003|STARTED|Period 3||8
3067940|NCT01306162|3788570|FG000|COMPLETED|Period 3||9
3067941|NCT01306162|3788571|FG001|COMPLETED|Period 3||8
3067942|NCT01306162|3788572|FG002|COMPLETED|Period 3||9
3067943|NCT01306162|3788573|FG003|COMPLETED|Period 3||8
3067944|NCT01306162|3788570|FG000|NOT COMPLETED|Period 3||0
3067945|NCT01306162|3788571|FG001|NOT COMPLETED|Period 3||0
3067946|NCT01306162|3788572|FG002|NOT COMPLETED|Period 3||0
3067947|NCT01306162|3788573|FG003|NOT COMPLETED|Period 3||0
3067948|NCT01306162|3788570|FG000|STARTED|Washout 2|No washout period. Treatment E followed directly after treatment D.|9
3067949|NCT01306162|3788571|FG001|STARTED|Washout 2|No washout period. Treatment D followed directly after treatment E.|8
3067950|NCT01306162|3788572|FG002|STARTED|Washout 2|The last dose of Dronedarone was followed by a washout period of at least 10 days.|9
3067951|NCT01306162|3788573|FG003|STARTED|Washout 2|The last dose of Dronedarone was followed by a washout period of at least 10 days.|8
3067952|NCT01306162|3788570|FG000|COMPLETED|Washout 2||9
3067953|NCT01306162|3788571|FG001|COMPLETED|Washout 2||8
3067954|NCT01306162|3788572|FG002|COMPLETED|Washout 2||9
3067955|NCT01306162|3788573|FG003|COMPLETED|Washout 2||8
3163031|NCT01882465|3890492|FG001|NOT COMPLETED|Period 2||0
3067956|NCT01306162|3788570|FG000|NOT COMPLETED|Washout 2||0
3067957|NCT01306162|3788571|FG001|NOT COMPLETED|Washout 2||0
3067958|NCT01306162|3788572|FG002|NOT COMPLETED|Washout 2||0
3067959|NCT01306162|3788573|FG003|NOT COMPLETED|Washout 2||0
3067960|NCT01306162|3788570|FG000|STARTED|Period 4||9
3067961|NCT01306162|3788571|FG001|STARTED|Period 4||8
3067962|NCT01306162|3788572|FG002|STARTED|Period 4||9
3067963|NCT01306162|3788573|FG003|STARTED|Period 4||8
3067964|NCT01306162|3788570|FG000|COMPLETED|Period 4||9
3067965|NCT01306162|3788571|FG001|COMPLETED|Period 4||8
3067966|NCT01306162|3788572|FG002|COMPLETED|Period 4||9
3067967|NCT01306162|3788573|FG003|COMPLETED|Period 4||8
3067968|NCT01306162|3788570|FG000|NOT COMPLETED|Period 4||0
3067969|NCT01306162|3788571|FG001|NOT COMPLETED|Period 4||0
3067970|NCT01306162|3788572|FG002|NOT COMPLETED|Period 4||0
3067971|NCT01306162|3788573|FG003|NOT COMPLETED|Period 4||0
3067972|NCT01306175|3788586|FG000|STARTED|First Intervention||20
3067973|NCT01306175|3788586|FG000|COMPLETED|First Intervention||20
3067974|NCT01306175|3788586|FG000|NOT COMPLETED|First Intervention||0
3067975|NCT01306175|3788586|FG000|STARTED|Washout Period of at Least 14 Days||20
3067976|NCT01306175|3788586|FG000|COMPLETED|Washout Period of at Least 14 Days||20
3067977|NCT01306175|3788586|FG000|NOT COMPLETED|Washout Period of at Least 14 Days||0
3067978|NCT01306175|3788586|FG000|STARTED|Second Intervention||20
3067979|NCT01306175|3788586|FG000|COMPLETED|Second Intervention||20
3067980|NCT01306175|3788586|FG000|NOT COMPLETED|Second Intervention||0
3067981|NCT01306201|3788592|FG000|STARTED|Overall Study||63
3067982|NCT01306201|3788592|FG000|COMPLETED|Overall Study|Total of 10 subjects were excluded from analysis|53
3067983|NCT01306201|3788592|FG000|NOT COMPLETED|Overall Study||10
3067984|NCT01306214|3788603|FG000|STARTED|Overall Study||189
3067985|NCT01306214|3788604|FG001|STARTED|Overall Study||187
3067986|NCT01306214|3788605|FG002|STARTED|Overall Study||190
3067987|NCT01306214|3788603|FG000|COMPLETED|Overall Study||161
3067988|NCT01306214|3788604|FG001|COMPLETED|Overall Study||159
3067989|NCT01306214|3788605|FG002|COMPLETED|Overall Study||168
3067990|NCT01306214|3788603|FG000|NOT COMPLETED|Overall Study||28
3067991|NCT01306214|3788604|FG001|NOT COMPLETED|Overall Study||28
3067992|NCT01306214|3788605|FG002|NOT COMPLETED|Overall Study||22
3067993|NCT01306253|3788615|FG000|STARTED|Overall Study||57
3067994|NCT01306253|3788616|FG001|STARTED|Overall Study||57
3067995|NCT01306253|3788615|FG000|COMPLETED|Overall Study||56
3067996|NCT01306253|3788616|FG001|COMPLETED|Overall Study||56
3067997|NCT01306253|3788615|FG000|NOT COMPLETED|Overall Study||1
3067998|NCT01306253|3788616|FG001|NOT COMPLETED|Overall Study||1
3067999|NCT01306292|3788624|FG000|STARTED|First Injection||10
3068000|NCT01306292|3788625|FG001|STARTED|First Injection||8
3068001|NCT01306292|3788626|FG002|STARTED|First Injection||8
3068002|NCT01306292|3788627|FG003|STARTED|First Injection||10
3068003|NCT01306292|3788624|FG000|COMPLETED|First Injection||10
3068004|NCT01306292|3788625|FG001|COMPLETED|First Injection||8
3068005|NCT01306292|3788626|FG002|COMPLETED|First Injection||8
3068006|NCT01306292|3788627|FG003|COMPLETED|First Injection||10
3068007|NCT01306292|3788624|FG000|NOT COMPLETED|First Injection||0
3068008|NCT01306292|3788625|FG001|NOT COMPLETED|First Injection||0
3068009|NCT01306292|3788626|FG002|NOT COMPLETED|First Injection||0
3068010|NCT01306292|3788627|FG003|NOT COMPLETED|First Injection||0
3068011|NCT01306292|3788624|FG000|STARTED|Washout (at Least 10 Minutes)||10
3068012|NCT01306292|3788625|FG001|STARTED|Washout (at Least 10 Minutes)||8
3068013|NCT01306292|3788626|FG002|STARTED|Washout (at Least 10 Minutes)||8
3068014|NCT01306292|3788627|FG003|STARTED|Washout (at Least 10 Minutes)||10
3068015|NCT01306292|3788624|FG000|COMPLETED|Washout (at Least 10 Minutes)||10
3068016|NCT01306292|3788625|FG001|COMPLETED|Washout (at Least 10 Minutes)||8
3068017|NCT01306292|3788626|FG002|COMPLETED|Washout (at Least 10 Minutes)||8
3068018|NCT01306292|3788627|FG003|COMPLETED|Washout (at Least 10 Minutes)||10
3068019|NCT01306292|3788624|FG000|NOT COMPLETED|Washout (at Least 10 Minutes)||0
3068020|NCT01306292|3788625|FG001|NOT COMPLETED|Washout (at Least 10 Minutes)||0
3068021|NCT01306292|3788626|FG002|NOT COMPLETED|Washout (at Least 10 Minutes)||0
3068022|NCT01306292|3788627|FG003|NOT COMPLETED|Washout (at Least 10 Minutes)||0
3068023|NCT01306292|3788624|FG000|STARTED|Second Injection||10
3068024|NCT01306292|3788625|FG001|STARTED|Second Injection||8
3068025|NCT01306292|3788626|FG002|STARTED|Second Injection||8
3068026|NCT01306292|3788627|FG003|STARTED|Second Injection||10
3068027|NCT01306292|3788624|FG000|COMPLETED|Second Injection||10
3068028|NCT01306292|3788625|FG001|COMPLETED|Second Injection||8
3068029|NCT01306292|3788626|FG002|COMPLETED|Second Injection|1 subject completed both injections but not 24-hour follow-up; all other values were recorded.|7
3068030|NCT01306292|3788627|FG003|COMPLETED|Second Injection||10
3068031|NCT01306292|3788624|FG000|NOT COMPLETED|Second Injection||0
3068032|NCT01306292|3788625|FG001|NOT COMPLETED|Second Injection||0
3068033|NCT01306292|3788626|FG002|NOT COMPLETED|Second Injection||1
3068034|NCT01306292|3788627|FG003|NOT COMPLETED|Second Injection||0
3068035|NCT01306305|3788637|FG000|STARTED|Overall Study||55
3068036|NCT01306305|3788638|FG001|STARTED|Overall Study||55
3068037|NCT01306305|3788637|FG000|COMPLETED|Overall Study||53
3068038|NCT01306305|3788638|FG001|COMPLETED|Overall Study||55
3068039|NCT01306305|3788637|FG000|NOT COMPLETED|Overall Study||2
3068040|NCT01306305|3788638|FG001|NOT COMPLETED|Overall Study||0
3068041|NCT01306331|3788646|FG000|STARTED|Overall Study||1659
3068042|NCT01306331|3788647|FG001|STARTED|Overall Study||1665
3068043|NCT01306331|3788646|FG000|COMPLETED|Overall Study||758
3068044|NCT01306331|3788647|FG001|COMPLETED|Overall Study||788
3068045|NCT01306331|3788646|FG000|NOT COMPLETED|Overall Study||901
3068046|NCT01306331|3788647|FG001|NOT COMPLETED|Overall Study||877
3068047|NCT01306617|3788656|FG000|STARTED|Overall Study||19
3068048|NCT01306617|3788657|FG001|STARTED|Overall Study||14
3068049|NCT01306617|3788658|FG002|STARTED|Overall Study||17
3068050|NCT01306617|3788656|FG000|COMPLETED|Overall Study|The number of participants who completed study drug|18
3068051|NCT01306617|3788657|FG001|COMPLETED|Overall Study|The number of participants who completed study drug|13
3068052|NCT01306617|3788658|FG002|COMPLETED|Overall Study|The number of participants who completed study drug|12
3068053|NCT01306617|3788656|FG000|NOT COMPLETED|Overall Study||1
3068054|NCT01306617|3788657|FG001|NOT COMPLETED|Overall Study||1
3068055|NCT01306617|3788658|FG002|NOT COMPLETED|Overall Study||5
3068056|NCT01306643|3788666|FG000|STARTED|Overall Study||18
3068057|NCT01306643|3788666|FG000|COMPLETED|Overall Study|Completed Study was defined as participants who completed through Cycle 12 (Week 48) per protocol.|5
3068058|NCT01306643|3788666|FG000|NOT COMPLETED|Overall Study||13
3068059|NCT01306656|3788672|FG000|STARTED|Overall Study||7
3068060|NCT01306656|3788673|FG001|STARTED|Overall Study||2
3068061|NCT01306656|3788672|FG000|COMPLETED|Overall Study||6
3068062|NCT01306656|3788673|FG001|COMPLETED|Overall Study||2
3068063|NCT01306656|3788672|FG000|NOT COMPLETED|Overall Study||1
3068064|NCT01306656|3788673|FG001|NOT COMPLETED|Overall Study||0
3068065|NCT01306877|3788683|FG000|STARTED|Overall Study||78
3068066|NCT01306877|3788684|FG001|STARTED|Overall Study||71
3068067|NCT01306877|3788683|FG000|COMPLETED|Overall Study||75
3068068|NCT01306877|3788684|FG001|COMPLETED|Overall Study||67
3068069|NCT01306877|3788683|FG000|NOT COMPLETED|Overall Study||3
3068070|NCT01306877|3788684|FG001|NOT COMPLETED|Overall Study||4
3068071|NCT01306890|3788690|FG000|STARTED|Overall Study||1976
3068072|NCT01306890|3788690|FG000|COMPLETED|Overall Study|Subjects were alive at the end of the study and had completed at least 3 years of follow up.|457
3068073|NCT01306890|3788690|FG000|NOT COMPLETED|Overall Study||1519
3068074|NCT01306942|3788697|FG000|STARTED|Phase I||6
3068075|NCT01306942|3788698|FG001|STARTED|Phase I||4
3068076|NCT01306942|3788699|FG002|STARTED|Phase I||0
3068077|NCT01306942|3788700|FG003|STARTED|Phase I||0
3068078|NCT01306942|3788697|FG000|COMPLETED|Phase I||1
3068079|NCT01306942|3788698|FG001|COMPLETED|Phase I||1
3068080|NCT01306942|3788699|FG002|COMPLETED|Phase I||0
3068081|NCT01306942|3788700|FG003|COMPLETED|Phase I||0
3068082|NCT01306942|3788697|FG000|NOT COMPLETED|Phase I||5
3068083|NCT01306942|3788698|FG001|NOT COMPLETED|Phase I||3
3068084|NCT01306942|3788699|FG002|NOT COMPLETED|Phase I||0
3068085|NCT01306942|3788700|FG003|NOT COMPLETED|Phase I||0
3068086|NCT01306942|3788697|FG000|STARTED|Phase II|Two patients from phase I with measurable disease and RP2D were included in the phase II analyses.|2
3068087|NCT01306942|3788698|FG001|STARTED|Phase II|Dasatinib 140mg was not the RP2D, so these patients were not included in the phase II analyses.|0
3068088|NCT01306942|3788699|FG002|STARTED|Phase II||0
3068089|NCT01306942|3788700|FG003|STARTED|Phase II||27
3068090|NCT01306942|3788697|FG000|COMPLETED|Phase II||0
3068091|NCT01306942|3788698|FG001|COMPLETED|Phase II||0
3068092|NCT01306942|3788699|FG002|COMPLETED|Phase II||0
3068093|NCT01306942|3788700|FG003|COMPLETED|Phase II||11
3068094|NCT01306942|3788697|FG000|NOT COMPLETED|Phase II||2
3068095|NCT01306942|3788698|FG001|NOT COMPLETED|Phase II||0
3068096|NCT01306942|3788699|FG002|NOT COMPLETED|Phase II||0
3068097|NCT01306942|3788700|FG003|NOT COMPLETED|Phase II||16
3068098|NCT01306968|3788716|FG000|STARTED|Overall Study||7
3068099|NCT01306968|3788717|FG001|STARTED|Overall Study||23
3068100|NCT01306968|3788718|FG002|STARTED|Overall Study||24
3068101|NCT01306968|3788719|FG003|STARTED|Overall Study|2 participants withdrew before chamber sessions were initiated|25
3068102|NCT01306968|3788716|FG000|COMPLETED|Overall Study||6
3068103|NCT01306968|3788717|FG001|COMPLETED|Overall Study||20
3068104|NCT01306968|3788718|FG002|COMPLETED|Overall Study||23
3068105|NCT01306968|3788719|FG003|COMPLETED|Overall Study||21
3068106|NCT01306968|3788716|FG000|NOT COMPLETED|Overall Study||1
3068107|NCT01306968|3788717|FG001|NOT COMPLETED|Overall Study||3
3068108|NCT01306968|3788718|FG002|NOT COMPLETED|Overall Study||1
3068109|NCT01306968|3788719|FG003|NOT COMPLETED|Overall Study||4
3068110|NCT01307007|3788733|FG000|STARTED|Overall Study||25
3068111|NCT01307007|3788734|FG001|STARTED|Overall Study||30
3068112|NCT01307007|3788733|FG000|COMPLETED|Overall Study||25
3068113|NCT01307007|3788734|FG001|COMPLETED|Overall Study||30
3068114|NCT01307007|3788733|FG000|NOT COMPLETED|Overall Study||0
3068115|NCT01307007|3788734|FG001|NOT COMPLETED|Overall Study||0
3068116|NCT01307020|3788750|FG000|STARTED|Overall Study||61
3068117|NCT01307020|3788751|FG001|STARTED|Overall Study||63
3068118|NCT01307020|3788752|FG002|STARTED|Overall Study||63
3068119|NCT01307020|3788753|FG003|STARTED|Overall Study||61
3068120|NCT01307020|3788754|FG004|STARTED|Overall Study||60
3068121|NCT01307020|3788755|FG005|STARTED|Overall Study||61
3068122|NCT01307020|3788756|FG006|STARTED|Overall Study||59
3068123|NCT01307020|3788757|FG007|STARTED|Overall Study||60
3068124|NCT01307020|3788758|FG008|STARTED|Overall Study||61
3068125|NCT01307020|3788759|FG009|STARTED|Overall Study||62
3068126|NCT01307020|3788750|FG000|Safety Population|Overall Study||61
3068127|NCT01307020|3788751|FG001|Safety Population|Overall Study||63
3068128|NCT01307020|3788752|FG002|Safety Population|Overall Study||63
3068129|NCT01307020|3788753|FG003|Safety Population|Overall Study||61
3068130|NCT01307020|3788754|FG004|Safety Population|Overall Study||60
3068131|NCT01307020|3788755|FG005|Safety Population|Overall Study||61
3068132|NCT01307020|3788756|FG006|Safety Population|Overall Study||59
3068133|NCT01307020|3788757|FG007|Safety Population|Overall Study||60
3068134|NCT01307020|3788758|FG008|Safety Population|Overall Study||61
3068135|NCT01307020|3788759|FG009|Safety Population|Overall Study||62
3068136|NCT01307020|3788750|FG000|ITT (>= 1 Assessment Post Randomization)|Overall Study||60
3068137|NCT01307020|3788751|FG001|ITT (>= 1 Assessment Post Randomization)|Overall Study||62
3068138|NCT01307020|3788752|FG002|ITT (>= 1 Assessment Post Randomization)|Overall Study||63
3068139|NCT01307020|3788753|FG003|ITT (>= 1 Assessment Post Randomization)|Overall Study||61
3068140|NCT01307020|3788754|FG004|ITT (>= 1 Assessment Post Randomization)|Overall Study||60
3068141|NCT01307020|3788755|FG005|ITT (>= 1 Assessment Post Randomization)|Overall Study||60
3068142|NCT01307020|3788756|FG006|ITT (>= 1 Assessment Post Randomization)|Overall Study||59
3068143|NCT01307020|3788757|FG007|ITT (>= 1 Assessment Post Randomization)|Overall Study||59
3068144|NCT01307020|3788758|FG008|ITT (>= 1 Assessment Post Randomization)|Overall Study||60
3068145|NCT01307020|3788759|FG009|ITT (>= 1 Assessment Post Randomization)|Overall Study||62
3068146|NCT01307020|3788750|FG000|COMPLETED|Overall Study||61
3068147|NCT01307020|3788751|FG001|COMPLETED|Overall Study||62
3068148|NCT01307020|3788752|FG002|COMPLETED|Overall Study||62
3068149|NCT01307020|3788753|FG003|COMPLETED|Overall Study||60
3068150|NCT01307020|3788754|FG004|COMPLETED|Overall Study||60
3068151|NCT01307020|3788755|FG005|COMPLETED|Overall Study||61
3068152|NCT01307020|3788756|FG006|COMPLETED|Overall Study||58
3068153|NCT01307020|3788757|FG007|COMPLETED|Overall Study||60
3068154|NCT01307020|3788758|FG008|COMPLETED|Overall Study||61
3068155|NCT01307020|3788759|FG009|COMPLETED|Overall Study||62
3068156|NCT01307020|3788750|FG000|NOT COMPLETED|Overall Study||0
3068157|NCT01307020|3788751|FG001|NOT COMPLETED|Overall Study||1
3068158|NCT01307020|3788752|FG002|NOT COMPLETED|Overall Study||1
3068159|NCT01307020|3788753|FG003|NOT COMPLETED|Overall Study||1
3068160|NCT01307020|3788754|FG004|NOT COMPLETED|Overall Study||0
3068161|NCT01307020|3788755|FG005|NOT COMPLETED|Overall Study||0
3068162|NCT01307020|3788756|FG006|NOT COMPLETED|Overall Study||1
3068163|NCT01307020|3788757|FG007|NOT COMPLETED|Overall Study||0
3068164|NCT01307020|3788758|FG008|NOT COMPLETED|Overall Study||0
3068165|NCT01307020|3788759|FG009|NOT COMPLETED|Overall Study||0
3068166|NCT01307098|3788784|FG000|STARTED|Overall Study||3
3068167|NCT01307098|3788785|FG001|STARTED|Overall Study||3
3068168|NCT01307098|3788786|FG002|STARTED|Overall Study||3
3068169|NCT01307098|3788784|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
3068170|NCT01307098|3788785|FG001|Received at Least 1 Dose of Study Drug|Overall Study||3
3068171|NCT01307098|3788786|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3
3068172|NCT01307098|3788784|FG000|COMPLETED|Overall Study||3
3068173|NCT01307098|3788785|FG001|COMPLETED|Overall Study||3
3068174|NCT01307098|3788786|FG002|COMPLETED|Overall Study||3
3068175|NCT01307098|3788784|FG000|NOT COMPLETED|Overall Study||0
3068176|NCT01307098|3788785|FG001|NOT COMPLETED|Overall Study||0
3068177|NCT01307098|3788786|FG002|NOT COMPLETED|Overall Study||0
3068178|NCT01307111|3788797|FG000|STARTED|IUD Insertion||42
3068179|NCT01307111|3788798|FG001|STARTED|IUD Insertion||40
3068180|NCT01307111|3788797|FG000|COMPLETED|IUD Insertion||40
3068181|NCT01307111|3788798|FG001|COMPLETED|IUD Insertion||40
3068182|NCT01307111|3788797|FG000|NOT COMPLETED|IUD Insertion||2
3068183|NCT01307111|3788798|FG001|NOT COMPLETED|IUD Insertion||0
3068184|NCT01307111|3788797|FG000|STARTED|1-2 Week IUD Check up||40
3068185|NCT01307111|3788798|FG001|STARTED|1-2 Week IUD Check up||40
3068186|NCT01307111|3788797|FG000|COMPLETED|1-2 Week IUD Check up||38
3068187|NCT01307111|3788798|FG001|COMPLETED|1-2 Week IUD Check up||38
3068188|NCT01307111|3788797|FG000|NOT COMPLETED|1-2 Week IUD Check up||2
3068189|NCT01307111|3788798|FG001|NOT COMPLETED|1-2 Week IUD Check up||2
3068190|NCT01307267|3788827|FG000|STARTED|Overall Study||4
3068191|NCT01307267|3788828|FG001|STARTED|Overall Study||3
3068192|NCT01307267|3788829|FG002|STARTED|Overall Study||6
3068193|NCT01307267|3788830|FG003|STARTED|Overall Study||4
3068194|NCT01307267|3788831|FG004|STARTED|Overall Study||3
3068195|NCT01307267|3788832|FG005|STARTED|Overall Study||42
3068196|NCT01307267|3788833|FG006|STARTED|Overall Study||3
3068197|NCT01307267|3788834|FG007|STARTED|Overall Study||4
3068198|NCT01307267|3788835|FG008|STARTED|Overall Study||31
3068199|NCT01307267|3788836|FG009|STARTED|Overall Study||5
3068200|NCT01307267|3788837|FG010|STARTED|Overall Study||6
3068201|NCT01307267|3788838|FG011|STARTED|Overall Study||11
3068202|NCT01307267|3788839|FG012|STARTED|Overall Study||3
3068203|NCT01307267|3788840|FG013|STARTED|Overall Study||3
3068204|NCT01307267|3788841|FG014|STARTED|Overall Study||4
3068205|NCT01307267|3788842|FG015|STARTED|Overall Study||3
3068206|NCT01307267|3788843|FG016|STARTED|Overall Study||3
3068207|NCT01307267|3788844|FG017|STARTED|Overall Study||3
3068208|NCT01307267|3788845|FG018|STARTED|Overall Study||4
3068209|NCT01307267|3788846|FG019|STARTED|Overall Study||32
3068210|NCT01307267|3788847|FG020|STARTED|Overall Study||3
3068211|NCT01307267|3788848|FG021|STARTED|Overall Study||5
3068212|NCT01307267|3788849|FG022|STARTED|Overall Study||4
3068213|NCT01307267|3788827|FG000|COMPLETED|Overall Study||0
3068214|NCT01307267|3788828|FG001|COMPLETED|Overall Study||0
3068215|NCT01307267|3788829|FG002|COMPLETED|Overall Study||1
3068216|NCT01307267|3788830|FG003|COMPLETED|Overall Study||1
3068217|NCT01307267|3788831|FG004|COMPLETED|Overall Study||2
3068218|NCT01307267|3788832|FG005|COMPLETED|Overall Study||1
3068219|NCT01307267|3788833|FG006|COMPLETED|Overall Study||1
3068220|NCT01307267|3788834|FG007|COMPLETED|Overall Study||0
3068221|NCT01307267|3788835|FG008|COMPLETED|Overall Study||1
3068222|NCT01307267|3788836|FG009|COMPLETED|Overall Study||0
3068223|NCT01307267|3788837|FG010|COMPLETED|Overall Study||0
3068224|NCT01307267|3788838|FG011|COMPLETED|Overall Study||0
3068225|NCT01307267|3788839|FG012|COMPLETED|Overall Study||2
3068226|NCT01307267|3788840|FG013|COMPLETED|Overall Study||3
3068227|NCT01307267|3788841|FG014|COMPLETED|Overall Study||2
3068228|NCT01307267|3788842|FG015|COMPLETED|Overall Study||2
3068229|NCT01307267|3788843|FG016|COMPLETED|Overall Study||2
3068230|NCT01307267|3788844|FG017|COMPLETED|Overall Study||2
3068231|NCT01307267|3788845|FG018|COMPLETED|Overall Study||2
3068232|NCT01307267|3788846|FG019|COMPLETED|Overall Study||0
3068233|NCT01307267|3788847|FG020|COMPLETED|Overall Study||0
3068234|NCT01307267|3788848|FG021|COMPLETED|Overall Study||0
3068235|NCT01307267|3788849|FG022|COMPLETED|Overall Study||0
3068236|NCT01307267|3788827|FG000|NOT COMPLETED|Overall Study||4
3068237|NCT01307267|3788828|FG001|NOT COMPLETED|Overall Study||3
3068238|NCT01307267|3788829|FG002|NOT COMPLETED|Overall Study||5
3068239|NCT01307267|3788830|FG003|NOT COMPLETED|Overall Study||3
3068240|NCT01307267|3788831|FG004|NOT COMPLETED|Overall Study||1
3068241|NCT01307267|3788832|FG005|NOT COMPLETED|Overall Study||41
3068242|NCT01307267|3788833|FG006|NOT COMPLETED|Overall Study||2
3068243|NCT01307267|3788834|FG007|NOT COMPLETED|Overall Study||4
3068244|NCT01307267|3788835|FG008|NOT COMPLETED|Overall Study||30
3068245|NCT01307267|3788836|FG009|NOT COMPLETED|Overall Study||5
3068246|NCT01307267|3788837|FG010|NOT COMPLETED|Overall Study||6
3068247|NCT01307267|3788838|FG011|NOT COMPLETED|Overall Study||11
3068248|NCT01307267|3788839|FG012|NOT COMPLETED|Overall Study||1
3068249|NCT01307267|3788840|FG013|NOT COMPLETED|Overall Study||0
3068250|NCT01307267|3788841|FG014|NOT COMPLETED|Overall Study||2
3068251|NCT01307267|3788842|FG015|NOT COMPLETED|Overall Study||1
3068252|NCT01307267|3788843|FG016|NOT COMPLETED|Overall Study||1
3068253|NCT01307267|3788844|FG017|NOT COMPLETED|Overall Study||1
3068254|NCT01307267|3788845|FG018|NOT COMPLETED|Overall Study||2
3068255|NCT01307267|3788846|FG019|NOT COMPLETED|Overall Study||32
3068256|NCT01307267|3788847|FG020|NOT COMPLETED|Overall Study||3
3068257|NCT01307267|3788848|FG021|NOT COMPLETED|Overall Study||5
3068258|NCT01307267|3788849|FG022|NOT COMPLETED|Overall Study||4
3068259|NCT01307319|3788911|FG000|STARTED|Overall Study|Randomized|239
3068260|NCT01307319|3788912|FG001|STARTED|Overall Study|Randomized|242
3068261|NCT01307319|3788913|FG002|STARTED|Overall Study|Randomized|234
3068262|NCT01307319|3788911|FG000|Safety Population|Overall Study||239
3068263|NCT01307319|3788912|FG001|Safety Population|Overall Study|One participant was randomized in error and did not receive study medication.|241
3068264|NCT01307319|3788913|FG002|Safety Population|Overall Study||234
3068265|NCT01307319|3788911|FG000|ITT Population|Overall Study|One participant provided no post-baseline assessment.|238
3068266|NCT01307319|3788912|FG001|ITT Population|Overall Study||241
3068267|NCT01307319|3788913|FG002|ITT Population|Overall Study||234
3068268|NCT01307319|3788911|FG000|COMPLETED|Overall Study||235
3068269|NCT01307319|3788912|FG001|COMPLETED|Overall Study||234
3068270|NCT01307319|3788913|FG002|COMPLETED|Overall Study||227
3068271|NCT01307319|3788911|FG000|NOT COMPLETED|Overall Study||4
3068272|NCT01307319|3788912|FG001|NOT COMPLETED|Overall Study||8
3068273|NCT01307319|3788913|FG002|NOT COMPLETED|Overall Study||7
3134320|NCT01701245|3859398|FG000|FAS Matched Data|Overall Study||42
3134321|NCT01701245|3859399|FG001|FAS Matched Data|Overall Study||32
3134322|NCT01701245|3859398|FG000|COMPLETED|Overall Study||37
3134323|NCT01701245|3859399|FG001|COMPLETED|Overall Study||33
3134324|NCT01701245|3859398|FG000|NOT COMPLETED|Overall Study||12
3134325|NCT01701245|3859399|FG001|NOT COMPLETED|Overall Study||15
3134326|NCT01701258|3859409|FG000|STARTED|Assessment and Scheduling||153
3134327|NCT01701258|3859410|FG001|STARTED|Assessment and Scheduling||0
3134328|NCT01701258|3859411|FG002|STARTED|Assessment and Scheduling||0
3134329|NCT01701258|3859412|FG003|STARTED|Assessment and Scheduling||0
3134330|NCT01701258|3859413|FG004|STARTED|Assessment and Scheduling||0
3134331|NCT01701258|3859414|FG005|STARTED|Assessment and Scheduling||0
3134332|NCT01701258|3859415|FG006|STARTED|Assessment and Scheduling||0
3134333|NCT01701258|3859416|FG007|STARTED|Assessment and Scheduling||0
3134334|NCT01701258|3859417|FG008|STARTED|Assessment and Scheduling||0
3134335|NCT01701258|3859418|FG009|STARTED|Assessment and Scheduling||0
3134336|NCT01701258|3859419|FG010|STARTED|Assessment and Scheduling||0
3134337|NCT01701258|3859420|FG011|STARTED|Assessment and Scheduling||0
3134338|NCT01701258|3859421|FG012|STARTED|Assessment and Scheduling||0
3134339|NCT01701258|3859409|FG000|Eligible After Screening Visit|Assessment and Scheduling||96
3134340|NCT01701258|3859410|FG001|Eligible After Screening Visit|Assessment and Scheduling||0
3134341|NCT01701258|3859411|FG002|Eligible After Screening Visit|Assessment and Scheduling||0
3134342|NCT01701258|3859412|FG003|Eligible After Screening Visit|Assessment and Scheduling||0
3134343|NCT01701258|3859413|FG004|Eligible After Screening Visit|Assessment and Scheduling||0
3134344|NCT01701258|3859414|FG005|Eligible After Screening Visit|Assessment and Scheduling||0
3134345|NCT01701258|3859415|FG006|Eligible After Screening Visit|Assessment and Scheduling||0
3134346|NCT01701258|3859416|FG007|Eligible After Screening Visit|Assessment and Scheduling||0
3134347|NCT01701258|3859417|FG008|Eligible After Screening Visit|Assessment and Scheduling||0
3134348|NCT01701258|3859418|FG009|Eligible After Screening Visit|Assessment and Scheduling||0
3134349|NCT01701258|3859419|FG010|Eligible After Screening Visit|Assessment and Scheduling||0
3134350|NCT01701258|3859420|FG011|Eligible After Screening Visit|Assessment and Scheduling||0
3134351|NCT01701258|3859421|FG012|Eligible After Screening Visit|Assessment and Scheduling||0
3068274|NCT01307397|3788921|FG000|STARTED|Overall Study||3219
3068275|NCT01307397|3788921|FG000|COMPLETED|Overall Study|A participant completed study in case of progressive disease, adverse events or consent withdrawn|3219
3068276|NCT01307397|3788921|FG000|NOT COMPLETED|Overall Study||0
3068277|NCT01307423|3788928|FG000|STARTED|Placebo-controlled Phase (Week 0 - 24)||176
3068278|NCT01307423|3788929|FG001|STARTED|Placebo-controlled Phase (Week 0 - 24)||175
3068279|NCT01307423|3788930|FG002|STARTED|Placebo-controlled Phase (Week 0 - 24)||177
3068280|NCT01307423|3788931|FG003|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
3068281|NCT01307423|3788932|FG004|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
3068282|NCT01307423|3788933|FG005|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
3068283|NCT01307423|3788934|FG006|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
3068284|NCT01307423|3788935|FG007|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
3068285|NCT01307423|3788936|FG008|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
3068286|NCT01307423|3788928|FG000|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||176
3068287|NCT01307423|3788929|FG001|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||175
3068288|NCT01307423|3788930|FG002|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||175
3068289|NCT01307423|3788931|FG003|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
3068290|NCT01307423|3788932|FG004|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
3068291|NCT01307423|3788933|FG005|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
3068292|NCT01307423|3788934|FG006|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
3068293|NCT01307423|3788935|FG007|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
3068294|NCT01307423|3788936|FG008|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
3068295|NCT01307423|3788928|FG000|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||166
3068296|NCT01307423|3788929|FG001|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||168
3068297|NCT01307423|3788930|FG002|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||166
3068298|NCT01307423|3788931|FG003|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
3068299|NCT01307423|3788932|FG004|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
3068300|NCT01307423|3788933|FG005|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
3068301|NCT01307423|3788934|FG006|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
3068302|NCT01307423|3788935|FG007|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
3068303|NCT01307423|3788936|FG008|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
3068304|NCT01307423|3788928|FG000|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)|One participant who escaped early did not complete Week 24|103
3068305|NCT01307423|3788929|FG001|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||73
3068306|NCT01307423|3788930|FG002|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||79
3068307|NCT01307423|3788931|FG003|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
3068308|NCT01307423|3788932|FG004|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
3068309|NCT01307423|3788933|FG005|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
3068310|NCT01307423|3788934|FG006|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
3068311|NCT01307423|3788935|FG007|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
3068312|NCT01307423|3788936|FG008|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
3068313|NCT01307423|3788928|FG000|COMPLETED|Placebo-controlled Phase (Week 0 - 24)|Two participants did not escape early and finished Week 24 did not enter the active treatment phase|156
3068314|NCT01307423|3788929|FG001|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||160
3068315|NCT01307423|3788930|FG002|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||155
3068316|NCT01307423|3788931|FG003|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
3068317|NCT01307423|3788932|FG004|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
3068318|NCT01307423|3788933|FG005|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
3068319|NCT01307423|3788934|FG006|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
3068320|NCT01307423|3788935|FG007|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
3068321|NCT01307423|3788936|FG008|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
3068322|NCT01307423|3788928|FG000|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||20
3068323|NCT01307423|3788929|FG001|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||15
3068324|NCT01307423|3788930|FG002|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||22
3068325|NCT01307423|3788931|FG003|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
3068326|NCT01307423|3788932|FG004|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
3068327|NCT01307423|3788933|FG005|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
3068328|NCT01307423|3788934|FG006|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
3068329|NCT01307423|3788935|FG007|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
3068330|NCT01307423|3788936|FG008|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
3068331|NCT01307423|3788928|FG000|STARTED|Active Treatment Phase (Week 25-52)||0
3068332|NCT01307423|3788929|FG001|STARTED|Active Treatment Phase (Week 25-52)|Nine participants who completed Week 24 did not enter active treatment phase|151
3068333|NCT01307423|3788930|FG002|STARTED|Active Treatment Phase (Week 25-52)|Five participants who completed Week 24 did not enter active treatment phase|150
3068334|NCT01307423|3788931|FG003|STARTED|Active Treatment Phase (Week 25-52)|Four participants who escaped early and completed Week 24 did not enter the active treatment phase.|46
3068335|NCT01307423|3788932|FG004|STARTED|Active Treatment Phase (Week 25-52)||26
3068336|NCT01307423|3788933|FG005|STARTED|Active Treatment Phase (Week 25-52)|Six participants who escaped early and completed Week 24 did not enter the active treatment phase|46
3068337|NCT01307423|3788934|FG006|STARTED|Active Treatment Phase (Week 25-52)||26
3068338|NCT01307423|3788935|FG007|STARTED|Active Treatment Phase (Week 25-52)||0
3068339|NCT01307423|3788936|FG008|STARTED|Active Treatment Phase (Week 25-52)||0
3068340|NCT01307423|3788928|FG000|COMPLETED|Active Treatment Phase (Week 25-52)||0
3068341|NCT01307423|3788929|FG001|COMPLETED|Active Treatment Phase (Week 25-52)||132
3068342|NCT01307423|3788930|FG002|COMPLETED|Active Treatment Phase (Week 25-52)||141
3068343|NCT01307423|3788931|FG003|COMPLETED|Active Treatment Phase (Week 25-52)||38
3068344|NCT01307423|3788932|FG004|COMPLETED|Active Treatment Phase (Week 25-52)||23
3068345|NCT01307423|3788933|FG005|COMPLETED|Active Treatment Phase (Week 25-52)||43
3068346|NCT01307423|3788934|FG006|COMPLETED|Active Treatment Phase (Week 25-52)||25
3068347|NCT01307423|3788935|FG007|COMPLETED|Active Treatment Phase (Week 25-52)||0
3068348|NCT01307423|3788936|FG008|COMPLETED|Active Treatment Phase (Week 25-52)||0
3068349|NCT01307423|3788928|FG000|NOT COMPLETED|Active Treatment Phase (Week 25-52)||0
3068350|NCT01307423|3788929|FG001|NOT COMPLETED|Active Treatment Phase (Week 25-52)||19
3068351|NCT01307423|3788930|FG002|NOT COMPLETED|Active Treatment Phase (Week 25-52)||9
3068352|NCT01307423|3788931|FG003|NOT COMPLETED|Active Treatment Phase (Week 25-52)||8
3068353|NCT01307423|3788932|FG004|NOT COMPLETED|Active Treatment Phase (Week 25-52)||3
3068354|NCT01307423|3788933|FG005|NOT COMPLETED|Active Treatment Phase (Week 25-52)||3
3068355|NCT01307423|3788934|FG006|NOT COMPLETED|Active Treatment Phase (Week 25-52)||1
3068356|NCT01307423|3788935|FG007|NOT COMPLETED|Active Treatment Phase (Week 25-52)||0
3068357|NCT01307423|3788936|FG008|NOT COMPLETED|Active Treatment Phase (Week 25-52)||0
3068358|NCT01307423|3788928|FG000|STARTED|Long-term Safety Phase (Year 2)||0
3068359|NCT01307423|3788929|FG001|STARTED|Long-term Safety Phase (Year 2)|10 participants who completed Week 52 did not enter the long-term safety phase|122
3068360|NCT01307423|3788930|FG002|STARTED|Long-term Safety Phase (Year 2)|7 participants who completed Week 52 did not enter the long-term safety phase|134
3068361|NCT01307423|3788931|FG003|STARTED|Long-term Safety Phase (Year 2)||0
3068362|NCT01307423|3788932|FG004|STARTED|Long-term Safety Phase (Year 2)||0
3068363|NCT01307423|3788933|FG005|STARTED|Long-term Safety Phase (Year 2)||0
3068364|NCT01307423|3788934|FG006|STARTED|Long-term Safety Phase (Year 2)||0
3068365|NCT01307423|3788935|FG007|STARTED|Long-term Safety Phase (Year 2)|Patients from the PBO/APR 20 mg EE and XO are combined;15 patients finished Wk 52;no entry into LTSP|57
3068366|NCT01307423|3788936|FG008|STARTED|Long-term Safety Phase (Year 2)|Patients from the PBO/APR 30 mg EE and XO are combined;5 patients finished Wk 52;no entry into LTSP|67
3068367|NCT01307423|3788928|FG000|COMPLETED|Long-term Safety Phase (Year 2)||0
3068368|NCT01307423|3788929|FG001|COMPLETED|Long-term Safety Phase (Year 2)||99
3068369|NCT01307423|3788930|FG002|COMPLETED|Long-term Safety Phase (Year 2)||109
3068370|NCT01307423|3788931|FG003|COMPLETED|Long-term Safety Phase (Year 2)||0
3068371|NCT01307423|3788932|FG004|COMPLETED|Long-term Safety Phase (Year 2)||0
3068372|NCT01307423|3788933|FG005|COMPLETED|Long-term Safety Phase (Year 2)||0
3068373|NCT01307423|3788934|FG006|COMPLETED|Long-term Safety Phase (Year 2)||0
3068374|NCT01307423|3788935|FG007|COMPLETED|Long-term Safety Phase (Year 2)||48
3068375|NCT01307423|3788936|FG008|COMPLETED|Long-term Safety Phase (Year 2)||60
3068376|NCT01307423|3788928|FG000|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
3068377|NCT01307423|3788929|FG001|NOT COMPLETED|Long-term Safety Phase (Year 2)||23
3068378|NCT01307423|3788930|FG002|NOT COMPLETED|Long-term Safety Phase (Year 2)||25
3068379|NCT01307423|3788931|FG003|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
3068380|NCT01307423|3788932|FG004|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
3068381|NCT01307423|3788933|FG005|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
3068382|NCT01307423|3788934|FG006|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
3068383|NCT01307423|3788935|FG007|NOT COMPLETED|Long-term Safety Phase (Year 2)||9
3068384|NCT01307423|3788936|FG008|NOT COMPLETED|Long-term Safety Phase (Year 2)||7
3068385|NCT01307423|3788928|FG000|STARTED|Long-term Safety Phase (Year 3)||0
3068386|NCT01307423|3788929|FG001|STARTED|Long-term Safety Phase (Year 3)||99
3068387|NCT01307423|3788930|FG002|STARTED|Long-term Safety Phase (Year 3)||109
3068388|NCT01307423|3788931|FG003|STARTED|Long-term Safety Phase (Year 3)||0
3068389|NCT01307423|3788932|FG004|STARTED|Long-term Safety Phase (Year 3)||0
3068390|NCT01307423|3788933|FG005|STARTED|Long-term Safety Phase (Year 3)||0
3068391|NCT01307423|3788934|FG006|STARTED|Long-term Safety Phase (Year 3)||0
3068392|NCT01307423|3788935|FG007|STARTED|Long-term Safety Phase (Year 3)||48
3068393|NCT01307423|3788936|FG008|STARTED|Long-term Safety Phase (Year 3)||60
3068394|NCT01307423|3788928|FG000|COMPLETED|Long-term Safety Phase (Year 3)||0
3068395|NCT01307423|3788929|FG001|COMPLETED|Long-term Safety Phase (Year 3)||90
3068396|NCT01307423|3788930|FG002|COMPLETED|Long-term Safety Phase (Year 3)||91
3068397|NCT01307423|3788931|FG003|COMPLETED|Long-term Safety Phase (Year 3)||0
3068398|NCT01307423|3788932|FG004|COMPLETED|Long-term Safety Phase (Year 3)||0
3068399|NCT01307423|3788933|FG005|COMPLETED|Long-term Safety Phase (Year 3)||0
3068400|NCT01307423|3788934|FG006|COMPLETED|Long-term Safety Phase (Year 3)||0
3068401|NCT01307423|3788935|FG007|COMPLETED|Long-term Safety Phase (Year 3)||40
3068402|NCT01307423|3788936|FG008|COMPLETED|Long-term Safety Phase (Year 3)||49
3068403|NCT01307423|3788928|FG000|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
3068404|NCT01307423|3788929|FG001|NOT COMPLETED|Long-term Safety Phase (Year 3)||9
3068405|NCT01307423|3788930|FG002|NOT COMPLETED|Long-term Safety Phase (Year 3)||18
3068406|NCT01307423|3788931|FG003|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
3068407|NCT01307423|3788932|FG004|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
3068408|NCT01307423|3788933|FG005|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
3068409|NCT01307423|3788934|FG006|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
3068410|NCT01307423|3788935|FG007|NOT COMPLETED|Long-term Safety Phase (Year 3)||8
3068411|NCT01307423|3788936|FG008|NOT COMPLETED|Long-term Safety Phase (Year 3)||11
3068412|NCT01307423|3788928|FG000|STARTED|Long-term Safety Phase (Year 4)||0
3136756|NCT01714947|3862017|FG000|STARTED|Part A||3
3068413|NCT01307423|3788929|FG001|STARTED|Long-term Safety Phase (Year 4)|1 participant who completed Year 3 did not continue treatment in Year 4|89
3068414|NCT01307423|3788930|FG002|STARTED|Long-term Safety Phase (Year 4)||91
3068415|NCT01307423|3788931|FG003|STARTED|Long-term Safety Phase (Year 4)||0
3068416|NCT01307423|3788932|FG004|STARTED|Long-term Safety Phase (Year 4)||0
3068417|NCT01307423|3788933|FG005|STARTED|Long-term Safety Phase (Year 4)||0
3068418|NCT01307423|3788934|FG006|STARTED|Long-term Safety Phase (Year 4)||0
3068419|NCT01307423|3788935|FG007|STARTED|Long-term Safety Phase (Year 4)||40
3068420|NCT01307423|3788936|FG008|STARTED|Long-term Safety Phase (Year 4)||49
3068421|NCT01307423|3788928|FG000|COMPLETED|Long-term Safety Phase (Year 4)||0
3068422|NCT01307423|3788929|FG001|COMPLETED|Long-term Safety Phase (Year 4)||81
3068423|NCT01307423|3788930|FG002|COMPLETED|Long-term Safety Phase (Year 4)||86
3068424|NCT01307423|3788931|FG003|COMPLETED|Long-term Safety Phase (Year 4)||0
3068425|NCT01307423|3788932|FG004|COMPLETED|Long-term Safety Phase (Year 4)||0
3068426|NCT01307423|3788933|FG005|COMPLETED|Long-term Safety Phase (Year 4)||0
3068427|NCT01307423|3788934|FG006|COMPLETED|Long-term Safety Phase (Year 4)||0
3068428|NCT01307423|3788935|FG007|COMPLETED|Long-term Safety Phase (Year 4)||38
3068429|NCT01307423|3788936|FG008|COMPLETED|Long-term Safety Phase (Year 4)||44
3068430|NCT01307423|3788928|FG000|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
3068431|NCT01307423|3788929|FG001|NOT COMPLETED|Long-term Safety Phase (Year 4)||8
3068432|NCT01307423|3788930|FG002|NOT COMPLETED|Long-term Safety Phase (Year 4)||5
3068433|NCT01307423|3788931|FG003|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
3068434|NCT01307423|3788932|FG004|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
3068435|NCT01307423|3788933|FG005|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
3068436|NCT01307423|3788934|FG006|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
3068437|NCT01307423|3788935|FG007|NOT COMPLETED|Long-term Safety Phase (Year 4)||2
3068438|NCT01307423|3788936|FG008|NOT COMPLETED|Long-term Safety Phase (Year 4)||5
3068439|NCT01307423|3788928|FG000|STARTED|Long-term Safety Phase (Year 5)||0
3068440|NCT01307423|3788929|FG001|STARTED|Long-term Safety Phase (Year 5)||81
3068441|NCT01307423|3788930|FG002|STARTED|Long-term Safety Phase (Year 5)||86
3068442|NCT01307423|3788931|FG003|STARTED|Long-term Safety Phase (Year 5)||0
3068443|NCT01307423|3788932|FG004|STARTED|Long-term Safety Phase (Year 5)||0
3068444|NCT01307423|3788933|FG005|STARTED|Long-term Safety Phase (Year 5)||0
3068445|NCT01307423|3788934|FG006|STARTED|Long-term Safety Phase (Year 5)||0
3068446|NCT01307423|3788935|FG007|STARTED|Long-term Safety Phase (Year 5)||38
3068447|NCT01307423|3788936|FG008|STARTED|Long-term Safety Phase (Year 5)||44
3068448|NCT01307423|3788928|FG000|COMPLETED|Long-term Safety Phase (Year 5)||0
3068449|NCT01307423|3788929|FG001|COMPLETED|Long-term Safety Phase (Year 5)||71
3068450|NCT01307423|3788930|FG002|COMPLETED|Long-term Safety Phase (Year 5)||80
3068451|NCT01307423|3788931|FG003|COMPLETED|Long-term Safety Phase (Year 5)||0
3068452|NCT01307423|3788932|FG004|COMPLETED|Long-term Safety Phase (Year 5)||0
3068453|NCT01307423|3788933|FG005|COMPLETED|Long-term Safety Phase (Year 5)||0
3068454|NCT01307423|3788934|FG006|COMPLETED|Long-term Safety Phase (Year 5)||0
3068455|NCT01307423|3788935|FG007|COMPLETED|Long-term Safety Phase (Year 5)||37
3068456|NCT01307423|3788936|FG008|COMPLETED|Long-term Safety Phase (Year 5)||41
3068457|NCT01307423|3788928|FG000|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
3068458|NCT01307423|3788929|FG001|NOT COMPLETED|Long-term Safety Phase (Year 5)||10
3068459|NCT01307423|3788930|FG002|NOT COMPLETED|Long-term Safety Phase (Year 5)||6
3068460|NCT01307423|3788931|FG003|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
3068461|NCT01307423|3788932|FG004|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
3068462|NCT01307423|3788933|FG005|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
3068463|NCT01307423|3788934|FG006|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
3068464|NCT01307423|3788935|FG007|NOT COMPLETED|Long-term Safety Phase (Year 5)||1
3068465|NCT01307423|3788936|FG008|NOT COMPLETED|Long-term Safety Phase (Year 5)||3
3068466|NCT01307449|3788972|FG000|STARTED|Overall Study||33
3068467|NCT01307449|3788973|FG001|STARTED|Overall Study||33
3068468|NCT01307449|3788974|FG002|STARTED|Overall Study||11
3068469|NCT01307449|3788975|FG003|STARTED|Overall Study||11
3068470|NCT01307449|3788972|FG000|COMPLETED|Overall Study||32
3068471|NCT01307449|3788973|FG001|COMPLETED|Overall Study||33
3068472|NCT01307449|3788974|FG002|COMPLETED|Overall Study||11
3068473|NCT01307449|3788975|FG003|COMPLETED|Overall Study||11
3068474|NCT01307449|3788972|FG000|NOT COMPLETED|Overall Study||1
3068475|NCT01307449|3788973|FG001|NOT COMPLETED|Overall Study||0
3068476|NCT01307449|3788974|FG002|NOT COMPLETED|Overall Study||0
3068477|NCT01307449|3788975|FG003|NOT COMPLETED|Overall Study||0
3068478|NCT01307462|3788985|FG000|STARTED|Overall Study||36
3068479|NCT01307462|3788985|FG000|COMPLETED|Overall Study||35
3068480|NCT01307462|3788985|FG000|NOT COMPLETED|Overall Study||1
3068481|NCT01307501|3788989|FG000|STARTED|Overall Study||40
3068482|NCT01307501|3788989|FG000|Intent-to-Treat (ITT) Population|Overall Study||40
3068483|NCT01307501|3788989|FG000|COMPLETED|Overall Study||17
3068484|NCT01307501|3788989|FG000|NOT COMPLETED|Overall Study||23
3068485|NCT01307579|3788995|FG000|STARTED|Overall Study||257
3068486|NCT01307579|3788996|FG001|STARTED|Overall Study||260
3068487|NCT01307579|3788995|FG000|COMPLETED|Overall Study||117
3068488|NCT01307579|3788996|FG001|COMPLETED|Overall Study||115
3068489|NCT01307579|3788995|FG000|NOT COMPLETED|Overall Study||140
3068490|NCT01307579|3788996|FG001|NOT COMPLETED|Overall Study||145
3068491|NCT01307618|3789004|FG000|STARTED|Overall Study||5
3068492|NCT01307618|3789005|FG001|STARTED|Overall Study||5
3068493|NCT01307618|3789004|FG000|COMPLETED|Overall Study||5
3068494|NCT01307618|3789005|FG001|COMPLETED|Overall Study||5
3068495|NCT01307618|3789004|FG000|NOT COMPLETED|Overall Study||0
3068496|NCT01307618|3789005|FG001|NOT COMPLETED|Overall Study||0
3068497|NCT01307748|3789014|FG000|STARTED|Overall Study||31
3068498|NCT01307748|3789015|FG001|STARTED|Overall Study||31
3068499|NCT01307748|3789016|FG002|STARTED|Overall Study||30
3068500|NCT01307748|3789014|FG000|COMPLETED|Overall Study||31
3068501|NCT01307748|3789015|FG001|COMPLETED|Overall Study||31
3068502|NCT01307748|3789016|FG002|COMPLETED|Overall Study||30
3068503|NCT01307748|3789014|FG000|NOT COMPLETED|Overall Study||0
3068504|NCT01307748|3789015|FG001|NOT COMPLETED|Overall Study||0
3068505|NCT01307748|3789016|FG002|NOT COMPLETED|Overall Study||0
3068506|NCT01307891|3789032|FG000|STARTED|Overall Study||42
3068507|NCT01307891|3789033|FG001|STARTED|Overall Study||22
3068508|NCT01307891|3789032|FG000|COMPLETED|Overall Study||39
3068509|NCT01307891|3789033|FG001|COMPLETED|Overall Study||21
3068510|NCT01307891|3789032|FG000|NOT COMPLETED|Overall Study||3
3068511|NCT01307891|3789033|FG001|NOT COMPLETED|Overall Study||1
3068512|NCT01307930|3789039|FG000|STARTED|Overall Study||20
3068513|NCT01307930|3789039|FG000|COMPLETED|Overall Study||18
3068514|NCT01307930|3789039|FG000|NOT COMPLETED|Overall Study||2
3068515|NCT01307956|3789043|FG000|STARTED|Overall Study||11
3068516|NCT01307956|3789043|FG000|COMPLETED|Overall Study||11
3068517|NCT01307956|3789043|FG000|NOT COMPLETED|Overall Study||0
3068518|NCT01308008|3789049|FG000|STARTED|4 Weeks||71
3068519|NCT01308008|3789050|FG001|STARTED|4 Weeks||73
3068520|NCT01308008|3789049|FG000|COMPLETED|4 Weeks||62
3068521|NCT01308008|3789050|FG001|COMPLETED|4 Weeks||71
3068522|NCT01308008|3789049|FG000|NOT COMPLETED|4 Weeks||9
3068523|NCT01308008|3789050|FG001|NOT COMPLETED|4 Weeks||2
3068524|NCT01308008|3789049|FG000|STARTED|6 Months||62
3068525|NCT01308008|3789050|FG001|STARTED|6 Months||71
3068526|NCT01308008|3789049|FG000|COMPLETED|6 Months||54
3068527|NCT01308008|3789050|FG001|COMPLETED|6 Months||62
3068528|NCT01308008|3789049|FG000|NOT COMPLETED|6 Months||8
3068529|NCT01308008|3789050|FG001|NOT COMPLETED|6 Months||9
3068530|NCT01308008|3789049|FG000|STARTED|12 Months||54
3068531|NCT01308008|3789050|FG001|STARTED|12 Months||62
3068532|NCT01308008|3789049|FG000|COMPLETED|12 Months||46
3068533|NCT01308008|3789050|FG001|COMPLETED|12 Months||58
3068534|NCT01308008|3789049|FG000|NOT COMPLETED|12 Months||8
3068535|NCT01308008|3789050|FG001|NOT COMPLETED|12 Months||4
3068536|NCT01308060|3789058|FG000|STARTED|Part A||252
3068537|NCT01308060|3789059|FG001|STARTED|Part A||83
3068538|NCT01308060|3789058|FG000|COMPLETED|Part A||238
3068539|NCT01308060|3789059|FG001|COMPLETED|Part A||77
3068540|NCT01308060|3789058|FG000|NOT COMPLETED|Part A||14
3068541|NCT01308060|3789059|FG001|NOT COMPLETED|Part A||6
3068542|NCT01308060|3789058|FG000|STARTED|Part B||238
3068543|NCT01308060|3789059|FG001|STARTED|Part B||77
3068544|NCT01308060|3789058|FG000|COMPLETED|Part B||219
3068545|NCT01308060|3789059|FG001|COMPLETED|Part B||69
3068546|NCT01308060|3789058|FG000|NOT COMPLETED|Part B||19
3068547|NCT01308060|3789059|FG001|NOT COMPLETED|Part B||8
3068548|NCT01308294|3789069|FG000|STARTED|Cycle 1||10
3068549|NCT01308294|3789070|FG001|STARTED|Cycle 1||6
3068550|NCT01308294|3789071|FG002|STARTED|Cycle 1||0
3068551|NCT01308294|3789069|FG000|COMPLETED|Cycle 1||10
3068552|NCT01308294|3789070|FG001|COMPLETED|Cycle 1||6
3068553|NCT01308294|3789071|FG002|COMPLETED|Cycle 1||0
3068554|NCT01308294|3789069|FG000|NOT COMPLETED|Cycle 1||0
3068555|NCT01308294|3789070|FG001|NOT COMPLETED|Cycle 1||0
3068556|NCT01308294|3789071|FG002|NOT COMPLETED|Cycle 1||0
3068557|NCT01308294|3789069|FG000|STARTED|Cycle 2||10
3068558|NCT01308294|3789070|FG001|STARTED|Cycle 2||6
3068559|NCT01308294|3789071|FG002|STARTED|Cycle 2||0
3068560|NCT01308294|3789069|FG000|COMPLETED|Cycle 2||10
3068561|NCT01308294|3789070|FG001|COMPLETED|Cycle 2||5
3068562|NCT01308294|3789071|FG002|COMPLETED|Cycle 2||0
3068563|NCT01308294|3789069|FG000|NOT COMPLETED|Cycle 2||0
3068564|NCT01308294|3789070|FG001|NOT COMPLETED|Cycle 2||1
3068565|NCT01308294|3789071|FG002|NOT COMPLETED|Cycle 2||0
3068566|NCT01308294|3789069|FG000|STARTED|Cycle 3||10
3068567|NCT01308294|3789070|FG001|STARTED|Cycle 3||5
3068568|NCT01308294|3789071|FG002|STARTED|Cycle 3||0
3068569|NCT01308294|3789069|FG000|COMPLETED|Cycle 3||10
3068570|NCT01308294|3789070|FG001|COMPLETED|Cycle 3||4
3068571|NCT01308294|3789071|FG002|COMPLETED|Cycle 3||0
3068572|NCT01308294|3789069|FG000|NOT COMPLETED|Cycle 3||0
3068573|NCT01308294|3789070|FG001|NOT COMPLETED|Cycle 3||1
3068574|NCT01308294|3789071|FG002|NOT COMPLETED|Cycle 3||0
3068575|NCT01308424|3789084|FG000|STARTED|Baseline Eligibility||242
3068576|NCT01308424|3789085|FG001|STARTED|Baseline Eligibility||0
3068577|NCT01308424|3789086|FG002|STARTED|Baseline Eligibility||0
3068578|NCT01308424|3789084|FG000|COMPLETED|Baseline Eligibility|Completed baseline run in and were eligible for randomization|171
3068579|NCT01308424|3789085|FG001|COMPLETED|Baseline Eligibility||0
3068580|NCT01308424|3789086|FG002|COMPLETED|Baseline Eligibility||0
3068581|NCT01308424|3789084|FG000|NOT COMPLETED|Baseline Eligibility||71
3068582|NCT01308424|3789085|FG001|NOT COMPLETED|Baseline Eligibility||0
3068583|NCT01308424|3789086|FG002|NOT COMPLETED|Baseline Eligibility||0
3068584|NCT01308424|3789084|FG000|STARTED|Randomization||0
3068585|NCT01308424|3789085|FG001|STARTED|Randomization||87
3068586|NCT01308424|3789086|FG002|STARTED|Randomization||84
3068587|NCT01308424|3789084|FG000|COMPLETED|Randomization||0
3068588|NCT01308424|3789085|FG001|COMPLETED|Randomization||84
3068589|NCT01308424|3789086|FG002|COMPLETED|Randomization||82
3068590|NCT01308424|3789084|FG000|NOT COMPLETED|Randomization||0
3068591|NCT01308424|3789085|FG001|NOT COMPLETED|Randomization||3
3068592|NCT01308424|3789086|FG002|NOT COMPLETED|Randomization||2
3068593|NCT01308450|3789093|FG000|STARTED|Overall Study|302 subjects were screen. 300 subjects were enrolled in this one site, one visit study.|302
3068594|NCT01308450|3789093|FG000|COMPLETED|Overall Study|Last subject was enrolled 06/28/2011|300
3068595|NCT01308450|3789093|FG000|NOT COMPLETED|Overall Study||2
3068596|NCT01308463|3789097|FG000|STARTED|Overall Study||29
3068597|NCT01308463|3789097|FG000|6 Months|Overall Study||23
3068598|NCT01308463|3789097|FG000|1 Year|Overall Study||21
3068599|NCT01308463|3789097|FG000|2 Years|Overall Study||18
3068600|NCT01308463|3789097|FG000|3 Years|Overall Study||17
3068601|NCT01308463|3789097|FG000|4 Years|Overall Study||20
3068602|NCT01308463|3789097|FG000|5 Years|Overall Study||20
3068603|NCT01308463|3789097|FG000|6 Years|Overall Study||11
3068604|NCT01308463|3789097|FG000|7 Years|Overall Study||12
3068605|NCT01308463|3789097|FG000|8 Years|Overall Study||14
3068606|NCT01308463|3789097|FG000|9 Years|Overall Study||11
3068607|NCT01308463|3789097|FG000|10 Years|Overall Study||8
3068608|NCT01308463|3789097|FG000|11 Years|Overall Study||8
3068609|NCT01308463|3789097|FG000|12 Years|Overall Study||2
3068610|NCT01308463|3789097|FG000|COMPLETED|Overall Study||0
3068611|NCT01308463|3789097|FG000|NOT COMPLETED|Overall Study||29
3068612|NCT01308476|3789103|FG000|STARTED|Overall Study|Entered and treated.|48
3068613|NCT01308476|3789104|FG001|STARTED|Overall Study|Entered and treated.|47
3068614|NCT01308476|3789103|FG000|COMPLETED|Overall Study||45
3068615|NCT01308476|3789104|FG001|COMPLETED|Overall Study||45
3068616|NCT01308476|3789103|FG000|NOT COMPLETED|Overall Study||3
3068617|NCT01308476|3789104|FG001|NOT COMPLETED|Overall Study||2
3068618|NCT01308567|3789113|FG000|STARTED|Overall Study|Randomized|391
3068619|NCT01308567|3789114|FG001|STARTED|Overall Study|Randomized|389
3068620|NCT01308567|3789115|FG002|STARTED|Overall Study|Randomized|388
3068621|NCT01308567|3789113|FG000|Treated|Overall Study|For 1 participant, actual treatment received was Cabazitaxel 25 mg/m^2.|388
3068622|NCT01308567|3789114|FG001|Treated|Overall Study|For 15 participants, actual treatment received was Cabazitaxel 25 mg/m^2.|382
3068623|NCT01308567|3789115|FG002|Treated|Overall Study|For 2 participants, actual treatment received was Cabazitaxel 20 mg/m^2.|377
3068624|NCT01308567|3789113|FG000|COMPLETED|Overall Study|Completed participants included those who withdrew treatment consent but were followed for survival.|389
3068625|NCT01308567|3789114|FG001|COMPLETED|Overall Study|Completed participants included those who withdrew treatment consent but were followed for survival.|385
3068626|NCT01308567|3789115|FG002|COMPLETED|Overall Study|Completed participants included those who withdrew treatment consent but were followed for survival.|384
3068627|NCT01308567|3789113|FG000|NOT COMPLETED|Overall Study||2
3068628|NCT01308567|3789114|FG001|NOT COMPLETED|Overall Study||4
3068629|NCT01308567|3789115|FG002|NOT COMPLETED|Overall Study||4
3068630|NCT01308580|3789125|FG000|STARTED|Overall Study||598
3068631|NCT01308580|3789126|FG001|STARTED|Overall Study||602
3068632|NCT01308580|3789125|FG000|Treated|Overall Study|Random assignment, was not actual treatment in some cases|587
3068633|NCT01308580|3789126|FG001|Treated|Overall Study|Random assignment, was not actual treatment in some cases|588
3068634|NCT01308580|3789125|FG000|COMPLETED|Overall Study|Completed participants included those who withdrew treatment consent but were followed for survival|586
3068635|NCT01308580|3789126|FG001|COMPLETED|Overall Study|Completed participants included those who withdrew treatment consent but were followed for survival|595
3068636|NCT01308580|3789125|FG000|NOT COMPLETED|Overall Study||12
3068637|NCT01308580|3789126|FG001|NOT COMPLETED|Overall Study||7
3068638|NCT01308619|3789135|FG000|STARTED|Overall Study||84
3068639|NCT01308619|3789136|FG001|STARTED|Overall Study||86
3068640|NCT01308619|3789135|FG000|COMPLETED|Overall Study||77
3068641|NCT01308619|3789136|FG001|COMPLETED|Overall Study||83
3068642|NCT01308619|3789135|FG000|NOT COMPLETED|Overall Study||7
3068643|NCT01308619|3789136|FG001|NOT COMPLETED|Overall Study||3
3068644|NCT01308736|3789146|FG000|STARTED|Overall Study||31
3068645|NCT01308736|3789147|FG001|STARTED|Overall Study||32
3068646|NCT01308736|3789146|FG000|COMPLETED|Overall Study||25
3068647|NCT01308736|3789147|FG001|COMPLETED|Overall Study||27
3068648|NCT01308736|3789146|FG000|NOT COMPLETED|Overall Study||6
3163032|NCT01882465|3890493|FG002|NOT COMPLETED|Period 2||0
3163033|NCT01882465|3890494|FG003|NOT COMPLETED|Period 2||0
3163034|NCT01882465|3890495|FG004|NOT COMPLETED|Period 2||1
3163035|NCT01882465|3890496|FG005|NOT COMPLETED|Period 2||0
3163036|NCT01882465|3890497|FG006|NOT COMPLETED|Period 2||0
3163037|NCT01882465|3890491|FG000|STARTED|Period 3||6
3163038|NCT01882465|3890492|FG001|STARTED|Period 3||6
3163039|NCT01882465|3890493|FG002|STARTED|Period 3||5
3068649|NCT01308736|3789147|FG001|NOT COMPLETED|Overall Study||5
3068650|NCT01308749|3789155|FG000|STARTED|Period 1: Double Blind Treatment||12
3068651|NCT01308749|3789156|FG001|STARTED|Period 1: Double Blind Treatment||13
3068652|NCT01308749|3789155|FG000|COMPLETED|Period 1: Double Blind Treatment||11
3068653|NCT01308749|3789156|FG001|COMPLETED|Period 1: Double Blind Treatment||13
3068654|NCT01308749|3789155|FG000|NOT COMPLETED|Period 1: Double Blind Treatment||1
3068655|NCT01308749|3789156|FG001|NOT COMPLETED|Period 1: Double Blind Treatment||0
3068656|NCT01308749|3789155|FG000|STARTED|Period 2: Open Label Treatment||11
3068657|NCT01308749|3789156|FG001|STARTED|Period 2: Open Label Treatment||13
3068658|NCT01308749|3789155|FG000|COMPLETED|Period 2: Open Label Treatment||11
3068659|NCT01308749|3789156|FG001|COMPLETED|Period 2: Open Label Treatment||11
3068660|NCT01308749|3789155|FG000|NOT COMPLETED|Period 2: Open Label Treatment||0
3068661|NCT01308749|3789156|FG001|NOT COMPLETED|Period 2: Open Label Treatment||2
3068662|NCT01308762|3789179|FG000|STARTED|Overall Study||6
3068663|NCT01308762|3789180|FG001|STARTED|Overall Study||7
3163040|NCT01882465|3890494|FG003|STARTED|Period 3||5
3068664|NCT01308762|3789181|FG002|STARTED|Overall Study||6
3068665|NCT01308762|3789179|FG000|COMPLETED|Overall Study||6
3068666|NCT01308762|3789180|FG001|COMPLETED|Overall Study|One patient was withdrawn as they were retrospecively found to have been ineligible at study entry|6
3068667|NCT01308762|3789181|FG002|COMPLETED|Overall Study||6
3068668|NCT01308762|3789179|FG000|NOT COMPLETED|Overall Study||0
3068669|NCT01308762|3789180|FG001|NOT COMPLETED|Overall Study||1
3068670|NCT01308762|3789181|FG002|NOT COMPLETED|Overall Study||0
3068671|NCT01308788|3789194|FG000|STARTED|6-month Treatment||14
3068672|NCT01308788|3789195|FG001|STARTED|6-month Treatment||21
3068673|NCT01308788|3789194|FG000|COMPLETED|6-month Treatment||14
3068674|NCT01308788|3789195|FG001|COMPLETED|6-month Treatment||21
3068675|NCT01308788|3789194|FG000|NOT COMPLETED|6-month Treatment||0
3068676|NCT01308788|3789195|FG001|NOT COMPLETED|6-month Treatment||0
3068677|NCT01308788|3789194|FG000|STARTED|2-year Treatment||14
3068678|NCT01308788|3789195|FG001|STARTED|2-year Treatment||21
3068679|NCT01308788|3789194|FG000|COMPLETED|2-year Treatment||10
3068680|NCT01308788|3789195|FG001|COMPLETED|2-year Treatment||10
3068681|NCT01308788|3789194|FG000|NOT COMPLETED|2-year Treatment||4
3068682|NCT01308788|3789195|FG001|NOT COMPLETED|2-year Treatment||11
3068683|NCT01308814|3789203|FG000|STARTED|Overall Study||86
3068684|NCT01308814|3789204|FG001|STARTED|Overall Study||86
3068685|NCT01308814|3789203|FG000|COMPLETED|Overall Study||69
3068686|NCT01308814|3789204|FG001|COMPLETED|Overall Study||63
3068687|NCT01308814|3789203|FG000|NOT COMPLETED|Overall Study||17
3068688|NCT01308814|3789204|FG001|NOT COMPLETED|Overall Study||23
3068689|NCT01308840|3789210|FG000|STARTED|Overall Study||31
3068690|NCT01308840|3789210|FG000|COMPLETED|Overall Study||31
3068691|NCT01308840|3789210|FG000|NOT COMPLETED|Overall Study||0
3068692|NCT01308853|3789214|FG000|STARTED|Overall Study||24
3068693|NCT01308853|3789214|FG000|COMPLETED|Overall Study||20
3068694|NCT01308853|3789214|FG000|NOT COMPLETED|Overall Study||4
3068695|NCT01308918|3789218|FG000|STARTED|Overall Study||50
3068696|NCT01308918|3789218|FG000|COMPLETED|Overall Study||50
3068697|NCT01308918|3789218|FG000|NOT COMPLETED|Overall Study||0
3068698|NCT01309100|3789222|FG000|STARTED|Overall Study||144
3068699|NCT01309100|3789222|FG000|COMPLETED|Overall Study||142
3068700|NCT01309100|3789222|FG000|NOT COMPLETED|Overall Study||2
3068701|NCT01309165|3789231|FG000|STARTED|Overall Study||19
3068702|NCT01309165|3789232|FG001|STARTED|Overall Study||16
3068703|NCT01309165|3789231|FG000|Received Allocated Intervention|Overall Study||16
3068704|NCT01309165|3789232|FG001|Received Allocated Intervention|Overall Study||14
3068705|NCT01309165|3789231|FG000|Included in Primary Analysis|Overall Study||14
3068706|NCT01309165|3789232|FG001|Included in Primary Analysis|Overall Study||12
3068707|NCT01309165|3789231|FG000|COMPLETED|Overall Study||13
3068708|NCT01309165|3789232|FG001|COMPLETED|Overall Study||9
3068709|NCT01309165|3789231|FG000|NOT COMPLETED|Overall Study||6
3068710|NCT01309165|3789232|FG001|NOT COMPLETED|Overall Study||7
3068711|NCT01309204|3789241|FG000|STARTED|Overall Study||452
3068712|NCT01309204|3789242|FG001|STARTED|Overall Study||436
3068713|NCT01309204|3789241|FG000|COMPLETED|Overall Study||385
3068714|NCT01309204|3789242|FG001|COMPLETED|Overall Study||361
3068715|NCT01309204|3789241|FG000|NOT COMPLETED|Overall Study||67
3068716|NCT01309204|3789242|FG001|NOT COMPLETED|Overall Study||75
3068717|NCT01309243|3789250|FG000|STARTED|Randomized Phase Through Week 96||400
3068718|NCT01309243|3789251|FG001|STARTED|Randomized Phase Through Week 96||399
3068719|NCT01309243|3789250|FG000|Randomized and Treated|Randomized Phase Through Week 96||394
3068720|NCT01309243|3789251|FG001|Randomized and Treated|Randomized Phase Through Week 96||392
3068721|NCT01309243|3789250|FG000|COMPLETED|Randomized Phase Through Week 96||316
3068722|NCT01309243|3789251|FG001|COMPLETED|Randomized Phase Through Week 96||290
3068723|NCT01309243|3789250|FG000|NOT COMPLETED|Randomized Phase Through Week 96||84
3068724|NCT01309243|3789251|FG001|NOT COMPLETED|Randomized Phase Through Week 96||109
3068725|NCT01309243|3789250|FG000|STARTED|Extension Phase|40 participants from the Randomized Phase continued the study in the Extension Phase.|40
3068726|NCT01309243|3789251|FG001|STARTED|Extension Phase|117 participants from the Randomized Phase continued the study in the Extension Phase.|117
3068727|NCT01309243|3789250|FG000|COMPLETED|Extension Phase||34
3068728|NCT01309243|3789251|FG001|COMPLETED|Extension Phase||117
3068729|NCT01309243|3789250|FG000|NOT COMPLETED|Extension Phase||6
3068730|NCT01309243|3789251|FG001|NOT COMPLETED|Extension Phase||0
3068731|NCT01309269|3789257|FG000|STARTED|Overall Study||1085
3068732|NCT01309269|3789257|FG000|Treated|Overall Study||978
3068733|NCT01309269|3789257|FG000|COMPLETED|Overall Study||245
3068734|NCT01309269|3789257|FG000|NOT COMPLETED|Overall Study||840
3068735|NCT01309282|3789261|FG000|STARTED|Overall Study||9
3068736|NCT01309282|3789261|FG000|COMPLETED|Overall Study||8
3068737|NCT01309282|3789261|FG000|NOT COMPLETED|Overall Study||1
3068738|NCT01309308|3789267|FG000|STARTED|Overall Study||75
3068739|NCT01309308|3789268|FG001|STARTED|Overall Study||75
3068740|NCT01309308|3789267|FG000|COMPLETED|Overall Study||69
3068741|NCT01309308|3789268|FG001|COMPLETED|Overall Study||71
3068742|NCT01309308|3789267|FG000|NOT COMPLETED|Overall Study||6
3068743|NCT01309308|3789268|FG001|NOT COMPLETED|Overall Study||4
3068744|NCT01309360|3789277|FG000|STARTED|Overall Study||40
3068745|NCT01309360|3789278|FG001|STARTED|Overall Study||40
3068746|NCT01309360|3789279|FG002|STARTED|Overall Study||40
3068747|NCT01309360|3789277|FG000|COMPLETED|Overall Study||40
3068748|NCT01309360|3789278|FG001|COMPLETED|Overall Study||40
3068749|NCT01309360|3789279|FG002|COMPLETED|Overall Study||40
3068750|NCT01309360|3789277|FG000|NOT COMPLETED|Overall Study||0
3068751|NCT01309360|3789278|FG001|NOT COMPLETED|Overall Study||0
3068752|NCT01309360|3789279|FG002|NOT COMPLETED|Overall Study||0
3068753|NCT01309386|3789289|FG000|STARTED|Overall Study||50
3068754|NCT01309386|3789290|FG001|STARTED|Overall Study||50
3068755|NCT01309386|3789289|FG000|COMPLETED|Overall Study||28
3068756|NCT01309386|3789290|FG001|COMPLETED|Overall Study||29
3068757|NCT01309386|3789289|FG000|NOT COMPLETED|Overall Study||22
3068758|NCT01309386|3789290|FG001|NOT COMPLETED|Overall Study||21
3068759|NCT01309451|3789298|FG000|STARTED|Overall Study|unit of measure is number of eyes|19
3068760|NCT01309451|3789299|FG001|STARTED|Overall Study|unit of measure is number of eyes|21
3068761|NCT01309451|3789298|FG000|COMPLETED|Overall Study|unit of measure is number of eyes|17
3068762|NCT01309451|3789299|FG001|COMPLETED|Overall Study|unit of measure is number of eyes|18
3068763|NCT01309451|3789298|FG000|NOT COMPLETED|Overall Study||2
3068764|NCT01309451|3789299|FG001|NOT COMPLETED|Overall Study||3
3068765|NCT01309646|3789309|FG000|STARTED|Overall Study||224
3068766|NCT01309646|3789310|FG001|STARTED|Overall Study||227
3068767|NCT01309646|3789309|FG000|COMPLETED|Overall Study||224
3068768|NCT01309646|3789310|FG001|COMPLETED|Overall Study||227
3068769|NCT01309646|3789309|FG000|NOT COMPLETED|Overall Study||0
3068770|NCT01309646|3789310|FG001|NOT COMPLETED|Overall Study||0
3068771|NCT01309659|3789318|FG000|STARTED|Overall Study||9
3068772|NCT01309659|3789319|FG001|STARTED|Overall Study||10
3068773|NCT01309659|3789318|FG000|COMPLETED|Overall Study||9
3068774|NCT01309659|3789319|FG001|COMPLETED|Overall Study||9
3068775|NCT01309659|3789318|FG000|NOT COMPLETED|Overall Study||0
3068776|NCT01309659|3789319|FG001|NOT COMPLETED|Overall Study||1
3068777|NCT01309737|3789328|FG000|STARTED|Week 0 to 16||383
3068778|NCT01309737|3789329|FG001|STARTED|Week 0 to 16||381
3068779|NCT01309737|3789330|FG002|STARTED|Week 0 to 16||196
3068780|NCT01309737|3789331|FG003|STARTED|Week 0 to 16||0
3068781|NCT01309737|3789332|FG004|STARTED|Week 0 to 16||0
3068782|NCT01309737|3789328|FG000|Treated|Week 0 to 16||382
3068783|NCT01309737|3789329|FG001|Treated|Week 0 to 16||381
3068784|NCT01309737|3789330|FG002|Treated|Week 0 to 16||196
3068785|NCT01309737|3789331|FG003|Treated|Week 0 to 16||0
3068786|NCT01309737|3789332|FG004|Treated|Week 0 to 16||0
3068787|NCT01309737|3789328|FG000|COMPLETED|Week 0 to 16||331
3068788|NCT01309737|3789329|FG001|COMPLETED|Week 0 to 16||341
3068789|NCT01309737|3789330|FG002|COMPLETED|Week 0 to 16||152
3068790|NCT01309737|3789331|FG003|COMPLETED|Week 0 to 16||0
3068791|NCT01309737|3789332|FG004|COMPLETED|Week 0 to 16||0
3068792|NCT01309737|3789328|FG000|NOT COMPLETED|Week 0 to 16||52
3068793|NCT01309737|3789329|FG001|NOT COMPLETED|Week 0 to 16||40
3068794|NCT01309737|3789330|FG002|NOT COMPLETED|Week 0 to 16||44
3068795|NCT01309737|3789331|FG003|NOT COMPLETED|Week 0 to 16||0
3068796|NCT01309737|3789332|FG004|NOT COMPLETED|Week 0 to 16||0
3068797|NCT01309737|3789328|FG000|STARTED|Week 16 to 52||331
3068798|NCT01309737|3789329|FG001|STARTED|Week 16 to 52||341
3068799|NCT01309737|3789330|FG002|STARTED|Week 16 to 52||0
3068800|NCT01309737|3789331|FG003|STARTED|Week 16 to 52||75
3068801|NCT01309737|3789332|FG004|STARTED|Week 16 to 52||77
3068802|NCT01309737|3789328|FG000|COMPLETED|Week 16 to 52||198
3068803|NCT01309737|3789329|FG001|COMPLETED|Week 16 to 52||238
3068804|NCT01309737|3789330|FG002|COMPLETED|Week 16 to 52||0
3068805|NCT01309737|3789331|FG003|COMPLETED|Week 16 to 52||41
3068806|NCT01309737|3789332|FG004|COMPLETED|Week 16 to 52||44
3068807|NCT01309737|3789328|FG000|NOT COMPLETED|Week 16 to 52||133
3068808|NCT01309737|3789329|FG001|NOT COMPLETED|Week 16 to 52||103
3068809|NCT01309737|3789330|FG002|NOT COMPLETED|Week 16 to 52||0
3068810|NCT01309737|3789331|FG003|NOT COMPLETED|Week 16 to 52||34
3068811|NCT01309737|3789332|FG004|NOT COMPLETED|Week 16 to 52||33
3068812|NCT01309802|3789357|FG000|STARTED|Overall Study||25
3068813|NCT01309802|3789358|FG001|STARTED|Overall Study||23
3068814|NCT01309802|3789357|FG000|COMPLETED|Overall Study||13
3068815|NCT01309802|3789358|FG001|COMPLETED|Overall Study||14
3068816|NCT01309802|3789357|FG000|NOT COMPLETED|Overall Study||12
3068817|NCT01309802|3789358|FG001|NOT COMPLETED|Overall Study||9
3068818|NCT01309828|3789366|FG000|STARTED|Overall Study||77
3068819|NCT01309828|3789367|FG001|STARTED|Overall Study||76
3068820|NCT01309828|3789366|FG000|COMPLETED|Overall Study||61
3068821|NCT01309828|3789367|FG001|COMPLETED|Overall Study||60
3068822|NCT01309828|3789366|FG000|NOT COMPLETED|Overall Study||16
3068823|NCT01309828|3789367|FG001|NOT COMPLETED|Overall Study||16
3068824|NCT01309841|3789376|FG000|STARTED|Overall Study||217
3068825|NCT01309841|3789377|FG001|STARTED|Overall Study||218
3068826|NCT01309841|3789378|FG002|STARTED|Overall Study||217
3068827|NCT01309841|3789376|FG000|COMPLETED|Overall Study||178
3068828|NCT01309841|3789377|FG001|COMPLETED|Overall Study||177
3068829|NCT01309841|3789378|FG002|COMPLETED|Overall Study||180
3068830|NCT01309841|3789376|FG000|NOT COMPLETED|Overall Study||39
3068831|NCT01309841|3789377|FG001|NOT COMPLETED|Overall Study||41
3068832|NCT01309841|3789378|FG002|NOT COMPLETED|Overall Study||37
3134352|NCT01701258|3859409|FG000|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||68
3134353|NCT01701258|3859410|FG001|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
3134354|NCT01701258|3859411|FG002|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
3134355|NCT01701258|3859412|FG003|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
3134356|NCT01701258|3859413|FG004|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
3134357|NCT01701258|3859414|FG005|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
3134358|NCT01701258|3859415|FG006|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
3068833|NCT01309867|3789386|FG000|STARTED|Overall Study||151
3068834|NCT01309867|3789387|FG001|STARTED|Overall Study||151
3068835|NCT01309867|3789386|FG000|COMPLETED|Overall Study||148
3068836|NCT01309867|3789387|FG001|COMPLETED|Overall Study||139
3068837|NCT01309867|3789386|FG000|NOT COMPLETED|Overall Study||3
3068838|NCT01309867|3789387|FG001|NOT COMPLETED|Overall Study||12
3068839|NCT01309880|3789393|FG000|STARTED|Overall Study||33
3068840|NCT01309880|3789394|FG001|STARTED|Overall Study||33
3068841|NCT01309880|3789393|FG000|COMPLETED|Overall Study||33
3068842|NCT01309880|3789394|FG001|COMPLETED|Overall Study||33
3068843|NCT01309880|3789393|FG000|NOT COMPLETED|Overall Study||0
3068844|NCT01309880|3789394|FG001|NOT COMPLETED|Overall Study||0
3068845|NCT01309893|3789400|FG000|STARTED|Week 1 - First Intervention||33
3068846|NCT01309893|3789401|FG001|STARTED|Week 1 - First Intervention||33
3068847|NCT01309893|3789400|FG000|COMPLETED|Week 1 - First Intervention||33
3068848|NCT01309893|3789401|FG001|COMPLETED|Week 1 - First Intervention||33
3068849|NCT01309893|3789400|FG000|NOT COMPLETED|Week 1 - First Intervention||0
3068850|NCT01309893|3789401|FG001|NOT COMPLETED|Week 1 - First Intervention||0
3068851|NCT01309893|3789400|FG000|STARTED|Week 2 - Crossover Intervention||33
3068852|NCT01309893|3789401|FG001|STARTED|Week 2 - Crossover Intervention||33
3068853|NCT01309893|3789400|FG000|COMPLETED|Week 2 - Crossover Intervention||32
3068854|NCT01309893|3789401|FG001|COMPLETED|Week 2 - Crossover Intervention||32
3068855|NCT01309893|3789400|FG000|NOT COMPLETED|Week 2 - Crossover Intervention||1
3068856|NCT01309893|3789401|FG001|NOT COMPLETED|Week 2 - Crossover Intervention||1
3068857|NCT01309906|3789407|FG000|STARTED|Overall Study||33
3068858|NCT01309906|3789408|FG001|STARTED|Overall Study||33
3068859|NCT01309906|3789407|FG000|COMPLETED|Overall Study||32
3068860|NCT01309906|3789408|FG001|COMPLETED|Overall Study||32
3068861|NCT01309906|3789407|FG000|NOT COMPLETED|Overall Study||1
3068862|NCT01309906|3789408|FG001|NOT COMPLETED|Overall Study||1
3068863|NCT01309919|3789416|FG000|STARTED|Overall Study||75
3068864|NCT01309919|3789417|FG001|STARTED|Overall Study||75
3068865|NCT01309919|3789416|FG000|COMPLETED|Overall Study||58
3068866|NCT01309919|3789417|FG001|COMPLETED|Overall Study||27
3068867|NCT01309919|3789416|FG000|NOT COMPLETED|Overall Study||17
3068868|NCT01309919|3789417|FG001|NOT COMPLETED|Overall Study||48
3068869|NCT01309997|3789425|FG000|STARTED|Overall Study||35
3068870|NCT01309997|3789426|FG001|STARTED|Overall Study||37
3068871|NCT01309997|3789425|FG000|Remained on First Arm Only|Overall Study||16
3068872|NCT01309997|3789426|FG001|Remained on First Arm Only|Overall Study||14
3068873|NCT01309997|3789425|FG000|Crossed Over to Second Arm|Overall Study||19
3068874|NCT01309997|3789426|FG001|Crossed Over to Second Arm|Overall Study||23
3068875|NCT01309997|3789425|FG000|COMPLETED|Overall Study||30
3068876|NCT01309997|3789426|FG001|COMPLETED|Overall Study||31
3068877|NCT01309997|3789425|FG000|NOT COMPLETED|Overall Study||5
3068878|NCT01309997|3789426|FG001|NOT COMPLETED|Overall Study||6
3068879|NCT01310036|3789443|FG000|STARTED|Overall Study||208
3068880|NCT01310036|3789443|FG000|COMPLETED|Overall Study||6
3068881|NCT01310036|3789443|FG000|NOT COMPLETED|Overall Study||202
3068882|NCT01310075|3789449|FG000|STARTED|Overall Study||45
3068883|NCT01310075|3789450|FG001|STARTED|Overall Study||45
3068884|NCT01310075|3789449|FG000|COMPLETED|Overall Study||31
3068885|NCT01310075|3789450|FG001|COMPLETED|Overall Study||35
3068886|NCT01310075|3789449|FG000|NOT COMPLETED|Overall Study||14
3068887|NCT01310075|3789450|FG001|NOT COMPLETED|Overall Study||10
3068888|NCT01310127|3789458|FG000|STARTED|Overall Study||12
3068889|NCT01310127|3789459|FG001|STARTED|Overall Study||11
3068890|NCT01310127|3789458|FG000|COMPLETED|Overall Study||10
3068891|NCT01310127|3789459|FG001|COMPLETED|Overall Study||10
3068892|NCT01310127|3789458|FG000|NOT COMPLETED|Overall Study||2
3068893|NCT01310127|3789459|FG001|NOT COMPLETED|Overall Study||1
3068894|NCT01310179|3789465|FG000|STARTED|Overall Study||12
3068895|NCT01310179|3789465|FG000|COMPLETED|Overall Study||12
3068896|NCT01310179|3789465|FG000|NOT COMPLETED|Overall Study||0
3068897|NCT01310231|3789471|FG000|STARTED|Overall Study||22
3068898|NCT01310231|3789472|FG001|STARTED|Overall Study||18
3068899|NCT01310231|3789471|FG000|Received Intervention|Overall Study||22
3068900|NCT01310231|3789472|FG001|Received Intervention|Overall Study||17
3068901|NCT01310231|3789471|FG000|Discontinued Intervention|Overall Study||0
3068902|NCT01310231|3789472|FG001|Discontinued Intervention|Overall Study||1
3068903|NCT01310231|3789471|FG000|Analyzed for Survival|Overall Study||22
3068904|NCT01310231|3789472|FG001|Analyzed for Survival|Overall Study||18
3068905|NCT01310231|3789471|FG000|Analyzed for Response, Toxicity, QOL|Overall Study||22
3068906|NCT01310231|3789472|FG001|Analyzed for Response, Toxicity, QOL|Overall Study||17
3068907|NCT01310231|3789471|FG000|COMPLETED|Overall Study||22
3068908|NCT01310231|3789472|FG001|COMPLETED|Overall Study||17
3068909|NCT01310231|3789471|FG000|NOT COMPLETED|Overall Study||0
3068910|NCT01310231|3789472|FG001|NOT COMPLETED|Overall Study||1
3068911|NCT01310400|3789481|FG000|STARTED|Overall Study||452
3068912|NCT01310400|3789482|FG001|STARTED|Overall Study||452
3068913|NCT01310400|3789483|FG002|STARTED|Overall Study||452
3068914|NCT01310400|3789481|FG000|COMPLETED|Overall Study||424
3068915|NCT01310400|3789482|FG001|COMPLETED|Overall Study||420
3068916|NCT01310400|3789483|FG002|COMPLETED|Overall Study||422
3068917|NCT01310400|3789481|FG000|NOT COMPLETED|Overall Study||28
3068918|NCT01310400|3789482|FG001|NOT COMPLETED|Overall Study||32
3068919|NCT01310400|3789483|FG002|NOT COMPLETED|Overall Study||30
3068920|NCT01310413|3789500|FG000|STARTED|Day 0 to Day 385||199
3068921|NCT01310413|3789501|FG001|STARTED|Day 0 to Day 385||198
3068922|NCT01310413|3789502|FG002|STARTED|Day 0 to Day 385||210
3068923|NCT01310413|3789503|FG003|STARTED|Day 0 to Day 385||75
3068924|NCT01310413|3789504|FG004|STARTED|Day 0 to Day 385||76
3068925|NCT01310413|3789505|FG005|STARTED|Day 0 to Day 385||80
3068926|NCT01310413|3789506|FG006|STARTED|Day 0 to Day 385|This group is only followed during the Unblinded Phase of the study, from Days U0 to U385.|0
3068927|NCT01310413|3789500|FG000|COMPLETED|Day 0 to Day 385||172
3068928|NCT01310413|3789501|FG001|COMPLETED|Day 0 to Day 385||190
3068929|NCT01310413|3789502|FG002|COMPLETED|Day 0 to Day 385||203
3068930|NCT01310413|3789503|FG003|COMPLETED|Day 0 to Day 385||67
3068931|NCT01310413|3789504|FG004|COMPLETED|Day 0 to Day 385||73
3068932|NCT01310413|3789505|FG005|COMPLETED|Day 0 to Day 385||77
3068933|NCT01310413|3789506|FG006|COMPLETED|Day 0 to Day 385|This group is only followed during the Unblinded Phase of the study, from Days U0 to U385.|0
3068934|NCT01310413|3789500|FG000|NOT COMPLETED|Day 0 to Day 385||27
3068935|NCT01310413|3789501|FG001|NOT COMPLETED|Day 0 to Day 385||8
3068936|NCT01310413|3789502|FG002|NOT COMPLETED|Day 0 to Day 385||7
3068937|NCT01310413|3789503|FG003|NOT COMPLETED|Day 0 to Day 385||8
3068938|NCT01310413|3789504|FG004|NOT COMPLETED|Day 0 to Day 385||3
3068939|NCT01310413|3789505|FG005|NOT COMPLETED|Day 0 to Day 385||3
3068940|NCT01310413|3789506|FG006|NOT COMPLETED|Day 0 to Day 385||0
3068941|NCT01310413|3789500|FG000|STARTED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
3068942|NCT01310413|3789501|FG001|STARTED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
3068943|NCT01310413|3789502|FG002|STARTED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
3068944|NCT01310413|3789503|FG003|STARTED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
3068945|NCT01310413|3789504|FG004|STARTED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
3068946|NCT01310413|3789505|FG005|STARTED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
3068947|NCT01310413|3789506|FG006|STARTED|From Day U0 to Day U385|Upto Day U42|155
3068948|NCT01310413|3789500|FG000|COMPLETED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
3068949|NCT01310413|3789501|FG001|COMPLETED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
3068950|NCT01310413|3789502|FG002|COMPLETED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
3068951|NCT01310413|3789503|FG003|COMPLETED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
3068952|NCT01310413|3789504|FG004|COMPLETED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
3068953|NCT01310413|3789505|FG005|COMPLETED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
3068954|NCT01310413|3789506|FG006|COMPLETED|From Day U0 to Day U385|Upto Day U42|152
3068955|NCT01310413|3789500|FG000|NOT COMPLETED|From Day U0 to Day U385||0
3068956|NCT01310413|3789501|FG001|NOT COMPLETED|From Day U0 to Day U385||0
3068957|NCT01310413|3789502|FG002|NOT COMPLETED|From Day U0 to Day U385||0
3068958|NCT01310413|3789503|FG003|NOT COMPLETED|From Day U0 to Day U385||0
3068959|NCT01310413|3789504|FG004|NOT COMPLETED|From Day U0 to Day U385||0
3068960|NCT01310413|3789505|FG005|NOT COMPLETED|From Day U0 to Day U385||0
3068961|NCT01310413|3789506|FG006|NOT COMPLETED|From Day U0 to Day U385||3
3068962|NCT01310582|3789537|FG000|STARTED|Overall Study||31
3068963|NCT01310582|3789538|FG001|STARTED|Overall Study||26
3068964|NCT01310582|3789537|FG000|COMPLETED|Overall Study||31
3068965|NCT01310582|3789538|FG001|COMPLETED|Overall Study||26
3068966|NCT01310582|3789537|FG000|NOT COMPLETED|Overall Study||0
3068967|NCT01310582|3789538|FG001|NOT COMPLETED|Overall Study||0
3068968|NCT01310699|3789546|FG000|STARTED|Overall Study||132
3068969|NCT01310699|3789547|FG001|STARTED|Overall Study||149
3068970|NCT01310699|3789546|FG000|COMPLETED|Overall Study||128
3068971|NCT01310699|3789547|FG001|COMPLETED|Overall Study||143
3068972|NCT01310699|3789546|FG000|NOT COMPLETED|Overall Study||4
3068973|NCT01310699|3789547|FG001|NOT COMPLETED|Overall Study||6
3068974|NCT01310777|3789558|FG000|STARTED|Overall Study||193
3068975|NCT01310777|3789559|FG001|STARTED|Overall Study||192
3068976|NCT01310777|3789560|FG002|STARTED|Overall Study||175
3068977|NCT01310777|3789558|FG000|COMPLETED|Overall Study||160
3068978|NCT01310777|3789559|FG001|COMPLETED|Overall Study||178
3068979|NCT01310777|3789560|FG002|COMPLETED|Overall Study||145
3068980|NCT01310777|3789558|FG000|NOT COMPLETED|Overall Study||33
3068981|NCT01310777|3789559|FG001|NOT COMPLETED|Overall Study||14
3068982|NCT01310777|3789560|FG002|NOT COMPLETED|Overall Study||30
3068983|NCT01310855|3789570|FG000|STARTED|Overall Study||19
3068984|NCT01310855|3789571|FG001|STARTED|Overall Study||19
3068985|NCT01310855|3789570|FG000|COMPLETED|Overall Study||19
3068986|NCT01310855|3789571|FG001|COMPLETED|Overall Study||19
3068987|NCT01310855|3789570|FG000|NOT COMPLETED|Overall Study||0
3068988|NCT01310855|3789571|FG001|NOT COMPLETED|Overall Study||0
3068989|NCT01310868|3789577|FG000|STARTED|Overall Study||72
3068990|NCT01310868|3789577|FG000|COMPLETED|Overall Study||59
3068991|NCT01310868|3789577|FG000|NOT COMPLETED|Overall Study||13
3068992|NCT01311024|3789583|FG000|STARTED|Overall Study||1530
3068993|NCT01311024|3789584|FG001|STARTED|Overall Study||811
3068994|NCT01311024|3789583|FG000|COMPLETED|Overall Study||1495
3068995|NCT01311024|3789584|FG001|COMPLETED|Overall Study||789
3068996|NCT01311024|3789583|FG000|NOT COMPLETED|Overall Study||35
3068997|NCT01311024|3789584|FG001|NOT COMPLETED|Overall Study||22
3068998|NCT01311102|3789592|FG000|STARTED|Overall Study||20
3068999|NCT01311102|3789593|FG001|STARTED|Overall Study||20
3069000|NCT01311102|3789592|FG000|COMPLETED|Overall Study||20
3069001|NCT01311102|3789593|FG001|COMPLETED|Overall Study||20
3069002|NCT01311102|3789592|FG000|NOT COMPLETED|Overall Study||0
3069003|NCT01311102|3789593|FG001|NOT COMPLETED|Overall Study||0
3069004|NCT01311362|3789601|FG000|STARTED|Ambrisentan Single Dose|All 20 study participants completed each study period. Total number of study participants: 20|20
3069005|NCT01311362|3789601|FG000|COMPLETED|Ambrisentan Single Dose||20
3069006|NCT01311362|3789601|FG000|NOT COMPLETED|Ambrisentan Single Dose||0
3069007|NCT01311362|3789601|FG000|STARTED|Ambrisentan Steady-state||20
3069008|NCT01311362|3789601|FG000|COMPLETED|Ambrisentan Steady-state||20
3069009|NCT01311362|3789601|FG000|NOT COMPLETED|Ambrisentan Steady-state||0
3069010|NCT01311362|3789601|FG000|STARTED|Ambrisentan and SJW||20
3069011|NCT01311362|3789601|FG000|COMPLETED|Ambrisentan and SJW||20
3069012|NCT01311362|3789601|FG000|NOT COMPLETED|Ambrisentan and SJW||0
3069013|NCT01311505|3789610|FG000|STARTED|First Intervention Period||10
3069014|NCT01311505|3789611|FG001|STARTED|First Intervention Period||11
3069015|NCT01311505|3789610|FG000|COMPLETED|First Intervention Period||10
3069016|NCT01311505|3789611|FG001|COMPLETED|First Intervention Period||10
3069017|NCT01311505|3789610|FG000|NOT COMPLETED|First Intervention Period||0
3069018|NCT01311505|3789611|FG001|NOT COMPLETED|First Intervention Period||1
3069019|NCT01311505|3789610|FG000|STARTED|Washout Period (at Least 7 Days)||10
3069020|NCT01311505|3789611|FG001|STARTED|Washout Period (at Least 7 Days)||10
3069021|NCT01311505|3789610|FG000|COMPLETED|Washout Period (at Least 7 Days)||10
3069022|NCT01311505|3789611|FG001|COMPLETED|Washout Period (at Least 7 Days)||10
3069023|NCT01311505|3789610|FG000|NOT COMPLETED|Washout Period (at Least 7 Days)||0
3069024|NCT01311505|3789611|FG001|NOT COMPLETED|Washout Period (at Least 7 Days)||0
3069025|NCT01311505|3789610|FG000|STARTED|Second Intervention Period||10
3069026|NCT01311505|3789611|FG001|STARTED|Second Intervention Period||10
3069027|NCT01311505|3789610|FG000|COMPLETED|Second Intervention Period||10
3069028|NCT01311505|3789611|FG001|COMPLETED|Second Intervention Period||10
3069029|NCT01311505|3789610|FG000|NOT COMPLETED|Second Intervention Period||0
3069030|NCT01311505|3789611|FG001|NOT COMPLETED|Second Intervention Period||0
3069031|NCT01311557|3789622|FG000|STARTED|Overall Study||651
3069032|NCT01311557|3789623|FG001|STARTED|Overall Study||651
3069033|NCT01311557|3789622|FG000|COMPLETED|Overall Study||646
3069034|NCT01311557|3789623|FG001|COMPLETED|Overall Study||645
3069035|NCT01311557|3789622|FG000|NOT COMPLETED|Overall Study||5
3069036|NCT01311557|3789623|FG001|NOT COMPLETED|Overall Study||6
3069037|NCT01311648|3789632|FG000|STARTED|Main Study||51
3069038|NCT01311648|3789633|FG001|STARTED|Main Study||43
3069039|NCT01311648|3789632|FG000|Started 0-<6 Years|Main Study||25
3069040|NCT01311648|3789633|FG001|Started 0-<6 Years|Main Study||43
3069041|NCT01311648|3789632|FG000|Started 6-12 Years|Main Study||26
3069042|NCT01311648|3789633|FG001|Started 6-12 Years|Main Study||0
3069043|NCT01311648|3789632|FG000|COMPLETED|Main Study||51
3069044|NCT01311648|3789633|FG001|COMPLETED|Main Study||22
3069045|NCT01311648|3789632|FG000|NOT COMPLETED|Main Study||0
3069046|NCT01311648|3789633|FG001|NOT COMPLETED|Main Study||21
3069047|NCT01311648|3789632|FG000|STARTED|Extension Study||46
3069048|NCT01311648|3789633|FG001|STARTED|Extension Study||36
3069049|NCT01311648|3789632|FG000|COMPLETED|Extension Study||45
3069050|NCT01311648|3789633|FG001|COMPLETED|Extension Study||25
3069051|NCT01311648|3789632|FG000|NOT COMPLETED|Extension Study||1
3069052|NCT01311648|3789633|FG001|NOT COMPLETED|Extension Study||11
3069053|NCT01311661|3789646|FG000|STARTED|Overall Study|Entered and treated|206
3069054|NCT01311661|3789646|FG000|Received Placebo|Overall Study||201
3069055|NCT01311661|3789646|FG000|Received Olo 2.5 mcg Bid|Overall Study||101
3069056|NCT01311661|3789646|FG000|Received Olo 5 mcg qd|Overall Study||101
3069057|NCT01311661|3789646|FG000|Received Olo 5 mcg Bid|Overall Study||101
3069058|NCT01311661|3789646|FG000|Received Olo 10 mcg qd|Overall Study||102
3069059|NCT01311661|3789646|FG000|COMPLETED|Overall Study||199
3069060|NCT01311661|3789646|FG000|NOT COMPLETED|Overall Study||7
3069061|NCT01311674|3789660|FG000|STARTED|Overall Study||72
3069062|NCT01311674|3789661|FG001|STARTED|Overall Study||69
3069063|NCT01311674|3789660|FG000|COMPLETED|Overall Study||28
3069064|NCT01311674|3789661|FG001|COMPLETED|Overall Study||29
3069065|NCT01311674|3789660|FG000|NOT COMPLETED|Overall Study||44
3069066|NCT01311674|3789661|FG001|NOT COMPLETED|Overall Study||40
3069067|NCT01311687|3789670|FG000|STARTED|Treatment Phase||302
3069068|NCT01311687|3789671|FG001|STARTED|Treatment Phase||153
3069069|NCT01311687|3789670|FG000|Received Study Drug|Treatment Phase||300
3069070|NCT01311687|3789671|FG001|Received Study Drug|Treatment Phase||150
3069071|NCT01311687|3789670|FG000|Crossed-over to Pomalidomide|Treatment Phase|Not applicable to participants initially randomized to receive pomalidomide|0
3069072|NCT01311687|3789671|FG001|Crossed-over to Pomalidomide|Treatment Phase|After Amendment 4 participants still on HD-Dex treatment were permitted to crossover to pomalidomide|11
3069073|NCT01311687|3789670|FG000|COMPLETED|Treatment Phase||302
3069074|NCT01311687|3789671|FG001|COMPLETED|Treatment Phase||153
3069075|NCT01311687|3789670|FG000|NOT COMPLETED|Treatment Phase||0
3069076|NCT01311687|3789671|FG001|NOT COMPLETED|Treatment Phase||0
3069077|NCT01311687|3789670|FG000|STARTED|PFS Follow-up Phase||11
3069078|NCT01311687|3789671|FG001|STARTED|PFS Follow-up Phase||8
3069079|NCT01311687|3789670|FG000|Crossed-over to Pomalidomide|PFS Follow-up Phase||11
3069080|NCT01311687|3789671|FG001|Crossed-over to Pomalidomide|PFS Follow-up Phase||0
3069081|NCT01311687|3789670|FG000|COMPLETED|PFS Follow-up Phase||11
3069082|NCT01311687|3789671|FG001|COMPLETED|PFS Follow-up Phase||8
3069083|NCT01311687|3789670|FG000|NOT COMPLETED|PFS Follow-up Phase||0
3069084|NCT01311687|3789671|FG001|NOT COMPLETED|PFS Follow-up Phase||0
3069085|NCT01311895|3789682|FG000|STARTED|Overall Study||175
3069086|NCT01311895|3789683|FG001|STARTED|Overall Study||175
3069087|NCT01311895|3789682|FG000|COMPLETED|Overall Study||175
3069088|NCT01311895|3789683|FG001|COMPLETED|Overall Study||175
3069089|NCT01311895|3789682|FG000|NOT COMPLETED|Overall Study||0
3069090|NCT01311895|3789683|FG001|NOT COMPLETED|Overall Study||0
3069091|NCT01312038|3789691|FG000|STARTED|Overall Study||13
3069092|NCT01312038|3789692|FG001|STARTED|Overall Study||12
3069093|NCT01312038|3789691|FG000|COMPLETED|Overall Study||13
3069094|NCT01312038|3789692|FG001|COMPLETED|Overall Study||12
3069095|NCT01312038|3789691|FG000|NOT COMPLETED|Overall Study||0
3069096|NCT01312038|3789692|FG001|NOT COMPLETED|Overall Study||0
3069097|NCT01312129|3789700|FG000|STARTED|First Intervention (24 Hours)||6
3069098|NCT01312129|3789701|FG001|STARTED|First Intervention (24 Hours)||7
3069099|NCT01312129|3789700|FG000|Control Cue|First Intervention (24 Hours)||6
3069100|NCT01312129|3789701|FG001|Control Cue|First Intervention (24 Hours)||7
3069101|NCT01312129|3789700|FG000|Alcohol Cue|First Intervention (24 Hours)||6
3069102|NCT01312129|3789701|FG001|Alcohol Cue|First Intervention (24 Hours)||7
3069103|NCT01312129|3789700|FG000|COMPLETED|First Intervention (24 Hours)||6
3069104|NCT01312129|3789701|FG001|COMPLETED|First Intervention (24 Hours)||7
3069105|NCT01312129|3789700|FG000|NOT COMPLETED|First Intervention (24 Hours)||0
3069106|NCT01312129|3789701|FG001|NOT COMPLETED|First Intervention (24 Hours)||0
3069107|NCT01312129|3789700|FG000|STARTED|Washout (1 Week)||6
3069108|NCT01312129|3789701|FG001|STARTED|Washout (1 Week)||7
3069109|NCT01312129|3789700|FG000|COMPLETED|Washout (1 Week)||6
3069110|NCT01312129|3789701|FG001|COMPLETED|Washout (1 Week)||7
3069111|NCT01312129|3789700|FG000|NOT COMPLETED|Washout (1 Week)||0
3069112|NCT01312129|3789701|FG001|NOT COMPLETED|Washout (1 Week)||0
3069113|NCT01312129|3789700|FG000|STARTED|Second Intervention (24 Hours)||6
3069114|NCT01312129|3789701|FG001|STARTED|Second Intervention (24 Hours)||7
3069115|NCT01312129|3789700|FG000|Control Cue|Second Intervention (24 Hours)||6
3069116|NCT01312129|3789701|FG001|Control Cue|Second Intervention (24 Hours)||6
3069117|NCT01312129|3789700|FG000|Alcohol Cue|Second Intervention (24 Hours)||6
3069118|NCT01312129|3789701|FG001|Alcohol Cue|Second Intervention (24 Hours)||6
3069119|NCT01312129|3789700|FG000|COMPLETED|Second Intervention (24 Hours)||6
3069120|NCT01312129|3789701|FG001|COMPLETED|Second Intervention (24 Hours)||6
3069121|NCT01312129|3789700|FG000|NOT COMPLETED|Second Intervention (24 Hours)||0
3069122|NCT01312129|3789701|FG001|NOT COMPLETED|Second Intervention (24 Hours)||1
3069123|NCT01312181|3789710|FG000|STARTED|Overall Study||80
3069124|NCT01312181|3789711|FG001|STARTED|Overall Study||77
3069125|NCT01312181|3789712|FG002|STARTED|Overall Study||83
3069126|NCT01312181|3789710|FG000|COMPLETED|Overall Study||78
3069127|NCT01312181|3789711|FG001|COMPLETED|Overall Study||71
3069128|NCT01312181|3789712|FG002|COMPLETED|Overall Study||75
3069129|NCT01312181|3789710|FG000|NOT COMPLETED|Overall Study||2
3069130|NCT01312181|3789711|FG001|NOT COMPLETED|Overall Study||6
3069131|NCT01312181|3789712|FG002|NOT COMPLETED|Overall Study||8
3069132|NCT01312233|3789723|FG000|STARTED|Overall Study||44
3069133|NCT01312233|3789724|FG001|STARTED|Overall Study||44
3069134|NCT01312233|3789725|FG002|STARTED|Overall Study||43
3069135|NCT01312233|3789723|FG000|COMPLETED|Overall Study||42
3069136|NCT01312233|3789724|FG001|COMPLETED|Overall Study||44
3069137|NCT01312233|3789725|FG002|COMPLETED|Overall Study||36
3069138|NCT01312233|3789723|FG000|NOT COMPLETED|Overall Study||2
3069139|NCT01312233|3789724|FG001|NOT COMPLETED|Overall Study||0
3069140|NCT01312233|3789725|FG002|NOT COMPLETED|Overall Study||7
3069141|NCT01312272|3789735|FG000|STARTED|Overall Study||12
3069142|NCT01312272|3789736|FG001|STARTED|Overall Study||12
3069143|NCT01312272|3789735|FG000|COMPLETED|Overall Study||12
3069144|NCT01312272|3789736|FG001|COMPLETED|Overall Study||11
3069145|NCT01312272|3789735|FG000|NOT COMPLETED|Overall Study||0
3069146|NCT01312272|3789736|FG001|NOT COMPLETED|Overall Study||1
3069147|NCT01312389|3789745|FG000|STARTED|Phase 1||3
3069148|NCT01312389|3789746|FG001|STARTED|Phase 1||0
3069149|NCT01312389|3789747|FG002|STARTED|Phase 1||0
3069150|NCT01312389|3789745|FG000|COMPLETED|Phase 1||3
3069151|NCT01312389|3789746|FG001|COMPLETED|Phase 1||0
3069152|NCT01312389|3789747|FG002|COMPLETED|Phase 1||0
3069153|NCT01312389|3789745|FG000|NOT COMPLETED|Phase 1||0
3069154|NCT01312389|3789746|FG001|NOT COMPLETED|Phase 1||0
3069155|NCT01312389|3789747|FG002|NOT COMPLETED|Phase 1||0
3069156|NCT01312389|3789745|FG000|STARTED|Phase 2||0
3069157|NCT01312389|3789746|FG001|STARTED|Phase 2||0
3069158|NCT01312389|3789747|FG002|STARTED|Phase 2||0
3069159|NCT01312389|3789745|FG000|COMPLETED|Phase 2||0
3069160|NCT01312389|3789746|FG001|COMPLETED|Phase 2||0
3069161|NCT01312389|3789747|FG002|COMPLETED|Phase 2||0
3069162|NCT01312389|3789745|FG000|NOT COMPLETED|Phase 2||0
3069163|NCT01312389|3789746|FG001|NOT COMPLETED|Phase 2||0
3069164|NCT01312389|3789747|FG002|NOT COMPLETED|Phase 2||0
3069165|NCT01312467|3789755|FG000|STARTED|Overall Study||45
3069166|NCT01312467|3789755|FG000|COMPLETED|Overall Study||32
3069167|NCT01312467|3789755|FG000|NOT COMPLETED|Overall Study||13
3069168|NCT01312519|3789762|FG000|STARTED|Overall Study||26
3069169|NCT01312519|3789763|FG001|STARTED|Overall Study||24
3069170|NCT01312519|3789762|FG000|COMPLETED|Overall Study||26
3069171|NCT01312519|3789763|FG001|COMPLETED|Overall Study||24
3069172|NCT01312519|3789762|FG000|NOT COMPLETED|Overall Study||0
3069173|NCT01312519|3789763|FG001|NOT COMPLETED|Overall Study||0
3069174|NCT01312675|3789771|FG000|STARTED|Overall Study||9
3069175|NCT01312675|3789772|FG001|STARTED|Overall Study||7
3069176|NCT01312675|3789771|FG000|COMPLETED|Overall Study||9
3069177|NCT01312675|3789772|FG001|COMPLETED|Overall Study||7
3069178|NCT01312675|3789771|FG000|NOT COMPLETED|Overall Study||0
3069179|NCT01312675|3789772|FG001|NOT COMPLETED|Overall Study||0
3069180|NCT01312766|3789780|FG000|STARTED|Overall Study||135
3069181|NCT01312766|3789781|FG001|STARTED|Overall Study||135
3069182|NCT01312766|3789780|FG000|COMPLETED|Overall Study||129
3069183|NCT01312766|3789781|FG001|COMPLETED|Overall Study||130
3069184|NCT01312766|3789780|FG000|NOT COMPLETED|Overall Study||6
3069185|NCT01312766|3789781|FG001|NOT COMPLETED|Overall Study||5
3069186|NCT01312779|3789787|FG000|STARTED|Overall Study||39
3069187|NCT01312779|3789787|FG000|Implanted With Device|Overall Study||12
3069188|NCT01312779|3789787|FG000|COMPLETED|Overall Study||7
3069189|NCT01312779|3789787|FG000|NOT COMPLETED|Overall Study||32
3069190|NCT01312805|3789802|FG000|STARTED|Overall Study||1016
3069191|NCT01312805|3789803|FG001|STARTED|Overall Study||1082
3069192|NCT01312805|3789802|FG000|COMPLETED|Overall Study||1016
3069193|NCT01312805|3789803|FG001|COMPLETED|Overall Study||1082
3069194|NCT01312805|3789802|FG000|NOT COMPLETED|Overall Study||0
3069195|NCT01312805|3789803|FG001|NOT COMPLETED|Overall Study||0
3069196|NCT01312818|3789809|FG000|STARTED|Overall Study||2
3069197|NCT01312818|3789809|FG000|COMPLETED|Overall Study||2
3069198|NCT01312818|3789809|FG000|NOT COMPLETED|Overall Study||0
3069199|NCT01312844|3789817|FG000|STARTED|Overall Study||4
3069200|NCT01312844|3789818|FG001|STARTED|Overall Study||3
3069201|NCT01312844|3789817|FG000|COMPLETED|Overall Study||4
3069202|NCT01312844|3789818|FG001|COMPLETED|Overall Study||3
3069203|NCT01312844|3789817|FG000|NOT COMPLETED|Overall Study||0
3069204|NCT01312844|3789818|FG001|NOT COMPLETED|Overall Study||0
3069205|NCT01312909|3789827|FG000|STARTED|Overall Study||109
3069206|NCT01312909|3789828|FG001|STARTED|Overall Study||103
3069207|NCT01312909|3789829|FG002|STARTED|Overall Study||100
3069208|NCT01312909|3789827|FG000|Treated|Overall Study||108
3069209|NCT01312909|3789828|FG001|Treated|Overall Study||100
3069210|NCT01312909|3789829|FG002|Treated|Overall Study||99
3069211|NCT01312909|3789827|FG000|COMPLETED|Overall Study||67
3069212|NCT01312909|3789828|FG001|COMPLETED|Overall Study||67
3069213|NCT01312909|3789829|FG002|COMPLETED|Overall Study||53
3069214|NCT01312909|3789827|FG000|NOT COMPLETED|Overall Study||42
3069215|NCT01312909|3789828|FG001|NOT COMPLETED|Overall Study||36
3069216|NCT01312909|3789829|FG002|NOT COMPLETED|Overall Study||47
3069217|NCT01312948|3789837|FG000|STARTED|Overall Study||6
3069218|NCT01312948|3789837|FG000|COMPLETED|Overall Study||6
3069219|NCT01312948|3789837|FG000|NOT COMPLETED|Overall Study||0
3069220|NCT01312961|3789846|FG000|STARTED|Overall Study||52
3069221|NCT01312961|3789847|FG001|STARTED|Overall Study||52
3069222|NCT01312961|3789846|FG000|Treated|Overall Study||52
3069223|NCT01312961|3789847|FG001|Treated|Overall Study||52
3069224|NCT01312961|3789846|FG000|COMPLETED|Overall Study||35
3069225|NCT01312961|3789847|FG001|COMPLETED|Overall Study||45
3069226|NCT01312961|3789846|FG000|NOT COMPLETED|Overall Study||17
3069227|NCT01312961|3789847|FG001|NOT COMPLETED|Overall Study||7
3069228|NCT01313039|3789854|FG000|STARTED|Overall Study||4
3069229|NCT01313039|3789854|FG000|COMPLETED|Overall Study||2
3069230|NCT01313039|3789854|FG000|NOT COMPLETED|Overall Study||2
3069231|NCT01313078|3789858|FG000|STARTED|Overall Study||4
3069232|NCT01313078|3789858|FG000|COMPLETED|Overall Study||1
3069233|NCT01313078|3789858|FG000|NOT COMPLETED|Overall Study||3
3069234|NCT01313117|3789862|FG000|STARTED|Cohort 1: Dose Level 1 (ALA 300mg Daily)||2
3069235|NCT01313117|3789862|FG000|COMPLETED|Cohort 1: Dose Level 1 (ALA 300mg Daily)||2
3069236|NCT01313117|3789862|FG000|NOT COMPLETED|Cohort 1: Dose Level 1 (ALA 300mg Daily)||0
3069237|NCT01313117|3789862|FG000|STARTED|Cohort 2: Dose Level 2 (ALA 600mg Daily)||2
3069238|NCT01313117|3789862|FG000|COMPLETED|Cohort 2: Dose Level 2 (ALA 600mg Daily)||1
3069239|NCT01313117|3789862|FG000|NOT COMPLETED|Cohort 2: Dose Level 2 (ALA 600mg Daily)||1
3069240|NCT01313117|3789862|FG000|STARTED|Cohort 3: Dose Level 3 (ALA 400mg Daily)||2
3069241|NCT01313117|3789862|FG000|COMPLETED|Cohort 3: Dose Level 3 (ALA 400mg Daily)||2
3069242|NCT01313117|3789862|FG000|NOT COMPLETED|Cohort 3: Dose Level 3 (ALA 400mg Daily)||0
3069243|NCT01313117|3789862|FG000|STARTED|Cohort 4: Dose Level 4 (ALA 500mg Daily)||2
3069244|NCT01313117|3789862|FG000|COMPLETED|Cohort 4: Dose Level 4 (ALA 500mg Daily)||2
3069245|NCT01313117|3789862|FG000|NOT COMPLETED|Cohort 4: Dose Level 4 (ALA 500mg Daily)||0
3069246|NCT01313117|3789862|FG000|STARTED|Cohort 5: Dose Level 2 (ALA 600mg Daily)||1
3069247|NCT01313117|3789862|FG000|COMPLETED|Cohort 5: Dose Level 2 (ALA 600mg Daily)||0
3069248|NCT01313117|3789862|FG000|NOT COMPLETED|Cohort 5: Dose Level 2 (ALA 600mg Daily)||1
3069249|NCT01313182|3789869|FG000|STARTED|Overall Study||842
3069250|NCT01313182|3789870|FG001|STARTED|Overall Study||855
3069251|NCT01313182|3789869|FG000|COMPLETED|Overall Study||776
3069252|NCT01313182|3789870|FG001|COMPLETED|Overall Study||763
3069253|NCT01313182|3789869|FG000|NOT COMPLETED|Overall Study||66
3069254|NCT01313182|3789870|FG001|NOT COMPLETED|Overall Study||92
3069255|NCT01313208|3789878|FG000|STARTED|Double-blind Phase (Weeks 1 - 12)||104
3069256|NCT01313208|3789879|FG001|STARTED|Double-blind Phase (Weeks 1 - 12)||106
3069257|NCT01313208|3789878|FG000|COMPLETED|Double-blind Phase (Weeks 1 - 12)||98
3069258|NCT01313208|3789879|FG001|COMPLETED|Double-blind Phase (Weeks 1 - 12)||101
3069259|NCT01313208|3789878|FG000|NOT COMPLETED|Double-blind Phase (Weeks 1 - 12)||6
3069260|NCT01313208|3789879|FG001|NOT COMPLETED|Double-blind Phase (Weeks 1 - 12)||5
3069261|NCT01313208|3789878|FG000|STARTED|Open-label Phase (Weeks 13 - 24)||98
3069262|NCT01313208|3789879|FG001|STARTED|Open-label Phase (Weeks 13 - 24)||101
3069263|NCT01313208|3789878|FG000|COMPLETED|Open-label Phase (Weeks 13 - 24)||92
3069264|NCT01313208|3789879|FG001|COMPLETED|Open-label Phase (Weeks 13 - 24)||98
3069265|NCT01313208|3789878|FG000|NOT COMPLETED|Open-label Phase (Weeks 13 - 24)||6
3069266|NCT01313208|3789879|FG001|NOT COMPLETED|Open-label Phase (Weeks 13 - 24)||3
3069267|NCT01313221|3789890|FG000|STARTED|Overall Study||144
3069268|NCT01313221|3789891|FG001|STARTED|Overall Study||143
3069269|NCT01313221|3789892|FG002|STARTED|Overall Study||23
3069270|NCT01313221|3789890|FG000|Randomized|Overall Study||144
3069271|NCT01313221|3789891|FG001|Randomized|Overall Study||143
3069272|NCT01313221|3789892|FG002|Randomized|Overall Study||0
3069273|NCT01313221|3789890|FG000|COMPLETED|Overall Study||132
3069274|NCT01313221|3789891|FG001|COMPLETED|Overall Study||135
3069275|NCT01313221|3789892|FG002|COMPLETED|Overall Study||0
3069276|NCT01313221|3789890|FG000|NOT COMPLETED|Overall Study||12
3069277|NCT01313221|3789891|FG001|NOT COMPLETED|Overall Study||8
3069278|NCT01313221|3789892|FG002|NOT COMPLETED|Overall Study||23
3069279|NCT01313286|3789900|FG000|STARTED|Period 1||8
3069280|NCT01313286|3789901|FG001|STARTED|Period 1||8
3069281|NCT01313286|3789900|FG000|COMPLETED|Period 1||6
3069282|NCT01313286|3789901|FG001|COMPLETED|Period 1||8
3069283|NCT01313286|3789900|FG000|NOT COMPLETED|Period 1||2
3069284|NCT01313286|3789901|FG001|NOT COMPLETED|Period 1||0
3069285|NCT01313286|3789900|FG000|STARTED|Period 2||6
3069286|NCT01313286|3789901|FG001|STARTED|Period 2||8
3069287|NCT01313286|3789900|FG000|COMPLETED|Period 2||6
3069288|NCT01313286|3789901|FG001|COMPLETED|Period 2||8
3069289|NCT01313286|3789900|FG000|NOT COMPLETED|Period 2||0
3069290|NCT01313286|3789901|FG001|NOT COMPLETED|Period 2||0
3069291|NCT01313299|3789910|FG000|STARTED|Overall Study||81
3069292|NCT01313299|3789911|FG001|STARTED|Overall Study||81
3069293|NCT01313299|3789912|FG002|STARTED|Overall Study||81
3069294|NCT01313299|3789910|FG000|COMPLETED|Overall Study||74
3069295|NCT01313299|3789911|FG001|COMPLETED|Overall Study||78
3069296|NCT01313299|3789912|FG002|COMPLETED|Overall Study||77
3069297|NCT01313299|3789910|FG000|NOT COMPLETED|Overall Study||7
3069298|NCT01313299|3789911|FG001|NOT COMPLETED|Overall Study||3
3069299|NCT01313299|3789912|FG002|NOT COMPLETED|Overall Study||4
3069300|NCT01313312|3789920|FG000|STARTED|Overall Study||258
3069301|NCT01313312|3789920|FG000|Cycle 1|Overall Study||254
3069302|NCT01313312|3789920|FG000|Cycle 2|Overall Study||229
3069303|NCT01313312|3789920|FG000|Cycle 3|Overall Study||175
3069304|NCT01313312|3789920|FG000|Cycle 4|Overall Study||81
3069305|NCT01313312|3789920|FG000|Cycle 5|Overall Study||11
3069306|NCT01313312|3789920|FG000|COMPLETED|Overall Study||222
3069307|NCT01313312|3789920|FG000|NOT COMPLETED|Overall Study||36
3069308|NCT01313494|3789926|FG000|STARTED|Overall Study||313
3069309|NCT01313494|3789927|FG001|STARTED|Overall Study||313
3069310|NCT01313494|3789926|FG000|Safety Set|Overall Study|2 patients in the placebo arm were misallocated and may have received roflumilast in error.|315
3069311|NCT01313494|3789927|FG001|Safety Set|Overall Study|2 patients in the placebo arm were misallocated and may have received roflumilast in error.|311
3069312|NCT01313494|3789926|FG000|COMPLETED|Overall Study||246
3069313|NCT01313494|3789927|FG001|COMPLETED|Overall Study||263
3069314|NCT01313494|3789926|FG000|NOT COMPLETED|Overall Study||67
3069315|NCT01313494|3789927|FG001|NOT COMPLETED|Overall Study||50
3069316|NCT01313507|3789933|FG000|STARTED|Overall Study||21
3069317|NCT01313507|3789933|FG000|COMPLETED|Overall Study||21
3069318|NCT01313507|3789933|FG000|NOT COMPLETED|Overall Study||0
3069319|NCT01313520|3789939|FG000|STARTED|Overall Study||30
3069320|NCT01313520|3789940|FG001|STARTED|Overall Study||31
3069321|NCT01313520|3789939|FG000|COMPLETED|Overall Study||30
3069322|NCT01313520|3789940|FG001|COMPLETED|Overall Study||31
3069323|NCT01313520|3789939|FG000|NOT COMPLETED|Overall Study||0
3069324|NCT01313520|3789940|FG001|NOT COMPLETED|Overall Study||0
3069325|NCT01313559|3789950|FG000|STARTED|Overall Study||4
3069326|NCT01313559|3789951|FG001|STARTED|Overall Study||2
3069327|NCT01313559|3789950|FG000|COMPLETED|Overall Study||0
3069328|NCT01313559|3789951|FG001|COMPLETED|Overall Study||0
3069329|NCT01313559|3789950|FG000|NOT COMPLETED|Overall Study||4
3069330|NCT01313559|3789951|FG001|NOT COMPLETED|Overall Study||2
3069331|NCT01313624|3789959|FG000|STARTED|Double-Blind Phase||134
3069332|NCT01313624|3789960|FG001|STARTED|Double-Blind Phase||132
3069333|NCT01313624|3789959|FG000|COMPLETED|Double-Blind Phase||96
3069334|NCT01313624|3789960|FG001|COMPLETED|Double-Blind Phase||122
3069335|NCT01313624|3789959|FG000|NOT COMPLETED|Double-Blind Phase||38
3069336|NCT01313624|3789960|FG001|NOT COMPLETED|Double-Blind Phase||10
3069337|NCT01313624|3789959|FG000|STARTED|Open-Label Phase||96
3069338|NCT01313624|3789960|FG001|STARTED|Open-Label Phase||122
3069339|NCT01313624|3789959|FG000|COMPLETED|Open-Label Phase||92
3069340|NCT01313624|3789960|FG001|COMPLETED|Open-Label Phase||109
3069341|NCT01313624|3789959|FG000|NOT COMPLETED|Open-Label Phase||4
3069342|NCT01313624|3789960|FG001|NOT COMPLETED|Open-Label Phase||13
3069343|NCT01313637|3789972|FG000|STARTED|Overall Study||275
3069344|NCT01313637|3789973|FG001|STARTED|Overall Study||407
3069345|NCT01313637|3789974|FG002|STARTED|Overall Study||404
3069346|NCT01313637|3789975|FG003|STARTED|Overall Study||403
3069347|NCT01313637|3789972|FG000|COMPLETED|Overall Study||183
3069348|NCT01313637|3789973|FG001|COMPLETED|Overall Study||312
3069349|NCT01313637|3789974|FG002|COMPLETED|Overall Study||298
3069350|NCT01313637|3789975|FG003|COMPLETED|Overall Study||325
3069351|NCT01313637|3789972|FG000|NOT COMPLETED|Overall Study||92
3069352|NCT01313637|3789973|FG001|NOT COMPLETED|Overall Study||95
3069353|NCT01313637|3789974|FG002|NOT COMPLETED|Overall Study||106
3069354|NCT01313637|3789975|FG003|NOT COMPLETED|Overall Study||78
3069355|NCT01313650|3789989|FG000|STARTED|Overall Study||280
3069356|NCT01313650|3789990|FG001|STARTED|Overall Study||418
3069357|NCT01313650|3789991|FG002|STARTED|Overall Study||421
3069358|NCT01313650|3789992|FG003|STARTED|Overall Study||413
3069359|NCT01313650|3789989|FG000|COMPLETED|Overall Study||204
3069360|NCT01313650|3789990|FG001|COMPLETED|Overall Study||324
3069361|NCT01313650|3789991|FG002|COMPLETED|Overall Study||318
3069362|NCT01313650|3789992|FG003|COMPLETED|Overall Study||332
3069363|NCT01313650|3789989|FG000|NOT COMPLETED|Overall Study||76
3069364|NCT01313650|3789990|FG001|NOT COMPLETED|Overall Study||94
3069365|NCT01313650|3789991|FG002|NOT COMPLETED|Overall Study||103
3069366|NCT01313650|3789992|FG003|NOT COMPLETED|Overall Study||81
3069367|NCT01313663|3790004|FG000|STARTED|Overall Study||9
3069368|NCT01313663|3790005|FG001|STARTED|Overall Study||11
3069369|NCT01313663|3790004|FG000|COMPLETED|Overall Study||5
3069370|NCT01313663|3790005|FG001|COMPLETED|Overall Study||3
3069371|NCT01313663|3790004|FG000|NOT COMPLETED|Overall Study||4
3069372|NCT01313663|3790005|FG001|NOT COMPLETED|Overall Study||8
3069373|NCT01313676|3790015|FG000|STARTED|Overall Study||4131
3069374|NCT01313676|3790016|FG001|STARTED|Overall Study||4157
3069375|NCT01313676|3790017|FG002|STARTED|Overall Study||4140
3069376|NCT01313676|3790018|FG003|STARTED|Overall Study||4140
3069377|NCT01313676|3790015|FG000|COMPLETED|Overall Study||2881
3069378|NCT01313676|3790016|FG001|COMPLETED|Overall Study||3044
3069379|NCT01313676|3790017|FG002|COMPLETED|Overall Study||3052
3069380|NCT01313676|3790018|FG003|COMPLETED|Overall Study||3146
3069381|NCT01313676|3790015|FG000|NOT COMPLETED|Overall Study||1250
3069382|NCT01313676|3790016|FG001|NOT COMPLETED|Overall Study||1113
3069383|NCT01313676|3790017|FG002|NOT COMPLETED|Overall Study||1088
3069384|NCT01313676|3790018|FG003|NOT COMPLETED|Overall Study||994
3069385|NCT01313728|3790029|FG000|STARTED|Informed Consent to Baseline||26
3069386|NCT01313728|3790029|FG000|COMPLETED|Informed Consent to Baseline|One subject withdrew after signing informed consent, but prior to Baseline measurements being taken.|25
3069387|NCT01313728|3790029|FG000|NOT COMPLETED|Informed Consent to Baseline||1
3069388|NCT01313728|3790029|FG000|STARTED|Baseline to Completion||25
3069389|NCT01313728|3790029|FG000|COMPLETED|Baseline to Completion||25
3069390|NCT01313728|3790029|FG000|NOT COMPLETED|Baseline to Completion||0
3069391|NCT01313767|3790036|FG000|STARTED|Overall Study||98
3069392|NCT01313767|3790037|FG001|STARTED|Overall Study||98
3069393|NCT01313767|3790036|FG000|COMPLETED|Overall Study||91
3069394|NCT01313767|3790037|FG001|COMPLETED|Overall Study||96
3069395|NCT01313767|3790036|FG000|NOT COMPLETED|Overall Study||7
3069396|NCT01313767|3790037|FG001|NOT COMPLETED|Overall Study||2
3069397|NCT01313780|3790045|FG000|STARTED|Overall Study|FAS|58
3069398|NCT01313780|3790046|FG001|STARTED|Overall Study|FAS|59
3069399|NCT01313780|3790045|FG000|COMPLETED|Overall Study|PPS|33
3069400|NCT01313780|3790046|FG001|COMPLETED|Overall Study|PPS|31
3069401|NCT01313780|3790045|FG000|NOT COMPLETED|Overall Study||25
3069402|NCT01313780|3790046|FG001|NOT COMPLETED|Overall Study||28
3069403|NCT01313858|3790055|FG000|STARTED|Overall Study||524
3069404|NCT01313858|3790056|FG001|STARTED|Overall Study||546
3069405|NCT01313858|3790057|FG002|STARTED|Overall Study||543
3069406|NCT01313858|3790055|FG000|COMPLETED|Overall Study||238
3069407|NCT01313858|3790056|FG001|COMPLETED|Overall Study||276
3069408|NCT01313858|3790057|FG002|COMPLETED|Overall Study||305
3069409|NCT01313858|3790055|FG000|NOT COMPLETED|Overall Study||286
3069410|NCT01313858|3790056|FG001|NOT COMPLETED|Overall Study||270
3069411|NCT01313858|3790057|FG002|NOT COMPLETED|Overall Study||238
3069412|NCT01313884|3790063|FG000|STARTED|Overall Study||3
3069413|NCT01313884|3790063|FG000|COMPLETED|Overall Study||2
3069414|NCT01313884|3790063|FG000|NOT COMPLETED|Overall Study||1
3069415|NCT01313897|3790067|FG000|STARTED|Overall Study||10
3069416|NCT01313897|3790067|FG000|COMPLETED|Overall Study||8
3069417|NCT01313897|3790067|FG000|NOT COMPLETED|Overall Study||2
3069418|NCT01313910|3790071|FG000|STARTED|Overall Study||8
3069419|NCT01313910|3790071|FG000|COMPLETED|Overall Study||8
3069420|NCT01313910|3790071|FG000|NOT COMPLETED|Overall Study||0
3069421|NCT01313936|3790077|FG000|STARTED|Overall Study||6
3069422|NCT01313936|3790078|FG001|STARTED|Overall Study||26
3069423|NCT01313936|3790077|FG000|COMPLETED|Overall Study||6
3069424|NCT01313936|3790078|FG001|COMPLETED|Overall Study||26
3069425|NCT01313936|3790077|FG000|NOT COMPLETED|Overall Study||0
3069426|NCT01313936|3790078|FG001|NOT COMPLETED|Overall Study||0
3069427|NCT01314001|3790093|FG000|STARTED|Overall Study||215
3069428|NCT01314001|3790094|FG001|STARTED|Overall Study||193
3069429|NCT01314001|3790095|FG002|STARTED|Overall Study||227
3069430|NCT01314001|3790096|FG003|STARTED|Overall Study||191
3069431|NCT01314001|3790097|FG004|STARTED|Overall Study||220
3069432|NCT01314001|3790098|FG005|STARTED|Overall Study||200
3069433|NCT01314001|3790093|FG000|End-of-Treatment Visit|Overall Study||156
3069434|NCT01314001|3790094|FG001|End-of-Treatment Visit|Overall Study||141
3069435|NCT01314001|3790095|FG002|End-of-Treatment Visit|Overall Study||179
3069436|NCT01314001|3790096|FG003|End-of-Treatment Visit|Overall Study||146
3069437|NCT01314001|3790097|FG004|End-of-Treatment Visit|Overall Study||174
3069438|NCT01314001|3790098|FG005|End-of-Treatment Visit|Overall Study||160
3069439|NCT01314001|3790093|FG000|6-Month Follow Up Survey|Overall Study||146
3069440|NCT01314001|3790094|FG001|6-Month Follow Up Survey|Overall Study||137
3069441|NCT01314001|3790095|FG002|6-Month Follow Up Survey|Overall Study||165
3069442|NCT01314001|3790096|FG003|6-Month Follow Up Survey|Overall Study||135
3069443|NCT01314001|3790097|FG004|6-Month Follow Up Survey|Overall Study||157
3069444|NCT01314001|3790098|FG005|6-Month Follow Up Survey|Overall Study||139
3069445|NCT01314001|3790093|FG000|COMPLETED|Overall Study||140
3069446|NCT01314001|3790094|FG001|COMPLETED|Overall Study||124
3069447|NCT01314001|3790095|FG002|COMPLETED|Overall Study||158
3069448|NCT01314001|3790096|FG003|COMPLETED|Overall Study||122
3069449|NCT01314001|3790097|FG004|COMPLETED|Overall Study||148
3069450|NCT01314001|3790098|FG005|COMPLETED|Overall Study||129
3069451|NCT01314001|3790093|FG000|NOT COMPLETED|Overall Study||75
3069452|NCT01314001|3790094|FG001|NOT COMPLETED|Overall Study||69
3069453|NCT01314001|3790095|FG002|NOT COMPLETED|Overall Study||69
3069454|NCT01314001|3790096|FG003|NOT COMPLETED|Overall Study||69
3069455|NCT01314001|3790097|FG004|NOT COMPLETED|Overall Study||72
3069456|NCT01314001|3790098|FG005|NOT COMPLETED|Overall Study||71
3069457|NCT01314014|3790112|FG000|STARTED|Overall Study||22
3069458|NCT01314014|3790112|FG000|COMPLETED|Overall Study|Treatment continued for as long as the subject derived benefit.|22
3069459|NCT01314014|3790112|FG000|NOT COMPLETED|Overall Study||0
3069460|NCT01314105|3790118|FG000|STARTED|Overall Study||7
3069461|NCT01314105|3790119|FG001|STARTED|Overall Study||12
3069462|NCT01314105|3790118|FG000|COMPLETED|Overall Study||0
3069463|NCT01314105|3790119|FG001|COMPLETED|Overall Study||0
3069464|NCT01314105|3790118|FG000|NOT COMPLETED|Overall Study||7
3069465|NCT01314105|3790119|FG001|NOT COMPLETED|Overall Study||12
3069466|NCT01314261|3790131|FG000|STARTED|Overall Study||9
3069467|NCT01314261|3790132|FG001|STARTED|Overall Study||9
3069468|NCT01314261|3790133|FG002|STARTED|Overall Study||10
3069469|NCT01314261|3790134|FG003|STARTED|Overall Study||9
3069470|NCT01314261|3790131|FG000|Discontinued ABT-267 or Placebo|Overall Study||1
3069471|NCT01314261|3790132|FG001|Discontinued ABT-267 or Placebo|Overall Study||0
3069472|NCT01314261|3790133|FG002|Discontinued ABT-267 or Placebo|Overall Study||1
3069473|NCT01314261|3790134|FG003|Discontinued ABT-267 or Placebo|Overall Study||0
3069474|NCT01314261|3790131|FG000|Discontinued pegIFN/RBV|Overall Study||1
3069475|NCT01314261|3790132|FG001|Discontinued pegIFN/RBV|Overall Study||4
3069476|NCT01314261|3790133|FG002|Discontinued pegIFN/RBV|Overall Study||5
3069477|NCT01314261|3790134|FG003|Discontinued pegIFN/RBV|Overall Study||1
3069478|NCT01314261|3790131|FG000|COMPLETED|Overall Study||7
3069479|NCT01314261|3790132|FG001|COMPLETED|Overall Study||5
3069480|NCT01314261|3790133|FG002|COMPLETED|Overall Study||7
3069481|NCT01314261|3790134|FG003|COMPLETED|Overall Study||6
3069482|NCT01314261|3790131|FG000|NOT COMPLETED|Overall Study||2
3069483|NCT01314261|3790132|FG001|NOT COMPLETED|Overall Study||4
3069484|NCT01314261|3790133|FG002|NOT COMPLETED|Overall Study||3
3069485|NCT01314261|3790134|FG003|NOT COMPLETED|Overall Study||3
3069486|NCT01314313|3790146|FG000|STARTED|Overall Study||1011
3069487|NCT01314313|3790147|FG001|STARTED|Overall Study||1021
3069488|NCT01314313|3790146|FG000|As Treated|Overall Study||994
3069489|NCT01314313|3790147|FG001|As Treated|Overall Study||944
3069490|NCT01314313|3790146|FG000|Valve Implanted|Overall Study||974
3069491|NCT01314313|3790147|FG001|Valve Implanted|Overall Study||936
3069492|NCT01314313|3790146|FG000|COMPLETED|Overall Study||784
3069493|NCT01314313|3790147|FG001|COMPLETED|Overall Study||710
3069494|NCT01314313|3790146|FG000|NOT COMPLETED|Overall Study||227
3069495|NCT01314313|3790147|FG001|NOT COMPLETED|Overall Study||311
3069496|NCT01314417|3790155|FG000|STARTED|Overall Study||2
3069497|NCT01314417|3790155|FG000|COMPLETED|Overall Study||2
3069498|NCT01314417|3790155|FG000|NOT COMPLETED|Overall Study||0
3069499|NCT01314443|3790163|FG000|STARTED|Overall Study||18
3069500|NCT01314443|3790164|FG001|STARTED|Overall Study||19
3069501|NCT01314443|3790165|FG002|STARTED|Overall Study||15
3069502|NCT01314443|3790166|FG003|STARTED|Overall Study||15
3069503|NCT01314443|3790163|FG000|COMPLETED|Overall Study||14
3069504|NCT01314443|3790164|FG001|COMPLETED|Overall Study||16
3069505|NCT01314443|3790165|FG002|COMPLETED|Overall Study||13
3069506|NCT01314443|3790166|FG003|COMPLETED|Overall Study||13
3069507|NCT01314443|3790163|FG000|NOT COMPLETED|Overall Study||4
3069508|NCT01314443|3790164|FG001|NOT COMPLETED|Overall Study||3
3069509|NCT01314443|3790165|FG002|NOT COMPLETED|Overall Study||2
3069510|NCT01314443|3790166|FG003|NOT COMPLETED|Overall Study||2
3069511|NCT01314703|3790176|FG000|STARTED|Overall Study||35
3069512|NCT01314703|3790176|FG000|Signed Informed Consent|Overall Study||35
3069513|NCT01314703|3790176|FG000|Completed Screen Visit|Overall Study||33
3069514|NCT01314703|3790176|FG000|Completed Treatment Visit|Overall Study||27
3069515|NCT01314703|3790176|FG000|Completed Study|Overall Study||27
3069516|NCT01314703|3790176|FG000|Excluded Prior to Screening Baseline|Overall Study||2
3069517|NCT01314703|3790176|FG000|Non Qualified Bacterial Screening Counts|Overall Study||3
3069518|NCT01314703|3790176|FG000|Discontinued When Enrollment Completed|Overall Study||3
3069519|NCT01314703|3790176|FG000|COMPLETED|Overall Study||27
3069520|NCT01314703|3790176|FG000|NOT COMPLETED|Overall Study||8
3069521|NCT01314716|3790183|FG000|STARTED|Double-Blind Phase||136
3069522|NCT01314716|3790184|FG001|STARTED|Double-Blind Phase||138
3069523|NCT01314716|3790183|FG000|Randomized and Treated|Double-Blind Phase||135
3069524|NCT01314716|3790184|FG001|Randomized and Treated|Double-Blind Phase||137
3069525|NCT01314716|3790183|FG000|COMPLETED|Double-Blind Phase||119
3069526|NCT01314716|3790184|FG001|COMPLETED|Double-Blind Phase||123
3069527|NCT01314716|3790183|FG000|NOT COMPLETED|Double-Blind Phase||17
3069528|NCT01314716|3790184|FG001|NOT COMPLETED|Double-Blind Phase||15
3069529|NCT01314716|3790183|FG000|STARTED|Open-Label Phase|7 participants in this group did not continue from the randomized to the open-label phase.|112
3069530|NCT01314716|3790184|FG001|STARTED|Open-Label Phase|13 participants in this group did not continue from the randomized to the open-label phase.|110
3069531|NCT01314716|3790183|FG000|COMPLETED|Open-Label Phase||102
3069532|NCT01314716|3790184|FG001|COMPLETED|Open-Label Phase||98
3069533|NCT01314716|3790183|FG000|NOT COMPLETED|Open-Label Phase||10
3069534|NCT01314716|3790184|FG001|NOT COMPLETED|Open-Label Phase||12
3069535|NCT01314742|3790194|FG000|STARTED|Overall Study||20
3069536|NCT01314742|3790195|FG001|STARTED|Overall Study||21
3069537|NCT01314742|3790194|FG000|COMPLETED|Overall Study||20
3069538|NCT01314742|3790195|FG001|COMPLETED|Overall Study||21
3069539|NCT01314742|3790194|FG000|NOT COMPLETED|Overall Study||0
3163041|NCT01882465|3890495|FG004|STARTED|Period 3||4
3163042|NCT01882465|3890496|FG005|STARTED|Period 3||5
3163043|NCT01882465|3890497|FG006|STARTED|Period 3||0
3069540|NCT01314742|3790195|FG001|NOT COMPLETED|Overall Study||0
3069541|NCT01314872|3790214|FG000|STARTED|Treatment Period 1||141
3069542|NCT01314872|3790215|FG001|STARTED|Treatment Period 1||144
3069543|NCT01314872|3790216|FG002|STARTED|Treatment Period 1||134
3069544|NCT01314872|3790217|FG003|STARTED|Treatment Period 1||150
3069545|NCT01314872|3790218|FG004|STARTED|Treatment Period 1||149
3069546|NCT01314872|3790219|FG005|STARTED|Treatment Period 1||135
3069547|NCT01314872|3790220|FG006|STARTED|Treatment Period 1||134
3069548|NCT01314872|3790221|FG007|STARTED|Treatment Period 1||64
3069549|NCT01314872|3790222|FG008|STARTED|Treatment Period 1||112
3069550|NCT01314872|3790223|FG009|STARTED|Treatment Period 1||122
3069551|NCT01314872|3790224|FG010|STARTED|Treatment Period 1||110
3069552|NCT01314872|3790225|FG011|STARTED|Treatment Period 1||0
3069553|NCT01314872|3790226|FG012|STARTED|Treatment Period 1||0
3069554|NCT01314872|3790227|FG013|STARTED|Treatment Period 1||0
3069555|NCT01314872|3790228|FG014|STARTED|Treatment Period 1||0
3069556|NCT01314872|3790214|FG000|COMPLETED|Treatment Period 1||131
3069557|NCT01314872|3790215|FG001|COMPLETED|Treatment Period 1||138
3069558|NCT01314872|3790216|FG002|COMPLETED|Treatment Period 1||128
3069559|NCT01314872|3790217|FG003|COMPLETED|Treatment Period 1||143
3069560|NCT01314872|3790218|FG004|COMPLETED|Treatment Period 1||142
3069561|NCT01314872|3790219|FG005|COMPLETED|Treatment Period 1||128
3069562|NCT01314872|3790220|FG006|COMPLETED|Treatment Period 1||126
3069563|NCT01314872|3790221|FG007|COMPLETED|Treatment Period 1||57
3069564|NCT01314872|3790222|FG008|COMPLETED|Treatment Period 1||106
3069565|NCT01314872|3790223|FG009|COMPLETED|Treatment Period 1||118
3069566|NCT01314872|3790224|FG010|COMPLETED|Treatment Period 1||107
3069567|NCT01314872|3790225|FG011|COMPLETED|Treatment Period 1||0
3069568|NCT01314872|3790226|FG012|COMPLETED|Treatment Period 1||0
3069569|NCT01314872|3790227|FG013|COMPLETED|Treatment Period 1||0
3069570|NCT01314872|3790228|FG014|COMPLETED|Treatment Period 1||0
3069571|NCT01314872|3790214|FG000|NOT COMPLETED|Treatment Period 1||10
3069572|NCT01314872|3790215|FG001|NOT COMPLETED|Treatment Period 1||6
3069573|NCT01314872|3790216|FG002|NOT COMPLETED|Treatment Period 1||6
3069574|NCT01314872|3790217|FG003|NOT COMPLETED|Treatment Period 1||7
3069575|NCT01314872|3790218|FG004|NOT COMPLETED|Treatment Period 1||7
3069576|NCT01314872|3790219|FG005|NOT COMPLETED|Treatment Period 1||7
3069577|NCT01314872|3790220|FG006|NOT COMPLETED|Treatment Period 1||8
3069578|NCT01314872|3790221|FG007|NOT COMPLETED|Treatment Period 1||7
3069579|NCT01314872|3790222|FG008|NOT COMPLETED|Treatment Period 1||6
3069580|NCT01314872|3790223|FG009|NOT COMPLETED|Treatment Period 1||4
3069581|NCT01314872|3790224|FG010|NOT COMPLETED|Treatment Period 1||3
3069582|NCT01314872|3790225|FG011|NOT COMPLETED|Treatment Period 1||0
3069583|NCT01314872|3790226|FG012|NOT COMPLETED|Treatment Period 1||0
3069584|NCT01314872|3790227|FG013|NOT COMPLETED|Treatment Period 1||0
3069585|NCT01314872|3790228|FG014|NOT COMPLETED|Treatment Period 1||0
3069586|NCT01314872|3790214|FG000|STARTED|Period 2||0
3069587|NCT01314872|3790215|FG001|STARTED|Period 2||0
3069588|NCT01314872|3790216|FG002|STARTED|Period 2||0
3069589|NCT01314872|3790217|FG003|STARTED|Period 2||0
3069590|NCT01314872|3790218|FG004|STARTED|Period 2||0
3069591|NCT01314872|3790219|FG005|STARTED|Period 2||0
3069592|NCT01314872|3790220|FG006|STARTED|Period 2||0
3069593|NCT01314872|3790221|FG007|STARTED|Period 2||0
3069594|NCT01314872|3790222|FG008|STARTED|Period 2||0
3069595|NCT01314872|3790223|FG009|STARTED|Period 2||0
3069596|NCT01314872|3790224|FG010|STARTED|Period 2||0
3069597|NCT01314872|3790225|FG011|STARTED|Period 2||223
3069598|NCT01314872|3790226|FG012|STARTED|Period 2||248
3069599|NCT01314872|3790227|FG013|STARTED|Period 2||240
3069600|NCT01314872|3790228|FG014|STARTED|Period 2||134
3069601|NCT01314872|3790214|FG000|COMPLETED|Period 2||0
3069602|NCT01314872|3790215|FG001|COMPLETED|Period 2||0
3069603|NCT01314872|3790216|FG002|COMPLETED|Period 2||0
3069604|NCT01314872|3790217|FG003|COMPLETED|Period 2||0
3069605|NCT01314872|3790218|FG004|COMPLETED|Period 2||0
3069606|NCT01314872|3790219|FG005|COMPLETED|Period 2||0
3069607|NCT01314872|3790220|FG006|COMPLETED|Period 2||0
3069608|NCT01314872|3790221|FG007|COMPLETED|Period 2||0
3069609|NCT01314872|3790222|FG008|COMPLETED|Period 2||0
3069610|NCT01314872|3790223|FG009|COMPLETED|Period 2||0
3069611|NCT01314872|3790224|FG010|COMPLETED|Period 2||0
3069612|NCT01314872|3790225|FG011|COMPLETED|Period 2||175
3069613|NCT01314872|3790226|FG012|COMPLETED|Period 2||188
3163044|NCT01882465|3890491|FG000|COMPLETED|Period 3||6
3069614|NCT01314872|3790227|FG013|COMPLETED|Period 2||187
3069615|NCT01314872|3790228|FG014|COMPLETED|Period 2||110
3069616|NCT01314872|3790214|FG000|NOT COMPLETED|Period 2||0
3069617|NCT01314872|3790215|FG001|NOT COMPLETED|Period 2||0
3069618|NCT01314872|3790216|FG002|NOT COMPLETED|Period 2||0
3069619|NCT01314872|3790217|FG003|NOT COMPLETED|Period 2||0
3069620|NCT01314872|3790218|FG004|NOT COMPLETED|Period 2||0
3069621|NCT01314872|3790219|FG005|NOT COMPLETED|Period 2||0
3069622|NCT01314872|3790220|FG006|NOT COMPLETED|Period 2||0
3069623|NCT01314872|3790221|FG007|NOT COMPLETED|Period 2||0
3069624|NCT01314872|3790222|FG008|NOT COMPLETED|Period 2||0
3069625|NCT01314872|3790223|FG009|NOT COMPLETED|Period 2||0
3069626|NCT01314872|3790224|FG010|NOT COMPLETED|Period 2||0
3069627|NCT01314872|3790225|FG011|NOT COMPLETED|Period 2||48
3069628|NCT01314872|3790226|FG012|NOT COMPLETED|Period 2||60
3069629|NCT01314872|3790227|FG013|NOT COMPLETED|Period 2||53
3069630|NCT01314872|3790228|FG014|NOT COMPLETED|Period 2||24
3069631|NCT01314911|3790262|FG000|STARTED|Overall Study||278
3069632|NCT01314911|3790263|FG001|STARTED|Overall Study||280
3069633|NCT01314911|3790262|FG000|COMPLETED|Overall Study||273
3069634|NCT01314911|3790263|FG001|COMPLETED|Overall Study||274
3069635|NCT01314911|3790262|FG000|NOT COMPLETED|Overall Study||5
3069636|NCT01314911|3790263|FG001|NOT COMPLETED|Overall Study||6
3069637|NCT01314963|3790269|FG000|STARTED|Overall Study||50
3069638|NCT01314963|3790269|FG000|COMPLETED|Overall Study||50
3069639|NCT01314963|3790269|FG000|NOT COMPLETED|Overall Study||0
3069640|NCT01315002|3790275|FG000|STARTED|Overall Study||61
3069641|NCT01315002|3790276|FG001|STARTED|Overall Study||60
3069642|NCT01315002|3790275|FG000|COMPLETED|Overall Study||56
3069643|NCT01315002|3790276|FG001|COMPLETED|Overall Study||55
3069644|NCT01315002|3790275|FG000|NOT COMPLETED|Overall Study||5
3069645|NCT01315002|3790276|FG001|NOT COMPLETED|Overall Study||5
3069646|NCT01315028|3790284|FG000|STARTED|Overall Study||10
3069647|NCT01315028|3790285|FG001|STARTED|Overall Study||10
3069648|NCT01315028|3790284|FG000|COMPLETED|Overall Study||9
3069649|NCT01315028|3790285|FG001|COMPLETED|Overall Study||9
3069650|NCT01315028|3790284|FG000|NOT COMPLETED|Overall Study||1
3069651|NCT01315028|3790285|FG001|NOT COMPLETED|Overall Study||1
3069652|NCT01315132|3790291|FG000|STARTED|Overall Study||47
3069653|NCT01315132|3790291|FG000|COMPLETED|Overall Study||46
3069654|NCT01315132|3790291|FG000|NOT COMPLETED|Overall Study||1
3069655|NCT01315145|3790297|FG000|STARTED|Overall Study||122
3069656|NCT01315145|3790298|FG001|STARTED|Overall Study||16
3069657|NCT01315145|3790297|FG000|COMPLETED|Overall Study||105
3069658|NCT01315145|3790298|FG001|COMPLETED|Overall Study||11
3069659|NCT01315145|3790297|FG000|NOT COMPLETED|Overall Study||17
3069660|NCT01315145|3790298|FG001|NOT COMPLETED|Overall Study||5
3069661|NCT01315158|3790306|FG000|STARTED|Overall Study||17
3069662|NCT01315158|3790307|FG001|STARTED|Overall Study||19
3069663|NCT01315158|3790306|FG000|COMPLETED|Overall Study||17
3069664|NCT01315158|3790307|FG001|COMPLETED|Overall Study||19
3069665|NCT01315158|3790306|FG000|NOT COMPLETED|Overall Study||0
3069666|NCT01315158|3790307|FG001|NOT COMPLETED|Overall Study||0
3069667|NCT01315236|3790315|FG000|STARTED|Double-blind Phase||44
3069668|NCT01315236|3790316|FG001|STARTED|Double-blind Phase||45
3069669|NCT01315236|3790315|FG000|COMPLETED|Double-blind Phase||40
3069670|NCT01315236|3790316|FG001|COMPLETED|Double-blind Phase||45
3069671|NCT01315236|3790315|FG000|NOT COMPLETED|Double-blind Phase||4
3069672|NCT01315236|3790316|FG001|NOT COMPLETED|Double-blind Phase||0
3069673|NCT01315236|3790315|FG000|STARTED|Open-label Phase|Some subjects did not consent to the open label after the double blind phase.|35
3069674|NCT01315236|3790316|FG001|STARTED|Open-label Phase|Some subjects did not consent to the open label after the double blind phase.|43
3069675|NCT01315236|3790315|FG000|COMPLETED|Open-label Phase||34
3069676|NCT01315236|3790316|FG001|COMPLETED|Open-label Phase||41
3069677|NCT01315236|3790315|FG000|NOT COMPLETED|Open-label Phase||1
3069678|NCT01315236|3790316|FG001|NOT COMPLETED|Open-label Phase||2
3069679|NCT01315236|3790315|FG000|STARTED|12-Month Follow-up Period|Some subjects did not consent to the 12 month safety.|27
3069680|NCT01315236|3790316|FG001|STARTED|12-Month Follow-up Period|Some subjects did not consent to the 12 month safety.|32
3069681|NCT01315236|3790315|FG000|COMPLETED|12-Month Follow-up Period||26
3069682|NCT01315236|3790316|FG001|COMPLETED|12-Month Follow-up Period||31
3069683|NCT01315236|3790315|FG000|NOT COMPLETED|12-Month Follow-up Period||1
3069684|NCT01315236|3790316|FG001|NOT COMPLETED|12-Month Follow-up Period||1
3069685|NCT01315249|3790326|FG000|STARTED|Overall Study||259
3069686|NCT01315249|3790327|FG001|STARTED|Overall Study||264
3069687|NCT01315249|3790326|FG000|COMPLETED|Overall Study||215
3069688|NCT01315249|3790327|FG001|COMPLETED|Overall Study||217
3069689|NCT01315249|3790326|FG000|NOT COMPLETED|Overall Study||44
3069690|NCT01315249|3790327|FG001|NOT COMPLETED|Overall Study||47
3069691|NCT01315574|3790335|FG000|STARTED|Overall Study||7
3069692|NCT01315574|3790336|FG001|STARTED|Overall Study||7
3069693|NCT01315574|3790335|FG000|COMPLETED|Overall Study||7
3069694|NCT01315574|3790336|FG001|COMPLETED|Overall Study||7
3069695|NCT01315574|3790335|FG000|NOT COMPLETED|Overall Study||0
3069696|NCT01315574|3790336|FG001|NOT COMPLETED|Overall Study||0
3069697|NCT01315665|3790344|FG000|STARTED|Overall Study||10
3069698|NCT01315665|3790345|FG001|STARTED|Overall Study||5
3069699|NCT01315665|3790344|FG000|COMPLETED|Overall Study||10
3069700|NCT01315665|3790345|FG001|COMPLETED|Overall Study||5
3069701|NCT01315665|3790344|FG000|NOT COMPLETED|Overall Study||0
3069702|NCT01315665|3790345|FG001|NOT COMPLETED|Overall Study||0
3069703|NCT01315678|3790355|FG000|STARTED|Overall Study||148
3069704|NCT01315678|3790356|FG001|STARTED|Overall Study||146
3069705|NCT01315678|3790355|FG000|COMPLETED|Overall Study||134
3069706|NCT01315678|3790356|FG001|COMPLETED|Overall Study||140
3069707|NCT01315678|3790355|FG000|NOT COMPLETED|Overall Study||14
3069708|NCT01315678|3790356|FG001|NOT COMPLETED|Overall Study||6
3069709|NCT01315847|3790366|FG000|STARTED|Part I, Period 1|Subjects who participated in Part I did not participate in Part III.|5
3069710|NCT01315847|3790367|FG001|STARTED|Part I, Period 1||0
3069711|NCT01315847|3790366|FG000|Received Telcagepant|Part I, Period 1||5
3069712|NCT01315847|3790367|FG001|Received Telcagepant|Part I, Period 1||0
3069713|NCT01315847|3790366|FG000|Received [11C]MK-4232|Part I, Period 1|One of these participants received [11C]MK-4232 only at baseline.|5
3069714|NCT01315847|3790367|FG001|Received [11C]MK-4232|Part I, Period 1||0
3069715|NCT01315847|3790366|FG000|COMPLETED|Part I, Period 1||2
3069716|NCT01315847|3790367|FG001|COMPLETED|Part I, Period 1||0
3069717|NCT01315847|3790366|FG000|NOT COMPLETED|Part I, Period 1||3
3069718|NCT01315847|3790367|FG001|NOT COMPLETED|Part I, Period 1||0
3069719|NCT01315847|3790366|FG000|STARTED|Part I, Period 2|One of these subjects did not participate in Part I, Period 1.|3
3069720|NCT01315847|3790367|FG001|STARTED|Part I, Period 2||0
3069721|NCT01315847|3790366|FG000|Received Telcagepant|Part I, Period 2||3
3069722|NCT01315847|3790367|FG001|Received Telcagepant|Part I, Period 2||0
3069723|NCT01315847|3790366|FG000|Received [11C]MK-4232|Part I, Period 2||3
3069724|NCT01315847|3790367|FG001|Received [11C]MK-4232|Part I, Period 2||0
3069725|NCT01315847|3790366|FG000|COMPLETED|Part I, Period 2||3
3069726|NCT01315847|3790367|FG001|COMPLETED|Part I, Period 2||0
3069727|NCT01315847|3790366|FG000|NOT COMPLETED|Part I, Period 2||0
3069728|NCT01315847|3790367|FG001|NOT COMPLETED|Part I, Period 2||0
3069729|NCT01315847|3790366|FG000|STARTED|Part III, Period 1||0
3069730|NCT01315847|3790367|FG001|STARTED|Part III, Period 1|Subjects who participated in Part III did not participate in Part I.|4
3069731|NCT01315847|3790366|FG000|Received Telcagepant|Part III, Period 1||0
3069732|NCT01315847|3790367|FG001|Received Telcagepant|Part III, Period 1||4
3069733|NCT01315847|3790366|FG000|Received [11C]MK-4232|Part III, Period 1||0
3069734|NCT01315847|3790367|FG001|Received [11C]MK-4232|Part III, Period 1|One of these participants received [11C]MK-4232 only at baseline.|4
3069735|NCT01315847|3790366|FG000|COMPLETED|Part III, Period 1||0
3069736|NCT01315847|3790367|FG001|COMPLETED|Part III, Period 1||3
3069737|NCT01315847|3790366|FG000|NOT COMPLETED|Part III, Period 1||0
3069738|NCT01315847|3790367|FG001|NOT COMPLETED|Part III, Period 1||1
3069739|NCT01315847|3790366|FG000|STARTED|Part III, Period 2||0
3069740|NCT01315847|3790367|FG001|STARTED|Part III, Period 2||3
3069741|NCT01315847|3790366|FG000|Received Telcagepant|Part III, Period 2||0
3069742|NCT01315847|3790367|FG001|Received Telcagepant|Part III, Period 2||3
3069743|NCT01315847|3790366|FG000|Received [11C]MK-4232|Part III, Period 2||0
3069744|NCT01315847|3790367|FG001|Received [11C]MK-4232|Part III, Period 2||3
3069745|NCT01315847|3790366|FG000|COMPLETED|Part III, Period 2||0
3069746|NCT01315847|3790367|FG001|COMPLETED|Part III, Period 2||3
3069747|NCT01315847|3790366|FG000|NOT COMPLETED|Part III, Period 2||0
3069748|NCT01315847|3790367|FG001|NOT COMPLETED|Part III, Period 2||0
3069749|NCT01316042|3790375|FG000|STARTED|Overall Study||2
3069750|NCT01316042|3790376|FG001|STARTED|Overall Study||2
3069751|NCT01316042|3790375|FG000|COMPLETED|Overall Study||2
3069752|NCT01316042|3790376|FG001|COMPLETED|Overall Study||1
3069753|NCT01316042|3790375|FG000|NOT COMPLETED|Overall Study||0
3069754|NCT01316042|3790376|FG001|NOT COMPLETED|Overall Study||1
3069755|NCT01316055|3790385|FG000|STARTED|Overall Study||13
3069756|NCT01316055|3790386|FG001|STARTED|Overall Study||17
3069757|NCT01316055|3790387|FG002|STARTED|Overall Study||12
3069758|NCT01316055|3790385|FG000|COMPLETED|Overall Study||12
3069759|NCT01316055|3790386|FG001|COMPLETED|Overall Study||17
3069760|NCT01316055|3790387|FG002|COMPLETED|Overall Study||12
3069761|NCT01316055|3790385|FG000|NOT COMPLETED|Overall Study||1
3069762|NCT01316055|3790386|FG001|NOT COMPLETED|Overall Study||0
3069763|NCT01316055|3790387|FG002|NOT COMPLETED|Overall Study||0
3069764|NCT01316211|3790400|FG000|STARTED|Overall Study||116
3069765|NCT01316211|3790401|FG001|STARTED|Overall Study||123
3069766|NCT01316211|3790400|FG000|COMPLETED|Overall Study||105
3069767|NCT01316211|3790401|FG001|COMPLETED|Overall Study||111
3069768|NCT01316211|3790400|FG000|NOT COMPLETED|Overall Study||11
3069769|NCT01316211|3790401|FG001|NOT COMPLETED|Overall Study||12
3069770|NCT01316224|3790407|FG000|STARTED|Overall Study||52
3069771|NCT01316224|3790407|FG000|Completed Visit 1 to Dermatologist|Overall Study||52
3069772|NCT01316224|3790407|FG000|Completed Visit 1 to Rheumatologist|Overall Study||49
3069773|NCT01316224|3790407|FG000|Completed Visit 2 to Dermatologist|Overall Study||51
3069774|NCT01316224|3790407|FG000|Completed Visit 3 to Dermatologist|Overall Study||48
3069775|NCT01316224|3790407|FG000|Completed Visit 3 to Rheumatologist|Overall Study||39
3069776|NCT01316224|3790407|FG000|Completed Visit 4 to Dermatologist|Overall Study||42
3069777|NCT01316224|3790407|FG000|Completed Visit 4 to Rheumatologist|Overall Study||28
3069778|NCT01316224|3790407|FG000|COMPLETED|Overall Study||42
3069779|NCT01316224|3790407|FG000|NOT COMPLETED|Overall Study||10
3069780|NCT01316263|3790413|FG000|STARTED|Overall Study||7
3069781|NCT01316263|3790414|FG001|STARTED|Overall Study||14
3069782|NCT01316263|3790413|FG000|Received Any Study Drug|Overall Study||7
3069783|NCT01316263|3790414|FG001|Received Any Study Drug|Overall Study||14
3069784|NCT01316263|3790413|FG000|COMPLETED|Overall Study||7
3069785|NCT01316263|3790414|FG001|COMPLETED|Overall Study||14
3069786|NCT01316263|3790413|FG000|NOT COMPLETED|Overall Study||0
3069787|NCT01316263|3790414|FG001|NOT COMPLETED|Overall Study||0
3069788|NCT01316276|3790422|FG000|STARTED|Overall Study||206
3069789|NCT01316276|3790422|FG000|COMPLETED|Overall Study||139
3069790|NCT01316276|3790422|FG000|NOT COMPLETED|Overall Study||67
3069791|NCT01316302|3790429|FG000|STARTED|Overall Study||30
3069792|NCT01316302|3790430|FG001|STARTED|Overall Study||33
3069793|NCT01316302|3790429|FG000|COMPLETED|Overall Study||20
3069794|NCT01316302|3790430|FG001|COMPLETED|Overall Study||22
3069795|NCT01316302|3790429|FG000|NOT COMPLETED|Overall Study||10
3069796|NCT01316302|3790430|FG001|NOT COMPLETED|Overall Study||11
3069797|NCT01316315|3790440|FG000|STARTED|Sequence 1||7
3069798|NCT01316315|3790441|FG001|STARTED|Sequence 1||7
3069799|NCT01316315|3790440|FG000|COMPLETED|Sequence 1||7
3069800|NCT01316315|3790441|FG001|COMPLETED|Sequence 1||7
3069801|NCT01316315|3790440|FG000|NOT COMPLETED|Sequence 1||0
3069802|NCT01316315|3790441|FG001|NOT COMPLETED|Sequence 1||0
3069803|NCT01316315|3790440|FG000|STARTED|Sequence 2||7
3069804|NCT01316315|3790441|FG001|STARTED|Sequence 2||7
3069805|NCT01316315|3790440|FG000|COMPLETED|Sequence 2||7
3069806|NCT01316315|3790441|FG001|COMPLETED|Sequence 2||7
3069807|NCT01316315|3790440|FG000|NOT COMPLETED|Sequence 2||0
3069808|NCT01316315|3790441|FG001|NOT COMPLETED|Sequence 2||0
3284290|NCT02763254|4018110|FG000|NOT COMPLETED|Overall Study||1
3284291|NCT02763566|4018118|FG000|STARTED|Overall Study||207
3284292|NCT02763566|4018119|FG001|STARTED|Overall Study||99
3284293|NCT02763566|4018120|FG002|STARTED|Overall Study||104
3284294|NCT02763566|4018121|FG003|STARTED|Overall Study||53
3284295|NCT02763566|4018118|FG000|COMPLETED|Overall Study||89
3284296|NCT02763566|4018119|FG001|COMPLETED|Overall Study||60
3284297|NCT02763566|4018120|FG002|COMPLETED|Overall Study||50
3284298|NCT02763566|4018121|FG003|COMPLETED|Overall Study||39
3284299|NCT02763566|4018118|FG000|NOT COMPLETED|Overall Study||118
3284300|NCT02763566|4018119|FG001|NOT COMPLETED|Overall Study||39
3284301|NCT02763566|4018120|FG002|NOT COMPLETED|Overall Study||54
3284302|NCT02763566|4018121|FG003|NOT COMPLETED|Overall Study||14
3284303|NCT02763579|4018137|FG000|STARTED|Overall Study||201
3069809|NCT01316341|3790452|FG000|STARTED|Overall Study||6
3069810|NCT01316341|3790453|FG001|STARTED|Overall Study||9
3069811|NCT01316341|3790454|FG002|STARTED|Overall Study||9
3069812|NCT01316341|3790452|FG000|COMPLETED|Overall Study||6
3069813|NCT01316341|3790453|FG001|COMPLETED|Overall Study||9
3069814|NCT01316341|3790454|FG002|COMPLETED|Overall Study||9
3069815|NCT01316341|3790452|FG000|NOT COMPLETED|Overall Study||0
3069816|NCT01316341|3790453|FG001|NOT COMPLETED|Overall Study||0
3069817|NCT01316341|3790454|FG002|NOT COMPLETED|Overall Study||0
3069818|NCT01316380|3790474|FG000|STARTED|Overall Study||156
3069819|NCT01316380|3790475|FG001|STARTED|Overall Study||154
3069820|NCT01316380|3790476|FG002|STARTED|Overall Study||155
3069821|NCT01316380|3790474|FG000|COMPLETED|Overall Study||154
3069822|NCT01316380|3790475|FG001|COMPLETED|Overall Study||149
3069823|NCT01316380|3790476|FG002|COMPLETED|Overall Study||152
3069824|NCT01316380|3790474|FG000|NOT COMPLETED|Overall Study||2
3069825|NCT01316380|3790475|FG001|NOT COMPLETED|Overall Study||5
3069826|NCT01316380|3790476|FG002|NOT COMPLETED|Overall Study||3
3069827|NCT01316419|3790484|FG000|STARTED|Overall Study||2089
3069828|NCT01316419|3790484|FG000|COMPLETED|Overall Study||1824
3069829|NCT01316419|3790484|FG000|NOT COMPLETED|Overall Study||265
3069830|NCT01316510|3790490|FG000|STARTED|Overall Study||12
3069831|NCT01316510|3790491|FG001|STARTED|Overall Study||12
3069832|NCT01316510|3790490|FG000|COMPLETED|Overall Study||12
3069833|NCT01316510|3790491|FG001|COMPLETED|Overall Study||12
3069834|NCT01316510|3790490|FG000|NOT COMPLETED|Overall Study||0
3069835|NCT01316510|3790491|FG001|NOT COMPLETED|Overall Study||0
3069836|NCT01316575|3790499|FG000|STARTED|Overall Study||20
3069837|NCT01316575|3790500|FG001|STARTED|Overall Study||20
3069838|NCT01316575|3790499|FG000|COMPLETED|Overall Study||18
3069839|NCT01316575|3790500|FG001|COMPLETED|Overall Study||19
3069840|NCT01316575|3790499|FG000|NOT COMPLETED|Overall Study||2
3069841|NCT01316575|3790500|FG001|NOT COMPLETED|Overall Study||1
3069842|NCT01316614|3790506|FG000|STARTED|Overall Study||137
3069843|NCT01316614|3790506|FG000|COMPLETED|Overall Study||100
3069844|NCT01316614|3790506|FG000|NOT COMPLETED|Overall Study||37
3069845|NCT01316692|3790511|FG000|STARTED|Overall Study||12
3284304|NCT02763579|4018138|FG001|STARTED|Overall Study||202
3284305|NCT02763579|4018137|FG000|COMPLETED|Overall Study||0
3284306|NCT02763579|4018138|FG001|COMPLETED|Overall Study||0
3284307|NCT02763579|4018137|FG000|NOT COMPLETED|Overall Study||201
3284308|NCT02763579|4018138|FG001|NOT COMPLETED|Overall Study||202
3284309|NCT02763644|4018146|FG000|STARTED|Overall Study||3
3069846|NCT01316692|3790511|FG000|COMPLETED|Overall Study||0
3069847|NCT01316692|3790511|FG000|NOT COMPLETED|Overall Study||12
3069848|NCT01316770|3790515|FG000|STARTED|Overall Study|Each study participant received the dexamethasone parotid irrigation on one side of mouth.|9
3069849|NCT01316770|3790516|FG001|STARTED|Overall Study|Each study participant received the placebo parotid irrigation on the other side of mouth.|9
3069850|NCT01316770|3790515|FG000|COMPLETED|Overall Study||9
3069851|NCT01316770|3790516|FG001|COMPLETED|Overall Study||9
3069852|NCT01316770|3790515|FG000|NOT COMPLETED|Overall Study||0
3069853|NCT01316770|3790516|FG001|NOT COMPLETED|Overall Study||0
3069854|NCT01316887|3790529|FG000|STARTED|Overall Study||109
3069855|NCT01316887|3790530|FG001|STARTED|Overall Study||227
3069856|NCT01316887|3790531|FG002|STARTED|Overall Study||226
3069857|NCT01316887|3790529|FG000|COMPLETED|Overall Study||66
3069858|NCT01316887|3790530|FG001|COMPLETED|Overall Study||133
3069859|NCT01316887|3790531|FG002|COMPLETED|Overall Study||143
3069860|NCT01316887|3790529|FG000|NOT COMPLETED|Overall Study||43
3069861|NCT01316887|3790530|FG001|NOT COMPLETED|Overall Study||94
3069862|NCT01316887|3790531|FG002|NOT COMPLETED|Overall Study||83
3069863|NCT01316900|3790544|FG000|STARTED|Overall Study||209
3069864|NCT01316900|3790545|FG001|STARTED|Overall Study||212
3069865|NCT01316900|3790546|FG002|STARTED|Overall Study||214
3069866|NCT01316900|3790547|FG003|STARTED|Overall Study||208
3069867|NCT01316900|3790544|FG000|COMPLETED|Overall Study||165
3069868|NCT01316900|3790545|FG001|COMPLETED|Overall Study||181
3069869|NCT01316900|3790546|FG002|COMPLETED|Overall Study||173
3069870|NCT01316900|3790547|FG003|COMPLETED|Overall Study||177
3069871|NCT01316900|3790544|FG000|NOT COMPLETED|Overall Study||44
3069872|NCT01316900|3790545|FG001|NOT COMPLETED|Overall Study||31
3069873|NCT01316900|3790546|FG002|NOT COMPLETED|Overall Study||41
3069874|NCT01316900|3790547|FG003|NOT COMPLETED|Overall Study||31
3069875|NCT01316913|3790561|FG000|STARTED|Overall Study||222
3069876|NCT01316913|3790562|FG001|STARTED|Overall Study||217
3069877|NCT01316913|3790563|FG002|STARTED|Overall Study||215
3069878|NCT01316913|3790564|FG003|STARTED|Overall Study||215
3069879|NCT01316913|3790561|FG000|COMPLETED|Overall Study||165
3069880|NCT01316913|3790562|FG001|COMPLETED|Overall Study||163
3069881|NCT01316913|3790563|FG002|COMPLETED|Overall Study||166
3069882|NCT01316913|3790564|FG003|COMPLETED|Overall Study||176
3069883|NCT01316913|3790561|FG000|NOT COMPLETED|Overall Study||57
3069884|NCT01316913|3790562|FG001|NOT COMPLETED|Overall Study||54
3069885|NCT01316913|3790563|FG002|NOT COMPLETED|Overall Study||49
3069886|NCT01316913|3790564|FG003|NOT COMPLETED|Overall Study||39
3069887|NCT01316926|3790575|FG000|STARTED|Period 1||30
3069888|NCT01316926|3790576|FG001|STARTED|Period 1||30
3069889|NCT01316926|3790575|FG000|COMPLETED|Period 1||30
3069890|NCT01316926|3790576|FG001|COMPLETED|Period 1||30
3069891|NCT01316926|3790575|FG000|NOT COMPLETED|Period 1||0
3069892|NCT01316926|3790576|FG001|NOT COMPLETED|Period 1||0
3069893|NCT01316926|3790575|FG000|STARTED|Period 2|One participant completed Period 1, but did not appear in Period 2|29
3069894|NCT01316926|3790576|FG001|STARTED|Period 2||30
3069895|NCT01316926|3790575|FG000|COMPLETED|Period 2||29
3069896|NCT01316926|3790576|FG001|COMPLETED|Period 2||30
3069897|NCT01316926|3790575|FG000|NOT COMPLETED|Period 2||0
3069898|NCT01316926|3790576|FG001|NOT COMPLETED|Period 2||0
3069899|NCT01316939|3790586|FG000|STARTED|Overall Study||76
3069900|NCT01316939|3790587|FG001|STARTED|Overall Study||77
3069901|NCT01316939|3790588|FG002|STARTED|Overall Study||76
3069902|NCT01316939|3790586|FG000|COMPLETED|Overall Study||13
3069903|NCT01316939|3790587|FG001|COMPLETED|Overall Study||9
3069904|NCT01316939|3790588|FG002|COMPLETED|Overall Study||7
3069905|NCT01316939|3790586|FG000|NOT COMPLETED|Overall Study||63
3069906|NCT01316939|3790587|FG001|NOT COMPLETED|Overall Study||68
3069907|NCT01316939|3790588|FG002|NOT COMPLETED|Overall Study||69
3069908|NCT01317004|3790598|FG000|STARTED|Overall Study||51
3069909|NCT01317004|3790599|FG001|STARTED|Overall Study||14
3069910|NCT01317004|3790598|FG000|Safety Set|Overall Study||50
3069911|NCT01317004|3790599|FG001|Safety Set|Overall Study||11
3069912|NCT01317004|3790598|FG000|COMPLETED|Overall Study||47
3069913|NCT01317004|3790599|FG001|COMPLETED|Overall Study||5
3069914|NCT01317004|3790598|FG000|NOT COMPLETED|Overall Study||4
3069915|NCT01317004|3790599|FG001|NOT COMPLETED|Overall Study||9
3069916|NCT01317030|3790607|FG000|STARTED|Overall Study||12
3069917|NCT01317030|3790608|FG001|STARTED|Overall Study||13
3069918|NCT01317030|3790607|FG000|COMPLETED|Overall Study||12
3069919|NCT01317030|3790608|FG001|COMPLETED|Overall Study||13
3069920|NCT01317030|3790607|FG000|NOT COMPLETED|Overall Study||0
3069921|NCT01317030|3790608|FG001|NOT COMPLETED|Overall Study||0
3069922|NCT01317095|3790616|FG000|STARTED|Overall Study||39
3069923|NCT01317095|3790617|FG001|STARTED|Overall Study||41
3069924|NCT01317095|3790616|FG000|COMPLETED|Overall Study||39
3069925|NCT01317095|3790617|FG001|COMPLETED|Overall Study||41
3069926|NCT01317095|3790616|FG000|NOT COMPLETED|Overall Study||0
3069927|NCT01317095|3790617|FG001|NOT COMPLETED|Overall Study||0
3069928|NCT01317160|3790625|FG000|STARTED|Overall Study||75
3069929|NCT01317160|3790626|FG001|STARTED|Overall Study||75
3069930|NCT01317160|3790625|FG000|Allocation to Treatment|Overall Study|1 patient was incorrect included|74
3069931|NCT01317160|3790626|FG001|Allocation to Treatment|Overall Study|1 patient was incorrect included|74
3069932|NCT01317160|3790625|FG000|COMPLETED|Overall Study||71
3069933|NCT01317160|3790626|FG001|COMPLETED|Overall Study||69
3069934|NCT01317160|3790625|FG000|NOT COMPLETED|Overall Study||4
3069935|NCT01317160|3790626|FG001|NOT COMPLETED|Overall Study||6
3069936|NCT01317199|3790636|FG000|STARTED|Dose-escalation Phase 1||14
3069937|NCT01317199|3790637|FG001|STARTED|Dose-escalation Phase 1||0
3069938|NCT01317199|3790638|FG002|STARTED|Dose-escalation Phase 1||0
3069939|NCT01317199|3790639|FG003|STARTED|Dose-escalation Phase 1||0
3069940|NCT01317199|3790636|FG000|Cycle 1: 500mg MPX Once Daily for 28 Day|Dose-escalation Phase 1||2
3069941|NCT01317199|3790637|FG001|Cycle 1: 500mg MPX Once Daily for 28 Day|Dose-escalation Phase 1||0
3069942|NCT01317199|3790638|FG002|Cycle 1: 500mg MPX Once Daily for 28 Day|Dose-escalation Phase 1||0
3069943|NCT01317199|3790639|FG003|Cycle 1: 500mg MPX Once Daily for 28 Day|Dose-escalation Phase 1||0
3069944|NCT01317199|3790636|FG000|Cycle 2: 1000mg MPX Daily for 28 Days|Dose-escalation Phase 1||2
3069945|NCT01317199|3790637|FG001|Cycle 2: 1000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
3069946|NCT01317199|3790638|FG002|Cycle 2: 1000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
3069947|NCT01317199|3790639|FG003|Cycle 2: 1000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
3069948|NCT01317199|3790636|FG000|Cycle 3: 2000mg MPX Daily for 28 Days|Dose-escalation Phase 1||2
3069949|NCT01317199|3790637|FG001|Cycle 3: 2000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
3069950|NCT01317199|3790638|FG002|Cycle 3: 2000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
3069951|NCT01317199|3790639|FG003|Cycle 3: 2000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
3069952|NCT01317199|3790636|FG000|Cycle 4: 3000mg MPX Daily for 28 Days|Dose-escalation Phase 1||2
3069953|NCT01317199|3790637|FG001|Cycle 4: 3000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
3069954|NCT01317199|3790638|FG002|Cycle 4: 3000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
3069955|NCT01317199|3790639|FG003|Cycle 4: 3000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
3069956|NCT01317199|3790636|FG000|Cycle 5: 4000mg MPX Daily for 28 Days|Dose-escalation Phase 1||6
3069957|NCT01317199|3790637|FG001|Cycle 5: 4000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
3069958|NCT01317199|3790638|FG002|Cycle 5: 4000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
3069959|NCT01317199|3790639|FG003|Cycle 5: 4000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
3069960|NCT01317199|3790636|FG000|COMPLETED|Dose-escalation Phase 1||7
3069961|NCT01317199|3790637|FG001|COMPLETED|Dose-escalation Phase 1||0
3069962|NCT01317199|3790638|FG002|COMPLETED|Dose-escalation Phase 1||0
3069963|NCT01317199|3790639|FG003|COMPLETED|Dose-escalation Phase 1||0
3069964|NCT01317199|3790636|FG000|NOT COMPLETED|Dose-escalation Phase 1||7
3069965|NCT01317199|3790637|FG001|NOT COMPLETED|Dose-escalation Phase 1||0
3069966|NCT01317199|3790638|FG002|NOT COMPLETED|Dose-escalation Phase 1||0
3069967|NCT01317199|3790639|FG003|NOT COMPLETED|Dose-escalation Phase 1||0
3069968|NCT01317199|3790636|FG000|STARTED|Randomized Phase 2||0
3069969|NCT01317199|3790637|FG001|STARTED|Randomized Phase 2||24
3069970|NCT01317199|3790638|FG002|STARTED|Randomized Phase 2||56
3069971|NCT01317199|3790639|FG003|STARTED|Randomized Phase 2||49
3069972|NCT01317199|3790636|FG000|COMPLETED|Randomized Phase 2||0
3069973|NCT01317199|3790637|FG001|COMPLETED|Randomized Phase 2||13
3069974|NCT01317199|3790638|FG002|COMPLETED|Randomized Phase 2||35
3069975|NCT01317199|3790639|FG003|COMPLETED|Randomized Phase 2||32
3069976|NCT01317199|3790636|FG000|NOT COMPLETED|Randomized Phase 2||0
3069977|NCT01317199|3790637|FG001|NOT COMPLETED|Randomized Phase 2||11
3069978|NCT01317199|3790638|FG002|NOT COMPLETED|Randomized Phase 2||21
3069979|NCT01317199|3790639|FG003|NOT COMPLETED|Randomized Phase 2||17
3069980|NCT01317277|3790658|FG000|STARTED|Overall Study||50
3069981|NCT01317277|3790659|FG001|STARTED|Overall Study||25
3069982|NCT01317277|3790658|FG000|COMPLETED|Overall Study||43
3069983|NCT01317277|3790659|FG001|COMPLETED|Overall Study||23
3069984|NCT01317277|3790658|FG000|NOT COMPLETED|Overall Study||7
3069985|NCT01317277|3790659|FG001|NOT COMPLETED|Overall Study||2
3069986|NCT01317472|3790667|FG000|STARTED|Overall Study||9
3069987|NCT01317472|3790668|FG001|STARTED|Overall Study||2
3069988|NCT01317472|3790667|FG000|COMPLETED|Overall Study||7
3069989|NCT01317472|3790668|FG001|COMPLETED|Overall Study||2
3069990|NCT01317472|3790667|FG000|NOT COMPLETED|Overall Study||2
3069991|NCT01317472|3790668|FG001|NOT COMPLETED|Overall Study||0
3069992|NCT01317550|3790678|FG000|STARTED|Overall Study||5
3069993|NCT01317550|3790679|FG001|STARTED|Overall Study||3
3069994|NCT01317550|3790680|FG002|STARTED|Overall Study||3
3069995|NCT01317550|3790681|FG003|STARTED|Overall Study||3
3069996|NCT01317550|3790678|FG000|COMPLETED|Overall Study||3
3069997|NCT01317550|3790679|FG001|COMPLETED|Overall Study||3
3069998|NCT01317550|3790680|FG002|COMPLETED|Overall Study||3
3069999|NCT01317550|3790681|FG003|COMPLETED|Overall Study||3
3070000|NCT01317550|3790678|FG000|NOT COMPLETED|Overall Study||2
3070001|NCT01317550|3790679|FG001|NOT COMPLETED|Overall Study||0
3070002|NCT01317550|3790680|FG002|NOT COMPLETED|Overall Study||0
3070003|NCT01317550|3790681|FG003|NOT COMPLETED|Overall Study||0
3070004|NCT01317615|3790691|FG000|STARTED|Overall Study||49
3070005|NCT01317615|3790691|FG000|COMPLETED|Overall Study||0
3070006|NCT01317615|3790691|FG000|NOT COMPLETED|Overall Study||49
3070007|NCT01317641|3790704|FG000|STARTED|Overall Study||4
3070008|NCT01317641|3790705|FG001|STARTED|Overall Study||7
3070009|NCT01317641|3790706|FG002|STARTED|Overall Study||3
3070010|NCT01317641|3790707|FG003|STARTED|Overall Study||4
3070011|NCT01317641|3790708|FG004|STARTED|Overall Study||3
3070012|NCT01317641|3790709|FG005|STARTED|Overall Study||3
3070013|NCT01317641|3790710|FG006|STARTED|Overall Study||38
3070014|NCT01317641|3790711|FG007|STARTED|Overall Study||38
3070015|NCT01317641|3790712|FG008|STARTED|Overall Study||36
3070016|NCT01317641|3790704|FG000|COMPLETED|Overall Study||3
3070017|NCT01317641|3790705|FG001|COMPLETED|Overall Study||6
3070018|NCT01317641|3790706|FG002|COMPLETED|Overall Study||3
3070019|NCT01317641|3790707|FG003|COMPLETED|Overall Study||3
3070020|NCT01317641|3790708|FG004|COMPLETED|Overall Study||3
3070021|NCT01317641|3790709|FG005|COMPLETED|Overall Study||3
3070022|NCT01317641|3790710|FG006|COMPLETED|Overall Study||35
3070023|NCT01317641|3790711|FG007|COMPLETED|Overall Study||33
3070024|NCT01317641|3790712|FG008|COMPLETED|Overall Study||31
3070025|NCT01317641|3790704|FG000|NOT COMPLETED|Overall Study||1
3070026|NCT01317641|3790705|FG001|NOT COMPLETED|Overall Study||1
3070027|NCT01317641|3790706|FG002|NOT COMPLETED|Overall Study||0
3070028|NCT01317641|3790707|FG003|NOT COMPLETED|Overall Study||1
3070029|NCT01317641|3790708|FG004|NOT COMPLETED|Overall Study||0
3070030|NCT01317641|3790709|FG005|NOT COMPLETED|Overall Study||0
3070031|NCT01317641|3790710|FG006|NOT COMPLETED|Overall Study||3
3070032|NCT01317641|3790711|FG007|NOT COMPLETED|Overall Study||5
3070033|NCT01317641|3790712|FG008|NOT COMPLETED|Overall Study||5
3070034|NCT01317667|3790751|FG000|STARTED|Overall Study||10
3070035|NCT01317667|3790752|FG001|STARTED|Overall Study||10
3070036|NCT01317667|3790753|FG002|STARTED|Overall Study||10
3070037|NCT01317667|3790751|FG000|COMPLETED|Overall Study||10
3070038|NCT01317667|3790752|FG001|COMPLETED|Overall Study||10
3070039|NCT01317667|3790753|FG002|COMPLETED|Overall Study|The original trial design was modified to limit the number of vaccinations in Group 3 to 1 dose.|10
3070040|NCT01317667|3790751|FG000|NOT COMPLETED|Overall Study||0
3070041|NCT01317667|3790752|FG001|NOT COMPLETED|Overall Study||0
3070042|NCT01317667|3790753|FG002|NOT COMPLETED|Overall Study||0
3070043|NCT01317797|3790764|FG000|STARTED|Overall Study||8
3070044|NCT01317797|3790765|FG001|STARTED|Overall Study||7
3070045|NCT01317797|3790766|FG002|STARTED|Overall Study||9
3070046|NCT01317797|3790764|FG000|COMPLETED|Overall Study||8
3070047|NCT01317797|3790765|FG001|COMPLETED|Overall Study||6
3070048|NCT01317797|3790766|FG002|COMPLETED|Overall Study||8
3070049|NCT01317797|3790764|FG000|NOT COMPLETED|Overall Study||0
3070050|NCT01317797|3790765|FG001|NOT COMPLETED|Overall Study||1
3070051|NCT01317797|3790766|FG002|NOT COMPLETED|Overall Study||1
3070052|NCT01317901|3790776|FG000|STARTED|Overall Study||6
3070053|NCT01317901|3790777|FG001|STARTED|Overall Study||6
3070054|NCT01317901|3790776|FG000|COMPLETED|Overall Study||6
3070055|NCT01317901|3790777|FG001|COMPLETED|Overall Study||6
3070056|NCT01317901|3790776|FG000|NOT COMPLETED|Overall Study||0
3070057|NCT01317901|3790777|FG001|NOT COMPLETED|Overall Study||0
3070058|NCT01317940|3790789|FG000|STARTED|Overall Study||19
3070059|NCT01317940|3790790|FG001|STARTED|Overall Study||10
3070060|NCT01317940|3790791|FG002|STARTED|Overall Study||20
3070061|NCT01317940|3790792|FG003|STARTED|Overall Study||6
3070062|NCT01317940|3790793|FG004|STARTED|Overall Study||13
3070063|NCT01317940|3790794|FG005|STARTED|Overall Study||4
3070064|NCT01317940|3790789|FG000|COMPLETED|Overall Study||18
3070065|NCT01317940|3790790|FG001|COMPLETED|Overall Study||10
3070066|NCT01317940|3790791|FG002|COMPLETED|Overall Study||15
3070067|NCT01317940|3790792|FG003|COMPLETED|Overall Study||5
3070068|NCT01317940|3790793|FG004|COMPLETED|Overall Study||12
3070069|NCT01317940|3790794|FG005|COMPLETED|Overall Study||4
3070070|NCT01317940|3790789|FG000|NOT COMPLETED|Overall Study||1
3070071|NCT01317940|3790790|FG001|NOT COMPLETED|Overall Study||0
3070072|NCT01317940|3790791|FG002|NOT COMPLETED|Overall Study||5
3070073|NCT01317940|3790792|FG003|NOT COMPLETED|Overall Study||1
3070074|NCT01317940|3790793|FG004|NOT COMPLETED|Overall Study||1
3070075|NCT01317940|3790794|FG005|NOT COMPLETED|Overall Study||0
3070076|NCT01318018|3790811|FG000|STARTED|Overall Study||10
3070077|NCT01318018|3790812|FG001|STARTED|Overall Study||10
3070078|NCT01318018|3790811|FG000|COMPLETED|Overall Study||10
3070079|NCT01318018|3790812|FG001|COMPLETED|Overall Study||10
3070080|NCT01318018|3790811|FG000|NOT COMPLETED|Overall Study||0
3070081|NCT01318018|3790812|FG001|NOT COMPLETED|Overall Study||0
3070082|NCT01318070|3790821|FG000|STARTED|Overall Study||111
3070083|NCT01318070|3790822|FG001|STARTED|Overall Study||113
3070084|NCT01318070|3790823|FG002|STARTED|Overall Study||115
3070085|NCT01318070|3790821|FG000|COMPLETED|Overall Study||109
3070086|NCT01318070|3790822|FG001|COMPLETED|Overall Study||111
3070087|NCT01318070|3790823|FG002|COMPLETED|Overall Study||108
3070088|NCT01318070|3790821|FG000|NOT COMPLETED|Overall Study||2
3070089|NCT01318070|3790822|FG001|NOT COMPLETED|Overall Study||2
3070090|NCT01318070|3790823|FG002|NOT COMPLETED|Overall Study||7
3070091|NCT01318083|3790834|FG000|STARTED|Overall Study||105
3070092|NCT01318083|3790835|FG001|STARTED|Overall Study||104
3070093|NCT01318083|3790836|FG002|STARTED|Overall Study||103
3070094|NCT01318083|3790834|FG000|COMPLETED|Overall Study||99
3070095|NCT01318083|3790835|FG001|COMPLETED|Overall Study||102
3070096|NCT01318083|3790836|FG002|COMPLETED|Overall Study||98
3070097|NCT01318083|3790834|FG000|NOT COMPLETED|Overall Study||6
3070098|NCT01318083|3790835|FG001|NOT COMPLETED|Overall Study||2
3070099|NCT01318083|3790836|FG002|NOT COMPLETED|Overall Study||5
3070100|NCT01318109|3790847|FG000|STARTED|Overall Study||92
3070101|NCT01318109|3790848|FG001|STARTED|Overall Study||96
3070102|NCT01318109|3790849|FG002|STARTED|Overall Study||100
3070103|NCT01318109|3790847|FG000|COMPLETED|Overall Study||91
3070104|NCT01318109|3790848|FG001|COMPLETED|Overall Study||93
3070105|NCT01318109|3790849|FG002|COMPLETED|Overall Study||100
3070106|NCT01318109|3790847|FG000|NOT COMPLETED|Overall Study||1
3070107|NCT01318109|3790848|FG001|NOT COMPLETED|Overall Study||3
3070108|NCT01318109|3790849|FG002|NOT COMPLETED|Overall Study||0
3070109|NCT01318122|3790859|FG000|STARTED|Enrolled - Long-Term Extension Study|5 randomized participants from alogliptin 12.5 & 25 mg group CCT-004 study did not enter this study|106
3070110|NCT01318122|3790860|FG001|STARTED|Enrolled - Long-Term Extension Study|5 randomized participants from alogliptin 12.5 & 25 mg group CCT-004 study did not enter this study|110
3070111|NCT01318122|3790861|FG002|STARTED|Enrolled - Long-Term Extension Study||57
3070112|NCT01318122|3790862|FG003|STARTED|Enrolled - Long-Term Extension Study||53
3070113|NCT01318122|3790859|FG000|COMPLETED|Enrolled - Long-Term Extension Study||105
3070114|NCT01318122|3790860|FG001|COMPLETED|Enrolled - Long-Term Extension Study||110
3070115|NCT01318122|3790861|FG002|COMPLETED|Enrolled - Long-Term Extension Study||55
3070116|NCT01318122|3790862|FG003|COMPLETED|Enrolled - Long-Term Extension Study||52
3070117|NCT01318122|3790859|FG000|NOT COMPLETED|Enrolled - Long-Term Extension Study||1
3070118|NCT01318122|3790860|FG001|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
3070119|NCT01318122|3790861|FG002|NOT COMPLETED|Enrolled - Long-Term Extension Study||2
3070120|NCT01318122|3790862|FG003|NOT COMPLETED|Enrolled - Long-Term Extension Study||1
3136757|NCT01714947|3862017|FG000|COMPLETED|Part A||3
3070121|NCT01318122|3790859|FG000|STARTED|Entered - Long-Term Extension Study||105
3070122|NCT01318122|3790860|FG001|STARTED|Entered - Long-Term Extension Study||110
3070123|NCT01318122|3790861|FG002|STARTED|Entered - Long-Term Extension Study||55
3070124|NCT01318122|3790862|FG003|STARTED|Entered - Long-Term Extension Study||52
3070125|NCT01318122|3790859|FG000|COMPLETED|Entered - Long-Term Extension Study||96
3070126|NCT01318122|3790860|FG001|COMPLETED|Entered - Long-Term Extension Study||99
3070127|NCT01318122|3790861|FG002|COMPLETED|Entered - Long-Term Extension Study||49
3070128|NCT01318122|3790862|FG003|COMPLETED|Entered - Long-Term Extension Study||48
3070129|NCT01318122|3790859|FG000|NOT COMPLETED|Entered - Long-Term Extension Study||9
3070130|NCT01318122|3790860|FG001|NOT COMPLETED|Entered - Long-Term Extension Study||11
3070131|NCT01318122|3790861|FG002|NOT COMPLETED|Entered - Long-Term Extension Study||6
3070132|NCT01318122|3790862|FG003|NOT COMPLETED|Entered - Long-Term Extension Study||4
3070133|NCT01318135|3790872|FG000|STARTED|Enrolled - Long-Term Extension Study||99
3070134|NCT01318135|3790873|FG001|STARTED|Enrolled - Long-Term Extension Study||102
3070135|NCT01318135|3790874|FG002|STARTED|Enrolled - Long-Term Extension Study||46
3070136|NCT01318135|3790875|FG003|STARTED|Enrolled - Long-Term Extension Study||49
3070137|NCT01318135|3790876|FG004|STARTED|Enrolled - Long-Term Extension Study||91
3070138|NCT01318135|3790877|FG005|STARTED|Enrolled - Long-Term Extension Study||90
3070139|NCT01318135|3790878|FG006|STARTED|Enrolled - Long-Term Extension Study||50
3070140|NCT01318135|3790879|FG007|STARTED|Enrolled - Long-Term Extension Study||49
3070141|NCT01318135|3790872|FG000|COMPLETED|Enrolled - Long-Term Extension Study||97
3070142|NCT01318135|3790873|FG001|COMPLETED|Enrolled - Long-Term Extension Study||102
3070143|NCT01318135|3790874|FG002|COMPLETED|Enrolled - Long-Term Extension Study||46
3070144|NCT01318135|3790875|FG003|COMPLETED|Enrolled - Long-Term Extension Study||49
3070145|NCT01318135|3790876|FG004|COMPLETED|Enrolled - Long-Term Extension Study||91
3070146|NCT01318135|3790877|FG005|COMPLETED|Enrolled - Long-Term Extension Study||90
3070147|NCT01318135|3790878|FG006|COMPLETED|Enrolled - Long-Term Extension Study||50
3070148|NCT01318135|3790879|FG007|COMPLETED|Enrolled - Long-Term Extension Study||49
3070149|NCT01318135|3790872|FG000|NOT COMPLETED|Enrolled - Long-Term Extension Study||2
3070150|NCT01318135|3790873|FG001|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
3070151|NCT01318135|3790874|FG002|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
3070152|NCT01318135|3790875|FG003|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
3070153|NCT01318135|3790876|FG004|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
3070154|NCT01318135|3790877|FG005|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
3070155|NCT01318135|3790878|FG006|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
3070156|NCT01318135|3790879|FG007|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
3070157|NCT01318135|3790872|FG000|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-005 but not entered OCT-005 are excluded in Participant Flow.|97
3070158|NCT01318135|3790873|FG001|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-005 but not entered OCT-005 are excluded in Participant Flow.|102
3070159|NCT01318135|3790874|FG002|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-005 but not entered OCT-005 are excluded in Participant Flow.|46
3070160|NCT01318135|3790875|FG003|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-005 but not entered OCT-005 are excluded in Participant Flow.|49
3070161|NCT01318135|3790876|FG004|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-006 but not entered OCT-005 are excluded in Participant Flow.|90
3070162|NCT01318135|3790877|FG005|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-006 but not entered OCT-005 are excluded in Participant Flow.|87
3070163|NCT01318135|3790878|FG006|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-006 but not entered OCT-005 are excluded in Participant Flow.|50
3070164|NCT01318135|3790879|FG007|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-006 but not entered OCT-005 are excluded in Participant Flow.|49
3070165|NCT01318135|3790872|FG000|COMPLETED|Entered - Long-Term Extension Study|296 participants enrolled and 294 completed glimepiride add-on study and entered the present study.|80
3070166|NCT01318135|3790873|FG001|COMPLETED|Entered - Long-Term Extension Study|296 participants enrolled and 294 completed glimepiride add-on study and entered the present study.|89
3070167|NCT01318135|3790874|FG002|COMPLETED|Entered - Long-Term Extension Study|296 participants enrolled and 294 completed glimepiride add-on study and entered the present study.|38
3070168|NCT01318135|3790875|FG003|COMPLETED|Entered - Long-Term Extension Study|296 participants enrolled and 294 completed glimepiride add-on study and entered the present study.|42
3070169|NCT01318135|3790876|FG004|COMPLETED|Entered - Long-Term Extension Study|280 participants enrolled and 276 completed metformin add-on study and entered the present study.|81
3070170|NCT01318135|3790877|FG005|COMPLETED|Entered - Long-Term Extension Study|280 participants enrolled and 276 completed metformin add-on study and entered the present study.|83
3070171|NCT01318135|3790878|FG006|COMPLETED|Entered - Long-Term Extension Study|280 participants enrolled and 276 completed metformin add-on study and entered the present study.|49
3070172|NCT01318135|3790879|FG007|COMPLETED|Entered - Long-Term Extension Study|280 participants enrolled and 276 completed metformin add-on study and entered the present study.|46
3070173|NCT01318135|3790872|FG000|NOT COMPLETED|Entered - Long-Term Extension Study||17
3070174|NCT01318135|3790873|FG001|NOT COMPLETED|Entered - Long-Term Extension Study||13
3070175|NCT01318135|3790874|FG002|NOT COMPLETED|Entered - Long-Term Extension Study||8
3070176|NCT01318135|3790875|FG003|NOT COMPLETED|Entered - Long-Term Extension Study||7
3070177|NCT01318135|3790876|FG004|NOT COMPLETED|Entered - Long-Term Extension Study||9
3070178|NCT01318135|3790877|FG005|NOT COMPLETED|Entered - Long-Term Extension Study||4
3070179|NCT01318135|3790878|FG006|NOT COMPLETED|Entered - Long-Term Extension Study||1
3070180|NCT01318135|3790879|FG007|NOT COMPLETED|Entered - Long-Term Extension Study||3
3070181|NCT01318278|3790892|FG000|STARTED|Overall Study||10
3070182|NCT01318278|3790893|FG001|STARTED|Overall Study||10
3070183|NCT01318278|3790894|FG002|STARTED|Overall Study||50
3070184|NCT01318278|3790892|FG000|COMPLETED|Overall Study||10
3070185|NCT01318278|3790893|FG001|COMPLETED|Overall Study||10
3070186|NCT01318278|3790894|FG002|COMPLETED|Overall Study||50
3070187|NCT01318278|3790892|FG000|NOT COMPLETED|Overall Study||0
3070188|NCT01318278|3790893|FG001|NOT COMPLETED|Overall Study||0
3070189|NCT01318278|3790894|FG002|NOT COMPLETED|Overall Study||0
3070190|NCT01318356|3790906|FG000|STARTED|Overall Study||51
3070191|NCT01318356|3790907|FG001|STARTED|Overall Study||52
3070192|NCT01318356|3790908|FG002|STARTED|Overall Study||52
3070193|NCT01318356|3790906|FG000|COMPLETED|Overall Study||43
3070194|NCT01318356|3790907|FG001|COMPLETED|Overall Study||49
3070195|NCT01318356|3790908|FG002|COMPLETED|Overall Study||50
3070196|NCT01318356|3790906|FG000|NOT COMPLETED|Overall Study||8
3070197|NCT01318356|3790907|FG001|NOT COMPLETED|Overall Study||3
3070198|NCT01318356|3790908|FG002|NOT COMPLETED|Overall Study||2
3070199|NCT01318382|3790916|FG000|STARTED|Overall Study||302
3070200|NCT01318382|3790916|FG000|COMPLETED|Overall Study||289
3070201|NCT01318382|3790916|FG000|NOT COMPLETED|Overall Study||13
3070202|NCT01318408|3790921|FG000|STARTED|Overall Study||24
3070203|NCT01318408|3790921|FG000|COMPLETED|Overall Study||16
3070204|NCT01318408|3790921|FG000|NOT COMPLETED|Overall Study||8
3070205|NCT01318499|3790928|FG000|STARTED|Overall Study||540
3070206|NCT01318499|3790929|FG001|STARTED|Overall Study||534
3070207|NCT01318499|3790930|FG002|STARTED|Overall Study||268
3070208|NCT01318499|3790928|FG000|COMPLETED|Overall Study||475
3070209|NCT01318499|3790929|FG001|COMPLETED|Overall Study||458
3070210|NCT01318499|3790930|FG002|COMPLETED|Overall Study||121
3070211|NCT01318499|3790928|FG000|NOT COMPLETED|Overall Study||65
3070212|NCT01318499|3790929|FG001|NOT COMPLETED|Overall Study||76
3070213|NCT01318499|3790930|FG002|NOT COMPLETED|Overall Study||147
3070214|NCT01318512|3790940|FG000|STARTED|Titration Period (4 Months)||340
3070215|NCT01318512|3790940|FG000|COMPLETED|Titration Period (4 Months)||340
3070216|NCT01318512|3790940|FG000|NOT COMPLETED|Titration Period (4 Months)||0
3070217|NCT01318512|3790940|FG000|STARTED|Maintenance Period (6 Months)||340
3070218|NCT01318512|3790940|FG000|COMPLETED|Maintenance Period (6 Months)||329
3070219|NCT01318512|3790940|FG000|NOT COMPLETED|Maintenance Period (6 Months)||11
3070220|NCT01318538|3790948|FG000|STARTED|Overall Study||52
3070221|NCT01318538|3790949|FG001|STARTED|Overall Study||106
3070222|NCT01318538|3790950|FG002|STARTED|Overall Study||8
3070223|NCT01318538|3790948|FG000|COMPLETED|Overall Study||52
3070224|NCT01318538|3790949|FG001|COMPLETED|Overall Study||106
3070225|NCT01318538|3790950|FG002|COMPLETED|Overall Study||8
3070226|NCT01318538|3790948|FG000|NOT COMPLETED|Overall Study||0
3070227|NCT01318538|3790949|FG001|NOT COMPLETED|Overall Study||0
3070228|NCT01318538|3790950|FG002|NOT COMPLETED|Overall Study||0
3070229|NCT01318577|3790960|FG000|STARTED|Overall Study||224
3070230|NCT01318577|3790961|FG001|STARTED|Overall Study||220
3070231|NCT01318577|3790960|FG000|COMPLETED|Overall Study||211
3070232|NCT01318577|3790961|FG001|COMPLETED|Overall Study||212
3070233|NCT01318577|3790960|FG000|NOT COMPLETED|Overall Study||13
3070234|NCT01318577|3790961|FG001|NOT COMPLETED|Overall Study||8
3070235|NCT01318694|3790971|FG000|STARTED|Overall Study||275
3070236|NCT01318694|3790972|FG001|STARTED|Overall Study||270
3070237|NCT01318694|3790973|FG002|STARTED|Overall Study||268
3070238|NCT01318694|3790974|FG003|STARTED|Overall Study||268
3070239|NCT01318694|3790971|FG000|Full Analysis Set|Overall Study||274
3070240|NCT01318694|3790972|FG001|Full Analysis Set|Overall Study||270
3070241|NCT01318694|3790973|FG002|Full Analysis Set|Overall Study||265
3070242|NCT01318694|3790974|FG003|Full Analysis Set|Overall Study||268
3070243|NCT01318694|3790971|FG000|Safety Set|Overall Study||273
3070244|NCT01318694|3790972|FG001|Safety Set|Overall Study||268
3070245|NCT01318694|3790973|FG002|Safety Set|Overall Study||265
3070246|NCT01318694|3790974|FG003|Safety Set|Overall Study||265
3070247|NCT01318694|3790971|FG000|COMPLETED|Overall Study||223
3070248|NCT01318694|3790972|FG001|COMPLETED|Overall Study||212
3070249|NCT01318694|3790973|FG002|COMPLETED|Overall Study||225
3070250|NCT01318694|3790974|FG003|COMPLETED|Overall Study||200
3070251|NCT01318694|3790971|FG000|NOT COMPLETED|Overall Study||52
3070252|NCT01318694|3790972|FG001|NOT COMPLETED|Overall Study||58
3070253|NCT01318694|3790973|FG002|NOT COMPLETED|Overall Study||43
3070254|NCT01318694|3790974|FG003|NOT COMPLETED|Overall Study||68
3070255|NCT01318733|3790984|FG000|STARTED|Overall Study||449
3070256|NCT01318733|3790984|FG000|COMPLETED|Overall Study||279
3070257|NCT01318733|3790984|FG000|NOT COMPLETED|Overall Study||170
3070258|NCT01318811|3790990|FG000|STARTED|Overall Study||4
3070259|NCT01318811|3790991|FG001|STARTED|Overall Study||8
3070260|NCT01318811|3790990|FG000|COMPLETED|Overall Study||3
3070261|NCT01318811|3790991|FG001|COMPLETED|Overall Study||4
3070262|NCT01318811|3790990|FG000|NOT COMPLETED|Overall Study||1
3070263|NCT01318811|3790991|FG001|NOT COMPLETED|Overall Study||4
3070264|NCT01318876|3790997|FG000|STARTED|Day 8 Survey||7645
3070265|NCT01318876|3790997|FG000|COMPLETED|Day 8 Survey||5825
3070266|NCT01318876|3790997|FG000|NOT COMPLETED|Day 8 Survey||1820
3070267|NCT01318876|3790997|FG000|STARTED|Day 29 Survey|All participants with a valid e-mail, have received the second survey|7549
3070268|NCT01318876|3790997|FG000|COMPLETED|Day 29 Survey||5724
3070269|NCT01318876|3790997|FG000|NOT COMPLETED|Day 29 Survey||1825
3070270|NCT01318902|3791005|FG000|STARTED|Overall Study||6
3070271|NCT01318902|3791006|FG001|STARTED|Overall Study||5
3070272|NCT01318902|3791007|FG002|STARTED|Overall Study||5
3070273|NCT01318902|3791008|FG003|STARTED|Overall Study||11
3070274|NCT01318902|3791005|FG000|COMPLETED|Overall Study||5
3070275|NCT01318902|3791006|FG001|COMPLETED|Overall Study||2
3070276|NCT01318902|3791007|FG002|COMPLETED|Overall Study||3
3070277|NCT01318902|3791008|FG003|COMPLETED|Overall Study||5
3070278|NCT01318902|3791005|FG000|NOT COMPLETED|Overall Study||1
3070279|NCT01318902|3791006|FG001|NOT COMPLETED|Overall Study||3
3070280|NCT01318902|3791007|FG002|NOT COMPLETED|Overall Study||2
3070281|NCT01318902|3791008|FG003|NOT COMPLETED|Overall Study||6
3070282|NCT01318915|3791020|FG000|STARTED|Overall Study||10
3070283|NCT01318915|3791020|FG000|COMPLETED|Overall Study||9
3070284|NCT01318915|3791020|FG000|NOT COMPLETED|Overall Study||1
3070285|NCT01318967|3791026|FG000|STARTED|Overall Study||10
3070286|NCT01318967|3791026|FG000|COMPLETED|Overall Study||10
3070287|NCT01318967|3791026|FG000|NOT COMPLETED|Overall Study||0
3070288|NCT01319045|3791031|FG000|STARTED|Overall Study||5
3070289|NCT01319045|3791031|FG000|COMPLETED|Overall Study|Study was discontinued due to low enrollment|3
3070290|NCT01319045|3791031|FG000|NOT COMPLETED|Overall Study||2
3070291|NCT01319110|3791037|FG000|STARTED|Overall Study||5
3070292|NCT01319110|3791038|FG001|STARTED|Overall Study||5
3070293|NCT01319110|3791037|FG000|COMPLETED|Overall Study||5
3070294|NCT01319110|3791038|FG001|COMPLETED|Overall Study||5
3070295|NCT01319110|3791037|FG000|NOT COMPLETED|Overall Study||0
3070296|NCT01319110|3791038|FG001|NOT COMPLETED|Overall Study||0
3070297|NCT01319318|3791044|FG000|STARTED|Overall Study||25
3070298|NCT01319318|3791044|FG000|COMPLETED|Overall Study||25
3070299|NCT01319318|3791044|FG000|NOT COMPLETED|Overall Study||0
3070300|NCT01319383|3791048|FG000|STARTED|Overall Study||12
3070301|NCT01319383|3791049|FG001|STARTED|Overall Study||13
3070302|NCT01319383|3791048|FG000|Step 1|Overall Study||8
3070303|NCT01319383|3791049|FG001|Step 1|Overall Study|The 2 participants without an ex vivo response were terminated from the study.|11
3070304|NCT01319383|3791048|FG000|Step 2|Overall Study|These participants demonstrated an ex vivo response in Step 1|8
3070305|NCT01319383|3791049|FG001|Step 2|Overall Study|The 7 participants without an in vivo response to single dose of VOR 400 mg PO were terminated.|4
3070306|NCT01319383|3791048|FG000|Step 2|Overall Study|The 4 without ex vivo response (Step 1) took a single dose to see if in vivo response would occur|4
3070307|NCT01319383|3791049|FG001|Step 2|Overall Study||0
3070308|NCT01319383|3791048|FG000|Step 3|Overall Study|None who qualified for the 2 series of 11 doses of VOR (taken M-T-W & off for 4 days for 4 wks).|0
3070309|NCT01319383|3791049|FG001|Step 3|Overall Study|3 Arm 1 participants enrolled here; 6/7 had in vivo response to 2 VOR doses given 72 hours apart.|6
3070310|NCT01319383|3791048|FG000|Step 4|Overall Study|Arm 1 did not have a Step 4|0
3070311|NCT01319383|3791049|FG001|Step 4|Overall Study|Only 3/6 completed the study.|3
3070312|NCT01319383|3791048|FG000|COMPLETED|Overall Study||0
3070313|NCT01319383|3791049|FG001|COMPLETED|Overall Study||3
3070314|NCT01319383|3791048|FG000|NOT COMPLETED|Overall Study||12
3070315|NCT01319383|3791049|FG001|NOT COMPLETED|Overall Study||10
3070316|NCT01319396|3791066|FG000|STARTED|Overall Study||24
3070317|NCT01319396|3791066|FG000|COMPLETED|Overall Study||24
3070318|NCT01319396|3791066|FG000|NOT COMPLETED|Overall Study||0
3070319|NCT01319422|3791072|FG000|STARTED|Overall Study||20
3070320|NCT01319422|3791073|FG001|STARTED|Overall Study||20
3070321|NCT01319422|3791072|FG000|COMPLETED|Overall Study||19
3070322|NCT01319422|3791073|FG001|COMPLETED|Overall Study||20
3070323|NCT01319422|3791072|FG000|NOT COMPLETED|Overall Study||1
3070324|NCT01319422|3791073|FG001|NOT COMPLETED|Overall Study||0
3070325|NCT01319500|3791081|FG000|STARTED|Overall Study||1187
3070326|NCT01319500|3791082|FG001|STARTED|Overall Study||2589
3070327|NCT01319500|3791081|FG000|COMPLETED|Overall Study||1187
3070328|NCT01319500|3791082|FG001|COMPLETED|Overall Study||2589
3070329|NCT01319500|3791081|FG000|NOT COMPLETED|Overall Study||0
3070330|NCT01319500|3791082|FG001|NOT COMPLETED|Overall Study||0
3070331|NCT01319539|3791093|FG000|STARTED|Overall Study||12
3070332|NCT01319539|3791093|FG000|COMPLETED|Overall Study||12
3070333|NCT01319539|3791093|FG000|NOT COMPLETED|Overall Study||0
3070334|NCT01319552|3791099|FG000|STARTED|Overall Study||14
3070335|NCT01319552|3791099|FG000|COMPLETED|Overall Study||14
3070336|NCT01319552|3791099|FG000|NOT COMPLETED|Overall Study||0
3070337|NCT01319617|3791104|FG000|STARTED|Overall Study||41
3070338|NCT01319617|3791104|FG000|COMPLETED|Overall Study||40
3070339|NCT01319617|3791104|FG000|NOT COMPLETED|Overall Study||1
3070340|NCT01319721|3791110|FG000|STARTED|Overall Study|The unit of measure is eyes.|48
3070341|NCT01319721|3791111|FG001|STARTED|Overall Study|The unit of measure is eyes.|48
3070342|NCT01319721|3791110|FG000|COMPLETED|Overall Study|The unit of measure is eyes.|47
3070343|NCT01319721|3791111|FG001|COMPLETED|Overall Study|The unit of measure is eyes.|42
3070344|NCT01319721|3791110|FG000|NOT COMPLETED|Overall Study||1
3070345|NCT01319721|3791111|FG001|NOT COMPLETED|Overall Study||6
3070346|NCT01319773|3791122|FG000|STARTED|Overall Study||10
3070347|NCT01319773|3791123|FG001|STARTED|Overall Study||10
3070348|NCT01319773|3791124|FG002|STARTED|Overall Study||8
3070349|NCT01319773|3791125|FG003|STARTED|Overall Study||8
3070350|NCT01319773|3791126|FG004|STARTED|Overall Study||8
3070351|NCT01319773|3791122|FG000|COMPLETED|Overall Study||10
3070352|NCT01319773|3791123|FG001|COMPLETED|Overall Study||10
3070353|NCT01319773|3791124|FG002|COMPLETED|Overall Study||8
3070354|NCT01319773|3791125|FG003|COMPLETED|Overall Study||8
3070355|NCT01319773|3791126|FG004|COMPLETED|Overall Study||8
3070356|NCT01319773|3791122|FG000|NOT COMPLETED|Overall Study||0
3070357|NCT01319773|3791123|FG001|NOT COMPLETED|Overall Study||0
3070358|NCT01319773|3791124|FG002|NOT COMPLETED|Overall Study||0
3070359|NCT01319773|3791125|FG003|NOT COMPLETED|Overall Study||0
3070360|NCT01319773|3791126|FG004|NOT COMPLETED|Overall Study||0
3070361|NCT01319799|3791136|FG000|STARTED|Overall Study||10
3070362|NCT01319799|3791136|FG000|COMPLETED|Overall Study||10
3070363|NCT01319799|3791136|FG000|NOT COMPLETED|Overall Study||0
3070364|NCT01319812|3791142|FG000|STARTED|Overall Study||161
3070365|NCT01319812|3791143|FG001|STARTED|Overall Study||302
3070366|NCT01319812|3791142|FG000|COMPLETED|Overall Study||145
3070367|NCT01319812|3791143|FG001|COMPLETED|Overall Study||280
3070368|NCT01319812|3791142|FG000|NOT COMPLETED|Overall Study||16
3070369|NCT01319812|3791143|FG001|NOT COMPLETED|Overall Study||22
3070370|NCT01319851|3791156|FG000|STARTED|Overall Study||3
3070371|NCT01319851|3791156|FG000|COMPLETED|Overall Study||3
3070372|NCT01319851|3791156|FG000|NOT COMPLETED|Overall Study||0
3070373|NCT01319877|3791162|FG000|STARTED|Overall Study||453
3070374|NCT01319877|3791163|FG001|STARTED|Overall Study||153
3070375|NCT01319877|3791162|FG000|COMPLETED|Overall Study||345
3070376|NCT01319877|3791163|FG001|COMPLETED|Overall Study||108
3070377|NCT01319877|3791162|FG000|NOT COMPLETED|Overall Study||108
3070378|NCT01319877|3791163|FG001|NOT COMPLETED|Overall Study||45
3070379|NCT01319929|3791170|FG000|STARTED|First Treatment Period (4 Weeks)||20
3070380|NCT01319929|3791171|FG001|STARTED|First Treatment Period (4 Weeks)||19
3070381|NCT01319929|3791170|FG000|COMPLETED|First Treatment Period (4 Weeks)||17
3070382|NCT01319929|3791171|FG001|COMPLETED|First Treatment Period (4 Weeks)||17
3070383|NCT01319929|3791170|FG000|NOT COMPLETED|First Treatment Period (4 Weeks)||3
3070384|NCT01319929|3791171|FG001|NOT COMPLETED|First Treatment Period (4 Weeks)||2
3070385|NCT01319929|3791170|FG000|STARTED|Washout Period (3 Weeks)||17
3070386|NCT01319929|3791171|FG001|STARTED|Washout Period (3 Weeks)||17
3070387|NCT01319929|3791170|FG000|COMPLETED|Washout Period (3 Weeks)||17
3070388|NCT01319929|3791171|FG001|COMPLETED|Washout Period (3 Weeks)||17
3070389|NCT01319929|3791170|FG000|NOT COMPLETED|Washout Period (3 Weeks)||0
3070390|NCT01319929|3791171|FG001|NOT COMPLETED|Washout Period (3 Weeks)||0
3070391|NCT01319929|3791170|FG000|STARTED|Second Treatment Period (4 Weeks)||17
3070392|NCT01319929|3791171|FG001|STARTED|Second Treatment Period (4 Weeks)||17
3070393|NCT01319929|3791170|FG000|COMPLETED|Second Treatment Period (4 Weeks)||16
3070394|NCT01319929|3791171|FG001|COMPLETED|Second Treatment Period (4 Weeks)||16
3070395|NCT01319929|3791170|FG000|NOT COMPLETED|Second Treatment Period (4 Weeks)||1
3070396|NCT01319929|3791171|FG001|NOT COMPLETED|Second Treatment Period (4 Weeks)||1
3070397|NCT01319994|3791180|FG000|STARTED|Overall Study||26
3070398|NCT01319994|3791181|FG001|STARTED|Overall Study||27
3070399|NCT01319994|3791180|FG000|Abto Keep Appoinment Shedule|Overall Study||23
3070400|NCT01319994|3791181|FG001|Abto Keep Appoinment Shedule|Overall Study||24
3070401|NCT01319994|3791180|FG000|Tolerated at Least 1.7g/Day Dose|Overall Study||19
3070402|NCT01319994|3791181|FG001|Tolerated at Least 1.7g/Day Dose|Overall Study||24
3070403|NCT01319994|3791180|FG000|Glucocorticoid Dose as Inc Cri|Overall Study||19
3070404|NCT01319994|3791181|FG001|Glucocorticoid Dose as Inc Cri|Overall Study||22
3070405|NCT01319994|3791180|FG000|Did Not Develop Overt Diabetes|Overall Study||19
3070406|NCT01319994|3791181|FG001|Did Not Develop Overt Diabetes|Overall Study||21
3070407|NCT01319994|3791180|FG000|COMPLETED|Overall Study||19
3070408|NCT01319994|3791181|FG001|COMPLETED|Overall Study||21
3070409|NCT01319994|3791180|FG000|NOT COMPLETED|Overall Study||7
3070410|NCT01319994|3791181|FG001|NOT COMPLETED|Overall Study||6
3070411|NCT01320033|3791190|FG000|STARTED|Overall Study||216
3070412|NCT01320033|3791191|FG001|STARTED|Overall Study||224
3070413|NCT01320033|3791192|FG002|STARTED|Overall Study||222
3070414|NCT01320033|3791190|FG000|COMPLETED|Overall Study||158
3070415|NCT01320033|3791191|FG001|COMPLETED|Overall Study||160
3070416|NCT01320033|3791192|FG002|COMPLETED|Overall Study||169
3070417|NCT01320033|3791190|FG000|NOT COMPLETED|Overall Study||58
3070418|NCT01320033|3791191|FG001|NOT COMPLETED|Overall Study||64
3070419|NCT01320033|3791192|FG002|NOT COMPLETED|Overall Study||53
3070420|NCT01320085|3791203|FG000|STARTED|Overall Study||41
3070421|NCT01320085|3791204|FG001|STARTED|Overall Study||117
3070422|NCT01320085|3791205|FG002|STARTED|Overall Study||25
3070423|NCT01320085|3791203|FG000|COMPLETED|Overall Study||0
3070424|NCT01320085|3791204|FG001|COMPLETED|Overall Study||0
3070425|NCT01320085|3791205|FG002|COMPLETED|Overall Study||0
3070426|NCT01320085|3791203|FG000|NOT COMPLETED|Overall Study||41
3070427|NCT01320085|3791204|FG001|NOT COMPLETED|Overall Study||117
3070428|NCT01320085|3791205|FG002|NOT COMPLETED|Overall Study||25
3070429|NCT01320137|3791215|FG000|STARTED|Overall Study||40
3070430|NCT01320137|3791216|FG001|STARTED|Overall Study||40
3070431|NCT01320137|3791215|FG000|COMPLETED|Overall Study||40
3070432|NCT01320137|3791216|FG001|COMPLETED|Overall Study||40
3070433|NCT01320137|3791215|FG000|NOT COMPLETED|Overall Study||0
3070434|NCT01320137|3791216|FG001|NOT COMPLETED|Overall Study||0
3070435|NCT01320150|3791224|FG000|STARTED|Overall Study||311
3070436|NCT01320150|3791224|FG000|PPP|Overall Study||34
3070437|NCT01320150|3791224|FG000|Non-PPP|Overall Study||211
3070438|NCT01320150|3791224|FG000|COMPLETED|Overall Study||245
3070439|NCT01320150|3791224|FG000|NOT COMPLETED|Overall Study||66
3070440|NCT01320202|3791230|FG000|STARTED|Overall Study||152
3284310|NCT02763644|4018147|FG001|STARTED|Overall Study||4
3284311|NCT02763644|4018146|FG000|COMPLETED|Overall Study||0
3284312|NCT02763644|4018147|FG001|COMPLETED|Overall Study||2
3284313|NCT02763644|4018146|FG000|NOT COMPLETED|Overall Study||3
3284314|NCT02763644|4018147|FG001|NOT COMPLETED|Overall Study||2
3284315|NCT02763826|4018162|FG000|STARTED|Part 1 Dose Escalation, 1 mA||3
3284316|NCT02763826|4018163|FG001|STARTED|Part 1 Dose Escalation, 1 mA||0
3284317|NCT02763826|4018164|FG002|STARTED|Part 1 Dose Escalation, 1 mA||0
3284318|NCT02763826|4018165|FG003|STARTED|Part 1 Dose Escalation, 1 mA||0
3284319|NCT02763826|4018166|FG004|STARTED|Part 1 Dose Escalation, 1 mA||0
3284320|NCT02763826|4018167|FG005|STARTED|Part 1 Dose Escalation, 1 mA||0
3284321|NCT02763826|4018168|FG006|STARTED|Part 1 Dose Escalation, 1 mA||0
3070441|NCT01320202|3791231|FG001|STARTED|Overall Study||153
3070442|NCT01320202|3791230|FG000|Comp 48 Wks in St 2|Overall Study||27
3070443|NCT01320202|3791231|FG001|Comp 48 Wks in St 2|Overall Study||27
3070444|NCT01320202|3791230|FG000|Comp St 2 Due to ESA/IV Iron Needs|Overall Study||69
3070445|NCT01320202|3791231|FG001|Comp St 2 Due to ESA/IV Iron Needs|Overall Study||82
3070446|NCT01320202|3791230|FG000|Enrolled in St 3|Overall Study||98
3070447|NCT01320202|3791231|FG001|Enrolled in St 3|Overall Study||109
3070448|NCT01320202|3791230|FG000|Completed St 3|Overall Study||79
3070449|NCT01320202|3791231|FG001|Completed St 3|Overall Study||82
3070450|NCT01320202|3791230|FG000|COMPLETED|Overall Study||96
3070451|NCT01320202|3791231|FG001|COMPLETED|Overall Study||109
3070452|NCT01320202|3791230|FG000|NOT COMPLETED|Overall Study||56
3070453|NCT01320202|3791231|FG001|NOT COMPLETED|Overall Study||44
3070454|NCT01320293|3791240|FG000|STARTED|Overall Study||18
3070455|NCT01320293|3791240|FG000|COMPLETED|Overall Study||16
3070456|NCT01320293|3791240|FG000|NOT COMPLETED|Overall Study||2
3070457|NCT01320553|3791248|FG000|STARTED|Overall Study||31
3070458|NCT01320553|3791249|FG001|STARTED|Overall Study||30
3070459|NCT01320553|3791250|FG002|STARTED|Overall Study||31
3070460|NCT01320553|3791251|FG003|STARTED|Overall Study||30
3070461|NCT01320553|3791248|FG000|COMPLETED|Overall Study||30
3070462|NCT01320553|3791249|FG001|COMPLETED|Overall Study||26
3070463|NCT01320553|3791250|FG002|COMPLETED|Overall Study||29
3070464|NCT01320553|3791251|FG003|COMPLETED|Overall Study||29
3070465|NCT01320553|3791248|FG000|NOT COMPLETED|Overall Study||1
3070466|NCT01320553|3791249|FG001|NOT COMPLETED|Overall Study||4
3070467|NCT01320553|3791250|FG002|NOT COMPLETED|Overall Study||2
3070468|NCT01320553|3791251|FG003|NOT COMPLETED|Overall Study||1
3070469|NCT01320722|3791266|FG000|STARTED|Overall Study||46
3070470|NCT01320722|3791267|FG001|STARTED|Overall Study||47
3070471|NCT01320722|3791268|FG002|STARTED|Overall Study||47
3070472|NCT01320722|3791269|FG003|STARTED|Overall Study||49
3070473|NCT01320722|3791270|FG004|STARTED|Overall Study||53
3070474|NCT01320722|3791266|FG000|Received Intervention|Overall Study||43
3070475|NCT01320722|3791267|FG001|Received Intervention|Overall Study||45
3070476|NCT01320722|3791268|FG002|Received Intervention|Overall Study||46
3070477|NCT01320722|3791269|FG003|Received Intervention|Overall Study||48
3070478|NCT01320722|3791270|FG004|Received Intervention|Overall Study||51
3070479|NCT01320722|3791266|FG000|COMPLETED|Overall Study||43
3070480|NCT01320722|3791267|FG001|COMPLETED|Overall Study||41
3070481|NCT01320722|3791268|FG002|COMPLETED|Overall Study||40
3070482|NCT01320722|3791269|FG003|COMPLETED|Overall Study||35
3070483|NCT01320722|3791270|FG004|COMPLETED|Overall Study||45
3070484|NCT01320722|3791266|FG000|NOT COMPLETED|Overall Study||3
3070485|NCT01320722|3791267|FG001|NOT COMPLETED|Overall Study||6
3070486|NCT01320722|3791268|FG002|NOT COMPLETED|Overall Study||7
3070487|NCT01320722|3791269|FG003|NOT COMPLETED|Overall Study||14
3070488|NCT01320722|3791270|FG004|NOT COMPLETED|Overall Study||8
3070489|NCT01320735|3791285|FG000|STARTED|Overall Study||300
3070490|NCT01320735|3791285|FG000|COMPLETED|Overall Study||194
3070491|NCT01320735|3791285|FG000|NOT COMPLETED|Overall Study||106
3070492|NCT01320826|3791289|FG000|STARTED|Overall Study||577
3070493|NCT01320826|3791289|FG000|COMPLETED|Overall Study||577
3070494|NCT01320826|3791289|FG000|NOT COMPLETED|Overall Study||0
3070495|NCT01320943|3791306|FG000|STARTED|Overall Study|13 participants did not restart TDF; 8 participants restarted TDF during the study.|21
3070496|NCT01320943|3791307|FG001|STARTED|Overall Study||22
3070497|NCT01320943|3791306|FG000|COMPLETED|Overall Study||20
3070498|NCT01320943|3791307|FG001|COMPLETED|Overall Study||20
3070499|NCT01320943|3791306|FG000|NOT COMPLETED|Overall Study||1
3070500|NCT01320943|3791307|FG001|NOT COMPLETED|Overall Study||2
3070501|NCT01321073|3791320|FG000|STARTED|Overall Study||64
3070502|NCT01321073|3791320|FG000|COMPLETED|Overall Study||57
3070503|NCT01321073|3791320|FG000|NOT COMPLETED|Overall Study||7
3070504|NCT01321151|3791326|FG000|STARTED|Overall Study|The boxer was treated once-a-day for 30 days.|6
3070505|NCT01321151|3791327|FG001|STARTED|Overall Study|The boxer was treated with once-a-day for 30 days.|6
3070506|NCT01321151|3791326|FG000|COMPLETED|Overall Study||6
3070507|NCT01321151|3791327|FG001|COMPLETED|Overall Study||6
3070508|NCT01321151|3791326|FG000|NOT COMPLETED|Overall Study||0
3070509|NCT01321151|3791327|FG001|NOT COMPLETED|Overall Study||0
3070510|NCT01321177|3791335|FG000|STARTED|Overall Study||223
3070511|NCT01321177|3791336|FG001|STARTED|Overall Study||181
3070512|NCT01321177|3791335|FG000|COMPLETED|Overall Study||147
3070513|NCT01321177|3791336|FG001|COMPLETED|Overall Study||84
3070514|NCT01321177|3791335|FG000|NOT COMPLETED|Overall Study||76
3070515|NCT01321177|3791336|FG001|NOT COMPLETED|Overall Study||97
3070516|NCT01321437|3791342|FG000|STARTED|Overall Study||11
3070517|NCT01321437|3791342|FG000|COMPLETED|Overall Study||11
3070518|NCT01321437|3791342|FG000|NOT COMPLETED|Overall Study||0
3070519|NCT01321541|3791348|FG000|STARTED|Overall Study||155
3070520|NCT01321541|3791349|FG001|STARTED|Overall Study||157
3070521|NCT01321541|3791348|FG000|COMPLETED|Overall Study||72
3070522|NCT01321541|3791349|FG001|COMPLETED|Overall Study||61
3070523|NCT01321541|3791348|FG000|NOT COMPLETED|Overall Study||83
3070524|NCT01321541|3791349|FG001|NOT COMPLETED|Overall Study||96
3070525|NCT01321554|3791357|FG000|STARTED|Randomization Phase||261
3070526|NCT01321554|3791358|FG001|STARTED|Randomization Phase||131
3070527|NCT01321554|3791359|FG002|STARTED|Randomization Phase||0
3070528|NCT01321554|3791360|FG003|STARTED|Randomization Phase||0
3070529|NCT01321554|3791357|FG000|COMPLETED|Randomization Phase||261
3070530|NCT01321554|3791358|FG001|COMPLETED|Randomization Phase||131
3070531|NCT01321554|3791359|FG002|COMPLETED|Randomization Phase||0
3070532|NCT01321554|3791360|FG003|COMPLETED|Randomization Phase||0
3070533|NCT01321554|3791357|FG000|NOT COMPLETED|Randomization Phase||0
3070534|NCT01321554|3791358|FG001|NOT COMPLETED|Randomization Phase||0
3070535|NCT01321554|3791359|FG002|NOT COMPLETED|Randomization Phase||0
3070536|NCT01321554|3791360|FG003|NOT COMPLETED|Randomization Phase||0
3070537|NCT01321554|3791357|FG000|STARTED|OOL Lenvatinib Treatment Period||0
3070538|NCT01321554|3791358|FG001|STARTED|OOL Lenvatinib Treatment Period||0
3070539|NCT01321554|3791359|FG002|STARTED|OOL Lenvatinib Treatment Period|Participants from randomization phase were re-randomized to OOL, treatment period.|85
3070540|NCT01321554|3791360|FG003|STARTED|OOL Lenvatinib Treatment Period|Participants from randomization phase were re-randomized to OOL, treatment period.|30
3070541|NCT01321554|3791357|FG000|COMPLETED|OOL Lenvatinib Treatment Period||0
3070542|NCT01321554|3791358|FG001|COMPLETED|OOL Lenvatinib Treatment Period||0
3070543|NCT01321554|3791359|FG002|COMPLETED|OOL Lenvatinib Treatment Period||85
3070544|NCT01321554|3791360|FG003|COMPLETED|OOL Lenvatinib Treatment Period||30
3070545|NCT01321554|3791357|FG000|NOT COMPLETED|OOL Lenvatinib Treatment Period||0
3070546|NCT01321554|3791358|FG001|NOT COMPLETED|OOL Lenvatinib Treatment Period||0
3070547|NCT01321554|3791359|FG002|NOT COMPLETED|OOL Lenvatinib Treatment Period||0
3070548|NCT01321554|3791360|FG003|NOT COMPLETED|OOL Lenvatinib Treatment Period||0
3070549|NCT01321606|3791370|FG000|STARTED|Overall Study||18
3070550|NCT01321606|3791371|FG001|STARTED|Overall Study||32
3070551|NCT01321606|3791372|FG002|STARTED|Overall Study||34
3070552|NCT01321606|3791373|FG003|STARTED|Overall Study||29
3070553|NCT01321606|3791370|FG000|COMPLETED|Overall Study||18
3070554|NCT01321606|3791371|FG001|COMPLETED|Overall Study||32
3070555|NCT01321606|3791372|FG002|COMPLETED|Overall Study||34
3070556|NCT01321606|3791373|FG003|COMPLETED|Overall Study||28
3070557|NCT01321606|3791370|FG000|NOT COMPLETED|Overall Study||0
3070558|NCT01321606|3791371|FG001|NOT COMPLETED|Overall Study||0
3070559|NCT01321606|3791372|FG002|NOT COMPLETED|Overall Study||0
3070560|NCT01321606|3791373|FG003|NOT COMPLETED|Overall Study||1
3070561|NCT01321710|3791386|FG000|STARTED|Overall Study||50
3070562|NCT01321710|3791387|FG001|STARTED|Overall Study||58
3070563|NCT01321710|3791388|FG002|STARTED|Overall Study||44
3070564|NCT01321710|3791386|FG000|COMPLETED|Overall Study||46
3070565|NCT01321710|3791387|FG001|COMPLETED|Overall Study||53
3070566|NCT01321710|3791388|FG002|COMPLETED|Overall Study||44
3070567|NCT01321710|3791386|FG000|NOT COMPLETED|Overall Study||4
3070568|NCT01321710|3791387|FG001|NOT COMPLETED|Overall Study||5
3070569|NCT01321710|3791388|FG002|NOT COMPLETED|Overall Study||0
3070570|NCT01321723|3791401|FG000|STARTED|Overall Study||32
3070571|NCT01321723|3791402|FG001|STARTED|Overall Study||33
3070572|NCT01321723|3791403|FG002|STARTED|Overall Study||32
3070573|NCT01321723|3791401|FG000|COMPLETED|Overall Study||27
3070574|NCT01321723|3791402|FG001|COMPLETED|Overall Study||28
3070575|NCT01321723|3791403|FG002|COMPLETED|Overall Study||28
3070576|NCT01321723|3791401|FG000|NOT COMPLETED|Overall Study||5
3070577|NCT01321723|3791402|FG001|NOT COMPLETED|Overall Study||5
3070578|NCT01321723|3791403|FG002|NOT COMPLETED|Overall Study||4
3070579|NCT01321749|3791413|FG000|STARTED|Overall Study||51
3070580|NCT01321749|3791414|FG001|STARTED|Overall Study||52
3070581|NCT01321749|3791413|FG000|COMPLETED|Overall Study||38
3070582|NCT01321749|3791414|FG001|COMPLETED|Overall Study||30
3070583|NCT01321749|3791413|FG000|NOT COMPLETED|Overall Study||13
3070584|NCT01321749|3791414|FG001|NOT COMPLETED|Overall Study||22
3070585|NCT01321879|3791420|FG000|STARTED|Overall Study||39
3070586|NCT01321879|3791420|FG000|COMPLETED|Overall Study||25
3070587|NCT01321879|3791420|FG000|NOT COMPLETED|Overall Study||14
3070588|NCT01322009|3791426|FG000|STARTED|Overall Study||7
3070589|NCT01322009|3791427|FG001|STARTED|Overall Study||7
3070590|NCT01322009|3791426|FG000|COMPLETED|Overall Study||7
3070591|NCT01322009|3791427|FG001|COMPLETED|Overall Study||4
3070592|NCT01322009|3791426|FG000|NOT COMPLETED|Overall Study||0
3070593|NCT01322009|3791427|FG001|NOT COMPLETED|Overall Study||3
3070594|NCT01322022|3791435|FG000|STARTED|Overall Study||20
3070595|NCT01322022|3791436|FG001|STARTED|Overall Study||20
3070596|NCT01322022|3791435|FG000|Week 4|Overall Study||15
3070597|NCT01322022|3791436|FG001|Week 4|Overall Study||18
3070598|NCT01322022|3791435|FG000|COMPLETED|Overall Study||15
3070599|NCT01322022|3791436|FG001|COMPLETED|Overall Study||18
3070600|NCT01322022|3791435|FG000|NOT COMPLETED|Overall Study||5
3070601|NCT01322022|3791436|FG001|NOT COMPLETED|Overall Study||2
3070602|NCT01322048|3791444|FG000|STARTED|Overall Study||21
3070603|NCT01322048|3791445|FG001|STARTED|Overall Study||26
3070604|NCT01322048|3791444|FG000|COMPLETED|Overall Study||21
3070605|NCT01322048|3791445|FG001|COMPLETED|Overall Study||26
3070606|NCT01322048|3791444|FG000|NOT COMPLETED|Overall Study||0
3070607|NCT01322048|3791445|FG001|NOT COMPLETED|Overall Study||0
3070608|NCT01322347|3791453|FG000|STARTED|Overall Study||147
3070609|NCT01322347|3791454|FG001|STARTED|Overall Study||147
3070610|NCT01322347|3791453|FG000|Completed 48 Wks in St 2|Overall Study||28
3070611|NCT01322347|3791454|FG001|Completed 48 Wks in St 2|Overall Study||22
3070612|NCT01322347|3791453|FG000|Comp St 2 Due to ESA/IV Iron Needs|Overall Study||68
3070613|NCT01322347|3791454|FG001|Comp St 2 Due to ESA/IV Iron Needs|Overall Study||90
3070614|NCT01322347|3791453|FG000|Enrolled in St 3|Overall Study||101
3070615|NCT01322347|3791454|FG001|Enrolled in St 3|Overall Study||113
3070616|NCT01322347|3791453|FG000|Completed St 3|Overall Study||82
3070617|NCT01322347|3791454|FG001|Completed St 3|Overall Study||86
3070618|NCT01322347|3791453|FG000|COMPLETED|Overall Study||96
3070619|NCT01322347|3791454|FG001|COMPLETED|Overall Study||112
3070620|NCT01322347|3791453|FG000|NOT COMPLETED|Overall Study||51
3070621|NCT01322347|3791454|FG001|NOT COMPLETED|Overall Study||35
3070622|NCT01322360|3791461|FG000|STARTED|Overall Study||50
3070623|NCT01322360|3791461|FG000|COMPLETED|Overall Study||50
3070624|NCT01322360|3791461|FG000|NOT COMPLETED|Overall Study||0
3070625|NCT01322386|3791468|FG000|STARTED|Overall Study||10
3070626|NCT01322386|3791469|FG001|STARTED|Overall Study||11
3070627|NCT01322386|3791468|FG000|COMPLETED|Overall Study||10
3070628|NCT01322386|3791469|FG001|COMPLETED|Overall Study||9
3070629|NCT01322386|3791468|FG000|NOT COMPLETED|Overall Study||0
3070630|NCT01322386|3791469|FG001|NOT COMPLETED|Overall Study||2
3070631|NCT01322490|3791480|FG000|STARTED|Treatment Period||432
3070632|NCT01322490|3791481|FG001|STARTED|Treatment Period||432
3070633|NCT01322490|3791482|FG002|STARTED|Treatment Period||433
3070634|NCT01322490|3791480|FG000|Treated|Treatment Period||429
3070635|NCT01322490|3791481|FG001|Treated|Treatment Period||429
3070636|NCT01322490|3791482|FG002|Treated|Treatment Period||428
3070637|NCT01322490|3791480|FG000|COMPLETED|Treatment Period||300
3070638|NCT01322490|3791481|FG001|COMPLETED|Treatment Period||279
3070639|NCT01322490|3791482|FG002|COMPLETED|Treatment Period||280
3070640|NCT01322490|3791480|FG000|NOT COMPLETED|Treatment Period||132
3070641|NCT01322490|3791481|FG001|NOT COMPLETED|Treatment Period||153
3070642|NCT01322490|3791482|FG002|NOT COMPLETED|Treatment Period||153
3070643|NCT01322490|3791480|FG000|STARTED|Long Term Follow-up Period|You did not have to complete treatment to enter follow up.|409
3070644|NCT01322490|3791481|FG001|STARTED|Long Term Follow-up Period|You did not have to complete treatment to enter follow up.|408
3070645|NCT01322490|3791482|FG002|STARTED|Long Term Follow-up Period|You did not have to complete treatment to enter follow up.|413
3070646|NCT01322490|3791480|FG000|COMPLETED|Long Term Follow-up Period||0
3070647|NCT01322490|3791481|FG001|COMPLETED|Long Term Follow-up Period||0
3070648|NCT01322490|3791482|FG002|COMPLETED|Long Term Follow-up Period||0
3070649|NCT01322490|3791480|FG000|NOT COMPLETED|Long Term Follow-up Period||409
3070650|NCT01322490|3791481|FG001|NOT COMPLETED|Long Term Follow-up Period||408
3070651|NCT01322490|3791482|FG002|NOT COMPLETED|Long Term Follow-up Period||413
3070652|NCT01322594|3791496|FG000|STARTED|Overall Study|RANDOMIZED SUBJECTS THROUGH STUDY DAY 240-300|6
3070653|NCT01322594|3791497|FG001|STARTED|Overall Study||3
3070654|NCT01322594|3791498|FG002|STARTED|Overall Study||3
3070655|NCT01322594|3791499|FG003|STARTED|Overall Study||6
3070656|NCT01322594|3791500|FG004|STARTED|Overall Study||7
3070657|NCT01322594|3791501|FG005|STARTED|Overall Study||6
3070658|NCT01322594|3791496|FG000|COMPLETED|Overall Study||6
3070659|NCT01322594|3791497|FG001|COMPLETED|Overall Study||3
3070660|NCT01322594|3791498|FG002|COMPLETED|Overall Study||3
3070661|NCT01322594|3791499|FG003|COMPLETED|Overall Study||6
3070662|NCT01322594|3791500|FG004|COMPLETED|Overall Study||7
3070663|NCT01322594|3791501|FG005|COMPLETED|Overall Study||6
3070664|NCT01322594|3791496|FG000|NOT COMPLETED|Overall Study||0
3070665|NCT01322594|3791497|FG001|NOT COMPLETED|Overall Study||0
3070666|NCT01322594|3791498|FG002|NOT COMPLETED|Overall Study||0
3070667|NCT01322594|3791499|FG003|NOT COMPLETED|Overall Study||0
3070668|NCT01322594|3791500|FG004|NOT COMPLETED|Overall Study||0
3070669|NCT01322594|3791501|FG005|NOT COMPLETED|Overall Study||0
3070670|NCT01322607|3791517|FG000|STARTED|Overall Study||11
3070671|NCT01322607|3791518|FG001|STARTED|Overall Study||9
3070672|NCT01322607|3791517|FG000|COMPLETED|Overall Study||10
3070673|NCT01322607|3791518|FG001|COMPLETED|Overall Study||9
3070674|NCT01322607|3791517|FG000|NOT COMPLETED|Overall Study||1
3070675|NCT01322607|3791518|FG001|NOT COMPLETED|Overall Study||0
3134359|NCT01701258|3859416|FG007|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
3134360|NCT01701258|3859417|FG008|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
3134361|NCT01701258|3859418|FG009|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
3134362|NCT01701258|3859419|FG010|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
3134363|NCT01701258|3859420|FG011|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
3134364|NCT01701258|3859421|FG012|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
3134365|NCT01701258|3859409|FG000|Returned for PET (Session 3)|Assessment and Scheduling||73
3134366|NCT01701258|3859410|FG001|Returned for PET (Session 3)|Assessment and Scheduling||0
3134367|NCT01701258|3859411|FG002|Returned for PET (Session 3)|Assessment and Scheduling||0
3134368|NCT01701258|3859412|FG003|Returned for PET (Session 3)|Assessment and Scheduling||0
3134369|NCT01701258|3859413|FG004|Returned for PET (Session 3)|Assessment and Scheduling||0
3134370|NCT01701258|3859414|FG005|Returned for PET (Session 3)|Assessment and Scheduling||0
3134371|NCT01701258|3859415|FG006|Returned for PET (Session 3)|Assessment and Scheduling||0
3134372|NCT01701258|3859416|FG007|Returned for PET (Session 3)|Assessment and Scheduling||0
3134373|NCT01701258|3859417|FG008|Returned for PET (Session 3)|Assessment and Scheduling||0
3134374|NCT01701258|3859418|FG009|Returned for PET (Session 3)|Assessment and Scheduling||0
3134375|NCT01701258|3859419|FG010|Returned for PET (Session 3)|Assessment and Scheduling||0
3070676|NCT01322633|3791526|FG000|STARTED|Overall Study||34178
3070677|NCT01322633|3791527|FG001|STARTED|Overall Study||27686
3070678|NCT01322633|3791526|FG000|COMPLETED|Overall Study||34178
3070679|NCT01322633|3791527|FG001|COMPLETED|Overall Study||27686
3070680|NCT01322633|3791526|FG000|NOT COMPLETED|Overall Study||0
3070681|NCT01322633|3791527|FG001|NOT COMPLETED|Overall Study||0
3070682|NCT01322815|3791535|FG000|STARTED|Overall Study||7
3070683|NCT01322815|3791536|FG001|STARTED|Overall Study||4
3070684|NCT01322815|3791535|FG000|COMPLETED|Overall Study||7
3070685|NCT01322815|3791536|FG001|COMPLETED|Overall Study||4
3070686|NCT01322815|3791535|FG000|NOT COMPLETED|Overall Study||0
3070687|NCT01322815|3791536|FG001|NOT COMPLETED|Overall Study||0
3070688|NCT01322841|3791544|FG000|STARTED|Overall Study||1116
3070689|NCT01322841|3791545|FG001|STARTED|Overall Study||1123
3070690|NCT01322841|3791544|FG000|COMPLETED|Overall Study||1116
3070691|NCT01322841|3791545|FG001|COMPLETED|Overall Study||1123
3070692|NCT01322841|3791544|FG000|NOT COMPLETED|Overall Study||0
3070693|NCT01322841|3791545|FG001|NOT COMPLETED|Overall Study||0
3070694|NCT01322945|3791553|FG000|STARTED|Overall Study||52
3070695|NCT01322945|3791554|FG001|STARTED|Overall Study||42
3070696|NCT01322945|3791553|FG000|COMPLETED|Overall Study||52
3070697|NCT01322945|3791554|FG001|COMPLETED|Overall Study||42
3070698|NCT01322945|3791553|FG000|NOT COMPLETED|Overall Study||0
3070699|NCT01322945|3791554|FG001|NOT COMPLETED|Overall Study||0
3070700|NCT01323010|3791564|FG000|STARTED|Overall Study||60
3070701|NCT01323010|3791565|FG001|STARTED|Overall Study||59
3070702|NCT01323010|3791564|FG000|COMPLETED|Overall Study||60
3070703|NCT01323010|3791565|FG001|COMPLETED|Overall Study||59
3070704|NCT01323010|3791564|FG000|NOT COMPLETED|Overall Study||0
3070705|NCT01323010|3791565|FG001|NOT COMPLETED|Overall Study||0
3070706|NCT01323140|3791583|FG000|STARTED|Overall Study||40
3070707|NCT01323140|3791583|FG000|COMPLETED|Overall Study||38
3070708|NCT01323140|3791583|FG000|NOT COMPLETED|Overall Study||2
3070709|NCT01323153|3791589|FG000|STARTED|Overall Study||150
3070710|NCT01323153|3791590|FG001|STARTED|Overall Study||150
3070711|NCT01323153|3791589|FG000|COMPLETED|Overall Study||133
3070712|NCT01323153|3791590|FG001|COMPLETED|Overall Study||142
3070713|NCT01323153|3791589|FG000|NOT COMPLETED|Overall Study||17
3070714|NCT01323153|3791590|FG001|NOT COMPLETED|Overall Study||8
3070715|NCT01323192|3791598|FG000|STARTED|Overall Study||143
3070716|NCT01323192|3791599|FG001|STARTED|Overall Study||141
3070717|NCT01323192|3791598|FG000|COMPLETED|Overall Study||134
3070718|NCT01323192|3791599|FG001|COMPLETED|Overall Study||135
3070719|NCT01323192|3791598|FG000|NOT COMPLETED|Overall Study||9
3070720|NCT01323192|3791599|FG001|NOT COMPLETED|Overall Study||6
3070721|NCT01323270|3791607|FG000|STARTED|Overall Study||373
3070722|NCT01323270|3791608|FG001|STARTED|Overall Study||376
3070723|NCT01323270|3791607|FG000|COMPLETED|Overall Study||330
3070724|NCT01323270|3791608|FG001|COMPLETED|Overall Study||347
3070725|NCT01323270|3791607|FG000|NOT COMPLETED|Overall Study||43
3070726|NCT01323270|3791608|FG001|NOT COMPLETED|Overall Study||29
3070727|NCT01323387|3791615|FG000|STARTED|Overall Study||178
3070728|NCT01323387|3791615|FG000|COMPLETED|Overall Study||94
3070729|NCT01323387|3791615|FG000|NOT COMPLETED|Overall Study||84
3070730|NCT01323478|3791621|FG000|STARTED|Overall Study||71
3070731|NCT01323478|3791621|FG000|COMPLETED|Overall Study||47
3070732|NCT01323478|3791621|FG000|NOT COMPLETED|Overall Study||24
3070733|NCT01323517|3791625|FG000|STARTED|Overall Study||26
3070734|NCT01323517|3791625|FG000|COMPLETED|Overall Study||26
3070735|NCT01323517|3791625|FG000|NOT COMPLETED|Overall Study||0
3070736|NCT01323530|3791636|FG000|STARTED|Phase 1b (Dose Escalation Phase)||8
3070737|NCT01323530|3791637|FG001|STARTED|Phase 1b (Dose Escalation Phase)||6
3070738|NCT01323530|3791638|FG002|STARTED|Phase 1b (Dose Escalation Phase)||5
3070739|NCT01323530|3791639|FG003|STARTED|Phase 1b (Dose Escalation Phase)||3
3070740|NCT01323530|3791640|FG004|STARTED|Phase 1b (Dose Escalation Phase)||6
3070741|NCT01323530|3791641|FG005|STARTED|Phase 1b (Dose Escalation Phase)||6
3070742|NCT01323530|3791642|FG006|STARTED|Phase 1b (Dose Escalation Phase)||0
3070743|NCT01323530|3791636|FG000|COMPLETED|Phase 1b (Dose Escalation Phase)||5
3070744|NCT01323530|3791637|FG001|COMPLETED|Phase 1b (Dose Escalation Phase)||4
3070745|NCT01323530|3791638|FG002|COMPLETED|Phase 1b (Dose Escalation Phase)||4
3070746|NCT01323530|3791639|FG003|COMPLETED|Phase 1b (Dose Escalation Phase)||3
3070747|NCT01323530|3791640|FG004|COMPLETED|Phase 1b (Dose Escalation Phase)||3
3070748|NCT01323530|3791641|FG005|COMPLETED|Phase 1b (Dose Escalation Phase)||3
3070749|NCT01323530|3791642|FG006|COMPLETED|Phase 1b (Dose Escalation Phase)||0
3070750|NCT01323530|3791636|FG000|NOT COMPLETED|Phase 1b (Dose Escalation Phase)||3
3070751|NCT01323530|3791637|FG001|NOT COMPLETED|Phase 1b (Dose Escalation Phase)||2
3070752|NCT01323530|3791638|FG002|NOT COMPLETED|Phase 1b (Dose Escalation Phase)||1
3070753|NCT01323530|3791639|FG003|NOT COMPLETED|Phase 1b (Dose Escalation Phase)||0
3070754|NCT01323530|3791640|FG004|NOT COMPLETED|Phase 1b (Dose Escalation Phase)||3
3070755|NCT01323530|3791641|FG005|NOT COMPLETED|Phase 1b (Dose Escalation Phase)||3
3070756|NCT01323530|3791642|FG006|NOT COMPLETED|Phase 1b (Dose Escalation Phase)||0
3070757|NCT01323530|3791636|FG000|STARTED|Phase 2 (Dose-confirmation Phase)||0
3070758|NCT01323530|3791637|FG001|STARTED|Phase 2 (Dose-confirmation Phase)||0
3070759|NCT01323530|3791638|FG002|STARTED|Phase 2 (Dose-confirmation Phase)||0
3070760|NCT01323530|3791639|FG003|STARTED|Phase 2 (Dose-confirmation Phase)||0
3070761|NCT01323530|3791640|FG004|STARTED|Phase 2 (Dose-confirmation Phase)||0
3070762|NCT01323530|3791641|FG005|STARTED|Phase 2 (Dose-confirmation Phase)||0
3070763|NCT01323530|3791642|FG006|STARTED|Phase 2 (Dose-confirmation Phase)||42
3070764|NCT01323530|3791636|FG000|COMPLETED|Phase 2 (Dose-confirmation Phase)||0
3070765|NCT01323530|3791637|FG001|COMPLETED|Phase 2 (Dose-confirmation Phase)||0
3070766|NCT01323530|3791638|FG002|COMPLETED|Phase 2 (Dose-confirmation Phase)||0
3070767|NCT01323530|3791639|FG003|COMPLETED|Phase 2 (Dose-confirmation Phase)||0
3070768|NCT01323530|3791640|FG004|COMPLETED|Phase 2 (Dose-confirmation Phase)||0
3070769|NCT01323530|3791641|FG005|COMPLETED|Phase 2 (Dose-confirmation Phase)||0
3070770|NCT01323530|3791642|FG006|COMPLETED|Phase 2 (Dose-confirmation Phase)||25
3070771|NCT01323530|3791636|FG000|NOT COMPLETED|Phase 2 (Dose-confirmation Phase)||0
3070772|NCT01323530|3791637|FG001|NOT COMPLETED|Phase 2 (Dose-confirmation Phase)||0
3070773|NCT01323530|3791638|FG002|NOT COMPLETED|Phase 2 (Dose-confirmation Phase)||0
3070774|NCT01323530|3791639|FG003|NOT COMPLETED|Phase 2 (Dose-confirmation Phase)||0
3070775|NCT01323530|3791640|FG004|NOT COMPLETED|Phase 2 (Dose-confirmation Phase)||0
3070776|NCT01323530|3791641|FG005|NOT COMPLETED|Phase 2 (Dose-confirmation Phase)||0
3070777|NCT01323530|3791642|FG006|NOT COMPLETED|Phase 2 (Dose-confirmation Phase)||17
3070778|NCT01323582|3791661|FG000|STARTED|Weeks 1-4 (First Period)||12
3070779|NCT01323582|3791662|FG001|STARTED|Weeks 1-4 (First Period)||14
3070780|NCT01323582|3791661|FG000|COMPLETED|Weeks 1-4 (First Period)||10
3070781|NCT01323582|3791662|FG001|COMPLETED|Weeks 1-4 (First Period)||12
3070782|NCT01323582|3791661|FG000|NOT COMPLETED|Weeks 1-4 (First Period)||2
3070783|NCT01323582|3791662|FG001|NOT COMPLETED|Weeks 1-4 (First Period)||2
3070784|NCT01323582|3791661|FG000|STARTED|Weeks 5-7 (Washout)||10
3070785|NCT01323582|3791662|FG001|STARTED|Weeks 5-7 (Washout)||12
3070786|NCT01323582|3791661|FG000|COMPLETED|Weeks 5-7 (Washout)||10
3070787|NCT01323582|3791662|FG001|COMPLETED|Weeks 5-7 (Washout)||11
3070788|NCT01323582|3791661|FG000|NOT COMPLETED|Weeks 5-7 (Washout)||0
3070789|NCT01323582|3791662|FG001|NOT COMPLETED|Weeks 5-7 (Washout)||1
3070790|NCT01323582|3791661|FG000|STARTED|Weeks 8-11 (Period 2)||10
3070791|NCT01323582|3791662|FG001|STARTED|Weeks 8-11 (Period 2)||11
3070792|NCT01323582|3791661|FG000|COMPLETED|Weeks 8-11 (Period 2)||10
3070793|NCT01323582|3791662|FG001|COMPLETED|Weeks 8-11 (Period 2)||10
3070794|NCT01323582|3791661|FG000|NOT COMPLETED|Weeks 8-11 (Period 2)||0
3070795|NCT01323582|3791662|FG001|NOT COMPLETED|Weeks 8-11 (Period 2)||1
3070796|NCT01323595|3791672|FG000|STARTED|Overall Study||39
3070797|NCT01323595|3791673|FG001|STARTED|Overall Study||39
3070798|NCT01323595|3791672|FG000|COMPLETED|Overall Study|Remaining subjects did not return questionnaire|16
3070799|NCT01323595|3791673|FG001|COMPLETED|Overall Study|Remaining subjects did not return questionaire|18
3070800|NCT01323595|3791672|FG000|NOT COMPLETED|Overall Study||23
3070801|NCT01323595|3791673|FG001|NOT COMPLETED|Overall Study||21
3070802|NCT01323621|3791683|FG000|STARTED|2-week, Single-blind Run In Period||739
3070803|NCT01323621|3791684|FG001|STARTED|2-week, Single-blind Run In Period||0
3070804|NCT01323621|3791685|FG002|STARTED|2-week, Single-blind Run In Period||0
3070805|NCT01323621|3791683|FG000|COMPLETED|2-week, Single-blind Run In Period||511
3070806|NCT01323621|3791684|FG001|COMPLETED|2-week, Single-blind Run In Period||0
3070807|NCT01323621|3791685|FG002|COMPLETED|2-week, Single-blind Run In Period||0
3070808|NCT01323621|3791683|FG000|NOT COMPLETED|2-week, Single-blind Run In Period||228
3070809|NCT01323621|3791684|FG001|NOT COMPLETED|2-week, Single-blind Run In Period||0
3070810|NCT01323621|3791685|FG002|NOT COMPLETED|2-week, Single-blind Run In Period||0
3070811|NCT01323621|3791683|FG000|STARTED|12-week, Double-blind Treatment Period||0
3070812|NCT01323621|3791684|FG001|STARTED|12-week, Double-blind Treatment Period||252
3070813|NCT01323621|3791685|FG002|STARTED|12-week, Double-blind Treatment Period||259
3070814|NCT01323621|3791683|FG000|COMPLETED|12-week, Double-blind Treatment Period||0
3070815|NCT01323621|3791684|FG001|COMPLETED|12-week, Double-blind Treatment Period||237
3070816|NCT01323621|3791685|FG002|COMPLETED|12-week, Double-blind Treatment Period||239
3070817|NCT01323621|3791683|FG000|NOT COMPLETED|12-week, Double-blind Treatment Period||0
3070818|NCT01323621|3791684|FG001|NOT COMPLETED|12-week, Double-blind Treatment Period||15
3070819|NCT01323621|3791685|FG002|NOT COMPLETED|12-week, Double-blind Treatment Period||20
3070820|NCT01323634|3791693|FG000|STARTED|2-week Run-in Period||733
3070821|NCT01323634|3791694|FG001|STARTED|2-week Run-in Period||0
3070822|NCT01323634|3791695|FG002|STARTED|2-week Run-in Period||0
3070823|NCT01323634|3791693|FG000|COMPLETED|2-week Run-in Period||521
3070824|NCT01323634|3791694|FG001|COMPLETED|2-week Run-in Period||0
3070825|NCT01323634|3791695|FG002|COMPLETED|2-week Run-in Period||0
3070826|NCT01323634|3791693|FG000|NOT COMPLETED|2-week Run-in Period||212
3070827|NCT01323634|3791694|FG001|NOT COMPLETED|2-week Run-in Period||0
3070828|NCT01323634|3791695|FG002|NOT COMPLETED|2-week Run-in Period||0
3070829|NCT01323634|3791693|FG000|STARTED|Double-Blind (DB) Treatment Period||0
3070830|NCT01323634|3791694|FG001|STARTED|Double-Blind (DB) Treatment Period||260
3070831|NCT01323634|3791695|FG002|STARTED|Double-Blind (DB) Treatment Period||261
3070832|NCT01323634|3791693|FG000|COMPLETED|Double-Blind (DB) Treatment Period||0
3070833|NCT01323634|3791694|FG001|COMPLETED|Double-Blind (DB) Treatment Period||235
3070834|NCT01323634|3791695|FG002|COMPLETED|Double-Blind (DB) Treatment Period||239
3070835|NCT01323634|3791693|FG000|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
3070836|NCT01323634|3791694|FG001|NOT COMPLETED|Double-Blind (DB) Treatment Period||25
3070837|NCT01323634|3791695|FG002|NOT COMPLETED|Double-Blind (DB) Treatment Period||22
3070838|NCT01323647|3791703|FG000|STARTED|Overall Study||470
3070839|NCT01323647|3791704|FG001|STARTED|Overall Study||487
3070840|NCT01323647|3791703|FG000|COMPLETED|Overall Study||461
3070841|NCT01323647|3791704|FG001|COMPLETED|Overall Study||487
3070842|NCT01323647|3791703|FG000|NOT COMPLETED|Overall Study||9
3070843|NCT01323647|3791704|FG001|NOT COMPLETED|Overall Study||0
3070844|NCT01323660|3791710|FG000|STARTED|Treatment Period 1 (12 Weeks)||84
3070845|NCT01323660|3791711|FG001|STARTED|Treatment Period 1 (12 Weeks)||22
3070846|NCT01323660|3791712|FG002|STARTED|Treatment Period 1 (12 Weeks)||24
3070847|NCT01323660|3791713|FG003|STARTED|Treatment Period 1 (12 Weeks)||36
3070848|NCT01323660|3791714|FG004|STARTED|Treatment Period 1 (12 Weeks)||71
3070849|NCT01323660|3791715|FG005|STARTED|Treatment Period 1 (12 Weeks)||70
3070850|NCT01323660|3791710|FG000|COMPLETED|Treatment Period 1 (12 Weeks)||65
3070851|NCT01323660|3791711|FG001|COMPLETED|Treatment Period 1 (12 Weeks)||21
3070852|NCT01323660|3791712|FG002|COMPLETED|Treatment Period 1 (12 Weeks)||19
3070853|NCT01323660|3791713|FG003|COMPLETED|Treatment Period 1 (12 Weeks)||31
3070854|NCT01323660|3791714|FG004|COMPLETED|Treatment Period 1 (12 Weeks)||61
3070855|NCT01323660|3791715|FG005|COMPLETED|Treatment Period 1 (12 Weeks)||61
3070856|NCT01323660|3791710|FG000|NOT COMPLETED|Treatment Period 1 (12 Weeks)||19
3070857|NCT01323660|3791711|FG001|NOT COMPLETED|Treatment Period 1 (12 Weeks)||1
3070858|NCT01323660|3791712|FG002|NOT COMPLETED|Treatment Period 1 (12 Weeks)||5
3070859|NCT01323660|3791713|FG003|NOT COMPLETED|Treatment Period 1 (12 Weeks)||5
3070860|NCT01323660|3791714|FG004|NOT COMPLETED|Treatment Period 1 (12 Weeks)||10
3070861|NCT01323660|3791715|FG005|NOT COMPLETED|Treatment Period 1 (12 Weeks)||9
3070862|NCT01323660|3791710|FG000|STARTED|Washout Period (14 Days)||65
3070863|NCT01323660|3791711|FG001|STARTED|Washout Period (14 Days)||21
3070864|NCT01323660|3791712|FG002|STARTED|Washout Period (14 Days)||19
3070865|NCT01323660|3791713|FG003|STARTED|Washout Period (14 Days)||31
3070866|NCT01323660|3791714|FG004|STARTED|Washout Period (14 Days)||61
3070867|NCT01323660|3791715|FG005|STARTED|Washout Period (14 Days)||61
3070868|NCT01323660|3791710|FG000|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|65
3070869|NCT01323660|3791711|FG001|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|21
3070870|NCT01323660|3791712|FG002|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|18
3070871|NCT01323660|3791713|FG003|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|28
3070872|NCT01323660|3791714|FG004|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|58
3070873|NCT01323660|3791715|FG005|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|59
3070874|NCT01323660|3791710|FG000|NOT COMPLETED|Washout Period (14 Days)||0
3070875|NCT01323660|3791711|FG001|NOT COMPLETED|Washout Period (14 Days)||0
3070876|NCT01323660|3791712|FG002|NOT COMPLETED|Washout Period (14 Days)||1
3070877|NCT01323660|3791713|FG003|NOT COMPLETED|Washout Period (14 Days)||3
3070878|NCT01323660|3791714|FG004|NOT COMPLETED|Washout Period (14 Days)||3
3070879|NCT01323660|3791715|FG005|NOT COMPLETED|Washout Period (14 Days)||2
3070880|NCT01323660|3791710|FG000|STARTED|Treatment Period 2 (12 Weeks)|"By crossover design, participants were assigned to a different treatment arm in each period."|67
3070881|NCT01323660|3791711|FG001|STARTED|Treatment Period 2 (12 Weeks)|"By crossover design, participants were assigned to a different treatment arm in each period."|18
3070882|NCT01323660|3791712|FG002|STARTED|Treatment Period 2 (12 Weeks)|"By crossover design, participants were assigned to a different treatment arm in each period."|17
3070883|NCT01323660|3791713|FG003|STARTED|Treatment Period 2 (12 Weeks)|"By crossover design, participants were assigned to a different treatment arm in each period."|28
3070884|NCT01323660|3791714|FG004|STARTED|Treatment Period 2 (12 Weeks)|"By crossover design, participants were assigned to a different treatment arm in each period."|59
3070885|NCT01323660|3791715|FG005|STARTED|Treatment Period 2 (12 Weeks)|"By crossover design, participants were assigned to a different treatment arm in each period."|58
3070886|NCT01323660|3791710|FG000|COMPLETED|Treatment Period 2 (12 Weeks)||55
3070887|NCT01323660|3791711|FG001|COMPLETED|Treatment Period 2 (12 Weeks)||17
3070888|NCT01323660|3791712|FG002|COMPLETED|Treatment Period 2 (12 Weeks)||14
3070889|NCT01323660|3791713|FG003|COMPLETED|Treatment Period 2 (12 Weeks)||25
3070890|NCT01323660|3791714|FG004|COMPLETED|Treatment Period 2 (12 Weeks)||55
3070891|NCT01323660|3791715|FG005|COMPLETED|Treatment Period 2 (12 Weeks)||51
3070892|NCT01323660|3791710|FG000|NOT COMPLETED|Treatment Period 2 (12 Weeks)||12
3070893|NCT01323660|3791711|FG001|NOT COMPLETED|Treatment Period 2 (12 Weeks)||1
3070894|NCT01323660|3791712|FG002|NOT COMPLETED|Treatment Period 2 (12 Weeks)||3
3070895|NCT01323660|3791713|FG003|NOT COMPLETED|Treatment Period 2 (12 Weeks)||3
3070896|NCT01323660|3791714|FG004|NOT COMPLETED|Treatment Period 2 (12 Weeks)||4
3070897|NCT01323660|3791715|FG005|NOT COMPLETED|Treatment Period 2 (12 Weeks)||7
3070898|NCT01323673|3791731|FG000|STARTED|Overall Study||62
3070899|NCT01323673|3791732|FG001|STARTED|Overall Study||63
3070900|NCT01323673|3791731|FG000|COMPLETED|Overall Study||59
3070901|NCT01323673|3791732|FG001|COMPLETED|Overall Study||58
3070902|NCT01323673|3791731|FG000|NOT COMPLETED|Overall Study||3
3070903|NCT01323673|3791732|FG001|NOT COMPLETED|Overall Study||5
3070904|NCT01323777|3791738|FG000|STARTED|Overall Study||65
3070905|NCT01323777|3791738|FG000|COMPLETED|Overall Study||65
3070906|NCT01323777|3791738|FG000|NOT COMPLETED|Overall Study||0
3070907|NCT01323790|3791752|FG000|STARTED|Overall Study||233
3070908|NCT01323790|3791753|FG001|STARTED|Overall Study||234
3070909|NCT01323790|3791754|FG002|STARTED|Overall Study||233
3070910|NCT01323790|3791752|FG000|COMPLETED|Overall Study||178
3070911|NCT01323790|3791753|FG001|COMPLETED|Overall Study||174
3070912|NCT01323790|3791754|FG002|COMPLETED|Overall Study||188
3070913|NCT01323790|3791752|FG000|NOT COMPLETED|Overall Study||55
3070914|NCT01323790|3791753|FG001|NOT COMPLETED|Overall Study||60
3070915|NCT01323790|3791754|FG002|NOT COMPLETED|Overall Study||45
3070916|NCT01323855|3791767|FG000|STARTED|Overall Study||9
3070917|NCT01323855|3791768|FG001|STARTED|Overall Study||9
3070918|NCT01323855|3791769|FG002|STARTED|Overall Study||8
3070919|NCT01323855|3791770|FG003|STARTED|Overall Study||9
3070920|NCT01323855|3791771|FG004|STARTED|Overall Study||11
3070921|NCT01323855|3791767|FG000|COMPLETED|Overall Study||9
3070922|NCT01323855|3791768|FG001|COMPLETED|Overall Study||9
3070923|NCT01323855|3791769|FG002|COMPLETED|Overall Study||8
3070924|NCT01323855|3791770|FG003|COMPLETED|Overall Study||9
3070925|NCT01323855|3791771|FG004|COMPLETED|Overall Study||11
3070926|NCT01323855|3791767|FG000|NOT COMPLETED|Overall Study||0
3070927|NCT01323855|3791768|FG001|NOT COMPLETED|Overall Study||0
3070928|NCT01323855|3791769|FG002|NOT COMPLETED|Overall Study||0
3070929|NCT01323855|3791770|FG003|NOT COMPLETED|Overall Study||0
3070930|NCT01323855|3791771|FG004|NOT COMPLETED|Overall Study||0
3070931|NCT01323920|3791783|FG000|STARTED|Overall Study||35
3070932|NCT01323920|3791783|FG000|COMPLETED|Overall Study||29
3070933|NCT01323920|3791783|FG000|NOT COMPLETED|Overall Study||6
3070934|NCT01323946|3791790|FG000|STARTED|Overall Study||46
3070935|NCT01323946|3791791|FG001|STARTED|Overall Study||34
3070936|NCT01323946|3791792|FG002|STARTED|Overall Study||33
3070937|NCT01323946|3791790|FG000|COMPLETED|Overall Study||43
3070938|NCT01323946|3791791|FG001|COMPLETED|Overall Study||31
3070939|NCT01323946|3791792|FG002|COMPLETED|Overall Study||33
3070940|NCT01323946|3791790|FG000|NOT COMPLETED|Overall Study||3
3070941|NCT01323946|3791791|FG001|NOT COMPLETED|Overall Study||3
3070942|NCT01323946|3791792|FG002|NOT COMPLETED|Overall Study||0
3070943|NCT01323959|3791805|FG000|STARTED|Overall Study||67
3070944|NCT01323959|3791806|FG001|STARTED|Overall Study||72
3070945|NCT01323959|3791807|FG002|STARTED|Overall Study||72
3070946|NCT01323959|3791805|FG000|COMPLETED|Overall Study||67
3070947|NCT01323959|3791806|FG001|COMPLETED|Overall Study||72
3070948|NCT01323959|3791807|FG002|COMPLETED|Overall Study||72
3070949|NCT01323959|3791805|FG000|NOT COMPLETED|Overall Study||0
3070950|NCT01323959|3791806|FG001|NOT COMPLETED|Overall Study||0
3070951|NCT01323959|3791807|FG002|NOT COMPLETED|Overall Study||0
3070952|NCT01323972|3791819|FG000|STARTED|Overall Study||81
3070953|NCT01323972|3791820|FG001|STARTED|Overall Study||79
3070954|NCT01323972|3791821|FG002|STARTED|Overall Study||80
3070955|NCT01323972|3791822|FG003|STARTED|Overall Study||80
3070956|NCT01323972|3791819|FG000|COMPLETED|Overall Study||79
3070957|NCT01323972|3791820|FG001|COMPLETED|Overall Study||76
3070958|NCT01323972|3791821|FG002|COMPLETED|Overall Study||78
3070959|NCT01323972|3791822|FG003|COMPLETED|Overall Study||79
3070960|NCT01323972|3791819|FG000|NOT COMPLETED|Overall Study||2
3070961|NCT01323972|3791820|FG001|NOT COMPLETED|Overall Study||3
3070962|NCT01323972|3791821|FG002|NOT COMPLETED|Overall Study||2
3070963|NCT01323972|3791822|FG003|NOT COMPLETED|Overall Study||1
3070964|NCT01323998|3791839|FG000|STARTED|Overall Study||200631
3070965|NCT01323998|3791840|FG001|STARTED|Overall Study||18681
3070966|NCT01323998|3791841|FG002|STARTED|Overall Study||10294
3070967|NCT01323998|3791842|FG003|STARTED|Overall Study||12052
3070968|NCT01323998|3791843|FG004|STARTED|Overall Study||6735
3070969|NCT01323998|3791839|FG000|COMPLETED|Overall Study||200631
3070970|NCT01323998|3791840|FG001|COMPLETED|Overall Study||18681
3070971|NCT01323998|3791841|FG002|COMPLETED|Overall Study||10294
3070972|NCT01323998|3791842|FG003|COMPLETED|Overall Study||12052
3070973|NCT01323998|3791843|FG004|COMPLETED|Overall Study||6735
3070974|NCT01323998|3791839|FG000|NOT COMPLETED|Overall Study||0
3070975|NCT01323998|3791840|FG001|NOT COMPLETED|Overall Study||0
3070976|NCT01323998|3791841|FG002|NOT COMPLETED|Overall Study||0
3070977|NCT01323998|3791842|FG003|NOT COMPLETED|Overall Study||0
3070978|NCT01323998|3791843|FG004|NOT COMPLETED|Overall Study||0
3070979|NCT01324024|3791855|FG000|STARTED|First Intervention (4 Weeks)||18
3070980|NCT01324024|3791856|FG001|STARTED|First Intervention (4 Weeks)||17
3070981|NCT01324024|3791855|FG000|COMPLETED|First Intervention (4 Weeks)||18
3070982|NCT01324024|3791856|FG001|COMPLETED|First Intervention (4 Weeks)||17
3070983|NCT01324024|3791855|FG000|NOT COMPLETED|First Intervention (4 Weeks)||0
3070984|NCT01324024|3791856|FG001|NOT COMPLETED|First Intervention (4 Weeks)||0
3070985|NCT01324024|3791855|FG000|STARTED|Washout (2 Weeks)||18
3070986|NCT01324024|3791856|FG001|STARTED|Washout (2 Weeks)||17
3070987|NCT01324024|3791855|FG000|COMPLETED|Washout (2 Weeks)||18
3070988|NCT01324024|3791856|FG001|COMPLETED|Washout (2 Weeks)||17
3070989|NCT01324024|3791855|FG000|NOT COMPLETED|Washout (2 Weeks)||0
3070990|NCT01324024|3791856|FG001|NOT COMPLETED|Washout (2 Weeks)||0
3070991|NCT01324024|3791855|FG000|STARTED|Second Intervention (4 Weeks)||18
3070992|NCT01324024|3791856|FG001|STARTED|Second Intervention (4 Weeks)||17
3070993|NCT01324024|3791855|FG000|COMPLETED|Second Intervention (4 Weeks)||16
3070994|NCT01324024|3791856|FG001|COMPLETED|Second Intervention (4 Weeks)||16
3070995|NCT01324024|3791855|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||2
3070996|NCT01324024|3791856|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||1
3070997|NCT01324102|3791868|FG000|STARTED|Overall Study|Yoga groups 3 and 5 (not including pre-randomization group)|11
3070998|NCT01324102|3791869|FG001|STARTED|Overall Study|Yoga group 4 and 6|12
3070999|NCT01324102|3791868|FG000|COMPLETED|Overall Study||10
3071000|NCT01324102|3791869|FG001|COMPLETED|Overall Study||6
3071001|NCT01324102|3791868|FG000|NOT COMPLETED|Overall Study||1
3071002|NCT01324102|3791869|FG001|NOT COMPLETED|Overall Study||6
3071003|NCT01324128|3791878|FG000|STARTED|Stage 1||710
3071004|NCT01324128|3791879|FG001|STARTED|Stage 1||349
3071005|NCT01324128|3791880|FG002|STARTED|Stage 1||0
3071006|NCT01324128|3791881|FG003|STARTED|Stage 1||0
3071007|NCT01324128|3791878|FG000|COMPLETED|Stage 1||515
3071008|NCT01324128|3791879|FG001|COMPLETED|Stage 1||293
3071009|NCT01324128|3791880|FG002|COMPLETED|Stage 1||0
3071010|NCT01324128|3791881|FG003|COMPLETED|Stage 1||0
3071011|NCT01324128|3791878|FG000|NOT COMPLETED|Stage 1||195
3071012|NCT01324128|3791879|FG001|NOT COMPLETED|Stage 1||56
3071013|NCT01324128|3791880|FG002|NOT COMPLETED|Stage 1||0
3071014|NCT01324128|3791881|FG003|NOT COMPLETED|Stage 1||0
3071015|NCT01324128|3791878|FG000|STARTED|Stage 2||0
3071016|NCT01324128|3791879|FG001|STARTED|Stage 2||0
3071017|NCT01324128|3791880|FG002|STARTED|Stage 2||50
3071018|NCT01324128|3791881|FG003|STARTED|Stage 2||49
3071019|NCT01324128|3791878|FG000|COMPLETED|Stage 2||0
3071020|NCT01324128|3791879|FG001|COMPLETED|Stage 2||0
3071021|NCT01324128|3791880|FG002|COMPLETED|Stage 2||42
3071022|NCT01324128|3791881|FG003|COMPLETED|Stage 2||46
3071023|NCT01324128|3791878|FG000|NOT COMPLETED|Stage 2||0
3071024|NCT01324128|3791879|FG001|NOT COMPLETED|Stage 2||0
3071025|NCT01324128|3791880|FG002|NOT COMPLETED|Stage 2||8
3071026|NCT01324128|3791881|FG003|NOT COMPLETED|Stage 2||3
3071027|NCT01324141|3791891|FG000|STARTED|Overall Study||6
3071028|NCT01324141|3791891|FG000|COMPLETED|Overall Study||4
3071029|NCT01324141|3791891|FG000|NOT COMPLETED|Overall Study||2
3071030|NCT01324232|3791909|FG000|STARTED|Overall Study||49
3071031|NCT01324232|3791910|FG001|STARTED|Overall Study||53
3071032|NCT01324232|3791911|FG002|STARTED|Overall Study||54
3071033|NCT01324232|3791912|FG003|STARTED|Overall Study||53
3071034|NCT01324232|3791909|FG000|COMPLETED|Overall Study||44
3071035|NCT01324232|3791910|FG001|COMPLETED|Overall Study||42
3071036|NCT01324232|3791911|FG002|COMPLETED|Overall Study||41
3071037|NCT01324232|3791912|FG003|COMPLETED|Overall Study||42
3071038|NCT01324232|3791909|FG000|NOT COMPLETED|Overall Study||5
3071039|NCT01324232|3791910|FG001|NOT COMPLETED|Overall Study||11
3071040|NCT01324232|3791911|FG002|NOT COMPLETED|Overall Study||13
3071041|NCT01324232|3791912|FG003|NOT COMPLETED|Overall Study||11
3071042|NCT01324271|3791927|FG000|STARTED|Overall Study||57
3071043|NCT01324271|3791928|FG001|STARTED|Overall Study||28
3071044|NCT01324271|3791927|FG000|COMPLETED|Overall Study||53
3071045|NCT01324271|3791928|FG001|COMPLETED|Overall Study||28
3071046|NCT01324271|3791927|FG000|NOT COMPLETED|Overall Study||4
3071047|NCT01324271|3791928|FG001|NOT COMPLETED|Overall Study||0
3071048|NCT01324310|3791934|FG000|STARTED|Overall Study||15
3071049|NCT01324310|3791934|FG000|COMPLETED|Overall Study||13
3071050|NCT01324310|3791934|FG000|NOT COMPLETED|Overall Study||2
3071051|NCT01324323|3791940|FG000|STARTED|Overall Study||14
3071052|NCT01324323|3791940|FG000|COMPLETED|Overall Study||13
3071053|NCT01324323|3791940|FG000|NOT COMPLETED|Overall Study||1
3071054|NCT01324349|3791954|FG000|STARTED|Overall Study||32
3071055|NCT01324349|3791955|FG001|STARTED|Overall Study||18
3071056|NCT01324349|3791954|FG000|COMPLETED|Overall Study||31
3071057|NCT01324349|3791955|FG001|COMPLETED|Overall Study||16
3071058|NCT01324349|3791954|FG000|NOT COMPLETED|Overall Study||1
3071059|NCT01324349|3791955|FG001|NOT COMPLETED|Overall Study||2
3071060|NCT01324388|3791964|FG000|STARTED|Part 1 of Study||23
3071061|NCT01324388|3791965|FG001|STARTED|Part 1 of Study||8
3071062|NCT01324388|3791966|FG002|STARTED|Part 1 of Study||0
3071063|NCT01324388|3791967|FG003|STARTED|Part 1 of Study||0
3071064|NCT01324388|3791964|FG000|Received at Least 1 Dose|Part 1 of Study||23
3071065|NCT01324388|3791965|FG001|Received at Least 1 Dose|Part 1 of Study||8
3071066|NCT01324388|3791966|FG002|Received at Least 1 Dose|Part 1 of Study||0
3071067|NCT01324388|3791967|FG003|Received at Least 1 Dose|Part 1 of Study||0
3071068|NCT01324388|3791964|FG000|COMPLETED|Part 1 of Study||19
3071069|NCT01324388|3791965|FG001|COMPLETED|Part 1 of Study||6
3071070|NCT01324388|3791966|FG002|COMPLETED|Part 1 of Study||0
3071071|NCT01324388|3791967|FG003|COMPLETED|Part 1 of Study||0
3071072|NCT01324388|3791964|FG000|NOT COMPLETED|Part 1 of Study||4
3071073|NCT01324388|3791965|FG001|NOT COMPLETED|Part 1 of Study||2
3284322|NCT02763826|4018169|FG007|STARTED|Part 1 Dose Escalation, 1 mA||0
3284323|NCT02763826|4018162|FG000|COMPLETED|Part 1 Dose Escalation, 1 mA||3
3071074|NCT01324388|3791966|FG002|NOT COMPLETED|Part 1 of Study||0
3071075|NCT01324388|3791967|FG003|NOT COMPLETED|Part 1 of Study||0
3071076|NCT01324388|3791964|FG000|STARTED|Part 2 of Study: First Intervention||0
3071077|NCT01324388|3791965|FG001|STARTED|Part 2 of Study: First Intervention||0
3071078|NCT01324388|3791966|FG002|STARTED|Part 2 of Study: First Intervention||10
3071079|NCT01324388|3791967|FG003|STARTED|Part 2 of Study: First Intervention||10
3071080|NCT01324388|3791964|FG000|COMPLETED|Part 2 of Study: First Intervention||0
3071081|NCT01324388|3791965|FG001|COMPLETED|Part 2 of Study: First Intervention||0
3071082|NCT01324388|3791966|FG002|COMPLETED|Part 2 of Study: First Intervention||10
3071083|NCT01324388|3791967|FG003|COMPLETED|Part 2 of Study: First Intervention||9
3071084|NCT01324388|3791964|FG000|NOT COMPLETED|Part 2 of Study: First Intervention||0
3071085|NCT01324388|3791965|FG001|NOT COMPLETED|Part 2 of Study: First Intervention||0
3071086|NCT01324388|3791966|FG002|NOT COMPLETED|Part 2 of Study: First Intervention||0
3071087|NCT01324388|3791967|FG003|NOT COMPLETED|Part 2 of Study: First Intervention||1
3071088|NCT01324388|3791964|FG000|STARTED|Part 2: Washout of at Least 21 Days||0
3071089|NCT01324388|3791965|FG001|STARTED|Part 2: Washout of at Least 21 Days||0
3071090|NCT01324388|3791966|FG002|STARTED|Part 2: Washout of at Least 21 Days||10
3071091|NCT01324388|3791967|FG003|STARTED|Part 2: Washout of at Least 21 Days||9
3071092|NCT01324388|3791964|FG000|COMPLETED|Part 2: Washout of at Least 21 Days||0
3284324|NCT02763826|4018163|FG001|COMPLETED|Part 1 Dose Escalation, 1 mA||0
3284325|NCT02763826|4018164|FG002|COMPLETED|Part 1 Dose Escalation, 1 mA||0
3071093|NCT01324388|3791965|FG001|COMPLETED|Part 2: Washout of at Least 21 Days||0
3071094|NCT01324388|3791966|FG002|COMPLETED|Part 2: Washout of at Least 21 Days||10
3071095|NCT01324388|3791967|FG003|COMPLETED|Part 2: Washout of at Least 21 Days||9
3071096|NCT01324388|3791964|FG000|NOT COMPLETED|Part 2: Washout of at Least 21 Days||0
3071097|NCT01324388|3791965|FG001|NOT COMPLETED|Part 2: Washout of at Least 21 Days||0
3071098|NCT01324388|3791966|FG002|NOT COMPLETED|Part 2: Washout of at Least 21 Days||0
3071099|NCT01324388|3791967|FG003|NOT COMPLETED|Part 2: Washout of at Least 21 Days||0
3071100|NCT01324388|3791964|FG000|STARTED|Part 2 of Study: Second Intervention||0
3071101|NCT01324388|3791965|FG001|STARTED|Part 2 of Study: Second Intervention||0
3071102|NCT01324388|3791966|FG002|STARTED|Part 2 of Study: Second Intervention||10
3071103|NCT01324388|3791967|FG003|STARTED|Part 2 of Study: Second Intervention||9
3071104|NCT01324388|3791964|FG000|COMPLETED|Part 2 of Study: Second Intervention||0
3071105|NCT01324388|3791965|FG001|COMPLETED|Part 2 of Study: Second Intervention||0
3071106|NCT01324388|3791966|FG002|COMPLETED|Part 2 of Study: Second Intervention||9
3071107|NCT01324388|3791967|FG003|COMPLETED|Part 2 of Study: Second Intervention||9
3071108|NCT01324388|3791964|FG000|NOT COMPLETED|Part 2 of Study: Second Intervention||0
3071109|NCT01324388|3791965|FG001|NOT COMPLETED|Part 2 of Study: Second Intervention||0
3071110|NCT01324388|3791966|FG002|NOT COMPLETED|Part 2 of Study: Second Intervention||1
3071111|NCT01324388|3791967|FG003|NOT COMPLETED|Part 2 of Study: Second Intervention||0
3071112|NCT01324401|3791981|FG000|STARTED|Overall Study||4
3071113|NCT01324401|3791982|FG001|STARTED|Overall Study|3 excluded from ITT analysis: 1 screen fail, 2 voluntary withdrawal pre-treatment|26
3071114|NCT01324401|3791981|FG000|COMPLETED|Overall Study|one (1) could not tolerate minimum starting dose|3
3071115|NCT01324401|3791982|FG001|COMPLETED|Overall Study|three (3) unable to complete due to adverse events|20
3071116|NCT01324401|3791981|FG000|NOT COMPLETED|Overall Study||1
3071117|NCT01324401|3791982|FG001|NOT COMPLETED|Overall Study||6
3071118|NCT01324440|3791990|FG000|STARTED|Overall Study||32
3071119|NCT01324440|3791991|FG001|STARTED|Overall Study||32
3071120|NCT01324440|3791990|FG000|COMPLETED|Overall Study||32
3071121|NCT01324440|3791991|FG001|COMPLETED|Overall Study||31
3071122|NCT01324440|3791990|FG000|NOT COMPLETED|Overall Study||0
3071123|NCT01324440|3791991|FG001|NOT COMPLETED|Overall Study||1
3071124|NCT01324453|3791999|FG000|STARTED|Overall Study||54
3071125|NCT01324453|3792000|FG001|STARTED|Overall Study||49
3071126|NCT01324453|3791999|FG000|COMPLETED|Overall Study||54
3071127|NCT01324453|3792000|FG001|COMPLETED|Overall Study||49
3071128|NCT01324453|3791999|FG000|NOT COMPLETED|Overall Study||0
3071129|NCT01324453|3792000|FG001|NOT COMPLETED|Overall Study||0
3071130|NCT01324518|3792009|FG000|STARTED|Overall Study||33
3071131|NCT01324518|3792010|FG001|STARTED|Overall Study||33
3071132|NCT01324518|3792011|FG002|STARTED|Overall Study||34
3071133|NCT01324518|3792009|FG000|COMPLETED|Overall Study||28
3071134|NCT01324518|3792010|FG001|COMPLETED|Overall Study||30
3071135|NCT01324518|3792011|FG002|COMPLETED|Overall Study||33
3071136|NCT01324518|3792009|FG000|NOT COMPLETED|Overall Study||5
3071137|NCT01324518|3792010|FG001|NOT COMPLETED|Overall Study||3
3071138|NCT01324518|3792011|FG002|NOT COMPLETED|Overall Study||1
3071139|NCT01324570|3792021|FG000|STARTED|Overall Study||6
3071140|NCT01324570|3792022|FG001|STARTED|Overall Study||35
3071141|NCT01324570|3792021|FG000|COMPLETED|Overall Study||2
3071142|NCT01324570|3792022|FG001|COMPLETED|Overall Study||21
3071143|NCT01324570|3792021|FG000|NOT COMPLETED|Overall Study||4
3071144|NCT01324570|3792022|FG001|NOT COMPLETED|Overall Study||14
3071145|NCT01324622|3792032|FG000|STARTED|Overall Study||13
3071146|NCT01324622|3792033|FG001|STARTED|Overall Study||11
3071147|NCT01324622|3792032|FG000|COMPLETED|Overall Study||4
3071148|NCT01324622|3792033|FG001|COMPLETED|Overall Study||4
3071149|NCT01324622|3792032|FG000|NOT COMPLETED|Overall Study||9
3071150|NCT01324622|3792033|FG001|NOT COMPLETED|Overall Study||7
3071151|NCT01324687|3792042|FG000|STARTED|Overall Study||1058
3071152|NCT01324687|3792043|FG001|STARTED|Overall Study||494
3071153|NCT01324687|3792042|FG000|COMPLETED|Overall Study||1058
3071154|NCT01324687|3792043|FG001|COMPLETED|Overall Study||479
3071155|NCT01324687|3792042|FG000|NOT COMPLETED|Overall Study||0
3071156|NCT01324687|3792043|FG001|NOT COMPLETED|Overall Study||15
3071157|NCT01324700|3792053|FG000|STARTED|Overall Study||22
3071158|NCT01324700|3792054|FG001|STARTED|Overall Study||20
3071159|NCT01324700|3792055|FG002|STARTED|Overall Study||49
3071160|NCT01324700|3792056|FG003|STARTED|Overall Study||48
3071161|NCT01324700|3792053|FG000|COMPLETED|Overall Study||13
3071162|NCT01324700|3792054|FG001|COMPLETED|Overall Study||16
3071163|NCT01324700|3792055|FG002|COMPLETED|Overall Study||33
3071164|NCT01324700|3792056|FG003|COMPLETED|Overall Study||37
3071165|NCT01324700|3792053|FG000|NOT COMPLETED|Overall Study||9
3071166|NCT01324700|3792054|FG001|NOT COMPLETED|Overall Study||4
3071167|NCT01324700|3792055|FG002|NOT COMPLETED|Overall Study||16
3071168|NCT01324700|3792056|FG003|NOT COMPLETED|Overall Study||11
3071169|NCT01324830|3792085|FG000|STARTED|Overall Study||3
3071170|NCT01324830|3792086|FG001|STARTED|Overall Study||3
3071171|NCT01324830|3792087|FG002|STARTED|Overall Study||3
3071172|NCT01324830|3792088|FG003|STARTED|Overall Study||3
3071173|NCT01324830|3792089|FG004|STARTED|Overall Study||7
3071174|NCT01324830|3792090|FG005|STARTED|Overall Study||7
3071175|NCT01324830|3792091|FG006|STARTED|Overall Study||3
3071176|NCT01324830|3792092|FG007|STARTED|Overall Study||3
3071177|NCT01324830|3792093|FG008|STARTED|Overall Study||5
3071178|NCT01324830|3792094|FG009|STARTED|Overall Study||6
3071179|NCT01324830|3792095|FG010|STARTED|Overall Study||4
3071180|NCT01324830|3792096|FG011|STARTED|Overall Study||1
3071181|NCT01324830|3792097|FG012|STARTED|Overall Study||1
3071182|NCT01324830|3792098|FG013|STARTED|Overall Study||1
3071183|NCT01324830|3792099|FG014|STARTED|Overall Study||1
3071184|NCT01324830|3792100|FG015|STARTED|Overall Study||3
3071185|NCT01324830|3792101|FG016|STARTED|Overall Study||3
3071186|NCT01324830|3792102|FG017|STARTED|Overall Study||6
3071187|NCT01324830|3792103|FG018|STARTED|Overall Study||6
3071188|NCT01324830|3792085|FG000|COMPLETED|Overall Study||0
3071189|NCT01324830|3792086|FG001|COMPLETED|Overall Study||0
3071190|NCT01324830|3792087|FG002|COMPLETED|Overall Study||0
3071191|NCT01324830|3792088|FG003|COMPLETED|Overall Study||0
3071192|NCT01324830|3792089|FG004|COMPLETED|Overall Study||0
3071193|NCT01324830|3792090|FG005|COMPLETED|Overall Study||0
3071194|NCT01324830|3792091|FG006|COMPLETED|Overall Study||0
3071195|NCT01324830|3792092|FG007|COMPLETED|Overall Study||0
3071196|NCT01324830|3792093|FG008|COMPLETED|Overall Study||0
3071197|NCT01324830|3792094|FG009|COMPLETED|Overall Study||0
3071198|NCT01324830|3792095|FG010|COMPLETED|Overall Study||0
3071199|NCT01324830|3792096|FG011|COMPLETED|Overall Study||0
3071200|NCT01324830|3792097|FG012|COMPLETED|Overall Study||0
3071201|NCT01324830|3792098|FG013|COMPLETED|Overall Study||0
3071202|NCT01324830|3792099|FG014|COMPLETED|Overall Study||0
3071203|NCT01324830|3792100|FG015|COMPLETED|Overall Study||0
3071204|NCT01324830|3792101|FG016|COMPLETED|Overall Study||0
3071205|NCT01324830|3792102|FG017|COMPLETED|Overall Study||0
3071206|NCT01324830|3792103|FG018|COMPLETED|Overall Study||0
3071207|NCT01324830|3792085|FG000|NOT COMPLETED|Overall Study||3
3071208|NCT01324830|3792086|FG001|NOT COMPLETED|Overall Study||3
3071209|NCT01324830|3792087|FG002|NOT COMPLETED|Overall Study||3
3071210|NCT01324830|3792088|FG003|NOT COMPLETED|Overall Study||3
3071211|NCT01324830|3792089|FG004|NOT COMPLETED|Overall Study||7
3071212|NCT01324830|3792090|FG005|NOT COMPLETED|Overall Study||7
3071213|NCT01324830|3792091|FG006|NOT COMPLETED|Overall Study||3
3071214|NCT01324830|3792092|FG007|NOT COMPLETED|Overall Study||3
3071215|NCT01324830|3792093|FG008|NOT COMPLETED|Overall Study||5
3071216|NCT01324830|3792094|FG009|NOT COMPLETED|Overall Study||6
3071217|NCT01324830|3792095|FG010|NOT COMPLETED|Overall Study||4
3071218|NCT01324830|3792096|FG011|NOT COMPLETED|Overall Study||1
3071219|NCT01324830|3792097|FG012|NOT COMPLETED|Overall Study||1
3071220|NCT01324830|3792098|FG013|NOT COMPLETED|Overall Study||1
3071221|NCT01324830|3792099|FG014|NOT COMPLETED|Overall Study||1
3071222|NCT01324830|3792100|FG015|NOT COMPLETED|Overall Study||3
3071223|NCT01324830|3792101|FG016|NOT COMPLETED|Overall Study||3
3071224|NCT01324830|3792102|FG017|NOT COMPLETED|Overall Study||6
3071225|NCT01324830|3792103|FG018|NOT COMPLETED|Overall Study||6
3071226|NCT01324882|3792151|FG000|STARTED|Overall Study|27 patients were randomized to this arm.|27
3071227|NCT01324882|3792152|FG001|STARTED|Overall Study|30 patients were randomized to this arm|30
3071228|NCT01324882|3792151|FG000|COMPLETED|Overall Study|27 patients had the colonoscopy|27
3071229|NCT01324882|3792152|FG001|COMPLETED|Overall Study|30 patients had the colonoscopy|30
3071230|NCT01324882|3792151|FG000|NOT COMPLETED|Overall Study||0
3071231|NCT01324882|3792152|FG001|NOT COMPLETED|Overall Study||0
3071232|NCT01324947|3792160|FG000|STARTED|Overall Study||74
3071233|NCT01324947|3792160|FG000|Safety Population|Overall Study|Safety Population includes those who were enrolled and received at least one dose of study drug|73
3071234|NCT01324947|3792160|FG000|Efficacy Evaluable Population (EEP)|Overall Study|Participants who received ≥ 1 dose of study drug and had at least 1 postbaseline efficacy assessment|64
3071235|NCT01324947|3792160|FG000|COMPLETED|Overall Study||0
3071236|NCT01324947|3792160|FG000|NOT COMPLETED|Overall Study||74
3071237|NCT01324999|3792166|FG000|STARTED|Overall Study||12
3071238|NCT01324999|3792166|FG000|COMPLETED|Overall Study||7
3071239|NCT01324999|3792166|FG000|NOT COMPLETED|Overall Study||5
3071240|NCT01325181|3792172|FG000|STARTED|Overall Study||18
3071241|NCT01325181|3792173|FG001|STARTED|Overall Study||16
3071242|NCT01325181|3792172|FG000|COMPLETED|Overall Study||18
3071243|NCT01325181|3792173|FG001|COMPLETED|Overall Study||14
3071244|NCT01325181|3792172|FG000|NOT COMPLETED|Overall Study||0
3071245|NCT01325181|3792173|FG001|NOT COMPLETED|Overall Study||2
3071246|NCT01325207|3792185|FG000|STARTED|Completed 4 Weeks/1 Cycle of Treatment||3
3071247|NCT01325207|3792186|FG001|STARTED|Completed 4 Weeks/1 Cycle of Treatment||3
3071248|NCT01325207|3792187|FG002|STARTED|Completed 4 Weeks/1 Cycle of Treatment||1
3071249|NCT01325207|3792188|FG003|STARTED|Completed 4 Weeks/1 Cycle of Treatment||1
3071250|NCT01325207|3792189|FG004|STARTED|Completed 4 Weeks/1 Cycle of Treatment||7
3071251|NCT01325207|3792190|FG005|STARTED|Completed 4 Weeks/1 Cycle of Treatment||19
3071252|NCT01325207|3792185|FG000|COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||3
3071253|NCT01325207|3792186|FG001|COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||3
3071254|NCT01325207|3792187|FG002|COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||1
3071255|NCT01325207|3792188|FG003|COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||1
3071256|NCT01325207|3792189|FG004|COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||5
3071257|NCT01325207|3792190|FG005|COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||19
3071258|NCT01325207|3792185|FG000|NOT COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||0
3071259|NCT01325207|3792186|FG001|NOT COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||0
3071260|NCT01325207|3792187|FG002|NOT COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||0
3071261|NCT01325207|3792188|FG003|NOT COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||0
3071262|NCT01325207|3792189|FG004|NOT COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||2
3071263|NCT01325207|3792190|FG005|NOT COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||0
3071264|NCT01325207|3792185|FG000|STARTED|Completed 8 Weeks/2 Cycles of Treatment||3
3071265|NCT01325207|3792186|FG001|STARTED|Completed 8 Weeks/2 Cycles of Treatment||3
3071266|NCT01325207|3792187|FG002|STARTED|Completed 8 Weeks/2 Cycles of Treatment||1
3071267|NCT01325207|3792188|FG003|STARTED|Completed 8 Weeks/2 Cycles of Treatment||1
3071268|NCT01325207|3792189|FG004|STARTED|Completed 8 Weeks/2 Cycles of Treatment||5
3071269|NCT01325207|3792190|FG005|STARTED|Completed 8 Weeks/2 Cycles of Treatment||19
3071270|NCT01325207|3792185|FG000|COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||2
3071271|NCT01325207|3792186|FG001|COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||2
3071272|NCT01325207|3792187|FG002|COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||1
3071273|NCT01325207|3792188|FG003|COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||1
3071274|NCT01325207|3792189|FG004|COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||3
3071275|NCT01325207|3792190|FG005|COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||14
3071276|NCT01325207|3792185|FG000|NOT COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||1
3071277|NCT01325207|3792186|FG001|NOT COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||1
3071278|NCT01325207|3792187|FG002|NOT COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||0
3071279|NCT01325207|3792188|FG003|NOT COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||0
3071280|NCT01325207|3792189|FG004|NOT COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||2
3071281|NCT01325207|3792190|FG005|NOT COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||5
3071282|NCT01325207|3792185|FG000|STARTED|Started 9th Week/Cycle 3 of Treatment||2
3071283|NCT01325207|3792186|FG001|STARTED|Started 9th Week/Cycle 3 of Treatment||2
3071284|NCT01325207|3792187|FG002|STARTED|Started 9th Week/Cycle 3 of Treatment||1
3071285|NCT01325207|3792188|FG003|STARTED|Started 9th Week/Cycle 3 of Treatment||1
3071286|NCT01325207|3792189|FG004|STARTED|Started 9th Week/Cycle 3 of Treatment||3
3071287|NCT01325207|3792190|FG005|STARTED|Started 9th Week/Cycle 3 of Treatment||14
3071288|NCT01325207|3792185|FG000|COMPLETED|Started 9th Week/Cycle 3 of Treatment||1
3071289|NCT01325207|3792186|FG001|COMPLETED|Started 9th Week/Cycle 3 of Treatment||0
3071290|NCT01325207|3792187|FG002|COMPLETED|Started 9th Week/Cycle 3 of Treatment||0
3071291|NCT01325207|3792188|FG003|COMPLETED|Started 9th Week/Cycle 3 of Treatment||0
3071292|NCT01325207|3792189|FG004|COMPLETED|Started 9th Week/Cycle 3 of Treatment||3
3071293|NCT01325207|3792190|FG005|COMPLETED|Started 9th Week/Cycle 3 of Treatment||9
3071294|NCT01325207|3792185|FG000|NOT COMPLETED|Started 9th Week/Cycle 3 of Treatment||1
3071295|NCT01325207|3792186|FG001|NOT COMPLETED|Started 9th Week/Cycle 3 of Treatment||2
3071296|NCT01325207|3792187|FG002|NOT COMPLETED|Started 9th Week/Cycle 3 of Treatment||1
3071297|NCT01325207|3792188|FG003|NOT COMPLETED|Started 9th Week/Cycle 3 of Treatment||1
3071298|NCT01325207|3792189|FG004|NOT COMPLETED|Started 9th Week/Cycle 3 of Treatment||0
3071299|NCT01325207|3792190|FG005|NOT COMPLETED|Started 9th Week/Cycle 3 of Treatment||5
3071300|NCT01325207|3792185|FG000|STARTED|Follow-up Every 3 Months Until Death||3
3071301|NCT01325207|3792186|FG001|STARTED|Follow-up Every 3 Months Until Death||3
3071302|NCT01325207|3792187|FG002|STARTED|Follow-up Every 3 Months Until Death||1
3071303|NCT01325207|3792188|FG003|STARTED|Follow-up Every 3 Months Until Death||1
3071304|NCT01325207|3792189|FG004|STARTED|Follow-up Every 3 Months Until Death||7
3071305|NCT01325207|3792190|FG005|STARTED|Follow-up Every 3 Months Until Death||19
3071306|NCT01325207|3792185|FG000|COMPLETED|Follow-up Every 3 Months Until Death||3
3071307|NCT01325207|3792186|FG001|COMPLETED|Follow-up Every 3 Months Until Death||3
3071308|NCT01325207|3792187|FG002|COMPLETED|Follow-up Every 3 Months Until Death||1
3071309|NCT01325207|3792188|FG003|COMPLETED|Follow-up Every 3 Months Until Death||1
3071310|NCT01325207|3792189|FG004|COMPLETED|Follow-up Every 3 Months Until Death||6
3071311|NCT01325207|3792190|FG005|COMPLETED|Follow-up Every 3 Months Until Death||18
3071312|NCT01325207|3792185|FG000|NOT COMPLETED|Follow-up Every 3 Months Until Death||0
3071313|NCT01325207|3792186|FG001|NOT COMPLETED|Follow-up Every 3 Months Until Death||0
3071314|NCT01325207|3792187|FG002|NOT COMPLETED|Follow-up Every 3 Months Until Death||0
3071315|NCT01325207|3792188|FG003|NOT COMPLETED|Follow-up Every 3 Months Until Death||0
3071316|NCT01325207|3792189|FG004|NOT COMPLETED|Follow-up Every 3 Months Until Death||1
3071317|NCT01325207|3792190|FG005|NOT COMPLETED|Follow-up Every 3 Months Until Death||1
3071318|NCT01325311|3792207|FG000|STARTED|Overall Study||8
3071319|NCT01325311|3792208|FG001|STARTED|Overall Study||7
3071320|NCT01325311|3792207|FG000|COMPLETED|Overall Study||8
3071321|NCT01325311|3792208|FG001|COMPLETED|Overall Study||7
3071322|NCT01325311|3792207|FG000|NOT COMPLETED|Overall Study||0
3071323|NCT01325311|3792208|FG001|NOT COMPLETED|Overall Study||0
3071324|NCT01325337|3792219|FG000|STARTED|Overall Study||61
3071325|NCT01325337|3792220|FG001|STARTED|Overall Study||61
3071326|NCT01325337|3792221|FG002|STARTED|Overall Study||62
3071327|NCT01325337|3792222|FG003|STARTED|Overall Study||62
3071328|NCT01325337|3792223|FG004|STARTED|Overall Study||61
3071329|NCT01325337|3792219|FG000|COMPLETED|Overall Study||56
3071330|NCT01325337|3792220|FG001|COMPLETED|Overall Study||52
3071331|NCT01325337|3792221|FG002|COMPLETED|Overall Study||53
3071332|NCT01325337|3792222|FG003|COMPLETED|Overall Study||52
3071333|NCT01325337|3792223|FG004|COMPLETED|Overall Study||53
3071334|NCT01325337|3792219|FG000|NOT COMPLETED|Overall Study||5
3071335|NCT01325337|3792220|FG001|NOT COMPLETED|Overall Study||9
3071336|NCT01325337|3792221|FG002|NOT COMPLETED|Overall Study||9
3071337|NCT01325337|3792222|FG003|NOT COMPLETED|Overall Study||10
3071338|NCT01325337|3792223|FG004|NOT COMPLETED|Overall Study||8
3071339|NCT01325350|3792240|FG000|STARTED|Overall Study||61
3071340|NCT01325350|3792241|FG001|STARTED|Overall Study||61
3071341|NCT01325350|3792242|FG002|STARTED|Overall Study||61
3071342|NCT01325350|3792243|FG003|STARTED|Overall Study||61
3071343|NCT01325350|3792244|FG004|STARTED|Overall Study||62
3071344|NCT01325350|3792240|FG000|COMPLETED|Overall Study||55
3071345|NCT01325350|3792241|FG001|COMPLETED|Overall Study||56
3071346|NCT01325350|3792242|FG002|COMPLETED|Overall Study||44
3071347|NCT01325350|3792243|FG003|COMPLETED|Overall Study||52
3071348|NCT01325350|3792244|FG004|COMPLETED|Overall Study||50
3071349|NCT01325350|3792240|FG000|NOT COMPLETED|Overall Study||6
3071350|NCT01325350|3792241|FG001|NOT COMPLETED|Overall Study||5
3071351|NCT01325350|3792242|FG002|NOT COMPLETED|Overall Study||17
3071352|NCT01325350|3792243|FG003|NOT COMPLETED|Overall Study||9
3071353|NCT01325350|3792244|FG004|NOT COMPLETED|Overall Study||12
3071354|NCT01325428|3792256|FG000|STARTED|Part A||26
3071355|NCT01325428|3792256|FG000|COMPLETED|Part A||10
3071356|NCT01325428|3792256|FG000|NOT COMPLETED|Part A||16
3071357|NCT01325428|3792256|FG000|STARTED|Part B||10
3071358|NCT01325428|3792256|FG000|COMPLETED|Part B||7
3071359|NCT01325428|3792256|FG000|NOT COMPLETED|Part B||3
3071360|NCT01325493|3792267|FG000|STARTED|Overall Study||30
3071361|NCT01325493|3792268|FG001|STARTED|Overall Study||24
3071362|NCT01325493|3792267|FG000|COMPLETED|Overall Study||29
3071363|NCT01325493|3792268|FG001|COMPLETED|Overall Study||21
3071364|NCT01325493|3792267|FG000|NOT COMPLETED|Overall Study||1
3071365|NCT01325493|3792268|FG001|NOT COMPLETED|Overall Study||3
3071366|NCT01325532|3792276|FG000|STARTED|Overall Study||17
3071367|NCT01325532|3792277|FG001|STARTED|Overall Study||13
3071368|NCT01325532|3792276|FG000|COMPLETED|Overall Study||15
3071369|NCT01325532|3792277|FG001|COMPLETED|Overall Study||13
3071370|NCT01325532|3792276|FG000|NOT COMPLETED|Overall Study||2
3071371|NCT01325532|3792277|FG001|NOT COMPLETED|Overall Study||0
3071372|NCT01325584|3792283|FG000|STARTED|Overall Study||12
3071373|NCT01325584|3792283|FG000|COMPLETED|Overall Study||11
3071374|NCT01325584|3792283|FG000|NOT COMPLETED|Overall Study||1
3071375|NCT01325623|3792287|FG000|STARTED|Overall Study||31
3071376|NCT01325623|3792287|FG000|COMPLETED|Overall Study||28
3071377|NCT01325623|3792287|FG000|NOT COMPLETED|Overall Study||3
3071378|NCT01325701|3792326|FG000|STARTED|Overall Study||70
3071379|NCT01325701|3792327|FG001|STARTED|Overall Study||8
3071380|NCT01325701|3792326|FG000|COMPLETED|Overall Study||49
3071381|NCT01325701|3792327|FG001|COMPLETED|Overall Study||5
3071382|NCT01325701|3792326|FG000|NOT COMPLETED|Overall Study||21
3071383|NCT01325701|3792327|FG001|NOT COMPLETED|Overall Study||3
3071384|NCT01325714|3792336|FG000|STARTED|Overall Study||101
3071385|NCT01325714|3792337|FG001|STARTED|Overall Study||102
3071386|NCT01325714|3792336|FG000|3 Month Assessment|Overall Study||82
3071387|NCT01325714|3792337|FG001|3 Month Assessment|Overall Study||86
3071388|NCT01325714|3792336|FG000|6 Month Asessment|Overall Study||75
3071389|NCT01325714|3792337|FG001|6 Month Asessment|Overall Study||82
3071390|NCT01325714|3792336|FG000|12 Month Assessment|Overall Study||67
3071391|NCT01325714|3792337|FG001|12 Month Assessment|Overall Study||71
3071392|NCT01325714|3792336|FG000|COMPLETED|Overall Study||67
3071393|NCT01325714|3792337|FG001|COMPLETED|Overall Study||71
3071394|NCT01325714|3792336|FG000|NOT COMPLETED|Overall Study||34
3071395|NCT01325714|3792337|FG001|NOT COMPLETED|Overall Study||31
3071396|NCT01325792|3792345|FG000|STARTED|Overall Study||104
3071397|NCT01325792|3792345|FG000|COMPLETED|Overall Study||87
3071398|NCT01325792|3792345|FG000|NOT COMPLETED|Overall Study||17
3071399|NCT01325870|3792352|FG000|STARTED|Overall Study||18
3071400|NCT01325870|3792353|FG001|STARTED|Overall Study||16
3071401|NCT01325870|3792354|FG002|STARTED|Overall Study||14
3071402|NCT01325870|3792352|FG000|COMPLETED|Overall Study||7
3071403|NCT01325870|3792353|FG001|COMPLETED|Overall Study||3
3071404|NCT01325870|3792354|FG002|COMPLETED|Overall Study||6
3071405|NCT01325870|3792352|FG000|NOT COMPLETED|Overall Study||11
3071406|NCT01325870|3792353|FG001|NOT COMPLETED|Overall Study||13
3071407|NCT01325870|3792354|FG002|NOT COMPLETED|Overall Study||8
3071408|NCT01326026|3792364|FG000|STARTED|Overall Study||111
3071409|NCT01326026|3792365|FG001|STARTED|Overall Study||111
3071410|NCT01326026|3792364|FG000|Exposed|Overall Study|One subject withdrew before exposure to trial drug|110
3071411|NCT01326026|3792365|FG001|Exposed|Overall Study||111
3071412|NCT01326026|3792364|FG000|COMPLETED|Overall Study||99
3071413|NCT01326026|3792365|FG001|COMPLETED|Overall Study||98
3071414|NCT01326026|3792364|FG000|NOT COMPLETED|Overall Study||12
3071415|NCT01326026|3792365|FG001|NOT COMPLETED|Overall Study||13
3071416|NCT01326481|3792371|FG000|STARTED|7.5 mg/kg TRC105, 1000 mg/m2 Cape||4
3071417|NCT01326481|3792371|FG000|COMPLETED|7.5 mg/kg TRC105, 1000 mg/m2 Cape||3
3071418|NCT01326481|3792371|FG000|NOT COMPLETED|7.5 mg/kg TRC105, 1000 mg/m2 Cape||1
3071419|NCT01326481|3792371|FG000|STARTED|10 mg/kg TRC105, 1000 mg/m2 Cape||15
3071420|NCT01326481|3792371|FG000|COMPLETED|10 mg/kg TRC105, 1000 mg/m2 Cape||15
3071421|NCT01326481|3792371|FG000|NOT COMPLETED|10 mg/kg TRC105, 1000 mg/m2 Cape||0
3071422|NCT01326533|3792379|FG000|STARTED|Overall Study||17
3071423|NCT01326533|3792380|FG001|STARTED|Overall Study||15
3071424|NCT01326533|3792379|FG000|COMPLETED|Overall Study||13
3071425|NCT01326533|3792380|FG001|COMPLETED|Overall Study||15
3071426|NCT01326533|3792379|FG000|NOT COMPLETED|Overall Study||4
3071427|NCT01326533|3792380|FG001|NOT COMPLETED|Overall Study||0
3071428|NCT01326546|3792388|FG000|STARTED|Overall Study||189
3071429|NCT01326546|3792389|FG001|STARTED|Overall Study||189
3071430|NCT01326546|3792388|FG000|COMPLETED|Overall Study||172
3071431|NCT01326546|3792389|FG001|COMPLETED|Overall Study||176
3071432|NCT01326546|3792388|FG000|NOT COMPLETED|Overall Study||17
3071433|NCT01326546|3792389|FG001|NOT COMPLETED|Overall Study||13
3071434|NCT01326702|3792402|FG000|STARTED|Overall Study||3
3071435|NCT01326702|3792403|FG001|STARTED|Overall Study||3
3071436|NCT01326702|3792404|FG002|STARTED|Overall Study||6
3071437|NCT01326702|3792405|FG003|STARTED|Overall Study||4
3071438|NCT01326702|3792406|FG004|STARTED|Overall Study||5
3071439|NCT01326702|3792407|FG005|STARTED|Overall Study||15
3071440|NCT01326702|3792408|FG006|STARTED|Overall Study||7
3071441|NCT01326702|3792402|FG000|COMPLETED|Overall Study||1
3071442|NCT01326702|3792403|FG001|COMPLETED|Overall Study||1
3071443|NCT01326702|3792404|FG002|COMPLETED|Overall Study||1
3071444|NCT01326702|3792405|FG003|COMPLETED|Overall Study||1
3071445|NCT01326702|3792406|FG004|COMPLETED|Overall Study||1
3071446|NCT01326702|3792407|FG005|COMPLETED|Overall Study||7
3071447|NCT01326702|3792408|FG006|COMPLETED|Overall Study||0
3071448|NCT01326702|3792402|FG000|NOT COMPLETED|Overall Study||2
3071449|NCT01326702|3792403|FG001|NOT COMPLETED|Overall Study||2
3071450|NCT01326702|3792404|FG002|NOT COMPLETED|Overall Study||5
3071451|NCT01326702|3792405|FG003|NOT COMPLETED|Overall Study||3
3071452|NCT01326702|3792406|FG004|NOT COMPLETED|Overall Study||4
3071453|NCT01326702|3792407|FG005|NOT COMPLETED|Overall Study||8
3071454|NCT01326702|3792408|FG006|NOT COMPLETED|Overall Study||7
3071455|NCT01326728|3792429|FG000|STARTED|Overall Study||47
3071456|NCT01326728|3792430|FG001|STARTED|Overall Study||9
3071457|NCT01326728|3792429|FG000|COMPLETED|Overall Study||0
3071458|NCT01326728|3792430|FG001|COMPLETED|Overall Study||0
3071459|NCT01326728|3792429|FG000|NOT COMPLETED|Overall Study||47
3071460|NCT01326728|3792430|FG001|NOT COMPLETED|Overall Study||9
3071461|NCT01326780|3792439|FG000|STARTED|Overall Study||106
3071462|NCT01326780|3792440|FG001|STARTED|Overall Study||109
3071463|NCT01326780|3792441|FG002|STARTED|Overall Study||109
3071464|NCT01326780|3792442|FG003|STARTED|Overall Study||107
3071465|NCT01326780|3792439|FG000|COMPLETED|Overall Study||93
3071466|NCT01326780|3792440|FG001|COMPLETED|Overall Study||100
3071467|NCT01326780|3792441|FG002|COMPLETED|Overall Study||103
3071468|NCT01326780|3792442|FG003|COMPLETED|Overall Study||94
3071469|NCT01326780|3792439|FG000|NOT COMPLETED|Overall Study||13
3071470|NCT01326780|3792440|FG001|NOT COMPLETED|Overall Study||9
3071471|NCT01326780|3792441|FG002|NOT COMPLETED|Overall Study||6
3071472|NCT01326780|3792442|FG003|NOT COMPLETED|Overall Study||13
3071473|NCT01326910|3792454|FG000|STARTED|Overall Study||45
3071474|NCT01326910|3792455|FG001|STARTED|Overall Study||45
3071475|NCT01326910|3792454|FG000|COMPLETED|Overall Study||41
3071476|NCT01326910|3792455|FG001|COMPLETED|Overall Study||42
3071477|NCT01326910|3792454|FG000|NOT COMPLETED|Overall Study||4
3071478|NCT01326910|3792455|FG001|NOT COMPLETED|Overall Study||3
3071479|NCT01326962|3792461|FG000|STARTED|Overall Study||28
3071480|NCT01326962|3792461|FG000|COMPLETED|Overall Study||21
3071481|NCT01326962|3792461|FG000|NOT COMPLETED|Overall Study||7
3071482|NCT01327053|3792467|FG000|STARTED|Overall Study||79
3071483|NCT01327053|3792468|FG001|STARTED|Overall Study||151
3071484|NCT01327053|3792467|FG000|Untreated|Overall Study||0
3071485|NCT01327053|3792468|FG001|Untreated|Overall Study|one patient randomized to LDE225 (sonidegib) 800 mg did not receive study treatment|1
3071486|NCT01327053|3792467|FG000|Patients Cont. to Next Phase of Trial|Overall Study||52
3071487|NCT01327053|3792468|FG001|Patients Cont. to Next Phase of Trial|Overall Study||89
3071488|NCT01327053|3792467|FG000|Survival Follow-up|Overall Study||33
3071489|NCT01327053|3792468|FG001|Survival Follow-up|Overall Study||49
3071490|NCT01327053|3792467|FG000|Post-treatment Follow-up|Overall Study||19
3071491|NCT01327053|3792468|FG001|Post-treatment Follow-up|Overall Study||40
3071492|NCT01327053|3792467|FG000|COMPLETED|Overall Study||0
3071493|NCT01327053|3792468|FG001|COMPLETED|Overall Study||0
3071494|NCT01327053|3792467|FG000|NOT COMPLETED|Overall Study||79
3071495|NCT01327053|3792468|FG001|NOT COMPLETED|Overall Study||151
3071496|NCT01327157|3792480|FG000|STARTED|01-90||7
3071497|NCT01327157|3792481|FG001|STARTED|01-90||7
3071498|NCT01327157|3792480|FG000|COMPLETED|01-90||7
3071499|NCT01327157|3792481|FG001|COMPLETED|01-90||7
3071500|NCT01327157|3792480|FG000|NOT COMPLETED|01-90||0
3071501|NCT01327157|3792481|FG001|NOT COMPLETED|01-90||0
3071502|NCT01327157|3792480|FG000|STARTED|91-180||7
3071503|NCT01327157|3792481|FG001|STARTED|91-180||0
3071504|NCT01327157|3792480|FG000|COMPLETED|91-180||7
3071505|NCT01327157|3792481|FG001|COMPLETED|91-180||0
3071506|NCT01327157|3792480|FG000|NOT COMPLETED|91-180||0
3071507|NCT01327157|3792481|FG001|NOT COMPLETED|91-180||0
3071508|NCT01327274|3792492|FG000|STARTED|Overall Study||15
3071509|NCT01327274|3792492|FG000|COMPLETED|Overall Study||15
3071510|NCT01327274|3792492|FG000|NOT COMPLETED|Overall Study||0
3071511|NCT01327300|3792497|FG000|STARTED|First Intervention (12 Weeks)||5
3071512|NCT01327300|3792498|FG001|STARTED|First Intervention (12 Weeks)||2
3071513|NCT01327300|3792497|FG000|COMPLETED|First Intervention (12 Weeks)||5
3071514|NCT01327300|3792498|FG001|COMPLETED|First Intervention (12 Weeks)||2
3071515|NCT01327300|3792497|FG000|NOT COMPLETED|First Intervention (12 Weeks)||0
3071516|NCT01327300|3792498|FG001|NOT COMPLETED|First Intervention (12 Weeks)||0
3071517|NCT01327300|3792497|FG000|STARTED|Washout (3 Weeks)||5
3071518|NCT01327300|3792498|FG001|STARTED|Washout (3 Weeks)||2
3071519|NCT01327300|3792497|FG000|COMPLETED|Washout (3 Weeks)||4
3071520|NCT01327300|3792498|FG001|COMPLETED|Washout (3 Weeks)||2
3071521|NCT01327300|3792497|FG000|NOT COMPLETED|Washout (3 Weeks)||1
3071522|NCT01327300|3792498|FG001|NOT COMPLETED|Washout (3 Weeks)||0
3071523|NCT01327300|3792497|FG000|STARTED|Second Intervention (12 Weeks)||4
3071524|NCT01327300|3792498|FG001|STARTED|Second Intervention (12 Weeks)||2
3071525|NCT01327300|3792497|FG000|COMPLETED|Second Intervention (12 Weeks)||4
3071526|NCT01327300|3792498|FG001|COMPLETED|Second Intervention (12 Weeks)||2
3071527|NCT01327300|3792497|FG000|NOT COMPLETED|Second Intervention (12 Weeks)||0
3071528|NCT01327300|3792498|FG001|NOT COMPLETED|Second Intervention (12 Weeks)||0
3071529|NCT01327313|3792518|FG000|STARTED|Overall Study||8
3071530|NCT01327313|3792519|FG001|STARTED|Overall Study||6
3071531|NCT01327313|3792520|FG002|STARTED|Overall Study||6
3071532|NCT01327313|3792521|FG003|STARTED|Overall Study||7
3071533|NCT01327313|3792518|FG000|COMPLETED|Overall Study||8
3071534|NCT01327313|3792519|FG001|COMPLETED|Overall Study||6
3071535|NCT01327313|3792520|FG002|COMPLETED|Overall Study||6
3071536|NCT01327313|3792521|FG003|COMPLETED|Overall Study||7
3071537|NCT01327313|3792518|FG000|NOT COMPLETED|Overall Study||0
3071538|NCT01327313|3792519|FG001|NOT COMPLETED|Overall Study||0
3071539|NCT01327313|3792520|FG002|NOT COMPLETED|Overall Study||0
3071540|NCT01327313|3792521|FG003|NOT COMPLETED|Overall Study||0
3071541|NCT01327339|3792531|FG000|STARTED|Overall Study||755
3071542|NCT01327339|3792531|FG000|COMPLETED|Overall Study||747
3071543|NCT01327339|3792531|FG000|NOT COMPLETED|Overall Study||8
3071544|NCT01327482|3792535|FG000|STARTED|Overall Study||10
3071545|NCT01327482|3792535|FG000|COMPLETED|Overall Study|The 10th participant completed 2/3 visits|9
3071546|NCT01327482|3792535|FG000|NOT COMPLETED|Overall Study||1
3071547|NCT01327495|3792545|FG000|STARTED|Overall Study||10
3071548|NCT01327495|3792546|FG001|STARTED|Overall Study||11
3071549|NCT01327495|3792547|FG002|STARTED|Overall Study||10
3071550|NCT01327495|3792548|FG003|STARTED|Overall Study||9
3071551|NCT01327495|3792549|FG004|STARTED|Overall Study||11
3071552|NCT01327495|3792550|FG005|STARTED|Overall Study||11
3071553|NCT01327495|3792545|FG000|COMPLETED|Overall Study|1 dropped due to decreased libido & energy, 1 dropped due to too much pain with acyline injections|8
3071554|NCT01327495|3792546|FG001|COMPLETED|Overall Study|1 subject declined prostate biopsy & no-showed to final visit, 1 subject dropped d/t elevated LFTs.|9
3071555|NCT01327495|3792547|FG002|COMPLETED|Overall Study|1 withdrawn due to injection AE. 1 drop-out (declined prostate biopsy and final visit).|8
3071556|NCT01327495|3792548|FG003|COMPLETED|Overall Study||9
3071557|NCT01327495|3792549|FG004|COMPLETED|Overall Study|1 dropped out pre drug finish, 2 non-compliant subjects dropped|8
3071558|NCT01327495|3792550|FG005|COMPLETED|Overall Study|1 subject withdrawn d/t elevated LFTs, 1 dropped out d/t ski accident|9
3071559|NCT01327495|3792545|FG000|NOT COMPLETED|Overall Study||2
3071560|NCT01327495|3792546|FG001|NOT COMPLETED|Overall Study||2
3071561|NCT01327495|3792547|FG002|NOT COMPLETED|Overall Study||2
3071562|NCT01327495|3792548|FG003|NOT COMPLETED|Overall Study||0
3071563|NCT01327495|3792549|FG004|NOT COMPLETED|Overall Study||3
3071564|NCT01327495|3792550|FG005|NOT COMPLETED|Overall Study||2
3071565|NCT01327508|3792572|FG000|STARTED|Overall Study||30
3071566|NCT01327508|3792573|FG001|STARTED|Overall Study||30
3071567|NCT01327508|3792572|FG000|COMPLETED|Overall Study||30
3071568|NCT01327508|3792573|FG001|COMPLETED|Overall Study||30
3071569|NCT01327508|3792572|FG000|NOT COMPLETED|Overall Study||0
3071570|NCT01327508|3792573|FG001|NOT COMPLETED|Overall Study||0
3071571|NCT01327547|3792581|FG000|STARTED|Overall Study||70
3071572|NCT01327547|3792582|FG001|STARTED|Overall Study||67
3071573|NCT01327547|3792581|FG000|Randomized and Not Treated|Overall Study||0
3071574|NCT01327547|3792582|FG001|Randomized and Not Treated|Overall Study|Randomized but was withdrawn prior to receiving treatment due to poor venous access.|1
3071575|NCT01327547|3792581|FG000|COMPLETED|Overall Study||50
3071576|NCT01327547|3792582|FG001|COMPLETED|Overall Study||45
3071577|NCT01327547|3792581|FG000|NOT COMPLETED|Overall Study||20
3071578|NCT01327547|3792582|FG001|NOT COMPLETED|Overall Study||22
3071579|NCT01327573|3792599|FG000|STARTED|Overall Study||11
3071580|NCT01327573|3792600|FG001|STARTED|Overall Study||5
3071581|NCT01327573|3792599|FG000|Received Treatment/Control as Allocated|Overall Study||10
3071582|NCT01327573|3792600|FG001|Received Treatment/Control as Allocated|Overall Study||5
3071583|NCT01327573|3792599|FG000|COMPLETED|Overall Study||8
3071584|NCT01327573|3792600|FG001|COMPLETED|Overall Study||4
3071585|NCT01327573|3792599|FG000|NOT COMPLETED|Overall Study||3
3071586|NCT01327573|3792600|FG001|NOT COMPLETED|Overall Study||1
3071587|NCT01327599|3792607|FG000|STARTED|Overall Study||60
3071588|NCT01327599|3792607|FG000|COMPLETED|Overall Study||57
3071589|NCT01327599|3792607|FG000|NOT COMPLETED|Overall Study||3
3071590|NCT01327612|3792618|FG000|STARTED|Overall Study||2
3071591|NCT01327612|3792619|FG001|STARTED|Overall Study||1
3071592|NCT01327612|3792620|FG002|STARTED|Overall Study||1
3071593|NCT01327612|3792621|FG003|STARTED|Overall Study||1
3071594|NCT01327612|3792622|FG004|STARTED|Overall Study||2
3071595|NCT01327612|3792623|FG005|STARTED|Overall Study||3
3071596|NCT01327612|3792624|FG006|STARTED|Overall Study||2
3071597|NCT01327612|3792618|FG000|COMPLETED|Overall Study||1
3071598|NCT01327612|3792619|FG001|COMPLETED|Overall Study||0
3071599|NCT01327612|3792620|FG002|COMPLETED|Overall Study||0
3071600|NCT01327612|3792621|FG003|COMPLETED|Overall Study||0
3071601|NCT01327612|3792622|FG004|COMPLETED|Overall Study||0
3071602|NCT01327612|3792623|FG005|COMPLETED|Overall Study||0
3071603|NCT01327612|3792624|FG006|COMPLETED|Overall Study||0
3071604|NCT01327612|3792618|FG000|NOT COMPLETED|Overall Study||1
3071605|NCT01327612|3792619|FG001|NOT COMPLETED|Overall Study||1
3071606|NCT01327612|3792620|FG002|NOT COMPLETED|Overall Study||1
3071607|NCT01327612|3792621|FG003|NOT COMPLETED|Overall Study||1
3071608|NCT01327612|3792622|FG004|NOT COMPLETED|Overall Study||2
3071609|NCT01327612|3792623|FG005|NOT COMPLETED|Overall Study||3
3071610|NCT01327612|3792624|FG006|NOT COMPLETED|Overall Study||2
3071611|NCT01327651|3792650|FG000|STARTED|Self-administered Dosing Period||60
3071612|NCT01327651|3792651|FG001|STARTED|Self-administered Dosing Period||59
3071613|NCT01327651|3792652|FG002|STARTED|Self-administered Dosing Period||60
3071614|NCT01327651|3792653|FG003|STARTED|Self-administered Dosing Period||60
3071615|NCT01327651|3792654|FG004|STARTED|Self-administered Dosing Period||59
3071616|NCT01327651|3792655|FG005|STARTED|Self-administered Dosing Period||59
3071617|NCT01327651|3792656|FG006|STARTED|Self-administered Dosing Period||59
3071618|NCT01327651|3792657|FG007|STARTED|Self-administered Dosing Period||60
3071619|NCT01327651|3792658|FG008|STARTED|Self-administered Dosing Period||60
3071620|NCT01327651|3792650|FG000|Week 10|Self-administered Dosing Period||59
3071621|NCT01327651|3792651|FG001|Week 10|Self-administered Dosing Period||58
3071622|NCT01327651|3792652|FG002|Week 10|Self-administered Dosing Period||60
3071623|NCT01327651|3792653|FG003|Week 10|Self-administered Dosing Period||60
3071624|NCT01327651|3792654|FG004|Week 10|Self-administered Dosing Period||59
3071625|NCT01327651|3792655|FG005|Week 10|Self-administered Dosing Period||59
3071626|NCT01327651|3792656|FG006|Week 10|Self-administered Dosing Period||57
3071627|NCT01327651|3792657|FG007|Week 10|Self-administered Dosing Period||57
3071628|NCT01327651|3792658|FG008|Week 10|Self-administered Dosing Period||56
3071629|NCT01327651|3792650|FG000|Week 14|Self-administered Dosing Period||59
3071630|NCT01327651|3792651|FG001|Week 14|Self-administered Dosing Period||55
3071631|NCT01327651|3792652|FG002|Week 14|Self-administered Dosing Period||57
3071632|NCT01327651|3792653|FG003|Week 14|Self-administered Dosing Period||60
3071633|NCT01327651|3792654|FG004|Week 14|Self-administered Dosing Period||58
3071634|NCT01327651|3792655|FG005|Week 14|Self-administered Dosing Period||59
3071635|NCT01327651|3792656|FG006|Week 14|Self-administered Dosing Period||54
3071636|NCT01327651|3792657|FG007|Week 14|Self-administered Dosing Period||51
3071637|NCT01327651|3792658|FG008|Week 14|Self-administered Dosing Period||54
3071638|NCT01327651|3792650|FG000|Week 18|Self-administered Dosing Period||57
3071639|NCT01327651|3792651|FG001|Week 18|Self-administered Dosing Period||56
3071640|NCT01327651|3792652|FG002|Week 18|Self-administered Dosing Period||56
3071641|NCT01327651|3792653|FG003|Week 18|Self-administered Dosing Period||60
3071642|NCT01327651|3792654|FG004|Week 18|Self-administered Dosing Period||57
3071643|NCT01327651|3792655|FG005|Week 18|Self-administered Dosing Period||59
3071644|NCT01327651|3792656|FG006|Week 18|Self-administered Dosing Period||53
3071645|NCT01327651|3792657|FG007|Week 18|Self-administered Dosing Period||49
3071646|NCT01327651|3792658|FG008|Week 18|Self-administered Dosing Period||53
3071647|NCT01327651|3792650|FG000|Week 22|Self-administered Dosing Period||59
3071648|NCT01327651|3792651|FG001|Week 22|Self-administered Dosing Period||56
3071649|NCT01327651|3792652|FG002|Week 22|Self-administered Dosing Period||55
3071650|NCT01327651|3792653|FG003|Week 22|Self-administered Dosing Period||58
3071651|NCT01327651|3792654|FG004|Week 22|Self-administered Dosing Period||56
3071652|NCT01327651|3792655|FG005|Week 22|Self-administered Dosing Period||59
3071653|NCT01327651|3792656|FG006|Week 22|Self-administered Dosing Period||50
3071654|NCT01327651|3792657|FG007|Week 22|Self-administered Dosing Period||50
3071655|NCT01327651|3792658|FG008|Week 22|Self-administered Dosing Period||51
3071656|NCT01327651|3792650|FG000|Week 26|Self-administered Dosing Period||58
3071657|NCT01327651|3792651|FG001|Week 26|Self-administered Dosing Period||56
3071658|NCT01327651|3792652|FG002|Week 26|Self-administered Dosing Period||53
3071659|NCT01327651|3792653|FG003|Week 26|Self-administered Dosing Period||57
3071660|NCT01327651|3792654|FG004|Week 26|Self-administered Dosing Period||56
3071661|NCT01327651|3792655|FG005|Week 26|Self-administered Dosing Period||58
3071662|NCT01327651|3792656|FG006|Week 26|Self-administered Dosing Period||50
3071663|NCT01327651|3792657|FG007|Week 26|Self-administered Dosing Period||51
3071664|NCT01327651|3792658|FG008|Week 26|Self-administered Dosing Period||49
3071665|NCT01327651|3792650|FG000|COMPLETED|Self-administered Dosing Period||56
3071666|NCT01327651|3792651|FG001|COMPLETED|Self-administered Dosing Period||56
3071667|NCT01327651|3792652|FG002|COMPLETED|Self-administered Dosing Period||56
3071668|NCT01327651|3792653|FG003|COMPLETED|Self-administered Dosing Period||57
3071669|NCT01327651|3792654|FG004|COMPLETED|Self-administered Dosing Period||56
3071670|NCT01327651|3792655|FG005|COMPLETED|Self-administered Dosing Period||59
3071671|NCT01327651|3792656|FG006|COMPLETED|Self-administered Dosing Period||49
3071672|NCT01327651|3792657|FG007|COMPLETED|Self-administered Dosing Period||50
3071673|NCT01327651|3792658|FG008|COMPLETED|Self-administered Dosing Period||49
3071674|NCT01327651|3792650|FG000|NOT COMPLETED|Self-administered Dosing Period||4
3071675|NCT01327651|3792651|FG001|NOT COMPLETED|Self-administered Dosing Period||3
3071676|NCT01327651|3792652|FG002|NOT COMPLETED|Self-administered Dosing Period||4
3071677|NCT01327651|3792653|FG003|NOT COMPLETED|Self-administered Dosing Period||3
3071678|NCT01327651|3792654|FG004|NOT COMPLETED|Self-administered Dosing Period||3
3071679|NCT01327651|3792655|FG005|NOT COMPLETED|Self-administered Dosing Period||0
3071680|NCT01327651|3792656|FG006|NOT COMPLETED|Self-administered Dosing Period||10
3071681|NCT01327651|3792657|FG007|NOT COMPLETED|Self-administered Dosing Period||10
3071682|NCT01327651|3792658|FG008|NOT COMPLETED|Self-administered Dosing Period||11
3071683|NCT01327651|3792650|FG000|STARTED|Post Study Follow-up||56
3071684|NCT01327651|3792651|FG001|STARTED|Post Study Follow-up||56
3071685|NCT01327651|3792652|FG002|STARTED|Post Study Follow-up||56
3071686|NCT01327651|3792653|FG003|STARTED|Post Study Follow-up||57
3071687|NCT01327651|3792654|FG004|STARTED|Post Study Follow-up||56
3071688|NCT01327651|3792655|FG005|STARTED|Post Study Follow-up||59
3071689|NCT01327651|3792656|FG006|STARTED|Post Study Follow-up||49
3071690|NCT01327651|3792657|FG007|STARTED|Post Study Follow-up||50
3071691|NCT01327651|3792658|FG008|STARTED|Post Study Follow-up||49
3071692|NCT01327651|3792650|FG000|COMPLETED|Post Study Follow-up||56
3071693|NCT01327651|3792651|FG001|COMPLETED|Post Study Follow-up||55
3071694|NCT01327651|3792652|FG002|COMPLETED|Post Study Follow-up||55
3071695|NCT01327651|3792653|FG003|COMPLETED|Post Study Follow-up||57
3071696|NCT01327651|3792654|FG004|COMPLETED|Post Study Follow-up||56
3071697|NCT01327651|3792655|FG005|COMPLETED|Post Study Follow-up||59
3071698|NCT01327651|3792656|FG006|COMPLETED|Post Study Follow-up||45
3071699|NCT01327651|3792657|FG007|COMPLETED|Post Study Follow-up||49
3071700|NCT01327651|3792658|FG008|COMPLETED|Post Study Follow-up||47
3071701|NCT01327651|3792650|FG000|NOT COMPLETED|Post Study Follow-up||0
3071702|NCT01327651|3792651|FG001|NOT COMPLETED|Post Study Follow-up||1
3071703|NCT01327651|3792652|FG002|NOT COMPLETED|Post Study Follow-up||1
3071704|NCT01327651|3792653|FG003|NOT COMPLETED|Post Study Follow-up||0
3284326|NCT02763826|4018165|FG003|COMPLETED|Part 1 Dose Escalation, 1 mA||0
3284327|NCT02763826|4018166|FG004|COMPLETED|Part 1 Dose Escalation, 1 mA||0
3284328|NCT02763826|4018167|FG005|COMPLETED|Part 1 Dose Escalation, 1 mA||0
3284329|NCT02763826|4018168|FG006|COMPLETED|Part 1 Dose Escalation, 1 mA||0
3284330|NCT02763826|4018169|FG007|COMPLETED|Part 1 Dose Escalation, 1 mA||0
3284331|NCT02763826|4018162|FG000|NOT COMPLETED|Part 1 Dose Escalation, 1 mA||0
3071705|NCT01327651|3792654|FG004|NOT COMPLETED|Post Study Follow-up||0
3071706|NCT01327651|3792655|FG005|NOT COMPLETED|Post Study Follow-up||0
3071707|NCT01327651|3792656|FG006|NOT COMPLETED|Post Study Follow-up||4
3071708|NCT01327651|3792657|FG007|NOT COMPLETED|Post Study Follow-up||1
3071709|NCT01327651|3792658|FG008|NOT COMPLETED|Post Study Follow-up||2
3071710|NCT01327677|3792699|FG000|STARTED|Overall Study||68
3071711|NCT01327677|3792700|FG001|STARTED|Overall Study||69
3071712|NCT01327677|3792699|FG000|COMPLETED|Overall Study||48
3071713|NCT01327677|3792700|FG001|COMPLETED|Overall Study||56
3071714|NCT01327677|3792699|FG000|NOT COMPLETED|Overall Study||20
3071715|NCT01327677|3792700|FG001|NOT COMPLETED|Overall Study||13
3071716|NCT01327703|3792708|FG000|STARTED|First Treatment Period||42
3071717|NCT01327703|3792709|FG001|STARTED|First Treatment Period||45
3071718|NCT01327703|3792708|FG000|COMPLETED|First Treatment Period||42
3071719|NCT01327703|3792709|FG001|COMPLETED|First Treatment Period||45
3071720|NCT01327703|3792708|FG000|NOT COMPLETED|First Treatment Period||0
3071721|NCT01327703|3792709|FG001|NOT COMPLETED|First Treatment Period||0
3071722|NCT01327703|3792708|FG000|STARTED|Second Treatment Period|Two participants discontinued between first and second treatment periods due to adverse event.|40
3071723|NCT01327703|3792709|FG001|STARTED|Second Treatment Period|One participant discontinued between first and second treatment periods due to adverse event.|44
3071724|NCT01327703|3792708|FG000|COMPLETED|Second Treatment Period||39
3071725|NCT01327703|3792709|FG001|COMPLETED|Second Treatment Period||42
3071726|NCT01327703|3792708|FG000|NOT COMPLETED|Second Treatment Period||1
3071727|NCT01327703|3792709|FG001|NOT COMPLETED|Second Treatment Period||2
3071728|NCT01327846|3792722|FG000|STARTED|Core Phase||2263
3071729|NCT01327846|3792723|FG001|STARTED|Core Phase||2284
3071730|NCT01327846|3792724|FG002|STARTED|Core Phase||2170
3071731|NCT01327846|3792725|FG003|STARTED|Core Phase||3344
3071732|NCT01327846|3792722|FG000|COMPLETED|Core Phase||2235
3071733|NCT01327846|3792723|FG001|COMPLETED|Core Phase||2252
3071734|NCT01327846|3792724|FG002|COMPLETED|Core Phase||2144
3071735|NCT01327846|3792725|FG003|COMPLETED|Core Phase||3311
3071736|NCT01327846|3792722|FG000|NOT COMPLETED|Core Phase||28
3071737|NCT01327846|3792723|FG001|NOT COMPLETED|Core Phase||32
3071738|NCT01327846|3792724|FG002|NOT COMPLETED|Core Phase||26
3071739|NCT01327846|3792725|FG003|NOT COMPLETED|Core Phase||33
3071740|NCT01327846|3792722|FG000|STARTED|Extension Phase||1267
3071741|NCT01327846|3792723|FG001|STARTED|Extension Phase||1287
3071742|NCT01327846|3792724|FG002|STARTED|Extension Phase||1279
3071743|NCT01327846|3792725|FG003|STARTED|Extension Phase||1944
3071744|NCT01327846|3792722|FG000|Stopped/Discontinued Study at Washout|Extension Phase||127
3071745|NCT01327846|3792723|FG001|Stopped/Discontinued Study at Washout|Extension Phase||97
3071746|NCT01327846|3792724|FG002|Stopped/Discontinued Study at Washout|Extension Phase||137
3071747|NCT01327846|3792725|FG003|Stopped/Discontinued Study at Washout|Extension Phase||178
3071748|NCT01327846|3792722|FG000|Completed Treatment Period|Extension Phase||41
3071749|NCT01327846|3792723|FG001|Completed Treatment Period|Extension Phase||45
3284332|NCT02763826|4018163|FG001|NOT COMPLETED|Part 1 Dose Escalation, 1 mA||0
3284333|NCT02763826|4018164|FG002|NOT COMPLETED|Part 1 Dose Escalation, 1 mA||0
3284334|NCT02763826|4018165|FG003|NOT COMPLETED|Part 1 Dose Escalation, 1 mA||0
3071750|NCT01327846|3792724|FG002|Completed Treatment Period|Extension Phase||49
3071751|NCT01327846|3792725|FG003|Completed Treatment Period|Extension Phase||60
3071752|NCT01327846|3792722|FG000|Details Missing|Extension Phase||0
3071753|NCT01327846|3792723|FG001|Details Missing|Extension Phase||1
3071754|NCT01327846|3792724|FG002|Details Missing|Extension Phase||1
3071755|NCT01327846|3792725|FG003|Details Missing|Extension Phase||0
3071756|NCT01327846|3792722|FG000|COMPLETED|Extension Phase||168
3071757|NCT01327846|3792723|FG001|COMPLETED|Extension Phase||143
3284335|NCT02763826|4018166|FG004|NOT COMPLETED|Part 1 Dose Escalation, 1 mA||0
3071758|NCT01327846|3792724|FG002|COMPLETED|Extension Phase||187
3071759|NCT01327846|3792725|FG003|COMPLETED|Extension Phase||238
3071760|NCT01327846|3792722|FG000|NOT COMPLETED|Extension Phase||1099
3071761|NCT01327846|3792723|FG001|NOT COMPLETED|Extension Phase||1144
3071762|NCT01327846|3792724|FG002|NOT COMPLETED|Extension Phase||1092
3071763|NCT01327846|3792725|FG003|NOT COMPLETED|Extension Phase||1706
3071764|NCT01327885|3792738|FG000|STARTED|Overall Study||228
3071765|NCT01327885|3792739|FG001|STARTED|Overall Study||224
3071766|NCT01327885|3792738|FG000|COMPLETED|Overall Study||0
3071767|NCT01327885|3792739|FG001|COMPLETED|Overall Study||0
3071768|NCT01327885|3792738|FG000|NOT COMPLETED|Overall Study||228
3071769|NCT01327885|3792739|FG001|NOT COMPLETED|Overall Study||224
3071770|NCT01327963|3792746|FG000|STARTED|Overall Study||110
3071771|NCT01327963|3792746|FG000|COMPLETED|Overall Study|110 participants signed informed consent to be included in the study.|110
3071772|NCT01327963|3792746|FG000|NOT COMPLETED|Overall Study||0
3071773|NCT01327976|3792754|FG000|STARTED|Overall Study||162
3071774|NCT01327976|3792755|FG001|STARTED|Overall Study||77
3071775|NCT01327976|3792754|FG000|COMPLETED|Overall Study||154
3071776|NCT01327976|3792755|FG001|COMPLETED|Overall Study||70
3071777|NCT01327976|3792754|FG000|NOT COMPLETED|Overall Study||8
3071778|NCT01327976|3792755|FG001|NOT COMPLETED|Overall Study||7
3071779|NCT01327989|3792763|FG000|STARTED|Overall Study||202
3071780|NCT01327989|3792763|FG000|COMPLETED|Overall Study||188
3071781|NCT01327989|3792763|FG000|NOT COMPLETED|Overall Study||14
3071782|NCT01328002|3792767|FG000|STARTED|Open-Label Period||116
3071783|NCT01328002|3792768|FG001|STARTED|Open-Label Period||0
3071784|NCT01328002|3792767|FG000|COMPLETED|Open-Label Period||20
3071785|NCT01328002|3792768|FG001|COMPLETED|Open-Label Period||0
3071786|NCT01328002|3792767|FG000|NOT COMPLETED|Open-Label Period||96
3071787|NCT01328002|3792768|FG001|NOT COMPLETED|Open-Label Period||0
3071788|NCT01328002|3792767|FG000|STARTED|Double-Blind Period||14
3071789|NCT01328002|3792768|FG001|STARTED|Double-Blind Period||6
3071790|NCT01328002|3792767|FG000|COMPLETED|Double-Blind Period||12
3071791|NCT01328002|3792768|FG001|COMPLETED|Double-Blind Period||6
3071792|NCT01328002|3792767|FG000|NOT COMPLETED|Double-Blind Period||2
3071793|NCT01328002|3792768|FG001|NOT COMPLETED|Double-Blind Period||0
3071794|NCT01328041|3792775|FG000|STARTED|Overall Study||183
3071795|NCT01328041|3792775|FG000|COMPLETED|Overall Study||126
3071796|NCT01328041|3792775|FG000|NOT COMPLETED|Overall Study||57
3071797|NCT01328054|3792779|FG000|STARTED|Placebo on Day 1 and Day 2 (2 Days)||57
3071798|NCT01328054|3792780|FG001|STARTED|Placebo on Day 1 and Day 2 (2 Days)||0
3071799|NCT01328054|3792779|FG000|COMPLETED|Placebo on Day 1 and Day 2 (2 Days)||57
3071800|NCT01328054|3792780|FG001|COMPLETED|Placebo on Day 1 and Day 2 (2 Days)||0
3071801|NCT01328054|3792779|FG000|NOT COMPLETED|Placebo on Day 1 and Day 2 (2 Days)||0
3071802|NCT01328054|3792780|FG001|NOT COMPLETED|Placebo on Day 1 and Day 2 (2 Days)||0
3071803|NCT01328054|3792779|FG000|STARTED|Lapatinib on Day 3 and Day 4 (2 Days)||0
3071804|NCT01328054|3792780|FG001|STARTED|Lapatinib on Day 3 and Day 4 (2 Days)|One par. was double dosed with lapatinib due to a dosing error - reason for difference in # Started.|58
3071805|NCT01328054|3792779|FG000|COMPLETED|Lapatinib on Day 3 and Day 4 (2 Days)||0
3071806|NCT01328054|3792780|FG001|COMPLETED|Lapatinib on Day 3 and Day 4 (2 Days)||53
3071807|NCT01328054|3792779|FG000|NOT COMPLETED|Lapatinib on Day 3 and Day 4 (2 Days)||0
3071808|NCT01328054|3792780|FG001|NOT COMPLETED|Lapatinib on Day 3 and Day 4 (2 Days)||5
3071809|NCT01328080|3792792|FG000|STARTED|Overall Study|11 subjects consented; 1 withdrew consent before first UVB treatment|11
3071810|NCT01328080|3792792|FG000|COMPLETED|Overall Study||6
3071811|NCT01328080|3792792|FG000|NOT COMPLETED|Overall Study||5
3071812|NCT01328158|3792796|FG000|STARTED|Overall Study||220
3071813|NCT01328158|3792796|FG000|COMPLETED|Overall Study||220
3071814|NCT01328158|3792796|FG000|NOT COMPLETED|Overall Study||0
3071815|NCT01328184|3792803|FG000|STARTED|Overall Study||18
3071816|NCT01328184|3792803|FG000|COMPLETED|Overall Study||18
3071817|NCT01328184|3792803|FG000|NOT COMPLETED|Overall Study||0
3134376|NCT01701258|3859420|FG011|Returned for PET (Session 3)|Assessment and Scheduling||0
3134377|NCT01701258|3859421|FG012|Returned for PET (Session 3)|Assessment and Scheduling||0
3134378|NCT01701258|3859409|FG000|Returned for EEG (Session 4)|Assessment and Scheduling||66
3134379|NCT01701258|3859410|FG001|Returned for EEG (Session 4)|Assessment and Scheduling||0
3134380|NCT01701258|3859411|FG002|Returned for EEG (Session 4)|Assessment and Scheduling||0
3134381|NCT01701258|3859412|FG003|Returned for EEG (Session 4)|Assessment and Scheduling||0
3134382|NCT01701258|3859413|FG004|Returned for EEG (Session 4)|Assessment and Scheduling||0
3134383|NCT01701258|3859414|FG005|Returned for EEG (Session 4)|Assessment and Scheduling||0
3134384|NCT01701258|3859415|FG006|Returned for EEG (Session 4)|Assessment and Scheduling||0
3134385|NCT01701258|3859416|FG007|Returned for EEG (Session 4)|Assessment and Scheduling||0
3134386|NCT01701258|3859417|FG008|Returned for EEG (Session 4)|Assessment and Scheduling||0
3134387|NCT01701258|3859418|FG009|Returned for EEG (Session 4)|Assessment and Scheduling||0
3134388|NCT01701258|3859419|FG010|Returned for EEG (Session 4)|Assessment and Scheduling||0
3134389|NCT01701258|3859420|FG011|Returned for EEG (Session 4)|Assessment and Scheduling||0
3134390|NCT01701258|3859421|FG012|Returned for EEG (Session 4)|Assessment and Scheduling||0
3134391|NCT01701258|3859409|FG000|COMPLETED|Assessment and Scheduling||70
3134392|NCT01701258|3859410|FG001|COMPLETED|Assessment and Scheduling||0
3134393|NCT01701258|3859411|FG002|COMPLETED|Assessment and Scheduling||0
3134394|NCT01701258|3859412|FG003|COMPLETED|Assessment and Scheduling||0
3134395|NCT01701258|3859413|FG004|COMPLETED|Assessment and Scheduling||0
3134396|NCT01701258|3859414|FG005|COMPLETED|Assessment and Scheduling||0
3134397|NCT01701258|3859415|FG006|COMPLETED|Assessment and Scheduling||0
3134398|NCT01701258|3859416|FG007|COMPLETED|Assessment and Scheduling||0
3134399|NCT01701258|3859417|FG008|COMPLETED|Assessment and Scheduling||0
3134400|NCT01701258|3859418|FG009|COMPLETED|Assessment and Scheduling||0
3071818|NCT01328249|3792811|FG000|STARTED|Overall Study||55
3071819|NCT01328249|3792812|FG001|STARTED|Overall Study||26
3071820|NCT01328249|3792811|FG000|COMPLETED|Overall Study||48
3071821|NCT01328249|3792812|FG001|COMPLETED|Overall Study||23
3071822|NCT01328249|3792811|FG000|NOT COMPLETED|Overall Study||7
3071823|NCT01328249|3792812|FG001|NOT COMPLETED|Overall Study||3
3071824|NCT01328366|3792820|FG000|STARTED|Overall Study||153
3071825|NCT01328366|3792820|FG000|COMPLETED|Overall Study||143
3071826|NCT01328366|3792820|FG000|NOT COMPLETED|Overall Study||10
3071827|NCT01328379|3792827|FG000|STARTED|Overall Study||143
3071828|NCT01328379|3792828|FG001|STARTED|Overall Study||144
3071829|NCT01328379|3792829|FG002|STARTED|Overall Study||143
3071830|NCT01328379|3792827|FG000|COMPLETED|Overall Study||142
3071831|NCT01328379|3792828|FG001|COMPLETED|Overall Study||144
3071832|NCT01328379|3792829|FG002|COMPLETED|Overall Study||143
3071833|NCT01328379|3792827|FG000|NOT COMPLETED|Overall Study||1
3071834|NCT01328379|3792828|FG001|NOT COMPLETED|Overall Study||0
3071835|NCT01328379|3792829|FG002|NOT COMPLETED|Overall Study||0
3071836|NCT01328405|3792839|FG000|STARTED|Overall Study||52
3071837|NCT01328405|3792840|FG001|STARTED|Overall Study||48
3071838|NCT01328405|3792839|FG000|COMPLETED|Overall Study||52
3071839|NCT01328405|3792840|FG001|COMPLETED|Overall Study||48
3071840|NCT01328405|3792839|FG000|NOT COMPLETED|Overall Study||0
3071841|NCT01328405|3792840|FG001|NOT COMPLETED|Overall Study||0
3071842|NCT01328431|3792848|FG000|STARTED|Baseline||390
3071843|NCT01328431|3792849|FG001|STARTED|Baseline||390
3071844|NCT01328431|3792848|FG000|COMPLETED|Baseline||390
3071845|NCT01328431|3792849|FG001|COMPLETED|Baseline|Two subjects enrolled in study twice. Protocol violation.|388
3071846|NCT01328431|3792848|FG000|NOT COMPLETED|Baseline||0
3071847|NCT01328431|3792849|FG001|NOT COMPLETED|Baseline||2
3071848|NCT01328431|3792848|FG000|STARTED|1 Month (1M)||390
3071849|NCT01328431|3792849|FG001|STARTED|1 Month (1M)||388
3071850|NCT01328431|3792848|FG000|COMPLETED|1 Month (1M)||335
3071851|NCT01328431|3792849|FG001|COMPLETED|1 Month (1M)||330
3071852|NCT01328431|3792848|FG000|NOT COMPLETED|1 Month (1M)||55
3071853|NCT01328431|3792849|FG001|NOT COMPLETED|1 Month (1M)||58
3071854|NCT01328431|3792848|FG000|STARTED|3 Month (3M)|Attempted to contact all subjects for 3M follow-up, regardless of whether they completed 1M.|390
3071855|NCT01328431|3792849|FG001|STARTED|3 Month (3M)|Attempted to contact all subjects for 3M follow-up, regardless of whether they completed 1M.|388
3071856|NCT01328431|3792848|FG000|COMPLETED|3 Month (3M)||313
3071857|NCT01328431|3792849|FG001|COMPLETED|3 Month (3M)||316
3071858|NCT01328431|3792848|FG000|NOT COMPLETED|3 Month (3M)||77
3071859|NCT01328431|3792849|FG001|NOT COMPLETED|3 Month (3M)||72
3071860|NCT01328431|3792848|FG000|STARTED|12 Month (12M)|Attempted to contact all subjects at 12M follow-up. Deceased subjects excluded.|388
3071861|NCT01328431|3792849|FG001|STARTED|12 Month (12M)|Attempted to contact all subjects at 12M follow-up. Deceased subjects excluded.|386
3071862|NCT01328431|3792848|FG000|COMPLETED|12 Month (12M)||304
3071863|NCT01328431|3792849|FG001|COMPLETED|12 Month (12M)||289
3071864|NCT01328431|3792848|FG000|NOT COMPLETED|12 Month (12M)||84
3071865|NCT01328431|3792849|FG001|NOT COMPLETED|12 Month (12M)||97
3071866|NCT01328444|3792855|FG000|STARTED|Treatment Period 1 (12 Weeks)||94
3071867|NCT01328444|3792856|FG001|STARTED|Treatment Period 1 (12 Weeks)||26
3071868|NCT01328444|3792857|FG002|STARTED|Treatment Period 1 (12 Weeks)||28
3071869|NCT01328444|3792858|FG003|STARTED|Treatment Period 1 (12 Weeks)||41
3071870|NCT01328444|3792859|FG004|STARTED|Treatment Period 1 (12 Weeks)||81
3071871|NCT01328444|3792860|FG005|STARTED|Treatment Period 1 (12 Weeks)||78
3071872|NCT01328444|3792855|FG000|COMPLETED|Treatment Period 1 (12 Weeks)||83
3071873|NCT01328444|3792856|FG001|COMPLETED|Treatment Period 1 (12 Weeks)||21
3071874|NCT01328444|3792857|FG002|COMPLETED|Treatment Period 1 (12 Weeks)||25
3071875|NCT01328444|3792858|FG003|COMPLETED|Treatment Period 1 (12 Weeks)||33
3071876|NCT01328444|3792859|FG004|COMPLETED|Treatment Period 1 (12 Weeks)||67
3071877|NCT01328444|3792860|FG005|COMPLETED|Treatment Period 1 (12 Weeks)||72
3071878|NCT01328444|3792855|FG000|NOT COMPLETED|Treatment Period 1 (12 Weeks)||11
3071879|NCT01328444|3792856|FG001|NOT COMPLETED|Treatment Period 1 (12 Weeks)||5
3071880|NCT01328444|3792857|FG002|NOT COMPLETED|Treatment Period 1 (12 Weeks)||3
3071881|NCT01328444|3792858|FG003|NOT COMPLETED|Treatment Period 1 (12 Weeks)||8
3071882|NCT01328444|3792859|FG004|NOT COMPLETED|Treatment Period 1 (12 Weeks)||14
3071883|NCT01328444|3792860|FG005|NOT COMPLETED|Treatment Period 1 (12 Weeks)||6
3071884|NCT01328444|3792855|FG000|STARTED|Washout Period (14 Days)||83
3071885|NCT01328444|3792856|FG001|STARTED|Washout Period (14 Days)||21
3071886|NCT01328444|3792857|FG002|STARTED|Washout Period (14 Days)||25
3071887|NCT01328444|3792858|FG003|STARTED|Washout Period (14 Days)||33
3071888|NCT01328444|3792859|FG004|STARTED|Washout Period (14 Days)||67
3071889|NCT01328444|3792860|FG005|STARTED|Washout Period (14 Days)||72
3071890|NCT01328444|3792855|FG000|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|82
3071891|NCT01328444|3792856|FG001|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|20
3071892|NCT01328444|3792857|FG002|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|25
3071893|NCT01328444|3792858|FG003|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|32
3071894|NCT01328444|3792859|FG004|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|66
3071895|NCT01328444|3792860|FG005|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|68
3071896|NCT01328444|3792855|FG000|NOT COMPLETED|Washout Period (14 Days)||1
3071897|NCT01328444|3792856|FG001|NOT COMPLETED|Washout Period (14 Days)||1
3071898|NCT01328444|3792857|FG002|NOT COMPLETED|Washout Period (14 Days)||0
3071899|NCT01328444|3792858|FG003|NOT COMPLETED|Washout Period (14 Days)||1
3071900|NCT01328444|3792859|FG004|NOT COMPLETED|Washout Period (14 Days)||1
3071901|NCT01328444|3792860|FG005|NOT COMPLETED|Washout Period (14 Days)||4
3071902|NCT01328444|3792855|FG000|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|76
3284336|NCT02763826|4018167|FG005|NOT COMPLETED|Part 1 Dose Escalation, 1 mA||0
3284337|NCT02763826|4018168|FG006|NOT COMPLETED|Part 1 Dose Escalation, 1 mA||0
3284338|NCT02763826|4018169|FG007|NOT COMPLETED|Part 1 Dose Escalation, 1 mA||0
3284339|NCT02763826|4018162|FG000|STARTED|Part 1 Dose Escalation, 2 mA||0
3071903|NCT01328444|3792856|FG001|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|23
3071904|NCT01328444|3792857|FG002|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|22
3071905|NCT01328444|3792858|FG003|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|35
3071906|NCT01328444|3792859|FG004|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|71
3071907|NCT01328444|3792860|FG005|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|66
3071908|NCT01328444|3792855|FG000|COMPLETED|Treatment Period 2 (12 Weeks)||65
3071909|NCT01328444|3792856|FG001|COMPLETED|Treatment Period 2 (12 Weeks)||22
3071910|NCT01328444|3792857|FG002|COMPLETED|Treatment Period 2 (12 Weeks)||19
3071911|NCT01328444|3792858|FG003|COMPLETED|Treatment Period 2 (12 Weeks)||30
3071912|NCT01328444|3792859|FG004|COMPLETED|Treatment Period 2 (12 Weeks)||63
3071913|NCT01328444|3792860|FG005|COMPLETED|Treatment Period 2 (12 Weeks)||59
3071914|NCT01328444|3792855|FG000|NOT COMPLETED|Treatment Period 2 (12 Weeks)||11
3071915|NCT01328444|3792856|FG001|NOT COMPLETED|Treatment Period 2 (12 Weeks)||1
3071916|NCT01328444|3792857|FG002|NOT COMPLETED|Treatment Period 2 (12 Weeks)||3
3071917|NCT01328444|3792858|FG003|NOT COMPLETED|Treatment Period 2 (12 Weeks)||5
3071918|NCT01328444|3792859|FG004|NOT COMPLETED|Treatment Period 2 (12 Weeks)||8
3071919|NCT01328444|3792860|FG005|NOT COMPLETED|Treatment Period 2 (12 Weeks)||7
3071920|NCT01328496|3792876|FG000|STARTED|Overall Study||10
3071921|NCT01328496|3792877|FG001|STARTED|Overall Study||4
3071922|NCT01328496|3792876|FG000|COMPLETED|Overall Study||9
3071923|NCT01328496|3792877|FG001|COMPLETED|Overall Study||4
3071924|NCT01328496|3792876|FG000|NOT COMPLETED|Overall Study||1
3071925|NCT01328496|3792877|FG001|NOT COMPLETED|Overall Study||0
3071926|NCT01328535|3792886|FG000|STARTED|Overall Study||25
3071927|NCT01328535|3792886|FG000|COMPLETED|Overall Study||24
3071928|NCT01328535|3792886|FG000|NOT COMPLETED|Overall Study||1
3071929|NCT01328548|3792894|FG000|STARTED|Overall Study||191
3071930|NCT01328548|3792895|FG001|STARTED|Overall Study||50
3071931|NCT01328548|3792894|FG000|COMPLETED|Overall Study||187
3071932|NCT01328548|3792895|FG001|COMPLETED|Overall Study||50
3071933|NCT01328548|3792894|FG000|NOT COMPLETED|Overall Study||4
3071934|NCT01328548|3792895|FG001|NOT COMPLETED|Overall Study||0
3071935|NCT01328574|3792901|FG000|STARTED|Overall Study||13
3071936|NCT01328574|3792901|FG000|COMPLETED|Overall Study||12
3071937|NCT01328574|3792901|FG000|NOT COMPLETED|Overall Study||1
3071938|NCT01328717|3792910|FG000|STARTED|Overall Study||78
3071939|NCT01328717|3792910|FG000|COMPLETED|Overall Study||77
3071940|NCT01328717|3792910|FG000|NOT COMPLETED|Overall Study||1
3071941|NCT01328743|3792916|FG000|STARTED|Overall Study||91
3071942|NCT01328743|3792917|FG001|STARTED|Overall Study||89
3071943|NCT01328743|3792916|FG000|COMPLETED|Overall Study||82
3071944|NCT01328743|3792917|FG001|COMPLETED|Overall Study||79
3071945|NCT01328743|3792916|FG000|NOT COMPLETED|Overall Study||9
3071946|NCT01328743|3792917|FG001|NOT COMPLETED|Overall Study||10
3071947|NCT01328756|3792923|FG000|STARTED|Overall Study||314
3071948|NCT01328756|3792923|FG000|COMPLETED|Overall Study||191
3071949|NCT01328756|3792923|FG000|NOT COMPLETED|Overall Study||123
3071950|NCT01328769|3792929|FG000|STARTED|Overall Study||25
3071951|NCT01328769|3792930|FG001|STARTED|Overall Study||24
3071952|NCT01328769|3792929|FG000|COMPLETED|Overall Study||25
3071953|NCT01328769|3792930|FG001|COMPLETED|Overall Study||23
3071954|NCT01328769|3792929|FG000|NOT COMPLETED|Overall Study||0
3071955|NCT01328769|3792930|FG001|NOT COMPLETED|Overall Study||1
3071956|NCT01328782|3792939|FG000|STARTED|Overall Study||43
3071957|NCT01328782|3792940|FG001|STARTED|Overall Study||42
3071958|NCT01328782|3792941|FG002|STARTED|Overall Study||39
3071959|NCT01328782|3792939|FG000|COMPLETED|Overall Study||43
3071960|NCT01328782|3792940|FG001|COMPLETED|Overall Study||42
3071961|NCT01328782|3792941|FG002|COMPLETED|Overall Study||39
3071962|NCT01328782|3792939|FG000|NOT COMPLETED|Overall Study||0
3071963|NCT01328782|3792940|FG001|NOT COMPLETED|Overall Study||0
3071964|NCT01328782|3792941|FG002|NOT COMPLETED|Overall Study||0
3071965|NCT01328873|3792949|FG000|STARTED|Overall Study||49
3071966|NCT01328873|3792949|FG000|COMPLETED|Overall Study||49
3071967|NCT01328873|3792949|FG000|NOT COMPLETED|Overall Study||0
3071968|NCT01328951|3792957|FG000|STARTED|Overall Study||321
3071969|NCT01328951|3792958|FG001|STARTED|Overall Study||322
3071970|NCT01328951|3792957|FG000|COMPLETED|Overall Study||0
3071971|NCT01328951|3792958|FG001|COMPLETED|Overall Study||0
3071972|NCT01328951|3792957|FG000|NOT COMPLETED|Overall Study||321
3071973|NCT01328951|3792958|FG001|NOT COMPLETED|Overall Study||322
3071974|NCT01328964|3792971|FG000|STARTED|Overall Study||2212
3071975|NCT01328964|3792972|FG001|STARTED|Overall Study||3270
3071976|NCT01328964|3792973|FG002|STARTED|Overall Study||4424
3071977|NCT01328964|3792971|FG000|COMPLETED|Overall Study||2212
3071978|NCT01328964|3792972|FG001|COMPLETED|Overall Study||3270
3071979|NCT01328964|3792973|FG002|COMPLETED|Overall Study||4424
3071980|NCT01328964|3792971|FG000|NOT COMPLETED|Overall Study||0
3071981|NCT01328964|3792972|FG001|NOT COMPLETED|Overall Study||0
3071982|NCT01328964|3792973|FG002|NOT COMPLETED|Overall Study||0
3071983|NCT01329029|3792983|FG000|STARTED|Overall Study||973
3071984|NCT01329029|3792984|FG001|STARTED|Overall Study||972
3071985|NCT01329029|3792983|FG000|Full Analysis Set (FAS)|Overall Study||969
3071986|NCT01329029|3792984|FG001|Full Analysis Set (FAS)|Overall Study||966
3071987|NCT01329029|3792983|FG000|Safety Population|Overall Study||968
3071988|NCT01329029|3792984|FG001|Safety Population|Overall Study||967
3071989|NCT01329029|3792983|FG000|COMPLETED|Overall Study||704
3071990|NCT01329029|3792984|FG001|COMPLETED|Overall Study||780
3071991|NCT01329029|3792983|FG000|NOT COMPLETED|Overall Study||269
3071992|NCT01329029|3792984|FG001|NOT COMPLETED|Overall Study||192
3071993|NCT01329185|3792992|FG000|STARTED|Overall Study||10
3071994|NCT01329185|3792993|FG001|STARTED|Overall Study||7
3071995|NCT01329185|3792992|FG000|CMV Disease|Overall Study||1
3071996|NCT01329185|3792993|FG001|CMV Disease|Overall Study||0
3071997|NCT01329185|3792992|FG000|PTLD|Overall Study||1
3071998|NCT01329185|3792993|FG001|PTLD|Overall Study||0
3071999|NCT01329185|3792992|FG000|COMPLETED|Overall Study||10
3072000|NCT01329185|3792993|FG001|COMPLETED|Overall Study||7
3072001|NCT01329185|3792992|FG000|NOT COMPLETED|Overall Study||0
3072002|NCT01329185|3792993|FG001|NOT COMPLETED|Overall Study||0
3072003|NCT01329198|3793001|FG000|STARTED|Overall Study||3
3072004|NCT01329198|3793002|FG001|STARTED|Overall Study||2
3072005|NCT01329198|3793001|FG000|COMPLETED|Overall Study||3
3072006|NCT01329198|3793002|FG001|COMPLETED|Overall Study||2
3072007|NCT01329198|3793001|FG000|NOT COMPLETED|Overall Study||0
3072008|NCT01329198|3793002|FG001|NOT COMPLETED|Overall Study||0
3072009|NCT01329263|3793015|FG000|STARTED|Overall Study||15
3072010|NCT01329263|3793016|FG001|STARTED|Overall Study||45
3072011|NCT01329263|3793015|FG000|Completed Period 1 Own Menthol|Overall Study||15
3072012|NCT01329263|3793016|FG001|Completed Period 1 Own Menthol|Overall Study||45
3072013|NCT01329263|3793015|FG000|Completed Period 2 Own or CCrush Menthol|Overall Study||10
3072014|NCT01329263|3793016|FG001|Completed Period 2 Own or CCrush Menthol|Overall Study||30
3072015|NCT01329263|3793015|FG000|CompletedPer 3 Own or CCrush Non-menthol|Overall Study||10
3072016|NCT01329263|3793016|FG001|CompletedPer 3 Own or CCrush Non-menthol|Overall Study||22
3072017|NCT01329263|3793015|FG000|COMPLETED|Overall Study||10
3072018|NCT01329263|3793016|FG001|COMPLETED|Overall Study||22
3072019|NCT01329263|3793015|FG000|NOT COMPLETED|Overall Study||5
3072020|NCT01329263|3793016|FG001|NOT COMPLETED|Overall Study||23
3072021|NCT01329328|3793027|FG000|STARTED|Overall Study||15
3072022|NCT01329328|3793028|FG001|STARTED|Overall Study||17
3072023|NCT01329328|3793029|FG002|STARTED|Overall Study||18
3072024|NCT01329328|3793027|FG000|COMPLETED|Overall Study||13
3072025|NCT01329328|3793028|FG001|COMPLETED|Overall Study||13
3072026|NCT01329328|3793029|FG002|COMPLETED|Overall Study||15
3072027|NCT01329328|3793027|FG000|NOT COMPLETED|Overall Study||2
3072028|NCT01329328|3793028|FG001|NOT COMPLETED|Overall Study||4
3072029|NCT01329328|3793029|FG002|NOT COMPLETED|Overall Study||3
3072030|NCT01329380|3793037|FG000|STARTED|Overall Study||403
3072031|NCT01329380|3793037|FG000|Safety Population|Overall Study||396
3072032|NCT01329380|3793037|FG000|COMPLETED|Overall Study||374
3072033|NCT01329380|3793037|FG000|NOT COMPLETED|Overall Study||29
3072034|NCT01329419|3793041|FG000|STARTED|Overall Study||4393
3072035|NCT01329419|3793041|FG000|COMPLETED|Overall Study||4158
3072036|NCT01329419|3793041|FG000|NOT COMPLETED|Overall Study||235
3072037|NCT01329562|3793048|FG000|STARTED|Overall Study||20
3072038|NCT01329562|3793049|FG001|STARTED|Overall Study||21
3072039|NCT01329562|3793048|FG000|COMPLETED|Overall Study||11
3072040|NCT01329562|3793049|FG001|COMPLETED|Overall Study||14
3072041|NCT01329562|3793048|FG000|NOT COMPLETED|Overall Study||9
3072042|NCT01329562|3793049|FG001|NOT COMPLETED|Overall Study||7
3072043|NCT01329679|3793057|FG000|STARTED|Overall Study||13
3072044|NCT01329679|3793058|FG001|STARTED|Overall Study||13
3072045|NCT01329679|3793057|FG000|COMPLETED|Overall Study||13
3072046|NCT01329679|3793058|FG001|COMPLETED|Overall Study||13
3072047|NCT01329679|3793057|FG000|NOT COMPLETED|Overall Study||0
3072048|NCT01329679|3793058|FG001|NOT COMPLETED|Overall Study||0
3072049|NCT01329848|3793066|FG000|STARTED|Overall Study||83
3072050|NCT01329848|3793066|FG000|COMPLETED|Overall Study||54
3072051|NCT01329848|3793066|FG000|NOT COMPLETED|Overall Study||29
3072052|NCT01329900|3793070|FG000|STARTED|Overall Study||50
3072053|NCT01329900|3793070|FG000|COMPLETED|Overall Study||49
3072054|NCT01329900|3793070|FG000|NOT COMPLETED|Overall Study||1
3072055|NCT01329939|3793078|FG000|STARTED|Overall Study||7
3072056|NCT01329939|3793079|FG001|STARTED|Overall Study||5
3072057|NCT01329939|3793080|FG002|STARTED|Overall Study||5
3072058|NCT01329939|3793081|FG003|STARTED|Overall Study||9
3072059|NCT01329939|3793078|FG000|COMPLETED|Overall Study||4
3072060|NCT01329939|3793079|FG001|COMPLETED|Overall Study||4
3072061|NCT01329939|3793080|FG002|COMPLETED|Overall Study||4
3072062|NCT01329939|3793081|FG003|COMPLETED|Overall Study||4
3072063|NCT01329939|3793078|FG000|NOT COMPLETED|Overall Study||3
3072064|NCT01329939|3793079|FG001|NOT COMPLETED|Overall Study||1
3072065|NCT01329939|3793080|FG002|NOT COMPLETED|Overall Study||1
3072066|NCT01329939|3793081|FG003|NOT COMPLETED|Overall Study||5
3072067|NCT01329978|3793094|FG000|STARTED|Sofosbuvir+PEG+RBV Treatment Period||52
3072068|NCT01329978|3793095|FG001|STARTED|Sofosbuvir+PEG+RBV Treatment Period||125
3072069|NCT01329978|3793096|FG002|STARTED|Sofosbuvir+PEG+RBV Treatment Period||155
3072070|NCT01329978|3793097|FG003|STARTED|Sofosbuvir+PEG+RBV Treatment Period||0
3072071|NCT01329978|3793098|FG004|STARTED|Sofosbuvir+PEG+RBV Treatment Period||0
3072072|NCT01329978|3793094|FG000|COMPLETED|Sofosbuvir+PEG+RBV Treatment Period|Participants in this group were not re-randomized for further treatment|48
3072073|NCT01329978|3793095|FG001|COMPLETED|Sofosbuvir+PEG+RBV Treatment Period|Participants in this group were not re-randomized for further treatment|112
3072074|NCT01329978|3793096|FG002|COMPLETED|Sofosbuvir+PEG+RBV Treatment Period|150 participants were re-randomized after 12 weeks of treatment.|150
3072075|NCT01329978|3793097|FG003|COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||0
3072076|NCT01329978|3793098|FG004|COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||0
3072077|NCT01329978|3793094|FG000|NOT COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||4
3072078|NCT01329978|3793095|FG001|NOT COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||13
3072079|NCT01329978|3793096|FG002|NOT COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||5
3072080|NCT01329978|3793097|FG003|NOT COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||0
3072081|NCT01329978|3793098|FG004|NOT COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||0
3072082|NCT01329978|3793094|FG000|STARTED|Rerandomization Treatment Period||0
3072083|NCT01329978|3793095|FG001|STARTED|Rerandomization Treatment Period||0
3072084|NCT01329978|3793096|FG002|STARTED|Rerandomization Treatment Period||0
3072085|NCT01329978|3793097|FG003|STARTED|Rerandomization Treatment Period|This group includes participants rerandomized from the SOF+PEG+RBV 12 week/Rerandomization Group.|75
3072086|NCT01329978|3793098|FG004|STARTED|Rerandomization Treatment Period|This group includes participants rerandomized from the SOF+PEG+RBV 12 week/Rerandomization Group.|75
3072087|NCT01329978|3793094|FG000|COMPLETED|Rerandomization Treatment Period||0
3072088|NCT01329978|3793095|FG001|COMPLETED|Rerandomization Treatment Period||0
3072089|NCT01329978|3793096|FG002|COMPLETED|Rerandomization Treatment Period||0
3072090|NCT01329978|3793097|FG003|COMPLETED|Rerandomization Treatment Period||70
3072091|NCT01329978|3793098|FG004|COMPLETED|Rerandomization Treatment Period||71
3072092|NCT01329978|3793094|FG000|NOT COMPLETED|Rerandomization Treatment Period||0
3072093|NCT01329978|3793095|FG001|NOT COMPLETED|Rerandomization Treatment Period||0
3072094|NCT01329978|3793096|FG002|NOT COMPLETED|Rerandomization Treatment Period||0
3072095|NCT01329978|3793097|FG003|NOT COMPLETED|Rerandomization Treatment Period||5
3072096|NCT01329978|3793098|FG004|NOT COMPLETED|Rerandomization Treatment Period||4
3072097|NCT01330017|3793115|FG000|STARTED|Overall Study||109
3072098|NCT01330017|3793116|FG001|STARTED|Overall Study||108
3072099|NCT01330017|3793117|FG002|STARTED|Overall Study||107
3072100|NCT01330017|3793118|FG003|STARTED|Overall Study||112
3072101|NCT01330017|3793119|FG004|STARTED|Overall Study||103
3072102|NCT01330017|3793115|FG000|COMPLETED|Overall Study||104
3072103|NCT01330017|3793116|FG001|COMPLETED|Overall Study||104
3072104|NCT01330017|3793117|FG002|COMPLETED|Overall Study||99
3072105|NCT01330017|3793118|FG003|COMPLETED|Overall Study||100
3072106|NCT01330017|3793119|FG004|COMPLETED|Overall Study||100
3072107|NCT01330017|3793115|FG000|NOT COMPLETED|Overall Study||5
3072108|NCT01330017|3793116|FG001|NOT COMPLETED|Overall Study||4
3072109|NCT01330017|3793117|FG002|NOT COMPLETED|Overall Study||8
3072110|NCT01330017|3793118|FG003|NOT COMPLETED|Overall Study||12
3072111|NCT01330017|3793119|FG004|NOT COMPLETED|Overall Study||3
3072112|NCT01330030|3793133|FG000|STARTED|Overall Study||121
3072113|NCT01330030|3793134|FG001|STARTED|Overall Study||122
3072114|NCT01330030|3793133|FG000|COMPLETED|Overall Study|number assessed at week 52 follow-up|105
3072115|NCT01330030|3793134|FG001|COMPLETED|Overall Study|number assessed at week 52 follow-up|105
3072116|NCT01330030|3793133|FG000|NOT COMPLETED|Overall Study||16
3072117|NCT01330030|3793134|FG001|NOT COMPLETED|Overall Study||17
3072118|NCT01330043|3793142|FG000|STARTED|Overall Study||111
3072119|NCT01330043|3793143|FG001|STARTED|Overall Study||112
3284340|NCT02763826|4018163|FG001|STARTED|Part 1 Dose Escalation, 2 mA||3
3284341|NCT02763826|4018164|FG002|STARTED|Part 1 Dose Escalation, 2 mA||0
3284342|NCT02763826|4018165|FG003|STARTED|Part 1 Dose Escalation, 2 mA||0
3284343|NCT02763826|4018166|FG004|STARTED|Part 1 Dose Escalation, 2 mA||0
3284344|NCT02763826|4018167|FG005|STARTED|Part 1 Dose Escalation, 2 mA||0
3284345|NCT02763826|4018168|FG006|STARTED|Part 1 Dose Escalation, 2 mA||0
3284346|NCT02763826|4018169|FG007|STARTED|Part 1 Dose Escalation, 2 mA||0
3284347|NCT02763826|4018162|FG000|COMPLETED|Part 1 Dose Escalation, 2 mA||0
3284348|NCT02763826|4018163|FG001|COMPLETED|Part 1 Dose Escalation, 2 mA||3
3284349|NCT02763826|4018164|FG002|COMPLETED|Part 1 Dose Escalation, 2 mA||0
3072120|NCT01330043|3793142|FG000|COMPLETED|Overall Study||111
3072121|NCT01330043|3793143|FG001|COMPLETED|Overall Study||108
3072122|NCT01330043|3793142|FG000|NOT COMPLETED|Overall Study||0
3072123|NCT01330043|3793143|FG001|NOT COMPLETED|Overall Study||4
3072124|NCT01330108|3793149|FG000|STARTED|Overall Study||32
3072125|NCT01330108|3793149|FG000|COMPLETED|Overall Study||28
3072126|NCT01330108|3793149|FG000|NOT COMPLETED|Overall Study||4
3072127|NCT01330134|3793155|FG000|STARTED|Overall Study||244
3072128|NCT01330134|3793156|FG001|STARTED|Overall Study||237
3072129|NCT01330134|3793155|FG000|COMPLETED|Overall Study||244
3072130|NCT01330134|3793156|FG001|COMPLETED|Overall Study||237
3072131|NCT01330134|3793155|FG000|NOT COMPLETED|Overall Study||0
3284350|NCT02763826|4018165|FG003|COMPLETED|Part 1 Dose Escalation, 2 mA||0
3072132|NCT01330134|3793156|FG001|NOT COMPLETED|Overall Study||0
3072133|NCT01330290|3793162|FG000|STARTED|Overall Study||148
3072134|NCT01330290|3793162|FG000|COMPLETED|Overall Study|As this is a cross-sectional study, the terms completed/not completed are not applicable.|148
3072135|NCT01330290|3793162|FG000|NOT COMPLETED|Overall Study||0
3072136|NCT01330303|3793166|FG000|STARTED|Period 1||20
3072137|NCT01330303|3793167|FG001|STARTED|Period 1||20
3072138|NCT01330303|3793166|FG000|COMPLETED|Period 1||19
3072139|NCT01330303|3793167|FG001|COMPLETED|Period 1||18
3072140|NCT01330303|3793166|FG000|NOT COMPLETED|Period 1||1
3072141|NCT01330303|3793167|FG001|NOT COMPLETED|Period 1||2
3072142|NCT01330303|3793166|FG000|STARTED|7-Day Washout Period||19
3072143|NCT01330303|3793167|FG001|STARTED|7-Day Washout Period||18
3072144|NCT01330303|3793166|FG000|COMPLETED|7-Day Washout Period||19
3072145|NCT01330303|3793167|FG001|COMPLETED|7-Day Washout Period||18
3072146|NCT01330303|3793166|FG000|NOT COMPLETED|7-Day Washout Period||0
3072147|NCT01330303|3793167|FG001|NOT COMPLETED|7-Day Washout Period||0
3072148|NCT01330303|3793166|FG000|STARTED|Period 2||19
3072149|NCT01330303|3793167|FG001|STARTED|Period 2||18
3072150|NCT01330303|3793166|FG000|COMPLETED|Period 2||19
3072151|NCT01330303|3793167|FG001|COMPLETED|Period 2||18
3072152|NCT01330303|3793166|FG000|NOT COMPLETED|Period 2||0
3072153|NCT01330303|3793167|FG001|NOT COMPLETED|Period 2||0
3072154|NCT01330316|3793176|FG000|STARTED|Overall Study||43
3072155|NCT01330316|3793177|FG001|STARTED|Overall Study||75
3072156|NCT01330316|3793176|FG000|COMPLETED|Overall Study||41
3072157|NCT01330316|3793177|FG001|COMPLETED|Overall Study||60
3072158|NCT01330316|3793176|FG000|NOT COMPLETED|Overall Study||2
3072159|NCT01330316|3793177|FG001|NOT COMPLETED|Overall Study||15
3072160|NCT01330355|3793185|FG000|STARTED|Overall Study||16
3072161|NCT01330355|3793186|FG001|STARTED|Overall Study||17
3072162|NCT01330355|3793185|FG000|COMPLETED|Overall Study||16
3072163|NCT01330355|3793186|FG001|COMPLETED|Overall Study||17
3072164|NCT01330355|3793185|FG000|NOT COMPLETED|Overall Study||0
3072165|NCT01330355|3793186|FG001|NOT COMPLETED|Overall Study||0
3072166|NCT01330381|3793194|FG000|STARTED|Double-blind Treatment Period (8 Weeks)||107
3072167|NCT01330381|3793195|FG001|STARTED|Double-blind Treatment Period (8 Weeks)||108
3072168|NCT01330381|3793196|FG002|STARTED|Double-blind Treatment Period (8 Weeks)||0
3072169|NCT01330381|3793194|FG000|Received Treatment|Double-blind Treatment Period (8 Weeks)||106
3072170|NCT01330381|3793195|FG001|Received Treatment|Double-blind Treatment Period (8 Weeks)||107
3072171|NCT01330381|3793196|FG002|Received Treatment|Double-blind Treatment Period (8 Weeks)||0
3072172|NCT01330381|3793194|FG000|COMPLETED|Double-blind Treatment Period (8 Weeks)||96
3072173|NCT01330381|3793195|FG001|COMPLETED|Double-blind Treatment Period (8 Weeks)||101
3072174|NCT01330381|3793196|FG002|COMPLETED|Double-blind Treatment Period (8 Weeks)||0
3072175|NCT01330381|3793194|FG000|NOT COMPLETED|Double-blind Treatment Period (8 Weeks)||11
3072176|NCT01330381|3793195|FG001|NOT COMPLETED|Double-blind Treatment Period (8 Weeks)||7
3072177|NCT01330381|3793196|FG002|NOT COMPLETED|Double-blind Treatment Period (8 Weeks)||0
3072178|NCT01330381|3793194|FG000|STARTED|Open-label Treatment Period (16 Weeks)||98
3072179|NCT01330381|3793195|FG001|STARTED|Open-label Treatment Period (16 Weeks)||0
3072180|NCT01330381|3793196|FG002|STARTED|Open-label Treatment Period (16 Weeks)||99
3072181|NCT01330381|3793194|FG000|COMPLETED|Open-label Treatment Period (16 Weeks)||88
3072182|NCT01330381|3793195|FG001|COMPLETED|Open-label Treatment Period (16 Weeks)||0
3072183|NCT01330381|3793196|FG002|COMPLETED|Open-label Treatment Period (16 Weeks)||81
3072184|NCT01330381|3793194|FG000|NOT COMPLETED|Open-label Treatment Period (16 Weeks)||10
3072185|NCT01330381|3793195|FG001|NOT COMPLETED|Open-label Treatment Period (16 Weeks)||0
3072186|NCT01330381|3793196|FG002|NOT COMPLETED|Open-label Treatment Period (16 Weeks)||18
3072187|NCT01330394|3793207|FG000|STARTED|Overall Study||17
3072188|NCT01330394|3793208|FG001|STARTED|Overall Study||16
3072189|NCT01330394|3793207|FG000|COMPLETED|Overall Study||17
3072190|NCT01330394|3793208|FG001|COMPLETED|Overall Study||16
3072191|NCT01330394|3793207|FG000|NOT COMPLETED|Overall Study||0
3072192|NCT01330394|3793208|FG001|NOT COMPLETED|Overall Study||0
3072193|NCT01330420|3793214|FG000|STARTED|Overall Study||28
3072194|NCT01330420|3793214|FG000|COMPLETED|Overall Study||24
3072195|NCT01330420|3793214|FG000|NOT COMPLETED|Overall Study||4
3072196|NCT01330433|3793220|FG000|STARTED|Overall Study||16
3072197|NCT01330433|3793221|FG001|STARTED|Overall Study||19
3072198|NCT01330433|3793220|FG000|COMPLETED|Overall Study||14
3072199|NCT01330433|3793221|FG001|COMPLETED|Overall Study||16
3072200|NCT01330433|3793220|FG000|NOT COMPLETED|Overall Study||2
3072201|NCT01330433|3793221|FG001|NOT COMPLETED|Overall Study||3
3072202|NCT01330459|3793229|FG000|STARTED|Overall Study||61
3072203|NCT01330459|3793230|FG001|STARTED|Overall Study||60
3072204|NCT01330459|3793229|FG000|COMPLETED|Overall Study||61
3072205|NCT01330459|3793230|FG001|COMPLETED|Overall Study||58
3072206|NCT01330459|3793229|FG000|NOT COMPLETED|Overall Study||0
3072207|NCT01330459|3793230|FG001|NOT COMPLETED|Overall Study||2
3072208|NCT01330628|3793240|FG000|STARTED|Overall Study||170
3072209|NCT01330628|3793241|FG001|STARTED|Overall Study||82
3072210|NCT01330628|3793240|FG000|30 Day Follow-up|Overall Study||165
3072211|NCT01330628|3793241|FG001|30 Day Follow-up|Overall Study||73
3072212|NCT01330628|3793240|FG000|6 Month Follow-up|Overall Study||135
3072213|NCT01330628|3793241|FG001|6 Month Follow-up|Overall Study||60
3072214|NCT01330628|3793240|FG000|COMPLETED|Overall Study||100
3072215|NCT01330628|3793241|FG001|COMPLETED|Overall Study||42
3072216|NCT01330628|3793240|FG000|NOT COMPLETED|Overall Study||70
3072217|NCT01330628|3793241|FG001|NOT COMPLETED|Overall Study||40
3072218|NCT01330914|3793247|FG000|STARTED|Overall Study||55
3072219|NCT01330914|3793247|FG000|COMPLETED|Overall Study||48
3072220|NCT01330914|3793247|FG000|NOT COMPLETED|Overall Study||7
3072221|NCT01330953|3793256|FG000|STARTED|Overall Study||8
3072222|NCT01330953|3793257|FG001|STARTED|Overall Study||6
3072223|NCT01330953|3793258|FG002|STARTED|Overall Study||6
3072224|NCT01330953|3793259|FG003|STARTED|Overall Study||6
3072225|NCT01330953|3793260|FG004|STARTED|Overall Study||6
3072226|NCT01330953|3793256|FG000|COMPLETED|Overall Study||8
3072227|NCT01330953|3793257|FG001|COMPLETED|Overall Study||6
3072228|NCT01330953|3793258|FG002|COMPLETED|Overall Study||6
3072229|NCT01330953|3793259|FG003|COMPLETED|Overall Study||6
3072230|NCT01330953|3793260|FG004|COMPLETED|Overall Study||6
3072231|NCT01330953|3793256|FG000|NOT COMPLETED|Overall Study||0
3072232|NCT01330953|3793257|FG001|NOT COMPLETED|Overall Study||0
3072233|NCT01330953|3793258|FG002|NOT COMPLETED|Overall Study||0
3072234|NCT01330953|3793259|FG003|NOT COMPLETED|Overall Study||0
3072235|NCT01330953|3793260|FG004|NOT COMPLETED|Overall Study||0
3072236|NCT01330966|3793277|FG000|STARTED|Overall Study||47
3072237|NCT01330966|3793277|FG000|COMPLETED|Overall Study|Tumor responses evaluable in 42 of 47 pts; 5 pts discontinued prior to first tumor assessment.|42
3072238|NCT01330966|3793277|FG000|NOT COMPLETED|Overall Study||5
3072239|NCT01331005|3793283|FG000|STARTED|Overall Study||64
3072240|NCT01331005|3793284|FG001|STARTED|Overall Study||61
3072241|NCT01331005|3793283|FG000|COMPLETED|Overall Study||60
3072242|NCT01331005|3793284|FG001|COMPLETED|Overall Study||57
3072243|NCT01331005|3793283|FG000|NOT COMPLETED|Overall Study||4
3072244|NCT01331005|3793284|FG001|NOT COMPLETED|Overall Study||4
3072245|NCT01331083|3793292|FG000|STARTED|Overall Study||43
3072246|NCT01331083|3793293|FG001|STARTED|Overall Study||25
3072247|NCT01331083|3793292|FG000|COMPLETED|Overall Study||43
3072248|NCT01331083|3793293|FG001|COMPLETED|Overall Study||25
3072249|NCT01331083|3793292|FG000|NOT COMPLETED|Overall Study||0
3072250|NCT01331083|3793293|FG001|NOT COMPLETED|Overall Study||0
3072251|NCT01331109|3793299|FG000|STARTED|Overall Study||57
3072252|NCT01331109|3793299|FG000|COMPLETED|Overall Study||0
3072253|NCT01331109|3793299|FG000|NOT COMPLETED|Overall Study||57
3072254|NCT01331161|3793305|FG000|STARTED|Overall Study||44
3072255|NCT01331161|3793306|FG001|STARTED|Overall Study||33
3072256|NCT01331161|3793305|FG000|COMPLETED|Overall Study||43
3072257|NCT01331161|3793306|FG001|COMPLETED|Overall Study||31
3072258|NCT01331161|3793305|FG000|NOT COMPLETED|Overall Study||1
3072259|NCT01331161|3793306|FG001|NOT COMPLETED|Overall Study||2
3072260|NCT01331213|3793316|FG000|STARTED|Overall Study||8
3072261|NCT01331213|3793317|FG001|STARTED|Overall Study||10
3072262|NCT01331213|3793316|FG000|COMPLETED|Overall Study||8
3072263|NCT01331213|3793317|FG001|COMPLETED|Overall Study||10
3072264|NCT01331213|3793316|FG000|NOT COMPLETED|Overall Study||0
3072265|NCT01331213|3793317|FG001|NOT COMPLETED|Overall Study||0
3072266|NCT01331239|3793325|FG000|STARTED|Part I: Core Study||12
3072267|NCT01331239|3793326|FG001|STARTED|Part I: Core Study||0
3072268|NCT01331239|3793327|FG002|STARTED|Part I: Core Study||0
3072269|NCT01331239|3793325|FG000|COMPLETED|Part I: Core Study||12
3072270|NCT01331239|3793326|FG001|COMPLETED|Part I: Core Study||0
3072271|NCT01331239|3793327|FG002|COMPLETED|Part I: Core Study||0
3072272|NCT01331239|3793325|FG000|NOT COMPLETED|Part I: Core Study||0
3072273|NCT01331239|3793326|FG001|NOT COMPLETED|Part I: Core Study||0
3072274|NCT01331239|3793327|FG002|NOT COMPLETED|Part I: Core Study||0
3072275|NCT01331239|3793325|FG000|STARTED|Part II: Core Study||0
3072276|NCT01331239|3793326|FG001|STARTED|Part II: Core Study||15
3072277|NCT01331239|3793327|FG002|STARTED|Part II: Core Study||4
3072278|NCT01331239|3793325|FG000|COMPLETED|Part II: Core Study||0
3072279|NCT01331239|3793326|FG001|COMPLETED|Part II: Core Study||7
3072280|NCT01331239|3793327|FG002|COMPLETED|Part II: Core Study||3
3072281|NCT01331239|3793325|FG000|NOT COMPLETED|Part II: Core Study||0
3072282|NCT01331239|3793326|FG001|NOT COMPLETED|Part II: Core Study||8
3072283|NCT01331239|3793327|FG002|NOT COMPLETED|Part II: Core Study||1
3072284|NCT01331291|3793345|FG000|STARTED|Overall Study||2
3072285|NCT01331291|3793346|FG001|STARTED|Overall Study||9
3072286|NCT01331291|3793345|FG000|COMPLETED|Overall Study||0
3072287|NCT01331291|3793346|FG001|COMPLETED|Overall Study||0
3072288|NCT01331291|3793345|FG000|NOT COMPLETED|Overall Study||2
3072289|NCT01331291|3793346|FG001|NOT COMPLETED|Overall Study||9
3072290|NCT01331304|3793353|FG000|STARTED|Overall Study||240
3072291|NCT01331304|3793354|FG001|STARTED|Overall Study||242
3072292|NCT01331304|3793353|FG000|COMPLETED|Overall Study||182
3072293|NCT01331304|3793354|FG001|COMPLETED|Overall Study||182
3072294|NCT01331304|3793353|FG000|NOT COMPLETED|Overall Study||58
3072295|NCT01331304|3793354|FG001|NOT COMPLETED|Overall Study||60
3072296|NCT01331408|3793361|FG000|STARTED|Overall Study||61
3072297|NCT01331408|3793361|FG000|COMPLETED|Overall Study||50
3072298|NCT01331408|3793361|FG000|NOT COMPLETED|Overall Study||11
3072299|NCT01331681|3793368|FG000|STARTED|Overall Study|randomized|136
3072300|NCT01331681|3793369|FG001|STARTED|Overall Study|randomized|135
3072301|NCT01331681|3793370|FG002|STARTED|Overall Study|randomized|135
3072302|NCT01331681|3793368|FG000|Participants Received Treatment|Overall Study|safety population|136
3072303|NCT01331681|3793369|FG001|Participants Received Treatment|Overall Study|safety population|135
3072304|NCT01331681|3793370|FG002|Participants Received Treatment|Overall Study|safety population|133
3072305|NCT01331681|3793368|FG000|Completed Week 52|Overall Study||125
3072306|NCT01331681|3793369|FG001|Completed Week 52|Overall Study||121
3072307|NCT01331681|3793370|FG002|Completed Week 52|Overall Study||115
3072308|NCT01331681|3793368|FG000|Completed Week 100|Overall Study||115
3072309|NCT01331681|3793369|FG001|Completed Week 100|Overall Study||110
3072310|NCT01331681|3793370|FG002|Completed Week 100|Overall Study||105
3072311|NCT01331681|3793368|FG000|Completed Week 148|Overall Study||101
3072312|NCT01331681|3793369|FG001|Completed Week 148|Overall Study||101
3072313|NCT01331681|3793370|FG002|Completed Week 148|Overall Study||100
3072314|NCT01331681|3793368|FG000|COMPLETED|Overall Study|Completed Week 148|101
3072315|NCT01331681|3793369|FG001|COMPLETED|Overall Study|Completed Week 148|101
3072316|NCT01331681|3793370|FG002|COMPLETED|Overall Study|Completed Week 148|100
3072317|NCT01331681|3793368|FG000|NOT COMPLETED|Overall Study||35
3072318|NCT01331681|3793369|FG001|NOT COMPLETED|Overall Study||34
3072319|NCT01331681|3793370|FG002|NOT COMPLETED|Overall Study||35
3072320|NCT01331694|3793384|FG000|STARTED|Overall Study||16684
3072321|NCT01331694|3793385|FG001|STARTED|Overall Study||14449
3072322|NCT01331694|3793386|FG002|STARTED|Overall Study||12659
3072323|NCT01331694|3793387|FG003|STARTED|Overall Study||12595
3072324|NCT01331694|3793388|FG004|STARTED|Overall Study||10617
3072325|NCT01331694|3793389|FG005|STARTED|Overall Study||9126
3072326|NCT01331694|3793384|FG000|COMPLETED|Overall Study||16684
3072327|NCT01331694|3793385|FG001|COMPLETED|Overall Study||14449
3072328|NCT01331694|3793386|FG002|COMPLETED|Overall Study||12659
3072329|NCT01331694|3793387|FG003|COMPLETED|Overall Study||12595
3072330|NCT01331694|3793388|FG004|COMPLETED|Overall Study||10617
3072331|NCT01331694|3793389|FG005|COMPLETED|Overall Study||9126
3072332|NCT01331694|3793384|FG000|NOT COMPLETED|Overall Study||0
3072333|NCT01331694|3793385|FG001|NOT COMPLETED|Overall Study||0
3072334|NCT01331694|3793386|FG002|NOT COMPLETED|Overall Study||0
3072335|NCT01331694|3793387|FG003|NOT COMPLETED|Overall Study||0
3072336|NCT01331694|3793388|FG004|NOT COMPLETED|Overall Study||0
3072337|NCT01331694|3793389|FG005|NOT COMPLETED|Overall Study||0
3072338|NCT01331824|3793403|FG000|STARTED|Overall Study||22
3072339|NCT01331824|3793403|FG000|COMPLETED|Overall Study||9
3072340|NCT01331824|3793403|FG000|NOT COMPLETED|Overall Study||13
3072341|NCT01331837|3793409|FG000|STARTED|Overall Study||1538
3072342|NCT01331837|3793410|FG001|STARTED|Overall Study||1542
3072343|NCT01331837|3793409|FG000|COMPLETED|Overall Study||1482
3072344|NCT01331837|3793410|FG001|COMPLETED|Overall Study||1475
3072345|NCT01331837|3793409|FG000|NOT COMPLETED|Overall Study||56
3072346|NCT01331837|3793410|FG001|NOT COMPLETED|Overall Study||67
3072347|NCT01332019|3793418|FG000|STARTED|Overall Study||530
3072348|NCT01332019|3793419|FG001|STARTED|Overall Study||547
3072349|NCT01332019|3793418|FG000|COMPLETED|Overall Study||417
3072350|NCT01332019|3793419|FG001|COMPLETED|Overall Study||425
3072351|NCT01332019|3793418|FG000|NOT COMPLETED|Overall Study||113
3072352|NCT01332019|3793419|FG001|NOT COMPLETED|Overall Study||122
3072353|NCT01332071|3793425|FG000|STARTED|Period 1||13
3072354|NCT01332071|3793426|FG001|STARTED|Period 1||13
3072355|NCT01332071|3793425|FG000|COMPLETED|Period 1||13
3072356|NCT01332071|3793426|FG001|COMPLETED|Period 1||13
3072357|NCT01332071|3793425|FG000|NOT COMPLETED|Period 1||0
3072358|NCT01332071|3793426|FG001|NOT COMPLETED|Period 1||0
3072359|NCT01332071|3793425|FG000|STARTED|7-Day Washout Period||13
3072360|NCT01332071|3793426|FG001|STARTED|7-Day Washout Period||13
3072361|NCT01332071|3793425|FG000|COMPLETED|7-Day Washout Period||13
3072362|NCT01332071|3793426|FG001|COMPLETED|7-Day Washout Period||13
3072363|NCT01332071|3793425|FG000|NOT COMPLETED|7-Day Washout Period||0
3072364|NCT01332071|3793426|FG001|NOT COMPLETED|7-Day Washout Period||0
3072365|NCT01332071|3793425|FG000|STARTED|Period 2||13
3072366|NCT01332071|3793426|FG001|STARTED|Period 2||13
3072367|NCT01332071|3793425|FG000|COMPLETED|Period 2||13
3072368|NCT01332071|3793426|FG001|COMPLETED|Period 2||13
3072369|NCT01332071|3793425|FG000|NOT COMPLETED|Period 2||0
3072370|NCT01332071|3793426|FG001|NOT COMPLETED|Period 2||0
3072371|NCT01332123|3793434|FG000|STARTED|Overall Study||10
3072372|NCT01332123|3793434|FG000|COMPLETED|Overall Study||10
3072373|NCT01332123|3793434|FG000|NOT COMPLETED|Overall Study||0
3072374|NCT01332149|3793441|FG000|STARTED|Overall Study|Assigned to study treatment.|314
3072375|NCT01332149|3793442|FG001|STARTED|Overall Study|Assigned to study treatment.|309
3072376|NCT01332149|3793441|FG000|Treated|Overall Study||313
3072377|NCT01332149|3793442|FG001|Treated|Overall Study||307
3072378|NCT01332149|3793441|FG000|COMPLETED|Overall Study||284
3072379|NCT01332149|3793442|FG001|COMPLETED|Overall Study||271
3072380|NCT01332149|3793441|FG000|NOT COMPLETED|Overall Study||30
3072381|NCT01332149|3793442|FG001|NOT COMPLETED|Overall Study||38
3072382|NCT01332188|3793452|FG000|STARTED|Overall Study||25
3072383|NCT01332188|3793453|FG001|STARTED|Overall Study||26
3072384|NCT01332188|3793454|FG002|STARTED|Overall Study||25
3072385|NCT01332188|3793455|FG003|STARTED|Overall Study||25
3072386|NCT01332188|3793452|FG000|COMPLETED|Overall Study||23
3072387|NCT01332188|3793453|FG001|COMPLETED|Overall Study||25
3072388|NCT01332188|3793454|FG002|COMPLETED|Overall Study||21
3072389|NCT01332188|3793455|FG003|COMPLETED|Overall Study||25
3072390|NCT01332188|3793452|FG000|NOT COMPLETED|Overall Study||2
3072391|NCT01332188|3793453|FG001|NOT COMPLETED|Overall Study||1
3072392|NCT01332188|3793454|FG002|NOT COMPLETED|Overall Study||4
3072393|NCT01332188|3793455|FG003|NOT COMPLETED|Overall Study||0
3072394|NCT01332227|3793467|FG000|STARTED|Overall Study|Participants who received treatment|72
3072395|NCT01332227|3793468|FG001|STARTED|Overall Study|Participants who received treatment|37
3072396|NCT01332227|3793467|FG000|COMPLETED|Overall Study||56
3072397|NCT01332227|3793468|FG001|COMPLETED|Overall Study||32
3072398|NCT01332227|3793467|FG000|NOT COMPLETED|Overall Study||16
3072399|NCT01332227|3793468|FG001|NOT COMPLETED|Overall Study||5
3072400|NCT01332253|3793476|FG000|STARTED|Overall Study||82
3072401|NCT01332253|3793477|FG001|STARTED|Overall Study||79
3072402|NCT01332253|3793476|FG000|COMPLETED|Overall Study||82
3072403|NCT01332253|3793477|FG001|COMPLETED|Overall Study||79
3072404|NCT01332253|3793476|FG000|NOT COMPLETED|Overall Study||0
3072405|NCT01332253|3793477|FG001|NOT COMPLETED|Overall Study||0
3072406|NCT01332292|3793483|FG000|STARTED|Treatment Period 1 (14 Days)||14
3072407|NCT01332292|3793484|FG001|STARTED|Treatment Period 1 (14 Days)||13
3072408|NCT01332292|3793483|FG000|COMPLETED|Treatment Period 1 (14 Days)||12
3072409|NCT01332292|3793484|FG001|COMPLETED|Treatment Period 1 (14 Days)||12
3072410|NCT01332292|3793483|FG000|NOT COMPLETED|Treatment Period 1 (14 Days)||2
3072411|NCT01332292|3793484|FG001|NOT COMPLETED|Treatment Period 1 (14 Days)||1
3072412|NCT01332292|3793483|FG000|STARTED|Washout Period (>=7 Days)||12
3072413|NCT01332292|3793484|FG001|STARTED|Washout Period (>=7 Days)||12
3072414|NCT01332292|3793483|FG000|COMPLETED|Washout Period (>=7 Days)||12
3072415|NCT01332292|3793484|FG001|COMPLETED|Washout Period (>=7 Days)||12
3072416|NCT01332292|3793483|FG000|NOT COMPLETED|Washout Period (>=7 Days)||0
3072417|NCT01332292|3793484|FG001|NOT COMPLETED|Washout Period (>=7 Days)||0
3072418|NCT01332292|3793483|FG000|STARTED|Treatment Period 2 (14 Days)||12
3072419|NCT01332292|3793484|FG001|STARTED|Treatment Period 2 (14 Days)||12
3072420|NCT01332292|3793483|FG000|COMPLETED|Treatment Period 2 (14 Days)||11
3072421|NCT01332292|3793484|FG001|COMPLETED|Treatment Period 2 (14 Days)||11
3072422|NCT01332292|3793483|FG000|NOT COMPLETED|Treatment Period 2 (14 Days)||1
3072423|NCT01332292|3793484|FG001|NOT COMPLETED|Treatment Period 2 (14 Days)||1
3072424|NCT01332305|3793497|FG000|STARTED|Overall Study||41
3072425|NCT01332305|3793498|FG001|STARTED|Overall Study||48
3072426|NCT01332305|3793499|FG002|STARTED|Overall Study||45
3072427|NCT01332305|3793500|FG003|STARTED|Overall Study||38
3072428|NCT01332305|3793501|FG004|STARTED|Overall Study||45
3072429|NCT01332305|3793497|FG000|COMPLETED|Overall Study||31
3072430|NCT01332305|3793498|FG001|COMPLETED|Overall Study||34
3072431|NCT01332305|3793499|FG002|COMPLETED|Overall Study||31
3072432|NCT01332305|3793500|FG003|COMPLETED|Overall Study||30
3072433|NCT01332305|3793501|FG004|COMPLETED|Overall Study||33
3072434|NCT01332305|3793497|FG000|NOT COMPLETED|Overall Study||10
3072435|NCT01332305|3793498|FG001|NOT COMPLETED|Overall Study||14
3072436|NCT01332305|3793499|FG002|NOT COMPLETED|Overall Study||14
3072437|NCT01332305|3793500|FG003|NOT COMPLETED|Overall Study||8
3072438|NCT01332305|3793501|FG004|NOT COMPLETED|Overall Study||12
3072439|NCT01332318|3793517|FG000|STARTED|Overall Study||34
3072440|NCT01332318|3793518|FG001|STARTED|Overall Study||32
3072441|NCT01332318|3793519|FG002|STARTED|Overall Study||34
3072442|NCT01332318|3793520|FG003|STARTED|Overall Study||30
3072443|NCT01332318|3793517|FG000|COMPLETED|Overall Study||32
3072444|NCT01332318|3793518|FG001|COMPLETED|Overall Study||28
3072445|NCT01332318|3793519|FG002|COMPLETED|Overall Study||33
3072446|NCT01332318|3793520|FG003|COMPLETED|Overall Study||28
3072447|NCT01332318|3793517|FG000|NOT COMPLETED|Overall Study||2
3072448|NCT01332318|3793518|FG001|NOT COMPLETED|Overall Study||4
3072449|NCT01332318|3793519|FG002|NOT COMPLETED|Overall Study||1
3072450|NCT01332318|3793520|FG003|NOT COMPLETED|Overall Study||2
3072451|NCT01332331|3793533|FG000|STARTED|Overall Study||21
3072452|NCT01332331|3793534|FG001|STARTED|Overall Study||20
3072453|NCT01332331|3793533|FG000|COMPLETED|Overall Study||19
3072454|NCT01332331|3793534|FG001|COMPLETED|Overall Study||18
3072455|NCT01332331|3793533|FG000|NOT COMPLETED|Overall Study||2
3072456|NCT01332331|3793534|FG001|NOT COMPLETED|Overall Study||2
3072457|NCT01332357|3793541|FG000|STARTED|Overall Study||6139
3072458|NCT01332357|3793541|FG000|COMPLETED|Overall Study||6139
3072459|NCT01332357|3793541|FG000|NOT COMPLETED|Overall Study||0
3072460|NCT01332435|3793549|FG000|STARTED|Overall Study||1572
3072461|NCT01332435|3793550|FG001|STARTED|Overall Study||1064
3072462|NCT01332435|3793551|FG002|STARTED|Overall Study||2604
3072463|NCT01332435|3793552|FG003|STARTED|Overall Study||1656
3072464|NCT01332435|3793549|FG000|COMPLETED|Overall Study||1572
3072465|NCT01332435|3793550|FG001|COMPLETED|Overall Study||1064
3072466|NCT01332435|3793551|FG002|COMPLETED|Overall Study||2604
3072467|NCT01332435|3793552|FG003|COMPLETED|Overall Study||1656
3072468|NCT01332435|3793549|FG000|NOT COMPLETED|Overall Study||0
3072469|NCT01332435|3793550|FG001|NOT COMPLETED|Overall Study||0
3072470|NCT01332435|3793551|FG002|NOT COMPLETED|Overall Study||0
3072471|NCT01332435|3793552|FG003|NOT COMPLETED|Overall Study||0
3072472|NCT01332461|3793565|FG000|STARTED|Overall Study||1291
3072473|NCT01332461|3793566|FG001|STARTED|Overall Study||4386
3072474|NCT01332461|3793565|FG000|COMPLETED|Overall Study||1291
3072475|NCT01332461|3793566|FG001|COMPLETED|Overall Study||4386
3072476|NCT01332461|3793565|FG000|NOT COMPLETED|Overall Study||0
3072477|NCT01332461|3793566|FG001|NOT COMPLETED|Overall Study||0
3072478|NCT01332487|3793574|FG000|STARTED|Overall Study||5554
3072479|NCT01332487|3793575|FG001|STARTED|Overall Study||3063
3072480|NCT01332487|3793574|FG000|COMPLETED|Overall Study||5554
3072481|NCT01332487|3793575|FG001|COMPLETED|Overall Study||3063
3072482|NCT01332487|3793574|FG000|NOT COMPLETED|Overall Study||0
3072483|NCT01332487|3793575|FG001|NOT COMPLETED|Overall Study||0
3072484|NCT01332500|3793585|FG000|STARTED|Overall Study||13257
3072485|NCT01332500|3793586|FG001|STARTED|Overall Study||39771
3072486|NCT01332500|3793587|FG002|STARTED|Overall Study||2903
3072487|NCT01332500|3793588|FG003|STARTED|Overall Study||5806
3072488|NCT01332500|3793585|FG000|COMPLETED|Overall Study||13257
3072489|NCT01332500|3793586|FG001|COMPLETED|Overall Study||39771
3072490|NCT01332500|3793587|FG002|COMPLETED|Overall Study||2903
3072491|NCT01332500|3793588|FG003|COMPLETED|Overall Study||5806
3072492|NCT01332500|3793585|FG000|NOT COMPLETED|Overall Study||0
3072493|NCT01332500|3793586|FG001|NOT COMPLETED|Overall Study||0
3072494|NCT01332500|3793587|FG002|NOT COMPLETED|Overall Study||0
3072495|NCT01332500|3793588|FG003|NOT COMPLETED|Overall Study||0
3072496|NCT01332578|3793598|FG000|STARTED|Period I||12
3072497|NCT01332578|3793599|FG001|STARTED|Period I||13
3072498|NCT01332578|3793598|FG000|COMPLETED|Period I||12
3072499|NCT01332578|3793599|FG001|COMPLETED|Period I||13
3072500|NCT01332578|3793598|FG000|NOT COMPLETED|Period I||0
3072501|NCT01332578|3793599|FG001|NOT COMPLETED|Period I||0
3072502|NCT01332578|3793598|FG000|STARTED|Washout Period||12
3072503|NCT01332578|3793599|FG001|STARTED|Washout Period||13
3072504|NCT01332578|3793598|FG000|COMPLETED|Washout Period||12
3072505|NCT01332578|3793599|FG001|COMPLETED|Washout Period||13
3072506|NCT01332578|3793598|FG000|NOT COMPLETED|Washout Period||0
3072507|NCT01332578|3793599|FG001|NOT COMPLETED|Washout Period||0
3072508|NCT01332578|3793598|FG000|STARTED|Period II||12
3072509|NCT01332578|3793599|FG001|STARTED|Period II||13
3072510|NCT01332578|3793598|FG000|COMPLETED|Period II||12
3072511|NCT01332578|3793599|FG001|COMPLETED|Period II||13
3072512|NCT01332578|3793598|FG000|NOT COMPLETED|Period II||0
3072513|NCT01332578|3793599|FG001|NOT COMPLETED|Period II||0
3072514|NCT01332630|3793606|FG000|STARTED|Overall Study||24
3072515|NCT01332630|3793606|FG000|COMPLETED|Overall Study||21
3072516|NCT01332630|3793606|FG000|NOT COMPLETED|Overall Study||3
3072517|NCT01332721|3793610|FG000|STARTED|Overall Study||38
3072518|NCT01332721|3793610|FG000|COMPLETED|Overall Study||38
3072519|NCT01332721|3793610|FG000|NOT COMPLETED|Overall Study||0
3072520|NCT01332851|3793616|FG000|STARTED|Overall Study||124
3072521|NCT01332851|3793617|FG001|STARTED|Overall Study||123
3072522|NCT01332851|3793616|FG000|Completed Intervention|Overall Study|9 no intervention, 8 <full dose, 107 full dose; 3 new caregivers enrolled-initial parent dropped out|107
3072523|NCT01332851|3793617|FG001|Completed Intervention|Overall Study|4 no intervention, 9 <full dose, 110 full dose; 4 new caregivers enrolled-initial parent dropped out|110
3072524|NCT01332851|3793616|FG000|Completed Follow up 1|Overall Study||116
3072525|NCT01332851|3793617|FG001|Completed Follow up 1|Overall Study|Includes 1 new caregiver enrolled due to initial parent no longer parenting|112
3072526|NCT01332851|3793616|FG000|Completed Follow up 2|Overall Study|Includes 1 new caregiver enrolled due to initial parent no longer parenting|111
3072527|NCT01332851|3793617|FG001|Completed Follow up 2|Overall Study|Includes 4 new caregivers enrolled due to initial parent no longer parenting|111
3072528|NCT01332851|3793616|FG000|Completed Follow up 3|Overall Study|Includes 3 new caregivers enrolled due to initial parent no longer parenting|113
3072529|NCT01332851|3793617|FG001|Completed Follow up 3|Overall Study|Includes 3 new caregivers enrolled due to initial parent no longer parenting|110
3072530|NCT01332851|3793616|FG000|COMPLETED|Overall Study||113
3072531|NCT01332851|3793617|FG001|COMPLETED|Overall Study||110
3072532|NCT01332851|3793616|FG000|NOT COMPLETED|Overall Study||11
3072533|NCT01332851|3793617|FG001|NOT COMPLETED|Overall Study||13
3072534|NCT01332981|3793627|FG000|STARTED|Overall Study||220
3072535|NCT01332981|3793627|FG000|COMPLETED|Overall Study||220
3072536|NCT01332981|3793627|FG000|NOT COMPLETED|Overall Study||0
3072537|NCT01332994|3793634|FG000|STARTED|Overall Study||519
3072538|NCT01332994|3793634|FG000|Completed Week 16|Overall Study||463
3072539|NCT01332994|3793634|FG000|Completed Week 32 (TCZ/TCZ)|Overall Study||200
3072540|NCT01332994|3793634|FG000|Completed Week 32 (TCZ/RTX)|Overall Study||26
3072541|NCT01332994|3793634|FG000|Completed Week 66 (TCZ/RTX)|Overall Study||25
3072542|NCT01332994|3793634|FG000|COMPLETED|Overall Study||448
3072543|NCT01332994|3793634|FG000|NOT COMPLETED|Overall Study||71
3072544|NCT01333033|3793640|FG000|STARTED|Overall Study||72
3072545|NCT01333033|3793641|FG001|STARTED|Overall Study||39
3072546|NCT01333033|3793642|FG002|STARTED|Overall Study||64
3072547|NCT01333033|3793643|FG003|STARTED|Overall Study||50
3072548|NCT01333033|3793644|FG004|STARTED|Overall Study||14
3072549|NCT01333033|3793645|FG005|STARTED|Overall Study||18
3072550|NCT01333033|3793640|FG000|COMPLETED|Overall Study||72
3072551|NCT01333033|3793641|FG001|COMPLETED|Overall Study||39
3072552|NCT01333033|3793642|FG002|COMPLETED|Overall Study||64
3072553|NCT01333033|3793643|FG003|COMPLETED|Overall Study||50
3072554|NCT01333033|3793644|FG004|COMPLETED|Overall Study||0
3072555|NCT01333033|3793645|FG005|COMPLETED|Overall Study||0
3072556|NCT01333033|3793640|FG000|NOT COMPLETED|Overall Study||0
3072557|NCT01333033|3793641|FG001|NOT COMPLETED|Overall Study||0
3072558|NCT01333033|3793642|FG002|NOT COMPLETED|Overall Study||0
3072559|NCT01333033|3793643|FG003|NOT COMPLETED|Overall Study||0
3072560|NCT01333033|3793644|FG004|NOT COMPLETED|Overall Study||14
3072561|NCT01333033|3793645|FG005|NOT COMPLETED|Overall Study||18
3072562|NCT01333059|3793665|FG000|STARTED|Overall Study||14
3072563|NCT01333059|3793666|FG001|STARTED|Overall Study||11
3072564|NCT01333059|3793665|FG000|COMPLETED|Overall Study||8
3072565|NCT01333059|3793666|FG001|COMPLETED|Overall Study||8
3072566|NCT01333059|3793665|FG000|NOT COMPLETED|Overall Study||6
3072567|NCT01333059|3793666|FG001|NOT COMPLETED|Overall Study||3
3072568|NCT01333072|3793676|FG000|STARTED|Overall Study||30
3072569|NCT01333072|3793677|FG001|STARTED|Overall Study||31
3072570|NCT01333072|3793676|FG000|COMPLETED|Overall Study||24
3072571|NCT01333072|3793677|FG001|COMPLETED|Overall Study||27
3072572|NCT01333072|3793676|FG000|NOT COMPLETED|Overall Study||6
3072573|NCT01333072|3793677|FG001|NOT COMPLETED|Overall Study||4
3072574|NCT01333098|3793683|FG000|STARTED|Overall Study||15
3072575|NCT01333098|3793683|FG000|COMPLETED|Overall Study||12
3072576|NCT01333098|3793683|FG000|NOT COMPLETED|Overall Study||3
3072577|NCT01333111|3793692|FG000|STARTED|Overall Study||30
3072578|NCT01333111|3793693|FG001|STARTED|Overall Study||29
3072579|NCT01333111|3793694|FG002|STARTED|Overall Study||15
3072580|NCT01333111|3793692|FG000|COMPLETED|Overall Study||28
3072581|NCT01333111|3793693|FG001|COMPLETED|Overall Study||26
3072582|NCT01333111|3793694|FG002|COMPLETED|Overall Study||13
3072583|NCT01333111|3793692|FG000|NOT COMPLETED|Overall Study||2
3072584|NCT01333111|3793693|FG001|NOT COMPLETED|Overall Study||3
3072585|NCT01333111|3793694|FG002|NOT COMPLETED|Overall Study||2
3072586|NCT01333189|3793704|FG000|STARTED|Overall Study||13
3072587|NCT01333189|3793705|FG001|STARTED|Overall Study||13
3072588|NCT01333189|3793704|FG000|COMPLETED|Overall Study||11
3072589|NCT01333189|3793705|FG001|COMPLETED|Overall Study||11
3072590|NCT01333189|3793704|FG000|NOT COMPLETED|Overall Study||2
3072591|NCT01333189|3793705|FG001|NOT COMPLETED|Overall Study||2
3072592|NCT01333397|3793716|FG000|STARTED|Overall Study||35
3163045|NCT01882465|3890492|FG001|COMPLETED|Period 3||6
3163046|NCT01882465|3890493|FG002|COMPLETED|Period 3||5
3163047|NCT01882465|3890494|FG003|COMPLETED|Period 3||5
3163048|NCT01882465|3890495|FG004|COMPLETED|Period 3||4
3163049|NCT01882465|3890496|FG005|COMPLETED|Period 3||5
3163050|NCT01882465|3890497|FG006|COMPLETED|Period 3||0
3163051|NCT01882465|3890491|FG000|NOT COMPLETED|Period 3||0
3072593|NCT01333397|3793717|FG001|STARTED|Overall Study||36
3072594|NCT01333397|3793718|FG002|STARTED|Overall Study||35
3072595|NCT01333397|3793719|FG003|STARTED|Overall Study||35
3072596|NCT01333397|3793720|FG004|STARTED|Overall Study||35
3072597|NCT01333397|3793716|FG000|COMPLETED|Overall Study||34
3072598|NCT01333397|3793717|FG001|COMPLETED|Overall Study||36
3072599|NCT01333397|3793718|FG002|COMPLETED|Overall Study||35
3072600|NCT01333397|3793719|FG003|COMPLETED|Overall Study||34
3072601|NCT01333397|3793720|FG004|COMPLETED|Overall Study||35
3072602|NCT01333397|3793716|FG000|NOT COMPLETED|Overall Study||1
3072603|NCT01333397|3793717|FG001|NOT COMPLETED|Overall Study||0
3072604|NCT01333397|3793718|FG002|NOT COMPLETED|Overall Study||0
3072605|NCT01333397|3793719|FG003|NOT COMPLETED|Overall Study||1
3072606|NCT01333397|3793720|FG004|NOT COMPLETED|Overall Study||0
3072607|NCT01333475|3793743|FG000|STARTED|Overall Study||12
3072608|NCT01333475|3793744|FG001|STARTED|Overall Study||9
3072609|NCT01333475|3793743|FG000|COMPLETED|Overall Study||10
3072610|NCT01333475|3793744|FG001|COMPLETED|Overall Study||6
3072611|NCT01333475|3793743|FG000|NOT COMPLETED|Overall Study||2
3072612|NCT01333475|3793744|FG001|NOT COMPLETED|Overall Study||3
3072613|NCT01333488|3793754|FG000|STARTED|Overall Study||2
3072614|NCT01333488|3793755|FG001|STARTED|Overall Study||1
3072615|NCT01333488|3793756|FG002|STARTED|Overall Study||3
3072616|NCT01333488|3793754|FG000|COMPLETED|Overall Study||2
3072617|NCT01333488|3793755|FG001|COMPLETED|Overall Study||1
3072618|NCT01333488|3793756|FG002|COMPLETED|Overall Study||3
3072619|NCT01333488|3793754|FG000|NOT COMPLETED|Overall Study||0
3072620|NCT01333488|3793755|FG001|NOT COMPLETED|Overall Study||0
3072621|NCT01333488|3793756|FG002|NOT COMPLETED|Overall Study||0
3072622|NCT01333501|3793767|FG000|STARTED|Overall Study||106
3072623|NCT01333501|3793768|FG001|STARTED|Overall Study||51
3072624|NCT01333501|3793767|FG000|Full Analysis Set (FAS)|Overall Study||80
3072625|NCT01333501|3793768|FG001|Full Analysis Set (FAS)|Overall Study||28
3072626|NCT01333501|3793767|FG000|Safety Population|Overall Study||104
3072627|NCT01333501|3793768|FG001|Safety Population|Overall Study||47
3072628|NCT01333501|3793767|FG000|COMPLETED|Overall Study||97
3072629|NCT01333501|3793768|FG001|COMPLETED|Overall Study||30
3072630|NCT01333501|3793767|FG000|NOT COMPLETED|Overall Study||9
3072631|NCT01333501|3793768|FG001|NOT COMPLETED|Overall Study||21
3072632|NCT01333527|3793776|FG000|STARTED|Overall Study||105
3072633|NCT01333527|3793777|FG001|STARTED|Overall Study||106
3072634|NCT01333527|3793776|FG000|COMPLETED|Overall Study||87
3072635|NCT01333527|3793777|FG001|COMPLETED|Overall Study||89
3072636|NCT01333527|3793776|FG000|NOT COMPLETED|Overall Study||18
3072637|NCT01333527|3793777|FG001|NOT COMPLETED|Overall Study||17
3072638|NCT01333592|3793785|FG000|STARTED|Overall Study||67
3072639|NCT01333592|3793786|FG001|STARTED|Overall Study||69
3072640|NCT01333592|3793785|FG000|COMPLETED|Overall Study||58
3072641|NCT01333592|3793786|FG001|COMPLETED|Overall Study||52
3072642|NCT01333592|3793785|FG000|NOT COMPLETED|Overall Study||9
3072643|NCT01333592|3793786|FG001|NOT COMPLETED|Overall Study||17
3072644|NCT01333722|3793794|FG000|STARTED|Overall Study||51
3072645|NCT01333722|3793795|FG001|STARTED|Overall Study||49
3072646|NCT01333722|3793794|FG000|COMPLETED|Overall Study||51
3072647|NCT01333722|3793795|FG001|COMPLETED|Overall Study||46
3072648|NCT01333722|3793794|FG000|NOT COMPLETED|Overall Study||0
3072649|NCT01333722|3793795|FG001|NOT COMPLETED|Overall Study||3
3072650|NCT01333813|3793803|FG000|STARTED|Overall Study||297
3072651|NCT01333813|3793803|FG000|COMPLETED|Overall Study||297
3072652|NCT01333813|3793803|FG000|NOT COMPLETED|Overall Study||0
3072653|NCT01333865|3793807|FG000|STARTED|Overall Study|25 participants signed consent, but only 19 completed screening and were analyzed at baseline.|19
3072654|NCT01333865|3793807|FG000|COMPLETED|Overall Study|2 participants were withdrawn. One was still analyzed, but one was withdrawn too early for analysis|17
3072655|NCT01333865|3793807|FG000|NOT COMPLETED|Overall Study||2
3072656|NCT01333943|3793813|FG000|STARTED|Overall Study||47
3072657|NCT01333943|3793814|FG001|STARTED|Overall Study||47
3163052|NCT01882465|3890492|FG001|NOT COMPLETED|Period 3||0
3163053|NCT01882465|3890493|FG002|NOT COMPLETED|Period 3||0
3072658|NCT01333943|3793813|FG000|COMPLETED|Overall Study||46
3072659|NCT01333943|3793814|FG001|COMPLETED|Overall Study||47
3072660|NCT01333943|3793813|FG000|NOT COMPLETED|Overall Study||1
3072661|NCT01333943|3793814|FG001|NOT COMPLETED|Overall Study||0
3134401|NCT01701258|3859419|FG010|COMPLETED|Assessment and Scheduling||0
3134402|NCT01701258|3859420|FG011|COMPLETED|Assessment and Scheduling||0
3134403|NCT01701258|3859421|FG012|COMPLETED|Assessment and Scheduling||0
3134404|NCT01701258|3859409|FG000|NOT COMPLETED|Assessment and Scheduling||83
3134405|NCT01701258|3859410|FG001|NOT COMPLETED|Assessment and Scheduling||0
3134406|NCT01701258|3859411|FG002|NOT COMPLETED|Assessment and Scheduling||0
3134407|NCT01701258|3859412|FG003|NOT COMPLETED|Assessment and Scheduling||0
3134408|NCT01701258|3859413|FG004|NOT COMPLETED|Assessment and Scheduling||0
3134409|NCT01701258|3859414|FG005|NOT COMPLETED|Assessment and Scheduling||0
3134410|NCT01701258|3859415|FG006|NOT COMPLETED|Assessment and Scheduling||0
3134411|NCT01701258|3859416|FG007|NOT COMPLETED|Assessment and Scheduling||0
3134412|NCT01701258|3859417|FG008|NOT COMPLETED|Assessment and Scheduling||0
3134413|NCT01701258|3859418|FG009|NOT COMPLETED|Assessment and Scheduling||0
3134414|NCT01701258|3859419|FG010|NOT COMPLETED|Assessment and Scheduling||0
3134415|NCT01701258|3859420|FG011|NOT COMPLETED|Assessment and Scheduling||0
3134416|NCT01701258|3859421|FG012|NOT COMPLETED|Assessment and Scheduling||0
3134417|NCT01701258|3859409|FG000|STARTED|Drug+fMRI (Session 2)||0
3134418|NCT01701258|3859410|FG001|STARTED|Drug+fMRI (Session 2)||0
3134419|NCT01701258|3859411|FG002|STARTED|Drug+fMRI (Session 2)||11
3134420|NCT01701258|3859412|FG003|STARTED|Drug+fMRI (Session 2)||11
3134421|NCT01701258|3859413|FG004|STARTED|Drug+fMRI (Session 2)||0
3134422|NCT01701258|3859414|FG005|STARTED|Drug+fMRI (Session 2)||9
3134423|NCT01701258|3859415|FG006|STARTED|Drug+fMRI (Session 2)||8
3134424|NCT01701258|3859416|FG007|STARTED|Drug+fMRI (Session 2)||0
3134425|NCT01701258|3859417|FG008|STARTED|Drug+fMRI (Session 2)||6
3134426|NCT01701258|3859418|FG009|STARTED|Drug+fMRI (Session 2)||6
3134427|NCT01701258|3859419|FG010|STARTED|Drug+fMRI (Session 2)||0
3134428|NCT01701258|3859420|FG011|STARTED|Drug+fMRI (Session 2)||10
3134429|NCT01701258|3859421|FG012|STARTED|Drug+fMRI (Session 2)||7
3134430|NCT01701258|3859409|FG000|Received Drug Challenge|Drug+fMRI (Session 2)||0
3134431|NCT01701258|3859410|FG001|Received Drug Challenge|Drug+fMRI (Session 2)||0
3134432|NCT01701258|3859411|FG002|Received Drug Challenge|Drug+fMRI (Session 2)||11
3134433|NCT01701258|3859412|FG003|Received Drug Challenge|Drug+fMRI (Session 2)||11
3134434|NCT01701258|3859413|FG004|Received Drug Challenge|Drug+fMRI (Session 2)||0
3134435|NCT01701258|3859414|FG005|Received Drug Challenge|Drug+fMRI (Session 2)||9
3134436|NCT01701258|3859415|FG006|Received Drug Challenge|Drug+fMRI (Session 2)||8
3134437|NCT01701258|3859416|FG007|Received Drug Challenge|Drug+fMRI (Session 2)||0
3134438|NCT01701258|3859417|FG008|Received Drug Challenge|Drug+fMRI (Session 2)||6
3134439|NCT01701258|3859418|FG009|Received Drug Challenge|Drug+fMRI (Session 2)||6
3134440|NCT01701258|3859419|FG010|Received Drug Challenge|Drug+fMRI (Session 2)||0
3134441|NCT01701258|3859420|FG011|Received Drug Challenge|Drug+fMRI (Session 2)||10
3134442|NCT01701258|3859421|FG012|Received Drug Challenge|Drug+fMRI (Session 2)||7
3134443|NCT01701258|3859409|FG000|COMPLETED|Drug+fMRI (Session 2)||0
3134444|NCT01701258|3859410|FG001|COMPLETED|Drug+fMRI (Session 2)||0
3134445|NCT01701258|3859411|FG002|COMPLETED|Drug+fMRI (Session 2)||11
3134446|NCT01701258|3859412|FG003|COMPLETED|Drug+fMRI (Session 2)||11
3134447|NCT01701258|3859413|FG004|COMPLETED|Drug+fMRI (Session 2)||0
3134448|NCT01701258|3859414|FG005|COMPLETED|Drug+fMRI (Session 2)||9
3134449|NCT01701258|3859415|FG006|COMPLETED|Drug+fMRI (Session 2)||8
3134450|NCT01701258|3859416|FG007|COMPLETED|Drug+fMRI (Session 2)||0
3134451|NCT01701258|3859417|FG008|COMPLETED|Drug+fMRI (Session 2)||6
3134452|NCT01701258|3859418|FG009|COMPLETED|Drug+fMRI (Session 2)||6
3134453|NCT01701258|3859419|FG010|COMPLETED|Drug+fMRI (Session 2)||0
3134454|NCT01701258|3859420|FG011|COMPLETED|Drug+fMRI (Session 2)||10
3134455|NCT01701258|3859421|FG012|COMPLETED|Drug+fMRI (Session 2)||7
3134456|NCT01701258|3859409|FG000|NOT COMPLETED|Drug+fMRI (Session 2)||0
3134457|NCT01701258|3859410|FG001|NOT COMPLETED|Drug+fMRI (Session 2)||0
3134458|NCT01701258|3859411|FG002|NOT COMPLETED|Drug+fMRI (Session 2)||0
3134459|NCT01701258|3859412|FG003|NOT COMPLETED|Drug+fMRI (Session 2)||0
3134460|NCT01701258|3859413|FG004|NOT COMPLETED|Drug+fMRI (Session 2)||0
3134461|NCT01701258|3859414|FG005|NOT COMPLETED|Drug+fMRI (Session 2)||0
3134462|NCT01701258|3859415|FG006|NOT COMPLETED|Drug+fMRI (Session 2)||0
3134463|NCT01701258|3859416|FG007|NOT COMPLETED|Drug+fMRI (Session 2)||0
3134464|NCT01701258|3859417|FG008|NOT COMPLETED|Drug+fMRI (Session 2)||0
3134465|NCT01701258|3859418|FG009|NOT COMPLETED|Drug+fMRI (Session 2)||0
3134466|NCT01701258|3859419|FG010|NOT COMPLETED|Drug+fMRI (Session 2)||0
3134467|NCT01701258|3859420|FG011|NOT COMPLETED|Drug+fMRI (Session 2)||0
3134468|NCT01701258|3859421|FG012|NOT COMPLETED|Drug+fMRI (Session 2)||0
3134469|NCT01701258|3859409|FG000|STARTED|PET (Session 3)||0
3134470|NCT01701258|3859410|FG001|STARTED|PET (Session 3)||20
3134471|NCT01701258|3859411|FG002|STARTED|PET (Session 3)||0
3134472|NCT01701258|3859412|FG003|STARTED|PET (Session 3)||0
3134473|NCT01701258|3859413|FG004|STARTED|PET (Session 3)||16
3134474|NCT01701258|3859414|FG005|STARTED|PET (Session 3)||0
3134475|NCT01701258|3859415|FG006|STARTED|PET (Session 3)||0
3134476|NCT01701258|3859416|FG007|STARTED|PET (Session 3)||19
3134477|NCT01701258|3859417|FG008|STARTED|PET (Session 3)||0
3134478|NCT01701258|3859418|FG009|STARTED|PET (Session 3)||0
3134479|NCT01701258|3859419|FG010|STARTED|PET (Session 3)||18
3134480|NCT01701258|3859420|FG011|STARTED|PET (Session 3)||0
3072662|NCT01333956|3793824|FG000|STARTED|Overall Study||30
3072663|NCT01333956|3793825|FG001|STARTED|Overall Study||30
3072664|NCT01333956|3793826|FG002|STARTED|Overall Study||30
3072665|NCT01333956|3793827|FG003|STARTED|Overall Study||30
3072666|NCT01333956|3793824|FG000|COMPLETED|Overall Study||28
3072667|NCT01333956|3793825|FG001|COMPLETED|Overall Study||26
3072668|NCT01333956|3793826|FG002|COMPLETED|Overall Study||29
3072669|NCT01333956|3793827|FG003|COMPLETED|Overall Study||28
3072670|NCT01333956|3793824|FG000|NOT COMPLETED|Overall Study||2
3072671|NCT01333956|3793825|FG001|NOT COMPLETED|Overall Study||4
3072672|NCT01333956|3793826|FG002|NOT COMPLETED|Overall Study||1
3072673|NCT01333956|3793827|FG003|NOT COMPLETED|Overall Study||2
3072674|NCT01334086|3793838|FG000|STARTED|Overall Study||41
3072675|NCT01334086|3793838|FG000|COMPLETED|Overall Study||41
3072676|NCT01334086|3793838|FG000|NOT COMPLETED|Overall Study||0
3072677|NCT01334125|3793844|FG000|STARTED|Overall Study||15
3072678|NCT01334125|3793845|FG001|STARTED|Overall Study||13
3072679|NCT01334125|3793844|FG000|COMPLETED|Overall Study|3 subjects move to another city|12
3284351|NCT02763826|4018166|FG004|COMPLETED|Part 1 Dose Escalation, 2 mA||0
3284352|NCT02763826|4018167|FG005|COMPLETED|Part 1 Dose Escalation, 2 mA||0
3284353|NCT02763826|4018168|FG006|COMPLETED|Part 1 Dose Escalation, 2 mA||0
3284354|NCT02763826|4018169|FG007|COMPLETED|Part 1 Dose Escalation, 2 mA||0
3284355|NCT02763826|4018162|FG000|NOT COMPLETED|Part 1 Dose Escalation, 2 mA||0
3284356|NCT02763826|4018163|FG001|NOT COMPLETED|Part 1 Dose Escalation, 2 mA||0
3284357|NCT02763826|4018164|FG002|NOT COMPLETED|Part 1 Dose Escalation, 2 mA||0
3284358|NCT02763826|4018165|FG003|NOT COMPLETED|Part 1 Dose Escalation, 2 mA||0
3284359|NCT02763826|4018166|FG004|NOT COMPLETED|Part 1 Dose Escalation, 2 mA||0
3284360|NCT02763826|4018167|FG005|NOT COMPLETED|Part 1 Dose Escalation, 2 mA||0
3284361|NCT02763826|4018168|FG006|NOT COMPLETED|Part 1 Dose Escalation, 2 mA||0
3284362|NCT02763826|4018169|FG007|NOT COMPLETED|Part 1 Dose Escalation, 2 mA||0
3284363|NCT02763826|4018162|FG000|STARTED|Part 1 Dose Escalation, 2.5 mA||0
3284364|NCT02763826|4018163|FG001|STARTED|Part 1 Dose Escalation, 2.5 mA||0
3284365|NCT02763826|4018164|FG002|STARTED|Part 1 Dose Escalation, 2.5 mA||3
3284366|NCT02763826|4018165|FG003|STARTED|Part 1 Dose Escalation, 2.5 mA||0
3284367|NCT02763826|4018166|FG004|STARTED|Part 1 Dose Escalation, 2.5 mA||0
3284368|NCT02763826|4018167|FG005|STARTED|Part 1 Dose Escalation, 2.5 mA||0
3284369|NCT02763826|4018168|FG006|STARTED|Part 1 Dose Escalation, 2.5 mA||0
3284370|NCT02763826|4018169|FG007|STARTED|Part 1 Dose Escalation, 2.5 mA||0
3284371|NCT02763826|4018162|FG000|COMPLETED|Part 1 Dose Escalation, 2.5 mA||0
3284372|NCT02763826|4018163|FG001|COMPLETED|Part 1 Dose Escalation, 2.5 mA||0
3284373|NCT02763826|4018164|FG002|COMPLETED|Part 1 Dose Escalation, 2.5 mA||3
3284374|NCT02763826|4018165|FG003|COMPLETED|Part 1 Dose Escalation, 2.5 mA||0
3284375|NCT02763826|4018166|FG004|COMPLETED|Part 1 Dose Escalation, 2.5 mA||0
3284376|NCT02763826|4018167|FG005|COMPLETED|Part 1 Dose Escalation, 2.5 mA||0
3284377|NCT02763826|4018168|FG006|COMPLETED|Part 1 Dose Escalation, 2.5 mA||0
3284378|NCT02763826|4018169|FG007|COMPLETED|Part 1 Dose Escalation, 2.5 mA||0
3284379|NCT02763826|4018162|FG000|NOT COMPLETED|Part 1 Dose Escalation, 2.5 mA||0
3284380|NCT02763826|4018163|FG001|NOT COMPLETED|Part 1 Dose Escalation, 2.5 mA||0
3284381|NCT02763826|4018164|FG002|NOT COMPLETED|Part 1 Dose Escalation, 2.5 mA||0
3284382|NCT02763826|4018165|FG003|NOT COMPLETED|Part 1 Dose Escalation, 2.5 mA||0
3284383|NCT02763826|4018166|FG004|NOT COMPLETED|Part 1 Dose Escalation, 2.5 mA||0
3284384|NCT02763826|4018167|FG005|NOT COMPLETED|Part 1 Dose Escalation, 2.5 mA||0
3284385|NCT02763826|4018168|FG006|NOT COMPLETED|Part 1 Dose Escalation, 2.5 mA||0
3284386|NCT02763826|4018169|FG007|NOT COMPLETED|Part 1 Dose Escalation, 2.5 mA||0
3284387|NCT02763826|4018162|FG000|STARTED|Part 1 Dose Escalation, 3 mA||0
3284388|NCT02763826|4018163|FG001|STARTED|Part 1 Dose Escalation, 3 mA||0
3284389|NCT02763826|4018164|FG002|STARTED|Part 1 Dose Escalation, 3 mA||0
3284390|NCT02763826|4018165|FG003|STARTED|Part 1 Dose Escalation, 3 mA||3
3284391|NCT02763826|4018166|FG004|STARTED|Part 1 Dose Escalation, 3 mA||0
3284392|NCT02763826|4018167|FG005|STARTED|Part 1 Dose Escalation, 3 mA||0
3284393|NCT02763826|4018168|FG006|STARTED|Part 1 Dose Escalation, 3 mA||0
3284394|NCT02763826|4018169|FG007|STARTED|Part 1 Dose Escalation, 3 mA||0
3284395|NCT02763826|4018162|FG000|COMPLETED|Part 1 Dose Escalation, 3 mA||0
3284396|NCT02763826|4018163|FG001|COMPLETED|Part 1 Dose Escalation, 3 mA||0
3284397|NCT02763826|4018164|FG002|COMPLETED|Part 1 Dose Escalation, 3 mA||0
3284398|NCT02763826|4018165|FG003|COMPLETED|Part 1 Dose Escalation, 3 mA||3
3284399|NCT02763826|4018166|FG004|COMPLETED|Part 1 Dose Escalation, 3 mA||0
3284400|NCT02763826|4018167|FG005|COMPLETED|Part 1 Dose Escalation, 3 mA||0
3284401|NCT02763826|4018168|FG006|COMPLETED|Part 1 Dose Escalation, 3 mA||0
3284402|NCT02763826|4018169|FG007|COMPLETED|Part 1 Dose Escalation, 3 mA||0
3284403|NCT02763826|4018162|FG000|NOT COMPLETED|Part 1 Dose Escalation, 3 mA||0
3284404|NCT02763826|4018163|FG001|NOT COMPLETED|Part 1 Dose Escalation, 3 mA||0
3284405|NCT02763826|4018164|FG002|NOT COMPLETED|Part 1 Dose Escalation, 3 mA||0
3284406|NCT02763826|4018165|FG003|NOT COMPLETED|Part 1 Dose Escalation, 3 mA||0
3284407|NCT02763826|4018166|FG004|NOT COMPLETED|Part 1 Dose Escalation, 3 mA||0
3284408|NCT02763826|4018167|FG005|NOT COMPLETED|Part 1 Dose Escalation, 3 mA||0
3284409|NCT02763826|4018168|FG006|NOT COMPLETED|Part 1 Dose Escalation, 3 mA||0
3284410|NCT02763826|4018169|FG007|NOT COMPLETED|Part 1 Dose Escalation, 3 mA||0
3134481|NCT01701258|3859421|FG012|STARTED|PET (Session 3)||0
3284411|NCT02763826|4018162|FG000|STARTED|Part 1 Dose Escalation, 3.5 mA||0
3284412|NCT02763826|4018163|FG001|STARTED|Part 1 Dose Escalation, 3.5 mA||0
3072680|NCT01334125|3793845|FG001|COMPLETED|Overall Study|3 subjects left for college and moved out of the area|10
3072681|NCT01334125|3793844|FG000|NOT COMPLETED|Overall Study||3
3072682|NCT01334125|3793845|FG001|NOT COMPLETED|Overall Study||3
3072683|NCT01334216|3793854|FG000|STARTED|Overall Study||168
3072684|NCT01334216|3793855|FG001|STARTED|Overall Study||194
3072685|NCT01334216|3793854|FG000|COMPLETED|Overall Study||168
3072686|NCT01334216|3793855|FG001|COMPLETED|Overall Study||194
3072687|NCT01334216|3793854|FG000|NOT COMPLETED|Overall Study||0
3072688|NCT01334216|3793855|FG001|NOT COMPLETED|Overall Study||0
3072689|NCT01334229|3793863|FG000|STARTED|Overall Study||11
3072690|NCT01334229|3793864|FG001|STARTED|Overall Study||11
3072691|NCT01334229|3793863|FG000|COMPLETED|Overall Study||11
3072692|NCT01334229|3793864|FG001|COMPLETED|Overall Study||11
3072693|NCT01334229|3793863|FG000|NOT COMPLETED|Overall Study||0
3072694|NCT01334229|3793864|FG001|NOT COMPLETED|Overall Study||0
3072695|NCT01334515|3793872|FG000|STARTED|Overall Study||16
3072696|NCT01334515|3793873|FG001|STARTED|Overall Study||36
3072697|NCT01334515|3793872|FG000|COMPLETED|Overall Study||4
3072698|NCT01334515|3793873|FG001|COMPLETED|Overall Study||7
3072699|NCT01334515|3793872|FG000|NOT COMPLETED|Overall Study||12
3072700|NCT01334515|3793873|FG001|NOT COMPLETED|Overall Study||29
3072701|NCT01334554|3793881|FG000|STARTED|Overall Study||23
3072702|NCT01334554|3793882|FG001|STARTED|Overall Study||23
3072703|NCT01334554|3793881|FG000|COMPLETED|Overall Study||19
3072704|NCT01334554|3793882|FG001|COMPLETED|Overall Study||21
3072705|NCT01334554|3793881|FG000|NOT COMPLETED|Overall Study||4
3072706|NCT01334554|3793882|FG001|NOT COMPLETED|Overall Study||2
3072707|NCT01334710|3793890|FG000|STARTED|Overall Study||3
3072708|NCT01334710|3793890|FG000|COMPLETED|Overall Study|Due to safety signals in a parallel trial ON OSI906 in hepatocellular cancer the trial was stopped.|0
3072709|NCT01334710|3793890|FG000|NOT COMPLETED|Overall Study||3
3072710|NCT01334723|3793897|FG000|STARTED|Overall Study||17293
3072711|NCT01334723|3793898|FG001|STARTED|Overall Study||17739
3072712|NCT01334723|3793897|FG000|COMPLETED|Overall Study||17293
3072713|NCT01334723|3793898|FG001|COMPLETED|Overall Study||17739
3072714|NCT01334723|3793897|FG000|NOT COMPLETED|Overall Study||0
3072715|NCT01334723|3793898|FG001|NOT COMPLETED|Overall Study||0
3072716|NCT01334827|3793918|FG000|STARTED|Overall Study||48
3072717|NCT01334827|3793918|FG000|COMPLETED|Overall Study||48
3072718|NCT01334827|3793918|FG000|NOT COMPLETED|Overall Study||0
3072719|NCT01334866|3793924|FG000|STARTED|Overall Study|91 subjects were enrolled in the study; with 89 subjects receiving the study treatment.|91
3072720|NCT01334866|3793924|FG000|COMPLETED|Overall Study||72
3072721|NCT01334866|3793924|FG000|NOT COMPLETED|Overall Study||19
3072722|NCT01334918|3793932|FG000|STARTED|Overall Study||63
3072723|NCT01334918|3793933|FG001|STARTED|Overall Study||61
3072724|NCT01334918|3793932|FG000|Randomized + 1 Stress Scan|Overall Study|Equates to Safety Analysis Set (SAF)|57
3072725|NCT01334918|3793933|FG001|Randomized + 1 Stress Scan|Overall Study|Equates to Safety Analysis Set (SAF)|61
3072726|NCT01334918|3793932|FG000|COMPLETED|Overall Study||55
3072727|NCT01334918|3793933|FG001|COMPLETED|Overall Study||60
3072728|NCT01334918|3793932|FG000|NOT COMPLETED|Overall Study||8
3072729|NCT01334918|3793933|FG001|NOT COMPLETED|Overall Study||1
3072730|NCT01334944|3793950|FG000|STARTED|Overall Study||11
3072731|NCT01334944|3793951|FG001|STARTED|Overall Study||139
3072732|NCT01334944|3793950|FG000|Received Singel Dose|Overall Study||1
3284413|NCT02763826|4018164|FG002|STARTED|Part 1 Dose Escalation, 3.5 mA||0
3284414|NCT02763826|4018165|FG003|STARTED|Part 1 Dose Escalation, 3.5 mA||0
3284415|NCT02763826|4018166|FG004|STARTED|Part 1 Dose Escalation, 3.5 mA||3
3284416|NCT02763826|4018167|FG005|STARTED|Part 1 Dose Escalation, 3.5 mA||0
3284417|NCT02763826|4018168|FG006|STARTED|Part 1 Dose Escalation, 3.5 mA||0
3284418|NCT02763826|4018169|FG007|STARTED|Part 1 Dose Escalation, 3.5 mA||0
3284419|NCT02763826|4018162|FG000|COMPLETED|Part 1 Dose Escalation, 3.5 mA||0
3284420|NCT02763826|4018163|FG001|COMPLETED|Part 1 Dose Escalation, 3.5 mA||0
3284421|NCT02763826|4018164|FG002|COMPLETED|Part 1 Dose Escalation, 3.5 mA||0
3284422|NCT02763826|4018165|FG003|COMPLETED|Part 1 Dose Escalation, 3.5 mA||0
3284423|NCT02763826|4018166|FG004|COMPLETED|Part 1 Dose Escalation, 3.5 mA||3
3284424|NCT02763826|4018167|FG005|COMPLETED|Part 1 Dose Escalation, 3.5 mA||0
3284425|NCT02763826|4018168|FG006|COMPLETED|Part 1 Dose Escalation, 3.5 mA||0
3284426|NCT02763826|4018169|FG007|COMPLETED|Part 1 Dose Escalation, 3.5 mA||0
3284427|NCT02763826|4018162|FG000|NOT COMPLETED|Part 1 Dose Escalation, 3.5 mA||0
3284428|NCT02763826|4018163|FG001|NOT COMPLETED|Part 1 Dose Escalation, 3.5 mA||0
3284429|NCT02763826|4018164|FG002|NOT COMPLETED|Part 1 Dose Escalation, 3.5 mA||0
3284430|NCT02763826|4018165|FG003|NOT COMPLETED|Part 1 Dose Escalation, 3.5 mA||0
3284431|NCT02763826|4018166|FG004|NOT COMPLETED|Part 1 Dose Escalation, 3.5 mA||0
3284432|NCT02763826|4018167|FG005|NOT COMPLETED|Part 1 Dose Escalation, 3.5 mA||0
3284433|NCT02763826|4018168|FG006|NOT COMPLETED|Part 1 Dose Escalation, 3.5 mA||0
3284434|NCT02763826|4018169|FG007|NOT COMPLETED|Part 1 Dose Escalation, 3.5 mA||0
3284435|NCT02763826|4018162|FG000|STARTED|Part 1 Dose Escalation, 4 mA||0
3284436|NCT02763826|4018163|FG001|STARTED|Part 1 Dose Escalation, 4 mA||0
3284437|NCT02763826|4018164|FG002|STARTED|Part 1 Dose Escalation, 4 mA||0
3284438|NCT02763826|4018165|FG003|STARTED|Part 1 Dose Escalation, 4 mA||0
3284439|NCT02763826|4018166|FG004|STARTED|Part 1 Dose Escalation, 4 mA||0
3284440|NCT02763826|4018167|FG005|STARTED|Part 1 Dose Escalation, 4 mA||3
3284441|NCT02763826|4018168|FG006|STARTED|Part 1 Dose Escalation, 4 mA||0
3284442|NCT02763826|4018169|FG007|STARTED|Part 1 Dose Escalation, 4 mA||0
3284443|NCT02763826|4018162|FG000|COMPLETED|Part 1 Dose Escalation, 4 mA||0
3284444|NCT02763826|4018163|FG001|COMPLETED|Part 1 Dose Escalation, 4 mA||0
3284445|NCT02763826|4018164|FG002|COMPLETED|Part 1 Dose Escalation, 4 mA||0
3284446|NCT02763826|4018165|FG003|COMPLETED|Part 1 Dose Escalation, 4 mA||0
3284447|NCT02763826|4018166|FG004|COMPLETED|Part 1 Dose Escalation, 4 mA||0
3284448|NCT02763826|4018167|FG005|COMPLETED|Part 1 Dose Escalation, 4 mA||3
3284449|NCT02763826|4018168|FG006|COMPLETED|Part 1 Dose Escalation, 4 mA||0
3284450|NCT02763826|4018169|FG007|COMPLETED|Part 1 Dose Escalation, 4 mA||0
3284451|NCT02763826|4018162|FG000|NOT COMPLETED|Part 1 Dose Escalation, 4 mA||0
3284452|NCT02763826|4018163|FG001|NOT COMPLETED|Part 1 Dose Escalation, 4 mA||0
3284453|NCT02763826|4018164|FG002|NOT COMPLETED|Part 1 Dose Escalation, 4 mA||0
3284454|NCT02763826|4018165|FG003|NOT COMPLETED|Part 1 Dose Escalation, 4 mA||0
3284455|NCT02763826|4018166|FG004|NOT COMPLETED|Part 1 Dose Escalation, 4 mA||0
3284456|NCT02763826|4018167|FG005|NOT COMPLETED|Part 1 Dose Escalation, 4 mA||0
3284457|NCT02763826|4018168|FG006|NOT COMPLETED|Part 1 Dose Escalation, 4 mA||0
3284458|NCT02763826|4018169|FG007|NOT COMPLETED|Part 1 Dose Escalation, 4 mA||0
3284459|NCT02763826|4018162|FG000|STARTED|Part 2 Montage Effect, 1st Intervention||0
3284460|NCT02763826|4018163|FG001|STARTED|Part 2 Montage Effect, 1st Intervention||0
3284461|NCT02763826|4018164|FG002|STARTED|Part 2 Montage Effect, 1st Intervention||0
3284462|NCT02763826|4018165|FG003|STARTED|Part 2 Montage Effect, 1st Intervention||0
3284463|NCT02763826|4018166|FG004|STARTED|Part 2 Montage Effect, 1st Intervention||0
3284464|NCT02763826|4018167|FG005|STARTED|Part 2 Montage Effect, 1st Intervention||6
3284465|NCT02763826|4018168|FG006|STARTED|Part 2 Montage Effect, 1st Intervention||6
3284466|NCT02763826|4018169|FG007|STARTED|Part 2 Montage Effect, 1st Intervention||7
3284467|NCT02763826|4018162|FG000|COMPLETED|Part 2 Montage Effect, 1st Intervention||0
3284468|NCT02763826|4018163|FG001|COMPLETED|Part 2 Montage Effect, 1st Intervention||0
3284469|NCT02763826|4018164|FG002|COMPLETED|Part 2 Montage Effect, 1st Intervention||0
3284470|NCT02763826|4018165|FG003|COMPLETED|Part 2 Montage Effect, 1st Intervention||0
3284471|NCT02763826|4018166|FG004|COMPLETED|Part 2 Montage Effect, 1st Intervention||0
3284472|NCT02763826|4018167|FG005|COMPLETED|Part 2 Montage Effect, 1st Intervention||6
3284473|NCT02763826|4018168|FG006|COMPLETED|Part 2 Montage Effect, 1st Intervention||6
3284474|NCT02763826|4018169|FG007|COMPLETED|Part 2 Montage Effect, 1st Intervention||7
3284475|NCT02763826|4018162|FG000|NOT COMPLETED|Part 2 Montage Effect, 1st Intervention||0
3284476|NCT02763826|4018163|FG001|NOT COMPLETED|Part 2 Montage Effect, 1st Intervention||0
3284477|NCT02763826|4018164|FG002|NOT COMPLETED|Part 2 Montage Effect, 1st Intervention||0
3284478|NCT02763826|4018165|FG003|NOT COMPLETED|Part 2 Montage Effect, 1st Intervention||0
3284479|NCT02763826|4018166|FG004|NOT COMPLETED|Part 2 Montage Effect, 1st Intervention||0
3284480|NCT02763826|4018167|FG005|NOT COMPLETED|Part 2 Montage Effect, 1st Intervention||0
3284481|NCT02763826|4018168|FG006|NOT COMPLETED|Part 2 Montage Effect, 1st Intervention||0
3284482|NCT02763826|4018169|FG007|NOT COMPLETED|Part 2 Montage Effect, 1st Intervention||0
3284483|NCT02763826|4018162|FG000|STARTED|Part 2 Montage Effect, 2nd Intervention||0
3284484|NCT02763826|4018163|FG001|STARTED|Part 2 Montage Effect, 2nd Intervention||0
3284485|NCT02763826|4018164|FG002|STARTED|Part 2 Montage Effect, 2nd Intervention||0
3284486|NCT02763826|4018165|FG003|STARTED|Part 2 Montage Effect, 2nd Intervention||0
3284487|NCT02763826|4018166|FG004|STARTED|Part 2 Montage Effect, 2nd Intervention||0
3284488|NCT02763826|4018167|FG005|STARTED|Part 2 Montage Effect, 2nd Intervention||6
3284489|NCT02763826|4018168|FG006|STARTED|Part 2 Montage Effect, 2nd Intervention||6
3284490|NCT02763826|4018169|FG007|STARTED|Part 2 Montage Effect, 2nd Intervention||6
3284491|NCT02763826|4018162|FG000|COMPLETED|Part 2 Montage Effect, 2nd Intervention||0
3284492|NCT02763826|4018163|FG001|COMPLETED|Part 2 Montage Effect, 2nd Intervention||0
3284493|NCT02763826|4018164|FG002|COMPLETED|Part 2 Montage Effect, 2nd Intervention||0
3284494|NCT02763826|4018165|FG003|COMPLETED|Part 2 Montage Effect, 2nd Intervention||0
3284495|NCT02763826|4018166|FG004|COMPLETED|Part 2 Montage Effect, 2nd Intervention||0
3284496|NCT02763826|4018167|FG005|COMPLETED|Part 2 Montage Effect, 2nd Intervention||6
3284497|NCT02763826|4018168|FG006|COMPLETED|Part 2 Montage Effect, 2nd Intervention||6
3284498|NCT02763826|4018169|FG007|COMPLETED|Part 2 Montage Effect, 2nd Intervention||6
3284499|NCT02763826|4018162|FG000|NOT COMPLETED|Part 2 Montage Effect, 2nd Intervention||0
3284500|NCT02763826|4018163|FG001|NOT COMPLETED|Part 2 Montage Effect, 2nd Intervention||0
3284501|NCT02763826|4018164|FG002|NOT COMPLETED|Part 2 Montage Effect, 2nd Intervention||0
3284502|NCT02763826|4018165|FG003|NOT COMPLETED|Part 2 Montage Effect, 2nd Intervention||0
3284503|NCT02763826|4018166|FG004|NOT COMPLETED|Part 2 Montage Effect, 2nd Intervention||0
3284504|NCT02763826|4018167|FG005|NOT COMPLETED|Part 2 Montage Effect, 2nd Intervention||0
3284505|NCT02763826|4018168|FG006|NOT COMPLETED|Part 2 Montage Effect, 2nd Intervention||0
3284506|NCT02763826|4018169|FG007|NOT COMPLETED|Part 2 Montage Effect, 2nd Intervention||0
3284507|NCT02763826|4018162|FG000|STARTED|Part 2 Montage Effect, 3rd Intervention||0
3284508|NCT02763826|4018163|FG001|STARTED|Part 2 Montage Effect, 3rd Intervention||0
3284509|NCT02763826|4018164|FG002|STARTED|Part 2 Montage Effect, 3rd Intervention||0
3284510|NCT02763826|4018165|FG003|STARTED|Part 2 Montage Effect, 3rd Intervention||0
3284511|NCT02763826|4018166|FG004|STARTED|Part 2 Montage Effect, 3rd Intervention||0
3284512|NCT02763826|4018167|FG005|STARTED|Part 2 Montage Effect, 3rd Intervention||6
3284513|NCT02763826|4018168|FG006|STARTED|Part 2 Montage Effect, 3rd Intervention||6
3284514|NCT02763826|4018169|FG007|STARTED|Part 2 Montage Effect, 3rd Intervention||6
3284515|NCT02763826|4018162|FG000|COMPLETED|Part 2 Montage Effect, 3rd Intervention||0
3284516|NCT02763826|4018163|FG001|COMPLETED|Part 2 Montage Effect, 3rd Intervention||0
3284517|NCT02763826|4018164|FG002|COMPLETED|Part 2 Montage Effect, 3rd Intervention||0
3284518|NCT02763826|4018165|FG003|COMPLETED|Part 2 Montage Effect, 3rd Intervention||0
3163054|NCT01882465|3890494|FG003|NOT COMPLETED|Period 3||0
3163055|NCT01882465|3890495|FG004|NOT COMPLETED|Period 3||0
3163056|NCT01882465|3890496|FG005|NOT COMPLETED|Period 3||0
3163057|NCT01882465|3890497|FG006|NOT COMPLETED|Period 3||0
3163058|NCT01882543|3890507|FG000|STARTED|Overall Study||37
3163059|NCT01882543|3890508|FG001|STARTED|Overall Study||32
3284519|NCT02763826|4018166|FG004|COMPLETED|Part 2 Montage Effect, 3rd Intervention||0
3284520|NCT02763826|4018167|FG005|COMPLETED|Part 2 Montage Effect, 3rd Intervention||6
3284521|NCT02763826|4018168|FG006|COMPLETED|Part 2 Montage Effect, 3rd Intervention||6
3284522|NCT02763826|4018169|FG007|COMPLETED|Part 2 Montage Effect, 3rd Intervention||6
3284523|NCT02763826|4018162|FG000|NOT COMPLETED|Part 2 Montage Effect, 3rd Intervention||0
3284524|NCT02763826|4018163|FG001|NOT COMPLETED|Part 2 Montage Effect, 3rd Intervention||0
3284525|NCT02763826|4018164|FG002|NOT COMPLETED|Part 2 Montage Effect, 3rd Intervention||0
3284526|NCT02763826|4018165|FG003|NOT COMPLETED|Part 2 Montage Effect, 3rd Intervention||0
3284527|NCT02763826|4018166|FG004|NOT COMPLETED|Part 2 Montage Effect, 3rd Intervention||0
3284528|NCT02763826|4018167|FG005|NOT COMPLETED|Part 2 Montage Effect, 3rd Intervention||0
3284529|NCT02763826|4018168|FG006|NOT COMPLETED|Part 2 Montage Effect, 3rd Intervention||0
3284530|NCT02763826|4018169|FG007|NOT COMPLETED|Part 2 Montage Effect, 3rd Intervention||0
3284531|NCT02763865|4018189|FG000|STARTED|Overall Study||5
3284532|NCT02763865|4018190|FG001|STARTED|Overall Study||5
3284533|NCT02763865|4018189|FG000|COMPLETED|Overall Study||5
3284534|NCT02763865|4018190|FG001|COMPLETED|Overall Study||5
3284535|NCT02763865|4018189|FG000|NOT COMPLETED|Overall Study||0
3284536|NCT02763865|4018190|FG001|NOT COMPLETED|Overall Study||0
3284537|NCT02764151|4018202|FG000|STARTED|Overall Study||2
3284538|NCT02764151|4018203|FG001|STARTED|Overall Study||4
3284539|NCT02764151|4018204|FG002|STARTED|Overall Study||3
3284540|NCT02764151|4018205|FG003|STARTED|Overall Study||8
3284541|NCT02764151|4018202|FG000|COMPLETED|Overall Study||2
3284542|NCT02764151|4018203|FG001|COMPLETED|Overall Study||4
3284543|NCT02764151|4018204|FG002|COMPLETED|Overall Study||3
3284544|NCT02764151|4018205|FG003|COMPLETED|Overall Study||5
3284545|NCT02764151|4018202|FG000|NOT COMPLETED|Overall Study||0
3284546|NCT02764151|4018203|FG001|NOT COMPLETED|Overall Study||0
3284547|NCT02764151|4018204|FG002|NOT COMPLETED|Overall Study||0
3284548|NCT02764151|4018205|FG003|NOT COMPLETED|Overall Study||3
3284549|NCT02764164|4018215|FG000|STARTED|Overall Study||1
3284550|NCT02764164|4018215|FG000|COMPLETED|Overall Study|Duration flexible up to 12mo, ended early (funding), 2 week time point achieved|1
3284551|NCT02764164|4018215|FG000|NOT COMPLETED|Overall Study||0
3284552|NCT02764190|4018221|FG000|STARTED|Overall Study||167
3284553|NCT02764190|4018222|FG001|STARTED|Overall Study||135
3284554|NCT02764190|4018221|FG000|1 Day Follow-up|Overall Study||161
3284555|NCT02764190|4018222|FG001|1 Day Follow-up|Overall Study||131
3284556|NCT02764190|4018221|FG000|3 Month Follow-up|Overall Study||156
3284557|NCT02764190|4018222|FG001|3 Month Follow-up|Overall Study||128
3284558|NCT02764190|4018221|FG000|6 Month Follow-up|Overall Study||155
3284559|NCT02764190|4018222|FG001|6 Month Follow-up|Overall Study||128
3284560|NCT02764190|4018221|FG000|12 Month Follow-up|Overall Study||150
3284561|NCT02764190|4018222|FG001|12 Month Follow-up|Overall Study||122
3284562|NCT02764190|4018221|FG000|COMPLETED|Overall Study||150
3284563|NCT02764190|4018222|FG001|COMPLETED|Overall Study||122
3284564|NCT02764190|4018221|FG000|NOT COMPLETED|Overall Study||17
3284565|NCT02764190|4018222|FG001|NOT COMPLETED|Overall Study||13
3284566|NCT02764229|4018228|FG000|STARTED|Overall Study||112
3284567|NCT02764229|4018228|FG000|COMPLETED|Overall Study||10
3284568|NCT02764229|4018228|FG000|NOT COMPLETED|Overall Study||102
3284569|NCT02764320|4018234|FG000|STARTED|Overall Study||361
3284570|NCT02764320|4018235|FG001|STARTED|Overall Study||359
3284571|NCT02764320|4018234|FG000|COMPLETED|Overall Study||310
3284572|NCT02764320|4018235|FG001|COMPLETED|Overall Study||310
3284573|NCT02764320|4018234|FG000|NOT COMPLETED|Overall Study||51
3284574|NCT02764320|4018235|FG001|NOT COMPLETED|Overall Study||49
3284575|NCT02764333|4018241|FG000|STARTED|Overall Study||29
3284576|NCT02764333|4018241|FG000|COMPLETED|Overall Study||28
3284577|NCT02764333|4018241|FG000|NOT COMPLETED|Overall Study||1
3284578|NCT02764385|4018247|FG000|STARTED|Overall Study||9145
3284579|NCT02764385|4018248|FG001|STARTED|Overall Study||6641
3284580|NCT02764385|4018247|FG000|COMPLETED|Overall Study||9145
3284581|NCT02764385|4018248|FG001|COMPLETED|Overall Study||6641
3284582|NCT02764385|4018247|FG000|NOT COMPLETED|Overall Study||0
3284583|NCT02764385|4018248|FG001|NOT COMPLETED|Overall Study||0
3284584|NCT02764697|4018254|FG000|STARTED|Overall Study||5
3284585|NCT02764697|4018254|FG000|COMPLETED|Overall Study||2
3284586|NCT02764697|4018254|FG000|NOT COMPLETED|Overall Study||3
3284587|NCT02764762|4018258|FG000|STARTED|Overall Study||55
3284588|NCT02764762|4018258|FG000|COMPLETED|Overall Study||46
3163060|NCT01882543|3890507|FG000|COMPLETED|Overall Study||33
3163061|NCT01882543|3890508|FG001|COMPLETED|Overall Study||29
3163062|NCT01882543|3890507|FG000|NOT COMPLETED|Overall Study||4
3284589|NCT02764762|4018258|FG000|NOT COMPLETED|Overall Study||9
3284590|NCT02764775|4018262|FG000|STARTED|Overall Study|All 14 participants were assigned to the Headpod utilization group.|14
3284591|NCT02764775|4018262|FG000|COMPLETED|Overall Study||8
3284592|NCT02764775|4018262|FG000|NOT COMPLETED|Overall Study||6
3284593|NCT02764970|4018268|FG000|STARTED|Overall Study||65
3284594|NCT02764970|4018269|FG001|STARTED|Overall Study||47
3284595|NCT02764970|4018268|FG000|COMPLETED|Overall Study||65
3284596|NCT02764970|4018269|FG001|COMPLETED|Overall Study||47
3284597|NCT02764970|4018268|FG000|NOT COMPLETED|Overall Study||0
3284598|NCT02764970|4018269|FG001|NOT COMPLETED|Overall Study||0
3284599|NCT02765035|4018277|FG000|STARTED|First Intervention (90 Days)||5
3284600|NCT02765035|4018278|FG001|STARTED|First Intervention (90 Days)||8
3284601|NCT02765035|4018277|FG000|COMPLETED|First Intervention (90 Days)||4
3284602|NCT02765035|4018278|FG001|COMPLETED|First Intervention (90 Days)||7
3284603|NCT02765035|4018277|FG000|NOT COMPLETED|First Intervention (90 Days)||1
3284604|NCT02765035|4018278|FG001|NOT COMPLETED|First Intervention (90 Days)||1
3284605|NCT02765035|4018277|FG000|STARTED|Second Intervention (30 Days)||4
3284606|NCT02765035|4018278|FG001|STARTED|Second Intervention (30 Days)||7
3284607|NCT02765035|4018277|FG000|COMPLETED|Second Intervention (30 Days)||2
3284608|NCT02765035|4018278|FG001|COMPLETED|Second Intervention (30 Days)||5
3284609|NCT02765035|4018277|FG000|NOT COMPLETED|Second Intervention (30 Days)||2
3284610|NCT02765035|4018278|FG001|NOT COMPLETED|Second Intervention (30 Days)||2
3284611|NCT02765100|4018287|FG000|STARTED|Overall Study||9
3284612|NCT02765100|4018288|FG001|STARTED|Overall Study||12
3284613|NCT02765100|4018287|FG000|COMPLETED|Overall Study||8
3284614|NCT02765100|4018288|FG001|COMPLETED|Overall Study||10
3284615|NCT02765100|4018287|FG000|NOT COMPLETED|Overall Study||1
3284616|NCT02765100|4018288|FG001|NOT COMPLETED|Overall Study||2
3284617|NCT02765165|4018301|FG000|STARTED|Treatment Period||3
3284618|NCT02765165|4018302|FG001|STARTED|Treatment Period||4
3284619|NCT02765165|4018303|FG002|STARTED|Treatment Period||3
3284620|NCT02765165|4018304|FG003|STARTED|Treatment Period||3
3284621|NCT02765165|4018305|FG004|STARTED|Treatment Period||6
3284622|NCT02765165|4018306|FG005|STARTED|Treatment Period||3
3284623|NCT02765165|4018307|FG006|STARTED|Treatment Period||4
3284624|NCT02765165|4018301|FG000|COMPLETED|Treatment Period|Open-ended design for participation until progression or other reason for withdrawal|0
3284625|NCT02765165|4018302|FG001|COMPLETED|Treatment Period|Open-ended design for participation until progression or other reason for withdrawal|0
3284626|NCT02765165|4018303|FG002|COMPLETED|Treatment Period|Open-ended design for participation until progression or other reason for withdrawal|0
3284627|NCT02765165|4018304|FG003|COMPLETED|Treatment Period|Open-ended design for participation until progression or other reason for withdrawal|0
3284628|NCT02765165|4018305|FG004|COMPLETED|Treatment Period|Open-ended design for participation until progression or other reason for withdrawal|0
3284629|NCT02765165|4018306|FG005|COMPLETED|Treatment Period|Open-ended design for participation until progression or other reason for withdrawal|0
3284630|NCT02765165|4018307|FG006|COMPLETED|Treatment Period|Open-ended design for participation until progression or other reason for withdrawal|0
3284631|NCT02765165|4018301|FG000|NOT COMPLETED|Treatment Period||3
3284632|NCT02765165|4018302|FG001|NOT COMPLETED|Treatment Period||4
3284633|NCT02765165|4018303|FG002|NOT COMPLETED|Treatment Period||3
3284634|NCT02765165|4018304|FG003|NOT COMPLETED|Treatment Period||3
3284635|NCT02765165|4018305|FG004|NOT COMPLETED|Treatment Period||6
3284636|NCT02765165|4018306|FG005|NOT COMPLETED|Treatment Period||3
3284637|NCT02765165|4018307|FG006|NOT COMPLETED|Treatment Period||4
3284638|NCT02765165|4018301|FG000|STARTED|Post-treatment Follow-up|Subjects who chose to enter follow-up, including long term follow-up for survival, after discontinuing treatment. Subjects were not required to enter follow-up.|1
3284639|NCT02765165|4018302|FG001|STARTED|Post-treatment Follow-up|Subjects who chose to enter follow-up, including long term follow-up for survival, after discontinuing treatment. Subjects were not required to enter follow-up.|3
3284640|NCT02765165|4018303|FG002|STARTED|Post-treatment Follow-up|Subjects who chose to enter follow-up, including long term follow-up for survival, after discontinuing treatment. Subjects were not required to enter follow-up.|3
3284641|NCT02765165|4018304|FG003|STARTED|Post-treatment Follow-up|Subjects who chose to enter follow-up, including long term follow-up for survival, after discontinuing treatment. Subjects were not required to enter follow-up.|3
3284642|NCT02765165|4018305|FG004|STARTED|Post-treatment Follow-up|Subjects who chose to enter follow-up, including long term follow-up for survival, after discontinuing treatment. Subjects were not required to enter follow-up.|3
3284643|NCT02765165|4018306|FG005|STARTED|Post-treatment Follow-up|Subjects who chose to enter follow-up, including long term follow-up for survival, after discontinuing treatment. Subjects were not required to enter follow-up.|3
3284644|NCT02765165|4018307|FG006|STARTED|Post-treatment Follow-up|Subjects who chose to enter follow-up, including long term follow-up for survival, after discontinuing treatment. Subjects were not required to enter follow-up.|1
3284645|NCT02765165|4018301|FG000|COMPLETED|Post-treatment Follow-up|Open-ended follow-up|0
3284646|NCT02765165|4018302|FG001|COMPLETED|Post-treatment Follow-up||0
3284647|NCT02765165|4018303|FG002|COMPLETED|Post-treatment Follow-up||0
3284648|NCT02765165|4018304|FG003|COMPLETED|Post-treatment Follow-up||0
3284649|NCT02765165|4018305|FG004|COMPLETED|Post-treatment Follow-up|Open-ended follow-up|0
3284650|NCT02765165|4018306|FG005|COMPLETED|Post-treatment Follow-up||0
3284651|NCT02765165|4018307|FG006|COMPLETED|Post-treatment Follow-up||0
3284652|NCT02765165|4018301|FG000|NOT COMPLETED|Post-treatment Follow-up||1
3284653|NCT02765165|4018302|FG001|NOT COMPLETED|Post-treatment Follow-up||3
3284654|NCT02765165|4018303|FG002|NOT COMPLETED|Post-treatment Follow-up||3
3284655|NCT02765165|4018304|FG003|NOT COMPLETED|Post-treatment Follow-up||3
3284656|NCT02765165|4018305|FG004|NOT COMPLETED|Post-treatment Follow-up||3
3284657|NCT02765165|4018306|FG005|NOT COMPLETED|Post-treatment Follow-up||3
3284658|NCT02765165|4018307|FG006|NOT COMPLETED|Post-treatment Follow-up||1
3284659|NCT02765256|4018329|FG000|STARTED|Overall Study||4
3284660|NCT02765256|4018330|FG001|STARTED|Overall Study||4
3284661|NCT02765256|4018329|FG000|COMPLETED|Overall Study||4
3284662|NCT02765256|4018330|FG001|COMPLETED|Overall Study||4
3284663|NCT02765256|4018329|FG000|NOT COMPLETED|Overall Study||0
3284664|NCT02765256|4018330|FG001|NOT COMPLETED|Overall Study||0
3284665|NCT02765269|4018338|FG000|STARTED|Overall Study||25
3072733|NCT01334944|3793951|FG001|Received Singel Dose|Overall Study||96
3072734|NCT01334944|3793950|FG000|Received Multiple Doses|Overall Study||10
3072735|NCT01334944|3793951|FG001|Received Multiple Doses|Overall Study||43
3072736|NCT01334944|3793950|FG000|COMPLETED|Overall Study||11
3072737|NCT01334944|3793951|FG001|COMPLETED|Overall Study||139
3072738|NCT01334944|3793950|FG000|NOT COMPLETED|Overall Study||0
3072739|NCT01334944|3793951|FG001|NOT COMPLETED|Overall Study||0
3072740|NCT01334957|3793960|FG000|STARTED|Overall Study||300
3072741|NCT01334957|3793960|FG000|Received Single Dose|Overall Study||252
3072742|NCT01334957|3793960|FG000|Received Multiple Doses|Overall Study||48
3072743|NCT01334957|3793960|FG000|COMPLETED|Overall Study||300
3072744|NCT01334957|3793960|FG000|NOT COMPLETED|Overall Study||0
3072745|NCT01335009|3793966|FG000|STARTED|Overall Study||40
3072746|NCT01335009|3793967|FG001|STARTED|Overall Study||36
3072747|NCT01335009|3793966|FG000|COMPLETED|Overall Study||9
3072748|NCT01335009|3793967|FG001|COMPLETED|Overall Study||3
3072749|NCT01335009|3793966|FG000|NOT COMPLETED|Overall Study||31
3072750|NCT01335009|3793967|FG001|NOT COMPLETED|Overall Study||33
3072751|NCT01335061|3793973|FG000|STARTED|Overall Study||25
3072752|NCT01335061|3793973|FG000|COMPLETED|Overall Study||25
3072753|NCT01335061|3793973|FG000|NOT COMPLETED|Overall Study||0
3072754|NCT01335191|3793986|FG000|STARTED|Overall Study||16
3072755|NCT01335191|3793987|FG001|STARTED|Overall Study||11
3072756|NCT01335191|3793986|FG000|COMPLETED|Overall Study||16
3072757|NCT01335191|3793987|FG001|COMPLETED|Overall Study||11
3072758|NCT01335191|3793986|FG000|NOT COMPLETED|Overall Study||0
3072759|NCT01335191|3793987|FG001|NOT COMPLETED|Overall Study||0
3072760|NCT01335204|3793993|FG000|STARTED|Overall Study||4
3072761|NCT01335204|3793993|FG000|COMPLETED|Overall Study||4
3072762|NCT01335204|3793993|FG000|NOT COMPLETED|Overall Study||0
3072763|NCT01335230|3794001|FG000|STARTED|Overall Study|subjects|10
3072764|NCT01335230|3794002|FG001|STARTED|Overall Study|subjects|10
3072765|NCT01335230|3794003|FG002|STARTED|Overall Study|subjects|10
3072766|NCT01335230|3794004|FG003|STARTED|Overall Study|subjects|10
3072767|NCT01335230|3794001|FG000|COMPLETED|Overall Study|subjects|10
3072768|NCT01335230|3794002|FG001|COMPLETED|Overall Study|subjects|10
3072769|NCT01335230|3794003|FG002|COMPLETED|Overall Study|subjects|10
3072770|NCT01335230|3794004|FG003|COMPLETED|Overall Study|subjects|10
3072771|NCT01335230|3794001|FG000|NOT COMPLETED|Overall Study||0
3072772|NCT01335230|3794002|FG001|NOT COMPLETED|Overall Study||0
3072773|NCT01335230|3794003|FG002|NOT COMPLETED|Overall Study||0
3072774|NCT01335230|3794004|FG003|NOT COMPLETED|Overall Study||0
3072775|NCT01335308|3794017|FG000|STARTED|Overall Study||198
3072776|NCT01335308|3794018|FG001|STARTED|Overall Study||212
3072777|NCT01335308|3794019|FG002|STARTED|Overall Study||235
3072778|NCT01335308|3794017|FG000|COMPLETED|Overall Study||158
3072779|NCT01335308|3794018|FG001|COMPLETED|Overall Study||145
3072780|NCT01335308|3794019|FG002|COMPLETED|Overall Study||154
3072781|NCT01335308|3794017|FG000|NOT COMPLETED|Overall Study||40
3072782|NCT01335308|3794018|FG001|NOT COMPLETED|Overall Study||67
3072783|NCT01335308|3794019|FG002|NOT COMPLETED|Overall Study||81
3072784|NCT01335464|3794029|FG000|STARTED|Overall Study||206
3072785|NCT01335464|3794030|FG001|STARTED|Overall Study||309
3072786|NCT01335464|3794029|FG000|COMPLETED|Overall Study||174
3072787|NCT01335464|3794030|FG001|COMPLETED|Overall Study||260
3072788|NCT01335464|3794029|FG000|NOT COMPLETED|Overall Study||32
3072789|NCT01335464|3794030|FG001|NOT COMPLETED|Overall Study||49
3072790|NCT01335477|3794038|FG000|STARTED|Overall Study||220
3072791|NCT01335477|3794039|FG001|STARTED|Overall Study||331
3072792|NCT01335477|3794038|FG000|COMPLETED|Overall Study||179
3072793|NCT01335477|3794039|FG001|COMPLETED|Overall Study||272
3072794|NCT01335477|3794038|FG000|NOT COMPLETED|Overall Study||41
3072795|NCT01335477|3794039|FG001|NOT COMPLETED|Overall Study||59
3072796|NCT01335542|3794047|FG000|STARTED|Overall Study||45
3072797|NCT01335542|3794048|FG001|STARTED|Overall Study||45
3072798|NCT01335542|3794047|FG000|COMPLETED|Overall Study||45
3072799|NCT01335542|3794048|FG001|COMPLETED|Overall Study||45
3072800|NCT01335542|3794047|FG000|NOT COMPLETED|Overall Study||0
3072801|NCT01335542|3794048|FG001|NOT COMPLETED|Overall Study||0
3072802|NCT01335620|3794054|FG000|STARTED|Overall Study||19
3072803|NCT01335620|3794054|FG000|COMPLETED|Overall Study||19
3072804|NCT01335620|3794054|FG000|NOT COMPLETED|Overall Study||0
3072805|NCT01335698|3794063|FG000|STARTED|Treatment Stage 1||23
3072806|NCT01335698|3794064|FG001|STARTED|Treatment Stage 1||12
3072807|NCT01335698|3794065|FG002|STARTED|Treatment Stage 1||21
3072808|NCT01335698|3794066|FG003|STARTED|Treatment Stage 1||35
3072809|NCT01335698|3794067|FG004|STARTED|Treatment Stage 1||8
3072810|NCT01335698|3794063|FG000|COMPLETED|Treatment Stage 1||15
3072811|NCT01335698|3794064|FG001|COMPLETED|Treatment Stage 1||4
3072812|NCT01335698|3794065|FG002|COMPLETED|Treatment Stage 1||16
3072813|NCT01335698|3794066|FG003|COMPLETED|Treatment Stage 1||26
3072814|NCT01335698|3794067|FG004|COMPLETED|Treatment Stage 1||6
3072815|NCT01335698|3794063|FG000|NOT COMPLETED|Treatment Stage 1||8
3072816|NCT01335698|3794064|FG001|NOT COMPLETED|Treatment Stage 1||8
3072817|NCT01335698|3794065|FG002|NOT COMPLETED|Treatment Stage 1||5
3072818|NCT01335698|3794066|FG003|NOT COMPLETED|Treatment Stage 1||9
3072819|NCT01335698|3794067|FG004|NOT COMPLETED|Treatment Stage 1||2
3284666|NCT02765269|4018339|FG001|STARTED|Overall Study||21
3072820|NCT01335698|3794063|FG000|STARTED|Treatment Stage 2||15
3072821|NCT01335698|3794064|FG001|STARTED|Treatment Stage 2||4
3072822|NCT01335698|3794065|FG002|STARTED|Treatment Stage 2||16
3072823|NCT01335698|3794066|FG003|STARTED|Treatment Stage 2||26
3072824|NCT01335698|3794067|FG004|STARTED|Treatment Stage 2||6
3072825|NCT01335698|3794063|FG000|COMPLETED|Treatment Stage 2||4
3072826|NCT01335698|3794064|FG001|COMPLETED|Treatment Stage 2||1
3072827|NCT01335698|3794065|FG002|COMPLETED|Treatment Stage 2||11
3072828|NCT01335698|3794066|FG003|COMPLETED|Treatment Stage 2||18
3072829|NCT01335698|3794067|FG004|COMPLETED|Treatment Stage 2||5
3072830|NCT01335698|3794063|FG000|NOT COMPLETED|Treatment Stage 2||11
3072831|NCT01335698|3794064|FG001|NOT COMPLETED|Treatment Stage 2||3
3072832|NCT01335698|3794065|FG002|NOT COMPLETED|Treatment Stage 2||5
3072833|NCT01335698|3794066|FG003|NOT COMPLETED|Treatment Stage 2||8
3072834|NCT01335698|3794067|FG004|NOT COMPLETED|Treatment Stage 2||1
3072835|NCT01335724|3794083|FG000|STARTED|Overall Study||36
3072836|NCT01335724|3794084|FG001|STARTED|Overall Study||36
3072837|NCT01335724|3794083|FG000|COMPLETED|Overall Study||36
3072838|NCT01335724|3794084|FG001|COMPLETED|Overall Study||36
3072839|NCT01335724|3794083|FG000|NOT COMPLETED|Overall Study||0
3072840|NCT01335724|3794084|FG001|NOT COMPLETED|Overall Study||0
3072841|NCT01335750|3794090|FG000|STARTED|Overall Study||32
3072842|NCT01335750|3794090|FG000|COMPLETED|Overall Study||32
3072843|NCT01335750|3794090|FG000|NOT COMPLETED|Overall Study||0
3072844|NCT01335789|3794104|FG000|STARTED|Overall Study||8
3072845|NCT01335789|3794105|FG001|STARTED|Overall Study||8
3072846|NCT01335789|3794104|FG000|COMPLETED|Overall Study||8
3072847|NCT01335789|3794105|FG001|COMPLETED|Overall Study||8
3072848|NCT01335789|3794104|FG000|NOT COMPLETED|Overall Study||0
3072849|NCT01335789|3794105|FG001|NOT COMPLETED|Overall Study||0
3072850|NCT01335867|3794113|FG000|STARTED|Overall Study||16
3072851|NCT01335867|3794114|FG001|STARTED|Overall Study||16
3072852|NCT01335867|3794113|FG000|COMPLETED|Overall Study||9
3072853|NCT01335867|3794114|FG001|COMPLETED|Overall Study||12
3072854|NCT01335867|3794113|FG000|NOT COMPLETED|Overall Study||7
3072855|NCT01335867|3794114|FG001|NOT COMPLETED|Overall Study||4
3072856|NCT01335932|3794129|FG000|STARTED|Overall Study||84
3072857|NCT01335932|3794130|FG001|STARTED|Overall Study||76
3072858|NCT01335932|3794129|FG000|COMPLETED|Overall Study||84
3072859|NCT01335932|3794130|FG001|COMPLETED|Overall Study||72
3072860|NCT01335932|3794129|FG000|NOT COMPLETED|Overall Study||0
3072861|NCT01335932|3794130|FG001|NOT COMPLETED|Overall Study||4
3072862|NCT01335971|3794139|FG000|STARTED|Overall Study||31
3072863|NCT01335971|3794140|FG001|STARTED|Overall Study||29
3072864|NCT01335971|3794141|FG002|STARTED|Overall Study||29
3072865|NCT01335971|3794139|FG000|COMPLETED|Overall Study||29
3072866|NCT01335971|3794140|FG001|COMPLETED|Overall Study||28
3072867|NCT01335971|3794141|FG002|COMPLETED|Overall Study||28
3072868|NCT01335971|3794139|FG000|NOT COMPLETED|Overall Study||2
3072869|NCT01335971|3794140|FG001|NOT COMPLETED|Overall Study||1
3072870|NCT01335971|3794141|FG002|NOT COMPLETED|Overall Study||1
3072871|NCT01336023|3794152|FG000|STARTED|Week 0 to Week 26||414
3072872|NCT01336023|3794153|FG001|STARTED|Week 0 to Week 26||834
3072873|NCT01336023|3794154|FG002|STARTED|Week 0 to Week 26||415
3072874|NCT01336023|3794152|FG000|Exposed|Week 0 to Week 26|1 subject withdrew before exposure to trial drug and was not included in the analysis|413
3072875|NCT01336023|3794153|FG001|Exposed|Week 0 to Week 26|8 subjects withdrew before exposure to trial drug and were not included in the analysis|826
3072876|NCT01336023|3794154|FG002|Exposed|Week 0 to Week 26|2 subjects withdrew before exposure to trial drug and were not included in the analysis|413
3072877|NCT01336023|3794152|FG000|COMPLETED|Week 0 to Week 26||366
3072878|NCT01336023|3794153|FG001|COMPLETED|Week 0 to Week 26||736
3072879|NCT01336023|3794154|FG002|COMPLETED|Week 0 to Week 26||342
3072880|NCT01336023|3794152|FG000|NOT COMPLETED|Week 0 to Week 26||48
3072881|NCT01336023|3794153|FG001|NOT COMPLETED|Week 0 to Week 26||98
3072882|NCT01336023|3794154|FG002|NOT COMPLETED|Week 0 to Week 26||73
3072883|NCT01336023|3794152|FG000|STARTED|Week 27 to 52|From the main trial, 33 subjects were not enrolled in the extension (week 27-52).|333
3072884|NCT01336023|3794153|FG001|STARTED|Week 27 to 52|From the main trial, 71 subjects were not enrolled in the extension (week 27-52).|665
3072885|NCT01336023|3794154|FG002|STARTED|Week 27 to 52|From the main trial, 29 subjects were not enrolled in the extension (week 27-52).|313
3072886|NCT01336023|3794152|FG000|COMPLETED|Week 27 to 52||305
3072887|NCT01336023|3794153|FG001|COMPLETED|Week 27 to 52||621
3072888|NCT01336023|3794154|FG002|COMPLETED|Week 27 to 52||285
3072889|NCT01336023|3794152|FG000|NOT COMPLETED|Week 27 to 52||28
3072890|NCT01336023|3794153|FG001|NOT COMPLETED|Week 27 to 52||44
3072891|NCT01336023|3794154|FG002|NOT COMPLETED|Week 27 to 52||28
3072892|NCT01336140|3794164|FG000|STARTED|Overall Study||150
3072893|NCT01336140|3794165|FG001|STARTED|Overall Study||150
3072894|NCT01336140|3794164|FG000|COMPLETED|Overall Study||150
3072895|NCT01336140|3794165|FG001|COMPLETED|Overall Study||150
3072896|NCT01336140|3794164|FG000|NOT COMPLETED|Overall Study||0
3072897|NCT01336140|3794165|FG001|NOT COMPLETED|Overall Study||0
3072898|NCT01336205|3794173|FG000|STARTED|Overall Study||563
3072899|NCT01336205|3794174|FG001|STARTED|Overall Study||281
3072900|NCT01336205|3794173|FG000|COMPLETED|Overall Study||330
3072901|NCT01336205|3794174|FG001|COMPLETED|Overall Study||192
3072902|NCT01336205|3794173|FG000|NOT COMPLETED|Overall Study||233
3072903|NCT01336205|3794174|FG001|NOT COMPLETED|Overall Study||89
3072904|NCT01336296|3794182|FG000|STARTED|Overall Study||40
3072905|NCT01336296|3794183|FG001|STARTED|Overall Study||21
3072906|NCT01336296|3794182|FG000|COMPLETED|Overall Study||35
3072907|NCT01336296|3794183|FG001|COMPLETED|Overall Study||17
3072908|NCT01336296|3794182|FG000|NOT COMPLETED|Overall Study||5
3072909|NCT01336296|3794183|FG001|NOT COMPLETED|Overall Study||4
3072910|NCT01336413|3794191|FG000|STARTED|Overall Study||27
3072911|NCT01336413|3794192|FG001|STARTED|Overall Study||26
3072912|NCT01336413|3794191|FG000|COMPLETED|Overall Study||26
3072913|NCT01336413|3794192|FG001|COMPLETED|Overall Study||18
3072914|NCT01336413|3794191|FG000|NOT COMPLETED|Overall Study||1
3072915|NCT01336413|3794192|FG001|NOT COMPLETED|Overall Study||8
3072916|NCT01336569|3794200|FG000|STARTED|Overall Study||49
3072917|NCT01336569|3794200|FG000|COMPLETED|Overall Study||45
3072918|NCT01336569|3794200|FG000|NOT COMPLETED|Overall Study||4
3072919|NCT01336608|3794207|FG000|STARTED|2-week, Single-blind Run-In Period||559
3072920|NCT01336608|3794208|FG001|STARTED|2-week, Single-blind Run-In Period||0
3072921|NCT01336608|3794209|FG002|STARTED|2-week, Single-blind Run-In Period||0
3072922|NCT01336608|3794210|FG003|STARTED|2-week, Single-blind Run-In Period||0
3072923|NCT01336608|3794207|FG000|COMPLETED|2-week, Single-blind Run-In Period||444
3072924|NCT01336608|3794208|FG001|COMPLETED|2-week, Single-blind Run-In Period||0
3072925|NCT01336608|3794209|FG002|COMPLETED|2-week, Single-blind Run-In Period||0
3072926|NCT01336608|3794210|FG003|COMPLETED|2-week, Single-blind Run-In Period||0
3072927|NCT01336608|3794207|FG000|NOT COMPLETED|2-week, Single-blind Run-In Period||115
3072928|NCT01336608|3794208|FG001|NOT COMPLETED|2-week, Single-blind Run-In Period||0
3072929|NCT01336608|3794209|FG002|NOT COMPLETED|2-week, Single-blind Run-In Period||0
3072930|NCT01336608|3794210|FG003|NOT COMPLETED|2-week, Single-blind Run-In Period||0
3072931|NCT01336608|3794207|FG000|STARTED|24-week, Double-blind Treatment Period||0
3072932|NCT01336608|3794208|FG001|STARTED|24-week, Double-blind Treatment Period||141
3072933|NCT01336608|3794209|FG002|STARTED|24-week, Double-blind Treatment Period||154
3072934|NCT01336608|3794210|FG003|STARTED|24-week, Double-blind Treatment Period||135
3072935|NCT01336608|3794207|FG000|Completed the Treatment Period|24-week, Double-blind Treatment Period||0
3072936|NCT01336608|3794208|FG001|Completed the Treatment Period|24-week, Double-blind Treatment Period|Par. were considered to have completed the TP if they attended Visit 6 (Week 24).|96
3072937|NCT01336608|3794209|FG002|Completed the Treatment Period|24-week, Double-blind Treatment Period|Par. were considered to have completed the TP if they attended Visit 6 (Week 24).|124
3072938|NCT01336608|3794210|FG003|Completed the Treatment Period|24-week, Double-blind Treatment Period|Par. were considered to have completed the TP if they attended Visit 6 (Week 24).|110
3072939|NCT01336608|3794207|FG000|COMPLETED|24-week, Double-blind Treatment Period||0
3072940|NCT01336608|3794208|FG001|COMPLETED|24-week, Double-blind Treatment Period|Par. completed study if attended Wk 24, had 1-wk follow-up contact and no early withdrawal.|97
3072941|NCT01336608|3794209|FG002|COMPLETED|24-week, Double-blind Treatment Period|Par. completed study if attended Wk 24, had 1-wk follow-up contact and no early withdrawal.|124
3072942|NCT01336608|3794210|FG003|COMPLETED|24-week, Double-blind Treatment Period|Par. completed study if attended Wk 24, had 1-wk follow-up contact and no early withdrawal.|111
3072943|NCT01336608|3794207|FG000|NOT COMPLETED|24-week, Double-blind Treatment Period||0
3072944|NCT01336608|3794208|FG001|NOT COMPLETED|24-week, Double-blind Treatment Period||44
3072945|NCT01336608|3794209|FG002|NOT COMPLETED|24-week, Double-blind Treatment Period||30
3072946|NCT01336608|3794210|FG003|NOT COMPLETED|24-week, Double-blind Treatment Period||24
3072947|NCT01336634|3794221|FG000|STARTED|Overall Study||84
3072948|NCT01336634|3794222|FG001|STARTED|Overall Study||57
3072949|NCT01336634|3794223|FG002|STARTED|Overall Study||36
3072950|NCT01336634|3794221|FG000|COMPLETED|Overall Study||0
3072951|NCT01336634|3794222|FG001|COMPLETED|Overall Study||0
3072952|NCT01336634|3794223|FG002|COMPLETED|Overall Study||0
3072953|NCT01336634|3794221|FG000|NOT COMPLETED|Overall Study||84
3072954|NCT01336634|3794222|FG001|NOT COMPLETED|Overall Study||57
3072955|NCT01336634|3794223|FG002|NOT COMPLETED|Overall Study||36
3072956|NCT01336647|3794237|FG000|STARTED|Overall Study||46
3072957|NCT01336647|3794238|FG001|STARTED|Overall Study||49
3072958|NCT01336647|3794239|FG002|STARTED|Overall Study||47
3072959|NCT01336647|3794237|FG000|COMPLETED|Overall Study||42
3072960|NCT01336647|3794238|FG001|COMPLETED|Overall Study||48
3072961|NCT01336647|3794239|FG002|COMPLETED|Overall Study||44
3072962|NCT01336647|3794237|FG000|NOT COMPLETED|Overall Study||4
3072963|NCT01336647|3794238|FG001|NOT COMPLETED|Overall Study||1
3072964|NCT01336647|3794239|FG002|NOT COMPLETED|Overall Study||3
3072965|NCT01336712|3794249|FG000|STARTED|Overall Study||30
3072966|NCT01336712|3794249|FG000|COMPLETED|Overall Study||27
3072967|NCT01336712|3794249|FG000|NOT COMPLETED|Overall Study||3
3072968|NCT01336738|3794258|FG000|STARTED|Overall Study||52
3072969|NCT01336738|3794259|FG001|STARTED|Overall Study||54
3072970|NCT01336738|3794260|FG002|STARTED|Overall Study||53
3072971|NCT01336738|3794261|FG003|STARTED|Overall Study||54
3072972|NCT01336738|3794262|FG004|STARTED|Overall Study||53
3072973|NCT01336738|3794258|FG000|COMPLETED|Overall Study||45
3072974|NCT01336738|3794259|FG001|COMPLETED|Overall Study||45
3072975|NCT01336738|3794260|FG002|COMPLETED|Overall Study||45
3072976|NCT01336738|3794261|FG003|COMPLETED|Overall Study||47
3072977|NCT01336738|3794262|FG004|COMPLETED|Overall Study||43
3072978|NCT01336738|3794258|FG000|NOT COMPLETED|Overall Study||7
3072979|NCT01336738|3794259|FG001|NOT COMPLETED|Overall Study||9
3072980|NCT01336738|3794260|FG002|NOT COMPLETED|Overall Study||8
3072981|NCT01336738|3794261|FG003|NOT COMPLETED|Overall Study||7
3072982|NCT01336738|3794262|FG004|NOT COMPLETED|Overall Study||10
3072983|NCT01336764|3794276|FG000|STARTED|Overall Study||12
3072984|NCT01336764|3794277|FG001|STARTED|Overall Study||10
3072985|NCT01336764|3794276|FG000|COMPLETED|Overall Study||7
3072986|NCT01336764|3794277|FG001|COMPLETED|Overall Study||5
3072987|NCT01336764|3794276|FG000|NOT COMPLETED|Overall Study||5
3072988|NCT01336764|3794277|FG001|NOT COMPLETED|Overall Study||5
3072989|NCT01336803|3794283|FG000|STARTED|Overall Study||21
3072990|NCT01336803|3794283|FG000|Bone Sarcoma|Overall Study||10
3072991|NCT01336803|3794283|FG000|Osteomyelitis|Overall Study||4
3072992|NCT01336803|3794283|FG000|Lymphoma|Overall Study||7
3072993|NCT01336803|3794283|FG000|COMPLETED|Overall Study||21
3072994|NCT01336803|3794283|FG000|NOT COMPLETED|Overall Study||0
3072995|NCT01336894|3794297|FG000|STARTED|Protocol Interventions||4
3072996|NCT01336894|3794298|FG001|STARTED|Protocol Interventions||7
3072997|NCT01336894|3794297|FG000|COMPLETED|Protocol Interventions||4
3072998|NCT01336894|3794298|FG001|COMPLETED|Protocol Interventions||7
3072999|NCT01336894|3794297|FG000|NOT COMPLETED|Protocol Interventions||0
3073000|NCT01336894|3794298|FG001|NOT COMPLETED|Protocol Interventions||0
3073001|NCT01336894|3794297|FG000|STARTED|Follow-up||4
3073002|NCT01336894|3794298|FG001|STARTED|Follow-up||7
3073003|NCT01336894|3794297|FG000|COMPLETED|Follow-up||2
3073004|NCT01336894|3794298|FG001|COMPLETED|Follow-up||0
3073005|NCT01336894|3794297|FG000|NOT COMPLETED|Follow-up||2
3073006|NCT01336894|3794298|FG001|NOT COMPLETED|Follow-up||7
3073007|NCT01336933|3794304|FG000|STARTED|Overall Study||34
3073008|NCT01336933|3794304|FG000|COMPLETED|Overall Study||33
3073009|NCT01336933|3794304|FG000|NOT COMPLETED|Overall Study||1
3073010|NCT01336959|3794312|FG000|STARTED|Overall Study||8
3073011|NCT01336959|3794313|FG001|STARTED|Overall Study||42
3073012|NCT01336959|3794314|FG002|STARTED|Overall Study||41
3073013|NCT01336959|3794312|FG000|COMPLETED|Overall Study||8
3073014|NCT01336959|3794313|FG001|COMPLETED|Overall Study||37
3073015|NCT01336959|3794314|FG002|COMPLETED|Overall Study||40
3073016|NCT01336959|3794312|FG000|NOT COMPLETED|Overall Study||0
3073017|NCT01336959|3794313|FG001|NOT COMPLETED|Overall Study||5
3073018|NCT01336959|3794314|FG002|NOT COMPLETED|Overall Study||1
3073019|NCT01336972|3794328|FG000|STARTED|Overall Study||10
3073020|NCT01336972|3794329|FG001|STARTED|Overall Study||10
3073021|NCT01336972|3794330|FG002|STARTED|Overall Study||9
3073022|NCT01336972|3794328|FG000|COMPLETED|Overall Study||9
3073023|NCT01336972|3794329|FG001|COMPLETED|Overall Study||9
3073024|NCT01336972|3794330|FG002|COMPLETED|Overall Study||9
3073025|NCT01336972|3794328|FG000|NOT COMPLETED|Overall Study||1
3073026|NCT01336972|3794329|FG001|NOT COMPLETED|Overall Study||1
3073027|NCT01336972|3794330|FG002|NOT COMPLETED|Overall Study||0
3073028|NCT01337050|3794342|FG000|STARTED|Overall Study||4
3073029|NCT01337050|3794343|FG001|STARTED|Overall Study||13
3073030|NCT01337050|3794344|FG002|STARTED|Overall Study||19
3073031|NCT01337050|3794342|FG000|COMPLETED|Overall Study||0
3073032|NCT01337050|3794343|FG001|COMPLETED|Overall Study||0
3073033|NCT01337050|3794344|FG002|COMPLETED|Overall Study||0
3073034|NCT01337050|3794342|FG000|NOT COMPLETED|Overall Study||4
3073035|NCT01337050|3794343|FG001|NOT COMPLETED|Overall Study||13
3073036|NCT01337050|3794344|FG002|NOT COMPLETED|Overall Study||19
3073037|NCT01337076|3794353|FG000|STARTED|Overall Study|subjects implanted|21
3073038|NCT01337076|3794353|FG000|COMPLETED|Overall Study|subjects met the primary endpoint of 6 months postimplant activation|19
3073039|NCT01337076|3794353|FG000|NOT COMPLETED|Overall Study||2
3073040|NCT01337089|3794357|FG000|STARTED|Overall Study||660
3073041|NCT01337089|3794357|FG000|Received at Least 1 Dose of Study Drug|Overall Study||660
3073042|NCT01337089|3794357|FG000|Safety Population|Overall Study||660
3073043|NCT01337089|3794357|FG000|Efficacy Dataset|Overall Study|One participant withdrew after administering nabiximols, but no efficacy data were collected.|659
3073044|NCT01337089|3794357|FG000|COMPLETED|Overall Study||256
3073045|NCT01337089|3794357|FG000|NOT COMPLETED|Overall Study||404
3073046|NCT01337115|3794363|FG000|STARTED|Overall Study||25
3073047|NCT01337115|3794364|FG001|STARTED|Overall Study||25
3073048|NCT01337115|3794363|FG000|COMPLETED|Overall Study|2 patients could not be assessed after 12h because of catheter dislocation|23
3073049|NCT01337115|3794364|FG001|COMPLETED|Overall Study||25
3073050|NCT01337115|3794363|FG000|NOT COMPLETED|Overall Study||2
3073051|NCT01337115|3794364|FG001|NOT COMPLETED|Overall Study||0
3073052|NCT01337167|3794374|FG000|STARTED|Infant Series||986
3073053|NCT01337167|3794375|FG001|STARTED|Infant Series||487
3073054|NCT01337167|3794374|FG000|COMPLETED|Infant Series||924
3073055|NCT01337167|3794375|FG001|COMPLETED|Infant Series||460
3073056|NCT01337167|3794374|FG000|NOT COMPLETED|Infant Series||62
3073057|NCT01337167|3794375|FG001|NOT COMPLETED|Infant Series||27
3073058|NCT01337167|3794374|FG000|STARTED|Interim Period||924
3073059|NCT01337167|3794375|FG001|STARTED|Interim Period||460
3073060|NCT01337167|3794374|FG000|COMPLETED|Interim Period||843
3073061|NCT01337167|3794375|FG001|COMPLETED|Interim Period||420
3073062|NCT01337167|3794374|FG000|NOT COMPLETED|Interim Period||81
3073063|NCT01337167|3794375|FG001|NOT COMPLETED|Interim Period||40
3073064|NCT01337167|3794374|FG000|STARTED|Toddler Vaccinations||843
3073065|NCT01337167|3794375|FG001|STARTED|Toddler Vaccinations||420
3073066|NCT01337167|3794374|FG000|COMPLETED|Toddler Vaccinations||829
3073067|NCT01337167|3794375|FG001|COMPLETED|Toddler Vaccinations||407
3073068|NCT01337167|3794374|FG000|NOT COMPLETED|Toddler Vaccinations||14
3073069|NCT01337167|3794375|FG001|NOT COMPLETED|Toddler Vaccinations||13
3073070|NCT01337297|3794383|FG000|STARTED|Overall Study||11
3073071|NCT01337297|3794384|FG001|STARTED|Overall Study||9
3073072|NCT01337297|3794383|FG000|COMPLETED|Overall Study||6
3073073|NCT01337297|3794384|FG001|COMPLETED|Overall Study||3
3073074|NCT01337297|3794383|FG000|NOT COMPLETED|Overall Study||5
3073075|NCT01337297|3794384|FG001|NOT COMPLETED|Overall Study||6
3073076|NCT01337336|3794392|FG000|STARTED|Overall Study||1078
3073077|NCT01337336|3794393|FG001|STARTED|Overall Study||2923
3073078|NCT01337336|3794392|FG000|COMPLETED|Overall Study||1078
3073079|NCT01337336|3794393|FG001|COMPLETED|Overall Study||2923
3073080|NCT01337336|3794392|FG000|NOT COMPLETED|Overall Study||0
3073081|NCT01337336|3794393|FG001|NOT COMPLETED|Overall Study||0
3073082|NCT01337596|3794408|FG000|STARTED|Overall Study||7
3073083|NCT01337596|3794409|FG001|STARTED|Overall Study||7
3073084|NCT01337596|3794410|FG002|STARTED|Overall Study||7
3073085|NCT01337596|3794411|FG003|STARTED|Overall Study||7
3073086|NCT01337596|3794412|FG004|STARTED|Overall Study||7
3073087|NCT01337596|3794413|FG005|STARTED|Overall Study||7
3073088|NCT01337596|3794414|FG006|STARTED|Overall Study||12
3073089|NCT01337596|3794415|FG007|STARTED|Overall Study||2
3073090|NCT01337596|3794416|FG008|STARTED|Overall Study||7
3073091|NCT01337596|3794408|FG000|Safety Population|Overall Study||7
3073092|NCT01337596|3794409|FG001|Safety Population|Overall Study||7
3073093|NCT01337596|3794410|FG002|Safety Population|Overall Study||7
3073094|NCT01337596|3794411|FG003|Safety Population|Overall Study||7
3073095|NCT01337596|3794412|FG004|Safety Population|Overall Study||7
3073096|NCT01337596|3794413|FG005|Safety Population|Overall Study||7
3073097|NCT01337596|3794414|FG006|Safety Population|Overall Study||12
3073098|NCT01337596|3794415|FG007|Safety Population|Overall Study||2
3073099|NCT01337596|3794416|FG008|Safety Population|Overall Study||7
3073100|NCT01337596|3794408|FG000|COMPLETED|Overall Study||7
3073101|NCT01337596|3794409|FG001|COMPLETED|Overall Study||7
3073102|NCT01337596|3794410|FG002|COMPLETED|Overall Study||7
3073103|NCT01337596|3794411|FG003|COMPLETED|Overall Study||7
3073104|NCT01337596|3794412|FG004|COMPLETED|Overall Study||5
3073105|NCT01337596|3794413|FG005|COMPLETED|Overall Study||7
3073106|NCT01337596|3794414|FG006|COMPLETED|Overall Study||12
3073107|NCT01337596|3794415|FG007|COMPLETED|Overall Study||2
3073108|NCT01337596|3794416|FG008|COMPLETED|Overall Study||7
3073109|NCT01337596|3794408|FG000|NOT COMPLETED|Overall Study||0
3073110|NCT01337596|3794409|FG001|NOT COMPLETED|Overall Study||0
3073111|NCT01337596|3794410|FG002|NOT COMPLETED|Overall Study||0
3073112|NCT01337596|3794411|FG003|NOT COMPLETED|Overall Study||0
3073113|NCT01337596|3794412|FG004|NOT COMPLETED|Overall Study||2
3073114|NCT01337596|3794413|FG005|NOT COMPLETED|Overall Study||0
3073115|NCT01337596|3794414|FG006|NOT COMPLETED|Overall Study||0
3073116|NCT01337596|3794415|FG007|NOT COMPLETED|Overall Study||0
3073117|NCT01337596|3794416|FG008|NOT COMPLETED|Overall Study||0
3073118|NCT01337635|3794441|FG000|STARTED|Overall Study||3
3073119|NCT01337635|3794442|FG001|STARTED|Overall Study||4
3073120|NCT01337635|3794441|FG000|COMPLETED|Overall Study||3
3073121|NCT01337635|3794442|FG001|COMPLETED|Overall Study||3
3073122|NCT01337635|3794441|FG000|NOT COMPLETED|Overall Study||0
3073123|NCT01337635|3794442|FG001|NOT COMPLETED|Overall Study||1
3073124|NCT01337674|3794450|FG000|STARTED|Treatment Period 1||6
3073125|NCT01337674|3794451|FG001|STARTED|Treatment Period 1|The discontinued participant was replaced|7
3073126|NCT01337674|3794452|FG002|STARTED|Treatment Period 1||6
3073127|NCT01337674|3794453|FG003|STARTED|Treatment Period 1|The discontinued participant was replaced|7
3073128|NCT01337674|3794450|FG000|COMPLETED|Treatment Period 1||6
3073129|NCT01337674|3794451|FG001|COMPLETED|Treatment Period 1||6
3073130|NCT01337674|3794452|FG002|COMPLETED|Treatment Period 1||6
3073131|NCT01337674|3794453|FG003|COMPLETED|Treatment Period 1||6
3073132|NCT01337674|3794450|FG000|NOT COMPLETED|Treatment Period 1||0
3073133|NCT01337674|3794451|FG001|NOT COMPLETED|Treatment Period 1||1
3073134|NCT01337674|3794452|FG002|NOT COMPLETED|Treatment Period 1||0
3073135|NCT01337674|3794453|FG003|NOT COMPLETED|Treatment Period 1||1
3073136|NCT01337674|3794450|FG000|STARTED|Two-week Washout Period||6
3073137|NCT01337674|3794451|FG001|STARTED|Two-week Washout Period||6
3073138|NCT01337674|3794452|FG002|STARTED|Two-week Washout Period||6
3073139|NCT01337674|3794453|FG003|STARTED|Two-week Washout Period||6
3073140|NCT01337674|3794450|FG000|COMPLETED|Two-week Washout Period||6
3073141|NCT01337674|3794451|FG001|COMPLETED|Two-week Washout Period||6
3073142|NCT01337674|3794452|FG002|COMPLETED|Two-week Washout Period||6
3073143|NCT01337674|3794453|FG003|COMPLETED|Two-week Washout Period||6
3073144|NCT01337674|3794450|FG000|NOT COMPLETED|Two-week Washout Period||0
3073145|NCT01337674|3794451|FG001|NOT COMPLETED|Two-week Washout Period||0
3073146|NCT01337674|3794452|FG002|NOT COMPLETED|Two-week Washout Period||0
3073147|NCT01337674|3794453|FG003|NOT COMPLETED|Two-week Washout Period||0
3073148|NCT01337674|3794450|FG000|STARTED|Treatment Period 2||6
3073149|NCT01337674|3794451|FG001|STARTED|Treatment Period 2||6
3073150|NCT01337674|3794452|FG002|STARTED|Treatment Period 2||6
3073151|NCT01337674|3794453|FG003|STARTED|Treatment Period 2||6
3073152|NCT01337674|3794450|FG000|COMPLETED|Treatment Period 2||6
3073153|NCT01337674|3794451|FG001|COMPLETED|Treatment Period 2||6
3073154|NCT01337674|3794452|FG002|COMPLETED|Treatment Period 2||5
3073155|NCT01337674|3794453|FG003|COMPLETED|Treatment Period 2||6
3073156|NCT01337674|3794450|FG000|NOT COMPLETED|Treatment Period 2||0
3073157|NCT01337674|3794451|FG001|NOT COMPLETED|Treatment Period 2||0
3073158|NCT01337674|3794452|FG002|NOT COMPLETED|Treatment Period 2||1
3073159|NCT01337674|3794453|FG003|NOT COMPLETED|Treatment Period 2||0
3073160|NCT01337687|3794468|FG000|STARTED|Overall Study||10
3073161|NCT01337687|3794469|FG001|STARTED|Overall Study||9
3073162|NCT01337687|3794468|FG000|COMPLETED|Overall Study||10
3073163|NCT01337687|3794469|FG001|COMPLETED|Overall Study||9
3073164|NCT01337687|3794468|FG000|NOT COMPLETED|Overall Study||0
3073165|NCT01337687|3794469|FG001|NOT COMPLETED|Overall Study||0
3073166|NCT01337700|3794477|FG000|STARTED|Overall Study||5
3073167|NCT01337700|3794478|FG001|STARTED|Overall Study||5
3073168|NCT01337700|3794477|FG000|COMPLETED|Overall Study||5
3073169|NCT01337700|3794478|FG001|COMPLETED|Overall Study||5
3073170|NCT01337700|3794477|FG000|NOT COMPLETED|Overall Study||0
3073171|NCT01337700|3794478|FG001|NOT COMPLETED|Overall Study||0
3073172|NCT01337739|3794486|FG000|STARTED|Overall Study||6
3073173|NCT01337739|3794487|FG001|STARTED|Overall Study||4
3073174|NCT01337739|3794486|FG000|COMPLETED|Overall Study||6
3073175|NCT01337739|3794487|FG001|COMPLETED|Overall Study||4
3073176|NCT01337739|3794486|FG000|NOT COMPLETED|Overall Study||0
3073177|NCT01337739|3794487|FG001|NOT COMPLETED|Overall Study||0
3073178|NCT01337960|3794496|FG000|STARTED|Overall Study||14
3073179|NCT01337960|3794497|FG001|STARTED|Overall Study||14
3073180|NCT01337960|3794498|FG002|STARTED|Overall Study||6
3073181|NCT01337960|3794496|FG000|COMPLETED|Overall Study||12
3073182|NCT01337960|3794497|FG001|COMPLETED|Overall Study||14
3073183|NCT01337960|3794498|FG002|COMPLETED|Overall Study||6
3073184|NCT01337960|3794496|FG000|NOT COMPLETED|Overall Study||2
3073185|NCT01337960|3794497|FG001|NOT COMPLETED|Overall Study||0
3073186|NCT01337960|3794498|FG002|NOT COMPLETED|Overall Study||0
3073187|NCT01337973|3794509|FG000|STARTED|Overall Study||60
3073188|NCT01337973|3794510|FG001|STARTED|Overall Study||60
3073189|NCT01337973|3794511|FG002|STARTED|Overall Study||60
3073190|NCT01337973|3794509|FG000|COMPLETED|Overall Study||44
3073191|NCT01337973|3794510|FG001|COMPLETED|Overall Study||45
3073192|NCT01337973|3794511|FG002|COMPLETED|Overall Study||49
3073193|NCT01337973|3794509|FG000|NOT COMPLETED|Overall Study||16
3073194|NCT01337973|3794510|FG001|NOT COMPLETED|Overall Study||15
3073195|NCT01337973|3794511|FG002|NOT COMPLETED|Overall Study||11
3073196|NCT01337986|3794521|FG000|STARTED|Overall Study||23
3073197|NCT01337986|3794522|FG001|STARTED|Overall Study||23
3073198|NCT01337986|3794521|FG000|COMPLETED|Overall Study||20
3073199|NCT01337986|3794522|FG001|COMPLETED|Overall Study||18
3073200|NCT01337986|3794521|FG000|NOT COMPLETED|Overall Study||3
3073201|NCT01337986|3794522|FG001|NOT COMPLETED|Overall Study||5
3073202|NCT01338012|3794544|FG000|STARTED|Overall Study||8
3073203|NCT01338012|3794544|FG000|COMPLETED|Overall Study||0
3073204|NCT01338012|3794544|FG000|NOT COMPLETED|Overall Study||8
3073205|NCT01338025|3794550|FG000|STARTED|Overall Study||16
3073206|NCT01338025|3794551|FG001|STARTED|Overall Study||17
3073207|NCT01338025|3794550|FG000|COMPLETED|Overall Study||5
3073208|NCT01338025|3794551|FG001|COMPLETED|Overall Study||6
3073209|NCT01338025|3794550|FG000|NOT COMPLETED|Overall Study||11
3073210|NCT01338025|3794551|FG001|NOT COMPLETED|Overall Study||11
3073211|NCT01338298|3794559|FG000|STARTED|Overall Study||24
3073212|NCT01338298|3794560|FG001|STARTED|Overall Study||18
3073213|NCT01338298|3794559|FG000|COMPLETED|Overall Study||20
3073214|NCT01338298|3794560|FG001|COMPLETED|Overall Study||15
3073215|NCT01338298|3794559|FG000|NOT COMPLETED|Overall Study||4
3073216|NCT01338298|3794560|FG001|NOT COMPLETED|Overall Study||3
3073217|NCT01338415|3794568|FG000|STARTED|Core + Extension||33
3073218|NCT01338415|3794569|FG001|STARTED|Core + Extension||31
3073219|NCT01338415|3794570|FG002|STARTED|Core + Extension||0
3073220|NCT01338415|3794568|FG000|Enrolled in FUTURE 3 Extension|Core + Extension||31
3073221|NCT01338415|3794569|FG001|Enrolled in FUTURE 3 Extension|Core + Extension||27
3073222|NCT01338415|3794570|FG002|Enrolled in FUTURE 3 Extension|Core + Extension||0
3073223|NCT01338415|3794568|FG000|COMPLETED|Core + Extension||23
3073224|NCT01338415|3794569|FG001|COMPLETED|Core + Extension||22
3073225|NCT01338415|3794570|FG002|COMPLETED|Core + Extension||0
3073226|NCT01338415|3794568|FG000|NOT COMPLETED|Core + Extension||10
3073227|NCT01338415|3794569|FG001|NOT COMPLETED|Core + Extension||9
3073228|NCT01338415|3794570|FG002|NOT COMPLETED|Core + Extension||0
3073229|NCT01338415|3794568|FG000|STARTED|Exceptional Use Treatment Period||0
3073230|NCT01338415|3794569|FG001|STARTED|Exceptional Use Treatment Period||0
3073231|NCT01338415|3794570|FG002|STARTED|Exceptional Use Treatment Period||10
3073232|NCT01338415|3794568|FG000|COMPLETED|Exceptional Use Treatment Period||0
3073233|NCT01338415|3794569|FG001|COMPLETED|Exceptional Use Treatment Period||0
3073234|NCT01338415|3794570|FG002|COMPLETED|Exceptional Use Treatment Period||4
3073235|NCT01338415|3794568|FG000|NOT COMPLETED|Exceptional Use Treatment Period||0
3073236|NCT01338415|3794569|FG001|NOT COMPLETED|Exceptional Use Treatment Period||0
3073237|NCT01338415|3794570|FG002|NOT COMPLETED|Exceptional Use Treatment Period||6
3073238|NCT01338493|3794578|FG000|STARTED|Enrolled||139
3073239|NCT01338493|3794578|FG000|COMPLETED|Enrolled||134
3073240|NCT01338493|3794578|FG000|NOT COMPLETED|Enrolled||5
3073241|NCT01338493|3794578|FG000|STARTED|Implant||134
3073242|NCT01338493|3794578|FG000|COMPLETED|Implant||134
3073243|NCT01338493|3794578|FG000|NOT COMPLETED|Implant||0
3073244|NCT01338493|3794578|FG000|STARTED|Discharge||134
3073245|NCT01338493|3794578|FG000|COMPLETED|Discharge||132
3073246|NCT01338493|3794578|FG000|NOT COMPLETED|Discharge||2
3073247|NCT01338493|3794578|FG000|STARTED|6 Months Follow up||132
3073248|NCT01338493|3794578|FG000|COMPLETED|6 Months Follow up||113
3073249|NCT01338493|3794578|FG000|NOT COMPLETED|6 Months Follow up||19
3073250|NCT01338493|3794578|FG000|STARTED|12 Months Follow up||113
3073251|NCT01338493|3794578|FG000|COMPLETED|12 Months Follow up||104
3073252|NCT01338493|3794578|FG000|NOT COMPLETED|12 Months Follow up||9
3073253|NCT01338493|3794578|FG000|STARTED|24 Months Follow up||104
3073254|NCT01338493|3794578|FG000|COMPLETED|24 Months Follow up||104
3073255|NCT01338493|3794578|FG000|NOT COMPLETED|24 Months Follow up||0
3073256|NCT01338506|3794584|FG000|STARTED|Overall Study||54
3073257|NCT01338506|3794585|FG001|STARTED|Overall Study||27
3073258|NCT01338506|3794584|FG000|COMPLETED|Overall Study||29
3073259|NCT01338506|3794585|FG001|COMPLETED|Overall Study||13
3073260|NCT01338506|3794584|FG000|NOT COMPLETED|Overall Study||25
3073261|NCT01338506|3794585|FG001|NOT COMPLETED|Overall Study||14
3073262|NCT01338610|3794598|FG000|STARTED|Overall Study||39
3073263|NCT01338610|3794599|FG001|STARTED|Overall Study||56
3073264|NCT01338610|3794600|FG002|STARTED|Overall Study||29
3073265|NCT01338610|3794598|FG000|COMPLETED|Overall Study||34
3073266|NCT01338610|3794599|FG001|COMPLETED|Overall Study||55
3073267|NCT01338610|3794600|FG002|COMPLETED|Overall Study||28
3073268|NCT01338610|3794598|FG000|NOT COMPLETED|Overall Study||5
3073269|NCT01338610|3794599|FG001|NOT COMPLETED|Overall Study||1
3073270|NCT01338610|3794600|FG002|NOT COMPLETED|Overall Study||1
3073271|NCT01338649|3794609|FG000|STARTED|Overall Study||13
3073272|NCT01338649|3794610|FG001|STARTED|Overall Study||14
3073273|NCT01338649|3794609|FG000|COMPLETED|Overall Study||13
3073274|NCT01338649|3794610|FG001|COMPLETED|Overall Study||14
3073275|NCT01338649|3794609|FG000|NOT COMPLETED|Overall Study||0
3073276|NCT01338649|3794610|FG001|NOT COMPLETED|Overall Study||0
3073277|NCT01338792|3794616|FG000|STARTED|Overall Study||47
3073278|NCT01338792|3794616|FG000|COMPLETED|Overall Study||43
3073279|NCT01338792|3794616|FG000|NOT COMPLETED|Overall Study||4
3073280|NCT01338818|3794620|FG000|STARTED|Overall Study||298
3073281|NCT01338818|3794620|FG000|COMPLETED|Overall Study||262
3073282|NCT01338818|3794620|FG000|NOT COMPLETED|Overall Study||36
3073283|NCT01338857|3794624|FG000|STARTED|Overall Study||12
3073284|NCT01338857|3794624|FG000|COMPLETED|Overall Study||1
3073285|NCT01338857|3794624|FG000|NOT COMPLETED|Overall Study||11
3073286|NCT01338870|3794634|FG000|STARTED|Overall Study||50
3073287|NCT01338870|3794635|FG001|STARTED|Overall Study||49
3073288|NCT01338870|3794636|FG002|STARTED|Overall Study||50
3073289|NCT01338870|3794637|FG003|STARTED|Overall Study||50
3073290|NCT01338870|3794638|FG004|STARTED|Overall Study||52
3073291|NCT01338870|3794639|FG005|STARTED|Overall Study||50
3073292|NCT01338870|3794634|FG000|COMPLETED|Overall Study||41
3073293|NCT01338870|3794635|FG001|COMPLETED|Overall Study||37
3073294|NCT01338870|3794636|FG002|COMPLETED|Overall Study||39
3073295|NCT01338870|3794637|FG003|COMPLETED|Overall Study||41
3073296|NCT01338870|3794638|FG004|COMPLETED|Overall Study||46
3073297|NCT01338870|3794639|FG005|COMPLETED|Overall Study||44
3073298|NCT01338870|3794634|FG000|NOT COMPLETED|Overall Study||9
3073299|NCT01338870|3794635|FG001|NOT COMPLETED|Overall Study||12
3073300|NCT01338870|3794636|FG002|NOT COMPLETED|Overall Study||11
3073301|NCT01338870|3794637|FG003|NOT COMPLETED|Overall Study||9
3073302|NCT01338870|3794638|FG004|NOT COMPLETED|Overall Study||6
3073303|NCT01338870|3794639|FG005|NOT COMPLETED|Overall Study||6
3073304|NCT01338987|3794658|FG000|STARTED|Overall Study||12
3073305|NCT01338987|3794659|FG001|STARTED|Overall Study||9
3073306|NCT01338987|3794660|FG002|STARTED|Overall Study||22
3073307|NCT01338987|3794661|FG003|STARTED|Overall Study||31
3073308|NCT01338987|3794662|FG004|STARTED|Overall Study||2
3073309|NCT01338987|3794658|FG000|COMPLETED|Overall Study||10
3073310|NCT01338987|3794659|FG001|COMPLETED|Overall Study||8
3073311|NCT01338987|3794660|FG002|COMPLETED|Overall Study||20
3073312|NCT01338987|3794661|FG003|COMPLETED|Overall Study||31
3073313|NCT01338987|3794662|FG004|COMPLETED|Overall Study||2
3073314|NCT01338987|3794658|FG000|NOT COMPLETED|Overall Study||2
3073315|NCT01338987|3794659|FG001|NOT COMPLETED|Overall Study||1
3073316|NCT01338987|3794660|FG002|NOT COMPLETED|Overall Study||2
3073317|NCT01338987|3794661|FG003|NOT COMPLETED|Overall Study||0
3073318|NCT01338987|3794662|FG004|NOT COMPLETED|Overall Study||0
3073319|NCT01339000|3794678|FG000|STARTED|Overall Study|The patient received day 1, 29, 36, 43, 50, and 57 vaccines but did not receive interleukin-7 (IL-7)|1
3073320|NCT01339000|3794679|FG001|STARTED|Overall Study||0
3073321|NCT01339000|3794678|FG000|COMPLETED|Overall Study||0
3073322|NCT01339000|3794679|FG001|COMPLETED|Overall Study||0
3073323|NCT01339000|3794678|FG000|NOT COMPLETED|Overall Study||1
3073324|NCT01339000|3794679|FG001|NOT COMPLETED|Overall Study||0
3073325|NCT01339013|3794688|FG000|STARTED|Overall Study||6
3073326|NCT01339013|3794688|FG000|COMPLETED|Overall Study||6
3073327|NCT01339013|3794688|FG000|NOT COMPLETED|Overall Study||0
3073328|NCT01339052|3794694|FG000|STARTED|Overall Study||15
3073329|NCT01339052|3794695|FG001|STARTED|Overall Study||50
3073330|NCT01339052|3794694|FG000|Measurable Disease|Overall Study||11
3073331|NCT01339052|3794695|FG001|Measurable Disease|Overall Study|Radiographic response evaluated on participants with measurable disease only.|40
3073332|NCT01339052|3794694|FG000|Evaluable Tumor Sample at Surgery|Overall Study||14
3073333|NCT01339052|3794695|FG001|Evaluable Tumor Sample at Surgery|Overall Study|Milestone is not relevant for non-surgical cohort.|0
3073334|NCT01339052|3794694|FG000|Evaluable Plasma Sample at Surgery|Overall Study||13
3073335|NCT01339052|3794695|FG001|Evaluable Plasma Sample at Surgery|Overall Study|Milestone is not relevant for non-surgical cohort.|0
3073336|NCT01339052|3794694|FG000|COMPLETED|Overall Study||0
3073337|NCT01339052|3794695|FG001|COMPLETED|Overall Study||0
3073338|NCT01339052|3794694|FG000|NOT COMPLETED|Overall Study||15
3073339|NCT01339052|3794695|FG001|NOT COMPLETED|Overall Study||50
3073340|NCT01339091|3794706|FG000|STARTED|Overall Study||288
3073341|NCT01339091|3794707|FG001|STARTED|Overall Study||285
3073342|NCT01339091|3794706|FG000|Safety Population|Overall Study||284
3073343|NCT01339091|3794707|FG001|Safety Population|Overall Study||284
3073344|NCT01339091|3794706|FG000|COMPLETED|Overall Study||261
3073345|NCT01339091|3794707|FG001|COMPLETED|Overall Study||257
3073346|NCT01339091|3794706|FG000|NOT COMPLETED|Overall Study||27
3073347|NCT01339091|3794707|FG001|NOT COMPLETED|Overall Study||28
3073348|NCT01339247|3794713|FG000|STARTED|Period 1||30
3073349|NCT01339247|3794714|FG001|STARTED|Period 1||30
3073350|NCT01339247|3794713|FG000|COMPLETED|Period 1||30
3073351|NCT01339247|3794714|FG001|COMPLETED|Period 1||30
3073352|NCT01339247|3794713|FG000|NOT COMPLETED|Period 1||0
3073353|NCT01339247|3794714|FG001|NOT COMPLETED|Period 1||0
3073354|NCT01339247|3794713|FG000|STARTED|Period 2||30
3073355|NCT01339247|3794714|FG001|STARTED|Period 2||30
3073356|NCT01339247|3794713|FG000|COMPLETED|Period 2||30
3073357|NCT01339247|3794714|FG001|COMPLETED|Period 2||30
3073358|NCT01339247|3794713|FG000|NOT COMPLETED|Period 2||0
3073359|NCT01339247|3794714|FG001|NOT COMPLETED|Period 2||0
3073360|NCT01339260|3794722|FG000|STARTED|Cycle 1|Intent-To-Treat: randomized patients|726
3073361|NCT01339260|3794723|FG001|STARTED|Cycle 1|Intent-To-Treat: randomized patients|729
3073362|NCT01339260|3794722|FG000|Safety Population|Cycle 1|Patients receiving netupitant/palonosetron combination|725
3073363|NCT01339260|3794723|FG001|Safety Population|Cycle 1|Patients receiving palonosetron|725
3073364|NCT01339260|3794722|FG000|Full Analysis Set|Cycle 1|Patients receiving chemotherapy and randomized to netupitant/palonosetron combination|724
3073365|NCT01339260|3794723|FG001|Full Analysis Set|Cycle 1|Patients receiving chemotherapy and randomized to palonosetron|725
3073366|NCT01339260|3794722|FG000|COMPLETED|Cycle 1||719
3073367|NCT01339260|3794723|FG001|COMPLETED|Cycle 1||719
3073368|NCT01339260|3794722|FG000|NOT COMPLETED|Cycle 1||7
3073369|NCT01339260|3794723|FG001|NOT COMPLETED|Cycle 1||10
3073370|NCT01339260|3794722|FG000|STARTED|Multi-cycle Extension|Patients scheduled to netupitant/palonosetron combination|635
3073371|NCT01339260|3794723|FG001|STARTED|Multi-cycle Extension|Patients scheduled to palonosetron|651
3073372|NCT01339260|3794722|FG000|Safety Population|Multi-cycle Extension|Patients receiving netupitant/palonosetron combination|635
3073373|NCT01339260|3794723|FG001|Safety Population|Multi-cycle Extension|Patients receiving palonosetron|651
3073374|NCT01339260|3794722|FG000|COMPLETED|Multi-cycle Extension|Patients completing at least number of cycles they were scheduled to|449
3073375|NCT01339260|3794723|FG001|COMPLETED|Multi-cycle Extension|Patients completing at least number of cycles they were scheduled to|458
3073376|NCT01339260|3794722|FG000|NOT COMPLETED|Multi-cycle Extension||186
3073377|NCT01339260|3794723|FG001|NOT COMPLETED|Multi-cycle Extension||193
3073378|NCT01339273|3794733|FG000|STARTED|Overall Study||36
3073379|NCT01339273|3794734|FG001|STARTED|Overall Study||36
3073380|NCT01339273|3794733|FG000|COMPLETED|Overall Study||28
3073381|NCT01339273|3794734|FG001|COMPLETED|Overall Study||28
3073382|NCT01339273|3794733|FG000|NOT COMPLETED|Overall Study||8
3073383|NCT01339273|3794734|FG001|NOT COMPLETED|Overall Study||8
3073384|NCT01339299|3794742|FG000|STARTED|Overall Study||50
3073385|NCT01339299|3794743|FG001|STARTED|Overall Study||50
3073386|NCT01339299|3794742|FG000|COMPLETED|Overall Study||50
3073387|NCT01339299|3794743|FG001|COMPLETED|Overall Study||50
3073388|NCT01339299|3794742|FG000|NOT COMPLETED|Overall Study||0
3073389|NCT01339299|3794743|FG001|NOT COMPLETED|Overall Study||0
3073390|NCT01339390|3794751|FG000|STARTED|Overall Study||1571
3073391|NCT01339390|3794752|FG001|STARTED|Overall Study||1598
3073392|NCT01339390|3794751|FG000|COMPLETED|Overall Study||1414
3073393|NCT01339390|3794752|FG001|COMPLETED|Overall Study||1442
3073394|NCT01339390|3794751|FG000|NOT COMPLETED|Overall Study||157
3073395|NCT01339390|3794752|FG001|NOT COMPLETED|Overall Study||156
3073396|NCT01339403|3794760|FG000|STARTED|Overall Study||24768
3073397|NCT01339403|3794761|FG001|STARTED|Overall Study||257600
3073398|NCT01339403|3794760|FG000|COMPLETED|Overall Study||24768
3073399|NCT01339403|3794761|FG001|COMPLETED|Overall Study||257600
3073400|NCT01339403|3794760|FG000|NOT COMPLETED|Overall Study||0
3073401|NCT01339403|3794761|FG001|NOT COMPLETED|Overall Study||0
3073402|NCT01339416|3794767|FG000|STARTED|Overall Study||8202
3073403|NCT01339416|3794767|FG000|COMPLETED|Overall Study||8202
3073404|NCT01339416|3794767|FG000|NOT COMPLETED|Overall Study||0
3073405|NCT01339429|3794771|FG000|STARTED|Overall Study||41
3073406|NCT01339429|3794771|FG000|COMPLETED|Overall Study||37
3073407|NCT01339429|3794771|FG000|NOT COMPLETED|Overall Study||4
3073408|NCT01339559|3794775|FG000|STARTED|Overall Study||766
3073409|NCT01339559|3794775|FG000|COMPLETED|Overall Study||368
3073410|NCT01339559|3794775|FG000|NOT COMPLETED|Overall Study||398
3073411|NCT01339832|3794780|FG000|STARTED|Overall Study||51
3073412|NCT01339832|3794780|FG000|COMPLETED|Overall Study||37
3073413|NCT01339832|3794780|FG000|NOT COMPLETED|Overall Study||14
3073414|NCT01339858|3794786|FG000|STARTED|Overall Study||30
3073415|NCT01339858|3794787|FG001|STARTED|Overall Study||30
3073416|NCT01339858|3794786|FG000|COMPLETED|Overall Study||14
3073417|NCT01339858|3794787|FG001|COMPLETED|Overall Study||18
3073418|NCT01339858|3794786|FG000|NOT COMPLETED|Overall Study||16
3073419|NCT01339858|3794787|FG001|NOT COMPLETED|Overall Study||12
3073420|NCT01339897|3794799|FG000|STARTED|Overall Study||7
3073421|NCT01339897|3794800|FG001|STARTED|Overall Study||6
3073422|NCT01339897|3794801|FG002|STARTED|Overall Study||6
3073423|NCT01339897|3794802|FG003|STARTED|Overall Study||6
3073424|NCT01339897|3794799|FG000|COMPLETED|Overall Study||6
3073425|NCT01339897|3794800|FG001|COMPLETED|Overall Study||6
3073426|NCT01339897|3794801|FG002|COMPLETED|Overall Study||6
3073427|NCT01339897|3794802|FG003|COMPLETED|Overall Study||5
3073428|NCT01339897|3794799|FG000|NOT COMPLETED|Overall Study||1
3073429|NCT01339897|3794800|FG001|NOT COMPLETED|Overall Study||0
3073430|NCT01339897|3794801|FG002|NOT COMPLETED|Overall Study||0
3073431|NCT01339897|3794802|FG003|NOT COMPLETED|Overall Study||1
3073432|NCT01339910|3794816|FG000|STARTED|Overall Study||135
3073433|NCT01339910|3794817|FG001|STARTED|Overall Study||137
3073434|NCT01339910|3794816|FG000|COMPLETED|Overall Study||132
3073435|NCT01339910|3794817|FG001|COMPLETED|Overall Study||133
3073436|NCT01339910|3794816|FG000|NOT COMPLETED|Overall Study||3
3073437|NCT01339910|3794817|FG001|NOT COMPLETED|Overall Study||4
3073438|NCT01339923|3794830|FG000|STARTED|Overall Study||253
3073439|NCT01339923|3794831|FG001|STARTED|Overall Study||250
3073440|NCT01339923|3794832|FG002|STARTED|Overall Study||251
3073441|NCT01339923|3794833|FG003|STARTED|Overall Study||104
3073442|NCT01339923|3794834|FG004|STARTED|Overall Study||300
3073443|NCT01339923|3794835|FG005|STARTED|Overall Study||126
3073444|NCT01339923|3794836|FG006|STARTED|Overall Study||125
3073445|NCT01339923|3794830|FG000|COMPLETED|Overall Study||239
3073446|NCT01339923|3794831|FG001|COMPLETED|Overall Study||234
3073447|NCT01339923|3794832|FG002|COMPLETED|Overall Study||243
3073448|NCT01339923|3794833|FG003|COMPLETED|Overall Study||100
3073449|NCT01339923|3794834|FG004|COMPLETED|Overall Study||295
3073450|NCT01339923|3794835|FG005|COMPLETED|Overall Study||117
3073451|NCT01339923|3794836|FG006|COMPLETED|Overall Study||111
3073452|NCT01339923|3794830|FG000|NOT COMPLETED|Overall Study||14
3073453|NCT01339923|3794831|FG001|NOT COMPLETED|Overall Study||16
3073454|NCT01339923|3794832|FG002|NOT COMPLETED|Overall Study||8
3073455|NCT01339923|3794833|FG003|NOT COMPLETED|Overall Study||4
3073456|NCT01339923|3794834|FG004|NOT COMPLETED|Overall Study||5
3073457|NCT01339923|3794835|FG005|NOT COMPLETED|Overall Study||9
3073458|NCT01339923|3794836|FG006|NOT COMPLETED|Overall Study||14
3073459|NCT01339936|3794865|FG000|STARTED|Overall Study|plus 2 screen failures|38
3073460|NCT01339936|3794865|FG000|COMPLETED|Overall Study|plus 1 excluded from analysis set|36
3073461|NCT01339936|3794865|FG000|NOT COMPLETED|Overall Study||2
3073462|NCT01340014|3794871|FG000|STARTED|Period 1, First 7 Days||55
3073463|NCT01340014|3794872|FG001|STARTED|Period 1, First 7 Days||57
3073464|NCT01340014|3794871|FG000|COMPLETED|Period 1, First 7 Days||53
3073465|NCT01340014|3794872|FG001|COMPLETED|Period 1, First 7 Days||57
3073466|NCT01340014|3794871|FG000|NOT COMPLETED|Period 1, First 7 Days||2
3073467|NCT01340014|3794872|FG001|NOT COMPLETED|Period 1, First 7 Days||0
3073468|NCT01340014|3794871|FG000|STARTED|Period 2, Second 7 Days||53
3073469|NCT01340014|3794872|FG001|STARTED|Period 2, Second 7 Days||57
3073470|NCT01340014|3794871|FG000|COMPLETED|Period 2, Second 7 Days||53
3073471|NCT01340014|3794872|FG001|COMPLETED|Period 2, Second 7 Days||56
3073472|NCT01340014|3794871|FG000|NOT COMPLETED|Period 2, Second 7 Days||0
3073473|NCT01340014|3794872|FG001|NOT COMPLETED|Period 2, Second 7 Days||1
3073474|NCT01340027|3794890|FG000|STARTED|Overall Study||81
3073475|NCT01340027|3794891|FG001|STARTED|Overall Study||78
3073476|NCT01340027|3794892|FG002|STARTED|Overall Study||79
3073477|NCT01340027|3794893|FG003|STARTED|Overall Study||79
3073478|NCT01340027|3794894|FG004|STARTED|Overall Study||156
3073479|NCT01340027|3794895|FG005|STARTED|Overall Study||78
3073480|NCT01340027|3794896|FG006|STARTED|Overall Study||149
3073481|NCT01340027|3794897|FG007|STARTED|Overall Study||149
3073482|NCT01340027|3794898|FG008|STARTED|Overall Study||144
3073483|NCT01340027|3794899|FG009|STARTED|Overall Study||152
3073484|NCT01340027|3794900|FG010|STARTED|Overall Study||81
3073485|NCT01340027|3794901|FG011|STARTED|Overall Study||81
3073486|NCT01340027|3794890|FG000|Received Treatment|Overall Study||81
3073487|NCT01340027|3794891|FG001|Received Treatment|Overall Study||78
3073488|NCT01340027|3794892|FG002|Received Treatment|Overall Study||78
3073489|NCT01340027|3794893|FG003|Received Treatment|Overall Study||79
3073490|NCT01340027|3794894|FG004|Received Treatment|Overall Study||156
3073491|NCT01340027|3794895|FG005|Received Treatment|Overall Study||78
3073492|NCT01340027|3794896|FG006|Received Treatment|Overall Study||149
3073493|NCT01340027|3794897|FG007|Received Treatment|Overall Study||149
3073494|NCT01340027|3794898|FG008|Received Treatment|Overall Study||144
3073495|NCT01340027|3794899|FG009|Received Treatment|Overall Study||152
3073496|NCT01340027|3794900|FG010|Received Treatment|Overall Study||81
3073497|NCT01340027|3794901|FG011|Received Treatment|Overall Study||81
3073498|NCT01340027|3794890|FG000|COMPLETED|Overall Study||76
3073499|NCT01340027|3794891|FG001|COMPLETED|Overall Study||71
3073500|NCT01340027|3794892|FG002|COMPLETED|Overall Study||75
3073501|NCT01340027|3794893|FG003|COMPLETED|Overall Study||75
3073502|NCT01340027|3794894|FG004|COMPLETED|Overall Study||146
3073503|NCT01340027|3794895|FG005|COMPLETED|Overall Study||74
3073504|NCT01340027|3794896|FG006|COMPLETED|Overall Study||142
3073505|NCT01340027|3794897|FG007|COMPLETED|Overall Study||142
3073506|NCT01340027|3794898|FG008|COMPLETED|Overall Study||136
3073507|NCT01340027|3794899|FG009|COMPLETED|Overall Study||146
3073508|NCT01340027|3794900|FG010|COMPLETED|Overall Study||79
3073509|NCT01340027|3794901|FG011|COMPLETED|Overall Study||77
3073510|NCT01340027|3794890|FG000|NOT COMPLETED|Overall Study||5
3073511|NCT01340027|3794891|FG001|NOT COMPLETED|Overall Study||7
3073512|NCT01340027|3794892|FG002|NOT COMPLETED|Overall Study||4
3073513|NCT01340027|3794893|FG003|NOT COMPLETED|Overall Study||4
3073514|NCT01340027|3794894|FG004|NOT COMPLETED|Overall Study||10
3073515|NCT01340027|3794895|FG005|NOT COMPLETED|Overall Study||4
3073516|NCT01340027|3794896|FG006|NOT COMPLETED|Overall Study||7
3073517|NCT01340027|3794897|FG007|NOT COMPLETED|Overall Study||7
3073518|NCT01340027|3794898|FG008|NOT COMPLETED|Overall Study||8
3073519|NCT01340027|3794899|FG009|NOT COMPLETED|Overall Study||6
3073520|NCT01340027|3794900|FG010|NOT COMPLETED|Overall Study||2
3073521|NCT01340027|3794901|FG011|NOT COMPLETED|Overall Study||4
3073522|NCT01340053|3794931|FG000|STARTED|Overall Study||47
3073523|NCT01340053|3794932|FG001|STARTED|Overall Study||46
3073524|NCT01340053|3794933|FG002|STARTED|Overall Study||47
3073525|NCT01340053|3794934|FG003|STARTED|Overall Study||46
3073526|NCT01340053|3794931|FG000|COMPLETED|Overall Study||43
3073527|NCT01340053|3794932|FG001|COMPLETED|Overall Study||44
3073528|NCT01340053|3794933|FG002|COMPLETED|Overall Study||43
3073529|NCT01340053|3794934|FG003|COMPLETED|Overall Study||43
3073530|NCT01340053|3794931|FG000|NOT COMPLETED|Overall Study||4
3073531|NCT01340053|3794932|FG001|NOT COMPLETED|Overall Study||2
3073532|NCT01340053|3794933|FG002|NOT COMPLETED|Overall Study||4
3073533|NCT01340053|3794934|FG003|NOT COMPLETED|Overall Study||3
3073534|NCT01340066|3794946|FG000|STARTED|Placebo Run in Period||94
3073535|NCT01340066|3794947|FG001|STARTED|Placebo Run in Period||0
3073536|NCT01340066|3794948|FG002|STARTED|Placebo Run in Period||0
3073537|NCT01340066|3794946|FG000|COMPLETED|Placebo Run in Period|Completed run in period and were eligible for randomization|67
3073538|NCT01340066|3794947|FG001|COMPLETED|Placebo Run in Period||0
3073539|NCT01340066|3794948|FG002|COMPLETED|Placebo Run in Period||0
3073540|NCT01340066|3794946|FG000|NOT COMPLETED|Placebo Run in Period||27
3073541|NCT01340066|3794947|FG001|NOT COMPLETED|Placebo Run in Period||0
3073542|NCT01340066|3794948|FG002|NOT COMPLETED|Placebo Run in Period||0
3073543|NCT01340066|3794946|FG000|STARTED|5 Week Double Blind Randomization Period||0
3073544|NCT01340066|3794947|FG001|STARTED|5 Week Double Blind Randomization Period||33
3073545|NCT01340066|3794948|FG002|STARTED|5 Week Double Blind Randomization Period||34
3073546|NCT01340066|3794946|FG000|COMPLETED|5 Week Double Blind Randomization Period||0
3073547|NCT01340066|3794947|FG001|COMPLETED|5 Week Double Blind Randomization Period||28
3073548|NCT01340066|3794948|FG002|COMPLETED|5 Week Double Blind Randomization Period||31
3073549|NCT01340066|3794946|FG000|NOT COMPLETED|5 Week Double Blind Randomization Period||0
3073550|NCT01340066|3794947|FG001|NOT COMPLETED|5 Week Double Blind Randomization Period||5
3073551|NCT01340066|3794948|FG002|NOT COMPLETED|5 Week Double Blind Randomization Period||3
3134482|NCT01701258|3859409|FG000|COMPLETED|PET (Session 3)||0
3134483|NCT01701258|3859410|FG001|COMPLETED|PET (Session 3)||20
3134484|NCT01701258|3859411|FG002|COMPLETED|PET (Session 3)||0
3134485|NCT01701258|3859412|FG003|COMPLETED|PET (Session 3)||0
3134486|NCT01701258|3859413|FG004|COMPLETED|PET (Session 3)||16
3134487|NCT01701258|3859414|FG005|COMPLETED|PET (Session 3)||0
3134488|NCT01701258|3859415|FG006|COMPLETED|PET (Session 3)||0
3134489|NCT01701258|3859416|FG007|COMPLETED|PET (Session 3)||19
3134490|NCT01701258|3859417|FG008|COMPLETED|PET (Session 3)||0
3134491|NCT01701258|3859418|FG009|COMPLETED|PET (Session 3)||0
3134492|NCT01701258|3859419|FG010|COMPLETED|PET (Session 3)||18
3134493|NCT01701258|3859420|FG011|COMPLETED|PET (Session 3)||0
3134494|NCT01701258|3859421|FG012|COMPLETED|PET (Session 3)||0
3134495|NCT01701258|3859409|FG000|NOT COMPLETED|PET (Session 3)||0
3134496|NCT01701258|3859410|FG001|NOT COMPLETED|PET (Session 3)||0
3134497|NCT01701258|3859411|FG002|NOT COMPLETED|PET (Session 3)||0
3134498|NCT01701258|3859412|FG003|NOT COMPLETED|PET (Session 3)||0
3134499|NCT01701258|3859413|FG004|NOT COMPLETED|PET (Session 3)||0
3134500|NCT01701258|3859414|FG005|NOT COMPLETED|PET (Session 3)||0
3134501|NCT01701258|3859415|FG006|NOT COMPLETED|PET (Session 3)||0
3134502|NCT01701258|3859416|FG007|NOT COMPLETED|PET (Session 3)||0
3134503|NCT01701258|3859417|FG008|NOT COMPLETED|PET (Session 3)||0
3134504|NCT01701258|3859418|FG009|NOT COMPLETED|PET (Session 3)||0
3134505|NCT01701258|3859419|FG010|NOT COMPLETED|PET (Session 3)||0
3134506|NCT01701258|3859420|FG011|NOT COMPLETED|PET (Session 3)||0
3134507|NCT01701258|3859421|FG012|NOT COMPLETED|PET (Session 3)||0
3134508|NCT01701258|3859409|FG000|STARTED|EEG (Session 4)||0
3134509|NCT01701258|3859410|FG001|STARTED|EEG (Session 4)||19
3134510|NCT01701258|3859411|FG002|STARTED|EEG (Session 4)||0
3134511|NCT01701258|3859412|FG003|STARTED|EEG (Session 4)||0
3134512|NCT01701258|3859413|FG004|STARTED|EEG (Session 4)||14
3134513|NCT01701258|3859414|FG005|STARTED|EEG (Session 4)||0
3134514|NCT01701258|3859415|FG006|STARTED|EEG (Session 4)||0
3134515|NCT01701258|3859416|FG007|STARTED|EEG (Session 4)||16
3134516|NCT01701258|3859417|FG008|STARTED|EEG (Session 4)||0
3134517|NCT01701258|3859418|FG009|STARTED|EEG (Session 4)||0
3134518|NCT01701258|3859419|FG010|STARTED|EEG (Session 4)||17
3134519|NCT01701258|3859420|FG011|STARTED|EEG (Session 4)||0
3134520|NCT01701258|3859421|FG012|STARTED|EEG (Session 4)||0
3134521|NCT01701258|3859409|FG000|COMPLETED|EEG (Session 4)||0
3134522|NCT01701258|3859410|FG001|COMPLETED|EEG (Session 4)||19
3134523|NCT01701258|3859411|FG002|COMPLETED|EEG (Session 4)||0
3134524|NCT01701258|3859412|FG003|COMPLETED|EEG (Session 4)||0
3134525|NCT01701258|3859413|FG004|COMPLETED|EEG (Session 4)||14
3134526|NCT01701258|3859414|FG005|COMPLETED|EEG (Session 4)||0
3134527|NCT01701258|3859415|FG006|COMPLETED|EEG (Session 4)||0
3134528|NCT01701258|3859416|FG007|COMPLETED|EEG (Session 4)||16
3134529|NCT01701258|3859417|FG008|COMPLETED|EEG (Session 4)||0
3134530|NCT01701258|3859418|FG009|COMPLETED|EEG (Session 4)||0
3134531|NCT01701258|3859419|FG010|COMPLETED|EEG (Session 4)||17
3134532|NCT01701258|3859420|FG011|COMPLETED|EEG (Session 4)||0
3134533|NCT01701258|3859421|FG012|COMPLETED|EEG (Session 4)||0
3134534|NCT01701258|3859409|FG000|NOT COMPLETED|EEG (Session 4)||0
3134535|NCT01701258|3859410|FG001|NOT COMPLETED|EEG (Session 4)||0
3134536|NCT01701258|3859411|FG002|NOT COMPLETED|EEG (Session 4)||0
3134537|NCT01701258|3859412|FG003|NOT COMPLETED|EEG (Session 4)||0
3134538|NCT01701258|3859413|FG004|NOT COMPLETED|EEG (Session 4)||0
3134539|NCT01701258|3859414|FG005|NOT COMPLETED|EEG (Session 4)||0
3134540|NCT01701258|3859415|FG006|NOT COMPLETED|EEG (Session 4)||0
3073552|NCT01340144|3794957|FG000|STARTED|Overall Study||625
3073553|NCT01340144|3794958|FG001|STARTED|Overall Study||625
3073554|NCT01340144|3794957|FG000|COMPLETED|Overall Study||553
3073555|NCT01340144|3794958|FG001|COMPLETED|Overall Study||567
3073556|NCT01340144|3794957|FG000|NOT COMPLETED|Overall Study||72
3073557|NCT01340144|3794958|FG001|NOT COMPLETED|Overall Study||58
3073558|NCT01340196|3794964|FG000|STARTED|Treat. Period 1 (Tenofovir)||16
3073559|NCT01340196|3794964|FG000|COMPLETED|Treat. Period 1 (Tenofovir)||16
3073560|NCT01340196|3794964|FG000|NOT COMPLETED|Treat. Period 1 (Tenofovir)||0
3073561|NCT01340196|3794964|FG000|STARTED|Treat. Period 2 (Tenofovir/Faldaprevir)||16
3073562|NCT01340196|3794964|FG000|COMPLETED|Treat. Period 2 (Tenofovir/Faldaprevir)||16
3073563|NCT01340196|3794964|FG000|NOT COMPLETED|Treat. Period 2 (Tenofovir/Faldaprevir)||0
3073564|NCT01340196|3794964|FG000|STARTED|Treat. Period 3 (Faldaprevir)||16
3073565|NCT01340196|3794964|FG000|COMPLETED|Treat. Period 3 (Faldaprevir)||14
3073566|NCT01340196|3794964|FG000|NOT COMPLETED|Treat. Period 3 (Faldaprevir)||2
3073567|NCT01340209|3794976|FG000|STARTED|Overall Study||57
3073568|NCT01340209|3794977|FG001|STARTED|Overall Study||114
3073569|NCT01340209|3794978|FG002|STARTED|Overall Study||114
3073570|NCT01340209|3794976|FG000|COMPLETED|Overall Study||52
3073571|NCT01340209|3794977|FG001|COMPLETED|Overall Study||106
3073572|NCT01340209|3794978|FG002|COMPLETED|Overall Study||106
3073573|NCT01340209|3794976|FG000|NOT COMPLETED|Overall Study||5
3073574|NCT01340209|3794977|FG001|NOT COMPLETED|Overall Study||8
3073575|NCT01340209|3794978|FG002|NOT COMPLETED|Overall Study||8
3073576|NCT01340300|3794990|FG000|STARTED|Overall Study||35
3073577|NCT01340300|3794991|FG001|STARTED|Overall Study||35
3073578|NCT01340300|3794992|FG002|STARTED|Overall Study||35
3073579|NCT01340300|3794993|FG003|STARTED|Overall Study||34
3073580|NCT01340300|3794990|FG000|Baseline Blood Sample|Overall Study||33
3073581|NCT01340300|3794991|FG001|Baseline Blood Sample|Overall Study||34
3073582|NCT01340300|3794992|FG002|Baseline Blood Sample|Overall Study||32
3073583|NCT01340300|3794993|FG003|Baseline Blood Sample|Overall Study||29
3073584|NCT01340300|3794990|FG000|Follow-up Blood Sample|Overall Study||25
3073585|NCT01340300|3794991|FG001|Follow-up Blood Sample|Overall Study||26
3073586|NCT01340300|3794992|FG002|Follow-up Blood Sample|Overall Study||19
3073587|NCT01340300|3794993|FG003|Follow-up Blood Sample|Overall Study||18
3073588|NCT01340300|3794990|FG000|COMPLETED|Overall Study||26
3073589|NCT01340300|3794991|FG001|COMPLETED|Overall Study||26
3073590|NCT01340300|3794992|FG002|COMPLETED|Overall Study||20
3073591|NCT01340300|3794993|FG003|COMPLETED|Overall Study||20
3073592|NCT01340300|3794990|FG000|NOT COMPLETED|Overall Study||9
3073593|NCT01340300|3794991|FG001|NOT COMPLETED|Overall Study||9
3073594|NCT01340300|3794992|FG002|NOT COMPLETED|Overall Study||15
3073595|NCT01340300|3794993|FG003|NOT COMPLETED|Overall Study||14
3073596|NCT01340482|3795006|FG000|STARTED|Overall Study||27
3073597|NCT01340482|3795007|FG001|STARTED|Overall Study||1
3073598|NCT01340482|3795008|FG002|STARTED|Overall Study||1
3073599|NCT01340482|3795006|FG000|COMPLETED|Overall Study||25
3073600|NCT01340482|3795007|FG001|COMPLETED|Overall Study||1
3073601|NCT01340482|3795008|FG002|COMPLETED|Overall Study||1
3073602|NCT01340482|3795006|FG000|NOT COMPLETED|Overall Study||2
3073603|NCT01340482|3795007|FG001|NOT COMPLETED|Overall Study||0
3073604|NCT01340482|3795008|FG002|NOT COMPLETED|Overall Study||0
3073605|NCT01340495|3795018|FG000|STARTED|Overall Study||70
3073606|NCT01340495|3795018|FG000|COMPLETED|Overall Study||69
3073607|NCT01340495|3795018|FG000|NOT COMPLETED|Overall Study||1
3073608|NCT01340586|3795024|FG000|STARTED|Overall Study||8
3073609|NCT01340586|3795025|FG001|STARTED|Overall Study||8
3073610|NCT01340586|3795024|FG000|COMPLETED|Overall Study||8
3073611|NCT01340586|3795025|FG001|COMPLETED|Overall Study||8
3073612|NCT01340586|3795024|FG000|NOT COMPLETED|Overall Study||0
3073613|NCT01340586|3795025|FG001|NOT COMPLETED|Overall Study||0
3073614|NCT01340625|3795038|FG000|STARTED|First Intervention||18
3073615|NCT01340625|3795039|FG001|STARTED|First Intervention||18
3073616|NCT01340625|3795038|FG000|COMPLETED|First Intervention||17
3073617|NCT01340625|3795039|FG001|COMPLETED|First Intervention||18
3073618|NCT01340625|3795038|FG000|NOT COMPLETED|First Intervention||1
3073619|NCT01340625|3795039|FG001|NOT COMPLETED|First Intervention||0
3073620|NCT01340625|3795038|FG000|STARTED|Washout Period of 28 Days||17
3073621|NCT01340625|3795039|FG001|STARTED|Washout Period of 28 Days||18
3073622|NCT01340625|3795038|FG000|COMPLETED|Washout Period of 28 Days||16
3073623|NCT01340625|3795039|FG001|COMPLETED|Washout Period of 28 Days||18
3073624|NCT01340625|3795038|FG000|NOT COMPLETED|Washout Period of 28 Days||1
3073625|NCT01340625|3795039|FG001|NOT COMPLETED|Washout Period of 28 Days||0
3073626|NCT01340625|3795038|FG000|STARTED|Second Intervention||16
3073627|NCT01340625|3795039|FG001|STARTED|Second Intervention||18
3073628|NCT01340625|3795038|FG000|COMPLETED|Second Intervention||16
3284667|NCT02765269|4018338|FG000|COMPLETED|Overall Study||25
3284668|NCT02765269|4018339|FG001|COMPLETED|Overall Study||21
3073629|NCT01340625|3795039|FG001|COMPLETED|Second Intervention||18
3073630|NCT01340625|3795038|FG000|NOT COMPLETED|Second Intervention||0
3073631|NCT01340625|3795039|FG001|NOT COMPLETED|Second Intervention||0
3073632|NCT01340651|3795045|FG000|STARTED|Overall Study||41
3073633|NCT01340651|3795045|FG000|COMPLETED|Overall Study||24
3073634|NCT01340651|3795045|FG000|NOT COMPLETED|Overall Study||17
3073635|NCT01340664|3795054|FG000|STARTED|Overall Study||93
3073636|NCT01340664|3795055|FG001|STARTED|Overall Study||93
3073637|NCT01340664|3795056|FG002|STARTED|Overall Study||93
3284669|NCT02765269|4018338|FG000|NOT COMPLETED|Overall Study||0
3073638|NCT01340664|3795054|FG000|COMPLETED|Overall Study||86
3073639|NCT01340664|3795055|FG001|COMPLETED|Overall Study||85
3073640|NCT01340664|3795056|FG002|COMPLETED|Overall Study||80
3073641|NCT01340664|3795054|FG000|NOT COMPLETED|Overall Study||7
3073642|NCT01340664|3795055|FG001|NOT COMPLETED|Overall Study||8
3073643|NCT01340664|3795056|FG002|NOT COMPLETED|Overall Study||13
3073644|NCT01340768|3795066|FG000|STARTED|Overall Study||436
3073645|NCT01340768|3795067|FG001|STARTED|Overall Study||434
3073646|NCT01340768|3795066|FG000|COMPLETED|Overall Study||419
3073647|NCT01340768|3795067|FG001|COMPLETED|Overall Study||429
3073648|NCT01340768|3795066|FG000|NOT COMPLETED|Overall Study||17
3073649|NCT01340768|3795067|FG001|NOT COMPLETED|Overall Study||5
3073650|NCT01340794|3795075|FG000|STARTED|Overall Study||2
3073651|NCT01340794|3795076|FG001|STARTED|Overall Study||5
3073652|NCT01340794|3795075|FG000|COMPLETED|Overall Study||2
3073653|NCT01340794|3795076|FG001|COMPLETED|Overall Study||4
3073654|NCT01340794|3795075|FG000|NOT COMPLETED|Overall Study||0
3073655|NCT01340794|3795076|FG001|NOT COMPLETED|Overall Study||1
3073656|NCT01340872|3795086|FG000|STARTED|Double-blind Phase||64
3073657|NCT01340872|3795087|FG001|STARTED|Double-blind Phase||64
3073658|NCT01340872|3795088|FG002|STARTED|Double-blind Phase|Not Applicable to double-blind phase|0
3073659|NCT01340872|3795089|FG003|STARTED|Double-blind Phase|Not Applicable to double-blind phase|0
3073660|NCT01340872|3795086|FG000|COMPLETED|Double-blind Phase||55
3073661|NCT01340872|3795087|FG001|COMPLETED|Double-blind Phase||53
3073662|NCT01340872|3795088|FG002|COMPLETED|Double-blind Phase|Not Applicable to double-blind phase|0
3073663|NCT01340872|3795089|FG003|COMPLETED|Double-blind Phase|Not Applicable to double-blind phase|0
3073664|NCT01340872|3795086|FG000|NOT COMPLETED|Double-blind Phase||9
3073665|NCT01340872|3795087|FG001|NOT COMPLETED|Double-blind Phase||11
3073666|NCT01340872|3795088|FG002|NOT COMPLETED|Double-blind Phase||0
3073667|NCT01340872|3795089|FG003|NOT COMPLETED|Double-blind Phase||0
3073668|NCT01340872|3795086|FG000|STARTED|Open-label Phase|Not Applicable to open-label phase|0
3073669|NCT01340872|3795087|FG001|STARTED|Open-label Phase|Not Applicable to open-label phase|0
3073670|NCT01340872|3795088|FG002|STARTED|Open-label Phase|Only subjects in DE, UK and HU could enter the open-label extension (OLE); OLE rejected by EC in AT|50
3073671|NCT01340872|3795089|FG003|STARTED|Open-label Phase|Only subjects in DE, UK and HU could enter the open-label extension (OLE); OLE rejected by EC in AT|47
3073672|NCT01340872|3795086|FG000|COMPLETED|Open-label Phase|Not Applicable to open-label phase|0
3073673|NCT01340872|3795087|FG001|COMPLETED|Open-label Phase|Not Applicable to open-label phase|0
3073674|NCT01340872|3795088|FG002|COMPLETED|Open-label Phase||37
3073675|NCT01340872|3795089|FG003|COMPLETED|Open-label Phase||36
3073676|NCT01340872|3795086|FG000|NOT COMPLETED|Open-label Phase||0
3073677|NCT01340872|3795087|FG001|NOT COMPLETED|Open-label Phase||0
3073678|NCT01340872|3795088|FG002|NOT COMPLETED|Open-label Phase||13
3073679|NCT01340872|3795089|FG003|NOT COMPLETED|Open-label Phase||11
3073680|NCT01340898|3795104|FG000|STARTED|Primary Phase||376
3073681|NCT01340898|3795105|FG001|STARTED|Primary Phase||187
3073682|NCT01340898|3795106|FG002|STARTED|Primary Phase||187
3073683|NCT01340898|3795104|FG000|COMPLETED|Primary Phase||360
3073684|NCT01340898|3795105|FG001|COMPLETED|Primary Phase||178
3073685|NCT01340898|3795106|FG002|COMPLETED|Primary Phase||181
3073686|NCT01340898|3795104|FG000|NOT COMPLETED|Primary Phase||16
3073687|NCT01340898|3795105|FG001|NOT COMPLETED|Primary Phase||9
3073688|NCT01340898|3795106|FG002|NOT COMPLETED|Primary Phase||6
3073689|NCT01340898|3795104|FG000|STARTED|Booster Phase||342
3073690|NCT01340898|3795105|FG001|STARTED|Booster Phase||166
3073691|NCT01340898|3795106|FG002|STARTED|Booster Phase||170
3073692|NCT01340898|3795104|FG000|COMPLETED|Booster Phase||332
3073693|NCT01340898|3795105|FG001|COMPLETED|Booster Phase||164
3073694|NCT01340898|3795106|FG002|COMPLETED|Booster Phase||163
3073695|NCT01340898|3795104|FG000|NOT COMPLETED|Booster Phase||10
3073696|NCT01340898|3795105|FG001|NOT COMPLETED|Booster Phase||2
3073697|NCT01340898|3795106|FG002|NOT COMPLETED|Booster Phase||7
3073698|NCT01340937|3795120|FG000|STARTED|Period 1: Infant Series||800
3073699|NCT01340937|3795121|FG001|STARTED|Period 1: Infant Series||797
3073700|NCT01340937|3795122|FG002|STARTED|Period 1: Infant Series||809
3073701|NCT01340937|3795123|FG003|STARTED|Period 1: Infant Series||402
3073702|NCT01340937|3795120|FG000|COMPLETED|Period 1: Infant Series||742
3073703|NCT01340937|3795121|FG001|COMPLETED|Period 1: Infant Series||737
3073704|NCT01340937|3795122|FG002|COMPLETED|Period 1: Infant Series||753
3073705|NCT01340937|3795123|FG003|COMPLETED|Period 1: Infant Series||370
3073706|NCT01340937|3795120|FG000|NOT COMPLETED|Period 1: Infant Series||58
3073707|NCT01340937|3795121|FG001|NOT COMPLETED|Period 1: Infant Series||60
3073708|NCT01340937|3795122|FG002|NOT COMPLETED|Period 1: Infant Series||56
3073709|NCT01340937|3795123|FG003|NOT COMPLETED|Period 1: Infant Series||32
3073710|NCT01340937|3795120|FG000|STARTED|Period 2: Interim Period||742
3073711|NCT01340937|3795121|FG001|STARTED|Period 2: Interim Period||737
3073712|NCT01340937|3795122|FG002|STARTED|Period 2: Interim Period||753
3073713|NCT01340937|3795123|FG003|STARTED|Period 2: Interim Period||370
3073714|NCT01340937|3795120|FG000|COMPLETED|Period 2: Interim Period||675
3073715|NCT01340937|3795121|FG001|COMPLETED|Period 2: Interim Period||658
3073716|NCT01340937|3795122|FG002|COMPLETED|Period 2: Interim Period||669
3073717|NCT01340937|3795123|FG003|COMPLETED|Period 2: Interim Period||329
3073718|NCT01340937|3795120|FG000|NOT COMPLETED|Period 2: Interim Period||67
3073719|NCT01340937|3795121|FG001|NOT COMPLETED|Period 2: Interim Period||79
3073720|NCT01340937|3795122|FG002|NOT COMPLETED|Period 2: Interim Period||84
3073721|NCT01340937|3795123|FG003|NOT COMPLETED|Period 2: Interim Period||41
3073722|NCT01340937|3795120|FG000|STARTED|Period 3: Toddler Vaccinations||675
3073723|NCT01340937|3795121|FG001|STARTED|Period 3: Toddler Vaccinations||658
3073724|NCT01340937|3795122|FG002|STARTED|Period 3: Toddler Vaccinations||669
3073725|NCT01340937|3795123|FG003|STARTED|Period 3: Toddler Vaccinations||329
3073726|NCT01340937|3795120|FG000|COMPLETED|Period 3: Toddler Vaccinations||666
3073727|NCT01340937|3795121|FG001|COMPLETED|Period 3: Toddler Vaccinations||641
3073728|NCT01340937|3795122|FG002|COMPLETED|Period 3: Toddler Vaccinations||660
3073729|NCT01340937|3795123|FG003|COMPLETED|Period 3: Toddler Vaccinations||319
3073730|NCT01340937|3795120|FG000|NOT COMPLETED|Period 3: Toddler Vaccinations||9
3073731|NCT01340937|3795121|FG001|NOT COMPLETED|Period 3: Toddler Vaccinations||17
3073732|NCT01340937|3795122|FG002|NOT COMPLETED|Period 3: Toddler Vaccinations||9
3073733|NCT01340937|3795123|FG003|NOT COMPLETED|Period 3: Toddler Vaccinations||10
3073734|NCT01340976|3795145|FG000|STARTED|Overall Study||4
3073735|NCT01340976|3795146|FG001|STARTED|Overall Study||3
3073736|NCT01340976|3795147|FG002|STARTED|Overall Study||7
3073737|NCT01340976|3795148|FG003|STARTED|Overall Study||5
3073738|NCT01340976|3795149|FG004|STARTED|Overall Study||7
3073739|NCT01340976|3795150|FG005|STARTED|Overall Study||7
3073740|NCT01340976|3795145|FG000|Received at Least 1 Dose of Study Drug|Overall Study||4
3073741|NCT01340976|3795146|FG001|Received at Least 1 Dose of Study Drug|Overall Study||3
3073742|NCT01340976|3795147|FG002|Received at Least 1 Dose of Study Drug|Overall Study||7
3073743|NCT01340976|3795148|FG003|Received at Least 1 Dose of Study Drug|Overall Study||5
3073744|NCT01340976|3795149|FG004|Received at Least 1 Dose of Study Drug|Overall Study||7
3073745|NCT01340976|3795150|FG005|Received at Least 1 Dose of Study Drug|Overall Study||7
3073746|NCT01340976|3795145|FG000|COMPLETED|Overall Study||0
3073747|NCT01340976|3795146|FG001|COMPLETED|Overall Study||1
3073748|NCT01340976|3795147|FG002|COMPLETED|Overall Study||4
3073749|NCT01340976|3795148|FG003|COMPLETED|Overall Study||2
3073750|NCT01340976|3795149|FG004|COMPLETED|Overall Study||5
3073751|NCT01340976|3795150|FG005|COMPLETED|Overall Study||6
3073752|NCT01340976|3795145|FG000|NOT COMPLETED|Overall Study||4
3073753|NCT01340976|3795146|FG001|NOT COMPLETED|Overall Study||2
3073754|NCT01340976|3795147|FG002|NOT COMPLETED|Overall Study||3
3073755|NCT01340976|3795148|FG003|NOT COMPLETED|Overall Study||3
3073756|NCT01340976|3795149|FG004|NOT COMPLETED|Overall Study||2
3073757|NCT01340976|3795150|FG005|NOT COMPLETED|Overall Study||1
3073758|NCT01341067|3795170|FG000|STARTED|Overall Study||30
3073759|NCT01341067|3795170|FG000|COMPLETED|Overall Study||26
3073760|NCT01341067|3795170|FG000|NOT COMPLETED|Overall Study||4
3073761|NCT01341301|3795174|FG000|STARTED|Overall Study||25
3073762|NCT01341301|3795174|FG000|COMPLETED|Overall Study||25
3073763|NCT01341301|3795174|FG000|NOT COMPLETED|Overall Study||0
3073764|NCT01341444|3795182|FG000|STARTED|Overall Study||31
3073765|NCT01341444|3795183|FG001|STARTED|Overall Study||32
3073766|NCT01341444|3795182|FG000|COMPLETED|Overall Study||26
3073767|NCT01341444|3795183|FG001|COMPLETED|Overall Study||29
3073768|NCT01341444|3795182|FG000|NOT COMPLETED|Overall Study||5
3073769|NCT01341444|3795183|FG001|NOT COMPLETED|Overall Study||3
3073770|NCT01341457|3795191|FG000|STARTED|Overall Study||7
3073771|NCT01341457|3795192|FG001|STARTED|Overall Study||10
3073772|NCT01341457|3795191|FG000|Received at Least One Dose of Study Drug|Overall Study||7
3073773|NCT01341457|3795192|FG001|Received at Least One Dose of Study Drug|Overall Study||10
3073774|NCT01341457|3795191|FG000|COMPLETED|Overall Study||5
3073775|NCT01341457|3795192|FG001|COMPLETED|Overall Study||10
3073776|NCT01341457|3795191|FG000|NOT COMPLETED|Overall Study||2
3073777|NCT01341457|3795192|FG001|NOT COMPLETED|Overall Study||0
3073778|NCT01341470|3795205|FG000|STARTED|Overall Study||6
3073779|NCT01341470|3795206|FG001|STARTED|Overall Study||9
3073780|NCT01341470|3795207|FG002|STARTED|Overall Study||10
3073781|NCT01341470|3795208|FG003|STARTED|Overall Study||10
3073782|NCT01341470|3795209|FG004|STARTED|Overall Study||2
3073783|NCT01341470|3795210|FG005|STARTED|Overall Study||10
3073784|NCT01341470|3795205|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6
3073785|NCT01341470|3795206|FG001|Received at Least 1 Dose of Study Drug|Overall Study||9
3073786|NCT01341470|3795207|FG002|Received at Least 1 Dose of Study Drug|Overall Study||10
3073787|NCT01341470|3795208|FG003|Received at Least 1 Dose of Study Drug|Overall Study||10
3073788|NCT01341470|3795209|FG004|Received at Least 1 Dose of Study Drug|Overall Study||2
3073789|NCT01341470|3795210|FG005|Received at Least 1 Dose of Study Drug|Overall Study||10
3073790|NCT01341470|3795205|FG000|COMPLETED|Overall Study||6
3073791|NCT01341470|3795206|FG001|COMPLETED|Overall Study||9
3073792|NCT01341470|3795207|FG002|COMPLETED|Overall Study||9
3073793|NCT01341470|3795208|FG003|COMPLETED|Overall Study||9
3073794|NCT01341470|3795209|FG004|COMPLETED|Overall Study||2
3073795|NCT01341470|3795210|FG005|COMPLETED|Overall Study||9
3073796|NCT01341470|3795205|FG000|NOT COMPLETED|Overall Study||0
3073797|NCT01341470|3795206|FG001|NOT COMPLETED|Overall Study||0
3073798|NCT01341470|3795207|FG002|NOT COMPLETED|Overall Study||1
3073799|NCT01341470|3795208|FG003|NOT COMPLETED|Overall Study||1
3073800|NCT01341470|3795209|FG004|NOT COMPLETED|Overall Study||0
3073801|NCT01341470|3795210|FG005|NOT COMPLETED|Overall Study||1
3073802|NCT01341639|3795228|FG000|STARTED|Infant Series||628
3073803|NCT01341639|3795229|FG001|STARTED|Infant Series||622
3073804|NCT01341639|3795228|FG000|Site 0048 Excluded|Infant Series||611
3073805|NCT01341639|3795229|FG001|Site 0048 Excluded|Infant Series||606
3073806|NCT01341639|3795228|FG000|Treated|Infant Series||610
3073807|NCT01341639|3795229|FG001|Treated|Infant Series||605
3073808|NCT01341639|3795228|FG000|COMPLETED|Infant Series||599
3073809|NCT01341639|3795229|FG001|COMPLETED|Infant Series||590
3073810|NCT01341639|3795228|FG000|NOT COMPLETED|Infant Series||29
3073811|NCT01341639|3795229|FG001|NOT COMPLETED|Infant Series||32
3073812|NCT01341639|3795228|FG000|STARTED|Interim Period||599
3073813|NCT01341639|3795229|FG001|STARTED|Interim Period||590
3073814|NCT01341639|3795228|FG000|COMPLETED|Interim Period||591
3073815|NCT01341639|3795229|FG001|COMPLETED|Interim Period||581
3073816|NCT01341639|3795228|FG000|NOT COMPLETED|Interim Period||8
3073817|NCT01341639|3795229|FG001|NOT COMPLETED|Interim Period||9
3073818|NCT01341639|3795228|FG000|STARTED|Toddler Dose|One participant randomized to the PR5I group mistakenly received INFANRIX™ hexa instead|590
3073819|NCT01341639|3795229|FG001|STARTED|Toddler Dose|One participant randomized to the PR5I group mistakenly received INFANRIX™ hexa instead|582
3073820|NCT01341639|3795228|FG000|COMPLETED|Toddler Dose||539
3073821|NCT01341639|3795229|FG001|COMPLETED|Toddler Dose||548
3073822|NCT01341639|3795228|FG000|NOT COMPLETED|Toddler Dose||51
3073823|NCT01341639|3795229|FG001|NOT COMPLETED|Toddler Dose||34
3073824|NCT01341639|3795228|FG000|STARTED|Post-Treatment||539
3073825|NCT01341639|3795229|FG001|STARTED|Post-Treatment||548
3073826|NCT01341639|3795228|FG000|COMPLETED|Post-Treatment||539
3073827|NCT01341639|3795229|FG001|COMPLETED|Post-Treatment||545
3073828|NCT01341639|3795228|FG000|NOT COMPLETED|Post-Treatment||0
3073829|NCT01341639|3795229|FG001|NOT COMPLETED|Post-Treatment||3
3073830|NCT01341652|3795237|FG000|STARTED|Overall Study||49
3073831|NCT01341652|3795238|FG001|STARTED|Overall Study||50
3073832|NCT01341652|3795237|FG000|COMPLETED|Overall Study||49
3073833|NCT01341652|3795238|FG001|COMPLETED|Overall Study||48
3073834|NCT01341652|3795237|FG000|NOT COMPLETED|Overall Study||0
3073835|NCT01341652|3795238|FG001|NOT COMPLETED|Overall Study||2
3073836|NCT01341730|3795246|FG000|STARTED|Overall Study||20
3073837|NCT01341730|3795247|FG001|STARTED|Overall Study||21
3073838|NCT01341730|3795246|FG000|COMPLETED|Overall Study||16
3073839|NCT01341730|3795247|FG001|COMPLETED|Overall Study||17
3073840|NCT01341730|3795246|FG000|NOT COMPLETED|Overall Study||4
3073841|NCT01341730|3795247|FG001|NOT COMPLETED|Overall Study||4
3073842|NCT01341782|3795257|FG000|STARTED|Overall Study||127
3073843|NCT01341782|3795258|FG001|STARTED|Overall Study||128
3073844|NCT01341782|3795257|FG000|COMPLETED|Overall Study||112
3073845|NCT01341782|3795258|FG001|COMPLETED|Overall Study||114
3073846|NCT01341782|3795257|FG000|NOT COMPLETED|Overall Study||15
3073847|NCT01341782|3795258|FG001|NOT COMPLETED|Overall Study||14
3073848|NCT01341912|3795264|FG000|STARTED|Overall Study||3
3073849|NCT01341912|3795264|FG000|COMPLETED|Overall Study||3
3073850|NCT01341912|3795264|FG000|NOT COMPLETED|Overall Study||0
3073851|NCT01341977|3795270|FG000|STARTED|Overall Study||288
3073852|NCT01341977|3795271|FG001|STARTED|Overall Study||285
3073853|NCT01341977|3795270|FG000|COMPLETED|Overall Study||274
3073854|NCT01341977|3795271|FG001|COMPLETED|Overall Study||270
3073855|NCT01341977|3795270|FG000|NOT COMPLETED|Overall Study||14
3073856|NCT01341977|3795271|FG001|NOT COMPLETED|Overall Study||15
3073857|NCT01341990|3795279|FG000|STARTED|Overall Study||35
3073858|NCT01341990|3795280|FG001|STARTED|Overall Study||33
3073859|NCT01341990|3795279|FG000|COMPLETED|Overall Study||32
3073860|NCT01341990|3795280|FG001|COMPLETED|Overall Study||32
3073861|NCT01341990|3795279|FG000|NOT COMPLETED|Overall Study||3
3073862|NCT01341990|3795280|FG001|NOT COMPLETED|Overall Study||1
3073863|NCT01342029|3795286|FG000|STARTED|Period 1||70
3073864|NCT01342029|3795287|FG001|STARTED|Period 1||72
3073865|NCT01342029|3795286|FG000|Dropout|Period 1||3
3073866|NCT01342029|3795287|FG001|Dropout|Period 1||1
3073867|NCT01342029|3795286|FG000|COMPLETED|Period 1||67
3073868|NCT01342029|3795287|FG001|COMPLETED|Period 1||71
3073869|NCT01342029|3795286|FG000|NOT COMPLETED|Period 1||3
3073870|NCT01342029|3795287|FG001|NOT COMPLETED|Period 1||1
3073871|NCT01342029|3795286|FG000|STARTED|Washout||67
3073872|NCT01342029|3795287|FG001|STARTED|Washout||71
3073873|NCT01342029|3795286|FG000|COMPLETED|Washout||67
3073874|NCT01342029|3795287|FG001|COMPLETED|Washout||67
3073875|NCT01342029|3795286|FG000|NOT COMPLETED|Washout||0
3073876|NCT01342029|3795287|FG001|NOT COMPLETED|Washout||4
3073877|NCT01342029|3795286|FG000|STARTED|Period 2||67
3073878|NCT01342029|3795287|FG001|STARTED|Period 2||67
3073879|NCT01342029|3795286|FG000|Dropout|Period 2||2
3073880|NCT01342029|3795287|FG001|Dropout|Period 2||0
3073881|NCT01342029|3795286|FG000|COMPLETED|Period 2||65
3073882|NCT01342029|3795287|FG001|COMPLETED|Period 2||67
3073883|NCT01342029|3795286|FG000|NOT COMPLETED|Period 2||2
3073884|NCT01342029|3795287|FG001|NOT COMPLETED|Period 2||0
3073885|NCT01342081|3795298|FG000|STARTED|Overall Study||161
3073886|NCT01342081|3795299|FG001|STARTED|Overall Study||164
3073887|NCT01342081|3795300|FG002|STARTED|Overall Study||164
3073888|NCT01342081|3795298|FG000|COMPLETED|Overall Study||159
3073889|NCT01342081|3795299|FG001|COMPLETED|Overall Study||162
3073890|NCT01342081|3795300|FG002|COMPLETED|Overall Study||163
3073891|NCT01342081|3795298|FG000|NOT COMPLETED|Overall Study||2
3073892|NCT01342081|3795299|FG001|NOT COMPLETED|Overall Study||2
3073893|NCT01342081|3795300|FG002|NOT COMPLETED|Overall Study||1
3073894|NCT01342094|3795310|FG000|STARTED|Overall Study||82
3073895|NCT01342094|3795311|FG001|STARTED|Overall Study||84
3073896|NCT01342094|3795310|FG000|COMPLETED|Overall Study||77
3073897|NCT01342094|3795311|FG001|COMPLETED|Overall Study||81
3073898|NCT01342094|3795310|FG000|NOT COMPLETED|Overall Study||5
3073899|NCT01342094|3795311|FG001|NOT COMPLETED|Overall Study||3
3073900|NCT01342107|3795319|FG000|STARTED|Overall Study||34
3073901|NCT01342107|3795320|FG001|STARTED|Overall Study||32
3073902|NCT01342107|3795319|FG000|COMPLETED|Overall Study||34
3073903|NCT01342107|3795320|FG001|COMPLETED|Overall Study||32
3073904|NCT01342107|3795319|FG000|NOT COMPLETED|Overall Study||0
3073905|NCT01342107|3795320|FG001|NOT COMPLETED|Overall Study||0
3073906|NCT01342172|3795326|FG000|STARTED|Overall Study||9
3073907|NCT01342172|3795326|FG000|COMPLETED|Overall Study||9
3073908|NCT01342172|3795326|FG000|NOT COMPLETED|Overall Study||0
3073909|NCT01342211|3795336|FG000|STARTED|Overall Study||19
3073910|NCT01342211|3795337|FG001|STARTED|Overall Study||19
3073911|NCT01342211|3795338|FG002|STARTED|Overall Study||18
3073912|NCT01342211|3795339|FG003|STARTED|Overall Study||19
3073913|NCT01342211|3795340|FG004|STARTED|Overall Study||18
3073914|NCT01342211|3795336|FG000|Treated|Overall Study||19
3073915|NCT01342211|3795337|FG001|Treated|Overall Study||17
3073916|NCT01342211|3795338|FG002|Treated|Overall Study||18
3073917|NCT01342211|3795339|FG003|Treated|Overall Study||19
3073918|NCT01342211|3795340|FG004|Treated|Overall Study||17
3073919|NCT01342211|3795336|FG000|COMPLETED|Overall Study||19
3073920|NCT01342211|3795337|FG001|COMPLETED|Overall Study||17
3073921|NCT01342211|3795338|FG002|COMPLETED|Overall Study||18
3073922|NCT01342211|3795339|FG003|COMPLETED|Overall Study||17
3073923|NCT01342211|3795340|FG004|COMPLETED|Overall Study||16
3073924|NCT01342211|3795336|FG000|NOT COMPLETED|Overall Study||0
3073925|NCT01342211|3795337|FG001|NOT COMPLETED|Overall Study||2
3073926|NCT01342211|3795338|FG002|NOT COMPLETED|Overall Study||0
3073927|NCT01342211|3795339|FG003|NOT COMPLETED|Overall Study||2
3073928|NCT01342211|3795340|FG004|NOT COMPLETED|Overall Study||2
3073929|NCT01342341|3795358|FG000|STARTED|Overall Study||24
3073930|NCT01342341|3795359|FG001|STARTED|Overall Study||24
3073931|NCT01342341|3795358|FG000|COMPLETED|Overall Study||20
3073932|NCT01342341|3795359|FG001|COMPLETED|Overall Study||20
3073933|NCT01342341|3795358|FG000|NOT COMPLETED|Overall Study||4
3073934|NCT01342341|3795359|FG001|NOT COMPLETED|Overall Study||4
3073935|NCT01342367|3795367|FG000|STARTED|Overall Study||32
3073936|NCT01342367|3795368|FG001|STARTED|Overall Study||42
3073937|NCT01342367|3795367|FG000|COMPLETED|Overall Study||30
3073938|NCT01342367|3795368|FG001|COMPLETED|Overall Study||40
3073939|NCT01342367|3795367|FG000|NOT COMPLETED|Overall Study||2
3073940|NCT01342367|3795368|FG001|NOT COMPLETED|Overall Study||2
3073941|NCT01342445|3795376|FG000|STARTED|Overall Study||26
3073942|NCT01342445|3795377|FG001|STARTED|Overall Study||24
3284670|NCT02765269|4018339|FG001|NOT COMPLETED|Overall Study||0
3284671|NCT02765490|4018347|FG000|STARTED|Overall Study||183
3284672|NCT02765490|4018348|FG001|STARTED|Overall Study||182
3284673|NCT02765490|4018347|FG000|COMPLETED|Overall Study||182
3284674|NCT02765490|4018348|FG001|COMPLETED|Overall Study||179
3284675|NCT02765490|4018347|FG000|NOT COMPLETED|Overall Study||1
3073943|NCT01342445|3795376|FG000|COMPLETED|Overall Study||26
3073944|NCT01342445|3795377|FG001|COMPLETED|Overall Study||22
3073945|NCT01342445|3795376|FG000|NOT COMPLETED|Overall Study||0
3073946|NCT01342445|3795377|FG001|NOT COMPLETED|Overall Study||2
3073947|NCT01342458|3795389|FG000|STARTED|Overall Study||28
3073948|NCT01342458|3795390|FG001|STARTED|Overall Study||28
3073949|NCT01342458|3795389|FG000|COMPLETED|Overall Study||26
3073950|NCT01342458|3795390|FG001|COMPLETED|Overall Study||24
3073951|NCT01342458|3795389|FG000|NOT COMPLETED|Overall Study||2
3073952|NCT01342458|3795390|FG001|NOT COMPLETED|Overall Study||4
3073953|NCT01342471|3795412|FG000|STARTED|Overall Study||29
3073954|NCT01342471|3795413|FG001|STARTED|Overall Study||29
3073955|NCT01342471|3795412|FG000|COMPLETED|Overall Study||24
3073956|NCT01342471|3795413|FG001|COMPLETED|Overall Study||23
3073957|NCT01342471|3795412|FG000|NOT COMPLETED|Overall Study||5
3073958|NCT01342471|3795413|FG001|NOT COMPLETED|Overall Study||6
3073959|NCT01342484|3795422|FG000|STARTED|Overall Study||15
3073960|NCT01342484|3795423|FG001|STARTED|Overall Study||10
3073961|NCT01342484|3795424|FG002|STARTED|Overall Study||14
3073962|NCT01342484|3795422|FG000|COMPLETED|Overall Study||13
3073963|NCT01342484|3795423|FG001|COMPLETED|Overall Study||10
3073964|NCT01342484|3795424|FG002|COMPLETED|Overall Study||13
3073965|NCT01342484|3795422|FG000|NOT COMPLETED|Overall Study||2
3073966|NCT01342484|3795423|FG001|NOT COMPLETED|Overall Study||0
3073967|NCT01342484|3795424|FG002|NOT COMPLETED|Overall Study||1
3073968|NCT01342510|3795436|FG000|STARTED|Overall Study||50
3073969|NCT01342510|3795437|FG001|STARTED|Overall Study||50
3073970|NCT01342510|3795438|FG002|STARTED|Overall Study||50
3073971|NCT01342510|3795439|FG003|STARTED|Overall Study||50
3073972|NCT01342510|3795436|FG000|COMPLETED|Overall Study||38
3073973|NCT01342510|3795437|FG001|COMPLETED|Overall Study||44
3073974|NCT01342510|3795438|FG002|COMPLETED|Overall Study||37
3073975|NCT01342510|3795439|FG003|COMPLETED|Overall Study||39
3073976|NCT01342510|3795436|FG000|NOT COMPLETED|Overall Study||12
3073977|NCT01342510|3795437|FG001|NOT COMPLETED|Overall Study||6
3073978|NCT01342510|3795438|FG002|NOT COMPLETED|Overall Study||13
3073979|NCT01342510|3795439|FG003|NOT COMPLETED|Overall Study||11
3073980|NCT01342523|3795485|FG000|STARTED|Overall Study||35
3073981|NCT01342523|3795486|FG001|STARTED|Overall Study||32
3073982|NCT01342523|3795487|FG002|STARTED|Overall Study||36
3073983|NCT01342523|3795488|FG003|STARTED|Overall Study||33
3073984|NCT01342523|3795489|FG004|STARTED|Overall Study||36
3073985|NCT01342523|3795490|FG005|STARTED|Overall Study||36
3073986|NCT01342523|3795491|FG006|STARTED|Overall Study||22
3073987|NCT01342523|3795492|FG007|STARTED|Overall Study||27
3073988|NCT01342523|3795493|FG008|STARTED|Overall Study||28
3073989|NCT01342523|3795494|FG009|STARTED|Overall Study||28
3073990|NCT01342523|3795495|FG010|STARTED|Overall Study||38
3073991|NCT01342523|3795496|FG011|STARTED|Overall Study||38
3073992|NCT01342523|3795497|FG012|STARTED|Overall Study||39
3073993|NCT01342523|3795498|FG013|STARTED|Overall Study||38
3073994|NCT01342523|3795499|FG014|STARTED|Overall Study||38
3073995|NCT01342523|3795500|FG015|STARTED|Overall Study||32
3073996|NCT01342523|3795501|FG016|STARTED|Overall Study||29
3073997|NCT01342523|3795502|FG017|STARTED|Overall Study||27
3073998|NCT01342523|3795503|FG018|STARTED|Overall Study||21
3073999|NCT01342523|3795504|FG019|STARTED|Overall Study||27
3074000|NCT01342523|3795505|FG020|STARTED|Overall Study||29
3074001|NCT01342523|3795506|FG021|STARTED|Overall Study||30
3074002|NCT01342523|3795507|FG022|STARTED|Overall Study||36
3074003|NCT01342523|3795508|FG023|STARTED|Overall Study||36
3074004|NCT01342523|3795509|FG024|STARTED|Overall Study||37
3074005|NCT01342523|3795510|FG025|STARTED|Overall Study||38
3074006|NCT01342523|3795511|FG026|STARTED|Overall Study||34
3074007|NCT01342523|3795512|FG027|STARTED|Overall Study||31
3074008|NCT01342523|3795513|FG028|STARTED|Overall Study||35
3074009|NCT01342523|3795514|FG029|STARTED|Overall Study||29
3074010|NCT01342523|3795515|FG030|STARTED|Overall Study||31
3074011|NCT01342523|3795516|FG031|STARTED|Overall Study||28
3074012|NCT01342523|3795485|FG000|COMPLETED|Overall Study||34
3074013|NCT01342523|3795486|FG001|COMPLETED|Overall Study||32
3074014|NCT01342523|3795487|FG002|COMPLETED|Overall Study||36
3074015|NCT01342523|3795488|FG003|COMPLETED|Overall Study||32
3074016|NCT01342523|3795489|FG004|COMPLETED|Overall Study||36
3074017|NCT01342523|3795490|FG005|COMPLETED|Overall Study||36
3074018|NCT01342523|3795491|FG006|COMPLETED|Overall Study||22
3074019|NCT01342523|3795492|FG007|COMPLETED|Overall Study||27
3074020|NCT01342523|3795493|FG008|COMPLETED|Overall Study||28
3074021|NCT01342523|3795494|FG009|COMPLETED|Overall Study||28
3074022|NCT01342523|3795495|FG010|COMPLETED|Overall Study||38
3074023|NCT01342523|3795496|FG011|COMPLETED|Overall Study||36
3074024|NCT01342523|3795497|FG012|COMPLETED|Overall Study||39
3074025|NCT01342523|3795498|FG013|COMPLETED|Overall Study||36
3074026|NCT01342523|3795499|FG014|COMPLETED|Overall Study||37
3074027|NCT01342523|3795500|FG015|COMPLETED|Overall Study||32
3074028|NCT01342523|3795501|FG016|COMPLETED|Overall Study||28
3074029|NCT01342523|3795502|FG017|COMPLETED|Overall Study||27
3074030|NCT01342523|3795503|FG018|COMPLETED|Overall Study||21
3074031|NCT01342523|3795504|FG019|COMPLETED|Overall Study||27
3074032|NCT01342523|3795505|FG020|COMPLETED|Overall Study||29
3074033|NCT01342523|3795506|FG021|COMPLETED|Overall Study||30
3074034|NCT01342523|3795507|FG022|COMPLETED|Overall Study||36
3074035|NCT01342523|3795508|FG023|COMPLETED|Overall Study||35
3074036|NCT01342523|3795509|FG024|COMPLETED|Overall Study||36
3074037|NCT01342523|3795510|FG025|COMPLETED|Overall Study||36
3074038|NCT01342523|3795511|FG026|COMPLETED|Overall Study||33
3074039|NCT01342523|3795512|FG027|COMPLETED|Overall Study||30
3074040|NCT01342523|3795513|FG028|COMPLETED|Overall Study||34
3074041|NCT01342523|3795514|FG029|COMPLETED|Overall Study||28
3074042|NCT01342523|3795515|FG030|COMPLETED|Overall Study||30
3074043|NCT01342523|3795516|FG031|COMPLETED|Overall Study||27
3074044|NCT01342523|3795485|FG000|NOT COMPLETED|Overall Study||1
3074045|NCT01342523|3795486|FG001|NOT COMPLETED|Overall Study||0
3074046|NCT01342523|3795487|FG002|NOT COMPLETED|Overall Study||0
3074047|NCT01342523|3795488|FG003|NOT COMPLETED|Overall Study||1
3074048|NCT01342523|3795489|FG004|NOT COMPLETED|Overall Study||0
3074049|NCT01342523|3795490|FG005|NOT COMPLETED|Overall Study||0
3074050|NCT01342523|3795491|FG006|NOT COMPLETED|Overall Study||0
3074051|NCT01342523|3795492|FG007|NOT COMPLETED|Overall Study||0
3074052|NCT01342523|3795493|FG008|NOT COMPLETED|Overall Study||0
3074053|NCT01342523|3795494|FG009|NOT COMPLETED|Overall Study||0
3074054|NCT01342523|3795495|FG010|NOT COMPLETED|Overall Study||0
3074055|NCT01342523|3795496|FG011|NOT COMPLETED|Overall Study||2
3074056|NCT01342523|3795497|FG012|NOT COMPLETED|Overall Study||0
3074057|NCT01342523|3795498|FG013|NOT COMPLETED|Overall Study||2
3074058|NCT01342523|3795499|FG014|NOT COMPLETED|Overall Study||1
3074059|NCT01342523|3795500|FG015|NOT COMPLETED|Overall Study||0
3074060|NCT01342523|3795501|FG016|NOT COMPLETED|Overall Study||1
3074061|NCT01342523|3795502|FG017|NOT COMPLETED|Overall Study||0
3074062|NCT01342523|3795503|FG018|NOT COMPLETED|Overall Study||0
3074063|NCT01342523|3795504|FG019|NOT COMPLETED|Overall Study||0
3074064|NCT01342523|3795505|FG020|NOT COMPLETED|Overall Study||0
3074065|NCT01342523|3795506|FG021|NOT COMPLETED|Overall Study||0
3074066|NCT01342523|3795507|FG022|NOT COMPLETED|Overall Study||0
3074067|NCT01342523|3795508|FG023|NOT COMPLETED|Overall Study||1
3074068|NCT01342523|3795509|FG024|NOT COMPLETED|Overall Study||1
3074069|NCT01342523|3795510|FG025|NOT COMPLETED|Overall Study||2
3074070|NCT01342523|3795511|FG026|NOT COMPLETED|Overall Study||1
3074071|NCT01342523|3795512|FG027|NOT COMPLETED|Overall Study||1
3074072|NCT01342523|3795513|FG028|NOT COMPLETED|Overall Study||1
3074073|NCT01342523|3795514|FG029|NOT COMPLETED|Overall Study||1
3074074|NCT01342523|3795515|FG030|NOT COMPLETED|Overall Study||1
3074075|NCT01342523|3795516|FG031|NOT COMPLETED|Overall Study||1
3074076|NCT01342549|3795531|FG000|STARTED|Overall Study||31
3074077|NCT01342549|3795532|FG001|STARTED|Overall Study||31
3074078|NCT01342549|3795531|FG000|COMPLETED|Overall Study||31
3074079|NCT01342549|3795532|FG001|COMPLETED|Overall Study||31
3074080|NCT01342549|3795531|FG000|NOT COMPLETED|Overall Study||0
3074081|NCT01342549|3795532|FG001|NOT COMPLETED|Overall Study||0
3074082|NCT01342640|3795538|FG000|STARTED|Overall Study||70
3074083|NCT01342640|3795538|FG000|COMPLETED|Overall Study||29
3074084|NCT01342640|3795538|FG000|NOT COMPLETED|Overall Study||41
3074085|NCT01342666|3795544|FG000|STARTED|Overall Study||26
3074086|NCT01342666|3795545|FG001|STARTED|Overall Study||24
3074087|NCT01342666|3795544|FG000|COMPLETED|Overall Study||26
3074088|NCT01342666|3795545|FG001|COMPLETED|Overall Study||24
3074089|NCT01342666|3795544|FG000|NOT COMPLETED|Overall Study||0
3074090|NCT01342666|3795545|FG001|NOT COMPLETED|Overall Study||0
3074091|NCT01342757|3795551|FG000|STARTED|Overall Study||12
3074092|NCT01342757|3795551|FG000|COMPLETED|Overall Study||12
3074093|NCT01342757|3795551|FG000|NOT COMPLETED|Overall Study||0
3074094|NCT01342770|3795555|FG000|STARTED|Overall Study||6
3074095|NCT01342770|3795555|FG000|COMPLETED|Overall Study||6
3074096|NCT01342770|3795555|FG000|NOT COMPLETED|Overall Study||0
3074097|NCT01342796|3795561|FG000|STARTED|Overall Study||43
3074098|NCT01342796|3795562|FG001|STARTED|Overall Study||41
3074099|NCT01342796|3795561|FG000|COMPLETED|Overall Study||40
3074100|NCT01342796|3795562|FG001|COMPLETED|Overall Study||38
3074101|NCT01342796|3795561|FG000|NOT COMPLETED|Overall Study||3
3074102|NCT01342796|3795562|FG001|NOT COMPLETED|Overall Study||3
3074103|NCT01342887|3795568|FG000|STARTED|Overall Study||6
3074104|NCT01342887|3795568|FG000|COMPLETED|Overall Study||4
3074105|NCT01342887|3795568|FG000|NOT COMPLETED|Overall Study||2
3074106|NCT01342913|3795574|FG000|STARTED|2-week Run-in Period||702
3074107|NCT01342913|3795575|FG001|STARTED|2-week Run-in Period||0
3074108|NCT01342913|3795576|FG002|STARTED|2-week Run-in Period||0
3074109|NCT01342913|3795574|FG000|COMPLETED|2-week Run-in Period||528
3074110|NCT01342913|3795575|FG001|COMPLETED|2-week Run-in Period||0
3074111|NCT01342913|3795576|FG002|COMPLETED|2-week Run-in Period||0
3074112|NCT01342913|3795574|FG000|NOT COMPLETED|2-week Run-in Period||174
3074113|NCT01342913|3795575|FG001|NOT COMPLETED|2-week Run-in Period||0
3074114|NCT01342913|3795576|FG002|NOT COMPLETED|2-week Run-in Period||0
3074115|NCT01342913|3795574|FG000|STARTED|Double-Blind Treatment Period||0
3074116|NCT01342913|3795575|FG001|STARTED|Double-Blind Treatment Period||262
3074117|NCT01342913|3795576|FG002|STARTED|Double-Blind Treatment Period||266
3074118|NCT01342913|3795574|FG000|COMPLETED|Double-Blind Treatment Period||0
3074119|NCT01342913|3795575|FG001|COMPLETED|Double-Blind Treatment Period||246
3074120|NCT01342913|3795576|FG002|COMPLETED|Double-Blind Treatment Period||243
3074121|NCT01342913|3795574|FG000|NOT COMPLETED|Double-Blind Treatment Period||0
3074122|NCT01342913|3795575|FG001|NOT COMPLETED|Double-Blind Treatment Period||16
3074123|NCT01342913|3795576|FG002|NOT COMPLETED|Double-Blind Treatment Period||23
3074124|NCT01342926|3795586|FG000|STARTED|Overall Study||46
3074125|NCT01342926|3795587|FG001|STARTED|Overall Study||46
3074126|NCT01342926|3795588|FG002|STARTED|Overall Study||48
3074127|NCT01342926|3795589|FG003|STARTED|Overall Study||51
3074128|NCT01342926|3795586|FG000|COMPLETED|Overall Study||37
3074129|NCT01342926|3795587|FG001|COMPLETED|Overall Study||31
3074130|NCT01342926|3795588|FG002|COMPLETED|Overall Study||34
3074131|NCT01342926|3795589|FG003|COMPLETED|Overall Study||39
3074132|NCT01342926|3795586|FG000|NOT COMPLETED|Overall Study||9
3074133|NCT01342926|3795587|FG001|NOT COMPLETED|Overall Study||15
3074134|NCT01342926|3795588|FG002|NOT COMPLETED|Overall Study||14
3074135|NCT01342926|3795589|FG003|NOT COMPLETED|Overall Study||12
3074136|NCT01342965|3795601|FG000|STARTED|Overall Study||110
3074137|NCT01342965|3795602|FG001|STARTED|Overall Study||107
3074138|NCT01342965|3795601|FG000|Received Treatment|Overall Study||110
3074139|NCT01342965|3795602|FG001|Received Treatment|Overall Study||104
3074140|NCT01342965|3795601|FG000|COMPLETED|Overall Study||1
3074141|NCT01342965|3795602|FG001|COMPLETED|Overall Study||0
3074142|NCT01342965|3795601|FG000|NOT COMPLETED|Overall Study||109
3074143|NCT01342965|3795602|FG001|NOT COMPLETED|Overall Study||107
3074144|NCT01343004|3795611|FG000|STARTED|Overall Study||821
3074145|NCT01343004|3795612|FG001|STARTED|Overall Study||824
3074146|NCT01343004|3795613|FG002|STARTED|Overall Study||818
3074147|NCT01343004|3795611|FG000|COMPLETED|Overall Study||637
3074148|NCT01343004|3795612|FG001|COMPLETED|Overall Study||606
3074149|NCT01343004|3795613|FG002|COMPLETED|Overall Study||658
3074150|NCT01343004|3795611|FG000|NOT COMPLETED|Overall Study||184
3074151|NCT01343004|3795612|FG001|NOT COMPLETED|Overall Study||218
3074152|NCT01343004|3795613|FG002|NOT COMPLETED|Overall Study||160
3074153|NCT01343043|3795625|FG000|STARTED|Overall Study||15
3074154|NCT01343043|3795626|FG001|STARTED|Overall Study||14
3074155|NCT01343043|3795627|FG002|STARTED|Overall Study||5
3074156|NCT01343043|3795628|FG003|STARTED|Overall Study||16
3074157|NCT01343043|3795625|FG000|Received T-cell Infusion|Overall Study||12
3074158|NCT01343043|3795626|FG001|Received T-cell Infusion|Overall Study||13
3074159|NCT01343043|3795627|FG002|Received T-cell Infusion|Overall Study||5
3074160|NCT01343043|3795628|FG003|Received T-cell Infusion|Overall Study||15
3074161|NCT01343043|3795625|FG000|COMPLETED|Overall Study||12
3074162|NCT01343043|3795626|FG001|COMPLETED|Overall Study||13
3074163|NCT01343043|3795627|FG002|COMPLETED|Overall Study||5
3074164|NCT01343043|3795628|FG003|COMPLETED|Overall Study||15
3074165|NCT01343043|3795625|FG000|NOT COMPLETED|Overall Study||3
3074166|NCT01343043|3795626|FG001|NOT COMPLETED|Overall Study||1
3074167|NCT01343043|3795627|FG002|NOT COMPLETED|Overall Study||0
3074168|NCT01343043|3795628|FG003|NOT COMPLETED|Overall Study||1
3074169|NCT01343056|3795645|FG000|STARTED|Overall Study||35
3074170|NCT01343056|3795646|FG001|STARTED|Overall Study||36
3074171|NCT01343056|3795647|FG002|STARTED|Overall Study||32
3074172|NCT01343056|3795648|FG003|STARTED|Overall Study||38
3074173|NCT01343056|3795645|FG000|COMPLETED|Overall Study||28
3074174|NCT01343056|3795646|FG001|COMPLETED|Overall Study||31
3074175|NCT01343056|3795647|FG002|COMPLETED|Overall Study||29
3074176|NCT01343056|3795648|FG003|COMPLETED|Overall Study||29
3074177|NCT01343056|3795645|FG000|NOT COMPLETED|Overall Study||7
3074178|NCT01343056|3795646|FG001|NOT COMPLETED|Overall Study||5
3074179|NCT01343056|3795647|FG002|NOT COMPLETED|Overall Study||3
3074180|NCT01343056|3795648|FG003|NOT COMPLETED|Overall Study||9
3074181|NCT01343082|3795662|FG000|STARTED|The run-in Period||51
3074182|NCT01343082|3795663|FG001|STARTED|The run-in Period||49
3074183|NCT01343082|3795664|FG002|STARTED|The run-in Period||48
3074184|NCT01343082|3795662|FG000|COMPLETED|The run-in Period||48
3074185|NCT01343082|3795663|FG001|COMPLETED|The run-in Period||45
3074186|NCT01343082|3795664|FG002|COMPLETED|The run-in Period||43
3074187|NCT01343082|3795662|FG000|NOT COMPLETED|The run-in Period||3
3074188|NCT01343082|3795663|FG001|NOT COMPLETED|The run-in Period||4
3074189|NCT01343082|3795664|FG002|NOT COMPLETED|The run-in Period||5
3074190|NCT01343082|3795662|FG000|STARTED|Treatment Period , Switched to DE-111||48
3074191|NCT01343082|3795663|FG001|STARTED|Treatment Period , Switched to DE-111||45
3074192|NCT01343082|3795664|FG002|STARTED|Treatment Period , Switched to DE-111||43
3074193|NCT01343082|3795662|FG000|COMPLETED|Treatment Period , Switched to DE-111||43
3074194|NCT01343082|3795663|FG001|COMPLETED|Treatment Period , Switched to DE-111||36
3074195|NCT01343082|3795664|FG002|COMPLETED|Treatment Period , Switched to DE-111||31
3074196|NCT01343082|3795662|FG000|NOT COMPLETED|Treatment Period , Switched to DE-111||5
3074197|NCT01343082|3795663|FG001|NOT COMPLETED|Treatment Period , Switched to DE-111||9
3074198|NCT01343082|3795664|FG002|NOT COMPLETED|Treatment Period , Switched to DE-111||12
3074199|NCT01343095|3795671|FG000|STARTED|Overall Study||2
3074200|NCT01343095|3795672|FG001|STARTED|Overall Study||3
3074201|NCT01343095|3795673|FG002|STARTED|Overall Study||3
3074202|NCT01343095|3795671|FG000|COMPLETED|Overall Study||2
3074203|NCT01343095|3795672|FG001|COMPLETED|Overall Study||3
3074204|NCT01343095|3795673|FG002|COMPLETED|Overall Study||3
3074205|NCT01343095|3795671|FG000|NOT COMPLETED|Overall Study||0
3074206|NCT01343095|3795672|FG001|NOT COMPLETED|Overall Study||0
3074207|NCT01343095|3795673|FG002|NOT COMPLETED|Overall Study||0
3074208|NCT01343160|3795683|FG000|STARTED|Overall Study||36
3074209|NCT01343160|3795683|FG000|COMPLETED|Overall Study||31
3074210|NCT01343160|3795683|FG000|NOT COMPLETED|Overall Study||5
3074211|NCT01343251|3795690|FG000|STARTED|Overall Study||16
3074212|NCT01343251|3795691|FG001|STARTED|Overall Study||17
3074213|NCT01343251|3795690|FG000|COMPLETED|Overall Study||16
3074214|NCT01343251|3795691|FG001|COMPLETED|Overall Study||17
3074215|NCT01343251|3795690|FG000|NOT COMPLETED|Overall Study||0
3074216|NCT01343251|3795691|FG001|NOT COMPLETED|Overall Study||0
3074217|NCT01343277|3795702|FG000|STARTED|Overall Study||384
3074218|NCT01343277|3795703|FG001|STARTED|Overall Study||193
3074219|NCT01343277|3795702|FG000|Treated|Overall Study||378
3074220|NCT01343277|3795703|FG001|Treated|Overall Study||172
3074221|NCT01343277|3795702|FG000|COMPLETED|Overall Study||0
3074222|NCT01343277|3795703|FG001|COMPLETED|Overall Study||0
3074223|NCT01343277|3795702|FG000|NOT COMPLETED|Overall Study||384
3074224|NCT01343277|3795703|FG001|NOT COMPLETED|Overall Study||193
3074225|NCT01343368|3795711|FG000|STARTED|Overall Study||9
3074226|NCT01343368|3795712|FG001|STARTED|Overall Study||10
3074227|NCT01343368|3795711|FG000|COMPLETED|Overall Study||7
3074228|NCT01343368|3795712|FG001|COMPLETED|Overall Study||10
3074229|NCT01343368|3795711|FG000|NOT COMPLETED|Overall Study||2
3074230|NCT01343368|3795712|FG001|NOT COMPLETED|Overall Study||0
3074231|NCT01343407|3795718|FG000|STARTED|First Treatment Period (Part 2)||2
3074232|NCT01343407|3795719|FG001|STARTED|First Treatment Period (Part 2)||2
3074233|NCT01343407|3795720|FG002|STARTED|First Treatment Period (Part 2)||3
3074234|NCT01343407|3795721|FG003|STARTED|First Treatment Period (Part 2)||3
3074235|NCT01343407|3795722|FG004|STARTED|First Treatment Period (Part 2)||3
3074236|NCT01343407|3795723|FG005|STARTED|First Treatment Period (Part 2)||3
3074237|NCT01343407|3795718|FG000|COMPLETED|First Treatment Period (Part 2)||2
3074238|NCT01343407|3795719|FG001|COMPLETED|First Treatment Period (Part 2)||2
3074239|NCT01343407|3795720|FG002|COMPLETED|First Treatment Period (Part 2)||3
3074240|NCT01343407|3795721|FG003|COMPLETED|First Treatment Period (Part 2)||3
3074241|NCT01343407|3795722|FG004|COMPLETED|First Treatment Period (Part 2)||3
3074242|NCT01343407|3795723|FG005|COMPLETED|First Treatment Period (Part 2)||3
3074243|NCT01343407|3795718|FG000|NOT COMPLETED|First Treatment Period (Part 2)||0
3074244|NCT01343407|3795719|FG001|NOT COMPLETED|First Treatment Period (Part 2)||0
3074245|NCT01343407|3795720|FG002|NOT COMPLETED|First Treatment Period (Part 2)||0
3074246|NCT01343407|3795721|FG003|NOT COMPLETED|First Treatment Period (Part 2)||0
3074247|NCT01343407|3795722|FG004|NOT COMPLETED|First Treatment Period (Part 2)||0
3074248|NCT01343407|3795723|FG005|NOT COMPLETED|First Treatment Period (Part 2)||0
3074249|NCT01343407|3795718|FG000|STARTED|First Washout (Part 2)||2
3074250|NCT01343407|3795719|FG001|STARTED|First Washout (Part 2)||2
3074251|NCT01343407|3795720|FG002|STARTED|First Washout (Part 2)||3
3074252|NCT01343407|3795721|FG003|STARTED|First Washout (Part 2)||3
3074253|NCT01343407|3795722|FG004|STARTED|First Washout (Part 2)||3
3074254|NCT01343407|3795723|FG005|STARTED|First Washout (Part 2)||3
3074255|NCT01343407|3795718|FG000|COMPLETED|First Washout (Part 2)||2
3074256|NCT01343407|3795719|FG001|COMPLETED|First Washout (Part 2)||2
3074257|NCT01343407|3795720|FG002|COMPLETED|First Washout (Part 2)||3
3074258|NCT01343407|3795721|FG003|COMPLETED|First Washout (Part 2)||3
3074259|NCT01343407|3795722|FG004|COMPLETED|First Washout (Part 2)||3
3074260|NCT01343407|3795723|FG005|COMPLETED|First Washout (Part 2)||3
3074261|NCT01343407|3795718|FG000|NOT COMPLETED|First Washout (Part 2)||0
3074262|NCT01343407|3795719|FG001|NOT COMPLETED|First Washout (Part 2)||0
3074263|NCT01343407|3795720|FG002|NOT COMPLETED|First Washout (Part 2)||0
3074264|NCT01343407|3795721|FG003|NOT COMPLETED|First Washout (Part 2)||0
3074265|NCT01343407|3795722|FG004|NOT COMPLETED|First Washout (Part 2)||0
3074266|NCT01343407|3795723|FG005|NOT COMPLETED|First Washout (Part 2)||0
3074267|NCT01343407|3795718|FG000|STARTED|Second Treatment Period (Part 2)||2
3074268|NCT01343407|3795719|FG001|STARTED|Second Treatment Period (Part 2)||2
3074269|NCT01343407|3795720|FG002|STARTED|Second Treatment Period (Part 2)||3
3074270|NCT01343407|3795721|FG003|STARTED|Second Treatment Period (Part 2)||3
3074271|NCT01343407|3795722|FG004|STARTED|Second Treatment Period (Part 2)||3
3074272|NCT01343407|3795723|FG005|STARTED|Second Treatment Period (Part 2)||3
3074273|NCT01343407|3795718|FG000|COMPLETED|Second Treatment Period (Part 2)||2
3074274|NCT01343407|3795719|FG001|COMPLETED|Second Treatment Period (Part 2)||2
3074275|NCT01343407|3795720|FG002|COMPLETED|Second Treatment Period (Part 2)||2
3074276|NCT01343407|3795721|FG003|COMPLETED|Second Treatment Period (Part 2)||3
3074277|NCT01343407|3795722|FG004|COMPLETED|Second Treatment Period (Part 2)||3
3074278|NCT01343407|3795723|FG005|COMPLETED|Second Treatment Period (Part 2)||3
3074279|NCT01343407|3795718|FG000|NOT COMPLETED|Second Treatment Period (Part 2)||0
3074280|NCT01343407|3795719|FG001|NOT COMPLETED|Second Treatment Period (Part 2)||0
3074281|NCT01343407|3795720|FG002|NOT COMPLETED|Second Treatment Period (Part 2)||1
3074282|NCT01343407|3795721|FG003|NOT COMPLETED|Second Treatment Period (Part 2)||0
3074283|NCT01343407|3795722|FG004|NOT COMPLETED|Second Treatment Period (Part 2)||0
3074284|NCT01343407|3795723|FG005|NOT COMPLETED|Second Treatment Period (Part 2)||0
3074285|NCT01343407|3795718|FG000|STARTED|Second Washout (Part 2)||2
3074286|NCT01343407|3795719|FG001|STARTED|Second Washout (Part 2)||2
3074287|NCT01343407|3795720|FG002|STARTED|Second Washout (Part 2)||2
3074288|NCT01343407|3795721|FG003|STARTED|Second Washout (Part 2)||3
3074289|NCT01343407|3795722|FG004|STARTED|Second Washout (Part 2)||3
3074290|NCT01343407|3795723|FG005|STARTED|Second Washout (Part 2)||3
3074291|NCT01343407|3795718|FG000|COMPLETED|Second Washout (Part 2)||2
3074292|NCT01343407|3795719|FG001|COMPLETED|Second Washout (Part 2)||2
3074293|NCT01343407|3795720|FG002|COMPLETED|Second Washout (Part 2)||1
3074294|NCT01343407|3795721|FG003|COMPLETED|Second Washout (Part 2)||3
3074295|NCT01343407|3795722|FG004|COMPLETED|Second Washout (Part 2)||3
3074296|NCT01343407|3795723|FG005|COMPLETED|Second Washout (Part 2)||3
3074297|NCT01343407|3795718|FG000|NOT COMPLETED|Second Washout (Part 2)||0
3074298|NCT01343407|3795719|FG001|NOT COMPLETED|Second Washout (Part 2)||0
3074299|NCT01343407|3795720|FG002|NOT COMPLETED|Second Washout (Part 2)||1
3074300|NCT01343407|3795721|FG003|NOT COMPLETED|Second Washout (Part 2)||0
3074301|NCT01343407|3795722|FG004|NOT COMPLETED|Second Washout (Part 2)||0
3074302|NCT01343407|3795723|FG005|NOT COMPLETED|Second Washout (Part 2)||0
3074303|NCT01343407|3795718|FG000|STARTED|Third Treatment Period (Part 2)||2
3074304|NCT01343407|3795719|FG001|STARTED|Third Treatment Period (Part 2)||2
3074305|NCT01343407|3795720|FG002|STARTED|Third Treatment Period (Part 2)||1
3074306|NCT01343407|3795721|FG003|STARTED|Third Treatment Period (Part 2)||3
3074307|NCT01343407|3795722|FG004|STARTED|Third Treatment Period (Part 2)||3
3074308|NCT01343407|3795723|FG005|STARTED|Third Treatment Period (Part 2)||3
3074309|NCT01343407|3795718|FG000|COMPLETED|Third Treatment Period (Part 2)||2
3074310|NCT01343407|3795719|FG001|COMPLETED|Third Treatment Period (Part 2)||2
3074311|NCT01343407|3795720|FG002|COMPLETED|Third Treatment Period (Part 2)||1
3074312|NCT01343407|3795721|FG003|COMPLETED|Third Treatment Period (Part 2)||3
3074313|NCT01343407|3795722|FG004|COMPLETED|Third Treatment Period (Part 2)||3
3074314|NCT01343407|3795723|FG005|COMPLETED|Third Treatment Period (Part 2)||3
3074315|NCT01343407|3795718|FG000|NOT COMPLETED|Third Treatment Period (Part 2)||0
3074316|NCT01343407|3795719|FG001|NOT COMPLETED|Third Treatment Period (Part 2)||0
3074317|NCT01343407|3795720|FG002|NOT COMPLETED|Third Treatment Period (Part 2)||0
3074318|NCT01343407|3795721|FG003|NOT COMPLETED|Third Treatment Period (Part 2)||0
3074319|NCT01343407|3795722|FG004|NOT COMPLETED|Third Treatment Period (Part 2)||0
3074320|NCT01343407|3795723|FG005|NOT COMPLETED|Third Treatment Period (Part 2)||0
3074321|NCT01343485|3795733|FG000|STARTED|Overall Study||185
3074322|NCT01343485|3795734|FG001|STARTED|Overall Study||180
3074323|NCT01343485|3795733|FG000|COMPLETED|Overall Study||36
3074324|NCT01343485|3795734|FG001|COMPLETED|Overall Study||46
3074325|NCT01343485|3795733|FG000|NOT COMPLETED|Overall Study||149
3074326|NCT01343485|3795734|FG001|NOT COMPLETED|Overall Study||134
3074327|NCT01343667|3795742|FG000|STARTED|Overall Study||425
3074328|NCT01343667|3795743|FG001|STARTED|Overall Study||972
3074329|NCT01343667|3795742|FG000|COMPLETED|Overall Study||413
3074330|NCT01343667|3795743|FG001|COMPLETED|Overall Study||916
3074331|NCT01343667|3795742|FG000|NOT COMPLETED|Overall Study||12
3074332|NCT01343667|3795743|FG001|NOT COMPLETED|Overall Study||56
3074333|NCT01343693|3795749|FG000|STARTED|Overall Study||119
3074334|NCT01343693|3795749|FG000|COMPLETED|Overall Study||110
3074335|NCT01343693|3795749|FG000|NOT COMPLETED|Overall Study||9
3074336|NCT01343823|3795757|FG000|STARTED|Overall Study||20
3074337|NCT01343823|3795758|FG001|STARTED|Overall Study||20
3074338|NCT01343823|3795759|FG002|STARTED|Overall Study||19
3074339|NCT01343823|3795760|FG003|STARTED|Overall Study||20
3074340|NCT01343823|3795757|FG000|COMPLETED|Overall Study||18
3074341|NCT01343823|3795758|FG001|COMPLETED|Overall Study||20
3074342|NCT01343823|3795759|FG002|COMPLETED|Overall Study||19
3074343|NCT01343823|3795760|FG003|COMPLETED|Overall Study||19
3074344|NCT01343823|3795757|FG000|NOT COMPLETED|Overall Study||2
3074345|NCT01343823|3795758|FG001|NOT COMPLETED|Overall Study||0
3074346|NCT01343823|3795759|FG002|NOT COMPLETED|Overall Study||0
3074347|NCT01343823|3795760|FG003|NOT COMPLETED|Overall Study||1
3074348|NCT01343888|3795773|FG000|STARTED|Overall Study|261 subject randomized; 259 subjects treated with at least one dose; 2 subjects were not treated|259
3074349|NCT01343888|3795774|FG001|STARTED|Overall Study|262 subject randomized; 261 subjects treated with at least one dose; 1 subject was not treated|261
3074350|NCT01343888|3795775|FG002|STARTED|Overall Study|133 subject randomized; 132 subjects treated with at least one dose; 1 subject was not treated|132
3074351|NCT01343888|3795773|FG000|COMPLETED|Overall Study||234
3074352|NCT01343888|3795774|FG001|COMPLETED|Overall Study||222
3074353|NCT01343888|3795775|FG002|COMPLETED|Overall Study||110
3074354|NCT01343888|3795773|FG000|NOT COMPLETED|Overall Study||25
3074355|NCT01343888|3795774|FG001|NOT COMPLETED|Overall Study||39
3074356|NCT01343888|3795775|FG002|NOT COMPLETED|Overall Study||22
3074357|NCT01343901|3795783|FG000|STARTED|Overall Study||210
3074358|NCT01343901|3795783|FG000|Efficacy Population|Overall Study||205
3074359|NCT01343901|3795783|FG000|COMPLETED|Overall Study||97
3074360|NCT01343901|3795783|FG000|NOT COMPLETED|Overall Study||113
3074361|NCT01344057|3795787|FG000|STARTED|Overall Study||63
3074362|NCT01344057|3795787|FG000|COMPLETED|Overall Study||62
3074363|NCT01344057|3795787|FG000|NOT COMPLETED|Overall Study||1
3074364|NCT01344161|3795793|FG000|STARTED|Overall Study||43
3074365|NCT01344161|3795794|FG001|STARTED|Overall Study||42
3074366|NCT01344161|3795793|FG000|COMPLETED|Overall Study||38
3074367|NCT01344161|3795794|FG001|COMPLETED|Overall Study||39
3074368|NCT01344161|3795793|FG000|NOT COMPLETED|Overall Study||5
3074369|NCT01344161|3795794|FG001|NOT COMPLETED|Overall Study||3
3074370|NCT01344226|3795800|FG000|STARTED|Overall Study||49
3074371|NCT01344226|3795800|FG000|COMPLETED|Overall Study||41
3074372|NCT01344226|3795800|FG000|NOT COMPLETED|Overall Study||8
3074373|NCT01344356|3795806|FG000|STARTED|Overall Study||1
3074374|NCT01344356|3795807|FG001|STARTED|Overall Study||18
3074375|NCT01344356|3795806|FG000|COMPLETED|Overall Study||1
3074376|NCT01344356|3795807|FG001|COMPLETED|Overall Study||9
3074377|NCT01344356|3795806|FG000|NOT COMPLETED|Overall Study||0
3074378|NCT01344356|3795807|FG001|NOT COMPLETED|Overall Study||9
3074379|NCT01344369|3795817|FG000|STARTED|First Intervention||18
3074380|NCT01344369|3795818|FG001|STARTED|First Intervention||18
3074381|NCT01344369|3795817|FG000|COMPLETED|First Intervention||18
3074382|NCT01344369|3795818|FG001|COMPLETED|First Intervention||18
3074383|NCT01344369|3795817|FG000|NOT COMPLETED|First Intervention||0
3074384|NCT01344369|3795818|FG001|NOT COMPLETED|First Intervention||0
3074385|NCT01344369|3795817|FG000|STARTED|Washout of 28 Days||18
3074386|NCT01344369|3795818|FG001|STARTED|Washout of 28 Days||18
3074387|NCT01344369|3795817|FG000|COMPLETED|Washout of 28 Days||17
3074388|NCT01344369|3795818|FG001|COMPLETED|Washout of 28 Days||17
3074389|NCT01344369|3795817|FG000|NOT COMPLETED|Washout of 28 Days||1
3074390|NCT01344369|3795818|FG001|NOT COMPLETED|Washout of 28 Days||1
3074391|NCT01344369|3795817|FG000|STARTED|Second Intervention||17
3074392|NCT01344369|3795818|FG001|STARTED|Second Intervention||17
3074393|NCT01344369|3795817|FG000|COMPLETED|Second Intervention||17
3074394|NCT01344369|3795818|FG001|COMPLETED|Second Intervention||16
3074395|NCT01344369|3795817|FG000|NOT COMPLETED|Second Intervention||0
3074396|NCT01344369|3795818|FG001|NOT COMPLETED|Second Intervention||1
3074397|NCT01344447|3795824|FG000|STARTED|Overall Study|Participant received study drug; Safety analysis set|479
3074398|NCT01344447|3795824|FG000|Fulfilled Requirement of FAS Population|Overall Study|Full Analysis Set (FAS)|457
3074399|NCT01344447|3795824|FG000|COMPLETED|Overall Study||471
3074400|NCT01344447|3795824|FG000|NOT COMPLETED|Overall Study||8
3074401|NCT01344460|3795832|FG000|STARTED|Overall Study|Participants received study drug; Safety analysis set|315
3074402|NCT01344460|3795832|FG000|Fulfilled Requirements of FAS Population|Overall Study|Full analysis set (FAS)|292
3074403|NCT01344460|3795832|FG000|COMPLETED|Overall Study||312
3074404|NCT01344460|3795832|FG000|NOT COMPLETED|Overall Study||3
3074405|NCT01344538|3795842|FG000|STARTED|Overall Study||16
3074406|NCT01344538|3795843|FG001|STARTED|Overall Study||17
3074407|NCT01344538|3795842|FG000|COMPLETED|Overall Study||14
3074408|NCT01344538|3795843|FG001|COMPLETED|Overall Study||16
3074409|NCT01344538|3795842|FG000|NOT COMPLETED|Overall Study||2
3074410|NCT01344538|3795843|FG001|NOT COMPLETED|Overall Study||1
3074411|NCT01344616|3795851|FG000|STARTED|Overall Study||244
3074412|NCT01344616|3795852|FG001|STARTED|Overall Study||238
3074413|NCT01344616|3795851|FG000|COMPLETED|Overall Study||209
3074414|NCT01344616|3795852|FG001|COMPLETED|Overall Study||194
3074415|NCT01344616|3795851|FG000|NOT COMPLETED|Overall Study||35
3074416|NCT01344616|3795852|FG001|NOT COMPLETED|Overall Study||44
3074417|NCT01344629|3795860|FG000|STARTED|Crossover Period 1||32
3074418|NCT01344629|3795861|FG001|STARTED|Crossover Period 1||32
3074419|NCT01344629|3795860|FG000|COMPLETED|Crossover Period 1||32
3074420|NCT01344629|3795861|FG001|COMPLETED|Crossover Period 1||32
3074421|NCT01344629|3795860|FG000|NOT COMPLETED|Crossover Period 1||0
3074422|NCT01344629|3795861|FG001|NOT COMPLETED|Crossover Period 1||0
3074423|NCT01344629|3795860|FG000|STARTED|Crossover Period 2||32
3074424|NCT01344629|3795861|FG001|STARTED|Crossover Period 2||32
3074425|NCT01344629|3795860|FG000|COMPLETED|Crossover Period 2||32
3074426|NCT01344629|3795861|FG001|COMPLETED|Crossover Period 2||31
3074427|NCT01344629|3795860|FG000|NOT COMPLETED|Crossover Period 2||0
3074428|NCT01344629|3795861|FG001|NOT COMPLETED|Crossover Period 2||1
3074429|NCT01344629|3795860|FG000|STARTED|Crossover Period 3||32
3074430|NCT01344629|3795861|FG001|STARTED|Crossover Period 3||31
3074431|NCT01344629|3795860|FG000|COMPLETED|Crossover Period 3||32
3074432|NCT01344629|3795861|FG001|COMPLETED|Crossover Period 3||31
3074433|NCT01344629|3795860|FG000|NOT COMPLETED|Crossover Period 3||0
3074434|NCT01344629|3795861|FG001|NOT COMPLETED|Crossover Period 3||0
3074435|NCT01344629|3795860|FG000|STARTED|Crossover Period 4||32
3074436|NCT01344629|3795861|FG001|STARTED|Crossover Period 4||31
3074437|NCT01344629|3795860|FG000|COMPLETED|Crossover Period 4||32
3074438|NCT01344629|3795861|FG001|COMPLETED|Crossover Period 4||31
3074439|NCT01344629|3795860|FG000|NOT COMPLETED|Crossover Period 4||0
3074440|NCT01344629|3795861|FG001|NOT COMPLETED|Crossover Period 4||0
3074441|NCT01344759|3795869|FG000|STARTED|Overall Study||30
3074442|NCT01344759|3795870|FG001|STARTED|Overall Study||30
3074443|NCT01344759|3795869|FG000|COMPLETED|Overall Study||30
3074444|NCT01344759|3795870|FG001|COMPLETED|Overall Study|Two of the original DEX group subjects were removed, due to receiving dexmedetomidine and propofol.|28
3074445|NCT01344759|3795869|FG000|NOT COMPLETED|Overall Study||0
3074446|NCT01344759|3795870|FG001|NOT COMPLETED|Overall Study||2
3074447|NCT01344824|3795882|FG000|STARTED|Overall Study||38
3074448|NCT01344824|3795882|FG000|COMPLETED|Overall Study||1
3074449|NCT01344824|3795882|FG000|NOT COMPLETED|Overall Study||37
3074450|NCT01344876|3795887|FG000|STARTED|Overall Study||4
3074451|NCT01344876|3795888|FG001|STARTED|Overall Study||3
3074452|NCT01344876|3795889|FG002|STARTED|Overall Study||4
3074453|NCT01344876|3795890|FG003|STARTED|Overall Study||6
3074454|NCT01344876|3795891|FG004|STARTED|Overall Study||3
3074455|NCT01344876|3795887|FG000|COMPLETED|Overall Study||3
3074456|NCT01344876|3795888|FG001|COMPLETED|Overall Study||3
3074457|NCT01344876|3795889|FG002|COMPLETED|Overall Study||3
3074458|NCT01344876|3795890|FG003|COMPLETED|Overall Study||3
3074459|NCT01344876|3795891|FG004|COMPLETED|Overall Study||2
3074460|NCT01344876|3795887|FG000|NOT COMPLETED|Overall Study||1
3074461|NCT01344876|3795888|FG001|NOT COMPLETED|Overall Study||0
3074462|NCT01344876|3795889|FG002|NOT COMPLETED|Overall Study||1
3074463|NCT01344876|3795890|FG003|NOT COMPLETED|Overall Study||3
3074464|NCT01344876|3795891|FG004|NOT COMPLETED|Overall Study||1
3074465|NCT01345019|3795906|FG000|STARTED|Blinded Treatment Phase||859
3074466|NCT01345019|3795907|FG001|STARTED|Blinded Treatment Phase||859
3074467|NCT01345019|3795906|FG000|Received Treatment|Blinded Treatment Phase||852
3074468|NCT01345019|3795907|FG001|Received Treatment|Blinded Treatment Phase||850
3074469|NCT01345019|3795906|FG000|COMPLETED|Blinded Treatment Phase||541
3074470|NCT01345019|3795907|FG001|COMPLETED|Blinded Treatment Phase||555
3074471|NCT01345019|3795906|FG000|NOT COMPLETED|Blinded Treatment Phase||318
3074472|NCT01345019|3795907|FG001|NOT COMPLETED|Blinded Treatment Phase||304
3074473|NCT01345019|3795906|FG000|STARTED|Open Label Treatment Phase||418
3074474|NCT01345019|3795907|FG001|STARTED|Open Label Treatment Phase||426
3074475|NCT01345019|3795906|FG000|COMPLETED|Open Label Treatment Phase||227
3074476|NCT01345019|3795907|FG001|COMPLETED|Open Label Treatment Phase||233
3074477|NCT01345019|3795906|FG000|NOT COMPLETED|Open Label Treatment Phase||191
3074478|NCT01345019|3795907|FG001|NOT COMPLETED|Open Label Treatment Phase||193
3074479|NCT01345058|3795917|FG000|STARTED|Overall Study||20
3074480|NCT01345058|3795918|FG001|STARTED|Overall Study||36
3074481|NCT01345058|3795917|FG000|Received Lacosamide|Overall Study||19
3074482|NCT01345058|3795918|FG001|Received Lacosamide|Overall Study||0
3074483|NCT01345058|3795917|FG000|COMPLETED|Overall Study||15
3074484|NCT01345058|3795918|FG001|COMPLETED|Overall Study||36
3074485|NCT01345058|3795917|FG000|NOT COMPLETED|Overall Study||5
3074486|NCT01345058|3795918|FG001|NOT COMPLETED|Overall Study||0
3074487|NCT01345123|3795927|FG000|STARTED|Overall Study||3323
3074488|NCT01345123|3795928|FG001|STARTED|Overall Study||3311
3074489|NCT01345123|3795929|FG002|STARTED|Overall Study||3291
3074490|NCT01345123|3795927|FG000|COMPLETED|Overall Study|3323 - 79 study participants who were no longer health plan eligible members (zero eligible months)|3244
3074491|NCT01345123|3795928|FG001|COMPLETED|Overall Study|3311 - 85 study participants who were no longer health plan eligible members (zero eligible months)|3226
3074492|NCT01345123|3795929|FG002|COMPLETED|Overall Study|3291 - 88 study participants who were no longer health plan eligible members (zero eligible months)|3203
3074493|NCT01345123|3795927|FG000|NOT COMPLETED|Overall Study||79
3074494|NCT01345123|3795928|FG001|NOT COMPLETED|Overall Study||85
3074495|NCT01345123|3795929|FG002|NOT COMPLETED|Overall Study||88
3074496|NCT01345162|3795940|FG000|STARTED|Overall Study||100
3074497|NCT01345162|3795941|FG001|STARTED|Overall Study||100
3074498|NCT01345162|3795940|FG000|COMPLETED|Overall Study||98
3074499|NCT01345162|3795941|FG001|COMPLETED|Overall Study||96
3074500|NCT01345162|3795940|FG000|NOT COMPLETED|Overall Study||2
3074501|NCT01345162|3795941|FG001|NOT COMPLETED|Overall Study||4
3074502|NCT01345188|3795947|FG000|STARTED|Randomization Ranolazine/Placebo 6 Weeks||28
3074503|NCT01345188|3795947|FG000|COMPLETED|Randomization Ranolazine/Placebo 6 Weeks||26
3074504|NCT01345188|3795947|FG000|NOT COMPLETED|Randomization Ranolazine/Placebo 6 Weeks||2
3074505|NCT01345188|3795947|FG000|STARTED|Crossover Ranolazine/Placebo 6 Weeks||26
3074506|NCT01345188|3795947|FG000|COMPLETED|Crossover Ranolazine/Placebo 6 Weeks||25
3074507|NCT01345188|3795947|FG000|NOT COMPLETED|Crossover Ranolazine/Placebo 6 Weeks||1
3074508|NCT01345253|3795956|FG000|STARTED|Double-blind (DB) Phase (52 Weeks)||226
3074509|NCT01345253|3795957|FG001|STARTED|Double-blind (DB) Phase (52 Weeks)||451
3074510|NCT01345253|3795956|FG000|COMPLETED|Double-blind (DB) Phase (52 Weeks)||170
3074511|NCT01345253|3795957|FG001|COMPLETED|Double-blind (DB) Phase (52 Weeks)||372
3074512|NCT01345253|3795956|FG000|NOT COMPLETED|Double-blind (DB) Phase (52 Weeks)||56
3074513|NCT01345253|3795957|FG001|NOT COMPLETED|Double-blind (DB) Phase (52 Weeks)||79
3074514|NCT01345253|3795956|FG000|STARTED|Open-label Phase (Up to Year 5 Week 44)|Only eligible China par. enrolled in OL phase from MITT + additional 9 China par. from Safety Pop|134
3074515|NCT01345253|3795957|FG001|STARTED|Open-label Phase (Up to Year 5 Week 44)|Only eligible China par. enrolled in OL phase from MITT + additional 16 China par. from Safety Pop|290
3074516|NCT01345253|3795956|FG000|COMPLETED|Open-label Phase (Up to Year 5 Week 44)||69
3074517|NCT01345253|3795957|FG001|COMPLETED|Open-label Phase (Up to Year 5 Week 44)||146
3074518|NCT01345253|3795956|FG000|NOT COMPLETED|Open-label Phase (Up to Year 5 Week 44)||65
3074519|NCT01345253|3795957|FG001|NOT COMPLETED|Open-label Phase (Up to Year 5 Week 44)||144
3074520|NCT01345292|3795968|FG000|STARTED|Overall Study||75
3074521|NCT01345292|3795969|FG001|STARTED|Overall Study||76
3074522|NCT01345292|3795970|FG002|STARTED|Overall Study||75
3074523|NCT01345292|3795968|FG000|COMPLETED|Overall Study||73
3074524|NCT01345292|3795969|FG001|COMPLETED|Overall Study||76
3074525|NCT01345292|3795970|FG002|COMPLETED|Overall Study||74
3074526|NCT01345292|3795968|FG000|NOT COMPLETED|Overall Study||2
3074527|NCT01345292|3795969|FG001|NOT COMPLETED|Overall Study||0
3074528|NCT01345292|3795970|FG002|NOT COMPLETED|Overall Study||1
3074529|NCT01345318|3795978|FG000|STARTED|Overall Study||191
3074530|NCT01345318|3795978|FG000|COMPLETED|Overall Study||111
3074531|NCT01345318|3795978|FG000|NOT COMPLETED|Overall Study||80
3074532|NCT01345513|3795983|FG000|STARTED|Overall Study||50
3074533|NCT01345513|3795983|FG000|COMPLETED|Overall Study||50
3074534|NCT01345513|3795983|FG000|NOT COMPLETED|Overall Study||0
3074535|NCT01345591|3795987|FG000|STARTED|Overall Study||20
3074536|NCT01345591|3795987|FG000|COMPLETED|Overall Study||19
3074537|NCT01345591|3795987|FG000|NOT COMPLETED|Overall Study||1
3074538|NCT01345630|3795998|FG000|STARTED|Overall Study||396
3074539|NCT01345630|3795999|FG001|STARTED|Overall Study||401
3074540|NCT01345630|3795998|FG000|COMPLETED|Overall Study||35
3074541|NCT01345630|3795999|FG001|COMPLETED|Overall Study||42
3074542|NCT01345630|3795998|FG000|NOT COMPLETED|Overall Study||361
3074543|NCT01345630|3795999|FG001|NOT COMPLETED|Overall Study||359
3074544|NCT01345669|3796011|FG000|STARTED|Overall Study||411
3074545|NCT01345669|3796012|FG001|STARTED|Overall Study||206
3074546|NCT01345669|3796011|FG000|COMPLETED|Overall Study||124
3074547|NCT01345669|3796012|FG001|COMPLETED|Overall Study||87
3074548|NCT01345669|3796011|FG000|NOT COMPLETED|Overall Study||287
3074549|NCT01345669|3796012|FG001|NOT COMPLETED|Overall Study||119
3074550|NCT01345682|3796020|FG000|STARTED|Overall Study|Randomised|322
3074551|NCT01345682|3796021|FG001|STARTED|Overall Study|Randomised|161
3074552|NCT01345682|3796020|FG000|COMPLETED|Overall Study||0
3074553|NCT01345682|3796021|FG001|COMPLETED|Overall Study||0
3074554|NCT01345682|3796020|FG000|NOT COMPLETED|Overall Study||322
3074555|NCT01345682|3796021|FG001|NOT COMPLETED|Overall Study||161
3074556|NCT01345721|3796030|FG000|STARTED|Overall Study||74
3074557|NCT01345721|3796031|FG001|STARTED|Overall Study||66
3074558|NCT01345721|3796032|FG002|STARTED|Overall Study||65
3074559|NCT01345721|3796030|FG000|COMPLETED|Overall Study||74
3074560|NCT01345721|3796031|FG001|COMPLETED|Overall Study||66
3074561|NCT01345721|3796032|FG002|COMPLETED|Overall Study||65
3074562|NCT01345721|3796030|FG000|NOT COMPLETED|Overall Study||0
3074563|NCT01345721|3796031|FG001|NOT COMPLETED|Overall Study||0
3074564|NCT01345721|3796032|FG002|NOT COMPLETED|Overall Study||0
3074565|NCT01345929|3796046|FG000|STARTED|Overall Study||533
3074566|NCT01345929|3796047|FG001|STARTED|Overall Study||535
3074567|NCT01345929|3796046|FG000|COMPLETED|Overall Study||512
3074568|NCT01345929|3796047|FG001|COMPLETED|Overall Study||516
3074569|NCT01345929|3796046|FG000|NOT COMPLETED|Overall Study||21
3074570|NCT01345929|3796047|FG001|NOT COMPLETED|Overall Study||19
3074571|NCT01346059|3796055|FG000|STARTED|Overall Study||1
3074572|NCT01346059|3796056|FG001|STARTED|Overall Study||1
3074573|NCT01346059|3796055|FG000|COMPLETED|Overall Study||0
3074574|NCT01346059|3796056|FG001|COMPLETED|Overall Study||1
3074575|NCT01346059|3796055|FG000|NOT COMPLETED|Overall Study||1
3074576|NCT01346059|3796056|FG001|NOT COMPLETED|Overall Study||0
3074577|NCT01346072|3796064|FG000|STARTED|Overall Study||11
3074578|NCT01346072|3796065|FG001|STARTED|Overall Study||10
3074579|NCT01346072|3796064|FG000|COMPLETED|Overall Study||11
3074580|NCT01346072|3796065|FG001|COMPLETED|Overall Study||10
3074581|NCT01346072|3796064|FG000|NOT COMPLETED|Overall Study||0
3074582|NCT01346072|3796065|FG001|NOT COMPLETED|Overall Study||0
3074583|NCT01346085|3796071|FG000|STARTED|Overall Study||10
3074584|NCT01346085|3796071|FG000|COMPLETED|Overall Study||10
3074585|NCT01346085|3796071|FG000|NOT COMPLETED|Overall Study||0
3074586|NCT01346176|3796078|FG000|STARTED|Recruited||49
3074587|NCT01346176|3796079|FG001|STARTED|Recruited||40
3074588|NCT01346176|3796080|FG002|STARTED|Recruited||43
3074589|NCT01346176|3796078|FG000|COMPLETED|Recruited||48
3074590|NCT01346176|3796079|FG001|COMPLETED|Recruited||40
3074591|NCT01346176|3796080|FG002|COMPLETED|Recruited||43
3074592|NCT01346176|3796078|FG000|NOT COMPLETED|Recruited||1
3074593|NCT01346176|3796079|FG001|NOT COMPLETED|Recruited||0
3074594|NCT01346176|3796080|FG002|NOT COMPLETED|Recruited||0
3074595|NCT01346176|3796078|FG000|STARTED|Completed Advance Directive||48
3074596|NCT01346176|3796079|FG001|STARTED|Completed Advance Directive||40
3074597|NCT01346176|3796080|FG002|STARTED|Completed Advance Directive||43
3074598|NCT01346176|3796078|FG000|COMPLETED|Completed Advance Directive||35
3074599|NCT01346176|3796079|FG001|COMPLETED|Completed Advance Directive||26
3074600|NCT01346176|3796080|FG002|COMPLETED|Completed Advance Directive||33
3074601|NCT01346176|3796078|FG000|NOT COMPLETED|Completed Advance Directive||13
3074602|NCT01346176|3796079|FG001|NOT COMPLETED|Completed Advance Directive||14
3074603|NCT01346176|3796080|FG002|NOT COMPLETED|Completed Advance Directive||10
3074604|NCT01346176|3796078|FG000|STARTED|Completed Satisfaction Survey||35
3074605|NCT01346176|3796079|FG001|STARTED|Completed Satisfaction Survey||26
3074606|NCT01346176|3796080|FG002|STARTED|Completed Satisfaction Survey||33
3074607|NCT01346176|3796078|FG000|COMPLETED|Completed Satisfaction Survey||29
3074608|NCT01346176|3796079|FG001|COMPLETED|Completed Satisfaction Survey||22
3074609|NCT01346176|3796080|FG002|COMPLETED|Completed Satisfaction Survey||27
3074610|NCT01346176|3796078|FG000|NOT COMPLETED|Completed Satisfaction Survey||6
3074611|NCT01346176|3796079|FG001|NOT COMPLETED|Completed Satisfaction Survey||4
3074612|NCT01346176|3796080|FG002|NOT COMPLETED|Completed Satisfaction Survey||6
3134541|NCT01701258|3859416|FG007|NOT COMPLETED|EEG (Session 4)||0
3134542|NCT01701258|3859417|FG008|NOT COMPLETED|EEG (Session 4)||0
3134543|NCT01701258|3859418|FG009|NOT COMPLETED|EEG (Session 4)||0
3134544|NCT01701258|3859419|FG010|NOT COMPLETED|EEG (Session 4)||0
3134545|NCT01701258|3859420|FG011|NOT COMPLETED|EEG (Session 4)||0
3134546|NCT01701258|3859421|FG012|NOT COMPLETED|EEG (Session 4)||0
3134547|NCT01701271|3859449|FG000|STARTED|Overall Study||20
3134548|NCT01701271|3859449|FG000|COMPLETED|Overall Study||20
3134549|NCT01701271|3859449|FG000|NOT COMPLETED|Overall Study||0
3134550|NCT01701362|3859456|FG000|STARTED|Overall Study||275
3134551|NCT01701362|3859457|FG001|STARTED|Overall Study||267
3134552|NCT01701362|3859456|FG000|TREATED|Overall Study||274
3134553|NCT01701362|3859457|FG001|TREATED|Overall Study||265
3134554|NCT01701362|3859456|FG000|COMPLETED|Overall Study||233
3134555|NCT01701362|3859457|FG001|COMPLETED|Overall Study||211
3134556|NCT01701362|3859456|FG000|NOT COMPLETED|Overall Study||42
3134557|NCT01701362|3859457|FG001|NOT COMPLETED|Overall Study||56
3134558|NCT01701375|3859463|FG000|STARTED|Overall Study||2
3134559|NCT01701375|3859463|FG000|COMPLETED|Overall Study||2
3134560|NCT01701375|3859463|FG000|NOT COMPLETED|Overall Study||0
3134561|NCT01701401|3859471|FG000|STARTED|Overall Study||217
3134562|NCT01701401|3859472|FG001|STARTED|Overall Study||218
3134563|NCT01701401|3859473|FG002|STARTED|Overall Study||217
3134564|NCT01701401|3859474|FG003|STARTED|Overall Study||218
3134565|NCT01701401|3859471|FG000|COMPLETED|Overall Study||207
3134566|NCT01701401|3859472|FG001|COMPLETED|Overall Study||209
3134567|NCT01701401|3859473|FG002|COMPLETED|Overall Study||212
3134568|NCT01701401|3859474|FG003|COMPLETED|Overall Study||212
3134569|NCT01701401|3859471|FG000|NOT COMPLETED|Overall Study||10
3134570|NCT01701401|3859472|FG001|NOT COMPLETED|Overall Study||9
3134571|NCT01701401|3859473|FG002|NOT COMPLETED|Overall Study||5
3134572|NCT01701401|3859474|FG003|NOT COMPLETED|Overall Study||6
3134573|NCT01701414|3859486|FG000|STARTED|Overall Study||19
3134574|NCT01701414|3859487|FG001|STARTED|Overall Study||19
3134575|NCT01701414|3859486|FG000|COMPLETED|Overall Study||18
3134576|NCT01701414|3859487|FG001|COMPLETED|Overall Study||18
3134577|NCT01701414|3859486|FG000|NOT COMPLETED|Overall Study||1
3134578|NCT01701414|3859487|FG001|NOT COMPLETED|Overall Study||1
3134579|NCT01701505|3859499|FG000|STARTED|Overall Study||8
3134580|NCT01701505|3859500|FG001|STARTED|Overall Study||8
3134581|NCT01701505|3859501|FG002|STARTED|Overall Study||8
3134582|NCT01701505|3859502|FG003|STARTED|Overall Study||8
3134583|NCT01701505|3859503|FG004|STARTED|Overall Study||8
3134584|NCT01701505|3859504|FG005|STARTED|Overall Study||8
3134585|NCT01701505|3859499|FG000|COMPLETED|Overall Study||8
3134586|NCT01701505|3859500|FG001|COMPLETED|Overall Study||8
3134587|NCT01701505|3859501|FG002|COMPLETED|Overall Study||8
3134588|NCT01701505|3859502|FG003|COMPLETED|Overall Study||8
3134589|NCT01701505|3859503|FG004|COMPLETED|Overall Study||8
3134590|NCT01701505|3859504|FG005|COMPLETED|Overall Study||8
3134591|NCT01701505|3859499|FG000|NOT COMPLETED|Overall Study||0
3134592|NCT01701505|3859500|FG001|NOT COMPLETED|Overall Study||0
3134593|NCT01701505|3859501|FG002|NOT COMPLETED|Overall Study||0
3134594|NCT01701505|3859502|FG003|NOT COMPLETED|Overall Study||0
3134595|NCT01701505|3859503|FG004|NOT COMPLETED|Overall Study||0
3134596|NCT01701505|3859504|FG005|NOT COMPLETED|Overall Study||0
3134597|NCT01701973|3859521|FG000|STARTED|Aim 1: First Intervention (1 Day)||23
3134598|NCT01701973|3859522|FG001|STARTED|Aim 1: First Intervention (1 Day)||21
3134599|NCT01701973|3859523|FG002|STARTED|Aim 1: First Intervention (1 Day)||0
3134600|NCT01701973|3859524|FG003|STARTED|Aim 1: First Intervention (1 Day)||0
3134601|NCT01701973|3859525|FG004|STARTED|Aim 1: First Intervention (1 Day)||0
3134602|NCT01701973|3859526|FG005|STARTED|Aim 1: First Intervention (1 Day)||0
3134603|NCT01701973|3859527|FG006|STARTED|Aim 1: First Intervention (1 Day)||0
3134604|NCT01701973|3859528|FG007|STARTED|Aim 1: First Intervention (1 Day)||0
3134605|NCT01701973|3859521|FG000|COMPLETED|Aim 1: First Intervention (1 Day)||23
3134606|NCT01701973|3859522|FG001|COMPLETED|Aim 1: First Intervention (1 Day)||20
3134607|NCT01701973|3859523|FG002|COMPLETED|Aim 1: First Intervention (1 Day)||0
3134608|NCT01701973|3859524|FG003|COMPLETED|Aim 1: First Intervention (1 Day)||0
3134609|NCT01701973|3859525|FG004|COMPLETED|Aim 1: First Intervention (1 Day)||0
3134610|NCT01701973|3859526|FG005|COMPLETED|Aim 1: First Intervention (1 Day)||0
3134611|NCT01701973|3859527|FG006|COMPLETED|Aim 1: First Intervention (1 Day)||0
3134612|NCT01701973|3859528|FG007|COMPLETED|Aim 1: First Intervention (1 Day)||0
3134613|NCT01701973|3859521|FG000|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0
3134614|NCT01701973|3859522|FG001|NOT COMPLETED|Aim 1: First Intervention (1 Day)||1
3134615|NCT01701973|3859523|FG002|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0
3134616|NCT01701973|3859524|FG003|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0
3074613|NCT01346189|3796092|FG000|STARTED|Overall Study||433
3074614|NCT01346189|3796093|FG001|STARTED|Overall Study||358
3074615|NCT01346189|3796094|FG002|STARTED|Overall Study||346
3074616|NCT01346189|3796095|FG003|STARTED|Overall Study||366
3074617|NCT01346189|3796092|FG000|COMPLETED|Overall Study|433 patients (64 primary care physicians) included in analysis|417
3074618|NCT01346189|3796093|FG001|COMPLETED|Overall Study|358 Patients (58 primary care physicians) included in analysis|341
3074619|NCT01346189|3796094|FG002|COMPLETED|Overall Study|346 patients (58 primary care physicians) included in analysis|332
3074620|NCT01346189|3796095|FG003|COMPLETED|Overall Study|366 patients (58 primary care physicians) included in analysis|355
3074621|NCT01346189|3796092|FG000|NOT COMPLETED|Overall Study||16
3074622|NCT01346189|3796093|FG001|NOT COMPLETED|Overall Study||17
3074623|NCT01346189|3796094|FG002|NOT COMPLETED|Overall Study||14
3074624|NCT01346189|3796095|FG003|NOT COMPLETED|Overall Study||11
3074625|NCT01346267|3796107|FG000|STARTED|Overall Study||93
3074626|NCT01346267|3796108|FG001|STARTED|Overall Study||94
3074627|NCT01346267|3796107|FG000|COMPLETED|Overall Study||70
3074628|NCT01346267|3796108|FG001|COMPLETED|Overall Study||67
3074629|NCT01346267|3796107|FG000|NOT COMPLETED|Overall Study||23
3074630|NCT01346267|3796108|FG001|NOT COMPLETED|Overall Study||27
3074631|NCT01346293|3796116|FG000|STARTED|Overall Study||2743
3074632|NCT01346293|3796117|FG001|STARTED|Overall Study||629
3074633|NCT01346293|3796116|FG000|COMPLETED|Overall Study||2676
3074634|NCT01346293|3796117|FG001|COMPLETED|Overall Study||608
3284676|NCT02765490|4018348|FG001|NOT COMPLETED|Overall Study||3
3284677|NCT02766023|4018356|FG000|STARTED|Overall Study||152
3284678|NCT02766023|4018357|FG001|STARTED|Overall Study||76
3284679|NCT02766023|4018356|FG000|COMPLETED|Overall Study||122
3284680|NCT02766023|4018357|FG001|COMPLETED|Overall Study||59
3284681|NCT02766023|4018356|FG000|NOT COMPLETED|Overall Study||30
3284682|NCT02766023|4018357|FG001|NOT COMPLETED|Overall Study||17
3284683|NCT02766088|4018363|FG000|STARTED|Overall Study||850
3284684|NCT02766088|4018363|FG000|COMPLETED|Overall Study||344
3284685|NCT02766088|4018363|FG000|NOT COMPLETED|Overall Study||506
3074635|NCT01346293|3796116|FG000|NOT COMPLETED|Overall Study||67
3074636|NCT01346293|3796117|FG001|NOT COMPLETED|Overall Study||21
3074637|NCT01346371|3796127|FG000|STARTED|Overall Study||20
3074638|NCT01346371|3796128|FG001|STARTED|Overall Study||20
3074639|NCT01346371|3796127|FG000|COMPLETED|Overall Study||18
3074640|NCT01346371|3796128|FG001|COMPLETED|Overall Study||20
3074641|NCT01346371|3796127|FG000|NOT COMPLETED|Overall Study||2
3074642|NCT01346371|3796128|FG001|NOT COMPLETED|Overall Study||0
3074643|NCT01346397|3796136|FG000|STARTED|Overall Study||85
3074644|NCT01346397|3796137|FG001|STARTED|Overall Study||85
3074645|NCT01346397|3796136|FG000|COMPLETED|Overall Study||85
3074646|NCT01346397|3796137|FG001|COMPLETED|Overall Study||85
3074647|NCT01346397|3796136|FG000|NOT COMPLETED|Overall Study||0
3074648|NCT01346397|3796137|FG001|NOT COMPLETED|Overall Study||0
3074649|NCT01346410|3796143|FG000|STARTED|Overall Study||1
3074650|NCT01346410|3796143|FG000|COMPLETED|Overall Study||0
3074651|NCT01346410|3796143|FG000|NOT COMPLETED|Overall Study||1
3074652|NCT01346475|3796149|FG000|STARTED|First Intervention||22
3074653|NCT01346475|3796150|FG001|STARTED|First Intervention||28
3074654|NCT01346475|3796149|FG000|COMPLETED|First Intervention||18
3074655|NCT01346475|3796150|FG001|COMPLETED|First Intervention||25
3074656|NCT01346475|3796149|FG000|NOT COMPLETED|First Intervention||4
3074657|NCT01346475|3796150|FG001|NOT COMPLETED|First Intervention||3
3074658|NCT01346475|3796149|FG000|STARTED|Second Intervention||18
3074659|NCT01346475|3796150|FG001|STARTED|Second Intervention||25
3074660|NCT01346475|3796149|FG000|COMPLETED|Second Intervention||18
3074661|NCT01346475|3796150|FG001|COMPLETED|Second Intervention||25
3074662|NCT01346475|3796149|FG000|NOT COMPLETED|Second Intervention||0
3074663|NCT01346475|3796150|FG001|NOT COMPLETED|Second Intervention||0
3074664|NCT01346488|3796156|FG000|STARTED|Overall Study||1968
3074665|NCT01346488|3796156|FG000|COMPLETED|Overall Study||1262
3074666|NCT01346488|3796156|FG000|NOT COMPLETED|Overall Study||706
3074667|NCT01346501|3796162|FG000|STARTED|Overall Study||79
3074668|NCT01346501|3796163|FG001|STARTED|Overall Study||93
3074669|NCT01346501|3796162|FG000|COMPLETED|Overall Study||68
3074670|NCT01346501|3796163|FG001|COMPLETED|Overall Study||80
3074671|NCT01346501|3796162|FG000|NOT COMPLETED|Overall Study||11
3074672|NCT01346501|3796163|FG001|NOT COMPLETED|Overall Study||13
3074673|NCT01346514|3796173|FG000|STARTED|Overall Study||91
3074674|NCT01346514|3796174|FG001|STARTED|Overall Study||90
3074675|NCT01346514|3796173|FG000|3 Month Assessment|Overall Study||83
3074676|NCT01346514|3796174|FG001|3 Month Assessment|Overall Study||68
3074677|NCT01346514|3796173|FG000|6 Month Assessment|Overall Study||74
3074678|NCT01346514|3796174|FG001|6 Month Assessment|Overall Study||61
3074679|NCT01346514|3796173|FG000|9 Month Assessment|Overall Study||67
3074680|NCT01346514|3796174|FG001|9 Month Assessment|Overall Study||59
3074681|NCT01346514|3796173|FG000|12 Month Assessment|Overall Study||62
3074682|NCT01346514|3796174|FG001|12 Month Assessment|Overall Study||53
3074683|NCT01346514|3796173|FG000|COMPLETED|Overall Study|Number of patients completing BL-12 months|62
3074684|NCT01346514|3796174|FG001|COMPLETED|Overall Study|Number of patients completing BL-12 months.|53
3074685|NCT01346514|3796173|FG000|NOT COMPLETED|Overall Study||29
3074686|NCT01346514|3796174|FG001|NOT COMPLETED|Overall Study||37
3074687|NCT01346540|3796184|FG000|STARTED|Overall Study||4
3074688|NCT01346540|3796185|FG001|STARTED|Overall Study||12
3074689|NCT01346540|3796184|FG000|COMPLETED|Overall Study||1
3284686|NCT02766244|4018367|FG000|STARTED|Overall Study||3
3074690|NCT01346540|3796185|FG001|COMPLETED|Overall Study||0
3074691|NCT01346540|3796184|FG000|NOT COMPLETED|Overall Study||3
3074692|NCT01346540|3796185|FG001|NOT COMPLETED|Overall Study||12
3074693|NCT01346592|3796195|FG000|STARTED|Overall Study||3136
3074694|NCT01346592|3796196|FG001|STARTED|Overall Study||1478
3074695|NCT01346592|3796197|FG002|STARTED|Overall Study||1486
3074696|NCT01346592|3796195|FG000|COMPLETED|Overall Study||2983
3074697|NCT01346592|3796196|FG001|COMPLETED|Overall Study||1389
3074698|NCT01346592|3796197|FG002|COMPLETED|Overall Study||1408
3074699|NCT01346592|3796195|FG000|NOT COMPLETED|Overall Study||153
3074700|NCT01346592|3796196|FG001|NOT COMPLETED|Overall Study||89
3074701|NCT01346592|3796197|FG002|NOT COMPLETED|Overall Study||78
3074702|NCT01346683|3796222|FG000|STARTED|Overall Study||45
3074703|NCT01346683|3796222|FG000|COMPLETED|Overall Study||45
3074704|NCT01346683|3796222|FG000|NOT COMPLETED|Overall Study||0
3074705|NCT01346696|3796226|FG000|STARTED|Overall Study||45
3074706|NCT01346696|3796226|FG000|COMPLETED|Overall Study||44
3074707|NCT01346696|3796226|FG000|NOT COMPLETED|Overall Study||1
3074708|NCT01346774|3796232|FG000|STARTED|Overall Study||80
3074709|NCT01346774|3796233|FG001|STARTED|Overall Study||80
3074710|NCT01346774|3796232|FG000|COMPLETED|Overall Study||67
3074711|NCT01346774|3796233|FG001|COMPLETED|Overall Study||63
3074712|NCT01346774|3796232|FG000|NOT COMPLETED|Overall Study||13
3074713|NCT01346774|3796233|FG001|NOT COMPLETED|Overall Study||17
3074714|NCT01346839|3796241|FG000|STARTED|Overall Study||683
3074715|NCT01346839|3796242|FG001|STARTED|Overall Study||573
3074716|NCT01346839|3796241|FG000|COMPLETED|Overall Study||369
3074717|NCT01346839|3796242|FG001|COMPLETED|Overall Study|All triggers were applied retrospectively on 7/19/2012.|364
3074718|NCT01346839|3796241|FG000|NOT COMPLETED|Overall Study||314
3074719|NCT01346839|3796242|FG001|NOT COMPLETED|Overall Study||209
3074720|NCT01346852|3796250|FG000|STARTED|Overall Study||41753
3074721|NCT01346852|3796251|FG001|STARTED|Overall Study||59684
3074722|NCT01346852|3796250|FG000|COMPLETED|Overall Study||41753
3074723|NCT01346852|3796251|FG001|COMPLETED|Overall Study||59684
3074724|NCT01346852|3796250|FG000|NOT COMPLETED|Overall Study||0
3074725|NCT01346852|3796251|FG001|NOT COMPLETED|Overall Study||0
3074726|NCT01346969|3796261|FG000|STARTED|Overall Study||28
3074727|NCT01346969|3796262|FG001|STARTED|Overall Study||14
3074728|NCT01346969|3796263|FG002|STARTED|Overall Study||13
3074729|NCT01346969|3796264|FG003|STARTED|Overall Study||13
3074730|NCT01346969|3796261|FG000|Safety Population|Overall Study||27
3074731|NCT01346969|3796262|FG001|Safety Population|Overall Study||14
3074732|NCT01346969|3796263|FG002|Safety Population|Overall Study||13
3074733|NCT01346969|3796264|FG003|Safety Population|Overall Study||13
3074734|NCT01346969|3796261|FG000|COMPLETED|Overall Study||26
3074735|NCT01346969|3796262|FG001|COMPLETED|Overall Study||14
3074736|NCT01346969|3796263|FG002|COMPLETED|Overall Study||10
3074737|NCT01346969|3796264|FG003|COMPLETED|Overall Study||12
3074738|NCT01346969|3796261|FG000|NOT COMPLETED|Overall Study||2
3074739|NCT01346969|3796262|FG001|NOT COMPLETED|Overall Study||0
3074740|NCT01346969|3796263|FG002|NOT COMPLETED|Overall Study||3
3074741|NCT01346969|3796264|FG003|NOT COMPLETED|Overall Study||1
3074742|NCT01347008|3796276|FG000|STARTED|Overall Study||21
3074743|NCT01347008|3796277|FG001|STARTED|Overall Study||20
3074744|NCT01347008|3796276|FG000|COMPLETED|Overall Study||21
3074745|NCT01347008|3796277|FG001|COMPLETED|Overall Study||20
3074746|NCT01347008|3796276|FG000|NOT COMPLETED|Overall Study||0
3074747|NCT01347008|3796277|FG001|NOT COMPLETED|Overall Study||0
3074748|NCT01347034|3796285|FG000|STARTED|Overall Study||6
3074749|NCT01347034|3796286|FG001|STARTED|Overall Study||14
3074750|NCT01347034|3796285|FG000|COMPLETED|Overall Study||6
3074751|NCT01347034|3796286|FG001|COMPLETED|Overall Study||14
3074752|NCT01347034|3796285|FG000|NOT COMPLETED|Overall Study||0
3074753|NCT01347034|3796286|FG001|NOT COMPLETED|Overall Study||0
3074754|NCT01347060|3796294|FG000|STARTED|Overall Study||9868
3074755|NCT01347060|3796295|FG001|STARTED|Overall Study||7580
3074756|NCT01347060|3796294|FG000|COMPLETED|Overall Study||9868
3074757|NCT01347060|3796295|FG001|COMPLETED|Overall Study||7580
3074758|NCT01347060|3796294|FG000|NOT COMPLETED|Overall Study||0
3074759|NCT01347060|3796295|FG001|NOT COMPLETED|Overall Study||0
3074760|NCT01347073|3796301|FG000|STARTED|Overall Study||23
3074761|NCT01347073|3796301|FG000|COMPLETED|Overall Study||21
3074762|NCT01347073|3796301|FG000|NOT COMPLETED|Overall Study||2
3074763|NCT01347086|3796321|FG000|STARTED|Overall Study||2
3074764|NCT01347086|3796322|FG001|STARTED|Overall Study||6
3074765|NCT01347086|3796323|FG002|STARTED|Overall Study|"2 participants were treated together with each dose level of Deleobuvir.~1 subject was not treated."|7
3074766|NCT01347086|3796324|FG003|STARTED|Overall Study||6
3074767|NCT01347086|3796325|FG004|STARTED|Overall Study||6
3074768|NCT01347086|3796326|FG005|STARTED|Overall Study||6
3074769|NCT01347086|3796327|FG006|STARTED|Overall Study|"2 participants treated together with each dose level of Deleobuvir.~1 subject was not treated."|7
3074770|NCT01347086|3796328|FG007|STARTED|Overall Study|One subject was not treated.|7
3074771|NCT01347086|3796329|FG008|STARTED|Overall Study||6
3074772|NCT01347086|3796330|FG009|STARTED|Overall Study|One subject was not treated.|7
3074773|NCT01347086|3796321|FG000|COMPLETED|Overall Study||2
3074774|NCT01347086|3796322|FG001|COMPLETED|Overall Study||6
3074775|NCT01347086|3796323|FG002|COMPLETED|Overall Study||6
3074776|NCT01347086|3796324|FG003|COMPLETED|Overall Study||6
3074777|NCT01347086|3796325|FG004|COMPLETED|Overall Study||6
3074778|NCT01347086|3796326|FG005|COMPLETED|Overall Study||6
3074779|NCT01347086|3796327|FG006|COMPLETED|Overall Study||6
3074780|NCT01347086|3796328|FG007|COMPLETED|Overall Study||6
3074781|NCT01347086|3796329|FG008|COMPLETED|Overall Study||6
3074782|NCT01347086|3796330|FG009|COMPLETED|Overall Study||6
3074783|NCT01347086|3796321|FG000|NOT COMPLETED|Overall Study||0
3074784|NCT01347086|3796322|FG001|NOT COMPLETED|Overall Study||0
3074785|NCT01347086|3796323|FG002|NOT COMPLETED|Overall Study||1
3074786|NCT01347086|3796324|FG003|NOT COMPLETED|Overall Study||0
3074787|NCT01347086|3796325|FG004|NOT COMPLETED|Overall Study||0
3074788|NCT01347086|3796326|FG005|NOT COMPLETED|Overall Study||0
3074789|NCT01347086|3796327|FG006|NOT COMPLETED|Overall Study||1
3074790|NCT01347086|3796328|FG007|NOT COMPLETED|Overall Study||1
3074791|NCT01347086|3796329|FG008|NOT COMPLETED|Overall Study||0
3074792|NCT01347086|3796330|FG009|NOT COMPLETED|Overall Study||1
3074793|NCT01347112|3796364|FG000|STARTED|Overall Study||16
3074794|NCT01347112|3796365|FG001|STARTED|Overall Study||17
3074795|NCT01347112|3796364|FG000|COMPLETED|Overall Study||12
3074796|NCT01347112|3796365|FG001|COMPLETED|Overall Study||5
3074797|NCT01347112|3796364|FG000|NOT COMPLETED|Overall Study||4
3074798|NCT01347112|3796365|FG001|NOT COMPLETED|Overall Study||12
3074799|NCT01347255|3796372|FG000|STARTED|Overall Study||24
3074800|NCT01347255|3796372|FG000|COMPLETED|Overall Study||24
3074801|NCT01347255|3796372|FG000|NOT COMPLETED|Overall Study||0
3074802|NCT01347307|3796381|FG000|STARTED|Overall Study||3
3074803|NCT01347307|3796382|FG001|STARTED|Overall Study||33
3074804|NCT01347307|3796381|FG000|COMPLETED|Overall Study||3
3074805|NCT01347307|3796382|FG001|COMPLETED|Overall Study||28
3074806|NCT01347307|3796381|FG000|NOT COMPLETED|Overall Study||0
3074807|NCT01347307|3796382|FG001|NOT COMPLETED|Overall Study||5
3074808|NCT01347333|3796390|FG000|STARTED|Overall Study||23
3074809|NCT01347333|3796391|FG001|STARTED|Overall Study|No participants were enrolled in the Primary Liver Tumor arm.|0
3074810|NCT01347333|3796390|FG000|COMPLETED|Overall Study||23
3074811|NCT01347333|3796391|FG001|COMPLETED|Overall Study||0
3074812|NCT01347333|3796390|FG000|NOT COMPLETED|Overall Study||0
3074813|NCT01347333|3796391|FG001|NOT COMPLETED|Overall Study||0
3074814|NCT01347541|3796399|FG000|STARTED|Overall Study||3
3074815|NCT01347541|3796400|FG001|STARTED|Overall Study||1
3074816|NCT01347541|3796399|FG000|COMPLETED|Overall Study||3
3074817|NCT01347541|3796400|FG001|COMPLETED|Overall Study||1
3074818|NCT01347541|3796399|FG000|NOT COMPLETED|Overall Study||0
3074819|NCT01347541|3796400|FG001|NOT COMPLETED|Overall Study||0
3074820|NCT01347554|3796408|FG000|STARTED|Overall Study||237
3074821|NCT01347554|3796409|FG001|STARTED|Overall Study||242
3074822|NCT01347554|3796408|FG000|COMPLETED|Overall Study|Final TIMI flow grade 0 or 1 patients or failed PCI cases (N=7) were excluded.|230
3074823|NCT01347554|3796409|FG001|COMPLETED|Overall Study|Final TIMI flow grade 0 or 1 patients or failed PCI cases (N=11) were excluded.|231
3074824|NCT01347554|3796408|FG000|NOT COMPLETED|Overall Study||7
3074825|NCT01347554|3796409|FG001|NOT COMPLETED|Overall Study||11
3074826|NCT01347580|3796417|FG000|STARTED|Overall Study|based on randomized treatment|909
3074827|NCT01347580|3796418|FG001|STARTED|Overall Study|based on randomized treatment|953
3074828|NCT01347580|3796417|FG000|Modified Intent to Treat Population|Overall Study|based on randomized treatment|906
3074829|NCT01347580|3796418|FG001|Modified Intent to Treat Population|Overall Study|based on randomized treatment|952
3074830|NCT01347580|3796417|FG000|Safety Population|Overall Study|based on actual treatment|908
3074831|NCT01347580|3796418|FG001|Safety Population|Overall Study|based on actual treatment|950
3074832|NCT01347580|3796417|FG000|COMPLETED|Overall Study|based on randomized treatment|844
3074833|NCT01347580|3796418|FG001|COMPLETED|Overall Study|based on randomized treatment|897
3074834|NCT01347580|3796417|FG000|NOT COMPLETED|Overall Study||65
3074835|NCT01347580|3796418|FG001|NOT COMPLETED|Overall Study||56
3074836|NCT01347710|3796424|FG000|STARTED|Overall Study||795
3074837|NCT01347710|3796424|FG000|COMPLETED|Overall Study||764
3074838|NCT01347710|3796424|FG000|NOT COMPLETED|Overall Study||31
3074839|NCT01347762|3796436|FG000|STARTED|Overall Study||10
3074840|NCT01347762|3796437|FG001|STARTED|Overall Study||8
3074841|NCT01347762|3796438|FG002|STARTED|Overall Study||16
3074842|NCT01347762|3796439|FG003|STARTED|Overall Study||18
3074843|NCT01347762|3796436|FG000|COMPLETED|Overall Study||6
3074844|NCT01347762|3796437|FG001|COMPLETED|Overall Study||6
3074845|NCT01347762|3796438|FG002|COMPLETED|Overall Study||7
3074846|NCT01347762|3796439|FG003|COMPLETED|Overall Study||10
3074847|NCT01347762|3796436|FG000|NOT COMPLETED|Overall Study||4
3074848|NCT01347762|3796437|FG001|NOT COMPLETED|Overall Study||2
3074849|NCT01347762|3796438|FG002|NOT COMPLETED|Overall Study||9
3074850|NCT01347762|3796439|FG003|NOT COMPLETED|Overall Study||8
3074851|NCT01347788|3796449|FG000|STARTED|Overall Study||11
3074852|NCT01347788|3796450|FG001|STARTED|Overall Study||10
3074853|NCT01347788|3796451|FG002|STARTED|Overall Study||13
3074854|NCT01347788|3796449|FG000|COMPLETED|Overall Study||11
3074855|NCT01347788|3796450|FG001|COMPLETED|Overall Study||10
3074856|NCT01347788|3796451|FG002|COMPLETED|Overall Study||13
3074857|NCT01347788|3796449|FG000|NOT COMPLETED|Overall Study||0
3074858|NCT01347788|3796450|FG001|NOT COMPLETED|Overall Study||0
3074859|NCT01347788|3796451|FG002|NOT COMPLETED|Overall Study||0
3074860|NCT01347866|3796476|FG000|STARTED|Overall Study||5
3074861|NCT01347866|3796477|FG001|STARTED|Overall Study||1
3074862|NCT01347866|3796478|FG002|STARTED|Overall Study||1
3074863|NCT01347866|3796479|FG003|STARTED|Overall Study||7
3074864|NCT01347866|3796480|FG004|STARTED|Overall Study||7
3074865|NCT01347866|3796481|FG005|STARTED|Overall Study||3
3074866|NCT01347866|3796482|FG006|STARTED|Overall Study||6
3074867|NCT01347866|3796483|FG007|STARTED|Overall Study||4
3074868|NCT01347866|3796484|FG008|STARTED|Overall Study||31
3074869|NCT01347866|3796485|FG009|STARTED|Overall Study||7
3074870|NCT01347866|3796486|FG010|STARTED|Overall Study||3
3074871|NCT01347866|3796487|FG011|STARTED|Overall Study||4
3074872|NCT01347866|3796488|FG012|STARTED|Overall Study||7
3074873|NCT01347866|3796489|FG013|STARTED|Overall Study||7
3074874|NCT01347866|3796490|FG014|STARTED|Overall Study||3
3074875|NCT01347866|3796491|FG015|STARTED|Overall Study||4
3074876|NCT01347866|3796492|FG016|STARTED|Overall Study||2
3074877|NCT01347866|3796476|FG000|COMPLETED|Overall Study||0
3074878|NCT01347866|3796477|FG001|COMPLETED|Overall Study||0
3074879|NCT01347866|3796478|FG002|COMPLETED|Overall Study||0
3074880|NCT01347866|3796479|FG003|COMPLETED|Overall Study||0
3074881|NCT01347866|3796480|FG004|COMPLETED|Overall Study||0
3074882|NCT01347866|3796481|FG005|COMPLETED|Overall Study||0
3074883|NCT01347866|3796482|FG006|COMPLETED|Overall Study||0
3074884|NCT01347866|3796483|FG007|COMPLETED|Overall Study||0
3074885|NCT01347866|3796484|FG008|COMPLETED|Overall Study||0
3074886|NCT01347866|3796485|FG009|COMPLETED|Overall Study||0
3074887|NCT01347866|3796486|FG010|COMPLETED|Overall Study||0
3074888|NCT01347866|3796487|FG011|COMPLETED|Overall Study||0
3074889|NCT01347866|3796488|FG012|COMPLETED|Overall Study||0
3074890|NCT01347866|3796489|FG013|COMPLETED|Overall Study||0
3074891|NCT01347866|3796490|FG014|COMPLETED|Overall Study||0
3074892|NCT01347866|3796491|FG015|COMPLETED|Overall Study||0
3074893|NCT01347866|3796492|FG016|COMPLETED|Overall Study||0
3074894|NCT01347866|3796476|FG000|NOT COMPLETED|Overall Study||5
3074895|NCT01347866|3796477|FG001|NOT COMPLETED|Overall Study||1
3074896|NCT01347866|3796478|FG002|NOT COMPLETED|Overall Study||1
3074897|NCT01347866|3796479|FG003|NOT COMPLETED|Overall Study||7
3074898|NCT01347866|3796480|FG004|NOT COMPLETED|Overall Study||7
3074899|NCT01347866|3796481|FG005|NOT COMPLETED|Overall Study||3
3074900|NCT01347866|3796482|FG006|NOT COMPLETED|Overall Study||6
3074901|NCT01347866|3796483|FG007|NOT COMPLETED|Overall Study||4
3074902|NCT01347866|3796484|FG008|NOT COMPLETED|Overall Study||31
3074903|NCT01347866|3796485|FG009|NOT COMPLETED|Overall Study||7
3074904|NCT01347866|3796486|FG010|NOT COMPLETED|Overall Study||3
3074905|NCT01347866|3796487|FG011|NOT COMPLETED|Overall Study||4
3074906|NCT01347866|3796488|FG012|NOT COMPLETED|Overall Study||7
3074907|NCT01347866|3796489|FG013|NOT COMPLETED|Overall Study||7
3074908|NCT01347866|3796490|FG014|NOT COMPLETED|Overall Study||3
3074909|NCT01347866|3796491|FG015|NOT COMPLETED|Overall Study||4
3074910|NCT01347866|3796492|FG016|NOT COMPLETED|Overall Study||2
3074911|NCT01347879|3796565|FG000|STARTED|Overall Study||53
3074912|NCT01347879|3796566|FG001|STARTED|Overall Study||100
3074913|NCT01347879|3796565|FG000|COMPLETED|Overall Study||46
3074914|NCT01347879|3796566|FG001|COMPLETED|Overall Study||83
3074915|NCT01347879|3796565|FG000|NOT COMPLETED|Overall Study||7
3074916|NCT01347879|3796566|FG001|NOT COMPLETED|Overall Study||17
3074917|NCT01347931|3796572|FG000|STARTED|Standard Oxygen Therapy||30
3074918|NCT01347931|3796572|FG000|COMPLETED|Standard Oxygen Therapy||29
3074919|NCT01347931|3796572|FG000|NOT COMPLETED|Standard Oxygen Therapy||1
3074920|NCT01347931|3796572|FG000|STARTED|NIOV System||29
3074921|NCT01347931|3796572|FG000|COMPLETED|NIOV System||29
3074922|NCT01347931|3796572|FG000|NOT COMPLETED|NIOV System||0
3074923|NCT01348087|3796578|FG000|STARTED|Overall Study||148
3074924|NCT01348087|3796578|FG000|COMPLETED|Overall Study||0
3074925|NCT01348087|3796578|FG000|NOT COMPLETED|Overall Study||148
3074926|NCT01348100|3796599|FG000|STARTED|Overall Study||2
3074927|NCT01348100|3796600|FG001|STARTED|Overall Study||2
3074928|NCT01348100|3796601|FG002|STARTED|Overall Study||15
3074929|NCT01348100|3796602|FG003|STARTED|Overall Study||15
3074930|NCT01348100|3796603|FG004|STARTED|Overall Study||15
3074931|NCT01348100|3796604|FG005|STARTED|Overall Study||16
3074932|NCT01348100|3796605|FG006|STARTED|Overall Study||16
3074933|NCT01348100|3796599|FG000|COMPLETED|Overall Study||2
3074934|NCT01348100|3796600|FG001|COMPLETED|Overall Study||2
3074935|NCT01348100|3796601|FG002|COMPLETED|Overall Study||13
3074936|NCT01348100|3796602|FG003|COMPLETED|Overall Study||14
3074937|NCT01348100|3796603|FG004|COMPLETED|Overall Study||14
3074938|NCT01348100|3796604|FG005|COMPLETED|Overall Study||14
3074939|NCT01348100|3796605|FG006|COMPLETED|Overall Study||13
3074940|NCT01348100|3796599|FG000|NOT COMPLETED|Overall Study||0
3074941|NCT01348100|3796600|FG001|NOT COMPLETED|Overall Study||0
3074942|NCT01348100|3796601|FG002|NOT COMPLETED|Overall Study||2
3074943|NCT01348100|3796602|FG003|NOT COMPLETED|Overall Study||1
3074944|NCT01348100|3796603|FG004|NOT COMPLETED|Overall Study||1
3074945|NCT01348100|3796604|FG005|NOT COMPLETED|Overall Study||2
3074946|NCT01348100|3796605|FG006|NOT COMPLETED|Overall Study||3
3074947|NCT01348139|3796626|FG000|STARTED|Period 1||5
3074948|NCT01348139|3796627|FG001|STARTED|Period 1||4
3074949|NCT01348139|3796628|FG002|STARTED|Period 1||4
3074950|NCT01348139|3796629|FG003|STARTED|Period 1||4
3074951|NCT01348139|3796630|FG004|STARTED|Period 1||5
3074952|NCT01348139|3796631|FG005|STARTED|Period 1||4
3074953|NCT01348139|3796626|FG000|COMPLETED|Period 1||4
3074954|NCT01348139|3796627|FG001|COMPLETED|Period 1||4
3074955|NCT01348139|3796628|FG002|COMPLETED|Period 1||4
3074956|NCT01348139|3796629|FG003|COMPLETED|Period 1||4
3074957|NCT01348139|3796630|FG004|COMPLETED|Period 1||5
3074958|NCT01348139|3796631|FG005|COMPLETED|Period 1||4
3074959|NCT01348139|3796626|FG000|NOT COMPLETED|Period 1||1
3074960|NCT01348139|3796627|FG001|NOT COMPLETED|Period 1||0
3074961|NCT01348139|3796628|FG002|NOT COMPLETED|Period 1||0
3074962|NCT01348139|3796629|FG003|NOT COMPLETED|Period 1||0
3074963|NCT01348139|3796630|FG004|NOT COMPLETED|Period 1||0
3074964|NCT01348139|3796631|FG005|NOT COMPLETED|Period 1||0
3074965|NCT01348139|3796626|FG000|STARTED|Period 2||4
3074966|NCT01348139|3796627|FG001|STARTED|Period 2||4
3074967|NCT01348139|3796628|FG002|STARTED|Period 2||4
3074968|NCT01348139|3796629|FG003|STARTED|Period 2||4
3074969|NCT01348139|3796630|FG004|STARTED|Period 2||5
3074970|NCT01348139|3796631|FG005|STARTED|Period 2||4
3074971|NCT01348139|3796626|FG000|COMPLETED|Period 2||4
3074972|NCT01348139|3796627|FG001|COMPLETED|Period 2||4
3074973|NCT01348139|3796628|FG002|COMPLETED|Period 2||4
3074974|NCT01348139|3796629|FG003|COMPLETED|Period 2||4
3074975|NCT01348139|3796630|FG004|COMPLETED|Period 2||5
3074976|NCT01348139|3796631|FG005|COMPLETED|Period 2||4
3074977|NCT01348139|3796626|FG000|NOT COMPLETED|Period 2||0
3074978|NCT01348139|3796627|FG001|NOT COMPLETED|Period 2||0
3074979|NCT01348139|3796628|FG002|NOT COMPLETED|Period 2||0
3074980|NCT01348139|3796629|FG003|NOT COMPLETED|Period 2||0
3074981|NCT01348139|3796630|FG004|NOT COMPLETED|Period 2||0
3074982|NCT01348139|3796631|FG005|NOT COMPLETED|Period 2||0
3074983|NCT01348139|3796626|FG000|STARTED|Period 3||4
3074984|NCT01348139|3796627|FG001|STARTED|Period 3||4
3074985|NCT01348139|3796628|FG002|STARTED|Period 3||4
3074986|NCT01348139|3796629|FG003|STARTED|Period 3||4
3074987|NCT01348139|3796630|FG004|STARTED|Period 3||5
3074988|NCT01348139|3796631|FG005|STARTED|Period 3||4
3074989|NCT01348139|3796626|FG000|COMPLETED|Period 3||4
3074990|NCT01348139|3796627|FG001|COMPLETED|Period 3||4
3074991|NCT01348139|3796628|FG002|COMPLETED|Period 3||4
3074992|NCT01348139|3796629|FG003|COMPLETED|Period 3||4
3074993|NCT01348139|3796630|FG004|COMPLETED|Period 3||5
3074994|NCT01348139|3796631|FG005|COMPLETED|Period 3||4
3074995|NCT01348139|3796626|FG000|NOT COMPLETED|Period 3||0
3074996|NCT01348139|3796627|FG001|NOT COMPLETED|Period 3||0
3074997|NCT01348139|3796628|FG002|NOT COMPLETED|Period 3||0
3074998|NCT01348139|3796629|FG003|NOT COMPLETED|Period 3||0
3074999|NCT01348139|3796630|FG004|NOT COMPLETED|Period 3||0
3075000|NCT01348139|3796631|FG005|NOT COMPLETED|Period 3||0
3075001|NCT01348139|3796626|FG000|STARTED|Period 4||4
3075002|NCT01348139|3796627|FG001|STARTED|Period 4||4
3075003|NCT01348139|3796628|FG002|STARTED|Period 4||4
3075004|NCT01348139|3796629|FG003|STARTED|Period 4||4
3075005|NCT01348139|3796630|FG004|STARTED|Period 4||5
3075006|NCT01348139|3796631|FG005|STARTED|Period 4||4
3075007|NCT01348139|3796626|FG000|COMPLETED|Period 4||4
3075008|NCT01348139|3796627|FG001|COMPLETED|Period 4||4
3075009|NCT01348139|3796628|FG002|COMPLETED|Period 4||4
3075010|NCT01348139|3796629|FG003|COMPLETED|Period 4||4
3075011|NCT01348139|3796630|FG004|COMPLETED|Period 4||5
3075012|NCT01348139|3796631|FG005|COMPLETED|Period 4||4
3075013|NCT01348139|3796626|FG000|NOT COMPLETED|Period 4||0
3075014|NCT01348139|3796627|FG001|NOT COMPLETED|Period 4||0
3075015|NCT01348139|3796628|FG002|NOT COMPLETED|Period 4||0
3075016|NCT01348139|3796629|FG003|NOT COMPLETED|Period 4||0
3075017|NCT01348139|3796630|FG004|NOT COMPLETED|Period 4||0
3075018|NCT01348139|3796631|FG005|NOT COMPLETED|Period 4||0
3075019|NCT01348139|3796626|FG000|STARTED|Period 5||4
3075020|NCT01348139|3796627|FG001|STARTED|Period 5||4
3075021|NCT01348139|3796628|FG002|STARTED|Period 5||4
3075022|NCT01348139|3796629|FG003|STARTED|Period 5||4
3075023|NCT01348139|3796630|FG004|STARTED|Period 5||5
3075024|NCT01348139|3796631|FG005|STARTED|Period 5||4
3075025|NCT01348139|3796626|FG000|COMPLETED|Period 5||4
3075026|NCT01348139|3796627|FG001|COMPLETED|Period 5||4
3075027|NCT01348139|3796628|FG002|COMPLETED|Period 5||4
3075028|NCT01348139|3796629|FG003|COMPLETED|Period 5||4
3075029|NCT01348139|3796630|FG004|COMPLETED|Period 5||5
3075030|NCT01348139|3796631|FG005|COMPLETED|Period 5||4
3075031|NCT01348139|3796626|FG000|NOT COMPLETED|Period 5||0
3075032|NCT01348139|3796627|FG001|NOT COMPLETED|Period 5||0
3075033|NCT01348139|3796628|FG002|NOT COMPLETED|Period 5||0
3075034|NCT01348139|3796629|FG003|NOT COMPLETED|Period 5||0
3075035|NCT01348139|3796630|FG004|NOT COMPLETED|Period 5||0
3075036|NCT01348139|3796631|FG005|NOT COMPLETED|Period 5||0
3075037|NCT01348139|3796626|FG000|STARTED|Period 6||4
3075038|NCT01348139|3796627|FG001|STARTED|Period 6||4
3075039|NCT01348139|3796628|FG002|STARTED|Period 6||4
3075040|NCT01348139|3796629|FG003|STARTED|Period 6||4
3075041|NCT01348139|3796630|FG004|STARTED|Period 6||5
3075042|NCT01348139|3796631|FG005|STARTED|Period 6||4
3075043|NCT01348139|3796626|FG000|COMPLETED|Period 6||4
3075044|NCT01348139|3796627|FG001|COMPLETED|Period 6||4
3075045|NCT01348139|3796628|FG002|COMPLETED|Period 6||4
3075046|NCT01348139|3796629|FG003|COMPLETED|Period 6||4
3075047|NCT01348139|3796630|FG004|COMPLETED|Period 6||5
3075048|NCT01348139|3796631|FG005|COMPLETED|Period 6||4
3075049|NCT01348139|3796626|FG000|NOT COMPLETED|Period 6||0
3075050|NCT01348139|3796627|FG001|NOT COMPLETED|Period 6||0
3075051|NCT01348139|3796628|FG002|NOT COMPLETED|Period 6||0
3075052|NCT01348139|3796629|FG003|NOT COMPLETED|Period 6||0
3075053|NCT01348139|3796630|FG004|NOT COMPLETED|Period 6||0
3075054|NCT01348139|3796631|FG005|NOT COMPLETED|Period 6||0
3075055|NCT01348165|3796652|FG000|STARTED|Overall Study||10
3075056|NCT01348165|3796653|FG001|STARTED|Overall Study||5
3075057|NCT01348165|3796654|FG002|STARTED|Overall Study||6
3075058|NCT01348165|3796655|FG003|STARTED|Overall Study||6
3075059|NCT01348165|3796656|FG004|STARTED|Overall Study||6
3075060|NCT01348165|3796657|FG005|STARTED|Overall Study||1
3075061|NCT01348165|3796658|FG006|STARTED|Overall Study||6
3075062|NCT01348165|3796652|FG000|COMPLETED|Overall Study||10
3075063|NCT01348165|3796653|FG001|COMPLETED|Overall Study||5
3075064|NCT01348165|3796654|FG002|COMPLETED|Overall Study||6
3075065|NCT01348165|3796655|FG003|COMPLETED|Overall Study||6
3075066|NCT01348165|3796656|FG004|COMPLETED|Overall Study||6
3075067|NCT01348165|3796657|FG005|COMPLETED|Overall Study||1
3075068|NCT01348165|3796658|FG006|COMPLETED|Overall Study||5
3075069|NCT01348165|3796652|FG000|NOT COMPLETED|Overall Study||0
3075070|NCT01348165|3796653|FG001|NOT COMPLETED|Overall Study||0
3075071|NCT01348165|3796654|FG002|NOT COMPLETED|Overall Study||0
3075072|NCT01348165|3796655|FG003|NOT COMPLETED|Overall Study||0
3075073|NCT01348165|3796656|FG004|NOT COMPLETED|Overall Study||0
3075074|NCT01348165|3796657|FG005|NOT COMPLETED|Overall Study||0
3075075|NCT01348165|3796658|FG006|NOT COMPLETED|Overall Study||1
3075076|NCT01348347|3796681|FG000|STARTED|Overall Study||3
3075077|NCT01348347|3796682|FG001|STARTED|Overall Study||6
3075078|NCT01348347|3796683|FG002|STARTED|Overall Study||6
3075079|NCT01348347|3796681|FG000|COMPLETED|Overall Study||0
3075080|NCT01348347|3796682|FG001|COMPLETED|Overall Study||0
3075081|NCT01348347|3796683|FG002|COMPLETED|Overall Study||0
3075082|NCT01348347|3796681|FG000|NOT COMPLETED|Overall Study||3
3075083|NCT01348347|3796682|FG001|NOT COMPLETED|Overall Study||6
3075084|NCT01348347|3796683|FG002|NOT COMPLETED|Overall Study||6
3075085|NCT01348425|3796694|FG000|STARTED|Overall Study||31
3075086|NCT01348425|3796695|FG001|STARTED|Overall Study||14
3075087|NCT01348425|3796694|FG000|COMPLETED|Overall Study||30
3075088|NCT01348425|3796695|FG001|COMPLETED|Overall Study||13
3075089|NCT01348425|3796694|FG000|NOT COMPLETED|Overall Study||1
3075090|NCT01348425|3796695|FG001|NOT COMPLETED|Overall Study||1
3075091|NCT01348490|3796700|FG000|STARTED|Overall Study||66
3075092|NCT01348490|3796700|FG000|COMPLETED|Overall Study||42
3075093|NCT01348490|3796700|FG000|NOT COMPLETED|Overall Study||24
3075094|NCT01348542|3796723|FG000|STARTED|Overall Study||13
3075095|NCT01348542|3796724|FG001|STARTED|Overall Study||11
3075096|NCT01348542|3796723|FG000|COMPLETED|Overall Study||10
3075097|NCT01348542|3796724|FG001|COMPLETED|Overall Study||11
3075098|NCT01348542|3796723|FG000|NOT COMPLETED|Overall Study||3
3075099|NCT01348542|3796724|FG001|NOT COMPLETED|Overall Study||0
3075100|NCT01348607|3796733|FG000|STARTED|Overall Study||1
3075101|NCT01348607|3796734|FG001|STARTED|Overall Study||0
3075102|NCT01348607|3796735|FG002|STARTED|Overall Study||0
3075103|NCT01348607|3796733|FG000|COMPLETED|Overall Study||1
3075104|NCT01348607|3796734|FG001|COMPLETED|Overall Study||0
3075105|NCT01348607|3796735|FG002|COMPLETED|Overall Study||0
3075106|NCT01348607|3796733|FG000|NOT COMPLETED|Overall Study||0
3075107|NCT01348607|3796734|FG001|NOT COMPLETED|Overall Study||0
3075108|NCT01348607|3796735|FG002|NOT COMPLETED|Overall Study||0
3075109|NCT01348698|3796743|FG000|STARTED|Overall Study||74
3075110|NCT01348698|3796743|FG000|COMPLETED|Overall Study||2
3075111|NCT01348698|3796743|FG000|NOT COMPLETED|Overall Study||72
3075112|NCT01348763|3796747|FG000|STARTED|With Tenofovir/Emtricitabine (10 Days)||13
3075113|NCT01348763|3796747|FG000|COMPLETED|With Tenofovir/Emtricitabine (10 Days)||11
3075114|NCT01348763|3796747|FG000|NOT COMPLETED|With Tenofovir/Emtricitabine (10 Days)||2
3075115|NCT01348763|3796747|FG000|STARTED|Without Tenofovir/Emtricitabine (11 Day)||11
3075116|NCT01348763|3796747|FG000|COMPLETED|Without Tenofovir/Emtricitabine (11 Day)||11
3075117|NCT01348763|3796747|FG000|NOT COMPLETED|Without Tenofovir/Emtricitabine (11 Day)||0
3075118|NCT01348776|3796751|FG000|STARTED|Overall Study|3 subjects were lost to follow-up: 2 after the 1-month follow-up, 1 after performing 4 treatments|87
3075119|NCT01348776|3796751|FG000|COMPLETED|Overall Study||84
3075120|NCT01348776|3796751|FG000|NOT COMPLETED|Overall Study||3
3075121|NCT01348789|3796764|FG000|STARTED|Overall Study||37
3075122|NCT01348789|3796764|FG000|COMPLETED|Overall Study|4 subjects did not complete all 3 treatments but were evaluated for primary and secondary endpoints.|33
3075123|NCT01348789|3796764|FG000|NOT COMPLETED|Overall Study||4
3075124|NCT01348828|3796775|FG000|STARTED|Overall Study||49
3075125|NCT01348828|3796775|FG000|COMPLETED|Overall Study||16
3075126|NCT01348828|3796775|FG000|NOT COMPLETED|Overall Study||33
3075127|NCT01348854|3796781|FG000|STARTED|Overall Study|53 eyes of 34 participants|34
3075128|NCT01348854|3796782|FG001|STARTED|Overall Study|10 eyes of 6 participants|6
3075129|NCT01348854|3796781|FG000|COMPLETED|Overall Study|47 eyes of 31 participants|31
3075130|NCT01348854|3796782|FG001|COMPLETED|Overall Study|9 eyes of 5 participants|5
3075131|NCT01348854|3796781|FG000|NOT COMPLETED|Overall Study||3
3075132|NCT01348854|3796782|FG001|NOT COMPLETED|Overall Study||1
3075133|NCT01349036|3796790|FG000|STARTED|Overall Study||14
3075134|NCT01349036|3796791|FG001|STARTED|Overall Study||24
3075135|NCT01349036|3796790|FG000|COMPLETED|Overall Study||0
3075136|NCT01349036|3796791|FG001|COMPLETED|Overall Study||0
3075137|NCT01349036|3796790|FG000|NOT COMPLETED|Overall Study||14
3075138|NCT01349036|3796791|FG001|NOT COMPLETED|Overall Study||24
3075139|NCT01349049|3796810|FG000|STARTED|Overall Study||3
3075140|NCT01349049|3796811|FG001|STARTED|Overall Study||7
3075141|NCT01349049|3796812|FG002|STARTED|Overall Study||3
3075142|NCT01349049|3796813|FG003|STARTED|Overall Study||3
3075143|NCT01349049|3796814|FG004|STARTED|Overall Study||3
3075144|NCT01349049|3796815|FG005|STARTED|Overall Study||6
3075145|NCT01349049|3796816|FG006|STARTED|Overall Study||5
3075146|NCT01349049|3796817|FG007|STARTED|Overall Study||4
3075147|NCT01349049|3796818|FG008|STARTED|Overall Study||56
3075148|NCT01349049|3796810|FG000|COMPLETED|Overall Study||0
3075149|NCT01349049|3796811|FG001|COMPLETED|Overall Study||0
3075150|NCT01349049|3796812|FG002|COMPLETED|Overall Study||0
3075151|NCT01349049|3796813|FG003|COMPLETED|Overall Study||0
3075152|NCT01349049|3796814|FG004|COMPLETED|Overall Study||0
3075153|NCT01349049|3796815|FG005|COMPLETED|Overall Study||0
3075154|NCT01349049|3796816|FG006|COMPLETED|Overall Study||0
3075155|NCT01349049|3796817|FG007|COMPLETED|Overall Study||0
3075156|NCT01349049|3796818|FG008|COMPLETED|Overall Study||1
3075157|NCT01349049|3796810|FG000|NOT COMPLETED|Overall Study||3
3075158|NCT01349049|3796811|FG001|NOT COMPLETED|Overall Study||7
3075159|NCT01349049|3796812|FG002|NOT COMPLETED|Overall Study||3
3075160|NCT01349049|3796813|FG003|NOT COMPLETED|Overall Study||3
3075161|NCT01349049|3796814|FG004|NOT COMPLETED|Overall Study||3
3075162|NCT01349049|3796815|FG005|NOT COMPLETED|Overall Study||6
3075163|NCT01349049|3796816|FG006|NOT COMPLETED|Overall Study||5
3075164|NCT01349049|3796817|FG007|NOT COMPLETED|Overall Study||4
3075165|NCT01349049|3796818|FG008|NOT COMPLETED|Overall Study||55
3075166|NCT01349114|3796852|FG000|STARTED|Overall Study||10
3075167|NCT01349114|3796853|FG001|STARTED|Overall Study||11
3075168|NCT01349114|3796852|FG000|COMPLETED|Overall Study||10
3075169|NCT01349114|3796853|FG001|COMPLETED|Overall Study||11
3075170|NCT01349114|3796852|FG000|NOT COMPLETED|Overall Study||0
3075171|NCT01349114|3796853|FG001|NOT COMPLETED|Overall Study||0
3075172|NCT01349140|3796861|FG000|STARTED|Overall Study|"We enrolled 14 subjects, and therefore Protocol Enrollment is 14. However, each leg of each subject was treated separately with a different dose of liposomal bupivacaine (Exparel); and, therefore the number of units for each subject was 2 and the total number of units analyzed was 28."|14
3075173|NCT01349140|3796861|FG000|COMPLETED|Overall Study|"We enrolled 14 subjects, and therefore Protocol Enrollment is 14. However, each leg of each subject was treated separately with a different dose of liposomal bupivacaine (Exparel); and, therefore the number of units for each subject was 2 and the total number of units analyzed was 28."|14
3075174|NCT01349140|3796861|FG000|NOT COMPLETED|Overall Study||0
3075175|NCT01349192|3796867|FG000|STARTED|Overall Study||24
3075176|NCT01349192|3796868|FG001|STARTED|Overall Study||23
3075177|NCT01349192|3796867|FG000|Evaluable for Primary Endpoint|Overall Study||22
3075178|NCT01349192|3796868|FG001|Evaluable for Primary Endpoint|Overall Study||19
3075179|NCT01349192|3796867|FG000|Withdrawals|Overall Study||3
3075180|NCT01349192|3796868|FG001|Withdrawals|Overall Study||6
3075181|NCT01349192|3796867|FG000|COMPLETED|Overall Study||21
3075182|NCT01349192|3796868|FG001|COMPLETED|Overall Study||17
3075183|NCT01349192|3796867|FG000|NOT COMPLETED|Overall Study||3
3075184|NCT01349192|3796868|FG001|NOT COMPLETED|Overall Study||6
3075185|NCT01349231|3796876|FG000|STARTED|Overall Study||10
3075186|NCT01349231|3796876|FG000|COMPLETED|Overall Study||10
3075187|NCT01349231|3796876|FG000|NOT COMPLETED|Overall Study||0
3075188|NCT01349465|3796882|FG000|STARTED|Overall Study||200
3075189|NCT01349465|3796883|FG001|STARTED|Overall Study||49
3075190|NCT01349465|3796882|FG000|COMPLETED|Overall Study||182
3075191|NCT01349465|3796883|FG001|COMPLETED|Overall Study||27
3075192|NCT01349465|3796882|FG000|NOT COMPLETED|Overall Study||18
3075193|NCT01349465|3796883|FG001|NOT COMPLETED|Overall Study||22
3075194|NCT01349491|3796893|FG000|STARTED|Overall Study||5
3075195|NCT01349491|3796894|FG001|STARTED|Overall Study||5
3075196|NCT01349491|3796893|FG000|COMPLETED|Overall Study||5
3075197|NCT01349491|3796894|FG001|COMPLETED|Overall Study||5
3075198|NCT01349491|3796893|FG000|NOT COMPLETED|Overall Study||0
3075199|NCT01349491|3796894|FG001|NOT COMPLETED|Overall Study||0
3075200|NCT01349569|3796900|FG000|STARTED|Overall Study||16
3075201|NCT01349569|3796900|FG000|COMPLETED|Overall Study||12
3075202|NCT01349569|3796900|FG000|NOT COMPLETED|Overall Study||4
3075203|NCT01349660|3796910|FG000|STARTED|Overall Study||6
3075204|NCT01349660|3796911|FG001|STARTED|Overall Study||6
3075205|NCT01349660|3796912|FG002|STARTED|Overall Study||76
3075206|NCT01349660|3796910|FG000|COMPLETED|Overall Study||0
3075207|NCT01349660|3796911|FG001|COMPLETED|Overall Study||0
3075208|NCT01349660|3796912|FG002|COMPLETED|Overall Study||0
3075209|NCT01349660|3796910|FG000|NOT COMPLETED|Overall Study||6
3075210|NCT01349660|3796911|FG001|NOT COMPLETED|Overall Study||6
3075211|NCT01349660|3796912|FG002|NOT COMPLETED|Overall Study||76
3075212|NCT01349673|3796927|FG000|STARTED|Overall Study||114
3075213|NCT01349673|3796927|FG000|Participants Entered Cycle 1|Overall Study||114
3075214|NCT01349673|3796927|FG000|Participants Entered Cycle 2|Overall Study||65
3075215|NCT01349673|3796927|FG000|Participants Entered Cycle 3|Overall Study||41
3075216|NCT01349673|3796927|FG000|Participants Entered Cycle 4|Overall Study||22
3075217|NCT01349673|3796927|FG000|Participants Entered Cycle 5|Overall Study||12
3075218|NCT01349673|3796927|FG000|Participants Entered Cycle 6|Overall Study||5
3075219|NCT01349673|3796927|FG000|Participants Entered Cycle 7|Overall Study||3
3075220|NCT01349673|3796927|FG000|Participants Entered Cycle 8|Overall Study||1
3075221|NCT01349673|3796927|FG000|Received At Least 1 Dose Of Study Drug|Overall Study||114
3075222|NCT01349673|3796927|FG000|COMPLETED|Overall Study||0
3075223|NCT01349673|3796927|FG000|NOT COMPLETED|Overall Study||114
3075224|NCT01349790|3796931|FG000|STARTED|Overall Study||40
3075225|NCT01349790|3796931|FG000|COMPLETED|Overall Study||31
3075226|NCT01349790|3796931|FG000|NOT COMPLETED|Overall Study||9
3075227|NCT01349803|3796939|FG000|STARTED|Overall Study||60
3075228|NCT01349803|3796940|FG001|STARTED|Overall Study||58
3075229|NCT01349803|3796941|FG002|STARTED|Overall Study||60
3075230|NCT01349803|3796942|FG003|STARTED|Overall Study||59
3075231|NCT01349803|3796939|FG000|COMPLETED|Overall Study||59
3075232|NCT01349803|3796940|FG001|COMPLETED|Overall Study||57
3075233|NCT01349803|3796941|FG002|COMPLETED|Overall Study||57
3075234|NCT01349803|3796942|FG003|COMPLETED|Overall Study||57
3075235|NCT01349803|3796939|FG000|NOT COMPLETED|Overall Study||1
3075236|NCT01349803|3796940|FG001|NOT COMPLETED|Overall Study||1
3075237|NCT01349803|3796941|FG002|NOT COMPLETED|Overall Study||3
3075238|NCT01349803|3796942|FG003|NOT COMPLETED|Overall Study||2
3075239|NCT01349816|3796960|FG000|STARTED|Overall Study||185
3075240|NCT01349816|3796960|FG000|GP MDI 36 µg|Overall Study||61
3075241|NCT01349816|3796960|FG000|GFF MDI 36/7.2 µg|Overall Study||58
3075242|NCT01349816|3796960|FG000|GFF MDI 36/9.6 µg|Overall Study||56
3075243|NCT01349816|3796960|FG000|GFF MDI 18/9.6 µg|Overall Study||57
3075244|NCT01349816|3796960|FG000|GFF MDI 9/9.6 µg|Overall Study||57
3075245|NCT01349816|3796960|FG000|FF MDI 9.6 µg|Overall Study||61
3075246|NCT01349816|3796960|FG000|COMPLETED|Overall Study||155
3075247|NCT01349816|3796960|FG000|NOT COMPLETED|Overall Study||30
3075248|NCT01349829|3796976|FG000|STARTED|Overall Study||126
3075249|NCT01349829|3796977|FG001|STARTED|Overall Study||125
3075250|NCT01349829|3796976|FG000|COMPLETED|Overall Study||117
3075251|NCT01349829|3796977|FG001|COMPLETED|Overall Study||102
3075252|NCT01349829|3796976|FG000|NOT COMPLETED|Overall Study||9
3075253|NCT01349829|3796977|FG001|NOT COMPLETED|Overall Study||23
3075254|NCT01349920|3796985|FG000|STARTED|Overall Study||15
3075255|NCT01349920|3796985|FG000|COMPLETED|Overall Study||15
3075256|NCT01349920|3796985|FG000|NOT COMPLETED|Overall Study||0
3075257|NCT01349933|3796991|FG000|STARTED|Overall Study||21
3075258|NCT01349933|3796991|FG000|COMPLETED|Overall Study||21
3075259|NCT01349933|3796991|FG000|NOT COMPLETED|Overall Study||0
3075260|NCT01349972|3796997|FG000|STARTED|Overall Study||114
3075261|NCT01349972|3796998|FG001|STARTED|Overall Study||58
3075262|NCT01349972|3796997|FG000|COMPLETED|Overall Study||109
3075263|NCT01349972|3796998|FG001|COMPLETED|Overall Study||56
3075264|NCT01349972|3796997|FG000|NOT COMPLETED|Overall Study||5
3075265|NCT01349972|3796998|FG001|NOT COMPLETED|Overall Study||2
3075266|NCT01350102|3797008|FG000|STARTED|Overall Study||0
3075267|NCT01350102|3797009|FG001|STARTED|Overall Study||1
3075268|NCT01350102|3797010|FG002|STARTED|Overall Study||1
3075269|NCT01350102|3797011|FG003|STARTED|Overall Study||0
3075270|NCT01350102|3797008|FG000|COMPLETED|Overall Study||0
3075271|NCT01350102|3797009|FG001|COMPLETED|Overall Study||1
3075272|NCT01350102|3797010|FG002|COMPLETED|Overall Study||0
3075273|NCT01350102|3797011|FG003|COMPLETED|Overall Study||0
3075274|NCT01350102|3797008|FG000|NOT COMPLETED|Overall Study||0
3075275|NCT01350102|3797009|FG001|NOT COMPLETED|Overall Study||0
3075276|NCT01350102|3797010|FG002|NOT COMPLETED|Overall Study||1
3075277|NCT01350102|3797011|FG003|NOT COMPLETED|Overall Study||0
3075278|NCT01350115|3797023|FG000|STARTED|Core Study (All Patients)||8
3075279|NCT01350115|3797024|FG001|STARTED|Core Study (All Patients)||2
3075280|NCT01350115|3797023|FG000|Safety Anlysis Set|Core Study (All Patients)||8
3075281|NCT01350115|3797024|FG001|Safety Anlysis Set|Core Study (All Patients)||2
3075282|NCT01350115|3797023|FG000|Pharmacodynamic Set|Core Study (All Patients)||7
3075283|NCT01350115|3797024|FG001|Pharmacodynamic Set|Core Study (All Patients)||2
3075284|NCT01350115|3797023|FG000|COMPLETED|Core Study (All Patients)||8
3075285|NCT01350115|3797024|FG001|COMPLETED|Core Study (All Patients)||2
3075286|NCT01350115|3797023|FG000|NOT COMPLETED|Core Study (All Patients)||0
3075287|NCT01350115|3797024|FG001|NOT COMPLETED|Core Study (All Patients)||0
3075288|NCT01350115|3797023|FG000|STARTED|Long Term Follow-Up (All Patients)||8
3075289|NCT01350115|3797024|FG001|STARTED|Long Term Follow-Up (All Patients)||2
3075290|NCT01350115|3797023|FG000|COMPLETED|Long Term Follow-Up (All Patients)||7
3075291|NCT01350115|3797024|FG001|COMPLETED|Long Term Follow-Up (All Patients)||0
3075292|NCT01350115|3797023|FG000|NOT COMPLETED|Long Term Follow-Up (All Patients)||1
3075293|NCT01350115|3797024|FG001|NOT COMPLETED|Long Term Follow-Up (All Patients)||2
3075294|NCT01350128|3797032|FG000|STARTED|Overall Study||103
3075295|NCT01350128|3797032|FG000|GP MDI 36 µg BID|Overall Study|Glycopyrronium Metered Dose Inhaler|49
3075296|NCT01350128|3797032|FG000|GP MDI 18 µg BID|Overall Study||49
3075297|NCT01350128|3797032|FG000|GP MDI 9 µg BID|Overall Study||49
3075298|NCT01350128|3797032|FG000|GP MDI 4.6 µg BID|Overall Study||45
3075299|NCT01350128|3797032|FG000|Placebo MDI BID|Overall Study||48
3075300|NCT01350128|3797032|FG000|Atrovent HFA 34 µg BID|Overall Study||48
3075301|NCT01350128|3797032|FG000|COMPLETED|Overall Study||89
3075302|NCT01350128|3797032|FG000|NOT COMPLETED|Overall Study||14
3075303|NCT01350141|3797049|FG000|STARTED|Overall Study||15
3075304|NCT01350141|3797050|FG001|STARTED|Overall Study||15
3075305|NCT01350141|3797051|FG002|STARTED|Overall Study||16
3075306|NCT01350141|3797049|FG000|Treated|Overall Study||14
3075307|NCT01350141|3797050|FG001|Treated|Overall Study||15
3075308|NCT01350141|3797051|FG002|Treated|Overall Study||16
3075309|NCT01350141|3797049|FG000|COMPLETED|Overall Study||12
3075310|NCT01350141|3797050|FG001|COMPLETED|Overall Study||15
3075311|NCT01350141|3797051|FG002|COMPLETED|Overall Study||15
3075312|NCT01350141|3797049|FG000|NOT COMPLETED|Overall Study||3
3075313|NCT01350141|3797050|FG001|NOT COMPLETED|Overall Study||0
3075314|NCT01350141|3797051|FG002|NOT COMPLETED|Overall Study||1
3075315|NCT01350245|3797061|FG000|STARTED|Overall Study||28
3075316|NCT01350245|3797061|FG000|COMPLETED|Overall Study||28
3075317|NCT01350245|3797061|FG000|NOT COMPLETED|Overall Study||0
3075318|NCT01350271|3797068|FG000|STARTED|Overall Study||70
3075319|NCT01350271|3797069|FG001|STARTED|Overall Study||70
3075320|NCT01350271|3797070|FG002|STARTED|Overall Study||74
3075321|NCT01350271|3797068|FG000|COMPLETED|Overall Study||49
3075322|NCT01350271|3797069|FG001|COMPLETED|Overall Study||53
3075323|NCT01350271|3797070|FG002|COMPLETED|Overall Study||48
3075324|NCT01350271|3797068|FG000|NOT COMPLETED|Overall Study||21
3075325|NCT01350271|3797069|FG001|NOT COMPLETED|Overall Study||17
3075326|NCT01350271|3797070|FG002|NOT COMPLETED|Overall Study||26
3075327|NCT01350336|3797081|FG000|STARTED|Overall Study||284
3075328|NCT01350336|3797081|FG000|COMPLETED|Overall Study||227
3075329|NCT01350336|3797081|FG000|NOT COMPLETED|Overall Study||57
3075330|NCT01350388|3797132|FG000|STARTED|Overall Study||40
3075331|NCT01350388|3797133|FG001|STARTED|Overall Study||40
3075332|NCT01350388|3797132|FG000|COMPLETED|Overall Study||37
3075333|NCT01350388|3797133|FG001|COMPLETED|Overall Study||39
3075334|NCT01350388|3797132|FG000|NOT COMPLETED|Overall Study||3
3075335|NCT01350388|3797133|FG001|NOT COMPLETED|Overall Study||1
3075336|NCT01350401|3797139|FG000|STARTED|Overall Study||4
3075337|NCT01350401|3797139|FG000|COMPLETED|Overall Study||4
3075338|NCT01350401|3797139|FG000|NOT COMPLETED|Overall Study||0
3075339|NCT01350414|3797147|FG000|STARTED|Overall Study||181
3075340|NCT01350414|3797147|FG000|Year 2|Overall Study||165
3075341|NCT01350414|3797147|FG000|Year 3|Overall Study||162
3075342|NCT01350414|3797147|FG000|Year 4|Overall Study||159
3075343|NCT01350414|3797147|FG000|Year 5|Overall Study||162
3075344|NCT01350414|3797147|FG000|COMPLETED|Overall Study||162
3075345|NCT01350414|3797147|FG000|NOT COMPLETED|Overall Study||19
3075346|NCT01350453|3797159|FG000|STARTED|Overall Study||11
3075347|NCT01350453|3797160|FG001|STARTED|Overall Study||8
3075348|NCT01350453|3797159|FG000|COMPLETED|Overall Study||9
3075349|NCT01350453|3797160|FG001|COMPLETED|Overall Study||7
3075350|NCT01350453|3797159|FG000|NOT COMPLETED|Overall Study||2
3075351|NCT01350453|3797160|FG001|NOT COMPLETED|Overall Study||1
3075352|NCT01350479|3797170|FG000|STARTED|Overall Study||94
3075353|NCT01350479|3797171|FG001|STARTED|Overall Study||106
3075354|NCT01350479|3797170|FG000|COMPLETED|Overall Study||94
3075355|NCT01350479|3797171|FG001|COMPLETED|Overall Study||106
3075356|NCT01350479|3797170|FG000|NOT COMPLETED|Overall Study||0
3075357|NCT01350479|3797171|FG001|NOT COMPLETED|Overall Study||0
3075358|NCT01350492|3797179|FG000|STARTED|Intervention||28
3075359|NCT01350492|3797180|FG001|STARTED|Intervention||26
3075360|NCT01350492|3797179|FG000|6-week MRI Scan|Intervention||24
3075361|NCT01350492|3797180|FG001|6-week MRI Scan|Intervention||22
3075362|NCT01350492|3797179|FG000|11-week MRI Scan|Intervention||23
3075363|NCT01350492|3797180|FG001|11-week MRI Scan|Intervention||21
3075364|NCT01350492|3797179|FG000|COMPLETED|Intervention||23
3075365|NCT01350492|3797180|FG001|COMPLETED|Intervention||20
3075366|NCT01350492|3797179|FG000|NOT COMPLETED|Intervention||5
3075367|NCT01350492|3797180|FG001|NOT COMPLETED|Intervention||6
3075368|NCT01350492|3797179|FG000|STARTED|Post Intervention Follow-Up||23
3075369|NCT01350492|3797180|FG001|STARTED|Post Intervention Follow-Up||20
3075370|NCT01350492|3797179|FG000|6-month MRI Scan|Post Intervention Follow-Up||20
3075371|NCT01350492|3797180|FG001|6-month MRI Scan|Post Intervention Follow-Up||20
3075372|NCT01350492|3797179|FG000|COMPLETED|Post Intervention Follow-Up||17
3075373|NCT01350492|3797180|FG001|COMPLETED|Post Intervention Follow-Up||18
3075374|NCT01350492|3797179|FG000|NOT COMPLETED|Post Intervention Follow-Up||6
3075375|NCT01350492|3797180|FG001|NOT COMPLETED|Post Intervention Follow-Up||2
3075376|NCT01350505|3797186|FG000|STARTED|Overall Study||21
3075377|NCT01350505|3797186|FG000|COMPLETED|Overall Study||17
3075378|NCT01350505|3797186|FG000|NOT COMPLETED|Overall Study||4
3075379|NCT01350544|3797192|FG000|STARTED|Overall Study||108
3075380|NCT01350544|3797193|FG001|STARTED|Overall Study||108
3075381|NCT01350544|3797192|FG000|COMPLETED|Overall Study||85
3075382|NCT01350544|3797193|FG001|COMPLETED|Overall Study||86
3075383|NCT01350544|3797192|FG000|NOT COMPLETED|Overall Study||23
3075384|NCT01350544|3797193|FG001|NOT COMPLETED|Overall Study||22
3075385|NCT01350804|3797203|FG000|STARTED|Core Study||138
3075386|NCT01350804|3797204|FG001|STARTED|Core Study||137
3075387|NCT01350804|3797205|FG002|STARTED|Core Study||138
3075388|NCT01350804|3797206|FG003|STARTED|Core Study||138
3075389|NCT01350804|3797203|FG000|Safety Set|Core Study|1 participant actually received placebo; participant was reassigned to placebo for safety analysis.|137
3075390|NCT01350804|3797204|FG001|Safety Set|Core Study|1 participant did not receive treatment; therefore participant was not counted in safety analysis.|136
3075391|NCT01350804|3797205|FG002|Safety Set|Core Study|1 participant actually received placebo; participant was reassigned to placebo for safety analysis.|139
3075392|NCT01350804|3797206|FG003|Safety Set|Core Study|1 participant did not receive treatment; therefore participant was not counted in safety analysis.|137
3075393|NCT01350804|3797203|FG000|Tratment Switch to AIN457 at Week 16|Core Study||0
3075394|NCT01350804|3797204|FG001|Tratment Switch to AIN457 at Week 16|Core Study||0
3075395|NCT01350804|3797205|FG002|Tratment Switch to AIN457 at Week 16|Core Study|15 participantsdiscontinued prior to the treatment switch|78
3075396|NCT01350804|3797206|FG003|Tratment Switch to AIN457 at Week 16|Core Study||0
3075397|NCT01350804|3797203|FG000|Treatment Switch to AIN457 at Week 24|Core Study||0
3075398|NCT01350804|3797204|FG001|Treatment Switch to AIN457 at Week 24|Core Study||0
3075399|NCT01350804|3797205|FG002|Treatment Switch to AIN457 at Week 24|Core Study||45
3075400|NCT01350804|3797206|FG003|Treatment Switch to AIN457 at Week 24|Core Study||37
3075401|NCT01350804|3797203|FG000|Full Analysis Set|Core Study||138
3075402|NCT01350804|3797204|FG001|Full Analysis Set|Core Study||137
3075403|NCT01350804|3797205|FG002|Full Analysis Set|Core Study||138
3075404|NCT01350804|3797206|FG003|Full Analysis Set|Core Study||138
3075405|NCT01350804|3797203|FG000|COMPLETED|Core Study||97
3075406|NCT01350804|3797204|FG001|COMPLETED|Core Study||90
3075407|NCT01350804|3797205|FG002|COMPLETED|Core Study||91
3075408|NCT01350804|3797206|FG003|COMPLETED|Core Study||112
3075409|NCT01350804|3797203|FG000|NOT COMPLETED|Core Study||41
3075410|NCT01350804|3797204|FG001|NOT COMPLETED|Core Study||47
3075411|NCT01350804|3797205|FG002|NOT COMPLETED|Core Study||47
3075412|NCT01350804|3797206|FG003|NOT COMPLETED|Core Study||26
3075413|NCT01350804|3797203|FG000|STARTED|Extension Study, Weeks 52 - 260||80
3075414|NCT01350804|3797204|FG001|STARTED|Extension Study, Weeks 52 - 260||79
3075415|NCT01350804|3797205|FG002|STARTED|Extension Study, Weeks 52 - 260|During the extension, these participants received AIN457.|72
3075416|NCT01350804|3797206|FG003|STARTED|Extension Study, Weeks 52 - 260|During the extension, these participants received AIN457.|23
3075417|NCT01350804|3797203|FG000|COMPLETED|Extension Study, Weeks 52 - 260||0
3075418|NCT01350804|3797204|FG001|COMPLETED|Extension Study, Weeks 52 - 260||0
3075419|NCT01350804|3797205|FG002|COMPLETED|Extension Study, Weeks 52 - 260||0
3075420|NCT01350804|3797206|FG003|COMPLETED|Extension Study, Weeks 52 - 260||0
3075421|NCT01350804|3797203|FG000|NOT COMPLETED|Extension Study, Weeks 52 - 260||80
3075422|NCT01350804|3797204|FG001|NOT COMPLETED|Extension Study, Weeks 52 - 260||79
3075423|NCT01350804|3797205|FG002|NOT COMPLETED|Extension Study, Weeks 52 - 260||72
3075424|NCT01350804|3797206|FG003|NOT COMPLETED|Extension Study, Weeks 52 - 260||23
3075425|NCT01350947|3797226|FG000|STARTED|Overall Study||11
3075426|NCT01350947|3797226|FG000|COMPLETED|Overall Study||11
3075427|NCT01350947|3797226|FG000|NOT COMPLETED|Overall Study||0
3075428|NCT01350973|3797233|FG000|STARTED|Overall Study||206
3075429|NCT01350973|3797234|FG001|STARTED|Overall Study||210
3075430|NCT01350973|3797235|FG002|STARTED|Overall Study||195
3075431|NCT01350973|3797233|FG000|Received Treatment|Overall Study||205
3075432|NCT01350973|3797234|FG001|Received Treatment|Overall Study||210
3075433|NCT01350973|3797235|FG002|Received Treatment|Overall Study||195
3075434|NCT01350973|3797233|FG000|COMPLETED|Overall Study||200
3075435|NCT01350973|3797234|FG001|COMPLETED|Overall Study||202
3075436|NCT01350973|3797235|FG002|COMPLETED|Overall Study||187
3075437|NCT01350973|3797233|FG000|NOT COMPLETED|Overall Study||6
3075438|NCT01350973|3797234|FG001|NOT COMPLETED|Overall Study||8
3075439|NCT01350973|3797235|FG002|NOT COMPLETED|Overall Study||8
3075440|NCT01350999|3797246|FG000|STARTED|Overall Study||165
3075441|NCT01350999|3797247|FG001|STARTED|Overall Study||171
3075442|NCT01350999|3797248|FG002|STARTED|Overall Study||167
3075443|NCT01350999|3797246|FG000|Treated|Overall Study||165
3075444|NCT01350999|3797247|FG001|Treated|Overall Study||171
3075445|NCT01350999|3797248|FG002|Treated|Overall Study||167
3075446|NCT01350999|3797246|FG000|COMPLETED|Overall Study||157
3075447|NCT01350999|3797247|FG001|COMPLETED|Overall Study||157
3075448|NCT01350999|3797248|FG002|COMPLETED|Overall Study||146
3075449|NCT01350999|3797246|FG000|NOT COMPLETED|Overall Study||8
3075450|NCT01350999|3797247|FG001|NOT COMPLETED|Overall Study||14
3075451|NCT01350999|3797248|FG002|NOT COMPLETED|Overall Study||21
3075452|NCT01351025|3797258|FG000|STARTED|Week 0 - 20||46
3075453|NCT01351025|3797259|FG001|STARTED|Week 0 - 20||48
3075454|NCT01351025|3797258|FG000|COMPLETED|Week 0 - 20||43
3075455|NCT01351025|3797259|FG001|COMPLETED|Week 0 - 20||47
3075456|NCT01351025|3797258|FG000|NOT COMPLETED|Week 0 - 20||3
3075457|NCT01351025|3797259|FG001|NOT COMPLETED|Week 0 - 20||1
3075458|NCT01351025|3797258|FG000|STARTED|Week 20 - 24||43
3075459|NCT01351025|3797259|FG001|STARTED|Week 20 - 24||47
3075460|NCT01351025|3797258|FG000|COMPLETED|Week 20 - 24||43
3075461|NCT01351025|3797259|FG001|COMPLETED|Week 20 - 24||47
3075462|NCT01351025|3797258|FG000|NOT COMPLETED|Week 20 - 24||0
3075463|NCT01351025|3797259|FG001|NOT COMPLETED|Week 20 - 24||0
3075464|NCT01351025|3797258|FG000|STARTED|Week 24 - 44||43
3075465|NCT01351025|3797259|FG001|STARTED|Week 24 - 44||47
3075466|NCT01351025|3797258|FG000|COMPLETED|Week 24 - 44||42
3075467|NCT01351025|3797259|FG001|COMPLETED|Week 24 - 44||43
3075468|NCT01351025|3797258|FG000|NOT COMPLETED|Week 24 - 44||1
3075469|NCT01351025|3797259|FG001|NOT COMPLETED|Week 24 - 44||4
3075470|NCT01351025|3797258|FG000|STARTED|Week 44 - 48||42
3075471|NCT01351025|3797259|FG001|STARTED|Week 44 - 48||43
3075472|NCT01351025|3797258|FG000|COMPLETED|Week 44 - 48||42
3075473|NCT01351025|3797259|FG001|COMPLETED|Week 44 - 48||43
3075474|NCT01351025|3797258|FG000|NOT COMPLETED|Week 44 - 48||0
3075475|NCT01351025|3797259|FG001|NOT COMPLETED|Week 44 - 48||0
3075476|NCT01351064|3797273|FG000|STARTED|Overall Study||42
3075477|NCT01351064|3797274|FG001|STARTED|Overall Study||42
3075478|NCT01351064|3797273|FG000|COMPLETED|Overall Study||42
3075479|NCT01351064|3797274|FG001|COMPLETED|Overall Study||42
3075480|NCT01351064|3797273|FG000|NOT COMPLETED|Overall Study||0
3075481|NCT01351064|3797274|FG001|NOT COMPLETED|Overall Study||0
3075482|NCT01351077|3797282|FG000|STARTED|Overall Study||180
3075483|NCT01351077|3797283|FG001|STARTED|Overall Study||180
3075484|NCT01351077|3797282|FG000|COMPLETED|Overall Study||180
3075485|NCT01351077|3797283|FG001|COMPLETED|Overall Study||180
3075486|NCT01351077|3797282|FG000|NOT COMPLETED|Overall Study||0
3075487|NCT01351077|3797283|FG001|NOT COMPLETED|Overall Study||0
3075488|NCT01351090|3797292|FG000|STARTED|Overall Study||43
3075489|NCT01351090|3797293|FG001|STARTED|Overall Study||42
3075490|NCT01351090|3797294|FG002|STARTED|Overall Study||42
3075491|NCT01351090|3797292|FG000|COMPLETED|Overall Study||32
3075492|NCT01351090|3797293|FG001|COMPLETED|Overall Study||31
3075493|NCT01351090|3797294|FG002|COMPLETED|Overall Study||36
3075494|NCT01351090|3797292|FG000|NOT COMPLETED|Overall Study||11
3075495|NCT01351090|3797293|FG001|NOT COMPLETED|Overall Study||11
3075496|NCT01351090|3797294|FG002|NOT COMPLETED|Overall Study||6
3075497|NCT01351337|3797302|FG000|STARTED|Overall Study||58
3075498|NCT01351337|3797302|FG000|COMPLETED|Overall Study||58
3075499|NCT01351337|3797302|FG000|NOT COMPLETED|Overall Study||0
3075500|NCT01351350|3797312|FG000|STARTED|Overall Study||8
3075501|NCT01351350|3797313|FG001|STARTED|Overall Study||29
3075502|NCT01351350|3797314|FG002|STARTED|Overall Study||11
3075503|NCT01351350|3797315|FG003|STARTED|Overall Study||13
3075504|NCT01351350|3797316|FG004|STARTED|Overall Study||7
3075505|NCT01351350|3797312|FG000|Treated|Overall Study||8
3075506|NCT01351350|3797313|FG001|Treated|Overall Study||29
3075507|NCT01351350|3797314|FG002|Treated|Overall Study||10
3075508|NCT01351350|3797315|FG003|Treated|Overall Study||13
3075509|NCT01351350|3797316|FG004|Treated|Overall Study||7
3075510|NCT01351350|3797312|FG000|Dose-escalation Evaluable|Overall Study||7
3075511|NCT01351350|3797313|FG001|Dose-escalation Evaluable|Overall Study||23
3075512|NCT01351350|3797314|FG002|Dose-escalation Evaluable|Overall Study||10
3075513|NCT01351350|3797315|FG003|Dose-escalation Evaluable|Overall Study||0
3075514|NCT01351350|3797316|FG004|Dose-escalation Evaluable|Overall Study||0
3075515|NCT01351350|3797312|FG000|COMPLETED|Overall Study||0
3075516|NCT01351350|3797313|FG001|COMPLETED|Overall Study||0
3075517|NCT01351350|3797314|FG002|COMPLETED|Overall Study||0
3075518|NCT01351350|3797315|FG003|COMPLETED|Overall Study||0
3075519|NCT01351350|3797316|FG004|COMPLETED|Overall Study||0
3075520|NCT01351350|3797312|FG000|NOT COMPLETED|Overall Study||8
3075521|NCT01351350|3797313|FG001|NOT COMPLETED|Overall Study||29
3075522|NCT01351350|3797314|FG002|NOT COMPLETED|Overall Study||11
3075523|NCT01351350|3797315|FG003|NOT COMPLETED|Overall Study||13
3075524|NCT01351350|3797316|FG004|NOT COMPLETED|Overall Study||7
3075525|NCT01351376|3797343|FG000|STARTED|Overall Study||10
3075526|NCT01351376|3797344|FG001|STARTED|Overall Study||11
3075527|NCT01351376|3797343|FG000|COMPLETED|Overall Study||10
3075528|NCT01351376|3797344|FG001|COMPLETED|Overall Study||11
3075529|NCT01351376|3797343|FG000|NOT COMPLETED|Overall Study||0
3075530|NCT01351376|3797344|FG001|NOT COMPLETED|Overall Study||0
3075531|NCT01351415|3797352|FG000|STARTED|Overall Study||245
3075532|NCT01351415|3797353|FG001|STARTED|Overall Study||240
3075533|NCT01351415|3797352|FG000|Treated Participants|Overall Study||243
3075534|NCT01351415|3797353|FG001|Treated Participants|Overall Study||232
3075535|NCT01351415|3797352|FG000|COMPLETED|Overall Study||0
3075536|NCT01351415|3797353|FG001|COMPLETED|Overall Study||0
3075537|NCT01351415|3797352|FG000|NOT COMPLETED|Overall Study||245
3075538|NCT01351415|3797353|FG001|NOT COMPLETED|Overall Study||240
3075539|NCT01351480|3797359|FG000|STARTED|Overall Study||34
3075540|NCT01351480|3797359|FG000|COMPLETED|Overall Study||26
3284687|NCT02766244|4018367|FG000|COMPLETED|Overall Study||3
3284688|NCT02766244|4018367|FG000|NOT COMPLETED|Overall Study||0
3284689|NCT02766283|4018376|FG000|STARTED|Overall Study||843
3284690|NCT02766283|4018376|FG000|COMPLETED|Overall Study||816
3284691|NCT02766283|4018376|FG000|NOT COMPLETED|Overall Study||27
3284692|NCT02766374|4018386|FG000|STARTED|Overall Study||35
3284693|NCT02766374|4018387|FG001|STARTED|Overall Study||33
3284694|NCT02766374|4018386|FG000|COMPLETED|Overall Study||25
3284695|NCT02766374|4018387|FG001|COMPLETED|Overall Study||30
3284696|NCT02766374|4018386|FG000|NOT COMPLETED|Overall Study||10
3284697|NCT02766374|4018387|FG001|NOT COMPLETED|Overall Study||3
3284698|NCT02766400|4018395|FG000|STARTED|Overall Study||21
3284699|NCT02766400|4018396|FG001|STARTED|Overall Study||22
3284700|NCT02766400|4018395|FG000|COMPLETED|Overall Study||19
3284701|NCT02766400|4018396|FG001|COMPLETED|Overall Study||20
3284702|NCT02766400|4018395|FG000|NOT COMPLETED|Overall Study||2
3284703|NCT02766400|4018396|FG001|NOT COMPLETED|Overall Study||2
3284704|NCT02766517|4018405|FG000|STARTED|Overall Study||19
3284705|NCT02766517|4018406|FG001|STARTED|Overall Study||9
3284706|NCT02766517|4018407|FG002|STARTED|Overall Study||9
3284707|NCT02766517|4018405|FG000|COMPLETED|Overall Study||19
3284708|NCT02766517|4018406|FG001|COMPLETED|Overall Study||9
3284709|NCT02766517|4018407|FG002|COMPLETED|Overall Study||9
3284710|NCT02766517|4018405|FG000|NOT COMPLETED|Overall Study||0
3284711|NCT02766517|4018406|FG001|NOT COMPLETED|Overall Study||0
3284712|NCT02766517|4018407|FG002|NOT COMPLETED|Overall Study||0
3075541|NCT01351480|3797359|FG000|NOT COMPLETED|Overall Study||8
3075542|NCT01351506|3797365|FG000|STARTED|Overall Study||602
3075543|NCT01351506|3797365|FG000|COMPLETED|Overall Study||465
3075544|NCT01351506|3797365|FG000|NOT COMPLETED|Overall Study||137
3075545|NCT01351623|3797371|FG000|STARTED|Overall Study||44
3075546|NCT01351623|3797371|FG000|COMPLETED|Overall Study||35
3075547|NCT01351623|3797371|FG000|NOT COMPLETED|Overall Study||9
3075548|NCT01351740|3797377|FG000|STARTED|Overall Study||25
3075549|NCT01351740|3797378|FG001|STARTED|Overall Study||25
3075550|NCT01351740|3797377|FG000|COMPLETED|Overall Study||23
3075551|NCT01351740|3797378|FG001|COMPLETED|Overall Study||19
3075552|NCT01351740|3797377|FG000|NOT COMPLETED|Overall Study||2
3075553|NCT01351740|3797378|FG001|NOT COMPLETED|Overall Study||6
3134617|NCT01701973|3859525|FG004|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0
3134618|NCT01701973|3859526|FG005|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0
3134619|NCT01701973|3859527|FG006|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0
3134620|NCT01701973|3859528|FG007|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0
3136758|NCT01714947|3862017|FG000|NOT COMPLETED|Part A||0
3284713|NCT02766608|4018420|FG000|STARTED|Overall Study||655
3284714|NCT02766608|4018421|FG001|STARTED|Overall Study||637
3284715|NCT02766608|4018422|FG002|STARTED|Overall Study||644
3284716|NCT02766608|4018423|FG003|STARTED|Overall Study||206
3284717|NCT02766608|4018424|FG004|STARTED|Overall Study||219
3284718|NCT02766608|4018420|FG000|COMPLETED|Overall Study||576
3075554|NCT01351753|3797391|FG000|STARTED|Overall Study||22
3075555|NCT01351753|3797392|FG001|STARTED|Overall Study||20
3075556|NCT01351753|3797393|FG002|STARTED|Overall Study||21
3075557|NCT01351753|3797394|FG003|STARTED|Overall Study||21
3075558|NCT01351753|3797395|FG004|STARTED|Overall Study||21
3075559|NCT01351753|3797396|FG005|STARTED|Overall Study||23
3075560|NCT01351753|3797391|FG000|COMPLETED|Overall Study||15
3075561|NCT01351753|3797392|FG001|COMPLETED|Overall Study||13
3075562|NCT01351753|3797393|FG002|COMPLETED|Overall Study||14
3075563|NCT01351753|3797394|FG003|COMPLETED|Overall Study||21
3075564|NCT01351753|3797395|FG004|COMPLETED|Overall Study||14
3075565|NCT01351753|3797396|FG005|COMPLETED|Overall Study||22
3075566|NCT01351753|3797391|FG000|NOT COMPLETED|Overall Study||7
3075567|NCT01351753|3797392|FG001|NOT COMPLETED|Overall Study||7
3075568|NCT01351753|3797393|FG002|NOT COMPLETED|Overall Study||7
3075569|NCT01351753|3797394|FG003|NOT COMPLETED|Overall Study||0
3075570|NCT01351753|3797395|FG004|NOT COMPLETED|Overall Study||7
3075571|NCT01351753|3797396|FG005|NOT COMPLETED|Overall Study||1
3075572|NCT01351766|3797412|FG000|STARTED|Overall Study||39
3075573|NCT01351766|3797412|FG000|COMPLETED|Overall Study||36
3075574|NCT01351766|3797412|FG000|NOT COMPLETED|Overall Study||3
3075575|NCT01351805|3797420|FG000|STARTED|Overall Study||6463
3075576|NCT01351805|3797421|FG001|STARTED|Overall Study||6464
3075577|NCT01351805|3797422|FG002|STARTED|Overall Study||6470
3075578|NCT01351805|3797423|FG003|STARTED|Overall Study||6474
3075579|NCT01351805|3797420|FG000|Knee Pain Cohort Within VITAL Trial|Overall Study||342
3075580|NCT01351805|3797421|FG001|Knee Pain Cohort Within VITAL Trial|Overall Study||332
3075581|NCT01351805|3797422|FG002|Knee Pain Cohort Within VITAL Trial|Overall Study||353
3075582|NCT01351805|3797423|FG003|Knee Pain Cohort Within VITAL Trial|Overall Study||371
3075583|NCT01351805|3797420|FG000|Biomarkers of Systemic Inflammation Cohort Within VITAL Trial|Overall Study||392
3075584|NCT01351805|3797421|FG001|Biomarkers of Systemic Inflammation Cohort Within VITAL Trial|Overall Study||392
3075585|NCT01351805|3797422|FG002|Biomarkers of Systemic Inflammation Cohort Within VITAL Trial|Overall Study||392
3075586|NCT01351805|3797423|FG003|Biomarkers of Systemic Inflammation Cohort Within VITAL Trial|Overall Study||385
3075587|NCT01351805|3797420|FG000|COMPLETED|Overall Study||6463
3075588|NCT01351805|3797421|FG001|COMPLETED|Overall Study||6464
3075589|NCT01351805|3797422|FG002|COMPLETED|Overall Study||6470
3075590|NCT01351805|3797423|FG003|COMPLETED|Overall Study||6474
3075591|NCT01351805|3797420|FG000|NOT COMPLETED|Overall Study||0
3075592|NCT01351805|3797421|FG001|NOT COMPLETED|Overall Study||0
3075593|NCT01351805|3797422|FG002|NOT COMPLETED|Overall Study||0
3075594|NCT01351805|3797423|FG003|NOT COMPLETED|Overall Study||0
3075595|NCT01352117|3797439|FG000|STARTED|Overall Study||96
3075596|NCT01352117|3797440|FG001|STARTED|Overall Study||96
3075597|NCT01352117|3797439|FG000|Entered Step 2 to Initiate Delayed ET|Overall Study||32
3075598|NCT01352117|3797440|FG001|Entered Step 2 to Initiate Delayed ET|Overall Study|Only Arm A participants could enter Step 2 to receive delayed ET.|0
3075599|NCT01352117|3797439|FG000|Study Week 48 Data Potential|Overall Study||80
3075600|NCT01352117|3797440|FG001|Study Week 48 Data Potential|Overall Study||83
3075601|NCT01352117|3797439|FG000|Study Week 96 Data Potential|Overall Study||58
3075602|NCT01352117|3797440|FG001|Study Week 96 Data Potential|Overall Study||61
3075603|NCT01352117|3797439|FG000|COMPLETED|Overall Study||75
3075604|NCT01352117|3797440|FG001|COMPLETED|Overall Study||72
3075605|NCT01352117|3797439|FG000|NOT COMPLETED|Overall Study||21
3075606|NCT01352117|3797440|FG001|NOT COMPLETED|Overall Study||24
3075607|NCT01352182|3797451|FG000|STARTED|Overall Study||8
3075608|NCT01352182|3797452|FG001|STARTED|Overall Study||4
3075609|NCT01352182|3797451|FG000|COMPLETED|Overall Study||8
3075610|NCT01352182|3797452|FG001|COMPLETED|Overall Study||4
3075611|NCT01352182|3797451|FG000|NOT COMPLETED|Overall Study||0
3075612|NCT01352182|3797452|FG001|NOT COMPLETED|Overall Study||0
3075613|NCT01352221|3797462|FG000|STARTED|Double-blind Phase||64
3075614|NCT01352221|3797463|FG001|STARTED|Double-blind Phase||64
3075615|NCT01352221|3797464|FG002|STARTED|Double-blind Phase|Not Applicable to double-blind phase|0
3075616|NCT01352221|3797465|FG003|STARTED|Double-blind Phase|Not Applicable to double-blind phase|0
3075617|NCT01352221|3797462|FG000|COMPLETED|Double-blind Phase||55
3075618|NCT01352221|3797463|FG001|COMPLETED|Double-blind Phase||53
3075619|NCT01352221|3797464|FG002|COMPLETED|Double-blind Phase|Not Applicable to double-blind phase|0
3075620|NCT01352221|3797465|FG003|COMPLETED|Double-blind Phase|Not Applicable to double-blind phase|0
3075621|NCT01352221|3797462|FG000|NOT COMPLETED|Double-blind Phase||9
3075622|NCT01352221|3797463|FG001|NOT COMPLETED|Double-blind Phase||11
3075623|NCT01352221|3797464|FG002|NOT COMPLETED|Double-blind Phase||0
3075624|NCT01352221|3797465|FG003|NOT COMPLETED|Double-blind Phase||0
3075625|NCT01352221|3797462|FG000|STARTED|Open-label Phase|Not Applicable to open-label phase|0
3075626|NCT01352221|3797463|FG001|STARTED|Open-label Phase|Not Applicable to open-label phase|0
3075627|NCT01352221|3797464|FG002|STARTED|Open-label Phase|Only subjects in DE, UK and HU could enter the open-label extension (OLE); OLE rejected by EC in AT|50
3075628|NCT01352221|3797465|FG003|STARTED|Open-label Phase|Only subjects in DE, UK and HU could enter the open-label extension (OLE); OLE rejected by EC in AT|47
3075629|NCT01352221|3797462|FG000|COMPLETED|Open-label Phase|Not Applicable to open-label phase|0
3075630|NCT01352221|3797463|FG001|COMPLETED|Open-label Phase|Not Applicable to open-label phase|0
3075631|NCT01352221|3797464|FG002|COMPLETED|Open-label Phase|Only subjects in DE, UK and HU could enter the open-label extension (OLE); OLE rejected by EC in AT|37
3075632|NCT01352221|3797465|FG003|COMPLETED|Open-label Phase|Only subjects in DE, UK and HU could enter the open-label extension (OLE); OLE rejected by EC in AT|36
3075633|NCT01352221|3797462|FG000|NOT COMPLETED|Open-label Phase||0
3075634|NCT01352221|3797463|FG001|NOT COMPLETED|Open-label Phase||0
3075635|NCT01352221|3797464|FG002|NOT COMPLETED|Open-label Phase||13
3075636|NCT01352221|3797465|FG003|NOT COMPLETED|Open-label Phase||11
3075637|NCT01352286|3797477|FG000|STARTED|Overall Study||25
3075638|NCT01352286|3797477|FG000|Received T-cells|Overall Study||25
3075639|NCT01352286|3797477|FG000|COMPLETED|Overall Study||25
3075640|NCT01352286|3797477|FG000|NOT COMPLETED|Overall Study||0
3075641|NCT01352442|3797482|FG000|STARTED|Overall Study||151
3075642|NCT01352442|3797482|FG000|COMPLETED|Overall Study||139
3075643|NCT01352442|3797482|FG000|NOT COMPLETED|Overall Study||12
3075644|NCT01352468|3797488|FG000|STARTED|Overall Study||22
3075645|NCT01352468|3797489|FG001|STARTED|Overall Study||22
3075646|NCT01352468|3797488|FG000|COMPLETED|Overall Study||17
3075647|NCT01352468|3797489|FG001|COMPLETED|Overall Study||18
3075648|NCT01352468|3797488|FG000|NOT COMPLETED|Overall Study||5
3075649|NCT01352468|3797489|FG001|NOT COMPLETED|Overall Study||4
3075650|NCT01352507|3797497|FG000|STARTED|Treatment Period 1||190
3075651|NCT01352507|3797498|FG001|STARTED|Treatment Period 1||193
3075652|NCT01352507|3797497|FG000|Received Treatment|Treatment Period 1||182
3075653|NCT01352507|3797498|FG001|Received Treatment|Treatment Period 1||188
3075654|NCT01352507|3797497|FG000|COMPLETED|Treatment Period 1||176
3075655|NCT01352507|3797498|FG001|COMPLETED|Treatment Period 1||184
3075656|NCT01352507|3797497|FG000|NOT COMPLETED|Treatment Period 1||14
3075657|NCT01352507|3797498|FG001|NOT COMPLETED|Treatment Period 1||9
3075658|NCT01352507|3797497|FG000|STARTED|Washout Period||176
3075659|NCT01352507|3797498|FG001|STARTED|Washout Period||184
3075660|NCT01352507|3797497|FG000|COMPLETED|Washout Period||176
3075661|NCT01352507|3797498|FG001|COMPLETED|Washout Period||183
3075662|NCT01352507|3797497|FG000|NOT COMPLETED|Washout Period||0
3075663|NCT01352507|3797498|FG001|NOT COMPLETED|Washout Period||1
3075664|NCT01352507|3797497|FG000|STARTED|Treatment Period 2||176
3075665|NCT01352507|3797498|FG001|STARTED|Treatment Period 2||183
3075666|NCT01352507|3797497|FG000|Received Treatment|Treatment Period 2||173
3075667|NCT01352507|3797498|FG001|Received Treatment|Treatment Period 2||181
3075668|NCT01352507|3797497|FG000|COMPLETED|Treatment Period 2|Six participants who completed Treatment Period 2 chose not to enter the Extension Phase.|170
3075669|NCT01352507|3797498|FG001|COMPLETED|Treatment Period 2|Seven participants who completed Treatment Period 2 chose not to enter the Extension Phase.|180
3075670|NCT01352507|3797497|FG000|NOT COMPLETED|Treatment Period 2||6
3075671|NCT01352507|3797498|FG001|NOT COMPLETED|Treatment Period 2||3
3075672|NCT01352507|3797497|FG000|STARTED|Extension Phase||164
3075673|NCT01352507|3797498|FG001|STARTED|Extension Phase||173
3075674|NCT01352507|3797497|FG000|COMPLETED|Extension Phase||164
3075675|NCT01352507|3797498|FG001|COMPLETED|Extension Phase||173
3075676|NCT01352507|3797497|FG000|NOT COMPLETED|Extension Phase||0
3075677|NCT01352507|3797498|FG001|NOT COMPLETED|Extension Phase||0
3075678|NCT01352546|3797510|FG000|STARTED|Overall Study||31
3075679|NCT01352546|3797510|FG000|COMPLETED|Overall Study||31
3075680|NCT01352546|3797510|FG000|NOT COMPLETED|Overall Study||0
3075681|NCT01352585|3797516|FG000|STARTED|Overall Study||23
3075682|NCT01352585|3797517|FG001|STARTED|Overall Study||24
3075683|NCT01352585|3797516|FG000|COMPLETED|Overall Study||15
3075684|NCT01352585|3797517|FG001|COMPLETED|Overall Study||21
3075685|NCT01352585|3797516|FG000|NOT COMPLETED|Overall Study||8
3075686|NCT01352585|3797517|FG001|NOT COMPLETED|Overall Study||3
3075687|NCT01352598|3797524|FG000|STARTED|Overall Study||84
3075688|NCT01352598|3797524|FG000|COMPLETED|Overall Study||72
3075689|NCT01352598|3797524|FG000|NOT COMPLETED|Overall Study||12
3075690|NCT01352637|3797532|FG000|STARTED|Exposure Therapy||97
3075691|NCT01352637|3797533|FG001|STARTED|Exposure Therapy||95
3075692|NCT01352637|3797534|FG002|STARTED|Exposure Therapy||0
3075693|NCT01352637|3797535|FG003|STARTED|Exposure Therapy||0
3075694|NCT01352637|3797532|FG000|COMPLETED|Exposure Therapy||70
3075695|NCT01352637|3797533|FG001|COMPLETED|Exposure Therapy||62
3075696|NCT01352637|3797534|FG002|COMPLETED|Exposure Therapy||0
3075697|NCT01352637|3797535|FG003|COMPLETED|Exposure Therapy||0
3075698|NCT01352637|3797532|FG000|NOT COMPLETED|Exposure Therapy||27
3075699|NCT01352637|3797533|FG001|NOT COMPLETED|Exposure Therapy||33
3075700|NCT01352637|3797534|FG002|NOT COMPLETED|Exposure Therapy||0
3075701|NCT01352637|3797535|FG003|NOT COMPLETED|Exposure Therapy||0
3075702|NCT01352637|3797532|FG000|STARTED|Drug||0
3075703|NCT01352637|3797533|FG001|STARTED|Drug||0
3075704|NCT01352637|3797534|FG002|STARTED|Drug||95
3075705|NCT01352637|3797535|FG003|STARTED|Drug||97
3075706|NCT01352637|3797532|FG000|COMPLETED|Drug||0
3075707|NCT01352637|3797533|FG001|COMPLETED|Drug||0
3075708|NCT01352637|3797534|FG002|COMPLETED|Drug||70
3075709|NCT01352637|3797535|FG003|COMPLETED|Drug||62
3075710|NCT01352637|3797532|FG000|NOT COMPLETED|Drug||0
3075711|NCT01352637|3797533|FG001|NOT COMPLETED|Drug||0
3075712|NCT01352637|3797534|FG002|NOT COMPLETED|Drug||25
3075713|NCT01352637|3797535|FG003|NOT COMPLETED|Drug||35
3075714|NCT01352715|3797547|FG000|STARTED|Overall Study||260
3075715|NCT01352715|3797548|FG001|STARTED|Overall Study||255
3075716|NCT01352715|3797547|FG000|COMPLETED|Overall Study||215
3075717|NCT01352715|3797548|FG001|COMPLETED|Overall Study||209
3075718|NCT01352715|3797547|FG000|NOT COMPLETED|Overall Study||45
3075719|NCT01352715|3797548|FG001|NOT COMPLETED|Overall Study||46
3075720|NCT01352741|3797554|FG000|STARTED|Open-label Tapentadol Titration Period|All participants started with 2 x 50 mg tapentadol PR and titrated upwards in steps of 100 mg/day.|445
3075721|NCT01352741|3797555|FG001|STARTED|Open-label Tapentadol Titration Period||0
3075722|NCT01352741|3797554|FG000|Switched to Open-label Continuation Arm|Open-label Tapentadol Titration Period||59
3075723|NCT01352741|3797555|FG001|Switched to Open-label Continuation Arm|Open-label Tapentadol Titration Period||0
3075724|NCT01352741|3797554|FG000|Full Analysis Set|Open-label Tapentadol Titration Period||436
3075725|NCT01352741|3797555|FG001|Full Analysis Set|Open-label Tapentadol Titration Period||0
3075726|NCT01352741|3797554|FG000|COMPLETED|Open-label Tapentadol Titration Period|59 of 73 participants not completing the titration period entered the open-label continuation arm.|372
3075727|NCT01352741|3797555|FG001|COMPLETED|Open-label Tapentadol Titration Period||0
3075728|NCT01352741|3797554|FG000|NOT COMPLETED|Open-label Tapentadol Titration Period||73
3075729|NCT01352741|3797555|FG001|NOT COMPLETED|Open-label Tapentadol Titration Period||0
3075730|NCT01352741|3797554|FG000|STARTED|Double-blind Comparative Period|Of the 313 participants that qualified for randomization 154 were randomized to tapentadol.|154
3075731|NCT01352741|3797555|FG001|STARTED|Double-blind Comparative Period|159 of the 313 participants that qualified were randomized to tapentadol and pregabalin treatment.|159
3075732|NCT01352741|3797554|FG000|Switched to Open-label Pick-up Arm|Double-blind Comparative Period||19
3075733|NCT01352741|3797555|FG001|Switched to Open-label Pick-up Arm|Double-blind Comparative Period||18
3075734|NCT01352741|3797554|FG000|No Pain Assessments Available|Double-blind Comparative Period||2
3075735|NCT01352741|3797555|FG001|No Pain Assessments Available|Double-blind Comparative Period||2
3075736|NCT01352741|3797554|FG000|Full Analysis Set|Double-blind Comparative Period||152
3075737|NCT01352741|3797555|FG001|Full Analysis Set|Double-blind Comparative Period||157
3075738|NCT01352741|3797554|FG000|Major Protocol Deviations|Double-blind Comparative Period||13
3075739|NCT01352741|3797555|FG001|Major Protocol Deviations|Double-blind Comparative Period||8
3075740|NCT01352741|3797554|FG000|Per Protocol Set|Double-blind Comparative Period||139
3075741|NCT01352741|3797555|FG001|Per Protocol Set|Double-blind Comparative Period||149
3075742|NCT01352741|3797554|FG000|painDetect Per Protocol Set|Double-blind Comparative Period||109
3075743|NCT01352741|3797555|FG001|painDetect Per Protocol Set|Double-blind Comparative Period||127
3075744|NCT01352741|3797554|FG000|SF-12 Per Protocol Set|Double-blind Comparative Period||131
3075745|NCT01352741|3797555|FG001|SF-12 Per Protocol Set|Double-blind Comparative Period||143
3075746|NCT01352741|3797554|FG000|EQ-5D Per Protocol Set|Double-blind Comparative Period||131
3075747|NCT01352741|3797555|FG001|EQ-5D Per Protocol Set|Double-blind Comparative Period||143
3075748|NCT01352741|3797554|FG000|HADS Per Protocol Set (PPS)|Double-blind Comparative Period||123
3075749|NCT01352741|3797555|FG001|HADS Per Protocol Set (PPS)|Double-blind Comparative Period||137
3075750|NCT01352741|3797554|FG000|Sleep Evaluation (Latency) PPS|Double-blind Comparative Period||123
3075751|NCT01352741|3797555|FG001|Sleep Evaluation (Latency) PPS|Double-blind Comparative Period||137
3075752|NCT01352741|3797554|FG000|Sleep Evaluations (Awakenings) PPS|Double-blind Comparative Period||123
3075753|NCT01352741|3797555|FG001|Sleep Evaluations (Awakenings) PPS|Double-blind Comparative Period||137
3075754|NCT01352741|3797554|FG000|Sleep Evaluations (Hours Slept) PPS|Double-blind Comparative Period||123
3075755|NCT01352741|3797555|FG001|Sleep Evaluations (Hours Slept) PPS|Double-blind Comparative Period||137
3284719|NCT02766608|4018421|FG001|COMPLETED|Overall Study||567
3284720|NCT02766608|4018422|FG002|COMPLETED|Overall Study||554
3284721|NCT02766608|4018423|FG003|COMPLETED|Overall Study||169
3075756|NCT01352741|3797554|FG000|COMPLETED|Double-blind Comparative Period||126
3075757|NCT01352741|3797555|FG001|COMPLETED|Double-blind Comparative Period||133
3075758|NCT01352741|3797554|FG000|NOT COMPLETED|Double-blind Comparative Period||28
3075759|NCT01352741|3797555|FG001|NOT COMPLETED|Double-blind Comparative Period||26
3075760|NCT01352741|3797554|FG000|STARTED|Open-Label Tapentadol Continuation Arm|59 of the 73 participants that did not qualify for the comparative period entered this arm.|59
3075761|NCT01352741|3797555|FG001|STARTED|Open-Label Tapentadol Continuation Arm|In this period no tapentadol PR and pregabalin treatment was planned by the protocol.|0
3075762|NCT01352741|3797554|FG000|Major Protocol Deviation|Open-Label Tapentadol Continuation Arm||2
3075763|NCT01352741|3797555|FG001|Major Protocol Deviation|Open-Label Tapentadol Continuation Arm||0
3075764|NCT01352741|3797554|FG000|Full Analysis Set|Open-Label Tapentadol Continuation Arm||57
3075765|NCT01352741|3797555|FG001|Full Analysis Set|Open-Label Tapentadol Continuation Arm||0
3075766|NCT01352741|3797554|FG000|COMPLETED|Open-Label Tapentadol Continuation Arm||51
3075767|NCT01352741|3797555|FG001|COMPLETED|Open-Label Tapentadol Continuation Arm||0
3075768|NCT01352741|3797554|FG000|NOT COMPLETED|Open-Label Tapentadol Continuation Arm||8
3075769|NCT01352741|3797555|FG001|NOT COMPLETED|Open-Label Tapentadol Continuation Arm||0
3075770|NCT01352741|3797554|FG000|STARTED|Open-Label Tapentadol Pick-Up Arm|19 from tapentadol in the comparative phase and 18 from tapentadol & pregabalin entered this arm.|37
3075771|NCT01352741|3797555|FG001|STARTED|Open-Label Tapentadol Pick-Up Arm|Participants did not continue treatment. They were switched to tapentadol PR or discontinued.|0
3075772|NCT01352741|3797554|FG000|COMPLETED|Open-Label Tapentadol Pick-Up Arm||37
3075773|NCT01352741|3797555|FG001|COMPLETED|Open-Label Tapentadol Pick-Up Arm||0
3075774|NCT01352741|3797554|FG000|NOT COMPLETED|Open-Label Tapentadol Pick-Up Arm||0
3075775|NCT01352741|3797555|FG001|NOT COMPLETED|Open-Label Tapentadol Pick-Up Arm||0
3075776|NCT01352793|3797577|FG000|STARTED|Overall Study||3804
3075777|NCT01352793|3797578|FG001|STARTED|Overall Study||1908
3075778|NCT01352793|3797577|FG000|Vaccination 1|Overall Study||3796
3075779|NCT01352793|3797578|FG001|Vaccination 1|Overall Study||1908
3075780|NCT01352793|3797577|FG000|Vaccination 2|Overall Study||3530
3075781|NCT01352793|3797578|FG001|Vaccination 2|Overall Study||1806
3075782|NCT01352793|3797577|FG000|Vaccination 3|Overall Study||3314
3075783|NCT01352793|3797578|FG001|Vaccination 3|Overall Study||1710
3075784|NCT01352793|3797577|FG000|COMPLETED|Overall Study||3219
3075785|NCT01352793|3797578|FG001|COMPLETED|Overall Study||1663
3075786|NCT01352793|3797577|FG000|NOT COMPLETED|Overall Study||585
3075787|NCT01352793|3797578|FG001|NOT COMPLETED|Overall Study||245
3284722|NCT02766608|4018424|FG004|COMPLETED|Overall Study||190
3284723|NCT02766608|4018420|FG000|NOT COMPLETED|Overall Study||79
3284724|NCT02766608|4018421|FG001|NOT COMPLETED|Overall Study||70
3284725|NCT02766608|4018422|FG002|NOT COMPLETED|Overall Study||90
3284726|NCT02766608|4018423|FG003|NOT COMPLETED|Overall Study||37
3075788|NCT01352845|3797586|FG000|STARTED|Overall Study||2471
3075789|NCT01352845|3797587|FG001|STARTED|Overall Study||822
3075790|NCT01352845|3797586|FG000|COMPLETED|Overall Study||1800
3075791|NCT01352845|3797587|FG001|COMPLETED|Overall Study||619
3075792|NCT01352845|3797586|FG000|NOT COMPLETED|Overall Study||671
3075793|NCT01352845|3797587|FG001|NOT COMPLETED|Overall Study||203
3075794|NCT01353079|3797595|FG000|STARTED|Overall Study||218
3075795|NCT01353079|3797596|FG001|STARTED|Overall Study||211
3075796|NCT01353079|3797595|FG000|COMPLETED|Overall Study||191
3075797|NCT01353079|3797596|FG001|COMPLETED|Overall Study||190
3075798|NCT01353079|3797595|FG000|NOT COMPLETED|Overall Study||27
3075799|NCT01353079|3797596|FG001|NOT COMPLETED|Overall Study||21
3075800|NCT01353144|3797606|FG000|STARTED|Overall Study||89
3075801|NCT01353144|3797607|FG001|STARTED|Overall Study||89
3075802|NCT01353144|3797606|FG000|COMPLETED|Overall Study||80
3075803|NCT01353144|3797607|FG001|COMPLETED|Overall Study||81
3075804|NCT01353144|3797606|FG000|NOT COMPLETED|Overall Study||9
3075805|NCT01353144|3797607|FG001|NOT COMPLETED|Overall Study||8
3075806|NCT01353196|3797617|FG000|STARTED|Overall Study||100
3075807|NCT01353196|3797618|FG001|STARTED|Overall Study||70
3075808|NCT01353196|3797617|FG000|COMPLETED|Overall Study||71
3075809|NCT01353196|3797618|FG001|COMPLETED|Overall Study||59
3075810|NCT01353196|3797617|FG000|NOT COMPLETED|Overall Study||29
3075811|NCT01353196|3797618|FG001|NOT COMPLETED|Overall Study||11
3075812|NCT01353222|3797626|FG000|STARTED|Overall Study||70
3075813|NCT01353222|3797627|FG001|STARTED|Overall Study||72
3075814|NCT01353222|3797626|FG000|DN24-02 Arm ≥1 Leukapheresis|Overall Study||67
3075815|NCT01353222|3797627|FG001|DN24-02 Arm ≥1 Leukapheresis|Overall Study||0
3075816|NCT01353222|3797626|FG000|Standard Care Arm ≥1 Post-baseline Visit|Overall Study||0
3075817|NCT01353222|3797627|FG001|Standard Care Arm ≥1 Post-baseline Visit|Overall Study||72
3075818|NCT01353222|3797626|FG000|COMPLETED|Overall Study||0
3075819|NCT01353222|3797627|FG001|COMPLETED|Overall Study||0
3075820|NCT01353222|3797626|FG000|NOT COMPLETED|Overall Study||70
3075821|NCT01353222|3797627|FG001|NOT COMPLETED|Overall Study||72
3075822|NCT01353274|3797633|FG000|STARTED|Overall Study||1157
3075823|NCT01353274|3797633|FG000|COMPLETED|Overall Study||1129
3075824|NCT01353274|3797633|FG000|NOT COMPLETED|Overall Study||28
3075825|NCT01353495|3797639|FG000|STARTED|Overall Study||19
3075826|NCT01353495|3797640|FG001|STARTED|Overall Study||20
3075827|NCT01353495|3797639|FG000|COMPLETED|Overall Study||19
3075828|NCT01353495|3797640|FG001|COMPLETED|Overall Study||20
3075829|NCT01353495|3797639|FG000|NOT COMPLETED|Overall Study||0
3075830|NCT01353495|3797640|FG001|NOT COMPLETED|Overall Study||0
3075831|NCT01353508|3797650|FG000|STARTED|Period 1 - First Intervention (7 Days)||8
3075832|NCT01353508|3797651|FG001|STARTED|Period 1 - First Intervention (7 Days)||8
3075833|NCT01353508|3797652|FG002|STARTED|Period 1 - First Intervention (7 Days)||8
3075834|NCT01353508|3797653|FG003|STARTED|Period 1 - First Intervention (7 Days)||8
3075835|NCT01353508|3797650|FG000|COMPLETED|Period 1 - First Intervention (7 Days)||8
3075836|NCT01353508|3797651|FG001|COMPLETED|Period 1 - First Intervention (7 Days)||8
3075837|NCT01353508|3797652|FG002|COMPLETED|Period 1 - First Intervention (7 Days)||8
3075838|NCT01353508|3797653|FG003|COMPLETED|Period 1 - First Intervention (7 Days)||7
3075839|NCT01353508|3797650|FG000|NOT COMPLETED|Period 1 - First Intervention (7 Days)||0
3075840|NCT01353508|3797651|FG001|NOT COMPLETED|Period 1 - First Intervention (7 Days)||0
3075841|NCT01353508|3797652|FG002|NOT COMPLETED|Period 1 - First Intervention (7 Days)||0
3075842|NCT01353508|3797653|FG003|NOT COMPLETED|Period 1 - First Intervention (7 Days)||1
3075843|NCT01353508|3797650|FG000|STARTED|Period 2 - Second Intervention (7 Days)||8
3075844|NCT01353508|3797651|FG001|STARTED|Period 2 - Second Intervention (7 Days)||8
3075845|NCT01353508|3797652|FG002|STARTED|Period 2 - Second Intervention (7 Days)||8
3075846|NCT01353508|3797653|FG003|STARTED|Period 2 - Second Intervention (7 Days)||7
3075847|NCT01353508|3797650|FG000|COMPLETED|Period 2 - Second Intervention (7 Days)||7
3075848|NCT01353508|3797651|FG001|COMPLETED|Period 2 - Second Intervention (7 Days)||8
3075849|NCT01353508|3797652|FG002|COMPLETED|Period 2 - Second Intervention (7 Days)||8
3075850|NCT01353508|3797653|FG003|COMPLETED|Period 2 - Second Intervention (7 Days)||7
3075851|NCT01353508|3797650|FG000|NOT COMPLETED|Period 2 - Second Intervention (7 Days)||1
3075852|NCT01353508|3797651|FG001|NOT COMPLETED|Period 2 - Second Intervention (7 Days)||0
3075853|NCT01353508|3797652|FG002|NOT COMPLETED|Period 2 - Second Intervention (7 Days)||0
3075854|NCT01353508|3797653|FG003|NOT COMPLETED|Period 2 - Second Intervention (7 Days)||0
3075855|NCT01353586|3797665|FG000|STARTED|Overall Study||167
3075856|NCT01353586|3797666|FG001|STARTED|Overall Study||19
3075857|NCT01353586|3797665|FG000|Participated in Workflow Phase|Overall Study||20
3075858|NCT01353586|3797666|FG001|Participated in Workflow Phase|Overall Study||0
3075859|NCT01353586|3797665|FG000|Participated in Roll-in Phase|Overall Study||22
3075860|NCT01353586|3797666|FG001|Participated in Roll-in Phase|Overall Study||0
3075861|NCT01353586|3797665|FG000|Participated in SNA Substudy|Overall Study||19
3075862|NCT01353586|3797666|FG001|Participated in SNA Substudy|Overall Study||19
3075863|NCT01353586|3797665|FG000|COMPLETED|Overall Study||160
3075864|NCT01353586|3797666|FG001|COMPLETED|Overall Study||17
3075865|NCT01353586|3797665|FG000|NOT COMPLETED|Overall Study||7
3075866|NCT01353586|3797666|FG001|NOT COMPLETED|Overall Study||2
3075867|NCT01353664|3797675|FG000|STARTED|Overall Study|Participants who received at least 1 dose of study drug.|19
3075868|NCT01353664|3797675|FG000|COMPLETED|Overall Study|Completed = Number of participants who continued on Romidepsin treatment|0
3075869|NCT01353664|3797675|FG000|NOT COMPLETED|Overall Study||19
3075870|NCT01353703|3797681|FG000|STARTED|Overall Study||112
3075871|NCT01353703|3797682|FG001|STARTED|Overall Study||112
3075872|NCT01353703|3797681|FG000|COMPLETED|Overall Study||111
3075873|NCT01353703|3797682|FG001|COMPLETED|Overall Study||112
3075874|NCT01353703|3797681|FG000|NOT COMPLETED|Overall Study||1
3075875|NCT01353703|3797682|FG001|NOT COMPLETED|Overall Study||0
3075876|NCT01353859|3797690|FG000|STARTED|Overall Study||39
3075877|NCT01353859|3797690|FG000|COMPLETED|Overall Study||35
3075878|NCT01353859|3797690|FG000|NOT COMPLETED|Overall Study||4
3075879|NCT01353898|3797700|FG000|STARTED|Overall Study||2
3075880|NCT01353898|3797701|FG001|STARTED|Overall Study||2
3075881|NCT01353898|3797702|FG002|STARTED|Overall Study||2
3075882|NCT01353898|3797703|FG003|STARTED|Overall Study||2
3075883|NCT01353898|3797704|FG004|STARTED|Overall Study||2
3075884|NCT01353898|3797705|FG005|STARTED|Overall Study||2
3075885|NCT01353898|3797700|FG000|COMPLETED|Overall Study||2
3075886|NCT01353898|3797701|FG001|COMPLETED|Overall Study||2
3075887|NCT01353898|3797702|FG002|COMPLETED|Overall Study||2
3075888|NCT01353898|3797703|FG003|COMPLETED|Overall Study||2
3075889|NCT01353898|3797704|FG004|COMPLETED|Overall Study||2
3075890|NCT01353898|3797705|FG005|COMPLETED|Overall Study||1
3075891|NCT01353898|3797700|FG000|NOT COMPLETED|Overall Study||0
3075892|NCT01353898|3797701|FG001|NOT COMPLETED|Overall Study||0
3075893|NCT01353898|3797702|FG002|NOT COMPLETED|Overall Study||0
3075894|NCT01353898|3797703|FG003|NOT COMPLETED|Overall Study||0
3075895|NCT01353898|3797704|FG004|NOT COMPLETED|Overall Study||0
3075896|NCT01353898|3797705|FG005|NOT COMPLETED|Overall Study||1
3075897|NCT01353911|3797727|FG000|STARTED|Overall Study||36
3075898|NCT01353911|3797728|FG001|STARTED|Overall Study||66
3075899|NCT01353911|3797729|FG002|STARTED|Overall Study||68
3075900|NCT01353911|3797730|FG003|STARTED|Overall Study||24
3075901|NCT01353911|3797731|FG004|STARTED|Overall Study||29
3075902|NCT01353911|3797732|FG005|STARTED|Overall Study||43
3075903|NCT01353911|3797733|FG006|STARTED|Overall Study||36
3075904|NCT01353911|3797734|FG007|STARTED|Overall Study||66
3075905|NCT01353911|3797727|FG000|COMPLETED|Overall Study||28
3075906|NCT01353911|3797728|FG001|COMPLETED|Overall Study||57
3075907|NCT01353911|3797729|FG002|COMPLETED|Overall Study||59
3075908|NCT01353911|3797730|FG003|COMPLETED|Overall Study||22
3075909|NCT01353911|3797731|FG004|COMPLETED|Overall Study||23
3075910|NCT01353911|3797732|FG005|COMPLETED|Overall Study||36
3075911|NCT01353911|3797733|FG006|COMPLETED|Overall Study||30
3075912|NCT01353911|3797734|FG007|COMPLETED|Overall Study||51
3075913|NCT01353911|3797727|FG000|NOT COMPLETED|Overall Study||8
3075914|NCT01353911|3797728|FG001|NOT COMPLETED|Overall Study||9
3075915|NCT01353911|3797729|FG002|NOT COMPLETED|Overall Study||9
3075916|NCT01353911|3797730|FG003|NOT COMPLETED|Overall Study||2
3075917|NCT01353911|3797731|FG004|NOT COMPLETED|Overall Study||6
3075918|NCT01353911|3797732|FG005|NOT COMPLETED|Overall Study||7
3075919|NCT01353911|3797733|FG006|NOT COMPLETED|Overall Study||6
3075920|NCT01353911|3797734|FG007|NOT COMPLETED|Overall Study||15
3075921|NCT01353963|3797752|FG000|STARTED|Overall Study||13
3075922|NCT01353963|3797752|FG000|COMPLETED|Overall Study||11
3075923|NCT01353963|3797752|FG000|NOT COMPLETED|Overall Study||2
3075924|NCT01353976|3797758|FG000|STARTED|Overall Study||130
3075925|NCT01353976|3797759|FG001|STARTED|Overall Study||134
3075926|NCT01353976|3797758|FG000|COMPLETED|Overall Study||82
3075927|NCT01353976|3797759|FG001|COMPLETED|Overall Study||83
3075928|NCT01353976|3797758|FG000|NOT COMPLETED|Overall Study||48
3075929|NCT01353976|3797759|FG001|NOT COMPLETED|Overall Study||51
3075930|NCT01354015|3797767|FG000|STARTED|Overall Study||50
3075931|NCT01354015|3797768|FG001|STARTED|Overall Study||48
3075932|NCT01354015|3797767|FG000|COMPLETED|Overall Study||44
3075933|NCT01354015|3797768|FG001|COMPLETED|Overall Study||43
3075934|NCT01354015|3797767|FG000|NOT COMPLETED|Overall Study||6
3075935|NCT01354015|3797768|FG001|NOT COMPLETED|Overall Study||5
3075936|NCT01354028|3797774|FG000|STARTED|Overall Study||15
3075937|NCT01354028|3797775|FG001|STARTED|Overall Study||15
3075938|NCT01354028|3797774|FG000|COMPLETED|Overall Study||13
3075939|NCT01354028|3797775|FG001|COMPLETED|Overall Study||10
3075940|NCT01354028|3797774|FG000|NOT COMPLETED|Overall Study||2
3075941|NCT01354028|3797775|FG001|NOT COMPLETED|Overall Study||5
3075942|NCT01354106|3797787|FG000|STARTED|Overall Study||26
3075943|NCT01354106|3797787|FG000|COMPLETED|Overall Study||24
3075944|NCT01354106|3797787|FG000|NOT COMPLETED|Overall Study||2
3075945|NCT01354132|3797795|FG000|STARTED|Randomization|1 never took study medication dropped by physician decision (White matter lesion on MRI)|32
3075946|NCT01354132|3797796|FG001|STARTED|Randomization|1 never took study medication due to subject withdrawal|31
3075947|NCT01354132|3797795|FG000|COMPLETED|Randomization||31
3075948|NCT01354132|3797796|FG001|COMPLETED|Randomization||30
3075949|NCT01354132|3797795|FG000|NOT COMPLETED|Randomization||1
3075950|NCT01354132|3797796|FG001|NOT COMPLETED|Randomization||1
3075951|NCT01354132|3797795|FG000|STARTED|Double Blind (Visits 1-7)|9 did not compete 7 study visits|31
3136759|NCT01714947|3862017|FG000|STARTED|Part B||3
3075952|NCT01354132|3797796|FG001|STARTED|Double Blind (Visits 1-7)|11 did not compete 7 study visits|30
3075953|NCT01354132|3797795|FG000|Completed More Than 1 Visit|Double Blind (Visits 1-7)||4
3075954|NCT01354132|3797796|FG001|Completed More Than 1 Visit|Double Blind (Visits 1-7)||5
3075955|NCT01354132|3797795|FG000|Stopped After First Visit|Double Blind (Visits 1-7)||3
3075956|NCT01354132|3797796|FG001|Stopped After First Visit|Double Blind (Visits 1-7)||2
3075957|NCT01354132|3797795|FG000|Didn't Complete at Least 1 Visit|Double Blind (Visits 1-7)||2
3075958|NCT01354132|3797796|FG001|Didn't Complete at Least 1 Visit|Double Blind (Visits 1-7)||4
3075959|NCT01354132|3797795|FG000|COMPLETED|Double Blind (Visits 1-7)||22
3075960|NCT01354132|3797796|FG001|COMPLETED|Double Blind (Visits 1-7)||19
3075961|NCT01354132|3797795|FG000|NOT COMPLETED|Double Blind (Visits 1-7)||9
3075962|NCT01354132|3797796|FG001|NOT COMPLETED|Double Blind (Visits 1-7)||11
3075963|NCT01354132|3797795|FG000|STARTED|1 Month Post Study Medication||22
3075964|NCT01354132|3797796|FG001|STARTED|1 Month Post Study Medication||19
3075965|NCT01354132|3797795|FG000|1 Follow-up Visit (Visit 8)|1 Month Post Study Medication||21
3075966|NCT01354132|3797796|FG001|1 Follow-up Visit (Visit 8)|1 Month Post Study Medication||16
3075967|NCT01354132|3797795|FG000|COMPLETED|1 Month Post Study Medication||21
3075968|NCT01354132|3797796|FG001|COMPLETED|1 Month Post Study Medication||16
3075969|NCT01354132|3797795|FG000|NOT COMPLETED|1 Month Post Study Medication||1
3075970|NCT01354132|3797796|FG001|NOT COMPLETED|1 Month Post Study Medication||3
3075971|NCT01354145|3797807|FG000|STARTED|Overall Study||97
3075972|NCT01354145|3797808|FG001|STARTED|Overall Study||97
3075973|NCT01354145|3797807|FG000|COMPLETED|Overall Study||58
3075974|NCT01354145|3797808|FG001|COMPLETED|Overall Study||63
3075975|NCT01354145|3797807|FG000|NOT COMPLETED|Overall Study||39
3075976|NCT01354145|3797808|FG001|NOT COMPLETED|Overall Study||34
3075977|NCT01354197|3797816|FG000|STARTED|Overall Study||4652
3075978|NCT01354197|3797816|FG000|COMPLETED|Overall Study||4652
3075979|NCT01354197|3797816|FG000|NOT COMPLETED|Overall Study||0
3075980|NCT01354223|3797823|FG000|STARTED|Overall Study||60
3075981|NCT01354223|3797824|FG001|STARTED|Overall Study||30
3075982|NCT01354223|3797823|FG000|COMPLETED|Overall Study||57
3075983|NCT01354223|3797824|FG001|COMPLETED|Overall Study||29
3075984|NCT01354223|3797823|FG000|NOT COMPLETED|Overall Study||3
3075985|NCT01354223|3797824|FG001|NOT COMPLETED|Overall Study||1
3075986|NCT01354314|3797834|FG000|STARTED|Overall Study||12
3075987|NCT01354314|3797835|FG001|STARTED|Overall Study||11
3075988|NCT01354314|3797836|FG002|STARTED|Overall Study||11
3075989|NCT01354314|3797837|FG003|STARTED|Overall Study||11
3075990|NCT01354314|3797834|FG000|Completed (ITT)|Overall Study||11
3075991|NCT01354314|3797835|FG001|Completed (ITT)|Overall Study||11
3075992|NCT01354314|3797836|FG002|Completed (ITT)|Overall Study||9
3075993|NCT01354314|3797837|FG003|Completed (ITT)|Overall Study||10
3075994|NCT01354314|3797834|FG000|COMPLETED|Overall Study||6
3075995|NCT01354314|3797835|FG001|COMPLETED|Overall Study||8
3075996|NCT01354314|3797836|FG002|COMPLETED|Overall Study||3
3075997|NCT01354314|3797837|FG003|COMPLETED|Overall Study||5
3075998|NCT01354314|3797834|FG000|NOT COMPLETED|Overall Study||6
3075999|NCT01354314|3797835|FG001|NOT COMPLETED|Overall Study||3
3076000|NCT01354314|3797836|FG002|NOT COMPLETED|Overall Study||8
3076001|NCT01354314|3797837|FG003|NOT COMPLETED|Overall Study||6
3076002|NCT01354353|3797855|FG000|STARTED|Overall Study||16
3076003|NCT01354353|3797856|FG001|STARTED|Overall Study|Included in this arm are six participants who erroneously received oral 80 mg LY2140023 BID.|12
3076004|NCT01354353|3797857|FG002|STARTED|Overall Study||11
3076005|NCT01354353|3797858|FG003|STARTED|Overall Study||12
3076006|NCT01354353|3797859|FG004|STARTED|Overall Study||12
3076007|NCT01354353|3797860|FG005|STARTED|Overall Study||12
3076008|NCT01354353|3797855|FG000|Received at Least One Dose of Study Drug|Overall Study||16
3076009|NCT01354353|3797856|FG001|Received at Least One Dose of Study Drug|Overall Study||11
3076010|NCT01354353|3797857|FG002|Received at Least One Dose of Study Drug|Overall Study||10
3076011|NCT01354353|3797858|FG003|Received at Least One Dose of Study Drug|Overall Study||11
3076012|NCT01354353|3797859|FG004|Received at Least One Dose of Study Drug|Overall Study||11
3076013|NCT01354353|3797860|FG005|Received at Least One Dose of Study Drug|Overall Study||11
3076014|NCT01354353|3797855|FG000|COMPLETED|Overall Study||13
3076015|NCT01354353|3797856|FG001|COMPLETED|Overall Study||11
3076016|NCT01354353|3797857|FG002|COMPLETED|Overall Study||9
3076017|NCT01354353|3797858|FG003|COMPLETED|Overall Study||7
3076018|NCT01354353|3797859|FG004|COMPLETED|Overall Study||11
3076019|NCT01354353|3797860|FG005|COMPLETED|Overall Study||6
3076020|NCT01354353|3797855|FG000|NOT COMPLETED|Overall Study||3
3076021|NCT01354353|3797856|FG001|NOT COMPLETED|Overall Study||1
3076022|NCT01354353|3797857|FG002|NOT COMPLETED|Overall Study||2
3076023|NCT01354353|3797858|FG003|NOT COMPLETED|Overall Study||5
3076024|NCT01354353|3797859|FG004|NOT COMPLETED|Overall Study||1
3076025|NCT01354353|3797860|FG005|NOT COMPLETED|Overall Study||6
3076026|NCT01354431|3797884|FG000|STARTED|Randomized to Enter Treatment Period||60
3076027|NCT01354431|3797885|FG001|STARTED|Randomized to Enter Treatment Period||54
3076028|NCT01354431|3797886|FG002|STARTED|Randomized to Enter Treatment Period||54
3076029|NCT01354431|3797884|FG000|COMPLETED|Randomized to Enter Treatment Period||59
3076030|NCT01354431|3797885|FG001|COMPLETED|Randomized to Enter Treatment Period||54
3076031|NCT01354431|3797886|FG002|COMPLETED|Randomized to Enter Treatment Period||54
3076032|NCT01354431|3797884|FG000|NOT COMPLETED|Randomized to Enter Treatment Period||1
3076033|NCT01354431|3797885|FG001|NOT COMPLETED|Randomized to Enter Treatment Period||0
3076034|NCT01354431|3797886|FG002|NOT COMPLETED|Randomized to Enter Treatment Period||0
3076035|NCT01354431|3797884|FG000|STARTED|Participants Treated||59
3076036|NCT01354431|3797885|FG001|STARTED|Participants Treated||54
3076037|NCT01354431|3797886|FG002|STARTED|Participants Treated||54
3076038|NCT01354431|3797884|FG000|COMPLETED|Participants Treated||0
3076039|NCT01354431|3797885|FG001|COMPLETED|Participants Treated||0
3076040|NCT01354431|3797886|FG002|COMPLETED|Participants Treated||0
3076041|NCT01354431|3797884|FG000|NOT COMPLETED|Participants Treated||59
3076042|NCT01354431|3797885|FG001|NOT COMPLETED|Participants Treated||54
3076043|NCT01354431|3797886|FG002|NOT COMPLETED|Participants Treated||54
3076044|NCT01354444|3797900|FG000|STARTED|Overall Study||14
3076045|NCT01354444|3797901|FG001|STARTED|Overall Study||15
3076046|NCT01354444|3797900|FG000|COMPLETED|Overall Study||6
3076047|NCT01354444|3797901|FG001|COMPLETED|Overall Study||11
3076048|NCT01354444|3797900|FG000|NOT COMPLETED|Overall Study||8
3076049|NCT01354444|3797901|FG001|NOT COMPLETED|Overall Study||4
3076050|NCT01354496|3797911|FG000|STARTED|Period 1||6
3076051|NCT01354496|3797912|FG001|STARTED|Period 1||6
3076052|NCT01354496|3797913|FG002|STARTED|Period 1||6
3076053|NCT01354496|3797914|FG003|STARTED|Period 1||6
3076054|NCT01354496|3797915|FG004|STARTED|Period 1||5
3076055|NCT01354496|3797916|FG005|STARTED|Period 1||6
3076056|NCT01354496|3797911|FG000|Received at Least 1 Dose of Study Drug|Period 1||6
3076057|NCT01354496|3797912|FG001|Received at Least 1 Dose of Study Drug|Period 1||6
3076058|NCT01354496|3797913|FG002|Received at Least 1 Dose of Study Drug|Period 1||6
3076059|NCT01354496|3797914|FG003|Received at Least 1 Dose of Study Drug|Period 1||6
3076060|NCT01354496|3797915|FG004|Received at Least 1 Dose of Study Drug|Period 1||5
3076061|NCT01354496|3797916|FG005|Received at Least 1 Dose of Study Drug|Period 1||6
3076062|NCT01354496|3797911|FG000|COMPLETED|Period 1||6
3076063|NCT01354496|3797912|FG001|COMPLETED|Period 1||6
3076064|NCT01354496|3797913|FG002|COMPLETED|Period 1||4
3076065|NCT01354496|3797914|FG003|COMPLETED|Period 1||6
3076066|NCT01354496|3797915|FG004|COMPLETED|Period 1||5
3076067|NCT01354496|3797916|FG005|COMPLETED|Period 1||6
3076068|NCT01354496|3797911|FG000|NOT COMPLETED|Period 1||0
3076069|NCT01354496|3797912|FG001|NOT COMPLETED|Period 1||0
3076070|NCT01354496|3797913|FG002|NOT COMPLETED|Period 1||2
3076071|NCT01354496|3797914|FG003|NOT COMPLETED|Period 1||0
3076072|NCT01354496|3797915|FG004|NOT COMPLETED|Period 1||0
3076073|NCT01354496|3797916|FG005|NOT COMPLETED|Period 1||0
3076074|NCT01354496|3797911|FG000|STARTED|Washout (at Least 14 Days)||6
3076075|NCT01354496|3797912|FG001|STARTED|Washout (at Least 14 Days)||6
3076076|NCT01354496|3797913|FG002|STARTED|Washout (at Least 14 Days)||4
3076077|NCT01354496|3797914|FG003|STARTED|Washout (at Least 14 Days)||6
3076078|NCT01354496|3797915|FG004|STARTED|Washout (at Least 14 Days)||5
3076079|NCT01354496|3797916|FG005|STARTED|Washout (at Least 14 Days)||6
3076080|NCT01354496|3797911|FG000|COMPLETED|Washout (at Least 14 Days)||6
3076081|NCT01354496|3797912|FG001|COMPLETED|Washout (at Least 14 Days)||6
3076082|NCT01354496|3797913|FG002|COMPLETED|Washout (at Least 14 Days)||4
3076083|NCT01354496|3797914|FG003|COMPLETED|Washout (at Least 14 Days)||6
3076084|NCT01354496|3797915|FG004|COMPLETED|Washout (at Least 14 Days)||5
3076085|NCT01354496|3797916|FG005|COMPLETED|Washout (at Least 14 Days)||6
3076086|NCT01354496|3797911|FG000|NOT COMPLETED|Washout (at Least 14 Days)||0
3076087|NCT01354496|3797912|FG001|NOT COMPLETED|Washout (at Least 14 Days)||0
3076088|NCT01354496|3797913|FG002|NOT COMPLETED|Washout (at Least 14 Days)||0
3076089|NCT01354496|3797914|FG003|NOT COMPLETED|Washout (at Least 14 Days)||0
3076090|NCT01354496|3797915|FG004|NOT COMPLETED|Washout (at Least 14 Days)||0
3076091|NCT01354496|3797916|FG005|NOT COMPLETED|Washout (at Least 14 Days)||0
3076092|NCT01354496|3797911|FG000|STARTED|Period 2||6
3076093|NCT01354496|3797912|FG001|STARTED|Period 2||6
3076094|NCT01354496|3797913|FG002|STARTED|Period 2||4
3076095|NCT01354496|3797914|FG003|STARTED|Period 2||6
3076096|NCT01354496|3797915|FG004|STARTED|Period 2||5
3076097|NCT01354496|3797916|FG005|STARTED|Period 2||6
3076098|NCT01354496|3797911|FG000|COMPLETED|Period 2||6
3076099|NCT01354496|3797912|FG001|COMPLETED|Period 2||6
3076100|NCT01354496|3797913|FG002|COMPLETED|Period 2||4
3076101|NCT01354496|3797914|FG003|COMPLETED|Period 2||5
3076102|NCT01354496|3797915|FG004|COMPLETED|Period 2||5
3076103|NCT01354496|3797916|FG005|COMPLETED|Period 2||6
3076104|NCT01354496|3797911|FG000|NOT COMPLETED|Period 2||0
3076105|NCT01354496|3797912|FG001|NOT COMPLETED|Period 2||0
3076106|NCT01354496|3797913|FG002|NOT COMPLETED|Period 2||0
3076107|NCT01354496|3797914|FG003|NOT COMPLETED|Period 2||1
3076108|NCT01354496|3797915|FG004|NOT COMPLETED|Period 2||0
3076109|NCT01354496|3797916|FG005|NOT COMPLETED|Period 2||0
3076110|NCT01354496|3797911|FG000|STARTED|Washout (at Least 14 Days)||6
3076111|NCT01354496|3797912|FG001|STARTED|Washout (at Least 14 Days)||6
3076112|NCT01354496|3797913|FG002|STARTED|Washout (at Least 14 Days)||4
3076113|NCT01354496|3797914|FG003|STARTED|Washout (at Least 14 Days)||5
3076114|NCT01354496|3797915|FG004|STARTED|Washout (at Least 14 Days)||5
3076115|NCT01354496|3797916|FG005|STARTED|Washout (at Least 14 Days)||6
3076116|NCT01354496|3797911|FG000|COMPLETED|Washout (at Least 14 Days)||6
3076117|NCT01354496|3797912|FG001|COMPLETED|Washout (at Least 14 Days)||5
3076118|NCT01354496|3797913|FG002|COMPLETED|Washout (at Least 14 Days)||4
3076119|NCT01354496|3797914|FG003|COMPLETED|Washout (at Least 14 Days)||4
3076120|NCT01354496|3797915|FG004|COMPLETED|Washout (at Least 14 Days)||5
3076121|NCT01354496|3797916|FG005|COMPLETED|Washout (at Least 14 Days)||6
3076122|NCT01354496|3797911|FG000|NOT COMPLETED|Washout (at Least 14 Days)||0
3076123|NCT01354496|3797912|FG001|NOT COMPLETED|Washout (at Least 14 Days)||1
3076124|NCT01354496|3797913|FG002|NOT COMPLETED|Washout (at Least 14 Days)||0
3076125|NCT01354496|3797914|FG003|NOT COMPLETED|Washout (at Least 14 Days)||1
3076126|NCT01354496|3797915|FG004|NOT COMPLETED|Washout (at Least 14 Days)||0
3076127|NCT01354496|3797916|FG005|NOT COMPLETED|Washout (at Least 14 Days)||0
3076128|NCT01354496|3797911|FG000|STARTED|Period 3||6
3076129|NCT01354496|3797912|FG001|STARTED|Period 3||5
3076130|NCT01354496|3797913|FG002|STARTED|Period 3||4
3076131|NCT01354496|3797914|FG003|STARTED|Period 3||4
3076132|NCT01354496|3797915|FG004|STARTED|Period 3||5
3076133|NCT01354496|3797916|FG005|STARTED|Period 3||6
3076134|NCT01354496|3797911|FG000|COMPLETED|Period 3||6
3076135|NCT01354496|3797912|FG001|COMPLETED|Period 3||5
3076136|NCT01354496|3797913|FG002|COMPLETED|Period 3||4
3076137|NCT01354496|3797914|FG003|COMPLETED|Period 3||4
3076138|NCT01354496|3797915|FG004|COMPLETED|Period 3||5
3076139|NCT01354496|3797916|FG005|COMPLETED|Period 3||6
3076140|NCT01354496|3797911|FG000|NOT COMPLETED|Period 3||0
3076141|NCT01354496|3797912|FG001|NOT COMPLETED|Period 3||0
3076142|NCT01354496|3797913|FG002|NOT COMPLETED|Period 3||0
3076143|NCT01354496|3797914|FG003|NOT COMPLETED|Period 3||0
3076144|NCT01354496|3797915|FG004|NOT COMPLETED|Period 3||0
3076145|NCT01354496|3797916|FG005|NOT COMPLETED|Period 3||0
3076146|NCT01354652|3797940|FG000|STARTED|Overall Study||3
3076147|NCT01354652|3797941|FG001|STARTED|Overall Study||2
3076148|NCT01354652|3797942|FG002|STARTED|Overall Study||0
3076149|NCT01354652|3797940|FG000|COMPLETED|Overall Study||0
3076150|NCT01354652|3797941|FG001|COMPLETED|Overall Study||0
3076151|NCT01354652|3797942|FG002|COMPLETED|Overall Study||0
3076152|NCT01354652|3797940|FG000|NOT COMPLETED|Overall Study||3
3076153|NCT01354652|3797941|FG001|NOT COMPLETED|Overall Study||2
3076154|NCT01354652|3797942|FG002|NOT COMPLETED|Overall Study||0
3076155|NCT01354691|3797953|FG000|STARTED|Overall Study||101
3076156|NCT01354691|3797954|FG001|STARTED|Overall Study||99
3076157|NCT01354691|3797953|FG000|ITT|Overall Study||99
3076158|NCT01354691|3797954|FG001|ITT|Overall Study||96
3076159|NCT01354691|3797953|FG000|PP|Overall Study||79
3076160|NCT01354691|3797954|FG001|PP|Overall Study||75
3076161|NCT01354691|3797953|FG000|COMPLETED|Overall Study||80
3076162|NCT01354691|3797954|FG001|COMPLETED|Overall Study||77
3076163|NCT01354691|3797953|FG000|NOT COMPLETED|Overall Study||21
3076164|NCT01354691|3797954|FG001|NOT COMPLETED|Overall Study||22
3076165|NCT01354899|3797960|FG000|STARTED|Overall Study||24
3076166|NCT01354899|3797960|FG000|COMPLETED|Overall Study||21
3076167|NCT01354899|3797960|FG000|NOT COMPLETED|Overall Study||3
3076168|NCT01354938|3797964|FG000|STARTED|Overall Study||220
3076169|NCT01354938|3797964|FG000|COMPLETED|Overall Study||219
3076170|NCT01354938|3797964|FG000|NOT COMPLETED|Overall Study||1
3076171|NCT01354964|3797970|FG000|STARTED|Overall Study||11
3076172|NCT01354964|3797971|FG001|STARTED|Overall Study||8
3076173|NCT01354964|3797970|FG000|COMPLETED|Overall Study||7
3076174|NCT01354964|3797971|FG001|COMPLETED|Overall Study||7
3076175|NCT01354964|3797970|FG000|NOT COMPLETED|Overall Study||4
3076176|NCT01354964|3797971|FG001|NOT COMPLETED|Overall Study||1
3076177|NCT01354990|3797979|FG000|STARTED|Overall Study||2974
3076178|NCT01354990|3797979|FG000|COMPLETED|Overall Study||2974
3076179|NCT01354990|3797979|FG000|NOT COMPLETED|Overall Study||0
3076180|NCT01355068|3797983|FG000|STARTED|First Intervention Period||13
3076181|NCT01355068|3797984|FG001|STARTED|First Intervention Period||13
3076182|NCT01355068|3797983|FG000|COMPLETED|First Intervention Period||13
3076183|NCT01355068|3797984|FG001|COMPLETED|First Intervention Period||11
3076184|NCT01355068|3797983|FG000|NOT COMPLETED|First Intervention Period||0
3076185|NCT01355068|3797984|FG001|NOT COMPLETED|First Intervention Period||2
3076186|NCT01355068|3797983|FG000|STARTED|Washout Period (at Least 7 Days)||13
3076187|NCT01355068|3797984|FG001|STARTED|Washout Period (at Least 7 Days)||11
3076188|NCT01355068|3797983|FG000|COMPLETED|Washout Period (at Least 7 Days)||13
3076189|NCT01355068|3797984|FG001|COMPLETED|Washout Period (at Least 7 Days)||11
3076190|NCT01355068|3797983|FG000|NOT COMPLETED|Washout Period (at Least 7 Days)||0
3076191|NCT01355068|3797984|FG001|NOT COMPLETED|Washout Period (at Least 7 Days)||0
3076192|NCT01355068|3797983|FG000|STARTED|Second Intervention Period||13
3076193|NCT01355068|3797984|FG001|STARTED|Second Intervention Period||11
3076194|NCT01355068|3797983|FG000|COMPLETED|Second Intervention Period||13
3076195|NCT01355068|3797984|FG001|COMPLETED|Second Intervention Period||11
3076196|NCT01355068|3797983|FG000|NOT COMPLETED|Second Intervention Period||0
3076197|NCT01355068|3797984|FG001|NOT COMPLETED|Second Intervention Period||0
3076198|NCT01355081|3797993|FG000|STARTED|Overall Study||119
3076199|NCT01355081|3797994|FG001|STARTED|Overall Study||123
3076200|NCT01355081|3797995|FG002|STARTED|Overall Study||124
3076201|NCT01355081|3797993|FG000|COMPLETED|Overall Study||112
3076202|NCT01355081|3797994|FG001|COMPLETED|Overall Study||113
3076203|NCT01355081|3797995|FG002|COMPLETED|Overall Study||113
3076204|NCT01355081|3797993|FG000|NOT COMPLETED|Overall Study||7
3076205|NCT01355081|3797994|FG001|NOT COMPLETED|Overall Study||10
3076206|NCT01355081|3797995|FG002|NOT COMPLETED|Overall Study||11
3076207|NCT01355159|3798005|FG000|STARTED|Overall Study||1228
3076208|NCT01355159|3798006|FG001|STARTED|Overall Study||1236
3076209|NCT01355159|3798005|FG000|COMPLETED|Overall Study||1144
3076210|NCT01355159|3798006|FG001|COMPLETED|Overall Study||1157
3076211|NCT01355159|3798005|FG000|NOT COMPLETED|Overall Study||84
3076212|NCT01355159|3798006|FG001|NOT COMPLETED|Overall Study||79
3076213|NCT01355224|3798016|FG000|STARTED|Overall Study||198
3076214|NCT01355224|3798017|FG001|STARTED|Overall Study||203
3076215|NCT01355224|3798018|FG002|STARTED|Overall Study||196
3076216|NCT01355224|3798019|FG003|STARTED|Overall Study||201
3076217|NCT01355224|3798016|FG000|Competed Baseline|Overall Study||191
3076218|NCT01355224|3798017|FG001|Competed Baseline|Overall Study||200
3076219|NCT01355224|3798018|FG002|Competed Baseline|Overall Study||193
3076220|NCT01355224|3798019|FG003|Competed Baseline|Overall Study||193
3076221|NCT01355224|3798016|FG000|COMPLETED|Overall Study||167
3076222|NCT01355224|3798017|FG001|COMPLETED|Overall Study||180
3076223|NCT01355224|3798018|FG002|COMPLETED|Overall Study||177
3076224|NCT01355224|3798019|FG003|COMPLETED|Overall Study||172
3076225|NCT01355224|3798016|FG000|NOT COMPLETED|Overall Study||31
3076226|NCT01355224|3798017|FG001|NOT COMPLETED|Overall Study||23
3076227|NCT01355224|3798018|FG002|NOT COMPLETED|Overall Study||19
3076228|NCT01355224|3798019|FG003|NOT COMPLETED|Overall Study||29
3076229|NCT01355289|3798041|FG000|STARTED|Core Study||17
3076230|NCT01355289|3798042|FG001|STARTED|Core Study||16
3076231|NCT01355289|3798043|FG002|STARTED|Core Study||18
3076232|NCT01355289|3798044|FG003|STARTED|Core Study||14
3076233|NCT01355289|3798045|FG004|STARTED|Core Study||0
3076234|NCT01355289|3798041|FG000|COMPLETED|Core Study||16
3076235|NCT01355289|3798042|FG001|COMPLETED|Core Study||16
3076236|NCT01355289|3798043|FG002|COMPLETED|Core Study||18
3076237|NCT01355289|3798044|FG003|COMPLETED|Core Study||12
3076238|NCT01355289|3798045|FG004|COMPLETED|Core Study||0
3076239|NCT01355289|3798041|FG000|NOT COMPLETED|Core Study||1
3076240|NCT01355289|3798042|FG001|NOT COMPLETED|Core Study||0
3076241|NCT01355289|3798043|FG002|NOT COMPLETED|Core Study||0
3076242|NCT01355289|3798044|FG003|NOT COMPLETED|Core Study||2
3076243|NCT01355289|3798045|FG004|NOT COMPLETED|Core Study||0
3076244|NCT01355289|3798041|FG000|STARTED|Open Label Extension||0
3076245|NCT01355289|3798042|FG001|STARTED|Open Label Extension||0
3076246|NCT01355289|3798043|FG002|STARTED|Open Label Extension||0
3076247|NCT01355289|3798044|FG003|STARTED|Open Label Extension||0
3076248|NCT01355289|3798045|FG004|STARTED|Open Label Extension||62
3076249|NCT01355289|3798041|FG000|COMPLETED|Open Label Extension||0
3076250|NCT01355289|3798042|FG001|COMPLETED|Open Label Extension||0
3076251|NCT01355289|3798043|FG002|COMPLETED|Open Label Extension||0
3076252|NCT01355289|3798044|FG003|COMPLETED|Open Label Extension||0
3076253|NCT01355289|3798045|FG004|COMPLETED|Open Label Extension||28
3076254|NCT01355289|3798041|FG000|NOT COMPLETED|Open Label Extension||0
3076255|NCT01355289|3798042|FG001|NOT COMPLETED|Open Label Extension||0
3076256|NCT01355289|3798043|FG002|NOT COMPLETED|Open Label Extension||0
3076257|NCT01355289|3798044|FG003|NOT COMPLETED|Open Label Extension||0
3076258|NCT01355289|3798045|FG004|NOT COMPLETED|Open Label Extension||34
3076259|NCT01355302|3798058|FG000|STARTED|Phase 1b|Replaced 1 subject; who discontinued study drug in first cycle|7
3076260|NCT01355302|3798059|FG001|STARTED|Phase 1b||0
3076261|NCT01355302|3798060|FG002|STARTED|Phase 1b||0
3076262|NCT01355302|3798058|FG000|COMPLETED|Phase 1b|The subject who completed 6 cycles was withdrawn by sponsor request.|1
3076263|NCT01355302|3798059|FG001|COMPLETED|Phase 1b||0
3076264|NCT01355302|3798060|FG002|COMPLETED|Phase 1b||0
3076265|NCT01355302|3798058|FG000|NOT COMPLETED|Phase 1b||6
3076266|NCT01355302|3798059|FG001|NOT COMPLETED|Phase 1b||0
3284727|NCT02766608|4018424|FG004|NOT COMPLETED|Overall Study||29
3284728|NCT02766673|4018439|FG000|STARTED|Overall Study||4
3284729|NCT02766673|4018440|FG001|STARTED|Overall Study||4
3284730|NCT02766673|4018441|FG002|STARTED|Overall Study||4
3284731|NCT02766673|4018442|FG003|STARTED|Overall Study||4
3284732|NCT02766673|4018443|FG004|STARTED|Overall Study||4
3284733|NCT02766673|4018444|FG005|STARTED|Overall Study||4
3284734|NCT02766673|4018439|FG000|COMPLETED|Overall Study||3
3284735|NCT02766673|4018440|FG001|COMPLETED|Overall Study||4
3284736|NCT02766673|4018441|FG002|COMPLETED|Overall Study||4
3284737|NCT02766673|4018442|FG003|COMPLETED|Overall Study||4
3284738|NCT02766673|4018443|FG004|COMPLETED|Overall Study||4
3284739|NCT02766673|4018444|FG005|COMPLETED|Overall Study||3
3284740|NCT02766673|4018439|FG000|NOT COMPLETED|Overall Study||1
3284741|NCT02766673|4018440|FG001|NOT COMPLETED|Overall Study||0
3284742|NCT02766673|4018441|FG002|NOT COMPLETED|Overall Study||0
3284743|NCT02766673|4018442|FG003|NOT COMPLETED|Overall Study||0
3284744|NCT02766673|4018443|FG004|NOT COMPLETED|Overall Study||0
3284745|NCT02766673|4018444|FG005|NOT COMPLETED|Overall Study||1
3284746|NCT02766777|4018452|FG000|STARTED|Overall Study||87
3284747|NCT02766777|4018452|FG000|Treated (Safety [SAF] Population)|Overall Study||87
3076267|NCT01355302|3798060|FG002|NOT COMPLETED|Phase 1b||0
3076268|NCT01355302|3798058|FG000|STARTED|Phase 2|Treatment arm not designated for phase 2.|0
3076269|NCT01355302|3798059|FG001|STARTED|Phase 2|The study was terminated prior to enrollment|0
3076270|NCT01355302|3798060|FG002|STARTED|Phase 2|The study was terminated prior to enrollment|0
3076271|NCT01355302|3798058|FG000|COMPLETED|Phase 2||0
3076272|NCT01355302|3798059|FG001|COMPLETED|Phase 2||0
3076273|NCT01355302|3798060|FG002|COMPLETED|Phase 2||0
3076274|NCT01355302|3798058|FG000|NOT COMPLETED|Phase 2||0
3076275|NCT01355302|3798059|FG001|NOT COMPLETED|Phase 2||0
3076276|NCT01355302|3798060|FG002|NOT COMPLETED|Phase 2||0
3076277|NCT01355419|3798068|FG000|STARTED|Overall Study||150
3076278|NCT01355419|3798068|FG000|COMPLETED|Overall Study||142
3076279|NCT01355419|3798068|FG000|NOT COMPLETED|Overall Study||8
3076280|NCT01355458|3798074|FG000|STARTED|Overall Study||129
3076281|NCT01355458|3798075|FG001|STARTED|Overall Study||131
3284748|NCT02766777|4018452|FG000|COMPLETED|Overall Study||53
3076282|NCT01355458|3798074|FG000|COMPLETED|Overall Study||127
3076283|NCT01355458|3798075|FG001|COMPLETED|Overall Study||127
3076284|NCT01355458|3798074|FG000|NOT COMPLETED|Overall Study||2
3076285|NCT01355458|3798075|FG001|NOT COMPLETED|Overall Study||4
3076286|NCT01355471|3798083|FG000|STARTED|Overall Study||148
3076287|NCT01355471|3798084|FG001|STARTED|Overall Study||145
3076288|NCT01355471|3798083|FG000|COMPLETED|Overall Study||141
3076289|NCT01355471|3798084|FG001|COMPLETED|Overall Study||142
3076290|NCT01355471|3798083|FG000|NOT COMPLETED|Overall Study||7
3076291|NCT01355471|3798084|FG001|NOT COMPLETED|Overall Study||3
3076292|NCT01355484|3798092|FG000|STARTED|Overall Study||160
3076293|NCT01355484|3798093|FG001|STARTED|Overall Study||161
3076294|NCT01355484|3798092|FG000|COMPLETED|Overall Study||109
3076295|NCT01355484|3798093|FG001|COMPLETED|Overall Study||107
3076296|NCT01355484|3798092|FG000|NOT COMPLETED|Overall Study||51
3076297|NCT01355484|3798093|FG001|NOT COMPLETED|Overall Study||54
3076298|NCT01355497|3798101|FG000|STARTED|Overall Study||165
3076299|NCT01355497|3798102|FG001|STARTED|Overall Study||165
3076300|NCT01355497|3798101|FG000|COMPLETED|Overall Study||99
3076301|NCT01355497|3798102|FG001|COMPLETED|Overall Study||102
3076302|NCT01355497|3798101|FG000|NOT COMPLETED|Overall Study||66
3076303|NCT01355497|3798102|FG001|NOT COMPLETED|Overall Study||63
3076304|NCT01355523|3798110|FG000|STARTED|Overall Study||28
3076305|NCT01355523|3798111|FG001|STARTED|Overall Study||26
3076306|NCT01355523|3798110|FG000|COMPLETED|Overall Study||27
3076307|NCT01355523|3798111|FG001|COMPLETED|Overall Study||16
3076308|NCT01355523|3798110|FG000|NOT COMPLETED|Overall Study||1
3076309|NCT01355523|3798111|FG001|NOT COMPLETED|Overall Study||10
3076310|NCT01355575|3798117|FG000|STARTED|Overall Study||15
3076311|NCT01355575|3798117|FG000|COMPLETED|Overall Study||13
3076312|NCT01355575|3798117|FG000|NOT COMPLETED|Overall Study||2
3076313|NCT01355588|3798129|FG000|STARTED|First Intervention (Day 1)||4
3076314|NCT01355588|3798130|FG001|STARTED|First Intervention (Day 1)||4
3076315|NCT01355588|3798131|FG002|STARTED|First Intervention (Day 1)||4
3076316|NCT01355588|3798132|FG003|STARTED|First Intervention (Day 1)||4
3076317|NCT01355588|3798129|FG000|COMPLETED|First Intervention (Day 1)||4
3076318|NCT01355588|3798130|FG001|COMPLETED|First Intervention (Day 1)||4
3076319|NCT01355588|3798131|FG002|COMPLETED|First Intervention (Day 1)||4
3076320|NCT01355588|3798132|FG003|COMPLETED|First Intervention (Day 1)||4
3076321|NCT01355588|3798129|FG000|NOT COMPLETED|First Intervention (Day 1)||0
3076322|NCT01355588|3798130|FG001|NOT COMPLETED|First Intervention (Day 1)||0
3076323|NCT01355588|3798131|FG002|NOT COMPLETED|First Intervention (Day 1)||0
3076324|NCT01355588|3798132|FG003|NOT COMPLETED|First Intervention (Day 1)||0
3076325|NCT01355588|3798129|FG000|STARTED|Washout (3-7 Days)||4
3076326|NCT01355588|3798130|FG001|STARTED|Washout (3-7 Days)||4
3076327|NCT01355588|3798131|FG002|STARTED|Washout (3-7 Days)||4
3076328|NCT01355588|3798132|FG003|STARTED|Washout (3-7 Days)||4
3076329|NCT01355588|3798129|FG000|COMPLETED|Washout (3-7 Days)||4
3076330|NCT01355588|3798130|FG001|COMPLETED|Washout (3-7 Days)||4
3076331|NCT01355588|3798131|FG002|COMPLETED|Washout (3-7 Days)||4
3076332|NCT01355588|3798132|FG003|COMPLETED|Washout (3-7 Days)||4
3076333|NCT01355588|3798129|FG000|NOT COMPLETED|Washout (3-7 Days)||0
3076334|NCT01355588|3798130|FG001|NOT COMPLETED|Washout (3-7 Days)||0
3076335|NCT01355588|3798131|FG002|NOT COMPLETED|Washout (3-7 Days)||0
3076336|NCT01355588|3798132|FG003|NOT COMPLETED|Washout (3-7 Days)||0
3076337|NCT01355588|3798129|FG000|STARTED|Second Intervention (After Washout)||4
3076338|NCT01355588|3798130|FG001|STARTED|Second Intervention (After Washout)||4
3076339|NCT01355588|3798131|FG002|STARTED|Second Intervention (After Washout)||4
3076340|NCT01355588|3798132|FG003|STARTED|Second Intervention (After Washout)||4
3076341|NCT01355588|3798129|FG000|COMPLETED|Second Intervention (After Washout)||4
3076342|NCT01355588|3798130|FG001|COMPLETED|Second Intervention (After Washout)||4
3076343|NCT01355588|3798131|FG002|COMPLETED|Second Intervention (After Washout)||4
3076344|NCT01355588|3798132|FG003|COMPLETED|Second Intervention (After Washout)||4
3076345|NCT01355588|3798129|FG000|NOT COMPLETED|Second Intervention (After Washout)||0
3076346|NCT01355588|3798130|FG001|NOT COMPLETED|Second Intervention (After Washout)||0
3076347|NCT01355588|3798131|FG002|NOT COMPLETED|Second Intervention (After Washout)||0
3076348|NCT01355588|3798132|FG003|NOT COMPLETED|Second Intervention (After Washout)||0
3076349|NCT01355588|3798129|FG000|STARTED|Washout (3-7 Days)||4
3076350|NCT01355588|3798130|FG001|STARTED|Washout (3-7 Days)||4
3076351|NCT01355588|3798131|FG002|STARTED|Washout (3-7 Days)||4
3076352|NCT01355588|3798132|FG003|STARTED|Washout (3-7 Days)||4
3076353|NCT01355588|3798129|FG000|COMPLETED|Washout (3-7 Days)||4
3076354|NCT01355588|3798130|FG001|COMPLETED|Washout (3-7 Days)||4
3076355|NCT01355588|3798131|FG002|COMPLETED|Washout (3-7 Days)||4
3076356|NCT01355588|3798132|FG003|COMPLETED|Washout (3-7 Days)||4
3076357|NCT01355588|3798129|FG000|NOT COMPLETED|Washout (3-7 Days)||0
3076358|NCT01355588|3798130|FG001|NOT COMPLETED|Washout (3-7 Days)||0
3076359|NCT01355588|3798131|FG002|NOT COMPLETED|Washout (3-7 Days)||0
3076360|NCT01355588|3798132|FG003|NOT COMPLETED|Washout (3-7 Days)||0
3076361|NCT01355588|3798129|FG000|STARTED|Third Intervention (After Washout)||4
3076362|NCT01355588|3798130|FG001|STARTED|Third Intervention (After Washout)||4
3076363|NCT01355588|3798131|FG002|STARTED|Third Intervention (After Washout)||4
3076364|NCT01355588|3798132|FG003|STARTED|Third Intervention (After Washout)||4
3076365|NCT01355588|3798129|FG000|COMPLETED|Third Intervention (After Washout)||4
3076366|NCT01355588|3798130|FG001|COMPLETED|Third Intervention (After Washout)||4
3076367|NCT01355588|3798131|FG002|COMPLETED|Third Intervention (After Washout)||4
3076368|NCT01355588|3798132|FG003|COMPLETED|Third Intervention (After Washout)||4
3076369|NCT01355588|3798129|FG000|NOT COMPLETED|Third Intervention (After Washout)||0
3076370|NCT01355588|3798130|FG001|NOT COMPLETED|Third Intervention (After Washout)||0
3076371|NCT01355588|3798131|FG002|NOT COMPLETED|Third Intervention (After Washout)||0
3076372|NCT01355588|3798132|FG003|NOT COMPLETED|Third Intervention (After Washout)||0
3076373|NCT01355588|3798129|FG000|STARTED|Washout (3-7 Days)||4
3076374|NCT01355588|3798130|FG001|STARTED|Washout (3-7 Days)||4
3076375|NCT01355588|3798131|FG002|STARTED|Washout (3-7 Days)||4
3076376|NCT01355588|3798132|FG003|STARTED|Washout (3-7 Days)||4
3076377|NCT01355588|3798129|FG000|COMPLETED|Washout (3-7 Days)||4
3076378|NCT01355588|3798130|FG001|COMPLETED|Washout (3-7 Days)||4
3076379|NCT01355588|3798131|FG002|COMPLETED|Washout (3-7 Days)||4
3076380|NCT01355588|3798132|FG003|COMPLETED|Washout (3-7 Days)||4
3076381|NCT01355588|3798129|FG000|NOT COMPLETED|Washout (3-7 Days)||0
3076382|NCT01355588|3798130|FG001|NOT COMPLETED|Washout (3-7 Days)||0
3076383|NCT01355588|3798131|FG002|NOT COMPLETED|Washout (3-7 Days)||0
3076384|NCT01355588|3798132|FG003|NOT COMPLETED|Washout (3-7 Days)||0
3076385|NCT01355588|3798129|FG000|STARTED|Fourth Intervention (After Washout)||4
3076386|NCT01355588|3798130|FG001|STARTED|Fourth Intervention (After Washout)||4
3076387|NCT01355588|3798131|FG002|STARTED|Fourth Intervention (After Washout)||4
3076388|NCT01355588|3798132|FG003|STARTED|Fourth Intervention (After Washout)||4
3076389|NCT01355588|3798129|FG000|COMPLETED|Fourth Intervention (After Washout)||4
3076390|NCT01355588|3798130|FG001|COMPLETED|Fourth Intervention (After Washout)||4
3076391|NCT01355588|3798131|FG002|COMPLETED|Fourth Intervention (After Washout)||4
3076392|NCT01355588|3798132|FG003|COMPLETED|Fourth Intervention (After Washout)||4
3076393|NCT01355588|3798129|FG000|NOT COMPLETED|Fourth Intervention (After Washout)||0
3076394|NCT01355588|3798130|FG001|NOT COMPLETED|Fourth Intervention (After Washout)||0
3076395|NCT01355588|3798131|FG002|NOT COMPLETED|Fourth Intervention (After Washout)||0
3076396|NCT01355588|3798132|FG003|NOT COMPLETED|Fourth Intervention (After Washout)||0
3076397|NCT01355627|3798144|FG000|STARTED|Overall Study||362
3076398|NCT01355627|3798145|FG001|STARTED|Overall Study||364
3076399|NCT01355627|3798144|FG000|Safety Analysis Set|Overall Study||362
3076400|NCT01355627|3798145|FG001|Safety Analysis Set|Overall Study||364
3076401|NCT01355627|3798144|FG000|Full Analysis Set|Overall Study|One participant's data for final follow-up is missing, completion status could not be confirmed.|361
3076402|NCT01355627|3798145|FG001|Full Analysis Set|Overall Study|One participant randomized to Current Practice actually received TachoSil®.|365
3076403|NCT01355627|3798144|FG000|COMPLETED|Overall Study||329
3076404|NCT01355627|3798145|FG001|COMPLETED|Overall Study||326
3076405|NCT01355627|3798144|FG000|NOT COMPLETED|Overall Study||33
3076406|NCT01355627|3798145|FG001|NOT COMPLETED|Overall Study||38
3076407|NCT01355679|3798151|FG000|STARTED|Overall Study||16
3076408|NCT01355679|3798151|FG000|COMPLETED|Overall Study||14
3076409|NCT01355679|3798151|FG000|NOT COMPLETED|Overall Study||2
3076410|NCT01355705|3798156|FG000|STARTED|Overall Study||14
3076411|NCT01355705|3798156|FG000|COMPLETED|Overall Study||14
3076412|NCT01355705|3798156|FG000|NOT COMPLETED|Overall Study||0
3076413|NCT01355796|3798161|FG000|STARTED|Overall Study||15
3076414|NCT01355796|3798162|FG001|STARTED|Overall Study||15
3076415|NCT01355796|3798161|FG000|First Intervention for 14 Days|Overall Study||15
3076416|NCT01355796|3798162|FG001|First Intervention for 14 Days|Overall Study||15
3076417|NCT01355796|3798161|FG000|Washout Period for 7 Days|Overall Study||15
3076418|NCT01355796|3798162|FG001|Washout Period for 7 Days|Overall Study||15
3076419|NCT01355796|3798161|FG000|Second Intervention for 14 Days|Overall Study||15
3076420|NCT01355796|3798162|FG001|Second Intervention for 14 Days|Overall Study||15
3076421|NCT01355796|3798161|FG000|COMPLETED|Overall Study||15
3076422|NCT01355796|3798162|FG001|COMPLETED|Overall Study||15
3076423|NCT01355796|3798161|FG000|NOT COMPLETED|Overall Study||0
3076424|NCT01355796|3798162|FG001|NOT COMPLETED|Overall Study||0
3076425|NCT01355978|3798168|FG000|STARTED|Overall Study||22
3076426|NCT01355978|3798168|FG000|COMPLETED|Overall Study||18
3076427|NCT01355978|3798168|FG000|NOT COMPLETED|Overall Study||4
3076428|NCT01356147|3798174|FG000|STARTED|Overall Study||5
3076429|NCT01356147|3798175|FG001|STARTED|Overall Study||6
3076430|NCT01356147|3798174|FG000|COMPLETED|Overall Study||5
3076431|NCT01356147|3798175|FG001|COMPLETED|Overall Study||6
3076432|NCT01356147|3798174|FG000|NOT COMPLETED|Overall Study||0
3076433|NCT01356147|3798175|FG001|NOT COMPLETED|Overall Study||0
3076434|NCT01356277|3798183|FG000|STARTED|Run-in||81
3076435|NCT01356277|3798184|FG001|STARTED|Run-in||88
3076436|NCT01356277|3798183|FG000|COMPLETED|Run-in||76
3076437|NCT01356277|3798184|FG001|COMPLETED|Run-in||88
3076438|NCT01356277|3798183|FG000|NOT COMPLETED|Run-in||5
3076439|NCT01356277|3798184|FG001|NOT COMPLETED|Run-in||0
3076440|NCT01356277|3798183|FG000|STARTED|Intervention Interval||76
3076441|NCT01356277|3798184|FG001|STARTED|Intervention Interval||88
3076442|NCT01356277|3798183|FG000|COMPLETED|Intervention Interval||66
3076443|NCT01356277|3798184|FG001|COMPLETED|Intervention Interval||81
3076444|NCT01356277|3798183|FG000|NOT COMPLETED|Intervention Interval||10
3076445|NCT01356277|3798184|FG001|NOT COMPLETED|Intervention Interval||7
3076446|NCT01356407|3798194|FG000|STARTED|Overall Study||150
3076447|NCT01356407|3798195|FG001|STARTED|Overall Study||150
3076448|NCT01356407|3798194|FG000|COMPLETED|Overall Study||144
3076449|NCT01356407|3798195|FG001|COMPLETED|Overall Study||146
3076450|NCT01356407|3798194|FG000|NOT COMPLETED|Overall Study||6
3076451|NCT01356407|3798195|FG001|NOT COMPLETED|Overall Study||4
3076452|NCT01356498|3798207|FG000|STARTED|Overall Study||35
3076453|NCT01356498|3798208|FG001|STARTED|Overall Study|2 other patients received no investigational drug in C0407 but elected to be followed in Observation|25
3076454|NCT01356498|3798209|FG002|STARTED|Overall Study||23
3076455|NCT01356498|3798210|FG003|STARTED|Overall Study||22
3076456|NCT01356498|3798211|FG004|STARTED|Overall Study||28
3076457|NCT01356498|3798212|FG005|STARTED|Overall Study||16
3076458|NCT01356498|3798207|FG000|COMPLETED|Overall Study||24
3076459|NCT01356498|3798208|FG001|COMPLETED|Overall Study||17
3076460|NCT01356498|3798209|FG002|COMPLETED|Overall Study||11
3076461|NCT01356498|3798210|FG003|COMPLETED|Overall Study||8
3076462|NCT01356498|3798211|FG004|COMPLETED|Overall Study||8
3076463|NCT01356498|3798212|FG005|COMPLETED|Overall Study||2
3076464|NCT01356498|3798207|FG000|NOT COMPLETED|Overall Study||11
3076465|NCT01356498|3798208|FG001|NOT COMPLETED|Overall Study||8
3076466|NCT01356498|3798209|FG002|NOT COMPLETED|Overall Study||12
3076467|NCT01356498|3798210|FG003|NOT COMPLETED|Overall Study||14
3076468|NCT01356498|3798211|FG004|NOT COMPLETED|Overall Study||20
3076469|NCT01356498|3798212|FG005|NOT COMPLETED|Overall Study||14
3076470|NCT01356589|3798232|FG000|STARTED|Overall Study||1288
3076471|NCT01356589|3798232|FG000|Treated|Overall Study||1285
3076472|NCT01356589|3798232|FG000|COMPLETED|Overall Study||1283
3076473|NCT01356589|3798232|FG000|NOT COMPLETED|Overall Study||5
3076474|NCT01356602|3798239|FG000|STARTED|Overall Study||133
3076475|NCT01356602|3798240|FG001|STARTED|Overall Study||132
3076476|NCT01356602|3798241|FG002|STARTED|Overall Study||132
3076477|NCT01356602|3798239|FG000|Safety Set|Overall Study|In this arm, 1 patient had only 3 placebo injections and 3 patients also took other active drug.|133
3076478|NCT01356602|3798240|FG001|Safety Set|Overall Study|In this arm, 3 patients also took other active drug.|133
3076479|NCT01356602|3798241|FG002|Safety Set|Overall Study|In this arm, 3 patients also took other active drug.|133
3076480|NCT01356602|3798239|FG000|Full Analysis Set|Overall Study||131
3076481|NCT01356602|3798240|FG001|Full Analysis Set|Overall Study||129
3076482|NCT01356602|3798241|FG002|Full Analysis Set|Overall Study||129
3076483|NCT01356602|3798239|FG000|COMPLETED|Overall Study||124
3076484|NCT01356602|3798240|FG001|COMPLETED|Overall Study||117
3076485|NCT01356602|3798241|FG002|COMPLETED|Overall Study||108
3076486|NCT01356602|3798239|FG000|NOT COMPLETED|Overall Study||9
3076487|NCT01356602|3798240|FG001|NOT COMPLETED|Overall Study||15
3076488|NCT01356602|3798241|FG002|NOT COMPLETED|Overall Study||24
3076489|NCT01356628|3798249|FG000|STARTED|Overall Study||23
3076490|NCT01356628|3798249|FG000|COMPLETED|Overall Study||23
3076491|NCT01356628|3798249|FG000|NOT COMPLETED|Overall Study||0
3076492|NCT01356940|3798255|FG000|STARTED|First Intervention (28 Days)||22
3076493|NCT01356940|3798256|FG001|STARTED|First Intervention (28 Days)||21
3076494|NCT01356940|3798255|FG000|COMPLETED|First Intervention (28 Days)||21
3076495|NCT01356940|3798256|FG001|COMPLETED|First Intervention (28 Days)||21
3076496|NCT01356940|3798255|FG000|NOT COMPLETED|First Intervention (28 Days)||1
3076497|NCT01356940|3798256|FG001|NOT COMPLETED|First Intervention (28 Days)||0
3076498|NCT01356940|3798255|FG000|STARTED|Washout (14 Days)||21
3076499|NCT01356940|3798256|FG001|STARTED|Washout (14 Days)||21
3076500|NCT01356940|3798255|FG000|COMPLETED|Washout (14 Days)||21
3076501|NCT01356940|3798256|FG001|COMPLETED|Washout (14 Days)||21
3076502|NCT01356940|3798255|FG000|NOT COMPLETED|Washout (14 Days)||0
3284749|NCT02766777|4018452|FG000|NOT COMPLETED|Overall Study||34
3284750|NCT02766907|4018458|FG000|STARTED|Overall Study||10
3284751|NCT02766907|4018459|FG001|STARTED|Overall Study||10
3076503|NCT01356940|3798256|FG001|NOT COMPLETED|Washout (14 Days)||0
3076504|NCT01356940|3798255|FG000|STARTED|Second Intervention (28 Days)||21
3076505|NCT01356940|3798256|FG001|STARTED|Second Intervention (28 Days)||21
3076506|NCT01356940|3798255|FG000|COMPLETED|Second Intervention (28 Days)||20
3076507|NCT01356940|3798256|FG001|COMPLETED|Second Intervention (28 Days)||21
3076508|NCT01356940|3798255|FG000|NOT COMPLETED|Second Intervention (28 Days)||1
3284752|NCT02766907|4018458|FG000|COMPLETED|Overall Study||9
3284753|NCT02766907|4018459|FG001|COMPLETED|Overall Study||9
3284754|NCT02766907|4018458|FG000|NOT COMPLETED|Overall Study||1
3284755|NCT02766907|4018459|FG001|NOT COMPLETED|Overall Study||1
3284756|NCT02767011|4018467|FG000|STARTED|Overall Study||16
3284757|NCT02767011|4018468|FG001|STARTED|Overall Study||14
3284758|NCT02767011|4018467|FG000|COMPLETED|Overall Study||16
3284759|NCT02767011|4018468|FG001|COMPLETED|Overall Study||14
3284760|NCT02767011|4018467|FG000|NOT COMPLETED|Overall Study||0
3284761|NCT02767011|4018468|FG001|NOT COMPLETED|Overall Study||0
3284762|NCT02767128|4018474|FG000|STARTED|Overall Study||14
3284763|NCT02767128|4018474|FG000|Baseline|Overall Study||14
3284764|NCT02767128|4018474|FG000|Fer-In-Sol|Overall Study||14
3284765|NCT02767128|4018474|FG000|Shohl's + Fer-In-Sol|Overall Study||14
3284766|NCT02767128|4018474|FG000|Triferic|Overall Study||14
3284767|NCT02767128|4018474|FG000|Shohl's + Triferic After 10 Min|Overall Study||14
3284768|NCT02767128|4018474|FG000|Shohl's + Triferic Immediately|Overall Study||14
3284769|NCT02767128|4018474|FG000|COMPLETED|Overall Study||14
3284770|NCT02767128|4018474|FG000|NOT COMPLETED|Overall Study||0
3284771|NCT02767271|4018490|FG000|STARTED|Overall Study||15
3284772|NCT02767271|4018491|FG001|STARTED|Overall Study||15
3284773|NCT02767271|4018490|FG000|Safety Population|Overall Study||15
3284774|NCT02767271|4018491|FG001|Safety Population|Overall Study||15
3284775|NCT02767271|4018490|FG000|Pharmacokinetic Pedis (PKP) Population|Overall Study||15
3284776|NCT02767271|4018491|FG001|Pharmacokinetic Pedis (PKP) Population|Overall Study||0
3284777|NCT02767271|4018490|FG000|Pharmacokinetic Cruris (PKC) Population|Overall Study||0
3076509|NCT01356940|3798256|FG001|NOT COMPLETED|Second Intervention (28 Days)||0
3076510|NCT01356966|3798266|FG000|STARTED|Overall Study||18
3076511|NCT01356966|3798267|FG001|STARTED|Overall Study||14
3076512|NCT01356966|3798266|FG000|COMPLETED|Overall Study||16
3076513|NCT01356966|3798267|FG001|COMPLETED|Overall Study||12
3076514|NCT01356966|3798266|FG000|NOT COMPLETED|Overall Study||2
3076515|NCT01356966|3798267|FG001|NOT COMPLETED|Overall Study||2
3076516|NCT01357135|3798276|FG000|STARTED|Overall Study||1874
3076517|NCT01357135|3798277|FG001|STARTED|Overall Study||733
3076518|NCT01357135|3798278|FG002|STARTED|Overall Study||846
3076519|NCT01357135|3798276|FG000|COMPLETED|Overall Study||1276
3076520|NCT01357135|3798277|FG001|COMPLETED|Overall Study||510
3076521|NCT01357135|3798278|FG002|COMPLETED|Overall Study||583
3076522|NCT01357135|3798276|FG000|NOT COMPLETED|Overall Study||598
3076523|NCT01357135|3798277|FG001|NOT COMPLETED|Overall Study||223
3076524|NCT01357135|3798278|FG002|NOT COMPLETED|Overall Study||263
3076525|NCT01357148|3798285|FG000|STARTED|Overall Study||143
3076526|NCT01357148|3798285|FG000|COMPLETED|Overall Study||143
3076527|NCT01357148|3798285|FG000|NOT COMPLETED|Overall Study||0
3076528|NCT01357161|3798293|FG000|STARTED|Part 1 (Open Label Run-in)||15
3076529|NCT01357161|3798294|FG001|STARTED|Part 1 (Open Label Run-in)||0
3076530|NCT01357161|3798295|FG002|STARTED|Part 1 (Open Label Run-in)||0
3076531|NCT01357161|3798293|FG000|COMPLETED|Part 1 (Open Label Run-in)||0
3076532|NCT01357161|3798294|FG001|COMPLETED|Part 1 (Open Label Run-in)||0
3076533|NCT01357161|3798295|FG002|COMPLETED|Part 1 (Open Label Run-in)||0
3076534|NCT01357161|3798293|FG000|NOT COMPLETED|Part 1 (Open Label Run-in)||15
3076535|NCT01357161|3798294|FG001|NOT COMPLETED|Part 1 (Open Label Run-in)||0
3076536|NCT01357161|3798295|FG002|NOT COMPLETED|Part 1 (Open Label Run-in)||0
3076537|NCT01357161|3798293|FG000|STARTED|Part 2 (Double-Blind Comparison)||0
3076538|NCT01357161|3798294|FG001|STARTED|Part 2 (Double-Blind Comparison)|New participants enrolled in Part 2.|59
3076539|NCT01357161|3798295|FG002|STARTED|Part 2 (Double-Blind Comparison)|New participants enrolled in Part 2.|62
3076540|NCT01357161|3798293|FG000|Treated|Part 2 (Double-Blind Comparison)||0
3076541|NCT01357161|3798294|FG001|Treated|Part 2 (Double-Blind Comparison)||59
3076542|NCT01357161|3798295|FG002|Treated|Part 2 (Double-Blind Comparison)||60
3076543|NCT01357161|3798293|FG000|COMPLETED|Part 2 (Double-Blind Comparison)||0
3076544|NCT01357161|3798294|FG001|COMPLETED|Part 2 (Double-Blind Comparison)||0
3076545|NCT01357161|3798295|FG002|COMPLETED|Part 2 (Double-Blind Comparison)||0
3076546|NCT01357161|3798293|FG000|NOT COMPLETED|Part 2 (Double-Blind Comparison)||0
3076547|NCT01357161|3798294|FG001|NOT COMPLETED|Part 2 (Double-Blind Comparison)||59
3076548|NCT01357161|3798295|FG002|NOT COMPLETED|Part 2 (Double-Blind Comparison)||62
3076549|NCT01357239|3798307|FG000|STARTED|Stratum: All Patients||31
3076550|NCT01357239|3798308|FG001|STARTED|Stratum: All Patients||27
3076551|NCT01357239|3798309|FG002|STARTED|Stratum: All Patients||39
3076552|NCT01357239|3798310|FG003|STARTED|Stratum: All Patients||42
3076553|NCT01357239|3798307|FG000|COMPLETED|Stratum: All Patients||31
3076554|NCT01357239|3798308|FG001|COMPLETED|Stratum: All Patients||27
3076555|NCT01357239|3798309|FG002|COMPLETED|Stratum: All Patients||37
3076556|NCT01357239|3798310|FG003|COMPLETED|Stratum: All Patients||40
3076557|NCT01357239|3798307|FG000|NOT COMPLETED|Stratum: All Patients||0
3076558|NCT01357239|3798308|FG001|NOT COMPLETED|Stratum: All Patients||0
3076559|NCT01357239|3798309|FG002|NOT COMPLETED|Stratum: All Patients||2
3076560|NCT01357239|3798310|FG003|NOT COMPLETED|Stratum: All Patients||2
3076561|NCT01357239|3798307|FG000|STARTED|Stratum I: Fully-Methylated||8
3076562|NCT01357239|3798308|FG001|STARTED|Stratum I: Fully-Methylated||6
3076563|NCT01357239|3798309|FG002|STARTED|Stratum I: Fully-Methylated||17
3076564|NCT01357239|3798310|FG003|STARTED|Stratum I: Fully-Methylated||22
3076565|NCT01357239|3798307|FG000|COMPLETED|Stratum I: Fully-Methylated||8
3076566|NCT01357239|3798308|FG001|COMPLETED|Stratum I: Fully-Methylated||6
3076567|NCT01357239|3798309|FG002|COMPLETED|Stratum I: Fully-Methylated||16
3076568|NCT01357239|3798310|FG003|COMPLETED|Stratum I: Fully-Methylated||22
3076569|NCT01357239|3798307|FG000|NOT COMPLETED|Stratum I: Fully-Methylated||0
3076570|NCT01357239|3798308|FG001|NOT COMPLETED|Stratum I: Fully-Methylated||0
3076571|NCT01357239|3798309|FG002|NOT COMPLETED|Stratum I: Fully-Methylated||1
3076572|NCT01357239|3798310|FG003|NOT COMPLETED|Stratum I: Fully-Methylated||0
3076573|NCT01357239|3798307|FG000|STARTED|Stratum II: Partially-Methylated||23
3076574|NCT01357239|3798308|FG001|STARTED|Stratum II: Partially-Methylated||21
3076575|NCT01357239|3798309|FG002|STARTED|Stratum II: Partially-Methylated||22
3076576|NCT01357239|3798310|FG003|STARTED|Stratum II: Partially-Methylated||20
3076577|NCT01357239|3798307|FG000|COMPLETED|Stratum II: Partially-Methylated||23
3076578|NCT01357239|3798308|FG001|COMPLETED|Stratum II: Partially-Methylated||21
3076579|NCT01357239|3798309|FG002|COMPLETED|Stratum II: Partially-Methylated||21
3076580|NCT01357239|3798310|FG003|COMPLETED|Stratum II: Partially-Methylated||18
3076581|NCT01357239|3798307|FG000|NOT COMPLETED|Stratum II: Partially-Methylated||0
3076582|NCT01357239|3798308|FG001|NOT COMPLETED|Stratum II: Partially-Methylated||0
3076583|NCT01357239|3798309|FG002|NOT COMPLETED|Stratum II: Partially-Methylated||1
3076584|NCT01357239|3798310|FG003|NOT COMPLETED|Stratum II: Partially-Methylated||2
3076585|NCT01357356|3798327|FG000|STARTED|Overall Study||188
3076586|NCT01357356|3798328|FG001|STARTED|Overall Study||188
3076587|NCT01357356|3798329|FG002|STARTED|Overall Study||186
3076588|NCT01357356|3798330|FG003|STARTED|Overall Study||188
3076589|NCT01357356|3798327|FG000|COMPLETED|Overall Study||166
3076590|NCT01357356|3798328|FG001|COMPLETED|Overall Study||163
3076591|NCT01357356|3798329|FG002|COMPLETED|Overall Study||158
3076592|NCT01357356|3798330|FG003|COMPLETED|Overall Study||171
3076593|NCT01357356|3798327|FG000|NOT COMPLETED|Overall Study||22
3076594|NCT01357356|3798328|FG001|NOT COMPLETED|Overall Study||25
3076595|NCT01357356|3798329|FG002|NOT COMPLETED|Overall Study||28
3076596|NCT01357356|3798330|FG003|NOT COMPLETED|Overall Study||17
3076597|NCT01357512|3798344|FG000|STARTED|Overall Study||65
3076598|NCT01357512|3798345|FG001|STARTED|Overall Study||65
3076599|NCT01357512|3798344|FG000|COMPLETED|Overall Study||53
3076600|NCT01357512|3798345|FG001|COMPLETED|Overall Study||60
3076601|NCT01357512|3798344|FG000|NOT COMPLETED|Overall Study||12
3076602|NCT01357512|3798345|FG001|NOT COMPLETED|Overall Study||5
3076603|NCT01357525|3798351|FG000|STARTED|Overall Study||50
3076604|NCT01357525|3798351|FG000|COMPLETED|Overall Study||49
3076605|NCT01357525|3798351|FG000|NOT COMPLETED|Overall Study||1
3076606|NCT01357551|3798357|FG000|STARTED|Overall Study||110
3076607|NCT01357551|3798358|FG001|STARTED|Overall Study||112
3076608|NCT01357551|3798357|FG000|COMPLETED|Overall Study||88
3076609|NCT01357551|3798358|FG001|COMPLETED|Overall Study||101
3076610|NCT01357551|3798357|FG000|NOT COMPLETED|Overall Study||22
3076611|NCT01357551|3798358|FG001|NOT COMPLETED|Overall Study||11
3076612|NCT01357564|3798369|FG000|STARTED|Short-term (4-month) Follow up||154
3076613|NCT01357564|3798370|FG001|STARTED|Short-term (4-month) Follow up||168
3076614|NCT01357564|3798369|FG000|COMPLETED|Short-term (4-month) Follow up||106
3076615|NCT01357564|3798370|FG001|COMPLETED|Short-term (4-month) Follow up||118
3076616|NCT01357564|3798369|FG000|NOT COMPLETED|Short-term (4-month) Follow up||48
3076617|NCT01357564|3798370|FG001|NOT COMPLETED|Short-term (4-month) Follow up||50
3076618|NCT01357564|3798369|FG000|STARTED|Long-term (8-month) Follow-up||106
3076619|NCT01357564|3798370|FG001|STARTED|Long-term (8-month) Follow-up||118
3076620|NCT01357564|3798369|FG000|COMPLETED|Long-term (8-month) Follow-up||104
3076621|NCT01357564|3798370|FG001|COMPLETED|Long-term (8-month) Follow-up||102
3076622|NCT01357564|3798369|FG000|NOT COMPLETED|Long-term (8-month) Follow-up||2
3076623|NCT01357564|3798370|FG001|NOT COMPLETED|Long-term (8-month) Follow-up||16
3076624|NCT01357577|3798380|FG000|STARTED|Overall Study||64
3076625|NCT01357577|3798381|FG001|STARTED|Overall Study||65
3076626|NCT01357577|3798380|FG000|Post-Treatment Assessment Completed|Overall Study||24
3076627|NCT01357577|3798381|FG001|Post-Treatment Assessment Completed|Overall Study||39
3076628|NCT01357577|3798380|FG000|COMPLETED|Overall Study||27
3076629|NCT01357577|3798381|FG001|COMPLETED|Overall Study||39
3076630|NCT01357577|3798380|FG000|NOT COMPLETED|Overall Study||37
3076631|NCT01357577|3798381|FG001|NOT COMPLETED|Overall Study||26
3076632|NCT01357616|3798390|FG000|STARTED|Overall Study||166
3076633|NCT01357616|3798391|FG001|STARTED|Overall Study||162
3076634|NCT01357616|3798390|FG000|COMPLETED|Overall Study||156
3076635|NCT01357616|3798391|FG001|COMPLETED|Overall Study||153
3076636|NCT01357616|3798390|FG000|NOT COMPLETED|Overall Study||10
3076637|NCT01357616|3798391|FG001|NOT COMPLETED|Overall Study||9
3076638|NCT01357655|3798399|FG000|STARTED|Overall Study||66
3076639|NCT01357655|3798400|FG001|STARTED|Overall Study||0
3076640|NCT01357655|3798399|FG000|COMPLETED|Overall Study||0
3076641|NCT01357655|3798400|FG001|COMPLETED|Overall Study||0
3076642|NCT01357655|3798399|FG000|NOT COMPLETED|Overall Study||66
3076643|NCT01357655|3798400|FG001|NOT COMPLETED|Overall Study||0
3076644|NCT01357720|3798407|FG000|STARTED|Overall Study||200
3076645|NCT01357720|3798408|FG001|STARTED|Overall Study||200
3076646|NCT01357720|3798407|FG000|COMPLETED|Overall Study||198
3076647|NCT01357720|3798408|FG001|COMPLETED|Overall Study||195
3076648|NCT01357720|3798407|FG000|NOT COMPLETED|Overall Study||2
3076649|NCT01357720|3798408|FG001|NOT COMPLETED|Overall Study||5
3076650|NCT01357850|3798418|FG000|STARTED|Overall Study||30
3076651|NCT01357850|3798419|FG001|STARTED|Overall Study||12
3076652|NCT01357850|3798420|FG002|STARTED|Overall Study||13
3076653|NCT01357850|3798421|FG003|STARTED|Overall Study||27
3076654|NCT01357850|3798418|FG000|COMPLETED|Overall Study||29
3076655|NCT01357850|3798419|FG001|COMPLETED|Overall Study||12
3076656|NCT01357850|3798420|FG002|COMPLETED|Overall Study||13
3076657|NCT01357850|3798421|FG003|COMPLETED|Overall Study||27
3076658|NCT01357850|3798418|FG000|NOT COMPLETED|Overall Study||1
3076659|NCT01357850|3798419|FG001|NOT COMPLETED|Overall Study||0
3076660|NCT01357850|3798420|FG002|NOT COMPLETED|Overall Study||0
3076661|NCT01357850|3798421|FG003|NOT COMPLETED|Overall Study||0
3076662|NCT01357889|3798434|FG000|STARTED|Single-dose Phase (BE Phase: 28 Days)||86
3076663|NCT01357889|3798435|FG001|STARTED|Single-dose Phase (BE Phase: 28 Days)||81
3076664|NCT01357889|3798434|FG000|COMPLETED|Single-dose Phase (BE Phase: 28 Days)||82
3076665|NCT01357889|3798435|FG001|COMPLETED|Single-dose Phase (BE Phase: 28 Days)||79
3076666|NCT01357889|3798434|FG000|NOT COMPLETED|Single-dose Phase (BE Phase: 28 Days)||4
3076667|NCT01357889|3798435|FG001|NOT COMPLETED|Single-dose Phase (BE Phase: 28 Days)||2
3076668|NCT01357889|3798434|FG000|STARTED|Multiple-dose Phase (MDP) (Overall)|After completion of the BE Phase, additional participants were randomized to the Overall Phase.|141
3076669|NCT01357889|3798435|FG001|STARTED|Multiple-dose Phase (MDP) (Overall)|After completion of the BE Phase, additional participants were randomized to the Overall Phase.|142
3076670|NCT01357889|3798434|FG000|COMPLETED|Multiple-dose Phase (MDP) (Overall)||125
3076671|NCT01357889|3798435|FG001|COMPLETED|Multiple-dose Phase (MDP) (Overall)||126
3076672|NCT01357889|3798434|FG000|NOT COMPLETED|Multiple-dose Phase (MDP) (Overall)||16
3076673|NCT01357889|3798435|FG001|NOT COMPLETED|Multiple-dose Phase (MDP) (Overall)||16
3076674|NCT01357889|3798434|FG000|STARTED|Follow-up Phase (FUP) (8 Weeks)|All participants who started the MDP entered the FUP, regardless of MDP completion status.|141
3136760|NCT01714947|3862017|FG000|COMPLETED|Part B||0
3076675|NCT01357889|3798435|FG001|STARTED|Follow-up Phase (FUP) (8 Weeks)|All participants who started the MDP entered the FUP, regardless of MDP completion status.|142
3076676|NCT01357889|3798434|FG000|COMPLETED|Follow-up Phase (FUP) (8 Weeks)||138
3076677|NCT01357889|3798435|FG001|COMPLETED|Follow-up Phase (FUP) (8 Weeks)||138
3076678|NCT01357889|3798434|FG000|NOT COMPLETED|Follow-up Phase (FUP) (8 Weeks)||3
3076679|NCT01357889|3798435|FG001|NOT COMPLETED|Follow-up Phase (FUP) (8 Weeks)||4
3076680|NCT01357915|3798445|FG000|STARTED|Overall Study||30
3076681|NCT01357915|3798446|FG001|STARTED|Overall Study||17
3076682|NCT01357915|3798445|FG000|COMPLETED|Overall Study||27
3076683|NCT01357915|3798446|FG001|COMPLETED|Overall Study||17
3076684|NCT01357915|3798445|FG000|NOT COMPLETED|Overall Study||3
3076685|NCT01357915|3798446|FG001|NOT COMPLETED|Overall Study||0
3076686|NCT01357980|3798456|FG000|STARTED|Overall Study||16
3076687|NCT01357980|3798457|FG001|STARTED|Overall Study||7
3076688|NCT01357980|3798458|FG002|STARTED|Overall Study||17
3076689|NCT01357980|3798459|FG003|STARTED|Overall Study||7
3076690|NCT01357980|3798456|FG000|COMPLETED|Overall Study||16
3076691|NCT01357980|3798457|FG001|COMPLETED|Overall Study||6
3076692|NCT01357980|3798458|FG002|COMPLETED|Overall Study||16
3076693|NCT01357980|3798459|FG003|COMPLETED|Overall Study||7
3076694|NCT01357980|3798456|FG000|NOT COMPLETED|Overall Study||0
3076695|NCT01357980|3798457|FG001|NOT COMPLETED|Overall Study||1
3076696|NCT01357980|3798458|FG002|NOT COMPLETED|Overall Study||1
3076697|NCT01357980|3798459|FG003|NOT COMPLETED|Overall Study||0
3076698|NCT01358175|3798472|FG000|STARTED|Overall Study||124
3076699|NCT01358175|3798473|FG001|STARTED|Overall Study||125
3076700|NCT01358175|3798474|FG002|STARTED|Overall Study||122
3076701|NCT01358175|3798472|FG000|COMPLETED|Overall Study||103
3076702|NCT01358175|3798473|FG001|COMPLETED|Overall Study||97
3076703|NCT01358175|3798474|FG002|COMPLETED|Overall Study||90
3076704|NCT01358175|3798472|FG000|NOT COMPLETED|Overall Study||21
3076705|NCT01358175|3798473|FG001|NOT COMPLETED|Overall Study||28
3076706|NCT01358175|3798474|FG002|NOT COMPLETED|Overall Study||32
3076707|NCT01358266|3798489|FG000|STARTED|Double-Masked Period||208
3076708|NCT01358266|3798490|FG001|STARTED|Double-Masked Period||208
3076709|NCT01358266|3798491|FG002|STARTED|Double-Masked Period||176
3076710|NCT01358266|3798489|FG000|COMPLETED|Double-Masked Period||175
3076711|NCT01358266|3798490|FG001|COMPLETED|Double-Masked Period||162
3076712|NCT01358266|3798491|FG002|COMPLETED|Double-Masked Period||137
3076713|NCT01358266|3798489|FG000|NOT COMPLETED|Double-Masked Period||33
3076714|NCT01358266|3798490|FG001|NOT COMPLETED|Double-Masked Period||46
3076715|NCT01358266|3798491|FG002|NOT COMPLETED|Double-Masked Period||39
3076716|NCT01358266|3798489|FG000|STARTED|Open-Label Period||119
3076717|NCT01358266|3798490|FG001|STARTED|Open-Label Period||102
3076718|NCT01358266|3798491|FG002|STARTED|Open-Label Period||114
3076719|NCT01358266|3798489|FG000|COMPLETED|Open-Label Period||63
3076720|NCT01358266|3798490|FG001|COMPLETED|Open-Label Period||58
3076721|NCT01358266|3798491|FG002|COMPLETED|Open-Label Period||44
3076722|NCT01358266|3798489|FG000|NOT COMPLETED|Open-Label Period||56
3076723|NCT01358266|3798490|FG001|NOT COMPLETED|Open-Label Period||44
3076724|NCT01358266|3798491|FG002|NOT COMPLETED|Open-Label Period||70
3076725|NCT01358331|3798506|FG000|STARTED|Overall Study||2
3076726|NCT01358331|3798507|FG001|STARTED|Overall Study||3
3076727|NCT01358331|3798508|FG002|STARTED|Overall Study||4
3076728|NCT01358331|3798509|FG003|STARTED|Overall Study||3
3076729|NCT01358331|3798510|FG004|STARTED|Overall Study||7
3076730|NCT01358331|3798511|FG005|STARTED|Overall Study||6
3076731|NCT01358331|3798506|FG000|COMPLETED|Overall Study||0
3076732|NCT01358331|3798507|FG001|COMPLETED|Overall Study||0
3076733|NCT01358331|3798508|FG002|COMPLETED|Overall Study||0
3076734|NCT01358331|3798509|FG003|COMPLETED|Overall Study||0
3076735|NCT01358331|3798510|FG004|COMPLETED|Overall Study||0
3076736|NCT01358331|3798511|FG005|COMPLETED|Overall Study||0
3076737|NCT01358331|3798506|FG000|NOT COMPLETED|Overall Study||2
3076738|NCT01358331|3798507|FG001|NOT COMPLETED|Overall Study||3
3076739|NCT01358331|3798508|FG002|NOT COMPLETED|Overall Study||4
3076740|NCT01358331|3798509|FG003|NOT COMPLETED|Overall Study||3
3076741|NCT01358331|3798510|FG004|NOT COMPLETED|Overall Study||7
3076742|NCT01358331|3798511|FG005|NOT COMPLETED|Overall Study||6
3076743|NCT01358357|3798527|FG000|STARTED|Open Label Phase||0
3076744|NCT01358357|3798528|FG001|STARTED|Open Label Phase||0
3076745|NCT01358357|3798529|FG002|STARTED|Open Label Phase||965
3076746|NCT01358357|3798527|FG000|COMPLETED|Open Label Phase||0
3076747|NCT01358357|3798528|FG001|COMPLETED|Open Label Phase||0
3076748|NCT01358357|3798529|FG002|COMPLETED|Open Label Phase||503
3076749|NCT01358357|3798527|FG000|NOT COMPLETED|Open Label Phase||0
3076750|NCT01358357|3798528|FG001|NOT COMPLETED|Open Label Phase||0
3076751|NCT01358357|3798529|FG002|NOT COMPLETED|Open Label Phase||462
3076752|NCT01358357|3798527|FG000|STARTED|Double-Blind Phase||246
3076753|NCT01358357|3798528|FG001|STARTED|Double-Blind Phase||250
3076754|NCT01358357|3798529|FG002|STARTED|Double-Blind Phase||0
3076755|NCT01358357|3798527|FG000|COMPLETED|Double-Blind Phase||166
3076756|NCT01358357|3798528|FG001|COMPLETED|Double-Blind Phase||150
3076757|NCT01358357|3798529|FG002|COMPLETED|Double-Blind Phase||0
3076758|NCT01358357|3798527|FG000|NOT COMPLETED|Double-Blind Phase||80
3076759|NCT01358357|3798528|FG001|NOT COMPLETED|Double-Blind Phase||100
3076760|NCT01358357|3798529|FG002|NOT COMPLETED|Double-Blind Phase||0
3134621|NCT01701973|3859521|FG000|STARTED|Aim 1: Second Intervention (1 Day)|1 subject was lost to follow-up in between Periods 1 and 2.|22
3134622|NCT01701973|3859522|FG001|STARTED|Aim 1: Second Intervention (1 Day)|3 subjects were lost to follow-up in between Periods 1 and 2.|17
3076761|NCT01358526|3798538|FG000|STARTED|Open-label Titration Period||1095
3076762|NCT01358526|3798539|FG001|STARTED|Open-label Titration Period||0
3076763|NCT01358526|3798540|FG002|STARTED|Open-label Titration Period||0
3076764|NCT01358526|3798538|FG000|COMPLETED|Open-label Titration Period|1 subject was randomized but never received double-blind treatment: Randomized Safety Population=600|601
3076765|NCT01358526|3798539|FG001|COMPLETED|Open-label Titration Period||0
3076766|NCT01358526|3798540|FG002|COMPLETED|Open-label Titration Period||0
3076767|NCT01358526|3798538|FG000|NOT COMPLETED|Open-label Titration Period||494
3076768|NCT01358526|3798539|FG001|NOT COMPLETED|Open-label Titration Period||0
3076769|NCT01358526|3798540|FG002|NOT COMPLETED|Open-label Titration Period||0
3076770|NCT01358526|3798538|FG000|STARTED|Double-blind Phase||0
3076771|NCT01358526|3798539|FG001|STARTED|Double-blind Phase|1 subject was randomized but never received double-blind treatment: Randomized Safety Population=600|298
3076772|NCT01358526|3798540|FG002|STARTED|Double-blind Phase|1 subject was randomized but never received double-blind treatment: Randomized Safety Population=600|302
3076773|NCT01358526|3798538|FG000|COMPLETED|Double-blind Phase||0
3076774|NCT01358526|3798539|FG001|COMPLETED|Double-blind Phase||218
3076775|NCT01358526|3798540|FG002|COMPLETED|Double-blind Phase||181
3076776|NCT01358526|3798538|FG000|NOT COMPLETED|Double-blind Phase||0
3076777|NCT01358526|3798539|FG001|NOT COMPLETED|Double-blind Phase||80
3076778|NCT01358526|3798540|FG002|NOT COMPLETED|Double-blind Phase||121
3076779|NCT01358578|3798551|FG000|STARTED|Induction Period||327
3076780|NCT01358578|3798552|FG001|STARTED|Induction Period||327
3076781|NCT01358578|3798553|FG002|STARTED|Induction Period||326
3076782|NCT01358578|3798554|FG003|STARTED|Induction Period||326
3076783|NCT01358578|3798555|FG004|STARTED|Induction Period|These groups are populated after the induction period|0
3076784|NCT01358578|3798556|FG005|STARTED|Induction Period|These groups are populated after the induction period|0
3076785|NCT01358578|3798551|FG000|COMPLETED|Induction Period||315
3076786|NCT01358578|3798552|FG001|COMPLETED|Induction Period||312
3076787|NCT01358578|3798553|FG002|COMPLETED|Induction Period||301
3076788|NCT01358578|3798554|FG003|COMPLETED|Induction Period||305
3076789|NCT01358578|3798555|FG004|COMPLETED|Induction Period|These groups are populated after the induction period|0
3076790|NCT01358578|3798556|FG005|COMPLETED|Induction Period|These groups are populated after the induction period|0
3076791|NCT01358578|3798551|FG000|NOT COMPLETED|Induction Period||12
3076792|NCT01358578|3798552|FG001|NOT COMPLETED|Induction Period||15
3076793|NCT01358578|3798553|FG002|NOT COMPLETED|Induction Period||25
3076794|NCT01358578|3798554|FG003|NOT COMPLETED|Induction Period||21
3076795|NCT01358578|3798555|FG004|NOT COMPLETED|Induction Period||0
3076796|NCT01358578|3798556|FG005|NOT COMPLETED|Induction Period||0
3076797|NCT01358578|3798551|FG000|STARTED|Maintenance Period||315
3076798|NCT01358578|3798552|FG001|STARTED|Maintenance Period||312
3076799|NCT01358578|3798553|FG002|STARTED|Maintenance Period||17
3076800|NCT01358578|3798554|FG003|STARTED|Maintenance Period||305
3076801|NCT01358578|3798555|FG004|STARTED|Maintenance Period||142
3076802|NCT01358578|3798556|FG005|STARTED|Maintenance Period||142
3076803|NCT01358578|3798551|FG000|COMPLETED|Maintenance Period||276
3076804|NCT01358578|3798552|FG001|COMPLETED|Maintenance Period||290
3076805|NCT01358578|3798553|FG002|COMPLETED|Maintenance Period||15
3076806|NCT01358578|3798554|FG003|COMPLETED|Maintenance Period||263
3076807|NCT01358578|3798555|FG004|COMPLETED|Maintenance Period||125
3076808|NCT01358578|3798556|FG005|COMPLETED|Maintenance Period||131
3076809|NCT01358578|3798551|FG000|NOT COMPLETED|Maintenance Period||39
3076810|NCT01358578|3798552|FG001|NOT COMPLETED|Maintenance Period||22
3076811|NCT01358578|3798553|FG002|NOT COMPLETED|Maintenance Period||2
3076812|NCT01358578|3798554|FG003|NOT COMPLETED|Maintenance Period||42
3076813|NCT01358578|3798555|FG004|NOT COMPLETED|Maintenance Period||17
3076814|NCT01358578|3798556|FG005|NOT COMPLETED|Maintenance Period||11
3076815|NCT01358578|3798551|FG000|STARTED|Follow-up Period|Patients prior to follow up who did not enter the extension study but received the 150 mg dose|148
3076816|NCT01358578|3798552|FG001|STARTED|Follow-up Period|Patients prior to follow up who did not enter the extension study but received the 300 mg dose|125
3076817|NCT01358578|3798553|FG002|STARTED|Follow-up Period|contains patients who participated in follow up period from induction and maintenance|26
3076818|NCT01358578|3798554|FG003|STARTED|Follow-up Period|contains patients who participated in follow up period from induction and maintenance|279
3076819|NCT01358578|3798555|FG004|STARTED|Follow-up Period|all placebo patients from induction were 1: 1 into either AIN457A 150 mg or 300 mg doses|0
3284778|NCT02767271|4018491|FG001|Pharmacokinetic Cruris (PKC) Population|Overall Study||15
3284779|NCT02767271|4018490|FG000|COMPLETED|Overall Study||15
3284780|NCT02767271|4018491|FG001|COMPLETED|Overall Study||15
3284781|NCT02767271|4018490|FG000|NOT COMPLETED|Overall Study||0
3284782|NCT02767271|4018491|FG001|NOT COMPLETED|Overall Study||0
3284783|NCT02767323|4018501|FG000|STARTED|Overall Study||83
3284784|NCT02767323|4018502|FG001|STARTED|Overall Study||42
3284785|NCT02767323|4018503|FG002|STARTED|Overall Study||58
3284786|NCT02767323|4018504|FG003|STARTED|Overall Study||1
3284787|NCT02767323|4018501|FG000|COMPLETED|Overall Study||49
3284788|NCT02767323|4018502|FG001|COMPLETED|Overall Study||17
3284789|NCT02767323|4018503|FG002|COMPLETED|Overall Study||28
3284790|NCT02767323|4018504|FG003|COMPLETED|Overall Study||1
3284791|NCT02767323|4018501|FG000|NOT COMPLETED|Overall Study||34
3284792|NCT02767323|4018502|FG001|NOT COMPLETED|Overall Study||25
3284793|NCT02767323|4018503|FG002|NOT COMPLETED|Overall Study||30
3284794|NCT02767323|4018504|FG003|NOT COMPLETED|Overall Study||0
3284795|NCT02767388|4018520|FG000|STARTED|Overall Study||15
3284796|NCT02767388|4018521|FG001|STARTED|Overall Study||15
3076820|NCT01358578|3798556|FG005|STARTED|Follow-up Period|all placebo patients from induction were 1: 1 into either AIN457A 150 mg or 300 mg doses|0
3076821|NCT01358578|3798551|FG000|COMPLETED|Follow-up Period||138
3076822|NCT01358578|3798552|FG001|COMPLETED|Follow-up Period||119
3076823|NCT01358578|3798553|FG002|COMPLETED|Follow-up Period|contains patients who completed follow up period from induction and maintenance|21
3076824|NCT01358578|3798554|FG003|COMPLETED|Follow-up Period|contains patients who completed follow up period from induction and maintenance|260
3076825|NCT01358578|3798555|FG004|COMPLETED|Follow-up Period|all placebo patients from induction were 1: 1 into either AIN457A 150 mg or 300 mg doses|0
3076826|NCT01358578|3798556|FG005|COMPLETED|Follow-up Period|all placebo patients from induction were 1: 1 into either AIN457A 150 mg or 300 mg doses|0
3076827|NCT01358578|3798551|FG000|NOT COMPLETED|Follow-up Period||10
3076828|NCT01358578|3798552|FG001|NOT COMPLETED|Follow-up Period||6
3076829|NCT01358578|3798553|FG002|NOT COMPLETED|Follow-up Period||5
3076830|NCT01358578|3798554|FG003|NOT COMPLETED|Follow-up Period||19
3076831|NCT01358578|3798555|FG004|NOT COMPLETED|Follow-up Period||0
3076832|NCT01358578|3798556|FG005|NOT COMPLETED|Follow-up Period||0
3076833|NCT01358708|3798586|FG000|STARTED|Double-Blind Treatment Phase||13
3076834|NCT01358708|3798587|FG001|STARTED|Double-Blind Treatment Phase||13
3076835|NCT01358708|3798586|FG000|Randomized|Double-Blind Treatment Phase||13
3076836|NCT01358708|3798587|FG001|Randomized|Double-Blind Treatment Phase||13
3076837|NCT01358708|3798586|FG000|Received Study Medication|Double-Blind Treatment Phase|For 1 subject, unused med not returned to the site and intake of study medication not confirmed.|12
3076838|NCT01358708|3798587|FG001|Received Study Medication|Double-Blind Treatment Phase||13
3076839|NCT01358708|3798586|FG000|COMPLETED|Double-Blind Treatment Phase||10
3076840|NCT01358708|3798587|FG001|COMPLETED|Double-Blind Treatment Phase||13
3076841|NCT01358708|3798586|FG000|NOT COMPLETED|Double-Blind Treatment Phase||3
3076842|NCT01358708|3798587|FG001|NOT COMPLETED|Double-Blind Treatment Phase||0
3076843|NCT01358708|3798586|FG000|STARTED|Open-Label Treatment Phase|Number of subjects on LACTEOL® during double-blind treatment and entering the Open-Label Phase|5
3076844|NCT01358708|3798587|FG001|STARTED|Open-Label Treatment Phase|Number of subjects on PLACEBO during double-blind treatment and entering the Open-Label Phase|12
3076845|NCT01358708|3798586|FG000|COMPLETED|Open-Label Treatment Phase||5
3076846|NCT01358708|3798587|FG001|COMPLETED|Open-Label Treatment Phase||12
3076847|NCT01358708|3798586|FG000|NOT COMPLETED|Open-Label Treatment Phase||0
3076848|NCT01358708|3798587|FG001|NOT COMPLETED|Open-Label Treatment Phase||0
3076849|NCT01358721|3798601|FG000|STARTED|Overall Study||22
3076850|NCT01358721|3798602|FG001|STARTED|Overall Study||22
3076851|NCT01358721|3798603|FG002|STARTED|Overall Study||23
3284797|NCT02767388|4018522|FG002|STARTED|Overall Study||15
3284798|NCT02767388|4018520|FG000|COMPLETED|Overall Study||8
3284799|NCT02767388|4018521|FG001|COMPLETED|Overall Study||10
3284800|NCT02767388|4018522|FG002|COMPLETED|Overall Study||12
3284801|NCT02767388|4018520|FG000|NOT COMPLETED|Overall Study||7
3284802|NCT02767388|4018521|FG001|NOT COMPLETED|Overall Study||5
3284803|NCT02767388|4018522|FG002|NOT COMPLETED|Overall Study||3
3284804|NCT02767427|4018532|FG000|STARTED|Overall Study||21
3284805|NCT02767427|4018533|FG001|STARTED|Overall Study||19
3284806|NCT02767427|4018532|FG000|COMPLETED|Overall Study||21
3284807|NCT02767427|4018533|FG001|COMPLETED|Overall Study||19
3284808|NCT02767427|4018532|FG000|NOT COMPLETED|Overall Study||0
3284809|NCT02767427|4018533|FG001|NOT COMPLETED|Overall Study||0
3284810|NCT02767492|4018541|FG000|STARTED|Overall Study||45
3284811|NCT02767492|4018542|FG001|STARTED|Overall Study||45
3284812|NCT02767492|4018541|FG000|COMPLETED|Overall Study||35
3284813|NCT02767492|4018542|FG001|COMPLETED|Overall Study||35
3284814|NCT02767492|4018541|FG000|NOT COMPLETED|Overall Study||10
3284815|NCT02767492|4018542|FG001|NOT COMPLETED|Overall Study||10
3284816|NCT02767609|4018548|FG000|STARTED|Overall Study||1
3284817|NCT02767609|4018548|FG000|COMPLETED|Overall Study||1
3284818|NCT02767609|4018548|FG000|NOT COMPLETED|Overall Study||0
3316585|NCT03115476|4049974|FG002|COMPLETED|Main Trials (LP0084-119x)||409
3316586|NCT03115476|4049972|FG000|NOT COMPLETED|Main Trials (LP0084-119x)||0
3316587|NCT03115476|4049973|FG001|NOT COMPLETED|Main Trials (LP0084-119x)||0
3316588|NCT03115476|4049974|FG002|NOT COMPLETED|Main Trials (LP0084-119x)||0
3316589|NCT03115476|4049972|FG000|STARTED|LP0084-1369||191
3316590|NCT03115476|4049973|FG001|STARTED|LP0084-1369||210
3316591|NCT03115476|4049974|FG002|STARTED|LP0084-1369||162
3316592|NCT03115476|4049972|FG000|COMPLETED|LP0084-1369|Trial was terminated by sponsor|0
3316593|NCT03115476|4049973|FG001|COMPLETED|LP0084-1369|Trial was terminated by sponsor|0
3316594|NCT03115476|4049974|FG002|COMPLETED|LP0084-1369|Trial was terminated by sponsor|0
3316595|NCT03115476|4049972|FG000|NOT COMPLETED|LP0084-1369||191
3316596|NCT03115476|4049973|FG001|NOT COMPLETED|LP0084-1369||210
3316597|NCT03115476|4049974|FG002|NOT COMPLETED|LP0084-1369||162
3316598|NCT03115580|4049984|FG000|STARTED|Overall Study||35
3316599|NCT03115580|4049985|FG001|STARTED|Overall Study||36
3316600|NCT03115580|4049984|FG000|COMPLETED|Overall Study||35
3316601|NCT03115580|4049985|FG001|COMPLETED|Overall Study||36
3316602|NCT03115580|4049984|FG000|NOT COMPLETED|Overall Study||0
3316603|NCT03115580|4049985|FG001|NOT COMPLETED|Overall Study||0
3316604|NCT03115801|4049993|FG000|STARTED|Overall Study||4
3316605|NCT03115801|4049994|FG001|STARTED|Overall Study||2
3316606|NCT03115801|4049993|FG000|COMPLETED|Overall Study||1
3316607|NCT03115801|4049994|FG001|COMPLETED|Overall Study||0
3316608|NCT03115801|4049993|FG000|NOT COMPLETED|Overall Study||3
3316609|NCT03115801|4049994|FG001|NOT COMPLETED|Overall Study||2
3316610|NCT03115827|4050000|FG000|STARTED|Overall Study||15
3076852|NCT01358721|3798604|FG003|STARTED|Overall Study||24
3076853|NCT01358721|3798601|FG000|COMPLETED|Overall Study||1
3076854|NCT01358721|3798602|FG001|COMPLETED|Overall Study||0
3076855|NCT01358721|3798603|FG002|COMPLETED|Overall Study||1
3076856|NCT01358721|3798604|FG003|COMPLETED|Overall Study||0
3076857|NCT01358721|3798601|FG000|NOT COMPLETED|Overall Study||21
3076858|NCT01358721|3798602|FG001|NOT COMPLETED|Overall Study||22
3076859|NCT01358721|3798603|FG002|NOT COMPLETED|Overall Study||22
3076860|NCT01358721|3798604|FG003|NOT COMPLETED|Overall Study||24
3076861|NCT01358734|3798617|FG000|STARTED|Overall Study||15
3076862|NCT01358734|3798618|FG001|STARTED|Overall Study||39
3076863|NCT01358734|3798619|FG002|STARTED|Overall Study||34
3076864|NCT01358734|3798617|FG000|Safety Population|Overall Study|The safety population includes all participants who received at least one dose of study drug.|14
3076865|NCT01358734|3798618|FG001|Safety Population|Overall Study|The safety population includes all participants who received at least one dose of study drug.|38
3076866|NCT01358734|3798619|FG002|Safety Population|Overall Study|The safety population includes all participants who received at least one dose of study drug.|32
3076867|NCT01358734|3798617|FG000|COMPLETED|Overall Study||0
3076868|NCT01358734|3798618|FG001|COMPLETED|Overall Study||0
3076869|NCT01358734|3798619|FG002|COMPLETED|Overall Study||0
3076870|NCT01358734|3798617|FG000|NOT COMPLETED|Overall Study||15
3076871|NCT01358734|3798618|FG001|NOT COMPLETED|Overall Study||39
3076872|NCT01358734|3798619|FG002|NOT COMPLETED|Overall Study||34
3076873|NCT01358760|3798630|FG000|STARTED|Overall Study||152
3076874|NCT01358760|3798631|FG001|STARTED|Overall Study||148
3076875|NCT01358760|3798632|FG002|STARTED|Overall Study||150
3076876|NCT01358760|3798630|FG000|Safety Population|Overall Study||150
3076877|NCT01358760|3798631|FG001|Safety Population|Overall Study||143
3076878|NCT01358760|3798632|FG002|Safety Population|Overall Study||148
3076879|NCT01358760|3798630|FG000|ITT Population|Overall Study||139
3076880|NCT01358760|3798631|FG001|ITT Population|Overall Study||134
3076881|NCT01358760|3798632|FG002|ITT Population|Overall Study||134
3076882|NCT01358760|3798630|FG000|COMPLETED|Overall Study||130
3076883|NCT01358760|3798631|FG001|COMPLETED|Overall Study||128
3076884|NCT01358760|3798632|FG002|COMPLETED|Overall Study||125
3076885|NCT01358760|3798630|FG000|NOT COMPLETED|Overall Study||22
3076886|NCT01358760|3798631|FG001|NOT COMPLETED|Overall Study||20
3076887|NCT01358760|3798632|FG002|NOT COMPLETED|Overall Study||25
3076888|NCT01358825|3798642|FG000|STARTED|Overall Study||12
3076889|NCT01358825|3798643|FG001|STARTED|Overall Study||46
3076890|NCT01358825|3798642|FG000|COMPLETED|Overall Study||12
3076891|NCT01358825|3798643|FG001|COMPLETED|Overall Study||45
3076892|NCT01358825|3798642|FG000|NOT COMPLETED|Overall Study||0
3076893|NCT01358825|3798643|FG001|NOT COMPLETED|Overall Study||1
3076894|NCT01358864|3798657|FG000|STARTED|Overall Study||49
3076895|NCT01358864|3798658|FG001|STARTED|Overall Study||99
3076896|NCT01358864|3798659|FG002|STARTED|Overall Study||103
3076897|NCT01358864|3798660|FG003|STARTED|Overall Study||29
3076898|NCT01358864|3798661|FG004|STARTED|Overall Study||57
3076899|NCT01358864|3798662|FG005|STARTED|Overall Study||55
3076900|NCT01358864|3798663|FG006|STARTED|Overall Study||146
3076901|NCT01358864|3798664|FG007|STARTED|Overall Study||140
3076902|NCT01358864|3798657|FG000|COMPLETED|Overall Study||18
3076903|NCT01358864|3798658|FG001|COMPLETED|Overall Study||86
3076904|NCT01358864|3798659|FG002|COMPLETED|Overall Study||87
3076905|NCT01358864|3798660|FG003|COMPLETED|Overall Study||10
3076906|NCT01358864|3798661|FG004|COMPLETED|Overall Study||46
3076907|NCT01358864|3798662|FG005|COMPLETED|Overall Study||42
3076908|NCT01358864|3798663|FG006|COMPLETED|Overall Study||81
3076909|NCT01358864|3798664|FG007|COMPLETED|Overall Study||85
3076910|NCT01358864|3798657|FG000|NOT COMPLETED|Overall Study||31
3076911|NCT01358864|3798658|FG001|NOT COMPLETED|Overall Study||13
3076912|NCT01358864|3798659|FG002|NOT COMPLETED|Overall Study||16
3076913|NCT01358864|3798660|FG003|NOT COMPLETED|Overall Study||19
3076914|NCT01358864|3798661|FG004|NOT COMPLETED|Overall Study||11
3076915|NCT01358864|3798662|FG005|NOT COMPLETED|Overall Study||13
3076916|NCT01358864|3798663|FG006|NOT COMPLETED|Overall Study||65
3076917|NCT01358864|3798664|FG007|NOT COMPLETED|Overall Study||55
3076918|NCT01358877|3798686|FG000|STARTED|Overall Study||2400
3076919|NCT01358877|3798687|FG001|STARTED|Overall Study||2404
3076920|NCT01358877|3798686|FG000|Did Not Receive Study Drug|Overall Study||22
3076921|NCT01358877|3798687|FG001|Did Not Receive Study Drug|Overall Study||13
3076922|NCT01358877|3798686|FG000|Received Study Drug (Safety Population)|Overall Study|24 placebo participants received at least 1 dose of pertuzumab and were included in pertuzumab arm.|2364
3076923|NCT01358877|3798687|FG001|Received Study Drug (Safety Population)|Overall Study|38 pertuzumab participants did not receive pertuzumab and were included in placebo arm.|2405
3076924|NCT01358877|3798686|FG000|COMPLETED|Overall Study||0
3076925|NCT01358877|3798687|FG001|COMPLETED|Overall Study||0
3076926|NCT01358877|3798686|FG000|NOT COMPLETED|Overall Study||2400
3076927|NCT01358877|3798687|FG001|NOT COMPLETED|Overall Study||2404
3076928|NCT01358968|3798693|FG000|STARTED|Period 1||20
3076929|NCT01358968|3798694|FG001|STARTED|Period 1||0
3076930|NCT01358968|3798695|FG002|STARTED|Period 1||0
3076931|NCT01358968|3798696|FG003|STARTED|Period 1||0
3076932|NCT01358968|3798693|FG000|Received at Least 1 Dose of Study Drug|Period 1||20
3076933|NCT01358968|3798694|FG001|Received at Least 1 Dose of Study Drug|Period 1||0
3076934|NCT01358968|3798695|FG002|Received at Least 1 Dose of Study Drug|Period 1||0
3076935|NCT01358968|3798696|FG003|Received at Least 1 Dose of Study Drug|Period 1||0
3076936|NCT01358968|3798693|FG000|COMPLETED|Period 1||20
3076937|NCT01358968|3798694|FG001|COMPLETED|Period 1||0
3076938|NCT01358968|3798695|FG002|COMPLETED|Period 1||0
3076939|NCT01358968|3798696|FG003|COMPLETED|Period 1||0
3076940|NCT01358968|3798693|FG000|NOT COMPLETED|Period 1||0
3076941|NCT01358968|3798694|FG001|NOT COMPLETED|Period 1||0
3076942|NCT01358968|3798695|FG002|NOT COMPLETED|Period 1||0
3076943|NCT01358968|3798696|FG003|NOT COMPLETED|Period 1||0
3076944|NCT01358968|3798693|FG000|STARTED|Period 2||0
3076945|NCT01358968|3798694|FG001|STARTED|Period 2||20
3076946|NCT01358968|3798695|FG002|STARTED|Period 2||0
3076947|NCT01358968|3798696|FG003|STARTED|Period 2||0
3076948|NCT01358968|3798693|FG000|Received at Least 1 Dose of Study Drug|Period 2||0
3076949|NCT01358968|3798694|FG001|Received at Least 1 Dose of Study Drug|Period 2||19
3076950|NCT01358968|3798695|FG002|Received at Least 1 Dose of Study Drug|Period 2||0
3076951|NCT01358968|3798696|FG003|Received at Least 1 Dose of Study Drug|Period 2||0
3076952|NCT01358968|3798693|FG000|COMPLETED|Period 2||0
3076953|NCT01358968|3798694|FG001|COMPLETED|Period 2||19
3076954|NCT01358968|3798695|FG002|COMPLETED|Period 2||0
3076955|NCT01358968|3798696|FG003|COMPLETED|Period 2||0
3076956|NCT01358968|3798693|FG000|NOT COMPLETED|Period 2||0
3076957|NCT01358968|3798694|FG001|NOT COMPLETED|Period 2||1
3076958|NCT01358968|3798695|FG002|NOT COMPLETED|Period 2||0
3076959|NCT01358968|3798696|FG003|NOT COMPLETED|Period 2||0
3076960|NCT01358968|3798693|FG000|STARTED|Continued Access Phase||0
3076961|NCT01358968|3798694|FG001|STARTED|Continued Access Phase||0
3076962|NCT01358968|3798695|FG002|STARTED|Continued Access Phase||12
3076963|NCT01358968|3798696|FG003|STARTED|Continued Access Phase||7
3076964|NCT01358968|3798693|FG000|Received at Least 1 Dose of Study Drug|Continued Access Phase||0
3076965|NCT01358968|3798694|FG001|Received at Least 1 Dose of Study Drug|Continued Access Phase||0
3076966|NCT01358968|3798695|FG002|Received at Least 1 Dose of Study Drug|Continued Access Phase||12
3076967|NCT01358968|3798696|FG003|Received at Least 1 Dose of Study Drug|Continued Access Phase||7
3076968|NCT01358968|3798693|FG000|COMPLETED|Continued Access Phase||0
3076969|NCT01358968|3798694|FG001|COMPLETED|Continued Access Phase||0
3076970|NCT01358968|3798695|FG002|COMPLETED|Continued Access Phase||0
3076971|NCT01358968|3798696|FG003|COMPLETED|Continued Access Phase||0
3076972|NCT01358968|3798693|FG000|NOT COMPLETED|Continued Access Phase||0
3076973|NCT01358968|3798694|FG001|NOT COMPLETED|Continued Access Phase||0
3076974|NCT01358968|3798695|FG002|NOT COMPLETED|Continued Access Phase||12
3076975|NCT01358968|3798696|FG003|NOT COMPLETED|Continued Access Phase||7
3076976|NCT01358981|3798713|FG000|STARTED|Period 1||2
3076977|NCT01358981|3798714|FG001|STARTED|Period 1||2
3076978|NCT01358981|3798715|FG002|STARTED|Period 1||2
3076979|NCT01358981|3798716|FG003|STARTED|Period 1||2
3076980|NCT01358981|3798717|FG004|STARTED|Period 1||3
3076981|NCT01358981|3798718|FG005|STARTED|Period 1||3
3076982|NCT01358981|3798719|FG006|STARTED|Period 1||3
3076983|NCT01358981|3798713|FG000|Received at Least 1dose of Study Drug|Period 1||2
3076984|NCT01358981|3798714|FG001|Received at Least 1dose of Study Drug|Period 1||2
3076985|NCT01358981|3798715|FG002|Received at Least 1dose of Study Drug|Period 1||2
3076986|NCT01358981|3798716|FG003|Received at Least 1dose of Study Drug|Period 1||2
3076987|NCT01358981|3798717|FG004|Received at Least 1dose of Study Drug|Period 1||3
3076988|NCT01358981|3798718|FG005|Received at Least 1dose of Study Drug|Period 1||3
3076989|NCT01358981|3798719|FG006|Received at Least 1dose of Study Drug|Period 1||3
3076990|NCT01358981|3798713|FG000|COMPLETED|Period 1||2
3076991|NCT01358981|3798714|FG001|COMPLETED|Period 1||2
3076992|NCT01358981|3798715|FG002|COMPLETED|Period 1||2
3076993|NCT01358981|3798716|FG003|COMPLETED|Period 1||1
3076994|NCT01358981|3798717|FG004|COMPLETED|Period 1||3
3076995|NCT01358981|3798718|FG005|COMPLETED|Period 1||3
3076996|NCT01358981|3798719|FG006|COMPLETED|Period 1||3
3076997|NCT01358981|3798713|FG000|NOT COMPLETED|Period 1||0
3076998|NCT01358981|3798714|FG001|NOT COMPLETED|Period 1||0
3076999|NCT01358981|3798715|FG002|NOT COMPLETED|Period 1||0
3077000|NCT01358981|3798716|FG003|NOT COMPLETED|Period 1||1
3077001|NCT01358981|3798717|FG004|NOT COMPLETED|Period 1||0
3077002|NCT01358981|3798718|FG005|NOT COMPLETED|Period 1||0
3077003|NCT01358981|3798719|FG006|NOT COMPLETED|Period 1||0
3077004|NCT01358981|3798713|FG000|STARTED|Period 2||2
3077005|NCT01358981|3798714|FG001|STARTED|Period 2||2
3077006|NCT01358981|3798715|FG002|STARTED|Period 2||2
3077007|NCT01358981|3798716|FG003|STARTED|Period 2|One participant who withdrew in period 1 was replaced by another participant in period 2.|2
3077008|NCT01358981|3798717|FG004|STARTED|Period 2||3
3077009|NCT01358981|3798718|FG005|STARTED|Period 2||3
3077010|NCT01358981|3798719|FG006|STARTED|Period 2||3
3077011|NCT01358981|3798713|FG000|COMPLETED|Period 2||2
3077012|NCT01358981|3798714|FG001|COMPLETED|Period 2||2
3077013|NCT01358981|3798715|FG002|COMPLETED|Period 2||2
3077014|NCT01358981|3798716|FG003|COMPLETED|Period 2||2
3077015|NCT01358981|3798717|FG004|COMPLETED|Period 2||3
3077016|NCT01358981|3798718|FG005|COMPLETED|Period 2||3
3077017|NCT01358981|3798719|FG006|COMPLETED|Period 2||3
3077018|NCT01358981|3798713|FG000|NOT COMPLETED|Period 2||0
3077019|NCT01358981|3798714|FG001|NOT COMPLETED|Period 2||0
3077020|NCT01358981|3798715|FG002|NOT COMPLETED|Period 2||0
3077021|NCT01358981|3798716|FG003|NOT COMPLETED|Period 2||0
3077022|NCT01358981|3798717|FG004|NOT COMPLETED|Period 2||0
3077023|NCT01358981|3798718|FG005|NOT COMPLETED|Period 2||0
3077024|NCT01358981|3798719|FG006|NOT COMPLETED|Period 2||0
3077025|NCT01358981|3798713|FG000|STARTED|Period 3||2
3077026|NCT01358981|3798714|FG001|STARTED|Period 3||2
3077027|NCT01358981|3798715|FG002|STARTED|Period 3||2
3077028|NCT01358981|3798716|FG003|STARTED|Period 3||2
3077029|NCT01358981|3798717|FG004|STARTED|Period 3||3
3077030|NCT01358981|3798718|FG005|STARTED|Period 3||3
3077031|NCT01358981|3798719|FG006|STARTED|Period 3||3
3077032|NCT01358981|3798713|FG000|COMPLETED|Period 3||2
3077033|NCT01358981|3798714|FG001|COMPLETED|Period 3||2
3077034|NCT01358981|3798715|FG002|COMPLETED|Period 3||2
3077035|NCT01358981|3798716|FG003|COMPLETED|Period 3||2
3077036|NCT01358981|3798717|FG004|COMPLETED|Period 3||3
3077037|NCT01358981|3798718|FG005|COMPLETED|Period 3||3
3077038|NCT01358981|3798719|FG006|COMPLETED|Period 3||3
3077039|NCT01358981|3798713|FG000|NOT COMPLETED|Period 3||0
3077040|NCT01358981|3798714|FG001|NOT COMPLETED|Period 3||0
3077041|NCT01358981|3798715|FG002|NOT COMPLETED|Period 3||0
3077042|NCT01358981|3798716|FG003|NOT COMPLETED|Period 3||0
3077043|NCT01358981|3798717|FG004|NOT COMPLETED|Period 3||0
3077044|NCT01358981|3798718|FG005|NOT COMPLETED|Period 3||0
3077045|NCT01358981|3798719|FG006|NOT COMPLETED|Period 3||0
3077046|NCT01358981|3798713|FG000|STARTED|Period 4||2
3077047|NCT01358981|3798714|FG001|STARTED|Period 4||2
3077048|NCT01358981|3798715|FG002|STARTED|Period 4||2
3077049|NCT01358981|3798716|FG003|STARTED|Period 4||2
3077050|NCT01358981|3798717|FG004|STARTED|Period 4|Part B was planned for only 3 dosing periods.|0
3077051|NCT01358981|3798718|FG005|STARTED|Period 4|Part B was planned for only 3 dosing periods.|0
3077052|NCT01358981|3798719|FG006|STARTED|Period 4|Part B was planned for only 3 dosing periods.|0
3077053|NCT01358981|3798713|FG000|COMPLETED|Period 4||2
3077054|NCT01358981|3798714|FG001|COMPLETED|Period 4||2
3077055|NCT01358981|3798715|FG002|COMPLETED|Period 4||2
3077056|NCT01358981|3798716|FG003|COMPLETED|Period 4||2
3077057|NCT01358981|3798717|FG004|COMPLETED|Period 4||0
3077058|NCT01358981|3798718|FG005|COMPLETED|Period 4||0
3077059|NCT01358981|3798719|FG006|COMPLETED|Period 4||0
3077060|NCT01358981|3798713|FG000|NOT COMPLETED|Period 4||0
3077061|NCT01358981|3798714|FG001|NOT COMPLETED|Period 4||0
3077062|NCT01358981|3798715|FG002|NOT COMPLETED|Period 4||0
3077063|NCT01358981|3798716|FG003|NOT COMPLETED|Period 4||0
3077064|NCT01358981|3798717|FG004|NOT COMPLETED|Period 4||0
3077065|NCT01358981|3798718|FG005|NOT COMPLETED|Period 4||0
3077066|NCT01358981|3798719|FG006|NOT COMPLETED|Period 4||0
3077067|NCT01359007|3798744|FG000|STARTED|Overall Study||5
3077068|NCT01359007|3798744|FG000|COMPLETED|Overall Study||3
3077069|NCT01359007|3798744|FG000|NOT COMPLETED|Overall Study||2
3077070|NCT01359046|3798751|FG000|STARTED|Overall Study||144
3077071|NCT01359046|3798752|FG001|STARTED|Overall Study||144
3077072|NCT01359046|3798751|FG000|COMPLETED|Overall Study||137
3077073|NCT01359046|3798752|FG001|COMPLETED|Overall Study||127
3077074|NCT01359046|3798751|FG000|NOT COMPLETED|Overall Study||7
3077075|NCT01359046|3798752|FG001|NOT COMPLETED|Overall Study||17
3077076|NCT01359111|3798758|FG000|STARTED|Overall Study||20
3077077|NCT01359111|3798758|FG000|COMPLETED|Overall Study||20
3077078|NCT01359111|3798758|FG000|NOT COMPLETED|Overall Study||0
3077079|NCT01359150|3798766|FG000|STARTED|Overall Study||112
3077080|NCT01359150|3798767|FG001|STARTED|Overall Study||111
3077081|NCT01359150|3798766|FG000|COMPLETED|Overall Study||105
3077082|NCT01359150|3798767|FG001|COMPLETED|Overall Study||106
3077083|NCT01359150|3798766|FG000|NOT COMPLETED|Overall Study||7
3077084|NCT01359150|3798767|FG001|NOT COMPLETED|Overall Study||5
3077085|NCT01359371|3798773|FG000|STARTED|Overall Study||131
3077086|NCT01359371|3798773|FG000|COMPLETED|Overall Study||131
3077087|NCT01359371|3798773|FG000|NOT COMPLETED|Overall Study||0
3077088|NCT01359410|3798784|FG000|STARTED|Overall Study||54
3077089|NCT01359410|3798785|FG001|STARTED|Overall Study||46
3077090|NCT01359410|3798784|FG000|COMPLETED|Overall Study||54
3077091|NCT01359410|3798785|FG001|COMPLETED|Overall Study||46
3077092|NCT01359410|3798784|FG000|NOT COMPLETED|Overall Study||0
3077093|NCT01359410|3798785|FG001|NOT COMPLETED|Overall Study||0
3077094|NCT01359449|3798793|FG000|STARTED|Overall Study||61
3077095|NCT01359449|3798794|FG001|STARTED|Overall Study||62
3077096|NCT01359449|3798793|FG000|COMPLETED|Overall Study||57
3077097|NCT01359449|3798794|FG001|COMPLETED|Overall Study||58
3077098|NCT01359449|3798793|FG000|NOT COMPLETED|Overall Study||4
3077099|NCT01359449|3798794|FG001|NOT COMPLETED|Overall Study||4
3077100|NCT01359592|3798800|FG000|STARTED|Initial Registration||158
3077101|NCT01359592|3798801|FG001|STARTED|Initial Registration||1
3077102|NCT01359592|3798802|FG002|STARTED|Initial Registration||0
3077103|NCT01359592|3798803|FG003|STARTED|Initial Registration||0
3077104|NCT01359592|3798800|FG000|Eligible and Evaluable|Initial Registration||132
3077105|NCT01359592|3798801|FG001|Eligible and Evaluable|Initial Registration||1
3077106|NCT01359592|3798802|FG002|Eligible and Evaluable|Initial Registration||0
3077107|NCT01359592|3798803|FG003|Eligible and Evaluable|Initial Registration||0
3077108|NCT01359592|3798800|FG000|COMPLETED|Initial Registration||129
3077109|NCT01359592|3798801|FG001|COMPLETED|Initial Registration||1
3077110|NCT01359592|3798802|FG002|COMPLETED|Initial Registration||0
3077111|NCT01359592|3798803|FG003|COMPLETED|Initial Registration||0
3077112|NCT01359592|3798800|FG000|NOT COMPLETED|Initial Registration||29
3077113|NCT01359592|3798801|FG001|NOT COMPLETED|Initial Registration||0
3077114|NCT01359592|3798802|FG002|NOT COMPLETED|Initial Registration||0
3077115|NCT01359592|3798803|FG003|NOT COMPLETED|Initial Registration||0
3077116|NCT01359592|3798800|FG000|STARTED|PET-Directed Therapy||0
3077117|NCT01359592|3798801|FG001|STARTED|PET-Directed Therapy||0
3077118|NCT01359592|3798802|FG002|STARTED|PET-Directed Therapy||137
3077119|NCT01359592|3798803|FG003|STARTED|PET-Directed Therapy||12
3077120|NCT01359592|3798800|FG000|Eligible and Evaluable|PET-Directed Therapy||0
3077121|NCT01359592|3798801|FG001|Eligible and Evaluable|PET-Directed Therapy||0
3077122|NCT01359592|3798802|FG002|Eligible and Evaluable|PET-Directed Therapy||113
3077123|NCT01359592|3798803|FG003|Eligible and Evaluable|PET-Directed Therapy||12
3077124|NCT01359592|3798800|FG000|COMPLETED|PET-Directed Therapy||0
3077125|NCT01359592|3798801|FG001|COMPLETED|PET-Directed Therapy||0
3077126|NCT01359592|3798802|FG002|COMPLETED|PET-Directed Therapy||111
3077127|NCT01359592|3798803|FG003|COMPLETED|PET-Directed Therapy||12
3077128|NCT01359592|3798800|FG000|NOT COMPLETED|PET-Directed Therapy||0
3077129|NCT01359592|3798801|FG001|NOT COMPLETED|PET-Directed Therapy||0
3077130|NCT01359592|3798802|FG002|NOT COMPLETED|PET-Directed Therapy||26
3077131|NCT01359592|3798803|FG003|NOT COMPLETED|PET-Directed Therapy||0
3077132|NCT01359644|3798828|FG000|STARTED|Treatment Period||15
3077133|NCT01359644|3798829|FG001|STARTED|Treatment Period||16
3077134|NCT01359644|3798830|FG002|STARTED|Treatment Period||14
3077135|NCT01359644|3798831|FG003|STARTED|Treatment Period||14
3077136|NCT01359644|3798832|FG004|STARTED|Treatment Period||15
3077137|NCT01359644|3798833|FG005|STARTED|Treatment Period||14
3077138|NCT01359644|3798834|FG006|STARTED|Treatment Period||41
3077139|NCT01359644|3798835|FG007|STARTED|Treatment Period||41
3077140|NCT01359644|3798836|FG008|STARTED|Treatment Period||21
3077141|NCT01359644|3798837|FG009|STARTED|Treatment Period||20
3077142|NCT01359644|3798828|FG000|COMPLETED|Treatment Period||15
3077143|NCT01359644|3798829|FG001|COMPLETED|Treatment Period||15
3077144|NCT01359644|3798830|FG002|COMPLETED|Treatment Period||13
3077145|NCT01359644|3798831|FG003|COMPLETED|Treatment Period||14
3077146|NCT01359644|3798832|FG004|COMPLETED|Treatment Period||15
3077147|NCT01359644|3798833|FG005|COMPLETED|Treatment Period||12
3077148|NCT01359644|3798834|FG006|COMPLETED|Treatment Period||41
3077149|NCT01359644|3798835|FG007|COMPLETED|Treatment Period||41
3077150|NCT01359644|3798836|FG008|COMPLETED|Treatment Period||21
3077151|NCT01359644|3798837|FG009|COMPLETED|Treatment Period||20
3077152|NCT01359644|3798828|FG000|NOT COMPLETED|Treatment Period||0
3077153|NCT01359644|3798829|FG001|NOT COMPLETED|Treatment Period||1
3077154|NCT01359644|3798830|FG002|NOT COMPLETED|Treatment Period||1
3077155|NCT01359644|3798831|FG003|NOT COMPLETED|Treatment Period||0
3077156|NCT01359644|3798832|FG004|NOT COMPLETED|Treatment Period||0
3077157|NCT01359644|3798833|FG005|NOT COMPLETED|Treatment Period||2
3077158|NCT01359644|3798834|FG006|NOT COMPLETED|Treatment Period||0
3077159|NCT01359644|3798835|FG007|NOT COMPLETED|Treatment Period||0
3077160|NCT01359644|3798836|FG008|NOT COMPLETED|Treatment Period||0
3077161|NCT01359644|3798837|FG009|NOT COMPLETED|Treatment Period||0
3077162|NCT01359644|3798828|FG000|STARTED|Follow-up Period||15
3077163|NCT01359644|3798829|FG001|STARTED|Follow-up Period||16
3077164|NCT01359644|3798830|FG002|STARTED|Follow-up Period||14
3077165|NCT01359644|3798831|FG003|STARTED|Follow-up Period||14
3077166|NCT01359644|3798832|FG004|STARTED|Follow-up Period||15
3077167|NCT01359644|3798833|FG005|STARTED|Follow-up Period||13
3077168|NCT01359644|3798834|FG006|STARTED|Follow-up Period||41
3077169|NCT01359644|3798835|FG007|STARTED|Follow-up Period||41
3077170|NCT01359644|3798836|FG008|STARTED|Follow-up Period||21
3077171|NCT01359644|3798837|FG009|STARTED|Follow-up Period||20
3077172|NCT01359644|3798828|FG000|COMPLETED|Follow-up Period||15
3077173|NCT01359644|3798829|FG001|COMPLETED|Follow-up Period||16
3077174|NCT01359644|3798830|FG002|COMPLETED|Follow-up Period||14
3077175|NCT01359644|3798831|FG003|COMPLETED|Follow-up Period||14
3077176|NCT01359644|3798832|FG004|COMPLETED|Follow-up Period||15
3077177|NCT01359644|3798833|FG005|COMPLETED|Follow-up Period||12
3077178|NCT01359644|3798834|FG006|COMPLETED|Follow-up Period||40
3077179|NCT01359644|3798835|FG007|COMPLETED|Follow-up Period||39
3077180|NCT01359644|3798836|FG008|COMPLETED|Follow-up Period||21
3077181|NCT01359644|3798837|FG009|COMPLETED|Follow-up Period||20
3077182|NCT01359644|3798828|FG000|NOT COMPLETED|Follow-up Period||0
3077183|NCT01359644|3798829|FG001|NOT COMPLETED|Follow-up Period||0
3077184|NCT01359644|3798830|FG002|NOT COMPLETED|Follow-up Period||0
3077185|NCT01359644|3798831|FG003|NOT COMPLETED|Follow-up Period||0
3077186|NCT01359644|3798832|FG004|NOT COMPLETED|Follow-up Period||0
3077187|NCT01359644|3798833|FG005|NOT COMPLETED|Follow-up Period||1
3077188|NCT01359644|3798834|FG006|NOT COMPLETED|Follow-up Period||1
3077189|NCT01359644|3798835|FG007|NOT COMPLETED|Follow-up Period||2
3077190|NCT01359644|3798836|FG008|NOT COMPLETED|Follow-up Period||0
3077191|NCT01359644|3798837|FG009|NOT COMPLETED|Follow-up Period||0
3077192|NCT01359735|3798872|FG000|STARTED|Overall Study||4
3077193|NCT01359735|3798873|FG001|STARTED|Overall Study||4
3284819|NCT02767765|4018552|FG000|STARTED|Overall Study||61
3284820|NCT02767765|4018552|FG000|COMPLETED|Overall Study||50
3284821|NCT02767765|4018552|FG000|NOT COMPLETED|Overall Study||11
3284822|NCT02767843|4018556|FG000|STARTED|Overall Study||4
3284823|NCT02767843|4018556|FG000|COMPLETED|Overall Study||4
3284824|NCT02767843|4018556|FG000|NOT COMPLETED|Overall Study||0
3284825|NCT02767869|4018564|FG000|STARTED|Overall Study||12
3284826|NCT02767869|4018565|FG001|STARTED|Overall Study||12
3284827|NCT02767869|4018564|FG000|COMPLETED|Overall Study||12
3284828|NCT02767869|4018565|FG001|COMPLETED|Overall Study||12
3284829|NCT02767869|4018564|FG000|NOT COMPLETED|Overall Study||0
3284830|NCT02767869|4018565|FG001|NOT COMPLETED|Overall Study||0
3077194|NCT01359735|3798872|FG000|COMPLETED|Overall Study||4
3077195|NCT01359735|3798873|FG001|COMPLETED|Overall Study||4
3077196|NCT01359735|3798872|FG000|NOT COMPLETED|Overall Study||0
3077197|NCT01359735|3798873|FG001|NOT COMPLETED|Overall Study||0
3077198|NCT01359748|3798883|FG000|STARTED|Overall Study||48
3077199|NCT01359748|3798884|FG001|STARTED|Overall Study||20
3077200|NCT01359748|3798885|FG002|STARTED|Overall Study||10
3077201|NCT01359748|3798886|FG003|STARTED|Overall Study||11
3077202|NCT01359748|3798883|FG000|COMPLETED|Overall Study||48
3077203|NCT01359748|3798884|FG001|COMPLETED|Overall Study||20
3077204|NCT01359748|3798885|FG002|COMPLETED|Overall Study||10
3077205|NCT01359748|3798886|FG003|COMPLETED|Overall Study||11
3077206|NCT01359748|3798883|FG000|NOT COMPLETED|Overall Study||0
3077207|NCT01359748|3798884|FG001|NOT COMPLETED|Overall Study||0
3077208|NCT01359748|3798885|FG002|NOT COMPLETED|Overall Study||0
3077209|NCT01359748|3798886|FG003|NOT COMPLETED|Overall Study||0
3077210|NCT01359904|3798896|FG000|STARTED|Overall Study||15
3077211|NCT01359904|3798897|FG001|STARTED|Overall Study||19
3077212|NCT01359904|3798896|FG000|COMPLETED|Overall Study||14
3077213|NCT01359904|3798897|FG001|COMPLETED|Overall Study||19
3077214|NCT01359904|3798896|FG000|NOT COMPLETED|Overall Study||1
3077215|NCT01359904|3798897|FG001|NOT COMPLETED|Overall Study||0
3077216|NCT01359943|3798906|FG000|STARTED|Double-blind (Weeks 0 - 16)||88
3077217|NCT01359943|3798907|FG001|STARTED|Double-blind (Weeks 0 - 16)||89
3077218|NCT01359943|3798908|FG002|STARTED|Double-blind (Weeks 0 - 16)||44
3077219|NCT01359943|3798906|FG000|COMPLETED|Double-blind (Weeks 0 - 16)||86
3077220|NCT01359943|3798907|FG001|COMPLETED|Double-blind (Weeks 0 - 16)||85
3077221|NCT01359943|3798908|FG002|COMPLETED|Double-blind (Weeks 0 - 16)||44
3077222|NCT01359943|3798906|FG000|NOT COMPLETED|Double-blind (Weeks 0 - 16)||2
3077223|NCT01359943|3798907|FG001|NOT COMPLETED|Double-blind (Weeks 0 - 16)||4
3077224|NCT01359943|3798908|FG002|NOT COMPLETED|Double-blind (Weeks 0 - 16)||0
3077225|NCT01359943|3798906|FG000|STARTED|Open Label 150 mg s.c. (Weeks 16 - 52)||86
3077226|NCT01359943|3798907|FG001|STARTED|Open Label 150 mg s.c. (Weeks 16 - 52)|One participant, who was continuing as of week 12, did not receive study drug at week 16.|84
3077227|NCT01359943|3798908|FG002|STARTED|Open Label 150 mg s.c. (Weeks 16 - 52)||44
3077228|NCT01359943|3798906|FG000|COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||78
3077229|NCT01359943|3798907|FG001|COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||71
3077230|NCT01359943|3798908|FG002|COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||36
3077231|NCT01359943|3798906|FG000|NOT COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||8
3077232|NCT01359943|3798907|FG001|NOT COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||13
3077233|NCT01359943|3798908|FG002|NOT COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||8
3077234|NCT01359943|3798906|FG000|STARTED|Follow-up (Weeks 52 - 60)||86
3077235|NCT01359943|3798907|FG001|STARTED|Follow-up (Weeks 52 - 60)||84
3077236|NCT01359943|3798908|FG002|STARTED|Follow-up (Weeks 52 - 60)||44
3077237|NCT01359943|3798906|FG000|COMPLETED|Follow-up (Weeks 52 - 60)||78
3077238|NCT01359943|3798907|FG001|COMPLETED|Follow-up (Weeks 52 - 60)||69
3077239|NCT01359943|3798908|FG002|COMPLETED|Follow-up (Weeks 52 - 60)||36
3077240|NCT01359943|3798906|FG000|NOT COMPLETED|Follow-up (Weeks 52 - 60)||8
3077241|NCT01359943|3798907|FG001|NOT COMPLETED|Follow-up (Weeks 52 - 60)||15
3077242|NCT01359943|3798908|FG002|NOT COMPLETED|Follow-up (Weeks 52 - 60)||8
3077243|NCT01359956|3798922|FG000|STARTED|Overall Study||67
3077244|NCT01359956|3798923|FG001|STARTED|Overall Study||69
3077245|NCT01359956|3798924|FG002|STARTED|Overall Study||71
3077246|NCT01359956|3798925|FG003|STARTED|Overall Study||62
3077247|NCT01359956|3798922|FG000|COMPLETED|Overall Study||6
3077248|NCT01359956|3798923|FG001|COMPLETED|Overall Study||5
3077249|NCT01359956|3798924|FG002|COMPLETED|Overall Study||4
3077250|NCT01359956|3798925|FG003|COMPLETED|Overall Study||4
3077251|NCT01359956|3798922|FG000|NOT COMPLETED|Overall Study||61
3077252|NCT01359956|3798923|FG001|NOT COMPLETED|Overall Study||64
3077253|NCT01359956|3798924|FG002|NOT COMPLETED|Overall Study||67
3077254|NCT01359956|3798925|FG003|NOT COMPLETED|Overall Study||58
3077255|NCT01360021|3798938|FG000|STARTED|Overall Study|Patients randomized|71
3077256|NCT01360021|3798939|FG001|STARTED|Overall Study|Patients randomized|71
3077257|NCT01360021|3798940|FG002|STARTED|Overall Study|Patients randomized|72
3077258|NCT01360021|3798938|FG000|COMPLETED|Overall Study|Patients who completed study|63
3077259|NCT01360021|3798939|FG001|COMPLETED|Overall Study|Patients who completed study|67
3077260|NCT01360021|3798940|FG002|COMPLETED|Overall Study|Patients who completed study|65
3077261|NCT01360021|3798938|FG000|NOT COMPLETED|Overall Study||8
3077262|NCT01360021|3798939|FG001|NOT COMPLETED|Overall Study||4
3077263|NCT01360021|3798940|FG002|NOT COMPLETED|Overall Study||7
3077264|NCT01360229|3798950|FG000|STARTED|Overall Study||47
3077265|NCT01360229|3798951|FG001|STARTED|Overall Study||47
3077266|NCT01360229|3798950|FG000|COMPLETED|Overall Study||44
3077267|NCT01360229|3798951|FG001|COMPLETED|Overall Study||45
3077268|NCT01360229|3798950|FG000|NOT COMPLETED|Overall Study||3
3077269|NCT01360229|3798951|FG001|NOT COMPLETED|Overall Study||2
3077270|NCT01360398|3798957|FG000|STARTED|Overall Study||127
3077271|NCT01360398|3798957|FG000|COMPLETED|Overall Study||105
3077272|NCT01360398|3798957|FG000|NOT COMPLETED|Overall Study||22
3077273|NCT01360450|3798963|FG000|STARTED|Overall Study||6
3077274|NCT01360450|3798964|FG001|STARTED|Overall Study||6
3077275|NCT01360450|3798963|FG000|Completed Treatment|Overall Study||6
3077276|NCT01360450|3798964|FG001|Completed Treatment|Overall Study||6
3077277|NCT01360450|3798963|FG000|COMPLETED|Overall Study||6
3077278|NCT01360450|3798964|FG001|COMPLETED|Overall Study||6
3077279|NCT01360450|3798963|FG000|NOT COMPLETED|Overall Study||0
3077280|NCT01360450|3798964|FG001|NOT COMPLETED|Overall Study||0
3077281|NCT01360554|3798973|FG000|STARTED|Overall Study|Three participants were randomized but not treated.|439
3077282|NCT01360554|3798974|FG001|STARTED|Overall Study|Three participants were randomized but not treated.|439
3077283|NCT01360554|3798973|FG000|Treated|Overall Study||436
3077284|NCT01360554|3798974|FG001|Treated|Overall Study||436
3077285|NCT01360554|3798973|FG000|COMPLETED|Overall Study||0
3077286|NCT01360554|3798974|FG001|COMPLETED|Overall Study||0
3077287|NCT01360554|3798973|FG000|NOT COMPLETED|Overall Study||439
3077288|NCT01360554|3798974|FG001|NOT COMPLETED|Overall Study||439
3077289|NCT01360632|3798983|FG000|STARTED|Phase A (8 Weeks)|A total of 1539 participants were enrolled, 7 discontinued before taking any sponsor-provided ADT|1532
3077290|NCT01360632|3798984|FG001|STARTED|Phase A (8 Weeks)|These participants were from the randomized sample.|0
3077291|NCT01360632|3798985|FG002|STARTED|Phase A (8 Weeks)|These participants were from the randomized sample.|0
3077292|NCT01360632|3798986|FG003|STARTED|Phase A (8 Weeks)|These participants were from the randomized sample.|0
3077293|NCT01360632|3798987|FG004|STARTED|Phase A (8 Weeks)||0
3077294|NCT01360632|3798983|FG000|COMPLETED|Phase A (8 Weeks)||1277
3077295|NCT01360632|3798984|FG001|COMPLETED|Phase A (8 Weeks)||0
3077296|NCT01360632|3798985|FG002|COMPLETED|Phase A (8 Weeks)||0
3077297|NCT01360632|3798986|FG003|COMPLETED|Phase A (8 Weeks)||0
3077298|NCT01360632|3798987|FG004|COMPLETED|Phase A (8 Weeks)||0
3077299|NCT01360632|3798983|FG000|NOT COMPLETED|Phase A (8 Weeks)||255
3077300|NCT01360632|3798984|FG001|NOT COMPLETED|Phase A (8 Weeks)||0
3077301|NCT01360632|3798985|FG002|NOT COMPLETED|Phase A (8 Weeks)||0
3077302|NCT01360632|3798986|FG003|NOT COMPLETED|Phase A (8 Weeks)||0
3077303|NCT01360632|3798987|FG004|NOT COMPLETED|Phase A (8 Weeks)||0
3077304|NCT01360632|3798983|FG000|STARTED|Phase B (6 Weeks)||0
3077305|NCT01360632|3798984|FG001|STARTED|Phase B (6 Weeks)|These participants were from the randomized sample.|226
3077306|NCT01360632|3798985|FG002|STARTED|Phase B (6 Weeks)|These participants were from the randomized sample.|230
3077307|NCT01360632|3798986|FG003|STARTED|Phase B (6 Weeks)|These participants were from the randomized sample.|221
3077308|NCT01360632|3798987|FG004|STARTED|Phase B (6 Weeks)||0
3077309|NCT01360632|3798983|FG000|COMPLETED|Phase B (6 Weeks)||0
3077310|NCT01360632|3798984|FG001|COMPLETED|Phase B (6 Weeks)||216
3077311|NCT01360632|3798985|FG002|COMPLETED|Phase B (6 Weeks)||210
3077312|NCT01360632|3798986|FG003|COMPLETED|Phase B (6 Weeks)||208
3077313|NCT01360632|3798987|FG004|COMPLETED|Phase B (6 Weeks)||0
3077314|NCT01360632|3798983|FG000|NOT COMPLETED|Phase B (6 Weeks)||0
3077315|NCT01360632|3798984|FG001|NOT COMPLETED|Phase B (6 Weeks)||10
3077316|NCT01360632|3798985|FG002|NOT COMPLETED|Phase B (6 Weeks)||20
3077317|NCT01360632|3798986|FG003|NOT COMPLETED|Phase B (6 Weeks)||13
3077318|NCT01360632|3798987|FG004|NOT COMPLETED|Phase B (6 Weeks)||0
3077319|NCT01360632|3798983|FG000|STARTED|Phase A+||0
3284831|NCT02767934|4018571|FG000|STARTED|Overall Study||12
3284832|NCT02767934|4018571|FG000|COMPLETED|Overall Study||12
3284833|NCT02767934|4018571|FG000|NOT COMPLETED|Overall Study||0
3077320|NCT01360632|3798984|FG001|STARTED|Phase A+||0
3077321|NCT01360632|3798985|FG002|STARTED|Phase A+||0
3077322|NCT01360632|3798986|FG003|STARTED|Phase A+||0
3077323|NCT01360632|3798987|FG004|STARTED|Phase A+||600
3077324|NCT01360632|3798983|FG000|COMPLETED|Phase A+||0
3077325|NCT01360632|3798984|FG001|COMPLETED|Phase A+||0
3077326|NCT01360632|3798985|FG002|COMPLETED|Phase A+||0
3077327|NCT01360632|3798986|FG003|COMPLETED|Phase A+||0
3077328|NCT01360632|3798987|FG004|COMPLETED|Phase A+||575
3077329|NCT01360632|3798983|FG000|NOT COMPLETED|Phase A+||0
3077330|NCT01360632|3798984|FG001|NOT COMPLETED|Phase A+||0
3077331|NCT01360632|3798985|FG002|NOT COMPLETED|Phase A+||0
3077332|NCT01360632|3798986|FG003|NOT COMPLETED|Phase A+||0
3077333|NCT01360632|3798987|FG004|NOT COMPLETED|Phase A+||25
3077334|NCT01360645|3798997|FG000|STARTED|Placebo+ADT Prospective Phase-A(8 Weeks)|826 participants were enrolled but 2 participants discontinued trial before taking study medication.|824
3077335|NCT01360645|3798998|FG001|STARTED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
3077336|NCT01360645|3798999|FG002|STARTED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
3077337|NCT01360645|3799000|FG003|STARTED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
3077338|NCT01360645|3798997|FG000|COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||710
3077339|NCT01360645|3798998|FG001|COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
3077340|NCT01360645|3798999|FG002|COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
3077341|NCT01360645|3799000|FG003|COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
3077342|NCT01360645|3798997|FG000|NOT COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||114
3077343|NCT01360645|3798998|FG001|NOT COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
3077344|NCT01360645|3798999|FG002|NOT COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
3077345|NCT01360645|3799000|FG003|NOT COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
3077346|NCT01360645|3798997|FG000|STARTED|Phase B (6 Weeks)||0
3077347|NCT01360645|3798998|FG001|STARTED|Phase B (6 Weeks)||188
3077348|NCT01360645|3798999|FG002|STARTED|Phase B (6 Weeks)||191
3077349|NCT01360645|3799000|FG003|STARTED|Phase B (6 Weeks)||0
3077350|NCT01360645|3798997|FG000|COMPLETED|Phase B (6 Weeks)||0
3077351|NCT01360645|3798998|FG001|COMPLETED|Phase B (6 Weeks)||174
3077352|NCT01360645|3798999|FG002|COMPLETED|Phase B (6 Weeks)||178
3077353|NCT01360645|3799000|FG003|COMPLETED|Phase B (6 Weeks)||0
3077354|NCT01360645|3798997|FG000|NOT COMPLETED|Phase B (6 Weeks)||0
3077355|NCT01360645|3798998|FG001|NOT COMPLETED|Phase B (6 Weeks)||14
3077356|NCT01360645|3798999|FG002|NOT COMPLETED|Phase B (6 Weeks)||13
3077357|NCT01360645|3799000|FG003|NOT COMPLETED|Phase B (6 Weeks)||0
3077358|NCT01360645|3798997|FG000|STARTED|Phase A+||0
3077359|NCT01360645|3798998|FG001|STARTED|Phase A+||0
3077360|NCT01360645|3798999|FG002|STARTED|Phase A+||0
3077361|NCT01360645|3799000|FG003|STARTED|Phase A+||331
3077362|NCT01360645|3798997|FG000|COMPLETED|Phase A+||0
3077363|NCT01360645|3798998|FG001|COMPLETED|Phase A+||0
3077364|NCT01360645|3798999|FG002|COMPLETED|Phase A+||0
3077365|NCT01360645|3799000|FG003|COMPLETED|Phase A+||307
3077366|NCT01360645|3798997|FG000|NOT COMPLETED|Phase A+||0
3077367|NCT01360645|3798998|FG001|NOT COMPLETED|Phase A+||0
3077368|NCT01360645|3798999|FG002|NOT COMPLETED|Phase A+||0
3077369|NCT01360645|3799000|FG003|NOT COMPLETED|Phase A+||24
3077370|NCT01360762|3799006|FG000|STARTED|Main Study Period (12-month Treatment)||74
3077371|NCT01360762|3799006|FG000|COMPLETED|Main Study Period (12-month Treatment)||45
3077372|NCT01360762|3799006|FG000|NOT COMPLETED|Main Study Period (12-month Treatment)||29
3077373|NCT01360762|3799006|FG000|STARTED|Whole Study Period||74
3077374|NCT01360762|3799006|FG000|COMPLETED|Whole Study Period||38
3077375|NCT01360762|3799006|FG000|NOT COMPLETED|Whole Study Period||36
3077376|NCT01360840|3799013|FG000|STARTED|Overall Study||60
3077377|NCT01360840|3799014|FG001|STARTED|Overall Study||60
3077378|NCT01360840|3799015|FG002|STARTED|Overall Study||60
3077379|NCT01360840|3799013|FG000|COMPLETED|Overall Study||50
3077380|NCT01360840|3799014|FG001|COMPLETED|Overall Study||50
3077381|NCT01360840|3799015|FG002|COMPLETED|Overall Study||51
3077382|NCT01360840|3799013|FG000|NOT COMPLETED|Overall Study||10
3077383|NCT01360840|3799014|FG001|NOT COMPLETED|Overall Study||10
3077384|NCT01360840|3799015|FG002|NOT COMPLETED|Overall Study||9
3077385|NCT01360866|3799029|FG000|STARTED|Overall Study||516
3077386|NCT01360866|3799030|FG001|STARTED|Overall Study||707
3077387|NCT01360866|3799031|FG002|STARTED|Overall Study||1645
3077388|NCT01360866|3799032|FG003|STARTED|Overall Study||76
3077389|NCT01360866|3799029|FG000|COMPLETED|Overall Study||295
3077390|NCT01360866|3799030|FG001|COMPLETED|Overall Study||420
3077391|NCT01360866|3799031|FG002|COMPLETED|Overall Study||1126
3077392|NCT01360866|3799032|FG003|COMPLETED|Overall Study||54
3077393|NCT01360866|3799029|FG000|NOT COMPLETED|Overall Study||221
3077394|NCT01360866|3799030|FG001|NOT COMPLETED|Overall Study||287
3077395|NCT01360866|3799031|FG002|NOT COMPLETED|Overall Study||519
3077396|NCT01360866|3799032|FG003|NOT COMPLETED|Overall Study||22
3077397|NCT01360996|3799045|FG000|STARTED|Overall Study||20
3077398|NCT01360996|3799046|FG001|STARTED|Overall Study||21
3077399|NCT01360996|3799047|FG002|STARTED|Overall Study||23
3077400|NCT01360996|3799045|FG000|COMPLETED|Overall Study||14
3077401|NCT01360996|3799046|FG001|COMPLETED|Overall Study||18
3077402|NCT01360996|3799047|FG002|COMPLETED|Overall Study||21
3077403|NCT01360996|3799045|FG000|NOT COMPLETED|Overall Study||6
3077404|NCT01360996|3799046|FG001|NOT COMPLETED|Overall Study||3
3077405|NCT01360996|3799047|FG002|NOT COMPLETED|Overall Study||2
3077406|NCT01361009|3799054|FG000|STARTED|Overall Study||2017
3077407|NCT01361009|3799054|FG000|COMPLETED|Overall Study||1901
3077408|NCT01361009|3799054|FG000|NOT COMPLETED|Overall Study||116
3077409|NCT01361048|3799061|FG000|STARTED|Overall Study||20
3077410|NCT01361048|3799062|FG001|STARTED|Overall Study||10
3077411|NCT01361048|3799063|FG002|STARTED|Overall Study||10
3077412|NCT01361048|3799061|FG000|COMPLETED|Overall Study||20
3077413|NCT01361048|3799062|FG001|COMPLETED|Overall Study||10
3077414|NCT01361048|3799063|FG002|COMPLETED|Overall Study||9
3077415|NCT01361048|3799061|FG000|NOT COMPLETED|Overall Study||0
3077416|NCT01361048|3799062|FG001|NOT COMPLETED|Overall Study||0
3077417|NCT01361048|3799063|FG002|NOT COMPLETED|Overall Study||1
3077418|NCT01361113|3799074|FG000|STARTED|Overall Study||21
3077419|NCT01361113|3799074|FG000|COMPLETED|Overall Study||21
3077420|NCT01361113|3799074|FG000|NOT COMPLETED|Overall Study||0
3077421|NCT01361126|3799082|FG000|STARTED|Overall Study||13
3077422|NCT01361126|3799083|FG001|STARTED|Overall Study||4
3077423|NCT01361126|3799082|FG000|COMPLETED|Overall Study||13
3077424|NCT01361126|3799083|FG001|COMPLETED|Overall Study||2
3077425|NCT01361126|3799082|FG000|NOT COMPLETED|Overall Study||0
3077426|NCT01361126|3799083|FG001|NOT COMPLETED|Overall Study||2
3077427|NCT01361178|3799092|FG000|STARTED|Overall Study||122
3077428|NCT01361178|3799093|FG001|STARTED|Overall Study||11
3077429|NCT01361178|3799092|FG000|COMPLETED|Overall Study||109
3077430|NCT01361178|3799093|FG001|COMPLETED|Overall Study||11
3077431|NCT01361178|3799092|FG000|NOT COMPLETED|Overall Study||13
3077432|NCT01361178|3799093|FG001|NOT COMPLETED|Overall Study||0
3077433|NCT01361217|3799099|FG000|STARTED|Overall Study||10
3077434|NCT01361217|3799099|FG000|COMPLETED|Overall Study||10
3077435|NCT01361217|3799099|FG000|NOT COMPLETED|Overall Study||0
3077436|NCT01361308|3799107|FG000|STARTED|Overall Study||306
3077437|NCT01361308|3799108|FG001|STARTED|Overall Study||308
3077438|NCT01361308|3799107|FG000|COMPLETED|Overall Study||271
3077439|NCT01361308|3799108|FG001|COMPLETED|Overall Study||278
3077440|NCT01361308|3799107|FG000|NOT COMPLETED|Overall Study||35
3077441|NCT01361308|3799108|FG001|NOT COMPLETED|Overall Study||30
3077442|NCT01361464|3799114|FG000|STARTED|Overall Study||21
3077443|NCT01361464|3799114|FG000|COMPLETED|Overall Study||18
3077444|NCT01361464|3799114|FG000|NOT COMPLETED|Overall Study||3
3077445|NCT01361568|3799124|FG000|STARTED|Overall Study||71
3077446|NCT01361568|3799125|FG001|STARTED|Overall Study||71
3077447|NCT01361568|3799126|FG002|STARTED|Overall Study||20
3077448|NCT01361568|3799127|FG003|STARTED|Overall Study||21
3077449|NCT01361568|3799128|FG004|STARTED|Overall Study||7
3077450|NCT01361568|3799129|FG005|STARTED|Overall Study||13
3077451|NCT01361568|3799124|FG000|COMPLETED|Overall Study||69
3077452|NCT01361568|3799125|FG001|COMPLETED|Overall Study||70
3077453|NCT01361568|3799126|FG002|COMPLETED|Overall Study||20
3077454|NCT01361568|3799127|FG003|COMPLETED|Overall Study||21
3077455|NCT01361568|3799128|FG004|COMPLETED|Overall Study||6
3077456|NCT01361568|3799129|FG005|COMPLETED|Overall Study||11
3077457|NCT01361568|3799124|FG000|NOT COMPLETED|Overall Study||2
3077458|NCT01361568|3799125|FG001|NOT COMPLETED|Overall Study||1
3077459|NCT01361568|3799126|FG002|NOT COMPLETED|Overall Study||0
3077460|NCT01361568|3799127|FG003|NOT COMPLETED|Overall Study||0
3077461|NCT01361568|3799128|FG004|NOT COMPLETED|Overall Study||1
3077462|NCT01361568|3799129|FG005|NOT COMPLETED|Overall Study||2
3077463|NCT01361594|3799146|FG000|STARTED|Overall Study||152
3077464|NCT01361594|3799147|FG001|STARTED|Overall Study||153
3077465|NCT01361594|3799146|FG000|COMPLETED|Overall Study||151
3077466|NCT01361594|3799147|FG001|COMPLETED|Overall Study||151
3077467|NCT01361594|3799146|FG000|NOT COMPLETED|Overall Study||1
3077468|NCT01361594|3799147|FG001|NOT COMPLETED|Overall Study||2
3077469|NCT01361607|3799155|FG000|STARTED|Overall Study|Two participants randomized to nabiximols did not receive any study drug|200
3077470|NCT01361607|3799156|FG001|STARTED|Overall Study||199
3077471|NCT01361607|3799155|FG000|Received at Least 1 Dose of Study Drug|Overall Study||198
3077472|NCT01361607|3799156|FG001|Received at Least 1 Dose of Study Drug|Overall Study||199
3077473|NCT01361607|3799155|FG000|Safety Population|Overall Study|One participant randomized to nabiximols received placebo Day 22 but analyzed as nabiximols-treated|199
3077474|NCT01361607|3799156|FG001|Safety Population|Overall Study|One participant randomized to placebo received nabiximols Day 1 but analyzed as nabiximols-treated|198
3077475|NCT01361607|3799155|FG000|ITT Population|Overall Study||198
3077476|NCT01361607|3799156|FG001|ITT Population|Overall Study|One participant randomized to placebo received nabiximols Day 1 but analyzed as placebo-treated|199
3284834|NCT02767947|4018578|FG000|STARTED|Overall Study||60
3284835|NCT02767947|4018579|FG001|STARTED|Overall Study||15
3284836|NCT02767947|4018578|FG000|Safety Population|Overall Study||60
3284837|NCT02767947|4018579|FG001|Safety Population|Overall Study||15
3284838|NCT02767947|4018578|FG000|Pharmacokinetic (PK) Population|Overall Study||12
3284839|NCT02767947|4018579|FG001|Pharmacokinetic (PK) Population|Overall Study||3
3284840|NCT02767947|4018578|FG000|COMPLETED|Overall Study||60
3284841|NCT02767947|4018579|FG001|COMPLETED|Overall Study||15
3284842|NCT02767947|4018578|FG000|NOT COMPLETED|Overall Study||0
3284843|NCT02767947|4018579|FG001|NOT COMPLETED|Overall Study||0
3284844|NCT02768103|4018585|FG000|STARTED|Overall Study||5
3284845|NCT02768103|4018585|FG000|COMPLETED|Overall Study||4
3284846|NCT02768103|4018585|FG000|NOT COMPLETED|Overall Study||1
3284847|NCT02768129|4018591|FG000|STARTED|Overall Study||11
3284848|NCT02768129|4018592|FG001|STARTED|Overall Study||10
3284849|NCT02768129|4018591|FG000|COMPLETED|Overall Study||11
3284850|NCT02768129|4018592|FG001|COMPLETED|Overall Study||10
3284851|NCT02768129|4018591|FG000|NOT COMPLETED|Overall Study||0
3284852|NCT02768129|4018592|FG001|NOT COMPLETED|Overall Study||0
3284853|NCT02768194|4018598|FG000|STARTED|Period 1||4
3284854|NCT02768194|4018599|FG001|STARTED|Period 1||4
3284855|NCT02768194|4018600|FG002|STARTED|Period 1||4
3284856|NCT02768194|4018601|FG003|STARTED|Period 1||4
3284857|NCT02768194|4018602|FG004|STARTED|Period 1||4
3284858|NCT02768194|4018603|FG005|STARTED|Period 1||4
3284859|NCT02768194|4018598|FG000|COMPLETED|Period 1||4
3284860|NCT02768194|4018599|FG001|COMPLETED|Period 1||4
3284861|NCT02768194|4018600|FG002|COMPLETED|Period 1||4
3284862|NCT02768194|4018601|FG003|COMPLETED|Period 1||3
3284863|NCT02768194|4018602|FG004|COMPLETED|Period 1||4
3284864|NCT02768194|4018603|FG005|COMPLETED|Period 1||4
3284865|NCT02768194|4018598|FG000|NOT COMPLETED|Period 1||0
3284866|NCT02768194|4018599|FG001|NOT COMPLETED|Period 1||0
3284867|NCT02768194|4018600|FG002|NOT COMPLETED|Period 1||0
3284868|NCT02768194|4018601|FG003|NOT COMPLETED|Period 1||1
3284869|NCT02768194|4018602|FG004|NOT COMPLETED|Period 1||0
3284870|NCT02768194|4018603|FG005|NOT COMPLETED|Period 1||0
3284871|NCT02768194|4018598|FG000|STARTED|Period 2||4
3284872|NCT02768194|4018599|FG001|STARTED|Period 2||4
3284873|NCT02768194|4018600|FG002|STARTED|Period 2||4
3284874|NCT02768194|4018601|FG003|STARTED|Period 2||3
3284875|NCT02768194|4018602|FG004|STARTED|Period 2||4
3284876|NCT02768194|4018603|FG005|STARTED|Period 2||4
3284877|NCT02768194|4018598|FG000|COMPLETED|Period 2||3
3284878|NCT02768194|4018599|FG001|COMPLETED|Period 2||4
3284879|NCT02768194|4018600|FG002|COMPLETED|Period 2||4
3284880|NCT02768194|4018601|FG003|COMPLETED|Period 2||3
3284881|NCT02768194|4018602|FG004|COMPLETED|Period 2||4
3284882|NCT02768194|4018603|FG005|COMPLETED|Period 2||4
3284883|NCT02768194|4018598|FG000|NOT COMPLETED|Period 2||1
3284884|NCT02768194|4018599|FG001|NOT COMPLETED|Period 2||0
3284885|NCT02768194|4018600|FG002|NOT COMPLETED|Period 2||0
3284886|NCT02768194|4018601|FG003|NOT COMPLETED|Period 2||0
3284887|NCT02768194|4018602|FG004|NOT COMPLETED|Period 2||0
3284888|NCT02768194|4018603|FG005|NOT COMPLETED|Period 2||0
3284889|NCT02768194|4018598|FG000|STARTED|Period 3||3
3284890|NCT02768194|4018599|FG001|STARTED|Period 3||4
3284891|NCT02768194|4018600|FG002|STARTED|Period 3||4
3284892|NCT02768194|4018601|FG003|STARTED|Period 3||3
3284893|NCT02768194|4018602|FG004|STARTED|Period 3||4
3284894|NCT02768194|4018603|FG005|STARTED|Period 3||4
3284895|NCT02768194|4018598|FG000|COMPLETED|Period 3||3
3284896|NCT02768194|4018599|FG001|COMPLETED|Period 3||3
3284897|NCT02768194|4018600|FG002|COMPLETED|Period 3||4
3284898|NCT02768194|4018601|FG003|COMPLETED|Period 3||3
3284899|NCT02768194|4018602|FG004|COMPLETED|Period 3||4
3284900|NCT02768194|4018603|FG005|COMPLETED|Period 3||4
3284901|NCT02768194|4018598|FG000|NOT COMPLETED|Period 3||0
3284902|NCT02768194|4018599|FG001|NOT COMPLETED|Period 3||1
3284903|NCT02768194|4018600|FG002|NOT COMPLETED|Period 3||0
3284904|NCT02768194|4018601|FG003|NOT COMPLETED|Period 3||0
3077477|NCT01361607|3799155|FG000|COMPLETED|Overall Study||136
3077478|NCT01361607|3799156|FG001|COMPLETED|Overall Study||158
3077479|NCT01361607|3799155|FG000|NOT COMPLETED|Overall Study||64
3077480|NCT01361607|3799156|FG001|NOT COMPLETED|Overall Study||41
3077481|NCT01361620|3799163|FG000|STARTED|Overall Study||132
3077482|NCT01361620|3799163|FG000|COMPLETED|Overall Study||132
3077483|NCT01361620|3799163|FG000|NOT COMPLETED|Overall Study||0
3077484|NCT01361633|3799169|FG000|STARTED|Overall Study||25
3077485|NCT01361633|3799170|FG001|STARTED|Overall Study||26
3077486|NCT01361633|3799169|FG000|COMPLETED|Overall Study||19
3077487|NCT01361633|3799170|FG001|COMPLETED|Overall Study||23
3077488|NCT01361633|3799169|FG000|NOT COMPLETED|Overall Study||6
3077489|NCT01361633|3799170|FG001|NOT COMPLETED|Overall Study||3
3077490|NCT01361711|3799178|FG000|STARTED|Trial Entry (Registration)||53
3077491|NCT01361711|3799178|FG000|Received Dose of Study Drug|Trial Entry (Registration)||52
3077492|NCT01361711|3799178|FG000|COMPLETED|Trial Entry (Registration)||52
3077493|NCT01361711|3799178|FG000|NOT COMPLETED|Trial Entry (Registration)||1
3077494|NCT01361711|3799178|FG000|STARTED|Week 9 Bone Marrow Response Assessment||52
3077495|NCT01361711|3799178|FG000|COMPLETED|Week 9 Bone Marrow Response Assessment||51
3077496|NCT01361711|3799178|FG000|NOT COMPLETED|Week 9 Bone Marrow Response Assessment||1
3077497|NCT01361711|3799178|FG000|STARTED|Continued Treatment After 9 Weeks||51
3077498|NCT01361711|3799178|FG000|COMPLETED|Continued Treatment After 9 Weeks||44
3077499|NCT01361711|3799178|FG000|NOT COMPLETED|Continued Treatment After 9 Weeks||7
3077500|NCT01361711|3799178|FG000|STARTED|Continued Treatment After 12 Weeks||44
3077501|NCT01361711|3799178|FG000|COMPLETED|Continued Treatment After 12 Weeks||41
3077502|NCT01361711|3799178|FG000|NOT COMPLETED|Continued Treatment After 12 Weeks||3
3077503|NCT01361711|3799178|FG000|STARTED|Completed Week 18 of Treatment||41
3077504|NCT01361711|3799178|FG000|COMPLETED|Completed Week 18 of Treatment||30
3077505|NCT01361711|3799178|FG000|NOT COMPLETED|Completed Week 18 of Treatment||11
3077506|NCT01361711|3799178|FG000|STARTED|10 Year Follow-up|All patients who receive at least one dose of study drug go into follow-up.|52
3077507|NCT01361711|3799178|FG000|COMPLETED|10 Year Follow-up||2
3077508|NCT01361711|3799178|FG000|NOT COMPLETED|10 Year Follow-up||50
3077509|NCT01361854|3799182|FG000|STARTED|Day 1||51
3077510|NCT01361854|3799183|FG001|STARTED|Day 1||51
3077511|NCT01361854|3799182|FG000|COMPLETED|Day 1||47
3077512|NCT01361854|3799183|FG001|COMPLETED|Day 1||48
3077513|NCT01361854|3799182|FG000|NOT COMPLETED|Day 1||4
3077514|NCT01361854|3799183|FG001|NOT COMPLETED|Day 1||3
3077515|NCT01361854|3799182|FG000|STARTED|Wash-out, Maximum 2 Weeks||47
3077516|NCT01361854|3799183|FG001|STARTED|Wash-out, Maximum 2 Weeks||48
3077517|NCT01361854|3799182|FG000|COMPLETED|Wash-out, Maximum 2 Weeks||47
3077518|NCT01361854|3799183|FG001|COMPLETED|Wash-out, Maximum 2 Weeks||48
3077519|NCT01361854|3799182|FG000|NOT COMPLETED|Wash-out, Maximum 2 Weeks||0
3077520|NCT01361854|3799183|FG001|NOT COMPLETED|Wash-out, Maximum 2 Weeks||0
3077521|NCT01361854|3799182|FG000|STARTED|Second Intervention||47
3077522|NCT01361854|3799183|FG001|STARTED|Second Intervention||48
3077523|NCT01361854|3799182|FG000|COMPLETED|Second Intervention||47
3077524|NCT01361854|3799183|FG001|COMPLETED|Second Intervention||48
3077525|NCT01361854|3799182|FG000|NOT COMPLETED|Second Intervention||0
3077526|NCT01361854|3799183|FG001|NOT COMPLETED|Second Intervention||0
3077527|NCT01361867|3799189|FG000|STARTED|Overall Study||15
3077528|NCT01361867|3799189|FG000|COMPLETED|Overall Study||15
3077529|NCT01361867|3799189|FG000|NOT COMPLETED|Overall Study||0
3077530|NCT01361919|3799196|FG000|STARTED|Overall Study||100
3077531|NCT01361919|3799197|FG001|STARTED|Overall Study||100
3077532|NCT01361919|3799198|FG002|STARTED|Overall Study||98
3077533|NCT01361919|3799196|FG000|COMPLETED|Overall Study||90
3077534|NCT01361919|3799197|FG001|COMPLETED|Overall Study||88
3077535|NCT01361919|3799198|FG002|COMPLETED|Overall Study||88
3077536|NCT01361919|3799196|FG000|NOT COMPLETED|Overall Study||10
3077537|NCT01361919|3799197|FG001|NOT COMPLETED|Overall Study||12
3077538|NCT01361919|3799198|FG002|NOT COMPLETED|Overall Study||10
3077539|NCT01362049|3799210|FG000|STARTED|Follow-Up at 7 Weeks||26
3077540|NCT01362049|3799211|FG001|STARTED|Follow-Up at 7 Weeks||19
3077541|NCT01362049|3799212|FG002|STARTED|Follow-Up at 7 Weeks||32
3077542|NCT01362049|3799213|FG003|STARTED|Follow-Up at 7 Weeks||25
3077543|NCT01362049|3799210|FG000|Randomized and Started PT Treatment|Follow-Up at 7 Weeks||26
3077544|NCT01362049|3799211|FG001|Randomized and Started PT Treatment|Follow-Up at 7 Weeks||18
3077545|NCT01362049|3799212|FG002|Randomized and Started PT Treatment|Follow-Up at 7 Weeks||32
3077546|NCT01362049|3799213|FG003|Randomized and Started PT Treatment|Follow-Up at 7 Weeks||25
3077547|NCT01362049|3799210|FG000|COMPLETED|Follow-Up at 7 Weeks||23
3077548|NCT01362049|3799211|FG001|COMPLETED|Follow-Up at 7 Weeks||16
3077549|NCT01362049|3799212|FG002|COMPLETED|Follow-Up at 7 Weeks||30
3077550|NCT01362049|3799213|FG003|COMPLETED|Follow-Up at 7 Weeks||24
3077551|NCT01362049|3799210|FG000|NOT COMPLETED|Follow-Up at 7 Weeks||3
3077552|NCT01362049|3799211|FG001|NOT COMPLETED|Follow-Up at 7 Weeks||3
3077553|NCT01362049|3799212|FG002|NOT COMPLETED|Follow-Up at 7 Weeks||2
3077554|NCT01362049|3799213|FG003|NOT COMPLETED|Follow-Up at 7 Weeks||1
3077555|NCT01362049|3799210|FG000|STARTED|Follow-Up at 52 Weeks (12 Months)||23
3077556|NCT01362049|3799211|FG001|STARTED|Follow-Up at 52 Weeks (12 Months)||16
3077557|NCT01362049|3799212|FG002|STARTED|Follow-Up at 52 Weeks (12 Months)||30
3077558|NCT01362049|3799213|FG003|STARTED|Follow-Up at 52 Weeks (12 Months)||24
3077559|NCT01362049|3799210|FG000|COMPLETED|Follow-Up at 52 Weeks (12 Months)||18
3077560|NCT01362049|3799211|FG001|COMPLETED|Follow-Up at 52 Weeks (12 Months)||13
3077561|NCT01362049|3799212|FG002|COMPLETED|Follow-Up at 52 Weeks (12 Months)||28
3077562|NCT01362049|3799213|FG003|COMPLETED|Follow-Up at 52 Weeks (12 Months)||21
3077563|NCT01362049|3799210|FG000|NOT COMPLETED|Follow-Up at 52 Weeks (12 Months)||5
3077564|NCT01362049|3799211|FG001|NOT COMPLETED|Follow-Up at 52 Weeks (12 Months)||3
3077565|NCT01362049|3799212|FG002|NOT COMPLETED|Follow-Up at 52 Weeks (12 Months)||2
3077566|NCT01362049|3799213|FG003|NOT COMPLETED|Follow-Up at 52 Weeks (12 Months)||3
3077567|NCT01362062|3799229|FG000|STARTED|Overall Study||48
3077568|NCT01362062|3799230|FG001|STARTED|Overall Study||62
3077569|NCT01362062|3799229|FG000|COMPLETED|Overall Study||22
3077570|NCT01362062|3799230|FG001|COMPLETED|Overall Study||62
3077571|NCT01362062|3799229|FG000|NOT COMPLETED|Overall Study||26
3077572|NCT01362062|3799230|FG001|NOT COMPLETED|Overall Study||0
3077573|NCT01362127|3799237|FG000|STARTED|Overall Study||90
3077574|NCT01362127|3799238|FG001|STARTED|Overall Study||91
3077575|NCT01362127|3799237|FG000|COMPLETED|Overall Study||90
3077576|NCT01362127|3799238|FG001|COMPLETED|Overall Study||91
3077577|NCT01362127|3799237|FG000|NOT COMPLETED|Overall Study||0
3077578|NCT01362127|3799238|FG001|NOT COMPLETED|Overall Study||0
3077579|NCT01362140|3799246|FG000|STARTED|Overall Study||49
3077580|NCT01362140|3799247|FG001|STARTED|Overall Study||98
3077581|NCT01362140|3799246|FG000|Received Treatment|Overall Study||49
3077582|NCT01362140|3799247|FG001|Received Treatment|Overall Study||97
3077583|NCT01362140|3799246|FG000|COMPLETED|Overall Study|Completed treatment in the double-blind treatment period|39
3077584|NCT01362140|3799247|FG001|COMPLETED|Overall Study|Completed treatment in the double-blind treatment period|87
3077585|NCT01362140|3799246|FG000|NOT COMPLETED|Overall Study||10
3077586|NCT01362140|3799247|FG001|NOT COMPLETED|Overall Study||11
3077587|NCT01362192|3799253|FG000|STARTED|Overall Study||20
3077588|NCT01362192|3799253|FG000|COMPLETED|Overall Study||16
3077589|NCT01362192|3799253|FG000|NOT COMPLETED|Overall Study||4
3077590|NCT01362205|3799259|FG000|STARTED|Overall Study||22
3077591|NCT01362205|3799260|FG001|STARTED|Overall Study||27
3077592|NCT01362205|3799259|FG000|COMPLETED|Overall Study||22
3077593|NCT01362205|3799260|FG001|COMPLETED|Overall Study||27
3077594|NCT01362205|3799259|FG000|NOT COMPLETED|Overall Study||0
3077595|NCT01362205|3799260|FG001|NOT COMPLETED|Overall Study||0
3077596|NCT01362244|3799268|FG000|STARTED|Overall Study||54
3077597|NCT01362244|3799269|FG001|STARTED|Overall Study||51
3077598|NCT01362244|3799268|FG000|COMPLETED|Overall Study||22
3077599|NCT01362244|3799269|FG001|COMPLETED|Overall Study||19
3077600|NCT01362244|3799268|FG000|NOT COMPLETED|Overall Study||32
3077601|NCT01362244|3799269|FG001|NOT COMPLETED|Overall Study||32
3077602|NCT01362270|3799277|FG000|STARTED|Overall Study||7
3077603|NCT01362270|3799278|FG001|STARTED|Overall Study||8
3077604|NCT01362270|3799277|FG000|COMPLETED|Overall Study||5
3077605|NCT01362270|3799278|FG001|COMPLETED|Overall Study||6
3077606|NCT01362270|3799277|FG000|NOT COMPLETED|Overall Study||2
3077607|NCT01362270|3799278|FG001|NOT COMPLETED|Overall Study||2
3077608|NCT01362296|3799286|FG000|STARTED|Randomized Phase (RP)||87
3077609|NCT01362296|3799287|FG001|STARTED|Randomized Phase (RP)||43
3077610|NCT01362296|3799288|FG002|STARTED|Randomized Phase (RP)||0
3077611|NCT01362296|3799289|FG003|STARTED|Randomized Phase (RP)||0
3077612|NCT01362296|3799286|FG000|COMPLETED|Randomized Phase (RP)||0
3077613|NCT01362296|3799287|FG001|COMPLETED|Randomized Phase (RP)||0
3077614|NCT01362296|3799288|FG002|COMPLETED|Randomized Phase (RP)||0
3077615|NCT01362296|3799289|FG003|COMPLETED|Randomized Phase (RP)||0
3077616|NCT01362296|3799286|FG000|NOT COMPLETED|Randomized Phase (RP)||87
3077617|NCT01362296|3799287|FG001|NOT COMPLETED|Randomized Phase (RP)||43
3077618|NCT01362296|3799288|FG002|NOT COMPLETED|Randomized Phase (RP)||0
3077619|NCT01362296|3799289|FG003|NOT COMPLETED|Randomized Phase (RP)||0
3077620|NCT01362296|3799286|FG000|STARTED|Crossover Phase|These participants elected to enter the Crossover Phase at the time of disease progression.|0
3077621|NCT01362296|3799287|FG001|STARTED|Crossover Phase|These participants elected to enter the Crossover Phase at the time of disease progression.|0
3284905|NCT02768194|4018602|FG004|NOT COMPLETED|Period 3||0
3284906|NCT02768194|4018603|FG005|NOT COMPLETED|Period 3||0
3284907|NCT02768298|4018613|FG000|STARTED|Overall Study||103
3284908|NCT02768298|4018614|FG001|STARTED|Overall Study||98
3284909|NCT02768298|4018613|FG000|COMPLETED|Overall Study||99
3284910|NCT02768298|4018614|FG001|COMPLETED|Overall Study||91
3284911|NCT02768298|4018613|FG000|NOT COMPLETED|Overall Study||4
3284912|NCT02768298|4018614|FG001|NOT COMPLETED|Overall Study||7
3284913|NCT02768558|4018622|FG000|STARTED|Overall Study||3
3284914|NCT02768558|4018623|FG001|STARTED|Overall Study||5
3284915|NCT02768558|4018622|FG000|Eligible|Overall Study||3
3284916|NCT02768558|4018623|FG001|Eligible|Overall Study||5
3284917|NCT02768558|4018622|FG000|COMPLETED|Overall Study||3
3284918|NCT02768558|4018623|FG001|COMPLETED|Overall Study||5
3284919|NCT02768558|4018622|FG000|NOT COMPLETED|Overall Study||0
3284920|NCT02768558|4018623|FG001|NOT COMPLETED|Overall Study||0
3284921|NCT02768753|4018631|FG000|STARTED|Overall Study||30
3284922|NCT02768753|4018632|FG001|STARTED|Overall Study||30
3284923|NCT02768753|4018631|FG000|COMPLETED|Overall Study||30
3284924|NCT02768753|4018632|FG001|COMPLETED|Overall Study||30
3284925|NCT02768753|4018631|FG000|NOT COMPLETED|Overall Study||0
3077622|NCT01362296|3799288|FG002|STARTED|Crossover Phase|These participants elected to enter the Crossover Phase at the time of disease progression.|23
3077623|NCT01362296|3799289|FG003|STARTED|Crossover Phase|These participants elected to enter the Crossover Phase at the time of disease progression.|2
3077624|NCT01362296|3799286|FG000|COMPLETED|Crossover Phase||0
3077625|NCT01362296|3799287|FG001|COMPLETED|Crossover Phase||0
3077626|NCT01362296|3799288|FG002|COMPLETED|Crossover Phase||0
3077627|NCT01362296|3799289|FG003|COMPLETED|Crossover Phase||0
3077628|NCT01362296|3799286|FG000|NOT COMPLETED|Crossover Phase||0
3077629|NCT01362296|3799287|FG001|NOT COMPLETED|Crossover Phase||0
3077630|NCT01362296|3799288|FG002|NOT COMPLETED|Crossover Phase||23
3077631|NCT01362296|3799289|FG003|NOT COMPLETED|Crossover Phase||2
3077632|NCT01362322|3799301|FG000|STARTED|Overall Study||335
3077633|NCT01362322|3799302|FG001|STARTED|Overall Study||336
3077634|NCT01362322|3799301|FG000|COMPLETED|Overall Study||330
3077635|NCT01362322|3799302|FG001|COMPLETED|Overall Study||329
3077636|NCT01362322|3799301|FG000|NOT COMPLETED|Overall Study||5
3077637|NCT01362322|3799302|FG001|NOT COMPLETED|Overall Study||7
3077638|NCT01362348|3799308|FG000|STARTED|Overall Study||19
3077639|NCT01362348|3799308|FG000|COMPLETED|Overall Study||5
3077640|NCT01362348|3799308|FG000|NOT COMPLETED|Overall Study||14
3077641|NCT01362439|3799312|FG000|STARTED|Overall Study||133
3077642|NCT01362439|3799312|FG000|COMPLETED|Overall Study||118
3077643|NCT01362439|3799312|FG000|NOT COMPLETED|Overall Study||15
3077644|NCT01362491|3799320|FG000|STARTED|Overall Study||91
3077645|NCT01362491|3799321|FG001|STARTED|Overall Study||89
3077646|NCT01362491|3799322|FG002|STARTED|Overall Study||46
3077647|NCT01362491|3799320|FG000|COMPLETED|Overall Study||90
3077648|NCT01362491|3799321|FG001|COMPLETED|Overall Study||89
3077649|NCT01362491|3799322|FG002|COMPLETED|Overall Study||46
3077650|NCT01362491|3799320|FG000|NOT COMPLETED|Overall Study||1
3077651|NCT01362491|3799321|FG001|NOT COMPLETED|Overall Study||0
3077652|NCT01362491|3799322|FG002|NOT COMPLETED|Overall Study||0
3077653|NCT01362517|3799331|FG000|STARTED|Overall Study||131
3077654|NCT01362517|3799331|FG000|COMPLETED|Overall Study||129
3077655|NCT01362517|3799331|FG000|NOT COMPLETED|Overall Study||2
3077656|NCT01362530|3799340|FG000|STARTED|Base Study (Cycle 1)||155
3077657|NCT01362530|3799341|FG001|STARTED|Base Study (Cycle 1)||152
3077658|NCT01362530|3799340|FG000|Received Study Treatment|Base Study (Cycle 1)||152
3077659|NCT01362530|3799341|FG001|Received Study Treatment|Base Study (Cycle 1)||150
3077660|NCT01362530|3799340|FG000|COMPLETED|Base Study (Cycle 1)||150
3077661|NCT01362530|3799341|FG001|COMPLETED|Base Study (Cycle 1)||149
3077662|NCT01362530|3799340|FG000|NOT COMPLETED|Base Study (Cycle 1)||5
3077663|NCT01362530|3799341|FG001|NOT COMPLETED|Base Study (Cycle 1)||3
3077664|NCT01362530|3799340|FG000|STARTED|Optional Extension (Cycles 2-6)||171
3284926|NCT02768753|4018632|FG001|NOT COMPLETED|Overall Study||0
3284927|NCT02768792|4018638|FG000|STARTED|Overall Study||38
3284928|NCT02768792|4018638|FG000|COMPLETED|Overall Study||37
3284929|NCT02768792|4018638|FG000|NOT COMPLETED|Overall Study||1
3077665|NCT01362530|3799341|FG001|STARTED|Optional Extension (Cycles 2-6)||0
3077666|NCT01362530|3799340|FG000|COMPLETED|Optional Extension (Cycles 2-6)||46
3077667|NCT01362530|3799341|FG001|COMPLETED|Optional Extension (Cycles 2-6)||0
3077668|NCT01362530|3799340|FG000|NOT COMPLETED|Optional Extension (Cycles 2-6)||125
3077669|NCT01362530|3799341|FG001|NOT COMPLETED|Optional Extension (Cycles 2-6)||0
3077670|NCT01362608|3799350|FG000|STARTED|Overall Study||67
3077671|NCT01362608|3799351|FG001|STARTED|Overall Study||69
3077672|NCT01362608|3799350|FG000|COMPLETED|Overall Study||63
3077673|NCT01362608|3799351|FG001|COMPLETED|Overall Study||61
3077674|NCT01362608|3799350|FG000|NOT COMPLETED|Overall Study||4
3077675|NCT01362608|3799351|FG001|NOT COMPLETED|Overall Study||8
3077676|NCT01362686|3799360|FG000|STARTED|Overall Study||67
3077677|NCT01362686|3799361|FG001|STARTED|Overall Study||66
3077678|NCT01362686|3799362|FG002|STARTED|Overall Study||63
3077679|NCT01362686|3799360|FG000|COMPLETED|Overall Study||59
3077680|NCT01362686|3799361|FG001|COMPLETED|Overall Study||54
3077681|NCT01362686|3799362|FG002|COMPLETED|Overall Study||53
3077682|NCT01362686|3799360|FG000|NOT COMPLETED|Overall Study||8
3077683|NCT01362686|3799361|FG001|NOT COMPLETED|Overall Study||12
3077684|NCT01362686|3799362|FG002|NOT COMPLETED|Overall Study||10
3077685|NCT01362790|3799376|FG000|STARTED|Pilot Phase & Phase 2||11
3077686|NCT01362790|3799377|FG001|STARTED|Pilot Phase & Phase 2||8
3077687|NCT01362790|3799378|FG002|STARTED|Pilot Phase & Phase 2||7
3077688|NCT01362790|3799379|FG003|STARTED|Pilot Phase & Phase 2||15
3077689|NCT01362790|3799380|FG004|STARTED|Pilot Phase & Phase 2||0
3077690|NCT01362790|3799381|FG005|STARTED|Pilot Phase & Phase 2||4
3077691|NCT01362790|3799382|FG006|STARTED|Pilot Phase & Phase 2||0
3077692|NCT01362790|3799376|FG000|COMPLETED|Pilot Phase & Phase 2||1
3077693|NCT01362790|3799377|FG001|COMPLETED|Pilot Phase & Phase 2||0
3077694|NCT01362790|3799378|FG002|COMPLETED|Pilot Phase & Phase 2||2
3077695|NCT01362790|3799379|FG003|COMPLETED|Pilot Phase & Phase 2||1
3077696|NCT01362790|3799380|FG004|COMPLETED|Pilot Phase & Phase 2||0
3077697|NCT01362790|3799381|FG005|COMPLETED|Pilot Phase & Phase 2||0
3077698|NCT01362790|3799382|FG006|COMPLETED|Pilot Phase & Phase 2||0
3077699|NCT01362790|3799376|FG000|NOT COMPLETED|Pilot Phase & Phase 2||10
3077700|NCT01362790|3799377|FG001|NOT COMPLETED|Pilot Phase & Phase 2||8
3077701|NCT01362790|3799378|FG002|NOT COMPLETED|Pilot Phase & Phase 2||5
3077702|NCT01362790|3799379|FG003|NOT COMPLETED|Pilot Phase & Phase 2||14
3077703|NCT01362790|3799380|FG004|NOT COMPLETED|Pilot Phase & Phase 2||0
3077704|NCT01362790|3799381|FG005|NOT COMPLETED|Pilot Phase & Phase 2||4
3077705|NCT01362790|3799382|FG006|NOT COMPLETED|Pilot Phase & Phase 2||0
3077706|NCT01362790|3799376|FG000|STARTED|Dose De-escalation of Regimen A||0
3077707|NCT01362790|3799377|FG001|STARTED|Dose De-escalation of Regimen A||0
3077708|NCT01362790|3799378|FG002|STARTED|Dose De-escalation of Regimen A||0
3284930|NCT02769065|4018672|FG000|STARTED|Overall Study||17
3077709|NCT01362790|3799379|FG003|STARTED|Dose De-escalation of Regimen A||0
3077710|NCT01362790|3799380|FG004|STARTED|Dose De-escalation of Regimen A||8
3077711|NCT01362790|3799381|FG005|STARTED|Dose De-escalation of Regimen A||0
3077712|NCT01362790|3799382|FG006|STARTED|Dose De-escalation of Regimen A||0
3077713|NCT01362790|3799376|FG000|COMPLETED|Dose De-escalation of Regimen A||0
3077714|NCT01362790|3799377|FG001|COMPLETED|Dose De-escalation of Regimen A||0
3077715|NCT01362790|3799378|FG002|COMPLETED|Dose De-escalation of Regimen A||0
3077716|NCT01362790|3799379|FG003|COMPLETED|Dose De-escalation of Regimen A||0
3077717|NCT01362790|3799380|FG004|COMPLETED|Dose De-escalation of Regimen A||2
3077718|NCT01362790|3799381|FG005|COMPLETED|Dose De-escalation of Regimen A||0
3077719|NCT01362790|3799382|FG006|COMPLETED|Dose De-escalation of Regimen A||0
3077720|NCT01362790|3799376|FG000|NOT COMPLETED|Dose De-escalation of Regimen A||0
3077721|NCT01362790|3799377|FG001|NOT COMPLETED|Dose De-escalation of Regimen A||0
3077722|NCT01362790|3799378|FG002|NOT COMPLETED|Dose De-escalation of Regimen A||0
3077723|NCT01362790|3799379|FG003|NOT COMPLETED|Dose De-escalation of Regimen A||0
3077724|NCT01362790|3799380|FG004|NOT COMPLETED|Dose De-escalation of Regimen A||6
3077725|NCT01362790|3799381|FG005|NOT COMPLETED|Dose De-escalation of Regimen A||0
3077726|NCT01362790|3799382|FG006|NOT COMPLETED|Dose De-escalation of Regimen A||0
3077727|NCT01362894|3799402|FG000|STARTED|Period One, 1 Week|One participant was not dispensed lenses until Period 2.|119
3077728|NCT01362894|3799403|FG001|STARTED|Period One, 1 Week|One participant was not dispensed lenses until Period 2.|117
3077729|NCT01362894|3799402|FG000|COMPLETED|Period One, 1 Week||119
3077730|NCT01362894|3799403|FG001|COMPLETED|Period One, 1 Week||117
3077731|NCT01362894|3799402|FG000|NOT COMPLETED|Period One, 1 Week||0
3077732|NCT01362894|3799403|FG001|NOT COMPLETED|Period One, 1 Week||0
3077733|NCT01362894|3799402|FG000|STARTED|Period Two, 1 Week|Two participants discontinued between Periods 1 and 2 due to discomfort (1) and poor fit (1).|118
3077734|NCT01362894|3799403|FG001|STARTED|Period Two, 1 Week|Three participants discontinued between Periods 1 and 2 due to unacceptable vision.|115
3077735|NCT01362894|3799402|FG000|COMPLETED|Period Two, 1 Week||118
3077736|NCT01362894|3799403|FG001|COMPLETED|Period Two, 1 Week||115
3077737|NCT01362894|3799402|FG000|NOT COMPLETED|Period Two, 1 Week||0
3077738|NCT01362894|3799403|FG001|NOT COMPLETED|Period Two, 1 Week||0
3077739|NCT01362907|3799409|FG000|STARTED|Period 1, One Week||20
3077740|NCT01362907|3799410|FG001|STARTED|Period 1, One Week||20
3077741|NCT01362907|3799409|FG000|COMPLETED|Period 1, One Week||20
3077742|NCT01362907|3799410|FG001|COMPLETED|Period 1, One Week||20
3077743|NCT01362907|3799409|FG000|NOT COMPLETED|Period 1, One Week||0
3077744|NCT01362907|3799410|FG001|NOT COMPLETED|Period 1, One Week||0
3077745|NCT01362907|3799409|FG000|STARTED|Period 2, One Week||20
3077746|NCT01362907|3799410|FG001|STARTED|Period 2, One Week||20
3077747|NCT01362907|3799409|FG000|COMPLETED|Period 2, One Week||20
3077748|NCT01362907|3799410|FG001|COMPLETED|Period 2, One Week||20
3077749|NCT01362907|3799409|FG000|NOT COMPLETED|Period 2, One Week||0
3077750|NCT01362907|3799410|FG001|NOT COMPLETED|Period 2, One Week||0
3077751|NCT01362946|3799416|FG000|STARTED|First Behavior Modification Block||24
3077752|NCT01362946|3799417|FG001|STARTED|First Behavior Modification Block||24
3077753|NCT01362946|3799416|FG000|COMPLETED|First Behavior Modification Block||24
3077754|NCT01362946|3799417|FG001|COMPLETED|First Behavior Modification Block||24
3077755|NCT01362946|3799416|FG000|NOT COMPLETED|First Behavior Modification Block||0
3077756|NCT01362946|3799417|FG001|NOT COMPLETED|First Behavior Modification Block||0
3077757|NCT01362946|3799416|FG000|STARTED|Second Behavior Modification Block|1 participant withdrew after last but before this treatment period - illness unrelated to study.|23
3077758|NCT01362946|3799417|FG001|STARTED|Second Behavior Modification Block||24
3077759|NCT01362946|3799416|FG000|COMPLETED|Second Behavior Modification Block||23
3077760|NCT01362946|3799417|FG001|COMPLETED|Second Behavior Modification Block||24
3077761|NCT01362946|3799416|FG000|NOT COMPLETED|Second Behavior Modification Block||0
3077762|NCT01362946|3799417|FG001|NOT COMPLETED|Second Behavior Modification Block||0
3077763|NCT01362959|3799425|FG000|STARTED|Overall Study||21
3077764|NCT01362959|3799426|FG001|STARTED|Overall Study||26
3077765|NCT01362959|3799425|FG000|COMPLETED|Overall Study||21
3077766|NCT01362959|3799426|FG001|COMPLETED|Overall Study||26
3077767|NCT01362959|3799425|FG000|NOT COMPLETED|Overall Study||0
3077768|NCT01362959|3799426|FG001|NOT COMPLETED|Overall Study||0
3077769|NCT01363011|3799434|FG000|STARTED|Main Study||33
3077770|NCT01363011|3799435|FG001|STARTED|Main Study||73
3077771|NCT01363011|3799434|FG000|COMPLETED|Main Study||29
3077772|NCT01363011|3799435|FG001|COMPLETED|Main Study||64
3077773|NCT01363011|3799434|FG000|NOT COMPLETED|Main Study||4
3077774|NCT01363011|3799435|FG001|NOT COMPLETED|Main Study||9
3077775|NCT01363011|3799434|FG000|STARTED|Extension Phase|11 participants who completed the main study did not enroll into the extension phase.|18
3077776|NCT01363011|3799435|FG001|STARTED|Extension Phase|15 participants who completed the main study did not enroll into the extension phase.|49
3077777|NCT01363011|3799434|FG000|COMPLETED|Extension Phase||13
3077778|NCT01363011|3799435|FG001|COMPLETED|Extension Phase||41
3077779|NCT01363011|3799434|FG000|NOT COMPLETED|Extension Phase||5
3077780|NCT01363011|3799435|FG001|NOT COMPLETED|Extension Phase||8
3077781|NCT01363050|3799441|FG000|STARTED|Overall Study||15
3077782|NCT01363050|3799441|FG000|COMPLETED|Overall Study||15
3077783|NCT01363050|3799441|FG000|NOT COMPLETED|Overall Study||0
3077784|NCT01363076|3799449|FG000|STARTED|Overall Study||7
3077785|NCT01363076|3799450|FG001|STARTED|Overall Study||13
3077786|NCT01363076|3799449|FG000|COMPLETED|Overall Study||7
3077787|NCT01363076|3799450|FG001|COMPLETED|Overall Study||12
3077788|NCT01363076|3799449|FG000|NOT COMPLETED|Overall Study||0
3077789|NCT01363076|3799450|FG001|NOT COMPLETED|Overall Study||1
3077790|NCT01363128|3799456|FG000|STARTED|Overall Study||69
3077791|NCT01363128|3799456|FG000|COMPLETED|Overall Study||69
3077792|NCT01363128|3799456|FG000|NOT COMPLETED|Overall Study||0
3077793|NCT01363258|3799462|FG000|STARTED|Overall Study||54
3077794|NCT01363258|3799463|FG001|STARTED|Overall Study||46
3077795|NCT01363258|3799462|FG000|COMPLETED|Overall Study||54
3077796|NCT01363258|3799463|FG001|COMPLETED|Overall Study||46
3077797|NCT01363258|3799462|FG000|NOT COMPLETED|Overall Study||0
3077798|NCT01363258|3799463|FG001|NOT COMPLETED|Overall Study||0
3077799|NCT01363297|3799474|FG000|STARTED|Overall Study||3
3077800|NCT01363297|3799475|FG001|STARTED|Overall Study||12
3077801|NCT01363297|3799476|FG002|STARTED|Overall Study||9
3077802|NCT01363297|3799477|FG003|STARTED|Overall Study||13
3077803|NCT01363297|3799478|FG004|STARTED|Overall Study||35
3077804|NCT01363297|3799474|FG000|COMPLETED|Overall Study||0
3077805|NCT01363297|3799475|FG001|COMPLETED|Overall Study||6
3077806|NCT01363297|3799476|FG002|COMPLETED|Overall Study||3
3077807|NCT01363297|3799477|FG003|COMPLETED|Overall Study||3
3077808|NCT01363297|3799478|FG004|COMPLETED|Overall Study||4
3077809|NCT01363297|3799474|FG000|NOT COMPLETED|Overall Study||3
3077810|NCT01363297|3799475|FG001|NOT COMPLETED|Overall Study||6
3077811|NCT01363297|3799476|FG002|NOT COMPLETED|Overall Study||6
3077812|NCT01363297|3799477|FG003|NOT COMPLETED|Overall Study||10
3077813|NCT01363297|3799478|FG004|NOT COMPLETED|Overall Study||31
3077814|NCT01363349|3799497|FG000|STARTED|Overall Study||133
3077815|NCT01363349|3799498|FG001|STARTED|Overall Study||136
3077816|NCT01363349|3799497|FG000|Randomized|Overall Study||133
3077817|NCT01363349|3799498|FG001|Randomized|Overall Study||136
3077818|NCT01363349|3799497|FG000|COMPLETED|Overall Study||66
3077819|NCT01363349|3799498|FG001|COMPLETED|Overall Study||66
3077820|NCT01363349|3799497|FG000|NOT COMPLETED|Overall Study||67
3077821|NCT01363349|3799498|FG001|NOT COMPLETED|Overall Study||70
3077822|NCT01363388|3799507|FG000|STARTED|Overall Study||23
3077823|NCT01363388|3799508|FG001|STARTED|Overall Study||22
3077824|NCT01363388|3799509|FG002|STARTED|Overall Study||22
3077825|NCT01363388|3799507|FG000|COMPLETED|Overall Study||18
3077826|NCT01363388|3799508|FG001|COMPLETED|Overall Study||19
3077827|NCT01363388|3799509|FG002|COMPLETED|Overall Study||18
3077828|NCT01363388|3799507|FG000|NOT COMPLETED|Overall Study||5
3077829|NCT01363388|3799508|FG001|NOT COMPLETED|Overall Study||3
3077830|NCT01363388|3799509|FG002|NOT COMPLETED|Overall Study||4
3077831|NCT01363401|3799519|FG000|STARTED|Overall Study|"Including 8 subjects of Phase 1 safety assessment. (Called Modified ITT in this clinical trials)"|41
3077832|NCT01363401|3799520|FG001|STARTED|Overall Study||31
3077833|NCT01363401|3799519|FG000|COMPLETED|Overall Study||39
3077834|NCT01363401|3799520|FG001|COMPLETED|Overall Study||27
3077835|NCT01363401|3799519|FG000|NOT COMPLETED|Overall Study||2
3077836|NCT01363401|3799520|FG001|NOT COMPLETED|Overall Study||4
3077837|NCT01363440|3799529|FG000|STARTED|Overall Study|randomized|156
3077838|NCT01363440|3799530|FG001|STARTED|Overall Study|randomized|156
3077839|NCT01363440|3799531|FG002|STARTED|Overall Study|randomized|154
3077840|NCT01363440|3799529|FG000|Participants Received Treatment|Overall Study|safety analysis set (SAF)|154
3077841|NCT01363440|3799530|FG001|Participants Received Treatment|Overall Study|safety analysis set (SAF)|155
3077842|NCT01363440|3799531|FG002|Participants Received Treatment|Overall Study|safety analysis set (SAF)|152
3077843|NCT01363440|3799529|FG000|Completed Week 52|Overall Study||145
3284931|NCT02769065|4018673|FG001|STARTED|Overall Study||6
3284932|NCT02769065|4018674|FG002|STARTED|Overall Study||6
3284933|NCT02769065|4018675|FG003|STARTED|Overall Study||6
3284934|NCT02769065|4018676|FG004|STARTED|Overall Study||6
3284935|NCT02769065|4018677|FG005|STARTED|Overall Study||6
3284936|NCT02769065|4018678|FG006|STARTED|Overall Study||7
3077844|NCT01363440|3799530|FG001|Completed Week 52|Overall Study||146
3077845|NCT01363440|3799531|FG002|Completed Week 52|Overall Study||144
3077846|NCT01363440|3799529|FG000|Completed Week 100|Overall Study||133
3077847|NCT01363440|3799530|FG001|Completed Week 100|Overall Study||125
3077848|NCT01363440|3799531|FG002|Completed Week 100|Overall Study||127
3284937|NCT02769065|4018679|FG007|STARTED|Overall Study||6
3284938|NCT02769065|4018680|FG008|STARTED|Overall Study||6
3284939|NCT02769065|4018681|FG009|STARTED|Overall Study||6
3284940|NCT02769065|4018682|FG010|STARTED|Overall Study||6
3284941|NCT02769065|4018683|FG011|STARTED|Overall Study||6
3284942|NCT02769065|4018684|FG012|STARTED|Overall Study||6
3284943|NCT02769065|4018685|FG013|STARTED|Overall Study||6
3284944|NCT02769065|4018686|FG014|STARTED|Overall Study||6
3284945|NCT02769065|4018687|FG015|STARTED|Overall Study||3
3284946|NCT02769065|4018688|FG016|STARTED|Overall Study||5
3284947|NCT02769065|4018689|FG017|STARTED|Overall Study||5
3284948|NCT02769065|4018690|FG018|STARTED|Overall Study||5
3284949|NCT02769065|4018691|FG019|STARTED|Overall Study||0
3284950|NCT02769065|4018692|FG020|STARTED|Overall Study||4
3284951|NCT02769065|4018693|FG021|STARTED|Overall Study||4
3284952|NCT02769065|4018694|FG022|STARTED|Overall Study||4
3284953|NCT02769065|4018695|FG023|STARTED|Overall Study||6
3284954|NCT02769065|4018696|FG024|STARTED|Overall Study||6
3077849|NCT01363440|3799529|FG000|COMPLETED|Overall Study|Completed Week 100|133
3077850|NCT01363440|3799530|FG001|COMPLETED|Overall Study|Completed Week 100|125
3284955|NCT02769065|4018697|FG025|STARTED|Overall Study||9
3077851|NCT01363440|3799531|FG002|COMPLETED|Overall Study|Completed Week 100|127
3284956|NCT02769065|4018698|FG026|STARTED|Overall Study||9
3077852|NCT01363440|3799529|FG000|NOT COMPLETED|Overall Study||23
2940835|NCT00639158|3653069|FG000|NOT COMPLETED|Overall Study||26
2940836|NCT00639158|3653070|FG001|NOT COMPLETED|Overall Study||30
2940837|NCT00639223|3653078|FG000|STARTED|Overall Study||22
2940838|NCT00639223|3653079|FG001|STARTED|Overall Study||21
2940839|NCT00639223|3653078|FG000|COMPLETED|Overall Study||22
2940840|NCT00639223|3653079|FG001|COMPLETED|Overall Study||19
2940841|NCT00639223|3653078|FG000|NOT COMPLETED|Overall Study||0
2940842|NCT00639223|3653079|FG001|NOT COMPLETED|Overall Study||2
2940843|NCT00639379|3653085|FG000|STARTED|Period 1 - 2 Weeks||44
2940844|NCT00639379|3653086|FG001|STARTED|Period 1 - 2 Weeks||45
2940845|NCT00639379|3653085|FG000|COMPLETED|Period 1 - 2 Weeks||39
2940846|NCT00639379|3653086|FG001|COMPLETED|Period 1 - 2 Weeks||45
2940847|NCT00639379|3653085|FG000|NOT COMPLETED|Period 1 - 2 Weeks||5
2940848|NCT00639379|3653086|FG001|NOT COMPLETED|Period 1 - 2 Weeks||0
2940849|NCT00639379|3653085|FG000|STARTED|Period 2 - 2 Weeks||39
2940850|NCT00639379|3653086|FG001|STARTED|Period 2 - 2 Weeks||45
2940851|NCT00639379|3653085|FG000|COMPLETED|Period 2 - 2 Weeks||39
2940852|NCT00639379|3653086|FG001|COMPLETED|Period 2 - 2 Weeks||45
3077853|NCT01363440|3799530|FG001|NOT COMPLETED|Overall Study||31
3077854|NCT01363440|3799531|FG002|NOT COMPLETED|Overall Study||27
3077855|NCT01363479|3799544|FG000|STARTED|Overall Study|number of randomised patients|371
3077856|NCT01363479|3799545|FG001|STARTED|Overall Study|number of randomised patients|372
3077857|NCT01363479|3799544|FG000|COMPLETED|Overall Study||359
3077858|NCT01363479|3799545|FG001|COMPLETED|Overall Study||351
3077859|NCT01363479|3799544|FG000|NOT COMPLETED|Overall Study||12
3077860|NCT01363479|3799545|FG001|NOT COMPLETED|Overall Study||21
3077861|NCT01363492|3799551|FG000|STARTED|Overall Study||14
3077862|NCT01363492|3799551|FG000|COMPLETED|Overall Study||14
3077863|NCT01363492|3799551|FG000|NOT COMPLETED|Overall Study||0
3077864|NCT01363661|3799559|FG000|STARTED|Overall Study||32
3077865|NCT01363661|3799560|FG001|STARTED|Overall Study||32
3077866|NCT01363661|3799559|FG000|COMPLETED|Overall Study||18
3077867|NCT01363661|3799560|FG001|COMPLETED|Overall Study||28
3077868|NCT01363661|3799559|FG000|NOT COMPLETED|Overall Study||14
3077869|NCT01363661|3799560|FG001|NOT COMPLETED|Overall Study||4
3077870|NCT01363700|3799569|FG000|STARTED|Epinastine vs Placebo Period1||43
3077871|NCT01363700|3799570|FG001|STARTED|Epinastine vs Placebo Period1||22
3077872|NCT01363700|3799571|FG002|STARTED|Epinastine vs Placebo Period1||22
3077873|NCT01363700|3799572|FG003|STARTED|Epinastine vs Placebo Period1|No Allocation|0
3077874|NCT01363700|3799573|FG004|STARTED|Epinastine vs Placebo Period1|No Allocation|0
3077875|NCT01363700|3799569|FG000|COMPLETED|Epinastine vs Placebo Period1||43
3077876|NCT01363700|3799570|FG001|COMPLETED|Epinastine vs Placebo Period1||21
3077877|NCT01363700|3799571|FG002|COMPLETED|Epinastine vs Placebo Period1||22
3077878|NCT01363700|3799572|FG003|COMPLETED|Epinastine vs Placebo Period1||0
3077879|NCT01363700|3799573|FG004|COMPLETED|Epinastine vs Placebo Period1||0
3077880|NCT01363700|3799569|FG000|NOT COMPLETED|Epinastine vs Placebo Period1||0
3077881|NCT01363700|3799570|FG001|NOT COMPLETED|Epinastine vs Placebo Period1||1
3077882|NCT01363700|3799571|FG002|NOT COMPLETED|Epinastine vs Placebo Period1||0
3077883|NCT01363700|3799572|FG003|NOT COMPLETED|Epinastine vs Placebo Period1||0
3077884|NCT01363700|3799573|FG004|NOT COMPLETED|Epinastine vs Placebo Period1||0
3077885|NCT01363700|3799569|FG000|STARTED|Epinastine vs Olopatadine Period2|No Allocation|0
3077886|NCT01363700|3799570|FG001|STARTED|Epinastine vs Olopatadine Period2|No Allocation|0
3077887|NCT01363700|3799571|FG002|STARTED|Epinastine vs Olopatadine Period2|No Allocation|0
3077888|NCT01363700|3799572|FG003|STARTED|Epinastine vs Olopatadine Period2||43
3077889|NCT01363700|3799573|FG004|STARTED|Epinastine vs Olopatadine Period2||43
3077890|NCT01363700|3799569|FG000|COMPLETED|Epinastine vs Olopatadine Period2||0
3077891|NCT01363700|3799570|FG001|COMPLETED|Epinastine vs Olopatadine Period2||0
3077892|NCT01363700|3799571|FG002|COMPLETED|Epinastine vs Olopatadine Period2||0
3077893|NCT01363700|3799572|FG003|COMPLETED|Epinastine vs Olopatadine Period2||43
3077894|NCT01363700|3799573|FG004|COMPLETED|Epinastine vs Olopatadine Period2||43
3077895|NCT01363700|3799569|FG000|NOT COMPLETED|Epinastine vs Olopatadine Period2||0
3077896|NCT01363700|3799570|FG001|NOT COMPLETED|Epinastine vs Olopatadine Period2||0
3077897|NCT01363700|3799571|FG002|NOT COMPLETED|Epinastine vs Olopatadine Period2||0
3077898|NCT01363700|3799572|FG003|NOT COMPLETED|Epinastine vs Olopatadine Period2||0
3077899|NCT01363700|3799573|FG004|NOT COMPLETED|Epinastine vs Olopatadine Period2||0
3077900|NCT01363713|3799584|FG000|STARTED|Overall Study|Assessed for eligibility|130
3077901|NCT01363713|3799584|FG000|ALLOCATED|Overall Study||130
3077902|NCT01363713|3799584|FG000|COMPLETED|Overall Study|Analysed (n=130)|124
3077903|NCT01363713|3799584|FG000|NOT COMPLETED|Overall Study||6
3077904|NCT01363765|3799590|FG000|STARTED|Overall Study|This is number of participants enrolled, each with one sample submitted to Xpert in intervention arm|18322
3077905|NCT01363765|3799591|FG001|STARTED|Overall Study|This is number of participants enrolled, each with one sample considered in baseline arm.|16436
3077906|NCT01363765|3799590|FG000|COMPLETED|Overall Study|Excluded were duplicates, non-residents, missing age, unavailability of system (smears done instead)|12522
3077907|NCT01363765|3799591|FG001|COMPLETED|Overall Study|Samples contributing to observation arm. Excluded were duplicates, non-residents, missing age.|11705
3077908|NCT01363765|3799590|FG000|NOT COMPLETED|Overall Study||5800
2940853|NCT00639379|3653085|FG000|NOT COMPLETED|Period 2 - 2 Weeks||0
2940854|NCT00639379|3653086|FG001|NOT COMPLETED|Period 2 - 2 Weeks||0
2940855|NCT00639418|3653096|FG000|STARTED|Overall Study||28101
2940856|NCT00639418|3653097|FG001|STARTED|Overall Study||35967
3077909|NCT01363765|3799591|FG001|NOT COMPLETED|Overall Study||4731
3077910|NCT01363843|3799599|FG000|STARTED|Overall Study||39
3077911|NCT01363843|3799599|FG000|COMPLETED|Overall Study|39 enrolled, 36 completed 8 cycles of mFOLFOX6, 35 completed chemo-radiation, 38 underwent surgery.|38
3077912|NCT01363843|3799599|FG000|NOT COMPLETED|Overall Study||1
3077913|NCT01363908|3799606|FG000|STARTED|Screening/Enrollment||14
3077914|NCT01363908|3799607|FG001|STARTED|Screening/Enrollment||16
3077915|NCT01363908|3799606|FG000|COMPLETED|Screening/Enrollment|One participant did not receive investigational product.|13
3077916|NCT01363908|3799607|FG001|COMPLETED|Screening/Enrollment||16
3077917|NCT01363908|3799606|FG000|NOT COMPLETED|Screening/Enrollment||1
3077918|NCT01363908|3799607|FG001|NOT COMPLETED|Screening/Enrollment||0
3077919|NCT01363908|3799606|FG000|STARTED|Pharmacokinetic (PK) Phase|Per study design, at least 8 participants in each age cohort participated in the PK phase.|8
3077920|NCT01363908|3799607|FG001|STARTED|Pharmacokinetic (PK) Phase|Per study design, at least 8 participants in each age cohort participated in the PK phase.|8
3077921|NCT01363908|3799606|FG000|COMPLETED|Pharmacokinetic (PK) Phase||8
3077922|NCT01363908|3799607|FG001|COMPLETED|Pharmacokinetic (PK) Phase||8
3077923|NCT01363908|3799606|FG000|NOT COMPLETED|Pharmacokinetic (PK) Phase||0
3077924|NCT01363908|3799607|FG001|NOT COMPLETED|Pharmacokinetic (PK) Phase||0
3077925|NCT01363908|3799606|FG000|STARTED|Chronic Dosing (CD) Phase|The CD phase enrolled willing participants who completed the PK phase plus additional participants.|13
3077926|NCT01363908|3799607|FG001|STARTED|Chronic Dosing (CD) Phase|The CD phase enrolled willing participants who completed the PK phase plus additional participants.|16
3077927|NCT01363908|3799606|FG000|COMPLETED|Chronic Dosing (CD) Phase||3
3077928|NCT01363908|3799607|FG001|COMPLETED|Chronic Dosing (CD) Phase||10
3077929|NCT01363908|3799606|FG000|NOT COMPLETED|Chronic Dosing (CD) Phase||10
3077930|NCT01363908|3799607|FG001|NOT COMPLETED|Chronic Dosing (CD) Phase||6
3077931|NCT01363986|3799613|FG000|STARTED|Overall Study||3
3077932|NCT01363986|3799613|FG000|COMPLETED|Overall Study||2
3077933|NCT01363986|3799613|FG000|NOT COMPLETED|Overall Study||1
3077934|NCT01363999|3799617|FG000|STARTED|A: RO5317116/F01 Bilayer Tablet||24
3077935|NCT01363999|3799617|FG000|COMPLETED|A: RO5317116/F01 Bilayer Tablet||24
3077936|NCT01363999|3799617|FG000|NOT COMPLETED|A: RO5317116/F01 Bilayer Tablet||0
3077937|NCT01363999|3799617|FG000|STARTED|B: RO5317116/F03 Bilayer Tablet||24
3077938|NCT01363999|3799617|FG000|COMPLETED|B: RO5317116/F03 Bilayer Tablet||24
3077939|NCT01363999|3799617|FG000|NOT COMPLETED|B: RO5317116/F03 Bilayer Tablet||0
3077940|NCT01363999|3799617|FG000|STARTED|C: RO5317116/ F04 Active-coated Tablet||24
3077941|NCT01363999|3799617|FG000|COMPLETED|C: RO5317116/ F04 Active-coated Tablet||24
3077942|NCT01363999|3799617|FG000|NOT COMPLETED|C: RO5317116/ F04 Active-coated Tablet||0
3077943|NCT01363999|3799617|FG000|STARTED|D: RO4607381/ F49 Tablet||24
3077944|NCT01363999|3799617|FG000|COMPLETED|D: RO4607381/ F49 Tablet||24
3077945|NCT01363999|3799617|FG000|NOT COMPLETED|D: RO4607381/ F49 Tablet||0
3077946|NCT01364090|3799627|FG000|STARTED|Overall Study||61
3077947|NCT01364090|3799628|FG001|STARTED|Overall Study||26
3077948|NCT01364090|3799629|FG002|STARTED|Overall Study||6
3077949|NCT01364090|3799627|FG000|COMPLETED|Overall Study||58
3077950|NCT01364090|3799628|FG001|COMPLETED|Overall Study||12
3077951|NCT01364090|3799629|FG002|COMPLETED|Overall Study||0
3077952|NCT01364090|3799627|FG000|NOT COMPLETED|Overall Study||3
3077953|NCT01364090|3799628|FG001|NOT COMPLETED|Overall Study||14
3077954|NCT01364090|3799629|FG002|NOT COMPLETED|Overall Study||6
3077955|NCT01364207|3799637|FG000|STARTED|First Visit (~1.5-2 Hours)||54
3077956|NCT01364207|3799638|FG001|STARTED|First Visit (~1.5-2 Hours)||58
3077957|NCT01364207|3799637|FG000|COMPLETED|First Visit (~1.5-2 Hours)||54
3077958|NCT01364207|3799638|FG001|COMPLETED|First Visit (~1.5-2 Hours)||58
3077959|NCT01364207|3799637|FG000|NOT COMPLETED|First Visit (~1.5-2 Hours)||0
3077960|NCT01364207|3799638|FG001|NOT COMPLETED|First Visit (~1.5-2 Hours)||0
3077961|NCT01364207|3799637|FG000|STARTED|Time Between Visits (2 Days to 4 Weeks)||54
3077962|NCT01364207|3799638|FG001|STARTED|Time Between Visits (2 Days to 4 Weeks)||58
3077963|NCT01364207|3799637|FG000|COMPLETED|Time Between Visits (2 Days to 4 Weeks)||52
3077964|NCT01364207|3799638|FG001|COMPLETED|Time Between Visits (2 Days to 4 Weeks)||54
3077965|NCT01364207|3799637|FG000|NOT COMPLETED|Time Between Visits (2 Days to 4 Weeks)||2
3077966|NCT01364207|3799638|FG001|NOT COMPLETED|Time Between Visits (2 Days to 4 Weeks)||4
3077967|NCT01364207|3799637|FG000|STARTED|Second Visit (~1.5-2 Hours)||52
3077968|NCT01364207|3799638|FG001|STARTED|Second Visit (~1.5-2 Hours)||54
3077969|NCT01364207|3799637|FG000|COMPLETED|Second Visit (~1.5-2 Hours)||52
3077970|NCT01364207|3799638|FG001|COMPLETED|Second Visit (~1.5-2 Hours)||54
3077971|NCT01364207|3799637|FG000|NOT COMPLETED|Second Visit (~1.5-2 Hours)||0
3077972|NCT01364207|3799638|FG001|NOT COMPLETED|Second Visit (~1.5-2 Hours)||0
3077973|NCT01364233|3799644|FG000|STARTED|Overall Study||10
3077974|NCT01364233|3799644|FG000|COMPLETED|Overall Study||9
3077975|NCT01364233|3799644|FG000|NOT COMPLETED|Overall Study||1
3077976|NCT01364259|3799650|FG000|STARTED|Overall Study||9
3077977|NCT01364259|3799651|FG001|STARTED|Overall Study||8
3077978|NCT01364259|3799650|FG000|COMPLETED|Overall Study||9
3077979|NCT01364259|3799651|FG001|COMPLETED|Overall Study||8
3077980|NCT01364259|3799650|FG000|NOT COMPLETED|Overall Study||0
3077981|NCT01364259|3799651|FG001|NOT COMPLETED|Overall Study||0
3077982|NCT01364298|3799659|FG000|STARTED|Overall Study||176
3077983|NCT01364298|3799660|FG001|STARTED|Overall Study||177
3077984|NCT01364298|3799659|FG000|Treated|Overall Study||174
3077985|NCT01364298|3799660|FG001|Treated|Overall Study||174
3077986|NCT01364298|3799659|FG000|COMPLETED|Overall Study||162
3077987|NCT01364298|3799660|FG001|COMPLETED|Overall Study||154
3077988|NCT01364298|3799659|FG000|NOT COMPLETED|Overall Study||14
3077989|NCT01364298|3799660|FG001|NOT COMPLETED|Overall Study||23
3134623|NCT01701973|3859523|FG002|STARTED|Aim 1: Second Intervention (1 Day)||0
3134624|NCT01701973|3859524|FG003|STARTED|Aim 1: Second Intervention (1 Day)||0
3134625|NCT01701973|3859525|FG004|STARTED|Aim 1: Second Intervention (1 Day)||0
3134626|NCT01701973|3859526|FG005|STARTED|Aim 1: Second Intervention (1 Day)||0
3134627|NCT01701973|3859527|FG006|STARTED|Aim 1: Second Intervention (1 Day)||0
3134628|NCT01701973|3859528|FG007|STARTED|Aim 1: Second Intervention (1 Day)||0
3134629|NCT01701973|3859521|FG000|COMPLETED|Aim 1: Second Intervention (1 Day)||22
3134630|NCT01701973|3859522|FG001|COMPLETED|Aim 1: Second Intervention (1 Day)||17
3134631|NCT01701973|3859523|FG002|COMPLETED|Aim 1: Second Intervention (1 Day)||0
3134632|NCT01701973|3859524|FG003|COMPLETED|Aim 1: Second Intervention (1 Day)||0
3134633|NCT01701973|3859525|FG004|COMPLETED|Aim 1: Second Intervention (1 Day)||0
3134634|NCT01701973|3859526|FG005|COMPLETED|Aim 1: Second Intervention (1 Day)||0
3134635|NCT01701973|3859527|FG006|COMPLETED|Aim 1: Second Intervention (1 Day)||0
3134636|NCT01701973|3859528|FG007|COMPLETED|Aim 1: Second Intervention (1 Day)||0
3134637|NCT01701973|3859521|FG000|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
3134638|NCT01701973|3859522|FG001|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
3134639|NCT01701973|3859523|FG002|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
3134640|NCT01701973|3859524|FG003|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
3134641|NCT01701973|3859525|FG004|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
3134642|NCT01701973|3859526|FG005|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
3134643|NCT01701973|3859527|FG006|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
3134644|NCT01701973|3859528|FG007|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
3134645|NCT01701973|3859521|FG000|STARTED|Aim 2: First Intervention (1 Day)||0
3134646|NCT01701973|3859522|FG001|STARTED|Aim 2: First Intervention (1 Day)||0
3134647|NCT01701973|3859523|FG002|STARTED|Aim 2: First Intervention (1 Day)||5
3134648|NCT01701973|3859524|FG003|STARTED|Aim 2: First Intervention (1 Day)||4
3134649|NCT01701973|3859525|FG004|STARTED|Aim 2: First Intervention (1 Day)||2
3134650|NCT01701973|3859526|FG005|STARTED|Aim 2: First Intervention (1 Day)||3
3134651|NCT01701973|3859527|FG006|STARTED|Aim 2: First Intervention (1 Day)||5
3134652|NCT01701973|3859528|FG007|STARTED|Aim 2: First Intervention (1 Day)||4
3134653|NCT01701973|3859521|FG000|COMPLETED|Aim 2: First Intervention (1 Day)||0
3134654|NCT01701973|3859522|FG001|COMPLETED|Aim 2: First Intervention (1 Day)||0
3134655|NCT01701973|3859523|FG002|COMPLETED|Aim 2: First Intervention (1 Day)||5
3134656|NCT01701973|3859524|FG003|COMPLETED|Aim 2: First Intervention (1 Day)||4
3134657|NCT01701973|3859525|FG004|COMPLETED|Aim 2: First Intervention (1 Day)||2
3134658|NCT01701973|3859526|FG005|COMPLETED|Aim 2: First Intervention (1 Day)||3
3134659|NCT01701973|3859527|FG006|COMPLETED|Aim 2: First Intervention (1 Day)||5
3134660|NCT01701973|3859528|FG007|COMPLETED|Aim 2: First Intervention (1 Day)||4
3134661|NCT01701973|3859521|FG000|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
3134662|NCT01701973|3859522|FG001|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
3134663|NCT01701973|3859523|FG002|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
3134664|NCT01701973|3859524|FG003|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
3134665|NCT01701973|3859525|FG004|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
3134666|NCT01701973|3859526|FG005|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
3134667|NCT01701973|3859527|FG006|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
3134668|NCT01701973|3859528|FG007|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
3134669|NCT01701973|3859521|FG000|STARTED|Aim 2: Second Intervention (1 Day)||0
3134670|NCT01701973|3859522|FG001|STARTED|Aim 2: Second Intervention (1 Day)||0
3134671|NCT01701973|3859523|FG002|STARTED|Aim 2: Second Intervention (1 Day)||5
3134672|NCT01701973|3859524|FG003|STARTED|Aim 2: Second Intervention (1 Day)||4
3134673|NCT01701973|3859525|FG004|STARTED|Aim 2: Second Intervention (1 Day)||2
3134674|NCT01701973|3859526|FG005|STARTED|Aim 2: Second Intervention (1 Day)||3
3134675|NCT01701973|3859527|FG006|STARTED|Aim 2: Second Intervention (1 Day)||5
3134676|NCT01701973|3859528|FG007|STARTED|Aim 2: Second Intervention (1 Day)|1 subject was lost to follow-up in between Periods 3 and 4.|3
3134677|NCT01701973|3859521|FG000|COMPLETED|Aim 2: Second Intervention (1 Day)||0
3134678|NCT01701973|3859522|FG001|COMPLETED|Aim 2: Second Intervention (1 Day)||0
3134679|NCT01701973|3859523|FG002|COMPLETED|Aim 2: Second Intervention (1 Day)||5
3134680|NCT01701973|3859524|FG003|COMPLETED|Aim 2: Second Intervention (1 Day)||4
3134681|NCT01701973|3859525|FG004|COMPLETED|Aim 2: Second Intervention (1 Day)||2
3134682|NCT01701973|3859526|FG005|COMPLETED|Aim 2: Second Intervention (1 Day)||3
3134683|NCT01701973|3859527|FG006|COMPLETED|Aim 2: Second Intervention (1 Day)||5
3134684|NCT01701973|3859528|FG007|COMPLETED|Aim 2: Second Intervention (1 Day)||3
3134685|NCT01701973|3859521|FG000|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
3134686|NCT01701973|3859522|FG001|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
3134687|NCT01701973|3859523|FG002|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
3134688|NCT01701973|3859524|FG003|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
3134689|NCT01701973|3859525|FG004|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
3134690|NCT01701973|3859526|FG005|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
3134691|NCT01701973|3859527|FG006|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
3284957|NCT02769065|4018699|FG027|STARTED|Overall Study||5
3284958|NCT02769065|4018700|FG028|STARTED|Overall Study||6
3284959|NCT02769065|4018701|FG029|STARTED|Overall Study||6
3284960|NCT02769065|4018672|FG000|COMPLETED|Overall Study||16
3284961|NCT02769065|4018673|FG001|COMPLETED|Overall Study||6
3077990|NCT01364389|3799669|FG000|STARTED|Overall Study||5
3077991|NCT01364389|3799670|FG001|STARTED|Overall Study||6
3077992|NCT01364389|3799671|FG002|STARTED|Overall Study||5
3077993|NCT01364389|3799669|FG000|Pharmacodynamic (PD) Analysis Set|Overall Study||5
3077994|NCT01364389|3799670|FG001|Pharmacodynamic (PD) Analysis Set|Overall Study||6
3077995|NCT01364389|3799671|FG002|Pharmacodynamic (PD) Analysis Set|Overall Study|One patient excluded: did not receive study drug; received placebo caps. and infusion only in error.|4
3077996|NCT01364389|3799669|FG000|COMPLETED|Overall Study||3
3077997|NCT01364389|3799670|FG001|COMPLETED|Overall Study||5
3077998|NCT01364389|3799671|FG002|COMPLETED|Overall Study||4
3077999|NCT01364389|3799669|FG000|NOT COMPLETED|Overall Study||2
3078000|NCT01364389|3799670|FG001|NOT COMPLETED|Overall Study||1
3078001|NCT01364389|3799671|FG002|NOT COMPLETED|Overall Study||1
3078002|NCT01364428|3799681|FG000|STARTED|Overall Study||186
3078003|NCT01364428|3799682|FG001|STARTED|Overall Study||187
3078004|NCT01364428|3799681|FG000|Exposed|Overall Study|Two subjects were randomised in error and withdrew prior to exposure to drug|184
3078005|NCT01364428|3799682|FG001|Exposed|Overall Study||187
3078006|NCT01364428|3799681|FG000|COMPLETED|Overall Study||166
3078007|NCT01364428|3799682|FG001|COMPLETED|Overall Study||172
3078008|NCT01364428|3799681|FG000|NOT COMPLETED|Overall Study||20
3078009|NCT01364428|3799682|FG001|NOT COMPLETED|Overall Study||15
3078010|NCT01364467|3799690|FG000|STARTED|Overall Study||10
3078011|NCT01364467|3799691|FG001|STARTED|Overall Study||20
3078012|NCT01364467|3799690|FG000|COMPLETED|Overall Study||9
3078013|NCT01364467|3799691|FG001|COMPLETED|Overall Study||18
3078014|NCT01364467|3799690|FG000|NOT COMPLETED|Overall Study||1
3078015|NCT01364467|3799691|FG001|NOT COMPLETED|Overall Study||2
3078016|NCT01364558|3799697|FG000|STARTED|Dose One||8
3078017|NCT01364558|3799698|FG001|STARTED|Dose One||8
3078018|NCT01364558|3799699|FG002|STARTED|Dose One||8
3078019|NCT01364558|3799697|FG000|COMPLETED|Dose One||8
3078020|NCT01364558|3799698|FG001|COMPLETED|Dose One||8
3078021|NCT01364558|3799699|FG002|COMPLETED|Dose One||8
3078022|NCT01364558|3799697|FG000|NOT COMPLETED|Dose One||0
3078023|NCT01364558|3799698|FG001|NOT COMPLETED|Dose One||0
3078024|NCT01364558|3799699|FG002|NOT COMPLETED|Dose One||0
3078025|NCT01364558|3799697|FG000|STARTED|Dose Two||8
3078026|NCT01364558|3799698|FG001|STARTED|Dose Two||8
3078027|NCT01364558|3799699|FG002|STARTED|Dose Two||8
3078028|NCT01364558|3799697|FG000|COMPLETED|Dose Two||8
3078029|NCT01364558|3799698|FG001|COMPLETED|Dose Two||8
3078030|NCT01364558|3799699|FG002|COMPLETED|Dose Two||8
3078031|NCT01364558|3799697|FG000|NOT COMPLETED|Dose Two||0
3078032|NCT01364558|3799698|FG001|NOT COMPLETED|Dose Two||0
3078033|NCT01364558|3799699|FG002|NOT COMPLETED|Dose Two||0
3078034|NCT01364558|3799697|FG000|STARTED|Dose Three||8
3078035|NCT01364558|3799698|FG001|STARTED|Dose Three||8
3078036|NCT01364558|3799699|FG002|STARTED|Dose Three||8
3078037|NCT01364558|3799697|FG000|COMPLETED|Dose Three||8
3078038|NCT01364558|3799698|FG001|COMPLETED|Dose Three||8
3078039|NCT01364558|3799699|FG002|COMPLETED|Dose Three||8
3078040|NCT01364558|3799697|FG000|NOT COMPLETED|Dose Three||0
3078041|NCT01364558|3799698|FG001|NOT COMPLETED|Dose Three||0
3078042|NCT01364558|3799699|FG002|NOT COMPLETED|Dose Three||0
3078043|NCT01364584|3799709|FG000|STARTED|Overall Study||11
3078044|NCT01364584|3799710|FG001|STARTED|Overall Study||12
3078045|NCT01364584|3799709|FG000|COMPLETED|Overall Study||11
3078046|NCT01364584|3799710|FG001|COMPLETED|Overall Study||12
3078047|NCT01364584|3799709|FG000|NOT COMPLETED|Overall Study||0
3078048|NCT01364584|3799710|FG001|NOT COMPLETED|Overall Study||0
3078049|NCT01364623|3799721|FG000|STARTED|Single Dose||8
3078050|NCT01364623|3799722|FG001|STARTED|Single Dose||8
3078051|NCT01364623|3799723|FG002|STARTED|Single Dose||8
3078052|NCT01364623|3799724|FG003|STARTED|Single Dose||0
3078053|NCT01364623|3799721|FG000|COMPLETED|Single Dose||8
3078054|NCT01364623|3799722|FG001|COMPLETED|Single Dose||8
3078055|NCT01364623|3799723|FG002|COMPLETED|Single Dose||8
3078056|NCT01364623|3799724|FG003|COMPLETED|Single Dose||0
3078057|NCT01364623|3799721|FG000|NOT COMPLETED|Single Dose||0
3078058|NCT01364623|3799722|FG001|NOT COMPLETED|Single Dose||0
3078059|NCT01364623|3799723|FG002|NOT COMPLETED|Single Dose||0
3078060|NCT01364623|3799724|FG003|NOT COMPLETED|Single Dose||0
3078061|NCT01364623|3799721|FG000|STARTED|Multiple Dose||0
3078062|NCT01364623|3799722|FG001|STARTED|Multiple Dose||0
3078063|NCT01364623|3799723|FG002|STARTED|Multiple Dose||0
3078064|NCT01364623|3799724|FG003|STARTED|Multiple Dose||8
3078065|NCT01364623|3799721|FG000|COMPLETED|Multiple Dose||0
3078066|NCT01364623|3799722|FG001|COMPLETED|Multiple Dose||0
3078067|NCT01364623|3799723|FG002|COMPLETED|Multiple Dose||0
3078068|NCT01364623|3799724|FG003|COMPLETED|Multiple Dose||8
3078069|NCT01364623|3799721|FG000|NOT COMPLETED|Multiple Dose||0
3078070|NCT01364623|3799722|FG001|NOT COMPLETED|Multiple Dose||0
3078071|NCT01364623|3799723|FG002|NOT COMPLETED|Multiple Dose||0
3078072|NCT01364623|3799724|FG003|NOT COMPLETED|Multiple Dose||0
3078073|NCT01364649|3799741|FG000|STARTED|Overall Study||225
3078074|NCT01364649|3799742|FG001|STARTED|Overall Study||222
3078075|NCT01364649|3799741|FG000|COMPLETED|Overall Study||169
3078076|NCT01364649|3799742|FG001|COMPLETED|Overall Study||179
3078077|NCT01364649|3799741|FG000|NOT COMPLETED|Overall Study||56
3078078|NCT01364649|3799742|FG001|NOT COMPLETED|Overall Study||43
3078079|NCT01364727|3799748|FG000|STARTED|Overall Study||35
3078080|NCT01364727|3799748|FG000|COMPLETED|Overall Study||33
3078081|NCT01364727|3799748|FG000|NOT COMPLETED|Overall Study||2
3078082|NCT01364740|3799754|FG000|STARTED|Overall Study||10
3078083|NCT01364740|3799754|FG000|COMPLETED|Overall Study||10
3078084|NCT01364740|3799754|FG000|NOT COMPLETED|Overall Study||0
3078085|NCT01364870|3799762|FG000|STARTED|Overall Study||122
3078086|NCT01364870|3799763|FG001|STARTED|Overall Study||123
3078087|NCT01364870|3799764|FG002|STARTED|Overall Study||72
3078088|NCT01364870|3799762|FG000|COMPLETED|Overall Study||100
3078089|NCT01364870|3799763|FG001|COMPLETED|Overall Study||93
3078090|NCT01364870|3799764|FG002|COMPLETED|Overall Study||58
3078091|NCT01364870|3799762|FG000|NOT COMPLETED|Overall Study||22
3078092|NCT01364870|3799763|FG001|NOT COMPLETED|Overall Study||30
3078093|NCT01364870|3799764|FG002|NOT COMPLETED|Overall Study||14
3078094|NCT01364896|3799772|FG000|STARTED|Overall Study||46
3078095|NCT01364896|3799772|FG000|COMPLETED|Overall Study||46
3078096|NCT01364896|3799772|FG000|NOT COMPLETED|Overall Study||0
3078097|NCT01364922|3799779|FG000|STARTED|Open-label (OL) Period||168
3078098|NCT01364922|3799780|FG001|STARTED|Open-label (OL) Period||0
3078099|NCT01364922|3799781|FG002|STARTED|Open-label (OL) Period||0
3078100|NCT01364922|3799779|FG000|COMPLETED|Open-label (OL) Period||146
3078101|NCT01364922|3799780|FG001|COMPLETED|Open-label (OL) Period||0
3078102|NCT01364922|3799781|FG002|COMPLETED|Open-label (OL) Period||0
3078103|NCT01364922|3799779|FG000|NOT COMPLETED|Open-label (OL) Period||22
3078104|NCT01364922|3799780|FG001|NOT COMPLETED|Open-label (OL) Period||0
3078105|NCT01364922|3799781|FG002|NOT COMPLETED|Open-label (OL) Period||0
3078106|NCT01364922|3799779|FG000|STARTED|Double-Blind (DB) Period||0
3078107|NCT01364922|3799780|FG001|STARTED|Double-Blind (DB) Period||99
3078108|NCT01364922|3799781|FG002|STARTED|Double-Blind (DB) Period||47
3078109|NCT01364922|3799779|FG000|COMPLETED|Double-Blind (DB) Period||0
3078110|NCT01364922|3799780|FG001|COMPLETED|Double-Blind (DB) Period||94
3078111|NCT01364922|3799781|FG002|COMPLETED|Double-Blind (DB) Period||42
3078112|NCT01364922|3799779|FG000|NOT COMPLETED|Double-Blind (DB) Period||0
3078113|NCT01364922|3799780|FG001|NOT COMPLETED|Double-Blind (DB) Period||5
3078114|NCT01364922|3799781|FG002|NOT COMPLETED|Double-Blind (DB) Period||5
3078115|NCT01365039|3799790|FG000|STARTED|Overall Study||86
3078116|NCT01365039|3799791|FG001|STARTED|Overall Study||87
3078117|NCT01365039|3799790|FG000|COMPLETED|Overall Study||85
3078118|NCT01365039|3799791|FG001|COMPLETED|Overall Study||87
3078119|NCT01365039|3799790|FG000|NOT COMPLETED|Overall Study||1
3078120|NCT01365039|3799791|FG001|NOT COMPLETED|Overall Study||0
3078121|NCT01365052|3799800|FG000|STARTED|Overall Study||217
3078122|NCT01365052|3799801|FG001|STARTED|Overall Study||109
3078123|NCT01365052|3799800|FG000|COMPLETED|Overall Study||213
3078124|NCT01365052|3799801|FG001|COMPLETED|Overall Study||105
3078125|NCT01365052|3799800|FG000|NOT COMPLETED|Overall Study||4
3078126|NCT01365052|3799801|FG001|NOT COMPLETED|Overall Study||4
3078127|NCT01365091|3799811|FG000|STARTED|Period 1||28
3078128|NCT01365091|3799812|FG001|STARTED|Period 1||28
3078129|NCT01365091|3799813|FG002|STARTED|Period 1||28
3078130|NCT01365091|3799814|FG003|STARTED|Period 1||28
3078131|NCT01365091|3799811|FG000|COMPLETED|Period 1||26
3078132|NCT01365091|3799812|FG001|COMPLETED|Period 1||26
3078133|NCT01365091|3799813|FG002|COMPLETED|Period 1||25
3078134|NCT01365091|3799814|FG003|COMPLETED|Period 1||25
3078135|NCT01365091|3799811|FG000|NOT COMPLETED|Period 1||2
3078136|NCT01365091|3799812|FG001|NOT COMPLETED|Period 1||2
3078137|NCT01365091|3799813|FG002|NOT COMPLETED|Period 1||3
3078138|NCT01365091|3799814|FG003|NOT COMPLETED|Period 1||3
3078139|NCT01365091|3799811|FG000|STARTED|Period 2||26
3078140|NCT01365091|3799812|FG001|STARTED|Period 2||26
3078141|NCT01365091|3799813|FG002|STARTED|Period 2||25
3078142|NCT01365091|3799814|FG003|STARTED|Period 2||25
3078143|NCT01365091|3799811|FG000|COMPLETED|Period 2||25
3078144|NCT01365091|3799812|FG001|COMPLETED|Period 2||26
3078145|NCT01365091|3799813|FG002|COMPLETED|Period 2||24
3078146|NCT01365091|3799814|FG003|COMPLETED|Period 2||25
3078147|NCT01365091|3799811|FG000|NOT COMPLETED|Period 2||1
3078148|NCT01365091|3799812|FG001|NOT COMPLETED|Period 2||0
3078149|NCT01365091|3799813|FG002|NOT COMPLETED|Period 2||1
3078150|NCT01365091|3799814|FG003|NOT COMPLETED|Period 2||0
3078151|NCT01365130|3799838|FG000|STARTED|Overall Study|15 patients were enrolled to the study but only 13 went on to begin treatment|15
3284962|NCT02769065|4018674|FG002|COMPLETED|Overall Study||6
3284963|NCT02769065|4018675|FG003|COMPLETED|Overall Study||6
3284964|NCT02769065|4018676|FG004|COMPLETED|Overall Study||6
3284965|NCT02769065|4018677|FG005|COMPLETED|Overall Study||6
3284966|NCT02769065|4018678|FG006|COMPLETED|Overall Study||6
3284967|NCT02769065|4018679|FG007|COMPLETED|Overall Study||6
3284968|NCT02769065|4018680|FG008|COMPLETED|Overall Study||6
3284969|NCT02769065|4018681|FG009|COMPLETED|Overall Study||6
3284970|NCT02769065|4018682|FG010|COMPLETED|Overall Study||5
3284971|NCT02769065|4018683|FG011|COMPLETED|Overall Study||6
3284972|NCT02769065|4018684|FG012|COMPLETED|Overall Study||6
3284973|NCT02769065|4018685|FG013|COMPLETED|Overall Study||6
3284974|NCT02769065|4018686|FG014|COMPLETED|Overall Study||6
3284975|NCT02769065|4018687|FG015|COMPLETED|Overall Study||3
3078152|NCT01365130|3799838|FG000|COMPLETED|Overall Study||13
3078153|NCT01365130|3799838|FG000|NOT COMPLETED|Overall Study||2
3078154|NCT01365273|3799844|FG000|STARTED|Overall Study||22
3078155|NCT01365273|3799845|FG001|STARTED|Overall Study||21
3078156|NCT01365273|3799844|FG000|Compl. Pts, Not Evaluable for Pain.|Overall Study||2
3078157|NCT01365273|3799845|FG001|Compl. Pts, Not Evaluable for Pain.|Overall Study||4
3078158|NCT01365273|3799844|FG000|COMPLETED|Overall Study||20
3078159|NCT01365273|3799845|FG001|COMPLETED|Overall Study||20
3078160|NCT01365273|3799844|FG000|NOT COMPLETED|Overall Study||2
3078161|NCT01365273|3799845|FG001|NOT COMPLETED|Overall Study||1
3078162|NCT01365455|3799854|FG000|STARTED|Induction Period||245
3078163|NCT01365455|3799855|FG001|STARTED|Induction Period||245
3078164|NCT01365455|3799856|FG002|STARTED|Induction Period||248
3078165|NCT01365455|3799857|FG003|STARTED|Induction Period||0
3078166|NCT01365455|3799858|FG004|STARTED|Induction Period||0
3078167|NCT01365455|3799854|FG000|COMPLETED|Induction Period||230
3078168|NCT01365455|3799855|FG001|COMPLETED|Induction Period||238
3078169|NCT01365455|3799856|FG002|COMPLETED|Induction Period||232
3078170|NCT01365455|3799857|FG003|COMPLETED|Induction Period||0
3078171|NCT01365455|3799858|FG004|COMPLETED|Induction Period||0
3078172|NCT01365455|3799854|FG000|NOT COMPLETED|Induction Period||15
3078173|NCT01365455|3799855|FG001|NOT COMPLETED|Induction Period||7
3078174|NCT01365455|3799856|FG002|NOT COMPLETED|Induction Period||16
3078175|NCT01365455|3799857|FG003|NOT COMPLETED|Induction Period||0
3078176|NCT01365455|3799858|FG004|NOT COMPLETED|Induction Period||0
3078177|NCT01365455|3799854|FG000|STARTED|Maintenance Period||230
3078178|NCT01365455|3799855|FG001|STARTED|Maintenance Period||238
3078179|NCT01365455|3799856|FG002|STARTED|Maintenance Period||18
3078180|NCT01365455|3799857|FG003|STARTED|Maintenance Period||109
3078181|NCT01365455|3799858|FG004|STARTED|Maintenance Period||105
3078182|NCT01365455|3799854|FG000|COMPLETED|Maintenance Period||201
3078183|NCT01365455|3799855|FG001|COMPLETED|Maintenance Period||215
3078184|NCT01365455|3799856|FG002|COMPLETED|Maintenance Period||15
3078185|NCT01365455|3799857|FG003|COMPLETED|Maintenance Period||100
3078186|NCT01365455|3799858|FG004|COMPLETED|Maintenance Period||92
3078187|NCT01365455|3799854|FG000|NOT COMPLETED|Maintenance Period||29
3078188|NCT01365455|3799855|FG001|NOT COMPLETED|Maintenance Period||23
3078189|NCT01365455|3799856|FG002|NOT COMPLETED|Maintenance Period||3
3078190|NCT01365455|3799857|FG003|NOT COMPLETED|Maintenance Period||9
3078191|NCT01365455|3799858|FG004|NOT COMPLETED|Maintenance Period||13
3078192|NCT01365455|3799854|FG000|STARTED|Follow-up Period||58
3078193|NCT01365455|3799855|FG001|STARTED|Follow-up Period||47
3078194|NCT01365455|3799856|FG002|STARTED|Follow-up Period||18
3078195|NCT01365455|3799857|FG003|STARTED|Follow-up Period||0
3078196|NCT01365455|3799858|FG004|STARTED|Follow-up Period||0
3078197|NCT01365455|3799854|FG000|COMPLETED|Follow-up Period||58
3078198|NCT01365455|3799855|FG001|COMPLETED|Follow-up Period||47
3078199|NCT01365455|3799856|FG002|COMPLETED|Follow-up Period||18
3078200|NCT01365455|3799857|FG003|COMPLETED|Follow-up Period||0
3078201|NCT01365455|3799858|FG004|COMPLETED|Follow-up Period||0
3078202|NCT01365455|3799854|FG000|NOT COMPLETED|Follow-up Period||0
3078203|NCT01365455|3799855|FG001|NOT COMPLETED|Follow-up Period||0
3078204|NCT01365455|3799856|FG002|NOT COMPLETED|Follow-up Period||0
3078205|NCT01365455|3799857|FG003|NOT COMPLETED|Follow-up Period||0
3078206|NCT01365455|3799858|FG004|NOT COMPLETED|Follow-up Period||0
3078207|NCT01365468|3799878|FG000|STARTED|Overall Study||4
3078208|NCT01365468|3799879|FG001|STARTED|Overall Study||5
3078209|NCT01365468|3799878|FG000|COMPLETED|Overall Study||0
3078210|NCT01365468|3799879|FG001|COMPLETED|Overall Study||5
3078211|NCT01365468|3799878|FG000|NOT COMPLETED|Overall Study||4
3078212|NCT01365468|3799879|FG001|NOT COMPLETED|Overall Study||0
3078213|NCT01365481|3799890|FG000|STARTED|Overall Study||23
3078214|NCT01365481|3799891|FG001|STARTED|Overall Study||52
3078215|NCT01365481|3799892|FG002|STARTED|Overall Study||18
3078216|NCT01365481|3799893|FG003|STARTED|Overall Study||57
3078217|NCT01365481|3799890|FG000|COMPLETED|Overall Study||16
3078218|NCT01365481|3799891|FG001|COMPLETED|Overall Study||37
3078219|NCT01365481|3799892|FG002|COMPLETED|Overall Study||14
3078220|NCT01365481|3799893|FG003|COMPLETED|Overall Study||50
3078221|NCT01365481|3799890|FG000|NOT COMPLETED|Overall Study||7
3078222|NCT01365481|3799891|FG001|NOT COMPLETED|Overall Study||15
3078223|NCT01365481|3799892|FG002|NOT COMPLETED|Overall Study||4
3078224|NCT01365481|3799893|FG003|NOT COMPLETED|Overall Study||7
3078225|NCT01365494|3799905|FG000|STARTED|Overall Study||126
3078226|NCT01365494|3799906|FG001|STARTED|Overall Study||124
3078227|NCT01365494|3799905|FG000|COMPLETED|Overall Study||124
3078228|NCT01365494|3799906|FG001|COMPLETED|Overall Study||121
3078229|NCT01365494|3799905|FG000|NOT COMPLETED|Overall Study||2
3078230|NCT01365494|3799906|FG001|NOT COMPLETED|Overall Study||3
3078231|NCT01365507|3799915|FG000|STARTED|Overall Study||136
3078232|NCT01365507|3799916|FG001|STARTED|Overall Study||140
3078233|NCT01365507|3799915|FG000|Exposed|Overall Study|Two subjects withdrew before exposure to trial drug|134
3078234|NCT01365507|3799916|FG001|Exposed|Overall Study||140
3078235|NCT01365507|3799915|FG000|COMPLETED|Overall Study||127
3078236|NCT01365507|3799916|FG001|COMPLETED|Overall Study||131
3078237|NCT01365507|3799915|FG000|NOT COMPLETED|Overall Study||9
3078238|NCT01365507|3799916|FG001|NOT COMPLETED|Overall Study||9
3078239|NCT01365546|3799922|FG000|STARTED|Overall Study|in this study 41 patients were screened but only 30 patients completed the study.|41
3078240|NCT01365546|3799922|FG000|COMPLETED|Overall Study||30
3078241|NCT01365546|3799922|FG000|NOT COMPLETED|Overall Study||11
3078242|NCT01365585|3799930|FG000|STARTED|Overall Study||227
3078243|NCT01365585|3799930|FG000|COMPLETED|Overall Study||227
3078244|NCT01365585|3799930|FG000|NOT COMPLETED|Overall Study||0
3078245|NCT01365611|3799934|FG000|STARTED|Overall Study||36
3078246|NCT01365611|3799934|FG000|COMPLETED|Overall Study||36
3078247|NCT01365611|3799934|FG000|NOT COMPLETED|Overall Study||0
3078248|NCT01365624|3799942|FG000|STARTED|Overall Study||15
3078249|NCT01365624|3799943|FG001|STARTED|Overall Study||15
3078250|NCT01365624|3799942|FG000|COMPLETED|Overall Study||15
3078251|NCT01365624|3799943|FG001|COMPLETED|Overall Study||15
3078252|NCT01365624|3799942|FG000|NOT COMPLETED|Overall Study||0
3078253|NCT01365624|3799943|FG001|NOT COMPLETED|Overall Study||0
3078254|NCT01365650|3799949|FG000|STARTED|Treatment A||24
3078255|NCT01365650|3799949|FG000|COMPLETED|Treatment A||24
3078256|NCT01365650|3799949|FG000|NOT COMPLETED|Treatment A||0
3078257|NCT01365650|3799949|FG000|STARTED|Treatment B||24
3078258|NCT01365650|3799949|FG000|COMPLETED|Treatment B||24
3078259|NCT01365650|3799949|FG000|NOT COMPLETED|Treatment B||0
3078260|NCT01365650|3799949|FG000|STARTED|Treatment C||24
3078261|NCT01365650|3799949|FG000|COMPLETED|Treatment C||24
3078262|NCT01365650|3799949|FG000|NOT COMPLETED|Treatment C||0
3078263|NCT01365793|3799961|FG000|STARTED|Overall Study||344
3078264|NCT01365793|3799962|FG001|STARTED|Overall Study||351
3078265|NCT01365793|3799963|FG002|STARTED|Overall Study||345
3078266|NCT01365793|3799964|FG003|STARTED|Overall Study||349
3078267|NCT01365793|3799961|FG000|COMPLETED|Overall Study||342
3078268|NCT01365793|3799962|FG001|COMPLETED|Overall Study||344
3078269|NCT01365793|3799963|FG002|COMPLETED|Overall Study||338
3078270|NCT01365793|3799964|FG003|COMPLETED|Overall Study||347
3078271|NCT01365793|3799961|FG000|NOT COMPLETED|Overall Study||2
3078272|NCT01365793|3799962|FG001|NOT COMPLETED|Overall Study||7
3078273|NCT01365793|3799963|FG002|NOT COMPLETED|Overall Study||7
3078274|NCT01365793|3799964|FG003|NOT COMPLETED|Overall Study||2
3078275|NCT01365819|3799976|FG000|STARTED|Overall Study||25
3078276|NCT01365819|3799977|FG001|STARTED|Overall Study||27
3078277|NCT01365819|3799976|FG000|COMPLETED|Overall Study||12
3078278|NCT01365819|3799977|FG001|COMPLETED|Overall Study||14
3078279|NCT01365819|3799976|FG000|NOT COMPLETED|Overall Study||13
3078280|NCT01365819|3799977|FG001|NOT COMPLETED|Overall Study||13
3078281|NCT01365845|3799983|FG000|STARTED|Induction Phase||18
3078282|NCT01365845|3799984|FG001|STARTED|Induction Phase||0
3078283|NCT01365845|3799985|FG002|STARTED|Induction Phase||0
3078284|NCT01365845|3799983|FG000|COMPLETED|Induction Phase||18
3078285|NCT01365845|3799984|FG001|COMPLETED|Induction Phase||0
3078286|NCT01365845|3799985|FG002|COMPLETED|Induction Phase||0
3078287|NCT01365845|3799983|FG000|NOT COMPLETED|Induction Phase||0
3078288|NCT01365845|3799984|FG001|NOT COMPLETED|Induction Phase||0
3078289|NCT01365845|3799985|FG002|NOT COMPLETED|Induction Phase||0
3078290|NCT01365845|3799983|FG000|STARTED|Treatment Phase||0
3078291|NCT01365845|3799984|FG001|STARTED|Treatment Phase||0
3078292|NCT01365845|3799985|FG002|STARTED|Treatment Phase||18
3078293|NCT01365845|3799983|FG000|COMPLETED|Treatment Phase||0
3078294|NCT01365845|3799984|FG001|COMPLETED|Treatment Phase||0
3078295|NCT01365845|3799985|FG002|COMPLETED|Treatment Phase||18
3078296|NCT01365845|3799983|FG000|NOT COMPLETED|Treatment Phase||0
3078297|NCT01365845|3799984|FG001|NOT COMPLETED|Treatment Phase||0
3078298|NCT01365845|3799985|FG002|NOT COMPLETED|Treatment Phase||0
3078299|NCT01365910|3799990|FG000|STARTED|Overall Study||30
3078300|NCT01365910|3799990|FG000|COMPLETED|Overall Study||0
3078301|NCT01365910|3799990|FG000|NOT COMPLETED|Overall Study||30
3078302|NCT01366196|3799996|FG000|STARTED|Overall Study||43
3078303|NCT01366196|3799997|FG001|STARTED|Overall Study||43
3078304|NCT01366196|3799996|FG000|COMPLETED|Overall Study||43
3078305|NCT01366196|3799997|FG001|COMPLETED|Overall Study||43
3078306|NCT01366196|3799996|FG000|NOT COMPLETED|Overall Study||0
3078307|NCT01366196|3799997|FG001|NOT COMPLETED|Overall Study||0
3078308|NCT01366209|3800005|FG000|STARTED|Overall Study||278
3078309|NCT01366209|3800006|FG001|STARTED|Overall Study||277
3078310|NCT01366209|3800005|FG000|COMPLETED|Overall Study|Participants completing study assessment at Week 52 were completers, even if treatment was withdrawn|243
3078311|NCT01366209|3800006|FG001|COMPLETED|Overall Study||241
3078312|NCT01366209|3800005|FG000|NOT COMPLETED|Overall Study||35
3078313|NCT01366209|3800006|FG001|NOT COMPLETED|Overall Study||36
3078314|NCT01366417|3800012|FG000|STARTED|Overall Study||43
3078315|NCT01366417|3800012|FG000|Signed Informed Consent|Overall Study|Microbial samples were taken from 43 subjects for screening baseline.|43
3078316|NCT01366417|3800012|FG000|Completed Screen Visit|Overall Study|33 subjects had qualifying screening bacterial counts and were eligible for the Treatment Visit|33
3078317|NCT01366417|3800012|FG000|Completed Treatment Visit|Overall Study|28 subjects were treated with ChloraPrep and 70% Isopropyl Alcohol (single topical treatment)|28
3078318|NCT01366417|3800012|FG000|Completed the Study|Overall Study|treatment baseline microbial counts not available until after treatment; subjects not evaluable|28
3078319|NCT01366417|3800012|FG000|Discontinued Prior to Treatment|Overall Study|5 eligible subjects were not treated because enrollment target of 25 was met and enrollment closed.|5
3078320|NCT01366417|3800012|FG000|Excluded From Analysis|Overall Study|3 subjects did not have qualifying Treatment Day microbial counts and were excluded from analysis|3
3078321|NCT01366417|3800012|FG000|COMPLETED|Overall Study|25 subjects included in the analysis|25
3078322|NCT01366417|3800012|FG000|NOT COMPLETED|Overall Study||18
3078323|NCT01366443|3800017|FG000|STARTED|Overall Study||288
3078324|NCT01366443|3800017|FG000|COMPLETED|Overall Study||285
3078325|NCT01366443|3800017|FG000|NOT COMPLETED|Overall Study||3
3078326|NCT01366495|3800026|FG000|STARTED|Testing Study||0
3078327|NCT01366495|3800027|FG001|STARTED|Testing Study||0
3078328|NCT01366495|3800028|FG002|STARTED|Testing Study||349
3078329|NCT01366495|3800029|FG003|STARTED|Testing Study||348
3078330|NCT01366495|3800026|FG000|COMPLETED|Testing Study||0
3078331|NCT01366495|3800027|FG001|COMPLETED|Testing Study||0
3078332|NCT01366495|3800028|FG002|COMPLETED|Testing Study||349
3078333|NCT01366495|3800029|FG003|COMPLETED|Testing Study||348
3078334|NCT01366495|3800026|FG000|NOT COMPLETED|Testing Study||0
3078335|NCT01366495|3800027|FG001|NOT COMPLETED|Testing Study||0
3078336|NCT01366495|3800028|FG002|NOT COMPLETED|Testing Study||0
3078337|NCT01366495|3800029|FG003|NOT COMPLETED|Testing Study||0
3078338|NCT01366495|3800026|FG000|STARTED|HIV Study||50
3078339|NCT01366495|3800027|FG001|STARTED|HIV Study||50
3078340|NCT01366495|3800028|FG002|STARTED|HIV Study||0
3078341|NCT01366495|3800029|FG003|STARTED|HIV Study||0
3078342|NCT01366495|3800026|FG000|COMPLETED|HIV Study||49
3078343|NCT01366495|3800027|FG001|COMPLETED|HIV Study||50
3078344|NCT01366495|3800028|FG002|COMPLETED|HIV Study||0
3078345|NCT01366495|3800029|FG003|COMPLETED|HIV Study||0
3078346|NCT01366495|3800026|FG000|NOT COMPLETED|HIV Study||1
3078347|NCT01366495|3800027|FG001|NOT COMPLETED|HIV Study||0
3078348|NCT01366495|3800028|FG002|NOT COMPLETED|HIV Study||0
3284976|NCT02769065|4018688|FG016|COMPLETED|Overall Study||5
3284977|NCT02769065|4018689|FG017|COMPLETED|Overall Study||5
3284978|NCT02769065|4018690|FG018|COMPLETED|Overall Study||5
3284979|NCT02769065|4018691|FG019|COMPLETED|Overall Study||0
3284980|NCT02769065|4018692|FG020|COMPLETED|Overall Study||4
3284981|NCT02769065|4018693|FG021|COMPLETED|Overall Study||4
3284982|NCT02769065|4018694|FG022|COMPLETED|Overall Study||4
3284983|NCT02769065|4018695|FG023|COMPLETED|Overall Study||6
3284984|NCT02769065|4018696|FG024|COMPLETED|Overall Study||6
3284985|NCT02769065|4018697|FG025|COMPLETED|Overall Study||9
3284986|NCT02769065|4018698|FG026|COMPLETED|Overall Study||9
3284987|NCT02769065|4018699|FG027|COMPLETED|Overall Study||5
3284988|NCT02769065|4018700|FG028|COMPLETED|Overall Study||6
3284989|NCT02769065|4018701|FG029|COMPLETED|Overall Study||6
3284990|NCT02769065|4018672|FG000|NOT COMPLETED|Overall Study||1
3284991|NCT02769065|4018673|FG001|NOT COMPLETED|Overall Study||0
3284992|NCT02769065|4018674|FG002|NOT COMPLETED|Overall Study||0
3284993|NCT02769065|4018675|FG003|NOT COMPLETED|Overall Study||0
3284994|NCT02769065|4018676|FG004|NOT COMPLETED|Overall Study||0
3284995|NCT02769065|4018677|FG005|NOT COMPLETED|Overall Study||0
3284996|NCT02769065|4018678|FG006|NOT COMPLETED|Overall Study||1
3284997|NCT02769065|4018679|FG007|NOT COMPLETED|Overall Study||0
3284998|NCT02769065|4018680|FG008|NOT COMPLETED|Overall Study||0
3284999|NCT02769065|4018681|FG009|NOT COMPLETED|Overall Study||0
3285000|NCT02769065|4018682|FG010|NOT COMPLETED|Overall Study||1
3285001|NCT02769065|4018683|FG011|NOT COMPLETED|Overall Study||0
3285002|NCT02769065|4018684|FG012|NOT COMPLETED|Overall Study||0
3285003|NCT02769065|4018685|FG013|NOT COMPLETED|Overall Study||0
3285004|NCT02769065|4018686|FG014|NOT COMPLETED|Overall Study||0
3285005|NCT02769065|4018687|FG015|NOT COMPLETED|Overall Study||0
3285006|NCT02769065|4018688|FG016|NOT COMPLETED|Overall Study||0
3285007|NCT02769065|4018689|FG017|NOT COMPLETED|Overall Study||0
3285008|NCT02769065|4018690|FG018|NOT COMPLETED|Overall Study||0
3285009|NCT02769065|4018691|FG019|NOT COMPLETED|Overall Study||0
3285010|NCT02769065|4018692|FG020|NOT COMPLETED|Overall Study||0
3285011|NCT02769065|4018693|FG021|NOT COMPLETED|Overall Study||0
3285012|NCT02769065|4018694|FG022|NOT COMPLETED|Overall Study||0
3285013|NCT02769065|4018695|FG023|NOT COMPLETED|Overall Study||0
3285014|NCT02769065|4018696|FG024|NOT COMPLETED|Overall Study||0
3285015|NCT02769065|4018697|FG025|NOT COMPLETED|Overall Study||0
3285016|NCT02769065|4018698|FG026|NOT COMPLETED|Overall Study||0
3285017|NCT02769065|4018699|FG027|NOT COMPLETED|Overall Study||0
3285018|NCT02769065|4018700|FG028|NOT COMPLETED|Overall Study||0
3285019|NCT02769065|4018701|FG029|NOT COMPLETED|Overall Study||0
3285020|NCT02769247|4018798|FG000|STARTED|Overall Study||40
3285021|NCT02769247|4018799|FG001|STARTED|Overall Study||40
3285022|NCT02769247|4018800|FG002|STARTED|Overall Study||40
3285023|NCT02769247|4018801|FG003|STARTED|Overall Study||40
3285024|NCT02769247|4018798|FG000|COMPLETED|Overall Study|unable to insert IUD in one patient; 1 pt decided against study participation after enrollment|38
3285025|NCT02769247|4018799|FG001|COMPLETED|Overall Study||40
3285026|NCT02769247|4018800|FG002|COMPLETED|Overall Study|1 took non-study med after enrollment/randomization, before IUD insertion (excluded from study)|39
3285027|NCT02769247|4018801|FG003|COMPLETED|Overall Study|1 patient decided against study participation after enrollment/randomization|39
3285028|NCT02769247|4018798|FG000|NOT COMPLETED|Overall Study||2
3285029|NCT02769247|4018799|FG001|NOT COMPLETED|Overall Study||0
3285030|NCT02769247|4018800|FG002|NOT COMPLETED|Overall Study||1
3285031|NCT02769247|4018801|FG003|NOT COMPLETED|Overall Study||1
3285032|NCT02769312|4018817|FG000|STARTED|Double-Blind (0-2 Weeks)||25
3285033|NCT02769312|4018818|FG001|STARTED|Double-Blind (0-2 Weeks)||25
3285034|NCT02769312|4018817|FG000|COMPLETED|Double-Blind (0-2 Weeks)||23
3285035|NCT02769312|4018818|FG001|COMPLETED|Double-Blind (0-2 Weeks)||24
3285036|NCT02769312|4018817|FG000|NOT COMPLETED|Double-Blind (0-2 Weeks)||2
3285037|NCT02769312|4018818|FG001|NOT COMPLETED|Double-Blind (0-2 Weeks)||1
3078349|NCT01366495|3800029|FG003|NOT COMPLETED|HIV Study||0
3078350|NCT01366521|3800043|FG000|STARTED|Overall Study||21
3078351|NCT01366521|3800044|FG001|STARTED|Overall Study||15
3078352|NCT01366521|3800045|FG002|STARTED|Overall Study||23
3285038|NCT02769312|4018817|FG000|STARTED|Unblinded (Optional 2-4 Weeks)|2 participants chose not to continue with the unblinded period.|21
3285039|NCT02769312|4018818|FG001|STARTED|Unblinded (Optional 2-4 Weeks)||24
3285040|NCT02769312|4018817|FG000|COMPLETED|Unblinded (Optional 2-4 Weeks)||20
3285041|NCT02769312|4018818|FG001|COMPLETED|Unblinded (Optional 2-4 Weeks)||23
3285042|NCT02769312|4018817|FG000|NOT COMPLETED|Unblinded (Optional 2-4 Weeks)||1
3285043|NCT02769312|4018818|FG001|NOT COMPLETED|Unblinded (Optional 2-4 Weeks)||1
3285044|NCT02769312|4018817|FG000|STARTED|Follow-up||23
3285045|NCT02769312|4018818|FG001|STARTED|Follow-up||24
3078353|NCT01366521|3800046|FG003|STARTED|Overall Study||11
3078354|NCT01366521|3800043|FG000|COMPLETED|Overall Study||20
3078355|NCT01366521|3800044|FG001|COMPLETED|Overall Study||14
3078356|NCT01366521|3800045|FG002|COMPLETED|Overall Study||21
3078357|NCT01366521|3800046|FG003|COMPLETED|Overall Study||11
3078358|NCT01366521|3800043|FG000|NOT COMPLETED|Overall Study||1
3078359|NCT01366521|3800044|FG001|NOT COMPLETED|Overall Study||1
3078360|NCT01366521|3800045|FG002|NOT COMPLETED|Overall Study||2
3078361|NCT01366521|3800046|FG003|NOT COMPLETED|Overall Study||0
3078362|NCT01366534|3800061|FG000|STARTED|Overall Study||28
3078363|NCT01366534|3800062|FG001|STARTED|Overall Study||27
3078364|NCT01366534|3800063|FG002|STARTED|Overall Study||12
3078365|NCT01366534|3800061|FG000|COMPLETED|Overall Study||26
3078366|NCT01366534|3800062|FG001|COMPLETED|Overall Study||25
3078367|NCT01366534|3800063|FG002|COMPLETED|Overall Study||12
3078368|NCT01366534|3800061|FG000|NOT COMPLETED|Overall Study||2
3078369|NCT01366534|3800062|FG001|NOT COMPLETED|Overall Study||2
3078370|NCT01366534|3800063|FG002|NOT COMPLETED|Overall Study||0
3078371|NCT01366638|3800074|FG000|STARTED|Overall Study||24
3078372|NCT01366638|3800075|FG001|STARTED|Overall Study||29
3078373|NCT01366638|3800076|FG002|STARTED|Overall Study||26
3078374|NCT01366638|3800074|FG000|COMPLETED|Overall Study||23
3078375|NCT01366638|3800075|FG001|COMPLETED|Overall Study||29
3078376|NCT01366638|3800076|FG002|COMPLETED|Overall Study||20
3078377|NCT01366638|3800074|FG000|NOT COMPLETED|Overall Study||1
3078378|NCT01366638|3800075|FG001|NOT COMPLETED|Overall Study||0
3078379|NCT01366638|3800076|FG002|NOT COMPLETED|Overall Study||6
3078380|NCT01366846|3800088|FG000|STARTED|Overall Study||235
3078381|NCT01366846|3800089|FG001|STARTED|Overall Study||228
3078382|NCT01366846|3800090|FG002|STARTED|Overall Study||47
3078383|NCT01366846|3800091|FG003|STARTED|Overall Study||46
3078384|NCT01366846|3800088|FG000|COMPLETED|Overall Study||232
3078385|NCT01366846|3800089|FG001|COMPLETED|Overall Study||224
3078386|NCT01366846|3800090|FG002|COMPLETED|Overall Study||46
3078387|NCT01366846|3800091|FG003|COMPLETED|Overall Study||45
3078388|NCT01366846|3800088|FG000|NOT COMPLETED|Overall Study||3
3078389|NCT01366846|3800089|FG001|NOT COMPLETED|Overall Study||4
3078390|NCT01366846|3800090|FG002|NOT COMPLETED|Overall Study||1
3078391|NCT01366846|3800091|FG003|NOT COMPLETED|Overall Study||1
3078392|NCT01366872|3800104|FG000|STARTED|Overall Study||50
3078393|NCT01366872|3800104|FG000|COMPLETED|Overall Study||50
3078394|NCT01366872|3800104|FG000|NOT COMPLETED|Overall Study||0
3078395|NCT01366885|3800108|FG000|STARTED|Overall Study|We started recruiting in February 2008 and recruited 20 mothers.|20
3078396|NCT01366885|3800108|FG000|COMPLETED|Overall Study|We completed our study when the last child born had reached 36 months of age.|19
3078397|NCT01366885|3800108|FG000|NOT COMPLETED|Overall Study||1
3078398|NCT01366976|3800114|FG000|STARTED|Overall Study||30
3078399|NCT01366976|3800115|FG001|STARTED|Overall Study||30
3078400|NCT01366976|3800114|FG000|COMPLETED|Overall Study||30
3078401|NCT01366976|3800115|FG001|COMPLETED|Overall Study||30
3285046|NCT02769312|4018817|FG000|COMPLETED|Follow-up||22
3285047|NCT02769312|4018818|FG001|COMPLETED|Follow-up||23
3285048|NCT02769312|4018817|FG000|NOT COMPLETED|Follow-up||1
3285049|NCT02769312|4018818|FG001|NOT COMPLETED|Follow-up||1
3285050|NCT02769351|4018825|FG000|STARTED|Overall Study|SP|46
3285051|NCT02769351|4018825|FG000|COMPLETED|Overall Study|SP|4
3285052|NCT02769351|4018825|FG000|NOT COMPLETED|Overall Study||42
3285053|NCT02769442|4018832|FG000|STARTED|Overall Study||309
3285054|NCT02769442|4018833|FG001|STARTED|Overall Study||291
3285055|NCT02769442|4018832|FG000|COMPLETED|Overall Study||309
3285056|NCT02769442|4018833|FG001|COMPLETED|Overall Study||291
3285057|NCT02769442|4018832|FG000|NOT COMPLETED|Overall Study||0
3285058|NCT02769442|4018833|FG001|NOT COMPLETED|Overall Study||0
3285059|NCT02769481|4018841|FG000|STARTED|Overall Study||213
3285060|NCT02769481|4018842|FG001|STARTED|Overall Study||213
3285061|NCT02769481|4018841|FG000|Study Complete at Week 60|Overall Study||193
3285062|NCT02769481|4018842|FG001|Study Complete at Week 60|Overall Study||192
3285063|NCT02769481|4018841|FG000|COMPLETED|Overall Study||180
3285064|NCT02769481|4018842|FG001|COMPLETED|Overall Study||177
3285065|NCT02769481|4018841|FG000|NOT COMPLETED|Overall Study||33
3285066|NCT02769481|4018842|FG001|NOT COMPLETED|Overall Study||36
3285067|NCT02769624|4018848|FG000|STARTED|Overall Study||7
3285068|NCT02769624|4018849|FG001|STARTED|Overall Study||8
3285069|NCT02769624|4018848|FG000|COMPLETED|Overall Study||7
3285070|NCT02769624|4018849|FG001|COMPLETED|Overall Study||7
3285071|NCT02769624|4018848|FG000|NOT COMPLETED|Overall Study||0
3285072|NCT02769624|4018849|FG001|NOT COMPLETED|Overall Study||1
3285073|NCT02769702|4018855|FG000|STARTED|Overall Study||2
3285074|NCT02769702|4018855|FG000|COMPLETED|Overall Study||2
3285075|NCT02769702|4018855|FG000|NOT COMPLETED|Overall Study||0
3285076|NCT02769858|4018859|FG000|STARTED|Overall Study||10
3285077|NCT02769858|4018859|FG000|COMPLETED|Overall Study||8
3285078|NCT02769858|4018859|FG000|NOT COMPLETED|Overall Study||2
3285079|NCT02770014|4018863|FG000|STARTED|Plasma Genotyping||43
3285080|NCT02770014|4018863|FG000|COMPLETED|Plasma Genotyping||43
3285081|NCT02770014|4018863|FG000|NOT COMPLETED|Plasma Genotyping||0
3285082|NCT02770014|4018863|FG000|STARTED|EGFR Exon 19 Pos, Treated With Erlotinib|A total of 11 participants were found to have an activating EGFR mutation (exon 19 del or L858R).|11
3078402|NCT01366976|3800114|FG000|NOT COMPLETED|Overall Study||0
3078403|NCT01366976|3800115|FG001|NOT COMPLETED|Overall Study||0
3078404|NCT01367080|3800123|FG000|STARTED|1st Administration||6
3078405|NCT01367080|3800124|FG001|STARTED|1st Administration||6
3078406|NCT01367080|3800123|FG000|COMPLETED|1st Administration||6
3078407|NCT01367080|3800124|FG001|COMPLETED|1st Administration||6
3078408|NCT01367080|3800123|FG000|NOT COMPLETED|1st Administration||0
3078409|NCT01367080|3800124|FG001|NOT COMPLETED|1st Administration||0
3078410|NCT01367080|3800123|FG000|STARTED|2nd Administration||6
3078411|NCT01367080|3800124|FG001|STARTED|2nd Administration||6
3078412|NCT01367080|3800123|FG000|COMPLETED|2nd Administration||6
3078413|NCT01367080|3800124|FG001|COMPLETED|2nd Administration||6
3078414|NCT01367080|3800123|FG000|NOT COMPLETED|2nd Administration||0
3078415|NCT01367080|3800124|FG001|NOT COMPLETED|2nd Administration||0
3078416|NCT01367119|3800134|FG000|STARTED|Overall Study||21
3078417|NCT01367119|3800135|FG001|STARTED|Overall Study||17
3078418|NCT01367119|3800134|FG000|COMPLETED|Overall Study||19
3078419|NCT01367119|3800135|FG001|COMPLETED|Overall Study||16
3078420|NCT01367119|3800134|FG000|NOT COMPLETED|Overall Study||2
3078421|NCT01367119|3800135|FG001|NOT COMPLETED|Overall Study||1
3078422|NCT01367158|3800152|FG000|STARTED|Overall Study||25
3078423|NCT01367158|3800153|FG001|STARTED|Overall Study||49
3078424|NCT01367158|3800154|FG002|STARTED|Overall Study||24
3078425|NCT01367158|3800155|FG003|STARTED|Overall Study||49
3078426|NCT01367158|3800156|FG004|STARTED|Overall Study||25
3078427|NCT01367158|3800157|FG005|STARTED|Overall Study||48
3078428|NCT01367158|3800158|FG006|STARTED|Overall Study||25
3078429|NCT01367158|3800159|FG007|STARTED|Overall Study||49
3078430|NCT01367158|3800160|FG008|STARTED|Overall Study||23
3078431|NCT01367158|3800161|FG009|STARTED|Overall Study||50
3078432|NCT01367158|3800162|FG010|STARTED|Overall Study||73
3078433|NCT01367158|3800152|FG000|COMPLETED|Overall Study||25
3078434|NCT01367158|3800153|FG001|COMPLETED|Overall Study||46
3078435|NCT01367158|3800154|FG002|COMPLETED|Overall Study||23
3078436|NCT01367158|3800155|FG003|COMPLETED|Overall Study||48
3285083|NCT02770014|4018863|FG000|COMPLETED|EGFR Exon 19 Pos, Treated With Erlotinib|Of the 11 participants that had an activating EGFR mutation, 6 started erlotinib treatment.|6
3285084|NCT02770014|4018863|FG000|NOT COMPLETED|EGFR Exon 19 Pos, Treated With Erlotinib||5
3285085|NCT02770170|4018872|FG000|STARTED|Overall Study||21
3285086|NCT02770170|4018873|FG001|STARTED|Overall Study||20
3285087|NCT02770170|4018874|FG002|STARTED|Overall Study||40
3285088|NCT02770170|4018875|FG003|STARTED|Overall Study||40
3285089|NCT02770170|4018872|FG000|COMPLETED|Overall Study||14
3285090|NCT02770170|4018873|FG001|COMPLETED|Overall Study||17
3285091|NCT02770170|4018874|FG002|COMPLETED|Overall Study||35
3285092|NCT02770170|4018875|FG003|COMPLETED|Overall Study||33
3285093|NCT02770170|4018872|FG000|NOT COMPLETED|Overall Study||7
3285094|NCT02770170|4018873|FG001|NOT COMPLETED|Overall Study||3
3285095|NCT02770170|4018874|FG002|NOT COMPLETED|Overall Study||5
3285096|NCT02770170|4018875|FG003|NOT COMPLETED|Overall Study||7
3285097|NCT02770248|4018887|FG000|STARTED|Overall Study||62
3285098|NCT02770248|4018888|FG001|STARTED|Overall Study||63
3285099|NCT02770248|4018887|FG000|COMPLETED|Overall Study||62
3285100|NCT02770248|4018888|FG001|COMPLETED|Overall Study||61
3285101|NCT02770248|4018887|FG000|NOT COMPLETED|Overall Study||0
3285102|NCT02770248|4018888|FG001|NOT COMPLETED|Overall Study||2
3285103|NCT02770287|4018894|FG000|STARTED|Overall Study||11
3285104|NCT02770287|4018894|FG000|COMPLETED|Overall Study||11
3285105|NCT02770287|4018894|FG000|NOT COMPLETED|Overall Study||0
3285106|NCT02770365|4018904|FG000|STARTED|Overall Study||277
3285107|NCT02770365|4018905|FG001|STARTED|Overall Study||279
3285108|NCT02770365|4018906|FG002|STARTED|Overall Study||139
3285109|NCT02770365|4018904|FG000|COMPLETED|Overall Study||272
3285110|NCT02770365|4018905|FG001|COMPLETED|Overall Study||275
3285111|NCT02770365|4018906|FG002|COMPLETED|Overall Study||139
3285112|NCT02770365|4018904|FG000|NOT COMPLETED|Overall Study||5
3285113|NCT02770365|4018905|FG001|NOT COMPLETED|Overall Study||4
3285114|NCT02770365|4018906|FG002|NOT COMPLETED|Overall Study||0
3285115|NCT02770521|4018916|FG000|STARTED|Period One||4
3285116|NCT02770521|4018917|FG001|STARTED|Period One||4
3285117|NCT02770521|4018918|FG002|STARTED|Period One||2
3285118|NCT02770521|4018919|FG003|STARTED|Period One||2
3285119|NCT02770521|4018920|FG004|STARTED|Period One||2
3285120|NCT02770521|4018921|FG005|STARTED|Period One||9
3285121|NCT02770521|4018916|FG000|Received Study Drug|Period One||4
3285122|NCT02770521|4018917|FG001|Received Study Drug|Period One||4
3285123|NCT02770521|4018918|FG002|Received Study Drug|Period One||2
3285124|NCT02770521|4018919|FG003|Received Study Drug|Period One||2
3285125|NCT02770521|4018920|FG004|Received Study Drug|Period One||2
3285126|NCT02770521|4018921|FG005|Received Study Drug|Period One||9
3285127|NCT02770521|4018916|FG000|COMPLETED|Period One||4
3285128|NCT02770521|4018917|FG001|COMPLETED|Period One||4
3285129|NCT02770521|4018918|FG002|COMPLETED|Period One||2
3285130|NCT02770521|4018919|FG003|COMPLETED|Period One||2
3285131|NCT02770521|4018920|FG004|COMPLETED|Period One||2
3285132|NCT02770521|4018921|FG005|COMPLETED|Period One||9
3285133|NCT02770521|4018916|FG000|NOT COMPLETED|Period One||0
3285134|NCT02770521|4018917|FG001|NOT COMPLETED|Period One||0
3285135|NCT02770521|4018918|FG002|NOT COMPLETED|Period One||0
3285136|NCT02770521|4018919|FG003|NOT COMPLETED|Period One||0
3078437|NCT01367158|3800156|FG004|COMPLETED|Overall Study||23
3078438|NCT01367158|3800157|FG005|COMPLETED|Overall Study||46
3078439|NCT01367158|3800158|FG006|COMPLETED|Overall Study||25
3078440|NCT01367158|3800159|FG007|COMPLETED|Overall Study||47
3285137|NCT02770521|4018920|FG004|NOT COMPLETED|Period One||0
3285138|NCT02770521|4018921|FG005|NOT COMPLETED|Period One||0
3285139|NCT02770521|4018916|FG000|STARTED|Period Two||4
3078441|NCT01367158|3800160|FG008|COMPLETED|Overall Study||23
3078442|NCT01367158|3800161|FG009|COMPLETED|Overall Study||50
3078443|NCT01367158|3800162|FG010|COMPLETED|Overall Study||72
3078444|NCT01367158|3800152|FG000|NOT COMPLETED|Overall Study||0
3078445|NCT01367158|3800153|FG001|NOT COMPLETED|Overall Study||3
3078446|NCT01367158|3800154|FG002|NOT COMPLETED|Overall Study||1
3078447|NCT01367158|3800155|FG003|NOT COMPLETED|Overall Study||1
3078448|NCT01367158|3800156|FG004|NOT COMPLETED|Overall Study||2
3078449|NCT01367158|3800157|FG005|NOT COMPLETED|Overall Study||2
3078450|NCT01367158|3800158|FG006|NOT COMPLETED|Overall Study||0
3078451|NCT01367158|3800159|FG007|NOT COMPLETED|Overall Study||2
3078452|NCT01367158|3800160|FG008|NOT COMPLETED|Overall Study||0
3078453|NCT01367158|3800161|FG009|NOT COMPLETED|Overall Study||0
3078454|NCT01367158|3800162|FG010|NOT COMPLETED|Overall Study||1
3078455|NCT01367236|3800199|FG000|STARTED|Overall Study||30
3078456|NCT01367236|3800200|FG001|STARTED|Overall Study||30
3078457|NCT01367236|3800199|FG000|COMPLETED|Overall Study||27
3078458|NCT01367236|3800200|FG001|COMPLETED|Overall Study||29
3078459|NCT01367236|3800199|FG000|NOT COMPLETED|Overall Study||3
3078460|NCT01367236|3800200|FG001|NOT COMPLETED|Overall Study||1
3078461|NCT01367249|3800208|FG000|STARTED|Overall Study||222
3078462|NCT01367249|3800209|FG001|STARTED|Overall Study||218
3078463|NCT01367249|3800208|FG000|COMPLETED|Overall Study||213
3078464|NCT01367249|3800209|FG001|COMPLETED|Overall Study||202
3078465|NCT01367249|3800208|FG000|NOT COMPLETED|Overall Study||9
3078466|NCT01367249|3800209|FG001|NOT COMPLETED|Overall Study||16
3078467|NCT01367262|3800215|FG000|STARTED|Overall Study||6
3078468|NCT01367262|3800215|FG000|COMPLETED|Overall Study||6
3078469|NCT01367262|3800215|FG000|NOT COMPLETED|Overall Study||0
3078470|NCT01367275|3800219|FG000|STARTED|Overall Study||8
3078471|NCT01367275|3800219|FG000|COMPLETED|Overall Study||5
3078472|NCT01367275|3800219|FG000|NOT COMPLETED|Overall Study||3
3078473|NCT01367444|3800230|FG000|STARTED|Overall Study||4
3078474|NCT01367444|3800231|FG001|STARTED|Overall Study||4
3078475|NCT01367444|3800232|FG002|STARTED|Overall Study||4
3078476|NCT01367444|3800233|FG003|STARTED|Overall Study||4
3078477|NCT01367444|3800234|FG004|STARTED|Overall Study||6
3078478|NCT01367444|3800235|FG005|STARTED|Overall Study||4
3078479|NCT01367444|3800236|FG006|STARTED|Overall Study||1
3078480|NCT01367444|3800230|FG000|COMPLETED|Overall Study||4
3078481|NCT01367444|3800231|FG001|COMPLETED|Overall Study||4
3078482|NCT01367444|3800232|FG002|COMPLETED|Overall Study||4
3078483|NCT01367444|3800233|FG003|COMPLETED|Overall Study||4
3078484|NCT01367444|3800234|FG004|COMPLETED|Overall Study||6
3078485|NCT01367444|3800235|FG005|COMPLETED|Overall Study||4
3078486|NCT01367444|3800236|FG006|COMPLETED|Overall Study||1
3078487|NCT01367444|3800230|FG000|NOT COMPLETED|Overall Study||0
3078488|NCT01367444|3800231|FG001|NOT COMPLETED|Overall Study||0
3078489|NCT01367444|3800232|FG002|NOT COMPLETED|Overall Study||0
3078490|NCT01367444|3800233|FG003|NOT COMPLETED|Overall Study||0
3078491|NCT01367444|3800234|FG004|NOT COMPLETED|Overall Study||0
3078492|NCT01367444|3800235|FG005|NOT COMPLETED|Overall Study||0
3078493|NCT01367444|3800236|FG006|NOT COMPLETED|Overall Study||0
3078494|NCT01367457|3800255|FG000|STARTED|Overall Study||193
3078495|NCT01367457|3800256|FG001|STARTED|Overall Study||23
3078496|NCT01367457|3800257|FG002|STARTED|Overall Study||26
3078497|NCT01367457|3800255|FG000|COMPLETED|Overall Study||5
3078498|NCT01367457|3800256|FG001|COMPLETED|Overall Study||23
3078499|NCT01367457|3800257|FG002|COMPLETED|Overall Study||26
3078500|NCT01367457|3800255|FG000|NOT COMPLETED|Overall Study||188
3078501|NCT01367457|3800256|FG001|NOT COMPLETED|Overall Study||0
3078502|NCT01367457|3800257|FG002|NOT COMPLETED|Overall Study||0
3078503|NCT01367665|3800267|FG000|STARTED|Overall Study||1119
3078504|NCT01367665|3800268|FG001|STARTED|Overall Study||96
3078505|NCT01367665|3800267|FG000|COMPLETED|Overall Study||677
3078506|NCT01367665|3800268|FG001|COMPLETED|Overall Study||41
3078507|NCT01367665|3800267|FG000|NOT COMPLETED|Overall Study||442
3078508|NCT01367665|3800268|FG001|NOT COMPLETED|Overall Study||55
3078509|NCT01367704|3800277|FG000|STARTED|Overall Study||998
3078510|NCT01367704|3800278|FG001|STARTED|Overall Study||1008
3078511|NCT01367704|3800277|FG000|COMPLETED|Overall Study||951
3078512|NCT01367704|3800278|FG001|COMPLETED|Overall Study||847
3078513|NCT01367704|3800277|FG000|NOT COMPLETED|Overall Study||47
3078514|NCT01367704|3800278|FG001|NOT COMPLETED|Overall Study||161
3078515|NCT01367834|3800286|FG000|STARTED|Overall Study||11
3078516|NCT01367834|3800287|FG001|STARTED|Overall Study||6
3078517|NCT01367834|3800286|FG000|COMPLETED|Overall Study||9
3078518|NCT01367834|3800287|FG001|COMPLETED|Overall Study||3
3078519|NCT01367834|3800286|FG000|NOT COMPLETED|Overall Study||2
3078520|NCT01367834|3800287|FG001|NOT COMPLETED|Overall Study||3
3078521|NCT01367847|3800295|FG000|STARTED|Overall Study||10
3078522|NCT01367847|3800296|FG001|STARTED|Overall Study||9
3078523|NCT01367847|3800295|FG000|COMPLETED|Overall Study||8
3078524|NCT01367847|3800296|FG001|COMPLETED|Overall Study||7
3078525|NCT01367847|3800295|FG000|NOT COMPLETED|Overall Study||2
3078526|NCT01367847|3800296|FG001|NOT COMPLETED|Overall Study||2
3078527|NCT01367860|3800305|FG000|STARTED|Overall Study||20
3078528|NCT01367860|3800306|FG001|STARTED|Overall Study||20
3078529|NCT01367860|3800305|FG000|COMPLETED|Overall Study||20
3078530|NCT01367860|3800306|FG001|COMPLETED|Overall Study||20
3078531|NCT01367860|3800305|FG000|NOT COMPLETED|Overall Study||0
3078532|NCT01367860|3800306|FG001|NOT COMPLETED|Overall Study||0
3078533|NCT01367886|3800312|FG000|STARTED|Overall Study||21
3078534|NCT01367886|3800312|FG000|COMPLETED|Overall Study||14
3078535|NCT01367886|3800312|FG000|NOT COMPLETED|Overall Study||7
3078536|NCT01368042|3800317|FG000|STARTED|Overall Study||265
3078537|NCT01368042|3800317|FG000|COMPLETED|Overall Study||235
3078538|NCT01368042|3800317|FG000|NOT COMPLETED|Overall Study||30
3078539|NCT01368081|3800334|FG000|STARTED|Overall Study||136
3078540|NCT01368081|3800335|FG001|STARTED|Overall Study||137
3078541|NCT01368081|3800336|FG002|STARTED|Overall Study||63
3078542|NCT01368081|3800337|FG003|STARTED|Overall Study||68
3078543|NCT01368081|3800338|FG004|STARTED|Overall Study||65
3078544|NCT01368081|3800339|FG005|STARTED|Overall Study||137
3078545|NCT01368081|3800340|FG006|STARTED|Overall Study||136
3078546|NCT01368081|3800341|FG007|STARTED|Overall Study||69
3078547|NCT01368081|3800342|FG008|STARTED|Overall Study||70
3078548|NCT01368081|3800343|FG009|STARTED|Overall Study||68
3078549|NCT01368081|3800344|FG010|STARTED|Overall Study||71
3078550|NCT01368081|3800345|FG011|STARTED|Overall Study||70
3078551|NCT01368081|3800346|FG012|STARTED|Overall Study||70
3078552|NCT01368081|3800334|FG000|COMPLETED|Overall Study||126
3078553|NCT01368081|3800335|FG001|COMPLETED|Overall Study||128
3078554|NCT01368081|3800336|FG002|COMPLETED|Overall Study||59
3078555|NCT01368081|3800337|FG003|COMPLETED|Overall Study||63
3078556|NCT01368081|3800338|FG004|COMPLETED|Overall Study||63
3078557|NCT01368081|3800339|FG005|COMPLETED|Overall Study||127
3078558|NCT01368081|3800340|FG006|COMPLETED|Overall Study||124
3078559|NCT01368081|3800341|FG007|COMPLETED|Overall Study||62
3078560|NCT01368081|3800342|FG008|COMPLETED|Overall Study||62
3285140|NCT02770521|4018917|FG001|STARTED|Period Two||4
3285141|NCT02770521|4018918|FG002|STARTED|Period Two||2
3285142|NCT02770521|4018919|FG003|STARTED|Period Two||2
3285143|NCT02770521|4018920|FG004|STARTED|Period Two||2
3285144|NCT02770521|4018921|FG005|STARTED|Period Two||9
3285145|NCT02770521|4018916|FG000|Received Study Drug|Period Two||4
3285146|NCT02770521|4018917|FG001|Received Study Drug|Period Two||4
3285147|NCT02770521|4018918|FG002|Received Study Drug|Period Two||2
3285148|NCT02770521|4018919|FG003|Received Study Drug|Period Two||2
3285149|NCT02770521|4018920|FG004|Received Study Drug|Period Two||2
3285150|NCT02770521|4018921|FG005|Received Study Drug|Period Two||9
3285151|NCT02770521|4018916|FG000|COMPLETED|Period Two||4
3285152|NCT02770521|4018917|FG001|COMPLETED|Period Two||4
3285153|NCT02770521|4018918|FG002|COMPLETED|Period Two||2
3285154|NCT02770521|4018919|FG003|COMPLETED|Period Two||2
3285155|NCT02770521|4018920|FG004|COMPLETED|Period Two||2
3285156|NCT02770521|4018921|FG005|COMPLETED|Period Two||9
3285157|NCT02770521|4018916|FG000|NOT COMPLETED|Period Two||0
3285158|NCT02770521|4018917|FG001|NOT COMPLETED|Period Two||0
3285159|NCT02770521|4018918|FG002|NOT COMPLETED|Period Two||0
3285160|NCT02770521|4018919|FG003|NOT COMPLETED|Period Two||0
3285161|NCT02770521|4018920|FG004|NOT COMPLETED|Period Two||0
3285162|NCT02770521|4018921|FG005|NOT COMPLETED|Period Two||0
3285163|NCT02770521|4018916|FG000|STARTED|Period Three|Not applicable. Part A only had two periods.|0
3285164|NCT02770521|4018917|FG001|STARTED|Period Three|Not applicable. Part A only had two periods.|0
3285165|NCT02770521|4018918|FG002|STARTED|Period Three||2
3285166|NCT02770521|4018919|FG003|STARTED|Period Three||2
3285167|NCT02770521|4018920|FG004|STARTED|Period Three||2
3285168|NCT02770521|4018921|FG005|STARTED|Period Three||9
3285169|NCT02770521|4018916|FG000|Received Study Drug|Period Three||0
3285170|NCT02770521|4018917|FG001|Received Study Drug|Period Three||0
3285171|NCT02770521|4018918|FG002|Received Study Drug|Period Three||2
3285172|NCT02770521|4018919|FG003|Received Study Drug|Period Three||2
3285173|NCT02770521|4018920|FG004|Received Study Drug|Period Three||2
3285174|NCT02770521|4018921|FG005|Received Study Drug|Period Three||9
3285175|NCT02770521|4018916|FG000|COMPLETED|Period Three||0
3285176|NCT02770521|4018917|FG001|COMPLETED|Period Three||0
3285177|NCT02770521|4018918|FG002|COMPLETED|Period Three||2
3285178|NCT02770521|4018919|FG003|COMPLETED|Period Three||2
3285179|NCT02770521|4018920|FG004|COMPLETED|Period Three||2
3285180|NCT02770521|4018921|FG005|COMPLETED|Period Three||9
3285181|NCT02770521|4018916|FG000|NOT COMPLETED|Period Three||0
3285182|NCT02770521|4018917|FG001|NOT COMPLETED|Period Three||0
3285183|NCT02770521|4018918|FG002|NOT COMPLETED|Period Three||0
3285184|NCT02770521|4018919|FG003|NOT COMPLETED|Period Three||0
3285185|NCT02770521|4018920|FG004|NOT COMPLETED|Period Three||0
3285186|NCT02770521|4018921|FG005|NOT COMPLETED|Period Three||0
3285187|NCT02770547|4018941|FG000|STARTED|Overall Study||16
3285188|NCT02770547|4018942|FG001|STARTED|Overall Study||16
3285189|NCT02770547|4018941|FG000|COMPLETED|Overall Study||15
3285190|NCT02770547|4018942|FG001|COMPLETED|Overall Study||15
3285191|NCT02770547|4018941|FG000|NOT COMPLETED|Overall Study||1
3285192|NCT02770547|4018942|FG001|NOT COMPLETED|Overall Study||1
3285193|NCT02770612|4018948|FG000|STARTED|Overall Study||51
3285194|NCT02770612|4018948|FG000|COMPLETED|Overall Study||50
3285195|NCT02770612|4018948|FG000|NOT COMPLETED|Overall Study||1
3285196|NCT02770625|4018952|FG000|STARTED|Overall Study||8
3078561|NCT01368081|3800343|FG009|COMPLETED|Overall Study||58
3078562|NCT01368081|3800344|FG010|COMPLETED|Overall Study||62
3078563|NCT01368081|3800345|FG011|COMPLETED|Overall Study||67
3285197|NCT02770625|4018952|FG000|COMPLETED|Overall Study||8
3285198|NCT02770625|4018952|FG000|NOT COMPLETED|Overall Study||0
3285199|NCT02770820|4018956|FG000|STARTED|Overall Study||7
3285200|NCT02770820|4018956|FG000|COMPLETED|Overall Study||4
3285201|NCT02770820|4018956|FG000|NOT COMPLETED|Overall Study||3
3285202|NCT02770846|4018962|FG000|STARTED|Overall Study||25
3078564|NCT01368081|3800346|FG012|COMPLETED|Overall Study||63
3078565|NCT01368081|3800334|FG000|NOT COMPLETED|Overall Study||10
3078566|NCT01368081|3800335|FG001|NOT COMPLETED|Overall Study||9
3078567|NCT01368081|3800336|FG002|NOT COMPLETED|Overall Study||4
3078568|NCT01368081|3800337|FG003|NOT COMPLETED|Overall Study||5
3078569|NCT01368081|3800338|FG004|NOT COMPLETED|Overall Study||2
3078570|NCT01368081|3800339|FG005|NOT COMPLETED|Overall Study||10
3078571|NCT01368081|3800340|FG006|NOT COMPLETED|Overall Study||12
3078572|NCT01368081|3800341|FG007|NOT COMPLETED|Overall Study||7
3078573|NCT01368081|3800342|FG008|NOT COMPLETED|Overall Study||8
3078574|NCT01368081|3800343|FG009|NOT COMPLETED|Overall Study||10
3078575|NCT01368081|3800344|FG010|NOT COMPLETED|Overall Study||9
3078576|NCT01368081|3800345|FG011|NOT COMPLETED|Overall Study||3
3078577|NCT01368081|3800346|FG012|NOT COMPLETED|Overall Study||7
3078578|NCT01368211|3800376|FG000|STARTED|First Platelets Transfusion||8
3078579|NCT01368211|3800377|FG001|STARTED|First Platelets Transfusion||7
3078580|NCT01368211|3800376|FG000|COMPLETED|First Platelets Transfusion||8
3078581|NCT01368211|3800377|FG001|COMPLETED|First Platelets Transfusion||7
3078582|NCT01368211|3800376|FG000|NOT COMPLETED|First Platelets Transfusion||0
3078583|NCT01368211|3800377|FG001|NOT COMPLETED|First Platelets Transfusion||0
3078584|NCT01368211|3800376|FG000|STARTED|Second Platelets Transfusion||8
3078585|NCT01368211|3800377|FG001|STARTED|Second Platelets Transfusion||7
3078586|NCT01368211|3800376|FG000|COMPLETED|Second Platelets Transfusion||7
3078587|NCT01368211|3800377|FG001|COMPLETED|Second Platelets Transfusion||5
3078588|NCT01368211|3800376|FG000|NOT COMPLETED|Second Platelets Transfusion||1
3078589|NCT01368211|3800377|FG001|NOT COMPLETED|Second Platelets Transfusion||2
3078590|NCT01368263|3800386|FG000|STARTED|Overall Study||6
3078591|NCT01368263|3800387|FG001|STARTED|Overall Study||1
3078592|NCT01368263|3800388|FG002|STARTED|Overall Study||1
3078593|NCT01368263|3800386|FG000|COMPLETED|Overall Study||6
3078594|NCT01368263|3800387|FG001|COMPLETED|Overall Study||1
3078595|NCT01368263|3800388|FG002|COMPLETED|Overall Study||1
3078596|NCT01368263|3800386|FG000|NOT COMPLETED|Overall Study||0
3078597|NCT01368263|3800387|FG001|NOT COMPLETED|Overall Study||0
3078598|NCT01368263|3800388|FG002|NOT COMPLETED|Overall Study||0
3078599|NCT01368276|3800398|FG000|STARTED|Overall Study||3
3078600|NCT01368276|3800399|FG001|STARTED|Overall Study||28
3078601|NCT01368276|3800398|FG000|COMPLETED|Overall Study||2
3078602|NCT01368276|3800399|FG001|COMPLETED|Overall Study||18
3078603|NCT01368276|3800398|FG000|NOT COMPLETED|Overall Study||1
3078604|NCT01368276|3800399|FG001|NOT COMPLETED|Overall Study||10
3078605|NCT01368406|3800407|FG000|STARTED|Overall Study||81
3078606|NCT01368406|3800408|FG001|STARTED|Overall Study||79
3078607|NCT01368406|3800407|FG000|COMPLETED|Overall Study||60
3078608|NCT01368406|3800408|FG001|COMPLETED|Overall Study||66
3078609|NCT01368406|3800407|FG000|NOT COMPLETED|Overall Study||21
3078610|NCT01368406|3800408|FG001|NOT COMPLETED|Overall Study||13
3078611|NCT01368432|3800416|FG000|STARTED|Overall Study||6
3078612|NCT01368432|3800417|FG001|STARTED|Overall Study||8
3285203|NCT02770846|4018963|FG001|STARTED|Overall Study||25
3285204|NCT02770846|4018962|FG000|COMPLETED|Overall Study||25
3285205|NCT02770846|4018963|FG001|COMPLETED|Overall Study||25
3285206|NCT02770846|4018962|FG000|NOT COMPLETED|Overall Study||0
3285207|NCT02770846|4018963|FG001|NOT COMPLETED|Overall Study||0
3285208|NCT02771093|4018973|FG000|STARTED|Overall Study||13
3285209|NCT02771093|4018974|FG001|STARTED|Overall Study||14
3285210|NCT02771093|4018973|FG000|COMPLETED|Overall Study||13
3285211|NCT02771093|4018974|FG001|COMPLETED|Overall Study||14
3285212|NCT02771093|4018973|FG000|NOT COMPLETED|Overall Study||0
3285213|NCT02771093|4018974|FG001|NOT COMPLETED|Overall Study||0
3285214|NCT02771145|4018980|FG000|STARTED|Overall Study||90
3285215|NCT02771145|4018980|FG000|COMPLETED|Overall Study||86
3285216|NCT02771145|4018980|FG000|NOT COMPLETED|Overall Study||4
3285217|NCT02771210|4019002|FG000|STARTED|Period 1||102
3285218|NCT02771210|4019003|FG001|STARTED|Period 1||102
3285219|NCT02771210|4019002|FG000|COMPLETED|Period 1||91
3285220|NCT02771210|4019003|FG001|COMPLETED|Period 1||84
3285221|NCT02771210|4019002|FG000|NOT COMPLETED|Period 1||11
3285222|NCT02771210|4019003|FG001|NOT COMPLETED|Period 1||18
3285223|NCT02771210|4019002|FG000|STARTED|Period 2||91
3285224|NCT02771210|4019003|FG001|STARTED|Period 2||84
3285225|NCT02771210|4019002|FG000|COMPLETED|Period 2||89
3285226|NCT02771210|4019003|FG001|COMPLETED|Period 2||81
3285227|NCT02771210|4019002|FG000|NOT COMPLETED|Period 2||2
3285228|NCT02771210|4019003|FG001|NOT COMPLETED|Period 2||3
3285229|NCT02771275|4019009|FG000|STARTED|Overall Study||13
3285230|NCT02771275|4019009|FG000|COMPLETED|Overall Study||0
3285231|NCT02771275|4019009|FG000|NOT COMPLETED|Overall Study||13
3285232|NCT02771340|4019016|FG000|STARTED|Overall Study||2
3285233|NCT02771340|4019017|FG001|STARTED|Overall Study||3
3285234|NCT02771340|4019018|FG002|STARTED|Overall Study||5
3078613|NCT01368432|3800416|FG000|COMPLETED|Overall Study||6
3078614|NCT01368432|3800417|FG001|COMPLETED|Overall Study||7
3078615|NCT01368432|3800416|FG000|NOT COMPLETED|Overall Study||0
3078616|NCT01368432|3800417|FG001|NOT COMPLETED|Overall Study||1
3078617|NCT01368497|3800437|FG000|STARTED|Overall Study||60
3285235|NCT02771340|4019016|FG000|COMPLETED|Overall Study||2
3285236|NCT02771340|4019017|FG001|COMPLETED|Overall Study||3
3285237|NCT02771340|4019018|FG002|COMPLETED|Overall Study||5
3285238|NCT02771340|4019016|FG000|NOT COMPLETED|Overall Study||0
3285239|NCT02771340|4019017|FG001|NOT COMPLETED|Overall Study||0
3078618|NCT01368497|3800437|FG000|End of Treatment|Overall Study|Five discontinued study drugs early and completed the follow-up period per protocol.|60
3078619|NCT01368497|3800437|FG000|COMPLETED|Overall Study||58
3078620|NCT01368497|3800437|FG000|NOT COMPLETED|Overall Study||2
3078621|NCT01368536|3800444|FG000|STARTED|Overall Study||138
3078622|NCT01368536|3800445|FG001|STARTED|Overall Study||137
3078623|NCT01368536|3800446|FG002|STARTED|Overall Study||142
3078624|NCT01368536|3800444|FG000|Full Analysis Set|Overall Study||138
3078625|NCT01368536|3800445|FG001|Full Analysis Set|Overall Study||137
3078626|NCT01368536|3800446|FG002|Full Analysis Set|Overall Study|One patient was excluded from efficacy analysis as there was no post baseline data|141
3078627|NCT01368536|3800444|FG000|COMPLETED|Overall Study||87
3078628|NCT01368536|3800445|FG001|COMPLETED|Overall Study||78
3078629|NCT01368536|3800446|FG002|COMPLETED|Overall Study||83
3078630|NCT01368536|3800444|FG000|NOT COMPLETED|Overall Study||51
3078631|NCT01368536|3800445|FG001|NOT COMPLETED|Overall Study||59
3078632|NCT01368536|3800446|FG002|NOT COMPLETED|Overall Study||59
3078633|NCT01368562|3800455|FG000|STARTED|Overall Study||26
3078634|NCT01368562|3800455|FG000|Received at Least 1 Dose of Study Drug|Overall Study||25
3078635|NCT01368562|3800455|FG000|COMPLETED|Overall Study||7
3078636|NCT01368562|3800455|FG000|NOT COMPLETED|Overall Study||19
3078637|NCT01368614|3800459|FG000|STARTED|Screening Period||90
3078638|NCT01368614|3800460|FG001|STARTED|Screening Period||0
3078639|NCT01368614|3800461|FG002|STARTED|Screening Period||0
3078640|NCT01368614|3800462|FG003|STARTED|Screening Period||0
3078641|NCT01368614|3800459|FG000|COMPLETED|Screening Period||32
3078642|NCT01368614|3800460|FG001|COMPLETED|Screening Period||0
3078643|NCT01368614|3800461|FG002|COMPLETED|Screening Period||0
3078644|NCT01368614|3800462|FG003|COMPLETED|Screening Period||0
3078645|NCT01368614|3800459|FG000|NOT COMPLETED|Screening Period||58
3078646|NCT01368614|3800460|FG001|NOT COMPLETED|Screening Period||0
3078647|NCT01368614|3800461|FG002|NOT COMPLETED|Screening Period||0
3078648|NCT01368614|3800462|FG003|NOT COMPLETED|Screening Period||0
3078649|NCT01368614|3800459|FG000|STARTED|Study Period||0
3078650|NCT01368614|3800460|FG001|STARTED|Study Period||11
3078651|NCT01368614|3800461|FG002|STARTED|Study Period||10
3078652|NCT01368614|3800462|FG003|STARTED|Study Period||11
3078653|NCT01368614|3800459|FG000|COMPLETED|Study Period||0
3078654|NCT01368614|3800460|FG001|COMPLETED|Study Period||10
3078655|NCT01368614|3800461|FG002|COMPLETED|Study Period||8
3078656|NCT01368614|3800462|FG003|COMPLETED|Study Period||8
3078657|NCT01368614|3800459|FG000|NOT COMPLETED|Study Period||0
3078658|NCT01368614|3800460|FG001|NOT COMPLETED|Study Period||1
3078659|NCT01368614|3800461|FG002|NOT COMPLETED|Study Period||2
3078660|NCT01368614|3800462|FG003|NOT COMPLETED|Study Period||3
3078661|NCT01368653|3800472|FG000|STARTED|Overall Study||47
3078662|NCT01368653|3800473|FG001|STARTED|Overall Study||46
3078663|NCT01368653|3800472|FG000|Completed 4-week Follow-up|Overall Study||44
3078664|NCT01368653|3800473|FG001|Completed 4-week Follow-up|Overall Study||37
3078665|NCT01368653|3800472|FG000|Smoked in Past 7 Days at 4-weeks|Overall Study|The first 40 who smoked between weeks 3 and 4 post-quit were eligible for Phase 2 (VLNC vs. Advice)|29
3078666|NCT01368653|3800473|FG001|Smoked in Past 7 Days at 4-weeks|Overall Study|The first 40 who smoked between weeks 3 and 4 post-quit were eligible for Phase 2 (VLNC vs. Advice)|20
3078667|NCT01368653|3800472|FG000|Randomized to Phase 2|Overall Study|The first 40 who smoked between weeks 3 and 4 post-quit were eligible for Phase 2 (VLNC vs. Advice)|21
3078668|NCT01368653|3800473|FG001|Randomized to Phase 2|Overall Study|The first 40 who smoked between weeks 3 and 4 post-quit were eligible for Phase 2 (VLNC vs. Advice)|19
3078669|NCT01368653|3800472|FG000|Randomized to VLNC in Phase 2|Overall Study|VLNC=6-week supply of Very Low Nicotine Cigarettes plus Advice to Quit (vs. Advice Only)|11
3078670|NCT01368653|3800473|FG001|Randomized to VLNC in Phase 2|Overall Study|VLNC=6-week supply of Very Low Nicotine Cigarettes plus Advice to Quit (vs. Advice Only)|9
3078671|NCT01368653|3800472|FG000|Randomized to Advice Only in Phase 2|Overall Study||10
3078672|NCT01368653|3800473|FG001|Randomized to Advice Only in Phase 2|Overall Study||10
3078673|NCT01368653|3800472|FG000|COMPLETED|Overall Study||41
3078674|NCT01368653|3800473|FG001|COMPLETED|Overall Study||37
3078675|NCT01368653|3800472|FG000|NOT COMPLETED|Overall Study||6
3078676|NCT01368653|3800473|FG001|NOT COMPLETED|Overall Study||9
3078677|NCT01368809|3800486|FG000|STARTED|Overall Study||50
3078678|NCT01368809|3800487|FG001|STARTED|Overall Study||50
3078679|NCT01368809|3800486|FG000|COMPLETED|Overall Study||50
3078680|NCT01368809|3800487|FG001|COMPLETED|Overall Study||50
3078681|NCT01368809|3800486|FG000|NOT COMPLETED|Overall Study||0
3078682|NCT01368809|3800487|FG001|NOT COMPLETED|Overall Study||0
3078683|NCT01368835|3800495|FG000|STARTED|Overall Study|103 Subjects Enrolled|103
3078684|NCT01368835|3800495|FG000|COMPLETED|Overall Study||70
3078685|NCT01368835|3800495|FG000|NOT COMPLETED|Overall Study||33
3078686|NCT01368874|3800503|FG000|STARTED|Overall Study||34
3078687|NCT01368874|3800504|FG001|STARTED|Overall Study||5
3078688|NCT01368874|3800505|FG002|STARTED|Overall Study||25
3078689|NCT01368874|3800503|FG000|COMPLETED|Overall Study||31
3078690|NCT01368874|3800504|FG001|COMPLETED|Overall Study||5
3078691|NCT01368874|3800505|FG002|COMPLETED|Overall Study||24
3078692|NCT01368874|3800503|FG000|NOT COMPLETED|Overall Study||3
3078693|NCT01368874|3800504|FG001|NOT COMPLETED|Overall Study||0
3078694|NCT01368874|3800505|FG002|NOT COMPLETED|Overall Study||1
3078695|NCT01368900|3800547|FG000|STARTED|Overall Study||68
3078696|NCT01368900|3800547|FG000|COMPLETED|Overall Study||61
3078697|NCT01368900|3800547|FG000|NOT COMPLETED|Overall Study||7
3134692|NCT01701973|3859528|FG007|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
3078698|NCT01368965|3800553|FG000|STARTED|Overall Study|Two subjects withdrew consent prior to study treatment. Data analyses are based on 52 subjects.|52
3078699|NCT01368965|3800553|FG000|Subject Withdrawal Prior to Treatment|Overall Study||2
3078700|NCT01368965|3800553|FG000|COMPLETED|Overall Study||40
3078701|NCT01368965|3800553|FG000|NOT COMPLETED|Overall Study||12
3078702|NCT01369030|3800559|FG000|STARTED|Overall Study||594
3078703|NCT01369030|3800559|FG000|COMPLETED|Overall Study||554
3078704|NCT01369030|3800559|FG000|NOT COMPLETED|Overall Study||40
3078705|NCT01369069|3800565|FG000|STARTED|Overall Study||581
3078706|NCT01369069|3800566|FG001|STARTED|Overall Study||570
3078707|NCT01369069|3800565|FG000|COMPLETED|Overall Study||564
3078708|NCT01369069|3800566|FG001|COMPLETED|Overall Study||554
3078709|NCT01369069|3800565|FG000|NOT COMPLETED|Overall Study||17
3078710|NCT01369069|3800566|FG001|NOT COMPLETED|Overall Study||16
3078711|NCT01369108|3800572|FG000|STARTED|Overall Study|120 teeth|60
3078712|NCT01369108|3800572|FG000|COMPLETED|Overall Study||49
3078713|NCT01369108|3800572|FG000|NOT COMPLETED|Overall Study||11
3078714|NCT01369199|3800577|FG000|STARTED|Overall Study||28
3078715|NCT01369199|3800577|FG000|End of Treatment (EOT)|Overall Study|1 withdrew consent before treatment,1 missed end of treatment (EOT) visit but completed follow-up.|26
3078716|NCT01369199|3800577|FG000|COMPLETED|Overall Study||25
3078717|NCT01369199|3800577|FG000|NOT COMPLETED|Overall Study||3
3078718|NCT01369225|3800587|FG000|STARTED|Overall Study||6
3078719|NCT01369225|3800588|FG001|STARTED|Overall Study||3
3078720|NCT01369225|3800589|FG002|STARTED|Overall Study||12
3078721|NCT01369225|3800590|FG003|STARTED|Overall Study||10
3078722|NCT01369225|3800591|FG004|STARTED|Overall Study||12
3078723|NCT01369225|3800592|FG005|STARTED|Overall Study||9
3078724|NCT01369225|3800587|FG000|COMPLETED|Overall Study||4
3078725|NCT01369225|3800588|FG001|COMPLETED|Overall Study||3
3078726|NCT01369225|3800589|FG002|COMPLETED|Overall Study||9
3078727|NCT01369225|3800590|FG003|COMPLETED|Overall Study||8
3078728|NCT01369225|3800591|FG004|COMPLETED|Overall Study||10
3078729|NCT01369225|3800592|FG005|COMPLETED|Overall Study||9
3078730|NCT01369225|3800587|FG000|NOT COMPLETED|Overall Study||2
3078731|NCT01369225|3800588|FG001|NOT COMPLETED|Overall Study||0
3078732|NCT01369225|3800589|FG002|NOT COMPLETED|Overall Study||3
3078733|NCT01369225|3800590|FG003|NOT COMPLETED|Overall Study||2
3078734|NCT01369225|3800591|FG004|NOT COMPLETED|Overall Study||2
3078735|NCT01369225|3800592|FG005|NOT COMPLETED|Overall Study||0
3078736|NCT01369329|3800609|FG000|STARTED|Overall Study||256
3078737|NCT01369329|3800610|FG001|STARTED|Overall Study||254
3078738|NCT01369329|3800611|FG002|STARTED|Overall Study||259
3078739|NCT01369329|3800609|FG000|COMPLETED|Overall Study||244
3285240|NCT02771340|4019018|FG002|NOT COMPLETED|Overall Study||0
3285241|NCT02771366|4019028|FG000|STARTED|Period 1||15
3285242|NCT02771366|4019029|FG001|STARTED|Period 1||15
3285243|NCT02771366|4019028|FG000|COMPLETED|Period 1||15
3285244|NCT02771366|4019029|FG001|COMPLETED|Period 1||13
3285245|NCT02771366|4019028|FG000|NOT COMPLETED|Period 1||0
3285246|NCT02771366|4019029|FG001|NOT COMPLETED|Period 1||2
3285247|NCT02771366|4019028|FG000|STARTED|Period 2 (Crossover)||15
3285248|NCT02771366|4019029|FG001|STARTED|Period 2 (Crossover)||13
3285249|NCT02771366|4019028|FG000|COMPLETED|Period 2 (Crossover)||13
3285250|NCT02771366|4019029|FG001|COMPLETED|Period 2 (Crossover)||13
3285251|NCT02771366|4019028|FG000|NOT COMPLETED|Period 2 (Crossover)||2
3285252|NCT02771366|4019029|FG001|NOT COMPLETED|Period 2 (Crossover)||0
3285253|NCT02771522|4019036|FG000|STARTED|Overall Study|119 teeth imaged with the Calcivis System from 30 patients|30
3285254|NCT02771522|4019036|FG000|COMPLETED|Overall Study|87 teeth imaged with the Calcivis System fro 22 patients|22
3285255|NCT02771522|4019036|FG000|NOT COMPLETED|Overall Study||8
3285256|NCT02771574|4019050|FG000|STARTED|Lyo Avexitide Dose Level 1 (3 Days)||3
3285257|NCT02771574|4019051|FG001|STARTED|Lyo Avexitide Dose Level 1 (3 Days)||0
3285258|NCT02771574|4019052|FG002|STARTED|Lyo Avexitide Dose Level 1 (3 Days)||0
3285259|NCT02771574|4019053|FG003|STARTED|Lyo Avexitide Dose Level 1 (3 Days)||0
3285260|NCT02771574|4019054|FG004|STARTED|Lyo Avexitide Dose Level 1 (3 Days)||0
3285261|NCT02771574|4019050|FG000|COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||3
3285262|NCT02771574|4019051|FG001|COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||0
3285263|NCT02771574|4019052|FG002|COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||0
3285264|NCT02771574|4019053|FG003|COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||0
3285265|NCT02771574|4019054|FG004|COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||0
3285266|NCT02771574|4019050|FG000|NOT COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||0
3285267|NCT02771574|4019051|FG001|NOT COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||0
3285268|NCT02771574|4019052|FG002|NOT COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||0
3285269|NCT02771574|4019053|FG003|NOT COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||0
3285270|NCT02771574|4019054|FG004|NOT COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||0
3285271|NCT02771574|4019050|FG000|STARTED|Lyo Avexitide Dose Level 2 (3 Days)||0
3285272|NCT02771574|4019051|FG001|STARTED|Lyo Avexitide Dose Level 2 (3 Days)||5
3285273|NCT02771574|4019052|FG002|STARTED|Lyo Avexitide Dose Level 2 (3 Days)||0
3285274|NCT02771574|4019053|FG003|STARTED|Lyo Avexitide Dose Level 2 (3 Days)||0
3285275|NCT02771574|4019054|FG004|STARTED|Lyo Avexitide Dose Level 2 (3 Days)||0
3285276|NCT02771574|4019050|FG000|COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||0
3285277|NCT02771574|4019051|FG001|COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||5
3285278|NCT02771574|4019052|FG002|COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||0
3285279|NCT02771574|4019053|FG003|COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||0
3285280|NCT02771574|4019054|FG004|COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||0
3078740|NCT01369329|3800610|FG001|COMPLETED|Overall Study||243
3078741|NCT01369329|3800611|FG002|COMPLETED|Overall Study||245
3078742|NCT01369329|3800609|FG000|NOT COMPLETED|Overall Study||12
3078743|NCT01369329|3800610|FG001|NOT COMPLETED|Overall Study||11
3078744|NCT01369329|3800611|FG002|NOT COMPLETED|Overall Study||14
3078745|NCT01369342|3800622|FG000|STARTED|Overall Study||214
3078746|NCT01369342|3800623|FG001|STARTED|Overall Study||213
3078747|NCT01369342|3800624|FG002|STARTED|Overall Study||213
3078748|NCT01369342|3800622|FG000|COMPLETED|Overall Study||201
3078749|NCT01369342|3800623|FG001|COMPLETED|Overall Study||204
3078750|NCT01369342|3800624|FG002|COMPLETED|Overall Study||210
3078751|NCT01369342|3800622|FG000|NOT COMPLETED|Overall Study||13
3078752|NCT01369342|3800623|FG001|NOT COMPLETED|Overall Study||9
3078753|NCT01369342|3800624|FG002|NOT COMPLETED|Overall Study||3
3078754|NCT01369355|3800638|FG000|STARTED|Week 0 - Week 44 (Maintenance)||133
3078755|NCT01369355|3800639|FG001|STARTED|Week 0 - Week 44 (Maintenance)||132
3078756|NCT01369355|3800640|FG002|STARTED|Week 0 - Week 44 (Maintenance)||132
3078757|NCT01369355|3800641|FG003|STARTED|Week 0 - Week 44 (Maintenance)||123
3078758|NCT01369355|3800642|FG004|STARTED|Week 0 - Week 44 (Maintenance)||285
3078759|NCT01369355|3800643|FG005|STARTED|Week 0 - Week 44 (Maintenance)||476
3078760|NCT01369355|3800644|FG006|STARTED|Week 0 - Week 44 (Maintenance)||0
3078761|NCT01369355|3800645|FG007|STARTED|Week 0 - Week 44 (Maintenance)||0
3078762|NCT01369355|3800646|FG008|STARTED|Week 0 - Week 44 (Maintenance)||0
3078763|NCT01369355|3800638|FG000|COMPLETED|Week 0 - Week 44 (Maintenance)||102
3078764|NCT01369355|3800639|FG001|COMPLETED|Week 0 - Week 44 (Maintenance)||103
3078765|NCT01369355|3800640|FG002|COMPLETED|Week 0 - Week 44 (Maintenance)||101
3078766|NCT01369355|3800641|FG003|COMPLETED|Week 0 - Week 44 (Maintenance)||93
3078767|NCT01369355|3800642|FG004|COMPLETED|Week 0 - Week 44 (Maintenance)||131
3078768|NCT01369355|3800643|FG005|COMPLETED|Week 0 - Week 44 (Maintenance)||204
3078769|NCT01369355|3800644|FG006|COMPLETED|Week 0 - Week 44 (Maintenance)||0
3078770|NCT01369355|3800645|FG007|COMPLETED|Week 0 - Week 44 (Maintenance)||0
3078771|NCT01369355|3800646|FG008|COMPLETED|Week 0 - Week 44 (Maintenance)||0
3078772|NCT01369355|3800638|FG000|NOT COMPLETED|Week 0 - Week 44 (Maintenance)||31
3078773|NCT01369355|3800639|FG001|NOT COMPLETED|Week 0 - Week 44 (Maintenance)||29
3078774|NCT01369355|3800640|FG002|NOT COMPLETED|Week 0 - Week 44 (Maintenance)||31
3078775|NCT01369355|3800641|FG003|NOT COMPLETED|Week 0 - Week 44 (Maintenance)||30
3078776|NCT01369355|3800642|FG004|NOT COMPLETED|Week 0 - Week 44 (Maintenance)||154
3078777|NCT01369355|3800643|FG005|NOT COMPLETED|Week 0 - Week 44 (Maintenance)||272
3078778|NCT01369355|3800644|FG006|NOT COMPLETED|Week 0 - Week 44 (Maintenance)||0
3078779|NCT01369355|3800645|FG007|NOT COMPLETED|Week 0 - Week 44 (Maintenance)||0
3078780|NCT01369355|3800646|FG008|NOT COMPLETED|Week 0 - Week 44 (Maintenance)||0
3078781|NCT01369355|3800638|FG000|STARTED|Long-term Extension (Week 44-272)||0
3078782|NCT01369355|3800639|FG001|STARTED|Long-term Extension (Week 44-272)||0
3078783|NCT01369355|3800640|FG002|STARTED|Long-term Extension (Week 44-272)||0
3078784|NCT01369355|3800641|FG003|STARTED|Long-term Extension (Week 44-272)||0
3078785|NCT01369355|3800642|FG004|STARTED|Long-term Extension (Week 44-272)||0
3078786|NCT01369355|3800643|FG005|STARTED|Long-term Extension (Week 44-272)||0
3078787|NCT01369355|3800644|FG006|STARTED|Long-term Extension (Week 44-272)||151
3078788|NCT01369355|3800645|FG007|STARTED|Long-term Extension (Week 44-272)||213
3078789|NCT01369355|3800646|FG008|STARTED|Long-term Extension (Week 44-272)||354
3078790|NCT01369355|3800638|FG000|COMPLETED|Long-term Extension (Week 44-272)||0
3078791|NCT01369355|3800639|FG001|COMPLETED|Long-term Extension (Week 44-272)||0
3078792|NCT01369355|3800640|FG002|COMPLETED|Long-term Extension (Week 44-272)||0
3078793|NCT01369355|3800641|FG003|COMPLETED|Long-term Extension (Week 44-272)||0
3078794|NCT01369355|3800642|FG004|COMPLETED|Long-term Extension (Week 44-272)||0
3078795|NCT01369355|3800643|FG005|COMPLETED|Long-term Extension (Week 44-272)||0
3078796|NCT01369355|3800644|FG006|COMPLETED|Long-term Extension (Week 44-272)||0
3078797|NCT01369355|3800645|FG007|COMPLETED|Long-term Extension (Week 44-272)||107
3078798|NCT01369355|3800646|FG008|COMPLETED|Long-term Extension (Week 44-272)||183
3078799|NCT01369355|3800638|FG000|NOT COMPLETED|Long-term Extension (Week 44-272)||0
3078800|NCT01369355|3800639|FG001|NOT COMPLETED|Long-term Extension (Week 44-272)||0
3078801|NCT01369355|3800640|FG002|NOT COMPLETED|Long-term Extension (Week 44-272)||0
3078802|NCT01369355|3800641|FG003|NOT COMPLETED|Long-term Extension (Week 44-272)||0
3078803|NCT01369355|3800642|FG004|NOT COMPLETED|Long-term Extension (Week 44-272)||0
3078804|NCT01369355|3800643|FG005|NOT COMPLETED|Long-term Extension (Week 44-272)||0
3078805|NCT01369355|3800644|FG006|NOT COMPLETED|Long-term Extension (Week 44-272)||151
3078806|NCT01369355|3800645|FG007|NOT COMPLETED|Long-term Extension (Week 44-272)||106
3078807|NCT01369355|3800646|FG008|NOT COMPLETED|Long-term Extension (Week 44-272)||171
3078808|NCT01369433|3800665|FG000|STARTED|Overall Study||209
3078809|NCT01369433|3800666|FG001|STARTED|Overall Study||16
3078810|NCT01369433|3800665|FG000|COMPLETED|Overall Study||0
3078811|NCT01369433|3800666|FG001|COMPLETED|Overall Study||0
3078812|NCT01369433|3800665|FG000|NOT COMPLETED|Overall Study||209
3078813|NCT01369433|3800666|FG001|NOT COMPLETED|Overall Study||16
3078814|NCT01369485|3800674|FG000|STARTED|Randomized Phase (Day 0 to Week 12)||80
3078815|NCT01369485|3800675|FG001|STARTED|Randomized Phase (Day 0 to Week 12)||83
3078816|NCT01369485|3800674|FG000|COMPLETED|Randomized Phase (Day 0 to Week 12)||57
3078817|NCT01369485|3800675|FG001|COMPLETED|Randomized Phase (Day 0 to Week 12)||66
3078818|NCT01369485|3800674|FG000|NOT COMPLETED|Randomized Phase (Day 0 to Week 12)||23
3078819|NCT01369485|3800675|FG001|NOT COMPLETED|Randomized Phase (Day 0 to Week 12)||17
3078820|NCT01369485|3800674|FG000|STARTED|Open Label Phase (Week 12 to Month 12)||57
3078821|NCT01369485|3800675|FG001|STARTED|Open Label Phase (Week 12 to Month 12)||66
3078822|NCT01369485|3800674|FG000|COMPLETED|Open Label Phase (Week 12 to Month 12)||24
3078823|NCT01369485|3800675|FG001|COMPLETED|Open Label Phase (Week 12 to Month 12)||26
3078824|NCT01369485|3800674|FG000|NOT COMPLETED|Open Label Phase (Week 12 to Month 12)||33
3078825|NCT01369485|3800675|FG001|NOT COMPLETED|Open Label Phase (Week 12 to Month 12)||40
3078826|NCT01369498|3800693|FG000|STARTED|Overall Study||12
3078827|NCT01369498|3800694|FG001|STARTED|Overall Study||12
3078828|NCT01369498|3800695|FG002|STARTED|Overall Study||15
3078829|NCT01369498|3800696|FG003|STARTED|Overall Study||15
3078830|NCT01369498|3800693|FG000|COMPLETED|Overall Study||0
3078831|NCT01369498|3800694|FG001|COMPLETED|Overall Study||0
3078832|NCT01369498|3800695|FG002|COMPLETED|Overall Study||0
3078833|NCT01369498|3800696|FG003|COMPLETED|Overall Study||0
3078834|NCT01369498|3800693|FG000|NOT COMPLETED|Overall Study||12
3078835|NCT01369498|3800694|FG001|NOT COMPLETED|Overall Study||12
3078836|NCT01369498|3800695|FG002|NOT COMPLETED|Overall Study||15
3078837|NCT01369498|3800696|FG003|NOT COMPLETED|Overall Study||15
3285281|NCT02771574|4019050|FG000|NOT COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||0
3285282|NCT02771574|4019051|FG001|NOT COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||0
3285283|NCT02771574|4019052|FG002|NOT COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||0
3285284|NCT02771574|4019053|FG003|NOT COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||0
3285285|NCT02771574|4019054|FG004|NOT COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||0
3285286|NCT02771574|4019050|FG000|STARTED|Lyo Avexitide Dose Level 3 (3 Days)||0
3285287|NCT02771574|4019051|FG001|STARTED|Lyo Avexitide Dose Level 3 (3 Days)||0
3285288|NCT02771574|4019052|FG002|STARTED|Lyo Avexitide Dose Level 3 (3 Days)||3
3285289|NCT02771574|4019053|FG003|STARTED|Lyo Avexitide Dose Level 3 (3 Days)||0
3285290|NCT02771574|4019054|FG004|STARTED|Lyo Avexitide Dose Level 3 (3 Days)||0
3285291|NCT02771574|4019050|FG000|COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||0
3285292|NCT02771574|4019051|FG001|COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||0
3285293|NCT02771574|4019052|FG002|COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||3
3285294|NCT02771574|4019053|FG003|COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||0
3285295|NCT02771574|4019054|FG004|COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||0
3285296|NCT02771574|4019050|FG000|NOT COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||0
3285297|NCT02771574|4019051|FG001|NOT COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||0
3285298|NCT02771574|4019052|FG002|NOT COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||0
3285299|NCT02771574|4019053|FG003|NOT COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||0
3285300|NCT02771574|4019054|FG004|NOT COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||0
3285301|NCT02771574|4019050|FG000|STARTED|Lyo Avexitide Dose Level 4 (3 Days)||0
3285302|NCT02771574|4019051|FG001|STARTED|Lyo Avexitide Dose Level 4 (3 Days)||0
3285303|NCT02771574|4019052|FG002|STARTED|Lyo Avexitide Dose Level 4 (3 Days)||0
3285304|NCT02771574|4019053|FG003|STARTED|Lyo Avexitide Dose Level 4 (3 Days)||3
3285305|NCT02771574|4019054|FG004|STARTED|Lyo Avexitide Dose Level 4 (3 Days)||0
3285306|NCT02771574|4019050|FG000|COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||0
3285307|NCT02771574|4019051|FG001|COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||0
3285308|NCT02771574|4019052|FG002|COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||0
3285309|NCT02771574|4019053|FG003|COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||3
3285310|NCT02771574|4019054|FG004|COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||0
3285311|NCT02771574|4019050|FG000|NOT COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||0
3285312|NCT02771574|4019051|FG001|NOT COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||0
3285313|NCT02771574|4019052|FG002|NOT COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||0
3285314|NCT02771574|4019053|FG003|NOT COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||0
3285315|NCT02771574|4019054|FG004|NOT COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||0
3285316|NCT02771574|4019050|FG000|STARTED|Liq Avexitide (3 Days)||0
3285317|NCT02771574|4019051|FG001|STARTED|Liq Avexitide (3 Days)||0
3285318|NCT02771574|4019052|FG002|STARTED|Liq Avexitide (3 Days)||0
3285319|NCT02771574|4019053|FG003|STARTED|Liq Avexitide (3 Days)||0
3285320|NCT02771574|4019054|FG004|STARTED|Liq Avexitide (3 Days)||5
3285321|NCT02771574|4019050|FG000|COMPLETED|Liq Avexitide (3 Days)||0
3285322|NCT02771574|4019051|FG001|COMPLETED|Liq Avexitide (3 Days)||0
3285323|NCT02771574|4019052|FG002|COMPLETED|Liq Avexitide (3 Days)||0
3285324|NCT02771574|4019053|FG003|COMPLETED|Liq Avexitide (3 Days)||0
3285325|NCT02771574|4019054|FG004|COMPLETED|Liq Avexitide (3 Days)||5
3285326|NCT02771574|4019050|FG000|NOT COMPLETED|Liq Avexitide (3 Days)||0
3285327|NCT02771574|4019051|FG001|NOT COMPLETED|Liq Avexitide (3 Days)||0
3285328|NCT02771574|4019052|FG002|NOT COMPLETED|Liq Avexitide (3 Days)||0
3285329|NCT02771574|4019053|FG003|NOT COMPLETED|Liq Avexitide (3 Days)||0
3285330|NCT02771574|4019054|FG004|NOT COMPLETED|Liq Avexitide (3 Days)||0
3285331|NCT02771990|4019071|FG000|STARTED|Overall Study||11
3285332|NCT02771990|4019072|FG001|STARTED|Overall Study||10
3285333|NCT02771990|4019071|FG000|COMPLETED|Overall Study||11
3285334|NCT02771990|4019072|FG001|COMPLETED|Overall Study||10
3285335|NCT02771990|4019071|FG000|NOT COMPLETED|Overall Study||0
3285336|NCT02771990|4019072|FG001|NOT COMPLETED|Overall Study||0
3285337|NCT02772302|4019080|FG000|STARTED|Overall Study||10
3285338|NCT02772302|4019081|FG001|STARTED|Overall Study||10
3285339|NCT02772302|4019080|FG000|COMPLETED|Overall Study||10
3285340|NCT02772302|4019081|FG001|COMPLETED|Overall Study||10
3285341|NCT02772302|4019080|FG000|NOT COMPLETED|Overall Study||0
3078838|NCT01369511|3800711|FG000|STARTED|Overall Study||98
3078839|NCT01369511|3800712|FG001|STARTED|Overall Study||104
3078840|NCT01369511|3800713|FG002|STARTED|Overall Study||98
3078841|NCT01369511|3800714|FG003|STARTED|Overall Study||100
3078842|NCT01369511|3800711|FG000|Received at Least 1 Dose of Study Drug|Overall Study||98
3078843|NCT01369511|3800712|FG001|Received at Least 1 Dose of Study Drug|Overall Study|One participant was a screen failure and inadvertently randomized but did not receive study drug.|103
3078844|NCT01369511|3800713|FG002|Received at Least 1 Dose of Study Drug|Overall Study||98
3078845|NCT01369511|3800714|FG003|Received at Least 1 Dose of Study Drug|Overall Study||100
3078846|NCT01369511|3800711|FG000|COMPLETED|Overall Study||85
3078847|NCT01369511|3800712|FG001|COMPLETED|Overall Study||91
3078848|NCT01369511|3800713|FG002|COMPLETED|Overall Study||87
3078849|NCT01369511|3800714|FG003|COMPLETED|Overall Study||89
3078850|NCT01369511|3800711|FG000|NOT COMPLETED|Overall Study||13
3078851|NCT01369511|3800712|FG001|NOT COMPLETED|Overall Study||13
3078852|NCT01369511|3800713|FG002|NOT COMPLETED|Overall Study||11
3078853|NCT01369511|3800714|FG003|NOT COMPLETED|Overall Study||11
3078854|NCT01369615|3800726|FG000|STARTED|Overall Study||9
3078855|NCT01369615|3800727|FG001|STARTED|Overall Study||14
3078856|NCT01369615|3800726|FG000|COMPLETED|Overall Study||9
3078857|NCT01369615|3800727|FG001|COMPLETED|Overall Study||12
3078858|NCT01369615|3800726|FG000|NOT COMPLETED|Overall Study||0
3078859|NCT01369615|3800727|FG001|NOT COMPLETED|Overall Study||2
3078860|NCT01369680|3800737|FG000|STARTED|Overall Study||3
3078861|NCT01369680|3800738|FG001|STARTED|Overall Study||3
3078862|NCT01369680|3800739|FG002|STARTED|Overall Study||3
3078863|NCT01369680|3800740|FG003|STARTED|Overall Study||3
3078864|NCT01369680|3800737|FG000|COMPLETED|Overall Study||3
3078865|NCT01369680|3800738|FG001|COMPLETED|Overall Study||3
3078866|NCT01369680|3800739|FG002|COMPLETED|Overall Study||2
3078867|NCT01369680|3800740|FG003|COMPLETED|Overall Study||1
3078868|NCT01369680|3800737|FG000|NOT COMPLETED|Overall Study||0
3078869|NCT01369680|3800738|FG001|NOT COMPLETED|Overall Study||0
3078870|NCT01369680|3800739|FG002|NOT COMPLETED|Overall Study||1
3078871|NCT01369680|3800740|FG003|NOT COMPLETED|Overall Study||2
3078872|NCT01369706|3800761|FG000|STARTED|Overall Study||388
3078873|NCT01369706|3800761|FG000|COMPLETED|Overall Study||388
3078874|NCT01369706|3800761|FG000|NOT COMPLETED|Overall Study||0
3078875|NCT01369732|3800767|FG000|STARTED|Overall Study||33
3078876|NCT01369732|3800768|FG001|STARTED|Overall Study||33
3078877|NCT01369732|3800767|FG000|COMPLETED|Overall Study||29
3078878|NCT01369732|3800768|FG001|COMPLETED|Overall Study||31
3078879|NCT01369732|3800767|FG000|NOT COMPLETED|Overall Study||4
3078880|NCT01369732|3800768|FG001|NOT COMPLETED|Overall Study||2
3078881|NCT01369745|3800779|FG000|STARTED|Overall Study||32
3078882|NCT01369745|3800780|FG001|STARTED|Overall Study||41
3078883|NCT01369745|3800781|FG002|STARTED|Overall Study||18
3078884|NCT01369745|3800782|FG003|STARTED|Overall Study||84
3078885|NCT01369745|3800783|FG004|STARTED|Overall Study||83
3078886|NCT01369745|3800779|FG000|COMPLETED|Overall Study||25
3078887|NCT01369745|3800780|FG001|COMPLETED|Overall Study||28
3078888|NCT01369745|3800781|FG002|COMPLETED|Overall Study||16
3078889|NCT01369745|3800782|FG003|COMPLETED|Overall Study||64
3078890|NCT01369745|3800783|FG004|COMPLETED|Overall Study||65
3078891|NCT01369745|3800779|FG000|NOT COMPLETED|Overall Study||7
3078892|NCT01369745|3800780|FG001|NOT COMPLETED|Overall Study||13
3078893|NCT01369745|3800781|FG002|NOT COMPLETED|Overall Study||2
3078894|NCT01369745|3800782|FG003|NOT COMPLETED|Overall Study||20
3078895|NCT01369745|3800783|FG004|NOT COMPLETED|Overall Study||18
3078896|NCT01369758|3800795|FG000|STARTED|Overall Study||290
3078897|NCT01369758|3800795|FG000|COMPLETED|Overall Study||290
3078898|NCT01369758|3800795|FG000|NOT COMPLETED|Overall Study||0
3078899|NCT01369784|3800799|FG000|STARTED|Overall Study||158
3078900|NCT01369784|3800799|FG000|COMPLETED|Overall Study||146
3078901|NCT01369784|3800799|FG000|NOT COMPLETED|Overall Study||12
3078902|NCT01369849|3800806|FG000|STARTED|Overall Study||6
3078903|NCT01369849|3800807|FG001|STARTED|Overall Study||4
3078904|NCT01369849|3800808|FG002|STARTED|Overall Study||5
3078905|NCT01369849|3800806|FG000|COMPLETED|Overall Study||6
3078906|NCT01369849|3800807|FG001|COMPLETED|Overall Study||3
3078907|NCT01369849|3800808|FG002|COMPLETED|Overall Study||4
3078908|NCT01369849|3800806|FG000|NOT COMPLETED|Overall Study||0
3078909|NCT01369849|3800807|FG001|NOT COMPLETED|Overall Study||1
3078910|NCT01369849|3800808|FG002|NOT COMPLETED|Overall Study||1
3078911|NCT01369875|3800820|FG000|STARTED|Overall Study||1
3078912|NCT01369875|3800821|FG001|STARTED|Overall Study||1
3078913|NCT01369875|3800820|FG000|COMPLETED|Overall Study||1
3078914|NCT01369875|3800821|FG001|COMPLETED|Overall Study||1
3078915|NCT01369875|3800820|FG000|NOT COMPLETED|Overall Study||0
3078916|NCT01369875|3800821|FG001|NOT COMPLETED|Overall Study||0
3078917|NCT01369888|3800831|FG000|STARTED|Overall Study||1
3078918|NCT01369888|3800832|FG001|STARTED|Overall Study||2
3078919|NCT01369888|3800833|FG002|STARTED|Overall Study||0
3078920|NCT01369888|3800834|FG003|STARTED|Overall Study||0
3078921|NCT01369888|3800831|FG000|COMPLETED|Overall Study||1
3078922|NCT01369888|3800832|FG001|COMPLETED|Overall Study||2
3078923|NCT01369888|3800833|FG002|COMPLETED|Overall Study||0
3078924|NCT01369888|3800834|FG003|COMPLETED|Overall Study||0
3078925|NCT01369888|3800831|FG000|NOT COMPLETED|Overall Study||0
3078926|NCT01369888|3800832|FG001|NOT COMPLETED|Overall Study||0
3078927|NCT01369888|3800833|FG002|NOT COMPLETED|Overall Study||0
3078928|NCT01369888|3800834|FG003|NOT COMPLETED|Overall Study||0
3078929|NCT01370005|3800843|FG000|STARTED|Overall Study||272
3078930|NCT01370005|3800844|FG001|STARTED|Overall Study||276
3078931|NCT01370005|3800845|FG002|STARTED|Overall Study||277
3078932|NCT01370005|3800843|FG000|COMPLETED|Overall Study||256
3078933|NCT01370005|3800844|FG001|COMPLETED|Overall Study||265
3078934|NCT01370005|3800845|FG002|COMPLETED|Overall Study||266
3078935|NCT01370005|3800843|FG000|NOT COMPLETED|Overall Study||16
3078936|NCT01370005|3800844|FG001|NOT COMPLETED|Overall Study||11
3078937|NCT01370005|3800845|FG002|NOT COMPLETED|Overall Study||11
3078938|NCT01370018|3800853|FG000|STARTED|Overall Study||4
3078939|NCT01370018|3800853|FG000|COMPLETED|Overall Study||3
3078940|NCT01370018|3800853|FG000|NOT COMPLETED|Overall Study||1
3078941|NCT01370083|3800859|FG000|STARTED|Overall Study||7
3078942|NCT01370083|3800860|FG001|STARTED|Overall Study||7
3078943|NCT01370083|3800859|FG000|COMPLETED|Overall Study||5
3078944|NCT01370083|3800860|FG001|COMPLETED|Overall Study||6
3078945|NCT01370083|3800859|FG000|NOT COMPLETED|Overall Study||2
3078946|NCT01370083|3800860|FG001|NOT COMPLETED|Overall Study||1
3134693|NCT01701999|3859570|FG000|STARTED|Overall Study||8
3134694|NCT01701999|3859571|FG001|STARTED|Overall Study||37
3134695|NCT01701999|3859570|FG000|COMPLETED|Overall Study||8
3134696|NCT01701999|3859571|FG001|COMPLETED|Overall Study||37
3134697|NCT01701999|3859570|FG000|NOT COMPLETED|Overall Study||0
3134698|NCT01701999|3859571|FG001|NOT COMPLETED|Overall Study||0
3134699|NCT01702025|3859581|FG000|STARTED|Overall Study||11
3134700|NCT01702025|3859582|FG001|STARTED|Overall Study||10
3285342|NCT02772302|4019081|FG001|NOT COMPLETED|Overall Study||0
3285343|NCT02772432|4019089|FG000|STARTED|Overall Study||31
3285344|NCT02772432|4019090|FG001|STARTED|Overall Study||22
3285345|NCT02772432|4019089|FG000|COMPLETED|Overall Study||19
3285346|NCT02772432|4019090|FG001|COMPLETED|Overall Study||21
3285347|NCT02772432|4019089|FG000|NOT COMPLETED|Overall Study||12
3285348|NCT02772432|4019090|FG001|NOT COMPLETED|Overall Study||1
3285349|NCT02772666|4019096|FG000|STARTED|O-Glas Then SFT||44
3285350|NCT02772666|4019096|FG000|COMPLETED|O-Glas Then SFT||44
3285351|NCT02772666|4019096|FG000|NOT COMPLETED|O-Glas Then SFT||0
3285352|NCT02772666|4019096|FG000|STARTED|SFT Then O-Glass||44
3285353|NCT02772666|4019096|FG000|COMPLETED|SFT Then O-Glass||44
3285354|NCT02772666|4019096|FG000|NOT COMPLETED|SFT Then O-Glass||0
3285355|NCT02772757|4019104|FG000|STARTED|Overall Study||22
3285356|NCT02772757|4019105|FG001|STARTED|Overall Study||24
3285357|NCT02772757|4019106|FG002|STARTED|Overall Study||26
3285358|NCT02772757|4019104|FG000|COMPLETED|Overall Study||21
3285359|NCT02772757|4019105|FG001|COMPLETED|Overall Study||21
3285360|NCT02772757|4019106|FG002|COMPLETED|Overall Study||21
3285361|NCT02772757|4019104|FG000|NOT COMPLETED|Overall Study||1
3285362|NCT02772757|4019105|FG001|NOT COMPLETED|Overall Study||3
3285363|NCT02772757|4019106|FG002|NOT COMPLETED|Overall Study||5
3285364|NCT02772783|4019115|FG000|STARTED|Experimental Condition 1, 1 Day||8
3285365|NCT02772783|4019116|FG001|STARTED|Experimental Condition 1, 1 Day||7
3285366|NCT02772783|4019115|FG000|COMPLETED|Experimental Condition 1, 1 Day||8
3285367|NCT02772783|4019116|FG001|COMPLETED|Experimental Condition 1, 1 Day||7
3285368|NCT02772783|4019115|FG000|NOT COMPLETED|Experimental Condition 1, 1 Day||0
3285369|NCT02772783|4019116|FG001|NOT COMPLETED|Experimental Condition 1, 1 Day||0
3285370|NCT02772783|4019115|FG000|STARTED|Wash-out, 1 Week||8
3285371|NCT02772783|4019116|FG001|STARTED|Wash-out, 1 Week||7
3285372|NCT02772783|4019115|FG000|COMPLETED|Wash-out, 1 Week||8
3285373|NCT02772783|4019116|FG001|COMPLETED|Wash-out, 1 Week||7
3285374|NCT02772783|4019115|FG000|NOT COMPLETED|Wash-out, 1 Week||0
3285375|NCT02772783|4019116|FG001|NOT COMPLETED|Wash-out, 1 Week||0
3285376|NCT02772783|4019115|FG000|STARTED|Comparison Condition, 1 Day||8
3285377|NCT02772783|4019116|FG001|STARTED|Comparison Condition, 1 Day||7
3285378|NCT02772783|4019115|FG000|COMPLETED|Comparison Condition, 1 Day||8
3285379|NCT02772783|4019116|FG001|COMPLETED|Comparison Condition, 1 Day||7
3285380|NCT02772783|4019115|FG000|NOT COMPLETED|Comparison Condition, 1 Day||0
3285381|NCT02772783|4019116|FG001|NOT COMPLETED|Comparison Condition, 1 Day||0
3285382|NCT02772783|4019115|FG000|STARTED|Wash-out, 1 Week||8
3285383|NCT02772783|4019116|FG001|STARTED|Wash-out, 1 Week||7
3285384|NCT02772783|4019115|FG000|COMPLETED|Wash-out, 1 Week||8
3285385|NCT02772783|4019116|FG001|COMPLETED|Wash-out, 1 Week||7
3285386|NCT02772783|4019115|FG000|NOT COMPLETED|Wash-out, 1 Week||0
3285387|NCT02772783|4019116|FG001|NOT COMPLETED|Wash-out, 1 Week||0
3285388|NCT02772783|4019115|FG000|STARTED|Experimental Condition 2, 1 Day||8
3285389|NCT02772783|4019116|FG001|STARTED|Experimental Condition 2, 1 Day||7
3285390|NCT02772783|4019115|FG000|COMPLETED|Experimental Condition 2, 1 Day||8
3285391|NCT02772783|4019116|FG001|COMPLETED|Experimental Condition 2, 1 Day||7
3285392|NCT02772783|4019115|FG000|NOT COMPLETED|Experimental Condition 2, 1 Day||0
3285393|NCT02772783|4019116|FG001|NOT COMPLETED|Experimental Condition 2, 1 Day||0
3285394|NCT02772809|4019124|FG000|STARTED|Overall Study||23
3285395|NCT02772809|4019124|FG000|COMPLETED|Overall Study||17
3285396|NCT02772809|4019124|FG000|NOT COMPLETED|Overall Study||6
3134701|NCT01702025|3859583|FG002|STARTED|Overall Study||10
3134702|NCT01702025|3859584|FG003|STARTED|Overall Study||10
3134703|NCT01702025|3859581|FG000|COMPLETED|Overall Study||9
3134704|NCT01702025|3859582|FG001|COMPLETED|Overall Study||9
3134705|NCT01702025|3859583|FG002|COMPLETED|Overall Study||9
3134706|NCT01702025|3859584|FG003|COMPLETED|Overall Study||10
3134707|NCT01702025|3859581|FG000|NOT COMPLETED|Overall Study||2
3134708|NCT01702025|3859582|FG001|NOT COMPLETED|Overall Study||1
3285397|NCT02772978|4019133|FG000|STARTED|Overall Study|First participant enrolled|10
3285398|NCT02772978|4019134|FG001|STARTED|Overall Study||9
3285399|NCT02772978|4019133|FG000|COMPLETED|Overall Study|Last participant enrolled|9
3285400|NCT02772978|4019134|FG001|COMPLETED|Overall Study||8
3078947|NCT01370174|3800870|FG000|STARTED|Overall Study||25
3078948|NCT01370174|3800871|FG001|STARTED|Overall Study||26
3078949|NCT01370174|3800872|FG002|STARTED|Overall Study||25
3078950|NCT01370174|3800873|FG003|STARTED|Overall Study||26
3078951|NCT01370174|3800870|FG000|COMPLETED|Overall Study||18
3078952|NCT01370174|3800871|FG001|COMPLETED|Overall Study||15
3078953|NCT01370174|3800872|FG002|COMPLETED|Overall Study||13
3078954|NCT01370174|3800873|FG003|COMPLETED|Overall Study||17
3078955|NCT01370174|3800870|FG000|NOT COMPLETED|Overall Study||7
3078956|NCT01370174|3800871|FG001|NOT COMPLETED|Overall Study||11
3078957|NCT01370174|3800872|FG002|NOT COMPLETED|Overall Study||12
3078958|NCT01370174|3800873|FG003|NOT COMPLETED|Overall Study||9
3078959|NCT01370213|3800886|FG000|STARTED|Overall Study||7
3078960|NCT01370213|3800887|FG001|STARTED|Overall Study||17
3078961|NCT01370213|3800888|FG002|STARTED|Overall Study||1
3078962|NCT01370213|3800886|FG000|COMPLETED|Overall Study||6
3078963|NCT01370213|3800887|FG001|COMPLETED|Overall Study||15
3078964|NCT01370213|3800888|FG002|COMPLETED|Overall Study||1
3078965|NCT01370213|3800886|FG000|NOT COMPLETED|Overall Study||1
3078966|NCT01370213|3800887|FG001|NOT COMPLETED|Overall Study||2
3078967|NCT01370213|3800888|FG002|NOT COMPLETED|Overall Study||0
3078968|NCT01370265|3800895|FG000|STARTED|Resting Myocardial Blood Flow (MBF)||6
3078969|NCT01370265|3800896|FG001|STARTED|Resting Myocardial Blood Flow (MBF)||6
3078970|NCT01370265|3800895|FG000|COMPLETED|Resting Myocardial Blood Flow (MBF)||6
3078971|NCT01370265|3800896|FG001|COMPLETED|Resting Myocardial Blood Flow (MBF)||6
3078972|NCT01370265|3800895|FG000|NOT COMPLETED|Resting Myocardial Blood Flow (MBF)||0
3078973|NCT01370265|3800896|FG001|NOT COMPLETED|Resting Myocardial Blood Flow (MBF)||0
3078974|NCT01370265|3800895|FG000|STARTED|Washout Period (50-minute Period Decay)||6
3078975|NCT01370265|3800896|FG001|STARTED|Washout Period (50-minute Period Decay)||6
3078976|NCT01370265|3800895|FG000|COMPLETED|Washout Period (50-minute Period Decay)||6
3078977|NCT01370265|3800896|FG001|COMPLETED|Washout Period (50-minute Period Decay)||6
3078978|NCT01370265|3800895|FG000|NOT COMPLETED|Washout Period (50-minute Period Decay)||0
3078979|NCT01370265|3800896|FG001|NOT COMPLETED|Washout Period (50-minute Period Decay)||0
3078980|NCT01370265|3800895|FG000|STARTED|First Intervention||6
3078981|NCT01370265|3800896|FG001|STARTED|First Intervention||6
3078982|NCT01370265|3800895|FG000|COMPLETED|First Intervention||5
3078983|NCT01370265|3800896|FG001|COMPLETED|First Intervention||5
3078984|NCT01370265|3800895|FG000|NOT COMPLETED|First Intervention||1
3078985|NCT01370265|3800896|FG001|NOT COMPLETED|First Intervention||1
3078986|NCT01370265|3800895|FG000|STARTED|Washout Period (50-minute Period Decay)||5
3285401|NCT02772978|4019133|FG000|NOT COMPLETED|Overall Study||1
3285402|NCT02772978|4019134|FG001|NOT COMPLETED|Overall Study||1
3285403|NCT02773368|4019141|FG000|STARTED|Overall Study||210
3285404|NCT02773368|4019142|FG001|STARTED|Overall Study||210
3285405|NCT02773368|4019141|FG000|Exposed|Overall Study||209
3285406|NCT02773368|4019142|FG001|Exposed|Overall Study||210
3285407|NCT02773368|4019141|FG000|COMPLETED|Overall Study||200
3285408|NCT02773368|4019142|FG001|COMPLETED|Overall Study||206
3285409|NCT02773368|4019141|FG000|NOT COMPLETED|Overall Study||10
3285410|NCT02773368|4019142|FG001|NOT COMPLETED|Overall Study||4
3285411|NCT02773446|4019154|FG000|STARTED|First Admission||7
3285412|NCT02773446|4019155|FG001|STARTED|First Admission||7
3285413|NCT02773446|4019156|FG002|STARTED|First Admission||7
3285414|NCT02773446|4019157|FG003|STARTED|First Admission||7
3285415|NCT02773446|4019158|FG004|STARTED|First Admission||0
3285416|NCT02773446|4019159|FG005|STARTED|First Admission||0
3285417|NCT02773446|4019154|FG000|COMPLETED|First Admission||6
3285418|NCT02773446|4019155|FG001|COMPLETED|First Admission||7
3285419|NCT02773446|4019156|FG002|COMPLETED|First Admission||7
3285420|NCT02773446|4019157|FG003|COMPLETED|First Admission||6
3285421|NCT02773446|4019158|FG004|COMPLETED|First Admission||0
3285422|NCT02773446|4019159|FG005|COMPLETED|First Admission||0
3285423|NCT02773446|4019154|FG000|NOT COMPLETED|First Admission||1
3285424|NCT02773446|4019155|FG001|NOT COMPLETED|First Admission||0
3285425|NCT02773446|4019156|FG002|NOT COMPLETED|First Admission||0
3285426|NCT02773446|4019157|FG003|NOT COMPLETED|First Admission||1
3285427|NCT02773446|4019158|FG004|NOT COMPLETED|First Admission||0
3285428|NCT02773446|4019159|FG005|NOT COMPLETED|First Admission||0
3285429|NCT02773446|4019154|FG000|STARTED|Second Admission||0
3285430|NCT02773446|4019155|FG001|STARTED|Second Admission||0
3285431|NCT02773446|4019156|FG002|STARTED|Second Admission||0
3285432|NCT02773446|4019157|FG003|STARTED|Second Admission||0
3285433|NCT02773446|4019158|FG004|STARTED|Second Admission||11
3285434|NCT02773446|4019159|FG005|STARTED|Second Admission||19
3285435|NCT02773446|4019154|FG000|COMPLETED|Second Admission||0
3285436|NCT02773446|4019155|FG001|COMPLETED|Second Admission||0
3285437|NCT02773446|4019156|FG002|COMPLETED|Second Admission||0
3285438|NCT02773446|4019157|FG003|COMPLETED|Second Admission||0
3285439|NCT02773446|4019158|FG004|COMPLETED|Second Admission||11
3285440|NCT02773446|4019159|FG005|COMPLETED|Second Admission||19
3285441|NCT02773446|4019154|FG000|NOT COMPLETED|Second Admission||0
3285442|NCT02773446|4019155|FG001|NOT COMPLETED|Second Admission||0
3285443|NCT02773446|4019156|FG002|NOT COMPLETED|Second Admission||0
3285444|NCT02773446|4019157|FG003|NOT COMPLETED|Second Admission||0
3285445|NCT02773446|4019158|FG004|NOT COMPLETED|Second Admission||0
3285446|NCT02773446|4019159|FG005|NOT COMPLETED|Second Admission||0
3285447|NCT02773537|4019179|FG000|STARTED|Overall Study||25
3285448|NCT02773537|4019180|FG001|STARTED|Overall Study||25
3285449|NCT02773537|4019181|FG002|STARTED|Overall Study||25
3078987|NCT01370265|3800896|FG001|STARTED|Washout Period (50-minute Period Decay)||5
3078988|NCT01370265|3800895|FG000|COMPLETED|Washout Period (50-minute Period Decay)||5
3078989|NCT01370265|3800896|FG001|COMPLETED|Washout Period (50-minute Period Decay)||5
3078990|NCT01370265|3800895|FG000|NOT COMPLETED|Washout Period (50-minute Period Decay)||0
3078991|NCT01370265|3800896|FG001|NOT COMPLETED|Washout Period (50-minute Period Decay)||0
3078992|NCT01370265|3800895|FG000|STARTED|Second Intervention||5
3078993|NCT01370265|3800896|FG001|STARTED|Second Intervention||5
3078994|NCT01370265|3800895|FG000|COMPLETED|Second Intervention||5
3078995|NCT01370265|3800896|FG001|COMPLETED|Second Intervention||5
3078996|NCT01370265|3800895|FG000|NOT COMPLETED|Second Intervention||0
3078997|NCT01370265|3800896|FG001|NOT COMPLETED|Second Intervention||0
3078998|NCT01370317|3800905|FG000|STARTED|Overall Study||18
3078999|NCT01370317|3800906|FG001|STARTED|Overall Study||9
3079000|NCT01370317|3800905|FG000|COMPLETED|Overall Study||17
3079001|NCT01370317|3800906|FG001|COMPLETED|Overall Study||8
3079002|NCT01370317|3800905|FG000|NOT COMPLETED|Overall Study||1
3079003|NCT01370317|3800906|FG001|NOT COMPLETED|Overall Study||1
3079004|NCT01370356|3800914|FG000|STARTED|Overall Study||751
3079005|NCT01370356|3800915|FG001|STARTED|Overall Study||742
3079006|NCT01370356|3800914|FG000|COMPLETED|Overall Study||559
3285450|NCT02773537|4019179|FG000|COMPLETED|Overall Study||25
3285451|NCT02773537|4019180|FG001|COMPLETED|Overall Study||24
3285452|NCT02773537|4019181|FG002|COMPLETED|Overall Study||21
3285453|NCT02773537|4019179|FG000|NOT COMPLETED|Overall Study||0
3285454|NCT02773537|4019180|FG001|NOT COMPLETED|Overall Study||1
3285455|NCT02773537|4019181|FG002|NOT COMPLETED|Overall Study||4
3285456|NCT02773758|4019191|FG000|STARTED|Overall Study||71
3285457|NCT02773758|4019192|FG001|STARTED|Overall Study||70
3285458|NCT02773758|4019191|FG000|COMPLETED|Overall Study||71
3285459|NCT02773758|4019192|FG001|COMPLETED|Overall Study||70
3285460|NCT02773758|4019191|FG000|NOT COMPLETED|Overall Study||0
3285461|NCT02773758|4019192|FG001|NOT COMPLETED|Overall Study||0
3285462|NCT02773836|4019204|FG000|STARTED|Wave 1- Pre-TPD Implementation||1000
3285463|NCT02773836|4019205|FG001|STARTED|Wave 1- Pre-TPD Implementation||1003
3285464|NCT02773836|4019206|FG002|STARTED|Wave 1- Pre-TPD Implementation||1001
3285465|NCT02773836|4019207|FG003|STARTED|Wave 1- Pre-TPD Implementation||1001
3285466|NCT02773836|4019208|FG004|STARTED|Wave 1- Pre-TPD Implementation||1000
3285467|NCT02773836|4019209|FG005|STARTED|Wave 1- Pre-TPD Implementation||1006
3285468|NCT02773836|4019204|FG000|COMPLETED|Wave 1- Pre-TPD Implementation||1000
3285469|NCT02773836|4019205|FG001|COMPLETED|Wave 1- Pre-TPD Implementation||1003
3285470|NCT02773836|4019206|FG002|COMPLETED|Wave 1- Pre-TPD Implementation||1001
3285471|NCT02773836|4019207|FG003|COMPLETED|Wave 1- Pre-TPD Implementation||1001
3285472|NCT02773836|4019208|FG004|COMPLETED|Wave 1- Pre-TPD Implementation||1000
3285473|NCT02773836|4019209|FG005|COMPLETED|Wave 1- Pre-TPD Implementation||1006
3285474|NCT02773836|4019204|FG000|NOT COMPLETED|Wave 1- Pre-TPD Implementation||0
3285475|NCT02773836|4019205|FG001|NOT COMPLETED|Wave 1- Pre-TPD Implementation||0
3285476|NCT02773836|4019206|FG002|NOT COMPLETED|Wave 1- Pre-TPD Implementation||0
3285477|NCT02773836|4019207|FG003|NOT COMPLETED|Wave 1- Pre-TPD Implementation||0
3285478|NCT02773836|4019208|FG004|NOT COMPLETED|Wave 1- Pre-TPD Implementation||0
3285479|NCT02773836|4019209|FG005|NOT COMPLETED|Wave 1- Pre-TPD Implementation||0
3285480|NCT02773836|4019204|FG000|STARTED|Wave 2- Post-TPD Implementation||1010
3285481|NCT02773836|4019205|FG001|STARTED|Wave 2- Post-TPD Implementation||1013
3285482|NCT02773836|4019206|FG002|STARTED|Wave 2- Post-TPD Implementation||1003
3285483|NCT02773836|4019207|FG003|STARTED|Wave 2- Post-TPD Implementation||1010
3285484|NCT02773836|4019208|FG004|STARTED|Wave 2- Post-TPD Implementation||1002
3285485|NCT02773836|4019209|FG005|STARTED|Wave 2- Post-TPD Implementation||998
3285486|NCT02773836|4019204|FG000|COMPLETED|Wave 2- Post-TPD Implementation||1010
3285487|NCT02773836|4019205|FG001|COMPLETED|Wave 2- Post-TPD Implementation||1013
3285488|NCT02773836|4019206|FG002|COMPLETED|Wave 2- Post-TPD Implementation||1003
3285489|NCT02773836|4019207|FG003|COMPLETED|Wave 2- Post-TPD Implementation||1010
3285490|NCT02773836|4019208|FG004|COMPLETED|Wave 2- Post-TPD Implementation||1002
3285491|NCT02773836|4019209|FG005|COMPLETED|Wave 2- Post-TPD Implementation||998
3285492|NCT02773836|4019204|FG000|NOT COMPLETED|Wave 2- Post-TPD Implementation||0
3285493|NCT02773836|4019205|FG001|NOT COMPLETED|Wave 2- Post-TPD Implementation||0
3285494|NCT02773836|4019206|FG002|NOT COMPLETED|Wave 2- Post-TPD Implementation||0
3285495|NCT02773836|4019207|FG003|NOT COMPLETED|Wave 2- Post-TPD Implementation||0
3285496|NCT02773836|4019208|FG004|NOT COMPLETED|Wave 2- Post-TPD Implementation||0
3285497|NCT02773836|4019209|FG005|NOT COMPLETED|Wave 2- Post-TPD Implementation||0
3285498|NCT02774213|4019229|FG000|STARTED|Overall Study||74
3285499|NCT02774213|4019229|FG000|COMPLETED|Overall Study||55
3285500|NCT02774213|4019229|FG000|NOT COMPLETED|Overall Study||19
3285501|NCT02774226|4019235|FG000|STARTED|Overall Study||8
3285502|NCT02774226|4019236|FG001|STARTED|Overall Study||7
3285503|NCT02774226|4019235|FG000|COMPLETED|Overall Study||8
3285504|NCT02774226|4019236|FG001|COMPLETED|Overall Study||7
3285505|NCT02774226|4019235|FG000|NOT COMPLETED|Overall Study||0
3285506|NCT02774226|4019236|FG001|NOT COMPLETED|Overall Study||0
3285507|NCT02774278|4019242|FG000|STARTED|Overall Study||264
3285508|NCT02774278|4019242|FG000|Safety Analysis Population (SAP)|Overall Study|SAP: all participants who received at least 1 dose of trial medication and had a safety follow-up.|261
3285509|NCT02774278|4019242|FG000|COMPLETED|Overall Study||0
3285510|NCT02774278|4019242|FG000|NOT COMPLETED|Overall Study||264
3285511|NCT02774343|4019248|FG000|STARTED|Overall Study||15
3285512|NCT02774343|4019249|FG001|STARTED|Overall Study||15
3079007|NCT01370356|3800915|FG001|COMPLETED|Overall Study||515
3079008|NCT01370356|3800914|FG000|NOT COMPLETED|Overall Study||192
3079009|NCT01370356|3800915|FG001|NOT COMPLETED|Overall Study||227
3079010|NCT01370369|3800921|FG000|STARTED|Overall Study||20
3079011|NCT01370369|3800921|FG000|COMPLETED|Overall Study||20
3079012|NCT01370369|3800921|FG000|NOT COMPLETED|Overall Study||0
3079013|NCT01370408|3800934|FG000|STARTED|Overall Study||85
3079014|NCT01370408|3800934|FG000|COMPLETED|Overall Study||76
3079015|NCT01370408|3800934|FG000|NOT COMPLETED|Overall Study||9
3079016|NCT01370460|3800940|FG000|STARTED|Overall Study||50
3079017|NCT01370460|3800941|FG001|STARTED|Overall Study||51
3079018|NCT01370460|3800940|FG000|COMPLETED|Overall Study||50
3079019|NCT01370460|3800941|FG001|COMPLETED|Overall Study||51
3079020|NCT01370460|3800940|FG000|NOT COMPLETED|Overall Study||0
3079021|NCT01370460|3800941|FG001|NOT COMPLETED|Overall Study||0
3079022|NCT01370499|3800950|FG000|STARTED|Overall Study||195
3079023|NCT01370499|3800951|FG001|STARTED|Overall Study||93
3079024|NCT01370499|3800950|FG000|Entered Abrupt Discontinuation Phase|Overall Study||188
3079025|NCT01370499|3800951|FG001|Entered Abrupt Discontinuation Phase|Overall Study|One participant who entered the abrupt discontinuation phase did not receive study drug.|85
3079026|NCT01370499|3800950|FG000|Received at Least 1 Dose of Study Drug|Overall Study||195
3079027|NCT01370499|3800951|FG001|Received at Least 1 Dose of Study Drug|Overall Study||92
3079028|NCT01370499|3800950|FG000|COMPLETED|Overall Study||84
3079029|NCT01370499|3800951|FG001|COMPLETED|Overall Study||49
3079030|NCT01370499|3800950|FG000|NOT COMPLETED|Overall Study||111
3079031|NCT01370499|3800951|FG001|NOT COMPLETED|Overall Study||44
3079032|NCT01370525|3800961|FG000|STARTED|Overall Study||171
3079033|NCT01370525|3800962|FG001|STARTED|Overall Study||169
3079034|NCT01370525|3800961|FG000|Patients Who Received Treatment|Overall Study||168
3079035|NCT01370525|3800962|FG001|Patients Who Received Treatment|Overall Study||163
3079036|NCT01370525|3800961|FG000|Patients Who Completed Treatment|Overall Study||163
3079037|NCT01370525|3800962|FG001|Patients Who Completed Treatment|Overall Study||158
3079038|NCT01370525|3800961|FG000|COMPLETED|Overall Study||163
3285513|NCT02774343|4019248|FG000|Received at Least One Capsule|Overall Study||12
3285514|NCT02774343|4019249|FG001|Received at Least One Capsule|Overall Study||14
3285515|NCT02774343|4019248|FG000|COMPLETED|Overall Study||9
3285516|NCT02774343|4019249|FG001|COMPLETED|Overall Study||12
3285517|NCT02774343|4019248|FG000|NOT COMPLETED|Overall Study||6
3285518|NCT02774343|4019249|FG001|NOT COMPLETED|Overall Study||3
3285519|NCT02774616|4019258|FG000|STARTED|Overall Study||95
3285520|NCT02774616|4019259|FG001|STARTED|Overall Study||167
3285521|NCT02774616|4019260|FG002|STARTED|Overall Study||16
3285522|NCT02774616|4019258|FG000|Died|Overall Study||6
3285523|NCT02774616|4019259|FG001|Died|Overall Study||3
3285524|NCT02774616|4019260|FG002|Died|Overall Study||1
3285525|NCT02774616|4019258|FG000|Withdrew Consent|Overall Study||3
3285526|NCT02774616|4019259|FG001|Withdrew Consent|Overall Study||3
3285527|NCT02774616|4019260|FG002|Withdrew Consent|Overall Study||0
3285528|NCT02774616|4019258|FG000|Lost to FU|Overall Study||2
3285529|NCT02774616|4019259|FG001|Lost to FU|Overall Study||0
3285530|NCT02774616|4019260|FG002|Lost to FU|Overall Study||0
3285531|NCT02774616|4019258|FG000|Device Explanted|Overall Study||2
3285532|NCT02774616|4019259|FG001|Device Explanted|Overall Study||1
3285533|NCT02774616|4019260|FG002|Device Explanted|Overall Study||1
3285534|NCT02774616|4019258|FG000|Other|Overall Study||2
3285535|NCT02774616|4019259|FG001|Other|Overall Study||4
3285536|NCT02774616|4019260|FG002|Other|Overall Study||1
3285537|NCT02774616|4019258|FG000|COMPLETED|Overall Study||80
3285538|NCT02774616|4019259|FG001|COMPLETED|Overall Study||156
3285539|NCT02774616|4019260|FG002|COMPLETED|Overall Study||13
3285540|NCT02774616|4019258|FG000|NOT COMPLETED|Overall Study||15
3285541|NCT02774616|4019259|FG001|NOT COMPLETED|Overall Study||11
3285542|NCT02774616|4019260|FG002|NOT COMPLETED|Overall Study||3
3285543|NCT02774681|4019270|FG000|STARTED|Treatment on Study||12
3285544|NCT02774681|4019270|FG000|Reached 1st Response/2 Cycles|Treatment on Study||10
3285545|NCT02774681|4019270|FG000|Went on to Start Cycle 3|Treatment on Study||5
3285546|NCT02774681|4019270|FG000|COMPLETED|Treatment on Study||5
3285547|NCT02774681|4019270|FG000|NOT COMPLETED|Treatment on Study||7
3285548|NCT02774681|4019270|FG000|STARTED|Follow-Up for 3 Years||12
3285549|NCT02774681|4019270|FG000|COMPLETED|Follow-Up for 3 Years||0
3285550|NCT02774681|4019270|FG000|NOT COMPLETED|Follow-Up for 3 Years||12
3285551|NCT02774798|4019277|FG000|STARTED|Overall Study||7
3285552|NCT02774798|4019278|FG001|STARTED|Overall Study||17
3285553|NCT02774798|4019279|FG002|STARTED|Overall Study||7
3285554|NCT02774798|4019277|FG000|COMPLETED|Overall Study||7
3285555|NCT02774798|4019278|FG001|COMPLETED|Overall Study||17
3285556|NCT02774798|4019279|FG002|COMPLETED|Overall Study||7
3285557|NCT02774798|4019277|FG000|NOT COMPLETED|Overall Study||0
3285558|NCT02774798|4019278|FG001|NOT COMPLETED|Overall Study||0
3285559|NCT02774798|4019279|FG002|NOT COMPLETED|Overall Study||0
3285560|NCT02774850|4019289|FG000|STARTED|Overall Study||610
3285561|NCT02774850|4019289|FG000|Induction I|Overall Study||585
3285562|NCT02774850|4019289|FG000|Early Discharge Eligible at Induction I|Overall Study|24 of these patients were managed as outpatients. 252 were managed as inpatients.|276
3285563|NCT02774850|4019289|FG000|Induction II|Overall Study||564
3285564|NCT02774850|4019289|FG000|Early Discharge Eligible at Induction II|Overall Study|114 of these patients were managed as outpatients. 379 were managed as inpatients.|493
3285565|NCT02774850|4019289|FG000|Intensification I|Overall Study||476
3316611|NCT03115827|4050000|FG000|COMPLETED|Overall Study||12
3079039|NCT01370525|3800962|FG001|COMPLETED|Overall Study||158
3079040|NCT01370525|3800961|FG000|NOT COMPLETED|Overall Study||8
3079041|NCT01370525|3800962|FG001|NOT COMPLETED|Overall Study||11
3079042|NCT01370538|3800970|FG000|STARTED|Overall Study||170
3079043|NCT01370538|3800971|FG001|STARTED|Overall Study||171
3079044|NCT01370538|3800970|FG000|Patients Who Received Treatment|Overall Study||165
3079045|NCT01370538|3800971|FG001|Patients Who Received Treatment|Overall Study||161
3079046|NCT01370538|3800970|FG000|Patients Who Completed Treatment|Overall Study||151
3079047|NCT01370538|3800971|FG001|Patients Who Completed Treatment|Overall Study||152
3079048|NCT01370538|3800970|FG000|COMPLETED|Overall Study||151
3079049|NCT01370538|3800971|FG001|COMPLETED|Overall Study||152
3079050|NCT01370538|3800970|FG000|NOT COMPLETED|Overall Study||19
3079051|NCT01370538|3800971|FG001|NOT COMPLETED|Overall Study||19
3079052|NCT01370564|3800977|FG000|STARTED|Overall Study||21
3079053|NCT01370564|3800977|FG000|COMPLETED|Overall Study||21
3079054|NCT01370564|3800977|FG000|NOT COMPLETED|Overall Study||0
3079055|NCT01370616|3800983|FG000|STARTED|Overall Study|Participants randomized|282
3079056|NCT01370616|3800984|FG001|STARTED|Overall Study|Participants randomized|283
3079057|NCT01370616|3800983|FG000|Treated|Overall Study||275
3079058|NCT01370616|3800984|FG001|Treated|Overall Study||275
3079059|NCT01370616|3800983|FG000|COMPLETED|Overall Study||220
3079060|NCT01370616|3800984|FG001|COMPLETED|Overall Study||216
3079061|NCT01370616|3800983|FG000|NOT COMPLETED|Overall Study||62
3079062|NCT01370616|3800984|FG001|NOT COMPLETED|Overall Study||67
3079063|NCT01370629|3800990|FG000|STARTED|Overall Study||2015
3079064|NCT01370629|3800990|FG000|COMPLETED|Overall Study||2009
3079065|NCT01370629|3800990|FG000|NOT COMPLETED|Overall Study||6
3079066|NCT01370642|3800997|FG000|STARTED|Overall Study||98
3079067|NCT01370642|3800998|FG001|STARTED|Overall Study||98
3079068|NCT01370642|3800999|FG002|STARTED|Overall Study||98
3079069|NCT01370642|3800997|FG000|FAS Population|Overall Study||98
3079070|NCT01370642|3800998|FG001|FAS Population|Overall Study||97
3079071|NCT01370642|3800999|FG002|FAS Population|Overall Study||98
3079072|NCT01370642|3800997|FG000|COMPLETED|Overall Study||90
3079073|NCT01370642|3800998|FG001|COMPLETED|Overall Study||92
3079074|NCT01370642|3800999|FG002|COMPLETED|Overall Study||69
3079075|NCT01370642|3800997|FG000|NOT COMPLETED|Overall Study||8
3079076|NCT01370642|3800998|FG001|NOT COMPLETED|Overall Study||6
3079077|NCT01370642|3800999|FG002|NOT COMPLETED|Overall Study||29
3079078|NCT01370655|3801019|FG000|STARTED|Period 1||7
3079079|NCT01370655|3801020|FG001|STARTED|Period 1||7
3079080|NCT01370655|3801021|FG002|STARTED|Period 1||3
3079081|NCT01370655|3801022|FG003|STARTED|Period 1||3
3079082|NCT01370655|3801023|FG004|STARTED|Period 1||3
3079083|NCT01370655|3801024|FG005|STARTED|Period 1||4
3079084|NCT01370655|3801025|FG006|STARTED|Period 1||4
3079085|NCT01370655|3801026|FG007|STARTED|Period 1||4
3079086|NCT01370655|3801027|FG008|STARTED|Period 1||3
3079087|NCT01370655|3801028|FG009|STARTED|Period 1||2
3079088|NCT01370655|3801029|FG010|STARTED|Period 1||3
3079089|NCT01370655|3801030|FG011|STARTED|Period 1||3
3079090|NCT01370655|3801019|FG000|COMPLETED|Period 1||5
3079091|NCT01370655|3801020|FG001|COMPLETED|Period 1||7
3079092|NCT01370655|3801021|FG002|COMPLETED|Period 1||3
3079093|NCT01370655|3801022|FG003|COMPLETED|Period 1||3
3079094|NCT01370655|3801023|FG004|COMPLETED|Period 1||3
3079095|NCT01370655|3801024|FG005|COMPLETED|Period 1||4
3079096|NCT01370655|3801025|FG006|COMPLETED|Period 1||3
3079097|NCT01370655|3801026|FG007|COMPLETED|Period 1||4
3079098|NCT01370655|3801027|FG008|COMPLETED|Period 1||3
3079099|NCT01370655|3801028|FG009|COMPLETED|Period 1||2
3079100|NCT01370655|3801029|FG010|COMPLETED|Period 1||3
3079101|NCT01370655|3801030|FG011|COMPLETED|Period 1||3
3079102|NCT01370655|3801019|FG000|NOT COMPLETED|Period 1||2
3079103|NCT01370655|3801020|FG001|NOT COMPLETED|Period 1||0
3079104|NCT01370655|3801021|FG002|NOT COMPLETED|Period 1||0
3079105|NCT01370655|3801022|FG003|NOT COMPLETED|Period 1||0
3079106|NCT01370655|3801023|FG004|NOT COMPLETED|Period 1||0
3079107|NCT01370655|3801024|FG005|NOT COMPLETED|Period 1||0
3079108|NCT01370655|3801025|FG006|NOT COMPLETED|Period 1||1
3079109|NCT01370655|3801026|FG007|NOT COMPLETED|Period 1||0
3079110|NCT01370655|3801027|FG008|NOT COMPLETED|Period 1||0
3079111|NCT01370655|3801028|FG009|NOT COMPLETED|Period 1||0
3079112|NCT01370655|3801029|FG010|NOT COMPLETED|Period 1||0
3079113|NCT01370655|3801030|FG011|NOT COMPLETED|Period 1||0
3079114|NCT01370655|3801019|FG000|STARTED|Period 2||5
3079115|NCT01370655|3801020|FG001|STARTED|Period 2||7
3079116|NCT01370655|3801021|FG002|STARTED|Period 2||3
3079117|NCT01370655|3801022|FG003|STARTED|Period 2||3
3079118|NCT01370655|3801023|FG004|STARTED|Period 2||3
3079119|NCT01370655|3801024|FG005|STARTED|Period 2||4
3079120|NCT01370655|3801025|FG006|STARTED|Period 2||3
3079121|NCT01370655|3801026|FG007|STARTED|Period 2||4
3079122|NCT01370655|3801027|FG008|STARTED|Period 2||3
3079123|NCT01370655|3801028|FG009|STARTED|Period 2||2
3079124|NCT01370655|3801029|FG010|STARTED|Period 2||3
3079125|NCT01370655|3801030|FG011|STARTED|Period 2||3
3079126|NCT01370655|3801019|FG000|COMPLETED|Period 2||5
3079127|NCT01370655|3801020|FG001|COMPLETED|Period 2||7
3079128|NCT01370655|3801021|FG002|COMPLETED|Period 2||1
3079129|NCT01370655|3801022|FG003|COMPLETED|Period 2||3
3079130|NCT01370655|3801023|FG004|COMPLETED|Period 2||2
3079131|NCT01370655|3801024|FG005|COMPLETED|Period 2||4
3079132|NCT01370655|3801025|FG006|COMPLETED|Period 2||2
3079133|NCT01370655|3801026|FG007|COMPLETED|Period 2||3
3079134|NCT01370655|3801027|FG008|COMPLETED|Period 2||1
3079135|NCT01370655|3801028|FG009|COMPLETED|Period 2||2
3079136|NCT01370655|3801029|FG010|COMPLETED|Period 2||2
3079137|NCT01370655|3801030|FG011|COMPLETED|Period 2||3
3079138|NCT01370655|3801019|FG000|NOT COMPLETED|Period 2||0
3079139|NCT01370655|3801020|FG001|NOT COMPLETED|Period 2||0
3079140|NCT01370655|3801021|FG002|NOT COMPLETED|Period 2||2
3079141|NCT01370655|3801022|FG003|NOT COMPLETED|Period 2||0
3079142|NCT01370655|3801023|FG004|NOT COMPLETED|Period 2||1
3079143|NCT01370655|3801024|FG005|NOT COMPLETED|Period 2||0
3079144|NCT01370655|3801025|FG006|NOT COMPLETED|Period 2||1
3079145|NCT01370655|3801026|FG007|NOT COMPLETED|Period 2||1
3079146|NCT01370655|3801027|FG008|NOT COMPLETED|Period 2||2
3079147|NCT01370655|3801028|FG009|NOT COMPLETED|Period 2||0
3079148|NCT01370655|3801029|FG010|NOT COMPLETED|Period 2||1
3079149|NCT01370655|3801030|FG011|NOT COMPLETED|Period 2||0
3079150|NCT01370694|3801040|FG000|STARTED|Overall Study||7
3079151|NCT01370694|3801040|FG000|COMPLETED|Overall Study||1
3079152|NCT01370694|3801040|FG000|NOT COMPLETED|Overall Study||6
3079153|NCT01370733|3801046|FG000|STARTED|Overall Study||103
3079154|NCT01370733|3801047|FG001|STARTED|Overall Study||99
3079155|NCT01370733|3801046|FG000|COMPLETED|Overall Study||86
3079156|NCT01370733|3801047|FG001|COMPLETED|Overall Study||77
3079157|NCT01370733|3801046|FG000|NOT COMPLETED|Overall Study||17
3079158|NCT01370733|3801047|FG001|NOT COMPLETED|Overall Study||22
3079159|NCT01370837|3801056|FG000|STARTED|Overall Study||12
3079160|NCT01370837|3801057|FG001|STARTED|Overall Study||12
3079161|NCT01370837|3801058|FG002|STARTED|Overall Study||17
3079162|NCT01370837|3801056|FG000|COMPLETED|Overall Study||12
3079163|NCT01370837|3801057|FG001|COMPLETED|Overall Study||12
3079164|NCT01370837|3801058|FG002|COMPLETED|Overall Study||17
3079165|NCT01370837|3801056|FG000|NOT COMPLETED|Overall Study||0
3079166|NCT01370837|3801057|FG001|NOT COMPLETED|Overall Study||0
3079167|NCT01370837|3801058|FG002|NOT COMPLETED|Overall Study||0
3079168|NCT01370863|3801068|FG000|STARTED|Overall Study||34
3079169|NCT01370863|3801069|FG001|STARTED|Overall Study||33
3079170|NCT01370863|3801068|FG000|COMPLETED|Overall Study||32
3079171|NCT01370863|3801069|FG001|COMPLETED|Overall Study||30
3079172|NCT01370863|3801068|FG000|NOT COMPLETED|Overall Study||2
3079173|NCT01370863|3801069|FG001|NOT COMPLETED|Overall Study||3
3079174|NCT01371006|3801077|FG000|STARTED|Overall Study||14
3079175|NCT01371006|3801078|FG001|STARTED|Overall Study||15
3079176|NCT01371006|3801077|FG000|COMPLETED|Overall Study||13
3079177|NCT01371006|3801078|FG001|COMPLETED|Overall Study||15
3079178|NCT01371006|3801077|FG000|NOT COMPLETED|Overall Study||1
3079179|NCT01371006|3801078|FG001|NOT COMPLETED|Overall Study||0
3079180|NCT01371032|3801106|FG000|STARTED|Overall Study||14
3079181|NCT01371032|3801107|FG001|STARTED|Overall Study||14
3079182|NCT01371032|3801106|FG000|COMPLETED|Overall Study||14
3079183|NCT01371032|3801107|FG001|COMPLETED|Overall Study||14
3079184|NCT01371032|3801106|FG000|NOT COMPLETED|Overall Study||0
3079185|NCT01371032|3801107|FG001|NOT COMPLETED|Overall Study||0
3079186|NCT01371110|3801117|FG000|STARTED|Overall Study||1
3079187|NCT01371110|3801118|FG001|STARTED|Overall Study||2
3079188|NCT01371110|3801117|FG000|COMPLETED|Overall Study||1
3079189|NCT01371110|3801118|FG001|COMPLETED|Overall Study||2
3079190|NCT01371110|3801117|FG000|NOT COMPLETED|Overall Study||0
3079191|NCT01371110|3801118|FG001|NOT COMPLETED|Overall Study||0
3079192|NCT01371539|3801124|FG000|STARTED|Period One: One Week||53
3079193|NCT01371539|3801125|FG001|STARTED|Period One: One Week||51
3079194|NCT01371539|3801124|FG000|COMPLETED|Period One: One Week||53
3079195|NCT01371539|3801125|FG001|COMPLETED|Period One: One Week||50
3079196|NCT01371539|3801124|FG000|NOT COMPLETED|Period One: One Week||0
3079197|NCT01371539|3801125|FG001|NOT COMPLETED|Period One: One Week||1
3079198|NCT01371539|3801124|FG000|STARTED|Period Two: One Week||53
3079199|NCT01371539|3801125|FG001|STARTED|Period Two: One Week||50
3079200|NCT01371539|3801124|FG000|COMPLETED|Period Two: One Week||53
3079201|NCT01371539|3801125|FG001|COMPLETED|Period Two: One Week||47
3079202|NCT01371539|3801124|FG000|NOT COMPLETED|Period Two: One Week||0
3079203|NCT01371539|3801125|FG001|NOT COMPLETED|Period Two: One Week||3
3079204|NCT01371552|3801131|FG000|STARTED|Part 1, First 3 Days||19
3079205|NCT01371552|3801132|FG001|STARTED|Part 1, First 3 Days||17
3079206|NCT01371552|3801133|FG002|STARTED|Part 1, First 3 Days||20
3079207|NCT01371552|3801134|FG003|STARTED|Part 1, First 3 Days||20
3079208|NCT01371552|3801135|FG004|STARTED|Part 1, First 3 Days||15
3079209|NCT01371552|3801136|FG005|STARTED|Part 1, First 3 Days||18
3079210|NCT01371552|3801131|FG000|COMPLETED|Part 1, First 3 Days||19
3079211|NCT01371552|3801132|FG001|COMPLETED|Part 1, First 3 Days||17
3079212|NCT01371552|3801133|FG002|COMPLETED|Part 1, First 3 Days||19
3079213|NCT01371552|3801134|FG003|COMPLETED|Part 1, First 3 Days||20
3079214|NCT01371552|3801135|FG004|COMPLETED|Part 1, First 3 Days||15
3079215|NCT01371552|3801136|FG005|COMPLETED|Part 1, First 3 Days||18
3079216|NCT01371552|3801131|FG000|NOT COMPLETED|Part 1, First 3 Days||0
3079217|NCT01371552|3801132|FG001|NOT COMPLETED|Part 1, First 3 Days||0
3079218|NCT01371552|3801133|FG002|NOT COMPLETED|Part 1, First 3 Days||1
3079219|NCT01371552|3801134|FG003|NOT COMPLETED|Part 1, First 3 Days||0
3079220|NCT01371552|3801135|FG004|NOT COMPLETED|Part 1, First 3 Days||0
3079221|NCT01371552|3801136|FG005|NOT COMPLETED|Part 1, First 3 Days||0
3079222|NCT01371552|3801131|FG000|STARTED|Part 1, Second 3 Days||19
3079223|NCT01371552|3801132|FG001|STARTED|Part 1, Second 3 Days||17
3079224|NCT01371552|3801133|FG002|STARTED|Part 1, Second 3 Days|1 subject discontinued after First 3 days due to positive slit lamp findings unrelated to lens wear|18
3079225|NCT01371552|3801134|FG003|STARTED|Part 1, Second 3 Days||20
3079226|NCT01371552|3801135|FG004|STARTED|Part 1, Second 3 Days||15
3079227|NCT01371552|3801136|FG005|STARTED|Part 1, Second 3 Days||18
3079228|NCT01371552|3801131|FG000|COMPLETED|Part 1, Second 3 Days|One subject did not complete period due to discomfort but continued to next, as allowed by protocol|18
3079229|NCT01371552|3801132|FG001|COMPLETED|Part 1, Second 3 Days||17
3079230|NCT01371552|3801133|FG002|COMPLETED|Part 1, Second 3 Days||18
3079231|NCT01371552|3801134|FG003|COMPLETED|Part 1, Second 3 Days||20
3079232|NCT01371552|3801135|FG004|COMPLETED|Part 1, Second 3 Days||15
3079233|NCT01371552|3801136|FG005|COMPLETED|Part 1, Second 3 Days||18
3079234|NCT01371552|3801131|FG000|NOT COMPLETED|Part 1, Second 3 Days||1
3079235|NCT01371552|3801132|FG001|NOT COMPLETED|Part 1, Second 3 Days||0
3079236|NCT01371552|3801133|FG002|NOT COMPLETED|Part 1, Second 3 Days||0
3079237|NCT01371552|3801134|FG003|NOT COMPLETED|Part 1, Second 3 Days||0
3079238|NCT01371552|3801135|FG004|NOT COMPLETED|Part 1, Second 3 Days||0
3079239|NCT01371552|3801136|FG005|NOT COMPLETED|Part 1, Second 3 Days||0
3079240|NCT01371552|3801131|FG000|STARTED|Part 1, Third 3 Days||19
3079241|NCT01371552|3801132|FG001|STARTED|Part 1, Third 3 Days||17
3079242|NCT01371552|3801133|FG002|STARTED|Part 1, Third 3 Days||18
3079243|NCT01371552|3801134|FG003|STARTED|Part 1, Third 3 Days||20
3079244|NCT01371552|3801135|FG004|STARTED|Part 1, Third 3 Days||15
3079245|NCT01371552|3801136|FG005|STARTED|Part 1, Third 3 Days||18
3079246|NCT01371552|3801131|FG000|COMPLETED|Part 1, Third 3 Days||19
3079247|NCT01371552|3801132|FG001|COMPLETED|Part 1, Third 3 Days||17
3079248|NCT01371552|3801133|FG002|COMPLETED|Part 1, Third 3 Days||18
3079249|NCT01371552|3801134|FG003|COMPLETED|Part 1, Third 3 Days||20
3079250|NCT01371552|3801135|FG004|COMPLETED|Part 1, Third 3 Days|One subject did not complete period due to randomization error, but continued into Part 2.|14
3079251|NCT01371552|3801136|FG005|COMPLETED|Part 1, Third 3 Days|One subject did not complete period due to discomfort, but continued into Part 2.|17
3079252|NCT01371552|3801131|FG000|NOT COMPLETED|Part 1, Third 3 Days||0
3079253|NCT01371552|3801132|FG001|NOT COMPLETED|Part 1, Third 3 Days||0
3079254|NCT01371552|3801133|FG002|NOT COMPLETED|Part 1, Third 3 Days||0
3079255|NCT01371552|3801134|FG003|NOT COMPLETED|Part 1, Third 3 Days||0
3079256|NCT01371552|3801135|FG004|NOT COMPLETED|Part 1, Third 3 Days||1
3079257|NCT01371552|3801136|FG005|NOT COMPLETED|Part 1, Third 3 Days||1
3079258|NCT01371552|3801131|FG000|STARTED|Part 2, One Week|One participant discontinued between Part 1 and Part 2 due to inconvenience|18
3079259|NCT01371552|3801132|FG001|STARTED|Part 2, One Week||17
3079260|NCT01371552|3801133|FG002|STARTED|Part 2, One Week||18
3079261|NCT01371552|3801134|FG003|STARTED|Part 2, One Week||20
3079262|NCT01371552|3801135|FG004|STARTED|Part 2, One Week||15
3079263|NCT01371552|3801136|FG005|STARTED|Part 2, One Week||18
3079264|NCT01371552|3801131|FG000|COMPLETED|Part 2, One Week||18
3079265|NCT01371552|3801132|FG001|COMPLETED|Part 2, One Week||17
3079266|NCT01371552|3801133|FG002|COMPLETED|Part 2, One Week||18
3079267|NCT01371552|3801134|FG003|COMPLETED|Part 2, One Week||20
3079268|NCT01371552|3801135|FG004|COMPLETED|Part 2, One Week||15
3079269|NCT01371552|3801136|FG005|COMPLETED|Part 2, One Week||18
3079270|NCT01371552|3801131|FG000|NOT COMPLETED|Part 2, One Week||0
3079271|NCT01371552|3801132|FG001|NOT COMPLETED|Part 2, One Week||0
3079272|NCT01371552|3801133|FG002|NOT COMPLETED|Part 2, One Week||0
3079273|NCT01371552|3801134|FG003|NOT COMPLETED|Part 2, One Week||0
3079274|NCT01371552|3801135|FG004|NOT COMPLETED|Part 2, One Week||0
3079275|NCT01371552|3801136|FG005|NOT COMPLETED|Part 2, One Week||0
3079276|NCT01371565|3801145|FG000|STARTED|Overall Study||4
3079277|NCT01371565|3801145|FG000|COMPLETED|Overall Study||1
3079278|NCT01371565|3801145|FG000|NOT COMPLETED|Overall Study||3
3079279|NCT01371643|3801151|FG000|STARTED|Overall Study||15
3079280|NCT01371643|3801152|FG001|STARTED|Overall Study||26
3079281|NCT01371643|3801151|FG000|COMPLETED|Overall Study||12
3079282|NCT01371643|3801152|FG001|COMPLETED|Overall Study||26
3079283|NCT01371643|3801151|FG000|NOT COMPLETED|Overall Study||3
3079284|NCT01371643|3801152|FG001|NOT COMPLETED|Overall Study||0
3079285|NCT01371656|3801160|FG000|STARTED|Overall Study||314
3079286|NCT01371656|3801161|FG001|STARTED|Overall Study||310
3079287|NCT01371656|3801160|FG000|COMPLETED|Overall Study||250
3079288|NCT01371656|3801161|FG001|COMPLETED|Overall Study||296
3079289|NCT01371656|3801160|FG000|NOT COMPLETED|Overall Study||64
3079290|NCT01371656|3801161|FG001|NOT COMPLETED|Overall Study||14
3079291|NCT01371708|3801170|FG000|STARTED|Overall Study||92
3079292|NCT01371708|3801171|FG001|STARTED|Overall Study||93
3079293|NCT01371708|3801172|FG002|STARTED|Overall Study||98
3079294|NCT01371708|3801170|FG000|Received Treatment|Overall Study||91
3079295|NCT01371708|3801171|FG001|Received Treatment|Overall Study||93
3079296|NCT01371708|3801172|FG002|Received Treatment|Overall Study||97
3079297|NCT01371708|3801170|FG000|COMPLETED|Overall Study||66
3079298|NCT01371708|3801171|FG001|COMPLETED|Overall Study||63
3079299|NCT01371708|3801172|FG002|COMPLETED|Overall Study||59
3079300|NCT01371708|3801170|FG000|NOT COMPLETED|Overall Study||26
3079301|NCT01371708|3801171|FG001|NOT COMPLETED|Overall Study||30
3079302|NCT01371708|3801172|FG002|NOT COMPLETED|Overall Study||39
3079303|NCT01371721|3801185|FG000|STARTED|Overall Study||88
3079304|NCT01371721|3801186|FG001|STARTED|Overall Study||89
3079305|NCT01371721|3801187|FG002|STARTED|Overall Study||92
3079306|NCT01371721|3801185|FG000|Treated|Overall Study||87
3079307|NCT01371721|3801186|FG001|Treated|Overall Study||89
3079308|NCT01371721|3801187|FG002|Treated|Overall Study||92
3079309|NCT01371721|3801185|FG000|COMPLETED|Overall Study||59
3079310|NCT01371721|3801186|FG001|COMPLETED|Overall Study||65
3079311|NCT01371721|3801187|FG002|COMPLETED|Overall Study||62
3079312|NCT01371721|3801185|FG000|NOT COMPLETED|Overall Study||29
3079313|NCT01371721|3801186|FG001|NOT COMPLETED|Overall Study||24
3079314|NCT01371721|3801187|FG002|NOT COMPLETED|Overall Study||30
3079315|NCT01371734|3801200|FG000|STARTED|Overall Study||120
3079316|NCT01371734|3801201|FG001|STARTED|Overall Study||122
3079317|NCT01371734|3801202|FG002|STARTED|Overall Study||121
3079318|NCT01371734|3801200|FG000|COMPLETED|Overall Study||97
3079319|NCT01371734|3801201|FG001|COMPLETED|Overall Study||103
3079320|NCT01371734|3801202|FG002|COMPLETED|Overall Study||104
3079321|NCT01371734|3801200|FG000|NOT COMPLETED|Overall Study||23
3079322|NCT01371734|3801201|FG001|NOT COMPLETED|Overall Study||19
3079323|NCT01371734|3801202|FG002|NOT COMPLETED|Overall Study||17
3079324|NCT01371747|3801216|FG000|STARTED|Overall Study||74
3079325|NCT01371747|3801217|FG001|STARTED|Overall Study||74
3079326|NCT01371747|3801218|FG002|STARTED|Overall Study||74
3079327|NCT01371747|3801219|FG003|STARTED|Overall Study||26
3079328|NCT01371747|3801220|FG004|STARTED|Overall Study||28
3079329|NCT01371747|3801221|FG005|STARTED|Overall Study||30
3079330|NCT01371747|3801216|FG000|COMPLETED|Overall Study||56
3079331|NCT01371747|3801217|FG001|COMPLETED|Overall Study||51
3079332|NCT01371747|3801218|FG002|COMPLETED|Overall Study||50
3079333|NCT01371747|3801219|FG003|COMPLETED|Overall Study||17
3079334|NCT01371747|3801220|FG004|COMPLETED|Overall Study||21
3079335|NCT01371747|3801221|FG005|COMPLETED|Overall Study||16
3079336|NCT01371747|3801216|FG000|NOT COMPLETED|Overall Study||18
3079337|NCT01371747|3801217|FG001|NOT COMPLETED|Overall Study||23
3079338|NCT01371747|3801218|FG002|NOT COMPLETED|Overall Study||24
3079339|NCT01371747|3801219|FG003|NOT COMPLETED|Overall Study||9
3079340|NCT01371747|3801220|FG004|NOT COMPLETED|Overall Study||7
3079341|NCT01371747|3801221|FG005|NOT COMPLETED|Overall Study||14
3079342|NCT01371786|3801238|FG000|STARTED|Overall Study||7
3079343|NCT01371786|3801239|FG001|STARTED|Overall Study||7
3079344|NCT01371786|3801238|FG000|COMPLETED|Overall Study||7
3079345|NCT01371786|3801239|FG001|COMPLETED|Overall Study||7
3079346|NCT01371786|3801238|FG000|NOT COMPLETED|Overall Study||0
3079347|NCT01371786|3801239|FG001|NOT COMPLETED|Overall Study||0
3079348|NCT01371825|3801245|FG000|STARTED|Overall Study||9
3079349|NCT01371825|3801245|FG000|Received at Least 1 Dose of Study Drug|Overall Study||9
3079350|NCT01371825|3801245|FG000|COMPLETED|Overall Study||5
3079351|NCT01371825|3801245|FG000|NOT COMPLETED|Overall Study||4
3079352|NCT01371838|3801251|FG000|STARTED|Overall Study||381
3079353|NCT01371838|3801252|FG001|STARTED|Overall Study||383
3079354|NCT01371838|3801251|FG000|COMPLETED|Overall Study||332
3285566|NCT02774850|4019289|FG000|Early Discharge Eligible at Int I|Overall Study|104 of these patients were managed as outpatients. 270 were managed as inpatients.|374
3285567|NCT02774850|4019289|FG000|Intensification II|Overall Study||342
3285568|NCT02774850|4019289|FG000|Early Discharge Eligible at Int II|Overall Study|56 of these patients were managed as outpatients. 229 were managed as inpatients.|285
3285569|NCT02774850|4019289|FG000|Intensification III|Overall Study||48
3285570|NCT02774850|4019289|FG000|Early Discharge Eligible at Int III|Overall Study|7 of these patients were managed as outpatients. 37 were managed as inpatients.|44
3285571|NCT02774850|4019289|FG000|COMPLETED|Overall Study||575
3285572|NCT02774850|4019289|FG000|NOT COMPLETED|Overall Study||35
3285573|NCT02774941|4019297|FG000|STARTED|Overall Study||110
3285574|NCT02774941|4019298|FG001|STARTED|Overall Study||110
3285575|NCT02774941|4019297|FG000|Subjects Excluded|Overall Study||1
3285576|NCT02774941|4019298|FG001|Subjects Excluded|Overall Study||2
3285577|NCT02774941|4019297|FG000|COMPLETED|Overall Study||109
3285578|NCT02774941|4019298|FG001|COMPLETED|Overall Study||108
3285579|NCT02774941|4019297|FG000|NOT COMPLETED|Overall Study||1
3285580|NCT02774941|4019298|FG001|NOT COMPLETED|Overall Study||2
3285581|NCT02775240|4019304|FG000|STARTED|Overall Study||18
3285582|NCT02775240|4019304|FG000|Started Treatment A|Overall Study||18
3285583|NCT02775240|4019304|FG000|Started Treatment B|Overall Study||17
3285584|NCT02775240|4019304|FG000|COMPLETED|Overall Study||17
3285585|NCT02775240|4019304|FG000|NOT COMPLETED|Overall Study||1
3285586|NCT02775344|4019313|FG000|STARTED|Overall Study||40
3285587|NCT02775344|4019314|FG001|STARTED|Overall Study||40
3285588|NCT02775344|4019313|FG000|COMPLETED|Overall Study||37
3285589|NCT02775344|4019314|FG001|COMPLETED|Overall Study||38
3285590|NCT02775344|4019313|FG000|NOT COMPLETED|Overall Study||3
3285591|NCT02775344|4019314|FG001|NOT COMPLETED|Overall Study||2
3285592|NCT02775617|4019322|FG000|STARTED|Overall Study|Participants are seen at via a survey of the community. 92.6% of the resident population|653
3285593|NCT02775617|4019323|FG001|STARTED|Overall Study|Participants are seen at via a survey of the community. 88.9% of the resident population|638
3285594|NCT02775617|4019322|FG000|COMPLETED|Overall Study|Participants are seen at via a survey of the community. 96.3% of the resident population|605
3285595|NCT02775617|4019323|FG001|COMPLETED|Overall Study|Participants are seen at via a survey of the community. 76.2% of the resident population|478
3079355|NCT01371838|3801252|FG001|COMPLETED|Overall Study||317
3079356|NCT01371838|3801251|FG000|NOT COMPLETED|Overall Study||49
3079357|NCT01371838|3801252|FG001|NOT COMPLETED|Overall Study||66
3079358|NCT01371851|3801260|FG000|STARTED|Overall Study|Eligible participants who showed up on day 1 of week 1 and received at least one dose of study med.|11
3079359|NCT01371851|3801261|FG001|STARTED|Overall Study|Eligible participants who showed up on day 1 of week 1 and received at least one dose of study med.|11
3079360|NCT01371851|3801260|FG000|COMPLETED|Overall Study||3
3079361|NCT01371851|3801261|FG001|COMPLETED|Overall Study||2
3079362|NCT01371851|3801260|FG000|NOT COMPLETED|Overall Study||8
3079363|NCT01371851|3801261|FG001|NOT COMPLETED|Overall Study||9
3079364|NCT01371877|3801269|FG000|STARTED|Overall Study||21
3079365|NCT01371877|3801270|FG001|STARTED|Overall Study||21
3079366|NCT01371877|3801269|FG000|COMPLETED|Overall Study||21
3079367|NCT01371877|3801270|FG001|COMPLETED|Overall Study||17
3079368|NCT01371877|3801269|FG000|NOT COMPLETED|Overall Study||0
3079369|NCT01371877|3801270|FG001|NOT COMPLETED|Overall Study||4
3079370|NCT01371994|3801278|FG000|STARTED|Overall Study||320
3079371|NCT01371994|3801279|FG001|STARTED|Overall Study||320
3079372|NCT01371994|3801278|FG000|Received Treatment|Overall Study||310
3079373|NCT01371994|3801279|FG001|Received Treatment|Overall Study||313
3079374|NCT01371994|3801278|FG000|COMPLETED|Overall Study||263
3079375|NCT01371994|3801279|FG001|COMPLETED|Overall Study||278
3079376|NCT01371994|3801278|FG000|NOT COMPLETED|Overall Study||57
3079377|NCT01371994|3801279|FG001|NOT COMPLETED|Overall Study||42
3079378|NCT01372085|3801295|FG000|STARTED|First Intervention (Period 1)||8
3079379|NCT01372085|3801296|FG001|STARTED|First Intervention (Period 1)||2
3079380|NCT01372085|3801297|FG002|STARTED|First Intervention (Period 1)||2
3079381|NCT01372085|3801298|FG003|STARTED|First Intervention (Period 1)||1
3079382|NCT01372085|3801299|FG004|STARTED|First Intervention (Period 1)|Replacement participant repeated Periods 1, 2 to fulfill treatment arm comparison requirements.|3
3079383|NCT01372085|3801300|FG005|STARTED|First Intervention (Period 1)||5
3079384|NCT01372085|3801301|FG006|STARTED|First Intervention (Period 1)||3
3079385|NCT01372085|3801302|FG007|STARTED|First Intervention (Period 1)||1
3079386|NCT01372085|3801303|FG008|STARTED|First Intervention (Period 1)||1
3079387|NCT01372085|3801304|FG009|STARTED|First Intervention (Period 1)||0
3079388|NCT01372085|3801295|FG000|COMPLETED|First Intervention (Period 1)||8
3079389|NCT01372085|3801296|FG001|COMPLETED|First Intervention (Period 1)||2
3079390|NCT01372085|3801297|FG002|COMPLETED|First Intervention (Period 1)||2
3079391|NCT01372085|3801298|FG003|COMPLETED|First Intervention (Period 1)||1
3079392|NCT01372085|3801299|FG004|COMPLETED|First Intervention (Period 1)||3
3079393|NCT01372085|3801300|FG005|COMPLETED|First Intervention (Period 1)||5
3079394|NCT01372085|3801301|FG006|COMPLETED|First Intervention (Period 1)||3
3079395|NCT01372085|3801302|FG007|COMPLETED|First Intervention (Period 1)||1
3079396|NCT01372085|3801303|FG008|COMPLETED|First Intervention (Period 1)||1
3079397|NCT01372085|3801304|FG009|COMPLETED|First Intervention (Period 1)||0
3079398|NCT01372085|3801295|FG000|NOT COMPLETED|First Intervention (Period 1)||0
3079399|NCT01372085|3801296|FG001|NOT COMPLETED|First Intervention (Period 1)||0
3079400|NCT01372085|3801297|FG002|NOT COMPLETED|First Intervention (Period 1)||0
3079401|NCT01372085|3801298|FG003|NOT COMPLETED|First Intervention (Period 1)||0
3079402|NCT01372085|3801299|FG004|NOT COMPLETED|First Intervention (Period 1)||0
3079403|NCT01372085|3801300|FG005|NOT COMPLETED|First Intervention (Period 1)||0
3079404|NCT01372085|3801301|FG006|NOT COMPLETED|First Intervention (Period 1)||0
3079405|NCT01372085|3801302|FG007|NOT COMPLETED|First Intervention (Period 1)||0
3079406|NCT01372085|3801303|FG008|NOT COMPLETED|First Intervention (Period 1)||0
3079407|NCT01372085|3801304|FG009|NOT COMPLETED|First Intervention (Period 1)||0
3079408|NCT01372085|3801295|FG000|STARTED|Washout Period 1|Pts completed one period and did not enter washout for Part A.|0
3079409|NCT01372085|3801296|FG001|STARTED|Washout Period 1|Pts completed one period and did not enter washout for Part A.|0
3079410|NCT01372085|3801297|FG002|STARTED|Washout Period 1||2
3079411|NCT01372085|3801298|FG003|STARTED|Washout Period 1||1
3079412|NCT01372085|3801299|FG004|STARTED|Washout Period 1||3
3079413|NCT01372085|3801300|FG005|STARTED|Washout Period 1||5
3079414|NCT01372085|3801301|FG006|STARTED|Washout Period 1||3
3079415|NCT01372085|3801302|FG007|STARTED|Washout Period 1||1
3079416|NCT01372085|3801303|FG008|STARTED|Washout Period 1||1
3079417|NCT01372085|3801304|FG009|STARTED|Washout Period 1||0
3079418|NCT01372085|3801295|FG000|COMPLETED|Washout Period 1||0
3079419|NCT01372085|3801296|FG001|COMPLETED|Washout Period 1||0
3079420|NCT01372085|3801297|FG002|COMPLETED|Washout Period 1||2
3079421|NCT01372085|3801298|FG003|COMPLETED|Washout Period 1||1
3079422|NCT01372085|3801299|FG004|COMPLETED|Washout Period 1||3
3079423|NCT01372085|3801300|FG005|COMPLETED|Washout Period 1||5
3079424|NCT01372085|3801301|FG006|COMPLETED|Washout Period 1||3
3079425|NCT01372085|3801302|FG007|COMPLETED|Washout Period 1||1
3079426|NCT01372085|3801303|FG008|COMPLETED|Washout Period 1||1
3079427|NCT01372085|3801304|FG009|COMPLETED|Washout Period 1||0
3079428|NCT01372085|3801295|FG000|NOT COMPLETED|Washout Period 1||0
3079429|NCT01372085|3801296|FG001|NOT COMPLETED|Washout Period 1||0
3079430|NCT01372085|3801297|FG002|NOT COMPLETED|Washout Period 1||0
3079431|NCT01372085|3801298|FG003|NOT COMPLETED|Washout Period 1||0
3079432|NCT01372085|3801299|FG004|NOT COMPLETED|Washout Period 1||0
3079433|NCT01372085|3801300|FG005|NOT COMPLETED|Washout Period 1||0
3079434|NCT01372085|3801301|FG006|NOT COMPLETED|Washout Period 1||0
3079435|NCT01372085|3801302|FG007|NOT COMPLETED|Washout Period 1||0
3079436|NCT01372085|3801303|FG008|NOT COMPLETED|Washout Period 1||0
3079437|NCT01372085|3801304|FG009|NOT COMPLETED|Washout Period 1||0
3079438|NCT01372085|3801295|FG000|STARTED|Second Intervention (Period 2)||0
3079439|NCT01372085|3801296|FG001|STARTED|Second Intervention (Period 2)||0
3079440|NCT01372085|3801297|FG002|STARTED|Second Intervention (Period 2)||2
3079441|NCT01372085|3801298|FG003|STARTED|Second Intervention (Period 2)||1
3079442|NCT01372085|3801299|FG004|STARTED|Second Intervention (Period 2)||3
3079443|NCT01372085|3801300|FG005|STARTED|Second Intervention (Period 2)||5
3079444|NCT01372085|3801301|FG006|STARTED|Second Intervention (Period 2)||3
3079445|NCT01372085|3801302|FG007|STARTED|Second Intervention (Period 2)||1
3079446|NCT01372085|3801303|FG008|STARTED|Second Intervention (Period 2)||1
3079447|NCT01372085|3801304|FG009|STARTED|Second Intervention (Period 2)||0
3079448|NCT01372085|3801295|FG000|COMPLETED|Second Intervention (Period 2)||0
3079449|NCT01372085|3801296|FG001|COMPLETED|Second Intervention (Period 2)||0
3079450|NCT01372085|3801297|FG002|COMPLETED|Second Intervention (Period 2)||2
3079451|NCT01372085|3801298|FG003|COMPLETED|Second Intervention (Period 2)||1
3079452|NCT01372085|3801299|FG004|COMPLETED|Second Intervention (Period 2)||3
3079453|NCT01372085|3801300|FG005|COMPLETED|Second Intervention (Period 2)||5
3079454|NCT01372085|3801301|FG006|COMPLETED|Second Intervention (Period 2)||3
3079455|NCT01372085|3801302|FG007|COMPLETED|Second Intervention (Period 2)||1
3079456|NCT01372085|3801303|FG008|COMPLETED|Second Intervention (Period 2)||1
3079457|NCT01372085|3801304|FG009|COMPLETED|Second Intervention (Period 2)||0
3079458|NCT01372085|3801295|FG000|NOT COMPLETED|Second Intervention (Period 2)||0
3079459|NCT01372085|3801296|FG001|NOT COMPLETED|Second Intervention (Period 2)||0
3079460|NCT01372085|3801297|FG002|NOT COMPLETED|Second Intervention (Period 2)||0
3079461|NCT01372085|3801298|FG003|NOT COMPLETED|Second Intervention (Period 2)||0
3079462|NCT01372085|3801299|FG004|NOT COMPLETED|Second Intervention (Period 2)||0
3079463|NCT01372085|3801300|FG005|NOT COMPLETED|Second Intervention (Period 2)||0
3079464|NCT01372085|3801301|FG006|NOT COMPLETED|Second Intervention (Period 2)||0
3079465|NCT01372085|3801302|FG007|NOT COMPLETED|Second Intervention (Period 2)||0
3079466|NCT01372085|3801303|FG008|NOT COMPLETED|Second Intervention (Period 2)||0
3079467|NCT01372085|3801304|FG009|NOT COMPLETED|Second Intervention (Period 2)||0
3079468|NCT01372085|3801295|FG000|STARTED|Washout Period 2||0
3079469|NCT01372085|3801296|FG001|STARTED|Washout Period 2||0
3079470|NCT01372085|3801297|FG002|STARTED|Washout Period 2||2
3079471|NCT01372085|3801298|FG003|STARTED|Washout Period 2||1
3079472|NCT01372085|3801299|FG004|STARTED|Washout Period 2||3
3079473|NCT01372085|3801300|FG005|STARTED|Washout Period 2||5
3079474|NCT01372085|3801301|FG006|STARTED|Washout Period 2||3
3079475|NCT01372085|3801302|FG007|STARTED|Washout Period 2||1
3079476|NCT01372085|3801303|FG008|STARTED|Washout Period 2||1
3079477|NCT01372085|3801304|FG009|STARTED|Washout Period 2||0
3079478|NCT01372085|3801295|FG000|COMPLETED|Washout Period 2||0
3079479|NCT01372085|3801296|FG001|COMPLETED|Washout Period 2||0
3079480|NCT01372085|3801297|FG002|COMPLETED|Washout Period 2||2
3079481|NCT01372085|3801298|FG003|COMPLETED|Washout Period 2||1
3079482|NCT01372085|3801299|FG004|COMPLETED|Washout Period 2|One participant discontinued Washout Period 2 and was replaced in Period 1.|2
3079483|NCT01372085|3801300|FG005|COMPLETED|Washout Period 2||5
3079484|NCT01372085|3801301|FG006|COMPLETED|Washout Period 2||3
3079485|NCT01372085|3801302|FG007|COMPLETED|Washout Period 2||1
3079486|NCT01372085|3801303|FG008|COMPLETED|Washout Period 2||1
3079487|NCT01372085|3801304|FG009|COMPLETED|Washout Period 2||0
3079488|NCT01372085|3801295|FG000|NOT COMPLETED|Washout Period 2||0
3079489|NCT01372085|3801296|FG001|NOT COMPLETED|Washout Period 2||0
3079490|NCT01372085|3801297|FG002|NOT COMPLETED|Washout Period 2||0
3079491|NCT01372085|3801298|FG003|NOT COMPLETED|Washout Period 2||0
3079492|NCT01372085|3801299|FG004|NOT COMPLETED|Washout Period 2||1
3079493|NCT01372085|3801300|FG005|NOT COMPLETED|Washout Period 2||0
3079494|NCT01372085|3801301|FG006|NOT COMPLETED|Washout Period 2||0
3079495|NCT01372085|3801302|FG007|NOT COMPLETED|Washout Period 2||0
3079496|NCT01372085|3801303|FG008|NOT COMPLETED|Washout Period 2||0
3079497|NCT01372085|3801304|FG009|NOT COMPLETED|Washout Period 2||0
3079498|NCT01372085|3801295|FG000|STARTED|Third Intervention (Period 3)||0
3079499|NCT01372085|3801296|FG001|STARTED|Third Intervention (Period 3)||0
3079500|NCT01372085|3801297|FG002|STARTED|Third Intervention (Period 3)||2
3079501|NCT01372085|3801298|FG003|STARTED|Third Intervention (Period 3)||1
3079502|NCT01372085|3801299|FG004|STARTED|Third Intervention (Period 3)||2
3079503|NCT01372085|3801300|FG005|STARTED|Third Intervention (Period 3)|Replacement pts repeated Period (P) 3 to fulfill requirement for P3 versus P4a comparison.|7
3079504|NCT01372085|3801301|FG006|STARTED|Third Intervention (Period 3)||3
3079505|NCT01372085|3801302|FG007|STARTED|Third Intervention (Period 3)||1
3079506|NCT01372085|3801303|FG008|STARTED|Third Intervention (Period 3)||1
3079507|NCT01372085|3801304|FG009|STARTED|Third Intervention (Period 3)||0
3079508|NCT01372085|3801295|FG000|COMPLETED|Third Intervention (Period 3)||0
3079509|NCT01372085|3801296|FG001|COMPLETED|Third Intervention (Period 3)||0
3079510|NCT01372085|3801297|FG002|COMPLETED|Third Intervention (Period 3)||2
3079511|NCT01372085|3801298|FG003|COMPLETED|Third Intervention (Period 3)||1
3079512|NCT01372085|3801299|FG004|COMPLETED|Third Intervention (Period 3)||2
3079513|NCT01372085|3801300|FG005|COMPLETED|Third Intervention (Period 3)||7
3079514|NCT01372085|3801301|FG006|COMPLETED|Third Intervention (Period 3)||3
3079515|NCT01372085|3801302|FG007|COMPLETED|Third Intervention (Period 3)||1
3079516|NCT01372085|3801303|FG008|COMPLETED|Third Intervention (Period 3)||1
3079517|NCT01372085|3801304|FG009|COMPLETED|Third Intervention (Period 3)||0
3079518|NCT01372085|3801295|FG000|NOT COMPLETED|Third Intervention (Period 3)||0
3079519|NCT01372085|3801296|FG001|NOT COMPLETED|Third Intervention (Period 3)||0
3079520|NCT01372085|3801297|FG002|NOT COMPLETED|Third Intervention (Period 3)||0
3079521|NCT01372085|3801298|FG003|NOT COMPLETED|Third Intervention (Period 3)||0
3079522|NCT01372085|3801299|FG004|NOT COMPLETED|Third Intervention (Period 3)||0
3079523|NCT01372085|3801300|FG005|NOT COMPLETED|Third Intervention (Period 3)||0
3079524|NCT01372085|3801301|FG006|NOT COMPLETED|Third Intervention (Period 3)||0
3079525|NCT01372085|3801302|FG007|NOT COMPLETED|Third Intervention (Period 3)||0
3079526|NCT01372085|3801303|FG008|NOT COMPLETED|Third Intervention (Period 3)||0
3079527|NCT01372085|3801304|FG009|NOT COMPLETED|Third Intervention (Period 3)||0
3079528|NCT01372085|3801295|FG000|STARTED|Washout Period 3||0
3079529|NCT01372085|3801296|FG001|STARTED|Washout Period 3||0
3079530|NCT01372085|3801297|FG002|STARTED|Washout Period 3||2
3079531|NCT01372085|3801298|FG003|STARTED|Washout Period 3||1
3079532|NCT01372085|3801299|FG004|STARTED|Washout Period 3||2
3079533|NCT01372085|3801300|FG005|STARTED|Washout Period 3||7
3079534|NCT01372085|3801301|FG006|STARTED|Washout Period 3||3
3079535|NCT01372085|3801302|FG007|STARTED|Washout Period 3||1
3079536|NCT01372085|3801303|FG008|STARTED|Washout Period 3||1
3079537|NCT01372085|3801304|FG009|STARTED|Washout Period 3||0
3079538|NCT01372085|3801295|FG000|COMPLETED|Washout Period 3||0
3079539|NCT01372085|3801296|FG001|COMPLETED|Washout Period 3||0
3079540|NCT01372085|3801297|FG002|COMPLETED|Washout Period 3||2
3079541|NCT01372085|3801298|FG003|COMPLETED|Washout Period 3||1
3079542|NCT01372085|3801299|FG004|COMPLETED|Washout Period 3||2
3079543|NCT01372085|3801300|FG005|COMPLETED|Washout Period 3|Two participants (pts) discontinued Washout P3 and were replaced in P3.|5
3079544|NCT01372085|3801301|FG006|COMPLETED|Washout Period 3||3
3079545|NCT01372085|3801302|FG007|COMPLETED|Washout Period 3||1
3079546|NCT01372085|3801303|FG008|COMPLETED|Washout Period 3||1
3079547|NCT01372085|3801304|FG009|COMPLETED|Washout Period 3||0
3079548|NCT01372085|3801295|FG000|NOT COMPLETED|Washout Period 3||0
3079549|NCT01372085|3801296|FG001|NOT COMPLETED|Washout Period 3||0
3079550|NCT01372085|3801297|FG002|NOT COMPLETED|Washout Period 3||0
3079551|NCT01372085|3801298|FG003|NOT COMPLETED|Washout Period 3||0
3079552|NCT01372085|3801299|FG004|NOT COMPLETED|Washout Period 3||0
3079553|NCT01372085|3801300|FG005|NOT COMPLETED|Washout Period 3||2
3079554|NCT01372085|3801301|FG006|NOT COMPLETED|Washout Period 3||0
3079555|NCT01372085|3801302|FG007|NOT COMPLETED|Washout Period 3||0
3079556|NCT01372085|3801303|FG008|NOT COMPLETED|Washout Period 3||0
3079557|NCT01372085|3801304|FG009|NOT COMPLETED|Washout Period 3||0
3079558|NCT01372085|3801295|FG000|STARTED|Forth Intervention (Period 4a/4b)||0
3079559|NCT01372085|3801296|FG001|STARTED|Forth Intervention (Period 4a/4b)||0
3079560|NCT01372085|3801297|FG002|STARTED|Forth Intervention (Period 4a/4b)||2
3079561|NCT01372085|3801298|FG003|STARTED|Forth Intervention (Period 4a/4b)||1
3079562|NCT01372085|3801299|FG004|STARTED|Forth Intervention (Period 4a/4b)||2
3079563|NCT01372085|3801300|FG005|STARTED|Forth Intervention (Period 4a/4b)||5
3079564|NCT01372085|3801301|FG006|STARTED|Forth Intervention (Period 4a/4b)||3
3079565|NCT01372085|3801302|FG007|STARTED|Forth Intervention (Period 4a/4b)||1
3079566|NCT01372085|3801303|FG008|STARTED|Forth Intervention (Period 4a/4b)||1
3079567|NCT01372085|3801304|FG009|STARTED|Forth Intervention (Period 4a/4b)|One pt was enrolled directly into P4b to fulfill requirement for safety and tolerability assessment.|1
3079568|NCT01372085|3801295|FG000|COMPLETED|Forth Intervention (Period 4a/4b)||0
3079569|NCT01372085|3801296|FG001|COMPLETED|Forth Intervention (Period 4a/4b)||0
3079570|NCT01372085|3801297|FG002|COMPLETED|Forth Intervention (Period 4a/4b)||2
3079571|NCT01372085|3801298|FG003|COMPLETED|Forth Intervention (Period 4a/4b)||1
3079572|NCT01372085|3801299|FG004|COMPLETED|Forth Intervention (Period 4a/4b)||2
3079573|NCT01372085|3801300|FG005|COMPLETED|Forth Intervention (Period 4a/4b)||5
3079574|NCT01372085|3801301|FG006|COMPLETED|Forth Intervention (Period 4a/4b)||3
3079575|NCT01372085|3801302|FG007|COMPLETED|Forth Intervention (Period 4a/4b)||1
3079576|NCT01372085|3801303|FG008|COMPLETED|Forth Intervention (Period 4a/4b)||1
3079577|NCT01372085|3801304|FG009|COMPLETED|Forth Intervention (Period 4a/4b)||1
3079578|NCT01372085|3801295|FG000|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
3079579|NCT01372085|3801296|FG001|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
3079580|NCT01372085|3801297|FG002|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
3079581|NCT01372085|3801298|FG003|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
3079582|NCT01372085|3801299|FG004|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
3079583|NCT01372085|3801300|FG005|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
3079584|NCT01372085|3801301|FG006|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
3079585|NCT01372085|3801302|FG007|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
3079586|NCT01372085|3801303|FG008|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
3079587|NCT01372085|3801304|FG009|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
3079588|NCT01372150|3801331|FG000|STARTED|Overall Study||112
3079589|NCT01372150|3801332|FG001|STARTED|Overall Study||113
3079590|NCT01372150|3801333|FG002|STARTED|Overall Study||115
3079591|NCT01372150|3801331|FG000|Treated|Overall Study||112
3079592|NCT01372150|3801332|FG001|Treated|Overall Study||112
3079593|NCT01372150|3801333|FG002|Treated|Overall Study||115
3079594|NCT01372150|3801331|FG000|COMPLETED|Overall Study||99
3079595|NCT01372150|3801332|FG001|COMPLETED|Overall Study||99
3079596|NCT01372150|3801333|FG002|COMPLETED|Overall Study||99
3079597|NCT01372150|3801331|FG000|NOT COMPLETED|Overall Study||13
3079598|NCT01372150|3801332|FG001|NOT COMPLETED|Overall Study||14
3079599|NCT01372150|3801333|FG002|NOT COMPLETED|Overall Study||16
3079600|NCT01372202|3801344|FG000|STARTED|Overall Study||13
3079601|NCT01372202|3801345|FG001|STARTED|Overall Study||9
3079602|NCT01372202|3801346|FG002|STARTED|Overall Study||9
3079603|NCT01372202|3801344|FG000|COMPLETED|Overall Study||13
3079604|NCT01372202|3801345|FG001|COMPLETED|Overall Study||9
3079605|NCT01372202|3801346|FG002|COMPLETED|Overall Study||9
3079606|NCT01372202|3801344|FG000|NOT COMPLETED|Overall Study||0
3079607|NCT01372202|3801345|FG001|NOT COMPLETED|Overall Study||0
3079608|NCT01372202|3801346|FG002|NOT COMPLETED|Overall Study||0
3079609|NCT01372254|3801361|FG000|STARTED|Overall Study||47
3079610|NCT01372254|3801362|FG001|STARTED|Overall Study||49
3079611|NCT01372254|3801361|FG000|COMPLETED|Overall Study||43
3079612|NCT01372254|3801362|FG001|COMPLETED|Overall Study||46
3079613|NCT01372254|3801361|FG000|NOT COMPLETED|Overall Study||4
3079614|NCT01372254|3801362|FG001|NOT COMPLETED|Overall Study||3
3079615|NCT01372384|3801368|FG000|STARTED|Overall Study||6
3079616|NCT01372384|3801368|FG000|COMPLETED|Overall Study||3
3079617|NCT01372384|3801368|FG000|NOT COMPLETED|Overall Study||3
3079618|NCT01372410|3801372|FG000|STARTED|Treatment Period 1 (7 Days)||20
3079619|NCT01372410|3801373|FG001|STARTED|Treatment Period 1 (7 Days)||21
3079620|NCT01372410|3801374|FG002|STARTED|Treatment Period 1 (7 Days)||19
3079621|NCT01372410|3801375|FG003|STARTED|Treatment Period 1 (7 Days)||20
3079622|NCT01372410|3801376|FG004|STARTED|Treatment Period 1 (7 Days)||21
3079623|NCT01372410|3801377|FG005|STARTED|Treatment Period 1 (7 Days)||21
3079624|NCT01372410|3801378|FG006|STARTED|Treatment Period 1 (7 Days)||22
3079625|NCT01372410|3801379|FG007|STARTED|Treatment Period 1 (7 Days)||19
3079626|NCT01372410|3801372|FG000|COMPLETED|Treatment Period 1 (7 Days)||19
3079627|NCT01372410|3801373|FG001|COMPLETED|Treatment Period 1 (7 Days)||19
3079628|NCT01372410|3801374|FG002|COMPLETED|Treatment Period 1 (7 Days)||19
3079629|NCT01372410|3801375|FG003|COMPLETED|Treatment Period 1 (7 Days)||20
3079630|NCT01372410|3801376|FG004|COMPLETED|Treatment Period 1 (7 Days)||19
3079631|NCT01372410|3801377|FG005|COMPLETED|Treatment Period 1 (7 Days)||21
3079632|NCT01372410|3801378|FG006|COMPLETED|Treatment Period 1 (7 Days)||20
3079633|NCT01372410|3801379|FG007|COMPLETED|Treatment Period 1 (7 Days)||19
3079634|NCT01372410|3801372|FG000|NOT COMPLETED|Treatment Period 1 (7 Days)||1
3079635|NCT01372410|3801373|FG001|NOT COMPLETED|Treatment Period 1 (7 Days)||2
3079636|NCT01372410|3801374|FG002|NOT COMPLETED|Treatment Period 1 (7 Days)||0
3079637|NCT01372410|3801375|FG003|NOT COMPLETED|Treatment Period 1 (7 Days)||0
3079638|NCT01372410|3801376|FG004|NOT COMPLETED|Treatment Period 1 (7 Days)||2
3079639|NCT01372410|3801377|FG005|NOT COMPLETED|Treatment Period 1 (7 Days)||0
3079640|NCT01372410|3801378|FG006|NOT COMPLETED|Treatment Period 1 (7 Days)||2
3079641|NCT01372410|3801379|FG007|NOT COMPLETED|Treatment Period 1 (7 Days)||0
3079642|NCT01372410|3801372|FG000|STARTED|Washout Period 1 (10-14 Days)||19
3079643|NCT01372410|3801373|FG001|STARTED|Washout Period 1 (10-14 Days)||19
3079644|NCT01372410|3801374|FG002|STARTED|Washout Period 1 (10-14 Days)||19
3079645|NCT01372410|3801375|FG003|STARTED|Washout Period 1 (10-14 Days)||20
3079646|NCT01372410|3801376|FG004|STARTED|Washout Period 1 (10-14 Days)||19
3079647|NCT01372410|3801377|FG005|STARTED|Washout Period 1 (10-14 Days)||21
3079648|NCT01372410|3801378|FG006|STARTED|Washout Period 1 (10-14 Days)||20
3079649|NCT01372410|3801379|FG007|STARTED|Washout Period 1 (10-14 Days)||19
3079650|NCT01372410|3801372|FG000|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|18
3079651|NCT01372410|3801373|FG001|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|19
3079652|NCT01372410|3801374|FG002|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|19
3079653|NCT01372410|3801375|FG003|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|20
3079654|NCT01372410|3801376|FG004|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|19
3079655|NCT01372410|3801377|FG005|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|21
3079656|NCT01372410|3801378|FG006|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|20
3079657|NCT01372410|3801379|FG007|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|18
3079658|NCT01372410|3801372|FG000|NOT COMPLETED|Washout Period 1 (10-14 Days)||1
3079659|NCT01372410|3801373|FG001|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
3079660|NCT01372410|3801374|FG002|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
3079661|NCT01372410|3801375|FG003|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
3079662|NCT01372410|3801376|FG004|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
3079663|NCT01372410|3801377|FG005|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
3079664|NCT01372410|3801378|FG006|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
3079665|NCT01372410|3801379|FG007|NOT COMPLETED|Washout Period 1 (10-14 Days)||1
3079666|NCT01372410|3801372|FG000|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|19
3079667|NCT01372410|3801373|FG001|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|21
3079668|NCT01372410|3801374|FG002|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|22
3079669|NCT01372410|3801375|FG003|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|17
3079670|NCT01372410|3801376|FG004|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|19
3079671|NCT01372410|3801377|FG005|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|16
3079672|NCT01372410|3801378|FG006|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|21
3134709|NCT01702025|3859583|FG002|NOT COMPLETED|Overall Study||1
3285596|NCT02775617|4019322|FG000|NOT COMPLETED|Overall Study||48
3285597|NCT02775617|4019323|FG001|NOT COMPLETED|Overall Study||160
3285598|NCT02775864|4019333|FG000|STARTED|Overall Study||26014
3285599|NCT02775864|4019334|FG001|STARTED|Overall Study||31117
3285600|NCT02775864|4019335|FG002|STARTED|Overall Study||11941
3079673|NCT01372410|3801379|FG007|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|19
3079674|NCT01372410|3801372|FG000|COMPLETED|Treatment Period 2 (7 Days)||19
3079675|NCT01372410|3801373|FG001|COMPLETED|Treatment Period 2 (7 Days)||21
3079676|NCT01372410|3801374|FG002|COMPLETED|Treatment Period 2 (7 Days)||22
3079677|NCT01372410|3801375|FG003|COMPLETED|Treatment Period 2 (7 Days)||17
3079678|NCT01372410|3801376|FG004|COMPLETED|Treatment Period 2 (7 Days)||19
3079679|NCT01372410|3801377|FG005|COMPLETED|Treatment Period 2 (7 Days)||16
3079680|NCT01372410|3801378|FG006|COMPLETED|Treatment Period 2 (7 Days)||21
3079681|NCT01372410|3801379|FG007|COMPLETED|Treatment Period 2 (7 Days)||19
3079682|NCT01372410|3801372|FG000|NOT COMPLETED|Treatment Period 2 (7 Days)||0
3079683|NCT01372410|3801373|FG001|NOT COMPLETED|Treatment Period 2 (7 Days)||0
3079684|NCT01372410|3801374|FG002|NOT COMPLETED|Treatment Period 2 (7 Days)||0
3079685|NCT01372410|3801375|FG003|NOT COMPLETED|Treatment Period 2 (7 Days)||0
3079686|NCT01372410|3801376|FG004|NOT COMPLETED|Treatment Period 2 (7 Days)||0
3079687|NCT01372410|3801377|FG005|NOT COMPLETED|Treatment Period 2 (7 Days)||0
3079688|NCT01372410|3801378|FG006|NOT COMPLETED|Treatment Period 2 (7 Days)||0
3079689|NCT01372410|3801379|FG007|NOT COMPLETED|Treatment Period 2 (7 Days)||0
3079690|NCT01372410|3801372|FG000|STARTED|Washout Period 2 (10-14 Days)||19
3079691|NCT01372410|3801373|FG001|STARTED|Washout Period 2 (10-14 Days)||21
3079692|NCT01372410|3801374|FG002|STARTED|Washout Period 2 (10-14 Days)||22
3079693|NCT01372410|3801375|FG003|STARTED|Washout Period 2 (10-14 Days)||17
3079694|NCT01372410|3801376|FG004|STARTED|Washout Period 2 (10-14 Days)||19
3079695|NCT01372410|3801377|FG005|STARTED|Washout Period 2 (10-14 Days)||16
3079696|NCT01372410|3801378|FG006|STARTED|Washout Period 2 (10-14 Days)||21
3079697|NCT01372410|3801379|FG007|STARTED|Washout Period 2 (10-14 Days)||19
3079698|NCT01372410|3801372|FG000|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|19
3079699|NCT01372410|3801373|FG001|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|21
3079700|NCT01372410|3801374|FG002|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|22
3079701|NCT01372410|3801375|FG003|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|17
3134710|NCT01702025|3859584|FG003|NOT COMPLETED|Overall Study||0
3285601|NCT02775864|4019336|FG003|STARTED|Overall Study||12849
3285602|NCT02775864|4019333|FG000|COMPLETED|Overall Study||22772
3285603|NCT02775864|4019334|FG001|COMPLETED|Overall Study||26218
3285604|NCT02775864|4019335|FG002|COMPLETED|Overall Study||10081
3285605|NCT02775864|4019336|FG003|COMPLETED|Overall Study||10765
3285606|NCT02775864|4019333|FG000|NOT COMPLETED|Overall Study||3242
3285607|NCT02775864|4019334|FG001|NOT COMPLETED|Overall Study||4899
3285608|NCT02775864|4019335|FG002|NOT COMPLETED|Overall Study||1860
3285609|NCT02775864|4019336|FG003|NOT COMPLETED|Overall Study||2084
3285610|NCT02775903|4019351|FG000|STARTED|Overall Study||42
3285611|NCT02775903|4019352|FG001|STARTED|Overall Study||42
3285612|NCT02775903|4019353|FG002|STARTED|Overall Study||64
3285613|NCT02775903|4019354|FG003|STARTED|Overall Study||65
3285614|NCT02775903|4019351|FG000|Received Study Treatment|Overall Study||38
3285615|NCT02775903|4019352|FG001|Received Study Treatment|Overall Study||41
3285616|NCT02775903|4019353|FG002|Received Study Treatment|Overall Study||64
3285617|NCT02775903|4019354|FG003|Received Study Treatment|Overall Study||62
3285618|NCT02775903|4019351|FG000|COMPLETED|Overall Study||0
3285619|NCT02775903|4019352|FG001|COMPLETED|Overall Study||1
3285620|NCT02775903|4019353|FG002|COMPLETED|Overall Study||0
3285621|NCT02775903|4019354|FG003|COMPLETED|Overall Study||0
3285622|NCT02775903|4019351|FG000|NOT COMPLETED|Overall Study||42
3285623|NCT02775903|4019352|FG001|NOT COMPLETED|Overall Study||41
3285624|NCT02775903|4019353|FG002|NOT COMPLETED|Overall Study||64
3285625|NCT02775903|4019354|FG003|NOT COMPLETED|Overall Study||65
3285626|NCT02775916|4019370|FG000|STARTED|Overall Study||20
3285627|NCT02775916|4019371|FG001|STARTED|Overall Study||10
3285628|NCT02775916|4019370|FG000|COMPLETED|Overall Study||17
3285629|NCT02775916|4019371|FG001|COMPLETED|Overall Study||10
3285630|NCT02775916|4019370|FG000|NOT COMPLETED|Overall Study||3
3285631|NCT02775916|4019371|FG001|NOT COMPLETED|Overall Study||0
3285632|NCT02776033|4019380|FG000|STARTED|Overall Study||18
3285633|NCT02776033|4019381|FG001|STARTED|Overall Study||23
3285634|NCT02776033|4019382|FG002|STARTED|Overall Study||24
3285635|NCT02776033|4019380|FG000|COMPLETED|Overall Study||14
3285636|NCT02776033|4019381|FG001|COMPLETED|Overall Study||21
3285637|NCT02776033|4019382|FG002|COMPLETED|Overall Study||22
3285638|NCT02776033|4019380|FG000|NOT COMPLETED|Overall Study||4
3285639|NCT02776033|4019381|FG001|NOT COMPLETED|Overall Study||2
3285640|NCT02776033|4019382|FG002|NOT COMPLETED|Overall Study||2
3285641|NCT02776553|4019398|FG000|STARTED|Overall Study|One subject was eliminated for repeated hospitalizations.|9
3285642|NCT02776553|4019399|FG001|STARTED|Overall Study|Two subjects were eliminated for repeated hospitalizations.|8
3285643|NCT02776553|4019398|FG000|COMPLETED|Overall Study||6
3285644|NCT02776553|4019399|FG001|COMPLETED|Overall Study||5
3285645|NCT02776553|4019398|FG000|NOT COMPLETED|Overall Study||3
3285646|NCT02776553|4019399|FG001|NOT COMPLETED|Overall Study||3
3285647|NCT02776644|4019407|FG000|STARTED|Overall Study||1223
3285648|NCT02776644|4019408|FG001|STARTED|Overall Study||126
3285649|NCT02776644|4019407|FG000|COMPLETED|Overall Study||1223
3285650|NCT02776644|4019408|FG001|COMPLETED|Overall Study||126
3285651|NCT02776644|4019407|FG000|NOT COMPLETED|Overall Study||0
3285652|NCT02776644|4019408|FG001|NOT COMPLETED|Overall Study||0
3079702|NCT01372410|3801376|FG004|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|17
3079703|NCT01372410|3801377|FG005|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|16
3079704|NCT01372410|3801378|FG006|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|20
3079705|NCT01372410|3801379|FG007|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|17
3079706|NCT01372410|3801372|FG000|NOT COMPLETED|Washout Period 2 (10-14 Days)||0
3079707|NCT01372410|3801373|FG001|NOT COMPLETED|Washout Period 2 (10-14 Days)||0
3079708|NCT01372410|3801374|FG002|NOT COMPLETED|Washout Period 2 (10-14 Days)||0
3079709|NCT01372410|3801375|FG003|NOT COMPLETED|Washout Period 2 (10-14 Days)||0
3079710|NCT01372410|3801376|FG004|NOT COMPLETED|Washout Period 2 (10-14 Days)||2
3079711|NCT01372410|3801377|FG005|NOT COMPLETED|Washout Period 2 (10-14 Days)||0
3079712|NCT01372410|3801378|FG006|NOT COMPLETED|Washout Period 2 (10-14 Days)||1
3079713|NCT01372410|3801379|FG007|NOT COMPLETED|Washout Period 2 (10-14 Days)||2
3079714|NCT01372410|3801372|FG000|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|21
3079715|NCT01372410|3801373|FG001|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|18
3079716|NCT01372410|3801374|FG002|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|16
3079717|NCT01372410|3801375|FG003|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|22
3285653|NCT02776670|4019416|FG000|STARTED|Overall Study||117
3285654|NCT02776670|4019417|FG001|STARTED|Overall Study||114
3285655|NCT02776670|4019416|FG000|Full Analysis Set (FAS)|Overall Study||117
3285656|NCT02776670|4019417|FG001|Full Analysis Set (FAS)|Overall Study||114
3285657|NCT02776670|4019416|FG000|Per Protocol Analysis Set (PPS)|Overall Study||115
3285658|NCT02776670|4019417|FG001|Per Protocol Analysis Set (PPS)|Overall Study||113
3285659|NCT02776670|4019416|FG000|Safety Analysis Set|Overall Study||117
3285660|NCT02776670|4019417|FG001|Safety Analysis Set|Overall Study||114
3285661|NCT02776670|4019416|FG000|COMPLETED|Overall Study||117
3285662|NCT02776670|4019417|FG001|COMPLETED|Overall Study||108
3285663|NCT02776670|4019416|FG000|NOT COMPLETED|Overall Study||0
3285664|NCT02776670|4019417|FG001|NOT COMPLETED|Overall Study||6
3285665|NCT02776683|4019423|FG000|STARTED|Pre-switch Period|Assigned to trial medication or enrolled/treated|123
3285666|NCT02776683|4019424|FG001|STARTED|Pre-switch Period||0
3285667|NCT02776683|4019423|FG000|COMPLETED|Pre-switch Period|Entered into Switch Set|43
3285668|NCT02776683|4019424|FG001|COMPLETED|Pre-switch Period||0
3285669|NCT02776683|4019423|FG000|NOT COMPLETED|Pre-switch Period||80
3285670|NCT02776683|4019424|FG001|NOT COMPLETED|Pre-switch Period||0
3285671|NCT02776683|4019423|FG000|STARTED|Post-switch Period||0
3285672|NCT02776683|4019424|FG001|STARTED|Post-switch Period|Entered into Switch Set|43
3285673|NCT02776683|4019423|FG000|COMPLETED|Post-switch Period||0
3285674|NCT02776683|4019424|FG001|COMPLETED|Post-switch Period||0
3285675|NCT02776683|4019423|FG000|NOT COMPLETED|Post-switch Period||0
3285676|NCT02776683|4019424|FG001|NOT COMPLETED|Post-switch Period||43
3285677|NCT02776774|4019428|FG000|STARTED|Overall Study||91
3285678|NCT02776774|4019428|FG000|COMPLETED|Overall Study|Total after data cleaning|91
3285679|NCT02776774|4019428|FG000|NOT COMPLETED|Overall Study||0
3285680|NCT02776904|4019434|FG000|STARTED|Overall Study||281
3285681|NCT02776904|4019435|FG001|STARTED|Overall Study||46
3285682|NCT02776904|4019434|FG000|Gait Assessment|Overall Study||178
3285683|NCT02776904|4019435|FG001|Gait Assessment|Overall Study||32
3285684|NCT02776904|4019434|FG000|ImPACT|Overall Study||21
3285685|NCT02776904|4019435|FG001|ImPACT|Overall Study|ImPACT testing for the concussed subjects was completed for the clinical assessment (not research).|46
3285686|NCT02776904|4019434|FG000|COMPLETED|Overall Study||281
3285687|NCT02776904|4019435|FG001|COMPLETED|Overall Study||46
3285688|NCT02776904|4019434|FG000|NOT COMPLETED|Overall Study||0
3285689|NCT02776904|4019435|FG001|NOT COMPLETED|Overall Study||0
3285690|NCT02777021|4019450|FG000|STARTED|Overall Study||60
3285691|NCT02777021|4019451|FG001|STARTED|Overall Study||94
3285692|NCT02777021|4019450|FG000|COMPLETED|Overall Study||43
3285693|NCT02777021|4019451|FG001|COMPLETED|Overall Study||77
3285694|NCT02777021|4019450|FG000|NOT COMPLETED|Overall Study||17
3285695|NCT02777021|4019451|FG001|NOT COMPLETED|Overall Study||17
3285696|NCT02777086|4019459|FG000|STARTED|Overall Study||261
3285697|NCT02777086|4019460|FG001|STARTED|Overall Study||250
3285698|NCT02777086|4019459|FG000|COMPLETED|Overall Study||165
3285699|NCT02777086|4019460|FG001|COMPLETED|Overall Study||151
3285700|NCT02777086|4019459|FG000|NOT COMPLETED|Overall Study||96
3285701|NCT02777086|4019460|FG001|NOT COMPLETED|Overall Study||99
3285702|NCT02777125|4019468|FG000|STARTED|Overall Study||488
3285703|NCT02777125|4019469|FG001|STARTED|Overall Study||492
3285704|NCT02777125|4019468|FG000|COMPLETED|Overall Study||445
3285705|NCT02777125|4019469|FG001|COMPLETED|Overall Study||445
3285706|NCT02777125|4019468|FG000|NOT COMPLETED|Overall Study||43
3285707|NCT02777125|4019469|FG001|NOT COMPLETED|Overall Study||47
3285708|NCT02777242|4019476|FG000|STARTED|Overall Study||65
3285709|NCT02777242|4019476|FG000|COMPLETED|Overall Study||59
3285710|NCT02777242|4019476|FG000|NOT COMPLETED|Overall Study||6
3285711|NCT02777268|4019480|FG000|STARTED|Overall Study||16
3285712|NCT02777268|4019480|FG000|COMPLETED|Overall Study||16
3285713|NCT02777268|4019480|FG000|NOT COMPLETED|Overall Study||0
3285714|NCT02777333|4019504|FG000|STARTED|Overall Study||15
3079718|NCT01372410|3801376|FG004|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|20
3079719|NCT01372410|3801377|FG005|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|19
3079720|NCT01372410|3801378|FG006|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|15
3079721|NCT01372410|3801379|FG007|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|18
3079722|NCT01372410|3801372|FG000|COMPLETED|Treatment Period 3 (7 Days)||21
3079723|NCT01372410|3801373|FG001|COMPLETED|Treatment Period 3 (7 Days)||18
3079724|NCT01372410|3801374|FG002|COMPLETED|Treatment Period 3 (7 Days)||15
3079725|NCT01372410|3801375|FG003|COMPLETED|Treatment Period 3 (7 Days)||22
3079726|NCT01372410|3801376|FG004|COMPLETED|Treatment Period 3 (7 Days)||20
3079727|NCT01372410|3801377|FG005|COMPLETED|Treatment Period 3 (7 Days)||18
3079728|NCT01372410|3801378|FG006|COMPLETED|Treatment Period 3 (7 Days)||15
3079729|NCT01372410|3801379|FG007|COMPLETED|Treatment Period 3 (7 Days)||18
3079730|NCT01372410|3801372|FG000|NOT COMPLETED|Treatment Period 3 (7 Days)||0
3079731|NCT01372410|3801373|FG001|NOT COMPLETED|Treatment Period 3 (7 Days)||0
3079732|NCT01372410|3801374|FG002|NOT COMPLETED|Treatment Period 3 (7 Days)||1
3079733|NCT01372410|3801375|FG003|NOT COMPLETED|Treatment Period 3 (7 Days)||0
3079734|NCT01372410|3801376|FG004|NOT COMPLETED|Treatment Period 3 (7 Days)||0
3079735|NCT01372410|3801377|FG005|NOT COMPLETED|Treatment Period 3 (7 Days)||1
3079736|NCT01372410|3801378|FG006|NOT COMPLETED|Treatment Period 3 (7 Days)||0
3079737|NCT01372410|3801379|FG007|NOT COMPLETED|Treatment Period 3 (7 Days)||0
3079738|NCT01372462|3801398|FG000|STARTED|NIOV - Room Air||15
3079739|NCT01372462|3801398|FG000|COMPLETED|NIOV - Room Air||15
3079740|NCT01372462|3801398|FG000|NOT COMPLETED|NIOV - Room Air||0
3079741|NCT01372462|3801398|FG000|STARTED|NIOV - Oxygen||15
3079742|NCT01372462|3801398|FG000|COMPLETED|NIOV - Oxygen||15
3079743|NCT01372462|3801398|FG000|NOT COMPLETED|NIOV - Oxygen||0
3079744|NCT01372462|3801398|FG000|STARTED|Oxygen Nasal Cannula||15
3079745|NCT01372462|3801398|FG000|COMPLETED|Oxygen Nasal Cannula||15
3079746|NCT01372462|3801398|FG000|NOT COMPLETED|Oxygen Nasal Cannula||0
3079747|NCT01372462|3801398|FG000|STARTED|No Treatment Control||15
3079748|NCT01372462|3801398|FG000|COMPLETED|No Treatment Control||15
3079749|NCT01372462|3801398|FG000|NOT COMPLETED|No Treatment Control||0
3079750|NCT01372501|3801408|FG000|STARTED|Overall Study||19
3079751|NCT01372501|3801408|FG000|COMPLETED|Overall Study||14
3079752|NCT01372501|3801408|FG000|NOT COMPLETED|Overall Study||5
3079753|NCT01372605|3801415|FG000|STARTED|Overall Study||149
3079754|NCT01372605|3801416|FG001|STARTED|Overall Study||155
3079755|NCT01372605|3801415|FG000|COMPLETED|Overall Study||137
3079756|NCT01372605|3801416|FG001|COMPLETED|Overall Study||145
3079757|NCT01372605|3801415|FG000|NOT COMPLETED|Overall Study||12
3079758|NCT01372605|3801416|FG001|NOT COMPLETED|Overall Study||10
3079759|NCT01372748|3801424|FG000|STARTED|Overall Study||11045
3079760|NCT01372748|3801425|FG001|STARTED|Overall Study||12642
3079761|NCT01372748|3801424|FG000|COMPLETED|Overall Study|defined as having vital status|11022
3079762|NCT01372748|3801425|FG001|COMPLETED|Overall Study|defined as having vital status|12603
3079763|NCT01372748|3801424|FG000|NOT COMPLETED|Overall Study||23
3079764|NCT01372748|3801425|FG001|NOT COMPLETED|Overall Study||39
3079765|NCT01372774|3801433|FG000|STARTED|Overall Study||96
3079766|NCT01372774|3801434|FG001|STARTED|Overall Study||98
3079767|NCT01372774|3801433|FG000|COMPLETED|Overall Study||92
3079768|NCT01372774|3801434|FG001|COMPLETED|Overall Study||93
3079769|NCT01372774|3801433|FG000|NOT COMPLETED|Overall Study||4
3079770|NCT01372774|3801434|FG001|NOT COMPLETED|Overall Study||5
3079771|NCT01372813|3801442|FG000|STARTED|Overall Study||3
3079772|NCT01372813|3801442|FG000|COMPLETED|Overall Study||3
3079773|NCT01372813|3801442|FG000|NOT COMPLETED|Overall Study||0
3079774|NCT01372878|3801446|FG000|STARTED|Overall Study||884
3285715|NCT02777333|4019505|FG001|STARTED|Overall Study||15
3285716|NCT02777333|4019504|FG000|COMPLETED|Overall Study||15
3285717|NCT02777333|4019505|FG001|COMPLETED|Overall Study||13
3285718|NCT02777333|4019504|FG000|NOT COMPLETED|Overall Study||0
3285719|NCT02777333|4019505|FG001|NOT COMPLETED|Overall Study||2
3285720|NCT02777554|4019513|FG000|STARTED|Overall Study||62
3285721|NCT02777554|4019514|FG001|STARTED|Overall Study||62
3285722|NCT02777554|4019515|FG002|STARTED|Overall Study||5
3285723|NCT02777554|4019516|FG003|STARTED|Overall Study||5
3285724|NCT02777554|4019517|FG004|STARTED|Overall Study||5
3285725|NCT02777554|4019518|FG005|STARTED|Overall Study||5
3285726|NCT02777554|4019513|FG000|COMPLETED|Overall Study||32
3285727|NCT02777554|4019514|FG001|COMPLETED|Overall Study||37
3285728|NCT02777554|4019515|FG002|COMPLETED|Overall Study||4
3285729|NCT02777554|4019516|FG003|COMPLETED|Overall Study||4
3285730|NCT02777554|4019517|FG004|COMPLETED|Overall Study||5
3285731|NCT02777554|4019518|FG005|COMPLETED|Overall Study||5
3285732|NCT02777554|4019513|FG000|NOT COMPLETED|Overall Study||30
3285733|NCT02777554|4019514|FG001|NOT COMPLETED|Overall Study||25
3285734|NCT02777554|4019515|FG002|NOT COMPLETED|Overall Study||1
3285735|NCT02777554|4019516|FG003|NOT COMPLETED|Overall Study||1
3285736|NCT02777554|4019517|FG004|NOT COMPLETED|Overall Study||0
3285737|NCT02777554|4019518|FG005|NOT COMPLETED|Overall Study||0
3285738|NCT02777749|4019541|FG000|STARTED|Overall Study||53
3285739|NCT02777749|4019542|FG001|STARTED|Overall Study||51
3285740|NCT02777749|4019543|FG002|STARTED|Overall Study||51
3285741|NCT02777749|4019541|FG000|COMPLETED|Overall Study||53
3285742|NCT02777749|4019542|FG001|COMPLETED|Overall Study||51
3079775|NCT01372878|3801446|FG000|COMPLETED|Overall Study||700
3079776|NCT01372878|3801446|FG000|NOT COMPLETED|Overall Study||184
3079777|NCT01372995|3801453|FG000|STARTED|Overall Study||10
3079778|NCT01372995|3801454|FG001|STARTED|Overall Study||10
3285743|NCT02777749|4019543|FG002|COMPLETED|Overall Study||51
3285744|NCT02777749|4019541|FG000|NOT COMPLETED|Overall Study||0
3285745|NCT02777749|4019542|FG001|NOT COMPLETED|Overall Study||0
3285746|NCT02777749|4019543|FG002|NOT COMPLETED|Overall Study||0
3285747|NCT02777827|4019555|FG000|STARTED|Treatment Period 1||5
3285748|NCT02777827|4019556|FG001|STARTED|Treatment Period 1||5
3285749|NCT02777827|4019557|FG002|STARTED|Treatment Period 1||5
3285750|NCT02777827|4019558|FG003|STARTED|Treatment Period 1||5
3285751|NCT02777827|4019559|FG004|STARTED|Treatment Period 1||4
3285752|NCT02777827|4019560|FG005|STARTED|Treatment Period 1||6
3285753|NCT02777827|4019555|FG000|COMPLETED|Treatment Period 1||5
3285754|NCT02777827|4019556|FG001|COMPLETED|Treatment Period 1||5
3285755|NCT02777827|4019557|FG002|COMPLETED|Treatment Period 1||5
3285756|NCT02777827|4019558|FG003|COMPLETED|Treatment Period 1||5
3285757|NCT02777827|4019559|FG004|COMPLETED|Treatment Period 1||4
3285758|NCT02777827|4019560|FG005|COMPLETED|Treatment Period 1||6
3285759|NCT02777827|4019555|FG000|NOT COMPLETED|Treatment Period 1||0
3285760|NCT02777827|4019556|FG001|NOT COMPLETED|Treatment Period 1||0
3285761|NCT02777827|4019557|FG002|NOT COMPLETED|Treatment Period 1||0
3285762|NCT02777827|4019558|FG003|NOT COMPLETED|Treatment Period 1||0
3285763|NCT02777827|4019559|FG004|NOT COMPLETED|Treatment Period 1||0
3285764|NCT02777827|4019560|FG005|NOT COMPLETED|Treatment Period 1||0
3285765|NCT02777827|4019555|FG000|STARTED|Washout Between Periods 1 and 2||5
3285766|NCT02777827|4019556|FG001|STARTED|Washout Between Periods 1 and 2||5
3285767|NCT02777827|4019557|FG002|STARTED|Washout Between Periods 1 and 2||5
3285768|NCT02777827|4019558|FG003|STARTED|Washout Between Periods 1 and 2||5
3285769|NCT02777827|4019559|FG004|STARTED|Washout Between Periods 1 and 2||4
3285770|NCT02777827|4019560|FG005|STARTED|Washout Between Periods 1 and 2||6
3285771|NCT02777827|4019555|FG000|COMPLETED|Washout Between Periods 1 and 2||5
3285772|NCT02777827|4019556|FG001|COMPLETED|Washout Between Periods 1 and 2||5
3285773|NCT02777827|4019557|FG002|COMPLETED|Washout Between Periods 1 and 2||5
3285774|NCT02777827|4019558|FG003|COMPLETED|Washout Between Periods 1 and 2||5
3285775|NCT02777827|4019559|FG004|COMPLETED|Washout Between Periods 1 and 2||4
3285776|NCT02777827|4019560|FG005|COMPLETED|Washout Between Periods 1 and 2||6
3285777|NCT02777827|4019555|FG000|NOT COMPLETED|Washout Between Periods 1 and 2||0
3285778|NCT02777827|4019556|FG001|NOT COMPLETED|Washout Between Periods 1 and 2||0
3285779|NCT02777827|4019557|FG002|NOT COMPLETED|Washout Between Periods 1 and 2||0
3285780|NCT02777827|4019558|FG003|NOT COMPLETED|Washout Between Periods 1 and 2||0
3285781|NCT02777827|4019559|FG004|NOT COMPLETED|Washout Between Periods 1 and 2||0
3285782|NCT02777827|4019560|FG005|NOT COMPLETED|Washout Between Periods 1 and 2||0
3285783|NCT02777827|4019555|FG000|STARTED|Treatment Period 2||5
3285784|NCT02777827|4019556|FG001|STARTED|Treatment Period 2||5
3285785|NCT02777827|4019557|FG002|STARTED|Treatment Period 2||5
3285786|NCT02777827|4019558|FG003|STARTED|Treatment Period 2||5
3285787|NCT02777827|4019559|FG004|STARTED|Treatment Period 2||4
3285788|NCT02777827|4019560|FG005|STARTED|Treatment Period 2||6
3285789|NCT02777827|4019555|FG000|COMPLETED|Treatment Period 2||5
3285790|NCT02777827|4019556|FG001|COMPLETED|Treatment Period 2||5
3285791|NCT02777827|4019557|FG002|COMPLETED|Treatment Period 2||5
3285792|NCT02777827|4019558|FG003|COMPLETED|Treatment Period 2||5
3285793|NCT02777827|4019559|FG004|COMPLETED|Treatment Period 2||4
3285794|NCT02777827|4019560|FG005|COMPLETED|Treatment Period 2||6
3285795|NCT02777827|4019555|FG000|NOT COMPLETED|Treatment Period 2||0
3285796|NCT02777827|4019556|FG001|NOT COMPLETED|Treatment Period 2||0
3285797|NCT02777827|4019557|FG002|NOT COMPLETED|Treatment Period 2||0
3285798|NCT02777827|4019558|FG003|NOT COMPLETED|Treatment Period 2||0
3285799|NCT02777827|4019559|FG004|NOT COMPLETED|Treatment Period 2||0
3285800|NCT02777827|4019560|FG005|NOT COMPLETED|Treatment Period 2||0
3285801|NCT02777827|4019555|FG000|STARTED|Washout Between Periods 2 and 3||5
3285802|NCT02777827|4019556|FG001|STARTED|Washout Between Periods 2 and 3||5
3285803|NCT02777827|4019557|FG002|STARTED|Washout Between Periods 2 and 3||5
3285804|NCT02777827|4019558|FG003|STARTED|Washout Between Periods 2 and 3||5
3285805|NCT02777827|4019559|FG004|STARTED|Washout Between Periods 2 and 3||4
3285806|NCT02777827|4019560|FG005|STARTED|Washout Between Periods 2 and 3||6
3285807|NCT02777827|4019555|FG000|COMPLETED|Washout Between Periods 2 and 3||5
3285808|NCT02777827|4019556|FG001|COMPLETED|Washout Between Periods 2 and 3||5
3285809|NCT02777827|4019557|FG002|COMPLETED|Washout Between Periods 2 and 3||5
3285810|NCT02777827|4019558|FG003|COMPLETED|Washout Between Periods 2 and 3||5
3285811|NCT02777827|4019559|FG004|COMPLETED|Washout Between Periods 2 and 3||4
3285812|NCT02777827|4019560|FG005|COMPLETED|Washout Between Periods 2 and 3||6
3285813|NCT02777827|4019555|FG000|NOT COMPLETED|Washout Between Periods 2 and 3||0
3285814|NCT02777827|4019556|FG001|NOT COMPLETED|Washout Between Periods 2 and 3||0
3285815|NCT02777827|4019557|FG002|NOT COMPLETED|Washout Between Periods 2 and 3||0
3285816|NCT02777827|4019558|FG003|NOT COMPLETED|Washout Between Periods 2 and 3||0
3285817|NCT02777827|4019559|FG004|NOT COMPLETED|Washout Between Periods 2 and 3||0
3285818|NCT02777827|4019560|FG005|NOT COMPLETED|Washout Between Periods 2 and 3||0
3285819|NCT02777827|4019555|FG000|STARTED|Treatment Period 3||5
3285820|NCT02777827|4019556|FG001|STARTED|Treatment Period 3||5
3285821|NCT02777827|4019557|FG002|STARTED|Treatment Period 3||5
3285822|NCT02777827|4019558|FG003|STARTED|Treatment Period 3||5
3079779|NCT01372995|3801455|FG002|STARTED|Overall Study|One participant was transferred to comfort care prior to completing the intervention.|11
3079780|NCT01372995|3801453|FG000|COMPLETED|Overall Study||10
3079781|NCT01372995|3801454|FG001|COMPLETED|Overall Study||9
3079782|NCT01372995|3801455|FG002|COMPLETED|Overall Study|The transferred participant was included in the intent to treat analyses.|10
3079783|NCT01372995|3801453|FG000|NOT COMPLETED|Overall Study||0
3079784|NCT01372995|3801454|FG001|NOT COMPLETED|Overall Study||1
3079785|NCT01372995|3801455|FG002|NOT COMPLETED|Overall Study||1
3079786|NCT01373164|3801468|FG000|STARTED|Overall Study||5
3079787|NCT01373164|3801469|FG001|STARTED|Overall Study||4
3079788|NCT01373164|3801470|FG002|STARTED|Overall Study||5
3079789|NCT01373164|3801471|FG003|STARTED|Overall Study||104
3079790|NCT01373164|3801472|FG004|STARTED|Overall Study||52
3079791|NCT01373164|3801468|FG000|Received at Least One Dose|Overall Study||5
3079792|NCT01373164|3801469|FG001|Received at Least One Dose|Overall Study||4
3079793|NCT01373164|3801470|FG002|Received at Least One Dose|Overall Study||5
3079794|NCT01373164|3801471|FG003|Received at Least One Dose|Overall Study||103
3079795|NCT01373164|3801472|FG004|Received at Least One Dose|Overall Study||52
3079796|NCT01373164|3801468|FG000|COMPLETED|Overall Study||5
3079797|NCT01373164|3801469|FG001|COMPLETED|Overall Study||3
3079798|NCT01373164|3801470|FG002|COMPLETED|Overall Study||4
3079799|NCT01373164|3801471|FG003|COMPLETED|Overall Study||92
3079800|NCT01373164|3801472|FG004|COMPLETED|Overall Study||50
3079801|NCT01373164|3801468|FG000|NOT COMPLETED|Overall Study||0
3079802|NCT01373164|3801469|FG001|NOT COMPLETED|Overall Study||1
3079803|NCT01373164|3801470|FG002|NOT COMPLETED|Overall Study||1
3079804|NCT01373164|3801471|FG003|NOT COMPLETED|Overall Study||12
3079805|NCT01373164|3801472|FG004|NOT COMPLETED|Overall Study||2
3079806|NCT01373229|3801487|FG000|STARTED|Overall Study||15
3079807|NCT01373229|3801487|FG000|COMPLETED|Overall Study||9
3079808|NCT01373229|3801487|FG000|NOT COMPLETED|Overall Study||6
3079809|NCT01373242|3801491|FG000|STARTED|Overall Study||54
3079810|NCT01373242|3801491|FG000|COMPLETED|Overall Study||38
3079811|NCT01373242|3801491|FG000|NOT COMPLETED|Overall Study||16
3079812|NCT01373281|3801499|FG000|STARTED|Vaccination Phase (Up to 25 Months)||6851
3079813|NCT01373281|3801500|FG001|STARTED|Vaccination Phase (Up to 25 Months)||3424
3079814|NCT01373281|3801499|FG000|COMPLETED|Vaccination Phase (Up to 25 Months)||6797
3079815|NCT01373281|3801500|FG001|COMPLETED|Vaccination Phase (Up to 25 Months)||3397
3079816|NCT01373281|3801499|FG000|NOT COMPLETED|Vaccination Phase (Up to 25 Months)||54
3079817|NCT01373281|3801500|FG001|NOT COMPLETED|Vaccination Phase (Up to 25 Months)||27
3079818|NCT01373281|3801499|FG000|STARTED|Surveillance Expansion Period||6797
3079819|NCT01373281|3801500|FG001|STARTED|Surveillance Expansion Period||3397
3079820|NCT01373281|3801499|FG000|COMPLETED|Surveillance Expansion Period||6595
3079821|NCT01373281|3801500|FG001|COMPLETED|Surveillance Expansion Period||3279
3079822|NCT01373281|3801499|FG000|NOT COMPLETED|Surveillance Expansion Period||202
3079823|NCT01373281|3801500|FG001|NOT COMPLETED|Surveillance Expansion Period||118
3079824|NCT01373294|3801515|FG000|STARTED|Overall Study||15
3079825|NCT01373294|3801516|FG001|STARTED|Overall Study||2
3079826|NCT01373294|3801515|FG000|COMPLETED|Overall Study||14
3079827|NCT01373294|3801516|FG001|COMPLETED|Overall Study||2
3079828|NCT01373294|3801515|FG000|NOT COMPLETED|Overall Study||1
3079829|NCT01373294|3801516|FG001|NOT COMPLETED|Overall Study||0
3285823|NCT02777827|4019559|FG004|STARTED|Treatment Period 3||4
3285824|NCT02777827|4019560|FG005|STARTED|Treatment Period 3||6
3285825|NCT02777827|4019555|FG000|COMPLETED|Treatment Period 3||5
3285826|NCT02777827|4019556|FG001|COMPLETED|Treatment Period 3||5
3285827|NCT02777827|4019557|FG002|COMPLETED|Treatment Period 3||5
3285828|NCT02777827|4019558|FG003|COMPLETED|Treatment Period 3||5
3285829|NCT02777827|4019559|FG004|COMPLETED|Treatment Period 3||4
3285830|NCT02777827|4019560|FG005|COMPLETED|Treatment Period 3||6
3285831|NCT02777827|4019555|FG000|NOT COMPLETED|Treatment Period 3||0
3285832|NCT02777827|4019556|FG001|NOT COMPLETED|Treatment Period 3||0
3285833|NCT02777827|4019557|FG002|NOT COMPLETED|Treatment Period 3||0
3285834|NCT02777827|4019558|FG003|NOT COMPLETED|Treatment Period 3||0
3285835|NCT02777827|4019559|FG004|NOT COMPLETED|Treatment Period 3||0
3285836|NCT02777827|4019560|FG005|NOT COMPLETED|Treatment Period 3||0
3285837|NCT02777827|4019555|FG000|STARTED|Washout Between Periods 3 and 4||5
3285838|NCT02777827|4019556|FG001|STARTED|Washout Between Periods 3 and 4||5
3285839|NCT02777827|4019557|FG002|STARTED|Washout Between Periods 3 and 4||5
3285840|NCT02777827|4019558|FG003|STARTED|Washout Between Periods 3 and 4||5
3285841|NCT02777827|4019559|FG004|STARTED|Washout Between Periods 3 and 4||4
3285842|NCT02777827|4019560|FG005|STARTED|Washout Between Periods 3 and 4||6
3285843|NCT02777827|4019555|FG000|COMPLETED|Washout Between Periods 3 and 4||5
3285844|NCT02777827|4019556|FG001|COMPLETED|Washout Between Periods 3 and 4||5
3285845|NCT02777827|4019557|FG002|COMPLETED|Washout Between Periods 3 and 4||4
3079830|NCT01373346|3801522|FG000|STARTED|Overall Study||15
3079831|NCT01373346|3801522|FG000|COMPLETED|Overall Study||14
3079832|NCT01373346|3801522|FG000|NOT COMPLETED|Overall Study||1
3079833|NCT01373450|3801531|FG000|STARTED|Crossover Period 1||2
3079834|NCT01373450|3801532|FG001|STARTED|Crossover Period 1||2
3079835|NCT01373450|3801533|FG002|STARTED|Crossover Period 1||2
3079836|NCT01373450|3801534|FG003|STARTED|Crossover Period 1||2
3079837|NCT01373450|3801535|FG004|STARTED|Crossover Period 1||2
3079838|NCT01373450|3801536|FG005|STARTED|Crossover Period 1||2
3079839|NCT01373450|3801531|FG000|COMPLETED|Crossover Period 1||2
3285846|NCT02777827|4019558|FG003|COMPLETED|Washout Between Periods 3 and 4||5
3079840|NCT01373450|3801532|FG001|COMPLETED|Crossover Period 1||2
3079841|NCT01373450|3801533|FG002|COMPLETED|Crossover Period 1||2
3079842|NCT01373450|3801534|FG003|COMPLETED|Crossover Period 1||2
3079843|NCT01373450|3801535|FG004|COMPLETED|Crossover Period 1||2
3079844|NCT01373450|3801536|FG005|COMPLETED|Crossover Period 1||2
3079845|NCT01373450|3801531|FG000|NOT COMPLETED|Crossover Period 1||0
3079846|NCT01373450|3801532|FG001|NOT COMPLETED|Crossover Period 1||0
3079847|NCT01373450|3801533|FG002|NOT COMPLETED|Crossover Period 1||0
3079848|NCT01373450|3801534|FG003|NOT COMPLETED|Crossover Period 1||0
3079849|NCT01373450|3801535|FG004|NOT COMPLETED|Crossover Period 1||0
3079850|NCT01373450|3801536|FG005|NOT COMPLETED|Crossover Period 1||0
3079851|NCT01373450|3801531|FG000|STARTED|7 Day Wash-out||2
3079852|NCT01373450|3801532|FG001|STARTED|7 Day Wash-out||2
3079853|NCT01373450|3801533|FG002|STARTED|7 Day Wash-out||2
3079854|NCT01373450|3801534|FG003|STARTED|7 Day Wash-out||2
3079855|NCT01373450|3801535|FG004|STARTED|7 Day Wash-out||2
3079856|NCT01373450|3801536|FG005|STARTED|7 Day Wash-out||2
3079857|NCT01373450|3801531|FG000|COMPLETED|7 Day Wash-out||2
3079858|NCT01373450|3801532|FG001|COMPLETED|7 Day Wash-out||2
3079859|NCT01373450|3801533|FG002|COMPLETED|7 Day Wash-out||2
3079860|NCT01373450|3801534|FG003|COMPLETED|7 Day Wash-out||2
3079861|NCT01373450|3801535|FG004|COMPLETED|7 Day Wash-out||2
3079862|NCT01373450|3801536|FG005|COMPLETED|7 Day Wash-out||2
3079863|NCT01373450|3801531|FG000|NOT COMPLETED|7 Day Wash-out||0
3079864|NCT01373450|3801532|FG001|NOT COMPLETED|7 Day Wash-out||0
3079865|NCT01373450|3801533|FG002|NOT COMPLETED|7 Day Wash-out||0
3079866|NCT01373450|3801534|FG003|NOT COMPLETED|7 Day Wash-out||0
3079867|NCT01373450|3801535|FG004|NOT COMPLETED|7 Day Wash-out||0
3079868|NCT01373450|3801536|FG005|NOT COMPLETED|7 Day Wash-out||0
3285847|NCT02777827|4019559|FG004|COMPLETED|Washout Between Periods 3 and 4||4
3285848|NCT02777827|4019560|FG005|COMPLETED|Washout Between Periods 3 and 4||6
3285849|NCT02777827|4019555|FG000|NOT COMPLETED|Washout Between Periods 3 and 4||0
3285850|NCT02777827|4019556|FG001|NOT COMPLETED|Washout Between Periods 3 and 4||0
3285851|NCT02777827|4019557|FG002|NOT COMPLETED|Washout Between Periods 3 and 4||1
3285852|NCT02777827|4019558|FG003|NOT COMPLETED|Washout Between Periods 3 and 4||0
3285853|NCT02777827|4019559|FG004|NOT COMPLETED|Washout Between Periods 3 and 4||0
3285854|NCT02777827|4019560|FG005|NOT COMPLETED|Washout Between Periods 3 and 4||0
3285855|NCT02777827|4019555|FG000|STARTED|Treatment Period 4||5
3285856|NCT02777827|4019556|FG001|STARTED|Treatment Period 4||5
3285857|NCT02777827|4019557|FG002|STARTED|Treatment Period 4||4
3285858|NCT02777827|4019558|FG003|STARTED|Treatment Period 4||5
3285859|NCT02777827|4019559|FG004|STARTED|Treatment Period 4||4
3285860|NCT02777827|4019560|FG005|STARTED|Treatment Period 4||6
3285861|NCT02777827|4019555|FG000|COMPLETED|Treatment Period 4||5
3285862|NCT02777827|4019556|FG001|COMPLETED|Treatment Period 4||5
3285863|NCT02777827|4019557|FG002|COMPLETED|Treatment Period 4||4
3285864|NCT02777827|4019558|FG003|COMPLETED|Treatment Period 4||5
3285865|NCT02777827|4019559|FG004|COMPLETED|Treatment Period 4||4
3285866|NCT02777827|4019560|FG005|COMPLETED|Treatment Period 4||6
3285867|NCT02777827|4019555|FG000|NOT COMPLETED|Treatment Period 4||0
3285868|NCT02777827|4019556|FG001|NOT COMPLETED|Treatment Period 4||0
3285869|NCT02777827|4019557|FG002|NOT COMPLETED|Treatment Period 4||0
3285870|NCT02777827|4019558|FG003|NOT COMPLETED|Treatment Period 4||0
3285871|NCT02777827|4019559|FG004|NOT COMPLETED|Treatment Period 4||0
3285872|NCT02777827|4019560|FG005|NOT COMPLETED|Treatment Period 4||0
3285873|NCT02777827|4019555|FG000|STARTED|Washout Between Periods 4 and 5||5
3285874|NCT02777827|4019556|FG001|STARTED|Washout Between Periods 4 and 5||5
3285875|NCT02777827|4019557|FG002|STARTED|Washout Between Periods 4 and 5||4
3285876|NCT02777827|4019558|FG003|STARTED|Washout Between Periods 4 and 5||5
3285877|NCT02777827|4019559|FG004|STARTED|Washout Between Periods 4 and 5||4
3285878|NCT02777827|4019560|FG005|STARTED|Washout Between Periods 4 and 5||6
3285879|NCT02777827|4019555|FG000|COMPLETED|Washout Between Periods 4 and 5||5
3285880|NCT02777827|4019556|FG001|COMPLETED|Washout Between Periods 4 and 5||5
3285881|NCT02777827|4019557|FG002|COMPLETED|Washout Between Periods 4 and 5||4
3285882|NCT02777827|4019558|FG003|COMPLETED|Washout Between Periods 4 and 5||5
3285883|NCT02777827|4019559|FG004|COMPLETED|Washout Between Periods 4 and 5||4
3285884|NCT02777827|4019560|FG005|COMPLETED|Washout Between Periods 4 and 5||6
3285885|NCT02777827|4019555|FG000|NOT COMPLETED|Washout Between Periods 4 and 5||0
3285886|NCT02777827|4019556|FG001|NOT COMPLETED|Washout Between Periods 4 and 5||0
3285887|NCT02777827|4019557|FG002|NOT COMPLETED|Washout Between Periods 4 and 5||0
3285888|NCT02777827|4019558|FG003|NOT COMPLETED|Washout Between Periods 4 and 5||0
3285889|NCT02777827|4019559|FG004|NOT COMPLETED|Washout Between Periods 4 and 5||0
3285890|NCT02777827|4019560|FG005|NOT COMPLETED|Washout Between Periods 4 and 5||0
3285891|NCT02777827|4019555|FG000|STARTED|Treatment Period 5||5
3285892|NCT02777827|4019556|FG001|STARTED|Treatment Period 5||5
3285893|NCT02777827|4019557|FG002|STARTED|Treatment Period 5||4
3285894|NCT02777827|4019558|FG003|STARTED|Treatment Period 5||5
3285895|NCT02777827|4019559|FG004|STARTED|Treatment Period 5||4
3285896|NCT02777827|4019560|FG005|STARTED|Treatment Period 5||6
3285897|NCT02777827|4019555|FG000|COMPLETED|Treatment Period 5||5
3285898|NCT02777827|4019556|FG001|COMPLETED|Treatment Period 5||5
3285899|NCT02777827|4019557|FG002|COMPLETED|Treatment Period 5||4
3285900|NCT02777827|4019558|FG003|COMPLETED|Treatment Period 5||5
3285901|NCT02777827|4019559|FG004|COMPLETED|Treatment Period 5||4
3285902|NCT02777827|4019560|FG005|COMPLETED|Treatment Period 5||6
3285903|NCT02777827|4019555|FG000|NOT COMPLETED|Treatment Period 5||0
3079869|NCT01373450|3801531|FG000|STARTED|Crossover Period 2||2
3079870|NCT01373450|3801532|FG001|STARTED|Crossover Period 2||2
3079871|NCT01373450|3801533|FG002|STARTED|Crossover Period 2||2
3079872|NCT01373450|3801534|FG003|STARTED|Crossover Period 2||2
3079873|NCT01373450|3801535|FG004|STARTED|Crossover Period 2||2
3079874|NCT01373450|3801536|FG005|STARTED|Crossover Period 2||2
3079875|NCT01373450|3801531|FG000|COMPLETED|Crossover Period 2||2
3079876|NCT01373450|3801532|FG001|COMPLETED|Crossover Period 2||2
3285904|NCT02777827|4019556|FG001|NOT COMPLETED|Treatment Period 5||0
3285905|NCT02777827|4019557|FG002|NOT COMPLETED|Treatment Period 5||0
3285906|NCT02777827|4019558|FG003|NOT COMPLETED|Treatment Period 5||0
3285907|NCT02777827|4019559|FG004|NOT COMPLETED|Treatment Period 5||0
3285908|NCT02777827|4019560|FG005|NOT COMPLETED|Treatment Period 5||0
3285909|NCT02777827|4019555|FG000|STARTED|Washout Between Periods 5 and 6||5
3285910|NCT02777827|4019556|FG001|STARTED|Washout Between Periods 5 and 6||5
3285911|NCT02777827|4019557|FG002|STARTED|Washout Between Periods 5 and 6||4
3285912|NCT02777827|4019558|FG003|STARTED|Washout Between Periods 5 and 6||5
3285913|NCT02777827|4019559|FG004|STARTED|Washout Between Periods 5 and 6||4
3285914|NCT02777827|4019560|FG005|STARTED|Washout Between Periods 5 and 6||6
3285915|NCT02777827|4019555|FG000|COMPLETED|Washout Between Periods 5 and 6||5
3285916|NCT02777827|4019556|FG001|COMPLETED|Washout Between Periods 5 and 6||5
3285917|NCT02777827|4019557|FG002|COMPLETED|Washout Between Periods 5 and 6||4
3285918|NCT02777827|4019558|FG003|COMPLETED|Washout Between Periods 5 and 6||5
3285919|NCT02777827|4019559|FG004|COMPLETED|Washout Between Periods 5 and 6||4
3285920|NCT02777827|4019560|FG005|COMPLETED|Washout Between Periods 5 and 6||6
3285921|NCT02777827|4019555|FG000|NOT COMPLETED|Washout Between Periods 5 and 6||0
3285922|NCT02777827|4019556|FG001|NOT COMPLETED|Washout Between Periods 5 and 6||0
3285923|NCT02777827|4019557|FG002|NOT COMPLETED|Washout Between Periods 5 and 6||0
3285924|NCT02777827|4019558|FG003|NOT COMPLETED|Washout Between Periods 5 and 6||0
3285925|NCT02777827|4019559|FG004|NOT COMPLETED|Washout Between Periods 5 and 6||0
3285926|NCT02777827|4019560|FG005|NOT COMPLETED|Washout Between Periods 5 and 6||0
3285927|NCT02777827|4019555|FG000|STARTED|Treatment Period 6||5
3285928|NCT02777827|4019556|FG001|STARTED|Treatment Period 6||5
3285929|NCT02777827|4019557|FG002|STARTED|Treatment Period 6||4
3285930|NCT02777827|4019558|FG003|STARTED|Treatment Period 6||5
3285931|NCT02777827|4019559|FG004|STARTED|Treatment Period 6||4
3285932|NCT02777827|4019560|FG005|STARTED|Treatment Period 6||6
3285933|NCT02777827|4019555|FG000|COMPLETED|Treatment Period 6||5
3285934|NCT02777827|4019556|FG001|COMPLETED|Treatment Period 6||5
3285935|NCT02777827|4019557|FG002|COMPLETED|Treatment Period 6||4
3285936|NCT02777827|4019558|FG003|COMPLETED|Treatment Period 6||5
3285937|NCT02777827|4019559|FG004|COMPLETED|Treatment Period 6||4
3285938|NCT02777827|4019560|FG005|COMPLETED|Treatment Period 6||6
3285939|NCT02777827|4019555|FG000|NOT COMPLETED|Treatment Period 6||0
3285940|NCT02777827|4019556|FG001|NOT COMPLETED|Treatment Period 6||0
3285941|NCT02777827|4019557|FG002|NOT COMPLETED|Treatment Period 6||0
3285942|NCT02777827|4019558|FG003|NOT COMPLETED|Treatment Period 6||0
3285943|NCT02777827|4019559|FG004|NOT COMPLETED|Treatment Period 6||0
3285944|NCT02777827|4019560|FG005|NOT COMPLETED|Treatment Period 6||0
3285945|NCT02777918|4019576|FG000|STARTED|Overall Study||53
3285946|NCT02777918|4019577|FG001|STARTED|Overall Study||47
3285947|NCT02777918|4019576|FG000|COMPLETED|Overall Study||50
3285948|NCT02777918|4019577|FG001|COMPLETED|Overall Study||43
3285949|NCT02777918|4019576|FG000|NOT COMPLETED|Overall Study||3
3285950|NCT02777918|4019577|FG001|NOT COMPLETED|Overall Study||4
3285951|NCT02777931|4019585|FG000|STARTED|Overall Study||49
3285952|NCT02777931|4019586|FG001|STARTED|Overall Study||52
3285953|NCT02777931|4019585|FG000|Safety Population|Overall Study||47
3285954|NCT02777931|4019586|FG001|Safety Population|Overall Study||50
3285955|NCT02777931|4019585|FG000|Modified Intent to Treat Population|Overall Study||46
3285956|NCT02777931|4019586|FG001|Modified Intent to Treat Population|Overall Study||50
3285957|NCT02777931|4019585|FG000|COMPLETED|Overall Study||37
3285958|NCT02777931|4019586|FG001|COMPLETED|Overall Study||39
3285959|NCT02777931|4019585|FG000|NOT COMPLETED|Overall Study||12
3285960|NCT02777931|4019586|FG001|NOT COMPLETED|Overall Study||13
3285961|NCT02777944|4019594|FG000|STARTED|Overall Study||157
3285962|NCT02777944|4019595|FG001|STARTED|Overall Study||156
3285963|NCT02777944|4019594|FG000|COMPLETED|Overall Study||157
3285964|NCT02777944|4019595|FG001|COMPLETED|Overall Study||156
3285965|NCT02777944|4019594|FG000|NOT COMPLETED|Overall Study||0
3285966|NCT02777944|4019595|FG001|NOT COMPLETED|Overall Study||0
3285967|NCT02777970|4019604|FG000|STARTED|Overall Study||261
3285968|NCT02777970|4019605|FG001|STARTED|Overall Study||262
3285969|NCT02777970|4019606|FG002|STARTED|Overall Study||131
3285970|NCT02777970|4019604|FG000|COMPLETED|Overall Study||260
3285971|NCT02777970|4019605|FG001|COMPLETED|Overall Study||261
3285972|NCT02777970|4019606|FG002|COMPLETED|Overall Study||131
3285973|NCT02777970|4019604|FG000|NOT COMPLETED|Overall Study||1
3285974|NCT02777970|4019605|FG001|NOT COMPLETED|Overall Study||1
3285975|NCT02777970|4019606|FG002|NOT COMPLETED|Overall Study||0
3285976|NCT02778074|4019618|FG000|STARTED|Overall Study||72
3285977|NCT02778074|4019619|FG001|STARTED|Overall Study||72
3285978|NCT02778074|4019618|FG000|COMPLETED|Overall Study||65
3285979|NCT02778074|4019619|FG001|COMPLETED|Overall Study||62
3285980|NCT02778074|4019618|FG000|NOT COMPLETED|Overall Study||7
3285981|NCT02778074|4019619|FG001|NOT COMPLETED|Overall Study||10
3285982|NCT02778100|4019627|FG000|STARTED|Period 1 (Common Cold)||18
3285983|NCT02778100|4019628|FG001|STARTED|Period 1 (Common Cold)||18
3079877|NCT01373450|3801533|FG002|COMPLETED|Crossover Period 2||2
3079878|NCT01373450|3801534|FG003|COMPLETED|Crossover Period 2||2
3079879|NCT01373450|3801535|FG004|COMPLETED|Crossover Period 2||2
3079880|NCT01373450|3801536|FG005|COMPLETED|Crossover Period 2||2
3079881|NCT01373450|3801531|FG000|NOT COMPLETED|Crossover Period 2||0
3079882|NCT01373450|3801532|FG001|NOT COMPLETED|Crossover Period 2||0
3079883|NCT01373450|3801533|FG002|NOT COMPLETED|Crossover Period 2||0
3079884|NCT01373450|3801534|FG003|NOT COMPLETED|Crossover Period 2||0
3079885|NCT01373450|3801535|FG004|NOT COMPLETED|Crossover Period 2||0
3079886|NCT01373450|3801536|FG005|NOT COMPLETED|Crossover Period 2||0
3079887|NCT01373450|3801531|FG000|STARTED|7 Day Wash-out||2
3079888|NCT01373450|3801532|FG001|STARTED|7 Day Wash-out||2
3079889|NCT01373450|3801533|FG002|STARTED|7 Day Wash-out||2
3079890|NCT01373450|3801534|FG003|STARTED|7 Day Wash-out||2
3079891|NCT01373450|3801535|FG004|STARTED|7 Day Wash-out||2
3079892|NCT01373450|3801536|FG005|STARTED|7 Day Wash-out||2
3079893|NCT01373450|3801531|FG000|COMPLETED|7 Day Wash-out||2
3079894|NCT01373450|3801532|FG001|COMPLETED|7 Day Wash-out||2
3079895|NCT01373450|3801533|FG002|COMPLETED|7 Day Wash-out||2
3079896|NCT01373450|3801534|FG003|COMPLETED|7 Day Wash-out||2
3079897|NCT01373450|3801535|FG004|COMPLETED|7 Day Wash-out||2
3079898|NCT01373450|3801536|FG005|COMPLETED|7 Day Wash-out||2
3079899|NCT01373450|3801531|FG000|NOT COMPLETED|7 Day Wash-out||0
3079900|NCT01373450|3801532|FG001|NOT COMPLETED|7 Day Wash-out||0
3079901|NCT01373450|3801533|FG002|NOT COMPLETED|7 Day Wash-out||0
3079902|NCT01373450|3801534|FG003|NOT COMPLETED|7 Day Wash-out||0
3079903|NCT01373450|3801535|FG004|NOT COMPLETED|7 Day Wash-out||0
3079904|NCT01373450|3801536|FG005|NOT COMPLETED|7 Day Wash-out||0
3079905|NCT01373450|3801531|FG000|STARTED|Crossover Period 3||2
3079906|NCT01373450|3801532|FG001|STARTED|Crossover Period 3||2
3079907|NCT01373450|3801533|FG002|STARTED|Crossover Period 3||2
3079908|NCT01373450|3801534|FG003|STARTED|Crossover Period 3||2
3079909|NCT01373450|3801535|FG004|STARTED|Crossover Period 3||2
3079910|NCT01373450|3801536|FG005|STARTED|Crossover Period 3||2
3079911|NCT01373450|3801531|FG000|COMPLETED|Crossover Period 3||2
3079912|NCT01373450|3801532|FG001|COMPLETED|Crossover Period 3||2
3079913|NCT01373450|3801533|FG002|COMPLETED|Crossover Period 3||2
3079914|NCT01373450|3801534|FG003|COMPLETED|Crossover Period 3||2
3079915|NCT01373450|3801535|FG004|COMPLETED|Crossover Period 3||2
3079916|NCT01373450|3801536|FG005|COMPLETED|Crossover Period 3||2
3079917|NCT01373450|3801531|FG000|NOT COMPLETED|Crossover Period 3||0
3079918|NCT01373450|3801532|FG001|NOT COMPLETED|Crossover Period 3||0
3079919|NCT01373450|3801533|FG002|NOT COMPLETED|Crossover Period 3||0
3079920|NCT01373450|3801534|FG003|NOT COMPLETED|Crossover Period 3||0
3079921|NCT01373450|3801535|FG004|NOT COMPLETED|Crossover Period 3||0
3079922|NCT01373450|3801536|FG005|NOT COMPLETED|Crossover Period 3||0
3079923|NCT01373450|3801531|FG000|STARTED|7 Day Wash-out||2
3079924|NCT01373450|3801532|FG001|STARTED|7 Day Wash-out||2
3079925|NCT01373450|3801533|FG002|STARTED|7 Day Wash-out||2
3079926|NCT01373450|3801534|FG003|STARTED|7 Day Wash-out||2
3079927|NCT01373450|3801535|FG004|STARTED|7 Day Wash-out||2
3079928|NCT01373450|3801536|FG005|STARTED|7 Day Wash-out||2
3079929|NCT01373450|3801531|FG000|COMPLETED|7 Day Wash-out||2
3079930|NCT01373450|3801532|FG001|COMPLETED|7 Day Wash-out||2
3079931|NCT01373450|3801533|FG002|COMPLETED|7 Day Wash-out||2
3079932|NCT01373450|3801534|FG003|COMPLETED|7 Day Wash-out||2
3079933|NCT01373450|3801535|FG004|COMPLETED|7 Day Wash-out||2
3079934|NCT01373450|3801536|FG005|COMPLETED|7 Day Wash-out||2
3079935|NCT01373450|3801531|FG000|NOT COMPLETED|7 Day Wash-out||0
3079936|NCT01373450|3801532|FG001|NOT COMPLETED|7 Day Wash-out||0
3079937|NCT01373450|3801533|FG002|NOT COMPLETED|7 Day Wash-out||0
3079938|NCT01373450|3801534|FG003|NOT COMPLETED|7 Day Wash-out||0
3079939|NCT01373450|3801535|FG004|NOT COMPLETED|7 Day Wash-out||0
3079940|NCT01373450|3801536|FG005|NOT COMPLETED|7 Day Wash-out||0
3079941|NCT01373450|3801531|FG000|STARTED|Crossover Period 4||2
3079942|NCT01373450|3801532|FG001|STARTED|Crossover Period 4||2
3079943|NCT01373450|3801533|FG002|STARTED|Crossover Period 4||2
3079944|NCT01373450|3801534|FG003|STARTED|Crossover Period 4||2
3079945|NCT01373450|3801535|FG004|STARTED|Crossover Period 4||2
3079946|NCT01373450|3801536|FG005|STARTED|Crossover Period 4||2
3079947|NCT01373450|3801531|FG000|COMPLETED|Crossover Period 4||2
3079948|NCT01373450|3801532|FG001|COMPLETED|Crossover Period 4||2
3079949|NCT01373450|3801533|FG002|COMPLETED|Crossover Period 4||2
3079950|NCT01373450|3801534|FG003|COMPLETED|Crossover Period 4||2
3079951|NCT01373450|3801535|FG004|COMPLETED|Crossover Period 4||2
3079952|NCT01373450|3801536|FG005|COMPLETED|Crossover Period 4||2
3079953|NCT01373450|3801531|FG000|NOT COMPLETED|Crossover Period 4||0
3079954|NCT01373450|3801532|FG001|NOT COMPLETED|Crossover Period 4||0
3079955|NCT01373450|3801533|FG002|NOT COMPLETED|Crossover Period 4||0
3079956|NCT01373450|3801534|FG003|NOT COMPLETED|Crossover Period 4||0
3079957|NCT01373450|3801535|FG004|NOT COMPLETED|Crossover Period 4||0
3079958|NCT01373450|3801536|FG005|NOT COMPLETED|Crossover Period 4||0
3079959|NCT01373489|3801552|FG000|STARTED|Overall Study||59
3079960|NCT01373489|3801553|FG001|STARTED|Overall Study||54
3079961|NCT01373489|3801552|FG000|COMPLETED|Overall Study||44
3079962|NCT01373489|3801553|FG001|COMPLETED|Overall Study||41
3079963|NCT01373489|3801552|FG000|NOT COMPLETED|Overall Study||15
3079964|NCT01373489|3801553|FG001|NOT COMPLETED|Overall Study||13
3079965|NCT01373580|3801559|FG000|STARTED|Overall Study||373
3079966|NCT01373580|3801559|FG000|COMPLETED|Overall Study||317
3079967|NCT01373580|3801559|FG000|NOT COMPLETED|Overall Study||56
3079968|NCT01373671|3801563|FG000|STARTED|Overall Study||764
3079969|NCT01373671|3801563|FG000|COMPLETED|Overall Study||672
3079970|NCT01373671|3801563|FG000|NOT COMPLETED|Overall Study||92
3079971|NCT01373918|3801570|FG000|STARTED|Overall Study||20
3079972|NCT01373918|3801571|FG001|STARTED|Overall Study||16
3079973|NCT01373918|3801570|FG000|COMPLETED|Overall Study||20
3079974|NCT01373918|3801571|FG001|COMPLETED|Overall Study||15
3079975|NCT01373918|3801570|FG000|NOT COMPLETED|Overall Study||0
3079976|NCT01373918|3801571|FG001|NOT COMPLETED|Overall Study||1
3079977|NCT01373931|3801579|FG000|STARTED|Lead-in Period||10
3079978|NCT01373931|3801580|FG001|STARTED|Lead-in Period||10
3079979|NCT01373931|3801579|FG000|Received at Least 1 Dose of Study Drug|Lead-in Period||8
3079980|NCT01373931|3801580|FG001|Received at Least 1 Dose of Study Drug|Lead-in Period||10
3079981|NCT01373931|3801579|FG000|COMPLETED|Lead-in Period||8
3079982|NCT01373931|3801580|FG001|COMPLETED|Lead-in Period||10
3079983|NCT01373931|3801579|FG000|NOT COMPLETED|Lead-in Period||2
3079984|NCT01373931|3801580|FG001|NOT COMPLETED|Lead-in Period||0
3079985|NCT01373931|3801579|FG000|STARTED|Period 1||8
3079986|NCT01373931|3801580|FG001|STARTED|Period 1||10
3079987|NCT01373931|3801579|FG000|COMPLETED|Period 1||6
3079988|NCT01373931|3801580|FG001|COMPLETED|Period 1||8
3079989|NCT01373931|3801579|FG000|NOT COMPLETED|Period 1||2
3079990|NCT01373931|3801580|FG001|NOT COMPLETED|Period 1||2
3079991|NCT01373931|3801579|FG000|STARTED|Period 2||6
3079992|NCT01373931|3801580|FG001|STARTED|Period 2||8
3079993|NCT01373931|3801579|FG000|COMPLETED|Period 2||6
3079994|NCT01373931|3801580|FG001|COMPLETED|Period 2||8
3079995|NCT01373931|3801579|FG000|NOT COMPLETED|Period 2||0
3079996|NCT01373931|3801580|FG001|NOT COMPLETED|Period 2||0
3079997|NCT01374087|3801589|FG000|STARTED|Overall Study||16
3079998|NCT01374087|3801590|FG001|STARTED|Overall Study||15
3079999|NCT01374087|3801589|FG000|COMPLETED|Overall Study||0
3080000|NCT01374087|3801590|FG001|COMPLETED|Overall Study||0
3080001|NCT01374087|3801589|FG000|NOT COMPLETED|Overall Study||16
3080002|NCT01374087|3801590|FG001|NOT COMPLETED|Overall Study||15
3080003|NCT01374178|3801596|FG000|STARTED|Period 1 (up to 24 Hours After Dosing)||11
3080004|NCT01374178|3801597|FG001|STARTED|Period 1 (up to 24 Hours After Dosing)||5
3080005|NCT01374178|3801596|FG000|Received at Least 1 Dose of LY2963016|Period 1 (up to 24 Hours After Dosing)||11
3080006|NCT01374178|3801597|FG001|Received at Least 1 Dose of LY2963016|Period 1 (up to 24 Hours After Dosing)||5
3080007|NCT01374178|3801596|FG000|COMPLETED|Period 1 (up to 24 Hours After Dosing)||11
3080008|NCT01374178|3801597|FG001|COMPLETED|Period 1 (up to 24 Hours After Dosing)||5
3080009|NCT01374178|3801596|FG000|NOT COMPLETED|Period 1 (up to 24 Hours After Dosing)||0
3080010|NCT01374178|3801597|FG001|NOT COMPLETED|Period 1 (up to 24 Hours After Dosing)||0
3080011|NCT01374178|3801596|FG000|STARTED|Washout Period of at Least 7 Days||11
3080012|NCT01374178|3801597|FG001|STARTED|Washout Period of at Least 7 Days||5
3080013|NCT01374178|3801596|FG000|COMPLETED|Washout Period of at Least 7 Days||10
3080014|NCT01374178|3801597|FG001|COMPLETED|Washout Period of at Least 7 Days||5
3080015|NCT01374178|3801596|FG000|NOT COMPLETED|Washout Period of at Least 7 Days||1
3080016|NCT01374178|3801597|FG001|NOT COMPLETED|Washout Period of at Least 7 Days||0
3080017|NCT01374178|3801596|FG000|STARTED|Period 2 (up to 24 Hours After Dosing)||10
3080018|NCT01374178|3801597|FG001|STARTED|Period 2 (up to 24 Hours After Dosing)||5
3080019|NCT01374178|3801596|FG000|COMPLETED|Period 2 (up to 24 Hours After Dosing)||8
3080020|NCT01374178|3801597|FG001|COMPLETED|Period 2 (up to 24 Hours After Dosing)||5
3080021|NCT01374178|3801596|FG000|NOT COMPLETED|Period 2 (up to 24 Hours After Dosing)||2
3080022|NCT01374178|3801597|FG001|NOT COMPLETED|Period 2 (up to 24 Hours After Dosing)||0
3080023|NCT01374217|3801603|FG000|STARTED|Overall Study||13
3080024|NCT01374217|3801603|FG000|COMPLETED|Overall Study||0
3080025|NCT01374217|3801603|FG000|NOT COMPLETED|Overall Study||13
3080026|NCT01374269|3801609|FG000|STARTED|Overall Study||46
3080027|NCT01374269|3801610|FG001|STARTED|Overall Study||44
3080028|NCT01374269|3801609|FG000|COMPLETED|Overall Study||40
3080029|NCT01374269|3801610|FG001|COMPLETED|Overall Study||39
3080030|NCT01374269|3801609|FG000|NOT COMPLETED|Overall Study||6
3080031|NCT01374269|3801610|FG001|NOT COMPLETED|Overall Study||5
3080032|NCT01374425|3801618|FG000|STARTED|Overall Study||188
3080033|NCT01374425|3801619|FG001|STARTED|Overall Study||188
3080034|NCT01374425|3801618|FG000|COMPLETED|Overall Study||0
3080035|NCT01374425|3801619|FG001|COMPLETED|Overall Study||0
3080036|NCT01374425|3801618|FG000|NOT COMPLETED|Overall Study||188
3080037|NCT01374425|3801619|FG001|NOT COMPLETED|Overall Study||188
3080038|NCT01374438|3801648|FG000|STARTED|Overall Study||16
3080039|NCT01374438|3801649|FG001|STARTED|Overall Study||13
3080040|NCT01374438|3801648|FG000|COMPLETED|Overall Study||16
3080041|NCT01374438|3801649|FG001|COMPLETED|Overall Study||13
3080042|NCT01374438|3801648|FG000|NOT COMPLETED|Overall Study||0
3080043|NCT01374438|3801649|FG001|NOT COMPLETED|Overall Study||0
3080044|NCT01374451|3801657|FG000|STARTED|Overall Study||79
3080045|NCT01374451|3801658|FG001|STARTED|Overall Study||81
3080046|NCT01374451|3801657|FG000|COMPLETED|Overall Study||78
3080047|NCT01374451|3801658|FG001|COMPLETED|Overall Study||81
3080048|NCT01374451|3801657|FG000|NOT COMPLETED|Overall Study||1
3080049|NCT01374451|3801658|FG001|NOT COMPLETED|Overall Study||0
3080050|NCT01374490|3801664|FG000|STARTED|Overall Study||250
3080051|NCT01374490|3801664|FG000|COMPLETED|Overall Study||190
3080052|NCT01374490|3801664|FG000|NOT COMPLETED|Overall Study||60
3080053|NCT01374516|3801670|FG000|STARTED|Vaccination Phase (Up to 25 Months)||13920
3080054|NCT01374516|3801671|FG001|STARTED|Vaccination Phase (Up to 25 Months)||6949
3080055|NCT01374516|3801670|FG000|COMPLETED|Vaccination Phase (Up to 25 Months)||13281
3080056|NCT01374516|3801671|FG001|COMPLETED|Vaccination Phase (Up to 25 Months)||6640
3080057|NCT01374516|3801670|FG000|NOT COMPLETED|Vaccination Phase (Up to 25 Months)||639
3080058|NCT01374516|3801671|FG001|NOT COMPLETED|Vaccination Phase (Up to 25 Months)||309
3080059|NCT01374516|3801670|FG000|STARTED|Surveillance Expansion Period||13281
3080060|NCT01374516|3801671|FG001|STARTED|Surveillance Expansion Period||6640
3080061|NCT01374516|3801670|FG000|COMPLETED|Surveillance Expansion Period||10932
3080062|NCT01374516|3801671|FG001|COMPLETED|Surveillance Expansion Period||5387
3080063|NCT01374516|3801670|FG000|NOT COMPLETED|Surveillance Expansion Period||2349
3080064|NCT01374516|3801671|FG001|NOT COMPLETED|Surveillance Expansion Period||1253
3080065|NCT01374568|3801686|FG000|STARTED|Overall Study||2
3080066|NCT01374568|3801687|FG001|STARTED|Overall Study||3
3080067|NCT01374568|3801686|FG000|COMPLETED|Overall Study||2
3080068|NCT01374568|3801687|FG001|COMPLETED|Overall Study||1
3080069|NCT01374568|3801686|FG000|NOT COMPLETED|Overall Study||0
3080070|NCT01374568|3801687|FG001|NOT COMPLETED|Overall Study||2
3080071|NCT01374802|3801693|FG000|STARTED|Overall Study||14
3080072|NCT01374802|3801693|FG000|COMPLETED|Overall Study||14
3080073|NCT01374802|3801693|FG000|NOT COMPLETED|Overall Study||0
3080074|NCT01374906|3801701|FG000|STARTED|Overall Study||74
3080075|NCT01374906|3801702|FG001|STARTED|Overall Study||76
3080076|NCT01374906|3801701|FG000|DC Dur Core Phs at/Prior to Data Cutoff|Overall Study||24
3080077|NCT01374906|3801702|FG001|DC Dur Core Phs at/Prior to Data Cutoff|Overall Study||22
3080078|NCT01374906|3801701|FG000|Completed Core Phase|Overall Study||50
3080079|NCT01374906|3801702|FG001|Completed Core Phase|Overall Study||54
3080080|NCT01374906|3801701|FG000|Completed Core/Did Not Enter Ext. Phase|Overall Study||10
3080081|NCT01374906|3801702|FG001|Completed Core/Did Not Enter Ext. Phase|Overall Study||13
3080082|NCT01374906|3801701|FG000|Completed Core Phase/Entered Ext. Phase|Overall Study||40
3080083|NCT01374906|3801702|FG001|Completed Core Phase/Entered Ext. Phase|Overall Study||41
3080084|NCT01374906|3801701|FG000|DC Dur Ext Phs at/Prior to Data Cutoff|Overall Study||16
3080085|NCT01374906|3801702|FG001|DC Dur Ext Phs at/Prior to Data Cutoff|Overall Study||26
3080086|NCT01374906|3801701|FG000|Completed Extension Phase|Overall Study||24
3080087|NCT01374906|3801702|FG001|Completed Extension Phase|Overall Study||15
3080088|NCT01374906|3801701|FG000|COMPLETED|Overall Study||34
3080089|NCT01374906|3801702|FG001|COMPLETED|Overall Study||28
3080090|NCT01374906|3801701|FG000|NOT COMPLETED|Overall Study||40
3080091|NCT01374906|3801702|FG001|NOT COMPLETED|Overall Study||48
3080092|NCT01374919|3801712|FG000|STARTED|Overall Study||60
3080093|NCT01374919|3801712|FG000|COMPLETED|Overall Study||58
3080094|NCT01374919|3801712|FG000|NOT COMPLETED|Overall Study||2
3080095|NCT01374971|3801716|FG000|STARTED|Overall Study||12
3080096|NCT01374971|3801716|FG000|COMPLETED|Overall Study||11
3080097|NCT01374971|3801716|FG000|NOT COMPLETED|Overall Study||1
3080098|NCT01375010|3801722|FG000|STARTED|Overall Study||43
3080099|NCT01375010|3801723|FG001|STARTED|Overall Study||42
3080100|NCT01375010|3801722|FG000|COMPLETED|Overall Study||31
3080101|NCT01375010|3801723|FG001|COMPLETED|Overall Study||38
3080102|NCT01375010|3801722|FG000|NOT COMPLETED|Overall Study||12
3080103|NCT01375010|3801723|FG001|NOT COMPLETED|Overall Study||4
3080104|NCT01375049|3801729|FG000|STARTED|Overall Study||105
3080105|NCT01375049|3801729|FG000|COMPLETED|Overall Study||55
3080106|NCT01375049|3801729|FG000|NOT COMPLETED|Overall Study||50
3080107|NCT01375075|3801743|FG000|STARTED|Overall Study||27
3080108|NCT01375075|3801744|FG001|STARTED|Overall Study||28
3080109|NCT01375075|3801745|FG002|STARTED|Overall Study||27
3080110|NCT01375075|3801746|FG003|STARTED|Overall Study||28
3080111|NCT01375075|3801747|FG004|STARTED|Overall Study||27
3080112|NCT01375075|3801748|FG005|STARTED|Overall Study||28
3080113|NCT01375075|3801743|FG000|Received at Least One Dose of Study Drug|Overall Study||27
3080114|NCT01375075|3801744|FG001|Received at Least One Dose of Study Drug|Overall Study||28
3080115|NCT01375075|3801745|FG002|Received at Least One Dose of Study Drug|Overall Study||27
3080116|NCT01375075|3801746|FG003|Received at Least One Dose of Study Drug|Overall Study||28
3080117|NCT01375075|3801747|FG004|Received at Least One Dose of Study Drug|Overall Study||27
3080118|NCT01375075|3801748|FG005|Received at Least One Dose of Study Drug|Overall Study||28
3080119|NCT01375075|3801743|FG000|COMPLETED|Overall Study||26
3080120|NCT01375075|3801744|FG001|COMPLETED|Overall Study||27
3080121|NCT01375075|3801745|FG002|COMPLETED|Overall Study||24
3080122|NCT01375075|3801746|FG003|COMPLETED|Overall Study||27
3080123|NCT01375075|3801747|FG004|COMPLETED|Overall Study||27
3080124|NCT01375075|3801748|FG005|COMPLETED|Overall Study||25
3080125|NCT01375075|3801743|FG000|NOT COMPLETED|Overall Study||1
3080126|NCT01375075|3801744|FG001|NOT COMPLETED|Overall Study||1
3080127|NCT01375075|3801745|FG002|NOT COMPLETED|Overall Study||3
3080128|NCT01375075|3801746|FG003|NOT COMPLETED|Overall Study||1
3080129|NCT01375075|3801747|FG004|NOT COMPLETED|Overall Study||0
3080130|NCT01375075|3801748|FG005|NOT COMPLETED|Overall Study||3
3080131|NCT01375127|3801772|FG000|STARTED|Overall Study||1
3080132|NCT01375127|3801773|FG001|STARTED|Overall Study||1
3080133|NCT01375127|3801774|FG002|STARTED|Overall Study||40
3080134|NCT01375127|3801775|FG003|STARTED|Overall Study||33
3080135|NCT01375127|3801776|FG004|STARTED|Overall Study||5
3080136|NCT01375127|3801777|FG005|STARTED|Overall Study||3
3080137|NCT01375127|3801772|FG000|COMPLETED|Overall Study||1
3080138|NCT01375127|3801773|FG001|COMPLETED|Overall Study||1
3080139|NCT01375127|3801774|FG002|COMPLETED|Overall Study||40
3080140|NCT01375127|3801775|FG003|COMPLETED|Overall Study||33
3080141|NCT01375127|3801776|FG004|COMPLETED|Overall Study||5
3080142|NCT01375127|3801777|FG005|COMPLETED|Overall Study||3
3080143|NCT01375127|3801772|FG000|NOT COMPLETED|Overall Study||0
3080144|NCT01375127|3801773|FG001|NOT COMPLETED|Overall Study||0
3080145|NCT01375127|3801774|FG002|NOT COMPLETED|Overall Study||0
3080146|NCT01375127|3801775|FG003|NOT COMPLETED|Overall Study||0
3080147|NCT01375127|3801776|FG004|NOT COMPLETED|Overall Study||0
3080148|NCT01375127|3801777|FG005|NOT COMPLETED|Overall Study||0
3080149|NCT01375140|3801791|FG000|STARTED|Overall Study||31
3080150|NCT01375140|3801791|FG000|COMPLETED|Overall Study||31
3080151|NCT01375140|3801791|FG000|NOT COMPLETED|Overall Study||0
3080152|NCT01375205|3801797|FG000|STARTED|Overall Study||54
3080153|NCT01375205|3801798|FG001|STARTED|Overall Study||46
3080154|NCT01375205|3801797|FG000|COMPLETED|Overall Study||33
3080155|NCT01375205|3801798|FG001|COMPLETED|Overall Study||33
3080156|NCT01375205|3801797|FG000|NOT COMPLETED|Overall Study||21
3080157|NCT01375205|3801798|FG001|NOT COMPLETED|Overall Study||13
3080158|NCT01375374|3801804|FG000|STARTED|Overall Study||11
3080159|NCT01375374|3801804|FG000|COMPLETED|Overall Study||10
3080160|NCT01375374|3801804|FG000|NOT COMPLETED|Overall Study||1
3080161|NCT01375491|3801811|FG000|STARTED|Overall Study||11
3080162|NCT01375491|3801812|FG001|STARTED|Overall Study||13
3080163|NCT01375491|3801813|FG002|STARTED|Overall Study||15
3080164|NCT01375491|3801811|FG000|COMPLETED|Overall Study||9
3080165|NCT01375491|3801812|FG001|COMPLETED|Overall Study||12
3080166|NCT01375491|3801813|FG002|COMPLETED|Overall Study||15
3080167|NCT01375491|3801811|FG000|NOT COMPLETED|Overall Study||2
3080168|NCT01375491|3801812|FG001|NOT COMPLETED|Overall Study||1
3080169|NCT01375491|3801813|FG002|NOT COMPLETED|Overall Study||0
3080170|NCT01375569|3801820|FG000|STARTED|Overall Study||11
3080171|NCT01375569|3801820|FG000|COMPLETED|Overall Study||11
3080172|NCT01375569|3801820|FG000|NOT COMPLETED|Overall Study||0
3080173|NCT01375608|3801824|FG000|STARTED|Overall Study||10
3080174|NCT01375608|3801824|FG000|COMPLETED|Overall Study||8
3080175|NCT01375608|3801824|FG000|NOT COMPLETED|Overall Study||2
3080176|NCT01375660|3801830|FG000|STARTED|Overall Study||102
3080177|NCT01375660|3801831|FG001|STARTED|Overall Study||103
3080178|NCT01375660|3801830|FG000|COMPLETED|Overall Study||86
3080179|NCT01375660|3801831|FG001|COMPLETED|Overall Study||87
3080180|NCT01375660|3801830|FG000|NOT COMPLETED|Overall Study||16
3080181|NCT01375660|3801831|FG001|NOT COMPLETED|Overall Study||16
3080182|NCT01375673|3801840|FG000|STARTED|Overall Study||7
3080183|NCT01375673|3801841|FG001|STARTED|Overall Study||7
3080184|NCT01375673|3801840|FG000|COMPLETED|Overall Study||7
3080185|NCT01375673|3801841|FG001|COMPLETED|Overall Study||6
3080186|NCT01375673|3801840|FG000|NOT COMPLETED|Overall Study||0
3080187|NCT01375673|3801841|FG001|NOT COMPLETED|Overall Study||1
3080188|NCT01375751|3801850|FG000|STARTED|Overall Study||56
3080189|NCT01375751|3801851|FG001|STARTED|Overall Study||56
3080190|NCT01375751|3801852|FG002|STARTED|Overall Study||56
3080191|NCT01375751|3801850|FG000|Received Treatment|Overall Study||56
3080192|NCT01375751|3801851|FG001|Received Treatment|Overall Study||55
3080193|NCT01375751|3801852|FG002|Received Treatment|Overall Study||56
3080194|NCT01375751|3801850|FG000|COMPLETED|Overall Study||56
3080195|NCT01375751|3801851|FG001|COMPLETED|Overall Study||55
3080196|NCT01375751|3801852|FG002|COMPLETED|Overall Study||56
3080197|NCT01375751|3801850|FG000|NOT COMPLETED|Overall Study||0
3080198|NCT01375751|3801851|FG001|NOT COMPLETED|Overall Study||1
3080199|NCT01375751|3801852|FG002|NOT COMPLETED|Overall Study||0
3080200|NCT01375764|3801865|FG000|STARTED|Overall Study||33
3080201|NCT01375764|3801866|FG001|STARTED|Overall Study||31
3080202|NCT01375764|3801867|FG002|STARTED|Overall Study||32
3080203|NCT01375764|3801868|FG003|STARTED|Overall Study||32
3080204|NCT01375764|3801869|FG004|STARTED|Overall Study||32
3080205|NCT01375764|3801865|FG000|Received Treatment|Overall Study||32
3080206|NCT01375764|3801866|FG001|Received Treatment|Overall Study||30
3080207|NCT01375764|3801867|FG002|Received Treatment|Overall Study||32
3080208|NCT01375764|3801868|FG003|Received Treatment|Overall Study||31
3080209|NCT01375764|3801869|FG004|Received Treatment|Overall Study||32
3080210|NCT01375764|3801865|FG000|COMPLETED|Overall Study||31
3080211|NCT01375764|3801866|FG001|COMPLETED|Overall Study||30
3080212|NCT01375764|3801867|FG002|COMPLETED|Overall Study||32
3080213|NCT01375764|3801868|FG003|COMPLETED|Overall Study||31
3080214|NCT01375764|3801869|FG004|COMPLETED|Overall Study||31
3080215|NCT01375764|3801865|FG000|NOT COMPLETED|Overall Study||2
3080216|NCT01375764|3801866|FG001|NOT COMPLETED|Overall Study||1
3080217|NCT01375764|3801867|FG002|NOT COMPLETED|Overall Study||0
3080218|NCT01375764|3801868|FG003|NOT COMPLETED|Overall Study||1
3080219|NCT01375764|3801869|FG004|NOT COMPLETED|Overall Study||1
3080220|NCT01375777|3801890|FG000|STARTED|Overall Study||46
3080221|NCT01375777|3801891|FG001|STARTED|Overall Study||45
3080222|NCT01375777|3801892|FG002|STARTED|Overall Study||46
3080223|NCT01375777|3801893|FG003|STARTED|Overall Study||45
3080224|NCT01375777|3801894|FG004|STARTED|Overall Study||46
3080225|NCT01375777|3801895|FG005|STARTED|Overall Study||45
3080226|NCT01375777|3801896|FG006|STARTED|Overall Study||46
3080227|NCT01375777|3801897|FG007|STARTED|Overall Study||46
3080228|NCT01375777|3801898|FG008|STARTED|Overall Study||46
3080229|NCT01375777|3801890|FG000|Received Treatment|Overall Study||45
3080230|NCT01375777|3801891|FG001|Received Treatment|Overall Study||45
3080231|NCT01375777|3801892|FG002|Received Treatment|Overall Study||45
3080232|NCT01375777|3801893|FG003|Received Treatment|Overall Study||45
3080233|NCT01375777|3801894|FG004|Received Treatment|Overall Study||46
3080234|NCT01375777|3801895|FG005|Received Treatment|Overall Study||45
3080235|NCT01375777|3801896|FG006|Received Treatment|Overall Study||45
3285984|NCT02778100|4019627|FG000|COMPLETED|Period 1 (Common Cold)||17
3285985|NCT02778100|4019628|FG001|COMPLETED|Period 1 (Common Cold)||18
3285986|NCT02778100|4019627|FG000|NOT COMPLETED|Period 1 (Common Cold)||1
3285987|NCT02778100|4019628|FG001|NOT COMPLETED|Period 1 (Common Cold)||0
3285988|NCT02778100|4019627|FG000|STARTED|Period 2 (No Cold Symptoms)||17
3285989|NCT02778100|4019628|FG001|STARTED|Period 2 (No Cold Symptoms)|Cohort 2 only administered NG to participants with a common cold who are taking oxymetazoline.|0
3285990|NCT02778100|4019627|FG000|COMPLETED|Period 2 (No Cold Symptoms)||17
3080236|NCT01375777|3801897|FG007|Received Treatment|Overall Study||45
3080237|NCT01375777|3801898|FG008|Received Treatment|Overall Study||45
3080238|NCT01375777|3801890|FG000|COMPLETED|Overall Study||44
3080239|NCT01375777|3801891|FG001|COMPLETED|Overall Study||42
3080240|NCT01375777|3801892|FG002|COMPLETED|Overall Study||45
3080241|NCT01375777|3801893|FG003|COMPLETED|Overall Study||45
3080242|NCT01375777|3801894|FG004|COMPLETED|Overall Study||45
3080243|NCT01375777|3801895|FG005|COMPLETED|Overall Study||44
3080244|NCT01375777|3801896|FG006|COMPLETED|Overall Study||44
3080245|NCT01375777|3801897|FG007|COMPLETED|Overall Study||44
3080246|NCT01375777|3801898|FG008|COMPLETED|Overall Study||44
3080247|NCT01375777|3801890|FG000|NOT COMPLETED|Overall Study||2
3080248|NCT01375777|3801891|FG001|NOT COMPLETED|Overall Study||3
3080249|NCT01375777|3801892|FG002|NOT COMPLETED|Overall Study||1
3080250|NCT01375777|3801893|FG003|NOT COMPLETED|Overall Study||0
3080251|NCT01375777|3801894|FG004|NOT COMPLETED|Overall Study||1
3080252|NCT01375777|3801895|FG005|NOT COMPLETED|Overall Study||1
3080253|NCT01375777|3801896|FG006|NOT COMPLETED|Overall Study||2
3080254|NCT01375777|3801897|FG007|NOT COMPLETED|Overall Study||2
3080255|NCT01375777|3801898|FG008|NOT COMPLETED|Overall Study||2
3080256|NCT01375946|3801918|FG000|STARTED|Overall Study||4
3080257|NCT01375946|3801919|FG001|STARTED|Overall Study||4
3080258|NCT01375946|3801920|FG002|STARTED|Overall Study||4
3080259|NCT01375946|3801921|FG003|STARTED|Overall Study||4
3080260|NCT01375946|3801922|FG004|STARTED|Overall Study||4
3080261|NCT01375946|3801923|FG005|STARTED|Overall Study||4
3080262|NCT01375946|3801918|FG000|COMPLETED|Overall Study||4
3080263|NCT01375946|3801919|FG001|COMPLETED|Overall Study||4
3080264|NCT01375946|3801920|FG002|COMPLETED|Overall Study||4
3080265|NCT01375946|3801921|FG003|COMPLETED|Overall Study||4
3080266|NCT01375946|3801922|FG004|COMPLETED|Overall Study||4
3080267|NCT01375946|3801923|FG005|COMPLETED|Overall Study||4
3080268|NCT01375946|3801918|FG000|NOT COMPLETED|Overall Study||0
3080269|NCT01375946|3801919|FG001|NOT COMPLETED|Overall Study||0
3080270|NCT01375946|3801920|FG002|NOT COMPLETED|Overall Study||0
3080271|NCT01375946|3801921|FG003|NOT COMPLETED|Overall Study||0
3080272|NCT01375946|3801922|FG004|NOT COMPLETED|Overall Study||0
3080273|NCT01375946|3801923|FG005|NOT COMPLETED|Overall Study||0
3080274|NCT01376037|3801929|FG000|STARTED|Overall Study||31
3080275|NCT01376037|3801930|FG001|STARTED|Overall Study||31
3080276|NCT01376037|3801929|FG000|COMPLETED|Overall Study||31
3080277|NCT01376037|3801930|FG001|COMPLETED|Overall Study||29
3080278|NCT01376037|3801929|FG000|NOT COMPLETED|Overall Study||0
3080279|NCT01376037|3801930|FG001|NOT COMPLETED|Overall Study||2
3080280|NCT01376050|3801938|FG000|STARTED|Overall Study||13
3080281|NCT01376050|3801939|FG001|STARTED|Overall Study||11
3080282|NCT01376050|3801938|FG000|COMPLETED|Overall Study||13
3080283|NCT01376050|3801939|FG001|COMPLETED|Overall Study||11
3080284|NCT01376050|3801938|FG000|NOT COMPLETED|Overall Study||0
3080285|NCT01376050|3801939|FG001|NOT COMPLETED|Overall Study||0
3080286|NCT01376089|3801947|FG000|STARTED|Overall Study||151
3080287|NCT01376089|3801948|FG001|STARTED|Overall Study||148
3080288|NCT01376089|3801947|FG000|COMPLETED|Overall Study||148
3080289|NCT01376089|3801948|FG001|COMPLETED|Overall Study||144
3080290|NCT01376089|3801947|FG000|NOT COMPLETED|Overall Study||3
3080291|NCT01376089|3801948|FG001|NOT COMPLETED|Overall Study||4
3080292|NCT01376167|3801961|FG000|STARTED|Overall Study||133
3080293|NCT01376167|3801962|FG001|STARTED|Overall Study||260
3080294|NCT01376167|3801963|FG002|STARTED|Overall Study||129
3080295|NCT01376167|3801961|FG000|COMPLETED|Overall Study||129
3080296|NCT01376167|3801962|FG001|COMPLETED|Overall Study||250
3080297|NCT01376167|3801963|FG002|COMPLETED|Overall Study||123
3080298|NCT01376167|3801961|FG000|NOT COMPLETED|Overall Study||4
3080299|NCT01376167|3801962|FG001|NOT COMPLETED|Overall Study||10
3080300|NCT01376167|3801963|FG002|NOT COMPLETED|Overall Study||6
3285991|NCT02778100|4019628|FG001|COMPLETED|Period 2 (No Cold Symptoms)||0
3285992|NCT02778100|4019627|FG000|NOT COMPLETED|Period 2 (No Cold Symptoms)||0
3080301|NCT01376245|3801978|FG000|STARTED|2-wk Single-blind Placebo Run-in Period||744
3080302|NCT01376245|3801979|FG001|STARTED|2-wk Single-blind Placebo Run-in Period||0
3080303|NCT01376245|3801980|FG002|STARTED|2-wk Single-blind Placebo Run-in Period||0
3080304|NCT01376245|3801981|FG003|STARTED|2-wk Single-blind Placebo Run-in Period||0
3080305|NCT01376245|3801982|FG004|STARTED|2-wk Single-blind Placebo Run-in Period||0
3080306|NCT01376245|3801978|FG000|COMPLETED|2-wk Single-blind Placebo Run-in Period||643
3080307|NCT01376245|3801979|FG001|COMPLETED|2-wk Single-blind Placebo Run-in Period||0
3080308|NCT01376245|3801980|FG002|COMPLETED|2-wk Single-blind Placebo Run-in Period||0
3080309|NCT01376245|3801981|FG003|COMPLETED|2-wk Single-blind Placebo Run-in Period||0
3080310|NCT01376245|3801982|FG004|COMPLETED|2-wk Single-blind Placebo Run-in Period||0
3080311|NCT01376245|3801978|FG000|NOT COMPLETED|2-wk Single-blind Placebo Run-in Period||101
3080312|NCT01376245|3801979|FG001|NOT COMPLETED|2-wk Single-blind Placebo Run-in Period||0
3080313|NCT01376245|3801980|FG002|NOT COMPLETED|2-wk Single-blind Placebo Run-in Period||0
3080314|NCT01376245|3801981|FG003|NOT COMPLETED|2-wk Single-blind Placebo Run-in Period||0
3080315|NCT01376245|3801982|FG004|NOT COMPLETED|2-wk Single-blind Placebo Run-in Period||0
3080316|NCT01376245|3801978|FG000|STARTED|24-week, Double-blind Treatment Period||0
3080317|NCT01376245|3801979|FG001|STARTED|24-week, Double-blind Treatment Period||162
3080318|NCT01376245|3801980|FG002|STARTED|24-week, Double-blind Treatment Period||160
3080319|NCT01376245|3801981|FG003|STARTED|24-week, Double-blind Treatment Period||161
3080320|NCT01376245|3801982|FG004|STARTED|24-week, Double-blind Treatment Period||160
3080321|NCT01376245|3801978|FG000|COMPLETED|24-week, Double-blind Treatment Period||0
3080322|NCT01376245|3801979|FG001|COMPLETED|24-week, Double-blind Treatment Period||130
3080323|NCT01376245|3801980|FG002|COMPLETED|24-week, Double-blind Treatment Period||135
3080324|NCT01376245|3801981|FG003|COMPLETED|24-week, Double-blind Treatment Period||138
3080325|NCT01376245|3801982|FG004|COMPLETED|24-week, Double-blind Treatment Period||134
3080326|NCT01376245|3801978|FG000|NOT COMPLETED|24-week, Double-blind Treatment Period||0
3080327|NCT01376245|3801979|FG001|NOT COMPLETED|24-week, Double-blind Treatment Period||32
3080328|NCT01376245|3801980|FG002|NOT COMPLETED|24-week, Double-blind Treatment Period||25
3080329|NCT01376245|3801981|FG003|NOT COMPLETED|24-week, Double-blind Treatment Period||23
3080330|NCT01376245|3801982|FG004|NOT COMPLETED|24-week, Double-blind Treatment Period||26
3080331|NCT01376297|3801994|FG000|STARTED|Overall Study|number of randomised patients|309
3080332|NCT01376297|3801995|FG001|STARTED|Overall Study|number of randomised patients|104
3080333|NCT01376297|3801994|FG000|COMPLETED|Overall Study|number of patients completing planned/unplanned chemotherapy cycles|181
3080334|NCT01376297|3801995|FG001|COMPLETED|Overall Study|number of patients completing planned/unplanned chemotherapy cycles|55
3080335|NCT01376297|3801994|FG000|NOT COMPLETED|Overall Study||128
3080336|NCT01376297|3801995|FG001|NOT COMPLETED|Overall Study||49
3134711|NCT01702233|3859601|FG000|STARTED|Overall Study||72
3134712|NCT01702233|3859602|FG001|STARTED|Overall Study||67
3134713|NCT01702233|3859603|FG002|STARTED|Overall Study||36
3134714|NCT01702233|3859601|FG000|Full Analysis Set (ITT)|Overall Study||66
3134715|NCT01702233|3859602|FG001|Full Analysis Set (ITT)|Overall Study||63
3134716|NCT01702233|3859603|FG002|Full Analysis Set (ITT)|Overall Study||31
3134717|NCT01702233|3859601|FG000|Per Protocol Set|Overall Study||58
3134718|NCT01702233|3859602|FG001|Per Protocol Set|Overall Study||58
3134719|NCT01702233|3859603|FG002|Per Protocol Set|Overall Study||27
3134720|NCT01702233|3859601|FG000|COMPLETED|Overall Study||66
3134721|NCT01702233|3859602|FG001|COMPLETED|Overall Study|One of these Patient completed the Trial but had no valid outcome measure after enrolment|64
3134722|NCT01702233|3859603|FG002|COMPLETED|Overall Study||31
3134723|NCT01702233|3859601|FG000|NOT COMPLETED|Overall Study||6
3134724|NCT01702233|3859602|FG001|NOT COMPLETED|Overall Study||3
3134725|NCT01702233|3859603|FG002|NOT COMPLETED|Overall Study||5
3134726|NCT01702246|3859612|FG000|STARTED|Overall Study||24
3134727|NCT01702246|3859612|FG000|COMPLETED|Overall Study||19
3134728|NCT01702246|3859612|FG000|NOT COMPLETED|Overall Study||5
3134729|NCT01702259|3859621|FG000|STARTED|Overall Study||34
3134730|NCT01702259|3859622|FG001|STARTED|Overall Study||34
3134731|NCT01702259|3859621|FG000|COMPLETED|Overall Study||34
3134732|NCT01702259|3859622|FG001|COMPLETED|Overall Study||34
3134733|NCT01702259|3859621|FG000|NOT COMPLETED|Overall Study||0
3134734|NCT01702259|3859622|FG001|NOT COMPLETED|Overall Study||0
3134735|NCT01702298|3859628|FG000|STARTED|Overall Study||42
3134736|NCT01702298|3859628|FG000|COMPLETED|Overall Study||41
3134737|NCT01702298|3859628|FG000|NOT COMPLETED|Overall Study||1
3134738|NCT01702311|3859634|FG000|STARTED|Overall Study||122
3134739|NCT01702311|3859635|FG001|STARTED|Overall Study||113
3134740|NCT01702311|3859634|FG000|COMPLETED|Overall Study||106
3134741|NCT01702311|3859635|FG001|COMPLETED|Overall Study||100
3134742|NCT01702311|3859634|FG000|NOT COMPLETED|Overall Study||16
3134743|NCT01702311|3859635|FG001|NOT COMPLETED|Overall Study||13
3134744|NCT01702363|3859644|FG000|STARTED|Overall Study||131
3134745|NCT01702363|3859644|FG000|COMPLETED|Overall Study||111
3134746|NCT01702363|3859644|FG000|NOT COMPLETED|Overall Study||20
3134747|NCT01702428|3859653|FG000|STARTED|Overall Study||1239
3134748|NCT01702428|3859654|FG001|STARTED|Overall Study||1232
3134749|NCT01702428|3859655|FG002|STARTED|Overall Study||1243
3134750|NCT01702428|3859656|FG003|STARTED|Overall Study||1289
3134751|NCT01702428|3859653|FG000|COMPLETED|Overall Study||1175
3134752|NCT01702428|3859654|FG001|COMPLETED|Overall Study||1162
3134753|NCT01702428|3859655|FG002|COMPLETED|Overall Study||1190
3134754|NCT01702428|3859656|FG003|COMPLETED|Overall Study||1232
3134755|NCT01702428|3859653|FG000|NOT COMPLETED|Overall Study||64
3134756|NCT01702428|3859654|FG001|NOT COMPLETED|Overall Study||70
3134757|NCT01702428|3859655|FG002|NOT COMPLETED|Overall Study||53
3134758|NCT01702428|3859656|FG003|NOT COMPLETED|Overall Study||57
3134759|NCT01702454|3859675|FG000|STARTED|Overall Study||241
3134760|NCT01702454|3859676|FG001|STARTED|Overall Study||229
3134761|NCT01702454|3859675|FG000|COMPLETED|Overall Study||238
3134762|NCT01702454|3859676|FG001|COMPLETED|Overall Study||221
3134763|NCT01702454|3859675|FG000|NOT COMPLETED|Overall Study||3
3134764|NCT01702454|3859676|FG001|NOT COMPLETED|Overall Study||8
3134765|NCT01702519|3859687|FG000|STARTED|Period 1||20
3134766|NCT01702519|3859688|FG001|STARTED|Period 1||20
3134767|NCT01702519|3859687|FG000|COMPLETED|Period 1||20
3134768|NCT01702519|3859688|FG001|COMPLETED|Period 1||20
3134769|NCT01702519|3859687|FG000|NOT COMPLETED|Period 1||0
3134770|NCT01702519|3859688|FG001|NOT COMPLETED|Period 1||0
3080337|NCT01376310|3802003|FG000|STARTED|Overall Study||126
3080338|NCT01376310|3802004|FG001|STARTED|Overall Study||33
3080339|NCT01376310|3802003|FG000|COMPLETED|Overall Study||90
3080340|NCT01376310|3802004|FG001|COMPLETED|Overall Study||22
3080341|NCT01376310|3802003|FG000|NOT COMPLETED|Overall Study||36
3080342|NCT01376310|3802004|FG001|NOT COMPLETED|Overall Study||11
3080343|NCT01376349|3802013|FG000|STARTED|Raondomized Treatment||147
3080344|NCT01376349|3802014|FG001|STARTED|Raondomized Treatment||149
3080345|NCT01376349|3802015|FG002|STARTED|Raondomized Treatment||147
3080346|NCT01376349|3802013|FG000|COMPLETED|Raondomized Treatment||123
3080347|NCT01376349|3802014|FG001|COMPLETED|Raondomized Treatment||114
3080348|NCT01376349|3802015|FG002|COMPLETED|Raondomized Treatment||118
3080349|NCT01376349|3802013|FG000|NOT COMPLETED|Raondomized Treatment||24
3080350|NCT01376349|3802014|FG001|NOT COMPLETED|Raondomized Treatment||35
3080351|NCT01376349|3802015|FG002|NOT COMPLETED|Raondomized Treatment||29
3080352|NCT01376349|3802013|FG000|STARTED|Optional Continuation Phase||0
3080353|NCT01376349|3802014|FG001|STARTED|Optional Continuation Phase||0
3080354|NCT01376349|3802015|FG002|STARTED|Optional Continuation Phase|Patients completing Arm III Placebo were offered the option of continuing High Dose DHEA|94
3080355|NCT01376349|3802013|FG000|COMPLETED|Optional Continuation Phase||0
3080356|NCT01376349|3802014|FG001|COMPLETED|Optional Continuation Phase||0
3080357|NCT01376349|3802015|FG002|COMPLETED|Optional Continuation Phase||94
3080358|NCT01376349|3802013|FG000|NOT COMPLETED|Optional Continuation Phase||0
3080359|NCT01376349|3802014|FG001|NOT COMPLETED|Optional Continuation Phase||0
3080360|NCT01376349|3802015|FG002|NOT COMPLETED|Optional Continuation Phase||0
3080361|NCT01376362|3802024|FG000|STARTED|Overall Study||5
3285993|NCT02778100|4019628|FG001|NOT COMPLETED|Period 2 (No Cold Symptoms)||0
3285994|NCT02778113|4019636|FG000|STARTED|Study Period One||4
3285995|NCT02778113|4019637|FG001|STARTED|Study Period One||4
3285996|NCT02778113|4019638|FG002|STARTED|Study Period One||4
3285997|NCT02778113|4019639|FG003|STARTED|Study Period One||4
3080362|NCT01376362|3802024|FG000|COMPLETED|Overall Study||5
3080363|NCT01376362|3802024|FG000|NOT COMPLETED|Overall Study||0
3080364|NCT01376388|3802028|FG000|STARTED|Overall Study||130
3080365|NCT01376388|3802028|FG000|COMPLETED|Overall Study||112
3080366|NCT01376388|3802028|FG000|NOT COMPLETED|Overall Study||18
3080367|NCT01376557|3802037|FG000|STARTED|Overall Study||59
3080368|NCT01376557|3802038|FG001|STARTED|Overall Study||60
3080369|NCT01376557|3802039|FG002|STARTED|Overall Study||60
3080370|NCT01376557|3802040|FG003|STARTED|Overall Study||60
3080371|NCT01376557|3802041|FG004|STARTED|Overall Study||60
3080372|NCT01376557|3802037|FG000|COMPLETED|Overall Study||51
3080373|NCT01376557|3802038|FG001|COMPLETED|Overall Study||54
3080374|NCT01376557|3802039|FG002|COMPLETED|Overall Study||55
3080375|NCT01376557|3802040|FG003|COMPLETED|Overall Study||54
3080376|NCT01376557|3802041|FG004|COMPLETED|Overall Study||53
3080377|NCT01376557|3802037|FG000|NOT COMPLETED|Overall Study||8
3080378|NCT01376557|3802038|FG001|NOT COMPLETED|Overall Study||6
3080379|NCT01376557|3802039|FG002|NOT COMPLETED|Overall Study||5
3080380|NCT01376557|3802040|FG003|NOT COMPLETED|Overall Study||6
3080381|NCT01376557|3802041|FG004|NOT COMPLETED|Overall Study||7
3080382|NCT01376700|3802053|FG000|STARTED|Overall Study||19
3080383|NCT01376700|3802053|FG000|COMPLETED|Overall Study||3
3080384|NCT01376700|3802053|FG000|NOT COMPLETED|Overall Study||16
3080385|NCT01376804|3802060|FG000|STARTED|Treatment Period||57
3080386|NCT01376804|3802060|FG000|Received Study Drug|Treatment Period||56
3080387|NCT01376804|3802060|FG000|COMPLETED|Treatment Period||49
3080388|NCT01376804|3802060|FG000|NOT COMPLETED|Treatment Period||8
3080389|NCT01376804|3802060|FG000|STARTED|Follow-up Period|6 of the 7 patients who withdrew from treatment continued to the Follow-up Period.|55
3080390|NCT01376804|3802060|FG000|COMPLETED|Follow-up Period||55
3080391|NCT01376804|3802060|FG000|NOT COMPLETED|Follow-up Period||0
3080392|NCT01376908|3802066|FG000|STARTED|Overall Study||27
3080393|NCT01376908|3802067|FG001|STARTED|Overall Study||29
3080394|NCT01376908|3802066|FG000|COMPLETED|Overall Study||25
3080395|NCT01376908|3802067|FG001|COMPLETED|Overall Study||26
3080396|NCT01376908|3802066|FG000|NOT COMPLETED|Overall Study||2
3080397|NCT01376908|3802067|FG001|NOT COMPLETED|Overall Study||3
3080398|NCT01377012|3802083|FG000|STARTED|Core Study||210
3080399|NCT01377012|3802084|FG001|STARTED|Core Study||213
3080400|NCT01377012|3802085|FG002|STARTED|Core Study||214
3080401|NCT01377012|3802083|FG000|wk16 Re-randomized to AIN 75mg NR|Core Study||0
3080402|NCT01377012|3802084|FG001|wk16 Re-randomized to AIN 75mg NR|Core Study||0
3080403|NCT01377012|3802085|FG002|wk16 Re-randomized to AIN 75mg NR|Core Study|NR=Non-responder|56
3080404|NCT01377012|3802083|FG000|wk16 Re-randomized to AIN 150mg NR|Core Study||0
3080405|NCT01377012|3802084|FG001|wk16 Re-randomized to AIN 150mg NR|Core Study||0
3080406|NCT01377012|3802085|FG002|wk16 Re-randomized to AIN 150mg NR|Core Study||53
3080407|NCT01377012|3802083|FG000|wk 24 Re-randomized to AIN 75 mg Res|Core Study||0
3080408|NCT01377012|3802084|FG001|wk 24 Re-randomized to AIN 75 mg Res|Core Study||0
3080409|NCT01377012|3802085|FG002|wk 24 Re-randomized to AIN 75 mg Res|Core Study|Res= responder|38
3080410|NCT01377012|3802083|FG000|wk 24 Re-randomized to AIN 150 mg Res|Core Study||0
3080411|NCT01377012|3802084|FG001|wk 24 Re-randomized to AIN 150 mg Res|Core Study||0
3080412|NCT01377012|3802085|FG002|wk 24 Re-randomized to AIN 150 mg Res|Core Study||34
3080413|NCT01377012|3802083|FG000|COMPLETED|Core Study||76
3080414|NCT01377012|3802084|FG001|COMPLETED|Core Study||81
3080415|NCT01377012|3802085|FG002|COMPLETED|Core Study||80
3080416|NCT01377012|3802083|FG000|NOT COMPLETED|Core Study||134
3080417|NCT01377012|3802084|FG001|NOT COMPLETED|Core Study||132
3080418|NCT01377012|3802085|FG002|NOT COMPLETED|Core Study||134
3080419|NCT01377012|3802083|FG000|STARTED|Extension Study, Weeks 104-260||57
3080420|NCT01377012|3802084|FG001|STARTED|Extension Study, Weeks 104-260||71
3080421|NCT01377012|3802085|FG002|STARTED|Extension Study, Weeks 104-260||68
3080422|NCT01377012|3802083|FG000|COMPLETED|Extension Study, Weeks 104-260||0
3080423|NCT01377012|3802084|FG001|COMPLETED|Extension Study, Weeks 104-260||0
3080424|NCT01377012|3802085|FG002|COMPLETED|Extension Study, Weeks 104-260||0
3080425|NCT01377012|3802083|FG000|NOT COMPLETED|Extension Study, Weeks 104-260||57
3080426|NCT01377012|3802084|FG001|NOT COMPLETED|Extension Study, Weeks 104-260||71
3080427|NCT01377012|3802085|FG002|NOT COMPLETED|Extension Study, Weeks 104-260||68
3080428|NCT01377194|3802096|FG000|STARTED|Overall Study||186
3080429|NCT01377194|3802097|FG001|STARTED|Overall Study||188
3080430|NCT01377194|3802098|FG002|STARTED|Overall Study||188
3080431|NCT01377194|3802096|FG000|COMPLETED|Overall Study||154
3080432|NCT01377194|3802097|FG001|COMPLETED|Overall Study||145
3080433|NCT01377194|3802098|FG002|COMPLETED|Overall Study||142
3080434|NCT01377194|3802096|FG000|NOT COMPLETED|Overall Study||32
3080435|NCT01377194|3802097|FG001|NOT COMPLETED|Overall Study||43
3080436|NCT01377194|3802098|FG002|NOT COMPLETED|Overall Study||46
3080437|NCT01377233|3802114|FG000|STARTED|Open-label||46
3080438|NCT01377233|3802115|FG001|STARTED|Open-label||0
3080439|NCT01377233|3802116|FG002|STARTED|Open-label||0
3080440|NCT01377233|3802117|FG003|STARTED|Open-label||0
3080441|NCT01377233|3802118|FG004|STARTED|Open-label||0
3080442|NCT01377233|3802114|FG000|COMPLETED|Open-label||42
3080443|NCT01377233|3802115|FG001|COMPLETED|Open-label||0
3080444|NCT01377233|3802116|FG002|COMPLETED|Open-label||0
3080445|NCT01377233|3802117|FG003|COMPLETED|Open-label||0
3080446|NCT01377233|3802118|FG004|COMPLETED|Open-label||0
3080447|NCT01377233|3802114|FG000|NOT COMPLETED|Open-label||4
3080448|NCT01377233|3802115|FG001|NOT COMPLETED|Open-label||0
3080449|NCT01377233|3802116|FG002|NOT COMPLETED|Open-label||0
3080450|NCT01377233|3802117|FG003|NOT COMPLETED|Open-label||0
3080451|NCT01377233|3802118|FG004|NOT COMPLETED|Open-label||0
3080452|NCT01377233|3802114|FG000|STARTED|Double-blind||0
3080453|NCT01377233|3802115|FG001|STARTED|Double-blind||11
3080454|NCT01377233|3802116|FG002|STARTED|Double-blind||10
3080455|NCT01377233|3802117|FG003|STARTED|Double-blind||11
3080456|NCT01377233|3802118|FG004|STARTED|Double-blind||10
3080457|NCT01377233|3802114|FG000|COMPLETED|Double-blind||0
3080458|NCT01377233|3802115|FG001|COMPLETED|Double-blind||10
3080459|NCT01377233|3802116|FG002|COMPLETED|Double-blind||8
3080460|NCT01377233|3802117|FG003|COMPLETED|Double-blind||7
3080461|NCT01377233|3802118|FG004|COMPLETED|Double-blind||8
3080462|NCT01377233|3802114|FG000|NOT COMPLETED|Double-blind||0
3080463|NCT01377233|3802115|FG001|NOT COMPLETED|Double-blind||1
3080464|NCT01377233|3802116|FG002|NOT COMPLETED|Double-blind||2
3080465|NCT01377233|3802117|FG003|NOT COMPLETED|Double-blind||4
3080466|NCT01377233|3802118|FG004|NOT COMPLETED|Double-blind||2
3080467|NCT01377389|3802134|FG000|STARTED|Overall Study||30
3080468|NCT01377389|3802134|FG000|COMPLETED|Overall Study||27
3080469|NCT01377389|3802134|FG000|NOT COMPLETED|Overall Study||3
3080470|NCT01377402|3802138|FG000|STARTED|Overall Study||982
3080471|NCT01377402|3802138|FG000|COMPLETED|Overall Study||982
3080472|NCT01377402|3802138|FG000|NOT COMPLETED|Overall Study||0
3080473|NCT01377467|3802146|FG000|STARTED|Overall Study||46
3080474|NCT01377467|3802147|FG001|STARTED|Overall Study||44
3080475|NCT01377467|3802146|FG000|COMPLETED|Overall Study||46
3080476|NCT01377467|3802147|FG001|COMPLETED|Overall Study||44
3080477|NCT01377467|3802146|FG000|NOT COMPLETED|Overall Study||0
3080478|NCT01377467|3802147|FG001|NOT COMPLETED|Overall Study||0
3080479|NCT01377480|3802157|FG000|STARTED|Overall Study|Includes 2 participants randomized to POS + BNZ but who only received POS|32
3080480|NCT01377480|3802158|FG001|STARTED|Overall Study||30
3080481|NCT01377480|3802159|FG002|STARTED|Overall Study|2 participants received only POS and were analyzed as part of the posaconazole group|28
3080482|NCT01377480|3802160|FG003|STARTED|Overall Study||30
3080483|NCT01377480|3802157|FG000|COMPLETED|Overall Study||32
3080484|NCT01377480|3802158|FG001|COMPLETED|Overall Study||29
3080485|NCT01377480|3802159|FG002|COMPLETED|Overall Study||18
3080486|NCT01377480|3802160|FG003|COMPLETED|Overall Study||19
3080487|NCT01377480|3802157|FG000|NOT COMPLETED|Overall Study||0
3080488|NCT01377480|3802158|FG001|NOT COMPLETED|Overall Study||1
3080489|NCT01377480|3802159|FG002|NOT COMPLETED|Overall Study||10
3080490|NCT01377480|3802160|FG003|NOT COMPLETED|Overall Study||11
3080491|NCT01377584|3802176|FG000|STARTED|Overall Study||8
3080492|NCT01377584|3802177|FG001|STARTED|Overall Study||8
3080493|NCT01377584|3802178|FG002|STARTED|Overall Study||10
3080494|NCT01377584|3802179|FG003|STARTED|Overall Study||10
3080495|NCT01377584|3802180|FG004|STARTED|Overall Study||12
3080496|NCT01377584|3802181|FG005|STARTED|Overall Study||12
3080497|NCT01377584|3802176|FG000|COMPLETED|Overall Study||5
3080498|NCT01377584|3802177|FG001|COMPLETED|Overall Study||5
3080499|NCT01377584|3802178|FG002|COMPLETED|Overall Study||6
3080500|NCT01377584|3802179|FG003|COMPLETED|Overall Study||6
3080501|NCT01377584|3802180|FG004|COMPLETED|Overall Study||9
3080502|NCT01377584|3802181|FG005|COMPLETED|Overall Study||9
3080503|NCT01377584|3802176|FG000|NOT COMPLETED|Overall Study||3
3080504|NCT01377584|3802177|FG001|NOT COMPLETED|Overall Study||3
3080505|NCT01377584|3802178|FG002|NOT COMPLETED|Overall Study||4
3080506|NCT01377584|3802179|FG003|NOT COMPLETED|Overall Study||4
3080507|NCT01377584|3802180|FG004|NOT COMPLETED|Overall Study||3
3080508|NCT01377584|3802181|FG005|NOT COMPLETED|Overall Study||3
3080509|NCT01377623|3802200|FG000|STARTED|Overall Study||33
3080510|NCT01377623|3802201|FG001|STARTED|Overall Study||33
3080511|NCT01377623|3802200|FG000|COMPLETED|Overall Study||26
3080512|NCT01377623|3802201|FG001|COMPLETED|Overall Study||28
3080513|NCT01377623|3802200|FG000|NOT COMPLETED|Overall Study||7
3080514|NCT01377623|3802201|FG001|NOT COMPLETED|Overall Study||5
3080515|NCT01377636|3802207|FG000|STARTED|Overall Study||20
3080516|NCT01377636|3802207|FG000|COMPLETED|Overall Study||20
3080517|NCT01377636|3802207|FG000|NOT COMPLETED|Overall Study||0
3080518|NCT01377844|3802215|FG000|STARTED|Overall Study||145
3080519|NCT01377844|3802216|FG001|STARTED|Overall Study||143
3080520|NCT01377844|3802215|FG000|Safety Population|Overall Study||145
3080521|NCT01377844|3802216|FG001|Safety Population|Overall Study||141
3080522|NCT01377844|3802215|FG000|COMPLETED|Overall Study||109
3080523|NCT01377844|3802216|FG001|COMPLETED|Overall Study||108
3080524|NCT01377844|3802215|FG000|NOT COMPLETED|Overall Study||36
3080525|NCT01377844|3802216|FG001|NOT COMPLETED|Overall Study||35
3080526|NCT01377922|3802225|FG000|STARTED|Overall Study||22
3080527|NCT01377922|3802226|FG001|STARTED|Overall Study||16
3080528|NCT01377922|3802225|FG000|COMPLETED|Overall Study||21
3080529|NCT01377922|3802226|FG001|COMPLETED|Overall Study||16
3080530|NCT01377922|3802225|FG000|NOT COMPLETED|Overall Study||1
3080531|NCT01377922|3802226|FG001|NOT COMPLETED|Overall Study||0
3080532|NCT01377987|3802232|FG000|STARTED|First Intervention (7 Days)||14
3080533|NCT01377987|3802233|FG001|STARTED|First Intervention (7 Days)||15
3080534|NCT01377987|3802232|FG000|COMPLETED|First Intervention (7 Days)||14
3080535|NCT01377987|3802233|FG001|COMPLETED|First Intervention (7 Days)||15
3080536|NCT01377987|3802232|FG000|NOT COMPLETED|First Intervention (7 Days)||0
3285998|NCT02778113|4019636|FG000|Received Study Drug|Study Period One||4
3285999|NCT02778113|4019637|FG001|Received Study Drug|Study Period One||4
3286000|NCT02778113|4019638|FG002|Received Study Drug|Study Period One||4
3286001|NCT02778113|4019639|FG003|Received Study Drug|Study Period One||4
3286002|NCT02778113|4019636|FG000|COMPLETED|Study Period One||4
3286003|NCT02778113|4019637|FG001|COMPLETED|Study Period One||4
3286004|NCT02778113|4019638|FG002|COMPLETED|Study Period One||4
3286005|NCT02778113|4019639|FG003|COMPLETED|Study Period One||4
3286006|NCT02778113|4019636|FG000|NOT COMPLETED|Study Period One||0
3286007|NCT02778113|4019637|FG001|NOT COMPLETED|Study Period One||0
3286008|NCT02778113|4019638|FG002|NOT COMPLETED|Study Period One||0
3286009|NCT02778113|4019639|FG003|NOT COMPLETED|Study Period One||0
3286010|NCT02778113|4019636|FG000|STARTED|Study Period Two||4
3286011|NCT02778113|4019637|FG001|STARTED|Study Period Two||4
3286012|NCT02778113|4019638|FG002|STARTED|Study Period Two||4
3286013|NCT02778113|4019639|FG003|STARTED|Study Period Two||4
3080537|NCT01377987|3802233|FG001|NOT COMPLETED|First Intervention (7 Days)||0
3080538|NCT01377987|3802232|FG000|STARTED|Washout (7 Days)||14
3080539|NCT01377987|3802233|FG001|STARTED|Washout (7 Days)||15
3080540|NCT01377987|3802232|FG000|COMPLETED|Washout (7 Days)||13
3080541|NCT01377987|3802233|FG001|COMPLETED|Washout (7 Days)||14
3080542|NCT01377987|3802232|FG000|NOT COMPLETED|Washout (7 Days)||1
3080543|NCT01377987|3802233|FG001|NOT COMPLETED|Washout (7 Days)||1
3080544|NCT01377987|3802232|FG000|STARTED|Second Intervention (7 Days)||13
3080545|NCT01377987|3802233|FG001|STARTED|Second Intervention (7 Days)||14
3080546|NCT01377987|3802232|FG000|COMPLETED|Second Intervention (7 Days)||13
3080547|NCT01377987|3802233|FG001|COMPLETED|Second Intervention (7 Days)||14
3080548|NCT01377987|3802232|FG000|NOT COMPLETED|Second Intervention (7 Days)||0
3080549|NCT01377987|3802233|FG001|NOT COMPLETED|Second Intervention (7 Days)||0
3080550|NCT01378065|3802239|FG000|STARTED|Overall Study|31 subjects were enrolled/consented. However, 1 subject was not implanted with a study device.|30
3080551|NCT01378065|3802239|FG000|6 Week|Overall Study||30
3080552|NCT01378065|3802239|FG000|3 Months|Overall Study||30
3080553|NCT01378065|3802239|FG000|6 Months|Overall Study||30
3080554|NCT01378065|3802239|FG000|12 Months|Overall Study||30
3080555|NCT01378065|3802239|FG000|COMPLETED|Overall Study||30
3080556|NCT01378065|3802239|FG000|NOT COMPLETED|Overall Study||0
3080557|NCT01378104|3802245|FG000|STARTED|Overall Study||92
3080558|NCT01378104|3802246|FG001|STARTED|Overall Study||86
3080559|NCT01378104|3802245|FG000|COMPLETED|Overall Study||65
3080560|NCT01378104|3802246|FG001|COMPLETED|Overall Study||60
3080561|NCT01378104|3802245|FG000|NOT COMPLETED|Overall Study||27
3080562|NCT01378104|3802246|FG001|NOT COMPLETED|Overall Study||26
3080563|NCT01378117|3802257|FG000|STARTED|Overall Study||31
3080564|NCT01378117|3802258|FG001|STARTED|Overall Study||30
3080565|NCT01378117|3802259|FG002|STARTED|Overall Study||29
3080566|NCT01378117|3802257|FG000|COMPLETED|Overall Study||27
3080567|NCT01378117|3802258|FG001|COMPLETED|Overall Study||29
3286014|NCT02778113|4019636|FG000|Received Study Drug|Study Period Two||4
3286015|NCT02778113|4019637|FG001|Received Study Drug|Study Period Two||4
3286016|NCT02778113|4019638|FG002|Received Study Drug|Study Period Two||4
3286017|NCT02778113|4019639|FG003|Received Study Drug|Study Period Two||4
3286018|NCT02778113|4019636|FG000|COMPLETED|Study Period Two||4
3286019|NCT02778113|4019637|FG001|COMPLETED|Study Period Two||4
3286020|NCT02778113|4019638|FG002|COMPLETED|Study Period Two||4
3286021|NCT02778113|4019639|FG003|COMPLETED|Study Period Two||4
3286022|NCT02778113|4019636|FG000|NOT COMPLETED|Study Period Two||0
3286023|NCT02778113|4019637|FG001|NOT COMPLETED|Study Period Two||0
3286024|NCT02778113|4019638|FG002|NOT COMPLETED|Study Period Two||0
3286025|NCT02778113|4019639|FG003|NOT COMPLETED|Study Period Two||0
3080568|NCT01378117|3802259|FG002|COMPLETED|Overall Study||26
3080569|NCT01378117|3802257|FG000|NOT COMPLETED|Overall Study||4
3080570|NCT01378117|3802258|FG001|NOT COMPLETED|Overall Study||1
3080571|NCT01378117|3802259|FG002|NOT COMPLETED|Overall Study||3
3080572|NCT01378195|3802274|FG000|STARTED|Overall Study||75
3080573|NCT01378195|3802275|FG001|STARTED|Overall Study||75
3080574|NCT01378195|3802274|FG000|COMPLETED|Overall Study||46
3080575|NCT01378195|3802275|FG001|COMPLETED|Overall Study||57
3080576|NCT01378195|3802274|FG000|NOT COMPLETED|Overall Study||29
3080577|NCT01378195|3802275|FG001|NOT COMPLETED|Overall Study||18
3080578|NCT01378221|3802283|FG000|STARTED|Overall Study||36
3080579|NCT01378221|3802284|FG001|STARTED|Overall Study||39
3080580|NCT01378221|3802283|FG000|COMPLETED|Overall Study||29
3080581|NCT01378221|3802284|FG001|COMPLETED|Overall Study||30
3080582|NCT01378221|3802283|FG000|NOT COMPLETED|Overall Study||7
3080583|NCT01378221|3802284|FG001|NOT COMPLETED|Overall Study||9
3080584|NCT01378273|3802292|FG000|STARTED|Overall Study||464
3080585|NCT01378273|3802293|FG001|STARTED|Overall Study||477
3080586|NCT01378273|3802292|FG000|COMPLETED|Overall Study||460
3080587|NCT01378273|3802293|FG001|COMPLETED|Overall Study||476
3080588|NCT01378273|3802292|FG000|NOT COMPLETED|Overall Study||4
3080589|NCT01378273|3802293|FG001|NOT COMPLETED|Overall Study||1
3080590|NCT01378299|3802303|FG000|STARTED|Overall Study||105
3080591|NCT01378299|3802303|FG000|BMI group1|Overall Study||38
3080592|NCT01378299|3802303|FG000|BMI Group 2|Overall Study||40
3080593|NCT01378299|3802303|FG000|BMI Group 3|Overall Study||27
3080594|NCT01378299|3802303|FG000|COMPLETED|Overall Study||74
3080595|NCT01378299|3802303|FG000|NOT COMPLETED|Overall Study||31
3080596|NCT01378325|3802335|FG000|STARTED|Overall Study||40
3080597|NCT01378325|3802336|FG001|STARTED|Overall Study||40
3080598|NCT01378325|3802335|FG000|COMPLETED|Overall Study||40
3080599|NCT01378325|3802336|FG001|COMPLETED|Overall Study||39
3080600|NCT01378325|3802335|FG000|NOT COMPLETED|Overall Study||0
3080601|NCT01378325|3802336|FG001|NOT COMPLETED|Overall Study||1
3080602|NCT01378377|3802345|FG000|STARTED|Overall Study||4
3080603|NCT01378377|3802346|FG001|STARTED|Overall Study||23
3080604|NCT01378377|3802347|FG002|STARTED|Overall Study||6
3080605|NCT01378377|3802345|FG000|COMPLETED|Overall Study||4
3080606|NCT01378377|3802346|FG001|COMPLETED|Overall Study||23
3080607|NCT01378377|3802347|FG002|COMPLETED|Overall Study||6
3080608|NCT01378377|3802345|FG000|NOT COMPLETED|Overall Study||0
3080609|NCT01378377|3802346|FG001|NOT COMPLETED|Overall Study||0
3080610|NCT01378377|3802347|FG002|NOT COMPLETED|Overall Study||0
3080611|NCT01378416|3802360|FG000|STARTED|Overall Study||16
3080612|NCT01378416|3802360|FG000|COMPLETED|Overall Study||16
3080613|NCT01378416|3802360|FG000|NOT COMPLETED|Overall Study||0
3080614|NCT01378429|3802366|FG000|STARTED|Overall Study||42
3080615|NCT01378429|3802367|FG001|STARTED|Overall Study||47
3080616|NCT01378429|3802366|FG000|COMPLETED|Overall Study||41
3080617|NCT01378429|3802367|FG001|COMPLETED|Overall Study||47
3080618|NCT01378429|3802366|FG000|NOT COMPLETED|Overall Study||1
3080619|NCT01378429|3802367|FG001|NOT COMPLETED|Overall Study||0
3080620|NCT01378520|3802376|FG000|STARTED|First Intervention (Day 2-3)||10
3080621|NCT01378520|3802377|FG001|STARTED|First Intervention (Day 2-3)||10
3080622|NCT01378520|3802376|FG000|COMPLETED|First Intervention (Day 2-3)||10
3080623|NCT01378520|3802377|FG001|COMPLETED|First Intervention (Day 2-3)||10
3080624|NCT01378520|3802376|FG000|NOT COMPLETED|First Intervention (Day 2-3)||0
3080625|NCT01378520|3802377|FG001|NOT COMPLETED|First Intervention (Day 2-3)||0
3080626|NCT01378520|3802376|FG000|STARTED|Second Intervention (Day 4-6)||10
3080627|NCT01378520|3802377|FG001|STARTED|Second Intervention (Day 4-6)||10
3080628|NCT01378520|3802376|FG000|COMPLETED|Second Intervention (Day 4-6)||10
3080629|NCT01378520|3802377|FG001|COMPLETED|Second Intervention (Day 4-6)||10
3080630|NCT01378520|3802376|FG000|NOT COMPLETED|Second Intervention (Day 4-6)||0
3080631|NCT01378520|3802377|FG001|NOT COMPLETED|Second Intervention (Day 4-6)||0
3080632|NCT01378858|3802385|FG000|STARTED|Overall Study||50
3080633|NCT01378858|3802386|FG001|STARTED|Overall Study||50
3080634|NCT01378858|3802385|FG000|COMPLETED|Overall Study||46
3080635|NCT01378858|3802386|FG001|COMPLETED|Overall Study||46
3080636|NCT01378858|3802385|FG000|NOT COMPLETED|Overall Study||4
3080637|NCT01378858|3802386|FG001|NOT COMPLETED|Overall Study||4
3080638|NCT01378962|3802392|FG000|STARTED|Overall Study||50
3080639|NCT01378962|3802392|FG000|COMPLETED|Overall Study||33
3286026|NCT02778113|4019636|FG000|STARTED|Study Period Three||4
3286027|NCT02778113|4019637|FG001|STARTED|Study Period Three||4
3286028|NCT02778113|4019638|FG002|STARTED|Study Period Three|One participant completed study period two, but did not enter study period three.|3
3286029|NCT02778113|4019639|FG003|STARTED|Study Period Three||4
3080640|NCT01378962|3802392|FG000|NOT COMPLETED|Overall Study||17
3080641|NCT01378975|3802398|FG000|STARTED|Overall Study||90
3080642|NCT01378975|3802399|FG001|STARTED|Overall Study||56
3080643|NCT01378975|3802398|FG000|COMPLETED|Overall Study||4
3080644|NCT01378975|3802399|FG001|COMPLETED|Overall Study||6
3080645|NCT01378975|3802398|FG000|NOT COMPLETED|Overall Study||86
3080646|NCT01378975|3802399|FG001|NOT COMPLETED|Overall Study||50
3080647|NCT01378988|3802408|FG000|STARTED|Overall Study||2
3080648|NCT01378988|3802409|FG001|STARTED|Overall Study||3
3080649|NCT01378988|3802408|FG000|COMPLETED|Overall Study||2
3080650|NCT01378988|3802409|FG001|COMPLETED|Overall Study||3
3080651|NCT01378988|3802408|FG000|NOT COMPLETED|Overall Study||0
3080652|NCT01378988|3802409|FG001|NOT COMPLETED|Overall Study||0
3080653|NCT01379183|3802417|FG000|STARTED|Overall Study||19
3080654|NCT01379183|3802418|FG001|STARTED|Overall Study||21
3080655|NCT01379183|3802417|FG000|COMPLETED|Overall Study||19
3080656|NCT01379183|3802418|FG001|COMPLETED|Overall Study||21
3080657|NCT01379183|3802417|FG000|NOT COMPLETED|Overall Study||0
3080658|NCT01379183|3802418|FG001|NOT COMPLETED|Overall Study||0
3080659|NCT01379222|3802426|FG000|STARTED|Overall Study||178
3080660|NCT01379222|3802426|FG000|COMPLETED|Overall Study||105
3080661|NCT01379222|3802426|FG000|NOT COMPLETED|Overall Study||73
3080662|NCT01379508|3802434|FG000|STARTED|Treatment to Week 104||99
3080663|NCT01379508|3802435|FG001|STARTED|Treatment to Week 104||22
3080664|NCT01379508|3802436|FG002|STARTED|Treatment to Week 104||109
3080665|NCT01379508|3802437|FG003|STARTED|Treatment to Week 104||11
3080666|NCT01379508|3802434|FG000|Completed Wk 24|Treatment to Week 104||93
3080667|NCT01379508|3802435|FG001|Completed Wk 24|Treatment to Week 104||22
3080668|NCT01379508|3802436|FG002|Completed Wk 24|Treatment to Week 104||107
3080669|NCT01379508|3802437|FG003|Completed Wk 24|Treatment to Week 104||11
3080670|NCT01379508|3802434|FG000|Treatment Exposure ≥ 52 Weeks|Treatment to Week 104||91
3080671|NCT01379508|3802435|FG001|Treatment Exposure ≥ 52 Weeks|Treatment to Week 104||21
3080672|NCT01379508|3802436|FG002|Treatment Exposure ≥ 52 Weeks|Treatment to Week 104||105
3080673|NCT01379508|3802437|FG003|Treatment Exposure ≥ 52 Weeks|Treatment to Week 104||11
3080674|NCT01379508|3802434|FG000|COMPLETED|Treatment to Week 104||80
3080675|NCT01379508|3802435|FG001|COMPLETED|Treatment to Week 104||19
3080676|NCT01379508|3802436|FG002|COMPLETED|Treatment to Week 104||96
3080677|NCT01379508|3802437|FG003|COMPLETED|Treatment to Week 104||11
3080678|NCT01379508|3802434|FG000|NOT COMPLETED|Treatment to Week 104||19
3080679|NCT01379508|3802435|FG001|NOT COMPLETED|Treatment to Week 104||3
3080680|NCT01379508|3802436|FG002|NOT COMPLETED|Treatment to Week 104||13
3080681|NCT01379508|3802437|FG003|NOT COMPLETED|Treatment to Week 104||0
3080682|NCT01379508|3802434|FG000|STARTED|Extension Period Weeks 109-156||64
3080683|NCT01379508|3802435|FG001|STARTED|Extension Period Weeks 109-156||17
3080684|NCT01379508|3802436|FG002|STARTED|Extension Period Weeks 109-156||79
3080685|NCT01379508|3802437|FG003|STARTED|Extension Period Weeks 109-156||10
3080686|NCT01379508|3802434|FG000|COMPLETED|Extension Period Weeks 109-156||45
3080687|NCT01379508|3802435|FG001|COMPLETED|Extension Period Weeks 109-156||14
3080688|NCT01379508|3802436|FG002|COMPLETED|Extension Period Weeks 109-156||65
3080689|NCT01379508|3802437|FG003|COMPLETED|Extension Period Weeks 109-156||10
3080690|NCT01379508|3802434|FG000|NOT COMPLETED|Extension Period Weeks 109-156||19
3080691|NCT01379508|3802435|FG001|NOT COMPLETED|Extension Period Weeks 109-156||3
3080692|NCT01379508|3802436|FG002|NOT COMPLETED|Extension Period Weeks 109-156||14
3080693|NCT01379508|3802437|FG003|NOT COMPLETED|Extension Period Weeks 109-156||0
3080694|NCT01379521|3802453|FG000|STARTED|Overall Study -Treatment Period||33
3080695|NCT01379521|3802454|FG001|STARTED|Overall Study -Treatment Period||26
3080696|NCT01379521|3802453|FG000|COMPLETED|Overall Study -Treatment Period||0
3080697|NCT01379521|3802454|FG001|COMPLETED|Overall Study -Treatment Period||0
3080698|NCT01379521|3802453|FG000|NOT COMPLETED|Overall Study -Treatment Period||33
3080699|NCT01379521|3802454|FG001|NOT COMPLETED|Overall Study -Treatment Period||26
3080700|NCT01379521|3802453|FG000|STARTED|Post-Treatment Evaluations||25
3080701|NCT01379521|3802454|FG001|STARTED|Post-Treatment Evaluations||21
3080702|NCT01379521|3802453|FG000|COMPLETED|Post-Treatment Evaluations||0
3080703|NCT01379521|3802454|FG001|COMPLETED|Post-Treatment Evaluations||0
3080704|NCT01379521|3802453|FG000|NOT COMPLETED|Post-Treatment Evaluations||25
3080705|NCT01379521|3802454|FG001|NOT COMPLETED|Post-Treatment Evaluations||21
3080706|NCT01379534|3802462|FG000|STARTED|Treatment Phase||22
3080707|NCT01379534|3802463|FG001|STARTED|Treatment Phase||31
3080708|NCT01379534|3802462|FG000|COMPLETED|Treatment Phase||0
3080709|NCT01379534|3802463|FG001|COMPLETED|Treatment Phase||0
3080710|NCT01379534|3802462|FG000|NOT COMPLETED|Treatment Phase||22
3080711|NCT01379534|3802463|FG001|NOT COMPLETED|Treatment Phase||31
3080712|NCT01379534|3802462|FG000|STARTED|Tumor Assessment Follow-up (f/u) Phase|All participants discontinued the Treatment Phase. Of these, only 6 qualified for f/u tumor assess..|4
3080713|NCT01379534|3802463|FG001|STARTED|Tumor Assessment Follow-up (f/u) Phase||2
3080714|NCT01379534|3802462|FG000|COMPLETED|Tumor Assessment Follow-up (f/u) Phase||0
3080715|NCT01379534|3802463|FG001|COMPLETED|Tumor Assessment Follow-up (f/u) Phase||0
3080716|NCT01379534|3802462|FG000|NOT COMPLETED|Tumor Assessment Follow-up (f/u) Phase||4
3080717|NCT01379534|3802463|FG001|NOT COMPLETED|Tumor Assessment Follow-up (f/u) Phase||2
3080718|NCT01379573|3802469|FG000|STARTED|Overall Study||74
3080719|NCT01379573|3802469|FG000|COMPLETED|Overall Study||63
3080720|NCT01379573|3802469|FG000|NOT COMPLETED|Overall Study||11
3080721|NCT01379625|3802475|FG000|STARTED|Overall Study||16
3080722|NCT01379625|3802476|FG001|STARTED|Overall Study||16
3080723|NCT01379625|3802475|FG000|COMPLETED|Overall Study||16
3080724|NCT01379625|3802476|FG001|COMPLETED|Overall Study||16
3080725|NCT01379625|3802475|FG000|NOT COMPLETED|Overall Study||0
3080726|NCT01379625|3802476|FG001|NOT COMPLETED|Overall Study||0
3080727|NCT01379651|3802484|FG000|STARTED|Overall Study||10
3080728|NCT01379651|3802485|FG001|STARTED|Overall Study||10
3080729|NCT01379651|3802484|FG000|COMPLETED|Overall Study||10
3080730|NCT01379651|3802485|FG001|COMPLETED|Overall Study||10
3080731|NCT01379651|3802484|FG000|NOT COMPLETED|Overall Study||0
3080732|NCT01379651|3802485|FG001|NOT COMPLETED|Overall Study||0
3080733|NCT01379664|3802493|FG000|STARTED|Overall Study||714
3080734|NCT01379664|3802494|FG001|STARTED|Overall Study||870
3080735|NCT01379664|3802493|FG000|COMPLETED|Overall Study||714
3080736|NCT01379664|3802494|FG001|COMPLETED|Overall Study||870
3080737|NCT01379664|3802493|FG000|NOT COMPLETED|Overall Study||0
3080738|NCT01379664|3802494|FG001|NOT COMPLETED|Overall Study||0
3080739|NCT01379703|3802500|FG000|STARTED|Study Start Through 9 Months|Participants taking lopinavir/ritonavir tablets/capsules or oral solution during the study (66/2288)|66
3080740|NCT01379703|3802501|FG001|STARTED|Study Start Through 9 Months|Participants taking the lopinavir/ritonavir capsule formulation (only) during study (1206/2288)|1206
3080741|NCT01379703|3802502|FG002|STARTED|Study Start Through 9 Months|Participants taking the lopinavir/ritonavir tablet formulation (only) during study (1016/2288)|1016
3080742|NCT01379703|3802500|FG000|COMPLETED|Study Start Through 9 Months||62
3080743|NCT01379703|3802501|FG001|COMPLETED|Study Start Through 9 Months|Participants taking the capsule formulation were followed for an additional 9 months (up to 18 mos).|1084
3080744|NCT01379703|3802502|FG002|COMPLETED|Study Start Through 9 Months||873
3080745|NCT01379703|3802500|FG000|NOT COMPLETED|Study Start Through 9 Months||4
3080746|NCT01379703|3802501|FG001|NOT COMPLETED|Study Start Through 9 Months||122
3080747|NCT01379703|3802502|FG002|NOT COMPLETED|Study Start Through 9 Months||143
3080748|NCT01379703|3802500|FG000|STARTED|9 Months Through 18 Months|Participants in this subgroup were followed for 9 months.|0
3080749|NCT01379703|3802501|FG001|STARTED|9 Months Through 18 Months|Participants taking the capsule formulation were followed for an additional 9 months (up to 18 mos).|1084
3080750|NCT01379703|3802502|FG002|STARTED|9 Months Through 18 Months|Participants in this subgroup were followed for 9 months.|0
3080751|NCT01379703|3802500|FG000|COMPLETED|9 Months Through 18 Months||0
3080752|NCT01379703|3802501|FG001|COMPLETED|9 Months Through 18 Months||854
3080753|NCT01379703|3802502|FG002|COMPLETED|9 Months Through 18 Months||0
3080754|NCT01379703|3802500|FG000|NOT COMPLETED|9 Months Through 18 Months||0
3080755|NCT01379703|3802501|FG001|NOT COMPLETED|9 Months Through 18 Months||230
3080756|NCT01379703|3802502|FG002|NOT COMPLETED|9 Months Through 18 Months||0
3080757|NCT01379768|3802514|FG000|STARTED|Overall Study||23
3080758|NCT01379768|3802515|FG001|STARTED|Overall Study||22
3080759|NCT01379768|3802516|FG002|STARTED|Overall Study||20
3080760|NCT01379768|3802514|FG000|COMPLETED|Overall Study||20
3080761|NCT01379768|3802515|FG001|COMPLETED|Overall Study||21
3080762|NCT01379768|3802516|FG002|COMPLETED|Overall Study||20
3080763|NCT01379768|3802514|FG000|NOT COMPLETED|Overall Study||3
3080764|NCT01379768|3802515|FG001|NOT COMPLETED|Overall Study||1
3080765|NCT01379768|3802516|FG002|NOT COMPLETED|Overall Study||0
3080766|NCT01379781|3802526|FG000|STARTED|Overall Study||27
3080767|NCT01379781|3802527|FG001|STARTED|Overall Study||27
3080768|NCT01379781|3802526|FG000|COMPLETED|Overall Study||16
3080769|NCT01379781|3802527|FG001|COMPLETED|Overall Study||19
3080770|NCT01379781|3802526|FG000|NOT COMPLETED|Overall Study||11
3080771|NCT01379781|3802527|FG001|NOT COMPLETED|Overall Study||8
3080772|NCT01379924|3802535|FG000|STARTED|Baseline||72
3080773|NCT01379924|3802536|FG001|STARTED|Baseline||68
3080774|NCT01379924|3802535|FG000|COMPLETED|Baseline||72
3080775|NCT01379924|3802536|FG001|COMPLETED|Baseline||68
3080776|NCT01379924|3802535|FG000|NOT COMPLETED|Baseline||0
3080777|NCT01379924|3802536|FG001|NOT COMPLETED|Baseline||0
3080778|NCT01379924|3802535|FG000|STARTED|12-month Assessment||72
3080779|NCT01379924|3802536|FG001|STARTED|12-month Assessment||68
3080780|NCT01379924|3802535|FG000|COMPLETED|12-month Assessment||62
3080781|NCT01379924|3802536|FG001|COMPLETED|12-month Assessment||55
3080782|NCT01379924|3802535|FG000|NOT COMPLETED|12-month Assessment||10
3080783|NCT01379924|3802536|FG001|NOT COMPLETED|12-month Assessment||13
3080784|NCT01379924|3802535|FG000|STARTED|24-month Assessment||62
3080785|NCT01379924|3802536|FG001|STARTED|24-month Assessment||55
3080786|NCT01379924|3802535|FG000|COMPLETED|24-month Assessment||55
3080787|NCT01379924|3802536|FG001|COMPLETED|24-month Assessment||52
3080788|NCT01379924|3802535|FG000|NOT COMPLETED|24-month Assessment||7
3080789|NCT01379924|3802536|FG001|NOT COMPLETED|24-month Assessment||3
3080790|NCT01379924|3802535|FG000|STARTED|36-month Assessment||55
3080791|NCT01379924|3802536|FG001|STARTED|36-month Assessment||52
3080792|NCT01379924|3802535|FG000|COMPLETED|36-month Assessment||52
3080793|NCT01379924|3802536|FG001|COMPLETED|36-month Assessment||48
3080794|NCT01379924|3802535|FG000|NOT COMPLETED|36-month Assessment||3
3080795|NCT01379924|3802536|FG001|NOT COMPLETED|36-month Assessment||4
3080796|NCT01379937|3802549|FG000|STARTED|Overall Study||156
3080797|NCT01379937|3802550|FG001|STARTED|Overall Study||156
3080798|NCT01379937|3802551|FG002|STARTED|Overall Study||104
3080799|NCT01379937|3802552|FG003|STARTED|Overall Study||104
3080800|NCT01379937|3802549|FG000|COMPLETED|Overall Study||155
3080801|NCT01379937|3802550|FG001|COMPLETED|Overall Study||153
3080802|NCT01379937|3802551|FG002|COMPLETED|Overall Study||102
3080803|NCT01379937|3802552|FG003|COMPLETED|Overall Study||103
3080804|NCT01379937|3802549|FG000|NOT COMPLETED|Overall Study||1
3080805|NCT01379937|3802550|FG001|NOT COMPLETED|Overall Study||3
3080806|NCT01379937|3802551|FG002|NOT COMPLETED|Overall Study||2
3080807|NCT01379937|3802552|FG003|NOT COMPLETED|Overall Study||1
3080808|NCT01379963|3802567|FG000|STARTED|Overall Study||780
3080809|NCT01379963|3802567|FG000|COMPLETED|Overall Study||780
3080810|NCT01379963|3802567|FG000|NOT COMPLETED|Overall Study||0
3080811|NCT01380080|3802573|FG000|STARTED|Overall Study||424
3080812|NCT01380080|3802574|FG001|STARTED|Overall Study||426
3080813|NCT01380080|3802573|FG000|COMPLETED|Overall Study||339
3080814|NCT01380080|3802574|FG001|COMPLETED|Overall Study||343
3080815|NCT01380080|3802573|FG000|NOT COMPLETED|Overall Study||85
3080816|NCT01380080|3802574|FG001|NOT COMPLETED|Overall Study||83
3080817|NCT01380093|3802580|FG000|STARTED|Naloxone Challenge Phase||80
3080818|NCT01380093|3802581|FG001|STARTED|Naloxone Challenge Phase||0
3286030|NCT02778113|4019636|FG000|Received Study Drug|Study Period Three||4
3286031|NCT02778113|4019637|FG001|Received Study Drug|Study Period Three||4
3286032|NCT02778113|4019638|FG002|Received Study Drug|Study Period Three||3
3080819|NCT01380093|3802582|FG002|STARTED|Naloxone Challenge Phase||0
3080820|NCT01380093|3802583|FG003|STARTED|Naloxone Challenge Phase||0
3080821|NCT01380093|3802584|FG004|STARTED|Naloxone Challenge Phase||0
3080822|NCT01380093|3802585|FG005|STARTED|Naloxone Challenge Phase||0
3080823|NCT01380093|3802586|FG006|STARTED|Naloxone Challenge Phase||0
3080824|NCT01380093|3802587|FG007|STARTED|Naloxone Challenge Phase||0
3080825|NCT01380093|3802588|FG008|STARTED|Naloxone Challenge Phase||0
3080826|NCT01380093|3802580|FG000|TREATED|Naloxone Challenge Phase||59
3080827|NCT01380093|3802581|FG001|TREATED|Naloxone Challenge Phase||0
3080828|NCT01380093|3802582|FG002|TREATED|Naloxone Challenge Phase||0
3080829|NCT01380093|3802583|FG003|TREATED|Naloxone Challenge Phase||0
3080830|NCT01380093|3802584|FG004|TREATED|Naloxone Challenge Phase||0
3080831|NCT01380093|3802585|FG005|TREATED|Naloxone Challenge Phase||0
3080832|NCT01380093|3802586|FG006|TREATED|Naloxone Challenge Phase||0
3080833|NCT01380093|3802587|FG007|TREATED|Naloxone Challenge Phase||0
3080834|NCT01380093|3802588|FG008|TREATED|Naloxone Challenge Phase||0
3080835|NCT01380093|3802580|FG000|COMPLETED|Naloxone Challenge Phase||59
3080836|NCT01380093|3802581|FG001|COMPLETED|Naloxone Challenge Phase||0
3080837|NCT01380093|3802582|FG002|COMPLETED|Naloxone Challenge Phase||0
3080838|NCT01380093|3802583|FG003|COMPLETED|Naloxone Challenge Phase||0
3080839|NCT01380093|3802584|FG004|COMPLETED|Naloxone Challenge Phase||0
3080840|NCT01380093|3802585|FG005|COMPLETED|Naloxone Challenge Phase||0
3080841|NCT01380093|3802586|FG006|COMPLETED|Naloxone Challenge Phase||0
3080842|NCT01380093|3802587|FG007|COMPLETED|Naloxone Challenge Phase||0
3080843|NCT01380093|3802588|FG008|COMPLETED|Naloxone Challenge Phase||0
3080844|NCT01380093|3802580|FG000|NOT COMPLETED|Naloxone Challenge Phase||21
3080845|NCT01380093|3802581|FG001|NOT COMPLETED|Naloxone Challenge Phase||0
3080846|NCT01380093|3802582|FG002|NOT COMPLETED|Naloxone Challenge Phase||0
3080847|NCT01380093|3802583|FG003|NOT COMPLETED|Naloxone Challenge Phase||0
3080848|NCT01380093|3802584|FG004|NOT COMPLETED|Naloxone Challenge Phase||0
3080849|NCT01380093|3802585|FG005|NOT COMPLETED|Naloxone Challenge Phase||0
3080850|NCT01380093|3802586|FG006|NOT COMPLETED|Naloxone Challenge Phase||0
3080851|NCT01380093|3802587|FG007|NOT COMPLETED|Naloxone Challenge Phase||0
3080852|NCT01380093|3802588|FG008|NOT COMPLETED|Naloxone Challenge Phase||0
3080853|NCT01380093|3802580|FG000|STARTED|Drug Discrimination Phase: Day 1||0
3080854|NCT01380093|3802581|FG001|STARTED|Drug Discrimination Phase: Day 1||30
3080855|NCT01380093|3802582|FG002|STARTED|Drug Discrimination Phase: Day 1||29
3080856|NCT01380093|3802583|FG003|STARTED|Drug Discrimination Phase: Day 1||0
3080857|NCT01380093|3802584|FG004|STARTED|Drug Discrimination Phase: Day 1||0
3080858|NCT01380093|3802585|FG005|STARTED|Drug Discrimination Phase: Day 1||0
3080859|NCT01380093|3802586|FG006|STARTED|Drug Discrimination Phase: Day 1||0
3080860|NCT01380093|3802587|FG007|STARTED|Drug Discrimination Phase: Day 1||0
3080861|NCT01380093|3802588|FG008|STARTED|Drug Discrimination Phase: Day 1||0
3080862|NCT01380093|3802580|FG000|COMPLETED|Drug Discrimination Phase: Day 1||0
3080863|NCT01380093|3802581|FG001|COMPLETED|Drug Discrimination Phase: Day 1||29
3080864|NCT01380093|3802582|FG002|COMPLETED|Drug Discrimination Phase: Day 1||29
3080865|NCT01380093|3802583|FG003|COMPLETED|Drug Discrimination Phase: Day 1||0
3080866|NCT01380093|3802584|FG004|COMPLETED|Drug Discrimination Phase: Day 1||0
3080867|NCT01380093|3802585|FG005|COMPLETED|Drug Discrimination Phase: Day 1||0
3080868|NCT01380093|3802586|FG006|COMPLETED|Drug Discrimination Phase: Day 1||0
3080869|NCT01380093|3802587|FG007|COMPLETED|Drug Discrimination Phase: Day 1||0
3080870|NCT01380093|3802588|FG008|COMPLETED|Drug Discrimination Phase: Day 1||0
3080871|NCT01380093|3802580|FG000|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
3080872|NCT01380093|3802581|FG001|NOT COMPLETED|Drug Discrimination Phase: Day 1||1
3080873|NCT01380093|3802582|FG002|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
3080874|NCT01380093|3802583|FG003|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
3080875|NCT01380093|3802584|FG004|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
3080876|NCT01380093|3802585|FG005|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
3080877|NCT01380093|3802586|FG006|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
3080878|NCT01380093|3802587|FG007|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
3080879|NCT01380093|3802588|FG008|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
3080880|NCT01380093|3802580|FG000|STARTED|Drug Discrimination Phase: Day 2||0
3080881|NCT01380093|3802581|FG001|STARTED|Drug Discrimination Phase: Day 2||29
3080882|NCT01380093|3802582|FG002|STARTED|Drug Discrimination Phase: Day 2||29
3080883|NCT01380093|3802583|FG003|STARTED|Drug Discrimination Phase: Day 2||0
3080884|NCT01380093|3802584|FG004|STARTED|Drug Discrimination Phase: Day 2||0
3080885|NCT01380093|3802585|FG005|STARTED|Drug Discrimination Phase: Day 2||0
3080886|NCT01380093|3802586|FG006|STARTED|Drug Discrimination Phase: Day 2||0
3080887|NCT01380093|3802587|FG007|STARTED|Drug Discrimination Phase: Day 2||0
3080888|NCT01380093|3802588|FG008|STARTED|Drug Discrimination Phase: Day 2||0
3080889|NCT01380093|3802580|FG000|COMPLETED|Drug Discrimination Phase: Day 2||0
3080890|NCT01380093|3802581|FG001|COMPLETED|Drug Discrimination Phase: Day 2||20
3080891|NCT01380093|3802582|FG002|COMPLETED|Drug Discrimination Phase: Day 2||16
3080892|NCT01380093|3802583|FG003|COMPLETED|Drug Discrimination Phase: Day 2||0
3080893|NCT01380093|3802584|FG004|COMPLETED|Drug Discrimination Phase: Day 2||0
3080894|NCT01380093|3802585|FG005|COMPLETED|Drug Discrimination Phase: Day 2||0
3080895|NCT01380093|3802586|FG006|COMPLETED|Drug Discrimination Phase: Day 2||0
3080896|NCT01380093|3802587|FG007|COMPLETED|Drug Discrimination Phase: Day 2||0
3080897|NCT01380093|3802588|FG008|COMPLETED|Drug Discrimination Phase: Day 2||0
3080898|NCT01380093|3802580|FG000|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
3080899|NCT01380093|3802581|FG001|NOT COMPLETED|Drug Discrimination Phase: Day 2||9
3080900|NCT01380093|3802582|FG002|NOT COMPLETED|Drug Discrimination Phase: Day 2||13
3080901|NCT01380093|3802583|FG003|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
3080902|NCT01380093|3802584|FG004|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
3080903|NCT01380093|3802585|FG005|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
3080904|NCT01380093|3802586|FG006|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
3080905|NCT01380093|3802587|FG007|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
3080906|NCT01380093|3802588|FG008|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
3080907|NCT01380093|3802580|FG000|STARTED|Treatment Phase: First Intervention||0
3080908|NCT01380093|3802581|FG001|STARTED|Treatment Phase: First Intervention||0
3080909|NCT01380093|3802582|FG002|STARTED|Treatment Phase: First Intervention||0
3080910|NCT01380093|3802583|FG003|STARTED|Treatment Phase: First Intervention||6
3080911|NCT01380093|3802584|FG004|STARTED|Treatment Phase: First Intervention||6
3080912|NCT01380093|3802585|FG005|STARTED|Treatment Phase: First Intervention||6
3080913|NCT01380093|3802586|FG006|STARTED|Treatment Phase: First Intervention||6
3080914|NCT01380093|3802587|FG007|STARTED|Treatment Phase: First Intervention||6
3080915|NCT01380093|3802588|FG008|STARTED|Treatment Phase: First Intervention||6
3080916|NCT01380093|3802580|FG000|COMPLETED|Treatment Phase: First Intervention||0
3286033|NCT02778113|4019639|FG003|Received Study Drug|Study Period Three||4
3286034|NCT02778113|4019636|FG000|COMPLETED|Study Period Three||4
3286035|NCT02778113|4019637|FG001|COMPLETED|Study Period Three||4
3286036|NCT02778113|4019638|FG002|COMPLETED|Study Period Three||3
3286037|NCT02778113|4019639|FG003|COMPLETED|Study Period Three||4
3286038|NCT02778113|4019636|FG000|NOT COMPLETED|Study Period Three||0
3286039|NCT02778113|4019637|FG001|NOT COMPLETED|Study Period Three||0
3286040|NCT02778113|4019638|FG002|NOT COMPLETED|Study Period Three||0
3286041|NCT02778113|4019639|FG003|NOT COMPLETED|Study Period Three||0
3286042|NCT02778113|4019636|FG000|STARTED|Study Period Four|One participant completed study period three, but did not enter study period four.|3
3286043|NCT02778113|4019637|FG001|STARTED|Study Period Four||4
3286044|NCT02778113|4019638|FG002|STARTED|Study Period Four|One participant completed study period three, but did not enter study period four.|2
3286045|NCT02778113|4019639|FG003|STARTED|Study Period Four||4
3286046|NCT02778113|4019636|FG000|Received Study Drug|Study Period Four||3
3286047|NCT02778113|4019637|FG001|Received Study Drug|Study Period Four||4
3286048|NCT02778113|4019638|FG002|Received Study Drug|Study Period Four||2
3286049|NCT02778113|4019639|FG003|Received Study Drug|Study Period Four||4
3286050|NCT02778113|4019636|FG000|COMPLETED|Study Period Four||3
3286051|NCT02778113|4019637|FG001|COMPLETED|Study Period Four||4
3286052|NCT02778113|4019638|FG002|COMPLETED|Study Period Four||2
3286053|NCT02778113|4019639|FG003|COMPLETED|Study Period Four||4
3286054|NCT02778113|4019636|FG000|NOT COMPLETED|Study Period Four||0
3080917|NCT01380093|3802581|FG001|COMPLETED|Treatment Phase: First Intervention||0
3080918|NCT01380093|3802582|FG002|COMPLETED|Treatment Phase: First Intervention||0
3080919|NCT01380093|3802583|FG003|COMPLETED|Treatment Phase: First Intervention||6
3080920|NCT01380093|3802584|FG004|COMPLETED|Treatment Phase: First Intervention||6
3080921|NCT01380093|3802585|FG005|COMPLETED|Treatment Phase: First Intervention||6
3080922|NCT01380093|3802586|FG006|COMPLETED|Treatment Phase: First Intervention||6
3080923|NCT01380093|3802587|FG007|COMPLETED|Treatment Phase: First Intervention||6
3080924|NCT01380093|3802588|FG008|COMPLETED|Treatment Phase: First Intervention||6
3080925|NCT01380093|3802580|FG000|NOT COMPLETED|Treatment Phase: First Intervention||0
3080926|NCT01380093|3802581|FG001|NOT COMPLETED|Treatment Phase: First Intervention||0
3080927|NCT01380093|3802582|FG002|NOT COMPLETED|Treatment Phase: First Intervention||0
3080928|NCT01380093|3802583|FG003|NOT COMPLETED|Treatment Phase: First Intervention||0
3080929|NCT01380093|3802584|FG004|NOT COMPLETED|Treatment Phase: First Intervention||0
3080930|NCT01380093|3802585|FG005|NOT COMPLETED|Treatment Phase: First Intervention||0
3080931|NCT01380093|3802586|FG006|NOT COMPLETED|Treatment Phase: First Intervention||0
3080932|NCT01380093|3802587|FG007|NOT COMPLETED|Treatment Phase: First Intervention||0
3080933|NCT01380093|3802588|FG008|NOT COMPLETED|Treatment Phase: First Intervention||0
3080934|NCT01380093|3802580|FG000|STARTED|Treatment Phase: Washout Period||0
3080935|NCT01380093|3802581|FG001|STARTED|Treatment Phase: Washout Period||0
3080936|NCT01380093|3802582|FG002|STARTED|Treatment Phase: Washout Period||0
3080937|NCT01380093|3802583|FG003|STARTED|Treatment Phase: Washout Period||6
3080938|NCT01380093|3802584|FG004|STARTED|Treatment Phase: Washout Period||6
3080939|NCT01380093|3802585|FG005|STARTED|Treatment Phase: Washout Period||6
3080940|NCT01380093|3802586|FG006|STARTED|Treatment Phase: Washout Period||6
3080941|NCT01380093|3802587|FG007|STARTED|Treatment Phase: Washout Period||6
3080942|NCT01380093|3802588|FG008|STARTED|Treatment Phase: Washout Period||6
3080943|NCT01380093|3802580|FG000|COMPLETED|Treatment Phase: Washout Period||0
3080944|NCT01380093|3802581|FG001|COMPLETED|Treatment Phase: Washout Period||0
3080945|NCT01380093|3802582|FG002|COMPLETED|Treatment Phase: Washout Period||0
3080946|NCT01380093|3802583|FG003|COMPLETED|Treatment Phase: Washout Period||6
3080947|NCT01380093|3802584|FG004|COMPLETED|Treatment Phase: Washout Period||6
3080948|NCT01380093|3802585|FG005|COMPLETED|Treatment Phase: Washout Period||6
3080949|NCT01380093|3802586|FG006|COMPLETED|Treatment Phase: Washout Period||6
3080950|NCT01380093|3802587|FG007|COMPLETED|Treatment Phase: Washout Period||6
3286055|NCT02778113|4019637|FG001|NOT COMPLETED|Study Period Four||0
3286056|NCT02778113|4019638|FG002|NOT COMPLETED|Study Period Four||0
3286057|NCT02778113|4019639|FG003|NOT COMPLETED|Study Period Four||0
3286058|NCT02778152|4019651|FG000|STARTED|Overall Study||13
3286059|NCT02778152|4019651|FG000|COMPLETED|Overall Study||13
3286060|NCT02778152|4019651|FG000|NOT COMPLETED|Overall Study||0
3080951|NCT01380093|3802588|FG008|COMPLETED|Treatment Phase: Washout Period||6
3080952|NCT01380093|3802580|FG000|NOT COMPLETED|Treatment Phase: Washout Period||0
3080953|NCT01380093|3802581|FG001|NOT COMPLETED|Treatment Phase: Washout Period||0
3286061|NCT02778555|4019658|FG000|STARTED|Overall Study||186
3286062|NCT02778555|4019659|FG001|STARTED|Overall Study||209
3286063|NCT02778555|4019660|FG002|STARTED|Overall Study||318
3286064|NCT02778555|4019658|FG000|COMPLETED|Overall Study||131
3286065|NCT02778555|4019659|FG001|COMPLETED|Overall Study||177
3286066|NCT02778555|4019660|FG002|COMPLETED|Overall Study||211
3286067|NCT02778555|4019658|FG000|NOT COMPLETED|Overall Study||55
3080954|NCT01380093|3802582|FG002|NOT COMPLETED|Treatment Phase: Washout Period||0
3080955|NCT01380093|3802583|FG003|NOT COMPLETED|Treatment Phase: Washout Period||0
3080956|NCT01380093|3802584|FG004|NOT COMPLETED|Treatment Phase: Washout Period||0
3080957|NCT01380093|3802585|FG005|NOT COMPLETED|Treatment Phase: Washout Period||0
3080958|NCT01380093|3802586|FG006|NOT COMPLETED|Treatment Phase: Washout Period||0
3080959|NCT01380093|3802587|FG007|NOT COMPLETED|Treatment Phase: Washout Period||0
3080960|NCT01380093|3802588|FG008|NOT COMPLETED|Treatment Phase: Washout Period||0
3080961|NCT01380093|3802580|FG000|STARTED|Treatment Phase: Second Intervention||0
3080962|NCT01380093|3802581|FG001|STARTED|Treatment Phase: Second Intervention||0
3080963|NCT01380093|3802582|FG002|STARTED|Treatment Phase: Second Intervention||0
3080964|NCT01380093|3802583|FG003|STARTED|Treatment Phase: Second Intervention||6
3080965|NCT01380093|3802584|FG004|STARTED|Treatment Phase: Second Intervention||6
3080966|NCT01380093|3802585|FG005|STARTED|Treatment Phase: Second Intervention||6
3080967|NCT01380093|3802586|FG006|STARTED|Treatment Phase: Second Intervention||6
3080968|NCT01380093|3802587|FG007|STARTED|Treatment Phase: Second Intervention||6
3080969|NCT01380093|3802588|FG008|STARTED|Treatment Phase: Second Intervention||6
3080970|NCT01380093|3802580|FG000|COMPLETED|Treatment Phase: Second Intervention||0
3080971|NCT01380093|3802581|FG001|COMPLETED|Treatment Phase: Second Intervention||0
3080972|NCT01380093|3802582|FG002|COMPLETED|Treatment Phase: Second Intervention||0
3080973|NCT01380093|3802583|FG003|COMPLETED|Treatment Phase: Second Intervention||5
3080974|NCT01380093|3802584|FG004|COMPLETED|Treatment Phase: Second Intervention||6
3080975|NCT01380093|3802585|FG005|COMPLETED|Treatment Phase: Second Intervention||6
3080976|NCT01380093|3802586|FG006|COMPLETED|Treatment Phase: Second Intervention||6
3080977|NCT01380093|3802587|FG007|COMPLETED|Treatment Phase: Second Intervention||6
3080978|NCT01380093|3802588|FG008|COMPLETED|Treatment Phase: Second Intervention||6
3080979|NCT01380093|3802580|FG000|NOT COMPLETED|Treatment Phase: Second Intervention||0
3080980|NCT01380093|3802581|FG001|NOT COMPLETED|Treatment Phase: Second Intervention||0
3080981|NCT01380093|3802582|FG002|NOT COMPLETED|Treatment Phase: Second Intervention||0
3080982|NCT01380093|3802583|FG003|NOT COMPLETED|Treatment Phase: Second Intervention||1
3080983|NCT01380093|3802584|FG004|NOT COMPLETED|Treatment Phase: Second Intervention||0
3080984|NCT01380093|3802585|FG005|NOT COMPLETED|Treatment Phase: Second Intervention||0
3080985|NCT01380093|3802586|FG006|NOT COMPLETED|Treatment Phase: Second Intervention||0
3080986|NCT01380093|3802587|FG007|NOT COMPLETED|Treatment Phase: Second Intervention||0
3080987|NCT01380093|3802588|FG008|NOT COMPLETED|Treatment Phase: Second Intervention||0
3080988|NCT01380093|3802580|FG000|STARTED|Treatment Phase: Washout Period||0
3080989|NCT01380093|3802581|FG001|STARTED|Treatment Phase: Washout Period||0
3080990|NCT01380093|3802582|FG002|STARTED|Treatment Phase: Washout Period||0
3080991|NCT01380093|3802583|FG003|STARTED|Treatment Phase: Washout Period||5
3080992|NCT01380093|3802584|FG004|STARTED|Treatment Phase: Washout Period||6
3080993|NCT01380093|3802585|FG005|STARTED|Treatment Phase: Washout Period||6
3080994|NCT01380093|3802586|FG006|STARTED|Treatment Phase: Washout Period||6
3080995|NCT01380093|3802587|FG007|STARTED|Treatment Phase: Washout Period||6
3080996|NCT01380093|3802588|FG008|STARTED|Treatment Phase: Washout Period||6
3080997|NCT01380093|3802580|FG000|COMPLETED|Treatment Phase: Washout Period||0
3080998|NCT01380093|3802581|FG001|COMPLETED|Treatment Phase: Washout Period||0
3080999|NCT01380093|3802582|FG002|COMPLETED|Treatment Phase: Washout Period||0
3081000|NCT01380093|3802583|FG003|COMPLETED|Treatment Phase: Washout Period||5
3081001|NCT01380093|3802584|FG004|COMPLETED|Treatment Phase: Washout Period||6
3081002|NCT01380093|3802585|FG005|COMPLETED|Treatment Phase: Washout Period||6
3081003|NCT01380093|3802586|FG006|COMPLETED|Treatment Phase: Washout Period||6
3081004|NCT01380093|3802587|FG007|COMPLETED|Treatment Phase: Washout Period||6
3081005|NCT01380093|3802588|FG008|COMPLETED|Treatment Phase: Washout Period||6
3081006|NCT01380093|3802580|FG000|NOT COMPLETED|Treatment Phase: Washout Period||0
3081007|NCT01380093|3802581|FG001|NOT COMPLETED|Treatment Phase: Washout Period||0
3081008|NCT01380093|3802582|FG002|NOT COMPLETED|Treatment Phase: Washout Period||0
3081009|NCT01380093|3802583|FG003|NOT COMPLETED|Treatment Phase: Washout Period||0
3081010|NCT01380093|3802584|FG004|NOT COMPLETED|Treatment Phase: Washout Period||0
3081011|NCT01380093|3802585|FG005|NOT COMPLETED|Treatment Phase: Washout Period||0
3081012|NCT01380093|3802586|FG006|NOT COMPLETED|Treatment Phase: Washout Period||0
3286068|NCT02778555|4019659|FG001|NOT COMPLETED|Overall Study||32
3286069|NCT02778555|4019660|FG002|NOT COMPLETED|Overall Study||107
3286070|NCT02778867|4019670|FG000|STARTED|Phase 1||67
3286071|NCT02778867|4019671|FG001|STARTED|Phase 1||62
3081013|NCT01380093|3802587|FG007|NOT COMPLETED|Treatment Phase: Washout Period||0
3081014|NCT01380093|3802588|FG008|NOT COMPLETED|Treatment Phase: Washout Period||0
3081015|NCT01380093|3802580|FG000|STARTED|Treatment Phase: Third Intervention||0
3081016|NCT01380093|3802581|FG001|STARTED|Treatment Phase: Third Intervention||0
3081017|NCT01380093|3802582|FG002|STARTED|Treatment Phase: Third Intervention||0
3081018|NCT01380093|3802583|FG003|STARTED|Treatment Phase: Third Intervention||5
3081019|NCT01380093|3802584|FG004|STARTED|Treatment Phase: Third Intervention||6
3081020|NCT01380093|3802585|FG005|STARTED|Treatment Phase: Third Intervention||6
3081021|NCT01380093|3802586|FG006|STARTED|Treatment Phase: Third Intervention||6
3081022|NCT01380093|3802587|FG007|STARTED|Treatment Phase: Third Intervention||6
3081023|NCT01380093|3802588|FG008|STARTED|Treatment Phase: Third Intervention||6
3081024|NCT01380093|3802580|FG000|COMPLETED|Treatment Phase: Third Intervention||0
3081025|NCT01380093|3802581|FG001|COMPLETED|Treatment Phase: Third Intervention||0
3081026|NCT01380093|3802582|FG002|COMPLETED|Treatment Phase: Third Intervention||0
3081027|NCT01380093|3802583|FG003|COMPLETED|Treatment Phase: Third Intervention||5
3081028|NCT01380093|3802584|FG004|COMPLETED|Treatment Phase: Third Intervention||6
3081029|NCT01380093|3802585|FG005|COMPLETED|Treatment Phase: Third Intervention||6
3081030|NCT01380093|3802586|FG006|COMPLETED|Treatment Phase: Third Intervention||6
3081031|NCT01380093|3802587|FG007|COMPLETED|Treatment Phase: Third Intervention||6
3081032|NCT01380093|3802588|FG008|COMPLETED|Treatment Phase: Third Intervention||4
3081033|NCT01380093|3802580|FG000|NOT COMPLETED|Treatment Phase: Third Intervention||0
3081034|NCT01380093|3802581|FG001|NOT COMPLETED|Treatment Phase: Third Intervention||0
3081035|NCT01380093|3802582|FG002|NOT COMPLETED|Treatment Phase: Third Intervention||0
3081036|NCT01380093|3802583|FG003|NOT COMPLETED|Treatment Phase: Third Intervention||0
3081037|NCT01380093|3802584|FG004|NOT COMPLETED|Treatment Phase: Third Intervention||0
3081038|NCT01380093|3802585|FG005|NOT COMPLETED|Treatment Phase: Third Intervention||0
3081039|NCT01380093|3802586|FG006|NOT COMPLETED|Treatment Phase: Third Intervention||0
3081040|NCT01380093|3802587|FG007|NOT COMPLETED|Treatment Phase: Third Intervention||0
3081041|NCT01380093|3802588|FG008|NOT COMPLETED|Treatment Phase: Third Intervention||2
3081042|NCT01380106|3802604|FG000|STARTED|Overall Study||16
3081043|NCT01380106|3802605|FG001|STARTED|Overall Study||17
3081044|NCT01380106|3802604|FG000|COMPLETED|Overall Study||16
3081045|NCT01380106|3802605|FG001|COMPLETED|Overall Study||17
3081046|NCT01380106|3802604|FG000|NOT COMPLETED|Overall Study||0
3081047|NCT01380106|3802605|FG001|NOT COMPLETED|Overall Study||0
3081048|NCT01380145|3802611|FG000|STARTED|Overall Study||13
3081049|NCT01380145|3802611|FG000|COMPLETED|Overall Study||9
3081050|NCT01380145|3802611|FG000|NOT COMPLETED|Overall Study||4
3081051|NCT01380184|3802617|FG000|STARTED|Part 1 (19 Days)||15
3081052|NCT01380184|3802617|FG000|COMPLETED|Part 1 (19 Days)||14
3081053|NCT01380184|3802617|FG000|NOT COMPLETED|Part 1 (19 Days)||1
3081054|NCT01380184|3802617|FG000|STARTED|Washout Period (≥2 Days)||14
3081055|NCT01380184|3802617|FG000|COMPLETED|Washout Period (≥2 Days)||14
3081056|NCT01380184|3802617|FG000|NOT COMPLETED|Washout Period (≥2 Days)||0
3081057|NCT01380184|3802617|FG000|STARTED|Part 2||14
3081058|NCT01380184|3802617|FG000|COMPLETED|Part 2||0
3081059|NCT01380184|3802617|FG000|NOT COMPLETED|Part 2||14
3081060|NCT01380197|3802623|FG000|STARTED|Overall Study||20
3081061|NCT01380197|3802624|FG001|STARTED|Overall Study||20
3081062|NCT01380197|3802623|FG000|COMPLETED|Overall Study||20
3081063|NCT01380197|3802624|FG001|COMPLETED|Overall Study||20
3081064|NCT01380197|3802623|FG000|NOT COMPLETED|Overall Study||0
3081065|NCT01380197|3802624|FG001|NOT COMPLETED|Overall Study||0
3081066|NCT01380327|3802633|FG000|STARTED|Overall Study|Number in intent-to-treat having reached maximum tolerated dose with =/> 1 one post-baseline measure|30
3081067|NCT01380327|3802634|FG001|STARTED|Overall Study|Number in intent-to-treat having reached maximum tolerated dose with =/> 1 one post-baseline measure|31
3081068|NCT01380327|3802635|FG002|STARTED|Overall Study|Number in intent-to-treat having reached maximum tolerated dose with =/> 1 one post-baseline measure|28
3081069|NCT01380327|3802633|FG000|COMPLETED|Overall Study||27
3081070|NCT01380327|3802634|FG001|COMPLETED|Overall Study||28
3081071|NCT01380327|3802635|FG002|COMPLETED|Overall Study||21
3081072|NCT01380327|3802633|FG000|NOT COMPLETED|Overall Study||3
3081073|NCT01380327|3802634|FG001|NOT COMPLETED|Overall Study||3
3081074|NCT01380327|3802635|FG002|NOT COMPLETED|Overall Study||7
3081075|NCT01380366|3802643|FG000|STARTED|Overall Study||15
3081076|NCT01380366|3802643|FG000|COMPLETED|Overall Study||15
3081077|NCT01380366|3802643|FG000|NOT COMPLETED|Overall Study||0
3081078|NCT01380379|3802648|FG000|STARTED|Overall Study||9
3081079|NCT01380379|3802648|FG000|COMPLETED|Overall Study||8
3081080|NCT01380379|3802648|FG000|NOT COMPLETED|Overall Study||1
3081081|NCT01380535|3802654|FG000|STARTED|Overall Study||29
3081082|NCT01380535|3802655|FG001|STARTED|Overall Study||31
3081083|NCT01380535|3802654|FG000|Baseline Population|Overall Study||29
3081084|NCT01380535|3802655|FG001|Baseline Population|Overall Study||31
3081085|NCT01380535|3802654|FG000|Safety Population|Overall Study||28
3081086|NCT01380535|3802655|FG001|Safety Population|Overall Study||28
3081087|NCT01380535|3802654|FG000|Intent-to-treat Population|Overall Study||29
3081088|NCT01380535|3802655|FG001|Intent-to-treat Population|Overall Study||24
3081089|NCT01380535|3802654|FG000|COMPLETED|Overall Study||22
3081090|NCT01380535|3802655|FG001|COMPLETED|Overall Study||16
3081091|NCT01380535|3802654|FG000|NOT COMPLETED|Overall Study||7
3081092|NCT01380535|3802655|FG001|NOT COMPLETED|Overall Study||15
3081093|NCT01380639|3802663|FG000|STARTED|Overall Study||42
3081094|NCT01380639|3802664|FG001|STARTED|Overall Study||40
3081095|NCT01380639|3802663|FG000|COMPLETED|Overall Study||36
3081096|NCT01380639|3802664|FG001|COMPLETED|Overall Study||36
3081097|NCT01380639|3802663|FG000|NOT COMPLETED|Overall Study||6
3081098|NCT01380639|3802664|FG001|NOT COMPLETED|Overall Study||4
3081099|NCT01380691|3802670|FG000|STARTED|Period 1||7
3081100|NCT01380691|3802671|FG001|STARTED|Period 1||7
3081101|NCT01380691|3802672|FG002|STARTED|Period 1||7
3081102|NCT01380691|3802673|FG003|STARTED|Period 1||7
3081103|NCT01380691|3802670|FG000|COMPLETED|Period 1||7
3081104|NCT01380691|3802671|FG001|COMPLETED|Period 1||7
3081105|NCT01380691|3802672|FG002|COMPLETED|Period 1||7
3081106|NCT01380691|3802673|FG003|COMPLETED|Period 1||7
3081107|NCT01380691|3802670|FG000|NOT COMPLETED|Period 1||0
3081108|NCT01380691|3802671|FG001|NOT COMPLETED|Period 1||0
3081109|NCT01380691|3802672|FG002|NOT COMPLETED|Period 1||0
3081110|NCT01380691|3802673|FG003|NOT COMPLETED|Period 1||0
3081111|NCT01380691|3802670|FG000|STARTED|Washout (7 Days)||7
3081112|NCT01380691|3802671|FG001|STARTED|Washout (7 Days)||7
3081113|NCT01380691|3802672|FG002|STARTED|Washout (7 Days)||7
3081114|NCT01380691|3802673|FG003|STARTED|Washout (7 Days)||7
3081115|NCT01380691|3802670|FG000|COMPLETED|Washout (7 Days)||7
3081116|NCT01380691|3802671|FG001|COMPLETED|Washout (7 Days)||7
3081117|NCT01380691|3802672|FG002|COMPLETED|Washout (7 Days)||6
3081118|NCT01380691|3802673|FG003|COMPLETED|Washout (7 Days)||6
3081119|NCT01380691|3802670|FG000|NOT COMPLETED|Washout (7 Days)||0
3081120|NCT01380691|3802671|FG001|NOT COMPLETED|Washout (7 Days)||0
3081121|NCT01380691|3802672|FG002|NOT COMPLETED|Washout (7 Days)||1
3081122|NCT01380691|3802673|FG003|NOT COMPLETED|Washout (7 Days)||1
3081123|NCT01380691|3802670|FG000|STARTED|Period 2||7
3081124|NCT01380691|3802671|FG001|STARTED|Period 2||7
3081125|NCT01380691|3802672|FG002|STARTED|Period 2||6
3081126|NCT01380691|3802673|FG003|STARTED|Period 2||6
3081127|NCT01380691|3802670|FG000|COMPLETED|Period 2||7
3081128|NCT01380691|3802671|FG001|COMPLETED|Period 2||7
3081129|NCT01380691|3802672|FG002|COMPLETED|Period 2||6
3081130|NCT01380691|3802673|FG003|COMPLETED|Period 2||6
3081131|NCT01380691|3802670|FG000|NOT COMPLETED|Period 2||0
3081132|NCT01380691|3802671|FG001|NOT COMPLETED|Period 2||0
3081133|NCT01380691|3802672|FG002|NOT COMPLETED|Period 2||0
3081134|NCT01380691|3802673|FG003|NOT COMPLETED|Period 2||0
3081135|NCT01380730|3802692|FG000|STARTED|Overall Study||78
3081136|NCT01380730|3802693|FG001|STARTED|Overall Study||79
3081137|NCT01380730|3802694|FG002|STARTED|Overall Study||79
3081138|NCT01380730|3802695|FG003|STARTED|Overall Study||79
3081139|NCT01380730|3802696|FG004|STARTED|Overall Study||78
3081140|NCT01380730|3802697|FG005|STARTED|Overall Study||79
3081141|NCT01380730|3802698|FG006|STARTED|Overall Study||79
3081142|NCT01380730|3802699|FG007|STARTED|Overall Study||80
3081143|NCT01380730|3802692|FG000|Received Treatment|Overall Study||78
3081144|NCT01380730|3802693|FG001|Received Treatment|Overall Study|2 participants did not receive treatment but were followed until the end of study|77
3081145|NCT01380730|3802694|FG002|Received Treatment|Overall Study||79
3081146|NCT01380730|3802695|FG003|Received Treatment|Overall Study||79
3081147|NCT01380730|3802696|FG004|Received Treatment|Overall Study||78
3081148|NCT01380730|3802697|FG005|Received Treatment|Overall Study||79
3081149|NCT01380730|3802698|FG006|Received Treatment|Overall Study||79
3081150|NCT01380730|3802699|FG007|Received Treatment|Overall Study||80
3081151|NCT01380730|3802692|FG000|COMPLETED|Overall Study||78
3081152|NCT01380730|3802693|FG001|COMPLETED|Overall Study||79
3081153|NCT01380730|3802694|FG002|COMPLETED|Overall Study||79
3081154|NCT01380730|3802695|FG003|COMPLETED|Overall Study||79
3081155|NCT01380730|3802696|FG004|COMPLETED|Overall Study||77
3081156|NCT01380730|3802697|FG005|COMPLETED|Overall Study||79
3081157|NCT01380730|3802698|FG006|COMPLETED|Overall Study||79
3081158|NCT01380730|3802699|FG007|COMPLETED|Overall Study||80
3081159|NCT01380730|3802692|FG000|NOT COMPLETED|Overall Study||0
3081160|NCT01380730|3802693|FG001|NOT COMPLETED|Overall Study||0
3081161|NCT01380730|3802694|FG002|NOT COMPLETED|Overall Study||0
3081162|NCT01380730|3802695|FG003|NOT COMPLETED|Overall Study||0
3081163|NCT01380730|3802696|FG004|NOT COMPLETED|Overall Study||1
3081164|NCT01380730|3802697|FG005|NOT COMPLETED|Overall Study||0
3081165|NCT01380730|3802698|FG006|NOT COMPLETED|Overall Study||0
3081166|NCT01380730|3802699|FG007|NOT COMPLETED|Overall Study||0
3081167|NCT01380743|3802721|FG000|STARTED|Overall Study||6
3081168|NCT01380743|3802722|FG001|STARTED|Overall Study||6
3081169|NCT01380743|3802723|FG002|STARTED|Overall Study||6
3081170|NCT01380743|3802724|FG003|STARTED|Overall Study||7
3081171|NCT01380743|3802721|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6
3081172|NCT01380743|3802722|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6
3081173|NCT01380743|3802723|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
3081174|NCT01380743|3802724|FG003|Received at Least 1 Dose of Study Drug|Overall Study||7
3081175|NCT01380743|3802721|FG000|COMPLETED|Overall Study||6
3081176|NCT01380743|3802722|FG001|COMPLETED|Overall Study||6
3081177|NCT01380743|3802723|FG002|COMPLETED|Overall Study||6
3081178|NCT01380743|3802724|FG003|COMPLETED|Overall Study||7
3081179|NCT01380743|3802721|FG000|NOT COMPLETED|Overall Study||0
3081180|NCT01380743|3802722|FG001|NOT COMPLETED|Overall Study||0
3081181|NCT01380743|3802723|FG002|NOT COMPLETED|Overall Study||0
3081182|NCT01380743|3802724|FG003|NOT COMPLETED|Overall Study||0
3081183|NCT01380769|3802736|FG000|STARTED|Overall Study||100
3081184|NCT01380769|3802737|FG001|STARTED|Overall Study||57
3134771|NCT01702519|3859687|FG000|STARTED|Washout Period||20
3081185|NCT01380769|3802736|FG000|COMPLETED|Overall Study|subjects in ITT with reported date of death, alive with progression, or alive without progression|91
3081186|NCT01380769|3802737|FG001|COMPLETED|Overall Study|subjects in ITT with reported date of death, alive with progression, or alive without progression|43
3081187|NCT01380769|3802736|FG000|NOT COMPLETED|Overall Study||9
3081188|NCT01380769|3802737|FG001|NOT COMPLETED|Overall Study||14
3081189|NCT01380782|3802745|FG000|STARTED|Overall Study||12
3081190|NCT01380782|3802746|FG001|STARTED|Overall Study||10
3081191|NCT01380782|3802747|FG002|STARTED|Overall Study||11
3081192|NCT01380782|3802748|FG003|STARTED|Overall Study||4
3081193|NCT01380782|3802745|FG000|COMPLETED|Overall Study||0
3081194|NCT01380782|3802746|FG001|COMPLETED|Overall Study||0
3081195|NCT01380782|3802747|FG002|COMPLETED|Overall Study||0
3081196|NCT01380782|3802748|FG003|COMPLETED|Overall Study||0
3081197|NCT01380782|3802745|FG000|NOT COMPLETED|Overall Study||12
3081198|NCT01380782|3802746|FG001|NOT COMPLETED|Overall Study||10
3081199|NCT01380782|3802747|FG002|NOT COMPLETED|Overall Study||11
3081200|NCT01380782|3802748|FG003|NOT COMPLETED|Overall Study||4
3081201|NCT01380834|3802762|FG000|STARTED|Overall Study||42
3081202|NCT01380834|3802763|FG001|STARTED|Overall Study||42
3081203|NCT01380834|3802762|FG000|COMPLETED|Overall Study||41
3081204|NCT01380834|3802763|FG001|COMPLETED|Overall Study||42
3081205|NCT01380834|3802762|FG000|NOT COMPLETED|Overall Study||1
3081206|NCT01380834|3802763|FG001|NOT COMPLETED|Overall Study||0
3081207|NCT01380899|3802772|FG000|STARTED|Overall Study||34
3081208|NCT01380899|3802773|FG001|STARTED|Overall Study||33
3081209|NCT01380899|3802774|FG002|STARTED|Overall Study||20
3081210|NCT01380899|3802772|FG000|COMPLETED|Overall Study||34
3081211|NCT01380899|3802773|FG001|COMPLETED|Overall Study||33
3081212|NCT01380899|3802774|FG002|COMPLETED|Overall Study||20
3081213|NCT01380899|3802772|FG000|NOT COMPLETED|Overall Study||0
3081214|NCT01380899|3802773|FG001|NOT COMPLETED|Overall Study||0
3081215|NCT01380899|3802774|FG002|NOT COMPLETED|Overall Study||0
3081216|NCT01380990|3802784|FG000|STARTED|Overall Study||20
3081217|NCT01380990|3802785|FG001|STARTED|Overall Study||16
3081218|NCT01380990|3802784|FG000|COMPLETED|Overall Study||19
3081219|NCT01380990|3802785|FG001|COMPLETED|Overall Study||15
3081220|NCT01380990|3802784|FG000|NOT COMPLETED|Overall Study||1
3081221|NCT01380990|3802785|FG001|NOT COMPLETED|Overall Study||1
3081222|NCT01381016|3802797|FG000|STARTED|Overall Study||13
3081223|NCT01381016|3802798|FG001|STARTED|Overall Study||17
3081224|NCT01381016|3802797|FG000|COMPLETED|Overall Study||10
3081225|NCT01381016|3802798|FG001|COMPLETED|Overall Study||11
3081226|NCT01381016|3802797|FG000|NOT COMPLETED|Overall Study||3
3081227|NCT01381016|3802798|FG001|NOT COMPLETED|Overall Study||6
3081228|NCT01381068|3802808|FG000|STARTED|Overall Study||25
3081229|NCT01381068|3802809|FG001|STARTED|Overall Study||24
3081230|NCT01381068|3802808|FG000|COMPLETED|Overall Study||24
3081231|NCT01381068|3802809|FG001|COMPLETED|Overall Study||24
3081232|NCT01381068|3802808|FG000|NOT COMPLETED|Overall Study||1
3081233|NCT01381068|3802809|FG001|NOT COMPLETED|Overall Study||0
3081234|NCT01381120|3802817|FG000|STARTED|Overall Study||50
3081235|NCT01381120|3802818|FG001|STARTED|Overall Study||27
3081236|NCT01381120|3802817|FG000|COMPLETED|Overall Study||39
3081237|NCT01381120|3802818|FG001|COMPLETED|Overall Study||18
3081238|NCT01381120|3802817|FG000|NOT COMPLETED|Overall Study||11
3081239|NCT01381120|3802818|FG001|NOT COMPLETED|Overall Study||9
3081240|NCT01381172|3802826|FG000|STARTED|Overall Study||74
3081241|NCT01381172|3802827|FG001|STARTED|Overall Study||86
3081242|NCT01381172|3802826|FG000|COMPLETED|Overall Study||64
3081243|NCT01381172|3802827|FG001|COMPLETED|Overall Study||73
3081244|NCT01381172|3802826|FG000|NOT COMPLETED|Overall Study||10
3081245|NCT01381172|3802827|FG001|NOT COMPLETED|Overall Study||13
3081246|NCT01381406|3802835|FG000|STARTED|Overall Study||2481
3081247|NCT01381406|3802836|FG001|STARTED|Overall Study||852
3081248|NCT01381406|3802835|FG000|COMPLETED|Overall Study||2481
3081249|NCT01381406|3802836|FG001|COMPLETED|Overall Study||852
3081250|NCT01381406|3802835|FG000|NOT COMPLETED|Overall Study||0
3081251|NCT01381406|3802836|FG001|NOT COMPLETED|Overall Study||0
3081252|NCT01381471|3802842|FG000|STARTED|Overall Study||11060
3081253|NCT01381471|3802842|FG000|COMPLETED|Overall Study||11060
3081254|NCT01381471|3802842|FG000|NOT COMPLETED|Overall Study||0
3081255|NCT01381549|3802849|FG000|STARTED|Overall Study||6
3081256|NCT01381549|3802850|FG001|STARTED|Overall Study||8
3081257|NCT01381549|3802851|FG002|STARTED|Overall Study||6
3081258|NCT01381549|3802849|FG000|COMPLETED|Overall Study||6
3081259|NCT01381549|3802850|FG001|COMPLETED|Overall Study||8
3081260|NCT01381549|3802851|FG002|COMPLETED|Overall Study||5
3081261|NCT01381549|3802849|FG000|NOT COMPLETED|Overall Study||0
3081262|NCT01381549|3802850|FG001|NOT COMPLETED|Overall Study||0
3081263|NCT01381549|3802851|FG002|NOT COMPLETED|Overall Study||1
3081264|NCT01381562|3802863|FG000|STARTED|Overall Study||5
3081265|NCT01381562|3802864|FG001|STARTED|Overall Study||4
3081266|NCT01381562|3802865|FG002|STARTED|Overall Study||5
3081267|NCT01381562|3802863|FG000|COMPLETED|Overall Study||5
3081268|NCT01381562|3802864|FG001|COMPLETED|Overall Study||3
3081269|NCT01381562|3802865|FG002|COMPLETED|Overall Study||5
3081270|NCT01381562|3802863|FG000|NOT COMPLETED|Overall Study||0
3081271|NCT01381562|3802864|FG001|NOT COMPLETED|Overall Study||1
3081272|NCT01381562|3802865|FG002|NOT COMPLETED|Overall Study||0
3081273|NCT01381575|3802876|FG000|STARTED|Overall Study||550
3081274|NCT01381575|3802877|FG001|STARTED|Overall Study||482
3081275|NCT01381575|3802878|FG002|STARTED|Overall Study||415
3081276|NCT01381575|3802876|FG000|COMPLETED|Overall Study||524
3081277|NCT01381575|3802877|FG001|COMPLETED|Overall Study||443
3081278|NCT01381575|3802878|FG002|COMPLETED|Overall Study||395
3081279|NCT01381575|3802876|FG000|NOT COMPLETED|Overall Study||26
3081280|NCT01381575|3802877|FG001|NOT COMPLETED|Overall Study||39
3081281|NCT01381575|3802878|FG002|NOT COMPLETED|Overall Study||20
3081282|NCT01381692|3802889|FG000|STARTED|Overall Study||7
3081283|NCT01381692|3802890|FG001|STARTED|Overall Study||2
3081284|NCT01381692|3802891|FG002|STARTED|Overall Study||0
3081285|NCT01381692|3802892|FG003|STARTED|Overall Study||0
3081286|NCT01381692|3802893|FG004|STARTED|Overall Study||0
3081287|NCT01381692|3802894|FG005|STARTED|Overall Study||0
3081288|NCT01381692|3802889|FG000|COMPLETED|Overall Study||6
3081289|NCT01381692|3802890|FG001|COMPLETED|Overall Study||2
3081290|NCT01381692|3802891|FG002|COMPLETED|Overall Study||0
3081291|NCT01381692|3802892|FG003|COMPLETED|Overall Study||0
3081292|NCT01381692|3802893|FG004|COMPLETED|Overall Study||0
3081293|NCT01381692|3802894|FG005|COMPLETED|Overall Study||0
3081294|NCT01381692|3802889|FG000|NOT COMPLETED|Overall Study||1
3081295|NCT01381692|3802890|FG001|NOT COMPLETED|Overall Study||0
3081296|NCT01381692|3802891|FG002|NOT COMPLETED|Overall Study||0
3081297|NCT01381692|3802892|FG003|NOT COMPLETED|Overall Study||0
3081298|NCT01381692|3802893|FG004|NOT COMPLETED|Overall Study||0
3081299|NCT01381692|3802894|FG005|NOT COMPLETED|Overall Study||0
3081300|NCT01381718|3802904|FG000|STARTED|Overall Study||56
3081301|NCT01381718|3802905|FG001|STARTED|Overall Study||56
3081302|NCT01381718|3802904|FG000|COMPLETED|Overall Study||51
3081303|NCT01381718|3802905|FG001|COMPLETED|Overall Study||43
3081304|NCT01381718|3802904|FG000|NOT COMPLETED|Overall Study||5
3081305|NCT01381718|3802905|FG001|NOT COMPLETED|Overall Study||13
3081306|NCT01381861|3802911|FG000|STARTED|Overall Study||23
3081307|NCT01381861|3802911|FG000|COMPLETED|Overall Study||23
3081308|NCT01381861|3802911|FG000|NOT COMPLETED|Overall Study||0
3081309|NCT01381874|3802918|FG000|STARTED|Overall Study||102
3081310|NCT01381874|3802919|FG001|STARTED|Overall Study||89
3081311|NCT01381874|3802920|FG002|STARTED|Overall Study||106
3081312|NCT01381874|3802918|FG000|Treated|Overall Study||102
3081313|NCT01381874|3802919|FG001|Treated|Overall Study||87
3081314|NCT01381874|3802920|FG002|Treated|Overall Study||104
3081315|NCT01381874|3802918|FG000|COMPLETED|Overall Study||25
3081316|NCT01381874|3802919|FG001|COMPLETED|Overall Study||26
3081317|NCT01381874|3802920|FG002|COMPLETED|Overall Study||30
3081318|NCT01381874|3802918|FG000|NOT COMPLETED|Overall Study||77
3081319|NCT01381874|3802919|FG001|NOT COMPLETED|Overall Study||63
3081320|NCT01381874|3802920|FG002|NOT COMPLETED|Overall Study||76
3081321|NCT01381900|3802931|FG000|STARTED|Overall Study||226
3081322|NCT01381900|3802932|FG001|STARTED|Overall Study||223
3081323|NCT01381900|3802933|FG002|STARTED|Overall Study||227
3081324|NCT01381900|3802931|FG000|COMPLETED|Overall Study||217
3081325|NCT01381900|3802932|FG001|COMPLETED|Overall Study||214
3081326|NCT01381900|3802933|FG002|COMPLETED|Overall Study||215
3081327|NCT01381900|3802931|FG000|NOT COMPLETED|Overall Study||9
3081328|NCT01381900|3802932|FG001|NOT COMPLETED|Overall Study||9
3081329|NCT01381900|3802933|FG002|NOT COMPLETED|Overall Study||12
3081330|NCT01381926|3802943|FG000|STARTED|Low/High Dose of 1st Treatment (2months)||5
3081331|NCT01381926|3802944|FG001|STARTED|Low/High Dose of 1st Treatment (2months)||5
3081332|NCT01381926|3802943|FG000|COMPLETED|Low/High Dose of 1st Treatment (2months)||3
3081333|NCT01381926|3802944|FG001|COMPLETED|Low/High Dose of 1st Treatment (2months)||4
3081334|NCT01381926|3802943|FG000|NOT COMPLETED|Low/High Dose of 1st Treatment (2months)||2
3081335|NCT01381926|3802944|FG001|NOT COMPLETED|Low/High Dose of 1st Treatment (2months)||1
3081336|NCT01381926|3802943|FG000|STARTED|Low/High Dose of 2nd Treatment (2months)||3
3081337|NCT01381926|3802944|FG001|STARTED|Low/High Dose of 2nd Treatment (2months)||4
3081338|NCT01381926|3802943|FG000|COMPLETED|Low/High Dose of 2nd Treatment (2months)||3
3081339|NCT01381926|3802944|FG001|COMPLETED|Low/High Dose of 2nd Treatment (2months)||4
3081340|NCT01381926|3802943|FG000|NOT COMPLETED|Low/High Dose of 2nd Treatment (2months)||0
3081341|NCT01381926|3802944|FG001|NOT COMPLETED|Low/High Dose of 2nd Treatment (2months)||0
3081342|NCT01381952|3802952|FG000|STARTED|Overall Study||20
3081343|NCT01381952|3802952|FG000|Collected Dose and Image Information|Overall Study||20
3081344|NCT01381952|3802952|FG000|COMPLETED|Overall Study||20
3081345|NCT01381952|3802952|FG000|NOT COMPLETED|Overall Study||0
3081346|NCT01382108|3802960|FG000|STARTED|Overall Study||20
3081347|NCT01382108|3802961|FG001|STARTED|Overall Study||19
3081348|NCT01382108|3802960|FG000|COMPLETED|Overall Study||20
3081349|NCT01382108|3802961|FG001|COMPLETED|Overall Study||19
3081350|NCT01382108|3802960|FG000|NOT COMPLETED|Overall Study||0
3081351|NCT01382108|3802961|FG001|NOT COMPLETED|Overall Study||0
3081352|NCT01382186|3802970|FG000|STARTED|Overall Study||33
3081353|NCT01382186|3802971|FG001|STARTED|Overall Study||819
3081354|NCT01382186|3802970|FG000|COMPLETED|Overall Study||32
3081355|NCT01382186|3802971|FG001|COMPLETED|Overall Study||819
3081356|NCT01382186|3802970|FG000|NOT COMPLETED|Overall Study||1
3081357|NCT01382186|3802971|FG001|NOT COMPLETED|Overall Study||0
3081358|NCT01382212|3802980|FG000|STARTED|Overall Study||13
3081359|NCT01382212|3802980|FG000|COMPLETED|Overall Study||11
3081360|NCT01382212|3802980|FG000|NOT COMPLETED|Overall Study||2
3081361|NCT01382225|3802986|FG000|STARTED|Overall Study||725
3081362|NCT01382225|3802987|FG001|STARTED|Overall Study||729
3081363|NCT01382225|3802986|FG000|COMPLETED|Overall Study||711
3081364|NCT01382225|3802987|FG001|COMPLETED|Overall Study||722
3081365|NCT01382225|3802986|FG000|NOT COMPLETED|Overall Study||14
3081366|NCT01382225|3802987|FG001|NOT COMPLETED|Overall Study||7
3081367|NCT01382251|3802995|FG000|STARTED|Overall Study||123
3081368|NCT01382251|3802996|FG001|STARTED|Overall Study||123
3081369|NCT01382251|3802995|FG000|COMPLETED|Overall Study||102
3081370|NCT01382251|3802996|FG001|COMPLETED|Overall Study||102
3081371|NCT01382251|3802995|FG000|NOT COMPLETED|Overall Study||21
3081372|NCT01382251|3802996|FG001|NOT COMPLETED|Overall Study||21
3081373|NCT01382303|3803003|FG000|STARTED|Overall Study||87
3081374|NCT01382303|3803004|FG001|STARTED|Overall Study||87
3081375|NCT01382303|3803003|FG000|COMPLETED|Overall Study||52
3081376|NCT01382303|3803004|FG001|COMPLETED|Overall Study||70
3081377|NCT01382303|3803003|FG000|NOT COMPLETED|Overall Study||35
3081378|NCT01382303|3803004|FG001|NOT COMPLETED|Overall Study||17
3081379|NCT01382446|3803012|FG000|STARTED|Overall Study||33
3081380|NCT01382446|3803013|FG001|STARTED|Overall Study||33
3081381|NCT01382446|3803012|FG000|COMPLETED|Overall Study||30
3081382|NCT01382446|3803013|FG001|COMPLETED|Overall Study||29
3286072|NCT02778867|4019672|FG002|STARTED|Phase 1||0
3286073|NCT02778867|4019673|FG003|STARTED|Phase 1||0
3286074|NCT02778867|4019670|FG000|COMPLETED|Phase 1||65
3286075|NCT02778867|4019671|FG001|COMPLETED|Phase 1||59
3286076|NCT02778867|4019672|FG002|COMPLETED|Phase 1||0
3286077|NCT02778867|4019673|FG003|COMPLETED|Phase 1||0
3286078|NCT02778867|4019670|FG000|NOT COMPLETED|Phase 1||2
3286079|NCT02778867|4019671|FG001|NOT COMPLETED|Phase 1||3
3286080|NCT02778867|4019672|FG002|NOT COMPLETED|Phase 1||0
3286081|NCT02778867|4019673|FG003|NOT COMPLETED|Phase 1||0
3286082|NCT02778867|4019670|FG000|STARTED|Phase 2|1FED non-responders from Phase 1 have the option to undergo 6FED in Phase 2|0
3286083|NCT02778867|4019671|FG001|STARTED|Phase 2|6FED non-responders from Phase 1 have the option to undergo SGC in Phase 2|0
3286084|NCT02778867|4019672|FG002|STARTED|Phase 2|Optional phase for 1FED non-responders|21
3286085|NCT02778867|4019673|FG003|STARTED|Phase 2|Optional phase for 6FED non-responders|11
3286086|NCT02778867|4019670|FG000|COMPLETED|Phase 2||0
3286087|NCT02778867|4019671|FG001|COMPLETED|Phase 2||0
3286088|NCT02778867|4019672|FG002|COMPLETED|Phase 2||20
3286089|NCT02778867|4019673|FG003|COMPLETED|Phase 2||9
3286090|NCT02778867|4019670|FG000|NOT COMPLETED|Phase 2||0
3286091|NCT02778867|4019671|FG001|NOT COMPLETED|Phase 2||0
3286092|NCT02778867|4019672|FG002|NOT COMPLETED|Phase 2||1
3286093|NCT02778867|4019673|FG003|NOT COMPLETED|Phase 2||2
3286094|NCT02778880|4019685|FG000|STARTED|Overall Study||45
3286095|NCT02778880|4019686|FG001|STARTED|Overall Study||45
3286096|NCT02778880|4019685|FG000|COMPLETED|Overall Study||44
3286097|NCT02778880|4019686|FG001|COMPLETED|Overall Study||42
3286098|NCT02778880|4019685|FG000|NOT COMPLETED|Overall Study||1
3286099|NCT02778880|4019686|FG001|NOT COMPLETED|Overall Study||3
3286100|NCT02778932|4019694|FG000|STARTED|Overall Study||74
3286101|NCT02778932|4019695|FG001|STARTED|Overall Study||74
3286102|NCT02778932|4019694|FG000|COMPLETED|Overall Study||74
3286103|NCT02778932|4019695|FG001|COMPLETED|Overall Study||74
3286104|NCT02778932|4019694|FG000|NOT COMPLETED|Overall Study||0
3286105|NCT02778932|4019695|FG001|NOT COMPLETED|Overall Study||0
3286106|NCT02779075|4019703|FG000|STARTED|Overall Study||16
3286107|NCT02779075|4019704|FG001|STARTED|Overall Study||13
3286108|NCT02779075|4019703|FG000|COMPLETED|Overall Study||14
3286109|NCT02779075|4019704|FG001|COMPLETED|Overall Study||10
3286110|NCT02779075|4019703|FG000|NOT COMPLETED|Overall Study||2
3286111|NCT02779075|4019704|FG001|NOT COMPLETED|Overall Study||3
3286112|NCT02779166|4019712|FG000|STARTED|Overall Study||50
3286113|NCT02779166|4019713|FG001|STARTED|Overall Study||48
3286114|NCT02779166|4019712|FG000|COMPLETED|Overall Study||50
3286115|NCT02779166|4019713|FG001|COMPLETED|Overall Study||48
3286116|NCT02779166|4019712|FG000|NOT COMPLETED|Overall Study||0
3286117|NCT02779166|4019713|FG001|NOT COMPLETED|Overall Study||0
3286118|NCT02779491|4019723|FG000|STARTED|Overall Study||32
3286119|NCT02779491|4019724|FG001|STARTED|Overall Study||27
3286120|NCT02779491|4019725|FG002|STARTED|Overall Study||18
3286121|NCT02779491|4019726|FG003|STARTED|Overall Study||17
3286122|NCT02779491|4019723|FG000|COMPLETED|Overall Study||32
3286123|NCT02779491|4019724|FG001|COMPLETED|Overall Study||26
3286124|NCT02779491|4019725|FG002|COMPLETED|Overall Study||17
3286125|NCT02779491|4019726|FG003|COMPLETED|Overall Study||15
3286126|NCT02779491|4019723|FG000|NOT COMPLETED|Overall Study||0
3081383|NCT01382446|3803012|FG000|NOT COMPLETED|Overall Study||3
3081384|NCT01382446|3803013|FG001|NOT COMPLETED|Overall Study||4
3081385|NCT01382602|3803021|FG000|STARTED|Overall Study||93
3081386|NCT01382602|3803022|FG001|STARTED|Overall Study||50
3081387|NCT01382602|3803021|FG000|COMPLETED|Overall Study||93
3081388|NCT01382602|3803022|FG001|COMPLETED|Overall Study||46
3081389|NCT01382602|3803021|FG000|NOT COMPLETED|Overall Study||0
3081390|NCT01382602|3803022|FG001|NOT COMPLETED|Overall Study||4
3286127|NCT02779491|4019724|FG001|NOT COMPLETED|Overall Study||1
3286128|NCT02779491|4019725|FG002|NOT COMPLETED|Overall Study||1
3286129|NCT02779491|4019726|FG003|NOT COMPLETED|Overall Study||2
3286130|NCT02779543|4019738|FG000|STARTED|Overall Study||100
3286131|NCT02779543|4019739|FG001|STARTED|Overall Study||100
3286132|NCT02779543|4019738|FG000|COMPLETED|Overall Study||100
3286133|NCT02779543|4019739|FG001|COMPLETED|Overall Study||100
3286134|NCT02779543|4019738|FG000|NOT COMPLETED|Overall Study||0
3286135|NCT02779543|4019739|FG001|NOT COMPLETED|Overall Study||0
3316612|NCT03115827|4050000|FG000|NOT COMPLETED|Overall Study||3
3316613|NCT03116152|4050006|FG000|STARTED|Overall Study||95
3316614|NCT03116152|4050007|FG001|STARTED|Overall Study||95
3081391|NCT01382719|3803032|FG000|STARTED|Overall Study||98
3081392|NCT01382719|3803033|FG001|STARTED|Overall Study||100
3081393|NCT01382719|3803034|FG002|STARTED|Overall Study||100
3081394|NCT01382719|3803035|FG003|STARTED|Overall Study||99
3081395|NCT01382719|3803032|FG000|Subjects Not Dosed|Overall Study||1
3081396|NCT01382719|3803033|FG001|Subjects Not Dosed|Overall Study||0
3081397|NCT01382719|3803034|FG002|Subjects Not Dosed|Overall Study||1
3081398|NCT01382719|3803035|FG003|Subjects Not Dosed|Overall Study||1
3081399|NCT01382719|3803032|FG000|COMPLETED|Overall Study||80
3286136|NCT02780115|4019751|FG000|STARTED|Overall Study||28
3286137|NCT02780115|4019752|FG001|STARTED|Overall Study||30
3286138|NCT02780115|4019753|FG002|STARTED|Overall Study||30
3081400|NCT01382719|3803033|FG001|COMPLETED|Overall Study||81
3081401|NCT01382719|3803034|FG002|COMPLETED|Overall Study||66
3081402|NCT01382719|3803035|FG003|COMPLETED|Overall Study||66
3081403|NCT01382719|3803032|FG000|NOT COMPLETED|Overall Study||18
3081404|NCT01382719|3803033|FG001|NOT COMPLETED|Overall Study||19
3081405|NCT01382719|3803034|FG002|NOT COMPLETED|Overall Study||34
3081406|NCT01382719|3803035|FG003|NOT COMPLETED|Overall Study||33
3081407|NCT01382901|3803047|FG000|STARTED|Overall Study||24
3081408|NCT01382901|3803048|FG001|STARTED|Overall Study||21
3081409|NCT01382901|3803047|FG000|COMPLETED|Overall Study||7
3081410|NCT01382901|3803048|FG001|COMPLETED|Overall Study||7
3081411|NCT01382901|3803047|FG000|NOT COMPLETED|Overall Study||17
3081412|NCT01382901|3803048|FG001|NOT COMPLETED|Overall Study||14
3081413|NCT01382940|3803054|FG000|STARTED|Overall Study||351
3081414|NCT01382940|3803054|FG000|Received Day 1 Infusion|Overall Study||351
3081415|NCT01382940|3803054|FG000|Received Day 15 Infusions|Overall Study||341
3081416|NCT01382940|3803054|FG000|Received Day 168 Infusion|Overall Study||290
3081417|NCT01382940|3803054|FG000|Received Day 182 Infusion|Overall Study||278
3081418|NCT01382940|3803054|FG000|COMPLETED|Overall Study||278
3081419|NCT01382940|3803054|FG000|NOT COMPLETED|Overall Study||73
3081420|NCT01383005|3803060|FG000|STARTED|Overall Study||34
3081421|NCT01383005|3803061|FG001|STARTED|Overall Study||60
3081422|NCT01383005|3803060|FG000|COMPLETED|Overall Study||34
3081423|NCT01383005|3803061|FG001|COMPLETED|Overall Study||60
3081424|NCT01383005|3803060|FG000|NOT COMPLETED|Overall Study||0
3081425|NCT01383005|3803061|FG001|NOT COMPLETED|Overall Study||0
3081426|NCT01383018|3803067|FG000|STARTED|Overall Study||1457
3081427|NCT01383018|3803067|FG000|COMPLETED|Overall Study||1082
3081428|NCT01383018|3803067|FG000|NOT COMPLETED|Overall Study||375
3134772|NCT01702519|3859688|FG001|STARTED|Washout Period||20
3134773|NCT01702519|3859687|FG000|COMPLETED|Washout Period||19
3134774|NCT01702519|3859688|FG001|COMPLETED|Washout Period||18
3134775|NCT01702519|3859687|FG000|NOT COMPLETED|Washout Period||1
3134776|NCT01702519|3859688|FG001|NOT COMPLETED|Washout Period||2
3134777|NCT01702519|3859687|FG000|STARTED|Period 2||19
3134778|NCT01702519|3859688|FG001|STARTED|Period 2||18
3134779|NCT01702519|3859687|FG000|COMPLETED|Period 2||19
3134780|NCT01702519|3859688|FG001|COMPLETED|Period 2||18
3134781|NCT01702519|3859687|FG000|NOT COMPLETED|Period 2||0
3134782|NCT01702519|3859688|FG001|NOT COMPLETED|Period 2||0
3134783|NCT01702532|3859700|FG000|STARTED|Overall Study||161
3134784|NCT01702532|3859701|FG001|STARTED|Overall Study||161
3134785|NCT01702532|3859700|FG000|Safety Population|Overall Study||161
3134786|NCT01702532|3859701|FG001|Safety Population|Overall Study|One subject randomized but did not receive the study treatment.|160
3134787|NCT01702532|3859700|FG000|COMPLETED|Overall Study||161
3134788|NCT01702532|3859701|FG001|COMPLETED|Overall Study||160
3134789|NCT01702532|3859700|FG000|NOT COMPLETED|Overall Study||0
3134790|NCT01702532|3859701|FG001|NOT COMPLETED|Overall Study||1
3134791|NCT01702558|3859713|FG000|STARTED|Overall Study||7
3134792|NCT01702558|3859714|FG001|STARTED|Overall Study||5
3134793|NCT01702558|3859715|FG002|STARTED|Overall Study||6
3134794|NCT01702558|3859716|FG003|STARTED|Overall Study||81
3134795|NCT01702558|3859717|FG004|STARTED|Overall Study||80
3134796|NCT01702558|3859713|FG000|COMPLETED|Overall Study||3
3134797|NCT01702558|3859714|FG001|COMPLETED|Overall Study||1
3134798|NCT01702558|3859715|FG002|COMPLETED|Overall Study||1
3134799|NCT01702558|3859716|FG003|COMPLETED|Overall Study||34
3134800|NCT01702558|3859717|FG004|COMPLETED|Overall Study||38
3134801|NCT01702558|3859713|FG000|NOT COMPLETED|Overall Study||4
3134802|NCT01702558|3859714|FG001|NOT COMPLETED|Overall Study||4
3134803|NCT01702558|3859715|FG002|NOT COMPLETED|Overall Study||5
3134804|NCT01702558|3859716|FG003|NOT COMPLETED|Overall Study||47
3134805|NCT01702558|3859717|FG004|NOT COMPLETED|Overall Study||42
3134806|NCT01702571|3859732|FG000|STARTED|Overall Study||2003
3134807|NCT01702571|3859733|FG001|STARTED|Overall Study||182
3134808|NCT01702571|3859732|FG000|COMPLETED|Overall Study|For one participant, the site incorrectly answered the question 'Did the participant complete follow-up as per protocol?' It was answered No, however the participant was in survival follow-up and the site should have answered Yes. This participant is wrongly counted in the 'discontinued from study' number.|494
3134809|NCT01702571|3859733|FG001|COMPLETED|Overall Study||65
3134810|NCT01702571|3859732|FG000|NOT COMPLETED|Overall Study||1509
3134811|NCT01702571|3859733|FG001|NOT COMPLETED|Overall Study||117
3134812|NCT01702844|3859739|FG000|STARTED|Overall Study||42
3134813|NCT01702844|3859739|FG000|Disease Progression|Overall Study||23
3134814|NCT01702844|3859739|FG000|COMPLETED|Overall Study||23
3134815|NCT01702844|3859739|FG000|NOT COMPLETED|Overall Study||19
3134816|NCT01702961|3859743|FG000|STARTED|Overall Study||75
3134817|NCT01702961|3859743|FG000|COMPLETED|Overall Study||28
3286139|NCT02780115|4019754|FG003|STARTED|Overall Study||32
3286140|NCT02780115|4019755|FG004|STARTED|Overall Study||31
3286141|NCT02780115|4019751|FG000|COMPLETED|Overall Study||28
3286142|NCT02780115|4019752|FG001|COMPLETED|Overall Study||29
3286143|NCT02780115|4019753|FG002|COMPLETED|Overall Study||29
3081429|NCT01383096|3803084|FG000|STARTED|First Intervention (8 Days)||19
3081430|NCT01383096|3803085|FG001|STARTED|First Intervention (8 Days)||17
3081431|NCT01383096|3803086|FG002|STARTED|First Intervention (8 Days)||16
3081432|NCT01383096|3803084|FG000|COMPLETED|First Intervention (8 Days)||19
3081433|NCT01383096|3803085|FG001|COMPLETED|First Intervention (8 Days)||17
3081434|NCT01383096|3803086|FG002|COMPLETED|First Intervention (8 Days)||16
3081435|NCT01383096|3803084|FG000|NOT COMPLETED|First Intervention (8 Days)||0
3081436|NCT01383096|3803085|FG001|NOT COMPLETED|First Intervention (8 Days)||0
3081437|NCT01383096|3803086|FG002|NOT COMPLETED|First Intervention (8 Days)||0
3081438|NCT01383096|3803084|FG000|STARTED|Second Intervention (8 Days)||19
3081439|NCT01383096|3803085|FG001|STARTED|Second Intervention (8 Days)||17
3081440|NCT01383096|3803086|FG002|STARTED|Second Intervention (8 Days)||16
3081441|NCT01383096|3803084|FG000|COMPLETED|Second Intervention (8 Days)||19
3081442|NCT01383096|3803085|FG001|COMPLETED|Second Intervention (8 Days)||16
3081443|NCT01383096|3803086|FG002|COMPLETED|Second Intervention (8 Days)||14
3081444|NCT01383096|3803084|FG000|NOT COMPLETED|Second Intervention (8 Days)||0
3081445|NCT01383096|3803085|FG001|NOT COMPLETED|Second Intervention (8 Days)||1
3081446|NCT01383096|3803086|FG002|NOT COMPLETED|Second Intervention (8 Days)||2
3081447|NCT01383096|3803084|FG000|STARTED|Third Intervention (8 Days)||19
3081448|NCT01383096|3803085|FG001|STARTED|Third Intervention (8 Days)||16
3081449|NCT01383096|3803086|FG002|STARTED|Third Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
3081450|NCT01383096|3803084|FG000|COMPLETED|Third Intervention (8 Days)||15
3081451|NCT01383096|3803085|FG001|COMPLETED|Third Intervention (8 Days)||12
3081452|NCT01383096|3803086|FG002|COMPLETED|Third Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
3081453|NCT01383096|3803084|FG000|NOT COMPLETED|Third Intervention (8 Days)||4
3081454|NCT01383096|3803085|FG001|NOT COMPLETED|Third Intervention (8 Days)||4
3081455|NCT01383096|3803086|FG002|NOT COMPLETED|Third Intervention (8 Days)||0
3081456|NCT01383096|3803084|FG000|STARTED|Fourth Intervention (8 Days)||15
3081457|NCT01383096|3803085|FG001|STARTED|Fourth Intervention (8 Days)||12
3081458|NCT01383096|3803086|FG002|STARTED|Fourth Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
3081459|NCT01383096|3803084|FG000|COMPLETED|Fourth Intervention (8 Days)||13
3081460|NCT01383096|3803085|FG001|COMPLETED|Fourth Intervention (8 Days)||12
3081461|NCT01383096|3803086|FG002|COMPLETED|Fourth Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
3081462|NCT01383096|3803084|FG000|NOT COMPLETED|Fourth Intervention (8 Days)||2
3081463|NCT01383096|3803085|FG001|NOT COMPLETED|Fourth Intervention (8 Days)||0
3081464|NCT01383096|3803086|FG002|NOT COMPLETED|Fourth Intervention (8 Days)||0
3081465|NCT01383096|3803084|FG000|STARTED|Fifth Intervention (8 Days)||13
3081466|NCT01383096|3803085|FG001|STARTED|Fifth Intervention (8 Days)|Only 4 interventions in Cohort 2.|0
3081467|NCT01383096|3803086|FG002|STARTED|Fifth Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
3081468|NCT01383096|3803084|FG000|COMPLETED|Fifth Intervention (8 Days)||11
3081469|NCT01383096|3803085|FG001|COMPLETED|Fifth Intervention (8 Days)|Only 4 interventions in Cohort 2.|0
3081470|NCT01383096|3803086|FG002|COMPLETED|Fifth Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
3081471|NCT01383096|3803084|FG000|NOT COMPLETED|Fifth Intervention (8 Days)||2
3081472|NCT01383096|3803085|FG001|NOT COMPLETED|Fifth Intervention (8 Days)||0
3081473|NCT01383096|3803086|FG002|NOT COMPLETED|Fifth Intervention (8 Days)||0
3081474|NCT01383161|3803125|FG000|STARTED|Overall Study||25
3081475|NCT01383161|3803126|FG001|STARTED|Overall Study||21
3081476|NCT01383161|3803125|FG000|COMPLETED|Overall Study||20
3081477|NCT01383161|3803126|FG001|COMPLETED|Overall Study||17
3081478|NCT01383161|3803125|FG000|NOT COMPLETED|Overall Study||5
3286144|NCT02780115|4019754|FG003|COMPLETED|Overall Study||31
3286145|NCT02780115|4019755|FG004|COMPLETED|Overall Study||30
3286146|NCT02780115|4019751|FG000|NOT COMPLETED|Overall Study||0
3286147|NCT02780115|4019752|FG001|NOT COMPLETED|Overall Study||1
3286148|NCT02780115|4019753|FG002|NOT COMPLETED|Overall Study||1
3286149|NCT02780115|4019754|FG003|NOT COMPLETED|Overall Study||1
3286150|NCT02780115|4019755|FG004|NOT COMPLETED|Overall Study||1
3286151|NCT02780167|4019772|FG000|STARTED|Overall Study||56
3286152|NCT02780167|4019773|FG001|STARTED|Overall Study||49
3286153|NCT02780167|4019774|FG002|STARTED|Overall Study||51
3286154|NCT02780167|4019775|FG003|STARTED|Overall Study||56
3286155|NCT02780167|4019776|FG004|STARTED|Overall Study||55
3286156|NCT02780167|4019772|FG000|COMPLETED|Overall Study||28
3286157|NCT02780167|4019773|FG001|COMPLETED|Overall Study||27
3286158|NCT02780167|4019774|FG002|COMPLETED|Overall Study||27
3286159|NCT02780167|4019775|FG003|COMPLETED|Overall Study||37
3286160|NCT02780167|4019776|FG004|COMPLETED|Overall Study||38
3286161|NCT02780167|4019772|FG000|NOT COMPLETED|Overall Study||28
3286162|NCT02780167|4019773|FG001|NOT COMPLETED|Overall Study||22
3286163|NCT02780167|4019774|FG002|NOT COMPLETED|Overall Study||24
3286164|NCT02780167|4019775|FG003|NOT COMPLETED|Overall Study||19
3286165|NCT02780167|4019776|FG004|NOT COMPLETED|Overall Study||17
3286166|NCT02780349|4019788|FG000|STARTED|Overall Study||103
3286167|NCT02780349|4019788|FG000|COMPLETED|Overall Study||101
3286168|NCT02780349|4019788|FG000|NOT COMPLETED|Overall Study||2
3286169|NCT02780388|4019797|FG000|STARTED|Overall Study||15
3286170|NCT02780388|4019798|FG001|STARTED|Overall Study||8
3286171|NCT02780388|4019799|FG002|STARTED|Overall Study||10
3286172|NCT02780388|4019800|FG003|STARTED|Overall Study||12
3286173|NCT02780388|4019801|FG004|STARTED|Overall Study||12
3081479|NCT01383161|3803126|FG001|NOT COMPLETED|Overall Study||4
3081480|NCT01383174|3803134|FG000|STARTED|Baseline Assessment||76
3081481|NCT01383174|3803135|FG001|STARTED|Baseline Assessment||75
3081482|NCT01383174|3803134|FG000|COMPLETED|Baseline Assessment|These 76 completed the baseline assessment and continued in the study.|76
3081483|NCT01383174|3803135|FG001|COMPLETED|Baseline Assessment|These 75 completed the baseline assessment and continued in the study.|75
3081484|NCT01383174|3803134|FG000|NOT COMPLETED|Baseline Assessment||0
3081485|NCT01383174|3803135|FG001|NOT COMPLETED|Baseline Assessment||0
3081486|NCT01383174|3803134|FG000|STARTED|3 Month Assessment||76
3081487|NCT01383174|3803135|FG001|STARTED|3 Month Assessment||75
3081488|NCT01383174|3803134|FG000|COMPLETED|3 Month Assessment|These 70 completed the 3 month assessment and continued in the study.|70
3081489|NCT01383174|3803135|FG001|COMPLETED|3 Month Assessment|These 74 completed the 3 month assessment and continued in the study.|74
3081490|NCT01383174|3803134|FG000|NOT COMPLETED|3 Month Assessment||6
3081491|NCT01383174|3803135|FG001|NOT COMPLETED|3 Month Assessment||1
3081492|NCT01383174|3803134|FG000|STARTED|6 Month Assessment|All 76 people were contacted at 6 months;1 person returned and 5 did not return to study at 6 months|76
3081493|NCT01383174|3803135|FG001|STARTED|6 Month Assessment||74
3081494|NCT01383174|3803134|FG000|COMPLETED|6 Month Assessment|These 71 completed the 6 month assessment and completed the study.|71
3081495|NCT01383174|3803135|FG001|COMPLETED|6 Month Assessment|These 73 completed the 6 month assessment and completed the study.|73
3081496|NCT01383174|3803134|FG000|NOT COMPLETED|6 Month Assessment||5
3081497|NCT01383174|3803135|FG001|NOT COMPLETED|6 Month Assessment||1
3081498|NCT01383200|3803143|FG000|STARTED|Overall Study||5
3081499|NCT01383200|3803144|FG001|STARTED|Overall Study||6
3081500|NCT01383200|3803143|FG000|COMPLETED|Overall Study||5
3081501|NCT01383200|3803144|FG001|COMPLETED|Overall Study||6
3081502|NCT01383200|3803143|FG000|NOT COMPLETED|Overall Study||0
3081503|NCT01383200|3803144|FG001|NOT COMPLETED|Overall Study||0
3081504|NCT01383213|3803152|FG000|STARTED|Overall Study||40
3081505|NCT01383213|3803153|FG001|STARTED|Overall Study||41
3081506|NCT01383213|3803152|FG000|COMPLETED|Overall Study||40
3081507|NCT01383213|3803153|FG001|COMPLETED|Overall Study||41
3081508|NCT01383213|3803152|FG000|NOT COMPLETED|Overall Study||0
3081509|NCT01383213|3803153|FG001|NOT COMPLETED|Overall Study||0
3081510|NCT01383317|3803161|FG000|STARTED|Overall Study||29
3081511|NCT01383317|3803162|FG001|STARTED|Overall Study||35
3081512|NCT01383317|3803161|FG000|COMPLETED|Overall Study||26
3081513|NCT01383317|3803162|FG001|COMPLETED|Overall Study||33
3081514|NCT01383317|3803161|FG000|NOT COMPLETED|Overall Study||3
3081515|NCT01383317|3803162|FG001|NOT COMPLETED|Overall Study||2
3081516|NCT01383356|3803168|FG000|STARTED|Period 1|Entered and treated.|29
3081517|NCT01383356|3803169|FG001|STARTED|Period 1|Entered and treated.|29
3081518|NCT01383356|3803168|FG000|COMPLETED|Period 1|Completed period 1.|21
3081519|NCT01383356|3803169|FG001|COMPLETED|Period 1|Completed period 1.|23
3081520|NCT01383356|3803168|FG000|NOT COMPLETED|Period 1||8
3081521|NCT01383356|3803169|FG001|NOT COMPLETED|Period 1||6
3081522|NCT01383356|3803168|FG000|STARTED|Washout Period (at Least 35 Days)||21
3081523|NCT01383356|3803169|FG001|STARTED|Washout Period (at Least 35 Days)||23
3081524|NCT01383356|3803168|FG000|COMPLETED|Washout Period (at Least 35 Days)||21
3081525|NCT01383356|3803169|FG001|COMPLETED|Washout Period (at Least 35 Days)||23
3081526|NCT01383356|3803168|FG000|NOT COMPLETED|Washout Period (at Least 35 Days)||0
3081527|NCT01383356|3803169|FG001|NOT COMPLETED|Washout Period (at Least 35 Days)||0
3081528|NCT01383356|3803168|FG000|STARTED|Period 2|Entered and treated.|21
3081529|NCT01383356|3803169|FG001|STARTED|Period 2|Entered and treated.|23
3081530|NCT01383356|3803168|FG000|COMPLETED|Period 2|Completed period 2.|21
3081531|NCT01383356|3803169|FG001|COMPLETED|Period 2|Completed period 2.|23
3081532|NCT01383356|3803168|FG000|NOT COMPLETED|Period 2||0
3081533|NCT01383356|3803169|FG001|NOT COMPLETED|Period 2||0
3081534|NCT01383421|3803175|FG000|STARTED|Overall Study|ITT population: all enrolled participants who received at least 1 dose of study drug.|1025
3081535|NCT01383421|3803175|FG000|COMPLETED|Overall Study||679
3081536|NCT01383421|3803175|FG000|NOT COMPLETED|Overall Study||346
3081537|NCT01383486|3803183|FG000|STARTED|Overall Study|Number of participants who were provided with investigational products|253
3081538|NCT01383486|3803183|FG000|Treated|Overall Study|Number of participants who took any study medication (Safety Population)|237
3286174|NCT02780388|4019797|FG000|COMPLETED|Overall Study||14
3286175|NCT02780388|4019798|FG001|COMPLETED|Overall Study||6
3286176|NCT02780388|4019799|FG002|COMPLETED|Overall Study||10
3286177|NCT02780388|4019800|FG003|COMPLETED|Overall Study||12
3286178|NCT02780388|4019801|FG004|COMPLETED|Overall Study||12
3286179|NCT02780388|4019797|FG000|NOT COMPLETED|Overall Study||1
3286180|NCT02780388|4019798|FG001|NOT COMPLETED|Overall Study||2
3286181|NCT02780388|4019799|FG002|NOT COMPLETED|Overall Study||0
3081539|NCT01383486|3803183|FG000|COMPLETED|Overall Study|Took any study medication and gave estimated duration of pain (Selection Evaluation Population)|235
3081540|NCT01383486|3803183|FG000|NOT COMPLETED|Overall Study||18
3081541|NCT01383499|3803188|FG000|STARTED|Period 1 (4 Weeks)||27
3081542|NCT01383499|3803189|FG001|STARTED|Period 1 (4 Weeks)||24
3081543|NCT01383499|3803190|FG002|STARTED|Period 1 (4 Weeks)||25
3081544|NCT01383499|3803191|FG003|STARTED|Period 1 (4 Weeks)||25
3081545|NCT01383499|3803188|FG000|COMPLETED|Period 1 (4 Weeks)||26
3081546|NCT01383499|3803189|FG001|COMPLETED|Period 1 (4 Weeks)||24
3081547|NCT01383499|3803190|FG002|COMPLETED|Period 1 (4 Weeks)||25
3286182|NCT02780388|4019800|FG003|NOT COMPLETED|Overall Study||0
3286183|NCT02780388|4019801|FG004|NOT COMPLETED|Overall Study||0
3081548|NCT01383499|3803191|FG003|COMPLETED|Period 1 (4 Weeks)||25
3081549|NCT01383499|3803188|FG000|NOT COMPLETED|Period 1 (4 Weeks)||1
3081550|NCT01383499|3803189|FG001|NOT COMPLETED|Period 1 (4 Weeks)||0
3081551|NCT01383499|3803190|FG002|NOT COMPLETED|Period 1 (4 Weeks)||0
3081552|NCT01383499|3803191|FG003|NOT COMPLETED|Period 1 (4 Weeks)||0
3081553|NCT01383499|3803188|FG000|STARTED|Period 2 (4 Weeks)||26
3081554|NCT01383499|3803189|FG001|STARTED|Period 2 (4 Weeks)||24
3081555|NCT01383499|3803190|FG002|STARTED|Period 2 (4 Weeks)||25
3081556|NCT01383499|3803191|FG003|STARTED|Period 2 (4 Weeks)||25
3081557|NCT01383499|3803188|FG000|COMPLETED|Period 2 (4 Weeks)||26
3081558|NCT01383499|3803189|FG001|COMPLETED|Period 2 (4 Weeks)||24
3081559|NCT01383499|3803190|FG002|COMPLETED|Period 2 (4 Weeks)||25
3081560|NCT01383499|3803191|FG003|COMPLETED|Period 2 (4 Weeks)||25
3081561|NCT01383499|3803188|FG000|NOT COMPLETED|Period 2 (4 Weeks)||0
3081562|NCT01383499|3803189|FG001|NOT COMPLETED|Period 2 (4 Weeks)||0
3081563|NCT01383499|3803190|FG002|NOT COMPLETED|Period 2 (4 Weeks)||0
3081564|NCT01383499|3803191|FG003|NOT COMPLETED|Period 2 (4 Weeks)||0
3081565|NCT01383499|3803188|FG000|STARTED|Period 3 (4 Weeks)||26
3081566|NCT01383499|3803189|FG001|STARTED|Period 3 (4 Weeks)||24
3081567|NCT01383499|3803190|FG002|STARTED|Period 3 (4 Weeks)||25
3081568|NCT01383499|3803191|FG003|STARTED|Period 3 (4 Weeks)||25
3081569|NCT01383499|3803188|FG000|COMPLETED|Period 3 (4 Weeks)||26
3081570|NCT01383499|3803189|FG001|COMPLETED|Period 3 (4 Weeks)||24
3081571|NCT01383499|3803190|FG002|COMPLETED|Period 3 (4 Weeks)||25
3081572|NCT01383499|3803191|FG003|COMPLETED|Period 3 (4 Weeks)||25
3081573|NCT01383499|3803188|FG000|NOT COMPLETED|Period 3 (4 Weeks)||0
3081574|NCT01383499|3803189|FG001|NOT COMPLETED|Period 3 (4 Weeks)||0
3081575|NCT01383499|3803190|FG002|NOT COMPLETED|Period 3 (4 Weeks)||0
3081576|NCT01383499|3803191|FG003|NOT COMPLETED|Period 3 (4 Weeks)||0
3081577|NCT01383616|3803206|FG000|STARTED|Overall Study||40
3081578|NCT01383616|3803207|FG001|STARTED|Overall Study||44
3081579|NCT01383616|3803206|FG000|COMPLETED|Overall Study||23
3081580|NCT01383616|3803207|FG001|COMPLETED|Overall Study||21
3081581|NCT01383616|3803206|FG000|NOT COMPLETED|Overall Study||17
3081582|NCT01383616|3803207|FG001|NOT COMPLETED|Overall Study||23
3081583|NCT01383707|3803217|FG000|STARTED|Overall Study||77
3081584|NCT01383707|3803217|FG000|COMPLETED|Overall Study||5
3081585|NCT01383707|3803217|FG000|NOT COMPLETED|Overall Study||72
3081586|NCT01383720|3803221|FG000|STARTED|Overall Study||11
3081587|NCT01383720|3803221|FG000|Primary Endpoint (Discharge/7 Days)|Overall Study||11
3081588|NCT01383720|3803221|FG000|COMPLETED|Overall Study|Study is continuing to 5 years. All patients are still in the study.|11
3081589|NCT01383720|3803221|FG000|NOT COMPLETED|Overall Study||0
3081590|NCT01383759|3803227|FG000|STARTED|Overall Study||19
3081591|NCT01383759|3803228|FG001|STARTED|Overall Study||1
3081592|NCT01383759|3803227|FG000|COMPLETED|Overall Study||19
3081593|NCT01383759|3803228|FG001|COMPLETED|Overall Study||1
3081594|NCT01383759|3803227|FG000|NOT COMPLETED|Overall Study||0
3081595|NCT01383759|3803228|FG001|NOT COMPLETED|Overall Study||0
3081596|NCT01383928|3803237|FG000|STARTED|Overall Study||7
3081597|NCT01383928|3803238|FG001|STARTED|Overall Study||7
3081598|NCT01383928|3803239|FG002|STARTED|Overall Study||50
3081599|NCT01383928|3803237|FG000|COMPLETED|Overall Study||2
3081600|NCT01383928|3803238|FG001|COMPLETED|Overall Study||0
3081601|NCT01383928|3803239|FG002|COMPLETED|Overall Study||10
3081602|NCT01383928|3803237|FG000|NOT COMPLETED|Overall Study||5
3081603|NCT01383928|3803238|FG001|NOT COMPLETED|Overall Study||7
3081604|NCT01383928|3803239|FG002|NOT COMPLETED|Overall Study||40
3081605|NCT01383954|3803249|FG000|STARTED|Overall Study||52
3081606|NCT01383954|3803249|FG000|Safety Population: Received Treatment|Overall Study||48
3081607|NCT01383954|3803249|FG000|COMPLETED|Overall Study||38
3081608|NCT01383954|3803249|FG000|NOT COMPLETED|Overall Study||14
3081609|NCT01383993|3803256|FG000|STARTED|Overall Study||15
3081610|NCT01383993|3803257|FG001|STARTED|Overall Study||4
3081611|NCT01383993|3803258|FG002|STARTED|Overall Study||2
3081612|NCT01383993|3803256|FG000|COMPLETED|Overall Study||12
3081613|NCT01383993|3803257|FG001|COMPLETED|Overall Study||3
3081614|NCT01383993|3803258|FG002|COMPLETED|Overall Study||1
3081615|NCT01383993|3803256|FG000|NOT COMPLETED|Overall Study||3
3081616|NCT01383993|3803257|FG001|NOT COMPLETED|Overall Study||1
3081617|NCT01383993|3803258|FG002|NOT COMPLETED|Overall Study||1
3081618|NCT01384019|3803269|FG000|STARTED|Overall Study||65
3081619|NCT01384019|3803270|FG001|STARTED|Overall Study||61
3081620|NCT01384019|3803269|FG000|COMPLETED|Overall Study||55
3081621|NCT01384019|3803270|FG001|COMPLETED|Overall Study||55
3081622|NCT01384019|3803269|FG000|NOT COMPLETED|Overall Study||10
3081623|NCT01384019|3803270|FG001|NOT COMPLETED|Overall Study||6
3081624|NCT01384292|3803279|FG000|STARTED|Part A||5
3081625|NCT01384292|3803280|FG001|STARTED|Part A||5
3081626|NCT01384292|3803281|FG002|STARTED|Part A||4
3081627|NCT01384292|3803279|FG000|COMPLETED|Part A||5
3081628|NCT01384292|3803280|FG001|COMPLETED|Part A||5
3081629|NCT01384292|3803281|FG002|COMPLETED|Part A||4
3081630|NCT01384292|3803279|FG000|NOT COMPLETED|Part A||0
3081631|NCT01384292|3803280|FG001|NOT COMPLETED|Part A||0
3081632|NCT01384292|3803281|FG002|NOT COMPLETED|Part A||0
3081633|NCT01384292|3803279|FG000|STARTED|Part B||3
3081634|NCT01384292|3803280|FG001|STARTED|Part B||6
3081635|NCT01384292|3803281|FG002|STARTED|Part B||0
3081636|NCT01384292|3803279|FG000|COMPLETED|Part B||2
3081637|NCT01384292|3803280|FG001|COMPLETED|Part B||6
3081638|NCT01384292|3803281|FG002|COMPLETED|Part B||0
3081639|NCT01384292|3803279|FG000|NOT COMPLETED|Part B||1
3081640|NCT01384292|3803280|FG001|NOT COMPLETED|Part B||0
3081641|NCT01384292|3803281|FG002|NOT COMPLETED|Part B||0
3081642|NCT01384539|3803293|FG000|STARTED|Overall Study||64
3081643|NCT01384539|3803294|FG001|STARTED|Overall Study||64
3081644|NCT01384539|3803293|FG000|COMPLETED|Overall Study||58
3081645|NCT01384539|3803294|FG001|COMPLETED|Overall Study||57
3081646|NCT01384539|3803293|FG000|NOT COMPLETED|Overall Study||6
3081647|NCT01384539|3803294|FG001|NOT COMPLETED|Overall Study||7
3081648|NCT01384591|3803303|FG000|STARTED|Overall Study||2
3081649|NCT01384591|3803304|FG001|STARTED|Overall Study||2
3081650|NCT01384591|3803305|FG002|STARTED|Overall Study||2
3081651|NCT01384591|3803303|FG000|COMPLETED|Overall Study||2
3081652|NCT01384591|3803304|FG001|COMPLETED|Overall Study||2
3081653|NCT01384591|3803305|FG002|COMPLETED|Overall Study||2
3081654|NCT01384591|3803303|FG000|NOT COMPLETED|Overall Study||0
3081655|NCT01384591|3803304|FG001|NOT COMPLETED|Overall Study||0
3081656|NCT01384591|3803305|FG002|NOT COMPLETED|Overall Study||0
3081657|NCT01384734|3803318|FG000|STARTED|Overall Study||50
3081658|NCT01384734|3803319|FG001|STARTED|Overall Study||49
3081659|NCT01384734|3803320|FG002|STARTED|Overall Study||51
3081660|NCT01384734|3803321|FG003|STARTED|Overall Study||50
3081661|NCT01384734|3803322|FG004|STARTED|Overall Study||51
3081662|NCT01384734|3803318|FG000|COMPLETED|Overall Study||33
3081663|NCT01384734|3803319|FG001|COMPLETED|Overall Study||25
3081664|NCT01384734|3803320|FG002|COMPLETED|Overall Study||28
3081665|NCT01384734|3803321|FG003|COMPLETED|Overall Study||22
3081666|NCT01384734|3803322|FG004|COMPLETED|Overall Study||22
3081667|NCT01384734|3803318|FG000|NOT COMPLETED|Overall Study||17
3081668|NCT01384734|3803319|FG001|NOT COMPLETED|Overall Study||24
3081669|NCT01384734|3803320|FG002|NOT COMPLETED|Overall Study||23
3081670|NCT01384734|3803321|FG003|NOT COMPLETED|Overall Study||28
3081671|NCT01384734|3803322|FG004|NOT COMPLETED|Overall Study||29
3081672|NCT01384760|3803333|FG000|STARTED|Overall Study||61
3081673|NCT01384760|3803334|FG001|STARTED|Overall Study||43
3081674|NCT01384760|3803333|FG000|Randomized|Overall Study||61
3081675|NCT01384760|3803334|FG001|Randomized|Overall Study||43
3081676|NCT01384760|3803333|FG000|COMPLETED|Overall Study||45
3081677|NCT01384760|3803334|FG001|COMPLETED|Overall Study||37
3081678|NCT01384760|3803333|FG000|NOT COMPLETED|Overall Study||16
3081679|NCT01384760|3803334|FG001|NOT COMPLETED|Overall Study||6
3081680|NCT01384877|3803342|FG000|STARTED|Treatment 1||17
3081681|NCT01384877|3803343|FG001|STARTED|Treatment 1||15
3081682|NCT01384877|3803342|FG000|COMPLETED|Treatment 1||17
3081683|NCT01384877|3803343|FG001|COMPLETED|Treatment 1||15
3081684|NCT01384877|3803342|FG000|NOT COMPLETED|Treatment 1||0
3081685|NCT01384877|3803343|FG001|NOT COMPLETED|Treatment 1||0
3081686|NCT01384877|3803342|FG000|STARTED|Treatment 2|1 Patient died between treatment periods|16
3081687|NCT01384877|3803343|FG001|STARTED|Treatment 2|2 Patients died between treatment periods|13
3081688|NCT01384877|3803342|FG000|COMPLETED|Treatment 2||14
3081689|NCT01384877|3803343|FG001|COMPLETED|Treatment 2||11
3081690|NCT01384877|3803342|FG000|NOT COMPLETED|Treatment 2||2
3081691|NCT01384877|3803343|FG001|NOT COMPLETED|Treatment 2||2
3081692|NCT01385098|3803349|FG000|STARTED|Overall Study||37
3286184|NCT02780622|4019817|FG000|STARTED|Treatment Period 1||10
3286185|NCT02780622|4019818|FG001|STARTED|Treatment Period 1||10
3286186|NCT02780622|4019817|FG000|COMPLETED|Treatment Period 1||10
3286187|NCT02780622|4019818|FG001|COMPLETED|Treatment Period 1||10
3286188|NCT02780622|4019817|FG000|NOT COMPLETED|Treatment Period 1||0
3286189|NCT02780622|4019818|FG001|NOT COMPLETED|Treatment Period 1||0
3286190|NCT02780622|4019817|FG000|STARTED|Treatment Period 2||10
3286191|NCT02780622|4019818|FG001|STARTED|Treatment Period 2||10
3081693|NCT01385098|3803349|FG000|COMPLETED|Overall Study|14 subjects did not complete. 4 subjects loss to follow-up & 10 subjects could not tolerate suppl.|23
3081694|NCT01385098|3803349|FG000|NOT COMPLETED|Overall Study||14
3081695|NCT01385137|3803357|FG000|STARTED|Evaluable at Baseline||131
3081696|NCT01385137|3803358|FG001|STARTED|Evaluable at Baseline||131
3081697|NCT01385137|3803357|FG000|COMPLETED|Evaluable at Baseline||122
3081698|NCT01385137|3803358|FG001|COMPLETED|Evaluable at Baseline||127
3081699|NCT01385137|3803357|FG000|NOT COMPLETED|Evaluable at Baseline||9
3081700|NCT01385137|3803358|FG001|NOT COMPLETED|Evaluable at Baseline||4
3081701|NCT01385137|3803357|FG000|STARTED|Evaluable for Primary Endpoint||131
3081702|NCT01385137|3803358|FG001|STARTED|Evaluable for Primary Endpoint||131
3081703|NCT01385137|3803357|FG000|COMPLETED|Evaluable for Primary Endpoint||102
3081704|NCT01385137|3803358|FG001|COMPLETED|Evaluable for Primary Endpoint||107
3081705|NCT01385137|3803357|FG000|NOT COMPLETED|Evaluable for Primary Endpoint||29
3081706|NCT01385137|3803358|FG001|NOT COMPLETED|Evaluable for Primary Endpoint||24
3286192|NCT02780622|4019817|FG000|COMPLETED|Treatment Period 2||10
3286193|NCT02780622|4019818|FG001|COMPLETED|Treatment Period 2||10
3286194|NCT02780622|4019817|FG000|NOT COMPLETED|Treatment Period 2||0
3286195|NCT02780622|4019818|FG001|NOT COMPLETED|Treatment Period 2||0
3286196|NCT02780661|4019825|FG000|STARTED|Period 1||10
3286197|NCT02780661|4019826|FG001|STARTED|Period 1||9
3286198|NCT02780661|4019825|FG000|COMPLETED|Period 1||10
3286199|NCT02780661|4019826|FG001|COMPLETED|Period 1||9
3286200|NCT02780661|4019825|FG000|NOT COMPLETED|Period 1||0
3286201|NCT02780661|4019826|FG001|NOT COMPLETED|Period 1||0
3286202|NCT02780661|4019825|FG000|STARTED|Wash Out Period||10
3286203|NCT02780661|4019826|FG001|STARTED|Wash Out Period||9
3286204|NCT02780661|4019825|FG000|COMPLETED|Wash Out Period||10
3286205|NCT02780661|4019826|FG001|COMPLETED|Wash Out Period||9
3286206|NCT02780661|4019825|FG000|NOT COMPLETED|Wash Out Period||0
3081707|NCT01385189|3803369|FG000|STARTED|Overall Study||12
3081708|NCT01385189|3803370|FG001|STARTED|Overall Study||12
3081709|NCT01385189|3803371|FG002|STARTED|Overall Study||4
3081710|NCT01385189|3803372|FG003|STARTED|Overall Study||4
3081711|NCT01385189|3803373|FG004|STARTED|Overall Study||8
3081712|NCT01385189|3803369|FG000|COMPLETED|Overall Study||11
3081713|NCT01385189|3803370|FG001|COMPLETED|Overall Study||11
3081714|NCT01385189|3803371|FG002|COMPLETED|Overall Study||4
3081715|NCT01385189|3803372|FG003|COMPLETED|Overall Study||3
3081716|NCT01385189|3803373|FG004|COMPLETED|Overall Study||6
3081717|NCT01385189|3803369|FG000|NOT COMPLETED|Overall Study||1
3081718|NCT01385189|3803370|FG001|NOT COMPLETED|Overall Study||1
3081719|NCT01385189|3803371|FG002|NOT COMPLETED|Overall Study||0
3081720|NCT01385189|3803372|FG003|NOT COMPLETED|Overall Study||1
3081721|NCT01385189|3803373|FG004|NOT COMPLETED|Overall Study||2
3081722|NCT01385202|3803392|FG000|STARTED|Overall Study|Per protocol, enrolled subjects were defined as those who signed inform consent form.|172
3081723|NCT01385202|3803392|FG000|Study Catheter Inserted|Overall Study||161
3081724|NCT01385202|3803392|FG000|Undergoing Ablation|Overall Study||160
3081725|NCT01385202|3803392|FG000|COMPLETED|Overall Study||154
3081726|NCT01385202|3803392|FG000|NOT COMPLETED|Overall Study||18
3081727|NCT01385293|3803398|FG000|STARTED|Overall Study||30
3081728|NCT01385293|3803398|FG000|COMPLETED|Overall Study||30
3081729|NCT01385293|3803398|FG000|NOT COMPLETED|Overall Study||0
3081730|NCT01385306|3803402|FG000|STARTED|Overall Study||6
3081731|NCT01385306|3803402|FG000|COMPLETED|Overall Study||6
3081732|NCT01385306|3803402|FG000|NOT COMPLETED|Overall Study||0
3081733|NCT01385371|3803408|FG000|STARTED|Overall Study||752
3081734|NCT01385371|3803409|FG001|STARTED|Overall Study||749
3081735|NCT01385371|3803408|FG000|COMPLETED|Overall Study||603
3081736|NCT01385371|3803409|FG001|COMPLETED|Overall Study||652
3081737|NCT01385371|3803408|FG000|NOT COMPLETED|Overall Study||149
3081738|NCT01385371|3803409|FG001|NOT COMPLETED|Overall Study||97
3081739|NCT01385566|3803421|FG000|STARTED|Overall Study||52
3081740|NCT01385566|3803422|FG001|STARTED|Overall Study||34
3081741|NCT01385566|3803423|FG002|STARTED|Overall Study||34
3081742|NCT01385566|3803424|FG003|STARTED|Overall Study||35
3081743|NCT01385566|3803425|FG004|STARTED|Overall Study||34
3081744|NCT01385566|3803426|FG005|STARTED|Overall Study||34
3081745|NCT01385566|3803421|FG000|COMPLETED|Overall Study||51
3081746|NCT01385566|3803422|FG001|COMPLETED|Overall Study||34
3081747|NCT01385566|3803423|FG002|COMPLETED|Overall Study||34
3081748|NCT01385566|3803424|FG003|COMPLETED|Overall Study||34
3081749|NCT01385566|3803425|FG004|COMPLETED|Overall Study||34
3081750|NCT01385566|3803426|FG005|COMPLETED|Overall Study||34
3081751|NCT01385566|3803421|FG000|NOT COMPLETED|Overall Study||1
3081752|NCT01385566|3803422|FG001|NOT COMPLETED|Overall Study||0
3081753|NCT01385566|3803423|FG002|NOT COMPLETED|Overall Study||0
3081754|NCT01385566|3803424|FG003|NOT COMPLETED|Overall Study||1
3081755|NCT01385566|3803425|FG004|NOT COMPLETED|Overall Study||0
3081756|NCT01385566|3803426|FG005|NOT COMPLETED|Overall Study||0
3081757|NCT01385579|3803444|FG000|STARTED|Overall Study||98
3081758|NCT01385579|3803445|FG001|STARTED|Overall Study||104
3081759|NCT01385579|3803444|FG000|COMPLETED|Overall Study||98
3081760|NCT01385579|3803445|FG001|COMPLETED|Overall Study||104
3081761|NCT01385579|3803444|FG000|NOT COMPLETED|Overall Study||0
3081762|NCT01385579|3803445|FG001|NOT COMPLETED|Overall Study||0
3081763|NCT01385644|3803453|FG000|STARTED|Overall Study||4
3081764|NCT01385644|3803454|FG001|STARTED|Overall Study||4
3081765|NCT01385644|3803453|FG000|COMPLETED|Overall Study||4
3081766|NCT01385644|3803454|FG001|COMPLETED|Overall Study||4
3081767|NCT01385644|3803453|FG000|NOT COMPLETED|Overall Study||0
3081768|NCT01385644|3803454|FG001|NOT COMPLETED|Overall Study||0
3081769|NCT01385696|3803460|FG000|STARTED|Overall Study||66
3081770|NCT01385696|3803461|FG001|STARTED|Overall Study|1 patient used Handihaler® once only, Genuair® zero times, & was excluded from the safety population|64
3081771|NCT01385696|3803460|FG000|COMPLETED|Overall Study||66
3081772|NCT01385696|3803461|FG001|COMPLETED|Overall Study||64
3081773|NCT01385696|3803460|FG000|NOT COMPLETED|Overall Study||0
3081774|NCT01385696|3803461|FG001|NOT COMPLETED|Overall Study||0
3081775|NCT01385748|3803471|FG000|STARTED|Overall Study||56
3081776|NCT01385748|3803472|FG001|STARTED|Overall Study||65
3081777|NCT01385748|3803473|FG002|STARTED|Overall Study||62
3081778|NCT01385748|3803471|FG000|COMPLETED|Overall Study||41
3081779|NCT01385748|3803472|FG001|COMPLETED|Overall Study||51
3081780|NCT01385748|3803473|FG002|COMPLETED|Overall Study||49
3081781|NCT01385748|3803471|FG000|NOT COMPLETED|Overall Study||15
3081782|NCT01385748|3803472|FG001|NOT COMPLETED|Overall Study||14
3081783|NCT01385748|3803473|FG002|NOT COMPLETED|Overall Study||13
3081784|NCT01385995|3803487|FG000|STARTED|Period 1, 2 Months||25
3081785|NCT01385995|3803488|FG001|STARTED|Period 1, 2 Months||25
3081786|NCT01385995|3803487|FG000|COMPLETED|Period 1, 2 Months||24
3081787|NCT01385995|3803488|FG001|COMPLETED|Period 1, 2 Months||25
3081788|NCT01385995|3803487|FG000|NOT COMPLETED|Period 1, 2 Months||1
3081789|NCT01385995|3803488|FG001|NOT COMPLETED|Period 1, 2 Months||0
3081790|NCT01385995|3803487|FG000|STARTED|Washout Period, 1 Month||24
3081791|NCT01385995|3803488|FG001|STARTED|Washout Period, 1 Month||25
3081792|NCT01385995|3803487|FG000|COMPLETED|Washout Period, 1 Month||24
3081793|NCT01385995|3803488|FG001|COMPLETED|Washout Period, 1 Month||25
3081794|NCT01385995|3803487|FG000|NOT COMPLETED|Washout Period, 1 Month||0
3081795|NCT01385995|3803488|FG001|NOT COMPLETED|Washout Period, 1 Month||0
3081796|NCT01385995|3803487|FG000|STARTED|Period 2, 2 Months||24
3081797|NCT01385995|3803488|FG001|STARTED|Period 2, 2 Months||25
3081798|NCT01385995|3803487|FG000|COMPLETED|Period 2, 2 Months||24
3081799|NCT01385995|3803488|FG001|COMPLETED|Period 2, 2 Months||25
3081800|NCT01385995|3803487|FG000|NOT COMPLETED|Period 2, 2 Months||0
3081801|NCT01385995|3803488|FG001|NOT COMPLETED|Period 2, 2 Months||0
3081802|NCT01386008|3803496|FG000|STARTED|Overall Study||20
3081803|NCT01386008|3803496|FG000|COMPLETED|Overall Study||0
3081804|NCT01386008|3803496|FG000|NOT COMPLETED|Overall Study||20
3081805|NCT01386528|3803500|FG000|STARTED|Overall Study||13
3081806|NCT01386528|3803500|FG000|COMPLETED|Overall Study||13
3081807|NCT01386528|3803500|FG000|NOT COMPLETED|Overall Study||0
3081808|NCT01386554|3803507|FG000|STARTED|Overall Study||4
3081809|NCT01386554|3803508|FG001|STARTED|Overall Study||35
3081810|NCT01386554|3803509|FG002|STARTED|Overall Study||21
3081811|NCT01386554|3803507|FG000|COMPLETED|Overall Study||1
3081812|NCT01386554|3803508|FG001|COMPLETED|Overall Study||26
3081813|NCT01386554|3803509|FG002|COMPLETED|Overall Study||15
3081814|NCT01386554|3803507|FG000|NOT COMPLETED|Overall Study||3
3081815|NCT01386554|3803508|FG001|NOT COMPLETED|Overall Study||9
3081816|NCT01386554|3803509|FG002|NOT COMPLETED|Overall Study||6
3081817|NCT01386606|3803523|FG000|STARTED|Overall Study||16
3081818|NCT01386606|3803524|FG001|STARTED|Overall Study||14
3081819|NCT01386606|3803525|FG002|STARTED|Overall Study||16
3081820|NCT01386606|3803526|FG003|STARTED|Overall Study||14
3081821|NCT01386606|3803523|FG000|COMPLETED|Overall Study||12
3081822|NCT01386606|3803524|FG001|COMPLETED|Overall Study||10
3081823|NCT01386606|3803525|FG002|COMPLETED|Overall Study||13
3081824|NCT01386606|3803526|FG003|COMPLETED|Overall Study||13
3081825|NCT01386606|3803523|FG000|NOT COMPLETED|Overall Study||4
3081826|NCT01386606|3803524|FG001|NOT COMPLETED|Overall Study||4
3081827|NCT01386606|3803525|FG002|NOT COMPLETED|Overall Study||3
3081828|NCT01386606|3803526|FG003|NOT COMPLETED|Overall Study||1
3081829|NCT01386632|3803542|FG000|STARTED|Overall Study||25
3081830|NCT01386632|3803543|FG001|STARTED|Overall Study||25
3081831|NCT01386632|3803542|FG000|COMPLETED|Overall Study||20
3081832|NCT01386632|3803543|FG001|COMPLETED|Overall Study||21
3081833|NCT01386632|3803542|FG000|NOT COMPLETED|Overall Study||5
3081834|NCT01386632|3803543|FG001|NOT COMPLETED|Overall Study||4
3081835|NCT01386645|3803552|FG000|STARTED|Overall Study||18
3081836|NCT01386645|3803553|FG001|STARTED|Overall Study||19
3081837|NCT01386645|3803554|FG002|STARTED|Overall Study||19
3081838|NCT01386645|3803552|FG000|COMPLETED|Overall Study||18
3081839|NCT01386645|3803553|FG001|COMPLETED|Overall Study||18
3081840|NCT01386645|3803554|FG002|COMPLETED|Overall Study||17
3081841|NCT01386645|3803552|FG000|NOT COMPLETED|Overall Study||0
3081842|NCT01386645|3803553|FG001|NOT COMPLETED|Overall Study||1
3081843|NCT01386645|3803554|FG002|NOT COMPLETED|Overall Study||2
3081844|NCT01386788|3803562|FG000|STARTED|Overall Study||102
3081845|NCT01386788|3803562|FG000|COMPLETED|Overall Study||100
3081846|NCT01386788|3803562|FG000|NOT COMPLETED|Overall Study||2
3081847|NCT01386944|3803566|FG000|STARTED|Overall Study||102
3081848|NCT01386944|3803566|FG000|COMPLETED|Overall Study||46
3081849|NCT01386944|3803566|FG000|NOT COMPLETED|Overall Study||56
3081850|NCT01386970|3803572|FG000|STARTED|Overall Study||20
2940857|NCT00639418|3653098|FG002|STARTED|Overall Study||36496
2940858|NCT00639418|3653099|FG003|STARTED|Overall Study||46930
2940859|NCT00639418|3653096|FG000|COMPLETED|Overall Study||28101
2940860|NCT00639418|3653097|FG001|COMPLETED|Overall Study||35967
2940861|NCT00639418|3653098|FG002|COMPLETED|Overall Study||36496
2940862|NCT00639418|3653099|FG003|COMPLETED|Overall Study||46930
3081851|NCT01386970|3803573|FG001|STARTED|Overall Study||23
3081852|NCT01386970|3803572|FG000|COMPLETED|Overall Study||16
3081853|NCT01386970|3803573|FG001|COMPLETED|Overall Study||21
3081854|NCT01386970|3803572|FG000|NOT COMPLETED|Overall Study||4
3081855|NCT01386970|3803573|FG001|NOT COMPLETED|Overall Study||2
3081856|NCT01386983|3803583|FG000|STARTED|Overall Study||264
3081857|NCT01386983|3803584|FG001|STARTED|Overall Study||68
3081858|NCT01386983|3803583|FG000|COMPLETED|Overall Study||264
3081859|NCT01386983|3803584|FG001|COMPLETED|Overall Study||68
3081860|NCT01386983|3803583|FG000|NOT COMPLETED|Overall Study||0
3081861|NCT01386983|3803584|FG001|NOT COMPLETED|Overall Study||0
3081862|NCT01387022|3803592|FG000|STARTED|Overall Study||29
3081863|NCT01387022|3803593|FG001|STARTED|Overall Study||30
3081864|NCT01387022|3803592|FG000|COMPLETED|Overall Study||28
3286207|NCT02780661|4019826|FG001|NOT COMPLETED|Wash Out Period||0
3286208|NCT02780661|4019825|FG000|STARTED|Period 2||10
3286209|NCT02780661|4019826|FG001|STARTED|Period 2||9
3286210|NCT02780661|4019825|FG000|COMPLETED|Period 2||10
3286211|NCT02780661|4019826|FG001|COMPLETED|Period 2||9
3286212|NCT02780661|4019825|FG000|NOT COMPLETED|Period 2||0
3081865|NCT01387022|3803593|FG001|COMPLETED|Overall Study||26
3081866|NCT01387022|3803592|FG000|NOT COMPLETED|Overall Study||1
3081867|NCT01387022|3803593|FG001|NOT COMPLETED|Overall Study||4
3081868|NCT01387074|3803599|FG000|STARTED|Overall Study||108
3081869|NCT01387074|3803599|FG000|COMPLETED|Overall Study||100
3081870|NCT01387074|3803599|FG000|NOT COMPLETED|Overall Study||8
3081871|NCT01387139|3803605|FG000|STARTED|Overall Study||99
3081872|NCT01387139|3803606|FG001|STARTED|Overall Study||84
3081873|NCT01387139|3803605|FG000|COMPLETED|Overall Study||99
3081874|NCT01387139|3803606|FG001|COMPLETED|Overall Study||84
3081875|NCT01387139|3803605|FG000|NOT COMPLETED|Overall Study||0
3081876|NCT01387139|3803606|FG001|NOT COMPLETED|Overall Study||0
3081877|NCT01387178|3803614|FG000|STARTED|Overall Study||11582
3286213|NCT02780661|4019826|FG001|NOT COMPLETED|Period 2||0
3081878|NCT01387178|3803615|FG001|STARTED|Overall Study||10641
3081879|NCT01387178|3803614|FG000|COMPLETED|Overall Study||11582
3081880|NCT01387178|3803615|FG001|COMPLETED|Overall Study||10641
3081881|NCT01387178|3803614|FG000|NOT COMPLETED|Overall Study||0
3081882|NCT01387178|3803615|FG001|NOT COMPLETED|Overall Study||0
3081883|NCT01387230|3803625|FG000|STARTED|Overall Study||68
3081884|NCT01387230|3803626|FG001|STARTED|Overall Study||69
3081885|NCT01387230|3803627|FG002|STARTED|Overall Study||69
3081886|NCT01387230|3803625|FG000|COMPLETED|Overall Study||50
3081887|NCT01387230|3803626|FG001|COMPLETED|Overall Study||62
3081888|NCT01387230|3803627|FG002|COMPLETED|Overall Study||56
3081889|NCT01387230|3803625|FG000|NOT COMPLETED|Overall Study||18
3081890|NCT01387230|3803626|FG001|NOT COMPLETED|Overall Study||7
3081891|NCT01387230|3803627|FG002|NOT COMPLETED|Overall Study||13
3081892|NCT01387269|3803637|FG000|STARTED|Overall Study||323
3081893|NCT01387269|3803638|FG001|STARTED|Overall Study||161
3081894|NCT01387269|3803637|FG000|ITT Population|Overall Study||323
3081895|NCT01387269|3803638|FG001|ITT Population|Overall Study||161
3081896|NCT01387269|3803637|FG000|MITT Population|Overall Study||284
3081897|NCT01387269|3803638|FG001|MITT Population|Overall Study||141
3081898|NCT01387269|3803637|FG000|Safety Population|Overall Study||320
3081899|NCT01387269|3803638|FG001|Safety Population|Overall Study||161
3081900|NCT01387269|3803637|FG000|COMPLETED|Overall Study||231
3081901|NCT01387269|3803638|FG001|COMPLETED|Overall Study||121
3081902|NCT01387269|3803637|FG000|NOT COMPLETED|Overall Study||92
3081903|NCT01387269|3803638|FG001|NOT COMPLETED|Overall Study||40
3081904|NCT01387282|3803646|FG000|STARTED|Overall Study||330
3081905|NCT01387282|3803647|FG001|STARTED|Overall Study||165
3081906|NCT01387282|3803646|FG000|ITT Population|Overall Study||330
3081907|NCT01387282|3803647|FG001|ITT Population|Overall Study||165
3081908|NCT01387282|3803646|FG000|MITT Population|Overall Study||268
3081909|NCT01387282|3803647|FG001|MITT Population|Overall Study||136
3081910|NCT01387282|3803646|FG000|Safety Population|Overall Study||330
3081911|NCT01387282|3803647|FG001|Safety Population|Overall Study||161
3081912|NCT01387282|3803646|FG000|COMPLETED|Overall Study||233
3081913|NCT01387282|3803647|FG001|COMPLETED|Overall Study||118
3081914|NCT01387282|3803646|FG000|NOT COMPLETED|Overall Study||97
3081915|NCT01387282|3803647|FG001|NOT COMPLETED|Overall Study||47
3081916|NCT01387347|3803655|FG000|STARTED|Overall Study||36
3081917|NCT01387347|3803656|FG001|STARTED|Overall Study||36
3081918|NCT01387347|3803655|FG000|COMPLETED|Overall Study||34
3081919|NCT01387347|3803656|FG001|COMPLETED|Overall Study||35
3081920|NCT01387347|3803655|FG000|NOT COMPLETED|Overall Study||2
3081921|NCT01387347|3803656|FG001|NOT COMPLETED|Overall Study||1
3081922|NCT01387464|3803668|FG000|STARTED|Overall Study||30
3081923|NCT01387464|3803669|FG001|STARTED|Overall Study||30
3081924|NCT01387464|3803668|FG000|Safety Population|Overall Study||30
3081925|NCT01387464|3803669|FG001|Safety Population|Overall Study||29
3081926|NCT01387464|3803668|FG000|Per-Protocol Population|Overall Study|Safety subjects who completed surgery|29
3081927|NCT01387464|3803669|FG001|Per-Protocol Population|Overall Study||29
3081928|NCT01387464|3803668|FG000|COMPLETED|Overall Study||29
3081929|NCT01387464|3803669|FG001|COMPLETED|Overall Study||29
3081930|NCT01387464|3803668|FG000|NOT COMPLETED|Overall Study||1
3081931|NCT01387464|3803669|FG001|NOT COMPLETED|Overall Study||1
3081932|NCT01387516|3803679|FG000|STARTED|Overall Study||80
3081933|NCT01387516|3803680|FG001|STARTED|Overall Study||68
3081934|NCT01387516|3803681|FG002|STARTED|Overall Study||79
3081935|NCT01387516|3803682|FG003|STARTED|Overall Study||69
3081936|NCT01387516|3803679|FG000|COMPLETED|Overall Study||75
3081937|NCT01387516|3803680|FG001|COMPLETED|Overall Study||63
3081938|NCT01387516|3803681|FG002|COMPLETED|Overall Study||75
3081939|NCT01387516|3803682|FG003|COMPLETED|Overall Study||65
3081940|NCT01387516|3803679|FG000|NOT COMPLETED|Overall Study||5
3081941|NCT01387516|3803680|FG001|NOT COMPLETED|Overall Study||5
3081942|NCT01387516|3803681|FG002|NOT COMPLETED|Overall Study||4
3081943|NCT01387516|3803682|FG003|NOT COMPLETED|Overall Study||4
3081944|NCT01387542|3803692|FG000|STARTED|Overall Study||40
3081945|NCT01387542|3803692|FG000|Treated|Overall Study||38
3081946|NCT01387542|3803692|FG000|COMPLETED|Overall Study||32
3081947|NCT01387542|3803692|FG000|NOT COMPLETED|Overall Study||8
3081948|NCT01387581|3803699|FG000|STARTED|Overall Study||108
3081949|NCT01387581|3803700|FG001|STARTED|Overall Study||107
3081950|NCT01387581|3803701|FG002|STARTED|Overall Study||12
3081951|NCT01387581|3803699|FG000|COMPLETED|Overall Study||101
3081952|NCT01387581|3803700|FG001|COMPLETED|Overall Study||101
3081953|NCT01387581|3803701|FG002|COMPLETED|Overall Study||9
3081954|NCT01387581|3803699|FG000|NOT COMPLETED|Overall Study||7
3081955|NCT01387581|3803700|FG001|NOT COMPLETED|Overall Study||6
3081956|NCT01387581|3803701|FG002|NOT COMPLETED|Overall Study||3
3081957|NCT01387594|3803711|FG000|STARTED|Overall Study||10
3081958|NCT01387594|3803712|FG001|STARTED|Overall Study||39
3081959|NCT01387594|3803711|FG000|COMPLETED|Overall Study||10
3081960|NCT01387594|3803712|FG001|COMPLETED|Overall Study||36
3081961|NCT01387594|3803711|FG000|NOT COMPLETED|Overall Study||0
3081962|NCT01387594|3803712|FG001|NOT COMPLETED|Overall Study||3
3081963|NCT01387607|3803723|FG000|STARTED|Overall Study||173
3081964|NCT01387607|3803724|FG001|STARTED|Overall Study||170
3081965|NCT01387607|3803723|FG000|Received Treatment|Overall Study||170
3081966|NCT01387607|3803724|FG001|Received Treatment|Overall Study||164
3081967|NCT01387607|3803723|FG000|COMPLETED|Overall Study||122
3081968|NCT01387607|3803724|FG001|COMPLETED|Overall Study||125
3081969|NCT01387607|3803723|FG000|NOT COMPLETED|Overall Study||51
3081970|NCT01387607|3803724|FG001|NOT COMPLETED|Overall Study||45
3081971|NCT01387672|3803736|FG000|STARTED|Overall Study||39
3081972|NCT01387672|3803737|FG001|STARTED|Overall Study||38
3081973|NCT01387672|3803738|FG002|STARTED|Overall Study||38
3081974|NCT01387672|3803739|FG003|STARTED|Overall Study||39
3081975|NCT01387672|3803740|FG004|STARTED|Overall Study||38
3081976|NCT01387672|3803741|FG005|STARTED|Overall Study||37
3081977|NCT01387672|3803736|FG000|COMPLETED|Overall Study||32
3081978|NCT01387672|3803737|FG001|COMPLETED|Overall Study||31
3081979|NCT01387672|3803738|FG002|COMPLETED|Overall Study||33
3081980|NCT01387672|3803739|FG003|COMPLETED|Overall Study||35
3081981|NCT01387672|3803740|FG004|COMPLETED|Overall Study||34
3081982|NCT01387672|3803741|FG005|COMPLETED|Overall Study||37
3081983|NCT01387672|3803736|FG000|NOT COMPLETED|Overall Study||7
3081984|NCT01387672|3803737|FG001|NOT COMPLETED|Overall Study||7
3081985|NCT01387672|3803738|FG002|NOT COMPLETED|Overall Study||5
3081986|NCT01387672|3803739|FG003|NOT COMPLETED|Overall Study||4
3081987|NCT01387672|3803740|FG004|NOT COMPLETED|Overall Study||4
3081988|NCT01387672|3803741|FG005|NOT COMPLETED|Overall Study||0
3081989|NCT01387737|3803758|FG000|STARTED|Overall Study||584
3081990|NCT01387737|3803759|FG001|STARTED|Overall Study||715
3081991|NCT01387737|3803758|FG000|COMPLETED|Overall Study||532
3081992|NCT01387737|3803759|FG001|COMPLETED|Overall Study||641
3081993|NCT01387737|3803758|FG000|NOT COMPLETED|Overall Study||52
3081994|NCT01387737|3803759|FG001|NOT COMPLETED|Overall Study||74
3081995|NCT01387789|3803765|FG000|STARTED|Overall Study||71
3081996|NCT01387789|3803765|FG000|COMPLETED|Overall Study||63
3081997|NCT01387789|3803765|FG000|NOT COMPLETED|Overall Study||8
3081998|NCT01387815|3803771|FG000|STARTED|Overall Study||302
3081999|NCT01387815|3803772|FG001|STARTED|Overall Study||293
3082000|NCT01387815|3803771|FG000|COMPLETED|Overall Study||162
3082001|NCT01387815|3803772|FG001|COMPLETED|Overall Study||189
3082002|NCT01387815|3803771|FG000|NOT COMPLETED|Overall Study||140
3082003|NCT01387815|3803772|FG001|NOT COMPLETED|Overall Study||104
3082004|NCT01387932|3803780|FG000|STARTED|Randomized and Treated||118
3082005|NCT01387932|3803781|FG001|STARTED|Randomized and Treated||117
3082006|NCT01387932|3803780|FG000|COMPLETED|Randomized and Treated||111
3082007|NCT01387932|3803781|FG001|COMPLETED|Randomized and Treated||113
3082008|NCT01387932|3803780|FG000|NOT COMPLETED|Randomized and Treated||7
3082009|NCT01387932|3803781|FG001|NOT COMPLETED|Randomized and Treated||4
3082010|NCT01387932|3803780|FG000|STARTED|Completion of TACE Cycle||111
3082011|NCT01387932|3803781|FG001|STARTED|Completion of TACE Cycle||113
3082012|NCT01387932|3803780|FG000|COMPLETED|Completion of TACE Cycle||111
3082013|NCT01387932|3803781|FG001|COMPLETED|Completion of TACE Cycle||113
3082014|NCT01387932|3803780|FG000|NOT COMPLETED|Completion of TACE Cycle||0
3082015|NCT01387932|3803781|FG001|NOT COMPLETED|Completion of TACE Cycle||0
3082016|NCT01387932|3803780|FG000|STARTED|Survival Follow-up||111
3286214|NCT02780687|4019835|FG000|STARTED|Overall Study||34
3286215|NCT02780687|4019836|FG001|STARTED|Overall Study||8
3286216|NCT02780687|4019835|FG000|COMPLETED|Overall Study||0
3286217|NCT02780687|4019836|FG001|COMPLETED|Overall Study||0
3286218|NCT02780687|4019835|FG000|NOT COMPLETED|Overall Study||34
3286219|NCT02780687|4019836|FG001|NOT COMPLETED|Overall Study||8
3286220|NCT02780700|4019841|FG000|STARTED|Overall Study||1
3286221|NCT02780700|4019841|FG000|COMPLETED|Overall Study||0
3286222|NCT02780700|4019841|FG000|NOT COMPLETED|Overall Study||1
3286223|NCT02780713|4019845|FG000|STARTED|Period 1: Variant A (100mg)|After washout period participants entered Treatment Period 2.|14
3286224|NCT02780713|4019846|FG001|STARTED|Period 1: Variant A (100mg)|After washout period participants entered Treatment Period 3.|0
3286225|NCT02780713|4019847|FG002|STARTED|Period 1: Variant A (100mg)|After washout period participants entered Treatment Period 4.|0
3286226|NCT02780713|4019848|FG003|STARTED|Period 1: Variant A (100mg)|After washout period participants entered Treatment Period 5.|0
3286227|NCT02780713|4019849|FG004|STARTED|Period 1: Variant A (100mg)||0
3286228|NCT02780713|4019845|FG000|COMPLETED|Period 1: Variant A (100mg)||14
3286229|NCT02780713|4019846|FG001|COMPLETED|Period 1: Variant A (100mg)||0
3286230|NCT02780713|4019847|FG002|COMPLETED|Period 1: Variant A (100mg)||0
3286231|NCT02780713|4019848|FG003|COMPLETED|Period 1: Variant A (100mg)||0
3286232|NCT02780713|4019849|FG004|COMPLETED|Period 1: Variant A (100mg)||0
3286233|NCT02780713|4019845|FG000|NOT COMPLETED|Period 1: Variant A (100mg)||0
3286234|NCT02780713|4019846|FG001|NOT COMPLETED|Period 1: Variant A (100mg)||0
3286235|NCT02780713|4019847|FG002|NOT COMPLETED|Period 1: Variant A (100mg)||0
3286236|NCT02780713|4019848|FG003|NOT COMPLETED|Period 1: Variant A (100mg)||0
3286237|NCT02780713|4019849|FG004|NOT COMPLETED|Period 1: Variant A (100mg)||0
3286238|NCT02780713|4019845|FG000|STARTED|Period 2: Reference (100mg)||0
3286239|NCT02780713|4019846|FG001|STARTED|Period 2: Reference (100mg)||14
3286240|NCT02780713|4019847|FG002|STARTED|Period 2: Reference (100mg)||0
3286241|NCT02780713|4019848|FG003|STARTED|Period 2: Reference (100mg)||0
3286242|NCT02780713|4019849|FG004|STARTED|Period 2: Reference (100mg)||0
3286243|NCT02780713|4019845|FG000|COMPLETED|Period 2: Reference (100mg)||0
3286244|NCT02780713|4019846|FG001|COMPLETED|Period 2: Reference (100mg)||14
3286245|NCT02780713|4019847|FG002|COMPLETED|Period 2: Reference (100mg)||0
3286246|NCT02780713|4019848|FG003|COMPLETED|Period 2: Reference (100mg)||0
3082017|NCT01387932|3803781|FG001|STARTED|Survival Follow-up||113
3082018|NCT01387932|3803780|FG000|COMPLETED|Survival Follow-up||27
3082019|NCT01387932|3803781|FG001|COMPLETED|Survival Follow-up||23
3082020|NCT01387932|3803780|FG000|NOT COMPLETED|Survival Follow-up||84
3082021|NCT01387932|3803781|FG001|NOT COMPLETED|Survival Follow-up||90
3082022|NCT01388166|3803789|FG000|STARTED|Overall Study||1253
3082023|NCT01388166|3803789|FG000|COMPLETED|Overall Study||1194
3082024|NCT01388166|3803789|FG000|NOT COMPLETED|Overall Study||59
3082025|NCT01388335|3803793|FG000|STARTED|Period 1||13
3082026|NCT01388335|3803793|FG000|Received at Least 1 Dose of Study Drug|Period 1||13
3082027|NCT01388335|3803793|FG000|COMPLETED|Period 1||12
3082028|NCT01388335|3803793|FG000|NOT COMPLETED|Period 1||1
3082029|NCT01388335|3803793|FG000|STARTED|Period 2||12
3082030|NCT01388335|3803793|FG000|Received at Least 1 Dose of Study Drug|Period 2||12
3082031|NCT01388335|3803793|FG000|COMPLETED|Period 2|Only 6 participants who completed Period 2 entered Safety Extension.|9
3082032|NCT01388335|3803793|FG000|NOT COMPLETED|Period 2||3
3082033|NCT01388335|3803793|FG000|STARTED|Safety Extension|Six completed Period 2 and 1 participant who discontinued Period 2 entered Safety Extension.|7
3082034|NCT01388335|3803793|FG000|COMPLETED|Safety Extension||0
3082035|NCT01388335|3803793|FG000|NOT COMPLETED|Safety Extension||7
3082036|NCT01388361|3803808|FG000|STARTED|Overall Study||236
3082037|NCT01388361|3803809|FG001|STARTED|Overall Study||88
3082038|NCT01388361|3803810|FG002|STARTED|Overall Study||89
3082039|NCT01388361|3803808|FG000|Exposed|Overall Study|Two subjects withdrew prior to exposure to IDeg during NN1250-3948|234
3082040|NCT01388361|3803809|FG001|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug.|87
3082041|NCT01388361|3803810|FG002|Exposed|Overall Study|Three subjects withdrew prior to exposure to trial drug.|86
3082042|NCT01388361|3803808|FG000|COMPLETED|Overall Study||224
3082043|NCT01388361|3803809|FG001|COMPLETED|Overall Study||76
3082044|NCT01388361|3803810|FG002|COMPLETED|Overall Study||75
3082045|NCT01388361|3803808|FG000|NOT COMPLETED|Overall Study||12
3082046|NCT01388361|3803809|FG001|NOT COMPLETED|Overall Study||12
3082047|NCT01388361|3803810|FG002|NOT COMPLETED|Overall Study||14
3082048|NCT01388478|3803818|FG000|STARTED|Overall Study||20
3082049|NCT01388478|3803818|FG000|COMPLETED|Overall Study||15
3082050|NCT01388478|3803818|FG000|NOT COMPLETED|Overall Study||5
3082051|NCT01388530|3803822|FG000|STARTED|Overall Study||25
3082052|NCT01388530|3803822|FG000|COMPLETED|Overall Study||20
3082053|NCT01388530|3803822|FG000|NOT COMPLETED|Overall Study||5
3082054|NCT01388543|3803828|FG000|STARTED|Day 7, Primary End Point||15
3082055|NCT01388543|3803829|FG001|STARTED|Day 7, Primary End Point||16
3082056|NCT01388543|3803828|FG000|COMPLETED|Day 7, Primary End Point||15
3082057|NCT01388543|3803829|FG001|COMPLETED|Day 7, Primary End Point||16
3082058|NCT01388543|3803828|FG000|NOT COMPLETED|Day 7, Primary End Point||0
3082059|NCT01388543|3803829|FG001|NOT COMPLETED|Day 7, Primary End Point||0
3082060|NCT01388543|3803828|FG000|STARTED|Day 14||15
3082061|NCT01388543|3803829|FG001|STARTED|Day 14||16
3082062|NCT01388543|3803828|FG000|COMPLETED|Day 14||14
3082063|NCT01388543|3803829|FG001|COMPLETED|Day 14||12
3082064|NCT01388543|3803828|FG000|NOT COMPLETED|Day 14||1
3082065|NCT01388543|3803829|FG001|NOT COMPLETED|Day 14||4
3082066|NCT01388647|3803837|FG000|STARTED|Overall Study||6
3286247|NCT02780713|4019849|FG004|COMPLETED|Period 2: Reference (100mg)||0
3286248|NCT02780713|4019845|FG000|NOT COMPLETED|Period 2: Reference (100mg)||0
3286249|NCT02780713|4019846|FG001|NOT COMPLETED|Period 2: Reference (100mg)||0
3286250|NCT02780713|4019847|FG002|NOT COMPLETED|Period 2: Reference (100mg)||0
3286251|NCT02780713|4019848|FG003|NOT COMPLETED|Period 2: Reference (100mg)||0
3286252|NCT02780713|4019849|FG004|NOT COMPLETED|Period 2: Reference (100mg)||0
3286253|NCT02780713|4019845|FG000|STARTED|Period 3: Variant B (100mg)||0
3286254|NCT02780713|4019846|FG001|STARTED|Period 3: Variant B (100mg)||0
3286255|NCT02780713|4019847|FG002|STARTED|Period 3: Variant B (100mg)||14
3286256|NCT02780713|4019848|FG003|STARTED|Period 3: Variant B (100mg)||0
3286257|NCT02780713|4019849|FG004|STARTED|Period 3: Variant B (100mg)||0
3286258|NCT02780713|4019845|FG000|COMPLETED|Period 3: Variant B (100mg)||0
3286259|NCT02780713|4019846|FG001|COMPLETED|Period 3: Variant B (100mg)||0
3286260|NCT02780713|4019847|FG002|COMPLETED|Period 3: Variant B (100mg)||12
3286261|NCT02780713|4019848|FG003|COMPLETED|Period 3: Variant B (100mg)||0
3286262|NCT02780713|4019849|FG004|COMPLETED|Period 3: Variant B (100mg)||0
3286263|NCT02780713|4019845|FG000|NOT COMPLETED|Period 3: Variant B (100mg)||0
3286264|NCT02780713|4019846|FG001|NOT COMPLETED|Period 3: Variant B (100mg)||0
3286265|NCT02780713|4019847|FG002|NOT COMPLETED|Period 3: Variant B (100mg)||2
3286266|NCT02780713|4019848|FG003|NOT COMPLETED|Period 3: Variant B (100mg)||0
3286267|NCT02780713|4019849|FG004|NOT COMPLETED|Period 3: Variant B (100mg)||0
3286268|NCT02780713|4019845|FG000|STARTED|Period 4: Variant C (100mg)||0
3286269|NCT02780713|4019846|FG001|STARTED|Period 4: Variant C (100mg)||0
3286270|NCT02780713|4019847|FG002|STARTED|Period 4: Variant C (100mg)||0
3286271|NCT02780713|4019848|FG003|STARTED|Period 4: Variant C (100mg)||12
3286272|NCT02780713|4019849|FG004|STARTED|Period 4: Variant C (100mg)||0
3286273|NCT02780713|4019845|FG000|COMPLETED|Period 4: Variant C (100mg)||0
3286274|NCT02780713|4019846|FG001|COMPLETED|Period 4: Variant C (100mg)||0
3286275|NCT02780713|4019847|FG002|COMPLETED|Period 4: Variant C (100mg)||0
3286276|NCT02780713|4019848|FG003|COMPLETED|Period 4: Variant C (100mg)||12
3286277|NCT02780713|4019849|FG004|COMPLETED|Period 4: Variant C (100mg)||0
3286278|NCT02780713|4019845|FG000|NOT COMPLETED|Period 4: Variant C (100mg)||0
3286279|NCT02780713|4019846|FG001|NOT COMPLETED|Period 4: Variant C (100mg)||0
3286280|NCT02780713|4019847|FG002|NOT COMPLETED|Period 4: Variant C (100mg)||0
3286281|NCT02780713|4019848|FG003|NOT COMPLETED|Period 4: Variant C (100mg)||0
3286282|NCT02780713|4019849|FG004|NOT COMPLETED|Period 4: Variant C (100mg)||0
3286283|NCT02780713|4019845|FG000|STARTED|Period 5: Variant B (300mg)||0
3286284|NCT02780713|4019846|FG001|STARTED|Period 5: Variant B (300mg)||0
3082067|NCT01388647|3803838|FG001|STARTED|Overall Study||6
3082068|NCT01388647|3803837|FG000|COMPLETED|Overall Study|one subject ended study treatment due to adverse events|5
3082069|NCT01388647|3803838|FG001|COMPLETED|Overall Study|two subjects ended study treatment due to adverse events|4
3082070|NCT01388647|3803837|FG000|NOT COMPLETED|Overall Study||1
3082071|NCT01388647|3803838|FG001|NOT COMPLETED|Overall Study||2
3082072|NCT01388777|3803845|FG000|STARTED|Overall Study||1
3082073|NCT01388777|3803845|FG000|Cryoablation|Overall Study||1
3082074|NCT01388777|3803845|FG000|COMPLETED|Overall Study||1
3082075|NCT01388777|3803845|FG000|NOT COMPLETED|Overall Study||0
3082076|NCT01388790|3803849|FG000|STARTED|Overall Study||40
3082077|NCT01388790|3803849|FG000|COMPLETED|Overall Study||32
3082078|NCT01388790|3803849|FG000|NOT COMPLETED|Overall Study||8
3082079|NCT01388816|3803857|FG000|STARTED|Overall Study||45
3082080|NCT01388816|3803858|FG001|STARTED|Overall Study||43
3082081|NCT01388816|3803859|FG002|STARTED|Overall Study||44
3082082|NCT01388816|3803860|FG003|STARTED|Overall Study||44
3082083|NCT01388816|3803857|FG000|COMPLETED|Overall Study||43
3082084|NCT01388816|3803858|FG001|COMPLETED|Overall Study||39
3082085|NCT01388816|3803859|FG002|COMPLETED|Overall Study||41
3082086|NCT01388816|3803860|FG003|COMPLETED|Overall Study||44
3082087|NCT01388816|3803857|FG000|NOT COMPLETED|Overall Study||2
3082088|NCT01388816|3803858|FG001|NOT COMPLETED|Overall Study||4
3082089|NCT01388816|3803859|FG002|NOT COMPLETED|Overall Study||3
3082090|NCT01388816|3803860|FG003|NOT COMPLETED|Overall Study||0
3082091|NCT01388907|3803875|FG000|STARTED|Overall Study||33
3082092|NCT01388907|3803876|FG001|STARTED|Overall Study||28
3082093|NCT01388907|3803875|FG000|COMPLETED|Overall Study||31
3082094|NCT01388907|3803876|FG001|COMPLETED|Overall Study||28
3082095|NCT01388907|3803875|FG000|NOT COMPLETED|Overall Study||2
3082096|NCT01388907|3803876|FG001|NOT COMPLETED|Overall Study||0
3082097|NCT01388946|3803886|FG000|STARTED|Overall Study||55
3082098|NCT01388946|3803887|FG001|STARTED|Overall Study||55
3082099|NCT01388946|3803886|FG000|COMPLETED|Overall Study||49
3082100|NCT01388946|3803887|FG001|COMPLETED|Overall Study||52
3082101|NCT01388946|3803886|FG000|NOT COMPLETED|Overall Study||6
3082102|NCT01388946|3803887|FG001|NOT COMPLETED|Overall Study||3
3082103|NCT01388985|3803895|FG000|STARTED|Overall Study|1 participant (from the 250 enrolled) did not receive any vaccination because of consent withdrawal.|249
3082104|NCT01388985|3803896|FG001|STARTED|Overall Study|1 participant (from the 250 enrolled) did not receive any vaccination because of consent withdrawal.|249
3082105|NCT01388985|3803895|FG000|Primary Vaccination Period|Overall Study||231
3082106|NCT01388985|3803896|FG001|Primary Vaccination Period|Overall Study||238
3082107|NCT01388985|3803895|FG000|COMPLETED|Overall Study|From those 200, 15 were excluded from the per protocol analysis.|200
3082108|NCT01388985|3803896|FG001|COMPLETED|Overall Study|From those 200, 28 were excluded from the per protocol analysis.|211
3082109|NCT01388985|3803895|FG000|NOT COMPLETED|Overall Study||49
3082110|NCT01388985|3803896|FG001|NOT COMPLETED|Overall Study||38
3082111|NCT01389076|3803902|FG000|STARTED|Overall Study||22
3082112|NCT01389076|3803902|FG000|COMPLETED|Overall Study||22
3082113|NCT01389076|3803902|FG000|NOT COMPLETED|Overall Study||0
3082114|NCT01389102|3803912|FG000|STARTED|Overall Study||75
3082115|NCT01389102|3803913|FG001|STARTED|Overall Study||76
3082116|NCT01389102|3803914|FG002|STARTED|Overall Study||77
3082117|NCT01389102|3803915|FG003|STARTED|Overall Study||76
3082118|NCT01389102|3803916|FG004|STARTED|Overall Study||74
3082119|NCT01389102|3803917|FG005|STARTED|Overall Study||76
3082120|NCT01389102|3803912|FG000|COMPLETED|Overall Study||57
3082121|NCT01389102|3803913|FG001|COMPLETED|Overall Study||64
3082122|NCT01389102|3803914|FG002|COMPLETED|Overall Study||58
3082123|NCT01389102|3803915|FG003|COMPLETED|Overall Study||69
3082124|NCT01389102|3803916|FG004|COMPLETED|Overall Study||61
3082125|NCT01389102|3803917|FG005|COMPLETED|Overall Study||68
3082126|NCT01389102|3803912|FG000|NOT COMPLETED|Overall Study||18
3082127|NCT01389102|3803913|FG001|NOT COMPLETED|Overall Study||12
3082128|NCT01389102|3803914|FG002|NOT COMPLETED|Overall Study||19
3082129|NCT01389102|3803915|FG003|NOT COMPLETED|Overall Study||7
3082130|NCT01389102|3803916|FG004|NOT COMPLETED|Overall Study||13
3082131|NCT01389102|3803917|FG005|NOT COMPLETED|Overall Study||8
3082132|NCT01389128|3803939|FG000|STARTED|Overall Study||40
3082133|NCT01389128|3803940|FG001|STARTED|Overall Study||40
3082134|NCT01389128|3803939|FG000|COMPLETED|Overall Study||35
3082135|NCT01389128|3803940|FG001|COMPLETED|Overall Study||34
3082136|NCT01389128|3803939|FG000|NOT COMPLETED|Overall Study||5
3082137|NCT01389128|3803940|FG001|NOT COMPLETED|Overall Study||6
3082138|NCT01389232|3803950|FG000|STARTED|Overall Study||100
3082139|NCT01389232|3803950|FG000|COMPLETED|Overall Study||81
3082140|NCT01389232|3803950|FG000|NOT COMPLETED|Overall Study||19
3082141|NCT01389245|3803964|FG000|STARTED|Overall Study||42
3286285|NCT02780713|4019847|FG002|STARTED|Period 5: Variant B (300mg)||0
3286286|NCT02780713|4019848|FG003|STARTED|Period 5: Variant B (300mg)||0
3286287|NCT02780713|4019849|FG004|STARTED|Period 5: Variant B (300mg)||12
3286288|NCT02780713|4019845|FG000|COMPLETED|Period 5: Variant B (300mg)||0
3286289|NCT02780713|4019846|FG001|COMPLETED|Period 5: Variant B (300mg)||0
3286290|NCT02780713|4019847|FG002|COMPLETED|Period 5: Variant B (300mg)||0
3286291|NCT02780713|4019848|FG003|COMPLETED|Period 5: Variant B (300mg)||0
3286292|NCT02780713|4019849|FG004|COMPLETED|Period 5: Variant B (300mg)||12
3286293|NCT02780713|4019845|FG000|NOT COMPLETED|Period 5: Variant B (300mg)||0
3286294|NCT02780713|4019846|FG001|NOT COMPLETED|Period 5: Variant B (300mg)||0
3286295|NCT02780713|4019847|FG002|NOT COMPLETED|Period 5: Variant B (300mg)||0
3082142|NCT01389245|3803964|FG000|COMPLETED|Overall Study||27
3082143|NCT01389245|3803964|FG000|NOT COMPLETED|Overall Study||15
3082144|NCT01389258|3803968|FG000|STARTED|Overall Study||45
3082145|NCT01389258|3803968|FG000|COMPLETED|Overall Study||40
3082146|NCT01389258|3803968|FG000|NOT COMPLETED|Overall Study||5
3082147|NCT01389284|3803975|FG000|STARTED|Overall Study||120
3082148|NCT01389284|3803976|FG001|STARTED|Overall Study||120
3082149|NCT01389284|3803977|FG002|STARTED|Overall Study||60
3082150|NCT01389284|3803975|FG000|COMPLETED|Overall Study||120
3082151|NCT01389284|3803976|FG001|COMPLETED|Overall Study||120
3082152|NCT01389284|3803977|FG002|COMPLETED|Overall Study||60
3082153|NCT01389284|3803975|FG000|NOT COMPLETED|Overall Study||0
3082154|NCT01389284|3803976|FG001|NOT COMPLETED|Overall Study||0
3082155|NCT01389284|3803977|FG002|NOT COMPLETED|Overall Study||0
3082156|NCT01389323|3803985|FG000|STARTED|Treatment Period (up to 48 Weeks)||246
3082157|NCT01389323|3803985|FG000|COMPLETED|Treatment Period (up to 48 Weeks)||151
3082158|NCT01389323|3803985|FG000|NOT COMPLETED|Treatment Period (up to 48 Weeks)||95
3082159|NCT01389323|3803985|FG000|STARTED|Follow-up Period (up to 48 Weeks)|Out of 246 participants who entered the treatment period, 221 continued in the follow-up period.|221
3082160|NCT01389323|3803985|FG000|COMPLETED|Follow-up Period (up to 48 Weeks)||184
3082161|NCT01389323|3803985|FG000|NOT COMPLETED|Follow-up Period (up to 48 Weeks)||37
3082162|NCT01389596|3803999|FG000|STARTED|Overall Study||104
3082163|NCT01389596|3804000|FG001|STARTED|Overall Study||97
3082164|NCT01389596|3804001|FG002|STARTED|Overall Study||94
3082165|NCT01389596|3803999|FG000|COMPLETED|Overall Study||94
3082166|NCT01389596|3804000|FG001|COMPLETED|Overall Study||81
3082167|NCT01389596|3804001|FG002|COMPLETED|Overall Study||84
3082168|NCT01389596|3803999|FG000|NOT COMPLETED|Overall Study||10
3082169|NCT01389596|3804000|FG001|NOT COMPLETED|Overall Study||16
3082170|NCT01389596|3804001|FG002|NOT COMPLETED|Overall Study||10
3082171|NCT01389752|3804009|FG000|STARTED|Study Period 1||11
3082172|NCT01389752|3804010|FG001|STARTED|Study Period 1||11
3082173|NCT01389752|3804009|FG000|COMPLETED|Study Period 1||11
3082174|NCT01389752|3804010|FG001|COMPLETED|Study Period 1||9
3082175|NCT01389752|3804009|FG000|NOT COMPLETED|Study Period 1||0
3082176|NCT01389752|3804010|FG001|NOT COMPLETED|Study Period 1||2
3082177|NCT01389752|3804009|FG000|STARTED|Study Period 2||11
3082178|NCT01389752|3804010|FG001|STARTED|Study Period 2||9
3082179|NCT01389752|3804009|FG000|COMPLETED|Study Period 2||10
3082180|NCT01389752|3804010|FG001|COMPLETED|Study Period 2||9
3082181|NCT01389752|3804009|FG000|NOT COMPLETED|Study Period 2||1
3082182|NCT01389752|3804010|FG001|NOT COMPLETED|Study Period 2||0
3082183|NCT01389765|3804017|FG000|STARTED|First Intervention (Day 1)||12
3082184|NCT01389765|3804018|FG001|STARTED|First Intervention (Day 1)||12
3082185|NCT01389765|3804017|FG000|COMPLETED|First Intervention (Day 1)||12
3082186|NCT01389765|3804018|FG001|COMPLETED|First Intervention (Day 1)||12
3082187|NCT01389765|3804017|FG000|NOT COMPLETED|First Intervention (Day 1)||0
3082188|NCT01389765|3804018|FG001|NOT COMPLETED|First Intervention (Day 1)||0
3082189|NCT01389765|3804017|FG000|STARTED|Washout Period (7 Days)||12
3082190|NCT01389765|3804018|FG001|STARTED|Washout Period (7 Days)||12
3082191|NCT01389765|3804017|FG000|COMPLETED|Washout Period (7 Days)||12
3082192|NCT01389765|3804018|FG001|COMPLETED|Washout Period (7 Days)||12
3082193|NCT01389765|3804017|FG000|NOT COMPLETED|Washout Period (7 Days)||0
3082194|NCT01389765|3804018|FG001|NOT COMPLETED|Washout Period (7 Days)||0
3082195|NCT01389765|3804017|FG000|STARTED|Second Intervention (Day 1)||12
3082196|NCT01389765|3804018|FG001|STARTED|Second Intervention (Day 1)||12
3082197|NCT01389765|3804017|FG000|COMPLETED|Second Intervention (Day 1)||12
3082198|NCT01389765|3804018|FG001|COMPLETED|Second Intervention (Day 1)||12
3082199|NCT01389765|3804017|FG000|NOT COMPLETED|Second Intervention (Day 1)||0
3082200|NCT01389765|3804018|FG001|NOT COMPLETED|Second Intervention (Day 1)||0
3082201|NCT01389856|3804026|FG000|STARTED|Overall Study|Randomized and treated. An additional 2 patients were randomized but not treated.|13
3082202|NCT01389856|3804027|FG001|STARTED|Overall Study|Randomized and treated.|8
3082203|NCT01389856|3804026|FG000|COMPLETED|Overall Study||13
3082204|NCT01389856|3804027|FG001|COMPLETED|Overall Study||8
3082205|NCT01389856|3804026|FG000|NOT COMPLETED|Overall Study||0
3082206|NCT01389856|3804027|FG001|NOT COMPLETED|Overall Study||0
3082207|NCT01389882|3804035|FG000|STARTED|Overall Study||13
3082208|NCT01389882|3804036|FG001|STARTED|Overall Study||11
3082209|NCT01389882|3804035|FG000|COMPLETED|Overall Study||12
3082210|NCT01389882|3804036|FG001|COMPLETED|Overall Study||7
3082211|NCT01389882|3804035|FG000|NOT COMPLETED|Overall Study||1
3082212|NCT01389882|3804036|FG001|NOT COMPLETED|Overall Study||4
3082213|NCT01389973|3804042|FG000|STARTED|Overall Study||20
3082214|NCT01389973|3804042|FG000|COMPLETED|Overall Study||0
3082215|NCT01389973|3804042|FG000|NOT COMPLETED|Overall Study||20
3082216|NCT01390038|3804046|FG000|STARTED|Overall Study||157
3082217|NCT01390038|3804046|FG000|COMPLETED|Overall Study||149
3082218|NCT01390038|3804046|FG000|NOT COMPLETED|Overall Study||8
3082219|NCT01390064|3804052|FG000|STARTED|Overall Study||3
3082220|NCT01390064|3804053|FG001|STARTED|Overall Study||3
3082221|NCT01390064|3804052|FG000|COMPLETED|Overall Study||3
3082222|NCT01390064|3804053|FG001|COMPLETED|Overall Study||3
3082223|NCT01390064|3804052|FG000|NOT COMPLETED|Overall Study||0
3082224|NCT01390064|3804053|FG001|NOT COMPLETED|Overall Study||0
3082225|NCT01390077|3804059|FG000|STARTED|Overall Study||8
3082226|NCT01390077|3804059|FG000|Treatment|Overall Study||7
3082227|NCT01390077|3804059|FG000|COMPLETED|Overall Study||7
3082228|NCT01390077|3804059|FG000|NOT COMPLETED|Overall Study||1
3082229|NCT01390220|3804068|FG000|STARTED|Test Dose Phase||292
3082230|NCT01390220|3804069|FG001|STARTED|Test Dose Phase|This arm not applicable in TDP.|0
3082231|NCT01390220|3804070|FG002|STARTED|Test Dose Phase|This arm not applicable in TDP.|0
3082232|NCT01390220|3804068|FG000|COMPLETED|Test Dose Phase||201
3082233|NCT01390220|3804069|FG001|COMPLETED|Test Dose Phase||0
3082234|NCT01390220|3804070|FG002|COMPLETED|Test Dose Phase||0
3082235|NCT01390220|3804068|FG000|NOT COMPLETED|Test Dose Phase||91
3082236|NCT01390220|3804069|FG001|NOT COMPLETED|Test Dose Phase||0
3082237|NCT01390220|3804070|FG002|NOT COMPLETED|Test Dose Phase||0
3082238|NCT01390220|3804068|FG000|STARTED|Comparative Phase|This arm not applicable in CP|0
3082239|NCT01390220|3804069|FG001|STARTED|Comparative Phase||134
3082240|NCT01390220|3804070|FG002|STARTED|Comparative Phase||67
3082241|NCT01390220|3804068|FG000|COMPLETED|Comparative Phase|This arm not applicable in CP|0
3082242|NCT01390220|3804069|FG001|COMPLETED|Comparative Phase||133
3082243|NCT01390220|3804070|FG002|COMPLETED|Comparative Phase||67
3082244|NCT01390220|3804068|FG000|NOT COMPLETED|Comparative Phase||0
3082245|NCT01390220|3804069|FG001|NOT COMPLETED|Comparative Phase||1
3082246|NCT01390220|3804070|FG002|NOT COMPLETED|Comparative Phase||0
3082247|NCT01390233|3804082|FG000|STARTED|Overall Study||35
3082248|NCT01390233|3804083|FG001|STARTED|Overall Study||31
3082249|NCT01390233|3804084|FG002|STARTED|Overall Study||36
3082250|NCT01390233|3804082|FG000|COMPLETED|Overall Study||30
3286296|NCT02780713|4019848|FG003|NOT COMPLETED|Period 5: Variant B (300mg)||0
3286297|NCT02780713|4019849|FG004|NOT COMPLETED|Period 5: Variant B (300mg)||0
3286298|NCT02780765|4019870|FG000|STARTED|Overall Study||30
3286299|NCT02780765|4019871|FG001|STARTED|Overall Study||30
3286300|NCT02780765|4019870|FG000|COMPLETED|Overall Study||30
3286301|NCT02780765|4019871|FG001|COMPLETED|Overall Study||30
3286302|NCT02780765|4019870|FG000|NOT COMPLETED|Overall Study||0
3082251|NCT01390233|3804083|FG001|COMPLETED|Overall Study||29
3082252|NCT01390233|3804084|FG002|COMPLETED|Overall Study||30
3082253|NCT01390233|3804082|FG000|NOT COMPLETED|Overall Study||5
3082254|NCT01390233|3804083|FG001|NOT COMPLETED|Overall Study||2
3082255|NCT01390233|3804084|FG002|NOT COMPLETED|Overall Study||6
3082256|NCT01390246|3804094|FG000|STARTED|Overall Study||30
3082257|NCT01390246|3804095|FG001|STARTED|Overall Study||35
3082258|NCT01390246|3804094|FG000|Visit 2: Quit Day|Overall Study||24
3082259|NCT01390246|3804095|FG001|Visit 2: Quit Day|Overall Study||24
3082260|NCT01390246|3804094|FG000|Visit 6: End of Treatment|Overall Study||15
3082261|NCT01390246|3804095|FG001|Visit 6: End of Treatment|Overall Study||15
3082262|NCT01390246|3804094|FG000|Visit 7: 36-38 Weeks Gestation|Overall Study||10
3082263|NCT01390246|3804095|FG001|Visit 7: 36-38 Weeks Gestation|Overall Study||10
3082264|NCT01390246|3804094|FG000|COMPLETED|Overall Study||10
3082265|NCT01390246|3804095|FG001|COMPLETED|Overall Study||10
3082266|NCT01390246|3804094|FG000|NOT COMPLETED|Overall Study||20
3082267|NCT01390246|3804095|FG001|NOT COMPLETED|Overall Study||25
3082268|NCT01390259|3804101|FG000|STARTED|Overall Study||5
3082269|NCT01390259|3804102|FG001|STARTED|Overall Study||6
3082270|NCT01390259|3804101|FG000|COMPLETED|Overall Study||5
3082271|NCT01390259|3804102|FG001|COMPLETED|Overall Study||6
3082272|NCT01390259|3804101|FG000|NOT COMPLETED|Overall Study||0
3082273|NCT01390259|3804102|FG001|NOT COMPLETED|Overall Study||0
3134818|NCT01702961|3859743|FG000|NOT COMPLETED|Overall Study||47
3134819|NCT01702987|3859749|FG000|STARTED|Overall Study||10
3134820|NCT01702987|3859750|FG001|STARTED|Overall Study||12
3134821|NCT01702987|3859749|FG000|COMPLETED|Overall Study||9
3134822|NCT01702987|3859750|FG001|COMPLETED|Overall Study||12
3134823|NCT01702987|3859749|FG000|NOT COMPLETED|Overall Study||1
3134824|NCT01702987|3859750|FG001|NOT COMPLETED|Overall Study||0
3134825|NCT01703000|3859756|FG000|STARTED|Overall Study||100
3134826|NCT01703000|3859756|FG000|COMPLETED|Overall Study||99
3134827|NCT01703000|3859756|FG000|NOT COMPLETED|Overall Study||1
3134828|NCT01703039|3859762|FG000|STARTED|Overall Study||9
3134829|NCT01703039|3859763|FG001|STARTED|Overall Study||12
3134830|NCT01703039|3859762|FG000|COMPLETED|Overall Study||6
3134831|NCT01703039|3859763|FG001|COMPLETED|Overall Study||7
3134832|NCT01703039|3859762|FG000|NOT COMPLETED|Overall Study||3
3134833|NCT01703039|3859763|FG001|NOT COMPLETED|Overall Study||5
3134834|NCT01703065|3859773|FG000|STARTED|Overall Study||9
3134835|NCT01703065|3859774|FG001|STARTED|Overall Study||0
3134836|NCT01703065|3859773|FG000|COMPLETED|Overall Study||8
3134837|NCT01703065|3859774|FG001|COMPLETED|Overall Study||0
3134838|NCT01703065|3859773|FG000|NOT COMPLETED|Overall Study||1
3134839|NCT01703065|3859774|FG001|NOT COMPLETED|Overall Study||0
3134840|NCT01703091|3859783|FG000|STARTED|Overall Study||98
3134841|NCT01703091|3859784|FG001|STARTED|Overall Study||99
3134842|NCT01703091|3859783|FG000|Received at Least One Dose of Study Drug|Overall Study||94
3134843|NCT01703091|3859784|FG001|Received at Least One Dose of Study Drug|Overall Study||98
3134844|NCT01703091|3859783|FG000|COMPLETED|Overall Study||89
3134845|NCT01703091|3859784|FG001|COMPLETED|Overall Study||95
3134846|NCT01703091|3859783|FG000|NOT COMPLETED|Overall Study||9
3134847|NCT01703091|3859784|FG001|NOT COMPLETED|Overall Study||4
3134848|NCT01703117|3859792|FG000|STARTED|Overall Study||26
3134849|NCT01703117|3859793|FG001|STARTED|Overall Study||24
3134850|NCT01703117|3859792|FG000|COMPLETED|Overall Study||22
3134851|NCT01703117|3859793|FG001|COMPLETED|Overall Study||20
3134852|NCT01703117|3859792|FG000|NOT COMPLETED|Overall Study||4
3134853|NCT01703117|3859793|FG001|NOT COMPLETED|Overall Study||4
3286303|NCT02780765|4019871|FG001|NOT COMPLETED|Overall Study||0
3286304|NCT02780856|4019877|FG000|STARTED|Overall Study||110
3286305|NCT02780856|4019877|FG000|COMPLETED|Overall Study||109
3082274|NCT01390272|3804109|FG000|STARTED|Overall Study||192
3082275|NCT01390272|3804110|FG001|STARTED|Overall Study||193
3082276|NCT01390272|3804109|FG000|6 Month Follow up|Overall Study|30 of 192 participants in the Titration Intervention group had missing blood pressure measurement|162
3082277|NCT01390272|3804110|FG001|6 Month Follow up|Overall Study|22 of 193 in the LPN control group had missing blood pressure measurement|171
3082278|NCT01390272|3804109|FG000|12 Month Follow up|Overall Study|53 of 192 participants in the Titration Intervention group had missing measurement|139
3082279|NCT01390272|3804110|FG001|12 Month Follow up|Overall Study|34 of 193 in the LPN control group had missing blood pressure measurement|159
3082280|NCT01390272|3804109|FG000|18 Month Follow up|Overall Study|37 of 192 participants in the Titration Intervention group had missing blood pressure measurement|155
3082281|NCT01390272|3804110|FG001|18 Month Follow up|Overall Study|33 of 193 in the LPN control group had missing blood pressure measurement|160
3082282|NCT01390272|3804109|FG000|COMPLETED|Overall Study||175
3082283|NCT01390272|3804110|FG001|COMPLETED|Overall Study||178
3082284|NCT01390272|3804109|FG000|NOT COMPLETED|Overall Study||17
3082285|NCT01390272|3804110|FG001|NOT COMPLETED|Overall Study||15
3082286|NCT01390298|3804116|FG000|STARTED|Overall Study||55
3082287|NCT01390298|3804116|FG000|COMPLETED|Overall Study||31
3082288|NCT01390298|3804116|FG000|NOT COMPLETED|Overall Study||24
3082289|NCT01390389|3804122|FG000|STARTED|Overall Study||10
3082290|NCT01390389|3804123|FG001|STARTED|Overall Study||9
3082291|NCT01390389|3804122|FG000|COMPLETED|Overall Study||6
3082292|NCT01390389|3804123|FG001|COMPLETED|Overall Study||8
3082293|NCT01390389|3804122|FG000|NOT COMPLETED|Overall Study||4
3082294|NCT01390389|3804123|FG001|NOT COMPLETED|Overall Study||1
3082295|NCT01390402|3804133|FG000|STARTED|Overall Study||6
3082296|NCT01390402|3804133|FG000|COMPLETED|Overall Study||1
3082297|NCT01390402|3804133|FG000|NOT COMPLETED|Overall Study||5
3082298|NCT01390428|3804143|FG000|STARTED|Overall Study||8
3082299|NCT01390428|3804144|FG001|STARTED|Overall Study||8
3082300|NCT01390428|3804145|FG002|STARTED|Overall Study||9
3082301|NCT01390428|3804146|FG003|STARTED|Overall Study||9
3082302|NCT01390428|3804147|FG004|STARTED|Overall Study||8
3082303|NCT01390428|3804148|FG005|STARTED|Overall Study||8
3082304|NCT01390428|3804143|FG000|COMPLETED|Overall Study||8
3082305|NCT01390428|3804144|FG001|COMPLETED|Overall Study||8
3082306|NCT01390428|3804145|FG002|COMPLETED|Overall Study||8
3082307|NCT01390428|3804146|FG003|COMPLETED|Overall Study||9
3082308|NCT01390428|3804147|FG004|COMPLETED|Overall Study||7
3082309|NCT01390428|3804148|FG005|COMPLETED|Overall Study||8
3082310|NCT01390428|3804143|FG000|NOT COMPLETED|Overall Study||0
3082311|NCT01390428|3804144|FG001|NOT COMPLETED|Overall Study||0
3082312|NCT01390428|3804145|FG002|NOT COMPLETED|Overall Study||1
3082313|NCT01390428|3804146|FG003|NOT COMPLETED|Overall Study||0
3082314|NCT01390428|3804147|FG004|NOT COMPLETED|Overall Study||1
3082315|NCT01390428|3804148|FG005|NOT COMPLETED|Overall Study||0
3082316|NCT01390441|3804167|FG000|STARTED|Treatment Period||23
3082317|NCT01390441|3804168|FG001|STARTED|Treatment Period||22
3082318|NCT01390441|3804169|FG002|STARTED|Treatment Period||18
3082319|NCT01390441|3804170|FG003|STARTED|Treatment Period||19
3082320|NCT01390441|3804171|FG004|STARTED|Treatment Period||18
3082321|NCT01390441|3804167|FG000|COMPLETED|Treatment Period||22
3082322|NCT01390441|3804168|FG001|COMPLETED|Treatment Period||21
3082323|NCT01390441|3804169|FG002|COMPLETED|Treatment Period||8
3082324|NCT01390441|3804170|FG003|COMPLETED|Treatment Period||6
3082325|NCT01390441|3804171|FG004|COMPLETED|Treatment Period||7
3082326|NCT01390441|3804167|FG000|NOT COMPLETED|Treatment Period||1
3082327|NCT01390441|3804168|FG001|NOT COMPLETED|Treatment Period||1
3082328|NCT01390441|3804169|FG002|NOT COMPLETED|Treatment Period||10
3082329|NCT01390441|3804170|FG003|NOT COMPLETED|Treatment Period||13
3082330|NCT01390441|3804171|FG004|NOT COMPLETED|Treatment Period||11
3082331|NCT01390441|3804167|FG000|STARTED|Extension Period|Not all participants entered the Extension Period due to early termination of the study.|15
3082332|NCT01390441|3804168|FG001|STARTED|Extension Period|Not all participants entered the Extension Period due to early termination of the study.|13
3082333|NCT01390441|3804169|FG002|STARTED|Extension Period|Not all participants entered the Extension Period due to early termination of the study.|1
3082334|NCT01390441|3804170|FG003|STARTED|Extension Period|Not all participants entered the Extension Period due to early termination of the study.|1
3082335|NCT01390441|3804171|FG004|STARTED|Extension Period|Not all participants entered the Extension Period due to early termination of the study.|3
3082336|NCT01390441|3804167|FG000|COMPLETED|Extension Period||12
3082337|NCT01390441|3804168|FG001|COMPLETED|Extension Period||12
3082338|NCT01390441|3804169|FG002|COMPLETED|Extension Period||1
3082339|NCT01390441|3804170|FG003|COMPLETED|Extension Period||0
3082340|NCT01390441|3804171|FG004|COMPLETED|Extension Period||3
3082341|NCT01390441|3804167|FG000|NOT COMPLETED|Extension Period||3
3082342|NCT01390441|3804168|FG001|NOT COMPLETED|Extension Period||1
3082343|NCT01390441|3804169|FG002|NOT COMPLETED|Extension Period||0
3082344|NCT01390441|3804170|FG003|NOT COMPLETED|Extension Period||1
3082345|NCT01390441|3804171|FG004|NOT COMPLETED|Extension Period||0
3082346|NCT01390584|3804211|FG000|STARTED|Step 1: Induction Tx (ABVD Then PET/CT)||4
3082347|NCT01390584|3804212|FG001|STARTED|Step 1: Induction Tx (ABVD Then PET/CT)||1
3082348|NCT01390584|3804213|FG002|STARTED|Step 1: Induction Tx (ABVD Then PET/CT)||1
3082349|NCT01390584|3804211|FG000|COMPLETED|Step 1: Induction Tx (ABVD Then PET/CT)||4
3082350|NCT01390584|3804212|FG001|COMPLETED|Step 1: Induction Tx (ABVD Then PET/CT)||1
3082351|NCT01390584|3804213|FG002|COMPLETED|Step 1: Induction Tx (ABVD Then PET/CT)||0
3082352|NCT01390584|3804211|FG000|NOT COMPLETED|Step 1: Induction Tx (ABVD Then PET/CT)||0
3082353|NCT01390584|3804212|FG001|NOT COMPLETED|Step 1: Induction Tx (ABVD Then PET/CT)||0
3082354|NCT01390584|3804213|FG002|NOT COMPLETED|Step 1: Induction Tx (ABVD Then PET/CT)||1
3082355|NCT01390584|3804211|FG000|STARTED|Step 2: ABVD or BEACOPP Then INRT||4
3082356|NCT01390584|3804212|FG001|STARTED|Step 2: ABVD or BEACOPP Then INRT||1
3082357|NCT01390584|3804213|FG002|STARTED|Step 2: ABVD or BEACOPP Then INRT||0
3082358|NCT01390584|3804211|FG000|COMPLETED|Step 2: ABVD or BEACOPP Then INRT||4
3082359|NCT01390584|3804212|FG001|COMPLETED|Step 2: ABVD or BEACOPP Then INRT||1
3082360|NCT01390584|3804213|FG002|COMPLETED|Step 2: ABVD or BEACOPP Then INRT||0
3082361|NCT01390584|3804211|FG000|NOT COMPLETED|Step 2: ABVD or BEACOPP Then INRT||0
3082362|NCT01390584|3804212|FG001|NOT COMPLETED|Step 2: ABVD or BEACOPP Then INRT||0
3082363|NCT01390584|3804213|FG002|NOT COMPLETED|Step 2: ABVD or BEACOPP Then INRT||0
3082364|NCT01390649|3804222|FG000|STARTED|Overall Study|Subjects treated with Privigen|57
3082365|NCT01390649|3804222|FG000|COMPLETED|Overall Study||56
3082366|NCT01390649|3804222|FG000|NOT COMPLETED|Overall Study||1
3082367|NCT01390779|3804226|FG000|STARTED|Overall Study||33
3082368|NCT01390779|3804226|FG000|COMPLETED|Overall Study||32
3082369|NCT01390779|3804226|FG000|NOT COMPLETED|Overall Study||1
3082370|NCT01390818|3804245|FG000|STARTED|Overall Study||3
3082371|NCT01390818|3804246|FG001|STARTED|Overall Study||3
3082372|NCT01390818|3804247|FG002|STARTED|Overall Study||3
3082373|NCT01390818|3804248|FG003|STARTED|Overall Study||4
3082374|NCT01390818|3804249|FG004|STARTED|Overall Study||4
3082375|NCT01390818|3804250|FG005|STARTED|Overall Study||3
3082376|NCT01390818|3804251|FG006|STARTED|Overall Study||19
3082377|NCT01390818|3804252|FG007|STARTED|Overall Study||14
3082378|NCT01390818|3804253|FG008|STARTED|Overall Study||3
3082379|NCT01390818|3804254|FG009|STARTED|Overall Study||3
3082380|NCT01390818|3804255|FG010|STARTED|Overall Study||4
3082381|NCT01390818|3804256|FG011|STARTED|Overall Study||26
3082382|NCT01390818|3804257|FG012|STARTED|Overall Study||24
3082383|NCT01390818|3804258|FG013|STARTED|Overall Study||18
3082384|NCT01390818|3804259|FG014|STARTED|Overall Study||15
3082385|NCT01390818|3804245|FG000|COMPLETED|Overall Study||3
3082386|NCT01390818|3804246|FG001|COMPLETED|Overall Study||3
3286306|NCT02780856|4019877|FG000|NOT COMPLETED|Overall Study||1
3286307|NCT02780869|4019886|FG000|STARTED|Overall Study||175
3286308|NCT02780869|4019887|FG001|STARTED|Overall Study||83
3286309|NCT02780869|4019886|FG000|COMPLETED|Overall Study||162
3286310|NCT02780869|4019887|FG001|COMPLETED|Overall Study||74
3286311|NCT02780869|4019886|FG000|NOT COMPLETED|Overall Study||13
3286312|NCT02780869|4019887|FG001|NOT COMPLETED|Overall Study||9
3286313|NCT02781051|4019893|FG000|STARTED|Overall Study||16
3286314|NCT02781051|4019893|FG000|COMPLETED|Overall Study||14
3286315|NCT02781051|4019893|FG000|NOT COMPLETED|Overall Study||2
3286316|NCT02781311|4019901|FG000|STARTED|Overall Study||74
3286317|NCT02781311|4019902|FG001|STARTED|Overall Study||83
3286318|NCT02781311|4019903|FG002|STARTED|Overall Study||12
3286319|NCT02781311|4019901|FG000|Safety Population (Treated)|Overall Study||73
3286320|NCT02781311|4019902|FG001|Safety Population (Treated)|Overall Study||81
3286321|NCT02781311|4019903|FG002|Safety Population (Treated)|Overall Study||12
3286322|NCT02781311|4019901|FG000|mITT Population|Overall Study||70
3286323|NCT02781311|4019902|FG001|mITT Population|Overall Study||78
3286324|NCT02781311|4019903|FG002|mITT Population|Overall Study||11
3286325|NCT02781311|4019901|FG000|COMPLETED|Overall Study||48
3286326|NCT02781311|4019902|FG001|COMPLETED|Overall Study||57
3286327|NCT02781311|4019903|FG002|COMPLETED|Overall Study||8
3286328|NCT02781311|4019901|FG000|NOT COMPLETED|Overall Study||26
3286329|NCT02781311|4019902|FG001|NOT COMPLETED|Overall Study||26
3286330|NCT02781311|4019903|FG002|NOT COMPLETED|Overall Study||4
3286331|NCT02781324|4019912|FG000|STARTED|Overall Study||33
3286332|NCT02781324|4019913|FG001|STARTED|Overall Study||33
3286333|NCT02781324|4019912|FG000|COMPLETED|Overall Study||31
3286334|NCT02781324|4019913|FG001|COMPLETED|Overall Study||31
3286335|NCT02781324|4019912|FG000|NOT COMPLETED|Overall Study||2
3286336|NCT02781324|4019913|FG001|NOT COMPLETED|Overall Study||2
3286337|NCT02781454|4019924|FG000|STARTED|Overall Study||8
3286338|NCT02781454|4019925|FG001|STARTED|Overall Study||6
3286339|NCT02781454|4019926|FG002|STARTED|Overall Study||6
3286340|NCT02781454|4019924|FG000|COMPLETED|Overall Study||8
3286341|NCT02781454|4019925|FG001|COMPLETED|Overall Study||6
3286342|NCT02781454|4019926|FG002|COMPLETED|Overall Study||5
3286343|NCT02781454|4019924|FG000|NOT COMPLETED|Overall Study||0
3286344|NCT02781454|4019925|FG001|NOT COMPLETED|Overall Study||0
3286345|NCT02781454|4019926|FG002|NOT COMPLETED|Overall Study||1
3286346|NCT02781480|4019937|FG000|STARTED|Overall Study||9
3286347|NCT02781480|4019938|FG001|STARTED|Overall Study||3
3286348|NCT02781480|4019939|FG002|STARTED|Overall Study||3
3286349|NCT02781480|4019937|FG000|COMPLETED|Overall Study||9
3286350|NCT02781480|4019938|FG001|COMPLETED|Overall Study||3
3286351|NCT02781480|4019939|FG002|COMPLETED|Overall Study||3
3286352|NCT02781480|4019937|FG000|NOT COMPLETED|Overall Study||0
3286353|NCT02781480|4019938|FG001|NOT COMPLETED|Overall Study||0
3286354|NCT02781480|4019939|FG002|NOT COMPLETED|Overall Study||0
3286355|NCT02781558|4019949|FG000|STARTED|Overall Study||101
3082387|NCT01390818|3804247|FG002|COMPLETED|Overall Study||3
3286356|NCT02781558|4019950|FG001|STARTED|Overall Study||103
3286357|NCT02781558|4019949|FG000|COMPLETED|Overall Study||98
3286358|NCT02781558|4019950|FG001|COMPLETED|Overall Study||101
3286359|NCT02781558|4019949|FG000|NOT COMPLETED|Overall Study||3
3286360|NCT02781558|4019950|FG001|NOT COMPLETED|Overall Study||2
3286361|NCT02781571|4019957|FG000|STARTED|Overall Study||79
3082388|NCT01390818|3804248|FG003|COMPLETED|Overall Study||4
3082389|NCT01390818|3804249|FG004|COMPLETED|Overall Study||4
3082390|NCT01390818|3804250|FG005|COMPLETED|Overall Study||3
3082391|NCT01390818|3804251|FG006|COMPLETED|Overall Study||19
3082392|NCT01390818|3804252|FG007|COMPLETED|Overall Study||14
3082393|NCT01390818|3804253|FG008|COMPLETED|Overall Study||3
3082394|NCT01390818|3804254|FG009|COMPLETED|Overall Study||3
3082395|NCT01390818|3804255|FG010|COMPLETED|Overall Study||4
3082396|NCT01390818|3804256|FG011|COMPLETED|Overall Study||26
3082397|NCT01390818|3804257|FG012|COMPLETED|Overall Study||24
3082398|NCT01390818|3804258|FG013|COMPLETED|Overall Study||18
3082399|NCT01390818|3804259|FG014|COMPLETED|Overall Study||15
3082400|NCT01390818|3804245|FG000|NOT COMPLETED|Overall Study||0
3082401|NCT01390818|3804246|FG001|NOT COMPLETED|Overall Study||0
3082402|NCT01390818|3804247|FG002|NOT COMPLETED|Overall Study||0
3082403|NCT01390818|3804248|FG003|NOT COMPLETED|Overall Study||0
3082404|NCT01390818|3804249|FG004|NOT COMPLETED|Overall Study||0
3082405|NCT01390818|3804250|FG005|NOT COMPLETED|Overall Study||0
3082406|NCT01390818|3804251|FG006|NOT COMPLETED|Overall Study||0
3082407|NCT01390818|3804252|FG007|NOT COMPLETED|Overall Study||0
3082408|NCT01390818|3804253|FG008|NOT COMPLETED|Overall Study||0
3082409|NCT01390818|3804254|FG009|NOT COMPLETED|Overall Study||0
3082410|NCT01390818|3804255|FG010|NOT COMPLETED|Overall Study||0
3082411|NCT01390818|3804256|FG011|NOT COMPLETED|Overall Study||0
3082412|NCT01390818|3804257|FG012|NOT COMPLETED|Overall Study||0
3082413|NCT01390818|3804258|FG013|NOT COMPLETED|Overall Study||0
3082414|NCT01390818|3804259|FG014|NOT COMPLETED|Overall Study||0
3082415|NCT01390844|3804363|FG000|STARTED|Treatment Phase||133
3082416|NCT01390844|3804364|FG001|STARTED|Treatment Phase||65
3082417|NCT01390844|3804365|FG002|STARTED|Treatment Phase||57
3082418|NCT01390844|3804366|FG003|STARTED|Treatment Phase||27
3082419|NCT01390844|3804363|FG000|Followed Good Clinical Practice (GCP)|Treatment Phase||133
3082420|NCT01390844|3804364|FG001|Followed Good Clinical Practice (GCP)|Treatment Phase||65
3082421|NCT01390844|3804365|FG002|Followed Good Clinical Practice (GCP)|Treatment Phase||47
3082422|NCT01390844|3804366|FG003|Followed Good Clinical Practice (GCP)|Treatment Phase||24
3082423|NCT01390844|3804363|FG000|COMPLETED|Treatment Phase||93
3082424|NCT01390844|3804364|FG001|COMPLETED|Treatment Phase||37
3082425|NCT01390844|3804365|FG002|COMPLETED|Treatment Phase||26
3082426|NCT01390844|3804366|FG003|COMPLETED|Treatment Phase||8
3082427|NCT01390844|3804363|FG000|NOT COMPLETED|Treatment Phase||40
3082428|NCT01390844|3804364|FG001|NOT COMPLETED|Treatment Phase||28
3082429|NCT01390844|3804365|FG002|NOT COMPLETED|Treatment Phase||31
3082430|NCT01390844|3804366|FG003|NOT COMPLETED|Treatment Phase||19
3082431|NCT01390844|3804363|FG000|STARTED|Follow-Up Phase||93
3082432|NCT01390844|3804364|FG001|STARTED|Follow-Up Phase||37
3082433|NCT01390844|3804365|FG002|STARTED|Follow-Up Phase||26
3082434|NCT01390844|3804366|FG003|STARTED|Follow-Up Phase||8
3082435|NCT01390844|3804363|FG000|COMPLETED|Follow-Up Phase||92
3082436|NCT01390844|3804364|FG001|COMPLETED|Follow-Up Phase||36
3082437|NCT01390844|3804365|FG002|COMPLETED|Follow-Up Phase||25
3082438|NCT01390844|3804366|FG003|COMPLETED|Follow-Up Phase||8
3082439|NCT01390844|3804363|FG000|NOT COMPLETED|Follow-Up Phase||1
3082440|NCT01390844|3804364|FG001|NOT COMPLETED|Follow-Up Phase||1
3082441|NCT01390844|3804365|FG002|NOT COMPLETED|Follow-Up Phase||1
3082442|NCT01390844|3804366|FG003|NOT COMPLETED|Follow-Up Phase||0
3082443|NCT01390857|3804376|FG000|STARTED|Overall Study||379
3082444|NCT01390857|3804376|FG000|COMPLETED|Overall Study||369
3082445|NCT01390857|3804376|FG000|NOT COMPLETED|Overall Study||10
3082446|NCT01390870|3804380|FG000|STARTED|Overall Study||400
3082447|NCT01390870|3804380|FG000|COMPLETED|Overall Study||400
3082448|NCT01390870|3804380|FG000|NOT COMPLETED|Overall Study||0
3082449|NCT01390909|3804390|FG000|STARTED|Overall Study||3454
3082450|NCT01390909|3804391|FG001|STARTED|Overall Study||3552
3082451|NCT01390909|3804392|FG002|STARTED|Overall Study||3552
3082452|NCT01390909|3804393|FG003|STARTED|Overall Study||602
3082453|NCT01390909|3804394|FG004|STARTED|Overall Study||613
3082454|NCT01390909|3804395|FG005|STARTED|Overall Study||613
3082455|NCT01390909|3804390|FG000|Participants in Subgroup|Overall Study||0
3082456|NCT01390909|3804391|FG001|Participants in Subgroup|Overall Study||3454
3082457|NCT01390909|3804392|FG002|Participants in Subgroup|Overall Study||0
3082458|NCT01390909|3804393|FG003|Participants in Subgroup|Overall Study||0
3082459|NCT01390909|3804394|FG004|Participants in Subgroup|Overall Study||602
3082460|NCT01390909|3804395|FG005|Participants in Subgroup|Overall Study||0
3082461|NCT01390909|3804390|FG000|COMPLETED|Overall Study||3454
3082462|NCT01390909|3804391|FG001|COMPLETED|Overall Study||3552
3082463|NCT01390909|3804392|FG002|COMPLETED|Overall Study||3552
3082464|NCT01390909|3804393|FG003|COMPLETED|Overall Study||602
3082465|NCT01390909|3804394|FG004|COMPLETED|Overall Study||613
3082466|NCT01390909|3804395|FG005|COMPLETED|Overall Study||613
3082467|NCT01390909|3804390|FG000|NOT COMPLETED|Overall Study||0
3082468|NCT01390909|3804391|FG001|NOT COMPLETED|Overall Study||0
3082469|NCT01390909|3804392|FG002|NOT COMPLETED|Overall Study||0
3082470|NCT01390909|3804393|FG003|NOT COMPLETED|Overall Study||0
3082471|NCT01390909|3804394|FG004|NOT COMPLETED|Overall Study||0
3082472|NCT01390909|3804395|FG005|NOT COMPLETED|Overall Study||0
3082473|NCT01390948|3804416|FG000|STARTED|Overall Study||59
3082474|NCT01390948|3804417|FG001|STARTED|Overall Study||62
3082475|NCT01390948|3804418|FG002|STARTED|Overall Study||3
3082476|NCT01390948|3804416|FG000|Treated|Overall Study||56
3082477|NCT01390948|3804417|FG001|Treated|Overall Study||60
3082478|NCT01390948|3804418|FG002|Treated|Overall Study||3
3082479|NCT01390948|3804416|FG000|COMPLETED|Overall Study||44
3082480|NCT01390948|3804417|FG001|COMPLETED|Overall Study||44
3082481|NCT01390948|3804418|FG002|COMPLETED|Overall Study||2
3082482|NCT01390948|3804416|FG000|NOT COMPLETED|Overall Study||15
3082483|NCT01390948|3804417|FG001|NOT COMPLETED|Overall Study||18
3082484|NCT01390948|3804418|FG002|NOT COMPLETED|Overall Study||1
3082485|NCT01391000|3804427|FG000|STARTED|Overall Study||35
3082486|NCT01391000|3804428|FG001|STARTED|Overall Study||35
3082487|NCT01391000|3804427|FG000|COMPLETED|Overall Study||33
3082488|NCT01391000|3804428|FG001|COMPLETED|Overall Study||35
3082489|NCT01391000|3804427|FG000|NOT COMPLETED|Overall Study||2
3082490|NCT01391000|3804428|FG001|NOT COMPLETED|Overall Study||0
3082491|NCT01391013|3804436|FG000|STARTED|Overall Study||15
3082492|NCT01391013|3804437|FG001|STARTED|Overall Study||15
3082493|NCT01391013|3804436|FG000|COMPLETED|Overall Study||15
3082494|NCT01391013|3804437|FG001|COMPLETED|Overall Study||15
3082495|NCT01391013|3804436|FG000|NOT COMPLETED|Overall Study||0
3082496|NCT01391013|3804437|FG001|NOT COMPLETED|Overall Study||0
3082497|NCT01391130|3804445|FG000|STARTED|Overall Study||73
3082498|NCT01391130|3804446|FG001|STARTED|Overall Study||37
3082499|NCT01391130|3804445|FG000|Received At Least One Dose of Study Drug|Overall Study||72
3082500|NCT01391130|3804446|FG001|Received At Least One Dose of Study Drug|Overall Study||36
3082501|NCT01391130|3804445|FG000|COMPLETED|Overall Study||67
3082502|NCT01391130|3804446|FG001|COMPLETED|Overall Study||31
3082503|NCT01391130|3804445|FG000|NOT COMPLETED|Overall Study||6
3082504|NCT01391130|3804446|FG001|NOT COMPLETED|Overall Study||6
3082505|NCT01391273|3804454|FG000|STARTED|Overall Study||88
3082506|NCT01391273|3804455|FG001|STARTED|Overall Study||85
3082507|NCT01391273|3804454|FG000|COMPLETED|Overall Study||84
3082508|NCT01391273|3804455|FG001|COMPLETED|Overall Study||83
3082509|NCT01391273|3804454|FG000|NOT COMPLETED|Overall Study||4
3082510|NCT01391273|3804455|FG001|NOT COMPLETED|Overall Study||2
3082511|NCT01391286|3804463|FG000|STARTED|Overall Study||18
3082512|NCT01391286|3804464|FG001|STARTED|Overall Study||18
3082513|NCT01391286|3804463|FG000|COMPLETED|Overall Study||18
3082514|NCT01391286|3804464|FG001|COMPLETED|Overall Study||18
3082515|NCT01391286|3804463|FG000|NOT COMPLETED|Overall Study||0
3082516|NCT01391286|3804464|FG001|NOT COMPLETED|Overall Study||0
3082517|NCT01391299|3804473|FG000|STARTED|Overall Study||57
3082518|NCT01391299|3804474|FG001|STARTED|Overall Study||60
3082519|NCT01391299|3804475|FG002|STARTED|Overall Study||58
3082520|NCT01391299|3804473|FG000|COMPLETED|Overall Study||57
3082521|NCT01391299|3804474|FG001|COMPLETED|Overall Study||59
3082522|NCT01391299|3804475|FG002|COMPLETED|Overall Study||56
3082523|NCT01391299|3804473|FG000|NOT COMPLETED|Overall Study||0
3082524|NCT01391299|3804474|FG001|NOT COMPLETED|Overall Study||1
3082525|NCT01391299|3804475|FG002|NOT COMPLETED|Overall Study||2
3082526|NCT01391312|3804485|FG000|STARTED|Overall Study||20
3082527|NCT01391312|3804486|FG001|STARTED|Overall Study||20
3082528|NCT01391312|3804485|FG000|COMPLETED|Overall Study||18
3082529|NCT01391312|3804486|FG001|COMPLETED|Overall Study||19
3082530|NCT01391312|3804485|FG000|NOT COMPLETED|Overall Study||2
3082531|NCT01391312|3804486|FG001|NOT COMPLETED|Overall Study||1
3082532|NCT01391325|3804492|FG000|STARTED|Overall Study||1732
3082533|NCT01391325|3804492|FG000|COMPLETED|Overall Study||1238
3082534|NCT01391325|3804492|FG000|NOT COMPLETED|Overall Study||494
3082535|NCT01391364|3804498|FG000|STARTED|Overall Study||222
3082536|NCT01391364|3804499|FG001|STARTED|Overall Study||216
3082537|NCT01391364|3804498|FG000|COMPLETED|Overall Study||217
3082538|NCT01391364|3804499|FG001|COMPLETED|Overall Study||214
3082539|NCT01391364|3804498|FG000|NOT COMPLETED|Overall Study||5
3082540|NCT01391364|3804499|FG001|NOT COMPLETED|Overall Study||2
3082541|NCT01391468|3804507|FG000|STARTED|Overall Study||24
3082542|NCT01391468|3804508|FG001|STARTED|Overall Study||23
3082543|NCT01391468|3804507|FG000|COMPLETED|Overall Study||18
3082544|NCT01391468|3804508|FG001|COMPLETED|Overall Study||21
3082545|NCT01391468|3804507|FG000|NOT COMPLETED|Overall Study||6
3082546|NCT01391468|3804508|FG001|NOT COMPLETED|Overall Study||2
3082547|NCT01391507|3804523|FG000|STARTED|Overall Study||10
3082548|NCT01391507|3804524|FG001|STARTED|Overall Study||8
3082549|NCT01391507|3804525|FG002|STARTED|Overall Study||6
3082550|NCT01391507|3804526|FG003|STARTED|Overall Study||12
3082551|NCT01391507|3804523|FG000|COMPLETED|Overall Study||6
3082552|NCT01391507|3804524|FG001|COMPLETED|Overall Study||4
3082553|NCT01391507|3804525|FG002|COMPLETED|Overall Study||2
3082554|NCT01391507|3804526|FG003|COMPLETED|Overall Study||5
3082555|NCT01391507|3804523|FG000|NOT COMPLETED|Overall Study||4
3082556|NCT01391507|3804524|FG001|NOT COMPLETED|Overall Study||4
3082557|NCT01391507|3804525|FG002|NOT COMPLETED|Overall Study||4
3082558|NCT01391507|3804526|FG003|NOT COMPLETED|Overall Study||7
3082559|NCT01391546|3804538|FG000|STARTED|Overall Study||177
3082560|NCT01391546|3804539|FG001|STARTED|Overall Study||177
3082561|NCT01391546|3804538|FG000|Vaccinated|Overall Study||176
3082562|NCT01391546|3804539|FG001|Vaccinated|Overall Study||177
3082563|NCT01391546|3804538|FG000|COMPLETED|Overall Study||176
3082564|NCT01391546|3804539|FG001|COMPLETED|Overall Study||177
3082565|NCT01391546|3804538|FG000|NOT COMPLETED|Overall Study||1
3082566|NCT01391546|3804539|FG001|NOT COMPLETED|Overall Study||0
3082567|NCT01391559|3804546|FG000|STARTED|First Intervention||10
3082568|NCT01391559|3804547|FG001|STARTED|First Intervention||10
3082569|NCT01391559|3804546|FG000|COMPLETED|First Intervention||10
3082570|NCT01391559|3804547|FG001|COMPLETED|First Intervention||10
3082571|NCT01391559|3804546|FG000|NOT COMPLETED|First Intervention||0
3082572|NCT01391559|3804547|FG001|NOT COMPLETED|First Intervention||0
3082573|NCT01391559|3804546|FG000|STARTED|Second Intervention||10
3082574|NCT01391559|3804547|FG001|STARTED|Second Intervention||10
3082575|NCT01391559|3804546|FG000|COMPLETED|Second Intervention||10
3082576|NCT01391559|3804547|FG001|COMPLETED|Second Intervention||10
3082577|NCT01391559|3804546|FG000|NOT COMPLETED|Second Intervention||0
3082578|NCT01391559|3804547|FG001|NOT COMPLETED|Second Intervention||0
3082579|NCT01391611|3804553|FG000|STARTED|Overall Study||25
3082580|NCT01391611|3804553|FG000|COMPLETED|Overall Study||3
3082581|NCT01391611|3804553|FG000|NOT COMPLETED|Overall Study||22
3082582|NCT01391663|3804561|FG000|STARTED|Overall Study||12
3082583|NCT01391663|3804562|FG001|STARTED|Overall Study||12
3082584|NCT01391663|3804563|FG002|STARTED|Overall Study||12
3082585|NCT01391663|3804564|FG003|STARTED|Overall Study||12
3082586|NCT01391663|3804561|FG000|COMPLETED|Overall Study||12
3082587|NCT01391663|3804562|FG001|COMPLETED|Overall Study||12
3082588|NCT01391663|3804563|FG002|COMPLETED|Overall Study||11
3082589|NCT01391663|3804564|FG003|COMPLETED|Overall Study||12
3082590|NCT01391663|3804561|FG000|NOT COMPLETED|Overall Study||0
3082591|NCT01391663|3804562|FG001|NOT COMPLETED|Overall Study||0
3082592|NCT01391663|3804563|FG002|NOT COMPLETED|Overall Study||1
3082593|NCT01391663|3804564|FG003|NOT COMPLETED|Overall Study||0
3082594|NCT01391793|3804576|FG000|STARTED|Overall Study||271
3082595|NCT01391793|3804577|FG001|STARTED|Overall Study||275
3082596|NCT01391793|3804576|FG000|Had a Positive Urine Culture|Overall Study||197
3082597|NCT01391793|3804577|FG001|Had a Positive Urine Culture|Overall Study||188
3082598|NCT01391793|3804576|FG000|COMPLETED|Overall Study||124
3082599|NCT01391793|3804577|FG001|COMPLETED|Overall Study||131
3082600|NCT01391793|3804576|FG000|NOT COMPLETED|Overall Study||147
3082601|NCT01391793|3804577|FG001|NOT COMPLETED|Overall Study||144
3082602|NCT01391819|3804583|FG000|STARTED|Overall Study||2116
3286362|NCT02781571|4019957|FG000|COMPLETED|Overall Study||79
3286363|NCT02781571|4019957|FG000|NOT COMPLETED|Overall Study||0
3286364|NCT02781610|4019965|FG000|STARTED|Overall Study||140
3286365|NCT02781610|4019966|FG001|STARTED|Overall Study||137
3286366|NCT02781610|4019967|FG002|STARTED|Overall Study||353
3286367|NCT02781610|4019968|FG003|STARTED|Overall Study||352
3286368|NCT02781610|4019965|FG000|COMPLETED|Overall Study||134
3286369|NCT02781610|4019966|FG001|COMPLETED|Overall Study||130
3286370|NCT02781610|4019967|FG002|COMPLETED|Overall Study||336
3286371|NCT02781610|4019968|FG003|COMPLETED|Overall Study||323
3286372|NCT02781610|4019965|FG000|NOT COMPLETED|Overall Study||6
3286373|NCT02781610|4019966|FG001|NOT COMPLETED|Overall Study||7
3286374|NCT02781610|4019967|FG002|NOT COMPLETED|Overall Study||17
3286375|NCT02781610|4019968|FG003|NOT COMPLETED|Overall Study||29
3286376|NCT02781649|4019981|FG000|STARTED|Overall Study|4 in this group had insufficient viral RNA for genotyping. They were treated as 1a|7
3286377|NCT02781649|4019982|FG001|STARTED|Overall Study||0
3286378|NCT02781649|4019983|FG002|STARTED|Overall Study||3
3286379|NCT02781649|4019981|FG000|COMPLETED|Overall Study||7
3286380|NCT02781649|4019982|FG001|COMPLETED|Overall Study||0
3286381|NCT02781649|4019983|FG002|COMPLETED|Overall Study||3
3286382|NCT02781649|4019981|FG000|NOT COMPLETED|Overall Study||0
3286383|NCT02781649|4019982|FG001|NOT COMPLETED|Overall Study||0
3286384|NCT02781649|4019983|FG002|NOT COMPLETED|Overall Study||0
3286385|NCT02781818|4019994|FG000|STARTED|Overall Study||20
3286386|NCT02781818|4019995|FG001|STARTED|Overall Study||18
3286387|NCT02781818|4019996|FG002|STARTED|Overall Study||17
3286388|NCT02781818|4019994|FG000|COMPLETED|Overall Study||16
3286389|NCT02781818|4019995|FG001|COMPLETED|Overall Study||16
3286390|NCT02781818|4019996|FG002|COMPLETED|Overall Study||16
3286391|NCT02781818|4019994|FG000|NOT COMPLETED|Overall Study||4
3286392|NCT02781818|4019995|FG001|NOT COMPLETED|Overall Study||2
3286393|NCT02781818|4019996|FG002|NOT COMPLETED|Overall Study||1
3286394|NCT02781844|4020008|FG000|STARTED|Treatment Period 1||5
3286395|NCT02781844|4020009|FG001|STARTED|Treatment Period 1||4
3286396|NCT02781844|4020010|FG002|STARTED|Treatment Period 1||4
3286397|NCT02781844|4020011|FG003|STARTED|Treatment Period 1||4
3286398|NCT02781844|4020012|FG004|STARTED|Treatment Period 1||4
3286399|NCT02781844|4020013|FG005|STARTED|Treatment Period 1||5
3286400|NCT02781844|4020014|FG006|STARTED|Treatment Period 1||4
3286401|NCT02781844|4020015|FG007|STARTED|Treatment Period 1||4
3286402|NCT02781844|4020008|FG000|COMPLETED|Treatment Period 1||5
3286403|NCT02781844|4020009|FG001|COMPLETED|Treatment Period 1||4
3286404|NCT02781844|4020010|FG002|COMPLETED|Treatment Period 1||4
3286405|NCT02781844|4020011|FG003|COMPLETED|Treatment Period 1||4
3286406|NCT02781844|4020012|FG004|COMPLETED|Treatment Period 1||4
3286407|NCT02781844|4020013|FG005|COMPLETED|Treatment Period 1||4
3082603|NCT01391819|3804583|FG000|COMPLETED|Overall Study||1714
3082604|NCT01391819|3804583|FG000|NOT COMPLETED|Overall Study||402
3082605|NCT01391832|3804592|FG000|STARTED|Overall Study||49
3082606|NCT01391832|3804593|FG001|STARTED|Overall Study||54
3082607|NCT01391832|3804592|FG000|1 Month Follow-Up|Overall Study||30
3082608|NCT01391832|3804593|FG001|1 Month Follow-Up|Overall Study||31
3082609|NCT01391832|3804592|FG000|3 Month Follow-Up|Overall Study||28
3082610|NCT01391832|3804593|FG001|3 Month Follow-Up|Overall Study||29
3082611|NCT01391832|3804592|FG000|COMPLETED|Overall Study||28
3082612|NCT01391832|3804593|FG001|COMPLETED|Overall Study||31
3286408|NCT02781844|4020014|FG006|COMPLETED|Treatment Period 1||4
3286409|NCT02781844|4020015|FG007|COMPLETED|Treatment Period 1||4
3286410|NCT02781844|4020008|FG000|NOT COMPLETED|Treatment Period 1||0
3286411|NCT02781844|4020009|FG001|NOT COMPLETED|Treatment Period 1||0
3082613|NCT01391832|3804592|FG000|NOT COMPLETED|Overall Study||21
3082614|NCT01391832|3804593|FG001|NOT COMPLETED|Overall Study||23
3082615|NCT01391858|3804601|FG000|STARTED|Overall Study||25
3082616|NCT01391858|3804602|FG001|STARTED|Overall Study||24
3082617|NCT01391858|3804601|FG000|COMPLETED|Overall Study||23
3082618|NCT01391858|3804602|FG001|COMPLETED|Overall Study||24
3082619|NCT01391858|3804601|FG000|NOT COMPLETED|Overall Study||2
3082620|NCT01391858|3804602|FG001|NOT COMPLETED|Overall Study||0
3082621|NCT01392053|3804610|FG000|STARTED|Overall Study||23
3082622|NCT01392053|3804611|FG001|STARTED|Overall Study||23
3082623|NCT01392053|3804610|FG000|COMPLETED|Overall Study||23
3082624|NCT01392053|3804611|FG001|COMPLETED|Overall Study||23
3082625|NCT01392053|3804610|FG000|NOT COMPLETED|Overall Study||0
3082626|NCT01392053|3804611|FG001|NOT COMPLETED|Overall Study||0
3082627|NCT01392183|3804619|FG000|STARTED|First Drug Administration||35
3082628|NCT01392183|3804620|FG001|STARTED|First Drug Administration||34
3082629|NCT01392183|3804619|FG000|Eligible to Cross Over to 2nd Drug|First Drug Administration||29
3082630|NCT01392183|3804620|FG001|Eligible to Cross Over to 2nd Drug|First Drug Administration||31
3082631|NCT01392183|3804619|FG000|COMPLETED|First Drug Administration||21
3082632|NCT01392183|3804620|FG001|COMPLETED|First Drug Administration||15
3082633|NCT01392183|3804619|FG000|NOT COMPLETED|First Drug Administration||14
3082634|NCT01392183|3804620|FG001|NOT COMPLETED|First Drug Administration||19
3082635|NCT01392183|3804619|FG000|STARTED|Second Drug Administration||21
3082636|NCT01392183|3804620|FG001|STARTED|Second Drug Administration||15
3082637|NCT01392183|3804619|FG000|Treatment Ended: Progression|Second Drug Administration||18
3082638|NCT01392183|3804620|FG001|Treatment Ended: Progression|Second Drug Administration||11
3082639|NCT01392183|3804619|FG000|Treatment Ended: Adverse Events|Second Drug Administration||1
3082640|NCT01392183|3804620|FG001|Treatment Ended: Adverse Events|Second Drug Administration||2
3082641|NCT01392183|3804619|FG000|Treatment Ended: Participant Withdrew|Second Drug Administration||2
3082642|NCT01392183|3804620|FG001|Treatment Ended: Participant Withdrew|Second Drug Administration||1
3082643|NCT01392183|3804619|FG000|Treatment Ended: Death|Second Drug Administration||0
3082644|NCT01392183|3804620|FG001|Treatment Ended: Death|Second Drug Administration||1
3082645|NCT01392183|3804619|FG000|COMPLETED|Second Drug Administration||21
3082646|NCT01392183|3804620|FG001|COMPLETED|Second Drug Administration||15
3082647|NCT01392183|3804619|FG000|NOT COMPLETED|Second Drug Administration||0
3082648|NCT01392183|3804620|FG001|NOT COMPLETED|Second Drug Administration||0
3082649|NCT01392300|3804630|FG000|STARTED|Main Period (MP)||210
3082650|NCT01392300|3804631|FG001|STARTED|Main Period (MP)||107
3082651|NCT01392300|3804632|FG002|STARTED|Main Period (MP)||0
3082652|NCT01392300|3804630|FG000|COMPLETED|Main Period (MP)||199
3082653|NCT01392300|3804631|FG001|COMPLETED|Main Period (MP)||100
3082654|NCT01392300|3804632|FG002|COMPLETED|Main Period (MP)||0
3082655|NCT01392300|3804630|FG000|NOT COMPLETED|Main Period (MP)||11
3082656|NCT01392300|3804631|FG001|NOT COMPLETED|Main Period (MP)||7
3082657|NCT01392300|3804632|FG002|NOT COMPLETED|Main Period (MP)||0
3082658|NCT01392300|3804630|FG000|STARTED|Open Label Extension (OLEX) Period|Subjects from double-blind arms were switched to arm OLEX IncobotulinumtoxinA (Xeomin) (...)|0
3082659|NCT01392300|3804631|FG001|STARTED|Open Label Extension (OLEX) Period|Subjects from double-blind arms were switched to arm OLEX IncobotulinumtoxinA (Xeomin) (...)|0
3082660|NCT01392300|3804632|FG002|STARTED|Open Label Extension (OLEX) Period|Subjects from double-blind arms were switched to arm OLEX IncobotulinumtoxinA (Xeomin) (...)|299
3082661|NCT01392300|3804630|FG000|COMPLETED|Open Label Extension (OLEX) Period||0
3082662|NCT01392300|3804631|FG001|COMPLETED|Open Label Extension (OLEX) Period||0
3082663|NCT01392300|3804632|FG002|COMPLETED|Open Label Extension (OLEX) Period||248
3082664|NCT01392300|3804630|FG000|NOT COMPLETED|Open Label Extension (OLEX) Period||0
3082665|NCT01392300|3804631|FG001|NOT COMPLETED|Open Label Extension (OLEX) Period||0
3082666|NCT01392300|3804632|FG002|NOT COMPLETED|Open Label Extension (OLEX) Period||51
3082667|NCT01392326|3804642|FG000|STARTED|Overall Study||202
3082668|NCT01392326|3804643|FG001|STARTED|Overall Study||202
3082669|NCT01392326|3804644|FG002|STARTED|Overall Study||202
3082670|NCT01392326|3804642|FG000|COMPLETED|Overall Study||155
3082671|NCT01392326|3804643|FG001|COMPLETED|Overall Study||167
3082672|NCT01392326|3804644|FG002|COMPLETED|Overall Study||154
3082673|NCT01392326|3804642|FG000|NOT COMPLETED|Overall Study||47
3082674|NCT01392326|3804643|FG001|NOT COMPLETED|Overall Study||35
3082675|NCT01392326|3804644|FG002|NOT COMPLETED|Overall Study||48
3082676|NCT01392378|3804657|FG000|STARTED|Infant Series||173
3082677|NCT01392378|3804658|FG001|STARTED|Infant Series||176
3082678|NCT01392378|3804659|FG002|STARTED|Infant Series||172
3082679|NCT01392378|3804660|FG003|STARTED|Infant Series||177
3082680|NCT01392378|3804661|FG004|STARTED|Infant Series||210
3082681|NCT01392378|3804657|FG000|Vaccinated Dose 1|Infant Series||173
3082682|NCT01392378|3804658|FG001|Vaccinated Dose 1|Infant Series||176
3082683|NCT01392378|3804659|FG002|Vaccinated Dose 1|Infant Series||172
3082684|NCT01392378|3804660|FG003|Vaccinated Dose 1|Infant Series||177
3286412|NCT02781844|4020010|FG002|NOT COMPLETED|Treatment Period 1||0
3286413|NCT02781844|4020011|FG003|NOT COMPLETED|Treatment Period 1||0
3286414|NCT02781844|4020012|FG004|NOT COMPLETED|Treatment Period 1||0
3286415|NCT02781844|4020013|FG005|NOT COMPLETED|Treatment Period 1||1
3286416|NCT02781844|4020014|FG006|NOT COMPLETED|Treatment Period 1||0
3286417|NCT02781844|4020015|FG007|NOT COMPLETED|Treatment Period 1||0
3286418|NCT02781844|4020008|FG000|STARTED|Treatment Period 2||5
3082685|NCT01392378|3804661|FG004|Vaccinated Dose 1|Infant Series||210
3286419|NCT02781844|4020009|FG001|STARTED|Treatment Period 2||4
3082686|NCT01392378|3804657|FG000|Vaccinated Dose 2|Infant Series||171
3082687|NCT01392378|3804658|FG001|Vaccinated Dose 2|Infant Series||174
3082688|NCT01392378|3804659|FG002|Vaccinated Dose 2|Infant Series||172
3082689|NCT01392378|3804660|FG003|Vaccinated Dose 2|Infant Series||177
3082690|NCT01392378|3804661|FG004|Vaccinated Dose 2|Infant Series||210
3082691|NCT01392378|3804657|FG000|Vaccinated Dose 3|Infant Series||170
3082692|NCT01392378|3804658|FG001|Vaccinated Dose 3|Infant Series||174
3082693|NCT01392378|3804659|FG002|Vaccinated Dose 3|Infant Series||172
3082694|NCT01392378|3804660|FG003|Vaccinated Dose 3|Infant Series||176
3082695|NCT01392378|3804661|FG004|Vaccinated Dose 3|Infant Series||210
3082696|NCT01392378|3804657|FG000|COMPLETED|Infant Series||169
3082697|NCT01392378|3804658|FG001|COMPLETED|Infant Series||174
3082698|NCT01392378|3804659|FG002|COMPLETED|Infant Series||172
3082699|NCT01392378|3804660|FG003|COMPLETED|Infant Series||175
3082700|NCT01392378|3804661|FG004|COMPLETED|Infant Series||210
3082701|NCT01392378|3804657|FG000|NOT COMPLETED|Infant Series||4
3082702|NCT01392378|3804658|FG001|NOT COMPLETED|Infant Series||2
3082703|NCT01392378|3804659|FG002|NOT COMPLETED|Infant Series||0
3082704|NCT01392378|3804660|FG003|NOT COMPLETED|Infant Series||2
3082705|NCT01392378|3804661|FG004|NOT COMPLETED|Infant Series||0
3082706|NCT01392378|3804657|FG000|STARTED|After Infant Series||169
3082707|NCT01392378|3804658|FG001|STARTED|After Infant Series||174
3082708|NCT01392378|3804659|FG002|STARTED|After Infant Series||172
3082709|NCT01392378|3804660|FG003|STARTED|After Infant Series||175
3082710|NCT01392378|3804661|FG004|STARTED|After Infant Series||210
3082711|NCT01392378|3804657|FG000|COMPLETED|After Infant Series||169
3082712|NCT01392378|3804658|FG001|COMPLETED|After Infant Series||173
3082713|NCT01392378|3804659|FG002|COMPLETED|After Infant Series||170
3082714|NCT01392378|3804660|FG003|COMPLETED|After Infant Series||175
3082715|NCT01392378|3804661|FG004|COMPLETED|After Infant Series||209
3082716|NCT01392378|3804657|FG000|NOT COMPLETED|After Infant Series||0
3082717|NCT01392378|3804658|FG001|NOT COMPLETED|After Infant Series||1
3082718|NCT01392378|3804659|FG002|NOT COMPLETED|After Infant Series||2
3082719|NCT01392378|3804660|FG003|NOT COMPLETED|After Infant Series||0
3082720|NCT01392378|3804661|FG004|NOT COMPLETED|After Infant Series||1
3082721|NCT01392378|3804657|FG000|STARTED|Toddler Dose||169
3082722|NCT01392378|3804658|FG001|STARTED|Toddler Dose||173
3082723|NCT01392378|3804659|FG002|STARTED|Toddler Dose||170
3082724|NCT01392378|3804660|FG003|STARTED|Toddler Dose||175
3082725|NCT01392378|3804661|FG004|STARTED|Toddler Dose||209
3082726|NCT01392378|3804657|FG000|COMPLETED|Toddler Dose||169
3082727|NCT01392378|3804658|FG001|COMPLETED|Toddler Dose||172
3082728|NCT01392378|3804659|FG002|COMPLETED|Toddler Dose||170
3082729|NCT01392378|3804660|FG003|COMPLETED|Toddler Dose||173
3082730|NCT01392378|3804661|FG004|COMPLETED|Toddler Dose||208
3082731|NCT01392378|3804657|FG000|NOT COMPLETED|Toddler Dose||0
3082732|NCT01392378|3804658|FG001|NOT COMPLETED|Toddler Dose||1
3082733|NCT01392378|3804659|FG002|NOT COMPLETED|Toddler Dose||0
3286420|NCT02781844|4020010|FG002|STARTED|Treatment Period 2||4
3286421|NCT02781844|4020011|FG003|STARTED|Treatment Period 2||4
3286422|NCT02781844|4020012|FG004|STARTED|Treatment Period 2||4
3286423|NCT02781844|4020013|FG005|STARTED|Treatment Period 2||4
3286424|NCT02781844|4020014|FG006|STARTED|Treatment Period 2||4
3286425|NCT02781844|4020015|FG007|STARTED|Treatment Period 2||4
3286426|NCT02781844|4020008|FG000|COMPLETED|Treatment Period 2||5
3286427|NCT02781844|4020009|FG001|COMPLETED|Treatment Period 2||4
3286428|NCT02781844|4020010|FG002|COMPLETED|Treatment Period 2||4
3286429|NCT02781844|4020011|FG003|COMPLETED|Treatment Period 2||4
3286430|NCT02781844|4020012|FG004|COMPLETED|Treatment Period 2||4
3286431|NCT02781844|4020013|FG005|COMPLETED|Treatment Period 2||4
3286432|NCT02781844|4020014|FG006|COMPLETED|Treatment Period 2||4
3286433|NCT02781844|4020015|FG007|COMPLETED|Treatment Period 2||4
3286434|NCT02781844|4020008|FG000|NOT COMPLETED|Treatment Period 2||0
3286435|NCT02781844|4020009|FG001|NOT COMPLETED|Treatment Period 2||0
3286436|NCT02781844|4020010|FG002|NOT COMPLETED|Treatment Period 2||0
3286437|NCT02781844|4020011|FG003|NOT COMPLETED|Treatment Period 2||0
3286438|NCT02781844|4020012|FG004|NOT COMPLETED|Treatment Period 2||0
3286439|NCT02781844|4020013|FG005|NOT COMPLETED|Treatment Period 2||0
3286440|NCT02781844|4020014|FG006|NOT COMPLETED|Treatment Period 2||0
3286441|NCT02781844|4020015|FG007|NOT COMPLETED|Treatment Period 2||0
3286442|NCT02782065|4020031|FG000|STARTED|Overall Study||58
3286443|NCT02782065|4020031|FG000|COMPLETED|Overall Study||58
3286444|NCT02782065|4020031|FG000|NOT COMPLETED|Overall Study||0
3286445|NCT02782169|4020038|FG000|STARTED|Overall Study||56
3286446|NCT02782169|4020039|FG001|STARTED|Overall Study||54
3286447|NCT02782169|4020038|FG000|COMPLETED|Overall Study||55
3286448|NCT02782169|4020039|FG001|COMPLETED|Overall Study||52
3286449|NCT02782169|4020038|FG000|NOT COMPLETED|Overall Study||1
3286450|NCT02782169|4020039|FG001|NOT COMPLETED|Overall Study||2
3286451|NCT02782325|4020047|FG000|STARTED|Blinded FMT Treatment (up to 24 Weeks)||4
3286452|NCT02782325|4020048|FG001|STARTED|Blinded FMT Treatment (up to 24 Weeks)||2
3286453|NCT02782325|4020049|FG002|STARTED|Blinded FMT Treatment (up to 24 Weeks)||0
3286454|NCT02782325|4020047|FG000|COMPLETED|Blinded FMT Treatment (up to 24 Weeks)||0
3082734|NCT01392378|3804660|FG003|NOT COMPLETED|Toddler Dose||2
3286455|NCT02782325|4020048|FG001|COMPLETED|Blinded FMT Treatment (up to 24 Weeks)||0
3286456|NCT02782325|4020049|FG002|COMPLETED|Blinded FMT Treatment (up to 24 Weeks)||0
3286457|NCT02782325|4020047|FG000|NOT COMPLETED|Blinded FMT Treatment (up to 24 Weeks)||4
3286458|NCT02782325|4020048|FG001|NOT COMPLETED|Blinded FMT Treatment (up to 24 Weeks)||2
3082735|NCT01392378|3804661|FG004|NOT COMPLETED|Toddler Dose||1
3082736|NCT01392443|3804683|FG000|STARTED|Overall Study||120
3082737|NCT01392443|3804683|FG000|COMPLETED|Overall Study||52
3082738|NCT01392443|3804683|FG000|NOT COMPLETED|Overall Study||68
3082739|NCT01392469|3804687|FG000|STARTED|Overall Study||21
3082740|NCT01392469|3804687|FG000|COMPLETED|Overall Study||17
3082741|NCT01392469|3804687|FG000|NOT COMPLETED|Overall Study||4
3082742|NCT01392495|3804702|FG000|STARTED|Overall Study||17
3082743|NCT01392495|3804702|FG000|Received 200 mg|Overall Study||4
3082744|NCT01392495|3804702|FG000|Received 400 mg|Overall Study||13
3082745|NCT01392495|3804702|FG000|COMPLETED|Overall Study||1
3082746|NCT01392495|3804702|FG000|NOT COMPLETED|Overall Study||16
3082747|NCT01392547|3804708|FG000|STARTED|Overall Study|567 bleeds by 69 subjects, 340 were treated with vatreptacog alfa and 227 with rFVIIa|72
3082748|NCT01392547|3804708|FG000|COMPLETED|Overall Study||64
3082749|NCT01392547|3804708|FG000|NOT COMPLETED|Overall Study||8
3082750|NCT01392560|3804714|FG000|STARTED|Overall Study||52
3082751|NCT01392560|3804714|FG000|COMPLETED|Overall Study||40
3082752|NCT01392560|3804714|FG000|NOT COMPLETED|Overall Study||12
3082753|NCT01392573|3804722|FG000|STARTED|Overall Study||207
3082754|NCT01392573|3804723|FG001|STARTED|Overall Study||206
3082755|NCT01392573|3804722|FG000|Exposed|Overall Study||207
3082756|NCT01392573|3804723|FG001|Exposed|Overall Study||206
3082757|NCT01392573|3804722|FG000|COMPLETED|Overall Study||175
3082758|NCT01392573|3804723|FG001|COMPLETED|Overall Study||171
3082759|NCT01392573|3804722|FG000|NOT COMPLETED|Overall Study||32
3082760|NCT01392573|3804723|FG001|NOT COMPLETED|Overall Study||35
3082761|NCT01392625|3804731|FG000|STARTED|Overall Study||18
3082762|NCT01392625|3804732|FG001|STARTED|Overall Study||19
3082763|NCT01392625|3804731|FG000|COMPLETED|Overall Study||16
3082764|NCT01392625|3804732|FG001|COMPLETED|Overall Study||18
3082765|NCT01392625|3804731|FG000|NOT COMPLETED|Overall Study||2
3082766|NCT01392625|3804732|FG001|NOT COMPLETED|Overall Study||1
3082767|NCT01392677|3804740|FG000|STARTED|Overall Study||109
3082768|NCT01392677|3804741|FG001|STARTED|Overall Study||109
3082769|NCT01392677|3804740|FG000|COMPLETED|Overall Study||101
3082770|NCT01392677|3804741|FG001|COMPLETED|Overall Study||101
3082771|NCT01392677|3804740|FG000|NOT COMPLETED|Overall Study||8
3082772|NCT01392677|3804741|FG001|NOT COMPLETED|Overall Study||8
3286459|NCT02782325|4020049|FG002|NOT COMPLETED|Blinded FMT Treatment (up to 24 Weeks)||0
3286460|NCT02782325|4020047|FG000|STARTED|Open Label FMT Period (up to 24 Weeks)||0
3286461|NCT02782325|4020048|FG001|STARTED|Open Label FMT Period (up to 24 Weeks)||0
3286462|NCT02782325|4020049|FG002|STARTED|Open Label FMT Period (up to 24 Weeks)|1 participant decided to not participate in the open label period|5
3286463|NCT02782325|4020047|FG000|COMPLETED|Open Label FMT Period (up to 24 Weeks)||0
3286464|NCT02782325|4020048|FG001|COMPLETED|Open Label FMT Period (up to 24 Weeks)||0
3286465|NCT02782325|4020049|FG002|COMPLETED|Open Label FMT Period (up to 24 Weeks)||1
3286466|NCT02782325|4020047|FG000|NOT COMPLETED|Open Label FMT Period (up to 24 Weeks)||0
3286467|NCT02782325|4020048|FG001|NOT COMPLETED|Open Label FMT Period (up to 24 Weeks)||0
3286468|NCT02782325|4020049|FG002|NOT COMPLETED|Open Label FMT Period (up to 24 Weeks)||4
3286469|NCT02782364|4020057|FG000|STARTED|Overall Study||18
3286470|NCT02782364|4020058|FG001|STARTED|Overall Study||18
3286471|NCT02782364|4020057|FG000|COMPLETED|Overall Study||18
3286472|NCT02782364|4020058|FG001|COMPLETED|Overall Study||18
3286473|NCT02782364|4020057|FG000|NOT COMPLETED|Overall Study||0
3286474|NCT02782364|4020058|FG001|NOT COMPLETED|Overall Study||0
3286475|NCT02782377|4020065|FG000|STARTED|Overall Study||40
3286476|NCT02782377|4020065|FG000|COMPLETED|Overall Study|data from five of the patients were excluded due to interpretation difficulties|35
3286477|NCT02782377|4020065|FG000|NOT COMPLETED|Overall Study||5
3286478|NCT02782676|4020070|FG000|STARTED|Overall Study||211
3286479|NCT02782676|4020071|FG001|STARTED|Overall Study||210
3286480|NCT02782676|4020070|FG000|COMPLETED|Overall Study||211
3286481|NCT02782676|4020071|FG001|COMPLETED|Overall Study||209
3286482|NCT02782676|4020070|FG000|NOT COMPLETED|Overall Study||0
3286483|NCT02782676|4020071|FG001|NOT COMPLETED|Overall Study||1
3286484|NCT02782741|4020079|FG000|STARTED|Blinded Treatment Period: up to Week 49||51
3286485|NCT02782741|4020080|FG001|STARTED|Blinded Treatment Period: up to Week 49||49
3286486|NCT02782741|4020079|FG000|Safety Population|Blinded Treatment Period: up to Week 49||51
3286487|NCT02782741|4020080|FG001|Safety Population|Blinded Treatment Period: up to Week 49||49
3286488|NCT02782741|4020079|FG000|COMPLETED|Blinded Treatment Period: up to Week 49||51
3286489|NCT02782741|4020080|FG001|COMPLETED|Blinded Treatment Period: up to Week 49||44
3286490|NCT02782741|4020079|FG000|NOT COMPLETED|Blinded Treatment Period: up to Week 49||0
3286491|NCT02782741|4020080|FG001|NOT COMPLETED|Blinded Treatment Period: up to Week 49||5
3286492|NCT02782741|4020079|FG000|STARTED|Open-label Long-term: Week 50 to 145||51
3286493|NCT02782741|4020080|FG001|STARTED|Open-label Long-term: Week 50 to 145||44
3286494|NCT02782741|4020079|FG000|Safety Population|Open-label Long-term: Week 50 to 145||51
3286495|NCT02782741|4020080|FG001|Safety Population|Open-label Long-term: Week 50 to 145||44
3286496|NCT02782741|4020079|FG000|COMPLETED|Open-label Long-term: Week 50 to 145||0
3286497|NCT02782741|4020080|FG001|COMPLETED|Open-label Long-term: Week 50 to 145||0
3286498|NCT02782741|4020079|FG000|NOT COMPLETED|Open-label Long-term: Week 50 to 145||51
3286499|NCT02782741|4020080|FG001|NOT COMPLETED|Open-label Long-term: Week 50 to 145||44
3286500|NCT02782780|4020092|FG000|STARTED|Overall Study||46
3082773|NCT01392703|3804747|FG000|STARTED|Day 1||26
3082774|NCT01392703|3804748|FG001|STARTED|Day 1||26
3082775|NCT01392703|3804749|FG002|STARTED|Day 1||26
3082776|NCT01392703|3804747|FG000|COMPLETED|Day 1||26
3082777|NCT01392703|3804748|FG001|COMPLETED|Day 1||26
3082778|NCT01392703|3804749|FG002|COMPLETED|Day 1||26
3082779|NCT01392703|3804747|FG000|NOT COMPLETED|Day 1||0
3082780|NCT01392703|3804748|FG001|NOT COMPLETED|Day 1||0
3082781|NCT01392703|3804749|FG002|NOT COMPLETED|Day 1||0
3082782|NCT01392703|3804747|FG000|STARTED|Day 5||26
3082783|NCT01392703|3804748|FG001|STARTED|Day 5|1 participant no longer met dosing criteria and dropped out during washout period prior to Day 5.|25
3082784|NCT01392703|3804749|FG002|STARTED|Day 5||26
3082785|NCT01392703|3804747|FG000|COMPLETED|Day 5||26
3082786|NCT01392703|3804748|FG001|COMPLETED|Day 5||25
3082787|NCT01392703|3804749|FG002|COMPLETED|Day 5||26
3082788|NCT01392703|3804747|FG000|NOT COMPLETED|Day 5||0
3082789|NCT01392703|3804748|FG001|NOT COMPLETED|Day 5||0
3082790|NCT01392703|3804749|FG002|NOT COMPLETED|Day 5||0
3082791|NCT01392703|3804747|FG000|STARTED|Day 9||26
3082792|NCT01392703|3804748|FG001|STARTED|Day 9||26
3082793|NCT01392703|3804749|FG002|STARTED|Day 9||25
3082794|NCT01392703|3804747|FG000|COMPLETED|Day 9||26
3082795|NCT01392703|3804748|FG001|COMPLETED|Day 9||26
3082796|NCT01392703|3804749|FG002|COMPLETED|Day 9||25
3082797|NCT01392703|3804747|FG000|NOT COMPLETED|Day 9||0
3082798|NCT01392703|3804748|FG001|NOT COMPLETED|Day 9||0
3082799|NCT01392703|3804749|FG002|NOT COMPLETED|Day 9||0
3082800|NCT01392742|3804759|FG000|STARTED|Overall Study||443
3082801|NCT01392742|3804759|FG000|COMPLETED|Overall Study||242
3082802|NCT01392742|3804759|FG000|NOT COMPLETED|Overall Study||201
3082803|NCT01392859|3804763|FG000|STARTED|Overall Study||15
3082804|NCT01392859|3804764|FG001|STARTED|Overall Study||13
3082805|NCT01392859|3804765|FG002|STARTED|Overall Study||183
3082806|NCT01392859|3804763|FG000|Wash Out 3-7 Days|Overall Study||15
3082807|NCT01392859|3804764|FG001|Wash Out 3-7 Days|Overall Study||13
3082808|NCT01392859|3804765|FG002|Wash Out 3-7 Days|Overall Study||0
3082809|NCT01392859|3804763|FG000|COMPLETED|Overall Study||13
3082810|NCT01392859|3804764|FG001|COMPLETED|Overall Study||13
3082811|NCT01392859|3804765|FG002|COMPLETED|Overall Study||183
3082812|NCT01392859|3804763|FG000|NOT COMPLETED|Overall Study||2
3082813|NCT01392859|3804764|FG001|NOT COMPLETED|Overall Study||0
3082814|NCT01392859|3804765|FG002|NOT COMPLETED|Overall Study||0
3082815|NCT01392963|3804773|FG000|STARTED|Week 0 (First Intervention)||11
3082816|NCT01392963|3804774|FG001|STARTED|Week 0 (First Intervention)||19
3082817|NCT01392963|3804773|FG000|COMPLETED|Week 0 (First Intervention)||11
3082818|NCT01392963|3804774|FG001|COMPLETED|Week 0 (First Intervention)||17
3082819|NCT01392963|3804773|FG000|NOT COMPLETED|Week 0 (First Intervention)||0
3082820|NCT01392963|3804774|FG001|NOT COMPLETED|Week 0 (First Intervention)||2
3082821|NCT01392963|3804773|FG000|STARTED|Week 12 (Second Intervention)||11
3082822|NCT01392963|3804774|FG001|STARTED|Week 12 (Second Intervention)||17
3082823|NCT01392963|3804773|FG000|COMPLETED|Week 12 (Second Intervention)||11
3082824|NCT01392963|3804774|FG001|COMPLETED|Week 12 (Second Intervention)||17
3082825|NCT01392963|3804773|FG000|NOT COMPLETED|Week 12 (Second Intervention)||0
3082826|NCT01392963|3804774|FG001|NOT COMPLETED|Week 12 (Second Intervention)||0
3082827|NCT01392963|3804773|FG000|STARTED|Week 24 Follow-up||11
3082828|NCT01392963|3804774|FG001|STARTED|Week 24 Follow-up||17
3082829|NCT01392963|3804773|FG000|COMPLETED|Week 24 Follow-up||9
3082830|NCT01392963|3804774|FG001|COMPLETED|Week 24 Follow-up||17
3082831|NCT01392963|3804773|FG000|NOT COMPLETED|Week 24 Follow-up||2
3082832|NCT01392963|3804774|FG001|NOT COMPLETED|Week 24 Follow-up||0
3082833|NCT01392989|3804782|FG000|STARTED|Total Lymphoid Irradiation (TLI)||44
3082834|NCT01392989|3804782|FG000|COMPLETED|Total Lymphoid Irradiation (TLI)||44
3082835|NCT01392989|3804782|FG000|NOT COMPLETED|Total Lymphoid Irradiation (TLI)||0
3082836|NCT01392989|3804782|FG000|STARTED|CIK Cell Infusion||31
3082837|NCT01392989|3804782|FG000|COMPLETED|CIK Cell Infusion||31
3082838|NCT01392989|3804782|FG000|NOT COMPLETED|CIK Cell Infusion||0
3082839|NCT01393106|3804787|FG000|STARTED|Overall Study||25
3082840|NCT01393106|3804787|FG000|COMPLETED|Overall Study|Completed: Disease Progression/Death|20
3082841|NCT01393106|3804787|FG000|NOT COMPLETED|Overall Study||5
3082842|NCT01393132|3804793|FG000|STARTED|Overall Study||6
3082843|NCT01393132|3804794|FG001|STARTED|Overall Study||3
3082844|NCT01393132|3804793|FG000|COMPLETED|Overall Study||6
3082845|NCT01393132|3804794|FG001|COMPLETED|Overall Study||3
3082846|NCT01393132|3804793|FG000|NOT COMPLETED|Overall Study||0
3082847|NCT01393132|3804794|FG001|NOT COMPLETED|Overall Study||0
3082848|NCT01393158|3804804|FG000|STARTED|Overall Study||6
3082849|NCT01393158|3804805|FG001|STARTED|Overall Study||10
3082850|NCT01393158|3804804|FG000|COMPLETED|Overall Study||5
3082851|NCT01393158|3804805|FG001|COMPLETED|Overall Study||10
3082852|NCT01393158|3804804|FG000|NOT COMPLETED|Overall Study||1
3082853|NCT01393158|3804805|FG001|NOT COMPLETED|Overall Study||0
3082854|NCT01393301|3804819|FG000|STARTED|Overall Study||26
3082855|NCT01393301|3804820|FG001|STARTED|Overall Study||27
3082856|NCT01393301|3804819|FG000|COMPLETED|Overall Study||17
3082857|NCT01393301|3804820|FG001|COMPLETED|Overall Study||24
3286501|NCT02782780|4020093|FG001|STARTED|Overall Study||39
3286502|NCT02782780|4020092|FG000|COMPLETED|Overall Study||39
3082858|NCT01393301|3804819|FG000|NOT COMPLETED|Overall Study||9
3082859|NCT01393301|3804820|FG001|NOT COMPLETED|Overall Study||3
3082860|NCT01393392|3804828|FG000|STARTED|Overall Study||44
3082861|NCT01393392|3804829|FG001|STARTED|Overall Study||43
3082862|NCT01393392|3804828|FG000|COMPLETED|Overall Study||33
3082863|NCT01393392|3804829|FG001|COMPLETED|Overall Study||24
3082864|NCT01393392|3804828|FG000|NOT COMPLETED|Overall Study||11
3082865|NCT01393392|3804829|FG001|NOT COMPLETED|Overall Study||19
3082866|NCT01393405|3804835|FG000|STARTED|Induction Period (week1-16)||179
3082867|NCT01393405|3804836|FG001|STARTED|Induction Period (week1-16)||0
3082868|NCT01393405|3804837|FG002|STARTED|Induction Period (week1-16)||0
3082869|NCT01393405|3804835|FG000|COMPLETED|Induction Period (week1-16)||84
3082870|NCT01393405|3804836|FG001|COMPLETED|Induction Period (week1-16)||0
3082871|NCT01393405|3804837|FG002|COMPLETED|Induction Period (week1-16)||0
3082872|NCT01393405|3804835|FG000|NOT COMPLETED|Induction Period (week1-16)||95
3082873|NCT01393405|3804836|FG001|NOT COMPLETED|Induction Period (week1-16)||0
3082874|NCT01393405|3804837|FG002|NOT COMPLETED|Induction Period (week1-16)||0
3082875|NCT01393405|3804835|FG000|STARTED|Maintenance Period Week||0
3082876|NCT01393405|3804836|FG001|STARTED|Maintenance Period Week||44
3082877|NCT01393405|3804837|FG002|STARTED|Maintenance Period Week||40
3082878|NCT01393405|3804835|FG000|COMPLETED|Maintenance Period Week||0
3082879|NCT01393405|3804836|FG001|COMPLETED|Maintenance Period Week||15
3082880|NCT01393405|3804837|FG002|COMPLETED|Maintenance Period Week||16
3082881|NCT01393405|3804835|FG000|NOT COMPLETED|Maintenance Period Week||0
3082882|NCT01393405|3804836|FG001|NOT COMPLETED|Maintenance Period Week||29
3082883|NCT01393405|3804837|FG002|NOT COMPLETED|Maintenance Period Week||24
3082884|NCT01393444|3804847|FG000|STARTED|Overall Study||6
3082885|NCT01393444|3804847|FG000|First (1st Implanted) Subject Enrolled|Overall Study|2011: Individual with cervical spinal cord injury enrolled and was eligible. Implanted in 2011.|1
3082886|NCT01393444|3804847|FG000|Second Subject Enrolled|Overall Study|2012: Second participant enrolled. Ineligible.|1
3082887|NCT01393444|3804847|FG000|Third Subject Enrolled|Overall Study|2013: Third participant enrolled. Withdrew due to family commitments.|1
3082888|NCT01393444|3804847|FG000|Fourth Subject Enrolled|Overall Study|2013: Fourth participant enrolled. Ineligible.|1
3082889|NCT01393444|3804847|FG000|Fifth (2nd Implanted) Subject Enrolled|Overall Study|2013: Individual with ALS enrolled and was eligible. Implanted in 2014.|1
3082890|NCT01393444|3804847|FG000|Sixth (3rd Implanted) Subject|Overall Study|2014: Individual with brachial plexus injury enrolled and was eligible. Implanted in 2015.|1
3082891|NCT01393444|3804847|FG000|COMPLETED|Overall Study|2015: Third implanted subject completed the study. This fulfilled the requirements of our grant.|3
3082892|NCT01393444|3804847|FG000|NOT COMPLETED|Overall Study||3
3082893|NCT01393457|3804855|FG000|STARTED|Overall Study||26
3082894|NCT01393457|3804856|FG001|STARTED|Overall Study||26
3082895|NCT01393457|3804857|FG002|STARTED|Overall Study||31
3082896|NCT01393457|3804858|FG003|STARTED|Overall Study||27
3082897|NCT01393457|3804855|FG000|COMPLETED|Overall Study||14
3082898|NCT01393457|3804856|FG001|COMPLETED|Overall Study||14
3082899|NCT01393457|3804857|FG002|COMPLETED|Overall Study||16
3082900|NCT01393457|3804858|FG003|COMPLETED|Overall Study||15
3082901|NCT01393457|3804855|FG000|NOT COMPLETED|Overall Study||12
3082902|NCT01393457|3804856|FG001|NOT COMPLETED|Overall Study||12
3082903|NCT01393457|3804857|FG002|NOT COMPLETED|Overall Study||15
3082904|NCT01393457|3804858|FG003|NOT COMPLETED|Overall Study||12
3082905|NCT01393600|3804868|FG000|STARTED|Treatment Period 1 (Day 1 to 14)||9
3082906|NCT01393600|3804869|FG001|STARTED|Treatment Period 1 (Day 1 to 14)||8
3082907|NCT01393600|3804870|FG002|STARTED|Treatment Period 1 (Day 1 to 14)||10
3082908|NCT01393600|3804871|FG003|STARTED|Treatment Period 1 (Day 1 to 14)||10
3082909|NCT01393600|3804868|FG000|COMPLETED|Treatment Period 1 (Day 1 to 14)||9
3082910|NCT01393600|3804869|FG001|COMPLETED|Treatment Period 1 (Day 1 to 14)||7
3082911|NCT01393600|3804870|FG002|COMPLETED|Treatment Period 1 (Day 1 to 14)||9
3082912|NCT01393600|3804871|FG003|COMPLETED|Treatment Period 1 (Day 1 to 14)||9
3082913|NCT01393600|3804868|FG000|NOT COMPLETED|Treatment Period 1 (Day 1 to 14)||0
3082914|NCT01393600|3804869|FG001|NOT COMPLETED|Treatment Period 1 (Day 1 to 14)||1
3082915|NCT01393600|3804870|FG002|NOT COMPLETED|Treatment Period 1 (Day 1 to 14)||1
3082916|NCT01393600|3804871|FG003|NOT COMPLETED|Treatment Period 1 (Day 1 to 14)||1
3082917|NCT01393600|3804868|FG000|STARTED|Treatment Period 2 (Day 15 to 28)||9
3082918|NCT01393600|3804869|FG001|STARTED|Treatment Period 2 (Day 15 to 28)||7
3082919|NCT01393600|3804870|FG002|STARTED|Treatment Period 2 (Day 15 to 28)||9
3082920|NCT01393600|3804871|FG003|STARTED|Treatment Period 2 (Day 15 to 28)||9
3082921|NCT01393600|3804868|FG000|COMPLETED|Treatment Period 2 (Day 15 to 28)||9
3082922|NCT01393600|3804869|FG001|COMPLETED|Treatment Period 2 (Day 15 to 28)||7
3082923|NCT01393600|3804870|FG002|COMPLETED|Treatment Period 2 (Day 15 to 28)||7
3082924|NCT01393600|3804871|FG003|COMPLETED|Treatment Period 2 (Day 15 to 28)||8
3082925|NCT01393600|3804868|FG000|NOT COMPLETED|Treatment Period 2 (Day 15 to 28)||0
3082926|NCT01393600|3804869|FG001|NOT COMPLETED|Treatment Period 2 (Day 15 to 28)||0
3082927|NCT01393600|3804870|FG002|NOT COMPLETED|Treatment Period 2 (Day 15 to 28)||2
3082928|NCT01393600|3804871|FG003|NOT COMPLETED|Treatment Period 2 (Day 15 to 28)||1
3082929|NCT01393600|3804868|FG000|STARTED|Follow-up Period (Day 29 to 35)||9
3082930|NCT01393600|3804869|FG001|STARTED|Follow-up Period (Day 29 to 35)||7
3082931|NCT01393600|3804870|FG002|STARTED|Follow-up Period (Day 29 to 35)||7
3082932|NCT01393600|3804871|FG003|STARTED|Follow-up Period (Day 29 to 35)||8
3082933|NCT01393600|3804868|FG000|COMPLETED|Follow-up Period (Day 29 to 35)||9
3082934|NCT01393600|3804869|FG001|COMPLETED|Follow-up Period (Day 29 to 35)||7
3082935|NCT01393600|3804870|FG002|COMPLETED|Follow-up Period (Day 29 to 35)||6
3082936|NCT01393600|3804871|FG003|COMPLETED|Follow-up Period (Day 29 to 35)||8
3082937|NCT01393600|3804868|FG000|NOT COMPLETED|Follow-up Period (Day 29 to 35)||0
3082938|NCT01393600|3804869|FG001|NOT COMPLETED|Follow-up Period (Day 29 to 35)||0
3082939|NCT01393600|3804870|FG002|NOT COMPLETED|Follow-up Period (Day 29 to 35)||1
3082940|NCT01393600|3804871|FG003|NOT COMPLETED|Follow-up Period (Day 29 to 35)||0
3082941|NCT01393613|3804887|FG000|STARTED|Overall Study||120
3082942|NCT01393613|3804888|FG001|STARTED|Overall Study||186
3082943|NCT01393613|3804889|FG002|STARTED|Overall Study||184
3082944|NCT01393613|3804890|FG003|STARTED|Overall Study||184
3082945|NCT01393613|3804887|FG000|COMPLETED|Overall Study||81
3082946|NCT01393613|3804888|FG001|COMPLETED|Overall Study||129
3082947|NCT01393613|3804889|FG002|COMPLETED|Overall Study||130
3082948|NCT01393613|3804890|FG003|COMPLETED|Overall Study||118
3082949|NCT01393613|3804887|FG000|NOT COMPLETED|Overall Study||39
3082950|NCT01393613|3804888|FG001|NOT COMPLETED|Overall Study||57
3082951|NCT01393613|3804889|FG002|NOT COMPLETED|Overall Study||54
3082952|NCT01393613|3804890|FG003|NOT COMPLETED|Overall Study||66
3082953|NCT01393626|3804906|FG000|STARTED|Overall Study||91
3082954|NCT01393626|3804907|FG001|STARTED|Overall Study||86
3082955|NCT01393626|3804908|FG002|STARTED|Overall Study||86
3082956|NCT01393626|3804909|FG003|STARTED|Overall Study||16
3082957|NCT01393626|3804906|FG000|COMPLETED|Overall Study||73
3082958|NCT01393626|3804907|FG001|COMPLETED|Overall Study||74
3082959|NCT01393626|3804908|FG002|COMPLETED|Overall Study||74
3082960|NCT01393626|3804909|FG003|COMPLETED|Overall Study||15
3082961|NCT01393626|3804906|FG000|NOT COMPLETED|Overall Study||18
3082962|NCT01393626|3804907|FG001|NOT COMPLETED|Overall Study||12
3082963|NCT01393626|3804908|FG002|NOT COMPLETED|Overall Study||12
3082964|NCT01393626|3804909|FG003|NOT COMPLETED|Overall Study||1
3082965|NCT01393704|3804928|FG000|STARTED|Overall Study||76
3082966|NCT01393704|3804929|FG001|STARTED|Overall Study||76
3082967|NCT01393704|3804928|FG000|COMPLETED|Overall Study||76
3082968|NCT01393704|3804929|FG001|COMPLETED|Overall Study||76
3082969|NCT01393704|3804928|FG000|NOT COMPLETED|Overall Study||0
3082970|NCT01393704|3804929|FG001|NOT COMPLETED|Overall Study||0
3082971|NCT01393717|3804935|FG000|STARTED|Overall Study||37
3082972|NCT01393717|3804936|FG001|STARTED|Overall Study||20
3082973|NCT01393717|3804935|FG000|COMPLETED|Overall Study||37
3082974|NCT01393717|3804936|FG001|COMPLETED|Overall Study||20
3082975|NCT01393717|3804935|FG000|NOT COMPLETED|Overall Study||0
3082976|NCT01393717|3804936|FG001|NOT COMPLETED|Overall Study||0
3082977|NCT01393730|3804946|FG000|STARTED|Overall Study||40
3082978|NCT01393730|3804946|FG000|Treated|Overall Study||38
3082979|NCT01393730|3804946|FG000|Evaluable AR Amplification|Overall Study||21
3082980|NCT01393730|3804946|FG000|Evaluable AR Mutation|Overall Study||14
3082981|NCT01393730|3804946|FG000|COMPLETED|Overall Study||34
3082982|NCT01393730|3804946|FG000|NOT COMPLETED|Overall Study||6
3082983|NCT01393743|3804952|FG000|STARTED|Core Study|Treated|82
3082984|NCT01393743|3804953|FG001|STARTED|Core Study|Treated|81
3082985|NCT01393743|3804954|FG002|STARTED|Core Study||0
3082986|NCT01393743|3804952|FG000|COMPLETED|Core Study||72
3082987|NCT01393743|3804953|FG001|COMPLETED|Core Study||68
3082988|NCT01393743|3804954|FG002|COMPLETED|Core Study||0
3082989|NCT01393743|3804952|FG000|NOT COMPLETED|Core Study||10
3082990|NCT01393743|3804953|FG001|NOT COMPLETED|Core Study||13
3082991|NCT01393743|3804954|FG002|NOT COMPLETED|Core Study||0
3082992|NCT01393743|3804952|FG000|STARTED|Extension Phase||0
3082993|NCT01393743|3804953|FG001|STARTED|Extension Phase||0
3082994|NCT01393743|3804954|FG002|STARTED|Extension Phase|Continuation into the Extension Phase was optional.|138
3082995|NCT01393743|3804952|FG000|COMPLETED|Extension Phase||0
3082996|NCT01393743|3804953|FG001|COMPLETED|Extension Phase||0
3082997|NCT01393743|3804954|FG002|COMPLETED|Extension Phase||78
3082998|NCT01393743|3804952|FG000|NOT COMPLETED|Extension Phase||0
3082999|NCT01393743|3804953|FG001|NOT COMPLETED|Extension Phase||0
3083000|NCT01393743|3804954|FG002|NOT COMPLETED|Extension Phase||60
3083001|NCT01393821|3804967|FG000|STARTED|Overall Study||14
3083002|NCT01393821|3804968|FG001|STARTED|Overall Study||13
3083003|NCT01393821|3804967|FG000|COMPLETED|Overall Study||9
3083004|NCT01393821|3804968|FG001|COMPLETED|Overall Study||10
3083005|NCT01393821|3804967|FG000|NOT COMPLETED|Overall Study||5
3083006|NCT01393821|3804968|FG001|NOT COMPLETED|Overall Study||3
3083007|NCT01393899|3804977|FG000|STARTED|Overall Study||59
3083008|NCT01393899|3804978|FG001|STARTED|Overall Study||60
3083009|NCT01393899|3804979|FG002|STARTED|Overall Study||61
3083010|NCT01393899|3804977|FG000|COMPLETED|Overall Study||27
3083011|NCT01393899|3804978|FG001|COMPLETED|Overall Study||32
3083012|NCT01393899|3804979|FG002|COMPLETED|Overall Study||38
3083013|NCT01393899|3804977|FG000|NOT COMPLETED|Overall Study||32
3083014|NCT01393899|3804978|FG001|NOT COMPLETED|Overall Study||28
3286503|NCT02782780|4020093|FG001|COMPLETED|Overall Study||32
3286504|NCT02782780|4020092|FG000|NOT COMPLETED|Overall Study||7
3286505|NCT02782780|4020093|FG001|NOT COMPLETED|Overall Study||7
3286506|NCT02782923|4020099|FG000|STARTED|Overall Study||19
3286507|NCT02782923|4020099|FG000|COMPLETED|Overall Study||4
3286508|NCT02782923|4020099|FG000|NOT COMPLETED|Overall Study||15
3286509|NCT02783027|4020105|FG000|STARTED|Overall Study||39
3286510|NCT02783027|4020106|FG001|STARTED|Overall Study||44
3286511|NCT02783027|4020105|FG000|COMPLETED|Overall Study||16
3286512|NCT02783027|4020106|FG001|COMPLETED|Overall Study||27
3083015|NCT01393899|3804979|FG002|NOT COMPLETED|Overall Study||23
3083016|NCT01393964|3804992|FG000|STARTED|Overall Study||8
3083017|NCT01393964|3804993|FG001|STARTED|Overall Study||9
3083018|NCT01393964|3804994|FG002|STARTED|Overall Study||9
3083019|NCT01393964|3804992|FG000|COMPLETED|Overall Study|Completed=treatment on-going|0
3083020|NCT01393964|3804993|FG001|COMPLETED|Overall Study|Completed=treatment on-going|0
3083021|NCT01393964|3804994|FG002|COMPLETED|Overall Study|Completed=treatment on-going|0
3286513|NCT02783027|4020105|FG000|NOT COMPLETED|Overall Study||23
3286514|NCT02783027|4020106|FG001|NOT COMPLETED|Overall Study||17
3083022|NCT01393964|3804992|FG000|NOT COMPLETED|Overall Study||8
3083023|NCT01393964|3804993|FG001|NOT COMPLETED|Overall Study||9
3083024|NCT01393964|3804994|FG002|NOT COMPLETED|Overall Study||9
3083025|NCT01393990|3805026|FG000|STARTED|Overall Study||4
3083026|NCT01393990|3805027|FG001|STARTED|Overall Study||3
3083027|NCT01393990|3805028|FG002|STARTED|Overall Study||3
3083028|NCT01393990|3805029|FG003|STARTED|Overall Study||3
3083029|NCT01393990|3805030|FG004|STARTED|Overall Study||5
3083030|NCT01393990|3805031|FG005|STARTED|Overall Study||3
3083031|NCT01393990|3805032|FG006|STARTED|Overall Study||3
3083032|NCT01393990|3805033|FG007|STARTED|Overall Study||7
3083033|NCT01393990|3805034|FG008|STARTED|Overall Study||6
3083034|NCT01393990|3805035|FG009|STARTED|Overall Study||3
3083035|NCT01393990|3805036|FG010|STARTED|Overall Study||3
3083036|NCT01393990|3805037|FG011|STARTED|Overall Study||3
3083037|NCT01393990|3805038|FG012|STARTED|Overall Study||3
3083038|NCT01393990|3805039|FG013|STARTED|Overall Study||5
3083039|NCT01393990|3805040|FG014|STARTED|Overall Study||18
3083040|NCT01393990|3805041|FG015|STARTED|Overall Study||8
3083041|NCT01393990|3805042|FG016|STARTED|Overall Study||3
3083042|NCT01393990|3805043|FG017|STARTED|Overall Study||6
3083043|NCT01393990|3805026|FG000|Received at Least 1 Dose of Study Drug|Overall Study||4
3083044|NCT01393990|3805027|FG001|Received at Least 1 Dose of Study Drug|Overall Study||3
3083045|NCT01393990|3805028|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3
3083046|NCT01393990|3805029|FG003|Received at Least 1 Dose of Study Drug|Overall Study||3
3083047|NCT01393990|3805030|FG004|Received at Least 1 Dose of Study Drug|Overall Study||5
3083048|NCT01393990|3805031|FG005|Received at Least 1 Dose of Study Drug|Overall Study||3
3083049|NCT01393990|3805032|FG006|Received at Least 1 Dose of Study Drug|Overall Study||3
3083050|NCT01393990|3805033|FG007|Received at Least 1 Dose of Study Drug|Overall Study||7
3083051|NCT01393990|3805034|FG008|Received at Least 1 Dose of Study Drug|Overall Study||6
3083052|NCT01393990|3805035|FG009|Received at Least 1 Dose of Study Drug|Overall Study||3
3083053|NCT01393990|3805036|FG010|Received at Least 1 Dose of Study Drug|Overall Study||3
3083054|NCT01393990|3805037|FG011|Received at Least 1 Dose of Study Drug|Overall Study||3
3083055|NCT01393990|3805038|FG012|Received at Least 1 Dose of Study Drug|Overall Study||3
3083056|NCT01393990|3805039|FG013|Received at Least 1 Dose of Study Drug|Overall Study||5
3134854|NCT01703169|3859801|FG000|STARTED|Overall Study||13
3286515|NCT02783066|4020112|FG000|STARTED|Overall Study||16
3286516|NCT02783066|4020112|FG000|COMPLETED|Overall Study|complete 4-week pulseflow offloading wearing test|3
3286517|NCT02783066|4020112|FG000|NOT COMPLETED|Overall Study||13
3286518|NCT02783170|4020119|FG000|STARTED|Overall Study||43
3286519|NCT02783170|4020120|FG001|STARTED|Overall Study||38
3286520|NCT02783170|4020119|FG000|Safety Population|Overall Study|Added subject randomized to sequential but got simultaneous.|42
3286521|NCT02783170|4020120|FG001|Safety Population|Overall Study|Excluded sub. randomized but not vaccinated. Excluded sub. randomized to seq. but got simultaneous.|38
3286522|NCT02783170|4020119|FG000|COMPLETED|Overall Study||42
3286523|NCT02783170|4020120|FG001|COMPLETED|Overall Study||38
3286524|NCT02783170|4020119|FG000|NOT COMPLETED|Overall Study||1
3286525|NCT02783170|4020120|FG001|NOT COMPLETED|Overall Study||0
3286526|NCT02783443|4020129|FG000|STARTED|Overall Study||30
3286527|NCT02783443|4020130|FG001|STARTED|Overall Study||30
3286528|NCT02783443|4020129|FG000|COMPLETED|Overall Study||30
3286529|NCT02783443|4020130|FG001|COMPLETED|Overall Study||30
3286530|NCT02783443|4020129|FG000|NOT COMPLETED|Overall Study||0
3286531|NCT02783443|4020130|FG001|NOT COMPLETED|Overall Study||0
3286532|NCT02783469|4020136|FG000|STARTED|Overall Study||1915
3286533|NCT02783469|4020136|FG000|COMPLETED|Overall Study||1915
3286534|NCT02783469|4020136|FG000|NOT COMPLETED|Overall Study||0
3286535|NCT02783573|4020143|FG000|STARTED|Placebo-Controlled Treatment Period||562
3286536|NCT02783573|4020144|FG001|STARTED|Placebo-Controlled Treatment Period||590
3286537|NCT02783573|4020145|FG002|STARTED|Placebo-Controlled Treatment Period||570
3286538|NCT02783573|4020143|FG000|Received at Least 1 Dose of Study Drug|Placebo-Controlled Treatment Period||558
3286539|NCT02783573|4020144|FG001|Received at Least 1 Dose of Study Drug|Placebo-Controlled Treatment Period||588
3286540|NCT02783573|4020145|FG002|Received at Least 1 Dose of Study Drug|Placebo-Controlled Treatment Period||568
3286541|NCT02783573|4020143|FG000|COMPLETED|Placebo-Controlled Treatment Period||26
3286542|NCT02783573|4020144|FG001|COMPLETED|Placebo-Controlled Treatment Period||28
3286543|NCT02783573|4020145|FG002|COMPLETED|Placebo-Controlled Treatment Period||22
3286544|NCT02783573|4020143|FG000|NOT COMPLETED|Placebo-Controlled Treatment Period||536
3286545|NCT02783573|4020144|FG001|NOT COMPLETED|Placebo-Controlled Treatment Period||562
3286546|NCT02783573|4020145|FG002|NOT COMPLETED|Placebo-Controlled Treatment Period||548
3286547|NCT02783573|4020143|FG000|STARTED|Delayed-Start Period|Participants from placebo group were randomized to Lanabecestat 20 mg and 50 mg.|0
3286548|NCT02783573|4020144|FG001|STARTED|Delayed-Start Period|Participants completed period 1 may not have entered period 2 due to early termination of the study.|17
3286549|NCT02783573|4020145|FG002|STARTED|Delayed-Start Period|Participants completed period 1 may not have entered period 2 due to early termination of the study.|12
3286550|NCT02783573|4020143|FG000|Received at Least 1 Dose of Study Drug|Delayed-Start Period||0
3286551|NCT02783573|4020144|FG001|Received at Least 1 Dose of Study Drug|Delayed-Start Period||14
3286552|NCT02783573|4020145|FG002|Received at Least 1 Dose of Study Drug|Delayed-Start Period||12
3286553|NCT02783573|4020143|FG000|COMPLETED|Delayed-Start Period||0
3286554|NCT02783573|4020144|FG001|COMPLETED|Delayed-Start Period||0
3286555|NCT02783573|4020145|FG002|COMPLETED|Delayed-Start Period||0
3083057|NCT01393990|3805040|FG014|Received at Least 1 Dose of Study Drug|Overall Study||18
3083058|NCT01393990|3805041|FG015|Received at Least 1 Dose of Study Drug|Overall Study||8
3083059|NCT01393990|3805042|FG016|Received at Least 1 Dose of Study Drug|Overall Study||3
3083060|NCT01393990|3805043|FG017|Received at Least 1 Dose of Study Drug|Overall Study||6
3083061|NCT01393990|3805026|FG000|COMPLETED|Overall Study||3
3083062|NCT01393990|3805027|FG001|COMPLETED|Overall Study||3
3083063|NCT01393990|3805028|FG002|COMPLETED|Overall Study||3
3083064|NCT01393990|3805029|FG003|COMPLETED|Overall Study||2
3083065|NCT01393990|3805030|FG004|COMPLETED|Overall Study||3
3083066|NCT01393990|3805031|FG005|COMPLETED|Overall Study||2
3083067|NCT01393990|3805032|FG006|COMPLETED|Overall Study||2
3083068|NCT01393990|3805033|FG007|COMPLETED|Overall Study||6
3083069|NCT01393990|3805034|FG008|COMPLETED|Overall Study||3
3083070|NCT01393990|3805035|FG009|COMPLETED|Overall Study||2
3083071|NCT01393990|3805036|FG010|COMPLETED|Overall Study||3
3083072|NCT01393990|3805037|FG011|COMPLETED|Overall Study||3
3286556|NCT02783573|4020143|FG000|NOT COMPLETED|Delayed-Start Period||0
3286557|NCT02783573|4020144|FG001|NOT COMPLETED|Delayed-Start Period||17
3286558|NCT02783573|4020145|FG002|NOT COMPLETED|Delayed-Start Period||12
3286559|NCT02783599|4020156|FG000|STARTED|Overall Study||51
3286560|NCT02783599|4020156|FG000|Received At Least One Dose of Study Drug|Overall Study||51
3286561|NCT02783599|4020156|FG000|COMPLETED|Overall Study||11
3286562|NCT02783599|4020156|FG000|NOT COMPLETED|Overall Study||40
3286563|NCT02783729|4020171|FG000|STARTED|Overall Study||208
3286564|NCT02783729|4020172|FG001|STARTED|Overall Study||263
3286565|NCT02783729|4020173|FG002|STARTED|Overall Study||266
3286566|NCT02783729|4020174|FG003|STARTED|Overall Study||269
3286567|NCT02783729|4020171|FG000|COMPLETED|Overall Study||198
3286568|NCT02783729|4020172|FG001|COMPLETED|Overall Study||246
3286569|NCT02783729|4020173|FG002|COMPLETED|Overall Study||258
3286570|NCT02783729|4020174|FG003|COMPLETED|Overall Study||260
3286571|NCT02783729|4020171|FG000|NOT COMPLETED|Overall Study||10
3286572|NCT02783729|4020172|FG001|NOT COMPLETED|Overall Study||17
3286573|NCT02783729|4020173|FG002|NOT COMPLETED|Overall Study||8
3286574|NCT02783729|4020174|FG003|NOT COMPLETED|Overall Study||9
3286575|NCT02783768|4020189|FG000|STARTED|Overall Study||6
3286576|NCT02783768|4020190|FG001|STARTED|Overall Study||5
3286577|NCT02783768|4020189|FG000|COMPLETED|Overall Study||5
3286578|NCT02783768|4020190|FG001|COMPLETED|Overall Study||5
3286579|NCT02783768|4020189|FG000|NOT COMPLETED|Overall Study||1
3286580|NCT02783768|4020190|FG001|NOT COMPLETED|Overall Study||0
3286581|NCT02783820|4020200|FG000|STARTED|Overall Study||6
3286582|NCT02783820|4020201|FG001|STARTED|Overall Study||6
3286583|NCT02783820|4020202|FG002|STARTED|Overall Study||6
3286584|NCT02783820|4020203|FG003|STARTED|Overall Study||6
3286585|NCT02783820|4020200|FG000|COMPLETED|Overall Study||6
3286586|NCT02783820|4020201|FG001|COMPLETED|Overall Study||6
3286587|NCT02783820|4020202|FG002|COMPLETED|Overall Study||6
3286588|NCT02783820|4020203|FG003|COMPLETED|Overall Study||6
3286589|NCT02783820|4020200|FG000|NOT COMPLETED|Overall Study||0
3286590|NCT02783820|4020201|FG001|NOT COMPLETED|Overall Study||0
3286591|NCT02783820|4020202|FG002|NOT COMPLETED|Overall Study||0
3286592|NCT02783820|4020203|FG003|NOT COMPLETED|Overall Study||0
3286593|NCT02783898|4020215|FG000|STARTED|Overall Study||125
3286594|NCT02783898|4020216|FG001|STARTED|Overall Study||117
3286595|NCT02783898|4020215|FG000|COMPLETED|Overall Study||124
3286596|NCT02783898|4020216|FG001|COMPLETED|Overall Study||116
3286597|NCT02783898|4020215|FG000|NOT COMPLETED|Overall Study||1
3286598|NCT02783898|4020216|FG001|NOT COMPLETED|Overall Study||1
3286599|NCT02783911|4020226|FG000|STARTED|Overall Study||11
3286600|NCT02783911|4020227|FG001|STARTED|Overall Study||46
3286601|NCT02783911|4020226|FG000|COMPLETED|Overall Study||8
3286602|NCT02783911|4020227|FG001|COMPLETED|Overall Study||14
3286603|NCT02783911|4020226|FG000|NOT COMPLETED|Overall Study||3
3286604|NCT02783911|4020227|FG001|NOT COMPLETED|Overall Study||32
3286605|NCT02783950|4020235|FG000|STARTED|Overall Study||182
3286606|NCT02783950|4020236|FG001|STARTED|Overall Study||174
3286607|NCT02783950|4020235|FG000|COMPLETED|Overall Study||175
3286608|NCT02783950|4020236|FG001|COMPLETED|Overall Study||165
3286609|NCT02783950|4020235|FG000|NOT COMPLETED|Overall Study||7
3286610|NCT02783950|4020236|FG001|NOT COMPLETED|Overall Study||9
3286611|NCT02784106|4020244|FG000|STARTED|Double-Blind Treatment Period (12 Weeks)||32
3286612|NCT02784106|4020245|FG001|STARTED|Double-Blind Treatment Period (12 Weeks)||33
3286613|NCT02784106|4020246|FG002|STARTED|Double-Blind Treatment Period (12 Weeks)||0
3286614|NCT02784106|4020247|FG003|STARTED|Double-Blind Treatment Period (12 Weeks)||0
3286615|NCT02784106|4020244|FG000|COMPLETED|Double-Blind Treatment Period (12 Weeks)||24
3286616|NCT02784106|4020245|FG001|COMPLETED|Double-Blind Treatment Period (12 Weeks)||27
3286617|NCT02784106|4020246|FG002|COMPLETED|Double-Blind Treatment Period (12 Weeks)||0
3083073|NCT01393990|3805038|FG012|COMPLETED|Overall Study||3
3083074|NCT01393990|3805039|FG013|COMPLETED|Overall Study||3
3083075|NCT01393990|3805040|FG014|COMPLETED|Overall Study||9
3083076|NCT01393990|3805041|FG015|COMPLETED|Overall Study||5
3083077|NCT01393990|3805042|FG016|COMPLETED|Overall Study||3
3286618|NCT02784106|4020247|FG003|COMPLETED|Double-Blind Treatment Period (12 Weeks)||0
3286619|NCT02784106|4020244|FG000|NOT COMPLETED|Double-Blind Treatment Period (12 Weeks)||8
3286620|NCT02784106|4020245|FG001|NOT COMPLETED|Double-Blind Treatment Period (12 Weeks)||6
3286621|NCT02784106|4020246|FG002|NOT COMPLETED|Double-Blind Treatment Period (12 Weeks)||0
3286622|NCT02784106|4020247|FG003|NOT COMPLETED|Double-Blind Treatment Period (12 Weeks)||0
3083078|NCT01393990|3805043|FG017|COMPLETED|Overall Study||6
3083079|NCT01393990|3805026|FG000|NOT COMPLETED|Overall Study||1
3083080|NCT01393990|3805027|FG001|NOT COMPLETED|Overall Study||0
3083081|NCT01393990|3805028|FG002|NOT COMPLETED|Overall Study||0
3083082|NCT01393990|3805029|FG003|NOT COMPLETED|Overall Study||1
3083083|NCT01393990|3805030|FG004|NOT COMPLETED|Overall Study||2
3083084|NCT01393990|3805031|FG005|NOT COMPLETED|Overall Study||1
3083085|NCT01393990|3805032|FG006|NOT COMPLETED|Overall Study||1
3083086|NCT01393990|3805033|FG007|NOT COMPLETED|Overall Study||1
3083087|NCT01393990|3805034|FG008|NOT COMPLETED|Overall Study||3
3083088|NCT01393990|3805035|FG009|NOT COMPLETED|Overall Study||1
3083089|NCT01393990|3805036|FG010|NOT COMPLETED|Overall Study||0
3083090|NCT01393990|3805037|FG011|NOT COMPLETED|Overall Study||0
3083091|NCT01393990|3805038|FG012|NOT COMPLETED|Overall Study||0
3083092|NCT01393990|3805039|FG013|NOT COMPLETED|Overall Study||2
3083093|NCT01393990|3805040|FG014|NOT COMPLETED|Overall Study||9
3083094|NCT01393990|3805041|FG015|NOT COMPLETED|Overall Study||3
3083095|NCT01393990|3805042|FG016|NOT COMPLETED|Overall Study||0
3083096|NCT01393990|3805043|FG017|NOT COMPLETED|Overall Study||0
3083097|NCT01394003|3805100|FG000|STARTED|Overall Study||3
3083098|NCT01394003|3805101|FG001|STARTED|Overall Study||8
3083099|NCT01394003|3805102|FG002|STARTED|Overall Study||3
3083100|NCT01394003|3805103|FG003|STARTED|Overall Study||6
3083101|NCT01394003|3805104|FG004|STARTED|Overall Study||3
3083102|NCT01394003|3805105|FG005|STARTED|Overall Study||3
3286623|NCT02784106|4020244|FG000|STARTED|Open-Label Extension Period (26 Weeks)||0
3286624|NCT02784106|4020245|FG001|STARTED|Open-Label Extension Period (26 Weeks)||0
3286625|NCT02784106|4020246|FG002|STARTED|Open-Label Extension Period (26 Weeks)||18
3286626|NCT02784106|4020247|FG003|STARTED|Open-Label Extension Period (26 Weeks)||21
3286627|NCT02784106|4020244|FG000|COMPLETED|Open-Label Extension Period (26 Weeks)||0
3286628|NCT02784106|4020245|FG001|COMPLETED|Open-Label Extension Period (26 Weeks)||0
3286629|NCT02784106|4020246|FG002|COMPLETED|Open-Label Extension Period (26 Weeks)||15
3286630|NCT02784106|4020247|FG003|COMPLETED|Open-Label Extension Period (26 Weeks)||19
3286631|NCT02784106|4020244|FG000|NOT COMPLETED|Open-Label Extension Period (26 Weeks)||0
3286632|NCT02784106|4020245|FG001|NOT COMPLETED|Open-Label Extension Period (26 Weeks)||0
3286633|NCT02784106|4020246|FG002|NOT COMPLETED|Open-Label Extension Period (26 Weeks)||3
3286634|NCT02784106|4020247|FG003|NOT COMPLETED|Open-Label Extension Period (26 Weeks)||2
3286635|NCT02784275|4020260|FG000|STARTED|Overall Study||16
3286636|NCT02784275|4020261|FG001|STARTED|Overall Study||16
3286637|NCT02784275|4020262|FG002|STARTED|Overall Study||17
3286638|NCT02784275|4020263|FG003|STARTED|Overall Study||15
3286639|NCT02784275|4020260|FG000|COMPLETED|Overall Study||15
3286640|NCT02784275|4020261|FG001|COMPLETED|Overall Study||16
3286641|NCT02784275|4020262|FG002|COMPLETED|Overall Study||16
3286642|NCT02784275|4020263|FG003|COMPLETED|Overall Study||14
3286643|NCT02784275|4020260|FG000|NOT COMPLETED|Overall Study||1
3286644|NCT02784275|4020261|FG001|NOT COMPLETED|Overall Study||0
3286645|NCT02784275|4020262|FG002|NOT COMPLETED|Overall Study||1
3286646|NCT02784275|4020263|FG003|NOT COMPLETED|Overall Study||1
3286647|NCT02784431|4020273|FG000|STARTED|Overall Study||20
3286648|NCT02784431|4020273|FG000|COMPLETED|Overall Study||0
3286649|NCT02784431|4020273|FG000|NOT COMPLETED|Overall Study||20
3286650|NCT02784444|4020281|FG000|STARTED|Overall Study||94
3286651|NCT02784444|4020282|FG001|STARTED|Overall Study||99
3286652|NCT02784444|4020283|FG002|STARTED|Overall Study||98
3286653|NCT02784444|4020284|FG003|STARTED|Overall Study||101
3286654|NCT02784444|4020281|FG000|COMPLETED|Overall Study||78
3286655|NCT02784444|4020282|FG001|COMPLETED|Overall Study||90
3286656|NCT02784444|4020283|FG002|COMPLETED|Overall Study||86
3286657|NCT02784444|4020284|FG003|COMPLETED|Overall Study||88
3286658|NCT02784444|4020281|FG000|NOT COMPLETED|Overall Study||16
3286659|NCT02784444|4020282|FG001|NOT COMPLETED|Overall Study||9
3286660|NCT02784444|4020283|FG002|NOT COMPLETED|Overall Study||12
3286661|NCT02784444|4020284|FG003|NOT COMPLETED|Overall Study||13
3286662|NCT02784548|4020294|FG000|STARTED|Overall Study||15
3286663|NCT02784548|4020294|FG000|COMPLETED|Overall Study||15
3286664|NCT02784548|4020294|FG000|NOT COMPLETED|Overall Study||0
3286665|NCT02784587|4020299|FG000|STARTED|Overall Study||25
3286666|NCT02784587|4020299|FG000|COMPLETED|Overall Study||25
3286667|NCT02784587|4020299|FG000|NOT COMPLETED|Overall Study||0
3286668|NCT02784613|4020303|FG000|STARTED|Overall Study||10
3286669|NCT02784613|4020303|FG000|COMPLETED|Overall Study||8
3286670|NCT02784613|4020303|FG000|NOT COMPLETED|Overall Study||2
3286671|NCT02784834|4020307|FG000|STARTED|Overall Study||2
3286672|NCT02784834|4020307|FG000|COMPLETED|Overall Study||1
3286673|NCT02784834|4020307|FG000|NOT COMPLETED|Overall Study||1
3286674|NCT02784925|4020311|FG000|STARTED|Overall Study||30
3286675|NCT02784925|4020311|FG000|COMPLETED|Overall Study||30
3286676|NCT02784925|4020311|FG000|NOT COMPLETED|Overall Study||0
3286677|NCT02785159|4020319|FG000|STARTED|Overall Study||62
3286678|NCT02785159|4020320|FG001|STARTED|Overall Study||58
3286679|NCT02785159|4020321|FG002|STARTED|Overall Study||15
3083103|NCT01394003|3805106|FG006|STARTED|Overall Study||6
3083104|NCT01394003|3805107|FG007|STARTED|Overall Study||2
3083105|NCT01394003|3805100|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
3083106|NCT01394003|3805101|FG001|Received at Least 1 Dose of Study Drug|Overall Study||8
3286680|NCT02785159|4020322|FG003|STARTED|Overall Study||17
3286681|NCT02785159|4020319|FG000|COMPLETED|Overall Study||51
3286682|NCT02785159|4020320|FG001|COMPLETED|Overall Study||45
3083107|NCT01394003|3805102|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3
3083108|NCT01394003|3805103|FG003|Received at Least 1 Dose of Study Drug|Overall Study||6
3083109|NCT01394003|3805104|FG004|Received at Least 1 Dose of Study Drug|Overall Study||3
3083110|NCT01394003|3805105|FG005|Received at Least 1 Dose of Study Drug|Overall Study||3
3083111|NCT01394003|3805106|FG006|Received at Least 1 Dose of Study Drug|Overall Study||6
3083112|NCT01394003|3805107|FG007|Received at Least 1 Dose of Study Drug|Overall Study||2
3083113|NCT01394003|3805100|FG000|COMPLETED|Overall Study||3
3083114|NCT01394003|3805101|FG001|COMPLETED|Overall Study||8
3083115|NCT01394003|3805102|FG002|COMPLETED|Overall Study||3
3083116|NCT01394003|3805103|FG003|COMPLETED|Overall Study||6
3083117|NCT01394003|3805104|FG004|COMPLETED|Overall Study||3
3083118|NCT01394003|3805105|FG005|COMPLETED|Overall Study||3
3083119|NCT01394003|3805106|FG006|COMPLETED|Overall Study||6
3083120|NCT01394003|3805107|FG007|COMPLETED|Overall Study||2
3083121|NCT01394003|3805100|FG000|NOT COMPLETED|Overall Study||0
3083122|NCT01394003|3805101|FG001|NOT COMPLETED|Overall Study||0
3083123|NCT01394003|3805102|FG002|NOT COMPLETED|Overall Study||0
3083124|NCT01394003|3805103|FG003|NOT COMPLETED|Overall Study||0
3083125|NCT01394003|3805104|FG004|NOT COMPLETED|Overall Study||0
3083126|NCT01394003|3805105|FG005|NOT COMPLETED|Overall Study||0
3286683|NCT02785159|4020321|FG002|COMPLETED|Overall Study||12
3286684|NCT02785159|4020322|FG003|COMPLETED|Overall Study||14
3286685|NCT02785159|4020319|FG000|NOT COMPLETED|Overall Study||11
3286686|NCT02785159|4020320|FG001|NOT COMPLETED|Overall Study||13
3286687|NCT02785159|4020321|FG002|NOT COMPLETED|Overall Study||3
3286688|NCT02785159|4020322|FG003|NOT COMPLETED|Overall Study||3
3286689|NCT02785172|4020336|FG000|STARTED|Overall Study||61
3286690|NCT02785172|4020337|FG001|STARTED|Overall Study||63
3286691|NCT02785172|4020338|FG002|STARTED|Overall Study||16
3286692|NCT02785172|4020339|FG003|STARTED|Overall Study||14
3286693|NCT02785172|4020336|FG000|COMPLETED|Overall Study||61
3286694|NCT02785172|4020337|FG001|COMPLETED|Overall Study||62
3286695|NCT02785172|4020338|FG002|COMPLETED|Overall Study||15
3286696|NCT02785172|4020339|FG003|COMPLETED|Overall Study||14
3286697|NCT02785172|4020336|FG000|NOT COMPLETED|Overall Study||0
3286698|NCT02785172|4020337|FG001|NOT COMPLETED|Overall Study||1
3286699|NCT02785172|4020338|FG002|NOT COMPLETED|Overall Study||1
3286700|NCT02785172|4020339|FG003|NOT COMPLETED|Overall Study||0
3286701|NCT02785185|4020353|FG000|STARTED|Overall Study||60
3286702|NCT02785185|4020354|FG001|STARTED|Overall Study||57
3286703|NCT02785185|4020355|FG002|STARTED|Overall Study||17
3286704|NCT02785185|4020356|FG003|STARTED|Overall Study||16
3286705|NCT02785185|4020353|FG000|COMPLETED|Overall Study||59
3286706|NCT02785185|4020354|FG001|COMPLETED|Overall Study||56
3286707|NCT02785185|4020355|FG002|COMPLETED|Overall Study||15
3286708|NCT02785185|4020356|FG003|COMPLETED|Overall Study||16
3286709|NCT02785185|4020353|FG000|NOT COMPLETED|Overall Study||1
3286710|NCT02785185|4020354|FG001|NOT COMPLETED|Overall Study||1
3286711|NCT02785185|4020355|FG002|NOT COMPLETED|Overall Study||2
3286712|NCT02785185|4020356|FG003|NOT COMPLETED|Overall Study||0
3286713|NCT02785354|4020369|FG000|STARTED|Overall Study||27060
3286714|NCT02785354|4020370|FG001|STARTED|Overall Study||31388
3286715|NCT02785354|4020371|FG002|STARTED|Overall Study||44653
3286716|NCT02785354|4020369|FG000|COMPLETED|Overall Study||27060
3286717|NCT02785354|4020370|FG001|COMPLETED|Overall Study||31388
3286718|NCT02785354|4020371|FG002|COMPLETED|Overall Study||44653
3286719|NCT02785354|4020369|FG000|NOT COMPLETED|Overall Study||0
3286720|NCT02785354|4020370|FG001|NOT COMPLETED|Overall Study||0
3286721|NCT02785354|4020371|FG002|NOT COMPLETED|Overall Study||0
3286722|NCT02785406|4020382|FG000|STARTED|Overall Study||10
3286723|NCT02785406|4020383|FG001|STARTED|Overall Study||10
3286724|NCT02785406|4020382|FG000|Completed First Week|Overall Study||10
3286725|NCT02785406|4020383|FG001|Completed First Week|Overall Study||10
3286726|NCT02785406|4020382|FG000|Completed Second Week|Overall Study||10
3286727|NCT02785406|4020383|FG001|Completed Second Week|Overall Study||10
3286728|NCT02785406|4020382|FG000|COMPLETED|Overall Study||10
3286729|NCT02785406|4020383|FG001|COMPLETED|Overall Study||10
3286730|NCT02785406|4020382|FG000|NOT COMPLETED|Overall Study||0
3286731|NCT02785406|4020383|FG001|NOT COMPLETED|Overall Study||0
3286732|NCT02785432|4020391|FG000|STARTED|Overall Study||4
3286733|NCT02785432|4020392|FG001|STARTED|Overall Study||7
3286734|NCT02785432|4020391|FG000|COMPLETED|Overall Study||4
3286735|NCT02785432|4020392|FG001|COMPLETED|Overall Study||7
3286736|NCT02785432|4020391|FG000|NOT COMPLETED|Overall Study||0
3286737|NCT02785432|4020392|FG001|NOT COMPLETED|Overall Study||0
3286738|NCT02785458|4020400|FG000|STARTED|Baseline||526
3286739|NCT02785458|4020401|FG001|STARTED|Baseline||479
3286740|NCT02785458|4020400|FG000|COMPLETED|Baseline||526
3083127|NCT01394003|3805106|FG006|NOT COMPLETED|Overall Study||0
3083128|NCT01394003|3805107|FG007|NOT COMPLETED|Overall Study||0
3083129|NCT01394081|3805133|FG000|STARTED|Overall Study||101
3083130|NCT01394081|3805134|FG001|STARTED|Overall Study||102
3083131|NCT01394081|3805133|FG000|COMPLETED|Overall Study||101
3083132|NCT01394081|3805134|FG001|COMPLETED|Overall Study||102
3083133|NCT01394081|3805133|FG000|NOT COMPLETED|Overall Study||0
3083134|NCT01394081|3805134|FG001|NOT COMPLETED|Overall Study||0
3286741|NCT02785458|4020401|FG001|COMPLETED|Baseline||479
3286742|NCT02785458|4020400|FG000|NOT COMPLETED|Baseline||0
3286743|NCT02785458|4020401|FG001|NOT COMPLETED|Baseline||0
3286744|NCT02785458|4020400|FG000|STARTED|1 Month||526
3286745|NCT02785458|4020401|FG001|STARTED|1 Month||479
3083135|NCT01394159|3805144|FG000|STARTED|Overall Study||28
3083136|NCT01394159|3805145|FG001|STARTED|Overall Study||28
3083137|NCT01394159|3805144|FG000|COMPLETED|Overall Study||28
3083138|NCT01394159|3805145|FG001|COMPLETED|Overall Study||28
3083139|NCT01394159|3805144|FG000|NOT COMPLETED|Overall Study||0
3083140|NCT01394159|3805145|FG001|NOT COMPLETED|Overall Study||0
3083141|NCT01394185|3805151|FG000|STARTED|Overall Study||8
3083142|NCT01394185|3805152|FG001|STARTED|Overall Study||2
3083143|NCT01394185|3805153|FG002|STARTED|Overall Study||2
3083144|NCT01394185|3805154|FG003|STARTED|Overall Study||4
3083145|NCT01394185|3805155|FG004|STARTED|Overall Study||6
3083146|NCT01394185|3805156|FG005|STARTED|Overall Study||3
3083147|NCT01394185|3805151|FG000|COMPLETED|Overall Study||2
3083148|NCT01394185|3805152|FG001|COMPLETED|Overall Study||2
3083149|NCT01394185|3805153|FG002|COMPLETED|Overall Study||2
3083150|NCT01394185|3805154|FG003|COMPLETED|Overall Study||3
3083151|NCT01394185|3805155|FG004|COMPLETED|Overall Study||2
3083152|NCT01394185|3805156|FG005|COMPLETED|Overall Study||2
3083153|NCT01394185|3805151|FG000|NOT COMPLETED|Overall Study||6
3083154|NCT01394185|3805152|FG001|NOT COMPLETED|Overall Study||0
3083155|NCT01394185|3805153|FG002|NOT COMPLETED|Overall Study||0
3083156|NCT01394185|3805154|FG003|NOT COMPLETED|Overall Study||1
3083157|NCT01394185|3805155|FG004|NOT COMPLETED|Overall Study||4
3083158|NCT01394185|3805156|FG005|NOT COMPLETED|Overall Study||1
3083159|NCT01394250|3805166|FG000|STARTED|Randomization and IV Placement Attempt||134
3083160|NCT01394250|3805167|FG001|STARTED|Randomization and IV Placement Attempt||134
3083161|NCT01394250|3805166|FG000|COMPLETED|Randomization and IV Placement Attempt||120
3083162|NCT01394250|3805167|FG001|COMPLETED|Randomization and IV Placement Attempt||121
3083163|NCT01394250|3805166|FG000|NOT COMPLETED|Randomization and IV Placement Attempt||14
3083164|NCT01394250|3805167|FG001|NOT COMPLETED|Randomization and IV Placement Attempt||13
3083165|NCT01394250|3805166|FG000|STARTED|Successful IV Placement & Follow-Up||120
3083166|NCT01394250|3805167|FG001|STARTED|Successful IV Placement & Follow-Up||121
3083167|NCT01394250|3805166|FG000|COMPLETED|Successful IV Placement & Follow-Up||114
3083168|NCT01394250|3805167|FG001|COMPLETED|Successful IV Placement & Follow-Up||110
3083169|NCT01394250|3805166|FG000|NOT COMPLETED|Successful IV Placement & Follow-Up||6
3083170|NCT01394250|3805167|FG001|NOT COMPLETED|Successful IV Placement & Follow-Up||11
3083171|NCT01394276|3805173|FG000|STARTED|Overall Study||322
3083172|NCT01394276|3805173|FG000|COMPLETED|Overall Study||260
3083173|NCT01394276|3805173|FG000|NOT COMPLETED|Overall Study||62
3083174|NCT01394510|3805182|FG000|STARTED|Overall Study||13
3083175|NCT01394510|3805182|FG000|COMPLETED|Overall Study||13
3083176|NCT01394510|3805182|FG000|NOT COMPLETED|Overall Study||0
3083177|NCT01394523|3805189|FG000|STARTED|Overall Study||13
3083178|NCT01394523|3805190|FG001|STARTED|Overall Study||13
3083179|NCT01394523|3805191|FG002|STARTED|Overall Study||13
3083180|NCT01394523|3805189|FG000|COMPLETED|Overall Study||12
3083181|NCT01394523|3805190|FG001|COMPLETED|Overall Study||13
3083182|NCT01394523|3805191|FG002|COMPLETED|Overall Study||13
3083183|NCT01394523|3805189|FG000|NOT COMPLETED|Overall Study||1
3083184|NCT01394523|3805190|FG001|NOT COMPLETED|Overall Study||0
3083185|NCT01394523|3805191|FG002|NOT COMPLETED|Overall Study||0
3083186|NCT01394614|3805201|FG000|STARTED|Overall Study||8
3083187|NCT01394614|3805202|FG001|STARTED|Overall Study||16
3083188|NCT01394614|3805201|FG000|COMPLETED|Overall Study||8
3083189|NCT01394614|3805202|FG001|COMPLETED|Overall Study||16
3083190|NCT01394614|3805201|FG000|NOT COMPLETED|Overall Study||0
3083191|NCT01394614|3805202|FG001|NOT COMPLETED|Overall Study||0
3083192|NCT01394627|3805208|FG000|STARTED|First Intervention (1 Day)||8
3083193|NCT01394627|3805209|FG001|STARTED|First Intervention (1 Day)||13
3083194|NCT01394627|3805208|FG000|COMPLETED|First Intervention (1 Day)||8
3083195|NCT01394627|3805209|FG001|COMPLETED|First Intervention (1 Day)||12
3083196|NCT01394627|3805208|FG000|NOT COMPLETED|First Intervention (1 Day)||0
3083197|NCT01394627|3805209|FG001|NOT COMPLETED|First Intervention (1 Day)||1
3083198|NCT01394627|3805208|FG000|STARTED|Washout (1-3 Months)||8
3083199|NCT01394627|3805209|FG001|STARTED|Washout (1-3 Months)||12
3083200|NCT01394627|3805208|FG000|COMPLETED|Washout (1-3 Months)||7
3083201|NCT01394627|3805209|FG001|COMPLETED|Washout (1-3 Months)||12
3083202|NCT01394627|3805208|FG000|NOT COMPLETED|Washout (1-3 Months)||1
3083203|NCT01394627|3805209|FG001|NOT COMPLETED|Washout (1-3 Months)||0
3083204|NCT01394627|3805208|FG000|STARTED|Second Intervention (1 Day)||7
3083205|NCT01394627|3805209|FG001|STARTED|Second Intervention (1 Day)||12
3083206|NCT01394627|3805208|FG000|COMPLETED|Second Intervention (1 Day)||7
3083207|NCT01394627|3805209|FG001|COMPLETED|Second Intervention (1 Day)||12
3083208|NCT01394627|3805208|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
3083209|NCT01394627|3805209|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
3083210|NCT01394692|3805217|FG000|STARTED|Overall Study||29
3083211|NCT01394692|3805218|FG001|STARTED|Overall Study||29
3083212|NCT01394692|3805217|FG000|COMPLETED|Overall Study||29
3083213|NCT01394692|3805218|FG001|COMPLETED|Overall Study||29
3083214|NCT01394692|3805217|FG000|NOT COMPLETED|Overall Study||0
3083215|NCT01394692|3805218|FG001|NOT COMPLETED|Overall Study||0
3083216|NCT01394705|3805226|FG000|STARTED|Overall Study||21
3083217|NCT01394705|3805227|FG001|STARTED|Overall Study||21
3083218|NCT01394705|3805226|FG000|COMPLETED|Overall Study||19
3083219|NCT01394705|3805227|FG001|COMPLETED|Overall Study||19
3083220|NCT01394705|3805226|FG000|NOT COMPLETED|Overall Study||2
3083221|NCT01394705|3805227|FG001|NOT COMPLETED|Overall Study||2
3083222|NCT01394718|3805236|FG000|STARTED|Overall Study||30
3083223|NCT01394718|3805237|FG001|STARTED|Overall Study||30
3083224|NCT01394718|3805236|FG000|COMPLETED|Overall Study||28
3083225|NCT01394718|3805237|FG001|COMPLETED|Overall Study||29
3083226|NCT01394718|3805236|FG000|NOT COMPLETED|Overall Study||2
3083227|NCT01394718|3805237|FG001|NOT COMPLETED|Overall Study||1
3083228|NCT01394939|3805247|FG000|STARTED|Overall Study||4
3083229|NCT01394939|3805248|FG001|STARTED|Overall Study||25
3083230|NCT01394939|3805249|FG002|STARTED|Overall Study||4
3083231|NCT01394939|3805250|FG003|STARTED|Overall Study||17
3083232|NCT01394939|3805247|FG000|COMPLETED|Overall Study||3
3083233|NCT01394939|3805248|FG001|COMPLETED|Overall Study||15
3083234|NCT01394939|3805249|FG002|COMPLETED|Overall Study||4
3083235|NCT01394939|3805250|FG003|COMPLETED|Overall Study||10
3083236|NCT01394939|3805247|FG000|NOT COMPLETED|Overall Study||1
3083237|NCT01394939|3805248|FG001|NOT COMPLETED|Overall Study||10
3083238|NCT01394939|3805249|FG002|NOT COMPLETED|Overall Study||0
3083239|NCT01394939|3805250|FG003|NOT COMPLETED|Overall Study||7
3083240|NCT01394952|3805262|FG000|STARTED|Overall Study||4952
3286746|NCT02785458|4020400|FG000|COMPLETED|1 Month||443
3286747|NCT02785458|4020401|FG001|COMPLETED|1 Month||404
3286748|NCT02785458|4020400|FG000|NOT COMPLETED|1 Month||83
3286749|NCT02785458|4020401|FG001|NOT COMPLETED|1 Month||75
3286750|NCT02785458|4020400|FG000|STARTED|3 Months||443
3286751|NCT02785458|4020401|FG001|STARTED|3 Months||404
3286752|NCT02785458|4020400|FG000|COMPLETED|3 Months||315
3286753|NCT02785458|4020401|FG001|COMPLETED|3 Months||293
3286754|NCT02785458|4020400|FG000|NOT COMPLETED|3 Months||128
3286755|NCT02785458|4020401|FG001|NOT COMPLETED|3 Months||111
3286756|NCT02785588|4020407|FG000|STARTED|Phase 1: Initial Feasibility Assessment||49
3286757|NCT02785588|4020407|FG000|COMPLETED|Phase 1: Initial Feasibility Assessment||47
3286758|NCT02785588|4020407|FG000|NOT COMPLETED|Phase 1: Initial Feasibility Assessment||2
3286759|NCT02785588|4020407|FG000|STARTED|Phase2 Controlled Image &Data Collection|Phase 2 participants represent newly enrolled participants.|5
3286760|NCT02785588|4020407|FG000|COMPLETED|Phase2 Controlled Image &Data Collection||5
3286761|NCT02785588|4020407|FG000|NOT COMPLETED|Phase2 Controlled Image &Data Collection||0
3286762|NCT02785770|4020411|FG000|STARTED|Intervention Period 1 (1 Day)||11
3286763|NCT02785770|4020412|FG001|STARTED|Intervention Period 1 (1 Day)||11
3286764|NCT02785770|4020413|FG002|STARTED|Intervention Period 1 (1 Day)||11
3286765|NCT02785770|4020414|FG003|STARTED|Intervention Period 1 (1 Day)||11
3286766|NCT02785770|4020411|FG000|COMPLETED|Intervention Period 1 (1 Day)||11
3286767|NCT02785770|4020412|FG001|COMPLETED|Intervention Period 1 (1 Day)||11
3286768|NCT02785770|4020413|FG002|COMPLETED|Intervention Period 1 (1 Day)||11
3286769|NCT02785770|4020414|FG003|COMPLETED|Intervention Period 1 (1 Day)||11
3286770|NCT02785770|4020411|FG000|NOT COMPLETED|Intervention Period 1 (1 Day)||0
3286771|NCT02785770|4020412|FG001|NOT COMPLETED|Intervention Period 1 (1 Day)||0
3286772|NCT02785770|4020413|FG002|NOT COMPLETED|Intervention Period 1 (1 Day)||0
3286773|NCT02785770|4020414|FG003|NOT COMPLETED|Intervention Period 1 (1 Day)||0
3286774|NCT02785770|4020411|FG000|STARTED|Washout Period 1 (7 Days)||11
3286775|NCT02785770|4020412|FG001|STARTED|Washout Period 1 (7 Days)||11
3286776|NCT02785770|4020413|FG002|STARTED|Washout Period 1 (7 Days)||11
3286777|NCT02785770|4020414|FG003|STARTED|Washout Period 1 (7 Days)||11
3286778|NCT02785770|4020411|FG000|COMPLETED|Washout Period 1 (7 Days)||11
3286779|NCT02785770|4020412|FG001|COMPLETED|Washout Period 1 (7 Days)||11
3286780|NCT02785770|4020413|FG002|COMPLETED|Washout Period 1 (7 Days)||11
3286781|NCT02785770|4020414|FG003|COMPLETED|Washout Period 1 (7 Days)||11
3286782|NCT02785770|4020411|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0
3286783|NCT02785770|4020412|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0
3286784|NCT02785770|4020413|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||0
3286785|NCT02785770|4020414|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||0
3286786|NCT02785770|4020411|FG000|STARTED|Intervention Period 2 (1 Day)||11
3286787|NCT02785770|4020412|FG001|STARTED|Intervention Period 2 (1 Day)||11
3286788|NCT02785770|4020413|FG002|STARTED|Intervention Period 2 (1 Day)||11
3286789|NCT02785770|4020414|FG003|STARTED|Intervention Period 2 (1 Day)||11
3286790|NCT02785770|4020411|FG000|COMPLETED|Intervention Period 2 (1 Day)||11
3286791|NCT02785770|4020412|FG001|COMPLETED|Intervention Period 2 (1 Day)||10
3286792|NCT02785770|4020413|FG002|COMPLETED|Intervention Period 2 (1 Day)||10
3286793|NCT02785770|4020414|FG003|COMPLETED|Intervention Period 2 (1 Day)||11
3286794|NCT02785770|4020411|FG000|NOT COMPLETED|Intervention Period 2 (1 Day)||0
3286795|NCT02785770|4020412|FG001|NOT COMPLETED|Intervention Period 2 (1 Day)||1
3286796|NCT02785770|4020413|FG002|NOT COMPLETED|Intervention Period 2 (1 Day)||1
3286797|NCT02785770|4020414|FG003|NOT COMPLETED|Intervention Period 2 (1 Day)||0
3286798|NCT02785770|4020411|FG000|STARTED|Washout Period 2 (7 Days)||11
3286799|NCT02785770|4020412|FG001|STARTED|Washout Period 2 (7 Days)||10
3286800|NCT02785770|4020413|FG002|STARTED|Washout Period 2 (7 Days)||10
3286801|NCT02785770|4020414|FG003|STARTED|Washout Period 2 (7 Days)||11
3286802|NCT02785770|4020411|FG000|COMPLETED|Washout Period 2 (7 Days)||11
3286803|NCT02785770|4020412|FG001|COMPLETED|Washout Period 2 (7 Days)||10
3286804|NCT02785770|4020413|FG002|COMPLETED|Washout Period 2 (7 Days)||10
3286805|NCT02785770|4020414|FG003|COMPLETED|Washout Period 2 (7 Days)||11
3286806|NCT02785770|4020411|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||0
3286807|NCT02785770|4020412|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0
3286808|NCT02785770|4020413|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0
3083241|NCT01394952|3805263|FG001|STARTED|Overall Study||4949
3083242|NCT01394952|3805262|FG000|Received at Least One Dose of Study Drug|Overall Study||4949
3083243|NCT01394952|3805263|FG001|Received at Least One Dose of Study Drug|Overall Study||4943
3083244|NCT01394952|3805262|FG000|COMPLETED|Overall Study||4935
3083245|NCT01394952|3805263|FG001|COMPLETED|Overall Study||4932
3083246|NCT01394952|3805262|FG000|NOT COMPLETED|Overall Study||17
3083247|NCT01394952|3805263|FG001|NOT COMPLETED|Overall Study||17
3083248|NCT01394978|3805272|FG000|STARTED|Overall Study||168
3083249|NCT01394978|3805273|FG001|STARTED|Overall Study||276
3083250|NCT01394978|3805272|FG000|COMPLETED|Overall Study||147
3083251|NCT01394978|3805273|FG001|COMPLETED|Overall Study||245
3083252|NCT01394978|3805272|FG000|NOT COMPLETED|Overall Study||21
3083253|NCT01394978|3805273|FG001|NOT COMPLETED|Overall Study||31
3083254|NCT01394991|3805282|FG000|STARTED|Overall Study||242
3083255|NCT01394991|3805283|FG001|STARTED|Overall Study||262
3286809|NCT02785770|4020414|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||0
3286810|NCT02785770|4020411|FG000|STARTED|Intervention Period 3 (1 Day)||11
3286811|NCT02785770|4020412|FG001|STARTED|Intervention Period 3 (1 Day)||10
3286812|NCT02785770|4020413|FG002|STARTED|Intervention Period 3 (1 Day)||10
3286813|NCT02785770|4020414|FG003|STARTED|Intervention Period 3 (1 Day)||11
3286814|NCT02785770|4020411|FG000|COMPLETED|Intervention Period 3 (1 Day)||11
3286815|NCT02785770|4020412|FG001|COMPLETED|Intervention Period 3 (1 Day)||10
3083256|NCT01394991|3805282|FG000|COMPLETED|Overall Study||183
3083257|NCT01394991|3805283|FG001|COMPLETED|Overall Study||190
3083258|NCT01394991|3805282|FG000|NOT COMPLETED|Overall Study||59
3083259|NCT01394991|3805283|FG001|NOT COMPLETED|Overall Study||72
3083260|NCT01395017|3805291|FG000|STARTED|Overall Study||100
3083261|NCT01395017|3805292|FG001|STARTED|Overall Study||102
3083262|NCT01395017|3805291|FG000|Treated|Overall Study||98
3083263|NCT01395017|3805292|FG001|Treated|Overall Study||101
3083264|NCT01395017|3805291|FG000|COMPLETED|Overall Study||0
3083265|NCT01395017|3805292|FG001|COMPLETED|Overall Study||0
3083266|NCT01395017|3805291|FG000|NOT COMPLETED|Overall Study||100
3083267|NCT01395017|3805292|FG001|NOT COMPLETED|Overall Study||102
3083268|NCT01395030|3805299|FG000|STARTED|Overall Study||64
3083269|NCT01395030|3805299|FG000|Complete FCH PET/CT|Overall Study||57
3083270|NCT01395030|3805299|FG000|Adequate Tissue for Analysis|Overall Study||50
3083271|NCT01395030|3805299|FG000|COMPLETED|Overall Study||57
3083272|NCT01395030|3805299|FG000|NOT COMPLETED|Overall Study||7
3083273|NCT01395043|3805305|FG000|STARTED|Overall Study||15
3083274|NCT01395043|3805305|FG000|COMPLETED|Overall Study||15
3083275|NCT01395043|3805305|FG000|NOT COMPLETED|Overall Study||0
3083276|NCT01395277|3805312|FG000|STARTED|Overall Study||15
3083277|NCT01395277|3805313|FG001|STARTED|Overall Study||15
3083278|NCT01395277|3805312|FG000|COMPLETED|Overall Study||15
3083279|NCT01395277|3805313|FG001|COMPLETED|Overall Study||15
3083280|NCT01395277|3805312|FG000|NOT COMPLETED|Overall Study||0
3083281|NCT01395277|3805313|FG001|NOT COMPLETED|Overall Study||0
3083282|NCT01395316|3805321|FG000|STARTED|Overall Study||8
3083283|NCT01395316|3805321|FG000|COMPLETED|Overall Study||5
3083284|NCT01395316|3805321|FG000|NOT COMPLETED|Overall Study||3
3083285|NCT01395329|3805328|FG000|STARTED|Overall Study||14
3083286|NCT01395329|3805329|FG001|STARTED|Overall Study||14
3083287|NCT01395329|3805330|FG002|STARTED|Overall Study||14
3083288|NCT01395329|3805328|FG000|COMPLETED|Overall Study||14
3083289|NCT01395329|3805329|FG001|COMPLETED|Overall Study||14
3083290|NCT01395329|3805330|FG002|COMPLETED|Overall Study||14
3083291|NCT01395329|3805328|FG000|NOT COMPLETED|Overall Study||0
3083292|NCT01395329|3805329|FG001|NOT COMPLETED|Overall Study||0
3083293|NCT01395329|3805330|FG002|NOT COMPLETED|Overall Study||0
3083294|NCT01395368|3805341|FG000|STARTED|Overall Study||108
3083295|NCT01395368|3805341|FG000|COMPLETED|Overall Study||92
3083296|NCT01395368|3805341|FG000|NOT COMPLETED|Overall Study||16
3083297|NCT01395394|3805348|FG000|STARTED|Baseline Study Visit||4
3083298|NCT01395394|3805349|FG001|STARTED|Baseline Study Visit||3
3083299|NCT01395394|3805350|FG002|STARTED|Baseline Study Visit||5
3083300|NCT01395394|3805348|FG000|COMPLETED|Baseline Study Visit||3
3083301|NCT01395394|3805349|FG001|COMPLETED|Baseline Study Visit||3
3083302|NCT01395394|3805350|FG002|COMPLETED|Baseline Study Visit||5
3083303|NCT01395394|3805348|FG000|NOT COMPLETED|Baseline Study Visit||1
3083304|NCT01395394|3805349|FG001|NOT COMPLETED|Baseline Study Visit||0
3083305|NCT01395394|3805350|FG002|NOT COMPLETED|Baseline Study Visit||0
3083306|NCT01395394|3805348|FG000|STARTED|Study Visit 2 (Non-responders Only)||3
3083307|NCT01395394|3805349|FG001|STARTED|Study Visit 2 (Non-responders Only)||0
3083308|NCT01395394|3805350|FG002|STARTED|Study Visit 2 (Non-responders Only)||0
3286816|NCT02785770|4020413|FG002|COMPLETED|Intervention Period 3 (1 Day)||10
3083309|NCT01395394|3805348|FG000|COMPLETED|Study Visit 2 (Non-responders Only)||3
3083310|NCT01395394|3805349|FG001|COMPLETED|Study Visit 2 (Non-responders Only)||0
3083311|NCT01395394|3805350|FG002|COMPLETED|Study Visit 2 (Non-responders Only)||0
3083312|NCT01395394|3805348|FG000|NOT COMPLETED|Study Visit 2 (Non-responders Only)||0
3083313|NCT01395394|3805349|FG001|NOT COMPLETED|Study Visit 2 (Non-responders Only)||0
3083314|NCT01395394|3805350|FG002|NOT COMPLETED|Study Visit 2 (Non-responders Only)||0
3083315|NCT01395524|3805361|FG000|STARTED|Overall Study||97
3083316|NCT01395524|3805362|FG001|STARTED|Overall Study||99
3083317|NCT01395524|3805363|FG002|STARTED|Overall Study||106
3083318|NCT01395524|3805361|FG000|COMPLETED|Overall Study||79
3083319|NCT01395524|3805362|FG001|COMPLETED|Overall Study||83
3083320|NCT01395524|3805363|FG002|COMPLETED|Overall Study||89
3083321|NCT01395524|3805361|FG000|NOT COMPLETED|Overall Study||18
3083322|NCT01395524|3805362|FG001|NOT COMPLETED|Overall Study||16
3083323|NCT01395524|3805363|FG002|NOT COMPLETED|Overall Study||17
3083324|NCT01395537|3805371|FG000|STARTED|Phase I||13
3083325|NCT01395537|3805371|FG000|COMPLETED|Phase I||13
3083326|NCT01395537|3805371|FG000|NOT COMPLETED|Phase I||0
3083327|NCT01395537|3805371|FG000|STARTED|Phase II||1
3083328|NCT01395537|3805371|FG000|COMPLETED|Phase II||1
3083329|NCT01395537|3805371|FG000|NOT COMPLETED|Phase II||0
3083330|NCT01395758|3805377|FG000|STARTED|Open-label Treatment Period||51
3083331|NCT01395758|3805378|FG001|STARTED|Open-label Treatment Period||45
3083332|NCT01395758|3805379|FG002|STARTED|Open-label Treatment Period||0
3083333|NCT01395758|3805377|FG000|COMPLETED|Open-label Treatment Period||47
3083334|NCT01395758|3805378|FG001|COMPLETED|Open-label Treatment Period||45
3083335|NCT01395758|3805379|FG002|COMPLETED|Open-label Treatment Period||0
3083336|NCT01395758|3805377|FG000|NOT COMPLETED|Open-label Treatment Period||4
3083337|NCT01395758|3805378|FG001|NOT COMPLETED|Open-label Treatment Period||0
3083338|NCT01395758|3805379|FG002|NOT COMPLETED|Open-label Treatment Period||0
3083339|NCT01395758|3805377|FG000|STARTED|Crossover Period||0
3083340|NCT01395758|3805378|FG001|STARTED|Crossover Period||0
3083341|NCT01395758|3805379|FG002|STARTED|Crossover Period||26
3083342|NCT01395758|3805377|FG000|COMPLETED|Crossover Period||0
3083343|NCT01395758|3805378|FG001|COMPLETED|Crossover Period||0
3083344|NCT01395758|3805379|FG002|COMPLETED|Crossover Period||26
3083345|NCT01395758|3805377|FG000|NOT COMPLETED|Crossover Period||0
3083346|NCT01395758|3805378|FG001|NOT COMPLETED|Crossover Period||0
3083347|NCT01395758|3805379|FG002|NOT COMPLETED|Crossover Period||0
3083348|NCT01395784|3805386|FG000|STARTED|Overall Study||32
3083349|NCT01395784|3805386|FG000|COMPLETED|Overall Study||17
3083350|NCT01395784|3805386|FG000|NOT COMPLETED|Overall Study||15
3134855|NCT01703169|3859801|FG000|COMPLETED|Overall Study||13
3134856|NCT01703169|3859801|FG000|NOT COMPLETED|Overall Study||0
3286817|NCT02785770|4020414|FG003|COMPLETED|Intervention Period 3 (1 Day)||10
3286818|NCT02785770|4020411|FG000|NOT COMPLETED|Intervention Period 3 (1 Day)||0
3286819|NCT02785770|4020412|FG001|NOT COMPLETED|Intervention Period 3 (1 Day)||0
3286820|NCT02785770|4020413|FG002|NOT COMPLETED|Intervention Period 3 (1 Day)||0
3286821|NCT02785770|4020414|FG003|NOT COMPLETED|Intervention Period 3 (1 Day)||1
3286822|NCT02785770|4020411|FG000|STARTED|Washout Period 3 (7 Days)||11
3286823|NCT02785770|4020412|FG001|STARTED|Washout Period 3 (7 Days)||10
3286824|NCT02785770|4020413|FG002|STARTED|Washout Period 3 (7 Days)||10
3286825|NCT02785770|4020414|FG003|STARTED|Washout Period 3 (7 Days)||10
3286826|NCT02785770|4020411|FG000|COMPLETED|Washout Period 3 (7 Days)||11
3286827|NCT02785770|4020412|FG001|COMPLETED|Washout Period 3 (7 Days)||10
3286828|NCT02785770|4020413|FG002|COMPLETED|Washout Period 3 (7 Days)||10
3286829|NCT02785770|4020414|FG003|COMPLETED|Washout Period 3 (7 Days)||10
3286830|NCT02785770|4020411|FG000|NOT COMPLETED|Washout Period 3 (7 Days)||0
3286831|NCT02785770|4020412|FG001|NOT COMPLETED|Washout Period 3 (7 Days)||0
3286832|NCT02785770|4020413|FG002|NOT COMPLETED|Washout Period 3 (7 Days)||0
3286833|NCT02785770|4020414|FG003|NOT COMPLETED|Washout Period 3 (7 Days)||0
3286834|NCT02785770|4020411|FG000|STARTED|Intervention Period 4 (1 Day)||11
3286835|NCT02785770|4020412|FG001|STARTED|Intervention Period 4 (1 Day)||10
3286836|NCT02785770|4020413|FG002|STARTED|Intervention Period 4 (1 Day)||10
3286837|NCT02785770|4020414|FG003|STARTED|Intervention Period 4 (1 Day)||10
3286838|NCT02785770|4020411|FG000|COMPLETED|Intervention Period 4 (1 Day)||11
3286839|NCT02785770|4020412|FG001|COMPLETED|Intervention Period 4 (1 Day)||10
3286840|NCT02785770|4020413|FG002|COMPLETED|Intervention Period 4 (1 Day)||10
3286841|NCT02785770|4020414|FG003|COMPLETED|Intervention Period 4 (1 Day)||10
3286842|NCT02785770|4020411|FG000|NOT COMPLETED|Intervention Period 4 (1 Day)||0
3286843|NCT02785770|4020412|FG001|NOT COMPLETED|Intervention Period 4 (1 Day)||0
3286844|NCT02785770|4020413|FG002|NOT COMPLETED|Intervention Period 4 (1 Day)||0
3286845|NCT02785770|4020414|FG003|NOT COMPLETED|Intervention Period 4 (1 Day)||0
3286846|NCT02785900|4020429|FG000|STARTED|Overall Study||117
3286847|NCT02785900|4020430|FG001|STARTED|Overall Study||123
3286848|NCT02785900|4020429|FG000|COMPLETED|Overall Study||0
3286849|NCT02785900|4020430|FG001|COMPLETED|Overall Study||0
3286850|NCT02785900|4020429|FG000|NOT COMPLETED|Overall Study||117
3286851|NCT02785900|4020430|FG001|NOT COMPLETED|Overall Study||123
3286852|NCT02785913|4020436|FG000|STARTED|Overall Study||26
3286853|NCT02785913|4020436|FG000|COMPLETED|Overall Study||0
3286854|NCT02785913|4020436|FG000|NOT COMPLETED|Overall Study||26
3286855|NCT02785939|4020443|FG000|STARTED|Overall Study||31
3286856|NCT02785939|4020444|FG001|STARTED|Overall Study||10
3286857|NCT02785939|4020443|FG000|Participants Re-registered to Palbociclib After Progression on Docetaxel|Overall Study||0
3286858|NCT02785939|4020444|FG001|Participants Re-registered to Palbociclib After Progression on Docetaxel|Overall Study||1
3286859|NCT02785939|4020443|FG000|COMPLETED|Overall Study||0
3286860|NCT02785939|4020444|FG001|COMPLETED|Overall Study||0
3286861|NCT02785939|4020443|FG000|NOT COMPLETED|Overall Study||31
3286862|NCT02785939|4020444|FG001|NOT COMPLETED|Overall Study||10
3286863|NCT02786004|4020452|FG000|STARTED|Overall Study||14
3286864|NCT02786004|4020453|FG001|STARTED|Overall Study||10
3286865|NCT02786004|4020452|FG000|COMPLETED|Overall Study||14
3286866|NCT02786004|4020453|FG001|COMPLETED|Overall Study||9
3286867|NCT02786004|4020452|FG000|NOT COMPLETED|Overall Study||0
3134857|NCT01703208|3859807|FG000|STARTED|Overall Study||2100
3134858|NCT01703208|3859808|FG001|STARTED|Overall Study||2102
3134859|NCT01703208|3859807|FG000|Treated|Overall Study||2092
3134860|NCT01703208|3859808|FG001|Treated|Overall Study||2100
3286868|NCT02786004|4020453|FG001|NOT COMPLETED|Overall Study||1
3286869|NCT02786134|4020463|FG000|STARTED|Overall Study||25
3083351|NCT01395797|3805396|FG000|STARTED|Overall Study||19
3083352|NCT01395797|3805397|FG001|STARTED|Overall Study||4
3083353|NCT01395797|3805398|FG002|STARTED|Overall Study||18
3083354|NCT01395797|3805399|FG003|STARTED|Overall Study||15
3083355|NCT01395797|3805400|FG004|STARTED|Overall Study||9
3083356|NCT01395797|3805401|FG005|STARTED|Overall Study||17
3083357|NCT01395797|3805396|FG000|COMPLETED|Overall Study||16
3083358|NCT01395797|3805397|FG001|COMPLETED|Overall Study||3
3286870|NCT02786134|4020464|FG001|STARTED|Overall Study||25
3286871|NCT02786134|4020463|FG000|COMPLETED|Overall Study||25
3286872|NCT02786134|4020464|FG001|COMPLETED|Overall Study||25
3286873|NCT02786134|4020463|FG000|NOT COMPLETED|Overall Study||0
3286874|NCT02786134|4020464|FG001|NOT COMPLETED|Overall Study||0
3286875|NCT02786355|4020470|FG000|STARTED|Overall Study||35
3286876|NCT02786355|4020470|FG000|COMPLETED|Overall Study||35
3286877|NCT02786355|4020470|FG000|NOT COMPLETED|Overall Study||0
3286878|NCT02786498|4020481|FG000|STARTED|Overall Study||27
3286879|NCT02786498|4020482|FG001|STARTED|Overall Study||24
3286880|NCT02786498|4020483|FG002|STARTED|Overall Study||24
3286881|NCT02786498|4020484|FG003|STARTED|Overall Study||27
3286882|NCT02786498|4020481|FG000|COMPLETED|Overall Study||25
3286883|NCT02786498|4020482|FG001|COMPLETED|Overall Study||24
3286884|NCT02786498|4020483|FG002|COMPLETED|Overall Study||24
3286885|NCT02786498|4020484|FG003|COMPLETED|Overall Study||26
3286886|NCT02786498|4020481|FG000|NOT COMPLETED|Overall Study||2
3286887|NCT02786498|4020482|FG001|NOT COMPLETED|Overall Study||0
3286888|NCT02786498|4020483|FG002|NOT COMPLETED|Overall Study||0
3286889|NCT02786498|4020484|FG003|NOT COMPLETED|Overall Study||1
3286890|NCT02786719|4020494|FG000|STARTED|Overall Study||13
3286891|NCT02786719|4020494|FG000|COMPLETED|Overall Study||12
3286892|NCT02786719|4020494|FG000|NOT COMPLETED|Overall Study||1
3286893|NCT02786771|4020500|FG000|STARTED|Overall Study||63
3286894|NCT02786771|4020501|FG001|STARTED|Overall Study||62
3286895|NCT02786771|4020500|FG000|COMPLETED|Overall Study||53
3286896|NCT02786771|4020501|FG001|COMPLETED|Overall Study||56
3286897|NCT02786771|4020500|FG000|NOT COMPLETED|Overall Study||10
3286898|NCT02786771|4020501|FG001|NOT COMPLETED|Overall Study||6
3286899|NCT02786810|4020507|FG000|STARTED|Overall Study||10
3286900|NCT02786810|4020507|FG000|COMPLETED|Overall Study||10
3286901|NCT02786810|4020507|FG000|NOT COMPLETED|Overall Study||0
3286902|NCT02786836|4020511|FG000|STARTED|Overall Study||76
3286903|NCT02786836|4020511|FG000|Eligible Patients Enrolled Into the Stud|Overall Study||76
3286904|NCT02786836|4020511|FG000|COMPLETED|Overall Study||62
3286905|NCT02786836|4020511|FG000|NOT COMPLETED|Overall Study||14
3286906|NCT02786901|4020519|FG000|STARTED|Overall Study||199
3286907|NCT02786901|4020520|FG001|STARTED|Overall Study||201
3286908|NCT02786901|4020521|FG002|STARTED|Overall Study||200
3286909|NCT02786901|4020519|FG000|COMPLETED|Overall Study||122
3286910|NCT02786901|4020520|FG001|COMPLETED|Overall Study||145
3286911|NCT02786901|4020521|FG002|COMPLETED|Overall Study||159
3286912|NCT02786901|4020519|FG000|NOT COMPLETED|Overall Study||77
3286913|NCT02786901|4020520|FG001|NOT COMPLETED|Overall Study||56
3286914|NCT02786901|4020521|FG002|NOT COMPLETED|Overall Study||41
3286915|NCT02786927|4020529|FG000|STARTED|Overall Study||212
3286916|NCT02786927|4020529|FG000|COMPLETED|Overall Study||207
3286917|NCT02786927|4020529|FG000|NOT COMPLETED|Overall Study||5
3286918|NCT02786953|4020536|FG000|STARTED|Overall Study||20
3286919|NCT02786953|4020537|FG001|STARTED|Overall Study||19
3286920|NCT02786953|4020536|FG000|Baseline Teen Survey Data Completed|Overall Study||20
3286921|NCT02786953|4020537|FG001|Baseline Teen Survey Data Completed|Overall Study|One participant withdrawn and data excluded due to becoming ineligible due to a new diagnosis|18
3286922|NCT02786953|4020536|FG000|Baseline Parent Survey Completed|Overall Study||20
3286923|NCT02786953|4020537|FG001|Baseline Parent Survey Completed|Overall Study|One participant withdrawn and data excluded due to becoming ineligible due to a new diagnosis|18
3286924|NCT02786953|4020536|FG000|Actigraph Data Complete|Overall Study||14
3286925|NCT02786953|4020537|FG001|Actigraph Data Complete|Overall Study|One participant withdrawn and data excluded due to becoming ineligible due to a new diagnosis|17
3286926|NCT02786953|4020536|FG000|A1C Data Baseline|Overall Study||20
3286927|NCT02786953|4020537|FG001|A1C Data Baseline|Overall Study|One participant withdrawn and data excluded due to becoming ineligible due to a new diagnosis|18
3286928|NCT02786953|4020536|FG000|Session 1 Completed|Overall Study||17
3286929|NCT02786953|4020537|FG001|Session 1 Completed|Overall Study||0
3286930|NCT02786953|4020536|FG000|Session 2 Completed|Overall Study||16
3286931|NCT02786953|4020537|FG001|Session 2 Completed|Overall Study||0
3286932|NCT02786953|4020536|FG000|Session 3 Completed|Overall Study||16
3286933|NCT02786953|4020537|FG001|Session 3 Completed|Overall Study||0
3286934|NCT02786953|4020536|FG000|3 Month Teen Survey Completed|Overall Study||17
3286935|NCT02786953|4020537|FG001|3 Month Teen Survey Completed|Overall Study||18
3286936|NCT02786953|4020536|FG000|3 Month Parent Survey Completed|Overall Study||17
3286937|NCT02786953|4020537|FG001|3 Month Parent Survey Completed|Overall Study||18
3286938|NCT02786953|4020536|FG000|A1C 3 Month|Overall Study||15
3286939|NCT02786953|4020537|FG001|A1C 3 Month|Overall Study||17
3286940|NCT02786953|4020536|FG000|COMPLETED|Overall Study||17
3286941|NCT02786953|4020537|FG001|COMPLETED|Overall Study||18
3286942|NCT02786953|4020536|FG000|NOT COMPLETED|Overall Study||3
3286943|NCT02786953|4020537|FG001|NOT COMPLETED|Overall Study||1
3286944|NCT02787057|4020545|FG000|STARTED|Overall Study||40
3083359|NCT01395797|3805398|FG002|COMPLETED|Overall Study||14
3083360|NCT01395797|3805399|FG003|COMPLETED|Overall Study||13
3083361|NCT01395797|3805400|FG004|COMPLETED|Overall Study||7
3083362|NCT01395797|3805401|FG005|COMPLETED|Overall Study||14
3083363|NCT01395797|3805396|FG000|NOT COMPLETED|Overall Study||3
3083364|NCT01395797|3805397|FG001|NOT COMPLETED|Overall Study||1
3083365|NCT01395797|3805398|FG002|NOT COMPLETED|Overall Study||4
3083366|NCT01395797|3805399|FG003|NOT COMPLETED|Overall Study||2
3083367|NCT01395797|3805400|FG004|NOT COMPLETED|Overall Study||2
3083368|NCT01395797|3805401|FG005|NOT COMPLETED|Overall Study||3
3083369|NCT01395810|3805425|FG000|STARTED|Overall Study||18
3083370|NCT01395810|3805426|FG001|STARTED|Overall Study||48
3083371|NCT01395810|3805427|FG002|STARTED|Overall Study||0
3083372|NCT01395810|3805428|FG003|STARTED|Overall Study||5
3083373|NCT01395810|3805425|FG000|After Switching the Arms|Overall Study|18 subjects started in this arm and additional 3 subjects from 40 IU/kg switched to this arm|21
3083374|NCT01395810|3805426|FG001|After Switching the Arms|Overall Study|48 subjects started in this arm, 3 subjects in 10 IU/kg+1 subject in on-demand switched to this arm|52
3083375|NCT01395810|3805427|FG002|After Switching the Arms|Overall Study|No subjects started in this arm initially, 2 patients in 40 IU/kg arm switched to this arm.|2
3083376|NCT01395810|3805428|FG003|After Switching the Arms|Overall Study||5
3083377|NCT01395810|3805425|FG000|COMPLETED|Overall Study||16
3083378|NCT01395810|3805426|FG001|COMPLETED|Overall Study||44
3083379|NCT01395810|3805427|FG002|COMPLETED|Overall Study||0
3083380|NCT01395810|3805428|FG003|COMPLETED|Overall Study||5
3083381|NCT01395810|3805425|FG000|NOT COMPLETED|Overall Study||2
3083382|NCT01395810|3805426|FG001|NOT COMPLETED|Overall Study||4
3083383|NCT01395810|3805427|FG002|NOT COMPLETED|Overall Study||0
3083384|NCT01395810|3805428|FG003|NOT COMPLETED|Overall Study||0
3083385|NCT01395823|3805441|FG000|STARTED|Overall Study||137
3083386|NCT01395823|3805442|FG001|STARTED|Overall Study||139
3083387|NCT01395823|3805441|FG000|COMPLETED|Overall Study||122
3083388|NCT01395823|3805442|FG001|COMPLETED|Overall Study||130
3083389|NCT01395823|3805441|FG000|NOT COMPLETED|Overall Study||15
3083390|NCT01395823|3805442|FG001|NOT COMPLETED|Overall Study||9
3083391|NCT01395888|3805450|FG000|STARTED|2-week Run-in Period||279
3083392|NCT01395888|3805451|FG001|STARTED|2-week Run-in Period||0
3083393|NCT01395888|3805452|FG002|STARTED|2-week Run-in Period||0
3083394|NCT01395888|3805450|FG000|COMPLETED|2-week Run-in Period||257
3083395|NCT01395888|3805451|FG001|COMPLETED|2-week Run-in Period||0
3083396|NCT01395888|3805452|FG002|COMPLETED|2-week Run-in Period||0
3083397|NCT01395888|3805450|FG000|NOT COMPLETED|2-week Run-in Period||22
3083398|NCT01395888|3805451|FG001|NOT COMPLETED|2-week Run-in Period||0
3083399|NCT01395888|3805452|FG002|NOT COMPLETED|2-week Run-in Period||0
3083400|NCT01395888|3805450|FG000|STARTED|Treatment Period (TP)||0
3083401|NCT01395888|3805451|FG001|STARTED|Treatment Period (TP)||127
3083402|NCT01395888|3805452|FG002|STARTED|Treatment Period (TP)||130
3083403|NCT01395888|3805450|FG000|Completed the Treatment Period|Treatment Period (TP)||0
3083404|NCT01395888|3805451|FG001|Completed the Treatment Period|Treatment Period (TP)|Participants were considered to have completed the TP if they attended Visit 5 (Week 12).|112
3286945|NCT02787057|4020546|FG001|STARTED|Overall Study||40
3286946|NCT02787057|4020545|FG000|COMPLETED|Overall Study||40
3286947|NCT02787057|4020546|FG001|COMPLETED|Overall Study||40
3286948|NCT02787057|4020545|FG000|NOT COMPLETED|Overall Study||0
3286949|NCT02787057|4020546|FG001|NOT COMPLETED|Overall Study||0
3286950|NCT02787083|4020554|FG000|STARTED|Overall Study||4
3286951|NCT02787083|4020555|FG001|STARTED|Overall Study||5
3286952|NCT02787083|4020554|FG000|COMPLETED|Overall Study||1
3286953|NCT02787083|4020555|FG001|COMPLETED|Overall Study||3
3286954|NCT02787083|4020554|FG000|NOT COMPLETED|Overall Study||3
3286955|NCT02787083|4020555|FG001|NOT COMPLETED|Overall Study||2
3286956|NCT02787291|4020561|FG000|STARTED|Overall Study||227
3286957|NCT02787291|4020561|FG000|COMPLETED|Overall Study||227
3286958|NCT02787291|4020561|FG000|NOT COMPLETED|Overall Study||0
3286959|NCT02787304|4020569|FG000|STARTED|Overall Study||49
3286960|NCT02787304|4020570|FG001|STARTED|Overall Study|One subject was randomized and received 1 dose of study drug but withdrew from the study.|50
3286961|NCT02787304|4020571|FG002|STARTED|Overall Study||49
3286962|NCT02787304|4020572|FG003|STARTED|Overall Study||49
3286963|NCT02787304|4020569|FG000|COMPLETED|Overall Study||13
3286964|NCT02787304|4020570|FG001|COMPLETED|Overall Study||12
3286965|NCT02787304|4020571|FG002|COMPLETED|Overall Study||8
3286966|NCT02787304|4020572|FG003|COMPLETED|Overall Study||15
3286967|NCT02787304|4020569|FG000|NOT COMPLETED|Overall Study||36
3286968|NCT02787304|4020570|FG001|NOT COMPLETED|Overall Study||38
3286969|NCT02787304|4020571|FG002|NOT COMPLETED|Overall Study||41
3286970|NCT02787304|4020572|FG003|NOT COMPLETED|Overall Study||34
3286971|NCT02787551|4020584|FG000|STARTED|Core Period: 26 Weeks||257
3286972|NCT02787551|4020585|FG001|STARTED|Core Period: 26 Weeks||257
3286973|NCT02787551|4020584|FG000|Treated|Core Period: 26 Weeks||255
3286974|NCT02787551|4020585|FG001|Treated|Core Period: 26 Weeks||256
3286975|NCT02787551|4020584|FG000|COMPLETED|Core Period: 26 Weeks|Out of 230 participants, 206 participants entered in single arm extension period.|230
3286976|NCT02787551|4020585|FG001|COMPLETED|Core Period: 26 Weeks||246
3286977|NCT02787551|4020584|FG000|NOT COMPLETED|Core Period: 26 Weeks||27
3286978|NCT02787551|4020585|FG001|NOT COMPLETED|Core Period: 26 Weeks||11
3286979|NCT02787551|4020584|FG000|STARTED|Extension Period:26 Weeks(Upto 52 Weeks)|Participants who completed core period and met eligibility criteria for extension period.|206
3286980|NCT02787551|4020585|FG001|STARTED|Extension Period:26 Weeks(Upto 52 Weeks)||0
3286981|NCT02787551|4020584|FG000|COMPLETED|Extension Period:26 Weeks(Upto 52 Weeks)||197
3286982|NCT02787551|4020585|FG001|COMPLETED|Extension Period:26 Weeks(Upto 52 Weeks)||0
3083405|NCT01395888|3805452|FG002|Completed the Treatment Period|Treatment Period (TP)|Participants were considered to have completed the TP if they attended Visit 5 (Week 12).|113
3083406|NCT01395888|3805450|FG000|COMPLETED|Treatment Period (TP)||0
3083407|NCT01395888|3805451|FG001|COMPLETED|Treatment Period (TP)|Par. completed the study if they completed the TP and a safety follow-up phone contact 1 week later.|112
3083408|NCT01395888|3805452|FG002|COMPLETED|Treatment Period (TP)|Par. completed the study if they completed the TP and a safety follow-up phone contact 1 week later.|113
3083409|NCT01395888|3805450|FG000|NOT COMPLETED|Treatment Period (TP)||0
3083410|NCT01395888|3805451|FG001|NOT COMPLETED|Treatment Period (TP)||15
3083411|NCT01395888|3805452|FG002|NOT COMPLETED|Treatment Period (TP)||17
3083412|NCT01395901|3805460|FG000|STARTED|Overall Study|Randomized Population|336
3083413|NCT01395901|3805461|FG001|STARTED|Overall Study|Randomized Population|334
3083414|NCT01395901|3805460|FG000|COMPLETED|Overall Study|Treated patients completing the study|326
3083415|NCT01395901|3805461|FG001|COMPLETED|Overall Study|Treated patients completing the study|329
3083416|NCT01395901|3805460|FG000|NOT COMPLETED|Overall Study||10
3083417|NCT01395901|3805461|FG001|NOT COMPLETED|Overall Study||5
3083418|NCT01395914|3805469|FG000|STARTED|Overall Study||345
3083419|NCT01395914|3805470|FG001|STARTED|Overall Study||168
3083420|NCT01395914|3805469|FG000|ITT Population|Overall Study||345
3083421|NCT01395914|3805470|FG001|ITT Population|Overall Study||168
3083422|NCT01395914|3805469|FG000|Safety Population|Overall Study||343
3083423|NCT01395914|3805470|FG001|Safety Population|Overall Study||167
3083424|NCT01395914|3805469|FG000|COMPLETED|Overall Study||273
3083425|NCT01395914|3805470|FG001|COMPLETED|Overall Study||131
3083426|NCT01395914|3805469|FG000|NOT COMPLETED|Overall Study||72
3083427|NCT01395914|3805470|FG001|NOT COMPLETED|Overall Study||37
3083428|NCT01395966|3805479|FG000|STARTED|Overall Study||109
3083429|NCT01395966|3805480|FG001|STARTED|Overall Study||110
3083430|NCT01395966|3805481|FG002|STARTED|Overall Study||112
3083431|NCT01395966|3805479|FG000|COMPLETED|Overall Study||99
3083432|NCT01395966|3805480|FG001|COMPLETED|Overall Study||91
3083433|NCT01395966|3805481|FG002|COMPLETED|Overall Study||104
3083434|NCT01395966|3805479|FG000|NOT COMPLETED|Overall Study||10
3083435|NCT01395966|3805480|FG001|NOT COMPLETED|Overall Study||19
3083436|NCT01395966|3805481|FG002|NOT COMPLETED|Overall Study||8
3083437|NCT01396005|3805491|FG000|STARTED|Overall Study||10
3083438|NCT01396005|3805492|FG001|STARTED|Overall Study||11
3083439|NCT01396005|3805491|FG000|COMPLETED|Overall Study||10
3083440|NCT01396005|3805492|FG001|COMPLETED|Overall Study||9
3083441|NCT01396005|3805491|FG000|NOT COMPLETED|Overall Study||0
3083442|NCT01396005|3805492|FG001|NOT COMPLETED|Overall Study||2
3083443|NCT01396044|3805502|FG000|STARTED|Overall Study||125
3083444|NCT01396044|3805503|FG001|STARTED|Overall Study||171
3083445|NCT01396044|3805502|FG000|COMPLETED|Overall Study||125
3286983|NCT02787551|4020584|FG000|NOT COMPLETED|Extension Period:26 Weeks(Upto 52 Weeks)||9
3286984|NCT02787551|4020585|FG001|NOT COMPLETED|Extension Period:26 Weeks(Upto 52 Weeks)||0
3286985|NCT02787564|4020596|FG000|STARTED|Overall Study||32
3286986|NCT02787564|4020597|FG001|STARTED|Overall Study||29
3286987|NCT02787564|4020596|FG000|COMPLETED|Overall Study|n=12 food bank users; n=13 non-food bank users|25
3286988|NCT02787564|4020597|FG001|COMPLETED|Overall Study|n=12 food bank users; n=15 non-food bank users|27
3286989|NCT02787564|4020596|FG000|NOT COMPLETED|Overall Study||7
3286990|NCT02787564|4020597|FG001|NOT COMPLETED|Overall Study||2
3286991|NCT02787655|4020605|FG000|STARTED|Overall Study||40
3286992|NCT02787655|4020606|FG001|STARTED|Overall Study||38
3286993|NCT02787655|4020605|FG000|COMPLETED|Overall Study||29
3286994|NCT02787655|4020606|FG001|COMPLETED|Overall Study||26
3286995|NCT02787655|4020605|FG000|NOT COMPLETED|Overall Study||11
3286996|NCT02787655|4020606|FG001|NOT COMPLETED|Overall Study||12
3286997|NCT02787681|4020612|FG000|STARTED|Overall Study||71
3286998|NCT02787681|4020612|FG000|COMPLETED|Overall Study||69
3286999|NCT02787681|4020612|FG000|NOT COMPLETED|Overall Study||2
3287000|NCT02787694|4020616|FG000|STARTED|Overall Study||22
3287001|NCT02787694|4020616|FG000|COMPLETED|Overall Study||17
3287002|NCT02787694|4020616|FG000|NOT COMPLETED|Overall Study||5
3287003|NCT02787863|4020628|FG000|STARTED|Overall Study||33
3287004|NCT02787863|4020629|FG001|STARTED|Overall Study||34
3287005|NCT02787863|4020630|FG002|STARTED|Overall Study||25
3287006|NCT02787863|4020631|FG003|STARTED|Overall Study||25
3083446|NCT01396044|3805503|FG001|COMPLETED|Overall Study||171
3083447|NCT01396044|3805502|FG000|NOT COMPLETED|Overall Study||0
3287007|NCT02787863|4020632|FG004|STARTED|Overall Study||32
3287008|NCT02787863|4020633|FG005|STARTED|Overall Study||18
3287009|NCT02787863|4020634|FG006|STARTED|Overall Study||25
3287010|NCT02787863|4020635|FG007|STARTED|Overall Study||27
3287011|NCT02787863|4020628|FG000|1 Year After Vaccination|Overall Study||32
3287012|NCT02787863|4020629|FG001|1 Year After Vaccination|Overall Study||33
3287013|NCT02787863|4020630|FG002|1 Year After Vaccination|Overall Study||23
3287014|NCT02787863|4020631|FG003|1 Year After Vaccination|Overall Study||25
3287015|NCT02787863|4020632|FG004|1 Year After Vaccination|Overall Study||32
3287016|NCT02787863|4020633|FG005|1 Year After Vaccination|Overall Study||18
3287017|NCT02787863|4020634|FG006|1 Year After Vaccination|Overall Study||25
3287018|NCT02787863|4020635|FG007|1 Year After Vaccination|Overall Study||27
3287019|NCT02787863|4020628|FG000|4 Years After Vaccination|Overall Study||32
3287020|NCT02787863|4020629|FG001|4 Years After Vaccination|Overall Study||33
3287021|NCT02787863|4020630|FG002|4 Years After Vaccination|Overall Study||23
3287022|NCT02787863|4020631|FG003|4 Years After Vaccination|Overall Study||25
3287023|NCT02787863|4020632|FG004|4 Years After Vaccination|Overall Study||32
3083448|NCT01396044|3805503|FG001|NOT COMPLETED|Overall Study||0
3083449|NCT01396057|3805511|FG000|STARTED|Overall Study||126
3083450|NCT01396057|3805512|FG001|STARTED|Overall Study||118
3083451|NCT01396057|3805511|FG000|COMPLETED|Overall Study||115
3083452|NCT01396057|3805512|FG001|COMPLETED|Overall Study||100
3083453|NCT01396057|3805511|FG000|NOT COMPLETED|Overall Study||11
3083454|NCT01396057|3805512|FG001|NOT COMPLETED|Overall Study||18
3083455|NCT01396070|3805518|FG000|STARTED|Overall Study||36
3083456|NCT01396070|3805518|FG000|COMPLETED|Overall Study||17
3083457|NCT01396070|3805518|FG000|NOT COMPLETED|Overall Study||19
3083458|NCT01396083|3805525|FG000|STARTED|Overall Study||124
3083459|NCT01396083|3805526|FG001|STARTED|Overall Study||119
3083460|NCT01396083|3805525|FG000|COMPLETED|Overall Study||113
3083461|NCT01396083|3805526|FG001|COMPLETED|Overall Study||72
3083462|NCT01396083|3805525|FG000|NOT COMPLETED|Overall Study||11
3083463|NCT01396083|3805526|FG001|NOT COMPLETED|Overall Study||47
3083464|NCT01396148|3805532|FG000|STARTED|Overall Study||6
3083465|NCT01396148|3805532|FG000|COMPLETED|Overall Study||5
3083466|NCT01396148|3805532|FG000|NOT COMPLETED|Overall Study||1
3083467|NCT01396161|3805545|FG000|STARTED|Overall Study||12
3287024|NCT02787863|4020633|FG005|4 Years After Vaccination|Overall Study||18
3287025|NCT02787863|4020634|FG006|4 Years After Vaccination|Overall Study||25
3287026|NCT02787863|4020635|FG007|4 Years After Vaccination|Overall Study||27
3287027|NCT02787863|4020628|FG000|COMPLETED|Overall Study||32
3287028|NCT02787863|4020629|FG001|COMPLETED|Overall Study||33
3287029|NCT02787863|4020630|FG002|COMPLETED|Overall Study||23
3287030|NCT02787863|4020631|FG003|COMPLETED|Overall Study||25
3287031|NCT02787863|4020632|FG004|COMPLETED|Overall Study||32
3287032|NCT02787863|4020633|FG005|COMPLETED|Overall Study||18
3287033|NCT02787863|4020634|FG006|COMPLETED|Overall Study||25
3287034|NCT02787863|4020635|FG007|COMPLETED|Overall Study||27
3287035|NCT02787863|4020628|FG000|NOT COMPLETED|Overall Study||1
3287036|NCT02787863|4020629|FG001|NOT COMPLETED|Overall Study||1
3287037|NCT02787863|4020630|FG002|NOT COMPLETED|Overall Study||2
3287038|NCT02787863|4020631|FG003|NOT COMPLETED|Overall Study||0
3287039|NCT02787863|4020632|FG004|NOT COMPLETED|Overall Study||0
3287040|NCT02787863|4020633|FG005|NOT COMPLETED|Overall Study||0
3287041|NCT02787863|4020634|FG006|NOT COMPLETED|Overall Study||0
3287042|NCT02787863|4020635|FG007|NOT COMPLETED|Overall Study||0
3287043|NCT02788019|4020678|FG000|STARTED|Overall Study||27
3287044|NCT02788019|4020679|FG001|STARTED|Overall Study||25
3287045|NCT02788019|4020678|FG000|COMPLETED|Overall Study||23
3287046|NCT02788019|4020679|FG001|COMPLETED|Overall Study||20
3287047|NCT02788019|4020678|FG000|NOT COMPLETED|Overall Study||4
3287048|NCT02788019|4020679|FG001|NOT COMPLETED|Overall Study||5
3287049|NCT02788097|4020687|FG000|STARTED|Overall Study||61
3287050|NCT02788097|4020688|FG001|STARTED|Overall Study||69
3287051|NCT02788097|4020687|FG000|COMPLETED|Overall Study||61
3287052|NCT02788097|4020688|FG001|COMPLETED|Overall Study||69
3287053|NCT02788097|4020687|FG000|NOT COMPLETED|Overall Study||0
3287054|NCT02788097|4020688|FG001|NOT COMPLETED|Overall Study||0
3287055|NCT02788175|4020694|FG000|STARTED|Overall Study||26
3287056|NCT02788175|4020694|FG000|Received Study Agent|Overall Study||20
3287057|NCT02788175|4020694|FG000|COMPLETED|Overall Study||13
3287058|NCT02788175|4020694|FG000|NOT COMPLETED|Overall Study||13
3287059|NCT02788188|4020705|FG000|STARTED|Overall Study||2
3287060|NCT02788188|4020706|FG001|STARTED|Overall Study||2
3287061|NCT02788188|4020707|FG002|STARTED|Overall Study||4
3287062|NCT02788188|4020708|FG003|STARTED|Overall Study||4
3287063|NCT02788188|4020709|FG004|STARTED|Overall Study||8
3287064|NCT02788188|4020710|FG005|STARTED|Overall Study||8
3287065|NCT02788188|4020711|FG006|STARTED|Overall Study||10
3287066|NCT02788188|4020705|FG000|COMPLETED|Overall Study||2
3287067|NCT02788188|4020706|FG001|COMPLETED|Overall Study||2
3287068|NCT02788188|4020707|FG002|COMPLETED|Overall Study||4
3287069|NCT02788188|4020708|FG003|COMPLETED|Overall Study||4
3287070|NCT02788188|4020709|FG004|COMPLETED|Overall Study||8
3287071|NCT02788188|4020710|FG005|COMPLETED|Overall Study||8
3287072|NCT02788188|4020711|FG006|COMPLETED|Overall Study||10
3287073|NCT02788188|4020705|FG000|NOT COMPLETED|Overall Study||0
3287074|NCT02788188|4020706|FG001|NOT COMPLETED|Overall Study||0
3287075|NCT02788188|4020707|FG002|NOT COMPLETED|Overall Study||0
3287076|NCT02788188|4020708|FG003|NOT COMPLETED|Overall Study||0
3287077|NCT02788188|4020709|FG004|NOT COMPLETED|Overall Study||0
3287078|NCT02788188|4020710|FG005|NOT COMPLETED|Overall Study||0
3287079|NCT02788188|4020711|FG006|NOT COMPLETED|Overall Study||0
3287080|NCT02788201|4020733|FG000|STARTED|Overall Study||1
3287081|NCT02788201|4020734|FG001|STARTED|Overall Study||1
3083468|NCT01396161|3805546|FG001|STARTED|Overall Study||5
3083469|NCT01396161|3805547|FG002|STARTED|Overall Study||9
3083470|NCT01396161|3805548|FG003|STARTED|Overall Study||9
3083471|NCT01396161|3805549|FG004|STARTED|Overall Study||9
3083472|NCT01396161|3805550|FG005|STARTED|Overall Study||9
3083473|NCT01396161|3805551|FG006|STARTED|Overall Study||11
3083474|NCT01396161|3805545|FG000|COMPLETED|Overall Study||12
3287082|NCT02788201|4020735|FG002|STARTED|Overall Study||1
3287083|NCT02788201|4020736|FG003|STARTED|Overall Study||1
3287084|NCT02788201|4020737|FG004|STARTED|Overall Study||1
3287085|NCT02788201|4020738|FG005|STARTED|Overall Study||3
3287086|NCT02788201|4020733|FG000|Did Not Start Treatment|Overall Study||0
3287087|NCT02788201|4020734|FG001|Did Not Start Treatment|Overall Study||0
3287088|NCT02788201|4020735|FG002|Did Not Start Treatment|Overall Study||0
3287089|NCT02788201|4020736|FG003|Did Not Start Treatment|Overall Study||0
3083475|NCT01396161|3805546|FG001|COMPLETED|Overall Study||5
3083476|NCT01396161|3805547|FG002|COMPLETED|Overall Study||9
3083477|NCT01396161|3805548|FG003|COMPLETED|Overall Study||9
3083478|NCT01396161|3805549|FG004|COMPLETED|Overall Study||8
3083479|NCT01396161|3805550|FG005|COMPLETED|Overall Study||9
3083480|NCT01396161|3805551|FG006|COMPLETED|Overall Study||10
3083481|NCT01396161|3805545|FG000|NOT COMPLETED|Overall Study||0
3083482|NCT01396161|3805546|FG001|NOT COMPLETED|Overall Study||0
3083483|NCT01396161|3805547|FG002|NOT COMPLETED|Overall Study||0
3083484|NCT01396161|3805548|FG003|NOT COMPLETED|Overall Study||0
3083485|NCT01396161|3805549|FG004|NOT COMPLETED|Overall Study||1
3083486|NCT01396161|3805550|FG005|NOT COMPLETED|Overall Study||0
3083487|NCT01396161|3805551|FG006|NOT COMPLETED|Overall Study||1
3083488|NCT01396187|3805577|FG000|STARTED|Overall Study||8
3083489|NCT01396187|3805578|FG001|STARTED|Overall Study||12
3083490|NCT01396187|3805579|FG002|STARTED|Overall Study||10
3083491|NCT01396187|3805580|FG003|STARTED|Overall Study||10
3083492|NCT01396187|3805581|FG004|STARTED|Overall Study||10
3083493|NCT01396187|3805577|FG000|COMPLETED|Overall Study||7
3083494|NCT01396187|3805578|FG001|COMPLETED|Overall Study||9
3083495|NCT01396187|3805579|FG002|COMPLETED|Overall Study||9
3083496|NCT01396187|3805580|FG003|COMPLETED|Overall Study||10
3083497|NCT01396187|3805581|FG004|COMPLETED|Overall Study||9
3083498|NCT01396187|3805577|FG000|NOT COMPLETED|Overall Study||1
3083499|NCT01396187|3805578|FG001|NOT COMPLETED|Overall Study||3
3083500|NCT01396187|3805579|FG002|NOT COMPLETED|Overall Study||1
3083501|NCT01396187|3805580|FG003|NOT COMPLETED|Overall Study||0
3083502|NCT01396187|3805581|FG004|NOT COMPLETED|Overall Study||1
3083503|NCT01396226|3805599|FG000|STARTED|Overall Study||12
3083504|NCT01396226|3805600|FG001|STARTED|Overall Study||6
3083505|NCT01396226|3805599|FG000|Patients Who Received Treatment|Overall Study||12
3287090|NCT02788201|4020737|FG004|Did Not Start Treatment|Overall Study||0
3287091|NCT02788201|4020738|FG005|Did Not Start Treatment|Overall Study||3
3287092|NCT02788201|4020733|FG000|COMPLETED|Overall Study||0
3287093|NCT02788201|4020734|FG001|COMPLETED|Overall Study||0
3287094|NCT02788201|4020735|FG002|COMPLETED|Overall Study||0
3287095|NCT02788201|4020736|FG003|COMPLETED|Overall Study||0
3287096|NCT02788201|4020737|FG004|COMPLETED|Overall Study||1
3287097|NCT02788201|4020738|FG005|COMPLETED|Overall Study||0
3287098|NCT02788201|4020733|FG000|NOT COMPLETED|Overall Study||1
3287099|NCT02788201|4020734|FG001|NOT COMPLETED|Overall Study||1
3287100|NCT02788201|4020735|FG002|NOT COMPLETED|Overall Study||1
3287101|NCT02788201|4020736|FG003|NOT COMPLETED|Overall Study||1
3287102|NCT02788201|4020737|FG004|NOT COMPLETED|Overall Study||0
3287103|NCT02788201|4020738|FG005|NOT COMPLETED|Overall Study||3
3287104|NCT02788279|4020757|FG000|STARTED|Overall Study||90
3287105|NCT02788279|4020758|FG001|STARTED|Overall Study||183
3287106|NCT02788279|4020759|FG002|STARTED|Overall Study||90
3287107|NCT02788279|4020757|FG000|Received Treatment (Safety Population)|Overall Study||80
3287108|NCT02788279|4020758|FG001|Received Treatment (Safety Population)|Overall Study||179
3287109|NCT02788279|4020759|FG002|Received Treatment (Safety Population)|Overall Study||90
3287110|NCT02788279|4020757|FG000|Modified ITT Population|Overall Study||57
3287111|NCT02788279|4020758|FG001|Modified ITT Population|Overall Study||125
3287112|NCT02788279|4020759|FG002|Modified ITT Population|Overall Study||61
3287113|NCT02788279|4020757|FG000|COMPLETED|Overall Study||0
3287114|NCT02788279|4020758|FG001|COMPLETED|Overall Study||0
3287115|NCT02788279|4020759|FG002|COMPLETED|Overall Study||0
3287116|NCT02788279|4020757|FG000|NOT COMPLETED|Overall Study||90
3287117|NCT02788279|4020758|FG001|NOT COMPLETED|Overall Study||183
3287118|NCT02788279|4020759|FG002|NOT COMPLETED|Overall Study||90
3287119|NCT02788357|4020772|FG000|STARTED|Overall Study||6
3287120|NCT02788357|4020773|FG001|STARTED|Overall Study||6
3287121|NCT02788357|4020772|FG000|COMPLETED|Overall Study||3
3287122|NCT02788357|4020773|FG001|COMPLETED|Overall Study||6
3287123|NCT02788357|4020772|FG000|NOT COMPLETED|Overall Study||3
3287124|NCT02788357|4020773|FG001|NOT COMPLETED|Overall Study||0
3287125|NCT02788474|4020781|FG000|STARTED|Double Blind Treatment Period||231
3287126|NCT02788474|4020782|FG001|STARTED|Double Blind Treatment Period||116
3287127|NCT02788474|4020781|FG000|Treated|Double Blind Treatment Period||230
3287128|NCT02788474|4020782|FG001|Treated|Double Blind Treatment Period||116
3287129|NCT02788474|4020781|FG000|COMPLETED|Double Blind Treatment Period||221
3287130|NCT02788474|4020782|FG001|COMPLETED|Double Blind Treatment Period||112
3287131|NCT02788474|4020781|FG000|NOT COMPLETED|Double Blind Treatment Period||10
3287132|NCT02788474|4020782|FG001|NOT COMPLETED|Double Blind Treatment Period||4
3287133|NCT02788474|4020781|FG000|STARTED|Open Label Treatment Period||221
3287134|NCT02788474|4020782|FG001|STARTED|Open Label Treatment Period||112
3287135|NCT02788474|4020781|FG000|COMPLETED|Open Label Treatment Period||189
3287136|NCT02788474|4020782|FG001|COMPLETED|Open Label Treatment Period||100
3083506|NCT01396226|3805600|FG001|Patients Who Received Treatment|Overall Study||6
3083507|NCT01396226|3805599|FG000|Patients Who Completed Treatment|Overall Study||12
3083508|NCT01396226|3805600|FG001|Patients Who Completed Treatment|Overall Study||6
3083509|NCT01396226|3805599|FG000|COMPLETED|Overall Study||12
3287137|NCT02788474|4020781|FG000|NOT COMPLETED|Open Label Treatment Period||32
3287138|NCT02788474|4020782|FG001|NOT COMPLETED|Open Label Treatment Period||12
3287139|NCT02788513|4020794|FG000|STARTED|Overall Study||123
3287140|NCT02788513|4020795|FG001|STARTED|Overall Study||122
3287141|NCT02788513|4020796|FG002|STARTED|Overall Study||122
3287142|NCT02788513|4020797|FG003|STARTED|Overall Study||123
3083510|NCT01396226|3805600|FG001|COMPLETED|Overall Study||6
3083511|NCT01396226|3805599|FG000|NOT COMPLETED|Overall Study||0
3083512|NCT01396226|3805600|FG001|NOT COMPLETED|Overall Study||0
3083513|NCT01396239|3805609|FG000|STARTED|Overall Study||4
3083514|NCT01396239|3805610|FG001|STARTED|Overall Study||2
3083515|NCT01396239|3805611|FG002|STARTED|Overall Study||4
3083516|NCT01396239|3805612|FG003|STARTED|Overall Study||2
3083517|NCT01396239|3805609|FG000|COMPLETED|Overall Study||4
3083518|NCT01396239|3805610|FG001|COMPLETED|Overall Study||2
3083519|NCT01396239|3805611|FG002|COMPLETED|Overall Study||4
3083520|NCT01396239|3805612|FG003|COMPLETED|Overall Study||2
3083521|NCT01396239|3805609|FG000|NOT COMPLETED|Overall Study||0
3083522|NCT01396239|3805610|FG001|NOT COMPLETED|Overall Study||0
3083523|NCT01396239|3805611|FG002|NOT COMPLETED|Overall Study||0
3083524|NCT01396239|3805612|FG003|NOT COMPLETED|Overall Study||0
3083525|NCT01396265|3805629|FG000|STARTED|Afatinib||22
3083526|NCT01396265|3805629|FG000|COMPLETED|Afatinib||22
3083527|NCT01396265|3805629|FG000|NOT COMPLETED|Afatinib||0
3083528|NCT01396265|3805629|FG000|STARTED|Washout||22
3083529|NCT01396265|3805629|FG000|COMPLETED|Washout||22
3083530|NCT01396265|3805629|FG000|NOT COMPLETED|Washout||0
3083531|NCT01396265|3805629|FG000|STARTED|Rifa+Afatinib||22
3083532|NCT01396265|3805629|FG000|COMPLETED|Rifa+Afatinib||21
3083533|NCT01396265|3805629|FG000|NOT COMPLETED|Rifa+Afatinib||1
3083534|NCT01396317|3805637|FG000|STARTED|Overall Study||10
3083535|NCT01396317|3805638|FG001|STARTED|Overall Study||10
3083536|NCT01396317|3805637|FG000|COMPLETED|Overall Study||9
3083537|NCT01396317|3805638|FG001|COMPLETED|Overall Study||10
3083538|NCT01396317|3805637|FG000|NOT COMPLETED|Overall Study||1
3083539|NCT01396317|3805638|FG001|NOT COMPLETED|Overall Study||0
3083540|NCT01396382|3805646|FG000|STARTED|Overall Study||97
3083541|NCT01396382|3805646|FG000|COMPLETED|Overall Study||97
3083542|NCT01396382|3805646|FG000|NOT COMPLETED|Overall Study||0
3083543|NCT01396395|3805653|FG000|STARTED|Overall Study||200
3083544|NCT01396395|3805654|FG001|STARTED|Overall Study||202
3083545|NCT01396395|3805653|FG000|Safety Analysis Set|Overall Study|1 subject randomized to standard was included in standard+nicorandil as nicorandil was received.|197
3083546|NCT01396395|3805654|FG001|Safety Analysis Set|Overall Study|4 subjects randomized to standard+nicorandil were included in standard as no nicorandil was received|205
3083547|NCT01396395|3805653|FG000|COMPLETED|Overall Study||160
3083548|NCT01396395|3805654|FG001|COMPLETED|Overall Study||175
3083549|NCT01396395|3805653|FG000|NOT COMPLETED|Overall Study||40
3083550|NCT01396395|3805654|FG001|NOT COMPLETED|Overall Study||27
3083551|NCT01396421|3805666|FG000|STARTED|Overall Study||180
3083552|NCT01396421|3805667|FG001|STARTED|Overall Study||182
3083553|NCT01396421|3805668|FG002|STARTED|Overall Study||90
3083554|NCT01396421|3805669|FG003|STARTED|Overall Study||184
3083555|NCT01396421|3805666|FG000|COMPLETED|Overall Study||121
3287143|NCT02788513|4020798|FG004|STARTED|Overall Study||120
3287144|NCT02788513|4020794|FG000|COMPLETED|Overall Study||114
3287145|NCT02788513|4020795|FG001|COMPLETED|Overall Study||114
3287146|NCT02788513|4020796|FG002|COMPLETED|Overall Study||114
3287147|NCT02788513|4020797|FG003|COMPLETED|Overall Study||117
3287148|NCT02788513|4020798|FG004|COMPLETED|Overall Study||115
3287149|NCT02788513|4020794|FG000|NOT COMPLETED|Overall Study||9
3287150|NCT02788513|4020795|FG001|NOT COMPLETED|Overall Study||8
3287151|NCT02788513|4020796|FG002|NOT COMPLETED|Overall Study||8
3287152|NCT02788513|4020797|FG003|NOT COMPLETED|Overall Study||6
3287153|NCT02788513|4020798|FG004|NOT COMPLETED|Overall Study||5
3287154|NCT02788656|4020812|FG000|STARTED|Overall Study||2
3287155|NCT02788656|4020813|FG001|STARTED|Overall Study||2
3287156|NCT02788656|4020812|FG000|COMPLETED|Overall Study||1
3287157|NCT02788656|4020813|FG001|COMPLETED|Overall Study||2
3287158|NCT02788656|4020812|FG000|NOT COMPLETED|Overall Study||1
3287159|NCT02788656|4020813|FG001|NOT COMPLETED|Overall Study||0
3287160|NCT02788747|4020822|FG000|STARTED|Overall Study||23
3287161|NCT02788747|4020823|FG001|STARTED|Overall Study||24
3287162|NCT02788747|4020824|FG002|STARTED|Overall Study||24
3287163|NCT02788747|4020822|FG000|COMPLETED|Overall Study||22
3287164|NCT02788747|4020823|FG001|COMPLETED|Overall Study||24
3287165|NCT02788747|4020824|FG002|COMPLETED|Overall Study||24
3287166|NCT02788747|4020822|FG000|NOT COMPLETED|Overall Study||1
3287167|NCT02788747|4020823|FG001|NOT COMPLETED|Overall Study||0
3287168|NCT02788747|4020824|FG002|NOT COMPLETED|Overall Study||0
3287169|NCT02788903|4020837|FG000|STARTED|Overall Study||567908
3287170|NCT02788903|4020838|FG001|STARTED|Overall Study||2054256
3287171|NCT02788903|4020837|FG000|COMPLETED|Overall Study||567908
3287172|NCT02788903|4020838|FG001|COMPLETED|Overall Study||2054256
3287173|NCT02788903|4020837|FG000|NOT COMPLETED|Overall Study||0
3287174|NCT02788903|4020838|FG001|NOT COMPLETED|Overall Study||0
3287175|NCT02789033|4020850|FG000|STARTED|Overall Study||17
3083556|NCT01396421|3805667|FG001|COMPLETED|Overall Study||124
3083557|NCT01396421|3805668|FG002|COMPLETED|Overall Study||56
3083558|NCT01396421|3805669|FG003|COMPLETED|Overall Study||109
3083559|NCT01396421|3805666|FG000|NOT COMPLETED|Overall Study||59
3083560|NCT01396421|3805667|FG001|NOT COMPLETED|Overall Study||58
3083561|NCT01396421|3805668|FG002|NOT COMPLETED|Overall Study||34
3083562|NCT01396421|3805669|FG003|NOT COMPLETED|Overall Study||75
3287176|NCT02789033|4020851|FG001|STARTED|Overall Study||17
3287177|NCT02789033|4020852|FG002|STARTED|Overall Study||17
3287178|NCT02789033|4020853|FG003|STARTED|Overall Study||17
3287179|NCT02789033|4020850|FG000|COMPLETED|Overall Study||15
3287180|NCT02789033|4020851|FG001|COMPLETED|Overall Study||15
3287181|NCT02789033|4020852|FG002|COMPLETED|Overall Study||16
3083563|NCT01396434|3805696|FG000|STARTED|Overall Study||2817
3083564|NCT01396434|3805697|FG001|STARTED|Overall Study||175
3083565|NCT01396434|3805698|FG002|STARTED|Overall Study||14
3083566|NCT01396434|3805696|FG000|COMPLETED|Overall Study||2806
3083567|NCT01396434|3805697|FG001|COMPLETED|Overall Study||175
3083568|NCT01396434|3805698|FG002|COMPLETED|Overall Study||14
3083569|NCT01396434|3805696|FG000|NOT COMPLETED|Overall Study||11
3083570|NCT01396434|3805697|FG001|NOT COMPLETED|Overall Study||0
3083571|NCT01396434|3805698|FG002|NOT COMPLETED|Overall Study||0
3083572|NCT01396447|3805710|FG000|STARTED|Overall Study||148
3083573|NCT01396447|3805711|FG001|STARTED|Overall Study||143
3083574|NCT01396447|3805712|FG002|STARTED|Overall Study||147
3287182|NCT02789033|4020853|FG003|COMPLETED|Overall Study||15
3287183|NCT02789033|4020850|FG000|NOT COMPLETED|Overall Study||2
3287184|NCT02789033|4020851|FG001|NOT COMPLETED|Overall Study||2
3287185|NCT02789033|4020852|FG002|NOT COMPLETED|Overall Study||1
3287186|NCT02789033|4020853|FG003|NOT COMPLETED|Overall Study||2
3316615|NCT03116152|4050006|FG000|Treated|Overall Study||94
3316616|NCT03116152|4050007|FG001|Treated|Overall Study||87
3316617|NCT03116152|4050006|FG000|COMPLETED|Overall Study||4
3316618|NCT03116152|4050007|FG001|COMPLETED|Overall Study||0
3316619|NCT03116152|4050006|FG000|NOT COMPLETED|Overall Study||91
3316620|NCT03116152|4050007|FG001|NOT COMPLETED|Overall Study||95
3316621|NCT03116230|4050015|FG000|STARTED|Overall Study||19
3316622|NCT03116230|4050016|FG001|STARTED|Overall Study||19
3316623|NCT03116230|4050015|FG000|COMPLETED|Overall Study||15
3316624|NCT03116230|4050016|FG001|COMPLETED|Overall Study||17
3316625|NCT03116230|4050015|FG000|NOT COMPLETED|Overall Study||4
3316626|NCT03116230|4050016|FG001|NOT COMPLETED|Overall Study||2
3316627|NCT03116698|4050026|FG000|STARTED|Overall Study||62
3316628|NCT03116698|4050027|FG001|STARTED|Overall Study||57
3316629|NCT03116698|4050028|FG002|STARTED|Overall Study||62
3316630|NCT03116698|4050029|FG003|STARTED|Overall Study||57
3316631|NCT03116698|4050026|FG000|COMPLETED|Overall Study||56
3316632|NCT03116698|4050027|FG001|COMPLETED|Overall Study||51
3316633|NCT03116698|4050028|FG002|COMPLETED|Overall Study||54
3316634|NCT03116698|4050029|FG003|COMPLETED|Overall Study||55
3316635|NCT03116698|4050026|FG000|NOT COMPLETED|Overall Study||6
3316636|NCT03116698|4050027|FG001|NOT COMPLETED|Overall Study||6
3316637|NCT03116698|4050028|FG002|NOT COMPLETED|Overall Study||8
3316638|NCT03116698|4050029|FG003|NOT COMPLETED|Overall Study||2
3316639|NCT03116828|4050041|FG000|STARTED|Overall Study||44
3316640|NCT03116828|4050042|FG001|STARTED|Overall Study||58
3316641|NCT03116828|4050041|FG000|COMPLETED|Overall Study||36
3316642|NCT03116828|4050042|FG001|COMPLETED|Overall Study||37
3316643|NCT03116828|4050041|FG000|NOT COMPLETED|Overall Study||8
3316644|NCT03116828|4050042|FG001|NOT COMPLETED|Overall Study||21
3316645|NCT03116841|4050048|FG000|STARTED|Overall Study||3
3316646|NCT03116841|4050048|FG000|COMPLETED|Overall Study||3
3316647|NCT03116841|4050048|FG000|NOT COMPLETED|Overall Study||0
3316648|NCT03117140|4050056|FG000|STARTED|Overall Study||40
3316649|NCT03117140|4050057|FG001|STARTED|Overall Study||40
3316650|NCT03117140|4050058|FG002|STARTED|Overall Study||40
3316651|NCT03117140|4050059|FG003|STARTED|Overall Study||40
3316652|NCT03117140|4050056|FG000|COMPLETED|Overall Study||40
3316653|NCT03117140|4050057|FG001|COMPLETED|Overall Study||40
3316654|NCT03117140|4050058|FG002|COMPLETED|Overall Study||40
3316655|NCT03117140|4050059|FG003|COMPLETED|Overall Study||40
3316656|NCT03117140|4050056|FG000|NOT COMPLETED|Overall Study||0
3316657|NCT03117140|4050057|FG001|NOT COMPLETED|Overall Study||0
3316658|NCT03117140|4050058|FG002|NOT COMPLETED|Overall Study||0
3316659|NCT03117140|4050059|FG003|NOT COMPLETED|Overall Study||0
3316660|NCT03117361|4050072|FG000|STARTED|Overall Study||10
3316661|NCT03117361|4050072|FG000|COMPLETED|Overall Study||0
3316662|NCT03117361|4050072|FG000|NOT COMPLETED|Overall Study||10
3316663|NCT03117517|4050078|FG000|STARTED|Overall Study||53
3316664|NCT03117517|4050079|FG001|STARTED|Overall Study||53
3316665|NCT03117517|4050078|FG000|COMPLETED|Overall Study||48
3316666|NCT03117517|4050079|FG001|COMPLETED|Overall Study||49
3316667|NCT03117517|4050078|FG000|NOT COMPLETED|Overall Study||5
3316668|NCT03117517|4050079|FG001|NOT COMPLETED|Overall Study||4
3316669|NCT03117569|4050091|FG000|STARTED|Overall Study||127
3316670|NCT03117569|4050092|FG001|STARTED|Overall Study||253
3316671|NCT03117569|4050091|FG000|COMPLETED|Overall Study||123
3316672|NCT03117569|4050092|FG001|COMPLETED|Overall Study||241
3316673|NCT03117569|4050091|FG000|NOT COMPLETED|Overall Study||4
3316674|NCT03117569|4050092|FG001|NOT COMPLETED|Overall Study||12
3083575|NCT01396447|3805713|FG003|STARTED|Overall Study||146
3083576|NCT01396447|3805710|FG000|Received Treatment|Overall Study||145
3083577|NCT01396447|3805711|FG001|Received Treatment|Overall Study||141
3316675|NCT03117634|4050104|FG000|STARTED|Overall Study||41
3316676|NCT03117634|4050105|FG001|STARTED|Overall Study||13
3316677|NCT03117634|4050104|FG000|COMPLETED|Overall Study||39
3316678|NCT03117634|4050105|FG001|COMPLETED|Overall Study||13
3316679|NCT03117634|4050104|FG000|NOT COMPLETED|Overall Study||2
3316680|NCT03117634|4050105|FG001|NOT COMPLETED|Overall Study||0
3316681|NCT03117738|4050113|FG000|STARTED|Overall Study||11
3316682|NCT03117738|4050114|FG001|STARTED|Overall Study||10
3316683|NCT03117738|4050113|FG000|COMPLETED|Overall Study||7
3316684|NCT03117738|4050114|FG001|COMPLETED|Overall Study||5
3316685|NCT03117738|4050113|FG000|NOT COMPLETED|Overall Study||4
3316686|NCT03117738|4050114|FG001|NOT COMPLETED|Overall Study||5
3316687|NCT03118297|4050122|FG000|STARTED|Overall Study||32
3316688|NCT03118297|4050123|FG001|STARTED|Overall Study||33
3083578|NCT01396447|3805712|FG002|Received Treatment|Overall Study||146
3083579|NCT01396447|3805713|FG003|Received Treatment|Overall Study||146
3083580|NCT01396447|3805710|FG000|COMPLETED|Overall Study||105
3083581|NCT01396447|3805711|FG001|COMPLETED|Overall Study||103
3083582|NCT01396447|3805712|FG002|COMPLETED|Overall Study||117
3083583|NCT01396447|3805713|FG003|COMPLETED|Overall Study||94
3287187|NCT02789111|4020865|FG000|STARTED|Overall Study||24
3287188|NCT02789111|4020866|FG001|STARTED|Overall Study||25
3287189|NCT02789111|4020865|FG000|COMPLETED|Overall Study||23
3287190|NCT02789111|4020866|FG001|COMPLETED|Overall Study||21
3287191|NCT02789111|4020865|FG000|NOT COMPLETED|Overall Study||1
3287192|NCT02789111|4020866|FG001|NOT COMPLETED|Overall Study||4
3287193|NCT02789137|4020874|FG000|STARTED|Overall Study||111
3287194|NCT02789137|4020874|FG000|COMPLETED|Overall Study||53
3287195|NCT02789137|4020874|FG000|NOT COMPLETED|Overall Study||58
3287196|NCT02789176|4020883|FG000|STARTED|Overall Study||99
3287197|NCT02789176|4020884|FG001|STARTED|Overall Study||55
3287198|NCT02789176|4020885|FG002|STARTED|Overall Study||95
3287199|NCT02789176|4020886|FG003|STARTED|Overall Study||54
3287200|NCT02789176|4020883|FG000|COMPLETED|Overall Study||91
3287201|NCT02789176|4020884|FG001|COMPLETED|Overall Study||53
3287202|NCT02789176|4020885|FG002|COMPLETED|Overall Study||85
3287203|NCT02789176|4020886|FG003|COMPLETED|Overall Study||53
3287204|NCT02789176|4020883|FG000|NOT COMPLETED|Overall Study||8
3287205|NCT02789176|4020884|FG001|NOT COMPLETED|Overall Study||2
3287206|NCT02789176|4020885|FG002|NOT COMPLETED|Overall Study||10
3287207|NCT02789176|4020886|FG003|NOT COMPLETED|Overall Study||1
3287208|NCT02789410|4020898|FG000|STARTED|Overall Study||66
3287209|NCT02789410|4020899|FG001|STARTED|Overall Study||68
3287210|NCT02789410|4020898|FG000|COMPLETED|Overall Study||66
3287211|NCT02789410|4020899|FG001|COMPLETED|Overall Study||68
3287212|NCT02789410|4020898|FG000|NOT COMPLETED|Overall Study||0
3287213|NCT02789410|4020899|FG001|NOT COMPLETED|Overall Study||0
3287214|NCT02790073|4020905|FG000|STARTED|Overall Study||14
3287215|NCT02790073|4020905|FG000|COMPLETED|Overall Study||11
3287216|NCT02790073|4020905|FG000|NOT COMPLETED|Overall Study||3
3287217|NCT02790281|4020909|FG000|STARTED|Overall Study||33
3287218|NCT02790281|4020909|FG000|COMPLETED|Overall Study||33
3287219|NCT02790281|4020909|FG000|NOT COMPLETED|Overall Study||0
3287220|NCT02790437|4020915|FG000|STARTED|Overall Study||16
3287221|NCT02790437|4020916|FG001|STARTED|Overall Study||3
3287222|NCT02790437|4020915|FG000|COMPLETED|Overall Study||13
3287223|NCT02790437|4020916|FG001|COMPLETED|Overall Study||3
3287224|NCT02790437|4020915|FG000|NOT COMPLETED|Overall Study||3
3287225|NCT02790437|4020916|FG001|NOT COMPLETED|Overall Study||0
3287226|NCT02790463|4020931|FG000|STARTED|Overall Study||782
3287227|NCT02790463|4020932|FG001|STARTED|Overall Study||681
3287228|NCT02790463|4020931|FG000|COMPLETED|Overall Study||782
3287229|NCT02790463|4020932|FG001|COMPLETED|Overall Study||372
3287230|NCT02790463|4020931|FG000|NOT COMPLETED|Overall Study||0
3287231|NCT02790463|4020932|FG001|NOT COMPLETED|Overall Study||309
3287232|NCT02790606|4020938|FG000|STARTED|Overall Study||110
3287233|NCT02790606|4020938|FG000|COMPLETED|Overall Study||75
3287234|NCT02790606|4020938|FG000|NOT COMPLETED|Overall Study||35
3287235|NCT02790736|4020944|FG000|STARTED|Overall Study||5
3287236|NCT02790736|4020945|FG001|STARTED|Overall Study||1
3287237|NCT02790736|4020944|FG000|COMPLETED|Overall Study||5
3287238|NCT02790736|4020945|FG001|COMPLETED|Overall Study||1
3287239|NCT02790736|4020944|FG000|NOT COMPLETED|Overall Study||0
3287240|NCT02790736|4020945|FG001|NOT COMPLETED|Overall Study||0
3287241|NCT02790788|4020953|FG000|STARTED|Overall Study||46
3287242|NCT02790788|4020954|FG001|STARTED|Overall Study||54
3287243|NCT02790788|4020953|FG000|COMPLETED|Overall Study||46
3287244|NCT02790788|4020954|FG001|COMPLETED|Overall Study||54
3287245|NCT02790788|4020953|FG000|NOT COMPLETED|Overall Study||0
3287246|NCT02790788|4020954|FG001|NOT COMPLETED|Overall Study||0
3287247|NCT02791191|4020965|FG000|STARTED|Overall Study||55
3287248|NCT02791191|4020966|FG001|STARTED|Overall Study||128
3287249|NCT02791191|4020967|FG002|STARTED|Overall Study||133
3287250|NCT02791191|4020965|FG000|Received One Dose of Study Drug|Overall Study||55
3287251|NCT02791191|4020966|FG001|Received One Dose of Study Drug|Overall Study||127
3287252|NCT02791191|4020967|FG002|Received One Dose of Study Drug|Overall Study||133
3287253|NCT02791191|4020965|FG000|COMPLETED|Overall Study||17
3287254|NCT02791191|4020966|FG001|COMPLETED|Overall Study||17
3287255|NCT02791191|4020967|FG002|COMPLETED|Overall Study||13
3287256|NCT02791191|4020965|FG000|NOT COMPLETED|Overall Study||38
3287257|NCT02791191|4020966|FG001|NOT COMPLETED|Overall Study||111
3287258|NCT02791191|4020967|FG002|NOT COMPLETED|Overall Study||120
3083584|NCT01396447|3805710|FG000|NOT COMPLETED|Overall Study||43
3083585|NCT01396447|3805711|FG001|NOT COMPLETED|Overall Study||40
3083586|NCT01396447|3805712|FG002|NOT COMPLETED|Overall Study||30
3083587|NCT01396447|3805713|FG003|NOT COMPLETED|Overall Study||52
3083588|NCT01396486|3805726|FG000|STARTED|Overall Study||20
3083589|NCT01396486|3805727|FG001|STARTED|Overall Study||19
3287259|NCT02791269|4020977|FG000|STARTED|Overall Study||4
3287260|NCT02791269|4020978|FG001|STARTED|Overall Study||20
3287261|NCT02791269|4020977|FG000|COMPLETED|Overall Study||4
3287262|NCT02791269|4020978|FG001|COMPLETED|Overall Study||19
3287263|NCT02791269|4020977|FG000|NOT COMPLETED|Overall Study||0
3287264|NCT02791269|4020978|FG001|NOT COMPLETED|Overall Study||1
3287265|NCT02791308|4020989|FG000|STARTED|Overall Study||195
3287266|NCT02791308|4020990|FG001|STARTED|Overall Study||196
3287267|NCT02791308|4020991|FG002|STARTED|Overall Study||196
3083590|NCT01396486|3805728|FG002|STARTED|Overall Study||22
3083591|NCT01396486|3805726|FG000|Exposed|Overall Study||19
3083592|NCT01396486|3805727|FG001|Exposed|Overall Study||16
3083593|NCT01396486|3805728|FG002|Exposed|Overall Study||17
3083594|NCT01396486|3805726|FG000|COMPLETED|Overall Study||10
3083595|NCT01396486|3805727|FG001|COMPLETED|Overall Study||7
3287268|NCT02791308|4020989|FG000|COMPLETED|Overall Study||185
3287269|NCT02791308|4020990|FG001|COMPLETED|Overall Study||187
3287270|NCT02791308|4020991|FG002|COMPLETED|Overall Study||179
3287271|NCT02791308|4020989|FG000|NOT COMPLETED|Overall Study||10
3287272|NCT02791308|4020990|FG001|NOT COMPLETED|Overall Study||9
3287273|NCT02791308|4020991|FG002|NOT COMPLETED|Overall Study||17
3287274|NCT02791399|4021001|FG000|STARTED|Overall Study||136
3287275|NCT02791399|4021002|FG001|STARTED|Overall Study||150
3287276|NCT02791399|4021001|FG000|COMPLETED|Overall Study||123
3287277|NCT02791399|4021002|FG001|COMPLETED|Overall Study||135
3287278|NCT02791399|4021001|FG000|NOT COMPLETED|Overall Study||13
3287279|NCT02791399|4021002|FG001|NOT COMPLETED|Overall Study||15
3287280|NCT02791438|4021010|FG000|STARTED|Run-In Period||22
3287281|NCT02791438|4021011|FG001|STARTED|Run-In Period||5
3287282|NCT02791438|4021010|FG000|COMPLETED|Run-In Period||22
3287283|NCT02791438|4021011|FG001|COMPLETED|Run-In Period||5
3287284|NCT02791438|4021010|FG000|NOT COMPLETED|Run-In Period||0
3287285|NCT02791438|4021011|FG001|NOT COMPLETED|Run-In Period||0
3287286|NCT02791438|4021010|FG000|STARTED|Treatment Period||22
3287287|NCT02791438|4021011|FG001|STARTED|Treatment Period||5
3287288|NCT02791438|4021010|FG000|COMPLETED|Treatment Period||19
3287289|NCT02791438|4021011|FG001|COMPLETED|Treatment Period||4
3287290|NCT02791438|4021010|FG000|NOT COMPLETED|Treatment Period||3
3287291|NCT02791438|4021011|FG001|NOT COMPLETED|Treatment Period||1
3287292|NCT02791490|4021019|FG000|STARTED|Overall Study||229
3287293|NCT02791490|4021020|FG001|STARTED|Overall Study||229
3287294|NCT02791490|4021019|FG000|COMPLETED|Overall Study||226
3287295|NCT02791490|4021020|FG001|COMPLETED|Overall Study||221
3287296|NCT02791490|4021019|FG000|NOT COMPLETED|Overall Study||3
3287297|NCT02791490|4021020|FG001|NOT COMPLETED|Overall Study||8
3287298|NCT02791516|4021028|FG000|STARTED|Overall Study||33
3287299|NCT02791516|4021029|FG001|STARTED|Overall Study||34
3287300|NCT02791516|4021028|FG000|Completed 6-month Treatment Period|Overall Study||33
3287301|NCT02791516|4021029|FG001|Completed 6-month Treatment Period|Overall Study||33
3287302|NCT02791516|4021028|FG000|COMPLETED|Overall Study||32
3287303|NCT02791516|4021029|FG001|COMPLETED|Overall Study||33
3287304|NCT02791516|4021028|FG000|NOT COMPLETED|Overall Study||1
3287305|NCT02791516|4021029|FG001|NOT COMPLETED|Overall Study||1
3287306|NCT02791659|4021037|FG000|STARTED|Overall Study||27
3287307|NCT02791659|4021038|FG001|STARTED|Overall Study||28
3287308|NCT02791659|4021037|FG000|COMPLETED|Overall Study||27
3287309|NCT02791659|4021038|FG001|COMPLETED|Overall Study||27
3287310|NCT02791659|4021037|FG000|NOT COMPLETED|Overall Study||0
3287311|NCT02791659|4021038|FG001|NOT COMPLETED|Overall Study||1
3287312|NCT02791763|4021047|FG000|STARTED|Overall Study||149
3287313|NCT02791763|4021048|FG001|STARTED|Overall Study||150
3287314|NCT02791763|4021049|FG002|STARTED|Overall Study||56
3287315|NCT02791763|4021047|FG000|COMPLETED|Overall Study||111
3287316|NCT02791763|4021048|FG001|COMPLETED|Overall Study||113
3287317|NCT02791763|4021049|FG002|COMPLETED|Overall Study||43
3287318|NCT02791763|4021047|FG000|NOT COMPLETED|Overall Study||38
3287319|NCT02791763|4021048|FG001|NOT COMPLETED|Overall Study||37
3287320|NCT02791763|4021049|FG002|NOT COMPLETED|Overall Study||13
3287321|NCT02791893|4021068|FG000|STARTED|Blinded Phase||13
3287322|NCT02791893|4021069|FG001|STARTED|Blinded Phase||14
3287323|NCT02791893|4021068|FG000|COMPLETED|Blinded Phase||10
3287324|NCT02791893|4021069|FG001|COMPLETED|Blinded Phase||10
3287325|NCT02791893|4021068|FG000|NOT COMPLETED|Blinded Phase||3
3287326|NCT02791893|4021069|FG001|NOT COMPLETED|Blinded Phase||4
3287327|NCT02791893|4021068|FG000|STARTED|Open Label Phase||10
3287328|NCT02791893|4021069|FG001|STARTED|Open Label Phase||10
3287329|NCT02791893|4021068|FG000|COMPLETED|Open Label Phase||7
3083596|NCT01396486|3805728|FG002|COMPLETED|Overall Study||10
3083597|NCT01396486|3805726|FG000|NOT COMPLETED|Overall Study||10
3083598|NCT01396486|3805727|FG001|NOT COMPLETED|Overall Study||12
3083599|NCT01396486|3805728|FG002|NOT COMPLETED|Overall Study||12
3083600|NCT01396512|3805738|FG000|STARTED|Overall Study||137
3083601|NCT01396512|3805739|FG001|STARTED|Overall Study||137
3083602|NCT01396512|3805738|FG000|COMPLETED|Overall Study||137
3083603|NCT01396512|3805739|FG001|COMPLETED|Overall Study||136
3083604|NCT01396512|3805738|FG000|NOT COMPLETED|Overall Study||0
3083605|NCT01396512|3805739|FG001|NOT COMPLETED|Overall Study||1
3083606|NCT01396525|3805745|FG000|STARTED|Overall Study||153
3083607|NCT01396525|3805745|FG000|COMPLETED|Overall Study||127
3083608|NCT01396525|3805745|FG000|NOT COMPLETED|Overall Study||26
3083609|NCT01396551|3805753|FG000|STARTED|Overall Study||69
3083610|NCT01396551|3805753|FG000|COMPLETED|Overall Study||69
3083611|NCT01396551|3805753|FG000|NOT COMPLETED|Overall Study||0
3083612|NCT01396837|3805757|FG000|STARTED|Overall Study||20
3083613|NCT01396837|3805757|FG000|COMPLETED|Overall Study||16
3287330|NCT02791893|4021069|FG001|COMPLETED|Open Label Phase||8
3083614|NCT01396837|3805757|FG000|NOT COMPLETED|Overall Study||4
3083615|NCT01397071|3805761|FG000|STARTED|Consumption of Beef Patty Alone||11
3287331|NCT02791893|4021068|FG000|NOT COMPLETED|Open Label Phase||3
3287332|NCT02791893|4021069|FG001|NOT COMPLETED|Open Label Phase||2
3287333|NCT02791906|4021077|FG000|STARTED|Overall Study||4
3083616|NCT01397071|3805761|FG000|COMPLETED|Consumption of Beef Patty Alone||11
3083617|NCT01397071|3805761|FG000|NOT COMPLETED|Consumption of Beef Patty Alone||0
3083618|NCT01397071|3805761|FG000|STARTED|Consumption of Beef Patty With Avocado||11
3083619|NCT01397071|3805761|FG000|COMPLETED|Consumption of Beef Patty With Avocado||11
3083620|NCT01397071|3805761|FG000|NOT COMPLETED|Consumption of Beef Patty With Avocado||0
3287334|NCT02791906|4021078|FG001|STARTED|Overall Study||3
3287335|NCT02791906|4021077|FG000|COMPLETED|Overall Study||2
3287336|NCT02791906|4021078|FG001|COMPLETED|Overall Study||2
3287337|NCT02791906|4021077|FG000|NOT COMPLETED|Overall Study||2
3287338|NCT02791906|4021078|FG001|NOT COMPLETED|Overall Study||1
3287339|NCT02791945|4021088|FG000|STARTED|Overall Study||14
3287340|NCT02791945|4021089|FG001|STARTED|Overall Study||16
3287341|NCT02791945|4021088|FG000|COMPLETED|Overall Study||12
3287342|NCT02791945|4021089|FG001|COMPLETED|Overall Study||14
3287343|NCT02791945|4021088|FG000|NOT COMPLETED|Overall Study||2
3287344|NCT02791945|4021089|FG001|NOT COMPLETED|Overall Study||2
3287345|NCT02792049|4021097|FG000|STARTED|Overall Study||35
3287346|NCT02792049|4021098|FG001|STARTED|Overall Study||35
3287347|NCT02792049|4021097|FG000|COMPLETED|Overall Study||35
3287348|NCT02792049|4021098|FG001|COMPLETED|Overall Study||35
3287349|NCT02792049|4021097|FG000|NOT COMPLETED|Overall Study||0
3287350|NCT02792049|4021098|FG001|NOT COMPLETED|Overall Study||0
3287351|NCT02792062|4021112|FG000|STARTED|Intervention Period 1 (6 Days)||2
3287352|NCT02792062|4021113|FG001|STARTED|Intervention Period 1 (6 Days)||2
3287353|NCT02792062|4021114|FG002|STARTED|Intervention Period 1 (6 Days)||2
3287354|NCT02792062|4021115|FG003|STARTED|Intervention Period 1 (6 Days)||2
3287355|NCT02792062|4021116|FG004|STARTED|Intervention Period 1 (6 Days)||2
3287356|NCT02792062|4021117|FG005|STARTED|Intervention Period 1 (6 Days)||2
3287357|NCT02792062|4021112|FG000|COMPLETED|Intervention Period 1 (6 Days)||2
3287358|NCT02792062|4021113|FG001|COMPLETED|Intervention Period 1 (6 Days)||2
3287359|NCT02792062|4021114|FG002|COMPLETED|Intervention Period 1 (6 Days)||2
3287360|NCT02792062|4021115|FG003|COMPLETED|Intervention Period 1 (6 Days)||2
3287361|NCT02792062|4021116|FG004|COMPLETED|Intervention Period 1 (6 Days)||2
3287362|NCT02792062|4021117|FG005|COMPLETED|Intervention Period 1 (6 Days)||2
3287363|NCT02792062|4021112|FG000|NOT COMPLETED|Intervention Period 1 (6 Days)||0
3287364|NCT02792062|4021113|FG001|NOT COMPLETED|Intervention Period 1 (6 Days)||0
3287365|NCT02792062|4021114|FG002|NOT COMPLETED|Intervention Period 1 (6 Days)||0
3287366|NCT02792062|4021115|FG003|NOT COMPLETED|Intervention Period 1 (6 Days)||0
3287367|NCT02792062|4021116|FG004|NOT COMPLETED|Intervention Period 1 (6 Days)||0
3287368|NCT02792062|4021117|FG005|NOT COMPLETED|Intervention Period 1 (6 Days)||0
3287369|NCT02792062|4021112|FG000|STARTED|Washout Period (at Least 14 Days)||2
3287370|NCT02792062|4021113|FG001|STARTED|Washout Period (at Least 14 Days)||2
3287371|NCT02792062|4021114|FG002|STARTED|Washout Period (at Least 14 Days)||2
3287372|NCT02792062|4021115|FG003|STARTED|Washout Period (at Least 14 Days)||2
3287373|NCT02792062|4021116|FG004|STARTED|Washout Period (at Least 14 Days)||2
3287374|NCT02792062|4021117|FG005|STARTED|Washout Period (at Least 14 Days)||2
3287375|NCT02792062|4021112|FG000|COMPLETED|Washout Period (at Least 14 Days)||2
3287376|NCT02792062|4021113|FG001|COMPLETED|Washout Period (at Least 14 Days)||2
3287377|NCT02792062|4021114|FG002|COMPLETED|Washout Period (at Least 14 Days)||2
3287378|NCT02792062|4021115|FG003|COMPLETED|Washout Period (at Least 14 Days)||2
3287379|NCT02792062|4021116|FG004|COMPLETED|Washout Period (at Least 14 Days)||2
3287380|NCT02792062|4021117|FG005|COMPLETED|Washout Period (at Least 14 Days)||2
3287381|NCT02792062|4021112|FG000|NOT COMPLETED|Washout Period (at Least 14 Days)||0
3287382|NCT02792062|4021113|FG001|NOT COMPLETED|Washout Period (at Least 14 Days)||0
3287383|NCT02792062|4021114|FG002|NOT COMPLETED|Washout Period (at Least 14 Days)||0
3287384|NCT02792062|4021115|FG003|NOT COMPLETED|Washout Period (at Least 14 Days)||0
3287385|NCT02792062|4021116|FG004|NOT COMPLETED|Washout Period (at Least 14 Days)||0
3287386|NCT02792062|4021117|FG005|NOT COMPLETED|Washout Period (at Least 14 Days)||0
3287387|NCT02792062|4021112|FG000|STARTED|Intervention Period 2 (6 Days)||2
3287388|NCT02792062|4021113|FG001|STARTED|Intervention Period 2 (6 Days)||2
3287389|NCT02792062|4021114|FG002|STARTED|Intervention Period 2 (6 Days)||2
3287390|NCT02792062|4021115|FG003|STARTED|Intervention Period 2 (6 Days)||2
3287391|NCT02792062|4021116|FG004|STARTED|Intervention Period 2 (6 Days)||2
3287392|NCT02792062|4021117|FG005|STARTED|Intervention Period 2 (6 Days)||2
3287393|NCT02792062|4021112|FG000|COMPLETED|Intervention Period 2 (6 Days)||2
3287394|NCT02792062|4021113|FG001|COMPLETED|Intervention Period 2 (6 Days)||2
3287395|NCT02792062|4021114|FG002|COMPLETED|Intervention Period 2 (6 Days)||2
3287396|NCT02792062|4021115|FG003|COMPLETED|Intervention Period 2 (6 Days)||2
3287397|NCT02792062|4021116|FG004|COMPLETED|Intervention Period 2 (6 Days)||2
3287398|NCT02792062|4021117|FG005|COMPLETED|Intervention Period 2 (6 Days)||2
3287399|NCT02792062|4021112|FG000|NOT COMPLETED|Intervention Period 2 (6 Days)||0
3287400|NCT02792062|4021113|FG001|NOT COMPLETED|Intervention Period 2 (6 Days)||0
3287401|NCT02792062|4021114|FG002|NOT COMPLETED|Intervention Period 2 (6 Days)||0
3287402|NCT02792062|4021115|FG003|NOT COMPLETED|Intervention Period 2 (6 Days)||0
3287403|NCT02792062|4021116|FG004|NOT COMPLETED|Intervention Period 2 (6 Days)||0
3287404|NCT02792062|4021117|FG005|NOT COMPLETED|Intervention Period 2 (6 Days)||0
3287405|NCT02792062|4021112|FG000|STARTED|Washout Period (at Least 14 Days)||2
3287406|NCT02792062|4021113|FG001|STARTED|Washout Period (at Least 14 Days)||2
3287407|NCT02792062|4021114|FG002|STARTED|Washout Period (at Least 14 Days)||2
3287408|NCT02792062|4021115|FG003|STARTED|Washout Period (at Least 14 Days)||2
3287409|NCT02792062|4021116|FG004|STARTED|Washout Period (at Least 14 Days)||2
3083621|NCT01397084|3805769|FG000|STARTED|Overall Study||108
3083622|NCT01397084|3805769|FG000|COMPLETED|Overall Study||100
3083623|NCT01397084|3805769|FG000|NOT COMPLETED|Overall Study||8
3083624|NCT01397253|3805775|FG000|STARTED|Overall Study||443
3287410|NCT02792062|4021117|FG005|STARTED|Washout Period (at Least 14 Days)||2
3287411|NCT02792062|4021112|FG000|COMPLETED|Washout Period (at Least 14 Days)||1
3287412|NCT02792062|4021113|FG001|COMPLETED|Washout Period (at Least 14 Days)||2
3287413|NCT02792062|4021114|FG002|COMPLETED|Washout Period (at Least 14 Days)||2
3287414|NCT02792062|4021115|FG003|COMPLETED|Washout Period (at Least 14 Days)||2
3287415|NCT02792062|4021116|FG004|COMPLETED|Washout Period (at Least 14 Days)||2
3287416|NCT02792062|4021117|FG005|COMPLETED|Washout Period (at Least 14 Days)||2
3287417|NCT02792062|4021112|FG000|NOT COMPLETED|Washout Period (at Least 14 Days)||1
3287418|NCT02792062|4021113|FG001|NOT COMPLETED|Washout Period (at Least 14 Days)||0
3287419|NCT02792062|4021114|FG002|NOT COMPLETED|Washout Period (at Least 14 Days)||0
3287420|NCT02792062|4021115|FG003|NOT COMPLETED|Washout Period (at Least 14 Days)||0
3287421|NCT02792062|4021116|FG004|NOT COMPLETED|Washout Period (at Least 14 Days)||0
3287422|NCT02792062|4021117|FG005|NOT COMPLETED|Washout Period (at Least 14 Days)||0
3287423|NCT02792062|4021112|FG000|STARTED|Intervention Period 3 (6 Days)||1
3287424|NCT02792062|4021113|FG001|STARTED|Intervention Period 3 (6 Days)||2
3287425|NCT02792062|4021114|FG002|STARTED|Intervention Period 3 (6 Days)||2
3287426|NCT02792062|4021115|FG003|STARTED|Intervention Period 3 (6 Days)||2
3287427|NCT02792062|4021116|FG004|STARTED|Intervention Period 3 (6 Days)||2
3287428|NCT02792062|4021117|FG005|STARTED|Intervention Period 3 (6 Days)||2
3287429|NCT02792062|4021112|FG000|COMPLETED|Intervention Period 3 (6 Days)||1
3287430|NCT02792062|4021113|FG001|COMPLETED|Intervention Period 3 (6 Days)||2
3287431|NCT02792062|4021114|FG002|COMPLETED|Intervention Period 3 (6 Days)||2
3287432|NCT02792062|4021115|FG003|COMPLETED|Intervention Period 3 (6 Days)||2
3287433|NCT02792062|4021116|FG004|COMPLETED|Intervention Period 3 (6 Days)||2
3287434|NCT02792062|4021117|FG005|COMPLETED|Intervention Period 3 (6 Days)||2
3287435|NCT02792062|4021112|FG000|NOT COMPLETED|Intervention Period 3 (6 Days)||0
3287436|NCT02792062|4021113|FG001|NOT COMPLETED|Intervention Period 3 (6 Days)||0
3287437|NCT02792062|4021114|FG002|NOT COMPLETED|Intervention Period 3 (6 Days)||0
3287438|NCT02792062|4021115|FG003|NOT COMPLETED|Intervention Period 3 (6 Days)||0
3287439|NCT02792062|4021116|FG004|NOT COMPLETED|Intervention Period 3 (6 Days)||0
3287440|NCT02792062|4021117|FG005|NOT COMPLETED|Intervention Period 3 (6 Days)||0
3287441|NCT02792192|4021129|FG000|STARTED|Overall Study||12
3287442|NCT02792192|4021130|FG001|STARTED|Overall Study||12
3287443|NCT02792192|4021131|FG002|STARTED|Overall Study||0
3287444|NCT02792192|4021132|FG003|STARTED|Overall Study||0
3287445|NCT02792192|4021129|FG000|COMPLETED|Overall Study||0
3287446|NCT02792192|4021130|FG001|COMPLETED|Overall Study||1
3287447|NCT02792192|4021131|FG002|COMPLETED|Overall Study||0
3287448|NCT02792192|4021132|FG003|COMPLETED|Overall Study||0
3287449|NCT02792192|4021129|FG000|NOT COMPLETED|Overall Study||12
3287450|NCT02792192|4021130|FG001|NOT COMPLETED|Overall Study||11
3287451|NCT02792192|4021131|FG002|NOT COMPLETED|Overall Study||0
3287452|NCT02792192|4021132|FG003|NOT COMPLETED|Overall Study||0
3287453|NCT02792218|4021145|FG000|STARTED|Overall Study||465
3287454|NCT02792218|4021146|FG001|STARTED|Overall Study||462
3287455|NCT02792218|4021145|FG000|COMPLETED|Overall Study||416
3287456|NCT02792218|4021146|FG001|COMPLETED|Overall Study||381
3287457|NCT02792218|4021145|FG000|NOT COMPLETED|Overall Study||49
3287458|NCT02792218|4021146|FG001|NOT COMPLETED|Overall Study||81
3287459|NCT02792231|4021154|FG000|STARTED|Overall Study||481
3287460|NCT02792231|4021155|FG001|STARTED|Overall Study||474
3287461|NCT02792231|4021154|FG000|COMPLETED|Overall Study||399
3287462|NCT02792231|4021155|FG001|COMPLETED|Overall Study||390
3287463|NCT02792231|4021154|FG000|NOT COMPLETED|Overall Study||82
3287464|NCT02792231|4021155|FG001|NOT COMPLETED|Overall Study||84
3287465|NCT02792504|4021161|FG000|STARTED|Overall Study||669
3287466|NCT02792504|4021161|FG000|Safety Analysis Set|Overall Study||639
3287467|NCT02792504|4021161|FG000|Efficacy Analysis Set|Overall Study||390
3287468|NCT02792504|4021161|FG000|COMPLETED|Overall Study||639
3287469|NCT02792504|4021161|FG000|NOT COMPLETED|Overall Study||30
3287470|NCT02792517|4021165|FG000|STARTED|Overall Study||41
3287471|NCT02792517|4021165|FG000|Received Erenumab|Overall Study||24
3287472|NCT02792517|4021165|FG000|COMPLETED|Overall Study||21
3287473|NCT02792517|4021165|FG000|NOT COMPLETED|Overall Study||20
3287474|NCT02792699|4021172|FG000|STARTED|Overall Study||104
3287475|NCT02792699|4021173|FG001|STARTED|Overall Study||104
3287476|NCT02792699|4021174|FG002|STARTED|Overall Study||103
3287477|NCT02792699|4021172|FG000|Received First Infusion of First Dose|Overall Study||104
3287478|NCT02792699|4021173|FG001|Received First Infusion of First Dose|Overall Study||104
3287479|NCT02792699|4021174|FG002|Received First Infusion of First Dose|Overall Study||103
3287480|NCT02792699|4021172|FG000|Received Second Infusion of First Dose|Overall Study||102
3287481|NCT02792699|4021173|FG001|Received Second Infusion of First Dose|Overall Study||103
3287482|NCT02792699|4021174|FG002|Received Second Infusion of First Dose|Overall Study||99
3287483|NCT02792699|4021172|FG000|Received First Infusion of Second Dose|Overall Study||97
3287484|NCT02792699|4021173|FG001|Received First Infusion of Second Dose|Overall Study||99
3287485|NCT02792699|4021174|FG002|Received First Infusion of Second Dose|Overall Study||95
3083625|NCT01397253|3805776|FG001|STARTED|Overall Study||392
3083626|NCT01397253|3805775|FG000|COMPLETED|Overall Study|Primary analysis, remaining patients included in a sensitivity analysis|317
3134861|NCT01703208|3859807|FG000|COMPLETED|Overall Study||0
3083627|NCT01397253|3805776|FG001|COMPLETED|Overall Study|Primary analysis, remaining patients included in a sensitivity analysis|243
3083628|NCT01397253|3805775|FG000|NOT COMPLETED|Overall Study||126
3083629|NCT01397253|3805776|FG001|NOT COMPLETED|Overall Study||149
3083630|NCT01397409|3805792|FG000|STARTED|Stage 1||9
3083631|NCT01397409|3805793|FG001|STARTED|Stage 1||6
3083632|NCT01397409|3805794|FG002|STARTED|Stage 1||6
3083633|NCT01397409|3805795|FG003|STARTED|Stage 1||3
3083634|NCT01397409|3805796|FG004|STARTED|Stage 1||0
3083635|NCT01397409|3805797|FG005|STARTED|Stage 1||0
3083636|NCT01397409|3805798|FG006|STARTED|Stage 1||0
3083637|NCT01397409|3805799|FG007|STARTED|Stage 1||0
3083638|NCT01397409|3805800|FG008|STARTED|Stage 1||0
3083639|NCT01397409|3805801|FG009|STARTED|Stage 1||0
3083640|NCT01397409|3805792|FG000|COMPLETED|Stage 1||9
3083641|NCT01397409|3805793|FG001|COMPLETED|Stage 1||6
3083642|NCT01397409|3805794|FG002|COMPLETED|Stage 1||6
3083643|NCT01397409|3805795|FG003|COMPLETED|Stage 1||3
3083644|NCT01397409|3805796|FG004|COMPLETED|Stage 1||0
3083645|NCT01397409|3805797|FG005|COMPLETED|Stage 1||0
3083646|NCT01397409|3805798|FG006|COMPLETED|Stage 1||0
3083647|NCT01397409|3805799|FG007|COMPLETED|Stage 1||0
3083648|NCT01397409|3805800|FG008|COMPLETED|Stage 1||0
3083649|NCT01397409|3805801|FG009|COMPLETED|Stage 1||0
3083650|NCT01397409|3805792|FG000|NOT COMPLETED|Stage 1||0
3083651|NCT01397409|3805793|FG001|NOT COMPLETED|Stage 1||0
3083652|NCT01397409|3805794|FG002|NOT COMPLETED|Stage 1||0
3083653|NCT01397409|3805795|FG003|NOT COMPLETED|Stage 1||0
3083654|NCT01397409|3805796|FG004|NOT COMPLETED|Stage 1||0
3083655|NCT01397409|3805797|FG005|NOT COMPLETED|Stage 1||0
3083656|NCT01397409|3805798|FG006|NOT COMPLETED|Stage 1||0
3083657|NCT01397409|3805799|FG007|NOT COMPLETED|Stage 1||0
3083658|NCT01397409|3805800|FG008|NOT COMPLETED|Stage 1||0
3083659|NCT01397409|3805801|FG009|NOT COMPLETED|Stage 1||0
3083660|NCT01397409|3805792|FG000|STARTED|Stage 2||0
3083661|NCT01397409|3805793|FG001|STARTED|Stage 2||0
3083662|NCT01397409|3805794|FG002|STARTED|Stage 2||0
3083663|NCT01397409|3805795|FG003|STARTED|Stage 2||0
3083664|NCT01397409|3805796|FG004|STARTED|Stage 2||67
3083665|NCT01397409|3805797|FG005|STARTED|Stage 2||58
3083666|NCT01397409|3805798|FG006|STARTED|Stage 2||58
3083667|NCT01397409|3805799|FG007|STARTED|Stage 2||0
3083668|NCT01397409|3805800|FG008|STARTED|Stage 2||0
3083669|NCT01397409|3805801|FG009|STARTED|Stage 2||0
3083670|NCT01397409|3805792|FG000|COMPLETED|Stage 2||0
3083671|NCT01397409|3805793|FG001|COMPLETED|Stage 2||0
3083672|NCT01397409|3805794|FG002|COMPLETED|Stage 2||0
3083673|NCT01397409|3805795|FG003|COMPLETED|Stage 2||0
3083674|NCT01397409|3805796|FG004|COMPLETED|Stage 2||59
3083675|NCT01397409|3805797|FG005|COMPLETED|Stage 2||54
3083676|NCT01397409|3805798|FG006|COMPLETED|Stage 2||58
3083677|NCT01397409|3805799|FG007|COMPLETED|Stage 2||0
3083678|NCT01397409|3805800|FG008|COMPLETED|Stage 2||0
3083679|NCT01397409|3805801|FG009|COMPLETED|Stage 2||0
3083680|NCT01397409|3805792|FG000|NOT COMPLETED|Stage 2||0
3083681|NCT01397409|3805793|FG001|NOT COMPLETED|Stage 2||0
3083682|NCT01397409|3805794|FG002|NOT COMPLETED|Stage 2||0
3083683|NCT01397409|3805795|FG003|NOT COMPLETED|Stage 2||0
3083684|NCT01397409|3805796|FG004|NOT COMPLETED|Stage 2||8
3083685|NCT01397409|3805797|FG005|NOT COMPLETED|Stage 2||4
3083686|NCT01397409|3805798|FG006|NOT COMPLETED|Stage 2||0
3083687|NCT01397409|3805799|FG007|NOT COMPLETED|Stage 2||0
3083688|NCT01397409|3805800|FG008|NOT COMPLETED|Stage 2||0
3083689|NCT01397409|3805801|FG009|NOT COMPLETED|Stage 2||0
3083690|NCT01397409|3805792|FG000|STARTED|Stage 3||0
3083691|NCT01397409|3805793|FG001|STARTED|Stage 3||0
3083692|NCT01397409|3805794|FG002|STARTED|Stage 3||0
3083693|NCT01397409|3805795|FG003|STARTED|Stage 3||0
3083694|NCT01397409|3805796|FG004|STARTED|Stage 3||0
3083695|NCT01397409|3805797|FG005|STARTED|Stage 3||0
3083696|NCT01397409|3805798|FG006|STARTED|Stage 3||0
3083697|NCT01397409|3805799|FG007|STARTED|Stage 3||23
3083698|NCT01397409|3805800|FG008|STARTED|Stage 3||25
3083699|NCT01397409|3805801|FG009|STARTED|Stage 3||16
3083700|NCT01397409|3805792|FG000|COMPLETED|Stage 3||0
3083701|NCT01397409|3805793|FG001|COMPLETED|Stage 3||0
3083702|NCT01397409|3805794|FG002|COMPLETED|Stage 3||0
3083703|NCT01397409|3805795|FG003|COMPLETED|Stage 3||0
3083704|NCT01397409|3805796|FG004|COMPLETED|Stage 3||0
3083705|NCT01397409|3805797|FG005|COMPLETED|Stage 3||0
3083706|NCT01397409|3805798|FG006|COMPLETED|Stage 3||0
3083707|NCT01397409|3805799|FG007|COMPLETED|Stage 3||21
3083708|NCT01397409|3805800|FG008|COMPLETED|Stage 3||25
3083709|NCT01397409|3805801|FG009|COMPLETED|Stage 3||16
3083710|NCT01397409|3805792|FG000|NOT COMPLETED|Stage 3||0
3083711|NCT01397409|3805793|FG001|NOT COMPLETED|Stage 3||0
3083712|NCT01397409|3805794|FG002|NOT COMPLETED|Stage 3||0
3083713|NCT01397409|3805795|FG003|NOT COMPLETED|Stage 3||0
3083714|NCT01397409|3805796|FG004|NOT COMPLETED|Stage 3||0
3083715|NCT01397409|3805797|FG005|NOT COMPLETED|Stage 3||0
3083716|NCT01397409|3805798|FG006|NOT COMPLETED|Stage 3||0
3083717|NCT01397409|3805799|FG007|NOT COMPLETED|Stage 3||2
3083718|NCT01397409|3805800|FG008|NOT COMPLETED|Stage 3||0
3083719|NCT01397409|3805801|FG009|NOT COMPLETED|Stage 3||0
3083720|NCT01397422|3805828|FG000|STARTED|Overall Study||22
3083721|NCT01397422|3805829|FG001|STARTED|Overall Study||20
3083722|NCT01397422|3805830|FG002|STARTED|Overall Study|Of the 3 participants who discontinued, 1 withdrew due to both an AE and an eGFR < 50 mL/min/1.73m^2|21
3083723|NCT01397422|3805831|FG003|STARTED|Overall Study||20
3083724|NCT01397422|3805828|FG000|COMPLETED|Overall Study||20
3083725|NCT01397422|3805829|FG001|COMPLETED|Overall Study||17
3134862|NCT01703208|3859808|FG001|COMPLETED|Overall Study||0
3083726|NCT01397422|3805830|FG002|COMPLETED|Overall Study|AE = adverse event; eGFR = estimated glomerular filtration rate|18
3083727|NCT01397422|3805831|FG003|COMPLETED|Overall Study||12
3083728|NCT01397422|3805828|FG000|NOT COMPLETED|Overall Study||2
3083729|NCT01397422|3805829|FG001|NOT COMPLETED|Overall Study||3
3083730|NCT01397422|3805830|FG002|NOT COMPLETED|Overall Study||3
3083731|NCT01397422|3805831|FG003|NOT COMPLETED|Overall Study||8
3083732|NCT01397448|3805846|FG000|STARTED|Overall Study||156
3083733|NCT01397448|3805847|FG001|STARTED|Overall Study|158 participants were randomized but 1 participant was not treated with drug.|157
3083734|NCT01397448|3805848|FG002|STARTED|Overall Study||158
3083735|NCT01397448|3805846|FG000|COMPLETED|Overall Study||138
3083736|NCT01397448|3805847|FG001|COMPLETED|Overall Study||142
3083737|NCT01397448|3805848|FG002|COMPLETED|Overall Study||140
3083738|NCT01397448|3805846|FG000|NOT COMPLETED|Overall Study||18
3083739|NCT01397448|3805847|FG001|NOT COMPLETED|Overall Study||15
3083740|NCT01397448|3805848|FG002|NOT COMPLETED|Overall Study||18
3083741|NCT01397461|3805859|FG000|STARTED|Overall Study||155
3083742|NCT01397461|3805860|FG001|STARTED|Overall Study||156
3083743|NCT01397461|3805861|FG002|STARTED|Overall Study||154
3083744|NCT01397461|3805859|FG000|COMPLETED|Overall Study||153
3083745|NCT01397461|3805860|FG001|COMPLETED|Overall Study||150
3083746|NCT01397461|3805861|FG002|COMPLETED|Overall Study||152
3083747|NCT01397461|3805859|FG000|NOT COMPLETED|Overall Study||2
3083748|NCT01397461|3805860|FG001|NOT COMPLETED|Overall Study||6
3083749|NCT01397461|3805861|FG002|NOT COMPLETED|Overall Study||2
3083750|NCT01397591|3805869|FG000|STARTED|Overall Study||2
3083751|NCT01397591|3805869|FG000|COMPLETED|Overall Study||2
3083752|NCT01397591|3805869|FG000|NOT COMPLETED|Overall Study||0
3083753|NCT01397617|3805877|FG000|STARTED|Overall Study||64
3083754|NCT01397617|3805878|FG001|STARTED|Overall Study||53
3083755|NCT01397617|3805879|FG002|STARTED|Overall Study||60
3083756|NCT01397617|3805877|FG000|COMPLETED|Overall Study||33
3083757|NCT01397617|3805878|FG001|COMPLETED|Overall Study||30
3083758|NCT01397617|3805879|FG002|COMPLETED|Overall Study||31
3083759|NCT01397617|3805877|FG000|NOT COMPLETED|Overall Study||31
3083760|NCT01397617|3805878|FG001|NOT COMPLETED|Overall Study||23
3083761|NCT01397617|3805879|FG002|NOT COMPLETED|Overall Study||29
3083762|NCT01397656|3805892|FG000|STARTED|Overall Study||33
3083763|NCT01397656|3805893|FG001|STARTED|Overall Study||30
3083764|NCT01397656|3805892|FG000|COMPLETED|Overall Study||33
3083765|NCT01397656|3805893|FG001|COMPLETED|Overall Study||30
3083766|NCT01397656|3805892|FG000|NOT COMPLETED|Overall Study||0
3083767|NCT01397656|3805893|FG001|NOT COMPLETED|Overall Study||0
3083768|NCT01397747|3805901|FG000|STARTED|Overall Study||11016
3083769|NCT01397747|3805901|FG000|COMPLETED|Overall Study||9989
3083770|NCT01397747|3805901|FG000|NOT COMPLETED|Overall Study||1027
3083771|NCT01397786|3805909|FG000|STARTED|Phase A|Subjects in NCT01668797 Phase A at IA-related study termination rolled over to NCT01397786 Phase A.|12
3083772|NCT01397786|3805910|FG001|STARTED|Phase A||0
3083773|NCT01397786|3805911|FG002|STARTED|Phase A||227
3083774|NCT01397786|3805909|FG000|COMPLETED|Phase A||12
3083775|NCT01397786|3805910|FG001|COMPLETED|Phase A||0
3083776|NCT01397786|3805911|FG002|COMPLETED|Phase A||199
3083777|NCT01397786|3805909|FG000|NOT COMPLETED|Phase A||0
3083778|NCT01397786|3805910|FG001|NOT COMPLETED|Phase A||0
3083779|NCT01397786|3805911|FG002|NOT COMPLETED|Phase A||28
3083780|NCT01397786|3805909|FG000|STARTED|Phase B||611
3083781|NCT01397786|3805910|FG001|STARTED|Phase B||204
3083782|NCT01397786|3805911|FG002|STARTED|Phase B||229
3083783|NCT01397786|3805909|FG000|COMPLETED|Phase B||308
3083784|NCT01397786|3805910|FG001|COMPLETED|Phase B||109
3083785|NCT01397786|3805911|FG002|COMPLETED|Phase B||91
3083786|NCT01397786|3805909|FG000|NOT COMPLETED|Phase B||303
3083787|NCT01397786|3805910|FG001|NOT COMPLETED|Phase B||95
3083788|NCT01397786|3805911|FG002|NOT COMPLETED|Phase B||138
3083789|NCT01397825|3805927|FG000|STARTED|Overall Study||13
3083790|NCT01397825|3805928|FG001|STARTED|Overall Study||4
3083791|NCT01397825|3805929|FG002|STARTED|Overall Study||25
3083792|NCT01397825|3805930|FG003|STARTED|Overall Study||3
3083793|NCT01397825|3805931|FG004|STARTED|Overall Study||0
3083794|NCT01397825|3805927|FG000|COMPLETED|Overall Study||0
3083795|NCT01397825|3805928|FG001|COMPLETED|Overall Study||0
3083796|NCT01397825|3805929|FG002|COMPLETED|Overall Study||0
3083797|NCT01397825|3805930|FG003|COMPLETED|Overall Study||0
3083798|NCT01397825|3805931|FG004|COMPLETED|Overall Study||0
3083799|NCT01397825|3805927|FG000|NOT COMPLETED|Overall Study||13
3083800|NCT01397825|3805928|FG001|NOT COMPLETED|Overall Study||4
3083801|NCT01397825|3805929|FG002|NOT COMPLETED|Overall Study||25
3083802|NCT01397825|3805930|FG003|NOT COMPLETED|Overall Study||3
3083803|NCT01397825|3805931|FG004|NOT COMPLETED|Overall Study||0
3083804|NCT01397851|3805947|FG000|STARTED|Overall Study||41634
3083805|NCT01397851|3805948|FG001|STARTED|Overall Study||39963
3083806|NCT01397851|3805947|FG000|COMPLETED|Overall Study||41555
3083807|NCT01397851|3805948|FG001|COMPLETED|Overall Study||39917
3083808|NCT01397851|3805947|FG000|NOT COMPLETED|Overall Study||79
3083809|NCT01397851|3805948|FG001|NOT COMPLETED|Overall Study||46
3083810|NCT01397890|3805956|FG000|STARTED|Overall Study||287
3083811|NCT01397890|3805957|FG001|STARTED|Overall Study||291
3083812|NCT01397890|3805956|FG000|Post-baseline Efficacy Data Collected|Overall Study|'Full Analysis Set' used for efficacy analysis|287
3083813|NCT01397890|3805957|FG001|Post-baseline Efficacy Data Collected|Overall Study|'Full Analysis Set' used for efficacy analysis|290
3083814|NCT01397890|3805956|FG000|Received Correct Randomized Treatment|Overall Study|'Safety Analysis Set' =287+3-1=289. 3 and 1 pts in respective groups received opposite treatment.|286
3083815|NCT01397890|3805957|FG001|Received Correct Randomized Treatment|Overall Study|'Safety Analysis Set' =291+1-3=289.|287
3083816|NCT01397890|3805956|FG000|COMPLETED|Overall Study||264
3083817|NCT01397890|3805957|FG001|COMPLETED|Overall Study||260
3083818|NCT01397890|3805956|FG000|NOT COMPLETED|Overall Study||23
3083819|NCT01397890|3805957|FG001|NOT COMPLETED|Overall Study||31
3083820|NCT01398059|3805963|FG000|STARTED|Overall Study||4
3083821|NCT01398059|3805964|FG001|STARTED|Overall Study||3
3083822|NCT01398059|3805965|FG002|STARTED|Overall Study||4
3083823|NCT01398059|3805966|FG003|STARTED|Overall Study||2
3083824|NCT01398059|3805967|FG004|STARTED|Overall Study||4
3083825|NCT01398059|3805968|FG005|STARTED|Overall Study||2
3083826|NCT01398059|3805963|FG000|COMPLETED|Overall Study||4
3083827|NCT01398059|3805964|FG001|COMPLETED|Overall Study||3
3083828|NCT01398059|3805965|FG002|COMPLETED|Overall Study||4
3083829|NCT01398059|3805966|FG003|COMPLETED|Overall Study||2
3083830|NCT01398059|3805967|FG004|COMPLETED|Overall Study||4
3083831|NCT01398059|3805968|FG005|COMPLETED|Overall Study||2
3083832|NCT01398059|3805963|FG000|NOT COMPLETED|Overall Study||0
3083833|NCT01398059|3805964|FG001|NOT COMPLETED|Overall Study||0
3083834|NCT01398059|3805965|FG002|NOT COMPLETED|Overall Study||0
3083835|NCT01398059|3805966|FG003|NOT COMPLETED|Overall Study||0
3083836|NCT01398059|3805967|FG004|NOT COMPLETED|Overall Study||0
3083837|NCT01398059|3805968|FG005|NOT COMPLETED|Overall Study||0
3083838|NCT01398176|3805978|FG000|STARTED|Overall Study||26
3083839|NCT01398176|3805979|FG001|STARTED|Overall Study||25
3083840|NCT01398176|3805978|FG000|COMPLETED|Overall Study||23
3083841|NCT01398176|3805979|FG001|COMPLETED|Overall Study||19
3083842|NCT01398176|3805978|FG000|NOT COMPLETED|Overall Study||3
3083843|NCT01398176|3805979|FG001|NOT COMPLETED|Overall Study||6
3083844|NCT01398280|3805987|FG000|STARTED|Overall Study||11
3083845|NCT01398280|3805988|FG001|STARTED|Overall Study||4
3083846|NCT01398280|3805987|FG000|COMPLETED|Overall Study||7
3083847|NCT01398280|3805988|FG001|COMPLETED|Overall Study||4
3083848|NCT01398280|3805987|FG000|NOT COMPLETED|Overall Study||4
3083849|NCT01398280|3805988|FG001|NOT COMPLETED|Overall Study||0
3083850|NCT01398358|3805997|FG000|STARTED|Overall Study||218
3083851|NCT01398358|3805998|FG001|STARTED|Overall Study||224
3083852|NCT01398358|3805999|FG002|STARTED|Overall Study||255
3083853|NCT01398358|3805997|FG000|COMPLETED|Overall Study||203
3083854|NCT01398358|3805998|FG001|COMPLETED|Overall Study||201
3083855|NCT01398358|3805999|FG002|COMPLETED|Overall Study||234
3083856|NCT01398358|3805997|FG000|NOT COMPLETED|Overall Study||15
3083857|NCT01398358|3805998|FG001|NOT COMPLETED|Overall Study||23
3083858|NCT01398358|3805999|FG002|NOT COMPLETED|Overall Study||21
3083859|NCT01398410|3806009|FG000|STARTED|Overall Study|Treated participants (all participants who received at least one dose of rabeprazole).|201
3083860|NCT01398410|3806010|FG001|STARTED|Overall Study||204
3083861|NCT01398410|3806009|FG000|COMPLETED|Overall Study||143
3083862|NCT01398410|3806010|FG001|COMPLETED|Overall Study||148
3083863|NCT01398410|3806009|FG000|NOT COMPLETED|Overall Study||58
3083864|NCT01398410|3806010|FG001|NOT COMPLETED|Overall Study||56
3083865|NCT01398475|3806016|FG000|STARTED|Overall Study||4
3083866|NCT01398475|3806017|FG001|STARTED|Overall Study||3
3083867|NCT01398475|3806018|FG002|STARTED|Overall Study||4
3083868|NCT01398475|3806019|FG003|STARTED|Overall Study||4
3083869|NCT01398475|3806016|FG000|Received First Intervention|Overall Study||4
3083870|NCT01398475|3806017|FG001|Received First Intervention|Overall Study||3
3083871|NCT01398475|3806018|FG002|Received First Intervention|Overall Study||4
3083872|NCT01398475|3806019|FG003|Received First Intervention|Overall Study||4
3083873|NCT01398475|3806016|FG000|Received Second Intervention|Overall Study||4
3083874|NCT01398475|3806017|FG001|Received Second Intervention|Overall Study||3
3083875|NCT01398475|3806018|FG002|Received Second Intervention|Overall Study||4
3083876|NCT01398475|3806019|FG003|Received Second Intervention|Overall Study||4
3083877|NCT01398475|3806016|FG000|Received Third Intervention|Overall Study||4
3083878|NCT01398475|3806017|FG001|Received Third Intervention|Overall Study||3
3083879|NCT01398475|3806018|FG002|Received Third Intervention|Overall Study||4
3083880|NCT01398475|3806019|FG003|Received Third Intervention|Overall Study||4
3083881|NCT01398475|3806016|FG000|Received Fourth Intervention|Overall Study||4
3083882|NCT01398475|3806017|FG001|Received Fourth Intervention|Overall Study||3
3083883|NCT01398475|3806018|FG002|Received Fourth Intervention|Overall Study||4
3083884|NCT01398475|3806019|FG003|Received Fourth Intervention|Overall Study||4
3083885|NCT01398475|3806016|FG000|COMPLETED|Overall Study||4
3083886|NCT01398475|3806017|FG001|COMPLETED|Overall Study||3
3083887|NCT01398475|3806018|FG002|COMPLETED|Overall Study||4
3083888|NCT01398475|3806019|FG003|COMPLETED|Overall Study||4
3083889|NCT01398475|3806016|FG000|NOT COMPLETED|Overall Study||0
3083890|NCT01398475|3806017|FG001|NOT COMPLETED|Overall Study||0
3083891|NCT01398475|3806018|FG002|NOT COMPLETED|Overall Study||0
3083892|NCT01398475|3806019|FG003|NOT COMPLETED|Overall Study||0
3083893|NCT01398514|3806031|FG000|STARTED|Overall Study||26
3083894|NCT01398514|3806032|FG001|STARTED|Overall Study||26
3083895|NCT01398514|3806031|FG000|COMPLETED|Overall Study||18
3083896|NCT01398514|3806032|FG001|COMPLETED|Overall Study||20
3083897|NCT01398514|3806031|FG000|NOT COMPLETED|Overall Study||8
3083898|NCT01398514|3806032|FG001|NOT COMPLETED|Overall Study||6
3083899|NCT01398566|3806040|FG000|STARTED|Overall Study|20 enrolled|20
3083900|NCT01398566|3806040|FG000|COMPLETED|Overall Study||20
3083901|NCT01398566|3806040|FG000|NOT COMPLETED|Overall Study||0
3083902|NCT01398787|3806044|FG000|STARTED|Overall Study||198
3083903|NCT01398787|3806044|FG000|COMPLETED|Overall Study||197
3083904|NCT01398787|3806044|FG000|NOT COMPLETED|Overall Study||1
3083905|NCT01398943|3806052|FG000|STARTED|First Intervention (1 Day)||15
3083906|NCT01398943|3806053|FG001|STARTED|First Intervention (1 Day)||15
3083907|NCT01398943|3806054|FG002|STARTED|First Intervention (1 Day)||15
3083908|NCT01398943|3806055|FG003|STARTED|First Intervention (1 Day)||15
3083909|NCT01398943|3806052|FG000|COMPLETED|First Intervention (1 Day)||15
3083910|NCT01398943|3806053|FG001|COMPLETED|First Intervention (1 Day)||15
3083911|NCT01398943|3806054|FG002|COMPLETED|First Intervention (1 Day)||15
3083912|NCT01398943|3806055|FG003|COMPLETED|First Intervention (1 Day)||15
3083913|NCT01398943|3806052|FG000|NOT COMPLETED|First Intervention (1 Day)||0
3083914|NCT01398943|3806053|FG001|NOT COMPLETED|First Intervention (1 Day)||0
3083915|NCT01398943|3806054|FG002|NOT COMPLETED|First Intervention (1 Day)||0
3083916|NCT01398943|3806055|FG003|NOT COMPLETED|First Intervention (1 Day)||0
3083917|NCT01398943|3806052|FG000|STARTED|Washout (2-7 Days)||15
3083918|NCT01398943|3806053|FG001|STARTED|Washout (2-7 Days)||15
3083919|NCT01398943|3806054|FG002|STARTED|Washout (2-7 Days)||15
3083920|NCT01398943|3806055|FG003|STARTED|Washout (2-7 Days)||15
3083921|NCT01398943|3806052|FG000|COMPLETED|Washout (2-7 Days)||15
3083922|NCT01398943|3806053|FG001|COMPLETED|Washout (2-7 Days)||15
3083923|NCT01398943|3806054|FG002|COMPLETED|Washout (2-7 Days)||15
3083924|NCT01398943|3806055|FG003|COMPLETED|Washout (2-7 Days)||15
3083925|NCT01398943|3806052|FG000|NOT COMPLETED|Washout (2-7 Days)||0
3083926|NCT01398943|3806053|FG001|NOT COMPLETED|Washout (2-7 Days)||0
3083927|NCT01398943|3806054|FG002|NOT COMPLETED|Washout (2-7 Days)||0
3083928|NCT01398943|3806055|FG003|NOT COMPLETED|Washout (2-7 Days)||0
3083929|NCT01398943|3806052|FG000|STARTED|Second Intervention (1 Day)||15
3083930|NCT01398943|3806053|FG001|STARTED|Second Intervention (1 Day)||15
3083931|NCT01398943|3806054|FG002|STARTED|Second Intervention (1 Day)||15
3083932|NCT01398943|3806055|FG003|STARTED|Second Intervention (1 Day)||15
3083933|NCT01398943|3806052|FG000|COMPLETED|Second Intervention (1 Day)||15
3083934|NCT01398943|3806053|FG001|COMPLETED|Second Intervention (1 Day)||15
3083935|NCT01398943|3806054|FG002|COMPLETED|Second Intervention (1 Day)||15
3083936|NCT01398943|3806055|FG003|COMPLETED|Second Intervention (1 Day)||15
3083937|NCT01398943|3806052|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
3083938|NCT01398943|3806053|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
3083939|NCT01398943|3806054|FG002|NOT COMPLETED|Second Intervention (1 Day)||0
3083940|NCT01398943|3806055|FG003|NOT COMPLETED|Second Intervention (1 Day)||0
3083941|NCT01398956|3806063|FG000|STARTED|Overall Study||44
3083942|NCT01398956|3806063|FG000|COMPLETED|Overall Study||34
3083943|NCT01398956|3806063|FG000|NOT COMPLETED|Overall Study||10
3083944|NCT01398982|3806070|FG000|STARTED|Overall Study||44
3083945|NCT01398982|3806071|FG001|STARTED|Overall Study||49
3083946|NCT01398982|3806070|FG000|COMPLETED|Overall Study||38
3083947|NCT01398982|3806071|FG001|COMPLETED|Overall Study||47
3083948|NCT01398982|3806070|FG000|NOT COMPLETED|Overall Study||6
3083949|NCT01398982|3806071|FG001|NOT COMPLETED|Overall Study||2
3083950|NCT01399008|3806080|FG000|STARTED|Overall Study||35
3083951|NCT01399008|3806081|FG001|STARTED|Overall Study||32
3083952|NCT01399008|3806082|FG002|STARTED|Overall Study||33
3083953|NCT01399008|3806080|FG000|COMPLETED|Overall Study||32
3083954|NCT01399008|3806081|FG001|COMPLETED|Overall Study||27
3083955|NCT01399008|3806082|FG002|COMPLETED|Overall Study||31
3083956|NCT01399008|3806080|FG000|NOT COMPLETED|Overall Study||3
3083957|NCT01399008|3806081|FG001|NOT COMPLETED|Overall Study||5
3083958|NCT01399008|3806082|FG002|NOT COMPLETED|Overall Study||2
3083959|NCT01399047|3806092|FG000|STARTED|Overall Study||10
3083960|NCT01399047|3806093|FG001|STARTED|Overall Study||9
3083961|NCT01399047|3806092|FG000|COMPLETED|Overall Study||10
3083962|NCT01399047|3806093|FG001|COMPLETED|Overall Study||8
3083963|NCT01399047|3806092|FG000|NOT COMPLETED|Overall Study||0
3083964|NCT01399047|3806093|FG001|NOT COMPLETED|Overall Study||1
3083965|NCT01399099|3806101|FG000|STARTED|Overall Study||67
3083966|NCT01399099|3806101|FG000|6 Months|Overall Study||47
3083967|NCT01399099|3806101|FG000|COMPLETED|Overall Study||36
3083968|NCT01399099|3806101|FG000|NOT COMPLETED|Overall Study||31
3083969|NCT01399125|3806108|FG000|STARTED|Overall Study||248
3083970|NCT01399125|3806109|FG001|STARTED|Overall Study||253
3083971|NCT01399125|3806108|FG000|Per Protocol (PP) Population|Overall Study||192
3083972|NCT01399125|3806109|FG001|Per Protocol (PP) Population|Overall Study||188
3083973|NCT01399125|3806108|FG000|COMPLETED|Overall Study||197
3083974|NCT01399125|3806109|FG001|COMPLETED|Overall Study||193
3083975|NCT01399125|3806108|FG000|NOT COMPLETED|Overall Study||51
3083976|NCT01399125|3806109|FG001|NOT COMPLETED|Overall Study||60
3083977|NCT01399190|3806115|FG000|STARTED|Overall Study||68
3083978|NCT01399190|3806115|FG000|Included in Final Analysis|Overall Study||63
3083979|NCT01399190|3806115|FG000|Evaluable for Primary Endpoint Analysis|Overall Study||60
3083980|NCT01399190|3806115|FG000|COMPLETED|Overall Study||48
3083981|NCT01399190|3806115|FG000|NOT COMPLETED|Overall Study||20
3083982|NCT01399229|3806119|FG000|STARTED|Overall Study||20
3083983|NCT01399229|3806120|FG001|STARTED|Overall Study||5
3083984|NCT01399229|3806121|FG002|STARTED|Overall Study||5
3083985|NCT01399229|3806119|FG000|COMPLETED|Overall Study||20
3083986|NCT01399229|3806120|FG001|COMPLETED|Overall Study||5
3083987|NCT01399229|3806121|FG002|COMPLETED|Overall Study||5
3083988|NCT01399229|3806119|FG000|NOT COMPLETED|Overall Study||0
3083989|NCT01399229|3806120|FG001|NOT COMPLETED|Overall Study||0
3083990|NCT01399229|3806121|FG002|NOT COMPLETED|Overall Study||0
3083991|NCT01399268|3806127|FG000|STARTED|Overall Study||15
3083992|NCT01399268|3806128|FG001|STARTED|Overall Study||15
3083993|NCT01399268|3806127|FG000|COMPLETED|Overall Study||15
3083994|NCT01399268|3806128|FG001|COMPLETED|Overall Study||15
3083995|NCT01399268|3806127|FG000|NOT COMPLETED|Overall Study||0
3083996|NCT01399268|3806128|FG001|NOT COMPLETED|Overall Study||0
3083997|NCT01399372|3806136|FG000|STARTED|Overall Study||47
3083998|NCT01399372|3806137|FG001|STARTED|Overall Study||44
3083999|NCT01399372|3806136|FG000|Eligible|Overall Study||44
3084000|NCT01399372|3806137|FG001|Eligible|Overall Study||43
3084001|NCT01399372|3806136|FG000|Eligible and Started Protocol Treatment|Overall Study||43
3084002|NCT01399372|3806137|FG001|Eligible and Started Protocol Treatment|Overall Study||43
3084003|NCT01399372|3806136|FG000|COMPLETED|Overall Study||44
3084004|NCT01399372|3806137|FG001|COMPLETED|Overall Study||43
3084005|NCT01399372|3806136|FG000|NOT COMPLETED|Overall Study||3
3084006|NCT01399372|3806137|FG001|NOT COMPLETED|Overall Study||1
3084007|NCT01399593|3806145|FG000|STARTED|Overall Study||51
3084008|NCT01399593|3806146|FG001|STARTED|Overall Study||51
3084009|NCT01399593|3806145|FG000|COMPLETED|Overall Study||48
3084010|NCT01399593|3806146|FG001|COMPLETED|Overall Study||49
3084011|NCT01399593|3806145|FG000|NOT COMPLETED|Overall Study||3
3084012|NCT01399593|3806146|FG001|NOT COMPLETED|Overall Study||2
3084013|NCT01399619|3806154|FG000|STARTED|Overall Study||123
3084014|NCT01399619|3806155|FG001|STARTED|Overall Study||84
3084015|NCT01399619|3806156|FG002|STARTED|Overall Study||86
3084016|NCT01399619|3806157|FG003|STARTED|Overall Study||17
3084017|NCT01399619|3806154|FG000|COMPLETED|Overall Study||98
3084018|NCT01399619|3806155|FG001|COMPLETED|Overall Study||84
3084019|NCT01399619|3806156|FG002|COMPLETED|Overall Study||74
3084020|NCT01399619|3806157|FG003|COMPLETED|Overall Study||0
3084021|NCT01399619|3806154|FG000|NOT COMPLETED|Overall Study||25
3084022|NCT01399619|3806155|FG001|NOT COMPLETED|Overall Study||0
3084023|NCT01399619|3806156|FG002|NOT COMPLETED|Overall Study||12
3084024|NCT01399619|3806157|FG003|NOT COMPLETED|Overall Study||17
3084025|NCT01399697|3806175|FG000|STARTED|Overall Study||96
3084026|NCT01399697|3806176|FG001|STARTED|Overall Study||83
3084027|NCT01399697|3806177|FG002|STARTED|Overall Study||82
3084028|NCT01399697|3806175|FG000|COMPLETED|Overall Study||55
3084029|NCT01399697|3806176|FG001|COMPLETED|Overall Study||80
3084030|NCT01399697|3806177|FG002|COMPLETED|Overall Study||78
3084031|NCT01399697|3806175|FG000|NOT COMPLETED|Overall Study||41
3084032|NCT01399697|3806176|FG001|NOT COMPLETED|Overall Study||3
3084033|NCT01399697|3806177|FG002|NOT COMPLETED|Overall Study||4
3084034|NCT01399723|3806190|FG000|STARTED|Overall Study||263
3084035|NCT01399723|3806191|FG001|STARTED|Overall Study||264
3084036|NCT01399723|3806190|FG000|COMPLETED|Overall Study||263
3084037|NCT01399723|3806191|FG001|COMPLETED|Overall Study||263
3084038|NCT01399723|3806190|FG000|NOT COMPLETED|Overall Study||0
3084039|NCT01399723|3806191|FG001|NOT COMPLETED|Overall Study||1
3084040|NCT01399736|3806200|FG000|STARTED|Overall Study||295
3084041|NCT01399736|3806201|FG001|STARTED|Overall Study||590
3084042|NCT01399736|3806200|FG000|COMPLETED|Overall Study||291
3084043|NCT01399736|3806201|FG001|COMPLETED|Overall Study||586
3084044|NCT01399736|3806200|FG000|NOT COMPLETED|Overall Study||4
3084045|NCT01399736|3806201|FG001|NOT COMPLETED|Overall Study||4
3084046|NCT01399788|3806215|FG000|STARTED|First Intervention Period||18
3084047|NCT01399788|3806216|FG001|STARTED|First Intervention Period||18
3084048|NCT01399788|3806215|FG000|COMPLETED|First Intervention Period||17
3084049|NCT01399788|3806216|FG001|COMPLETED|First Intervention Period||18
3084050|NCT01399788|3806215|FG000|NOT COMPLETED|First Intervention Period||1
3084051|NCT01399788|3806216|FG001|NOT COMPLETED|First Intervention Period||0
3084052|NCT01399788|3806215|FG000|STARTED|Washout Period (at Least 1 Week)||17
3084053|NCT01399788|3806216|FG001|STARTED|Washout Period (at Least 1 Week)||18
3084054|NCT01399788|3806215|FG000|COMPLETED|Washout Period (at Least 1 Week)||17
3084055|NCT01399788|3806216|FG001|COMPLETED|Washout Period (at Least 1 Week)||18
3084056|NCT01399788|3806215|FG000|NOT COMPLETED|Washout Period (at Least 1 Week)||0
3084057|NCT01399788|3806216|FG001|NOT COMPLETED|Washout Period (at Least 1 Week)||0
3084058|NCT01399788|3806215|FG000|STARTED|Second Intervention Period||17
3084059|NCT01399788|3806216|FG001|STARTED|Second Intervention Period||18
3084060|NCT01399788|3806215|FG000|COMPLETED|Second Intervention Period||17
3084061|NCT01399788|3806216|FG001|COMPLETED|Second Intervention Period||18
3084062|NCT01399788|3806215|FG000|NOT COMPLETED|Second Intervention Period||0
3084063|NCT01399788|3806216|FG001|NOT COMPLETED|Second Intervention Period||0
3084064|NCT01399827|3806224|FG000|STARTED|Overall Study||1
3084065|NCT01399827|3806225|FG001|STARTED|Overall Study||1
3084066|NCT01399827|3806224|FG000|COMPLETED|Overall Study||1
3084067|NCT01399827|3806225|FG001|COMPLETED|Overall Study||1
3084068|NCT01399827|3806224|FG000|NOT COMPLETED|Overall Study||0
3084069|NCT01399827|3806225|FG001|NOT COMPLETED|Overall Study||0
3084070|NCT01399866|3806233|FG000|STARTED|Overall Study||32
3084071|NCT01399866|3806234|FG001|STARTED|Overall Study||30
3084072|NCT01399866|3806233|FG000|COMPLETED|Overall Study||28
3084073|NCT01399866|3806234|FG001|COMPLETED|Overall Study||28
3084074|NCT01399866|3806233|FG000|NOT COMPLETED|Overall Study||4
3084075|NCT01399866|3806234|FG001|NOT COMPLETED|Overall Study||2
3084076|NCT01399905|3806242|FG000|STARTED|Overall Study||7
3084077|NCT01399905|3806243|FG001|STARTED|Overall Study||7
3084078|NCT01399905|3806242|FG000|COMPLETED|Overall Study|Subject withdrew from the study before receiving treatment.|6
3084079|NCT01399905|3806243|FG001|COMPLETED|Overall Study|Subject was treated at least one dose of carbidopa before withdrawing from the study.|6
3084080|NCT01399905|3806242|FG000|NOT COMPLETED|Overall Study||1
3084081|NCT01399905|3806243|FG001|NOT COMPLETED|Overall Study||1
3084082|NCT01400113|3806256|FG000|STARTED|Overall Study||60
3084083|NCT01400113|3806257|FG001|STARTED|Overall Study||60
3084084|NCT01400113|3806256|FG000|COMPLETED|Overall Study||59
3084085|NCT01400113|3806257|FG001|COMPLETED|Overall Study||59
3084086|NCT01400113|3806256|FG000|NOT COMPLETED|Overall Study||1
3084087|NCT01400113|3806257|FG001|NOT COMPLETED|Overall Study||1
3084088|NCT01400139|3806263|FG000|STARTED|HYD Core Study||922
3084089|NCT01400139|3806263|FG000|COMPLETED|HYD Core Study||410
3084090|NCT01400139|3806263|FG000|NOT COMPLETED|HYD Core Study||512
3084091|NCT01400139|3806263|FG000|STARTED|HYD Extension Period|Subjects completing the Core Study were offered an option to enter the 24-week open-label Extension|106
3084092|NCT01400139|3806263|FG000|COMPLETED|HYD Extension Period||83
3084093|NCT01400139|3806263|FG000|NOT COMPLETED|HYD Extension Period||23
3084094|NCT01400243|3806271|FG000|STARTED|Overall Study||64
3084095|NCT01400243|3806272|FG001|STARTED|Overall Study||63
3084096|NCT01400243|3806271|FG000|COMPLETED|Overall Study||56
3084097|NCT01400243|3806272|FG001|COMPLETED|Overall Study||52
3084098|NCT01400243|3806271|FG000|NOT COMPLETED|Overall Study||8
3084099|NCT01400243|3806272|FG001|NOT COMPLETED|Overall Study||11
3084100|NCT01400412|3806282|FG000|STARTED|Overall Study||130
3084101|NCT01400412|3806283|FG001|STARTED|Overall Study||132
3084102|NCT01400412|3806282|FG000|COMPLETED|Overall Study||120
3084103|NCT01400412|3806283|FG001|COMPLETED|Overall Study||115
3084104|NCT01400412|3806282|FG000|NOT COMPLETED|Overall Study||10
3084105|NCT01400412|3806283|FG001|NOT COMPLETED|Overall Study||17
3084106|NCT01400425|3806291|FG000|STARTED|Overall Study||239
3084107|NCT01400425|3806291|FG000|COMPLETED|Overall Study||229
3084108|NCT01400425|3806291|FG000|NOT COMPLETED|Overall Study||10
3084109|NCT01400451|3806300|FG000|STARTED|28 Day Lead In With Vemurafenib Alone||6
3084110|NCT01400451|3806301|FG001|STARTED|28 Day Lead In With Vemurafenib Alone||4
3084111|NCT01400451|3806302|FG002|STARTED|28 Day Lead In With Vemurafenib Alone||2
3084112|NCT01400451|3806300|FG000|COMPLETED|28 Day Lead In With Vemurafenib Alone||6
3084113|NCT01400451|3806301|FG001|COMPLETED|28 Day Lead In With Vemurafenib Alone||4
3084114|NCT01400451|3806302|FG002|COMPLETED|28 Day Lead In With Vemurafenib Alone||2
3084115|NCT01400451|3806300|FG000|NOT COMPLETED|28 Day Lead In With Vemurafenib Alone||0
3084116|NCT01400451|3806301|FG001|NOT COMPLETED|28 Day Lead In With Vemurafenib Alone||0
3084117|NCT01400451|3806302|FG002|NOT COMPLETED|28 Day Lead In With Vemurafenib Alone||0
3084118|NCT01400451|3806300|FG000|STARTED|Combination Treatment (or Intended)||6
3084119|NCT01400451|3806301|FG001|STARTED|Combination Treatment (or Intended)||4
3084120|NCT01400451|3806302|FG002|STARTED|Combination Treatment (or Intended)|Did not start Ipilimumab but remained on vemurafenib alone.|2
3084121|NCT01400451|3806300|FG000|COMPLETED|Combination Treatment (or Intended)||0
3084122|NCT01400451|3806301|FG001|COMPLETED|Combination Treatment (or Intended)||0
3084123|NCT01400451|3806302|FG002|COMPLETED|Combination Treatment (or Intended)||0
3084124|NCT01400451|3806300|FG000|NOT COMPLETED|Combination Treatment (or Intended)||6
3084125|NCT01400451|3806301|FG001|NOT COMPLETED|Combination Treatment (or Intended)||4
3084126|NCT01400451|3806302|FG002|NOT COMPLETED|Combination Treatment (or Intended)||2
3084127|NCT01400477|3806317|FG000|STARTED|Overall Study||40
3084128|NCT01400477|3806318|FG001|STARTED|Overall Study||40
3084129|NCT01400477|3806317|FG000|COMPLETED|Overall Study||38
3084130|NCT01400477|3806318|FG001|COMPLETED|Overall Study||40
3084131|NCT01400477|3806317|FG000|NOT COMPLETED|Overall Study||2
3084132|NCT01400477|3806318|FG001|NOT COMPLETED|Overall Study||0
3084133|NCT01400503|3806324|FG000|STARTED|Overall Study||60
3084134|NCT01400503|3806324|FG000|COMPLETED|Overall Study||0
3084135|NCT01400503|3806324|FG000|NOT COMPLETED|Overall Study||60
3084136|NCT01400516|3806330|FG000|STARTED|Primary Trial||12
3084137|NCT01400516|3806331|FG001|STARTED|Primary Trial||14
3084138|NCT01400516|3806330|FG000|COMPLETED|Primary Trial||12
3084139|NCT01400516|3806331|FG001|COMPLETED|Primary Trial||12
3084140|NCT01400516|3806330|FG000|NOT COMPLETED|Primary Trial||0
3084141|NCT01400516|3806331|FG001|NOT COMPLETED|Primary Trial||2
3084142|NCT01400516|3806330|FG000|STARTED|Extension Trial|Only 6 participants in the Control arm entered the Extension Trial.|6
3084143|NCT01400516|3806331|FG001|STARTED|Extension Trial|Only 7 participants in the Teriparatide arm entered the Extension Trial.|7
3084144|NCT01400516|3806330|FG000|COMPLETED|Extension Trial||6
3084145|NCT01400516|3806331|FG001|COMPLETED|Extension Trial||7
3084146|NCT01400516|3806330|FG000|NOT COMPLETED|Extension Trial||0
3084147|NCT01400516|3806331|FG001|NOT COMPLETED|Extension Trial||0
3084148|NCT01400698|3806341|FG000|STARTED|Overall Study||23
3084149|NCT01400698|3806342|FG001|STARTED|Overall Study||23
3084150|NCT01400698|3806343|FG002|STARTED|Overall Study||2
3084151|NCT01400698|3806344|FG003|STARTED|Overall Study||14
3084152|NCT01400698|3806345|FG004|STARTED|Overall Study||14
3084153|NCT01400698|3806346|FG005|STARTED|Overall Study||15
3084154|NCT01400698|3806341|FG000|COMPLETED|Overall Study||8
3084155|NCT01400698|3806342|FG001|COMPLETED|Overall Study||12
3084156|NCT01400698|3806343|FG002|COMPLETED|Overall Study||0
3084157|NCT01400698|3806344|FG003|COMPLETED|Overall Study||6
3084158|NCT01400698|3806345|FG004|COMPLETED|Overall Study||7
3084159|NCT01400698|3806346|FG005|COMPLETED|Overall Study||9
3084160|NCT01400698|3806341|FG000|NOT COMPLETED|Overall Study||15
3084161|NCT01400698|3806342|FG001|NOT COMPLETED|Overall Study||11
3084162|NCT01400698|3806343|FG002|NOT COMPLETED|Overall Study||2
3084163|NCT01400698|3806344|FG003|NOT COMPLETED|Overall Study||8
3084164|NCT01400698|3806345|FG004|NOT COMPLETED|Overall Study||7
3084165|NCT01400698|3806346|FG005|NOT COMPLETED|Overall Study||6
3084166|NCT01400815|3806358|FG000|STARTED|Overall Study||118
3084167|NCT01400815|3806359|FG001|STARTED|Overall Study||116
3084168|NCT01400815|3806358|FG000|COMPLETED|Overall Study||80
3084169|NCT01400815|3806359|FG001|COMPLETED|Overall Study||95
3084170|NCT01400815|3806358|FG000|NOT COMPLETED|Overall Study||38
3084171|NCT01400815|3806359|FG001|NOT COMPLETED|Overall Study||21
3084172|NCT01400841|3806365|FG000|STARTED|Initial Study Phase (6 Months)|2 of the 18 consented subjects did not receive the device|16
3084173|NCT01400841|3806365|FG000|COMPLETED|Initial Study Phase (6 Months)||15
3084174|NCT01400841|3806365|FG000|NOT COMPLETED|Initial Study Phase (6 Months)||1
3084175|NCT01400841|3806365|FG000|STARTED|Extended Study Phase (2 Years)|"1 subject refused further participation~1 subject death prior to agreeing to extended follow-up"|13
3084176|NCT01400841|3806365|FG000|COMPLETED|Extended Study Phase (2 Years)||11
3084177|NCT01400841|3806365|FG000|NOT COMPLETED|Extended Study Phase (2 Years)||2
3084178|NCT01400880|3806369|FG000|STARTED|Overall Study|patients were added throughout the study. There was not a set number of patients that we began with|103
3084179|NCT01400880|3806369|FG000|COMPLETED|Overall Study|patients were added throughout the study. There was not a set number of patients that we began with|101
3084180|NCT01400880|3806369|FG000|NOT COMPLETED|Overall Study||2
3084181|NCT01400893|3806375|FG000|STARTED|Overall Study||69
3084182|NCT01400893|3806376|FG001|STARTED|Overall Study||65
3084183|NCT01400893|3806375|FG000|COMPLETED|Overall Study||42
3084184|NCT01400893|3806376|FG001|COMPLETED|Overall Study||38
3084185|NCT01400893|3806375|FG000|NOT COMPLETED|Overall Study||27
3084186|NCT01400893|3806376|FG001|NOT COMPLETED|Overall Study||27
3084187|NCT01400906|3806384|FG000|STARTED|Treatment Period 1||6
3084188|NCT01400906|3806385|FG001|STARTED|Treatment Period 1||6
3084189|NCT01400906|3806386|FG002|STARTED|Treatment Period 1||6
3084190|NCT01400906|3806387|FG003|STARTED|Treatment Period 1||6
3084191|NCT01400906|3806388|FG004|STARTED|Treatment Period 1||6
3084192|NCT01400906|3806389|FG005|STARTED|Treatment Period 1||5
3084193|NCT01400906|3806384|FG000|COMPLETED|Treatment Period 1||6
3084194|NCT01400906|3806385|FG001|COMPLETED|Treatment Period 1||6
3084195|NCT01400906|3806386|FG002|COMPLETED|Treatment Period 1||6
3084196|NCT01400906|3806387|FG003|COMPLETED|Treatment Period 1||6
3084197|NCT01400906|3806388|FG004|COMPLETED|Treatment Period 1||6
3084198|NCT01400906|3806389|FG005|COMPLETED|Treatment Period 1||5
3084199|NCT01400906|3806384|FG000|NOT COMPLETED|Treatment Period 1||0
3084200|NCT01400906|3806385|FG001|NOT COMPLETED|Treatment Period 1||0
3084201|NCT01400906|3806386|FG002|NOT COMPLETED|Treatment Period 1||0
3084202|NCT01400906|3806387|FG003|NOT COMPLETED|Treatment Period 1||0
3084203|NCT01400906|3806388|FG004|NOT COMPLETED|Treatment Period 1||0
3084204|NCT01400906|3806389|FG005|NOT COMPLETED|Treatment Period 1||0
3084205|NCT01400906|3806384|FG000|STARTED|Washout Period 1||6
3084206|NCT01400906|3806385|FG001|STARTED|Washout Period 1||6
3084207|NCT01400906|3806386|FG002|STARTED|Washout Period 1||6
3084208|NCT01400906|3806387|FG003|STARTED|Washout Period 1||6
3084209|NCT01400906|3806388|FG004|STARTED|Washout Period 1||6
3084210|NCT01400906|3806389|FG005|STARTED|Washout Period 1||5
3084211|NCT01400906|3806384|FG000|COMPLETED|Washout Period 1||6
3084212|NCT01400906|3806385|FG001|COMPLETED|Washout Period 1||6
3084213|NCT01400906|3806386|FG002|COMPLETED|Washout Period 1||6
3084214|NCT01400906|3806387|FG003|COMPLETED|Washout Period 1||6
3084215|NCT01400906|3806388|FG004|COMPLETED|Washout Period 1||6
3084216|NCT01400906|3806389|FG005|COMPLETED|Washout Period 1||5
3084217|NCT01400906|3806384|FG000|NOT COMPLETED|Washout Period 1||0
3084218|NCT01400906|3806385|FG001|NOT COMPLETED|Washout Period 1||0
3084219|NCT01400906|3806386|FG002|NOT COMPLETED|Washout Period 1||0
3084220|NCT01400906|3806387|FG003|NOT COMPLETED|Washout Period 1||0
3084221|NCT01400906|3806388|FG004|NOT COMPLETED|Washout Period 1||0
3084222|NCT01400906|3806389|FG005|NOT COMPLETED|Washout Period 1||0
3084223|NCT01400906|3806384|FG000|STARTED|Treatment Period 2||6
3084224|NCT01400906|3806385|FG001|STARTED|Treatment Period 2||6
3084225|NCT01400906|3806386|FG002|STARTED|Treatment Period 2||6
3084226|NCT01400906|3806387|FG003|STARTED|Treatment Period 2||6
3084227|NCT01400906|3806388|FG004|STARTED|Treatment Period 2||6
3084228|NCT01400906|3806389|FG005|STARTED|Treatment Period 2||5
3084229|NCT01400906|3806384|FG000|COMPLETED|Treatment Period 2||6
3084230|NCT01400906|3806385|FG001|COMPLETED|Treatment Period 2||6
3084231|NCT01400906|3806386|FG002|COMPLETED|Treatment Period 2||6
3084232|NCT01400906|3806387|FG003|COMPLETED|Treatment Period 2||6
3084233|NCT01400906|3806388|FG004|COMPLETED|Treatment Period 2||6
3084234|NCT01400906|3806389|FG005|COMPLETED|Treatment Period 2||5
3084235|NCT01400906|3806384|FG000|NOT COMPLETED|Treatment Period 2||0
3084236|NCT01400906|3806385|FG001|NOT COMPLETED|Treatment Period 2||0
3084237|NCT01400906|3806386|FG002|NOT COMPLETED|Treatment Period 2||0
3084238|NCT01400906|3806387|FG003|NOT COMPLETED|Treatment Period 2||0
3084239|NCT01400906|3806388|FG004|NOT COMPLETED|Treatment Period 2||0
3084240|NCT01400906|3806389|FG005|NOT COMPLETED|Treatment Period 2||0
3084241|NCT01400906|3806384|FG000|STARTED|Washout Period 2||6
3084242|NCT01400906|3806385|FG001|STARTED|Washout Period 2||6
3084243|NCT01400906|3806386|FG002|STARTED|Washout Period 2||6
3084244|NCT01400906|3806387|FG003|STARTED|Washout Period 2||6
3084245|NCT01400906|3806388|FG004|STARTED|Washout Period 2||6
3084246|NCT01400906|3806389|FG005|STARTED|Washout Period 2||5
3084247|NCT01400906|3806384|FG000|COMPLETED|Washout Period 2||6
3084248|NCT01400906|3806385|FG001|COMPLETED|Washout Period 2||6
3084249|NCT01400906|3806386|FG002|COMPLETED|Washout Period 2||6
3084250|NCT01400906|3806387|FG003|COMPLETED|Washout Period 2||6
3084251|NCT01400906|3806388|FG004|COMPLETED|Washout Period 2||6
3084252|NCT01400906|3806389|FG005|COMPLETED|Washout Period 2||5
3084253|NCT01400906|3806384|FG000|NOT COMPLETED|Washout Period 2||0
3084254|NCT01400906|3806385|FG001|NOT COMPLETED|Washout Period 2||0
3084255|NCT01400906|3806386|FG002|NOT COMPLETED|Washout Period 2||0
3084256|NCT01400906|3806387|FG003|NOT COMPLETED|Washout Period 2||0
3084257|NCT01400906|3806388|FG004|NOT COMPLETED|Washout Period 2||0
3084258|NCT01400906|3806389|FG005|NOT COMPLETED|Washout Period 2||0
3084259|NCT01400906|3806384|FG000|STARTED|Treatment Period 3||6
3084260|NCT01400906|3806385|FG001|STARTED|Treatment Period 3||6
3084261|NCT01400906|3806386|FG002|STARTED|Treatment Period 3||6
3084262|NCT01400906|3806387|FG003|STARTED|Treatment Period 3||6
3084263|NCT01400906|3806388|FG004|STARTED|Treatment Period 3||6
3084264|NCT01400906|3806389|FG005|STARTED|Treatment Period 3||5
3084265|NCT01400906|3806384|FG000|COMPLETED|Treatment Period 3||6
3084266|NCT01400906|3806385|FG001|COMPLETED|Treatment Period 3||6
3084267|NCT01400906|3806386|FG002|COMPLETED|Treatment Period 3||6
3084268|NCT01400906|3806387|FG003|COMPLETED|Treatment Period 3||6
3084269|NCT01400906|3806388|FG004|COMPLETED|Treatment Period 3||6
3084270|NCT01400906|3806389|FG005|COMPLETED|Treatment Period 3||5
3084271|NCT01400906|3806384|FG000|NOT COMPLETED|Treatment Period 3||0
3084272|NCT01400906|3806385|FG001|NOT COMPLETED|Treatment Period 3||0
3084273|NCT01400906|3806386|FG002|NOT COMPLETED|Treatment Period 3||0
3084274|NCT01400906|3806387|FG003|NOT COMPLETED|Treatment Period 3||0
3084275|NCT01400906|3806388|FG004|NOT COMPLETED|Treatment Period 3||0
3084276|NCT01400906|3806389|FG005|NOT COMPLETED|Treatment Period 3||0
3084277|NCT01400919|3806397|FG000|STARTED|Overall Study||75
3084278|NCT01400919|3806397|FG000|COMPLETED|Overall Study||67
3084279|NCT01400919|3806397|FG000|NOT COMPLETED|Overall Study||8
3084280|NCT01400932|3806403|FG000|STARTED|Overall Study||178
3084281|NCT01400932|3806404|FG001|STARTED|Overall Study||182
3084282|NCT01400932|3806403|FG000|COMPLETED|Overall Study||164
3084283|NCT01400932|3806404|FG001|COMPLETED|Overall Study||167
3084284|NCT01400932|3806403|FG000|NOT COMPLETED|Overall Study||14
3084285|NCT01400932|3806404|FG001|NOT COMPLETED|Overall Study||15
3084286|NCT01400958|3806412|FG000|STARTED|Overall Study||3
3084287|NCT01400958|3806413|FG001|STARTED|Overall Study||3
3084288|NCT01400958|3806412|FG000|COMPLETED|Overall Study||2
3084289|NCT01400958|3806413|FG001|COMPLETED|Overall Study||1
3084290|NCT01400958|3806412|FG000|NOT COMPLETED|Overall Study||1
3084291|NCT01400958|3806413|FG001|NOT COMPLETED|Overall Study||2
3084292|NCT01400971|3806419|FG000|STARTED|Overall Study||4299
3084293|NCT01400971|3806419|FG000|Complete Treatment Data|Overall Study||2528
3084294|NCT01400971|3806419|FG000|COMPLETED|Overall Study||3382
3084295|NCT01400971|3806419|FG000|NOT COMPLETED|Overall Study||917
3084296|NCT01401010|3806425|FG000|STARTED|Overall Study||6
3084297|NCT01401010|3806426|FG001|STARTED|Overall Study||6
3084298|NCT01401010|3806425|FG000|COMPLETED|Overall Study||5
3084299|NCT01401010|3806426|FG001|COMPLETED|Overall Study||6
3084300|NCT01401010|3806425|FG000|NOT COMPLETED|Overall Study||1
3084301|NCT01401010|3806426|FG001|NOT COMPLETED|Overall Study||0
3084302|NCT01401023|3806437|FG000|STARTED|Overall Study||10
3084303|NCT01401023|3806437|FG000|COMPLETED|Overall Study||10
3084304|NCT01401023|3806437|FG000|NOT COMPLETED|Overall Study||0
3084305|NCT01401062|3806445|FG000|STARTED|Overall Study||11
3084306|NCT01401062|3806446|FG001|STARTED|Overall Study||12
3084307|NCT01401062|3806445|FG000|COMPLETED|Overall Study||0
3084308|NCT01401062|3806446|FG001|COMPLETED|Overall Study|At time of data entry, these 4 patients are still undergoing follow-up|4
3084309|NCT01401062|3806445|FG000|NOT COMPLETED|Overall Study||11
3084310|NCT01401062|3806446|FG001|NOT COMPLETED|Overall Study||8
3084311|NCT01401101|3806454|FG000|STARTED|Overall Study||206
3084312|NCT01401101|3806455|FG001|STARTED|Overall Study||198
3084313|NCT01401101|3806454|FG000|COMPLETED|Overall Study||184
3084314|NCT01401101|3806455|FG001|COMPLETED|Overall Study||171
3084315|NCT01401101|3806454|FG000|NOT COMPLETED|Overall Study||22
3084316|NCT01401101|3806455|FG001|NOT COMPLETED|Overall Study||27
3084317|NCT01401153|3806463|FG000|STARTED|First Test Day||66
3084318|NCT01401153|3806464|FG001|STARTED|First Test Day||55
3084319|NCT01401153|3806463|FG000|COMPLETED|First Test Day||65
3084320|NCT01401153|3806464|FG001|COMPLETED|First Test Day||45
3084321|NCT01401153|3806463|FG000|NOT COMPLETED|First Test Day||1
3084322|NCT01401153|3806464|FG001|NOT COMPLETED|First Test Day||10
3084323|NCT01401153|3806463|FG000|STARTED|Second Test Day||45
3084324|NCT01401153|3806464|FG001|STARTED|Second Test Day||65
3084325|NCT01401153|3806463|FG000|COMPLETED|Second Test Day||45
3084326|NCT01401153|3806464|FG001|COMPLETED|Second Test Day||60
3084327|NCT01401153|3806463|FG000|NOT COMPLETED|Second Test Day||0
3084328|NCT01401153|3806464|FG001|NOT COMPLETED|Second Test Day||5
3084329|NCT01401166|3806473|FG000|STARTED|Crossover Treatment 1 (Cycles 1 to 4)|A total of 124 participants were randomized, but 2 did not receive any treatment.|122
3084330|NCT01401166|3806474|FG001|STARTED|Crossover Treatment 1 (Cycles 1 to 4)|A total of 124 participants were randomized, but 2 did not receive any treatment.|122
3084331|NCT01401166|3806475|FG002|STARTED|Crossover Treatment 1 (Cycles 1 to 4)|A total of 121 participants were randomized who all received study treatment.|121
3084332|NCT01401166|3806476|FG003|STARTED|Crossover Treatment 1 (Cycles 1 to 4)|A total of 119 participants were randomized, but 1 did not receive any treatment.|118
3084333|NCT01401166|3806473|FG000|COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||119
3084334|NCT01401166|3806474|FG001|COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||120
3084335|NCT01401166|3806475|FG002|COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||119
3084336|NCT01401166|3806476|FG003|COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||116
3084337|NCT01401166|3806473|FG000|NOT COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||3
3084338|NCT01401166|3806474|FG001|NOT COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||2
3084339|NCT01401166|3806475|FG002|NOT COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||2
3084340|NCT01401166|3806476|FG003|NOT COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||2
3084341|NCT01401166|3806473|FG000|STARTED|Crossover Treatment 2 (Cycles 5 to 8)||119
3084342|NCT01401166|3806474|FG001|STARTED|Crossover Treatment 2 (Cycles 5 to 8)||120
3084343|NCT01401166|3806475|FG002|STARTED|Crossover Treatment 2 (Cycles 5 to 8)||119
3084344|NCT01401166|3806476|FG003|STARTED|Crossover Treatment 2 (Cycles 5 to 8)||116
3084345|NCT01401166|3806473|FG000|COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||113
3084346|NCT01401166|3806474|FG001|COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||116
3084347|NCT01401166|3806475|FG002|COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||107
3084348|NCT01401166|3806476|FG003|COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||105
3084349|NCT01401166|3806473|FG000|NOT COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||6
3084350|NCT01401166|3806474|FG001|NOT COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||4
3084351|NCT01401166|3806475|FG002|NOT COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||12
3084352|NCT01401166|3806476|FG003|NOT COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||11
3084353|NCT01401166|3806473|FG000|STARTED|Continuation Treatment (Cycles 9 to 18)||113
3084354|NCT01401166|3806474|FG001|STARTED|Continuation Treatment (Cycles 9 to 18)||116
3084355|NCT01401166|3806475|FG002|STARTED|Continuation Treatment (Cycles 9 to 18)||107
3084356|NCT01401166|3806476|FG003|STARTED|Continuation Treatment (Cycles 9 to 18)||105
3084357|NCT01401166|3806473|FG000|COMPLETED|Continuation Treatment (Cycles 9 to 18)||109
3084358|NCT01401166|3806474|FG001|COMPLETED|Continuation Treatment (Cycles 9 to 18)||109
3084359|NCT01401166|3806475|FG002|COMPLETED|Continuation Treatment (Cycles 9 to 18)||105
3084360|NCT01401166|3806476|FG003|COMPLETED|Continuation Treatment (Cycles 9 to 18)||102
3084361|NCT01401166|3806473|FG000|NOT COMPLETED|Continuation Treatment (Cycles 9 to 18)||4
3084362|NCT01401166|3806474|FG001|NOT COMPLETED|Continuation Treatment (Cycles 9 to 18)||7
3084363|NCT01401166|3806475|FG002|NOT COMPLETED|Continuation Treatment (Cycles 9 to 18)||2
3084364|NCT01401166|3806476|FG003|NOT COMPLETED|Continuation Treatment (Cycles 9 to 18)||3
3084365|NCT01401166|3806473|FG000|STARTED|Safety Follow-Up Period|All 124 randomized participants entered follow-up regardless of whether they received treatment.|124
3084366|NCT01401166|3806474|FG001|STARTED|Safety Follow-Up Period|All 124 randomized participants entered follow-up regardless of whether they received treatment.|124
3084367|NCT01401166|3806475|FG002|STARTED|Safety Follow-Up Period|All 121 randomized participants entered follow-up regardless of whether they received treatment.|121
3084368|NCT01401166|3806476|FG003|STARTED|Safety Follow-Up Period|All 119 randomized participants entered follow-up regardless of whether they received treatment.|119
3084369|NCT01401166|3806473|FG000|COMPLETED|Safety Follow-Up Period||99
3084370|NCT01401166|3806474|FG001|COMPLETED|Safety Follow-Up Period||106
3084371|NCT01401166|3806475|FG002|COMPLETED|Safety Follow-Up Period||104
3084372|NCT01401166|3806476|FG003|COMPLETED|Safety Follow-Up Period||100
3084373|NCT01401166|3806473|FG000|NOT COMPLETED|Safety Follow-Up Period||25
3084374|NCT01401166|3806474|FG001|NOT COMPLETED|Safety Follow-Up Period||18
3084375|NCT01401166|3806475|FG002|NOT COMPLETED|Safety Follow-Up Period||17
3084376|NCT01401166|3806476|FG003|NOT COMPLETED|Safety Follow-Up Period||19
3084377|NCT01401257|3806497|FG000|STARTED|Overall Study||21
3084378|NCT01401257|3806498|FG001|STARTED|Overall Study||21
3084379|NCT01401257|3806499|FG002|STARTED|Overall Study||19
3084380|NCT01401257|3806500|FG003|STARTED|Overall Study||19
3084381|NCT01401257|3806497|FG000|COMPLETED|Overall Study||21
3084382|NCT01401257|3806498|FG001|COMPLETED|Overall Study||19
3084383|NCT01401257|3806499|FG002|COMPLETED|Overall Study||16
3084384|NCT01401257|3806500|FG003|COMPLETED|Overall Study||17
3084385|NCT01401257|3806497|FG000|NOT COMPLETED|Overall Study||0
3084386|NCT01401257|3806498|FG001|NOT COMPLETED|Overall Study||2
3084387|NCT01401257|3806499|FG002|NOT COMPLETED|Overall Study||3
3084388|NCT01401257|3806500|FG003|NOT COMPLETED|Overall Study||2
3084389|NCT01401283|3806512|FG000|STARTED|Overall Study||89
3084390|NCT01401283|3806513|FG001|STARTED|Overall Study||91
3084391|NCT01401283|3806512|FG000|COMPLETED|Overall Study||79
3084392|NCT01401283|3806513|FG001|COMPLETED|Overall Study||81
3084393|NCT01401283|3806512|FG000|NOT COMPLETED|Overall Study||10
3084394|NCT01401283|3806513|FG001|NOT COMPLETED|Overall Study||10
3134863|NCT01703208|3859807|FG000|NOT COMPLETED|Overall Study||2100
3134864|NCT01703208|3859808|FG001|NOT COMPLETED|Overall Study||2102
3134865|NCT01703221|3859817|FG000|STARTED|Phase A (Up to 24 Weeks)||166
3134866|NCT01703221|3859818|FG001|STARTED|Phase A (Up to 24 Weeks)||165
3134867|NCT01703221|3859819|FG002|STARTED|Phase A (Up to 24 Weeks)||83
3134868|NCT01703221|3859817|FG000|COMPLETED|Phase A (Up to 24 Weeks)||159
3134869|NCT01703221|3859818|FG001|COMPLETED|Phase A (Up to 24 Weeks)||161
3134870|NCT01703221|3859819|FG002|COMPLETED|Phase A (Up to 24 Weeks)||80
3134871|NCT01703221|3859817|FG000|NOT COMPLETED|Phase A (Up to 24 Weeks)||7
3134872|NCT01703221|3859818|FG001|NOT COMPLETED|Phase A (Up to 24 Weeks)||4
3134873|NCT01703221|3859819|FG002|NOT COMPLETED|Phase A (Up to 24 Weeks)||3
3134874|NCT01703221|3859817|FG000|STARTED|Phase B - (Week 25 to 52)||159
3134875|NCT01703221|3859818|FG001|STARTED|Phase B - (Week 25 to 52)||161
3134876|NCT01703221|3859819|FG002|STARTED|Phase B - (Week 25 to 52)||80
3134877|NCT01703221|3859817|FG000|COMPLETED|Phase B - (Week 25 to 52)||143
3134878|NCT01703221|3859818|FG001|COMPLETED|Phase B - (Week 25 to 52)||147
3134879|NCT01703221|3859819|FG002|COMPLETED|Phase B - (Week 25 to 52)||75
3134880|NCT01703221|3859817|FG000|NOT COMPLETED|Phase B - (Week 25 to 52)||16
3084395|NCT01401322|3806519|FG000|STARTED|Overall Study||5
3084396|NCT01401322|3806519|FG000|COMPLETED|Overall Study||3
3084397|NCT01401322|3806519|FG000|NOT COMPLETED|Overall Study||2
3084398|NCT01401361|3806523|FG000|STARTED|Overall Study||150
3084399|NCT01401361|3806523|FG000|COMPLETED|Overall Study|16 subjects were withdrawn prior to the use of the investigational device|122
3084400|NCT01401361|3806523|FG000|NOT COMPLETED|Overall Study||28
3084401|NCT01401452|3806527|FG000|STARTED|Overall Study||246
3084402|NCT01401452|3806527|FG000|Visit 1 (Baseline)|Overall Study||246
3084403|NCT01401452|3806527|FG000|Visit 2 (1 Month)|Overall Study||225
3084404|NCT01401452|3806527|FG000|Visit 3 (3 Months)|Overall Study||217
3084405|NCT01401452|3806527|FG000|Visit 4 (6 Months)|Overall Study||172
3084406|NCT01401452|3806527|FG000|Visit 5 (9 Months)|Overall Study||175
3084407|NCT01401452|3806527|FG000|COMPLETED|Overall Study||174
3084408|NCT01401452|3806527|FG000|NOT COMPLETED|Overall Study||72
3084409|NCT01401465|3806533|FG000|STARTED|Treatment Period 1||165
3084410|NCT01401465|3806534|FG001|STARTED|Treatment Period 1||162
3084411|NCT01401465|3806533|FG000|COMPLETED|Treatment Period 1||150
3084412|NCT01401465|3806534|FG001|COMPLETED|Treatment Period 1||146
3084413|NCT01401465|3806533|FG000|NOT COMPLETED|Treatment Period 1||15
3084414|NCT01401465|3806534|FG001|NOT COMPLETED|Treatment Period 1||16
3084415|NCT01401465|3806533|FG000|STARTED|Washout||150
3084416|NCT01401465|3806534|FG001|STARTED|Washout||146
3084417|NCT01401465|3806533|FG000|COMPLETED|Washout||150
3084418|NCT01401465|3806534|FG001|COMPLETED|Washout||146
3084419|NCT01401465|3806533|FG000|NOT COMPLETED|Washout||0
3084420|NCT01401465|3806534|FG001|NOT COMPLETED|Washout||0
3084421|NCT01401465|3806533|FG000|STARTED|Treatment Period 2||150
3084422|NCT01401465|3806534|FG001|STARTED|Treatment Period 2||146
3084423|NCT01401465|3806533|FG000|COMPLETED|Treatment Period 2||150
3084424|NCT01401465|3806534|FG001|COMPLETED|Treatment Period 2||144
3084425|NCT01401465|3806533|FG000|NOT COMPLETED|Treatment Period 2||0
3084426|NCT01401465|3806534|FG001|NOT COMPLETED|Treatment Period 2||2
3084427|NCT01401478|3806543|FG000|STARTED|Overall Study||86
3084428|NCT01401478|3806543|FG000|COMPLETED|Overall Study||55
3084429|NCT01401478|3806543|FG000|NOT COMPLETED|Overall Study||31
3084430|NCT01401517|3806550|FG000|STARTED|Overall Study||18
3084431|NCT01401517|3806551|FG001|STARTED|Overall Study||19
3084432|NCT01401517|3806552|FG002|STARTED|Overall Study||18
3084433|NCT01401517|3806550|FG000|COMPLETED|Overall Study||15
3084434|NCT01401517|3806551|FG001|COMPLETED|Overall Study||17
3084435|NCT01401517|3806552|FG002|COMPLETED|Overall Study||15
3084436|NCT01401517|3806550|FG000|NOT COMPLETED|Overall Study||3
3084437|NCT01401517|3806551|FG001|NOT COMPLETED|Overall Study||2
3084438|NCT01401517|3806552|FG002|NOT COMPLETED|Overall Study||3
3084439|NCT01401530|3806563|FG000|STARTED|Overall Study||3
3084440|NCT01401530|3806564|FG001|STARTED|Overall Study||7
3084441|NCT01401530|3806565|FG002|STARTED|Overall Study||3
3084442|NCT01401530|3806563|FG000|COMPLETED|Overall Study||0
3084443|NCT01401530|3806564|FG001|COMPLETED|Overall Study||1
3084444|NCT01401530|3806565|FG002|COMPLETED|Overall Study||0
3084445|NCT01401530|3806563|FG000|NOT COMPLETED|Overall Study||3
3084446|NCT01401530|3806564|FG001|NOT COMPLETED|Overall Study||6
3084447|NCT01401530|3806565|FG002|NOT COMPLETED|Overall Study||3
3084448|NCT01401543|3806575|FG000|STARTED|First Intervention||6
3084449|NCT01401543|3806576|FG001|STARTED|First Intervention||6
3084450|NCT01401543|3806577|FG002|STARTED|First Intervention||6
3084451|NCT01401543|3806578|FG003|STARTED|First Intervention||6
3084452|NCT01401543|3806575|FG000|COMPLETED|First Intervention||6
3084453|NCT01401543|3806576|FG001|COMPLETED|First Intervention||6
3084454|NCT01401543|3806577|FG002|COMPLETED|First Intervention||6
3084455|NCT01401543|3806578|FG003|COMPLETED|First Intervention||6
3084456|NCT01401543|3806575|FG000|NOT COMPLETED|First Intervention||0
3084457|NCT01401543|3806576|FG001|NOT COMPLETED|First Intervention||0
3084458|NCT01401543|3806577|FG002|NOT COMPLETED|First Intervention||0
3084459|NCT01401543|3806578|FG003|NOT COMPLETED|First Intervention||0
3084460|NCT01401543|3806575|FG000|STARTED|First Washout Period of 1 Week||6
3084461|NCT01401543|3806576|FG001|STARTED|First Washout Period of 1 Week||6
2940863|NCT00639418|3653096|FG000|NOT COMPLETED|Overall Study||0
2940864|NCT00639418|3653097|FG001|NOT COMPLETED|Overall Study||0
2940865|NCT00639418|3653098|FG002|NOT COMPLETED|Overall Study||0
2940866|NCT00639418|3653099|FG003|NOT COMPLETED|Overall Study||0
2940867|NCT00639457|3653115|FG000|STARTED|Overall Study||22
2940868|NCT00639457|3653116|FG001|STARTED|Overall Study||22
2940869|NCT00639457|3653115|FG000|COMPLETED|Overall Study||20
2940870|NCT00639457|3653116|FG001|COMPLETED|Overall Study||19
2940871|NCT00639457|3653115|FG000|NOT COMPLETED|Overall Study||2
3084462|NCT01401543|3806577|FG002|STARTED|First Washout Period of 1 Week||6
3084463|NCT01401543|3806578|FG003|STARTED|First Washout Period of 1 Week||6
3084464|NCT01401543|3806575|FG000|COMPLETED|First Washout Period of 1 Week||6
3084465|NCT01401543|3806576|FG001|COMPLETED|First Washout Period of 1 Week||6
3084466|NCT01401543|3806577|FG002|COMPLETED|First Washout Period of 1 Week||6
3084467|NCT01401543|3806578|FG003|COMPLETED|First Washout Period of 1 Week||6
3084468|NCT01401543|3806575|FG000|NOT COMPLETED|First Washout Period of 1 Week||0
3084469|NCT01401543|3806576|FG001|NOT COMPLETED|First Washout Period of 1 Week||0
3084470|NCT01401543|3806577|FG002|NOT COMPLETED|First Washout Period of 1 Week||0
3084471|NCT01401543|3806578|FG003|NOT COMPLETED|First Washout Period of 1 Week||0
3084472|NCT01401543|3806575|FG000|STARTED|Second Intervention||6
3084473|NCT01401543|3806576|FG001|STARTED|Second Intervention||6
3084474|NCT01401543|3806577|FG002|STARTED|Second Intervention||6
3084475|NCT01401543|3806578|FG003|STARTED|Second Intervention||6
3084476|NCT01401543|3806575|FG000|COMPLETED|Second Intervention||6
3084477|NCT01401543|3806576|FG001|COMPLETED|Second Intervention||6
3084478|NCT01401543|3806577|FG002|COMPLETED|Second Intervention||6
3084479|NCT01401543|3806578|FG003|COMPLETED|Second Intervention||6
3084480|NCT01401543|3806575|FG000|NOT COMPLETED|Second Intervention||0
3084481|NCT01401543|3806576|FG001|NOT COMPLETED|Second Intervention||0
3084482|NCT01401543|3806577|FG002|NOT COMPLETED|Second Intervention||0
3084483|NCT01401543|3806578|FG003|NOT COMPLETED|Second Intervention||0
3084484|NCT01401543|3806575|FG000|STARTED|Second Washout Period of 1 Week||6
3084485|NCT01401543|3806576|FG001|STARTED|Second Washout Period of 1 Week||6
3084486|NCT01401543|3806577|FG002|STARTED|Second Washout Period of 1 Week||6
3084487|NCT01401543|3806578|FG003|STARTED|Second Washout Period of 1 Week||6
3084488|NCT01401543|3806575|FG000|COMPLETED|Second Washout Period of 1 Week||6
3084489|NCT01401543|3806576|FG001|COMPLETED|Second Washout Period of 1 Week||6
3084490|NCT01401543|3806577|FG002|COMPLETED|Second Washout Period of 1 Week||6
3084491|NCT01401543|3806578|FG003|COMPLETED|Second Washout Period of 1 Week||6
3084492|NCT01401543|3806575|FG000|NOT COMPLETED|Second Washout Period of 1 Week||0
3084493|NCT01401543|3806576|FG001|NOT COMPLETED|Second Washout Period of 1 Week||0
3084494|NCT01401543|3806577|FG002|NOT COMPLETED|Second Washout Period of 1 Week||0
3084495|NCT01401543|3806578|FG003|NOT COMPLETED|Second Washout Period of 1 Week||0
3084496|NCT01401543|3806575|FG000|STARTED|Third Intervention||6
3084497|NCT01401543|3806576|FG001|STARTED|Third Intervention||6
3084498|NCT01401543|3806577|FG002|STARTED|Third Intervention||6
3084499|NCT01401543|3806578|FG003|STARTED|Third Intervention||6
3084500|NCT01401543|3806575|FG000|COMPLETED|Third Intervention||6
3084501|NCT01401543|3806576|FG001|COMPLETED|Third Intervention||6
3084502|NCT01401543|3806577|FG002|COMPLETED|Third Intervention||6
3084503|NCT01401543|3806578|FG003|COMPLETED|Third Intervention||6
3084504|NCT01401543|3806575|FG000|NOT COMPLETED|Third Intervention||0
3084505|NCT01401543|3806576|FG001|NOT COMPLETED|Third Intervention||0
3084506|NCT01401543|3806577|FG002|NOT COMPLETED|Third Intervention||0
3084507|NCT01401543|3806578|FG003|NOT COMPLETED|Third Intervention||0
3084508|NCT01401543|3806575|FG000|STARTED|Third Washout Period of 1 Week||6
3084509|NCT01401543|3806576|FG001|STARTED|Third Washout Period of 1 Week||6
3084510|NCT01401543|3806577|FG002|STARTED|Third Washout Period of 1 Week||6
3084511|NCT01401543|3806578|FG003|STARTED|Third Washout Period of 1 Week||6
3084512|NCT01401543|3806575|FG000|COMPLETED|Third Washout Period of 1 Week||6
3084513|NCT01401543|3806576|FG001|COMPLETED|Third Washout Period of 1 Week||6
3084514|NCT01401543|3806577|FG002|COMPLETED|Third Washout Period of 1 Week||6
3084515|NCT01401543|3806578|FG003|COMPLETED|Third Washout Period of 1 Week||6
3084516|NCT01401543|3806575|FG000|NOT COMPLETED|Third Washout Period of 1 Week||0
3084517|NCT01401543|3806576|FG001|NOT COMPLETED|Third Washout Period of 1 Week||0
3084518|NCT01401543|3806577|FG002|NOT COMPLETED|Third Washout Period of 1 Week||0
3084519|NCT01401543|3806578|FG003|NOT COMPLETED|Third Washout Period of 1 Week||0
3084520|NCT01401543|3806575|FG000|STARTED|Fourth Intervention||6
3084521|NCT01401543|3806576|FG001|STARTED|Fourth Intervention||6
3084522|NCT01401543|3806577|FG002|STARTED|Fourth Intervention||6
3084523|NCT01401543|3806578|FG003|STARTED|Fourth Intervention||6
3084524|NCT01401543|3806575|FG000|COMPLETED|Fourth Intervention||6
3084525|NCT01401543|3806576|FG001|COMPLETED|Fourth Intervention||6
3084526|NCT01401543|3806577|FG002|COMPLETED|Fourth Intervention||6
3084527|NCT01401543|3806578|FG003|COMPLETED|Fourth Intervention||6
3084528|NCT01401543|3806575|FG000|NOT COMPLETED|Fourth Intervention||0
3084529|NCT01401543|3806576|FG001|NOT COMPLETED|Fourth Intervention||0
3084530|NCT01401543|3806577|FG002|NOT COMPLETED|Fourth Intervention||0
3084531|NCT01401543|3806578|FG003|NOT COMPLETED|Fourth Intervention||0
3084532|NCT01401582|3806594|FG000|STARTED|Overall Study||226
3084533|NCT01401582|3806595|FG001|STARTED|Overall Study||408
3084534|NCT01401582|3806594|FG000|Baseline Completed|Overall Study||168
3084535|NCT01401582|3806595|FG001|Baseline Completed|Overall Study||348
3084536|NCT01401582|3806594|FG000|COMPLETED|Overall Study||116
3084537|NCT01401582|3806595|FG001|COMPLETED|Overall Study||291
3084538|NCT01401582|3806594|FG000|NOT COMPLETED|Overall Study||110
3084539|NCT01401582|3806595|FG001|NOT COMPLETED|Overall Study||117
3084540|NCT01401595|3806606|FG000|STARTED|Recruitment and Screening|Of 345 calls, 75 potential NES subjects attended the screening visit and provided informed consent.|75
3084541|NCT01401595|3806607|FG001|STARTED|Recruitment and Screening|Of 32 calls, 12 control subjects attended an initial screening visit.|12
3084542|NCT01401595|3806606|FG000|COMPLETED|Recruitment and Screening|Of the 75, 32 remained interested/eligible after the initial screening period.|32
3084543|NCT01401595|3806607|FG001|COMPLETED|Recruitment and Screening|10 of the 12 remained eligible/interested after the initial screening visit.|10
3084544|NCT01401595|3806606|FG000|NOT COMPLETED|Recruitment and Screening||43
3084545|NCT01401595|3806607|FG001|NOT COMPLETED|Recruitment and Screening||2
3084546|NCT01401595|3806606|FG000|STARTED|Imaging and Treatment (for NE Arm)||32
3084547|NCT01401595|3806607|FG001|STARTED|Imaging and Treatment (for NE Arm)||10
3084548|NCT01401595|3806606|FG000|COMPLETED|Imaging and Treatment (for NE Arm)||18
3084549|NCT01401595|3806607|FG001|COMPLETED|Imaging and Treatment (for NE Arm)||10
3084550|NCT01401595|3806606|FG000|NOT COMPLETED|Imaging and Treatment (for NE Arm)||14
3084551|NCT01401595|3806607|FG001|NOT COMPLETED|Imaging and Treatment (for NE Arm)||0
3084552|NCT01401647|3806617|FG000|STARTED|Overall Study||972
3084553|NCT01401647|3806618|FG001|STARTED|Overall Study||993
3084554|NCT01401647|3806619|FG002|STARTED|Overall Study||1059
3084555|NCT01401647|3806617|FG000|COMPLETED|Overall Study||968
3084556|NCT01401647|3806618|FG001|COMPLETED|Overall Study||985
3084557|NCT01401647|3806619|FG002|COMPLETED|Overall Study||1056
3084558|NCT01401647|3806617|FG000|NOT COMPLETED|Overall Study||4
3084559|NCT01401647|3806618|FG001|NOT COMPLETED|Overall Study||8
3084560|NCT01401647|3806619|FG002|NOT COMPLETED|Overall Study||3
3084561|NCT01401699|3806627|FG000|STARTED|Overall Study||109
3084562|NCT01401699|3806627|FG000|COMPLETED|Overall Study||109
3084563|NCT01401699|3806627|FG000|NOT COMPLETED|Overall Study||0
3084564|NCT01401842|3806633|FG000|STARTED|Overall Study||298
3084565|NCT01401842|3806634|FG001|STARTED|Overall Study||284
3084566|NCT01401842|3806633|FG000|COMPLETED|Overall Study||230
3084567|NCT01401842|3806634|FG001|COMPLETED|Overall Study||217
3084568|NCT01401842|3806633|FG000|NOT COMPLETED|Overall Study||68
3084569|NCT01401842|3806634|FG001|NOT COMPLETED|Overall Study||67
3084570|NCT01401907|3806642|FG000|STARTED|Overall Study||175
3084571|NCT01401907|3806643|FG001|STARTED|Overall Study||175
3084572|NCT01401907|3806642|FG000|12 Week Outcomes|Overall Study||148
3084573|NCT01401907|3806643|FG001|12 Week Outcomes|Overall Study||153
3084574|NCT01401907|3806642|FG000|COMPLETED|Overall Study||118
3084575|NCT01401907|3806643|FG001|COMPLETED|Overall Study||124
3084576|NCT01401907|3806642|FG000|NOT COMPLETED|Overall Study||57
3084577|NCT01401907|3806643|FG001|NOT COMPLETED|Overall Study||51
3084578|NCT01401959|3806654|FG000|STARTED|Enrolled||54
3084579|NCT01401959|3806655|FG001|STARTED|Enrolled||42
3084580|NCT01401959|3806656|FG002|STARTED|Enrolled||31
3084581|NCT01401959|3806654|FG000|COMPLETED|Enrolled||53
3084582|NCT01401959|3806655|FG001|COMPLETED|Enrolled||42
3084583|NCT01401959|3806656|FG002|COMPLETED|Enrolled||31
3084584|NCT01401959|3806654|FG000|NOT COMPLETED|Enrolled||1
3084585|NCT01401959|3806655|FG001|NOT COMPLETED|Enrolled||0
3084586|NCT01401959|3806656|FG002|NOT COMPLETED|Enrolled||0
3084587|NCT01401959|3806654|FG000|STARTED|Treated||53
3084588|NCT01401959|3806655|FG001|STARTED|Treated||42
3084589|NCT01401959|3806656|FG002|STARTED|Treated||31
3084590|NCT01401959|3806654|FG000|COMPLETED|Treated||46
3084591|NCT01401959|3806655|FG001|COMPLETED|Treated||34
3084592|NCT01401959|3806656|FG002|COMPLETED|Treated||26
3084593|NCT01401959|3806654|FG000|NOT COMPLETED|Treated||7
3084594|NCT01401959|3806655|FG001|NOT COMPLETED|Treated||8
3084595|NCT01401959|3806656|FG002|NOT COMPLETED|Treated||5
3084596|NCT01402011|3806669|FG000|STARTED|Delayed Treatment Period||29
3084597|NCT01402011|3806670|FG001|STARTED|Delayed Treatment Period||23
3287486|NCT02792699|4021172|FG000|Received Second Infusion of Second Dose|Overall Study||97
3287487|NCT02792699|4021173|FG001|Received Second Infusion of Second Dose|Overall Study||99
3287488|NCT02792699|4021174|FG002|Received Second Infusion of Second Dose|Overall Study||93
3287489|NCT02792699|4021172|FG000|COMPLETED|Overall Study||95
3163063|NCT01882543|3890508|FG001|NOT COMPLETED|Overall Study||3
3163064|NCT01882647|3890517|FG000|STARTED|Overall Study||110
3163065|NCT01882647|3890518|FG001|STARTED|Overall Study||112
3163066|NCT01882647|3890517|FG000|COMPLETED|Overall Study||108
3163067|NCT01882647|3890518|FG001|COMPLETED|Overall Study||106
3163068|NCT01882647|3890517|FG000|NOT COMPLETED|Overall Study||2
3163069|NCT01882647|3890518|FG001|NOT COMPLETED|Overall Study||6
3163070|NCT01882725|3890524|FG000|STARTED|Overall Study||14
3163071|NCT01882725|3890524|FG000|COMPLETED|Overall Study||14
3163072|NCT01882725|3890524|FG000|NOT COMPLETED|Overall Study||0
3163073|NCT01882764|3890530|FG000|STARTED|Overall Study||47
3163074|NCT01882764|3890531|FG001|STARTED|Overall Study||19
3084598|NCT01402011|3806671|FG002|STARTED|Delayed Treatment Period||26
3084599|NCT01402011|3806669|FG000|COMPLETED|Delayed Treatment Period|One patient with needle phobia declined to be treated before the 1st set of injections|28
3084600|NCT01402011|3806670|FG001|COMPLETED|Delayed Treatment Period||23
3084601|NCT01402011|3806671|FG002|COMPLETED|Delayed Treatment Period||26
3084602|NCT01402011|3806669|FG000|NOT COMPLETED|Delayed Treatment Period||1
3084603|NCT01402011|3806670|FG001|NOT COMPLETED|Delayed Treatment Period||0
3084604|NCT01402011|3806671|FG002|NOT COMPLETED|Delayed Treatment Period||0
3084605|NCT01402011|3806669|FG000|STARTED|Active Treatment Period||28
3084606|NCT01402011|3806670|FG001|STARTED|Active Treatment Period||23
3084607|NCT01402011|3806671|FG002|STARTED|Active Treatment Period||26
3084608|NCT01402011|3806669|FG000|COMPLETED|Active Treatment Period||27
3084609|NCT01402011|3806670|FG001|COMPLETED|Active Treatment Period||20
3084610|NCT01402011|3806671|FG002|COMPLETED|Active Treatment Period||26
3084611|NCT01402011|3806669|FG000|NOT COMPLETED|Active Treatment Period||1
3084612|NCT01402011|3806670|FG001|NOT COMPLETED|Active Treatment Period||3
3084613|NCT01402011|3806671|FG002|NOT COMPLETED|Active Treatment Period||0
3084614|NCT01402011|3806669|FG000|STARTED|Nine Month Follow-up||27
3084615|NCT01402011|3806670|FG001|STARTED|Nine Month Follow-up||20
3084616|NCT01402011|3806671|FG002|STARTED|Nine Month Follow-up||26
3084617|NCT01402011|3806669|FG000|COMPLETED|Nine Month Follow-up||27
3084618|NCT01402011|3806670|FG001|COMPLETED|Nine Month Follow-up||19
3084619|NCT01402011|3806671|FG002|COMPLETED|Nine Month Follow-up||26
3084620|NCT01402011|3806669|FG000|NOT COMPLETED|Nine Month Follow-up||0
3084621|NCT01402011|3806670|FG001|NOT COMPLETED|Nine Month Follow-up||1
3084622|NCT01402011|3806671|FG002|NOT COMPLETED|Nine Month Follow-up||0
3163075|NCT01882764|3890530|FG000|COMPLETED|Overall Study||0
3163076|NCT01882764|3890531|FG001|COMPLETED|Overall Study||1
3287490|NCT02792699|4021173|FG001|COMPLETED|Overall Study||94
3084623|NCT01402050|3806684|FG000|STARTED|Overall Study||185
3084624|NCT01402050|3806685|FG001|STARTED|Overall Study||191
3084625|NCT01402050|3806684|FG000|COMPLETED|Overall Study||185
3084626|NCT01402050|3806685|FG001|COMPLETED|Overall Study||191
3084627|NCT01402050|3806684|FG000|NOT COMPLETED|Overall Study||0
3084628|NCT01402050|3806685|FG001|NOT COMPLETED|Overall Study||0
3084629|NCT01402063|3806693|FG000|STARTED|Overall Study||42
3084630|NCT01402063|3806694|FG001|STARTED|Overall Study||21
3084631|NCT01402063|3806693|FG000|COMPLETED|Overall Study||39
3084632|NCT01402063|3806694|FG001|COMPLETED|Overall Study||18
3084633|NCT01402063|3806693|FG000|NOT COMPLETED|Overall Study||3
3084634|NCT01402063|3806694|FG001|NOT COMPLETED|Overall Study||3
3084635|NCT01402102|3806702|FG000|STARTED|Overall Study||30
3084636|NCT01402102|3806703|FG001|STARTED|Overall Study||30
3084637|NCT01402102|3806702|FG000|COMPLETED|Overall Study||28
3084638|NCT01402102|3806703|FG001|COMPLETED|Overall Study||27
3084639|NCT01402102|3806702|FG000|NOT COMPLETED|Overall Study||2
3084640|NCT01402102|3806703|FG001|NOT COMPLETED|Overall Study||3
3084641|NCT01402115|3806713|FG000|STARTED|Overall Study||30
3084642|NCT01402115|3806714|FG001|STARTED|Overall Study||30
3084643|NCT01402115|3806713|FG000|COMPLETED|Overall Study||29
3084644|NCT01402115|3806714|FG001|COMPLETED|Overall Study||29
3084645|NCT01402115|3806713|FG000|NOT COMPLETED|Overall Study||1
3084646|NCT01402115|3806714|FG001|NOT COMPLETED|Overall Study||1
3084647|NCT01402128|3806722|FG000|STARTED|Overall Study||40
3084648|NCT01402128|3806723|FG001|STARTED|Overall Study||40
3084649|NCT01402128|3806722|FG000|COMPLETED|Overall Study||39
3084650|NCT01402128|3806723|FG001|COMPLETED|Overall Study||40
3084651|NCT01402128|3806722|FG000|NOT COMPLETED|Overall Study||1
3084652|NCT01402128|3806723|FG001|NOT COMPLETED|Overall Study||0
3084653|NCT01402141|3806731|FG000|STARTED|Overall Study||30
3084654|NCT01402141|3806732|FG001|STARTED|Overall Study||30
3084655|NCT01402141|3806731|FG000|COMPLETED|Overall Study||29
3084656|NCT01402141|3806732|FG001|COMPLETED|Overall Study||28
3084657|NCT01402141|3806731|FG000|NOT COMPLETED|Overall Study||1
3084658|NCT01402141|3806732|FG001|NOT COMPLETED|Overall Study||2
3084659|NCT01402284|3806739|FG000|STARTED|Overall Study||45
3084660|NCT01402284|3806739|FG000|COMPLETED|Overall Study||31
3084661|NCT01402284|3806739|FG000|NOT COMPLETED|Overall Study||14
3084662|NCT01402375|3806749|FG000|STARTED|Overall Study||120
3084663|NCT01402375|3806750|FG001|STARTED|Overall Study||120
3084664|NCT01402375|3806751|FG002|STARTED|Overall Study||120
3084665|NCT01402375|3806752|FG003|STARTED|Overall Study||120
3084666|NCT01402375|3806753|FG004|STARTED|Overall Study||120
3084667|NCT01402375|3806754|FG005|STARTED|Overall Study||120
3084668|NCT01402375|3806749|FG000|COMPLETED|Overall Study||120
3084669|NCT01402375|3806750|FG001|COMPLETED|Overall Study||120
3084670|NCT01402375|3806751|FG002|COMPLETED|Overall Study||120
3084671|NCT01402375|3806752|FG003|COMPLETED|Overall Study||120
3084672|NCT01402375|3806753|FG004|COMPLETED|Overall Study||120
3084673|NCT01402375|3806754|FG005|COMPLETED|Overall Study||120
3084674|NCT01402375|3806749|FG000|NOT COMPLETED|Overall Study||0
3084675|NCT01402375|3806750|FG001|NOT COMPLETED|Overall Study||0
3084676|NCT01402375|3806751|FG002|NOT COMPLETED|Overall Study||0
3084677|NCT01402375|3806752|FG003|NOT COMPLETED|Overall Study||0
3084678|NCT01402375|3806753|FG004|NOT COMPLETED|Overall Study||0
3084679|NCT01402375|3806754|FG005|NOT COMPLETED|Overall Study||0
3084680|NCT01402427|3806770|FG000|STARTED|Overall Study||297
3084681|NCT01402427|3806771|FG001|STARTED|Overall Study||294
3084682|NCT01402427|3806770|FG000|COMPLETED|Overall Study||297
3084683|NCT01402427|3806771|FG001|COMPLETED|Overall Study||294
3084684|NCT01402427|3806770|FG000|NOT COMPLETED|Overall Study||0
3084685|NCT01402427|3806771|FG001|NOT COMPLETED|Overall Study||0
3084686|NCT01402492|3806780|FG000|STARTED|Overall Study||100
3084687|NCT01402492|3806781|FG001|STARTED|Overall Study||100
3084688|NCT01402492|3806782|FG002|STARTED|Overall Study||102
3084689|NCT01402492|3806780|FG000|COMPLETED|Overall Study||79
3084690|NCT01402492|3806781|FG001|COMPLETED|Overall Study||83
3084691|NCT01402492|3806782|FG002|COMPLETED|Overall Study||86
3084692|NCT01402492|3806780|FG000|NOT COMPLETED|Overall Study||21
3084693|NCT01402492|3806781|FG001|NOT COMPLETED|Overall Study||17
3084694|NCT01402492|3806782|FG002|NOT COMPLETED|Overall Study||16
3084695|NCT01402544|3806790|FG000|STARTED|Overall Study||12
3084696|NCT01402544|3806790|FG000|COMPLETED|Overall Study||6
3084697|NCT01402544|3806790|FG000|NOT COMPLETED|Overall Study||6
3084698|NCT01402570|3806794|FG000|STARTED|Overall Study||20
3084699|NCT01402570|3806794|FG000|COMPLETED|Overall Study||19
3084700|NCT01402570|3806794|FG000|NOT COMPLETED|Overall Study||1
3084701|NCT01402700|3806799|FG000|STARTED|Overall Study||75
3084702|NCT01402700|3806799|FG000|COMPLETED|Overall Study||68
3084703|NCT01402700|3806799|FG000|NOT COMPLETED|Overall Study||7
3084704|NCT01402817|3806803|FG000|STARTED|Overall Study||19
3084705|NCT01402817|3806803|FG000|COMPLETED|Overall Study||8
3084706|NCT01402817|3806803|FG000|NOT COMPLETED|Overall Study||11
3084707|NCT01402869|3806811|FG000|STARTED|Overall Study||30
3084708|NCT01402869|3806812|FG001|STARTED|Overall Study||30
3084709|NCT01402869|3806813|FG002|STARTED|Overall Study||31
3084710|NCT01402869|3806811|FG000|COMPLETED|Overall Study||30
3084711|NCT01402869|3806812|FG001|COMPLETED|Overall Study||30
3084712|NCT01402869|3806813|FG002|COMPLETED|Overall Study||30
3084713|NCT01402869|3806811|FG000|NOT COMPLETED|Overall Study||0
3084714|NCT01402869|3806812|FG001|NOT COMPLETED|Overall Study||0
3084715|NCT01402869|3806813|FG002|NOT COMPLETED|Overall Study||1
3084716|NCT01402908|3806823|FG000|STARTED|Overall Study||258
3084717|NCT01402908|3806824|FG001|STARTED|Overall Study||261
3084718|NCT01402908|3806823|FG000|COMPLETED|Overall Study||224
3084719|NCT01402908|3806824|FG001|COMPLETED|Overall Study||243
3084720|NCT01402908|3806823|FG000|NOT COMPLETED|Overall Study||34
3084721|NCT01402908|3806824|FG001|NOT COMPLETED|Overall Study||18
3084722|NCT01402947|3806832|FG000|STARTED|First Intervention||15
3084723|NCT01402947|3806833|FG001|STARTED|First Intervention||15
3084724|NCT01402947|3806832|FG000|COMPLETED|First Intervention||15
3084725|NCT01402947|3806833|FG001|COMPLETED|First Intervention||14
3084726|NCT01402947|3806832|FG000|NOT COMPLETED|First Intervention||0
3084727|NCT01402947|3806833|FG001|NOT COMPLETED|First Intervention||1
3084728|NCT01402947|3806832|FG000|STARTED|Second Intervention||15
3084729|NCT01402947|3806833|FG001|STARTED|Second Intervention||14
3084730|NCT01402947|3806832|FG000|COMPLETED|Second Intervention||15
3084731|NCT01402947|3806833|FG001|COMPLETED|Second Intervention||14
3084732|NCT01402947|3806832|FG000|NOT COMPLETED|Second Intervention||0
3084733|NCT01402947|3806833|FG001|NOT COMPLETED|Second Intervention||0
3084734|NCT01402986|3806843|FG000|STARTED|Overall Study||76
3084735|NCT01402986|3806844|FG001|STARTED|Overall Study||150
3084736|NCT01402986|3806845|FG002|STARTED|Overall Study||75
3084737|NCT01402986|3806846|FG003|STARTED|Overall Study||151
3084738|NCT01402986|3806843|FG000|COMPLETED|Overall Study||67
3084739|NCT01402986|3806844|FG001|COMPLETED|Overall Study||135
3084740|NCT01402986|3806845|FG002|COMPLETED|Overall Study||67
3084741|NCT01402986|3806846|FG003|COMPLETED|Overall Study||129
3084742|NCT01402986|3806843|FG000|NOT COMPLETED|Overall Study||9
3084743|NCT01402986|3806844|FG001|NOT COMPLETED|Overall Study||15
3084744|NCT01402986|3806845|FG002|NOT COMPLETED|Overall Study||8
3084745|NCT01402986|3806846|FG003|NOT COMPLETED|Overall Study||22
3084746|NCT01403051|3806858|FG000|STARTED|Overall Study||81
3084747|NCT01403051|3806859|FG001|STARTED|Overall Study||86
3084748|NCT01403051|3806858|FG000|Initiated Study Treatment|Overall Study||81
3084749|NCT01403051|3806859|FG001|Initiated Study Treatment|Overall Study||86
3084750|NCT01403051|3806858|FG000|COMPLETED|Overall Study||71
3084751|NCT01403051|3806859|FG001|COMPLETED|Overall Study||80
3084752|NCT01403051|3806858|FG000|NOT COMPLETED|Overall Study||10
3084753|NCT01403051|3806859|FG001|NOT COMPLETED|Overall Study||6
3084754|NCT01403064|3806870|FG000|STARTED|Overall Study||24
3084755|NCT01403064|3806871|FG001|STARTED|Overall Study||7
3084756|NCT01403064|3806872|FG002|STARTED|Overall Study||23
3084757|NCT01403064|3806873|FG003|STARTED|Overall Study||22
3084758|NCT01403064|3806870|FG000|COMPLETED|Overall Study||23
3084759|NCT01403064|3806871|FG001|COMPLETED|Overall Study||7
3084760|NCT01403064|3806872|FG002|COMPLETED|Overall Study||19
3084761|NCT01403064|3806873|FG003|COMPLETED|Overall Study||19
3084762|NCT01403064|3806870|FG000|NOT COMPLETED|Overall Study||1
3084763|NCT01403064|3806871|FG001|NOT COMPLETED|Overall Study||0
3084764|NCT01403064|3806872|FG002|NOT COMPLETED|Overall Study||4
3084765|NCT01403064|3806873|FG003|NOT COMPLETED|Overall Study||3
3084766|NCT01403090|3806888|FG000|STARTED|Overall Study||8
3084767|NCT01403090|3806888|FG000|COMPLETED|Overall Study||8
3084768|NCT01403090|3806888|FG000|NOT COMPLETED|Overall Study||0
3084769|NCT01403116|3806894|FG000|STARTED|Overall Study||161
3084770|NCT01403116|3806895|FG001|STARTED|Overall Study||160
3084771|NCT01403116|3806894|FG000|Randomized|Overall Study||162
3084772|NCT01403116|3806895|FG001|Randomized|Overall Study||163
3084773|NCT01403116|3806894|FG000|Randomized in Error/ No Treatment Recvd|Overall Study||1
3084774|NCT01403116|3806895|FG001|Randomized in Error/ No Treatment Recvd|Overall Study||3
3084775|NCT01403116|3806894|FG000|COMPLETED|Overall Study||129
3084776|NCT01403116|3806895|FG001|COMPLETED|Overall Study||133
3084777|NCT01403116|3806894|FG000|NOT COMPLETED|Overall Study||32
3084778|NCT01403116|3806895|FG001|NOT COMPLETED|Overall Study||27
3084779|NCT01403246|3806901|FG000|STARTED|Overall Study||9
3084780|NCT01403246|3806901|FG000|COMPLETED|Overall Study||9
3084781|NCT01403246|3806901|FG000|NOT COMPLETED|Overall Study||0
3084782|NCT01403376|3806908|FG000|STARTED|Overall Study||41
3084783|NCT01403376|3806909|FG001|STARTED|Overall Study||41
3084784|NCT01403376|3806910|FG002|STARTED|Overall Study||46
3084785|NCT01403376|3806908|FG000|COMPLETED|Overall Study||41
3084786|NCT01403376|3806909|FG001|COMPLETED|Overall Study||41
3084787|NCT01403376|3806910|FG002|COMPLETED|Overall Study||46
3084788|NCT01403376|3806908|FG000|NOT COMPLETED|Overall Study||0
3084789|NCT01403376|3806909|FG001|NOT COMPLETED|Overall Study||0
3084790|NCT01403376|3806910|FG002|NOT COMPLETED|Overall Study||0
3084791|NCT01403441|3806918|FG000|STARTED|Overall Study||3
3084792|NCT01403441|3806918|FG000|COMPLETED|Overall Study||3
3084793|NCT01403441|3806918|FG000|NOT COMPLETED|Overall Study||0
3084794|NCT01403584|3806924|FG000|STARTED|First Intervention (1 Night)||11
3084795|NCT01403584|3806925|FG001|STARTED|First Intervention (1 Night)||10
3084796|NCT01403584|3806924|FG000|COMPLETED|First Intervention (1 Night)||11
3084797|NCT01403584|3806925|FG001|COMPLETED|First Intervention (1 Night)||10
3084798|NCT01403584|3806924|FG000|NOT COMPLETED|First Intervention (1 Night)||0
3084799|NCT01403584|3806925|FG001|NOT COMPLETED|First Intervention (1 Night)||0
3084800|NCT01403584|3806924|FG000|STARTED|Second Intervention(1 Night)||10
3084801|NCT01403584|3806925|FG001|STARTED|Second Intervention(1 Night)||11
3084802|NCT01403584|3806924|FG000|COMPLETED|Second Intervention(1 Night)||10
3084803|NCT01403584|3806925|FG001|COMPLETED|Second Intervention(1 Night)||11
3084804|NCT01403584|3806924|FG000|NOT COMPLETED|Second Intervention(1 Night)||0
3084805|NCT01403584|3806925|FG001|NOT COMPLETED|Second Intervention(1 Night)||0
3084806|NCT01403610|3806935|FG000|STARTED|Overall Study||5
3084807|NCT01403610|3806936|FG001|STARTED|Overall Study||6
3084808|NCT01403610|3806937|FG002|STARTED|Overall Study||4
3084809|NCT01403610|3806938|FG003|STARTED|Overall Study||13
3084810|NCT01403610|3806935|FG000|COMPLETED|Overall Study||3
3084811|NCT01403610|3806936|FG001|COMPLETED|Overall Study||3
3084812|NCT01403610|3806937|FG002|COMPLETED|Overall Study||4
3084813|NCT01403610|3806938|FG003|COMPLETED|Overall Study||13
3084814|NCT01403610|3806935|FG000|NOT COMPLETED|Overall Study||2
3084815|NCT01403610|3806936|FG001|NOT COMPLETED|Overall Study||3
3084816|NCT01403610|3806937|FG002|NOT COMPLETED|Overall Study||0
3084817|NCT01403610|3806938|FG003|NOT COMPLETED|Overall Study||0
3084818|NCT01403805|3806950|FG000|STARTED|Overall Study||94
3084819|NCT01403805|3806951|FG001|STARTED|Overall Study||105
3084820|NCT01403805|3806950|FG000|Pneumonia Diagnosis|Overall Study||21
3084821|NCT01403805|3806951|FG001|Pneumonia Diagnosis|Overall Study||2
3084822|NCT01403805|3806950|FG000|COMPLETED|Overall Study||94
3084823|NCT01403805|3806951|FG001|COMPLETED|Overall Study||98
3084824|NCT01403805|3806950|FG000|NOT COMPLETED|Overall Study||0
3084825|NCT01403805|3806951|FG001|NOT COMPLETED|Overall Study||7
3084826|NCT01403987|3806964|FG000|STARTED|Overall Study||34
3084827|NCT01403987|3806965|FG001|STARTED|Overall Study||34
3084828|NCT01403987|3806966|FG002|STARTED|Overall Study||68
3084829|NCT01403987|3806964|FG000|COMPLETED|Overall Study||16
3084830|NCT01403987|3806965|FG001|COMPLETED|Overall Study||17
3084831|NCT01403987|3806966|FG002|COMPLETED|Overall Study||50
3084832|NCT01403987|3806964|FG000|NOT COMPLETED|Overall Study||18
3084833|NCT01403987|3806965|FG001|NOT COMPLETED|Overall Study||17
3084834|NCT01403987|3806966|FG002|NOT COMPLETED|Overall Study||18
3084835|NCT01404039|3806983|FG000|STARTED|Overall Study||5
3084836|NCT01404039|3806984|FG001|STARTED|Overall Study||5
3084837|NCT01404039|3806985|FG002|STARTED|Overall Study||5
3084838|NCT01404039|3806986|FG003|STARTED|Overall Study||10
3084839|NCT01404039|3806987|FG004|STARTED|Overall Study||10
3084840|NCT01404039|3806988|FG005|STARTED|Overall Study||10
3084841|NCT01404039|3806989|FG006|STARTED|Overall Study||10
3084842|NCT01404039|3806990|FG007|STARTED|Overall Study||15
3163077|NCT01882764|3890530|FG000|NOT COMPLETED|Overall Study||47
3163078|NCT01882764|3890531|FG001|NOT COMPLETED|Overall Study||18
3163079|NCT01882803|3890537|FG000|STARTED|Overall Study||129
3163080|NCT01882803|3890537|FG000|COMPLETED|Overall Study|Subject received treatment in 28-day cycles until disease progression or unacceptable toxicity.|35
3163081|NCT01882803|3890537|FG000|NOT COMPLETED|Overall Study||94
3163082|NCT01882829|3890542|FG000|STARTED|Overall Study||20
3287491|NCT02792699|4021174|FG002|COMPLETED|Overall Study||93
3287492|NCT02792699|4021172|FG000|NOT COMPLETED|Overall Study||9
3287493|NCT02792699|4021173|FG001|NOT COMPLETED|Overall Study||10
3287494|NCT02792699|4021174|FG002|NOT COMPLETED|Overall Study||10
3287495|NCT02792777|4021191|FG000|STARTED|Overall Study||96
3287496|NCT02792777|4021192|FG001|STARTED|Overall Study||52
3287497|NCT02792777|4021191|FG000|COMPLETED|Overall Study||89
3287498|NCT02792777|4021192|FG001|COMPLETED|Overall Study||52
3287499|NCT02792777|4021191|FG000|NOT COMPLETED|Overall Study||7
3084843|NCT01404039|3806991|FG008|STARTED|Overall Study||15
3084844|NCT01404039|3806992|FG009|STARTED|Overall Study||15
3084845|NCT01404039|3806993|FG010|STARTED|Overall Study||15
3084846|NCT01404039|3806994|FG011|STARTED|Overall Study||0
3084847|NCT01404039|3806995|FG012|STARTED|Overall Study||0
3084848|NCT01404039|3806983|FG000|COMPLETED|Overall Study||4
3084849|NCT01404039|3806984|FG001|COMPLETED|Overall Study||5
3084850|NCT01404039|3806985|FG002|COMPLETED|Overall Study||5
3084851|NCT01404039|3806986|FG003|COMPLETED|Overall Study||10
3084852|NCT01404039|3806987|FG004|COMPLETED|Overall Study||10
3084853|NCT01404039|3806988|FG005|COMPLETED|Overall Study||10
3084854|NCT01404039|3806989|FG006|COMPLETED|Overall Study||10
3084855|NCT01404039|3806990|FG007|COMPLETED|Overall Study||15
3084856|NCT01404039|3806991|FG008|COMPLETED|Overall Study||15
3084857|NCT01404039|3806992|FG009|COMPLETED|Overall Study||14
3084858|NCT01404039|3806993|FG010|COMPLETED|Overall Study||14
3084859|NCT01404039|3806994|FG011|COMPLETED|Overall Study||0
3084860|NCT01404039|3806995|FG012|COMPLETED|Overall Study||0
3084861|NCT01404039|3806983|FG000|NOT COMPLETED|Overall Study||1
3084862|NCT01404039|3806984|FG001|NOT COMPLETED|Overall Study||0
3084863|NCT01404039|3806985|FG002|NOT COMPLETED|Overall Study||0
3084864|NCT01404039|3806986|FG003|NOT COMPLETED|Overall Study||0
3084865|NCT01404039|3806987|FG004|NOT COMPLETED|Overall Study||0
3287500|NCT02792777|4021192|FG001|NOT COMPLETED|Overall Study||0
3287501|NCT02792829|4021207|FG000|STARTED|Treatment Period 1||10
3084866|NCT01404039|3806988|FG005|NOT COMPLETED|Overall Study||0
3084867|NCT01404039|3806989|FG006|NOT COMPLETED|Overall Study||0
3084868|NCT01404039|3806990|FG007|NOT COMPLETED|Overall Study||0
3084869|NCT01404039|3806991|FG008|NOT COMPLETED|Overall Study||0
3084870|NCT01404039|3806992|FG009|NOT COMPLETED|Overall Study||1
3084871|NCT01404039|3806993|FG010|NOT COMPLETED|Overall Study||1
3084872|NCT01404039|3806994|FG011|NOT COMPLETED|Overall Study||0
3084873|NCT01404039|3806995|FG012|NOT COMPLETED|Overall Study||0
3084874|NCT01404078|3807021|FG000|STARTED|Overall Study|725 Started on Phase 1 run in low dose polycap 645 started on phase 2 run in full dose polycap|261
3084875|NCT01404078|3807022|FG001|STARTED|Overall Study|725 Started on Phase 1 run in low dose polycap 645 started on phase 2 run in full dose polycap|257
3084876|NCT01404078|3807021|FG000|COMPLETED|Overall Study||243
3287502|NCT02792829|4021208|FG001|STARTED|Treatment Period 1||10
3287503|NCT02792829|4021209|FG002|STARTED|Treatment Period 1||5
3084877|NCT01404078|3807022|FG001|COMPLETED|Overall Study||237
3084878|NCT01404078|3807021|FG000|NOT COMPLETED|Overall Study||18
3084879|NCT01404078|3807022|FG001|NOT COMPLETED|Overall Study||20
3084880|NCT01404208|3807030|FG000|STARTED|Overall Study||70
3084881|NCT01404208|3807031|FG001|STARTED|Overall Study||72
3084882|NCT01404208|3807030|FG000|COMPLETED|Overall Study||67
3084883|NCT01404208|3807031|FG001|COMPLETED|Overall Study||72
3084884|NCT01404208|3807030|FG000|NOT COMPLETED|Overall Study||3
3084885|NCT01404208|3807031|FG001|NOT COMPLETED|Overall Study||0
3084886|NCT01404234|3807037|FG000|STARTED|Overall Study||61
3084887|NCT01404234|3807037|FG000|COMPLETED|Overall Study||59
3084888|NCT01404234|3807037|FG000|NOT COMPLETED|Overall Study||2
3084889|NCT01404260|3807043|FG000|STARTED|Overall Study||109
3084890|NCT01404260|3807044|FG001|STARTED|Overall Study||110
3084891|NCT01404260|3807043|FG000|COMPLETED|Overall Study||106
3084892|NCT01404260|3807044|FG001|COMPLETED|Overall Study||101
3084893|NCT01404260|3807043|FG000|NOT COMPLETED|Overall Study||3
3084894|NCT01404260|3807044|FG001|NOT COMPLETED|Overall Study||9
3084895|NCT01404325|3807052|FG000|STARTED|Overall Study||67
3084896|NCT01404325|3807053|FG001|STARTED|Overall Study||63
3084897|NCT01404325|3807052|FG000|COMPLETED|Overall Study||63
3084898|NCT01404325|3807053|FG001|COMPLETED|Overall Study||61
3084899|NCT01404325|3807052|FG000|NOT COMPLETED|Overall Study||4
3084900|NCT01404325|3807053|FG001|NOT COMPLETED|Overall Study||2
3084901|NCT01404429|3807061|FG000|STARTED|Overall Study||47
3084902|NCT01404429|3807062|FG001|STARTED|Overall Study||53
3084903|NCT01404429|3807061|FG000|COMPLETED|Overall Study||38
3084904|NCT01404429|3807062|FG001|COMPLETED|Overall Study||46
3084905|NCT01404429|3807061|FG000|NOT COMPLETED|Overall Study||9
3084906|NCT01404429|3807062|FG001|NOT COMPLETED|Overall Study||7
3084907|NCT01404559|3807072|FG000|STARTED|Overall Study||5
3084908|NCT01404559|3807073|FG001|STARTED|Overall Study||5
3084909|NCT01404559|3807074|FG002|STARTED|Overall Study||4
3084910|NCT01404559|3807075|FG003|STARTED|Overall Study||14
3084911|NCT01404559|3807072|FG000|COMPLETED|Overall Study||5
3084912|NCT01404559|3807073|FG001|COMPLETED|Overall Study||5
3084913|NCT01404559|3807074|FG002|COMPLETED|Overall Study||4
3084914|NCT01404559|3807075|FG003|COMPLETED|Overall Study||14
3084915|NCT01404559|3807072|FG000|NOT COMPLETED|Overall Study||0
3084916|NCT01404559|3807073|FG001|NOT COMPLETED|Overall Study||0
3084917|NCT01404559|3807074|FG002|NOT COMPLETED|Overall Study||0
3084918|NCT01404559|3807075|FG003|NOT COMPLETED|Overall Study||0
3084919|NCT01404572|3807082|FG000|STARTED|Overall Study||4
3084920|NCT01404572|3807083|FG001|STARTED|Overall Study||4
3084921|NCT01404572|3807084|FG002|STARTED|Overall Study||4
3084922|NCT01404572|3807082|FG000|COMPLETED|Overall Study||4
3084923|NCT01404572|3807083|FG001|COMPLETED|Overall Study||4
3084924|NCT01404572|3807084|FG002|COMPLETED|Overall Study||4
3084925|NCT01404572|3807082|FG000|NOT COMPLETED|Overall Study||0
3084926|NCT01404572|3807083|FG001|NOT COMPLETED|Overall Study||0
3084927|NCT01404572|3807084|FG002|NOT COMPLETED|Overall Study||0
3084928|NCT01404611|3807098|FG000|STARTED|Overall Study||112
3084929|NCT01404611|3807099|FG001|STARTED|Overall Study||108
3084930|NCT01404611|3807100|FG002|STARTED|Overall Study||111
3084931|NCT01404611|3807098|FG000|COMPLETED|Overall Study||104
3084932|NCT01404611|3807099|FG001|COMPLETED|Overall Study||89
3084933|NCT01404611|3807100|FG002|COMPLETED|Overall Study||106
3084934|NCT01404611|3807098|FG000|NOT COMPLETED|Overall Study||8
3084935|NCT01404611|3807099|FG001|NOT COMPLETED|Overall Study||19
3084936|NCT01404611|3807100|FG002|NOT COMPLETED|Overall Study||5
3084937|NCT01404650|3807108|FG000|STARTED|Overall Study|Twenty-five patients received a median of 2 cycles of AUY922.|25
3084938|NCT01404650|3807108|FG000|COMPLETED|Overall Study||25
3084939|NCT01404650|3807108|FG000|NOT COMPLETED|Overall Study||0
3084940|NCT01404832|3807112|FG000|STARTED|Overall Study||21
3084941|NCT01404832|3807112|FG000|COMPLETED|Overall Study||21
3084942|NCT01404832|3807112|FG000|NOT COMPLETED|Overall Study||0
3084943|NCT01404923|3807118|FG000|STARTED|Overall Study||222
3084944|NCT01404923|3807119|FG001|STARTED|Overall Study||214
3084945|NCT01404923|3807118|FG000|COMPLETED|Overall Study||199
3084946|NCT01404923|3807119|FG001|COMPLETED|Overall Study||197
3084947|NCT01404923|3807118|FG000|NOT COMPLETED|Overall Study||23
3084948|NCT01404923|3807119|FG001|NOT COMPLETED|Overall Study||17
3084949|NCT01404936|3807125|FG000|STARTED|Overall Study||30
3084950|NCT01404936|3807125|FG000|COMPLETED|Overall Study||30
3084951|NCT01404936|3807125|FG000|NOT COMPLETED|Overall Study||0
3084952|NCT01404949|3807129|FG000|STARTED|Overall Study||17
3084953|NCT01404949|3807129|FG000|COMPLETED|Overall Study||16
3084954|NCT01404949|3807129|FG000|NOT COMPLETED|Overall Study||1
3084955|NCT01404988|3807136|FG000|STARTED|Overall Study||33
3084956|NCT01404988|3807137|FG001|STARTED|Overall Study||33
3084957|NCT01404988|3807138|FG002|STARTED|Overall Study||33
3084958|NCT01404988|3807136|FG000|COMPLETED|Overall Study||27
3084959|NCT01404988|3807137|FG001|COMPLETED|Overall Study||29
3084960|NCT01404988|3807138|FG002|COMPLETED|Overall Study||30
3084961|NCT01404988|3807136|FG000|NOT COMPLETED|Overall Study||6
3084962|NCT01404988|3807137|FG001|NOT COMPLETED|Overall Study||4
3084963|NCT01404988|3807138|FG002|NOT COMPLETED|Overall Study||3
3084964|NCT01405027|3807151|FG000|STARTED|Overall Study||84
3084965|NCT01405027|3807152|FG001|STARTED|Overall Study||113
3084966|NCT01405027|3807151|FG000|COMPLETED|Overall Study||52
3084967|NCT01405027|3807152|FG001|COMPLETED|Overall Study||62
3084968|NCT01405027|3807151|FG000|NOT COMPLETED|Overall Study||32
3084969|NCT01405027|3807152|FG001|NOT COMPLETED|Overall Study||51
3084970|NCT01405053|3807162|FG000|STARTED|Overall Study||25
3084971|NCT01405053|3807163|FG001|STARTED|Overall Study||12
3084972|NCT01405053|3807162|FG000|COMPLETED|Overall Study||15
3084973|NCT01405053|3807163|FG001|COMPLETED|Overall Study||4
3084974|NCT01405053|3807162|FG000|NOT COMPLETED|Overall Study||10
3084975|NCT01405053|3807163|FG001|NOT COMPLETED|Overall Study||8
3084976|NCT01405196|3807173|FG000|STARTED|Overall Study||45
3084977|NCT01405196|3807174|FG001|STARTED|Overall Study||47
3084978|NCT01405196|3807175|FG002|STARTED|Overall Study||46
3084979|NCT01405196|3807176|FG003|STARTED|Overall Study||45
3084980|NCT01405196|3807173|FG000|COMPLETED|Overall Study||34
3084981|NCT01405196|3807174|FG001|COMPLETED|Overall Study||35
3084982|NCT01405196|3807175|FG002|COMPLETED|Overall Study||23
3084983|NCT01405196|3807176|FG003|COMPLETED|Overall Study||36
3084984|NCT01405196|3807173|FG000|NOT COMPLETED|Overall Study||11
3084985|NCT01405196|3807174|FG001|NOT COMPLETED|Overall Study||12
3084986|NCT01405196|3807175|FG002|NOT COMPLETED|Overall Study||23
3084987|NCT01405196|3807176|FG003|NOT COMPLETED|Overall Study||9
3084988|NCT01405313|3807187|FG000|STARTED|Overall Study||21
3084989|NCT01405313|3807187|FG000|COMPLETED|Overall Study||21
3084990|NCT01405313|3807187|FG000|NOT COMPLETED|Overall Study||0
3084991|NCT01405456|3807197|FG000|STARTED|Overall Study||25
3084992|NCT01405456|3807198|FG001|STARTED|Overall Study||21
3084993|NCT01405456|3807197|FG000|COMPLETED|Overall Study||22
3084994|NCT01405456|3807198|FG001|COMPLETED|Overall Study||20
3084995|NCT01405456|3807197|FG000|NOT COMPLETED|Overall Study||3
3084996|NCT01405456|3807198|FG001|NOT COMPLETED|Overall Study||1
3084997|NCT01405469|3807204|FG000|STARTED|Overall Study||16
3084998|NCT01405469|3807204|FG000|COMPLETED|Overall Study||16
3084999|NCT01405469|3807204|FG000|NOT COMPLETED|Overall Study||0
3085000|NCT01405508|3807213|FG000|STARTED|Overall Study||26
3085001|NCT01405508|3807214|FG001|STARTED|Overall Study||26
3085002|NCT01405508|3807215|FG002|STARTED|Overall Study||27
3085003|NCT01405508|3807216|FG003|STARTED|Overall Study||26
3085004|NCT01405508|3807213|FG000|COMPLETED|Overall Study||25
3085005|NCT01405508|3807214|FG001|COMPLETED|Overall Study||25
3085006|NCT01405508|3807215|FG002|COMPLETED|Overall Study||27
3085007|NCT01405508|3807216|FG003|COMPLETED|Overall Study||26
3085008|NCT01405508|3807213|FG000|NOT COMPLETED|Overall Study||1
3085009|NCT01405508|3807214|FG001|NOT COMPLETED|Overall Study||1
3085010|NCT01405508|3807215|FG002|NOT COMPLETED|Overall Study||0
3085011|NCT01405508|3807216|FG003|NOT COMPLETED|Overall Study||0
3085012|NCT01405560|3807226|FG000|STARTED|Overall Study||42
3085013|NCT01405560|3807226|FG000|COMPLETED|Overall Study||41
3085014|NCT01405560|3807226|FG000|NOT COMPLETED|Overall Study||1
3085015|NCT01405742|3807230|FG000|STARTED|Overall Study||2
3085016|NCT01405742|3807231|FG001|STARTED|Overall Study||2
3085017|NCT01405742|3807230|FG000|COMPLETED|Overall Study||1
3085018|NCT01405742|3807231|FG001|COMPLETED|Overall Study||2
3085019|NCT01405742|3807230|FG000|NOT COMPLETED|Overall Study||1
3085020|NCT01405742|3807231|FG001|NOT COMPLETED|Overall Study||0
3085021|NCT01405768|3807239|FG000|STARTED|Overall Study||28
3085022|NCT01405768|3807240|FG001|STARTED|Overall Study||28
3085023|NCT01405768|3807239|FG000|COMPLETED|Overall Study||24
3085024|NCT01405768|3807240|FG001|COMPLETED|Overall Study||28
3085025|NCT01405768|3807239|FG000|NOT COMPLETED|Overall Study||4
3085026|NCT01405768|3807240|FG001|NOT COMPLETED|Overall Study||0
3085027|NCT01405794|3807246|FG000|STARTED|First Dose Placebo (14 Days)||12
3085028|NCT01405794|3807246|FG000|COMPLETED|First Dose Placebo (14 Days)||12
3085029|NCT01405794|3807246|FG000|NOT COMPLETED|First Dose Placebo (14 Days)||0
3085030|NCT01405794|3807246|FG000|STARTED|72 hr Washout||12
3085031|NCT01405794|3807246|FG000|COMPLETED|72 hr Washout||12
3085032|NCT01405794|3807246|FG000|NOT COMPLETED|72 hr Washout||0
3085033|NCT01405794|3807246|FG000|STARTED|Second Dose 32ppm Oral Silver (14 Days)||12
3085034|NCT01405794|3807246|FG000|COMPLETED|Second Dose 32ppm Oral Silver (14 Days)||12
3085035|NCT01405794|3807246|FG000|NOT COMPLETED|Second Dose 32ppm Oral Silver (14 Days)||0
3085036|NCT01405820|3807258|FG000|STARTED|Randomized Treatment Period||54
3085037|NCT01405820|3807259|FG001|STARTED|Randomized Treatment Period||45
3085038|NCT01405820|3807260|FG002|STARTED|Randomized Treatment Period||52
3085039|NCT01405820|3807261|FG003|STARTED|Randomized Treatment Period||54
3085040|NCT01405820|3807262|FG004|STARTED|Randomized Treatment Period||47
3085041|NCT01405820|3807263|FG005|STARTED|Randomized Treatment Period||38
3085042|NCT01405820|3807258|FG000|Safety Population|Randomized Treatment Period||54
3085043|NCT01405820|3807259|FG001|Safety Population|Randomized Treatment Period||45
3085044|NCT01405820|3807260|FG002|Safety Population|Randomized Treatment Period||52
3085045|NCT01405820|3807261|FG003|Safety Population|Randomized Treatment Period|1 participant did not receive any study medication.|53
3085046|NCT01405820|3807262|FG004|Safety Population|Randomized Treatment Period||47
3085047|NCT01405820|3807263|FG005|Safety Population|Randomized Treatment Period||38
3085048|NCT01405820|3807258|FG000|COMPLETED|Randomized Treatment Period||43
3085049|NCT01405820|3807259|FG001|COMPLETED|Randomized Treatment Period||35
3085050|NCT01405820|3807260|FG002|COMPLETED|Randomized Treatment Period||9
3085051|NCT01405820|3807261|FG003|COMPLETED|Randomized Treatment Period||3
3085052|NCT01405820|3807262|FG004|COMPLETED|Randomized Treatment Period||2
3085053|NCT01405820|3807263|FG005|COMPLETED|Randomized Treatment Period||1
3085054|NCT01405820|3807258|FG000|NOT COMPLETED|Randomized Treatment Period||11
3085055|NCT01405820|3807259|FG001|NOT COMPLETED|Randomized Treatment Period||10
3085056|NCT01405820|3807260|FG002|NOT COMPLETED|Randomized Treatment Period||43
3085057|NCT01405820|3807261|FG003|NOT COMPLETED|Randomized Treatment Period||51
3085058|NCT01405820|3807262|FG004|NOT COMPLETED|Randomized Treatment Period||45
3085059|NCT01405820|3807263|FG005|NOT COMPLETED|Randomized Treatment Period||37
3085060|NCT01405820|3807258|FG000|STARTED|Open-Label Treatment Period|1 participant discontinued randomized period due to an adverse event but entered open-label period.|44
3085061|NCT01405820|3807259|FG001|STARTED|Open-Label Treatment Period||35
3085062|NCT01405820|3807260|FG002|STARTED|Open-Label Treatment Period||42
3085063|NCT01405820|3807261|FG003|STARTED|Open-Label Treatment Period||42
3085064|NCT01405820|3807262|FG004|STARTED|Open-Label Treatment Period||42
3085065|NCT01405820|3807263|FG005|STARTED|Open-Label Treatment Period||32
3085066|NCT01405820|3807258|FG000|COMPLETED|Open-Label Treatment Period||40
3085067|NCT01405820|3807259|FG001|COMPLETED|Open-Label Treatment Period||33
3085068|NCT01405820|3807260|FG002|COMPLETED|Open-Label Treatment Period||39
3085069|NCT01405820|3807261|FG003|COMPLETED|Open-Label Treatment Period||37
3085070|NCT01405820|3807262|FG004|COMPLETED|Open-Label Treatment Period||40
3085071|NCT01405820|3807263|FG005|COMPLETED|Open-Label Treatment Period||30
3085072|NCT01405820|3807258|FG000|NOT COMPLETED|Open-Label Treatment Period||4
3085073|NCT01405820|3807259|FG001|NOT COMPLETED|Open-Label Treatment Period||2
3085074|NCT01405820|3807260|FG002|NOT COMPLETED|Open-Label Treatment Period||3
3085075|NCT01405820|3807261|FG003|NOT COMPLETED|Open-Label Treatment Period||5
3085076|NCT01405820|3807262|FG004|NOT COMPLETED|Open-Label Treatment Period||2
3085077|NCT01405820|3807263|FG005|NOT COMPLETED|Open-Label Treatment Period||2
3085078|NCT01405898|3807285|FG000|STARTED|Overall Study||34
3085079|NCT01405898|3807286|FG001|STARTED|Overall Study||34
3085080|NCT01405898|3807285|FG000|COMPLETED|Overall Study||32
3085081|NCT01405898|3807286|FG001|COMPLETED|Overall Study||32
3085082|NCT01405898|3807285|FG000|NOT COMPLETED|Overall Study||2
3085083|NCT01405898|3807286|FG001|NOT COMPLETED|Overall Study||2
3085084|NCT01405911|3807295|FG000|STARTED|Overall Study||83
3085085|NCT01405911|3807296|FG001|STARTED|Overall Study||82
3085086|NCT01405911|3807297|FG002|STARTED|Overall Study||77
3085087|NCT01405911|3807295|FG000|Treated|Overall Study||82
3085088|NCT01405911|3807296|FG001|Treated|Overall Study|1 participant received study drug but was discontinued due to pre-treatment lab AE.|82
3085089|NCT01405911|3807297|FG002|Treated|Overall Study||77
3085090|NCT01405911|3807295|FG000|COMPLETED|Overall Study||79
3085091|NCT01405911|3807296|FG001|COMPLETED|Overall Study||79
3085092|NCT01405911|3807297|FG002|COMPLETED|Overall Study||76
3085093|NCT01405911|3807295|FG000|NOT COMPLETED|Overall Study||4
3085094|NCT01405911|3807296|FG001|NOT COMPLETED|Overall Study||3
3085095|NCT01405911|3807297|FG002|NOT COMPLETED|Overall Study||1
3085096|NCT01405924|3807305|FG000|STARTED|Overall Study||111
3085097|NCT01405924|3807305|FG000|COMPLETED|Overall Study||101
3085098|NCT01405924|3807305|FG000|NOT COMPLETED|Overall Study||10
3085099|NCT01405937|3807313|FG000|STARTED|Overall Study||25
3085100|NCT01405937|3807314|FG001|STARTED|Overall Study||26
3085101|NCT01405937|3807313|FG000|COMPLETED|Overall Study||25
3085102|NCT01405937|3807314|FG001|COMPLETED|Overall Study||26
3085103|NCT01405937|3807313|FG000|NOT COMPLETED|Overall Study||0
3085104|NCT01405937|3807314|FG001|NOT COMPLETED|Overall Study||0
3085105|NCT01405950|3807322|FG000|STARTED|Overall Study||8
3085106|NCT01405950|3807323|FG001|STARTED|Overall Study||2
3085107|NCT01405950|3807324|FG002|STARTED|Overall Study||0
3085108|NCT01405950|3807325|FG003|STARTED|Overall Study||0
3085109|NCT01405950|3807322|FG000|COMPLETED|Overall Study||7
3085110|NCT01405950|3807323|FG001|COMPLETED|Overall Study||2
3085111|NCT01405950|3807324|FG002|COMPLETED|Overall Study||0
3085112|NCT01405950|3807325|FG003|COMPLETED|Overall Study||0
3085113|NCT01405950|3807322|FG000|NOT COMPLETED|Overall Study||1
3085114|NCT01405950|3807323|FG001|NOT COMPLETED|Overall Study||0
3085115|NCT01405950|3807324|FG002|NOT COMPLETED|Overall Study||0
3085116|NCT01405950|3807325|FG003|NOT COMPLETED|Overall Study||0
3085117|NCT01406015|3807335|FG000|STARTED|Overall Study||19
3085118|NCT01406015|3807336|FG001|STARTED|Overall Study||19
3085119|NCT01406015|3807335|FG000|COMPLETED|Overall Study||16
3085120|NCT01406015|3807336|FG001|COMPLETED|Overall Study||16
3085121|NCT01406015|3807335|FG000|NOT COMPLETED|Overall Study||3
3085122|NCT01406015|3807336|FG001|NOT COMPLETED|Overall Study||3
3085123|NCT01406223|3807346|FG000|STARTED|Overall Study||18
3085124|NCT01406223|3807347|FG001|STARTED|Overall Study||19
3085125|NCT01406223|3807348|FG002|STARTED|Overall Study||20
3085126|NCT01406223|3807349|FG003|STARTED|Overall Study||19
3085127|NCT01406223|3807346|FG000|COMPLETED|Overall Study||6
3085128|NCT01406223|3807347|FG001|COMPLETED|Overall Study||7
3085129|NCT01406223|3807348|FG002|COMPLETED|Overall Study||2
3085130|NCT01406223|3807349|FG003|COMPLETED|Overall Study||3
3085131|NCT01406223|3807346|FG000|NOT COMPLETED|Overall Study||12
3085132|NCT01406223|3807347|FG001|NOT COMPLETED|Overall Study||12
3085133|NCT01406223|3807348|FG002|NOT COMPLETED|Overall Study||18
3085134|NCT01406223|3807349|FG003|NOT COMPLETED|Overall Study||16
3085135|NCT01406444|3807362|FG000|STARTED|Overall Study||33
3085136|NCT01406444|3807363|FG001|STARTED|Overall Study||33
3085137|NCT01406444|3807364|FG002|STARTED|Overall Study||16
3085138|NCT01406444|3807362|FG000|COMPLETED|Overall Study||23
3085139|NCT01406444|3807363|FG001|COMPLETED|Overall Study||24
3085140|NCT01406444|3807364|FG002|COMPLETED|Overall Study||14
3085141|NCT01406444|3807362|FG000|NOT COMPLETED|Overall Study||10
3085142|NCT01406444|3807363|FG001|NOT COMPLETED|Overall Study||9
3085143|NCT01406444|3807364|FG002|NOT COMPLETED|Overall Study||2
3085144|NCT01406574|3807372|FG000|STARTED|Overall Study||7
3085145|NCT01406574|3807373|FG001|STARTED|Overall Study||4
3085146|NCT01406574|3807374|FG002|STARTED|Overall Study||7
3085147|NCT01406574|3807375|FG003|STARTED|Overall Study||5
3085148|NCT01406574|3807372|FG000|COMPLETED|Overall Study||6
3085149|NCT01406574|3807373|FG001|COMPLETED|Overall Study||3
3085150|NCT01406574|3807374|FG002|COMPLETED|Overall Study||6
3085151|NCT01406574|3807375|FG003|COMPLETED|Overall Study||1
3085152|NCT01406574|3807372|FG000|NOT COMPLETED|Overall Study||1
3085153|NCT01406574|3807373|FG001|NOT COMPLETED|Overall Study||1
3085154|NCT01406574|3807374|FG002|NOT COMPLETED|Overall Study||1
3085155|NCT01406574|3807375|FG003|NOT COMPLETED|Overall Study||4
3085156|NCT01406652|3807388|FG000|STARTED|Overall Study||109
3085157|NCT01406652|3807389|FG001|STARTED|Overall Study||115
3085158|NCT01406652|3807388|FG000|COMPLETED|Overall Study||89
3085159|NCT01406652|3807389|FG001|COMPLETED|Overall Study||95
3085160|NCT01406652|3807388|FG000|NOT COMPLETED|Overall Study||20
3085161|NCT01406652|3807389|FG001|NOT COMPLETED|Overall Study||20
3085162|NCT01406717|3807399|FG000|STARTED|Overall Study||180
3085163|NCT01406717|3807400|FG001|STARTED|Overall Study||180
3085164|NCT01406717|3807399|FG000|COMPLETED|Overall Study||137
3085165|NCT01406717|3807400|FG001|COMPLETED|Overall Study||149
3085166|NCT01406717|3807399|FG000|NOT COMPLETED|Overall Study||43
3085167|NCT01406717|3807400|FG001|NOT COMPLETED|Overall Study||31
3085168|NCT01406795|3807416|FG000|STARTED|Overall Study||1
3085169|NCT01406795|3807416|FG000|COMPLETED|Overall Study||0
3085170|NCT01406795|3807416|FG000|NOT COMPLETED|Overall Study||1
3085171|NCT01406873|3807422|FG000|STARTED|Overall Study||21
3085172|NCT01406873|3807423|FG001|STARTED|Overall Study||21
3085173|NCT01406873|3807422|FG000|COMPLETED|Overall Study||20
3085174|NCT01406873|3807423|FG001|COMPLETED|Overall Study||20
3085175|NCT01406873|3807422|FG000|NOT COMPLETED|Overall Study||1
3085176|NCT01406873|3807423|FG001|NOT COMPLETED|Overall Study||1
3085177|NCT01406938|3807441|FG000|STARTED|Induction Period||482
3085178|NCT01406938|3807442|FG001|STARTED|Induction Period||484
3085179|NCT01406938|3807443|FG002|STARTED|Induction Period||0
3085180|NCT01406938|3807444|FG003|STARTED|Induction Period||0
3085181|NCT01406938|3807445|FG004|STARTED|Induction Period||0
3085182|NCT01406938|3807446|FG005|STARTED|Induction Period||0
3085183|NCT01406938|3807441|FG000|FAS:Patients Assigned Study Treatment|Induction Period||482
3085184|NCT01406938|3807442|FG001|FAS:Patients Assigned Study Treatment|Induction Period||483
3085185|NCT01406938|3807443|FG002|FAS:Patients Assigned Study Treatment|Induction Period||0
3085186|NCT01406938|3807444|FG003|FAS:Patients Assigned Study Treatment|Induction Period||0
3085187|NCT01406938|3807445|FG004|FAS:Patients Assigned Study Treatment|Induction Period||0
3085188|NCT01406938|3807446|FG005|FAS:Patients Assigned Study Treatment|Induction Period||0
3085189|NCT01406938|3807441|FG000|COMPLETED|Induction Period||464
3085190|NCT01406938|3807442|FG001|COMPLETED|Induction Period||464
3085191|NCT01406938|3807443|FG002|COMPLETED|Induction Period||0
3085192|NCT01406938|3807444|FG003|COMPLETED|Induction Period||0
3085193|NCT01406938|3807445|FG004|COMPLETED|Induction Period||0
3085194|NCT01406938|3807446|FG005|COMPLETED|Induction Period||0
3085195|NCT01406938|3807441|FG000|NOT COMPLETED|Induction Period||18
3085196|NCT01406938|3807442|FG001|NOT COMPLETED|Induction Period||20
3085197|NCT01406938|3807443|FG002|NOT COMPLETED|Induction Period||0
3085198|NCT01406938|3807444|FG003|NOT COMPLETED|Induction Period||0
3085199|NCT01406938|3807445|FG004|NOT COMPLETED|Induction Period||0
3085200|NCT01406938|3807446|FG005|NOT COMPLETED|Induction Period||0
3085201|NCT01406938|3807441|FG000|STARTED|Maintenance Period||0
3085202|NCT01406938|3807442|FG001|STARTED|Maintenance Period||0
3085203|NCT01406938|3807443|FG002|STARTED|Maintenance Period||203
3085204|NCT01406938|3807444|FG003|STARTED|Maintenance Period||217
3085205|NCT01406938|3807445|FG004|STARTED|Maintenance Period||206
3085206|NCT01406938|3807446|FG005|STARTED|Maintenance Period||217
3085207|NCT01406938|3807441|FG000|FAS: Patients Assigned Treatment Drug|Maintenance Period||0
3085208|NCT01406938|3807442|FG001|FAS: Patients Assigned Treatment Drug|Maintenance Period||0
3085209|NCT01406938|3807443|FG002|FAS: Patients Assigned Treatment Drug|Maintenance Period||203
3085210|NCT01406938|3807444|FG003|FAS: Patients Assigned Treatment Drug|Maintenance Period||216
3085211|NCT01406938|3807445|FG004|FAS: Patients Assigned Treatment Drug|Maintenance Period||206
3085212|NCT01406938|3807446|FG005|FAS: Patients Assigned Treatment Drug|Maintenance Period||217
3085213|NCT01406938|3807441|FG000|COMPLETED|Maintenance Period||0
3085214|NCT01406938|3807442|FG001|COMPLETED|Maintenance Period||0
3085215|NCT01406938|3807443|FG002|COMPLETED|Maintenance Period||186
3085216|NCT01406938|3807444|FG003|COMPLETED|Maintenance Period||199
3085217|NCT01406938|3807445|FG004|COMPLETED|Maintenance Period||181
3287504|NCT02792829|4021210|FG003|STARTED|Treatment Period 1||5
3287505|NCT02792829|4021211|FG004|STARTED|Treatment Period 1||5
3085218|NCT01406938|3807446|FG005|COMPLETED|Maintenance Period||201
3085219|NCT01406938|3807441|FG000|NOT COMPLETED|Maintenance Period||0
3085220|NCT01406938|3807442|FG001|NOT COMPLETED|Maintenance Period||0
3085221|NCT01406938|3807443|FG002|NOT COMPLETED|Maintenance Period||17
3085222|NCT01406938|3807444|FG003|NOT COMPLETED|Maintenance Period||18
3085223|NCT01406938|3807445|FG004|NOT COMPLETED|Maintenance Period||25
3085224|NCT01406938|3807446|FG005|NOT COMPLETED|Maintenance Period||16
3085225|NCT01406938|3807441|FG000|STARTED|Follow up||26
3287506|NCT02792829|4021212|FG005|STARTED|Treatment Period 1||5
3287507|NCT02792829|4021213|FG006|STARTED|Treatment Period 1||10
3287508|NCT02792829|4021214|FG007|STARTED|Treatment Period 1||10
3085226|NCT01406938|3807442|FG001|STARTED|Follow up||23
3085227|NCT01406938|3807443|FG002|STARTED|Follow up||40
3085228|NCT01406938|3807444|FG003|STARTED|Follow up||39
3085229|NCT01406938|3807445|FG004|STARTED|Follow up||40
3085230|NCT01406938|3807446|FG005|STARTED|Follow up||35
3085231|NCT01406938|3807441|FG000|COMPLETED|Follow up||18
3085232|NCT01406938|3807442|FG001|COMPLETED|Follow up||18
3085233|NCT01406938|3807443|FG002|COMPLETED|Follow up||32
3085234|NCT01406938|3807444|FG003|COMPLETED|Follow up||36
3085235|NCT01406938|3807445|FG004|COMPLETED|Follow up||31
3085236|NCT01406938|3807446|FG005|COMPLETED|Follow up||32
3085237|NCT01406938|3807441|FG000|NOT COMPLETED|Follow up||8
3085238|NCT01406938|3807442|FG001|NOT COMPLETED|Follow up||5
3085239|NCT01406938|3807443|FG002|NOT COMPLETED|Follow up||8
3085240|NCT01406938|3807444|FG003|NOT COMPLETED|Follow up||3
3085241|NCT01406938|3807445|FG004|NOT COMPLETED|Follow up||9
3085242|NCT01406938|3807446|FG005|NOT COMPLETED|Follow up||3
3085243|NCT01406990|3807466|FG000|STARTED|Overall Study||15
3085244|NCT01406990|3807466|FG000|COMPLETED|Overall Study||15
3085245|NCT01406990|3807466|FG000|NOT COMPLETED|Overall Study||0
3085246|NCT01407068|3807470|FG000|STARTED|Overall Study||60
3085247|NCT01407068|3807470|FG000|COMPLETED|Overall Study||60
3085248|NCT01407068|3807470|FG000|NOT COMPLETED|Overall Study||0
3085249|NCT01407094|3807479|FG000|STARTED|Stage 1|Stage 1 Sertraline (SERT): 34 exited|146
3085250|NCT01407094|3807480|FG001|STARTED|Stage 1|Stage 1 Placebo (PBO): 27 exited.|150
3085251|NCT01407094|3807481|FG002|STARTED|Stage 1|Bupropion (BUP) was used only in Stage 2 for non-responders to SERT.|0
3085252|NCT01407094|3807479|FG000|COMPLETED|Stage 1|One participant completed Stage 1 but did not continue to Stage 2.|112
3085253|NCT01407094|3807480|FG001|COMPLETED|Stage 1|Four participants completed Stage 1 but did not continue to Stage 2.|123
3085254|NCT01407094|3807481|FG002|COMPLETED|Stage 1||0
3085255|NCT01407094|3807479|FG000|NOT COMPLETED|Stage 1||34
3085256|NCT01407094|3807480|FG001|NOT COMPLETED|Stage 1||27
3085257|NCT01407094|3807481|FG002|NOT COMPLETED|Stage 1||0
3085258|NCT01407094|3807479|FG000|STARTED|Stage 2|Stage 2 SERT includes Stage 1 SERT responders (n=61) and Stage 1 PBO non-responders (n=73).|134
3085259|NCT01407094|3807480|FG001|STARTED|Stage 2|Stage 2 PBO includes Stage 1 PBO responders (n=47); 1 early exit (n=46).|46
3085260|NCT01407094|3807481|FG002|STARTED|Stage 2|Stage 2 BUP includes Stage 1 SERT non-responders (n=54); 1 early exit (n=53).|53
3085261|NCT01407094|3807479|FG000|COMPLETED|Stage 2||113
3085262|NCT01407094|3807480|FG001|COMPLETED|Stage 2||35
3085263|NCT01407094|3807481|FG002|COMPLETED|Stage 2||38
3085264|NCT01407094|3807479|FG000|NOT COMPLETED|Stage 2||21
3085265|NCT01407094|3807480|FG001|NOT COMPLETED|Stage 2||11
3085266|NCT01407094|3807481|FG002|NOT COMPLETED|Stage 2||15
3085267|NCT01407107|3807492|FG000|STARTED|Overall Study||7
3085268|NCT01407107|3807493|FG001|STARTED|Overall Study||3
3085269|NCT01407107|3807494|FG002|STARTED|Overall Study||3
3085270|NCT01407107|3807492|FG000|COMPLETED|Overall Study||7
3085271|NCT01407107|3807493|FG001|COMPLETED|Overall Study||3
3085272|NCT01407107|3807494|FG002|COMPLETED|Overall Study||3
3085273|NCT01407107|3807492|FG000|NOT COMPLETED|Overall Study||0
3085274|NCT01407107|3807493|FG001|NOT COMPLETED|Overall Study||0
3085275|NCT01407107|3807494|FG002|NOT COMPLETED|Overall Study||0
3085276|NCT01407276|3807510|FG000|STARTED|Overall Study||6
3085277|NCT01407276|3807511|FG001|STARTED|Overall Study||6
3085278|NCT01407276|3807512|FG002|STARTED|Overall Study||6
3085279|NCT01407276|3807513|FG003|STARTED|Overall Study||6
3085280|NCT01407276|3807514|FG004|STARTED|Overall Study||6
3085281|NCT01407276|3807515|FG005|STARTED|Overall Study||6
3085282|NCT01407276|3807516|FG006|STARTED|Overall Study||6
3085283|NCT01407276|3807517|FG007|STARTED|Overall Study||7
3085284|NCT01407276|3807510|FG000|COMPLETED|Overall Study||6
3085285|NCT01407276|3807511|FG001|COMPLETED|Overall Study||6
3085286|NCT01407276|3807512|FG002|COMPLETED|Overall Study||6
3085287|NCT01407276|3807513|FG003|COMPLETED|Overall Study||6
3085288|NCT01407276|3807514|FG004|COMPLETED|Overall Study||6
3085289|NCT01407276|3807515|FG005|COMPLETED|Overall Study||6
3085290|NCT01407276|3807516|FG006|COMPLETED|Overall Study||6
3085291|NCT01407276|3807517|FG007|COMPLETED|Overall Study||6
3085292|NCT01407276|3807510|FG000|NOT COMPLETED|Overall Study||0
3085293|NCT01407276|3807511|FG001|NOT COMPLETED|Overall Study||0
3085294|NCT01407276|3807512|FG002|NOT COMPLETED|Overall Study||0
3085295|NCT01407276|3807513|FG003|NOT COMPLETED|Overall Study||0
3085296|NCT01407276|3807514|FG004|NOT COMPLETED|Overall Study||0
3085297|NCT01407276|3807515|FG005|NOT COMPLETED|Overall Study||0
3085298|NCT01407276|3807516|FG006|NOT COMPLETED|Overall Study||0
3085299|NCT01407276|3807517|FG007|NOT COMPLETED|Overall Study||1
3085300|NCT01407354|3807542|FG000|STARTED|First Intervention||20
3085301|NCT01407354|3807543|FG001|STARTED|First Intervention||17
3085302|NCT01407354|3807542|FG000|COMPLETED|First Intervention||18
3085303|NCT01407354|3807543|FG001|COMPLETED|First Intervention||15
3085304|NCT01407354|3807542|FG000|NOT COMPLETED|First Intervention||2
3085305|NCT01407354|3807543|FG001|NOT COMPLETED|First Intervention||2
3085306|NCT01407354|3807542|FG000|STARTED|Second Intervention||18
3085307|NCT01407354|3807543|FG001|STARTED|Second Intervention||15
3085308|NCT01407354|3807542|FG000|COMPLETED|Second Intervention||18
3085309|NCT01407354|3807543|FG001|COMPLETED|Second Intervention||13
3085310|NCT01407354|3807542|FG000|NOT COMPLETED|Second Intervention||0
3085311|NCT01407354|3807543|FG001|NOT COMPLETED|Second Intervention||2
3085312|NCT01407367|3807552|FG000|STARTED|Overall Study||108
3287509|NCT02792829|4021207|FG000|COMPLETED|Treatment Period 1||10
3085313|NCT01407367|3807553|FG001|STARTED|Overall Study||242
3085314|NCT01407367|3807552|FG000|COMPLETED|Overall Study||68
3085315|NCT01407367|3807553|FG001|COMPLETED|Overall Study||164
3287510|NCT02792829|4021208|FG001|COMPLETED|Treatment Period 1||10
3085316|NCT01407367|3807552|FG000|NOT COMPLETED|Overall Study||40
3287511|NCT02792829|4021209|FG002|COMPLETED|Treatment Period 1||5
3287512|NCT02792829|4021210|FG003|COMPLETED|Treatment Period 1||5
3287513|NCT02792829|4021211|FG004|COMPLETED|Treatment Period 1||5
3085317|NCT01407367|3807553|FG001|NOT COMPLETED|Overall Study||78
3085318|NCT01407523|3807562|FG000|STARTED|Overall Study||16
3085319|NCT01407523|3807562|FG000|COMPLETED|Overall Study||16
3085320|NCT01407523|3807562|FG000|NOT COMPLETED|Overall Study||0
3085321|NCT01407575|3807568|FG000|STARTED|Overall Study||7
3085322|NCT01407575|3807569|FG001|STARTED|Overall Study||6
3085323|NCT01407575|3807568|FG000|COMPLETED|Overall Study||5
3085324|NCT01407575|3807569|FG001|COMPLETED|Overall Study||5
3085325|NCT01407575|3807568|FG000|NOT COMPLETED|Overall Study||2
3287514|NCT02792829|4021212|FG005|COMPLETED|Treatment Period 1||5
3287515|NCT02792829|4021213|FG006|COMPLETED|Treatment Period 1||10
3287516|NCT02792829|4021214|FG007|COMPLETED|Treatment Period 1||10
3085326|NCT01407575|3807569|FG001|NOT COMPLETED|Overall Study||1
3085327|NCT01407926|3807577|FG000|STARTED|Overall Study||142
3085328|NCT01407926|3807577|FG000|COMPLETED|Overall Study||87
3085329|NCT01407926|3807577|FG000|NOT COMPLETED|Overall Study||55
3085330|NCT01407952|3807584|FG000|STARTED|Overall Study||297
3085331|NCT01407952|3807585|FG001|STARTED|Overall Study||303
3085332|NCT01407952|3807584|FG000|COMPLETED|Overall Study||251
3085333|NCT01407952|3807585|FG001|COMPLETED|Overall Study||266
3085334|NCT01407952|3807584|FG000|NOT COMPLETED|Overall Study||46
3085335|NCT01407952|3807585|FG001|NOT COMPLETED|Overall Study||37
3085336|NCT01408030|3807595|FG000|STARTED|Treatment Phase (on Drug)||29
3085337|NCT01408030|3807596|FG001|STARTED|Treatment Phase (on Drug)||31
3085338|NCT01408030|3807597|FG002|STARTED|Treatment Phase (on Drug)||33
3085339|NCT01408030|3807598|FG003|STARTED|Treatment Phase (on Drug)||28
3085340|NCT01408030|3807595|FG000|COMPLETED|Treatment Phase (on Drug)||26
3085341|NCT01408030|3807596|FG001|COMPLETED|Treatment Phase (on Drug)||24
3085342|NCT01408030|3807597|FG002|COMPLETED|Treatment Phase (on Drug)||32
3085343|NCT01408030|3807598|FG003|COMPLETED|Treatment Phase (on Drug)||25
3085344|NCT01408030|3807595|FG000|NOT COMPLETED|Treatment Phase (on Drug)||3
3085345|NCT01408030|3807596|FG001|NOT COMPLETED|Treatment Phase (on Drug)||7
3085346|NCT01408030|3807597|FG002|NOT COMPLETED|Treatment Phase (on Drug)||1
3085347|NCT01408030|3807598|FG003|NOT COMPLETED|Treatment Phase (on Drug)||3
3085348|NCT01408030|3807595|FG000|STARTED|Observation Phase (Off Drug)||26
3085349|NCT01408030|3807596|FG001|STARTED|Observation Phase (Off Drug)||24
3085350|NCT01408030|3807597|FG002|STARTED|Observation Phase (Off Drug)||32
3085351|NCT01408030|3807598|FG003|STARTED|Observation Phase (Off Drug)||25
3085352|NCT01408030|3807595|FG000|COMPLETED|Observation Phase (Off Drug)||22
3085353|NCT01408030|3807596|FG001|COMPLETED|Observation Phase (Off Drug)||18
3085354|NCT01408030|3807597|FG002|COMPLETED|Observation Phase (Off Drug)||26
3085355|NCT01408030|3807598|FG003|COMPLETED|Observation Phase (Off Drug)||21
3085356|NCT01408030|3807595|FG000|NOT COMPLETED|Observation Phase (Off Drug)||4
3085357|NCT01408030|3807596|FG001|NOT COMPLETED|Observation Phase (Off Drug)||6
3085358|NCT01408030|3807597|FG002|NOT COMPLETED|Observation Phase (Off Drug)||6
3085359|NCT01408030|3807598|FG003|NOT COMPLETED|Observation Phase (Off Drug)||4
3085360|NCT01408043|3807608|FG000|STARTED|Overall Study||25
3085361|NCT01408043|3807608|FG000|COMPLETED|Overall Study||24
3085362|NCT01408043|3807608|FG000|NOT COMPLETED|Overall Study||1
3134881|NCT01703221|3859818|FG001|NOT COMPLETED|Phase B - (Week 25 to 52)||14
3134882|NCT01703221|3859819|FG002|NOT COMPLETED|Phase B - (Week 25 to 52)||5
3134883|NCT01703260|3859836|FG000|STARTED|Overall Study||7
3134884|NCT01703260|3859837|FG001|STARTED|Overall Study||7
3134885|NCT01703260|3859838|FG002|STARTED|Overall Study||6
3134886|NCT01703260|3859836|FG000|COMPLETED|Overall Study||4
3134887|NCT01703260|3859837|FG001|COMPLETED|Overall Study||3
3134888|NCT01703260|3859838|FG002|COMPLETED|Overall Study||3
3134889|NCT01703260|3859836|FG000|NOT COMPLETED|Overall Study||3
3134890|NCT01703260|3859837|FG001|NOT COMPLETED|Overall Study||4
3134891|NCT01703260|3859838|FG002|NOT COMPLETED|Overall Study||3
3134892|NCT01703286|3859846|FG000|STARTED|Period 1 Including Washout||7
3134893|NCT01703286|3859847|FG001|STARTED|Period 1 Including Washout||7
3134894|NCT01703286|3859848|FG002|STARTED|Period 1 Including Washout||7
3287517|NCT02792829|4021207|FG000|NOT COMPLETED|Treatment Period 1||0
3287518|NCT02792829|4021208|FG001|NOT COMPLETED|Treatment Period 1||0
3287519|NCT02792829|4021209|FG002|NOT COMPLETED|Treatment Period 1||0
3134895|NCT01703286|3859849|FG003|STARTED|Period 1 Including Washout||7
3134896|NCT01703286|3859850|FG004|STARTED|Period 1 Including Washout||7
3134897|NCT01703286|3859851|FG005|STARTED|Period 1 Including Washout||7
3134898|NCT01703286|3859846|FG000|COMPLETED|Period 1 Including Washout||7
3134899|NCT01703286|3859847|FG001|COMPLETED|Period 1 Including Washout||7
3134900|NCT01703286|3859848|FG002|COMPLETED|Period 1 Including Washout||7
3134901|NCT01703286|3859849|FG003|COMPLETED|Period 1 Including Washout||6
3134902|NCT01703286|3859850|FG004|COMPLETED|Period 1 Including Washout||7
3134903|NCT01703286|3859851|FG005|COMPLETED|Period 1 Including Washout||6
3134904|NCT01703286|3859846|FG000|NOT COMPLETED|Period 1 Including Washout||0
3134905|NCT01703286|3859847|FG001|NOT COMPLETED|Period 1 Including Washout||0
3134906|NCT01703286|3859848|FG002|NOT COMPLETED|Period 1 Including Washout||0
3287520|NCT02792829|4021210|FG003|NOT COMPLETED|Treatment Period 1||0
3287521|NCT02792829|4021211|FG004|NOT COMPLETED|Treatment Period 1||0
3287522|NCT02792829|4021212|FG005|NOT COMPLETED|Treatment Period 1||0
3287523|NCT02792829|4021213|FG006|NOT COMPLETED|Treatment Period 1||0
3287524|NCT02792829|4021214|FG007|NOT COMPLETED|Treatment Period 1||0
3085363|NCT01408147|3807614|FG000|STARTED|Overall Study|174 participants|174
3085364|NCT01408147|3807615|FG001|STARTED|Overall Study|197 participants|197
3085365|NCT01408147|3807614|FG000|COMPLETED|Overall Study|1 clinic withdrew due to low census|174
3085366|NCT01408147|3807615|FG001|COMPLETED|Overall Study||196
3085367|NCT01408147|3807614|FG000|NOT COMPLETED|Overall Study||0
3085368|NCT01408147|3807615|FG001|NOT COMPLETED|Overall Study||1
3085369|NCT01408277|3807623|FG000|STARTED|Overall Study||28
3085370|NCT01408277|3807624|FG001|STARTED|Overall Study||27
3085371|NCT01408277|3807623|FG000|COMPLETED|Overall Study||20
3085372|NCT01408277|3807624|FG001|COMPLETED|Overall Study||23
3085373|NCT01408277|3807623|FG000|NOT COMPLETED|Overall Study||8
3085374|NCT01408277|3807624|FG001|NOT COMPLETED|Overall Study||4
3085375|NCT01408303|3807633|FG000|STARTED|Overall Study||215
3085376|NCT01408303|3807634|FG001|STARTED|Overall Study||216
3085377|NCT01408303|3807635|FG002|STARTED|Overall Study||216
3085378|NCT01408303|3807633|FG000|COMPLETED|Overall Study||209
3085379|NCT01408303|3807634|FG001|COMPLETED|Overall Study||204
3085380|NCT01408303|3807635|FG002|COMPLETED|Overall Study||210
3085381|NCT01408303|3807633|FG000|NOT COMPLETED|Overall Study||6
3085382|NCT01408303|3807634|FG001|NOT COMPLETED|Overall Study||12
3085383|NCT01408303|3807635|FG002|NOT COMPLETED|Overall Study||6
3085384|NCT01408329|3807645|FG000|STARTED|Overall Study||13
3085385|NCT01408329|3807646|FG001|STARTED|Overall Study||15
3085386|NCT01408329|3807645|FG000|COMPLETED|Overall Study||10
3085387|NCT01408329|3807646|FG001|COMPLETED|Overall Study||11
3085388|NCT01408329|3807645|FG000|NOT COMPLETED|Overall Study||3
3085389|NCT01408329|3807646|FG001|NOT COMPLETED|Overall Study||4
3085390|NCT01408459|3807654|FG000|STARTED|Overall Study||22
3085391|NCT01408459|3807655|FG001|STARTED|Overall Study||15
3085392|NCT01408459|3807654|FG000|COMPLETED|Overall Study||21
3085393|NCT01408459|3807655|FG001|COMPLETED|Overall Study||14
3085394|NCT01408459|3807654|FG000|NOT COMPLETED|Overall Study||1
3085395|NCT01408459|3807655|FG001|NOT COMPLETED|Overall Study||1
3085396|NCT01408485|3807662|FG000|STARTED|Overall Study||200
3085397|NCT01408485|3807662|FG000|COMPLETED|Overall Study||179
3085398|NCT01408485|3807662|FG000|NOT COMPLETED|Overall Study||21
3085399|NCT01408537|3807666|FG000|STARTED|Overall Study||152
3085400|NCT01408537|3807666|FG000|COMPLETED|Overall Study||144
3085401|NCT01408537|3807666|FG000|NOT COMPLETED|Overall Study||8
3085402|NCT01408563|3807681|FG000|STARTED|Overall Study||33
3085403|NCT01408563|3807681|FG000|Received Transplant|Overall Study||31
3085404|NCT01408563|3807681|FG000|COMPLETED|Overall Study||31
3085405|NCT01408563|3807681|FG000|NOT COMPLETED|Overall Study||2
3085406|NCT01408576|3807688|FG000|STARTED|Overall Study||244
3085407|NCT01408576|3807689|FG001|STARTED|Overall Study||498
3085408|NCT01408576|3807690|FG002|STARTED|Overall Study||508
3085409|NCT01408576|3807688|FG000|COMPLETED|Overall Study||56
3085410|NCT01408576|3807689|FG001|COMPLETED|Overall Study||0
3085411|NCT01408576|3807690|FG002|COMPLETED|Overall Study||0
3085412|NCT01408576|3807688|FG000|NOT COMPLETED|Overall Study||188
3085413|NCT01408576|3807689|FG001|NOT COMPLETED|Overall Study||498
3085414|NCT01408576|3807690|FG002|NOT COMPLETED|Overall Study||508
3085415|NCT01408628|3807710|FG000|STARTED|Consented||51
3085416|NCT01408628|3807710|FG000|COMPLETED|Consented||39
3085417|NCT01408628|3807710|FG000|NOT COMPLETED|Consented||12
3085418|NCT01408628|3807710|FG000|STARTED|Started Classes/Intervention||39
3085419|NCT01408628|3807710|FG000|COMPLETED|Started Classes/Intervention||39
3085420|NCT01408628|3807710|FG000|NOT COMPLETED|Started Classes/Intervention||0
3085421|NCT01408628|3807710|FG000|STARTED|Completed 6 Month Follow-Up||39
3085422|NCT01408628|3807710|FG000|COMPLETED|Completed 6 Month Follow-Up||25
3085423|NCT01408628|3807710|FG000|NOT COMPLETED|Completed 6 Month Follow-Up||14
3085424|NCT01408706|3807717|FG000|STARTED|Overall Study||30
3085425|NCT01408706|3807718|FG001|STARTED|Overall Study||30
3085426|NCT01408706|3807717|FG000|COMPLETED|Overall Study||29
3085427|NCT01408706|3807718|FG001|COMPLETED|Overall Study||30
3085428|NCT01408706|3807717|FG000|NOT COMPLETED|Overall Study||1
3085429|NCT01408706|3807718|FG001|NOT COMPLETED|Overall Study||0
3085430|NCT01408719|3807746|FG000|STARTED|First Intervention (35 Days)||2
3085431|NCT01408719|3807747|FG001|STARTED|First Intervention (35 Days)||3
3085432|NCT01408719|3807748|FG002|STARTED|First Intervention (35 Days)||2
3085433|NCT01408719|3807749|FG003|STARTED|First Intervention (35 Days)||2
3085434|NCT01408719|3807750|FG004|STARTED|First Intervention (35 Days)||4
3085435|NCT01408719|3807751|FG005|STARTED|First Intervention (35 Days)||3
3085436|NCT01408719|3807752|FG006|STARTED|First Intervention (35 Days)||2
3085437|NCT01408719|3807753|FG007|STARTED|First Intervention (35 Days)||3
3085438|NCT01408719|3807754|FG008|STARTED|First Intervention (35 Days)||2
3085439|NCT01408719|3807755|FG009|STARTED|First Intervention (35 Days)||1
3085440|NCT01408719|3807756|FG010|STARTED|First Intervention (35 Days)||2
3085441|NCT01408719|3807757|FG011|STARTED|First Intervention (35 Days)||2
3085442|NCT01408719|3807758|FG012|STARTED|First Intervention (35 Days)||2
3085443|NCT01408719|3807759|FG013|STARTED|First Intervention (35 Days)||5
3085444|NCT01408719|3807760|FG014|STARTED|First Intervention (35 Days)||1
3085445|NCT01408719|3807761|FG015|STARTED|First Intervention (35 Days)||2
3085446|NCT01408719|3807762|FG016|STARTED|First Intervention (35 Days)||3
3085447|NCT01408719|3807763|FG017|STARTED|First Intervention (35 Days)||2
3085448|NCT01408719|3807764|FG018|STARTED|First Intervention (35 Days)||1
3085449|NCT01408719|3807765|FG019|STARTED|First Intervention (35 Days)||1
3085450|NCT01408719|3807746|FG000|COMPLETED|First Intervention (35 Days)||2
3085451|NCT01408719|3807747|FG001|COMPLETED|First Intervention (35 Days)||3
3085452|NCT01408719|3807748|FG002|COMPLETED|First Intervention (35 Days)||1
3085453|NCT01408719|3807749|FG003|COMPLETED|First Intervention (35 Days)||2
3085454|NCT01408719|3807750|FG004|COMPLETED|First Intervention (35 Days)||3
3085455|NCT01408719|3807751|FG005|COMPLETED|First Intervention (35 Days)||3
3085456|NCT01408719|3807752|FG006|COMPLETED|First Intervention (35 Days)||2
3085457|NCT01408719|3807753|FG007|COMPLETED|First Intervention (35 Days)||3
3085458|NCT01408719|3807754|FG008|COMPLETED|First Intervention (35 Days)||1
3085459|NCT01408719|3807755|FG009|COMPLETED|First Intervention (35 Days)||1
3085460|NCT01408719|3807756|FG010|COMPLETED|First Intervention (35 Days)||2
3085461|NCT01408719|3807757|FG011|COMPLETED|First Intervention (35 Days)||2
3085462|NCT01408719|3807758|FG012|COMPLETED|First Intervention (35 Days)||2
3085463|NCT01408719|3807759|FG013|COMPLETED|First Intervention (35 Days)||4
3085464|NCT01408719|3807760|FG014|COMPLETED|First Intervention (35 Days)||1
3085465|NCT01408719|3807761|FG015|COMPLETED|First Intervention (35 Days)||2
3085466|NCT01408719|3807762|FG016|COMPLETED|First Intervention (35 Days)||2
3085467|NCT01408719|3807763|FG017|COMPLETED|First Intervention (35 Days)||2
3085468|NCT01408719|3807764|FG018|COMPLETED|First Intervention (35 Days)||0
3085469|NCT01408719|3807765|FG019|COMPLETED|First Intervention (35 Days)||1
3085470|NCT01408719|3807746|FG000|NOT COMPLETED|First Intervention (35 Days)||0
3085471|NCT01408719|3807747|FG001|NOT COMPLETED|First Intervention (35 Days)||0
3085472|NCT01408719|3807748|FG002|NOT COMPLETED|First Intervention (35 Days)||1
3085473|NCT01408719|3807749|FG003|NOT COMPLETED|First Intervention (35 Days)||0
3085474|NCT01408719|3807750|FG004|NOT COMPLETED|First Intervention (35 Days)||1
3085475|NCT01408719|3807751|FG005|NOT COMPLETED|First Intervention (35 Days)||0
3085476|NCT01408719|3807752|FG006|NOT COMPLETED|First Intervention (35 Days)||0
3085477|NCT01408719|3807753|FG007|NOT COMPLETED|First Intervention (35 Days)||0
3085478|NCT01408719|3807754|FG008|NOT COMPLETED|First Intervention (35 Days)||1
3085479|NCT01408719|3807755|FG009|NOT COMPLETED|First Intervention (35 Days)||0
3085480|NCT01408719|3807756|FG010|NOT COMPLETED|First Intervention (35 Days)||0
3085481|NCT01408719|3807757|FG011|NOT COMPLETED|First Intervention (35 Days)||0
3085482|NCT01408719|3807758|FG012|NOT COMPLETED|First Intervention (35 Days)||0
3085483|NCT01408719|3807759|FG013|NOT COMPLETED|First Intervention (35 Days)||1
3085484|NCT01408719|3807760|FG014|NOT COMPLETED|First Intervention (35 Days)||0
3085485|NCT01408719|3807761|FG015|NOT COMPLETED|First Intervention (35 Days)||0
3085486|NCT01408719|3807762|FG016|NOT COMPLETED|First Intervention (35 Days)||1
3085487|NCT01408719|3807763|FG017|NOT COMPLETED|First Intervention (35 Days)||0
3085488|NCT01408719|3807764|FG018|NOT COMPLETED|First Intervention (35 Days)||1
3085489|NCT01408719|3807765|FG019|NOT COMPLETED|First Intervention (35 Days)||0
3085490|NCT01408719|3807746|FG000|STARTED|Washout Period (28 Days)||2
3085491|NCT01408719|3807747|FG001|STARTED|Washout Period (28 Days)||3
3085492|NCT01408719|3807748|FG002|STARTED|Washout Period (28 Days)||1
3085493|NCT01408719|3807749|FG003|STARTED|Washout Period (28 Days)||2
3085494|NCT01408719|3807750|FG004|STARTED|Washout Period (28 Days)||3
3085495|NCT01408719|3807751|FG005|STARTED|Washout Period (28 Days)||3
3085496|NCT01408719|3807752|FG006|STARTED|Washout Period (28 Days)||2
3085497|NCT01408719|3807753|FG007|STARTED|Washout Period (28 Days)||3
3085498|NCT01408719|3807754|FG008|STARTED|Washout Period (28 Days)||1
3085499|NCT01408719|3807755|FG009|STARTED|Washout Period (28 Days)||1
3085500|NCT01408719|3807756|FG010|STARTED|Washout Period (28 Days)||2
3085501|NCT01408719|3807757|FG011|STARTED|Washout Period (28 Days)||2
3085502|NCT01408719|3807758|FG012|STARTED|Washout Period (28 Days)||2
3085503|NCT01408719|3807759|FG013|STARTED|Washout Period (28 Days)||4
3085504|NCT01408719|3807760|FG014|STARTED|Washout Period (28 Days)||1
3085505|NCT01408719|3807761|FG015|STARTED|Washout Period (28 Days)||2
3085506|NCT01408719|3807762|FG016|STARTED|Washout Period (28 Days)||2
3085507|NCT01408719|3807763|FG017|STARTED|Washout Period (28 Days)||2
3085508|NCT01408719|3807764|FG018|STARTED|Washout Period (28 Days)||0
3085509|NCT01408719|3807765|FG019|STARTED|Washout Period (28 Days)||1
3085510|NCT01408719|3807746|FG000|COMPLETED|Washout Period (28 Days)||2
3085511|NCT01408719|3807747|FG001|COMPLETED|Washout Period (28 Days)||3
3085512|NCT01408719|3807748|FG002|COMPLETED|Washout Period (28 Days)||1
3085513|NCT01408719|3807749|FG003|COMPLETED|Washout Period (28 Days)||2
3085514|NCT01408719|3807750|FG004|COMPLETED|Washout Period (28 Days)||3
3085515|NCT01408719|3807751|FG005|COMPLETED|Washout Period (28 Days)||3
3085516|NCT01408719|3807752|FG006|COMPLETED|Washout Period (28 Days)||2
3085517|NCT01408719|3807753|FG007|COMPLETED|Washout Period (28 Days)||3
3085518|NCT01408719|3807754|FG008|COMPLETED|Washout Period (28 Days)||1
3085519|NCT01408719|3807755|FG009|COMPLETED|Washout Period (28 Days)||1
3085520|NCT01408719|3807756|FG010|COMPLETED|Washout Period (28 Days)||2
3085521|NCT01408719|3807757|FG011|COMPLETED|Washout Period (28 Days)||2
3085522|NCT01408719|3807758|FG012|COMPLETED|Washout Period (28 Days)||2
3085523|NCT01408719|3807759|FG013|COMPLETED|Washout Period (28 Days)||4
3085524|NCT01408719|3807760|FG014|COMPLETED|Washout Period (28 Days)||1
3085525|NCT01408719|3807761|FG015|COMPLETED|Washout Period (28 Days)||2
3085526|NCT01408719|3807762|FG016|COMPLETED|Washout Period (28 Days)||2
3085527|NCT01408719|3807763|FG017|COMPLETED|Washout Period (28 Days)||2
3085528|NCT01408719|3807764|FG018|COMPLETED|Washout Period (28 Days)||0
3085529|NCT01408719|3807765|FG019|COMPLETED|Washout Period (28 Days)||1
3085530|NCT01408719|3807746|FG000|NOT COMPLETED|Washout Period (28 Days)||0
3085531|NCT01408719|3807747|FG001|NOT COMPLETED|Washout Period (28 Days)||0
3085532|NCT01408719|3807748|FG002|NOT COMPLETED|Washout Period (28 Days)||0
3085533|NCT01408719|3807749|FG003|NOT COMPLETED|Washout Period (28 Days)||0
3085534|NCT01408719|3807750|FG004|NOT COMPLETED|Washout Period (28 Days)||0
3085535|NCT01408719|3807751|FG005|NOT COMPLETED|Washout Period (28 Days)||0
3085536|NCT01408719|3807752|FG006|NOT COMPLETED|Washout Period (28 Days)||0
3085537|NCT01408719|3807753|FG007|NOT COMPLETED|Washout Period (28 Days)||0
3085538|NCT01408719|3807754|FG008|NOT COMPLETED|Washout Period (28 Days)||0
3085539|NCT01408719|3807755|FG009|NOT COMPLETED|Washout Period (28 Days)||0
3085540|NCT01408719|3807756|FG010|NOT COMPLETED|Washout Period (28 Days)||0
3085541|NCT01408719|3807757|FG011|NOT COMPLETED|Washout Period (28 Days)||0
3085542|NCT01408719|3807758|FG012|NOT COMPLETED|Washout Period (28 Days)||0
3085543|NCT01408719|3807759|FG013|NOT COMPLETED|Washout Period (28 Days)||0
3085544|NCT01408719|3807760|FG014|NOT COMPLETED|Washout Period (28 Days)||0
3085545|NCT01408719|3807761|FG015|NOT COMPLETED|Washout Period (28 Days)||0
3085546|NCT01408719|3807762|FG016|NOT COMPLETED|Washout Period (28 Days)||0
3085547|NCT01408719|3807763|FG017|NOT COMPLETED|Washout Period (28 Days)||0
3085548|NCT01408719|3807764|FG018|NOT COMPLETED|Washout Period (28 Days)||0
3085549|NCT01408719|3807765|FG019|NOT COMPLETED|Washout Period (28 Days)||0
3085550|NCT01408719|3807746|FG000|STARTED|Second Intervention (35 Days)||2
3085551|NCT01408719|3807747|FG001|STARTED|Second Intervention (35 Days)||3
3085552|NCT01408719|3807748|FG002|STARTED|Second Intervention (35 Days)||1
3085553|NCT01408719|3807749|FG003|STARTED|Second Intervention (35 Days)||2
3085554|NCT01408719|3807750|FG004|STARTED|Second Intervention (35 Days)||3
3085555|NCT01408719|3807751|FG005|STARTED|Second Intervention (35 Days)||3
3085556|NCT01408719|3807752|FG006|STARTED|Second Intervention (35 Days)||2
3085557|NCT01408719|3807753|FG007|STARTED|Second Intervention (35 Days)||3
3085558|NCT01408719|3807754|FG008|STARTED|Second Intervention (35 Days)||1
3085559|NCT01408719|3807755|FG009|STARTED|Second Intervention (35 Days)||1
3085560|NCT01408719|3807756|FG010|STARTED|Second Intervention (35 Days)||2
3085561|NCT01408719|3807757|FG011|STARTED|Second Intervention (35 Days)||2
3085562|NCT01408719|3807758|FG012|STARTED|Second Intervention (35 Days)||2
3085563|NCT01408719|3807759|FG013|STARTED|Second Intervention (35 Days)||4
3085564|NCT01408719|3807760|FG014|STARTED|Second Intervention (35 Days)||1
3085565|NCT01408719|3807761|FG015|STARTED|Second Intervention (35 Days)||2
3085566|NCT01408719|3807762|FG016|STARTED|Second Intervention (35 Days)||2
3085567|NCT01408719|3807763|FG017|STARTED|Second Intervention (35 Days)||2
3085568|NCT01408719|3807764|FG018|STARTED|Second Intervention (35 Days)||0
3085569|NCT01408719|3807765|FG019|STARTED|Second Intervention (35 Days)||1
3085570|NCT01408719|3807746|FG000|COMPLETED|Second Intervention (35 Days)||2
3085571|NCT01408719|3807747|FG001|COMPLETED|Second Intervention (35 Days)||3
3085572|NCT01408719|3807748|FG002|COMPLETED|Second Intervention (35 Days)||1
3085573|NCT01408719|3807749|FG003|COMPLETED|Second Intervention (35 Days)||2
3085574|NCT01408719|3807750|FG004|COMPLETED|Second Intervention (35 Days)||3
3085575|NCT01408719|3807751|FG005|COMPLETED|Second Intervention (35 Days)||3
3085576|NCT01408719|3807752|FG006|COMPLETED|Second Intervention (35 Days)||2
3085577|NCT01408719|3807753|FG007|COMPLETED|Second Intervention (35 Days)||3
3085578|NCT01408719|3807754|FG008|COMPLETED|Second Intervention (35 Days)||1
3085579|NCT01408719|3807755|FG009|COMPLETED|Second Intervention (35 Days)||1
3085580|NCT01408719|3807756|FG010|COMPLETED|Second Intervention (35 Days)||2
3085581|NCT01408719|3807757|FG011|COMPLETED|Second Intervention (35 Days)||2
3085582|NCT01408719|3807758|FG012|COMPLETED|Second Intervention (35 Days)||2
3085583|NCT01408719|3807759|FG013|COMPLETED|Second Intervention (35 Days)||3
3085584|NCT01408719|3807760|FG014|COMPLETED|Second Intervention (35 Days)||1
3085585|NCT01408719|3807761|FG015|COMPLETED|Second Intervention (35 Days)||2
3085586|NCT01408719|3807762|FG016|COMPLETED|Second Intervention (35 Days)||2
3085587|NCT01408719|3807763|FG017|COMPLETED|Second Intervention (35 Days)||2
3085588|NCT01408719|3807764|FG018|COMPLETED|Second Intervention (35 Days)||0
3085589|NCT01408719|3807765|FG019|COMPLETED|Second Intervention (35 Days)||1
3085590|NCT01408719|3807746|FG000|NOT COMPLETED|Second Intervention (35 Days)||0
3085591|NCT01408719|3807747|FG001|NOT COMPLETED|Second Intervention (35 Days)||0
3085592|NCT01408719|3807748|FG002|NOT COMPLETED|Second Intervention (35 Days)||0
3085593|NCT01408719|3807749|FG003|NOT COMPLETED|Second Intervention (35 Days)||0
3085594|NCT01408719|3807750|FG004|NOT COMPLETED|Second Intervention (35 Days)||0
3085595|NCT01408719|3807751|FG005|NOT COMPLETED|Second Intervention (35 Days)||0
3085596|NCT01408719|3807752|FG006|NOT COMPLETED|Second Intervention (35 Days)||0
3085597|NCT01408719|3807753|FG007|NOT COMPLETED|Second Intervention (35 Days)||0
3085598|NCT01408719|3807754|FG008|NOT COMPLETED|Second Intervention (35 Days)||0
3085599|NCT01408719|3807755|FG009|NOT COMPLETED|Second Intervention (35 Days)||0
3085600|NCT01408719|3807756|FG010|NOT COMPLETED|Second Intervention (35 Days)||0
3085601|NCT01408719|3807757|FG011|NOT COMPLETED|Second Intervention (35 Days)||0
3085602|NCT01408719|3807758|FG012|NOT COMPLETED|Second Intervention (35 Days)||0
3085603|NCT01408719|3807759|FG013|NOT COMPLETED|Second Intervention (35 Days)||1
3085604|NCT01408719|3807760|FG014|NOT COMPLETED|Second Intervention (35 Days)||0
3085605|NCT01408719|3807761|FG015|NOT COMPLETED|Second Intervention (35 Days)||0
3085606|NCT01408719|3807762|FG016|NOT COMPLETED|Second Intervention (35 Days)||0
3085607|NCT01408719|3807763|FG017|NOT COMPLETED|Second Intervention (35 Days)||0
3085608|NCT01408719|3807764|FG018|NOT COMPLETED|Second Intervention (35 Days)||0
3085609|NCT01408719|3807765|FG019|NOT COMPLETED|Second Intervention (35 Days)||0
3085610|NCT01408719|3807746|FG000|STARTED|Washout Period (28 Days)||2
3085611|NCT01408719|3807747|FG001|STARTED|Washout Period (28 Days)||3
3085612|NCT01408719|3807748|FG002|STARTED|Washout Period (28 Days)||1
3085613|NCT01408719|3807749|FG003|STARTED|Washout Period (28 Days)||2
3085614|NCT01408719|3807750|FG004|STARTED|Washout Period (28 Days)||3
3085615|NCT01408719|3807751|FG005|STARTED|Washout Period (28 Days)||3
3085616|NCT01408719|3807752|FG006|STARTED|Washout Period (28 Days)||2
3085617|NCT01408719|3807753|FG007|STARTED|Washout Period (28 Days)||3
3085618|NCT01408719|3807754|FG008|STARTED|Washout Period (28 Days)||1
3085619|NCT01408719|3807755|FG009|STARTED|Washout Period (28 Days)||1
3085620|NCT01408719|3807756|FG010|STARTED|Washout Period (28 Days)||2
3085621|NCT01408719|3807757|FG011|STARTED|Washout Period (28 Days)||2
3085622|NCT01408719|3807758|FG012|STARTED|Washout Period (28 Days)||2
3085623|NCT01408719|3807759|FG013|STARTED|Washout Period (28 Days)||3
3085624|NCT01408719|3807760|FG014|STARTED|Washout Period (28 Days)||1
3085625|NCT01408719|3807761|FG015|STARTED|Washout Period (28 Days)||1
3085626|NCT01408719|3807762|FG016|STARTED|Washout Period (28 Days)||2
3085627|NCT01408719|3807763|FG017|STARTED|Washout Period (28 Days)||2
3085628|NCT01408719|3807764|FG018|STARTED|Washout Period (28 Days)||0
3085629|NCT01408719|3807765|FG019|STARTED|Washout Period (28 Days)||1
3085630|NCT01408719|3807746|FG000|COMPLETED|Washout Period (28 Days)||2
3085631|NCT01408719|3807747|FG001|COMPLETED|Washout Period (28 Days)||3
3085632|NCT01408719|3807748|FG002|COMPLETED|Washout Period (28 Days)||1
3085633|NCT01408719|3807749|FG003|COMPLETED|Washout Period (28 Days)||2
3085634|NCT01408719|3807750|FG004|COMPLETED|Washout Period (28 Days)||3
3085635|NCT01408719|3807751|FG005|COMPLETED|Washout Period (28 Days)||3
3085636|NCT01408719|3807752|FG006|COMPLETED|Washout Period (28 Days)||2
3085637|NCT01408719|3807753|FG007|COMPLETED|Washout Period (28 Days)||3
3085638|NCT01408719|3807754|FG008|COMPLETED|Washout Period (28 Days)||1
3085639|NCT01408719|3807755|FG009|COMPLETED|Washout Period (28 Days)||1
3085640|NCT01408719|3807756|FG010|COMPLETED|Washout Period (28 Days)||2
3085641|NCT01408719|3807757|FG011|COMPLETED|Washout Period (28 Days)||2
3085642|NCT01408719|3807758|FG012|COMPLETED|Washout Period (28 Days)||2
3085643|NCT01408719|3807759|FG013|COMPLETED|Washout Period (28 Days)||3
3085644|NCT01408719|3807760|FG014|COMPLETED|Washout Period (28 Days)||1
3085645|NCT01408719|3807761|FG015|COMPLETED|Washout Period (28 Days)||1
3085646|NCT01408719|3807762|FG016|COMPLETED|Washout Period (28 Days)||2
3085647|NCT01408719|3807763|FG017|COMPLETED|Washout Period (28 Days)||2
3085648|NCT01408719|3807764|FG018|COMPLETED|Washout Period (28 Days)||0
3085649|NCT01408719|3807765|FG019|COMPLETED|Washout Period (28 Days)||1
3085650|NCT01408719|3807746|FG000|NOT COMPLETED|Washout Period (28 Days)||0
3085651|NCT01408719|3807747|FG001|NOT COMPLETED|Washout Period (28 Days)||0
3085652|NCT01408719|3807748|FG002|NOT COMPLETED|Washout Period (28 Days)||0
3085653|NCT01408719|3807749|FG003|NOT COMPLETED|Washout Period (28 Days)||0
3085654|NCT01408719|3807750|FG004|NOT COMPLETED|Washout Period (28 Days)||0
3085655|NCT01408719|3807751|FG005|NOT COMPLETED|Washout Period (28 Days)||0
3085656|NCT01408719|3807752|FG006|NOT COMPLETED|Washout Period (28 Days)||0
3085657|NCT01408719|3807753|FG007|NOT COMPLETED|Washout Period (28 Days)||0
3085658|NCT01408719|3807754|FG008|NOT COMPLETED|Washout Period (28 Days)||0
3085659|NCT01408719|3807755|FG009|NOT COMPLETED|Washout Period (28 Days)||0
3085660|NCT01408719|3807756|FG010|NOT COMPLETED|Washout Period (28 Days)||0
3085661|NCT01408719|3807757|FG011|NOT COMPLETED|Washout Period (28 Days)||0
3085662|NCT01408719|3807758|FG012|NOT COMPLETED|Washout Period (28 Days)||0
3085663|NCT01408719|3807759|FG013|NOT COMPLETED|Washout Period (28 Days)||0
3085664|NCT01408719|3807760|FG014|NOT COMPLETED|Washout Period (28 Days)||0
3085665|NCT01408719|3807761|FG015|NOT COMPLETED|Washout Period (28 Days)||0
3085666|NCT01408719|3807762|FG016|NOT COMPLETED|Washout Period (28 Days)||0
3085667|NCT01408719|3807763|FG017|NOT COMPLETED|Washout Period (28 Days)||0
3085668|NCT01408719|3807764|FG018|NOT COMPLETED|Washout Period (28 Days)||0
3085669|NCT01408719|3807765|FG019|NOT COMPLETED|Washout Period (28 Days)||0
3085670|NCT01408719|3807746|FG000|STARTED|Third Intervention (35 Days)||2
3085671|NCT01408719|3807747|FG001|STARTED|Third Intervention (35 Days)||3
3085672|NCT01408719|3807748|FG002|STARTED|Third Intervention (35 Days)||1
3085673|NCT01408719|3807749|FG003|STARTED|Third Intervention (35 Days)||2
3085674|NCT01408719|3807750|FG004|STARTED|Third Intervention (35 Days)||3
3085675|NCT01408719|3807751|FG005|STARTED|Third Intervention (35 Days)||3
3085676|NCT01408719|3807752|FG006|STARTED|Third Intervention (35 Days)||2
3085677|NCT01408719|3807753|FG007|STARTED|Third Intervention (35 Days)||3
3085678|NCT01408719|3807754|FG008|STARTED|Third Intervention (35 Days)||1
3085679|NCT01408719|3807755|FG009|STARTED|Third Intervention (35 Days)||1
3085680|NCT01408719|3807756|FG010|STARTED|Third Intervention (35 Days)||2
3085681|NCT01408719|3807757|FG011|STARTED|Third Intervention (35 Days)||2
3085682|NCT01408719|3807758|FG012|STARTED|Third Intervention (35 Days)||2
3085683|NCT01408719|3807759|FG013|STARTED|Third Intervention (35 Days)||3
3085684|NCT01408719|3807760|FG014|STARTED|Third Intervention (35 Days)||1
3085685|NCT01408719|3807761|FG015|STARTED|Third Intervention (35 Days)||1
3085686|NCT01408719|3807762|FG016|STARTED|Third Intervention (35 Days)||2
3085687|NCT01408719|3807763|FG017|STARTED|Third Intervention (35 Days)||2
3085688|NCT01408719|3807764|FG018|STARTED|Third Intervention (35 Days)||0
3085689|NCT01408719|3807765|FG019|STARTED|Third Intervention (35 Days)||1
3085690|NCT01408719|3807746|FG000|COMPLETED|Third Intervention (35 Days)||2
3085691|NCT01408719|3807747|FG001|COMPLETED|Third Intervention (35 Days)||3
3085692|NCT01408719|3807748|FG002|COMPLETED|Third Intervention (35 Days)||1
3085693|NCT01408719|3807749|FG003|COMPLETED|Third Intervention (35 Days)||2
3085694|NCT01408719|3807750|FG004|COMPLETED|Third Intervention (35 Days)||3
3085695|NCT01408719|3807751|FG005|COMPLETED|Third Intervention (35 Days)||3
3085696|NCT01408719|3807752|FG006|COMPLETED|Third Intervention (35 Days)||2
3085697|NCT01408719|3807753|FG007|COMPLETED|Third Intervention (35 Days)||2
3085698|NCT01408719|3807754|FG008|COMPLETED|Third Intervention (35 Days)||1
3085699|NCT01408719|3807755|FG009|COMPLETED|Third Intervention (35 Days)||1
3085700|NCT01408719|3807756|FG010|COMPLETED|Third Intervention (35 Days)||2
3085701|NCT01408719|3807757|FG011|COMPLETED|Third Intervention (35 Days)||2
3085702|NCT01408719|3807758|FG012|COMPLETED|Third Intervention (35 Days)||2
3085703|NCT01408719|3807759|FG013|COMPLETED|Third Intervention (35 Days)||3
3085704|NCT01408719|3807760|FG014|COMPLETED|Third Intervention (35 Days)||1
3085705|NCT01408719|3807761|FG015|COMPLETED|Third Intervention (35 Days)||1
3085706|NCT01408719|3807762|FG016|COMPLETED|Third Intervention (35 Days)||2
3085707|NCT01408719|3807763|FG017|COMPLETED|Third Intervention (35 Days)||2
3085708|NCT01408719|3807764|FG018|COMPLETED|Third Intervention (35 Days)||0
3085709|NCT01408719|3807765|FG019|COMPLETED|Third Intervention (35 Days)||1
3085710|NCT01408719|3807746|FG000|NOT COMPLETED|Third Intervention (35 Days)||0
3085711|NCT01408719|3807747|FG001|NOT COMPLETED|Third Intervention (35 Days)||0
3085712|NCT01408719|3807748|FG002|NOT COMPLETED|Third Intervention (35 Days)||0
3085713|NCT01408719|3807749|FG003|NOT COMPLETED|Third Intervention (35 Days)||0
3085714|NCT01408719|3807750|FG004|NOT COMPLETED|Third Intervention (35 Days)||0
3085715|NCT01408719|3807751|FG005|NOT COMPLETED|Third Intervention (35 Days)||0
3085716|NCT01408719|3807752|FG006|NOT COMPLETED|Third Intervention (35 Days)||0
3085717|NCT01408719|3807753|FG007|NOT COMPLETED|Third Intervention (35 Days)||1
3085718|NCT01408719|3807754|FG008|NOT COMPLETED|Third Intervention (35 Days)||0
3085719|NCT01408719|3807755|FG009|NOT COMPLETED|Third Intervention (35 Days)||0
3085720|NCT01408719|3807756|FG010|NOT COMPLETED|Third Intervention (35 Days)||0
3085721|NCT01408719|3807757|FG011|NOT COMPLETED|Third Intervention (35 Days)||0
3085722|NCT01408719|3807758|FG012|NOT COMPLETED|Third Intervention (35 Days)||0
3085723|NCT01408719|3807759|FG013|NOT COMPLETED|Third Intervention (35 Days)||0
3085724|NCT01408719|3807760|FG014|NOT COMPLETED|Third Intervention (35 Days)||0
3085725|NCT01408719|3807761|FG015|NOT COMPLETED|Third Intervention (35 Days)||0
3085726|NCT01408719|3807762|FG016|NOT COMPLETED|Third Intervention (35 Days)||0
3085727|NCT01408719|3807763|FG017|NOT COMPLETED|Third Intervention (35 Days)||0
3085728|NCT01408719|3807764|FG018|NOT COMPLETED|Third Intervention (35 Days)||0
3085729|NCT01408719|3807765|FG019|NOT COMPLETED|Third Intervention (35 Days)||0
3085730|NCT01408719|3807746|FG000|STARTED|Washout Period (28 Days)||2
3085731|NCT01408719|3807747|FG001|STARTED|Washout Period (28 Days)||3
3085732|NCT01408719|3807748|FG002|STARTED|Washout Period (28 Days)||1
3085733|NCT01408719|3807749|FG003|STARTED|Washout Period (28 Days)||2
3085734|NCT01408719|3807750|FG004|STARTED|Washout Period (28 Days)||3
3085735|NCT01408719|3807751|FG005|STARTED|Washout Period (28 Days)||3
3085736|NCT01408719|3807752|FG006|STARTED|Washout Period (28 Days)||2
3085737|NCT01408719|3807753|FG007|STARTED|Washout Period (28 Days)||2
3085738|NCT01408719|3807754|FG008|STARTED|Washout Period (28 Days)||1
3085739|NCT01408719|3807755|FG009|STARTED|Washout Period (28 Days)||1
3085740|NCT01408719|3807756|FG010|STARTED|Washout Period (28 Days)||2
3085741|NCT01408719|3807757|FG011|STARTED|Washout Period (28 Days)||2
3085742|NCT01408719|3807758|FG012|STARTED|Washout Period (28 Days)||1
3085743|NCT01408719|3807759|FG013|STARTED|Washout Period (28 Days)||3
3085744|NCT01408719|3807760|FG014|STARTED|Washout Period (28 Days)||1
3085745|NCT01408719|3807761|FG015|STARTED|Washout Period (28 Days)||1
3085746|NCT01408719|3807762|FG016|STARTED|Washout Period (28 Days)||2
3085747|NCT01408719|3807763|FG017|STARTED|Washout Period (28 Days)||2
3085748|NCT01408719|3807764|FG018|STARTED|Washout Period (28 Days)||0
3085749|NCT01408719|3807765|FG019|STARTED|Washout Period (28 Days)||1
3085750|NCT01408719|3807746|FG000|COMPLETED|Washout Period (28 Days)||2
3085751|NCT01408719|3807747|FG001|COMPLETED|Washout Period (28 Days)||3
3085752|NCT01408719|3807748|FG002|COMPLETED|Washout Period (28 Days)||1
3085753|NCT01408719|3807749|FG003|COMPLETED|Washout Period (28 Days)||2
3085754|NCT01408719|3807750|FG004|COMPLETED|Washout Period (28 Days)||3
3085755|NCT01408719|3807751|FG005|COMPLETED|Washout Period (28 Days)||3
3085756|NCT01408719|3807752|FG006|COMPLETED|Washout Period (28 Days)||2
3085757|NCT01408719|3807753|FG007|COMPLETED|Washout Period (28 Days)||2
3085758|NCT01408719|3807754|FG008|COMPLETED|Washout Period (28 Days)||1
3085759|NCT01408719|3807755|FG009|COMPLETED|Washout Period (28 Days)||1
3085760|NCT01408719|3807756|FG010|COMPLETED|Washout Period (28 Days)||2
3085761|NCT01408719|3807757|FG011|COMPLETED|Washout Period (28 Days)||2
3085762|NCT01408719|3807758|FG012|COMPLETED|Washout Period (28 Days)||1
3085763|NCT01408719|3807759|FG013|COMPLETED|Washout Period (28 Days)||3
3085764|NCT01408719|3807760|FG014|COMPLETED|Washout Period (28 Days)||1
3085765|NCT01408719|3807761|FG015|COMPLETED|Washout Period (28 Days)||1
3085766|NCT01408719|3807762|FG016|COMPLETED|Washout Period (28 Days)||2
3085767|NCT01408719|3807763|FG017|COMPLETED|Washout Period (28 Days)||2
3085768|NCT01408719|3807764|FG018|COMPLETED|Washout Period (28 Days)||0
3085769|NCT01408719|3807765|FG019|COMPLETED|Washout Period (28 Days)||1
3085770|NCT01408719|3807746|FG000|NOT COMPLETED|Washout Period (28 Days)||0
3085771|NCT01408719|3807747|FG001|NOT COMPLETED|Washout Period (28 Days)||0
3085772|NCT01408719|3807748|FG002|NOT COMPLETED|Washout Period (28 Days)||0
3085773|NCT01408719|3807749|FG003|NOT COMPLETED|Washout Period (28 Days)||0
3085774|NCT01408719|3807750|FG004|NOT COMPLETED|Washout Period (28 Days)||0
3085775|NCT01408719|3807751|FG005|NOT COMPLETED|Washout Period (28 Days)||0
3085776|NCT01408719|3807752|FG006|NOT COMPLETED|Washout Period (28 Days)||0
3085777|NCT01408719|3807753|FG007|NOT COMPLETED|Washout Period (28 Days)||0
3085778|NCT01408719|3807754|FG008|NOT COMPLETED|Washout Period (28 Days)||0
3085779|NCT01408719|3807755|FG009|NOT COMPLETED|Washout Period (28 Days)||0
3085780|NCT01408719|3807756|FG010|NOT COMPLETED|Washout Period (28 Days)||0
3085781|NCT01408719|3807757|FG011|NOT COMPLETED|Washout Period (28 Days)||0
3085782|NCT01408719|3807758|FG012|NOT COMPLETED|Washout Period (28 Days)||0
3085783|NCT01408719|3807759|FG013|NOT COMPLETED|Washout Period (28 Days)||0
3085784|NCT01408719|3807760|FG014|NOT COMPLETED|Washout Period (28 Days)||0
3085785|NCT01408719|3807761|FG015|NOT COMPLETED|Washout Period (28 Days)||0
3085786|NCT01408719|3807762|FG016|NOT COMPLETED|Washout Period (28 Days)||0
3085787|NCT01408719|3807763|FG017|NOT COMPLETED|Washout Period (28 Days)||0
3085788|NCT01408719|3807764|FG018|NOT COMPLETED|Washout Period (28 Days)||0
3085789|NCT01408719|3807765|FG019|NOT COMPLETED|Washout Period (28 Days)||0
3085790|NCT01408719|3807746|FG000|STARTED|Fourth Intervention (35 Days)||2
3085791|NCT01408719|3807747|FG001|STARTED|Fourth Intervention (35 Days)||3
3085792|NCT01408719|3807748|FG002|STARTED|Fourth Intervention (35 Days)||1
3085793|NCT01408719|3807749|FG003|STARTED|Fourth Intervention (35 Days)||2
3085794|NCT01408719|3807750|FG004|STARTED|Fourth Intervention (35 Days)||3
3085795|NCT01408719|3807751|FG005|STARTED|Fourth Intervention (35 Days)||3
3085796|NCT01408719|3807752|FG006|STARTED|Fourth Intervention (35 Days)||2
3085797|NCT01408719|3807753|FG007|STARTED|Fourth Intervention (35 Days)||2
3085798|NCT01408719|3807754|FG008|STARTED|Fourth Intervention (35 Days)||1
3085799|NCT01408719|3807755|FG009|STARTED|Fourth Intervention (35 Days)||1
3085800|NCT01408719|3807756|FG010|STARTED|Fourth Intervention (35 Days)||2
3085801|NCT01408719|3807757|FG011|STARTED|Fourth Intervention (35 Days)||2
3085802|NCT01408719|3807758|FG012|STARTED|Fourth Intervention (35 Days)||1
3085803|NCT01408719|3807759|FG013|STARTED|Fourth Intervention (35 Days)||3
3085804|NCT01408719|3807760|FG014|STARTED|Fourth Intervention (35 Days)||1
3085805|NCT01408719|3807761|FG015|STARTED|Fourth Intervention (35 Days)||1
3085806|NCT01408719|3807762|FG016|STARTED|Fourth Intervention (35 Days)||2
3085807|NCT01408719|3807763|FG017|STARTED|Fourth Intervention (35 Days)||2
3085808|NCT01408719|3807764|FG018|STARTED|Fourth Intervention (35 Days)||0
3085809|NCT01408719|3807765|FG019|STARTED|Fourth Intervention (35 Days)||1
3085810|NCT01408719|3807746|FG000|COMPLETED|Fourth Intervention (35 Days)||2
3085811|NCT01408719|3807747|FG001|COMPLETED|Fourth Intervention (35 Days)||3
3085812|NCT01408719|3807748|FG002|COMPLETED|Fourth Intervention (35 Days)||1
3085813|NCT01408719|3807749|FG003|COMPLETED|Fourth Intervention (35 Days)||2
3085814|NCT01408719|3807750|FG004|COMPLETED|Fourth Intervention (35 Days)||3
3085815|NCT01408719|3807751|FG005|COMPLETED|Fourth Intervention (35 Days)||3
3085816|NCT01408719|3807752|FG006|COMPLETED|Fourth Intervention (35 Days)||2
3085817|NCT01408719|3807753|FG007|COMPLETED|Fourth Intervention (35 Days)||2
3085818|NCT01408719|3807754|FG008|COMPLETED|Fourth Intervention (35 Days)||1
3085819|NCT01408719|3807755|FG009|COMPLETED|Fourth Intervention (35 Days)||1
3085820|NCT01408719|3807756|FG010|COMPLETED|Fourth Intervention (35 Days)||2
3085821|NCT01408719|3807757|FG011|COMPLETED|Fourth Intervention (35 Days)||2
3085822|NCT01408719|3807758|FG012|COMPLETED|Fourth Intervention (35 Days)||1
3085823|NCT01408719|3807759|FG013|COMPLETED|Fourth Intervention (35 Days)||3
3085824|NCT01408719|3807760|FG014|COMPLETED|Fourth Intervention (35 Days)||1
3085825|NCT01408719|3807761|FG015|COMPLETED|Fourth Intervention (35 Days)||1
3085826|NCT01408719|3807762|FG016|COMPLETED|Fourth Intervention (35 Days)||2
3085827|NCT01408719|3807763|FG017|COMPLETED|Fourth Intervention (35 Days)||2
3085828|NCT01408719|3807764|FG018|COMPLETED|Fourth Intervention (35 Days)||0
3085829|NCT01408719|3807765|FG019|COMPLETED|Fourth Intervention (35 Days)||1
3085830|NCT01408719|3807746|FG000|NOT COMPLETED|Fourth Intervention (35 Days)||0
3085831|NCT01408719|3807747|FG001|NOT COMPLETED|Fourth Intervention (35 Days)||0
3085832|NCT01408719|3807748|FG002|NOT COMPLETED|Fourth Intervention (35 Days)||0
3085833|NCT01408719|3807749|FG003|NOT COMPLETED|Fourth Intervention (35 Days)||0
3085834|NCT01408719|3807750|FG004|NOT COMPLETED|Fourth Intervention (35 Days)||0
3085835|NCT01408719|3807751|FG005|NOT COMPLETED|Fourth Intervention (35 Days)||0
3085836|NCT01408719|3807752|FG006|NOT COMPLETED|Fourth Intervention (35 Days)||0
3085837|NCT01408719|3807753|FG007|NOT COMPLETED|Fourth Intervention (35 Days)||0
3085838|NCT01408719|3807754|FG008|NOT COMPLETED|Fourth Intervention (35 Days)||0
3085839|NCT01408719|3807755|FG009|NOT COMPLETED|Fourth Intervention (35 Days)||0
3085840|NCT01408719|3807756|FG010|NOT COMPLETED|Fourth Intervention (35 Days)||0
3085841|NCT01408719|3807757|FG011|NOT COMPLETED|Fourth Intervention (35 Days)||0
3085842|NCT01408719|3807758|FG012|NOT COMPLETED|Fourth Intervention (35 Days)||0
3085843|NCT01408719|3807759|FG013|NOT COMPLETED|Fourth Intervention (35 Days)||0
3085844|NCT01408719|3807760|FG014|NOT COMPLETED|Fourth Intervention (35 Days)||0
3085845|NCT01408719|3807761|FG015|NOT COMPLETED|Fourth Intervention (35 Days)||0
3085846|NCT01408719|3807762|FG016|NOT COMPLETED|Fourth Intervention (35 Days)||0
3085847|NCT01408719|3807763|FG017|NOT COMPLETED|Fourth Intervention (35 Days)||0
3085848|NCT01408719|3807764|FG018|NOT COMPLETED|Fourth Intervention (35 Days)||0
3287525|NCT02792829|4021207|FG000|STARTED|Wash Out Period||10
3287526|NCT02792829|4021208|FG001|STARTED|Wash Out Period||10
3287527|NCT02792829|4021209|FG002|STARTED|Wash Out Period||5
3085849|NCT01408719|3807765|FG019|NOT COMPLETED|Fourth Intervention (35 Days)||0
3085850|NCT01408732|3807775|FG000|STARTED|Overall Study||9
3085851|NCT01408732|3807776|FG001|STARTED|Overall Study||9
3085852|NCT01408732|3807775|FG000|COMPLETED|Overall Study||7
3085853|NCT01408732|3807776|FG001|COMPLETED|Overall Study||7
3085854|NCT01408732|3807775|FG000|NOT COMPLETED|Overall Study||2
3085855|NCT01408732|3807776|FG001|NOT COMPLETED|Overall Study||2
3085856|NCT01408862|3807782|FG000|STARTED|Overall Study||20
3085857|NCT01408862|3807782|FG000|COMPLETED|Overall Study||20
3085858|NCT01408862|3807782|FG000|NOT COMPLETED|Overall Study||0
3085859|NCT01408888|3807787|FG000|STARTED|First Intervention||18
3085860|NCT01408888|3807788|FG001|STARTED|First Intervention||11
3085861|NCT01408888|3807787|FG000|Received at Least 1 Dose of Drug|First Intervention||18
3085862|NCT01408888|3807788|FG001|Received at Least 1 Dose of Drug|First Intervention||11
3085863|NCT01408888|3807787|FG000|COMPLETED|First Intervention||18
3085864|NCT01408888|3807788|FG001|COMPLETED|First Intervention||8
3085865|NCT01408888|3807787|FG000|NOT COMPLETED|First Intervention||0
3085866|NCT01408888|3807788|FG001|NOT COMPLETED|First Intervention||3
3085867|NCT01408888|3807787|FG000|STARTED|Washout of at Least 21 Days||18
3085868|NCT01408888|3807788|FG001|STARTED|Washout of at Least 21 Days||8
3085869|NCT01408888|3807787|FG000|COMPLETED|Washout of at Least 21 Days||18
3085870|NCT01408888|3807788|FG001|COMPLETED|Washout of at Least 21 Days||8
3085871|NCT01408888|3807787|FG000|NOT COMPLETED|Washout of at Least 21 Days||0
3085872|NCT01408888|3807788|FG001|NOT COMPLETED|Washout of at Least 21 Days||0
3085873|NCT01408888|3807787|FG000|STARTED|Second Intervention||18
3085874|NCT01408888|3807788|FG001|STARTED|Second Intervention||8
3085875|NCT01408888|3807787|FG000|COMPLETED|Second Intervention||16
3085876|NCT01408888|3807788|FG001|COMPLETED|Second Intervention||8
3085877|NCT01408888|3807787|FG000|NOT COMPLETED|Second Intervention||2
3085878|NCT01408888|3807788|FG001|NOT COMPLETED|Second Intervention||0
3085879|NCT01408901|3807808|FG000|STARTED|6-Week Follow-Up||53
3085880|NCT01408901|3807809|FG001|STARTED|6-Week Follow-Up||53
3085881|NCT01408901|3807810|FG002|STARTED|6-Week Follow-Up||53
3085882|NCT01408901|3807811|FG003|STARTED|6-Week Follow-Up||51
3085883|NCT01408901|3807808|FG000|COMPLETED|6-Week Follow-Up||50
3085884|NCT01408901|3807809|FG001|COMPLETED|6-Week Follow-Up||51
3085885|NCT01408901|3807810|FG002|COMPLETED|6-Week Follow-Up||50
3085886|NCT01408901|3807811|FG003|COMPLETED|6-Week Follow-Up||47
3085887|NCT01408901|3807808|FG000|NOT COMPLETED|6-Week Follow-Up||3
3085888|NCT01408901|3807809|FG001|NOT COMPLETED|6-Week Follow-Up||2
3085889|NCT01408901|3807810|FG002|NOT COMPLETED|6-Week Follow-Up||3
3085890|NCT01408901|3807811|FG003|NOT COMPLETED|6-Week Follow-Up||4
3085891|NCT01408901|3807808|FG000|STARTED|12-Week Follow-Up (Primary Endpoint)||50
3085892|NCT01408901|3807809|FG001|STARTED|12-Week Follow-Up (Primary Endpoint)||52
3085893|NCT01408901|3807810|FG002|STARTED|12-Week Follow-Up (Primary Endpoint)||50
3085894|NCT01408901|3807811|FG003|STARTED|12-Week Follow-Up (Primary Endpoint)||49
3085895|NCT01408901|3807808|FG000|COMPLETED|12-Week Follow-Up (Primary Endpoint)||49
3085896|NCT01408901|3807809|FG001|COMPLETED|12-Week Follow-Up (Primary Endpoint)||50
3085897|NCT01408901|3807810|FG002|COMPLETED|12-Week Follow-Up (Primary Endpoint)||50
3085898|NCT01408901|3807811|FG003|COMPLETED|12-Week Follow-Up (Primary Endpoint)||46
3085899|NCT01408901|3807808|FG000|NOT COMPLETED|12-Week Follow-Up (Primary Endpoint)||1
3085900|NCT01408901|3807809|FG001|NOT COMPLETED|12-Week Follow-Up (Primary Endpoint)||2
3085901|NCT01408901|3807810|FG002|NOT COMPLETED|12-Week Follow-Up (Primary Endpoint)||0
3085902|NCT01408901|3807811|FG003|NOT COMPLETED|12-Week Follow-Up (Primary Endpoint)||3
3085903|NCT01408901|3807808|FG000|STARTED|26-Week Follow-Up||49
3085904|NCT01408901|3807809|FG001|STARTED|26-Week Follow-Up||52
3085905|NCT01408901|3807810|FG002|STARTED|26-Week Follow-Up||50
3085906|NCT01408901|3807811|FG003|STARTED|26-Week Follow-Up||47
3085907|NCT01408901|3807808|FG000|COMPLETED|26-Week Follow-Up||48
3085908|NCT01408901|3807809|FG001|COMPLETED|26-Week Follow-Up||50
3085909|NCT01408901|3807810|FG002|COMPLETED|26-Week Follow-Up||50
3085910|NCT01408901|3807811|FG003|COMPLETED|26-Week Follow-Up||46
3085911|NCT01408901|3807808|FG000|NOT COMPLETED|26-Week Follow-Up||1
3085912|NCT01408901|3807809|FG001|NOT COMPLETED|26-Week Follow-Up||2
3085913|NCT01408901|3807810|FG002|NOT COMPLETED|26-Week Follow-Up||0
3085914|NCT01408901|3807811|FG003|NOT COMPLETED|26-Week Follow-Up||1
3085915|NCT01408914|3807826|FG000|STARTED|Overall Study||60
3085916|NCT01408914|3807827|FG001|STARTED|Overall Study||60
3085917|NCT01408914|3807828|FG002|STARTED|Overall Study||60
3085918|NCT01408914|3807826|FG000|COMPLETED|Overall Study||48
3085919|NCT01408914|3807827|FG001|COMPLETED|Overall Study||48
3085920|NCT01408914|3807828|FG002|COMPLETED|Overall Study||47
3085921|NCT01408914|3807826|FG000|NOT COMPLETED|Overall Study||12
3085922|NCT01408914|3807827|FG001|NOT COMPLETED|Overall Study||12
3085923|NCT01408914|3807828|FG002|NOT COMPLETED|Overall Study||13
3085924|NCT01408992|3807836|FG000|STARTED|Overall Study||558
3085925|NCT01408992|3807836|FG000|COMPLETED|Overall Study||558
3085926|NCT01408992|3807836|FG000|NOT COMPLETED|Overall Study||0
3085927|NCT01409096|3807850|FG000|STARTED|Overall Study||40
3085928|NCT01409096|3807851|FG001|STARTED|Overall Study||40
3085929|NCT01409096|3807850|FG000|COMPLETED|Overall Study||38
3085930|NCT01409096|3807851|FG001|COMPLETED|Overall Study||35
3085931|NCT01409096|3807850|FG000|NOT COMPLETED|Overall Study||2
3085932|NCT01409096|3807851|FG001|NOT COMPLETED|Overall Study||5
3085933|NCT01409213|3807857|FG000|STARTED|Overall Study||1523
3085934|NCT01409213|3807857|FG000|COMPLETED|Overall Study||1523
3085935|NCT01409213|3807857|FG000|NOT COMPLETED|Overall Study||0
3085936|NCT01409239|3807863|FG000|STARTED|Overall Study||16
3085937|NCT01409239|3807864|FG001|STARTED|Overall Study||17
3085938|NCT01409239|3807863|FG000|COMPLETED|Overall Study||16
3085939|NCT01409239|3807864|FG001|COMPLETED|Overall Study||17
3085940|NCT01409239|3807863|FG000|NOT COMPLETED|Overall Study||0
3085941|NCT01409239|3807864|FG001|NOT COMPLETED|Overall Study||0
3085942|NCT01409291|3807872|FG000|STARTED|Overall Study||36
3085943|NCT01409291|3807873|FG001|STARTED|Overall Study||28
3085944|NCT01409291|3807872|FG000|COMPLETED|Overall Study||29
3085945|NCT01409291|3807873|FG001|COMPLETED|Overall Study||19
3085946|NCT01409291|3807872|FG000|NOT COMPLETED|Overall Study||7
3085947|NCT01409291|3807873|FG001|NOT COMPLETED|Overall Study||9
3085948|NCT01409382|3807881|FG000|STARTED|Overall Study||240
3085949|NCT01409382|3807882|FG001|STARTED|Overall Study||240
3085950|NCT01409382|3807881|FG000|COMPLETED|Overall Study||159
3085951|NCT01409382|3807882|FG001|COMPLETED|Overall Study||160
3085952|NCT01409382|3807881|FG000|NOT COMPLETED|Overall Study||81
3085953|NCT01409382|3807882|FG001|NOT COMPLETED|Overall Study||80
3085954|NCT01409434|3807892|FG000|STARTED|Overall Study||44
3085955|NCT01409434|3807892|FG000|COMPLETED|Overall Study||40
3085956|NCT01409434|3807892|FG000|NOT COMPLETED|Overall Study||4
3085957|NCT01409564|3807898|FG000|STARTED|Overall Study||23
3085958|NCT01409564|3807899|FG001|STARTED|Overall Study||23
3085959|NCT01409564|3807898|FG000|COMPLETED|Overall Study||18
3085960|NCT01409564|3807899|FG001|COMPLETED|Overall Study||18
3085961|NCT01409564|3807898|FG000|NOT COMPLETED|Overall Study||5
3085962|NCT01409564|3807899|FG001|NOT COMPLETED|Overall Study||5
3085963|NCT01409707|3807912|FG000|STARTED|Overall Study||41
3085964|NCT01409707|3807913|FG001|STARTED|Overall Study||45
3085965|NCT01409707|3807914|FG002|STARTED|Overall Study||40
3085966|NCT01409707|3807912|FG000|COMPLETED|Overall Study||36
3085967|NCT01409707|3807913|FG001|COMPLETED|Overall Study||28
3085968|NCT01409707|3807914|FG002|COMPLETED|Overall Study||24
3085969|NCT01409707|3807912|FG000|NOT COMPLETED|Overall Study||5
3085970|NCT01409707|3807913|FG001|NOT COMPLETED|Overall Study||17
3085971|NCT01409707|3807914|FG002|NOT COMPLETED|Overall Study||16
3085972|NCT01409811|3807921|FG000|STARTED|Overall Study||9
3085973|NCT01409811|3807921|FG000|COMPLETED|Overall Study||8
3085974|NCT01409811|3807921|FG000|NOT COMPLETED|Overall Study||1
3085975|NCT01409837|3807927|FG000|STARTED|Overall Study||17
3085976|NCT01409837|3807928|FG001|STARTED|Overall Study||16
3085977|NCT01409837|3807927|FG000|6th Week|Overall Study||17
3085978|NCT01409837|3807928|FG001|6th Week|Overall Study||16
3085979|NCT01409837|3807927|FG000|12th Week|Overall Study|Moved away to another location|16
3085980|NCT01409837|3807928|FG001|12th Week|Overall Study||16
3085981|NCT01409837|3807927|FG000|24th Week|Overall Study||16
3085982|NCT01409837|3807928|FG001|24th Week|Overall Study|Diagnosed with Lymphocytic Lymphoma and withdrawn|15
3085983|NCT01409837|3807927|FG000|48th Week|Overall Study|Lost to follow-up|15
3085984|NCT01409837|3807928|FG001|48th Week|Overall Study||15
3085985|NCT01409837|3807927|FG000|96th Week|Overall Study||15
3085986|NCT01409837|3807928|FG001|96th Week|Overall Study||15
3085987|NCT01409837|3807927|FG000|102nd Week|Overall Study||15
3085988|NCT01409837|3807928|FG001|102nd Week|Overall Study|Married another wife|14
3085989|NCT01409837|3807927|FG000|114th Week|Overall Study||15
3085990|NCT01409837|3807928|FG001|114th Week|Overall Study||14
3085991|NCT01409837|3807927|FG000|138th Week|Overall Study||15
3085992|NCT01409837|3807928|FG001|138th Week|Overall Study||14
3085993|NCT01409837|3807927|FG000|186th Week|Overall Study|Moved away to another location|14
3085994|NCT01409837|3807928|FG001|186th Week|Overall Study||14
3085995|NCT01409837|3807927|FG000|282nd Week|Overall Study||14
3287528|NCT02792829|4021210|FG003|STARTED|Wash Out Period||5
3287529|NCT02792829|4021211|FG004|STARTED|Wash Out Period||5
3287530|NCT02792829|4021212|FG005|STARTED|Wash Out Period||5
3287531|NCT02792829|4021213|FG006|STARTED|Wash Out Period||10
3287532|NCT02792829|4021214|FG007|STARTED|Wash Out Period||10
3287533|NCT02792829|4021207|FG000|COMPLETED|Wash Out Period||10
3287534|NCT02792829|4021208|FG001|COMPLETED|Wash Out Period||10
3287535|NCT02792829|4021209|FG002|COMPLETED|Wash Out Period||5
3287536|NCT02792829|4021210|FG003|COMPLETED|Wash Out Period||5
3287537|NCT02792829|4021211|FG004|COMPLETED|Wash Out Period||5
3287538|NCT02792829|4021212|FG005|COMPLETED|Wash Out Period||5
3287539|NCT02792829|4021213|FG006|COMPLETED|Wash Out Period||10
3287540|NCT02792829|4021214|FG007|COMPLETED|Wash Out Period||10
3287541|NCT02792829|4021207|FG000|NOT COMPLETED|Wash Out Period||0
3287542|NCT02792829|4021208|FG001|NOT COMPLETED|Wash Out Period||0
3287543|NCT02792829|4021209|FG002|NOT COMPLETED|Wash Out Period||0
3085996|NCT01409837|3807928|FG001|282nd Week|Overall Study||14
3085997|NCT01409837|3807927|FG000|COMPLETED|Overall Study||14
3085998|NCT01409837|3807928|FG001|COMPLETED|Overall Study||14
3287544|NCT02792829|4021210|FG003|NOT COMPLETED|Wash Out Period||0
3287545|NCT02792829|4021211|FG004|NOT COMPLETED|Wash Out Period||0
3287546|NCT02792829|4021212|FG005|NOT COMPLETED|Wash Out Period||0
3287547|NCT02792829|4021213|FG006|NOT COMPLETED|Wash Out Period||0
3287548|NCT02792829|4021214|FG007|NOT COMPLETED|Wash Out Period||0
3287549|NCT02792829|4021207|FG000|STARTED|Treatment Period 2||10
3287550|NCT02792829|4021208|FG001|STARTED|Treatment Period 2||10
3287551|NCT02792829|4021209|FG002|STARTED|Treatment Period 2||5
3287552|NCT02792829|4021210|FG003|STARTED|Treatment Period 2||5
3287553|NCT02792829|4021211|FG004|STARTED|Treatment Period 2||5
3085999|NCT01409837|3807927|FG000|NOT COMPLETED|Overall Study||3
3086000|NCT01409837|3807928|FG001|NOT COMPLETED|Overall Study||2
3287554|NCT02792829|4021212|FG005|STARTED|Treatment Period 2||5
3086001|NCT01409915|3807938|FG000|STARTED|Overall Study||21
3086002|NCT01409915|3807939|FG001|STARTED|Overall Study||23
3086003|NCT01409915|3807938|FG000|COMPLETED|Overall Study||20
3086004|NCT01409915|3807939|FG001|COMPLETED|Overall Study||20
3086005|NCT01409915|3807938|FG000|NOT COMPLETED|Overall Study||1
3086006|NCT01409915|3807939|FG001|NOT COMPLETED|Overall Study||3
3086007|NCT01409928|3807945|FG000|STARTED|Overall Study||16
3086008|NCT01409928|3807945|FG000|COMPLETED|Overall Study||4
3086009|NCT01409928|3807945|FG000|NOT COMPLETED|Overall Study||12
3086010|NCT01409993|3807951|FG000|STARTED|Overall Study||25
3086011|NCT01409993|3807952|FG001|STARTED|Overall Study||26
3086012|NCT01409993|3807953|FG002|STARTED|Overall Study||14
3086013|NCT01409993|3807954|FG003|STARTED|Overall Study||13
3086014|NCT01409993|3807951|FG000|COMPLETED|Overall Study||21
3086015|NCT01409993|3807952|FG001|COMPLETED|Overall Study||21
3086016|NCT01409993|3807953|FG002|COMPLETED|Overall Study||11
3086017|NCT01409993|3807954|FG003|COMPLETED|Overall Study||8
3086018|NCT01409993|3807951|FG000|NOT COMPLETED|Overall Study||4
3086019|NCT01409993|3807952|FG001|NOT COMPLETED|Overall Study||5
3086020|NCT01409993|3807953|FG002|NOT COMPLETED|Overall Study||3
3086021|NCT01409993|3807954|FG003|NOT COMPLETED|Overall Study||5
3086022|NCT01410058|3807970|FG000|STARTED|Washout Day 0||13
3086023|NCT01410058|3807971|FG001|STARTED|Washout Day 0||6
3086024|NCT01410058|3807970|FG000|COMPLETED|Washout Day 0||13
3086025|NCT01410058|3807971|FG001|COMPLETED|Washout Day 0||6
3086026|NCT01410058|3807970|FG000|NOT COMPLETED|Washout Day 0||0
3086027|NCT01410058|3807971|FG001|NOT COMPLETED|Washout Day 0||0
3086028|NCT01410058|3807970|FG000|STARTED|Baseline Day 22||13
3086029|NCT01410058|3807971|FG001|STARTED|Baseline Day 22||6
3086030|NCT01410058|3807970|FG000|COMPLETED|Baseline Day 22||13
3086031|NCT01410058|3807971|FG001|COMPLETED|Baseline Day 22||6
3086032|NCT01410058|3807970|FG000|NOT COMPLETED|Baseline Day 22||0
3086033|NCT01410058|3807971|FG001|NOT COMPLETED|Baseline Day 22||0
3086034|NCT01410058|3807970|FG000|STARTED|Day 35||13
3086035|NCT01410058|3807971|FG001|STARTED|Day 35||6
3086036|NCT01410058|3807970|FG000|COMPLETED|Day 35||13
3086037|NCT01410058|3807971|FG001|COMPLETED|Day 35||6
3086038|NCT01410058|3807970|FG000|NOT COMPLETED|Day 35||0
3086039|NCT01410058|3807971|FG001|NOT COMPLETED|Day 35||0
3086040|NCT01410084|3807981|FG000|STARTED|Overall Study||38
3086041|NCT01410084|3807982|FG001|STARTED|Overall Study||30
3086042|NCT01410084|3807981|FG000|COMPLETED|Overall Study||37
3086043|NCT01410084|3807982|FG001|COMPLETED|Overall Study||27
3086044|NCT01410084|3807981|FG000|NOT COMPLETED|Overall Study||1
3086045|NCT01410084|3807982|FG001|NOT COMPLETED|Overall Study||3
3086046|NCT01410097|3807990|FG000|STARTED|Overall Study||556
3086047|NCT01410097|3807991|FG001|STARTED|Overall Study||533
3086048|NCT01410097|3807990|FG000|COMPLETED|Overall Study||551
3086049|NCT01410097|3807991|FG001|COMPLETED|Overall Study||530
3086050|NCT01410097|3807990|FG000|NOT COMPLETED|Overall Study||5
3086051|NCT01410097|3807991|FG001|NOT COMPLETED|Overall Study||3
3086052|NCT01410110|3807999|FG000|STARTED|Overall Study||24
3086053|NCT01410110|3808000|FG001|STARTED|Overall Study||24
3086054|NCT01410110|3807999|FG000|Randomization|Overall Study||24
3086055|NCT01410110|3808000|FG001|Randomization|Overall Study||24
3086056|NCT01410110|3807999|FG000|3 Months (End of Intervention)|Overall Study||20
3086057|NCT01410110|3808000|FG001|3 Months (End of Intervention)|Overall Study||22
3086058|NCT01410110|3807999|FG000|6 Month Follow-up|Overall Study||20
3086059|NCT01410110|3808000|FG001|6 Month Follow-up|Overall Study||22
3086060|NCT01410110|3807999|FG000|COMPLETED|Overall Study||20
3086061|NCT01410110|3808000|FG001|COMPLETED|Overall Study||22
3086062|NCT01410110|3807999|FG000|NOT COMPLETED|Overall Study||4
3086063|NCT01410110|3808000|FG001|NOT COMPLETED|Overall Study||2
3086064|NCT01410227|3808006|FG000|STARTED|Overall Study||8
3086065|NCT01410227|3808007|FG001|STARTED|Overall Study||8
3086066|NCT01410227|3808008|FG002|STARTED|Overall Study||15
3086067|NCT01410227|3808009|FG003|STARTED|Overall Study||6
3086068|NCT01410227|3808006|FG000|COMPLETED|Overall Study||4
3086069|NCT01410227|3808007|FG001|COMPLETED|Overall Study||8
3086070|NCT01410227|3808008|FG002|COMPLETED|Overall Study||13
3086071|NCT01410227|3808009|FG003|COMPLETED|Overall Study||5
3086072|NCT01410227|3808006|FG000|NOT COMPLETED|Overall Study||4
3086073|NCT01410227|3808007|FG001|NOT COMPLETED|Overall Study||0
3086074|NCT01410227|3808008|FG002|NOT COMPLETED|Overall Study||2
3086075|NCT01410227|3808009|FG003|NOT COMPLETED|Overall Study||1
3086076|NCT01410240|3808022|FG000|STARTED|Overall Study||53
3086077|NCT01410240|3808023|FG001|STARTED|Overall Study||53
3086078|NCT01410240|3808024|FG002|STARTED|Overall Study||12
3086079|NCT01410240|3808022|FG000|COMPLETED|Overall Study||52
3086080|NCT01410240|3808023|FG001|COMPLETED|Overall Study||52
3086081|NCT01410240|3808024|FG002|COMPLETED|Overall Study||10
3086082|NCT01410240|3808022|FG000|NOT COMPLETED|Overall Study||1
3086083|NCT01410240|3808023|FG001|NOT COMPLETED|Overall Study||1
3086084|NCT01410240|3808024|FG002|NOT COMPLETED|Overall Study||2
3086085|NCT01410344|3808033|FG000|STARTED|Overall Study||20
3086086|NCT01410344|3808033|FG000|COMPLETED|Overall Study||17
3086087|NCT01410344|3808033|FG000|NOT COMPLETED|Overall Study||3
3086088|NCT01410357|3808041|FG000|STARTED|Overall Study||100
3086089|NCT01410357|3808042|FG001|STARTED|Overall Study||100
3086090|NCT01410357|3808041|FG000|COMPLETED|Overall Study||74
3086091|NCT01410357|3808042|FG001|COMPLETED|Overall Study||76
3086092|NCT01410357|3808041|FG000|NOT COMPLETED|Overall Study||26
3086093|NCT01410357|3808042|FG001|NOT COMPLETED|Overall Study||24
3086094|NCT01410409|3808052|FG000|STARTED|Overall Study||50
3086095|NCT01410409|3808053|FG001|STARTED|Overall Study||50
3086096|NCT01410409|3808052|FG000|COMPLETED|Overall Study||49
3086097|NCT01410409|3808053|FG001|COMPLETED|Overall Study||46
3086098|NCT01410409|3808052|FG000|NOT COMPLETED|Overall Study||1
3086099|NCT01410409|3808053|FG001|NOT COMPLETED|Overall Study||4
3086100|NCT01410448|3808061|FG000|STARTED|Overall Study||193
3086101|NCT01410448|3808062|FG001|STARTED|Overall Study||190
3086102|NCT01410448|3808061|FG000|Intent-to Treat (ITT) Analysis Set|Overall Study||193
3086103|NCT01410448|3808062|FG001|Intent-to Treat (ITT) Analysis Set|Overall Study||190
3086104|NCT01410448|3808061|FG000|Modified ITT Analysis Set|Overall Study||161
3086105|NCT01410448|3808062|FG001|Modified ITT Analysis Set|Overall Study||149
3086106|NCT01410448|3808061|FG000|COMPLETED|Overall Study||181
3086107|NCT01410448|3808062|FG001|COMPLETED|Overall Study||155
3086108|NCT01410448|3808061|FG000|NOT COMPLETED|Overall Study||12
3086109|NCT01410448|3808062|FG001|NOT COMPLETED|Overall Study||35
3086110|NCT01410474|3808070|FG000|STARTED|Overall Study||173
3086111|NCT01410474|3808071|FG001|STARTED|Overall Study||168
3086112|NCT01410474|3808070|FG000|COMPLETED|Overall Study||173
3086113|NCT01410474|3808071|FG001|COMPLETED|Overall Study||167
3086114|NCT01410474|3808070|FG000|NOT COMPLETED|Overall Study||0
3086115|NCT01410474|3808071|FG001|NOT COMPLETED|Overall Study||1
3086116|NCT01410552|3808084|FG000|STARTED|Overall Study||1013
3287555|NCT02792829|4021213|FG006|STARTED|Treatment Period 2||10
3287556|NCT02792829|4021214|FG007|STARTED|Treatment Period 2||10
3086117|NCT01410552|3808084|FG000|COMPLETED|Overall Study||877
3086118|NCT01410552|3808084|FG000|NOT COMPLETED|Overall Study||136
3086119|NCT01410565|3808090|FG000|STARTED|Open Label Phase Apaziquone||0
3086120|NCT01410565|3808091|FG001|STARTED|Open Label Phase Apaziquone||0
3086121|NCT01410565|3808092|FG002|STARTED|Open Label Phase Apaziquone||66
3086122|NCT01410565|3808090|FG000|COMPLETED|Open Label Phase Apaziquone||0
3086123|NCT01410565|3808091|FG001|COMPLETED|Open Label Phase Apaziquone||0
3086124|NCT01410565|3808092|FG002|COMPLETED|Open Label Phase Apaziquone||58
3086125|NCT01410565|3808090|FG000|NOT COMPLETED|Open Label Phase Apaziquone||0
3086126|NCT01410565|3808091|FG001|NOT COMPLETED|Open Label Phase Apaziquone||0
3086127|NCT01410565|3808092|FG002|NOT COMPLETED|Open Label Phase Apaziquone||8
3086128|NCT01410565|3808090|FG000|STARTED|Double Blind Phase|All 66 patients received one dose of Apaziquone in the open label phase.|13
3086129|NCT01410565|3808091|FG001|STARTED|Double Blind Phase||15
3086130|NCT01410565|3808092|FG002|STARTED|Double Blind Phase||0
3086131|NCT01410565|3808090|FG000|COMPLETED|Double Blind Phase||0
3086132|NCT01410565|3808091|FG001|COMPLETED|Double Blind Phase||0
3086133|NCT01410565|3808092|FG002|COMPLETED|Double Blind Phase||0
3086134|NCT01410565|3808090|FG000|NOT COMPLETED|Double Blind Phase||13
3086135|NCT01410565|3808091|FG001|NOT COMPLETED|Double Blind Phase||15
3086136|NCT01410565|3808092|FG002|NOT COMPLETED|Double Blind Phase||0
3086137|NCT01410604|3808100|FG000|STARTED|Overall Study||15
3086138|NCT01410604|3808101|FG001|STARTED|Overall Study||16
3086139|NCT01410604|3808100|FG000|COMPLETED|Overall Study||12
3086140|NCT01410604|3808101|FG001|COMPLETED|Overall Study||14
3086141|NCT01410604|3808100|FG000|NOT COMPLETED|Overall Study||3
3086142|NCT01410604|3808101|FG001|NOT COMPLETED|Overall Study||2
3086143|NCT01410773|3808107|FG000|STARTED|Overall Study||110
3086144|NCT01410773|3808107|FG000|COMPLETED|Overall Study||110
3086145|NCT01410773|3808107|FG000|NOT COMPLETED|Overall Study||0
3086146|NCT01410812|3808114|FG000|STARTED|Overall Study||75
3086147|NCT01410812|3808115|FG001|STARTED|Overall Study||75
3086148|NCT01410812|3808116|FG002|STARTED|Overall Study||76
3086149|NCT01410812|3808114|FG000|COMPLETED|Overall Study||75
3086150|NCT01410812|3808115|FG001|COMPLETED|Overall Study||75
3086151|NCT01410812|3808116|FG002|COMPLETED|Overall Study||76
3086152|NCT01410812|3808114|FG000|NOT COMPLETED|Overall Study||0
3086153|NCT01410812|3808115|FG001|NOT COMPLETED|Overall Study||0
3086154|NCT01410812|3808116|FG002|NOT COMPLETED|Overall Study||0
3086155|NCT01410890|3808126|FG000|STARTED|Overall Study||10
3086156|NCT01410890|3808127|FG001|STARTED|Overall Study||11
3086157|NCT01410890|3808126|FG000|Treated|Overall Study||10
3086158|NCT01410890|3808127|FG001|Treated|Overall Study||10
3086159|NCT01410890|3808126|FG000|COMPLETED|Overall Study||10
3086160|NCT01410890|3808127|FG001|COMPLETED|Overall Study||10
3086161|NCT01410890|3808126|FG000|NOT COMPLETED|Overall Study||0
3086162|NCT01410890|3808127|FG001|NOT COMPLETED|Overall Study||1
3086163|NCT01411085|3808135|FG000|STARTED|Overall Study||10
3086164|NCT01411085|3808135|FG000|COMPLETED|Overall Study||7
3086165|NCT01411085|3808135|FG000|NOT COMPLETED|Overall Study||3
3086166|NCT01411137|3808139|FG000|STARTED|Part 1: Dose Conversion||43
3086167|NCT01411137|3808139|FG000|COMPLETED|Part 1: Dose Conversion||33
3086168|NCT01411137|3808139|FG000|NOT COMPLETED|Part 1: Dose Conversion||10
3086169|NCT01411137|3808139|FG000|STARTED|Part 2: Open-Label Extension|1 subject who completed Part 1 did not elect to continue into Part 2.|32
3086170|NCT01411137|3808139|FG000|COMPLETED|Part 2: Open-Label Extension||25
3086171|NCT01411137|3808139|FG000|NOT COMPLETED|Part 2: Open-Label Extension||7
3086172|NCT01411137|3808139|FG000|STARTED|Part 3: Open-Label Extension|Two sites with 11 completers of Part 2 did not participate in Part 3. Two subjects lost contact.|12
3086173|NCT01411137|3808139|FG000|COMPLETED|Part 3: Open-Label Extension||12
3086174|NCT01411137|3808139|FG000|NOT COMPLETED|Part 3: Open-Label Extension||0
3086175|NCT01411215|3808156|FG000|STARTED|Overall Study||69
3086176|NCT01411215|3808157|FG001|STARTED|Overall Study||91
3086177|NCT01411215|3808156|FG000|Treated|Overall Study||69
3134907|NCT01703286|3859849|FG003|NOT COMPLETED|Period 1 Including Washout||1
3086178|NCT01411215|3808157|FG001|Treated|Overall Study|1 participant was considered as screen failure and therefore not treated.|90
3086179|NCT01411215|3808156|FG000|COMPLETED|Overall Study||3
3086180|NCT01411215|3808157|FG001|COMPLETED|Overall Study||7
3086181|NCT01411215|3808156|FG000|NOT COMPLETED|Overall Study||66
3086182|NCT01411215|3808157|FG001|NOT COMPLETED|Overall Study||84
3086183|NCT01411228|3808166|FG000|STARTED|Overall Study||5
3086184|NCT01411228|3808167|FG001|STARTED|Overall Study||5
3086185|NCT01411228|3808168|FG002|STARTED|Overall Study||5
3086186|NCT01411228|3808166|FG000|COMPLETED|Overall Study||4
3086187|NCT01411228|3808167|FG001|COMPLETED|Overall Study||5
3086188|NCT01411228|3808168|FG002|COMPLETED|Overall Study||4
3086189|NCT01411228|3808166|FG000|NOT COMPLETED|Overall Study||1
3086190|NCT01411228|3808167|FG001|NOT COMPLETED|Overall Study||0
3086191|NCT01411228|3808168|FG002|NOT COMPLETED|Overall Study||1
3086192|NCT01411241|3808178|FG000|STARTED|Overall Study||309
3086193|NCT01411241|3808179|FG001|STARTED|Overall Study||315
3086194|NCT01411241|3808178|FG000|COMPLETED|Overall Study||298
3086195|NCT01411241|3808179|FG001|COMPLETED|Overall Study||293
3086196|NCT01411241|3808178|FG000|NOT COMPLETED|Overall Study||11
3086197|NCT01411241|3808179|FG001|NOT COMPLETED|Overall Study||22
3086198|NCT01411267|3808191|FG000|STARTED|Overall Study||0
3086199|NCT01411267|3808192|FG001|STARTED|Overall Study||3
3086200|NCT01411267|3808193|FG002|STARTED|Overall Study||2
3086201|NCT01411267|3808194|FG003|STARTED|Overall Study||5
3086202|NCT01411267|3808195|FG004|STARTED|Overall Study||2
3086203|NCT01411267|3808196|FG005|STARTED|Overall Study||12
3086204|NCT01411267|3808197|FG006|STARTED|Overall Study||0
3086205|NCT01411267|3808198|FG007|STARTED|Overall Study||0
3086206|NCT01411267|3808199|FG008|STARTED|Overall Study||0
3086207|NCT01411267|3808200|FG009|STARTED|Overall Study||0
3086208|NCT01411267|3808191|FG000|COMPLETED|Overall Study||0
3086209|NCT01411267|3808192|FG001|COMPLETED|Overall Study||3
3086210|NCT01411267|3808193|FG002|COMPLETED|Overall Study||2
3086211|NCT01411267|3808194|FG003|COMPLETED|Overall Study||4
3086212|NCT01411267|3808195|FG004|COMPLETED|Overall Study||0
3086213|NCT01411267|3808196|FG005|COMPLETED|Overall Study||10
3086214|NCT01411267|3808197|FG006|COMPLETED|Overall Study||0
3086215|NCT01411267|3808198|FG007|COMPLETED|Overall Study||0
3086216|NCT01411267|3808199|FG008|COMPLETED|Overall Study||0
3086217|NCT01411267|3808200|FG009|COMPLETED|Overall Study||0
3086218|NCT01411267|3808191|FG000|NOT COMPLETED|Overall Study||0
3086219|NCT01411267|3808192|FG001|NOT COMPLETED|Overall Study||0
3086220|NCT01411267|3808193|FG002|NOT COMPLETED|Overall Study||0
3086221|NCT01411267|3808194|FG003|NOT COMPLETED|Overall Study||1
3086222|NCT01411267|3808195|FG004|NOT COMPLETED|Overall Study||2
3086223|NCT01411267|3808196|FG005|NOT COMPLETED|Overall Study||2
3086224|NCT01411267|3808197|FG006|NOT COMPLETED|Overall Study||0
3086225|NCT01411267|3808198|FG007|NOT COMPLETED|Overall Study||0
3086226|NCT01411267|3808199|FG008|NOT COMPLETED|Overall Study||0
3086227|NCT01411267|3808200|FG009|NOT COMPLETED|Overall Study||0
3086228|NCT01411319|3808218|FG000|STARTED|Overall Study||25
3086229|NCT01411319|3808218|FG000|COMPLETED|Overall Study||24
3086230|NCT01411319|3808218|FG000|NOT COMPLETED|Overall Study||1
3086231|NCT01411488|3808224|FG000|STARTED|Overall Study||41
3086232|NCT01411488|3808225|FG001|STARTED|Overall Study||38
3086233|NCT01411488|3808224|FG000|COMPLETED|Overall Study||41
3086234|NCT01411488|3808225|FG001|COMPLETED|Overall Study||38
3086235|NCT01411488|3808224|FG000|NOT COMPLETED|Overall Study||0
3086236|NCT01411488|3808225|FG001|NOT COMPLETED|Overall Study||0
3086237|NCT01411501|3808235|FG000|STARTED|Overall Study||168
3086238|NCT01411501|3808236|FG001|STARTED|Overall Study||172
3086239|NCT01411501|3808237|FG002|STARTED|Overall Study||165
3086240|NCT01411501|3808238|FG003|STARTED|Overall Study||170
3086241|NCT01411501|3808235|FG000|COMPLETED|Overall Study||158
3086242|NCT01411501|3808236|FG001|COMPLETED|Overall Study||166
3086243|NCT01411501|3808237|FG002|COMPLETED|Overall Study||159
3086244|NCT01411501|3808238|FG003|COMPLETED|Overall Study||163
3086245|NCT01411501|3808235|FG000|NOT COMPLETED|Overall Study||10
3086246|NCT01411501|3808236|FG001|NOT COMPLETED|Overall Study||6
3086247|NCT01411501|3808237|FG002|NOT COMPLETED|Overall Study||6
3086248|NCT01411501|3808238|FG003|NOT COMPLETED|Overall Study||7
3086249|NCT01411527|3808250|FG000|STARTED|Overall Study||1864
3086250|NCT01411527|3808251|FG001|STARTED|Overall Study||93
3086251|NCT01411527|3808250|FG000|COMPLETED|Overall Study||1864
3086252|NCT01411527|3808251|FG001|COMPLETED|Overall Study||93
3086253|NCT01411527|3808250|FG000|NOT COMPLETED|Overall Study||0
3086254|NCT01411527|3808251|FG001|NOT COMPLETED|Overall Study||0
3086255|NCT01411592|3808258|FG000|STARTED|Overall Study||14
3086256|NCT01411592|3808259|FG001|STARTED|Overall Study||16
3086257|NCT01411592|3808258|FG000|5-Year Time Frame|Overall Study||14
3086258|NCT01411592|3808259|FG001|5-Year Time Frame|Overall Study||16
3086259|NCT01411592|3808258|FG000|COMPLETED|Overall Study||14
3086260|NCT01411592|3808259|FG001|COMPLETED|Overall Study||16
3086261|NCT01411592|3808258|FG000|NOT COMPLETED|Overall Study||0
3086262|NCT01411592|3808259|FG001|NOT COMPLETED|Overall Study||0
3086263|NCT01411696|3808265|FG000|STARTED|Overall Study||289
3086264|NCT01411696|3808265|FG000|COMPLETED|Overall Study||289
3086265|NCT01411696|3808265|FG000|NOT COMPLETED|Overall Study||0
3086266|NCT01411774|3808271|FG000|STARTED|Overall Study||72
3086267|NCT01411774|3808272|FG001|STARTED|Overall Study||70
3086268|NCT01411774|3808271|FG000|COMPLETED|Overall Study||72
3086269|NCT01411774|3808272|FG001|COMPLETED|Overall Study||67
3086270|NCT01411774|3808271|FG000|NOT COMPLETED|Overall Study||0
3086271|NCT01411774|3808272|FG001|NOT COMPLETED|Overall Study||3
3086272|NCT01411839|3808280|FG000|STARTED|Overall Study||20
3086273|NCT01411839|3808281|FG001|STARTED|Overall Study||20
3086274|NCT01411839|3808280|FG000|COMPLETED|Overall Study||16
3086275|NCT01411839|3808281|FG001|COMPLETED|Overall Study||17
3086276|NCT01411839|3808280|FG000|NOT COMPLETED|Overall Study||4
3086277|NCT01411839|3808281|FG001|NOT COMPLETED|Overall Study||3
3086278|NCT01411852|3808289|FG000|STARTED|Prehospital Intervention Phase|1 patient randomized to 2000 mL bolus arm but received 250 mL bolus. Analyzed in 2000 mL arm.|95
3086279|NCT01411852|3808290|FG001|STARTED|Prehospital Intervention Phase|One patient was in police custody at the time of enrollment. Patient's data omitted from analyses.|96
3086280|NCT01411852|3808289|FG000|COMPLETED|Prehospital Intervention Phase|12 patients had the intervention stopped prior to hospital arrival|83
3086281|NCT01411852|3808290|FG001|COMPLETED|Prehospital Intervention Phase|7 patients had intervention stopped prior to hospital arrival|89
3086282|NCT01411852|3808289|FG000|NOT COMPLETED|Prehospital Intervention Phase||12
3086283|NCT01411852|3808290|FG001|NOT COMPLETED|Prehospital Intervention Phase||7
3086284|NCT01411852|3808289|FG000|STARTED|Hospital Intervention Phase||83
3086285|NCT01411852|3808290|FG001|STARTED|Hospital Intervention Phase||89
3086286|NCT01411852|3808289|FG000|COMPLETED|Hospital Intervention Phase|24 patients had intervention stopped prior to 2 hours after arrival or hemorrhage control|59
3086287|NCT01411852|3808290|FG001|COMPLETED|Hospital Intervention Phase|18 patients had intervention stopped prior to 2 hours after arrival or hemorrhage control|71
3086288|NCT01411852|3808289|FG000|NOT COMPLETED|Hospital Intervention Phase||24
3086289|NCT01411852|3808290|FG001|NOT COMPLETED|Hospital Intervention Phase||18
3086290|NCT01411891|3808300|FG000|STARTED|Overall Study||50
3086291|NCT01411891|3808301|FG001|STARTED|Overall Study||50
3086292|NCT01411891|3808300|FG000|COMPLETED|Overall Study||47
3086293|NCT01411891|3808301|FG001|COMPLETED|Overall Study||48
3086294|NCT01411891|3808300|FG000|NOT COMPLETED|Overall Study||3
3086295|NCT01411891|3808301|FG001|NOT COMPLETED|Overall Study||2
3086296|NCT01411917|3808309|FG000|STARTED|Overall Study||32
3086297|NCT01411917|3808310|FG001|STARTED|Overall Study||37
3086298|NCT01411917|3808309|FG000|COMPLETED|Overall Study||32
3086299|NCT01411917|3808310|FG001|COMPLETED|Overall Study||36
3086300|NCT01411917|3808309|FG000|NOT COMPLETED|Overall Study||0
3086301|NCT01411917|3808310|FG001|NOT COMPLETED|Overall Study||1
3086302|NCT01411995|3808318|FG000|STARTED|Overall Study||100
3086303|NCT01411995|3808319|FG001|STARTED|Overall Study||100
3086304|NCT01411995|3808318|FG000|COMPLETED|Overall Study||100
3086305|NCT01411995|3808319|FG001|COMPLETED|Overall Study||99
3086306|NCT01411995|3808318|FG000|NOT COMPLETED|Overall Study||0
3086307|NCT01411995|3808319|FG001|NOT COMPLETED|Overall Study||1
3086308|NCT01412021|3808325|FG000|STARTED|Overall Study||375
3086309|NCT01412021|3808325|FG000|Case Report Forms Locked|Overall Study||368
3086310|NCT01412021|3808325|FG000|COMPLETED|Overall Study||356
3086311|NCT01412021|3808325|FG000|NOT COMPLETED|Overall Study||19
3086312|NCT01412060|3808329|FG000|STARTED|Open-label Run-in Period (RIP)||765
3086313|NCT01412060|3808330|FG001|STARTED|Open-label Run-in Period (RIP)||0
3086314|NCT01412060|3808331|FG002|STARTED|Open-label Run-in Period (RIP)||0
3086315|NCT01412060|3808329|FG000|COMPLETED|Open-label Run-in Period (RIP)||418
3086316|NCT01412060|3808330|FG001|COMPLETED|Open-label Run-in Period (RIP)||0
3086317|NCT01412060|3808331|FG002|COMPLETED|Open-label Run-in Period (RIP)||0
3086318|NCT01412060|3808329|FG000|NOT COMPLETED|Open-label Run-in Period (RIP)||347
3086319|NCT01412060|3808330|FG001|NOT COMPLETED|Open-label Run-in Period (RIP)||0
3086320|NCT01412060|3808331|FG002|NOT COMPLETED|Open-label Run-in Period (RIP)||0
3086321|NCT01412060|3808329|FG000|STARTED|Period Between RIP and SP||418
3086322|NCT01412060|3808330|FG001|STARTED|Period Between RIP and SP||0
3086323|NCT01412060|3808331|FG002|STARTED|Period Between RIP and SP||0
3086324|NCT01412060|3808329|FG000|COMPLETED|Period Between RIP and SP||364
3086325|NCT01412060|3808330|FG001|COMPLETED|Period Between RIP and SP||0
3086326|NCT01412060|3808331|FG002|COMPLETED|Period Between RIP and SP||0
3086327|NCT01412060|3808329|FG000|NOT COMPLETED|Period Between RIP and SP||54
3287557|NCT02792829|4021207|FG000|COMPLETED|Treatment Period 2||10
3287558|NCT02792829|4021208|FG001|COMPLETED|Treatment Period 2||9
3287559|NCT02792829|4021209|FG002|COMPLETED|Treatment Period 2||5
3287560|NCT02792829|4021210|FG003|COMPLETED|Treatment Period 2||5
3287561|NCT02792829|4021211|FG004|COMPLETED|Treatment Period 2||4
3287562|NCT02792829|4021212|FG005|COMPLETED|Treatment Period 2||5
3287563|NCT02792829|4021213|FG006|COMPLETED|Treatment Period 2||9
3287564|NCT02792829|4021214|FG007|COMPLETED|Treatment Period 2||8
3287565|NCT02792829|4021207|FG000|NOT COMPLETED|Treatment Period 2||0
3287566|NCT02792829|4021208|FG001|NOT COMPLETED|Treatment Period 2||1
3287567|NCT02792829|4021209|FG002|NOT COMPLETED|Treatment Period 2||0
3287568|NCT02792829|4021210|FG003|NOT COMPLETED|Treatment Period 2||0
3287569|NCT02792829|4021211|FG004|NOT COMPLETED|Treatment Period 2||1
3287570|NCT02792829|4021212|FG005|NOT COMPLETED|Treatment Period 2||0
3287571|NCT02792829|4021213|FG006|NOT COMPLETED|Treatment Period 2||1
3287572|NCT02792829|4021214|FG007|NOT COMPLETED|Treatment Period 2||2
3287573|NCT02792959|4021240|FG000|STARTED|Overall Study||11
3287574|NCT02792959|4021240|FG000|COMPLETED|Overall Study||10
3287575|NCT02792959|4021240|FG000|NOT COMPLETED|Overall Study||1
3287576|NCT02793128|4021244|FG000|STARTED|Overall Study||71
3287577|NCT02793128|4021244|FG000|COMPLETED|Overall Study||62
3287578|NCT02793128|4021244|FG000|NOT COMPLETED|Overall Study||9
3287579|NCT02793154|4021259|FG000|STARTED|Part A (Single Group-up to 12 Days)||4
3287580|NCT02793154|4021260|FG001|STARTED|Part A (Single Group-up to 12 Days)||0
3086328|NCT01412060|3808330|FG001|NOT COMPLETED|Period Between RIP and SP||0
3086329|NCT01412060|3808331|FG002|NOT COMPLETED|Period Between RIP and SP||0
3086330|NCT01412060|3808329|FG000|STARTED|Open-label Stabilization Period (SP)||364
3086331|NCT01412060|3808330|FG001|STARTED|Open-label Stabilization Period (SP)||0
3086332|NCT01412060|3808331|FG002|STARTED|Open-label Stabilization Period (SP)||0
3086333|NCT01412060|3808329|FG000|COMPLETED|Open-label Stabilization Period (SP)||264
3086334|NCT01412060|3808330|FG001|COMPLETED|Open-label Stabilization Period (SP)||0
3086335|NCT01412060|3808331|FG002|COMPLETED|Open-label Stabilization Period (SP)||0
3086336|NCT01412060|3808329|FG000|NOT COMPLETED|Open-label Stabilization Period (SP)||100
3086337|NCT01412060|3808330|FG001|NOT COMPLETED|Open-label Stabilization Period (SP)||0
3086338|NCT01412060|3808331|FG002|NOT COMPLETED|Open-label Stabilization Period (SP)||0
3086339|NCT01412060|3808329|FG000|STARTED|Period Between SP and DBP||264
3086340|NCT01412060|3808330|FG001|STARTED|Period Between SP and DBP||0
3086341|NCT01412060|3808331|FG002|STARTED|Period Between SP and DBP||0
3086342|NCT01412060|3808329|FG000|COMPLETED|Period Between SP and DBP||200
3086343|NCT01412060|3808330|FG001|COMPLETED|Period Between SP and DBP||0
3086344|NCT01412060|3808331|FG002|COMPLETED|Period Between SP and DBP||0
3086345|NCT01412060|3808329|FG000|NOT COMPLETED|Period Between SP and DBP||64
3086346|NCT01412060|3808330|FG001|NOT COMPLETED|Period Between SP and DBP||0
3086347|NCT01412060|3808331|FG002|NOT COMPLETED|Period Between SP and DBP||0
3086348|NCT01412060|3808329|FG000|STARTED|Double-blind Treatment Phase (DBP)||0
3086349|NCT01412060|3808330|FG001|STARTED|Double-blind Treatment Phase (DBP)||99
3086350|NCT01412060|3808331|FG002|STARTED|Double-blind Treatment Phase (DBP)||101
3086351|NCT01412060|3808329|FG000|COMPLETED|Double-blind Treatment Phase (DBP)||0
3086352|NCT01412060|3808330|FG001|COMPLETED|Double-blind Treatment Phase (DBP)||16
3086353|NCT01412060|3808331|FG002|COMPLETED|Double-blind Treatment Phase (DBP)||18
3086354|NCT01412060|3808329|FG000|NOT COMPLETED|Double-blind Treatment Phase (DBP)||0
3086355|NCT01412060|3808330|FG001|NOT COMPLETED|Double-blind Treatment Phase (DBP)||83
3086356|NCT01412060|3808331|FG002|NOT COMPLETED|Double-blind Treatment Phase (DBP)||83
3086357|NCT01412086|3808341|FG000|STARTED|Overall Study||112
3086358|NCT01412086|3808341|FG000|COMPLETED|Overall Study||112
3086359|NCT01412086|3808341|FG000|NOT COMPLETED|Overall Study||0
3086360|NCT01412151|3808345|FG000|STARTED|Week 0 - 306 - Treatment Period||10
3086361|NCT01412151|3808345|FG000|COMPLETED|Week 0 - 306 - Treatment Period||5
3086362|NCT01412151|3808345|FG000|NOT COMPLETED|Week 0 - 306 - Treatment Period||5
3086363|NCT01412151|3808345|FG000|STARTED|Week 306 - 310 - Washout Period||5
3086364|NCT01412151|3808345|FG000|COMPLETED|Week 306 - 310 - Washout Period||3
3086365|NCT01412151|3808345|FG000|NOT COMPLETED|Week 306 - 310 - Washout Period||2
3086366|NCT01412164|3808351|FG000|STARTED|Overall Study||730
3086367|NCT01412164|3808351|FG000|COMPLETED|Overall Study||683
3086368|NCT01412164|3808351|FG000|NOT COMPLETED|Overall Study||47
3086369|NCT01412229|3808355|FG000|STARTED|Overall Study||39
3086370|NCT01412229|3808355|FG000|COMPLETED|Overall Study||38
3086371|NCT01412229|3808355|FG000|NOT COMPLETED|Overall Study||1
3086372|NCT01412281|3808364|FG000|STARTED|Overall Study||110
3086373|NCT01412281|3808365|FG001|STARTED|Overall Study||110
3086374|NCT01412281|3808366|FG002|STARTED|Overall Study||110
3086375|NCT01412281|3808367|FG003|STARTED|Overall Study||110
3086376|NCT01412281|3808364|FG000|COMPLETED|Overall Study||110
3086377|NCT01412281|3808365|FG001|COMPLETED|Overall Study||110
3086378|NCT01412281|3808366|FG002|COMPLETED|Overall Study||110
3086379|NCT01412281|3808367|FG003|COMPLETED|Overall Study||110
3086380|NCT01412281|3808364|FG000|NOT COMPLETED|Overall Study||0
3086381|NCT01412281|3808365|FG001|NOT COMPLETED|Overall Study||0
3086382|NCT01412281|3808366|FG002|NOT COMPLETED|Overall Study||0
3086383|NCT01412281|3808367|FG003|NOT COMPLETED|Overall Study||0
3086384|NCT01412372|3808379|FG000|STARTED|Overall Study||30
3086385|NCT01412372|3808380|FG001|STARTED|Overall Study||31
3086386|NCT01412372|3808379|FG000|COMPLETED|Overall Study||26
3086387|NCT01412372|3808380|FG001|COMPLETED|Overall Study||28
3086388|NCT01412372|3808379|FG000|NOT COMPLETED|Overall Study||4
3086389|NCT01412372|3808380|FG001|NOT COMPLETED|Overall Study||3
3086390|NCT01412424|3808386|FG000|STARTED|Core Treatment Period||155
3086391|NCT01412424|3808386|FG000|COMPLETED|Core Treatment Period||102
3086392|NCT01412424|3808386|FG000|NOT COMPLETED|Core Treatment Period||53
3086393|NCT01412424|3808386|FG000|STARTED|Extension Treatment Period|86% of participants who completed the core period voluntarily entered the optional extension period.|88
3086394|NCT01412424|3808386|FG000|COMPLETED|Extension Treatment Period||82
3086395|NCT01412424|3808386|FG000|NOT COMPLETED|Extension Treatment Period||6
3086396|NCT01412541|3808398|FG000|STARTED|Overall Study||372
3086397|NCT01412541|3808399|FG001|STARTED|Overall Study||160
3086398|NCT01412541|3808398|FG000|COMPLETED|Overall Study||246
3086399|NCT01412541|3808399|FG001|COMPLETED|Overall Study||117
3086400|NCT01412541|3808398|FG000|NOT COMPLETED|Overall Study||126
3086401|NCT01412541|3808399|FG001|NOT COMPLETED|Overall Study||43
3086402|NCT01412554|3808408|FG000|STARTED|Overall Study|103 persons re-examined in 2012-13 out of 158 persons originally examined in 1991-96.|103
3086403|NCT01412554|3808408|FG000|COMPLETED|Overall Study||103
3086404|NCT01412554|3808408|FG000|NOT COMPLETED|Overall Study||0
3086405|NCT01412710|3808414|FG000|STARTED|Overall Study||50
3086406|NCT01412710|3808415|FG001|STARTED|Overall Study||27
3086407|NCT01412710|3808414|FG000|COMPLETED|Overall Study||46
3086408|NCT01412710|3808415|FG001|COMPLETED|Overall Study||22
3086409|NCT01412710|3808414|FG000|NOT COMPLETED|Overall Study||4
3086410|NCT01412710|3808415|FG001|NOT COMPLETED|Overall Study||5
3086411|NCT01412801|3808427|FG000|STARTED|Overall Study||91
3086412|NCT01412801|3808428|FG001|STARTED|Overall Study||89
3086413|NCT01412801|3808429|FG002|STARTED|Overall Study||90
3086414|NCT01412801|3808430|FG003|STARTED|Overall Study||91
3086415|NCT01412801|3808431|FG004|STARTED|Overall Study||88
3086416|NCT01412801|3808432|FG005|STARTED|Overall Study||87
3086417|NCT01412801|3808427|FG000|COMPLETED|Overall Study||87
3086418|NCT01412801|3808428|FG001|COMPLETED|Overall Study||84
3086419|NCT01412801|3808429|FG002|COMPLETED|Overall Study||83
3086420|NCT01412801|3808430|FG003|COMPLETED|Overall Study||87
3086421|NCT01412801|3808431|FG004|COMPLETED|Overall Study||85
3086422|NCT01412801|3808432|FG005|COMPLETED|Overall Study||84
3086423|NCT01412801|3808427|FG000|NOT COMPLETED|Overall Study||4
3086424|NCT01412801|3808428|FG001|NOT COMPLETED|Overall Study||5
3086425|NCT01412801|3808429|FG002|NOT COMPLETED|Overall Study||7
3086426|NCT01412801|3808430|FG003|NOT COMPLETED|Overall Study||4
3086427|NCT01412801|3808431|FG004|NOT COMPLETED|Overall Study||3
3086428|NCT01412801|3808432|FG005|NOT COMPLETED|Overall Study||3
3086429|NCT01412866|3808457|FG000|STARTED|Overall Study||58
3086430|NCT01412866|3808458|FG001|STARTED|Overall Study||66
3086431|NCT01412866|3808457|FG000|COMPLETED|Overall Study||57
3086432|NCT01412866|3808458|FG001|COMPLETED|Overall Study||64
3086433|NCT01412866|3808457|FG000|NOT COMPLETED|Overall Study||1
3086434|NCT01412866|3808458|FG001|NOT COMPLETED|Overall Study||2
3086435|NCT01412879|3808466|FG000|STARTED|Initial Registration (Induction Therapy)||18
3086436|NCT01412879|3808467|FG001|STARTED|Initial Registration (Induction Therapy)||35
3086437|NCT01412879|3808468|FG002|STARTED|Initial Registration (Induction Therapy)||0
3086438|NCT01412879|3808466|FG000|Treatment Started|Initial Registration (Induction Therapy)||17
3086439|NCT01412879|3808467|FG001|Treatment Started|Initial Registration (Induction Therapy)||35
3086440|NCT01412879|3808468|FG002|Treatment Started|Initial Registration (Induction Therapy)||0
3086441|NCT01412879|3808466|FG000|COMPLETED|Initial Registration (Induction Therapy)||5
3086442|NCT01412879|3808467|FG001|COMPLETED|Initial Registration (Induction Therapy)||27
3086443|NCT01412879|3808468|FG002|COMPLETED|Initial Registration (Induction Therapy)||0
3086444|NCT01412879|3808466|FG000|NOT COMPLETED|Initial Registration (Induction Therapy)||13
3086445|NCT01412879|3808467|FG001|NOT COMPLETED|Initial Registration (Induction Therapy)||8
3086446|NCT01412879|3808468|FG002|NOT COMPLETED|Initial Registration (Induction Therapy)||0
3086447|NCT01412879|3808466|FG000|STARTED|Consolidation Therapy||0
3086448|NCT01412879|3808467|FG001|STARTED|Consolidation Therapy||0
3086449|NCT01412879|3808468|FG002|STARTED|Consolidation Therapy|Only eligible patients who are able to have stem cell harvested receive consolidation therapy.|26
3086450|NCT01412879|3808466|FG000|COMPLETED|Consolidation Therapy||0
3086451|NCT01412879|3808467|FG001|COMPLETED|Consolidation Therapy||0
3086452|NCT01412879|3808468|FG002|COMPLETED|Consolidation Therapy||26
3086453|NCT01412879|3808466|FG000|NOT COMPLETED|Consolidation Therapy||0
3086454|NCT01412879|3808467|FG001|NOT COMPLETED|Consolidation Therapy||0
3086455|NCT01412879|3808468|FG002|NOT COMPLETED|Consolidation Therapy||0
3086456|NCT01412918|3808480|FG000|STARTED|Overall Study||20
3086457|NCT01412918|3808481|FG001|STARTED|Overall Study||1
3086458|NCT01412918|3808480|FG000|COMPLETED|Overall Study||20
3086459|NCT01412918|3808481|FG001|COMPLETED|Overall Study||1
3086460|NCT01412918|3808480|FG000|NOT COMPLETED|Overall Study||0
3086461|NCT01412918|3808481|FG001|NOT COMPLETED|Overall Study||0
3086462|NCT01412944|3808490|FG000|STARTED|IV: Per Previous CAIN457A2304 Treatment||0
3086463|NCT01412944|3808491|FG001|STARTED|IV: Per Previous CAIN457A2304 Treatment||0
3086464|NCT01412944|3808492|FG002|STARTED|IV: Per Previous CAIN457A2304 Treatment||15
3086465|NCT01412944|3808493|FG003|STARTED|IV: Per Previous CAIN457A2304 Treatment||6
3086466|NCT01412944|3808494|FG004|STARTED|IV: Per Previous CAIN457A2304 Treatment||14
3086467|NCT01412944|3808495|FG005|STARTED|IV: Per Previous CAIN457A2304 Treatment||8
3086468|NCT01412944|3808490|FG000|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
3086469|NCT01412944|3808491|FG001|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
3086470|NCT01412944|3808492|FG002|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||14
3086471|NCT01412944|3808493|FG003|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||6
3086472|NCT01412944|3808494|FG004|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||14
3086473|NCT01412944|3808495|FG005|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||6
3086474|NCT01412944|3808490|FG000|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
3086475|NCT01412944|3808491|FG001|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
3086476|NCT01412944|3808492|FG002|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||1
3086477|NCT01412944|3808493|FG003|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
3086478|NCT01412944|3808494|FG004|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
3086479|NCT01412944|3808495|FG005|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||2
3287581|NCT02793154|4021261|FG002|STARTED|Part A (Single Group-up to 12 Days)||0
3287582|NCT02793154|4021259|FG000|COMPLETED|Part A (Single Group-up to 12 Days)||4
3287583|NCT02793154|4021260|FG001|COMPLETED|Part A (Single Group-up to 12 Days)||0
3287584|NCT02793154|4021261|FG002|COMPLETED|Part A (Single Group-up to 12 Days)||0
3287585|NCT02793154|4021259|FG000|NOT COMPLETED|Part A (Single Group-up to 12 Days)||0
3287586|NCT02793154|4021260|FG001|NOT COMPLETED|Part A (Single Group-up to 12 Days)||0
3287587|NCT02793154|4021261|FG002|NOT COMPLETED|Part A (Single Group-up to 12 Days)||0
3287588|NCT02793154|4021259|FG000|STARTED|Part B (Parallel Group-up to 84 Days)||0
3287589|NCT02793154|4021260|FG001|STARTED|Part B (Parallel Group-up to 84 Days)||0
3086480|NCT01412944|3808490|FG000|STARTED|IV: Per CAIN457A2307||21
3287590|NCT02793154|4021261|FG002|STARTED|Part B (Parallel Group-up to 84 Days)||0
3086481|NCT01412944|3808491|FG001|STARTED|IV: Per CAIN457A2307||22
3086482|NCT01412944|3808492|FG002|STARTED|IV: Per CAIN457A2307||0
3086483|NCT01412944|3808493|FG003|STARTED|IV: Per CAIN457A2307||0
2940872|NCT00639457|3653116|FG001|NOT COMPLETED|Overall Study||3
2940873|NCT00639509|3653122|FG000|STARTED|Overall Study||24
2940874|NCT00639509|3653122|FG000|COMPLETED|Overall Study||23
3086484|NCT01412944|3808494|FG004|STARTED|IV: Per CAIN457A2307||0
3086485|NCT01412944|3808495|FG005|STARTED|IV: Per CAIN457A2307||0
3086486|NCT01412944|3808490|FG000|COMPLETED|IV: Per CAIN457A2307||20
3086487|NCT01412944|3808491|FG001|COMPLETED|IV: Per CAIN457A2307||20
3086488|NCT01412944|3808492|FG002|COMPLETED|IV: Per CAIN457A2307||0
3086489|NCT01412944|3808493|FG003|COMPLETED|IV: Per CAIN457A2307||0
3086490|NCT01412944|3808494|FG004|COMPLETED|IV: Per CAIN457A2307||0
3086491|NCT01412944|3808495|FG005|COMPLETED|IV: Per CAIN457A2307||0
3086492|NCT01412944|3808490|FG000|NOT COMPLETED|IV: Per CAIN457A2307||1
3086493|NCT01412944|3808491|FG001|NOT COMPLETED|IV: Per CAIN457A2307||2
3086494|NCT01412944|3808492|FG002|NOT COMPLETED|IV: Per CAIN457A2307||0
3086495|NCT01412944|3808493|FG003|NOT COMPLETED|IV: Per CAIN457A2307||0
3086496|NCT01412944|3808494|FG004|NOT COMPLETED|IV: Per CAIN457A2307||0
3086497|NCT01412944|3808495|FG005|NOT COMPLETED|IV: Per CAIN457A2307||0
3086498|NCT01412944|3808490|FG000|STARTED|Entire: IV + Maintenance||0
3086499|NCT01412944|3808491|FG001|STARTED|Entire: IV + Maintenance||0
3086500|NCT01412944|3808492|FG002|STARTED|Entire: IV + Maintenance||15
3086501|NCT01412944|3808493|FG003|STARTED|Entire: IV + Maintenance||6
3086502|NCT01412944|3808494|FG004|STARTED|Entire: IV + Maintenance||14
3086503|NCT01412944|3808495|FG005|STARTED|Entire: IV + Maintenance||8
3086504|NCT01412944|3808490|FG000|COMPLETED|Entire: IV + Maintenance||0
3086505|NCT01412944|3808491|FG001|COMPLETED|Entire: IV + Maintenance||0
3086506|NCT01412944|3808492|FG002|COMPLETED|Entire: IV + Maintenance||14
3086507|NCT01412944|3808493|FG003|COMPLETED|Entire: IV + Maintenance||5
3086508|NCT01412944|3808494|FG004|COMPLETED|Entire: IV + Maintenance||11
3086509|NCT01412944|3808495|FG005|COMPLETED|Entire: IV + Maintenance||6
3086510|NCT01412944|3808490|FG000|NOT COMPLETED|Entire: IV + Maintenance||0
3086511|NCT01412944|3808491|FG001|NOT COMPLETED|Entire: IV + Maintenance||0
3086512|NCT01412944|3808492|FG002|NOT COMPLETED|Entire: IV + Maintenance||1
3086513|NCT01412944|3808493|FG003|NOT COMPLETED|Entire: IV + Maintenance||1
3086514|NCT01412944|3808494|FG004|NOT COMPLETED|Entire: IV + Maintenance||3
3086515|NCT01412944|3808495|FG005|NOT COMPLETED|Entire: IV + Maintenance||2
3086516|NCT01412944|3808490|FG000|STARTED|Entire: IV + Maintenance||21
3086517|NCT01412944|3808491|FG001|STARTED|Entire: IV + Maintenance||22
3086518|NCT01412944|3808492|FG002|STARTED|Entire: IV + Maintenance||0
3086519|NCT01412944|3808493|FG003|STARTED|Entire: IV + Maintenance||0
3086520|NCT01412944|3808494|FG004|STARTED|Entire: IV + Maintenance||0
3086521|NCT01412944|3808495|FG005|STARTED|Entire: IV + Maintenance||0
3086522|NCT01412944|3808490|FG000|COMPLETED|Entire: IV + Maintenance||19
3086523|NCT01412944|3808491|FG001|COMPLETED|Entire: IV + Maintenance||17
3086524|NCT01412944|3808492|FG002|COMPLETED|Entire: IV + Maintenance||0
3086525|NCT01412944|3808493|FG003|COMPLETED|Entire: IV + Maintenance||0
3086526|NCT01412944|3808494|FG004|COMPLETED|Entire: IV + Maintenance||0
3086527|NCT01412944|3808495|FG005|COMPLETED|Entire: IV + Maintenance||0
3086528|NCT01412944|3808490|FG000|NOT COMPLETED|Entire: IV + Maintenance||2
3086529|NCT01412944|3808491|FG001|NOT COMPLETED|Entire: IV + Maintenance||5
3086530|NCT01412944|3808492|FG002|NOT COMPLETED|Entire: IV + Maintenance||0
3086531|NCT01412944|3808493|FG003|NOT COMPLETED|Entire: IV + Maintenance||0
3086532|NCT01412944|3808494|FG004|NOT COMPLETED|Entire: IV + Maintenance||0
3086533|NCT01412944|3808495|FG005|NOT COMPLETED|Entire: IV + Maintenance||0
3086534|NCT01412944|3808490|FG000|STARTED|Follow-up||0
3086535|NCT01412944|3808491|FG001|STARTED|Follow-up||0
3086536|NCT01412944|3808492|FG002|STARTED|Follow-up||2
3086537|NCT01412944|3808493|FG003|STARTED|Follow-up||1
3086538|NCT01412944|3808494|FG004|STARTED|Follow-up||2
3086539|NCT01412944|3808495|FG005|STARTED|Follow-up||0
3086540|NCT01412944|3808490|FG000|COMPLETED|Follow-up||0
3086541|NCT01412944|3808491|FG001|COMPLETED|Follow-up||0
3086542|NCT01412944|3808492|FG002|COMPLETED|Follow-up||2
3086543|NCT01412944|3808493|FG003|COMPLETED|Follow-up||1
3086544|NCT01412944|3808494|FG004|COMPLETED|Follow-up||2
3086545|NCT01412944|3808495|FG005|COMPLETED|Follow-up||0
3086546|NCT01412944|3808490|FG000|NOT COMPLETED|Follow-up||0
3086547|NCT01412944|3808491|FG001|NOT COMPLETED|Follow-up||0
3086548|NCT01412944|3808492|FG002|NOT COMPLETED|Follow-up||0
3086549|NCT01412944|3808493|FG003|NOT COMPLETED|Follow-up||0
3086550|NCT01412944|3808494|FG004|NOT COMPLETED|Follow-up||0
3086551|NCT01412944|3808495|FG005|NOT COMPLETED|Follow-up||0
3086552|NCT01412957|3808513|FG000|STARTED|Overall Study||189
3086553|NCT01412957|3808514|FG001|STARTED|Overall Study||188
3086554|NCT01412957|3808513|FG000|COMPLETED|Overall Study|Participants continuing study at the time of data cut-off|40
3086555|NCT01412957|3808514|FG001|COMPLETED|Overall Study|Participants continuing study at the time of data cut-off|31
3086556|NCT01412957|3808513|FG000|NOT COMPLETED|Overall Study||149
3086557|NCT01412957|3808514|FG001|NOT COMPLETED|Overall Study||157
3086558|NCT01412983|3808520|FG000|STARTED|1st Period||50
3086559|NCT01412983|3808521|FG001|STARTED|1st Period||50
3086560|NCT01412983|3808520|FG000|COMPLETED|1st Period||50
3086561|NCT01412983|3808521|FG001|COMPLETED|1st Period||46
3086562|NCT01412983|3808520|FG000|NOT COMPLETED|1st Period||0
3086563|NCT01412983|3808521|FG001|NOT COMPLETED|1st Period||4
3086564|NCT01412983|3808520|FG000|STARTED|2nd Period||50
3086565|NCT01412983|3808521|FG001|STARTED|2nd Period||46
3086566|NCT01412983|3808520|FG000|COMPLETED|2nd Period||50
3086567|NCT01412983|3808521|FG001|COMPLETED|2nd Period||46
3086568|NCT01412983|3808520|FG000|NOT COMPLETED|2nd Period||0
3086569|NCT01412983|3808521|FG001|NOT COMPLETED|2nd Period||0
3086570|NCT01413087|3808530|FG000|STARTED|Overall Study||6
3086571|NCT01413087|3808531|FG001|STARTED|Overall Study||6
3086572|NCT01413087|3808530|FG000|COMPLETED|Overall Study||6
3086573|NCT01413087|3808531|FG001|COMPLETED|Overall Study||6
3086574|NCT01413087|3808530|FG000|NOT COMPLETED|Overall Study||0
3086575|NCT01413087|3808531|FG001|NOT COMPLETED|Overall Study||0
3086576|NCT01413178|3808539|FG000|STARTED|Overall Study||105
3086577|NCT01413178|3808540|FG001|STARTED|Overall Study||100
3086578|NCT01413178|3808539|FG000|COMPLETED|Overall Study||104
3086579|NCT01413178|3808540|FG001|COMPLETED|Overall Study||98
3086580|NCT01413178|3808539|FG000|NOT COMPLETED|Overall Study||1
3086581|NCT01413178|3808540|FG001|NOT COMPLETED|Overall Study||2
3086582|NCT01413191|3808546|FG000|STARTED|Overall Study||18
3086583|NCT01413191|3808546|FG000|COMPLETED|Overall Study||7
3086584|NCT01413191|3808546|FG000|NOT COMPLETED|Overall Study||11
3086585|NCT01413204|3808553|FG000|STARTED|Overall Study||90
3086586|NCT01413204|3808554|FG001|STARTED|Overall Study||89
3086587|NCT01413204|3808555|FG002|STARTED|Overall Study||93
3086588|NCT01413204|3808553|FG000|COMPLETED|Overall Study||84
3086589|NCT01413204|3808554|FG001|COMPLETED|Overall Study||83
3086590|NCT01413204|3808555|FG002|COMPLETED|Overall Study||74
3086591|NCT01413204|3808553|FG000|NOT COMPLETED|Overall Study||6
3086592|NCT01413204|3808554|FG001|NOT COMPLETED|Overall Study||6
3086593|NCT01413204|3808555|FG002|NOT COMPLETED|Overall Study||19
3086594|NCT01413360|3808563|FG000|STARTED|Overall Study||10
3086595|NCT01413360|3808563|FG000|COMPLETED|Overall Study||7
3086596|NCT01413360|3808563|FG000|NOT COMPLETED|Overall Study||3
3086597|NCT01413503|3808567|FG000|STARTED|Overall Study||50
3086598|NCT01413503|3808567|FG000|COMPLETED|Overall Study||49
3086599|NCT01413503|3808567|FG000|NOT COMPLETED|Overall Study||1
3086600|NCT01413516|3808573|FG000|STARTED|Overall Study||8
3086601|NCT01413516|3808574|FG001|STARTED|Overall Study||9
3086602|NCT01413516|3808573|FG000|COMPLETED|Overall Study||8
3086603|NCT01413516|3808574|FG001|COMPLETED|Overall Study||9
3086604|NCT01413516|3808573|FG000|NOT COMPLETED|Overall Study||0
3086605|NCT01413516|3808574|FG001|NOT COMPLETED|Overall Study||0
3086606|NCT01413542|3808582|FG000|STARTED|Overall Study||6
3086607|NCT01413542|3808583|FG001|STARTED|Overall Study||6
3086608|NCT01413542|3808584|FG002|STARTED|Overall Study||9
3086609|NCT01413542|3808585|FG003|STARTED|Overall Study||8
3086610|NCT01413542|3808582|FG000|COMPLETED|Overall Study||5
3086611|NCT01413542|3808583|FG001|COMPLETED|Overall Study||6
3086612|NCT01413542|3808584|FG002|COMPLETED|Overall Study||6
3086613|NCT01413542|3808585|FG003|COMPLETED|Overall Study||7
3086614|NCT01413542|3808582|FG000|NOT COMPLETED|Overall Study||1
3086615|NCT01413542|3808583|FG001|NOT COMPLETED|Overall Study||0
3086616|NCT01413542|3808584|FG002|NOT COMPLETED|Overall Study||3
3086617|NCT01413542|3808585|FG003|NOT COMPLETED|Overall Study||1
3086618|NCT01413750|3808601|FG000|STARTED|Overall Study||6
3086619|NCT01413750|3808602|FG001|STARTED|Overall Study||6
3086620|NCT01413750|3808603|FG002|STARTED|Overall Study||4
3086621|NCT01413750|3808604|FG003|STARTED|Overall Study||7
3086622|NCT01413750|3808601|FG000|COMPLETED|Overall Study||6
3086623|NCT01413750|3808602|FG001|COMPLETED|Overall Study||6
3086624|NCT01413750|3808603|FG002|COMPLETED|Overall Study||4
3086625|NCT01413750|3808604|FG003|COMPLETED|Overall Study||7
3086626|NCT01413750|3808601|FG000|NOT COMPLETED|Overall Study||0
3086627|NCT01413750|3808602|FG001|NOT COMPLETED|Overall Study||0
3086628|NCT01413750|3808603|FG002|NOT COMPLETED|Overall Study||0
3086629|NCT01413750|3808604|FG003|NOT COMPLETED|Overall Study||0
3086630|NCT01413958|3808617|FG000|STARTED|Overall Study||288
3086631|NCT01413958|3808618|FG001|STARTED|Overall Study||287
3086632|NCT01413958|3808617|FG000|COMPLETED|Overall Study||288
3086633|NCT01413958|3808618|FG001|COMPLETED|Overall Study||286
3086634|NCT01413958|3808617|FG000|NOT COMPLETED|Overall Study||0
3086635|NCT01413958|3808618|FG001|NOT COMPLETED|Overall Study||1
3086636|NCT01414010|3808629|FG000|STARTED|Overall Study||8
3086637|NCT01414010|3808630|FG001|STARTED|Overall Study||8
3086638|NCT01414010|3808631|FG002|STARTED|Overall Study||8
3086639|NCT01414010|3808632|FG003|STARTED|Overall Study||8
3086640|NCT01414010|3808629|FG000|COMPLETED|Overall Study||6
3086641|NCT01414010|3808630|FG001|COMPLETED|Overall Study||8
3086642|NCT01414010|3808631|FG002|COMPLETED|Overall Study||8
3086643|NCT01414010|3808632|FG003|COMPLETED|Overall Study||8
3086644|NCT01414010|3808629|FG000|NOT COMPLETED|Overall Study||2
3086645|NCT01414010|3808630|FG001|NOT COMPLETED|Overall Study||0
3086646|NCT01414010|3808631|FG002|NOT COMPLETED|Overall Study||0
3086647|NCT01414010|3808632|FG003|NOT COMPLETED|Overall Study||0
3086648|NCT01414036|3808650|FG000|STARTED|Received Allocated Intervention||23
3086649|NCT01414036|3808651|FG001|STARTED|Received Allocated Intervention||24
3086650|NCT01414036|3808650|FG000|COMPLETED|Received Allocated Intervention||23
3086651|NCT01414036|3808651|FG001|COMPLETED|Received Allocated Intervention||11
3086652|NCT01414036|3808650|FG000|NOT COMPLETED|Received Allocated Intervention||0
3086653|NCT01414036|3808651|FG001|NOT COMPLETED|Received Allocated Intervention||13
3086654|NCT01414036|3808650|FG000|STARTED|Completed 3 Month Survey||23
3086655|NCT01414036|3808651|FG001|STARTED|Completed 3 Month Survey||24
3086656|NCT01414036|3808650|FG000|COMPLETED|Completed 3 Month Survey||14
3086657|NCT01414036|3808651|FG001|COMPLETED|Completed 3 Month Survey||19
3086658|NCT01414036|3808650|FG000|NOT COMPLETED|Completed 3 Month Survey||9
3086659|NCT01414036|3808651|FG001|NOT COMPLETED|Completed 3 Month Survey||5
3086660|NCT01414075|3808661|FG000|STARTED|Overall Study||24
3086661|NCT01414075|3808662|FG001|STARTED|Overall Study||12
3086662|NCT01414075|3808663|FG002|STARTED|Overall Study||12
3086663|NCT01414075|3808664|FG003|STARTED|Overall Study||12
3086664|NCT01414075|3808661|FG000|Efficacy Evaluable (EE) Population|Overall Study||23
3086665|NCT01414075|3808662|FG001|Efficacy Evaluable (EE) Population|Overall Study||12
3086666|NCT01414075|3808663|FG002|Efficacy Evaluable (EE) Population|Overall Study||10
3086667|NCT01414075|3808664|FG003|Efficacy Evaluable (EE) Population|Overall Study||10
3086668|NCT01414075|3808661|FG000|COMPLETED|Overall Study||21
3086669|NCT01414075|3808662|FG001|COMPLETED|Overall Study||12
3086670|NCT01414075|3808663|FG002|COMPLETED|Overall Study||10
3086671|NCT01414075|3808664|FG003|COMPLETED|Overall Study||10
3086672|NCT01414075|3808661|FG000|NOT COMPLETED|Overall Study||3
3086673|NCT01414075|3808662|FG001|NOT COMPLETED|Overall Study||0
3086674|NCT01414075|3808663|FG002|NOT COMPLETED|Overall Study||2
3086675|NCT01414075|3808664|FG003|NOT COMPLETED|Overall Study||2
3086676|NCT01414114|3808674|FG000|STARTED|Overall Study||37
3086677|NCT01414114|3808674|FG000|COMPLETED|Overall Study|Completed 12-week treatment period|32
3086678|NCT01414114|3808674|FG000|NOT COMPLETED|Overall Study||5
3086679|NCT01414153|3808684|FG000|STARTED|Overall Study||38
3086680|NCT01414153|3808685|FG001|STARTED|Overall Study||40
3086681|NCT01414153|3808686|FG002|STARTED|Overall Study||39
3086682|NCT01414153|3808687|FG003|STARTED|Overall Study||41
3086683|NCT01414153|3808684|FG000|COMPLETED|Overall Study||30
3086684|NCT01414153|3808685|FG001|COMPLETED|Overall Study||38
3086685|NCT01414153|3808686|FG002|COMPLETED|Overall Study||35
3086686|NCT01414153|3808687|FG003|COMPLETED|Overall Study||37
3086687|NCT01414153|3808684|FG000|NOT COMPLETED|Overall Study||8
3086688|NCT01414153|3808685|FG001|NOT COMPLETED|Overall Study||2
3086689|NCT01414153|3808686|FG002|NOT COMPLETED|Overall Study||4
3086690|NCT01414153|3808687|FG003|NOT COMPLETED|Overall Study||4
3134908|NCT01703286|3859850|FG004|NOT COMPLETED|Period 1 Including Washout||0
3134909|NCT01703286|3859851|FG005|NOT COMPLETED|Period 1 Including Washout||1
3134910|NCT01703286|3859846|FG000|STARTED|Period 2 Including Washout||7
3134911|NCT01703286|3859847|FG001|STARTED|Period 2 Including Washout||7
3134912|NCT01703286|3859848|FG002|STARTED|Period 2 Including Washout||7
3134913|NCT01703286|3859849|FG003|STARTED|Period 2 Including Washout||6
3134914|NCT01703286|3859850|FG004|STARTED|Period 2 Including Washout||7
3134915|NCT01703286|3859851|FG005|STARTED|Period 2 Including Washout||6
3134916|NCT01703286|3859846|FG000|COMPLETED|Period 2 Including Washout||7
3134917|NCT01703286|3859847|FG001|COMPLETED|Period 2 Including Washout||7
3134918|NCT01703286|3859848|FG002|COMPLETED|Period 2 Including Washout||7
3134919|NCT01703286|3859849|FG003|COMPLETED|Period 2 Including Washout||5
3134920|NCT01703286|3859850|FG004|COMPLETED|Period 2 Including Washout||7
3134921|NCT01703286|3859851|FG005|COMPLETED|Period 2 Including Washout||6
3134922|NCT01703286|3859846|FG000|NOT COMPLETED|Period 2 Including Washout||0
3134923|NCT01703286|3859847|FG001|NOT COMPLETED|Period 2 Including Washout||0
3134924|NCT01703286|3859848|FG002|NOT COMPLETED|Period 2 Including Washout||0
3134925|NCT01703286|3859849|FG003|NOT COMPLETED|Period 2 Including Washout||1
3134926|NCT01703286|3859850|FG004|NOT COMPLETED|Period 2 Including Washout||0
3134927|NCT01703286|3859851|FG005|NOT COMPLETED|Period 2 Including Washout||0
3134928|NCT01703286|3859846|FG000|STARTED|Period 3 Including Washout||7
3134929|NCT01703286|3859847|FG001|STARTED|Period 3 Including Washout||7
3134930|NCT01703286|3859848|FG002|STARTED|Period 3 Including Washout||7
3134931|NCT01703286|3859849|FG003|STARTED|Period 3 Including Washout||5
3134932|NCT01703286|3859850|FG004|STARTED|Period 3 Including Washout||7
3134933|NCT01703286|3859851|FG005|STARTED|Period 3 Including Washout||6
3134934|NCT01703286|3859846|FG000|COMPLETED|Period 3 Including Washout||7
3134935|NCT01703286|3859847|FG001|COMPLETED|Period 3 Including Washout||7
3134936|NCT01703286|3859848|FG002|COMPLETED|Period 3 Including Washout||7
3134937|NCT01703286|3859849|FG003|COMPLETED|Period 3 Including Washout||5
3134938|NCT01703286|3859850|FG004|COMPLETED|Period 3 Including Washout||7
3134939|NCT01703286|3859851|FG005|COMPLETED|Period 3 Including Washout||6
3134940|NCT01703286|3859846|FG000|NOT COMPLETED|Period 3 Including Washout||0
3134941|NCT01703286|3859847|FG001|NOT COMPLETED|Period 3 Including Washout||0
3134942|NCT01703286|3859848|FG002|NOT COMPLETED|Period 3 Including Washout||0
3134943|NCT01703286|3859849|FG003|NOT COMPLETED|Period 3 Including Washout||0
3134944|NCT01703286|3859850|FG004|NOT COMPLETED|Period 3 Including Washout||0
3134945|NCT01703286|3859851|FG005|NOT COMPLETED|Period 3 Including Washout||0
3134946|NCT01703507|3859864|FG000|STARTED|Overall Study||6
3134947|NCT01703507|3859865|FG001|STARTED|Overall Study||11
3134948|NCT01703507|3859864|FG000|COMPLETED|Overall Study||5
3134949|NCT01703507|3859865|FG001|COMPLETED|Overall Study||11
3134950|NCT01703507|3859864|FG000|NOT COMPLETED|Overall Study||1
3134951|NCT01703507|3859865|FG001|NOT COMPLETED|Overall Study||0
3134952|NCT01703598|3859871|FG000|STARTED|Overall Study||69
3134953|NCT01703598|3859871|FG000|COMPLETED|Overall Study||69
3134954|NCT01703598|3859871|FG000|NOT COMPLETED|Overall Study||0
3134955|NCT01703663|3859875|FG000|STARTED|First Treatment Period||20
3134956|NCT01703663|3859876|FG001|STARTED|First Treatment Period||20
3134957|NCT01703663|3859875|FG000|COMPLETED|First Treatment Period||20
3134958|NCT01703663|3859876|FG001|COMPLETED|First Treatment Period||20
3086691|NCT01414205|3808699|FG000|STARTED|Overall Study||41
3086692|NCT01414205|3808700|FG001|STARTED|Overall Study||39
3086693|NCT01414205|3808699|FG000|Received Study Drug|Overall Study||40
3086694|NCT01414205|3808700|FG001|Received Study Drug|Overall Study||38
3086695|NCT01414205|3808699|FG000|COMPLETED|Overall Study||34
3086696|NCT01414205|3808700|FG001|COMPLETED|Overall Study||32
3086697|NCT01414205|3808699|FG000|NOT COMPLETED|Overall Study||7
3086698|NCT01414205|3808700|FG001|NOT COMPLETED|Overall Study||7
3086699|NCT01414244|3808708|FG000|STARTED|Overall Study||54
3086700|NCT01414244|3808709|FG001|STARTED|Overall Study||52
3086701|NCT01414244|3808708|FG000|COMPLETED|Overall Study||54
3086702|NCT01414244|3808709|FG001|COMPLETED|Overall Study||52
3086703|NCT01414244|3808708|FG000|NOT COMPLETED|Overall Study||0
3086704|NCT01414244|3808709|FG001|NOT COMPLETED|Overall Study||0
3086705|NCT01414257|3808715|FG000|STARTED|Overall Study||2860
3086706|NCT01414257|3808715|FG000|COMPLETED|Overall Study||2838
3086707|NCT01414257|3808715|FG000|NOT COMPLETED|Overall Study||22
3086708|NCT01414413|3808721|FG000|STARTED|Overall Study|Adult population denominator for cluster randomised trial|8194
3086709|NCT01414413|3808722|FG001|STARTED|Overall Study|Adult population denominator for cluster randomised trial|8466
3086710|NCT01414413|3808721|FG000|COMPLETED|Overall Study|Adult population denominator for cluster randomised trial|8194
3086711|NCT01414413|3808722|FG001|COMPLETED|Overall Study|Adult population denominator for cluster randomised trial|8466
3086712|NCT01414413|3808721|FG000|NOT COMPLETED|Overall Study||0
3086713|NCT01414413|3808722|FG001|NOT COMPLETED|Overall Study||0
3086714|NCT01414426|3808730|FG000|STARTED|Overall Study||10
3086715|NCT01414426|3808731|FG001|STARTED|Overall Study||10
3086716|NCT01414426|3808730|FG000|COMPLETED|Overall Study||9
3086717|NCT01414426|3808731|FG001|COMPLETED|Overall Study||8
3086718|NCT01414426|3808730|FG000|NOT COMPLETED|Overall Study||1
3086719|NCT01414426|3808731|FG001|NOT COMPLETED|Overall Study||2
3086720|NCT01414634|3808737|FG000|STARTED|Overall Study||1
3086721|NCT01414634|3808738|FG001|STARTED|Overall Study||1
3086722|NCT01414634|3808739|FG002|STARTED|Overall Study||1
3086723|NCT01414634|3808740|FG003|STARTED|Overall Study||1
3086724|NCT01414634|3808741|FG004|STARTED|Overall Study||1
3086725|NCT01414634|3808742|FG005|STARTED|Overall Study||2
3086726|NCT01414634|3808743|FG006|STARTED|Overall Study||1
3086727|NCT01414634|3808744|FG007|STARTED|Overall Study||1
3086728|NCT01414634|3808737|FG000|COMPLETED|Overall Study||1
3086729|NCT01414634|3808738|FG001|COMPLETED|Overall Study||1
3086730|NCT01414634|3808739|FG002|COMPLETED|Overall Study||1
3086731|NCT01414634|3808740|FG003|COMPLETED|Overall Study||1
3086732|NCT01414634|3808741|FG004|COMPLETED|Overall Study||1
3086733|NCT01414634|3808742|FG005|COMPLETED|Overall Study||2
3086734|NCT01414634|3808743|FG006|COMPLETED|Overall Study||1
3086735|NCT01414634|3808744|FG007|COMPLETED|Overall Study||1
3086736|NCT01414634|3808737|FG000|NOT COMPLETED|Overall Study||0
3086737|NCT01414634|3808738|FG001|NOT COMPLETED|Overall Study||0
3086738|NCT01414634|3808739|FG002|NOT COMPLETED|Overall Study||0
3086739|NCT01414634|3808740|FG003|NOT COMPLETED|Overall Study||0
3086740|NCT01414634|3808741|FG004|NOT COMPLETED|Overall Study||0
3086741|NCT01414634|3808742|FG005|NOT COMPLETED|Overall Study||0
3086742|NCT01414634|3808743|FG006|NOT COMPLETED|Overall Study||0
3086743|NCT01414634|3808744|FG007|NOT COMPLETED|Overall Study||0
3086744|NCT01414738|3808755|FG000|STARTED|Overall Study||49
3086745|NCT01414738|3808755|FG000|Follow-up (3 Months)|Overall Study||18
3086746|NCT01414738|3808755|FG000|Follow-up (6 Months)|Overall Study||8
3086747|NCT01414738|3808755|FG000|Follow-up (9 Months)|Overall Study||5
3086748|NCT01414738|3808755|FG000|COMPLETED|Overall Study||5
3086749|NCT01414738|3808755|FG000|NOT COMPLETED|Overall Study||44
3086750|NCT01414855|3808759|FG000|STARTED|Overall Study||100
3086751|NCT01414855|3808759|FG000|COMPLETED|Overall Study||71
3086752|NCT01414855|3808759|FG000|NOT COMPLETED|Overall Study||29
3086753|NCT01415232|3808763|FG000|STARTED|Overall Study||160
3086754|NCT01415232|3808763|FG000|COMPLETED|Overall Study||160
3086755|NCT01415232|3808763|FG000|NOT COMPLETED|Overall Study||0
3086756|NCT01415349|3808767|FG000|STARTED|Treatment Period 1||21
3086757|NCT01415349|3808768|FG001|STARTED|Treatment Period 1||21
3086758|NCT01415349|3808767|FG000|COMPLETED|Treatment Period 1||21
3287591|NCT02793154|4021259|FG000|COMPLETED|Part B (Parallel Group-up to 84 Days)||0
3287592|NCT02793154|4021260|FG001|COMPLETED|Part B (Parallel Group-up to 84 Days)||0
3287593|NCT02793154|4021261|FG002|COMPLETED|Part B (Parallel Group-up to 84 Days)||0
3287594|NCT02793154|4021259|FG000|NOT COMPLETED|Part B (Parallel Group-up to 84 Days)||0
3287595|NCT02793154|4021260|FG001|NOT COMPLETED|Part B (Parallel Group-up to 84 Days)||0
3287596|NCT02793154|4021261|FG002|NOT COMPLETED|Part B (Parallel Group-up to 84 Days)||0
3287597|NCT02793232|4021278|FG000|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||2
3287598|NCT02793232|4021279|FG001|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||2
3086759|NCT01415349|3808768|FG001|COMPLETED|Treatment Period 1||19
3086760|NCT01415349|3808767|FG000|NOT COMPLETED|Treatment Period 1||0
3086761|NCT01415349|3808768|FG001|NOT COMPLETED|Treatment Period 1||2
3086762|NCT01415349|3808767|FG000|STARTED|Treatment Period 2||21
3086763|NCT01415349|3808768|FG001|STARTED|Treatment Period 2||19
3086764|NCT01415349|3808767|FG000|COMPLETED|Treatment Period 2||21
3086765|NCT01415349|3808768|FG001|COMPLETED|Treatment Period 2||19
3086766|NCT01415349|3808767|FG000|NOT COMPLETED|Treatment Period 2||0
3086767|NCT01415349|3808768|FG001|NOT COMPLETED|Treatment Period 2||0
3086768|NCT01415401|3808774|FG000|STARTED|Overall Study||54
3086769|NCT01415401|3808774|FG000|COMPLETED|Overall Study||47
3086770|NCT01415401|3808774|FG000|NOT COMPLETED|Overall Study||7
3086771|NCT01415427|3808782|FG000|STARTED|Overall Study||29
3086772|NCT01415427|3808783|FG001|STARTED|Overall Study||29
3086773|NCT01415427|3808784|FG002|STARTED|Overall Study||59
3086774|NCT01415427|3808785|FG003|STARTED|Overall Study||56
3086775|NCT01415427|3808782|FG000|COMPLETED|Overall Study||0
3086776|NCT01415427|3808783|FG001|COMPLETED|Overall Study||0
3086777|NCT01415427|3808784|FG002|COMPLETED|Overall Study||1
3086778|NCT01415427|3808785|FG003|COMPLETED|Overall Study||0
3086779|NCT01415427|3808782|FG000|NOT COMPLETED|Overall Study||29
3086780|NCT01415427|3808783|FG001|NOT COMPLETED|Overall Study||29
2940875|NCT00639509|3653122|FG000|NOT COMPLETED|Overall Study||1
2940876|NCT00639678|3653130|FG000|STARTED|Overall Study||74
2940877|NCT00639678|3653131|FG001|STARTED|Overall Study||6
3086781|NCT01415427|3808784|FG002|NOT COMPLETED|Overall Study||58
3086782|NCT01415427|3808785|FG003|NOT COMPLETED|Overall Study||56
3086783|NCT01415440|3808800|FG000|STARTED|Overall Study||41
3086784|NCT01415440|3808801|FG001|STARTED|Overall Study||29
3086785|NCT01415440|3808802|FG002|STARTED|Overall Study||29
3086786|NCT01415440|3808800|FG000|COMPLETED|Overall Study||37
3086787|NCT01415440|3808801|FG001|COMPLETED|Overall Study||28
3086788|NCT01415440|3808802|FG002|COMPLETED|Overall Study||27
3086789|NCT01415440|3808800|FG000|NOT COMPLETED|Overall Study||4
3086790|NCT01415440|3808801|FG001|NOT COMPLETED|Overall Study||1
3086791|NCT01415440|3808802|FG002|NOT COMPLETED|Overall Study||2
3086792|NCT01415453|3808809|FG000|STARTED|Overall Study||1
3086793|NCT01415453|3808809|FG000|Imaging Study|Overall Study||1
3086794|NCT01415453|3808809|FG000|COMPLETED|Overall Study||1
3086795|NCT01415453|3808809|FG000|NOT COMPLETED|Overall Study||0
3086796|NCT01415518|3808815|FG000|STARTED|Overall Study||292
3086797|NCT01415518|3808816|FG001|STARTED|Overall Study||292
3086798|NCT01415518|3808815|FG000|Patients Who Received Study Treatment|Overall Study||290
3086799|NCT01415518|3808816|FG001|Patients Who Received Study Treatment|Overall Study||292
3086800|NCT01415518|3808815|FG000|Pts With Correct Randomized Treatment|Overall Study|Efficacy analysis used 290 patients. Safety analysis used 290+3=293 patients.|290
3086801|NCT01415518|3808816|FG001|Pts With Correct Randomized Treatment|Overall Study|Efficacy analysis used 292 patients. Safety analysis used 292-3=289 patients.|289
3086802|NCT01415518|3808815|FG000|COMPLETED|Overall Study||276
3086803|NCT01415518|3808816|FG001|COMPLETED|Overall Study||261
3086804|NCT01415518|3808815|FG000|NOT COMPLETED|Overall Study||16
3086805|NCT01415518|3808816|FG001|NOT COMPLETED|Overall Study||31
3086806|NCT01415531|3808824|FG000|STARTED|Overall Study||214
3086807|NCT01415531|3808825|FG001|STARTED|Overall Study||427
3086808|NCT01415531|3808824|FG000|COMPLETED|Overall Study||189
3086809|NCT01415531|3808825|FG001|COMPLETED|Overall Study||390
3086810|NCT01415531|3808824|FG000|NOT COMPLETED|Overall Study||25
3086811|NCT01415531|3808825|FG001|NOT COMPLETED|Overall Study||37
3086812|NCT01415583|3808833|FG000|STARTED|Overall Study||157
3086813|NCT01415583|3808834|FG001|STARTED|Overall Study||157
3086814|NCT01415583|3808833|FG000|COMPLETED|Overall Study||157
3086815|NCT01415583|3808834|FG001|COMPLETED|Overall Study||157
3086816|NCT01415583|3808833|FG000|NOT COMPLETED|Overall Study||0
3086817|NCT01415583|3808834|FG001|NOT COMPLETED|Overall Study||0
3086818|NCT01415908|3808842|FG000|STARTED|Overall Study||11
3086819|NCT01415908|3808843|FG001|STARTED|Overall Study||4
3086820|NCT01415908|3808842|FG000|COMPLETED|Overall Study||10
3086821|NCT01415908|3808843|FG001|COMPLETED|Overall Study||4
3086822|NCT01415908|3808842|FG000|NOT COMPLETED|Overall Study||1
3086823|NCT01415908|3808843|FG001|NOT COMPLETED|Overall Study||0
3086824|NCT01415921|3808851|FG000|STARTED|Overall Study||16
3086825|NCT01415921|3808852|FG001|STARTED|Overall Study||17
3086826|NCT01415921|3808851|FG000|COMPLETED|Overall Study||13
3086827|NCT01415921|3808852|FG001|COMPLETED|Overall Study||14
3086828|NCT01415921|3808851|FG000|NOT COMPLETED|Overall Study||3
3086829|NCT01415921|3808852|FG001|NOT COMPLETED|Overall Study||3
3086830|NCT01415934|3808860|FG000|STARTED|Overall Study||192
3086831|NCT01415934|3808861|FG001|STARTED|Overall Study||189
3086832|NCT01415934|3808860|FG000|COMPLETED|Overall Study||189
3086833|NCT01415934|3808861|FG001|COMPLETED|Overall Study||182
3086834|NCT01415934|3808860|FG000|NOT COMPLETED|Overall Study||3
3086835|NCT01415934|3808861|FG001|NOT COMPLETED|Overall Study||7
3287599|NCT02793232|4021280|FG002|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||2
3287600|NCT02793232|4021281|FG003|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||2
3287601|NCT02793232|4021282|FG004|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||7
3287602|NCT02793232|4021283|FG005|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||12
3287603|NCT02793232|4021284|FG006|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||9
3287604|NCT02793232|4021285|FG007|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||2
3287605|NCT02793232|4021286|FG008|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||8
3287606|NCT02793232|4021278|FG000|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||2
3287607|NCT02793232|4021279|FG001|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||2
3086836|NCT01415960|3808867|FG000|STARTED|Overall Study||163
3086837|NCT01415960|3808867|FG000|ITT|Overall Study||161
3086838|NCT01415960|3808867|FG000|PK Subgroup|Overall Study||30
3086839|NCT01415960|3808867|FG000|COMPLETED|Overall Study|Patients completed Study (151) Per protocol Patients (146)|151
3086840|NCT01415960|3808867|FG000|NOT COMPLETED|Overall Study||12
3086841|NCT01416025|3808873|FG000|STARTED|Overall Study||14
3086842|NCT01416025|3808874|FG001|STARTED|Overall Study||15
3086843|NCT01416025|3808873|FG000|COMPLETED|Overall Study||14
3086844|NCT01416025|3808874|FG001|COMPLETED|Overall Study||15
3086845|NCT01416025|3808873|FG000|NOT COMPLETED|Overall Study||0
3086846|NCT01416025|3808874|FG001|NOT COMPLETED|Overall Study||0
3086847|NCT01416129|3808882|FG000|STARTED|Control Condition: Ischial Containment||5
3086848|NCT01416129|3808883|FG001|STARTED|Control Condition: Ischial Containment||5
3086849|NCT01416129|3808882|FG000|COMPLETED|Control Condition: Ischial Containment||5
3086850|NCT01416129|3808883|FG001|COMPLETED|Control Condition: Ischial Containment||5
3086851|NCT01416129|3808882|FG000|NOT COMPLETED|Control Condition: Ischial Containment||0
3086852|NCT01416129|3808883|FG001|NOT COMPLETED|Control Condition: Ischial Containment||0
3086853|NCT01416129|3808882|FG000|STARTED|Experimental Condition: Brimless||5
3086854|NCT01416129|3808883|FG001|STARTED|Experimental Condition: Brimless||5
3086855|NCT01416129|3808882|FG000|COMPLETED|Experimental Condition: Brimless||5
3086856|NCT01416129|3808883|FG001|COMPLETED|Experimental Condition: Brimless||5
3086857|NCT01416129|3808882|FG000|NOT COMPLETED|Experimental Condition: Brimless||0
3086858|NCT01416129|3808883|FG001|NOT COMPLETED|Experimental Condition: Brimless||0
3086859|NCT01416142|3808889|FG000|STARTED|Cross Over at Movie Intermission||32
3086860|NCT01416142|3808890|FG001|STARTED|Cross Over at Movie Intermission||31
3086861|NCT01416142|3808891|FG002|STARTED|Cross Over at Movie Intermission||0
3086862|NCT01416142|3808889|FG000|COMPLETED|Cross Over at Movie Intermission||32
3086863|NCT01416142|3808890|FG001|COMPLETED|Cross Over at Movie Intermission||31
3086864|NCT01416142|3808891|FG002|COMPLETED|Cross Over at Movie Intermission||0
3086865|NCT01416142|3808889|FG000|NOT COMPLETED|Cross Over at Movie Intermission||0
3086866|NCT01416142|3808890|FG001|NOT COMPLETED|Cross Over at Movie Intermission||0
3086867|NCT01416142|3808891|FG002|NOT COMPLETED|Cross Over at Movie Intermission||0
3086868|NCT01416142|3808889|FG000|STARTED|PureVision2 HD||0
3287608|NCT02793232|4021280|FG002|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||2
3287609|NCT02793232|4021281|FG003|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||2
3086869|NCT01416142|3808890|FG001|STARTED|PureVision2 HD||0
3086870|NCT01416142|3808891|FG002|STARTED|PureVision2 HD||63
3086871|NCT01416142|3808889|FG000|COMPLETED|PureVision2 HD||0
3086872|NCT01416142|3808890|FG001|COMPLETED|PureVision2 HD||0
3086873|NCT01416142|3808891|FG002|COMPLETED|PureVision2 HD||62
3086874|NCT01416142|3808889|FG000|NOT COMPLETED|PureVision2 HD||0
3086875|NCT01416142|3808890|FG001|NOT COMPLETED|PureVision2 HD||0
3086876|NCT01416142|3808891|FG002|NOT COMPLETED|PureVision2 HD||1
3086877|NCT01416155|3808899|FG000|STARTED|Overall Study||97
3086878|NCT01416155|3808899|FG000|COMPLETED|Overall Study||39
3086879|NCT01416155|3808899|FG000|NOT COMPLETED|Overall Study||58
3086880|NCT01416181|3808905|FG000|STARTED|Part 1||449
3086881|NCT01416181|3808906|FG001|STARTED|Part 1||440
3086882|NCT01416181|3808905|FG000|Withdrew Prior to Dosing|Part 1||0
3086883|NCT01416181|3808906|FG001|Withdrew Prior to Dosing|Part 1||1
3086884|NCT01416181|3808905|FG000|COMPLETED|Part 1|Completed Study through Week 108|312
3086885|NCT01416181|3808906|FG001|COMPLETED|Part 1|Completed Study through Week 108|326
3086886|NCT01416181|3808905|FG000|NOT COMPLETED|Part 1||137
3086887|NCT01416181|3808906|FG001|NOT COMPLETED|Part 1||114
3086888|NCT01416181|3808905|FG000|STARTED|Part 2||274
3086889|NCT01416181|3808906|FG001|STARTED|Part 2||292
3086890|NCT01416181|3808905|FG000|Completed Treatment for 48 Weeks|Part 2|completed study treatment for 48 weeks in Part 2|98
3086891|NCT01416181|3808906|FG001|Completed Treatment for 48 Weeks|Part 2|completed study treatment for 48 weeks in Part 2|111
3086892|NCT01416181|3808905|FG000|Completed Treatment for 96 Weeks|Part 2|completed study treatment for 96 weeks in Part 2|1
3086893|NCT01416181|3808906|FG001|Completed Treatment for 96 Weeks|Part 2|completed study treatment for 96 weeks in Part 2|0
3086894|NCT01416181|3808905|FG000|Completed Treatment for > 96 Weeks|Part 2||1
3086895|NCT01416181|3808906|FG001|Completed Treatment for > 96 Weeks|Part 2||0
3086896|NCT01416181|3808905|FG000|COMPLETED|Part 2||3
3086897|NCT01416181|3808906|FG001|COMPLETED|Part 2||6
3086898|NCT01416181|3808905|FG000|NOT COMPLETED|Part 2||271
3086899|NCT01416181|3808906|FG001|NOT COMPLETED|Part 2||286
3086900|NCT01416194|3808915|FG000|STARTED|Overall Study||1111
3086901|NCT01416194|3808916|FG001|STARTED|Overall Study||2720
3086902|NCT01416194|3808917|FG002|STARTED|Overall Study||6666
3086903|NCT01416194|3808915|FG000|COMPLETED|Overall Study||1111
3086904|NCT01416194|3808916|FG001|COMPLETED|Overall Study||2720
3086905|NCT01416194|3808917|FG002|COMPLETED|Overall Study||6666
3086906|NCT01416194|3808915|FG000|NOT COMPLETED|Overall Study||0
3086907|NCT01416194|3808916|FG001|NOT COMPLETED|Overall Study||0
3086908|NCT01416194|3808917|FG002|NOT COMPLETED|Overall Study||0
3086909|NCT01416389|3808929|FG000|STARTED|Overall Study||26
3086910|NCT01416389|3808930|FG001|STARTED|Overall Study||13
3086911|NCT01416389|3808929|FG000|Received at Least 1 Dose of Study Drug|Overall Study||26
3086912|NCT01416389|3808930|FG001|Received at Least 1 Dose of Study Drug|Overall Study||13
3086913|NCT01416389|3808929|FG000|COMPLETED|Overall Study||23
3086914|NCT01416389|3808930|FG001|COMPLETED|Overall Study||13
3086915|NCT01416389|3808929|FG000|NOT COMPLETED|Overall Study||3
3086916|NCT01416389|3808930|FG001|NOT COMPLETED|Overall Study||0
3086917|NCT01416441|3808938|FG000|STARTED|Overall Study||170
3086918|NCT01416441|3808938|FG000|COMPLETED|Overall Study||89
3086919|NCT01416441|3808938|FG000|NOT COMPLETED|Overall Study||81
3086920|NCT01416571|3808942|FG000|STARTED|Overall Study||78
3086921|NCT01416571|3808942|FG000|COMPLETED|Overall Study|Number of subjects completed at Day 385.|76
3086922|NCT01416571|3808942|FG000|NOT COMPLETED|Overall Study||2
3086923|NCT01416584|3808949|FG000|STARTED|Overall Study||30
3086924|NCT01416584|3808950|FG001|STARTED|Overall Study||35
3086925|NCT01416584|3808951|FG002|STARTED|Overall Study||33
3086926|NCT01416584|3808949|FG000|COMPLETED|Overall Study||27
3086927|NCT01416584|3808950|FG001|COMPLETED|Overall Study||33
3086928|NCT01416584|3808951|FG002|COMPLETED|Overall Study||32
3086929|NCT01416584|3808949|FG000|NOT COMPLETED|Overall Study||3
3086930|NCT01416584|3808950|FG001|NOT COMPLETED|Overall Study||2
3086931|NCT01416584|3808951|FG002|NOT COMPLETED|Overall Study||1
3086932|NCT01416610|3808965|FG000|STARTED|Overall Study||88
3086933|NCT01416610|3808965|FG000|Intention to Treat|Overall Study||88
3086934|NCT01416610|3808965|FG000|Safety Population|Overall Study||86
3086935|NCT01416610|3808965|FG000|Per Protocol|Overall Study||83
3086936|NCT01416610|3808965|FG000|Completed Treatment|Overall Study||47
3086937|NCT01416610|3808965|FG000|Completed Follow-up|Overall Study||45
3086938|NCT01416610|3808965|FG000|COMPLETED|Overall Study||45
3086939|NCT01416610|3808965|FG000|NOT COMPLETED|Overall Study||43
3086940|NCT01416636|3808975|FG000|STARTED|Overall Study||53
3086941|NCT01416636|3808976|FG001|STARTED|Overall Study||52
3086942|NCT01416636|3808975|FG000|COMPLETED|Overall Study||45
3086943|NCT01416636|3808976|FG001|COMPLETED|Overall Study||46
3086944|NCT01416636|3808975|FG000|NOT COMPLETED|Overall Study||8
3086945|NCT01416636|3808976|FG001|NOT COMPLETED|Overall Study||6
3086946|NCT01416805|3808984|FG000|STARTED|Overall Study||49
3086947|NCT01416805|3808985|FG001|STARTED|Overall Study||51
3086948|NCT01416805|3808984|FG000|COMPLETED|Overall Study||45
3086949|NCT01416805|3808985|FG001|COMPLETED|Overall Study||47
3086950|NCT01416805|3808984|FG000|NOT COMPLETED|Overall Study||4
3086951|NCT01416805|3808985|FG001|NOT COMPLETED|Overall Study||4
3086952|NCT01416987|3808991|FG000|STARTED|Overall Study||600
3086953|NCT01416987|3808991|FG000|COMPLETED|Overall Study||600
3086954|NCT01416987|3808991|FG000|NOT COMPLETED|Overall Study||0
3086955|NCT01417000|3808997|FG000|STARTED|Overall Study|62 subjects randomized into Cy/GVAX + CRS-207 arm; 61 subjects received ≥ 1 protocol-specified drug.|61
3086956|NCT01417000|3808998|FG001|STARTED|Overall Study|31 subjects randomized into Cy/GVAX arm; 29 subjects received ≥ 1 protocol-specified drug.|29
3086957|NCT01417000|3808997|FG000|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/death/study close, so no subjects completed study."|0
3086958|NCT01417000|3808998|FG001|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/death/study close, so no subjects completed study."|0
3086959|NCT01417000|3808997|FG000|NOT COMPLETED|Overall Study||61
3086960|NCT01417000|3808998|FG001|NOT COMPLETED|Overall Study||29
3086961|NCT01417026|3809006|FG000|STARTED|Overall Study||16
3086962|NCT01417026|3809007|FG001|STARTED|Overall Study||13
3086963|NCT01417026|3809006|FG000|COMPLETED|Overall Study||14
3086964|NCT01417026|3809007|FG001|COMPLETED|Overall Study||13
3086965|NCT01417026|3809006|FG000|NOT COMPLETED|Overall Study||2
3086966|NCT01417026|3809007|FG001|NOT COMPLETED|Overall Study||0
3086967|NCT01417078|3809013|FG000|STARTED|Overall Study||31
3086968|NCT01417078|3809013|FG000|COMPLETED|Overall Study||30
3086969|NCT01417078|3809013|FG000|NOT COMPLETED|Overall Study||1
3086970|NCT01417104|3809021|FG000|STARTED|Overall Study||34
3086971|NCT01417104|3809022|FG001|STARTED|Overall Study||37
3086972|NCT01417104|3809021|FG000|COMPLETED|Overall Study||28
3086973|NCT01417104|3809022|FG001|COMPLETED|Overall Study||35
3086974|NCT01417104|3809021|FG000|NOT COMPLETED|Overall Study||6
3086975|NCT01417104|3809022|FG001|NOT COMPLETED|Overall Study||2
3086976|NCT01417156|3809028|FG000|STARTED|Overall Study||20
3086977|NCT01417156|3809028|FG000|COMPLETED|Overall Study||6
3086978|NCT01417156|3809028|FG000|NOT COMPLETED|Overall Study||14
3086979|NCT01417195|3809034|FG000|STARTED|Overall Study||60
3086980|NCT01417195|3809035|FG001|STARTED|Overall Study||62
3086981|NCT01417195|3809034|FG000|COMPLETED|Overall Study||57
3086982|NCT01417195|3809035|FG001|COMPLETED|Overall Study||61
3086983|NCT01417195|3809034|FG000|NOT COMPLETED|Overall Study||3
3086984|NCT01417195|3809035|FG001|NOT COMPLETED|Overall Study||1
3086985|NCT01417234|3809042|FG000|STARTED|Overall Study||30
3086986|NCT01417234|3809042|FG000|COMPLETED|Overall Study||27
3086987|NCT01417234|3809042|FG000|NOT COMPLETED|Overall Study||3
3086988|NCT01417455|3809054|FG000|STARTED|Overall Study||16
3086989|NCT01417455|3809055|FG001|STARTED|Overall Study||16
3086990|NCT01417455|3809056|FG002|STARTED|Overall Study||17
3086991|NCT01417455|3809057|FG003|STARTED|Overall Study||17
3086992|NCT01417455|3809058|FG004|STARTED|Overall Study||30
3086993|NCT01417455|3809059|FG005|STARTED|Overall Study||13
3086994|NCT01417455|3809060|FG006|STARTED|Overall Study||13
3086995|NCT01417455|3809061|FG007|STARTED|Overall Study||25
3086996|NCT01417455|3809054|FG000|COMPLETED|Overall Study||16
3086997|NCT01417455|3809055|FG001|COMPLETED|Overall Study||16
3086998|NCT01417455|3809056|FG002|COMPLETED|Overall Study||17
3086999|NCT01417455|3809057|FG003|COMPLETED|Overall Study||17
3087000|NCT01417455|3809058|FG004|COMPLETED|Overall Study||30
3087001|NCT01417455|3809059|FG005|COMPLETED|Overall Study||13
3087002|NCT01417455|3809060|FG006|COMPLETED|Overall Study||13
3087003|NCT01417455|3809061|FG007|COMPLETED|Overall Study||25
3087004|NCT01417455|3809054|FG000|NOT COMPLETED|Overall Study||0
3087005|NCT01417455|3809055|FG001|NOT COMPLETED|Overall Study||0
3087006|NCT01417455|3809056|FG002|NOT COMPLETED|Overall Study||0
3087007|NCT01417455|3809057|FG003|NOT COMPLETED|Overall Study||0
3087008|NCT01417455|3809058|FG004|NOT COMPLETED|Overall Study||0
3087009|NCT01417455|3809059|FG005|NOT COMPLETED|Overall Study||0
3087010|NCT01417455|3809060|FG006|NOT COMPLETED|Overall Study||0
3087011|NCT01417455|3809061|FG007|NOT COMPLETED|Overall Study||0
3087012|NCT01417481|3809081|FG000|STARTED|First Intervention (8 Weeks)||8
3087013|NCT01417481|3809082|FG001|STARTED|First Intervention (8 Weeks)||7
3087014|NCT01417481|3809081|FG000|COMPLETED|First Intervention (8 Weeks)||8
3087015|NCT01417481|3809082|FG001|COMPLETED|First Intervention (8 Weeks)||5
3287610|NCT02793232|4021282|FG004|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||6
3287611|NCT02793232|4021283|FG005|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||12
3287612|NCT02793232|4021284|FG006|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||8
3287613|NCT02793232|4021285|FG007|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||2
3287614|NCT02793232|4021286|FG008|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||8
3287615|NCT02793232|4021278|FG000|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||0
3287616|NCT02793232|4021279|FG001|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||0
3287617|NCT02793232|4021280|FG002|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||0
3287618|NCT02793232|4021281|FG003|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||0
3287619|NCT02793232|4021282|FG004|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||1
3087016|NCT01417481|3809081|FG000|NOT COMPLETED|First Intervention (8 Weeks)||0
3087017|NCT01417481|3809082|FG001|NOT COMPLETED|First Intervention (8 Weeks)||2
3087018|NCT01417481|3809081|FG000|STARTED|Washout (2 Weeks)||8
3087019|NCT01417481|3809082|FG001|STARTED|Washout (2 Weeks)||5
3087020|NCT01417481|3809081|FG000|COMPLETED|Washout (2 Weeks)||8
3087021|NCT01417481|3809082|FG001|COMPLETED|Washout (2 Weeks)||5
3087022|NCT01417481|3809081|FG000|NOT COMPLETED|Washout (2 Weeks)||0
3087023|NCT01417481|3809082|FG001|NOT COMPLETED|Washout (2 Weeks)||0
3087024|NCT01417481|3809081|FG000|STARTED|Second Period (8 Weeks)||8
3087025|NCT01417481|3809082|FG001|STARTED|Second Period (8 Weeks)||5
3087026|NCT01417481|3809081|FG000|COMPLETED|Second Period (8 Weeks)||8
3087027|NCT01417481|3809082|FG001|COMPLETED|Second Period (8 Weeks)||5
3087028|NCT01417481|3809081|FG000|NOT COMPLETED|Second Period (8 Weeks)||0
3087029|NCT01417481|3809082|FG001|NOT COMPLETED|Second Period (8 Weeks)||0
3087030|NCT01417741|3809090|FG000|STARTED|Overall Study||75
3087031|NCT01417741|3809091|FG001|STARTED|Overall Study||86
3087032|NCT01417741|3809090|FG000|COMPLETED|Overall Study||75
3087033|NCT01417741|3809091|FG001|COMPLETED|Overall Study|only 73 received the post op day phone phone call|86
3087034|NCT01417741|3809090|FG000|NOT COMPLETED|Overall Study||0
3087035|NCT01417741|3809091|FG001|NOT COMPLETED|Overall Study||0
3087036|NCT01417780|3809100|FG000|STARTED|Overall Study||15
3087037|NCT01417780|3809101|FG001|STARTED|Overall Study||17
3087038|NCT01417780|3809102|FG002|STARTED|Overall Study||11
3087039|NCT01417780|3809100|FG000|COMPLETED|Overall Study||14
3087040|NCT01417780|3809101|FG001|COMPLETED|Overall Study||14
3087041|NCT01417780|3809102|FG002|COMPLETED|Overall Study||9
3087042|NCT01417780|3809100|FG000|NOT COMPLETED|Overall Study||1
3087043|NCT01417780|3809101|FG001|NOT COMPLETED|Overall Study||3
3087044|NCT01417780|3809102|FG002|NOT COMPLETED|Overall Study||2
3087045|NCT01417936|3809110|FG000|STARTED|Overall Study||26
3087046|NCT01417936|3809110|FG000|COMPLETED|Overall Study||26
3087047|NCT01417936|3809110|FG000|NOT COMPLETED|Overall Study||0
3087048|NCT01418001|3809114|FG000|STARTED|Overall Study||5
3087049|NCT01418001|3809114|FG000|COMPLETED|Overall Study||5
3087050|NCT01418001|3809114|FG000|NOT COMPLETED|Overall Study||0
3087051|NCT01418209|3809122|FG000|STARTED|Overall Study||97
3087052|NCT01418209|3809123|FG001|STARTED|Overall Study||96
3087053|NCT01418209|3809124|FG002|STARTED|Overall Study||146
3087054|NCT01418209|3809122|FG000|COMPLETED|Overall Study||95
3087055|NCT01418209|3809123|FG001|COMPLETED|Overall Study||93
3087056|NCT01418209|3809124|FG002|COMPLETED|Overall Study||142
3087057|NCT01418209|3809122|FG000|NOT COMPLETED|Overall Study||2
3087058|NCT01418209|3809123|FG001|NOT COMPLETED|Overall Study||3
3087059|NCT01418209|3809124|FG002|NOT COMPLETED|Overall Study||4
3087060|NCT01418339|3809134|FG000|STARTED|Overall Study||90
3087061|NCT01418339|3809135|FG001|STARTED|Overall Study||45
3087062|NCT01418339|3809134|FG000|COMPLETED|Overall Study||78
3087063|NCT01418339|3809135|FG001|COMPLETED|Overall Study||35
3087064|NCT01418339|3809134|FG000|NOT COMPLETED|Overall Study||12
3087065|NCT01418339|3809135|FG001|NOT COMPLETED|Overall Study||10
3087066|NCT01418352|3809145|FG000|STARTED|Overall Study||20
3087067|NCT01418352|3809146|FG001|STARTED|Overall Study||21
3087068|NCT01418352|3809147|FG002|STARTED|Overall Study||21
3087069|NCT01418352|3809148|FG003|STARTED|Overall Study||21
3087070|NCT01418352|3809145|FG000|COMPLETED|Overall Study||17
3087071|NCT01418352|3809146|FG001|COMPLETED|Overall Study||17
3087072|NCT01418352|3809147|FG002|COMPLETED|Overall Study||16
3087073|NCT01418352|3809148|FG003|COMPLETED|Overall Study||18
3087074|NCT01418352|3809145|FG000|NOT COMPLETED|Overall Study||3
3087075|NCT01418352|3809146|FG001|NOT COMPLETED|Overall Study||4
3087076|NCT01418352|3809147|FG002|NOT COMPLETED|Overall Study||5
3087077|NCT01418352|3809148|FG003|NOT COMPLETED|Overall Study||3
3087078|NCT01418365|3809160|FG000|STARTED|First Intervention||15
3087079|NCT01418365|3809161|FG001|STARTED|First Intervention||15
3087080|NCT01418365|3809160|FG000|COMPLETED|First Intervention||14
3087081|NCT01418365|3809161|FG001|COMPLETED|First Intervention||14
3087082|NCT01418365|3809160|FG000|NOT COMPLETED|First Intervention||1
3087083|NCT01418365|3809161|FG001|NOT COMPLETED|First Intervention||1
3087084|NCT01418365|3809160|FG000|STARTED|Second Intervention||14
3087085|NCT01418365|3809161|FG001|STARTED|Second Intervention||14
3087086|NCT01418365|3809160|FG000|COMPLETED|Second Intervention||14
3087087|NCT01418365|3809161|FG001|COMPLETED|Second Intervention||13
3087088|NCT01418365|3809160|FG000|NOT COMPLETED|Second Intervention||0
3087089|NCT01418365|3809161|FG001|NOT COMPLETED|Second Intervention||1
3087090|NCT01418378|3809169|FG000|STARTED|Overall Study|A total of 191 subjects were enrolled into the study. 13/191 did not receive a study implant|90
3134959|NCT01703663|3859875|FG000|NOT COMPLETED|First Treatment Period||0
3087091|NCT01418378|3809170|FG001|STARTED|Overall Study|A total of 191 subjects were enrolled into the study. 13/191 did not receive a study implant|88
3087092|NCT01418378|3809169|FG000|Subjects Who Received Study Implant|Overall Study|the number of subjects implanted with study implant|90
3087093|NCT01418378|3809170|FG001|Subjects Who Received Study Implant|Overall Study|the number of subjects implanted with study implant|88
3087094|NCT01418378|3809169|FG000|COMPLETED|Overall Study||89
3087095|NCT01418378|3809170|FG001|COMPLETED|Overall Study||83
3087096|NCT01418378|3809169|FG000|NOT COMPLETED|Overall Study||1
3087097|NCT01418378|3809170|FG001|NOT COMPLETED|Overall Study||5
3087098|NCT01418482|3809176|FG000|STARTED|Overall Study||15
3087099|NCT01418482|3809176|FG000|COMPLETED|Overall Study||15
3087100|NCT01418482|3809176|FG000|NOT COMPLETED|Overall Study||0
3087101|NCT01418703|3809182|FG000|STARTED|Overall Study||13
3087102|NCT01418703|3809183|FG001|STARTED|Overall Study||13
3087103|NCT01418703|3809184|FG002|STARTED|Overall Study||6
3087104|NCT01418703|3809185|FG003|STARTED|Overall Study||6
3087105|NCT01418703|3809182|FG000|COMPLETED|Overall Study||13
3087106|NCT01418703|3809183|FG001|COMPLETED|Overall Study||13
3087107|NCT01418703|3809184|FG002|COMPLETED|Overall Study||6
3087108|NCT01418703|3809185|FG003|COMPLETED|Overall Study||6
3087109|NCT01418703|3809182|FG000|NOT COMPLETED|Overall Study||0
3087110|NCT01418703|3809183|FG001|NOT COMPLETED|Overall Study||0
3087111|NCT01418703|3809184|FG002|NOT COMPLETED|Overall Study||0
3087112|NCT01418703|3809185|FG003|NOT COMPLETED|Overall Study||0
3087113|NCT01418937|3809192|FG000|STARTED|Overall Study||164
3087114|NCT01418937|3809192|FG000|COMPLETED|Overall Study||156
3087115|NCT01418937|3809192|FG000|NOT COMPLETED|Overall Study||8
3087116|NCT01419015|3809196|FG000|STARTED|Overall Study||17
3087117|NCT01419015|3809196|FG000|COMPLETED|Overall Study||15
3087118|NCT01419015|3809196|FG000|NOT COMPLETED|Overall Study||2
3087119|NCT01419028|3809200|FG000|STARTED|Overall Study||48
3087120|NCT01419028|3809200|FG000|COMPLETED|Overall Study||48
3087121|NCT01419028|3809200|FG000|NOT COMPLETED|Overall Study||0
3087122|NCT01419080|3809204|FG000|STARTED|Overall Study||797
3087123|NCT01419080|3809204|FG000|COMPLETED|Overall Study||666
3087124|NCT01419080|3809204|FG000|NOT COMPLETED|Overall Study||131
3087125|NCT01419171|3809210|FG000|STARTED|Overall Study||328
3087126|NCT01419171|3809210|FG000|COMPLETED|Overall Study||328
3087127|NCT01419171|3809210|FG000|NOT COMPLETED|Overall Study||0
3087128|NCT01419184|3809216|FG000|STARTED|Overall Study||128
3087129|NCT01419184|3809217|FG001|STARTED|Overall Study||121
3087130|NCT01419184|3809216|FG000|Received at Least 1 Dose of Study Drug|Overall Study||118
3087131|NCT01419184|3809217|FG001|Received at Least 1 Dose of Study Drug|Overall Study||106
3087132|NCT01419184|3809216|FG000|COMPLETED|Overall Study|6 participants did not complete the study due to no valid infection-related length of stay (IRLOS)|118
3087133|NCT01419184|3809217|FG001|COMPLETED|Overall Study|13 participants did not complete the study due to no valid infection-related length of stay (IRLOS)|106
3087134|NCT01419184|3809216|FG000|NOT COMPLETED|Overall Study||10
3087135|NCT01419184|3809217|FG001|NOT COMPLETED|Overall Study||15
3087136|NCT01419197|3809225|FG000|STARTED|Overall Study||404
3087137|NCT01419197|3809226|FG001|STARTED|Overall Study||198
3087138|NCT01419197|3809225|FG000|Switched to Trastuzumab Emtansine|Overall Study||0
3087139|NCT01419197|3809226|FG001|Switched to Trastuzumab Emtansine|Overall Study||94
3087140|NCT01419197|3809225|FG000|COMPLETED|Overall Study||0
3087141|NCT01419197|3809226|FG001|COMPLETED|Overall Study||0
3087142|NCT01419197|3809225|FG000|NOT COMPLETED|Overall Study||404
3087143|NCT01419197|3809226|FG001|NOT COMPLETED|Overall Study||198
3087144|NCT01419236|3809235|FG000|STARTED|Overall Study||36
3087145|NCT01419236|3809236|FG001|STARTED|Overall Study||40
3087146|NCT01419236|3809235|FG000|Received at Least 1 Dose of Study Drug|Overall Study||35
3087147|NCT01419236|3809236|FG001|Received at Least 1 Dose of Study Drug|Overall Study||39
3087148|NCT01419236|3809235|FG000|COMPLETED|Overall Study||31
3087149|NCT01419236|3809236|FG001|COMPLETED|Overall Study||35
3087150|NCT01419236|3809235|FG000|NOT COMPLETED|Overall Study||5
3087151|NCT01419236|3809236|FG001|NOT COMPLETED|Overall Study||5
3087152|NCT01419249|3809244|FG000|STARTED|Overall Study||318
3087153|NCT01419249|3809245|FG001|STARTED|Overall Study||140
3087154|NCT01419249|3809244|FG000|COMPLETED|Overall Study||318
3087155|NCT01419249|3809245|FG001|COMPLETED|Overall Study||140
3087156|NCT01419249|3809244|FG000|NOT COMPLETED|Overall Study||0
3087157|NCT01419249|3809245|FG001|NOT COMPLETED|Overall Study||0
3087158|NCT01419275|3809252|FG000|STARTED|Overall Study||126
3087159|NCT01419275|3809252|FG000|COMPLETED|Overall Study||126
3087160|NCT01419275|3809252|FG000|NOT COMPLETED|Overall Study||0
3087161|NCT01419314|3809258|FG000|STARTED|Start of Study|minor comfort issues were reported within the first 2 weeks of the trial|23
3087162|NCT01419314|3809259|FG001|STARTED|Start of Study|No comfort issues reported.|22
3087163|NCT01419314|3809258|FG000|COMPLETED|Start of Study||23
3087164|NCT01419314|3809259|FG001|COMPLETED|Start of Study||22
3087165|NCT01419314|3809258|FG000|NOT COMPLETED|Start of Study||0
3087166|NCT01419314|3809259|FG001|NOT COMPLETED|Start of Study||0
3087167|NCT01419314|3809258|FG000|STARTED|Follow-up at Week 3 of the Trial|3 participants discontinued the trial, 3 failed to return for additional follow-ups.|23
3087168|NCT01419314|3809259|FG001|STARTED|Follow-up at Week 3 of the Trial|one participant failed to return for the 3 week follow-up|22
3087169|NCT01419314|3809258|FG000|COMPLETED|Follow-up at Week 3 of the Trial||17
3087170|NCT01419314|3809259|FG001|COMPLETED|Follow-up at Week 3 of the Trial||21
3087171|NCT01419314|3809258|FG000|NOT COMPLETED|Follow-up at Week 3 of the Trial||6
3087172|NCT01419314|3809259|FG001|NOT COMPLETED|Follow-up at Week 3 of the Trial||1
3087173|NCT01419314|3809258|FG000|STARTED|Follow-up at Week 6 of the Trial||17
3087174|NCT01419314|3809259|FG001|STARTED|Follow-up at Week 6 of the Trial|2 participants did not return for their final follow-up|21
3087175|NCT01419314|3809258|FG000|COMPLETED|Follow-up at Week 6 of the Trial|2 people who missed the first follow-up, returned for the final follow-up at week 6 (n=18).|16
3087176|NCT01419314|3809259|FG001|COMPLETED|Follow-up at Week 6 of the Trial||19
3087177|NCT01419314|3809258|FG000|NOT COMPLETED|Follow-up at Week 6 of the Trial||1
3087178|NCT01419314|3809259|FG001|NOT COMPLETED|Follow-up at Week 6 of the Trial||2
3087179|NCT01419535|3809271|FG000|STARTED|Overall Study||9
3087180|NCT01419535|3809272|FG001|STARTED|Overall Study||10
3087181|NCT01419535|3809271|FG000|COMPLETED|Overall Study||8
3087182|NCT01419535|3809272|FG001|COMPLETED|Overall Study||8
3087183|NCT01419535|3809271|FG000|NOT COMPLETED|Overall Study||1
3087184|NCT01419535|3809272|FG001|NOT COMPLETED|Overall Study||2
3087185|NCT01419626|3809281|FG000|STARTED|Overall Study||46
3087186|NCT01419626|3809282|FG001|STARTED|Overall Study||47
3087187|NCT01419626|3809283|FG002|STARTED|Overall Study||47
3087188|NCT01419626|3809281|FG000|COMPLETED|Overall Study||42
3087189|NCT01419626|3809282|FG001|COMPLETED|Overall Study||44
3087190|NCT01419626|3809283|FG002|COMPLETED|Overall Study||44
3087191|NCT01419626|3809281|FG000|NOT COMPLETED|Overall Study||4
3087192|NCT01419626|3809282|FG001|NOT COMPLETED|Overall Study||3
3087193|NCT01419626|3809283|FG002|NOT COMPLETED|Overall Study||3
3087194|NCT01419639|3809291|FG000|STARTED|Overall Study||10
3087195|NCT01419639|3809291|FG000|COMPLETED|Overall Study||9
3087196|NCT01419639|3809291|FG000|NOT COMPLETED|Overall Study||1
3087197|NCT01419665|3809297|FG000|STARTED|Combination Treatment||312
3087198|NCT01419665|3809298|FG001|STARTED|Combination Treatment||315
3087199|NCT01419665|3809297|FG000|COMPLETED|Combination Treatment||274
3087200|NCT01419665|3809298|FG001|COMPLETED|Combination Treatment||274
3087201|NCT01419665|3809297|FG000|NOT COMPLETED|Combination Treatment||38
3087202|NCT01419665|3809298|FG001|NOT COMPLETED|Combination Treatment||41
3087203|NCT01419665|3809297|FG000|STARTED|Maintenance Treatment and/or Follow up||254
3087204|NCT01419665|3809298|FG001|STARTED|Maintenance Treatment and/or Follow up||252
3087205|NCT01419665|3809297|FG000|COMPLETED|Maintenance Treatment and/or Follow up||132
3087206|NCT01419665|3809298|FG001|COMPLETED|Maintenance Treatment and/or Follow up||150
3087207|NCT01419665|3809297|FG000|NOT COMPLETED|Maintenance Treatment and/or Follow up||122
3087208|NCT01419665|3809298|FG001|NOT COMPLETED|Maintenance Treatment and/or Follow up||102
3087209|NCT01419665|3809297|FG000|STARTED|Open Label Phase||44
3087210|NCT01419665|3809298|FG001|STARTED|Open Label Phase||39
3087211|NCT01419665|3809297|FG000|COMPLETED|Open Label Phase||43
3087212|NCT01419665|3809298|FG001|COMPLETED|Open Label Phase||38
3087213|NCT01419665|3809297|FG000|NOT COMPLETED|Open Label Phase||1
3087214|NCT01419665|3809298|FG001|NOT COMPLETED|Open Label Phase||1
3087215|NCT01419717|3809306|FG000|STARTED|Overall Study||129
3087216|NCT01419717|3809306|FG000|Received Denosumab|Overall Study||128
3087217|NCT01419717|3809306|FG000|COMPLETED|Overall Study||4
3087218|NCT01419717|3809306|FG000|NOT COMPLETED|Overall Study||125
3087219|NCT01419769|3809310|FG000|STARTED|Overall Study||33
3087220|NCT01419769|3809310|FG000|COMPLETED|Overall Study||29
3087221|NCT01419769|3809310|FG000|NOT COMPLETED|Overall Study||4
3087222|NCT01419795|3809316|FG000|STARTED|Overall Study||3
3087223|NCT01419795|3809317|FG001|STARTED|Overall Study||0
3087224|NCT01419795|3809316|FG000|COMPLETED|Overall Study||3
3087225|NCT01419795|3809317|FG001|COMPLETED|Overall Study||0
3087226|NCT01419795|3809316|FG000|NOT COMPLETED|Overall Study||0
3087227|NCT01419795|3809317|FG001|NOT COMPLETED|Overall Study||0
3087228|NCT01419977|3809325|FG000|STARTED|Overall Study||16
3087229|NCT01419977|3809326|FG001|STARTED|Overall Study||13
3087230|NCT01419977|3809325|FG000|COMPLETED|Overall Study||16
3087231|NCT01419977|3809326|FG001|COMPLETED|Overall Study||13
3087232|NCT01419977|3809325|FG000|NOT COMPLETED|Overall Study||0
3087233|NCT01419977|3809326|FG001|NOT COMPLETED|Overall Study||0
3087234|NCT01420016|3809334|FG000|STARTED|Primary Analysis||6970
3087235|NCT01420016|3809335|FG001|STARTED|Primary Analysis||6411
3087236|NCT01420016|3809336|FG002|STARTED|Primary Analysis||0
3087237|NCT01420016|3809337|FG003|STARTED|Primary Analysis||0
3087238|NCT01420016|3809334|FG000|COMPLETED|Primary Analysis|Reflects patient participants included in final analysis.|4043
3087239|NCT01420016|3809335|FG001|COMPLETED|Primary Analysis|Reflects patient participants included in final analysis.|3871
3087240|NCT01420016|3809336|FG002|COMPLETED|Primary Analysis||0
3087241|NCT01420016|3809337|FG003|COMPLETED|Primary Analysis||0
3087242|NCT01420016|3809334|FG000|NOT COMPLETED|Primary Analysis||2927
3087243|NCT01420016|3809335|FG001|NOT COMPLETED|Primary Analysis||2540
3087244|NCT01420016|3809336|FG002|NOT COMPLETED|Primary Analysis||0
3087245|NCT01420016|3809337|FG003|NOT COMPLETED|Primary Analysis||0
3087246|NCT01420016|3809334|FG000|STARTED|Safety Analysis||0
3087247|NCT01420016|3809335|FG001|STARTED|Safety Analysis||0
3087248|NCT01420016|3809336|FG002|STARTED|Safety Analysis||6392
3087249|NCT01420016|3809337|FG003|STARTED|Safety Analysis||5159
3087250|NCT01420016|3809334|FG000|COMPLETED|Safety Analysis||0
3087251|NCT01420016|3809335|FG001|COMPLETED|Safety Analysis||0
3087252|NCT01420016|3809336|FG002|COMPLETED|Safety Analysis||6392
3087253|NCT01420016|3809337|FG003|COMPLETED|Safety Analysis||5159
3087254|NCT01420016|3809334|FG000|NOT COMPLETED|Safety Analysis||0
3087255|NCT01420016|3809335|FG001|NOT COMPLETED|Safety Analysis||0
3087256|NCT01420016|3809336|FG002|NOT COMPLETED|Safety Analysis||0
3087257|NCT01420016|3809337|FG003|NOT COMPLETED|Safety Analysis||0
3087258|NCT01420068|3809345|FG000|STARTED|Overall Study||51
3087259|NCT01420068|3809346|FG001|STARTED|Overall Study||55
3087260|NCT01420068|3809345|FG000|COMPLETED|Overall Study||49
3087261|NCT01420068|3809346|FG001|COMPLETED|Overall Study||50
3087262|NCT01420068|3809345|FG000|NOT COMPLETED|Overall Study||2
3087263|NCT01420068|3809346|FG001|NOT COMPLETED|Overall Study||5
3087264|NCT01420081|3809361|FG000|STARTED|Overall Study||3
3087265|NCT01420081|3809362|FG001|STARTED|Overall Study||1
3087266|NCT01420081|3809363|FG002|STARTED|Overall Study||11
3087267|NCT01420081|3809364|FG003|STARTED|Overall Study||3
3087268|NCT01420081|3809365|FG004|STARTED|Overall Study||20
3087269|NCT01420081|3809366|FG005|STARTED|Overall Study||20
3087270|NCT01420081|3809367|FG006|STARTED|Overall Study||3
3087271|NCT01420081|3809368|FG007|STARTED|Overall Study||3
3087272|NCT01420081|3809369|FG008|STARTED|Overall Study||3
3087273|NCT01420081|3809361|FG000|COMPLETED|Overall Study||0
3087274|NCT01420081|3809362|FG001|COMPLETED|Overall Study||0
3087275|NCT01420081|3809363|FG002|COMPLETED|Overall Study||0
3087276|NCT01420081|3809364|FG003|COMPLETED|Overall Study||0
3087277|NCT01420081|3809365|FG004|COMPLETED|Overall Study||0
3087278|NCT01420081|3809366|FG005|COMPLETED|Overall Study||0
3087279|NCT01420081|3809367|FG006|COMPLETED|Overall Study||0
3087280|NCT01420081|3809368|FG007|COMPLETED|Overall Study||0
3087281|NCT01420081|3809369|FG008|COMPLETED|Overall Study||0
3087282|NCT01420081|3809361|FG000|NOT COMPLETED|Overall Study||3
3087283|NCT01420081|3809362|FG001|NOT COMPLETED|Overall Study||1
3087284|NCT01420081|3809363|FG002|NOT COMPLETED|Overall Study||11
3087285|NCT01420081|3809364|FG003|NOT COMPLETED|Overall Study||3
3087286|NCT01420081|3809365|FG004|NOT COMPLETED|Overall Study||20
3087287|NCT01420081|3809366|FG005|NOT COMPLETED|Overall Study||20
3087288|NCT01420081|3809367|FG006|NOT COMPLETED|Overall Study||3
3087289|NCT01420081|3809368|FG007|NOT COMPLETED|Overall Study||3
3087290|NCT01420081|3809369|FG008|NOT COMPLETED|Overall Study||3
3087291|NCT01420146|3809385|FG000|STARTED|Overall Study||20
3087292|NCT01420146|3809385|FG000|COMPLETED|Overall Study||20
3087293|NCT01420146|3809385|FG000|NOT COMPLETED|Overall Study||0
3087294|NCT01420289|3809391|FG000|STARTED|Overall Study||18
3087295|NCT01420289|3809392|FG001|STARTED|Overall Study||16
3087296|NCT01420289|3809391|FG000|COMPLETED|Overall Study||18
3087297|NCT01420289|3809392|FG001|COMPLETED|Overall Study||16
3087298|NCT01420289|3809391|FG000|NOT COMPLETED|Overall Study||0
3087299|NCT01420289|3809392|FG001|NOT COMPLETED|Overall Study||0
3087300|NCT01420536|3809400|FG000|STARTED|Period 1 (30 Days)||22
3087301|NCT01420536|3809401|FG001|STARTED|Period 1 (30 Days)||22
3087302|NCT01420536|3809400|FG000|COMPLETED|Period 1 (30 Days)|Participants declined to participate further before changing interventions.|19
3087303|NCT01420536|3809401|FG001|COMPLETED|Period 1 (30 Days)||22
3087304|NCT01420536|3809400|FG000|NOT COMPLETED|Period 1 (30 Days)||3
3087305|NCT01420536|3809401|FG001|NOT COMPLETED|Period 1 (30 Days)||0
3087306|NCT01420536|3809400|FG000|STARTED|Period 2 (30 Days)||19
3087307|NCT01420536|3809401|FG001|STARTED|Period 2 (30 Days)||22
3087308|NCT01420536|3809400|FG000|COMPLETED|Period 2 (30 Days)||19
3087309|NCT01420536|3809401|FG001|COMPLETED|Period 2 (30 Days)||22
3087310|NCT01420536|3809400|FG000|NOT COMPLETED|Period 2 (30 Days)||0
3087311|NCT01420536|3809401|FG001|NOT COMPLETED|Period 2 (30 Days)||0
3087312|NCT01420549|3809411|FG000|STARTED|Overall Study||66
3087313|NCT01420549|3809412|FG001|STARTED|Overall Study||63
3087314|NCT01420549|3809411|FG000|COMPLETED|Overall Study||59
3087315|NCT01420549|3809412|FG001|COMPLETED|Overall Study||58
3087316|NCT01420549|3809411|FG000|NOT COMPLETED|Overall Study||7
3087317|NCT01420549|3809412|FG001|NOT COMPLETED|Overall Study||5
3087318|NCT01420627|3809418|FG000|STARTED|Adagen Lead-in Period||7
3087319|NCT01420627|3809418|FG000|COMPLETED|Adagen Lead-in Period||7
3087320|NCT01420627|3809418|FG000|NOT COMPLETED|Adagen Lead-in Period||0
3087321|NCT01420627|3809418|FG000|STARTED|EZN-2279 Treatment Period||7
3087322|NCT01420627|3809418|FG000|COMPLETED|EZN-2279 Treatment Period||6
3087323|NCT01420627|3809418|FG000|NOT COMPLETED|EZN-2279 Treatment Period||1
3087324|NCT01420627|3809418|FG000|STARTED|EZN-2279 Maintenance Period||6
3087325|NCT01420627|3809418|FG000|COMPLETED|EZN-2279 Maintenance Period||6
3087326|NCT01420627|3809418|FG000|NOT COMPLETED|EZN-2279 Maintenance Period||0
3087327|NCT01420653|3809430|FG000|STARTED|Overall Study||110
3087328|NCT01420653|3809431|FG001|STARTED|Overall Study||111
3087329|NCT01420653|3809432|FG002|STARTED|Overall Study||112
3087330|NCT01420653|3809433|FG003|STARTED|Overall Study||75
3087331|NCT01420653|3809430|FG000|COMPLETED|Overall Study||107
3087332|NCT01420653|3809431|FG001|COMPLETED|Overall Study||108
3087333|NCT01420653|3809432|FG002|COMPLETED|Overall Study||108
3087334|NCT01420653|3809433|FG003|COMPLETED|Overall Study||68
3087335|NCT01420653|3809430|FG000|NOT COMPLETED|Overall Study||3
3087336|NCT01420653|3809431|FG001|NOT COMPLETED|Overall Study||3
3087337|NCT01420653|3809432|FG002|NOT COMPLETED|Overall Study||4
3087338|NCT01420653|3809433|FG003|NOT COMPLETED|Overall Study||7
3087339|NCT01420679|3809445|FG000|STARTED|Overall Study||14
3087340|NCT01420679|3809446|FG001|STARTED|Overall Study||7
3087341|NCT01420679|3809445|FG000|COMPLETED|Overall Study||0
3087342|NCT01420679|3809446|FG001|COMPLETED|Overall Study||0
3087343|NCT01420679|3809445|FG000|NOT COMPLETED|Overall Study||14
3087344|NCT01420679|3809446|FG001|NOT COMPLETED|Overall Study||7
3087345|NCT01420848|3809455|FG000|STARTED|Overall Study||24
3087346|NCT01420848|3809456|FG001|STARTED|Overall Study||25
3087347|NCT01420848|3809457|FG002|STARTED|Overall Study||22
3087348|NCT01420848|3809455|FG000|COMPLETED|Overall Study||24
3087349|NCT01420848|3809456|FG001|COMPLETED|Overall Study||25
3087350|NCT01420848|3809457|FG002|COMPLETED|Overall Study||22
3087351|NCT01420848|3809455|FG000|NOT COMPLETED|Overall Study||0
3087352|NCT01420848|3809456|FG001|NOT COMPLETED|Overall Study||0
3087353|NCT01420848|3809457|FG002|NOT COMPLETED|Overall Study||0
3087354|NCT01420926|3809467|FG000|STARTED|Overall Study||82
3087355|NCT01420926|3809468|FG001|STARTED|Overall Study||81
3087356|NCT01420926|3809467|FG000|COMPLETED|Overall Study||22
3087357|NCT01420926|3809468|FG001|COMPLETED|Overall Study||16
3087358|NCT01420926|3809467|FG000|NOT COMPLETED|Overall Study||60
3087359|NCT01420926|3809468|FG001|NOT COMPLETED|Overall Study||65
3087360|NCT01421017|3809477|FG000|STARTED|Overall Study||12
3087361|NCT01421017|3809478|FG001|STARTED|Overall Study||12
3087362|NCT01421017|3809479|FG002|STARTED|Overall Study||7
3087363|NCT01421017|3809477|FG000|COMPLETED|Overall Study||10
3087364|NCT01421017|3809478|FG001|COMPLETED|Overall Study||6
3087365|NCT01421017|3809479|FG002|COMPLETED|Overall Study||4
3087366|NCT01421017|3809477|FG000|NOT COMPLETED|Overall Study||2
3087367|NCT01421017|3809478|FG001|NOT COMPLETED|Overall Study||6
3087368|NCT01421017|3809479|FG002|NOT COMPLETED|Overall Study||3
3087369|NCT01421134|3809489|FG000|STARTED|Overall Study||109
3087370|NCT01421134|3809490|FG001|STARTED|Overall Study||102
3087371|NCT01421134|3809489|FG000|COMPLETED|Overall Study||102
3087372|NCT01421134|3809490|FG001|COMPLETED|Overall Study||87
3087373|NCT01421134|3809489|FG000|NOT COMPLETED|Overall Study||7
3087374|NCT01421134|3809490|FG001|NOT COMPLETED|Overall Study||15
3287620|NCT02793232|4021283|FG005|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||0
3287621|NCT02793232|4021284|FG006|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||1
3287622|NCT02793232|4021285|FG007|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||0
3287623|NCT02793232|4021286|FG008|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||0
3287624|NCT02793232|4021278|FG000|STARTED|Washout Period 1(Part A:at Least 10days)||2
3287625|NCT02793232|4021279|FG001|STARTED|Washout Period 1(Part A:at Least 10days)||2
3087375|NCT01421147|3809498|FG000|STARTED|Treatment Period||269
3087376|NCT01421147|3809499|FG001|STARTED|Treatment Period||267
3087377|NCT01421147|3809498|FG000|Received at Least 1 Dose of Study Drug|Treatment Period||268
3087378|NCT01421147|3809499|FG001|Received at Least 1 Dose of Study Drug|Treatment Period||267
3087379|NCT01421147|3809498|FG000|COMPLETED|Treatment Period||253
3087380|NCT01421147|3809499|FG001|COMPLETED|Treatment Period||256
3087381|NCT01421147|3809498|FG000|NOT COMPLETED|Treatment Period||16
3087382|NCT01421147|3809499|FG001|NOT COMPLETED|Treatment Period||11
3087383|NCT01421147|3809498|FG000|STARTED|Extension Period||253
3087384|NCT01421147|3809499|FG001|STARTED|Extension Period||256
3087385|NCT01421147|3809498|FG000|COMPLETED|Extension Period||245
3087386|NCT01421147|3809499|FG001|COMPLETED|Extension Period||245
3087387|NCT01421147|3809498|FG000|NOT COMPLETED|Extension Period||8
3087388|NCT01421147|3809499|FG001|NOT COMPLETED|Extension Period||11
3287626|NCT02793232|4021280|FG002|STARTED|Washout Period 1(Part A:at Least 10days)||2
3287627|NCT02793232|4021281|FG003|STARTED|Washout Period 1(Part A:at Least 10days)||2
3287628|NCT02793232|4021282|FG004|STARTED|Washout Period 1(Part A:at Least 10days)||0
3287629|NCT02793232|4021283|FG005|STARTED|Washout Period 1(Part A:at Least 10days)||0
3287630|NCT02793232|4021284|FG006|STARTED|Washout Period 1(Part A:at Least 10days)||0
3087389|NCT01421186|3809510|FG000|STARTED|Overall Study||31
3087390|NCT01421186|3809511|FG001|STARTED|Overall Study||4
3087391|NCT01421186|3809512|FG002|STARTED|Overall Study||18
3087392|NCT01421186|3809513|FG003|STARTED|Overall Study||21
3087393|NCT01421186|3809514|FG004|STARTED|Overall Study||17
3087394|NCT01421186|3809510|FG000|COMPLETED|Overall Study||31
3087395|NCT01421186|3809511|FG001|COMPLETED|Overall Study||4
3087396|NCT01421186|3809512|FG002|COMPLETED|Overall Study||18
3087397|NCT01421186|3809513|FG003|COMPLETED|Overall Study||21
3087398|NCT01421186|3809514|FG004|COMPLETED|Overall Study||17
3087399|NCT01421186|3809510|FG000|NOT COMPLETED|Overall Study||0
3087400|NCT01421186|3809511|FG001|NOT COMPLETED|Overall Study||0
3087401|NCT01421186|3809512|FG002|NOT COMPLETED|Overall Study||0
3087402|NCT01421186|3809513|FG003|NOT COMPLETED|Overall Study||0
3087403|NCT01421186|3809514|FG004|NOT COMPLETED|Overall Study||0
3087404|NCT01421225|3809534|FG000|STARTED|Overall Study||4
3087405|NCT01421225|3809535|FG001|STARTED|Overall Study||6
3087406|NCT01421225|3809534|FG000|COMPLETED|Overall Study||4
3087407|NCT01421225|3809535|FG001|COMPLETED|Overall Study||5
3087408|NCT01421225|3809534|FG000|NOT COMPLETED|Overall Study||0
3087409|NCT01421225|3809535|FG001|NOT COMPLETED|Overall Study||1
3087410|NCT01421277|3809544|FG000|STARTED|Overall Study||25
3087411|NCT01421277|3809545|FG001|STARTED|Overall Study||191
3087412|NCT01421277|3809544|FG000|COMPLETED|Overall Study|Completed the online survey for at least one migraine attack.|25
3087413|NCT01421277|3809545|FG001|COMPLETED|Overall Study|Completed the online survey for at least one migraine attack.|99
3087414|NCT01421277|3809544|FG000|NOT COMPLETED|Overall Study||0
3087415|NCT01421277|3809545|FG001|NOT COMPLETED|Overall Study||92
3087416|NCT01421303|3809551|FG000|STARTED|Overall Study||80
3087417|NCT01421303|3809551|FG000|COMPLETED|Overall Study||58
3087418|NCT01421303|3809551|FG000|NOT COMPLETED|Overall Study||22
3087419|NCT01421342|3809558|FG000|STARTED|Acute Treatment Phase (12 Weeks)||511
3087420|NCT01421342|3809559|FG001|STARTED|Acute Treatment Phase (12 Weeks)||506
3087421|NCT01421342|3809560|FG002|STARTED|Acute Treatment Phase (12 Weeks)||505
3087422|NCT01421342|3809558|FG000|COMPLETED|Acute Treatment Phase (12 Weeks)||353
3087423|NCT01421342|3809559|FG001|COMPLETED|Acute Treatment Phase (12 Weeks)||378
3087424|NCT01421342|3809560|FG002|COMPLETED|Acute Treatment Phase (12 Weeks)||406
3087425|NCT01421342|3809558|FG000|NOT COMPLETED|Acute Treatment Phase (12 Weeks)||158
3287631|NCT02793232|4021285|FG007|STARTED|Washout Period 1(Part A:at Least 10days)||0
3287632|NCT02793232|4021286|FG008|STARTED|Washout Period 1(Part A:at Least 10days)||0
3287633|NCT02793232|4021278|FG000|COMPLETED|Washout Period 1(Part A:at Least 10days)||2
3287634|NCT02793232|4021279|FG001|COMPLETED|Washout Period 1(Part A:at Least 10days)||2
3287635|NCT02793232|4021280|FG002|COMPLETED|Washout Period 1(Part A:at Least 10days)||2
3287636|NCT02793232|4021281|FG003|COMPLETED|Washout Period 1(Part A:at Least 10days)||2
3287637|NCT02793232|4021282|FG004|COMPLETED|Washout Period 1(Part A:at Least 10days)||0
3287638|NCT02793232|4021283|FG005|COMPLETED|Washout Period 1(Part A:at Least 10days)||0
3287639|NCT02793232|4021284|FG006|COMPLETED|Washout Period 1(Part A:at Least 10days)||0
3287640|NCT02793232|4021285|FG007|COMPLETED|Washout Period 1(Part A:at Least 10days)||0
3287641|NCT02793232|4021286|FG008|COMPLETED|Washout Period 1(Part A:at Least 10days)||0
3287642|NCT02793232|4021278|FG000|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
3287643|NCT02793232|4021279|FG001|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
3287644|NCT02793232|4021280|FG002|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
3287645|NCT02793232|4021281|FG003|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
3287646|NCT02793232|4021282|FG004|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
3287647|NCT02793232|4021283|FG005|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
3287648|NCT02793232|4021284|FG006|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
3287649|NCT02793232|4021285|FG007|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
3287650|NCT02793232|4021286|FG008|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
3287651|NCT02793232|4021278|FG000|STARTED|Period 2 (Part A: 5 Days)||2
3287652|NCT02793232|4021279|FG001|STARTED|Period 2 (Part A: 5 Days)||2
3287653|NCT02793232|4021280|FG002|STARTED|Period 2 (Part A: 5 Days)||2
3287654|NCT02793232|4021281|FG003|STARTED|Period 2 (Part A: 5 Days)||2
3287655|NCT02793232|4021282|FG004|STARTED|Period 2 (Part A: 5 Days)||0
3287656|NCT02793232|4021283|FG005|STARTED|Period 2 (Part A: 5 Days)||0
3287657|NCT02793232|4021284|FG006|STARTED|Period 2 (Part A: 5 Days)||0
3287658|NCT02793232|4021285|FG007|STARTED|Period 2 (Part A: 5 Days)||0
3287659|NCT02793232|4021286|FG008|STARTED|Period 2 (Part A: 5 Days)||0
3287660|NCT02793232|4021278|FG000|COMPLETED|Period 2 (Part A: 5 Days)||2
3287661|NCT02793232|4021279|FG001|COMPLETED|Period 2 (Part A: 5 Days)||2
3287662|NCT02793232|4021280|FG002|COMPLETED|Period 2 (Part A: 5 Days)||2
3287663|NCT02793232|4021281|FG003|COMPLETED|Period 2 (Part A: 5 Days)||2
3287664|NCT02793232|4021282|FG004|COMPLETED|Period 2 (Part A: 5 Days)||0
3287665|NCT02793232|4021283|FG005|COMPLETED|Period 2 (Part A: 5 Days)||0
3287666|NCT02793232|4021284|FG006|COMPLETED|Period 2 (Part A: 5 Days)||0
3287667|NCT02793232|4021285|FG007|COMPLETED|Period 2 (Part A: 5 Days)||0
3287668|NCT02793232|4021286|FG008|COMPLETED|Period 2 (Part A: 5 Days)||0
3287669|NCT02793232|4021278|FG000|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
3287670|NCT02793232|4021279|FG001|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
3287671|NCT02793232|4021280|FG002|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
3287672|NCT02793232|4021281|FG003|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
3287673|NCT02793232|4021282|FG004|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
3287674|NCT02793232|4021283|FG005|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
3287675|NCT02793232|4021284|FG006|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
3287676|NCT02793232|4021285|FG007|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
3287677|NCT02793232|4021286|FG008|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
3087426|NCT01421342|3809559|FG001|NOT COMPLETED|Acute Treatment Phase (12 Weeks)||128
3087427|NCT01421342|3809560|FG002|NOT COMPLETED|Acute Treatment Phase (12 Weeks)||99
3087428|NCT01421342|3809558|FG000|STARTED|Completed to Week 12 But Then Withdrawn||353
3087429|NCT01421342|3809559|FG001|STARTED|Completed to Week 12 But Then Withdrawn||378
3087430|NCT01421342|3809560|FG002|STARTED|Completed to Week 12 But Then Withdrawn||406
3087431|NCT01421342|3809558|FG000|COMPLETED|Completed to Week 12 But Then Withdrawn||204
3087432|NCT01421342|3809559|FG001|COMPLETED|Completed to Week 12 But Then Withdrawn||253
3087433|NCT01421342|3809560|FG002|COMPLETED|Completed to Week 12 But Then Withdrawn||268
3087434|NCT01421342|3809558|FG000|NOT COMPLETED|Completed to Week 12 But Then Withdrawn||149
3087435|NCT01421342|3809559|FG001|NOT COMPLETED|Completed to Week 12 But Then Withdrawn||125
3087436|NCT01421342|3809560|FG002|NOT COMPLETED|Completed to Week 12 But Then Withdrawn||138
3087437|NCT01421342|3809558|FG000|STARTED|Continuation of Treatment (Week 12 - 36)||204
3087438|NCT01421342|3809559|FG001|STARTED|Continuation of Treatment (Week 12 - 36)||253
3087439|NCT01421342|3809560|FG002|STARTED|Continuation of Treatment (Week 12 - 36)||268
3087440|NCT01421342|3809558|FG000|COMPLETED|Continuation of Treatment (Week 12 - 36)||152
3087441|NCT01421342|3809559|FG001|COMPLETED|Continuation of Treatment (Week 12 - 36)||194
3087442|NCT01421342|3809560|FG002|COMPLETED|Continuation of Treatment (Week 12 - 36)||203
3087443|NCT01421342|3809558|FG000|NOT COMPLETED|Continuation of Treatment (Week 12 - 36)||52
3087444|NCT01421342|3809559|FG001|NOT COMPLETED|Continuation of Treatment (Week 12 - 36)||59
3087445|NCT01421342|3809560|FG002|NOT COMPLETED|Continuation of Treatment (Week 12 - 36)||65
3087446|NCT01421355|3809568|FG000|STARTED|Overall Study||21
3087447|NCT01421355|3809568|FG000|COMPLETED|Overall Study||15
3087448|NCT01421355|3809568|FG000|NOT COMPLETED|Overall Study||6
3087449|NCT01421459|3809574|FG000|STARTED|Overall Study||379
3087450|NCT01421459|3809575|FG001|STARTED|Overall Study||380
3087451|NCT01421459|3809574|FG000|Received at Least 1 Dose of Study Drug|Overall Study||376
3087452|NCT01421459|3809575|FG001|Received at Least 1 Dose of Study Drug|Overall Study||380
3087453|NCT01421459|3809574|FG000|COMPLETED|Overall Study||334
3087454|NCT01421459|3809575|FG001|COMPLETED|Overall Study||328
3087455|NCT01421459|3809574|FG000|NOT COMPLETED|Overall Study||45
3087456|NCT01421459|3809575|FG001|NOT COMPLETED|Overall Study||52
3087457|NCT01421472|3809585|FG000|STARTED|Overall Study||67
3087458|NCT01421472|3809586|FG001|STARTED|Overall Study||33
3087459|NCT01421472|3809587|FG002|STARTED|Overall Study||64
3087460|NCT01421472|3809588|FG003|STARTED|Overall Study||32
3087461|NCT01421472|3809585|FG000|COMPLETED|Overall Study||67
3087462|NCT01421472|3809586|FG001|COMPLETED|Overall Study||33
3087463|NCT01421472|3809587|FG002|COMPLETED|Overall Study||64
3087464|NCT01421472|3809588|FG003|COMPLETED|Overall Study||32
3087465|NCT01421472|3809585|FG000|NOT COMPLETED|Overall Study||0
3087466|NCT01421472|3809586|FG001|NOT COMPLETED|Overall Study||0
3087467|NCT01421472|3809587|FG002|NOT COMPLETED|Overall Study||0
3087468|NCT01421472|3809588|FG003|NOT COMPLETED|Overall Study||0
3087469|NCT01421498|3809600|FG000|STARTED|Overall Study||293
3087470|NCT01421498|3809601|FG001|STARTED|Overall Study||295
3087471|NCT01421498|3809600|FG000|COMPLETED|Overall Study||281
3087472|NCT01421498|3809601|FG001|COMPLETED|Overall Study||284
3087473|NCT01421498|3809600|FG000|NOT COMPLETED|Overall Study||12
3087474|NCT01421498|3809601|FG001|NOT COMPLETED|Overall Study||11
3087475|NCT01421511|3809609|FG000|STARTED|Overall Study||332
3087476|NCT01421511|3809610|FG001|STARTED|Overall Study||334
3087477|NCT01421511|3809609|FG000|COMPLETED|Overall Study||313
3087478|NCT01421511|3809610|FG001|COMPLETED|Overall Study||306
3087479|NCT01421511|3809609|FG000|NOT COMPLETED|Overall Study||19
3087480|NCT01421511|3809610|FG001|NOT COMPLETED|Overall Study||28
3087481|NCT01421589|3809617|FG000|STARTED|Overall Study||15
3087482|NCT01421589|3809617|FG000|COMPLETED|Overall Study||15
3087483|NCT01421589|3809617|FG000|NOT COMPLETED|Overall Study||0
3134960|NCT01703663|3859876|FG001|NOT COMPLETED|First Treatment Period||0
3134961|NCT01703663|3859875|FG000|STARTED|Second Treatment Period||11
3134962|NCT01703663|3859876|FG001|STARTED|Second Treatment Period||8
3134963|NCT01703663|3859875|FG000|COMPLETED|Second Treatment Period||11
3134964|NCT01703663|3859876|FG001|COMPLETED|Second Treatment Period||8
3134965|NCT01703663|3859875|FG000|NOT COMPLETED|Second Treatment Period||0
3134966|NCT01703663|3859876|FG001|NOT COMPLETED|Second Treatment Period||0
3134967|NCT01703702|3859884|FG000|STARTED|Overall Study||308
3134968|NCT01703702|3859885|FG001|STARTED|Overall Study||310
3134969|NCT01703702|3859884|FG000|COMPLETED|Overall Study||272
3134970|NCT01703702|3859885|FG001|COMPLETED|Overall Study||288
3134971|NCT01703702|3859884|FG000|NOT COMPLETED|Overall Study||36
3134972|NCT01703702|3859885|FG001|NOT COMPLETED|Overall Study||22
3136761|NCT01714947|3862017|FG000|NOT COMPLETED|Part B||3
3136762|NCT01715064|3862023|FG000|STARTED|Overall Study||18
3136763|NCT01715064|3862024|FG001|STARTED|Overall Study||18
3136764|NCT01715064|3862023|FG000|COMPLETED|Overall Study||18
3136765|NCT01715064|3862024|FG001|COMPLETED|Overall Study||18
3136766|NCT01715064|3862023|FG000|NOT COMPLETED|Overall Study||0
3136767|NCT01715064|3862024|FG001|NOT COMPLETED|Overall Study||0
3136768|NCT01715129|3862030|FG000|STARTED|Overall Study||126
3136769|NCT01715129|3862030|FG000|COMPLETED|Overall Study||117
3136770|NCT01715129|3862030|FG000|NOT COMPLETED|Overall Study||9
3136771|NCT01715207|3862036|FG000|STARTED|Overall Study||15
3136772|NCT01715207|3862037|FG001|STARTED|Overall Study||15
3136773|NCT01715207|3862036|FG000|COMPLETED|Overall Study||14
3136774|NCT01715207|3862037|FG001|COMPLETED|Overall Study||14
3136775|NCT01715207|3862036|FG000|NOT COMPLETED|Overall Study||1
3136776|NCT01715207|3862037|FG001|NOT COMPLETED|Overall Study||1
3136777|NCT01715233|3862045|FG000|STARTED|Overall Study||21
3136778|NCT01715233|3862045|FG000|COMPLETED|Overall Study||21
3136779|NCT01715233|3862045|FG000|NOT COMPLETED|Overall Study||0
3136780|NCT01715298|3862052|FG000|STARTED|Overall Study||216
3136781|NCT01715298|3862053|FG001|STARTED|Overall Study||216
3136782|NCT01715298|3862052|FG000|Full Analysis Set (FAS)|Overall Study|patients were analyzed according to the treatment to which they were randomized|215
3136783|NCT01715298|3862053|FG001|Full Analysis Set (FAS)|Overall Study||214
3136784|NCT01715298|3862052|FG000|COMPLETED|Overall Study||209
3136785|NCT01715298|3862053|FG001|COMPLETED|Overall Study||205
3136786|NCT01715298|3862052|FG000|NOT COMPLETED|Overall Study||7
3136787|NCT01715298|3862053|FG001|NOT COMPLETED|Overall Study||11
3136788|NCT01715415|3862061|FG000|STARTED|Double-blind Treatment||297
3136789|NCT01715415|3862062|FG001|STARTED|Double-blind Treatment||98
3136790|NCT01715415|3862061|FG000|Randomized But Not Treated|Double-blind Treatment||0
3136791|NCT01715415|3862062|FG001|Randomized But Not Treated|Double-blind Treatment||1
3136792|NCT01715415|3862061|FG000|COMPLETED|Double-blind Treatment|The number of participants who completed double-blind study drug.|292
3136793|NCT01715415|3862062|FG001|COMPLETED|Double-blind Treatment|The number of participants who completed double-blind study drug.|96
3136794|NCT01715415|3862061|FG000|NOT COMPLETED|Double-blind Treatment||5
3136795|NCT01715415|3862062|FG001|NOT COMPLETED|Double-blind Treatment||2
3136796|NCT01715415|3862061|FG000|STARTED|Open-label Treatment|not applicable to this arm|0
3136797|NCT01715415|3862062|FG001|STARTED|Open-label Treatment||96
3136798|NCT01715415|3862061|FG000|COMPLETED|Open-label Treatment|not applicable to this arm|0
3136799|NCT01715415|3862062|FG001|COMPLETED|Open-label Treatment|The number of participants who completed open-label study drug.|94
3136800|NCT01715415|3862061|FG000|NOT COMPLETED|Open-label Treatment||0
3136801|NCT01715415|3862062|FG001|NOT COMPLETED|Open-label Treatment||2
3136802|NCT01715571|3862069|FG000|STARTED|Overall Study||11
3136803|NCT01715571|3862069|FG000|COMPLETED|Overall Study||3
3136804|NCT01715571|3862069|FG000|NOT COMPLETED|Overall Study||8
3136805|NCT01715805|3862073|FG000|STARTED|Placebo + ADT Lead-in Period||1022
3136806|NCT01715805|3862074|FG001|STARTED|Placebo + ADT Lead-in Period||0
3087484|NCT01421641|3809624|FG000|STARTED|Overall Study||37
3087485|NCT01421641|3809625|FG001|STARTED|Overall Study||37
3087486|NCT01421641|3809624|FG000|COMPLETED|Overall Study||35
3087487|NCT01421641|3809625|FG001|COMPLETED|Overall Study||35
3087488|NCT01421641|3809624|FG000|NOT COMPLETED|Overall Study||2
3087489|NCT01421641|3809625|FG001|NOT COMPLETED|Overall Study||2
3087490|NCT01421654|3809633|FG000|STARTED|Overall Study||11
3087491|NCT01421654|3809634|FG001|STARTED|Overall Study||9
3087492|NCT01421654|3809633|FG000|COMPLETED|Overall Study||11
3087493|NCT01421654|3809634|FG001|COMPLETED|Overall Study|10 subjects completed study, but 1 subject was found to not meet IEC at the end; data was not used.|9
3087494|NCT01421654|3809633|FG000|NOT COMPLETED|Overall Study||0
3087495|NCT01421654|3809634|FG001|NOT COMPLETED|Overall Study||0
3087496|NCT01421667|3809644|FG000|STARTED|Overall Study||35
3087497|NCT01421667|3809645|FG001|STARTED|Overall Study||68
3087498|NCT01421667|3809646|FG002|STARTED|Overall Study||53
3087499|NCT01421667|3809647|FG003|STARTED|Overall Study||16
3087500|NCT01421667|3809644|FG000|COMPLETED|Overall Study|Completed per protocol due to death [24] or study termination by sponsor [11]|35
3087501|NCT01421667|3809645|FG001|COMPLETED|Overall Study|Completed per protocol due to death [45] or study termination by sponsor [21]|66
3087502|NCT01421667|3809646|FG002|COMPLETED|Overall Study|Completed per protocol due to death [33] or study termination by sponsor [18]|51
3087503|NCT01421667|3809647|FG003|COMPLETED|Overall Study|Completed per protocol due to death [7] or study termination by sponsor [8]|15
3087504|NCT01421667|3809644|FG000|NOT COMPLETED|Overall Study||0
3087505|NCT01421667|3809645|FG001|NOT COMPLETED|Overall Study||2
3087506|NCT01421667|3809646|FG002|NOT COMPLETED|Overall Study||2
3087507|NCT01421667|3809647|FG003|NOT COMPLETED|Overall Study||1
3087508|NCT01421719|3809665|FG000|STARTED|Overall Study||20
3087509|NCT01421719|3809665|FG000|COMPLETED|Overall Study||16
3087510|NCT01421719|3809665|FG000|NOT COMPLETED|Overall Study||4
3087511|NCT01422070|3809672|FG000|STARTED|Overall Study|Number of patients admitted to 140 intensive care units|5031
3087512|NCT01422070|3809673|FG001|STARTED|Overall Study|Number of patients admitted to 27 intensive care units.|803
3087513|NCT01422070|3809672|FG000|COMPLETED|Overall Study||5031
3087514|NCT01422070|3809673|FG001|COMPLETED|Overall Study||803
3087515|NCT01422070|3809672|FG000|NOT COMPLETED|Overall Study||0
3087516|NCT01422070|3809673|FG001|NOT COMPLETED|Overall Study||0
3087517|NCT01422135|3809678|FG000|STARTED|Overall Study||4
3087518|NCT01422135|3809679|FG001|STARTED|Overall Study||4
3087519|NCT01422135|3809680|FG002|STARTED|Overall Study||4
3087520|NCT01422135|3809681|FG003|STARTED|Overall Study||4
3087521|NCT01422135|3809682|FG004|STARTED|Overall Study||4
3087522|NCT01422135|3809683|FG005|STARTED|Overall Study||4
3087523|NCT01422135|3809678|FG000|COMPLETED|Overall Study||4
3087524|NCT01422135|3809679|FG001|COMPLETED|Overall Study||4
3087525|NCT01422135|3809680|FG002|COMPLETED|Overall Study||3
3087526|NCT01422135|3809681|FG003|COMPLETED|Overall Study||4
3087527|NCT01422135|3809682|FG004|COMPLETED|Overall Study||4
3087528|NCT01422135|3809683|FG005|COMPLETED|Overall Study||3
3087529|NCT01422135|3809678|FG000|NOT COMPLETED|Overall Study||0
3087530|NCT01422135|3809679|FG001|NOT COMPLETED|Overall Study||0
3087531|NCT01422135|3809680|FG002|NOT COMPLETED|Overall Study||1
3087532|NCT01422135|3809681|FG003|NOT COMPLETED|Overall Study||0
3087533|NCT01422135|3809682|FG004|NOT COMPLETED|Overall Study||0
3087534|NCT01422135|3809683|FG005|NOT COMPLETED|Overall Study||1
3087535|NCT01422161|3809691|FG000|STARTED|Overall Study||10
3087536|NCT01422161|3809692|FG001|STARTED|Overall Study||6
3087537|NCT01422161|3809691|FG000|COMPLETED|Overall Study||10
3087538|NCT01422161|3809692|FG001|COMPLETED|Overall Study||6
3087539|NCT01422161|3809691|FG000|NOT COMPLETED|Overall Study||0
3087540|NCT01422161|3809692|FG001|NOT COMPLETED|Overall Study||0
3087541|NCT01422187|3809709|FG000|STARTED|Overall Study||8
3087542|NCT01422187|3809710|FG001|STARTED|Overall Study||9
3087543|NCT01422187|3809711|FG002|STARTED|Overall Study||2
3087544|NCT01422187|3809709|FG000|COMPLETED|Overall Study||7
3087545|NCT01422187|3809710|FG001|COMPLETED|Overall Study||8
3087546|NCT01422187|3809711|FG002|COMPLETED|Overall Study||2
3087547|NCT01422187|3809709|FG000|NOT COMPLETED|Overall Study||1
3087548|NCT01422187|3809710|FG001|NOT COMPLETED|Overall Study||1
3087549|NCT01422187|3809711|FG002|NOT COMPLETED|Overall Study||0
3087550|NCT01422200|3809721|FG000|STARTED|Overall Study||11
3087551|NCT01422200|3809722|FG001|STARTED|Overall Study||11
3087552|NCT01422200|3809721|FG000|COMPLETED|Overall Study||11
3087553|NCT01422200|3809722|FG001|COMPLETED|Overall Study||11
3087554|NCT01422200|3809721|FG000|NOT COMPLETED|Overall Study||0
3087555|NCT01422200|3809722|FG001|NOT COMPLETED|Overall Study||0
3087556|NCT01422213|3809733|FG000|STARTED|Overall Study||196
3087557|NCT01422213|3809734|FG001|STARTED|Overall Study||195
3087558|NCT01422213|3809735|FG002|STARTED|Overall Study||207
3087559|NCT01422213|3809733|FG000|COMPLETED|Overall Study||163
3087560|NCT01422213|3809734|FG001|COMPLETED|Overall Study||173
3087561|NCT01422213|3809735|FG002|COMPLETED|Overall Study||178
3087562|NCT01422213|3809733|FG000|NOT COMPLETED|Overall Study||33
3087563|NCT01422213|3809734|FG001|NOT COMPLETED|Overall Study||22
3087564|NCT01422213|3809735|FG002|NOT COMPLETED|Overall Study||29
3087565|NCT01422226|3809745|FG000|STARTED|Overall Study||1
3087566|NCT01422226|3809746|FG001|STARTED|Overall Study||2
3087567|NCT01422226|3809745|FG000|COMPLETED|Overall Study||1
3087568|NCT01422226|3809746|FG001|COMPLETED|Overall Study||2
3087569|NCT01422226|3809745|FG000|NOT COMPLETED|Overall Study||0
3087570|NCT01422226|3809746|FG001|NOT COMPLETED|Overall Study||0
3087571|NCT01422239|3809754|FG000|STARTED|Overall Study||14
3087572|NCT01422239|3809755|FG001|STARTED|Overall Study||6
3087573|NCT01422239|3809754|FG000|COMPLETED|Overall Study||10
3087574|NCT01422239|3809755|FG001|COMPLETED|Overall Study||3
3087575|NCT01422239|3809754|FG000|NOT COMPLETED|Overall Study||4
3087576|NCT01422239|3809755|FG001|NOT COMPLETED|Overall Study||3
3087577|NCT01422304|3809763|FG000|STARTED|Overall Study|Randomized|598
3087578|NCT01422304|3809764|FG001|STARTED|Overall Study|Randomized|600
3087579|NCT01422304|3809763|FG000|Treated|Overall Study||595
3087580|NCT01422304|3809764|FG001|Treated|Overall Study|1 given sugammadex; thus All Participants as Treated (APaT) Ns are 596 Sugammadex, 588 Usual Care|589
3087581|NCT01422304|3809763|FG000|COMPLETED|Overall Study||574
3087582|NCT01422304|3809764|FG001|COMPLETED|Overall Study||563
3087583|NCT01422304|3809763|FG000|NOT COMPLETED|Overall Study||24
3087584|NCT01422304|3809764|FG001|NOT COMPLETED|Overall Study||37
3087585|NCT01422356|3809770|FG000|STARTED|Overall Study||200
3087586|NCT01422356|3809770|FG000|COMPLETED|Overall Study||169
3087587|NCT01422356|3809770|FG000|NOT COMPLETED|Overall Study||31
3087588|NCT01422369|3809774|FG000|STARTED|NK-104 4mg QD||28
3087589|NCT01422369|3809774|FG000|COMPLETED|NK-104 4mg QD||28
3087590|NCT01422369|3809774|FG000|NOT COMPLETED|NK-104 4mg QD||0
3087591|NCT01422369|3809774|FG000|STARTED|Prezista 800mg/100mg QD||28
3087592|NCT01422369|3809774|FG000|COMPLETED|Prezista 800mg/100mg QD||28
3087593|NCT01422369|3809774|FG000|NOT COMPLETED|Prezista 800mg/100mg QD||0
3087594|NCT01422369|3809774|FG000|STARTED|NK-104 4mg QD & Prezista 800mg/100mg QD||28
3087595|NCT01422369|3809774|FG000|COMPLETED|NK-104 4mg QD & Prezista 800mg/100mg QD||27
3087596|NCT01422369|3809774|FG000|NOT COMPLETED|NK-104 4mg QD & Prezista 800mg/100mg QD||1
3087597|NCT01422382|3809779|FG000|STARTED|NK-104 4mg Once Daily (QD)||28
3087598|NCT01422382|3809779|FG000|COMPLETED|NK-104 4mg Once Daily (QD)||28
3087599|NCT01422382|3809779|FG000|NOT COMPLETED|NK-104 4mg Once Daily (QD)||0
3087600|NCT01422382|3809779|FG000|STARTED|Diltiazem 240 mg QD||28
3087601|NCT01422382|3809779|FG000|COMPLETED|Diltiazem 240 mg QD||28
3087602|NCT01422382|3809779|FG000|NOT COMPLETED|Diltiazem 240 mg QD||0
3087603|NCT01422382|3809779|FG000|STARTED|NK-104 4mg QD and Diltiazem 240 mg QD||28
3087604|NCT01422382|3809779|FG000|COMPLETED|NK-104 4mg QD and Diltiazem 240 mg QD||27
3087605|NCT01422382|3809779|FG000|NOT COMPLETED|NK-104 4mg QD and Diltiazem 240 mg QD||1
3087606|NCT01422408|3809783|FG000|STARTED|Overall Study||34
3087607|NCT01422408|3809783|FG000|COMPLETED|Overall Study||30
3087608|NCT01422408|3809783|FG000|NOT COMPLETED|Overall Study||4
3087609|NCT01422434|3809790|FG000|STARTED|Overall Study||227
3087610|NCT01422434|3809791|FG001|STARTED|Overall Study||226
3087611|NCT01422434|3809792|FG002|STARTED|Overall Study||223
3087612|NCT01422434|3809790|FG000|COMPLETED|Overall Study||216
3087613|NCT01422434|3809791|FG001|COMPLETED|Overall Study||221
3087614|NCT01422434|3809792|FG002|COMPLETED|Overall Study||217
3087615|NCT01422434|3809790|FG000|NOT COMPLETED|Overall Study||11
3087616|NCT01422434|3809791|FG001|NOT COMPLETED|Overall Study||5
3087617|NCT01422434|3809792|FG002|NOT COMPLETED|Overall Study||6
3087618|NCT01422538|3809803|FG000|STARTED|Overall Study||10
3087619|NCT01422538|3809804|FG001|STARTED|Overall Study||10
3087620|NCT01422538|3809805|FG002|STARTED|Overall Study||10
3087621|NCT01422538|3809803|FG000|COMPLETED|Overall Study||10
3087622|NCT01422538|3809804|FG001|COMPLETED|Overall Study||8
3087623|NCT01422538|3809805|FG002|COMPLETED|Overall Study||8
3087624|NCT01422538|3809803|FG000|NOT COMPLETED|Overall Study||0
3087625|NCT01422538|3809804|FG001|NOT COMPLETED|Overall Study||2
3087626|NCT01422538|3809805|FG002|NOT COMPLETED|Overall Study||2
3087627|NCT01422720|3809814|FG000|STARTED|Overall Study||72
3087628|NCT01422720|3809814|FG000|Safety Set|Overall Study||72
3087629|NCT01422720|3809814|FG000|Full Analysis Set (FAS)|Overall Study||71
3087630|NCT01422720|3809814|FG000|Per-Protocol Set (PPS)|Overall Study||55
3087631|NCT01422720|3809814|FG000|COMPLETED|Overall Study||50
3087632|NCT01422720|3809814|FG000|NOT COMPLETED|Overall Study||22
3087633|NCT01422824|3809822|FG000|STARTED|Overall Study||185
3087634|NCT01422824|3809822|FG000|Treated|Overall Study||184
3087635|NCT01422824|3809822|FG000|COMPLETED|Overall Study||147
3087636|NCT01422824|3809822|FG000|NOT COMPLETED|Overall Study||38
3087637|NCT01422850|3809826|FG000|STARTED|Overall Study||21
3087638|NCT01422850|3809826|FG000|Week 4 - First Treatment|Overall Study||21
3087639|NCT01422850|3809826|FG000|Week 5|Overall Study|One patient withdrawn by PI due to progressive disease|20
3087640|NCT01422850|3809826|FG000|Week 9 - Second Treatment|Overall Study||20
3087641|NCT01422850|3809826|FG000|Week 14 - Third Treatment|Overall Study|One patient withdrawn by PI and referred to external radiotherapy due to progressive disease.|19
3087642|NCT01422850|3809826|FG000|Week 15|Overall Study|One patient withdrawn by PI due to increased PSA. Started bicalutamide treatment.|18
3087643|NCT01422850|3809826|FG000|COMPLETED|Overall Study||18
3087644|NCT01422850|3809826|FG000|NOT COMPLETED|Overall Study||3
3087645|NCT01422876|3809842|FG000|STARTED|Week 24||137
3087646|NCT01422876|3809843|FG001|STARTED|Week 24||136
3087647|NCT01422876|3809844|FG002|STARTED|Week 24||141
3087648|NCT01422876|3809845|FG003|STARTED|Week 24||140
3087649|NCT01422876|3809846|FG004|STARTED|Week 24||132
3087650|NCT01422876|3809847|FG005|STARTED|Week 24||137
3087651|NCT01422876|3809848|FG006|STARTED|Week 24||136
3087652|NCT01422876|3809849|FG007|STARTED|Week 24||135
3087653|NCT01422876|3809850|FG008|STARTED|Week 24||134
3087654|NCT01422876|3809851|FG009|STARTED|Week 24||135
3087655|NCT01422876|3809842|FG000|COMPLETED|Week 24||131
3087656|NCT01422876|3809843|FG001|COMPLETED|Week 24||133
3087657|NCT01422876|3809844|FG002|COMPLETED|Week 24||136
3087658|NCT01422876|3809845|FG003|COMPLETED|Week 24||132
3087659|NCT01422876|3809846|FG004|COMPLETED|Week 24||125
3087660|NCT01422876|3809847|FG005|COMPLETED|Week 24||131
3087661|NCT01422876|3809848|FG006|COMPLETED|Week 24||130
3087662|NCT01422876|3809849|FG007|COMPLETED|Week 24||128
3087663|NCT01422876|3809850|FG008|COMPLETED|Week 24||128
3087664|NCT01422876|3809851|FG009|COMPLETED|Week 24||125
3087665|NCT01422876|3809842|FG000|NOT COMPLETED|Week 24||6
3087666|NCT01422876|3809843|FG001|NOT COMPLETED|Week 24||3
3087667|NCT01422876|3809844|FG002|NOT COMPLETED|Week 24||5
3087668|NCT01422876|3809845|FG003|NOT COMPLETED|Week 24||8
3087669|NCT01422876|3809846|FG004|NOT COMPLETED|Week 24||7
3087670|NCT01422876|3809847|FG005|NOT COMPLETED|Week 24||6
3087671|NCT01422876|3809848|FG006|NOT COMPLETED|Week 24||6
3087672|NCT01422876|3809849|FG007|NOT COMPLETED|Week 24||7
3087673|NCT01422876|3809850|FG008|NOT COMPLETED|Week 24||6
3087674|NCT01422876|3809851|FG009|NOT COMPLETED|Week 24||10
3087675|NCT01422876|3809842|FG000|STARTED|Week 52||137
3087676|NCT01422876|3809843|FG001|STARTED|Week 52||136
3087677|NCT01422876|3809844|FG002|STARTED|Week 52||141
3087678|NCT01422876|3809845|FG003|STARTED|Week 52||140
3087679|NCT01422876|3809846|FG004|STARTED|Week 52||132
3087680|NCT01422876|3809847|FG005|STARTED|Week 52||137
3087681|NCT01422876|3809848|FG006|STARTED|Week 52||136
3087682|NCT01422876|3809849|FG007|STARTED|Week 52||135
3087683|NCT01422876|3809850|FG008|STARTED|Week 52||134
3087684|NCT01422876|3809851|FG009|STARTED|Week 52||135
3087685|NCT01422876|3809842|FG000|COMPLETED|Week 52||125
3087686|NCT01422876|3809843|FG001|COMPLETED|Week 52||126
3087687|NCT01422876|3809844|FG002|COMPLETED|Week 52||128
3087688|NCT01422876|3809845|FG003|COMPLETED|Week 52||122
3087689|NCT01422876|3809846|FG004|COMPLETED|Week 52||117
3087690|NCT01422876|3809847|FG005|COMPLETED|Week 52||120
3087691|NCT01422876|3809848|FG006|COMPLETED|Week 52||120
3087692|NCT01422876|3809849|FG007|COMPLETED|Week 52||112
3087693|NCT01422876|3809850|FG008|COMPLETED|Week 52||113
3087694|NCT01422876|3809851|FG009|COMPLETED|Week 52||118
3087695|NCT01422876|3809842|FG000|NOT COMPLETED|Week 52||12
3087696|NCT01422876|3809843|FG001|NOT COMPLETED|Week 52||10
3087697|NCT01422876|3809844|FG002|NOT COMPLETED|Week 52||13
3087698|NCT01422876|3809845|FG003|NOT COMPLETED|Week 52||18
3087699|NCT01422876|3809846|FG004|NOT COMPLETED|Week 52||15
3087700|NCT01422876|3809847|FG005|NOT COMPLETED|Week 52||17
3087701|NCT01422876|3809848|FG006|NOT COMPLETED|Week 52||16
3087702|NCT01422876|3809849|FG007|NOT COMPLETED|Week 52||23
3087703|NCT01422876|3809850|FG008|NOT COMPLETED|Week 52||21
3087704|NCT01422876|3809851|FG009|NOT COMPLETED|Week 52||17
3087705|NCT01422889|3809869|FG000|STARTED|Overall Study||1120
3087706|NCT01422889|3809869|FG000|COMPLETED|Overall Study|9 subjects did not receive a study stent therefore 1111 subjects were eligible for follow up.|1111
3087707|NCT01422889|3809869|FG000|NOT COMPLETED|Overall Study||9
3087708|NCT01422915|3809873|FG000|STARTED|Overall Study|1 subject with abnormal liver chemistries removed during the first period.|4
3087709|NCT01422915|3809873|FG000|COMPLETED|Overall Study||3
3087710|NCT01422915|3809873|FG000|NOT COMPLETED|Overall Study||1
3087711|NCT01423084|3809880|FG000|STARTED|Overall Study||170
3087712|NCT01423084|3809881|FG001|STARTED|Overall Study||174
3087713|NCT01423084|3809880|FG000|COMPLETED|Overall Study||168
3087714|NCT01423084|3809881|FG001|COMPLETED|Overall Study||170
3087715|NCT01423084|3809880|FG000|NOT COMPLETED|Overall Study||2
3087716|NCT01423084|3809881|FG001|NOT COMPLETED|Overall Study||4
3087717|NCT01423162|3809890|FG000|STARTED|Overall Study||11
3087718|NCT01423162|3809891|FG001|STARTED|Overall Study||9
3087719|NCT01423162|3809890|FG000|COMPLETED|Overall Study|Crossover design: All subjects (n=20) completed both arms|11
3087720|NCT01423162|3809891|FG001|COMPLETED|Overall Study|Crossover design: All subjects (n=20) completed both arms|9
3087721|NCT01423162|3809890|FG000|NOT COMPLETED|Overall Study||0
3087722|NCT01423162|3809891|FG001|NOT COMPLETED|Overall Study||0
3087723|NCT01423253|3809897|FG000|STARTED|Overall Study||48
3087724|NCT01423253|3809897|FG000|COMPLETED|Overall Study||39
3087725|NCT01423253|3809897|FG000|NOT COMPLETED|Overall Study||9
3087726|NCT01423604|3809904|FG000|STARTED|Safety Run-In||9
3087727|NCT01423604|3809905|FG001|STARTED|Safety Run-In||0
3087728|NCT01423604|3809904|FG000|COMPLETED|Safety Run-In||0
3087729|NCT01423604|3809905|FG001|COMPLETED|Safety Run-In||0
3087730|NCT01423604|3809904|FG000|NOT COMPLETED|Safety Run-In||9
3087731|NCT01423604|3809905|FG001|NOT COMPLETED|Safety Run-In||0
3087732|NCT01423604|3809904|FG000|STARTED|Randomized||64
3087733|NCT01423604|3809905|FG001|STARTED|Randomized||63
3087734|NCT01423604|3809904|FG000|COMPLETED|Randomized|As of 07August2015, 1 subject was receiving treatment in the randomized portion.|1
3087735|NCT01423604|3809905|FG001|COMPLETED|Randomized||0
3087736|NCT01423604|3809904|FG000|NOT COMPLETED|Randomized||63
3087737|NCT01423604|3809905|FG001|NOT COMPLETED|Randomized||63
3087738|NCT01423617|3809914|FG000|STARTED|Overall Study||46
3087739|NCT01423617|3809915|FG001|STARTED|Overall Study||46
3087740|NCT01423617|3809914|FG000|COMPLETED|Overall Study||46
3087741|NCT01423617|3809915|FG001|COMPLETED|Overall Study||45
3087742|NCT01423617|3809914|FG000|NOT COMPLETED|Overall Study||0
3087743|NCT01423617|3809915|FG001|NOT COMPLETED|Overall Study||1
3087744|NCT01423760|3809923|FG000|STARTED|Overall Study||14
3087745|NCT01423760|3809924|FG001|STARTED|Overall Study||13
3087746|NCT01423760|3809923|FG000|Number of Tecemotide Subjects|Overall Study||12
3087747|NCT01423760|3809924|FG001|Number of Tecemotide Subjects|Overall Study||8
3087748|NCT01423760|3809923|FG000|Number of Non-treatment Subjects|Overall Study||2
3087749|NCT01423760|3809924|FG001|Number of Non-treatment Subjects|Overall Study||5
3087750|NCT01423760|3809923|FG000|Safety Analysis Set|Overall Study||12
3087751|NCT01423760|3809924|FG001|Safety Analysis Set|Overall Study||8
3087752|NCT01423760|3809923|FG000|COMPLETED|Overall Study||14
3087753|NCT01423760|3809924|FG001|COMPLETED|Overall Study||13
3087754|NCT01423760|3809923|FG000|NOT COMPLETED|Overall Study||0
3087755|NCT01423760|3809924|FG001|NOT COMPLETED|Overall Study||0
3087756|NCT01423773|3809930|FG000|STARTED|Period One, 2 Days||10
3087757|NCT01423773|3809931|FG001|STARTED|Period One, 2 Days||10
3087758|NCT01423773|3809930|FG000|COMPLETED|Period One, 2 Days||10
3087759|NCT01423773|3809931|FG001|COMPLETED|Period One, 2 Days||10
3087760|NCT01423773|3809930|FG000|NOT COMPLETED|Period One, 2 Days||0
3087761|NCT01423773|3809931|FG001|NOT COMPLETED|Period One, 2 Days||0
3087762|NCT01423773|3809930|FG000|STARTED|Period 2, 2 Days||10
3087763|NCT01423773|3809931|FG001|STARTED|Period 2, 2 Days||10
3087764|NCT01423773|3809930|FG000|COMPLETED|Period 2, 2 Days||10
3087765|NCT01423773|3809931|FG001|COMPLETED|Period 2, 2 Days||10
3087766|NCT01423773|3809930|FG000|NOT COMPLETED|Period 2, 2 Days||0
3087767|NCT01423773|3809931|FG001|NOT COMPLETED|Period 2, 2 Days||0
3087768|NCT01423812|3809939|FG000|STARTED|Overall Study||30
3087769|NCT01423812|3809940|FG001|STARTED|Overall Study||30
3087770|NCT01423812|3809939|FG000|COMPLETED|Overall Study||27
3087771|NCT01423812|3809940|FG001|COMPLETED|Overall Study||26
3087772|NCT01423812|3809939|FG000|NOT COMPLETED|Overall Study||3
3087773|NCT01423812|3809940|FG001|NOT COMPLETED|Overall Study||4
3087774|NCT01423916|3809951|FG000|STARTED|Overall Study||74
3087775|NCT01423916|3809952|FG001|STARTED|Overall Study||73
3087776|NCT01423916|3809953|FG002|STARTED|Overall Study||71
3087777|NCT01423916|3809951|FG000|COMPLETED|Overall Study||63
3087778|NCT01423916|3809952|FG001|COMPLETED|Overall Study||53
3087779|NCT01423916|3809953|FG002|COMPLETED|Overall Study||64
3087780|NCT01423916|3809951|FG000|NOT COMPLETED|Overall Study||11
3087781|NCT01423916|3809952|FG001|NOT COMPLETED|Overall Study||20
3087782|NCT01423916|3809953|FG002|NOT COMPLETED|Overall Study||7
3087783|NCT01424033|3809972|FG000|STARTED|Overall Study||5
3087784|NCT01424033|3809972|FG000|COMPLETED|Overall Study||0
3087785|NCT01424033|3809972|FG000|NOT COMPLETED|Overall Study||5
3087786|NCT01424072|3809979|FG000|STARTED|Overall Study||27
3087787|NCT01424072|3809980|FG001|STARTED|Overall Study||26
3087788|NCT01424072|3809981|FG002|STARTED|Overall Study||22
3087789|NCT01424072|3809979|FG000|COMPLETED|Overall Study||27
3087790|NCT01424072|3809980|FG001|COMPLETED|Overall Study||26
3087791|NCT01424072|3809981|FG002|COMPLETED|Overall Study||22
3087792|NCT01424072|3809979|FG000|NOT COMPLETED|Overall Study||0
3087793|NCT01424072|3809980|FG001|NOT COMPLETED|Overall Study||0
3087794|NCT01424072|3809981|FG002|NOT COMPLETED|Overall Study||0
3087795|NCT01424189|3809991|FG000|STARTED|Overall Study||386
3087796|NCT01424189|3809992|FG001|STARTED|Overall Study||188
3087797|NCT01424189|3809991|FG000|COMPLETED|Overall Study||373
3087798|NCT01424189|3809992|FG001|COMPLETED|Overall Study||182
3087799|NCT01424189|3809991|FG000|NOT COMPLETED|Overall Study||13
3087800|NCT01424189|3809992|FG001|NOT COMPLETED|Overall Study||6
3087801|NCT01424215|3810000|FG000|STARTED|Overall Study||50
3087802|NCT01424215|3810001|FG001|STARTED|Overall Study||50
3087803|NCT01424215|3810000|FG000|COMPLETED|Overall Study||50
3087804|NCT01424215|3810001|FG001|COMPLETED|Overall Study||50
3287678|NCT02793232|4021278|FG000|STARTED|Washout Period 2(Part A:at Least 10days)||2
3287679|NCT02793232|4021279|FG001|STARTED|Washout Period 2(Part A:at Least 10days)||2
3287680|NCT02793232|4021280|FG002|STARTED|Washout Period 2(Part A:at Least 10days)||2
3287681|NCT02793232|4021281|FG003|STARTED|Washout Period 2(Part A:at Least 10days)||2
3287682|NCT02793232|4021282|FG004|STARTED|Washout Period 2(Part A:at Least 10days)||0
3287683|NCT02793232|4021283|FG005|STARTED|Washout Period 2(Part A:at Least 10days)||0
3287684|NCT02793232|4021284|FG006|STARTED|Washout Period 2(Part A:at Least 10days)||0
3287685|NCT02793232|4021285|FG007|STARTED|Washout Period 2(Part A:at Least 10days)||0
3287686|NCT02793232|4021286|FG008|STARTED|Washout Period 2(Part A:at Least 10days)||0
3287687|NCT02793232|4021278|FG000|COMPLETED|Washout Period 2(Part A:at Least 10days)||2
3287688|NCT02793232|4021279|FG001|COMPLETED|Washout Period 2(Part A:at Least 10days)||2
3287689|NCT02793232|4021280|FG002|COMPLETED|Washout Period 2(Part A:at Least 10days)||2
3287690|NCT02793232|4021281|FG003|COMPLETED|Washout Period 2(Part A:at Least 10days)||2
3287691|NCT02793232|4021282|FG004|COMPLETED|Washout Period 2(Part A:at Least 10days)||0
3287692|NCT02793232|4021283|FG005|COMPLETED|Washout Period 2(Part A:at Least 10days)||0
3287693|NCT02793232|4021284|FG006|COMPLETED|Washout Period 2(Part A:at Least 10days)||0
3287694|NCT02793232|4021285|FG007|COMPLETED|Washout Period 2(Part A:at Least 10days)||0
3287695|NCT02793232|4021286|FG008|COMPLETED|Washout Period 2(Part A:at Least 10days)||0
3287696|NCT02793232|4021278|FG000|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
3287697|NCT02793232|4021279|FG001|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
3287698|NCT02793232|4021280|FG002|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
3287699|NCT02793232|4021281|FG003|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
3287700|NCT02793232|4021282|FG004|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
3087805|NCT01424215|3810000|FG000|NOT COMPLETED|Overall Study||0
3087806|NCT01424215|3810001|FG001|NOT COMPLETED|Overall Study||0
3087807|NCT01424228|3810009|FG000|STARTED|Overall Study||182
3087808|NCT01424228|3810010|FG001|STARTED|Overall Study||182
3087809|NCT01424228|3810009|FG000|COMPLETED|Overall Study||126
3087810|NCT01424228|3810010|FG001|COMPLETED|Overall Study||135
3087811|NCT01424228|3810009|FG000|NOT COMPLETED|Overall Study||56
3087812|NCT01424228|3810010|FG001|NOT COMPLETED|Overall Study||47
3087813|NCT01424293|3810016|FG000|STARTED|Overall Study||7
3087814|NCT01424293|3810016|FG000|COMPLETED|Overall Study||7
3087815|NCT01424293|3810016|FG000|NOT COMPLETED|Overall Study||0
3087816|NCT01424306|3810020|FG000|STARTED|Overall Study||4
3087817|NCT01424306|3810021|FG001|STARTED|Overall Study||4
3087818|NCT01424306|3810022|FG002|STARTED|Overall Study||3
3087819|NCT01424306|3810023|FG003|STARTED|Overall Study||3
3087820|NCT01424306|3810024|FG004|STARTED|Overall Study||5
3087821|NCT01424306|3810025|FG005|STARTED|Overall Study||6
3087822|NCT01424306|3810020|FG000|COMPLETED|Overall Study||4
3087823|NCT01424306|3810021|FG001|COMPLETED|Overall Study||4
3087824|NCT01424306|3810022|FG002|COMPLETED|Overall Study||3
3087825|NCT01424306|3810023|FG003|COMPLETED|Overall Study||3
3087826|NCT01424306|3810024|FG004|COMPLETED|Overall Study||4
3087827|NCT01424306|3810025|FG005|COMPLETED|Overall Study||6
3087828|NCT01424306|3810020|FG000|NOT COMPLETED|Overall Study||0
3087829|NCT01424306|3810021|FG001|NOT COMPLETED|Overall Study||0
3087830|NCT01424306|3810022|FG002|NOT COMPLETED|Overall Study||0
3087831|NCT01424306|3810023|FG003|NOT COMPLETED|Overall Study||0
3287701|NCT02793232|4021283|FG005|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
3287702|NCT02793232|4021284|FG006|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
3287703|NCT02793232|4021285|FG007|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
3287704|NCT02793232|4021286|FG008|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
3287705|NCT02793232|4021278|FG000|STARTED|Period 3 (Part A: 5 Days)||2
3287706|NCT02793232|4021279|FG001|STARTED|Period 3 (Part A: 5 Days)||2
3087832|NCT01424306|3810024|FG004|NOT COMPLETED|Overall Study||1
3087833|NCT01424306|3810025|FG005|NOT COMPLETED|Overall Study||0
3087834|NCT01424397|3810069|FG000|STARTED|Period-1 (8 Days)||7
3087835|NCT01424397|3810070|FG001|STARTED|Period-1 (8 Days)||8
3087836|NCT01424397|3810071|FG002|STARTED|Period-1 (8 Days)||8
3087837|NCT01424397|3810072|FG003|STARTED|Period-1 (8 Days)||8
3087838|NCT01424397|3810073|FG004|STARTED|Period-1 (8 Days)||8
3087839|NCT01424397|3810074|FG005|STARTED|Period-1 (8 Days)||8
3087840|NCT01424397|3810075|FG006|STARTED|Period-1 (8 Days)||4
3287707|NCT02793232|4021280|FG002|STARTED|Period 3 (Part A: 5 Days)||2
3287708|NCT02793232|4021281|FG003|STARTED|Period 3 (Part A: 5 Days)||2
3287709|NCT02793232|4021282|FG004|STARTED|Period 3 (Part A: 5 Days)||0
3287710|NCT02793232|4021283|FG005|STARTED|Period 3 (Part A: 5 Days)||0
3287711|NCT02793232|4021284|FG006|STARTED|Period 3 (Part A: 5 Days)||0
3287712|NCT02793232|4021285|FG007|STARTED|Period 3 (Part A: 5 Days)||0
3287713|NCT02793232|4021286|FG008|STARTED|Period 3 (Part A: 5 Days)||0
3287714|NCT02793232|4021278|FG000|COMPLETED|Period 3 (Part A: 5 Days)||2
3287715|NCT02793232|4021279|FG001|COMPLETED|Period 3 (Part A: 5 Days)||2
3287716|NCT02793232|4021280|FG002|COMPLETED|Period 3 (Part A: 5 Days)||2
3287717|NCT02793232|4021281|FG003|COMPLETED|Period 3 (Part A: 5 Days)||2
3287718|NCT02793232|4021282|FG004|COMPLETED|Period 3 (Part A: 5 Days)||0
3287719|NCT02793232|4021283|FG005|COMPLETED|Period 3 (Part A: 5 Days)||0
3287720|NCT02793232|4021284|FG006|COMPLETED|Period 3 (Part A: 5 Days)||0
3287721|NCT02793232|4021285|FG007|COMPLETED|Period 3 (Part A: 5 Days)||0
3287722|NCT02793232|4021286|FG008|COMPLETED|Period 3 (Part A: 5 Days)||0
3287723|NCT02793232|4021278|FG000|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
3287724|NCT02793232|4021279|FG001|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
3287725|NCT02793232|4021280|FG002|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
3287726|NCT02793232|4021281|FG003|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
3287727|NCT02793232|4021282|FG004|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
3287728|NCT02793232|4021283|FG005|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
3287729|NCT02793232|4021284|FG006|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
3287730|NCT02793232|4021285|FG007|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
3287731|NCT02793232|4021286|FG008|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
3287732|NCT02793232|4021278|FG000|STARTED|Washout Period 3(Part A:at Least 10days)||2
3287733|NCT02793232|4021279|FG001|STARTED|Washout Period 3(Part A:at Least 10days)||2
3287734|NCT02793232|4021280|FG002|STARTED|Washout Period 3(Part A:at Least 10days)||2
3287735|NCT02793232|4021281|FG003|STARTED|Washout Period 3(Part A:at Least 10days)||2
3287736|NCT02793232|4021282|FG004|STARTED|Washout Period 3(Part A:at Least 10days)||0
3287737|NCT02793232|4021283|FG005|STARTED|Washout Period 3(Part A:at Least 10days)||0
3287738|NCT02793232|4021284|FG006|STARTED|Washout Period 3(Part A:at Least 10days)||0
3287739|NCT02793232|4021285|FG007|STARTED|Washout Period 3(Part A:at Least 10days)||0
3287740|NCT02793232|4021286|FG008|STARTED|Washout Period 3(Part A:at Least 10days)||0
3287741|NCT02793232|4021278|FG000|COMPLETED|Washout Period 3(Part A:at Least 10days)||2
3287742|NCT02793232|4021279|FG001|COMPLETED|Washout Period 3(Part A:at Least 10days)||2
3287743|NCT02793232|4021280|FG002|COMPLETED|Washout Period 3(Part A:at Least 10days)||2
3287744|NCT02793232|4021281|FG003|COMPLETED|Washout Period 3(Part A:at Least 10days)||2
3287745|NCT02793232|4021282|FG004|COMPLETED|Washout Period 3(Part A:at Least 10days)||0
3287746|NCT02793232|4021283|FG005|COMPLETED|Washout Period 3(Part A:at Least 10days)||0
3287747|NCT02793232|4021284|FG006|COMPLETED|Washout Period 3(Part A:at Least 10days)||0
3287748|NCT02793232|4021285|FG007|COMPLETED|Washout Period 3(Part A:at Least 10days)||0
3287749|NCT02793232|4021286|FG008|COMPLETED|Washout Period 3(Part A:at Least 10days)||0
3287750|NCT02793232|4021278|FG000|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
3287751|NCT02793232|4021279|FG001|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
3287752|NCT02793232|4021280|FG002|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
3287753|NCT02793232|4021281|FG003|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
3087841|NCT01424397|3810076|FG007|STARTED|Period-1 (8 Days)||4
3087842|NCT01424397|3810077|FG008|STARTED|Period-1 (8 Days)||4
3087843|NCT01424397|3810078|FG009|STARTED|Period-1 (8 Days)||3
3087844|NCT01424397|3810079|FG010|STARTED|Period-1 (8 Days)||4
3087845|NCT01424397|3810080|FG011|STARTED|Period-1 (8 Days)||4
3087846|NCT01424397|3810069|FG000|COMPLETED|Period-1 (8 Days)||7
3087847|NCT01424397|3810070|FG001|COMPLETED|Period-1 (8 Days)||8
3087848|NCT01424397|3810071|FG002|COMPLETED|Period-1 (8 Days)||8
3087849|NCT01424397|3810072|FG003|COMPLETED|Period-1 (8 Days)||8
3087850|NCT01424397|3810073|FG004|COMPLETED|Period-1 (8 Days)||8
3087851|NCT01424397|3810074|FG005|COMPLETED|Period-1 (8 Days)||8
3087852|NCT01424397|3810075|FG006|COMPLETED|Period-1 (8 Days)||4
3087853|NCT01424397|3810076|FG007|COMPLETED|Period-1 (8 Days)||4
3087854|NCT01424397|3810077|FG008|COMPLETED|Period-1 (8 Days)||4
3087855|NCT01424397|3810078|FG009|COMPLETED|Period-1 (8 Days)||3
3087856|NCT01424397|3810079|FG010|COMPLETED|Period-1 (8 Days)||4
3087857|NCT01424397|3810080|FG011|COMPLETED|Period-1 (8 Days)||4
3087858|NCT01424397|3810069|FG000|NOT COMPLETED|Period-1 (8 Days)||0
3087859|NCT01424397|3810070|FG001|NOT COMPLETED|Period-1 (8 Days)||0
3087860|NCT01424397|3810071|FG002|NOT COMPLETED|Period-1 (8 Days)||0
3087861|NCT01424397|3810072|FG003|NOT COMPLETED|Period-1 (8 Days)||0
3087862|NCT01424397|3810073|FG004|NOT COMPLETED|Period-1 (8 Days)||0
3087863|NCT01424397|3810074|FG005|NOT COMPLETED|Period-1 (8 Days)||0
3087864|NCT01424397|3810075|FG006|NOT COMPLETED|Period-1 (8 Days)||0
3087865|NCT01424397|3810076|FG007|NOT COMPLETED|Period-1 (8 Days)||0
3087866|NCT01424397|3810077|FG008|NOT COMPLETED|Period-1 (8 Days)||0
3087867|NCT01424397|3810078|FG009|NOT COMPLETED|Period-1 (8 Days)||0
3287754|NCT02793232|4021282|FG004|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
3287755|NCT02793232|4021283|FG005|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
3287756|NCT02793232|4021284|FG006|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
3287757|NCT02793232|4021285|FG007|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
3287758|NCT02793232|4021286|FG008|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
3287759|NCT02793232|4021278|FG000|STARTED|Period 4 (Part A: 5 Days)||2
3287760|NCT02793232|4021279|FG001|STARTED|Period 4 (Part A: 5 Days)||2
3287761|NCT02793232|4021280|FG002|STARTED|Period 4 (Part A: 5 Days)||2
3287762|NCT02793232|4021281|FG003|STARTED|Period 4 (Part A: 5 Days)||2
3287763|NCT02793232|4021282|FG004|STARTED|Period 4 (Part A: 5 Days)||0
3287764|NCT02793232|4021283|FG005|STARTED|Period 4 (Part A: 5 Days)||0
3287765|NCT02793232|4021284|FG006|STARTED|Period 4 (Part A: 5 Days)||0
3087868|NCT01424397|3810079|FG010|NOT COMPLETED|Period-1 (8 Days)||0
3087869|NCT01424397|3810080|FG011|NOT COMPLETED|Period-1 (8 Days)||0
3087870|NCT01424397|3810069|FG000|STARTED|Washout Period-1 (14-20 Days)||7
3087871|NCT01424397|3810070|FG001|STARTED|Washout Period-1 (14-20 Days)||8
3087872|NCT01424397|3810071|FG002|STARTED|Washout Period-1 (14-20 Days)||8
3087873|NCT01424397|3810072|FG003|STARTED|Washout Period-1 (14-20 Days)||8
3087874|NCT01424397|3810073|FG004|STARTED|Washout Period-1 (14-20 Days)||8
3087875|NCT01424397|3810074|FG005|STARTED|Washout Period-1 (14-20 Days)||8
3087876|NCT01424397|3810075|FG006|STARTED|Washout Period-1 (14-20 Days)||4
3087877|NCT01424397|3810076|FG007|STARTED|Washout Period-1 (14-20 Days)||4
3087878|NCT01424397|3810077|FG008|STARTED|Washout Period-1 (14-20 Days)||4
3087879|NCT01424397|3810078|FG009|STARTED|Washout Period-1 (14-20 Days)||3
3087880|NCT01424397|3810079|FG010|STARTED|Washout Period-1 (14-20 Days)||4
3087881|NCT01424397|3810080|FG011|STARTED|Washout Period-1 (14-20 Days)||4
3087882|NCT01424397|3810069|FG000|COMPLETED|Washout Period-1 (14-20 Days)||7
3087883|NCT01424397|3810070|FG001|COMPLETED|Washout Period-1 (14-20 Days)||8
3087884|NCT01424397|3810071|FG002|COMPLETED|Washout Period-1 (14-20 Days)||8
3087885|NCT01424397|3810072|FG003|COMPLETED|Washout Period-1 (14-20 Days)||8
3087886|NCT01424397|3810073|FG004|COMPLETED|Washout Period-1 (14-20 Days)||8
3087887|NCT01424397|3810074|FG005|COMPLETED|Washout Period-1 (14-20 Days)||8
3087888|NCT01424397|3810075|FG006|COMPLETED|Washout Period-1 (14-20 Days)||4
3087889|NCT01424397|3810076|FG007|COMPLETED|Washout Period-1 (14-20 Days)||4
3087890|NCT01424397|3810077|FG008|COMPLETED|Washout Period-1 (14-20 Days)||4
3087891|NCT01424397|3810078|FG009|COMPLETED|Washout Period-1 (14-20 Days)||3
3087892|NCT01424397|3810079|FG010|COMPLETED|Washout Period-1 (14-20 Days)||4
3087893|NCT01424397|3810080|FG011|COMPLETED|Washout Period-1 (14-20 Days)||4
3087894|NCT01424397|3810069|FG000|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
3087895|NCT01424397|3810070|FG001|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
3087896|NCT01424397|3810071|FG002|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
3087897|NCT01424397|3810072|FG003|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
3087898|NCT01424397|3810073|FG004|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
3087899|NCT01424397|3810074|FG005|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
3087900|NCT01424397|3810075|FG006|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
3087901|NCT01424397|3810076|FG007|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
3087902|NCT01424397|3810077|FG008|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
3087903|NCT01424397|3810078|FG009|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
3087904|NCT01424397|3810079|FG010|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
3087905|NCT01424397|3810080|FG011|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
3287766|NCT02793232|4021285|FG007|STARTED|Period 4 (Part A: 5 Days)||0
3287767|NCT02793232|4021286|FG008|STARTED|Period 4 (Part A: 5 Days)||0
3087906|NCT01424397|3810069|FG000|STARTED|Period-2 (8 Days)||7
3087907|NCT01424397|3810070|FG001|STARTED|Period-2 (8 Days)||8
3087908|NCT01424397|3810071|FG002|STARTED|Period-2 (8 Days)||8
3087909|NCT01424397|3810072|FG003|STARTED|Period-2 (8 Days)||8
3087910|NCT01424397|3810073|FG004|STARTED|Period-2 (8 Days)||8
3087911|NCT01424397|3810074|FG005|STARTED|Period-2 (8 Days)||8
3087912|NCT01424397|3810075|FG006|STARTED|Period-2 (8 Days)||4
3087913|NCT01424397|3810076|FG007|STARTED|Period-2 (8 Days)||4
3087914|NCT01424397|3810077|FG008|STARTED|Period-2 (8 Days)||4
3087915|NCT01424397|3810078|FG009|STARTED|Period-2 (8 Days)||3
3087916|NCT01424397|3810079|FG010|STARTED|Period-2 (8 Days)||4
3087917|NCT01424397|3810080|FG011|STARTED|Period-2 (8 Days)||4
3087918|NCT01424397|3810069|FG000|COMPLETED|Period-2 (8 Days)||7
3087919|NCT01424397|3810070|FG001|COMPLETED|Period-2 (8 Days)||8
3087920|NCT01424397|3810071|FG002|COMPLETED|Period-2 (8 Days)||7
3087921|NCT01424397|3810072|FG003|COMPLETED|Period-2 (8 Days)||8
3087922|NCT01424397|3810073|FG004|COMPLETED|Period-2 (8 Days)||8
3087923|NCT01424397|3810074|FG005|COMPLETED|Period-2 (8 Days)||8
3087924|NCT01424397|3810075|FG006|COMPLETED|Period-2 (8 Days)||4
3087925|NCT01424397|3810076|FG007|COMPLETED|Period-2 (8 Days)||4
3087926|NCT01424397|3810077|FG008|COMPLETED|Period-2 (8 Days)||4
3087927|NCT01424397|3810078|FG009|COMPLETED|Period-2 (8 Days)||3
3087928|NCT01424397|3810079|FG010|COMPLETED|Period-2 (8 Days)||4
3087929|NCT01424397|3810080|FG011|COMPLETED|Period-2 (8 Days)||4
3087930|NCT01424397|3810069|FG000|NOT COMPLETED|Period-2 (8 Days)||0
3087931|NCT01424397|3810070|FG001|NOT COMPLETED|Period-2 (8 Days)||0
3087932|NCT01424397|3810071|FG002|NOT COMPLETED|Period-2 (8 Days)||1
3087933|NCT01424397|3810072|FG003|NOT COMPLETED|Period-2 (8 Days)||0
3087934|NCT01424397|3810073|FG004|NOT COMPLETED|Period-2 (8 Days)||0
3087935|NCT01424397|3810074|FG005|NOT COMPLETED|Period-2 (8 Days)||0
3087936|NCT01424397|3810075|FG006|NOT COMPLETED|Period-2 (8 Days)||0
3087937|NCT01424397|3810076|FG007|NOT COMPLETED|Period-2 (8 Days)||0
3087938|NCT01424397|3810077|FG008|NOT COMPLETED|Period-2 (8 Days)||0
3087939|NCT01424397|3810078|FG009|NOT COMPLETED|Period-2 (8 Days)||0
3087940|NCT01424397|3810079|FG010|NOT COMPLETED|Period-2 (8 Days)||0
3087941|NCT01424397|3810080|FG011|NOT COMPLETED|Period-2 (8 Days)||0
3087942|NCT01424397|3810069|FG000|STARTED|Washout Period-2 (14-20 Days)||7
3087943|NCT01424397|3810070|FG001|STARTED|Washout Period-2 (14-20 Days)||8
3087944|NCT01424397|3810071|FG002|STARTED|Washout Period-2 (14-20 Days)||7
3087945|NCT01424397|3810072|FG003|STARTED|Washout Period-2 (14-20 Days)||8
3087946|NCT01424397|3810073|FG004|STARTED|Washout Period-2 (14-20 Days)||8
3087947|NCT01424397|3810074|FG005|STARTED|Washout Period-2 (14-20 Days)||8
3087948|NCT01424397|3810075|FG006|STARTED|Washout Period-2 (14-20 Days)||4
3087949|NCT01424397|3810076|FG007|STARTED|Washout Period-2 (14-20 Days)||4
3087950|NCT01424397|3810077|FG008|STARTED|Washout Period-2 (14-20 Days)||4
3087951|NCT01424397|3810078|FG009|STARTED|Washout Period-2 (14-20 Days)||3
3087952|NCT01424397|3810079|FG010|STARTED|Washout Period-2 (14-20 Days)||4
3087953|NCT01424397|3810080|FG011|STARTED|Washout Period-2 (14-20 Days)||4
3087954|NCT01424397|3810069|FG000|COMPLETED|Washout Period-2 (14-20 Days)||7
3087955|NCT01424397|3810070|FG001|COMPLETED|Washout Period-2 (14-20 Days)||8
3087956|NCT01424397|3810071|FG002|COMPLETED|Washout Period-2 (14-20 Days)||7
3087957|NCT01424397|3810072|FG003|COMPLETED|Washout Period-2 (14-20 Days)||8
3087958|NCT01424397|3810073|FG004|COMPLETED|Washout Period-2 (14-20 Days)||8
3087959|NCT01424397|3810074|FG005|COMPLETED|Washout Period-2 (14-20 Days)||8
3087960|NCT01424397|3810075|FG006|COMPLETED|Washout Period-2 (14-20 Days)||4
3087961|NCT01424397|3810076|FG007|COMPLETED|Washout Period-2 (14-20 Days)||4
3087962|NCT01424397|3810077|FG008|COMPLETED|Washout Period-2 (14-20 Days)||4
3087963|NCT01424397|3810078|FG009|COMPLETED|Washout Period-2 (14-20 Days)||3
3087964|NCT01424397|3810079|FG010|COMPLETED|Washout Period-2 (14-20 Days)||4
3087965|NCT01424397|3810080|FG011|COMPLETED|Washout Period-2 (14-20 Days)||4
3087966|NCT01424397|3810069|FG000|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
3087967|NCT01424397|3810070|FG001|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
3087968|NCT01424397|3810071|FG002|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
3087969|NCT01424397|3810072|FG003|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
3087970|NCT01424397|3810073|FG004|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
3087971|NCT01424397|3810074|FG005|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
3087972|NCT01424397|3810075|FG006|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
3087973|NCT01424397|3810076|FG007|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
3087974|NCT01424397|3810077|FG008|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
3087975|NCT01424397|3810078|FG009|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
3087976|NCT01424397|3810079|FG010|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
3087977|NCT01424397|3810080|FG011|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
3087978|NCT01424397|3810069|FG000|STARTED|Period-3 (8 Days)||7
3087979|NCT01424397|3810070|FG001|STARTED|Period-3 (8 Days)||8
3087980|NCT01424397|3810071|FG002|STARTED|Period-3 (8 Days)||7
3087981|NCT01424397|3810072|FG003|STARTED|Period-3 (8 Days)||8
3087982|NCT01424397|3810073|FG004|STARTED|Period-3 (8 Days)||8
3087983|NCT01424397|3810074|FG005|STARTED|Period-3 (8 Days)||8
3087984|NCT01424397|3810075|FG006|STARTED|Period-3 (8 Days)||4
3087985|NCT01424397|3810076|FG007|STARTED|Period-3 (8 Days)||4
3087986|NCT01424397|3810077|FG008|STARTED|Period-3 (8 Days)||4
3087987|NCT01424397|3810078|FG009|STARTED|Period-3 (8 Days)||3
3087988|NCT01424397|3810079|FG010|STARTED|Period-3 (8 Days)||4
3087989|NCT01424397|3810080|FG011|STARTED|Period-3 (8 Days)||4
3087990|NCT01424397|3810069|FG000|COMPLETED|Period-3 (8 Days)||7
3087991|NCT01424397|3810070|FG001|COMPLETED|Period-3 (8 Days)||8
3087992|NCT01424397|3810071|FG002|COMPLETED|Period-3 (8 Days)||7
3087993|NCT01424397|3810072|FG003|COMPLETED|Period-3 (8 Days)||8
3087994|NCT01424397|3810073|FG004|COMPLETED|Period-3 (8 Days)||8
3087995|NCT01424397|3810074|FG005|COMPLETED|Period-3 (8 Days)||8
3087996|NCT01424397|3810075|FG006|COMPLETED|Period-3 (8 Days)||4
3087997|NCT01424397|3810076|FG007|COMPLETED|Period-3 (8 Days)||4
3087998|NCT01424397|3810077|FG008|COMPLETED|Period-3 (8 Days)||4
3087999|NCT01424397|3810078|FG009|COMPLETED|Period-3 (8 Days)||3
3088000|NCT01424397|3810079|FG010|COMPLETED|Period-3 (8 Days)||4
3088001|NCT01424397|3810080|FG011|COMPLETED|Period-3 (8 Days)||4
3088002|NCT01424397|3810069|FG000|NOT COMPLETED|Period-3 (8 Days)||0
3088003|NCT01424397|3810070|FG001|NOT COMPLETED|Period-3 (8 Days)||0
3088004|NCT01424397|3810071|FG002|NOT COMPLETED|Period-3 (8 Days)||0
3088005|NCT01424397|3810072|FG003|NOT COMPLETED|Period-3 (8 Days)||0
3088006|NCT01424397|3810073|FG004|NOT COMPLETED|Period-3 (8 Days)||0
3088007|NCT01424397|3810074|FG005|NOT COMPLETED|Period-3 (8 Days)||0
3088008|NCT01424397|3810075|FG006|NOT COMPLETED|Period-3 (8 Days)||0
3088009|NCT01424397|3810076|FG007|NOT COMPLETED|Period-3 (8 Days)||0
3088010|NCT01424397|3810077|FG008|NOT COMPLETED|Period-3 (8 Days)||0
3088011|NCT01424397|3810078|FG009|NOT COMPLETED|Period-3 (8 Days)||0
3088012|NCT01424397|3810079|FG010|NOT COMPLETED|Period-3 (8 Days)||0
3088013|NCT01424397|3810080|FG011|NOT COMPLETED|Period-3 (8 Days)||0
3088014|NCT01424501|3810100|FG000|STARTED|Overall Study||7
3088015|NCT01424501|3810101|FG001|STARTED|Overall Study||6
3088016|NCT01424501|3810102|FG002|STARTED|Overall Study||24
3088017|NCT01424501|3810103|FG003|STARTED|Overall Study||25
3088018|NCT01424501|3810104|FG004|STARTED|Overall Study||40
3088019|NCT01424501|3810105|FG005|STARTED|Overall Study||40
3088020|NCT01424501|3810100|FG000|COMPLETED|Overall Study||6
3088021|NCT01424501|3810101|FG001|COMPLETED|Overall Study||5
3088022|NCT01424501|3810102|FG002|COMPLETED|Overall Study||22
3088023|NCT01424501|3810103|FG003|COMPLETED|Overall Study||25
3088024|NCT01424501|3810104|FG004|COMPLETED|Overall Study||40
3088025|NCT01424501|3810105|FG005|COMPLETED|Overall Study||40
3088026|NCT01424501|3810100|FG000|NOT COMPLETED|Overall Study||1
3088027|NCT01424501|3810101|FG001|NOT COMPLETED|Overall Study||1
3088028|NCT01424501|3810102|FG002|NOT COMPLETED|Overall Study||2
3088029|NCT01424501|3810103|FG003|NOT COMPLETED|Overall Study||0
3088030|NCT01424501|3810104|FG004|NOT COMPLETED|Overall Study||0
3088031|NCT01424501|3810105|FG005|NOT COMPLETED|Overall Study||0
3088032|NCT01424514|3810120|FG000|STARTED|Period 1:Intervention Period 1 (14 Days)||20
3088033|NCT01424514|3810121|FG001|STARTED|Period 1:Intervention Period 1 (14 Days)||20
3088034|NCT01424514|3810120|FG000|COMPLETED|Period 1:Intervention Period 1 (14 Days)||19
3287768|NCT02793232|4021278|FG000|COMPLETED|Period 4 (Part A: 5 Days)||2
3287769|NCT02793232|4021279|FG001|COMPLETED|Period 4 (Part A: 5 Days)||2
3287770|NCT02793232|4021280|FG002|COMPLETED|Period 4 (Part A: 5 Days)||2
3287771|NCT02793232|4021281|FG003|COMPLETED|Period 4 (Part A: 5 Days)||2
3287772|NCT02793232|4021282|FG004|COMPLETED|Period 4 (Part A: 5 Days)||0
3287773|NCT02793232|4021283|FG005|COMPLETED|Period 4 (Part A: 5 Days)||0
3088035|NCT01424514|3810121|FG001|COMPLETED|Period 1:Intervention Period 1 (14 Days)||19
3088036|NCT01424514|3810120|FG000|NOT COMPLETED|Period 1:Intervention Period 1 (14 Days)||1
3088037|NCT01424514|3810121|FG001|NOT COMPLETED|Period 1:Intervention Period 1 (14 Days)||1
3088038|NCT01424514|3810120|FG000|STARTED|Period 2:Washout Period (4 Weeks)||19
3088039|NCT01424514|3810121|FG001|STARTED|Period 2:Washout Period (4 Weeks)||19
3088040|NCT01424514|3810120|FG000|COMPLETED|Period 2:Washout Period (4 Weeks)||19
3088041|NCT01424514|3810121|FG001|COMPLETED|Period 2:Washout Period (4 Weeks)||19
3287774|NCT02793232|4021284|FG006|COMPLETED|Period 4 (Part A: 5 Days)||0
3287775|NCT02793232|4021285|FG007|COMPLETED|Period 4 (Part A: 5 Days)||0
3287776|NCT02793232|4021286|FG008|COMPLETED|Period 4 (Part A: 5 Days)||0
3287777|NCT02793232|4021278|FG000|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
3287778|NCT02793232|4021279|FG001|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
3287779|NCT02793232|4021280|FG002|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
3287780|NCT02793232|4021281|FG003|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
3287781|NCT02793232|4021282|FG004|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
3287782|NCT02793232|4021283|FG005|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
3287783|NCT02793232|4021284|FG006|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
3287784|NCT02793232|4021285|FG007|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
3287785|NCT02793232|4021286|FG008|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
3287786|NCT02793622|4021322|FG000|STARTED|Overall Study||391
3287787|NCT02793622|4021323|FG001|STARTED|Overall Study||391
3287788|NCT02793622|4021322|FG000|COMPLETED|Overall Study||338
3287789|NCT02793622|4021323|FG001|COMPLETED|Overall Study||349
3287790|NCT02793622|4021322|FG000|NOT COMPLETED|Overall Study||53
3287791|NCT02793622|4021323|FG001|NOT COMPLETED|Overall Study||42
3287792|NCT02793674|4021331|FG000|STARTED|Overall Study||9
3287793|NCT02793674|4021332|FG001|STARTED|Overall Study||12
3287794|NCT02793674|4021331|FG000|COMPLETED|Overall Study||9
3287795|NCT02793674|4021332|FG001|COMPLETED|Overall Study||12
3287796|NCT02793674|4021331|FG000|NOT COMPLETED|Overall Study||0
3287797|NCT02793674|4021332|FG001|NOT COMPLETED|Overall Study||0
3287798|NCT02793817|4021346|FG000|STARTED|Overall Study||261
3287799|NCT02793817|4021347|FG001|STARTED|Overall Study||259
3088042|NCT01424514|3810120|FG000|NOT COMPLETED|Period 2:Washout Period (4 Weeks)||0
3088043|NCT01424514|3810121|FG001|NOT COMPLETED|Period 2:Washout Period (4 Weeks)||0
3088044|NCT01424514|3810120|FG000|STARTED|Period 3:Intervention Period 2 (14 Days)||19
3088045|NCT01424514|3810121|FG001|STARTED|Period 3:Intervention Period 2 (14 Days)||19
3088046|NCT01424514|3810120|FG000|COMPLETED|Period 3:Intervention Period 2 (14 Days)||18
3088047|NCT01424514|3810121|FG001|COMPLETED|Period 3:Intervention Period 2 (14 Days)||19
3088048|NCT01424514|3810120|FG000|NOT COMPLETED|Period 3:Intervention Period 2 (14 Days)||1
3088049|NCT01424514|3810121|FG001|NOT COMPLETED|Period 3:Intervention Period 2 (14 Days)||0
3088050|NCT01424566|3810132|FG000|STARTED|Single-blind Treatment||406
3088051|NCT01424566|3810133|FG001|STARTED|Single-blind Treatment|Participants were not enrolled in this arm in the single-blind period.|0
3088052|NCT01424566|3810134|FG002|STARTED|Single-blind Treatment|Participants were not enrolled in this arm in the single-blind period.|0
3088053|NCT01424566|3810132|FG000|Received at Least 1 Dose of Study Drug|Single-blind Treatment|Two participants did not administer any study drug.|404
3088054|NCT01424566|3810133|FG001|Received at Least 1 Dose of Study Drug|Single-blind Treatment||0
3088055|NCT01424566|3810134|FG002|Received at Least 1 Dose of Study Drug|Single-blind Treatment||0
3088056|NCT01424566|3810132|FG000|Single-blind Safety Population|Single-blind Treatment||404
3088057|NCT01424566|3810133|FG001|Single-blind Safety Population|Single-blind Treatment||0
3088058|NCT01424566|3810134|FG002|Single-blind Safety Population|Single-blind Treatment||0
3088059|NCT01424566|3810132|FG000|Met Randomization Criteria|Single-blind Treatment||206
3088060|NCT01424566|3810133|FG001|Met Randomization Criteria|Single-blind Treatment||0
3088061|NCT01424566|3810134|FG002|Met Randomization Criteria|Single-blind Treatment||0
3088062|NCT01424566|3810132|FG000|COMPLETED|Single-blind Treatment||206
3088063|NCT01424566|3810133|FG001|COMPLETED|Single-blind Treatment||0
3088064|NCT01424566|3810134|FG002|COMPLETED|Single-blind Treatment||0
3088065|NCT01424566|3810132|FG000|NOT COMPLETED|Single-blind Treatment||200
3088066|NCT01424566|3810133|FG001|NOT COMPLETED|Single-blind Treatment||0
3088067|NCT01424566|3810134|FG002|NOT COMPLETED|Single-blind Treatment||0
3088068|NCT01424566|3810132|FG000|STARTED|Double-blind Treatment|Participants were not enrolled in this arm in the double-blind period.|0
3088069|NCT01424566|3810133|FG001|STARTED|Double-blind Treatment|Participants were not enrolled in this arm in the single-blind period.|103
3088070|NCT01424566|3810134|FG002|STARTED|Double-blind Treatment|Participants were not enrolled in this arm in the single-blind period.|103
3088071|NCT01424566|3810132|FG000|Received at Least 1 Dose of Study Drug|Double-blind Treatment||0
3088072|NCT01424566|3810133|FG001|Received at Least 1 Dose of Study Drug|Double-blind Treatment||103
3088073|NCT01424566|3810134|FG002|Received at Least 1 Dose of Study Drug|Double-blind Treatment||103
3088074|NCT01424566|3810132|FG000|Randomized Safety Population|Double-blind Treatment||0
3088075|NCT01424566|3810133|FG001|Randomized Safety Population|Double-blind Treatment||103
3088076|NCT01424566|3810134|FG002|Randomized Safety Population|Double-blind Treatment||103
3088077|NCT01424566|3810132|FG000|ITT Population|Double-blind Treatment||0
3088078|NCT01424566|3810133|FG001|ITT Population|Double-blind Treatment||103
3088079|NCT01424566|3810134|FG002|ITT Population|Double-blind Treatment||103
3088080|NCT01424566|3810132|FG000|COMPLETED|Double-blind Treatment||0
3088081|NCT01424566|3810133|FG001|COMPLETED|Double-blind Treatment||78
3088082|NCT01424566|3810134|FG002|COMPLETED|Double-blind Treatment||88
3088083|NCT01424566|3810132|FG000|NOT COMPLETED|Double-blind Treatment||0
3088084|NCT01424566|3810133|FG001|NOT COMPLETED|Double-blind Treatment||25
3088085|NCT01424566|3810134|FG002|NOT COMPLETED|Double-blind Treatment||15
3088086|NCT01424644|3810143|FG000|STARTED|Overall Study||402
3088087|NCT01424644|3810144|FG001|STARTED|Overall Study||399
3088088|NCT01424644|3810143|FG000|COMPLETED|Overall Study||369
3088089|NCT01424644|3810144|FG001|COMPLETED|Overall Study||372
3088090|NCT01424644|3810143|FG000|NOT COMPLETED|Overall Study||33
3088091|NCT01424644|3810144|FG001|NOT COMPLETED|Overall Study||27
3088092|NCT01424670|3810152|FG000|STARTED|6-Month Intensive Period (182 Days)||341
3088093|NCT01424670|3810153|FG001|STARTED|6-Month Intensive Period (182 Days)||170
3088094|NCT01424670|3810152|FG000|Received at Least 1 Dose of Study Drug|6-Month Intensive Period (182 Days)||341
3088095|NCT01424670|3810153|FG001|Received at Least 1 Dose of Study Drug|6-Month Intensive Period (182 Days)||170
3088096|NCT01424670|3810152|FG000|COMPLETED|6-Month Intensive Period (182 Days)||322
3088097|NCT01424670|3810153|FG001|COMPLETED|6-Month Intensive Period (182 Days)||156
3088098|NCT01424670|3810152|FG000|NOT COMPLETED|6-Month Intensive Period (182 Days)||19
3088099|NCT01424670|3810153|FG001|NOT COMPLETED|6-Month Intensive Period (182 Days)||14
3088100|NCT01424670|3810152|FG000|STARTED|Continuation Period||322
3088101|NCT01424670|3810153|FG001|STARTED|Continuation Period||156
3088102|NCT01424670|3810152|FG000|COMPLETED|Continuation Period||288
3088103|NCT01424670|3810153|FG001|COMPLETED|Continuation Period||142
3088104|NCT01424670|3810152|FG000|NOT COMPLETED|Continuation Period||34
3088105|NCT01424670|3810153|FG001|NOT COMPLETED|Continuation Period||14
3088106|NCT01424722|3810161|FG000|STARTED|Overall Study||2258
3088107|NCT01424722|3810161|FG000|COMPLETED|Overall Study||0
3088108|NCT01424722|3810161|FG000|NOT COMPLETED|Overall Study||2258
3088109|NCT01424813|3810167|FG000|STARTED|Overall Study||79
3088110|NCT01424813|3810168|FG001|STARTED|Overall Study||79
3088111|NCT01424813|3810167|FG000|Treated|Overall Study|Safety set and full analysis set|79
3088112|NCT01424813|3810168|FG001|Treated|Overall Study|Safety set and full analysis set|78
3088113|NCT01424813|3810167|FG000|COMPLETED|Overall Study||74
3088114|NCT01424813|3810168|FG001|COMPLETED|Overall Study||77
3088115|NCT01424813|3810167|FG000|NOT COMPLETED|Overall Study||5
3088116|NCT01424813|3810168|FG001|NOT COMPLETED|Overall Study||2
3088117|NCT01424930|3810176|FG000|STARTED|Overall Study||7
3088118|NCT01424930|3810177|FG001|STARTED|Overall Study||18
3088119|NCT01424930|3810176|FG000|Completed Food Safety Evaluation|Overall Study||6
3088120|NCT01424930|3810177|FG001|Completed Food Safety Evaluation|Overall Study||18
3088121|NCT01424930|3810176|FG000|COMPLETED|Overall Study||3
3088122|NCT01424930|3810177|FG001|COMPLETED|Overall Study||4
3088123|NCT01424930|3810176|FG000|NOT COMPLETED|Overall Study||4
3088124|NCT01424930|3810177|FG001|NOT COMPLETED|Overall Study||14
3088125|NCT01424943|3810185|FG000|STARTED|Overall Study||25
3088126|NCT01424943|3810186|FG001|STARTED|Overall Study||24
3088127|NCT01424943|3810185|FG000|COMPLETED|Overall Study||12
3088128|NCT01424943|3810186|FG001|COMPLETED|Overall Study||23
3088129|NCT01424943|3810185|FG000|NOT COMPLETED|Overall Study||13
3088130|NCT01424943|3810186|FG001|NOT COMPLETED|Overall Study||1
3088131|NCT01425190|3810195|FG000|STARTED|Overall Study||16
3088132|NCT01425190|3810196|FG001|STARTED|Overall Study|The study was terminated prior to enrolling participants in Cohort 2.|0
3088133|NCT01425190|3810197|FG002|STARTED|Overall Study|The study was terminated prior to enrolling participants in Cohort 3.|0
3088134|NCT01425190|3810195|FG000|COMPLETED|Overall Study||15
3088135|NCT01425190|3810196|FG001|COMPLETED|Overall Study||0
3088136|NCT01425190|3810197|FG002|COMPLETED|Overall Study||0
3088137|NCT01425190|3810195|FG000|NOT COMPLETED|Overall Study||1
3088138|NCT01425190|3810196|FG001|NOT COMPLETED|Overall Study||0
3088139|NCT01425190|3810197|FG002|NOT COMPLETED|Overall Study||0
3088140|NCT01425203|3810207|FG000|STARTED|Treatment Phase||159
3088141|NCT01425203|3810208|FG001|STARTED|Treatment Phase||79
3088142|NCT01425203|3810209|FG002|STARTED|Treatment Phase||0
3088143|NCT01425203|3810207|FG000|Treated (FAS)|Treatment Phase||159
3088144|NCT01425203|3810208|FG001|Treated (FAS)|Treatment Phase||78
3088145|NCT01425203|3810209|FG002|Treated (FAS)|Treatment Phase||0
3088146|NCT01425203|3810207|FG000|COMPLETED|Treatment Phase||132
3088147|NCT01425203|3810208|FG001|COMPLETED|Treatment Phase||42
3088148|NCT01425203|3810209|FG002|COMPLETED|Treatment Phase||0
3088149|NCT01425203|3810207|FG000|NOT COMPLETED|Treatment Phase||27
3088150|NCT01425203|3810208|FG001|NOT COMPLETED|Treatment Phase||37
3088151|NCT01425203|3810209|FG002|NOT COMPLETED|Treatment Phase||0
3088152|NCT01425203|3810207|FG000|STARTED|Crossover Phase|Phase only for participants in PBO + PR Control arm who failed futility rule at TW12 or 24|0
3088153|NCT01425203|3810208|FG001|STARTED|Crossover Phase|Phase only for participants in PBO + PR Control arm who failed futility rule at TW12 or 24|0
3088154|NCT01425203|3810209|FG002|STARTED|Crossover Phase|Phase only for participants in PBO + PR Control arm who failed futility rule at TW12 or 24|27
3088155|NCT01425203|3810207|FG000|COMPLETED|Crossover Phase||0
3088156|NCT01425203|3810208|FG001|COMPLETED|Crossover Phase||0
3088157|NCT01425203|3810209|FG002|COMPLETED|Crossover Phase||21
3088158|NCT01425203|3810207|FG000|NOT COMPLETED|Crossover Phase||0
3088159|NCT01425203|3810208|FG001|NOT COMPLETED|Crossover Phase||0
3088160|NCT01425203|3810209|FG002|NOT COMPLETED|Crossover Phase||6
3088161|NCT01425203|3810207|FG000|STARTED|Follow-up Phase|6 participants who started treatment in RGT BOC + PR arm did not enter follow-up.|153
3088162|NCT01425203|3810208|FG001|STARTED|Follow-up Phase|27 starting treatment in PBO+PR Control arm switched to Crossover arm and 2 did not enter follow-up|49
3088163|NCT01425203|3810209|FG002|STARTED|Follow-up Phase|All participants treated in crossover arm entered follow-up.|27
3088164|NCT01425203|3810207|FG000|COMPLETED|Follow-up Phase||153
3088165|NCT01425203|3810208|FG001|COMPLETED|Follow-up Phase||49
3088166|NCT01425203|3810209|FG002|COMPLETED|Follow-up Phase||27
3088167|NCT01425203|3810207|FG000|NOT COMPLETED|Follow-up Phase||0
3088168|NCT01425203|3810208|FG001|NOT COMPLETED|Follow-up Phase||0
3088169|NCT01425203|3810209|FG002|NOT COMPLETED|Follow-up Phase||0
3088170|NCT01425229|3810217|FG000|STARTED|Bosentan Single Dose||16
3088171|NCT01425229|3810217|FG000|COMPLETED|Bosentan Single Dose||16
3088172|NCT01425229|3810217|FG000|NOT COMPLETED|Bosentan Single Dose||0
3088173|NCT01425229|3810217|FG000|STARTED|Bosentan Steady-state||16
3088174|NCT01425229|3810217|FG000|COMPLETED|Bosentan Steady-state||16
3088175|NCT01425229|3810217|FG000|NOT COMPLETED|Bosentan Steady-state||0
3088176|NCT01425229|3810217|FG000|STARTED|Bosentan During Clarithromycin||16
3088177|NCT01425229|3810217|FG000|COMPLETED|Bosentan During Clarithromycin||16
3088178|NCT01425229|3810217|FG000|NOT COMPLETED|Bosentan During Clarithromycin||0
3088179|NCT01425268|3810227|FG000|STARTED|Overall Study|106 Subjects Randomized to AeroForm Arm / 98 Subjects Treated (Implanted)|106
3088180|NCT01425268|3810228|FG001|STARTED|Overall Study|52 Subjects Randomized to Saline Arm / 52 Subjects Treated (Implanted)|52
3088181|NCT01425268|3810227|FG000|COMPLETED|Overall Study||98
3088182|NCT01425268|3810228|FG001|COMPLETED|Overall Study||52
3088183|NCT01425268|3810227|FG000|NOT COMPLETED|Overall Study||8
3088184|NCT01425268|3810228|FG001|NOT COMPLETED|Overall Study||0
3088185|NCT01425281|3810236|FG000|STARTED|At 30-day Clinical Follow-up|Intent-to-Treat (ITT) Population|335
3088186|NCT01425281|3810237|FG001|STARTED|At 30-day Clinical Follow-up|Intent-to-Treat (ITT) Population|166
3088187|NCT01425281|3810236|FG000|COMPLETED|At 30-day Clinical Follow-up||334
3088188|NCT01425281|3810237|FG001|COMPLETED|At 30-day Clinical Follow-up||166
3088189|NCT01425281|3810236|FG000|NOT COMPLETED|At 30-day Clinical Follow-up||1
3088190|NCT01425281|3810237|FG001|NOT COMPLETED|At 30-day Clinical Follow-up||0
3088191|NCT01425281|3810236|FG000|STARTED|At 180-day Clinical Follow-up||334
3088192|NCT01425281|3810237|FG001|STARTED|At 180-day Clinical Follow-up||166
3088193|NCT01425281|3810236|FG000|COMPLETED|At 180-day Clinical Follow-up||331
3088194|NCT01425281|3810237|FG001|COMPLETED|At 180-day Clinical Follow-up||165
3088195|NCT01425281|3810236|FG000|NOT COMPLETED|At 180-day Clinical Follow-up||3
3088196|NCT01425281|3810237|FG001|NOT COMPLETED|At 180-day Clinical Follow-up||1
3088197|NCT01425281|3810236|FG000|STARTED|At 1-year Clinical Follow-up||331
3088198|NCT01425281|3810237|FG001|STARTED|At 1-year Clinical Follow-up||165
3088199|NCT01425281|3810236|FG000|COMPLETED|At 1-year Clinical Follow-up||329
3088200|NCT01425281|3810237|FG001|COMPLETED|At 1-year Clinical Follow-up||164
3287800|NCT02793817|4021346|FG000|COMPLETED|Overall Study||258
3287801|NCT02793817|4021347|FG001|COMPLETED|Overall Study||254
3287802|NCT02793817|4021346|FG000|NOT COMPLETED|Overall Study||3
3287803|NCT02793817|4021347|FG001|NOT COMPLETED|Overall Study||5
3287804|NCT02793856|4021357|FG000|STARTED|Overall Study||2
3088201|NCT01425281|3810236|FG000|NOT COMPLETED|At 1-year Clinical Follow-up||2
3088202|NCT01425281|3810237|FG001|NOT COMPLETED|At 1-year Clinical Follow-up||1
3088203|NCT01425281|3810236|FG000|STARTED|At 2-year Clinical Follow-up||329
3088204|NCT01425281|3810237|FG001|STARTED|At 2-year Clinical Follow-up||164
3088205|NCT01425281|3810236|FG000|COMPLETED|At 2-year Clinical Follow-up||323
3088206|NCT01425281|3810237|FG001|COMPLETED|At 2-year Clinical Follow-up||163
3088207|NCT01425281|3810236|FG000|NOT COMPLETED|At 2-year Clinical Follow-up||6
3088208|NCT01425281|3810237|FG001|NOT COMPLETED|At 2-year Clinical Follow-up||1
3088209|NCT01425281|3810236|FG000|STARTED|At 3-year Clinical Follow-up||323
3088210|NCT01425281|3810237|FG001|STARTED|At 3-year Clinical Follow-up||163
3088211|NCT01425281|3810236|FG000|COMPLETED|At 3-year Clinical Follow-up||318
3088212|NCT01425281|3810237|FG001|COMPLETED|At 3-year Clinical Follow-up||157
3088213|NCT01425281|3810236|FG000|NOT COMPLETED|At 3-year Clinical Follow-up||5
3088214|NCT01425281|3810237|FG001|NOT COMPLETED|At 3-year Clinical Follow-up||6
3088215|NCT01425281|3810236|FG000|STARTED|At 4-year Clinical Follow-up||318
3088216|NCT01425281|3810237|FG001|STARTED|At 4-year Clinical Follow-up||157
3088217|NCT01425281|3810236|FG000|COMPLETED|At 4-year Clinical Follow-up||288
3088218|NCT01425281|3810237|FG001|COMPLETED|At 4-year Clinical Follow-up||136
3088219|NCT01425281|3810236|FG000|NOT COMPLETED|At 4-year Clinical Follow-up||30
3088220|NCT01425281|3810237|FG001|NOT COMPLETED|At 4-year Clinical Follow-up||21
3088221|NCT01425281|3810236|FG000|STARTED|At 5-year Clinical Follow-up||288
3088222|NCT01425281|3810237|FG001|STARTED|At 5-year Clinical Follow-up||136
3088223|NCT01425281|3810236|FG000|COMPLETED|At 5-year Clinical Follow-up||256
3088224|NCT01425281|3810237|FG001|COMPLETED|At 5-year Clinical Follow-up||125
3088225|NCT01425281|3810236|FG000|NOT COMPLETED|At 5-year Clinical Follow-up||32
3088226|NCT01425281|3810237|FG001|NOT COMPLETED|At 5-year Clinical Follow-up||11
3088227|NCT01425307|3810246|FG000|STARTED|Overall Study|Randomized Sample: 61; Intention-to Treat Sample:61|61
3088228|NCT01425307|3810247|FG001|STARTED|Overall Study|Randomized Sample: 60; Intention-to Treat Sample:60|60
3088229|NCT01425307|3810246|FG000|COMPLETED|Overall Study|Treatment Phase: 42; 6-Month Follow up: 58|42
3088230|NCT01425307|3810247|FG001|COMPLETED|Overall Study|Treatment Phase: 41; 6-Month Follow-up:59|41
3088231|NCT01425307|3810246|FG000|NOT COMPLETED|Overall Study||19
3088232|NCT01425307|3810247|FG001|NOT COMPLETED|Overall Study||19
3088233|NCT01425359|3810257|FG000|STARTED|Overall Study||476
3088234|NCT01425359|3810258|FG001|STARTED|Overall Study||473
3088235|NCT01425359|3810257|FG000|COMPLETED|Overall Study||457
3088236|NCT01425359|3810258|FG001|COMPLETED|Overall Study||451
3088237|NCT01425359|3810257|FG000|NOT COMPLETED|Overall Study||19
3088238|NCT01425359|3810258|FG001|NOT COMPLETED|Overall Study||22
3088239|NCT01425463|3810267|FG000|STARTED|Overall Study||130
3088240|NCT01425463|3810268|FG001|STARTED|Overall Study||126
3088241|NCT01425463|3810267|FG000|Safety Set|Overall Study||126
3088242|NCT01425463|3810268|FG001|Safety Set|Overall Study||122
3088243|NCT01425463|3810267|FG000|Full Analysis Set|Overall Study||122
3088244|NCT01425463|3810268|FG001|Full Analysis Set|Overall Study||116
3088245|NCT01425463|3810267|FG000|COMPLETED|Overall Study||106
3088246|NCT01425463|3810268|FG001|COMPLETED|Overall Study||102
3088247|NCT01425463|3810267|FG000|NOT COMPLETED|Overall Study||24
3088248|NCT01425463|3810268|FG001|NOT COMPLETED|Overall Study||24
3088249|NCT01425528|3810276|FG000|STARTED|Overall Study||6
3088250|NCT01425528|3810277|FG001|STARTED|Overall Study||6
3088251|NCT01425528|3810276|FG000|COMPLETED|Overall Study||5
3088252|NCT01425528|3810277|FG001|COMPLETED|Overall Study||5
3088253|NCT01425528|3810276|FG000|NOT COMPLETED|Overall Study||1
3088254|NCT01425528|3810277|FG001|NOT COMPLETED|Overall Study||1
3088255|NCT01425632|3810286|FG000|STARTED|Overall Study||161
3088256|NCT01425632|3810287|FG001|STARTED|Overall Study||166
3088257|NCT01425632|3810288|FG002|STARTED|Overall Study||163
3088258|NCT01425632|3810286|FG000|COMPLETED|Overall Study||160
3088259|NCT01425632|3810287|FG001|COMPLETED|Overall Study||165
3287805|NCT02793856|4021358|FG001|STARTED|Overall Study||4
3287806|NCT02793856|4021359|FG002|STARTED|Overall Study||3
3287807|NCT02793856|4021360|FG003|STARTED|Overall Study||3
3287808|NCT02793856|4021357|FG000|COMPLETED|Overall Study||2
3287809|NCT02793856|4021358|FG001|COMPLETED|Overall Study||4
3287810|NCT02793856|4021359|FG002|COMPLETED|Overall Study||3
3287811|NCT02793856|4021360|FG003|COMPLETED|Overall Study||3
3287812|NCT02793856|4021357|FG000|NOT COMPLETED|Overall Study||0
3287813|NCT02793856|4021358|FG001|NOT COMPLETED|Overall Study||0
3287814|NCT02793856|4021359|FG002|NOT COMPLETED|Overall Study||0
3287815|NCT02793856|4021360|FG003|NOT COMPLETED|Overall Study||0
3287816|NCT02793947|4021400|FG000|STARTED|Overall Study||47
3287817|NCT02793947|4021401|FG001|STARTED|Overall Study||55
3287818|NCT02793947|4021400|FG000|COMPLETED|Overall Study||45
3287819|NCT02793947|4021401|FG001|COMPLETED|Overall Study||50
3287820|NCT02793947|4021400|FG000|NOT COMPLETED|Overall Study||2
3287821|NCT02793947|4021401|FG001|NOT COMPLETED|Overall Study||5
3287822|NCT02794103|4021407|FG000|STARTED|Overall Study||18
3287823|NCT02794103|4021407|FG000|COMPLETED|Overall Study||15
3287824|NCT02794103|4021407|FG000|NOT COMPLETED|Overall Study||3
3287825|NCT02794207|4021413|FG000|STARTED|Overall Study||32
3287826|NCT02794207|4021414|FG001|STARTED|Overall Study||54
3287827|NCT02794207|4021413|FG000|COMPLETED|Overall Study||32
3287828|NCT02794207|4021414|FG001|COMPLETED|Overall Study||54
3287829|NCT02794207|4021413|FG000|NOT COMPLETED|Overall Study||0
3287830|NCT02794207|4021414|FG001|NOT COMPLETED|Overall Study||0
3287831|NCT02794246|4021419|FG000|STARTED|Overall Study||6
3088260|NCT01425632|3810288|FG002|COMPLETED|Overall Study||159
3088261|NCT01425632|3810286|FG000|NOT COMPLETED|Overall Study||1
3088262|NCT01425632|3810287|FG001|NOT COMPLETED|Overall Study||1
3088263|NCT01425632|3810288|FG002|NOT COMPLETED|Overall Study||4
3088264|NCT01425723|3810298|FG000|STARTED|Overall Study|13 participants in <6 Years Old Age Cohort and 14 participants in 6 to <12 Years Old Age Cohort.|27
3088265|NCT01425723|3810299|FG001|STARTED|Overall Study||93
3088266|NCT01425723|3810298|FG000|Weekly Prophylaxis|Overall Study||23
3088267|NCT01425723|3810299|FG001|Weekly Prophylaxis|Overall Study||51
3088268|NCT01425723|3810298|FG000|Individualized Prophylaxis|Overall Study||5
3088269|NCT01425723|3810299|FG001|Individualized Prophylaxis|Overall Study||31
3088270|NCT01425723|3810298|FG000|Personalized Prophylaxis|Overall Study||2
3088271|NCT01425723|3810299|FG001|Personalized Prophylaxis|Overall Study||17
3088272|NCT01425723|3810298|FG000|Episodic|Overall Study||0
3088273|NCT01425723|3810299|FG001|Episodic|Overall Study||15
3088274|NCT01425723|3810298|FG000|Surgery Subgroup|Overall Study||1
3088275|NCT01425723|3810299|FG001|Surgery Subgroup|Overall Study||15
3088276|NCT01425723|3810298|FG000|COMPLETED|Overall Study||23
3088277|NCT01425723|3810299|FG001|COMPLETED|Overall Study||75
3088278|NCT01425723|3810298|FG000|NOT COMPLETED|Overall Study||4
3088279|NCT01425723|3810299|FG001|NOT COMPLETED|Overall Study||18
3088280|NCT01425749|3810316|FG000|STARTED|Overall Study||13
3088281|NCT01425749|3810317|FG001|STARTED|Overall Study||12
3088282|NCT01425749|3810316|FG000|COMPLETED|Overall Study||13
3088283|NCT01425749|3810317|FG001|COMPLETED|Overall Study||11
3088284|NCT01425749|3810316|FG000|NOT COMPLETED|Overall Study||0
3088285|NCT01425749|3810317|FG001|NOT COMPLETED|Overall Study||1
3088286|NCT01425801|3810326|FG000|STARTED|Period 1||9
3088287|NCT01425801|3810327|FG001|STARTED|Period 1||9
3088288|NCT01425801|3810328|FG002|STARTED|Period 1||9
3088289|NCT01425801|3810329|FG003|STARTED|Period 1||12
3088290|NCT01425801|3810330|FG004|STARTED|Period 1||13
3088291|NCT01425801|3810331|FG005|STARTED|Period 1||10
3088292|NCT01425801|3810326|FG000|COMPLETED|Period 1||9
3088293|NCT01425801|3810327|FG001|COMPLETED|Period 1||9
3088294|NCT01425801|3810328|FG002|COMPLETED|Period 1||9
3088295|NCT01425801|3810329|FG003|COMPLETED|Period 1||12
3088296|NCT01425801|3810330|FG004|COMPLETED|Period 1||12
3088297|NCT01425801|3810331|FG005|COMPLETED|Period 1||10
3088298|NCT01425801|3810326|FG000|NOT COMPLETED|Period 1||0
3088299|NCT01425801|3810327|FG001|NOT COMPLETED|Period 1||0
3088300|NCT01425801|3810328|FG002|NOT COMPLETED|Period 1||0
3088301|NCT01425801|3810329|FG003|NOT COMPLETED|Period 1||0
3088302|NCT01425801|3810330|FG004|NOT COMPLETED|Period 1||1
3088303|NCT01425801|3810331|FG005|NOT COMPLETED|Period 1||0
3088304|NCT01425801|3810326|FG000|STARTED|Period 2||9
3163083|NCT01882829|3890542|FG000|COMPLETED|Overall Study||14
3163084|NCT01882829|3890542|FG000|NOT COMPLETED|Overall Study||6
3163085|NCT01882868|3890546|FG000|STARTED|Overall Study||62
3163086|NCT01882868|3890546|FG000|COMPLETED|Overall Study||62
3163087|NCT01882868|3890546|FG000|NOT COMPLETED|Overall Study||0
3163088|NCT01882907|3890552|FG000|STARTED|Overall Study||117
3163089|NCT01882907|3890553|FG001|STARTED|Overall Study||111
3163090|NCT01882907|3890552|FG000|COMPLETED|Overall Study||103
3287832|NCT02794246|4021419|FG000|Treated|Overall Study||3
3287833|NCT02794246|4021419|FG000|COMPLETED|Overall Study||0
3287834|NCT02794246|4021419|FG000|NOT COMPLETED|Overall Study||6
3287835|NCT02794441|4021425|FG000|STARTED|Overall Study||7
3287836|NCT02794441|4021426|FG001|STARTED|Overall Study||5
3287837|NCT02794441|4021425|FG000|COMPLETED|Overall Study||6
3287838|NCT02794441|4021426|FG001|COMPLETED|Overall Study||5
3287839|NCT02794441|4021425|FG000|NOT COMPLETED|Overall Study||1
3287840|NCT02794441|4021426|FG001|NOT COMPLETED|Overall Study||0
3287841|NCT02794480|4021434|FG000|STARTED|Period 1: Treatment Period 1 (28 Days)||80
3287842|NCT02794480|4021435|FG001|STARTED|Period 1: Treatment Period 1 (28 Days)||82
3287843|NCT02794480|4021436|FG002|STARTED|Period 1: Treatment Period 1 (28 Days)||81
3287844|NCT02794480|4021437|FG003|STARTED|Period 1: Treatment Period 1 (28 Days)||81
3287845|NCT02794480|4021434|FG000|COMPLETED|Period 1: Treatment Period 1 (28 Days)||80
3287846|NCT02794480|4021435|FG001|COMPLETED|Period 1: Treatment Period 1 (28 Days)||80
3287847|NCT02794480|4021436|FG002|COMPLETED|Period 1: Treatment Period 1 (28 Days)||79
3287848|NCT02794480|4021437|FG003|COMPLETED|Period 1: Treatment Period 1 (28 Days)||78
3287849|NCT02794480|4021434|FG000|NOT COMPLETED|Period 1: Treatment Period 1 (28 Days)||0
3287850|NCT02794480|4021435|FG001|NOT COMPLETED|Period 1: Treatment Period 1 (28 Days)||2
3287851|NCT02794480|4021436|FG002|NOT COMPLETED|Period 1: Treatment Period 1 (28 Days)||2
3287852|NCT02794480|4021437|FG003|NOT COMPLETED|Period 1: Treatment Period 1 (28 Days)||3
3287853|NCT02794480|4021434|FG000|STARTED|Period 2: Treatment Period 2 (28 Days)||80
3287854|NCT02794480|4021435|FG001|STARTED|Period 2: Treatment Period 2 (28 Days)||80
3287855|NCT02794480|4021436|FG002|STARTED|Period 2: Treatment Period 2 (28 Days)||79
3287856|NCT02794480|4021437|FG003|STARTED|Period 2: Treatment Period 2 (28 Days)||78
3287857|NCT02794480|4021434|FG000|COMPLETED|Period 2: Treatment Period 2 (28 Days)||79
3287858|NCT02794480|4021435|FG001|COMPLETED|Period 2: Treatment Period 2 (28 Days)||80
3163091|NCT01882907|3890553|FG001|COMPLETED|Overall Study||83
3163092|NCT01882907|3890552|FG000|NOT COMPLETED|Overall Study||14
3287859|NCT02794480|4021436|FG002|COMPLETED|Period 2: Treatment Period 2 (28 Days)||79
3088305|NCT01425801|3810327|FG001|STARTED|Period 2||9
3088306|NCT01425801|3810328|FG002|STARTED|Period 2||9
3088307|NCT01425801|3810329|FG003|STARTED|Period 2||12
3163093|NCT01882907|3890553|FG001|NOT COMPLETED|Overall Study||28
3163094|NCT01882985|3890561|FG000|STARTED|Overall Study||14
3088308|NCT01425801|3810330|FG004|STARTED|Period 2||12
3088309|NCT01425801|3810331|FG005|STARTED|Period 2||10
3088310|NCT01425801|3810326|FG000|COMPLETED|Period 2||9
3088311|NCT01425801|3810327|FG001|COMPLETED|Period 2||9
3088312|NCT01425801|3810328|FG002|COMPLETED|Period 2||9
3088313|NCT01425801|3810329|FG003|COMPLETED|Period 2||12
3088314|NCT01425801|3810330|FG004|COMPLETED|Period 2||11
3088315|NCT01425801|3810331|FG005|COMPLETED|Period 2||10
3088316|NCT01425801|3810326|FG000|NOT COMPLETED|Period 2||0
3088317|NCT01425801|3810327|FG001|NOT COMPLETED|Period 2||0
3088318|NCT01425801|3810328|FG002|NOT COMPLETED|Period 2||0
3088319|NCT01425801|3810329|FG003|NOT COMPLETED|Period 2||0
3088320|NCT01425801|3810330|FG004|NOT COMPLETED|Period 2||1
3088321|NCT01425801|3810331|FG005|NOT COMPLETED|Period 2||0
3088322|NCT01425801|3810326|FG000|STARTED|Period 3||9
3088323|NCT01425801|3810327|FG001|STARTED|Period 3||9
3088324|NCT01425801|3810328|FG002|STARTED|Period 3||9
3088325|NCT01425801|3810329|FG003|STARTED|Period 3||12
3088326|NCT01425801|3810330|FG004|STARTED|Period 3||11
3088327|NCT01425801|3810331|FG005|STARTED|Period 3||10
3088328|NCT01425801|3810326|FG000|COMPLETED|Period 3||9
3088329|NCT01425801|3810327|FG001|COMPLETED|Period 3||9
3088330|NCT01425801|3810328|FG002|COMPLETED|Period 3||8
3088331|NCT01425801|3810329|FG003|COMPLETED|Period 3||12
3088332|NCT01425801|3810330|FG004|COMPLETED|Period 3||11
3088333|NCT01425801|3810331|FG005|COMPLETED|Period 3||10
3088334|NCT01425801|3810326|FG000|NOT COMPLETED|Period 3||0
3088335|NCT01425801|3810327|FG001|NOT COMPLETED|Period 3||0
3088336|NCT01425801|3810328|FG002|NOT COMPLETED|Period 3||1
3088337|NCT01425801|3810329|FG003|NOT COMPLETED|Period 3||0
3088338|NCT01425801|3810330|FG004|NOT COMPLETED|Period 3||0
3088339|NCT01425801|3810331|FG005|NOT COMPLETED|Period 3||0
3088340|NCT01425801|3810326|FG000|STARTED|Period 4||9
3088341|NCT01425801|3810327|FG001|STARTED|Period 4||9
3088342|NCT01425801|3810328|FG002|STARTED|Period 4||8
3088343|NCT01425801|3810329|FG003|STARTED|Period 4||12
3088344|NCT01425801|3810330|FG004|STARTED|Period 4||11
3088345|NCT01425801|3810331|FG005|STARTED|Period 4||10
3088346|NCT01425801|3810326|FG000|COMPLETED|Period 4||9
3088347|NCT01425801|3810327|FG001|COMPLETED|Period 4||9
3088348|NCT01425801|3810328|FG002|COMPLETED|Period 4||7
3088349|NCT01425801|3810329|FG003|COMPLETED|Period 4||12
3088350|NCT01425801|3810330|FG004|COMPLETED|Period 4||11
3088351|NCT01425801|3810331|FG005|COMPLETED|Period 4||10
3088352|NCT01425801|3810326|FG000|NOT COMPLETED|Period 4||0
3088353|NCT01425801|3810327|FG001|NOT COMPLETED|Period 4||0
3088354|NCT01425801|3810328|FG002|NOT COMPLETED|Period 4||1
3088355|NCT01425801|3810329|FG003|NOT COMPLETED|Period 4||0
3088356|NCT01425801|3810330|FG004|NOT COMPLETED|Period 4||0
3088357|NCT01425801|3810331|FG005|NOT COMPLETED|Period 4||0
3088358|NCT01425801|3810326|FG000|STARTED|Period 5||9
3088359|NCT01425801|3810327|FG001|STARTED|Period 5||9
3088360|NCT01425801|3810328|FG002|STARTED|Period 5||7
3088361|NCT01425801|3810329|FG003|STARTED|Period 5||12
3088362|NCT01425801|3810330|FG004|STARTED|Period 5||11
3088363|NCT01425801|3810331|FG005|STARTED|Period 5||10
3088364|NCT01425801|3810326|FG000|COMPLETED|Period 5||9
3088365|NCT01425801|3810327|FG001|COMPLETED|Period 5||9
3088366|NCT01425801|3810328|FG002|COMPLETED|Period 5||7
3088367|NCT01425801|3810329|FG003|COMPLETED|Period 5||12
3088368|NCT01425801|3810330|FG004|COMPLETED|Period 5||11
3088369|NCT01425801|3810331|FG005|COMPLETED|Period 5||10
3088370|NCT01425801|3810326|FG000|NOT COMPLETED|Period 5||0
3088371|NCT01425801|3810327|FG001|NOT COMPLETED|Period 5||0
3088372|NCT01425801|3810328|FG002|NOT COMPLETED|Period 5||0
3088373|NCT01425801|3810329|FG003|NOT COMPLETED|Period 5||0
3088374|NCT01425801|3810330|FG004|NOT COMPLETED|Period 5||0
3287860|NCT02794480|4021437|FG003|COMPLETED|Period 2: Treatment Period 2 (28 Days)||77
3287861|NCT02794480|4021434|FG000|NOT COMPLETED|Period 2: Treatment Period 2 (28 Days)||1
3287862|NCT02794480|4021435|FG001|NOT COMPLETED|Period 2: Treatment Period 2 (28 Days)||0
3287863|NCT02794480|4021436|FG002|NOT COMPLETED|Period 2: Treatment Period 2 (28 Days)||0
3287864|NCT02794480|4021437|FG003|NOT COMPLETED|Period 2: Treatment Period 2 (28 Days)||1
3287865|NCT02794597|4021447|FG000|STARTED|Overall Study||63
3287866|NCT02794597|4021448|FG001|STARTED|Overall Study||56
3287867|NCT02794597|4021447|FG000|COMPLETED|Overall Study||63
3287868|NCT02794597|4021448|FG001|COMPLETED|Overall Study||56
3287869|NCT02794597|4021447|FG000|NOT COMPLETED|Overall Study||0
3287870|NCT02794597|4021448|FG001|NOT COMPLETED|Overall Study||0
3287871|NCT02794727|4021457|FG000|STARTED|Overall Study||44
3287872|NCT02794727|4021458|FG001|STARTED|Overall Study||46
3287873|NCT02794727|4021459|FG002|STARTED|Overall Study||45
3287874|NCT02794727|4021457|FG000|COMPLETED|Overall Study||44
3287875|NCT02794727|4021458|FG001|COMPLETED|Overall Study||46
3287876|NCT02794727|4021459|FG002|COMPLETED|Overall Study||44
3287877|NCT02794727|4021457|FG000|NOT COMPLETED|Overall Study||0
3287878|NCT02794727|4021458|FG001|NOT COMPLETED|Overall Study||0
3287879|NCT02794727|4021459|FG002|NOT COMPLETED|Overall Study||1
3088375|NCT01425801|3810331|FG005|NOT COMPLETED|Period 5||0
3088376|NCT01425801|3810326|FG000|STARTED|Period 6||9
3088377|NCT01425801|3810327|FG001|STARTED|Period 6||9
3088378|NCT01425801|3810328|FG002|STARTED|Period 6||7
3088379|NCT01425801|3810329|FG003|STARTED|Period 6||12
3088380|NCT01425801|3810330|FG004|STARTED|Period 6||11
3088381|NCT01425801|3810331|FG005|STARTED|Period 6||10
3088382|NCT01425801|3810326|FG000|COMPLETED|Period 6||9
3088383|NCT01425801|3810327|FG001|COMPLETED|Period 6||9
3287880|NCT02794766|4021469|FG000|STARTED|Overall Study||15
3088384|NCT01425801|3810328|FG002|COMPLETED|Period 6||7
3088385|NCT01425801|3810329|FG003|COMPLETED|Period 6||12
3088386|NCT01425801|3810330|FG004|COMPLETED|Period 6||11
3088387|NCT01425801|3810331|FG005|COMPLETED|Period 6||10
3088388|NCT01425801|3810326|FG000|NOT COMPLETED|Period 6||0
3088389|NCT01425801|3810327|FG001|NOT COMPLETED|Period 6||0
3088390|NCT01425801|3810328|FG002|NOT COMPLETED|Period 6||0
3088391|NCT01425801|3810329|FG003|NOT COMPLETED|Period 6||0
3088392|NCT01425801|3810330|FG004|NOT COMPLETED|Period 6||0
3088393|NCT01425801|3810331|FG005|NOT COMPLETED|Period 6||0
3088394|NCT01425814|3810345|FG000|STARTED|Period 1||12
3088395|NCT01425814|3810346|FG001|STARTED|Period 1||11
3088396|NCT01425814|3810347|FG002|STARTED|Period 1||12
3088397|NCT01425814|3810348|FG003|STARTED|Period 1||10
3088398|NCT01425814|3810349|FG004|STARTED|Period 1||12
3088399|NCT01425814|3810350|FG005|STARTED|Period 1||13
3088400|NCT01425814|3810345|FG000|COMPLETED|Period 1||12
3088401|NCT01425814|3810346|FG001|COMPLETED|Period 1||10
3088402|NCT01425814|3810347|FG002|COMPLETED|Period 1||12
3088403|NCT01425814|3810348|FG003|COMPLETED|Period 1||10
3088404|NCT01425814|3810349|FG004|COMPLETED|Period 1||12
3088405|NCT01425814|3810350|FG005|COMPLETED|Period 1||13
3088406|NCT01425814|3810345|FG000|NOT COMPLETED|Period 1||0
3088407|NCT01425814|3810346|FG001|NOT COMPLETED|Period 1||1
3088408|NCT01425814|3810347|FG002|NOT COMPLETED|Period 1||0
3088409|NCT01425814|3810348|FG003|NOT COMPLETED|Period 1||0
3088410|NCT01425814|3810349|FG004|NOT COMPLETED|Period 1||0
3088411|NCT01425814|3810350|FG005|NOT COMPLETED|Period 1||0
3088412|NCT01425814|3810345|FG000|STARTED|Period 2||12
3088413|NCT01425814|3810346|FG001|STARTED|Period 2||10
3088414|NCT01425814|3810347|FG002|STARTED|Period 2||12
3088415|NCT01425814|3810348|FG003|STARTED|Period 2||10
3088416|NCT01425814|3810349|FG004|STARTED|Period 2||12
3088417|NCT01425814|3810350|FG005|STARTED|Period 2||13
3088418|NCT01425814|3810345|FG000|COMPLETED|Period 2||12
3088419|NCT01425814|3810346|FG001|COMPLETED|Period 2||9
3088420|NCT01425814|3810347|FG002|COMPLETED|Period 2||12
3088421|NCT01425814|3810348|FG003|COMPLETED|Period 2||10
3088422|NCT01425814|3810349|FG004|COMPLETED|Period 2||12
3088423|NCT01425814|3810350|FG005|COMPLETED|Period 2||13
3088424|NCT01425814|3810345|FG000|NOT COMPLETED|Period 2||0
3088425|NCT01425814|3810346|FG001|NOT COMPLETED|Period 2||1
3088426|NCT01425814|3810347|FG002|NOT COMPLETED|Period 2||0
3088427|NCT01425814|3810348|FG003|NOT COMPLETED|Period 2||0
3088428|NCT01425814|3810349|FG004|NOT COMPLETED|Period 2||0
3088429|NCT01425814|3810350|FG005|NOT COMPLETED|Period 2||0
3088430|NCT01425814|3810345|FG000|STARTED|Period 3||12
3088431|NCT01425814|3810346|FG001|STARTED|Period 3||9
3088432|NCT01425814|3810347|FG002|STARTED|Period 3||12
3088433|NCT01425814|3810348|FG003|STARTED|Period 3||10
3088434|NCT01425814|3810349|FG004|STARTED|Period 3||12
3088435|NCT01425814|3810350|FG005|STARTED|Period 3||13
3088436|NCT01425814|3810345|FG000|COMPLETED|Period 3||12
3088437|NCT01425814|3810346|FG001|COMPLETED|Period 3||9
3088438|NCT01425814|3810347|FG002|COMPLETED|Period 3||12
3088439|NCT01425814|3810348|FG003|COMPLETED|Period 3||10
3088440|NCT01425814|3810349|FG004|COMPLETED|Period 3||12
3088441|NCT01425814|3810350|FG005|COMPLETED|Period 3||12
3088442|NCT01425814|3810345|FG000|NOT COMPLETED|Period 3||0
3088443|NCT01425814|3810346|FG001|NOT COMPLETED|Period 3||0
3088444|NCT01425814|3810347|FG002|NOT COMPLETED|Period 3||0
3088445|NCT01425814|3810348|FG003|NOT COMPLETED|Period 3||0
3088446|NCT01425814|3810349|FG004|NOT COMPLETED|Period 3||0
3088447|NCT01425814|3810350|FG005|NOT COMPLETED|Period 3||1
3088448|NCT01425814|3810345|FG000|STARTED|Period 4||12
3088449|NCT01425814|3810346|FG001|STARTED|Period 4||9
3088450|NCT01425814|3810347|FG002|STARTED|Period 4||12
3088451|NCT01425814|3810348|FG003|STARTED|Period 4||10
3088452|NCT01425814|3810349|FG004|STARTED|Period 4||12
3088453|NCT01425814|3810350|FG005|STARTED|Period 4||12
3088454|NCT01425814|3810345|FG000|COMPLETED|Period 4||11
3088455|NCT01425814|3810346|FG001|COMPLETED|Period 4||9
3088456|NCT01425814|3810347|FG002|COMPLETED|Period 4||11
3088457|NCT01425814|3810348|FG003|COMPLETED|Period 4||10
3088458|NCT01425814|3810349|FG004|COMPLETED|Period 4||12
3088459|NCT01425814|3810350|FG005|COMPLETED|Period 4||12
3088460|NCT01425814|3810345|FG000|NOT COMPLETED|Period 4||1
3088461|NCT01425814|3810346|FG001|NOT COMPLETED|Period 4||0
3088462|NCT01425814|3810347|FG002|NOT COMPLETED|Period 4||1
3088463|NCT01425814|3810348|FG003|NOT COMPLETED|Period 4||0
3088464|NCT01425814|3810349|FG004|NOT COMPLETED|Period 4||0
3088465|NCT01425814|3810350|FG005|NOT COMPLETED|Period 4||0
3088466|NCT01425814|3810345|FG000|STARTED|Period 5||11
3088467|NCT01425814|3810346|FG001|STARTED|Period 5||9
3088468|NCT01425814|3810347|FG002|STARTED|Period 5||11
3088469|NCT01425814|3810348|FG003|STARTED|Period 5||10
3088470|NCT01425814|3810349|FG004|STARTED|Period 5||12
3088471|NCT01425814|3810350|FG005|STARTED|Period 5||12
3088472|NCT01425814|3810345|FG000|COMPLETED|Period 5||11
3088473|NCT01425814|3810346|FG001|COMPLETED|Period 5||9
3088474|NCT01425814|3810347|FG002|COMPLETED|Period 5||10
3088475|NCT01425814|3810348|FG003|COMPLETED|Period 5||10
3088476|NCT01425814|3810349|FG004|COMPLETED|Period 5||12
3088477|NCT01425814|3810350|FG005|COMPLETED|Period 5||11
3088478|NCT01425814|3810345|FG000|NOT COMPLETED|Period 5||0
3088479|NCT01425814|3810346|FG001|NOT COMPLETED|Period 5||0
3088480|NCT01425814|3810347|FG002|NOT COMPLETED|Period 5||1
3088481|NCT01425814|3810348|FG003|NOT COMPLETED|Period 5||0
3088482|NCT01425814|3810349|FG004|NOT COMPLETED|Period 5||0
3088483|NCT01425814|3810350|FG005|NOT COMPLETED|Period 5||1
3287881|NCT02794766|4021470|FG001|STARTED|Overall Study||15
3287882|NCT02794766|4021471|FG002|STARTED|Overall Study||15
3287883|NCT02794766|4021469|FG000|COMPLETED|Overall Study||15
3287884|NCT02794766|4021470|FG001|COMPLETED|Overall Study||15
3287885|NCT02794766|4021471|FG002|COMPLETED|Overall Study||14
3287886|NCT02794766|4021469|FG000|NOT COMPLETED|Overall Study||0
3287887|NCT02794766|4021470|FG001|NOT COMPLETED|Overall Study||0
3287888|NCT02794766|4021471|FG002|NOT COMPLETED|Overall Study||1
3287889|NCT02794844|4021479|FG000|STARTED|Overall Study||28
3088484|NCT01425853|3810366|FG000|STARTED|Overall Study||304
3088485|NCT01425853|3810367|FG001|STARTED|Overall Study||302
3088486|NCT01425853|3810366|FG000|Safety Population|Overall Study||304
3088487|NCT01425853|3810367|FG001|Safety Population|Overall Study||299
3088488|NCT01425853|3810366|FG000|Per Protocol (PP)|Overall Study||264
3088489|NCT01425853|3810367|FG001|Per Protocol (PP)|Overall Study||258
3088490|NCT01425853|3810366|FG000|COMPLETED|Overall Study||240
3088491|NCT01425853|3810367|FG001|COMPLETED|Overall Study||225
3088492|NCT01425853|3810366|FG000|NOT COMPLETED|Overall Study||64
3088493|NCT01425853|3810367|FG001|NOT COMPLETED|Overall Study||77
3088494|NCT01425879|3810374|FG000|STARTED|Overall Study||8
3088495|NCT01425879|3810374|FG000|COMPLETED|Overall Study||8
3088496|NCT01425879|3810374|FG000|NOT COMPLETED|Overall Study||0
3088497|NCT01426009|3810378|FG000|STARTED|Period 1-First Intervention (7 Days)||139
3088498|NCT01426009|3810378|FG000|EP-101 Via Nebulizer|Period 1-First Intervention (7 Days)||23
3088499|NCT01426009|3810378|FG000|EP-101 Via Nebulizer|Period 1-First Intervention (7 Days)||24
3088500|NCT01426009|3810378|FG000|EP-101 Via Nebulizer|Period 1-First Intervention (7 Days)||22
3088501|NCT01426009|3810378|FG000|EP-101 Via Nebulizer|Period 1-First Intervention (7 Days)||23
3088502|NCT01426009|3810378|FG000|Ipratropium Bromide|Period 1-First Intervention (7 Days)||23
3088503|NCT01426009|3810378|FG000|Placebo|Period 1-First Intervention (7 Days)||24
3088504|NCT01426009|3810378|FG000|COMPLETED|Period 1-First Intervention (7 Days)||137
3088505|NCT01426009|3810378|FG000|NOT COMPLETED|Period 1-First Intervention (7 Days)||2
3088506|NCT01426009|3810378|FG000|STARTED|Washout 1||137
3088507|NCT01426009|3810378|FG000|COMPLETED|Washout 1||135
3088508|NCT01426009|3810378|FG000|NOT COMPLETED|Washout 1||2
3088509|NCT01426009|3810378|FG000|STARTED|Period 2-Second Intervention (7 Days)||135
3088510|NCT01426009|3810378|FG000|EP-101 Via Nebulizer|Period 2-Second Intervention (7 Days)||22
3088511|NCT01426009|3810378|FG000|EP-101 Via Nebulizer|Period 2-Second Intervention (7 Days)||24
3088512|NCT01426009|3810378|FG000|EP-101 Via Nebulizer|Period 2-Second Intervention (7 Days)||24
3088513|NCT01426009|3810378|FG000|EP-101 Via Nebulizer|Period 2-Second Intervention (7 Days)||23
3088514|NCT01426009|3810378|FG000|Ipratropium Bromide|Period 2-Second Intervention (7 Days)||21
3088515|NCT01426009|3810378|FG000|Placebo|Period 2-Second Intervention (7 Days)||21
3088516|NCT01426009|3810378|FG000|COMPLETED|Period 2-Second Intervention (7 Days)||130
3088517|NCT01426009|3810378|FG000|NOT COMPLETED|Period 2-Second Intervention (7 Days)||5
3088518|NCT01426009|3810378|FG000|STARTED|Washout 2||130
3088519|NCT01426009|3810378|FG000|COMPLETED|Washout 2||129
3088520|NCT01426009|3810378|FG000|NOT COMPLETED|Washout 2||1
3088521|NCT01426009|3810378|FG000|STARTED|Period 3-Third Intervention (7 Days)||129
3088522|NCT01426009|3810378|FG000|EP-101 Via Nebulizer|Period 3-Third Intervention (7 Days)||19
3088523|NCT01426009|3810378|FG000|EP-101 Via Nebulizer|Period 3-Third Intervention (7 Days)||23
3088524|NCT01426009|3810378|FG000|EP-101 Via Nebulizer|Period 3-Third Intervention (7 Days)||22
3088525|NCT01426009|3810378|FG000|EP-101 Via Nebulizer|Period 3-Third Intervention (7 Days)||20
3088526|NCT01426009|3810378|FG000|Ipratropium Bromide|Period 3-Third Intervention (7 Days)||23
3088527|NCT01426009|3810378|FG000|Placebo|Period 3-Third Intervention (7 Days)||22
3088528|NCT01426009|3810378|FG000|COMPLETED|Period 3-Third Intervention (7 Days)||129
3088529|NCT01426009|3810378|FG000|NOT COMPLETED|Period 3-Third Intervention (7 Days)||0
3088530|NCT01426009|3810378|FG000|STARTED|Washout 3||129
3088531|NCT01426009|3810378|FG000|COMPLETED|Washout 3||128
3088532|NCT01426009|3810378|FG000|NOT COMPLETED|Washout 3||1
3088533|NCT01426009|3810378|FG000|STARTED|Period 4-Fourth Intervention (7 Days)||128
3088534|NCT01426009|3810378|FG000|EP-101 Via Nebulizer|Period 4-Fourth Intervention (7 Days)||10
3088535|NCT01426009|3810378|FG000|EP-101 Via Nebulizer|Period 4-Fourth Intervention (7 Days)||7
3088536|NCT01426009|3810378|FG000|EP-101 Via Nebulizer|Period 4-Fourth Intervention (7 Days)||8
3088537|NCT01426009|3810378|FG000|EP-101 Via Nebulizer|Period 4-Fourth Intervention (7 Days)||9
3088538|NCT01426009|3810378|FG000|Ipratropium Bromide|Period 4-Fourth Intervention (7 Days)||8
3088539|NCT01426009|3810378|FG000|Tiotropium Bromide|Period 4-Fourth Intervention (7 Days)||76
3287890|NCT02794844|4021479|FG000|COMPLETED|Overall Study||23
3287891|NCT02794844|4021479|FG000|NOT COMPLETED|Overall Study||5
3287892|NCT02794870|4021485|FG000|STARTED|Overall Study||22
3287893|NCT02794870|4021486|FG001|STARTED|Overall Study||11
3287894|NCT02794870|4021485|FG000|Received Inoculation|Overall Study||21
3287895|NCT02794870|4021486|FG001|Received Inoculation|Overall Study||11
3287896|NCT02794870|4021485|FG000|COMPLETED|Overall Study||20
3287897|NCT02794870|4021486|FG001|COMPLETED|Overall Study||11
3287898|NCT02794870|4021485|FG000|NOT COMPLETED|Overall Study||2
3287899|NCT02794870|4021486|FG001|NOT COMPLETED|Overall Study||0
3287900|NCT02794974|4021494|FG000|STARTED|Overall Study||14
3287901|NCT02794974|4021495|FG001|STARTED|Overall Study||15
3287902|NCT02794974|4021494|FG000|COMPLETED|Overall Study||14
3287903|NCT02794974|4021495|FG001|COMPLETED|Overall Study||14
3287904|NCT02794974|4021494|FG000|NOT COMPLETED|Overall Study||0
3287905|NCT02794974|4021495|FG001|NOT COMPLETED|Overall Study||1
3287906|NCT02795117|4021504|FG000|STARTED|Overall Study||193
3088540|NCT01426009|3810378|FG000|Placebo|Period 4-Fourth Intervention (7 Days)||10
3088541|NCT01426009|3810378|FG000|COMPLETED|Period 4-Fourth Intervention (7 Days)||127
3088542|NCT01426009|3810378|FG000|NOT COMPLETED|Period 4-Fourth Intervention (7 Days)||1
3088543|NCT01426009|3810378|FG000|STARTED|Washout 4||127
3088544|NCT01426009|3810378|FG000|COMPLETED|Washout 4||126
3088545|NCT01426009|3810378|FG000|NOT COMPLETED|Washout 4||1
3088546|NCT01426191|3810394|FG000|STARTED|Overall Study||2032
3088547|NCT01426191|3810394|FG000|COMPLETED|Overall Study||2032
3088548|NCT01426191|3810394|FG000|NOT COMPLETED|Overall Study||0
3088549|NCT01426217|3810400|FG000|STARTED|Overall Study||314
3088550|NCT01426217|3810401|FG001|STARTED|Overall Study||280
3088551|NCT01426217|3810400|FG000|COMPLETED|Overall Study||306
3088552|NCT01426217|3810401|FG001|COMPLETED|Overall Study||266
3088553|NCT01426217|3810400|FG000|NOT COMPLETED|Overall Study||8
3088554|NCT01426217|3810401|FG001|NOT COMPLETED|Overall Study||14
3088555|NCT01426230|3810409|FG000|STARTED|Overall Study|90 patients were enrolled, but only 86 received study treatment.|86
3088556|NCT01426230|3810410|FG001|STARTED|Overall Study||111
3088557|NCT01426230|3810409|FG000|COMPLETED|Overall Study||55
3088558|NCT01426230|3810410|FG001|COMPLETED|Overall Study||84
3287907|NCT02795117|4021505|FG001|STARTED|Overall Study||193
3287908|NCT02795117|4021506|FG002|STARTED|Overall Study||100
3287909|NCT02795117|4021504|FG000|COMPLETED|Overall Study||175
3287910|NCT02795117|4021505|FG001|COMPLETED|Overall Study||166
3287911|NCT02795117|4021506|FG002|COMPLETED|Overall Study||88
3287912|NCT02795117|4021504|FG000|NOT COMPLETED|Overall Study||18
3287913|NCT02795117|4021505|FG001|NOT COMPLETED|Overall Study||27
3287914|NCT02795117|4021506|FG002|NOT COMPLETED|Overall Study||12
3287915|NCT02795767|4021517|FG000|STARTED|Overall Study||68
3287916|NCT02795767|4021518|FG001|STARTED|Overall Study||10
3287917|NCT02795767|4021519|FG002|STARTED|Overall Study||10
3287918|NCT02795767|4021517|FG000|Received at Least One Dose of Emicizumab|Overall Study||68
3287919|NCT02795767|4021518|FG001|Received at Least One Dose of Emicizumab|Overall Study||10
3287920|NCT02795767|4021519|FG002|Received at Least One Dose of Emicizumab|Overall Study||10
3287921|NCT02795767|4021517|FG000|Dose Up-Titrated to 3 mg/kg QW|Overall Study||0
3287922|NCT02795767|4021518|FG001|Dose Up-Titrated to 3 mg/kg QW|Overall Study||0
3287923|NCT02795767|4021519|FG002|Dose Up-Titrated to 3 mg/kg QW|Overall Study||3
3287924|NCT02795767|4021517|FG000|Completed 52 Weeks in Study|Overall Study||67
3287925|NCT02795767|4021518|FG001|Completed 52 Weeks in Study|Overall Study||10
3287926|NCT02795767|4021519|FG002|Completed 52 Weeks in Study|Overall Study||9
3287927|NCT02795767|4021517|FG000|COMPLETED|Overall Study||67
3287928|NCT02795767|4021518|FG001|COMPLETED|Overall Study||10
3287929|NCT02795767|4021519|FG002|COMPLETED|Overall Study||10
3287930|NCT02795767|4021517|FG000|NOT COMPLETED|Overall Study||1
3287931|NCT02795767|4021518|FG001|NOT COMPLETED|Overall Study||0
3287932|NCT02795767|4021519|FG002|NOT COMPLETED|Overall Study||0
3287933|NCT02795780|4021533|FG000|STARTED|Overall Study||25
3287934|NCT02795780|4021534|FG001|STARTED|Overall Study||54
3287935|NCT02795780|4021533|FG000|COMPLETED|Overall Study||25
3287936|NCT02795780|4021534|FG001|COMPLETED|Overall Study||54
3287937|NCT02795780|4021533|FG000|NOT COMPLETED|Overall Study||0
3287938|NCT02795780|4021534|FG001|NOT COMPLETED|Overall Study||0
3287939|NCT02795819|4021542|FG000|STARTED|Overall Study||0
3287940|NCT02795819|4021543|FG001|STARTED|Overall Study||6
3287941|NCT02795819|4021544|FG002|STARTED|Overall Study||0
3287942|NCT02795819|4021545|FG003|STARTED|Overall Study||0
3287943|NCT02795819|4021546|FG004|STARTED|Overall Study||0
3287944|NCT02795819|4021547|FG005|STARTED|Overall Study||0
3287945|NCT02795819|4021548|FG006|STARTED|Overall Study||0
3287946|NCT02795819|4021542|FG000|COMPLETED|Overall Study||0
3287947|NCT02795819|4021543|FG001|COMPLETED|Overall Study||6
3287948|NCT02795819|4021544|FG002|COMPLETED|Overall Study||0
3287949|NCT02795819|4021545|FG003|COMPLETED|Overall Study||0
3287950|NCT02795819|4021546|FG004|COMPLETED|Overall Study||0
3287951|NCT02795819|4021547|FG005|COMPLETED|Overall Study||0
3287952|NCT02795819|4021548|FG006|COMPLETED|Overall Study||0
3287953|NCT02795819|4021542|FG000|NOT COMPLETED|Overall Study||0
3287954|NCT02795819|4021543|FG001|NOT COMPLETED|Overall Study||0
3287955|NCT02795819|4021544|FG002|NOT COMPLETED|Overall Study||0
3287956|NCT02795819|4021545|FG003|NOT COMPLETED|Overall Study||0
3287957|NCT02795819|4021546|FG004|NOT COMPLETED|Overall Study||0
3287958|NCT02795819|4021547|FG005|NOT COMPLETED|Overall Study||0
3287959|NCT02795819|4021548|FG006|NOT COMPLETED|Overall Study||0
3287960|NCT02795832|4021564|FG000|STARTED|Overall Study||8
3287961|NCT02795832|4021565|FG001|STARTED|Overall Study||4
3287962|NCT02795832|4021566|FG002|STARTED|Overall Study||8
3287963|NCT02795832|4021567|FG003|STARTED|Overall Study||3
3287964|NCT02795832|4021568|FG004|STARTED|Overall Study||20
3287965|NCT02795832|4021569|FG005|STARTED|Overall Study||10
3287966|NCT02795832|4021564|FG000|COMPLETED|Overall Study||8
3287967|NCT02795832|4021565|FG001|COMPLETED|Overall Study||4
3287968|NCT02795832|4021566|FG002|COMPLETED|Overall Study||8
3287969|NCT02795832|4021567|FG003|COMPLETED|Overall Study||3
3287970|NCT02795832|4021568|FG004|COMPLETED|Overall Study||20
3287971|NCT02795832|4021569|FG005|COMPLETED|Overall Study||7
3287972|NCT02795832|4021564|FG000|NOT COMPLETED|Overall Study||0
3088559|NCT01426230|3810409|FG000|NOT COMPLETED|Overall Study||31
3287973|NCT02795832|4021565|FG001|NOT COMPLETED|Overall Study||0
3287974|NCT02795832|4021566|FG002|NOT COMPLETED|Overall Study||0
3287975|NCT02795832|4021567|FG003|NOT COMPLETED|Overall Study||0
3287976|NCT02795832|4021568|FG004|NOT COMPLETED|Overall Study||0
3088560|NCT01426230|3810410|FG001|NOT COMPLETED|Overall Study||27
3088561|NCT01426269|3810415|FG000|STARTED|Period 1: 12 Weeks||235
3088562|NCT01426269|3810416|FG001|STARTED|Period 1: 12 Weeks||0
3088563|NCT01426269|3810417|FG002|STARTED|Period 1: 12 Weeks||0
3088564|NCT01426269|3810415|FG000|COMPLETED|Period 1: 12 Weeks||180
3088565|NCT01426269|3810416|FG001|COMPLETED|Period 1: 12 Weeks||0
3088566|NCT01426269|3810417|FG002|COMPLETED|Period 1: 12 Weeks||0
3088567|NCT01426269|3810415|FG000|NOT COMPLETED|Period 1: 12 Weeks||55
3088568|NCT01426269|3810416|FG001|NOT COMPLETED|Period 1: 12 Weeks||0
3088569|NCT01426269|3810417|FG002|NOT COMPLETED|Period 1: 12 Weeks||0
3088570|NCT01426269|3810415|FG000|STARTED|Eligibility for Period 2, Randomization||180
3088571|NCT01426269|3810416|FG001|STARTED|Eligibility for Period 2, Randomization||0
3088572|NCT01426269|3810417|FG002|STARTED|Eligibility for Period 2, Randomization||0
3088573|NCT01426269|3810415|FG000|COMPLETED|Eligibility for Period 2, Randomization||130
3088574|NCT01426269|3810416|FG001|COMPLETED|Eligibility for Period 2, Randomization||0
3088575|NCT01426269|3810417|FG002|COMPLETED|Eligibility for Period 2, Randomization||0
3088576|NCT01426269|3810415|FG000|NOT COMPLETED|Eligibility for Period 2, Randomization||50
3088577|NCT01426269|3810416|FG001|NOT COMPLETED|Eligibility for Period 2, Randomization||0
3088578|NCT01426269|3810417|FG002|NOT COMPLETED|Eligibility for Period 2, Randomization||0
3088579|NCT01426269|3810415|FG000|STARTED|Period 2: 40 Weeks||0
3088580|NCT01426269|3810416|FG001|STARTED|Period 2: 40 Weeks||65
3088581|NCT01426269|3810417|FG002|STARTED|Period 2: 40 Weeks||65
3088582|NCT01426269|3810415|FG000|COMPLETED|Period 2: 40 Weeks||0
3088583|NCT01426269|3810416|FG001|COMPLETED|Period 2: 40 Weeks||27
3088584|NCT01426269|3810417|FG002|COMPLETED|Period 2: 40 Weeks||18
3088585|NCT01426269|3810415|FG000|NOT COMPLETED|Period 2: 40 Weeks||0
3088586|NCT01426269|3810416|FG001|NOT COMPLETED|Period 2: 40 Weeks||38
3088587|NCT01426269|3810417|FG002|NOT COMPLETED|Period 2: 40 Weeks||47
3088588|NCT01426347|3810430|FG000|STARTED|Overall Study||41
3088589|NCT01426347|3810431|FG001|STARTED|Overall Study||42
3088590|NCT01426347|3810430|FG000|COMPLETED|Overall Study||34
3088591|NCT01426347|3810431|FG001|COMPLETED|Overall Study||39
3088592|NCT01426347|3810430|FG000|NOT COMPLETED|Overall Study||7
3088593|NCT01426347|3810431|FG001|NOT COMPLETED|Overall Study||3
3088594|NCT01426360|3810439|FG000|STARTED|Overall Study||38
3088595|NCT01426360|3810440|FG001|STARTED|Overall Study||41
3088596|NCT01426360|3810439|FG000|COMPLETED|Overall Study||38
3088597|NCT01426360|3810440|FG001|COMPLETED|Overall Study||41
3088598|NCT01426360|3810439|FG000|NOT COMPLETED|Overall Study||0
3088599|NCT01426360|3810440|FG001|NOT COMPLETED|Overall Study||0
3088600|NCT01426373|3810446|FG000|STARTED|Overall Study||165
3088601|NCT01426373|3810446|FG000|COMPLETED|Overall Study|Completed the last follow-up visit 12 months after last treatment|131
3088602|NCT01426373|3810446|FG000|NOT COMPLETED|Overall Study||34
3088603|NCT01426386|3810458|FG000|STARTED|Overall Study||42
3088604|NCT01426386|3810459|FG001|STARTED|Overall Study||45
3088605|NCT01426386|3810460|FG002|STARTED|Overall Study||44
3088606|NCT01426386|3810461|FG003|STARTED|Overall Study||44
3088607|NCT01426386|3810462|FG004|STARTED|Overall Study||47
3088608|NCT01426386|3810463|FG005|STARTED|Overall Study||43
3088609|NCT01426386|3810458|FG000|COMPLETED|Overall Study||39
3088610|NCT01426386|3810459|FG001|COMPLETED|Overall Study||39
3088611|NCT01426386|3810460|FG002|COMPLETED|Overall Study||42
3088612|NCT01426386|3810461|FG003|COMPLETED|Overall Study||44
3088613|NCT01426386|3810462|FG004|COMPLETED|Overall Study||43
3088614|NCT01426386|3810463|FG005|COMPLETED|Overall Study||42
3088615|NCT01426386|3810458|FG000|NOT COMPLETED|Overall Study||3
3088616|NCT01426386|3810459|FG001|NOT COMPLETED|Overall Study||6
3088617|NCT01426386|3810460|FG002|NOT COMPLETED|Overall Study||2
3088618|NCT01426386|3810461|FG003|NOT COMPLETED|Overall Study||0
3088619|NCT01426386|3810462|FG004|NOT COMPLETED|Overall Study||4
3088620|NCT01426386|3810463|FG005|NOT COMPLETED|Overall Study||1
3088621|NCT01426412|3810486|FG000|STARTED|Overall Study||6
3088622|NCT01426412|3810487|FG001|STARTED|Overall Study||6
3088623|NCT01426412|3810488|FG002|STARTED|Overall Study||6
3088624|NCT01426412|3810489|FG003|STARTED|Overall Study||6
3088625|NCT01426412|3810490|FG004|STARTED|Overall Study||6
3088626|NCT01426412|3810491|FG005|STARTED|Overall Study||6
3088627|NCT01426412|3810492|FG006|STARTED|Overall Study||6
3088628|NCT01426412|3810493|FG007|STARTED|Overall Study||10
3088629|NCT01426412|3810494|FG008|STARTED|Overall Study||17
3088630|NCT01426412|3810486|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6
3088631|NCT01426412|3810487|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6
3088632|NCT01426412|3810488|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
3088633|NCT01426412|3810489|FG003|Received at Least 1 Dose of Study Drug|Overall Study||6
3287977|NCT02795832|4021569|FG005|NOT COMPLETED|Overall Study||3
3287978|NCT02796092|4021593|FG000|STARTED|Overall Study||50
3287979|NCT02796092|4021594|FG001|STARTED|Overall Study||50
3287980|NCT02796092|4021593|FG000|COMPLETED|Overall Study||50
3287981|NCT02796092|4021594|FG001|COMPLETED|Overall Study||50
3287982|NCT02796092|4021593|FG000|NOT COMPLETED|Overall Study||0
3287983|NCT02796092|4021594|FG001|NOT COMPLETED|Overall Study||0
3088634|NCT01426412|3810490|FG004|Received at Least 1 Dose of Study Drug|Overall Study||6
3088635|NCT01426412|3810491|FG005|Received at Least 1 Dose of Study Drug|Overall Study||6
3088636|NCT01426412|3810492|FG006|Received at Least 1 Dose of Study Drug|Overall Study||6
3088637|NCT01426412|3810493|FG007|Received at Least 1 Dose of Study Drug|Overall Study||10
3088638|NCT01426412|3810494|FG008|Received at Least 1 Dose of Study Drug|Overall Study||17
3088639|NCT01426412|3810486|FG000|COMPLETED|Overall Study||5
3088640|NCT01426412|3810487|FG001|COMPLETED|Overall Study||6
3088641|NCT01426412|3810488|FG002|COMPLETED|Overall Study||6
3088642|NCT01426412|3810489|FG003|COMPLETED|Overall Study||6
3088643|NCT01426412|3810490|FG004|COMPLETED|Overall Study||5
3088644|NCT01426412|3810491|FG005|COMPLETED|Overall Study||6
3088645|NCT01426412|3810492|FG006|COMPLETED|Overall Study||6
3088646|NCT01426412|3810493|FG007|COMPLETED|Overall Study||7
3088647|NCT01426412|3810494|FG008|COMPLETED|Overall Study||16
3088648|NCT01426412|3810486|FG000|NOT COMPLETED|Overall Study||1
3088649|NCT01426412|3810487|FG001|NOT COMPLETED|Overall Study||0
3088650|NCT01426412|3810488|FG002|NOT COMPLETED|Overall Study||0
3088651|NCT01426412|3810489|FG003|NOT COMPLETED|Overall Study||0
3088652|NCT01426412|3810490|FG004|NOT COMPLETED|Overall Study||1
3088653|NCT01426412|3810491|FG005|NOT COMPLETED|Overall Study||0
3088654|NCT01426412|3810492|FG006|NOT COMPLETED|Overall Study||0
3088655|NCT01426412|3810493|FG007|NOT COMPLETED|Overall Study||3
3088656|NCT01426412|3810494|FG008|NOT COMPLETED|Overall Study||1
3088657|NCT01426425|3810525|FG000|STARTED|Overall Study||572
3088658|NCT01426425|3810525|FG000|EP Study|Overall Study|EP study used to assess inclusion and exclusion criteria.|550
3088659|NCT01426425|3810525|FG000|Intent to Treat|Overall Study|Met all inclusion and no exclusion criteria.|399
3088660|NCT01426425|3810525|FG000|COMPLETED|Overall Study|The pre-specified modified intent-to-treat analysis set was used for the primary objectives.|397
3088661|NCT01426425|3810525|FG000|NOT COMPLETED|Overall Study||175
3088662|NCT01426438|3810532|FG000|STARTED|Overall Study||50
3088663|NCT01426438|3810533|FG001|STARTED|Overall Study||49
3088664|NCT01426438|3810532|FG000|COMPLETED|Overall Study||35
3088665|NCT01426438|3810533|FG001|COMPLETED|Overall Study||39
3088666|NCT01426438|3810532|FG000|NOT COMPLETED|Overall Study||15
3088667|NCT01426438|3810533|FG001|NOT COMPLETED|Overall Study||10
3088668|NCT01426581|3810541|FG000|STARTED|Overall Study||62
3088669|NCT01426581|3810542|FG001|STARTED|Overall Study||58
3088670|NCT01426581|3810541|FG000|COMPLETED|Overall Study||62
3088671|NCT01426581|3810542|FG001|COMPLETED|Overall Study||58
3088672|NCT01426581|3810541|FG000|NOT COMPLETED|Overall Study||0
3088673|NCT01426581|3810542|FG001|NOT COMPLETED|Overall Study||0
3088674|NCT01426763|3810552|FG000|STARTED|Overall Study||6
3088675|NCT01426763|3810553|FG001|STARTED|Overall Study||6
3088676|NCT01426763|3810552|FG000|COMPLETED|Overall Study||6
3088677|NCT01426763|3810553|FG001|COMPLETED|Overall Study||6
3088678|NCT01426763|3810552|FG000|NOT COMPLETED|Overall Study||0
3088679|NCT01426763|3810553|FG001|NOT COMPLETED|Overall Study||0
3088680|NCT01426789|3810563|FG000|STARTED|Part 1||68
3088681|NCT01426789|3810564|FG001|STARTED|Part 1||32
3088682|NCT01426789|3810565|FG002|STARTED|Part 1||0
3088683|NCT01426789|3810566|FG003|STARTED|Part 1||0
3088684|NCT01426789|3810567|FG004|STARTED|Part 1||0
3088685|NCT01426789|3810568|FG005|STARTED|Part 1||0
3088686|NCT01426789|3810563|FG000|COMPLETED|Part 1||62
3088687|NCT01426789|3810564|FG001|COMPLETED|Part 1||28
3088688|NCT01426789|3810565|FG002|COMPLETED|Part 1||0
3088689|NCT01426789|3810566|FG003|COMPLETED|Part 1||0
3088690|NCT01426789|3810567|FG004|COMPLETED|Part 1||0
3088691|NCT01426789|3810568|FG005|COMPLETED|Part 1||0
3088692|NCT01426789|3810563|FG000|NOT COMPLETED|Part 1||6
3088693|NCT01426789|3810564|FG001|NOT COMPLETED|Part 1||4
3088694|NCT01426789|3810565|FG002|NOT COMPLETED|Part 1||0
3088695|NCT01426789|3810566|FG003|NOT COMPLETED|Part 1||0
3287984|NCT02796144|4021603|FG000|STARTED|Overall Study||23
3287985|NCT02796144|4021604|FG001|STARTED|Overall Study||24
3287986|NCT02796144|4021605|FG002|STARTED|Overall Study||24
3287987|NCT02796144|4021603|FG000|COMPLETED|Overall Study||18
3287988|NCT02796144|4021604|FG001|COMPLETED|Overall Study||21
3287989|NCT02796144|4021605|FG002|COMPLETED|Overall Study||18
3287990|NCT02796144|4021603|FG000|NOT COMPLETED|Overall Study||5
3287991|NCT02796144|4021604|FG001|NOT COMPLETED|Overall Study||3
3287992|NCT02796144|4021605|FG002|NOT COMPLETED|Overall Study||6
3287993|NCT02796274|4021615|FG000|STARTED|Overall Study||219
3287994|NCT02796274|4021615|FG000|COMPLETED|Overall Study||219
3287995|NCT02796274|4021615|FG000|NOT COMPLETED|Overall Study||0
3287996|NCT02796300|4021621|FG000|STARTED|Overall Study||10
3287997|NCT02796300|4021622|FG001|STARTED|Overall Study||22
3287998|NCT02796300|4021621|FG000|COMPLETED|Overall Study||10
3287999|NCT02796300|4021622|FG001|COMPLETED|Overall Study||22
3288000|NCT02796300|4021621|FG000|NOT COMPLETED|Overall Study||0
3288001|NCT02796300|4021622|FG001|NOT COMPLETED|Overall Study||0
3288002|NCT02796352|4021628|FG000|STARTED|Overall Study||1
3288003|NCT02796352|4021628|FG000|COMPLETED|Overall Study||1
3288004|NCT02796352|4021628|FG000|NOT COMPLETED|Overall Study||0
3288005|NCT02796560|4021634|FG000|STARTED|Overall Study||38
3288006|NCT02796560|4021635|FG001|STARTED|Overall Study||38
3288007|NCT02796560|4021634|FG000|COMPLETED|Overall Study||34
3288008|NCT02796560|4021635|FG001|COMPLETED|Overall Study||36
3288009|NCT02796560|4021634|FG000|NOT COMPLETED|Overall Study||4
3288010|NCT02796560|4021635|FG001|NOT COMPLETED|Overall Study||2
3288011|NCT02796625|4021641|FG000|STARTED|Overall Study||80
3288012|NCT02796625|4021641|FG000|COMPLETED|Overall Study||61
3088696|NCT01426789|3810567|FG004|NOT COMPLETED|Part 1||0
3088697|NCT01426789|3810568|FG005|NOT COMPLETED|Part 1||0
3288013|NCT02796625|4021641|FG000|NOT COMPLETED|Overall Study||19
3288014|NCT02796651|4021645|FG000|STARTED|Overall Study||132
3288015|NCT02796651|4021645|FG000|Formoterol Fumarate (FF) 6 μg|Overall Study||107
3288016|NCT02796651|4021645|FG000|Formoterol Fumarate (FF) 12 μg|Overall Study||121
3088698|NCT01426789|3810563|FG000|STARTED|Part 2||0
3088699|NCT01426789|3810564|FG001|STARTED|Part 2||0
3088700|NCT01426789|3810565|FG002|STARTED|Part 2||49
3088701|NCT01426789|3810566|FG003|STARTED|Part 2||13
3088702|NCT01426789|3810567|FG004|STARTED|Part 2||27
3088703|NCT01426789|3810568|FG005|STARTED|Part 2||1
3088704|NCT01426789|3810563|FG000|COMPLETED|Part 2||0
3088705|NCT01426789|3810564|FG001|COMPLETED|Part 2||0
3088706|NCT01426789|3810565|FG002|COMPLETED|Part 2||34
3088707|NCT01426789|3810566|FG003|COMPLETED|Part 2||12
3088708|NCT01426789|3810567|FG004|COMPLETED|Part 2||19
3088709|NCT01426789|3810568|FG005|COMPLETED|Part 2||1
3088710|NCT01426789|3810563|FG000|NOT COMPLETED|Part 2||0
3088711|NCT01426789|3810564|FG001|NOT COMPLETED|Part 2||0
3088712|NCT01426789|3810565|FG002|NOT COMPLETED|Part 2||15
3088713|NCT01426789|3810566|FG003|NOT COMPLETED|Part 2||1
3088714|NCT01426789|3810567|FG004|NOT COMPLETED|Part 2||8
3088715|NCT01426789|3810568|FG005|NOT COMPLETED|Part 2||0
3088716|NCT01426828|3810578|FG000|STARTED|Overall Study Evaluations||22
3088717|NCT01426828|3810579|FG001|STARTED|Overall Study Evaluations||18
3088718|NCT01426828|3810578|FG000|COMPLETED|Overall Study Evaluations||17
3088719|NCT01426828|3810579|FG001|COMPLETED|Overall Study Evaluations||15
3088720|NCT01426828|3810578|FG000|NOT COMPLETED|Overall Study Evaluations||5
3088721|NCT01426828|3810579|FG001|NOT COMPLETED|Overall Study Evaluations||3
3088722|NCT01426828|3810578|FG000|STARTED|Immune Response Analysis||17
3088723|NCT01426828|3810579|FG001|STARTED|Immune Response Analysis||15
3088724|NCT01426828|3810578|FG000|COMPLETED|Immune Response Analysis||8
3088725|NCT01426828|3810579|FG001|COMPLETED|Immune Response Analysis||8
3088726|NCT01426828|3810578|FG000|NOT COMPLETED|Immune Response Analysis||9
3088727|NCT01426828|3810579|FG001|NOT COMPLETED|Immune Response Analysis||7
3088728|NCT01426854|3810587|FG000|STARTED|Overall Study||131
3088729|NCT01426854|3810588|FG001|STARTED|Overall Study||129
3088730|NCT01426854|3810587|FG000|COMPLETED|Overall Study||119
3088731|NCT01426854|3810588|FG001|COMPLETED|Overall Study||98
3088732|NCT01426854|3810587|FG000|NOT COMPLETED|Overall Study||12
3088733|NCT01426854|3810588|FG001|NOT COMPLETED|Overall Study||31
3088734|NCT01426867|3810597|FG000|STARTED|Overall Study||33
3088735|NCT01426867|3810598|FG001|STARTED|Overall Study||34
3088736|NCT01426867|3810599|FG002|STARTED|Overall Study||34
3088737|NCT01426867|3810597|FG000|COMPLETED|Overall Study||33
3088738|NCT01426867|3810598|FG001|COMPLETED|Overall Study||34
3088739|NCT01426867|3810599|FG002|COMPLETED|Overall Study||34
3088740|NCT01426867|3810597|FG000|NOT COMPLETED|Overall Study||0
3088741|NCT01426867|3810598|FG001|NOT COMPLETED|Overall Study||0
3088742|NCT01426867|3810599|FG002|NOT COMPLETED|Overall Study||0
3088743|NCT01426958|3810607|FG000|STARTED|Overall Study||24
3088744|NCT01426958|3810607|FG000|COMPLETED|Overall Study||22
3088745|NCT01426958|3810607|FG000|NOT COMPLETED|Overall Study||2
3088746|NCT01427296|3810617|FG000|STARTED|Overall Study||1041
3088747|NCT01427296|3810618|FG001|STARTED|Overall Study||1051
3088748|NCT01427296|3810617|FG000|COMPLETED|Overall Study||1041
3088749|NCT01427296|3810618|FG001|COMPLETED|Overall Study||1051
3088750|NCT01427296|3810617|FG000|NOT COMPLETED|Overall Study||0
3088751|NCT01427296|3810618|FG001|NOT COMPLETED|Overall Study||0
3088752|NCT01427309|3810628|FG000|STARTED|Overall Study||7253
3088753|NCT01427309|3810629|FG001|STARTED|Overall Study||7244
3088754|NCT01427309|3810630|FG002|STARTED|Overall Study||8737
3088755|NCT01427309|3810631|FG003|STARTED|Overall Study||8749
3088756|NCT01427309|3810628|FG000|COMPLETED|Overall Study||6881
3088757|NCT01427309|3810629|FG001|COMPLETED|Overall Study||6837
3088758|NCT01427309|3810630|FG002|COMPLETED|Overall Study||8376
3088759|NCT01427309|3810631|FG003|COMPLETED|Overall Study||8373
3088760|NCT01427309|3810628|FG000|NOT COMPLETED|Overall Study||372
3088761|NCT01427309|3810629|FG001|NOT COMPLETED|Overall Study||407
3088762|NCT01427309|3810630|FG002|NOT COMPLETED|Overall Study||361
3088763|NCT01427309|3810631|FG003|NOT COMPLETED|Overall Study||376
3088764|NCT01427504|3810647|FG000|STARTED|Overall Study||4
3088765|NCT01427504|3810648|FG001|STARTED|Overall Study||3
3088766|NCT01427504|3810649|FG002|STARTED|Overall Study||4
3088767|NCT01427504|3810650|FG003|STARTED|Overall Study||6
3088768|NCT01427504|3810651|FG004|STARTED|Overall Study||3
3088769|NCT01427504|3810652|FG005|STARTED|Overall Study||6
3088770|NCT01427504|3810647|FG000|Received Boceprevir|Overall Study||4
3088771|NCT01427504|3810648|FG001|Received Boceprevir|Overall Study||3
3088772|NCT01427504|3810649|FG002|Received Boceprevir|Overall Study||3
3088773|NCT01427504|3810650|FG003|Received Boceprevir|Overall Study||5
3088774|NCT01427504|3810651|FG004|Received Boceprevir|Overall Study||2
3088775|NCT01427504|3810652|FG005|Received Boceprevir|Overall Study||4
3088776|NCT01427504|3810647|FG000|Received Etravirine|Overall Study||4
3088777|NCT01427504|3810648|FG001|Received Etravirine|Overall Study||2
3088778|NCT01427504|3810649|FG002|Received Etravirine|Overall Study||4
3088779|NCT01427504|3810650|FG003|Received Etravirine|Overall Study||6
3088780|NCT01427504|3810651|FG004|Received Etravirine|Overall Study||2
3088781|NCT01427504|3810652|FG005|Received Etravirine|Overall Study||4
3088782|NCT01427504|3810647|FG000|Received Combination|Overall Study||4
3088783|NCT01427504|3810648|FG001|Received Combination|Overall Study||3
3088784|NCT01427504|3810649|FG002|Received Combination|Overall Study||3
3088785|NCT01427504|3810650|FG003|Received Combination|Overall Study||6
3088786|NCT01427504|3810651|FG004|Received Combination|Overall Study||3
3088787|NCT01427504|3810652|FG005|Received Combination|Overall Study||6
3088788|NCT01427504|3810647|FG000|COMPLETED|Overall Study||4
3088789|NCT01427504|3810648|FG001|COMPLETED|Overall Study||2
3088790|NCT01427504|3810649|FG002|COMPLETED|Overall Study||3
3088791|NCT01427504|3810650|FG003|COMPLETED|Overall Study||5
3088792|NCT01427504|3810651|FG004|COMPLETED|Overall Study||2
3088793|NCT01427504|3810652|FG005|COMPLETED|Overall Study||4
3088794|NCT01427504|3810647|FG000|NOT COMPLETED|Overall Study||0
3088795|NCT01427504|3810648|FG001|NOT COMPLETED|Overall Study||1
3088796|NCT01427504|3810649|FG002|NOT COMPLETED|Overall Study||1
3088797|NCT01427504|3810650|FG003|NOT COMPLETED|Overall Study||1
3088798|NCT01427504|3810651|FG004|NOT COMPLETED|Overall Study||1
3088799|NCT01427504|3810652|FG005|NOT COMPLETED|Overall Study||2
3088800|NCT01427517|3810672|FG000|STARTED|Overall Study||3
3088801|NCT01427517|3810673|FG001|STARTED|Overall Study||3
3088802|NCT01427517|3810674|FG002|STARTED|Overall Study||3
3088803|NCT01427517|3810672|FG000|COMPLETED|Overall Study||3
3088804|NCT01427517|3810673|FG001|COMPLETED|Overall Study||3
3088805|NCT01427517|3810674|FG002|COMPLETED|Overall Study||3
3088806|NCT01427517|3810672|FG000|NOT COMPLETED|Overall Study||0
3088807|NCT01427517|3810673|FG001|NOT COMPLETED|Overall Study||0
3088808|NCT01427517|3810674|FG002|NOT COMPLETED|Overall Study||0
3088809|NCT01427595|3810682|FG000|STARTED|Overall Study||25
3088810|NCT01427595|3810682|FG000|COMPLETED|Overall Study||12
3088811|NCT01427595|3810682|FG000|NOT COMPLETED|Overall Study||13
2940878|NCT00639678|3653132|FG002|STARTED|Overall Study||217
2940879|NCT00639678|3653133|FG003|STARTED|Overall Study||23
2940880|NCT00639678|3653130|FG000|COMPLETED|Overall Study||70
2940881|NCT00639678|3653131|FG001|COMPLETED|Overall Study||5
2940882|NCT00639678|3653132|FG002|COMPLETED|Overall Study||206
2940883|NCT00639678|3653133|FG003|COMPLETED|Overall Study||23
2940884|NCT00639678|3653130|FG000|NOT COMPLETED|Overall Study||4
3088812|NCT01427608|3810688|FG000|STARTED|Overall Study||64
3088813|NCT01427608|3810689|FG001|STARTED|Overall Study||62
3088814|NCT01427608|3810688|FG000|COMPLETED|Overall Study||43
3088815|NCT01427608|3810689|FG001|COMPLETED|Overall Study||24
3088816|NCT01427608|3810688|FG000|NOT COMPLETED|Overall Study||21
3088817|NCT01427608|3810689|FG001|NOT COMPLETED|Overall Study||38
3088818|NCT01427738|3810699|FG000|STARTED|Overall Study||110
3088819|NCT01427738|3810700|FG001|STARTED|Overall Study||111
3088820|NCT01427738|3810699|FG000|COMPLETED|Overall Study||91
3088821|NCT01427738|3810700|FG001|COMPLETED|Overall Study||90
3088822|NCT01427738|3810699|FG000|NOT COMPLETED|Overall Study||19
3088823|NCT01427738|3810700|FG001|NOT COMPLETED|Overall Study||21
3088824|NCT01427751|3810708|FG000|STARTED|Overall Study||154
3088825|NCT01427751|3810709|FG001|STARTED|Overall Study||153
3088826|NCT01427751|3810708|FG000|COMPLETED|Overall Study||112
3088827|NCT01427751|3810709|FG001|COMPLETED|Overall Study||139
3088828|NCT01427751|3810708|FG000|NOT COMPLETED|Overall Study||42
3088829|NCT01427751|3810709|FG001|NOT COMPLETED|Overall Study||14
3088830|NCT01427803|3810717|FG000|STARTED|Overall Study||526
3088831|NCT01427803|3810718|FG001|STARTED|Overall Study||252
3088832|NCT01427803|3810717|FG000|Purchased Product|Overall Study|Only 516 participants used e-diary|525
3088833|NCT01427803|3810718|FG001|Purchased Product|Overall Study||252
3088834|NCT01427803|3810717|FG000|Baseline Assessment|Overall Study||516
3088835|NCT01427803|3810718|FG001|Baseline Assessment|Overall Study|only interviewed participants were assessed|130
3088836|NCT01427803|3810717|FG000|Took Product|Overall Study|Those who took at least one dose of investigational product. Only 502 qualified for data analysis.|508
3088837|NCT01427803|3810718|FG001|Took Product|Overall Study|Those who took at least one dose of investigational product as logged in e diary & 1 on Health Log.|237
3088838|NCT01427803|3810717|FG000|COMPLETED|Overall Study||463
3088839|NCT01427803|3810718|FG001|COMPLETED|Overall Study|130 participants interviewed. Remaining subjects continued in trial to collect safety information.|226
3088840|NCT01427803|3810717|FG000|NOT COMPLETED|Overall Study||63
3088841|NCT01427803|3810718|FG001|NOT COMPLETED|Overall Study||26
3088842|NCT01427881|3810722|FG000|STARTED|Overall Study||43
3088843|NCT01427881|3810722|FG000|COMPLETED|Overall Study||43
3088844|NCT01427881|3810722|FG000|NOT COMPLETED|Overall Study||0
3088845|NCT01427907|3810728|FG000|STARTED|Overall Study|Randomized|20
3088846|NCT01427907|3810729|FG001|STARTED|Overall Study|Randomized|18
3088847|NCT01427907|3810728|FG000|COMPLETED|Overall Study|Completed study|17
3088848|NCT01427907|3810729|FG001|COMPLETED|Overall Study|Completed study|14
3088849|NCT01427907|3810728|FG000|NOT COMPLETED|Overall Study||3
3088850|NCT01427907|3810729|FG001|NOT COMPLETED|Overall Study||4
3088851|NCT01427920|3810737|FG000|STARTED|Overall Study||174
3088852|NCT01427920|3810738|FG001|STARTED|Overall Study||174
3088853|NCT01427920|3810737|FG000|Exposed|Overall Study||174
3088854|NCT01427920|3810738|FG001|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|173
3088855|NCT01427920|3810737|FG000|COMPLETED|Overall Study||165
3088856|NCT01427920|3810738|FG001|COMPLETED|Overall Study||157
3088857|NCT01427920|3810737|FG000|NOT COMPLETED|Overall Study||9
3088858|NCT01427920|3810738|FG001|NOT COMPLETED|Overall Study||17
3088859|NCT01427933|3810746|FG000|STARTED|Overall Study||71
3088860|NCT01427933|3810747|FG001|STARTED|Overall Study||70
3088861|NCT01427933|3810746|FG000|Received at Least 1 Dose of Study Drug|Overall Study||69
3088862|NCT01427933|3810747|FG001|Received at Least 1 Dose of Study Drug|Overall Study||65
3088863|NCT01427933|3810746|FG000|COMPLETED|Overall Study||63
3088864|NCT01427933|3810747|FG001|COMPLETED|Overall Study||57
3088865|NCT01427933|3810746|FG000|NOT COMPLETED|Overall Study||8
3088866|NCT01427933|3810747|FG001|NOT COMPLETED|Overall Study||13
3088867|NCT01427972|3810766|FG000|STARTED|Treatment Period 1 (21 Days)||3
2940885|NCT00639678|3653131|FG001|NOT COMPLETED|Overall Study||1
2940886|NCT00639678|3653132|FG002|NOT COMPLETED|Overall Study||11
3088868|NCT01427972|3810767|FG001|STARTED|Treatment Period 1 (21 Days)||4
3088869|NCT01427972|3810768|FG002|STARTED|Treatment Period 1 (21 Days)||4
3088870|NCT01427972|3810769|FG003|STARTED|Treatment Period 1 (21 Days)||3
3088871|NCT01427972|3810770|FG004|STARTED|Treatment Period 1 (21 Days)||4
3088872|NCT01427972|3810771|FG005|STARTED|Treatment Period 1 (21 Days)||3
3088873|NCT01427972|3810772|FG006|STARTED|Treatment Period 1 (21 Days)||3
3088874|NCT01427972|3810773|FG007|STARTED|Treatment Period 1 (21 Days)||5
3288017|NCT02796651|4021645|FG000|Formoterol Fumarate (FF) 24 μg|Overall Study||105
3288018|NCT02796651|4021645|FG000|Perforomist 20 μg|Overall Study||118
3288019|NCT02796651|4021645|FG000|Perforomist 40 μg|Overall Study||108
3088875|NCT01427972|3810774|FG008|STARTED|Treatment Period 1 (21 Days)||3
3088876|NCT01427972|3810775|FG009|STARTED|Treatment Period 1 (21 Days)||3
3088877|NCT01427972|3810776|FG010|STARTED|Treatment Period 1 (21 Days)||3
3088878|NCT01427972|3810777|FG011|STARTED|Treatment Period 1 (21 Days)||4
3088879|NCT01427972|3810766|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||3
3088880|NCT01427972|3810767|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||4
3088881|NCT01427972|3810768|FG002|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||4
3088882|NCT01427972|3810769|FG003|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||3
3088883|NCT01427972|3810770|FG004|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||4
3088884|NCT01427972|3810771|FG005|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||3
3088885|NCT01427972|3810772|FG006|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||3
3288020|NCT02796651|4021645|FG000|Placebo (Lactose Monohydrate)|Overall Study||38
3288021|NCT02796651|4021645|FG000|COMPLETED|Overall Study||106
3288022|NCT02796651|4021645|FG000|NOT COMPLETED|Overall Study||26
3288023|NCT02796664|4021662|FG000|STARTED|Overall Study||29
3288024|NCT02796664|4021663|FG001|STARTED|Overall Study||29
3288025|NCT02796664|4021662|FG000|COMPLETED|Overall Study||28
3288026|NCT02796664|4021663|FG001|COMPLETED|Overall Study||24
3288027|NCT02796664|4021662|FG000|NOT COMPLETED|Overall Study||1
3288028|NCT02796664|4021663|FG001|NOT COMPLETED|Overall Study||5
3288029|NCT02796677|4021675|FG000|STARTED|Overall Study||317
3288030|NCT02796677|4021676|FG001|STARTED|Overall Study||478
3288031|NCT02796677|4021677|FG002|STARTED|Overall Study||320
3288032|NCT02796677|4021678|FG003|STARTED|Overall Study||479
3288033|NCT02796677|4021675|FG000|Completed Treatment and Follow-up|Overall Study||279
3288034|NCT02796677|4021676|FG001|Completed Treatment and Follow-up|Overall Study||405
3288035|NCT02796677|4021677|FG002|Completed Treatment and Follow-up|Overall Study||267
3288036|NCT02796677|4021678|FG003|Completed Treatment and Follow-up|Overall Study||403
3288037|NCT02796677|4021675|FG000|COMPLETED|Overall Study||279
3288038|NCT02796677|4021676|FG001|COMPLETED|Overall Study||405
3288039|NCT02796677|4021677|FG002|COMPLETED|Overall Study||267
3288040|NCT02796677|4021678|FG003|COMPLETED|Overall Study||405
3288041|NCT02796677|4021675|FG000|NOT COMPLETED|Overall Study||38
3288042|NCT02796677|4021676|FG001|NOT COMPLETED|Overall Study||73
3288043|NCT02796677|4021677|FG002|NOT COMPLETED|Overall Study||53
3288044|NCT02796677|4021678|FG003|NOT COMPLETED|Overall Study||74
3288045|NCT02796755|4021692|FG000|STARTED|Overall Study||15
3288046|NCT02796755|4021693|FG001|STARTED|Overall Study||15
3288047|NCT02796755|4021692|FG000|COMPLETED|Overall Study||13
3288048|NCT02796755|4021693|FG001|COMPLETED|Overall Study||15
3288049|NCT02796755|4021692|FG000|NOT COMPLETED|Overall Study||2
3288050|NCT02796755|4021693|FG001|NOT COMPLETED|Overall Study||0
3288051|NCT02796924|4021699|FG000|STARTED|Overall Study||10
3288052|NCT02796924|4021699|FG000|COMPLETED|Overall Study||10
3288053|NCT02796924|4021699|FG000|NOT COMPLETED|Overall Study||0
3288054|NCT02796963|4021707|FG000|STARTED|Overall Study||383
3288055|NCT02796963|4021708|FG001|STARTED|Overall Study||328
3288056|NCT02796963|4021709|FG002|STARTED|Overall Study||316
3288057|NCT02796963|4021710|FG003|STARTED|Overall Study||354
3288058|NCT02796963|4021707|FG000|First Follow up|Overall Study||293
3288059|NCT02796963|4021708|FG001|First Follow up|Overall Study||279
3288060|NCT02796963|4021709|FG002|First Follow up|Overall Study||257
3288061|NCT02796963|4021710|FG003|First Follow up|Overall Study||291
3288062|NCT02796963|4021707|FG000|Second Follow up|Overall Study||280
3288063|NCT02796963|4021708|FG001|Second Follow up|Overall Study||260
3288064|NCT02796963|4021709|FG002|Second Follow up|Overall Study||255
3288065|NCT02796963|4021710|FG003|Second Follow up|Overall Study||293
3288066|NCT02796963|4021707|FG000|Third Follow up|Overall Study||276
3288067|NCT02796963|4021708|FG001|Third Follow up|Overall Study||237
3288068|NCT02796963|4021709|FG002|Third Follow up|Overall Study||245
3288069|NCT02796963|4021710|FG003|Third Follow up|Overall Study||286
3288070|NCT02796963|4021707|FG000|Fourth Follow up|Overall Study||275
3288071|NCT02796963|4021708|FG001|Fourth Follow up|Overall Study||233
3288072|NCT02796963|4021709|FG002|Fourth Follow up|Overall Study||236
3288073|NCT02796963|4021710|FG003|Fourth Follow up|Overall Study||263
3288074|NCT02796963|4021707|FG000|HIV Sero Converted|Overall Study||19
3288075|NCT02796963|4021708|FG001|HIV Sero Converted|Overall Study||19
3288076|NCT02796963|4021709|FG002|HIV Sero Converted|Overall Study||11
3288077|NCT02796963|4021710|FG003|HIV Sero Converted|Overall Study||19
3288078|NCT02796963|4021707|FG000|COMPLETED|Overall Study||294
3288079|NCT02796963|4021708|FG001|COMPLETED|Overall Study||252
3288080|NCT02796963|4021709|FG002|COMPLETED|Overall Study||247
3288081|NCT02796963|4021710|FG003|COMPLETED|Overall Study||282
3288082|NCT02796963|4021707|FG000|NOT COMPLETED|Overall Study||89
3288083|NCT02796963|4021708|FG001|NOT COMPLETED|Overall Study||76
3088886|NCT01427972|3810773|FG007|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||5
3088887|NCT01427972|3810774|FG008|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||3
3088888|NCT01427972|3810775|FG009|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||3
3088889|NCT01427972|3810776|FG010|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||3
3088890|NCT01427972|3810777|FG011|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||4
3088891|NCT01427972|3810766|FG000|COMPLETED|Treatment Period 1 (21 Days)||3
3088892|NCT01427972|3810767|FG001|COMPLETED|Treatment Period 1 (21 Days)||4
3088893|NCT01427972|3810768|FG002|COMPLETED|Treatment Period 1 (21 Days)||4
3088894|NCT01427972|3810769|FG003|COMPLETED|Treatment Period 1 (21 Days)||3
3088895|NCT01427972|3810770|FG004|COMPLETED|Treatment Period 1 (21 Days)||4
3088896|NCT01427972|3810771|FG005|COMPLETED|Treatment Period 1 (21 Days)||3
3088897|NCT01427972|3810772|FG006|COMPLETED|Treatment Period 1 (21 Days)||3
3088898|NCT01427972|3810773|FG007|COMPLETED|Treatment Period 1 (21 Days)||4
3088899|NCT01427972|3810774|FG008|COMPLETED|Treatment Period 1 (21 Days)||3
3088900|NCT01427972|3810775|FG009|COMPLETED|Treatment Period 1 (21 Days)||3
3088901|NCT01427972|3810776|FG010|COMPLETED|Treatment Period 1 (21 Days)||3
3088902|NCT01427972|3810777|FG011|COMPLETED|Treatment Period 1 (21 Days)||4
3088903|NCT01427972|3810766|FG000|NOT COMPLETED|Treatment Period 1 (21 Days)||0
3088904|NCT01427972|3810767|FG001|NOT COMPLETED|Treatment Period 1 (21 Days)||0
3088905|NCT01427972|3810768|FG002|NOT COMPLETED|Treatment Period 1 (21 Days)||0
3088906|NCT01427972|3810769|FG003|NOT COMPLETED|Treatment Period 1 (21 Days)||0
3088907|NCT01427972|3810770|FG004|NOT COMPLETED|Treatment Period 1 (21 Days)||0
3088908|NCT01427972|3810771|FG005|NOT COMPLETED|Treatment Period 1 (21 Days)||0
3288084|NCT02796963|4021709|FG002|NOT COMPLETED|Overall Study||69
3288085|NCT02796963|4021710|FG003|NOT COMPLETED|Overall Study||72
3288086|NCT02797054|4021723|FG000|STARTED|Post-test||387
3288087|NCT02797054|4021724|FG001|STARTED|Post-test||383
3288088|NCT02797054|4021725|FG002|STARTED|Post-test||435
3288089|NCT02797054|4021723|FG000|COMPLETED|Post-test||380
3288090|NCT02797054|4021724|FG001|COMPLETED|Post-test||372
3288091|NCT02797054|4021725|FG002|COMPLETED|Post-test||87
3288092|NCT02797054|4021723|FG000|NOT COMPLETED|Post-test||7
3288093|NCT02797054|4021724|FG001|NOT COMPLETED|Post-test||11
3288094|NCT02797054|4021725|FG002|NOT COMPLETED|Post-test||348
3288095|NCT02797054|4021723|FG000|STARTED|Follow-up||387
3288096|NCT02797054|4021724|FG001|STARTED|Follow-up||383
3288097|NCT02797054|4021725|FG002|STARTED|Follow-up||435
3288098|NCT02797054|4021723|FG000|COMPLETED|Follow-up||178
3288099|NCT02797054|4021724|FG001|COMPLETED|Follow-up||155
3288100|NCT02797054|4021725|FG002|COMPLETED|Follow-up||150
3288101|NCT02797054|4021723|FG000|NOT COMPLETED|Follow-up||209
3288102|NCT02797054|4021724|FG001|NOT COMPLETED|Follow-up||228
3288103|NCT02797054|4021725|FG002|NOT COMPLETED|Follow-up||285
3288104|NCT02797080|4021733|FG000|STARTED|Overall Study||38
3288105|NCT02797080|4021733|FG000|COMPLETED|Overall Study||36
3288106|NCT02797080|4021733|FG000|NOT COMPLETED|Overall Study||2
3288107|NCT02797132|4021737|FG000|STARTED|Part A (15 Days)||12
3288108|NCT02797132|4021737|FG000|Part A (<14 kg Weight)|Part A (15 Days)||4
3288109|NCT02797132|4021737|FG000|Part A (>=14 kg Weight)|Part A (15 Days)||8
3288110|NCT02797132|4021737|FG000|COMPLETED|Part A (15 Days)||11
3288111|NCT02797132|4021737|FG000|NOT COMPLETED|Part A (15 Days)||1
3288112|NCT02797132|4021737|FG000|STARTED|Part B (24 Weeks)|Participants from Part A may have participated in Part B.|60
3288113|NCT02797132|4021737|FG000|Part B (<14 kg Weight)|Part B (24 Weeks)||19
3288114|NCT02797132|4021737|FG000|Part B (>=14 kg Weight)|Part B (24 Weeks)||41
3288115|NCT02797132|4021737|FG000|COMPLETED|Part B (24 Weeks)||57
3288116|NCT02797132|4021737|FG000|NOT COMPLETED|Part B (24 Weeks)||3
3288117|NCT02797171|4021756|FG000|STARTED|Overall Study||23
3288118|NCT02797171|4021757|FG001|STARTED|Overall Study||23
3288119|NCT02797171|4021758|FG002|STARTED|Overall Study||7
3288120|NCT02797171|4021759|FG003|STARTED|Overall Study||16
3288121|NCT02797171|4021760|FG004|STARTED|Overall Study||10
3288122|NCT02797171|4021761|FG005|STARTED|Overall Study||1
3288123|NCT02797171|4021756|FG000|Safety Population|Overall Study||23
3288124|NCT02797171|4021757|FG001|Safety Population|Overall Study||23
3288125|NCT02797171|4021758|FG002|Safety Population|Overall Study||7
3288126|NCT02797171|4021759|FG003|Safety Population|Overall Study||16
3288127|NCT02797171|4021760|FG004|Safety Population|Overall Study||10
3288128|NCT02797171|4021761|FG005|Safety Population|Overall Study||1
3288129|NCT02797171|4021756|FG000|COMPLETED|Overall Study||19
3288130|NCT02797171|4021757|FG001|COMPLETED|Overall Study||21
3288131|NCT02797171|4021758|FG002|COMPLETED|Overall Study||5
3288132|NCT02797171|4021759|FG003|COMPLETED|Overall Study||15
3288133|NCT02797171|4021760|FG004|COMPLETED|Overall Study||8
3288134|NCT02797171|4021761|FG005|COMPLETED|Overall Study||0
3288135|NCT02797171|4021756|FG000|NOT COMPLETED|Overall Study||4
3288136|NCT02797171|4021757|FG001|NOT COMPLETED|Overall Study||2
3288137|NCT02797171|4021758|FG002|NOT COMPLETED|Overall Study||2
3288138|NCT02797171|4021759|FG003|NOT COMPLETED|Overall Study||1
3288139|NCT02797171|4021760|FG004|NOT COMPLETED|Overall Study||2
3288140|NCT02797171|4021761|FG005|NOT COMPLETED|Overall Study||1
3288141|NCT02797522|4021786|FG000|STARTED|Overall Study||4
3288142|NCT02797522|4021787|FG001|STARTED|Overall Study||4
3088909|NCT01427972|3810772|FG006|NOT COMPLETED|Treatment Period 1 (21 Days)||0
3288143|NCT02797522|4021788|FG002|STARTED|Overall Study||4
3288144|NCT02797522|4021789|FG003|STARTED|Overall Study||4
3288145|NCT02797522|4021790|FG004|STARTED|Overall Study||4
3288146|NCT02797522|4021791|FG005|STARTED|Overall Study||4
3088910|NCT01427972|3810773|FG007|NOT COMPLETED|Treatment Period 1 (21 Days)||1
3088911|NCT01427972|3810774|FG008|NOT COMPLETED|Treatment Period 1 (21 Days)||0
3088912|NCT01427972|3810775|FG009|NOT COMPLETED|Treatment Period 1 (21 Days)||0
3088913|NCT01427972|3810776|FG010|NOT COMPLETED|Treatment Period 1 (21 Days)||0
3088914|NCT01427972|3810777|FG011|NOT COMPLETED|Treatment Period 1 (21 Days)||0
3088915|NCT01427972|3810766|FG000|STARTED|Washout (at Least 28 Days)||3
3088916|NCT01427972|3810767|FG001|STARTED|Washout (at Least 28 Days)||4
3088917|NCT01427972|3810768|FG002|STARTED|Washout (at Least 28 Days)||4
3088918|NCT01427972|3810769|FG003|STARTED|Washout (at Least 28 Days)||3
3288147|NCT02797522|4021792|FG006|STARTED|Overall Study||12
3288148|NCT02797522|4021793|FG007|STARTED|Overall Study||4
3288149|NCT02797522|4021794|FG008|STARTED|Overall Study||2
3288150|NCT02797522|4021795|FG009|STARTED|Overall Study||4
3288151|NCT02797522|4021796|FG010|STARTED|Overall Study||1
3288152|NCT02797522|4021786|FG000|COMPLETED|Overall Study||4
3288153|NCT02797522|4021787|FG001|COMPLETED|Overall Study||4
3288154|NCT02797522|4021788|FG002|COMPLETED|Overall Study||4
3288155|NCT02797522|4021789|FG003|COMPLETED|Overall Study||4
3288156|NCT02797522|4021790|FG004|COMPLETED|Overall Study||4
3288157|NCT02797522|4021791|FG005|COMPLETED|Overall Study||4
3288158|NCT02797522|4021792|FG006|COMPLETED|Overall Study||12
3288159|NCT02797522|4021793|FG007|COMPLETED|Overall Study||0
3288160|NCT02797522|4021794|FG008|COMPLETED|Overall Study||0
3288161|NCT02797522|4021795|FG009|COMPLETED|Overall Study||0
3288162|NCT02797522|4021796|FG010|COMPLETED|Overall Study||0
3288163|NCT02797522|4021786|FG000|NOT COMPLETED|Overall Study||0
3288164|NCT02797522|4021787|FG001|NOT COMPLETED|Overall Study||0
3288165|NCT02797522|4021788|FG002|NOT COMPLETED|Overall Study||0
3288166|NCT02797522|4021789|FG003|NOT COMPLETED|Overall Study||0
3288167|NCT02797522|4021790|FG004|NOT COMPLETED|Overall Study||0
3288168|NCT02797522|4021791|FG005|NOT COMPLETED|Overall Study||0
3288169|NCT02797522|4021792|FG006|NOT COMPLETED|Overall Study||0
3288170|NCT02797522|4021793|FG007|NOT COMPLETED|Overall Study||4
3288171|NCT02797522|4021794|FG008|NOT COMPLETED|Overall Study||2
3288172|NCT02797522|4021795|FG009|NOT COMPLETED|Overall Study||4
3288173|NCT02797522|4021796|FG010|NOT COMPLETED|Overall Study||1
3288174|NCT02797613|4021826|FG000|STARTED|Overall Study||55
3288175|NCT02797613|4021827|FG001|STARTED|Overall Study||55
3288176|NCT02797613|4021826|FG000|COMPLETED|Overall Study||55
3288177|NCT02797613|4021827|FG001|COMPLETED|Overall Study||55
3288178|NCT02797613|4021826|FG000|NOT COMPLETED|Overall Study||0
3288179|NCT02797613|4021827|FG001|NOT COMPLETED|Overall Study||0
3288180|NCT02797678|4021833|FG000|STARTED|Screening Phase||62
3288181|NCT02797678|4021834|FG001|STARTED|Screening Phase||0
3288182|NCT02797678|4021835|FG002|STARTED|Screening Phase||0
3288183|NCT02797678|4021836|FG003|STARTED|Screening Phase||0
3288184|NCT02797678|4021833|FG000|COMPLETED|Screening Phase||37
3288185|NCT02797678|4021834|FG001|COMPLETED|Screening Phase||0
3288186|NCT02797678|4021835|FG002|COMPLETED|Screening Phase||0
3288187|NCT02797678|4021836|FG003|COMPLETED|Screening Phase||0
3288188|NCT02797678|4021833|FG000|NOT COMPLETED|Screening Phase||25
3288189|NCT02797678|4021834|FG001|NOT COMPLETED|Screening Phase||0
3288190|NCT02797678|4021835|FG002|NOT COMPLETED|Screening Phase||0
3288191|NCT02797678|4021836|FG003|NOT COMPLETED|Screening Phase||0
3288192|NCT02797678|4021833|FG000|STARTED|First Intervention (5 Nights)||0
3288193|NCT02797678|4021834|FG001|STARTED|First Intervention (5 Nights)||20
3288194|NCT02797678|4021835|FG002|STARTED|First Intervention (5 Nights)||17
3288195|NCT02797678|4021836|FG003|STARTED|First Intervention (5 Nights)||0
3288196|NCT02797678|4021833|FG000|COMPLETED|First Intervention (5 Nights)||0
3288197|NCT02797678|4021834|FG001|COMPLETED|First Intervention (5 Nights)||19
3288198|NCT02797678|4021835|FG002|COMPLETED|First Intervention (5 Nights)||17
3288199|NCT02797678|4021836|FG003|COMPLETED|First Intervention (5 Nights)||0
3288200|NCT02797678|4021833|FG000|NOT COMPLETED|First Intervention (5 Nights)||0
3288201|NCT02797678|4021834|FG001|NOT COMPLETED|First Intervention (5 Nights)||1
3288202|NCT02797678|4021835|FG002|NOT COMPLETED|First Intervention (5 Nights)||0
3288203|NCT02797678|4021836|FG003|NOT COMPLETED|First Intervention (5 Nights)||0
3288204|NCT02797678|4021833|FG000|STARTED|Washout||0
3288205|NCT02797678|4021834|FG001|STARTED|Washout||19
3288206|NCT02797678|4021835|FG002|STARTED|Washout||17
3288207|NCT02797678|4021836|FG003|STARTED|Washout||0
3288208|NCT02797678|4021833|FG000|COMPLETED|Washout||0
3288209|NCT02797678|4021834|FG001|COMPLETED|Washout||19
3288210|NCT02797678|4021835|FG002|COMPLETED|Washout||17
3288211|NCT02797678|4021836|FG003|COMPLETED|Washout||0
3288212|NCT02797678|4021833|FG000|NOT COMPLETED|Washout||0
3288213|NCT02797678|4021834|FG001|NOT COMPLETED|Washout||0
3288214|NCT02797678|4021835|FG002|NOT COMPLETED|Washout||0
3288215|NCT02797678|4021836|FG003|NOT COMPLETED|Washout||0
3288216|NCT02797678|4021833|FG000|STARTED|Second Intervention (5 Nights)||0
3288217|NCT02797678|4021834|FG001|STARTED|Second Intervention (5 Nights)||19
3288218|NCT02797678|4021835|FG002|STARTED|Second Intervention (5 Nights)||17
3288219|NCT02797678|4021836|FG003|STARTED|Second Intervention (5 Nights)||0
3288220|NCT02797678|4021833|FG000|COMPLETED|Second Intervention (5 Nights)||0
3288221|NCT02797678|4021834|FG001|COMPLETED|Second Intervention (5 Nights)||19
3288222|NCT02797678|4021835|FG002|COMPLETED|Second Intervention (5 Nights)||16
3288223|NCT02797678|4021836|FG003|COMPLETED|Second Intervention (5 Nights)||0
3288224|NCT02797678|4021833|FG000|NOT COMPLETED|Second Intervention (5 Nights)||0
3288225|NCT02797678|4021834|FG001|NOT COMPLETED|Second Intervention (5 Nights)||0
3316689|NCT03118297|4050122|FG000|COMPLETED|Overall Study||32
3088919|NCT01427972|3810770|FG004|STARTED|Washout (at Least 28 Days)||4
3088920|NCT01427972|3810771|FG005|STARTED|Washout (at Least 28 Days)||3
3088921|NCT01427972|3810772|FG006|STARTED|Washout (at Least 28 Days)||3
3088922|NCT01427972|3810773|FG007|STARTED|Washout (at Least 28 Days)||4
3088923|NCT01427972|3810774|FG008|STARTED|Washout (at Least 28 Days)||3
3088924|NCT01427972|3810775|FG009|STARTED|Washout (at Least 28 Days)||3
3088925|NCT01427972|3810776|FG010|STARTED|Washout (at Least 28 Days)||3
3088926|NCT01427972|3810777|FG011|STARTED|Washout (at Least 28 Days)||4
3088927|NCT01427972|3810766|FG000|COMPLETED|Washout (at Least 28 Days)||3
3088928|NCT01427972|3810767|FG001|COMPLETED|Washout (at Least 28 Days)||4
3088929|NCT01427972|3810768|FG002|COMPLETED|Washout (at Least 28 Days)||4
3088930|NCT01427972|3810769|FG003|COMPLETED|Washout (at Least 28 Days)||3
3088931|NCT01427972|3810770|FG004|COMPLETED|Washout (at Least 28 Days)||4
3088932|NCT01427972|3810771|FG005|COMPLETED|Washout (at Least 28 Days)||1
3088933|NCT01427972|3810772|FG006|COMPLETED|Washout (at Least 28 Days)||3
3088934|NCT01427972|3810773|FG007|COMPLETED|Washout (at Least 28 Days)||4
3088935|NCT01427972|3810774|FG008|COMPLETED|Washout (at Least 28 Days)||3
3088936|NCT01427972|3810775|FG009|COMPLETED|Washout (at Least 28 Days)||3
3088937|NCT01427972|3810776|FG010|COMPLETED|Washout (at Least 28 Days)||3
3088938|NCT01427972|3810777|FG011|COMPLETED|Washout (at Least 28 Days)||4
3088939|NCT01427972|3810766|FG000|NOT COMPLETED|Washout (at Least 28 Days)||0
3088940|NCT01427972|3810767|FG001|NOT COMPLETED|Washout (at Least 28 Days)||0
3088941|NCT01427972|3810768|FG002|NOT COMPLETED|Washout (at Least 28 Days)||0
3088942|NCT01427972|3810769|FG003|NOT COMPLETED|Washout (at Least 28 Days)||0
3088943|NCT01427972|3810770|FG004|NOT COMPLETED|Washout (at Least 28 Days)||0
3088944|NCT01427972|3810771|FG005|NOT COMPLETED|Washout (at Least 28 Days)||2
3088945|NCT01427972|3810772|FG006|NOT COMPLETED|Washout (at Least 28 Days)||0
3088946|NCT01427972|3810773|FG007|NOT COMPLETED|Washout (at Least 28 Days)||0
3088947|NCT01427972|3810774|FG008|NOT COMPLETED|Washout (at Least 28 Days)||0
3288226|NCT02797678|4021835|FG002|NOT COMPLETED|Second Intervention (5 Nights)||1
3288227|NCT02797678|4021836|FG003|NOT COMPLETED|Second Intervention (5 Nights)||0
3288228|NCT02797678|4021833|FG000|STARTED|Sub-Study||0
3288229|NCT02797678|4021834|FG001|STARTED|Sub-Study||0
3288230|NCT02797678|4021835|FG002|STARTED|Sub-Study||0
3288231|NCT02797678|4021836|FG003|STARTED|Sub-Study||9
3288232|NCT02797678|4021833|FG000|COMPLETED|Sub-Study||0
3288233|NCT02797678|4021834|FG001|COMPLETED|Sub-Study||0
3288234|NCT02797678|4021835|FG002|COMPLETED|Sub-Study||0
3288235|NCT02797678|4021836|FG003|COMPLETED|Sub-Study||9
3288236|NCT02797678|4021833|FG000|NOT COMPLETED|Sub-Study||0
3288237|NCT02797678|4021834|FG001|NOT COMPLETED|Sub-Study||0
3288238|NCT02797678|4021835|FG002|NOT COMPLETED|Sub-Study||0
3288239|NCT02797678|4021836|FG003|NOT COMPLETED|Sub-Study||0
3288240|NCT02797808|4021851|FG000|STARTED|Overall Study||23
3288241|NCT02797808|4021852|FG001|STARTED|Overall Study||18
3288242|NCT02797808|4021851|FG000|COMPLETED|Overall Study||16
3288243|NCT02797808|4021852|FG001|COMPLETED|Overall Study||15
3288244|NCT02797808|4021851|FG000|NOT COMPLETED|Overall Study||7
3288245|NCT02797808|4021852|FG001|NOT COMPLETED|Overall Study||3
3288246|NCT02797821|4021861|FG000|STARTED|Overall Study||8
3288247|NCT02797821|4021862|FG001|STARTED|Overall Study||10
3288248|NCT02797821|4021863|FG002|STARTED|Overall Study||9
3288249|NCT02797821|4021861|FG000|Received at Least 1 Dose of Study Drug|Overall Study||8
3288250|NCT02797821|4021862|FG001|Received at Least 1 Dose of Study Drug|Overall Study||10
3288251|NCT02797821|4021863|FG002|Received at Least 1 Dose of Study Drug|Overall Study||9
3288252|NCT02797821|4021861|FG000|COMPLETED|Overall Study||8
3288253|NCT02797821|4021862|FG001|COMPLETED|Overall Study||10
3288254|NCT02797821|4021863|FG002|COMPLETED|Overall Study||9
3288255|NCT02797821|4021861|FG000|NOT COMPLETED|Overall Study||0
3288256|NCT02797821|4021862|FG001|NOT COMPLETED|Overall Study||0
3288257|NCT02797821|4021863|FG002|NOT COMPLETED|Overall Study||0
3288258|NCT02798211|4021874|FG000|STARTED|Period 1||103
3288259|NCT02798211|4021875|FG001|STARTED|Period 1||103
3288260|NCT02798211|4021876|FG002|STARTED|Period 1||52
3288261|NCT02798211|4021877|FG003|STARTED|Period 1||0
3288262|NCT02798211|4021878|FG004|STARTED|Period 1||0
3288263|NCT02798211|4021879|FG005|STARTED|Period 1||0
3288264|NCT02798211|4021874|FG000|COMPLETED|Period 1||97
3288265|NCT02798211|4021875|FG001|COMPLETED|Period 1||93
3288266|NCT02798211|4021876|FG002|COMPLETED|Period 1||46
3288267|NCT02798211|4021877|FG003|COMPLETED|Period 1||0
3288268|NCT02798211|4021878|FG004|COMPLETED|Period 1||0
3288269|NCT02798211|4021879|FG005|COMPLETED|Period 1||0
3288270|NCT02798211|4021874|FG000|NOT COMPLETED|Period 1||6
3288271|NCT02798211|4021875|FG001|NOT COMPLETED|Period 1||10
3288272|NCT02798211|4021876|FG002|NOT COMPLETED|Period 1||6
3288273|NCT02798211|4021877|FG003|NOT COMPLETED|Period 1||0
3288274|NCT02798211|4021878|FG004|NOT COMPLETED|Period 1||0
3288275|NCT02798211|4021879|FG005|NOT COMPLETED|Period 1||0
3288276|NCT02798211|4021874|FG000|STARTED|Period 2||97
3288277|NCT02798211|4021875|FG001|STARTED|Period 2||0
3288278|NCT02798211|4021876|FG002|STARTED|Period 2||0
3288279|NCT02798211|4021877|FG003|STARTED|Period 2||50
3288280|NCT02798211|4021878|FG004|STARTED|Period 2||42
3288281|NCT02798211|4021879|FG005|STARTED|Period 2||46
3288282|NCT02798211|4021874|FG000|COMPLETED|Period 2||83
3288283|NCT02798211|4021875|FG001|COMPLETED|Period 2||0
3288284|NCT02798211|4021876|FG002|COMPLETED|Period 2||0
3288285|NCT02798211|4021877|FG003|COMPLETED|Period 2||43
3288286|NCT02798211|4021878|FG004|COMPLETED|Period 2||34
3088948|NCT01427972|3810775|FG009|NOT COMPLETED|Washout (at Least 28 Days)||0
3088949|NCT01427972|3810776|FG010|NOT COMPLETED|Washout (at Least 28 Days)||0
3288287|NCT02798211|4021879|FG005|COMPLETED|Period 2||40
3288288|NCT02798211|4021874|FG000|NOT COMPLETED|Period 2||14
3288289|NCT02798211|4021875|FG001|NOT COMPLETED|Period 2||0
3288290|NCT02798211|4021876|FG002|NOT COMPLETED|Period 2||0
3288291|NCT02798211|4021877|FG003|NOT COMPLETED|Period 2||7
3288292|NCT02798211|4021878|FG004|NOT COMPLETED|Period 2||8
3088950|NCT01427972|3810777|FG011|NOT COMPLETED|Washout (at Least 28 Days)||0
3088951|NCT01427972|3810766|FG000|STARTED|Treatment Period 2 (21 Days)||3
3088952|NCT01427972|3810767|FG001|STARTED|Treatment Period 2 (21 Days)||4
3288293|NCT02798211|4021879|FG005|NOT COMPLETED|Period 2||6
3288294|NCT02798289|4021891|FG000|STARTED|Overall Study||55
3288295|NCT02798289|4021891|FG000|COMPLETED|Overall Study||55
3088953|NCT01427972|3810768|FG002|STARTED|Treatment Period 2 (21 Days)||4
3088954|NCT01427972|3810769|FG003|STARTED|Treatment Period 2 (21 Days)||3
3088955|NCT01427972|3810770|FG004|STARTED|Treatment Period 2 (21 Days)||4
3088956|NCT01427972|3810771|FG005|STARTED|Treatment Period 2 (21 Days)||1
3163095|NCT01882985|3890561|FG000|COMPLETED|Overall Study||12
3163096|NCT01882985|3890561|FG000|NOT COMPLETED|Overall Study||2
3288296|NCT02798289|4021891|FG000|NOT COMPLETED|Overall Study||0
3288297|NCT02798315|4021895|FG000|STARTED|Overall Study||40
3288298|NCT02798315|4021895|FG000|COMPLETED|Overall Study||39
3288299|NCT02798315|4021895|FG000|NOT COMPLETED|Overall Study||1
3288300|NCT02798354|4021902|FG000|STARTED|First Intervention Period||1184
3288301|NCT02798354|4021903|FG001|STARTED|First Intervention Period||2176
3288302|NCT02798354|4021904|FG002|STARTED|First Intervention Period||990
3288303|NCT02798354|4021902|FG000|Control Data Error 1|First Intervention Period||440
3288304|NCT02798354|4021903|FG001|Control Data Error 1|First Intervention Period||549
3288305|NCT02798354|4021904|FG002|Control Data Error 1|First Intervention Period||345
3288306|NCT02798354|4021902|FG000|Intervention Data Error 1|First Intervention Period||744
3288307|NCT02798354|4021903|FG001|Intervention Data Error 1|First Intervention Period||1627
3288308|NCT02798354|4021904|FG002|Intervention Data Error 1|First Intervention Period||645
3288309|NCT02798354|4021902|FG000|COMPLETED|First Intervention Period||1184
3288310|NCT02798354|4021903|FG001|COMPLETED|First Intervention Period||2176
3288311|NCT02798354|4021904|FG002|COMPLETED|First Intervention Period||990
3288312|NCT02798354|4021902|FG000|NOT COMPLETED|First Intervention Period||0
3288313|NCT02798354|4021903|FG001|NOT COMPLETED|First Intervention Period||0
3288314|NCT02798354|4021904|FG002|NOT COMPLETED|First Intervention Period||0
3288315|NCT02798354|4021902|FG000|STARTED|Second Intervention Period||2617
3288316|NCT02798354|4021903|FG001|STARTED|Second Intervention Period||1047
3288317|NCT02798354|4021904|FG002|STARTED|Second Intervention Period||1368
3288318|NCT02798354|4021902|FG000|Control Data Error 2|Second Intervention Period||1378
3288319|NCT02798354|4021903|FG001|Control Data Error 2|Second Intervention Period||593
3288320|NCT02798354|4021904|FG002|Control Data Error 2|Second Intervention Period||668
3288321|NCT02798354|4021902|FG000|Intervention Data Error 2|Second Intervention Period||1239
3288322|NCT02798354|4021903|FG001|Intervention Data Error 2|Second Intervention Period||454
3288323|NCT02798354|4021904|FG002|Intervention Data Error 2|Second Intervention Period||700
3288324|NCT02798354|4021902|FG000|COMPLETED|Second Intervention Period||2617
3288325|NCT02798354|4021903|FG001|COMPLETED|Second Intervention Period||1047
3288326|NCT02798354|4021904|FG002|COMPLETED|Second Intervention Period||1368
3288327|NCT02798354|4021902|FG000|NOT COMPLETED|Second Intervention Period||0
3288328|NCT02798354|4021903|FG001|NOT COMPLETED|Second Intervention Period||0
3163097|NCT01883141|3890565|FG000|STARTED|Overall Study||31
3163098|NCT01883141|3890565|FG000|Passing Eligibility|Overall Study||30
3163099|NCT01883141|3890565|FG000|EP Study Performed|Overall Study||30
3163100|NCT01883141|3890565|FG000|Usable EP Data|Overall Study||26
3163101|NCT01883141|3890565|FG000|BiV Pacing-Distal|Overall Study||24
3163102|NCT01883141|3890565|FG000|BiV Pacing-Mid|Overall Study||25
3288329|NCT02798354|4021904|FG002|NOT COMPLETED|Second Intervention Period||0
3288330|NCT02798354|4021902|FG000|STARTED|Third Intervention Period||746
3288331|NCT02798354|4021903|FG001|STARTED|Third Intervention Period||1010
3288332|NCT02798354|4021904|FG002|STARTED|Third Intervention Period||2715
3288333|NCT02798354|4021902|FG000|Control Data Error 3|Third Intervention Period||419
3288334|NCT02798354|4021903|FG001|Control Data Error 3|Third Intervention Period||620
3288335|NCT02798354|4021904|FG002|Control Data Error 3|Third Intervention Period||1467
3288336|NCT02798354|4021902|FG000|Intervention Data Error 3|Third Intervention Period||327
3288337|NCT02798354|4021903|FG001|Intervention Data Error 3|Third Intervention Period||390
3288338|NCT02798354|4021904|FG002|Intervention Data Error 3|Third Intervention Period||1248
3288339|NCT02798354|4021902|FG000|COMPLETED|Third Intervention Period||746
3288340|NCT02798354|4021903|FG001|COMPLETED|Third Intervention Period||1010
3288341|NCT02798354|4021904|FG002|COMPLETED|Third Intervention Period||2715
3288342|NCT02798354|4021902|FG000|NOT COMPLETED|Third Intervention Period||0
3288343|NCT02798354|4021903|FG001|NOT COMPLETED|Third Intervention Period||0
3288344|NCT02798354|4021904|FG002|NOT COMPLETED|Third Intervention Period||0
3288345|NCT02798380|4021918|FG000|STARTED|Overall Study||30
3288346|NCT02798380|4021918|FG000|COMPLETED|Overall Study||30
3288347|NCT02798380|4021918|FG000|NOT COMPLETED|Overall Study||0
3288348|NCT02798627|4021924|FG000|STARTED|Overall Study||27
3288349|NCT02798627|4021925|FG001|STARTED|Overall Study||28
3288350|NCT02798627|4021924|FG000|COMPLETED|Overall Study||27
3288351|NCT02798627|4021925|FG001|COMPLETED|Overall Study||28
3288352|NCT02798627|4021924|FG000|NOT COMPLETED|Overall Study||0
3088957|NCT01427972|3810772|FG006|STARTED|Treatment Period 2 (21 Days)||3
3088958|NCT01427972|3810773|FG007|STARTED|Treatment Period 2 (21 Days)||4
3088959|NCT01427972|3810774|FG008|STARTED|Treatment Period 2 (21 Days)||3
3088960|NCT01427972|3810775|FG009|STARTED|Treatment Period 2 (21 Days)||3
3088961|NCT01427972|3810776|FG010|STARTED|Treatment Period 2 (21 Days)||3
3088962|NCT01427972|3810777|FG011|STARTED|Treatment Period 2 (21 Days)||4
3088963|NCT01427972|3810766|FG000|COMPLETED|Treatment Period 2 (21 Days)||3
3088964|NCT01427972|3810767|FG001|COMPLETED|Treatment Period 2 (21 Days)||3
3088965|NCT01427972|3810768|FG002|COMPLETED|Treatment Period 2 (21 Days)||4
3088966|NCT01427972|3810769|FG003|COMPLETED|Treatment Period 2 (21 Days)||3
3088967|NCT01427972|3810770|FG004|COMPLETED|Treatment Period 2 (21 Days)||4
3088968|NCT01427972|3810771|FG005|COMPLETED|Treatment Period 2 (21 Days)||1
3088969|NCT01427972|3810772|FG006|COMPLETED|Treatment Period 2 (21 Days)||3
3088970|NCT01427972|3810773|FG007|COMPLETED|Treatment Period 2 (21 Days)||4
3088971|NCT01427972|3810774|FG008|COMPLETED|Treatment Period 2 (21 Days)||3
3088972|NCT01427972|3810775|FG009|COMPLETED|Treatment Period 2 (21 Days)||3
3088973|NCT01427972|3810776|FG010|COMPLETED|Treatment Period 2 (21 Days)||3
3088974|NCT01427972|3810777|FG011|COMPLETED|Treatment Period 2 (21 Days)||4
3088975|NCT01427972|3810766|FG000|NOT COMPLETED|Treatment Period 2 (21 Days)||0
3088976|NCT01427972|3810767|FG001|NOT COMPLETED|Treatment Period 2 (21 Days)||1
3088977|NCT01427972|3810768|FG002|NOT COMPLETED|Treatment Period 2 (21 Days)||0
3088978|NCT01427972|3810769|FG003|NOT COMPLETED|Treatment Period 2 (21 Days)||0
3088979|NCT01427972|3810770|FG004|NOT COMPLETED|Treatment Period 2 (21 Days)||0
3088980|NCT01427972|3810771|FG005|NOT COMPLETED|Treatment Period 2 (21 Days)||0
3088981|NCT01427972|3810772|FG006|NOT COMPLETED|Treatment Period 2 (21 Days)||0
3088982|NCT01427972|3810773|FG007|NOT COMPLETED|Treatment Period 2 (21 Days)||0
3088983|NCT01427972|3810774|FG008|NOT COMPLETED|Treatment Period 2 (21 Days)||0
3088984|NCT01427972|3810775|FG009|NOT COMPLETED|Treatment Period 2 (21 Days)||0
3088985|NCT01427972|3810776|FG010|NOT COMPLETED|Treatment Period 2 (21 Days)||0
3088986|NCT01427972|3810777|FG011|NOT COMPLETED|Treatment Period 2 (21 Days)||0
3134973|NCT01703741|3859896|FG000|STARTED|Overall Study||145
3134974|NCT01703741|3859896|FG000|Per Protocol (PP) Population|Overall Study|Subjects having 24 hr pharmacokinetic (PK) data for testosterone, with no major protocol violations.|106
3134975|NCT01703741|3859896|FG000|COMPLETED|Overall Study||127
3134976|NCT01703741|3859896|FG000|NOT COMPLETED|Overall Study||18
3134977|NCT01703819|3859902|FG000|STARTED|Overall Study||34
3134978|NCT01703819|3859903|FG001|STARTED|Overall Study||32
3134979|NCT01703819|3859902|FG000|COMPLETED|Overall Study||34
3134980|NCT01703819|3859903|FG001|COMPLETED|Overall Study||30
3134981|NCT01703819|3859902|FG000|NOT COMPLETED|Overall Study||0
3134982|NCT01703819|3859903|FG001|NOT COMPLETED|Overall Study||2
3134983|NCT01703832|3859911|FG000|STARTED|Overall Study||33
3134984|NCT01703832|3859912|FG001|STARTED|Overall Study||32
3134985|NCT01703832|3859911|FG000|COMPLETED|Overall Study||32
3134986|NCT01703832|3859912|FG001|COMPLETED|Overall Study||32
3134987|NCT01703832|3859911|FG000|NOT COMPLETED|Overall Study||1
3134988|NCT01703832|3859912|FG001|NOT COMPLETED|Overall Study||0
3134989|NCT01703845|3859920|FG000|STARTED|Overall Study|started are actually the randomized|16
3134990|NCT01703845|3859921|FG001|STARTED|Overall Study|started are actually the randomized|16
3134991|NCT01703845|3859920|FG000|COMPLETED|Overall Study||13
3134992|NCT01703845|3859921|FG001|COMPLETED|Overall Study||16
3134993|NCT01703845|3859920|FG000|NOT COMPLETED|Overall Study||3
3134994|NCT01703845|3859921|FG001|NOT COMPLETED|Overall Study||0
3134995|NCT01703858|3859932|FG000|STARTED|Overall Study||5
3134996|NCT01703858|3859933|FG001|STARTED|Overall Study||5
3134997|NCT01703858|3859934|FG002|STARTED|Overall Study||5
3134998|NCT01703858|3859932|FG000|COMPLETED|Overall Study||5
3134999|NCT01703858|3859933|FG001|COMPLETED|Overall Study||4
3135000|NCT01703858|3859934|FG002|COMPLETED|Overall Study||5
3135001|NCT01703858|3859932|FG000|NOT COMPLETED|Overall Study||0
3135002|NCT01703858|3859933|FG001|NOT COMPLETED|Overall Study||1
3135003|NCT01703858|3859934|FG002|NOT COMPLETED|Overall Study||0
3135004|NCT01703988|3859951|FG000|STARTED|Overall Study||8
3135005|NCT01703988|3859952|FG001|STARTED|Overall Study||8
3135006|NCT01703988|3859953|FG002|STARTED|Overall Study||9
3135007|NCT01703988|3859954|FG003|STARTED|Overall Study||9
3135008|NCT01703988|3859951|FG000|COMPLETED|Overall Study||8
3135009|NCT01703988|3859952|FG001|COMPLETED|Overall Study||8
3135010|NCT01703988|3859953|FG002|COMPLETED|Overall Study||9
3135011|NCT01703988|3859954|FG003|COMPLETED|Overall Study||8
3135012|NCT01703988|3859951|FG000|NOT COMPLETED|Overall Study||0
3135013|NCT01703988|3859952|FG001|NOT COMPLETED|Overall Study||0
3135014|NCT01703988|3859953|FG002|NOT COMPLETED|Overall Study||0
3135015|NCT01703988|3859954|FG003|NOT COMPLETED|Overall Study||1
3135016|NCT01704079|3859967|FG000|STARTED|Overall Study||72
3135017|NCT01704079|3859968|FG001|STARTED|Overall Study||144
3135018|NCT01704079|3859967|FG000|Entered Extension Study|Overall Study||53
3135019|NCT01704079|3859968|FG001|Entered Extension Study|Overall Study||102
3135020|NCT01704079|3859967|FG000|COMPLETED|Overall Study||58
3135021|NCT01704079|3859968|FG001|COMPLETED|Overall Study||121
3135022|NCT01704079|3859967|FG000|NOT COMPLETED|Overall Study||14
3135023|NCT01704079|3859968|FG001|NOT COMPLETED|Overall Study||23
3135024|NCT01704196|3859976|FG000|STARTED|Overall Study||90
3135025|NCT01704196|3859977|FG001|STARTED|Overall Study||89
3135026|NCT01704196|3859976|FG000|COMPLETED|Overall Study||71
3135027|NCT01704196|3859977|FG001|COMPLETED|Overall Study||65
3135028|NCT01704196|3859976|FG000|NOT COMPLETED|Overall Study||19
3088987|NCT01428024|3810789|FG000|STARTED|Overall Study||30
3088988|NCT01428024|3810790|FG001|STARTED|Overall Study||30
3088989|NCT01428024|3810789|FG000|COMPLETED|Overall Study||29
3088990|NCT01428024|3810790|FG001|COMPLETED|Overall Study||29
3088991|NCT01428024|3810789|FG000|NOT COMPLETED|Overall Study||1
3088992|NCT01428024|3810790|FG001|NOT COMPLETED|Overall Study||1
3088993|NCT01428063|3810810|FG000|STARTED|Overall Study||99
3088994|NCT01428063|3810811|FG001|STARTED|Overall Study||122
3088995|NCT01428063|3810812|FG002|STARTED|Overall Study||6
3088996|NCT01428063|3810810|FG000|COMPLETED|Overall Study||89
3088997|NCT01428063|3810811|FG001|COMPLETED|Overall Study||112
3088998|NCT01428063|3810812|FG002|COMPLETED|Overall Study||5
3088999|NCT01428063|3810810|FG000|NOT COMPLETED|Overall Study||10
3089000|NCT01428063|3810811|FG001|NOT COMPLETED|Overall Study||10
3089001|NCT01428063|3810812|FG002|NOT COMPLETED|Overall Study||1
3089002|NCT01428076|3810833|FG000|STARTED|Overall Study||9
3089003|NCT01428076|3810834|FG001|STARTED|Overall Study||12
3089004|NCT01428076|3810833|FG000|COMPLETED|Overall Study||9
3089005|NCT01428076|3810834|FG001|COMPLETED|Overall Study||11
3089006|NCT01428076|3810833|FG000|NOT COMPLETED|Overall Study||0
3089007|NCT01428076|3810834|FG001|NOT COMPLETED|Overall Study||1
3089008|NCT01428115|3810842|FG000|STARTED|Overall Study||83
3089009|NCT01428115|3810842|FG000|COMPLETED|Overall Study||62
3089010|NCT01428115|3810842|FG000|NOT COMPLETED|Overall Study||21
3089011|NCT01428128|3810847|FG000|STARTED|Overall Study||50
3089012|NCT01428128|3810847|FG000|COMPLETED|Overall Study||33
3089013|NCT01428128|3810847|FG000|NOT COMPLETED|Overall Study||17
3089014|NCT01428193|3810852|FG000|STARTED|Overall Study||4
3089015|NCT01428193|3810852|FG000|COMPLETED|Overall Study||2
3089016|NCT01428193|3810852|FG000|NOT COMPLETED|Overall Study||2
3089017|NCT01428219|3810856|FG000|STARTED|Overall Study||25
3089018|NCT01428219|3810856|FG000|COMPLETED|Overall Study||22
3089019|NCT01428219|3810856|FG000|NOT COMPLETED|Overall Study||3
3089020|NCT01428245|3810860|FG000|STARTED|Overall Study||1
3089021|NCT01428245|3810860|FG000|COMPLETED|Overall Study||1
3089022|NCT01428245|3810860|FG000|NOT COMPLETED|Overall Study||0
3089023|NCT01428258|3810866|FG000|STARTED|Intervention 1||17
3089024|NCT01428258|3810867|FG001|STARTED|Intervention 1||15
3089025|NCT01428258|3810866|FG000|COMPLETED|Intervention 1||15
3089026|NCT01428258|3810867|FG001|COMPLETED|Intervention 1||15
3089027|NCT01428258|3810866|FG000|NOT COMPLETED|Intervention 1||2
3089028|NCT01428258|3810867|FG001|NOT COMPLETED|Intervention 1||0
3089029|NCT01428258|3810866|FG000|STARTED|Intervention 2||15
3089030|NCT01428258|3810867|FG001|STARTED|Intervention 2||15
3089031|NCT01428258|3810866|FG000|COMPLETED|Intervention 2||15
3089032|NCT01428258|3810867|FG001|COMPLETED|Intervention 2||15
3089033|NCT01428258|3810866|FG000|NOT COMPLETED|Intervention 2||0
3089034|NCT01428258|3810867|FG001|NOT COMPLETED|Intervention 2||0
3089035|NCT01428336|3810883|FG000|STARTED|Overall Study||10
3089036|NCT01428336|3810884|FG001|STARTED|Overall Study||12
3089037|NCT01428336|3810883|FG000|COMPLETED|Overall Study||10
3089038|NCT01428336|3810884|FG001|COMPLETED|Overall Study||12
3089039|NCT01428336|3810883|FG000|NOT COMPLETED|Overall Study||0
3089040|NCT01428336|3810884|FG001|NOT COMPLETED|Overall Study||0
3089041|NCT01428453|3810895|FG000|STARTED|Overall Study||62
3089042|NCT01428453|3810896|FG001|STARTED|Overall Study||61
3089043|NCT01428453|3810895|FG000|COMPLETED|Overall Study||56
3089044|NCT01428453|3810896|FG001|COMPLETED|Overall Study||52
3089045|NCT01428453|3810895|FG000|NOT COMPLETED|Overall Study||6
3089046|NCT01428453|3810896|FG001|NOT COMPLETED|Overall Study||9
3089047|NCT01428583|3810904|FG000|STARTED|Overall Study||395
3089048|NCT01428583|3810904|FG000|COMPLETED|Overall Study||158
3089049|NCT01428583|3810904|FG000|NOT COMPLETED|Overall Study||237
3089050|NCT01428661|3810911|FG000|STARTED|Double-Masked Phase||254
3089051|NCT01428661|3810912|FG001|STARTED|Double-Masked Phase||253
3089052|NCT01428661|3810913|FG002|STARTED|Double-Masked Phase|Does not apply.|0
3089053|NCT01428661|3810911|FG000|COMPLETED|Double-Masked Phase||197
3089054|NCT01428661|3810912|FG001|COMPLETED|Double-Masked Phase||204
3089055|NCT01428661|3810913|FG002|COMPLETED|Double-Masked Phase|Does not apply.|0
3089056|NCT01428661|3810911|FG000|NOT COMPLETED|Double-Masked Phase||57
3089057|NCT01428661|3810912|FG001|NOT COMPLETED|Double-Masked Phase||49
3089058|NCT01428661|3810913|FG002|NOT COMPLETED|Double-Masked Phase||0
3089059|NCT01428661|3810911|FG000|STARTED|Open Label Extension|Does not apply.|0
3089060|NCT01428661|3810912|FG001|STARTED|Open Label Extension|Does not apply.|0
3089061|NCT01428661|3810913|FG002|STARTED|Open Label Extension||339
3089062|NCT01428661|3810911|FG000|COMPLETED|Open Label Extension|Does not apply.|0
3089063|NCT01428661|3810912|FG001|COMPLETED|Open Label Extension|Does not apply.|0
3089064|NCT01428661|3810913|FG002|COMPLETED|Open Label Extension||19
3089065|NCT01428661|3810911|FG000|NOT COMPLETED|Open Label Extension||0
3089066|NCT01428661|3810912|FG001|NOT COMPLETED|Open Label Extension||0
3089067|NCT01428661|3810913|FG002|NOT COMPLETED|Open Label Extension||320
3089068|NCT01428713|3810921|FG000|STARTED|Overall Study||9
3089069|NCT01428713|3810922|FG001|STARTED|Overall Study||8
3089070|NCT01428713|3810921|FG000|COMPLETED|Overall Study||6
3089071|NCT01428713|3810922|FG001|COMPLETED|Overall Study||3
3089072|NCT01428713|3810921|FG000|NOT COMPLETED|Overall Study||3
3089073|NCT01428713|3810922|FG001|NOT COMPLETED|Overall Study||5
3089074|NCT01428765|3810928|FG000|STARTED|Overall Study||1063
3089075|NCT01428765|3810928|FG000|COMPLETED|Overall Study||1063
3089076|NCT01428765|3810928|FG000|NOT COMPLETED|Overall Study||0
3089077|NCT01428882|3810934|FG000|STARTED|Overall Study||67
3089078|NCT01428882|3810935|FG001|STARTED|Overall Study||68
3089079|NCT01428882|3810934|FG000|COMPLETED|Overall Study||61
3089080|NCT01428882|3810935|FG001|COMPLETED|Overall Study||58
3089081|NCT01428882|3810934|FG000|NOT COMPLETED|Overall Study||6
3089082|NCT01428882|3810935|FG001|NOT COMPLETED|Overall Study||10
3089083|NCT01429051|3810941|FG000|STARTED|Titration Phase||45
3089084|NCT01429051|3810941|FG000|COMPLETED|Titration Phase||33
3089085|NCT01429051|3810941|FG000|NOT COMPLETED|Titration Phase||12
3089086|NCT01429051|3810941|FG000|STARTED|Efficacy Phase|Participants titrated to 200 or 400 μg INFS in Titration Phase|15
3089087|NCT01429051|3810941|FG000|COMPLETED|Efficacy Phase||13
3089088|NCT01429051|3810941|FG000|NOT COMPLETED|Efficacy Phase||2
3089089|NCT01429051|3810941|FG000|STARTED|Tolerability Phase|Participants entered directly from the Titration or Efficacy Phase|31
3089090|NCT01429051|3810941|FG000|COMPLETED|Tolerability Phase||16
3089091|NCT01429051|3810941|FG000|NOT COMPLETED|Tolerability Phase||15
3089092|NCT01429064|3810956|FG000|STARTED|Overall Study||19
3089093|NCT01429064|3810957|FG001|STARTED|Overall Study||22
3089094|NCT01429064|3810958|FG002|STARTED|Overall Study||19
3089095|NCT01429064|3810959|FG003|STARTED|Overall Study||16
3089096|NCT01429064|3810956|FG000|COMPLETED|Overall Study||19
3089097|NCT01429064|3810957|FG001|COMPLETED|Overall Study||22
3089098|NCT01429064|3810958|FG002|COMPLETED|Overall Study||19
3089099|NCT01429064|3810959|FG003|COMPLETED|Overall Study||16
3089100|NCT01429064|3810956|FG000|NOT COMPLETED|Overall Study||0
3089101|NCT01429064|3810957|FG001|NOT COMPLETED|Overall Study||0
3089102|NCT01429064|3810958|FG002|NOT COMPLETED|Overall Study||0
3089103|NCT01429064|3810959|FG003|NOT COMPLETED|Overall Study||0
3089104|NCT01429077|3810971|FG000|STARTED|Overall Study||19
3089105|NCT01429077|3810972|FG001|STARTED|Overall Study||17
3089106|NCT01429077|3810971|FG000|Completed 6-week Intervention|Overall Study||19
3089107|NCT01429077|3810972|FG001|Completed 6-week Intervention|Overall Study||17
3089108|NCT01429077|3810971|FG000|COMPLETED|Overall Study||19
3089109|NCT01429077|3810972|FG001|COMPLETED|Overall Study||14
3089110|NCT01429077|3810971|FG000|NOT COMPLETED|Overall Study||0
3089111|NCT01429077|3810972|FG001|NOT COMPLETED|Overall Study||3
3089112|NCT01429259|3810978|FG000|STARTED|Overall Study||30
3089113|NCT01429259|3810978|FG000|COMPLETED|Overall Study||30
3089114|NCT01429259|3810978|FG000|NOT COMPLETED|Overall Study||0
3089115|NCT01429272|3810986|FG000|STARTED|Overall Study||30
3089116|NCT01429272|3810987|FG001|STARTED|Overall Study||31
3089117|NCT01429272|3810988|FG002|STARTED|Overall Study||19
3089118|NCT01429272|3810989|FG003|STARTED|Overall Study||19
3089119|NCT01429272|3810986|FG000|COMPLETED|Overall Study||24
3089120|NCT01429272|3810987|FG001|COMPLETED|Overall Study||22
3089121|NCT01429272|3810988|FG002|COMPLETED|Overall Study||15
3089122|NCT01429272|3810989|FG003|COMPLETED|Overall Study||14
3089123|NCT01429272|3810986|FG000|NOT COMPLETED|Overall Study||6
3089124|NCT01429272|3810987|FG001|NOT COMPLETED|Overall Study||9
3089125|NCT01429272|3810988|FG002|NOT COMPLETED|Overall Study||4
3089126|NCT01429272|3810989|FG003|NOT COMPLETED|Overall Study||5
3089127|NCT01429285|3811001|FG000|STARTED|Overall Study||175
3089128|NCT01429285|3811002|FG001|STARTED|Overall Study||175
3089129|NCT01429285|3811001|FG000|Given IV Opioids|Overall Study|9 patients never given IV opioids|166
3089130|NCT01429285|3811002|FG001|Given IV Opioids|Overall Study|4 patients never given IV opioids|171
3089131|NCT01429285|3811001|FG000|Completed Primary Outcome Data|Overall Study|5 patients had missing data|161
3089132|NCT01429285|3811002|FG001|Completed Primary Outcome Data|Overall Study|3 patients had missing data|168
3089133|NCT01429285|3811001|FG000|Confirmation of no Duplicate Enrollment|Overall Study|8 patients were enrolled twice at two separate ED visits, which was only noted at study conclusion.|153
3089134|NCT01429285|3811002|FG001|Confirmation of no Duplicate Enrollment|Overall Study|2 patients were enrolled twice, at two separate ED visits, which was only noted at study conclusion|166
3089135|NCT01429285|3811001|FG000|COMPLETED|Overall Study||153
3089136|NCT01429285|3811002|FG001|COMPLETED|Overall Study||166
3089137|NCT01429285|3811001|FG000|NOT COMPLETED|Overall Study||22
3089138|NCT01429285|3811002|FG001|NOT COMPLETED|Overall Study||9
3089139|NCT01429298|3811010|FG000|STARTED|Overall Study||175
3089140|NCT01429298|3811011|FG001|STARTED|Overall Study||175
3089141|NCT01429298|3811010|FG000|Given IV Opioids|Overall Study|4 never given IV opioids|171
3089142|NCT01429298|3811011|FG001|Given IV Opioids|Overall Study|6 never given IV opioids|169
3089143|NCT01429298|3811010|FG000|COMPLETED|Overall Study||171
3089144|NCT01429298|3811011|FG001|COMPLETED|Overall Study||169
3089145|NCT01429298|3811010|FG000|NOT COMPLETED|Overall Study||4
3089146|NCT01429298|3811011|FG001|NOT COMPLETED|Overall Study||6
3089147|NCT01429350|3811019|FG000|STARTED|Overall Study||53
3089148|NCT01429350|3811020|FG001|STARTED|Overall Study||55
3089149|NCT01429350|3811019|FG000|As-Treated|Overall Study||62
3089150|NCT01429350|3811020|FG001|As-Treated|Overall Study||43
3089151|NCT01429350|3811019|FG000|Per Protocol|Overall Study||41
3089152|NCT01429350|3811020|FG001|Per Protocol|Overall Study||37
3089153|NCT01429350|3811019|FG000|90 Day|Overall Study||46
3089154|NCT01429350|3811020|FG001|90 Day|Overall Study||50
3089155|NCT01429350|3811019|FG000|COMPLETED|Overall Study||46
3089156|NCT01429350|3811020|FG001|COMPLETED|Overall Study||50
3089157|NCT01429350|3811019|FG000|NOT COMPLETED|Overall Study||7
3089158|NCT01429350|3811020|FG001|NOT COMPLETED|Overall Study||5
3089159|NCT01429441|3811028|FG000|STARTED|Overall Study||146
3089160|NCT01429441|3811029|FG001|STARTED|Overall Study||74
3089161|NCT01429441|3811028|FG000|COMPLETED|Overall Study||108
3089162|NCT01429441|3811029|FG001|COMPLETED|Overall Study||51
3089163|NCT01429441|3811028|FG000|NOT COMPLETED|Overall Study||38
3089164|NCT01429441|3811029|FG001|NOT COMPLETED|Overall Study||23
3089165|NCT01429454|3811037|FG000|STARTED|Overall Study||62
3089166|NCT01429454|3811038|FG001|STARTED|Overall Study||65
3089167|NCT01429454|3811037|FG000|COMPLETED|Overall Study||35
3089168|NCT01429454|3811038|FG001|COMPLETED|Overall Study||35
3089169|NCT01429454|3811037|FG000|NOT COMPLETED|Overall Study||27
3089170|NCT01429454|3811038|FG001|NOT COMPLETED|Overall Study||30
3089171|NCT01429532|3811048|FG000|STARTED|Overall Study||40
3089172|NCT01429532|3811049|FG001|STARTED|Overall Study||40
3089173|NCT01429532|3811050|FG002|STARTED|Overall Study||40
3089174|NCT01429532|3811048|FG000|COMPLETED|Overall Study||40
3089175|NCT01429532|3811049|FG001|COMPLETED|Overall Study||40
3089176|NCT01429532|3811050|FG002|COMPLETED|Overall Study||40
3089177|NCT01429532|3811048|FG000|NOT COMPLETED|Overall Study||0
3089178|NCT01429532|3811049|FG001|NOT COMPLETED|Overall Study||0
3089179|NCT01429532|3811050|FG002|NOT COMPLETED|Overall Study||0
3089180|NCT01429584|3811060|FG000|STARTED|Overall Study||15
3089181|NCT01429584|3811061|FG001|STARTED|Overall Study||15
3089182|NCT01429584|3811060|FG000|COMPLETED|Overall Study||14
3089183|NCT01429584|3811061|FG001|COMPLETED|Overall Study||14
3089184|NCT01429584|3811060|FG000|NOT COMPLETED|Overall Study||1
3089185|NCT01429584|3811061|FG001|NOT COMPLETED|Overall Study||1
3089186|NCT01429623|3811069|FG000|STARTED|Overall Study|103 allocated, 1 withdrew consent prior to first dose, 4 lacked post baseline data|102
3089187|NCT01429623|3811070|FG001|STARTED|Overall Study|107 allocated, 4 lacked post baseline data|107
3089188|NCT01429623|3811069|FG000|Converted to Alzheimer's|Overall Study|14 of 99|14
3089189|NCT01429623|3811070|FG001|Converted to Alzheimer's|Overall Study|21 of 103|21
3089190|NCT01429623|3811069|FG000|COMPLETED|Overall Study||51
3089191|NCT01429623|3811070|FG001|COMPLETED|Overall Study||48
3089192|NCT01429623|3811069|FG000|NOT COMPLETED|Overall Study||51
3089193|NCT01429623|3811070|FG001|NOT COMPLETED|Overall Study||59
3089194|NCT01429792|3811076|FG000|STARTED|Overall Study||1013
3089195|NCT01429792|3811076|FG000|Genotype 1|Overall Study||687
3089196|NCT01429792|3811076|FG000|Genotype 2 & 3|Overall Study||305
3089197|NCT01429792|3811076|FG000|Genotype 4|Overall Study||5
3288353|NCT02798627|4021925|FG001|NOT COMPLETED|Overall Study||0
3288354|NCT02798835|4021934|FG000|STARTED|Overall Study||60
3288355|NCT02798835|4021935|FG001|STARTED|Overall Study||60
3288356|NCT02798835|4021936|FG002|STARTED|Overall Study||60
3288357|NCT02798835|4021934|FG000|COMPLETED|Overall Study||60
3288358|NCT02798835|4021935|FG001|COMPLETED|Overall Study||60
3288359|NCT02798835|4021936|FG002|COMPLETED|Overall Study||57
3288360|NCT02798835|4021934|FG000|NOT COMPLETED|Overall Study||0
3288361|NCT02798835|4021935|FG001|NOT COMPLETED|Overall Study||0
3288362|NCT02798835|4021936|FG002|NOT COMPLETED|Overall Study||3
3288363|NCT02798861|4021944|FG000|STARTED|Overall Study||160
3288364|NCT02798861|4021944|FG000|COMPLETED|Overall Study||137
3288365|NCT02798861|4021944|FG000|NOT COMPLETED|Overall Study||23
3288366|NCT02798952|4021948|FG000|STARTED|Overall Study||302
3288367|NCT02798952|4021948|FG000|COMPLETED|Overall Study||302
3288368|NCT02798952|4021948|FG000|NOT COMPLETED|Overall Study||0
3288369|NCT02798978|4021959|FG000|STARTED|Part 1 (30 Days)||10
3288370|NCT02798978|4021960|FG001|STARTED|Part 1 (30 Days)||6
3288371|NCT02798978|4021961|FG002|STARTED|Part 1 (30 Days)||6
3288372|NCT02798978|4021962|FG003|STARTED|Part 1 (30 Days)||6
3288373|NCT02798978|4021963|FG004|STARTED|Part 1 (30 Days)||6
3288374|NCT02798978|4021964|FG005|STARTED|Part 1 (30 Days)||6
3288375|NCT02798978|4021965|FG006|STARTED|Part 1 (30 Days)||0
3288376|NCT02798978|4021959|FG000|COMPLETED|Part 1 (30 Days)||10
3288377|NCT02798978|4021960|FG001|COMPLETED|Part 1 (30 Days)||6
3288378|NCT02798978|4021961|FG002|COMPLETED|Part 1 (30 Days)||6
3288379|NCT02798978|4021962|FG003|COMPLETED|Part 1 (30 Days)||6
3288380|NCT02798978|4021963|FG004|COMPLETED|Part 1 (30 Days)||6
3288381|NCT02798978|4021964|FG005|COMPLETED|Part 1 (30 Days)||6
3288382|NCT02798978|4021965|FG006|COMPLETED|Part 1 (30 Days)||0
3288383|NCT02798978|4021959|FG000|NOT COMPLETED|Part 1 (30 Days)||0
3288384|NCT02798978|4021960|FG001|NOT COMPLETED|Part 1 (30 Days)||0
3288385|NCT02798978|4021961|FG002|NOT COMPLETED|Part 1 (30 Days)||0
3288386|NCT02798978|4021962|FG003|NOT COMPLETED|Part 1 (30 Days)||0
3288387|NCT02798978|4021963|FG004|NOT COMPLETED|Part 1 (30 Days)||0
3288388|NCT02798978|4021964|FG005|NOT COMPLETED|Part 1 (30 Days)||0
3288389|NCT02798978|4021965|FG006|NOT COMPLETED|Part 1 (30 Days)||0
3288390|NCT02798978|4021959|FG000|STARTED|Part 2 (45 Days)||0
3288391|NCT02798978|4021960|FG001|STARTED|Part 2 (45 Days)||0
3288392|NCT02798978|4021961|FG002|STARTED|Part 2 (45 Days)||0
3288393|NCT02798978|4021962|FG003|STARTED|Part 2 (45 Days)||0
3288394|NCT02798978|4021963|FG004|STARTED|Part 2 (45 Days)||0
3288395|NCT02798978|4021964|FG005|STARTED|Part 2 (45 Days)||0
3288396|NCT02798978|4021965|FG006|STARTED|Part 2 (45 Days)||0
3288397|NCT02798978|4021959|FG000|COMPLETED|Part 2 (45 Days)||0
3288398|NCT02798978|4021960|FG001|COMPLETED|Part 2 (45 Days)||0
3288399|NCT02798978|4021961|FG002|COMPLETED|Part 2 (45 Days)||0
3288400|NCT02798978|4021962|FG003|COMPLETED|Part 2 (45 Days)||0
3288401|NCT02798978|4021963|FG004|COMPLETED|Part 2 (45 Days)||0
3288402|NCT02798978|4021964|FG005|COMPLETED|Part 2 (45 Days)||0
3288403|NCT02798978|4021965|FG006|COMPLETED|Part 2 (45 Days)||0
3288404|NCT02798978|4021959|FG000|NOT COMPLETED|Part 2 (45 Days)||0
3288405|NCT02798978|4021960|FG001|NOT COMPLETED|Part 2 (45 Days)||0
3288406|NCT02798978|4021961|FG002|NOT COMPLETED|Part 2 (45 Days)||0
3288407|NCT02798978|4021962|FG003|NOT COMPLETED|Part 2 (45 Days)||0
3288408|NCT02798978|4021963|FG004|NOT COMPLETED|Part 2 (45 Days)||0
3288409|NCT02798978|4021964|FG005|NOT COMPLETED|Part 2 (45 Days)||0
3089198|NCT01429792|3811076|FG000|COMPLETED|Overall Study||607
3089199|NCT01429792|3811076|FG000|NOT COMPLETED|Overall Study||406
3089200|NCT01429987|3811084|FG000|STARTED|Overall Study||238
3089201|NCT01429987|3811085|FG001|STARTED|Overall Study||238
3089202|NCT01429987|3811086|FG002|STARTED|Overall Study||238
3089203|NCT01429987|3811087|FG003|STARTED|Overall Study||237
3089204|NCT01429987|3811084|FG000|COMPLETED|Overall Study||189
3089205|NCT01429987|3811085|FG001|COMPLETED|Overall Study||176
3089206|NCT01429987|3811086|FG002|COMPLETED|Overall Study||202
3089207|NCT01429987|3811087|FG003|COMPLETED|Overall Study||171
3089208|NCT01429987|3811084|FG000|NOT COMPLETED|Overall Study||49
3089209|NCT01429987|3811085|FG001|NOT COMPLETED|Overall Study||62
3089210|NCT01429987|3811086|FG002|NOT COMPLETED|Overall Study||36
3089211|NCT01429987|3811087|FG003|NOT COMPLETED|Overall Study||66
3089212|NCT01430091|3811097|FG000|STARTED|Overall Study||18
3089213|NCT01430091|3811097|FG000|COMPLETED|Overall Study||18
3089214|NCT01430091|3811097|FG000|NOT COMPLETED|Overall Study||0
3089215|NCT01430104|3811111|FG000|STARTED|14-Day Lead-In Period||30
3089216|NCT01430104|3811111|FG000|COMPLETED|14-Day Lead-In Period||30
3089217|NCT01430104|3811111|FG000|NOT COMPLETED|14-Day Lead-In Period||0
3089218|NCT01430104|3811111|FG000|STARTED|28-Day Teriparatide Treatment Period|1 participant withdrew from the study after completing the 14-day Lead-in Period.|29
3089219|NCT01430104|3811111|FG000|Received at Least 1 Dose of Teriparatide|28-Day Teriparatide Treatment Period||29
3089220|NCT01430104|3811111|FG000|COMPLETED|28-Day Teriparatide Treatment Period||28
3089221|NCT01430104|3811111|FG000|NOT COMPLETED|28-Day Teriparatide Treatment Period||1
3089222|NCT01430130|3811118|FG000|STARTED|Overall Study||12
3089223|NCT01430130|3811118|FG000|COMPLETED|Overall Study||10
3089224|NCT01430130|3811118|FG000|NOT COMPLETED|Overall Study||2
3089225|NCT01430169|3811124|FG000|STARTED|Overall Study||20
3089226|NCT01430169|3811124|FG000|COMPLETED|Overall Study||20
3089227|NCT01430169|3811124|FG000|NOT COMPLETED|Overall Study||0
3089228|NCT01430182|3811130|FG000|STARTED|Overall Study||9
3089229|NCT01430182|3811131|FG001|STARTED|Overall Study||8
3089230|NCT01430182|3811130|FG000|COMPLETED|Overall Study||9
3089231|NCT01430182|3811131|FG001|COMPLETED|Overall Study||8
3089232|NCT01430182|3811130|FG000|NOT COMPLETED|Overall Study||0
3089233|NCT01430182|3811131|FG001|NOT COMPLETED|Overall Study||0
3288410|NCT02798978|4021965|FG006|NOT COMPLETED|Part 2 (45 Days)||0
3288411|NCT02799069|4021990|FG000|STARTED|Overall Study||76
3288412|NCT02799069|4021991|FG001|STARTED|Overall Study||248
3288413|NCT02799069|4021992|FG002|STARTED|Overall Study||247
3288414|NCT02799069|4021990|FG000|ITT/Safety|Overall Study||76
3288415|NCT02799069|4021991|FG001|ITT/Safety|Overall Study||248
3288416|NCT02799069|4021992|FG002|ITT/Safety|Overall Study|1 subject received medication without Illumination and thus was excluded from ITT/safety population|246
3288417|NCT02799069|4021990|FG000|COMPLETED|Overall Study||68
3288418|NCT02799069|4021991|FG001|COMPLETED|Overall Study||241
3288419|NCT02799069|4021992|FG002|COMPLETED|Overall Study||240
3288420|NCT02799069|4021990|FG000|NOT COMPLETED|Overall Study||8
3288421|NCT02799069|4021991|FG001|NOT COMPLETED|Overall Study||7
3288422|NCT02799069|4021992|FG002|NOT COMPLETED|Overall Study||7
3288423|NCT02799082|4022002|FG000|STARTED|Overall Study||41
3288424|NCT02799082|4022003|FG001|STARTED|Overall Study||81
3288425|NCT02799082|4022002|FG000|COMPLETED|Overall Study||37
3288426|NCT02799082|4022003|FG001|COMPLETED|Overall Study||77
3288427|NCT02799082|4022002|FG000|NOT COMPLETED|Overall Study||4
3288428|NCT02799082|4022003|FG001|NOT COMPLETED|Overall Study||4
3288429|NCT02799290|4022012|FG000|STARTED|Overall Study||24
3288430|NCT02799290|4022013|FG001|STARTED|Overall Study||13
3288431|NCT02799290|4022014|FG002|STARTED|Overall Study||11
3288432|NCT02799290|4022012|FG000|COMPLETED|Overall Study||24
3288433|NCT02799290|4022013|FG001|COMPLETED|Overall Study||13
3288434|NCT02799290|4022014|FG002|COMPLETED|Overall Study||11
3288435|NCT02799290|4022012|FG000|NOT COMPLETED|Overall Study||0
3288436|NCT02799290|4022013|FG001|NOT COMPLETED|Overall Study||0
3288437|NCT02799290|4022014|FG002|NOT COMPLETED|Overall Study||0
3288438|NCT02799381|4022028|FG000|STARTED|Overall Study||33
3288439|NCT02799381|4022029|FG001|STARTED|Overall Study||28
3288440|NCT02799381|4022028|FG000|COMPLETED|Overall Study||29
3288441|NCT02799381|4022029|FG001|COMPLETED|Overall Study||25
3288442|NCT02799381|4022028|FG000|NOT COMPLETED|Overall Study||4
3288443|NCT02799381|4022029|FG001|NOT COMPLETED|Overall Study||3
3288444|NCT02799472|4022037|FG000|STARTED|Overall Study||11
3288445|NCT02799472|4022038|FG001|STARTED|Overall Study||28
3288446|NCT02799472|4022037|FG000|COMPLETED|Overall Study||7
3288447|NCT02799472|4022038|FG001|COMPLETED|Overall Study||23
3288448|NCT02799472|4022037|FG000|NOT COMPLETED|Overall Study||4
3288449|NCT02799472|4022038|FG001|NOT COMPLETED|Overall Study||5
3288450|NCT02799667|4022046|FG000|STARTED|Overall Study||55
3288451|NCT02799667|4022047|FG001|STARTED|Overall Study||55
3288452|NCT02799667|4022046|FG000|COMPLETED|Overall Study||54
3288453|NCT02799667|4022047|FG001|COMPLETED|Overall Study||54
3288454|NCT02799667|4022046|FG000|NOT COMPLETED|Overall Study||1
3288455|NCT02799667|4022047|FG001|NOT COMPLETED|Overall Study||1
3288456|NCT02799745|4022055|FG000|STARTED|Overall Study||114
3288457|NCT02799745|4022056|FG001|STARTED|Overall Study||113
3288458|NCT02799745|4022055|FG000|Treated|Overall Study||112
3288459|NCT02799745|4022056|FG001|Treated|Overall Study||113
3089234|NCT01430299|3811139|FG000|STARTED|Overall Study||20
3089235|NCT01430299|3811140|FG001|STARTED|Overall Study||23
3288460|NCT02799745|4022055|FG000|COMPLETED|Overall Study||58
3089236|NCT01430299|3811139|FG000|COMPLETED|Overall Study||16
3089237|NCT01430299|3811140|FG001|COMPLETED|Overall Study||21
3089238|NCT01430299|3811139|FG000|NOT COMPLETED|Overall Study||4
3089239|NCT01430299|3811140|FG001|NOT COMPLETED|Overall Study||2
3089240|NCT01430325|3811150|FG000|STARTED|Overall Study||10
3089241|NCT01430325|3811151|FG001|STARTED|Overall Study||12
3089242|NCT01430325|3811152|FG002|STARTED|Overall Study||8
3089243|NCT01430325|3811153|FG003|STARTED|Overall Study||12
3089244|NCT01430325|3811150|FG000|COMPLETED|Overall Study||10
3089245|NCT01430325|3811151|FG001|COMPLETED|Overall Study||12
3089246|NCT01430325|3811152|FG002|COMPLETED|Overall Study||8
3089247|NCT01430325|3811153|FG003|COMPLETED|Overall Study||12
3089248|NCT01430325|3811150|FG000|NOT COMPLETED|Overall Study||0
3089249|NCT01430325|3811151|FG001|NOT COMPLETED|Overall Study||0
3089250|NCT01430325|3811152|FG002|NOT COMPLETED|Overall Study||0
3089251|NCT01430325|3811153|FG003|NOT COMPLETED|Overall Study||0
3089252|NCT01430403|3811166|FG000|STARTED|Overall Study|Intent-to-treat|259
3089253|NCT01430403|3811167|FG001|STARTED|Overall Study|Intent-to-treat|130
3089254|NCT01430403|3811168|FG002|STARTED|Overall Study|Intent-to-treat|89
3089255|NCT01430403|3811166|FG000|COMPLETED|Overall Study||242
3089256|NCT01430403|3811167|FG001|COMPLETED|Overall Study||121
3089257|NCT01430403|3811168|FG002|COMPLETED|Overall Study||81
3089258|NCT01430403|3811166|FG000|NOT COMPLETED|Overall Study||17
3089259|NCT01430403|3811167|FG001|NOT COMPLETED|Overall Study||9
3089260|NCT01430403|3811168|FG002|NOT COMPLETED|Overall Study||8
3089261|NCT01430442|3811189|FG000|STARTED|Overall Study||85
3089262|NCT01430442|3811190|FG001|STARTED|Overall Study||68
3089263|NCT01430442|3811191|FG002|STARTED|Overall Study||91
3288461|NCT02799745|4022056|FG001|COMPLETED|Overall Study||42
3288462|NCT02799745|4022055|FG000|NOT COMPLETED|Overall Study||56
3288463|NCT02799745|4022056|FG001|NOT COMPLETED|Overall Study||71
3288464|NCT02799784|4022062|FG000|STARTED|Treatment Period 1 (TP1- 8 Weeks)||117
3288465|NCT02799784|4022063|FG001|STARTED|Treatment Period 1 (TP1- 8 Weeks)||119
3288466|NCT02799784|4022062|FG000|COMPLETED|Treatment Period 1 (TP1- 8 Weeks)||111
3288467|NCT02799784|4022063|FG001|COMPLETED|Treatment Period 1 (TP1- 8 Weeks)||118
3288468|NCT02799784|4022062|FG000|NOT COMPLETED|Treatment Period 1 (TP1- 8 Weeks)||6
3288469|NCT02799784|4022063|FG001|NOT COMPLETED|Treatment Period 1 (TP1- 8 Weeks)||1
3288470|NCT02799784|4022062|FG000|STARTED|Washout Period (3 Weeks)||111
3288471|NCT02799784|4022063|FG001|STARTED|Washout Period (3 Weeks)||118
3288472|NCT02799784|4022062|FG000|COMPLETED|Washout Period (3 Weeks)||111
3288473|NCT02799784|4022063|FG001|COMPLETED|Washout Period (3 Weeks)||118
3288474|NCT02799784|4022062|FG000|NOT COMPLETED|Washout Period (3 Weeks)||0
3288475|NCT02799784|4022063|FG001|NOT COMPLETED|Washout Period (3 Weeks)||0
3288476|NCT02799784|4022062|FG000|STARTED|Treatment Period 2 (TP2 - 8 Weeks)||111
3288477|NCT02799784|4022063|FG001|STARTED|Treatment Period 2 (TP2 - 8 Weeks)||118
3288478|NCT02799784|4022062|FG000|COMPLETED|Treatment Period 2 (TP2 - 8 Weeks)||110
3288479|NCT02799784|4022063|FG001|COMPLETED|Treatment Period 2 (TP2 - 8 Weeks)||115
3288480|NCT02799784|4022062|FG000|NOT COMPLETED|Treatment Period 2 (TP2 - 8 Weeks)||1
3288481|NCT02799784|4022063|FG001|NOT COMPLETED|Treatment Period 2 (TP2 - 8 Weeks)||3
3288482|NCT02800148|4022072|FG000|STARTED|Overall Study||224
3288483|NCT02800148|4022073|FG001|STARTED|Overall Study||224
3288484|NCT02800148|4022074|FG002|STARTED|Overall Study||219
3288485|NCT02800148|4022072|FG000|COMPLETED|Overall Study||199
3288486|NCT02800148|4022073|FG001|COMPLETED|Overall Study||204
3288487|NCT02800148|4022074|FG002|COMPLETED|Overall Study||194
3288488|NCT02800148|4022072|FG000|NOT COMPLETED|Overall Study||25
3288489|NCT02800148|4022073|FG001|NOT COMPLETED|Overall Study||20
3288490|NCT02800148|4022074|FG002|NOT COMPLETED|Overall Study||25
3288491|NCT02800213|4022084|FG000|STARTED|First Intervention||35
3288492|NCT02800213|4022085|FG001|STARTED|First Intervention||35
3288493|NCT02800213|4022084|FG000|COMPLETED|First Intervention||35
3288494|NCT02800213|4022085|FG001|COMPLETED|First Intervention||35
3288495|NCT02800213|4022084|FG000|NOT COMPLETED|First Intervention||0
3288496|NCT02800213|4022085|FG001|NOT COMPLETED|First Intervention||0
3288497|NCT02800213|4022084|FG000|STARTED|Second Intervention||35
3288498|NCT02800213|4022085|FG001|STARTED|Second Intervention||35
3288499|NCT02800213|4022084|FG000|COMPLETED|Second Intervention||35
3288500|NCT02800213|4022085|FG001|COMPLETED|Second Intervention||35
3288501|NCT02800213|4022084|FG000|NOT COMPLETED|Second Intervention||0
3288502|NCT02800213|4022085|FG001|NOT COMPLETED|Second Intervention||0
3316690|NCT03118297|4050123|FG001|COMPLETED|Overall Study||31
3316691|NCT03118297|4050122|FG000|NOT COMPLETED|Overall Study||0
3316692|NCT03118297|4050123|FG001|NOT COMPLETED|Overall Study||2
3316693|NCT03118466|4050129|FG000|STARTED|Overall Study||40
3316694|NCT03118466|4050129|FG000|COMPLETED|Overall Study||40
3316695|NCT03118466|4050129|FG000|NOT COMPLETED|Overall Study||0
3316696|NCT03118518|4050135|FG000|STARTED|Overall Study||108
3316697|NCT03118518|4050136|FG001|STARTED|Overall Study||102
3316698|NCT03118518|4050135|FG000|Subject Treated According to Randomization Assignment|Overall Study||104
3316699|NCT03118518|4050136|FG001|Subject Treated According to Randomization Assignment|Overall Study||99
3316700|NCT03118518|4050135|FG000|COMPLETED|Overall Study||102
3316701|NCT03118518|4050136|FG001|COMPLETED|Overall Study||91
3316702|NCT03118518|4050135|FG000|NOT COMPLETED|Overall Study||6
3316703|NCT03118518|4050136|FG001|NOT COMPLETED|Overall Study||11
3089264|NCT01430442|3811192|FG003|STARTED|Overall Study||90
3089265|NCT01430442|3811193|FG004|STARTED|Overall Study||121
3089266|NCT01430442|3811194|FG005|STARTED|Overall Study||92
3089267|NCT01430442|3811195|FG006|STARTED|Overall Study||229
3089268|NCT01430442|3811196|FG007|STARTED|Overall Study||109
3089269|NCT01430442|3811189|FG000|COMPLETED|Overall Study||72
3089270|NCT01430442|3811190|FG001|COMPLETED|Overall Study||62
3089271|NCT01430442|3811191|FG002|COMPLETED|Overall Study||86
3089272|NCT01430442|3811192|FG003|COMPLETED|Overall Study||86
3089273|NCT01430442|3811193|FG004|COMPLETED|Overall Study||112
3089274|NCT01430442|3811194|FG005|COMPLETED|Overall Study||84
3089275|NCT01430442|3811195|FG006|COMPLETED|Overall Study||210
3089276|NCT01430442|3811196|FG007|COMPLETED|Overall Study||100
3089277|NCT01430442|3811189|FG000|NOT COMPLETED|Overall Study||13
3089278|NCT01430442|3811190|FG001|NOT COMPLETED|Overall Study||6
3089279|NCT01430442|3811191|FG002|NOT COMPLETED|Overall Study||5
3089280|NCT01430442|3811192|FG003|NOT COMPLETED|Overall Study||4
3089281|NCT01430442|3811193|FG004|NOT COMPLETED|Overall Study||9
3288503|NCT02800356|4022091|FG000|STARTED|Overall Study||20
3288504|NCT02800356|4022091|FG000|COMPLETED|Overall Study||20
3288505|NCT02800356|4022091|FG000|NOT COMPLETED|Overall Study||0
3288506|NCT02800642|4022095|FG000|STARTED|Overall Study||162
3288507|NCT02800642|4022095|FG000|COMPLETED|Overall Study||137
3288508|NCT02800642|4022095|FG000|NOT COMPLETED|Overall Study||25
3288509|NCT02800928|4022099|FG000|STARTED|Overall Study||9
3288510|NCT02800928|4022100|FG001|STARTED|Overall Study||8
3288511|NCT02800928|4022099|FG000|COMPLETED|Overall Study||7
3288512|NCT02800928|4022100|FG001|COMPLETED|Overall Study||6
3288513|NCT02800928|4022099|FG000|NOT COMPLETED|Overall Study||2
3288514|NCT02800928|4022100|FG001|NOT COMPLETED|Overall Study||2
3288515|NCT02801006|4022106|FG000|STARTED|Lens 1||22
3288516|NCT02801006|4022107|FG001|STARTED|Lens 1||19
3288517|NCT02801006|4022106|FG000|COMPLETED|Lens 1||22
3288518|NCT02801006|4022107|FG001|COMPLETED|Lens 1||19
3288519|NCT02801006|4022106|FG000|NOT COMPLETED|Lens 1||0
3288520|NCT02801006|4022107|FG001|NOT COMPLETED|Lens 1||0
3288521|NCT02801006|4022106|FG000|STARTED|Lens 2||22
3288522|NCT02801006|4022107|FG001|STARTED|Lens 2||19
3288523|NCT02801006|4022106|FG000|COMPLETED|Lens 2||22
3288524|NCT02801006|4022107|FG001|COMPLETED|Lens 2||19
3288525|NCT02801006|4022106|FG000|NOT COMPLETED|Lens 2||0
3288526|NCT02801006|4022107|FG001|NOT COMPLETED|Lens 2||0
3288527|NCT02801370|4022117|FG000|STARTED|Overall Study||130
3288528|NCT02801370|4022118|FG001|STARTED|Overall Study||132
3288529|NCT02801370|4022117|FG000|COMPLETED|Overall Study||123
3288530|NCT02801370|4022118|FG001|COMPLETED|Overall Study||132
3288531|NCT02801370|4022117|FG000|NOT COMPLETED|Overall Study||7
3288532|NCT02801370|4022118|FG001|NOT COMPLETED|Overall Study||0
3288533|NCT02801396|4022125|FG000|STARTED|Period 1||17
3288534|NCT02801396|4022126|FG001|STARTED|Period 1||17
3288535|NCT02801396|4022127|FG002|STARTED|Period 1||17
3288536|NCT02801396|4022128|FG003|STARTED|Period 1||16
3288537|NCT02801396|4022129|FG004|STARTED|Period 1||17
3288538|NCT02801396|4022130|FG005|STARTED|Period 1||17
3288539|NCT02801396|4022125|FG000|COMPLETED|Period 1||17
3288540|NCT02801396|4022126|FG001|COMPLETED|Period 1||17
3288541|NCT02801396|4022127|FG002|COMPLETED|Period 1||17
3288542|NCT02801396|4022128|FG003|COMPLETED|Period 1||16
3288543|NCT02801396|4022129|FG004|COMPLETED|Period 1||16
3288544|NCT02801396|4022130|FG005|COMPLETED|Period 1||17
3288545|NCT02801396|4022125|FG000|NOT COMPLETED|Period 1||0
3288546|NCT02801396|4022126|FG001|NOT COMPLETED|Period 1||0
3288547|NCT02801396|4022127|FG002|NOT COMPLETED|Period 1||0
3288548|NCT02801396|4022128|FG003|NOT COMPLETED|Period 1||0
3288549|NCT02801396|4022129|FG004|NOT COMPLETED|Period 1||1
3288550|NCT02801396|4022130|FG005|NOT COMPLETED|Period 1||0
3288551|NCT02801396|4022125|FG000|STARTED|Period 2||17
3288552|NCT02801396|4022126|FG001|STARTED|Period 2||17
3288553|NCT02801396|4022127|FG002|STARTED|Period 2||17
3288554|NCT02801396|4022128|FG003|STARTED|Period 2||16
3288555|NCT02801396|4022129|FG004|STARTED|Period 2||16
3288556|NCT02801396|4022130|FG005|STARTED|Period 2||17
3288557|NCT02801396|4022125|FG000|COMPLETED|Period 2||17
3288558|NCT02801396|4022126|FG001|COMPLETED|Period 2||17
3288559|NCT02801396|4022127|FG002|COMPLETED|Period 2||17
3288560|NCT02801396|4022128|FG003|COMPLETED|Period 2||16
3288561|NCT02801396|4022129|FG004|COMPLETED|Period 2||16
3288562|NCT02801396|4022130|FG005|COMPLETED|Period 2||17
3288563|NCT02801396|4022125|FG000|NOT COMPLETED|Period 2||0
3288564|NCT02801396|4022126|FG001|NOT COMPLETED|Period 2||0
3288565|NCT02801396|4022127|FG002|NOT COMPLETED|Period 2||0
3288566|NCT02801396|4022128|FG003|NOT COMPLETED|Period 2||0
3288567|NCT02801396|4022129|FG004|NOT COMPLETED|Period 2||0
3288568|NCT02801396|4022130|FG005|NOT COMPLETED|Period 2||0
3288569|NCT02801396|4022125|FG000|STARTED|Period 3||17
3288570|NCT02801396|4022126|FG001|STARTED|Period 3||17
3288571|NCT02801396|4022127|FG002|STARTED|Period 3||17
3288572|NCT02801396|4022128|FG003|STARTED|Period 3||16
3288573|NCT02801396|4022129|FG004|STARTED|Period 3||16
3288574|NCT02801396|4022130|FG005|STARTED|Period 3||17
3288575|NCT02801396|4022125|FG000|COMPLETED|Period 3||17
3288576|NCT02801396|4022126|FG001|COMPLETED|Period 3||17
3288577|NCT02801396|4022127|FG002|COMPLETED|Period 3||17
3288578|NCT02801396|4022128|FG003|COMPLETED|Period 3||16
3089282|NCT01430442|3811194|FG005|NOT COMPLETED|Overall Study||8
3089283|NCT01430442|3811195|FG006|NOT COMPLETED|Overall Study||19
3089284|NCT01430442|3811196|FG007|NOT COMPLETED|Overall Study||9
3288579|NCT02801396|4022129|FG004|COMPLETED|Period 3||16
3288580|NCT02801396|4022130|FG005|COMPLETED|Period 3||17
3288581|NCT02801396|4022125|FG000|NOT COMPLETED|Period 3||0
3288582|NCT02801396|4022126|FG001|NOT COMPLETED|Period 3||0
3288583|NCT02801396|4022127|FG002|NOT COMPLETED|Period 3||0
3288584|NCT02801396|4022128|FG003|NOT COMPLETED|Period 3||0
3089285|NCT01430455|3811214|FG000|STARTED|Overall Study||7
3089286|NCT01430455|3811214|FG000|COMPLETED|Overall Study||5
3089287|NCT01430455|3811214|FG000|NOT COMPLETED|Overall Study||2
3089288|NCT01430468|3811220|FG000|STARTED|Overall Study||22
3089289|NCT01430468|3811221|FG001|STARTED|Overall Study||22
3089290|NCT01430468|3811220|FG000|COMPLETED|Overall Study||15
3089291|NCT01430468|3811221|FG001|COMPLETED|Overall Study||16
3089292|NCT01430468|3811220|FG000|NOT COMPLETED|Overall Study||7
3288585|NCT02801396|4022129|FG004|NOT COMPLETED|Period 3||0
3288586|NCT02801396|4022130|FG005|NOT COMPLETED|Period 3||0
3288587|NCT02801578|4022138|FG000|STARTED|Overall Study||11
3288588|NCT02801578|4022138|FG000|COMPLETED|Overall Study||9
3288589|NCT02801578|4022138|FG000|NOT COMPLETED|Overall Study||2
3288590|NCT02801617|4022144|FG000|STARTED|Overall Study||51
3288591|NCT02801617|4022145|FG001|STARTED|Overall Study||56
3288592|NCT02801617|4022144|FG000|COMPLETED|Overall Study||49
3288593|NCT02801617|4022145|FG001|COMPLETED|Overall Study||50
3288594|NCT02801617|4022144|FG000|NOT COMPLETED|Overall Study||2
3288595|NCT02801617|4022145|FG001|NOT COMPLETED|Overall Study||6
3288596|NCT02801669|4022157|FG000|STARTED|Overall Study||492
3288597|NCT02801669|4022158|FG001|STARTED|Overall Study||492
3288598|NCT02801669|4022157|FG000|Received at Least 1 Dose of Study Drug|Overall Study||492
3288599|NCT02801669|4022158|FG001|Received at Least 1 Dose of Study Drug|Overall Study||490
3288600|NCT02801669|4022157|FG000|COMPLETED|Overall Study||341
3288601|NCT02801669|4022158|FG001|COMPLETED|Overall Study||340
3288602|NCT02801669|4022157|FG000|NOT COMPLETED|Overall Study||151
3288603|NCT02801669|4022158|FG001|NOT COMPLETED|Overall Study||152
3288604|NCT02801877|4022168|FG000|STARTED|Overall Study||74
3288605|NCT02801877|4022169|FG001|STARTED|Overall Study||75
3288606|NCT02801877|4022170|FG002|STARTED|Overall Study||76
3288607|NCT02801877|4022171|FG003|STARTED|Overall Study||76
3288608|NCT02801877|4022168|FG000|COMPLETED|Overall Study||71
3288609|NCT02801877|4022169|FG001|COMPLETED|Overall Study||74
3288610|NCT02801877|4022170|FG002|COMPLETED|Overall Study||70
3288611|NCT02801877|4022171|FG003|COMPLETED|Overall Study||76
3288612|NCT02801877|4022168|FG000|NOT COMPLETED|Overall Study||3
3288613|NCT02801877|4022169|FG001|NOT COMPLETED|Overall Study||1
3288614|NCT02801877|4022170|FG002|NOT COMPLETED|Overall Study||6
3288615|NCT02801877|4022171|FG003|NOT COMPLETED|Overall Study||0
3288616|NCT02801942|4022183|FG000|STARTED|Overall Study||12
3288617|NCT02801942|4022184|FG001|STARTED|Overall Study||10
3288618|NCT02801942|4022183|FG000|COMPLETED|Overall Study||12
3288619|NCT02801942|4022184|FG001|COMPLETED|Overall Study||10
3288620|NCT02801942|4022183|FG000|NOT COMPLETED|Overall Study||0
3288621|NCT02801942|4022184|FG001|NOT COMPLETED|Overall Study||0
3288622|NCT02802111|4022192|FG000|STARTED|First Intervention (5 Min of Drug)||12
3288623|NCT02802111|4022193|FG001|STARTED|First Intervention (5 Min of Drug)||12
3288624|NCT02802111|4022192|FG000|COMPLETED|First Intervention (5 Min of Drug)||12
3288625|NCT02802111|4022193|FG001|COMPLETED|First Intervention (5 Min of Drug)||12
3288626|NCT02802111|4022192|FG000|NOT COMPLETED|First Intervention (5 Min of Drug)||0
3288627|NCT02802111|4022193|FG001|NOT COMPLETED|First Intervention (5 Min of Drug)||0
3288628|NCT02802111|4022192|FG000|STARTED|Washout (4 Hours)||12
3288629|NCT02802111|4022193|FG001|STARTED|Washout (4 Hours)||12
3288630|NCT02802111|4022192|FG000|COMPLETED|Washout (4 Hours)||12
3288631|NCT02802111|4022193|FG001|COMPLETED|Washout (4 Hours)||12
3288632|NCT02802111|4022192|FG000|NOT COMPLETED|Washout (4 Hours)||0
3288633|NCT02802111|4022193|FG001|NOT COMPLETED|Washout (4 Hours)||0
3288634|NCT02802111|4022192|FG000|STARTED|Second Intervention (5 Min of Drug)||12
3288635|NCT02802111|4022193|FG001|STARTED|Second Intervention (5 Min of Drug)||12
3288636|NCT02802111|4022192|FG000|COMPLETED|Second Intervention (5 Min of Drug)||12
3288637|NCT02802111|4022193|FG001|COMPLETED|Second Intervention (5 Min of Drug)||12
3288638|NCT02802111|4022192|FG000|NOT COMPLETED|Second Intervention (5 Min of Drug)||0
3288639|NCT02802111|4022193|FG001|NOT COMPLETED|Second Intervention (5 Min of Drug)||0
3288640|NCT02802241|4022203|FG000|STARTED|Overall Study||97
3288641|NCT02802241|4022204|FG001|STARTED|Overall Study||97
3288642|NCT02802241|4022205|FG002|STARTED|Overall Study||48
3288643|NCT02802241|4022206|FG003|STARTED|Overall Study||98
3288644|NCT02802241|4022203|FG000|Planned Analysis|Overall Study||89
3288645|NCT02802241|4022204|FG001|Planned Analysis|Overall Study||86
3288646|NCT02802241|4022205|FG002|Planned Analysis|Overall Study|Not included in primary analysis|0
3288647|NCT02802241|4022206|FG003|Planned Analysis|Overall Study||87
3288648|NCT02802241|4022203|FG000|COMPLETED|Overall Study||68
3288649|NCT02802241|4022204|FG001|COMPLETED|Overall Study||71
3288650|NCT02802241|4022205|FG002|COMPLETED|Overall Study|Not included in primary analysis|0
3288651|NCT02802241|4022206|FG003|COMPLETED|Overall Study||72
3288652|NCT02802241|4022203|FG000|NOT COMPLETED|Overall Study||29
3288653|NCT02802241|4022204|FG001|NOT COMPLETED|Overall Study||26
3288654|NCT02802241|4022205|FG002|NOT COMPLETED|Overall Study||48
3288655|NCT02802241|4022206|FG003|NOT COMPLETED|Overall Study||26
3288656|NCT02802319|4022218|FG000|STARTED|Overall Study||22
3288657|NCT02802319|4022219|FG001|STARTED|Overall Study||22
3288658|NCT02802319|4022218|FG000|COMPLETED|Overall Study||20
3288659|NCT02802319|4022219|FG001|COMPLETED|Overall Study||17
3288660|NCT02802319|4022218|FG000|NOT COMPLETED|Overall Study||2
3288661|NCT02802319|4022219|FG001|NOT COMPLETED|Overall Study||5
3288662|NCT02802345|4022227|FG000|STARTED|Overall Study||136
3288663|NCT02802345|4022228|FG001|STARTED|Overall Study||138
3288664|NCT02802345|4022227|FG000|Treated|Overall Study||136
3089293|NCT01430468|3811221|FG001|NOT COMPLETED|Overall Study||6
3089294|NCT01430559|3811229|FG000|STARTED|Overall Study||146
3089295|NCT01430559|3811230|FG001|STARTED|Overall Study||147
3089296|NCT01430559|3811229|FG000|Treated|Overall Study||143
3089297|NCT01430559|3811230|FG001|Treated|Overall Study||144
3089298|NCT01430559|3811229|FG000|COMPLETED|Overall Study||126
3089299|NCT01430559|3811230|FG001|COMPLETED|Overall Study||135
3089300|NCT01430559|3811229|FG000|NOT COMPLETED|Overall Study||20
3089301|NCT01430559|3811230|FG001|NOT COMPLETED|Overall Study||12
3089302|NCT01430585|3811241|FG000|STARTED|Overall Study||14
3089303|NCT01430585|3811241|FG000|COMPLETED|Overall Study||0
3089304|NCT01430585|3811241|FG000|NOT COMPLETED|Overall Study||14
3089305|NCT01430611|3811253|FG000|STARTED|Overall Study||332
3089306|NCT01430611|3811254|FG001|STARTED|Overall Study||333
3288665|NCT02802345|4022228|FG001|Treated|Overall Study||137
3288666|NCT02802345|4022227|FG000|COMPLETED|Overall Study||104
3288667|NCT02802345|4022228|FG001|COMPLETED|Overall Study||108
3288668|NCT02802345|4022227|FG000|NOT COMPLETED|Overall Study||32
3288669|NCT02802345|4022228|FG001|NOT COMPLETED|Overall Study||30
3288670|NCT02802449|4022236|FG000|STARTED|Overall Study||111
3288671|NCT02802449|4022237|FG001|STARTED|Overall Study||219
3288672|NCT02802449|4022236|FG000|COMPLETED|Overall Study||102
3288673|NCT02802449|4022237|FG001|COMPLETED|Overall Study||202
3288674|NCT02802449|4022236|FG000|NOT COMPLETED|Overall Study||9
3288675|NCT02802449|4022237|FG001|NOT COMPLETED|Overall Study||17
3288676|NCT02802501|4022246|FG000|STARTED|Double-blind (Up to Day 180)||50
3288677|NCT02802501|4022247|FG001|STARTED|Double-blind (Up to Day 180)||50
3288678|NCT02802501|4022248|FG002|STARTED|Double-blind (Up to Day 180)||50
3288679|NCT02802501|4022246|FG000|COMPLETED|Double-blind (Up to Day 180)||50
3288680|NCT02802501|4022247|FG001|COMPLETED|Double-blind (Up to Day 180)||50
3288681|NCT02802501|4022248|FG002|COMPLETED|Double-blind (Up to Day 180)||50
3288682|NCT02802501|4022246|FG000|NOT COMPLETED|Double-blind (Up to Day 180)||0
3288683|NCT02802501|4022247|FG001|NOT COMPLETED|Double-blind (Up to Day 180)||0
3288684|NCT02802501|4022248|FG002|NOT COMPLETED|Double-blind (Up to Day 180)||0
3288685|NCT02802501|4022246|FG000|STARTED|Open-Label (Day 180 to Day 195)|Participants who had no relapse prior to Day 180 received open-label Primaquine|6
3288686|NCT02802501|4022247|FG001|STARTED|Open-Label (Day 180 to Day 195)|Participants who had no relapse prior to Day 180 received open-label Primaquine|12
3288687|NCT02802501|4022248|FG002|STARTED|Open-Label (Day 180 to Day 195)|Participants who had no relapse prior to Day 180 received open-label Primaquine|26
3288688|NCT02802501|4022246|FG000|COMPLETED|Open-Label (Day 180 to Day 195)||6
3288689|NCT02802501|4022247|FG001|COMPLETED|Open-Label (Day 180 to Day 195)||12
3288690|NCT02802501|4022248|FG002|COMPLETED|Open-Label (Day 180 to Day 195)||26
3288691|NCT02802501|4022246|FG000|NOT COMPLETED|Open-Label (Day 180 to Day 195)||0
3288692|NCT02802501|4022247|FG001|NOT COMPLETED|Open-Label (Day 180 to Day 195)||0
3288693|NCT02802501|4022248|FG002|NOT COMPLETED|Open-Label (Day 180 to Day 195)||0
3288694|NCT02802514|4022261|FG000|STARTED|Session 1 (up to Day 8)||1
3288695|NCT02802514|4022262|FG001|STARTED|Session 1 (up to Day 8)||1
3288696|NCT02802514|4022263|FG002|STARTED|Session 1 (up to Day 8)||1
3288697|NCT02802514|4022264|FG003|STARTED|Session 1 (up to Day 8)||1
3288698|NCT02802514|4022261|FG000|COMPLETED|Session 1 (up to Day 8)||1
3288699|NCT02802514|4022262|FG001|COMPLETED|Session 1 (up to Day 8)||1
3288700|NCT02802514|4022263|FG002|COMPLETED|Session 1 (up to Day 8)||1
3288701|NCT02802514|4022264|FG003|COMPLETED|Session 1 (up to Day 8)||1
3288702|NCT02802514|4022261|FG000|NOT COMPLETED|Session 1 (up to Day 8)||0
3288703|NCT02802514|4022262|FG001|NOT COMPLETED|Session 1 (up to Day 8)||0
3288704|NCT02802514|4022263|FG002|NOT COMPLETED|Session 1 (up to Day 8)||0
3288705|NCT02802514|4022264|FG003|NOT COMPLETED|Session 1 (up to Day 8)||0
3288706|NCT02802514|4022261|FG000|STARTED|Wash Out Period (up to Week 9)||1
3288707|NCT02802514|4022262|FG001|STARTED|Wash Out Period (up to Week 9)||1
3288708|NCT02802514|4022263|FG002|STARTED|Wash Out Period (up to Week 9)||1
3288709|NCT02802514|4022264|FG003|STARTED|Wash Out Period (up to Week 9)||1
3288710|NCT02802514|4022261|FG000|COMPLETED|Wash Out Period (up to Week 9)||1
3288711|NCT02802514|4022262|FG001|COMPLETED|Wash Out Period (up to Week 9)||1
3288712|NCT02802514|4022263|FG002|COMPLETED|Wash Out Period (up to Week 9)||1
3288713|NCT02802514|4022264|FG003|COMPLETED|Wash Out Period (up to Week 9)||1
3288714|NCT02802514|4022261|FG000|NOT COMPLETED|Wash Out Period (up to Week 9)||0
3288715|NCT02802514|4022262|FG001|NOT COMPLETED|Wash Out Period (up to Week 9)||0
3288716|NCT02802514|4022263|FG002|NOT COMPLETED|Wash Out Period (up to Week 9)||0
3288717|NCT02802514|4022264|FG003|NOT COMPLETED|Wash Out Period (up to Week 9)||0
3288718|NCT02802514|4022261|FG000|STARTED|Session 2 (Up to Day 8)||1
3288719|NCT02802514|4022262|FG001|STARTED|Session 2 (Up to Day 8)||1
3288720|NCT02802514|4022263|FG002|STARTED|Session 2 (Up to Day 8)||1
3288721|NCT02802514|4022264|FG003|STARTED|Session 2 (Up to Day 8)||1
3288722|NCT02802514|4022261|FG000|COMPLETED|Session 2 (Up to Day 8)||1
3288723|NCT02802514|4022262|FG001|COMPLETED|Session 2 (Up to Day 8)||1
3288724|NCT02802514|4022263|FG002|COMPLETED|Session 2 (Up to Day 8)||1
3288725|NCT02802514|4022264|FG003|COMPLETED|Session 2 (Up to Day 8)||1
3288726|NCT02802514|4022261|FG000|NOT COMPLETED|Session 2 (Up to Day 8)||0
3288727|NCT02802514|4022262|FG001|NOT COMPLETED|Session 2 (Up to Day 8)||0
3288728|NCT02802514|4022263|FG002|NOT COMPLETED|Session 2 (Up to Day 8)||0
3288729|NCT02802514|4022264|FG003|NOT COMPLETED|Session 2 (Up to Day 8)||0
3288730|NCT02802735|4022280|FG000|STARTED|Overall Study||4
3089307|NCT01430611|3811253|FG000|COMPLETED|Overall Study||315
3089308|NCT01430611|3811254|FG001|COMPLETED|Overall Study||318
3089309|NCT01430611|3811253|FG000|NOT COMPLETED|Overall Study||17
3089310|NCT01430611|3811254|FG001|NOT COMPLETED|Overall Study||15
3089311|NCT01430624|3811263|FG000|STARTED|Overall Study|Initial potential eligible screened enrolled|82
3089312|NCT01430624|3811264|FG001|STARTED|Overall Study||82
3089313|NCT01430624|3811265|FG002|STARTED|Overall Study||81
3089314|NCT01430624|3811263|FG000|Eligible Baseline Completes|Overall Study||77
3089315|NCT01430624|3811264|FG001|Eligible Baseline Completes|Overall Study||77
3288731|NCT02802735|4022281|FG001|STARTED|Overall Study||4
3288732|NCT02802735|4022282|FG002|STARTED|Overall Study||4
3288733|NCT02802735|4022283|FG003|STARTED|Overall Study||12
3288734|NCT02802735|4022284|FG004|STARTED|Overall Study||4
3288735|NCT02802735|4022280|FG000|COMPLETED|Overall Study||4
3288736|NCT02802735|4022281|FG001|COMPLETED|Overall Study||3
3288737|NCT02802735|4022282|FG002|COMPLETED|Overall Study||4
3288738|NCT02802735|4022283|FG003|COMPLETED|Overall Study||12
3288739|NCT02802735|4022284|FG004|COMPLETED|Overall Study||4
3288740|NCT02802735|4022280|FG000|NOT COMPLETED|Overall Study||0
3288741|NCT02802735|4022281|FG001|NOT COMPLETED|Overall Study||1
3288742|NCT02802735|4022282|FG002|NOT COMPLETED|Overall Study||0
3288743|NCT02802735|4022283|FG003|NOT COMPLETED|Overall Study||0
3288744|NCT02802735|4022284|FG004|NOT COMPLETED|Overall Study||0
3288745|NCT02802865|4022301|FG000|STARTED|Overall Study||35
3288746|NCT02802865|4022302|FG001|STARTED|Overall Study||35
3288747|NCT02802865|4022301|FG000|COMPLETED|Overall Study||34
3288748|NCT02802865|4022302|FG001|COMPLETED|Overall Study||33
3288749|NCT02802865|4022301|FG000|NOT COMPLETED|Overall Study||1
3288750|NCT02802865|4022302|FG001|NOT COMPLETED|Overall Study||2
3288751|NCT02802878|4022310|FG000|STARTED|Overall Study||21
3288752|NCT02802878|4022311|FG001|STARTED|Overall Study||21
3288753|NCT02802878|4022310|FG000|COMPLETED|Overall Study||17
3288754|NCT02802878|4022311|FG001|COMPLETED|Overall Study||18
3288755|NCT02802878|4022310|FG000|NOT COMPLETED|Overall Study||4
3288756|NCT02802878|4022311|FG001|NOT COMPLETED|Overall Study||3
3288757|NCT02803138|4022317|FG000|STARTED|Overall Study||236
3288758|NCT02803138|4022317|FG000|COMPLETED|Overall Study||166
3288759|NCT02803138|4022317|FG000|NOT COMPLETED|Overall Study||70
3288760|NCT02803164|4022325|FG000|STARTED|Overall Study||10
3288761|NCT02803164|4022326|FG001|STARTED|Overall Study||11
3288762|NCT02803164|4022325|FG000|COMPLETED|Overall Study||10
3288763|NCT02803164|4022326|FG001|COMPLETED|Overall Study||11
3288764|NCT02803164|4022325|FG000|NOT COMPLETED|Overall Study||0
3288765|NCT02803164|4022326|FG001|NOT COMPLETED|Overall Study||0
3288766|NCT02803229|4022336|FG000|STARTED|Overall Study||15
3288767|NCT02803229|4022337|FG001|STARTED|Overall Study||13
3288768|NCT02803229|4022336|FG000|COMPLETED|Overall Study||11
3288769|NCT02803229|4022337|FG001|COMPLETED|Overall Study||7
3288770|NCT02803229|4022336|FG000|NOT COMPLETED|Overall Study||4
3288771|NCT02803229|4022337|FG001|NOT COMPLETED|Overall Study||6
3288772|NCT02803580|4022343|FG000|STARTED|Overall Study||209
3288773|NCT02803580|4022343|FG000|COMPLETED|Overall Study||173
3288774|NCT02803580|4022343|FG000|NOT COMPLETED|Overall Study||36
3288775|NCT02803749|4022349|FG000|STARTED|Overall Study||17
3288776|NCT02803749|4022350|FG001|STARTED|Overall Study||4
3288777|NCT02803749|4022349|FG000|COMPLETED|Overall Study||12
3288778|NCT02803749|4022350|FG001|COMPLETED|Overall Study||4
3288779|NCT02803749|4022349|FG000|NOT COMPLETED|Overall Study||5
3288780|NCT02803749|4022350|FG001|NOT COMPLETED|Overall Study||0
3288781|NCT02804178|4022356|FG000|STARTED|Overall Study||10
3288782|NCT02804178|4022356|FG000|COMPLETED|Overall Study||9
3288783|NCT02804178|4022356|FG000|NOT COMPLETED|Overall Study||1
3288784|NCT02804399|4022360|FG000|STARTED|Period 1||12
3288785|NCT02804399|4022361|FG001|STARTED|Period 1||0
3288786|NCT02804399|4022360|FG000|COMPLETED|Period 1||12
3288787|NCT02804399|4022361|FG001|COMPLETED|Period 1||0
3288788|NCT02804399|4022360|FG000|NOT COMPLETED|Period 1||0
3288789|NCT02804399|4022361|FG001|NOT COMPLETED|Period 1||0
3288790|NCT02804399|4022360|FG000|STARTED|Washout Period at Least 10 Days||12
3288791|NCT02804399|4022361|FG001|STARTED|Washout Period at Least 10 Days||0
3288792|NCT02804399|4022360|FG000|COMPLETED|Washout Period at Least 10 Days||12
3288793|NCT02804399|4022361|FG001|COMPLETED|Washout Period at Least 10 Days||0
3288794|NCT02804399|4022360|FG000|NOT COMPLETED|Washout Period at Least 10 Days||0
3288795|NCT02804399|4022361|FG001|NOT COMPLETED|Washout Period at Least 10 Days||0
3288796|NCT02804399|4022360|FG000|STARTED|Period 2||0
3288797|NCT02804399|4022361|FG001|STARTED|Period 2||12
3288798|NCT02804399|4022360|FG000|COMPLETED|Period 2||0
3288799|NCT02804399|4022361|FG001|COMPLETED|Period 2||11
3288800|NCT02804399|4022360|FG000|NOT COMPLETED|Period 2||0
3288801|NCT02804399|4022361|FG001|NOT COMPLETED|Period 2||1
3288802|NCT02804594|4022372|FG000|STARTED|Overall Study||10
3288803|NCT02804594|4022373|FG001|STARTED|Overall Study||5
3288804|NCT02804594|4022372|FG000|COMPLETED|Overall Study||10
3288805|NCT02804594|4022373|FG001|COMPLETED|Overall Study||5
3288806|NCT02804594|4022372|FG000|NOT COMPLETED|Overall Study||0
3288807|NCT02804594|4022373|FG001|NOT COMPLETED|Overall Study||0
3288808|NCT02804750|4022381|FG000|STARTED|Period 1||17
3288809|NCT02804750|4022382|FG001|STARTED|Period 1||18
3288810|NCT02804750|4022381|FG000|COMPLETED|Period 1||17
3288811|NCT02804750|4022382|FG001|COMPLETED|Period 1||15
3288812|NCT02804750|4022381|FG000|NOT COMPLETED|Period 1||0
3288813|NCT02804750|4022382|FG001|NOT COMPLETED|Period 1||3
3288814|NCT02804750|4022381|FG000|STARTED|Period 2||17
3288815|NCT02804750|4022382|FG001|STARTED|Period 2||15
3288816|NCT02804750|4022381|FG000|COMPLETED|Period 2||16
3288817|NCT02804750|4022382|FG001|COMPLETED|Period 2||15
3288818|NCT02804750|4022381|FG000|NOT COMPLETED|Period 2||1
3089316|NCT01430624|3811265|FG002|Eligible Baseline Completes|Overall Study||79
3089317|NCT01430624|3811263|FG000|COMPLETED|Overall Study|Completed one or more follow-ups|54
3089318|NCT01430624|3811264|FG001|COMPLETED|Overall Study|Completed one or more follow-ups|48
3089319|NCT01430624|3811265|FG002|COMPLETED|Overall Study|Completed one or more follow-ups|52
3089320|NCT01430624|3811263|FG000|NOT COMPLETED|Overall Study||28
3089321|NCT01430624|3811264|FG001|NOT COMPLETED|Overall Study||34
3089322|NCT01430624|3811265|FG002|NOT COMPLETED|Overall Study||29
3089323|NCT01430741|3811281|FG000|STARTED|Overall Study||22
3089324|NCT01430741|3811282|FG001|STARTED|Overall Study||87
3089325|NCT01430741|3811283|FG002|STARTED|Overall Study||47
3089326|NCT01430741|3811284|FG003|STARTED|Overall Study||81
3089327|NCT01430741|3811281|FG000|COMPLETED|Overall Study||22
3089328|NCT01430741|3811282|FG001|COMPLETED|Overall Study||87
3089329|NCT01430741|3811283|FG002|COMPLETED|Overall Study||37
3089330|NCT01430741|3811284|FG003|COMPLETED|Overall Study||81
3089331|NCT01430741|3811281|FG000|NOT COMPLETED|Overall Study||0
3089332|NCT01430741|3811282|FG001|NOT COMPLETED|Overall Study||0
3089333|NCT01430741|3811283|FG002|NOT COMPLETED|Overall Study||10
3089334|NCT01430741|3811284|FG003|NOT COMPLETED|Overall Study||0
3089335|NCT01430754|3811297|FG000|STARTED|Run-In Phase||57
3089336|NCT01430754|3811298|FG001|STARTED|Run-In Phase|During the run-in phase, participants were treated with tasimelteon only.|0
3089337|NCT01430754|3811297|FG000|Entrained - After Run-In Phase|Run-In Phase||24
3089338|NCT01430754|3811298|FG001|Entrained - After Run-In Phase|Run-In Phase||0
3089339|NCT01430754|3811297|FG000|COMPLETED|Run-In Phase|Defined as the number of patients who entered the randomized-withdrawal phase|20
3089340|NCT01430754|3811298|FG001|COMPLETED|Run-In Phase||0
3089341|NCT01430754|3811297|FG000|NOT COMPLETED|Run-In Phase||37
3089342|NCT01430754|3811298|FG001|NOT COMPLETED|Run-In Phase||0
3089343|NCT01430754|3811297|FG000|STARTED|Randomized Phase||10
3089344|NCT01430754|3811298|FG001|STARTED|Randomized Phase||10
3089345|NCT01430754|3811297|FG000|COMPLETED|Randomized Phase||10
3089346|NCT01430754|3811298|FG001|COMPLETED|Randomized Phase||10
3089347|NCT01430754|3811297|FG000|NOT COMPLETED|Randomized Phase||0
3089348|NCT01430754|3811298|FG001|NOT COMPLETED|Randomized Phase||0
3089349|NCT01430819|3811308|FG000|STARTED|Overall Study||150
3089350|NCT01430819|3811309|FG001|STARTED|Overall Study||150
3089351|NCT01430819|3811308|FG000|COMPLETED|Overall Study||150
3089352|NCT01430819|3811309|FG001|COMPLETED|Overall Study||150
3089353|NCT01430819|3811308|FG000|NOT COMPLETED|Overall Study||0
3089354|NCT01430819|3811309|FG001|NOT COMPLETED|Overall Study||0
3089355|NCT01431014|3811317|FG000|STARTED|Overall Study||34
3089356|NCT01431014|3811318|FG001|STARTED|Overall Study||34
3089357|NCT01431014|3811317|FG000|COMPLETED|Overall Study||31
3089358|NCT01431014|3811318|FG001|COMPLETED|Overall Study||25
3089359|NCT01431014|3811317|FG000|NOT COMPLETED|Overall Study||3
3089360|NCT01431014|3811318|FG001|NOT COMPLETED|Overall Study||9
3089361|NCT01431079|3811326|FG000|STARTED|Overall Study||45
3089362|NCT01431079|3811327|FG001|STARTED|Overall Study||45
3089363|NCT01431079|3811326|FG000|Post-test|Overall Study||45
3089364|NCT01431079|3811327|FG001|Post-test|Overall Study||45
3089365|NCT01431079|3811326|FG000|COMPLETED|Overall Study||10
3089366|NCT01431079|3811327|FG001|COMPLETED|Overall Study||6
3089367|NCT01431079|3811326|FG000|NOT COMPLETED|Overall Study||35
3089368|NCT01431079|3811327|FG001|NOT COMPLETED|Overall Study||39
3089369|NCT01431105|3811357|FG000|STARTED|Overall Study||34
3163103|NCT01883141|3890565|FG000|BiV Pacing-Standard Therapy|Overall Study||26
3163104|NCT01883141|3890565|FG000|Multispot-pacing|Overall Study||24
3163105|NCT01883141|3890565|FG000|BiV Pacing-Anterior|Overall Study||23
3163106|NCT01883141|3890565|FG000|Biv Pacing-Posterior|Overall Study||22
3163107|NCT01883141|3890565|FG000|Multivein|Overall Study||23
3163108|NCT01883141|3890565|FG000|COMPLETED|Overall Study|Exit form with exit reason available|31
3163109|NCT01883141|3890565|FG000|NOT COMPLETED|Overall Study||0
3163110|NCT01883362|3890571|FG000|STARTED|Treatment||30
3288819|NCT02804750|4022382|FG001|NOT COMPLETED|Period 2||0
3288820|NCT02804750|4022381|FG000|STARTED|Period 3||16
3288821|NCT02804750|4022382|FG001|STARTED|Period 3||15
3288822|NCT02804750|4022381|FG000|COMPLETED|Period 3||16
3288823|NCT02804750|4022382|FG001|COMPLETED|Period 3||13
3288824|NCT02804750|4022381|FG000|NOT COMPLETED|Period 3||0
3288825|NCT02804750|4022382|FG001|NOT COMPLETED|Period 3||2
3288826|NCT02804750|4022381|FG000|STARTED|Period 4|Per-protocol, Group 1 did not participate in Period 4.|0
3288827|NCT02804750|4022382|FG001|STARTED|Period 4|One participant completed Period 3 but did not start Period 4 due to a pre-scheduled surgery.|12
3288828|NCT02804750|4022381|FG000|COMPLETED|Period 4||0
3288829|NCT02804750|4022382|FG001|COMPLETED|Period 4||7
3288830|NCT02804750|4022381|FG000|NOT COMPLETED|Period 4||0
3288831|NCT02804750|4022382|FG001|NOT COMPLETED|Period 4||5
3288832|NCT02804763|4022394|FG000|STARTED|Double-Blind Period (Week 1 to Week 24)||45
3288833|NCT02804763|4022395|FG001|STARTED|Double-Blind Period (Week 1 to Week 24)||45
3288834|NCT02804763|4022396|FG002|STARTED|Double-Blind Period (Week 1 to Week 24)||45
3288835|NCT02804763|4022397|FG003|STARTED|Double-Blind Period (Week 1 to Week 24)||47
3288836|NCT02804763|4022394|FG000|Completed Week 24|Double-Blind Period (Week 1 to Week 24)||44
3288837|NCT02804763|4022395|FG001|Completed Week 24|Double-Blind Period (Week 1 to Week 24)||45
3288838|NCT02804763|4022396|FG002|Completed Week 24|Double-Blind Period (Week 1 to Week 24)||44
3089370|NCT01431105|3811357|FG000|COMPLETED|Overall Study||34
3089371|NCT01431105|3811357|FG000|NOT COMPLETED|Overall Study||0
3089372|NCT01431131|3811363|FG000|STARTED|Overall Study||12
3163111|NCT01883362|3890572|FG001|STARTED|Treatment||30
3089373|NCT01431131|3811364|FG001|STARTED|Overall Study||12
3089374|NCT01431131|3811363|FG000|COMPLETED|Overall Study||12
3089375|NCT01431131|3811364|FG001|COMPLETED|Overall Study||12
3089376|NCT01431131|3811363|FG000|NOT COMPLETED|Overall Study||0
3089377|NCT01431131|3811364|FG001|NOT COMPLETED|Overall Study||0
3089378|NCT01431144|3811372|FG000|STARTED|Overall Study||13
3089379|NCT01431144|3811373|FG001|STARTED|Overall Study||14
3089380|NCT01431144|3811372|FG000|COMPLETED|Overall Study||11
3089381|NCT01431144|3811373|FG001|COMPLETED|Overall Study||14
3089382|NCT01431144|3811372|FG000|NOT COMPLETED|Overall Study||2
3288839|NCT02804763|4022397|FG003|Completed Week 24|Double-Blind Period (Week 1 to Week 24)||45
3288840|NCT02804763|4022394|FG000|Finished Wk24 Began Observational Period|Double-Blind Period (Week 1 to Week 24)||44
3288841|NCT02804763|4022395|FG001|Finished Wk24 Began Observational Period|Double-Blind Period (Week 1 to Week 24)||44
3288842|NCT02804763|4022396|FG002|Finished Wk24 Began Observational Period|Double-Blind Period (Week 1 to Week 24)||44
3288843|NCT02804763|4022397|FG003|Finished Wk24 Began Observational Period|Double-Blind Period (Week 1 to Week 24)||45
3288844|NCT02804763|4022394|FG000|COMPLETED|Double-Blind Period (Week 1 to Week 24)||44
3288845|NCT02804763|4022395|FG001|COMPLETED|Double-Blind Period (Week 1 to Week 24)||44
3288846|NCT02804763|4022396|FG002|COMPLETED|Double-Blind Period (Week 1 to Week 24)||44
3288847|NCT02804763|4022397|FG003|COMPLETED|Double-Blind Period (Week 1 to Week 24)||45
3288848|NCT02804763|4022394|FG000|NOT COMPLETED|Double-Blind Period (Week 1 to Week 24)||1
3288849|NCT02804763|4022395|FG001|NOT COMPLETED|Double-Blind Period (Week 1 to Week 24)||1
3288850|NCT02804763|4022396|FG002|NOT COMPLETED|Double-Blind Period (Week 1 to Week 24)||1
3288851|NCT02804763|4022397|FG003|NOT COMPLETED|Double-Blind Period (Week 1 to Week 24)||2
3288852|NCT02804763|4022394|FG000|STARTED|Observational Period (Wk 24 to Wk 48)||44
3288853|NCT02804763|4022395|FG001|STARTED|Observational Period (Wk 24 to Wk 48)||44
3288854|NCT02804763|4022396|FG002|STARTED|Observational Period (Wk 24 to Wk 48)||44
3288855|NCT02804763|4022397|FG003|STARTED|Observational Period (Wk 24 to Wk 48)||45
3288856|NCT02804763|4022394|FG000|COMPLETED|Observational Period (Wk 24 to Wk 48)||38
3288857|NCT02804763|4022395|FG001|COMPLETED|Observational Period (Wk 24 to Wk 48)||43
3288858|NCT02804763|4022396|FG002|COMPLETED|Observational Period (Wk 24 to Wk 48)||41
3288859|NCT02804763|4022397|FG003|COMPLETED|Observational Period (Wk 24 to Wk 48)||42
3288860|NCT02804763|4022394|FG000|NOT COMPLETED|Observational Period (Wk 24 to Wk 48)||6
3288861|NCT02804763|4022395|FG001|NOT COMPLETED|Observational Period (Wk 24 to Wk 48)||1
3288862|NCT02804763|4022396|FG002|NOT COMPLETED|Observational Period (Wk 24 to Wk 48)||3
3288863|NCT02804763|4022397|FG003|NOT COMPLETED|Observational Period (Wk 24 to Wk 48)||3
3288864|NCT02805179|4022411|FG000|STARTED|Overall Study||26
3288865|NCT02805179|4022411|FG000|Eligible Patients That Started Dose-intensified Chemo-radiation|Overall Study||23
3288866|NCT02805179|4022411|FG000|Subset of Participants, Boosted to Both High B-value Diffusion and Perfusion|Overall Study||13
3288867|NCT02805179|4022411|FG000|COMPLETED|Overall Study||23
3288868|NCT02805179|4022411|FG000|NOT COMPLETED|Overall Study||3
3288869|NCT02805309|4022418|FG000|STARTED|Overall Study||18
3288870|NCT02805309|4022419|FG001|STARTED|Overall Study||17
3288871|NCT02805309|4022420|FG002|STARTED|Overall Study||19
3288872|NCT02805309|4022418|FG000|COMPLETED|Overall Study||16
3288873|NCT02805309|4022419|FG001|COMPLETED|Overall Study||13
3288874|NCT02805309|4022420|FG002|COMPLETED|Overall Study||16
3288875|NCT02805309|4022418|FG000|NOT COMPLETED|Overall Study||2
3288876|NCT02805309|4022419|FG001|NOT COMPLETED|Overall Study||4
3288877|NCT02805309|4022420|FG002|NOT COMPLETED|Overall Study||3
3288878|NCT02805647|4022430|FG000|STARTED|Overall Study|at the moment of submision|100
3288879|NCT02805647|4022431|FG001|STARTED|Overall Study|at the moment of submision|122
3288880|NCT02805647|4022430|FG000|COMPLETED|Overall Study|after laboratory tests|100
3288881|NCT02805647|4022431|FG001|COMPLETED|Overall Study|after laboratory tests|122
3288882|NCT02805647|4022430|FG000|NOT COMPLETED|Overall Study||0
3288883|NCT02805647|4022431|FG001|NOT COMPLETED|Overall Study||0
3288884|NCT02805660|4022444|FG000|STARTED|Overall Study||5
3288885|NCT02805660|4022445|FG001|STARTED|Overall Study||4
3288886|NCT02805660|4022446|FG002|STARTED|Overall Study||11
3288887|NCT02805660|4022447|FG003|STARTED|Overall Study||18
3288888|NCT02805660|4022448|FG004|STARTED|Overall Study||3
3288889|NCT02805660|4022449|FG005|STARTED|Overall Study||23
3288890|NCT02805660|4022450|FG006|STARTED|Overall Study||19
3288891|NCT02805660|4022444|FG000|COMPLETED|Overall Study||0
3288892|NCT02805660|4022445|FG001|COMPLETED|Overall Study||0
3288893|NCT02805660|4022446|FG002|COMPLETED|Overall Study||0
3288894|NCT02805660|4022447|FG003|COMPLETED|Overall Study||0
3288895|NCT02805660|4022448|FG004|COMPLETED|Overall Study||0
3288896|NCT02805660|4022449|FG005|COMPLETED|Overall Study||0
3288897|NCT02805660|4022450|FG006|COMPLETED|Overall Study||0
3288898|NCT02805660|4022444|FG000|NOT COMPLETED|Overall Study||5
3288899|NCT02805660|4022445|FG001|NOT COMPLETED|Overall Study||4
3288900|NCT02805660|4022446|FG002|NOT COMPLETED|Overall Study||11
3288901|NCT02805660|4022447|FG003|NOT COMPLETED|Overall Study||18
3288902|NCT02805660|4022448|FG004|NOT COMPLETED|Overall Study||3
3288903|NCT02805660|4022449|FG005|NOT COMPLETED|Overall Study||23
3288904|NCT02805660|4022450|FG006|NOT COMPLETED|Overall Study||19
3288905|NCT02805790|4022481|FG000|STARTED|First Intervention (4 Weeks)||14
3288906|NCT02805790|4022482|FG001|STARTED|First Intervention (4 Weeks)||16
3288907|NCT02805790|4022481|FG000|COMPLETED|First Intervention (4 Weeks)||14
3089383|NCT01431144|3811373|FG001|NOT COMPLETED|Overall Study||0
3089384|NCT01431170|3811381|FG000|STARTED|Overall Study||12
3089385|NCT01431170|3811382|FG001|STARTED|Overall Study||12
3089386|NCT01431170|3811381|FG000|COMPLETED|Overall Study||9
3089387|NCT01431170|3811382|FG001|COMPLETED|Overall Study||11
3089388|NCT01431170|3811381|FG000|NOT COMPLETED|Overall Study||3
3089389|NCT01431170|3811382|FG001|NOT COMPLETED|Overall Study||1
3089390|NCT01431209|3811400|FG000|STARTED|Overall Study||47
3089391|NCT01431209|3811401|FG001|STARTED|Overall Study||13
3288908|NCT02805790|4022482|FG001|COMPLETED|First Intervention (4 Weeks)||16
3288909|NCT02805790|4022481|FG000|NOT COMPLETED|First Intervention (4 Weeks)||0
3288910|NCT02805790|4022482|FG001|NOT COMPLETED|First Intervention (4 Weeks)||0
3288911|NCT02805790|4022481|FG000|STARTED|Washout (4 Weeks)||14
3288912|NCT02805790|4022482|FG001|STARTED|Washout (4 Weeks)||16
3288913|NCT02805790|4022481|FG000|COMPLETED|Washout (4 Weeks)||14
3288914|NCT02805790|4022482|FG001|COMPLETED|Washout (4 Weeks)||16
3288915|NCT02805790|4022481|FG000|NOT COMPLETED|Washout (4 Weeks)||0
3288916|NCT02805790|4022482|FG001|NOT COMPLETED|Washout (4 Weeks)||0
3288917|NCT02805790|4022481|FG000|STARTED|Second Intervention (4 Weeks)||14
3288918|NCT02805790|4022482|FG001|STARTED|Second Intervention (4 Weeks)||16
3288919|NCT02805790|4022481|FG000|COMPLETED|Second Intervention (4 Weeks)||14
3288920|NCT02805790|4022482|FG001|COMPLETED|Second Intervention (4 Weeks)||15
3288921|NCT02805790|4022481|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||0
3288922|NCT02805790|4022482|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||1
3288923|NCT02805907|4022490|FG000|STARTED|Overall Study||56
3288924|NCT02805907|4022491|FG001|STARTED|Overall Study||56
3288925|NCT02805907|4022490|FG000|COMPLETED|Overall Study||53
3288926|NCT02805907|4022491|FG001|COMPLETED|Overall Study||53
3288927|NCT02805907|4022490|FG000|NOT COMPLETED|Overall Study||3
3288928|NCT02805907|4022491|FG001|NOT COMPLETED|Overall Study||3
3288929|NCT02805972|4022499|FG000|STARTED|Intervention Visit 1||23
3288930|NCT02805972|4022500|FG001|STARTED|Intervention Visit 1||18
3288931|NCT02805972|4022499|FG000|COMPLETED|Intervention Visit 1||23
3288932|NCT02805972|4022500|FG001|COMPLETED|Intervention Visit 1||18
3288933|NCT02805972|4022499|FG000|NOT COMPLETED|Intervention Visit 1||0
3288934|NCT02805972|4022500|FG001|NOT COMPLETED|Intervention Visit 1||0
3288935|NCT02805972|4022499|FG000|STARTED|Washout Period||23
3288936|NCT02805972|4022500|FG001|STARTED|Washout Period||18
3288937|NCT02805972|4022499|FG000|COMPLETED|Washout Period||20
3288938|NCT02805972|4022500|FG001|COMPLETED|Washout Period||18
3288939|NCT02805972|4022499|FG000|NOT COMPLETED|Washout Period||3
3288940|NCT02805972|4022500|FG001|NOT COMPLETED|Washout Period||0
3288941|NCT02805972|4022499|FG000|STARTED|Intervention Visit 2||20
3288942|NCT02805972|4022500|FG001|STARTED|Intervention Visit 2||18
3288943|NCT02805972|4022499|FG000|COMPLETED|Intervention Visit 2||20
3288944|NCT02805972|4022500|FG001|COMPLETED|Intervention Visit 2||18
3288945|NCT02805972|4022499|FG000|NOT COMPLETED|Intervention Visit 2||0
3288946|NCT02805972|4022500|FG001|NOT COMPLETED|Intervention Visit 2||0
3288947|NCT02806024|4022518|FG000|STARTED|Overall Study||7
3288948|NCT02806024|4022519|FG001|STARTED|Overall Study||7
3288949|NCT02806024|4022518|FG000|COMPLETED|Overall Study||6
3288950|NCT02806024|4022519|FG001|COMPLETED|Overall Study||5
3288951|NCT02806024|4022518|FG000|NOT COMPLETED|Overall Study||1
3288952|NCT02806024|4022519|FG001|NOT COMPLETED|Overall Study||2
3288953|NCT02806232|4022534|FG000|STARTED|Overall Study||60
3288954|NCT02806232|4022535|FG001|STARTED|Overall Study||60
3288955|NCT02806232|4022536|FG002|STARTED|Overall Study||60
3288956|NCT02806232|4022537|FG003|STARTED|Overall Study||60
3288957|NCT02806232|4022538|FG004|STARTED|Overall Study||60
3288958|NCT02806232|4022539|FG005|STARTED|Overall Study||60
3288959|NCT02806232|4022540|FG006|STARTED|Overall Study||60
3288960|NCT02806232|4022541|FG007|STARTED|Overall Study||20
3288961|NCT02806232|4022542|FG008|STARTED|Overall Study||4
3288962|NCT02806232|4022534|FG000|COMPLETED|Overall Study||59
3288963|NCT02806232|4022535|FG001|COMPLETED|Overall Study||56
3288964|NCT02806232|4022536|FG002|COMPLETED|Overall Study||59
3288965|NCT02806232|4022537|FG003|COMPLETED|Overall Study||60
3288966|NCT02806232|4022538|FG004|COMPLETED|Overall Study||58
3288967|NCT02806232|4022539|FG005|COMPLETED|Overall Study||58
3288968|NCT02806232|4022540|FG006|COMPLETED|Overall Study||60
3288969|NCT02806232|4022541|FG007|COMPLETED|Overall Study||20
3288970|NCT02806232|4022542|FG008|COMPLETED|Overall Study||4
3288971|NCT02806232|4022534|FG000|NOT COMPLETED|Overall Study||1
3288972|NCT02806232|4022535|FG001|NOT COMPLETED|Overall Study||4
3288973|NCT02806232|4022536|FG002|NOT COMPLETED|Overall Study||1
3288974|NCT02806232|4022537|FG003|NOT COMPLETED|Overall Study||0
3288975|NCT02806232|4022538|FG004|NOT COMPLETED|Overall Study||2
3288976|NCT02806232|4022539|FG005|NOT COMPLETED|Overall Study||2
3288977|NCT02806232|4022540|FG006|NOT COMPLETED|Overall Study||0
3288978|NCT02806232|4022541|FG007|NOT COMPLETED|Overall Study||0
3288979|NCT02806232|4022542|FG008|NOT COMPLETED|Overall Study||0
3288980|NCT02806414|4022562|FG000|STARTED|Overall Study||25
3288981|NCT02806414|4022562|FG000|COMPLETED|Overall Study||23
3288982|NCT02806414|4022562|FG000|NOT COMPLETED|Overall Study||2
3288983|NCT02806505|4022568|FG000|STARTED|Overall Study||38
3288984|NCT02806505|4022569|FG001|STARTED|Overall Study||43
3288985|NCT02806505|4022568|FG000|COMPLETED|Overall Study||28
3288986|NCT02806505|4022569|FG001|COMPLETED|Overall Study||32
3288987|NCT02806505|4022568|FG000|NOT COMPLETED|Overall Study||10
3288988|NCT02806505|4022569|FG001|NOT COMPLETED|Overall Study||11
3288989|NCT02806544|4022575|FG000|STARTED|Overall Study||35
3288990|NCT02806544|4022575|FG000|COMPLETED|Overall Study||31
3288991|NCT02806544|4022575|FG000|NOT COMPLETED|Overall Study||4
3288992|NCT02806713|4022581|FG000|STARTED|Overall Study||46
3089392|NCT01431209|3811400|FG000|COMPLETED|Overall Study||43
3089393|NCT01431209|3811401|FG001|COMPLETED|Overall Study||12
3089394|NCT01431209|3811400|FG000|NOT COMPLETED|Overall Study||4
3089395|NCT01431209|3811401|FG001|NOT COMPLETED|Overall Study||1
3089396|NCT01431274|3811412|FG000|STARTED|Overall Study||528
3089397|NCT01431274|3811413|FG001|STARTED|Overall Study||525
3089398|NCT01431274|3811414|FG002|STARTED|Overall Study||527
3089399|NCT01431274|3811415|FG003|STARTED|Overall Study||522
3089400|NCT01431274|3811416|FG004|STARTED|Overall Study||522
3089401|NCT01431274|3811412|FG000|COMPLETED|Overall Study||431
3089402|NCT01431274|3811413|FG001|COMPLETED|Overall Study||448
3089403|NCT01431274|3811414|FG002|COMPLETED|Overall Study||455
3089404|NCT01431274|3811415|FG003|COMPLETED|Overall Study||462
3089405|NCT01431274|3811416|FG004|COMPLETED|Overall Study||466
3089406|NCT01431274|3811412|FG000|NOT COMPLETED|Overall Study||97
3089407|NCT01431274|3811413|FG001|NOT COMPLETED|Overall Study||77
3089408|NCT01431274|3811414|FG002|NOT COMPLETED|Overall Study||72
3288993|NCT02806713|4022582|FG001|STARTED|Overall Study||46
3288994|NCT02806713|4022581|FG000|COMPLETED|Overall Study||44
3288995|NCT02806713|4022582|FG001|COMPLETED|Overall Study||44
3288996|NCT02806713|4022581|FG000|NOT COMPLETED|Overall Study||2
3288997|NCT02806713|4022582|FG001|NOT COMPLETED|Overall Study||2
3288998|NCT02806726|4022588|FG000|STARTED|Overall Study|Subjects were treated contralaterally|7
3288999|NCT02806726|4022588|FG000|COMPLETED|Overall Study|Subjects were treated contralaterally|6
3289000|NCT02806726|4022588|FG000|NOT COMPLETED|Overall Study||1
3289001|NCT02806869|4022595|FG000|STARTED|First Intervention (1 Day)||24
3289002|NCT02806869|4022596|FG001|STARTED|First Intervention (1 Day)||24
3289003|NCT02806869|4022595|FG000|COMPLETED|First Intervention (1 Day)||13
3289004|NCT02806869|4022596|FG001|COMPLETED|First Intervention (1 Day)||12
3289005|NCT02806869|4022595|FG000|NOT COMPLETED|First Intervention (1 Day)||11
3289006|NCT02806869|4022596|FG001|NOT COMPLETED|First Intervention (1 Day)||12
3289007|NCT02806869|4022595|FG000|STARTED|Washout (7 Days)||7
3289008|NCT02806869|4022596|FG001|STARTED|Washout (7 Days)||7
3289009|NCT02806869|4022595|FG000|COMPLETED|Washout (7 Days)||7
3289010|NCT02806869|4022596|FG001|COMPLETED|Washout (7 Days)||7
3289011|NCT02806869|4022595|FG000|NOT COMPLETED|Washout (7 Days)||0
3289012|NCT02806869|4022596|FG001|NOT COMPLETED|Washout (7 Days)||0
3289013|NCT02806869|4022595|FG000|STARTED|Second Intervention (1 Day)||7
3289014|NCT02806869|4022596|FG001|STARTED|Second Intervention (1 Day)||7
3289015|NCT02806869|4022595|FG000|COMPLETED|Second Intervention (1 Day)||7
3289016|NCT02806869|4022596|FG001|COMPLETED|Second Intervention (1 Day)||5
3289017|NCT02806869|4022595|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
3289018|NCT02806869|4022596|FG001|NOT COMPLETED|Second Intervention (1 Day)||2
3289019|NCT02806895|4022604|FG000|STARTED|Overall Study||17
3289020|NCT02806895|4022605|FG001|STARTED|Overall Study||17
3289021|NCT02806895|4022604|FG000|COMPLETED|Overall Study||16
3289022|NCT02806895|4022605|FG001|COMPLETED|Overall Study||17
3289023|NCT02806895|4022604|FG000|NOT COMPLETED|Overall Study||1
3289024|NCT02806895|4022605|FG001|NOT COMPLETED|Overall Study||0
3289025|NCT02806908|4022614|FG000|STARTED|Overall Study||11
3289026|NCT02806908|4022615|FG001|STARTED|Overall Study||13
3289027|NCT02806908|4022614|FG000|COMPLETED|Overall Study||10
3289028|NCT02806908|4022615|FG001|COMPLETED|Overall Study||12
3289029|NCT02806908|4022614|FG000|NOT COMPLETED|Overall Study||1
3289030|NCT02806908|4022615|FG001|NOT COMPLETED|Overall Study||1
3289031|NCT02806947|4022624|FG000|STARTED|Overall Study||58
3289032|NCT02806947|4022625|FG001|STARTED|Overall Study||64
3289033|NCT02806947|4022624|FG000|COMPLETED|Overall Study||53
3289034|NCT02806947|4022625|FG001|COMPLETED|Overall Study||63
3289035|NCT02806947|4022624|FG000|NOT COMPLETED|Overall Study||5
3289036|NCT02806947|4022625|FG001|NOT COMPLETED|Overall Study||1
3289037|NCT02806973|4022631|FG000|STARTED|Period 1||8
3289038|NCT02806973|4022632|FG001|STARTED|Period 1||8
3289039|NCT02806973|4022633|FG002|STARTED|Period 1||8
3289040|NCT02806973|4022634|FG003|STARTED|Period 1||8
3289041|NCT02806973|4022631|FG000|COMPLETED|Period 1||8
3289042|NCT02806973|4022632|FG001|COMPLETED|Period 1||6
3289043|NCT02806973|4022633|FG002|COMPLETED|Period 1||7
3289044|NCT02806973|4022634|FG003|COMPLETED|Period 1||6
3289045|NCT02806973|4022631|FG000|NOT COMPLETED|Period 1||0
3289046|NCT02806973|4022632|FG001|NOT COMPLETED|Period 1||2
3289047|NCT02806973|4022633|FG002|NOT COMPLETED|Period 1||1
3289048|NCT02806973|4022634|FG003|NOT COMPLETED|Period 1||2
3289049|NCT02806973|4022631|FG000|STARTED|Period 2||8
3289050|NCT02806973|4022632|FG001|STARTED|Period 2||6
3289051|NCT02806973|4022633|FG002|STARTED|Period 2||7
3289052|NCT02806973|4022634|FG003|STARTED|Period 2||6
3289053|NCT02806973|4022631|FG000|COMPLETED|Period 2||8
3289054|NCT02806973|4022632|FG001|COMPLETED|Period 2||6
3289055|NCT02806973|4022633|FG002|COMPLETED|Period 2||7
3289056|NCT02806973|4022634|FG003|COMPLETED|Period 2||6
3289057|NCT02806973|4022631|FG000|NOT COMPLETED|Period 2||0
3289058|NCT02806973|4022632|FG001|NOT COMPLETED|Period 2||0
3289059|NCT02806973|4022633|FG002|NOT COMPLETED|Period 2||0
3289060|NCT02806973|4022634|FG003|NOT COMPLETED|Period 2||0
3289061|NCT02806973|4022631|FG000|STARTED|Period 3||8
3289062|NCT02806973|4022632|FG001|STARTED|Period 3||6
3289063|NCT02806973|4022633|FG002|STARTED|Period 3||7
3289064|NCT02806973|4022634|FG003|STARTED|Period 3||6
3289065|NCT02806973|4022631|FG000|COMPLETED|Period 3||8
3289066|NCT02806973|4022632|FG001|COMPLETED|Period 3||6
3289067|NCT02806973|4022633|FG002|COMPLETED|Period 3||6
3289068|NCT02806973|4022634|FG003|COMPLETED|Period 3||3
3089409|NCT01431274|3811415|FG003|NOT COMPLETED|Overall Study||60
3089410|NCT01431274|3811416|FG004|NOT COMPLETED|Overall Study||56
3089411|NCT01431287|3811433|FG000|STARTED|Overall Study|started are actually the randomized|510
3089412|NCT01431287|3811434|FG001|STARTED|Overall Study||507
3089413|NCT01431287|3811435|FG002|STARTED|Overall Study||507
3289069|NCT02806973|4022631|FG000|NOT COMPLETED|Period 3||0
3289070|NCT02806973|4022632|FG001|NOT COMPLETED|Period 3||0
3289071|NCT02806973|4022633|FG002|NOT COMPLETED|Period 3||1
3289072|NCT02806973|4022634|FG003|NOT COMPLETED|Period 3||3
3289073|NCT02806973|4022631|FG000|STARTED|Period 4||8
3289074|NCT02806973|4022632|FG001|STARTED|Period 4||6
3289075|NCT02806973|4022633|FG002|STARTED|Period 4||6
3289076|NCT02806973|4022634|FG003|STARTED|Period 4||3
3289077|NCT02806973|4022631|FG000|COMPLETED|Period 4||8
3289078|NCT02806973|4022632|FG001|COMPLETED|Period 4||6
3289079|NCT02806973|4022633|FG002|COMPLETED|Period 4||6
3289080|NCT02806973|4022634|FG003|COMPLETED|Period 4||3
3289081|NCT02806973|4022631|FG000|NOT COMPLETED|Period 4||0
3289082|NCT02806973|4022632|FG001|NOT COMPLETED|Period 4||0
3289083|NCT02806973|4022633|FG002|NOT COMPLETED|Period 4||0
3289084|NCT02806973|4022634|FG003|NOT COMPLETED|Period 4||0
3289085|NCT02806986|4022644|FG000|STARTED|Treatment Stage 1||61
3289086|NCT02806986|4022644|FG000|COMPLETED|Treatment Stage 1||60
3289087|NCT02806986|4022644|FG000|NOT COMPLETED|Treatment Stage 1||1
3289088|NCT02806986|4022644|FG000|STARTED|Treatment Stage 2||60
3289089|NCT02806986|4022644|FG000|COMPLETED|Treatment Stage 2||55
3289090|NCT02806986|4022644|FG000|NOT COMPLETED|Treatment Stage 2||5
3289091|NCT02807259|4022654|FG000|STARTED|Baseline (3 Months)||405
3289092|NCT02807259|4022655|FG001|STARTED|Baseline (3 Months)||404
3289093|NCT02807259|4022654|FG000|COMPLETED|Baseline (3 Months)||328
3289094|NCT02807259|4022655|FG001|COMPLETED|Baseline (3 Months)||292
3289095|NCT02807259|4022654|FG000|NOT COMPLETED|Baseline (3 Months)||77
3289096|NCT02807259|4022655|FG001|NOT COMPLETED|Baseline (3 Months)||112
3289097|NCT02807259|4022654|FG000|STARTED|Midline (3 Months)||352
3289098|NCT02807259|4022655|FG001|STARTED|Midline (3 Months)||223
3289099|NCT02807259|4022654|FG000|COMPLETED|Midline (3 Months)||322
3289100|NCT02807259|4022655|FG001|COMPLETED|Midline (3 Months)||189
3289101|NCT02807259|4022654|FG000|NOT COMPLETED|Midline (3 Months)||30
3289102|NCT02807259|4022655|FG001|NOT COMPLETED|Midline (3 Months)||34
3289103|NCT02807259|4022654|FG000|STARTED|Endline (3 Months)||323
3289104|NCT02807259|4022655|FG001|STARTED|Endline (3 Months)||346
3289105|NCT02807259|4022654|FG000|COMPLETED|Endline (3 Months)||288
3289106|NCT02807259|4022655|FG001|COMPLETED|Endline (3 Months)||259
3289107|NCT02807259|4022654|FG000|NOT COMPLETED|Endline (3 Months)||35
3289108|NCT02807259|4022655|FG001|NOT COMPLETED|Endline (3 Months)||87
3289109|NCT02807376|4022665|FG000|STARTED|Overall Study||139
3289110|NCT02807376|4022666|FG001|STARTED|Overall Study||131
3289111|NCT02807376|4022665|FG000|COMPLETED|Overall Study||136
3289112|NCT02807376|4022666|FG001|COMPLETED|Overall Study||130
3289113|NCT02807376|4022665|FG000|NOT COMPLETED|Overall Study||3
3289114|NCT02807376|4022666|FG001|NOT COMPLETED|Overall Study||1
3289115|NCT02807402|4022672|FG000|STARTED|Overall Study||522
3289116|NCT02807402|4022672|FG000|COMPLETED|Overall Study||516
3289117|NCT02807402|4022672|FG000|NOT COMPLETED|Overall Study||6
3289118|NCT02807623|4022687|FG000|STARTED|Overall Study||98
3289119|NCT02807623|4022688|FG001|STARTED|Overall Study||100
3289120|NCT02807623|4022689|FG002|STARTED|Overall Study||102
3289121|NCT02807623|4022687|FG000|COMPLETED|Overall Study||75
3289122|NCT02807623|4022688|FG001|COMPLETED|Overall Study||79
3289123|NCT02807623|4022689|FG002|COMPLETED|Overall Study||79
3289124|NCT02807623|4022687|FG000|NOT COMPLETED|Overall Study||23
3289125|NCT02807623|4022688|FG001|NOT COMPLETED|Overall Study||21
3289126|NCT02807623|4022689|FG002|NOT COMPLETED|Overall Study||23
3289127|NCT02807844|4022716|FG000|STARTED|Overall Study||6
3289128|NCT02807844|4022717|FG001|STARTED|Overall Study||12
3289129|NCT02807844|4022718|FG002|STARTED|Overall Study||12
3289130|NCT02807844|4022719|FG003|STARTED|Overall Study||13
3289131|NCT02807844|4022720|FG004|STARTED|Overall Study||6
3289132|NCT02807844|4022721|FG005|STARTED|Overall Study||11
3289133|NCT02807844|4022722|FG006|STARTED|Overall Study||20
3289134|NCT02807844|4022723|FG007|STARTED|Overall Study||20
3289135|NCT02807844|4022724|FG008|STARTED|Overall Study||21
3289136|NCT02807844|4022725|FG009|STARTED|Overall Study||20
3289137|NCT02807844|4022716|FG000|COMPLETED|Overall Study||0
3289138|NCT02807844|4022717|FG001|COMPLETED|Overall Study||0
3289139|NCT02807844|4022718|FG002|COMPLETED|Overall Study||0
3289140|NCT02807844|4022719|FG003|COMPLETED|Overall Study||0
3289141|NCT02807844|4022720|FG004|COMPLETED|Overall Study||0
3289142|NCT02807844|4022721|FG005|COMPLETED|Overall Study||0
3289143|NCT02807844|4022722|FG006|COMPLETED|Overall Study||0
3289144|NCT02807844|4022723|FG007|COMPLETED|Overall Study||0
3289145|NCT02807844|4022724|FG008|COMPLETED|Overall Study||0
3289146|NCT02807844|4022725|FG009|COMPLETED|Overall Study||0
3289147|NCT02807844|4022716|FG000|NOT COMPLETED|Overall Study||6
3289148|NCT02807844|4022717|FG001|NOT COMPLETED|Overall Study||12
3289149|NCT02807844|4022718|FG002|NOT COMPLETED|Overall Study||12
3089414|NCT01431287|3811436|FG003|STARTED|Overall Study||508
3089415|NCT01431287|3811437|FG004|STARTED|Overall Study||507
3289150|NCT02807844|4022719|FG003|NOT COMPLETED|Overall Study||13
3289151|NCT02807844|4022720|FG004|NOT COMPLETED|Overall Study||6
3289152|NCT02807844|4022721|FG005|NOT COMPLETED|Overall Study||11
3289153|NCT02807844|4022722|FG006|NOT COMPLETED|Overall Study||20
3289154|NCT02807844|4022723|FG007|NOT COMPLETED|Overall Study||20
3089416|NCT01431287|3811433|FG000|COMPLETED|Overall Study||412
3089417|NCT01431287|3811434|FG001|COMPLETED|Overall Study||409
3089418|NCT01431287|3811435|FG002|COMPLETED|Overall Study||410
3089419|NCT01431287|3811436|FG003|COMPLETED|Overall Study||445
3089420|NCT01431287|3811437|FG004|COMPLETED|Overall Study||430
3089421|NCT01431287|3811433|FG000|NOT COMPLETED|Overall Study||98
3089422|NCT01431287|3811434|FG001|NOT COMPLETED|Overall Study||98
3089423|NCT01431287|3811435|FG002|NOT COMPLETED|Overall Study||97
3089424|NCT01431287|3811436|FG003|NOT COMPLETED|Overall Study||63
3089425|NCT01431287|3811437|FG004|NOT COMPLETED|Overall Study||77
3089426|NCT01431300|3811452|FG000|STARTED|Overall Study|One subject with indeterminate pregnancy test, subject declined to proceed|11
3089427|NCT01431300|3811453|FG001|STARTED|Overall Study||10
3089428|NCT01431300|3811454|FG002|STARTED|Overall Study||10
3089429|NCT01431300|3811452|FG000|COMPLETED|Overall Study||10
3089430|NCT01431300|3811453|FG001|COMPLETED|Overall Study||10
3089431|NCT01431300|3811454|FG002|COMPLETED|Overall Study||10
3089432|NCT01431300|3811452|FG000|NOT COMPLETED|Overall Study||1
3089433|NCT01431300|3811453|FG001|NOT COMPLETED|Overall Study||0
3089434|NCT01431300|3811454|FG002|NOT COMPLETED|Overall Study||0
3089435|NCT01431313|3811465|FG000|STARTED|Overall Study||20
3089436|NCT01431313|3811466|FG001|STARTED|Overall Study||20
3089437|NCT01431313|3811467|FG002|STARTED|Overall Study||8
3089438|NCT01431313|3811465|FG000|COMPLETED|Overall Study||20
3089439|NCT01431313|3811466|FG001|COMPLETED|Overall Study||20
3089440|NCT01431313|3811467|FG002|COMPLETED|Overall Study||8
3089441|NCT01431313|3811465|FG000|NOT COMPLETED|Overall Study||0
3089442|NCT01431313|3811466|FG001|NOT COMPLETED|Overall Study||0
3089443|NCT01431313|3811467|FG002|NOT COMPLETED|Overall Study||0
3089444|NCT01431339|3811478|FG000|STARTED|Overall Study||371
3089445|NCT01431339|3811479|FG001|STARTED|Overall Study||368
3089446|NCT01431339|3811478|FG000|Safety Population|Overall Study||368
3089447|NCT01431339|3811479|FG001|Safety Population|Overall Study||367
3089448|NCT01431339|3811478|FG000|COMPLETED|Overall Study||332
3089449|NCT01431339|3811479|FG001|COMPLETED|Overall Study||333
3089450|NCT01431339|3811478|FG000|NOT COMPLETED|Overall Study||39
3089451|NCT01431339|3811479|FG001|NOT COMPLETED|Overall Study||35
3089452|NCT01431391|3811487|FG000|STARTED|Overall Study||34
3089453|NCT01431391|3811488|FG001|STARTED|Overall Study||34
3089454|NCT01431391|3811487|FG000|Received ≥1 Leaukapheresis|Overall Study||34
3089455|NCT01431391|3811488|FG001|Received ≥1 Leaukapheresis|Overall Study||34
3089456|NCT01431391|3811487|FG000|COMPLETED|Overall Study||26
3089457|NCT01431391|3811488|FG001|COMPLETED|Overall Study||30
3089458|NCT01431391|3811487|FG000|NOT COMPLETED|Overall Study||8
3089459|NCT01431391|3811488|FG001|NOT COMPLETED|Overall Study||4
3089460|NCT01431521|3811499|FG000|STARTED|Overall Study||10
3089461|NCT01431521|3811500|FG001|STARTED|Overall Study||5
3089462|NCT01431521|3811501|FG002|STARTED|Overall Study||11
3089463|NCT01431521|3811502|FG003|STARTED|Overall Study||5
3089464|NCT01431521|3811499|FG000|Treated|Overall Study||10
3089465|NCT01431521|3811500|FG001|Treated|Overall Study||5
3089466|NCT01431521|3811501|FG002|Treated|Overall Study||10
3089467|NCT01431521|3811502|FG003|Treated|Overall Study||5
3089468|NCT01431521|3811499|FG000|COMPLETED|Overall Study||10
3089469|NCT01431521|3811500|FG001|COMPLETED|Overall Study||5
3089470|NCT01431521|3811501|FG002|COMPLETED|Overall Study||10
3089471|NCT01431521|3811502|FG003|COMPLETED|Overall Study||5
3089472|NCT01431521|3811499|FG000|NOT COMPLETED|Overall Study||0
3089473|NCT01431521|3811500|FG001|NOT COMPLETED|Overall Study||0
3089474|NCT01431521|3811501|FG002|NOT COMPLETED|Overall Study||1
3089475|NCT01431521|3811502|FG003|NOT COMPLETED|Overall Study||0
3089476|NCT01431534|3811514|FG000|STARTED|Treatment Phase||4
3089477|NCT01431534|3811515|FG001|STARTED|Treatment Phase||3
3089478|NCT01431534|3811516|FG002|STARTED|Treatment Phase||13
3089479|NCT01431534|3811514|FG000|COMPLETED|Treatment Phase||0
3089480|NCT01431534|3811515|FG001|COMPLETED|Treatment Phase||0
3089481|NCT01431534|3811516|FG002|COMPLETED|Treatment Phase|Participants completing Treatment Phase could continue in Extension Phase.|2
3089482|NCT01431534|3811514|FG000|NOT COMPLETED|Treatment Phase||4
3089483|NCT01431534|3811515|FG001|NOT COMPLETED|Treatment Phase||3
3089484|NCT01431534|3811516|FG002|NOT COMPLETED|Treatment Phase||11
3089485|NCT01431534|3811514|FG000|STARTED|Extension Phase|No participants continued in Extension Phase.|0
3089486|NCT01431534|3811515|FG001|STARTED|Extension Phase|No participants continued in Extension Phase.|0
3089487|NCT01431534|3811516|FG002|STARTED|Extension Phase|Participants from Treatment Phase who continued in Extension Phase.|2
3089488|NCT01431534|3811514|FG000|COMPLETED|Extension Phase||0
3089489|NCT01431534|3811515|FG001|COMPLETED|Extension Phase||0
3089490|NCT01431534|3811516|FG002|COMPLETED|Extension Phase||2
3089491|NCT01431534|3811514|FG000|NOT COMPLETED|Extension Phase||0
3089492|NCT01431534|3811515|FG001|NOT COMPLETED|Extension Phase||0
3089493|NCT01431534|3811516|FG002|NOT COMPLETED|Extension Phase||0
3089494|NCT01431573|3811524|FG000|STARTED|Overall Study||8
3089495|NCT01431573|3811524|FG000|COMPLETED|Overall Study||8
3089496|NCT01431573|3811524|FG000|NOT COMPLETED|Overall Study||0
3089497|NCT01431638|3811531|FG000|STARTED|Overall Study||133
3089498|NCT01431638|3811532|FG001|STARTED|Overall Study||132
3089499|NCT01431638|3811533|FG002|STARTED|Overall Study||132
3089500|NCT01431638|3811531|FG000|Completed Core Study|Overall Study||124
3089501|NCT01431638|3811532|FG001|Completed Core Study|Overall Study||117
3089502|NCT01431638|3811533|FG002|Completed Core Study|Overall Study||108
3089503|NCT01431638|3811531|FG000|Entered Extension 1 Study|Overall Study||85
3089504|NCT01431638|3811532|FG001|Entered Extension 1 Study|Overall Study||71
3089505|NCT01431638|3811533|FG002|Entered Extension 1 Study|Overall Study||76
3089506|NCT01431638|3811531|FG000|COMPLETED|Overall Study||67
3089507|NCT01431638|3811532|FG001|COMPLETED|Overall Study||61
3089508|NCT01431638|3811533|FG002|COMPLETED|Overall Study||70
3089509|NCT01431638|3811531|FG000|NOT COMPLETED|Overall Study||66
3089510|NCT01431638|3811532|FG001|NOT COMPLETED|Overall Study||71
3089511|NCT01431638|3811533|FG002|NOT COMPLETED|Overall Study||62
3089512|NCT01431703|3811541|FG000|STARTED|Overall Study||326
3089513|NCT01431703|3811541|FG000|COMPLETED|Overall Study||326
3089514|NCT01431703|3811541|FG000|NOT COMPLETED|Overall Study||0
3089515|NCT01431716|3811545|FG000|STARTED|Overall Study||42
3089516|NCT01431716|3811545|FG000|COMPLETED|Overall Study||41
3089517|NCT01431716|3811545|FG000|NOT COMPLETED|Overall Study||1
3089518|NCT01431755|3811549|FG000|STARTED|Overall Study||54
3089519|NCT01431755|3811549|FG000|COMPLETED|Overall Study||49
3089520|NCT01431755|3811549|FG000|NOT COMPLETED|Overall Study||5
3089521|NCT01431794|3811560|FG000|STARTED|Overall Study||13
3089522|NCT01431794|3811561|FG001|STARTED|Overall Study|not started due to early study's termination|0
3089523|NCT01431794|3811562|FG002|STARTED|Overall Study|not started due to early study's termination|0
3089524|NCT01431794|3811563|FG003|STARTED|Overall Study|not started due to early study's termination|0
3089525|NCT01431794|3811564|FG004|STARTED|Overall Study|not started due to early study's termination|0
3089526|NCT01431794|3811560|FG000|COMPLETED|Overall Study||13
3089527|NCT01431794|3811561|FG001|COMPLETED|Overall Study|not started due to early study's termination|0
3089528|NCT01431794|3811562|FG002|COMPLETED|Overall Study|not started due to early study's termination|0
3089529|NCT01431794|3811563|FG003|COMPLETED|Overall Study|not started due to early study's termination|0
3089530|NCT01431794|3811564|FG004|COMPLETED|Overall Study|not started due to early study's termination|0
3089531|NCT01431794|3811560|FG000|NOT COMPLETED|Overall Study||0
3089532|NCT01431794|3811561|FG001|NOT COMPLETED|Overall Study||0
3089533|NCT01431794|3811562|FG002|NOT COMPLETED|Overall Study||0
3089534|NCT01431794|3811563|FG003|NOT COMPLETED|Overall Study||0
3089535|NCT01431794|3811564|FG004|NOT COMPLETED|Overall Study||0
3089536|NCT01431846|3811579|FG000|STARTED|Overall Study||8
3089537|NCT01431846|3811580|FG001|STARTED|Overall Study||3
3089538|NCT01431846|3811581|FG002|STARTED|Overall Study||8
3089539|NCT01431846|3811579|FG000|COMPLETED|Overall Study||8
3089540|NCT01431846|3811580|FG001|COMPLETED|Overall Study||3
3089541|NCT01431846|3811581|FG002|COMPLETED|Overall Study||8
3089542|NCT01431846|3811579|FG000|NOT COMPLETED|Overall Study||0
3089543|NCT01431846|3811580|FG001|NOT COMPLETED|Overall Study||0
3089544|NCT01431846|3811581|FG002|NOT COMPLETED|Overall Study||0
3089545|NCT01431950|3811591|FG000|STARTED|Overall Study||119
3089546|NCT01431950|3811592|FG001|STARTED|Overall Study||119
3089547|NCT01431950|3811591|FG000|COMPLETED|Overall Study||100
3089548|NCT01431950|3811592|FG001|COMPLETED|Overall Study||104
3089549|NCT01431950|3811591|FG000|NOT COMPLETED|Overall Study||19
3089550|NCT01431950|3811592|FG001|NOT COMPLETED|Overall Study||15
3089551|NCT01431963|3811598|FG000|STARTED|Overall Study||67
3089552|NCT01431963|3811598|FG000|Begin Escalation Phase (EP; 6 Weeks)|Overall Study||67
3089553|NCT01431963|3811598|FG000|Received Treatment|Overall Study||65
3089554|NCT01431963|3811598|FG000|Complete EP (6 Weeks)|Overall Study||52
3089555|NCT01431963|3811598|FG000|Begin Maintenance Phase (MP; 24 Weeks)|Overall Study||52
3089556|NCT01431963|3811598|FG000|Complete MP (24 Weeks)|Overall Study||42
3089557|NCT01431963|3811598|FG000|Begin Extension Phase (ExP; gt= 24weeks)|Overall Study|Only Japanese participants in ExP,lamotrigine monotherapy was available in Korea. (>=24weeks)|19
3089558|NCT01431963|3811598|FG000|Complete ExP (gt= 24 Weeks)|Overall Study|(>=24 weeks); gt= abbreviation for greater than or equal to|19
3089559|NCT01431963|3811598|FG000|COMPLETED|Overall Study||32
3089560|NCT01431963|3811598|FG000|NOT COMPLETED|Overall Study||35
3089561|NCT01431976|3811602|FG000|STARTED|Overall Study||20
3089562|NCT01431976|3811602|FG000|COMPLETED|Overall Study||6
3089563|NCT01431976|3811602|FG000|NOT COMPLETED|Overall Study||14
3089564|NCT01431989|3811606|FG000|STARTED|Period 1||14
3089565|NCT01431989|3811607|FG001|STARTED|Period 1||14
3089566|NCT01431989|3811606|FG000|COMPLETED|Period 1||14
3089567|NCT01431989|3811607|FG001|COMPLETED|Period 1||14
3089568|NCT01431989|3811606|FG000|NOT COMPLETED|Period 1||0
3089569|NCT01431989|3811607|FG001|NOT COMPLETED|Period 1||0
3089570|NCT01431989|3811606|FG000|STARTED|14-Day Washout Period||14
3089571|NCT01431989|3811607|FG001|STARTED|14-Day Washout Period||14
3089572|NCT01431989|3811606|FG000|COMPLETED|14-Day Washout Period||14
3089573|NCT01431989|3811607|FG001|COMPLETED|14-Day Washout Period||14
3089574|NCT01431989|3811606|FG000|NOT COMPLETED|14-Day Washout Period||0
3089575|NCT01431989|3811607|FG001|NOT COMPLETED|14-Day Washout Period||0
3089576|NCT01431989|3811606|FG000|STARTED|Period 2||14
3089577|NCT01431989|3811607|FG001|STARTED|Period 2||14
3089578|NCT01431989|3811606|FG000|COMPLETED|Period 2||14
3089579|NCT01431989|3811607|FG001|COMPLETED|Period 2||14
3089580|NCT01431989|3811606|FG000|NOT COMPLETED|Period 2||0
3089581|NCT01431989|3811607|FG001|NOT COMPLETED|Period 2||0
3089582|NCT01432015|3811615|FG000|STARTED|Overall Study||10
3089583|NCT01432015|3811616|FG001|STARTED|Overall Study||10
3089584|NCT01432015|3811615|FG000|COMPLETED|Overall Study||10
3089585|NCT01432015|3811616|FG001|COMPLETED|Overall Study||10
3089586|NCT01432015|3811615|FG000|NOT COMPLETED|Overall Study||0
3089587|NCT01432015|3811616|FG001|NOT COMPLETED|Overall Study||0
3089588|NCT01432145|3811622|FG000|STARTED|Overall Study|Corrected from 75. 75 was entered in error|74
3089589|NCT01432145|3811622|FG000|COMPLETED|Overall Study||67
3089590|NCT01432145|3811622|FG000|NOT COMPLETED|Overall Study||7
3089591|NCT01432171|3811628|FG000|STARTED|Overall Study||18
3089592|NCT01432171|3811629|FG001|STARTED|Overall Study||19
3089593|NCT01432171|3811628|FG000|COMPLETED|Overall Study||4
3089594|NCT01432171|3811629|FG001|COMPLETED|Overall Study||8
3089595|NCT01432171|3811628|FG000|NOT COMPLETED|Overall Study||14
3089596|NCT01432171|3811629|FG001|NOT COMPLETED|Overall Study||11
3089597|NCT01432236|3811637|FG000|STARTED|Overall Study||96
3089598|NCT01432236|3811638|FG001|STARTED|Overall Study||97
3089599|NCT01432236|3811637|FG000|COMPLETED|Overall Study||70
3089600|NCT01432236|3811638|FG001|COMPLETED|Overall Study||79
3089601|NCT01432236|3811637|FG000|NOT COMPLETED|Overall Study||26
3089602|NCT01432236|3811638|FG001|NOT COMPLETED|Overall Study||18
3089603|NCT01432262|3811653|FG000|STARTED|Overall Study||162
3089604|NCT01432262|3811654|FG001|STARTED|Overall Study||162
3089605|NCT01432262|3811653|FG000|Vaccinated|Overall Study||162
3089606|NCT01432262|3811654|FG001|Vaccinated|Overall Study||161
3089607|NCT01432262|3811653|FG000|COMPLETED|Overall Study||160
3089608|NCT01432262|3811654|FG001|COMPLETED|Overall Study||161
3089609|NCT01432262|3811653|FG000|NOT COMPLETED|Overall Study||2
3089610|NCT01432262|3811654|FG001|NOT COMPLETED|Overall Study||1
3089611|NCT01432275|3811660|FG000|STARTED|First BG Meter System (7 Days)||90
3089612|NCT01432275|3811661|FG001|STARTED|First BG Meter System (7 Days)||87
3089613|NCT01432275|3811660|FG000|COMPLETED|First BG Meter System (7 Days)||90
3089614|NCT01432275|3811661|FG001|COMPLETED|First BG Meter System (7 Days)||84
3089615|NCT01432275|3811660|FG000|NOT COMPLETED|First BG Meter System (7 Days)||0
3089616|NCT01432275|3811661|FG001|NOT COMPLETED|First BG Meter System (7 Days)||3
3089617|NCT01432275|3811660|FG000|STARTED|Second BG Meter System (7 Days)||90
3089618|NCT01432275|3811661|FG001|STARTED|Second BG Meter System (7 Days)||84
3089619|NCT01432275|3811660|FG000|COMPLETED|Second BG Meter System (7 Days)||88
3089620|NCT01432275|3811661|FG001|COMPLETED|Second BG Meter System (7 Days)||81
3089621|NCT01432275|3811660|FG000|NOT COMPLETED|Second BG Meter System (7 Days)||2
3089622|NCT01432275|3811661|FG001|NOT COMPLETED|Second BG Meter System (7 Days)||3
3089623|NCT01432275|3811660|FG000|STARTED|ADC With Calculator (10 Days)||88
3089624|NCT01432275|3811661|FG001|STARTED|ADC With Calculator (10 Days)||81
3089625|NCT01432275|3811660|FG000|COMPLETED|ADC With Calculator (10 Days)||85
3089626|NCT01432275|3811661|FG001|COMPLETED|ADC With Calculator (10 Days)||79
3089627|NCT01432275|3811660|FG000|NOT COMPLETED|ADC With Calculator (10 Days)||3
3089628|NCT01432275|3811661|FG001|NOT COMPLETED|ADC With Calculator (10 Days)||2
3089629|NCT01432327|3811671|FG000|STARTED|Baseline||56
3089630|NCT01432327|3811672|FG001|STARTED|Baseline||57
3089631|NCT01432327|3811673|FG002|STARTED|Baseline||57
3089632|NCT01432327|3811674|FG003|STARTED|Baseline||57
3089633|NCT01432327|3811671|FG000|COMPLETED|Baseline||56
3089634|NCT01432327|3811672|FG001|COMPLETED|Baseline||57
3089635|NCT01432327|3811673|FG002|COMPLETED|Baseline||57
3089636|NCT01432327|3811674|FG003|COMPLETED|Baseline||57
3089637|NCT01432327|3811671|FG000|NOT COMPLETED|Baseline||0
3089638|NCT01432327|3811672|FG001|NOT COMPLETED|Baseline||0
3089639|NCT01432327|3811673|FG002|NOT COMPLETED|Baseline||0
3089640|NCT01432327|3811674|FG003|NOT COMPLETED|Baseline||0
3089641|NCT01432327|3811671|FG000|STARTED|Posttest 3 Months||56
3089642|NCT01432327|3811672|FG001|STARTED|Posttest 3 Months||57
3089643|NCT01432327|3811673|FG002|STARTED|Posttest 3 Months||57
3089644|NCT01432327|3811674|FG003|STARTED|Posttest 3 Months||57
3089645|NCT01432327|3811671|FG000|COMPLETED|Posttest 3 Months||52
3089646|NCT01432327|3811672|FG001|COMPLETED|Posttest 3 Months||55
3089647|NCT01432327|3811673|FG002|COMPLETED|Posttest 3 Months||55
3089648|NCT01432327|3811674|FG003|COMPLETED|Posttest 3 Months||56
3089649|NCT01432327|3811671|FG000|NOT COMPLETED|Posttest 3 Months||4
3089650|NCT01432327|3811672|FG001|NOT COMPLETED|Posttest 3 Months||2
3089651|NCT01432327|3811673|FG002|NOT COMPLETED|Posttest 3 Months||2
3089652|NCT01432327|3811674|FG003|NOT COMPLETED|Posttest 3 Months||1
3089653|NCT01432327|3811671|FG000|STARTED|Posttest 6 Months||52
3089654|NCT01432327|3811672|FG001|STARTED|Posttest 6 Months||55
3089655|NCT01432327|3811673|FG002|STARTED|Posttest 6 Months||55
3089656|NCT01432327|3811674|FG003|STARTED|Posttest 6 Months||56
3089657|NCT01432327|3811671|FG000|COMPLETED|Posttest 6 Months||52
3089658|NCT01432327|3811672|FG001|COMPLETED|Posttest 6 Months||55
3089659|NCT01432327|3811673|FG002|COMPLETED|Posttest 6 Months||50
3089660|NCT01432327|3811674|FG003|COMPLETED|Posttest 6 Months||54
3089661|NCT01432327|3811671|FG000|NOT COMPLETED|Posttest 6 Months||0
3089662|NCT01432327|3811672|FG001|NOT COMPLETED|Posttest 6 Months||0
3089663|NCT01432327|3811673|FG002|NOT COMPLETED|Posttest 6 Months||5
3089664|NCT01432327|3811674|FG003|NOT COMPLETED|Posttest 6 Months||2
3089665|NCT01432327|3811671|FG000|STARTED|Posttest 1 Year||52
3089666|NCT01432327|3811672|FG001|STARTED|Posttest 1 Year||55
3089667|NCT01432327|3811673|FG002|STARTED|Posttest 1 Year||50
3089668|NCT01432327|3811674|FG003|STARTED|Posttest 1 Year||54
3089669|NCT01432327|3811671|FG000|COMPLETED|Posttest 1 Year||28
3089670|NCT01432327|3811672|FG001|COMPLETED|Posttest 1 Year||27
3089671|NCT01432327|3811673|FG002|COMPLETED|Posttest 1 Year||30
3089672|NCT01432327|3811674|FG003|COMPLETED|Posttest 1 Year||31
3089673|NCT01432327|3811671|FG000|NOT COMPLETED|Posttest 1 Year||24
3089674|NCT01432327|3811672|FG001|NOT COMPLETED|Posttest 1 Year||28
3089675|NCT01432327|3811673|FG002|NOT COMPLETED|Posttest 1 Year||20
3089676|NCT01432327|3811674|FG003|NOT COMPLETED|Posttest 1 Year||23
3089677|NCT01432366|3811684|FG000|STARTED|Overall Study||460
3089678|NCT01432366|3811684|FG000|COMPLETED|Overall Study||392
3089679|NCT01432366|3811684|FG000|NOT COMPLETED|Overall Study||68
3089680|NCT01432379|3811688|FG000|STARTED|Overall Study||1168
3089681|NCT01432379|3811688|FG000|COMPLETED|Overall Study||783
3089682|NCT01432379|3811688|FG000|NOT COMPLETED|Overall Study||385
3089683|NCT01432405|3811694|FG000|STARTED|Overall Study||12
3089684|NCT01432405|3811695|FG001|STARTED|Overall Study||12
3089685|NCT01432405|3811694|FG000|COMPLETED|Overall Study||11
3089686|NCT01432405|3811695|FG001|COMPLETED|Overall Study||10
3089687|NCT01432405|3811694|FG000|NOT COMPLETED|Overall Study||1
3089688|NCT01432405|3811695|FG001|NOT COMPLETED|Overall Study||2
3089689|NCT01432444|3811701|FG000|STARTED|Tolerability/Cross-titration Phase||325
3089690|NCT01432444|3811702|FG001|STARTED|Tolerability/Cross-titration Phase||0
3089691|NCT01432444|3811703|FG002|STARTED|Tolerability/Cross-titration Phase||0
3089692|NCT01432444|3811701|FG000|COMPLETED|Tolerability/Cross-titration Phase||265
3089693|NCT01432444|3811702|FG001|COMPLETED|Tolerability/Cross-titration Phase||0
3089694|NCT01432444|3811703|FG002|COMPLETED|Tolerability/Cross-titration Phase||0
3089695|NCT01432444|3811701|FG000|NOT COMPLETED|Tolerability/Cross-titration Phase||60
3089696|NCT01432444|3811702|FG001|NOT COMPLETED|Tolerability/Cross-titration Phase||0
3089697|NCT01432444|3811703|FG002|NOT COMPLETED|Tolerability/Cross-titration Phase||0
3089698|NCT01432444|3811701|FG000|STARTED|Treatment Phase||0
3089699|NCT01432444|3811702|FG001|STARTED|Treatment Phase||433
3089700|NCT01432444|3811703|FG002|STARTED|Treatment Phase||0
3089701|NCT01432444|3811701|FG000|COMPLETED|Treatment Phase||0
3089702|NCT01432444|3811702|FG001|COMPLETED|Treatment Phase||293
3089703|NCT01432444|3811703|FG002|COMPLETED|Treatment Phase||0
3089704|NCT01432444|3811701|FG000|NOT COMPLETED|Treatment Phase||0
3089705|NCT01432444|3811702|FG001|NOT COMPLETED|Treatment Phase||140
3089706|NCT01432444|3811703|FG002|NOT COMPLETED|Treatment Phase||0
3089707|NCT01432444|3811701|FG000|STARTED|Extension Phase||0
3089708|NCT01432444|3811702|FG001|STARTED|Extension Phase||0
3089709|NCT01432444|3811703|FG002|STARTED|Extension Phase||192
3089710|NCT01432444|3811701|FG000|COMPLETED|Extension Phase||0
3089711|NCT01432444|3811702|FG001|COMPLETED|Extension Phase||0
3089712|NCT01432444|3811703|FG002|COMPLETED|Extension Phase||0
3089713|NCT01432444|3811701|FG000|NOT COMPLETED|Extension Phase||0
3089714|NCT01432444|3811702|FG001|NOT COMPLETED|Extension Phase||0
3089715|NCT01432444|3811703|FG002|NOT COMPLETED|Extension Phase||192
3089716|NCT01432457|3811711|FG000|STARTED|Overall Study||306
3089717|NCT01432457|3811712|FG001|STARTED|Overall Study||306
3089718|NCT01432457|3811713|FG002|STARTED|Overall Study||312
3089719|NCT01432457|3811711|FG000|COMPLETED|Overall Study||269
3089720|NCT01432457|3811712|FG001|COMPLETED|Overall Study||258
3089721|NCT01432457|3811713|FG002|COMPLETED|Overall Study||253
3089722|NCT01432457|3811711|FG000|NOT COMPLETED|Overall Study||37
3089723|NCT01432457|3811712|FG001|NOT COMPLETED|Overall Study||48
3089724|NCT01432457|3811713|FG002|NOT COMPLETED|Overall Study||59
3089725|NCT01432535|3811724|FG000|STARTED|Overall Study||12
3089726|NCT01432535|3811725|FG001|STARTED|Overall Study|One participant later determined ineligible is not included in baseline/efficacy analyses.|7
3089727|NCT01432535|3811726|FG002|STARTED|Overall Study||6
3089728|NCT01432535|3811724|FG000|COMPLETED|Overall Study||12
3089729|NCT01432535|3811725|FG001|COMPLETED|Overall Study||7
3089730|NCT01432535|3811726|FG002|COMPLETED|Overall Study||6
3089731|NCT01432535|3811724|FG000|NOT COMPLETED|Overall Study||0
3089732|NCT01432535|3811725|FG001|NOT COMPLETED|Overall Study||0
3089733|NCT01432535|3811726|FG002|NOT COMPLETED|Overall Study||0
3089734|NCT01432561|3811734|FG000|STARTED|Overall Study||8
3089735|NCT01432561|3811734|FG000|COMPLETED|Overall Study||8
3089736|NCT01432561|3811734|FG000|NOT COMPLETED|Overall Study||0
3089737|NCT01432574|3811738|FG000|STARTED|Overall Study||150
3089738|NCT01432574|3811738|FG000|COMPLETED|Overall Study||147
3089739|NCT01432574|3811738|FG000|NOT COMPLETED|Overall Study||3
3089740|NCT01432600|3811747|FG000|STARTED|Overall Study||10
3089741|NCT01432600|3811748|FG001|STARTED|Overall Study||36
3089742|NCT01432600|3811749|FG002|STARTED|Overall Study||34
3089743|NCT01432600|3811747|FG000|COMPLETED|Overall Study||10
3089744|NCT01432600|3811748|FG001|COMPLETED|Overall Study||35
3089745|NCT01432600|3811749|FG002|COMPLETED|Overall Study||33
3089746|NCT01432600|3811747|FG000|NOT COMPLETED|Overall Study||0
3089747|NCT01432600|3811748|FG001|NOT COMPLETED|Overall Study||1
3089748|NCT01432600|3811749|FG002|NOT COMPLETED|Overall Study||1
3089749|NCT01432626|3811759|FG000|STARTED|Overall Study||10
3089750|NCT01432626|3811759|FG000|COMPLETED|Overall Study|Completed both images|3
3089751|NCT01432626|3811759|FG000|NOT COMPLETED|Overall Study||7
3089752|NCT01432730|3811763|FG000|STARTED|Period 1||12
3289155|NCT02807844|4022724|FG008|NOT COMPLETED|Overall Study||21
3289156|NCT02807844|4022725|FG009|NOT COMPLETED|Overall Study||20
3289157|NCT02807857|4022751|FG000|STARTED|Enrolled Set||1415
3289158|NCT02807857|4022751|FG000|COMPLETED|Enrolled Set||864
3289159|NCT02807857|4022751|FG000|NOT COMPLETED|Enrolled Set||551
3289160|NCT02807857|4022751|FG000|STARTED|Follow-Up Set||864
3289161|NCT02807857|4022751|FG000|COMPLETED|Follow-Up Set||680
3089753|NCT01432730|3811764|FG001|STARTED|Period 1||12
3089754|NCT01432730|3811763|FG000|COMPLETED|Period 1||10
3089755|NCT01432730|3811764|FG001|COMPLETED|Period 1||12
3089756|NCT01432730|3811763|FG000|NOT COMPLETED|Period 1||2
3089757|NCT01432730|3811764|FG001|NOT COMPLETED|Period 1||0
3089758|NCT01432730|3811763|FG000|STARTED|Period 2||10
3089759|NCT01432730|3811764|FG001|STARTED|Period 2||12
3289162|NCT02807857|4022751|FG000|NOT COMPLETED|Follow-Up Set||184
3289163|NCT02807948|4022761|FG000|STARTED|Overall Study||132
3289164|NCT02807948|4022762|FG001|STARTED|Overall Study||57
3289165|NCT02807948|4022761|FG000|COMPLETED|Overall Study||131
3089760|NCT01432730|3811763|FG000|COMPLETED|Period 2||10
3089761|NCT01432730|3811764|FG001|COMPLETED|Period 2||8
3089762|NCT01432730|3811763|FG000|NOT COMPLETED|Period 2||0
3089763|NCT01432730|3811764|FG001|NOT COMPLETED|Period 2||4
3089764|NCT01432756|3811774|FG000|STARTED|Overall Study||32
3089765|NCT01432756|3811775|FG001|STARTED|Overall Study||34
3089766|NCT01432756|3811776|FG002|STARTED|Overall Study||32
3089767|NCT01432756|3811777|FG003|STARTED|Overall Study||34
3089768|NCT01432756|3811774|FG000|COMPLETED|Overall Study||31
3089769|NCT01432756|3811775|FG001|COMPLETED|Overall Study||34
3089770|NCT01432756|3811776|FG002|COMPLETED|Overall Study||30
3089771|NCT01432756|3811777|FG003|COMPLETED|Overall Study||33
3089772|NCT01432756|3811774|FG000|NOT COMPLETED|Overall Study||1
3089773|NCT01432756|3811775|FG001|NOT COMPLETED|Overall Study||0
3089774|NCT01432756|3811776|FG002|NOT COMPLETED|Overall Study||2
3089775|NCT01432756|3811777|FG003|NOT COMPLETED|Overall Study||1
3089776|NCT01432886|3811787|FG000|STARTED|Overall Study||6
3089777|NCT01432886|3811788|FG001|STARTED|Overall Study||6
3089778|NCT01432886|3811787|FG000|COMPLETED|Overall Study|Discontinuation met per discontinuation criteria|6
3089779|NCT01432886|3811788|FG001|COMPLETED|Overall Study|Discontinuation met per discontinuation criteria|6
3089780|NCT01432886|3811787|FG000|NOT COMPLETED|Overall Study||0
3089781|NCT01432886|3811788|FG001|NOT COMPLETED|Overall Study||0
3089782|NCT01432938|3811795|FG000|STARTED|First Intervention||14
3289166|NCT02807948|4022762|FG001|COMPLETED|Overall Study||57
3289167|NCT02807948|4022761|FG000|NOT COMPLETED|Overall Study||1
3289168|NCT02807948|4022762|FG001|NOT COMPLETED|Overall Study||0
3089783|NCT01432938|3811796|FG001|STARTED|First Intervention||14
3089784|NCT01432938|3811795|FG000|Received at Least 1 Dose of Study Drug|First Intervention||14
3089785|NCT01432938|3811796|FG001|Received at Least 1 Dose of Study Drug|First Intervention||14
3089786|NCT01432938|3811795|FG000|COMPLETED|First Intervention||12
3089787|NCT01432938|3811796|FG001|COMPLETED|First Intervention||14
3089788|NCT01432938|3811795|FG000|NOT COMPLETED|First Intervention||2
3089789|NCT01432938|3811796|FG001|NOT COMPLETED|First Intervention||0
3089790|NCT01432938|3811795|FG000|STARTED|Washout Period of at Least 24 Days||12
3089791|NCT01432938|3811796|FG001|STARTED|Washout Period of at Least 24 Days||14
3089792|NCT01432938|3811795|FG000|COMPLETED|Washout Period of at Least 24 Days||12
3089793|NCT01432938|3811796|FG001|COMPLETED|Washout Period of at Least 24 Days||14
3089794|NCT01432938|3811795|FG000|NOT COMPLETED|Washout Period of at Least 24 Days||0
3089795|NCT01432938|3811796|FG001|NOT COMPLETED|Washout Period of at Least 24 Days||0
3089796|NCT01432938|3811795|FG000|STARTED|Second Intervention||12
3089797|NCT01432938|3811796|FG001|STARTED|Second Intervention||14
3089798|NCT01432938|3811795|FG000|COMPLETED|Second Intervention||11
3089799|NCT01432938|3811796|FG001|COMPLETED|Second Intervention||14
3089800|NCT01432938|3811795|FG000|NOT COMPLETED|Second Intervention||1
3089801|NCT01432938|3811796|FG001|NOT COMPLETED|Second Intervention||0
3089802|NCT01432951|3811803|FG000|STARTED|Treatment Phase (Day 1 to 30)||26
3089803|NCT01432951|3811803|FG000|Received at Least One Dose of Study Drug|Treatment Phase (Day 1 to 30)||25
3089804|NCT01432951|3811803|FG000|PK Sampling (no Dosing) Days 15-17|Treatment Phase (Day 1 to 30)||23
3089805|NCT01432951|3811803|FG000|Progressive Disease|Treatment Phase (Day 1 to 30)||10
3089806|NCT01432951|3811803|FG000|COMPLETED|Treatment Phase (Day 1 to 30)||25
3089807|NCT01432951|3811803|FG000|NOT COMPLETED|Treatment Phase (Day 1 to 30)||1
3089808|NCT01432951|3811803|FG000|STARTED|Safety Extension Day 30 to End of Study|Participants had the option to continue on to safety extension period.|15
3089809|NCT01432951|3811803|FG000|COMPLETED|Safety Extension Day 30 to End of Study||15
3089810|NCT01432951|3811803|FG000|NOT COMPLETED|Safety Extension Day 30 to End of Study||0
3089811|NCT01433016|3811808|FG000|STARTED|Overall Study||20
3089812|NCT01433016|3811808|FG000|COMPLETED|Overall Study||20
3089813|NCT01433016|3811808|FG000|NOT COMPLETED|Overall Study||0
3089814|NCT01433042|3811812|FG000|STARTED|Overall Study||225
3089815|NCT01433042|3811812|FG000|COMPLETED|Overall Study||224
3089816|NCT01433042|3811812|FG000|NOT COMPLETED|Overall Study||1
3089817|NCT01433055|3811818|FG000|STARTED|Overall Study||29
3089818|NCT01433055|3811819|FG001|STARTED|Overall Study||23
3089819|NCT01433055|3811818|FG000|COMPLETED|Overall Study||27
3089820|NCT01433055|3811819|FG001|COMPLETED|Overall Study||23
3089821|NCT01433055|3811818|FG000|NOT COMPLETED|Overall Study||2
3089822|NCT01433055|3811819|FG001|NOT COMPLETED|Overall Study||0
3135029|NCT01704196|3859977|FG001|NOT COMPLETED|Overall Study||24
3135030|NCT01704261|3859985|FG000|STARTED|Overall Study||154
3135031|NCT01704261|3859986|FG001|STARTED|Overall Study||153
3135032|NCT01704261|3859985|FG000|COMPLETED|Overall Study||141
3135033|NCT01704261|3859986|FG001|COMPLETED|Overall Study||138
3135034|NCT01704261|3859985|FG000|NOT COMPLETED|Overall Study||13
3135035|NCT01704261|3859986|FG001|NOT COMPLETED|Overall Study||15
3135036|NCT01704287|3859995|FG000|STARTED|Initial Treatment Period||180
3135037|NCT01704287|3859996|FG001|STARTED|Initial Treatment Period||181
3135038|NCT01704287|3859997|FG002|STARTED|Initial Treatment Period||179
3135039|NCT01704287|3859998|FG003|STARTED|Initial Treatment Period||0
3135040|NCT01704287|3859999|FG004|STARTED|Initial Treatment Period||0
3135041|NCT01704287|3859995|FG000|Treated|Initial Treatment Period||178
3135042|NCT01704287|3859996|FG001|Treated|Initial Treatment Period||179
3135043|NCT01704287|3859997|FG002|Treated|Initial Treatment Period||171
3135044|NCT01704287|3859998|FG003|Treated|Initial Treatment Period||0
3135045|NCT01704287|3859999|FG004|Treated|Initial Treatment Period||0
3135046|NCT01704287|3859995|FG000|COMPLETED|Initial Treatment Period||33
3135047|NCT01704287|3859996|FG001|COMPLETED|Initial Treatment Period||47
3089823|NCT01433081|3811827|FG000|STARTED|Overall Study||25
3089824|NCT01433081|3811828|FG001|STARTED|Overall Study||25
3089825|NCT01433081|3811827|FG000|COMPLETED|Overall Study||23
3089826|NCT01433081|3811828|FG001|COMPLETED|Overall Study||23
3089827|NCT01433081|3811827|FG000|NOT COMPLETED|Overall Study||2
3089828|NCT01433081|3811828|FG001|NOT COMPLETED|Overall Study||2
3089829|NCT01433107|3811837|FG000|STARTED|Overall Study||145
3089830|NCT01433107|3811838|FG001|STARTED|Overall Study||145
3089831|NCT01433107|3811837|FG000|COMPLETED|Overall Study||118
3089832|NCT01433107|3811838|FG001|COMPLETED|Overall Study||128
3089833|NCT01433107|3811837|FG000|NOT COMPLETED|Overall Study||27
3089834|NCT01433107|3811838|FG001|NOT COMPLETED|Overall Study||17
3089835|NCT01433159|3811846|FG000|STARTED|Overall Study||9
3089836|NCT01433159|3811847|FG001|STARTED|Overall Study||10
3089837|NCT01433159|3811846|FG000|COMPLETED|Overall Study||7
3089838|NCT01433159|3811847|FG001|COMPLETED|Overall Study||9
3089839|NCT01433159|3811846|FG000|NOT COMPLETED|Overall Study||2
3089840|NCT01433159|3811847|FG001|NOT COMPLETED|Overall Study||1
3089841|NCT01433172|3811856|FG000|STARTED|Overall Study||3
3089842|NCT01433172|3811857|FG001|STARTED|Overall Study||37
3089843|NCT01433172|3811858|FG002|STARTED|Overall Study||33
3089844|NCT01433172|3811856|FG000|COMPLETED|Overall Study||3
3089845|NCT01433172|3811857|FG001|COMPLETED|Overall Study||34
3089846|NCT01433172|3811858|FG002|COMPLETED|Overall Study||32
3089847|NCT01433172|3811856|FG000|NOT COMPLETED|Overall Study||0
3089848|NCT01433172|3811857|FG001|NOT COMPLETED|Overall Study||3
3089849|NCT01433172|3811858|FG002|NOT COMPLETED|Overall Study||1
3089850|NCT01433250|3811868|FG000|STARTED|Overall Study||22
3089851|NCT01433250|3811869|FG001|STARTED|Overall Study||17
3089852|NCT01433250|3811868|FG000|COMPLETED|Overall Study||19
3089853|NCT01433250|3811869|FG001|COMPLETED|Overall Study||14
3089854|NCT01433250|3811868|FG000|NOT COMPLETED|Overall Study||3
3089855|NCT01433250|3811869|FG001|NOT COMPLETED|Overall Study||3
3089856|NCT01433263|3811877|FG000|STARTED|Overall Study||29
3089857|NCT01433263|3811878|FG001|STARTED|Overall Study||28
3089858|NCT01433263|3811877|FG000|COMPLETED|Overall Study||10
3089859|NCT01433263|3811878|FG001|COMPLETED|Overall Study||16
3089860|NCT01433263|3811877|FG000|NOT COMPLETED|Overall Study||19
3089861|NCT01433263|3811878|FG001|NOT COMPLETED|Overall Study||12
3089862|NCT01433354|3811887|FG000|STARTED|Overall Study|120 enrolled of which 119 were administered drug|119
3089863|NCT01433354|3811887|FG000|COMPLETED|Overall Study||0
3089864|NCT01433354|3811887|FG000|NOT COMPLETED|Overall Study||119
3089865|NCT01433549|3811901|FG000|STARTED|Phase 1: First Study Product||12
3089866|NCT01433549|3811902|FG001|STARTED|Phase 1: First Study Product||13
3089867|NCT01433549|3811901|FG000|COMPLETED|Phase 1: First Study Product||12
3089868|NCT01433549|3811902|FG001|COMPLETED|Phase 1: First Study Product||13
3089869|NCT01433549|3811901|FG000|NOT COMPLETED|Phase 1: First Study Product||0
3089870|NCT01433549|3811902|FG001|NOT COMPLETED|Phase 1: First Study Product||0
3089871|NCT01433549|3811901|FG000|STARTED|Phase 2: Second Study Product||12
3089872|NCT01433549|3811902|FG001|STARTED|Phase 2: Second Study Product||13
3089873|NCT01433549|3811901|FG000|COMPLETED|Phase 2: Second Study Product||12
3089874|NCT01433549|3811902|FG001|COMPLETED|Phase 2: Second Study Product||12
3089875|NCT01433549|3811901|FG000|NOT COMPLETED|Phase 2: Second Study Product||0
3089876|NCT01433549|3811902|FG001|NOT COMPLETED|Phase 2: Second Study Product||1
3089877|NCT01433731|3811912|FG000|STARTED|Overall Study||3
3089878|NCT01433731|3811913|FG001|STARTED|Overall Study||5
3089879|NCT01433731|3811914|FG002|STARTED|Overall Study||5
3089880|NCT01433731|3811915|FG003|STARTED|Overall Study||5
3089881|NCT01433731|3811912|FG000|COMPLETED|Overall Study||3
3089882|NCT01433731|3811913|FG001|COMPLETED|Overall Study||5
3089883|NCT01433731|3811914|FG002|COMPLETED|Overall Study||5
3089884|NCT01433731|3811915|FG003|COMPLETED|Overall Study||5
3089885|NCT01433731|3811912|FG000|NOT COMPLETED|Overall Study||0
3089886|NCT01433731|3811913|FG001|NOT COMPLETED|Overall Study||0
3089887|NCT01433731|3811914|FG002|NOT COMPLETED|Overall Study||0
3089888|NCT01433731|3811915|FG003|NOT COMPLETED|Overall Study||0
3089889|NCT01433913|3811925|FG000|STARTED|Overall Study||10
3089890|NCT01433913|3811926|FG001|STARTED|Overall Study||10
3089891|NCT01433913|3811925|FG000|COMPLETED|Overall Study||9
3089892|NCT01433913|3811926|FG001|COMPLETED|Overall Study||10
3089893|NCT01433913|3811925|FG000|NOT COMPLETED|Overall Study||1
3089894|NCT01433913|3811926|FG001|NOT COMPLETED|Overall Study||0
3089895|NCT01433978|3811935|FG000|STARTED|Core Study||11
3089896|NCT01433978|3811936|FG001|STARTED|Core Study||12
3089897|NCT01433978|3811937|FG002|STARTED|Core Study||0
3089898|NCT01433978|3811935|FG000|COMPLETED|Core Study||0
3089899|NCT01433978|3811936|FG001|COMPLETED|Core Study||1
3089900|NCT01433978|3811937|FG002|COMPLETED|Core Study||0
3089901|NCT01433978|3811935|FG000|NOT COMPLETED|Core Study||11
3089902|NCT01433978|3811936|FG001|NOT COMPLETED|Core Study||11
3089903|NCT01433978|3811937|FG002|NOT COMPLETED|Core Study||0
3089904|NCT01433978|3811935|FG000|STARTED|Extension Phase||0
3089905|NCT01433978|3811936|FG001|STARTED|Extension Phase||0
3089906|NCT01433978|3811937|FG002|STARTED|Extension Phase||6
3089907|NCT01433978|3811935|FG000|COMPLETED|Extension Phase||0
3089908|NCT01433978|3811936|FG001|COMPLETED|Extension Phase||0
3089909|NCT01433978|3811937|FG002|COMPLETED|Extension Phase||0
3089910|NCT01433978|3811935|FG000|NOT COMPLETED|Extension Phase||0
3089911|NCT01433978|3811936|FG001|NOT COMPLETED|Extension Phase||0
3089912|NCT01433978|3811937|FG002|NOT COMPLETED|Extension Phase||6
3089913|NCT01433991|3811948|FG000|STARTED|Pretreatment Phase (Single Agent Run-in)||5
3089914|NCT01433991|3811949|FG001|STARTED|Pretreatment Phase (Single Agent Run-in)||3
3089915|NCT01433991|3811950|FG002|STARTED|Pretreatment Phase (Single Agent Run-in)||14
3089916|NCT01433991|3811951|FG003|STARTED|Pretreatment Phase (Single Agent Run-in)||8
3089917|NCT01433991|3811948|FG000|COMPLETED|Pretreatment Phase (Single Agent Run-in)||3
3089918|NCT01433991|3811949|FG001|COMPLETED|Pretreatment Phase (Single Agent Run-in)||3
3089919|NCT01433991|3811950|FG002|COMPLETED|Pretreatment Phase (Single Agent Run-in)||14
3089920|NCT01433991|3811951|FG003|COMPLETED|Pretreatment Phase (Single Agent Run-in)||8
3089921|NCT01433991|3811948|FG000|NOT COMPLETED|Pretreatment Phase (Single Agent Run-in)||2
3089922|NCT01433991|3811949|FG001|NOT COMPLETED|Pretreatment Phase (Single Agent Run-in)||0
3089923|NCT01433991|3811950|FG002|NOT COMPLETED|Pretreatment Phase (Single Agent Run-in)||0
3089924|NCT01433991|3811951|FG003|NOT COMPLETED|Pretreatment Phase (Single Agent Run-in)||0
3089925|NCT01433991|3811948|FG000|STARTED|Treatment Phase (Combination Agent)||3
3089926|NCT01433991|3811949|FG001|STARTED|Treatment Phase (Combination Agent)||3
3089927|NCT01433991|3811950|FG002|STARTED|Treatment Phase (Combination Agent)||14
3089928|NCT01433991|3811951|FG003|STARTED|Treatment Phase (Combination Agent)||8
3089929|NCT01433991|3811948|FG000|COMPLETED|Treatment Phase (Combination Agent)||1
3089930|NCT01433991|3811949|FG001|COMPLETED|Treatment Phase (Combination Agent)||2
3089931|NCT01433991|3811950|FG002|COMPLETED|Treatment Phase (Combination Agent)||8
3089932|NCT01433991|3811951|FG003|COMPLETED|Treatment Phase (Combination Agent)||2
3089933|NCT01433991|3811948|FG000|NOT COMPLETED|Treatment Phase (Combination Agent)||2
3089934|NCT01433991|3811949|FG001|NOT COMPLETED|Treatment Phase (Combination Agent)||1
3089935|NCT01433991|3811950|FG002|NOT COMPLETED|Treatment Phase (Combination Agent)||6
3089936|NCT01433991|3811951|FG003|NOT COMPLETED|Treatment Phase (Combination Agent)||6
3089937|NCT01434030|3811967|FG000|STARTED|Overall Study||57
3089938|NCT01434030|3811967|FG000|COMPLETED|Overall Study||56
3089939|NCT01434030|3811967|FG000|NOT COMPLETED|Overall Study||1
3089940|NCT01434121|3811975|FG000|STARTED|Overall Study||8
3089941|NCT01434121|3811976|FG001|STARTED|Overall Study||8
3089942|NCT01434121|3811977|FG002|STARTED|Overall Study||8
3089943|NCT01434121|3811975|FG000|COMPLETED|Overall Study||8
3089944|NCT01434121|3811976|FG001|COMPLETED|Overall Study||8
3089945|NCT01434121|3811977|FG002|COMPLETED|Overall Study||8
3089946|NCT01434121|3811975|FG000|NOT COMPLETED|Overall Study||0
3089947|NCT01434121|3811976|FG001|NOT COMPLETED|Overall Study||0
3089948|NCT01434121|3811977|FG002|NOT COMPLETED|Overall Study||0
3089949|NCT01434186|3811990|FG000|STARTED|Overall Study||2
3089950|NCT01434186|3811991|FG001|STARTED|Overall Study||4
3089951|NCT01434186|3811990|FG000|COMPLETED|Overall Study||2
3089952|NCT01434186|3811991|FG001|COMPLETED|Overall Study||4
3089953|NCT01434186|3811990|FG000|NOT COMPLETED|Overall Study||0
3089954|NCT01434186|3811991|FG001|NOT COMPLETED|Overall Study||0
3089955|NCT01434290|3811999|FG000|STARTED|Overall Study||127
3089956|NCT01434290|3812000|FG001|STARTED|Overall Study||128
3089957|NCT01434290|3811999|FG000|COMPLETED|Overall Study|Eligible subjects included in analysis|119
3089958|NCT01434290|3812000|FG001|COMPLETED|Overall Study|Eligible subjects included in analysis|121
3089959|NCT01434290|3811999|FG000|NOT COMPLETED|Overall Study||8
3089960|NCT01434290|3812000|FG001|NOT COMPLETED|Overall Study||7
3089961|NCT01434342|3812009|FG000|STARTED|Overall Study||98
3089962|NCT01434342|3812010|FG001|STARTED|Overall Study||48
3089963|NCT01434342|3812009|FG000|COMPLETED|Overall Study||50
3089964|NCT01434342|3812010|FG001|COMPLETED|Overall Study||31
3089965|NCT01434342|3812009|FG000|NOT COMPLETED|Overall Study||48
3089966|NCT01434342|3812010|FG001|NOT COMPLETED|Overall Study||17
3089967|NCT01434472|3812016|FG000|STARTED|Overall Study||20
3089968|NCT01434472|3812016|FG000|COMPLETED|Overall Study||20
3089969|NCT01434472|3812016|FG000|NOT COMPLETED|Overall Study||0
3089970|NCT01434641|3812020|FG000|STARTED|Overall Study||102
3089971|NCT01434641|3812020|FG000|COMPLETED|Overall Study||102
3089972|NCT01434641|3812020|FG000|NOT COMPLETED|Overall Study||0
3089973|NCT01434654|3812026|FG000|STARTED|Overall Study||7
3089974|NCT01434654|3812027|FG001|STARTED|Overall Study||12
3089975|NCT01434654|3812026|FG000|COMPLETED|Overall Study||5
3089976|NCT01434654|3812027|FG001|COMPLETED|Overall Study||12
3089977|NCT01434654|3812026|FG000|NOT COMPLETED|Overall Study||2
3089978|NCT01434654|3812027|FG001|NOT COMPLETED|Overall Study||0
3089979|NCT01434667|3812037|FG000|STARTED|Overall Study||39
3089980|NCT01434667|3812038|FG001|STARTED|Overall Study||75
3089981|NCT01434667|3812037|FG000|COMPLETED|Overall Study||34
3089982|NCT01434667|3812038|FG001|COMPLETED|Overall Study||65
3089983|NCT01434667|3812037|FG000|NOT COMPLETED|Overall Study||5
3089984|NCT01434667|3812038|FG001|NOT COMPLETED|Overall Study||10
3089985|NCT01434680|3812048|FG000|STARTED|Overall Study||299
3089986|NCT01434680|3812049|FG001|STARTED|Overall Study||268
3089987|NCT01434680|3812050|FG002|STARTED|Overall Study||306
3089988|NCT01434680|3812051|FG003|STARTED|Overall Study||119
3089989|NCT01434680|3812048|FG000|COMPLETED|Overall Study||296
3089990|NCT01434680|3812049|FG001|COMPLETED|Overall Study||266
3089991|NCT01434680|3812050|FG002|COMPLETED|Overall Study||304
3089992|NCT01434680|3812051|FG003|COMPLETED|Overall Study||119
3089993|NCT01434680|3812048|FG000|NOT COMPLETED|Overall Study||3
3089994|NCT01434680|3812049|FG001|NOT COMPLETED|Overall Study||2
3089995|NCT01434680|3812050|FG002|NOT COMPLETED|Overall Study||2
3089996|NCT01434680|3812051|FG003|NOT COMPLETED|Overall Study||0
3089997|NCT01434693|3812065|FG000|STARTED|Overall Study||9
3089998|NCT01434693|3812066|FG001|STARTED|Overall Study||9
3089999|NCT01434693|3812067|FG002|STARTED|Overall Study||9
3090000|NCT01434693|3812068|FG003|STARTED|Overall Study||9
3090001|NCT01434693|3812065|FG000|COMPLETED|Overall Study||6
3090002|NCT01434693|3812066|FG001|COMPLETED|Overall Study||9
3090003|NCT01434693|3812067|FG002|COMPLETED|Overall Study||8
3090004|NCT01434693|3812068|FG003|COMPLETED|Overall Study||8
3090005|NCT01434693|3812065|FG000|NOT COMPLETED|Overall Study||3
3090006|NCT01434693|3812066|FG001|NOT COMPLETED|Overall Study||0
3090007|NCT01434693|3812067|FG002|NOT COMPLETED|Overall Study||1
3090008|NCT01434693|3812068|FG003|NOT COMPLETED|Overall Study||1
3090009|NCT01434810|3812080|FG000|STARTED|Overall Study||224
3090010|NCT01434810|3812081|FG001|STARTED|Overall Study||223
3090011|NCT01434810|3812080|FG000|COMPLETED|Overall Study||201
3090012|NCT01434810|3812081|FG001|COMPLETED|Overall Study||213
3090013|NCT01434810|3812080|FG000|NOT COMPLETED|Overall Study||23
3090014|NCT01434810|3812081|FG001|NOT COMPLETED|Overall Study||10
3090015|NCT01434823|3812089|FG000|STARTED|Overall Study||824
3090016|NCT01434823|3812090|FG001|STARTED|Overall Study||785
3090017|NCT01434823|3812089|FG000|COMPLETED|Overall Study||820
3090018|NCT01434823|3812090|FG001|COMPLETED|Overall Study||778
3090019|NCT01434823|3812089|FG000|NOT COMPLETED|Overall Study||4
3090020|NCT01434823|3812090|FG001|NOT COMPLETED|Overall Study||7
3090021|NCT01435018|3812100|FG000|STARTED|Overall Study||135
3090022|NCT01435018|3812101|FG001|STARTED|Overall Study||60
3090023|NCT01435018|3812102|FG002|STARTED|Overall Study||139
3090024|NCT01435018|3812100|FG000|COMPLETED|Overall Study||88
3090025|NCT01435018|3812101|FG001|COMPLETED|Overall Study||26
3090026|NCT01435018|3812102|FG002|COMPLETED|Overall Study||98
3090027|NCT01435018|3812100|FG000|NOT COMPLETED|Overall Study||47
3090028|NCT01435018|3812101|FG001|NOT COMPLETED|Overall Study||34
3090029|NCT01435018|3812102|FG002|NOT COMPLETED|Overall Study||41
3090030|NCT01435031|3812112|FG000|STARTED|ITT at 1 Month|ITT population|222
3090031|NCT01435031|3812112|FG000|COMPLETED|ITT at 1 Month||216
3090032|NCT01435031|3812112|FG000|NOT COMPLETED|ITT at 1 Month||6
3090033|NCT01435031|3812112|FG000|STARTED|ITT at 6 Months||216
3090034|NCT01435031|3812112|FG000|COMPLETED|ITT at 6 Months||211
3090035|NCT01435031|3812112|FG000|NOT COMPLETED|ITT at 6 Months||5
3090036|NCT01435031|3812112|FG000|STARTED|ITT at 1 Year||211
3090037|NCT01435031|3812112|FG000|COMPLETED|ITT at 1 Year||202
3090038|NCT01435031|3812112|FG000|NOT COMPLETED|ITT at 1 Year||9
3090039|NCT01435031|3812112|FG000|STARTED|ITT at 2 Years||202
3090040|NCT01435031|3812112|FG000|COMPLETED|ITT at 2 Years||189
3090041|NCT01435031|3812112|FG000|NOT COMPLETED|ITT at 2 Years||13
3090042|NCT01435031|3812112|FG000|STARTED|ITT at 3 Years||189
3090043|NCT01435031|3812112|FG000|COMPLETED|ITT at 3 Years||178
3090044|NCT01435031|3812112|FG000|NOT COMPLETED|ITT at 3 Years||11
3090045|NCT01435031|3812112|FG000|STARTED|ITT at 4 Years||178
3090046|NCT01435031|3812112|FG000|COMPLETED|ITT at 4 Years||171
3090047|NCT01435031|3812112|FG000|NOT COMPLETED|ITT at 4 Years||7
3090048|NCT01435122|3812116|FG000|STARTED|Overall Study||30
3090049|NCT01435122|3812116|FG000|COMPLETED|Overall Study||22
3090050|NCT01435122|3812116|FG000|NOT COMPLETED|Overall Study||8
3090051|NCT01435174|3812120|FG000|STARTED|Overall Study||17
3090052|NCT01435174|3812120|FG000|COMPLETED|Overall Study||8
3090053|NCT01435174|3812120|FG000|NOT COMPLETED|Overall Study||9
3090054|NCT01435265|3812126|FG000|STARTED|Overall Study||3
3090055|NCT01435265|3812127|FG001|STARTED|Overall Study||4
3090056|NCT01435265|3812126|FG000|COMPLETED|Overall Study||3
3090057|NCT01435265|3812127|FG001|COMPLETED|Overall Study||3
3090058|NCT01435265|3812126|FG000|NOT COMPLETED|Overall Study||0
3090059|NCT01435265|3812127|FG001|NOT COMPLETED|Overall Study||1
3090060|NCT01435304|3812135|FG000|STARTED|Overall Study||50
3090061|NCT01435304|3812136|FG001|STARTED|Overall Study||50
3090062|NCT01435304|3812135|FG000|COMPLETED|Overall Study||50
3090063|NCT01435304|3812136|FG001|COMPLETED|Overall Study||50
3090064|NCT01435304|3812135|FG000|NOT COMPLETED|Overall Study||0
3090065|NCT01435304|3812136|FG001|NOT COMPLETED|Overall Study||0
3090066|NCT01435356|3812144|FG000|STARTED|Overall Study||48
3090067|NCT01435356|3812145|FG001|STARTED|Overall Study||29
3090068|NCT01435356|3812144|FG000|COMPLETED|Overall Study||16
3090069|NCT01435356|3812145|FG001|COMPLETED|Overall Study||5
3090070|NCT01435356|3812144|FG000|NOT COMPLETED|Overall Study||32
3090071|NCT01435356|3812145|FG001|NOT COMPLETED|Overall Study||24
3090072|NCT01435382|3812155|FG000|STARTED|Overall Study||12
3090073|NCT01435382|3812156|FG001|STARTED|Overall Study||13
3090074|NCT01435382|3812157|FG002|STARTED|Overall Study||13
3090075|NCT01435382|3812158|FG003|STARTED|Overall Study||11
3090076|NCT01435382|3812155|FG000|COMPLETED|Overall Study||11
3090077|NCT01435382|3812156|FG001|COMPLETED|Overall Study||11
3090078|NCT01435382|3812157|FG002|COMPLETED|Overall Study||12
3090079|NCT01435382|3812158|FG003|COMPLETED|Overall Study||10
3090080|NCT01435382|3812155|FG000|NOT COMPLETED|Overall Study||1
3090081|NCT01435382|3812156|FG001|NOT COMPLETED|Overall Study||2
3090082|NCT01435382|3812157|FG002|NOT COMPLETED|Overall Study||1
3090083|NCT01435382|3812158|FG003|NOT COMPLETED|Overall Study||1
3090084|NCT01435460|3812176|FG000|STARTED|Overall Study||151
3090085|NCT01435460|3812177|FG001|STARTED|Overall Study||149
3090086|NCT01435460|3812176|FG000|COMPLETED|Overall Study||140
3090087|NCT01435460|3812177|FG001|COMPLETED|Overall Study||143
3090088|NCT01435460|3812176|FG000|NOT COMPLETED|Overall Study||11
3090089|NCT01435460|3812177|FG001|NOT COMPLETED|Overall Study||6
3090090|NCT01435512|3812185|FG000|STARTED|Overall Study||67
3090091|NCT01435512|3812186|FG001|STARTED|Overall Study||68
3090092|NCT01435512|3812185|FG000|COMPLETED|Overall Study||67
3090093|NCT01435512|3812186|FG001|COMPLETED|Overall Study||68
3090094|NCT01435512|3812185|FG000|NOT COMPLETED|Overall Study||0
3090095|NCT01435512|3812186|FG001|NOT COMPLETED|Overall Study||0
3090096|NCT01435577|3812194|FG000|STARTED|Overall Study||64
3090097|NCT01435577|3812195|FG001|STARTED|Overall Study||65
3090098|NCT01435577|3812194|FG000|COMPLETED|Overall Study||47
3090099|NCT01435577|3812195|FG001|COMPLETED|Overall Study||13
3090100|NCT01435577|3812194|FG000|NOT COMPLETED|Overall Study||17
3090101|NCT01435577|3812195|FG001|NOT COMPLETED|Overall Study||52
3090102|NCT01435603|3812207|FG000|STARTED|Overall Study||167
3090103|NCT01435603|3812208|FG001|STARTED|Overall Study||164
3090104|NCT01435603|3812207|FG000|COMPLETED|Overall Study||128
3090105|NCT01435603|3812208|FG001|COMPLETED|Overall Study||129
3090106|NCT01435603|3812207|FG000|NOT COMPLETED|Overall Study||39
3090107|NCT01435603|3812208|FG001|NOT COMPLETED|Overall Study||35
3090108|NCT01435616|3812216|FG000|STARTED|Overall Study||1003
3090109|NCT01435616|3812217|FG001|STARTED|Overall Study||535
3090110|NCT01435616|3812216|FG000|Received at Least 1 Dose of Study Drug|Overall Study||1003
3090111|NCT01435616|3812217|FG001|Received at Least 1 Dose of Study Drug|Overall Study||535
3090112|NCT01435616|3812216|FG000|COMPLETED|Overall Study||832
3090113|NCT01435616|3812217|FG001|COMPLETED|Overall Study||455
3090114|NCT01435616|3812216|FG000|NOT COMPLETED|Overall Study||171
3090115|NCT01435616|3812217|FG001|NOT COMPLETED|Overall Study||80
3090116|NCT01435655|3812225|FG000|STARTED|Overall Study||10
3090117|NCT01435655|3812225|FG000|COMPLETED|Overall Study||7
3090118|NCT01435655|3812225|FG000|NOT COMPLETED|Overall Study||3
3090119|NCT01435759|3812234|FG000|STARTED|Antidepressant Lead-in Phase|Of these 1197 subjects, 19 subjects were not dosed.|1197
3090120|NCT01435759|3812235|FG001|STARTED|Antidepressant Lead-in Phase||0
3090121|NCT01435759|3812236|FG002|STARTED|Antidepressant Lead-in Phase||0
3090122|NCT01435759|3812237|FG003|STARTED|Antidepressant Lead-in Phase||0
3090123|NCT01435759|3812238|FG004|STARTED|Antidepressant Lead-in Phase||0
3090124|NCT01435759|3812239|FG005|STARTED|Antidepressant Lead-in Phase||0
3090125|NCT01435759|3812234|FG000|COMPLETED|Antidepressant Lead-in Phase||855
3090126|NCT01435759|3812235|FG001|COMPLETED|Antidepressant Lead-in Phase||0
3090127|NCT01435759|3812236|FG002|COMPLETED|Antidepressant Lead-in Phase||0
3090128|NCT01435759|3812237|FG003|COMPLETED|Antidepressant Lead-in Phase||0
3090129|NCT01435759|3812238|FG004|COMPLETED|Antidepressant Lead-in Phase||0
3090130|NCT01435759|3812239|FG005|COMPLETED|Antidepressant Lead-in Phase||0
3090131|NCT01435759|3812234|FG000|NOT COMPLETED|Antidepressant Lead-in Phase||342
3090132|NCT01435759|3812235|FG001|NOT COMPLETED|Antidepressant Lead-in Phase||0
3090133|NCT01435759|3812236|FG002|NOT COMPLETED|Antidepressant Lead-in Phase||0
3090134|NCT01435759|3812237|FG003|NOT COMPLETED|Antidepressant Lead-in Phase||0
3090135|NCT01435759|3812238|FG004|NOT COMPLETED|Antidepressant Lead-in Phase||0
3090136|NCT01435759|3812239|FG005|NOT COMPLETED|Antidepressant Lead-in Phase||0
3090137|NCT01435759|3812234|FG000|STARTED|Double-blind Phase|These subjects were not included in the Safety Dose Response Evaluable Set or Safety Analysis Set.|463
3090138|NCT01435759|3812235|FG001|STARTED|Double-blind Phase||78
3090139|NCT01435759|3812236|FG002|STARTED|Double-blind Phase|One subject was not dosed.|78
3090140|NCT01435759|3812237|FG003|STARTED|Double-blind Phase|Two subjects were not dosed.|78
3090141|NCT01435759|3812238|FG004|STARTED|Double-blind Phase||78
3090142|NCT01435759|3812239|FG005|STARTED|Double-blind Phase||80
3090143|NCT01435759|3812234|FG000|COMPLETED|Double-blind Phase||397
3090144|NCT01435759|3812235|FG001|COMPLETED|Double-blind Phase||71
3090145|NCT01435759|3812236|FG002|COMPLETED|Double-blind Phase||71
3090146|NCT01435759|3812237|FG003|COMPLETED|Double-blind Phase||69
3090147|NCT01435759|3812238|FG004|COMPLETED|Double-blind Phase||69
3090148|NCT01435759|3812239|FG005|COMPLETED|Double-blind Phase||71
3090149|NCT01435759|3812234|FG000|NOT COMPLETED|Double-blind Phase||66
3090150|NCT01435759|3812235|FG001|NOT COMPLETED|Double-blind Phase||7
3090151|NCT01435759|3812236|FG002|NOT COMPLETED|Double-blind Phase||7
3090152|NCT01435759|3812237|FG003|NOT COMPLETED|Double-blind Phase||9
3090153|NCT01435759|3812238|FG004|NOT COMPLETED|Double-blind Phase||9
3090154|NCT01435759|3812239|FG005|NOT COMPLETED|Double-blind Phase||9
3090155|NCT01435772|3812254|FG000|STARTED|Overall Study||3
3090156|NCT01435772|3812255|FG001|STARTED|Overall Study||3
3090157|NCT01435772|3812256|FG002|STARTED|Overall Study||15
3090158|NCT01435772|3812254|FG000|COMPLETED|Overall Study||0
3090159|NCT01435772|3812255|FG001|COMPLETED|Overall Study||0
3090160|NCT01435772|3812256|FG002|COMPLETED|Overall Study||0
3090161|NCT01435772|3812254|FG000|NOT COMPLETED|Overall Study||3
3090162|NCT01435772|3812255|FG001|NOT COMPLETED|Overall Study||3
3090163|NCT01435772|3812256|FG002|NOT COMPLETED|Overall Study||15
3090164|NCT01435798|3812265|FG000|STARTED|Overall Study|Crossover design|26
3090165|NCT01435798|3812265|FG000|0% MTD|Overall Study||25
3090166|NCT01435798|3812265|FG000|25% MTD|Overall Study||26
3090167|NCT01435798|3812265|FG000|50% MTD|Overall Study||25
3090168|NCT01435798|3812265|FG000|100% MTD|Overall Study||25
3090169|NCT01435798|3812265|FG000|COMPLETED|Overall Study|Crossover design|25
3090170|NCT01435798|3812265|FG000|NOT COMPLETED|Overall Study||1
3090171|NCT01435824|3812275|FG000|STARTED|First Intervention||8
3090172|NCT01435824|3812276|FG001|STARTED|First Intervention||8
3090173|NCT01435824|3812275|FG000|COMPLETED|First Intervention||8
3090174|NCT01435824|3812276|FG001|COMPLETED|First Intervention||8
3090175|NCT01435824|3812275|FG000|NOT COMPLETED|First Intervention||0
3090176|NCT01435824|3812276|FG001|NOT COMPLETED|First Intervention||0
3090177|NCT01435824|3812275|FG000|STARTED|Washout of 1-2 Weeks||8
3090178|NCT01435824|3812276|FG001|STARTED|Washout of 1-2 Weeks||8
3090179|NCT01435824|3812275|FG000|COMPLETED|Washout of 1-2 Weeks||8
3090180|NCT01435824|3812276|FG001|COMPLETED|Washout of 1-2 Weeks||8
3090181|NCT01435824|3812275|FG000|NOT COMPLETED|Washout of 1-2 Weeks||0
3090182|NCT01435824|3812276|FG001|NOT COMPLETED|Washout of 1-2 Weeks||0
3090183|NCT01435824|3812275|FG000|STARTED|Second Intervention||8
3090184|NCT01435824|3812276|FG001|STARTED|Second Intervention||8
3090185|NCT01435824|3812275|FG000|COMPLETED|Second Intervention||8
3090186|NCT01435824|3812276|FG001|COMPLETED|Second Intervention||8
3090187|NCT01435824|3812275|FG000|NOT COMPLETED|Second Intervention||0
3090188|NCT01435824|3812276|FG001|NOT COMPLETED|Second Intervention||0
3090189|NCT01435928|3812284|FG000|STARTED|Open Label Phase - up to 24 Weeks||676
3090190|NCT01435928|3812285|FG001|STARTED|Open Label Phase - up to 24 Weeks||0
3090191|NCT01435928|3812286|FG002|STARTED|Open Label Phase - up to 24 Weeks||0
3090192|NCT01435928|3812284|FG000|COMPLETED|Open Label Phase - up to 24 Weeks||287
3090193|NCT01435928|3812285|FG001|COMPLETED|Open Label Phase - up to 24 Weeks||0
3090194|NCT01435928|3812286|FG002|COMPLETED|Open Label Phase - up to 24 Weeks||0
3090195|NCT01435928|3812284|FG000|NOT COMPLETED|Open Label Phase - up to 24 Weeks||389
3090196|NCT01435928|3812285|FG001|NOT COMPLETED|Open Label Phase - up to 24 Weeks||0
3090197|NCT01435928|3812286|FG002|NOT COMPLETED|Open Label Phase - up to 24 Weeks||0
3090198|NCT01435928|3812284|FG000|STARTED|Double Blind Phase - 28 Weeks||0
3090199|NCT01435928|3812285|FG001|STARTED|Double Blind Phase - 28 Weeks||144
3090200|NCT01435928|3812286|FG002|STARTED|Double Blind Phase - 28 Weeks||141
3090201|NCT01435928|3812284|FG000|COMPLETED|Double Blind Phase - 28 Weeks||0
3090202|NCT01435928|3812285|FG001|COMPLETED|Double Blind Phase - 28 Weeks||28
3090203|NCT01435928|3812286|FG002|COMPLETED|Double Blind Phase - 28 Weeks||20
3090204|NCT01435928|3812284|FG000|NOT COMPLETED|Double Blind Phase - 28 Weeks||0
3090205|NCT01435928|3812285|FG001|NOT COMPLETED|Double Blind Phase - 28 Weeks||116
3090206|NCT01435928|3812286|FG002|NOT COMPLETED|Double Blind Phase - 28 Weeks||121
3090207|NCT01436006|3812293|FG000|STARTED|Overall Study||6700
3090208|NCT01436006|3812293|FG000|COMPLETED|Overall Study||6663
3090209|NCT01436006|3812293|FG000|NOT COMPLETED|Overall Study||37
3090210|NCT01436045|3812305|FG000|STARTED|Overall Study||6
3090211|NCT01436045|3812306|FG001|STARTED|Overall Study||6
3090212|NCT01436045|3812305|FG000|COMPLETED|Overall Study||6
3090213|NCT01436045|3812306|FG001|COMPLETED|Overall Study||6
3090214|NCT01436045|3812305|FG000|NOT COMPLETED|Overall Study||0
3090215|NCT01436045|3812306|FG001|NOT COMPLETED|Overall Study||0
3090216|NCT01436071|3812314|FG000|STARTED|Overall Study|These participants were randomized to trial medication.|124
3090217|NCT01436071|3812315|FG001|STARTED|Overall Study|These participants were randomized to trial medication.|124
3090218|NCT01436071|3812314|FG000|Safety Population|Overall Study|These randomized participants received at least a single dose of trial medication.|121
3090219|NCT01436071|3812315|FG001|Safety Population|Overall Study|These randomized participants received at least a single dose of trial medication.|121
3090220|NCT01436071|3812314|FG000|COMPLETED|Overall Study||98
3090221|NCT01436071|3812315|FG001|COMPLETED|Overall Study||110
3090222|NCT01436071|3812314|FG000|NOT COMPLETED|Overall Study||26
3090223|NCT01436071|3812315|FG001|NOT COMPLETED|Overall Study||14
3090224|NCT01436110|3812324|FG000|STARTED|Overall Study|These participants were randomized to trial medication.|116
3090225|NCT01436110|3812325|FG001|STARTED|Overall Study|These participants were randomized to trial medication.|117
3090226|NCT01436110|3812326|FG002|STARTED|Overall Study|These participants were randomized to trial medication.|118
3090227|NCT01436110|3812324|FG000|Intent-to-Treat Population|Overall Study|These randomized participants received at least a single dose of trial medication.|115
3090228|NCT01436110|3812325|FG001|Intent-to-Treat Population|Overall Study|These randomized participants received at least a single dose of trial medication.|117
3090229|NCT01436110|3812326|FG002|Intent-to-Treat Population|Overall Study|These randomized participants received at least a single dose of trial medication.|115
3090230|NCT01436110|3812324|FG000|COMPLETED|Overall Study||77
3090231|NCT01436110|3812325|FG001|COMPLETED|Overall Study||91
3090232|NCT01436110|3812326|FG002|COMPLETED|Overall Study||95
3090233|NCT01436110|3812324|FG000|NOT COMPLETED|Overall Study||39
3090234|NCT01436110|3812325|FG001|NOT COMPLETED|Overall Study||26
3090235|NCT01436110|3812326|FG002|NOT COMPLETED|Overall Study||23
3090236|NCT01436149|3812336|FG000|STARTED|Antidepressant Lead-in Phase|Twenty-three subjects were enrolled but not dosed.|1262
3090237|NCT01436149|3812337|FG001|STARTED|Antidepressant Lead-in Phase||0
3090238|NCT01436149|3812338|FG002|STARTED|Antidepressant Lead-in Phase||0
3090239|NCT01436149|3812336|FG000|COMPLETED|Antidepressant Lead-in Phase||896
3090240|NCT01436149|3812337|FG001|COMPLETED|Antidepressant Lead-in Phase||0
3090241|NCT01436149|3812338|FG002|COMPLETED|Antidepressant Lead-in Phase||0
3090242|NCT01436149|3812336|FG000|NOT COMPLETED|Antidepressant Lead-in Phase||366
3090243|NCT01436149|3812337|FG001|NOT COMPLETED|Antidepressant Lead-in Phase||0
3090244|NCT01436149|3812338|FG002|NOT COMPLETED|Antidepressant Lead-in Phase||0
3090245|NCT01436149|3812336|FG000|STARTED|Randomized Phase|These subjects were not included in the Safety Analysis Set or Full Analysis Set.|492
3090246|NCT01436149|3812337|FG001|STARTED|Randomized Phase|One subject did not receive at least 1 dose of double-blind treatment.|202
3090247|NCT01436149|3812338|FG002|STARTED|Randomized Phase|One subject did not receive at least 1 dose of double-blind treatment.|202
3090248|NCT01436149|3812336|FG000|COMPLETED|Randomized Phase||415
3090249|NCT01436149|3812337|FG001|COMPLETED|Randomized Phase||164
3090250|NCT01436149|3812338|FG002|COMPLETED|Randomized Phase|1 subject completed the study without a Visit 14 MADRS and was not included in the completers set.|160
3090251|NCT01436149|3812336|FG000|NOT COMPLETED|Randomized Phase||77
3090252|NCT01436149|3812337|FG001|NOT COMPLETED|Randomized Phase||38
3090253|NCT01436149|3812338|FG002|NOT COMPLETED|Randomized Phase||42
3090254|NCT01436162|3812346|FG000|STARTED|Single-blind Lead-in Phase|Ten subjects were enrolled but not dosed.|1105
3090255|NCT01436162|3812347|FG001|STARTED|Single-blind Lead-in Phase||0
3090256|NCT01436162|3812348|FG002|STARTED|Single-blind Lead-in Phase||0
3090257|NCT01436162|3812346|FG000|COMPLETED|Single-blind Lead-in Phase||823
3090258|NCT01436162|3812347|FG001|COMPLETED|Single-blind Lead-in Phase||0
3090259|NCT01436162|3812348|FG002|COMPLETED|Single-blind Lead-in Phase||0
3090260|NCT01436162|3812346|FG000|NOT COMPLETED|Single-blind Lead-in Phase||282
3090261|NCT01436162|3812347|FG001|NOT COMPLETED|Single-blind Lead-in Phase||0
3090262|NCT01436162|3812348|FG002|NOT COMPLETED|Single-blind Lead-in Phase||0
3090263|NCT01436162|3812346|FG000|STARTED|Randomized Phase|These subjects were not included in the Safety Analysis Set or Full Analysis Set.|397
3090264|NCT01436162|3812347|FG001|STARTED|Randomized Phase|One subject was randomized to this arm but did not receive at least 1 dose of double-blind treatment|212
3090265|NCT01436162|3812348|FG002|STARTED|Randomized Phase|One subject was randomized to this arm but did not receive at least 1 dose of double-blind treatment|214
3090266|NCT01436162|3812346|FG000|COMPLETED|Randomized Phase||353
3090267|NCT01436162|3812347|FG001|COMPLETED|Randomized Phase||181
3090268|NCT01436162|3812348|FG002|COMPLETED|Randomized Phase||189
3090269|NCT01436162|3812346|FG000|NOT COMPLETED|Randomized Phase||44
3090270|NCT01436162|3812347|FG001|NOT COMPLETED|Randomized Phase||31
3090271|NCT01436162|3812348|FG002|NOT COMPLETED|Randomized Phase||25
3090272|NCT01436175|3812356|FG000|STARTED|Overall Study||1570
3090273|NCT01436175|3812356|FG000|COMPLETED|Overall Study||300
3090274|NCT01436175|3812356|FG000|NOT COMPLETED|Overall Study||1270
3090275|NCT01436201|3812361|FG000|STARTED|Overall Study||24
3090276|NCT01436201|3812361|FG000|Received at Least 1 Dose of Study Drug|Overall Study||24
3090277|NCT01436201|3812361|FG000|COMPLETED|Overall Study||20
3090278|NCT01436201|3812361|FG000|NOT COMPLETED|Overall Study||4
3090279|NCT01436266|3812369|FG000|STARTED|Overall Study||1
3090280|NCT01436266|3812370|FG001|STARTED|Overall Study||1
3090281|NCT01436266|3812369|FG000|COMPLETED|Overall Study||1
3090282|NCT01436266|3812370|FG001|COMPLETED|Overall Study||1
3090283|NCT01436266|3812369|FG000|NOT COMPLETED|Overall Study||0
3090284|NCT01436266|3812370|FG001|NOT COMPLETED|Overall Study||0
3090285|NCT01436279|3812378|FG000|STARTED|Overall Study||30
3090286|NCT01436279|3812379|FG001|STARTED|Overall Study||20
3090287|NCT01436279|3812378|FG000|COMPLETED|Overall Study||30
3090288|NCT01436279|3812379|FG001|COMPLETED|Overall Study||20
3090289|NCT01436279|3812378|FG000|NOT COMPLETED|Overall Study||0
3090290|NCT01436279|3812379|FG001|NOT COMPLETED|Overall Study||0
3090291|NCT01436305|3812390|FG000|STARTED|Overall Study||6
3090292|NCT01436305|3812391|FG001|STARTED|Overall Study||6
3090293|NCT01436305|3812392|FG002|STARTED|Overall Study||7
3090294|NCT01436305|3812390|FG000|COMPLETED|Overall Study||4
3090295|NCT01436305|3812391|FG001|COMPLETED|Overall Study||2
3090296|NCT01436305|3812392|FG002|COMPLETED|Overall Study||7
3090297|NCT01436305|3812390|FG000|NOT COMPLETED|Overall Study||2
3090298|NCT01436305|3812391|FG001|NOT COMPLETED|Overall Study||4
3090299|NCT01436305|3812392|FG002|NOT COMPLETED|Overall Study||0
3090300|NCT01436357|3812402|FG000|STARTED|Overall Study||274
3090301|NCT01436357|3812403|FG001|STARTED|Overall Study||274
3090302|NCT01436357|3812402|FG000|Stage 1|Overall Study||49
3090303|NCT01436357|3812403|FG001|Stage 1|Overall Study||48
3090304|NCT01436357|3812402|FG000|Stage 2|Overall Study||225
3090305|NCT01436357|3812403|FG001|Stage 2|Overall Study||226
3090306|NCT01436357|3812402|FG000|COMPLETED|Overall Study||152
3090307|NCT01436357|3812403|FG001|COMPLETED|Overall Study||146
3090308|NCT01436357|3812402|FG000|NOT COMPLETED|Overall Study||122
3090309|NCT01436357|3812403|FG001|NOT COMPLETED|Overall Study||128
3090310|NCT01436370|3812417|FG000|STARTED|Overall Study||6
3090311|NCT01436370|3812418|FG001|STARTED|Overall Study||6
3090312|NCT01436370|3812419|FG002|STARTED|Overall Study||10
3090313|NCT01436370|3812420|FG003|STARTED|Overall Study||10
3090314|NCT01436370|3812421|FG004|STARTED|Overall Study||19
3090315|NCT01436370|3812422|FG005|STARTED|Overall Study||19
3090316|NCT01436370|3812423|FG006|STARTED|Overall Study||16
3090317|NCT01436370|3812424|FG007|STARTED|Overall Study||16
3090318|NCT01436370|3812417|FG000|COMPLETED|Overall Study||6
3090319|NCT01436370|3812418|FG001|COMPLETED|Overall Study||6
3090320|NCT01436370|3812419|FG002|COMPLETED|Overall Study||10
3090321|NCT01436370|3812420|FG003|COMPLETED|Overall Study||10
3090322|NCT01436370|3812421|FG004|COMPLETED|Overall Study||18
3090323|NCT01436370|3812422|FG005|COMPLETED|Overall Study||19
3090324|NCT01436370|3812423|FG006|COMPLETED|Overall Study||16
3090325|NCT01436370|3812424|FG007|COMPLETED|Overall Study||16
3090326|NCT01436370|3812417|FG000|NOT COMPLETED|Overall Study||0
3090327|NCT01436370|3812418|FG001|NOT COMPLETED|Overall Study||0
3090328|NCT01436370|3812419|FG002|NOT COMPLETED|Overall Study||0
3090329|NCT01436370|3812420|FG003|NOT COMPLETED|Overall Study||0
3090330|NCT01436370|3812421|FG004|NOT COMPLETED|Overall Study||1
3090331|NCT01436370|3812422|FG005|NOT COMPLETED|Overall Study||0
3090332|NCT01436370|3812423|FG006|NOT COMPLETED|Overall Study||0
3090333|NCT01436370|3812424|FG007|NOT COMPLETED|Overall Study||0
3090334|NCT01436396|3812452|FG000|STARTED|Overall Study||396
3090335|NCT01436396|3812453|FG001|STARTED|Overall Study||396
3090336|NCT01436396|3812452|FG000|Vaccinated|Overall Study||394
3090337|NCT01436396|3812453|FG001|Vaccinated|Overall Study||393
3090338|NCT01436396|3812452|FG000|COMPLETED|Overall Study||364
3090339|NCT01436396|3812453|FG001|COMPLETED|Overall Study||354
3090340|NCT01436396|3812452|FG000|NOT COMPLETED|Overall Study||32
3090341|NCT01436396|3812453|FG001|NOT COMPLETED|Overall Study||42
3090342|NCT01436435|3812459|FG000|STARTED|Overall Study||241
3090343|NCT01436435|3812459|FG000|COMPLETED|Overall Study||177
3090344|NCT01436435|3812459|FG000|NOT COMPLETED|Overall Study||64
3090345|NCT01436500|3812465|FG000|STARTED|Overall Study||12
3090346|NCT01436500|3812466|FG001|STARTED|Overall Study||12
3090347|NCT01436500|3812467|FG002|STARTED|Overall Study||12
3090348|NCT01436500|3812468|FG003|STARTED|Overall Study||6
3090349|NCT01436500|3812469|FG004|STARTED|Overall Study||13
3090350|NCT01436500|3812465|FG000|COMPLETED|Overall Study||9
3090351|NCT01436500|3812466|FG001|COMPLETED|Overall Study||9
3090352|NCT01436500|3812467|FG002|COMPLETED|Overall Study||7
3090353|NCT01436500|3812468|FG003|COMPLETED|Overall Study||5
3090354|NCT01436500|3812469|FG004|COMPLETED|Overall Study||9
3090355|NCT01436500|3812465|FG000|NOT COMPLETED|Overall Study||3
3090356|NCT01436500|3812466|FG001|NOT COMPLETED|Overall Study||3
3090357|NCT01436500|3812467|FG002|NOT COMPLETED|Overall Study||5
3090358|NCT01436500|3812468|FG003|NOT COMPLETED|Overall Study||1
3090359|NCT01436500|3812469|FG004|NOT COMPLETED|Overall Study||4
3090360|NCT01436526|3812484|FG000|STARTED|Period 1||14
3090361|NCT01436526|3812485|FG001|STARTED|Period 1||14
3090362|NCT01436526|3812484|FG000|Participants Received Treatment|Period 1||14
3090363|NCT01436526|3812485|FG001|Participants Received Treatment|Period 1||14
3090364|NCT01436526|3812484|FG000|COMPLETED|Period 1||14
3090365|NCT01436526|3812485|FG001|COMPLETED|Period 1||14
3090366|NCT01436526|3812484|FG000|NOT COMPLETED|Period 1||0
3090367|NCT01436526|3812485|FG001|NOT COMPLETED|Period 1||0
3090368|NCT01436526|3812484|FG000|STARTED|Period 2|1 participant withdrew his consent after completing the first period.|13
3090369|NCT01436526|3812485|FG001|STARTED|Period 2|1 participant withdrew his consent after completing the first period.|13
3090370|NCT01436526|3812484|FG000|Participants Received Treatment|Period 2||13
3090371|NCT01436526|3812485|FG001|Participants Received Treatment|Period 2||13
3090372|NCT01436526|3812484|FG000|COMPLETED|Period 2||13
3090373|NCT01436526|3812485|FG001|COMPLETED|Period 2||13
3090374|NCT01436526|3812484|FG000|NOT COMPLETED|Period 2||0
3090375|NCT01436526|3812485|FG001|NOT COMPLETED|Period 2||0
3090376|NCT01436643|3812494|FG000|STARTED|2-week Pre-treatment||0
3090377|NCT01436643|3812495|FG001|STARTED|2-week Pre-treatment||0
3090378|NCT01436643|3812496|FG002|STARTED|2-week Pre-treatment||0
3090379|NCT01436643|3812497|FG003|STARTED|2-week Pre-treatment||54
3090380|NCT01436643|3812494|FG000|COMPLETED|2-week Pre-treatment||0
3090381|NCT01436643|3812495|FG001|COMPLETED|2-week Pre-treatment||0
3090382|NCT01436643|3812496|FG002|COMPLETED|2-week Pre-treatment||0
3090383|NCT01436643|3812497|FG003|COMPLETED|2-week Pre-treatment||44
3090384|NCT01436643|3812494|FG000|NOT COMPLETED|2-week Pre-treatment||0
3090385|NCT01436643|3812495|FG001|NOT COMPLETED|2-week Pre-treatment||0
3090386|NCT01436643|3812496|FG002|NOT COMPLETED|2-week Pre-treatment||0
3090387|NCT01436643|3812497|FG003|NOT COMPLETED|2-week Pre-treatment||10
3090388|NCT01436643|3812494|FG000|STARTED|Core Phase (16 Weeks)||17
3090389|NCT01436643|3812495|FG001|STARTED|Core Phase (16 Weeks)||15
3090390|NCT01436643|3812496|FG002|STARTED|Core Phase (16 Weeks)||20
3090391|NCT01436643|3812497|FG003|STARTED|Core Phase (16 Weeks)||0
3090392|NCT01436643|3812494|FG000|COMPLETED|Core Phase (16 Weeks)||16
3090393|NCT01436643|3812495|FG001|COMPLETED|Core Phase (16 Weeks)||11
3090394|NCT01436643|3812496|FG002|COMPLETED|Core Phase (16 Weeks)||17
3090395|NCT01436643|3812497|FG003|COMPLETED|Core Phase (16 Weeks)||0
3090396|NCT01436643|3812494|FG000|NOT COMPLETED|Core Phase (16 Weeks)||1
3090397|NCT01436643|3812495|FG001|NOT COMPLETED|Core Phase (16 Weeks)||4
3090398|NCT01436643|3812496|FG002|NOT COMPLETED|Core Phase (16 Weeks)||3
3090399|NCT01436643|3812497|FG003|NOT COMPLETED|Core Phase (16 Weeks)||0
3090400|NCT01436799|3812509|FG000|STARTED|Overall Study||20
3090401|NCT01436799|3812510|FG001|STARTED|Overall Study||20
3090402|NCT01436799|3812509|FG000|COMPLETED|Overall Study||20
3090403|NCT01436799|3812510|FG001|COMPLETED|Overall Study||20
3090404|NCT01436799|3812509|FG000|NOT COMPLETED|Overall Study||0
3090405|NCT01436799|3812510|FG001|NOT COMPLETED|Overall Study||0
3090406|NCT01437098|3812516|FG000|STARTED|Overall Study||55
3090407|NCT01437098|3812516|FG000|30 Days|Overall Study||51
3090408|NCT01437098|3812516|FG000|6 Months|Overall Study||47
3090409|NCT01437098|3812516|FG000|12 Months|Overall Study||45
3090410|NCT01437098|3812516|FG000|24 Months|Overall Study||42
3090411|NCT01437098|3812516|FG000|36 Months|Overall Study||36
3090412|NCT01437098|3812516|FG000|COMPLETED|Overall Study||42
3090413|NCT01437098|3812516|FG000|NOT COMPLETED|Overall Study||13
3090414|NCT01437124|3812528|FG000|STARTED|Overall Study||83
3090415|NCT01437124|3812528|FG000|COMPLETED|Overall Study||83
3090416|NCT01437124|3812528|FG000|NOT COMPLETED|Overall Study||0
3090417|NCT01437267|3812538|FG000|STARTED|Overall Study||20
3090418|NCT01437267|3812539|FG001|STARTED|Overall Study||20
3090419|NCT01437267|3812540|FG002|STARTED|Overall Study||20
3090420|NCT01437267|3812541|FG003|STARTED|Overall Study||20
3090421|NCT01437267|3812542|FG004|STARTED|Overall Study||20
3090422|NCT01437267|3812543|FG005|STARTED|Overall Study||20
3090423|NCT01437267|3812538|FG000|COMPLETED|Overall Study||20
3090424|NCT01437267|3812539|FG001|COMPLETED|Overall Study||19
3090425|NCT01437267|3812540|FG002|COMPLETED|Overall Study||20
3090426|NCT01437267|3812541|FG003|COMPLETED|Overall Study||19
3090427|NCT01437267|3812542|FG004|COMPLETED|Overall Study||20
3090428|NCT01437267|3812543|FG005|COMPLETED|Overall Study||20
3090429|NCT01437267|3812538|FG000|NOT COMPLETED|Overall Study||0
3090430|NCT01437267|3812539|FG001|NOT COMPLETED|Overall Study||1
3090431|NCT01437267|3812540|FG002|NOT COMPLETED|Overall Study||0
3090432|NCT01437267|3812541|FG003|NOT COMPLETED|Overall Study||1
3090433|NCT01437267|3812542|FG004|NOT COMPLETED|Overall Study||0
3090434|NCT01437267|3812543|FG005|NOT COMPLETED|Overall Study||0
3090435|NCT01437319|3812557|FG000|STARTED|Phase I||282
3090436|NCT01437319|3812558|FG001|STARTED|Phase I||0
3090437|NCT01437319|3812559|FG002|STARTED|Phase I||0
3090438|NCT01437319|3812557|FG000|COMPLETED|Phase I||227
3090439|NCT01437319|3812558|FG001|COMPLETED|Phase I||0
3090440|NCT01437319|3812559|FG002|COMPLETED|Phase I||0
3090441|NCT01437319|3812557|FG000|NOT COMPLETED|Phase I||55
3090442|NCT01437319|3812558|FG001|NOT COMPLETED|Phase I||0
3090443|NCT01437319|3812559|FG002|NOT COMPLETED|Phase I||0
3090444|NCT01437319|3812557|FG000|STARTED|Phase II||0
3090445|NCT01437319|3812558|FG001|STARTED|Phase II||115
3090446|NCT01437319|3812559|FG002|STARTED|Phase II||112
3090447|NCT01437319|3812557|FG000|COMPLETED|Phase II||0
3090448|NCT01437319|3812558|FG001|COMPLETED|Phase II||71
3090449|NCT01437319|3812559|FG002|COMPLETED|Phase II||75
3090450|NCT01437319|3812557|FG000|NOT COMPLETED|Phase II||0
3090451|NCT01437319|3812558|FG001|NOT COMPLETED|Phase II||44
3090452|NCT01437319|3812559|FG002|NOT COMPLETED|Phase II||37
3090453|NCT01437397|3812573|FG000|STARTED|Overall Study||338
3090454|NCT01437397|3812574|FG001|STARTED|Overall Study||338
3090455|NCT01437397|3812575|FG002|STARTED|Overall Study||340
3090456|NCT01437397|3812576|FG003|STARTED|Overall Study||339
3090457|NCT01437397|3812577|FG004|STARTED|Overall Study||337
3090458|NCT01437397|3812573|FG000|COMPLETED|Overall Study||272
3090459|NCT01437397|3812574|FG001|COMPLETED|Overall Study||276
3090460|NCT01437397|3812575|FG002|COMPLETED|Overall Study||268
3090461|NCT01437397|3812576|FG003|COMPLETED|Overall Study||270
3090462|NCT01437397|3812577|FG004|COMPLETED|Overall Study||236
3090463|NCT01437397|3812573|FG000|NOT COMPLETED|Overall Study||66
3090464|NCT01437397|3812574|FG001|NOT COMPLETED|Overall Study||62
3090465|NCT01437397|3812575|FG002|NOT COMPLETED|Overall Study||72
3090466|NCT01437397|3812576|FG003|NOT COMPLETED|Overall Study||69
3090467|NCT01437397|3812577|FG004|NOT COMPLETED|Overall Study||101
3090468|NCT01437423|3812589|FG000|STARTED|Overall Study||662
3090469|NCT01437423|3812589|FG000|COMPLETED|Overall Study||647
3090470|NCT01437423|3812589|FG000|NOT COMPLETED|Overall Study||15
3090471|NCT01437449|3812593|FG000|STARTED|Overall Study||27
3090472|NCT01437449|3812593|FG000|COMPLETED|Overall Study||27
3090473|NCT01437449|3812593|FG000|NOT COMPLETED|Overall Study||0
3090474|NCT01437488|3812597|FG000|STARTED|Overall Study||14
3090475|NCT01437488|3812597|FG000|COMPLETED|Overall Study||14
3090476|NCT01437488|3812597|FG000|NOT COMPLETED|Overall Study||0
3090477|NCT01437501|3812606|FG000|STARTED|Overall Study||148
3090478|NCT01437501|3812607|FG001|STARTED|Overall Study||143
3090479|NCT01437501|3812606|FG000|COMPLETED|Overall Study||135
3090480|NCT01437501|3812607|FG001|COMPLETED|Overall Study||132
3090481|NCT01437501|3812606|FG000|NOT COMPLETED|Overall Study||13
3090482|NCT01437501|3812607|FG001|NOT COMPLETED|Overall Study||11
3090483|NCT01437540|3812617|FG000|STARTED|Overall Study||392
3090484|NCT01437540|3812618|FG001|STARTED|Overall Study||198
3090485|NCT01437540|3812617|FG000|COMPLETED|Overall Study||265
3090486|NCT01437540|3812618|FG001|COMPLETED|Overall Study||133
3090487|NCT01437540|3812617|FG000|NOT COMPLETED|Overall Study||127
3090488|NCT01437540|3812618|FG001|NOT COMPLETED|Overall Study||65
3090489|NCT01437605|3812626|FG000|STARTED|Overall Study||9
3090490|NCT01437605|3812627|FG001|STARTED|Overall Study||5
3090491|NCT01437605|3812626|FG000|COMPLETED|Overall Study||9
3090492|NCT01437605|3812627|FG001|COMPLETED|Overall Study||5
3090493|NCT01437605|3812626|FG000|NOT COMPLETED|Overall Study||0
3090494|NCT01437605|3812627|FG001|NOT COMPLETED|Overall Study||0
3090495|NCT01437852|3812633|FG000|STARTED|Overall Study||30
3090496|NCT01437852|3812633|FG000|Received StrataGraft Skin Tissue|Overall Study||30
3090497|NCT01437852|3812633|FG000|Received Autograft|Overall Study||30
3090498|NCT01437852|3812633|FG000|COMPLETED|Overall Study||30
3090499|NCT01437852|3812633|FG000|NOT COMPLETED|Overall Study||0
3090500|NCT01437878|3812640|FG000|STARTED|Overall Study|Patient discontinued the study prior to initiation of study treatment|1
3090501|NCT01437878|3812641|FG001|STARTED|Overall Study||1
3090502|NCT01437878|3812640|FG000|COMPLETED|Overall Study||0
3090503|NCT01437878|3812641|FG001|COMPLETED|Overall Study||1
3090504|NCT01437878|3812640|FG000|NOT COMPLETED|Overall Study||1
3090505|NCT01437878|3812641|FG001|NOT COMPLETED|Overall Study||0
3090506|NCT01437943|3812649|FG000|STARTED|Overall Study||7
3090507|NCT01437943|3812650|FG001|STARTED|Overall Study||3
3090508|NCT01437943|3812649|FG000|COMPLETED|Overall Study||0
3090509|NCT01437943|3812650|FG001|COMPLETED|Overall Study||1
3090510|NCT01437943|3812649|FG000|NOT COMPLETED|Overall Study||7
3090511|NCT01437943|3812650|FG001|NOT COMPLETED|Overall Study||2
3090512|NCT01437995|3812659|FG000|STARTED|Overall Study||151
3090513|NCT01437995|3812660|FG001|STARTED|Overall Study||149
3090514|NCT01437995|3812661|FG002|STARTED|Overall Study||155
3090515|NCT01437995|3812659|FG000|Included in Treatment Failure Analysis|Overall Study||150
3090516|NCT01437995|3812660|FG001|Included in Treatment Failure Analysis|Overall Study||146
3090517|NCT01437995|3812661|FG002|Included in Treatment Failure Analysis|Overall Study||151
3090518|NCT01437995|3812659|FG000|COMPLETED|Overall Study||140
3090519|NCT01437995|3812660|FG001|COMPLETED|Overall Study||131
3090520|NCT01437995|3812661|FG002|COMPLETED|Overall Study||135
3090521|NCT01437995|3812659|FG000|NOT COMPLETED|Overall Study||11
3090522|NCT01437995|3812660|FG001|NOT COMPLETED|Overall Study||18
3090523|NCT01437995|3812661|FG002|NOT COMPLETED|Overall Study||20
3090524|NCT01438008|3812671|FG000|STARTED|Overall Study||4
3090525|NCT01438008|3812672|FG001|STARTED|Overall Study||5
3090526|NCT01438008|3812671|FG000|COMPLETED|Overall Study||4
3090527|NCT01438008|3812672|FG001|COMPLETED|Overall Study||5
3090528|NCT01438008|3812671|FG000|NOT COMPLETED|Overall Study||0
3090529|NCT01438008|3812672|FG001|NOT COMPLETED|Overall Study||0
3090530|NCT01438060|3812680|FG000|STARTED|Acute Phase: Double-blind, 10 Weeks||102
3090531|NCT01438060|3812681|FG001|STARTED|Acute Phase: Double-blind, 10 Weeks||106
3090532|NCT01438060|3812680|FG000|COMPLETED|Acute Phase: Double-blind, 10 Weeks||84
3090533|NCT01438060|3812681|FG001|COMPLETED|Acute Phase: Double-blind, 10 Weeks||88
3090534|NCT01438060|3812680|FG000|NOT COMPLETED|Acute Phase: Double-blind, 10 Weeks||18
3090535|NCT01438060|3812681|FG001|NOT COMPLETED|Acute Phase: Double-blind, 10 Weeks||18
3090536|NCT01438060|3812680|FG000|STARTED|Extension Phase: Week 10 to Week 130|80 out of the 84 participants entered extension phase. All were treated with open-label aripiprazole|80
3090537|NCT01438060|3812681|FG001|STARTED|Extension Phase: Week 10 to Week 130|Of the 88 participants, who completed Acute Phase, 81 opted to enter 130-week extension phase|81
3090538|NCT01438060|3812680|FG000|COMPLETED|Extension Phase: Week 10 to Week 130||22
3090539|NCT01438060|3812681|FG001|COMPLETED|Extension Phase: Week 10 to Week 130||25
3090540|NCT01438060|3812680|FG000|NOT COMPLETED|Extension Phase: Week 10 to Week 130||58
3090541|NCT01438060|3812681|FG001|NOT COMPLETED|Extension Phase: Week 10 to Week 130||56
3090542|NCT01438060|3812680|FG000|STARTED|On Study Beyond Week 140||0
3090543|NCT01438060|3812681|FG001|STARTED|On Study Beyond Week 140|9 participants in France who showed improvement at Week 140 continued treatment beyond 140 weeks|9
3090544|NCT01438060|3812680|FG000|COMPLETED|On Study Beyond Week 140||0
3090545|NCT01438060|3812681|FG001|COMPLETED|On Study Beyond Week 140||1
3090546|NCT01438060|3812680|FG000|NOT COMPLETED|On Study Beyond Week 140||0
3090547|NCT01438060|3812681|FG001|NOT COMPLETED|On Study Beyond Week 140||8
3090548|NCT01438151|3812692|FG000|STARTED|Overall Study||11
3090549|NCT01438151|3812692|FG000|COMPLETED|Overall Study||3
3090550|NCT01438151|3812692|FG000|NOT COMPLETED|Overall Study||8
3090551|NCT01438177|3812696|FG000|STARTED|Overall Study||11
3090552|NCT01438177|3812696|FG000|COMPLETED|Overall Study|Patients who were off due to disease progression|9
3090553|NCT01438177|3812696|FG000|NOT COMPLETED|Overall Study||2
3090554|NCT01438229|3812700|FG000|STARTED|Overall Study||47
3090555|NCT01438229|3812700|FG000|Excluded Due to Renal Artery Anatomy|Overall Study||1
3090556|NCT01438229|3812700|FG000|Underwent Procedure|Overall Study||46
3090557|NCT01438229|3812700|FG000|COMPLETED|Overall Study||44
3090558|NCT01438229|3812700|FG000|NOT COMPLETED|Overall Study||3
3090559|NCT01438294|3812706|FG000|STARTED|Overall Study||16
3090560|NCT01438294|3812707|FG001|STARTED|Overall Study||20
3090561|NCT01438294|3812706|FG000|COMPLETED|Overall Study||13
3090562|NCT01438294|3812707|FG001|COMPLETED|Overall Study||13
3090563|NCT01438294|3812706|FG000|NOT COMPLETED|Overall Study||3
3090564|NCT01438294|3812707|FG001|NOT COMPLETED|Overall Study||7
3090565|NCT01438307|3812715|FG000|STARTED|Overall Study||14
3090566|NCT01438307|3812716|FG001|STARTED|Overall Study||14
3090567|NCT01438307|3812715|FG000|COMPLETED|Overall Study||13
3090568|NCT01438307|3812716|FG001|COMPLETED|Overall Study||13
3090569|NCT01438307|3812715|FG000|NOT COMPLETED|Overall Study||1
3090570|NCT01438307|3812716|FG001|NOT COMPLETED|Overall Study||1
3090571|NCT01438411|3812722|FG000|STARTED|Overall Study||53
3090572|NCT01438411|3812722|FG000|COMPLETED|Overall Study||40
3090573|NCT01438411|3812722|FG000|NOT COMPLETED|Overall Study||13
3289169|NCT02808052|4022770|FG000|STARTED|Overall Study||4
3289170|NCT02808052|4022771|FG001|STARTED|Overall Study||3
3289171|NCT02808052|4022772|FG002|STARTED|Overall Study||2
3289172|NCT02808052|4022770|FG000|COMPLETED|Overall Study||4
3289173|NCT02808052|4022771|FG001|COMPLETED|Overall Study||3
3289174|NCT02808052|4022772|FG002|COMPLETED|Overall Study||2
3289175|NCT02808052|4022770|FG000|NOT COMPLETED|Overall Study||0
3289176|NCT02808052|4022771|FG001|NOT COMPLETED|Overall Study||0
3289177|NCT02808052|4022772|FG002|NOT COMPLETED|Overall Study||0
3289178|NCT02808130|4022786|FG000|STARTED|Overall Study||15
3090574|NCT01438424|3812726|FG000|STARTED|Overall Study|Received treatment|1051
3090575|NCT01438424|3812726|FG000|COMPLETED|Overall Study|Completed treatment|634
3090576|NCT01438424|3812726|FG000|NOT COMPLETED|Overall Study||417
3090577|NCT01438476|3812742|FG000|STARTED|Overall Study||116
3090578|NCT01438476|3812743|FG001|STARTED|Overall Study||45
3090579|NCT01438476|3812742|FG000|COMPLETED|Overall Study||106
3090580|NCT01438476|3812743|FG001|COMPLETED|Overall Study||34
3090581|NCT01438476|3812742|FG000|NOT COMPLETED|Overall Study||10
3090582|NCT01438476|3812743|FG001|NOT COMPLETED|Overall Study||11
3090583|NCT01438489|3812752|FG000|STARTED|Overall Study||103
3090584|NCT01438489|3812753|FG001|STARTED|Overall Study||100
3090585|NCT01438489|3812754|FG002|STARTED|Overall Study||104
3090586|NCT01438489|3812752|FG000|COMPLETED|Overall Study||77
3090587|NCT01438489|3812753|FG001|COMPLETED|Overall Study||84
3090588|NCT01438489|3812754|FG002|COMPLETED|Overall Study||85
3090589|NCT01438489|3812752|FG000|NOT COMPLETED|Overall Study||26
3090590|NCT01438489|3812753|FG001|NOT COMPLETED|Overall Study||16
3090591|NCT01438489|3812754|FG002|NOT COMPLETED|Overall Study||19
3090592|NCT01438541|3812764|FG000|STARTED|Overall Study||29
3090593|NCT01438541|3812764|FG000|COMPLETED|Overall Study||22
3090594|NCT01438541|3812764|FG000|NOT COMPLETED|Overall Study||7
3090595|NCT01438710|3812768|FG000|STARTED|First Week of Treatment|Patients are only treated with Prograf/generic Tacrolimus during the first week.|0
3090596|NCT01438710|3812769|FG001|STARTED|First Week of Treatment||44
3289179|NCT02808130|4022787|FG001|STARTED|Overall Study||15
3289180|NCT02808130|4022788|FG002|STARTED|Overall Study||15
3090597|NCT01438710|3812768|FG000|COMPLETED|First Week of Treatment|Patients are only treated with Prograf/generic Tacrolimus during the first week.|0
3090598|NCT01438710|3812769|FG001|COMPLETED|First Week of Treatment||41
3090599|NCT01438710|3812768|FG000|NOT COMPLETED|First Week of Treatment||0
3090600|NCT01438710|3812769|FG001|NOT COMPLETED|First Week of Treatment||3
3090601|NCT01438710|3812768|FG000|STARTED|Second Week of Treatment|Patients completing the first week will continue on LCP-Tacro treatment during the second week.|41
3090602|NCT01438710|3812769|FG001|STARTED|Second Week of Treatment|Patients are only treated with LCP-Tacro during the second week.|0
3090603|NCT01438710|3812768|FG000|COMPLETED|Second Week of Treatment||40
3090604|NCT01438710|3812769|FG001|COMPLETED|Second Week of Treatment|Patients are only treated with LCP-Tacro during the second week.|0
3090605|NCT01438710|3812768|FG000|NOT COMPLETED|Second Week of Treatment||1
3090606|NCT01438710|3812769|FG001|NOT COMPLETED|Second Week of Treatment||0
3090607|NCT01438814|3812776|FG000|STARTED|Overall Study||344
3090608|NCT01438814|3812777|FG001|STARTED|Overall Study||345
3090609|NCT01438814|3812776|FG000|COMPLETED|Overall Study||330
3090610|NCT01438814|3812777|FG001|COMPLETED|Overall Study||331
3090611|NCT01438814|3812776|FG000|NOT COMPLETED|Overall Study||14
3090612|NCT01438814|3812777|FG001|NOT COMPLETED|Overall Study||14
3090613|NCT01438840|3812785|FG000|STARTED|Core Study||17
3090614|NCT01438840|3812786|FG001|STARTED|Core Study||32
3090615|NCT01438840|3812787|FG002|STARTED|Core Study||0
3090616|NCT01438840|3812785|FG000|COMPLETED|Core Study||1
3090617|NCT01438840|3812786|FG001|COMPLETED|Core Study||22
3090618|NCT01438840|3812787|FG002|COMPLETED|Core Study||0
3090619|NCT01438840|3812785|FG000|NOT COMPLETED|Core Study||16
3090620|NCT01438840|3812786|FG001|NOT COMPLETED|Core Study||10
3090621|NCT01438840|3812787|FG002|NOT COMPLETED|Core Study||0
3090622|NCT01438840|3812785|FG000|STARTED|Extension Phase||0
3090623|NCT01438840|3812786|FG001|STARTED|Extension Phase||0
3090624|NCT01438840|3812787|FG002|STARTED|Extension Phase|39 participants met eligibility criteria for the Extension Phase.|39
3090625|NCT01438840|3812785|FG000|COMPLETED|Extension Phase||0
3090626|NCT01438840|3812786|FG001|COMPLETED|Extension Phase||0
3090627|NCT01438840|3812787|FG002|COMPLETED|Extension Phase||29
3090628|NCT01438840|3812785|FG000|NOT COMPLETED|Extension Phase||0
3090629|NCT01438840|3812786|FG001|NOT COMPLETED|Extension Phase||0
3090630|NCT01438840|3812787|FG002|NOT COMPLETED|Extension Phase||10
3090631|NCT01438957|3812799|FG000|STARTED|Overall Study||22
3090632|NCT01438957|3812800|FG001|STARTED|Overall Study||23
3090633|NCT01438957|3812801|FG002|STARTED|Overall Study||24
3090634|NCT01438957|3812802|FG003|STARTED|Overall Study||25
3090635|NCT01438957|3812803|FG004|STARTED|Overall Study||25
3090636|NCT01438957|3812799|FG000|COMPLETED|Overall Study||21
3090637|NCT01438957|3812800|FG001|COMPLETED|Overall Study||22
3090638|NCT01438957|3812801|FG002|COMPLETED|Overall Study||24
3090639|NCT01438957|3812802|FG003|COMPLETED|Overall Study||24
3090640|NCT01438957|3812803|FG004|COMPLETED|Overall Study||25
3090641|NCT01438957|3812799|FG000|NOT COMPLETED|Overall Study||1
3090642|NCT01438957|3812800|FG001|NOT COMPLETED|Overall Study||1
3090643|NCT01438957|3812801|FG002|NOT COMPLETED|Overall Study||0
3090644|NCT01438957|3812802|FG003|NOT COMPLETED|Overall Study||1
3090645|NCT01438957|3812803|FG004|NOT COMPLETED|Overall Study||0
3090646|NCT01438996|3812818|FG000|STARTED|Overall Study||18
3090647|NCT01438996|3812819|FG001|STARTED|Overall Study||13
3090648|NCT01438996|3812820|FG002|STARTED|Overall Study||20
3090649|NCT01438996|3812818|FG000|COMPLETED|Overall Study||14
3090650|NCT01438996|3812819|FG001|COMPLETED|Overall Study||12
3090651|NCT01438996|3812820|FG002|COMPLETED|Overall Study||20
3090652|NCT01438996|3812818|FG000|NOT COMPLETED|Overall Study||4
3090653|NCT01438996|3812819|FG001|NOT COMPLETED|Overall Study||1
3090654|NCT01438996|3812820|FG002|NOT COMPLETED|Overall Study||0
3090655|NCT01439009|3812830|FG000|STARTED|Overall Study||50
3090656|NCT01439009|3812831|FG001|STARTED|Overall Study||50
3090657|NCT01439009|3812830|FG000|COMPLETED|Overall Study||42
3289181|NCT02808130|4022789|FG003|STARTED|Overall Study||15
3289182|NCT02808130|4022790|FG004|STARTED|Overall Study||15
3289183|NCT02808130|4022791|FG005|STARTED|Overall Study||15
3289184|NCT02808130|4022786|FG000|COMPLETED|Overall Study||15
3289185|NCT02808130|4022787|FG001|COMPLETED|Overall Study||15
3289186|NCT02808130|4022788|FG002|COMPLETED|Overall Study||15
3289187|NCT02808130|4022789|FG003|COMPLETED|Overall Study||15
3289188|NCT02808130|4022790|FG004|COMPLETED|Overall Study||15
3289189|NCT02808130|4022791|FG005|COMPLETED|Overall Study||15
3289190|NCT02808130|4022786|FG000|NOT COMPLETED|Overall Study||0
3289191|NCT02808130|4022787|FG001|NOT COMPLETED|Overall Study||0
3289192|NCT02808130|4022788|FG002|NOT COMPLETED|Overall Study||0
3289193|NCT02808130|4022789|FG003|NOT COMPLETED|Overall Study||0
3289194|NCT02808130|4022790|FG004|NOT COMPLETED|Overall Study||0
3289195|NCT02808130|4022791|FG005|NOT COMPLETED|Overall Study||0
3289196|NCT02808312|4022813|FG000|STARTED|Overall Study||10
3289197|NCT02808312|4022814|FG001|STARTED|Overall Study||10
3289198|NCT02808312|4022815|FG002|STARTED|Overall Study||17
3289199|NCT02808312|4022816|FG003|STARTED|Overall Study||10
3289200|NCT02808312|4022817|FG004|STARTED|Overall Study||10
3289201|NCT02808312|4022813|FG000|COMPLETED|Overall Study||10
3289202|NCT02808312|4022814|FG001|COMPLETED|Overall Study||10
3289203|NCT02808312|4022815|FG002|COMPLETED|Overall Study||16
3289204|NCT02808312|4022816|FG003|COMPLETED|Overall Study||10
3289205|NCT02808312|4022817|FG004|COMPLETED|Overall Study||10
3289206|NCT02808312|4022813|FG000|NOT COMPLETED|Overall Study||0
3289207|NCT02808312|4022814|FG001|NOT COMPLETED|Overall Study||0
3090658|NCT01439009|3812831|FG001|COMPLETED|Overall Study||47
3090659|NCT01439009|3812830|FG000|NOT COMPLETED|Overall Study||8
3090660|NCT01439009|3812831|FG001|NOT COMPLETED|Overall Study||3
3090661|NCT01439035|3812837|FG000|STARTED|Overall Study||6
3090662|NCT01439035|3812837|FG000|COMPLETED|Overall Study||6
3090663|NCT01439035|3812837|FG000|NOT COMPLETED|Overall Study||0
3090664|NCT01439074|3812843|FG000|STARTED|Overall Study||75
3090665|NCT01439074|3812844|FG001|STARTED|Overall Study||87
3090666|NCT01439074|3812843|FG000|COMPLETED|Overall Study||66
3090667|NCT01439074|3812844|FG001|COMPLETED|Overall Study||74
3090668|NCT01439074|3812843|FG000|NOT COMPLETED|Overall Study||9
3090669|NCT01439074|3812844|FG001|NOT COMPLETED|Overall Study||13
3090670|NCT01439087|3812850|FG000|STARTED|Overall Study||2
3090671|NCT01439087|3812850|FG000|COMPLETED|Overall Study||2
3090672|NCT01439087|3812850|FG000|NOT COMPLETED|Overall Study||0
3090673|NCT01439126|3812856|FG000|STARTED|Overall Study||68
3090674|NCT01439126|3812857|FG001|STARTED|Overall Study||67
3090675|NCT01439126|3812856|FG000|COMPLETED|Overall Study||37
3090676|NCT01439126|3812857|FG001|COMPLETED|Overall Study||25
3090677|NCT01439126|3812856|FG000|NOT COMPLETED|Overall Study||31
3090678|NCT01439126|3812857|FG001|NOT COMPLETED|Overall Study||42
3135048|NCT01704287|3859997|FG002|COMPLETED|Initial Treatment Period||6
3135049|NCT01704287|3859998|FG003|COMPLETED|Initial Treatment Period||0
3135050|NCT01704287|3859999|FG004|COMPLETED|Initial Treatment Period||0
3135051|NCT01704287|3859995|FG000|NOT COMPLETED|Initial Treatment Period||147
3135052|NCT01704287|3859996|FG001|NOT COMPLETED|Initial Treatment Period||134
3135053|NCT01704287|3859997|FG002|NOT COMPLETED|Initial Treatment Period||173
3135054|NCT01704287|3859998|FG003|NOT COMPLETED|Initial Treatment Period||0
3135055|NCT01704287|3859999|FG004|NOT COMPLETED|Initial Treatment Period||0
3135056|NCT01704287|3859995|FG000|STARTED|Switch to Pembrolizumab Treatment Period||0
3135057|NCT01704287|3859996|FG001|STARTED|Switch to Pembrolizumab Treatment Period||0
3135058|NCT01704287|3859997|FG002|STARTED|Switch to Pembrolizumab Treatment Period||0
3135059|NCT01704287|3859998|FG003|STARTED|Switch to Pembrolizumab Treatment Period||53
3135060|NCT01704287|3859999|FG004|STARTED|Switch to Pembrolizumab Treatment Period||45
3135061|NCT01704287|3859995|FG000|COMPLETED|Switch to Pembrolizumab Treatment Period||0
3135062|NCT01704287|3859996|FG001|COMPLETED|Switch to Pembrolizumab Treatment Period||0
3135063|NCT01704287|3859997|FG002|COMPLETED|Switch to Pembrolizumab Treatment Period||0
3135064|NCT01704287|3859998|FG003|COMPLETED|Switch to Pembrolizumab Treatment Period||15
3135065|NCT01704287|3859999|FG004|COMPLETED|Switch to Pembrolizumab Treatment Period||7
3135066|NCT01704287|3859995|FG000|NOT COMPLETED|Switch to Pembrolizumab Treatment Period||0
3135067|NCT01704287|3859996|FG001|NOT COMPLETED|Switch to Pembrolizumab Treatment Period||0
3135068|NCT01704287|3859997|FG002|NOT COMPLETED|Switch to Pembrolizumab Treatment Period||0
3135069|NCT01704287|3859998|FG003|NOT COMPLETED|Switch to Pembrolizumab Treatment Period||38
3135070|NCT01704287|3859999|FG004|NOT COMPLETED|Switch to Pembrolizumab Treatment Period||38
3135071|NCT01704456|3860020|FG000|STARTED|Overall Study||67
3135072|NCT01704456|3860021|FG001|STARTED|Overall Study||63
3135073|NCT01704456|3860020|FG000|COMPLETED|Overall Study||59
3135074|NCT01704456|3860021|FG001|COMPLETED|Overall Study||49
3135075|NCT01704456|3860020|FG000|NOT COMPLETED|Overall Study||8
3135076|NCT01704456|3860021|FG001|NOT COMPLETED|Overall Study||14
3135077|NCT01704495|3860031|FG000|STARTED|Subjects Randomized||162
3135078|NCT01704495|3860032|FG001|STARTED|Subjects Randomized||156
3135079|NCT01704495|3860033|FG002|STARTED|Subjects Randomized||160
3135080|NCT01704495|3860034|FG003|STARTED|Subjects Randomized||162
3135081|NCT01704495|3860031|FG000|COMPLETED|Subjects Randomized||140
3135082|NCT01704495|3860032|FG001|COMPLETED|Subjects Randomized||141
3135083|NCT01704495|3860033|FG002|COMPLETED|Subjects Randomized||144
3135084|NCT01704495|3860034|FG003|COMPLETED|Subjects Randomized||145
3135085|NCT01704495|3860031|FG000|NOT COMPLETED|Subjects Randomized||22
3135086|NCT01704495|3860032|FG001|NOT COMPLETED|Subjects Randomized||15
3135087|NCT01704495|3860033|FG002|NOT COMPLETED|Subjects Randomized||16
3135088|NCT01704495|3860034|FG003|NOT COMPLETED|Subjects Randomized||17
3135089|NCT01704495|3860031|FG000|STARTED|Optional Safety Extension|46 subjects did not enter safety extension|116
3135090|NCT01704495|3860032|FG001|STARTED|Optional Safety Extension|35 subjects did not enter safety extension|121
3135091|NCT01704495|3860033|FG002|STARTED|Optional Safety Extension|46 subjects did not enter safety extension|114
3135092|NCT01704495|3860034|FG003|STARTED|Optional Safety Extension|46 subjects did not enter safety extension|116
3135093|NCT01704495|3860031|FG000|COMPLETED|Optional Safety Extension||87
3135094|NCT01704495|3860032|FG001|COMPLETED|Optional Safety Extension||88
3135095|NCT01704495|3860033|FG002|COMPLETED|Optional Safety Extension||83
3135096|NCT01704495|3860034|FG003|COMPLETED|Optional Safety Extension||85
3135097|NCT01704495|3860031|FG000|NOT COMPLETED|Optional Safety Extension||29
3135098|NCT01704495|3860032|FG001|NOT COMPLETED|Optional Safety Extension||33
3135099|NCT01704495|3860033|FG002|NOT COMPLETED|Optional Safety Extension||31
3135100|NCT01704495|3860034|FG003|NOT COMPLETED|Optional Safety Extension||31
3135101|NCT01704521|3860046|FG000|STARTED|Overall Study||3
3135102|NCT01704521|3860047|FG001|STARTED|Overall Study||2
3135103|NCT01704521|3860046|FG000|COMPLETED|Overall Study||3
3135104|NCT01704521|3860047|FG001|COMPLETED|Overall Study||2
3135105|NCT01704521|3860046|FG000|NOT COMPLETED|Overall Study||0
3135106|NCT01704521|3860047|FG001|NOT COMPLETED|Overall Study||0
3135107|NCT01704599|3860053|FG000|STARTED|Overall Study|Study was started January 22, 2010|8
3135108|NCT01704599|3860053|FG000|COMPLETED|Overall Study|11 screened 8 entered study 1 terminated.|7
3090679|NCT01439165|3812865|FG000|STARTED|Overall Study||1002
3090680|NCT01439165|3812866|FG001|STARTED|Overall Study||328
3090681|NCT01439165|3812865|FG000|COMPLETED|Overall Study||981
3090682|NCT01439165|3812866|FG001|COMPLETED|Overall Study||326
3090683|NCT01439165|3812865|FG000|NOT COMPLETED|Overall Study||21
3090684|NCT01439165|3812866|FG001|NOT COMPLETED|Overall Study||2
3090685|NCT01439204|3812874|FG000|STARTED|Overall Study||36
3090686|NCT01439204|3812875|FG001|STARTED|Overall Study||36
3090687|NCT01439204|3812874|FG000|COMPLETED|Overall Study||32
3090688|NCT01439204|3812875|FG001|COMPLETED|Overall Study||33
3090689|NCT01439204|3812874|FG000|NOT COMPLETED|Overall Study||4
3090690|NCT01439204|3812875|FG001|NOT COMPLETED|Overall Study||3
3090691|NCT01439282|3812883|FG000|STARTED|Overall Study||67
3090692|NCT01439282|3812884|FG001|STARTED|Overall Study||10
3090693|NCT01439282|3812883|FG000|COMPLETED|Overall Study||59
3090694|NCT01439282|3812884|FG001|COMPLETED|Overall Study||9
3090695|NCT01439282|3812883|FG000|NOT COMPLETED|Overall Study||8
3090696|NCT01439282|3812884|FG001|NOT COMPLETED|Overall Study||1
3090697|NCT01439360|3812893|FG000|STARTED|Overall Study||6006
3090698|NCT01439360|3812894|FG001|STARTED|Overall Study||6012
3090699|NCT01439360|3812893|FG000|COMPLETED|Overall Study||5808
3090700|NCT01439360|3812894|FG001|COMPLETED|Overall Study||5804
3090701|NCT01439360|3812893|FG000|NOT COMPLETED|Overall Study||198
3090702|NCT01439360|3812894|FG001|NOT COMPLETED|Overall Study||208
3090703|NCT01439373|3812902|FG000|STARTED|Monotherapy (Day 1)||11
3090704|NCT01439373|3812903|FG001|STARTED|Monotherapy (Day 1)||5
3090705|NCT01439373|3812902|FG000|COMPLETED|Monotherapy (Day 1)||11
3090706|NCT01439373|3812903|FG001|COMPLETED|Monotherapy (Day 1)||4
3090707|NCT01439373|3812902|FG000|NOT COMPLETED|Monotherapy (Day 1)||0
3090708|NCT01439373|3812903|FG001|NOT COMPLETED|Monotherapy (Day 1)||1
3090709|NCT01439373|3812902|FG000|STARTED|Combined With PEG and RIBA (Day 2 to 28)||11
3090710|NCT01439373|3812903|FG001|STARTED|Combined With PEG and RIBA (Day 2 to 28)||4
3090711|NCT01439373|3812902|FG000|COMPLETED|Combined With PEG and RIBA (Day 2 to 28)||9
3090712|NCT01439373|3812903|FG001|COMPLETED|Combined With PEG and RIBA (Day 2 to 28)||4
3090713|NCT01439373|3812902|FG000|NOT COMPLETED|Combined With PEG and RIBA (Day 2 to 28)||2
3090714|NCT01439373|3812903|FG001|NOT COMPLETED|Combined With PEG and RIBA (Day 2 to 28)||0
3090715|NCT01439555|3812913|FG000|STARTED|Overall Study||11
3090716|NCT01439555|3812913|FG000|COMPLETED|Overall Study||10
3090717|NCT01439555|3812913|FG000|NOT COMPLETED|Overall Study||1
3090718|NCT01439568|3812919|FG000|STARTED|Overall Study||47
3090719|NCT01439568|3812920|FG001|STARTED|Overall Study||43
3090720|NCT01439568|3812919|FG000|Received at Least One Dose of Study Drug|Overall Study||47
3090721|NCT01439568|3812920|FG001|Received at Least One Dose of Study Drug|Overall Study||43
3090722|NCT01439568|3812919|FG000|COMPLETED|Overall Study||44
3090723|NCT01439568|3812920|FG001|COMPLETED|Overall Study||41
3090724|NCT01439568|3812919|FG000|NOT COMPLETED|Overall Study||3
3090725|NCT01439568|3812920|FG001|NOT COMPLETED|Overall Study||2
3090726|NCT01439581|3812928|FG000|STARTED|Overall Study||216
3090727|NCT01439581|3812929|FG001|STARTED|Overall Study||212
3090728|NCT01439581|3812928|FG000|COMPLETED|Overall Study||216
3090729|NCT01439581|3812929|FG001|COMPLETED|Overall Study||212
3090730|NCT01439581|3812928|FG000|NOT COMPLETED|Overall Study||0
3090731|NCT01439581|3812929|FG001|NOT COMPLETED|Overall Study||0
3090732|NCT01439594|3812935|FG000|STARTED|Overall Study||17
3090733|NCT01439594|3812935|FG000|COMPLETED|Overall Study||17
3090734|NCT01439594|3812935|FG000|NOT COMPLETED|Overall Study||0
3090735|NCT01439620|3812939|FG000|STARTED|Overall Study||7
3090736|NCT01439620|3812939|FG000|COMPLETED|Overall Study||7
3090737|NCT01439620|3812939|FG000|NOT COMPLETED|Overall Study||0
3090738|NCT01439633|3812943|FG000|STARTED|Overall Study||22
3090739|NCT01439633|3812943|FG000|COMPLETED|Overall Study||22
3090740|NCT01439633|3812943|FG000|NOT COMPLETED|Overall Study||0
3090741|NCT01439672|3812947|FG000|STARTED|Overall Study||35
3090742|NCT01439672|3812947|FG000|COMPLETED|Overall Study||11
3090743|NCT01439672|3812947|FG000|NOT COMPLETED|Overall Study||24
3090744|NCT01439711|3812951|FG000|STARTED|Overall Study||108
3090745|NCT01439711|3812951|FG000|COMPLETED|Overall Study||68
3090746|NCT01439711|3812951|FG000|NOT COMPLETED|Overall Study||40
3090747|NCT01439724|3812957|FG000|STARTED|Overall Study||47
3090748|NCT01439724|3812958|FG001|STARTED|Overall Study||47
3090749|NCT01439724|3812957|FG000|COMPLETED|Overall Study||38
3090750|NCT01439724|3812958|FG001|COMPLETED|Overall Study||39
3090751|NCT01439724|3812957|FG000|NOT COMPLETED|Overall Study||9
3090752|NCT01439724|3812958|FG001|NOT COMPLETED|Overall Study||8
3090753|NCT01439815|3812966|FG000|STARTED|Overall Study||11
3090754|NCT01439815|3812967|FG001|STARTED|Overall Study||11
3090755|NCT01439815|3812966|FG000|All Randomized Participant Population|Overall Study||11
3090756|NCT01439815|3812967|FG001|All Randomized Participant Population|Overall Study||11
3090757|NCT01439815|3812966|FG000|COMPLETED|Overall Study||11
3090758|NCT01439815|3812967|FG001|COMPLETED|Overall Study||9
3090759|NCT01439815|3812966|FG000|NOT COMPLETED|Overall Study||0
3090760|NCT01439815|3812967|FG001|NOT COMPLETED|Overall Study||2
3090761|NCT01439854|3812975|FG000|STARTED|Overall Study||8
3090762|NCT01439854|3812976|FG001|STARTED|Overall Study||10
3090763|NCT01439854|3812975|FG000|COMPLETED|Overall Study||8
3090764|NCT01439854|3812976|FG001|COMPLETED|Overall Study||10
3090765|NCT01439854|3812975|FG000|NOT COMPLETED|Overall Study||0
3090766|NCT01439854|3812976|FG001|NOT COMPLETED|Overall Study||0
3090767|NCT01439867|3812984|FG000|STARTED|Overall Study||8
3090768|NCT01439867|3812985|FG001|STARTED|Overall Study||10
3090769|NCT01439867|3812984|FG000|Received Treatment|Overall Study||7
3090770|NCT01439867|3812985|FG001|Received Treatment|Overall Study||10
3090771|NCT01439867|3812984|FG000|COMPLETED|Overall Study||2
3090772|NCT01439867|3812985|FG001|COMPLETED|Overall Study||2
3090773|NCT01439867|3812984|FG000|NOT COMPLETED|Overall Study||6
3090774|NCT01439867|3812985|FG001|NOT COMPLETED|Overall Study||8
3090775|NCT01439880|3812995|FG000|STARTED|SOC-controlled Period (Year 1)||442
3090776|NCT01439880|3812996|FG001|STARTED|SOC-controlled Period (Year 1)||882
3090777|NCT01439880|3812995|FG000|Received Evolocumab|SOC-controlled Period (Year 1)||0
3090778|NCT01439880|3812996|FG001|Received Evolocumab|SOC-controlled Period (Year 1)||881
3090779|NCT01439880|3812995|FG000|COMPLETED|SOC-controlled Period (Year 1)||398
3090780|NCT01439880|3812996|FG001|COMPLETED|SOC-controlled Period (Year 1)||822
3090781|NCT01439880|3812995|FG000|NOT COMPLETED|SOC-controlled Period (Year 1)||44
3090782|NCT01439880|3812996|FG001|NOT COMPLETED|SOC-controlled Period (Year 1)||60
3090783|NCT01439880|3812995|FG000|STARTED|All-IP Period (Years 2 to 5)||398
3090784|NCT01439880|3812996|FG001|STARTED|All-IP Period (Years 2 to 5)||822
3090785|NCT01439880|3812995|FG000|Received Evolocumab|All-IP Period (Years 2 to 5)||374
3090786|NCT01439880|3812996|FG001|Received Evolocumab|All-IP Period (Years 2 to 5)||777
3090787|NCT01439880|3812995|FG000|COMPLETED|All-IP Period (Years 2 to 5)||328
3090788|NCT01439880|3812996|FG001|COMPLETED|All-IP Period (Years 2 to 5)||682
3090789|NCT01439880|3812995|FG000|NOT COMPLETED|All-IP Period (Years 2 to 5)||70
3090790|NCT01439880|3812996|FG001|NOT COMPLETED|All-IP Period (Years 2 to 5)||140
3090791|NCT01439945|3813016|FG000|STARTED|Double-Blind Treatment Phase||97
3090792|NCT01439945|3813017|FG001|STARTED|Double-Blind Treatment Phase||96
3090793|NCT01439945|3813018|FG002|STARTED|Double-Blind Treatment Phase||48
3090794|NCT01439945|3813019|FG003|STARTED|Double-Blind Treatment Phase||48
3090795|NCT01439945|3813016|FG000|COMPLETED|Double-Blind Treatment Phase||93
3090796|NCT01439945|3813017|FG001|COMPLETED|Double-Blind Treatment Phase||91
3090797|NCT01439945|3813018|FG002|COMPLETED|Double-Blind Treatment Phase||45
3090798|NCT01439945|3813019|FG003|COMPLETED|Double-Blind Treatment Phase||46
3090799|NCT01439945|3813016|FG000|NOT COMPLETED|Double-Blind Treatment Phase||4
3090800|NCT01439945|3813017|FG001|NOT COMPLETED|Double-Blind Treatment Phase||5
3090801|NCT01439945|3813018|FG002|NOT COMPLETED|Double-Blind Treatment Phase||3
3090802|NCT01439945|3813019|FG003|NOT COMPLETED|Double-Blind Treatment Phase||2
3090803|NCT01439945|3813016|FG000|STARTED|Optional Continuation Phase||72
3090804|NCT01439945|3813017|FG001|STARTED|Optional Continuation Phase||44
3090805|NCT01439945|3813018|FG002|STARTED|Optional Continuation Phase||0
3090806|NCT01439945|3813019|FG003|STARTED|Optional Continuation Phase||0
3090807|NCT01439945|3813016|FG000|COMPLETED|Optional Continuation Phase||72
3090808|NCT01439945|3813017|FG001|COMPLETED|Optional Continuation Phase||44
3090809|NCT01439945|3813018|FG002|COMPLETED|Optional Continuation Phase||0
3090810|NCT01439945|3813019|FG003|COMPLETED|Optional Continuation Phase||0
3090811|NCT01439945|3813016|FG000|NOT COMPLETED|Optional Continuation Phase||0
3090812|NCT01439945|3813017|FG001|NOT COMPLETED|Optional Continuation Phase||0
3090813|NCT01439945|3813018|FG002|NOT COMPLETED|Optional Continuation Phase||0
3090814|NCT01439945|3813019|FG003|NOT COMPLETED|Optional Continuation Phase||0
3090815|NCT01439971|3813035|FG000|STARTED|Overall Study||1
3090816|NCT01439971|3813036|FG001|STARTED|Overall Study||7
3090817|NCT01439971|3813037|FG002|STARTED|Overall Study||8
3090818|NCT01439971|3813038|FG003|STARTED|Overall Study||6
3090819|NCT01439971|3813039|FG004|STARTED|Overall Study||7
3090820|NCT01439971|3813035|FG000|Received Treatment|Overall Study||1
3090821|NCT01439971|3813036|FG001|Received Treatment|Overall Study||6
3090822|NCT01439971|3813037|FG002|Received Treatment|Overall Study||6
3090823|NCT01439971|3813038|FG003|Received Treatment|Overall Study||6
3090824|NCT01439971|3813039|FG004|Received Treatment|Overall Study||6
3090825|NCT01439971|3813035|FG000|COMPLETED|Overall Study||1
3090826|NCT01439971|3813036|FG001|COMPLETED|Overall Study||6
3090827|NCT01439971|3813037|FG002|COMPLETED|Overall Study||6
3090828|NCT01439971|3813038|FG003|COMPLETED|Overall Study||6
3090829|NCT01439971|3813039|FG004|COMPLETED|Overall Study||6
3090830|NCT01439971|3813035|FG000|NOT COMPLETED|Overall Study||0
3090831|NCT01439971|3813036|FG001|NOT COMPLETED|Overall Study||1
3090832|NCT01439971|3813037|FG002|NOT COMPLETED|Overall Study||2
3090833|NCT01439971|3813038|FG003|NOT COMPLETED|Overall Study||0
3090834|NCT01439971|3813039|FG004|NOT COMPLETED|Overall Study||1
3090835|NCT01440049|3813051|FG000|STARTED|Overall Study||160
3090836|NCT01440049|3813051|FG000|COMPLETED|Overall Study||155
3090837|NCT01440049|3813051|FG000|NOT COMPLETED|Overall Study||5
3090838|NCT01440101|3813058|FG000|STARTED|Overall Study||12
3090839|NCT01440101|3813059|FG001|STARTED|Overall Study||47
3090840|NCT01440101|3813060|FG002|STARTED|Overall Study||47
3090841|NCT01440101|3813058|FG000|COMPLETED|Overall Study||10
3090842|NCT01440101|3813059|FG001|COMPLETED|Overall Study||43
3090843|NCT01440101|3813060|FG002|COMPLETED|Overall Study||46
3090844|NCT01440101|3813058|FG000|NOT COMPLETED|Overall Study||2
3090845|NCT01440101|3813059|FG001|NOT COMPLETED|Overall Study||4
3090846|NCT01440101|3813060|FG002|NOT COMPLETED|Overall Study||1
3090847|NCT01440283|3813069|FG000|STARTED|Overall Study||14
3090848|NCT01440283|3813069|FG000|COMPLETED|Overall Study||4
3090849|NCT01440283|3813069|FG000|NOT COMPLETED|Overall Study||10
3090850|NCT01440322|3813081|FG000|STARTED|Overall Study||97
3090851|NCT01440322|3813082|FG001|STARTED|Overall Study||50
3090852|NCT01440322|3813081|FG000|COMPLETED|Overall Study||90
3090853|NCT01440322|3813082|FG001|COMPLETED|Overall Study||49
3090854|NCT01440322|3813081|FG000|NOT COMPLETED|Overall Study||7
3090855|NCT01440322|3813082|FG001|NOT COMPLETED|Overall Study||1
3090856|NCT01440374|3813091|FG000|STARTED|Part 1: Open-label Phase||17
3090857|NCT01440374|3813092|FG001|STARTED|Part 1: Open-label Phase||0
3090858|NCT01440374|3813093|FG002|STARTED|Part 1: Open-label Phase||0
3090859|NCT01440374|3813094|FG003|STARTED|Part 1: Open-label Phase||0
3090860|NCT01440374|3813091|FG000|COMPLETED|Part 1: Open-label Phase||11
3090861|NCT01440374|3813092|FG001|COMPLETED|Part 1: Open-label Phase||0
3090862|NCT01440374|3813093|FG002|COMPLETED|Part 1: Open-label Phase||0
3090863|NCT01440374|3813094|FG003|COMPLETED|Part 1: Open-label Phase||0
3090864|NCT01440374|3813091|FG000|NOT COMPLETED|Part 1: Open-label Phase||6
3090865|NCT01440374|3813092|FG001|NOT COMPLETED|Part 1: Open-label Phase||0
3090866|NCT01440374|3813093|FG002|NOT COMPLETED|Part 1: Open-label Phase||0
3090867|NCT01440374|3813094|FG003|NOT COMPLETED|Part 1: Open-label Phase||0
3090868|NCT01440374|3813091|FG000|STARTED|Part 2; Double-blind Phase||0
3090869|NCT01440374|3813092|FG001|STARTED|Part 2; Double-blind Phase||47
3090870|NCT01440374|3813093|FG002|STARTED|Part 2; Double-blind Phase||98
3090871|NCT01440374|3813094|FG003|STARTED|Part 2; Double-blind Phase||0
3090872|NCT01440374|3813091|FG000|COMPLETED|Part 2; Double-blind Phase||0
3090873|NCT01440374|3813092|FG001|COMPLETED|Part 2; Double-blind Phase||27
3090874|NCT01440374|3813093|FG002|COMPLETED|Part 2; Double-blind Phase||43
3090875|NCT01440374|3813094|FG003|COMPLETED|Part 2; Double-blind Phase||0
3090876|NCT01440374|3813091|FG000|NOT COMPLETED|Part 2; Double-blind Phase||0
3090877|NCT01440374|3813092|FG001|NOT COMPLETED|Part 2; Double-blind Phase||20
3090878|NCT01440374|3813093|FG002|NOT COMPLETED|Part 2; Double-blind Phase||55
3090879|NCT01440374|3813094|FG003|NOT COMPLETED|Part 2; Double-blind Phase||0
3090880|NCT01440374|3813091|FG000|STARTED|Part 3: Extension||0
3090881|NCT01440374|3813092|FG001|STARTED|Part 3: Extension||0
3090882|NCT01440374|3813093|FG002|STARTED|Part 3: Extension||0
3090883|NCT01440374|3813094|FG003|STARTED|Part 3: Extension||59
3090884|NCT01440374|3813091|FG000|COMPLETED|Part 3: Extension||0
3090885|NCT01440374|3813092|FG001|COMPLETED|Part 3: Extension||0
3090886|NCT01440374|3813093|FG002|COMPLETED|Part 3: Extension||0
3090887|NCT01440374|3813094|FG003|COMPLETED|Part 3: Extension||27
3090888|NCT01440374|3813091|FG000|NOT COMPLETED|Part 3: Extension||0
3090889|NCT01440374|3813092|FG001|NOT COMPLETED|Part 3: Extension||0
3090890|NCT01440374|3813093|FG002|NOT COMPLETED|Part 3: Extension||0
3090891|NCT01440374|3813094|FG003|NOT COMPLETED|Part 3: Extension||32
3090892|NCT01440387|3813108|FG000|STARTED|Overall Study||56
3090893|NCT01440387|3813109|FG001|STARTED|Overall Study||56
3090894|NCT01440387|3813108|FG000|COMPLETED|Overall Study||56
3090895|NCT01440387|3813109|FG001|COMPLETED|Overall Study||56
3090896|NCT01440387|3813108|FG000|NOT COMPLETED|Overall Study||0
3090897|NCT01440387|3813109|FG001|NOT COMPLETED|Overall Study||0
3090898|NCT01440543|3813119|FG000|STARTED|Overall Study||106
3090899|NCT01440543|3813120|FG001|STARTED|Overall Study||105
3090900|NCT01440543|3813121|FG002|STARTED|Overall Study||102
3090901|NCT01440543|3813122|FG003|STARTED|Overall Study||107
3090902|NCT01440543|3813119|FG000|COMPLETED|Overall Study||102
3090903|NCT01440543|3813120|FG001|COMPLETED|Overall Study||101
3090904|NCT01440543|3813121|FG002|COMPLETED|Overall Study||100
3090905|NCT01440543|3813122|FG003|COMPLETED|Overall Study||101
3090906|NCT01440543|3813119|FG000|NOT COMPLETED|Overall Study||4
3090907|NCT01440543|3813120|FG001|NOT COMPLETED|Overall Study||4
3090908|NCT01440543|3813121|FG002|NOT COMPLETED|Overall Study||2
3090909|NCT01440543|3813122|FG003|NOT COMPLETED|Overall Study||6
3090910|NCT01440569|3813134|FG000|STARTED|Main Study||296
3090911|NCT01440569|3813135|FG001|STARTED|Main Study||18
3090912|NCT01440569|3813134|FG000|Enrolled and Treated|Main Study||295
3090913|NCT01440569|3813135|FG001|Enrolled and Treated|Main Study||18
3090914|NCT01440569|3813134|FG000|COMPLETED|Main Study||260
3090915|NCT01440569|3813135|FG001|COMPLETED|Main Study||14
3090916|NCT01440569|3813134|FG000|NOT COMPLETED|Main Study||36
3090917|NCT01440569|3813135|FG001|NOT COMPLETED|Main Study||4
3090918|NCT01440569|3813134|FG000|STARTED|Open-Label Rollover Phase|9 participants who completed the Main Study did not enroll into the Rollover Phase.|251
3090919|NCT01440569|3813135|FG001|STARTED|Open-Label Rollover Phase|1 participant who completed the Main Study did not enroll into the Rollover Phase.|13
3090920|NCT01440569|3813134|FG000|COMPLETED|Open-Label Rollover Phase||204
3090921|NCT01440569|3813135|FG001|COMPLETED|Open-Label Rollover Phase||7
3090922|NCT01440569|3813134|FG000|NOT COMPLETED|Open-Label Rollover Phase||47
3090923|NCT01440569|3813135|FG001|NOT COMPLETED|Open-Label Rollover Phase||6
3090924|NCT01440634|3813143|FG000|STARTED|Cross Sectional Phase||0
3090925|NCT01440634|3813144|FG001|STARTED|Cross Sectional Phase||347
3090926|NCT01440634|3813143|FG000|COMPLETED|Cross Sectional Phase||0
3090927|NCT01440634|3813144|FG001|COMPLETED|Cross Sectional Phase||347
3090928|NCT01440634|3813143|FG000|NOT COMPLETED|Cross Sectional Phase||0
3090929|NCT01440634|3813144|FG001|NOT COMPLETED|Cross Sectional Phase||0
3090930|NCT01440634|3813143|FG000|STARTED|Randomization Phase||30
3090931|NCT01440634|3813144|FG001|STARTED|Randomization Phase||24
3090932|NCT01440634|3813143|FG000|COMPLETED|Randomization Phase||24
3090933|NCT01440634|3813144|FG001|COMPLETED|Randomization Phase||14
3090934|NCT01440634|3813143|FG000|NOT COMPLETED|Randomization Phase||6
3090935|NCT01440634|3813144|FG001|NOT COMPLETED|Randomization Phase||10
3090936|NCT01440647|3813152|FG000|STARTED|Overall Study||16
3090937|NCT01440647|3813153|FG001|STARTED|Overall Study||18
3090938|NCT01440647|3813152|FG000|COMPLETED|Overall Study||14
3090939|NCT01440647|3813153|FG001|COMPLETED|Overall Study||15
3090940|NCT01440647|3813152|FG000|NOT COMPLETED|Overall Study||2
3090941|NCT01440647|3813153|FG001|NOT COMPLETED|Overall Study||3
3090942|NCT01440764|3813161|FG000|STARTED|Test Day 1||4
3090943|NCT01440764|3813162|FG001|STARTED|Test Day 1||2
3090944|NCT01440764|3813163|FG002|STARTED|Test Day 1||6
3090945|NCT01440764|3813164|FG003|STARTED|Test Day 1||1
3090946|NCT01440764|3813165|FG004|STARTED|Test Day 1||3
3090947|NCT01440764|3813166|FG005|STARTED|Test Day 1||5
3090948|NCT01440764|3813167|FG006|STARTED|Test Day 1||3
3090949|NCT01440764|3813161|FG000|COMPLETED|Test Day 1||4
3090950|NCT01440764|3813162|FG001|COMPLETED|Test Day 1||2
3090951|NCT01440764|3813163|FG002|COMPLETED|Test Day 1||6
3090952|NCT01440764|3813164|FG003|COMPLETED|Test Day 1||1
3090953|NCT01440764|3813165|FG004|COMPLETED|Test Day 1||3
3090954|NCT01440764|3813166|FG005|COMPLETED|Test Day 1||5
3090955|NCT01440764|3813167|FG006|COMPLETED|Test Day 1||3
3090956|NCT01440764|3813161|FG000|NOT COMPLETED|Test Day 1||0
3090957|NCT01440764|3813162|FG001|NOT COMPLETED|Test Day 1||0
3090958|NCT01440764|3813163|FG002|NOT COMPLETED|Test Day 1||0
3090959|NCT01440764|3813164|FG003|NOT COMPLETED|Test Day 1||0
3090960|NCT01440764|3813165|FG004|NOT COMPLETED|Test Day 1||0
3090961|NCT01440764|3813166|FG005|NOT COMPLETED|Test Day 1||0
3090962|NCT01440764|3813167|FG006|NOT COMPLETED|Test Day 1||0
3090963|NCT01440764|3813161|FG000|STARTED|Test Day 2|Following Test Day 1, 1 subject withdrew from the study before beginning Test Day 2.|3
3090964|NCT01440764|3813162|FG001|STARTED|Test Day 2||2
3090965|NCT01440764|3813163|FG002|STARTED|Test Day 2||6
3090966|NCT01440764|3813164|FG003|STARTED|Test Day 2||1
3090967|NCT01440764|3813165|FG004|STARTED|Test Day 2||3
3090968|NCT01440764|3813166|FG005|STARTED|Test Day 2||5
3090969|NCT01440764|3813167|FG006|STARTED|Test Day 2||3
3090970|NCT01440764|3813161|FG000|COMPLETED|Test Day 2||3
3090971|NCT01440764|3813162|FG001|COMPLETED|Test Day 2||2
3090972|NCT01440764|3813163|FG002|COMPLETED|Test Day 2||6
3090973|NCT01440764|3813164|FG003|COMPLETED|Test Day 2||1
3090974|NCT01440764|3813165|FG004|COMPLETED|Test Day 2||3
3090975|NCT01440764|3813166|FG005|COMPLETED|Test Day 2||5
3090976|NCT01440764|3813167|FG006|COMPLETED|Test Day 2||3
3090977|NCT01440764|3813161|FG000|NOT COMPLETED|Test Day 2||0
3090978|NCT01440764|3813162|FG001|NOT COMPLETED|Test Day 2||0
3090979|NCT01440764|3813163|FG002|NOT COMPLETED|Test Day 2||0
3090980|NCT01440764|3813164|FG003|NOT COMPLETED|Test Day 2||0
3090981|NCT01440764|3813165|FG004|NOT COMPLETED|Test Day 2||0
3090982|NCT01440764|3813166|FG005|NOT COMPLETED|Test Day 2||0
3090983|NCT01440764|3813167|FG006|NOT COMPLETED|Test Day 2||0
3090984|NCT01440764|3813161|FG000|STARTED|Test Day 3||3
3090985|NCT01440764|3813162|FG001|STARTED|Test Day 3||2
3090986|NCT01440764|3813163|FG002|STARTED|Test Day 3||6
3090987|NCT01440764|3813164|FG003|STARTED|Test Day 3||1
3090988|NCT01440764|3813165|FG004|STARTED|Test Day 3||3
3090989|NCT01440764|3813166|FG005|STARTED|Test Day 3||5
3090990|NCT01440764|3813167|FG006|STARTED|Test Day 3||3
3090991|NCT01440764|3813161|FG000|COMPLETED|Test Day 3||3
3090992|NCT01440764|3813162|FG001|COMPLETED|Test Day 3||2
3090993|NCT01440764|3813163|FG002|COMPLETED|Test Day 3||6
3090994|NCT01440764|3813164|FG003|COMPLETED|Test Day 3||1
3090995|NCT01440764|3813165|FG004|COMPLETED|Test Day 3||3
3090996|NCT01440764|3813166|FG005|COMPLETED|Test Day 3||5
3090997|NCT01440764|3813167|FG006|COMPLETED|Test Day 3||3
3090998|NCT01440764|3813161|FG000|NOT COMPLETED|Test Day 3||0
3090999|NCT01440764|3813162|FG001|NOT COMPLETED|Test Day 3||0
3091000|NCT01440764|3813163|FG002|NOT COMPLETED|Test Day 3||0
3091001|NCT01440764|3813164|FG003|NOT COMPLETED|Test Day 3||0
3091002|NCT01440764|3813165|FG004|NOT COMPLETED|Test Day 3||0
3091003|NCT01440764|3813166|FG005|NOT COMPLETED|Test Day 3||0
3091004|NCT01440764|3813167|FG006|NOT COMPLETED|Test Day 3||0
3091005|NCT01440803|3813187|FG000|STARTED|Overall Study||13
3091006|NCT01440803|3813188|FG001|STARTED|Overall Study||28
3091007|NCT01440803|3813187|FG000|Period 1 - Forteo/Placebo|Overall Study||13
3091008|NCT01440803|3813188|FG001|Period 1 - Forteo/Placebo|Overall Study||28
3091009|NCT01440803|3813187|FG000|Period 2 - Forteo/Forteo|Overall Study||13
3091010|NCT01440803|3813188|FG001|Period 2 - Forteo/Forteo|Overall Study||28
3091011|NCT01440803|3813187|FG000|Period 3 - Forteo Open Label|Overall Study||13
3091012|NCT01440803|3813188|FG001|Period 3 - Forteo Open Label|Overall Study||27
3091013|NCT01440803|3813187|FG000|COMPLETED|Overall Study||11
3091014|NCT01440803|3813188|FG001|COMPLETED|Overall Study||24
3091015|NCT01440803|3813187|FG000|NOT COMPLETED|Overall Study||2
3091016|NCT01440803|3813188|FG001|NOT COMPLETED|Overall Study||4
3091017|NCT01440816|3813197|FG000|STARTED|Overall Study||3
3091018|NCT01440816|3813198|FG001|STARTED|Overall Study||12
3091019|NCT01440816|3813197|FG000|COMPLETED|Overall Study||2
3091020|NCT01440816|3813198|FG001|COMPLETED|Overall Study||1
3091021|NCT01440816|3813197|FG000|NOT COMPLETED|Overall Study||1
3091022|NCT01440816|3813198|FG001|NOT COMPLETED|Overall Study||11
3091023|NCT01440881|3813208|FG000|STARTED|Overall Study||14
3091024|NCT01440881|3813209|FG001|STARTED|Overall Study||15
3091025|NCT01440881|3813208|FG000|COMPLETED|Overall Study||14
3091026|NCT01440881|3813209|FG001|COMPLETED|Overall Study||14
3091027|NCT01440881|3813208|FG000|NOT COMPLETED|Overall Study||0
3091028|NCT01440881|3813209|FG001|NOT COMPLETED|Overall Study||1
3091029|NCT01440920|3813219|FG000|STARTED|Overall Study||3
3091030|NCT01440920|3813220|FG001|STARTED|Overall Study||3
3091031|NCT01440920|3813221|FG002|STARTED|Overall Study||3
3091032|NCT01440920|3813219|FG000|COMPLETED|Overall Study||3
3091033|NCT01440920|3813220|FG001|COMPLETED|Overall Study||3
3091034|NCT01440920|3813221|FG002|COMPLETED|Overall Study||3
3091035|NCT01440920|3813219|FG000|NOT COMPLETED|Overall Study||0
3091036|NCT01440920|3813220|FG001|NOT COMPLETED|Overall Study||0
3091037|NCT01440920|3813221|FG002|NOT COMPLETED|Overall Study||0
3091038|NCT01440946|3813231|FG000|STARTED|Overall Study||15
3091039|NCT01440946|3813232|FG001|STARTED|Overall Study||15
3091040|NCT01440946|3813231|FG000|COMPLETED|Overall Study||13
3091041|NCT01440946|3813232|FG001|COMPLETED|Overall Study||14
3091042|NCT01440946|3813231|FG000|NOT COMPLETED|Overall Study||2
3091043|NCT01440946|3813232|FG001|NOT COMPLETED|Overall Study||1
3091044|NCT01440959|3813239|FG000|STARTED|Overall Study||30
3091045|NCT01440959|3813239|FG000|COMPLETED|Overall Study||30
3091046|NCT01440959|3813239|FG000|NOT COMPLETED|Overall Study||0
3091047|NCT01440972|3813245|FG000|STARTED|Overall Study||24
3091048|NCT01440972|3813246|FG001|STARTED|Overall Study||21
3091049|NCT01440972|3813245|FG000|COMPLETED|Overall Study||21
3091050|NCT01440972|3813246|FG001|COMPLETED|Overall Study||19
3091051|NCT01440972|3813245|FG000|NOT COMPLETED|Overall Study||3
3091052|NCT01440972|3813246|FG001|NOT COMPLETED|Overall Study||2
3091053|NCT01441037|3813252|FG000|STARTED|Overall Study||27
3091054|NCT01441037|3813252|FG000|COMPLETED|Overall Study||27
3091055|NCT01441037|3813252|FG000|NOT COMPLETED|Overall Study||0
3091056|NCT01441063|3813256|FG000|STARTED|Tocilizumab Alone||8
3091057|NCT01441063|3813256|FG000|COMPLETED|Tocilizumab Alone||5
3091058|NCT01441063|3813256|FG000|NOT COMPLETED|Tocilizumab Alone||3
3091059|NCT01441063|3813256|FG000|STARTED|Tocilizumab + Zidovudine /Valganciclovir||3
3091060|NCT01441063|3813256|FG000|COMPLETED|Tocilizumab + Zidovudine /Valganciclovir||2
3091061|NCT01441063|3813256|FG000|NOT COMPLETED|Tocilizumab + Zidovudine /Valganciclovir||1
3091062|NCT01441076|3813263|FG000|STARTED|Overall Study||6
3091063|NCT01441076|3813263|FG000|COMPLETED|Overall Study||4
3091064|NCT01441076|3813263|FG000|NOT COMPLETED|Overall Study||2
3091065|NCT01441102|3813267|FG000|STARTED|Overall Study|Two participants withdrew prior to Month 6; therefore, two additional participants were enrolled.|7
3091066|NCT01441102|3813267|FG000|COMPLETED|Overall Study||4
3091067|NCT01441102|3813267|FG000|NOT COMPLETED|Overall Study||3
3091068|NCT01441180|3813274|FG000|STARTED|Overall Study||10
3091069|NCT01441180|3813275|FG001|STARTED|Overall Study||25
3091070|NCT01441180|3813276|FG002|STARTED|Overall Study||25
3091071|NCT01441180|3813274|FG000|COMPLETED|Overall Study||9
3091072|NCT01441180|3813275|FG001|COMPLETED|Overall Study||24
3091073|NCT01441180|3813276|FG002|COMPLETED|Overall Study||22
3091074|NCT01441180|3813274|FG000|NOT COMPLETED|Overall Study||1
3091075|NCT01441180|3813275|FG001|NOT COMPLETED|Overall Study||1
3091076|NCT01441180|3813276|FG002|NOT COMPLETED|Overall Study||3
3091077|NCT01441245|3813289|FG000|STARTED|Overall Study||30
3091078|NCT01441245|3813290|FG001|STARTED|Overall Study||27
3091079|NCT01441245|3813289|FG000|COMPLETED|Overall Study||30
3091080|NCT01441245|3813290|FG001|COMPLETED|Overall Study||27
3091081|NCT01441245|3813289|FG000|NOT COMPLETED|Overall Study||0
3091082|NCT01441245|3813290|FG001|NOT COMPLETED|Overall Study||0
3091083|NCT01441401|3813312|FG000|STARTED|Overall Study||82
3091084|NCT01441401|3813312|FG000|COMPLETED|Overall Study|Number of participants whose survey form was collected was presented.|82
3091085|NCT01441401|3813312|FG000|NOT COMPLETED|Overall Study||0
3091086|NCT01441414|3813330|FG000|STARTED|Overall Study||18
3091087|NCT01441414|3813330|FG000|COMPLETED|Overall Study||3
3091088|NCT01441414|3813330|FG000|NOT COMPLETED|Overall Study||15
3091089|NCT01441440|3813349|FG000|STARTED|Overall Study|Safety analysis set|183
3091090|NCT01441440|3813350|FG001|STARTED|Overall Study|Safety analysis set|174
3091091|NCT01441440|3813351|FG002|STARTED|Overall Study|Safety analysis set|180
3091092|NCT01441440|3813349|FG000|COMPLETED|Overall Study||166
3091093|NCT01441440|3813350|FG001|COMPLETED|Overall Study||151
3091094|NCT01441440|3813351|FG002|COMPLETED|Overall Study||158
3091095|NCT01441440|3813349|FG000|NOT COMPLETED|Overall Study||17
3091096|NCT01441440|3813350|FG001|NOT COMPLETED|Overall Study||23
3091097|NCT01441440|3813351|FG002|NOT COMPLETED|Overall Study||22
3091098|NCT01441466|3813361|FG000|STARTED|Overall Study||37
3091099|NCT01441466|3813362|FG001|STARTED|Overall Study||11
3091100|NCT01441466|3813361|FG000|COMPLETED|Overall Study||37
3091101|NCT01441466|3813362|FG001|COMPLETED|Overall Study||11
3091102|NCT01441466|3813361|FG000|NOT COMPLETED|Overall Study||0
3091103|NCT01441466|3813362|FG001|NOT COMPLETED|Overall Study||0
3091104|NCT01441492|3813371|FG000|STARTED|Overall Study||197
3091105|NCT01441492|3813372|FG001|STARTED|Overall Study||202
3091106|NCT01441492|3813371|FG000|COMPLETED|Overall Study||170
3091107|NCT01441492|3813372|FG001|COMPLETED|Overall Study||174
3091108|NCT01441492|3813371|FG000|NOT COMPLETED|Overall Study||27
3289208|NCT02808312|4022815|FG002|NOT COMPLETED|Overall Study||1
3289209|NCT02808312|4022816|FG003|NOT COMPLETED|Overall Study||0
3289210|NCT02808312|4022817|FG004|NOT COMPLETED|Overall Study||0
3289211|NCT02808338|4022834|FG000|STARTED|Screening||25
3289212|NCT02808338|4022834|FG000|COMPLETED|Screening||15
3289213|NCT02808338|4022834|FG000|NOT COMPLETED|Screening||10
3091109|NCT01441492|3813372|FG001|NOT COMPLETED|Overall Study||28
3091110|NCT01441570|3813382|FG000|STARTED|Overall Study||6
3091111|NCT01441570|3813383|FG001|STARTED|Overall Study||5
3091112|NCT01441570|3813382|FG000|COMPLETED|Overall Study||6
3091113|NCT01441570|3813383|FG001|COMPLETED|Overall Study||5
3091114|NCT01441570|3813382|FG000|NOT COMPLETED|Overall Study||0
3091115|NCT01441570|3813383|FG001|NOT COMPLETED|Overall Study||0
3091116|NCT01441596|3813392|FG000|STARTED|Overall Study||40
3091117|NCT01441596|3813393|FG001|STARTED|Overall Study||38
3289214|NCT02808338|4022834|FG000|STARTED|Overnight In-lab Polysomonography||15
3091118|NCT01441596|3813394|FG002|STARTED|Overall Study||43
3091119|NCT01441596|3813392|FG000|COMPLETED|Overall Study||36
3091120|NCT01441596|3813393|FG001|COMPLETED|Overall Study||35
3091121|NCT01441596|3813394|FG002|COMPLETED|Overall Study||39
3091122|NCT01441596|3813392|FG000|NOT COMPLETED|Overall Study||4
3091123|NCT01441596|3813393|FG001|NOT COMPLETED|Overall Study||3
3091124|NCT01441596|3813394|FG002|NOT COMPLETED|Overall Study||4
3091125|NCT01441635|3813412|FG000|STARTED|Overall Study||32
3091126|NCT01441635|3813413|FG001|STARTED|Overall Study||33
3091127|NCT01441635|3813414|FG002|STARTED|Overall Study||16
3091128|NCT01441635|3813415|FG003|STARTED|Overall Study||35
3091129|NCT01441635|3813416|FG004|STARTED|Overall Study||18
3091130|NCT01441635|3813417|FG005|STARTED|Overall Study||34
3091131|NCT01441635|3813418|FG006|STARTED|Overall Study||30
3091132|NCT01441635|3813419|FG007|STARTED|Overall Study||30
3091133|NCT01441635|3813420|FG008|STARTED|Overall Study||16
3091134|NCT01441635|3813421|FG009|STARTED|Overall Study||27
3091135|NCT01441635|3813412|FG000|COMPLETED|Overall Study||26
3091136|NCT01441635|3813413|FG001|COMPLETED|Overall Study||27
3091137|NCT01441635|3813414|FG002|COMPLETED|Overall Study||13
3091138|NCT01441635|3813415|FG003|COMPLETED|Overall Study||28
3091139|NCT01441635|3813416|FG004|COMPLETED|Overall Study||16
3091140|NCT01441635|3813417|FG005|COMPLETED|Overall Study||29
3091141|NCT01441635|3813418|FG006|COMPLETED|Overall Study||24
3091142|NCT01441635|3813419|FG007|COMPLETED|Overall Study||26
3091143|NCT01441635|3813420|FG008|COMPLETED|Overall Study||14
3091144|NCT01441635|3813421|FG009|COMPLETED|Overall Study||25
3091145|NCT01441635|3813412|FG000|NOT COMPLETED|Overall Study||6
3091146|NCT01441635|3813413|FG001|NOT COMPLETED|Overall Study||6
3091147|NCT01441635|3813414|FG002|NOT COMPLETED|Overall Study||3
3091148|NCT01441635|3813415|FG003|NOT COMPLETED|Overall Study||7
3091149|NCT01441635|3813416|FG004|NOT COMPLETED|Overall Study||2
3091150|NCT01441635|3813417|FG005|NOT COMPLETED|Overall Study||5
3091151|NCT01441635|3813418|FG006|NOT COMPLETED|Overall Study||6
3091152|NCT01441635|3813419|FG007|NOT COMPLETED|Overall Study||4
3091153|NCT01441635|3813420|FG008|NOT COMPLETED|Overall Study||2
3091154|NCT01441635|3813421|FG009|NOT COMPLETED|Overall Study||2
3091155|NCT01441765|3813445|FG000|STARTED|Overall Study||11
3091156|NCT01441765|3813446|FG001|STARTED|Overall Study|not opened|0
3091157|NCT01441765|3813445|FG000|COMPLETED|Overall Study||10
3091158|NCT01441765|3813446|FG001|COMPLETED|Overall Study|not opened|0
3091159|NCT01441765|3813445|FG000|NOT COMPLETED|Overall Study||1
3091160|NCT01441765|3813446|FG001|NOT COMPLETED|Overall Study||0
3091161|NCT01441843|3813454|FG000|STARTED|Overall Study||200
3091162|NCT01441843|3813455|FG001|STARTED|Overall Study||200
3091163|NCT01441843|3813454|FG000|COMPLETED|Overall Study||188
3091164|NCT01441843|3813455|FG001|COMPLETED|Overall Study||195
3091165|NCT01441843|3813454|FG000|NOT COMPLETED|Overall Study||12
3091166|NCT01441843|3813455|FG001|NOT COMPLETED|Overall Study||5
3091167|NCT01441882|3813461|FG000|STARTED|Overall Study||19
3091168|NCT01441882|3813461|FG000|COMPLETED|Overall Study||13
3091169|NCT01441882|3813461|FG000|NOT COMPLETED|Overall Study||6
3091170|NCT01441960|3813465|FG000|STARTED|First Neuromuscular Blocking Agent:||26
3091171|NCT01441960|3813466|FG001|STARTED|First Neuromuscular Blocking Agent:||19
3091172|NCT01441960|3813465|FG000|COMPLETED|First Neuromuscular Blocking Agent:||18
3091173|NCT01441960|3813466|FG001|COMPLETED|First Neuromuscular Blocking Agent:||13
3091174|NCT01441960|3813465|FG000|NOT COMPLETED|First Neuromuscular Blocking Agent:||8
3091175|NCT01441960|3813466|FG001|NOT COMPLETED|First Neuromuscular Blocking Agent:||6
3091176|NCT01441960|3813465|FG000|STARTED|Second Neuromuscular Blocking Agent||18
3091177|NCT01441960|3813466|FG001|STARTED|Second Neuromuscular Blocking Agent||13
3091178|NCT01441960|3813465|FG000|COMPLETED|Second Neuromuscular Blocking Agent||18
3091179|NCT01441960|3813466|FG001|COMPLETED|Second Neuromuscular Blocking Agent||13
3091180|NCT01441960|3813465|FG000|NOT COMPLETED|Second Neuromuscular Blocking Agent||0
3091181|NCT01441960|3813466|FG001|NOT COMPLETED|Second Neuromuscular Blocking Agent||0
3091182|NCT01441973|3813478|FG000|STARTED|Overall Study||15
3091183|NCT01441973|3813479|FG001|STARTED|Overall Study||16
3091184|NCT01441973|3813478|FG000|COMPLETED|Overall Study|Still receiving treatment|0
3091185|NCT01441973|3813479|FG001|COMPLETED|Overall Study|Still receiving treatment|0
3091186|NCT01441973|3813478|FG000|NOT COMPLETED|Overall Study||15
3091187|NCT01441973|3813479|FG001|NOT COMPLETED|Overall Study||16
3091188|NCT01442038|3813488|FG000|STARTED|Overall Study||1332
3091189|NCT01442038|3813489|FG001|STARTED|Overall Study||1319
3091190|NCT01442038|3813488|FG000|COMPLETED|Overall Study||1029
3091191|NCT01442038|3813489|FG001|COMPLETED|Overall Study||1040
3091192|NCT01442038|3813488|FG000|NOT COMPLETED|Overall Study||303
3091193|NCT01442038|3813489|FG001|NOT COMPLETED|Overall Study||279
3091194|NCT01442064|3813501|FG000|STARTED|Overall Study||97
3091195|NCT01442064|3813502|FG001|STARTED|Overall Study||103
3091196|NCT01442064|3813503|FG002|STARTED|Overall Study||104
3091197|NCT01442064|3813504|FG003|STARTED|Overall Study||98
3091198|NCT01442064|3813505|FG004|STARTED|Overall Study||107
3091199|NCT01442064|3813506|FG005|STARTED|Overall Study||99
3091200|NCT01442064|3813501|FG000|Ranibizumab-Treated Subjects|Overall Study|Includes participants who received Ranibizumab in either the initial studies or the extension study.|93
3091201|NCT01442064|3813502|FG001|Ranibizumab-Treated Subjects|Overall Study||103
3091202|NCT01442064|3813503|FG002|Ranibizumab-Treated Subjects|Overall Study||104
3091203|NCT01442064|3813504|FG003|Ranibizumab-Treated Subjects|Overall Study||96
3091204|NCT01442064|3813505|FG004|Ranibizumab-Treated Subjects|Overall Study||107
3091205|NCT01442064|3813506|FG005|Ranibizumab-Treated Subjects|Overall Study||99
3091206|NCT01442064|3813501|FG000|Received Study Drug in Extension Study|Overall Study||61
3091207|NCT01442064|3813502|FG001|Received Study Drug in Extension Study|Overall Study||70
3091208|NCT01442064|3813503|FG002|Received Study Drug in Extension Study|Overall Study||60
3091209|NCT01442064|3813504|FG003|Received Study Drug in Extension Study|Overall Study||70
3091210|NCT01442064|3813505|FG004|Received Study Drug in Extension Study|Overall Study||89
3091211|NCT01442064|3813506|FG005|Received Study Drug in Extension Study|Overall Study||81
3091212|NCT01442064|3813501|FG000|COMPLETED|Overall Study||0
3091213|NCT01442064|3813502|FG001|COMPLETED|Overall Study||2
3091214|NCT01442064|3813503|FG002|COMPLETED|Overall Study||0
3091215|NCT01442064|3813504|FG003|COMPLETED|Overall Study||0
3091216|NCT01442064|3813505|FG004|COMPLETED|Overall Study||1
3091217|NCT01442064|3813506|FG005|COMPLETED|Overall Study||0
3091218|NCT01442064|3813501|FG000|NOT COMPLETED|Overall Study||97
3091219|NCT01442064|3813502|FG001|NOT COMPLETED|Overall Study||101
3091220|NCT01442064|3813503|FG002|NOT COMPLETED|Overall Study||104
3091221|NCT01442064|3813504|FG003|NOT COMPLETED|Overall Study||98
3091222|NCT01442064|3813505|FG004|NOT COMPLETED|Overall Study||106
3091223|NCT01442064|3813506|FG005|NOT COMPLETED|Overall Study||99
3091224|NCT01442103|3813523|FG000|STARTED|Overall Study||10
3091225|NCT01442103|3813523|FG000|COMPLETED|Overall Study||8
3091226|NCT01442103|3813523|FG000|NOT COMPLETED|Overall Study||2
3091227|NCT01442129|3813529|FG000|STARTED|Overall Study||20
3091228|NCT01442129|3813530|FG001|STARTED|Overall Study||10
3091229|NCT01442129|3813529|FG000|COMPLETED|Overall Study|Treatment withheld from 1 patient randomized before results of screening PRA known|20
3091230|NCT01442129|3813530|FG001|COMPLETED|Overall Study||10
3091231|NCT01442129|3813529|FG000|NOT COMPLETED|Overall Study||0
3091232|NCT01442129|3813530|FG001|NOT COMPLETED|Overall Study||0
3091233|NCT01442155|3813536|FG000|STARTED|Overall Study||74
3091234|NCT01442155|3813536|FG000|COMPLETED|Overall Study||9
3091235|NCT01442155|3813536|FG000|NOT COMPLETED|Overall Study||65
3091236|NCT01442181|3813542|FG000|STARTED|Overall Study||14
3091237|NCT01442181|3813543|FG001|STARTED|Overall Study||11
3091238|NCT01442181|3813542|FG000|COMPLETED|Overall Study||10
3091239|NCT01442181|3813543|FG001|COMPLETED|Overall Study||8
3091240|NCT01442181|3813542|FG000|NOT COMPLETED|Overall Study||4
3091241|NCT01442181|3813543|FG001|NOT COMPLETED|Overall Study||3
3091242|NCT01442376|3813553|FG000|STARTED|Overall Study|Randomized patients|169
3091243|NCT01442376|3813554|FG001|STARTED|Overall Study|Randomized patients|169
3091244|NCT01442376|3813555|FG002|STARTED|Overall Study|Randomized patients|164
3091245|NCT01442376|3813553|FG000|COMPLETED|Overall Study||166
3091246|NCT01442376|3813554|FG001|COMPLETED|Overall Study||160
3091247|NCT01442376|3813555|FG002|COMPLETED|Overall Study||159
3091248|NCT01442376|3813553|FG000|NOT COMPLETED|Overall Study||3
3091249|NCT01442376|3813554|FG001|NOT COMPLETED|Overall Study||9
3091250|NCT01442376|3813555|FG002|NOT COMPLETED|Overall Study||5
3091251|NCT01442493|3813565|FG000|STARTED|Overall Study||149
3091252|NCT01442493|3813566|FG001|STARTED|Overall Study||151
3091253|NCT01442493|3813565|FG000|COMPLETED|Overall Study||146
3091254|NCT01442493|3813566|FG001|COMPLETED|Overall Study||149
3091255|NCT01442493|3813565|FG000|NOT COMPLETED|Overall Study||3
3091256|NCT01442493|3813566|FG001|NOT COMPLETED|Overall Study||2
3091257|NCT01442675|3813572|FG000|STARTED|Overall Study||834
3091258|NCT01442675|3813572|FG000|Safety Analysis Set|Overall Study|Safety Analysis Set are subjects who received study vaccine and for whom safety data were available.|831
3091259|NCT01442675|3813572|FG000|Per-Protocol Analysis Set|Overall Study|The Per-Protocol Analysis Set are subjects with no pre-defined protocol deviations.|781
3091260|NCT01442675|3813572|FG000|COMPLETED|Overall Study||822
3091261|NCT01442675|3813572|FG000|NOT COMPLETED|Overall Study||12
3289215|NCT02808338|4022834|FG000|Modified Philips BiPAP ASV|Overnight In-lab Polysomonography||13
3289216|NCT02808338|4022834|FG000|ResMed S7 VPAP Adapt|Overnight In-lab Polysomonography||13
3289217|NCT02808338|4022834|FG000|Philips BiPAP AutoSV Advanced System One|Overnight In-lab Polysomonography||12
3289218|NCT02808338|4022834|FG000|ResMed S9 VPAP Adapt|Overnight In-lab Polysomonography||12
3289219|NCT02808338|4022834|FG000|COMPLETED|Overnight In-lab Polysomonography||13
3091262|NCT01442688|3813579|FG000|STARTED|First Intervention||31
3091263|NCT01442688|3813580|FG001|STARTED|First Intervention||31
3091264|NCT01442688|3813579|FG000|COMPLETED|First Intervention||29
3091265|NCT01442688|3813580|FG001|COMPLETED|First Intervention||31
3091266|NCT01442688|3813579|FG000|NOT COMPLETED|First Intervention||2
3091267|NCT01442688|3813580|FG001|NOT COMPLETED|First Intervention||0
3091268|NCT01442688|3813579|FG000|STARTED|Second Intervention||29
3091269|NCT01442688|3813580|FG001|STARTED|Second Intervention||31
3091270|NCT01442688|3813579|FG000|COMPLETED|Second Intervention||28
3091271|NCT01442688|3813580|FG001|COMPLETED|Second Intervention||31
3091272|NCT01442688|3813579|FG000|NOT COMPLETED|Second Intervention||1
3091273|NCT01442688|3813580|FG001|NOT COMPLETED|Second Intervention||0
3091274|NCT01442714|3813586|FG000|STARTED|Overall Study||33
3091275|NCT01442714|3813586|FG000|COMPLETED|Overall Study||21
3091276|NCT01442714|3813586|FG000|NOT COMPLETED|Overall Study||12
3091277|NCT01442779|3813592|FG000|STARTED|Overall Study||18
3091278|NCT01442779|3813592|FG000|COMPLETED|Overall Study||11
3091279|NCT01442779|3813592|FG000|NOT COMPLETED|Overall Study||7
3091280|NCT01442844|3813598|FG000|STARTED|Overall Study||1
3091281|NCT01442844|3813599|FG001|STARTED|Overall Study||2
3091282|NCT01442844|3813598|FG000|COMPLETED|Overall Study||1
3091283|NCT01442844|3813599|FG001|COMPLETED|Overall Study||2
3091284|NCT01442844|3813598|FG000|NOT COMPLETED|Overall Study||0
3091285|NCT01442844|3813599|FG001|NOT COMPLETED|Overall Study||0
3091286|NCT01443026|3813607|FG000|STARTED|Overall Study||29
3091287|NCT01443026|3813608|FG001|STARTED|Overall Study||37
3091288|NCT01443026|3813607|FG000|COMPLETED|Overall Study||26
3091289|NCT01443026|3813608|FG001|COMPLETED|Overall Study||32
3091290|NCT01443026|3813607|FG000|NOT COMPLETED|Overall Study||3
3091291|NCT01443026|3813608|FG001|NOT COMPLETED|Overall Study||5
3091292|NCT01443078|3813614|FG000|STARTED|Overall Study||42
3091293|NCT01443078|3813614|FG000|COMPLETED|Overall Study||13
3091294|NCT01443078|3813614|FG000|NOT COMPLETED|Overall Study||29
3091295|NCT01443130|3813624|FG000|STARTED|Overall Study||300
3091296|NCT01443130|3813625|FG001|STARTED|Overall Study||300
3091297|NCT01443130|3813626|FG002|STARTED|Overall Study||300
3091298|NCT01443130|3813627|FG003|STARTED|Overall Study||270
3091299|NCT01443130|3813628|FG004|STARTED|Overall Study||274
3091300|NCT01443130|3813629|FG005|STARTED|Overall Study||259
3091301|NCT01443130|3813624|FG000|COMPLETED|Overall Study||232
3091302|NCT01443130|3813625|FG001|COMPLETED|Overall Study||231
3091303|NCT01443130|3813626|FG002|COMPLETED|Overall Study||223
3091304|NCT01443130|3813627|FG003|COMPLETED|Overall Study||231
3091305|NCT01443130|3813628|FG004|COMPLETED|Overall Study||230
3091306|NCT01443130|3813629|FG005|COMPLETED|Overall Study||225
3091307|NCT01443130|3813624|FG000|NOT COMPLETED|Overall Study||68
3091308|NCT01443130|3813625|FG001|NOT COMPLETED|Overall Study||69
3091309|NCT01443130|3813626|FG002|NOT COMPLETED|Overall Study||77
3091310|NCT01443130|3813627|FG003|NOT COMPLETED|Overall Study||39
3091311|NCT01443130|3813628|FG004|NOT COMPLETED|Overall Study||44
3091312|NCT01443130|3813629|FG005|NOT COMPLETED|Overall Study||34
3091313|NCT01443364|3813643|FG000|STARTED|Overall Study||132
3091314|NCT01443364|3813643|FG000|COMPLETED|Overall Study||91
3091315|NCT01443364|3813643|FG000|NOT COMPLETED|Overall Study||41
3091316|NCT01443403|3813651|FG000|STARTED|Overall Study||61
3091317|NCT01443403|3813652|FG001|STARTED|Overall Study||61
3091318|NCT01443403|3813653|FG002|STARTED|Overall Study||61
3091319|NCT01443403|3813654|FG003|STARTED|Overall Study||61
3091320|NCT01443403|3813651|FG000|Received Treatment|Overall Study||61
3091321|NCT01443403|3813652|FG001|Received Treatment|Overall Study||61
3091322|NCT01443403|3813653|FG002|Received Treatment|Overall Study||60
3091323|NCT01443403|3813654|FG003|Received Treatment|Overall Study||61
3091324|NCT01443403|3813651|FG000|COMPLETED|Overall Study||55
3091325|NCT01443403|3813652|FG001|COMPLETED|Overall Study||55
3091326|NCT01443403|3813653|FG002|COMPLETED|Overall Study||54
3091327|NCT01443403|3813654|FG003|COMPLETED|Overall Study||52
3091328|NCT01443403|3813651|FG000|NOT COMPLETED|Overall Study||6
3091329|NCT01443403|3813652|FG001|NOT COMPLETED|Overall Study||6
3091330|NCT01443403|3813653|FG002|NOT COMPLETED|Overall Study||7
3091331|NCT01443403|3813654|FG003|NOT COMPLETED|Overall Study||9
3091332|NCT01443442|3813669|FG000|STARTED|Overall Study||12
3091333|NCT01443442|3813670|FG001|STARTED|Overall Study||11
3091334|NCT01443442|3813669|FG000|COMPLETED|Overall Study||12
3091335|NCT01443442|3813670|FG001|COMPLETED|Overall Study||11
3091336|NCT01443442|3813669|FG000|NOT COMPLETED|Overall Study||0
3091337|NCT01443442|3813670|FG001|NOT COMPLETED|Overall Study||0
3091338|NCT01443494|3813676|FG000|STARTED|Overall Study||19
3091339|NCT01443494|3813676|FG000|COMPLETED|Overall Study||19
3091340|NCT01443494|3813676|FG000|NOT COMPLETED|Overall Study||0
3091341|NCT01443546|3813683|FG000|STARTED|Overall Study||9
3091342|NCT01443546|3813684|FG001|STARTED|Overall Study||9
3091343|NCT01443546|3813685|FG002|STARTED|Overall Study||8
3091344|NCT01443546|3813683|FG000|COMPLETED|Overall Study||9
3091345|NCT01443546|3813684|FG001|COMPLETED|Overall Study||9
3091346|NCT01443546|3813685|FG002|COMPLETED|Overall Study||8
3091347|NCT01443546|3813683|FG000|NOT COMPLETED|Overall Study||0
3091348|NCT01443546|3813684|FG001|NOT COMPLETED|Overall Study||0
3091349|NCT01443546|3813685|FG002|NOT COMPLETED|Overall Study||0
3091350|NCT01443845|3813697|FG000|STARTED|Overall Study||1176
3091351|NCT01443845|3813698|FG001|STARTED|Overall Study||1178
3091352|NCT01443845|3813697|FG000|COMPLETED|Overall Study||922
3091353|NCT01443845|3813698|FG001|COMPLETED|Overall Study||841
3091354|NCT01443845|3813697|FG000|NOT COMPLETED|Overall Study||254
3091355|NCT01443845|3813698|FG001|NOT COMPLETED|Overall Study||337
3091356|NCT01443858|3813707|FG000|STARTED|Overall Study||25
3091357|NCT01443858|3813708|FG001|STARTED|Overall Study||25
3091358|NCT01443858|3813709|FG002|STARTED|Overall Study||25
3091359|NCT01443858|3813707|FG000|COMPLETED|Overall Study||10
3091360|NCT01443858|3813708|FG001|COMPLETED|Overall Study||12
3091361|NCT01443858|3813709|FG002|COMPLETED|Overall Study||18
3091362|NCT01443858|3813707|FG000|NOT COMPLETED|Overall Study||15
3091363|NCT01443858|3813708|FG001|NOT COMPLETED|Overall Study||13
3091364|NCT01443858|3813709|FG002|NOT COMPLETED|Overall Study||7
3091365|NCT01444027|3813720|FG000|STARTED|Overall Study||172
3091366|NCT01444027|3813721|FG001|STARTED|Overall Study||171
3091367|NCT01444027|3813722|FG002|STARTED|Overall Study||171
3091368|NCT01444027|3813720|FG000|Received Intervention as Assigned|Overall Study||168
3091369|NCT01444027|3813721|FG001|Received Intervention as Assigned|Overall Study||161
3091370|NCT01444027|3813722|FG002|Received Intervention as Assigned|Overall Study||147
3091371|NCT01444027|3813720|FG000|1 Month Follow-up|Overall Study||160
3091372|NCT01444027|3813721|FG001|1 Month Follow-up|Overall Study||159
3091373|NCT01444027|3813722|FG002|1 Month Follow-up|Overall Study||141
3091374|NCT01444027|3813720|FG000|3 Month Follow-up|Overall Study||142
3091375|NCT01444027|3813721|FG001|3 Month Follow-up|Overall Study||141
3091376|NCT01444027|3813722|FG002|3 Month Follow-up|Overall Study||133
3091377|NCT01444027|3813720|FG000|COMPLETED|Overall Study||142
3091378|NCT01444027|3813721|FG001|COMPLETED|Overall Study||141
3091379|NCT01444027|3813722|FG002|COMPLETED|Overall Study||133
3091380|NCT01444027|3813720|FG000|NOT COMPLETED|Overall Study||30
3091381|NCT01444027|3813721|FG001|NOT COMPLETED|Overall Study||30
3091382|NCT01444027|3813722|FG002|NOT COMPLETED|Overall Study||38
3091383|NCT01444287|3813730|FG000|STARTED|Period 1||22
3091384|NCT01444287|3813730|FG000|COMPLETED|Period 1||22
3091385|NCT01444287|3813730|FG000|NOT COMPLETED|Period 1||0
3091386|NCT01444287|3813730|FG000|STARTED|Period 2||22
3091387|NCT01444287|3813730|FG000|COMPLETED|Period 2||22
3091388|NCT01444287|3813730|FG000|NOT COMPLETED|Period 2||0
3091389|NCT01444287|3813730|FG000|STARTED|Period 3||22
3091390|NCT01444287|3813730|FG000|COMPLETED|Period 3||22
3091391|NCT01444287|3813730|FG000|NOT COMPLETED|Period 3||0
3091392|NCT01444287|3813730|FG000|STARTED|Period 4||22
3091393|NCT01444287|3813730|FG000|COMPLETED|Period 4||22
3091394|NCT01444287|3813730|FG000|NOT COMPLETED|Period 4||0
3091395|NCT01444300|3813746|FG000|STARTED|Overall Study||12
3091396|NCT01444300|3813747|FG001|STARTED|Overall Study||12
3091397|NCT01444300|3813746|FG000|COMPLETED|Overall Study||8
3091398|NCT01444300|3813747|FG001|COMPLETED|Overall Study||12
3091399|NCT01444300|3813746|FG000|NOT COMPLETED|Overall Study||4
3091400|NCT01444300|3813747|FG001|NOT COMPLETED|Overall Study||0
3091401|NCT01444378|3813754|FG000|STARTED|Overall Study|A total of 141 patients were enrolled into MOMENTUM|141
3091402|NCT01444378|3813754|FG000|COMPLETED|Overall Study||124
3091403|NCT01444378|3813754|FG000|NOT COMPLETED|Overall Study||17
3091404|NCT01444391|3813761|FG000|STARTED|Overall Study||42
3091405|NCT01444391|3813761|FG000|COMPLETED|Overall Study||41
3091406|NCT01444391|3813761|FG000|NOT COMPLETED|Overall Study||1
3091407|NCT01444417|3813767|FG000|STARTED|Overall Study||20
3091408|NCT01444417|3813768|FG001|STARTED|Overall Study||42
3091409|NCT01444417|3813767|FG000|Received Treatment|Overall Study||19
3091410|NCT01444417|3813768|FG001|Received Treatment|Overall Study||42
3091411|NCT01444417|3813767|FG000|COMPLETED|Overall Study||18
3091412|NCT01444417|3813768|FG001|COMPLETED|Overall Study||41
3091413|NCT01444417|3813767|FG000|NOT COMPLETED|Overall Study||2
3091414|NCT01444417|3813768|FG001|NOT COMPLETED|Overall Study||1
3091415|NCT01444430|3813776|FG000|STARTED|Overall Study||5846
3091416|NCT01444430|3813777|FG001|STARTED|Overall Study||5847
3091417|NCT01444430|3813776|FG000|COMPLETED|Overall Study||5785
3091418|NCT01444430|3813777|FG001|COMPLETED|Overall Study||5766
3091419|NCT01444430|3813776|FG000|NOT COMPLETED|Overall Study||61
3091420|NCT01444430|3813777|FG001|NOT COMPLETED|Overall Study||81
3091421|NCT01444456|3813783|FG000|STARTED|Overall Study||1262
3091422|NCT01444456|3813783|FG000|Received Darbepoetin Alfa or Other ESA|Overall Study||1158
3091423|NCT01444456|3813783|FG000|Received Darbepoetin Alfa|Overall Study||1134
3289220|NCT02808338|4022834|FG000|NOT COMPLETED|Overnight In-lab Polysomonography||2
3289221|NCT02808338|4022834|FG000|STARTED|Take Home Period||13
3289222|NCT02808338|4022834|FG000|COMPLETED|Take Home Period||13
3289223|NCT02808338|4022834|FG000|NOT COMPLETED|Take Home Period||0
3289224|NCT02808429|4022848|FG000|STARTED|Overall Study||5
3289225|NCT02808429|4022849|FG001|STARTED|Overall Study||6
3289226|NCT02808429|4022850|FG002|STARTED|Overall Study||5
3289227|NCT02808429|4022848|FG000|COMPLETED|Overall Study||2
3289228|NCT02808429|4022849|FG001|COMPLETED|Overall Study||5
3289229|NCT02808429|4022850|FG002|COMPLETED|Overall Study||3
3289230|NCT02808429|4022848|FG000|NOT COMPLETED|Overall Study||3
3289231|NCT02808429|4022849|FG001|NOT COMPLETED|Overall Study||1
3289232|NCT02808429|4022850|FG002|NOT COMPLETED|Overall Study||2
3289233|NCT02808819|4022860|FG000|STARTED|Overall Study||220
3289234|NCT02808819|4022861|FG001|STARTED|Overall Study||226
3289235|NCT02808819|4022860|FG000|Treated|Overall Study||220
3289236|NCT02808819|4022861|FG001|Treated|Overall Study||226
3289237|NCT02808819|4022860|FG000|COMPLETED|Overall Study||189
3289238|NCT02808819|4022861|FG001|COMPLETED|Overall Study||195
3289239|NCT02808819|4022860|FG000|NOT COMPLETED|Overall Study||31
3289240|NCT02808819|4022861|FG001|NOT COMPLETED|Overall Study||31
3289241|NCT02808975|4022870|FG000|STARTED|Overall Study||103
3289242|NCT02808975|4022871|FG001|STARTED|Overall Study||103
3289243|NCT02808975|4022870|FG000|COMPLETED|Overall Study||81
3289244|NCT02808975|4022871|FG001|COMPLETED|Overall Study||84
3289245|NCT02808975|4022870|FG000|NOT COMPLETED|Overall Study||22
3289246|NCT02808975|4022871|FG001|NOT COMPLETED|Overall Study||19
3289247|NCT02809053|4022879|FG000|STARTED|Overall Study||157
3289248|NCT02809053|4022880|FG001|STARTED|Overall Study||158
3289249|NCT02809053|4022879|FG000|Completed Treatment|Overall Study||156
3289250|NCT02809053|4022880|FG001|Completed Treatment|Overall Study||156
3289251|NCT02809053|4022879|FG000|COMPLETED|Overall Study||150
3091424|NCT01444456|3813783|FG000|COMPLETED|Overall Study|Defined as 4 weeks after last dose of ESA or chemotherapy or 13 weeks after enrolment|977
3091425|NCT01444456|3813783|FG000|NOT COMPLETED|Overall Study||285
3091426|NCT01444651|3813789|FG000|STARTED|Overall Study||36
3091427|NCT01444651|3813790|FG001|STARTED|Overall Study||37
3091428|NCT01444651|3813789|FG000|COMPLETED|Overall Study||25
3091429|NCT01444651|3813790|FG001|COMPLETED|Overall Study||28
3289252|NCT02809053|4022880|FG001|COMPLETED|Overall Study||152
3289253|NCT02809053|4022879|FG000|NOT COMPLETED|Overall Study||7
3289254|NCT02809053|4022880|FG001|NOT COMPLETED|Overall Study||6
3289255|NCT02809183|4022891|FG000|STARTED|Overall Study||25
3289256|NCT02809183|4022892|FG001|STARTED|Overall Study||25
3289257|NCT02809183|4022893|FG002|STARTED|Overall Study||25
3091430|NCT01444651|3813789|FG000|NOT COMPLETED|Overall Study||11
3091431|NCT01444651|3813790|FG001|NOT COMPLETED|Overall Study||9
3091432|NCT01444716|3813796|FG000|STARTED|Overall Study||34
3091433|NCT01444716|3813796|FG000|COMPLETED|Overall Study||34
3091434|NCT01444716|3813796|FG000|NOT COMPLETED|Overall Study||0
3091435|NCT01444742|3813800|FG000|STARTED|Overall Study||81
3091436|NCT01444742|3813800|FG000|COMPLETED|Overall Study||80
3091437|NCT01444742|3813800|FG000|NOT COMPLETED|Overall Study||1
3091438|NCT01444781|3813807|FG000|STARTED|Overall Study||416
3091439|NCT01444781|3813808|FG001|STARTED|Overall Study||415
3091440|NCT01444781|3813809|FG002|STARTED|Overall Study||275
3091441|NCT01444781|3813807|FG000|COMPLETED|Overall Study||413
3091442|NCT01444781|3813808|FG001|COMPLETED|Overall Study||411
3091443|NCT01444781|3813809|FG002|COMPLETED|Overall Study||272
3091444|NCT01444781|3813807|FG000|NOT COMPLETED|Overall Study||3
3091445|NCT01444781|3813808|FG001|NOT COMPLETED|Overall Study||4
3091446|NCT01444781|3813809|FG002|NOT COMPLETED|Overall Study||3
3091447|NCT01444898|3813824|FG000|STARTED|Overall Study||10
3091448|NCT01444898|3813824|FG000|COMPLETED|Overall Study||9
3091449|NCT01444898|3813824|FG000|NOT COMPLETED|Overall Study||1
3091450|NCT01444911|3813830|FG000|STARTED|Overall Study||16
3091451|NCT01444911|3813831|FG001|STARTED|Overall Study||13
3091452|NCT01444911|3813830|FG000|COMPLETED|Overall Study||8
3091453|NCT01444911|3813831|FG001|COMPLETED|Overall Study||13
3091454|NCT01444911|3813830|FG000|NOT COMPLETED|Overall Study||8
3091455|NCT01444911|3813831|FG001|NOT COMPLETED|Overall Study||0
3091456|NCT01444924|3813839|FG000|STARTED|Overall Study||31
3091457|NCT01444924|3813840|FG001|STARTED|Overall Study||33
3091458|NCT01444924|3813839|FG000|COMPLETED|Overall Study||31
3091459|NCT01444924|3813840|FG001|COMPLETED|Overall Study||33
3091460|NCT01444924|3813839|FG000|NOT COMPLETED|Overall Study||0
3091461|NCT01444924|3813840|FG001|NOT COMPLETED|Overall Study||0
3091462|NCT01445028|3813848|FG000|STARTED|Overall Study||58
3091463|NCT01445028|3813849|FG001|STARTED|Overall Study||54
3091464|NCT01445028|3813848|FG000|COMPLETED|Overall Study||58
3091465|NCT01445028|3813849|FG001|COMPLETED|Overall Study||51
3091466|NCT01445028|3813848|FG000|NOT COMPLETED|Overall Study||0
3091467|NCT01445028|3813849|FG001|NOT COMPLETED|Overall Study||3
3091468|NCT01445080|3813864|FG000|STARTED|Overall Study||7
3091469|NCT01445080|3813865|FG001|STARTED|Overall Study||5
3091470|NCT01445080|3813866|FG002|STARTED|Overall Study||12
3091471|NCT01445080|3813867|FG003|STARTED|Overall Study||8
3091472|NCT01445080|3813868|FG004|STARTED|Overall Study||4
3091473|NCT01445080|3813869|FG005|STARTED|Overall Study||9
3091474|NCT01445080|3813870|FG006|STARTED|Overall Study||2
3091475|NCT01445080|3813871|FG007|STARTED|Overall Study||5
3091476|NCT01445080|3813872|FG008|STARTED|Overall Study||18
3091477|NCT01445080|3813864|FG000|COMPLETED|Overall Study||0
3091478|NCT01445080|3813865|FG001|COMPLETED|Overall Study||0
3091479|NCT01445080|3813866|FG002|COMPLETED|Overall Study||0
3091480|NCT01445080|3813867|FG003|COMPLETED|Overall Study||0
3091481|NCT01445080|3813868|FG004|COMPLETED|Overall Study||0
3091482|NCT01445080|3813869|FG005|COMPLETED|Overall Study||0
3091483|NCT01445080|3813870|FG006|COMPLETED|Overall Study||0
3091484|NCT01445080|3813871|FG007|COMPLETED|Overall Study||0
3091485|NCT01445080|3813872|FG008|COMPLETED|Overall Study||0
3091486|NCT01445080|3813864|FG000|NOT COMPLETED|Overall Study||7
3091487|NCT01445080|3813865|FG001|NOT COMPLETED|Overall Study||5
3091488|NCT01445080|3813866|FG002|NOT COMPLETED|Overall Study||12
3091489|NCT01445080|3813867|FG003|NOT COMPLETED|Overall Study||8
3091490|NCT01445080|3813868|FG004|NOT COMPLETED|Overall Study||4
3091491|NCT01445080|3813869|FG005|NOT COMPLETED|Overall Study||9
3091492|NCT01445080|3813870|FG006|NOT COMPLETED|Overall Study||2
3091493|NCT01445080|3813871|FG007|NOT COMPLETED|Overall Study||5
3091494|NCT01445080|3813872|FG008|NOT COMPLETED|Overall Study||18
3091495|NCT01445171|3813907|FG000|STARTED|Overall Study||295
3091496|NCT01445171|3813907|FG000|Implanted With Study Device|Overall Study||287
3091497|NCT01445171|3813907|FG000|COMPLETED|Overall Study||200
3091498|NCT01445171|3813907|FG000|NOT COMPLETED|Overall Study||95
3091499|NCT01445301|3813916|FG000|STARTED|Overall Study||204
3091500|NCT01445301|3813917|FG001|STARTED|Overall Study||297
3091501|NCT01445301|3813918|FG002|STARTED|Overall Study||299
3091502|NCT01445301|3813916|FG000|COMPLETED|Overall Study||183
3091503|NCT01445301|3813917|FG001|COMPLETED|Overall Study||262
3091504|NCT01445301|3813918|FG002|COMPLETED|Overall Study||290
3091505|NCT01445301|3813916|FG000|NOT COMPLETED|Overall Study||21
3091506|NCT01445301|3813917|FG001|NOT COMPLETED|Overall Study||35
3091507|NCT01445301|3813918|FG002|NOT COMPLETED|Overall Study||9
3091508|NCT01445535|3813930|FG000|STARTED|Overall Study||3
3091509|NCT01445535|3813931|FG001|STARTED|Overall Study||3
3091510|NCT01445535|3813932|FG002|STARTED|Overall Study||3
3091511|NCT01445535|3813933|FG003|STARTED|Overall Study||6
3091512|NCT01445535|3813930|FG000|COMPLETED|Overall Study||2
3091513|NCT01445535|3813931|FG001|COMPLETED|Overall Study||3
3091514|NCT01445535|3813932|FG002|COMPLETED|Overall Study||2
3091515|NCT01445535|3813933|FG003|COMPLETED|Overall Study||4
3091516|NCT01445535|3813930|FG000|NOT COMPLETED|Overall Study||1
3091517|NCT01445535|3813931|FG001|NOT COMPLETED|Overall Study||0
3091518|NCT01445535|3813932|FG002|NOT COMPLETED|Overall Study||1
3091519|NCT01445535|3813933|FG003|NOT COMPLETED|Overall Study||2
3135109|NCT01704599|3860053|FG000|NOT COMPLETED|Overall Study||1
3135110|NCT01704651|3860082|FG000|STARTED|Overall Study||71
3135111|NCT01704651|3860083|FG001|STARTED|Overall Study||75
3135112|NCT01704651|3860082|FG000|COMPLETED|Overall Study||66
3091520|NCT01445548|3813944|FG000|STARTED|Overall Study||6
3091521|NCT01445548|3813944|FG000|COMPLETED|Overall Study||5
3091522|NCT01445548|3813944|FG000|NOT COMPLETED|Overall Study||1
3091523|NCT01445613|3813948|FG000|STARTED|30-day Follow-up||1200
3091524|NCT01445613|3813948|FG000|COMPLETED|30-day Follow-up||1165
3091525|NCT01445613|3813948|FG000|NOT COMPLETED|30-day Follow-up||35
3091526|NCT01445613|3813948|FG000|STARTED|1-year Follow-up||1165
3091527|NCT01445613|3813948|FG000|COMPLETED|1-year Follow-up||1088
3091528|NCT01445613|3813948|FG000|NOT COMPLETED|1-year Follow-up||77
3091529|NCT01445626|3813958|FG000|STARTED|Overall Study||87
3091530|NCT01445626|3813958|FG000|COMPLETED|Overall Study||87
3091531|NCT01445626|3813958|FG000|NOT COMPLETED|Overall Study||0
3091532|NCT01445652|3813964|FG000|STARTED|Overall Study||57
3091533|NCT01445652|3813965|FG001|STARTED|Overall Study||53
3091534|NCT01445652|3813964|FG000|COMPLETED|Overall Study||47
3091535|NCT01445652|3813965|FG001|COMPLETED|Overall Study||50
3091536|NCT01445652|3813964|FG000|NOT COMPLETED|Overall Study||10
3091537|NCT01445652|3813965|FG001|NOT COMPLETED|Overall Study||3
3091538|NCT01445678|3813973|FG000|STARTED|Overall Study||482
3091539|NCT01445678|3813974|FG001|STARTED|Overall Study||497
3091540|NCT01445678|3813973|FG000|COMPLETED|Overall Study||452
3091541|NCT01445678|3813974|FG001|COMPLETED|Overall Study||476
3091542|NCT01445678|3813973|FG000|NOT COMPLETED|Overall Study||30
3091543|NCT01445678|3813974|FG001|NOT COMPLETED|Overall Study||21
3091544|NCT01445730|3813980|FG000|STARTED|Overall Study||82
3091545|NCT01445730|3813980|FG000|COMPLETED|Overall Study||71
3091546|NCT01445730|3813980|FG000|NOT COMPLETED|Overall Study||11
3091547|NCT01445769|3813984|FG000|STARTED|Overall Study||45
3091548|NCT01445769|3813984|FG000|COMPLETED|Overall Study||37
3091549|NCT01445769|3813984|FG000|NOT COMPLETED|Overall Study||8
3091550|NCT01445821|3813992|FG000|STARTED|Overall Study||22
3091551|NCT01445821|3813993|FG001|STARTED|Overall Study||22
3091552|NCT01445821|3813992|FG000|COMPLETED|Overall Study||22
3091553|NCT01445821|3813993|FG001|COMPLETED|Overall Study||22
3091554|NCT01445821|3813992|FG000|NOT COMPLETED|Overall Study||0
3091555|NCT01445821|3813993|FG001|NOT COMPLETED|Overall Study||0
3091556|NCT01445847|3814001|FG000|STARTED|Overall Study||50
3091557|NCT01445847|3814002|FG001|STARTED|Overall Study||50
3091558|NCT01445847|3814001|FG000|COMPLETED|Overall Study||36
3091559|NCT01445847|3814002|FG001|COMPLETED|Overall Study||36
3091560|NCT01445847|3814001|FG000|NOT COMPLETED|Overall Study||14
3091561|NCT01445847|3814002|FG001|NOT COMPLETED|Overall Study||14
3091562|NCT01445873|3814008|FG000|STARTED|Overall Study||36
3091563|NCT01445873|3814008|FG000|COMPLETED|Overall Study||36
3091564|NCT01445873|3814008|FG000|NOT COMPLETED|Overall Study||0
3091565|NCT01445886|3814012|FG000|STARTED|Overall Study||33
3091566|NCT01445886|3814012|FG000|COMPLETED|Overall Study||28
3091567|NCT01445886|3814012|FG000|NOT COMPLETED|Overall Study||5
3091568|NCT01445951|3814021|FG000|STARTED|Overall Study||174
3091569|NCT01445951|3814022|FG001|STARTED|Overall Study||174
3091570|NCT01445951|3814023|FG002|STARTED|Overall Study||170
3091571|NCT01445951|3814021|FG000|COMPLETED|Overall Study||130
3091572|NCT01445951|3814022|FG001|COMPLETED|Overall Study||138
3091573|NCT01445951|3814023|FG002|COMPLETED|Overall Study||151
3091574|NCT01445951|3814021|FG000|NOT COMPLETED|Overall Study||44
3091575|NCT01445951|3814022|FG001|NOT COMPLETED|Overall Study||36
3091576|NCT01445951|3814023|FG002|NOT COMPLETED|Overall Study||19
3091577|NCT01446003|3814031|FG000|STARTED|Period 1||16
3091578|NCT01446003|3814032|FG001|STARTED|Period 1||15
3091579|NCT01446003|3814031|FG000|COMPLETED|Period 1||14
3091580|NCT01446003|3814032|FG001|COMPLETED|Period 1||15
3091581|NCT01446003|3814031|FG000|NOT COMPLETED|Period 1||2
3091582|NCT01446003|3814032|FG001|NOT COMPLETED|Period 1||0
3091583|NCT01446003|3814031|FG000|STARTED|Period 2||14
3091584|NCT01446003|3814032|FG001|STARTED|Period 2||15
3091585|NCT01446003|3814031|FG000|COMPLETED|Period 2||13
3091586|NCT01446003|3814032|FG001|COMPLETED|Period 2||15
3091587|NCT01446003|3814031|FG000|NOT COMPLETED|Period 2||1
3091588|NCT01446003|3814032|FG001|NOT COMPLETED|Period 2||0
3091589|NCT01446042|3814041|FG000|STARTED|Overall Study||142
3091590|NCT01446042|3814042|FG001|STARTED|Overall Study||86
3091591|NCT01446042|3814043|FG002|STARTED|Overall Study||78
3091592|NCT01446042|3814041|FG000|COMPLETED|Overall Study||122
3091593|NCT01446042|3814042|FG001|COMPLETED|Overall Study||83
3091594|NCT01446042|3814043|FG002|COMPLETED|Overall Study||69
3091595|NCT01446042|3814041|FG000|NOT COMPLETED|Overall Study||20
3091596|NCT01446042|3814042|FG001|NOT COMPLETED|Overall Study||3
3091597|NCT01446042|3814043|FG002|NOT COMPLETED|Overall Study||9
3091598|NCT01446159|3814055|FG000|STARTED|Overall Study||3
3091599|NCT01446159|3814056|FG001|STARTED|Overall Study||3
3091600|NCT01446159|3814057|FG002|STARTED|Overall Study||92
3091601|NCT01446159|3814058|FG003|STARTED|Overall Study||85
3091602|NCT01446159|3814055|FG000|COMPLETED|Overall Study||0
3091603|NCT01446159|3814056|FG001|COMPLETED|Overall Study||0
3091604|NCT01446159|3814057|FG002|COMPLETED|Overall Study||21
3091605|NCT01446159|3814058|FG003|COMPLETED|Overall Study||23
3091606|NCT01446159|3814055|FG000|NOT COMPLETED|Overall Study||3
3091607|NCT01446159|3814056|FG001|NOT COMPLETED|Overall Study||3
3091608|NCT01446159|3814057|FG002|NOT COMPLETED|Overall Study||71
3091609|NCT01446159|3814058|FG003|NOT COMPLETED|Overall Study||62
3091610|NCT01446237|3814070|FG000|STARTED|Overall Study||125
3091611|NCT01446237|3814070|FG000|COMPLETED|Overall Study||115
3091612|NCT01446237|3814070|FG000|NOT COMPLETED|Overall Study||10
3091613|NCT01446289|3814078|FG000|STARTED|Overall Study||51
3091614|NCT01446289|3814079|FG001|STARTED|Overall Study||35
3091615|NCT01446289|3814080|FG002|STARTED|Overall Study||51
3091616|NCT01446289|3814081|FG003|STARTED|Overall Study||35
3091617|NCT01446289|3814078|FG000|COMPLETED|Overall Study||50
3289258|NCT02809183|4022894|FG003|STARTED|Overall Study||26
3289259|NCT02809183|4022895|FG004|STARTED|Overall Study||6
3289260|NCT02809183|4022896|FG005|STARTED|Overall Study||28
3289261|NCT02809183|4022891|FG000|COMPLETED|Overall Study||25
3289262|NCT02809183|4022892|FG001|COMPLETED|Overall Study||25
3289263|NCT02809183|4022893|FG002|COMPLETED|Overall Study||25
3289264|NCT02809183|4022894|FG003|COMPLETED|Overall Study||26
3289265|NCT02809183|4022895|FG004|COMPLETED|Overall Study||6
3091618|NCT01446289|3814079|FG001|COMPLETED|Overall Study||35
3091619|NCT01446289|3814080|FG002|COMPLETED|Overall Study||50
3091620|NCT01446289|3814081|FG003|COMPLETED|Overall Study||35
3091621|NCT01446289|3814078|FG000|NOT COMPLETED|Overall Study||1
3091622|NCT01446289|3814079|FG001|NOT COMPLETED|Overall Study||0
3091623|NCT01446289|3814080|FG002|NOT COMPLETED|Overall Study||1
3091624|NCT01446289|3814081|FG003|NOT COMPLETED|Overall Study||0
3091625|NCT01446419|3814095|FG000|STARTED|Overall Study||147
3091626|NCT01446419|3814096|FG001|STARTED|Overall Study||78
3091627|NCT01446419|3814095|FG000|3 Month Follow-up|Overall Study||146
3091628|NCT01446419|3814096|FG001|3 Month Follow-up|Overall Study||77
3091629|NCT01446419|3814095|FG000|6 Month Follow-up|Overall Study||144
3091630|NCT01446419|3814096|FG001|6 Month Follow-up|Overall Study||77
3091631|NCT01446419|3814095|FG000|12 Month Follow-up|Overall Study||142
3091632|NCT01446419|3814096|FG001|12 Month Follow-up|Overall Study||77
3091633|NCT01446419|3814095|FG000|COMPLETED|Overall Study||142
3091634|NCT01446419|3814096|FG001|COMPLETED|Overall Study||77
3091635|NCT01446419|3814095|FG000|NOT COMPLETED|Overall Study||5
3091636|NCT01446419|3814096|FG001|NOT COMPLETED|Overall Study||1
3091637|NCT01446666|3814102|FG000|STARTED|Overall Study|Among the 423 participants who consented, 15 withdrew the consent and one died.|407
3091638|NCT01446666|3814102|FG000|COMPLETED|Overall Study||326
3091639|NCT01446666|3814102|FG000|NOT COMPLETED|Overall Study||81
3091640|NCT01446705|3814109|FG000|STARTED|Overall Study||50446
3091641|NCT01446705|3814110|FG001|STARTED|Overall Study||6627
3091642|NCT01446705|3814109|FG000|COMPLETED|Overall Study||50446
3091643|NCT01446705|3814110|FG001|COMPLETED|Overall Study||6627
3091644|NCT01446705|3814109|FG000|NOT COMPLETED|Overall Study||0
3091645|NCT01446705|3814110|FG001|NOT COMPLETED|Overall Study||0
3091646|NCT01446809|3814128|FG000|STARTED|Overall Study||14
3091647|NCT01446809|3814129|FG001|STARTED|Overall Study||7
3091648|NCT01446809|3814130|FG002|STARTED|Overall Study||2
3091649|NCT01446809|3814128|FG000|COMPLETED|Overall Study||14
3091650|NCT01446809|3814129|FG001|COMPLETED|Overall Study||7
3091651|NCT01446809|3814130|FG002|COMPLETED|Overall Study||0
3091652|NCT01446809|3814128|FG000|NOT COMPLETED|Overall Study||0
3091653|NCT01446809|3814129|FG001|NOT COMPLETED|Overall Study||0
3091654|NCT01446809|3814130|FG002|NOT COMPLETED|Overall Study||2
3091655|NCT01446874|3814142|FG000|STARTED|Overall Study||20
3091656|NCT01446874|3814143|FG001|STARTED|Overall Study||50
3091657|NCT01446874|3814144|FG002|STARTED|Overall Study||80
3091658|NCT01446874|3814142|FG000|COMPLETED|Overall Study||18
3091659|NCT01446874|3814143|FG001|COMPLETED|Overall Study||46
3091660|NCT01446874|3814144|FG002|COMPLETED|Overall Study||62
3091661|NCT01446874|3814142|FG000|NOT COMPLETED|Overall Study||2
3091662|NCT01446874|3814143|FG001|NOT COMPLETED|Overall Study||4
3091663|NCT01446874|3814144|FG002|NOT COMPLETED|Overall Study||18
3091664|NCT01446913|3814155|FG000|STARTED|Overall Study||86
3091665|NCT01446913|3814156|FG001|STARTED|Overall Study||82
3091666|NCT01446913|3814157|FG002|STARTED|Overall Study||84
3091667|NCT01446913|3814155|FG000|Patients With Sleep Study|Overall Study||53
3091668|NCT01446913|3814156|FG001|Patients With Sleep Study|Overall Study||56
3091669|NCT01446913|3814157|FG002|Patients With Sleep Study|Overall Study||29
3091670|NCT01446913|3814155|FG000|Patients With Sleep Apnea|Overall Study||39
3091671|NCT01446913|3814156|FG001|Patients With Sleep Apnea|Overall Study||45
3091672|NCT01446913|3814157|FG002|Patients With Sleep Apnea|Overall Study||21
3091673|NCT01446913|3814155|FG000|COMPLETED|Overall Study||77
3091674|NCT01446913|3814156|FG001|COMPLETED|Overall Study||73
3091675|NCT01446913|3814157|FG002|COMPLETED|Overall Study||73
3091676|NCT01446913|3814155|FG000|NOT COMPLETED|Overall Study||9
3091677|NCT01446913|3814156|FG001|NOT COMPLETED|Overall Study||9
3091678|NCT01446913|3814157|FG002|NOT COMPLETED|Overall Study||11
3091679|NCT01446965|3814173|FG000|STARTED|Randominization||1554
3091680|NCT01446965|3814174|FG001|STARTED|Randominization||794
3091681|NCT01446965|3814173|FG000|COMPLETED|Randominization||1524
3091682|NCT01446965|3814174|FG001|COMPLETED|Randominization||778
3289266|NCT02809183|4022896|FG005|COMPLETED|Overall Study||28
3091683|NCT01446965|3814173|FG000|NOT COMPLETED|Randominization||30
3091684|NCT01446965|3814174|FG001|NOT COMPLETED|Randominization||16
3091685|NCT01446965|3814173|FG000|STARTED|Participants Followed and Analyzed||1524
3091686|NCT01446965|3814174|FG001|STARTED|Participants Followed and Analyzed||778
3091687|NCT01446965|3814173|FG000|Received WCD|Participants Followed and Analyzed||1481
3091688|NCT01446965|3814174|FG001|Received WCD|Participants Followed and Analyzed||0
3091689|NCT01446965|3814173|FG000|Never Wore WCD|Participants Followed and Analyzed||43
3091690|NCT01446965|3814174|FG001|Never Wore WCD|Participants Followed and Analyzed||0
3091691|NCT01446965|3814173|FG000|Never Given WCD|Participants Followed and Analyzed||0
3091692|NCT01446965|3814174|FG001|Never Given WCD|Participants Followed and Analyzed||758
3289267|NCT02809183|4022891|FG000|NOT COMPLETED|Overall Study||0
3289268|NCT02809183|4022892|FG001|NOT COMPLETED|Overall Study||0
3091693|NCT01446965|3814173|FG000|Given WCD Out of Protocol|Participants Followed and Analyzed||0
3091694|NCT01446965|3814174|FG001|Given WCD Out of Protocol|Participants Followed and Analyzed||20
3091695|NCT01446965|3814173|FG000|COMPLETED|Participants Followed and Analyzed||1514
3091696|NCT01446965|3814174|FG001|COMPLETED|Participants Followed and Analyzed||766
3091697|NCT01446965|3814173|FG000|NOT COMPLETED|Participants Followed and Analyzed||10
3091698|NCT01446965|3814174|FG001|NOT COMPLETED|Participants Followed and Analyzed||12
3091699|NCT01447017|3814182|FG000|STARTED|Overall Study||45
3091700|NCT01447017|3814183|FG001|STARTED|Overall Study||24
3091701|NCT01447017|3814182|FG000|Performed Visit 2|Overall Study||43
3091702|NCT01447017|3814183|FG001|Performed Visit 2|Overall Study||24
3091703|NCT01447017|3814182|FG000|COMPLETED|Overall Study|In safety analysis: 42. In efficacy analyses: 40 in full analysis set, and 39 in per-protocol set.|35
3091704|NCT01447017|3814183|FG001|COMPLETED|Overall Study|In safety analysis: 24. In efficacy analyses: 24 in full analysis set, and 22 in per-protocol set.|14
3091705|NCT01447017|3814182|FG000|NOT COMPLETED|Overall Study||10
3091706|NCT01447017|3814183|FG001|NOT COMPLETED|Overall Study||10
3091707|NCT01447121|3814189|FG000|STARTED|Overall Study||118
3091708|NCT01447121|3814189|FG000|COMPLETED|Overall Study||118
3091709|NCT01447121|3814189|FG000|NOT COMPLETED|Overall Study||0
3091710|NCT01447225|3814198|FG000|STARTED|Overall Study||3
3091711|NCT01447225|3814199|FG001|STARTED|Overall Study||8
3091712|NCT01447225|3814200|FG002|STARTED|Overall Study||5
3091713|NCT01447225|3814201|FG003|STARTED|Overall Study||3
3091714|NCT01447225|3814202|FG004|STARTED|Overall Study||3
3091715|NCT01447225|3814203|FG005|STARTED|Overall Study||3
3091716|NCT01447225|3814204|FG006|STARTED|Overall Study||7
3091717|NCT01447225|3814205|FG007|STARTED|Overall Study||4
3091718|NCT01447225|3814206|FG008|STARTED|Overall Study||3
3091719|NCT01447225|3814207|FG009|STARTED|Overall Study||4
3091720|NCT01447225|3814198|FG000|COMPLETED|Overall Study||3
3091721|NCT01447225|3814199|FG001|COMPLETED|Overall Study||8
3091722|NCT01447225|3814200|FG002|COMPLETED|Overall Study||5
3091723|NCT01447225|3814201|FG003|COMPLETED|Overall Study||3
3091724|NCT01447225|3814202|FG004|COMPLETED|Overall Study||3
3091725|NCT01447225|3814203|FG005|COMPLETED|Overall Study||3
3091726|NCT01447225|3814204|FG006|COMPLETED|Overall Study||7
3091727|NCT01447225|3814205|FG007|COMPLETED|Overall Study||4
3091728|NCT01447225|3814206|FG008|COMPLETED|Overall Study||3
3091729|NCT01447225|3814207|FG009|COMPLETED|Overall Study||4
3091730|NCT01447225|3814198|FG000|NOT COMPLETED|Overall Study||0
3091731|NCT01447225|3814199|FG001|NOT COMPLETED|Overall Study||0
3091732|NCT01447225|3814200|FG002|NOT COMPLETED|Overall Study||0
3091733|NCT01447225|3814201|FG003|NOT COMPLETED|Overall Study||0
3091734|NCT01447225|3814202|FG004|NOT COMPLETED|Overall Study||0
3091735|NCT01447225|3814203|FG005|NOT COMPLETED|Overall Study||0
3091736|NCT01447225|3814204|FG006|NOT COMPLETED|Overall Study||0
3091737|NCT01447225|3814205|FG007|NOT COMPLETED|Overall Study||0
3091738|NCT01447225|3814206|FG008|NOT COMPLETED|Overall Study||0
3091739|NCT01447225|3814207|FG009|NOT COMPLETED|Overall Study||0
3091740|NCT01447407|3814243|FG000|STARTED|Overall Study||41
3091741|NCT01447407|3814244|FG001|STARTED|Overall Study||40
3091742|NCT01447407|3814245|FG002|STARTED|Overall Study||41
3091743|NCT01447407|3814246|FG003|STARTED|Overall Study||42
3091744|NCT01447407|3814243|FG000|COMPLETED|Overall Study||39
3091745|NCT01447407|3814244|FG001|COMPLETED|Overall Study||40
3091746|NCT01447407|3814245|FG002|COMPLETED|Overall Study||40
3091747|NCT01447407|3814246|FG003|COMPLETED|Overall Study||40
3091748|NCT01447407|3814243|FG000|NOT COMPLETED|Overall Study||2
3091749|NCT01447407|3814244|FG001|NOT COMPLETED|Overall Study||0
3091750|NCT01447407|3814245|FG002|NOT COMPLETED|Overall Study||1
3091751|NCT01447407|3814246|FG003|NOT COMPLETED|Overall Study||2
3091752|NCT01447420|3814259|FG000|STARTED|Overall Study||39
3091753|NCT01447420|3814260|FG001|STARTED|Overall Study||72
3091754|NCT01447420|3814261|FG002|STARTED|Overall Study||18
3091755|NCT01447420|3814259|FG000|COMPLETED|Overall Study||29
3091756|NCT01447420|3814260|FG001|COMPLETED|Overall Study||45
3091757|NCT01447420|3814261|FG002|COMPLETED|Overall Study||8
3091758|NCT01447420|3814259|FG000|NOT COMPLETED|Overall Study||10
3091759|NCT01447420|3814260|FG001|NOT COMPLETED|Overall Study||27
3091760|NCT01447420|3814261|FG002|NOT COMPLETED|Overall Study||10
3091761|NCT01447433|3814270|FG000|STARTED|Overall Study||26
3091762|NCT01447433|3814271|FG001|STARTED|Overall Study||27
3091763|NCT01447433|3814270|FG000|COMPLETED|Overall Study||22
3091764|NCT01447433|3814271|FG001|COMPLETED|Overall Study||21
3091765|NCT01447433|3814270|FG000|NOT COMPLETED|Overall Study||4
3091766|NCT01447433|3814271|FG001|NOT COMPLETED|Overall Study||6
3091767|NCT01447446|3814283|FG000|STARTED|Overall Study|Started means participants who started treatment and included in core population.|2312
3091768|NCT01447446|3814284|FG001|STARTED|Overall Study||496
3091769|NCT01447446|3814285|FG002|STARTED|Overall Study||292
3091770|NCT01447446|3814286|FG003|STARTED|Overall Study||93
3091771|NCT01447446|3814287|FG004|STARTED|Overall Study||821
3091772|NCT01447446|3814288|FG005|STARTED|Overall Study||86
3091773|NCT01447446|3814283|FG000|COMPLETED|Overall Study|Completed means the participants who completed the 24- weeks of follow-up period.|1590
3091774|NCT01447446|3814284|FG001|COMPLETED|Overall Study|Insuff.=Insufficient VR= Virological response TRT.=Treatment SVR= Sustained Virological Response|331
3091775|NCT01447446|3814285|FG002|COMPLETED|Overall Study||192
3091776|NCT01447446|3814286|FG003|COMPLETED|Overall Study||60
3091777|NCT01447446|3814287|FG004|COMPLETED|Overall Study||610
3091778|NCT01447446|3814288|FG005|COMPLETED|Overall Study||54
3091779|NCT01447446|3814283|FG000|NOT COMPLETED|Overall Study||722
3091780|NCT01447446|3814284|FG001|NOT COMPLETED|Overall Study||165
3091781|NCT01447446|3814285|FG002|NOT COMPLETED|Overall Study||100
3091782|NCT01447446|3814286|FG003|NOT COMPLETED|Overall Study||33
3091783|NCT01447446|3814287|FG004|NOT COMPLETED|Overall Study||211
3091784|NCT01447446|3814288|FG005|NOT COMPLETED|Overall Study||32
3091785|NCT01447511|3814313|FG000|STARTED|Control Period||8
3091786|NCT01447511|3814314|FG001|STARTED|Control Period||5
3091787|NCT01447511|3814315|FG002|STARTED|Control Period||9
3091788|NCT01447511|3814316|FG003|STARTED|Control Period||3
3091789|NCT01447511|3814317|FG004|STARTED|Control Period||4
3091790|NCT01447511|3814313|FG000|COMPLETED|Control Period||8
3091791|NCT01447511|3814314|FG001|COMPLETED|Control Period||5
3091792|NCT01447511|3814315|FG002|COMPLETED|Control Period||9
3091793|NCT01447511|3814316|FG003|COMPLETED|Control Period||3
3091794|NCT01447511|3814317|FG004|COMPLETED|Control Period||4
3091795|NCT01447511|3814313|FG000|NOT COMPLETED|Control Period||0
3091796|NCT01447511|3814314|FG001|NOT COMPLETED|Control Period||0
3091797|NCT01447511|3814315|FG002|NOT COMPLETED|Control Period||0
3091798|NCT01447511|3814316|FG003|NOT COMPLETED|Control Period||0
3091799|NCT01447511|3814317|FG004|NOT COMPLETED|Control Period||0
3091800|NCT01447511|3814313|FG000|STARTED|Fluconazole Period||8
3091801|NCT01447511|3814314|FG001|STARTED|Fluconazole Period||0
3091802|NCT01447511|3814315|FG002|STARTED|Fluconazole Period||9
3091803|NCT01447511|3814316|FG003|STARTED|Fluconazole Period||3
3091804|NCT01447511|3814317|FG004|STARTED|Fluconazole Period||4
3091805|NCT01447511|3814313|FG000|COMPLETED|Fluconazole Period||8
3091806|NCT01447511|3814314|FG001|COMPLETED|Fluconazole Period||0
3091807|NCT01447511|3814315|FG002|COMPLETED|Fluconazole Period||8
3091808|NCT01447511|3814316|FG003|COMPLETED|Fluconazole Period||3
3091809|NCT01447511|3814317|FG004|COMPLETED|Fluconazole Period||4
3091810|NCT01447511|3814313|FG000|NOT COMPLETED|Fluconazole Period||0
3091811|NCT01447511|3814314|FG001|NOT COMPLETED|Fluconazole Period||0
3091812|NCT01447511|3814315|FG002|NOT COMPLETED|Fluconazole Period||1
3091813|NCT01447511|3814316|FG003|NOT COMPLETED|Fluconazole Period||0
3091814|NCT01447511|3814317|FG004|NOT COMPLETED|Fluconazole Period||0
3091815|NCT01447511|3814313|FG000|STARTED|Rifampin Period||8
3091816|NCT01447511|3814314|FG001|STARTED|Rifampin Period||5
3091817|NCT01447511|3814315|FG002|STARTED|Rifampin Period||8
3091818|NCT01447511|3814316|FG003|STARTED|Rifampin Period||3
3091819|NCT01447511|3814317|FG004|STARTED|Rifampin Period||4
3091820|NCT01447511|3814313|FG000|COMPLETED|Rifampin Period||8
3091821|NCT01447511|3814314|FG001|COMPLETED|Rifampin Period||5
3091822|NCT01447511|3814315|FG002|COMPLETED|Rifampin Period||8
3091823|NCT01447511|3814316|FG003|COMPLETED|Rifampin Period||2
3091824|NCT01447511|3814317|FG004|COMPLETED|Rifampin Period||4
3091825|NCT01447511|3814313|FG000|NOT COMPLETED|Rifampin Period||0
3091826|NCT01447511|3814314|FG001|NOT COMPLETED|Rifampin Period||0
3091827|NCT01447511|3814315|FG002|NOT COMPLETED|Rifampin Period||0
3091828|NCT01447511|3814316|FG003|NOT COMPLETED|Rifampin Period||1
3091829|NCT01447511|3814317|FG004|NOT COMPLETED|Rifampin Period||0
3091830|NCT01447576|3814329|FG000|STARTED|Overall Study||1036
3091831|NCT01447576|3814329|FG000|COMPLETED|Overall Study||560
3091832|NCT01447576|3814329|FG000|NOT COMPLETED|Overall Study||476
3091833|NCT01447706|3814335|FG000|STARTED|Overall Study||140
3091834|NCT01447706|3814336|FG001|STARTED|Overall Study|3 patients enrolled but not dosed|83
3091835|NCT01447706|3814335|FG000|COMPLETED|Overall Study||140
3091836|NCT01447706|3814336|FG001|COMPLETED|Overall Study||80
3091837|NCT01447706|3814335|FG000|NOT COMPLETED|Overall Study||0
3091838|NCT01447706|3814336|FG001|NOT COMPLETED|Overall Study||3
3091839|NCT01447719|3814346|FG000|STARTED|Overall Study||152
3091840|NCT01447719|3814346|FG000|Valid AV-45 Scan Acquired|Overall Study||147
3091841|NCT01447719|3814346|FG000|Deceased <2 Years After AV-45 Scan|Overall Study||66
3091842|NCT01447719|3814346|FG000|COMPLETED|Overall Study||59
3091843|NCT01447719|3814346|FG000|NOT COMPLETED|Overall Study||93
3091844|NCT01447849|3814359|FG000|STARTED|First Intervention||10
3091845|NCT01447849|3814360|FG001|STARTED|First Intervention||10
3091846|NCT01447849|3814361|FG002|STARTED|First Intervention||10
3289269|NCT02809183|4022893|FG002|NOT COMPLETED|Overall Study||0
3289270|NCT02809183|4022894|FG003|NOT COMPLETED|Overall Study||0
3289271|NCT02809183|4022895|FG004|NOT COMPLETED|Overall Study||0
3091847|NCT01447849|3814362|FG003|STARTED|First Intervention||10
3091848|NCT01447849|3814359|FG000|COMPLETED|First Intervention||10
3091849|NCT01447849|3814360|FG001|COMPLETED|First Intervention||10
3091850|NCT01447849|3814361|FG002|COMPLETED|First Intervention||10
3091851|NCT01447849|3814362|FG003|COMPLETED|First Intervention||10
3091852|NCT01447849|3814359|FG000|NOT COMPLETED|First Intervention||0
3091853|NCT01447849|3814360|FG001|NOT COMPLETED|First Intervention||0
3091854|NCT01447849|3814361|FG002|NOT COMPLETED|First Intervention||0
3091855|NCT01447849|3814362|FG003|NOT COMPLETED|First Intervention||0
3091856|NCT01447849|3814359|FG000|STARTED|Washout Period for 1 Week||10
3091857|NCT01447849|3814360|FG001|STARTED|Washout Period for 1 Week||10
3091858|NCT01447849|3814361|FG002|STARTED|Washout Period for 1 Week||10
3091859|NCT01447849|3814362|FG003|STARTED|Washout Period for 1 Week||10
3091860|NCT01447849|3814359|FG000|COMPLETED|Washout Period for 1 Week||10
3091861|NCT01447849|3814360|FG001|COMPLETED|Washout Period for 1 Week||10
3091862|NCT01447849|3814361|FG002|COMPLETED|Washout Period for 1 Week||10
3091863|NCT01447849|3814362|FG003|COMPLETED|Washout Period for 1 Week||10
3091864|NCT01447849|3814359|FG000|NOT COMPLETED|Washout Period for 1 Week||0
3091865|NCT01447849|3814360|FG001|NOT COMPLETED|Washout Period for 1 Week||0
3091866|NCT01447849|3814361|FG002|NOT COMPLETED|Washout Period for 1 Week||0
3091867|NCT01447849|3814362|FG003|NOT COMPLETED|Washout Period for 1 Week||0
3091868|NCT01447849|3814359|FG000|STARTED|Second Intervention||10
3091869|NCT01447849|3814360|FG001|STARTED|Second Intervention||10
3091870|NCT01447849|3814361|FG002|STARTED|Second Intervention||10
3091871|NCT01447849|3814362|FG003|STARTED|Second Intervention||10
3091872|NCT01447849|3814359|FG000|COMPLETED|Second Intervention||10
3091873|NCT01447849|3814360|FG001|COMPLETED|Second Intervention||10
3091874|NCT01447849|3814361|FG002|COMPLETED|Second Intervention||10
3091875|NCT01447849|3814362|FG003|COMPLETED|Second Intervention||10
3091876|NCT01447849|3814359|FG000|NOT COMPLETED|Second Intervention||0
3091877|NCT01447849|3814360|FG001|NOT COMPLETED|Second Intervention||0
3091878|NCT01447849|3814361|FG002|NOT COMPLETED|Second Intervention||0
3091879|NCT01447849|3814362|FG003|NOT COMPLETED|Second Intervention||0
3091880|NCT01447888|3814374|FG000|STARTED|Overall Study||45
3091881|NCT01447888|3814375|FG001|STARTED|Overall Study||55
3091882|NCT01447888|3814374|FG000|COMPLETED|Overall Study||45
3091883|NCT01447888|3814375|FG001|COMPLETED|Overall Study||55
3091884|NCT01447888|3814374|FG000|NOT COMPLETED|Overall Study||0
3091885|NCT01447888|3814375|FG001|NOT COMPLETED|Overall Study||0
3091886|NCT01447914|3814381|FG000|STARTED|Overall Study||16
3091887|NCT01447914|3814381|FG000|COMPLETED|Overall Study||16
3091888|NCT01447914|3814381|FG000|NOT COMPLETED|Overall Study||0
3091889|NCT01447927|3814387|FG000|STARTED|Overall Study||38
3091890|NCT01447927|3814388|FG001|STARTED|Overall Study||36
3091891|NCT01447927|3814387|FG000|COMPLETED|Overall Study||33
3091892|NCT01447927|3814388|FG001|COMPLETED|Overall Study||33
3091893|NCT01447927|3814387|FG000|NOT COMPLETED|Overall Study||5
3091894|NCT01447927|3814388|FG001|NOT COMPLETED|Overall Study||3
3091895|NCT01448044|3814396|FG000|STARTED|Treatment Period||82
3091896|NCT01448044|3814397|FG001|STARTED|Treatment Period||42
3091897|NCT01448044|3814396|FG000|COMPLETED|Treatment Period||59
3091898|NCT01448044|3814397|FG001|COMPLETED|Treatment Period||26
3091899|NCT01448044|3814396|FG000|NOT COMPLETED|Treatment Period||23
3091900|NCT01448044|3814397|FG001|NOT COMPLETED|Treatment Period||16
3091901|NCT01448044|3814396|FG000|STARTED|Follow Up Period|Out of 82 participants who entered the treatment period, 77 continued in the follow-up period.|77
3091902|NCT01448044|3814397|FG001|STARTED|Follow Up Period|Out of 42 participants who entered the treatment period, 40 continued in the follow-up period.|40
3091903|NCT01448044|3814396|FG000|COMPLETED|Follow Up Period||65
3091904|NCT01448044|3814397|FG001|COMPLETED|Follow Up Period||26
3091905|NCT01448044|3814396|FG000|NOT COMPLETED|Follow Up Period||12
3091906|NCT01448044|3814397|FG001|NOT COMPLETED|Follow Up Period||14
3091907|NCT01448057|3814405|FG000|STARTED|Overall Study||170
3091908|NCT01448057|3814406|FG001|STARTED|Overall Study||171
3091909|NCT01448057|3814405|FG000|COMPLETED|Overall Study||162
3091910|NCT01448057|3814406|FG001|COMPLETED|Overall Study||167
3091911|NCT01448057|3814405|FG000|NOT COMPLETED|Overall Study||8
3091912|NCT01448057|3814406|FG001|NOT COMPLETED|Overall Study||4
3091913|NCT01448213|3814414|FG000|STARTED|Overall Study||130
3091914|NCT01448213|3814415|FG001|STARTED|Overall Study||134
3091915|NCT01448213|3814414|FG000|COMPLETED|Overall Study||113
3091916|NCT01448213|3814415|FG001|COMPLETED|Overall Study||112
3091917|NCT01448213|3814414|FG000|NOT COMPLETED|Overall Study||17
3091918|NCT01448213|3814415|FG001|NOT COMPLETED|Overall Study||22
3091919|NCT01448356|3814421|FG000|STARTED|Overall Study||10
3091920|NCT01448356|3814421|FG000|COMPLETED|Overall Study|cross-over|10
3091921|NCT01448356|3814421|FG000|NOT COMPLETED|Overall Study||0
3091922|NCT01448421|3814426|FG000|STARTED|Overall Study||37
3091923|NCT01448421|3814426|FG000|COMPLETED|Overall Study||37
3091924|NCT01448421|3814426|FG000|NOT COMPLETED|Overall Study||0
3091925|NCT01448447|3814432|FG000|STARTED|Overall Study||20
3091926|NCT01448447|3814433|FG001|STARTED|Overall Study||0
3091927|NCT01448447|3814432|FG000|COMPLETED|Overall Study||20
3091928|NCT01448447|3814433|FG001|COMPLETED|Overall Study||0
3091929|NCT01448447|3814432|FG000|NOT COMPLETED|Overall Study||0
3091930|NCT01448447|3814433|FG001|NOT COMPLETED|Overall Study||0
3091931|NCT01448486|3814441|FG000|STARTED|Overall Study||3
3091932|NCT01448486|3814442|FG001|STARTED|Overall Study||3
3091933|NCT01448486|3814441|FG000|COMPLETED|Overall Study||3
3091934|NCT01448486|3814442|FG001|COMPLETED|Overall Study||3
3091935|NCT01448486|3814441|FG000|NOT COMPLETED|Overall Study||0
3091936|NCT01448486|3814442|FG001|NOT COMPLETED|Overall Study||0
3091937|NCT01448525|3814450|FG000|STARTED|Overall Study||44
3091938|NCT01448525|3814451|FG001|STARTED|Overall Study||44
3091939|NCT01448525|3814450|FG000|COMPLETED|Overall Study||43
3091940|NCT01448525|3814451|FG001|COMPLETED|Overall Study||42
3091941|NCT01448525|3814450|FG000|NOT COMPLETED|Overall Study||1
3091942|NCT01448525|3814451|FG001|NOT COMPLETED|Overall Study||2
3091943|NCT01448616|3814460|FG000|STARTED|Lead-In (Observational Phase)||73
3091944|NCT01448616|3814461|FG001|STARTED|Lead-In (Observational Phase)|N/A during observational phase as participants randomized subsequently|0
3091945|NCT01448616|3814462|FG002|STARTED|Lead-In (Observational Phase)|N/A during observational phase as participants randomized subsequently|0
3091946|NCT01448616|3814463|FG003|STARTED|Lead-In (Observational Phase)|N/A during observational phase as participants randomized subsequently|0
3091947|NCT01448616|3814460|FG000|COMPLETED|Lead-In (Observational Phase)|Participants who swabbed >90% completed this phase and were randomized to treatment 2:2:1.|64
3091948|NCT01448616|3814461|FG001|COMPLETED|Lead-In (Observational Phase)|completed >90% of sample collection to qualify for randomization for next phase|0
3091949|NCT01448616|3814462|FG002|COMPLETED|Lead-In (Observational Phase)||0
3091950|NCT01448616|3814463|FG003|COMPLETED|Lead-In (Observational Phase)||0
3091951|NCT01448616|3814460|FG000|NOT COMPLETED|Lead-In (Observational Phase)||9
3091952|NCT01448616|3814461|FG001|NOT COMPLETED|Lead-In (Observational Phase)||0
3091953|NCT01448616|3814462|FG002|NOT COMPLETED|Lead-In (Observational Phase)||0
3091954|NCT01448616|3814463|FG003|NOT COMPLETED|Lead-In (Observational Phase)||0
3091955|NCT01448616|3814460|FG000|STARTED|Study Drug (Treatment Phase)|All qualifying participants from this group moved to treatment group.|0
3091956|NCT01448616|3814461|FG001|STARTED|Study Drug (Treatment Phase)||24
3091957|NCT01448616|3814462|FG002|STARTED|Study Drug (Treatment Phase)||27
3091958|NCT01448616|3814463|FG003|STARTED|Study Drug (Treatment Phase)||13
3091959|NCT01448616|3814460|FG000|COMPLETED|Study Drug (Treatment Phase)||0
3091960|NCT01448616|3814461|FG001|COMPLETED|Study Drug (Treatment Phase)||22
3091961|NCT01448616|3814462|FG002|COMPLETED|Study Drug (Treatment Phase)||23
3091962|NCT01448616|3814463|FG003|COMPLETED|Study Drug (Treatment Phase)||9
3091963|NCT01448616|3814460|FG000|NOT COMPLETED|Study Drug (Treatment Phase)||0
3091964|NCT01448616|3814461|FG001|NOT COMPLETED|Study Drug (Treatment Phase)||2
3091965|NCT01448616|3814462|FG002|NOT COMPLETED|Study Drug (Treatment Phase)||4
3091966|NCT01448616|3814463|FG003|NOT COMPLETED|Study Drug (Treatment Phase)||4
3091967|NCT01448707|3814478|FG000|STARTED|Overall Study||137
3091968|NCT01448707|3814479|FG001|STARTED|Overall Study||136
3091969|NCT01448707|3814478|FG000|COMPLETED|Overall Study||119
3091970|NCT01448707|3814479|FG001|COMPLETED|Overall Study||118
3091971|NCT01448707|3814478|FG000|NOT COMPLETED|Overall Study||18
3091972|NCT01448707|3814479|FG001|NOT COMPLETED|Overall Study||18
3091973|NCT01448824|3814493|FG000|STARTED|Part 1 Period 1: Multiple Ascending Dose||12
3091974|NCT01448824|3814494|FG001|STARTED|Part 1 Period 1: Multiple Ascending Dose||4
3091975|NCT01448824|3814495|FG002|STARTED|Part 1 Period 1: Multiple Ascending Dose||4
3091976|NCT01448824|3814496|FG003|STARTED|Part 1 Period 1: Multiple Ascending Dose||10
3091977|NCT01448824|3814497|FG004|STARTED|Part 1 Period 1: Multiple Ascending Dose||16
3091978|NCT01448824|3814498|FG005|STARTED|Part 1 Period 1: Multiple Ascending Dose||12
3091979|NCT01448824|3814499|FG006|STARTED|Part 1 Period 1: Multiple Ascending Dose||12
3091980|NCT01448824|3814500|FG007|STARTED|Part 1 Period 1: Multiple Ascending Dose||0
3091981|NCT01448824|3814493|FG000|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||12
3091982|NCT01448824|3814494|FG001|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||4
3091983|NCT01448824|3814495|FG002|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||4
3091984|NCT01448824|3814496|FG003|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||10
3091985|NCT01448824|3814497|FG004|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||16
3091986|NCT01448824|3814498|FG005|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||12
3091987|NCT01448824|3814499|FG006|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||12
3091988|NCT01448824|3814500|FG007|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||0
3091989|NCT01448824|3814493|FG000|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||12
3091990|NCT01448824|3814494|FG001|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||4
3091991|NCT01448824|3814495|FG002|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||4
3091992|NCT01448824|3814496|FG003|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||9
3091993|NCT01448824|3814497|FG004|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||14
3091994|NCT01448824|3814498|FG005|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||10
3091995|NCT01448824|3814499|FG006|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||11
3091996|NCT01448824|3814500|FG007|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||0
3091997|NCT01448824|3814493|FG000|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||0
3091998|NCT01448824|3814494|FG001|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||0
3091999|NCT01448824|3814495|FG002|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||0
3092000|NCT01448824|3814496|FG003|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||1
3092001|NCT01448824|3814497|FG004|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||2
3092002|NCT01448824|3814498|FG005|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||2
3092003|NCT01448824|3814499|FG006|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||1
3092004|NCT01448824|3814500|FG007|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||0
3092005|NCT01448824|3814493|FG000|STARTED|Part 1: Washout Period||12
3092006|NCT01448824|3814494|FG001|STARTED|Part 1: Washout Period||4
3092007|NCT01448824|3814495|FG002|STARTED|Part 1: Washout Period||4
3092008|NCT01448824|3814496|FG003|STARTED|Part 1: Washout Period|Participants in Part 1 Cohorts B through D participated in Period 1 only.|0
3092009|NCT01448824|3814497|FG004|STARTED|Part 1: Washout Period|Participants in Part 1 Cohort B participated in Period 1 only.|0
3092010|NCT01448824|3814498|FG005|STARTED|Part 1: Washout Period|Participants in Part 1 Cohort C participated in Period 1 only.|0
3092011|NCT01448824|3814499|FG006|STARTED|Part 1: Washout Period|Participants in Part 1 Cohort D participated in Period 1 only.|0
3092012|NCT01448824|3814500|FG007|STARTED|Part 1: Washout Period||0
3092013|NCT01448824|3814493|FG000|COMPLETED|Part 1: Washout Period||11
3092014|NCT01448824|3814494|FG001|COMPLETED|Part 1: Washout Period||4
3092015|NCT01448824|3814495|FG002|COMPLETED|Part 1: Washout Period||4
3092016|NCT01448824|3814496|FG003|COMPLETED|Part 1: Washout Period||0
3092017|NCT01448824|3814497|FG004|COMPLETED|Part 1: Washout Period||0
3092018|NCT01448824|3814498|FG005|COMPLETED|Part 1: Washout Period||0
3092019|NCT01448824|3814499|FG006|COMPLETED|Part 1: Washout Period||0
3092020|NCT01448824|3814500|FG007|COMPLETED|Part 1: Washout Period||0
3092021|NCT01448824|3814493|FG000|NOT COMPLETED|Part 1: Washout Period||1
3092022|NCT01448824|3814494|FG001|NOT COMPLETED|Part 1: Washout Period||0
3092023|NCT01448824|3814495|FG002|NOT COMPLETED|Part 1: Washout Period||0
3092024|NCT01448824|3814496|FG003|NOT COMPLETED|Part 1: Washout Period||0
3092025|NCT01448824|3814497|FG004|NOT COMPLETED|Part 1: Washout Period||0
3092026|NCT01448824|3814498|FG005|NOT COMPLETED|Part 1: Washout Period||0
3092027|NCT01448824|3814499|FG006|NOT COMPLETED|Part 1: Washout Period||0
3092028|NCT01448824|3814500|FG007|NOT COMPLETED|Part 1: Washout Period||0
3092029|NCT01448824|3814493|FG000|STARTED|Part 1 Period 2: Multiple Ascending Dose||11
3092030|NCT01448824|3814494|FG001|STARTED|Part 1 Period 2: Multiple Ascending Dose||4
3092031|NCT01448824|3814495|FG002|STARTED|Part 1 Period 2: Multiple Ascending Dose||4
3092032|NCT01448824|3814496|FG003|STARTED|Part 1 Period 2: Multiple Ascending Dose|Participants in Part 1 Cohorts B through D participated in Period 1 only.|0
3092033|NCT01448824|3814497|FG004|STARTED|Part 1 Period 2: Multiple Ascending Dose|Participants in Part 1 Cohort B participated in Period 1 only.|0
3092034|NCT01448824|3814498|FG005|STARTED|Part 1 Period 2: Multiple Ascending Dose|Participants in Part 1 Cohort C participated in Period 1 only.|0
3092035|NCT01448824|3814499|FG006|STARTED|Part 1 Period 2: Multiple Ascending Dose|Participants in Part 1 Cohort D participated in Period 1 only.|0
3092036|NCT01448824|3814500|FG007|STARTED|Part 1 Period 2: Multiple Ascending Dose||0
3092037|NCT01448824|3814493|FG000|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||11
3092038|NCT01448824|3814494|FG001|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||4
3092039|NCT01448824|3814495|FG002|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||4
3092040|NCT01448824|3814496|FG003|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||0
3092041|NCT01448824|3814497|FG004|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||0
3092042|NCT01448824|3814498|FG005|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||0
3092043|NCT01448824|3814499|FG006|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||0
3092044|NCT01448824|3814500|FG007|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||0
3092045|NCT01448824|3814493|FG000|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||11
3092046|NCT01448824|3814494|FG001|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||4
3092047|NCT01448824|3814495|FG002|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||4
3092048|NCT01448824|3814496|FG003|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
3092049|NCT01448824|3814497|FG004|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
3092050|NCT01448824|3814498|FG005|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
3092051|NCT01448824|3814499|FG006|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
3092052|NCT01448824|3814500|FG007|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
3092053|NCT01448824|3814493|FG000|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
3092054|NCT01448824|3814494|FG001|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
3092055|NCT01448824|3814495|FG002|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
3092056|NCT01448824|3814496|FG003|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
3092057|NCT01448824|3814497|FG004|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
3092058|NCT01448824|3814498|FG005|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
3092059|NCT01448824|3814499|FG006|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
3092060|NCT01448824|3814500|FG007|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
3092061|NCT01448824|3814493|FG000|STARTED|Part 2 Period 1: Drug-drug Interaction||0
3092062|NCT01448824|3814494|FG001|STARTED|Part 2 Period 1: Drug-drug Interaction||0
3092063|NCT01448824|3814495|FG002|STARTED|Part 2 Period 1: Drug-drug Interaction||0
3092064|NCT01448824|3814496|FG003|STARTED|Part 2 Period 1: Drug-drug Interaction||0
3092065|NCT01448824|3814497|FG004|STARTED|Part 2 Period 1: Drug-drug Interaction||0
3092066|NCT01448824|3814498|FG005|STARTED|Part 2 Period 1: Drug-drug Interaction||0
3092067|NCT01448824|3814499|FG006|STARTED|Part 2 Period 1: Drug-drug Interaction||0
3092068|NCT01448824|3814500|FG007|STARTED|Part 2 Period 1: Drug-drug Interaction||12
3092069|NCT01448824|3814493|FG000|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||0
3092070|NCT01448824|3814494|FG001|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||0
3092071|NCT01448824|3814495|FG002|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||0
3092072|NCT01448824|3814496|FG003|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||0
3092073|NCT01448824|3814497|FG004|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||0
3092074|NCT01448824|3814498|FG005|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||0
3092075|NCT01448824|3814499|FG006|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||0
3092076|NCT01448824|3814500|FG007|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||12
3092077|NCT01448824|3814493|FG000|COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
3092078|NCT01448824|3814494|FG001|COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
3092079|NCT01448824|3814495|FG002|COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
3092080|NCT01448824|3814496|FG003|COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
3092081|NCT01448824|3814497|FG004|COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
3092082|NCT01448824|3814498|FG005|COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
3092083|NCT01448824|3814499|FG006|COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
3092084|NCT01448824|3814500|FG007|COMPLETED|Part 2 Period 1: Drug-drug Interaction||11
3092085|NCT01448824|3814493|FG000|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
3092086|NCT01448824|3814494|FG001|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
3092087|NCT01448824|3814495|FG002|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
3092088|NCT01448824|3814496|FG003|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
3092089|NCT01448824|3814497|FG004|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
3092090|NCT01448824|3814498|FG005|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
3092091|NCT01448824|3814499|FG006|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
3092092|NCT01448824|3814500|FG007|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||1
3092093|NCT01448824|3814493|FG000|STARTED|Part 2: Washout Period||0
3092094|NCT01448824|3814494|FG001|STARTED|Part 2: Washout Period||0
3092095|NCT01448824|3814495|FG002|STARTED|Part 2: Washout Period||0
3092096|NCT01448824|3814496|FG003|STARTED|Part 2: Washout Period||0
3092097|NCT01448824|3814497|FG004|STARTED|Part 2: Washout Period||0
3092098|NCT01448824|3814498|FG005|STARTED|Part 2: Washout Period||0
3092099|NCT01448824|3814499|FG006|STARTED|Part 2: Washout Period||0
3092100|NCT01448824|3814500|FG007|STARTED|Part 2: Washout Period||11
3092101|NCT01448824|3814493|FG000|COMPLETED|Part 2: Washout Period||0
3092102|NCT01448824|3814494|FG001|COMPLETED|Part 2: Washout Period||0
3092103|NCT01448824|3814495|FG002|COMPLETED|Part 2: Washout Period||0
3092104|NCT01448824|3814496|FG003|COMPLETED|Part 2: Washout Period||0
3092105|NCT01448824|3814497|FG004|COMPLETED|Part 2: Washout Period||0
3092106|NCT01448824|3814498|FG005|COMPLETED|Part 2: Washout Period||0
3092107|NCT01448824|3814499|FG006|COMPLETED|Part 2: Washout Period||0
3092108|NCT01448824|3814500|FG007|COMPLETED|Part 2: Washout Period||11
3092109|NCT01448824|3814493|FG000|NOT COMPLETED|Part 2: Washout Period||0
3092110|NCT01448824|3814494|FG001|NOT COMPLETED|Part 2: Washout Period||0
3092111|NCT01448824|3814495|FG002|NOT COMPLETED|Part 2: Washout Period||0
3092112|NCT01448824|3814496|FG003|NOT COMPLETED|Part 2: Washout Period||0
3092113|NCT01448824|3814497|FG004|NOT COMPLETED|Part 2: Washout Period||0
3092114|NCT01448824|3814498|FG005|NOT COMPLETED|Part 2: Washout Period||0
3092115|NCT01448824|3814499|FG006|NOT COMPLETED|Part 2: Washout Period||0
3092116|NCT01448824|3814500|FG007|NOT COMPLETED|Part 2: Washout Period||0
3092117|NCT01448824|3814493|FG000|STARTED|Part 2 Period 2: Drug-drug Interaction||0
3092118|NCT01448824|3814494|FG001|STARTED|Part 2 Period 2: Drug-drug Interaction||0
3092119|NCT01448824|3814495|FG002|STARTED|Part 2 Period 2: Drug-drug Interaction||0
3092120|NCT01448824|3814496|FG003|STARTED|Part 2 Period 2: Drug-drug Interaction||0
3092121|NCT01448824|3814497|FG004|STARTED|Part 2 Period 2: Drug-drug Interaction||0
3092122|NCT01448824|3814498|FG005|STARTED|Part 2 Period 2: Drug-drug Interaction||0
3092123|NCT01448824|3814499|FG006|STARTED|Part 2 Period 2: Drug-drug Interaction||0
3092124|NCT01448824|3814500|FG007|STARTED|Part 2 Period 2: Drug-drug Interaction||11
3092125|NCT01448824|3814493|FG000|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||0
3092126|NCT01448824|3814494|FG001|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||0
3092127|NCT01448824|3814495|FG002|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||0
3092128|NCT01448824|3814496|FG003|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||0
3092129|NCT01448824|3814497|FG004|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||0
3092130|NCT01448824|3814498|FG005|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||0
3092131|NCT01448824|3814499|FG006|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||0
3092132|NCT01448824|3814500|FG007|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||11
3092133|NCT01448824|3814493|FG000|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||0
3092134|NCT01448824|3814494|FG001|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||0
3092135|NCT01448824|3814495|FG002|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||0
3092136|NCT01448824|3814496|FG003|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||0
3092137|NCT01448824|3814497|FG004|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||0
3092138|NCT01448824|3814498|FG005|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||0
3092139|NCT01448824|3814499|FG006|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||0
3092140|NCT01448824|3814500|FG007|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||10
3092141|NCT01448824|3814493|FG000|COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
3092142|NCT01448824|3814494|FG001|COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
3092143|NCT01448824|3814495|FG002|COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
3092144|NCT01448824|3814496|FG003|COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
3092145|NCT01448824|3814497|FG004|COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
3092146|NCT01448824|3814498|FG005|COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
3092147|NCT01448824|3814499|FG006|COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
3092148|NCT01448824|3814500|FG007|COMPLETED|Part 2 Period 2: Drug-drug Interaction||8
3092149|NCT01448824|3814493|FG000|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
3092150|NCT01448824|3814494|FG001|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
3092151|NCT01448824|3814495|FG002|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
3092152|NCT01448824|3814496|FG003|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
3092153|NCT01448824|3814497|FG004|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
3092154|NCT01448824|3814498|FG005|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
3092155|NCT01448824|3814499|FG006|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
3092156|NCT01448824|3814500|FG007|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||3
3092157|NCT01448850|3814530|FG000|STARTED|Overall Study||164
3092158|NCT01448850|3814531|FG001|STARTED|Overall Study||160
3092159|NCT01448850|3814530|FG000|COMPLETED|Overall Study||130
3092160|NCT01448850|3814531|FG001|COMPLETED|Overall Study||120
3092161|NCT01448850|3814530|FG000|NOT COMPLETED|Overall Study||34
3092162|NCT01448850|3814531|FG001|NOT COMPLETED|Overall Study||40
3092163|NCT01449006|3814540|FG000|STARTED|Overall Study||8
3092164|NCT01449006|3814541|FG001|STARTED|Overall Study||9
3092165|NCT01449006|3814540|FG000|COMPLETED|Overall Study||5
3092166|NCT01449006|3814541|FG001|COMPLETED|Overall Study||9
3092167|NCT01449006|3814540|FG000|NOT COMPLETED|Overall Study||3
3092168|NCT01449006|3814541|FG001|NOT COMPLETED|Overall Study||0
3092169|NCT01449240|3814547|FG000|STARTED|Overall Study||10
3092170|NCT01449240|3814547|FG000|COMPLETED|Overall Study||10
3092171|NCT01449240|3814547|FG000|NOT COMPLETED|Overall Study||0
3092172|NCT01449266|3814551|FG000|STARTED|Overall Study||10
3092173|NCT01449266|3814551|FG000|COMPLETED|Overall Study||10
3092174|NCT01449266|3814551|FG000|NOT COMPLETED|Overall Study||0
3092175|NCT01449279|3814555|FG000|STARTED|Overall Study||22
3092176|NCT01449279|3814555|FG000|COMPLETED|Overall Study||15
3092177|NCT01449279|3814555|FG000|NOT COMPLETED|Overall Study||7
3092178|NCT01449305|3814559|FG000|STARTED|Overall Study||44
3092179|NCT01449305|3814559|FG000|COMPLETED|Overall Study||42
3092180|NCT01449305|3814559|FG000|NOT COMPLETED|Overall Study||2
3092181|NCT01449370|3814588|FG000|STARTED|Overall Study||6
3092182|NCT01449370|3814589|FG001|STARTED|Overall Study||6
3092183|NCT01449370|3814590|FG002|STARTED|Overall Study||8
3092184|NCT01449370|3814591|FG003|STARTED|Overall Study||4
3092185|NCT01449370|3814592|FG004|STARTED|Overall Study||3
3092186|NCT01449370|3814593|FG005|STARTED|Overall Study||3
3092187|NCT01449370|3814594|FG006|STARTED|Overall Study||3
3092188|NCT01449370|3814595|FG007|STARTED|Overall Study||3
3092189|NCT01449370|3814596|FG008|STARTED|Overall Study||12
3092190|NCT01449370|3814597|FG009|STARTED|Overall Study||3
3092191|NCT01449370|3814598|FG010|STARTED|Overall Study||3
3092192|NCT01449370|3814599|FG011|STARTED|Overall Study||3
3092193|NCT01449370|3814600|FG012|STARTED|Overall Study||3
3092194|NCT01449370|3814601|FG013|STARTED|Overall Study||11
3092195|NCT01449370|3814602|FG014|STARTED|Overall Study||3
3092196|NCT01449370|3814603|FG015|STARTED|Overall Study||3
3092197|NCT01449370|3814604|FG016|STARTED|Overall Study||7
3092198|NCT01449370|3814605|FG017|STARTED|Overall Study||3
3092199|NCT01449370|3814606|FG018|STARTED|Overall Study||3
3092200|NCT01449370|3814607|FG019|STARTED|Overall Study||3
3092201|NCT01449370|3814608|FG020|STARTED|Overall Study||6
3092202|NCT01449370|3814609|FG021|STARTED|Overall Study||4
3092203|NCT01449370|3814610|FG022|STARTED|Overall Study||4
3092204|NCT01449370|3814611|FG023|STARTED|Overall Study||10
3092205|NCT01449370|3814612|FG024|STARTED|Overall Study||8
3092206|NCT01449370|3814588|FG000|COMPLETED|Overall Study||0
3092207|NCT01449370|3814589|FG001|COMPLETED|Overall Study||0
3092208|NCT01449370|3814590|FG002|COMPLETED|Overall Study||0
3092209|NCT01449370|3814591|FG003|COMPLETED|Overall Study||0
3092210|NCT01449370|3814592|FG004|COMPLETED|Overall Study||0
3092211|NCT01449370|3814593|FG005|COMPLETED|Overall Study||0
3092212|NCT01449370|3814594|FG006|COMPLETED|Overall Study||0
3092213|NCT01449370|3814595|FG007|COMPLETED|Overall Study||0
3092214|NCT01449370|3814596|FG008|COMPLETED|Overall Study||0
3092215|NCT01449370|3814597|FG009|COMPLETED|Overall Study||0
3092216|NCT01449370|3814598|FG010|COMPLETED|Overall Study||0
3092217|NCT01449370|3814599|FG011|COMPLETED|Overall Study||0
3092218|NCT01449370|3814600|FG012|COMPLETED|Overall Study||0
3092219|NCT01449370|3814601|FG013|COMPLETED|Overall Study||0
3092220|NCT01449370|3814602|FG014|COMPLETED|Overall Study||0
3092221|NCT01449370|3814603|FG015|COMPLETED|Overall Study||0
3092222|NCT01449370|3814604|FG016|COMPLETED|Overall Study||0
3092223|NCT01449370|3814605|FG017|COMPLETED|Overall Study||0
3092224|NCT01449370|3814606|FG018|COMPLETED|Overall Study||0
3092225|NCT01449370|3814607|FG019|COMPLETED|Overall Study||0
3092226|NCT01449370|3814608|FG020|COMPLETED|Overall Study||0
3092227|NCT01449370|3814609|FG021|COMPLETED|Overall Study||0
3092228|NCT01449370|3814610|FG022|COMPLETED|Overall Study||0
3092229|NCT01449370|3814611|FG023|COMPLETED|Overall Study||0
3092230|NCT01449370|3814612|FG024|COMPLETED|Overall Study||0
3092231|NCT01449370|3814588|FG000|NOT COMPLETED|Overall Study||6
3092232|NCT01449370|3814589|FG001|NOT COMPLETED|Overall Study||6
3092233|NCT01449370|3814590|FG002|NOT COMPLETED|Overall Study||8
3092234|NCT01449370|3814591|FG003|NOT COMPLETED|Overall Study||4
3092235|NCT01449370|3814592|FG004|NOT COMPLETED|Overall Study||3
3092236|NCT01449370|3814593|FG005|NOT COMPLETED|Overall Study||3
3092237|NCT01449370|3814594|FG006|NOT COMPLETED|Overall Study||3
3092238|NCT01449370|3814595|FG007|NOT COMPLETED|Overall Study||3
3092239|NCT01449370|3814596|FG008|NOT COMPLETED|Overall Study||12
3092240|NCT01449370|3814597|FG009|NOT COMPLETED|Overall Study||3
3092241|NCT01449370|3814598|FG010|NOT COMPLETED|Overall Study||3
3092242|NCT01449370|3814599|FG011|NOT COMPLETED|Overall Study||3
3092243|NCT01449370|3814600|FG012|NOT COMPLETED|Overall Study||3
3092244|NCT01449370|3814601|FG013|NOT COMPLETED|Overall Study||11
3092245|NCT01449370|3814602|FG014|NOT COMPLETED|Overall Study||3
3092246|NCT01449370|3814603|FG015|NOT COMPLETED|Overall Study||3
3092247|NCT01449370|3814604|FG016|NOT COMPLETED|Overall Study||7
3092248|NCT01449370|3814605|FG017|NOT COMPLETED|Overall Study||3
3092249|NCT01449370|3814606|FG018|NOT COMPLETED|Overall Study||3
3092250|NCT01449370|3814607|FG019|NOT COMPLETED|Overall Study||3
3092251|NCT01449370|3814608|FG020|NOT COMPLETED|Overall Study||6
3092252|NCT01449370|3814609|FG021|NOT COMPLETED|Overall Study||4
3092253|NCT01449370|3814610|FG022|NOT COMPLETED|Overall Study||4
3092254|NCT01449370|3814611|FG023|NOT COMPLETED|Overall Study||10
3092255|NCT01449370|3814612|FG024|NOT COMPLETED|Overall Study||8
3092256|NCT01449461|3814691|FG000|STARTED|Overall Study||6
3092257|NCT01449461|3814692|FG001|STARTED|Overall Study||18
3092258|NCT01449461|3814693|FG002|STARTED|Overall Study||18
3092259|NCT01449461|3814694|FG003|STARTED|Overall Study||32
3092260|NCT01449461|3814695|FG004|STARTED|Overall Study||48
3092261|NCT01449461|3814696|FG005|STARTED|Overall Study||15
3092262|NCT01449461|3814691|FG000|COMPLETED|Overall Study||0
3092263|NCT01449461|3814692|FG001|COMPLETED|Overall Study||0
3092264|NCT01449461|3814693|FG002|COMPLETED|Overall Study||0
3092265|NCT01449461|3814694|FG003|COMPLETED|Overall Study||0
3092266|NCT01449461|3814695|FG004|COMPLETED|Overall Study||0
3092267|NCT01449461|3814696|FG005|COMPLETED|Overall Study||0
3092268|NCT01449461|3814691|FG000|NOT COMPLETED|Overall Study||6
3092269|NCT01449461|3814692|FG001|NOT COMPLETED|Overall Study||18
3092270|NCT01449461|3814693|FG002|NOT COMPLETED|Overall Study||18
3092271|NCT01449461|3814694|FG003|NOT COMPLETED|Overall Study||32
3092272|NCT01449461|3814695|FG004|NOT COMPLETED|Overall Study||48
3092273|NCT01449461|3814696|FG005|NOT COMPLETED|Overall Study||15
3092274|NCT01449513|3814721|FG000|STARTED|Overall Study||16
3092275|NCT01449513|3814722|FG001|STARTED|Overall Study||8
3092276|NCT01449513|3814721|FG000|COMPLETED|Overall Study||16
3092277|NCT01449513|3814722|FG001|COMPLETED|Overall Study||8
3092278|NCT01449513|3814721|FG000|NOT COMPLETED|Overall Study||0
3092279|NCT01449513|3814722|FG001|NOT COMPLETED|Overall Study||0
3092280|NCT01449526|3814730|FG000|STARTED|Overall Study||83
3092281|NCT01449526|3814731|FG001|STARTED|Overall Study||83
3092282|NCT01449526|3814730|FG000|COMPLETED|Overall Study||81
3092283|NCT01449526|3814731|FG001|COMPLETED|Overall Study||77
3092284|NCT01449526|3814730|FG000|NOT COMPLETED|Overall Study||2
3092285|NCT01449526|3814731|FG001|NOT COMPLETED|Overall Study||6
3092286|NCT01449539|3814737|FG000|STARTED|Overall Study||8
3092287|NCT01449539|3814737|FG000|COMPLETED|Overall Study||4
3092288|NCT01449539|3814737|FG000|NOT COMPLETED|Overall Study||4
3092289|NCT01449630|3814750|FG000|STARTED|Period 1||2
3092290|NCT01449630|3814751|FG001|STARTED|Period 1||6
3092291|NCT01449630|3814752|FG002|STARTED|Period 1||2
3092292|NCT01449630|3814753|FG003|STARTED|Period 1||2
3092293|NCT01449630|3814754|FG004|STARTED|Period 1||5
3092294|NCT01449630|3814755|FG005|STARTED|Period 1||2
3092295|NCT01449630|3814756|FG006|STARTED|Period 1||2
3092296|NCT01449630|3814757|FG007|STARTED|Period 1||6
3092297|NCT01449630|3814758|FG008|STARTED|Period 1||2
3092298|NCT01449630|3814750|FG000|Received at Least 1 Dose|Period 1||2
3092299|NCT01449630|3814751|FG001|Received at Least 1 Dose|Period 1||6
3092300|NCT01449630|3814752|FG002|Received at Least 1 Dose|Period 1||2
3092301|NCT01449630|3814753|FG003|Received at Least 1 Dose|Period 1||2
3092302|NCT01449630|3814754|FG004|Received at Least 1 Dose|Period 1||5
3092303|NCT01449630|3814755|FG005|Received at Least 1 Dose|Period 1||1
3092304|NCT01449630|3814756|FG006|Received at Least 1 Dose|Period 1||2
3092305|NCT01449630|3814757|FG007|Received at Least 1 Dose|Period 1||6
3092306|NCT01449630|3814758|FG008|Received at Least 1 Dose|Period 1||2
3289272|NCT02809183|4022896|FG005|NOT COMPLETED|Overall Study||0
3289273|NCT02809430|4022913|FG000|STARTED|Overall Study||90
3289274|NCT02809430|4022913|FG000|Failed 3-night run-in Because no Evidence of Obstructive Sleep Apnea|Overall Study|14 with CPAP < 3 hours, 5 without evidence of OSA, 9 with evidence of central or complex sleep apnea|28
3289275|NCT02809430|4022913|FG000|Stopped CPAP During Inpatient Rehabilitation|Overall Study|10 of 62 participants stopped CPAP after the run-in and prior to discharge from IPR|10
3289276|NCT02809430|4022913|FG000|COMPLETED|Overall Study||52
3289277|NCT02809430|4022913|FG000|NOT COMPLETED|Overall Study||38
3289278|NCT02809833|4022920|FG000|STARTED|Overall Study||850
3289279|NCT02809833|4022920|FG000|COMPLETED|Overall Study||550
3289280|NCT02809833|4022920|FG000|NOT COMPLETED|Overall Study||300
3289281|NCT02809846|4022926|FG000|STARTED|Overall Study||17
3289282|NCT02809846|4022927|FG001|STARTED|Overall Study||16
3289283|NCT02809846|4022926|FG000|COMPLETED|Overall Study||8
3289284|NCT02809846|4022927|FG001|COMPLETED|Overall Study||9
3289285|NCT02809846|4022926|FG000|NOT COMPLETED|Overall Study||9
3289286|NCT02809846|4022927|FG001|NOT COMPLETED|Overall Study||7
3289287|NCT02809859|4022933|FG000|STARTED|Overall Study||139
3289288|NCT02809859|4022933|FG000|COMPLETED|Overall Study||125
3289289|NCT02809859|4022933|FG000|NOT COMPLETED|Overall Study||14
3289290|NCT02809911|4022939|FG000|STARTED|Overall Study|This is the Initial Treatment Population (subjects that started the Enrollment Visit / Visit 2)|22
3289291|NCT02809911|4022940|FG001|STARTED|Overall Study|This is the Initial Treatment Population (subjects that started the Enrollment Visit / Visit 2)|19
3289292|NCT02809911|4022939|FG000|COMPLETED|Overall Study|This is the Initial Treatment Population (subjects that completed the Enrollment Visit / Visit 2)|22
3289293|NCT02809911|4022940|FG001|COMPLETED|Overall Study|This is the Initial Treatment Population (subjects that completed the Enrollment Visit / Visit 2)|19
3289294|NCT02809911|4022939|FG000|NOT COMPLETED|Overall Study||0
3289295|NCT02809911|4022940|FG001|NOT COMPLETED|Overall Study||0
3289296|NCT02809976|4022946|FG000|STARTED|Overall Study||11
3289297|NCT02809976|4022946|FG000|COMPLETED|Overall Study||9
3289298|NCT02809976|4022946|FG000|NOT COMPLETED|Overall Study||2
3289299|NCT02810327|4022952|FG000|STARTED|Overall Study||76
3092307|NCT01449630|3814750|FG000|COMPLETED|Period 1||1
3092308|NCT01449630|3814751|FG001|COMPLETED|Period 1||6
3092309|NCT01449630|3814752|FG002|COMPLETED|Period 1||2
3092310|NCT01449630|3814753|FG003|COMPLETED|Period 1||1
3092311|NCT01449630|3814754|FG004|COMPLETED|Period 1||5
3092312|NCT01449630|3814755|FG005|COMPLETED|Period 1||1
3092313|NCT01449630|3814756|FG006|COMPLETED|Period 1||2
3092314|NCT01449630|3814757|FG007|COMPLETED|Period 1||6
3092315|NCT01449630|3814758|FG008|COMPLETED|Period 1||2
3092316|NCT01449630|3814750|FG000|NOT COMPLETED|Period 1||1
3092317|NCT01449630|3814751|FG001|NOT COMPLETED|Period 1||0
3092318|NCT01449630|3814752|FG002|NOT COMPLETED|Period 1||0
3092319|NCT01449630|3814753|FG003|NOT COMPLETED|Period 1||1
3092320|NCT01449630|3814754|FG004|NOT COMPLETED|Period 1||0
3092321|NCT01449630|3814755|FG005|NOT COMPLETED|Period 1||1
3092322|NCT01449630|3814756|FG006|NOT COMPLETED|Period 1||0
3092323|NCT01449630|3814757|FG007|NOT COMPLETED|Period 1||0
3092324|NCT01449630|3814758|FG008|NOT COMPLETED|Period 1||0
3092325|NCT01449630|3814750|FG000|STARTED|Period 2||1
3092326|NCT01449630|3814751|FG001|STARTED|Period 2||6
3092327|NCT01449630|3814752|FG002|STARTED|Period 2||2
3092328|NCT01449630|3814753|FG003|STARTED|Period 2||1
3092329|NCT01449630|3814754|FG004|STARTED|Period 2||5
3092330|NCT01449630|3814755|FG005|STARTED|Period 2||1
3092331|NCT01449630|3814756|FG006|STARTED|Period 2||2
3092332|NCT01449630|3814757|FG007|STARTED|Period 2||6
3092333|NCT01449630|3814758|FG008|STARTED|Period 2||2
3092334|NCT01449630|3814750|FG000|COMPLETED|Period 2||1
3092335|NCT01449630|3814751|FG001|COMPLETED|Period 2||6
3092336|NCT01449630|3814752|FG002|COMPLETED|Period 2||2
3092337|NCT01449630|3814753|FG003|COMPLETED|Period 2||1
3092338|NCT01449630|3814754|FG004|COMPLETED|Period 2||5
3092339|NCT01449630|3814755|FG005|COMPLETED|Period 2||1
3092340|NCT01449630|3814756|FG006|COMPLETED|Period 2||1
3092341|NCT01449630|3814757|FG007|COMPLETED|Period 2||6
3092342|NCT01449630|3814758|FG008|COMPLETED|Period 2||2
3092343|NCT01449630|3814750|FG000|NOT COMPLETED|Period 2||0
3092344|NCT01449630|3814751|FG001|NOT COMPLETED|Period 2||0
3092345|NCT01449630|3814752|FG002|NOT COMPLETED|Period 2||0
3092346|NCT01449630|3814753|FG003|NOT COMPLETED|Period 2||0
3092347|NCT01449630|3814754|FG004|NOT COMPLETED|Period 2||0
3092348|NCT01449630|3814755|FG005|NOT COMPLETED|Period 2||0
3092349|NCT01449630|3814756|FG006|NOT COMPLETED|Period 2||1
3092350|NCT01449630|3814757|FG007|NOT COMPLETED|Period 2||0
3092351|NCT01449630|3814758|FG008|NOT COMPLETED|Period 2||0
3092352|NCT01449630|3814750|FG000|STARTED|Period 3||1
3092353|NCT01449630|3814751|FG001|STARTED|Period 3||6
3092354|NCT01449630|3814752|FG002|STARTED|Period 3||2
3092355|NCT01449630|3814753|FG003|STARTED|Period 3||1
3092356|NCT01449630|3814754|FG004|STARTED|Period 3||5
3092357|NCT01449630|3814755|FG005|STARTED|Period 3||1
3092358|NCT01449630|3814756|FG006|STARTED|Period 3||1
3092359|NCT01449630|3814757|FG007|STARTED|Period 3||6
3092360|NCT01449630|3814758|FG008|STARTED|Period 3||2
3092361|NCT01449630|3814750|FG000|COMPLETED|Period 3||1
3092362|NCT01449630|3814751|FG001|COMPLETED|Period 3||6
3092363|NCT01449630|3814752|FG002|COMPLETED|Period 3||2
3092364|NCT01449630|3814753|FG003|COMPLETED|Period 3||1
3092365|NCT01449630|3814754|FG004|COMPLETED|Period 3||5
3092366|NCT01449630|3814755|FG005|COMPLETED|Period 3||1
3092367|NCT01449630|3814756|FG006|COMPLETED|Period 3||1
3092368|NCT01449630|3814757|FG007|COMPLETED|Period 3||6
3092369|NCT01449630|3814758|FG008|COMPLETED|Period 3||2
3092370|NCT01449630|3814750|FG000|NOT COMPLETED|Period 3||0
3092371|NCT01449630|3814751|FG001|NOT COMPLETED|Period 3||0
3092372|NCT01449630|3814752|FG002|NOT COMPLETED|Period 3||0
3092373|NCT01449630|3814753|FG003|NOT COMPLETED|Period 3||0
3092374|NCT01449630|3814754|FG004|NOT COMPLETED|Period 3||0
3092375|NCT01449630|3814755|FG005|NOT COMPLETED|Period 3||0
3092376|NCT01449630|3814756|FG006|NOT COMPLETED|Period 3||0
3092377|NCT01449630|3814757|FG007|NOT COMPLETED|Period 3||0
3092378|NCT01449630|3814758|FG008|NOT COMPLETED|Period 3||0
3092379|NCT01449682|3814782|FG000|STARTED|Overall Study||5
3092380|NCT01449682|3814783|FG001|STARTED|Overall Study||5
3289300|NCT02810327|4022953|FG001|STARTED|Overall Study||41
3289301|NCT02810327|4022952|FG000|COMPLETED|Overall Study||69
3289302|NCT02810327|4022953|FG001|COMPLETED|Overall Study||34
3289303|NCT02810327|4022952|FG000|NOT COMPLETED|Overall Study||7
3289304|NCT02810327|4022953|FG001|NOT COMPLETED|Overall Study||7
3289305|NCT02810340|4022962|FG000|STARTED|Overall Study||20
3289306|NCT02810340|4022963|FG001|STARTED|Overall Study||20
3289307|NCT02810340|4022964|FG002|STARTED|Overall Study||20
3289308|NCT02810340|4022962|FG000|COMPLETED|Overall Study||19
3289309|NCT02810340|4022963|FG001|COMPLETED|Overall Study||19
3289310|NCT02810340|4022964|FG002|COMPLETED|Overall Study||19
3289311|NCT02810340|4022962|FG000|NOT COMPLETED|Overall Study||1
3289312|NCT02810340|4022963|FG001|NOT COMPLETED|Overall Study||1
3289313|NCT02810340|4022964|FG002|NOT COMPLETED|Overall Study||1
3289314|NCT02810392|4022974|FG000|STARTED|Overall Study||9
3289315|NCT02810392|4022975|FG001|STARTED|Overall Study||10
3289316|NCT02810392|4022974|FG000|COMPLETED|Overall Study||8
3289317|NCT02810392|4022975|FG001|COMPLETED|Overall Study||9
3092381|NCT01449682|3814782|FG000|COMPLETED|Overall Study||4
3092382|NCT01449682|3814783|FG001|COMPLETED|Overall Study||4
3092383|NCT01449682|3814782|FG000|NOT COMPLETED|Overall Study||1
3092384|NCT01449682|3814783|FG001|NOT COMPLETED|Overall Study||1
3092385|NCT01449708|3814791|FG000|STARTED|Overall Study||61
3092386|NCT01449708|3814792|FG001|STARTED|Overall Study||63
3092387|NCT01449708|3814791|FG000|COMPLETED|Overall Study||59
3092388|NCT01449708|3814792|FG001|COMPLETED|Overall Study||60
3092389|NCT01449708|3814791|FG000|NOT COMPLETED|Overall Study||2
3092390|NCT01449708|3814792|FG001|NOT COMPLETED|Overall Study||3
3092391|NCT01449721|3814803|FG000|STARTED|Overall Study||112
3289318|NCT02810392|4022974|FG000|NOT COMPLETED|Overall Study||1
3289319|NCT02810392|4022975|FG001|NOT COMPLETED|Overall Study||1
3289320|NCT02810457|4022983|FG000|STARTED|Overall Study|362 patients received study treatment|364
3092392|NCT01449721|3814804|FG001|STARTED|Overall Study||30
3092393|NCT01449721|3814803|FG000|COMPLETED|Overall Study||112
3092394|NCT01449721|3814804|FG001|COMPLETED|Overall Study||28
3092395|NCT01449721|3814803|FG000|NOT COMPLETED|Overall Study||0
3092396|NCT01449721|3814804|FG001|NOT COMPLETED|Overall Study||2
3092397|NCT01449734|3814810|FG000|STARTED|Overall Study||215
3092398|NCT01449734|3814810|FG000|COMPLETED|Overall Study||215
3092399|NCT01449734|3814810|FG000|NOT COMPLETED|Overall Study||0
3092400|NCT01449747|3814816|FG000|STARTED|Overall Study||12
3092401|NCT01449747|3814817|FG001|STARTED|Overall Study||12
3092402|NCT01449747|3814816|FG000|COMPLETED|Overall Study||12
3092403|NCT01449747|3814817|FG001|COMPLETED|Overall Study||12
3092404|NCT01449747|3814816|FG000|NOT COMPLETED|Overall Study||0
3092405|NCT01449747|3814817|FG001|NOT COMPLETED|Overall Study||0
3092406|NCT01449812|3814826|FG000|STARTED|Overall Study||272
3092407|NCT01449812|3814827|FG001|STARTED|Overall Study||273
3092408|NCT01449812|3814828|FG002|STARTED|Overall Study||280
3092409|NCT01449812|3814826|FG000|COMPLETED|Overall Study||270
3092410|NCT01449812|3814827|FG001|COMPLETED|Overall Study||273
3092411|NCT01449812|3814828|FG002|COMPLETED|Overall Study||279
3092412|NCT01449812|3814826|FG000|NOT COMPLETED|Overall Study||2
3092413|NCT01449812|3814827|FG001|NOT COMPLETED|Overall Study||0
3092414|NCT01449812|3814828|FG002|NOT COMPLETED|Overall Study||1
3092415|NCT01449864|3814836|FG000|STARTED|Overall Study||22
3092416|NCT01449864|3814836|FG000|COMPLETED|Overall Study||17
3092417|NCT01449864|3814836|FG000|NOT COMPLETED|Overall Study||5
3092418|NCT01449929|3814842|FG000|STARTED|Randomization Phase 96 Week||242
3092419|NCT01449929|3814843|FG001|STARTED|Randomization Phase 96 Week||242
3092420|NCT01449929|3814844|FG002|STARTED|Randomization Phase 96 Week||0
3092421|NCT01449929|3814842|FG000|COMPLETED|Randomization Phase 96 Week||209
3092422|NCT01449929|3814843|FG001|COMPLETED|Randomization Phase 96 Week||189
3092423|NCT01449929|3814844|FG002|COMPLETED|Randomization Phase 96 Week||0
3092424|NCT01449929|3814842|FG000|NOT COMPLETED|Randomization Phase 96 Week||33
3092425|NCT01449929|3814843|FG001|NOT COMPLETED|Randomization Phase 96 Week||53
3092426|NCT01449929|3814844|FG002|NOT COMPLETED|Randomization Phase 96 Week||0
3092427|NCT01449929|3814842|FG000|STARTED|Extension Phase Approximately 3 Years||0
3092428|NCT01449929|3814843|FG001|STARTED|Extension Phase Approximately 3 Years||0
3092429|NCT01449929|3814844|FG002|STARTED|Extension Phase Approximately 3 Years||123
3092430|NCT01449929|3814842|FG000|COMPLETED|Extension Phase Approximately 3 Years||0
3092431|NCT01449929|3814843|FG001|COMPLETED|Extension Phase Approximately 3 Years||0
3092432|NCT01449929|3814844|FG002|COMPLETED|Extension Phase Approximately 3 Years||115
3092433|NCT01449929|3814842|FG000|NOT COMPLETED|Extension Phase Approximately 3 Years||0
3092434|NCT01449929|3814843|FG001|NOT COMPLETED|Extension Phase Approximately 3 Years||0
3092435|NCT01449929|3814844|FG002|NOT COMPLETED|Extension Phase Approximately 3 Years||8
3092436|NCT01449955|3814856|FG000|STARTED|Overall Study||28
3289321|NCT02810457|4022984|FG001|STARTED|Overall Study|366 patients received study treatment|367
3289322|NCT02810457|4022983|FG000|COMPLETED|Overall Study||37
3289323|NCT02810457|4022984|FG001|COMPLETED|Overall Study||38
3092437|NCT01449955|3814857|FG001|STARTED|Overall Study||26
3092438|NCT01449955|3814856|FG000|COMPLETED|Overall Study||27
3092439|NCT01449955|3814857|FG001|COMPLETED|Overall Study||24
3092440|NCT01449955|3814856|FG000|NOT COMPLETED|Overall Study||1
3092441|NCT01449955|3814857|FG001|NOT COMPLETED|Overall Study||2
3092442|NCT01450007|3814873|FG000|STARTED|Overall Study||44
3092443|NCT01450007|3814874|FG001|STARTED|Overall Study||42
3092444|NCT01450007|3814875|FG002|STARTED|Overall Study||44
3092445|NCT01450007|3814873|FG000|COMPLETED|Overall Study||42
3092446|NCT01450007|3814874|FG001|COMPLETED|Overall Study||37
3092447|NCT01450007|3814875|FG002|COMPLETED|Overall Study||41
3092448|NCT01450007|3814873|FG000|NOT COMPLETED|Overall Study||2
3092449|NCT01450007|3814874|FG001|NOT COMPLETED|Overall Study||5
3092450|NCT01450007|3814875|FG002|NOT COMPLETED|Overall Study||3
3092451|NCT01450098|3814885|FG000|STARTED|Period 1||8
3092452|NCT01450098|3814886|FG001|STARTED|Period 1||31
3092453|NCT01450098|3814885|FG000|Received at Least 1 Dose of Study Drug|Period 1||8
3092454|NCT01450098|3814886|FG001|Received at Least 1 Dose of Study Drug|Period 1||31
3092455|NCT01450098|3814885|FG000|COMPLETED|Period 1||8
3092456|NCT01450098|3814886|FG001|COMPLETED|Period 1||31
3092457|NCT01450098|3814885|FG000|NOT COMPLETED|Period 1||0
3092458|NCT01450098|3814886|FG001|NOT COMPLETED|Period 1||0
3092459|NCT01450098|3814885|FG000|STARTED|Washout Period of at Least 14 Days||8
3092460|NCT01450098|3814886|FG001|STARTED|Washout Period of at Least 14 Days||31
3092461|NCT01450098|3814885|FG000|COMPLETED|Washout Period of at Least 14 Days||8
3092462|NCT01450098|3814886|FG001|COMPLETED|Washout Period of at Least 14 Days||31
3289324|NCT02810457|4022983|FG000|NOT COMPLETED|Overall Study||327
3289325|NCT02810457|4022984|FG001|NOT COMPLETED|Overall Study||329
3289326|NCT02810509|4022992|FG000|STARTED|Overall Study||584
3289327|NCT02810509|4022993|FG001|STARTED|Overall Study||1230
3289328|NCT02810509|4022992|FG000|COMPLETED|Overall Study||584
3289329|NCT02810509|4022993|FG001|COMPLETED|Overall Study||1230
3289330|NCT02810509|4022992|FG000|NOT COMPLETED|Overall Study||0
3289331|NCT02810509|4022993|FG001|NOT COMPLETED|Overall Study||0
3092463|NCT01450098|3814885|FG000|NOT COMPLETED|Washout Period of at Least 14 Days||0
3092464|NCT01450098|3814886|FG001|NOT COMPLETED|Washout Period of at Least 14 Days||0
3092465|NCT01450098|3814885|FG000|STARTED|Period 2||8
3092466|NCT01450098|3814886|FG001|STARTED|Period 2||31
3289332|NCT02810873|4023003|FG000|STARTED|Overall Study||6
3289333|NCT02810873|4023004|FG001|STARTED|Overall Study||13
3092467|NCT01450098|3814885|FG000|Received at Least 1 Dose of Study Drug|Period 2||8
3092468|NCT01450098|3814886|FG001|Received at Least 1 Dose of Study Drug|Period 2||31
3092469|NCT01450098|3814885|FG000|COMPLETED|Period 2||8
3092470|NCT01450098|3814886|FG001|COMPLETED|Period 2||31
3092471|NCT01450098|3814885|FG000|NOT COMPLETED|Period 2||0
3092472|NCT01450098|3814886|FG001|NOT COMPLETED|Period 2||0
3092473|NCT01450098|3814885|FG000|STARTED|Washout of at Least 14 Days||8
3092474|NCT01450098|3814886|FG001|STARTED|Washout of at Least 14 Days||31
3092475|NCT01450098|3814885|FG000|COMPLETED|Washout of at Least 14 Days||8
3092476|NCT01450098|3814886|FG001|COMPLETED|Washout of at Least 14 Days||31
3092477|NCT01450098|3814885|FG000|NOT COMPLETED|Washout of at Least 14 Days||0
3092478|NCT01450098|3814886|FG001|NOT COMPLETED|Washout of at Least 14 Days||0
3092479|NCT01450098|3814885|FG000|STARTED|Period 3||8
3092480|NCT01450098|3814886|FG001|STARTED|Period 3||31
3092481|NCT01450098|3814885|FG000|Received at Least 1 Dose of Study Drug|Period 3||8
3092482|NCT01450098|3814886|FG001|Received at Least 1 Dose of Study Drug|Period 3||30
3092483|NCT01450098|3814885|FG000|COMPLETED|Period 3||8
3092484|NCT01450098|3814886|FG001|COMPLETED|Period 3||28
3092485|NCT01450098|3814885|FG000|NOT COMPLETED|Period 3||0
3092486|NCT01450098|3814886|FG001|NOT COMPLETED|Period 3||3
3092487|NCT01450137|3814901|FG000|STARTED|Up to Week 12||20
3092488|NCT01450137|3814902|FG001|STARTED|Up to Week 12||10
3092489|NCT01450137|3814901|FG000|COMPLETED|Up to Week 12||18
3092490|NCT01450137|3814902|FG001|COMPLETED|Up to Week 12||7
3092491|NCT01450137|3814901|FG000|NOT COMPLETED|Up to Week 12||2
3092492|NCT01450137|3814902|FG001|NOT COMPLETED|Up to Week 12||3
3092493|NCT01450137|3814901|FG000|STARTED|Week 12 to Study End||18
3092494|NCT01450137|3814902|FG001|STARTED|Week 12 to Study End||7
3092495|NCT01450137|3814901|FG000|COMPLETED|Week 12 to Study End||18
3092496|NCT01450137|3814902|FG001|COMPLETED|Week 12 to Study End||5
3092497|NCT01450137|3814901|FG000|NOT COMPLETED|Week 12 to Study End||0
3092498|NCT01450137|3814902|FG001|NOT COMPLETED|Week 12 to Study End||2
3092499|NCT01450189|3814911|FG000|STARTED|Overall Study||9
3092500|NCT01450189|3814912|FG001|STARTED|Overall Study||18
3092501|NCT01450189|3814913|FG002|STARTED|Overall Study||19
3092502|NCT01450189|3814911|FG000|COMPLETED|Overall Study||9
3092503|NCT01450189|3814912|FG001|COMPLETED|Overall Study||18
3092504|NCT01450189|3814913|FG002|COMPLETED|Overall Study||19
3092505|NCT01450189|3814911|FG000|NOT COMPLETED|Overall Study||0
3092506|NCT01450189|3814912|FG001|NOT COMPLETED|Overall Study||0
3092507|NCT01450189|3814913|FG002|NOT COMPLETED|Overall Study||0
3092508|NCT01450306|3814930|FG000|STARTED|Overall Study||10
3092509|NCT01450306|3814931|FG001|STARTED|Overall Study||10
3092510|NCT01450306|3814930|FG000|COMPLETED|Overall Study||10
3092511|NCT01450306|3814931|FG001|COMPLETED|Overall Study||10
3092512|NCT01450306|3814930|FG000|NOT COMPLETED|Overall Study||0
3092513|NCT01450306|3814931|FG001|NOT COMPLETED|Overall Study||0
3092514|NCT01450319|3814937|FG000|STARTED|Overall Study||70
3092515|NCT01450319|3814937|FG000|COMPLETED|Overall Study||70
3092516|NCT01450319|3814937|FG000|NOT COMPLETED|Overall Study||0
3092517|NCT01450397|3814941|FG000|STARTED|Overall Study||5
3092518|NCT01450397|3814941|FG000|COMPLETED|Overall Study||5
3092519|NCT01450397|3814941|FG000|NOT COMPLETED|Overall Study||0
3092520|NCT01450540|3814947|FG000|STARTED|Overall Study||123
3092521|NCT01450540|3814948|FG001|STARTED|Overall Study||118
3092522|NCT01450540|3814947|FG000|COMPLETED|Overall Study||101
3092523|NCT01450540|3814948|FG001|COMPLETED|Overall Study||82
3092524|NCT01450540|3814947|FG000|NOT COMPLETED|Overall Study||22
3092525|NCT01450540|3814948|FG001|NOT COMPLETED|Overall Study||36
3092526|NCT01450631|3814958|FG000|STARTED|Overall Study||46
3092527|NCT01450631|3814959|FG001|STARTED|Overall Study||46
3092528|NCT01450631|3814958|FG000|COMPLETED|Overall Study||43
3092529|NCT01450631|3814959|FG001|COMPLETED|Overall Study||42
3092530|NCT01450631|3814958|FG000|NOT COMPLETED|Overall Study||3
3092531|NCT01450631|3814959|FG001|NOT COMPLETED|Overall Study||4
3092532|NCT01450683|3814965|FG000|STARTED|Overall Study||4
3092533|NCT01450683|3814965|FG000|COMPLETED|Overall Study||2
3092534|NCT01450683|3814965|FG000|NOT COMPLETED|Overall Study||2
3092535|NCT01450696|3814971|FG000|STARTED|Overall Study||148
3289334|NCT02810873|4023003|FG000|COMPLETED|Overall Study||6
3289335|NCT02810873|4023004|FG001|COMPLETED|Overall Study||13
3289336|NCT02810873|4023003|FG000|NOT COMPLETED|Overall Study||0
3289337|NCT02810873|4023004|FG001|NOT COMPLETED|Overall Study||0
3289338|NCT02810951|4023011|FG000|STARTED|Overall Study||6
3092536|NCT01450696|3814972|FG001|STARTED|Overall Study||148
3092537|NCT01450696|3814971|FG000|Treated (Safety Population)|Overall Study||147
3092538|NCT01450696|3814972|FG001|Treated (Safety Population)|Overall Study||147
3092539|NCT01450696|3814971|FG000|COMPLETED|Overall Study||0
3092540|NCT01450696|3814972|FG001|COMPLETED|Overall Study||0
3092541|NCT01450696|3814971|FG000|NOT COMPLETED|Overall Study||148
3092542|NCT01450696|3814972|FG001|NOT COMPLETED|Overall Study||148
3092543|NCT01450761|3814980|FG000|STARTED|Randomization||566
3092544|NCT01450761|3814981|FG001|STARTED|Randomization||566
3092545|NCT01450761|3814980|FG000|COMPLETED|Randomization||562
3092546|NCT01450761|3814981|FG001|COMPLETED|Randomization||561
3092547|NCT01450761|3814980|FG000|NOT COMPLETED|Randomization||4
3092548|NCT01450761|3814981|FG001|NOT COMPLETED|Randomization||5
3092549|NCT01450761|3814980|FG000|STARTED|Lead-in Chemotherapy||562
3092550|NCT01450761|3814981|FG001|STARTED|Lead-in Chemotherapy||561
3092551|NCT01450761|3814980|FG000|COMPLETED|Lead-in Chemotherapy||478
3289339|NCT02810951|4023011|FG000|FCX-007 Injection|Overall Study||6
3092552|NCT01450761|3814981|FG001|COMPLETED|Lead-in Chemotherapy||476
3092553|NCT01450761|3814980|FG000|NOT COMPLETED|Lead-in Chemotherapy||84
3092554|NCT01450761|3814981|FG001|NOT COMPLETED|Lead-in Chemotherapy||85
3092555|NCT01450761|3814980|FG000|STARTED|Treatment With Blinded Study Therapy||478
3092556|NCT01450761|3814981|FG001|STARTED|Treatment With Blinded Study Therapy||476
3092557|NCT01450761|3814980|FG000|COMPLETED|Treatment With Blinded Study Therapy||0
3092558|NCT01450761|3814981|FG001|COMPLETED|Treatment With Blinded Study Therapy||0
3092559|NCT01450761|3814980|FG000|NOT COMPLETED|Treatment With Blinded Study Therapy||478
3092560|NCT01450761|3814981|FG001|NOT COMPLETED|Treatment With Blinded Study Therapy||476
3092561|NCT01450787|3814989|FG000|STARTED|Overall Study||38
3092562|NCT01450787|3814990|FG001|STARTED|Overall Study||25
3092563|NCT01450787|3814989|FG000|COMPLETED|Overall Study||38
3092564|NCT01450787|3814990|FG001|COMPLETED|Overall Study||25
3092565|NCT01450787|3814989|FG000|NOT COMPLETED|Overall Study||0
3092566|NCT01450787|3814990|FG001|NOT COMPLETED|Overall Study||0
3092567|NCT01450800|3814998|FG000|STARTED|Overall Study|82 participants were randomized to nitrofurantoin|82
3092568|NCT01450800|3814999|FG001|STARTED|Overall Study|81 participants were randomized to placebo|81
3092569|NCT01450800|3814998|FG000|COMPLETED|Overall Study||81
3092570|NCT01450800|3814999|FG001|COMPLETED|Overall Study||78
3092571|NCT01450800|3814998|FG000|NOT COMPLETED|Overall Study||1
3092572|NCT01450800|3814999|FG001|NOT COMPLETED|Overall Study||3
3092573|NCT01450813|3815011|FG000|STARTED|Overall Study||20
3092574|NCT01450813|3815012|FG001|STARTED|Overall Study||20
3092575|NCT01450813|3815013|FG002|STARTED|Overall Study||20
3092576|NCT01450813|3815014|FG003|STARTED|Overall Study||20
3092577|NCT01450813|3815011|FG000|COMPLETED|Overall Study||19
3092578|NCT01450813|3815012|FG001|COMPLETED|Overall Study||19
3092579|NCT01450813|3815013|FG002|COMPLETED|Overall Study||20
3092580|NCT01450813|3815014|FG003|COMPLETED|Overall Study||17
3092581|NCT01450813|3815011|FG000|NOT COMPLETED|Overall Study||1
3092582|NCT01450813|3815012|FG001|NOT COMPLETED|Overall Study||1
3092583|NCT01450813|3815013|FG002|NOT COMPLETED|Overall Study||0
3092584|NCT01450813|3815014|FG003|NOT COMPLETED|Overall Study||3
3092585|NCT01450826|3815028|FG000|STARTED|Overall Study||70
3092586|NCT01450826|3815029|FG001|STARTED|Overall Study||66
3092587|NCT01450826|3815028|FG000|COMPLETED|Overall Study||70
3092588|NCT01450826|3815029|FG001|COMPLETED|Overall Study||66
3092589|NCT01450826|3815028|FG000|NOT COMPLETED|Overall Study||0
3092590|NCT01450826|3815029|FG001|NOT COMPLETED|Overall Study||0
3092591|NCT01450943|3815038|FG000|STARTED|Overall Study||28
3092592|NCT01450943|3815039|FG001|STARTED|Overall Study||42
3092593|NCT01450943|3815040|FG002|STARTED|Overall Study||48
3092594|NCT01450943|3815038|FG000|COMPLETED|Overall Study||26
3092595|NCT01450943|3815039|FG001|COMPLETED|Overall Study||35
3092596|NCT01450943|3815040|FG002|COMPLETED|Overall Study||42
3092597|NCT01450943|3815038|FG000|NOT COMPLETED|Overall Study||2
3092598|NCT01450943|3815039|FG001|NOT COMPLETED|Overall Study||7
3092599|NCT01450943|3815040|FG002|NOT COMPLETED|Overall Study||6
3092600|NCT01451164|3815056|FG000|STARTED|Overall Study||115
3092601|NCT01451164|3815057|FG001|STARTED|Overall Study||115
3092602|NCT01451164|3815058|FG002|STARTED|Overall Study||113
3092603|NCT01451164|3815059|FG003|STARTED|Overall Study||116
3092604|NCT01451164|3815056|FG000|COMPLETED|Overall Study||72
3092605|NCT01451164|3815057|FG001|COMPLETED|Overall Study||81
3092606|NCT01451164|3815058|FG002|COMPLETED|Overall Study||68
3092607|NCT01451164|3815059|FG003|COMPLETED|Overall Study||70
3092608|NCT01451164|3815056|FG000|NOT COMPLETED|Overall Study||43
3092609|NCT01451164|3815057|FG001|NOT COMPLETED|Overall Study||34
3092610|NCT01451164|3815058|FG002|NOT COMPLETED|Overall Study||45
3092611|NCT01451164|3815059|FG003|NOT COMPLETED|Overall Study||46
3092612|NCT01451203|3815071|FG000|STARTED|Double-blind Treatment Period||158
3092613|NCT01451203|3815072|FG001|STARTED|Double-blind Treatment Period||161
3092614|NCT01451203|3815071|FG000|Received Treatment|Double-blind Treatment Period||157
3092615|NCT01451203|3815072|FG001|Received Treatment|Double-blind Treatment Period||159
3092616|NCT01451203|3815071|FG000|Received Rescue Treatment|Double-blind Treatment Period|Participants who did not achieve improvement at & after Week 24 were dropped out of study schedule.|70
3092617|NCT01451203|3815072|FG001|Received Rescue Treatment|Double-blind Treatment Period|Participants who did not achieve improvement at & after Week 24 were dropped out of study schedule.|36
3092618|NCT01451203|3815071|FG000|COMPLETED|Double-blind Treatment Period||73
3092619|NCT01451203|3815072|FG001|COMPLETED|Double-blind Treatment Period||111
3092620|NCT01451203|3815071|FG000|NOT COMPLETED|Double-blind Treatment Period||85
3092621|NCT01451203|3815072|FG001|NOT COMPLETED|Double-blind Treatment Period||50
3092622|NCT01451203|3815071|FG000|STARTED|Post-treatment Period|Two participants received rescue treatment and did not enter this period.|71
3092623|NCT01451203|3815072|FG001|STARTED|Post-treatment Period|Three participants received rescue treatment and did not enter this period.|108
3092624|NCT01451203|3815071|FG000|Received Rescue Treatment|Post-treatment Period|Participants who presented with flares at any time were dropped out of study schedule.|12
3092625|NCT01451203|3815072|FG001|Received Rescue Treatment|Post-treatment Period|Participants who presented with flares at any time were dropped out of study schedule.|28
3092626|NCT01451203|3815071|FG000|COMPLETED|Post-treatment Period||57
3092627|NCT01451203|3815072|FG001|COMPLETED|Post-treatment Period||74
3092628|NCT01451203|3815071|FG000|NOT COMPLETED|Post-treatment Period||14
3092629|NCT01451203|3815072|FG001|NOT COMPLETED|Post-treatment Period||34
3092630|NCT01451372|3815078|FG000|STARTED|Overall Study||69
3092631|NCT01451372|3815078|FG000|COMPLETED|Overall Study||69
3092632|NCT01451372|3815078|FG000|NOT COMPLETED|Overall Study||0
3092633|NCT01451385|3815082|FG000|STARTED|Overall Study||376
3092634|NCT01451385|3815082|FG000|COMPLETED|Overall Study||285
3092635|NCT01451385|3815082|FG000|NOT COMPLETED|Overall Study||91
3092636|NCT01451398|3815088|FG000|STARTED|Overall Study||177
3092637|NCT01451398|3815089|FG001|STARTED|Overall Study||176
3092638|NCT01451398|3815088|FG000|COMPLETED|Overall Study||150
3092639|NCT01451398|3815089|FG001|COMPLETED|Overall Study||139
3092640|NCT01451398|3815088|FG000|NOT COMPLETED|Overall Study||27
3092641|NCT01451398|3815089|FG001|NOT COMPLETED|Overall Study||37
3092642|NCT01451411|3815097|FG000|STARTED|Overall Study||3
3092643|NCT01451411|3815098|FG001|STARTED|Overall Study||1
3092644|NCT01451411|3815097|FG000|COMPLETED|Overall Study||3
3092645|NCT01451411|3815098|FG001|COMPLETED|Overall Study||1
3092646|NCT01451411|3815097|FG000|NOT COMPLETED|Overall Study||0
3092647|NCT01451411|3815098|FG001|NOT COMPLETED|Overall Study||0
3092648|NCT01451424|3815108|FG000|STARTED|Overall Study||9
3092649|NCT01451424|3815109|FG001|STARTED|Overall Study||9
3092650|NCT01451424|3815110|FG002|STARTED|Overall Study||12
3092651|NCT01451424|3815111|FG003|STARTED|Overall Study||10
3092652|NCT01451424|3815108|FG000|COMPLETED|Overall Study||8
3092653|NCT01451424|3815109|FG001|COMPLETED|Overall Study||7
3092654|NCT01451424|3815110|FG002|COMPLETED|Overall Study||11
3092655|NCT01451424|3815111|FG003|COMPLETED|Overall Study||5
3092656|NCT01451424|3815108|FG000|NOT COMPLETED|Overall Study||1
3092657|NCT01451424|3815109|FG001|NOT COMPLETED|Overall Study||2
3092658|NCT01451424|3815110|FG002|NOT COMPLETED|Overall Study||1
3092659|NCT01451424|3815111|FG003|NOT COMPLETED|Overall Study||5
3092660|NCT01451437|3815135|FG000|STARTED|Overall Study||1
3092661|NCT01451437|3815136|FG001|STARTED|Overall Study||1
3092662|NCT01451437|3815137|FG002|STARTED|Overall Study||3
3092663|NCT01451437|3815138|FG003|STARTED|Overall Study||1
3092664|NCT01451437|3815139|FG004|STARTED|Overall Study||4
3092665|NCT01451437|3815140|FG005|STARTED|Overall Study||3
3092666|NCT01451437|3815141|FG006|STARTED|Overall Study||6
3092667|NCT01451437|3815142|FG007|STARTED|Overall Study||3
3092668|NCT01451437|3815143|FG008|STARTED|Overall Study||4
3092669|NCT01451437|3815135|FG000|COMPLETED|Overall Study||0
3092670|NCT01451437|3815136|FG001|COMPLETED|Overall Study||0
3092671|NCT01451437|3815137|FG002|COMPLETED|Overall Study||0
3092672|NCT01451437|3815138|FG003|COMPLETED|Overall Study||0
3092673|NCT01451437|3815139|FG004|COMPLETED|Overall Study||0
3092674|NCT01451437|3815140|FG005|COMPLETED|Overall Study||0
3092675|NCT01451437|3815141|FG006|COMPLETED|Overall Study||0
3092676|NCT01451437|3815142|FG007|COMPLETED|Overall Study||0
3092677|NCT01451437|3815143|FG008|COMPLETED|Overall Study||0
3092678|NCT01451437|3815135|FG000|NOT COMPLETED|Overall Study||1
3092679|NCT01451437|3815136|FG001|NOT COMPLETED|Overall Study||1
3092680|NCT01451437|3815137|FG002|NOT COMPLETED|Overall Study||3
3092681|NCT01451437|3815138|FG003|NOT COMPLETED|Overall Study||1
3092682|NCT01451437|3815139|FG004|NOT COMPLETED|Overall Study||4
3092683|NCT01451437|3815140|FG005|NOT COMPLETED|Overall Study||3
3092684|NCT01451437|3815141|FG006|NOT COMPLETED|Overall Study||6
3092685|NCT01451437|3815142|FG007|NOT COMPLETED|Overall Study||3
3092686|NCT01451437|3815143|FG008|NOT COMPLETED|Overall Study||4
3092687|NCT01451463|3815172|FG000|STARTED|Overall Study||11
3092688|NCT01451463|3815172|FG000|COMPLETED|Overall Study||11
3092689|NCT01451463|3815172|FG000|NOT COMPLETED|Overall Study||0
3092690|NCT01451541|3815184|FG000|STARTED|Overall Study||283
3092691|NCT01451541|3815185|FG001|STARTED|Overall Study||282
3092692|NCT01451541|3815186|FG002|STARTED|Overall Study|283 randomized. ITT = 281 (2 subjects discontinued prior to study medication).|281
3092693|NCT01451541|3815184|FG000|COMPLETED|Overall Study||247
3092694|NCT01451541|3815185|FG001|COMPLETED|Overall Study||257
3092695|NCT01451541|3815186|FG002|COMPLETED|Overall Study||254
3092696|NCT01451541|3815184|FG000|NOT COMPLETED|Overall Study||36
3092697|NCT01451541|3815185|FG001|NOT COMPLETED|Overall Study||25
3092698|NCT01451541|3815186|FG002|NOT COMPLETED|Overall Study||27
3092699|NCT01451554|3815198|FG000|STARTED|Overall Study||33
3092700|NCT01451554|3815199|FG001|STARTED|Overall Study||32
3092701|NCT01451554|3815198|FG000|COMPLETED|Overall Study||19
3092702|NCT01451554|3815199|FG001|COMPLETED|Overall Study||23
3092703|NCT01451554|3815198|FG000|NOT COMPLETED|Overall Study||14
3092704|NCT01451554|3815199|FG001|NOT COMPLETED|Overall Study||9
3092705|NCT01451606|3815207|FG000|STARTED|Overall Study||16
3092706|NCT01451606|3815208|FG001|STARTED|Overall Study||18
3092707|NCT01451606|3815207|FG000|COMPLETED|Overall Study||12
3092708|NCT01451606|3815208|FG001|COMPLETED|Overall Study||15
3092709|NCT01451606|3815207|FG000|NOT COMPLETED|Overall Study||4
3092710|NCT01451606|3815208|FG001|NOT COMPLETED|Overall Study||3
3135113|NCT01704651|3860083|FG001|COMPLETED|Overall Study||68
3135114|NCT01704651|3860082|FG000|NOT COMPLETED|Overall Study||5
3135115|NCT01704651|3860083|FG001|NOT COMPLETED|Overall Study||7
3135116|NCT01704755|3860091|FG000|STARTED|Overall Study||208
3135117|NCT01704755|3860092|FG001|STARTED|Overall Study||172
3135118|NCT01704755|3860091|FG000|Completed Study Drug|Overall Study||204
3135119|NCT01704755|3860092|FG001|Completed Study Drug|Overall Study||163
3135120|NCT01704755|3860091|FG000|COMPLETED|Overall Study||196
3135121|NCT01704755|3860092|FG001|COMPLETED|Overall Study||165
3135122|NCT01704755|3860091|FG000|NOT COMPLETED|Overall Study||12
3135123|NCT01704755|3860092|FG001|NOT COMPLETED|Overall Study||7
3135124|NCT01704781|3860103|FG000|STARTED|Overall Study||3
3135125|NCT01704781|3860104|FG001|STARTED|Overall Study||3
3135126|NCT01704781|3860105|FG002|STARTED|Overall Study||6
3135127|NCT01704781|3860106|FG003|STARTED|Overall Study||12
3092711|NCT01451632|3815216|FG000|STARTED|Overall Study||8
3092712|NCT01451632|3815217|FG001|STARTED|Overall Study||4
3092713|NCT01451632|3815218|FG002|STARTED|Overall Study||3
3092714|NCT01451632|3815219|FG003|STARTED|Overall Study||3
3092715|NCT01451632|3815220|FG004|STARTED|Overall Study||4
3092716|NCT01451632|3815221|FG005|STARTED|Overall Study||4
3092717|NCT01451632|3815222|FG006|STARTED|Overall Study||8
3092718|NCT01451632|3815223|FG007|STARTED|Overall Study||6
3092719|NCT01451632|3815224|FG008|STARTED|Overall Study||4
3092720|NCT01451632|3815225|FG009|STARTED|Overall Study||4
3092721|NCT01451632|3815216|FG000|COMPLETED|Overall Study||8
3092722|NCT01451632|3815217|FG001|COMPLETED|Overall Study||4
3092723|NCT01451632|3815218|FG002|COMPLETED|Overall Study||3
3092724|NCT01451632|3815219|FG003|COMPLETED|Overall Study||3
3092725|NCT01451632|3815220|FG004|COMPLETED|Overall Study||4
3092726|NCT01451632|3815221|FG005|COMPLETED|Overall Study||4
3092727|NCT01451632|3815222|FG006|COMPLETED|Overall Study||8
3092728|NCT01451632|3815223|FG007|COMPLETED|Overall Study||6
3092729|NCT01451632|3815224|FG008|COMPLETED|Overall Study||4
3092730|NCT01451632|3815225|FG009|COMPLETED|Overall Study||4
3092731|NCT01451632|3815216|FG000|NOT COMPLETED|Overall Study||0
3092732|NCT01451632|3815217|FG001|NOT COMPLETED|Overall Study||0
3092733|NCT01451632|3815218|FG002|NOT COMPLETED|Overall Study||0
3092734|NCT01451632|3815219|FG003|NOT COMPLETED|Overall Study||0
3092735|NCT01451632|3815220|FG004|NOT COMPLETED|Overall Study||0
3092736|NCT01451632|3815221|FG005|NOT COMPLETED|Overall Study||0
3092737|NCT01451632|3815222|FG006|NOT COMPLETED|Overall Study||0
3092738|NCT01451632|3815223|FG007|NOT COMPLETED|Overall Study||0
3092739|NCT01451632|3815224|FG008|NOT COMPLETED|Overall Study||0
3092740|NCT01451632|3815225|FG009|NOT COMPLETED|Overall Study||0
3092741|NCT01451645|3815252|FG000|STARTED|Overall Study||41
3092742|NCT01451645|3815253|FG001|STARTED|Overall Study||41
3092743|NCT01451645|3815252|FG000|COMPLETED|Overall Study||32
3092744|NCT01451645|3815253|FG001|COMPLETED|Overall Study||33
3092745|NCT01451645|3815252|FG000|NOT COMPLETED|Overall Study||9
3092746|NCT01451645|3815253|FG001|NOT COMPLETED|Overall Study||8
3092747|NCT01451749|3815261|FG000|STARTED|Overall Study||216
3092748|NCT01451749|3815262|FG001|STARTED|Overall Study||108
3092749|NCT01451749|3815261|FG000|COMPLETED|Overall Study||184
3092750|NCT01451749|3815262|FG001|COMPLETED|Overall Study||94
3092751|NCT01451749|3815261|FG000|NOT COMPLETED|Overall Study||32
3092752|NCT01451749|3815262|FG001|NOT COMPLETED|Overall Study||14
3092753|NCT01451762|3815273|FG000|STARTED|Overall Study||30
3092754|NCT01451762|3815274|FG001|STARTED|Overall Study||30
3092755|NCT01451762|3815275|FG002|STARTED|Overall Study||30
3092756|NCT01451762|3815273|FG000|COMPLETED|Overall Study||27
3092757|NCT01451762|3815274|FG001|COMPLETED|Overall Study||24
3092758|NCT01451762|3815275|FG002|COMPLETED|Overall Study||24
3092759|NCT01451762|3815273|FG000|NOT COMPLETED|Overall Study||3
3092760|NCT01451762|3815274|FG001|NOT COMPLETED|Overall Study||6
3092761|NCT01451762|3815275|FG002|NOT COMPLETED|Overall Study||6
3092762|NCT01451775|3815283|FG000|STARTED|Overall Study||3
3092763|NCT01451775|3815284|FG001|STARTED|Overall Study||3
3092764|NCT01451775|3815285|FG002|STARTED|Overall Study||3
3092765|NCT01451775|3815286|FG003|STARTED|Overall Study||3
3092766|NCT01451775|3815287|FG004|STARTED|Overall Study||3
3092767|NCT01451775|3815288|FG005|STARTED|Overall Study||3
3092768|NCT01451775|3815283|FG000|COMPLETED|Overall Study||3
3092769|NCT01451775|3815284|FG001|COMPLETED|Overall Study||3
3092770|NCT01451775|3815285|FG002|COMPLETED|Overall Study||3
3092771|NCT01451775|3815286|FG003|COMPLETED|Overall Study||3
3092772|NCT01451775|3815287|FG004|COMPLETED|Overall Study||3
3092773|NCT01451775|3815288|FG005|COMPLETED|Overall Study||3
3092774|NCT01451775|3815283|FG000|NOT COMPLETED|Overall Study||0
3092775|NCT01451775|3815284|FG001|NOT COMPLETED|Overall Study||0
3092776|NCT01451775|3815285|FG002|NOT COMPLETED|Overall Study||0
3092777|NCT01451775|3815286|FG003|NOT COMPLETED|Overall Study||0
3092778|NCT01451775|3815287|FG004|NOT COMPLETED|Overall Study||0
3092779|NCT01451775|3815288|FG005|NOT COMPLETED|Overall Study||0
3092780|NCT01451814|3815298|FG000|STARTED|Overall Study||35
3092781|NCT01451814|3815299|FG001|STARTED|Overall Study||31
3092782|NCT01451814|3815298|FG000|Attended a Session|Overall Study||35
3092783|NCT01451814|3815299|FG001|Attended a Session|Overall Study||31
3092784|NCT01451814|3815298|FG000|COMPLETED|Overall Study||29
3092785|NCT01451814|3815299|FG001|COMPLETED|Overall Study||26
3092786|NCT01451814|3815298|FG000|NOT COMPLETED|Overall Study||6
3092787|NCT01451814|3815299|FG001|NOT COMPLETED|Overall Study||5
3092788|NCT01451827|3815309|FG000|STARTED|Overall Study||45
3092789|NCT01451827|3815310|FG001|STARTED|Overall Study||45
3092790|NCT01451827|3815311|FG002|STARTED|Overall Study||44
3092791|NCT01451827|3815312|FG003|STARTED|Overall Study||43
3092792|NCT01451827|3815309|FG000|COMPLETED|Overall Study||42
3092793|NCT01451827|3815310|FG001|COMPLETED|Overall Study||40
3092794|NCT01451827|3815311|FG002|COMPLETED|Overall Study||42
3092795|NCT01451827|3815312|FG003|COMPLETED|Overall Study||39
3092796|NCT01451827|3815309|FG000|NOT COMPLETED|Overall Study||3
3092797|NCT01451827|3815310|FG001|NOT COMPLETED|Overall Study||5
3092798|NCT01451827|3815311|FG002|NOT COMPLETED|Overall Study||2
3092799|NCT01451827|3815312|FG003|NOT COMPLETED|Overall Study||4
3092800|NCT01451931|3815325|FG000|STARTED|Overall Study||909
3092801|NCT01451931|3815326|FG001|STARTED|Overall Study||901
3092802|NCT01451931|3815327|FG002|STARTED|Overall Study||966
3092803|NCT01451931|3815325|FG000|Baseline Data Collection|Overall Study||908
3092804|NCT01451931|3815326|FG001|Baseline Data Collection|Overall Study||893
3092805|NCT01451931|3815327|FG002|Baseline Data Collection|Overall Study||958
3092806|NCT01451931|3815325|FG000|6-month Follow up|Overall Study||876
3092807|NCT01451931|3815326|FG001|6-month Follow up|Overall Study||843
3092808|NCT01451931|3815327|FG002|6-month Follow up|Overall Study||923
3092809|NCT01451931|3815325|FG000|COMPLETED|Overall Study||876
3092810|NCT01451931|3815326|FG001|COMPLETED|Overall Study||843
3092811|NCT01451931|3815327|FG002|COMPLETED|Overall Study||923
3092812|NCT01451931|3815325|FG000|NOT COMPLETED|Overall Study||33
3092813|NCT01451931|3815326|FG001|NOT COMPLETED|Overall Study||58
3092814|NCT01451931|3815327|FG002|NOT COMPLETED|Overall Study||43
3092815|NCT01451983|3815340|FG000|STARTED|Overall Study||26
3092816|NCT01451983|3815341|FG001|STARTED|Overall Study||27
3092817|NCT01451983|3815342|FG002|STARTED|Overall Study||61
3092818|NCT01451983|3815343|FG003|STARTED|Overall Study||24
3092819|NCT01451983|3815340|FG000|COMPLETED|Overall Study||26
3092820|NCT01451983|3815341|FG001|COMPLETED|Overall Study||27
3092821|NCT01451983|3815342|FG002|COMPLETED|Overall Study||61
3092822|NCT01451983|3815343|FG003|COMPLETED|Overall Study||24
3092823|NCT01451983|3815340|FG000|NOT COMPLETED|Overall Study||0
3092824|NCT01451983|3815341|FG001|NOT COMPLETED|Overall Study||0
3092825|NCT01451983|3815342|FG002|NOT COMPLETED|Overall Study||0
3092826|NCT01451983|3815343|FG003|NOT COMPLETED|Overall Study||0
3092827|NCT01451996|3815357|FG000|STARTED|Overall Study||83
3092828|NCT01451996|3815358|FG001|STARTED|Overall Study||87
3092829|NCT01451996|3815359|FG002|STARTED|Overall Study||85
3092830|NCT01451996|3815360|FG003|STARTED|Overall Study||85
3092831|NCT01451996|3815357|FG000|COMPLETED|Overall Study||83
3092832|NCT01451996|3815358|FG001|COMPLETED|Overall Study||87
3092833|NCT01451996|3815359|FG002|COMPLETED|Overall Study||85
3092834|NCT01451996|3815360|FG003|COMPLETED|Overall Study||85
3092835|NCT01451996|3815357|FG000|NOT COMPLETED|Overall Study||0
3092836|NCT01451996|3815358|FG001|NOT COMPLETED|Overall Study||0
3092837|NCT01451996|3815359|FG002|NOT COMPLETED|Overall Study||0
3092838|NCT01451996|3815360|FG003|NOT COMPLETED|Overall Study||0
3092839|NCT01452126|3815370|FG000|STARTED|Overall Study||49
3092840|NCT01452126|3815370|FG000|COMPLETED|Overall Study||49
3092841|NCT01452126|3815370|FG000|NOT COMPLETED|Overall Study||0
3092842|NCT01452152|3815381|FG000|STARTED|Overall Study||5
3092843|NCT01452152|3815382|FG001|STARTED|Overall Study||0
3092844|NCT01452152|3815383|FG002|STARTED|Overall Study||4
3092845|NCT01452152|3815381|FG000|COMPLETED|Overall Study||0
3092846|NCT01452152|3815382|FG001|COMPLETED|Overall Study||0
3092847|NCT01452152|3815383|FG002|COMPLETED|Overall Study||0
3092848|NCT01452152|3815381|FG000|NOT COMPLETED|Overall Study||5
3092849|NCT01452152|3815382|FG001|NOT COMPLETED|Overall Study||0
3092850|NCT01452152|3815383|FG002|NOT COMPLETED|Overall Study||4
3092851|NCT01452191|3815394|FG000|STARTED|Overall Study||373
3092852|NCT01452191|3815395|FG001|STARTED|Overall Study||369
3092853|NCT01452191|3815396|FG002|STARTED|Overall Study||370
3092854|NCT01452191|3815394|FG000|COMPLETED|Overall Study||241
3092855|NCT01452191|3815395|FG001|COMPLETED|Overall Study||252
3092856|NCT01452191|3815396|FG002|COMPLETED|Overall Study||258
3092857|NCT01452191|3815394|FG000|NOT COMPLETED|Overall Study||132
3092858|NCT01452191|3815395|FG001|NOT COMPLETED|Overall Study||117
3092859|NCT01452191|3815396|FG002|NOT COMPLETED|Overall Study||112
3092860|NCT01452269|3815406|FG000|STARTED|Overall Study||48
3092861|NCT01452269|3815407|FG001|STARTED|Overall Study||56
3092862|NCT01452269|3815406|FG000|COMPLETED|Overall Study||47
3092863|NCT01452269|3815407|FG001|COMPLETED|Overall Study||51
3289340|NCT02810951|4023011|FG000|No FCX-007 Injection|Overall Study||6
3289341|NCT02810951|4023011|FG000|COMPLETED|Overall Study||5
3289342|NCT02810951|4023011|FG000|NOT COMPLETED|Overall Study||1
3289343|NCT02810964|4023019|FG000|STARTED|Placebo Run-In Phase (2 Weeks)||32
3092864|NCT01452269|3815406|FG000|NOT COMPLETED|Overall Study||1
3092865|NCT01452269|3815407|FG001|NOT COMPLETED|Overall Study||5
3092866|NCT01452347|3815415|FG000|STARTED|Overall Study||168
3092867|NCT01452347|3815416|FG001|STARTED|Overall Study||84
3092868|NCT01452347|3815415|FG000|COMPLETED|Overall Study||151
3092869|NCT01452347|3815416|FG001|COMPLETED|Overall Study||77
3092870|NCT01452347|3815415|FG000|NOT COMPLETED|Overall Study||17
3092871|NCT01452347|3815416|FG001|NOT COMPLETED|Overall Study||7
3092872|NCT01452412|3815426|FG000|STARTED|Overall Study||74
3092873|NCT01452412|3815427|FG001|STARTED|Overall Study||75
3092874|NCT01452412|3815426|FG000|COMPLETED|Overall Study||46
3092875|NCT01452412|3815427|FG001|COMPLETED|Overall Study||58
3092876|NCT01452412|3815426|FG000|NOT COMPLETED|Overall Study||28
3092877|NCT01452412|3815427|FG001|NOT COMPLETED|Overall Study||17
3092878|NCT01452425|3815433|FG000|STARTED|Overall Study||10
3092879|NCT01452425|3815433|FG000|COMPLETED|Overall Study||10
3092880|NCT01452425|3815433|FG000|NOT COMPLETED|Overall Study||0
3092881|NCT01452529|3815440|FG000|STARTED|Run-in Period||905
3092882|NCT01452529|3815441|FG001|STARTED|Run-in Period||0
3092883|NCT01452529|3815442|FG002|STARTED|Run-in Period||0
3092884|NCT01452529|3815440|FG000|COMPLETED|Run-in Period||592
3289344|NCT02810964|4023020|FG001|STARTED|Placebo Run-In Phase (2 Weeks)||32
3092885|NCT01452529|3815441|FG001|COMPLETED|Run-in Period||0
3092886|NCT01452529|3815442|FG002|COMPLETED|Run-in Period||0
3092887|NCT01452529|3815440|FG000|NOT COMPLETED|Run-in Period||313
3092888|NCT01452529|3815441|FG001|NOT COMPLETED|Run-in Period||0
3092889|NCT01452529|3815442|FG002|NOT COMPLETED|Run-in Period||0
3092890|NCT01452529|3815440|FG000|STARTED|Double-blind (DB) Period||0
3135128|NCT01704781|3860107|FG004|STARTED|Overall Study||12
3092891|NCT01452529|3815441|FG001|STARTED|Double-blind (DB) Period|Four subjects were randomized but did not receive DB medication|296
3092892|NCT01452529|3815442|FG002|STARTED|Double-blind (DB) Period||292
3092893|NCT01452529|3815440|FG000|COMPLETED|Double-blind (DB) Period||0
3092894|NCT01452529|3815441|FG001|COMPLETED|Double-blind (DB) Period|4 subjects who did not receive DB medication were still counted as discontinued in the DB period|229
3092895|NCT01452529|3815442|FG002|COMPLETED|Double-blind (DB) Period||210
3092896|NCT01452529|3815440|FG000|NOT COMPLETED|Double-blind (DB) Period||0
3092897|NCT01452529|3815441|FG001|NOT COMPLETED|Double-blind (DB) Period||67
3092898|NCT01452529|3815442|FG002|NOT COMPLETED|Double-blind (DB) Period||82
3092899|NCT01452789|3815451|FG000|STARTED|Overall Study||33
3092900|NCT01452789|3815452|FG001|STARTED|Overall Study||30
3092901|NCT01452789|3815451|FG000|COMPLETED|Overall Study||30
3092902|NCT01452789|3815452|FG001|COMPLETED|Overall Study||28
3092903|NCT01452789|3815451|FG000|NOT COMPLETED|Overall Study||3
3092904|NCT01452789|3815452|FG001|NOT COMPLETED|Overall Study||2
3092905|NCT01452919|3815458|FG000|STARTED|Open-Label Treatment||123
3092906|NCT01452919|3815459|FG001|STARTED|Open-Label Treatment||0
3092907|NCT01452919|3815460|FG002|STARTED|Open-Label Treatment||0
3092908|NCT01452919|3815458|FG000|Received at Least 1 Dose of Study Drug|Open-Label Treatment||123
3092909|NCT01452919|3815459|FG001|Received at Least 1 Dose of Study Drug|Open-Label Treatment||0
3092910|NCT01452919|3815460|FG002|Received at Least 1 Dose of Study Drug|Open-Label Treatment||0
3092911|NCT01452919|3815458|FG000|COMPLETED|Open-Label Treatment||103
3092912|NCT01452919|3815459|FG001|COMPLETED|Open-Label Treatment||0
3092913|NCT01452919|3815460|FG002|COMPLETED|Open-Label Treatment||0
3092914|NCT01452919|3815458|FG000|NOT COMPLETED|Open-Label Treatment||20
3092915|NCT01452919|3815459|FG001|NOT COMPLETED|Open-Label Treatment||0
3092916|NCT01452919|3815460|FG002|NOT COMPLETED|Open-Label Treatment||0
3092917|NCT01452919|3815458|FG000|STARTED|Randomization Treatment||0
3092918|NCT01452919|3815459|FG001|STARTED|Randomization Treatment||50
3092919|NCT01452919|3815460|FG002|STARTED|Randomization Treatment||53
3092920|NCT01452919|3815458|FG000|Received at Least 1 Dose of Study Drug|Randomization Treatment||0
3092921|NCT01452919|3815459|FG001|Received at Least 1 Dose of Study Drug|Randomization Treatment||50
3092922|NCT01452919|3815460|FG002|Received at Least 1 Dose of Study Drug|Randomization Treatment||53
3092923|NCT01452919|3815458|FG000|COMPLETED|Randomization Treatment||0
3092924|NCT01452919|3815459|FG001|COMPLETED|Randomization Treatment||47
3092925|NCT01452919|3815460|FG002|COMPLETED|Randomization Treatment||51
3092926|NCT01452919|3815458|FG000|NOT COMPLETED|Randomization Treatment||0
3092927|NCT01452919|3815459|FG001|NOT COMPLETED|Randomization Treatment||3
3092928|NCT01452919|3815460|FG002|NOT COMPLETED|Randomization Treatment||2
3092929|NCT01453023|3815470|FG000|STARTED|Treatment Period (TP) 1||13
3092930|NCT01453023|3815471|FG001|STARTED|Treatment Period (TP) 1||13
3092931|NCT01453023|3815470|FG000|COMPLETED|Treatment Period (TP) 1||12
3092932|NCT01453023|3815471|FG001|COMPLETED|Treatment Period (TP) 1||12
3289345|NCT02810964|4023019|FG000|COMPLETED|Placebo Run-In Phase (2 Weeks)||32
3289346|NCT02810964|4023020|FG001|COMPLETED|Placebo Run-In Phase (2 Weeks)||32
3289347|NCT02810964|4023019|FG000|NOT COMPLETED|Placebo Run-In Phase (2 Weeks)||0
3289348|NCT02810964|4023020|FG001|NOT COMPLETED|Placebo Run-In Phase (2 Weeks)||0
3289349|NCT02810964|4023019|FG000|STARTED|Double-Blind Treatment Phase (16 Weeks)||32
3289350|NCT02810964|4023020|FG001|STARTED|Double-Blind Treatment Phase (16 Weeks)||32
3092933|NCT01453023|3815470|FG000|NOT COMPLETED|Treatment Period (TP) 1||1
3092934|NCT01453023|3815471|FG001|NOT COMPLETED|Treatment Period (TP) 1||1
3092935|NCT01453023|3815470|FG000|STARTED|Washout Period||12
3092936|NCT01453023|3815471|FG001|STARTED|Washout Period||12
3092937|NCT01453023|3815470|FG000|COMPLETED|Washout Period||12
3092938|NCT01453023|3815471|FG001|COMPLETED|Washout Period||12
3092939|NCT01453023|3815470|FG000|NOT COMPLETED|Washout Period||0
3092940|NCT01453023|3815471|FG001|NOT COMPLETED|Washout Period||0
3092941|NCT01453023|3815470|FG000|STARTED|Treatment Period 2||12
3092942|NCT01453023|3815471|FG001|STARTED|Treatment Period 2||12
3092943|NCT01453023|3815470|FG000|COMPLETED|Treatment Period 2||12
3092944|NCT01453023|3815471|FG001|COMPLETED|Treatment Period 2||11
3092945|NCT01453023|3815470|FG000|NOT COMPLETED|Treatment Period 2||0
3092946|NCT01453023|3815471|FG001|NOT COMPLETED|Treatment Period 2||1
3092947|NCT01453036|3815480|FG000|STARTED|Overall Study||308
3092948|NCT01453036|3815481|FG001|STARTED|Overall Study||308
3092949|NCT01453036|3815482|FG002|STARTED|Overall Study||308
3092950|NCT01453036|3815480|FG000|COMPLETED|Overall Study||282
3092951|NCT01453036|3815481|FG001|COMPLETED|Overall Study||193
3092952|NCT01453036|3815482|FG002|COMPLETED|Overall Study||277
3092953|NCT01453036|3815480|FG000|NOT COMPLETED|Overall Study||26
3092954|NCT01453036|3815481|FG001|NOT COMPLETED|Overall Study||115
3092955|NCT01453036|3815482|FG002|NOT COMPLETED|Overall Study||31
3092956|NCT01453049|3815492|FG000|STARTED|Overall Study||42
3092957|NCT01453049|3815493|FG001|STARTED|Overall Study||44
3092958|NCT01453049|3815492|FG000|COMPLETED|Overall Study||1
3092959|NCT01453049|3815493|FG001|COMPLETED|Overall Study||2
3092960|NCT01453049|3815492|FG000|NOT COMPLETED|Overall Study||41
3092961|NCT01453049|3815493|FG001|NOT COMPLETED|Overall Study||42
3289351|NCT02810964|4023019|FG000|COMPLETED|Double-Blind Treatment Phase (16 Weeks)||29
3289352|NCT02810964|4023020|FG001|COMPLETED|Double-Blind Treatment Phase (16 Weeks)||29
3289353|NCT02810964|4023019|FG000|NOT COMPLETED|Double-Blind Treatment Phase (16 Weeks)||3
3289354|NCT02810964|4023020|FG001|NOT COMPLETED|Double-Blind Treatment Phase (16 Weeks)||3
3289355|NCT02811159|4023026|FG000|STARTED|Treatment Course 1||20
3092962|NCT01453075|3815501|FG000|STARTED|Overall Study||16
3092963|NCT01453075|3815502|FG001|STARTED|Overall Study||15
3092964|NCT01453075|3815501|FG000|COMPLETED|Overall Study||11
3092965|NCT01453075|3815502|FG001|COMPLETED|Overall Study||14
3092966|NCT01453075|3815501|FG000|NOT COMPLETED|Overall Study||5
3092967|NCT01453075|3815502|FG001|NOT COMPLETED|Overall Study||1
3092968|NCT01453153|3815511|FG000|STARTED|Overall Study||4
3092969|NCT01453153|3815512|FG001|STARTED|Overall Study||4
3092970|NCT01453153|3815513|FG002|STARTED|Overall Study||20
3092971|NCT01453153|3815511|FG000|COMPLETED|Overall Study||0
3092972|NCT01453153|3815512|FG001|COMPLETED|Overall Study||0
3092973|NCT01453153|3815513|FG002|COMPLETED|Overall Study||0
3092974|NCT01453153|3815511|FG000|NOT COMPLETED|Overall Study||4
3092975|NCT01453153|3815512|FG001|NOT COMPLETED|Overall Study||4
3092976|NCT01453153|3815513|FG002|NOT COMPLETED|Overall Study||20
3092977|NCT01453166|3815528|FG000|STARTED|Overall Study||42
3092978|NCT01453166|3815529|FG001|STARTED|Overall Study||41
3092979|NCT01453166|3815530|FG002|STARTED|Overall Study||39
3092980|NCT01453166|3815528|FG000|COMPLETED|Overall Study||40
3092981|NCT01453166|3815529|FG001|COMPLETED|Overall Study||39
3092982|NCT01453166|3815530|FG002|COMPLETED|Overall Study||38
3092983|NCT01453166|3815528|FG000|NOT COMPLETED|Overall Study||2
3092984|NCT01453166|3815529|FG001|NOT COMPLETED|Overall Study||2
3092985|NCT01453166|3815530|FG002|NOT COMPLETED|Overall Study||1
3092986|NCT01453205|3815541|FG000|STARTED|Overall Study||80
3092987|NCT01453205|3815542|FG001|STARTED|Overall Study||52
3092988|NCT01453205|3815543|FG002|STARTED|Overall Study||55
3092989|NCT01453205|3815541|FG000|COMPLETED|Overall Study||0
3092990|NCT01453205|3815542|FG001|COMPLETED|Overall Study||0
3092991|NCT01453205|3815543|FG002|COMPLETED|Overall Study||1
3092992|NCT01453205|3815541|FG000|NOT COMPLETED|Overall Study||80
3092993|NCT01453205|3815542|FG001|NOT COMPLETED|Overall Study||52
3092994|NCT01453205|3815543|FG002|NOT COMPLETED|Overall Study||54
3092995|NCT01453296|3815554|FG000|STARTED|Treatment Period 1||14
3092996|NCT01453296|3815555|FG001|STARTED|Treatment Period 1||14
3092997|NCT01453296|3815554|FG000|COMPLETED|Treatment Period 1||13
3092998|NCT01453296|3815555|FG001|COMPLETED|Treatment Period 1||13
3092999|NCT01453296|3815554|FG000|NOT COMPLETED|Treatment Period 1||1
3093000|NCT01453296|3815555|FG001|NOT COMPLETED|Treatment Period 1||1
3093001|NCT01453296|3815554|FG000|STARTED|Washout Period||13
3093002|NCT01453296|3815555|FG001|STARTED|Washout Period||13
3093003|NCT01453296|3815554|FG000|COMPLETED|Washout Period||13
3093004|NCT01453296|3815555|FG001|COMPLETED|Washout Period||13
3093005|NCT01453296|3815554|FG000|NOT COMPLETED|Washout Period||0
3093006|NCT01453296|3815555|FG001|NOT COMPLETED|Washout Period||0
3093007|NCT01453296|3815554|FG000|STARTED|Treatment Period 2||13
3093008|NCT01453296|3815555|FG001|STARTED|Treatment Period 2||13
3093009|NCT01453296|3815554|FG000|COMPLETED|Treatment Period 2||11
3093010|NCT01453296|3815555|FG001|COMPLETED|Treatment Period 2||13
3093011|NCT01453296|3815554|FG000|NOT COMPLETED|Treatment Period 2||2
3093012|NCT01453296|3815555|FG001|NOT COMPLETED|Treatment Period 2||0
3093013|NCT01453348|3815564|FG000|STARTED|Overall Study||84
3093014|NCT01453348|3815565|FG001|STARTED|Overall Study||84
3093015|NCT01453348|3815566|FG002|STARTED|Overall Study||84
3093016|NCT01453348|3815564|FG000|COMPLETED|Overall Study||83
3093017|NCT01453348|3815565|FG001|COMPLETED|Overall Study||83
3093018|NCT01453348|3815566|FG002|COMPLETED|Overall Study||83
3093019|NCT01453348|3815564|FG000|NOT COMPLETED|Overall Study||1
3093020|NCT01453348|3815565|FG001|NOT COMPLETED|Overall Study||1
3093021|NCT01453348|3815566|FG002|NOT COMPLETED|Overall Study||1
3093022|NCT01453361|3815577|FG000|STARTED|Overall Study||18
3093023|NCT01453361|3815577|FG000|COMPLETED|Overall Study||2
3093024|NCT01453361|3815577|FG000|NOT COMPLETED|Overall Study||16
3093025|NCT01453374|3815581|FG000|STARTED|Overall Study||27
3093026|NCT01453374|3815581|FG000|COMPLETED|Overall Study|Defined as receiving 7 injections and 2 follow-up visits.|9
3093027|NCT01453374|3815581|FG000|NOT COMPLETED|Overall Study||18
3093028|NCT01453387|3815589|FG000|STARTED|Overall Study||21
3093029|NCT01453387|3815590|FG001|STARTED|Overall Study||7
3093030|NCT01453387|3815589|FG000|COMPLETED|Overall Study||21
3093031|NCT01453387|3815590|FG001|COMPLETED|Overall Study||7
3093032|NCT01453387|3815589|FG000|NOT COMPLETED|Overall Study||0
3093033|NCT01453387|3815590|FG001|NOT COMPLETED|Overall Study||0
3093034|NCT01453413|3815613|FG000|STARTED|Overall Study||297
3093035|NCT01453413|3815613|FG000|COMPLETED|Overall Study||297
3093036|NCT01453413|3815613|FG000|NOT COMPLETED|Overall Study||0
3093037|NCT01453439|3815619|FG000|STARTED|Treatment Phase||61
3093038|NCT01453439|3815620|FG001|STARTED|Treatment Phase||59
3093039|NCT01453439|3815619|FG000|COMPLETED|Treatment Phase||44
3093040|NCT01453439|3815620|FG001|COMPLETED|Treatment Phase||48
3093041|NCT01453439|3815619|FG000|NOT COMPLETED|Treatment Phase||17
3093042|NCT01453439|3815620|FG001|NOT COMPLETED|Treatment Phase||11
3093043|NCT01453439|3815619|FG000|STARTED|Follow-up||44
3093044|NCT01453439|3815620|FG001|STARTED|Follow-up||48
3093045|NCT01453439|3815619|FG000|COMPLETED|Follow-up||39
3093046|NCT01453439|3815620|FG001|COMPLETED|Follow-up||37
3093047|NCT01453439|3815619|FG000|NOT COMPLETED|Follow-up||5
3093048|NCT01453439|3815620|FG001|NOT COMPLETED|Follow-up||11
3093049|NCT01453569|3815629|FG000|STARTED|Overall Study||86
3093050|NCT01453569|3815630|FG001|STARTED|Overall Study||84
3093051|NCT01453569|3815631|FG002|STARTED|Overall Study||85
3093052|NCT01453569|3815629|FG000|COMPLETED|Overall Study||75
3093053|NCT01453569|3815630|FG001|COMPLETED|Overall Study||70
3093054|NCT01453569|3815631|FG002|COMPLETED|Overall Study||78
3093055|NCT01453569|3815629|FG000|NOT COMPLETED|Overall Study||11
3093056|NCT01453569|3815630|FG001|NOT COMPLETED|Overall Study||14
3093057|NCT01453569|3815631|FG002|NOT COMPLETED|Overall Study||7
3093058|NCT01453595|3815642|FG000|STARTED|Overall Study||2
3093059|NCT01453595|3815643|FG001|STARTED|Overall Study||6
3093060|NCT01453595|3815644|FG002|STARTED|Overall Study||2
3093061|NCT01453595|3815642|FG000|COMPLETED|Overall Study||0
3093062|NCT01453595|3815643|FG001|COMPLETED|Overall Study||5
3093063|NCT01453595|3815644|FG002|COMPLETED|Overall Study||0
3093064|NCT01453595|3815642|FG000|NOT COMPLETED|Overall Study||2
3093065|NCT01453595|3815643|FG001|NOT COMPLETED|Overall Study||1
3093066|NCT01453595|3815644|FG002|NOT COMPLETED|Overall Study||2
3093067|NCT01453725|3815652|FG000|STARTED|Overall Study||98
3093068|NCT01453725|3815653|FG001|STARTED|Overall Study||100
3093069|NCT01453725|3815652|FG000|COMPLETED|Overall Study||85
3093070|NCT01453725|3815653|FG001|COMPLETED|Overall Study||89
3093071|NCT01453725|3815652|FG000|NOT COMPLETED|Overall Study||13
3093072|NCT01453725|3815653|FG001|NOT COMPLETED|Overall Study||11
3093073|NCT01453855|3815663|FG000|STARTED|Overall Study||442
3093074|NCT01453855|3815664|FG001|STARTED|Overall Study||422
3093075|NCT01453855|3815663|FG000|COMPLETED|Overall Study||432
3093076|NCT01453855|3815664|FG001|COMPLETED|Overall Study||408
3093077|NCT01453855|3815663|FG000|NOT COMPLETED|Overall Study||10
3093078|NCT01453855|3815664|FG001|NOT COMPLETED|Overall Study||14
3093079|NCT01453894|3815672|FG000|STARTED|Overall Study||225
3093080|NCT01453894|3815673|FG001|STARTED|Overall Study||225
3093081|NCT01453894|3815672|FG000|COMPLETED|Overall Study||225
3093082|NCT01453894|3815673|FG001|COMPLETED|Overall Study||225
3093083|NCT01453894|3815672|FG000|NOT COMPLETED|Overall Study||0
3093084|NCT01453894|3815673|FG001|NOT COMPLETED|Overall Study||0
3093085|NCT01453998|3815682|FG000|STARTED|Before Protocol Amendment 2||85
3093086|NCT01453998|3815683|FG001|STARTED|Before Protocol Amendment 2||88
3093087|NCT01453998|3815684|FG002|STARTED|Before Protocol Amendment 2||99
3093088|NCT01453998|3815682|FG000|COMPLETED|Before Protocol Amendment 2||85
3093089|NCT01453998|3815683|FG001|COMPLETED|Before Protocol Amendment 2||88
3093090|NCT01453998|3815684|FG002|COMPLETED|Before Protocol Amendment 2||99
3093091|NCT01453998|3815682|FG000|NOT COMPLETED|Before Protocol Amendment 2||0
3093092|NCT01453998|3815683|FG001|NOT COMPLETED|Before Protocol Amendment 2||0
3289356|NCT02811159|4023026|FG000|COMPLETED|Treatment Course 1||19
3289357|NCT02811159|4023026|FG000|NOT COMPLETED|Treatment Course 1||1
3289358|NCT02811159|4023026|FG000|STARTED|Treatment Course 2|Not all participants who completed the Treatment Course 1 entered the Treatment Course 2.|4
3289359|NCT02811159|4023026|FG000|COMPLETED|Treatment Course 2||4
3289360|NCT02811159|4023026|FG000|NOT COMPLETED|Treatment Course 2||0
3289361|NCT02811302|4023030|FG000|STARTED|Overall Study||1495
3289362|NCT02811302|4023030|FG000|COMPLETED|Overall Study||1282
3289363|NCT02811302|4023030|FG000|NOT COMPLETED|Overall Study||213
3289364|NCT02811419|4023037|FG000|STARTED|Overall Study||369
3289365|NCT02811419|4023038|FG001|STARTED|Overall Study||371
3289366|NCT02811419|4023037|FG000|COMPLETED|Overall Study||357
3289367|NCT02811419|4023038|FG001|COMPLETED|Overall Study||358
3289368|NCT02811419|4023037|FG000|NOT COMPLETED|Overall Study||12
3289369|NCT02811419|4023038|FG001|NOT COMPLETED|Overall Study||13
3289370|NCT02811445|4023046|FG000|STARTED|Overall Study||18
3289371|NCT02811445|4023047|FG001|STARTED|Overall Study||11
3289372|NCT02811445|4023046|FG000|COMPLETED|Overall Study||18
3289373|NCT02811445|4023047|FG001|COMPLETED|Overall Study||11
3289374|NCT02811445|4023046|FG000|NOT COMPLETED|Overall Study||0
3289375|NCT02811445|4023047|FG001|NOT COMPLETED|Overall Study||0
3289376|NCT02811640|4023053|FG000|STARTED|Overall Study||12
3289377|NCT02811640|4023053|FG000|COMPLETED|Overall Study||10
3289378|NCT02811640|4023053|FG000|NOT COMPLETED|Overall Study||2
3289379|NCT02811861|4023060|FG000|STARTED|Overall Study||357
3289380|NCT02811861|4023061|FG001|STARTED|Overall Study||355
3289381|NCT02811861|4023062|FG002|STARTED|Overall Study||357
3289382|NCT02811861|4023060|FG000|Treated|Overall Study||355
3289383|NCT02811861|4023061|FG001|Treated|Overall Study||352
3289384|NCT02811861|4023062|FG002|Treated|Overall Study||340
3289385|NCT02811861|4023060|FG000|COMPLETED|Overall Study||0
3289386|NCT02811861|4023061|FG001|COMPLETED|Overall Study||0
3289387|NCT02811861|4023062|FG002|COMPLETED|Overall Study||0
3289388|NCT02811861|4023060|FG000|NOT COMPLETED|Overall Study||357
3289389|NCT02811861|4023061|FG001|NOT COMPLETED|Overall Study||355
3289390|NCT02811861|4023062|FG002|NOT COMPLETED|Overall Study||357
3289391|NCT02811913|4023070|FG000|STARTED|Overall Study||20
3289392|NCT02811913|4023070|FG000|COMPLETED|Overall Study||16
3289393|NCT02811913|4023070|FG000|NOT COMPLETED|Overall Study||4
3289394|NCT02811965|4023079|FG000|STARTED|Overall Study||21
3289395|NCT02811965|4023079|FG000|COMPLETED|Overall Study||21
3093093|NCT01453998|3815684|FG002|NOT COMPLETED|Before Protocol Amendment 2||0
3093094|NCT01453998|3815682|FG000|STARTED|After Protocol Amendment 2.||131
3093095|NCT01453998|3815683|FG001|STARTED|After Protocol Amendment 2.||130
3093096|NCT01453998|3815684|FG002|STARTED|After Protocol Amendment 2.||124
3093097|NCT01453998|3815682|FG000|COMPLETED|After Protocol Amendment 2.||130
3093098|NCT01453998|3815683|FG001|COMPLETED|After Protocol Amendment 2.||130
3093099|NCT01453998|3815684|FG002|COMPLETED|After Protocol Amendment 2.||124
3093100|NCT01453998|3815682|FG000|NOT COMPLETED|After Protocol Amendment 2.||1
3093101|NCT01453998|3815683|FG001|NOT COMPLETED|After Protocol Amendment 2.||0
3093102|NCT01453998|3815684|FG002|NOT COMPLETED|After Protocol Amendment 2.||0
3289396|NCT02811965|4023079|FG000|NOT COMPLETED|Overall Study||0
3093103|NCT01454063|3815697|FG000|STARTED|Randomized||202
3093104|NCT01454063|3815698|FG001|STARTED|Randomized||203
3093105|NCT01454063|3815697|FG000|COMPLETED|Randomized||201
3093106|NCT01454063|3815698|FG001|COMPLETED|Randomized||201
3093107|NCT01454063|3815697|FG000|NOT COMPLETED|Randomized||1
3093108|NCT01454063|3815698|FG001|NOT COMPLETED|Randomized||2
3093109|NCT01454063|3815697|FG000|STARTED|Treated||201
3093110|NCT01454063|3815698|FG001|STARTED|Treated||201
3093111|NCT01454063|3815697|FG000|COMPLETED|Treated||199
3093112|NCT01454063|3815698|FG001|COMPLETED|Treated||201
3093113|NCT01454063|3815697|FG000|NOT COMPLETED|Treated||2
3093114|NCT01454063|3815698|FG001|NOT COMPLETED|Treated||0
3093115|NCT01454076|3815709|FG000|STARTED|Overall Study||29
3093116|NCT01454076|3815710|FG001|STARTED|Overall Study||20
3093117|NCT01454076|3815711|FG002|STARTED|Overall Study||24
3093118|NCT01454076|3815712|FG003|STARTED|Overall Study||18
3093119|NCT01454076|3815713|FG004|STARTED|Overall Study||21
3093120|NCT01454076|3815709|FG000|COMPLETED|Overall Study||16
3093121|NCT01454076|3815710|FG001|COMPLETED|Overall Study||14
3093122|NCT01454076|3815711|FG002|COMPLETED|Overall Study||15
3093123|NCT01454076|3815712|FG003|COMPLETED|Overall Study||16
3093124|NCT01454076|3815713|FG004|COMPLETED|Overall Study||15
3093125|NCT01454076|3815709|FG000|NOT COMPLETED|Overall Study||13
3093126|NCT01454076|3815710|FG001|NOT COMPLETED|Overall Study||6
3093127|NCT01454076|3815711|FG002|NOT COMPLETED|Overall Study||9
3093128|NCT01454076|3815712|FG003|NOT COMPLETED|Overall Study||2
3093129|NCT01454076|3815713|FG004|NOT COMPLETED|Overall Study||6
3093130|NCT01454102|3815750|FG000|STARTED|Overall Study||12
3093131|NCT01454102|3815751|FG001|STARTED|Overall Study||15
3093132|NCT01454102|3815752|FG002|STARTED|Overall Study||15
3093133|NCT01454102|3815753|FG003|STARTED|Overall Study||12
3093134|NCT01454102|3815754|FG004|STARTED|Overall Study||21
3093135|NCT01454102|3815755|FG005|STARTED|Overall Study||52
3093136|NCT01454102|3815756|FG006|STARTED|Overall Study||24
3093137|NCT01454102|3815757|FG007|STARTED|Overall Study||25
3093138|NCT01454102|3815758|FG008|STARTED|Overall Study||13
3093139|NCT01454102|3815759|FG009|STARTED|Overall Study||13
3093140|NCT01454102|3815760|FG010|STARTED|Overall Study||12
3093141|NCT01454102|3815761|FG011|STARTED|Overall Study||31
3093142|NCT01454102|3815762|FG012|STARTED|Overall Study||40
3093143|NCT01454102|3815763|FG013|STARTED|Overall Study||38
3093144|NCT01454102|3815764|FG014|STARTED|Overall Study||39
3093145|NCT01454102|3815765|FG015|STARTED|Overall Study||14
3093146|NCT01454102|3815750|FG000|COMPLETED|Overall Study||12
3093147|NCT01454102|3815751|FG001|COMPLETED|Overall Study||15
3093148|NCT01454102|3815752|FG002|COMPLETED|Overall Study||15
3093149|NCT01454102|3815753|FG003|COMPLETED|Overall Study||12
3093150|NCT01454102|3815754|FG004|COMPLETED|Overall Study||18
3093151|NCT01454102|3815755|FG005|COMPLETED|Overall Study||49
3093152|NCT01454102|3815756|FG006|COMPLETED|Overall Study||22
3093153|NCT01454102|3815757|FG007|COMPLETED|Overall Study||25
3093154|NCT01454102|3815758|FG008|COMPLETED|Overall Study||12
3093155|NCT01454102|3815759|FG009|COMPLETED|Overall Study||13
3093156|NCT01454102|3815760|FG010|COMPLETED|Overall Study||12
3093157|NCT01454102|3815761|FG011|COMPLETED|Overall Study||27
3093158|NCT01454102|3815762|FG012|COMPLETED|Overall Study||33
3093159|NCT01454102|3815763|FG013|COMPLETED|Overall Study||34
3093160|NCT01454102|3815764|FG014|COMPLETED|Overall Study||36
3093161|NCT01454102|3815765|FG015|COMPLETED|Overall Study||13
3093162|NCT01454102|3815750|FG000|NOT COMPLETED|Overall Study||0
3093163|NCT01454102|3815751|FG001|NOT COMPLETED|Overall Study||0
3093164|NCT01454102|3815752|FG002|NOT COMPLETED|Overall Study||0
3093165|NCT01454102|3815753|FG003|NOT COMPLETED|Overall Study||0
3093166|NCT01454102|3815754|FG004|NOT COMPLETED|Overall Study||3
3093167|NCT01454102|3815755|FG005|NOT COMPLETED|Overall Study||3
3093168|NCT01454102|3815756|FG006|NOT COMPLETED|Overall Study||2
3093169|NCT01454102|3815757|FG007|NOT COMPLETED|Overall Study||0
3093170|NCT01454102|3815758|FG008|NOT COMPLETED|Overall Study||1
3093171|NCT01454102|3815759|FG009|NOT COMPLETED|Overall Study||0
3093172|NCT01454102|3815760|FG010|NOT COMPLETED|Overall Study||0
3093173|NCT01454102|3815761|FG011|NOT COMPLETED|Overall Study||4
3093174|NCT01454102|3815762|FG012|NOT COMPLETED|Overall Study||7
3093175|NCT01454102|3815763|FG013|NOT COMPLETED|Overall Study||4
3093176|NCT01454102|3815764|FG014|NOT COMPLETED|Overall Study||3
3093177|NCT01454102|3815765|FG015|NOT COMPLETED|Overall Study||1
3093178|NCT01454258|3815800|FG000|STARTED|Overall Study||10100
3093179|NCT01454258|3815800|FG000|COMPLETED|Overall Study||9103
3093180|NCT01454258|3815800|FG000|NOT COMPLETED|Overall Study||997
3093181|NCT01454284|3815808|FG000|STARTED|Overall Study||664
3093182|NCT01454284|3815809|FG001|STARTED|Overall Study||450
3093183|NCT01454284|3815808|FG000|Received at Least 1 Dose of Study Drug|Overall Study||663
3093184|NCT01454284|3815809|FG001|Received at Least 1 Dose of Study Drug|Overall Study||449
3093185|NCT01454284|3815808|FG000|COMPLETED|Overall Study||548
3093186|NCT01454284|3815809|FG001|COMPLETED|Overall Study||377
3093187|NCT01454284|3815808|FG000|NOT COMPLETED|Overall Study||116
3093188|NCT01454284|3815809|FG001|NOT COMPLETED|Overall Study||73
3093189|NCT01454362|3815817|FG000|STARTED|Overall Study||28
3093190|NCT01454362|3815818|FG001|STARTED|Overall Study||23
3093191|NCT01454362|3815817|FG000|COMPLETED|Overall Study||28
3093192|NCT01454362|3815818|FG001|COMPLETED|Overall Study||23
3093193|NCT01454362|3815817|FG000|NOT COMPLETED|Overall Study||0
3093194|NCT01454362|3815818|FG001|NOT COMPLETED|Overall Study||0
3093195|NCT01454401|3815826|FG000|STARTED|Overall Study|ITT|44
3093196|NCT01454401|3815826|FG000|COMPLETED|Overall Study|Per Protocol (PP)|39
3093197|NCT01454401|3815826|FG000|NOT COMPLETED|Overall Study||5
3093198|NCT01454414|3815832|FG000|STARTED|Overall Study||79
3093199|NCT01454414|3815833|FG001|STARTED|Overall Study||80
3093200|NCT01454414|3815832|FG000|Baseline: Subjects That Sent Uniforms|Overall Study||67
3093201|NCT01454414|3815833|FG001|Baseline: Subjects That Sent Uniforms|Overall Study||66
3093202|NCT01454414|3815832|FG000|COMPLETED|Overall Study||66
3093203|NCT01454414|3815833|FG001|COMPLETED|Overall Study||64
3093204|NCT01454414|3815832|FG000|NOT COMPLETED|Overall Study||13
3093205|NCT01454414|3815833|FG001|NOT COMPLETED|Overall Study||16
3093206|NCT01454505|3815842|FG000|STARTED|Overall Study||35
3093207|NCT01454505|3815843|FG001|STARTED|Overall Study||15
3093208|NCT01454505|3815844|FG002|STARTED|Overall Study||40
3093209|NCT01454505|3815845|FG003|STARTED|Overall Study||20
3093210|NCT01454505|3815842|FG000|COMPLETED|Overall Study||35
3093211|NCT01454505|3815843|FG001|COMPLETED|Overall Study||15
3093212|NCT01454505|3815844|FG002|COMPLETED|Overall Study||40
3093213|NCT01454505|3815845|FG003|COMPLETED|Overall Study||20
3093214|NCT01454505|3815842|FG000|NOT COMPLETED|Overall Study||0
3093215|NCT01454505|3815843|FG001|NOT COMPLETED|Overall Study||0
3093216|NCT01454505|3815844|FG002|NOT COMPLETED|Overall Study||0
3093217|NCT01454505|3815845|FG003|NOT COMPLETED|Overall Study||0
3093218|NCT01454531|3815855|FG000|STARTED|Overall Study||196
3093219|NCT01454531|3815855|FG000|Subjects Treated|Overall Study||192
3093220|NCT01454531|3815855|FG000|COMPLETED|Overall Study||173
3093221|NCT01454531|3815855|FG000|NOT COMPLETED|Overall Study||23
3093222|NCT01454570|3815859|FG000|STARTED|Overall Study||19
3093223|NCT01454570|3815859|FG000|COMPLETED|Overall Study||10
3093224|NCT01454570|3815859|FG000|NOT COMPLETED|Overall Study||9
3093225|NCT01454583|3815866|FG000|STARTED|1st Year|From initially 15337 pat. 351 withdrawed from the registry, 14986 pat. were assigned to the groups.|10177
3093226|NCT01454583|3815867|FG001|STARTED|1st Year||2696
3093227|NCT01454583|3815868|FG002|STARTED|1st Year||2113
3093228|NCT01454583|3815866|FG000|COMPLETED|1st Year||9120
3093229|NCT01454583|3815867|FG001|COMPLETED|1st Year||2378
3093230|NCT01454583|3815868|FG002|COMPLETED|1st Year||1933
3093231|NCT01454583|3815866|FG000|NOT COMPLETED|1st Year||1057
3093232|NCT01454583|3815867|FG001|NOT COMPLETED|1st Year||318
3093233|NCT01454583|3815868|FG002|NOT COMPLETED|1st Year||180
3093234|NCT01454583|3815866|FG000|STARTED|2nd Year||10177
3093235|NCT01454583|3815867|FG001|STARTED|2nd Year||2696
3093236|NCT01454583|3815868|FG002|STARTED|2nd Year||2113
3093237|NCT01454583|3815866|FG000|COMPLETED|2nd Year||6212
3093238|NCT01454583|3815867|FG001|COMPLETED|2nd Year||1647
3093239|NCT01454583|3815868|FG002|COMPLETED|2nd Year||1376
3289397|NCT02812160|4023097|FG000|STARTED|Overall Study||187
3289398|NCT02812160|4023098|FG001|STARTED|Overall Study||101
3289399|NCT02812160|4023097|FG000|COMPLETED|Overall Study||187
3289400|NCT02812160|4023098|FG001|COMPLETED|Overall Study||101
3289401|NCT02812160|4023097|FG000|NOT COMPLETED|Overall Study||0
3289402|NCT02812160|4023098|FG001|NOT COMPLETED|Overall Study||0
3093240|NCT01454583|3815866|FG000|NOT COMPLETED|2nd Year||3965
3093241|NCT01454583|3815867|FG001|NOT COMPLETED|2nd Year||1049
3093242|NCT01454583|3815868|FG002|NOT COMPLETED|2nd Year||737
3093243|NCT01454583|3815866|FG000|STARTED|3rd Year||3791
3093244|NCT01454583|3815867|FG001|STARTED|3rd Year||982
3093245|NCT01454583|3815868|FG002|STARTED|3rd Year||582
3093246|NCT01454583|3815866|FG000|COMPLETED|3rd Year||1832
3093247|NCT01454583|3815867|FG001|COMPLETED|3rd Year||470
3093248|NCT01454583|3815868|FG002|COMPLETED|3rd Year||285
3093249|NCT01454583|3815866|FG000|NOT COMPLETED|3rd Year||1959
3093250|NCT01454583|3815867|FG001|NOT COMPLETED|3rd Year||512
3093251|NCT01454583|3815868|FG002|NOT COMPLETED|3rd Year||297
3093252|NCT01454596|3815888|FG000|STARTED|Overall Study||1
3093253|NCT01454596|3815889|FG001|STARTED|Overall Study||1
3093254|NCT01454596|3815890|FG002|STARTED|Overall Study||1
3093255|NCT01454596|3815891|FG003|STARTED|Overall Study||1
3093256|NCT01454596|3815892|FG004|STARTED|Overall Study||1
3093257|NCT01454596|3815893|FG005|STARTED|Overall Study||1
3093258|NCT01454596|3815894|FG006|STARTED|Overall Study||1
3093259|NCT01454596|3815895|FG007|STARTED|Overall Study||3
3093260|NCT01454596|3815896|FG008|STARTED|Overall Study||3
3093261|NCT01454596|3815897|FG009|STARTED|Overall Study||3
3093262|NCT01454596|3815898|FG010|STARTED|Overall Study||1
3093263|NCT01454596|3815899|FG011|STARTED|Overall Study||1
3093264|NCT01454596|3815888|FG000|COMPLETED|Overall Study||1
3093265|NCT01454596|3815889|FG001|COMPLETED|Overall Study||1
3093266|NCT01454596|3815890|FG002|COMPLETED|Overall Study||1
3093267|NCT01454596|3815891|FG003|COMPLETED|Overall Study||1
3093268|NCT01454596|3815892|FG004|COMPLETED|Overall Study||1
3289403|NCT02812186|4023106|FG000|STARTED|Period 1||40
3289404|NCT02812186|4023107|FG001|STARTED|Period 1||39
3289405|NCT02812186|4023106|FG000|COMPLETED|Period 1||29
3289406|NCT02812186|4023107|FG001|COMPLETED|Period 1||24
3289407|NCT02812186|4023106|FG000|NOT COMPLETED|Period 1||11
3289408|NCT02812186|4023107|FG001|NOT COMPLETED|Period 1||15
3289409|NCT02812186|4023106|FG000|STARTED|Period 2||29
3289410|NCT02812186|4023107|FG001|STARTED|Period 2||24
3289411|NCT02812186|4023106|FG000|COMPLETED|Period 2||29
3093269|NCT01454596|3815893|FG005|COMPLETED|Overall Study||1
3093270|NCT01454596|3815894|FG006|COMPLETED|Overall Study||1
3093271|NCT01454596|3815895|FG007|COMPLETED|Overall Study||3
3093272|NCT01454596|3815896|FG008|COMPLETED|Overall Study||3
3093273|NCT01454596|3815897|FG009|COMPLETED|Overall Study||2
3093274|NCT01454596|3815898|FG010|COMPLETED|Overall Study||0
3289412|NCT02812186|4023107|FG001|COMPLETED|Period 2||24
3289413|NCT02812186|4023106|FG000|NOT COMPLETED|Period 2||0
3093275|NCT01454596|3815899|FG011|COMPLETED|Overall Study||1
3093276|NCT01454596|3815888|FG000|NOT COMPLETED|Overall Study||0
3093277|NCT01454596|3815889|FG001|NOT COMPLETED|Overall Study||0
3093278|NCT01454596|3815890|FG002|NOT COMPLETED|Overall Study||0
3093279|NCT01454596|3815891|FG003|NOT COMPLETED|Overall Study||0
3093280|NCT01454596|3815892|FG004|NOT COMPLETED|Overall Study||0
3093281|NCT01454596|3815893|FG005|NOT COMPLETED|Overall Study||0
3093282|NCT01454596|3815894|FG006|NOT COMPLETED|Overall Study||0
3093283|NCT01454596|3815895|FG007|NOT COMPLETED|Overall Study||0
3093284|NCT01454596|3815896|FG008|NOT COMPLETED|Overall Study||0
3093285|NCT01454596|3815897|FG009|NOT COMPLETED|Overall Study||1
3093286|NCT01454596|3815898|FG010|NOT COMPLETED|Overall Study||1
3093287|NCT01454596|3815899|FG011|NOT COMPLETED|Overall Study||0
3093288|NCT01454726|3815927|FG000|STARTED|Overall Study||16
3093289|NCT01454726|3815928|FG001|STARTED|Overall Study||11
3093290|NCT01454726|3815927|FG000|COMPLETED|Overall Study||16
3093291|NCT01454726|3815928|FG001|COMPLETED|Overall Study||10
3093292|NCT01454726|3815927|FG000|NOT COMPLETED|Overall Study||0
3093293|NCT01454726|3815928|FG001|NOT COMPLETED|Overall Study||1
3093294|NCT01454739|3815936|FG000|STARTED|Overall Study|30 participants in <6 Years Old Age Cohort and 31 participants in 6 to <12 Years Old Age Cohort.|61
3093295|NCT01454739|3815937|FG001|STARTED|Overall Study||179
3093296|NCT01454739|3815936|FG000|Tailored Prophylaxis|Overall Study||59
3093297|NCT01454739|3815937|FG001|Tailored Prophylaxis|Overall Study||131
3093298|NCT01454739|3815936|FG000|Weekly Prophylaxis|Overall Study||0
3093299|NCT01454739|3815937|FG001|Weekly Prophylaxis|Overall Study||34
3093300|NCT01454739|3815936|FG000|Personalized Prophylaxis|Overall Study||3
3093301|NCT01454739|3815937|FG001|Personalized Prophylaxis|Overall Study||23
3093302|NCT01454739|3815936|FG000|Episodic|Overall Study||0
3093303|NCT01454739|3815937|FG001|Episodic|Overall Study||13
3093304|NCT01454739|3815936|FG000|Surgery Subgroup|Overall Study||2
3093305|NCT01454739|3815937|FG001|Surgery Subgroup|Overall Study||26
3093306|NCT01454739|3815936|FG000|COMPLETED|Overall Study||54
3093307|NCT01454739|3815937|FG001|COMPLETED|Overall Study||158
3093308|NCT01454739|3815936|FG000|NOT COMPLETED|Overall Study||7
3093309|NCT01454739|3815937|FG001|NOT COMPLETED|Overall Study||21
3093310|NCT01454778|3815950|FG000|STARTED|Overall Study||50
3093311|NCT01454778|3815950|FG000|COMPLETED|Overall Study||47
3093312|NCT01454778|3815950|FG000|NOT COMPLETED|Overall Study||3
3093313|NCT01454791|3815956|FG000|STARTED|Overall Study||20
3093314|NCT01454791|3815957|FG001|STARTED|Overall Study||20
3093315|NCT01454791|3815956|FG000|COMPLETED|Overall Study|20 subjects started with Diclofenac, then switched to placebo|20
3093316|NCT01454791|3815957|FG001|COMPLETED|Overall Study|20 subjects started with placebo, then switched to Diclofenac|20
3093317|NCT01454791|3815956|FG000|NOT COMPLETED|Overall Study||0
3093318|NCT01454791|3815957|FG001|NOT COMPLETED|Overall Study||0
3093319|NCT01454830|3815967|FG000|STARTED|Overall Study||61
3093320|NCT01454830|3815968|FG001|STARTED|Overall Study||57
3093321|NCT01454830|3815967|FG000|COMPLETED|Overall Study||30
3093322|NCT01454830|3815968|FG001|COMPLETED|Overall Study||30
3093323|NCT01454830|3815967|FG000|NOT COMPLETED|Overall Study||31
3093324|NCT01454830|3815968|FG001|NOT COMPLETED|Overall Study||27
3093325|NCT01454934|3815976|FG000|STARTED|Overall Study||270
3093326|NCT01454934|3815977|FG001|STARTED|Overall Study||270
3093327|NCT01454934|3815976|FG000|COMPLETED|Overall Study||0
3093328|NCT01454934|3815977|FG001|COMPLETED|Overall Study||0
3093329|NCT01454934|3815976|FG000|NOT COMPLETED|Overall Study||270
3093330|NCT01454934|3815977|FG001|NOT COMPLETED|Overall Study||270
3093331|NCT01454947|3815991|FG000|STARTED|Overall Study||27
3093332|NCT01454947|3815992|FG001|STARTED|Overall Study||42
3093333|NCT01454947|3815993|FG002|STARTED|Overall Study||35
3093334|NCT01454947|3815994|FG003|STARTED|Overall Study||20
3093335|NCT01454947|3815995|FG004|STARTED|Overall Study||34
3093336|NCT01454947|3815996|FG005|STARTED|Overall Study||35
3093337|NCT01454947|3815997|FG006|STARTED|Overall Study||27
3093338|NCT01454947|3815998|FG007|STARTED|Overall Study||28
3093339|NCT01454947|3815991|FG000|COMPLETED|Overall Study||24
3093340|NCT01454947|3815992|FG001|COMPLETED|Overall Study||38
3093341|NCT01454947|3815993|FG002|COMPLETED|Overall Study||32
3093342|NCT01454947|3815994|FG003|COMPLETED|Overall Study||19
3093343|NCT01454947|3815995|FG004|COMPLETED|Overall Study||33
3093344|NCT01454947|3815996|FG005|COMPLETED|Overall Study||32
3093345|NCT01454947|3815997|FG006|COMPLETED|Overall Study||26
3093346|NCT01454947|3815998|FG007|COMPLETED|Overall Study||23
3093347|NCT01454947|3815991|FG000|NOT COMPLETED|Overall Study||3
3093348|NCT01454947|3815992|FG001|NOT COMPLETED|Overall Study||4
3093349|NCT01454947|3815993|FG002|NOT COMPLETED|Overall Study||3
3093350|NCT01454947|3815994|FG003|NOT COMPLETED|Overall Study||1
3093351|NCT01454947|3815995|FG004|NOT COMPLETED|Overall Study||1
3093352|NCT01454947|3815996|FG005|NOT COMPLETED|Overall Study||3
3093353|NCT01454947|3815997|FG006|NOT COMPLETED|Overall Study||1
3093354|NCT01454947|3815998|FG007|NOT COMPLETED|Overall Study||5
3093355|NCT01455012|3816018|FG000|STARTED|Overall Study||41
3093356|NCT01455012|3816019|FG001|STARTED|Overall Study||40
3093357|NCT01455012|3816018|FG000|COMPLETED|Overall Study||30
3093358|NCT01455012|3816019|FG001|COMPLETED|Overall Study||36
3093359|NCT01455012|3816018|FG000|NOT COMPLETED|Overall Study||11
3093360|NCT01455012|3816019|FG001|NOT COMPLETED|Overall Study||4
3093361|NCT01455064|3816025|FG000|STARTED|Overall Study||31
3093362|NCT01455064|3816025|FG000|COMPLETED|Overall Study||30
3093363|NCT01455064|3816025|FG000|NOT COMPLETED|Overall Study||1
3093364|NCT01455181|3816029|FG000|STARTED|Overall Study||24
3093365|NCT01455181|3816029|FG000|COMPLETED|Overall Study||24
3093366|NCT01455181|3816029|FG000|NOT COMPLETED|Overall Study||0
3093367|NCT01455194|3816036|FG000|STARTED|Overall Study||153
3093368|NCT01455194|3816037|FG001|STARTED|Overall Study||120
3093369|NCT01455194|3816038|FG002|STARTED|Overall Study||122
3093370|NCT01455194|3816039|FG003|STARTED|Overall Study||125
3093371|NCT01455194|3816036|FG000|COMPLETED|Overall Study||0
3093372|NCT01455194|3816037|FG001|COMPLETED|Overall Study||89
3093373|NCT01455194|3816038|FG002|COMPLETED|Overall Study||92
3093374|NCT01455194|3816039|FG003|COMPLETED|Overall Study||97
3093375|NCT01455194|3816036|FG000|NOT COMPLETED|Overall Study||153
3093376|NCT01455194|3816037|FG001|NOT COMPLETED|Overall Study||31
3093377|NCT01455194|3816038|FG002|NOT COMPLETED|Overall Study||30
3093378|NCT01455194|3816039|FG003|NOT COMPLETED|Overall Study||28
3093379|NCT01455220|3816052|FG000|STARTED|Overall Study||45
3093380|NCT01455220|3816052|FG000|COMPLETED|Overall Study||15
3093381|NCT01455220|3816052|FG000|NOT COMPLETED|Overall Study||30
3093382|NCT01455415|3816061|FG000|STARTED|Period 1|Started=Treated|154
3093383|NCT01455415|3816062|FG001|STARTED|Period 1|Started=Treated|147
3093384|NCT01455415|3816061|FG000|COMPLETED|Period 1||135
3093385|NCT01455415|3816062|FG001|COMPLETED|Period 1||123
3093386|NCT01455415|3816061|FG000|NOT COMPLETED|Period 1||19
3093387|NCT01455415|3816062|FG001|NOT COMPLETED|Period 1||24
3093388|NCT01455415|3816061|FG000|STARTED|Washout||135
3093389|NCT01455415|3816062|FG001|STARTED|Washout||123
3093390|NCT01455415|3816061|FG000|COMPLETED|Washout||127
3093391|NCT01455415|3816062|FG001|COMPLETED|Washout||116
3093392|NCT01455415|3816061|FG000|NOT COMPLETED|Washout||8
3093393|NCT01455415|3816062|FG001|NOT COMPLETED|Washout||7
3093394|NCT01455415|3816061|FG000|STARTED|Period 2||127
3093395|NCT01455415|3816062|FG001|STARTED|Period 2||116
3093396|NCT01455415|3816061|FG000|COMPLETED|Period 2||114
3093397|NCT01455415|3816062|FG001|COMPLETED|Period 2||106
3093398|NCT01455415|3816061|FG000|NOT COMPLETED|Period 2||13
3093399|NCT01455415|3816062|FG001|NOT COMPLETED|Period 2||10
3093400|NCT01455415|3816061|FG000|STARTED|Follow-up||114
3093401|NCT01455415|3816062|FG001|STARTED|Follow-up||106
3093402|NCT01455415|3816061|FG000|COMPLETED|Follow-up||111
3093403|NCT01455415|3816062|FG001|COMPLETED|Follow-up||104
3093404|NCT01455415|3816061|FG000|NOT COMPLETED|Follow-up||3
3093405|NCT01455415|3816062|FG001|NOT COMPLETED|Follow-up||2
3093406|NCT01455428|3816070|FG000|STARTED|Overall Study||112
3093407|NCT01455428|3816071|FG001|STARTED|Overall Study||110
3093408|NCT01455428|3816070|FG000|Treated|Overall Study||111
3093409|NCT01455428|3816071|FG001|Treated|Overall Study||109
3093410|NCT01455428|3816070|FG000|COMPLETED|Overall Study||98
3093411|NCT01455428|3816071|FG001|COMPLETED|Overall Study||92
3093412|NCT01455428|3816070|FG000|NOT COMPLETED|Overall Study||14
3093413|NCT01455428|3816071|FG001|NOT COMPLETED|Overall Study||18
3093414|NCT01455519|3816079|FG000|STARTED|Overall Study||12
3093415|NCT01455519|3816080|FG001|STARTED|Overall Study||23
3093416|NCT01455519|3816079|FG000|COMPLETED|Overall Study||8
3093417|NCT01455519|3816080|FG001|COMPLETED|Overall Study||18
3093418|NCT01455519|3816079|FG000|NOT COMPLETED|Overall Study||4
3093419|NCT01455519|3816080|FG001|NOT COMPLETED|Overall Study||5
3093420|NCT01455545|3816086|FG000|STARTED|Overall Study||55
3093421|NCT01455545|3816087|FG001|STARTED|Overall Study||45
3093422|NCT01455545|3816086|FG000|COMPLETED|Overall Study||55
3093423|NCT01455545|3816087|FG001|COMPLETED|Overall Study||45
3093424|NCT01455545|3816086|FG000|NOT COMPLETED|Overall Study||0
3093425|NCT01455545|3816087|FG001|NOT COMPLETED|Overall Study||0
3093426|NCT01456000|3816104|FG000|STARTED|Overall Study||178
3093427|NCT01456000|3816105|FG001|STARTED|Overall Study||175
3093428|NCT01456000|3816104|FG000|COMPLETED|Overall Study||170
3093429|NCT01456000|3816105|FG001|COMPLETED|Overall Study||172
3093430|NCT01456000|3816104|FG000|NOT COMPLETED|Overall Study||8
3093431|NCT01456000|3816105|FG001|NOT COMPLETED|Overall Study||3
3093432|NCT01456039|3816114|FG000|STARTED|Phase 1 (First Step)||3
3093433|NCT01456039|3816115|FG001|STARTED|Phase 1 (First Step)||8
3093434|NCT01456039|3816116|FG002|STARTED|Phase 1 (First Step)||0
3093435|NCT01456039|3816114|FG000|COMPLETED|Phase 1 (First Step)|Completed = on treatment|1
3093436|NCT01456039|3816115|FG001|COMPLETED|Phase 1 (First Step)|Completed = on treatment|1
3093437|NCT01456039|3816116|FG002|COMPLETED|Phase 1 (First Step)||0
3093438|NCT01456039|3816114|FG000|NOT COMPLETED|Phase 1 (First Step)||2
3093439|NCT01456039|3816115|FG001|NOT COMPLETED|Phase 1 (First Step)||7
3093440|NCT01456039|3816116|FG002|NOT COMPLETED|Phase 1 (First Step)||0
3093441|NCT01456039|3816114|FG000|STARTED|Phase 2 (Second Step)||0
3093442|NCT01456039|3816115|FG001|STARTED|Phase 2 (Second Step)||0
3093443|NCT01456039|3816116|FG002|STARTED|Phase 2 (Second Step)||40
3093444|NCT01456039|3816114|FG000|COMPLETED|Phase 2 (Second Step)||0
3289414|NCT02812186|4023107|FG001|NOT COMPLETED|Period 2||0
3289415|NCT02812238|4023116|FG000|STARTED|First Intervention||19
3289416|NCT02812238|4023117|FG001|STARTED|First Intervention||19
3289417|NCT02812238|4023116|FG000|COMPLETED|First Intervention||18
3289418|NCT02812238|4023117|FG001|COMPLETED|First Intervention||19
3093445|NCT01456039|3816115|FG001|COMPLETED|Phase 2 (Second Step)||0
3093446|NCT01456039|3816116|FG002|COMPLETED|Phase 2 (Second Step)||7
3093447|NCT01456039|3816114|FG000|NOT COMPLETED|Phase 2 (Second Step)||0
3093448|NCT01456039|3816115|FG001|NOT COMPLETED|Phase 2 (Second Step)||0
3093449|NCT01456039|3816116|FG002|NOT COMPLETED|Phase 2 (Second Step)||33
3093450|NCT01456052|3816135|FG000|STARTED|Overall Study||10
3135129|NCT01704781|3860103|FG000|COMPLETED|Overall Study||3
3093451|NCT01456052|3816136|FG001|STARTED|Overall Study|One subject did not receive any study drug. That subject is not included in the safety population.|25
3093452|NCT01456052|3816137|FG002|STARTED|Overall Study||24
3093453|NCT01456052|3816135|FG000|COMPLETED|Overall Study||8
3093454|NCT01456052|3816136|FG001|COMPLETED|Overall Study||20
3093455|NCT01456052|3816137|FG002|COMPLETED|Overall Study||19
3093456|NCT01456052|3816135|FG000|NOT COMPLETED|Overall Study||2
3093457|NCT01456052|3816136|FG001|NOT COMPLETED|Overall Study||5
3093458|NCT01456052|3816137|FG002|NOT COMPLETED|Overall Study||5
3093459|NCT01456130|3816146|FG000|STARTED|Overall Study||67
3093460|NCT01456130|3816146|FG000|COMPLETED|Overall Study||57
3093461|NCT01456130|3816146|FG000|NOT COMPLETED|Overall Study||10
3093462|NCT01456143|3816150|FG000|STARTED|Overall Study||33
3093463|NCT01456143|3816150|FG000|COMPLETED|Overall Study||33
3093464|NCT01456143|3816150|FG000|NOT COMPLETED|Overall Study||0
3093465|NCT01456169|3816157|FG000|STARTED|Overall Study|Indicates participants who were randomized into the double-blind treatment period|133
3093466|NCT01456169|3816158|FG001|STARTED|Overall Study|Indicates participants who were randomized into the double-blind treatment period|127
3093467|NCT01456169|3816159|FG002|STARTED|Overall Study|Indicates participants who were randomized into the double-blind treatment period|135
3093468|NCT01456169|3816157|FG000|COMPLETED|Overall Study||123
3093469|NCT01456169|3816158|FG001|COMPLETED|Overall Study||122
3093470|NCT01456169|3816159|FG002|COMPLETED|Overall Study||123
3093471|NCT01456169|3816157|FG000|NOT COMPLETED|Overall Study||10
3093472|NCT01456169|3816158|FG001|NOT COMPLETED|Overall Study||5
3093473|NCT01456169|3816159|FG002|NOT COMPLETED|Overall Study||12
3093474|NCT01456195|3816171|FG000|STARTED|Overall Study||143
3093475|NCT01456195|3816172|FG001|STARTED|Overall Study||137
3093476|NCT01456195|3816173|FG002|STARTED|Overall Study||141
3093477|NCT01456195|3816171|FG000|COMPLETED|Overall Study||132
3093478|NCT01456195|3816172|FG001|COMPLETED|Overall Study||127
3093479|NCT01456195|3816173|FG002|COMPLETED|Overall Study||127
3093480|NCT01456195|3816171|FG000|NOT COMPLETED|Overall Study||11
3093481|NCT01456195|3816172|FG001|NOT COMPLETED|Overall Study||10
3093482|NCT01456195|3816173|FG002|NOT COMPLETED|Overall Study||14
3093483|NCT01456221|3816183|FG000|STARTED|Overall Study||183
3093484|NCT01456221|3816184|FG001|STARTED|Overall Study||183
3093485|NCT01456221|3816183|FG000|COMPLETED|Overall Study||119
3093486|NCT01456221|3816184|FG001|COMPLETED|Overall Study||126
3093487|NCT01456221|3816183|FG000|NOT COMPLETED|Overall Study||64
3093488|NCT01456221|3816184|FG001|NOT COMPLETED|Overall Study||57
3093489|NCT01456299|3816193|FG000|STARTED|Overall Study||34
3093490|NCT01456299|3816194|FG001|STARTED|Overall Study||34
3093491|NCT01456299|3816195|FG002|STARTED|Overall Study||34
3093492|NCT01456299|3816193|FG000|COMPLETED|Overall Study||34
3093493|NCT01456299|3816194|FG001|COMPLETED|Overall Study||33
3093494|NCT01456299|3816195|FG002|COMPLETED|Overall Study||33
3093495|NCT01456299|3816193|FG000|NOT COMPLETED|Overall Study||0
3093496|NCT01456299|3816194|FG001|NOT COMPLETED|Overall Study||1
3093497|NCT01456299|3816195|FG002|NOT COMPLETED|Overall Study||1
3093498|NCT01456494|3816205|FG000|STARTED|Initial Inpatient Visit||24
3289419|NCT02812238|4023116|FG000|NOT COMPLETED|First Intervention||1
3289420|NCT02812238|4023117|FG001|NOT COMPLETED|First Intervention||0
3289421|NCT02812238|4023116|FG000|STARTED|Second Intervention||18
3289422|NCT02812238|4023117|FG001|STARTED|Second Intervention||19
3289423|NCT02812238|4023116|FG000|COMPLETED|Second Intervention||18
3289424|NCT02812238|4023117|FG001|COMPLETED|Second Intervention||18
3289425|NCT02812238|4023116|FG000|NOT COMPLETED|Second Intervention||0
3289426|NCT02812238|4023117|FG001|NOT COMPLETED|Second Intervention||1
3289427|NCT02812342|4023123|FG000|STARTED|Overall Study||10
3289428|NCT02812342|4023123|FG000|COMPLETED|Overall Study||10
3289429|NCT02812342|4023123|FG000|NOT COMPLETED|Overall Study||0
3289430|NCT02812771|4023127|FG000|STARTED|Overall Study||62
3289431|NCT02812771|4023127|FG000|COMPLETED|Overall Study||50
3289432|NCT02812771|4023127|FG000|NOT COMPLETED|Overall Study||12
3289433|NCT02813070|4023134|FG000|STARTED|Overall Study||28
3289434|NCT02813070|4023135|FG001|STARTED|Overall Study||23
3289435|NCT02813070|4023136|FG002|STARTED|Overall Study||36
3289436|NCT02813070|4023134|FG000|Treated (Safety Population)|Overall Study||25
3289437|NCT02813070|4023135|FG001|Treated (Safety Population)|Overall Study||20
3289438|NCT02813070|4023136|FG002|Treated (Safety Population)|Overall Study||25
3289439|NCT02813070|4023134|FG000|COMPLETED|Overall Study||25
3289440|NCT02813070|4023135|FG001|COMPLETED|Overall Study||20
3289441|NCT02813070|4023136|FG002|COMPLETED|Overall Study||25
3289442|NCT02813070|4023134|FG000|NOT COMPLETED|Overall Study||3
3289443|NCT02813070|4023135|FG001|NOT COMPLETED|Overall Study||3
3289444|NCT02813070|4023136|FG002|NOT COMPLETED|Overall Study||11
3289445|NCT02813265|4023145|FG000|STARTED|Overall Study||459
3289446|NCT02813265|4023146|FG001|STARTED|Overall Study||456
3289447|NCT02813265|4023145|FG000|COMPLETED|Overall Study||455
3289448|NCT02813265|4023146|FG001|COMPLETED|Overall Study||453
3289449|NCT02813265|4023145|FG000|NOT COMPLETED|Overall Study||4
3289450|NCT02813265|4023146|FG001|NOT COMPLETED|Overall Study||3
3289451|NCT02813421|4023154|FG000|STARTED|Overall Study||5
3093499|NCT01456494|3816206|FG001|STARTED|Initial Inpatient Visit||26
3289452|NCT02813421|4023155|FG001|STARTED|Overall Study||6
3289453|NCT02813421|4023154|FG000|COMPLETED|Overall Study||3
3289454|NCT02813421|4023155|FG001|COMPLETED|Overall Study||3
3093500|NCT01456494|3816205|FG000|COMPLETED|Initial Inpatient Visit||24
3093501|NCT01456494|3816206|FG001|COMPLETED|Initial Inpatient Visit||26
3093502|NCT01456494|3816205|FG000|NOT COMPLETED|Initial Inpatient Visit||0
3093503|NCT01456494|3816206|FG001|NOT COMPLETED|Initial Inpatient Visit||0
3093504|NCT01456494|3816205|FG000|STARTED|Follow-Up Visit (Post 30-day Discharge)||24
3093505|NCT01456494|3816206|FG001|STARTED|Follow-Up Visit (Post 30-day Discharge)||26
3093506|NCT01456494|3816205|FG000|COMPLETED|Follow-Up Visit (Post 30-day Discharge)||19
3093507|NCT01456494|3816206|FG001|COMPLETED|Follow-Up Visit (Post 30-day Discharge)||20
3093508|NCT01456494|3816205|FG000|NOT COMPLETED|Follow-Up Visit (Post 30-day Discharge)||5
3093509|NCT01456494|3816206|FG001|NOT COMPLETED|Follow-Up Visit (Post 30-day Discharge)||6
3093510|NCT01456780|3816215|FG000|STARTED|Overall Study||20
3093511|NCT01456780|3816216|FG001|STARTED|Overall Study||20
3093512|NCT01456780|3816217|FG002|STARTED|Overall Study||20
3093513|NCT01456780|3816215|FG000|COMPLETED|Overall Study||17
3093514|NCT01456780|3816216|FG001|COMPLETED|Overall Study||17
3093515|NCT01456780|3816217|FG002|COMPLETED|Overall Study||20
3093516|NCT01456780|3816215|FG000|NOT COMPLETED|Overall Study||3
3093517|NCT01456780|3816216|FG001|NOT COMPLETED|Overall Study||3
3093518|NCT01456780|3816217|FG002|NOT COMPLETED|Overall Study||0
3093519|NCT01456897|3816227|FG000|STARTED|Overall Study||184
3093520|NCT01456897|3816228|FG001|STARTED|Overall Study||98
3093521|NCT01456897|3816227|FG000|COMPLETED|Overall Study||109
3093522|NCT01456897|3816228|FG001|COMPLETED|Overall Study||41
3093523|NCT01456897|3816227|FG000|NOT COMPLETED|Overall Study||75
3093524|NCT01456897|3816228|FG001|NOT COMPLETED|Overall Study||57
3093525|NCT01456936|3816238|FG000|STARTED|Overall Study||2037
3093526|NCT01456936|3816239|FG001|STARTED|Overall Study||2034
3093527|NCT01456936|3816240|FG002|STARTED|Overall Study||2038
3093528|NCT01456936|3816241|FG003|STARTED|Overall Study||2035
3093529|NCT01456936|3816238|FG000|Randomized and Treated|Overall Study||2016
3093530|NCT01456936|3816239|FG001|Randomized and Treated|Overall Study||2006
3093531|NCT01456936|3816240|FG002|Randomized and Treated|Overall Study||2022
3093532|NCT01456936|3816241|FG003|Randomized and Treated|Overall Study||2014
3093533|NCT01456936|3816238|FG000|COMPLETED|Overall Study||1598
3093534|NCT01456936|3816239|FG001|COMPLETED|Overall Study||1586
3093535|NCT01456936|3816240|FG002|COMPLETED|Overall Study||1557
3093536|NCT01456936|3816241|FG003|COMPLETED|Overall Study||1552
3093537|NCT01456936|3816238|FG000|NOT COMPLETED|Overall Study||439
3093538|NCT01456936|3816239|FG001|NOT COMPLETED|Overall Study||448
3093539|NCT01456936|3816240|FG002|NOT COMPLETED|Overall Study||481
3093540|NCT01456936|3816241|FG003|NOT COMPLETED|Overall Study||483
3093541|NCT01456949|3816251|FG000|STARTED|Enrollment||402
3093542|NCT01456949|3816251|FG000|Treated|Enrollment||359
3093543|NCT01456949|3816251|FG000|Modified Intent to Treat Group (mITT)|Enrollment||354
3093544|NCT01456949|3816251|FG000|COMPLETED|Enrollment|6 rollover subjects not included in final analysis. 359 treated; 354 treated & met all I/E criteria.|365
3093545|NCT01456949|3816251|FG000|NOT COMPLETED|Enrollment||37
3093546|NCT01456949|3816251|FG000|STARTED|Study Cryoablation Procedure & Follow-up||365
3093547|NCT01456949|3816251|FG000|3-month Follow-up Visit Completed|Study Cryoablation Procedure & Follow-up|Of 354 subjects who were treated and met all I/E criteria (mITT group).|344
3093548|NCT01456949|3816251|FG000|6-month Follow-up Visit Completed|Study Cryoablation Procedure & Follow-up|Of mITT group.|342
3093549|NCT01456949|3816251|FG000|12-month Follow-up Visit Completed|Study Cryoablation Procedure & Follow-up|Of mITT group.|325
3093550|NCT01456949|3816251|FG000|24-month Follow-up Visit Completed|Study Cryoablation Procedure & Follow-up|Of mITT group.|309
3093551|NCT01456949|3816251|FG000|36-month Follow-up Visit Completed|Study Cryoablation Procedure & Follow-up|Of mITT group.|298
3093552|NCT01456949|3816251|FG000|COMPLETED|Study Cryoablation Procedure & Follow-up|5 subjects completed at least 36 months of follow-up but did not complete a 36 month follow-up visit|303
3093553|NCT01456949|3816251|FG000|NOT COMPLETED|Study Cryoablation Procedure & Follow-up||62
3093554|NCT01456962|3816257|FG000|STARTED|Overall Study||16
3093555|NCT01456962|3816258|FG001|STARTED|Overall Study||20
3093556|NCT01456962|3816257|FG000|COMPLETED|Overall Study||14
3093557|NCT01456962|3816258|FG001|COMPLETED|Overall Study||19
3093558|NCT01456962|3816257|FG000|NOT COMPLETED|Overall Study||2
3093559|NCT01456962|3816258|FG001|NOT COMPLETED|Overall Study||1
3093560|NCT01457014|3816264|FG000|STARTED|First Night||74
3093561|NCT01457014|3816265|FG001|STARTED|First Night||0
3093562|NCT01457014|3816266|FG002|STARTED|First Night||0
3093563|NCT01457014|3816267|FG003|STARTED|First Night||0
3093564|NCT01457014|3816264|FG000|COMPLETED|First Night||34
3093565|NCT01457014|3816265|FG001|COMPLETED|First Night||0
3093566|NCT01457014|3816266|FG002|COMPLETED|First Night||0
3093567|NCT01457014|3816267|FG003|COMPLETED|First Night||0
3093568|NCT01457014|3816264|FG000|NOT COMPLETED|First Night||40
3093569|NCT01457014|3816265|FG001|NOT COMPLETED|First Night||0
3093570|NCT01457014|3816266|FG002|NOT COMPLETED|First Night||0
3093571|NCT01457014|3816267|FG003|NOT COMPLETED|First Night||0
3093572|NCT01457014|3816264|FG000|STARTED|Second Night|The Diagnostic PSG was only completed on the First night|0
3093573|NCT01457014|3816265|FG001|STARTED|Second Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|12
3093574|NCT01457014|3816266|FG002|STARTED|Second Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
3093575|NCT01457014|3816267|FG003|STARTED|Second Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
3093576|NCT01457014|3816264|FG000|COMPLETED|Second Night|The Diagnostic PSG was only completed on the First night|0
3093577|NCT01457014|3816265|FG001|COMPLETED|Second Night||12
3093578|NCT01457014|3816266|FG002|COMPLETED|Second Night||11
3093579|NCT01457014|3816267|FG003|COMPLETED|Second Night||11
3093580|NCT01457014|3816264|FG000|NOT COMPLETED|Second Night||0
3093581|NCT01457014|3816265|FG001|NOT COMPLETED|Second Night||0
3093582|NCT01457014|3816266|FG002|NOT COMPLETED|Second Night||0
3093583|NCT01457014|3816267|FG003|NOT COMPLETED|Second Night||0
3093584|NCT01457014|3816264|FG000|STARTED|Third Night|The Diagnostic PSG was only completed on the First night|0
3093585|NCT01457014|3816265|FG001|STARTED|Third Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
3093586|NCT01457014|3816266|FG002|STARTED|Third Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
3093587|NCT01457014|3816267|FG003|STARTED|Third Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|12
3093588|NCT01457014|3816264|FG000|COMPLETED|Third Night|The Diagnostic PSG was only completed on the First night|0
3093589|NCT01457014|3816265|FG001|COMPLETED|Third Night||11
3093590|NCT01457014|3816266|FG002|COMPLETED|Third Night||11
3093591|NCT01457014|3816267|FG003|COMPLETED|Third Night||12
3093592|NCT01457014|3816264|FG000|NOT COMPLETED|Third Night||0
3093593|NCT01457014|3816265|FG001|NOT COMPLETED|Third Night||0
3093594|NCT01457014|3816266|FG002|NOT COMPLETED|Third Night||0
3093595|NCT01457014|3816267|FG003|NOT COMPLETED|Third Night||0
3093596|NCT01457014|3816264|FG000|STARTED|Fourth Night|The Diagnostic PSG was only completed on the First night|0
3093597|NCT01457014|3816265|FG001|STARTED|Fourth Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
3093598|NCT01457014|3816266|FG002|STARTED|Fourth Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|12
3093599|NCT01457014|3816267|FG003|STARTED|Fourth Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
3093600|NCT01457014|3816264|FG000|COMPLETED|Fourth Night|The Diagnostic PSG was only completed on the First night|0
3093601|NCT01457014|3816265|FG001|COMPLETED|Fourth Night||11
3093602|NCT01457014|3816266|FG002|COMPLETED|Fourth Night||12
3093603|NCT01457014|3816267|FG003|COMPLETED|Fourth Night||11
3093604|NCT01457014|3816264|FG000|NOT COMPLETED|Fourth Night||0
3093605|NCT01457014|3816265|FG001|NOT COMPLETED|Fourth Night||0
3093606|NCT01457014|3816266|FG002|NOT COMPLETED|Fourth Night||0
3093607|NCT01457014|3816267|FG003|NOT COMPLETED|Fourth Night||0
3093608|NCT01457118|3816279|FG000|STARTED|Overall Study||20
3093609|NCT01457118|3816280|FG001|STARTED|Overall Study||4
3093610|NCT01457118|3816281|FG002|STARTED|Overall Study||1
3093611|NCT01457118|3816282|FG003|STARTED|Overall Study||2
3093612|NCT01457118|3816279|FG000|COMPLETED|Overall Study||0
3093613|NCT01457118|3816280|FG001|COMPLETED|Overall Study||0
3093614|NCT01457118|3816281|FG002|COMPLETED|Overall Study||0
3093615|NCT01457118|3816282|FG003|COMPLETED|Overall Study||0
3093616|NCT01457118|3816279|FG000|NOT COMPLETED|Overall Study||20
3093617|NCT01457118|3816280|FG001|NOT COMPLETED|Overall Study||4
3093618|NCT01457118|3816281|FG002|NOT COMPLETED|Overall Study||1
3093619|NCT01457118|3816282|FG003|NOT COMPLETED|Overall Study||2
3093620|NCT01457196|3816292|FG000|STARTED|Overall Study||2074
3093621|NCT01457196|3816292|FG000|COMPLETED|Overall Study||2074
3093622|NCT01457196|3816292|FG000|NOT COMPLETED|Overall Study||0
3093623|NCT01457339|3816300|FG000|STARTED|Period 1 (50 mg)||7
3093624|NCT01457339|3816301|FG001|STARTED|Period 1 (50 mg)||24
3093625|NCT01457339|3816300|FG000|COMPLETED|Period 1 (50 mg)||7
3093626|NCT01457339|3816301|FG001|COMPLETED|Period 1 (50 mg)||24
3093627|NCT01457339|3816300|FG000|NOT COMPLETED|Period 1 (50 mg)||0
3093628|NCT01457339|3816301|FG001|NOT COMPLETED|Period 1 (50 mg)||0
3093629|NCT01457339|3816300|FG000|STARTED|Period 2 (70 mg)||7
3093630|NCT01457339|3816301|FG001|STARTED|Period 2 (70 mg)||24
3093631|NCT01457339|3816300|FG000|COMPLETED|Period 2 (70 mg)||7
3093632|NCT01457339|3816301|FG001|COMPLETED|Period 2 (70 mg)||24
3093633|NCT01457339|3816300|FG000|NOT COMPLETED|Period 2 (70 mg)||0
3093634|NCT01457339|3816301|FG001|NOT COMPLETED|Period 2 (70 mg)||0
3093635|NCT01457339|3816300|FG000|STARTED|Period 3 (100 mg)||7
3093636|NCT01457339|3816301|FG001|STARTED|Period 3 (100 mg)||24
3093637|NCT01457339|3816300|FG000|COMPLETED|Period 3 (100 mg)||7
3093638|NCT01457339|3816301|FG001|COMPLETED|Period 3 (100 mg)||23
3093639|NCT01457339|3816300|FG000|NOT COMPLETED|Period 3 (100 mg)||0
3093640|NCT01457339|3816301|FG001|NOT COMPLETED|Period 3 (100 mg)||1
3093641|NCT01457339|3816300|FG000|STARTED|Period 4 (150 mg)||7
3093642|NCT01457339|3816301|FG001|STARTED|Period 4 (150 mg)||23
3093643|NCT01457339|3816300|FG000|COMPLETED|Period 4 (150 mg)||7
3093644|NCT01457339|3816301|FG001|COMPLETED|Period 4 (150 mg)||23
3093645|NCT01457339|3816300|FG000|NOT COMPLETED|Period 4 (150 mg)||0
3093646|NCT01457339|3816301|FG001|NOT COMPLETED|Period 4 (150 mg)||0
3093647|NCT01457339|3816300|FG000|STARTED|Period 5 (200 mg)||7
3093648|NCT01457339|3816301|FG001|STARTED|Period 5 (200 mg)||23
3093649|NCT01457339|3816300|FG000|COMPLETED|Period 5 (200 mg)||7
3093650|NCT01457339|3816301|FG001|COMPLETED|Period 5 (200 mg)||22
3093651|NCT01457339|3816300|FG000|NOT COMPLETED|Period 5 (200 mg)||0
3093652|NCT01457339|3816301|FG001|NOT COMPLETED|Period 5 (200 mg)||1
3093653|NCT01457339|3816300|FG000|STARTED|Period 6 (250 mg)||7
3093654|NCT01457339|3816301|FG001|STARTED|Period 6 (250 mg)||22
3093655|NCT01457339|3816300|FG000|COMPLETED|Period 6 (250 mg)||6
3093656|NCT01457339|3816301|FG001|COMPLETED|Period 6 (250 mg)||21
3093657|NCT01457339|3816300|FG000|NOT COMPLETED|Period 6 (250 mg)||1
3093658|NCT01457339|3816301|FG001|NOT COMPLETED|Period 6 (250 mg)||1
3093659|NCT01457352|3816326|FG000|STARTED|Period 1||392
3093660|NCT01457352|3816327|FG001|STARTED|Period 1||0
3093661|NCT01457352|3816326|FG000|COMPLETED|Period 1||376
3093662|NCT01457352|3816327|FG001|COMPLETED|Period 1||0
3093663|NCT01457352|3816326|FG000|NOT COMPLETED|Period 1||16
3093664|NCT01457352|3816327|FG001|NOT COMPLETED|Period 1||0
3093665|NCT01457352|3816326|FG000|STARTED|Period 2||376
3093666|NCT01457352|3816327|FG001|STARTED|Period 2||0
3093667|NCT01457352|3816326|FG000|COMPLETED|Period 2||296
3093668|NCT01457352|3816327|FG001|COMPLETED|Period 2||0
3093669|NCT01457352|3816326|FG000|NOT COMPLETED|Period 2||80
3093670|NCT01457352|3816327|FG001|NOT COMPLETED|Period 2||0
3093671|NCT01457352|3816326|FG000|STARTED|Period 3||147
3093672|NCT01457352|3816327|FG001|STARTED|Period 3||149
3093673|NCT01457352|3816326|FG000|Randomization|Period 3||147
3093674|NCT01457352|3816327|FG001|Randomization|Period 3||149
3093675|NCT01457352|3816326|FG000|COMPLETED|Period 3||146
3093676|NCT01457352|3816327|FG001|COMPLETED|Period 3||144
3093677|NCT01457352|3816326|FG000|NOT COMPLETED|Period 3||1
3093678|NCT01457352|3816327|FG001|NOT COMPLETED|Period 3||5
3093679|NCT01457417|3816342|FG000|STARTED|Overall Study||3
3093680|NCT01457417|3816343|FG001|STARTED|Overall Study||3
3093681|NCT01457417|3816344|FG002|STARTED|Overall Study||4
3093682|NCT01457417|3816345|FG003|STARTED|Overall Study||3
3093683|NCT01457417|3816346|FG004|STARTED|Overall Study||19
3093684|NCT01457417|3816342|FG000|COMPLETED|Overall Study||3
3093685|NCT01457417|3816343|FG001|COMPLETED|Overall Study||3
3093686|NCT01457417|3816344|FG002|COMPLETED|Overall Study||4
3093687|NCT01457417|3816345|FG003|COMPLETED|Overall Study||3
3093688|NCT01457417|3816346|FG004|COMPLETED|Overall Study||19
3093689|NCT01457417|3816342|FG000|NOT COMPLETED|Overall Study||0
3093690|NCT01457417|3816343|FG001|NOT COMPLETED|Overall Study||0
3093691|NCT01457417|3816344|FG002|NOT COMPLETED|Overall Study||0
3093692|NCT01457417|3816345|FG003|NOT COMPLETED|Overall Study||0
3093693|NCT01457417|3816346|FG004|NOT COMPLETED|Overall Study||0
3093694|NCT01457430|3816360|FG000|STARTED|Overall Study||19
3093695|NCT01457430|3816360|FG000|COMPLETED|Overall Study||19
3093696|NCT01457430|3816360|FG000|NOT COMPLETED|Overall Study||0
3093697|NCT01457521|3816367|FG000|STARTED|Overall Study||123
3093698|NCT01457521|3816368|FG001|STARTED|Overall Study||127
3093699|NCT01457521|3816367|FG000|COMPLETED|Overall Study||111
3093700|NCT01457521|3816368|FG001|COMPLETED|Overall Study||117
3093701|NCT01457521|3816367|FG000|NOT COMPLETED|Overall Study||12
3093702|NCT01457521|3816368|FG001|NOT COMPLETED|Overall Study||10
3093703|NCT01457573|3816374|FG000|STARTED|Overall Study||10
3093704|NCT01457573|3816374|FG000|COMPLETED|Overall Study||10
3093705|NCT01457573|3816374|FG000|NOT COMPLETED|Overall Study||0
3093706|NCT01457703|3816381|FG000|STARTED|Overall Study||29
3093707|NCT01457703|3816382|FG001|STARTED|Overall Study||33
3093708|NCT01457703|3816381|FG000|COMPLETED|Overall Study||23
3093709|NCT01457703|3816382|FG001|COMPLETED|Overall Study||22
3093710|NCT01457703|3816381|FG000|NOT COMPLETED|Overall Study||6
3093711|NCT01457703|3816382|FG001|NOT COMPLETED|Overall Study||11
3093712|NCT01457846|3816392|FG000|STARTED|Overall Study||41
3093713|NCT01457846|3816393|FG001|STARTED|Overall Study||30
3093714|NCT01457846|3816392|FG000|Received Treatment|Overall Study||40
3093715|NCT01457846|3816393|FG001|Received Treatment|Overall Study||27
3093716|NCT01457846|3816392|FG000|Did Not Receive Treatment|Overall Study||1
3093717|NCT01457846|3816393|FG001|Did Not Receive Treatment|Overall Study||3
3093718|NCT01457846|3816392|FG000|Ongoing Treatment at Data Cut-off|Overall Study||1
3093719|NCT01457846|3816393|FG001|Ongoing Treatment at Data Cut-off|Overall Study||1
3093720|NCT01457846|3816392|FG000|COMPLETED|Overall Study||0
3093721|NCT01457846|3816393|FG001|COMPLETED|Overall Study||0
3093722|NCT01457846|3816392|FG000|NOT COMPLETED|Overall Study||41
3093723|NCT01457846|3816393|FG001|NOT COMPLETED|Overall Study||30
3093724|NCT01457885|3816399|FG000|STARTED|Overall Study||74
3093725|NCT01457885|3816399|FG000|COMPLETED|Overall Study||74
3093726|NCT01457885|3816399|FG000|NOT COMPLETED|Overall Study||0
3093727|NCT01457924|3816408|FG000|STARTED|Treatment Phase (Weeks 0-24)||67
3093728|NCT01457924|3816409|FG001|STARTED|Treatment Phase (Weeks 0-24)||34
3093729|NCT01457924|3816410|FG002|STARTED|Treatment Phase (Weeks 0-24)||32
3093730|NCT01457924|3816411|FG003|STARTED|Treatment Phase (Weeks 0-24)||34
3093731|NCT01457924|3816412|FG004|STARTED|Treatment Phase (Weeks 0-24)||64
3093732|NCT01457924|3816408|FG000|Completed to Week 12|Treatment Phase (Weeks 0-24)||65
3093733|NCT01457924|3816409|FG001|Completed to Week 12|Treatment Phase (Weeks 0-24)||31
3093734|NCT01457924|3816410|FG002|Completed to Week 12|Treatment Phase (Weeks 0-24)||30
3093735|NCT01457924|3816411|FG003|Completed to Week 12|Treatment Phase (Weeks 0-24)||33
3093736|NCT01457924|3816412|FG004|Completed to Week 12|Treatment Phase (Weeks 0-24)||60
3093737|NCT01457924|3816408|FG000|COMPLETED|Treatment Phase (Weeks 0-24)||64
3093738|NCT01457924|3816409|FG001|COMPLETED|Treatment Phase (Weeks 0-24)||29
3093739|NCT01457924|3816410|FG002|COMPLETED|Treatment Phase (Weeks 0-24)||30
3093740|NCT01457924|3816411|FG003|COMPLETED|Treatment Phase (Weeks 0-24)||33
3093741|NCT01457924|3816412|FG004|COMPLETED|Treatment Phase (Weeks 0-24)||58
3093742|NCT01457924|3816408|FG000|NOT COMPLETED|Treatment Phase (Weeks 0-24)||3
3093743|NCT01457924|3816409|FG001|NOT COMPLETED|Treatment Phase (Weeks 0-24)||5
3093744|NCT01457924|3816410|FG002|NOT COMPLETED|Treatment Phase (Weeks 0-24)||2
3093745|NCT01457924|3816411|FG003|NOT COMPLETED|Treatment Phase (Weeks 0-24)||1
3093746|NCT01457924|3816412|FG004|NOT COMPLETED|Treatment Phase (Weeks 0-24)||6
3093747|NCT01457924|3816408|FG000|STARTED|FUP (Weeks 24-48)||66
3093748|NCT01457924|3816409|FG001|STARTED|FUP (Weeks 24-48)||31
3093749|NCT01457924|3816410|FG002|STARTED|FUP (Weeks 24-48)||32
3093750|NCT01457924|3816411|FG003|STARTED|FUP (Weeks 24-48)||33
3093751|NCT01457924|3816412|FG004|STARTED|FUP (Weeks 24-48)||59
3093752|NCT01457924|3816408|FG000|COMPLETED|FUP (Weeks 24-48)||63
3093753|NCT01457924|3816409|FG001|COMPLETED|FUP (Weeks 24-48)||30
3093754|NCT01457924|3816410|FG002|COMPLETED|FUP (Weeks 24-48)||30
3093755|NCT01457924|3816411|FG003|COMPLETED|FUP (Weeks 24-48)||32
3093756|NCT01457924|3816412|FG004|COMPLETED|FUP (Weeks 24-48)||57
3093757|NCT01457924|3816408|FG000|NOT COMPLETED|FUP (Weeks 24-48)||3
3093758|NCT01457924|3816409|FG001|NOT COMPLETED|FUP (Weeks 24-48)||1
3093759|NCT01457924|3816410|FG002|NOT COMPLETED|FUP (Weeks 24-48)||2
3093760|NCT01457924|3816411|FG003|NOT COMPLETED|FUP (Weeks 24-48)||1
3093761|NCT01457924|3816412|FG004|NOT COMPLETED|FUP (Weeks 24-48)||2
3093762|NCT01457924|3816408|FG000|STARTED|Individualized FUP (Weeks 48+)||16
3093763|NCT01457924|3816409|FG001|STARTED|Individualized FUP (Weeks 48+)||18
3093764|NCT01457924|3816410|FG002|STARTED|Individualized FUP (Weeks 48+)||16
3093765|NCT01457924|3816411|FG003|STARTED|Individualized FUP (Weeks 48+)||20
3093766|NCT01457924|3816412|FG004|STARTED|Individualized FUP (Weeks 48+)||42
3093767|NCT01457924|3816408|FG000|COMPLETED|Individualized FUP (Weeks 48+)||11
3093768|NCT01457924|3816409|FG001|COMPLETED|Individualized FUP (Weeks 48+)||14
3093769|NCT01457924|3816410|FG002|COMPLETED|Individualized FUP (Weeks 48+)||12
3093770|NCT01457924|3816411|FG003|COMPLETED|Individualized FUP (Weeks 48+)||15
3093771|NCT01457924|3816412|FG004|COMPLETED|Individualized FUP (Weeks 48+)||36
3093772|NCT01457924|3816408|FG000|NOT COMPLETED|Individualized FUP (Weeks 48+)||5
3093773|NCT01457924|3816409|FG001|NOT COMPLETED|Individualized FUP (Weeks 48+)||4
3093774|NCT01457924|3816410|FG002|NOT COMPLETED|Individualized FUP (Weeks 48+)||4
3093775|NCT01457924|3816411|FG003|NOT COMPLETED|Individualized FUP (Weeks 48+)||5
3093776|NCT01457924|3816412|FG004|NOT COMPLETED|Individualized FUP (Weeks 48+)||6
3093777|NCT01457950|3816426|FG000|STARTED|Double-Blind Phase||69
3093778|NCT01457950|3816427|FG001|STARTED|Double-Blind Phase||66
3093779|NCT01457950|3816428|FG002|STARTED|Double-Blind Phase||0
3093780|NCT01457950|3816429|FG003|STARTED|Double-Blind Phase||0
3093781|NCT01457950|3816426|FG000|Completed the 6 Month Assessment|Double-Blind Phase|"Completed 6 month assessment refers to par. that completed at least one 6 month assessment."|62
3093782|NCT01457950|3816427|FG001|Completed the 6 Month Assessment|Double-Blind Phase|"Completed 6 month assessment refers to par. that completed at least one 6 month assessment."|64
3093783|NCT01457950|3816428|FG002|Completed the 6 Month Assessment|Double-Blind Phase||0
3093784|NCT01457950|3816429|FG003|Completed the 6 Month Assessment|Double-Blind Phase||0
3093785|NCT01457950|3816426|FG000|COMPLETED|Double-Blind Phase|"Completed refers to par. that did not have a withdraw reason at the 6 month visit."|60
3093786|NCT01457950|3816427|FG001|COMPLETED|Double-Blind Phase|"Completed refers to par. that did not have a withdraw reason at the 6 month visit."|63
3093787|NCT01457950|3816428|FG002|COMPLETED|Double-Blind Phase||0
3093788|NCT01457950|3816429|FG003|COMPLETED|Double-Blind Phase||0
3093789|NCT01457950|3816426|FG000|NOT COMPLETED|Double-Blind Phase||9
3093790|NCT01457950|3816427|FG001|NOT COMPLETED|Double-Blind Phase||3
3093791|NCT01457950|3816428|FG002|NOT COMPLETED|Double-Blind Phase||0
3093792|NCT01457950|3816429|FG003|NOT COMPLETED|Double-Blind Phase||0
3093793|NCT01457950|3816426|FG000|STARTED|Open-Label Phase||0
3093794|NCT01457950|3816427|FG001|STARTED|Open-Label Phase||0
3093795|NCT01457950|3816428|FG002|STARTED|Open-Label Phase||60
3093796|NCT01457950|3816429|FG003|STARTED|Open-Label Phase||63
3093797|NCT01457950|3816426|FG000|COMPLETED|Open-Label Phase||0
3093798|NCT01457950|3816427|FG001|COMPLETED|Open-Label Phase||0
3093799|NCT01457950|3816428|FG002|COMPLETED|Open-Label Phase||58
3093800|NCT01457950|3816429|FG003|COMPLETED|Open-Label Phase||61
3093801|NCT01457950|3816426|FG000|NOT COMPLETED|Open-Label Phase||0
3093802|NCT01457950|3816427|FG001|NOT COMPLETED|Open-Label Phase||0
3093803|NCT01457950|3816428|FG002|NOT COMPLETED|Open-Label Phase||2
3093804|NCT01457950|3816429|FG003|NOT COMPLETED|Open-Label Phase||2
3093805|NCT01458106|3816442|FG000|STARTED|Overall Study||36
3093806|NCT01458106|3816443|FG001|STARTED|Overall Study||35
3093807|NCT01458106|3816442|FG000|PK Subgroup|Overall Study||25
3093808|NCT01458106|3816443|FG001|PK Subgroup|Overall Study||35
3093809|NCT01458106|3816442|FG000|Non-PK Subgroup|Overall Study||11
3093810|NCT01458106|3816443|FG001|Non-PK Subgroup|Overall Study||0
3093811|NCT01458106|3816442|FG000|COMPLETED|Overall Study||33
3093812|NCT01458106|3816443|FG001|COMPLETED|Overall Study||34
3093813|NCT01458106|3816442|FG000|NOT COMPLETED|Overall Study||3
3093814|NCT01458106|3816443|FG001|NOT COMPLETED|Overall Study||1
3093815|NCT01458119|3816452|FG000|STARTED|Overall Study||85
3093816|NCT01458119|3816452|FG000|Received at Least 1 Dose of Study Drug|Overall Study||85
3093817|NCT01458119|3816452|FG000|Safety Population|Overall Study||85
3093818|NCT01458119|3816452|FG000|Intent to Treat (ITT) Population|Overall Study||85
3093819|NCT01458119|3816452|FG000|ITT-Amenable Population|Overall Study||68
3093820|NCT01458119|3816452|FG000|COMPLETED|Overall Study||65
3093821|NCT01458119|3816452|FG000|NOT COMPLETED|Overall Study||20
3135130|NCT01704781|3860104|FG001|COMPLETED|Overall Study||3
3135131|NCT01704781|3860105|FG002|COMPLETED|Overall Study||6
3135132|NCT01704781|3860106|FG003|COMPLETED|Overall Study||12
3135133|NCT01704781|3860107|FG004|COMPLETED|Overall Study||12
3135134|NCT01704781|3860103|FG000|NOT COMPLETED|Overall Study||0
3135135|NCT01704781|3860104|FG001|NOT COMPLETED|Overall Study||0
3135136|NCT01704781|3860105|FG002|NOT COMPLETED|Overall Study||0
3135137|NCT01704781|3860106|FG003|NOT COMPLETED|Overall Study||0
3135138|NCT01704781|3860107|FG004|NOT COMPLETED|Overall Study||0
3135139|NCT01704846|3860123|FG000|STARTED|Treatment Period 1||30
3135140|NCT01704846|3860124|FG001|STARTED|Treatment Period 1||30
3135141|NCT01704846|3860123|FG000|COMPLETED|Treatment Period 1||30
3135142|NCT01704846|3860124|FG001|COMPLETED|Treatment Period 1||30
3135143|NCT01704846|3860123|FG000|NOT COMPLETED|Treatment Period 1||0
3093822|NCT01458132|3816459|FG000|STARTED|Overall Study||15
3093823|NCT01458132|3816460|FG001|STARTED|Overall Study||4
3093824|NCT01458132|3816459|FG000|COMPLETED|Overall Study||0
3093825|NCT01458132|3816460|FG001|COMPLETED|Overall Study||1
3093826|NCT01458132|3816459|FG000|NOT COMPLETED|Overall Study||15
3093827|NCT01458132|3816460|FG001|NOT COMPLETED|Overall Study||3
3093828|NCT01458171|3816466|FG000|STARTED|Overall Study||23
3093829|NCT01458171|3816466|FG000|COMPLETED|Overall Study||22
3093830|NCT01458171|3816466|FG000|NOT COMPLETED|Overall Study||1
3093831|NCT01458210|3816472|FG000|STARTED|Lead-in (1st Course of Ortho-Cyclen)||22
3093832|NCT01458210|3816472|FG000|Received at Least One Dose of Study Drug|Lead-in (1st Course of Ortho-Cyclen)||22
3093833|NCT01458210|3816472|FG000|COMPLETED|Lead-in (1st Course of Ortho-Cyclen)||22
3093834|NCT01458210|3816472|FG000|NOT COMPLETED|Lead-in (1st Course of Ortho-Cyclen)||0
3093835|NCT01458210|3816472|FG000|STARTED|Ortho-Cyclen Alone (Period 1)||22
3093836|NCT01458210|3816472|FG000|COMPLETED|Ortho-Cyclen Alone (Period 1)||18
3093837|NCT01458210|3816472|FG000|NOT COMPLETED|Ortho-Cyclen Alone (Period 1)||4
3093838|NCT01458210|3816472|FG000|STARTED|Ortho-Cyclen + Dulaglutide (Period 2)|1 participant received Ortho-Cyclen, discontinued due to Adverse Event before receiving Dulaglutide.|18
3093839|NCT01458210|3816472|FG000|COMPLETED|Ortho-Cyclen + Dulaglutide (Period 2)||15
3093840|NCT01458210|3816472|FG000|NOT COMPLETED|Ortho-Cyclen + Dulaglutide (Period 2)||3
3093841|NCT01458249|3816481|FG000|STARTED|Overall Study||52
3093842|NCT01458249|3816481|FG000|Participants Treated|Overall Study||51
3093843|NCT01458249|3816481|FG000|COMPLETED|Overall Study||44
3093844|NCT01458249|3816481|FG000|NOT COMPLETED|Overall Study||8
3093845|NCT01458275|3816489|FG000|STARTED|Overall Study||283
3093846|NCT01458275|3816490|FG001|STARTED|Overall Study||282
3093847|NCT01458275|3816491|FG002|STARTED|Overall Study||282
3093848|NCT01458275|3816489|FG000|COMPLETED|Overall Study||269
3093849|NCT01458275|3816490|FG001|COMPLETED|Overall Study||269
3093850|NCT01458275|3816491|FG002|COMPLETED|Overall Study||273
3093851|NCT01458275|3816489|FG000|NOT COMPLETED|Overall Study||14
3093852|NCT01458275|3816490|FG001|NOT COMPLETED|Overall Study||13
3093853|NCT01458275|3816491|FG002|NOT COMPLETED|Overall Study||9
3093854|NCT01458288|3816501|FG000|STARTED|Overall Study||12
3093855|NCT01458288|3816501|FG000|COMPLETED|Overall Study||12
3093856|NCT01458288|3816501|FG000|NOT COMPLETED|Overall Study||0
3093857|NCT01458327|3816506|FG000|STARTED|Overall Study||3
3093858|NCT01458327|3816506|FG000|COMPLETED|Overall Study||3
3093859|NCT01458327|3816506|FG000|NOT COMPLETED|Overall Study||0
3093860|NCT01458366|3816516|FG000|STARTED|Period 1: 70mg/m^2||5
3093861|NCT01458366|3816517|FG001|STARTED|Period 1: 70mg/m^2||0
3093862|NCT01458366|3816518|FG002|STARTED|Period 1: 70mg/m^2||0
3093863|NCT01458366|3816519|FG003|STARTED|Period 1: 70mg/m^2||0
3093864|NCT01458366|3816520|FG004|STARTED|Period 1: 70mg/m^2||0
3093865|NCT01458366|3816516|FG000|COMPLETED|Period 1: 70mg/m^2||3
3093866|NCT01458366|3816517|FG001|COMPLETED|Period 1: 70mg/m^2||0
3093867|NCT01458366|3816518|FG002|COMPLETED|Period 1: 70mg/m^2||0
3093868|NCT01458366|3816519|FG003|COMPLETED|Period 1: 70mg/m^2||0
3093869|NCT01458366|3816520|FG004|COMPLETED|Period 1: 70mg/m^2||0
3093870|NCT01458366|3816516|FG000|NOT COMPLETED|Period 1: 70mg/m^2||2
3093871|NCT01458366|3816517|FG001|NOT COMPLETED|Period 1: 70mg/m^2||0
3093872|NCT01458366|3816518|FG002|NOT COMPLETED|Period 1: 70mg/m^2||0
3093873|NCT01458366|3816519|FG003|NOT COMPLETED|Period 1: 70mg/m^2||0
3093874|NCT01458366|3816520|FG004|NOT COMPLETED|Period 1: 70mg/m^2||0
3093875|NCT01458366|3816516|FG000|STARTED|Period 2: 50mg/m^2||0
3093876|NCT01458366|3816517|FG001|STARTED|Period 2: 50mg/m^2||0
3093877|NCT01458366|3816518|FG002|STARTED|Period 2: 50mg/m^2||0
3093878|NCT01458366|3816519|FG003|STARTED|Period 2: 50mg/m^2||0
3093879|NCT01458366|3816520|FG004|STARTED|Period 2: 50mg/m^2||0
3093880|NCT01458366|3816516|FG000|COMPLETED|Period 2: 50mg/m^2||0
3093881|NCT01458366|3816517|FG001|COMPLETED|Period 2: 50mg/m^2||0
3093882|NCT01458366|3816518|FG002|COMPLETED|Period 2: 50mg/m^2||0
3093883|NCT01458366|3816519|FG003|COMPLETED|Period 2: 50mg/m^2||0
3093884|NCT01458366|3816520|FG004|COMPLETED|Period 2: 50mg/m^2||0
3093885|NCT01458366|3816516|FG000|NOT COMPLETED|Period 2: 50mg/m^2||0
3093886|NCT01458366|3816517|FG001|NOT COMPLETED|Period 2: 50mg/m^2||0
3093887|NCT01458366|3816518|FG002|NOT COMPLETED|Period 2: 50mg/m^2||0
3093888|NCT01458366|3816519|FG003|NOT COMPLETED|Period 2: 50mg/m^2||0
3093889|NCT01458366|3816520|FG004|NOT COMPLETED|Period 2: 50mg/m^2||0
3093890|NCT01458366|3816516|FG000|STARTED|Period 3: 90mg/m^2||0
3093891|NCT01458366|3816517|FG001|STARTED|Period 3: 90mg/m^2||0
3093892|NCT01458366|3816518|FG002|STARTED|Period 3: 90mg/m^2||3
3093893|NCT01458366|3816519|FG003|STARTED|Period 3: 90mg/m^2||0
3093894|NCT01458366|3816520|FG004|STARTED|Period 3: 90mg/m^2||0
3093895|NCT01458366|3816516|FG000|COMPLETED|Period 3: 90mg/m^2||0
3093896|NCT01458366|3816517|FG001|COMPLETED|Period 3: 90mg/m^2||0
3093897|NCT01458366|3816518|FG002|COMPLETED|Period 3: 90mg/m^2||3
3093898|NCT01458366|3816519|FG003|COMPLETED|Period 3: 90mg/m^2||0
3093899|NCT01458366|3816520|FG004|COMPLETED|Period 3: 90mg/m^2||0
3093900|NCT01458366|3816516|FG000|NOT COMPLETED|Period 3: 90mg/m^2||0
3093901|NCT01458366|3816517|FG001|NOT COMPLETED|Period 3: 90mg/m^2||0
3093902|NCT01458366|3816518|FG002|NOT COMPLETED|Period 3: 90mg/m^2||0
3093903|NCT01458366|3816519|FG003|NOT COMPLETED|Period 3: 90mg/m^2||0
3093904|NCT01458366|3816520|FG004|NOT COMPLETED|Period 3: 90mg/m^2||0
3093905|NCT01458366|3816516|FG000|STARTED|Period 4: 120mg/m^2||0
3093906|NCT01458366|3816517|FG001|STARTED|Period 4: 120mg/m^2||0
3093907|NCT01458366|3816518|FG002|STARTED|Period 4: 120mg/m^2||0
3093908|NCT01458366|3816519|FG003|STARTED|Period 4: 120mg/m^2||3
3093909|NCT01458366|3816520|FG004|STARTED|Period 4: 120mg/m^2||0
3093910|NCT01458366|3816516|FG000|COMPLETED|Period 4: 120mg/m^2||0
3093911|NCT01458366|3816517|FG001|COMPLETED|Period 4: 120mg/m^2||0
3093912|NCT01458366|3816518|FG002|COMPLETED|Period 4: 120mg/m^2||0
3093913|NCT01458366|3816519|FG003|COMPLETED|Period 4: 120mg/m^2||3
3093914|NCT01458366|3816520|FG004|COMPLETED|Period 4: 120mg/m^2||0
3093915|NCT01458366|3816516|FG000|NOT COMPLETED|Period 4: 120mg/m^2||0
3093916|NCT01458366|3816517|FG001|NOT COMPLETED|Period 4: 120mg/m^2||0
3093917|NCT01458366|3816518|FG002|NOT COMPLETED|Period 4: 120mg/m^2||0
3093918|NCT01458366|3816519|FG003|NOT COMPLETED|Period 4: 120mg/m^2||0
3093919|NCT01458366|3816520|FG004|NOT COMPLETED|Period 4: 120mg/m^2||0
3093920|NCT01458366|3816516|FG000|STARTED|Period 5: Maximum Tolerated Dose (MTD)||0
3093921|NCT01458366|3816517|FG001|STARTED|Period 5: Maximum Tolerated Dose (MTD)||0
3093922|NCT01458366|3816518|FG002|STARTED|Period 5: Maximum Tolerated Dose (MTD)||0
3093923|NCT01458366|3816519|FG003|STARTED|Period 5: Maximum Tolerated Dose (MTD)||0
3093924|NCT01458366|3816520|FG004|STARTED|Period 5: Maximum Tolerated Dose (MTD)||27
3093925|NCT01458366|3816516|FG000|COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||0
3093926|NCT01458366|3816517|FG001|COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||0
3093927|NCT01458366|3816518|FG002|COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||0
3093928|NCT01458366|3816519|FG003|COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||0
3093929|NCT01458366|3816520|FG004|COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||26
3093930|NCT01458366|3816516|FG000|NOT COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||0
3093931|NCT01458366|3816517|FG001|NOT COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||0
3093932|NCT01458366|3816518|FG002|NOT COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||0
3093933|NCT01458366|3816519|FG003|NOT COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||0
3093934|NCT01458366|3816520|FG004|NOT COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||1
3093935|NCT01458392|3816531|FG000|STARTED|Overall Study||2
3093936|NCT01458392|3816532|FG001|STARTED|Overall Study||13
3093937|NCT01458392|3816533|FG002|STARTED|Overall Study||31
3093938|NCT01458392|3816531|FG000|COMPLETED|Overall Study||0
3093939|NCT01458392|3816532|FG001|COMPLETED|Overall Study||0
3093940|NCT01458392|3816533|FG002|COMPLETED|Overall Study||0
3093941|NCT01458392|3816531|FG000|NOT COMPLETED|Overall Study||2
3093942|NCT01458392|3816532|FG001|NOT COMPLETED|Overall Study||13
3093943|NCT01458392|3816533|FG002|NOT COMPLETED|Overall Study||31
3093944|NCT01458418|3816549|FG000|STARTED|Overall Study||0
3093945|NCT01458418|3816550|FG001|STARTED|Overall Study||0
3093946|NCT01458418|3816551|FG002|STARTED|Overall Study||0
3093947|NCT01458418|3816552|FG003|STARTED|Overall Study||4
3093948|NCT01458418|3816549|FG000|COMPLETED|Overall Study||0
3093949|NCT01458418|3816550|FG001|COMPLETED|Overall Study||0
3093950|NCT01458418|3816551|FG002|COMPLETED|Overall Study||0
3093951|NCT01458418|3816552|FG003|COMPLETED|Overall Study||4
3093952|NCT01458418|3816549|FG000|NOT COMPLETED|Overall Study||0
3093953|NCT01458418|3816550|FG001|NOT COMPLETED|Overall Study||0
3093954|NCT01458418|3816551|FG002|NOT COMPLETED|Overall Study||0
3093955|NCT01458418|3816552|FG003|NOT COMPLETED|Overall Study||0
3093956|NCT01458522|3816564|FG000|STARTED|Overall Study||37
3093957|NCT01458522|3816565|FG001|STARTED|Overall Study||37
3093958|NCT01458522|3816564|FG000|Received First Drug|Overall Study||35
3093959|NCT01458522|3816565|FG001|Received First Drug|Overall Study||35
3093960|NCT01458522|3816564|FG000|Crossover to Second Drug|Overall Study||15
3093961|NCT01458522|3816565|FG001|Crossover to Second Drug|Overall Study||10
3093962|NCT01458522|3816564|FG000|COMPLETED|Overall Study||34
3093963|NCT01458522|3816565|FG001|COMPLETED|Overall Study||26
3093964|NCT01458522|3816564|FG000|NOT COMPLETED|Overall Study||3
3289455|NCT02813421|4023154|FG000|NOT COMPLETED|Overall Study||2
3289456|NCT02813421|4023155|FG001|NOT COMPLETED|Overall Study||3
3289457|NCT02813473|4023161|FG000|STARTED|Overall Study||223
3289458|NCT02813473|4023161|FG000|COMPLETED|Overall Study||223
3289459|NCT02813473|4023161|FG000|NOT COMPLETED|Overall Study||0
3289460|NCT02813551|4023167|FG000|STARTED|Overall Study||59
3289461|NCT02813551|4023168|FG001|STARTED|Overall Study||59
3289462|NCT02813551|4023167|FG000|COMPLETED|Overall Study||58
3289463|NCT02813551|4023168|FG001|COMPLETED|Overall Study||57
3289464|NCT02813551|4023167|FG000|NOT COMPLETED|Overall Study||1
3289465|NCT02813551|4023168|FG001|NOT COMPLETED|Overall Study||2
3289466|NCT02813577|4023174|FG000|STARTED|Overall Study||4
3289467|NCT02813577|4023174|FG000|COMPLETED|Overall Study|Study was terminated and only some results at 1 month follow up are available.|0
3289468|NCT02813577|4023174|FG000|NOT COMPLETED|Overall Study||4
3316704|NCT03118596|4050144|FG000|STARTED|Overall Study||90
3316705|NCT03118596|4050145|FG001|STARTED|Overall Study||90
3316706|NCT03118596|4050144|FG000|Treated|Overall Study||2
3316707|NCT03118596|4050145|FG001|Treated|Overall Study||0
3316708|NCT03118596|4050144|FG000|Failed|Overall Study||0
3316709|NCT03118596|4050145|FG001|Failed|Overall Study||4
3316710|NCT03118596|4050144|FG000|COMPLETED|Overall Study||90
3093965|NCT01458522|3816565|FG001|NOT COMPLETED|Overall Study||11
3093966|NCT01458535|3816583|FG000|STARTED|Overall Study||10
3316711|NCT03118596|4050145|FG001|COMPLETED|Overall Study||86
3316712|NCT03118596|4050144|FG000|NOT COMPLETED|Overall Study||0
3316713|NCT03118596|4050145|FG001|NOT COMPLETED|Overall Study||4
3316714|NCT03118739|4050153|FG000|STARTED|Overall Study||32
3316715|NCT03118739|4050154|FG001|STARTED|Overall Study||28
3316716|NCT03118739|4050153|FG000|Completed 12 Weeks of Treatment|Overall Study||26
3316717|NCT03118739|4050154|FG001|Completed 12 Weeks of Treatment|Overall Study||25
3093967|NCT01458535|3816584|FG001|STARTED|Overall Study||10
3093968|NCT01458535|3816585|FG002|STARTED|Overall Study||10
3093969|NCT01458535|3816586|FG003|STARTED|Overall Study||10
3093970|NCT01458535|3816587|FG004|STARTED|Overall Study||10
3093971|NCT01458535|3816588|FG005|STARTED|Overall Study||11
3093972|NCT01458535|3816583|FG000|COMPLETED|Overall Study||10
3093973|NCT01458535|3816584|FG001|COMPLETED|Overall Study||8
3093974|NCT01458535|3816585|FG002|COMPLETED|Overall Study||8
3093975|NCT01458535|3816586|FG003|COMPLETED|Overall Study||6
3093976|NCT01458535|3816587|FG004|COMPLETED|Overall Study||6
3093977|NCT01458535|3816588|FG005|COMPLETED|Overall Study||7
3093978|NCT01458535|3816583|FG000|NOT COMPLETED|Overall Study||0
3093979|NCT01458535|3816584|FG001|NOT COMPLETED|Overall Study||2
3093980|NCT01458535|3816585|FG002|NOT COMPLETED|Overall Study||2
3093981|NCT01458535|3816586|FG003|NOT COMPLETED|Overall Study||4
3093982|NCT01458535|3816587|FG004|NOT COMPLETED|Overall Study||4
3093983|NCT01458535|3816588|FG005|NOT COMPLETED|Overall Study||4
3093984|NCT01458561|3816604|FG000|STARTED|Overall Study||0
3093985|NCT01458561|3816605|FG001|STARTED|Overall Study||1
3093986|NCT01458561|3816604|FG000|COMPLETED|Overall Study||0
3093987|NCT01458561|3816605|FG001|COMPLETED|Overall Study||1
3093988|NCT01458561|3816604|FG000|NOT COMPLETED|Overall Study||0
3093989|NCT01458561|3816605|FG001|NOT COMPLETED|Overall Study||0
3093990|NCT01458574|3816644|FG000|STARTED|Overall Study||198
3093991|NCT01458574|3816645|FG001|STARTED|Overall Study||197
3093992|NCT01458574|3816646|FG002|STARTED|Overall Study||198
3093993|NCT01458574|3816644|FG000|Treated|Overall Study||198
3093994|NCT01458574|3816645|FG001|Treated|Overall Study||196
3093995|NCT01458574|3816646|FG002|Treated|Overall Study||198
3093996|NCT01458574|3816644|FG000|COMPLETED|Overall Study||111
3093997|NCT01458574|3816645|FG001|COMPLETED|Overall Study||126
3093998|NCT01458574|3816646|FG002|COMPLETED|Overall Study||53
3093999|NCT01458574|3816644|FG000|NOT COMPLETED|Overall Study||87
3094000|NCT01458574|3816645|FG001|NOT COMPLETED|Overall Study||71
3094001|NCT01458574|3816646|FG002|NOT COMPLETED|Overall Study||145
3094002|NCT01458587|3816656|FG000|STARTED|Overall Study||35
3094003|NCT01458587|3816657|FG001|STARTED|Overall Study||35
3094004|NCT01458587|3816656|FG000|COMPLETED|Overall Study||34
3094005|NCT01458587|3816657|FG001|COMPLETED|Overall Study||35
3094006|NCT01458587|3816656|FG000|NOT COMPLETED|Overall Study||1
3094007|NCT01458587|3816657|FG001|NOT COMPLETED|Overall Study||0
3094008|NCT01458639|3816665|FG000|STARTED|Overall Study||18
3094009|NCT01458639|3816665|FG000|COMPLETED|Overall Study||12
3094010|NCT01458639|3816665|FG000|NOT COMPLETED|Overall Study||6
3094011|NCT01458951|3816672|FG000|STARTED|Overall Study||429
3094012|NCT01458951|3816673|FG001|STARTED|Overall Study||6
3094013|NCT01458951|3816674|FG002|STARTED|Overall Study||112
3094014|NCT01458951|3816672|FG000|COMPLETED|Overall Study||397
3094015|NCT01458951|3816673|FG001|COMPLETED|Overall Study||5
3094016|NCT01458951|3816674|FG002|COMPLETED|Overall Study||97
3094017|NCT01458951|3816672|FG000|NOT COMPLETED|Overall Study||32
3094018|NCT01458951|3816673|FG001|NOT COMPLETED|Overall Study||1
3094019|NCT01458951|3816674|FG002|NOT COMPLETED|Overall Study||15
3094020|NCT01458990|3816683|FG000|STARTED|Overall Study||45
3094021|NCT01458990|3816684|FG001|STARTED|Overall Study||15
3094022|NCT01458990|3816683|FG000|COMPLETED|Overall Study||45
3094023|NCT01458990|3816684|FG001|COMPLETED|Overall Study||15
3094024|NCT01458990|3816683|FG000|NOT COMPLETED|Overall Study||0
3094025|NCT01458990|3816684|FG001|NOT COMPLETED|Overall Study||0
3094026|NCT01459016|3816692|FG000|STARTED|Overall Study||56
3094027|NCT01459016|3816692|FG000|COMPLETED|Overall Study||41
3094028|NCT01459016|3816692|FG000|NOT COMPLETED|Overall Study||15
3094029|NCT01459068|3816698|FG000|STARTED|Overall Study||165
3094030|NCT01459068|3816699|FG001|STARTED|Overall Study||182
3094031|NCT01459068|3816698|FG000|COMPLETED|Overall Study||126
3094032|NCT01459068|3816699|FG001|COMPLETED|Overall Study||148
3289469|NCT02813681|4023181|FG000|STARTED|Overall Study||27
3289470|NCT02813681|4023182|FG001|STARTED|Overall Study||34
3289471|NCT02813681|4023183|FG002|STARTED|Overall Study||19
3289472|NCT02813681|4023181|FG000|COMPLETED|Overall Study||22
3289473|NCT02813681|4023182|FG001|COMPLETED|Overall Study||28
3289474|NCT02813681|4023183|FG002|COMPLETED|Overall Study||19
3289475|NCT02813681|4023181|FG000|NOT COMPLETED|Overall Study||5
3289476|NCT02813681|4023182|FG001|NOT COMPLETED|Overall Study||6
3289477|NCT02813681|4023183|FG002|NOT COMPLETED|Overall Study||0
3289478|NCT02813694|4023195|FG000|STARTED|Overall Study|Intent to Treat Analysis Set|370
3289479|NCT02813694|4023196|FG001|STARTED|Overall Study|Intent to Treat Analysis Set|368
3289480|NCT02813694|4023195|FG000|COMPLETED|Overall Study||353
3289481|NCT02813694|4023196|FG001|COMPLETED|Overall Study|Completed Study (Late Follow Up Assessment)|354
3289482|NCT02813694|4023195|FG000|NOT COMPLETED|Overall Study||17
3094033|NCT01459068|3816698|FG000|NOT COMPLETED|Overall Study||39
3094034|NCT01459068|3816699|FG001|NOT COMPLETED|Overall Study||34
3094035|NCT01459588|3816709|FG000|STARTED|Overall Study||105
3094036|NCT01459588|3816710|FG001|STARTED|Overall Study||51
3094037|NCT01459588|3816711|FG002|STARTED|Overall Study||103
3094038|NCT01459588|3816712|FG003|STARTED|Overall Study||56
3094039|NCT01459588|3816709|FG000|COMPLETED|Overall Study||104
3094040|NCT01459588|3816710|FG001|COMPLETED|Overall Study||49
3094041|NCT01459588|3816711|FG002|COMPLETED|Overall Study||102
3094042|NCT01459588|3816712|FG003|COMPLETED|Overall Study||55
3094043|NCT01459588|3816709|FG000|NOT COMPLETED|Overall Study||1
3094044|NCT01459588|3816710|FG001|NOT COMPLETED|Overall Study||2
3094045|NCT01459588|3816711|FG002|NOT COMPLETED|Overall Study||1
3094046|NCT01459588|3816712|FG003|NOT COMPLETED|Overall Study||1
3094047|NCT01459614|3816724|FG000|STARTED|Overall Study||29
3094048|NCT01459614|3816725|FG001|STARTED|Overall Study||10
3094049|NCT01459614|3816724|FG000|COMPLETED|Overall Study||28
3094050|NCT01459614|3816725|FG001|COMPLETED|Overall Study||10
3094051|NCT01459614|3816724|FG000|NOT COMPLETED|Overall Study||1
3094052|NCT01459614|3816725|FG001|NOT COMPLETED|Overall Study||0
3094053|NCT01459653|3816731|FG000|STARTED|Overall Study||1496
3094054|NCT01459653|3816731|FG000|COMPLETED|Overall Study||828
3094055|NCT01459653|3816731|FG000|NOT COMPLETED|Overall Study||668
3094056|NCT01459705|3816805|FG000|STARTED|Overall Study||54
3094057|NCT01459705|3816806|FG001|STARTED|Overall Study||54
3094058|NCT01459705|3816807|FG002|STARTED|Overall Study||54
3094059|NCT01459705|3816805|FG000|COMPLETED|Overall Study||32
3094060|NCT01459705|3816806|FG001|COMPLETED|Overall Study||30
3094061|NCT01459705|3816807|FG002|COMPLETED|Overall Study||47
3094062|NCT01459705|3816805|FG000|NOT COMPLETED|Overall Study||22
3094063|NCT01459705|3816806|FG001|NOT COMPLETED|Overall Study||24
3094064|NCT01459705|3816807|FG002|NOT COMPLETED|Overall Study||7
3094065|NCT01459718|3816815|FG000|STARTED|Overall Study||13
3094066|NCT01459718|3816815|FG000|Safety Analysis Set|Overall Study||13
3094067|NCT01459718|3816815|FG000|COMPLETED|Overall Study||10
3094068|NCT01459718|3816815|FG000|NOT COMPLETED|Overall Study||3
3094069|NCT01459783|3816821|FG000|STARTED|Baseline to 6 Months||71
3094070|NCT01459783|3816822|FG001|STARTED|Baseline to 6 Months||73
3094071|NCT01459783|3816821|FG000|COMPLETED|Baseline to 6 Months||39
3094072|NCT01459783|3816822|FG001|COMPLETED|Baseline to 6 Months||53
3094073|NCT01459783|3816821|FG000|NOT COMPLETED|Baseline to 6 Months||32
3094074|NCT01459783|3816822|FG001|NOT COMPLETED|Baseline to 6 Months||20
3094075|NCT01459783|3816821|FG000|STARTED|6 Months to 12 Months||39
3094076|NCT01459783|3816822|FG001|STARTED|6 Months to 12 Months||53
3094077|NCT01459783|3816821|FG000|COMPLETED|6 Months to 12 Months||20
3094078|NCT01459783|3816822|FG001|COMPLETED|6 Months to 12 Months||23
3094079|NCT01459783|3816821|FG000|NOT COMPLETED|6 Months to 12 Months||19
3094080|NCT01459783|3816822|FG001|NOT COMPLETED|6 Months to 12 Months||30
3094081|NCT01459796|3816830|FG000|STARTED|Overall Study||94
3094082|NCT01459796|3816831|FG001|STARTED|Overall Study||126
3094083|NCT01459796|3816830|FG000|COMPLETED|Overall Study||0
3094084|NCT01459796|3816831|FG001|COMPLETED|Overall Study||0
3094085|NCT01459796|3816830|FG000|NOT COMPLETED|Overall Study||94
3094086|NCT01459796|3816831|FG001|NOT COMPLETED|Overall Study||126
3094087|NCT01459913|3816841|FG000|STARTED|Overall Study||106
3094088|NCT01459913|3816842|FG001|STARTED|Overall Study||52
3094089|NCT01459913|3816843|FG002|STARTED|Overall Study||19
3094090|NCT01459913|3816844|FG003|STARTED|Overall Study||62
3094091|NCT01459913|3816841|FG000|COMPLETED|Overall Study||65
3094092|NCT01459913|3816842|FG001|COMPLETED|Overall Study||32
3094093|NCT01459913|3816843|FG002|COMPLETED|Overall Study||6
3094094|NCT01459913|3816844|FG003|COMPLETED|Overall Study||29
3094095|NCT01459913|3816841|FG000|NOT COMPLETED|Overall Study||41
3094096|NCT01459913|3816842|FG001|NOT COMPLETED|Overall Study||20
3094097|NCT01459913|3816843|FG002|NOT COMPLETED|Overall Study||13
3094098|NCT01459913|3816844|FG003|NOT COMPLETED|Overall Study||33
3094099|NCT01460225|3816856|FG000|STARTED|Overall Study|January 2009.|19
3094100|NCT01460225|3816856|FG000|COMPLETED|Overall Study|November 2010|19
3094101|NCT01460225|3816856|FG000|NOT COMPLETED|Overall Study||0
3094102|NCT01460290|3816861|FG000|STARTED|Overall Study||15
3094103|NCT01460290|3816861|FG000|COMPLETED|Overall Study||11
3094104|NCT01460290|3816861|FG000|NOT COMPLETED|Overall Study||4
3094105|NCT01460303|3816868|FG000|STARTED|Overall Study||25
3094106|NCT01460303|3816869|FG001|STARTED|Overall Study||24
3094107|NCT01460303|3816868|FG000|COMPLETED|Overall Study||25
3094108|NCT01460303|3816869|FG001|COMPLETED|Overall Study||24
3094109|NCT01460303|3816868|FG000|NOT COMPLETED|Overall Study||0
3094110|NCT01460303|3816869|FG001|NOT COMPLETED|Overall Study||0
3094111|NCT01460342|3816877|FG000|STARTED|Overall Study||304
3094112|NCT01460342|3816878|FG001|STARTED|Overall Study||306
3094113|NCT01460342|3816877|FG000|Received at Least 1 Dose of Study Drug|Overall Study||304
3094114|NCT01460342|3816878|FG001|Received at Least 1 Dose of Study Drug|Overall Study||306
3094115|NCT01460342|3816877|FG000|COMPLETED|Overall Study||293
3094116|NCT01460342|3816878|FG001|COMPLETED|Overall Study||292
3094117|NCT01460342|3816877|FG000|NOT COMPLETED|Overall Study||11
3094118|NCT01460342|3816878|FG001|NOT COMPLETED|Overall Study||14
3094119|NCT01460368|3816886|FG000|STARTED|Part A||7
3094120|NCT01460368|3816887|FG001|STARTED|Part A||0
3094121|NCT01460368|3816888|FG002|STARTED|Part A||0
3094122|NCT01460368|3816889|FG003|STARTED|Part A||0
3094123|NCT01460368|3816890|FG004|STARTED|Part A||0
3094124|NCT01460368|3816891|FG005|STARTED|Part A||0
3094125|NCT01460368|3816892|FG006|STARTED|Part A||0
3094126|NCT01460368|3816886|FG000|Received at Least One Dose of Study Drug|Part A||7
3094127|NCT01460368|3816887|FG001|Received at Least One Dose of Study Drug|Part A||0
3094128|NCT01460368|3816888|FG002|Received at Least One Dose of Study Drug|Part A||0
3094129|NCT01460368|3816889|FG003|Received at Least One Dose of Study Drug|Part A||0
3094130|NCT01460368|3816890|FG004|Received at Least One Dose of Study Drug|Part A||0
3094131|NCT01460368|3816891|FG005|Received at Least One Dose of Study Drug|Part A||0
3094132|NCT01460368|3816892|FG006|Received at Least One Dose of Study Drug|Part A||0
3094133|NCT01460368|3816886|FG000|COMPLETED|Part A||7
3094134|NCT01460368|3816887|FG001|COMPLETED|Part A||0
3094135|NCT01460368|3816888|FG002|COMPLETED|Part A||0
3094136|NCT01460368|3816889|FG003|COMPLETED|Part A||0
3094137|NCT01460368|3816890|FG004|COMPLETED|Part A||0
3094138|NCT01460368|3816891|FG005|COMPLETED|Part A||0
3094139|NCT01460368|3816892|FG006|COMPLETED|Part A||0
3094140|NCT01460368|3816886|FG000|NOT COMPLETED|Part A||0
3094141|NCT01460368|3816887|FG001|NOT COMPLETED|Part A||0
3094142|NCT01460368|3816888|FG002|NOT COMPLETED|Part A||0
3094143|NCT01460368|3816889|FG003|NOT COMPLETED|Part A||0
3094144|NCT01460368|3816890|FG004|NOT COMPLETED|Part A||0
3094145|NCT01460368|3816891|FG005|NOT COMPLETED|Part A||0
3094146|NCT01460368|3816892|FG006|NOT COMPLETED|Part A||0
3094147|NCT01460368|3816886|FG000|STARTED|Part B: First Intervention (Period 1)||0
3094148|NCT01460368|3816887|FG001|STARTED|Part B: First Intervention (Period 1)||10
3094149|NCT01460368|3816888|FG002|STARTED|Part B: First Intervention (Period 1)||10
3094150|NCT01460368|3816889|FG003|STARTED|Part B: First Intervention (Period 1)||10
3094151|NCT01460368|3816890|FG004|STARTED|Part B: First Intervention (Period 1)||10
3094152|NCT01460368|3816891|FG005|STARTED|Part B: First Intervention (Period 1)||10
3094153|NCT01460368|3816892|FG006|STARTED|Part B: First Intervention (Period 1)||10
3094154|NCT01460368|3816886|FG000|Received at Least One Dose of Study Drug|Part B: First Intervention (Period 1)||0
3094155|NCT01460368|3816887|FG001|Received at Least One Dose of Study Drug|Part B: First Intervention (Period 1)||10
3094156|NCT01460368|3816888|FG002|Received at Least One Dose of Study Drug|Part B: First Intervention (Period 1)||10
3094157|NCT01460368|3816889|FG003|Received at Least One Dose of Study Drug|Part B: First Intervention (Period 1)||10
3094158|NCT01460368|3816890|FG004|Received at Least One Dose of Study Drug|Part B: First Intervention (Period 1)||10
3094159|NCT01460368|3816891|FG005|Received at Least One Dose of Study Drug|Part B: First Intervention (Period 1)||10
3094160|NCT01460368|3816892|FG006|Received at Least One Dose of Study Drug|Part B: First Intervention (Period 1)||10
3094161|NCT01460368|3816886|FG000|COMPLETED|Part B: First Intervention (Period 1)||0
3094162|NCT01460368|3816887|FG001|COMPLETED|Part B: First Intervention (Period 1)||10
3094163|NCT01460368|3816888|FG002|COMPLETED|Part B: First Intervention (Period 1)||10
3094164|NCT01460368|3816889|FG003|COMPLETED|Part B: First Intervention (Period 1)||10
3094165|NCT01460368|3816890|FG004|COMPLETED|Part B: First Intervention (Period 1)||9
3094166|NCT01460368|3816891|FG005|COMPLETED|Part B: First Intervention (Period 1)||10
3094167|NCT01460368|3816892|FG006|COMPLETED|Part B: First Intervention (Period 1)||10
3094168|NCT01460368|3816886|FG000|NOT COMPLETED|Part B: First Intervention (Period 1)||0
3094169|NCT01460368|3816887|FG001|NOT COMPLETED|Part B: First Intervention (Period 1)||0
3094170|NCT01460368|3816888|FG002|NOT COMPLETED|Part B: First Intervention (Period 1)||0
3094171|NCT01460368|3816889|FG003|NOT COMPLETED|Part B: First Intervention (Period 1)||0
3094172|NCT01460368|3816890|FG004|NOT COMPLETED|Part B: First Intervention (Period 1)||1
3094173|NCT01460368|3816891|FG005|NOT COMPLETED|Part B: First Intervention (Period 1)||0
3094174|NCT01460368|3816892|FG006|NOT COMPLETED|Part B: First Intervention (Period 1)||0
3094175|NCT01460368|3816886|FG000|STARTED|Part B: Washout (up to 15 Days)||0
3094176|NCT01460368|3816887|FG001|STARTED|Part B: Washout (up to 15 Days)||10
3094177|NCT01460368|3816888|FG002|STARTED|Part B: Washout (up to 15 Days)||10
3094178|NCT01460368|3816889|FG003|STARTED|Part B: Washout (up to 15 Days)||10
3094179|NCT01460368|3816890|FG004|STARTED|Part B: Washout (up to 15 Days)||9
3094180|NCT01460368|3816891|FG005|STARTED|Part B: Washout (up to 15 Days)||10
3094181|NCT01460368|3816892|FG006|STARTED|Part B: Washout (up to 15 Days)||10
3094182|NCT01460368|3816886|FG000|COMPLETED|Part B: Washout (up to 15 Days)||0
3094183|NCT01460368|3816887|FG001|COMPLETED|Part B: Washout (up to 15 Days)||10
3094184|NCT01460368|3816888|FG002|COMPLETED|Part B: Washout (up to 15 Days)||10
3094185|NCT01460368|3816889|FG003|COMPLETED|Part B: Washout (up to 15 Days)||10
3094186|NCT01460368|3816890|FG004|COMPLETED|Part B: Washout (up to 15 Days)||9
3094187|NCT01460368|3816891|FG005|COMPLETED|Part B: Washout (up to 15 Days)||10
3094188|NCT01460368|3816892|FG006|COMPLETED|Part B: Washout (up to 15 Days)||10
3094189|NCT01460368|3816886|FG000|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
3094190|NCT01460368|3816887|FG001|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
3094191|NCT01460368|3816888|FG002|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
3094192|NCT01460368|3816889|FG003|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
3094193|NCT01460368|3816890|FG004|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
3094194|NCT01460368|3816891|FG005|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
3094195|NCT01460368|3816892|FG006|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
3094196|NCT01460368|3816886|FG000|STARTED|Part B: Second Intervention (Period 2)||0
3094197|NCT01460368|3816887|FG001|STARTED|Part B: Second Intervention (Period 2)||10
3094198|NCT01460368|3816888|FG002|STARTED|Part B: Second Intervention (Period 2)||10
3094199|NCT01460368|3816889|FG003|STARTED|Part B: Second Intervention (Period 2)||10
3094200|NCT01460368|3816890|FG004|STARTED|Part B: Second Intervention (Period 2)||9
3094201|NCT01460368|3816891|FG005|STARTED|Part B: Second Intervention (Period 2)||10
3094202|NCT01460368|3816892|FG006|STARTED|Part B: Second Intervention (Period 2)||10
3094203|NCT01460368|3816886|FG000|COMPLETED|Part B: Second Intervention (Period 2)||0
3094204|NCT01460368|3816887|FG001|COMPLETED|Part B: Second Intervention (Period 2)||8
3094205|NCT01460368|3816888|FG002|COMPLETED|Part B: Second Intervention (Period 2)||10
3094206|NCT01460368|3816889|FG003|COMPLETED|Part B: Second Intervention (Period 2)||10
3094207|NCT01460368|3816890|FG004|COMPLETED|Part B: Second Intervention (Period 2)||9
3094208|NCT01460368|3816891|FG005|COMPLETED|Part B: Second Intervention (Period 2)||10
3094209|NCT01460368|3816892|FG006|COMPLETED|Part B: Second Intervention (Period 2)||9
3094210|NCT01460368|3816886|FG000|NOT COMPLETED|Part B: Second Intervention (Period 2)||0
3135144|NCT01704846|3860124|FG001|NOT COMPLETED|Treatment Period 1||0
3094211|NCT01460368|3816887|FG001|NOT COMPLETED|Part B: Second Intervention (Period 2)||2
3094212|NCT01460368|3816888|FG002|NOT COMPLETED|Part B: Second Intervention (Period 2)||0
3094213|NCT01460368|3816889|FG003|NOT COMPLETED|Part B: Second Intervention (Period 2)||0
3094214|NCT01460368|3816890|FG004|NOT COMPLETED|Part B: Second Intervention (Period 2)||0
3094215|NCT01460368|3816891|FG005|NOT COMPLETED|Part B: Second Intervention (Period 2)||0
3094216|NCT01460368|3816892|FG006|NOT COMPLETED|Part B: Second Intervention (Period 2)||1
3094217|NCT01460368|3816886|FG000|STARTED|Part B: Washout (up to 15 Days)||0
3094218|NCT01460368|3816887|FG001|STARTED|Part B: Washout (up to 15 Days)||8
3094219|NCT01460368|3816888|FG002|STARTED|Part B: Washout (up to 15 Days)||10
3094220|NCT01460368|3816889|FG003|STARTED|Part B: Washout (up to 15 Days)||10
3094221|NCT01460368|3816890|FG004|STARTED|Part B: Washout (up to 15 Days)||9
3094222|NCT01460368|3816891|FG005|STARTED|Part B: Washout (up to 15 Days)||10
3094223|NCT01460368|3816892|FG006|STARTED|Part B: Washout (up to 15 Days)||9
3094224|NCT01460368|3816886|FG000|COMPLETED|Part B: Washout (up to 15 Days)||0
3094225|NCT01460368|3816887|FG001|COMPLETED|Part B: Washout (up to 15 Days)||8
3094226|NCT01460368|3816888|FG002|COMPLETED|Part B: Washout (up to 15 Days)||9
3094227|NCT01460368|3816889|FG003|COMPLETED|Part B: Washout (up to 15 Days)||10
3094228|NCT01460368|3816890|FG004|COMPLETED|Part B: Washout (up to 15 Days)||9
3094229|NCT01460368|3816891|FG005|COMPLETED|Part B: Washout (up to 15 Days)||10
3094230|NCT01460368|3816892|FG006|COMPLETED|Part B: Washout (up to 15 Days)||9
3094231|NCT01460368|3816886|FG000|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
3094232|NCT01460368|3816887|FG001|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
3094233|NCT01460368|3816888|FG002|NOT COMPLETED|Part B: Washout (up to 15 Days)||1
3094234|NCT01460368|3816889|FG003|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
3094235|NCT01460368|3816890|FG004|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
3094236|NCT01460368|3816891|FG005|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
3094237|NCT01460368|3816892|FG006|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
3094238|NCT01460368|3816886|FG000|STARTED|Part B: Third Interventions (Period 3)||0
3094239|NCT01460368|3816887|FG001|STARTED|Part B: Third Interventions (Period 3)||8
3094240|NCT01460368|3816888|FG002|STARTED|Part B: Third Interventions (Period 3)||9
3289483|NCT02813694|4023196|FG001|NOT COMPLETED|Overall Study||14
3289484|NCT02814175|4023204|FG000|STARTED|Part 1||122
3289485|NCT02814175|4023205|FG001|STARTED|Part 1||123
3289486|NCT02814175|4023206|FG002|STARTED|Part 1||0
3289487|NCT02814175|4023207|FG003|STARTED|Part 1||0
3289488|NCT02814175|4023208|FG004|STARTED|Part 1||0
3289489|NCT02814175|4023209|FG005|STARTED|Part 1||0
3289490|NCT02814175|4023204|FG000|COMPLETED|Part 1||110
3289491|NCT02814175|4023205|FG001|COMPLETED|Part 1||117
3289492|NCT02814175|4023206|FG002|COMPLETED|Part 1||0
3289493|NCT02814175|4023207|FG003|COMPLETED|Part 1||0
3289494|NCT02814175|4023208|FG004|COMPLETED|Part 1||0
3289495|NCT02814175|4023209|FG005|COMPLETED|Part 1||0
3289496|NCT02814175|4023204|FG000|NOT COMPLETED|Part 1||12
3289497|NCT02814175|4023205|FG001|NOT COMPLETED|Part 1||6
3289498|NCT02814175|4023206|FG002|NOT COMPLETED|Part 1||0
3289499|NCT02814175|4023207|FG003|NOT COMPLETED|Part 1||0
3289500|NCT02814175|4023208|FG004|NOT COMPLETED|Part 1||0
3289501|NCT02814175|4023209|FG005|NOT COMPLETED|Part 1||0
3289502|NCT02814175|4023204|FG000|STARTED|Part 2||0
3289503|NCT02814175|4023205|FG001|STARTED|Part 2||0
3289504|NCT02814175|4023206|FG002|STARTED|Part 2||15
3289505|NCT02814175|4023207|FG003|STARTED|Part 2||95
3289506|NCT02814175|4023208|FG004|STARTED|Part 2||54
3289507|NCT02814175|4023209|FG005|STARTED|Part 2||63
3289508|NCT02814175|4023204|FG000|COMPLETED|Part 2||0
3289509|NCT02814175|4023205|FG001|COMPLETED|Part 2||0
3289510|NCT02814175|4023206|FG002|COMPLETED|Part 2||15
3289511|NCT02814175|4023207|FG003|COMPLETED|Part 2||91
3289512|NCT02814175|4023208|FG004|COMPLETED|Part 2||52
3289513|NCT02814175|4023209|FG005|COMPLETED|Part 2||57
3289514|NCT02814175|4023204|FG000|NOT COMPLETED|Part 2||0
3289515|NCT02814175|4023205|FG001|NOT COMPLETED|Part 2||0
3289516|NCT02814175|4023206|FG002|NOT COMPLETED|Part 2||0
3289517|NCT02814175|4023207|FG003|NOT COMPLETED|Part 2||4
3289518|NCT02814175|4023208|FG004|NOT COMPLETED|Part 2||2
3289519|NCT02814175|4023209|FG005|NOT COMPLETED|Part 2||6
3289520|NCT02814227|4023223|FG000|STARTED|Overall Study||52
3289521|NCT02814227|4023223|FG000|COMPLETED|Overall Study||52
3289522|NCT02814227|4023223|FG000|NOT COMPLETED|Overall Study||0
3289523|NCT02814279|4023229|FG000|STARTED|Overall Study||21
3289524|NCT02814279|4023230|FG001|STARTED|Overall Study||21
3289525|NCT02814279|4023229|FG000|COMPLETED|Overall Study||21
3289526|NCT02814279|4023230|FG001|COMPLETED|Overall Study||21
3289527|NCT02814279|4023229|FG000|NOT COMPLETED|Overall Study||0
3289528|NCT02814279|4023230|FG001|NOT COMPLETED|Overall Study||0
3289529|NCT02814448|4023241|FG000|STARTED|Overall Study||27
3289530|NCT02814448|4023242|FG001|STARTED|Overall Study||24
3289531|NCT02814448|4023243|FG002|STARTED|Overall Study||26
3289532|NCT02814448|4023244|FG003|STARTED|Overall Study||25
3289533|NCT02814448|4023245|FG004|STARTED|Overall Study||28
3289534|NCT02814448|4023241|FG000|COMPLETED|Overall Study||27
3289535|NCT02814448|4023242|FG001|COMPLETED|Overall Study||24
3289536|NCT02814448|4023243|FG002|COMPLETED|Overall Study||25
3289537|NCT02814448|4023244|FG003|COMPLETED|Overall Study||25
3289538|NCT02814448|4023245|FG004|COMPLETED|Overall Study||26
3289539|NCT02814448|4023241|FG000|NOT COMPLETED|Overall Study||0
3289540|NCT02814448|4023242|FG001|NOT COMPLETED|Overall Study||0
3289541|NCT02814448|4023243|FG002|NOT COMPLETED|Overall Study||1
3289542|NCT02814448|4023244|FG003|NOT COMPLETED|Overall Study||0
3094241|NCT01460368|3816889|FG003|STARTED|Part B: Third Interventions (Period 3)||10
3094242|NCT01460368|3816890|FG004|STARTED|Part B: Third Interventions (Period 3)||9
3094243|NCT01460368|3816891|FG005|STARTED|Part B: Third Interventions (Period 3)||10
3094244|NCT01460368|3816892|FG006|STARTED|Part B: Third Interventions (Period 3)||9
3094245|NCT01460368|3816886|FG000|COMPLETED|Part B: Third Interventions (Period 3)||0
3094246|NCT01460368|3816887|FG001|COMPLETED|Part B: Third Interventions (Period 3)||8
3094247|NCT01460368|3816888|FG002|COMPLETED|Part B: Third Interventions (Period 3)||8
3094248|NCT01460368|3816889|FG003|COMPLETED|Part B: Third Interventions (Period 3)||9
3094249|NCT01460368|3816890|FG004|COMPLETED|Part B: Third Interventions (Period 3)||9
3094250|NCT01460368|3816891|FG005|COMPLETED|Part B: Third Interventions (Period 3)||9
3094251|NCT01460368|3816892|FG006|COMPLETED|Part B: Third Interventions (Period 3)||9
3094252|NCT01460368|3816886|FG000|NOT COMPLETED|Part B: Third Interventions (Period 3)||0
3094253|NCT01460368|3816887|FG001|NOT COMPLETED|Part B: Third Interventions (Period 3)||0
3094254|NCT01460368|3816888|FG002|NOT COMPLETED|Part B: Third Interventions (Period 3)||1
3094255|NCT01460368|3816889|FG003|NOT COMPLETED|Part B: Third Interventions (Period 3)||1
3094256|NCT01460368|3816890|FG004|NOT COMPLETED|Part B: Third Interventions (Period 3)||0
3094257|NCT01460368|3816891|FG005|NOT COMPLETED|Part B: Third Interventions (Period 3)||1
3094258|NCT01460368|3816892|FG006|NOT COMPLETED|Part B: Third Interventions (Period 3)||0
3094259|NCT01460381|3816903|FG000|STARTED|Period 1 (Days 1-7)||7
3094260|NCT01460381|3816904|FG001|STARTED|Period 1 (Days 1-7)||11
3094261|NCT01460381|3816903|FG000|Received at Least 1 Dose of Study Drug|Period 1 (Days 1-7)||7
3094262|NCT01460381|3816904|FG001|Received at Least 1 Dose of Study Drug|Period 1 (Days 1-7)||11
3094263|NCT01460381|3816903|FG000|COMPLETED|Period 1 (Days 1-7)||7
3094264|NCT01460381|3816904|FG001|COMPLETED|Period 1 (Days 1-7)||11
3094265|NCT01460381|3816903|FG000|NOT COMPLETED|Period 1 (Days 1-7)||0
3094266|NCT01460381|3816904|FG001|NOT COMPLETED|Period 1 (Days 1-7)||0
3094267|NCT01460381|3816903|FG000|STARTED|Period 2 (Days 8-15)||7
3094268|NCT01460381|3816904|FG001|STARTED|Period 2 (Days 8-15)|CYP2C19 extensive metabolizers did not participate in Period 2.|0
3094269|NCT01460381|3816903|FG000|COMPLETED|Period 2 (Days 8-15)|One participant was lost to follow-up after completing Period 2 and did not complete the study.|6
3094270|NCT01460381|3816904|FG001|COMPLETED|Period 2 (Days 8-15)|CYP2C19 extensive metabolizers did not participate in Period 2|0
3094271|NCT01460381|3816903|FG000|NOT COMPLETED|Period 2 (Days 8-15)||1
3094272|NCT01460381|3816904|FG001|NOT COMPLETED|Period 2 (Days 8-15)||0
3094273|NCT01460407|3816912|FG000|STARTED|Period 1: Day 1 to Day 5||14
3094274|NCT01460407|3816913|FG001|STARTED|Period 1: Day 1 to Day 5||0
3094275|NCT01460407|3816912|FG000|COMPLETED|Period 1: Day 1 to Day 5||14
3094276|NCT01460407|3816913|FG001|COMPLETED|Period 1: Day 1 to Day 5||0
3094277|NCT01460407|3816912|FG000|NOT COMPLETED|Period 1: Day 1 to Day 5||0
3094278|NCT01460407|3816913|FG001|NOT COMPLETED|Period 1: Day 1 to Day 5||0
3094279|NCT01460407|3816912|FG000|STARTED|Period 2: Day 6 to Day 14||0
3094280|NCT01460407|3816913|FG001|STARTED|Period 2: Day 6 to Day 14||14
3094281|NCT01460407|3816912|FG000|COMPLETED|Period 2: Day 6 to Day 14||0
3094282|NCT01460407|3816913|FG001|COMPLETED|Period 2: Day 6 to Day 14||13
3094283|NCT01460407|3816912|FG000|NOT COMPLETED|Period 2: Day 6 to Day 14||0
3094284|NCT01460407|3816913|FG001|NOT COMPLETED|Period 2: Day 6 to Day 14||1
3094285|NCT01460446|3816922|FG000|STARTED|Overall Study||105
3094286|NCT01460446|3816923|FG001|STARTED|Overall Study||113
3094287|NCT01460446|3816922|FG000|COMPLETED|Overall Study||100
3094288|NCT01460446|3816923|FG001|COMPLETED|Overall Study||93
3094289|NCT01460446|3816922|FG000|NOT COMPLETED|Overall Study||5
3094290|NCT01460446|3816923|FG001|NOT COMPLETED|Overall Study||20
3094291|NCT01460628|3816930|FG000|STARTED|Overall Study||25
3094292|NCT01460628|3816930|FG000|COMPLETED|Overall Study||20
3094293|NCT01460628|3816930|FG000|NOT COMPLETED|Overall Study||5
3094294|NCT01460719|3816934|FG000|STARTED|Overall Study||80
3094295|NCT01460719|3816934|FG000|Vaccination 1 (Day 1)|Overall Study||80
3094296|NCT01460719|3816934|FG000|Vaccination 2 (~Day 30)|Overall Study||78
3094297|NCT01460719|3816934|FG000|Vaccination 3 (~Day 60)|Overall Study||78
3094298|NCT01460719|3816934|FG000|Vaccination 4 (~Day 90)|Overall Study||78
3094299|NCT01460719|3816934|FG000|COMPLETED|Overall Study||78
3094300|NCT01460719|3816934|FG000|NOT COMPLETED|Overall Study||2
3094301|NCT01460732|3816938|FG000|STARTED|Overall Study||81
3094302|NCT01460732|3816938|FG000|COMPLETED|Overall Study||81
3094303|NCT01460732|3816938|FG000|NOT COMPLETED|Overall Study||0
3094304|NCT01460875|3816944|FG000|STARTED|Overall Study||34
3094305|NCT01460875|3816944|FG000|COMPLETED|Overall Study||34
3094306|NCT01460875|3816944|FG000|NOT COMPLETED|Overall Study||0
3094307|NCT01460901|3816948|FG000|STARTED|Overall Study|First enrollment|5
3094308|NCT01460901|3816948|FG000|tV-CTL Infusion|Overall Study||3
3094309|NCT01460901|3816948|FG000|COMPLETED|Overall Study|Follow-up completed|3
3289543|NCT02814448|4023245|FG004|NOT COMPLETED|Overall Study||2
3289544|NCT02814565|4023259|FG000|STARTED|Overall Study||90
3289545|NCT02814565|4023260|FG001|STARTED|Overall Study||90
3289546|NCT02814565|4023259|FG000|COMPLETED|Overall Study||89
3289547|NCT02814565|4023260|FG001|COMPLETED|Overall Study||88
3289548|NCT02814565|4023259|FG000|NOT COMPLETED|Overall Study||1
3289549|NCT02814565|4023260|FG001|NOT COMPLETED|Overall Study||2
3289550|NCT02814643|4023268|FG000|STARTED|Overall Study||51
3289551|NCT02814643|4023269|FG001|STARTED|Overall Study||52
3289552|NCT02814643|4023268|FG000|COMPLETED|Overall Study||50
3289553|NCT02814643|4023269|FG001|COMPLETED|Overall Study||49
3289554|NCT02814643|4023268|FG000|NOT COMPLETED|Overall Study||1
3094310|NCT01460901|3816948|FG000|NOT COMPLETED|Overall Study||2
3094311|NCT01460927|3816955|FG000|STARTED|Overall Study||25
3094312|NCT01460927|3816955|FG000|COMPLETED|Overall Study||25
3094313|NCT01460927|3816955|FG000|NOT COMPLETED|Overall Study||0
3094314|NCT01460940|3816963|FG000|STARTED|Overall Study||24
3094315|NCT01460940|3816963|FG000|COMPLETED|Overall Study||24
3094316|NCT01460940|3816963|FG000|NOT COMPLETED|Overall Study||0
3094317|NCT01461005|3816967|FG000|STARTED|Overall Study||1
3094318|NCT01461005|3816967|FG000|COMPLETED|Overall Study||0
3094319|NCT01461005|3816967|FG000|NOT COMPLETED|Overall Study||1
3094320|NCT01461044|3816974|FG000|STARTED|Overall Study||150
3094321|NCT01461044|3816975|FG001|STARTED|Overall Study||77
3094322|NCT01461044|3816974|FG000|Participants Alive at Inclusion|Overall Study||127
3094323|NCT01461044|3816975|FG001|Participants Alive at Inclusion|Overall Study||58
3094324|NCT01461044|3816974|FG000|COMPLETED|Overall Study||80
3094325|NCT01461044|3816975|FG001|COMPLETED|Overall Study||37
3094326|NCT01461044|3816974|FG000|NOT COMPLETED|Overall Study||70
3094327|NCT01461044|3816975|FG001|NOT COMPLETED|Overall Study||40
3094328|NCT01461057|3816986|FG000|STARTED|Overall Study||15
3094329|NCT01461057|3816987|FG001|STARTED|Overall Study||15
3094330|NCT01461057|3816986|FG000|COMPLETED|Overall Study||0
3094331|NCT01461057|3816987|FG001|COMPLETED|Overall Study||0
3094332|NCT01461057|3816986|FG000|NOT COMPLETED|Overall Study||15
3094333|NCT01461057|3816987|FG001|NOT COMPLETED|Overall Study||15
3094334|NCT01461096|3816995|FG000|STARTED|Overall Study||288
3094335|NCT01461096|3816996|FG001|STARTED|Overall Study||287
3094336|NCT01461096|3816995|FG000|Did Not Start Treatment|Overall Study||0
3094337|NCT01461096|3816996|FG001|Did Not Start Treatment|Overall Study|Randomized but never started treatment and was discontinued from the study|1
3094338|NCT01461096|3816995|FG000|COMPLETED|Overall Study||226
3094339|NCT01461096|3816996|FG001|COMPLETED|Overall Study||226
3094340|NCT01461096|3816995|FG000|NOT COMPLETED|Overall Study||62
3094341|NCT01461096|3816996|FG001|NOT COMPLETED|Overall Study||61
3094342|NCT01461369|3817006|FG000|STARTED|Overall Study||104
3094343|NCT01461369|3817007|FG001|STARTED|Overall Study||98
3094344|NCT01461369|3817008|FG002|STARTED|Overall Study||103
3094345|NCT01461369|3817006|FG000|COMPLETED|Overall Study||91
3094346|NCT01461369|3817007|FG001|COMPLETED|Overall Study||81
3094347|NCT01461369|3817008|FG002|COMPLETED|Overall Study||86
3094348|NCT01461369|3817006|FG000|NOT COMPLETED|Overall Study||13
3094349|NCT01461369|3817007|FG001|NOT COMPLETED|Overall Study||17
3094350|NCT01461369|3817008|FG002|NOT COMPLETED|Overall Study||17
3094351|NCT01461473|3817018|FG000|STARTED|Overall Study||72
3094352|NCT01461473|3817019|FG001|STARTED|Overall Study||59
3094353|NCT01461473|3817018|FG000|COMPLETED|Overall Study||67
3094354|NCT01461473|3817019|FG001|COMPLETED|Overall Study||55
3094355|NCT01461473|3817018|FG000|NOT COMPLETED|Overall Study||5
3094356|NCT01461473|3817019|FG001|NOT COMPLETED|Overall Study||4
3094357|NCT01461499|3817027|FG000|STARTED|Overall Study||119
3094358|NCT01461499|3817028|FG001|STARTED|Overall Study||118
3094359|NCT01461499|3817027|FG000|COMPLETED|Overall Study||111
3094360|NCT01461499|3817028|FG001|COMPLETED|Overall Study||114
3094361|NCT01461499|3817027|FG000|NOT COMPLETED|Overall Study||8
3094362|NCT01461499|3817028|FG001|NOT COMPLETED|Overall Study||4
3094363|NCT01461538|3817039|FG000|STARTED|Overall Study||46
3094364|NCT01461538|3817040|FG001|STARTED|Overall Study||28
3094365|NCT01461538|3817041|FG002|STARTED|Overall Study||9
3094366|NCT01461538|3817039|FG000|COMPLETED|Overall Study||28
3094367|NCT01461538|3817040|FG001|COMPLETED|Overall Study||20
3094368|NCT01461538|3817041|FG002|COMPLETED|Overall Study||7
3094369|NCT01461538|3817039|FG000|NOT COMPLETED|Overall Study||18
3094370|NCT01461538|3817040|FG001|NOT COMPLETED|Overall Study||8
3094371|NCT01461538|3817041|FG002|NOT COMPLETED|Overall Study||2
3094372|NCT01461551|3817054|FG000|STARTED|Overall Study||35
3094373|NCT01461551|3817055|FG001|STARTED|Overall Study||35
3094374|NCT01461551|3817056|FG002|STARTED|Overall Study||35
3094375|NCT01461551|3817054|FG000|COMPLETED|Overall Study||33
3094376|NCT01461551|3817055|FG001|COMPLETED|Overall Study||34
3094377|NCT01461551|3817056|FG002|COMPLETED|Overall Study||33
3094378|NCT01461551|3817054|FG000|NOT COMPLETED|Overall Study||2
3094379|NCT01461551|3817055|FG001|NOT COMPLETED|Overall Study||1
3094380|NCT01461551|3817056|FG002|NOT COMPLETED|Overall Study||2
3094381|NCT01461655|3817064|FG000|STARTED|Overall Study||40
3094382|NCT01461655|3817064|FG000|COMPLETED|Overall Study||40
3094383|NCT01461655|3817064|FG000|NOT COMPLETED|Overall Study||0
3094384|NCT01461668|3817071|FG000|STARTED|Overall Study||27
3094385|NCT01461668|3817072|FG001|STARTED|Overall Study||26
3094386|NCT01461668|3817071|FG000|COMPLETED|Overall Study||25
3094387|NCT01461668|3817072|FG001|COMPLETED|Overall Study||25
3094388|NCT01461668|3817071|FG000|NOT COMPLETED|Overall Study||2
3094389|NCT01461668|3817072|FG001|NOT COMPLETED|Overall Study||1
3094390|NCT01461707|3817080|FG000|STARTED|Overall Study||15
3094391|NCT01461707|3817081|FG001|STARTED|Overall Study||15
3094392|NCT01461707|3817080|FG000|COMPLETED|Overall Study||14
3094393|NCT01461707|3817081|FG001|COMPLETED|Overall Study||15
3094394|NCT01461707|3817080|FG000|NOT COMPLETED|Overall Study||1
3094395|NCT01461707|3817081|FG001|NOT COMPLETED|Overall Study||0
3094396|NCT01461733|3817089|FG000|STARTED|Overall Study||12
3094397|NCT01461733|3817090|FG001|STARTED|Overall Study||12
3094398|NCT01461733|3817089|FG000|COMPLETED|Overall Study||8
3094399|NCT01461733|3817090|FG001|COMPLETED|Overall Study||8
3094400|NCT01461733|3817089|FG000|NOT COMPLETED|Overall Study||4
3094401|NCT01461733|3817090|FG001|NOT COMPLETED|Overall Study||4
3094402|NCT01461811|3817098|FG000|STARTED|Overall Study||95
3094403|NCT01461811|3817099|FG001|STARTED|Overall Study||49
3094404|NCT01461811|3817098|FG000|COMPLETED|Overall Study||91
3094405|NCT01461811|3817099|FG001|COMPLETED|Overall Study||46
3094406|NCT01461811|3817098|FG000|NOT COMPLETED|Overall Study||4
3094407|NCT01461811|3817099|FG001|NOT COMPLETED|Overall Study||3
3094408|NCT01461824|3817108|FG000|STARTED|Overall Study||12
3094409|NCT01461824|3817109|FG001|STARTED|Overall Study||11
3094410|NCT01461824|3817110|FG002|STARTED|Overall Study||11
3094411|NCT01461824|3817108|FG000|COMPLETED|Overall Study||10
3094412|NCT01461824|3817109|FG001|COMPLETED|Overall Study||7
3094413|NCT01461824|3817110|FG002|COMPLETED|Overall Study||8
3094414|NCT01461824|3817108|FG000|NOT COMPLETED|Overall Study||2
3094415|NCT01461824|3817109|FG001|NOT COMPLETED|Overall Study||4
3094416|NCT01461824|3817110|FG002|NOT COMPLETED|Overall Study||3
3094417|NCT01461863|3817120|FG000|STARTED|Overall Study||48
3094418|NCT01461863|3817121|FG001|STARTED|Overall Study||48
3094419|NCT01461863|3817120|FG000|COMPLETED|Overall Study||48
3094420|NCT01461863|3817121|FG001|COMPLETED|Overall Study||48
3094421|NCT01461863|3817120|FG000|NOT COMPLETED|Overall Study||0
3094422|NCT01461863|3817121|FG001|NOT COMPLETED|Overall Study||0
3094423|NCT01461928|3817129|FG000|STARTED|Induction (up to 8 Months)||692
3094424|NCT01461928|3817130|FG001|STARTED|Induction (up to 8 Months)||0
3094425|NCT01461928|3817131|FG002|STARTED|Induction (up to 8 Months)||0
3094426|NCT01461928|3817129|FG000|COMPLETED|Induction (up to 8 Months)||494
3094427|NCT01461928|3817130|FG001|COMPLETED|Induction (up to 8 Months)||0
3094428|NCT01461928|3817131|FG002|COMPLETED|Induction (up to 8 Months)||0
3094429|NCT01461928|3817129|FG000|NOT COMPLETED|Induction (up to 8 Months)||198
3094430|NCT01461928|3817130|FG001|NOT COMPLETED|Induction (up to 8 Months)||0
3094431|NCT01461928|3817131|FG002|NOT COMPLETED|Induction (up to 8 Months)||0
3094432|NCT01461928|3817129|FG000|STARTED|Maintenance I (24 Months)||494
3094433|NCT01461928|3817130|FG001|STARTED|Maintenance I (24 Months)||0
3094434|NCT01461928|3817131|FG002|STARTED|Maintenance I (24 Months)||0
3094435|NCT01461928|3817129|FG000|COMPLETED|Maintenance I (24 Months)|Responders during 2 yrs Maint I treatment|276
3094436|NCT01461928|3817130|FG001|COMPLETED|Maintenance I (24 Months)||0
3094437|NCT01461928|3817131|FG002|COMPLETED|Maintenance I (24 Months)||0
3094438|NCT01461928|3817129|FG000|NOT COMPLETED|Maintenance I (24 Months)||218
3094439|NCT01461928|3817130|FG001|NOT COMPLETED|Maintenance I (24 Months)||0
3094440|NCT01461928|3817131|FG002|NOT COMPLETED|Maintenance I (24 Months)||0
3094441|NCT01461928|3817129|FG000|STARTED|Maintenance II (15 Months)||0
3094442|NCT01461928|3817130|FG001|STARTED|Maintenance II (15 Months)||138
3094443|NCT01461928|3817131|FG002|STARTED|Maintenance II (15 Months)||138
3094444|NCT01461928|3817129|FG000|COMPLETED|Maintenance II (15 Months)||0
3094445|NCT01461928|3817130|FG001|COMPLETED|Maintenance II (15 Months)|6 participants did not receive treatment|115
3094446|NCT01461928|3817131|FG002|COMPLETED|Maintenance II (15 Months)||111
3094447|NCT01461928|3817129|FG000|NOT COMPLETED|Maintenance II (15 Months)||0
3094448|NCT01461928|3817130|FG001|NOT COMPLETED|Maintenance II (15 Months)||23
3094449|NCT01461928|3817131|FG002|NOT COMPLETED|Maintenance II (15 Months)||27
3094450|NCT01461980|3817145|FG000|STARTED|Overall Study||888
3094451|NCT01461980|3817146|FG001|STARTED|Overall Study||878
3094452|NCT01461980|3817147|FG002|STARTED|Overall Study||882
3094453|NCT01461980|3817145|FG000|Vaccination 1|Overall Study||884
3094454|NCT01461980|3817146|FG001|Vaccination 1|Overall Study||870
3094455|NCT01461980|3817147|FG002|Vaccination 1|Overall Study||875
3094456|NCT01461980|3817145|FG000|Vaccination 2|Overall Study||802
3094457|NCT01461980|3817146|FG001|Vaccination 2|Overall Study||819
3094458|NCT01461980|3817147|FG002|Vaccination 2|Overall Study||799
3094459|NCT01461980|3817145|FG000|Vaccination 3|Overall Study||757
3094460|NCT01461980|3817146|FG001|Vaccination 3|Overall Study||777
3094461|NCT01461980|3817147|FG002|Vaccination 3|Overall Study||748
3094462|NCT01461980|3817145|FG000|COMPLETED|Overall Study||722
3094463|NCT01461980|3817146|FG001|COMPLETED|Overall Study||733
3094464|NCT01461980|3817147|FG002|COMPLETED|Overall Study||717
3094465|NCT01461980|3817145|FG000|NOT COMPLETED|Overall Study||166
3094466|NCT01461980|3817146|FG001|NOT COMPLETED|Overall Study||145
3094467|NCT01461980|3817147|FG002|NOT COMPLETED|Overall Study||165
3094468|NCT01461993|3817159|FG000|STARTED|Overall Study||999
3094469|NCT01461993|3817160|FG001|STARTED|Overall Study||998
3094470|NCT01461993|3817161|FG002|STARTED|Overall Study||502
3094471|NCT01461993|3817159|FG000|COMPLETED|Overall Study||848
3094472|NCT01461993|3817160|FG001|COMPLETED|Overall Study||841
3094473|NCT01461993|3817161|FG002|COMPLETED|Overall Study||438
3094474|NCT01461993|3817159|FG000|NOT COMPLETED|Overall Study||151
3094475|NCT01461993|3817160|FG001|NOT COMPLETED|Overall Study||157
3094476|NCT01461993|3817161|FG002|NOT COMPLETED|Overall Study||64
3094477|NCT01462045|3817173|FG000|STARTED|Overall Study||11
3094478|NCT01462045|3817174|FG001|STARTED|Overall Study||11
3094479|NCT01462045|3817175|FG002|STARTED|Overall Study||7
3094480|NCT01462045|3817173|FG000|COMPLETED|Overall Study||11
3094481|NCT01462045|3817174|FG001|COMPLETED|Overall Study||10
3094482|NCT01462045|3817175|FG002|COMPLETED|Overall Study||7
3094483|NCT01462045|3817173|FG000|NOT COMPLETED|Overall Study||0
3094484|NCT01462045|3817174|FG001|NOT COMPLETED|Overall Study||1
3094485|NCT01462045|3817175|FG002|NOT COMPLETED|Overall Study||0
3094486|NCT01462084|3817183|FG000|STARTED|Overall Study||11
3094487|NCT01462084|3817184|FG001|STARTED|Overall Study||10
3094488|NCT01462084|3817183|FG000|Included for Analysis|Overall Study||9
3094489|NCT01462084|3817184|FG001|Included for Analysis|Overall Study||9
3094490|NCT01462084|3817183|FG000|COMPLETED|Overall Study||9
3094491|NCT01462084|3817184|FG001|COMPLETED|Overall Study||9
3094492|NCT01462084|3817183|FG000|NOT COMPLETED|Overall Study||2
3094493|NCT01462084|3817184|FG001|NOT COMPLETED|Overall Study||1
3094494|NCT01462110|3817193|FG000|STARTED|Overall Study||44
3094495|NCT01462110|3817194|FG001|STARTED|Overall Study||43
3094496|NCT01462110|3817193|FG000|COMPLETED|Overall Study||43
3094497|NCT01462110|3817194|FG001|COMPLETED|Overall Study||43
3094498|NCT01462110|3817193|FG000|NOT COMPLETED|Overall Study||1
3094499|NCT01462110|3817194|FG001|NOT COMPLETED|Overall Study||0
3094500|NCT01462162|3817200|FG000|STARTED|Overall Study||120
3094501|NCT01462162|3817200|FG000|COMPLETED|Overall Study||108
3094502|NCT01462162|3817200|FG000|NOT COMPLETED|Overall Study||12
3094503|NCT01462227|3817207|FG000|STARTED|First Assignment||4
3094504|NCT01462227|3817208|FG001|STARTED|First Assignment||2
3094505|NCT01462227|3817209|FG002|STARTED|First Assignment||6
3094506|NCT01462227|3817210|FG003|STARTED|First Assignment||5
3094507|NCT01462227|3817207|FG000|COMPLETED|First Assignment||4
3094508|NCT01462227|3817208|FG001|COMPLETED|First Assignment||2
3094509|NCT01462227|3817209|FG002|COMPLETED|First Assignment||6
3094510|NCT01462227|3817210|FG003|COMPLETED|First Assignment||5
3094511|NCT01462227|3817207|FG000|NOT COMPLETED|First Assignment||0
3094512|NCT01462227|3817208|FG001|NOT COMPLETED|First Assignment||0
3094513|NCT01462227|3817209|FG002|NOT COMPLETED|First Assignment||0
3094514|NCT01462227|3817210|FG003|NOT COMPLETED|First Assignment||0
3094515|NCT01462227|3817207|FG000|STARTED|Second Assignment||4
3094516|NCT01462227|3817208|FG001|STARTED|Second Assignment||2
3094517|NCT01462227|3817209|FG002|STARTED|Second Assignment||6
3094518|NCT01462227|3817210|FG003|STARTED|Second Assignment||5
3094519|NCT01462227|3817207|FG000|COMPLETED|Second Assignment||3
3094520|NCT01462227|3817208|FG001|COMPLETED|Second Assignment||1
3094521|NCT01462227|3817209|FG002|COMPLETED|Second Assignment||5
3094522|NCT01462227|3817210|FG003|COMPLETED|Second Assignment||5
3094523|NCT01462227|3817207|FG000|NOT COMPLETED|Second Assignment||1
3094524|NCT01462227|3817208|FG001|NOT COMPLETED|Second Assignment||1
3289555|NCT02814643|4023269|FG001|NOT COMPLETED|Overall Study||3
3289556|NCT02814656|4023279|FG000|STARTED|Overall Study||6
3289557|NCT02814656|4023280|FG001|STARTED|Overall Study||6
3289558|NCT02814656|4023281|FG002|STARTED|Overall Study||6
3289559|NCT02814656|4023282|FG003|STARTED|Overall Study||6
3289560|NCT02814656|4023279|FG000|COMPLETED|Overall Study||6
3289561|NCT02814656|4023280|FG001|COMPLETED|Overall Study||6
3289562|NCT02814656|4023281|FG002|COMPLETED|Overall Study||6
3289563|NCT02814656|4023282|FG003|COMPLETED|Overall Study||6
3289564|NCT02814656|4023279|FG000|NOT COMPLETED|Overall Study||0
3289565|NCT02814656|4023280|FG001|NOT COMPLETED|Overall Study||0
3289566|NCT02814656|4023281|FG002|NOT COMPLETED|Overall Study||0
3289567|NCT02814656|4023282|FG003|NOT COMPLETED|Overall Study||0
3289568|NCT02814838|4023294|FG000|STARTED|Overall Study||50
3289569|NCT02814838|4023295|FG001|STARTED|Overall Study||26
3289570|NCT02814838|4023294|FG000|COMPLETED|Overall Study||48
3289571|NCT02814838|4023295|FG001|COMPLETED|Overall Study||25
3289572|NCT02814838|4023294|FG000|NOT COMPLETED|Overall Study||2
3289573|NCT02814838|4023295|FG001|NOT COMPLETED|Overall Study||1
3289574|NCT02814890|4023303|FG000|STARTED|Overall Study||33
3289575|NCT02814890|4023304|FG001|STARTED|Overall Study||32
3289576|NCT02814890|4023303|FG000|COMPLETED|Overall Study||30
3289577|NCT02814890|4023304|FG001|COMPLETED|Overall Study||30
3289578|NCT02814890|4023303|FG000|NOT COMPLETED|Overall Study||3
3289579|NCT02814890|4023304|FG001|NOT COMPLETED|Overall Study||2
3289580|NCT02815293|4023319|FG000|STARTED|Overall Study||10
3289581|NCT02815293|4023320|FG001|STARTED|Overall Study||8
3289582|NCT02815293|4023321|FG002|STARTED|Overall Study||18
3289583|NCT02815293|4023319|FG000|COMPLETED|Overall Study||0
3289584|NCT02815293|4023320|FG001|COMPLETED|Overall Study||0
3289585|NCT02815293|4023321|FG002|COMPLETED|Overall Study||0
3289586|NCT02815293|4023319|FG000|NOT COMPLETED|Overall Study||10
3289587|NCT02815293|4023320|FG001|NOT COMPLETED|Overall Study||8
3289588|NCT02815293|4023321|FG002|NOT COMPLETED|Overall Study||18
3289589|NCT02815644|4023329|FG000|STARTED|Treatment Period 1 + Washout||11
3289590|NCT02815644|4023330|FG001|STARTED|Treatment Period 1 + Washout||11
3289591|NCT02815644|4023329|FG000|COMPLETED|Treatment Period 1 + Washout||11
3289592|NCT02815644|4023330|FG001|COMPLETED|Treatment Period 1 + Washout||11
3289593|NCT02815644|4023329|FG000|NOT COMPLETED|Treatment Period 1 + Washout||0
3289594|NCT02815644|4023330|FG001|NOT COMPLETED|Treatment Period 1 + Washout||0
3289595|NCT02815644|4023329|FG000|STARTED|Treatment Period 2||11
3289596|NCT02815644|4023330|FG001|STARTED|Treatment Period 2||11
3289597|NCT02815644|4023329|FG000|COMPLETED|Treatment Period 2||11
3289598|NCT02815644|4023330|FG001|COMPLETED|Treatment Period 2||11
3289599|NCT02815644|4023329|FG000|NOT COMPLETED|Treatment Period 2||0
3289600|NCT02815644|4023330|FG001|NOT COMPLETED|Treatment Period 2||0
3289601|NCT02815670|4023336|FG000|STARTED|Overall Study||1
3289602|NCT02815670|4023336|FG000|COMPLETED|Overall Study||0
3289603|NCT02815670|4023336|FG000|NOT COMPLETED|Overall Study||1
3289604|NCT02815709|4023345|FG000|STARTED|Overall Study||82
3289605|NCT02815709|4023346|FG001|STARTED|Overall Study||86
3289606|NCT02815709|4023347|FG002|STARTED|Overall Study||82
3289607|NCT02815709|4023348|FG003|STARTED|Overall Study||84
3289608|NCT02815709|4023349|FG004|STARTED|Overall Study||84
3094525|NCT01462227|3817209|FG002|NOT COMPLETED|Second Assignment||1
3094526|NCT01462227|3817210|FG003|NOT COMPLETED|Second Assignment||0
3094527|NCT01462253|3817218|FG000|STARTED|Overall Study||35
3094528|NCT01462253|3817218|FG000|COMPLETED|Overall Study||27
3094529|NCT01462253|3817218|FG000|NOT COMPLETED|Overall Study||8
3094530|NCT01462266|3817224|FG000|STARTED|Overall Study||330
3094531|NCT01462266|3817225|FG001|STARTED|Overall Study||330
3094532|NCT01462266|3817224|FG000|Treated|Overall Study|One participant was randomized in error and did not receive study medication.|329
3094533|NCT01462266|3817225|FG001|Treated|Overall Study|One participant was randomized in error and did not receive study medication.|329
3094534|NCT01462266|3817224|FG000|COMPLETED|Overall Study||295
3094535|NCT01462266|3817225|FG001|COMPLETED|Overall Study||303
3094536|NCT01462266|3817224|FG000|NOT COMPLETED|Overall Study||35
3094537|NCT01462266|3817225|FG001|NOT COMPLETED|Overall Study||27
3094538|NCT01462279|3817231|FG000|STARTED|Overall Study||20
3094539|NCT01462279|3817231|FG000|COMPLETED|Overall Study||17
3094540|NCT01462279|3817231|FG000|NOT COMPLETED|Overall Study||3
3094541|NCT01462292|3817238|FG000|STARTED|Overall Study||16
3094542|NCT01462292|3817239|FG001|STARTED|Overall Study||17
3094543|NCT01462292|3817240|FG002|STARTED|Overall Study||18
3094544|NCT01462292|3817238|FG000|COMPLETED|Overall Study||16
3094545|NCT01462292|3817239|FG001|COMPLETED|Overall Study||17
3094546|NCT01462292|3817240|FG002|COMPLETED|Overall Study||18
3094547|NCT01462292|3817238|FG000|NOT COMPLETED|Overall Study||0
3094548|NCT01462292|3817239|FG001|NOT COMPLETED|Overall Study||0
3094549|NCT01462292|3817240|FG002|NOT COMPLETED|Overall Study||0
3094550|NCT01462305|3817253|FG000|STARTED|Overall Study||18
3094551|NCT01462305|3817254|FG001|STARTED|Overall Study||17
3094552|NCT01462305|3817253|FG000|COMPLETED|Overall Study||16
3094553|NCT01462305|3817254|FG001|COMPLETED|Overall Study||13
3094554|NCT01462305|3817253|FG000|NOT COMPLETED|Overall Study||2
3094555|NCT01462305|3817254|FG001|NOT COMPLETED|Overall Study||4
3094556|NCT01462318|3817262|FG000|STARTED|Main Study / TP-DI Study||113
3094557|NCT01462318|3817263|FG001|STARTED|Main Study / TP-DI Study||20
3094558|NCT01462318|3817264|FG002|STARTED|Main Study / TP-DI Study||0
3094559|NCT01462318|3817262|FG000|Enrolled in Intensive PK Substudy|Main Study / TP-DI Study||26
3094560|NCT01462318|3817263|FG001|Enrolled in Intensive PK Substudy|Main Study / TP-DI Study||0
3094561|NCT01462318|3817264|FG002|Enrolled in Intensive PK Substudy|Main Study / TP-DI Study||0
3094562|NCT01462318|3817262|FG000|COMPLETED|Main Study / TP-DI Study||105
3094563|NCT01462318|3817263|FG001|COMPLETED|Main Study / TP-DI Study||20
3094564|NCT01462318|3817264|FG002|COMPLETED|Main Study / TP-DI Study||0
3094565|NCT01462318|3817262|FG000|NOT COMPLETED|Main Study / TP-DI Study||8
3094566|NCT01462318|3817263|FG001|NOT COMPLETED|Main Study / TP-DI Study||0
3094567|NCT01462318|3817264|FG002|NOT COMPLETED|Main Study / TP-DI Study||0
3094568|NCT01462318|3817262|FG000|STARTED|Extension Phase|95 participants from the Main Study entered the Extension Phase|0
3094569|NCT01462318|3817263|FG001|STARTED|Extension Phase|20 participants from the TP-DI Study entered the Extension Phase|0
3094570|NCT01462318|3817264|FG002|STARTED|Extension Phase|10 participants from the Main Study did not enter the Extension Phase.|115
3094571|NCT01462318|3817262|FG000|COMPLETED|Extension Phase||0
3094572|NCT01462318|3817263|FG001|COMPLETED|Extension Phase||0
3094573|NCT01462318|3817264|FG002|COMPLETED|Extension Phase||70
3094574|NCT01462318|3817262|FG000|NOT COMPLETED|Extension Phase||0
3094575|NCT01462318|3817263|FG001|NOT COMPLETED|Extension Phase||0
3094576|NCT01462318|3817264|FG002|NOT COMPLETED|Extension Phase||45
3094577|NCT01462344|3817271|FG000|STARTED|Overall Study||3107
3094578|NCT01462344|3817272|FG001|STARTED|Overall Study||3101
3094579|NCT01462344|3817271|FG000|COMPLETED|Overall Study||2724
3094580|NCT01462344|3817272|FG001|COMPLETED|Overall Study||2751
3094581|NCT01462344|3817271|FG000|NOT COMPLETED|Overall Study||383
3094582|NCT01462344|3817272|FG001|NOT COMPLETED|Overall Study||350
3094583|NCT01462357|3817281|FG000|STARTED|Overall Study||359
3094584|NCT01462357|3817282|FG001|STARTED|Overall Study||358
3094585|NCT01462357|3817283|FG002|STARTED|Overall Study||358
3094586|NCT01462357|3817281|FG000|COMPLETED|Overall Study||351
3094587|NCT01462357|3817282|FG001|COMPLETED|Overall Study||339
3094588|NCT01462357|3817283|FG002|COMPLETED|Overall Study||346
3094589|NCT01462357|3817281|FG000|NOT COMPLETED|Overall Study||8
3094590|NCT01462357|3817282|FG001|NOT COMPLETED|Overall Study||19
3094591|NCT01462357|3817283|FG002|NOT COMPLETED|Overall Study||12
3094592|NCT01462435|3817295|FG000|STARTED|Overall Study||106
3094593|NCT01462435|3817296|FG001|STARTED|Overall Study||109
3094594|NCT01462435|3817297|FG002|STARTED|Overall Study||107
3094595|NCT01462435|3817298|FG003|STARTED|Overall Study||106
3094596|NCT01462435|3817295|FG000|COMPLETED|Overall Study||105
3094597|NCT01462435|3817296|FG001|COMPLETED|Overall Study||109
3094598|NCT01462435|3817297|FG002|COMPLETED|Overall Study||106
3094599|NCT01462435|3817298|FG003|COMPLETED|Overall Study||101
3094600|NCT01462435|3817295|FG000|NOT COMPLETED|Overall Study||1
3094601|NCT01462435|3817296|FG001|NOT COMPLETED|Overall Study||0
3094602|NCT01462435|3817297|FG002|NOT COMPLETED|Overall Study||1
3094603|NCT01462435|3817298|FG003|NOT COMPLETED|Overall Study||5
3094604|NCT01462565|3817308|FG000|STARTED|Overall Study||16
3094605|NCT01462565|3817308|FG000|COMPLETED|Overall Study||16
3094606|NCT01462565|3817308|FG000|NOT COMPLETED|Overall Study||0
3094607|NCT01462695|3817314|FG000|STARTED|Overall Study||17
3094608|NCT01462695|3817315|FG001|STARTED|Overall Study||13
3094609|NCT01462695|3817314|FG000|COMPLETED|Overall Study||0
3094610|NCT01462695|3817315|FG001|COMPLETED|Overall Study||0
3094611|NCT01462695|3817314|FG000|NOT COMPLETED|Overall Study||17
3094612|NCT01462695|3817315|FG001|NOT COMPLETED|Overall Study||13
3094613|NCT01462773|3817321|FG000|STARTED|Overall Study||16
3094614|NCT01462773|3817321|FG000|COMPLETED|Overall Study||16
3094615|NCT01462773|3817321|FG000|NOT COMPLETED|Overall Study||0
3094616|NCT01462812|3817328|FG000|STARTED|Overall Study||111
3094617|NCT01462812|3817329|FG001|STARTED|Overall Study||112
3094618|NCT01462812|3817328|FG000|COMPLETED|Overall Study||111
3094619|NCT01462812|3817329|FG001|COMPLETED|Overall Study||111
3094620|NCT01462812|3817328|FG000|NOT COMPLETED|Overall Study||0
3094621|NCT01462812|3817329|FG001|NOT COMPLETED|Overall Study||1
3094622|NCT01462877|3817335|FG000|STARTED|Overall Study||506
3094623|NCT01462877|3817335|FG000|Safety Set|Overall Study||492
3094624|NCT01462877|3817335|FG000|Full Analysis Set|Overall Study||468
3094625|NCT01462877|3817335|FG000|Per-protocol Set|Overall Study||364
3094626|NCT01462877|3817335|FG000|COMPLETED|Overall Study||435
3094627|NCT01462877|3817335|FG000|NOT COMPLETED|Overall Study||71
3094628|NCT01462929|3817342|FG000|STARTED|Overall Study||171
3094629|NCT01462929|3817343|FG001|STARTED|Overall Study||158
3094630|NCT01462929|3817344|FG002|STARTED|Overall Study||85
3094631|NCT01462929|3817342|FG000|COMPLETED|Overall Study||166
3094632|NCT01462929|3817343|FG001|COMPLETED|Overall Study||154
3094633|NCT01462929|3817344|FG002|COMPLETED|Overall Study||80
3094634|NCT01462929|3817342|FG000|NOT COMPLETED|Overall Study||5
3094635|NCT01462929|3817343|FG001|NOT COMPLETED|Overall Study||4
3094636|NCT01462929|3817344|FG002|NOT COMPLETED|Overall Study||5
3094637|NCT01462942|3817357|FG000|STARTED|Overall Study||194
3094638|NCT01462942|3817358|FG001|STARTED|Overall Study||385
3094639|NCT01462942|3817359|FG002|STARTED|Overall Study||381
3094640|NCT01462942|3817360|FG003|STARTED|Overall Study||385
3094641|NCT01462942|3817361|FG004|STARTED|Overall Study||384
3094642|NCT01462942|3817357|FG000|COMPLETED|Overall Study||160
3094643|NCT01462942|3817358|FG001|COMPLETED|Overall Study||351
3094644|NCT01462942|3817359|FG002|COMPLETED|Overall Study||341
3094645|NCT01462942|3817360|FG003|COMPLETED|Overall Study||335
3094646|NCT01462942|3817361|FG004|COMPLETED|Overall Study||339
3094647|NCT01462942|3817357|FG000|NOT COMPLETED|Overall Study||34
3094648|NCT01462942|3817358|FG001|NOT COMPLETED|Overall Study||34
3094649|NCT01462942|3817359|FG002|NOT COMPLETED|Overall Study||40
3094650|NCT01462942|3817360|FG003|NOT COMPLETED|Overall Study||50
3094651|NCT01462942|3817361|FG004|NOT COMPLETED|Overall Study||45
3094652|NCT01463007|3817373|FG000|STARTED|Overall Study||41
3094653|NCT01463007|3817373|FG000|COMPLETED|Overall Study||40
3094654|NCT01463007|3817373|FG000|NOT COMPLETED|Overall Study||1
3094655|NCT01463033|3817380|FG000|STARTED|Overall Study||66
3094656|NCT01463033|3817381|FG001|STARTED|Overall Study||60
3094657|NCT01463033|3817380|FG000|COMPLETED|Overall Study|3 deaths, 4 lost to follow up|59
3094658|NCT01463033|3817381|FG001|COMPLETED|Overall Study|2 deaths, 4 lost to follow up|54
3094659|NCT01463033|3817380|FG000|NOT COMPLETED|Overall Study||7
3094660|NCT01463033|3817381|FG001|NOT COMPLETED|Overall Study||6
3094661|NCT01463098|3817402|FG000|STARTED|Part A (11 Days)||16
3094662|NCT01463098|3817403|FG001|STARTED|Part A (11 Days)||6
3094663|NCT01463098|3817404|FG002|STARTED|Part A (11 Days)||6
3094664|NCT01463098|3817405|FG003|STARTED|Part A (11 Days)||6
3094665|NCT01463098|3817406|FG004|STARTED|Part A (11 Days)||6
3094666|NCT01463098|3817407|FG005|STARTED|Part A (11 Days)||6
3094667|NCT01463098|3817408|FG006|STARTED|Part A (11 Days)||6
3094668|NCT01463098|3817409|FG007|STARTED|Part A (11 Days)||6
3094669|NCT01463098|3817410|FG008|STARTED|Part A (11 Days)||6
3289609|NCT02815709|4023345|FG000|Treated With Study Medication|Overall Study||76
3289610|NCT02815709|4023346|FG001|Treated With Study Medication|Overall Study||79
3289611|NCT02815709|4023347|FG002|Treated With Study Medication|Overall Study||79
3289612|NCT02815709|4023348|FG003|Treated With Study Medication|Overall Study||79
3289613|NCT02815709|4023349|FG004|Treated With Study Medication|Overall Study||76
3289614|NCT02815709|4023345|FG000|COMPLETED|Overall Study|Completed Study|75
3289615|NCT02815709|4023346|FG001|COMPLETED|Overall Study|Completed Study|78
3289616|NCT02815709|4023347|FG002|COMPLETED|Overall Study|Completed Study|75
3289617|NCT02815709|4023348|FG003|COMPLETED|Overall Study|Completed Study|76
3289618|NCT02815709|4023349|FG004|COMPLETED|Overall Study|Completed Study|74
3289619|NCT02815709|4023345|FG000|NOT COMPLETED|Overall Study||7
3289620|NCT02815709|4023346|FG001|NOT COMPLETED|Overall Study||8
3289621|NCT02815709|4023347|FG002|NOT COMPLETED|Overall Study||7
3289622|NCT02815709|4023348|FG003|NOT COMPLETED|Overall Study||8
3289623|NCT02815709|4023349|FG004|NOT COMPLETED|Overall Study||10
3289624|NCT02815735|4023362|FG000|STARTED|First Intervention (4 Weeks)||36
3289625|NCT02815735|4023363|FG001|STARTED|First Intervention (4 Weeks)||38
3289626|NCT02815735|4023362|FG000|COMPLETED|First Intervention (4 Weeks)||34
3289627|NCT02815735|4023363|FG001|COMPLETED|First Intervention (4 Weeks)||37
3289628|NCT02815735|4023362|FG000|NOT COMPLETED|First Intervention (4 Weeks)||2
3289629|NCT02815735|4023363|FG001|NOT COMPLETED|First Intervention (4 Weeks)||1
3289630|NCT02815735|4023362|FG000|STARTED|Second Intervention (4 Weeks)||34
3094670|NCT01463098|3817411|FG009|STARTED|Part A (11 Days)||0
3094671|NCT01463098|3817412|FG010|STARTED|Part A (11 Days)||0
3094672|NCT01463098|3817413|FG011|STARTED|Part A (11 Days)||0
3094673|NCT01463098|3817414|FG012|STARTED|Part A (11 Days)||0
3094674|NCT01463098|3817415|FG013|STARTED|Part A (11 Days)||0
3094675|NCT01463098|3817402|FG000|COMPLETED|Part A (11 Days)||14
3094676|NCT01463098|3817403|FG001|COMPLETED|Part A (11 Days)||6
3094677|NCT01463098|3817404|FG002|COMPLETED|Part A (11 Days)||6
3094678|NCT01463098|3817405|FG003|COMPLETED|Part A (11 Days)||6
3094679|NCT01463098|3817406|FG004|COMPLETED|Part A (11 Days)||5
3094680|NCT01463098|3817407|FG005|COMPLETED|Part A (11 Days)||6
3094681|NCT01463098|3817408|FG006|COMPLETED|Part A (11 Days)||6
3094682|NCT01463098|3817409|FG007|COMPLETED|Part A (11 Days)||6
3094683|NCT01463098|3817410|FG008|COMPLETED|Part A (11 Days)||5
3094684|NCT01463098|3817411|FG009|COMPLETED|Part A (11 Days)||0
3094685|NCT01463098|3817412|FG010|COMPLETED|Part A (11 Days)||0
3094686|NCT01463098|3817413|FG011|COMPLETED|Part A (11 Days)||0
3094687|NCT01463098|3817414|FG012|COMPLETED|Part A (11 Days)||0
3094688|NCT01463098|3817415|FG013|COMPLETED|Part A (11 Days)||0
3094689|NCT01463098|3817402|FG000|NOT COMPLETED|Part A (11 Days)||2
3094690|NCT01463098|3817403|FG001|NOT COMPLETED|Part A (11 Days)||0
3094691|NCT01463098|3817404|FG002|NOT COMPLETED|Part A (11 Days)||0
3094692|NCT01463098|3817405|FG003|NOT COMPLETED|Part A (11 Days)||0
3094693|NCT01463098|3817406|FG004|NOT COMPLETED|Part A (11 Days)||1
3094694|NCT01463098|3817407|FG005|NOT COMPLETED|Part A (11 Days)||0
3094695|NCT01463098|3817408|FG006|NOT COMPLETED|Part A (11 Days)||0
3094696|NCT01463098|3817409|FG007|NOT COMPLETED|Part A (11 Days)||0
3094697|NCT01463098|3817410|FG008|NOT COMPLETED|Part A (11 Days)||1
3094698|NCT01463098|3817411|FG009|NOT COMPLETED|Part A (11 Days)||0
3094699|NCT01463098|3817412|FG010|NOT COMPLETED|Part A (11 Days)||0
3094700|NCT01463098|3817413|FG011|NOT COMPLETED|Part A (11 Days)||0
3094701|NCT01463098|3817414|FG012|NOT COMPLETED|Part A (11 Days)||0
3094702|NCT01463098|3817415|FG013|NOT COMPLETED|Part A (11 Days)||0
3094703|NCT01463098|3817402|FG000|STARTED|Part B (11 Days)||0
3094704|NCT01463098|3817403|FG001|STARTED|Part B (11 Days)||0
3094705|NCT01463098|3817404|FG002|STARTED|Part B (11 Days)||0
3094706|NCT01463098|3817405|FG003|STARTED|Part B (11 Days)||0
3094707|NCT01463098|3817406|FG004|STARTED|Part B (11 Days)||0
3094708|NCT01463098|3817407|FG005|STARTED|Part B (11 Days)||0
3094709|NCT01463098|3817408|FG006|STARTED|Part B (11 Days)||0
3094710|NCT01463098|3817409|FG007|STARTED|Part B (11 Days)||0
3094711|NCT01463098|3817410|FG008|STARTED|Part B (11 Days)||0
3094712|NCT01463098|3817411|FG009|STARTED|Part B (11 Days)||12
3094713|NCT01463098|3817412|FG010|STARTED|Part B (11 Days)||11
3094714|NCT01463098|3817413|FG011|STARTED|Part B (11 Days)||13
3094715|NCT01463098|3817414|FG012|STARTED|Part B (11 Days)||10
3094716|NCT01463098|3817415|FG013|STARTED|Part B (11 Days)||12
3094717|NCT01463098|3817402|FG000|COMPLETED|Part B (11 Days)||0
3094718|NCT01463098|3817403|FG001|COMPLETED|Part B (11 Days)||0
3094719|NCT01463098|3817404|FG002|COMPLETED|Part B (11 Days)||0
3094720|NCT01463098|3817405|FG003|COMPLETED|Part B (11 Days)||0
3094721|NCT01463098|3817406|FG004|COMPLETED|Part B (11 Days)||0
3094722|NCT01463098|3817407|FG005|COMPLETED|Part B (11 Days)||0
3094723|NCT01463098|3817408|FG006|COMPLETED|Part B (11 Days)||0
3094724|NCT01463098|3817409|FG007|COMPLETED|Part B (11 Days)||0
3094725|NCT01463098|3817410|FG008|COMPLETED|Part B (11 Days)||0
3094726|NCT01463098|3817411|FG009|COMPLETED|Part B (11 Days)||12
3094727|NCT01463098|3817412|FG010|COMPLETED|Part B (11 Days)||11
3094728|NCT01463098|3817413|FG011|COMPLETED|Part B (11 Days)||12
3094729|NCT01463098|3817414|FG012|COMPLETED|Part B (11 Days)||10
3094730|NCT01463098|3817415|FG013|COMPLETED|Part B (11 Days)||12
3094731|NCT01463098|3817402|FG000|NOT COMPLETED|Part B (11 Days)||0
3094732|NCT01463098|3817403|FG001|NOT COMPLETED|Part B (11 Days)||0
3094733|NCT01463098|3817404|FG002|NOT COMPLETED|Part B (11 Days)||0
3094734|NCT01463098|3817405|FG003|NOT COMPLETED|Part B (11 Days)||0
3094735|NCT01463098|3817406|FG004|NOT COMPLETED|Part B (11 Days)||0
3094736|NCT01463098|3817407|FG005|NOT COMPLETED|Part B (11 Days)||0
3094737|NCT01463098|3817408|FG006|NOT COMPLETED|Part B (11 Days)||0
3094738|NCT01463098|3817409|FG007|NOT COMPLETED|Part B (11 Days)||0
3094739|NCT01463098|3817410|FG008|NOT COMPLETED|Part B (11 Days)||0
3094740|NCT01463098|3817411|FG009|NOT COMPLETED|Part B (11 Days)||0
3094741|NCT01463098|3817412|FG010|NOT COMPLETED|Part B (11 Days)||0
3094742|NCT01463098|3817413|FG011|NOT COMPLETED|Part B (11 Days)||1
3094743|NCT01463098|3817414|FG012|NOT COMPLETED|Part B (11 Days)||0
3094744|NCT01463098|3817415|FG013|NOT COMPLETED|Part B (11 Days)||0
3094745|NCT01463111|3817464|FG000|STARTED|Overall Study||26
3094746|NCT01463111|3817464|FG000|COMPLETED|Overall Study||17
3094747|NCT01463111|3817464|FG000|NOT COMPLETED|Overall Study||9
3094748|NCT01463202|3817470|FG000|STARTED|Overall Study||79
3094749|NCT01463202|3817471|FG001|STARTED|Overall Study||78
3094750|NCT01463202|3817470|FG000|COMPLETED|Overall Study||79
3094751|NCT01463202|3817471|FG001|COMPLETED|Overall Study||78
3289631|NCT02815735|4023363|FG001|STARTED|Second Intervention (4 Weeks)||37
3289632|NCT02815735|4023362|FG000|COMPLETED|Second Intervention (4 Weeks)||33
3289633|NCT02815735|4023363|FG001|COMPLETED|Second Intervention (4 Weeks)||37
3289634|NCT02815735|4023362|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||1
3289635|NCT02815735|4023363|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||0
3289636|NCT02815982|4023382|FG000|STARTED|Overall Study||27
3289637|NCT02815982|4023383|FG001|STARTED|Overall Study||26
3289638|NCT02815982|4023384|FG002|STARTED|Overall Study||27
3289639|NCT02815982|4023385|FG003|STARTED|Overall Study||26
3289640|NCT02815982|4023382|FG000|COMPLETED|Overall Study||27
3289641|NCT02815982|4023383|FG001|COMPLETED|Overall Study||26
3289642|NCT02815982|4023384|FG002|COMPLETED|Overall Study||27
3289643|NCT02815982|4023385|FG003|COMPLETED|Overall Study||26
3289644|NCT02815982|4023382|FG000|NOT COMPLETED|Overall Study||0
3094752|NCT01463202|3817470|FG000|NOT COMPLETED|Overall Study||0
3094753|NCT01463202|3817471|FG001|NOT COMPLETED|Overall Study||0
3094754|NCT01463267|3817481|FG000|STARTED|Overall Study||15
3094755|NCT01463267|3817482|FG001|STARTED|Overall Study||15
3094756|NCT01463267|3817483|FG002|STARTED|Overall Study||15
3094757|NCT01463267|3817484|FG003|STARTED|Overall Study||15
3094758|NCT01463267|3817481|FG000|COMPLETED|Overall Study||14
3094759|NCT01463267|3817482|FG001|COMPLETED|Overall Study||15
3094760|NCT01463267|3817483|FG002|COMPLETED|Overall Study||13
3094761|NCT01463267|3817484|FG003|COMPLETED|Overall Study||13
3094762|NCT01463267|3817481|FG000|NOT COMPLETED|Overall Study||1
3094763|NCT01463267|3817482|FG001|NOT COMPLETED|Overall Study||0
3094764|NCT01463267|3817483|FG002|NOT COMPLETED|Overall Study||2
3094765|NCT01463267|3817484|FG003|NOT COMPLETED|Overall Study||2
3094766|NCT01463306|3817497|FG000|STARTED|Overall Study||384
3094767|NCT01463306|3817498|FG001|STARTED|Overall Study||210
3094768|NCT01463306|3817499|FG002|STARTED|Overall Study||11
3094769|NCT01463306|3817497|FG000|COMPLETED|Overall Study||298
3094770|NCT01463306|3817498|FG001|COMPLETED|Overall Study||158
3094771|NCT01463306|3817499|FG002|COMPLETED|Overall Study||6
3094772|NCT01463306|3817497|FG000|NOT COMPLETED|Overall Study||86
3094773|NCT01463306|3817498|FG001|NOT COMPLETED|Overall Study||52
3094774|NCT01463306|3817499|FG002|NOT COMPLETED|Overall Study||5
3094775|NCT01463358|3817509|FG000|STARTED|Overall Study||49
3094776|NCT01463358|3817510|FG001|STARTED|Overall Study||52
3094777|NCT01463358|3817509|FG000|COMPLETED|Overall Study||46
3094778|NCT01463358|3817510|FG001|COMPLETED|Overall Study||47
3094779|NCT01463358|3817509|FG000|NOT COMPLETED|Overall Study||3
3094780|NCT01463358|3817510|FG001|NOT COMPLETED|Overall Study||5
3094781|NCT01463384|3817516|FG000|STARTED|Overall Study||13
3094782|NCT01463384|3817516|FG000|COMPLETED|Overall Study||13
3094783|NCT01463384|3817516|FG000|NOT COMPLETED|Overall Study||0
3094784|NCT01463527|3817524|FG000|STARTED|Overall Study||83
3094785|NCT01463527|3817525|FG001|STARTED|Overall Study||84
3094786|NCT01463527|3817524|FG000|COMPLETED|Overall Study||77
3094787|NCT01463527|3817525|FG001|COMPLETED|Overall Study||77
3094788|NCT01463527|3817524|FG000|NOT COMPLETED|Overall Study||6
3094789|NCT01463527|3817525|FG001|NOT COMPLETED|Overall Study||7
3094790|NCT01463631|3817535|FG000|STARTED|Overall Study||3
3094791|NCT01463631|3817536|FG001|STARTED|Overall Study||4
3094792|NCT01463631|3817537|FG002|STARTED|Overall Study||5
3094793|NCT01463631|3817538|FG003|STARTED|Overall Study||15
3094794|NCT01463631|3817535|FG000|Received at Least One Dose of Study Drug|Overall Study||3
3094795|NCT01463631|3817536|FG001|Received at Least One Dose of Study Drug|Overall Study||4
3094796|NCT01463631|3817537|FG002|Received at Least One Dose of Study Drug|Overall Study||5
3094797|NCT01463631|3817538|FG003|Received at Least One Dose of Study Drug|Overall Study||15
3094798|NCT01463631|3817535|FG000|COMPLETED|Overall Study||3
3094799|NCT01463631|3817536|FG001|COMPLETED|Overall Study||4
3094800|NCT01463631|3817537|FG002|COMPLETED|Overall Study||4
3094801|NCT01463631|3817538|FG003|COMPLETED|Overall Study||9
3094802|NCT01463631|3817535|FG000|NOT COMPLETED|Overall Study||0
3094803|NCT01463631|3817536|FG001|NOT COMPLETED|Overall Study||0
3094804|NCT01463631|3817537|FG002|NOT COMPLETED|Overall Study||1
3094805|NCT01463631|3817538|FG003|NOT COMPLETED|Overall Study||6
3094806|NCT01463683|3817553|FG000|STARTED|Overall Study||309
3094807|NCT01463683|3817554|FG001|STARTED|Overall Study||309
3094808|NCT01463683|3817555|FG002|STARTED|Overall Study||104
3094809|NCT01463683|3817553|FG000|Received Vaccination 1 (Day 1)|Overall Study||309
3094810|NCT01463683|3817554|FG001|Received Vaccination 1 (Day 1)|Overall Study||308
3289645|NCT02815982|4023383|FG001|NOT COMPLETED|Overall Study||0
3289646|NCT02815982|4023384|FG002|NOT COMPLETED|Overall Study||0
3289647|NCT02815982|4023385|FG003|NOT COMPLETED|Overall Study||0
3094811|NCT01463683|3817555|FG002|Received Vaccination 1 (Day 1)|Overall Study||104
3094812|NCT01463683|3817553|FG000|Received Vaccination 2 (Month 1)|Overall Study||302
3094813|NCT01463683|3817554|FG001|Received Vaccination 2 (Month 1)|Overall Study||300
3094814|NCT01463683|3817555|FG002|Received Vaccination 2 (Month 1)|Overall Study||103
3094815|NCT01463683|3817553|FG000|Received Vaccination 3 (Month 6)|Overall Study||290
3094816|NCT01463683|3817554|FG001|Received Vaccination 3 (Month 6)|Overall Study||281
3094817|NCT01463683|3817555|FG002|Received Vaccination 3 (Month 6)|Overall Study||93
3094818|NCT01463683|3817553|FG000|COMPLETED|Overall Study||290
3094819|NCT01463683|3817554|FG001|COMPLETED|Overall Study||278
3094820|NCT01463683|3817555|FG002|COMPLETED|Overall Study||93
3094821|NCT01463683|3817553|FG000|NOT COMPLETED|Overall Study||19
3094822|NCT01463683|3817554|FG001|NOT COMPLETED|Overall Study||31
3289648|NCT02816138|4023397|FG000|STARTED|Overall Study||15
3289649|NCT02816138|4023397|FG000|COMPLETED|Overall Study||14
3289650|NCT02816138|4023397|FG000|NOT COMPLETED|Overall Study||1
3289651|NCT02816346|4023406|FG000|STARTED|Overall Study||10
3289652|NCT02816346|4023407|FG001|STARTED|Overall Study||10
3289653|NCT02816346|4023408|FG002|STARTED|Overall Study||10
3289654|NCT02816346|4023409|FG003|STARTED|Overall Study||10
3289655|NCT02816346|4023410|FG004|STARTED|Overall Study||16
3289656|NCT02816346|4023406|FG000|COMPLETED|Overall Study||10
3289657|NCT02816346|4023407|FG001|COMPLETED|Overall Study||10
3289658|NCT02816346|4023408|FG002|COMPLETED|Overall Study||10
3289659|NCT02816346|4023409|FG003|COMPLETED|Overall Study||10
3289660|NCT02816346|4023410|FG004|COMPLETED|Overall Study||16
3289661|NCT02816346|4023406|FG000|NOT COMPLETED|Overall Study||0
3289662|NCT02816346|4023407|FG001|NOT COMPLETED|Overall Study||0
3289663|NCT02816346|4023408|FG002|NOT COMPLETED|Overall Study||0
3289664|NCT02816346|4023409|FG003|NOT COMPLETED|Overall Study||0
3289665|NCT02816346|4023410|FG004|NOT COMPLETED|Overall Study||0
3289666|NCT02816398|4023422|FG000|STARTED|Overall Study||26
3289667|NCT02816398|4023422|FG000|COMPLETED|Overall Study||12
3094823|NCT01463683|3817555|FG002|NOT COMPLETED|Overall Study||11
3094824|NCT01463696|3817571|FG000|STARTED|Overall Study||1
3094825|NCT01463696|3817572|FG001|STARTED|Overall Study||6
3094826|NCT01463696|3817573|FG002|STARTED|Overall Study||3
3094827|NCT01463696|3817574|FG003|STARTED|Overall Study||7
3094828|NCT01463696|3817575|FG004|STARTED|Overall Study||3
3094829|NCT01463696|3817576|FG005|STARTED|Overall Study||6
3094830|NCT01463696|3817577|FG006|STARTED|Overall Study||16
3094831|NCT01463696|3817578|FG007|STARTED|Overall Study||6
3094832|NCT01463696|3817571|FG000|Treated|Overall Study||1
3094833|NCT01463696|3817572|FG001|Treated|Overall Study||6
3094834|NCT01463696|3817573|FG002|Treated|Overall Study||3
3094835|NCT01463696|3817574|FG003|Treated|Overall Study||7
3094836|NCT01463696|3817575|FG004|Treated|Overall Study||3
3094837|NCT01463696|3817576|FG005|Treated|Overall Study||6
3094838|NCT01463696|3817577|FG006|Treated|Overall Study||15
3094839|NCT01463696|3817578|FG007|Treated|Overall Study||6
3094840|NCT01463696|3817571|FG000|COMPLETED|Overall Study||1
3094841|NCT01463696|3817572|FG001|COMPLETED|Overall Study||4
3094842|NCT01463696|3817573|FG002|COMPLETED|Overall Study||2
3094843|NCT01463696|3817574|FG003|COMPLETED|Overall Study||3
3094844|NCT01463696|3817575|FG004|COMPLETED|Overall Study||2
3094845|NCT01463696|3817576|FG005|COMPLETED|Overall Study||3
3094846|NCT01463696|3817577|FG006|COMPLETED|Overall Study||6
3094847|NCT01463696|3817578|FG007|COMPLETED|Overall Study||2
3094848|NCT01463696|3817571|FG000|NOT COMPLETED|Overall Study||0
3094849|NCT01463696|3817572|FG001|NOT COMPLETED|Overall Study||2
3094850|NCT01463696|3817573|FG002|NOT COMPLETED|Overall Study||1
3094851|NCT01463696|3817574|FG003|NOT COMPLETED|Overall Study||4
3094852|NCT01463696|3817575|FG004|NOT COMPLETED|Overall Study||1
3094853|NCT01463696|3817576|FG005|NOT COMPLETED|Overall Study||3
3094854|NCT01463696|3817577|FG006|NOT COMPLETED|Overall Study||10
3094855|NCT01463696|3817578|FG007|NOT COMPLETED|Overall Study||4
3094856|NCT01463878|3817598|FG000|STARTED|Overall Study||9
3094857|NCT01463878|3817599|FG001|STARTED|Overall Study||9
3094858|NCT01463878|3817598|FG000|COMPLETED|Overall Study||7
3094859|NCT01463878|3817599|FG001|COMPLETED|Overall Study||7
3094860|NCT01463878|3817598|FG000|NOT COMPLETED|Overall Study||2
3094861|NCT01463878|3817599|FG001|NOT COMPLETED|Overall Study||2
3094862|NCT01463982|3817609|FG000|STARTED|Overall Study||3
3094863|NCT01463982|3817610|FG001|STARTED|Overall Study||8
3094864|NCT01463982|3817611|FG002|STARTED|Overall Study||4
3094865|NCT01463982|3817612|FG003|STARTED|Overall Study||6
3094866|NCT01463982|3817609|FG000|COMPLETED|Overall Study||3
3094867|NCT01463982|3817610|FG001|COMPLETED|Overall Study||7
3094868|NCT01463982|3817611|FG002|COMPLETED|Overall Study||2
3094869|NCT01463982|3817612|FG003|COMPLETED|Overall Study||6
3094870|NCT01463982|3817609|FG000|NOT COMPLETED|Overall Study||0
3094871|NCT01463982|3817610|FG001|NOT COMPLETED|Overall Study||1
3094872|NCT01463982|3817611|FG002|NOT COMPLETED|Overall Study||2
3094873|NCT01463982|3817612|FG003|NOT COMPLETED|Overall Study||0
3094874|NCT01464021|3817622|FG000|STARTED|Overall Study||26
3094875|NCT01464021|3817622|FG000|COMPLETED|Overall Study||0
3094876|NCT01464021|3817622|FG000|NOT COMPLETED|Overall Study||26
3094877|NCT01464190|3817628|FG000|STARTED|Overall Study||391
3094878|NCT01464190|3817629|FG001|STARTED|Overall Study||268
3094879|NCT01464190|3817628|FG000|COMPLETED|Overall Study||322
3094880|NCT01464190|3817629|FG001|COMPLETED|Overall Study||227
3094881|NCT01464190|3817628|FG000|NOT COMPLETED|Overall Study||69
3094882|NCT01464190|3817629|FG001|NOT COMPLETED|Overall Study||41
3135145|NCT01704846|3860123|FG000|STARTED|Treatment Period 2||30
3135146|NCT01704846|3860124|FG001|STARTED|Treatment Period 2||30
3135147|NCT01704846|3860123|FG000|COMPLETED|Treatment Period 2||30
3135148|NCT01704846|3860124|FG001|COMPLETED|Treatment Period 2||29
3135149|NCT01704846|3860123|FG000|NOT COMPLETED|Treatment Period 2||0
3135150|NCT01704846|3860124|FG001|NOT COMPLETED|Treatment Period 2||1
3135151|NCT01704846|3860123|FG000|STARTED|Treatment Period 3||30
3135152|NCT01704846|3860124|FG001|STARTED|Treatment Period 3||29
3135153|NCT01704846|3860123|FG000|COMPLETED|Treatment Period 3||30
3135154|NCT01704846|3860124|FG001|COMPLETED|Treatment Period 3||29
3135155|NCT01704846|3860123|FG000|NOT COMPLETED|Treatment Period 3||0
3135156|NCT01704846|3860124|FG001|NOT COMPLETED|Treatment Period 3||0
3135157|NCT01704846|3860123|FG000|STARTED|Treatment Period 4||30
3135158|NCT01704846|3860124|FG001|STARTED|Treatment Period 4||29
3135159|NCT01704846|3860123|FG000|COMPLETED|Treatment Period 4||30
3135160|NCT01704846|3860124|FG001|COMPLETED|Treatment Period 4||29
3135161|NCT01704846|3860123|FG000|NOT COMPLETED|Treatment Period 4||0
3135162|NCT01704846|3860124|FG001|NOT COMPLETED|Treatment Period 4||0
3135163|NCT01704976|3860132|FG000|STARTED|Overall Study||14
3135164|NCT01704976|3860133|FG001|STARTED|Overall Study||13
3135165|NCT01704976|3860132|FG000|COMPLETED|Overall Study|One participant completed < 11 SR-WBV sessions and was excluded from the statistical analysis|13
3135166|NCT01704976|3860133|FG001|COMPLETED|Overall Study|2 participants completed < 11 SR-WBV sessions, they were excluded from statistical analysis|11
3135167|NCT01704976|3860132|FG000|NOT COMPLETED|Overall Study||1
3135168|NCT01704976|3860133|FG001|NOT COMPLETED|Overall Study||2
3135169|NCT01705080|3860142|FG000|STARTED|Overall Study||147
3135170|NCT01705080|3860143|FG001|STARTED|Overall Study||101
3135171|NCT01705080|3860144|FG002|STARTED|Overall Study||28
3135172|NCT01705080|3860142|FG000|Renal Artery Ablation Procedure|Overall Study||147
3135173|NCT01705080|3860143|FG001|Renal Artery Ablation Procedure|Overall Study||101
3135174|NCT01705080|3860144|FG002|Renal Artery Ablation Procedure|Overall Study||28
3135175|NCT01705080|3860142|FG000|Discharge Following Renal Artery Ablation Procedure|Overall Study||147
3094883|NCT01464229|3817637|FG000|STARTED|Overall Study||10
3094884|NCT01464229|3817638|FG001|STARTED|Overall Study||10
3094885|NCT01464229|3817637|FG000|COMPLETED|Overall Study||5
3094886|NCT01464229|3817638|FG001|COMPLETED|Overall Study||8
3094887|NCT01464229|3817637|FG000|NOT COMPLETED|Overall Study||5
3094888|NCT01464229|3817638|FG001|NOT COMPLETED|Overall Study||2
3094889|NCT01464255|3817646|FG000|STARTED|Overall Study||25
3094890|NCT01464255|3817647|FG001|STARTED|Overall Study||25
3094891|NCT01464255|3817646|FG000|COMPLETED|Overall Study||25
3094892|NCT01464255|3817647|FG001|COMPLETED|Overall Study||24
3094893|NCT01464255|3817646|FG000|NOT COMPLETED|Overall Study||0
3094894|NCT01464255|3817647|FG001|NOT COMPLETED|Overall Study||1
3094895|NCT01464307|3817656|FG000|STARTED|Main Period||144
3094896|NCT01464307|3817657|FG001|STARTED|Main Period||145
3094897|NCT01464307|3817656|FG000|Treated|Main Period||144
3094898|NCT01464307|3817657|FG001|Treated|Main Period||145
3094899|NCT01464307|3817656|FG000|COMPLETED|Main Period||129
3094900|NCT01464307|3817657|FG001|COMPLETED|Main Period||140
3094901|NCT01464307|3817656|FG000|NOT COMPLETED|Main Period||15
3094902|NCT01464307|3817657|FG001|NOT COMPLETED|Main Period||5
3094903|NCT01464307|3817656|FG000|STARTED|Open-Label Extension Period||269
3094904|NCT01464307|3817657|FG001|STARTED|Open-Label Extension Period||0
3094905|NCT01464307|3817656|FG000|Treated|Open-Label Extension Period||269
3094906|NCT01464307|3817657|FG001|Treated|Open-Label Extension Period||0
3094907|NCT01464307|3817656|FG000|COMPLETED|Open-Label Extension Period||218
3094908|NCT01464307|3817657|FG001|COMPLETED|Open-Label Extension Period||0
3094909|NCT01464307|3817656|FG000|NOT COMPLETED|Open-Label Extension Period||51
3094910|NCT01464307|3817657|FG001|NOT COMPLETED|Open-Label Extension Period||0
3094911|NCT01464333|3817664|FG000|STARTED|Overall Study||389
3094912|NCT01464333|3817664|FG000|COMPLETED|Overall Study||226
3094913|NCT01464333|3817664|FG000|NOT COMPLETED|Overall Study||163
3094914|NCT01464346|3817668|FG000|STARTED|Overall Study||29
3094915|NCT01464346|3817669|FG001|STARTED|Overall Study||32
3094916|NCT01464346|3817670|FG002|STARTED|Overall Study||29
3094917|NCT01464346|3817668|FG000|COMPLETED|Overall Study||29
3094918|NCT01464346|3817669|FG001|COMPLETED|Overall Study||32
3094919|NCT01464346|3817670|FG002|COMPLETED|Overall Study||28
3094920|NCT01464346|3817668|FG000|NOT COMPLETED|Overall Study||0
3094921|NCT01464346|3817669|FG001|NOT COMPLETED|Overall Study||0
3094922|NCT01464346|3817670|FG002|NOT COMPLETED|Overall Study||1
3094923|NCT01464359|3817678|FG000|STARTED|Overall Study||3
3094924|NCT01464359|3817678|FG000|COMPLETED|Overall Study||3
3094925|NCT01464359|3817678|FG000|NOT COMPLETED|Overall Study||0
3094926|NCT01464424|3817682|FG000|STARTED|Period 1, First 6 Weeks||42
3094927|NCT01464424|3817683|FG001|STARTED|Period 1, First 6 Weeks||42
3094928|NCT01464424|3817682|FG000|COMPLETED|Period 1, First 6 Weeks||42
3094929|NCT01464424|3817683|FG001|COMPLETED|Period 1, First 6 Weeks||41
3094930|NCT01464424|3817682|FG000|NOT COMPLETED|Period 1, First 6 Weeks||0
3094931|NCT01464424|3817683|FG001|NOT COMPLETED|Period 1, First 6 Weeks||1
3094932|NCT01464424|3817682|FG000|STARTED|Period 2, Second 6 Weeks||42
3094933|NCT01464424|3817683|FG001|STARTED|Period 2, Second 6 Weeks||41
3094934|NCT01464424|3817682|FG000|COMPLETED|Period 2, Second 6 Weeks||42
3094935|NCT01464424|3817683|FG001|COMPLETED|Period 2, Second 6 Weeks||41
3094936|NCT01464424|3817682|FG000|NOT COMPLETED|Period 2, Second 6 Weeks||0
3094937|NCT01464424|3817683|FG001|NOT COMPLETED|Period 2, Second 6 Weeks||0
3094938|NCT01464619|3817691|FG000|STARTED|Overall Study||32
3094939|NCT01464619|3817692|FG001|STARTED|Overall Study||29
3094940|NCT01464619|3817691|FG000|COMPLETED|Overall Study||29
3094941|NCT01464619|3817692|FG001|COMPLETED|Overall Study||25
3094942|NCT01464619|3817691|FG000|NOT COMPLETED|Overall Study||3
3094943|NCT01464619|3817692|FG001|NOT COMPLETED|Overall Study||4
3094944|NCT01464697|3817702|FG000|STARTED|Overall Study||93
3094945|NCT01464697|3817703|FG001|STARTED|Overall Study||96
3094946|NCT01464697|3817702|FG000|COMPLETED|Overall Study||90
3094947|NCT01464697|3817703|FG001|COMPLETED|Overall Study||86
3094948|NCT01464697|3817702|FG000|NOT COMPLETED|Overall Study||3
3094949|NCT01464697|3817703|FG001|NOT COMPLETED|Overall Study||10
3094950|NCT01464775|3817711|FG000|STARTED|Overall Study||123
3094951|NCT01464775|3817712|FG001|STARTED|Overall Study||44
3094952|NCT01464775|3817711|FG000|COMPLETED|Overall Study||112
3094953|NCT01464775|3817712|FG001|COMPLETED|Overall Study||38
3094954|NCT01464775|3817711|FG000|NOT COMPLETED|Overall Study||11
3094955|NCT01464775|3817712|FG001|NOT COMPLETED|Overall Study||6
3094956|NCT01464788|3817723|FG000|STARTED|Overall Study||30
3094957|NCT01464788|3817724|FG001|STARTED|Overall Study||31
3094958|NCT01464788|3817725|FG002|STARTED|Overall Study||29
3094959|NCT01464788|3817723|FG000|COMPLETED|Overall Study||30
3094960|NCT01464788|3817724|FG001|COMPLETED|Overall Study||29
3094961|NCT01464788|3817725|FG002|COMPLETED|Overall Study||29
3094962|NCT01464788|3817723|FG000|NOT COMPLETED|Overall Study||0
3094963|NCT01464788|3817724|FG001|NOT COMPLETED|Overall Study||2
3094964|NCT01464788|3817725|FG002|NOT COMPLETED|Overall Study||0
3094965|NCT01464827|3817749|FG000|STARTED|Overall Study||80
3094966|NCT01464827|3817750|FG001|STARTED|Overall Study||43
3094967|NCT01464827|3817751|FG002|STARTED|Overall Study||39
3094968|NCT01464827|3817752|FG003|STARTED|Overall Study||40
3094969|NCT01464827|3817753|FG004|STARTED|Overall Study||80
3094970|NCT01464827|3817754|FG005|STARTED|Overall Study||39
3094971|NCT01464827|3817755|FG006|STARTED|Overall Study||41
3094972|NCT01464827|3817756|FG007|STARTED|Overall Study||40
3094973|NCT01464827|3817757|FG008|STARTED|Overall Study||40
3094974|NCT01464827|3817758|FG009|STARTED|Overall Study||47
3094975|NCT01464827|3817759|FG010|STARTED|Overall Study||23
3094976|NCT01464827|3817760|FG011|STARTED|Overall Study||23
3094977|NCT01464827|3817761|FG012|STARTED|Overall Study||23
3094978|NCT01464827|3817762|FG013|STARTED|Overall Study||22
3094979|NCT01464827|3817749|FG000|Treated|Overall Study||80
3094980|NCT01464827|3817750|FG001|Treated|Overall Study||41
3094981|NCT01464827|3817751|FG002|Treated|Overall Study||39
3094982|NCT01464827|3817752|FG003|Treated|Overall Study||40
3094983|NCT01464827|3817753|FG004|Treated|Overall Study||79
3094984|NCT01464827|3817754|FG005|Treated|Overall Study||39
3094985|NCT01464827|3817755|FG006|Treated|Overall Study||40
3094986|NCT01464827|3817756|FG007|Treated|Overall Study||40
3094987|NCT01464827|3817757|FG008|Treated|Overall Study||40
3094988|NCT01464827|3817758|FG009|Treated|Overall Study||45
3094989|NCT01464827|3817759|FG010|Treated|Overall Study||23
3094990|NCT01464827|3817760|FG011|Treated|Overall Study||22
3094991|NCT01464827|3817761|FG012|Treated|Overall Study||23
3094992|NCT01464827|3817762|FG013|Treated|Overall Study||20
3094993|NCT01464827|3817749|FG000|COMPLETED|Overall Study||77
3094994|NCT01464827|3817750|FG001|COMPLETED|Overall Study||36
3094995|NCT01464827|3817751|FG002|COMPLETED|Overall Study||39
3094996|NCT01464827|3817752|FG003|COMPLETED|Overall Study||36
3094997|NCT01464827|3817753|FG004|COMPLETED|Overall Study||72
3094998|NCT01464827|3817754|FG005|COMPLETED|Overall Study||38
3094999|NCT01464827|3817755|FG006|COMPLETED|Overall Study||37
3095000|NCT01464827|3817756|FG007|COMPLETED|Overall Study||37
3095001|NCT01464827|3817757|FG008|COMPLETED|Overall Study||37
3095002|NCT01464827|3817758|FG009|COMPLETED|Overall Study||44
3095003|NCT01464827|3817759|FG010|COMPLETED|Overall Study||21
3095004|NCT01464827|3817760|FG011|COMPLETED|Overall Study||21
3095005|NCT01464827|3817761|FG012|COMPLETED|Overall Study||21
3095006|NCT01464827|3817762|FG013|COMPLETED|Overall Study||19
3095007|NCT01464827|3817749|FG000|NOT COMPLETED|Overall Study||3
3095008|NCT01464827|3817750|FG001|NOT COMPLETED|Overall Study||7
3095009|NCT01464827|3817751|FG002|NOT COMPLETED|Overall Study||0
3095010|NCT01464827|3817752|FG003|NOT COMPLETED|Overall Study||4
3095011|NCT01464827|3817753|FG004|NOT COMPLETED|Overall Study||8
3095012|NCT01464827|3817754|FG005|NOT COMPLETED|Overall Study||1
3095013|NCT01464827|3817755|FG006|NOT COMPLETED|Overall Study||4
3095014|NCT01464827|3817756|FG007|NOT COMPLETED|Overall Study||3
3289668|NCT02816398|4023422|FG000|NOT COMPLETED|Overall Study||14
3289669|NCT02816710|4023429|FG000|STARTED|Overall Study||38
3289670|NCT02816710|4023430|FG001|STARTED|Overall Study||38
3289671|NCT02816710|4023431|FG002|STARTED|Overall Study||36
3289672|NCT02816710|4023429|FG000|COMPLETED|Overall Study||34
3289673|NCT02816710|4023430|FG001|COMPLETED|Overall Study||35
3289674|NCT02816710|4023431|FG002|COMPLETED|Overall Study||29
3289675|NCT02816710|4023429|FG000|NOT COMPLETED|Overall Study||4
3289676|NCT02816710|4023430|FG001|NOT COMPLETED|Overall Study||3
3289677|NCT02816710|4023431|FG002|NOT COMPLETED|Overall Study||7
3289678|NCT02816723|4023444|FG000|STARTED|Overall Study||30
3289679|NCT02816723|4023445|FG001|STARTED|Overall Study||30
3289680|NCT02816723|4023444|FG000|COMPLETED|Overall Study||24
3289681|NCT02816723|4023445|FG001|COMPLETED|Overall Study||28
3289682|NCT02816723|4023444|FG000|NOT COMPLETED|Overall Study||6
3289683|NCT02816723|4023445|FG001|NOT COMPLETED|Overall Study||2
3289684|NCT02817087|4023453|FG000|STARTED|Overall Study||16
3289685|NCT02817087|4023454|FG001|STARTED|Overall Study||15
3289686|NCT02817087|4023453|FG000|COMPLETED|Overall Study|1 pt was withdrawn early d/t concurrent disease. One pt. withdrew ICF d/t transportation concerns|14
3289687|NCT02817087|4023454|FG001|COMPLETED|Overall Study||15
3289688|NCT02817087|4023453|FG000|NOT COMPLETED|Overall Study||2
3289689|NCT02817087|4023454|FG001|NOT COMPLETED|Overall Study||0
3289690|NCT02817516|4023464|FG000|STARTED|Overall Study||6
3289691|NCT02817516|4023465|FG001|STARTED|Overall Study||6
3289692|NCT02817516|4023466|FG002|STARTED|Overall Study||6
3289693|NCT02817516|4023467|FG003|STARTED|Overall Study||6
3289694|NCT02817516|4023464|FG000|COMPLETED|Overall Study||6
3289695|NCT02817516|4023465|FG001|COMPLETED|Overall Study||6
3289696|NCT02817516|4023466|FG002|COMPLETED|Overall Study||5
3289697|NCT02817516|4023467|FG003|COMPLETED|Overall Study||6
3289698|NCT02817516|4023464|FG000|NOT COMPLETED|Overall Study||0
3289699|NCT02817516|4023465|FG001|NOT COMPLETED|Overall Study||0
3289700|NCT02817516|4023466|FG002|NOT COMPLETED|Overall Study||1
3289701|NCT02817516|4023467|FG003|NOT COMPLETED|Overall Study||0
3289702|NCT02817555|4023482|FG000|STARTED|Overall Study||24
3289703|NCT02817555|4023483|FG001|STARTED|Overall Study||26
3289704|NCT02817555|4023482|FG000|COMPLETED|Overall Study||21
3289705|NCT02817555|4023483|FG001|COMPLETED|Overall Study||21
3289706|NCT02817555|4023482|FG000|NOT COMPLETED|Overall Study||3
3289707|NCT02817555|4023483|FG001|NOT COMPLETED|Overall Study||5
3289708|NCT02817594|4023489|FG000|STARTED|Overall Study||51
3289709|NCT02817594|4023489|FG000|Received Treatment|Overall Study||50
3289710|NCT02817594|4023489|FG000|COMPLETED|Overall Study||48
3289711|NCT02817594|4023489|FG000|NOT COMPLETED|Overall Study||3
3289712|NCT02817763|4023499|FG000|STARTED|Overall Study||20
3289713|NCT02817763|4023500|FG001|STARTED|Overall Study||20
3289714|NCT02817763|4023499|FG000|COMPLETED|Overall Study||20
3289715|NCT02817763|4023500|FG001|COMPLETED|Overall Study||20
3289716|NCT02817763|4023499|FG000|NOT COMPLETED|Overall Study||0
3289717|NCT02817763|4023500|FG001|NOT COMPLETED|Overall Study||0
3317236|NCT03124758|4050768|FG000|NOT COMPLETED|Overall Study||0
3095015|NCT01464827|3817757|FG008|NOT COMPLETED|Overall Study||3
3095016|NCT01464827|3817758|FG009|NOT COMPLETED|Overall Study||3
3095017|NCT01464827|3817759|FG010|NOT COMPLETED|Overall Study||2
3095018|NCT01464827|3817760|FG011|NOT COMPLETED|Overall Study||2
3095019|NCT01464827|3817761|FG012|NOT COMPLETED|Overall Study||2
3095020|NCT01464827|3817762|FG013|NOT COMPLETED|Overall Study||3
3095021|NCT01464840|3817806|FG000|STARTED|Overall Study||10
3095022|NCT01464840|3817807|FG001|STARTED|Overall Study||10
3095023|NCT01464840|3817808|FG002|STARTED|Overall Study||10
3095024|NCT01464840|3817806|FG000|COMPLETED|Overall Study||10
3095025|NCT01464840|3817807|FG001|COMPLETED|Overall Study||10
3095026|NCT01464840|3817808|FG002|COMPLETED|Overall Study||10
3095027|NCT01464840|3817806|FG000|NOT COMPLETED|Overall Study||0
3095028|NCT01464840|3817807|FG001|NOT COMPLETED|Overall Study||0
3095029|NCT01464840|3817808|FG002|NOT COMPLETED|Overall Study||0
3095030|NCT01464879|3817816|FG000|STARTED|Overall Study||20
3095031|NCT01464879|3817816|FG000|Hand Application (2.50 mL)|Overall Study||20
3095032|NCT01464879|3817816|FG000|Washout Period|Overall Study||20
3095033|NCT01464879|3817816|FG000|Applicator Application (1.25 mL)|Overall Study|One subject discontinued due to non-compliance.|19
3095034|NCT01464879|3817816|FG000|Applicator Application (2.50 mL)|Overall Study|One subject discontinued due to physician's decision.|18
3095035|NCT01464879|3817816|FG000|Applicator Application (3.75 mL)|Overall Study||18
3095036|NCT01464879|3817816|FG000|COMPLETED|Overall Study||18
3095037|NCT01464879|3817816|FG000|NOT COMPLETED|Overall Study||2
3095038|NCT01464931|3817828|FG000|STARTED|Overall Study||16
3095039|NCT01464931|3817829|FG001|STARTED|Overall Study||16
3095040|NCT01464931|3817828|FG000|COMPLETED|Overall Study||15
3095041|NCT01464931|3817829|FG001|COMPLETED|Overall Study||16
3095042|NCT01464931|3817828|FG000|NOT COMPLETED|Overall Study||1
3095043|NCT01464931|3817829|FG001|NOT COMPLETED|Overall Study||0
3095044|NCT01464996|3817842|FG000|STARTED|Overall Study||24
3095045|NCT01464996|3817842|FG000|OptiBond XTR|Overall Study||23
3095046|NCT01464996|3817842|FG000|OptiBond FL|Overall Study||24
3095047|NCT01464996|3817842|FG000|COMPLETED|Overall Study||24
3095048|NCT01464996|3817842|FG000|NOT COMPLETED|Overall Study||0
3095049|NCT01465022|3817851|FG000|STARTED|Overall Study||64
3095050|NCT01465022|3817852|FG001|STARTED|Overall Study||63
3095051|NCT01465022|3817853|FG002|STARTED|Overall Study||70
3095052|NCT01465022|3817851|FG000|COMPLETED|Overall Study||41
3095053|NCT01465022|3817852|FG001|COMPLETED|Overall Study||40
3095054|NCT01465022|3817853|FG002|COMPLETED|Overall Study||0
3095055|NCT01465022|3817851|FG000|NOT COMPLETED|Overall Study||23
3095056|NCT01465022|3817852|FG001|NOT COMPLETED|Overall Study||23
3095057|NCT01465022|3817853|FG002|NOT COMPLETED|Overall Study||70
3095058|NCT01465048|3817862|FG000|STARTED|Overall Study||6
3095059|NCT01465048|3817863|FG001|STARTED|Overall Study||6
3095060|NCT01465048|3817864|FG002|STARTED|Overall Study||6
3095061|NCT01465048|3817862|FG000|COMPLETED|Overall Study||6
3095062|NCT01465048|3817863|FG001|COMPLETED|Overall Study||6
3095063|NCT01465048|3817864|FG002|COMPLETED|Overall Study||6
3095064|NCT01465048|3817862|FG000|NOT COMPLETED|Overall Study||0
3095065|NCT01465048|3817863|FG001|NOT COMPLETED|Overall Study||0
3095066|NCT01465048|3817864|FG002|NOT COMPLETED|Overall Study||0
3095067|NCT01465178|3817874|FG000|STARTED|Overall Study||31
3095068|NCT01465178|3817875|FG001|STARTED|Overall Study||31
3095069|NCT01465178|3817874|FG000|COMPLETED|Overall Study||30
3095070|NCT01465178|3817875|FG001|COMPLETED|Overall Study||31
3095071|NCT01465178|3817874|FG000|NOT COMPLETED|Overall Study||1
3095072|NCT01465178|3817875|FG001|NOT COMPLETED|Overall Study||0
3095073|NCT01465191|3817884|FG000|STARTED|Overall Study||56
3095074|NCT01465191|3817885|FG001|STARTED|Overall Study||63
3095075|NCT01465191|3817886|FG002|STARTED|Overall Study||50
3095076|NCT01465191|3817884|FG000|COMPLETED|Overall Study||47
3095077|NCT01465191|3817885|FG001|COMPLETED|Overall Study||54
3095078|NCT01465191|3817886|FG002|COMPLETED|Overall Study||43
3095079|NCT01465191|3817884|FG000|NOT COMPLETED|Overall Study||9
3095080|NCT01465191|3817885|FG001|NOT COMPLETED|Overall Study||9
3095081|NCT01465191|3817886|FG002|NOT COMPLETED|Overall Study||7
3095082|NCT01465334|3817899|FG000|STARTED|Overall Study||15
3095083|NCT01465334|3817900|FG001|STARTED|Overall Study||15
3095084|NCT01465334|3817899|FG000|Complete Part A Induction|Overall Study||12
3095085|NCT01465334|3817900|FG001|Complete Part A Induction|Overall Study||15
3095086|NCT01465334|3817899|FG000|Complete Part B Induction|Overall Study||7
3095087|NCT01465334|3817900|FG001|Complete Part B Induction|Overall Study||15
3095088|NCT01465334|3817899|FG000|Eligible for Allogeneic Transplant|Overall Study||9
3095089|NCT01465334|3817900|FG001|Eligible for Allogeneic Transplant|Overall Study||9
3095090|NCT01465334|3817899|FG000|COMPLETED|Overall Study||13
3095091|NCT01465334|3817900|FG001|COMPLETED|Overall Study||9
3095092|NCT01465334|3817899|FG000|NOT COMPLETED|Overall Study||2
3095093|NCT01465334|3817900|FG001|NOT COMPLETED|Overall Study||6
3095094|NCT01465347|3817906|FG000|STARTED|Overall Study||3
3095095|NCT01465347|3817907|FG001|STARTED|Overall Study||56
3095096|NCT01465347|3817906|FG000|COMPLETED|Overall Study||2
3095097|NCT01465347|3817907|FG001|COMPLETED|Overall Study||53
3095098|NCT01465347|3817906|FG000|NOT COMPLETED|Overall Study||1
3095099|NCT01465347|3817907|FG001|NOT COMPLETED|Overall Study||3
3095100|NCT01465386|3817916|FG000|STARTED|Overall Study||6
3095101|NCT01465386|3817916|FG000|COMPLETED|Overall Study||2
3095102|NCT01465386|3817916|FG000|NOT COMPLETED|Overall Study||4
3095103|NCT01465412|3817924|FG000|STARTED|Overall Study||12
3095104|NCT01465412|3817925|FG001|STARTED|Overall Study||12
3095105|NCT01465412|3817926|FG002|STARTED|Overall Study||9
3095106|NCT01465412|3817927|FG003|STARTED|Overall Study||9
3095107|NCT01465412|3817924|FG000|COMPLETED|Overall Study||12
3095108|NCT01465412|3817925|FG001|COMPLETED|Overall Study||12
3095109|NCT01465412|3817926|FG002|COMPLETED|Overall Study||9
3095110|NCT01465412|3817927|FG003|COMPLETED|Overall Study||9
3095111|NCT01465412|3817924|FG000|NOT COMPLETED|Overall Study||0
3095112|NCT01465412|3817925|FG001|NOT COMPLETED|Overall Study||0
3095113|NCT01465412|3817926|FG002|NOT COMPLETED|Overall Study||0
3095114|NCT01465412|3817927|FG003|NOT COMPLETED|Overall Study||0
3095115|NCT01465464|3817939|FG000|STARTED|Overall Study||444
3095116|NCT01465464|3817940|FG001|STARTED|Overall Study||444
3095117|NCT01465464|3817939|FG000|COMPLETED|Overall Study||0
3095118|NCT01465464|3817940|FG001|COMPLETED|Overall Study||0
3095119|NCT01465464|3817939|FG000|NOT COMPLETED|Overall Study||444
3095120|NCT01465464|3817940|FG001|NOT COMPLETED|Overall Study||444
3095121|NCT01465659|3817950|FG000|STARTED|Completed 1 Cycle of Treatment||7
3095122|NCT01465659|3817951|FG001|STARTED|Completed 1 Cycle of Treatment||5
3095123|NCT01465659|3817952|FG002|STARTED|Completed 1 Cycle of Treatment||6
3095124|NCT01465659|3817953|FG003|STARTED|Completed 1 Cycle of Treatment||11
3095125|NCT01465659|3817950|FG000|Completed 1 Cycle of Treatment|Completed 1 Cycle of Treatment||7
3095126|NCT01465659|3817951|FG001|Completed 1 Cycle of Treatment|Completed 1 Cycle of Treatment||4
3095127|NCT01465659|3817952|FG002|Completed 1 Cycle of Treatment|Completed 1 Cycle of Treatment||6
3095128|NCT01465659|3817953|FG003|Completed 1 Cycle of Treatment|Completed 1 Cycle of Treatment||11
3095129|NCT01465659|3817950|FG000|COMPLETED|Completed 1 Cycle of Treatment||7
3095130|NCT01465659|3817951|FG001|COMPLETED|Completed 1 Cycle of Treatment||4
3095131|NCT01465659|3817952|FG002|COMPLETED|Completed 1 Cycle of Treatment||6
3095132|NCT01465659|3817953|FG003|COMPLETED|Completed 1 Cycle of Treatment||10
3095133|NCT01465659|3817950|FG000|NOT COMPLETED|Completed 1 Cycle of Treatment||0
3095134|NCT01465659|3817951|FG001|NOT COMPLETED|Completed 1 Cycle of Treatment||1
3095135|NCT01465659|3817952|FG002|NOT COMPLETED|Completed 1 Cycle of Treatment||0
3095136|NCT01465659|3817953|FG003|NOT COMPLETED|Completed 1 Cycle of Treatment||1
3095137|NCT01465659|3817950|FG000|STARTED|Completed 2 Cycles/Reached 1st Response||7
3095138|NCT01465659|3817951|FG001|STARTED|Completed 2 Cycles/Reached 1st Response||4
3095139|NCT01465659|3817952|FG002|STARTED|Completed 2 Cycles/Reached 1st Response||6
3095140|NCT01465659|3817953|FG003|STARTED|Completed 2 Cycles/Reached 1st Response||10
3095141|NCT01465659|3817950|FG000|Attempted 2 Cycles of Treatment|Completed 2 Cycles/Reached 1st Response||7
3095142|NCT01465659|3817951|FG001|Attempted 2 Cycles of Treatment|Completed 2 Cycles/Reached 1st Response||4
3095143|NCT01465659|3817952|FG002|Attempted 2 Cycles of Treatment|Completed 2 Cycles/Reached 1st Response||6
3095144|NCT01465659|3817953|FG003|Attempted 2 Cycles of Treatment|Completed 2 Cycles/Reached 1st Response||10
3289718|NCT02817776|4023506|FG000|STARTED|Overall Study|33 excluded prior to procedure. 348 had study catheter inserted (Safety Population)|381
3289719|NCT02817776|4023506|FG000|COMPLETED|Overall Study||293
3289720|NCT02817776|4023506|FG000|NOT COMPLETED|Overall Study||88
3289721|NCT02817828|4023510|FG000|STARTED|Overall Study||1553
3289722|NCT02817828|4023510|FG000|COMPLETED|Overall Study||1218
3289723|NCT02817828|4023510|FG000|NOT COMPLETED|Overall Study||335
3289724|NCT02817841|4023519|FG000|STARTED|Overall Study||1864
3289725|NCT02817841|4023519|FG000|COMPLETED|Overall Study||1016
3289726|NCT02817841|4023519|FG000|NOT COMPLETED|Overall Study||848
3289727|NCT02817906|4023529|FG000|STARTED|Overall Study|87 patients were randomized but only 86 received study drug. The number completed and discontinued is based on the 86 patients that received study drug.|86
3289728|NCT02817906|4023530|FG001|STARTED|Overall Study|90 patients were randomized but only 89 received study drug. The number completed and discontinued is based on 89 patients that received study drug.|89
3289729|NCT02817906|4023529|FG000|COMPLETED|Overall Study||70
3289730|NCT02817906|4023530|FG001|COMPLETED|Overall Study||84
3289731|NCT02817906|4023529|FG000|NOT COMPLETED|Overall Study||16
3289732|NCT02817906|4023530|FG001|NOT COMPLETED|Overall Study||5
3289733|NCT02818036|4023538|FG000|STARTED|Overall Study||42
3289734|NCT02818036|4023539|FG001|STARTED|Overall Study||40
3289735|NCT02818036|4023538|FG000|COMPLETED|Overall Study||40
3289736|NCT02818036|4023539|FG001|COMPLETED|Overall Study||40
3289737|NCT02818036|4023538|FG000|NOT COMPLETED|Overall Study||2
3289738|NCT02818036|4023539|FG001|NOT COMPLETED|Overall Study||0
3289739|NCT02818114|4023545|FG000|STARTED|Overall Study||8
3289740|NCT02818114|4023545|FG000|COMPLETED|Overall Study||7
3289741|NCT02818114|4023545|FG000|NOT COMPLETED|Overall Study||1
3289742|NCT02818244|4023554|FG000|STARTED|Overall Study||25
3289743|NCT02818244|4023555|FG001|STARTED|Overall Study||25
3289744|NCT02818244|4023556|FG002|STARTED|Overall Study||25
3289745|NCT02818244|4023557|FG003|STARTED|Overall Study||25
3289746|NCT02818244|4023554|FG000|COMPLETED|Overall Study||25
3289747|NCT02818244|4023555|FG001|COMPLETED|Overall Study||25
3289748|NCT02818244|4023556|FG002|COMPLETED|Overall Study||25
3289749|NCT02818244|4023557|FG003|COMPLETED|Overall Study||25
3289750|NCT02818244|4023554|FG000|NOT COMPLETED|Overall Study||0
3289751|NCT02818244|4023555|FG001|NOT COMPLETED|Overall Study||0
3289752|NCT02818244|4023556|FG002|NOT COMPLETED|Overall Study||0
3289753|NCT02818244|4023557|FG003|NOT COMPLETED|Overall Study||0
3289754|NCT02818569|4023567|FG000|STARTED|Overall Study||8
3289755|NCT02818569|4023568|FG001|STARTED|Overall Study||7
3289756|NCT02818569|4023567|FG000|COMPLETED|Overall Study||8
3289757|NCT02818569|4023568|FG001|COMPLETED|Overall Study||7
3289758|NCT02818569|4023567|FG000|NOT COMPLETED|Overall Study||0
3289759|NCT02818569|4023568|FG001|NOT COMPLETED|Overall Study||0
3289760|NCT02818777|4023577|FG000|STARTED|Overall Study|The number of baseline participants was 13.|13
3095145|NCT01465659|3817950|FG000|Reached 1st Response|Completed 2 Cycles/Reached 1st Response||7
3095146|NCT01465659|3817951|FG001|Reached 1st Response|Completed 2 Cycles/Reached 1st Response||4
3095147|NCT01465659|3817952|FG002|Reached 1st Response|Completed 2 Cycles/Reached 1st Response||6
3095148|NCT01465659|3817953|FG003|Reached 1st Response|Completed 2 Cycles/Reached 1st Response||10
3095149|NCT01465659|3817950|FG000|Assessed to Move on to Next Cycle|Completed 2 Cycles/Reached 1st Response||7
3095150|NCT01465659|3817951|FG001|Assessed to Move on to Next Cycle|Completed 2 Cycles/Reached 1st Response||4
3095151|NCT01465659|3817952|FG002|Assessed to Move on to Next Cycle|Completed 2 Cycles/Reached 1st Response||4
3095152|NCT01465659|3817953|FG003|Assessed to Move on to Next Cycle|Completed 2 Cycles/Reached 1st Response||10
3095153|NCT01465659|3817950|FG000|COMPLETED|Completed 2 Cycles/Reached 1st Response||5
3095154|NCT01465659|3817951|FG001|COMPLETED|Completed 2 Cycles/Reached 1st Response||4
3095155|NCT01465659|3817952|FG002|COMPLETED|Completed 2 Cycles/Reached 1st Response||4
3095156|NCT01465659|3817953|FG003|COMPLETED|Completed 2 Cycles/Reached 1st Response||9
3095157|NCT01465659|3817950|FG000|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||2
3095158|NCT01465659|3817951|FG001|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0
3095159|NCT01465659|3817952|FG002|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||2
3095160|NCT01465659|3817953|FG003|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||1
3095161|NCT01465659|3817950|FG000|STARTED|Went on to Cycle 3 and Beyond||5
3095162|NCT01465659|3817951|FG001|STARTED|Went on to Cycle 3 and Beyond||4
3095163|NCT01465659|3817952|FG002|STARTED|Went on to Cycle 3 and Beyond||4
3095164|NCT01465659|3817953|FG003|STARTED|Went on to Cycle 3 and Beyond||9
3095165|NCT01465659|3817950|FG000|COMPLETED|Went on to Cycle 3 and Beyond||5
3095166|NCT01465659|3817951|FG001|COMPLETED|Went on to Cycle 3 and Beyond||4
3095167|NCT01465659|3817952|FG002|COMPLETED|Went on to Cycle 3 and Beyond||4
3095168|NCT01465659|3817953|FG003|COMPLETED|Went on to Cycle 3 and Beyond||9
3095169|NCT01465659|3817950|FG000|NOT COMPLETED|Went on to Cycle 3 and Beyond||0
3095170|NCT01465659|3817951|FG001|NOT COMPLETED|Went on to Cycle 3 and Beyond||0
3095171|NCT01465659|3817952|FG002|NOT COMPLETED|Went on to Cycle 3 and Beyond||0
3095172|NCT01465659|3817953|FG003|NOT COMPLETED|Went on to Cycle 3 and Beyond||0
3095173|NCT01465659|3817950|FG000|STARTED|Completed Follow for 1 Year||7
3095174|NCT01465659|3817951|FG001|STARTED|Completed Follow for 1 Year||4
3095175|NCT01465659|3817952|FG002|STARTED|Completed Follow for 1 Year||6
3095176|NCT01465659|3817953|FG003|STARTED|Completed Follow for 1 Year||11
3095177|NCT01465659|3817950|FG000|COMPLETED|Completed Follow for 1 Year||1
3095178|NCT01465659|3817951|FG001|COMPLETED|Completed Follow for 1 Year||1
3095179|NCT01465659|3817952|FG002|COMPLETED|Completed Follow for 1 Year||4
3095180|NCT01465659|3817953|FG003|COMPLETED|Completed Follow for 1 Year||7
3095181|NCT01465659|3817950|FG000|NOT COMPLETED|Completed Follow for 1 Year||6
3095182|NCT01465659|3817951|FG001|NOT COMPLETED|Completed Follow for 1 Year||3
3095183|NCT01465659|3817952|FG002|NOT COMPLETED|Completed Follow for 1 Year||2
3095184|NCT01465659|3817953|FG003|NOT COMPLETED|Completed Follow for 1 Year||4
3095185|NCT01465763|3817969|FG000|STARTED|Overall Study||476
3095186|NCT01465763|3817970|FG001|STARTED|Overall Study||16
3095187|NCT01465763|3817971|FG002|STARTED|Overall Study||122
3095188|NCT01465763|3817969|FG000|COMPLETED|Overall Study||445
3095189|NCT01465763|3817970|FG001|COMPLETED|Overall Study||15
3095190|NCT01465763|3817971|FG002|COMPLETED|Overall Study||118
3095191|NCT01465763|3817969|FG000|NOT COMPLETED|Overall Study||31
3095192|NCT01465763|3817970|FG001|NOT COMPLETED|Overall Study||1
3095193|NCT01465763|3817971|FG002|NOT COMPLETED|Overall Study||4
3095194|NCT01465802|3817983|FG000|STARTED|Overall Study||66
3095195|NCT01465802|3817984|FG001|STARTED|Overall Study||66
3095196|NCT01465802|3817985|FG002|STARTED|Overall Study||7
3095197|NCT01465802|3817986|FG003|STARTED|Overall Study|An additional 5 participants were enrolled in Cohort II but not treated.|67
3095198|NCT01465802|3817987|FG004|STARTED|Overall Study||25
3095199|NCT01465802|3817983|FG000|COMPLETED|Overall Study||33
3095200|NCT01465802|3817984|FG001|COMPLETED|Overall Study||42
3095201|NCT01465802|3817985|FG002|COMPLETED|Overall Study||7
3095202|NCT01465802|3817986|FG003|COMPLETED|Overall Study||38
3095203|NCT01465802|3817987|FG004|COMPLETED|Overall Study||13
3095204|NCT01465802|3817983|FG000|NOT COMPLETED|Overall Study||33
3095205|NCT01465802|3817984|FG001|NOT COMPLETED|Overall Study||24
3095206|NCT01465802|3817985|FG002|NOT COMPLETED|Overall Study||0
3095207|NCT01465802|3817986|FG003|NOT COMPLETED|Overall Study||29
3095208|NCT01465802|3817987|FG004|NOT COMPLETED|Overall Study||12
3095209|NCT01465841|3818001|FG000|STARTED|Overall Study||517
3095210|NCT01465841|3818001|FG000|COMPLETED|Overall Study||449
3095211|NCT01465841|3818001|FG000|NOT COMPLETED|Overall Study||68
3095212|NCT01465958|3818005|FG000|STARTED|Run-in Phase||11
3095213|NCT01465958|3818006|FG001|STARTED|Run-in Phase||0
3095214|NCT01465958|3818005|FG000|COMPLETED|Run-in Phase||10
3095215|NCT01465958|3818006|FG001|COMPLETED|Run-in Phase||0
3289761|NCT02818777|4023577|FG000|COMPLETED|Overall Study||10
3289762|NCT02818777|4023577|FG000|NOT COMPLETED|Overall Study||3
3289763|NCT02818998|4023590|FG000|STARTED|Overall Study||155
3289764|NCT02818998|4023591|FG001|STARTED|Overall Study||154
3289765|NCT02818998|4023592|FG002|STARTED|Overall Study||154
3289766|NCT02818998|4023590|FG000|Completed Week 52 Visit|Overall Study||144
3289767|NCT02818998|4023591|FG001|Completed Week 52 Visit|Overall Study||146
3289768|NCT02818998|4023592|FG002|Completed Week 52 Visit|Overall Study||140
3289769|NCT02818998|4023590|FG000|COMPLETED|Overall Study||137
3289770|NCT02818998|4023591|FG001|COMPLETED|Overall Study||138
3289771|NCT02818998|4023592|FG002|COMPLETED|Overall Study||136
3095216|NCT01465958|3818005|FG000|NOT COMPLETED|Run-in Phase||1
3095217|NCT01465958|3818006|FG001|NOT COMPLETED|Run-in Phase||0
3095218|NCT01465958|3818005|FG000|STARTED|Intravenous (IV) Phase|One subject entered the IV phase directly.|11
3095219|NCT01465958|3818006|FG001|STARTED|Intravenous (IV) Phase||0
3095220|NCT01465958|3818005|FG000|COMPLETED|Intravenous (IV) Phase||11
3095221|NCT01465958|3818006|FG001|COMPLETED|Intravenous (IV) Phase||0
3095222|NCT01465958|3818005|FG000|NOT COMPLETED|Intravenous (IV) Phase||0
3095223|NCT01465958|3818006|FG001|NOT COMPLETED|Intravenous (IV) Phase||0
3095224|NCT01465958|3818005|FG000|STARTED|Subcutaneous (SC) Phase|After completing the intravenous (IV) phase, subjects entered the subcutaneous (SC) phase.|0
3095225|NCT01465958|3818006|FG001|STARTED|Subcutaneous (SC) Phase|Eleven subjects completed the IV phase and entered the SC phase.|11
3095226|NCT01465958|3818005|FG000|COMPLETED|Subcutaneous (SC) Phase||0
3095227|NCT01465958|3818006|FG001|COMPLETED|Subcutaneous (SC) Phase||10
3289772|NCT02818998|4023590|FG000|NOT COMPLETED|Overall Study||18
3289773|NCT02818998|4023591|FG001|NOT COMPLETED|Overall Study||16
3289774|NCT02818998|4023592|FG002|NOT COMPLETED|Overall Study||18
3289775|NCT02819011|4023602|FG000|STARTED|Overall Study||22
3289776|NCT02819011|4023603|FG001|STARTED|Overall Study||22
3289777|NCT02819011|4023602|FG000|COMPLETED|Overall Study||15
3289778|NCT02819011|4023603|FG001|COMPLETED|Overall Study||17
3289779|NCT02819011|4023602|FG000|NOT COMPLETED|Overall Study||7
3289780|NCT02819011|4023603|FG001|NOT COMPLETED|Overall Study||5
3289781|NCT02819284|4023612|FG000|STARTED|Overall Study||452
3289782|NCT02819284|4023613|FG001|STARTED|Overall Study||453
3289783|NCT02819284|4023612|FG000|COMPLETED|Overall Study||447
3289784|NCT02819284|4023613|FG001|COMPLETED|Overall Study||448
3289785|NCT02819284|4023612|FG000|NOT COMPLETED|Overall Study||5
3289786|NCT02819284|4023613|FG001|NOT COMPLETED|Overall Study||5
3289787|NCT02819297|4023621|FG000|STARTED|Overall Study||299
3289788|NCT02819297|4023622|FG001|STARTED|Overall Study||304
3289789|NCT02819297|4023621|FG000|COMPLETED|Overall Study||239
3289790|NCT02819297|4023622|FG001|COMPLETED|Overall Study||252
3289791|NCT02819297|4023621|FG000|NOT COMPLETED|Overall Study||60
3289792|NCT02819297|4023622|FG001|NOT COMPLETED|Overall Study||52
3289793|NCT02819310|4023628|FG000|STARTED|Overall Study||330
3289794|NCT02819310|4023628|FG000|COMPLETED|Overall Study||221
3289795|NCT02819310|4023628|FG000|NOT COMPLETED|Overall Study||109
3289796|NCT02819323|4023635|FG000|STARTED|Overall Study||31
3289797|NCT02819323|4023636|FG001|STARTED|Overall Study||28
3289798|NCT02819323|4023637|FG002|STARTED|Overall Study||32
3289799|NCT02819323|4023635|FG000|COMPLETED|Overall Study||26
3289800|NCT02819323|4023636|FG001|COMPLETED|Overall Study||26
3289801|NCT02819323|4023637|FG002|COMPLETED|Overall Study||31
3289802|NCT02819323|4023635|FG000|NOT COMPLETED|Overall Study||5
3289803|NCT02819323|4023636|FG001|NOT COMPLETED|Overall Study||2
3289804|NCT02819323|4023637|FG002|NOT COMPLETED|Overall Study||1
3289805|NCT02819479|4023645|FG000|STARTED|Overall Study||10
3289806|NCT02819479|4023645|FG000|COMPLETED|Overall Study|2 subjects experienced recurrence of radiation necrosis requiring intervention at approx. month 11.|8
3289807|NCT02819479|4023645|FG000|NOT COMPLETED|Overall Study||2
3289808|NCT02819557|4023650|FG000|STARTED|Overall Study||14
3289809|NCT02819557|4023650|FG000|Safety Population|Overall Study||14
3289810|NCT02819557|4023650|FG000|Pharmacokinetics (PK) Population|Overall Study||14
3289811|NCT02819557|4023650|FG000|Evaluable Population|Overall Study||14
3289812|NCT02819557|4023650|FG000|COMPLETED|Overall Study||14
3289813|NCT02819557|4023650|FG000|NOT COMPLETED|Overall Study||0
3289814|NCT02819726|4023657|FG000|STARTED|Part A (All Participants)||98
3289815|NCT02819726|4023658|FG001|STARTED|Part A (All Participants)||98
3289816|NCT02819726|4023659|FG002|STARTED|Part A (All Participants)||98
3289817|NCT02819726|4023660|FG003|STARTED|Part A (All Participants)||0
3289818|NCT02819726|4023657|FG000|COMPLETED|Part A (All Participants)||92
3289819|NCT02819726|4023658|FG001|COMPLETED|Part A (All Participants)||88
3289820|NCT02819726|4023659|FG002|COMPLETED|Part A (All Participants)||87
3289821|NCT02819726|4023660|FG003|COMPLETED|Part A (All Participants)||0
3289822|NCT02819726|4023657|FG000|NOT COMPLETED|Part A (All Participants)||6
3289823|NCT02819726|4023658|FG001|NOT COMPLETED|Part A (All Participants)||10
3289824|NCT02819726|4023659|FG002|NOT COMPLETED|Part A (All Participants)||11
3289825|NCT02819726|4023660|FG003|NOT COMPLETED|Part A (All Participants)||0
3289826|NCT02819726|4023657|FG000|STARTED|Part B (All Participants)|19 participants who completed Part A were not eligible for Part B|73
3289827|NCT02819726|4023658|FG001|STARTED|Part B (All Participants)|18 participants completing Part A were not eligible for Part B|70
3289828|NCT02819726|4023659|FG002|STARTED|Part B (All Participants)|5 participants completing Part A were ineligible for Part B.|39
3289829|NCT02819726|4023660|FG003|STARTED|Part B (All Participants)|5 participants completing Part A were ineligible for Part B.|38
3289830|NCT02819726|4023657|FG000|COMPLETED|Part B (All Participants)||70
3289831|NCT02819726|4023658|FG001|COMPLETED|Part B (All Participants)||68
3289832|NCT02819726|4023659|FG002|COMPLETED|Part B (All Participants)||35
3289833|NCT02819726|4023660|FG003|COMPLETED|Part B (All Participants)||36
3289834|NCT02819726|4023657|FG000|NOT COMPLETED|Part B (All Participants)||3
3289835|NCT02819726|4023658|FG001|NOT COMPLETED|Part B (All Participants)||2
3289836|NCT02819726|4023659|FG002|NOT COMPLETED|Part B (All Participants)||4
3289837|NCT02819726|4023660|FG003|NOT COMPLETED|Part B (All Participants)||2
3289838|NCT02819973|4023671|FG000|STARTED|Overall Study||114
3289839|NCT02819973|4023672|FG001|STARTED|Overall Study||114
3289840|NCT02819973|4023673|FG002|STARTED|Overall Study||115
3316718|NCT03118739|4050153|FG000|Completed 24 Weeks of Treatment|Overall Study||24
3095228|NCT01465958|3818005|FG000|NOT COMPLETED|Subcutaneous (SC) Phase||0
3095229|NCT01465958|3818006|FG001|NOT COMPLETED|Subcutaneous (SC) Phase||1
3095230|NCT01465997|3818015|FG000|STARTED|Overall Study||279
3095231|NCT01465997|3818016|FG001|STARTED|Overall Study||269
3095232|NCT01465997|3818015|FG000|COMPLETED|Overall Study||211
3095233|NCT01465997|3818016|FG001|COMPLETED|Overall Study||180
3095234|NCT01465997|3818015|FG000|NOT COMPLETED|Overall Study||68
3095235|NCT01465997|3818016|FG001|NOT COMPLETED|Overall Study||89
3095236|NCT01466062|3818024|FG000|STARTED|Overall Study||28
3095237|NCT01466062|3818024|FG000|COMPLETED|Overall Study||26
3095238|NCT01466062|3818024|FG000|NOT COMPLETED|Overall Study||2
3095239|NCT01466075|3818028|FG000|STARTED|Overall Study||207
3095240|NCT01466075|3818028|FG000|COMPLETED|Overall Study||207
3095241|NCT01466075|3818028|FG000|NOT COMPLETED|Overall Study||0
3095242|NCT01466127|3818034|FG000|STARTED|Overall Study||30
3095243|NCT01466127|3818035|FG001|STARTED|Overall Study||30
3095244|NCT01466127|3818034|FG000|COMPLETED|Overall Study||16
3095245|NCT01466127|3818035|FG001|COMPLETED|Overall Study||14
3095246|NCT01466127|3818034|FG000|NOT COMPLETED|Overall Study||14
3095247|NCT01466127|3818035|FG001|NOT COMPLETED|Overall Study||16
3095248|NCT01466153|3818044|FG000|STARTED|Overall Study||62
3095249|NCT01466153|3818045|FG001|STARTED|Overall Study||36
3095250|NCT01466153|3818046|FG002|STARTED|Overall Study||61
3095251|NCT01466153|3818044|FG000|COMPLETED|Overall Study||33
3289841|NCT02819973|4023671|FG000|COMPLETED|Overall Study|2 withdrawn by request, 4 determined after randomization to be not eligible|108
3289842|NCT02819973|4023672|FG001|COMPLETED|Overall Study|3 determined after randomization to be not eligible|111
3289843|NCT02819973|4023673|FG002|COMPLETED|Overall Study|2 withdrawn by request, 2 determined after randomization to be not eligible|111
3289844|NCT02819973|4023671|FG000|NOT COMPLETED|Overall Study||6
3289845|NCT02819973|4023672|FG001|NOT COMPLETED|Overall Study||3
3289846|NCT02819973|4023673|FG002|NOT COMPLETED|Overall Study||4
3289847|NCT02820038|4023691|FG000|STARTED|Overall Study||78
3289848|NCT02820038|4023692|FG001|STARTED|Overall Study||77
3289849|NCT02820038|4023693|FG002|STARTED|Overall Study||65
3289850|NCT02820038|4023694|FG003|STARTED|Overall Study||66
3289851|NCT02820038|4023691|FG000|COMPLETED|Overall Study||68
3289852|NCT02820038|4023692|FG001|COMPLETED|Overall Study||52
3289853|NCT02820038|4023693|FG002|COMPLETED|Overall Study||60
3289854|NCT02820038|4023694|FG003|COMPLETED|Overall Study||44
3289855|NCT02820038|4023691|FG000|NOT COMPLETED|Overall Study||10
3289856|NCT02820038|4023692|FG001|NOT COMPLETED|Overall Study||25
3289857|NCT02820038|4023693|FG002|NOT COMPLETED|Overall Study||5
3289858|NCT02820038|4023694|FG003|NOT COMPLETED|Overall Study||22
3289859|NCT02820181|4023707|FG000|STARTED|Overall Study||30
3289860|NCT02820181|4023708|FG001|STARTED|Overall Study||30
3289861|NCT02820181|4023707|FG000|COMPLETED|Overall Study||30
3289862|NCT02820181|4023708|FG001|COMPLETED|Overall Study||30
3289863|NCT02820181|4023707|FG000|NOT COMPLETED|Overall Study||0
3289864|NCT02820181|4023708|FG001|NOT COMPLETED|Overall Study||0
3289865|NCT02820298|4023716|FG000|STARTED|Overall Study||13
3289866|NCT02820298|4023717|FG001|STARTED|Overall Study||12
3289867|NCT02820298|4023716|FG000|COMPLETED|Overall Study||12
3289868|NCT02820298|4023717|FG001|COMPLETED|Overall Study||10
3289869|NCT02820298|4023716|FG000|NOT COMPLETED|Overall Study||1
3289870|NCT02820298|4023717|FG001|NOT COMPLETED|Overall Study||2
3289871|NCT02820324|4023734|FG000|STARTED|Overall Study||78
3289872|NCT02820324|4023735|FG001|STARTED|Overall Study||82
3289873|NCT02820324|4023736|FG002|STARTED|Overall Study||82
3289874|NCT02820324|4023737|FG003|STARTED|Overall Study||82
3289875|NCT02820324|4023738|FG004|STARTED|Overall Study||83
3289876|NCT02820324|4023734|FG000|Treated With Study Medication|Overall Study||77
3289877|NCT02820324|4023735|FG001|Treated With Study Medication|Overall Study||80
3289878|NCT02820324|4023736|FG002|Treated With Study Medication|Overall Study||80
3289879|NCT02820324|4023737|FG003|Treated With Study Medication|Overall Study||81
3289880|NCT02820324|4023738|FG004|Treated With Study Medication|Overall Study||83
3289881|NCT02820324|4023734|FG000|COMPLETED|Overall Study||76
3289882|NCT02820324|4023735|FG001|COMPLETED|Overall Study||79
3289883|NCT02820324|4023736|FG002|COMPLETED|Overall Study||79
3289884|NCT02820324|4023737|FG003|COMPLETED|Overall Study||79
3289885|NCT02820324|4023738|FG004|COMPLETED|Overall Study||80
3289886|NCT02820324|4023734|FG000|NOT COMPLETED|Overall Study||2
3289887|NCT02820324|4023735|FG001|NOT COMPLETED|Overall Study||3
3289888|NCT02820324|4023736|FG002|NOT COMPLETED|Overall Study||3
3289889|NCT02820324|4023737|FG003|NOT COMPLETED|Overall Study||3
3289890|NCT02820324|4023738|FG004|NOT COMPLETED|Overall Study||3
3289891|NCT02820597|4023750|FG000|STARTED|Overall Study||27
3289892|NCT02820597|4023750|FG000|1-day Post Treatment|Overall Study||27
3289893|NCT02820597|4023750|FG000|7-day Post Treatment|Overall Study||27
3289894|NCT02820597|4023750|FG000|30-day Post Treatment|Overall Study||27
3289895|NCT02820597|4023750|FG000|90-day Post Treatment|Overall Study|2 participants missed the 90-day visit, 1 participant was lost to follow-up.|24
3095252|NCT01466153|3818045|FG001|COMPLETED|Overall Study||12
3095253|NCT01466153|3818046|FG002|COMPLETED|Overall Study||36
3095254|NCT01466153|3818044|FG000|NOT COMPLETED|Overall Study||29
3095255|NCT01466153|3818045|FG001|NOT COMPLETED|Overall Study||24
3095256|NCT01466153|3818046|FG002|NOT COMPLETED|Overall Study||25
3095257|NCT01466166|3818056|FG000|STARTED|Overall Study||188
3095258|NCT01466166|3818056|FG000|Received Treatment|Overall Study||188
3289896|NCT02820597|4023750|FG000|180-day Post Treatment|Overall Study|3 participants missed the 180-day visit, 3 participants were lost to follow-up.|21
3095259|NCT01466166|3818056|FG000|Completed 24 Weeks of Treatment|Overall Study||55
3095260|NCT01466166|3818056|FG000|COMPLETED|Overall Study||25
3095261|NCT01466166|3818056|FG000|NOT COMPLETED|Overall Study||163
3095262|NCT01466179|3818060|FG000|STARTED|Overall Study|Participants enrolled during the first 3 stages of the study|189
3095263|NCT01466179|3818060|FG000|COMPLETED|Overall Study|Completed 5 cycles of treatment; Data as of the time of the data cut-off date (10 October 2013).|10
3095264|NCT01466179|3818060|FG000|NOT COMPLETED|Overall Study||179
3095265|NCT01466192|3818067|FG000|STARTED|Overall Study||108
3095266|NCT01466192|3818067|FG000|COMPLETED|Overall Study||104
3095267|NCT01466192|3818067|FG000|NOT COMPLETED|Overall Study||4
3095268|NCT01466270|3818073|FG000|STARTED|Overall Study||31
3095269|NCT01466270|3818074|FG001|STARTED|Overall Study||31
3095270|NCT01466270|3818073|FG000|COMPLETED|Overall Study||19
3095271|NCT01466270|3818074|FG001|COMPLETED|Overall Study||25
3095272|NCT01466270|3818073|FG000|NOT COMPLETED|Overall Study||12
3095273|NCT01466270|3818074|FG001|NOT COMPLETED|Overall Study||6
3095274|NCT01466348|3818082|FG000|STARTED|Period I - First Intervention||36
3095275|NCT01466348|3818083|FG001|STARTED|Period I - First Intervention||36
3163112|NCT01883362|3890571|FG000|COMPLETED|Treatment||14
3163113|NCT01883362|3890572|FG001|COMPLETED|Treatment||16
3163114|NCT01883362|3890571|FG000|NOT COMPLETED|Treatment||16
3163115|NCT01883362|3890572|FG001|NOT COMPLETED|Treatment||14
3289897|NCT02820597|4023750|FG000|COMPLETED|Overall Study|12 participants were lost to follow-up.|15
3289898|NCT02820597|4023750|FG000|NOT COMPLETED|Overall Study||12
3289899|NCT02820844|4023756|FG000|STARTED|Double-blinded (Up to 48 Weeks)||124
3289900|NCT02820844|4023757|FG001|STARTED|Double-blinded (Up to 48 Weeks)||124
3289901|NCT02820844|4023758|FG002|STARTED|Double-blinded (Up to 48 Weeks)||0
3289902|NCT02820844|4023759|FG003|STARTED|Double-blinded (Up to 48 Weeks)||0
3289903|NCT02820844|4023760|FG004|STARTED|Double-blinded (Up to 48 Weeks)||0
3289904|NCT02820844|4023761|FG005|STARTED|Double-blinded (Up to 48 Weeks)||0
3289905|NCT02820844|4023756|FG000|COMPLETED|Double-blinded (Up to 48 Weeks)||119
3289906|NCT02820844|4023757|FG001|COMPLETED|Double-blinded (Up to 48 Weeks)||115
3289907|NCT02820844|4023758|FG002|COMPLETED|Double-blinded (Up to 48 Weeks)||0
3289908|NCT02820844|4023759|FG003|COMPLETED|Double-blinded (Up to 48 Weeks)||0
3289909|NCT02820844|4023760|FG004|COMPLETED|Double-blinded (Up to 48 Weeks)||0
3289910|NCT02820844|4023761|FG005|COMPLETED|Double-blinded (Up to 48 Weeks)||0
3289911|NCT02820844|4023756|FG000|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||5
3289912|NCT02820844|4023757|FG001|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||9
3289913|NCT02820844|4023758|FG002|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
3289914|NCT02820844|4023759|FG003|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
3289915|NCT02820844|4023760|FG004|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
3289916|NCT02820844|4023761|FG005|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
3289917|NCT02820844|4023756|FG000|STARTED|Open-label(2nd Treatment-Up to 48 Weeks)||0
3289918|NCT02820844|4023757|FG001|STARTED|Open-label(2nd Treatment-Up to 48 Weeks)||0
3289919|NCT02820844|4023758|FG002|STARTED|Open-label(2nd Treatment-Up to 48 Weeks)||108
3289920|NCT02820844|4023759|FG003|STARTED|Open-label(2nd Treatment-Up to 48 Weeks)||88
3289921|NCT02820844|4023760|FG004|STARTED|Open-label(2nd Treatment-Up to 48 Weeks)||0
3289922|NCT02820844|4023761|FG005|STARTED|Open-label(2nd Treatment-Up to 48 Weeks)||0
3289923|NCT02820844|4023756|FG000|COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0
3289924|NCT02820844|4023757|FG001|COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0
3163116|NCT01883362|3890571|FG000|STARTED|Post Treatment Follow-up||26
3163117|NCT01883362|3890572|FG001|STARTED|Post Treatment Follow-up||27
3163118|NCT01883362|3890571|FG000|COMPLETED|Post Treatment Follow-up||10
3163119|NCT01883362|3890572|FG001|COMPLETED|Post Treatment Follow-up||13
3289925|NCT02820844|4023758|FG002|COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||99
3289926|NCT02820844|4023759|FG003|COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||84
3289927|NCT02820844|4023760|FG004|COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0
3289928|NCT02820844|4023761|FG005|COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0
3289929|NCT02820844|4023756|FG000|NOT COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0
3289930|NCT02820844|4023757|FG001|NOT COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0
3289931|NCT02820844|4023758|FG002|NOT COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||9
3289932|NCT02820844|4023759|FG003|NOT COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||4
3289933|NCT02820844|4023760|FG004|NOT COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0
3289934|NCT02820844|4023761|FG005|NOT COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0
3289935|NCT02820844|4023756|FG000|STARTED|Open-label(3rd Treatment-Up to 48 Weeks)||0
3289936|NCT02820844|4023757|FG001|STARTED|Open-label(3rd Treatment-Up to 48 Weeks)||0
3289937|NCT02820844|4023758|FG002|STARTED|Open-label(3rd Treatment-Up to 48 Weeks)||0
3289938|NCT02820844|4023759|FG003|STARTED|Open-label(3rd Treatment-Up to 48 Weeks)||0
3289939|NCT02820844|4023760|FG004|STARTED|Open-label(3rd Treatment-Up to 48 Weeks)||56
3289940|NCT02820844|4023761|FG005|STARTED|Open-label(3rd Treatment-Up to 48 Weeks)||43
3289941|NCT02820844|4023756|FG000|COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0
3289942|NCT02820844|4023757|FG001|COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0
3289943|NCT02820844|4023758|FG002|COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0
3289944|NCT02820844|4023759|FG003|COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0
3289945|NCT02820844|4023760|FG004|COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||54
3289946|NCT02820844|4023761|FG005|COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||42
3289947|NCT02820844|4023756|FG000|NOT COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0
3289948|NCT02820844|4023757|FG001|NOT COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0
3095276|NCT01466348|3818082|FG000|Intent To Treat (ITT) Population|Period I - First Intervention||36
3095277|NCT01466348|3818083|FG001|Intent To Treat (ITT) Population|Period I - First Intervention|1 participant withdrew prior receiving the treatment|35
3095278|NCT01466348|3818082|FG000|COMPLETED|Period I - First Intervention||36
3095279|NCT01466348|3818083|FG001|COMPLETED|Period I - First Intervention||35
3289949|NCT02820844|4023758|FG002|NOT COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0
3289950|NCT02820844|4023759|FG003|NOT COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0
3289951|NCT02820844|4023760|FG004|NOT COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||2
3289952|NCT02820844|4023761|FG005|NOT COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||1
3289953|NCT02820870|4023780|FG000|STARTED|Before Intervention|These are a separate set of visits from the intervention period and have different visit numbers.|15
3289954|NCT02820870|4023781|FG001|STARTED|Before Intervention|These are a separate set of visits from the intervention period and have different visit numbers.|28
3289955|NCT02820870|4023780|FG000|COMPLETED|Before Intervention||15
3289956|NCT02820870|4023781|FG001|COMPLETED|Before Intervention||28
3289957|NCT02820870|4023780|FG000|NOT COMPLETED|Before Intervention||0
3289958|NCT02820870|4023781|FG001|NOT COMPLETED|Before Intervention||0
3289959|NCT02820870|4023780|FG000|STARTED|Intervention||15
3289960|NCT02820870|4023781|FG001|STARTED|Intervention||28
3289961|NCT02820870|4023780|FG000|COMPLETED|Intervention||15
3289962|NCT02820870|4023781|FG001|COMPLETED|Intervention||28
3289963|NCT02820870|4023780|FG000|NOT COMPLETED|Intervention||0
3289964|NCT02820870|4023781|FG001|NOT COMPLETED|Intervention||0
3289965|NCT02820870|4023780|FG000|STARTED|Post Intervention|These are a separate set of visits from the intervention period and have different visit numbers.|15
3289966|NCT02820870|4023781|FG001|STARTED|Post Intervention|These are a separate set of visits from the intervention period and have different visit numbers.|28
3289967|NCT02820870|4023780|FG000|COMPLETED|Post Intervention||15
3289968|NCT02820870|4023781|FG001|COMPLETED|Post Intervention||28
3289969|NCT02820870|4023780|FG000|NOT COMPLETED|Post Intervention||0
3289970|NCT02820870|4023781|FG001|NOT COMPLETED|Post Intervention||0
3289971|NCT02821104|4023789|FG000|STARTED|Overall Study||77
3289972|NCT02821104|4023789|FG000|COMPLETED|Overall Study||77
3289973|NCT02821104|4023789|FG000|NOT COMPLETED|Overall Study||0
3289974|NCT02821338|4023796|FG000|STARTED|Overall Study||15
3289975|NCT02821338|4023797|FG001|STARTED|Overall Study||15
3289976|NCT02821338|4023796|FG000|COMPLETED|Overall Study|12 out of 15 subjects assigned to Sequence 1 completed the study, and provided two data points.|12
3289977|NCT02821338|4023797|FG001|COMPLETED|Overall Study|13 out of 15 subjects assigned to Sequence 2 completed the study, and provided two data points.|13
3289978|NCT02821338|4023796|FG000|NOT COMPLETED|Overall Study||3
3289979|NCT02821338|4023797|FG001|NOT COMPLETED|Overall Study||2
3289980|NCT02821403|4023805|FG000|STARTED|"First Intervention (1 Month)"||40
3289981|NCT02821403|4023806|FG001|STARTED|"First Intervention (1 Month)"||40
3289982|NCT02821403|4023805|FG000|Used Clear Lens|"First Intervention (1 Month)"||13
3289983|NCT02821403|4023806|FG001|Used Clear Lens|"First Intervention (1 Month)"||13
3289984|NCT02821403|4023805|FG000|Used Yellow Tinted Lens|"First Intervention (1 Month)"||13
3289985|NCT02821403|4023806|FG001|Used Yellow Tinted Lens|"First Intervention (1 Month)"||14
3289986|NCT02821403|4023805|FG000|Used Blue-filtering Coated Lens|"First Intervention (1 Month)"||14
3289987|NCT02821403|4023806|FG001|Used Blue-filtering Coated Lens|"First Intervention (1 Month)"||13
3289988|NCT02821403|4023805|FG000|COMPLETED|"First Intervention (1 Month)"||40
3289989|NCT02821403|4023806|FG001|COMPLETED|"First Intervention (1 Month)"||40
3289990|NCT02821403|4023805|FG000|NOT COMPLETED|"First Intervention (1 Month)"||0
3289991|NCT02821403|4023806|FG001|NOT COMPLETED|"First Intervention (1 Month)"||0
3289992|NCT02821403|4023805|FG000|STARTED|"Second Intervention (1 Month)"||40
3289993|NCT02821403|4023806|FG001|STARTED|"Second Intervention (1 Month)"||40
3289994|NCT02821403|4023805|FG000|Used Clear Lens|"Second Intervention (1 Month)"||13
3289995|NCT02821403|4023806|FG001|Used Clear Lens|"Second Intervention (1 Month)"||14
3289996|NCT02821403|4023805|FG000|Used Yellow Tinted Lens|"Second Intervention (1 Month)"||14
3289997|NCT02821403|4023806|FG001|Used Yellow Tinted Lens|"Second Intervention (1 Month)"||13
3289998|NCT02821403|4023805|FG000|Used Blue-filtering Coated Lens|"Second Intervention (1 Month)"||13
3289999|NCT02821403|4023806|FG001|Used Blue-filtering Coated Lens|"Second Intervention (1 Month)"||13
3290000|NCT02821403|4023805|FG000|COMPLETED|"Second Intervention (1 Month)"||40
3290001|NCT02821403|4023806|FG001|COMPLETED|"Second Intervention (1 Month)"||40
3290002|NCT02821403|4023805|FG000|NOT COMPLETED|"Second Intervention (1 Month)"||0
3290003|NCT02821403|4023806|FG001|NOT COMPLETED|"Second Intervention (1 Month)"||0
3290004|NCT02821403|4023805|FG000|STARTED|"Third Intervention (1 Month)"||40
3290005|NCT02821403|4023806|FG001|STARTED|"Third Intervention (1 Month)"||40
3290006|NCT02821403|4023805|FG000|Used Clear Lens|"Third Intervention (1 Month)"||14
3290007|NCT02821403|4023806|FG001|Used Clear Lens|"Third Intervention (1 Month)"||13
3290008|NCT02821403|4023805|FG000|Used Yellow Tinted Lens|"Third Intervention (1 Month)"||13
3290009|NCT02821403|4023806|FG001|Used Yellow Tinted Lens|"Third Intervention (1 Month)"||13
3290010|NCT02821403|4023805|FG000|Used Blue-filtering Coated Lens|"Third Intervention (1 Month)"||13
3290011|NCT02821403|4023806|FG001|Used Blue-filtering Coated Lens|"Third Intervention (1 Month)"||14
3290012|NCT02821403|4023805|FG000|COMPLETED|"Third Intervention (1 Month)"||40
3290013|NCT02821403|4023806|FG001|COMPLETED|"Third Intervention (1 Month)"||40
3290014|NCT02821403|4023805|FG000|NOT COMPLETED|"Third Intervention (1 Month)"||0
3290015|NCT02821403|4023806|FG001|NOT COMPLETED|"Third Intervention (1 Month)"||0
3290016|NCT02821416|4023820|FG000|STARTED|Overall Study||23
3290017|NCT02821416|4023821|FG001|STARTED|Overall Study||23
3095280|NCT01466348|3818082|FG000|NOT COMPLETED|Period I - First Intervention||0
3095281|NCT01466348|3818083|FG001|NOT COMPLETED|Period I - First Intervention||1
3095282|NCT01466348|3818082|FG000|STARTED|Period II - Second Intervention||35
3095283|NCT01466348|3818083|FG001|STARTED|Period II - Second Intervention||36
3095284|NCT01466348|3818082|FG000|COMPLETED|Period II - Second Intervention||35
3095285|NCT01466348|3818083|FG001|COMPLETED|Period II - Second Intervention||36
3095286|NCT01466348|3818082|FG000|NOT COMPLETED|Period II - Second Intervention||0
3095287|NCT01466348|3818083|FG001|NOT COMPLETED|Period II - Second Intervention||0
3095288|NCT01466361|3818095|FG000|STARTED|Overall Study||52
3095289|NCT01466361|3818096|FG001|STARTED|Overall Study||34
3095290|NCT01466361|3818097|FG002|STARTED|Overall Study||60
3095291|NCT01466361|3818098|FG003|STARTED|Overall Study||41
3095292|NCT01466361|3818095|FG000|COMPLETED|Overall Study||52
3095293|NCT01466361|3818096|FG001|COMPLETED|Overall Study||34
3095294|NCT01466361|3818097|FG002|COMPLETED|Overall Study||60
3290018|NCT02821416|4023820|FG000|COMPLETED|Overall Study||20
3290019|NCT02821416|4023821|FG001|COMPLETED|Overall Study||22
3290020|NCT02821416|4023820|FG000|NOT COMPLETED|Overall Study||3
3290021|NCT02821416|4023821|FG001|NOT COMPLETED|Overall Study||1
3290022|NCT02821455|4023828|FG000|STARTED|Overall Study||19
3290023|NCT02821455|4023828|FG000|COMPLETED|Overall Study||19
3290024|NCT02821455|4023828|FG000|NOT COMPLETED|Overall Study||0
3290025|NCT02821715|4023832|FG000|STARTED|Overall Study||8
3290026|NCT02821715|4023833|FG001|STARTED|Overall Study||8
3290027|NCT02821715|4023834|FG002|STARTED|Overall Study||8
3290028|NCT02821715|4023835|FG003|STARTED|Overall Study||9
3290029|NCT02821715|4023836|FG004|STARTED|Overall Study||6
3290030|NCT02821715|4023837|FG005|STARTED|Overall Study||9
3290031|NCT02821715|4023832|FG000|COMPLETED|Overall Study||7
3290032|NCT02821715|4023833|FG001|COMPLETED|Overall Study||8
3290033|NCT02821715|4023834|FG002|COMPLETED|Overall Study||8
3290034|NCT02821715|4023835|FG003|COMPLETED|Overall Study||9
3290035|NCT02821715|4023836|FG004|COMPLETED|Overall Study||6
3290036|NCT02821715|4023837|FG005|COMPLETED|Overall Study||9
3290037|NCT02821715|4023832|FG000|NOT COMPLETED|Overall Study||1
3290038|NCT02821715|4023833|FG001|NOT COMPLETED|Overall Study||0
3290039|NCT02821715|4023834|FG002|NOT COMPLETED|Overall Study||0
3290040|NCT02821715|4023835|FG003|NOT COMPLETED|Overall Study||0
3290041|NCT02821715|4023836|FG004|NOT COMPLETED|Overall Study||0
3290042|NCT02821715|4023837|FG005|NOT COMPLETED|Overall Study||0
3290043|NCT02821819|4023845|FG000|STARTED|Overall Study||15
3290044|NCT02821819|4023845|FG000|COMPLETED|Overall Study||14
3290045|NCT02821819|4023845|FG000|NOT COMPLETED|Overall Study||1
3290046|NCT02821910|4023855|FG000|STARTED|Overall Study||7
3290047|NCT02821910|4023856|FG001|STARTED|Overall Study||8
3290048|NCT02821910|4023857|FG002|STARTED|Overall Study||10
3290049|NCT02821910|4023858|FG003|STARTED|Overall Study||10
3290050|NCT02821910|4023859|FG004|STARTED|Overall Study||7
3290051|NCT02821910|4023860|FG005|STARTED|Overall Study||8
3290052|NCT02821910|4023855|FG000|COMPLETED|Overall Study||6
3290053|NCT02821910|4023856|FG001|COMPLETED|Overall Study||8
3290054|NCT02821910|4023857|FG002|COMPLETED|Overall Study||8
3290055|NCT02821910|4023858|FG003|COMPLETED|Overall Study||10
3290056|NCT02821910|4023859|FG004|COMPLETED|Overall Study||7
3290057|NCT02821910|4023860|FG005|COMPLETED|Overall Study||7
3290058|NCT02821910|4023855|FG000|NOT COMPLETED|Overall Study||1
3290059|NCT02821910|4023856|FG001|NOT COMPLETED|Overall Study||0
3290060|NCT02821910|4023857|FG002|NOT COMPLETED|Overall Study||2
3290061|NCT02821910|4023858|FG003|NOT COMPLETED|Overall Study||0
3290062|NCT02821910|4023859|FG004|NOT COMPLETED|Overall Study||0
3290063|NCT02821910|4023860|FG005|NOT COMPLETED|Overall Study||1
3290064|NCT02821962|4023876|FG000|STARTED|Overall Study||19
3290065|NCT02821962|4023877|FG001|STARTED|Overall Study||21
3290066|NCT02821962|4023876|FG000|COMPLETED|Overall Study||17
3290067|NCT02821962|4023877|FG001|COMPLETED|Overall Study||21
3095295|NCT01466361|3818098|FG003|COMPLETED|Overall Study||41
3095296|NCT01466361|3818095|FG000|NOT COMPLETED|Overall Study||0
3290068|NCT02821962|4023876|FG000|NOT COMPLETED|Overall Study||2
3290069|NCT02821962|4023877|FG001|NOT COMPLETED|Overall Study||0
3290070|NCT02822222|4023885|FG000|STARTED|Overall Study||16
3290071|NCT02822222|4023886|FG001|STARTED|Overall Study||6
3290072|NCT02822222|4023885|FG000|COMPLETED|Overall Study||15
3290073|NCT02822222|4023886|FG001|COMPLETED|Overall Study||6
3290074|NCT02822222|4023885|FG000|NOT COMPLETED|Overall Study||1
3290075|NCT02822222|4023886|FG001|NOT COMPLETED|Overall Study||0
3290076|NCT02822235|4023894|FG000|STARTED|Cross-sectional Phase (Day 1)||264
3290077|NCT02822235|4023895|FG001|STARTED|Cross-sectional Phase (Day 1)||143
3290078|NCT02822235|4023894|FG000|COMPLETED|Cross-sectional Phase (Day 1)||118
3290079|NCT02822235|4023895|FG001|COMPLETED|Cross-sectional Phase (Day 1)||36
3290080|NCT02822235|4023894|FG000|NOT COMPLETED|Cross-sectional Phase (Day 1)||146
3290081|NCT02822235|4023895|FG001|NOT COMPLETED|Cross-sectional Phase (Day 1)||107
3290082|NCT02822235|4023894|FG000|STARTED|Prospective Phase (Day 1 up to Month 12)||118
3290083|NCT02822235|4023895|FG001|STARTED|Prospective Phase (Day 1 up to Month 12)||36
3290084|NCT02822235|4023894|FG000|COMPLETED|Prospective Phase (Day 1 up to Month 12)||107
3290085|NCT02822235|4023895|FG001|COMPLETED|Prospective Phase (Day 1 up to Month 12)||34
3290086|NCT02822235|4023894|FG000|NOT COMPLETED|Prospective Phase (Day 1 up to Month 12)||11
3290087|NCT02822235|4023895|FG001|NOT COMPLETED|Prospective Phase (Day 1 up to Month 12)||2
3290088|NCT02822287|4023908|FG000|STARTED|Overall Study||57
3290089|NCT02822287|4023908|FG000|COMPLETED|Overall Study||57
3095297|NCT01466361|3818096|FG001|NOT COMPLETED|Overall Study||0
3095298|NCT01466361|3818097|FG002|NOT COMPLETED|Overall Study||0
3095299|NCT01466361|3818098|FG003|NOT COMPLETED|Overall Study||0
3095300|NCT01466387|3818119|FG000|STARTED|Overall Study||101
3095301|NCT01466387|3818120|FG001|STARTED|Overall Study||100
3095302|NCT01466387|3818121|FG002|STARTED|Overall Study||99
3095303|NCT01466387|3818122|FG003|STARTED|Overall Study||101
3095304|NCT01466387|3818123|FG004|STARTED|Overall Study||51
3095305|NCT01466387|3818124|FG005|STARTED|Overall Study||100
3095306|NCT01466387|3818119|FG000|COMPLETED|Overall Study||100
3095307|NCT01466387|3818120|FG001|COMPLETED|Overall Study||100
3095308|NCT01466387|3818121|FG002|COMPLETED|Overall Study||98
3095309|NCT01466387|3818122|FG003|COMPLETED|Overall Study||99
3095310|NCT01466387|3818123|FG004|COMPLETED|Overall Study||51
3095311|NCT01466387|3818124|FG005|COMPLETED|Overall Study||99
3095312|NCT01466387|3818119|FG000|NOT COMPLETED|Overall Study||1
3095313|NCT01466387|3818120|FG001|NOT COMPLETED|Overall Study||0
3095314|NCT01466387|3818121|FG002|NOT COMPLETED|Overall Study||1
3095315|NCT01466387|3818122|FG003|NOT COMPLETED|Overall Study||2
3095316|NCT01466387|3818123|FG004|NOT COMPLETED|Overall Study||0
3095317|NCT01466387|3818124|FG005|NOT COMPLETED|Overall Study||1
3095318|NCT01466491|3818151|FG000|STARTED|Overall Study||83
3095319|NCT01466491|3818152|FG001|STARTED|Overall Study||83
3095320|NCT01466491|3818153|FG002|STARTED|Overall Study||83
3163120|NCT01883362|3890571|FG000|NOT COMPLETED|Post Treatment Follow-up||16
3163121|NCT01883362|3890572|FG001|NOT COMPLETED|Post Treatment Follow-up||14
3163122|NCT01883427|3890584|FG000|STARTED|Overall Study||20
3290090|NCT02822287|4023908|FG000|NOT COMPLETED|Overall Study||0
3290091|NCT02822599|4023914|FG000|STARTED|Overall Study|First subject enrolled on 6-1-17.|15
3290092|NCT02822599|4023915|FG001|STARTED|Overall Study|First subject enrolled on 6-1-17.|15
3290093|NCT02822599|4023914|FG000|COMPLETED|Overall Study||15
3290094|NCT02822599|4023915|FG001|COMPLETED|Overall Study||15
3290095|NCT02822599|4023914|FG000|NOT COMPLETED|Overall Study||0
3290096|NCT02822599|4023915|FG001|NOT COMPLETED|Overall Study||0
3290097|NCT02822612|4023926|FG000|STARTED|Overall Study||14
3290098|NCT02822612|4023927|FG001|STARTED|Overall Study||13
3290099|NCT02822612|4023928|FG002|STARTED|Overall Study||14
3290100|NCT02822612|4023929|FG003|STARTED|Overall Study||4
3290101|NCT02822612|4023930|FG004|STARTED|Overall Study||15
3290102|NCT02822612|4023926|FG000|COMPLETED|Overall Study||14
3290103|NCT02822612|4023927|FG001|COMPLETED|Overall Study||13
3290104|NCT02822612|4023928|FG002|COMPLETED|Overall Study||14
3290105|NCT02822612|4023929|FG003|COMPLETED|Overall Study||4
3290106|NCT02822612|4023930|FG004|COMPLETED|Overall Study||15
3290107|NCT02822612|4023926|FG000|NOT COMPLETED|Overall Study||0
3290108|NCT02822612|4023927|FG001|NOT COMPLETED|Overall Study||0
3290109|NCT02822612|4023928|FG002|NOT COMPLETED|Overall Study||0
3290110|NCT02822612|4023929|FG003|NOT COMPLETED|Overall Study||0
3290111|NCT02822612|4023930|FG004|NOT COMPLETED|Overall Study||0
3290112|NCT02822794|4023946|FG000|STARTED|Overall Study||57
3290113|NCT02822794|4023947|FG001|STARTED|Overall Study||60
3290114|NCT02822794|4023946|FG000|COMPLETED|Overall Study||56
3290115|NCT02822794|4023947|FG001|COMPLETED|Overall Study||60
3290116|NCT02822794|4023946|FG000|NOT COMPLETED|Overall Study||1
3163123|NCT01883427|3890585|FG001|STARTED|Overall Study||20
3163124|NCT01883427|3890584|FG000|COMPLETED|Overall Study||20
3163125|NCT01883427|3890585|FG001|COMPLETED|Overall Study||20
3290117|NCT02822794|4023947|FG001|NOT COMPLETED|Overall Study||0
3290118|NCT02822885|4023960|FG000|STARTED|Overall Study||70
3290119|NCT02822885|4023960|FG000|COMPLETED|Overall Study||70
3290120|NCT02822885|4023960|FG000|NOT COMPLETED|Overall Study||0
3290121|NCT02822950|4023964|FG000|STARTED|Overall Study||10
3290122|NCT02822950|4023964|FG000|COMPLETED|Overall Study||10
3290123|NCT02822950|4023964|FG000|NOT COMPLETED|Overall Study||0
3290124|NCT02823080|4023970|FG000|STARTED|Overall Study||24
3290125|NCT02823080|4023971|FG001|STARTED|Overall Study||24
3290126|NCT02823080|4023970|FG000|COMPLETED|Overall Study||24
3290127|NCT02823080|4023971|FG001|COMPLETED|Overall Study||24
3290128|NCT02823080|4023970|FG000|NOT COMPLETED|Overall Study||0
3290129|NCT02823080|4023971|FG001|NOT COMPLETED|Overall Study||0
3290130|NCT02823431|4023980|FG000|STARTED|Overall Study||11
3290131|NCT02823431|4023981|FG001|STARTED|Overall Study||12
3290132|NCT02823431|4023980|FG000|COMPLETED|Overall Study||11
3290133|NCT02823431|4023981|FG001|COMPLETED|Overall Study||12
3290134|NCT02823431|4023980|FG000|NOT COMPLETED|Overall Study||0
3290135|NCT02823431|4023981|FG001|NOT COMPLETED|Overall Study||0
3290136|NCT02823470|4023989|FG000|STARTED|Overall Study||9
3290137|NCT02823470|4023990|FG001|STARTED|Overall Study||15
3290138|NCT02823470|4023989|FG000|COMPLETED|Overall Study||0
3290139|NCT02823470|4023990|FG001|COMPLETED|Overall Study||0
3290140|NCT02823470|4023989|FG000|NOT COMPLETED|Overall Study||9
3290141|NCT02823470|4023990|FG001|NOT COMPLETED|Overall Study||15
3290142|NCT02823600|4023999|FG000|STARTED|Overall Study||68
3290143|NCT02823600|4023999|FG000|COMPLETED|Overall Study||68
3290144|NCT02823600|4023999|FG000|NOT COMPLETED|Overall Study||0
3095321|NCT01466491|3818154|FG003|STARTED|Overall Study||83
3290145|NCT02823964|4024005|FG000|STARTED|Overall Study||25
3290146|NCT02823964|4024005|FG000|COMPLETED|Overall Study||20
3290147|NCT02823964|4024005|FG000|NOT COMPLETED|Overall Study||5
3290148|NCT02824198|4024011|FG000|STARTED|Overall Study||89
3290149|NCT02824198|4024012|FG001|STARTED|Overall Study||29
3290150|NCT02824198|4024011|FG000|COMPLETED|Overall Study||74
3290151|NCT02824198|4024012|FG001|COMPLETED|Overall Study||26
3095322|NCT01466491|3818151|FG000|COMPLETED|Overall Study||83
3095323|NCT01466491|3818152|FG001|COMPLETED|Overall Study||80
3095324|NCT01466491|3818153|FG002|COMPLETED|Overall Study||80
3095325|NCT01466491|3818154|FG003|COMPLETED|Overall Study||83
3095326|NCT01466491|3818151|FG000|NOT COMPLETED|Overall Study||0
3095327|NCT01466491|3818152|FG001|NOT COMPLETED|Overall Study||3
3095328|NCT01466491|3818153|FG002|NOT COMPLETED|Overall Study||3
3095329|NCT01466491|3818154|FG003|NOT COMPLETED|Overall Study||0
3095330|NCT01466595|3818166|FG000|STARTED|Overall Study||49
3095331|NCT01466595|3818167|FG001|STARTED|Overall Study||24
3095332|NCT01466595|3818166|FG000|COMPLETED|Overall Study||49
3095333|NCT01466595|3818167|FG001|COMPLETED|Overall Study||23
3095334|NCT01466595|3818166|FG000|NOT COMPLETED|Overall Study||0
3095335|NCT01466595|3818167|FG001|NOT COMPLETED|Overall Study||1
3095336|NCT01466660|3818175|FG000|STARTED|Overall Study||160
3095337|NCT01466660|3818176|FG001|STARTED|Overall Study||159
3095338|NCT01466660|3818175|FG000|COMPLETED|Overall Study|On treatment at analysis cut-off date, 12 April 2019|0
3290152|NCT02824198|4024011|FG000|NOT COMPLETED|Overall Study||15
3290153|NCT02824198|4024012|FG001|NOT COMPLETED|Overall Study||3
3290154|NCT02824224|4024022|FG000|STARTED|Overall Study||19
3290155|NCT02824224|4024023|FG001|STARTED|Overall Study||18
3290156|NCT02824224|4024022|FG000|COMPLETED|Overall Study||17
3290157|NCT02824224|4024023|FG001|COMPLETED|Overall Study||17
3290158|NCT02824224|4024022|FG000|NOT COMPLETED|Overall Study||2
3290159|NCT02824224|4024023|FG001|NOT COMPLETED|Overall Study||1
3290160|NCT02824432|4024031|FG000|STARTED|Overall Study||18
3290161|NCT02824432|4024032|FG001|STARTED|Overall Study||19
3290162|NCT02824432|4024031|FG000|COMPLETED|Overall Study||17
3290163|NCT02824432|4024032|FG001|COMPLETED|Overall Study||19
3290164|NCT02824432|4024031|FG000|NOT COMPLETED|Overall Study||1
3290165|NCT02824432|4024032|FG001|NOT COMPLETED|Overall Study||0
3290166|NCT02824562|4024040|FG000|STARTED|Overall Study||22
3290167|NCT02824562|4024041|FG001|STARTED|Overall Study||22
3290168|NCT02824562|4024040|FG000|COMPLETED|Overall Study||19
3290169|NCT02824562|4024041|FG001|COMPLETED|Overall Study||17
3290170|NCT02824562|4024040|FG000|NOT COMPLETED|Overall Study||3
3290171|NCT02824562|4024041|FG001|NOT COMPLETED|Overall Study||5
3290172|NCT02824913|4024049|FG000|STARTED|First Intervention (1 Day)||1
3290173|NCT02824913|4024050|FG001|STARTED|First Intervention (1 Day)||0
3290174|NCT02824913|4024049|FG000|COMPLETED|First Intervention (1 Day)|Only one subject was enrolled in the study and received both study treatments.|1
3290175|NCT02824913|4024050|FG001|COMPLETED|First Intervention (1 Day)||0
3290176|NCT02824913|4024049|FG000|NOT COMPLETED|First Intervention (1 Day)||0
3290177|NCT02824913|4024050|FG001|NOT COMPLETED|First Intervention (1 Day)||0
3290178|NCT02824913|4024049|FG000|STARTED|Washout (7-14 Days)||1
3290179|NCT02824913|4024050|FG001|STARTED|Washout (7-14 Days)||0
3290180|NCT02824913|4024049|FG000|COMPLETED|Washout (7-14 Days)||1
3290181|NCT02824913|4024050|FG001|COMPLETED|Washout (7-14 Days)||0
3290182|NCT02824913|4024049|FG000|NOT COMPLETED|Washout (7-14 Days)||0
3290183|NCT02824913|4024050|FG001|NOT COMPLETED|Washout (7-14 Days)||0
3290184|NCT02824913|4024049|FG000|STARTED|Second Intervention (1 Day)||1
3290185|NCT02824913|4024050|FG001|STARTED|Second Intervention (1 Day)||0
3290186|NCT02824913|4024049|FG000|COMPLETED|Second Intervention (1 Day)||1
3290187|NCT02824913|4024050|FG001|COMPLETED|Second Intervention (1 Day)||0
3290188|NCT02824913|4024049|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
3290189|NCT02824913|4024050|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
3290190|NCT02825212|4024058|FG000|STARTED|Overall Study||10
3290191|NCT02825212|4024058|FG000|COMPLETED|Overall Study||10
3290192|NCT02825212|4024058|FG000|NOT COMPLETED|Overall Study||0
3290193|NCT02825251|4024064|FG000|STARTED|Overall Study||236
3290194|NCT02825251|4024065|FG001|STARTED|Overall Study||236
3290195|NCT02825251|4024064|FG000|COMPLETED|Overall Study||233
3290196|NCT02825251|4024065|FG001|COMPLETED|Overall Study||230
3290197|NCT02825251|4024064|FG000|NOT COMPLETED|Overall Study||3
3290198|NCT02825251|4024065|FG001|NOT COMPLETED|Overall Study||6
3290199|NCT02825420|4024073|FG000|STARTED|Overall Study||131
3290200|NCT02825420|4024074|FG001|STARTED|Overall Study||89
3290201|NCT02825420|4024073|FG000|COMPLETED|Overall Study||88
3290202|NCT02825420|4024074|FG001|COMPLETED|Overall Study||72
3290203|NCT02825420|4024073|FG000|NOT COMPLETED|Overall Study||43
3290204|NCT02825420|4024074|FG001|NOT COMPLETED|Overall Study||17
3290205|NCT02825550|4024085|FG000|STARTED|Overall Study||13
3290206|NCT02825550|4024085|FG000|COMPLETED|Overall Study||12
3290207|NCT02825550|4024085|FG000|NOT COMPLETED|Overall Study||1
3290208|NCT02825680|4024093|FG000|STARTED|Overall Study||82
3290209|NCT02825680|4024094|FG001|STARTED|Overall Study||55
3290210|NCT02825680|4024093|FG000|COMPLETED|Overall Study||82
3290211|NCT02825680|4024094|FG001|COMPLETED|Overall Study||39
3290212|NCT02825680|4024093|FG000|NOT COMPLETED|Overall Study||0
3290213|NCT02825680|4024094|FG001|NOT COMPLETED|Overall Study||16
3290214|NCT02825849|4024102|FG000|STARTED|Overall Study||22
3290215|NCT02825849|4024103|FG001|STARTED|Overall Study||5
3136807|NCT01715805|3862075|FG002|STARTED|Placebo + ADT Lead-in Period||0
3290216|NCT02825849|4024102|FG000|COMPLETED|Overall Study||22
3290217|NCT02825849|4024103|FG001|COMPLETED|Overall Study||5
3290218|NCT02825849|4024102|FG000|NOT COMPLETED|Overall Study||0
3290219|NCT02825849|4024103|FG001|NOT COMPLETED|Overall Study||0
3290220|NCT02825966|4024109|FG000|STARTED|Overall Study||35
3290221|NCT02825966|4024109|FG000|COMPLETED|Overall Study||35
3290222|NCT02825966|4024109|FG000|NOT COMPLETED|Overall Study||0
3095339|NCT01466660|3818176|FG001|COMPLETED|Overall Study|On treatment at analysis cut-off date, 12 April 2019|0
3095340|NCT01466660|3818175|FG000|NOT COMPLETED|Overall Study||160
3095341|NCT01466660|3818176|FG001|NOT COMPLETED|Overall Study||159
3095342|NCT01466673|3818184|FG000|STARTED|Overall Study||100
3095343|NCT01466673|3818185|FG001|STARTED|Overall Study||101
3095344|NCT01466673|3818184|FG000|COMPLETED|Overall Study||93
3095345|NCT01466673|3818185|FG001|COMPLETED|Overall Study||95
3095346|NCT01466673|3818184|FG000|NOT COMPLETED|Overall Study||7
3095347|NCT01466673|3818185|FG001|NOT COMPLETED|Overall Study||6
3095348|NCT01466751|3818193|FG000|STARTED|Overall Study||14
3095349|NCT01466751|3818194|FG001|STARTED|Overall Study||14
3095350|NCT01466751|3818193|FG000|COMPLETED|Overall Study||13
3095351|NCT01466751|3818194|FG001|COMPLETED|Overall Study||14
3095352|NCT01466751|3818193|FG000|NOT COMPLETED|Overall Study||1
3095353|NCT01466751|3818194|FG001|NOT COMPLETED|Overall Study||0
3095354|NCT01466764|3818204|FG000|STARTED|Overall Study||5
3095355|NCT01466764|3818205|FG001|STARTED|Overall Study||5
3095356|NCT01466764|3818204|FG000|COMPLETED|Overall Study||5
3095357|NCT01466764|3818205|FG001|COMPLETED|Overall Study||5
3095358|NCT01466764|3818204|FG000|NOT COMPLETED|Overall Study||0
3095359|NCT01466764|3818205|FG001|NOT COMPLETED|Overall Study||0
3095360|NCT01466790|3818219|FG000|STARTED|Overall Study|Not including 1 participant who was randomized to this group, but never received treatment.|24
3095361|NCT01466790|3818220|FG001|STARTED|Overall Study||15
3095362|NCT01466790|3818221|FG002|STARTED|Overall Study||27
3095363|NCT01466790|3818222|FG003|STARTED|Overall Study||14
3095364|NCT01466790|3818223|FG004|STARTED|Overall Study||30
3095365|NCT01466790|3818224|FG005|STARTED|Overall Study||16
3095366|NCT01466790|3818225|FG006|STARTED|Overall Study||27
3095367|NCT01466790|3818226|FG007|STARTED|Overall Study||14
3095368|NCT01466790|3818219|FG000|COMPLETED|Overall Study||20
3095369|NCT01466790|3818220|FG001|COMPLETED|Overall Study||14
3095370|NCT01466790|3818221|FG002|COMPLETED|Overall Study||27
3095371|NCT01466790|3818222|FG003|COMPLETED|Overall Study||14
3095372|NCT01466790|3818223|FG004|COMPLETED|Overall Study||27
3095373|NCT01466790|3818224|FG005|COMPLETED|Overall Study||16
3095374|NCT01466790|3818225|FG006|COMPLETED|Overall Study||26
3095375|NCT01466790|3818226|FG007|COMPLETED|Overall Study||13
3095376|NCT01466790|3818219|FG000|NOT COMPLETED|Overall Study||4
3095377|NCT01466790|3818220|FG001|NOT COMPLETED|Overall Study||1
3095378|NCT01466790|3818221|FG002|NOT COMPLETED|Overall Study||0
3095379|NCT01466790|3818222|FG003|NOT COMPLETED|Overall Study||0
3095380|NCT01466790|3818223|FG004|NOT COMPLETED|Overall Study||3
3095381|NCT01466790|3818224|FG005|NOT COMPLETED|Overall Study||0
3095382|NCT01466790|3818225|FG006|NOT COMPLETED|Overall Study||1
3095383|NCT01466790|3818226|FG007|NOT COMPLETED|Overall Study||1
3095384|NCT01466881|3818240|FG000|STARTED|Overall Study||42
3095385|NCT01466881|3818240|FG000|Eligible and Treated|Overall Study||37
3095386|NCT01466881|3818240|FG000|COMPLETED|Overall Study||2
3095387|NCT01466881|3818240|FG000|NOT COMPLETED|Overall Study||40
3095388|NCT01466972|3818246|FG000|STARTED|Overall Study||30
3095389|NCT01466972|3818246|FG000|COMPLETED|Overall Study||30
3095390|NCT01466972|3818246|FG000|NOT COMPLETED|Overall Study||0
3095391|NCT01466985|3818253|FG000|STARTED|Overall Study||6
3095392|NCT01466985|3818254|FG001|STARTED|Overall Study||6
3095393|NCT01466985|3818255|FG002|STARTED|Overall Study||6
3095394|NCT01466985|3818253|FG000|COMPLETED|Overall Study||6
3095395|NCT01466985|3818254|FG001|COMPLETED|Overall Study||6
3095396|NCT01466985|3818255|FG002|COMPLETED|Overall Study||6
3095397|NCT01466985|3818253|FG000|NOT COMPLETED|Overall Study||0
3095398|NCT01466985|3818254|FG001|NOT COMPLETED|Overall Study||0
3095399|NCT01466985|3818255|FG002|NOT COMPLETED|Overall Study||0
3095400|NCT01467037|3818266|FG000|STARTED|Overall Study||374
3095401|NCT01467037|3818266|FG000|COMPLETED|Overall Study||374
3095402|NCT01467037|3818266|FG000|NOT COMPLETED|Overall Study||0
3095403|NCT01467063|3818273|FG000|STARTED|Overall Study||6
3095404|NCT01467063|3818274|FG001|STARTED|Overall Study||7
3095405|NCT01467063|3818273|FG000|COMPLETED|Overall Study||5
3095406|NCT01467063|3818274|FG001|COMPLETED|Overall Study||7
3095407|NCT01467063|3818273|FG000|NOT COMPLETED|Overall Study||1
3095408|NCT01467063|3818274|FG001|NOT COMPLETED|Overall Study||0
3095409|NCT01467076|3818283|FG000|STARTED|Overall Study||3
3095410|NCT01467076|3818284|FG001|STARTED|Overall Study||2
3095411|NCT01467076|3818285|FG002|STARTED|Overall Study||2
3095412|NCT01467076|3818283|FG000|COMPLETED|Overall Study||2
3095413|NCT01467076|3818284|FG001|COMPLETED|Overall Study||2
3095414|NCT01467076|3818285|FG002|COMPLETED|Overall Study||2
3095415|NCT01467076|3818283|FG000|NOT COMPLETED|Overall Study||1
3095416|NCT01467076|3818284|FG001|NOT COMPLETED|Overall Study||0
3095417|NCT01467076|3818285|FG002|NOT COMPLETED|Overall Study||0
3095418|NCT01467271|3818293|FG000|STARTED|Overall Study||540
3095419|NCT01467271|3818293|FG000|COMPLETED|Overall Study||338
3095420|NCT01467271|3818293|FG000|NOT COMPLETED|Overall Study||202
3095421|NCT01467427|3818299|FG000|STARTED|Overall Study||12
3095422|NCT01467427|3818300|FG001|STARTED|Overall Study||13
3095423|NCT01467427|3818299|FG000|Completed Main Phase|Overall Study||11
3095424|NCT01467427|3818300|FG001|Completed Main Phase|Overall Study||13
3095425|NCT01467427|3818299|FG000|COMPLETED|Overall Study||0
3095426|NCT01467427|3818300|FG001|COMPLETED|Overall Study||0
3095427|NCT01467427|3818299|FG000|NOT COMPLETED|Overall Study||12
3095428|NCT01467427|3818300|FG001|NOT COMPLETED|Overall Study||13
3095429|NCT01467466|3818310|FG000|STARTED|Overall Study||1300
3095430|NCT01467466|3818311|FG001|STARTED|Overall Study||1292
3095431|NCT01467466|3818312|FG002|STARTED|Overall Study||1294
3095432|NCT01467466|3818313|FG003|STARTED|Overall Study||1291
3095433|NCT01467466|3818310|FG000|COMPLETED|Overall Study||1191
3095434|NCT01467466|3818311|FG001|COMPLETED|Overall Study||1188
3095435|NCT01467466|3818312|FG002|COMPLETED|Overall Study||1190
3095436|NCT01467466|3818313|FG003|COMPLETED|Overall Study||1203
3095437|NCT01467466|3818310|FG000|NOT COMPLETED|Overall Study||109
3095438|NCT01467466|3818311|FG001|NOT COMPLETED|Overall Study||104
3095439|NCT01467466|3818312|FG002|NOT COMPLETED|Overall Study||104
3095440|NCT01467466|3818313|FG003|NOT COMPLETED|Overall Study||88
3095441|NCT01467479|3818326|FG000|STARTED|Overall Study||55
3095442|NCT01467479|3818327|FG001|STARTED|Overall Study||69
3095443|NCT01467479|3818328|FG002|STARTED|Overall Study||61
3095444|NCT01467479|3818326|FG000|Treated|Overall Study||54
3095445|NCT01467479|3818327|FG001|Treated|Overall Study||69
3095446|NCT01467479|3818328|FG002|Treated|Overall Study||59
3095447|NCT01467479|3818326|FG000|COMPLETED|Overall Study||46
3095448|NCT01467479|3818327|FG001|COMPLETED|Overall Study||52
3095449|NCT01467479|3818328|FG002|COMPLETED|Overall Study||45
3095450|NCT01467479|3818326|FG000|NOT COMPLETED|Overall Study||9
3095451|NCT01467479|3818327|FG001|NOT COMPLETED|Overall Study||17
3095452|NCT01467479|3818328|FG002|NOT COMPLETED|Overall Study||16
3095453|NCT01467492|3818339|FG000|STARTED|Overall Study||83
3095454|NCT01467492|3818340|FG001|STARTED|Overall Study||38
3095455|NCT01467492|3818339|FG000|COMPLETED|Overall Study||61
3095456|NCT01467492|3818340|FG001|COMPLETED|Overall Study||25
3095457|NCT01467492|3818339|FG000|NOT COMPLETED|Overall Study||22
3095458|NCT01467492|3818340|FG001|NOT COMPLETED|Overall Study||13
3095459|NCT01467505|3818349|FG000|STARTED|Overall Study||51
3095460|NCT01467505|3818350|FG001|STARTED|Overall Study||10
3095461|NCT01467505|3818349|FG000|COMPLETED|Overall Study||18
3095462|NCT01467505|3818350|FG001|COMPLETED|Overall Study||7
3095463|NCT01467505|3818349|FG000|NOT COMPLETED|Overall Study||33
3095464|NCT01467505|3818350|FG001|NOT COMPLETED|Overall Study||3
3095465|NCT01467557|3818358|FG000|STARTED|Overall Study||601
3095466|NCT01467557|3818359|FG001|STARTED|Overall Study||570
3095467|NCT01467557|3818358|FG000|2 Week Survey Completed|Overall Study||551
3095468|NCT01467557|3818359|FG001|2 Week Survey Completed|Overall Study||522
3095469|NCT01467557|3818358|FG000|4 Month Survey Completed|Overall Study||533
3095470|NCT01467557|3818359|FG001|4 Month Survey Completed|Overall Study||493
3095471|NCT01467557|3818358|FG000|12 Month Survey Completed|Overall Study||502
3095472|NCT01467557|3818359|FG001|12 Month Survey Completed|Overall Study||463
3095473|NCT01467557|3818358|FG000|COMPLETED|Overall Study||502
3095474|NCT01467557|3818359|FG001|COMPLETED|Overall Study||463
3095475|NCT01467557|3818358|FG000|NOT COMPLETED|Overall Study||99
3095476|NCT01467557|3818359|FG001|NOT COMPLETED|Overall Study||107
3095477|NCT01467570|3818367|FG000|STARTED|Overall Study||75
3095478|NCT01467570|3818368|FG001|STARTED|Overall Study||72
3095479|NCT01467570|3818367|FG000|COMPLETED|Overall Study||67
3095480|NCT01467570|3818368|FG001|COMPLETED|Overall Study||63
3095481|NCT01467570|3818367|FG000|NOT COMPLETED|Overall Study||8
3095482|NCT01467570|3818368|FG001|NOT COMPLETED|Overall Study||9
3095483|NCT01467583|3818379|FG000|STARTED|Overall Study||16
3095484|NCT01467583|3818380|FG001|STARTED|Overall Study||4
3095485|NCT01467583|3818381|FG002|STARTED|Overall Study||12
3095486|NCT01467583|3818379|FG000|COMPLETED|Overall Study|Both patients completed > 1 dose and so their data was included in the results.|14
3095487|NCT01467583|3818380|FG001|COMPLETED|Overall Study|Death unrelated to study drug on day #3. Data to that point is included in the results|3
3095488|NCT01467583|3818381|FG002|COMPLETED|Overall Study||10
3095489|NCT01467583|3818379|FG000|NOT COMPLETED|Overall Study||2
3095490|NCT01467583|3818380|FG001|NOT COMPLETED|Overall Study||1
3095491|NCT01467583|3818381|FG002|NOT COMPLETED|Overall Study||2
3095492|NCT01467661|3818392|FG000|STARTED|Overall Study||53
3095493|NCT01467661|3818392|FG000|Completed SPD422-308 (NCT01214915)|Overall Study||42
3095494|NCT01467661|3818392|FG000|Started SPD422-309 (NCT01467661)|Overall Study||41
3095495|NCT01467661|3818392|FG000|Started Post Marketing Trial|Overall Study||33
3095496|NCT01467661|3818392|FG000|COMPLETED|Overall Study||32
3095497|NCT01467661|3818392|FG000|NOT COMPLETED|Overall Study||21
3095498|NCT01467700|3818402|FG000|STARTED|Overall Study||115
3095499|NCT01467700|3818403|FG001|STARTED|Overall Study||128
3095500|NCT01467700|3818404|FG002|STARTED|Overall Study||124
3095501|NCT01467700|3818405|FG003|STARTED|Overall Study||123
3095502|NCT01467700|3818402|FG000|Safety Set - Received Treatment|Overall Study||115
3095503|NCT01467700|3818403|FG001|Safety Set - Received Treatment|Overall Study||127
3095504|NCT01467700|3818404|FG002|Safety Set - Received Treatment|Overall Study||124
3095505|NCT01467700|3818405|FG003|Safety Set - Received Treatment|Overall Study||123
3095506|NCT01467700|3818402|FG000|COMPLETED|Overall Study||86
3095507|NCT01467700|3818403|FG001|COMPLETED|Overall Study||100
3095508|NCT01467700|3818404|FG002|COMPLETED|Overall Study||97
3095509|NCT01467700|3818405|FG003|COMPLETED|Overall Study||96
3095510|NCT01467700|3818402|FG000|NOT COMPLETED|Overall Study||29
3095511|NCT01467700|3818403|FG001|NOT COMPLETED|Overall Study||28
3095512|NCT01467700|3818404|FG002|NOT COMPLETED|Overall Study||27
3095513|NCT01467700|3818405|FG003|NOT COMPLETED|Overall Study||27
3095514|NCT01467713|3818419|FG000|STARTED|Overall Study||164
3095515|NCT01467713|3818420|FG001|STARTED|Overall Study||164
3095516|NCT01467713|3818421|FG002|STARTED|Overall Study||160
3095517|NCT01467713|3818422|FG003|STARTED|Overall Study||154
3095518|NCT01467713|3818419|FG000|Safety Analysis Set: Received Treatment|Overall Study||163
3095519|NCT01467713|3818420|FG001|Safety Analysis Set: Received Treatment|Overall Study||164
3095520|NCT01467713|3818421|FG002|Safety Analysis Set: Received Treatment|Overall Study||159
3095521|NCT01467713|3818422|FG003|Safety Analysis Set: Received Treatment|Overall Study||154
3095522|NCT01467713|3818419|FG000|COMPLETED|Overall Study||62
3095523|NCT01467713|3818420|FG001|COMPLETED|Overall Study||60
3095524|NCT01467713|3818421|FG002|COMPLETED|Overall Study||58
3095525|NCT01467713|3818422|FG003|COMPLETED|Overall Study||45
3095526|NCT01467713|3818419|FG000|NOT COMPLETED|Overall Study||102
3095527|NCT01467713|3818420|FG001|NOT COMPLETED|Overall Study||104
3095528|NCT01467713|3818421|FG002|NOT COMPLETED|Overall Study||102
3095529|NCT01467713|3818422|FG003|NOT COMPLETED|Overall Study||109
3095530|NCT01467882|3818432|FG000|STARTED|Overall Study||44
3095531|NCT01467882|3818432|FG000|COMPLETED|Overall Study||44
3095532|NCT01467882|3818432|FG000|NOT COMPLETED|Overall Study||0
3095533|NCT01467934|3818446|FG000|STARTED|Overall Study||208
3095534|NCT01467934|3818447|FG001|STARTED|Overall Study||212
3095535|NCT01467934|3818448|FG002|STARTED|Overall Study||110
3095536|NCT01467934|3818446|FG000|COMPLETED|Overall Study||208
3095537|NCT01467934|3818447|FG001|COMPLETED|Overall Study||212
3095538|NCT01467934|3818448|FG002|COMPLETED|Overall Study||110
3095539|NCT01467934|3818446|FG000|NOT COMPLETED|Overall Study||0
3095540|NCT01467934|3818447|FG001|NOT COMPLETED|Overall Study||0
3095541|NCT01467934|3818448|FG002|NOT COMPLETED|Overall Study||0
3095542|NCT01467947|3818456|FG000|STARTED|Overall Study||46
3095543|NCT01467947|3818456|FG000|COMPLETED|Overall Study||46
3095544|NCT01467947|3818456|FG000|NOT COMPLETED|Overall Study||0
3095545|NCT01467960|3818466|FG000|STARTED|Overall Study||30
3095546|NCT01467960|3818467|FG001|STARTED|Overall Study||30
3095547|NCT01467960|3818468|FG002|STARTED|Overall Study||30
3095548|NCT01467960|3818469|FG003|STARTED|Overall Study||30
3095549|NCT01467960|3818470|FG004|STARTED|Overall Study||30
3095550|NCT01467960|3818471|FG005|STARTED|Overall Study||30
3095551|NCT01467960|3818466|FG000|COMPLETED|Overall Study||30
3095552|NCT01467960|3818467|FG001|COMPLETED|Overall Study||30
3095553|NCT01467960|3818468|FG002|COMPLETED|Overall Study||30
3095554|NCT01467960|3818469|FG003|COMPLETED|Overall Study||0
3095555|NCT01467960|3818470|FG004|COMPLETED|Overall Study||0
3095556|NCT01467960|3818471|FG005|COMPLETED|Overall Study||0
3095557|NCT01467960|3818466|FG000|NOT COMPLETED|Overall Study||0
3095558|NCT01467960|3818467|FG001|NOT COMPLETED|Overall Study||0
3095559|NCT01467960|3818468|FG002|NOT COMPLETED|Overall Study||0
3095560|NCT01467960|3818469|FG003|NOT COMPLETED|Overall Study||30
3095561|NCT01467960|3818470|FG004|NOT COMPLETED|Overall Study||30
3095562|NCT01467960|3818471|FG005|NOT COMPLETED|Overall Study||30
3095563|NCT01467999|3818485|FG000|STARTED|Overall Study||22
3095564|NCT01467999|3818485|FG000|COMPLETED|Overall Study||9
3095565|NCT01467999|3818485|FG000|NOT COMPLETED|Overall Study||13
3095566|NCT01468012|3818492|FG000|STARTED|Overall Study||9
3095567|NCT01468012|3818493|FG001|STARTED|Overall Study||10
3095568|NCT01468012|3818494|FG002|STARTED|Overall Study||4
3095569|NCT01468012|3818492|FG000|COMPLETED|Overall Study||7
3095570|NCT01468012|3818493|FG001|COMPLETED|Overall Study||9
3095571|NCT01468012|3818494|FG002|COMPLETED|Overall Study||0
3095572|NCT01468012|3818492|FG000|NOT COMPLETED|Overall Study||2
3095573|NCT01468012|3818493|FG001|NOT COMPLETED|Overall Study||1
3095574|NCT01468012|3818494|FG002|NOT COMPLETED|Overall Study||4
3095575|NCT01468077|3818505|FG000|STARTED|Overall Study||22
3095576|NCT01468077|3818506|FG001|STARTED|Overall Study||25
3095577|NCT01468077|3818505|FG000|COMPLETED|Overall Study||18
3095578|NCT01468077|3818506|FG001|COMPLETED|Overall Study||22
3095579|NCT01468077|3818505|FG000|NOT COMPLETED|Overall Study||4
3095580|NCT01468077|3818506|FG001|NOT COMPLETED|Overall Study||3
3095581|NCT01468181|3818517|FG000|STARTED|Overall Study||131
3095582|NCT01468181|3818518|FG001|STARTED|Overall Study||61
3095583|NCT01468181|3818519|FG002|STARTED|Overall Study||65
3095584|NCT01468181|3818520|FG003|STARTED|Overall Study||66
3095585|NCT01468181|3818521|FG004|STARTED|Overall Study||71
3095586|NCT01468181|3818517|FG000|Received at Least 1 Dose of Study Drug|Overall Study||131
3095587|NCT01468181|3818518|FG001|Received at Least 1 Dose of Study Drug|Overall Study||61
3095588|NCT01468181|3818519|FG002|Received at Least 1 Dose of Study Drug|Overall Study||65
3095589|NCT01468181|3818520|FG003|Received at Least 1 Dose of Study Drug|Overall Study||66
3095590|NCT01468181|3818521|FG004|Received at Least 1 Dose of Study Drug|Overall Study||71
3095591|NCT01468181|3818517|FG000|COMPLETED|Overall Study||121
3095592|NCT01468181|3818518|FG001|COMPLETED|Overall Study||59
3095593|NCT01468181|3818519|FG002|COMPLETED|Overall Study||57
3095594|NCT01468181|3818520|FG003|COMPLETED|Overall Study||63
3095595|NCT01468181|3818521|FG004|COMPLETED|Overall Study||66
3095596|NCT01468181|3818517|FG000|NOT COMPLETED|Overall Study||10
3095597|NCT01468181|3818518|FG001|NOT COMPLETED|Overall Study||2
3095598|NCT01468181|3818519|FG002|NOT COMPLETED|Overall Study||8
3095599|NCT01468181|3818520|FG003|NOT COMPLETED|Overall Study||3
3095600|NCT01468181|3818521|FG004|NOT COMPLETED|Overall Study||5
3095601|NCT01468207|3818535|FG000|STARTED|Treatment Period 1||154
3095602|NCT01468207|3818536|FG001|STARTED|Treatment Period 1||153
3095603|NCT01468207|3818537|FG002|STARTED|Treatment Period 1||0
3095604|NCT01468207|3818538|FG003|STARTED|Treatment Period 1||0
3095605|NCT01468207|3818539|FG004|STARTED|Treatment Period 1||0
3095606|NCT01468207|3818540|FG005|STARTED|Treatment Period 1||0
3095607|NCT01468207|3818535|FG000|Received Study Drug|Treatment Period 1||152
3095608|NCT01468207|3818536|FG001|Received Study Drug|Treatment Period 1||153
3095609|NCT01468207|3818537|FG002|Received Study Drug|Treatment Period 1||0
3095610|NCT01468207|3818538|FG003|Received Study Drug|Treatment Period 1||0
3095611|NCT01468207|3818539|FG004|Received Study Drug|Treatment Period 1||0
3095612|NCT01468207|3818540|FG005|Received Study Drug|Treatment Period 1||0
3095613|NCT01468207|3818535|FG000|COMPLETED|Treatment Period 1||145
3095614|NCT01468207|3818536|FG001|COMPLETED|Treatment Period 1||145
3095615|NCT01468207|3818537|FG002|COMPLETED|Treatment Period 1||0
3095616|NCT01468207|3818538|FG003|COMPLETED|Treatment Period 1||0
3095617|NCT01468207|3818539|FG004|COMPLETED|Treatment Period 1||0
3095618|NCT01468207|3818540|FG005|COMPLETED|Treatment Period 1||0
3095619|NCT01468207|3818535|FG000|NOT COMPLETED|Treatment Period 1||9
3095620|NCT01468207|3818536|FG001|NOT COMPLETED|Treatment Period 1||8
3095621|NCT01468207|3818537|FG002|NOT COMPLETED|Treatment Period 1||0
3095622|NCT01468207|3818538|FG003|NOT COMPLETED|Treatment Period 1||0
3095623|NCT01468207|3818539|FG004|NOT COMPLETED|Treatment Period 1||0
3095624|NCT01468207|3818540|FG005|NOT COMPLETED|Treatment Period 1||0
3095625|NCT01468207|3818535|FG000|STARTED|Treatment Period 2||0
3095626|NCT01468207|3818536|FG001|STARTED|Treatment Period 2||0
3095627|NCT01468207|3818537|FG002|STARTED|Treatment Period 2||145
3095628|NCT01468207|3818538|FG003|STARTED|Treatment Period 2||49
3095629|NCT01468207|3818539|FG004|STARTED|Treatment Period 2||48
3095630|NCT01468207|3818540|FG005|STARTED|Treatment Period 2||48
3095631|NCT01468207|3818535|FG000|COMPLETED|Treatment Period 2||0
3095632|NCT01468207|3818536|FG001|COMPLETED|Treatment Period 2||0
3095633|NCT01468207|3818537|FG002|COMPLETED|Treatment Period 2||93
3095634|NCT01468207|3818538|FG003|COMPLETED|Treatment Period 2||22
3290223|NCT02825992|4024116|FG000|STARTED|Overall Study|The procedure was terminated for clinical reasons in 2 patients, therefore only 127 were treated.|129
3290224|NCT02825992|4024116|FG000|COMPLETED|Overall Study||121
3095635|NCT01468207|3818539|FG004|COMPLETED|Treatment Period 2||27
3095636|NCT01468207|3818540|FG005|COMPLETED|Treatment Period 2||28
3095637|NCT01468207|3818535|FG000|NOT COMPLETED|Treatment Period 2||0
3095638|NCT01468207|3818536|FG001|NOT COMPLETED|Treatment Period 2||0
3095639|NCT01468207|3818537|FG002|NOT COMPLETED|Treatment Period 2||52
3095640|NCT01468207|3818538|FG003|NOT COMPLETED|Treatment Period 2||27
3095641|NCT01468207|3818539|FG004|NOT COMPLETED|Treatment Period 2||21
3095642|NCT01468207|3818540|FG005|NOT COMPLETED|Treatment Period 2||20
3095643|NCT01468233|3818560|FG000|STARTED|Treatment Period 1||163
3095644|NCT01468233|3818561|FG001|STARTED|Treatment Period 1||163
3095645|NCT01468233|3818562|FG002|STARTED|Treatment Period 1||0
3095646|NCT01468233|3818563|FG003|STARTED|Treatment Period 1||0
3095647|NCT01468233|3818564|FG004|STARTED|Treatment Period 1||0
3095648|NCT01468233|3818565|FG005|STARTED|Treatment Period 1||0
3095649|NCT01468233|3818560|FG000|COMPLETED|Treatment Period 1||151
3095650|NCT01468233|3818561|FG001|COMPLETED|Treatment Period 1||155
3095651|NCT01468233|3818562|FG002|COMPLETED|Treatment Period 1||0
3095652|NCT01468233|3818563|FG003|COMPLETED|Treatment Period 1||0
3095653|NCT01468233|3818564|FG004|COMPLETED|Treatment Period 1||0
3095654|NCT01468233|3818565|FG005|COMPLETED|Treatment Period 1||0
3095655|NCT01468233|3818560|FG000|NOT COMPLETED|Treatment Period 1||12
3095656|NCT01468233|3818561|FG001|NOT COMPLETED|Treatment Period 1||8
3095657|NCT01468233|3818562|FG002|NOT COMPLETED|Treatment Period 1||0
3095658|NCT01468233|3818563|FG003|NOT COMPLETED|Treatment Period 1||0
3095659|NCT01468233|3818564|FG004|NOT COMPLETED|Treatment Period 1||0
3095660|NCT01468233|3818565|FG005|NOT COMPLETED|Treatment Period 1||0
3095661|NCT01468233|3818560|FG000|STARTED|Treatment Period 2||0
3095662|NCT01468233|3818561|FG001|STARTED|Treatment Period 2||0
3095663|NCT01468233|3818562|FG002|STARTED|Treatment Period 2||151
3095664|NCT01468233|3818563|FG003|STARTED|Treatment Period 2||51
3095665|NCT01468233|3818564|FG004|STARTED|Treatment Period 2||53
3095666|NCT01468233|3818565|FG005|STARTED|Treatment Period 2||51
3095667|NCT01468233|3818560|FG000|COMPLETED|Treatment Period 2||0
3095668|NCT01468233|3818561|FG001|COMPLETED|Treatment Period 2||0
3095669|NCT01468233|3818562|FG002|COMPLETED|Treatment Period 2||40
3095670|NCT01468233|3818563|FG003|COMPLETED|Treatment Period 2||23
3095671|NCT01468233|3818564|FG004|COMPLETED|Treatment Period 2||25
3095672|NCT01468233|3818565|FG005|COMPLETED|Treatment Period 2||28
3095673|NCT01468233|3818560|FG000|NOT COMPLETED|Treatment Period 2||0
3095674|NCT01468233|3818561|FG001|NOT COMPLETED|Treatment Period 2||0
3095675|NCT01468233|3818562|FG002|NOT COMPLETED|Treatment Period 2||111
3095676|NCT01468233|3818563|FG003|NOT COMPLETED|Treatment Period 2||28
3095677|NCT01468233|3818564|FG004|NOT COMPLETED|Treatment Period 2||28
3095678|NCT01468233|3818565|FG005|NOT COMPLETED|Treatment Period 2||23
3095679|NCT01468311|3818583|FG000|STARTED|Overall Study||6
3095680|NCT01468311|3818583|FG000|COMPLETED|Overall Study||4
3095681|NCT01468311|3818583|FG000|NOT COMPLETED|Overall Study||2
3095682|NCT01468337|3818587|FG000|STARTED|Overall Study||5
3095683|NCT01468337|3818587|FG000|Week 2|Overall Study||5
3095684|NCT01468337|3818587|FG000|Received Interferon Gamma-1b at Week 4|Overall Study|One participant received additional Interferon gamma-1b dosing at Week 4 and after Week 8|2
3095685|NCT01468337|3818587|FG000|Received Interferon Gamma-1b After Wk 8|Overall Study|Two participants had 2 Interferon gamma-1b dosing cycles after Wk 8|4
3095686|NCT01468337|3818587|FG000|Week 48|Overall Study|Two participants did not have a Week 48 visit but completed the study.|3
3095687|NCT01468337|3818587|FG000|COMPLETED|Overall Study||5
3095688|NCT01468337|3818587|FG000|NOT COMPLETED|Overall Study||0
3095689|NCT01468350|3818595|FG000|STARTED|(PART A) Day 1, Day 3||6
3095690|NCT01468350|3818596|FG001|STARTED|(PART A) Day 1, Day 3||5
3095691|NCT01468350|3818597|FG002|STARTED|(PART A) Day 1, Day 3||0
3095692|NCT01468350|3818598|FG003|STARTED|(PART A) Day 1, Day 3||0
3095693|NCT01468350|3818595|FG000|COMPLETED|(PART A) Day 1, Day 3||6
3095694|NCT01468350|3818596|FG001|COMPLETED|(PART A) Day 1, Day 3||5
3095695|NCT01468350|3818597|FG002|COMPLETED|(PART A) Day 1, Day 3||0
3095696|NCT01468350|3818598|FG003|COMPLETED|(PART A) Day 1, Day 3||0
3290225|NCT02825992|4024116|FG000|NOT COMPLETED|Overall Study||8
3290226|NCT02826421|4024130|FG000|STARTED|Overall Study||22
3290227|NCT02826421|4024131|FG001|STARTED|Overall Study||29
3290228|NCT02826421|4024132|FG002|STARTED|Overall Study||28
3290229|NCT02826421|4024133|FG003|STARTED|Overall Study||30
3290230|NCT02826421|4024130|FG000|Treated|Overall Study||19
3095697|NCT01468350|3818595|FG000|NOT COMPLETED|(PART A) Day 1, Day 3||0
3095698|NCT01468350|3818596|FG001|NOT COMPLETED|(PART A) Day 1, Day 3||0
3095699|NCT01468350|3818597|FG002|NOT COMPLETED|(PART A) Day 1, Day 3||0
3095700|NCT01468350|3818598|FG003|NOT COMPLETED|(PART A) Day 1, Day 3||0
3095701|NCT01468350|3818595|FG000|STARTED|(PART B) Day 1, Day 15||0
3095702|NCT01468350|3818596|FG001|STARTED|(PART B) Day 1, Day 15||0
3095703|NCT01468350|3818597|FG002|STARTED|(PART B) Day 1, Day 15||12
3095704|NCT01468350|3818598|FG003|STARTED|(PART B) Day 1, Day 15||12
3095705|NCT01468350|3818595|FG000|COMPLETED|(PART B) Day 1, Day 15||0
3095706|NCT01468350|3818596|FG001|COMPLETED|(PART B) Day 1, Day 15||0
3095707|NCT01468350|3818597|FG002|COMPLETED|(PART B) Day 1, Day 15||12
3095708|NCT01468350|3818598|FG003|COMPLETED|(PART B) Day 1, Day 15||12
3095709|NCT01468350|3818595|FG000|NOT COMPLETED|(PART B) Day 1, Day 15||0
3095710|NCT01468350|3818596|FG001|NOT COMPLETED|(PART B) Day 1, Day 15||0
3095711|NCT01468350|3818597|FG002|NOT COMPLETED|(PART B) Day 1, Day 15||0
3095712|NCT01468350|3818598|FG003|NOT COMPLETED|(PART B) Day 1, Day 15||0
3095713|NCT01468454|3818608|FG000|STARTED|Overall Study||128
3095714|NCT01468454|3818608|FG000|PETs Completed|Overall Study||128
3095715|NCT01468454|3818608|FG000|Had Both PET and Surgery|Overall Study||119
3095716|NCT01468454|3818608|FG000|COMPLETED|Overall Study||119
3095717|NCT01468454|3818608|FG000|NOT COMPLETED|Overall Study||9
3095718|NCT01468532|3818613|FG000|STARTED|Overall Study||18
3095719|NCT01468532|3818613|FG000|COMPLETED|Overall Study||18
3095720|NCT01468532|3818613|FG000|NOT COMPLETED|Overall Study||0
3095721|NCT01468558|3818617|FG000|STARTED|Overall Study||24
3095722|NCT01468558|3818617|FG000|COMPLETED|Overall Study||22
3095723|NCT01468558|3818617|FG000|NOT COMPLETED|Overall Study||2
3095724|NCT01468584|3818625|FG000|STARTED|Overall Study||10
3095725|NCT01468584|3818625|FG000|COMPLETED|Overall Study||10
3095726|NCT01468584|3818625|FG000|NOT COMPLETED|Overall Study||0
3095727|NCT01468597|3818629|FG000|STARTED|Overall Study||184
3095728|NCT01468597|3818629|FG000|COMPLETED|Overall Study||149
3095729|NCT01468597|3818629|FG000|NOT COMPLETED|Overall Study||35
3095730|NCT01468675|3818635|FG000|STARTED|Overall Study||2699
3095731|NCT01468675|3818636|FG001|STARTED|Overall Study||3376
3095732|NCT01468675|3818635|FG000|COMPLETED|Overall Study||1699
3095733|NCT01468675|3818636|FG001|COMPLETED|Overall Study||2004
3095734|NCT01468675|3818635|FG000|NOT COMPLETED|Overall Study||1000
3095735|NCT01468675|3818636|FG001|NOT COMPLETED|Overall Study||1372
3095736|NCT01468701|3818659|FG000|STARTED|Overall Study||4964
3095737|NCT01468701|3818660|FG001|STARTED|Overall Study||5103
3095738|NCT01468701|3818661|FG002|STARTED|Overall Study||1784
3095739|NCT01468701|3818662|FG003|STARTED|Overall Study||715
3095740|NCT01468701|3818663|FG004|STARTED|Overall Study||1736
3095741|NCT01468701|3818664|FG005|STARTED|Overall Study||128
3095742|NCT01468701|3818665|FG006|STARTED|Overall Study||1209
3095743|NCT01468701|3818666|FG007|STARTED|Overall Study||5
3095744|NCT01468701|3818667|FG008|STARTED|Overall Study||3879
3095745|NCT01468701|3818668|FG009|STARTED|Overall Study||4962
3095746|NCT01468701|3818669|FG010|STARTED|Overall Study||4054
3095747|NCT01468701|3818670|FG011|STARTED|Overall Study||4538
3095748|NCT01468701|3818671|FG012|STARTED|Overall Study||333
3095749|NCT01468701|3818672|FG013|STARTED|Overall Study||2182
3095750|NCT01468701|3818673|FG014|STARTED|Overall Study||214
3095751|NCT01468701|3818674|FG015|STARTED|Overall Study||1418
3095752|NCT01468701|3818675|FG016|STARTED|Overall Study||11
3095753|NCT01468701|3818659|FG000|All Eligible Patient|Overall Study||4873
3095754|NCT01468701|3818660|FG001|All Eligible Patient|Overall Study||4963
3095755|NCT01468701|3818661|FG002|All Eligible Patient|Overall Study||1755
3095756|NCT01468701|3818662|FG003|All Eligible Patient|Overall Study||703
3095757|NCT01468701|3818663|FG004|All Eligible Patient|Overall Study||1714
3095758|NCT01468701|3818664|FG005|All Eligible Patient|Overall Study||126
3095759|NCT01468701|3818665|FG006|All Eligible Patient|Overall Study||1170
3095760|NCT01468701|3818666|FG007|All Eligible Patient|Overall Study||4
3095761|NCT01468701|3818667|FG008|All Eligible Patient|Overall Study||3839
3095762|NCT01468701|3818668|FG009|All Eligible Patient|Overall Study||4836
3095763|NCT01468701|3818669|FG010|All Eligible Patient|Overall Study||4015
3095764|NCT01468701|3818670|FG011|All Eligible Patient|Overall Study||4505
3095765|NCT01468701|3818671|FG012|All Eligible Patient|Overall Study||332
3095766|NCT01468701|3818672|FG013|All Eligible Patient|Overall Study||2163
3095767|NCT01468701|3818673|FG014|All Eligible Patient|Overall Study||213
3095768|NCT01468701|3818674|FG015|All Eligible Patient|Overall Study||1386
3095769|NCT01468701|3818675|FG016|All Eligible Patient|Overall Study||11
3095770|NCT01468701|3818659|FG000|COMPLETED|Overall Study||3965
3095771|NCT01468701|3818660|FG001|COMPLETED|Overall Study||0
3095772|NCT01468701|3818661|FG002|COMPLETED|Overall Study||0
3095773|NCT01468701|3818662|FG003|COMPLETED|Overall Study||0
3095774|NCT01468701|3818663|FG004|COMPLETED|Overall Study||0
3095775|NCT01468701|3818664|FG005|COMPLETED|Overall Study||0
3095776|NCT01468701|3818665|FG006|COMPLETED|Overall Study||0
3095777|NCT01468701|3818666|FG007|COMPLETED|Overall Study||0
3095778|NCT01468701|3818667|FG008|COMPLETED|Overall Study||3219
3095779|NCT01468701|3818668|FG009|COMPLETED|Overall Study||3780
3095780|NCT01468701|3818669|FG010|COMPLETED|Overall Study||3256
2940887|NCT00639678|3653133|FG003|NOT COMPLETED|Overall Study||0
2940888|NCT00639717|3653145|FG000|STARTED|Overall Study||48
2940889|NCT00639717|3653145|FG000|COMPLETED|Overall Study||48
2940890|NCT00639717|3653145|FG000|NOT COMPLETED|Overall Study||0
2940891|NCT00639769|3653149|FG000|STARTED|Overall Study||40
2940892|NCT00639769|3653149|FG000|COMPLETED|Overall Study||0
2940893|NCT00639769|3653149|FG000|NOT COMPLETED|Overall Study||40
2940894|NCT00639860|3653153|FG000|STARTED|Overall Study||10
2940895|NCT00639860|3653153|FG000|COMPLETED|Overall Study||10
3095781|NCT01468701|3818670|FG011|COMPLETED|Overall Study||3672
3095782|NCT01468701|3818671|FG012|COMPLETED|Overall Study||284
3095783|NCT01468701|3818672|FG013|COMPLETED|Overall Study||1712
3095784|NCT01468701|3818673|FG014|COMPLETED|Overall Study||151
3095785|NCT01468701|3818674|FG015|COMPLETED|Overall Study||1056
3095786|NCT01468701|3818675|FG016|COMPLETED|Overall Study||10
3095787|NCT01468701|3818659|FG000|NOT COMPLETED|Overall Study||999
3095788|NCT01468701|3818660|FG001|NOT COMPLETED|Overall Study||5103
3095789|NCT01468701|3818661|FG002|NOT COMPLETED|Overall Study||1784
3095790|NCT01468701|3818662|FG003|NOT COMPLETED|Overall Study||715
3095791|NCT01468701|3818663|FG004|NOT COMPLETED|Overall Study||1736
3095792|NCT01468701|3818664|FG005|NOT COMPLETED|Overall Study||128
3095793|NCT01468701|3818665|FG006|NOT COMPLETED|Overall Study||1209
3095794|NCT01468701|3818666|FG007|NOT COMPLETED|Overall Study||5
3095795|NCT01468701|3818667|FG008|NOT COMPLETED|Overall Study||660
3095796|NCT01468701|3818668|FG009|NOT COMPLETED|Overall Study||1182
3095797|NCT01468701|3818669|FG010|NOT COMPLETED|Overall Study||798
3095798|NCT01468701|3818670|FG011|NOT COMPLETED|Overall Study||866
3095799|NCT01468701|3818671|FG012|NOT COMPLETED|Overall Study||49
3095800|NCT01468701|3818672|FG013|NOT COMPLETED|Overall Study||470
3095801|NCT01468701|3818673|FG014|NOT COMPLETED|Overall Study||63
3095802|NCT01468701|3818674|FG015|NOT COMPLETED|Overall Study||362
3095803|NCT01468701|3818675|FG016|NOT COMPLETED|Overall Study||1
3095804|NCT01468818|3818688|FG000|STARTED|Overall Study||18
3095805|NCT01468818|3818688|FG000|COMPLETED|Overall Study||16
3095806|NCT01468818|3818688|FG000|NOT COMPLETED|Overall Study||2
3095807|NCT01468844|3818694|FG000|STARTED|Overall Study||4
3095808|NCT01468844|3818695|FG001|STARTED|Overall Study||2
3095809|NCT01468844|3818694|FG000|COMPLETED|Overall Study||2
3095810|NCT01468844|3818695|FG001|COMPLETED|Overall Study||2
3095811|NCT01468844|3818694|FG000|NOT COMPLETED|Overall Study||2
3095812|NCT01468844|3818695|FG001|NOT COMPLETED|Overall Study||0
3095813|NCT01468896|3818706|FG000|STARTED|Overall Study||6
3095814|NCT01468896|3818707|FG001|STARTED|Overall Study||17
3095815|NCT01468896|3818706|FG000|COMPLETED|Overall Study||6
3095816|NCT01468896|3818707|FG001|COMPLETED|Overall Study||17
3095817|NCT01468896|3818706|FG000|NOT COMPLETED|Overall Study||0
3095818|NCT01468896|3818707|FG001|NOT COMPLETED|Overall Study||0
3095819|NCT01468909|3818716|FG000|STARTED|Overall Study||52
3095820|NCT01468909|3818717|FG001|STARTED|Overall Study||54
3095821|NCT01468909|3818716|FG000|COMPLETED|Overall Study||50
3095822|NCT01468909|3818717|FG001|COMPLETED|Overall Study||52
3095823|NCT01468909|3818716|FG000|NOT COMPLETED|Overall Study||2
3095824|NCT01468909|3818717|FG001|NOT COMPLETED|Overall Study||2
3095825|NCT01468974|3818723|FG000|STARTED|1 Month Follow-up|Intent-to-treat (ITT) population|35
3095826|NCT01468974|3818723|FG000|COMPLETED|1 Month Follow-up||34
3095827|NCT01468974|3818723|FG000|NOT COMPLETED|1 Month Follow-up||1
3095828|NCT01468974|3818723|FG000|STARTED|6 Months Follow-up||34
3095829|NCT01468974|3818723|FG000|COMPLETED|6 Months Follow-up||34
3095830|NCT01468974|3818723|FG000|NOT COMPLETED|6 Months Follow-up||0
3095831|NCT01468974|3818723|FG000|STARTED|1 Year Follow-up||34
3095832|NCT01468974|3818723|FG000|COMPLETED|1 Year Follow-up||34
3095833|NCT01468974|3818723|FG000|NOT COMPLETED|1 Year Follow-up||0
3095834|NCT01468974|3818723|FG000|STARTED|2 Years Follow-up||34
3095835|NCT01468974|3818723|FG000|COMPLETED|2 Years Follow-up||32
3095836|NCT01468974|3818723|FG000|NOT COMPLETED|2 Years Follow-up||2
3095837|NCT01468974|3818723|FG000|STARTED|3 Years Follow-up||32
3095838|NCT01468974|3818723|FG000|COMPLETED|3 Years Follow-up||26
3095839|NCT01468974|3818723|FG000|NOT COMPLETED|3 Years Follow-up||6
3095840|NCT01468987|3818729|FG000|STARTED|Overall Study||691
3095841|NCT01468987|3818730|FG001|STARTED|Overall Study||678
3095842|NCT01468987|3818729|FG000|Received at Least 1 Dose of Study Drug|Overall Study||691
3095843|NCT01468987|3818730|FG001|Received at Least 1 Dose of Study Drug|Overall Study||677
3095844|NCT01468987|3818729|FG000|COMPLETED|Overall Study||620
3095845|NCT01468987|3818730|FG001|COMPLETED|Overall Study||618
3095846|NCT01468987|3818729|FG000|NOT COMPLETED|Overall Study||71
3095847|NCT01468987|3818730|FG001|NOT COMPLETED|Overall Study||60
3095848|NCT01469000|3818740|FG000|STARTED|Overall Study||129
3095849|NCT01469000|3818741|FG001|STARTED|Overall Study||66
3095850|NCT01469000|3818740|FG000|Received at Least 1 Dose of Study Drug|Overall Study||126
3095851|NCT01469000|3818741|FG001|Received at Least 1 Dose of Study Drug|Overall Study||65
3095852|NCT01469000|3818740|FG000|COMPLETED|Overall Study||109
3095853|NCT01469000|3818741|FG001|COMPLETED|Overall Study||62
3095854|NCT01469000|3818740|FG000|NOT COMPLETED|Overall Study||20
3095855|NCT01469000|3818741|FG001|NOT COMPLETED|Overall Study||4
3095856|NCT01469013|3818752|FG000|STARTED|Part A (Treatment Period)||24
3095857|NCT01469013|3818753|FG001|STARTED|Part A (Treatment Period)||24
3095858|NCT01469013|3818754|FG002|STARTED|Part A (Treatment Period)||24
3095859|NCT01469013|3818755|FG003|STARTED|Part A (Treatment Period)||24
3095860|NCT01469013|3818756|FG004|STARTED|Part A (Treatment Period)||49
3095861|NCT01469013|3818757|FG005|STARTED|Part A (Treatment Period)||0
3095862|NCT01469013|3818758|FG006|STARTED|Part A (Treatment Period)||0
3095863|NCT01469013|3818759|FG007|STARTED|Part A (Treatment Period)||0
3095864|NCT01469013|3818760|FG008|STARTED|Part A (Treatment Period)||0
3095865|NCT01469013|3818761|FG009|STARTED|Part A (Treatment Period)||0
3095866|NCT01469013|3818762|FG010|STARTED|Part A (Treatment Period)||0
3095867|NCT01469013|3818763|FG011|STARTED|Part A (Treatment Period)||0
3095868|NCT01469013|3818764|FG012|STARTED|Part A (Treatment Period)||0
3095869|NCT01469013|3818752|FG000|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||24
3095870|NCT01469013|3818753|FG001|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||24
3095871|NCT01469013|3818754|FG002|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||24
3095872|NCT01469013|3818755|FG003|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||24
3095873|NCT01469013|3818756|FG004|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||49
3095874|NCT01469013|3818757|FG005|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0
3095875|NCT01469013|3818758|FG006|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0
3095876|NCT01469013|3818759|FG007|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0
3095877|NCT01469013|3818760|FG008|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0
3095878|NCT01469013|3818761|FG009|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0
3095879|NCT01469013|3818762|FG010|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0
3095880|NCT01469013|3818763|FG011|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0
3095881|NCT01469013|3818764|FG012|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0
3095882|NCT01469013|3818752|FG000|COMPLETED|Part A (Treatment Period)||23
3095883|NCT01469013|3818753|FG001|COMPLETED|Part A (Treatment Period)||24
3095884|NCT01469013|3818754|FG002|COMPLETED|Part A (Treatment Period)||23
3095885|NCT01469013|3818755|FG003|COMPLETED|Part A (Treatment Period)||24
3095886|NCT01469013|3818756|FG004|COMPLETED|Part A (Treatment Period)||48
3095887|NCT01469013|3818757|FG005|COMPLETED|Part A (Treatment Period)||0
3095888|NCT01469013|3818758|FG006|COMPLETED|Part A (Treatment Period)||0
3095889|NCT01469013|3818759|FG007|COMPLETED|Part A (Treatment Period)||0
3095890|NCT01469013|3818760|FG008|COMPLETED|Part A (Treatment Period)||0
3095891|NCT01469013|3818761|FG009|COMPLETED|Part A (Treatment Period)||0
3095892|NCT01469013|3818762|FG010|COMPLETED|Part A (Treatment Period)||0
3095893|NCT01469013|3818763|FG011|COMPLETED|Part A (Treatment Period)||0
3095894|NCT01469013|3818764|FG012|COMPLETED|Part A (Treatment Period)||0
3095895|NCT01469013|3818752|FG000|NOT COMPLETED|Part A (Treatment Period)||1
3095896|NCT01469013|3818753|FG001|NOT COMPLETED|Part A (Treatment Period)||0
3095897|NCT01469013|3818754|FG002|NOT COMPLETED|Part A (Treatment Period)||1
3095898|NCT01469013|3818755|FG003|NOT COMPLETED|Part A (Treatment Period)||0
3095899|NCT01469013|3818756|FG004|NOT COMPLETED|Part A (Treatment Period)||1
3095900|NCT01469013|3818757|FG005|NOT COMPLETED|Part A (Treatment Period)||0
3095901|NCT01469013|3818758|FG006|NOT COMPLETED|Part A (Treatment Period)||0
3095902|NCT01469013|3818759|FG007|NOT COMPLETED|Part A (Treatment Period)||0
3095903|NCT01469013|3818760|FG008|NOT COMPLETED|Part A (Treatment Period)||0
3095904|NCT01469013|3818761|FG009|NOT COMPLETED|Part A (Treatment Period)||0
3095905|NCT01469013|3818762|FG010|NOT COMPLETED|Part A (Treatment Period)||0
3095906|NCT01469013|3818763|FG011|NOT COMPLETED|Part A (Treatment Period)||0
3095907|NCT01469013|3818764|FG012|NOT COMPLETED|Part A (Treatment Period)||0
3095908|NCT01469013|3818752|FG000|STARTED|Part B (Extension Period)||0
3095909|NCT01469013|3818753|FG001|STARTED|Part B (Extension Period)||0
3095910|NCT01469013|3818754|FG002|STARTED|Part B (Extension Period)||0
3095911|NCT01469013|3818755|FG003|STARTED|Part B (Extension Period)||0
3095912|NCT01469013|3818756|FG004|STARTED|Part B (Extension Period)||0
3095913|NCT01469013|3818757|FG005|STARTED|Part B (Extension Period)||12
3095914|NCT01469013|3818758|FG006|STARTED|Part B (Extension Period)||12
3095915|NCT01469013|3818759|FG007|STARTED|Part B (Extension Period)||23
3095916|NCT01469013|3818760|FG008|STARTED|Part B (Extension Period)||24
3095917|NCT01469013|3818761|FG009|STARTED|Part B (Extension Period)||11
3095918|NCT01469013|3818762|FG010|STARTED|Part B (Extension Period)||12
3095919|NCT01469013|3818763|FG011|STARTED|Part B (Extension Period)||24
3095920|NCT01469013|3818764|FG012|STARTED|Part B (Extension Period)||24
3095921|NCT01469013|3818752|FG000|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||0
3095922|NCT01469013|3818753|FG001|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||0
3095923|NCT01469013|3818754|FG002|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||0
3095924|NCT01469013|3818755|FG003|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||0
3095925|NCT01469013|3818756|FG004|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||0
3095926|NCT01469013|3818757|FG005|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||12
3095927|NCT01469013|3818758|FG006|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||12
3095928|NCT01469013|3818759|FG007|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||23
3095929|NCT01469013|3818760|FG008|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||24
3095930|NCT01469013|3818761|FG009|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||11
3095931|NCT01469013|3818762|FG010|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||12
3095932|NCT01469013|3818763|FG011|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||24
3095933|NCT01469013|3818764|FG012|Received at Least 1 Dose of Study Drug|Part B (Extension Period)|1 participant discontinued prior to receiving study drug|23
3095934|NCT01469013|3818752|FG000|COMPLETED|Part B (Extension Period)||0
3095935|NCT01469013|3818753|FG001|COMPLETED|Part B (Extension Period)||0
3095936|NCT01469013|3818754|FG002|COMPLETED|Part B (Extension Period)||0
3095937|NCT01469013|3818755|FG003|COMPLETED|Part B (Extension Period)||0
3095938|NCT01469013|3818756|FG004|COMPLETED|Part B (Extension Period)||0
3095939|NCT01469013|3818757|FG005|COMPLETED|Part B (Extension Period)||10
3095940|NCT01469013|3818758|FG006|COMPLETED|Part B (Extension Period)||7
3095941|NCT01469013|3818759|FG007|COMPLETED|Part B (Extension Period)||18
3095942|NCT01469013|3818760|FG008|COMPLETED|Part B (Extension Period)||20
3095943|NCT01469013|3818761|FG009|COMPLETED|Part B (Extension Period)||8
3095944|NCT01469013|3818762|FG010|COMPLETED|Part B (Extension Period)||10
3095945|NCT01469013|3818763|FG011|COMPLETED|Part B (Extension Period)||18
3095946|NCT01469013|3818764|FG012|COMPLETED|Part B (Extension Period)||18
3095947|NCT01469013|3818752|FG000|NOT COMPLETED|Part B (Extension Period)||0
3095948|NCT01469013|3818753|FG001|NOT COMPLETED|Part B (Extension Period)||0
3095949|NCT01469013|3818754|FG002|NOT COMPLETED|Part B (Extension Period)||0
3095950|NCT01469013|3818755|FG003|NOT COMPLETED|Part B (Extension Period)||0
3095951|NCT01469013|3818756|FG004|NOT COMPLETED|Part B (Extension Period)||0
3095952|NCT01469013|3818757|FG005|NOT COMPLETED|Part B (Extension Period)||2
3095953|NCT01469013|3818758|FG006|NOT COMPLETED|Part B (Extension Period)||5
3095954|NCT01469013|3818759|FG007|NOT COMPLETED|Part B (Extension Period)||5
3095955|NCT01469013|3818760|FG008|NOT COMPLETED|Part B (Extension Period)||4
3095956|NCT01469013|3818761|FG009|NOT COMPLETED|Part B (Extension Period)||3
3095957|NCT01469013|3818762|FG010|NOT COMPLETED|Part B (Extension Period)||2
3095958|NCT01469013|3818763|FG011|NOT COMPLETED|Part B (Extension Period)||6
3095959|NCT01469013|3818764|FG012|NOT COMPLETED|Part B (Extension Period)||6
3095960|NCT01469039|3818794|FG000|STARTED|Overall Study||207
3095961|NCT01469039|3818795|FG001|STARTED|Overall Study||208
3095962|NCT01469039|3818796|FG002|STARTED|Overall Study||208
3095963|NCT01469039|3818794|FG000|COMPLETED|Overall Study||130
3095964|NCT01469039|3818795|FG001|COMPLETED|Overall Study||135
3095965|NCT01469039|3818796|FG002|COMPLETED|Overall Study||95
3095966|NCT01469039|3818794|FG000|NOT COMPLETED|Overall Study||77
3095967|NCT01469039|3818795|FG001|NOT COMPLETED|Overall Study||73
3095968|NCT01469039|3818796|FG002|NOT COMPLETED|Overall Study||113
3095969|NCT01469052|3818810|FG000|STARTED|Overall Study||6
3095970|NCT01469052|3818811|FG001|STARTED|Overall Study||4
3095971|NCT01469052|3818812|FG002|STARTED|Overall Study||6
3095972|NCT01469052|3818813|FG003|STARTED|Overall Study||6
3095973|NCT01469052|3818814|FG004|STARTED|Overall Study||8
3095974|NCT01469052|3818815|FG005|STARTED|Overall Study||6
3095975|NCT01469052|3818810|FG000|COMPLETED|Overall Study||0
3095976|NCT01469052|3818811|FG001|COMPLETED|Overall Study||0
3095977|NCT01469052|3818812|FG002|COMPLETED|Overall Study||0
3095978|NCT01469052|3818813|FG003|COMPLETED|Overall Study||1
3095979|NCT01469052|3818814|FG004|COMPLETED|Overall Study||0
3095980|NCT01469052|3818815|FG005|COMPLETED|Overall Study||0
3095981|NCT01469052|3818810|FG000|NOT COMPLETED|Overall Study||6
3095982|NCT01469052|3818811|FG001|NOT COMPLETED|Overall Study||4
3095983|NCT01469052|3818812|FG002|NOT COMPLETED|Overall Study||6
3095984|NCT01469052|3818813|FG003|NOT COMPLETED|Overall Study||5
3095985|NCT01469052|3818814|FG004|NOT COMPLETED|Overall Study||8
3095986|NCT01469052|3818815|FG005|NOT COMPLETED|Overall Study||6
3095987|NCT01469065|3818832|FG000|STARTED|Overall Study||16
3095988|NCT01469065|3818833|FG001|STARTED|Overall Study||17
3095989|NCT01469065|3818834|FG002|STARTED|Overall Study||16
3095990|NCT01469065|3818835|FG003|STARTED|Overall Study||16
3095991|NCT01469065|3818836|FG004|STARTED|Overall Study||17
3095992|NCT01469065|3818832|FG000|COMPLETED|Overall Study||16
3095993|NCT01469065|3818833|FG001|COMPLETED|Overall Study||16
3095994|NCT01469065|3818834|FG002|COMPLETED|Overall Study||16
3095995|NCT01469065|3818835|FG003|COMPLETED|Overall Study||16
3095996|NCT01469065|3818836|FG004|COMPLETED|Overall Study||16
3095997|NCT01469065|3818832|FG000|NOT COMPLETED|Overall Study||0
3095998|NCT01469065|3818833|FG001|NOT COMPLETED|Overall Study||1
3095999|NCT01469065|3818834|FG002|NOT COMPLETED|Overall Study||0
3096000|NCT01469065|3818835|FG003|NOT COMPLETED|Overall Study||0
3096001|NCT01469065|3818836|FG004|NOT COMPLETED|Overall Study||1
3096002|NCT01469182|3818854|FG000|STARTED|Overall Study||610
3096003|NCT01469182|3818855|FG001|STARTED|Overall Study||304
3096004|NCT01469182|3818854|FG000|Treated|Overall Study||609
3096005|NCT01469182|3818855|FG001|Treated|Overall Study||304
3096006|NCT01469182|3818854|FG000|COMPLETED|Overall Study||575
3096007|NCT01469182|3818855|FG001|COMPLETED|Overall Study||298
3096008|NCT01469182|3818854|FG000|NOT COMPLETED|Overall Study||35
3096009|NCT01469182|3818855|FG001|NOT COMPLETED|Overall Study||6
3096010|NCT01469221|3818863|FG000|STARTED|Open Label Phase||0
3096011|NCT01469221|3818864|FG001|STARTED|Open Label Phase||0
3096012|NCT01469221|3818865|FG002|STARTED|Open Label Phase||47
3096013|NCT01469221|3818863|FG000|COMPLETED|Open Label Phase||0
3096014|NCT01469221|3818864|FG001|COMPLETED|Open Label Phase||0
3096015|NCT01469221|3818865|FG002|COMPLETED|Open Label Phase||44
3096016|NCT01469221|3818863|FG000|NOT COMPLETED|Open Label Phase||0
3096017|NCT01469221|3818864|FG001|NOT COMPLETED|Open Label Phase||0
3096018|NCT01469221|3818865|FG002|NOT COMPLETED|Open Label Phase||3
3096019|NCT01469221|3818863|FG000|STARTED|Double Blind Phase||14
3096020|NCT01469221|3818864|FG001|STARTED|Double Blind Phase||17
3096021|NCT01469221|3818865|FG002|STARTED|Double Blind Phase||0
3096022|NCT01469221|3818863|FG000|COMPLETED|Double Blind Phase||0
3096023|NCT01469221|3818864|FG001|COMPLETED|Double Blind Phase||0
3096024|NCT01469221|3818865|FG002|COMPLETED|Double Blind Phase||0
3096025|NCT01469221|3818863|FG000|NOT COMPLETED|Double Blind Phase||14
3096026|NCT01469221|3818864|FG001|NOT COMPLETED|Double Blind Phase||17
3096027|NCT01469221|3818865|FG002|NOT COMPLETED|Double Blind Phase||0
3135176|NCT01705080|3860143|FG001|Discharge Following Renal Artery Ablation Procedure|Overall Study|Reason Not Completed: Withdrawal by Subject=1|100
3135177|NCT01705080|3860144|FG002|Discharge Following Renal Artery Ablation Procedure|Overall Study||28
3135178|NCT01705080|3860142|FG000|COMPLETED|Overall Study||72
3135179|NCT01705080|3860143|FG001|COMPLETED|Overall Study||49
3135180|NCT01705080|3860144|FG002|COMPLETED|Overall Study||12
3135181|NCT01705080|3860142|FG000|NOT COMPLETED|Overall Study||75
3135182|NCT01705080|3860143|FG001|NOT COMPLETED|Overall Study||52
3135183|NCT01705080|3860144|FG002|NOT COMPLETED|Overall Study||16
3135184|NCT01705145|3860152|FG000|STARTED|Part A||9
3135185|NCT01705145|3860152|FG000|COMPLETED|Part A||9
3135186|NCT01705145|3860152|FG000|NOT COMPLETED|Part A||0
3135187|NCT01705145|3860152|FG000|STARTED|Part B|Eight participants from Part A continued in Part B of the study.|34
3135188|NCT01705145|3860152|FG000|COMPLETED|Part B||33
3135189|NCT01705145|3860152|FG000|NOT COMPLETED|Part B||1
3135190|NCT01705236|3860168|FG000|STARTED|Overall Study||87
3135191|NCT01705236|3860168|FG000|COMPLETED|Overall Study||60
3135192|NCT01705236|3860168|FG000|NOT COMPLETED|Overall Study||27
3135193|NCT01705288|3860174|FG000|STARTED|Overall Study||52
3135194|NCT01705288|3860175|FG001|STARTED|Overall Study||51
3135195|NCT01705288|3860174|FG000|COMPLETED|Overall Study||52
3135196|NCT01705288|3860175|FG001|COMPLETED|Overall Study||51
3135197|NCT01705288|3860174|FG000|NOT COMPLETED|Overall Study||0
3135198|NCT01705288|3860175|FG001|NOT COMPLETED|Overall Study||0
3135199|NCT01705496|3860181|FG000|STARTED|Overall Study||23
3135200|NCT01705496|3860181|FG000|COMPLETED|Overall Study||19
3135201|NCT01705496|3860181|FG000|NOT COMPLETED|Overall Study||4
3135202|NCT01705509|3860185|FG000|STARTED|Inclusion CPET||14
3135203|NCT01705509|3860185|FG000|COMPLETED|Inclusion CPET||7
3135204|NCT01705509|3860185|FG000|NOT COMPLETED|Inclusion CPET||7
3135205|NCT01705509|3860185|FG000|STARTED|CPET w/ Ranexa||7
3135206|NCT01705509|3860185|FG000|COMPLETED|CPET w/ Ranexa||5
3135207|NCT01705509|3860185|FG000|NOT COMPLETED|CPET w/ Ranexa||2
3135208|NCT01705574|3860191|FG000|STARTED|Double-Blind Phase||293
3135209|NCT01705574|3860192|FG001|STARTED|Double-Blind Phase||290
3135210|NCT01705574|3860193|FG002|STARTED|Double-Blind Phase||0
3135211|NCT01705574|3860194|FG003|STARTED|Double-Blind Phase||0
3135212|NCT01705574|3860191|FG000|COMPLETED|Double-Blind Phase||260
3135213|NCT01705574|3860192|FG001|COMPLETED|Double-Blind Phase||249
3135214|NCT01705574|3860193|FG002|COMPLETED|Double-Blind Phase||0
3135215|NCT01705574|3860194|FG003|COMPLETED|Double-Blind Phase||0
3135216|NCT01705574|3860191|FG000|NOT COMPLETED|Double-Blind Phase||33
3135217|NCT01705574|3860192|FG001|NOT COMPLETED|Double-Blind Phase||41
3135218|NCT01705574|3860193|FG002|NOT COMPLETED|Double-Blind Phase||0
3135219|NCT01705574|3860194|FG003|NOT COMPLETED|Double-Blind Phase||0
3135220|NCT01705574|3860191|FG000|STARTED|Open-Label Extension Phase||246
3135221|NCT01705574|3860192|FG001|STARTED|Open-Label Extension Phase|Participants either entered the OL GEN arm or OL ATV+RTV+TVD arm.|0
3135222|NCT01705574|3860193|FG002|STARTED|Open-Label Extension Phase|159 participants entered from the DB ATV+RTV+TVD arm.|159
3135223|NCT01705574|3860194|FG003|STARTED|Open-Label Extension Phase|53 participants entered from the DB ATV+ RTV + TVD arm.|53
3135224|NCT01705574|3860191|FG000|COMPLETED|Open-Label Extension Phase||231
3135225|NCT01705574|3860192|FG001|COMPLETED|Open-Label Extension Phase||0
3135226|NCT01705574|3860193|FG002|COMPLETED|Open-Label Extension Phase||148
3135227|NCT01705574|3860194|FG003|COMPLETED|Open-Label Extension Phase||48
3135228|NCT01705574|3860191|FG000|NOT COMPLETED|Open-Label Extension Phase||15
3135229|NCT01705574|3860192|FG001|NOT COMPLETED|Open-Label Extension Phase||0
3135230|NCT01705574|3860193|FG002|NOT COMPLETED|Open-Label Extension Phase||11
3135231|NCT01705574|3860194|FG003|NOT COMPLETED|Open-Label Extension Phase||5
3135232|NCT01705587|3860212|FG000|STARTED|Overall Study||7
3135233|NCT01705587|3860213|FG001|STARTED|Overall Study||6
3135234|NCT01705587|3860212|FG000|COMPLETED|Overall Study||7
3135235|NCT01705587|3860213|FG001|COMPLETED|Overall Study||5
3135236|NCT01705587|3860212|FG000|NOT COMPLETED|Overall Study||0
3135237|NCT01705587|3860213|FG001|NOT COMPLETED|Overall Study||1
3135238|NCT01705652|3860221|FG000|STARTED|Overall Study||9
3135239|NCT01705652|3860222|FG001|STARTED|Overall Study||12
3135240|NCT01705652|3860221|FG000|COMPLETED|Overall Study||6
3135241|NCT01705652|3860222|FG001|COMPLETED|Overall Study||9
3135242|NCT01705652|3860221|FG000|NOT COMPLETED|Overall Study||3
3135243|NCT01705652|3860222|FG001|NOT COMPLETED|Overall Study||3
3135244|NCT01705691|3860230|FG000|STARTED|Overall Study||19
3135245|NCT01705691|3860231|FG001|STARTED|Overall Study||30
3135246|NCT01705691|3860230|FG000|COMPLETED|Overall Study||16
3135247|NCT01705691|3860231|FG001|COMPLETED|Overall Study||24
3135248|NCT01705691|3860230|FG000|NOT COMPLETED|Overall Study||3
3135249|NCT01705691|3860231|FG001|NOT COMPLETED|Overall Study||6
3135250|NCT01705717|3860239|FG000|STARTED|Overall Study||37
3135251|NCT01705717|3860240|FG001|STARTED|Overall Study||12
3135252|NCT01705717|3860239|FG000|COMPLETED|Overall Study||35
3135253|NCT01705717|3860240|FG001|COMPLETED|Overall Study||7
3135254|NCT01705717|3860239|FG000|NOT COMPLETED|Overall Study||2
3135255|NCT01705717|3860240|FG001|NOT COMPLETED|Overall Study||5
3096028|NCT01469234|3818875|FG000|STARTED|Overall Study||85
3096029|NCT01469234|3818876|FG001|STARTED|Overall Study||85
3096030|NCT01469234|3818877|FG002|STARTED|Overall Study||85
3096031|NCT01469234|3818875|FG000|COMPLETED|Overall Study||85
3096032|NCT01469234|3818876|FG001|COMPLETED|Overall Study||85
3096033|NCT01469234|3818877|FG002|COMPLETED|Overall Study||85
3096034|NCT01469234|3818875|FG000|NOT COMPLETED|Overall Study||0
3096035|NCT01469234|3818876|FG001|NOT COMPLETED|Overall Study||0
3096036|NCT01469234|3818877|FG002|NOT COMPLETED|Overall Study||0
3096037|NCT01469364|3818885|FG000|STARTED|Overall Study||30
3096038|NCT01469364|3818885|FG000|COMPLETED|Overall Study||28
3096039|NCT01469364|3818885|FG000|NOT COMPLETED|Overall Study||2
3096040|NCT01469377|3818892|FG000|STARTED|Overall Study||269
3096041|NCT01469377|3818893|FG001|STARTED|Overall Study||274
3096042|NCT01469377|3818894|FG002|STARTED|Overall Study||276
3096043|NCT01469377|3818892|FG000|COMPLETED|Overall Study||234
3096044|NCT01469377|3818893|FG001|COMPLETED|Overall Study||226
3096045|NCT01469377|3818894|FG002|COMPLETED|Overall Study||210
3096046|NCT01469377|3818892|FG000|NOT COMPLETED|Overall Study||35
3096047|NCT01469377|3818893|FG001|NOT COMPLETED|Overall Study||48
3096048|NCT01469377|3818894|FG002|NOT COMPLETED|Overall Study||66
3096049|NCT01469546|3818902|FG000|STARTED|Received 5 mg Dose||42
3096050|NCT01469546|3818902|FG000|Completed First Cycle|Received 5 mg Dose||30
3096051|NCT01469546|3818902|FG000|COMPLETED|Received 5 mg Dose||19
3096052|NCT01469546|3818902|FG000|NOT COMPLETED|Received 5 mg Dose||23
3096053|NCT01469546|3818902|FG000|STARTED|Dose Escalation to 10 mg||19
3096054|NCT01469546|3818902|FG000|COMPLETED|Dose Escalation to 10 mg||19
3096055|NCT01469546|3818902|FG000|NOT COMPLETED|Dose Escalation to 10 mg||0
3096056|NCT01469585|3818908|FG000|STARTED|Overall Study||11
3096057|NCT01469585|3818909|FG001|STARTED|Overall Study||9
3096058|NCT01469585|3818908|FG000|COMPLETED|Overall Study||4
3096059|NCT01469585|3818909|FG001|COMPLETED|Overall Study||6
3096060|NCT01469585|3818908|FG000|NOT COMPLETED|Overall Study||7
3096061|NCT01469585|3818909|FG001|NOT COMPLETED|Overall Study||3
3096062|NCT01469637|3818919|FG000|STARTED|First Intervention||22
3096063|NCT01469637|3818920|FG001|STARTED|First Intervention||22
3096064|NCT01469637|3818919|FG000|COMPLETED|First Intervention||22
3096065|NCT01469637|3818920|FG001|COMPLETED|First Intervention||21
3096066|NCT01469637|3818919|FG000|NOT COMPLETED|First Intervention||0
3096067|NCT01469637|3818920|FG001|NOT COMPLETED|First Intervention||1
3096068|NCT01469637|3818919|FG000|STARTED|Second Intervention||22
3096069|NCT01469637|3818920|FG001|STARTED|Second Intervention||21
3096070|NCT01469637|3818919|FG000|COMPLETED|Second Intervention||21
3096071|NCT01469637|3818920|FG001|COMPLETED|Second Intervention||21
3096072|NCT01469637|3818919|FG000|NOT COMPLETED|Second Intervention||1
3096073|NCT01469637|3818920|FG001|NOT COMPLETED|Second Intervention||0
3096074|NCT01469715|3818926|FG000|STARTED|Overall Study||16
3096075|NCT01469715|3818926|FG000|COMPLETED|Overall Study||16
3096076|NCT01469715|3818926|FG000|NOT COMPLETED|Overall Study||0
3096077|NCT01469767|3818930|FG000|STARTED|Overall Study||10
3096078|NCT01469767|3818930|FG000|COMPLETED|Overall Study||10
3096079|NCT01469767|3818930|FG000|NOT COMPLETED|Overall Study||0
3096080|NCT01469819|3818934|FG000|STARTED|Overall Study||37
3096081|NCT01469819|3818934|FG000|COMPLETED|Overall Study||29
3096082|NCT01469819|3818934|FG000|NOT COMPLETED|Overall Study||8
3096083|NCT01470001|3818946|FG000|STARTED|Overall Study||58
3096084|NCT01470001|3818947|FG001|STARTED|Overall Study||60
3096085|NCT01470001|3818946|FG000|COMPLETED|Overall Study||53
3096086|NCT01470001|3818947|FG001|COMPLETED|Overall Study||58
3096087|NCT01470001|3818946|FG000|NOT COMPLETED|Overall Study||5
3096088|NCT01470001|3818947|FG001|NOT COMPLETED|Overall Study||2
3096089|NCT01470027|3818959|FG000|STARTED|Overall Study||16
3096090|NCT01470027|3818960|FG001|STARTED|Overall Study||15
3096091|NCT01470027|3818961|FG002|STARTED|Overall Study||16
3096092|NCT01470027|3818959|FG000|COMPLETED|Overall Study||15
3096093|NCT01470027|3818960|FG001|COMPLETED|Overall Study||14
3096094|NCT01470027|3818961|FG002|COMPLETED|Overall Study||15
3096095|NCT01470027|3818959|FG000|NOT COMPLETED|Overall Study||1
3096096|NCT01470027|3818960|FG001|NOT COMPLETED|Overall Study||1
3096097|NCT01470027|3818961|FG002|NOT COMPLETED|Overall Study||1
3096098|NCT01470118|3818978|FG000|STARTED|Overall Study||43
3096099|NCT01470118|3818979|FG001|STARTED|Overall Study||43
3096100|NCT01470118|3818980|FG002|STARTED|Overall Study||41
3096101|NCT01470118|3818978|FG000|COMPLETED|Overall Study||38
3096102|NCT01470118|3818979|FG001|COMPLETED|Overall Study||38
3096103|NCT01470118|3818980|FG002|COMPLETED|Overall Study||39
3096104|NCT01470118|3818978|FG000|NOT COMPLETED|Overall Study||5
3096105|NCT01470118|3818979|FG001|NOT COMPLETED|Overall Study||5
3096106|NCT01470118|3818980|FG002|NOT COMPLETED|Overall Study||2
3096107|NCT01470144|3818988|FG000|STARTED|Overall Study||41
3096108|NCT01470144|3818988|FG000|COMPLETED|Overall Study|"Completed corresponds to subjects switching to commercial EFI upon market approval/reimbursement"|31
3096109|NCT01470144|3818988|FG000|NOT COMPLETED|Overall Study||10
3096110|NCT01470170|3818997|FG000|STARTED|Overall Study||34
3096111|NCT01470170|3818998|FG001|STARTED|Overall Study||35
3096112|NCT01470170|3818999|FG002|STARTED|Overall Study||34
3096113|NCT01470170|3819000|FG003|STARTED|Overall Study||36
3096114|NCT01470170|3819001|FG004|STARTED|Overall Study||34
3096115|NCT01470170|3818997|FG000|COMPLETED|Overall Study||34
3096116|NCT01470170|3818998|FG001|COMPLETED|Overall Study||35
3096117|NCT01470170|3818999|FG002|COMPLETED|Overall Study||34
3096118|NCT01470170|3819000|FG003|COMPLETED|Overall Study||36
3096119|NCT01470170|3819001|FG004|COMPLETED|Overall Study||34
3096120|NCT01470170|3818997|FG000|NOT COMPLETED|Overall Study||0
3096121|NCT01470170|3818998|FG001|NOT COMPLETED|Overall Study||0
3096122|NCT01470170|3818999|FG002|NOT COMPLETED|Overall Study||0
3096123|NCT01470170|3819000|FG003|NOT COMPLETED|Overall Study||0
3096124|NCT01470170|3819001|FG004|NOT COMPLETED|Overall Study||0
3096125|NCT01470196|3819013|FG000|STARTED|Overall Study||31
3096126|NCT01470196|3819013|FG000|COMPLETED|Overall Study||31
3096127|NCT01470196|3819013|FG000|NOT COMPLETED|Overall Study||0
3096128|NCT01470248|3819017|FG000|STARTED|Overall Study||20
3096129|NCT01470248|3819017|FG000|COMPLETED|Overall Study||19
3096130|NCT01470248|3819017|FG000|NOT COMPLETED|Overall Study||1
3096131|NCT01470417|3819023|FG000|STARTED|Overall Study||3
3096132|NCT01470417|3819024|FG001|STARTED|Overall Study||7
3096133|NCT01470417|3819023|FG000|COMPLETED|Overall Study||3
3096134|NCT01470417|3819024|FG001|COMPLETED|Overall Study||5
3096135|NCT01470417|3819023|FG000|NOT COMPLETED|Overall Study||0
3096136|NCT01470417|3819024|FG001|NOT COMPLETED|Overall Study||2
3096137|NCT01470469|3819032|FG000|STARTED|Overall Study||21
3096138|NCT01470469|3819033|FG001|STARTED|Overall Study||62
3096139|NCT01470469|3819032|FG000|COMPLETED|Overall Study||11
3096140|NCT01470469|3819033|FG001|COMPLETED|Overall Study||38
3096141|NCT01470469|3819032|FG000|NOT COMPLETED|Overall Study||10
3096142|NCT01470469|3819033|FG001|NOT COMPLETED|Overall Study||24
3096143|NCT01470599|3819041|FG000|STARTED|Overall Study||62
3096144|NCT01470599|3819042|FG001|STARTED|Overall Study||88
3096145|NCT01470599|3819041|FG000|COMPLETED|Overall Study||43
3096146|NCT01470599|3819042|FG001|COMPLETED|Overall Study||45
3096147|NCT01470599|3819041|FG000|NOT COMPLETED|Overall Study||19
3096148|NCT01470599|3819042|FG001|NOT COMPLETED|Overall Study||43
3096149|NCT01470612|3819050|FG000|STARTED|Overall Study||175
3096150|NCT01470612|3819051|FG001|STARTED|Overall Study||769
3096151|NCT01470612|3819050|FG000|COMPLETED|Overall Study||91
3096152|NCT01470612|3819051|FG001|COMPLETED|Overall Study||104
3096153|NCT01470612|3819050|FG000|NOT COMPLETED|Overall Study||84
3096154|NCT01470612|3819051|FG001|NOT COMPLETED|Overall Study||665
3096155|NCT01470651|3819059|FG000|STARTED|Overall Study||13
3096156|NCT01470651|3819060|FG001|STARTED|Overall Study||13
3096157|NCT01470651|3819059|FG000|COMPLETED|Overall Study||6
3096158|NCT01470651|3819060|FG001|COMPLETED|Overall Study||10
3096159|NCT01470651|3819059|FG000|NOT COMPLETED|Overall Study||7
3096160|NCT01470651|3819060|FG001|NOT COMPLETED|Overall Study||3
3096161|NCT01470781|3819068|FG000|STARTED|Overall Study||39
3096162|NCT01470781|3819069|FG001|STARTED|Overall Study||33
3096163|NCT01470781|3819068|FG000|Midpoint Assessment|Overall Study||30
3096164|NCT01470781|3819069|FG001|Midpoint Assessment|Overall Study||30
3096165|NCT01470781|3819068|FG000|Post-Treatment Assessment|Overall Study||22
3096166|NCT01470781|3819069|FG001|Post-Treatment Assessment|Overall Study||23
3096167|NCT01470781|3819068|FG000|COMPLETED|Overall Study||21
3096168|NCT01470781|3819069|FG001|COMPLETED|Overall Study||21
3096169|NCT01470781|3819068|FG000|NOT COMPLETED|Overall Study||18
3096170|NCT01470781|3819069|FG001|NOT COMPLETED|Overall Study||12
3096171|NCT01470859|3819078|FG000|STARTED|Overall Study||15
3096172|NCT01470859|3819079|FG001|STARTED|Overall Study||15
3096173|NCT01470859|3819078|FG000|COMPLETED|Overall Study||14
3096174|NCT01470859|3819079|FG001|COMPLETED|Overall Study||15
3096175|NCT01470859|3819078|FG000|NOT COMPLETED|Overall Study||1
3096176|NCT01470859|3819079|FG001|NOT COMPLETED|Overall Study||0
3096177|NCT01470989|3819087|FG000|STARTED|Overall Study||227
3096178|NCT01470989|3819088|FG001|STARTED|Overall Study||229
3096179|NCT01470989|3819087|FG000|Completed Core Study|Overall Study||208
3096180|NCT01470989|3819088|FG001|Completed Core Study|Overall Study||208
3096181|NCT01470989|3819087|FG000|Entered Extension 1 Study|Overall Study||174
3096182|NCT01470989|3819088|FG001|Entered Extension 1 Study|Overall Study||161
3096183|NCT01470989|3819087|FG000|Completed Extension 1 Study|Overall Study||165
3096184|NCT01470989|3819088|FG001|Completed Extension 1 Study|Overall Study||152
3096185|NCT01470989|3819087|FG000|Entered Extension 2 Study|Overall Study||141
3096186|NCT01470989|3819088|FG001|Entered Extension 2 Study|Overall Study||131
3096187|NCT01470989|3819087|FG000|Completed Extension 2 Study|Overall Study||132
3096188|NCT01470989|3819088|FG001|Completed Extension 2 Study|Overall Study||117
3096189|NCT01470989|3819087|FG000|Entered Extension 3|Overall Study||87
3096190|NCT01470989|3819088|FG001|Entered Extension 3|Overall Study||49
3096191|NCT01470989|3819087|FG000|COMPLETED|Overall Study||79
3096192|NCT01470989|3819088|FG001|COMPLETED|Overall Study||43
3096193|NCT01470989|3819087|FG000|NOT COMPLETED|Overall Study||148
3096194|NCT01470989|3819088|FG001|NOT COMPLETED|Overall Study||186
3096195|NCT01471015|3819099|FG000|STARTED|Overall Study||10
3096196|NCT01471015|3819100|FG001|STARTED|Overall Study||10
3096197|NCT01471015|3819101|FG002|STARTED|Overall Study||10
3096198|NCT01471015|3819099|FG000|COMPLETED|Overall Study||10
3096199|NCT01471015|3819100|FG001|COMPLETED|Overall Study||9
3096200|NCT01471015|3819101|FG002|COMPLETED|Overall Study||9
3096201|NCT01471015|3819099|FG000|NOT COMPLETED|Overall Study||0
3096202|NCT01471015|3819100|FG001|NOT COMPLETED|Overall Study||1
3096203|NCT01471015|3819101|FG002|NOT COMPLETED|Overall Study||1
3096204|NCT01471028|3819111|FG000|STARTED|VTI-208||96
3096205|NCT01471028|3819112|FG001|STARTED|VTI-208||107
3096206|NCT01471028|3819111|FG000|COMPLETED|VTI-208||56
3096207|NCT01471028|3819112|FG001|COMPLETED|VTI-208||63
3096208|NCT01471028|3819111|FG000|NOT COMPLETED|VTI-208||40
3096209|NCT01471028|3819112|FG001|NOT COMPLETED|VTI-208||44
3096210|NCT01471028|3819111|FG000|STARTED|VTI-208E||56
3096211|NCT01471028|3819112|FG001|STARTED|VTI-208E||63
3096212|NCT01471028|3819111|FG000|Database Lock, 31 July 2015|VTI-208E||56
3096213|NCT01471028|3819112|FG001|Database Lock, 31 July 2015|VTI-208E||63
3096214|NCT01471028|3819111|FG000|COMPLETED|VTI-208E||48
3096215|NCT01471028|3819112|FG001|COMPLETED|VTI-208E||51
3096216|NCT01471028|3819111|FG000|NOT COMPLETED|VTI-208E||8
3096217|NCT01471028|3819112|FG001|NOT COMPLETED|VTI-208E||12
3096218|NCT01471041|3819121|FG000|STARTED|Overall Study||54
3096219|NCT01471041|3819121|FG000|COMPLETED|Overall Study||47
3096220|NCT01471041|3819121|FG000|NOT COMPLETED|Overall Study||7
3096221|NCT01471054|3819127|FG000|STARTED|Overall Study||5
3096222|NCT01471054|3819128|FG001|STARTED|Overall Study||1
3096223|NCT01471054|3819127|FG000|COMPLETED|Overall Study||1
3096224|NCT01471054|3819128|FG001|COMPLETED|Overall Study||1
3096225|NCT01471054|3819127|FG000|NOT COMPLETED|Overall Study||4
3096226|NCT01471054|3819128|FG001|NOT COMPLETED|Overall Study||0
3096227|NCT01471093|3819146|FG000|STARTED|Overall Study||25
3096228|NCT01471093|3819147|FG001|STARTED|Overall Study||25
3096229|NCT01471093|3819148|FG002|STARTED|Overall Study||25
3096230|NCT01471093|3819149|FG003|STARTED|Overall Study||25
3096231|NCT01471093|3819146|FG000|COMPLETED|Overall Study||24
3096232|NCT01471093|3819147|FG001|COMPLETED|Overall Study||25
3096233|NCT01471093|3819148|FG002|COMPLETED|Overall Study||25
3096234|NCT01471093|3819149|FG003|COMPLETED|Overall Study||25
3096235|NCT01471093|3819146|FG000|NOT COMPLETED|Overall Study||1
3096236|NCT01471093|3819147|FG001|NOT COMPLETED|Overall Study||0
3096237|NCT01471093|3819148|FG002|NOT COMPLETED|Overall Study||0
3096238|NCT01471093|3819149|FG003|NOT COMPLETED|Overall Study||0
3096239|NCT01471171|3819155|FG000|STARTED|Treatment Period 1||57
3096240|NCT01471171|3819156|FG001|STARTED|Treatment Period 1||55
3096241|NCT01471171|3819155|FG000|COMPLETED|Treatment Period 1||53
3096242|NCT01471171|3819156|FG001|COMPLETED|Treatment Period 1||54
3096243|NCT01471171|3819155|FG000|NOT COMPLETED|Treatment Period 1||4
3096244|NCT01471171|3819156|FG001|NOT COMPLETED|Treatment Period 1||1
3096245|NCT01471171|3819155|FG000|STARTED|Treatment Period 2||53
3096246|NCT01471171|3819156|FG001|STARTED|Treatment Period 2||54
3096247|NCT01471171|3819155|FG000|COMPLETED|Treatment Period 2||52
3096248|NCT01471171|3819156|FG001|COMPLETED|Treatment Period 2||54
3096249|NCT01471171|3819155|FG000|NOT COMPLETED|Treatment Period 2||1
3096250|NCT01471171|3819156|FG001|NOT COMPLETED|Treatment Period 2||0
3096251|NCT01471197|3819164|FG000|STARTED|Overall Study||6
3096252|NCT01471197|3819165|FG001|STARTED|Overall Study||2
3096253|NCT01471197|3819164|FG000|COMPLETED|Overall Study||0
3096254|NCT01471197|3819165|FG001|COMPLETED|Overall Study||0
3096255|NCT01471197|3819164|FG000|NOT COMPLETED|Overall Study||6
3096256|NCT01471197|3819165|FG001|NOT COMPLETED|Overall Study||2
3096257|NCT01471353|3819171|FG000|STARTED|Overall Study||42
3096258|NCT01471353|3819171|FG000|COMPLETED|Overall Study||39
3096259|NCT01471353|3819171|FG000|NOT COMPLETED|Overall Study||3
3096260|NCT01471379|3819178|FG000|STARTED|Overall Study||1
3096261|NCT01471379|3819179|FG001|STARTED|Overall Study||1
3096262|NCT01471379|3819180|FG002|STARTED|Overall Study||0
3096263|NCT01471379|3819178|FG000|COMPLETED|Overall Study||0
3096264|NCT01471379|3819179|FG001|COMPLETED|Overall Study||0
3096265|NCT01471379|3819180|FG002|COMPLETED|Overall Study||0
3096266|NCT01471379|3819178|FG000|NOT COMPLETED|Overall Study||1
3096267|NCT01471379|3819179|FG001|NOT COMPLETED|Overall Study||1
3096268|NCT01471379|3819180|FG002|NOT COMPLETED|Overall Study||0
3096269|NCT01471457|3819191|FG000|STARTED|Overall Study||92
3096270|NCT01471457|3819192|FG001|STARTED|Overall Study||92
3096271|NCT01471457|3819191|FG000|COMPLETED|Overall Study||73
3096272|NCT01471457|3819192|FG001|COMPLETED|Overall Study||74
3096273|NCT01471457|3819191|FG000|NOT COMPLETED|Overall Study||19
3096274|NCT01471457|3819192|FG001|NOT COMPLETED|Overall Study||18
3096275|NCT01471522|3819200|FG000|STARTED|Overall Study||2588
3096276|NCT01471522|3819201|FG001|STARTED|Overall Study||2591
3096277|NCT01471522|3819200|FG000|COMPLETED|Overall Study||2524
3096278|NCT01471522|3819201|FG001|COMPLETED|Overall Study||2543
3096279|NCT01471522|3819200|FG000|NOT COMPLETED|Overall Study||64
3096280|NCT01471522|3819201|FG001|NOT COMPLETED|Overall Study||48
3096281|NCT01471574|3819212|FG000|STARTED|Treatment Period||132
3096282|NCT01471574|3819213|FG001|STARTED|Treatment Period||39
3096283|NCT01471574|3819214|FG002|STARTED|Treatment Period||106
3096284|NCT01471574|3819215|FG003|STARTED|Treatment Period||24
3096285|NCT01471574|3819212|FG000|COMPLETED|Treatment Period||101
3096286|NCT01471574|3819213|FG001|COMPLETED|Treatment Period||29
3096287|NCT01471574|3819214|FG002|COMPLETED|Treatment Period||82
3096288|NCT01471574|3819215|FG003|COMPLETED|Treatment Period||21
3096289|NCT01471574|3819212|FG000|NOT COMPLETED|Treatment Period||31
3096290|NCT01471574|3819213|FG001|NOT COMPLETED|Treatment Period||10
3096291|NCT01471574|3819214|FG002|NOT COMPLETED|Treatment Period||24
3096292|NCT01471574|3819215|FG003|NOT COMPLETED|Treatment Period||3
3096293|NCT01471574|3819212|FG000|STARTED|Follow-up Period||121
3096294|NCT01471574|3819213|FG001|STARTED|Follow-up Period||34
3096295|NCT01471574|3819214|FG002|STARTED|Follow-up Period||102
3096296|NCT01471574|3819215|FG003|STARTED|Follow-up Period||24
3096297|NCT01471574|3819212|FG000|COMPLETED|Follow-up Period||114
3096298|NCT01471574|3819213|FG001|COMPLETED|Follow-up Period||32
3096299|NCT01471574|3819214|FG002|COMPLETED|Follow-up Period||95
3096300|NCT01471574|3819215|FG003|COMPLETED|Follow-up Period||21
3096301|NCT01471574|3819212|FG000|NOT COMPLETED|Follow-up Period||7
3096302|NCT01471574|3819213|FG001|NOT COMPLETED|Follow-up Period||2
3096303|NCT01471574|3819214|FG002|NOT COMPLETED|Follow-up Period||7
3096304|NCT01471574|3819215|FG003|NOT COMPLETED|Follow-up Period||3
3096305|NCT01471626|3819231|FG000|STARTED|Overall Study||21
3096306|NCT01471626|3819231|FG000|COMPLETED|Overall Study||21
3096307|NCT01471626|3819231|FG000|NOT COMPLETED|Overall Study||0
3096308|NCT01471639|3819235|FG000|STARTED|Overall Study||37
3096309|NCT01471639|3819235|FG000|COMPLETED|Overall Study||37
3096310|NCT01471639|3819235|FG000|NOT COMPLETED|Overall Study||0
3096311|NCT01471691|3819241|FG000|STARTED|Overall Study||8
3096312|NCT01471691|3819242|FG001|STARTED|Overall Study||6
3096313|NCT01471691|3819241|FG000|COMPLETED|Overall Study||8
3096314|NCT01471691|3819242|FG001|COMPLETED|Overall Study||5
3096315|NCT01471691|3819241|FG000|NOT COMPLETED|Overall Study||0
3096316|NCT01471691|3819242|FG001|NOT COMPLETED|Overall Study||1
3096317|NCT01471782|3819254|FG000|STARTED|Overall Study||5
3096318|NCT01471782|3819255|FG001|STARTED|Overall Study||7
3096319|NCT01471782|3819256|FG002|STARTED|Overall Study||5
3096320|NCT01471782|3819257|FG003|STARTED|Overall Study||6
3096321|NCT01471782|3819258|FG004|STARTED|Overall Study||26
3096322|NCT01471782|3819259|FG005|STARTED|Overall Study||44
3096323|NCT01471782|3819254|FG000|COMPLETED|Overall Study|Completed 5 cycles|0
3096324|NCT01471782|3819255|FG001|COMPLETED|Overall Study|Completed 5 cycles|1
3096325|NCT01471782|3819256|FG002|COMPLETED|Overall Study|Completed 5 cycles|0
3096326|NCT01471782|3819257|FG003|COMPLETED|Overall Study|Completed 5 cycles|1
3096327|NCT01471782|3819258|FG004|COMPLETED|Overall Study|Completed 5 cycles|0
3096328|NCT01471782|3819259|FG005|COMPLETED|Overall Study|Completed 5 cycles|3
3096329|NCT01471782|3819254|FG000|NOT COMPLETED|Overall Study||5
3096330|NCT01471782|3819255|FG001|NOT COMPLETED|Overall Study||6
3096331|NCT01471782|3819256|FG002|NOT COMPLETED|Overall Study||5
3096332|NCT01471782|3819257|FG003|NOT COMPLETED|Overall Study||5
3096333|NCT01471782|3819258|FG004|NOT COMPLETED|Overall Study||26
3096334|NCT01471782|3819259|FG005|NOT COMPLETED|Overall Study||41
3096335|NCT01472185|3819286|FG000|STARTED|Overall Study||232
3096336|NCT01472185|3819287|FG001|STARTED|Overall Study||233
3096337|NCT01472185|3819286|FG000|COMPLETED|Overall Study||198
3096338|NCT01472185|3819287|FG001|COMPLETED|Overall Study||199
3096339|NCT01472185|3819286|FG000|NOT COMPLETED|Overall Study||34
3096340|NCT01472185|3819287|FG001|NOT COMPLETED|Overall Study||34
3096341|NCT01472289|3819293|FG000|STARTED|Overall Study||17
3096342|NCT01472289|3819293|FG000|COMPLETED|Overall Study||15
3096343|NCT01472289|3819293|FG000|NOT COMPLETED|Overall Study||2
3096344|NCT01472341|3819297|FG000|STARTED|Overall Study||507
3096345|NCT01472341|3819297|FG000|COMPLETED|Overall Study||235
3096346|NCT01472341|3819297|FG000|NOT COMPLETED|Overall Study||272
3096347|NCT01472380|3819301|FG000|STARTED|Efavirenz Alone||30
3096348|NCT01472380|3819301|FG000|COMPLETED|Efavirenz Alone||29
3096349|NCT01472380|3819301|FG000|NOT COMPLETED|Efavirenz Alone||1
3096350|NCT01472380|3819301|FG000|STARTED|Fenofibric Acid (FFA) Alone||29
3096351|NCT01472380|3819301|FG000|COMPLETED|Fenofibric Acid (FFA) Alone||29
3096352|NCT01472380|3819301|FG000|NOT COMPLETED|Fenofibric Acid (FFA) Alone||0
3096353|NCT01472380|3819301|FG000|STARTED|1 Day Period Between Dosing||29
3096354|NCT01472380|3819301|FG000|COMPLETED|1 Day Period Between Dosing||28
3096355|NCT01472380|3819301|FG000|NOT COMPLETED|1 Day Period Between Dosing||1
3096356|NCT01472380|3819301|FG000|STARTED|Efavirenz and FFA||28
3096357|NCT01472380|3819301|FG000|COMPLETED|Efavirenz and FFA||28
3096358|NCT01472380|3819301|FG000|NOT COMPLETED|Efavirenz and FFA||0
3096359|NCT01472432|3819310|FG000|STARTED|Overall Study||53
3096360|NCT01472432|3819311|FG001|STARTED|Overall Study||53
3096361|NCT01472432|3819310|FG000|Ulcer Reduction|Overall Study||13
3096362|NCT01472432|3819311|FG001|Ulcer Reduction|Overall Study||33
3096363|NCT01472432|3819310|FG000|COMPLETED|Overall Study||53
3096364|NCT01472432|3819311|FG001|COMPLETED|Overall Study||53
3096365|NCT01472432|3819310|FG000|NOT COMPLETED|Overall Study||0
3096366|NCT01472432|3819311|FG001|NOT COMPLETED|Overall Study||0
3096367|NCT01472445|3819321|FG000|STARTED|Overall Study||25
3096368|NCT01472445|3819322|FG001|STARTED|Overall Study||16
3096369|NCT01472445|3819321|FG000|COMPLETED|Overall Study||25
3096370|NCT01472445|3819322|FG001|COMPLETED|Overall Study||16
3096371|NCT01472445|3819321|FG000|NOT COMPLETED|Overall Study||0
3096372|NCT01472445|3819322|FG001|NOT COMPLETED|Overall Study||0
3096373|NCT01472549|3819332|FG000|STARTED|Overall Study||572
3096374|NCT01472549|3819333|FG001|STARTED|Overall Study||575
3096375|NCT01472549|3819332|FG000|COMPLETED|Overall Study||572
3096376|NCT01472549|3819333|FG001|COMPLETED|Overall Study||575
3096377|NCT01472549|3819332|FG000|NOT COMPLETED|Overall Study||0
3096378|NCT01472549|3819333|FG001|NOT COMPLETED|Overall Study||0
3096379|NCT01472562|3819339|FG000|STARTED|Induction Phase (Week 1- 48)||38
3096380|NCT01472562|3819339|FG000|COMPLETED|Induction Phase (Week 1- 48)||27
3096381|NCT01472562|3819339|FG000|NOT COMPLETED|Induction Phase (Week 1- 48)||11
3096382|NCT01472562|3819339|FG000|STARTED|Maintenance Phase (Week 49 to PD)||27
3096383|NCT01472562|3819339|FG000|COMPLETED|Maintenance Phase (Week 49 to PD)||4
3096384|NCT01472562|3819339|FG000|NOT COMPLETED|Maintenance Phase (Week 49 to PD)||23
3096385|NCT01472718|3819345|FG000|STARTED|Overall Study||104
3096386|NCT01472718|3819346|FG001|STARTED|Overall Study||104
3096387|NCT01472718|3819345|FG000|COMPLETED|Overall Study||98
3096388|NCT01472718|3819346|FG001|COMPLETED|Overall Study||97
3096389|NCT01472718|3819345|FG000|NOT COMPLETED|Overall Study||6
3096390|NCT01472718|3819346|FG001|NOT COMPLETED|Overall Study||7
3135256|NCT01705730|3860245|FG000|STARTED|Overall Study|Participants who received study drug|68
3096391|NCT01472757|3819356|FG000|STARTED|Overall Study||91
3096392|NCT01472757|3819357|FG001|STARTED|Overall Study||93
3096393|NCT01472757|3819358|FG002|STARTED|Overall Study||95
3096394|NCT01472757|3819359|FG003|STARTED|Overall Study||94
3096395|NCT01472757|3819356|FG000|Full Analysis Set|Overall Study||91
3096396|NCT01472757|3819357|FG001|Full Analysis Set|Overall Study||93
3096397|NCT01472757|3819358|FG002|Full Analysis Set|Overall Study||92
3096398|NCT01472757|3819359|FG003|Full Analysis Set|Overall Study||92
3096399|NCT01472757|3819356|FG000|COMPLETED|Overall Study||61
3096400|NCT01472757|3819357|FG001|COMPLETED|Overall Study||80
3096401|NCT01472757|3819358|FG002|COMPLETED|Overall Study||76
3096402|NCT01472757|3819359|FG003|COMPLETED|Overall Study||75
3096403|NCT01472757|3819356|FG000|NOT COMPLETED|Overall Study||30
3096404|NCT01472757|3819357|FG001|NOT COMPLETED|Overall Study||13
3096405|NCT01472757|3819358|FG002|NOT COMPLETED|Overall Study||19
3096406|NCT01472757|3819359|FG003|NOT COMPLETED|Overall Study||19
3096407|NCT01472822|3819371|FG000|STARTED|Overall Study||30
3096408|NCT01472822|3819372|FG001|STARTED|Overall Study||30
3096409|NCT01472822|3819371|FG000|COMPLETED|Overall Study||28
3096410|NCT01472822|3819372|FG001|COMPLETED|Overall Study||28
3096411|NCT01472822|3819371|FG000|NOT COMPLETED|Overall Study||2
3096412|NCT01472822|3819372|FG001|NOT COMPLETED|Overall Study||2
3096413|NCT01472835|3819380|FG000|STARTED|Overall Study||37
3096414|NCT01472835|3819381|FG001|STARTED|Overall Study||36
3096415|NCT01472835|3819380|FG000|COMPLETED|Overall Study||35
3096416|NCT01472835|3819381|FG001|COMPLETED|Overall Study||36
3096417|NCT01472835|3819380|FG000|NOT COMPLETED|Overall Study||2
3096418|NCT01472835|3819381|FG001|NOT COMPLETED|Overall Study||0
3096419|NCT01472874|3819390|FG000|STARTED|Overall Study||8
3096420|NCT01472874|3819390|FG000|COMPLETED|Overall Study||8
3096421|NCT01472874|3819390|FG000|NOT COMPLETED|Overall Study||0
3096422|NCT01472939|3819398|FG000|STARTED|Overall Study||123
3096423|NCT01472939|3819399|FG001|STARTED|Overall Study||119
3096424|NCT01472939|3819400|FG002|STARTED|Overall Study||119
3096425|NCT01472939|3819401|FG003|STARTED|Overall Study||119
3096426|NCT01472939|3819398|FG000|COMPLETED|Overall Study||103
3096427|NCT01472939|3819399|FG001|COMPLETED|Overall Study||105
3096428|NCT01472939|3819400|FG002|COMPLETED|Overall Study||108
3096429|NCT01472939|3819401|FG003|COMPLETED|Overall Study||99
3096430|NCT01472939|3819398|FG000|NOT COMPLETED|Overall Study||20
3096431|NCT01472939|3819399|FG001|NOT COMPLETED|Overall Study||14
3096432|NCT01472939|3819400|FG002|NOT COMPLETED|Overall Study||11
3096433|NCT01472939|3819401|FG003|NOT COMPLETED|Overall Study||20
3096434|NCT01472965|3819416|FG000|STARTED|Overall Study||49
3096435|NCT01472965|3819417|FG001|STARTED|Overall Study||46
3096436|NCT01472965|3819416|FG000|COMPLETED|Overall Study||48
3096437|NCT01472965|3819417|FG001|COMPLETED|Overall Study||46
3096438|NCT01472965|3819416|FG000|NOT COMPLETED|Overall Study||1
3096439|NCT01472965|3819417|FG001|NOT COMPLETED|Overall Study||0
3096440|NCT01473160|3819423|FG000|STARTED|Overall Study||9
3096441|NCT01473160|3819423|FG000|COMPLETED|Overall Study||9
3096442|NCT01473160|3819423|FG000|NOT COMPLETED|Overall Study||0
3096443|NCT01473355|3819429|FG000|STARTED|Overall Study||45
3096444|NCT01473355|3819429|FG000|COMPLETED|Overall Study||39
3096445|NCT01473355|3819429|FG000|NOT COMPLETED|Overall Study||6
3096446|NCT01473368|3819437|FG000|STARTED|Overall Study||14
3096447|NCT01473368|3819438|FG001|STARTED|Overall Study||12
3096448|NCT01473368|3819439|FG002|STARTED|Overall Study||15
3096449|NCT01473368|3819440|FG003|STARTED|Overall Study||12
3096450|NCT01473368|3819437|FG000|COMPLETED|Overall Study||13
3096451|NCT01473368|3819438|FG001|COMPLETED|Overall Study||12
3096452|NCT01473368|3819439|FG002|COMPLETED|Overall Study||12
3096453|NCT01473368|3819440|FG003|COMPLETED|Overall Study||12
3096454|NCT01473368|3819437|FG000|NOT COMPLETED|Overall Study||1
3096455|NCT01473368|3819438|FG001|NOT COMPLETED|Overall Study||0
3096456|NCT01473368|3819439|FG002|NOT COMPLETED|Overall Study||3
3096457|NCT01473368|3819440|FG003|NOT COMPLETED|Overall Study||0
3096458|NCT01473381|3819470|FG000|STARTED|Overall Study||290
3096459|NCT01473381|3819471|FG001|STARTED|Overall Study||292
3096460|NCT01473381|3819472|FG002|STARTED|Overall Study||291
3096461|NCT01473381|3819473|FG003|STARTED|Overall Study||289
3096462|NCT01473381|3819470|FG000|Safety Population|Overall Study||281
3096463|NCT01473381|3819471|FG001|Safety Population|Overall Study||288
3096464|NCT01473381|3819472|FG002|Safety Population|Overall Study||287
3096465|NCT01473381|3819473|FG003|Safety Population|Overall Study||282
3096466|NCT01473381|3819470|FG000|COMPLETED|Overall Study||210
3096467|NCT01473381|3819471|FG001|COMPLETED|Overall Study||199
3096468|NCT01473381|3819472|FG002|COMPLETED|Overall Study||189
3096469|NCT01473381|3819473|FG003|COMPLETED|Overall Study||200
3096470|NCT01473381|3819470|FG000|NOT COMPLETED|Overall Study||80
3096471|NCT01473381|3819471|FG001|NOT COMPLETED|Overall Study||93
3096472|NCT01473381|3819472|FG002|NOT COMPLETED|Overall Study||102
3096473|NCT01473381|3819473|FG003|NOT COMPLETED|Overall Study||89
3096474|NCT01473394|3819486|FG000|STARTED|Overall Study||253
3096475|NCT01473394|3819487|FG001|STARTED|Overall Study||255
3096476|NCT01473394|3819486|FG000|COMPLETED|Overall Study||208
3096477|NCT01473394|3819487|FG001|COMPLETED|Overall Study||212
3096478|NCT01473394|3819486|FG000|NOT COMPLETED|Overall Study||45
3096479|NCT01473394|3819487|FG001|NOT COMPLETED|Overall Study||43
3096480|NCT01473407|3819495|FG000|STARTED|Overall Study||306
3096481|NCT01473407|3819496|FG001|STARTED|Overall Study||306
3096482|NCT01473407|3819495|FG000|COMPLETED|Overall Study||252
3096483|NCT01473407|3819496|FG001|COMPLETED|Overall Study||259
3096484|NCT01473407|3819495|FG000|NOT COMPLETED|Overall Study||54
3096485|NCT01473407|3819496|FG001|NOT COMPLETED|Overall Study||47
3096486|NCT01473420|3819504|FG000|STARTED|Titration Period (18 Weeks)||160
3096487|NCT01473420|3819505|FG001|STARTED|Titration Period (18 Weeks)||160
3096488|NCT01473420|3819504|FG000|Treated|Titration Period (18 Weeks)||80
3096489|NCT01473420|3819505|FG001|Treated|Titration Period (18 Weeks)||86
3096490|NCT01473420|3819504|FG000|COMPLETED|Titration Period (18 Weeks)||124
3096491|NCT01473420|3819505|FG001|COMPLETED|Titration Period (18 Weeks)||122
3096492|NCT01473420|3819504|FG000|NOT COMPLETED|Titration Period (18 Weeks)||36
3096493|NCT01473420|3819505|FG001|NOT COMPLETED|Titration Period (18 Weeks)||38
3096494|NCT01473420|3819504|FG000|STARTED|Maintenance Period (16 Weeks)||124
3096495|NCT01473420|3819505|FG001|STARTED|Maintenance Period (16 Weeks)||122
3096496|NCT01473420|3819504|FG000|COMPLETED|Maintenance Period (16 Weeks)||106
3096497|NCT01473420|3819505|FG001|COMPLETED|Maintenance Period (16 Weeks)||105
3096498|NCT01473420|3819504|FG000|NOT COMPLETED|Maintenance Period (16 Weeks)||18
3096499|NCT01473420|3819505|FG001|NOT COMPLETED|Maintenance Period (16 Weeks)||17
3096500|NCT01473524|3819520|FG000|STARTED|DB Phase||71
3096501|NCT01473524|3819521|FG001|STARTED|DB Phase||73
3096502|NCT01473524|3819522|FG002|STARTED|DB Phase||73
3096503|NCT01473524|3819523|FG003|STARTED|DB Phase||0
3096504|NCT01473524|3819524|FG004|STARTED|DB Phase||0
3096505|NCT01473524|3819525|FG005|STARTED|DB Phase||0
3096506|NCT01473524|3819520|FG000|Received at Least 1 Dose of Study Drug|DB Phase||70
3096507|NCT01473524|3819521|FG001|Received at Least 1 Dose of Study Drug|DB Phase||73
3096508|NCT01473524|3819522|FG002|Received at Least 1 Dose of Study Drug|DB Phase||73
3096509|NCT01473524|3819523|FG003|Received at Least 1 Dose of Study Drug|DB Phase||0
3096510|NCT01473524|3819524|FG004|Received at Least 1 Dose of Study Drug|DB Phase||0
3096511|NCT01473524|3819525|FG005|Received at Least 1 Dose of Study Drug|DB Phase||0
3096512|NCT01473524|3819520|FG000|COMPLETED|DB Phase||64
3096513|NCT01473524|3819521|FG001|COMPLETED|DB Phase||64
3096514|NCT01473524|3819522|FG002|COMPLETED|DB Phase||70
3096515|NCT01473524|3819523|FG003|COMPLETED|DB Phase||0
3096516|NCT01473524|3819524|FG004|COMPLETED|DB Phase||0
3096517|NCT01473524|3819525|FG005|COMPLETED|DB Phase||0
3096518|NCT01473524|3819520|FG000|NOT COMPLETED|DB Phase||7
3096519|NCT01473524|3819521|FG001|NOT COMPLETED|DB Phase||9
3096520|NCT01473524|3819522|FG002|NOT COMPLETED|DB Phase||3
3096521|NCT01473524|3819523|FG003|NOT COMPLETED|DB Phase||0
3096522|NCT01473524|3819524|FG004|NOT COMPLETED|DB Phase||0
3096523|NCT01473524|3819525|FG005|NOT COMPLETED|DB Phase||0
3096524|NCT01473524|3819520|FG000|STARTED|LTSE Phase||0
3096525|NCT01473524|3819521|FG001|STARTED|LTSE Phase||0
3096526|NCT01473524|3819522|FG002|STARTED|LTSE Phase||0
3096527|NCT01473524|3819523|FG003|STARTED|LTSE Phase|One participant in the double-blind OCA 5-10 mg group did not enroll in the LTSE phase.|63
3096528|NCT01473524|3819524|FG004|STARTED|LTSE Phase||64
3096529|NCT01473524|3819525|FG005|STARTED|LTSE Phase|Four participants in the double-blind placebo group did not enroll in the LTSE phase.|66
3096530|NCT01473524|3819520|FG000|Received at Least 1 Dose of OCA in LTSE|LTSE Phase||0
3096531|NCT01473524|3819521|FG001|Received at Least 1 Dose of OCA in LTSE|LTSE Phase||0
3096532|NCT01473524|3819522|FG002|Received at Least 1 Dose of OCA in LTSE|LTSE Phase||0
3096533|NCT01473524|3819523|FG003|Received at Least 1 Dose of OCA in LTSE|LTSE Phase||63
3096534|NCT01473524|3819524|FG004|Received at Least 1 Dose of OCA in LTSE|LTSE Phase||64
3096535|NCT01473524|3819525|FG005|Received at Least 1 Dose of OCA in LTSE|LTSE Phase||66
3096536|NCT01473524|3819520|FG000|COMPLETED|LTSE Phase||0
3096537|NCT01473524|3819521|FG001|COMPLETED|LTSE Phase||0
3096538|NCT01473524|3819522|FG002|COMPLETED|LTSE Phase||0
3096539|NCT01473524|3819523|FG003|COMPLETED|LTSE Phase||54
3096540|NCT01473524|3819524|FG004|COMPLETED|LTSE Phase||47
3096541|NCT01473524|3819525|FG005|COMPLETED|LTSE Phase||45
3096542|NCT01473524|3819520|FG000|NOT COMPLETED|LTSE Phase||0
3096543|NCT01473524|3819521|FG001|NOT COMPLETED|LTSE Phase||0
3096544|NCT01473524|3819522|FG002|NOT COMPLETED|LTSE Phase||0
3096545|NCT01473524|3819523|FG003|NOT COMPLETED|LTSE Phase||9
3096546|NCT01473524|3819524|FG004|NOT COMPLETED|LTSE Phase||17
3096547|NCT01473524|3819525|FG005|NOT COMPLETED|LTSE Phase||21
3096548|NCT01473563|3819547|FG000|STARTED|Overall Study||52
3096549|NCT01473563|3819547|FG000|Received at Least 1 Dose of Study Drug|Overall Study||52
3096550|NCT01473563|3819547|FG000|COMPLETED|Overall Study||51
3096551|NCT01473563|3819547|FG000|NOT COMPLETED|Overall Study||1
3096552|NCT01473589|3819553|FG000|STARTED|Overall Study||60
3096553|NCT01473589|3819554|FG001|STARTED|Overall Study||62
3096554|NCT01473589|3819553|FG000|Received at Least 1 Dose of Study Drug|Overall Study|Randomized participants who received at least 1 dose of study drug.|60
3096555|NCT01473589|3819554|FG001|Received at Least 1 Dose of Study Drug|Overall Study|Randomized participants who received at least 1 dose of study drug.|61
3096556|NCT01473589|3819553|FG000|Completed 6 Months|Overall Study||51
3096557|NCT01473589|3819554|FG001|Completed 6 Months|Overall Study||54
3096558|NCT01473589|3819553|FG000|Completed 12 Months|Overall Study||49
3096559|NCT01473589|3819554|FG001|Completed 12 Months|Overall Study||48
3096560|NCT01473589|3819553|FG000|COMPLETED|Overall Study||49
3096561|NCT01473589|3819554|FG001|COMPLETED|Overall Study||46
3096562|NCT01473589|3819553|FG000|NOT COMPLETED|Overall Study||11
3096563|NCT01473589|3819554|FG001|NOT COMPLETED|Overall Study||16
3096564|NCT01473602|3819564|FG000|STARTED|Overall Study||18
3096565|NCT01473602|3819565|FG001|STARTED|Overall Study||21
3096566|NCT01473602|3819564|FG000|Received at Least 1 Dose of Study Drug|Overall Study||18
3135257|NCT01705730|3860245|FG000|COMPLETED|Overall Study||59
3096567|NCT01473602|3819565|FG001|Received at Least 1 Dose of Study Drug|Overall Study||20
3096568|NCT01473602|3819564|FG000|Completed 6 Months|Overall Study||12
3096569|NCT01473602|3819565|FG001|Completed 6 Months|Overall Study||15
3096570|NCT01473602|3819564|FG000|Completed 12 Months|Overall Study||10
3096571|NCT01473602|3819565|FG001|Completed 12 Months|Overall Study||13
3096572|NCT01473602|3819564|FG000|COMPLETED|Overall Study||10
3096573|NCT01473602|3819565|FG001|COMPLETED|Overall Study||13
3096574|NCT01473602|3819564|FG000|NOT COMPLETED|Overall Study||8
3096575|NCT01473602|3819565|FG001|NOT COMPLETED|Overall Study||8
3096576|NCT01473745|3819575|FG000|STARTED|Overall Study||24
3096577|NCT01473745|3819576|FG001|STARTED|Overall Study||24
3096578|NCT01473745|3819575|FG000|COMPLETED|Overall Study||24
3096579|NCT01473745|3819576|FG001|COMPLETED|Overall Study||24
3096580|NCT01473745|3819575|FG000|NOT COMPLETED|Overall Study||0
3096581|NCT01473745|3819576|FG001|NOT COMPLETED|Overall Study||0
3096582|NCT01473758|3819584|FG000|STARTED|Cycle 1||38
3096583|NCT01473758|3819585|FG001|STARTED|Cycle 1||43
3096584|NCT01473758|3819586|FG002|STARTED|Cycle 1||0
3096585|NCT01473758|3819587|FG003|STARTED|Cycle 1||0
3096586|NCT01473758|3819584|FG000|COMPLETED|Cycle 1||27
3096587|NCT01473758|3819585|FG001|COMPLETED|Cycle 1||40
3096588|NCT01473758|3819586|FG002|COMPLETED|Cycle 1||0
3096589|NCT01473758|3819587|FG003|COMPLETED|Cycle 1||0
3096590|NCT01473758|3819584|FG000|NOT COMPLETED|Cycle 1||11
3096591|NCT01473758|3819585|FG001|NOT COMPLETED|Cycle 1||3
3096592|NCT01473758|3819586|FG002|NOT COMPLETED|Cycle 1||0
3096593|NCT01473758|3819587|FG003|NOT COMPLETED|Cycle 1||0
3096594|NCT01473758|3819584|FG000|STARTED|Cycle 2||0
3096595|NCT01473758|3819585|FG001|STARTED|Cycle 2||0
3096596|NCT01473758|3819586|FG002|STARTED|Cycle 2||10
3096597|NCT01473758|3819587|FG003|STARTED|Cycle 2||4
3096598|NCT01473758|3819584|FG000|COMPLETED|Cycle 2||0
3096599|NCT01473758|3819585|FG001|COMPLETED|Cycle 2||0
3096600|NCT01473758|3819586|FG002|COMPLETED|Cycle 2||5
3096601|NCT01473758|3819587|FG003|COMPLETED|Cycle 2||4
3096602|NCT01473758|3819584|FG000|NOT COMPLETED|Cycle 2||0
3096603|NCT01473758|3819585|FG001|NOT COMPLETED|Cycle 2||0
3096604|NCT01473758|3819586|FG002|NOT COMPLETED|Cycle 2||5
3096605|NCT01473758|3819587|FG003|NOT COMPLETED|Cycle 2||0
3096606|NCT01473836|3819595|FG000|STARTED|Overall Study||38
3096607|NCT01473836|3819595|FG000|COMPLETED|Overall Study||32
3096608|NCT01473836|3819595|FG000|NOT COMPLETED|Overall Study||6
3096609|NCT01473940|3819603|FG000|STARTED|Induction Therapy||3
3096610|NCT01473940|3819604|FG001|STARTED|Induction Therapy||4
3096611|NCT01473940|3819605|FG002|STARTED|Induction Therapy||6
3096612|NCT01473940|3819606|FG003|STARTED|Induction Therapy||8
3096613|NCT01473940|3819603|FG000|Started Treatment|Induction Therapy||3
3096614|NCT01473940|3819604|FG001|Started Treatment|Induction Therapy||4
3096615|NCT01473940|3819605|FG002|Started Treatment|Induction Therapy||6
3096616|NCT01473940|3819606|FG003|Started Treatment|Induction Therapy||8
3096617|NCT01473940|3819603|FG000|Completed Induction- 12 Weeks|Induction Therapy||3
3096618|NCT01473940|3819604|FG001|Completed Induction- 12 Weeks|Induction Therapy||3
3096619|NCT01473940|3819605|FG002|Completed Induction- 12 Weeks|Induction Therapy||4
3096620|NCT01473940|3819606|FG003|Completed Induction- 12 Weeks|Induction Therapy||7
3096621|NCT01473940|3819603|FG000|COMPLETED|Induction Therapy||3
3096622|NCT01473940|3819604|FG001|COMPLETED|Induction Therapy||3
3096623|NCT01473940|3819605|FG002|COMPLETED|Induction Therapy||4
3096624|NCT01473940|3819606|FG003|COMPLETED|Induction Therapy||7
3096625|NCT01473940|3819603|FG000|NOT COMPLETED|Induction Therapy||0
3096626|NCT01473940|3819604|FG001|NOT COMPLETED|Induction Therapy||1
3096627|NCT01473940|3819605|FG002|NOT COMPLETED|Induction Therapy||2
3096628|NCT01473940|3819606|FG003|NOT COMPLETED|Induction Therapy||1
3096629|NCT01473940|3819603|FG000|STARTED|Maintenance Therapy||3
3096630|NCT01473940|3819604|FG001|STARTED|Maintenance Therapy||3
3096631|NCT01473940|3819605|FG002|STARTED|Maintenance Therapy||4
3096632|NCT01473940|3819606|FG003|STARTED|Maintenance Therapy||7
3096633|NCT01473940|3819603|FG000|Evaluated for Response|Maintenance Therapy||3
3096634|NCT01473940|3819604|FG001|Evaluated for Response|Maintenance Therapy||3
3096635|NCT01473940|3819605|FG002|Evaluated for Response|Maintenance Therapy||4
3096636|NCT01473940|3819606|FG003|Evaluated for Response|Maintenance Therapy||7
3096637|NCT01473940|3819603|FG000|Went on to Start Maintenance Therapy|Maintenance Therapy||2
3096638|NCT01473940|3819604|FG001|Went on to Start Maintenance Therapy|Maintenance Therapy||1
3096639|NCT01473940|3819605|FG002|Went on to Start Maintenance Therapy|Maintenance Therapy||3
3096640|NCT01473940|3819606|FG003|Went on to Start Maintenance Therapy|Maintenance Therapy||3
3096641|NCT01473940|3819603|FG000|COMPLETED|Maintenance Therapy||2
3096642|NCT01473940|3819604|FG001|COMPLETED|Maintenance Therapy||1
3096643|NCT01473940|3819605|FG002|COMPLETED|Maintenance Therapy||3
3096644|NCT01473940|3819606|FG003|COMPLETED|Maintenance Therapy||3
3096645|NCT01473940|3819603|FG000|NOT COMPLETED|Maintenance Therapy||1
3096646|NCT01473940|3819604|FG001|NOT COMPLETED|Maintenance Therapy||2
3096647|NCT01473940|3819605|FG002|NOT COMPLETED|Maintenance Therapy||1
3096648|NCT01473940|3819606|FG003|NOT COMPLETED|Maintenance Therapy||4
3096649|NCT01473940|3819603|FG000|STARTED|Follow-up Until Death||3
3096650|NCT01473940|3819604|FG001|STARTED|Follow-up Until Death||4
3096651|NCT01473940|3819605|FG002|STARTED|Follow-up Until Death||5
3096652|NCT01473940|3819606|FG003|STARTED|Follow-up Until Death||7
3096653|NCT01473940|3819603|FG000|COMPLETED|Follow-up Until Death||3
3096654|NCT01473940|3819604|FG001|COMPLETED|Follow-up Until Death||4
3096655|NCT01473940|3819605|FG002|COMPLETED|Follow-up Until Death||5
3096656|NCT01473940|3819606|FG003|COMPLETED|Follow-up Until Death||7
3096657|NCT01473940|3819603|FG000|NOT COMPLETED|Follow-up Until Death||0
3096658|NCT01473940|3819604|FG001|NOT COMPLETED|Follow-up Until Death||0
3096659|NCT01473940|3819605|FG002|NOT COMPLETED|Follow-up Until Death||0
3096660|NCT01473940|3819606|FG003|NOT COMPLETED|Follow-up Until Death||0
3096661|NCT01473953|3819624|FG000|STARTED|Overall Study||6
3096662|NCT01473953|3819625|FG001|STARTED|Overall Study||6
3096663|NCT01473953|3819626|FG002|STARTED|Overall Study||6
3096664|NCT01473953|3819627|FG003|STARTED|Overall Study||5
3096665|NCT01473953|3819628|FG004|STARTED|Overall Study||8
3096666|NCT01473953|3819624|FG000|COMPLETED|Overall Study||5
3096667|NCT01473953|3819625|FG001|COMPLETED|Overall Study||6
3096668|NCT01473953|3819626|FG002|COMPLETED|Overall Study||6
3096669|NCT01473953|3819627|FG003|COMPLETED|Overall Study||5
3096670|NCT01473953|3819628|FG004|COMPLETED|Overall Study||8
3096671|NCT01473953|3819624|FG000|NOT COMPLETED|Overall Study||1
3096672|NCT01473953|3819625|FG001|NOT COMPLETED|Overall Study||0
3096673|NCT01473953|3819626|FG002|NOT COMPLETED|Overall Study||0
3096674|NCT01473953|3819627|FG003|NOT COMPLETED|Overall Study||0
3096675|NCT01473953|3819628|FG004|NOT COMPLETED|Overall Study||0
3096676|NCT01473992|3819642|FG000|STARTED|Overall Study||10
3096677|NCT01473992|3819643|FG001|STARTED|Overall Study||10
3096678|NCT01473992|3819644|FG002|STARTED|Overall Study||5
3096679|NCT01473992|3819642|FG000|COMPLETED|Overall Study||10
3096680|NCT01473992|3819643|FG001|COMPLETED|Overall Study||10
3096681|NCT01473992|3819644|FG002|COMPLETED|Overall Study||5
3096682|NCT01473992|3819642|FG000|NOT COMPLETED|Overall Study||0
3096683|NCT01473992|3819643|FG001|NOT COMPLETED|Overall Study||0
3096684|NCT01473992|3819644|FG002|NOT COMPLETED|Overall Study||0
3096685|NCT01474018|3819654|FG000|STARTED|Overall Study||5
3096686|NCT01474018|3819655|FG001|STARTED|Overall Study||10
3096687|NCT01474018|3819654|FG000|COMPLETED|Overall Study|Writing paper|5
3096688|NCT01474018|3819655|FG001|COMPLETED|Overall Study||7
3096689|NCT01474018|3819654|FG000|NOT COMPLETED|Overall Study||0
3096690|NCT01474018|3819655|FG001|NOT COMPLETED|Overall Study||3
3096691|NCT01474109|3819664|FG000|STARTED|Period 1: Baseline to Week 16||95
3096692|NCT01474109|3819665|FG001|STARTED|Period 1: Baseline to Week 16||97
3096693|NCT01474109|3819666|FG002|STARTED|Period 1: Baseline to Week 16||97
3096694|NCT01474109|3819664|FG000|COMPLETED|Period 1: Baseline to Week 16||88
3096695|NCT01474109|3819665|FG001|COMPLETED|Period 1: Baseline to Week 16||91
3096696|NCT01474109|3819666|FG002|COMPLETED|Period 1: Baseline to Week 16||95
3096697|NCT01474109|3819664|FG000|NOT COMPLETED|Period 1: Baseline to Week 16||7
3096698|NCT01474109|3819665|FG001|NOT COMPLETED|Period 1: Baseline to Week 16||6
3096699|NCT01474109|3819666|FG002|NOT COMPLETED|Period 1: Baseline to Week 16||2
3096700|NCT01474109|3819664|FG000|STARTED|Period 2: Week 16 to End of Study||88
3096701|NCT01474109|3819665|FG001|STARTED|Period 2: Week 16 to End of Study||91
3096702|NCT01474109|3819666|FG002|STARTED|Period 2: Week 16 to End of Study||95
3096703|NCT01474109|3819664|FG000|COMPLETED|Period 2: Week 16 to End of Study||70
3096704|NCT01474109|3819665|FG001|COMPLETED|Period 2: Week 16 to End of Study||73
3096705|NCT01474109|3819666|FG002|COMPLETED|Period 2: Week 16 to End of Study||83
3096706|NCT01474109|3819664|FG000|NOT COMPLETED|Period 2: Week 16 to End of Study||18
3096707|NCT01474109|3819665|FG001|NOT COMPLETED|Period 2: Week 16 to End of Study||18
3096708|NCT01474109|3819666|FG002|NOT COMPLETED|Period 2: Week 16 to End of Study||12
3096709|NCT01474122|3819677|FG000|STARTED|Period 1: Baseline to Week 16||88
3096710|NCT01474122|3819678|FG001|STARTED|Period 1: Baseline to Week 16|One patient was randomised but did not receive study treatment|88
3096711|NCT01474122|3819679|FG002|STARTED|Period 1: Baseline to Week 16||89
3096712|NCT01474122|3819677|FG000|COMPLETED|Period 1: Baseline to Week 16||87
3096713|NCT01474122|3819678|FG001|COMPLETED|Period 1: Baseline to Week 16||86
3096714|NCT01474122|3819679|FG002|COMPLETED|Period 1: Baseline to Week 16||88
3096715|NCT01474122|3819677|FG000|NOT COMPLETED|Period 1: Baseline to Week 16||1
3096716|NCT01474122|3819678|FG001|NOT COMPLETED|Period 1: Baseline to Week 16||2
3096717|NCT01474122|3819679|FG002|NOT COMPLETED|Period 1: Baseline to Week 16||1
3096718|NCT01474122|3819677|FG000|STARTED|Period 2: Week 16 to End of Study||87
3096719|NCT01474122|3819678|FG001|STARTED|Period 2: Week 16 to End of Study||86
3096720|NCT01474122|3819679|FG002|STARTED|Period 2: Week 16 to End of Study||88
3096721|NCT01474122|3819677|FG000|COMPLETED|Period 2: Week 16 to End of Study|Patients on treatment at the time of study termination|70
3096722|NCT01474122|3819678|FG001|COMPLETED|Period 2: Week 16 to End of Study|Patients on treatment at the time of study termination|73
3096723|NCT01474122|3819679|FG002|COMPLETED|Period 2: Week 16 to End of Study|Patients on treatment at the time of study termination|73
3096724|NCT01474122|3819677|FG000|NOT COMPLETED|Period 2: Week 16 to End of Study||17
3096725|NCT01474122|3819678|FG001|NOT COMPLETED|Period 2: Week 16 to End of Study||13
3096726|NCT01474122|3819679|FG002|NOT COMPLETED|Period 2: Week 16 to End of Study||15
3096727|NCT01474200|3819691|FG000|STARTED|Overall Study||110
3096728|NCT01474200|3819692|FG001|STARTED|Overall Study||114
3096729|NCT01474200|3819691|FG000|COMPLETED|Overall Study||81
3096730|NCT01474200|3819692|FG001|COMPLETED|Overall Study||84
3096731|NCT01474200|3819691|FG000|NOT COMPLETED|Overall Study||29
3096732|NCT01474200|3819692|FG001|NOT COMPLETED|Overall Study||30
3096733|NCT01474213|3819700|FG000|STARTED|Overall Study||20
3096734|NCT01474213|3819701|FG001|STARTED|Overall Study||20
3096735|NCT01474213|3819700|FG000|COMPLETED|Overall Study||20
3096736|NCT01474213|3819701|FG001|COMPLETED|Overall Study||20
3096737|NCT01474213|3819700|FG000|NOT COMPLETED|Overall Study||0
3096738|NCT01474213|3819701|FG001|NOT COMPLETED|Overall Study||0
3096739|NCT01474239|3819713|FG000|STARTED|Overall Study||59
3096740|NCT01474239|3819714|FG001|STARTED|Overall Study||32
3096741|NCT01474239|3819713|FG000|COMPLETED|Overall Study||0
3096742|NCT01474239|3819714|FG001|COMPLETED|Overall Study||0
3096743|NCT01474239|3819713|FG000|NOT COMPLETED|Overall Study||59
3096744|NCT01474239|3819714|FG001|NOT COMPLETED|Overall Study||32
3096745|NCT01474291|3819722|FG000|STARTED|Overall Study||603
3096746|NCT01474291|3819722|FG000|Evaluable for Efficacy|Overall Study|Received tocilizumab infusion and met all inclusion/exclusion criteria|577
3096747|NCT01474291|3819722|FG000|COMPLETED|Overall Study||383
3096748|NCT01474291|3819722|FG000|NOT COMPLETED|Overall Study||220
3096749|NCT01474317|3819729|FG000|STARTED|Overall Study||226
3096750|NCT01474317|3819729|FG000|COMPLETED|Overall Study||224
3096751|NCT01474317|3819729|FG000|NOT COMPLETED|Overall Study||2
3096752|NCT01474434|3819737|FG000|STARTED|Treatment Period 1 (5 Days [Day 1 - 5])||8
3096753|NCT01474434|3819738|FG001|STARTED|Treatment Period 1 (5 Days [Day 1 - 5])||9
3096754|NCT01474434|3819739|FG002|STARTED|Treatment Period 1 (5 Days [Day 1 - 5])||11
3096755|NCT01474434|3819740|FG003|STARTED|Treatment Period 1 (5 Days [Day 1 - 5])||13
3096756|NCT01474434|3819737|FG000|COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||7
3096757|NCT01474434|3819738|FG001|COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||9
3096758|NCT01474434|3819739|FG002|COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||10
3096759|NCT01474434|3819740|FG003|COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||11
3096760|NCT01474434|3819737|FG000|NOT COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||1
3096761|NCT01474434|3819738|FG001|NOT COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||0
3096762|NCT01474434|3819739|FG002|NOT COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||1
3096763|NCT01474434|3819740|FG003|NOT COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||2
3096764|NCT01474434|3819737|FG000|STARTED|Treatment Period 2(5 Days[Day 36 - 40])||7
3096765|NCT01474434|3819738|FG001|STARTED|Treatment Period 2(5 Days[Day 36 - 40])||9
3096766|NCT01474434|3819739|FG002|STARTED|Treatment Period 2(5 Days[Day 36 - 40])||10
3096767|NCT01474434|3819740|FG003|STARTED|Treatment Period 2(5 Days[Day 36 - 40])||11
3096768|NCT01474434|3819737|FG000|COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||7
3096769|NCT01474434|3819738|FG001|COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||9
3096770|NCT01474434|3819739|FG002|COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||10
3096771|NCT01474434|3819740|FG003|COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||11
3096772|NCT01474434|3819737|FG000|NOT COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||0
3096773|NCT01474434|3819738|FG001|NOT COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||0
3096774|NCT01474434|3819739|FG002|NOT COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||0
3096775|NCT01474434|3819740|FG003|NOT COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||0
3096776|NCT01474486|3819754|FG000|STARTED|Overall Study||28
3096777|NCT01474486|3819754|FG000|Treated|Overall Study||22
3096778|NCT01474486|3819754|FG000|COMPLETED|Overall Study||20
3096779|NCT01474486|3819754|FG000|NOT COMPLETED|Overall Study||8
3096780|NCT01474512|3819765|FG000|STARTED|Induction Period||431
3096781|NCT01474512|3819766|FG001|STARTED|Induction Period||432
3096782|NCT01474512|3819767|FG002|STARTED|Induction Period||433
3096783|NCT01474512|3819768|FG003|STARTED|Induction Period||0
3096784|NCT01474512|3819769|FG004|STARTED|Induction Period||0
3096785|NCT01474512|3819770|FG005|STARTED|Induction Period||0
3096786|NCT01474512|3819771|FG006|STARTED|Induction Period||0
3096787|NCT01474512|3819772|FG007|STARTED|Induction Period||0
3096788|NCT01474512|3819773|FG008|STARTED|Induction Period||0
3096789|NCT01474512|3819774|FG009|STARTED|Induction Period||0
3096790|NCT01474512|3819775|FG010|STARTED|Induction Period||0
3096791|NCT01474512|3819776|FG011|STARTED|Induction Period||0
3096792|NCT01474512|3819777|FG012|STARTED|Induction Period||0
3096793|NCT01474512|3819778|FG013|STARTED|Induction Period||0
3096794|NCT01474512|3819779|FG014|STARTED|Induction Period||0
3096795|NCT01474512|3819780|FG015|STARTED|Induction Period||0
3096796|NCT01474512|3819781|FG016|STARTED|Induction Period||0
3096797|NCT01474512|3819782|FG017|STARTED|Induction Period||0
3096798|NCT01474512|3819765|FG000|Received Study Drug|Induction Period||431
3096799|NCT01474512|3819766|FG001|Received Study Drug|Induction Period||432
3096800|NCT01474512|3819767|FG002|Received Study Drug|Induction Period||433
3096801|NCT01474512|3819768|FG003|Received Study Drug|Induction Period||0
3096802|NCT01474512|3819769|FG004|Received Study Drug|Induction Period||0
3096803|NCT01474512|3819770|FG005|Received Study Drug|Induction Period||0
3096804|NCT01474512|3819771|FG006|Received Study Drug|Induction Period||0
3096805|NCT01474512|3819772|FG007|Received Study Drug|Induction Period||0
3096806|NCT01474512|3819773|FG008|Received Study Drug|Induction Period||0
3096807|NCT01474512|3819774|FG009|Received Study Drug|Induction Period||0
3096808|NCT01474512|3819775|FG010|Received Study Drug|Induction Period||0
3096809|NCT01474512|3819776|FG011|Received Study Drug|Induction Period||0
3096810|NCT01474512|3819777|FG012|Received Study Drug|Induction Period||0
3096811|NCT01474512|3819778|FG013|Received Study Drug|Induction Period||0
3096812|NCT01474512|3819779|FG014|Received Study Drug|Induction Period||0
3096813|NCT01474512|3819780|FG015|Received Study Drug|Induction Period||0
3096814|NCT01474512|3819781|FG016|Received Study Drug|Induction Period||0
3096815|NCT01474512|3819782|FG017|Received Study Drug|Induction Period||0
3096816|NCT01474512|3819765|FG000|COMPLETED|Induction Period||407
3096817|NCT01474512|3819766|FG001|COMPLETED|Induction Period||408
3096818|NCT01474512|3819767|FG002|COMPLETED|Induction Period||415
3096819|NCT01474512|3819768|FG003|COMPLETED|Induction Period||0
3096820|NCT01474512|3819769|FG004|COMPLETED|Induction Period||0
3096821|NCT01474512|3819770|FG005|COMPLETED|Induction Period||0
3096822|NCT01474512|3819771|FG006|COMPLETED|Induction Period||0
3096823|NCT01474512|3819772|FG007|COMPLETED|Induction Period||0
3096824|NCT01474512|3819773|FG008|COMPLETED|Induction Period||0
3096825|NCT01474512|3819774|FG009|COMPLETED|Induction Period||0
3096826|NCT01474512|3819775|FG010|COMPLETED|Induction Period||0
3096827|NCT01474512|3819776|FG011|COMPLETED|Induction Period||0
3096828|NCT01474512|3819777|FG012|COMPLETED|Induction Period||0
3096829|NCT01474512|3819778|FG013|COMPLETED|Induction Period||0
3096830|NCT01474512|3819779|FG014|COMPLETED|Induction Period||0
3096831|NCT01474512|3819780|FG015|COMPLETED|Induction Period||0
3096832|NCT01474512|3819781|FG016|COMPLETED|Induction Period||0
3096833|NCT01474512|3819782|FG017|COMPLETED|Induction Period||0
3096834|NCT01474512|3819765|FG000|NOT COMPLETED|Induction Period||24
3096835|NCT01474512|3819766|FG001|NOT COMPLETED|Induction Period||24
3096836|NCT01474512|3819767|FG002|NOT COMPLETED|Induction Period||18
3096837|NCT01474512|3819768|FG003|NOT COMPLETED|Induction Period||0
3096838|NCT01474512|3819769|FG004|NOT COMPLETED|Induction Period||0
3096839|NCT01474512|3819770|FG005|NOT COMPLETED|Induction Period||0
3096840|NCT01474512|3819771|FG006|NOT COMPLETED|Induction Period||0
3096841|NCT01474512|3819772|FG007|NOT COMPLETED|Induction Period||0
3096842|NCT01474512|3819773|FG008|NOT COMPLETED|Induction Period||0
3096843|NCT01474512|3819774|FG009|NOT COMPLETED|Induction Period||0
3096844|NCT01474512|3819775|FG010|NOT COMPLETED|Induction Period||0
3096845|NCT01474512|3819776|FG011|NOT COMPLETED|Induction Period||0
3096846|NCT01474512|3819777|FG012|NOT COMPLETED|Induction Period||0
3096847|NCT01474512|3819778|FG013|NOT COMPLETED|Induction Period||0
3096848|NCT01474512|3819779|FG014|NOT COMPLETED|Induction Period||0
3096849|NCT01474512|3819780|FG015|NOT COMPLETED|Induction Period||0
3096850|NCT01474512|3819781|FG016|NOT COMPLETED|Induction Period||0
3096851|NCT01474512|3819782|FG017|NOT COMPLETED|Induction Period||0
3096852|NCT01474512|3819765|FG000|STARTED|Maintenance Period||0
3096853|NCT01474512|3819766|FG001|STARTED|Maintenance Period||0
3096854|NCT01474512|3819767|FG002|STARTED|Maintenance Period||0
3096855|NCT01474512|3819768|FG003|STARTED|Maintenance Period||226
3096856|NCT01474512|3819769|FG004|STARTED|Maintenance Period|One participant withdrew end of Induction but re-randomized and treated with maintenance dose ixe.|227
3096857|NCT01474512|3819770|FG005|STARTED|Maintenance Period||229
3096858|NCT01474512|3819771|FG006|STARTED|Maintenance Period||16
3096859|NCT01474512|3819772|FG007|STARTED|Maintenance Period||391
3096860|NCT01474512|3819773|FG008|STARTED|Maintenance Period||78
3290231|NCT02826421|4024131|FG001|Treated|Overall Study||26
3290232|NCT02826421|4024132|FG002|Treated|Overall Study||26
3290233|NCT02826421|4024133|FG003|Treated|Overall Study||28
3290234|NCT02826421|4024130|FG000|COMPLETED|Overall Study||19
3290235|NCT02826421|4024131|FG001|COMPLETED|Overall Study||26
3290236|NCT02826421|4024132|FG002|COMPLETED|Overall Study||26
3096861|NCT01474512|3819774|FG009|STARTED|Maintenance Period||62
3096862|NCT01474512|3819775|FG010|STARTED|Maintenance Period||0
3096863|NCT01474512|3819776|FG011|STARTED|Maintenance Period||0
3096864|NCT01474512|3819777|FG012|STARTED|Maintenance Period||0
3096865|NCT01474512|3819778|FG013|STARTED|Maintenance Period||0
3096866|NCT01474512|3819779|FG014|STARTED|Maintenance Period||0
3096867|NCT01474512|3819780|FG015|STARTED|Maintenance Period||0
3096868|NCT01474512|3819781|FG016|STARTED|Maintenance Period||0
3096869|NCT01474512|3819782|FG017|STARTED|Maintenance Period||0
3096870|NCT01474512|3819765|FG000|Received Study Drug|Maintenance Period||0
3096871|NCT01474512|3819766|FG001|Received Study Drug|Maintenance Period||0
3096872|NCT01474512|3819767|FG002|Received Study Drug|Maintenance Period||0
3096873|NCT01474512|3819768|FG003|Received Study Drug|Maintenance Period||226
3096874|NCT01474512|3819769|FG004|Received Study Drug|Maintenance Period||227
3096875|NCT01474512|3819770|FG005|Received Study Drug|Maintenance Period||229
3096876|NCT01474512|3819771|FG006|Received Study Drug|Maintenance Period||16
3096877|NCT01474512|3819772|FG007|Received Study Drug|Maintenance Period||391
3096878|NCT01474512|3819773|FG008|Received Study Drug|Maintenance Period||78
3096879|NCT01474512|3819774|FG009|Received Study Drug|Maintenance Period||62
3096880|NCT01474512|3819775|FG010|Received Study Drug|Maintenance Period||0
3096881|NCT01474512|3819776|FG011|Received Study Drug|Maintenance Period||0
3096882|NCT01474512|3819777|FG012|Received Study Drug|Maintenance Period||0
3096883|NCT01474512|3819778|FG013|Received Study Drug|Maintenance Period||0
3096884|NCT01474512|3819779|FG014|Received Study Drug|Maintenance Period||0
3096885|NCT01474512|3819780|FG015|Received Study Drug|Maintenance Period||0
3096886|NCT01474512|3819781|FG016|Received Study Drug|Maintenance Period||0
3096887|NCT01474512|3819782|FG017|Received Study Drug|Maintenance Period||0
3096888|NCT01474512|3819765|FG000|Relapsed Population Received Drug|Maintenance Period||0
3096889|NCT01474512|3819766|FG001|Relapsed Population Received Drug|Maintenance Period||0
3096890|NCT01474512|3819767|FG002|Relapsed Population Received Drug|Maintenance Period||0
3096891|NCT01474512|3819768|FG003|Relapsed Population Received Drug|Maintenance Period||0
3096892|NCT01474512|3819769|FG004|Relapsed Population Received Drug|Maintenance Period||0
3096893|NCT01474512|3819770|FG005|Relapsed Population Received Drug|Maintenance Period||0
3096894|NCT01474512|3819771|FG006|Relapsed Population Received Drug|Maintenance Period||0
3096895|NCT01474512|3819772|FG007|Relapsed Population Received Drug|Maintenance Period||0
3096896|NCT01474512|3819773|FG008|Relapsed Population Received Drug|Maintenance Period||0
3096897|NCT01474512|3819774|FG009|Relapsed Population Received Drug|Maintenance Period||0
3096898|NCT01474512|3819775|FG010|Relapsed Population Received Drug|Maintenance Period||348
3290237|NCT02826421|4024133|FG003|COMPLETED|Overall Study||28
3096899|NCT01474512|3819776|FG011|Relapsed Population Received Drug|Maintenance Period||0
3096900|NCT01474512|3819777|FG012|Relapsed Population Received Drug|Maintenance Period||0
3096901|NCT01474512|3819778|FG013|Relapsed Population Received Drug|Maintenance Period||0
3096902|NCT01474512|3819779|FG014|Relapsed Population Received Drug|Maintenance Period||0
3096903|NCT01474512|3819780|FG015|Relapsed Population Received Drug|Maintenance Period||0
3096904|NCT01474512|3819781|FG016|Relapsed Population Received Drug|Maintenance Period||0
3096905|NCT01474512|3819782|FG017|Relapsed Population Received Drug|Maintenance Period||0
3096906|NCT01474512|3819765|FG000|Relapsed Population Completers|Maintenance Period||0
3096907|NCT01474512|3819766|FG001|Relapsed Population Completers|Maintenance Period||0
3096908|NCT01474512|3819767|FG002|Relapsed Population Completers|Maintenance Period||0
3096909|NCT01474512|3819768|FG003|Relapsed Population Completers|Maintenance Period||0
3096910|NCT01474512|3819769|FG004|Relapsed Population Completers|Maintenance Period||0
3096911|NCT01474512|3819770|FG005|Relapsed Population Completers|Maintenance Period||0
3096912|NCT01474512|3819771|FG006|Relapsed Population Completers|Maintenance Period||0
3096913|NCT01474512|3819772|FG007|Relapsed Population Completers|Maintenance Period||0
3096914|NCT01474512|3819773|FG008|Relapsed Population Completers|Maintenance Period||0
3096915|NCT01474512|3819774|FG009|Relapsed Population Completers|Maintenance Period||0
3096916|NCT01474512|3819775|FG010|Relapsed Population Completers|Maintenance Period||321
3096917|NCT01474512|3819776|FG011|Relapsed Population Completers|Maintenance Period||0
3096918|NCT01474512|3819777|FG012|Relapsed Population Completers|Maintenance Period||0
3096919|NCT01474512|3819778|FG013|Relapsed Population Completers|Maintenance Period||0
3096920|NCT01474512|3819779|FG014|Relapsed Population Completers|Maintenance Period||0
3096921|NCT01474512|3819780|FG015|Relapsed Population Completers|Maintenance Period||0
3096922|NCT01474512|3819781|FG016|Relapsed Population Completers|Maintenance Period||0
3096923|NCT01474512|3819782|FG017|Relapsed Population Completers|Maintenance Period||0
3096924|NCT01474512|3819765|FG000|COMPLETED|Maintenance Period||0
3096925|NCT01474512|3819766|FG001|COMPLETED|Maintenance Period||0
3096926|NCT01474512|3819767|FG002|COMPLETED|Maintenance Period||0
3096927|NCT01474512|3819768|FG003|COMPLETED|Maintenance Period||24
3096928|NCT01474512|3819769|FG004|COMPLETED|Maintenance Period||108
3096929|NCT01474512|3819770|FG005|COMPLETED|Maintenance Period||177
3096930|NCT01474512|3819771|FG006|COMPLETED|Maintenance Period||6
3096931|NCT01474512|3819772|FG007|COMPLETED|Maintenance Period||350
3096932|NCT01474512|3819773|FG008|COMPLETED|Maintenance Period||62
3096933|NCT01474512|3819774|FG009|COMPLETED|Maintenance Period||44
3096934|NCT01474512|3819775|FG010|COMPLETED|Maintenance Period||0
3096935|NCT01474512|3819776|FG011|COMPLETED|Maintenance Period||0
3096936|NCT01474512|3819777|FG012|COMPLETED|Maintenance Period||0
3096937|NCT01474512|3819778|FG013|COMPLETED|Maintenance Period||0
3096938|NCT01474512|3819779|FG014|COMPLETED|Maintenance Period||0
3096939|NCT01474512|3819780|FG015|COMPLETED|Maintenance Period||0
3096940|NCT01474512|3819781|FG016|COMPLETED|Maintenance Period||0
3096941|NCT01474512|3819782|FG017|COMPLETED|Maintenance Period||0
3096942|NCT01474512|3819765|FG000|NOT COMPLETED|Maintenance Period||0
3096943|NCT01474512|3819766|FG001|NOT COMPLETED|Maintenance Period||0
3096944|NCT01474512|3819767|FG002|NOT COMPLETED|Maintenance Period||0
3096945|NCT01474512|3819768|FG003|NOT COMPLETED|Maintenance Period||202
3096946|NCT01474512|3819769|FG004|NOT COMPLETED|Maintenance Period||119
3096947|NCT01474512|3819770|FG005|NOT COMPLETED|Maintenance Period||52
3096948|NCT01474512|3819771|FG006|NOT COMPLETED|Maintenance Period||10
3096949|NCT01474512|3819772|FG007|NOT COMPLETED|Maintenance Period||41
3096950|NCT01474512|3819773|FG008|NOT COMPLETED|Maintenance Period||16
3096951|NCT01474512|3819774|FG009|NOT COMPLETED|Maintenance Period||18
3096952|NCT01474512|3819775|FG010|NOT COMPLETED|Maintenance Period||0
3096953|NCT01474512|3819776|FG011|NOT COMPLETED|Maintenance Period||0
3096954|NCT01474512|3819777|FG012|NOT COMPLETED|Maintenance Period||0
3096955|NCT01474512|3819778|FG013|NOT COMPLETED|Maintenance Period||0
3096956|NCT01474512|3819779|FG014|NOT COMPLETED|Maintenance Period||0
3096957|NCT01474512|3819780|FG015|NOT COMPLETED|Maintenance Period||0
3096958|NCT01474512|3819781|FG016|NOT COMPLETED|Maintenance Period||0
3096959|NCT01474512|3819782|FG017|NOT COMPLETED|Maintenance Period||0
3096960|NCT01474512|3819765|FG000|STARTED|Long-Term Extension Period||0
3096961|NCT01474512|3819766|FG001|STARTED|Long-Term Extension Period||0
3096962|NCT01474512|3819767|FG002|STARTED|Long-Term Extension Period||0
3096963|NCT01474512|3819768|FG003|STARTED|Long-Term Extension Period||0
3096964|NCT01474512|3819769|FG004|STARTED|Long-Term Extension Period||0
3096965|NCT01474512|3819770|FG005|STARTED|Long-Term Extension Period||0
3096966|NCT01474512|3819771|FG006|STARTED|Long-Term Extension Period||0
3096967|NCT01474512|3819772|FG007|STARTED|Long-Term Extension Period||0
3096968|NCT01474512|3819773|FG008|STARTED|Long-Term Extension Period||0
3096969|NCT01474512|3819774|FG009|STARTED|Long-Term Extension Period||0
3096970|NCT01474512|3819775|FG010|STARTED|Long-Term Extension Period||0
3096971|NCT01474512|3819776|FG011|STARTED|Long-Term Extension Period|9 participants did not start the long-term extension period.|26
3290238|NCT02826421|4024130|FG000|NOT COMPLETED|Overall Study||3
3290239|NCT02826421|4024131|FG001|NOT COMPLETED|Overall Study||3
3290240|NCT02826421|4024132|FG002|NOT COMPLETED|Overall Study||2
3290241|NCT02826421|4024133|FG003|NOT COMPLETED|Overall Study||2
3290242|NCT02826603|4024146|FG000|STARTED|Overall Study||550
3290243|NCT02826603|4024147|FG001|STARTED|Overall Study||552
3290244|NCT02826603|4024146|FG000|COMPLETED|Overall Study||489
3290245|NCT02826603|4024147|FG001|COMPLETED|Overall Study||488
3290246|NCT02826603|4024146|FG000|NOT COMPLETED|Overall Study||61
3096972|NCT01474512|3819777|FG012|STARTED|Long-Term Extension Period|Participants received Ixe alone at the start of long-term extension.|1054
3096973|NCT01474512|3819778|FG013|STARTED|Long-Term Extension Period|Participants received Ixe in all dosing regimens, including participants who switched PBO to Ixe.|1075
3096974|NCT01474512|3819779|FG014|STARTED|Long-Term Extension Period||0
3096975|NCT01474512|3819780|FG015|STARTED|Long-Term Extension Period||0
3096976|NCT01474512|3819781|FG016|STARTED|Long-Term Extension Period||0
3096977|NCT01474512|3819782|FG017|STARTED|Long-Term Extension Period||0
3096978|NCT01474512|3819765|FG000|COMPLETED|Long-Term Extension Period||0
3096979|NCT01474512|3819766|FG001|COMPLETED|Long-Term Extension Period||0
3096980|NCT01474512|3819767|FG002|COMPLETED|Long-Term Extension Period||0
3096981|NCT01474512|3819768|FG003|COMPLETED|Long-Term Extension Period||0
3096982|NCT01474512|3819769|FG004|COMPLETED|Long-Term Extension Period||0
3096983|NCT01474512|3819770|FG005|COMPLETED|Long-Term Extension Period||0
3096984|NCT01474512|3819771|FG006|COMPLETED|Long-Term Extension Period||0
3096985|NCT01474512|3819772|FG007|COMPLETED|Long-Term Extension Period||0
3096986|NCT01474512|3819773|FG008|COMPLETED|Long-Term Extension Period||0
3096987|NCT01474512|3819774|FG009|COMPLETED|Long-Term Extension Period||0
3096988|NCT01474512|3819775|FG010|COMPLETED|Long-Term Extension Period||0
3096989|NCT01474512|3819776|FG011|COMPLETED|Long-Term Extension Period||0
3096990|NCT01474512|3819777|FG012|COMPLETED|Long-Term Extension Period||836
3096991|NCT01474512|3819778|FG013|COMPLETED|Long-Term Extension Period||855
3096992|NCT01474512|3819779|FG014|COMPLETED|Long-Term Extension Period||0
3096993|NCT01474512|3819780|FG015|COMPLETED|Long-Term Extension Period||0
3096994|NCT01474512|3819781|FG016|COMPLETED|Long-Term Extension Period||0
3096995|NCT01474512|3819782|FG017|COMPLETED|Long-Term Extension Period||0
3096996|NCT01474512|3819765|FG000|NOT COMPLETED|Long-Term Extension Period||0
3096997|NCT01474512|3819766|FG001|NOT COMPLETED|Long-Term Extension Period||0
3096998|NCT01474512|3819767|FG002|NOT COMPLETED|Long-Term Extension Period||0
3096999|NCT01474512|3819768|FG003|NOT COMPLETED|Long-Term Extension Period||0
3097000|NCT01474512|3819769|FG004|NOT COMPLETED|Long-Term Extension Period||0
3097001|NCT01474512|3819770|FG005|NOT COMPLETED|Long-Term Extension Period||0
3097002|NCT01474512|3819771|FG006|NOT COMPLETED|Long-Term Extension Period||0
3097003|NCT01474512|3819772|FG007|NOT COMPLETED|Long-Term Extension Period||0
3097004|NCT01474512|3819773|FG008|NOT COMPLETED|Long-Term Extension Period||0
3097005|NCT01474512|3819774|FG009|NOT COMPLETED|Long-Term Extension Period||0
3097006|NCT01474512|3819775|FG010|NOT COMPLETED|Long-Term Extension Period||0
3097007|NCT01474512|3819776|FG011|NOT COMPLETED|Long-Term Extension Period||26
3097008|NCT01474512|3819777|FG012|NOT COMPLETED|Long-Term Extension Period||218
3097009|NCT01474512|3819778|FG013|NOT COMPLETED|Long-Term Extension Period||220
3097010|NCT01474512|3819779|FG014|NOT COMPLETED|Long-Term Extension Period||0
3097011|NCT01474512|3819780|FG015|NOT COMPLETED|Long-Term Extension Period||0
3097012|NCT01474512|3819781|FG016|NOT COMPLETED|Long-Term Extension Period||0
3097013|NCT01474512|3819782|FG017|NOT COMPLETED|Long-Term Extension Period||0
3097014|NCT01474512|3819765|FG000|STARTED|Post-Treatment Follow-Up||0
3097015|NCT01474512|3819766|FG001|STARTED|Post-Treatment Follow-Up||0
3097016|NCT01474512|3819767|FG002|STARTED|Post-Treatment Follow-Up||0
3097017|NCT01474512|3819768|FG003|STARTED|Post-Treatment Follow-Up||0
3290247|NCT02826603|4024147|FG001|NOT COMPLETED|Overall Study||64
3290248|NCT02826694|4024156|FG000|STARTED|Overall Study||61
3290249|NCT02826694|4024157|FG001|STARTED|Overall Study||45
3290250|NCT02826694|4024156|FG000|Decision Group|Overall Study||41
3290251|NCT02826694|4024157|FG001|Decision Group|Overall Study||30
3290252|NCT02826694|4024156|FG000|Control Group|Overall Study||20
3290253|NCT02826694|4024157|FG001|Control Group|Overall Study||15
3290254|NCT02826694|4024156|FG000|COMPLETED|Overall Study||61
3290255|NCT02826694|4024157|FG001|COMPLETED|Overall Study||45
3290256|NCT02826694|4024156|FG000|NOT COMPLETED|Overall Study||0
3290257|NCT02826694|4024157|FG001|NOT COMPLETED|Overall Study||0
3290258|NCT02826798|4024170|FG000|STARTED|Overall Study||25
3290259|NCT02826798|4024171|FG001|STARTED|Overall Study||26
3290260|NCT02826798|4024172|FG002|STARTED|Overall Study||26
3290261|NCT02826798|4024173|FG003|STARTED|Overall Study||25
3290262|NCT02826798|4024174|FG004|STARTED|Overall Study||26
3290263|NCT02826798|4024170|FG000|COMPLETED|Overall Study||25
3097018|NCT01474512|3819769|FG004|STARTED|Post-Treatment Follow-Up||0
3097019|NCT01474512|3819770|FG005|STARTED|Post-Treatment Follow-Up||0
3097020|NCT01474512|3819771|FG006|STARTED|Post-Treatment Follow-Up||0
3097021|NCT01474512|3819772|FG007|STARTED|Post-Treatment Follow-Up||0
3097022|NCT01474512|3819773|FG008|STARTED|Post-Treatment Follow-Up||0
3097023|NCT01474512|3819774|FG009|STARTED|Post-Treatment Follow-Up||0
3097024|NCT01474512|3819775|FG010|STARTED|Post-Treatment Follow-Up||0
3097025|NCT01474512|3819776|FG011|STARTED|Post-Treatment Follow-Up||0
3097026|NCT01474512|3819777|FG012|STARTED|Post-Treatment Follow-Up||0
3097027|NCT01474512|3819778|FG013|STARTED|Post-Treatment Follow-Up||0
3097028|NCT01474512|3819779|FG014|STARTED|Post-Treatment Follow-Up|Includes participants who started the post treatment follow-up period.|18
3097029|NCT01474512|3819780|FG015|STARTED|Post-Treatment Follow-Up|Includes participants who started the post treatment follow-up period.|25
3135258|NCT01705730|3860245|FG000|NOT COMPLETED|Overall Study||9
3290264|NCT02826798|4024171|FG001|COMPLETED|Overall Study||25
3290265|NCT02826798|4024172|FG002|COMPLETED|Overall Study||26
3290266|NCT02826798|4024173|FG003|COMPLETED|Overall Study||24
3290267|NCT02826798|4024174|FG004|COMPLETED|Overall Study||26
3290268|NCT02826798|4024170|FG000|NOT COMPLETED|Overall Study||0
3290269|NCT02826798|4024171|FG001|NOT COMPLETED|Overall Study||1
3097030|NCT01474512|3819781|FG016|STARTED|Post-Treatment Follow-Up|Includes participants who started the post treatment follow-up period.|700
3097031|NCT01474512|3819782|FG017|STARTED|Post-Treatment Follow-Up|Includes participants who started the post treatment follow-up period.|285
3097032|NCT01474512|3819765|FG000|COMPLETED|Post-Treatment Follow-Up||0
3097033|NCT01474512|3819766|FG001|COMPLETED|Post-Treatment Follow-Up||0
3097034|NCT01474512|3819767|FG002|COMPLETED|Post-Treatment Follow-Up||0
3097035|NCT01474512|3819768|FG003|COMPLETED|Post-Treatment Follow-Up||0
3097036|NCT01474512|3819769|FG004|COMPLETED|Post-Treatment Follow-Up||0
3097037|NCT01474512|3819770|FG005|COMPLETED|Post-Treatment Follow-Up||0
3097038|NCT01474512|3819771|FG006|COMPLETED|Post-Treatment Follow-Up||0
3097039|NCT01474512|3819772|FG007|COMPLETED|Post-Treatment Follow-Up||0
3097040|NCT01474512|3819773|FG008|COMPLETED|Post-Treatment Follow-Up||0
3097041|NCT01474512|3819774|FG009|COMPLETED|Post-Treatment Follow-Up||0
3097042|NCT01474512|3819775|FG010|COMPLETED|Post-Treatment Follow-Up||0
3097043|NCT01474512|3819776|FG011|COMPLETED|Post-Treatment Follow-Up||0
3097044|NCT01474512|3819777|FG012|COMPLETED|Post-Treatment Follow-Up||0
3097045|NCT01474512|3819778|FG013|COMPLETED|Post-Treatment Follow-Up||0
3097046|NCT01474512|3819779|FG014|COMPLETED|Post-Treatment Follow-Up||0
3097047|NCT01474512|3819780|FG015|COMPLETED|Post-Treatment Follow-Up||17
3097048|NCT01474512|3819781|FG016|COMPLETED|Post-Treatment Follow-Up||544
3097049|NCT01474512|3819782|FG017|COMPLETED|Post-Treatment Follow-Up||239
3097050|NCT01474512|3819765|FG000|NOT COMPLETED|Post-Treatment Follow-Up||0
3097051|NCT01474512|3819766|FG001|NOT COMPLETED|Post-Treatment Follow-Up||0
3097052|NCT01474512|3819767|FG002|NOT COMPLETED|Post-Treatment Follow-Up||0
3097053|NCT01474512|3819768|FG003|NOT COMPLETED|Post-Treatment Follow-Up||0
3097054|NCT01474512|3819769|FG004|NOT COMPLETED|Post-Treatment Follow-Up||0
3097055|NCT01474512|3819770|FG005|NOT COMPLETED|Post-Treatment Follow-Up||0
3097056|NCT01474512|3819771|FG006|NOT COMPLETED|Post-Treatment Follow-Up||0
3097057|NCT01474512|3819772|FG007|NOT COMPLETED|Post-Treatment Follow-Up||0
3097058|NCT01474512|3819773|FG008|NOT COMPLETED|Post-Treatment Follow-Up||0
3097059|NCT01474512|3819774|FG009|NOT COMPLETED|Post-Treatment Follow-Up||0
3097060|NCT01474512|3819775|FG010|NOT COMPLETED|Post-Treatment Follow-Up||0
3097061|NCT01474512|3819776|FG011|NOT COMPLETED|Post-Treatment Follow-Up||0
3097062|NCT01474512|3819777|FG012|NOT COMPLETED|Post-Treatment Follow-Up||0
3097063|NCT01474512|3819778|FG013|NOT COMPLETED|Post-Treatment Follow-Up||0
3097064|NCT01474512|3819779|FG014|NOT COMPLETED|Post-Treatment Follow-Up||18
3097065|NCT01474512|3819780|FG015|NOT COMPLETED|Post-Treatment Follow-Up||8
3097066|NCT01474512|3819781|FG016|NOT COMPLETED|Post-Treatment Follow-Up||156
3097067|NCT01474512|3819782|FG017|NOT COMPLETED|Post-Treatment Follow-Up||46
3097068|NCT01474538|3819814|FG000|STARTED|Treatment Period 1||60
3097069|NCT01474538|3819815|FG001|STARTED|Treatment Period 1||62
3097070|NCT01474538|3819814|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 1||60
3097071|NCT01474538|3819815|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 1||62
3097072|NCT01474538|3819814|FG000|COMPLETED|Treatment Period 1||57
3097073|NCT01474538|3819815|FG001|COMPLETED|Treatment Period 1||58
3097074|NCT01474538|3819814|FG000|NOT COMPLETED|Treatment Period 1||3
3097075|NCT01474538|3819815|FG001|NOT COMPLETED|Treatment Period 1||4
3097076|NCT01474538|3819814|FG000|STARTED|Treatment Period 2||57
3097077|NCT01474538|3819815|FG001|STARTED|Treatment Period 2||58
3097078|NCT01474538|3819814|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 2||57
3097079|NCT01474538|3819815|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 2||58
3097080|NCT01474538|3819814|FG000|COMPLETED|Treatment Period 2||51
3097081|NCT01474538|3819815|FG001|COMPLETED|Treatment Period 2||56
3097082|NCT01474538|3819814|FG000|NOT COMPLETED|Treatment Period 2||6
3097083|NCT01474538|3819815|FG001|NOT COMPLETED|Treatment Period 2||2
3097084|NCT01474551|3819821|FG000|STARTED|Overall Study||2
3097085|NCT01474551|3819821|FG000|COMPLETED|Overall Study||1
3097086|NCT01474551|3819821|FG000|NOT COMPLETED|Overall Study||1
3097087|NCT01474590|3819827|FG000|STARTED|Overall Study||133
3097088|NCT01474590|3819828|FG001|STARTED|Overall Study||133
3097089|NCT01474590|3819827|FG000|COMPLETED|Overall Study||105
3097090|NCT01474590|3819828|FG001|COMPLETED|Overall Study||116
3097091|NCT01474590|3819827|FG000|NOT COMPLETED|Overall Study||28
3097092|NCT01474590|3819828|FG001|NOT COMPLETED|Overall Study||17
3097093|NCT01474681|3819836|FG000|STARTED|Overall Study||1
3097094|NCT01474681|3819837|FG001|STARTED|Overall Study||8
3097095|NCT01474681|3819838|FG002|STARTED|Overall Study||3
3097096|NCT01474681|3819839|FG003|STARTED|Overall Study||15
3097097|NCT01474681|3819836|FG000|COMPLETED|Overall Study||1
3097098|NCT01474681|3819837|FG001|COMPLETED|Overall Study||5
3097099|NCT01474681|3819838|FG002|COMPLETED|Overall Study||1
3097100|NCT01474681|3819839|FG003|COMPLETED|Overall Study||9
3097101|NCT01474681|3819836|FG000|NOT COMPLETED|Overall Study||0
3097102|NCT01474681|3819837|FG001|NOT COMPLETED|Overall Study||3
3097103|NCT01474681|3819838|FG002|NOT COMPLETED|Overall Study||2
3097104|NCT01474681|3819839|FG003|NOT COMPLETED|Overall Study||6
3097105|NCT01474746|3819855|FG000|STARTED|Overall Study||30
3097106|NCT01474746|3819856|FG001|STARTED|Overall Study||27
3097107|NCT01474746|3819855|FG000|COMPLETED|Overall Study||27
3097108|NCT01474746|3819856|FG001|COMPLETED|Overall Study||25
3097109|NCT01474746|3819855|FG000|NOT COMPLETED|Overall Study||3
3097110|NCT01474746|3819856|FG001|NOT COMPLETED|Overall Study||2
3097111|NCT01474772|3819864|FG000|STARTED|Period 1|STARTED=treated. In Period 1 a participant discontinued due to an AE and later died due to the AE.|101
3097112|NCT01474772|3819865|FG001|STARTED|Period 1|STARTED=treated|102
3097113|NCT01474772|3819864|FG000|COMPLETED|Period 1||89
3097114|NCT01474772|3819865|FG001|COMPLETED|Period 1||99
3097115|NCT01474772|3819864|FG000|NOT COMPLETED|Period 1||12
3097116|NCT01474772|3819865|FG001|NOT COMPLETED|Period 1||3
3097117|NCT01474772|3819864|FG000|STARTED|Washout||89
3097118|NCT01474772|3819865|FG001|STARTED|Washout||99
3097119|NCT01474772|3819864|FG000|COMPLETED|Washout||86
3097120|NCT01474772|3819865|FG001|COMPLETED|Washout||97
3097121|NCT01474772|3819864|FG000|NOT COMPLETED|Washout||3
3097122|NCT01474772|3819865|FG001|NOT COMPLETED|Washout||2
3097123|NCT01474772|3819864|FG000|STARTED|Period 2||86
3097124|NCT01474772|3819865|FG001|STARTED|Period 2||97
3097125|NCT01474772|3819864|FG000|COMPLETED|Period 2||77
3097126|NCT01474772|3819865|FG001|COMPLETED|Period 2||87
3097127|NCT01474772|3819864|FG000|NOT COMPLETED|Period 2||9
3097128|NCT01474772|3819865|FG001|NOT COMPLETED|Period 2||10
3097129|NCT01474772|3819864|FG000|STARTED|Follow-up||77
3097130|NCT01474772|3819865|FG001|STARTED|Follow-up||87
3097131|NCT01474772|3819864|FG000|COMPLETED|Follow-up||77
3097132|NCT01474772|3819865|FG001|COMPLETED|Follow-up||86
3097133|NCT01474772|3819864|FG000|NOT COMPLETED|Follow-up||0
3097134|NCT01474772|3819865|FG001|NOT COMPLETED|Follow-up||1
3097135|NCT01474863|3819874|FG000|STARTED|Overall Study||26
3097136|NCT01474863|3819875|FG001|STARTED|Overall Study||22
3097137|NCT01474863|3819876|FG002|STARTED|Overall Study||24
3097138|NCT01474863|3819874|FG000|COMPLETED|Overall Study||26
3097139|NCT01474863|3819875|FG001|COMPLETED|Overall Study||22
3097140|NCT01474863|3819876|FG002|COMPLETED|Overall Study||24
3097141|NCT01474863|3819874|FG000|NOT COMPLETED|Overall Study||0
3097142|NCT01474863|3819875|FG001|NOT COMPLETED|Overall Study||0
3097143|NCT01474863|3819876|FG002|NOT COMPLETED|Overall Study||0
3097144|NCT01474876|3819887|FG000|STARTED|Overall Study||403
3097145|NCT01474876|3819888|FG001|STARTED|Overall Study||151
3097146|NCT01474876|3819889|FG002|STARTED|Overall Study||1
3097147|NCT01474876|3819887|FG000|COMPLETED|Overall Study||337
3097148|NCT01474876|3819888|FG001|COMPLETED|Overall Study||128
3097149|NCT01474876|3819889|FG002|COMPLETED|Overall Study||1
3097150|NCT01474876|3819887|FG000|NOT COMPLETED|Overall Study||66
3097151|NCT01474876|3819888|FG001|NOT COMPLETED|Overall Study||23
3097152|NCT01474876|3819889|FG002|NOT COMPLETED|Overall Study||0
3097153|NCT01474915|3819897|FG000|STARTED|Overall Study||60
3097154|NCT01474915|3819898|FG001|STARTED|Overall Study||61
3097155|NCT01474915|3819897|FG000|COMPLETED|Overall Study||50
3097156|NCT01474915|3819898|FG001|COMPLETED|Overall Study||51
3097157|NCT01474915|3819897|FG000|NOT COMPLETED|Overall Study||10
3097158|NCT01474915|3819898|FG001|NOT COMPLETED|Overall Study||10
3097159|NCT01474993|3819907|FG000|STARTED|Overall Study||15
3097160|NCT01474993|3819908|FG001|STARTED|Overall Study||29
3097161|NCT01474993|3819907|FG000|COMPLETED|Overall Study||14
3097162|NCT01474993|3819908|FG001|COMPLETED|Overall Study||26
3097163|NCT01474993|3819907|FG000|NOT COMPLETED|Overall Study||1
3097164|NCT01474993|3819908|FG001|NOT COMPLETED|Overall Study||3
3097165|NCT01475071|3819916|FG000|STARTED|Overall Study||100
3097166|NCT01475071|3819916|FG000|COMPLETED|Overall Study||92
3097167|NCT01475071|3819916|FG000|NOT COMPLETED|Overall Study||8
3097168|NCT01475097|3819924|FG000|STARTED|Overall Study||128
3097169|NCT01475097|3819925|FG001|STARTED|Overall Study||127
3097170|NCT01475097|3819924|FG000|COMPLETED|Overall Study||127
3097171|NCT01475097|3819925|FG001|COMPLETED|Overall Study||126
3097172|NCT01475097|3819924|FG000|NOT COMPLETED|Overall Study||1
3097173|NCT01475097|3819925|FG001|NOT COMPLETED|Overall Study||1
3097174|NCT01475136|3819935|FG000|STARTED|Overall Study||7
3097175|NCT01475136|3819936|FG001|STARTED|Overall Study||9
3097176|NCT01475136|3819937|FG002|STARTED|Overall Study||9
3097177|NCT01475136|3819938|FG003|STARTED|Overall Study||12
3097178|NCT01475136|3819935|FG000|Received 1 Dose of Study Drug|Overall Study||7
3097179|NCT01475136|3819936|FG001|Received 1 Dose of Study Drug|Overall Study||6
3097180|NCT01475136|3819937|FG002|Received 1 Dose of Study Drug|Overall Study||6
3097181|NCT01475136|3819938|FG003|Received 1 Dose of Study Drug|Overall Study||7
3097182|NCT01475136|3819935|FG000|COMPLETED|Overall Study||6
3097183|NCT01475136|3819936|FG001|COMPLETED|Overall Study||6
3097184|NCT01475136|3819937|FG002|COMPLETED|Overall Study||6
3097185|NCT01475136|3819938|FG003|COMPLETED|Overall Study||7
3097186|NCT01475136|3819935|FG000|NOT COMPLETED|Overall Study||1
3097187|NCT01475136|3819936|FG001|NOT COMPLETED|Overall Study||3
3097188|NCT01475136|3819937|FG002|NOT COMPLETED|Overall Study||3
3097189|NCT01475136|3819938|FG003|NOT COMPLETED|Overall Study||5
3097190|NCT01475162|3819948|FG000|STARTED|Overall Study||14
3097191|NCT01475162|3819948|FG000|COMPLETED|Overall Study||0
3097192|NCT01475162|3819948|FG000|NOT COMPLETED|Overall Study||14
3097193|NCT01475175|3819953|FG000|STARTED|Overall Study||12
3097194|NCT01475175|3819953|FG000|COMPLETED|Overall Study||12
3097195|NCT01475175|3819953|FG000|NOT COMPLETED|Overall Study||0
3097196|NCT01475214|3819960|FG000|STARTED|Overall Study||84
3097197|NCT01475214|3819961|FG001|STARTED|Overall Study||79
3097198|NCT01475214|3819962|FG002|STARTED|Overall Study||81
3097199|NCT01475214|3819960|FG000|COMPLETED|Overall Study||79
3097200|NCT01475214|3819961|FG001|COMPLETED|Overall Study||75
3097201|NCT01475214|3819962|FG002|COMPLETED|Overall Study||79
3097202|NCT01475214|3819960|FG000|NOT COMPLETED|Overall Study||5
3097203|NCT01475214|3819961|FG001|NOT COMPLETED|Overall Study||4
3097204|NCT01475214|3819962|FG002|NOT COMPLETED|Overall Study||2
3097205|NCT01475253|3819974|FG000|STARTED|Randomized, Blinded Study||47
3097206|NCT01475253|3819975|FG001|STARTED|Randomized, Blinded Study||46
3097207|NCT01475253|3819976|FG002|STARTED|Randomized, Blinded Study||11
3097208|NCT01475253|3819977|FG003|STARTED|Randomized, Blinded Study||0
3097209|NCT01475253|3819974|FG000|COMPLETED|Randomized, Blinded Study||45
3097210|NCT01475253|3819975|FG001|COMPLETED|Randomized, Blinded Study||45
3097211|NCT01475253|3819976|FG002|COMPLETED|Randomized, Blinded Study||11
3097212|NCT01475253|3819977|FG003|COMPLETED|Randomized, Blinded Study||0
3290270|NCT02826798|4024172|FG002|NOT COMPLETED|Overall Study||0
3290271|NCT02826798|4024173|FG003|NOT COMPLETED|Overall Study||1
3290272|NCT02826798|4024174|FG004|NOT COMPLETED|Overall Study||0
3290273|NCT02827500|4024188|FG000|STARTED|Overall Study||52
3290274|NCT02827500|4024189|FG001|STARTED|Overall Study||52
3097213|NCT01475253|3819974|FG000|NOT COMPLETED|Randomized, Blinded Study||2
3097214|NCT01475253|3819975|FG001|NOT COMPLETED|Randomized, Blinded Study||1
3097215|NCT01475253|3819976|FG002|NOT COMPLETED|Randomized, Blinded Study||0
3097216|NCT01475253|3819977|FG003|NOT COMPLETED|Randomized, Blinded Study||0
3097217|NCT01475253|3819974|FG000|STARTED|Open Label Extension||0
3097218|NCT01475253|3819975|FG001|STARTED|Open Label Extension||0
3097219|NCT01475253|3819976|FG002|STARTED|Open Label Extension||0
3097220|NCT01475253|3819977|FG003|STARTED|Open Label Extension||56
3097221|NCT01475253|3819974|FG000|COMPLETED|Open Label Extension||0
3097222|NCT01475253|3819975|FG001|COMPLETED|Open Label Extension||0
3097223|NCT01475253|3819976|FG002|COMPLETED|Open Label Extension||0
3097224|NCT01475253|3819977|FG003|COMPLETED|Open Label Extension||56
3097225|NCT01475253|3819974|FG000|NOT COMPLETED|Open Label Extension||0
3097226|NCT01475253|3819975|FG001|NOT COMPLETED|Open Label Extension||0
3097227|NCT01475253|3819976|FG002|NOT COMPLETED|Open Label Extension||0
3097228|NCT01475253|3819977|FG003|NOT COMPLETED|Open Label Extension||0
3135259|NCT01705964|3860251|FG000|STARTED|Overall Study||25
3135260|NCT01705964|3860252|FG001|STARTED|Overall Study||24
3135261|NCT01705964|3860251|FG000|COMPLETED|Overall Study||25
3135262|NCT01705964|3860252|FG001|COMPLETED|Overall Study||24
3135263|NCT01705964|3860251|FG000|NOT COMPLETED|Overall Study||0
3135264|NCT01705964|3860252|FG001|NOT COMPLETED|Overall Study||0
3135265|NCT01705977|3860260|FG000|STARTED|Overall Study||2002
3135266|NCT01705977|3860261|FG001|STARTED|Overall Study||2001
3135267|NCT01705977|3860260|FG000|COMPLETED|Overall Study||1729
3135268|NCT01705977|3860261|FG001|COMPLETED|Overall Study||1741
3135269|NCT01705977|3860260|FG000|NOT COMPLETED|Overall Study||273
3135270|NCT01705977|3860261|FG001|NOT COMPLETED|Overall Study||260
3135271|NCT01706003|3860269|FG000|STARTED|Overall Study||23
3135272|NCT01706003|3860270|FG001|STARTED|Overall Study||22
3135273|NCT01706003|3860269|FG000|COMPLETED|Overall Study||12
3135274|NCT01706003|3860270|FG001|COMPLETED|Overall Study||18
3135275|NCT01706003|3860269|FG000|NOT COMPLETED|Overall Study||11
3135276|NCT01706003|3860270|FG001|NOT COMPLETED|Overall Study||4
3135277|NCT01706081|3860278|FG000|STARTED|Overall Study||40
3135278|NCT01706081|3860279|FG001|STARTED|Overall Study||42
3135279|NCT01706081|3860278|FG000|COMPLETED|Overall Study||40
3135280|NCT01706081|3860279|FG001|COMPLETED|Overall Study||42
3135281|NCT01706081|3860278|FG000|NOT COMPLETED|Overall Study||0
3135282|NCT01706081|3860279|FG001|NOT COMPLETED|Overall Study||0
3135283|NCT01706146|3860285|FG000|STARTED|Overall Study||59
3135284|NCT01706146|3860285|FG000|COMPLETED|Overall Study|1 pt developed permanent AF; 1 pt needed dual antiplatelet therapy; 3 possible TIA; 1 withdraw|53
3135285|NCT01706146|3860285|FG000|NOT COMPLETED|Overall Study||6
3135286|NCT01706159|3860291|FG000|STARTED|Overall Study||14
3135287|NCT01706159|3860292|FG001|STARTED|Overall Study||6
3135288|NCT01706159|3860291|FG000|Exposed|Overall Study|One subject was not exposed to rFXIII.|13
3135289|NCT01706159|3860292|FG001|Exposed|Overall Study|One subject was not exposed to placebo.|5
3135290|NCT01706159|3860291|FG000|Completers (With Baron Score at Week 8)|Overall Study||6
3135291|NCT01706159|3860292|FG001|Completers (With Baron Score at Week 8)|Overall Study||3
3135292|NCT01706159|3860291|FG000|COMPLETED|Overall Study||6
3135293|NCT01706159|3860292|FG001|COMPLETED|Overall Study||4
3135294|NCT01706159|3860291|FG000|NOT COMPLETED|Overall Study||8
3135295|NCT01706159|3860292|FG001|NOT COMPLETED|Overall Study||2
3135296|NCT01706198|3860300|FG000|STARTED|Overall Study||2119
3135297|NCT01706198|3860301|FG001|STARTED|Overall Study||2114
3135298|NCT01706198|3860300|FG000|COMPLETED|Overall Study||1946
3135299|NCT01706198|3860301|FG001|COMPLETED|Overall Study||1920
3135300|NCT01706198|3860300|FG000|NOT COMPLETED|Overall Study||173
3135301|NCT01706198|3860301|FG001|NOT COMPLETED|Overall Study||194
3135302|NCT01706250|3860307|FG000|STARTED|Overall Study||20
3135303|NCT01706250|3860307|FG000|COMPLETED|Overall Study||18
3135304|NCT01706250|3860307|FG000|NOT COMPLETED|Overall Study||2
3135305|NCT01706263|3860316|FG000|STARTED|Overall Study||28
3135306|NCT01706263|3860316|FG000|COMPLETED|Overall Study||28
3135307|NCT01706263|3860316|FG000|NOT COMPLETED|Overall Study||0
3135308|NCT01706328|3860323|FG000|STARTED|2-week Run-in Period||993
3135309|NCT01706328|3860324|FG001|STARTED|2-week Run-in Period||0
3135310|NCT01706328|3860325|FG002|STARTED|2-week Run-in Period||0
3135311|NCT01706328|3860323|FG000|COMPLETED|2-week Run-in Period||828
3135312|NCT01706328|3860324|FG001|COMPLETED|2-week Run-in Period||0
3135313|NCT01706328|3860325|FG002|COMPLETED|2-week Run-in Period||0
3135314|NCT01706328|3860323|FG000|NOT COMPLETED|2-week Run-in Period||165
3135315|NCT01706328|3860324|FG001|NOT COMPLETED|2-week Run-in Period||0
3135316|NCT01706328|3860325|FG002|NOT COMPLETED|2-week Run-in Period||0
3135317|NCT01706328|3860323|FG000|STARTED|12-week Double-blind Treatment Period||0
3290275|NCT02827500|4024188|FG000|COMPLETED|Overall Study||33
3097229|NCT01475305|3819987|FG000|STARTED|Overall Study||4
3097230|NCT01475305|3819988|FG001|STARTED|Overall Study||3
3097231|NCT01475305|3819987|FG000|End of Quarantine, Day 15|Overall Study||4
3097232|NCT01475305|3819988|FG001|End of Quarantine, Day 15|Overall Study||3
3097233|NCT01475305|3819987|FG000|COMPLETED|Overall Study||4
3097234|NCT01475305|3819988|FG001|COMPLETED|Overall Study||3
3097235|NCT01475305|3819987|FG000|NOT COMPLETED|Overall Study||0
3097236|NCT01475305|3819988|FG001|NOT COMPLETED|Overall Study||0
3097237|NCT01475331|3819997|FG000|STARTED|Overall Study||23
3097238|NCT01475331|3819998|FG001|STARTED|Overall Study||23
3097239|NCT01475331|3819997|FG000|COMPLETED|Overall Study||18
3097240|NCT01475331|3819998|FG001|COMPLETED|Overall Study||21
3097241|NCT01475331|3819997|FG000|NOT COMPLETED|Overall Study||5
3097242|NCT01475331|3819998|FG001|NOT COMPLETED|Overall Study||2
3097243|NCT01475370|3820007|FG000|STARTED|Overall Study||3
3097244|NCT01475370|3820008|FG001|STARTED|Overall Study||3
3097245|NCT01475370|3820009|FG002|STARTED|Overall Study||3
3097246|NCT01475370|3820007|FG000|COMPLETED|Overall Study||0
3097247|NCT01475370|3820008|FG001|COMPLETED|Overall Study||0
3097248|NCT01475370|3820009|FG002|COMPLETED|Overall Study||0
3097249|NCT01475370|3820007|FG000|NOT COMPLETED|Overall Study||3
3097250|NCT01475370|3820008|FG001|NOT COMPLETED|Overall Study||3
3097251|NCT01475370|3820009|FG002|NOT COMPLETED|Overall Study||3
3097252|NCT01475461|3820023|FG000|STARTED|Run-in Period||376
3097253|NCT01475461|3820024|FG001|STARTED|Run-in Period||0
3097254|NCT01475461|3820025|FG002|STARTED|Run-in Period||0
3097255|NCT01475461|3820026|FG003|STARTED|Run-in Period||0
3097256|NCT01475461|3820027|FG004|STARTED|Run-in Period||0
3097257|NCT01475461|3820028|FG005|STARTED|Run-in Period||0
3097258|NCT01475461|3820029|FG006|STARTED|Run-in Period||0
3097259|NCT01475461|3820023|FG000|COMPLETED|Run-in Period||335
3097260|NCT01475461|3820024|FG001|COMPLETED|Run-in Period||0
3097261|NCT01475461|3820025|FG002|COMPLETED|Run-in Period||0
3097262|NCT01475461|3820026|FG003|COMPLETED|Run-in Period||0
3097263|NCT01475461|3820027|FG004|COMPLETED|Run-in Period||0
3097264|NCT01475461|3820028|FG005|COMPLETED|Run-in Period||0
3097265|NCT01475461|3820029|FG006|COMPLETED|Run-in Period||0
3097266|NCT01475461|3820023|FG000|NOT COMPLETED|Run-in Period||41
3097267|NCT01475461|3820024|FG001|NOT COMPLETED|Run-in Period||0
3097268|NCT01475461|3820025|FG002|NOT COMPLETED|Run-in Period||0
3097269|NCT01475461|3820026|FG003|NOT COMPLETED|Run-in Period||0
3097270|NCT01475461|3820027|FG004|NOT COMPLETED|Run-in Period||0
3097271|NCT01475461|3820028|FG005|NOT COMPLETED|Run-in Period||0
3097272|NCT01475461|3820029|FG006|NOT COMPLETED|Run-in Period||0
3097273|NCT01475461|3820023|FG000|STARTED|Treatment Period||0
3097274|NCT01475461|3820024|FG001|STARTED|Treatment Period||57
3097275|NCT01475461|3820025|FG002|STARTED|Treatment Period||57
3097276|NCT01475461|3820026|FG003|STARTED|Treatment Period||54
3097277|NCT01475461|3820027|FG004|STARTED|Treatment Period||56
3097278|NCT01475461|3820028|FG005|STARTED|Treatment Period||56
3097279|NCT01475461|3820029|FG006|STARTED|Treatment Period||55
3097280|NCT01475461|3820023|FG000|COMPLETED|Treatment Period||0
3097281|NCT01475461|3820024|FG001|COMPLETED|Treatment Period||48
3097282|NCT01475461|3820025|FG002|COMPLETED|Treatment Period||53
3097283|NCT01475461|3820026|FG003|COMPLETED|Treatment Period||46
3097284|NCT01475461|3820027|FG004|COMPLETED|Treatment Period||52
3097285|NCT01475461|3820028|FG005|COMPLETED|Treatment Period||51
3097286|NCT01475461|3820029|FG006|COMPLETED|Treatment Period||53
3097287|NCT01475461|3820023|FG000|NOT COMPLETED|Treatment Period||0
3097288|NCT01475461|3820024|FG001|NOT COMPLETED|Treatment Period||9
3097289|NCT01475461|3820025|FG002|NOT COMPLETED|Treatment Period||4
3097290|NCT01475461|3820026|FG003|NOT COMPLETED|Treatment Period||8
3097291|NCT01475461|3820027|FG004|NOT COMPLETED|Treatment Period||4
3097292|NCT01475461|3820028|FG005|NOT COMPLETED|Treatment Period||5
3097293|NCT01475461|3820029|FG006|NOT COMPLETED|Treatment Period||2
3097294|NCT01475474|3820062|FG000|STARTED|Baseline Period - 4 Weeks||97
3097295|NCT01475474|3820062|FG000|COMPLETED|Baseline Period - 4 Weeks||91
3097296|NCT01475474|3820062|FG000|NOT COMPLETED|Baseline Period - 4 Weeks||6
3097297|NCT01475474|3820062|FG000|STARTED|Treatment Period - 12 Weeks||91
3097298|NCT01475474|3820062|FG000|COMPLETED|Treatment Period - 12 Weeks||73
3097299|NCT01475474|3820062|FG000|NOT COMPLETED|Treatment Period - 12 Weeks||18
3097300|NCT01475474|3820062|FG000|STARTED|Return to Baseline Period - 4 Weeks||73
3097301|NCT01475474|3820062|FG000|COMPLETED|Return to Baseline Period - 4 Weeks||71
3097302|NCT01475474|3820062|FG000|NOT COMPLETED|Return to Baseline Period - 4 Weeks||2
3097303|NCT01475487|3820069|FG000|STARTED|Overall Study||25
3097304|NCT01475487|3820070|FG001|STARTED|Overall Study||25
3097305|NCT01475487|3820069|FG000|COMPLETED|Overall Study||23
3097306|NCT01475487|3820070|FG001|COMPLETED|Overall Study||24
3097307|NCT01475487|3820069|FG000|NOT COMPLETED|Overall Study||2
3097308|NCT01475487|3820070|FG001|NOT COMPLETED|Overall Study||1
3097309|NCT01475513|3820078|FG000|STARTED|Overall Study||20
3097310|NCT01475513|3820079|FG001|STARTED|Overall Study||26
3097311|NCT01475513|3820078|FG000|COMPLETED|Overall Study||17
3097312|NCT01475513|3820079|FG001|COMPLETED|Overall Study||16
3097313|NCT01475513|3820078|FG000|NOT COMPLETED|Overall Study||3
3097314|NCT01475513|3820079|FG001|NOT COMPLETED|Overall Study||10
3097315|NCT01475643|3820089|FG000|STARTED|Overall Study|53 included in Intent-to-treat (ITT) population, due to no post-treatment assessment.|54
3097316|NCT01475643|3820090|FG001|STARTED|Overall Study|52 included in Intent-to-treat (ITT) population, due to no post-treatment assessment.|53
3097317|NCT01475643|3820089|FG000|COMPLETED|Overall Study||40
3097318|NCT01475643|3820090|FG001|COMPLETED|Overall Study||43
3097319|NCT01475643|3820089|FG000|NOT COMPLETED|Overall Study||14
3097320|NCT01475643|3820090|FG001|NOT COMPLETED|Overall Study||10
3097321|NCT01475721|3820098|FG000|STARTED|Overall Study||5834
3097322|NCT01475721|3820099|FG001|STARTED|Overall Study||5845
3097323|NCT01475721|3820098|FG000|COMPLETED|Overall Study||5823
3097324|NCT01475721|3820099|FG001|COMPLETED|Overall Study||5831
3097325|NCT01475721|3820098|FG000|NOT COMPLETED|Overall Study||11
3097326|NCT01475721|3820099|FG001|NOT COMPLETED|Overall Study||14
3097327|NCT01475734|3820107|FG000|STARTED|Overall Study||22
3097328|NCT01475734|3820108|FG001|STARTED|Overall Study||22
3097329|NCT01475734|3820107|FG000|COMPLETED|Overall Study||20
3097330|NCT01475734|3820108|FG001|COMPLETED|Overall Study||21
3097331|NCT01475734|3820107|FG000|NOT COMPLETED|Overall Study||2
3097332|NCT01475734|3820108|FG001|NOT COMPLETED|Overall Study||1
3097333|NCT01475825|3820118|FG000|STARTED|Overall Study||104
3097334|NCT01475825|3820119|FG001|STARTED|Overall Study||51
3097335|NCT01475825|3820120|FG002|STARTED|Overall Study||102
3097336|NCT01475825|3820121|FG003|STARTED|Overall Study||52
3097337|NCT01475825|3820118|FG000|Randomized and Treated|Overall Study||104
3097338|NCT01475825|3820119|FG001|Randomized and Treated|Overall Study||51
3097339|NCT01475825|3820120|FG002|Randomized and Treated|Overall Study||102
3097340|NCT01475825|3820121|FG003|Randomized and Treated|Overall Study||52
3097341|NCT01475825|3820118|FG000|Completed Blinded Treatment Period|Overall Study||60
3097342|NCT01475825|3820119|FG001|Completed Blinded Treatment Period|Overall Study||42
3097343|NCT01475825|3820120|FG002|Completed Blinded Treatment Period|Overall Study||59
3097344|NCT01475825|3820121|FG003|Completed Blinded Treatment Period|Overall Study||40
3097345|NCT01475825|3820118|FG000|Entered Open-Label Continuation|Overall Study||45
3097346|NCT01475825|3820119|FG001|Entered Open-Label Continuation|Overall Study||31
3097347|NCT01475825|3820120|FG002|Entered Open-Label Continuation|Overall Study||44
3097348|NCT01475825|3820121|FG003|Entered Open-Label Continuation|Overall Study||29
3097349|NCT01475825|3820118|FG000|Completed Open-Label Continuation|Overall Study||37
3097350|NCT01475825|3820119|FG001|Completed Open-Label Continuation|Overall Study||19
3097351|NCT01475825|3820120|FG002|Completed Open-Label Continuation|Overall Study||38
3097352|NCT01475825|3820121|FG003|Completed Open-Label Continuation|Overall Study||22
3097353|NCT01475825|3820118|FG000|COMPLETED|Overall Study||37
3097354|NCT01475825|3820119|FG001|COMPLETED|Overall Study||19
3097355|NCT01475825|3820120|FG002|COMPLETED|Overall Study||38
3097356|NCT01475825|3820121|FG003|COMPLETED|Overall Study||22
3097357|NCT01475825|3820118|FG000|NOT COMPLETED|Overall Study||67
3097358|NCT01475825|3820119|FG001|NOT COMPLETED|Overall Study||32
3097359|NCT01475825|3820120|FG002|NOT COMPLETED|Overall Study||64
3097360|NCT01475825|3820121|FG003|NOT COMPLETED|Overall Study||30
3097361|NCT01475838|3820133|FG000|STARTED|Randomized Phase||293
3097362|NCT01475838|3820134|FG001|STARTED|Randomized Phase||145
3097363|NCT01475838|3820133|FG000|COMPLETED|Randomized Phase||263
3097364|NCT01475838|3820134|FG001|COMPLETED|Randomized Phase||109
3097365|NCT01475838|3820133|FG000|NOT COMPLETED|Randomized Phase||30
3097366|NCT01475838|3820134|FG001|NOT COMPLETED|Randomized Phase||36
3097367|NCT01475838|3820133|FG000|STARTED|Extension Phase||42
3097368|NCT01475838|3820134|FG001|STARTED|Extension Phase||20
3097369|NCT01475838|3820133|FG000|COMPLETED|Extension Phase||41
3097370|NCT01475838|3820134|FG001|COMPLETED|Extension Phase||20
3097371|NCT01475838|3820133|FG000|NOT COMPLETED|Extension Phase||1
3097372|NCT01475838|3820134|FG001|NOT COMPLETED|Extension Phase||0
3097373|NCT01475851|3820143|FG000|STARTED|Overall Study||13
3097374|NCT01475851|3820144|FG001|STARTED|Overall Study||21
3097375|NCT01475851|3820143|FG000|COMPLETED|Overall Study||12
3097376|NCT01475851|3820144|FG001|COMPLETED|Overall Study||21
3097377|NCT01475851|3820143|FG000|NOT COMPLETED|Overall Study||1
3290276|NCT02827500|4024189|FG001|COMPLETED|Overall Study||45
3290277|NCT02827500|4024188|FG000|NOT COMPLETED|Overall Study||19
3290278|NCT02827500|4024189|FG001|NOT COMPLETED|Overall Study||7
3290279|NCT02827708|4024197|FG000|STARTED|Overall Study||163
3290280|NCT02827708|4024198|FG001|STARTED|Overall Study||161
3290281|NCT02827708|4024197|FG000|Full Analysis Set (FAS)|Overall Study||163
3290282|NCT02827708|4024198|FG001|Full Analysis Set (FAS)|Overall Study||161
3290283|NCT02827708|4024197|FG000|Safety Analysis Set (SAS)|Overall Study||163
3290284|NCT02827708|4024198|FG001|Safety Analysis Set (SAS)|Overall Study||161
3290285|NCT02827708|4024197|FG000|COMPLETED|Overall Study||158
3097378|NCT01475851|3820144|FG001|NOT COMPLETED|Overall Study||0
3097379|NCT01475955|3820155|FG000|STARTED|Overall Study||48
3097380|NCT01475955|3820156|FG001|STARTED|Overall Study||48
3097381|NCT01475955|3820157|FG002|STARTED|Overall Study||47
3097382|NCT01475955|3820158|FG003|STARTED|Overall Study||46
3097383|NCT01475955|3820159|FG004|STARTED|Overall Study||46
3097384|NCT01475955|3820155|FG000|COMPLETED|Overall Study||47
3097385|NCT01475955|3820156|FG001|COMPLETED|Overall Study||48
3097386|NCT01475955|3820157|FG002|COMPLETED|Overall Study||44
3097387|NCT01475955|3820158|FG003|COMPLETED|Overall Study||46
3097388|NCT01475955|3820159|FG004|COMPLETED|Overall Study||46
3097389|NCT01475955|3820155|FG000|NOT COMPLETED|Overall Study||1
3097390|NCT01475955|3820156|FG001|NOT COMPLETED|Overall Study||0
3097391|NCT01475955|3820157|FG002|NOT COMPLETED|Overall Study||3
3097392|NCT01475955|3820158|FG003|NOT COMPLETED|Overall Study||0
3097393|NCT01475955|3820159|FG004|NOT COMPLETED|Overall Study||0
3290286|NCT02827708|4024198|FG001|COMPLETED|Overall Study||156
3097394|NCT01476202|3820193|FG000|STARTED|Overall Study||40
3097395|NCT01476202|3820194|FG001|STARTED|Overall Study||40
3097396|NCT01476202|3820195|FG002|STARTED|Overall Study||40
3097397|NCT01476202|3820193|FG000|COMPLETED|Overall Study||40
3097398|NCT01476202|3820194|FG001|COMPLETED|Overall Study||40
3097399|NCT01476202|3820195|FG002|COMPLETED|Overall Study||40
3097400|NCT01476202|3820193|FG000|NOT COMPLETED|Overall Study||0
3097401|NCT01476202|3820194|FG001|NOT COMPLETED|Overall Study||0
3097402|NCT01476202|3820195|FG002|NOT COMPLETED|Overall Study||0
3097403|NCT01476267|3820206|FG000|STARTED|Overall Study||6
3097404|NCT01476267|3820206|FG000|COMPLETED|Overall Study||6
3097405|NCT01476267|3820206|FG000|NOT COMPLETED|Overall Study||0
3097406|NCT01476345|3820210|FG000|STARTED|Period 1||40
3097407|NCT01476345|3820211|FG001|STARTED|Period 1||40
3290287|NCT02827708|4024197|FG000|NOT COMPLETED|Overall Study||5
3290288|NCT02827708|4024198|FG001|NOT COMPLETED|Overall Study||5
3290289|NCT02828020|4024207|FG000|STARTED|Treatment Period||559
3290290|NCT02828020|4024208|FG001|STARTED|Treatment Period||556
3290291|NCT02828020|4024209|FG002|STARTED|Treatment Period||557
3097408|NCT01476345|3820210|FG000|Received at Least 1 Dose of Study Drug|Period 1||40
3097409|NCT01476345|3820211|FG001|Received at Least 1 Dose of Study Drug|Period 1||40
3097410|NCT01476345|3820210|FG000|COMPLETED|Period 1||40
3097411|NCT01476345|3820211|FG001|COMPLETED|Period 1||40
3097412|NCT01476345|3820210|FG000|NOT COMPLETED|Period 1||0
3097413|NCT01476345|3820211|FG001|NOT COMPLETED|Period 1||0
3097414|NCT01476345|3820210|FG000|STARTED|Period 2||40
3097415|NCT01476345|3820211|FG001|STARTED|Period 2||40
3097416|NCT01476345|3820210|FG000|COMPLETED|Period 2|1 did not enter Period 3 due to participant's decision.|40
3097417|NCT01476345|3820211|FG001|COMPLETED|Period 2|1 did not enter Period 3 due to participant's decision.|40
3097418|NCT01476345|3820210|FG000|NOT COMPLETED|Period 2||0
3097419|NCT01476345|3820211|FG001|NOT COMPLETED|Period 2||0
3097420|NCT01476345|3820210|FG000|STARTED|Period 3||39
3097421|NCT01476345|3820211|FG001|STARTED|Period 3||39
3097422|NCT01476345|3820210|FG000|COMPLETED|Period 3||39
3097423|NCT01476345|3820211|FG001|COMPLETED|Period 3||39
3097424|NCT01476345|3820210|FG000|NOT COMPLETED|Period 3||0
3097425|NCT01476345|3820211|FG001|NOT COMPLETED|Period 3||0
3097426|NCT01476345|3820210|FG000|STARTED|Period 4||39
3097427|NCT01476345|3820211|FG001|STARTED|Period 4||39
3097428|NCT01476345|3820210|FG000|COMPLETED|Period 4||39
3097429|NCT01476345|3820211|FG001|COMPLETED|Period 4||39
3097430|NCT01476345|3820210|FG000|NOT COMPLETED|Period 4||0
3097431|NCT01476345|3820211|FG001|NOT COMPLETED|Period 4||0
3097432|NCT01476449|3820219|FG000|STARTED|Overall Study||10
3097433|NCT01476449|3820220|FG001|STARTED|Overall Study||10
3097434|NCT01476449|3820219|FG000|COMPLETED|Overall Study||8
3097435|NCT01476449|3820220|FG001|COMPLETED|Overall Study||8
3097436|NCT01476449|3820219|FG000|NOT COMPLETED|Overall Study||2
3097437|NCT01476449|3820220|FG001|NOT COMPLETED|Overall Study||2
3097438|NCT01476475|3820228|FG000|STARTED|Overall Study||161
3097439|NCT01476475|3820229|FG001|STARTED|Overall Study||162
3097440|NCT01476475|3820228|FG000|COMPLETED|Overall Study||150
3097441|NCT01476475|3820229|FG001|COMPLETED|Overall Study||159
3097442|NCT01476475|3820228|FG000|NOT COMPLETED|Overall Study||11
3097443|NCT01476475|3820229|FG001|NOT COMPLETED|Overall Study||3
3097444|NCT01476644|3820236|FG000|STARTED|Overall Study||161
3097445|NCT01476644|3820236|FG000|COMPLETED|Overall Study||122
3097446|NCT01476644|3820236|FG000|NOT COMPLETED|Overall Study||39
3097447|NCT01476696|3820241|FG000|STARTED|Overall Study||15
3097448|NCT01476696|3820242|FG001|STARTED|Overall Study||9
3097449|NCT01476696|3820243|FG002|STARTED|Overall Study||9
3097450|NCT01476696|3820241|FG000|Received at Least 1 Dose of Study Drug|Overall Study||15
3097451|NCT01476696|3820242|FG001|Received at Least 1 Dose of Study Drug|Overall Study||9
3097452|NCT01476696|3820243|FG002|Received at Least 1 Dose of Study Drug|Overall Study||9
3097453|NCT01476696|3820241|FG000|COMPLETED|Overall Study||12
3097454|NCT01476696|3820242|FG001|COMPLETED|Overall Study||8
3097455|NCT01476696|3820243|FG002|COMPLETED|Overall Study||9
3097456|NCT01476696|3820241|FG000|NOT COMPLETED|Overall Study||3
3097457|NCT01476696|3820242|FG001|NOT COMPLETED|Overall Study||1
3097458|NCT01476696|3820243|FG002|NOT COMPLETED|Overall Study||0
3097459|NCT01476722|3820256|FG000|STARTED|Overall Study||125
3097460|NCT01476722|3820256|FG000|COMPLETED|Overall Study||124
3097461|NCT01476722|3820256|FG000|NOT COMPLETED|Overall Study||1
3097462|NCT01476748|3820263|FG000|STARTED|Overall Study||5
3097463|NCT01476748|3820264|FG001|STARTED|Overall Study||5
3097464|NCT01476748|3820265|FG002|STARTED|Overall Study||5
3097465|NCT01476748|3820263|FG000|COMPLETED|Overall Study||5
3097466|NCT01476748|3820264|FG001|COMPLETED|Overall Study||5
3097467|NCT01476748|3820265|FG002|COMPLETED|Overall Study||5
3097468|NCT01476748|3820263|FG000|NOT COMPLETED|Overall Study||0
3097469|NCT01476748|3820264|FG001|NOT COMPLETED|Overall Study||0
3097470|NCT01476748|3820265|FG002|NOT COMPLETED|Overall Study||0
3097471|NCT01477320|3820275|FG000|STARTED|Overall Study||62
3097472|NCT01477320|3820276|FG001|STARTED|Overall Study||62
3097473|NCT01477320|3820275|FG000|COMPLETED|Overall Study||55
3097474|NCT01477320|3820276|FG001|COMPLETED|Overall Study||47
3097475|NCT01477320|3820275|FG000|NOT COMPLETED|Overall Study||7
3097476|NCT01477320|3820276|FG001|NOT COMPLETED|Overall Study||15
3097477|NCT01477333|3820282|FG000|STARTED|Overall Study||18
3097478|NCT01477333|3820282|FG000|COMPLETED|Overall Study||15
3097479|NCT01477333|3820282|FG000|NOT COMPLETED|Overall Study||3
3097480|NCT01477450|3820293|FG000|STARTED|Overall Study||10
3097481|NCT01477450|3820294|FG001|STARTED|Overall Study||10
3097482|NCT01477450|3820295|FG002|STARTED|Overall Study||10
3097483|NCT01477450|3820293|FG000|COMPLETED|Overall Study||10
3097484|NCT01477450|3820294|FG001|COMPLETED|Overall Study||10
3097485|NCT01477450|3820295|FG002|COMPLETED|Overall Study||10
3097486|NCT01477450|3820293|FG000|NOT COMPLETED|Overall Study||0
3097487|NCT01477450|3820294|FG001|NOT COMPLETED|Overall Study||0
3097488|NCT01477450|3820295|FG002|NOT COMPLETED|Overall Study||0
3097489|NCT01477463|3820305|FG000|STARTED|Overall Study||18
3097490|NCT01477463|3820306|FG001|STARTED|Overall Study||6
3097491|NCT01477463|3820305|FG000|COMPLETED|Overall Study||18
3097492|NCT01477463|3820306|FG001|COMPLETED|Overall Study||6
3097493|NCT01477463|3820305|FG000|NOT COMPLETED|Overall Study||0
3097494|NCT01477463|3820306|FG001|NOT COMPLETED|Overall Study||0
3097495|NCT01477567|3820321|FG000|STARTED|Overall Study||5
3097496|NCT01477567|3820322|FG001|STARTED|Overall Study||6
3097497|NCT01477567|3820323|FG002|STARTED|Overall Study||6
3097498|NCT01477567|3820324|FG003|STARTED|Overall Study||6
3097499|NCT01477567|3820325|FG004|STARTED|Overall Study||6
3097500|NCT01477567|3820326|FG005|STARTED|Overall Study||5
3097501|NCT01477567|3820327|FG006|STARTED|Overall Study||6
3097502|NCT01477567|3820321|FG000|Received at Least 1 Dose of Study Drug|Overall Study||5
3097503|NCT01477567|3820322|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6
3097504|NCT01477567|3820323|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
3097505|NCT01477567|3820324|FG003|Received at Least 1 Dose of Study Drug|Overall Study||6
3097506|NCT01477567|3820325|FG004|Received at Least 1 Dose of Study Drug|Overall Study||6
3097507|NCT01477567|3820326|FG005|Received at Least 1 Dose of Study Drug|Overall Study||5
3097508|NCT01477567|3820327|FG006|Received at Least 1 Dose of Study Drug|Overall Study||6
3097509|NCT01477567|3820321|FG000|COMPLETED|Overall Study||5
3097510|NCT01477567|3820322|FG001|COMPLETED|Overall Study||6
3097511|NCT01477567|3820323|FG002|COMPLETED|Overall Study||6
3097512|NCT01477567|3820324|FG003|COMPLETED|Overall Study||6
3097513|NCT01477567|3820325|FG004|COMPLETED|Overall Study||6
3097514|NCT01477567|3820326|FG005|COMPLETED|Overall Study||5
3097515|NCT01477567|3820327|FG006|COMPLETED|Overall Study||6
3097516|NCT01477567|3820321|FG000|NOT COMPLETED|Overall Study||0
3097517|NCT01477567|3820322|FG001|NOT COMPLETED|Overall Study||0
3097518|NCT01477567|3820323|FG002|NOT COMPLETED|Overall Study||0
3097519|NCT01477567|3820324|FG003|NOT COMPLETED|Overall Study||0
3290292|NCT02828020|4024207|FG000|Safety Population: Received Study Drug|Treatment Period||485
3290293|NCT02828020|4024208|FG001|Safety Population: Received Study Drug|Treatment Period||466
3290294|NCT02828020|4024209|FG002|Safety Population: Received Study Drug|Treatment Period||485
3290295|NCT02828020|4024207|FG000|COMPLETED|Treatment Period||479
3290296|NCT02828020|4024208|FG001|COMPLETED|Treatment Period||457
3290297|NCT02828020|4024209|FG002|COMPLETED|Treatment Period||479
3290298|NCT02828020|4024207|FG000|NOT COMPLETED|Treatment Period||80
3290299|NCT02828020|4024208|FG001|NOT COMPLETED|Treatment Period||99
3290300|NCT02828020|4024209|FG002|NOT COMPLETED|Treatment Period||78
3316719|NCT03118739|4050154|FG001|Completed 24 Weeks of Treatment|Overall Study||25
3097520|NCT01477567|3820325|FG004|NOT COMPLETED|Overall Study||0
3097521|NCT01477567|3820326|FG005|NOT COMPLETED|Overall Study||0
3097522|NCT01477567|3820327|FG006|NOT COMPLETED|Overall Study||0
3097523|NCT01477710|3820348|FG000|STARTED|Overall Study||30
3097524|NCT01477710|3820348|FG000|COMPLETED|Overall Study||30
3097525|NCT01477710|3820348|FG000|NOT COMPLETED|Overall Study||0
3097526|NCT01477749|3820356|FG000|STARTED|Overall Study||47
3097527|NCT01477749|3820356|FG000|COMPLETED|Overall Study||43
3097528|NCT01477749|3820356|FG000|NOT COMPLETED|Overall Study||4
3097529|NCT01477762|3820364|FG000|STARTED|Overall Study||25
3097530|NCT01477762|3820365|FG001|STARTED|Overall Study||33
3097531|NCT01477762|3820366|FG002|STARTED|Overall Study||20
3097532|NCT01477762|3820367|FG003|STARTED|Overall Study||13
3097533|NCT01477762|3820364|FG000|COMPLETED|Overall Study||16
3097534|NCT01477762|3820365|FG001|COMPLETED|Overall Study||20
3097535|NCT01477762|3820366|FG002|COMPLETED|Overall Study||16
3097536|NCT01477762|3820367|FG003|COMPLETED|Overall Study||11
3097537|NCT01477762|3820364|FG000|NOT COMPLETED|Overall Study||9
3097538|NCT01477762|3820365|FG001|NOT COMPLETED|Overall Study||13
3097539|NCT01477762|3820366|FG002|NOT COMPLETED|Overall Study||4
3097540|NCT01477762|3820367|FG003|NOT COMPLETED|Overall Study||2
3097541|NCT01477853|3820380|FG000|STARTED|Phase A||55
3097542|NCT01477853|3820381|FG001|STARTED|Phase A||56
3097543|NCT01477853|3820382|FG002|STARTED|Phase A||55
3097544|NCT01477853|3820380|FG000|COMPLETED|Phase A||12
3097545|NCT01477853|3820381|FG001|COMPLETED|Phase A||11
3097546|NCT01477853|3820382|FG002|COMPLETED|Phase A||11
3097547|NCT01477853|3820380|FG000|NOT COMPLETED|Phase A||43
3097548|NCT01477853|3820381|FG001|NOT COMPLETED|Phase A||45
3097549|NCT01477853|3820382|FG002|NOT COMPLETED|Phase A||44
3097550|NCT01477853|3820380|FG000|STARTED|Phase B||12
3097551|NCT01477853|3820381|FG001|STARTED|Phase B||11
3097552|NCT01477853|3820382|FG002|STARTED|Phase B||11
3097553|NCT01477853|3820380|FG000|COMPLETED|Phase B||0
3097554|NCT01477853|3820381|FG001|COMPLETED|Phase B||0
3097555|NCT01477853|3820382|FG002|COMPLETED|Phase B||0
3097556|NCT01477853|3820380|FG000|NOT COMPLETED|Phase B||12
3097557|NCT01477853|3820381|FG001|NOT COMPLETED|Phase B||11
3097558|NCT01477853|3820382|FG002|NOT COMPLETED|Phase B||11
3097559|NCT01477892|3820392|FG000|STARTED|Overall Study||7
3097560|NCT01477892|3820393|FG001|STARTED|Overall Study||7
3097561|NCT01477892|3820392|FG000|COMPLETED|Overall Study||7
3097562|NCT01477892|3820393|FG001|COMPLETED|Overall Study||5
3097563|NCT01477892|3820392|FG000|NOT COMPLETED|Overall Study||0
3097564|NCT01477892|3820393|FG001|NOT COMPLETED|Overall Study||2
3097565|NCT01478009|3820401|FG000|STARTED|Overall Study||50
3097566|NCT01478009|3820402|FG001|STARTED|Overall Study||50
3097567|NCT01478009|3820401|FG000|COMPLETED|Overall Study||49
3097568|NCT01478009|3820402|FG001|COMPLETED|Overall Study||49
3097569|NCT01478009|3820401|FG000|NOT COMPLETED|Overall Study||1
3097570|NCT01478009|3820402|FG001|NOT COMPLETED|Overall Study||1
3097571|NCT01478048|3820410|FG000|STARTED|Overall Study||77
3097572|NCT01478048|3820411|FG001|STARTED|Overall Study||75
3097573|NCT01478048|3820410|FG000|Received Treatment|Overall Study|1 randomized to E-Bd but received Bd. Included in E-Bd group for efficacy and Bd group for safety|76
3097574|NCT01478048|3820411|FG001|Received Treatment|Overall Study|1 randomized to E-Bd but received Bd. Included in E-Bd group for efficacy and Bd group for safety|74
3097575|NCT01478048|3820410|FG000|COMPLETED|Overall Study||0
3097576|NCT01478048|3820411|FG001|COMPLETED|Overall Study||0
3097577|NCT01478048|3820410|FG000|NOT COMPLETED|Overall Study||77
3097578|NCT01478048|3820411|FG001|NOT COMPLETED|Overall Study||75
3097579|NCT01478087|3820417|FG000|STARTED|Overall Study||3
3097580|NCT01478087|3820417|FG000|COMPLETED|Overall Study||2
3097581|NCT01478087|3820417|FG000|NOT COMPLETED|Overall Study||1
3097582|NCT01478256|3820423|FG000|STARTED|Overall Study||15
3097583|NCT01478256|3820424|FG001|STARTED|Overall Study||15
3097584|NCT01478256|3820423|FG000|COMPLETED|Overall Study||15
3097585|NCT01478256|3820424|FG001|COMPLETED|Overall Study||15
3097586|NCT01478256|3820423|FG000|NOT COMPLETED|Overall Study||0
3097587|NCT01478256|3820424|FG001|NOT COMPLETED|Overall Study||0
3097588|NCT01478321|3820432|FG000|STARTED|Concurrent Therapy (5 Weeks)||54
3097589|NCT01478321|3820432|FG000|COMPLETED|Concurrent Therapy (5 Weeks)||38
3097590|NCT01478321|3820432|FG000|NOT COMPLETED|Concurrent Therapy (5 Weeks)||16
3097591|NCT01478321|3820432|FG000|STARTED|Started Adjuvant Therapy||38
3097592|NCT01478321|3820432|FG000|Completed First Cycle|Started Adjuvant Therapy||37
3097593|NCT01478321|3820432|FG000|COMPLETED|Started Adjuvant Therapy||37
3097594|NCT01478321|3820432|FG000|NOT COMPLETED|Started Adjuvant Therapy||1
3097595|NCT01478321|3820432|FG000|STARTED|Adjuvant Therapy Until PD or Toxicity||37
3097596|NCT01478321|3820432|FG000|Went on to Cycle 2 +|Adjuvant Therapy Until PD or Toxicity||27
3097597|NCT01478321|3820432|FG000|COMPLETED|Adjuvant Therapy Until PD or Toxicity||27
3097598|NCT01478321|3820432|FG000|NOT COMPLETED|Adjuvant Therapy Until PD or Toxicity||10
3097599|NCT01478321|3820432|FG000|STARTED|Follow-up Until Death or 12.31.18 Occurs||54
3097600|NCT01478321|3820432|FG000|COMPLETED|Follow-up Until Death or 12.31.18 Occurs||54
3097601|NCT01478321|3820432|FG000|NOT COMPLETED|Follow-up Until Death or 12.31.18 Occurs||0
3097602|NCT01478347|3820436|FG000|STARTED|Visit 1-Visit 3 (Day 0-91) - Part I||18
3097603|NCT01478347|3820436|FG000|COMPLETED|Visit 1-Visit 3 (Day 0-91) - Part I||17
3097604|NCT01478347|3820436|FG000|NOT COMPLETED|Visit 1-Visit 3 (Day 0-91) - Part I||1
3097605|NCT01478347|3820436|FG000|STARTED|Visit 4-Visit 7 (Day 151-331) - Part II||12
3097606|NCT01478347|3820436|FG000|COMPLETED|Visit 4-Visit 7 (Day 151-331) - Part II||4
3097607|NCT01478347|3820436|FG000|NOT COMPLETED|Visit 4-Visit 7 (Day 151-331) - Part II||8
3097608|NCT01478360|3820442|FG000|STARTED|Overall Study||31
3097609|NCT01478360|3820443|FG001|STARTED|Overall Study||15
3097610|NCT01478360|3820442|FG000|PD (Pharmacodynamic) Analysis Set|Overall Study||31
3097611|NCT01478360|3820443|FG001|PD (Pharmacodynamic) Analysis Set|Overall Study||15
3097612|NCT01478360|3820442|FG000|PK (Pharmacokinetics) Analysis Set|Overall Study|Serum samples were collected during the study and analyzed only for the AIN457 group|31
3097613|NCT01478360|3820443|FG001|PK (Pharmacokinetics) Analysis Set|Overall Study||0
3097614|NCT01478360|3820442|FG000|COMPLETED|Overall Study||29
3097615|NCT01478360|3820443|FG001|COMPLETED|Overall Study||12
3097616|NCT01478360|3820442|FG000|NOT COMPLETED|Overall Study||2
3097617|NCT01478360|3820443|FG001|NOT COMPLETED|Overall Study||3
3097618|NCT01478373|3820449|FG000|STARTED|Treatment Phase||39
3097619|NCT01478373|3820449|FG000|COMPLETED|Treatment Phase||38
3097620|NCT01478373|3820449|FG000|NOT COMPLETED|Treatment Phase||1
3097621|NCT01478373|3820449|FG000|STARTED|Survival Phase||38
3097622|NCT01478373|3820449|FG000|COMPLETED|Survival Phase||0
3097623|NCT01478373|3820449|FG000|NOT COMPLETED|Survival Phase||38
3097624|NCT01478581|3820457|FG000|STARTED|Overall Study||13
3097625|NCT01478581|3820458|FG001|STARTED|Overall Study||18
3097626|NCT01478581|3820459|FG002|STARTED|Overall Study||18
3097627|NCT01478581|3820460|FG003|STARTED|Overall Study|Simon 2-stage design - cohort 4 expansion per stage 1 data (≥3 Clinical Benefit Responders observed|43
3097628|NCT01478581|3820457|FG000|COMPLETED|Overall Study||13
3097629|NCT01478581|3820458|FG001|COMPLETED|Overall Study||18
3097630|NCT01478581|3820459|FG002|COMPLETED|Overall Study||18
3097631|NCT01478581|3820460|FG003|COMPLETED|Overall Study||43
3097632|NCT01478581|3820457|FG000|NOT COMPLETED|Overall Study||0
3097633|NCT01478581|3820458|FG001|NOT COMPLETED|Overall Study||0
3097634|NCT01478581|3820459|FG002|NOT COMPLETED|Overall Study||0
3097635|NCT01478581|3820460|FG003|NOT COMPLETED|Overall Study||0
3097636|NCT01478594|3820476|FG000|STARTED|Overall Study||177
3097637|NCT01478594|3820477|FG001|STARTED|Overall Study||88
3097638|NCT01478594|3820476|FG000|Treated|Overall Study||177
3097639|NCT01478594|3820477|FG001|Treated|Overall Study||87
3097640|NCT01478594|3820476|FG000|COMPLETED|Overall Study|Participants still on study as of 28 February 2014|112
3097641|NCT01478594|3820477|FG001|COMPLETED|Overall Study|Participants still on study as of 28 February 2014|60
3097642|NCT01478594|3820476|FG000|NOT COMPLETED|Overall Study||65
3097643|NCT01478594|3820477|FG001|NOT COMPLETED|Overall Study||28
3097644|NCT01478620|3820536|FG000|STARTED|Overall Study||125
3097645|NCT01478620|3820536|FG000|COMPLETED|Overall Study||119
3097646|NCT01478620|3820536|FG000|NOT COMPLETED|Overall Study||6
3097647|NCT01478828|3820540|FG000|STARTED|Overall Study||2
3097648|NCT01478828|3820540|FG000|COMPLETED|Overall Study||1
3097649|NCT01478828|3820540|FG000|NOT COMPLETED|Overall Study||1
3097650|NCT01478854|3820545|FG000|STARTED|Overall Study||30
3097651|NCT01478854|3820545|FG000|COMPLETED|Overall Study||30
3097652|NCT01478854|3820545|FG000|NOT COMPLETED|Overall Study||0
3097653|NCT01478958|3820552|FG000|STARTED|Overall Study||67
3097654|NCT01478958|3820553|FG001|STARTED|Overall Study||66
3097655|NCT01478958|3820554|FG002|STARTED|Overall Study||69
3097656|NCT01478958|3820552|FG000|COMPLETED|Overall Study||65
3097657|NCT01478958|3820553|FG001|COMPLETED|Overall Study||64
3097658|NCT01478958|3820554|FG002|COMPLETED|Overall Study||66
3097659|NCT01478958|3820552|FG000|NOT COMPLETED|Overall Study||2
3097660|NCT01478958|3820553|FG001|NOT COMPLETED|Overall Study||2
3097661|NCT01478958|3820554|FG002|NOT COMPLETED|Overall Study||3
3097662|NCT01478971|3820562|FG000|STARTED|Standard of Care Period||184
3097663|NCT01478971|3820562|FG000|Received Treatment|Standard of Care Period||178
3097664|NCT01478971|3820562|FG000|COMPLETED|Standard of Care Period||159
3097665|NCT01478971|3820562|FG000|NOT COMPLETED|Standard of Care Period||25
3097666|NCT01478971|3820562|FG000|STARTED|Peginesatide Treatment Period|2 participants terminated the study before transitioning to peginesatide for unknown reasons|157
3097667|NCT01478971|3820562|FG000|COMPLETED|Peginesatide Treatment Period||143
3097668|NCT01478971|3820562|FG000|NOT COMPLETED|Peginesatide Treatment Period||14
3097669|NCT01479127|3820570|FG000|STARTED|Overall Study|started oral study drug (full safety sample)|8
3097670|NCT01479127|3820570|FG000|Started LCIG|Overall Study||6
3097671|NCT01479127|3820570|FG000|COMPLETED|Overall Study||5
3097672|NCT01479127|3820570|FG000|NOT COMPLETED|Overall Study||3
3097673|NCT01479270|3820580|FG000|STARTED|Overall Study||28
3097674|NCT01479270|3820581|FG001|STARTED|Overall Study||28
3097675|NCT01479270|3820580|FG000|COMPLETED|Overall Study||28
3097676|NCT01479270|3820581|FG001|COMPLETED|Overall Study||28
3097677|NCT01479270|3820580|FG000|NOT COMPLETED|Overall Study||0
3097678|NCT01479270|3820581|FG001|NOT COMPLETED|Overall Study||0
3097679|NCT01479348|3820590|FG000|STARTED|Overall Study||5
3097680|NCT01479348|3820591|FG001|STARTED|Overall Study||0
3097681|NCT01479348|3820590|FG000|COMPLETED|Overall Study||5
3097682|NCT01479348|3820591|FG001|COMPLETED|Overall Study||0
3097683|NCT01479348|3820590|FG000|NOT COMPLETED|Overall Study||0
3097684|NCT01479348|3820591|FG001|NOT COMPLETED|Overall Study||0
3097685|NCT01479374|3820598|FG000|STARTED|Overall Study||66
3097686|NCT01479374|3820599|FG001|STARTED|Overall Study||68
3097687|NCT01479374|3820600|FG002|STARTED|Overall Study||68
3097688|NCT01479374|3820598|FG000|COMPLETED|Overall Study||63
3097689|NCT01479374|3820599|FG001|COMPLETED|Overall Study||60
3097690|NCT01479374|3820600|FG002|COMPLETED|Overall Study||63
3097691|NCT01479374|3820598|FG000|NOT COMPLETED|Overall Study||3
3097692|NCT01479374|3820599|FG001|NOT COMPLETED|Overall Study||8
3097693|NCT01479374|3820600|FG002|NOT COMPLETED|Overall Study||5
3097694|NCT01479426|3820610|FG000|STARTED|Overall Study||40
3097695|NCT01479426|3820611|FG001|STARTED|Overall Study||40
3097696|NCT01479426|3820610|FG000|COMPLETED|Overall Study||36
3097697|NCT01479426|3820611|FG001|COMPLETED|Overall Study||37
3097698|NCT01479426|3820610|FG000|NOT COMPLETED|Overall Study||4
3097699|NCT01479426|3820611|FG001|NOT COMPLETED|Overall Study||3
3097700|NCT01479439|3820620|FG000|STARTED|Overall Study||15
3097701|NCT01479439|3820621|FG001|STARTED|Overall Study||13
3097702|NCT01479439|3820622|FG002|STARTED|Overall Study||8
3097703|NCT01479439|3820620|FG000|COMPLETED|Overall Study||14
3097704|NCT01479439|3820621|FG001|COMPLETED|Overall Study||12
3097705|NCT01479439|3820622|FG002|COMPLETED|Overall Study||6
3097706|NCT01479439|3820620|FG000|NOT COMPLETED|Overall Study||1
3097707|NCT01479439|3820621|FG001|NOT COMPLETED|Overall Study||1
3097708|NCT01479439|3820622|FG002|NOT COMPLETED|Overall Study||2
3097709|NCT01479465|3820637|FG000|STARTED|Overall Study||11
3097710|NCT01479465|3820638|FG001|STARTED|Overall Study||84
3097711|NCT01479465|3820639|FG002|STARTED|Overall Study||86
3097712|NCT01479465|3820640|FG003|STARTED|Overall Study||85
3097713|NCT01479465|3820637|FG000|COMPLETED|Overall Study||0
3097714|NCT01479465|3820638|FG001|COMPLETED|Overall Study||0
3097715|NCT01479465|3820639|FG002|COMPLETED|Overall Study||0
3097716|NCT01479465|3820640|FG003|COMPLETED|Overall Study||0
3097717|NCT01479465|3820637|FG000|NOT COMPLETED|Overall Study||11
3097718|NCT01479465|3820638|FG001|NOT COMPLETED|Overall Study||84
3097719|NCT01479465|3820639|FG002|NOT COMPLETED|Overall Study||86
3097720|NCT01479465|3820640|FG003|NOT COMPLETED|Overall Study||85
3097721|NCT01479478|3820652|FG000|STARTED|Overall Study||125
3097722|NCT01479478|3820653|FG001|STARTED|Overall Study||126
3097723|NCT01479478|3820652|FG000|COMPLETED|Overall Study||125
3097724|NCT01479478|3820653|FG001|COMPLETED|Overall Study||126
3097725|NCT01479478|3820652|FG000|NOT COMPLETED|Overall Study||0
3097726|NCT01479478|3820653|FG001|NOT COMPLETED|Overall Study||0
3097727|NCT01479517|3820662|FG000|STARTED|Overall Study||10
3097728|NCT01479517|3820663|FG001|STARTED|Overall Study||10
3097729|NCT01479517|3820664|FG002|STARTED|Overall Study||10
3097730|NCT01479517|3820662|FG000|COMPLETED|Overall Study||10
3097731|NCT01479517|3820663|FG001|COMPLETED|Overall Study||10
3097732|NCT01479517|3820664|FG002|COMPLETED|Overall Study||10
3097733|NCT01479517|3820662|FG000|NOT COMPLETED|Overall Study||0
3097734|NCT01479517|3820663|FG001|NOT COMPLETED|Overall Study||0
3097735|NCT01479517|3820664|FG002|NOT COMPLETED|Overall Study||0
3097736|NCT01479530|3820674|FG000|STARTED|Overall Study||158
3097737|NCT01479530|3820675|FG001|STARTED|Overall Study||163
3097738|NCT01479530|3820674|FG000|COMPLETED|Overall Study||148
3097739|NCT01479530|3820675|FG001|COMPLETED|Overall Study||151
3097740|NCT01479530|3820674|FG000|NOT COMPLETED|Overall Study||10
3097741|NCT01479530|3820675|FG001|NOT COMPLETED|Overall Study||12
3097742|NCT01479543|3820686|FG000|STARTED|Overall Study||21
3097743|NCT01479543|3820687|FG001|STARTED|Overall Study||20
3097744|NCT01479543|3820688|FG002|STARTED|Overall Study||21
3097745|NCT01479543|3820689|FG003|STARTED|Overall Study||20
3097746|NCT01479543|3820690|FG004|STARTED|Overall Study||21
3097747|NCT01479543|3820686|FG000|COMPLETED|Overall Study||20
3097748|NCT01479543|3820687|FG001|COMPLETED|Overall Study||20
3097749|NCT01479543|3820688|FG002|COMPLETED|Overall Study||20
3097750|NCT01479543|3820689|FG003|COMPLETED|Overall Study||20
3097751|NCT01479543|3820690|FG004|COMPLETED|Overall Study||20
3097752|NCT01479543|3820686|FG000|NOT COMPLETED|Overall Study||1
3097753|NCT01479543|3820687|FG001|NOT COMPLETED|Overall Study||0
3097754|NCT01479543|3820688|FG002|NOT COMPLETED|Overall Study||1
3097755|NCT01479543|3820689|FG003|NOT COMPLETED|Overall Study||0
3097756|NCT01479543|3820690|FG004|NOT COMPLETED|Overall Study||1
3097757|NCT01479595|3820704|FG000|STARTED|Overall Study||44
3097758|NCT01479595|3820705|FG001|STARTED|Overall Study||21
3097759|NCT01479595|3820704|FG000|PK Analysis Set|Overall Study||42
3097760|NCT01479595|3820705|FG001|PK Analysis Set|Overall Study||0
3097761|NCT01479595|3820704|FG000|Per Protocol Analysis Set|Overall Study||41
3097762|NCT01479595|3820705|FG001|Per Protocol Analysis Set|Overall Study||20
3097763|NCT01479595|3820704|FG000|COMPLETED|Overall Study||42
3097764|NCT01479595|3820705|FG001|COMPLETED|Overall Study||19
3097765|NCT01479595|3820704|FG000|NOT COMPLETED|Overall Study||2
3097766|NCT01479595|3820705|FG001|NOT COMPLETED|Overall Study||2
3097767|NCT01479621|3820717|FG000|STARTED|Pre-Assignment Period (Run-In Placebo)||909
3097768|NCT01479621|3820718|FG001|STARTED|Pre-Assignment Period (Run-In Placebo)||0
3097769|NCT01479621|3820719|FG002|STARTED|Pre-Assignment Period (Run-In Placebo)||0
3097770|NCT01479621|3820720|FG003|STARTED|Pre-Assignment Period (Run-In Placebo)||0
3097771|NCT01479621|3820721|FG004|STARTED|Pre-Assignment Period (Run-In Placebo)||0
3097772|NCT01479621|3820722|FG005|STARTED|Pre-Assignment Period (Run-In Placebo)||0
3097773|NCT01479621|3820723|FG006|STARTED|Pre-Assignment Period (Run-In Placebo)||0
3097774|NCT01479621|3820717|FG000|COMPLETED|Pre-Assignment Period (Run-In Placebo)||622
3097775|NCT01479621|3820718|FG001|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
3097776|NCT01479621|3820719|FG002|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
3097777|NCT01479621|3820720|FG003|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
3097778|NCT01479621|3820721|FG004|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
3097779|NCT01479621|3820722|FG005|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
3097780|NCT01479621|3820723|FG006|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
3097781|NCT01479621|3820717|FG000|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||287
3097782|NCT01479621|3820718|FG001|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
3097783|NCT01479621|3820719|FG002|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
3097784|NCT01479621|3820720|FG003|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
3097785|NCT01479621|3820721|FG004|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
3097786|NCT01479621|3820722|FG005|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
3097787|NCT01479621|3820723|FG006|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
3097788|NCT01479621|3820717|FG000|STARTED|Treatment Period||0
3097789|NCT01479621|3820718|FG001|STARTED|Treatment Period||103
3097790|NCT01479621|3820719|FG002|STARTED|Treatment Period||104
3097791|NCT01479621|3820720|FG003|STARTED|Treatment Period||104
3097792|NCT01479621|3820721|FG004|STARTED|Treatment Period||103
3097793|NCT01479621|3820722|FG005|STARTED|Treatment Period||104
3097794|NCT01479621|3820723|FG006|STARTED|Treatment Period||104
3097795|NCT01479621|3820717|FG000|Safety Population|Treatment Period||0
3097796|NCT01479621|3820718|FG001|Safety Population|Treatment Period||103
3097797|NCT01479621|3820719|FG002|Safety Population|Treatment Period||104
3097798|NCT01479621|3820720|FG003|Safety Population|Treatment Period||104
3097799|NCT01479621|3820721|FG004|Safety Population|Treatment Period||103
3097800|NCT01479621|3820722|FG005|Safety Population|Treatment Period||104
3097801|NCT01479621|3820723|FG006|Safety Population|Treatment Period||104
3097802|NCT01479621|3820717|FG000|Full Analysis Set|Treatment Period||0
3097803|NCT01479621|3820718|FG001|Full Analysis Set|Treatment Period||102
3097804|NCT01479621|3820719|FG002|Full Analysis Set|Treatment Period||101
3097805|NCT01479621|3820720|FG003|Full Analysis Set|Treatment Period||102
3097806|NCT01479621|3820721|FG004|Full Analysis Set|Treatment Period||102
3097807|NCT01479621|3820722|FG005|Full Analysis Set|Treatment Period||102
3097808|NCT01479621|3820723|FG006|Full Analysis Set|Treatment Period||102
3097809|NCT01479621|3820717|FG000|COMPLETED|Treatment Period||0
3097810|NCT01479621|3820718|FG001|COMPLETED|Treatment Period||79
3097811|NCT01479621|3820719|FG002|COMPLETED|Treatment Period||83
3097812|NCT01479621|3820720|FG003|COMPLETED|Treatment Period||92
3097813|NCT01479621|3820721|FG004|COMPLETED|Treatment Period||82
3290301|NCT02828020|4024207|FG000|STARTED|Safety Follow-up Period|1 participant who did not complete the Treatment Period, was counted in the Safety Follow-up Period.|480
3290302|NCT02828020|4024208|FG001|STARTED|Safety Follow-up Period|1 participant who did not complete the Treatment Period, was counted in the Safety Follow-up Period.|458
3290303|NCT02828020|4024209|FG002|STARTED|Safety Follow-up Period|1 participant who did not complete the Treatment Period, was counted in the Safety Follow-up Period.|480
3290304|NCT02828020|4024207|FG000|COMPLETED|Safety Follow-up Period||460
3097814|NCT01479621|3820722|FG005|COMPLETED|Treatment Period||63
3097815|NCT01479621|3820723|FG006|COMPLETED|Treatment Period||84
3097816|NCT01479621|3820717|FG000|NOT COMPLETED|Treatment Period||0
3097817|NCT01479621|3820718|FG001|NOT COMPLETED|Treatment Period||24
3097818|NCT01479621|3820719|FG002|NOT COMPLETED|Treatment Period||21
3097819|NCT01479621|3820720|FG003|NOT COMPLETED|Treatment Period||12
3097820|NCT01479621|3820721|FG004|NOT COMPLETED|Treatment Period||21
3097821|NCT01479621|3820722|FG005|NOT COMPLETED|Treatment Period||41
3097822|NCT01479621|3820723|FG006|NOT COMPLETED|Treatment Period||20
3097823|NCT01479725|3820739|FG000|STARTED|Overall Study||6
3097824|NCT01479725|3820740|FG001|STARTED|Overall Study||2
3097825|NCT01479725|3820739|FG000|COMPLETED|Overall Study||4
3097826|NCT01479725|3820740|FG001|COMPLETED|Overall Study||1
3097827|NCT01479725|3820739|FG000|NOT COMPLETED|Overall Study||2
3097828|NCT01479725|3820740|FG001|NOT COMPLETED|Overall Study||1
3097829|NCT01479764|3820748|FG000|STARTED|Randomized||76
3097830|NCT01479764|3820749|FG001|STARTED|Randomized||78
3097831|NCT01479764|3820748|FG000|COMPLETED|Randomized|2 randomized participants did not receive study drug|74
3097832|NCT01479764|3820749|FG001|COMPLETED|Randomized|1 randomized participant did not receive study drug|77
3097833|NCT01479764|3820748|FG000|NOT COMPLETED|Randomized||2
3097834|NCT01479764|3820749|FG001|NOT COMPLETED|Randomized||1
3097835|NCT01479764|3820748|FG000|STARTED|Treated||74
3097836|NCT01479764|3820749|FG001|STARTED|Treated||77
3097837|NCT01479764|3820748|FG000|COMPLETED|Treated||74
3097838|NCT01479764|3820749|FG001|COMPLETED|Treated||75
3097839|NCT01479764|3820748|FG000|NOT COMPLETED|Treated||0
3097840|NCT01479764|3820749|FG001|NOT COMPLETED|Treated||2
3097841|NCT01479777|3820755|FG000|STARTED|Overall Study||12
3097842|NCT01479777|3820755|FG000|COMPLETED|Overall Study||10
3097843|NCT01479777|3820755|FG000|NOT COMPLETED|Overall Study||2
3097844|NCT01479868|3820759|FG000|STARTED|Overall Study|Restricted to subject who received at least one dose of treatment (TMC435/RBV/PegIFN).|106
3097845|NCT01479868|3820759|FG000|COMPLETED|Overall Study||97
3097846|NCT01479868|3820759|FG000|NOT COMPLETED|Overall Study||9
3097847|NCT01479985|3820765|FG000|STARTED|Overall Study||167
3097848|NCT01479985|3820766|FG001|STARTED|Overall Study||86
3097849|NCT01479985|3820765|FG000|Baseline Survey|Overall Study||166
3097850|NCT01479985|3820766|FG001|Baseline Survey|Overall Study||85
3097851|NCT01479985|3820765|FG000|COMPLETED|Overall Study||161
3097852|NCT01479985|3820766|FG001|COMPLETED|Overall Study||80
3097853|NCT01479985|3820765|FG000|NOT COMPLETED|Overall Study||6
3097854|NCT01479985|3820766|FG001|NOT COMPLETED|Overall Study||6
3097855|NCT01480076|3820774|FG000|STARTED|Overall Study|enrolled and started run-in treatment|901
3097856|NCT01480076|3820774|FG000|Intent to Treat Population|Overall Study|Received ≥1 dose of study drug & provided ≥1 efficacy assessment at Baseline & the 3-month visit.|835
3097857|NCT01480076|3820774|FG000|COMPLETED|Overall Study||611
3097858|NCT01480076|3820774|FG000|NOT COMPLETED|Overall Study||290
3097859|NCT01480089|3820792|FG000|STARTED|Overall Study||25
3097860|NCT01480089|3820793|FG001|STARTED|Overall Study||30
3097861|NCT01480089|3820792|FG000|COMPLETED|Overall Study||25
3097862|NCT01480089|3820793|FG001|COMPLETED|Overall Study||30
3097863|NCT01480089|3820792|FG000|NOT COMPLETED|Overall Study||0
3097864|NCT01480089|3820793|FG001|NOT COMPLETED|Overall Study||0
3097865|NCT01480219|3820801|FG000|STARTED|Overall Study||325
3097866|NCT01480219|3820802|FG001|STARTED|Overall Study||142
3097867|NCT01480219|3820801|FG000|COMPLETED|Overall Study||325
3097868|NCT01480219|3820802|FG001|COMPLETED|Overall Study||142
3097869|NCT01480219|3820801|FG000|NOT COMPLETED|Overall Study||0
3097870|NCT01480219|3820802|FG001|NOT COMPLETED|Overall Study||0
3097871|NCT01480232|3820812|FG000|STARTED|Overall Study||40
3097872|NCT01480232|3820813|FG001|STARTED|Overall Study||41
3097873|NCT01480232|3820814|FG002|STARTED|Overall Study||38
3097874|NCT01480232|3820815|FG003|STARTED|Overall Study||41
3097875|NCT01480232|3820812|FG000|COMPLETED|Overall Study||22
3097876|NCT01480232|3820813|FG001|COMPLETED|Overall Study||19
3097877|NCT01480232|3820814|FG002|COMPLETED|Overall Study||21
3097878|NCT01480232|3820815|FG003|COMPLETED|Overall Study||22
3097879|NCT01480232|3820812|FG000|NOT COMPLETED|Overall Study||18
3097880|NCT01480232|3820813|FG001|NOT COMPLETED|Overall Study||22
3097881|NCT01480232|3820814|FG002|NOT COMPLETED|Overall Study||17
3097882|NCT01480232|3820815|FG003|NOT COMPLETED|Overall Study||19
3097883|NCT01480258|3820827|FG000|STARTED|Infant Series||656
3097884|NCT01480258|3820828|FG001|STARTED|Infant Series||659
3097885|NCT01480258|3820827|FG000|Vaccinated|Infant Series||653
3097886|NCT01480258|3820828|FG001|Vaccinated|Infant Series||659
3097887|NCT01480258|3820827|FG000|COMPLETED|Infant Series||649
3097888|NCT01480258|3820828|FG001|COMPLETED|Infant Series||651
3097889|NCT01480258|3820827|FG000|NOT COMPLETED|Infant Series||7
3097890|NCT01480258|3820828|FG001|NOT COMPLETED|Infant Series||8
3097891|NCT01480258|3820827|FG000|STARTED|Interim Period||649
3097892|NCT01480258|3820828|FG001|STARTED|Interim Period||651
3097893|NCT01480258|3820827|FG000|COMPLETED|Interim Period||639
3097894|NCT01480258|3820828|FG001|COMPLETED|Interim Period||642
3097895|NCT01480258|3820827|FG000|NOT COMPLETED|Interim Period||10
3097896|NCT01480258|3820828|FG001|NOT COMPLETED|Interim Period||9
3097897|NCT01480258|3820827|FG000|STARTED|Toddler Dose||639
3097898|NCT01480258|3820828|FG001|STARTED|Toddler Dose||642
3097899|NCT01480258|3820827|FG000|COMPLETED|Toddler Dose||639
3097900|NCT01480258|3820828|FG001|COMPLETED|Toddler Dose||642
3097901|NCT01480258|3820827|FG000|NOT COMPLETED|Toddler Dose||0
3097902|NCT01480258|3820828|FG001|NOT COMPLETED|Toddler Dose||0
3097903|NCT01480284|3820836|FG000|STARTED|Overall Study||110
3097904|NCT01480284|3820837|FG001|STARTED|Overall Study||56
3097905|NCT01480284|3820836|FG000|COMPLETED|Overall Study||102
3097906|NCT01480284|3820837|FG001|COMPLETED|Overall Study||56
3097907|NCT01480284|3820836|FG000|NOT COMPLETED|Overall Study||8
3097908|NCT01480284|3820837|FG001|NOT COMPLETED|Overall Study||0
3097909|NCT01480297|3820843|FG000|STARTED|Overall Study||8
3097910|NCT01480297|3820843|FG000|COMPLETED|Overall Study||8
3097911|NCT01480297|3820843|FG000|NOT COMPLETED|Overall Study||0
3097912|NCT01480596|3820849|FG000|STARTED|Overall Study||22
3097913|NCT01480596|3820850|FG001|STARTED|Overall Study||18
3097914|NCT01480596|3820849|FG000|COMPLETED|Overall Study||17
3097915|NCT01480596|3820850|FG001|COMPLETED|Overall Study||16
3097916|NCT01480596|3820849|FG000|NOT COMPLETED|Overall Study||5
3097917|NCT01480596|3820850|FG001|NOT COMPLETED|Overall Study||2
3097918|NCT01480674|3820856|FG000|STARTED|Overall Study||160
3097919|NCT01480674|3820856|FG000|Safety Set|Overall Study||154
3097920|NCT01480674|3820856|FG000|Analysed Set|Overall Study||128
3097921|NCT01480674|3820856|FG000|COMPLETED|Overall Study||125
3097922|NCT01480674|3820856|FG000|NOT COMPLETED|Overall Study||35
3097923|NCT01480843|3820860|FG000|STARTED|Overall Study||65
3097924|NCT01480843|3820860|FG000|COMPLETED|Overall Study||60
3097925|NCT01480843|3820860|FG000|NOT COMPLETED|Overall Study||5
3097926|NCT01481116|3820867|FG000|STARTED|Overall Study||824
3097927|NCT01481116|3820868|FG001|STARTED|Overall Study||817
3097928|NCT01481116|3820869|FG002|STARTED|Overall Study||813
3097929|NCT01481116|3820867|FG000|Treated|Overall Study||822
3097930|NCT01481116|3820868|FG001|Treated|Overall Study||816
3097931|NCT01481116|3820869|FG002|Treated|Overall Study||813
3097932|NCT01481116|3820867|FG000|COMPLETED|Overall Study||0
3097933|NCT01481116|3820868|FG001|COMPLETED|Overall Study||0
3097934|NCT01481116|3820869|FG002|COMPLETED|Overall Study||0
3097935|NCT01481116|3820867|FG000|NOT COMPLETED|Overall Study||824
3097936|NCT01481116|3820868|FG001|NOT COMPLETED|Overall Study||817
3097937|NCT01481116|3820869|FG002|NOT COMPLETED|Overall Study||813
3097938|NCT01481129|3820877|FG000|STARTED|Overall Study||22
3097939|NCT01481129|3820877|FG000|COMPLETED|Overall Study||22
3097940|NCT01481129|3820877|FG000|NOT COMPLETED|Overall Study||0
3097941|NCT01481324|3820884|FG000|STARTED|Overall Study||21
3097942|NCT01481324|3820885|FG001|STARTED|Overall Study||24
3097943|NCT01481324|3820886|FG002|STARTED|Overall Study||22
3097944|NCT01481324|3820884|FG000|Month 1-Wear Rate Data|Overall Study||15
3097945|NCT01481324|3820885|FG001|Month 1-Wear Rate Data|Overall Study||16
3097946|NCT01481324|3820886|FG002|Month 1-Wear Rate Data|Overall Study||8
3097947|NCT01481324|3820884|FG000|Month 2-Wear Rate Data|Overall Study||9
3097948|NCT01481324|3820885|FG001|Month 2-Wear Rate Data|Overall Study||13
3097949|NCT01481324|3820886|FG002|Month 2-Wear Rate Data|Overall Study||7
3097950|NCT01481324|3820884|FG000|Month 3-Wear Rate Data|Overall Study||7
3097951|NCT01481324|3820885|FG001|Month 3-Wear Rate Data|Overall Study||11
3097952|NCT01481324|3820886|FG002|Month 3-Wear Rate Data|Overall Study||6
3097953|NCT01481324|3820884|FG000|COMPLETED|Overall Study||21
3097954|NCT01481324|3820885|FG001|COMPLETED|Overall Study||22
3097955|NCT01481324|3820886|FG002|COMPLETED|Overall Study||20
3097956|NCT01481324|3820884|FG000|NOT COMPLETED|Overall Study||0
3097957|NCT01481324|3820885|FG001|NOT COMPLETED|Overall Study||2
3097958|NCT01481324|3820886|FG002|NOT COMPLETED|Overall Study||2
3097959|NCT01481376|3820894|FG000|STARTED|Overall Study||200
3097960|NCT01481376|3820894|FG000|COMPLETED|Overall Study||169
3097961|NCT01481376|3820894|FG000|NOT COMPLETED|Overall Study||31
3097962|NCT01481545|3820900|FG000|STARTED|Overall Study||16
3097963|NCT01481545|3820901|FG001|STARTED|Overall Study||46
3097964|NCT01481545|3820900|FG000|COMPLETED|Overall Study||11
3097965|NCT01481545|3820901|FG001|COMPLETED|Overall Study||40
3097966|NCT01481545|3820900|FG000|NOT COMPLETED|Overall Study||5
3097967|NCT01481545|3820901|FG001|NOT COMPLETED|Overall Study||6
3097968|NCT01481558|3820911|FG000|STARTED|Overall Study||20
3097969|NCT01481558|3820912|FG001|STARTED|Overall Study||20
3097970|NCT01481558|3820911|FG000|COMPLETED|Overall Study||20
3097971|NCT01481558|3820912|FG001|COMPLETED|Overall Study||20
3097972|NCT01481558|3820911|FG000|NOT COMPLETED|Overall Study||0
3097973|NCT01481558|3820912|FG001|NOT COMPLETED|Overall Study||0
3097974|NCT01481740|3820920|FG000|STARTED|Overall Study||90
3097975|NCT01481740|3820921|FG001|STARTED|Overall Study||88
3097976|NCT01481740|3820920|FG000|COMPLETED|Overall Study||79
3097977|NCT01481740|3820921|FG001|COMPLETED|Overall Study||81
3097978|NCT01481740|3820920|FG000|NOT COMPLETED|Overall Study||11
3097979|NCT01481740|3820921|FG001|NOT COMPLETED|Overall Study||7
3097980|NCT01481779|3820929|FG000|STARTED|Overall Study||295
3097981|NCT01481779|3820930|FG001|STARTED|Overall Study||160
3097982|NCT01481779|3820929|FG000|Received at Least 1 Dose of Study Drug|Overall Study||294
3097983|NCT01481779|3820930|FG001|Received at Least 1 Dose of Study Drug|Overall Study||159
3097984|NCT01481779|3820929|FG000|COMPLETED|Overall Study||225
3097985|NCT01481779|3820930|FG001|COMPLETED|Overall Study||132
3097986|NCT01481779|3820929|FG000|NOT COMPLETED|Overall Study||70
3097987|NCT01481779|3820930|FG001|NOT COMPLETED|Overall Study||28
3097988|NCT01481896|3820936|FG000|STARTED|Overall Study|The 126 participants includes 5 participants with bilateral hip replacements for a total of 131 THAs|126
3097989|NCT01481896|3820936|FG000|Min 4.75 yr Follow-up, Revised or Dead|Overall Study|114 participants with 119 THAs had at least 4.75 year follow-up or were known revised or deceased|114
3097990|NCT01481896|3820936|FG000|COMPLETED|Overall Study|The 114 participants includes 5 participants with bilateral hip replacements for a total of 119 THAs|114
3097991|NCT01481896|3820936|FG000|NOT COMPLETED|Overall Study||12
3097992|NCT01482065|3820952|FG000|STARTED|Overall Study||4
3097993|NCT01482065|3820953|FG001|STARTED|Overall Study||5
3097994|NCT01482065|3820952|FG000|COMPLETED|Overall Study||4
3097995|NCT01482065|3820953|FG001|COMPLETED|Overall Study||4
3097996|NCT01482065|3820952|FG000|NOT COMPLETED|Overall Study||0
3097997|NCT01482065|3820953|FG001|NOT COMPLETED|Overall Study||1
3097998|NCT01482091|3820961|FG000|STARTED|Overall Study||25
3097999|NCT01482091|3820962|FG001|STARTED|Overall Study||24
3098000|NCT01482091|3820961|FG000|COMPLETED|Overall Study||25
3098001|NCT01482091|3820962|FG001|COMPLETED|Overall Study||24
3098002|NCT01482091|3820961|FG000|NOT COMPLETED|Overall Study||0
3098003|NCT01482091|3820962|FG001|NOT COMPLETED|Overall Study||0
3098004|NCT01482169|3820968|FG000|STARTED|Overall Study||48
3098005|NCT01482169|3820968|FG000|COMPLETED|Overall Study||46
3098006|NCT01482169|3820968|FG000|NOT COMPLETED|Overall Study||2
3098007|NCT01482221|3820978|FG000|STARTED|Overall Study||101
3098008|NCT01482221|3820979|FG001|STARTED|Overall Study||101
3098009|NCT01482221|3820980|FG002|STARTED|Overall Study||100
3098010|NCT01482221|3820978|FG000|COMPLETED|Overall Study||80
3098011|NCT01482221|3820979|FG001|COMPLETED|Overall Study||81
3098012|NCT01482221|3820980|FG002|COMPLETED|Overall Study||77
3098013|NCT01482221|3820978|FG000|NOT COMPLETED|Overall Study||21
3098014|NCT01482221|3820979|FG001|NOT COMPLETED|Overall Study||20
3098015|NCT01482221|3820980|FG002|NOT COMPLETED|Overall Study||23
3098016|NCT01482312|3820988|FG000|STARTED|Period 1, 90 Minutes of Wear||10
3098017|NCT01482312|3820989|FG001|STARTED|Period 1, 90 Minutes of Wear||9
3098018|NCT01482312|3820990|FG002|STARTED|Period 1, 90 Minutes of Wear||10
3098019|NCT01482312|3820988|FG000|COMPLETED|Period 1, 90 Minutes of Wear||9
3098020|NCT01482312|3820989|FG001|COMPLETED|Period 1, 90 Minutes of Wear||9
3098021|NCT01482312|3820990|FG002|COMPLETED|Period 1, 90 Minutes of Wear||10
3098022|NCT01482312|3820988|FG000|NOT COMPLETED|Period 1, 90 Minutes of Wear||1
3098023|NCT01482312|3820989|FG001|NOT COMPLETED|Period 1, 90 Minutes of Wear||0
3098024|NCT01482312|3820990|FG002|NOT COMPLETED|Period 1, 90 Minutes of Wear||0
3098025|NCT01482312|3820988|FG000|STARTED|Period 2, 90 Minutes of Wear||9
3098026|NCT01482312|3820989|FG001|STARTED|Period 2, 90 Minutes of Wear||9
3098027|NCT01482312|3820990|FG002|STARTED|Period 2, 90 Minutes of Wear|One participant discontinued between Period 1 and Period 2|9
3098028|NCT01482312|3820988|FG000|COMPLETED|Period 2, 90 Minutes of Wear||8
3098029|NCT01482312|3820989|FG001|COMPLETED|Period 2, 90 Minutes of Wear||9
3098030|NCT01482312|3820990|FG002|COMPLETED|Period 2, 90 Minutes of Wear||9
3098031|NCT01482312|3820988|FG000|NOT COMPLETED|Period 2, 90 Minutes of Wear||1
3098032|NCT01482312|3820989|FG001|NOT COMPLETED|Period 2, 90 Minutes of Wear||0
3098033|NCT01482312|3820990|FG002|NOT COMPLETED|Period 2, 90 Minutes of Wear||0
3098034|NCT01482312|3820988|FG000|STARTED|Period 3, 90 Minutes of Wear||8
3098035|NCT01482312|3820989|FG001|STARTED|Period 3, 90 Minutes of Wear||9
3098036|NCT01482312|3820990|FG002|STARTED|Period 3, 90 Minutes of Wear||9
3098037|NCT01482312|3820988|FG000|COMPLETED|Period 3, 90 Minutes of Wear||8
3098038|NCT01482312|3820989|FG001|COMPLETED|Period 3, 90 Minutes of Wear||9
3098039|NCT01482312|3820990|FG002|COMPLETED|Period 3, 90 Minutes of Wear||9
3098040|NCT01482312|3820988|FG000|NOT COMPLETED|Period 3, 90 Minutes of Wear||0
3098041|NCT01482312|3820989|FG001|NOT COMPLETED|Period 3, 90 Minutes of Wear||0
3098042|NCT01482312|3820990|FG002|NOT COMPLETED|Period 3, 90 Minutes of Wear||0
3098043|NCT01482351|3821000|FG000|STARTED|Overall Study||68
3098044|NCT01482351|3821000|FG000|6 Months|Overall Study|14 dropped out|54
3098045|NCT01482351|3821000|FG000|12 Months|Overall Study||54
3098046|NCT01482351|3821000|FG000|COMPLETED|Overall Study||54
3098047|NCT01482351|3821000|FG000|NOT COMPLETED|Overall Study||14
3098048|NCT01482429|3821010|FG000|STARTED|Care Usual||0
3098049|NCT01482429|3821011|FG001|STARTED|Care Usual||269
3098050|NCT01482429|3821010|FG000|COMPLETED|Care Usual||0
3098051|NCT01482429|3821011|FG001|COMPLETED|Care Usual||96
3098052|NCT01482429|3821010|FG000|NOT COMPLETED|Care Usual||0
3098053|NCT01482429|3821011|FG001|NOT COMPLETED|Care Usual||173
3098054|NCT01482429|3821010|FG000|STARTED|Protocol||414
3098055|NCT01482429|3821011|FG001|STARTED|Protocol||0
3098056|NCT01482429|3821010|FG000|COMPLETED|Protocol||139
3098057|NCT01482429|3821011|FG001|COMPLETED|Protocol||0
3098058|NCT01482429|3821010|FG000|NOT COMPLETED|Protocol||275
3098059|NCT01482429|3821011|FG001|NOT COMPLETED|Protocol||0
3098060|NCT01482715|3821030|FG000|STARTED|Overall Study||6
3098061|NCT01482715|3821031|FG001|STARTED|Overall Study||3
3098062|NCT01482715|3821032|FG002|STARTED|Overall Study||4
3098063|NCT01482715|3821033|FG003|STARTED|Overall Study||9
3098064|NCT01482715|3821034|FG004|STARTED|Overall Study||4
3098065|NCT01482715|3821035|FG005|STARTED|Overall Study||3
3098066|NCT01482715|3821036|FG006|STARTED|Overall Study||8
3098067|NCT01482715|3821037|FG007|STARTED|Overall Study||9
3098068|NCT01482715|3821038|FG008|STARTED|Overall Study||7
3098069|NCT01482715|3821039|FG009|STARTED|Overall Study||3
3098070|NCT01482715|3821040|FG010|STARTED|Overall Study||42
3098071|NCT01482715|3821041|FG011|STARTED|Overall Study||12
3098072|NCT01482715|3821042|FG012|STARTED|Overall Study||26
3098073|NCT01482715|3821030|FG000|COMPLETED|Overall Study||6
3098074|NCT01482715|3821031|FG001|COMPLETED|Overall Study||3
3098075|NCT01482715|3821032|FG002|COMPLETED|Overall Study||4
3098076|NCT01482715|3821033|FG003|COMPLETED|Overall Study||9
3098077|NCT01482715|3821034|FG004|COMPLETED|Overall Study||4
3098078|NCT01482715|3821035|FG005|COMPLETED|Overall Study||3
3098079|NCT01482715|3821036|FG006|COMPLETED|Overall Study||8
3098080|NCT01482715|3821037|FG007|COMPLETED|Overall Study||9
3098081|NCT01482715|3821038|FG008|COMPLETED|Overall Study||7
3098082|NCT01482715|3821039|FG009|COMPLETED|Overall Study||3
3098083|NCT01482715|3821040|FG010|COMPLETED|Overall Study||42
3098084|NCT01482715|3821041|FG011|COMPLETED|Overall Study||12
3098085|NCT01482715|3821042|FG012|COMPLETED|Overall Study||26
3098086|NCT01482715|3821030|FG000|NOT COMPLETED|Overall Study||0
3098087|NCT01482715|3821031|FG001|NOT COMPLETED|Overall Study||0
3098088|NCT01482715|3821032|FG002|NOT COMPLETED|Overall Study||0
3098089|NCT01482715|3821033|FG003|NOT COMPLETED|Overall Study||0
3098090|NCT01482715|3821034|FG004|NOT COMPLETED|Overall Study||0
3098091|NCT01482715|3821035|FG005|NOT COMPLETED|Overall Study||0
3098092|NCT01482715|3821036|FG006|NOT COMPLETED|Overall Study||0
3098093|NCT01482715|3821037|FG007|NOT COMPLETED|Overall Study||0
3098094|NCT01482715|3821038|FG008|NOT COMPLETED|Overall Study||0
3098095|NCT01482715|3821039|FG009|NOT COMPLETED|Overall Study||0
3098096|NCT01482715|3821040|FG010|NOT COMPLETED|Overall Study||0
3098097|NCT01482715|3821041|FG011|NOT COMPLETED|Overall Study||0
3098098|NCT01482715|3821042|FG012|NOT COMPLETED|Overall Study||0
3098099|NCT01482767|3821085|FG000|STARTED|Overall Study||135
3098100|NCT01482767|3821086|FG001|STARTED|Overall Study||127
3098101|NCT01482767|3821085|FG000|COMPLETED|Overall Study||81
3098102|NCT01482767|3821086|FG001|COMPLETED|Overall Study||78
3098103|NCT01482767|3821085|FG000|NOT COMPLETED|Overall Study||54
3098104|NCT01482767|3821086|FG001|NOT COMPLETED|Overall Study||49
3098105|NCT01482819|3821092|FG000|STARTED|Overall Study||21
3098106|NCT01482819|3821092|FG000|COMPLETED|Overall Study||19
3098107|NCT01482819|3821092|FG000|NOT COMPLETED|Overall Study||2
3098108|NCT01482884|3821102|FG000|STARTED|Overall Study|One participant did not receive study treatment|56
3098109|NCT01482884|3821103|FG001|STARTED|Overall Study||55
3098110|NCT01482884|3821102|FG000|COMPLETED|Overall Study||43
3098111|NCT01482884|3821103|FG001|COMPLETED|Overall Study||37
3098112|NCT01482884|3821102|FG000|NOT COMPLETED|Overall Study||13
3098113|NCT01482884|3821103|FG001|NOT COMPLETED|Overall Study||18
3098114|NCT01482910|3821111|FG000|STARTED|Overall Study||228
3098115|NCT01482910|3821112|FG001|STARTED|Overall Study||76
3098116|NCT01482910|3821111|FG000|Completed Week 28|Overall Study||216
3098117|NCT01482910|3821112|FG001|Completed Week 28|Overall Study||71
3098118|NCT01482910|3821111|FG000|COMPLETED|Overall Study||213
3098119|NCT01482910|3821112|FG001|COMPLETED|Overall Study||67
3098120|NCT01482910|3821111|FG000|NOT COMPLETED|Overall Study||15
3098121|NCT01482910|3821112|FG001|NOT COMPLETED|Overall Study||9
3098122|NCT01482962|3821122|FG000|STARTED|Overall Study||138
3098123|NCT01482962|3821123|FG001|STARTED|Overall Study||133
3098124|NCT01482962|3821122|FG000|Safety Population: Received Study Drug|Overall Study||137
3098125|NCT01482962|3821123|FG001|Safety Population: Received Study Drug|Overall Study||127
3098126|NCT01482962|3821122|FG000|COMPLETED|Overall Study||0
3098127|NCT01482962|3821123|FG001|COMPLETED|Overall Study||0
3098128|NCT01482962|3821122|FG000|NOT COMPLETED|Overall Study||138
3098129|NCT01482962|3821123|FG001|NOT COMPLETED|Overall Study||133
3098130|NCT01483118|3821133|FG000|STARTED|Overall Study||23
3098131|NCT01483118|3821134|FG001|STARTED|Overall Study||22
3098132|NCT01483118|3821133|FG000|Completed 3 Months|Overall Study||15
3098133|NCT01483118|3821134|FG001|Completed 3 Months|Overall Study||11
3098134|NCT01483118|3821133|FG000|COMPLETED|Overall Study||11
3098135|NCT01483118|3821134|FG001|COMPLETED|Overall Study||6
3098136|NCT01483118|3821133|FG000|NOT COMPLETED|Overall Study||12
3098137|NCT01483118|3821134|FG001|NOT COMPLETED|Overall Study||16
3098138|NCT01483144|3821145|FG000|STARTED|Overall Study||56
3098139|NCT01483144|3821146|FG001|STARTED|Overall Study||57
3098140|NCT01483144|3821147|FG002|STARTED|Overall Study||58
3098141|NCT01483144|3821145|FG000|COMPLETED|Overall Study||41
3098142|NCT01483144|3821146|FG001|COMPLETED|Overall Study||44
3098143|NCT01483144|3821147|FG002|COMPLETED|Overall Study||43
3098144|NCT01483144|3821145|FG000|NOT COMPLETED|Overall Study||15
3098145|NCT01483144|3821146|FG001|NOT COMPLETED|Overall Study||13
3098146|NCT01483144|3821147|FG002|NOT COMPLETED|Overall Study||15
3135318|NCT01706328|3860324|FG001|STARTED|12-week Double-blind Treatment Period||412
3135319|NCT01706328|3860325|FG002|STARTED|12-week Double-blind Treatment Period||416
3135320|NCT01706328|3860323|FG000|COMPLETED|12-week Double-blind Treatment Period||0
3135321|NCT01706328|3860324|FG001|COMPLETED|12-week Double-blind Treatment Period||366
3135322|NCT01706328|3860325|FG002|COMPLETED|12-week Double-blind Treatment Period||371
3135323|NCT01706328|3860323|FG000|NOT COMPLETED|12-week Double-blind Treatment Period||0
3135324|NCT01706328|3860324|FG001|NOT COMPLETED|12-week Double-blind Treatment Period||46
3135325|NCT01706328|3860325|FG002|NOT COMPLETED|12-week Double-blind Treatment Period||45
3135326|NCT01706458|3860333|FG000|STARTED|Overall Study||9
3135327|NCT01706458|3860334|FG001|STARTED|Overall Study||9
3135328|NCT01706458|3860333|FG000|COMPLETED|Overall Study||6
3135329|NCT01706458|3860334|FG001|COMPLETED|Overall Study||5
3135330|NCT01706458|3860333|FG000|NOT COMPLETED|Overall Study||3
3135331|NCT01706458|3860334|FG001|NOT COMPLETED|Overall Study||4
3135332|NCT01706497|3860340|FG000|STARTED|Overall Study||177
3135333|NCT01706497|3860340|FG000|COMPLETED|Overall Study||177
3135334|NCT01706497|3860340|FG000|NOT COMPLETED|Overall Study||0
3135335|NCT01706536|3860349|FG000|STARTED|Overall Study||57
3135336|NCT01706536|3860350|FG001|STARTED|Overall Study||55
3135337|NCT01706536|3860351|FG002|STARTED|Overall Study||54
3135338|NCT01706536|3860352|FG003|STARTED|Overall Study||57
3135339|NCT01706536|3860353|FG004|STARTED|Overall Study||59
3135340|NCT01706536|3860349|FG000|COMPLETED|Overall Study||53
3135341|NCT01706536|3860350|FG001|COMPLETED|Overall Study||51
3098147|NCT01483183|3821165|FG000|STARTED|Overall Study||4
3098148|NCT01483183|3821166|FG001|STARTED|Overall Study||1
3098149|NCT01483183|3821167|FG002|STARTED|Overall Study||5
3098150|NCT01483183|3821168|FG003|STARTED|Overall Study||3
3098151|NCT01483183|3821169|FG004|STARTED|Overall Study||4
3098152|NCT01483183|3821170|FG005|STARTED|Overall Study||4
3098153|NCT01483183|3821171|FG006|STARTED|Overall Study||6
3098154|NCT01483183|3821172|FG007|STARTED|Overall Study||4
3098155|NCT01483183|3821173|FG008|STARTED|Overall Study||4
3098156|NCT01483183|3821174|FG009|STARTED|Overall Study||5
3098157|NCT01483183|3821165|FG000|COMPLETED|Overall Study||4
3098158|NCT01483183|3821166|FG001|COMPLETED|Overall Study||1
3098159|NCT01483183|3821167|FG002|COMPLETED|Overall Study||5
3098160|NCT01483183|3821168|FG003|COMPLETED|Overall Study||3
3098161|NCT01483183|3821169|FG004|COMPLETED|Overall Study||4
3098162|NCT01483183|3821170|FG005|COMPLETED|Overall Study||4
3098163|NCT01483183|3821171|FG006|COMPLETED|Overall Study||4
3098164|NCT01483183|3821172|FG007|COMPLETED|Overall Study||4
3098165|NCT01483183|3821173|FG008|COMPLETED|Overall Study||4
3098166|NCT01483183|3821174|FG009|COMPLETED|Overall Study||4
3098167|NCT01483183|3821165|FG000|NOT COMPLETED|Overall Study||0
3098168|NCT01483183|3821166|FG001|NOT COMPLETED|Overall Study||0
3098169|NCT01483183|3821167|FG002|NOT COMPLETED|Overall Study||0
3098170|NCT01483183|3821168|FG003|NOT COMPLETED|Overall Study||0
3098171|NCT01483183|3821169|FG004|NOT COMPLETED|Overall Study||0
3098172|NCT01483183|3821170|FG005|NOT COMPLETED|Overall Study||0
3098173|NCT01483183|3821171|FG006|NOT COMPLETED|Overall Study||2
3098174|NCT01483183|3821172|FG007|NOT COMPLETED|Overall Study||0
3098175|NCT01483183|3821173|FG008|NOT COMPLETED|Overall Study||0
3098176|NCT01483183|3821174|FG009|NOT COMPLETED|Overall Study||1
3098177|NCT01483352|3821202|FG000|STARTED|Overall Study||12
3098178|NCT01483352|3821202|FG000|COMPLETED|Overall Study||12
3098179|NCT01483352|3821202|FG000|NOT COMPLETED|Overall Study||0
3098180|NCT01483378|3821206|FG000|STARTED|Overall Study||100
3098181|NCT01483378|3821207|FG001|STARTED|Overall Study||66
3098182|NCT01483378|3821206|FG000|COMPLETED|Overall Study||100
3098183|NCT01483378|3821207|FG001|COMPLETED|Overall Study||66
3098184|NCT01483378|3821206|FG000|NOT COMPLETED|Overall Study||0
3098185|NCT01483378|3821207|FG001|NOT COMPLETED|Overall Study||0
3098186|NCT01483560|3821215|FG000|STARTED|Overall Study||219
3098187|NCT01483560|3821216|FG001|STARTED|Overall Study||209
3098188|NCT01483560|3821215|FG000|COMPLETED|Overall Study||193
3098189|NCT01483560|3821216|FG001|COMPLETED|Overall Study||194
3098190|NCT01483560|3821215|FG000|NOT COMPLETED|Overall Study||26
3098191|NCT01483560|3821216|FG001|NOT COMPLETED|Overall Study||15
3098192|NCT01483599|3821229|FG000|STARTED|Controlled Period (CP) (up to Week 16)||42
3098193|NCT01483599|3821230|FG001|STARTED|Controlled Period (CP) (up to Week 16)||41
3098194|NCT01483599|3821231|FG002|STARTED|Controlled Period (CP) (up to Week 16)||41
3098195|NCT01483599|3821232|FG003|STARTED|Controlled Period (CP) (up to Week 16)||42
3098196|NCT01483599|3821233|FG004|STARTED|Controlled Period (CP) (up to Week 16)||42
3098197|NCT01483599|3821234|FG005|STARTED|Controlled Period (CP) (up to Week 16)||42
3098198|NCT01483599|3821235|FG006|STARTED|Controlled Period (CP) (up to Week 16)||43
3098199|NCT01483599|3821236|FG007|STARTED|Controlled Period (CP) (up to Week 16)||0
3098200|NCT01483599|3821237|FG008|STARTED|Controlled Period (CP) (up to Week 16)||0
3098201|NCT01483599|3821238|FG009|STARTED|Controlled Period (CP) (up to Week 16)||0
3098202|NCT01483599|3821239|FG010|STARTED|Controlled Period (CP) (up to Week 16)||0
3098203|NCT01483599|3821240|FG011|STARTED|Controlled Period (CP) (up to Week 16)||0
3098204|NCT01483599|3821241|FG012|STARTED|Controlled Period (CP) (up to Week 16)||0
3098205|NCT01483599|3821242|FG013|STARTED|Controlled Period (CP) (up to Week 16)||0
3098206|NCT01483599|3821229|FG000|Treated|Controlled Period (CP) (up to Week 16)||42
3098207|NCT01483599|3821230|FG001|Treated|Controlled Period (CP) (up to Week 16)||41
3098208|NCT01483599|3821231|FG002|Treated|Controlled Period (CP) (up to Week 16)||41
3098209|NCT01483599|3821232|FG003|Treated|Controlled Period (CP) (up to Week 16)||42
3098210|NCT01483599|3821233|FG004|Treated|Controlled Period (CP) (up to Week 16)||42
3098211|NCT01483599|3821234|FG005|Treated|Controlled Period (CP) (up to Week 16)||41
3098212|NCT01483599|3821235|FG006|Treated|Controlled Period (CP) (up to Week 16)||43
3098213|NCT01483599|3821236|FG007|Treated|Controlled Period (CP) (up to Week 16)||0
3098214|NCT01483599|3821237|FG008|Treated|Controlled Period (CP) (up to Week 16)||0
3098215|NCT01483599|3821238|FG009|Treated|Controlled Period (CP) (up to Week 16)||0
3098216|NCT01483599|3821239|FG010|Treated|Controlled Period (CP) (up to Week 16)||0
3098217|NCT01483599|3821240|FG011|Treated|Controlled Period (CP) (up to Week 16)||0
3098218|NCT01483599|3821241|FG012|Treated|Controlled Period (CP) (up to Week 16)||0
3098219|NCT01483599|3821242|FG013|Treated|Controlled Period (CP) (up to Week 16)||0
3098220|NCT01483599|3821229|FG000|COMPLETED|Controlled Period (CP) (up to Week 16)||39
3098221|NCT01483599|3821230|FG001|COMPLETED|Controlled Period (CP) (up to Week 16)||38
3098222|NCT01483599|3821231|FG002|COMPLETED|Controlled Period (CP) (up to Week 16)||41
3098223|NCT01483599|3821232|FG003|COMPLETED|Controlled Period (CP) (up to Week 16)||39
3098224|NCT01483599|3821233|FG004|COMPLETED|Controlled Period (CP) (up to Week 16)||40
3098225|NCT01483599|3821234|FG005|COMPLETED|Controlled Period (CP) (up to Week 16)||38
3098226|NCT01483599|3821235|FG006|COMPLETED|Controlled Period (CP) (up to Week 16)||39
3098227|NCT01483599|3821236|FG007|COMPLETED|Controlled Period (CP) (up to Week 16)||0
3098228|NCT01483599|3821237|FG008|COMPLETED|Controlled Period (CP) (up to Week 16)||0
3098229|NCT01483599|3821238|FG009|COMPLETED|Controlled Period (CP) (up to Week 16)||0
3098230|NCT01483599|3821239|FG010|COMPLETED|Controlled Period (CP) (up to Week 16)||0
3098231|NCT01483599|3821240|FG011|COMPLETED|Controlled Period (CP) (up to Week 16)||0
3098232|NCT01483599|3821241|FG012|COMPLETED|Controlled Period (CP) (up to Week 16)||0
3098233|NCT01483599|3821242|FG013|COMPLETED|Controlled Period (CP) (up to Week 16)||0
3098234|NCT01483599|3821229|FG000|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||3
3098235|NCT01483599|3821230|FG001|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||3
3098236|NCT01483599|3821231|FG002|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
3098237|NCT01483599|3821232|FG003|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||3
3098238|NCT01483599|3821233|FG004|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||2
3098239|NCT01483599|3821234|FG005|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||4
3098240|NCT01483599|3821235|FG006|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||4
3098241|NCT01483599|3821236|FG007|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
3098242|NCT01483599|3821237|FG008|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
3098243|NCT01483599|3821238|FG009|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
3098244|NCT01483599|3821239|FG010|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
3098245|NCT01483599|3821240|FG011|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
3098246|NCT01483599|3821241|FG012|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
3098247|NCT01483599|3821242|FG013|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
3098248|NCT01483599|3821229|FG000|STARTED|After Controlled Period(Week 16-Week 40)||0
3098249|NCT01483599|3821230|FG001|STARTED|After Controlled Period(Week 16-Week 40)||0
3098250|NCT01483599|3821231|FG002|STARTED|After Controlled Period(Week 16-Week 40)||0
3098251|NCT01483599|3821232|FG003|STARTED|After Controlled Period(Week 16-Week 40)||0
3098252|NCT01483599|3821233|FG004|STARTED|After Controlled Period(Week 16-Week 40)||0
3098253|NCT01483599|3821234|FG005|STARTED|After Controlled Period(Week 16-Week 40)||0
3098254|NCT01483599|3821235|FG006|STARTED|After Controlled Period(Week 16-Week 40)||0
3098255|NCT01483599|3821236|FG007|STARTED|After Controlled Period(Week 16-Week 40)||39
3098256|NCT01483599|3821237|FG008|STARTED|After Controlled Period(Week 16-Week 40)||38
3098257|NCT01483599|3821238|FG009|STARTED|After Controlled Period(Week 16-Week 40)||41
3098258|NCT01483599|3821239|FG010|STARTED|After Controlled Period(Week 16-Week 40)||39
3098259|NCT01483599|3821240|FG011|STARTED|After Controlled Period(Week 16-Week 40)||40
3098260|NCT01483599|3821241|FG012|STARTED|After Controlled Period(Week 16-Week 40)||38
3098261|NCT01483599|3821242|FG013|STARTED|After Controlled Period(Week 16-Week 40)||39
3098262|NCT01483599|3821229|FG000|COMPLETED|After Controlled Period(Week 16-Week 40)||0
3098263|NCT01483599|3821230|FG001|COMPLETED|After Controlled Period(Week 16-Week 40)||0
3098264|NCT01483599|3821231|FG002|COMPLETED|After Controlled Period(Week 16-Week 40)||0
3098265|NCT01483599|3821232|FG003|COMPLETED|After Controlled Period(Week 16-Week 40)||0
3098266|NCT01483599|3821233|FG004|COMPLETED|After Controlled Period(Week 16-Week 40)||0
3098267|NCT01483599|3821234|FG005|COMPLETED|After Controlled Period(Week 16-Week 40)||0
3098268|NCT01483599|3821235|FG006|COMPLETED|After Controlled Period(Week 16-Week 40)||0
3098269|NCT01483599|3821236|FG007|COMPLETED|After Controlled Period(Week 16-Week 40)||37
3098270|NCT01483599|3821237|FG008|COMPLETED|After Controlled Period(Week 16-Week 40)||29
3098271|NCT01483599|3821238|FG009|COMPLETED|After Controlled Period(Week 16-Week 40)||37
3098272|NCT01483599|3821239|FG010|COMPLETED|After Controlled Period(Week 16-Week 40)||37
3098273|NCT01483599|3821240|FG011|COMPLETED|After Controlled Period(Week 16-Week 40)||39
3098274|NCT01483599|3821241|FG012|COMPLETED|After Controlled Period(Week 16-Week 40)||35
3098275|NCT01483599|3821242|FG013|COMPLETED|After Controlled Period(Week 16-Week 40)||32
3098276|NCT01483599|3821229|FG000|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
3098277|NCT01483599|3821230|FG001|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
3098278|NCT01483599|3821231|FG002|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
3098279|NCT01483599|3821232|FG003|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
3098280|NCT01483599|3821233|FG004|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
3098281|NCT01483599|3821234|FG005|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
3098282|NCT01483599|3821235|FG006|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
3098283|NCT01483599|3821236|FG007|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||2
3098284|NCT01483599|3821237|FG008|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||9
3098285|NCT01483599|3821238|FG009|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||4
3098286|NCT01483599|3821239|FG010|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||2
3098287|NCT01483599|3821240|FG011|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||1
3098288|NCT01483599|3821241|FG012|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||3
3098289|NCT01483599|3821242|FG013|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||7
3098290|NCT01483625|3821273|FG000|STARTED|Overall Study||72
3098291|NCT01483625|3821274|FG001|STARTED|Overall Study||68
3098292|NCT01483625|3821273|FG000|COMPLETED|Overall Study||68
3098293|NCT01483625|3821274|FG001|COMPLETED|Overall Study||66
3098294|NCT01483625|3821273|FG000|NOT COMPLETED|Overall Study||4
3098295|NCT01483625|3821274|FG001|NOT COMPLETED|Overall Study||2
3098296|NCT01483651|3821280|FG000|STARTED|Overall Study||1
3098297|NCT01483651|3821281|FG001|STARTED|Overall Study||3
3098298|NCT01483651|3821282|FG002|STARTED|Overall Study||2
3098299|NCT01483651|3821283|FG003|STARTED|Overall Study||1
3098300|NCT01483651|3821284|FG004|STARTED|Overall Study||2
3098301|NCT01483651|3821285|FG005|STARTED|Overall Study||2
3098302|NCT01483651|3821280|FG000|COMPLETED|Overall Study||1
3098303|NCT01483651|3821281|FG001|COMPLETED|Overall Study||2
3098304|NCT01483651|3821282|FG002|COMPLETED|Overall Study||1
3098305|NCT01483651|3821283|FG003|COMPLETED|Overall Study||1
3098306|NCT01483651|3821284|FG004|COMPLETED|Overall Study||2
3098307|NCT01483651|3821285|FG005|COMPLETED|Overall Study||1
3098308|NCT01483651|3821280|FG000|NOT COMPLETED|Overall Study||0
3098309|NCT01483651|3821281|FG001|NOT COMPLETED|Overall Study||1
3098310|NCT01483651|3821282|FG002|NOT COMPLETED|Overall Study||1
3098311|NCT01483651|3821283|FG003|NOT COMPLETED|Overall Study||0
3098312|NCT01483651|3821284|FG004|NOT COMPLETED|Overall Study||0
3098313|NCT01483651|3821285|FG005|NOT COMPLETED|Overall Study||1
3098314|NCT01483690|3821295|FG000|STARTED|Overall Study||5
3098315|NCT01483690|3821296|FG001|STARTED|Overall Study||18
3098316|NCT01483690|3821295|FG000|COMPLETED|Overall Study||3
3098317|NCT01483690|3821296|FG001|COMPLETED|Overall Study||13
3098318|NCT01483690|3821295|FG000|NOT COMPLETED|Overall Study||2
3098319|NCT01483690|3821296|FG001|NOT COMPLETED|Overall Study||5
3098320|NCT01483807|3821302|FG000|STARTED|First Treatment Phase (7 Weeks)||10
3098321|NCT01483807|3821303|FG001|STARTED|First Treatment Phase (7 Weeks)||10
3098322|NCT01483807|3821302|FG000|COMPLETED|First Treatment Phase (7 Weeks)||10
3098323|NCT01483807|3821303|FG001|COMPLETED|First Treatment Phase (7 Weeks)||10
3098324|NCT01483807|3821302|FG000|NOT COMPLETED|First Treatment Phase (7 Weeks)||0
3098325|NCT01483807|3821303|FG001|NOT COMPLETED|First Treatment Phase (7 Weeks)||0
3098326|NCT01483807|3821302|FG000|STARTED|Washout (2 Weeks)||10
3098327|NCT01483807|3821303|FG001|STARTED|Washout (2 Weeks)||10
3098328|NCT01483807|3821302|FG000|COMPLETED|Washout (2 Weeks)||10
3098329|NCT01483807|3821303|FG001|COMPLETED|Washout (2 Weeks)||10
3098330|NCT01483807|3821302|FG000|NOT COMPLETED|Washout (2 Weeks)||0
3098331|NCT01483807|3821303|FG001|NOT COMPLETED|Washout (2 Weeks)||0
3098332|NCT01483807|3821302|FG000|STARTED|Second Treatment Phase (7 Weeks)||10
3098333|NCT01483807|3821303|FG001|STARTED|Second Treatment Phase (7 Weeks)||10
3098334|NCT01483807|3821302|FG000|COMPLETED|Second Treatment Phase (7 Weeks)||10
3098335|NCT01483807|3821303|FG001|COMPLETED|Second Treatment Phase (7 Weeks)||10
3098336|NCT01483807|3821302|FG000|NOT COMPLETED|Second Treatment Phase (7 Weeks)||0
3098337|NCT01483807|3821303|FG001|NOT COMPLETED|Second Treatment Phase (7 Weeks)||0
3098338|NCT01483820|3821311|FG000|STARTED|Overall Study||8
3098339|NCT01483820|3821311|FG000|COMPLETED|Overall Study||0
3098340|NCT01483820|3821311|FG000|NOT COMPLETED|Overall Study||8
3098341|NCT01483924|3821320|FG000|STARTED|Overall Study||12
3098342|NCT01483924|3821321|FG001|STARTED|Overall Study||12
3098343|NCT01483924|3821322|FG002|STARTED|Overall Study||12
3098344|NCT01483924|3821323|FG003|STARTED|Overall Study||12
3098345|NCT01483924|3821324|FG004|STARTED|Overall Study||12
3098346|NCT01483924|3821320|FG000|COMPLETED|Overall Study||10
3098347|NCT01483924|3821321|FG001|COMPLETED|Overall Study||12
3098348|NCT01483924|3821322|FG002|COMPLETED|Overall Study||11
3098349|NCT01483924|3821323|FG003|COMPLETED|Overall Study||8
3098350|NCT01483924|3821324|FG004|COMPLETED|Overall Study||10
3098351|NCT01483924|3821320|FG000|NOT COMPLETED|Overall Study||2
3098352|NCT01483924|3821321|FG001|NOT COMPLETED|Overall Study||0
3098353|NCT01483924|3821322|FG002|NOT COMPLETED|Overall Study||1
3098354|NCT01483924|3821323|FG003|NOT COMPLETED|Overall Study||4
3098355|NCT01483924|3821324|FG004|NOT COMPLETED|Overall Study||2
3098356|NCT01483937|3821347|FG000|STARTED|Overall Study||15
3098357|NCT01483937|3821348|FG001|STARTED|Overall Study||17
3098358|NCT01483937|3821347|FG000|COMPLETED|Overall Study||11
3098359|NCT01483937|3821348|FG001|COMPLETED|Overall Study||14
3098360|NCT01483937|3821347|FG000|NOT COMPLETED|Overall Study||4
3098361|NCT01483937|3821348|FG001|NOT COMPLETED|Overall Study||3
3098362|NCT01483963|3821362|FG000|STARTED|Overall Study||10
3098363|NCT01483963|3821363|FG001|STARTED|Overall Study||10
3098364|NCT01483963|3821364|FG002|STARTED|Overall Study||10
3098365|NCT01483963|3821365|FG003|STARTED|Overall Study||10
3098366|NCT01483963|3821366|FG004|STARTED|Overall Study||10
3098367|NCT01483963|3821362|FG000|COMPLETED|Overall Study||10
3098368|NCT01483963|3821363|FG001|COMPLETED|Overall Study||10
3098369|NCT01483963|3821364|FG002|COMPLETED|Overall Study||10
3098370|NCT01483963|3821365|FG003|COMPLETED|Overall Study||10
3098371|NCT01483963|3821366|FG004|COMPLETED|Overall Study||10
3098372|NCT01483963|3821362|FG000|NOT COMPLETED|Overall Study||0
3098373|NCT01483963|3821363|FG001|NOT COMPLETED|Overall Study||0
3098374|NCT01483963|3821364|FG002|NOT COMPLETED|Overall Study||0
3098375|NCT01483963|3821365|FG003|NOT COMPLETED|Overall Study||0
3098376|NCT01483963|3821366|FG004|NOT COMPLETED|Overall Study||0
3098377|NCT01484028|3821379|FG000|STARTED|Period 1||66
3098378|NCT01484028|3821380|FG001|STARTED|Period 1||70
3098379|NCT01484028|3821381|FG002|STARTED|Period 1||64
3098380|NCT01484028|3821382|FG003|STARTED|Period 1||67
3098381|NCT01484028|3821379|FG000|COMPLETED|Period 1||66
3098382|NCT01484028|3821380|FG001|COMPLETED|Period 1||67
3098383|NCT01484028|3821381|FG002|COMPLETED|Period 1||64
3098384|NCT01484028|3821382|FG003|COMPLETED|Period 1||66
3098385|NCT01484028|3821379|FG000|NOT COMPLETED|Period 1||0
3098386|NCT01484028|3821380|FG001|NOT COMPLETED|Period 1||3
3098387|NCT01484028|3821381|FG002|NOT COMPLETED|Period 1||0
3098388|NCT01484028|3821382|FG003|NOT COMPLETED|Period 1||1
3098389|NCT01484028|3821379|FG000|STARTED|Period 2||66
3098390|NCT01484028|3821380|FG001|STARTED|Period 2||67
3098391|NCT01484028|3821381|FG002|STARTED|Period 2||64
3098392|NCT01484028|3821382|FG003|STARTED|Period 2||66
3098393|NCT01484028|3821379|FG000|COMPLETED|Period 2||66
3098394|NCT01484028|3821380|FG001|COMPLETED|Period 2||67
3098395|NCT01484028|3821381|FG002|COMPLETED|Period 2||64
3098396|NCT01484028|3821382|FG003|COMPLETED|Period 2||66
3098397|NCT01484028|3821379|FG000|NOT COMPLETED|Period 2||0
3098398|NCT01484028|3821380|FG001|NOT COMPLETED|Period 2||0
3098399|NCT01484028|3821381|FG002|NOT COMPLETED|Period 2||0
3098400|NCT01484028|3821382|FG003|NOT COMPLETED|Period 2||0
3098401|NCT01484041|3821390|FG000|STARTED|Overall Study||12
3098402|NCT01484041|3821390|FG000|COMPLETED|Overall Study||12
3098403|NCT01484041|3821390|FG000|NOT COMPLETED|Overall Study||0
3098404|NCT01484054|3821394|FG000|STARTED|Period 1||50
3098405|NCT01484054|3821395|FG001|STARTED|Period 1||50
3098406|NCT01484054|3821394|FG000|COMPLETED|Period 1||50
3098407|NCT01484054|3821395|FG001|COMPLETED|Period 1||49
3098408|NCT01484054|3821394|FG000|NOT COMPLETED|Period 1||0
3098409|NCT01484054|3821395|FG001|NOT COMPLETED|Period 1||1
3098410|NCT01484054|3821394|FG000|STARTED|Period 2||50
3098411|NCT01484054|3821395|FG001|STARTED|Period 2||49
3098412|NCT01484054|3821394|FG000|COMPLETED|Period 2||50
3098413|NCT01484054|3821395|FG001|COMPLETED|Period 2||49
3098414|NCT01484054|3821394|FG000|NOT COMPLETED|Period 2||0
3098415|NCT01484054|3821395|FG001|NOT COMPLETED|Period 2||0
3098416|NCT01484132|3821402|FG000|STARTED|Overall Study||113
3098417|NCT01484132|3821402|FG000|Pre-treatment Urine Sample|Overall Study|Urine samples were collected twice pre-treatment. 101 subjects completed at least one urine sample.|101
3098418|NCT01484132|3821402|FG000|COMPLETED|Overall Study|91 subjects had at least one pre-treatment and at least one post-treatment urine sample.|91
3098419|NCT01484132|3821402|FG000|NOT COMPLETED|Overall Study||22
3098420|NCT01484197|3821406|FG000|STARTED|Treatment Period 1||9
3098421|NCT01484197|3821407|FG001|STARTED|Treatment Period 1||9
3098422|NCT01484197|3821408|FG002|STARTED|Treatment Period 1||9
3098423|NCT01484197|3821409|FG003|STARTED|Treatment Period 1||9
3098424|NCT01484197|3821406|FG000|COMPLETED|Treatment Period 1||8
3098425|NCT01484197|3821407|FG001|COMPLETED|Treatment Period 1||9
3098426|NCT01484197|3821408|FG002|COMPLETED|Treatment Period 1||9
3098427|NCT01484197|3821409|FG003|COMPLETED|Treatment Period 1||9
3098428|NCT01484197|3821406|FG000|NOT COMPLETED|Treatment Period 1||1
3098429|NCT01484197|3821407|FG001|NOT COMPLETED|Treatment Period 1||0
3098430|NCT01484197|3821408|FG002|NOT COMPLETED|Treatment Period 1||0
3098431|NCT01484197|3821409|FG003|NOT COMPLETED|Treatment Period 1||0
3098432|NCT01484197|3821406|FG000|STARTED|Treatment Period 2|1 patient completed Period 1 but did not enter Period 2 due to a Protocol deviation.|7
3098433|NCT01484197|3821407|FG001|STARTED|Treatment Period 2|1 patient completed Period 1 but did not enter Period 2 due to an Adverse event (AE).|8
3098434|NCT01484197|3821408|FG002|STARTED|Treatment Period 2||9
3098435|NCT01484197|3821409|FG003|STARTED|Treatment Period 2||9
3098436|NCT01484197|3821406|FG000|COMPLETED|Treatment Period 2||7
3098437|NCT01484197|3821407|FG001|COMPLETED|Treatment Period 2||8
3098438|NCT01484197|3821408|FG002|COMPLETED|Treatment Period 2||9
3098439|NCT01484197|3821409|FG003|COMPLETED|Treatment Period 2||8
3098440|NCT01484197|3821406|FG000|NOT COMPLETED|Treatment Period 2||0
3098441|NCT01484197|3821407|FG001|NOT COMPLETED|Treatment Period 2||0
3098442|NCT01484197|3821408|FG002|NOT COMPLETED|Treatment Period 2||0
3098443|NCT01484197|3821409|FG003|NOT COMPLETED|Treatment Period 2||1
3098444|NCT01484197|3821406|FG000|STARTED|Treatment Period 3||7
3098445|NCT01484197|3821407|FG001|STARTED|Treatment Period 3||8
3098446|NCT01484197|3821408|FG002|STARTED|Treatment Period 3||9
3098447|NCT01484197|3821409|FG003|STARTED|Treatment Period 3||8
3098448|NCT01484197|3821406|FG000|COMPLETED|Treatment Period 3||7
3098449|NCT01484197|3821407|FG001|COMPLETED|Treatment Period 3||8
3098450|NCT01484197|3821408|FG002|COMPLETED|Treatment Period 3||9
3098451|NCT01484197|3821409|FG003|COMPLETED|Treatment Period 3||8
3098452|NCT01484197|3821406|FG000|NOT COMPLETED|Treatment Period 3||0
3098453|NCT01484197|3821407|FG001|NOT COMPLETED|Treatment Period 3||0
3098454|NCT01484197|3821408|FG002|NOT COMPLETED|Treatment Period 3||0
3098455|NCT01484197|3821409|FG003|NOT COMPLETED|Treatment Period 3||0
3098456|NCT01484197|3821406|FG000|STARTED|Treatment Period 4||7
3098457|NCT01484197|3821407|FG001|STARTED|Treatment Period 4||8
3098458|NCT01484197|3821408|FG002|STARTED|Treatment Period 4||9
3290305|NCT02828020|4024208|FG001|COMPLETED|Safety Follow-up Period||440
3290306|NCT02828020|4024209|FG002|COMPLETED|Safety Follow-up Period||461
3290307|NCT02828020|4024207|FG000|NOT COMPLETED|Safety Follow-up Period||20
3290308|NCT02828020|4024208|FG001|NOT COMPLETED|Safety Follow-up Period||18
3290309|NCT02828020|4024209|FG002|NOT COMPLETED|Safety Follow-up Period||19
3290310|NCT02828111|4024222|FG000|STARTED|Overall Study||6
3290311|NCT02828111|4024223|FG001|STARTED|Overall Study||6
3290312|NCT02828111|4024224|FG002|STARTED|Overall Study||6
3290313|NCT02828111|4024225|FG003|STARTED|Overall Study||6
3290314|NCT02828111|4024226|FG004|STARTED|Overall Study||12
3290315|NCT02828111|4024222|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6
3290316|NCT02828111|4024223|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6
3290317|NCT02828111|4024224|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
3290318|NCT02828111|4024225|FG003|Received at Least 1 Dose of Study Drug|Overall Study||6
3290319|NCT02828111|4024226|FG004|Received at Least 1 Dose of Study Drug|Overall Study||12
3290320|NCT02828111|4024222|FG000|COMPLETED|Overall Study||6
3290321|NCT02828111|4024223|FG001|COMPLETED|Overall Study||6
3290322|NCT02828111|4024224|FG002|COMPLETED|Overall Study||4
3290323|NCT02828111|4024225|FG003|COMPLETED|Overall Study||5
3290324|NCT02828111|4024226|FG004|COMPLETED|Overall Study||11
3290325|NCT02828111|4024222|FG000|NOT COMPLETED|Overall Study||0
3290326|NCT02828111|4024223|FG001|NOT COMPLETED|Overall Study||0
3290327|NCT02828111|4024224|FG002|NOT COMPLETED|Overall Study||2
3098459|NCT01484197|3821409|FG003|STARTED|Treatment Period 4|2 patients completed Period 3 but did not enter Period 4 due to a Protocol deviation and an AE.|6
3098460|NCT01484197|3821406|FG000|COMPLETED|Treatment Period 4||7
3098461|NCT01484197|3821407|FG001|COMPLETED|Treatment Period 4||8
3098462|NCT01484197|3821408|FG002|COMPLETED|Treatment Period 4||9
3098463|NCT01484197|3821409|FG003|COMPLETED|Treatment Period 4||6
3098464|NCT01484197|3821406|FG000|NOT COMPLETED|Treatment Period 4||0
3098465|NCT01484197|3821407|FG001|NOT COMPLETED|Treatment Period 4||0
3098466|NCT01484197|3821408|FG002|NOT COMPLETED|Treatment Period 4||0
3098467|NCT01484197|3821409|FG003|NOT COMPLETED|Treatment Period 4||0
3098468|NCT01484275|3821421|FG000|STARTED|Overall Study||43
3098469|NCT01484275|3821422|FG001|STARTED|Overall Study||42
3098470|NCT01484275|3821421|FG000|COMPLETED|Overall Study||0
3098471|NCT01484275|3821422|FG001|COMPLETED|Overall Study||0
3098472|NCT01484275|3821421|FG000|NOT COMPLETED|Overall Study||43
3098473|NCT01484275|3821422|FG001|NOT COMPLETED|Overall Study||42
3098474|NCT01484288|3821428|FG000|STARTED|Overall Study||11
3098475|NCT01484288|3821428|FG000|COMPLETED|Overall Study||11
3098476|NCT01484288|3821428|FG000|NOT COMPLETED|Overall Study||0
3098477|NCT01484340|3821434|FG000|STARTED|Overall Study||281
3098478|NCT01484340|3821435|FG001|STARTED|Overall Study||279
3098479|NCT01484340|3821434|FG000|COMPLETED|Overall Study||281
3098480|NCT01484340|3821435|FG001|COMPLETED|Overall Study||279
3098481|NCT01484340|3821434|FG000|NOT COMPLETED|Overall Study||0
3098482|NCT01484340|3821435|FG001|NOT COMPLETED|Overall Study||0
3098483|NCT01484431|3821444|FG000|STARTED|Period 1: Low Dose||6
3098484|NCT01484431|3821445|FG001|STARTED|Period 1: Low Dose||7
3098485|NCT01484431|3821446|FG002|STARTED|Period 1: Low Dose||6
3098486|NCT01484431|3821444|FG000|Received 2 mg|Period 1: Low Dose||1
3098487|NCT01484431|3821445|FG001|Received 2 mg|Period 1: Low Dose||0
3098488|NCT01484431|3821446|FG002|Received 2 mg|Period 1: Low Dose||0
3098489|NCT01484431|3821444|FG000|Received 4 mg|Period 1: Low Dose||5
3098490|NCT01484431|3821445|FG001|Received 4 mg|Period 1: Low Dose||0
3098491|NCT01484431|3821446|FG002|Received 4 mg|Period 1: Low Dose||0
3098492|NCT01484431|3821444|FG000|Received 5 mg|Period 1: Low Dose||0
3098493|NCT01484431|3821445|FG001|Received 5 mg|Period 1: Low Dose||7
3098494|NCT01484431|3821446|FG002|Received 5 mg|Period 1: Low Dose||0
3098495|NCT01484431|3821444|FG000|Received 10 mg|Period 1: Low Dose||0
3098496|NCT01484431|3821445|FG001|Received 10 mg|Period 1: Low Dose||0
3098497|NCT01484431|3821446|FG002|Received 10 mg|Period 1: Low Dose||6
3098498|NCT01484431|3821444|FG000|COMPLETED|Period 1: Low Dose||6
3098499|NCT01484431|3821445|FG001|COMPLETED|Period 1: Low Dose||7
3098500|NCT01484431|3821446|FG002|COMPLETED|Period 1: Low Dose||6
3098501|NCT01484431|3821444|FG000|NOT COMPLETED|Period 1: Low Dose||0
3098502|NCT01484431|3821445|FG001|NOT COMPLETED|Period 1: Low Dose||0
3098503|NCT01484431|3821446|FG002|NOT COMPLETED|Period 1: Low Dose||0
3098504|NCT01484431|3821444|FG000|STARTED|Period 1: High Dose||6
3098505|NCT01484431|3821445|FG001|STARTED|Period 1: High Dose||7
3098506|NCT01484431|3821446|FG002|STARTED|Period 1: High Dose||6
3098507|NCT01484431|3821444|FG000|Received 8 mg|Period 1: High Dose||1
3098508|NCT01484431|3821445|FG001|Received 8 mg|Period 1: High Dose||0
3098509|NCT01484431|3821446|FG002|Received 8 mg|Period 1: High Dose||0
3098510|NCT01484431|3821444|FG000|Received 10 mg|Period 1: High Dose||1
3098511|NCT01484431|3821445|FG001|Received 10 mg|Period 1: High Dose||1
3098512|NCT01484431|3821446|FG002|Received 10 mg|Period 1: High Dose||0
3098513|NCT01484431|3821444|FG000|Received 15 mg|Period 1: High Dose||1
3098514|NCT01484431|3821445|FG001|Received 15 mg|Period 1: High Dose||1
3098515|NCT01484431|3821446|FG002|Received 15 mg|Period 1: High Dose||0
3098516|NCT01484431|3821444|FG000|Received 20 mg|Period 1: High Dose||3
3098517|NCT01484431|3821445|FG001|Received 20 mg|Period 1: High Dose||5
3098518|NCT01484431|3821446|FG002|Received 20 mg|Period 1: High Dose||1
3098519|NCT01484431|3821444|FG000|Received 40 mg|Period 1: High Dose||0
3098520|NCT01484431|3821445|FG001|Received 40 mg|Period 1: High Dose||0
3098521|NCT01484431|3821446|FG002|Received 40 mg|Period 1: High Dose||5
3098522|NCT01484431|3821444|FG000|COMPLETED|Period 1: High Dose||6
3098523|NCT01484431|3821445|FG001|COMPLETED|Period 1: High Dose||6
3098524|NCT01484431|3821446|FG002|COMPLETED|Period 1: High Dose||6
3098525|NCT01484431|3821444|FG000|NOT COMPLETED|Period 1: High Dose||0
3098526|NCT01484431|3821445|FG001|NOT COMPLETED|Period 1: High Dose||1
3098527|NCT01484431|3821446|FG002|NOT COMPLETED|Period 1: High Dose||0
3098528|NCT01484431|3821444|FG000|STARTED|Period 2||6
3098529|NCT01484431|3821445|FG001|STARTED|Period 2||6
3098530|NCT01484431|3821446|FG002|STARTED|Period 2||6
3098531|NCT01484431|3821444|FG000|Received 7 mg|Period 2||1
3098532|NCT01484431|3821445|FG001|Received 7 mg|Period 2||0
3098533|NCT01484431|3821446|FG002|Received 7 mg|Period 2||0
3098534|NCT01484431|3821444|FG000|Received 7.5 mg|Period 2||0
3098535|NCT01484431|3821445|FG001|Received 7.5 mg|Period 2||2
3098536|NCT01484431|3821446|FG002|Received 7.5 mg|Period 2||0
3098537|NCT01484431|3821444|FG000|Received 8 mg|Period 2||1
3098538|NCT01484431|3821445|FG001|Received 8 mg|Period 2||0
3098539|NCT01484431|3821446|FG002|Received 8 mg|Period 2||0
3098540|NCT01484431|3821444|FG000|Received 10 mg|Period 2||0
3098541|NCT01484431|3821445|FG001|Received 10 mg|Period 2||1
3098542|NCT01484431|3821446|FG002|Received 10 mg|Period 2||0
3098543|NCT01484431|3821444|FG000|Received 15 mg|Period 2||1
3098544|NCT01484431|3821445|FG001|Received 15 mg|Period 2||2
3098545|NCT01484431|3821446|FG002|Received 15 mg|Period 2||1
3098546|NCT01484431|3821444|FG000|Received 20 mg|Period 2||3
3098547|NCT01484431|3821445|FG001|Received 20 mg|Period 2||1
3098548|NCT01484431|3821446|FG002|Received 20 mg|Period 2||4
3098549|NCT01484431|3821444|FG000|Received 40 mg|Period 2||0
3098550|NCT01484431|3821445|FG001|Received 40 mg|Period 2||0
3098551|NCT01484431|3821446|FG002|Received 40 mg|Period 2||1
3098552|NCT01484431|3821444|FG000|COMPLETED|Period 2||5
3098553|NCT01484431|3821445|FG001|COMPLETED|Period 2||5
3098554|NCT01484431|3821446|FG002|COMPLETED|Period 2||4
3098555|NCT01484431|3821444|FG000|NOT COMPLETED|Period 2||1
3098556|NCT01484431|3821445|FG001|NOT COMPLETED|Period 2||1
3098557|NCT01484431|3821446|FG002|NOT COMPLETED|Period 2||2
3098558|NCT01484496|3821461|FG000|STARTED|Period 1||280
3098559|NCT01484496|3821462|FG001|STARTED|Period 1||556
3098560|NCT01484496|3821463|FG002|STARTED|Period 1||0
3098561|NCT01484496|3821464|FG003|STARTED|Period 1||0
3098562|NCT01484496|3821461|FG000|COMPLETED|Period 1||214
3098563|NCT01484496|3821462|FG001|COMPLETED|Period 1||463
3098564|NCT01484496|3821463|FG002|COMPLETED|Period 1||0
3098565|NCT01484496|3821464|FG003|COMPLETED|Period 1||0
3098566|NCT01484496|3821461|FG000|NOT COMPLETED|Period 1||66
3098567|NCT01484496|3821462|FG001|NOT COMPLETED|Period 1||93
3098568|NCT01484496|3821463|FG002|NOT COMPLETED|Period 1||0
3098569|NCT01484496|3821464|FG003|NOT COMPLETED|Period 1||0
3098570|NCT01484496|3821461|FG000|STARTED|Period 2||0
3098571|NCT01484496|3821462|FG001|STARTED|Period 2||0
3098572|NCT01484496|3821463|FG002|STARTED|Period 2||206
3098573|NCT01484496|3821464|FG003|STARTED|Period 2||456
3098574|NCT01484496|3821461|FG000|COMPLETED|Period 2||0
3098575|NCT01484496|3821462|FG001|COMPLETED|Period 2||0
3098576|NCT01484496|3821463|FG002|COMPLETED|Period 2||191
3098577|NCT01484496|3821464|FG003|COMPLETED|Period 2||434
3098578|NCT01484496|3821461|FG000|NOT COMPLETED|Period 2||0
3098579|NCT01484496|3821462|FG001|NOT COMPLETED|Period 2||0
3290328|NCT02828111|4024225|FG003|NOT COMPLETED|Overall Study||1
3290329|NCT02828111|4024226|FG004|NOT COMPLETED|Overall Study||1
3290330|NCT02828137|4024250|FG000|STARTED|Overall Study||41
3290331|NCT02828137|4024251|FG001|STARTED|Overall Study||41
3290332|NCT02828137|4024252|FG002|STARTED|Overall Study||41
3290333|NCT02828137|4024250|FG000|COMPLETED|Overall Study||41
3098580|NCT01484496|3821463|FG002|NOT COMPLETED|Period 2||15
3098581|NCT01484496|3821464|FG003|NOT COMPLETED|Period 2||22
3098582|NCT01484561|3821474|FG000|STARTED|Overall Study||97
3098583|NCT01484561|3821475|FG001|STARTED|Overall Study||51
3098584|NCT01484561|3821474|FG000|COMPLETED|Overall Study||88
3098585|NCT01484561|3821475|FG001|COMPLETED|Overall Study||45
3098586|NCT01484561|3821474|FG000|NOT COMPLETED|Overall Study||9
3098587|NCT01484561|3821475|FG001|NOT COMPLETED|Overall Study||6
3098588|NCT01484626|3821481|FG000|STARTED|Overall Study||3
3098589|NCT01484626|3821481|FG000|COMPLETED|Overall Study||3
3098590|NCT01484626|3821481|FG000|NOT COMPLETED|Overall Study||0
3098591|NCT01484652|3821487|FG000|STARTED|Overall Study||166
3098592|NCT01484652|3821488|FG001|STARTED|Overall Study||163
3098593|NCT01484652|3821487|FG000|COMPLETED|Overall Study||151
3098594|NCT01484652|3821488|FG001|COMPLETED|Overall Study||142
3098595|NCT01484652|3821487|FG000|NOT COMPLETED|Overall Study||15
3098596|NCT01484652|3821488|FG001|NOT COMPLETED|Overall Study||21
3098597|NCT01484834|3821498|FG000|STARTED|Overall Study||65
3098598|NCT01484834|3821499|FG001|STARTED|Overall Study||62
3098599|NCT01484834|3821500|FG002|STARTED|Overall Study||39
3098600|NCT01484834|3821501|FG003|STARTED|Overall Study||24
3098601|NCT01484834|3821498|FG000|COMPLETED|Overall Study||60
3098602|NCT01484834|3821499|FG001|COMPLETED|Overall Study||54
3098603|NCT01484834|3821500|FG002|COMPLETED|Overall Study||38
3290334|NCT02828137|4024251|FG001|COMPLETED|Overall Study||41
3290335|NCT02828137|4024252|FG002|COMPLETED|Overall Study||41
3290336|NCT02828137|4024250|FG000|NOT COMPLETED|Overall Study||0
3290337|NCT02828137|4024251|FG001|NOT COMPLETED|Overall Study||0
3290338|NCT02828137|4024252|FG002|NOT COMPLETED|Overall Study||0
3290339|NCT02828241|4024262|FG000|STARTED|Overall Study||38
3290340|NCT02828241|4024263|FG001|STARTED|Overall Study||23
3098604|NCT01484834|3821501|FG003|COMPLETED|Overall Study||20
3098605|NCT01484834|3821498|FG000|NOT COMPLETED|Overall Study||5
3098606|NCT01484834|3821499|FG001|NOT COMPLETED|Overall Study||8
3098607|NCT01484834|3821500|FG002|NOT COMPLETED|Overall Study||1
3098608|NCT01484834|3821501|FG003|NOT COMPLETED|Overall Study||4
3290341|NCT02828241|4024262|FG000|COMPLETED|Overall Study||30
3290342|NCT02828241|4024263|FG001|COMPLETED|Overall Study||21
3290343|NCT02828241|4024262|FG000|NOT COMPLETED|Overall Study||8
3290344|NCT02828241|4024263|FG001|NOT COMPLETED|Overall Study||2
3098609|NCT01484873|3821511|FG000|STARTED|Overall Study||10
3098610|NCT01484873|3821511|FG000|COMPLETED|Overall Study||8
3098611|NCT01484873|3821511|FG000|NOT COMPLETED|Overall Study||2
3098612|NCT01484912|3821518|FG000|STARTED|Overall Study||39
3098613|NCT01484912|3821519|FG001|STARTED|Overall Study||40
3098614|NCT01484912|3821518|FG000|COMPLETED|Overall Study||38
3098615|NCT01484912|3821519|FG001|COMPLETED|Overall Study||39
3098616|NCT01484912|3821518|FG000|NOT COMPLETED|Overall Study||1
3098617|NCT01484912|3821519|FG001|NOT COMPLETED|Overall Study||1
3098618|NCT01484938|3821525|FG000|STARTED|Overall Study||175
3098619|NCT01484938|3821525|FG000|COMPLETED|Overall Study||171
3098620|NCT01484938|3821525|FG000|NOT COMPLETED|Overall Study||4
3098621|NCT01484951|3821529|FG000|STARTED|Overall Study||74
3098622|NCT01484951|3821529|FG000|COMPLETED|Overall Study||69
3098623|NCT01484951|3821529|FG000|NOT COMPLETED|Overall Study||5
3098624|NCT01484977|3821533|FG000|STARTED|Overall Study||120
3290345|NCT02828267|4024274|FG000|STARTED|Overall Study||10
3290346|NCT02828267|4024275|FG001|STARTED|Overall Study||21
3290347|NCT02828267|4024276|FG002|STARTED|Overall Study||24
3098625|NCT01484977|3821533|FG000|COMPLETED|Overall Study||93
3098626|NCT01484977|3821533|FG000|NOT COMPLETED|Overall Study||27
3098627|NCT01485055|3821537|FG000|STARTED|Overall Study||11
3098628|NCT01485055|3821537|FG000|COMPLETED|Overall Study||11
3098629|NCT01485055|3821537|FG000|NOT COMPLETED|Overall Study||0
3098630|NCT01485094|3821544|FG000|STARTED|Overall Study||20
3098631|NCT01485094|3821545|FG001|STARTED|Overall Study||20
3098632|NCT01485094|3821546|FG002|STARTED|Overall Study||19
3098633|NCT01485094|3821544|FG000|COMPLETED|Overall Study||17
3098634|NCT01485094|3821545|FG001|COMPLETED|Overall Study||18
3098635|NCT01485094|3821546|FG002|COMPLETED|Overall Study||18
3098636|NCT01485094|3821544|FG000|NOT COMPLETED|Overall Study||3
3098637|NCT01485094|3821545|FG001|NOT COMPLETED|Overall Study||2
3098638|NCT01485094|3821546|FG002|NOT COMPLETED|Overall Study||1
3098639|NCT01485120|3821554|FG000|STARTED|Overall Study||34
3098640|NCT01485120|3821554|FG000|COMPLETED|Overall Study||32
3098641|NCT01485120|3821554|FG000|NOT COMPLETED|Overall Study||2
3098642|NCT01485172|3821565|FG000|STARTED|Overall Study||40
3098643|NCT01485172|3821566|FG001|STARTED|Overall Study||13
3098644|NCT01485172|3821567|FG002|STARTED|Overall Study||41
3098645|NCT01485172|3821568|FG003|STARTED|Overall Study||40
3098646|NCT01485172|3821569|FG004|STARTED|Overall Study||39
3098647|NCT01485172|3821570|FG005|STARTED|Overall Study||13
3098648|NCT01485172|3821565|FG000|COMPLETED|Overall Study||33
3098649|NCT01485172|3821566|FG001|COMPLETED|Overall Study||12
3098650|NCT01485172|3821567|FG002|COMPLETED|Overall Study||34
3098651|NCT01485172|3821568|FG003|COMPLETED|Overall Study||32
3098652|NCT01485172|3821569|FG004|COMPLETED|Overall Study||34
3098653|NCT01485172|3821570|FG005|COMPLETED|Overall Study||9
3098654|NCT01485172|3821565|FG000|NOT COMPLETED|Overall Study||7
3098655|NCT01485172|3821566|FG001|NOT COMPLETED|Overall Study||1
3098656|NCT01485172|3821567|FG002|NOT COMPLETED|Overall Study||7
3098657|NCT01485172|3821568|FG003|NOT COMPLETED|Overall Study||8
3098658|NCT01485172|3821569|FG004|NOT COMPLETED|Overall Study||5
3098659|NCT01485172|3821570|FG005|NOT COMPLETED|Overall Study||4
3098660|NCT01485354|3821584|FG000|STARTED|Overall Study||17
3098661|NCT01485354|3821584|FG000|COMPLETED|Overall Study||12
3098662|NCT01485354|3821584|FG000|NOT COMPLETED|Overall Study||5
3098663|NCT01485380|3821588|FG000|STARTED|Overall Study||20
3098664|NCT01485380|3821588|FG000|COMPLETED|Overall Study||17
3098665|NCT01485380|3821588|FG000|NOT COMPLETED|Overall Study||3
3098666|NCT01485393|3821592|FG000|STARTED|Overall Study||5
3098667|NCT01485393|3821593|FG001|STARTED|Overall Study||5
3098668|NCT01485393|3821592|FG000|COMPLETED|Overall Study||5
3098669|NCT01485393|3821593|FG001|COMPLETED|Overall Study||5
3098670|NCT01485393|3821592|FG000|NOT COMPLETED|Overall Study||0
3098671|NCT01485393|3821593|FG001|NOT COMPLETED|Overall Study||0
3098672|NCT01485536|3821600|FG000|STARTED|Overall Study||21
3098673|NCT01485536|3821600|FG000|COMPLETED|Overall Study||17
3098674|NCT01485536|3821600|FG000|NOT COMPLETED|Overall Study||4
3098675|NCT01485588|3821607|FG000|STARTED|Overall Study||6
3098676|NCT01485588|3821608|FG001|STARTED|Overall Study||6
3098677|NCT01485588|3821609|FG002|STARTED|Overall Study||6
3098678|NCT01485588|3821607|FG000|COMPLETED|Overall Study||6
3098679|NCT01485588|3821608|FG001|COMPLETED|Overall Study||6
3098680|NCT01485588|3821609|FG002|COMPLETED|Overall Study||6
3098681|NCT01485588|3821607|FG000|NOT COMPLETED|Overall Study||0
3290348|NCT02828267|4024277|FG003|STARTED|Overall Study||20
3290349|NCT02828267|4024274|FG000|COMPLETED|Overall Study||10
3290350|NCT02828267|4024275|FG001|COMPLETED|Overall Study||21
3290351|NCT02828267|4024276|FG002|COMPLETED|Overall Study||24
3290352|NCT02828267|4024277|FG003|COMPLETED|Overall Study||20
3290353|NCT02828267|4024274|FG000|NOT COMPLETED|Overall Study||0
3290354|NCT02828267|4024275|FG001|NOT COMPLETED|Overall Study||0
3290355|NCT02828267|4024276|FG002|NOT COMPLETED|Overall Study||0
3290356|NCT02828267|4024277|FG003|NOT COMPLETED|Overall Study||0
3290357|NCT02828358|4024291|FG000|STARTED|Overall Study||56
3290358|NCT02828358|4024292|FG001|STARTED|Overall Study||22
3290359|NCT02828358|4024291|FG000|COMPLETED|Overall Study||11
3290360|NCT02828358|4024292|FG001|COMPLETED|Overall Study||0
3290361|NCT02828358|4024291|FG000|NOT COMPLETED|Overall Study||45
3290362|NCT02828358|4024292|FG001|NOT COMPLETED|Overall Study||22
3316720|NCT03118739|4050153|FG000|COMPLETED|Overall Study||25
3316721|NCT03118739|4050154|FG001|COMPLETED|Overall Study||24
3316722|NCT03118739|4050153|FG000|NOT COMPLETED|Overall Study||7
3316723|NCT03118739|4050154|FG001|NOT COMPLETED|Overall Study||4
3316724|NCT03118765|4050165|FG000|STARTED|Overall Study||30
3316725|NCT03118765|4050166|FG001|STARTED|Overall Study||32
3316726|NCT03118765|4050167|FG002|STARTED|Overall Study||31
3316727|NCT03118765|4050168|FG003|STARTED|Overall Study||32
3316728|NCT03118765|4050169|FG004|STARTED|Overall Study||30
3316729|NCT03118765|4050165|FG000|COMPLETED|Overall Study||26
3316730|NCT03118765|4050166|FG001|COMPLETED|Overall Study||30
3098682|NCT01485588|3821608|FG001|NOT COMPLETED|Overall Study||0
3098683|NCT01485588|3821609|FG002|NOT COMPLETED|Overall Study||0
3316731|NCT03118765|4050167|FG002|COMPLETED|Overall Study||26
3316732|NCT03118765|4050168|FG003|COMPLETED|Overall Study||29
3098684|NCT01485614|3821623|FG000|STARTED|Randomization||96
3098685|NCT01485614|3821624|FG001|STARTED|Randomization||90
3098686|NCT01485614|3821625|FG002|STARTED|Randomization||9
3098687|NCT01485614|3821626|FG003|STARTED|Randomization||5
3098688|NCT01485614|3821623|FG000|COMPLETED|Randomization||95
3098689|NCT01485614|3821624|FG001|COMPLETED|Randomization||90
3098690|NCT01485614|3821625|FG002|COMPLETED|Randomization||9
3098691|NCT01485614|3821626|FG003|COMPLETED|Randomization||5
3098692|NCT01485614|3821623|FG000|NOT COMPLETED|Randomization||1
3098693|NCT01485614|3821624|FG001|NOT COMPLETED|Randomization||0
3098694|NCT01485614|3821625|FG002|NOT COMPLETED|Randomization||0
3098695|NCT01485614|3821626|FG003|NOT COMPLETED|Randomization||0
3098696|NCT01485614|3821623|FG000|STARTED|Weeks 0-20||95
3098697|NCT01485614|3821624|FG001|STARTED|Weeks 0-20||90
3098698|NCT01485614|3821625|FG002|STARTED|Weeks 0-20||9
3098699|NCT01485614|3821626|FG003|STARTED|Weeks 0-20||5
3098700|NCT01485614|3821623|FG000|Treated|Weeks 0-20||95
3098701|NCT01485614|3821624|FG001|Treated|Weeks 0-20||90
3098702|NCT01485614|3821625|FG002|Treated|Weeks 0-20||9
3098703|NCT01485614|3821626|FG003|Treated|Weeks 0-20||5
3098704|NCT01485614|3821623|FG000|COMPLETED|Weeks 0-20||85
3098705|NCT01485614|3821624|FG001|COMPLETED|Weeks 0-20||86
3098706|NCT01485614|3821625|FG002|COMPLETED|Weeks 0-20||8
3098707|NCT01485614|3821626|FG003|COMPLETED|Weeks 0-20||5
3098708|NCT01485614|3821623|FG000|NOT COMPLETED|Weeks 0-20||10
3098709|NCT01485614|3821624|FG001|NOT COMPLETED|Weeks 0-20||4
3098710|NCT01485614|3821625|FG002|NOT COMPLETED|Weeks 0-20||1
3098711|NCT01485614|3821626|FG003|NOT COMPLETED|Weeks 0-20||0
3098712|NCT01485614|3821623|FG000|STARTED|Weeks 20-54||85
3098713|NCT01485614|3821624|FG001|STARTED|Weeks 20-54||86
3098714|NCT01485614|3821625|FG002|STARTED|Weeks 20-54||8
3098715|NCT01485614|3821626|FG003|STARTED|Weeks 20-54||5
3098716|NCT01485614|3821623|FG000|COMPLETED|Weeks 20-54||74
3098717|NCT01485614|3821624|FG001|COMPLETED|Weeks 20-54||78
3098718|NCT01485614|3821625|FG002|COMPLETED|Weeks 20-54||6
3098719|NCT01485614|3821626|FG003|COMPLETED|Weeks 20-54||5
3098720|NCT01485614|3821623|FG000|NOT COMPLETED|Weeks 20-54||11
3098721|NCT01485614|3821624|FG001|NOT COMPLETED|Weeks 20-54||8
3098722|NCT01485614|3821625|FG002|NOT COMPLETED|Weeks 20-54||2
3098723|NCT01485614|3821626|FG003|NOT COMPLETED|Weeks 20-54||0
3098724|NCT01485627|3821644|FG000|STARTED|Overall Study|139 patients and 105 caregivers|244
3098725|NCT01485627|3821645|FG001|STARTED|Overall Study|142 patients and 99 caregivers|241
3098726|NCT01485627|3821644|FG000|Allocated Caregivers: Total|Overall Study||105
3098727|NCT01485627|3821645|FG001|Allocated Caregivers: Total|Overall Study||99
3098728|NCT01485627|3821644|FG000|Bereaved Caregivers: Total|Overall Study||63
3098729|NCT01485627|3821645|FG001|Bereaved Caregivers: Total|Overall Study||64
3098730|NCT01485627|3821644|FG000|Bereaved Caregivers: 1 Month|Overall Study||51
3098731|NCT01485627|3821645|FG001|Bereaved Caregivers: 1 Month|Overall Study||51
3098732|NCT01485627|3821644|FG000|Bereaved Caregivers: 2 Month Completed|Overall Study||49
3098733|NCT01485627|3821645|FG001|Bereaved Caregivers: 2 Month Completed|Overall Study||52
3290363|NCT02828436|4024297|FG000|STARTED|Period 1||0
3290364|NCT02828436|4024298|FG001|STARTED|Period 1||9
3290365|NCT02828436|4024297|FG000|COMPLETED|Period 1||0
3290366|NCT02828436|4024298|FG001|COMPLETED|Period 1||5
3290367|NCT02828436|4024297|FG000|NOT COMPLETED|Period 1||0
3290368|NCT02828436|4024298|FG001|NOT COMPLETED|Period 1||4
3290369|NCT02828436|4024297|FG000|STARTED|Period 2||9
3290370|NCT02828436|4024298|FG001|STARTED|Period 2||0
3290371|NCT02828436|4024297|FG000|COMPLETED|Period 2||1
3290372|NCT02828436|4024298|FG001|COMPLETED|Period 2||0
3098734|NCT01485627|3821644|FG000|Bereaved Caregivers: 7 Month Completed|Overall Study||48
3098735|NCT01485627|3821645|FG001|Bereaved Caregivers: 7 Month Completed|Overall Study||49
3098736|NCT01485627|3821644|FG000|COMPLETED|Overall Study|130 patients and 48 caregivers|178
3098737|NCT01485627|3821645|FG001|COMPLETED|Overall Study|135 patients and 49 caregivers|184
3098738|NCT01485627|3821644|FG000|NOT COMPLETED|Overall Study||66
3098739|NCT01485627|3821645|FG001|NOT COMPLETED|Overall Study||57
3098740|NCT01485640|3821655|FG000|STARTED|Overall Study||162
3098741|NCT01485640|3821655|FG000|COMPLETED|Overall Study||40
3098742|NCT01485640|3821655|FG000|NOT COMPLETED|Overall Study||122
3098743|NCT01485770|3821661|FG000|STARTED|First Intervention (2 Weeks)||17
3098744|NCT01485770|3821662|FG001|STARTED|First Intervention (2 Weeks)||16
3098745|NCT01485770|3821661|FG000|COMPLETED|First Intervention (2 Weeks)||17
3098746|NCT01485770|3821662|FG001|COMPLETED|First Intervention (2 Weeks)||16
3098747|NCT01485770|3821661|FG000|NOT COMPLETED|First Intervention (2 Weeks)||0
3098748|NCT01485770|3821662|FG001|NOT COMPLETED|First Intervention (2 Weeks)||0
3098749|NCT01485770|3821661|FG000|STARTED|Second Intervention (2 Weeks)||17
3098750|NCT01485770|3821662|FG001|STARTED|Second Intervention (2 Weeks)||16
3098751|NCT01485770|3821661|FG000|COMPLETED|Second Intervention (2 Weeks)||17
3098752|NCT01485770|3821662|FG001|COMPLETED|Second Intervention (2 Weeks)||16
3098753|NCT01485770|3821661|FG000|NOT COMPLETED|Second Intervention (2 Weeks)||0
3098754|NCT01485770|3821662|FG001|NOT COMPLETED|Second Intervention (2 Weeks)||0
3098755|NCT01485796|3821670|FG000|STARTED|Period 1: Epoch 1 (Ramp-up)||37
3290373|NCT02828436|4024297|FG000|NOT COMPLETED|Period 2||8
3098756|NCT01485796|3821670|FG000|Treated in Epoch 1|Period 1: Epoch 1 (Ramp-up)||37
3098757|NCT01485796|3821670|FG000|COMPLETED|Period 1: Epoch 1 (Ramp-up)||36
3098758|NCT01485796|3821670|FG000|NOT COMPLETED|Period 1: Epoch 1 (Ramp-up)||1
3098759|NCT01485796|3821670|FG000|STARTED|Period 2: Epoch 2||36
3098760|NCT01485796|3821670|FG000|Treated in Epoch 2|Period 2: Epoch 2||36
3098761|NCT01485796|3821670|FG000|COMPLETED|Period 2: Epoch 2||1
3098762|NCT01485796|3821670|FG000|NOT COMPLETED|Period 2: Epoch 2||35
3098763|NCT01485796|3821670|FG000|STARTED|Overall Trial (Incl. Safety Follow-up)||37
3098764|NCT01485796|3821670|FG000|Treated in Epoch 1 (Ramp-up)|Overall Trial (Incl. Safety Follow-up)||37
3290374|NCT02828436|4024298|FG001|NOT COMPLETED|Period 2||0
3290375|NCT02828644|4024306|FG000|STARTED|Overall Study||88
3098765|NCT01485796|3821670|FG000|Completed Epoch 1 (Ramp-up)|Overall Trial (Incl. Safety Follow-up)||36
3098766|NCT01485796|3821670|FG000|Started Epoch 2|Overall Trial (Incl. Safety Follow-up)||36
3098767|NCT01485796|3821670|FG000|Treated in Epoch 2|Overall Trial (Incl. Safety Follow-up)||36
3098768|NCT01485796|3821670|FG000|Completed Epoch 2|Overall Trial (Incl. Safety Follow-up)||1
3098769|NCT01485796|3821670|FG000|Switch to Safety Follow-up|Overall Trial (Incl. Safety Follow-up)||26
3098770|NCT01485796|3821670|FG000|Completed Safety Follow-up|Overall Trial (Incl. Safety Follow-up)||24
3098771|NCT01485796|3821670|FG000|COMPLETED|Overall Trial (Incl. Safety Follow-up)|1 subject who completed Epoch 2 + 24 subjects who completed the safety follow-up|25
3098772|NCT01485796|3821670|FG000|NOT COMPLETED|Overall Trial (Incl. Safety Follow-up)||12
3098773|NCT01485887|3821678|FG000|STARTED|Overall Study||50
3098774|NCT01485887|3821678|FG000|COMPLETED|Overall Study||38
3098775|NCT01485887|3821678|FG000|NOT COMPLETED|Overall Study||12
3098776|NCT01485991|3821684|FG000|STARTED|Overall Study||385
3098777|NCT01485991|3821685|FG001|STARTED|Overall Study||386
3098778|NCT01485991|3821684|FG000|Treated|Overall Study||379
3098779|NCT01485991|3821685|FG001|Treated|Overall Study||384
3098780|NCT01485991|3821684|FG000|COMPLETED|Overall Study||353
3098781|NCT01485991|3821685|FG001|COMPLETED|Overall Study||350
3098782|NCT01485991|3821684|FG000|NOT COMPLETED|Overall Study||32
3098783|NCT01485991|3821685|FG001|NOT COMPLETED|Overall Study||36
3098784|NCT01486043|3821691|FG000|STARTED|Overall Study||4
3098785|NCT01486043|3821691|FG000|COMPLETED|Overall Study|Study terminated due to insufficient recruitment|2
3098786|NCT01486043|3821691|FG000|NOT COMPLETED|Overall Study||2
3098787|NCT01486199|3821697|FG000|STARTED|Baseline Study Day||10
3098788|NCT01486199|3821698|FG001|STARTED|Baseline Study Day||10
3098789|NCT01486199|3821697|FG000|COMPLETED|Baseline Study Day||10
3098790|NCT01486199|3821698|FG001|COMPLETED|Baseline Study Day||9
3098791|NCT01486199|3821697|FG000|NOT COMPLETED|Baseline Study Day||0
3098792|NCT01486199|3821698|FG001|NOT COMPLETED|Baseline Study Day||1
3098793|NCT01486199|3821697|FG000|STARTED|Two Year Period Between Study Days||10
3098794|NCT01486199|3821698|FG001|STARTED|Two Year Period Between Study Days||0
3098795|NCT01486199|3821697|FG000|COMPLETED|Two Year Period Between Study Days||9
3098796|NCT01486199|3821698|FG001|COMPLETED|Two Year Period Between Study Days||0
3098797|NCT01486199|3821697|FG000|NOT COMPLETED|Two Year Period Between Study Days||1
3098798|NCT01486199|3821698|FG001|NOT COMPLETED|Two Year Period Between Study Days||0
3098799|NCT01486199|3821697|FG000|STARTED|Study Day at t= 2 Years||9
3098800|NCT01486199|3821698|FG001|STARTED|Study Day at t= 2 Years||0
3098801|NCT01486199|3821697|FG000|COMPLETED|Study Day at t= 2 Years||9
3098802|NCT01486199|3821698|FG001|COMPLETED|Study Day at t= 2 Years||0
3098803|NCT01486199|3821697|FG000|NOT COMPLETED|Study Day at t= 2 Years||0
3098804|NCT01486199|3821698|FG001|NOT COMPLETED|Study Day at t= 2 Years||0
3098805|NCT01486238|3821706|FG000|STARTED|Overall Study||23
3098806|NCT01486238|3821707|FG001|STARTED|Overall Study||49
3098807|NCT01486238|3821706|FG000|COMPLETED|Overall Study||21
3098808|NCT01486238|3821707|FG001|COMPLETED|Overall Study||43
3098809|NCT01486238|3821706|FG000|NOT COMPLETED|Overall Study||2
3098810|NCT01486238|3821707|FG001|NOT COMPLETED|Overall Study||6
3098811|NCT01486264|3821715|FG000|STARTED|Overall Study||142
3098812|NCT01486264|3821716|FG001|STARTED|Overall Study||141
3098813|NCT01486264|3821715|FG000|Treated|Overall Study||142
3098814|NCT01486264|3821716|FG001|Treated|Overall Study||140
3098815|NCT01486264|3821715|FG000|COMPLETED|Overall Study||113
3098816|NCT01486264|3821716|FG001|COMPLETED|Overall Study||94
3098817|NCT01486264|3821715|FG000|NOT COMPLETED|Overall Study||29
3098818|NCT01486264|3821716|FG001|NOT COMPLETED|Overall Study||47
3098819|NCT01486316|3821725|FG000|STARTED|Overall Study|prior to study closure, 24 subjects were enrolled 7 subjects randomized to Control Arm|7
3098820|NCT01486316|3821726|FG001|STARTED|Overall Study|prior to study closure, 24 subjects were enrolled with 10 being randomized to HFRS Guided Arm|10
3098821|NCT01486316|3821727|FG002|STARTED|Overall Study|Exited prior to implant|5
3098822|NCT01486316|3821728|FG003|STARTED|Overall Study|Exited prior to 6 month visit|2
3098823|NCT01486316|3821725|FG000|COMPLETED|Overall Study||3
3098824|NCT01486316|3821726|FG001|COMPLETED|Overall Study||7
3098825|NCT01486316|3821727|FG002|COMPLETED|Overall Study||0
3098826|NCT01486316|3821728|FG003|COMPLETED|Overall Study||0
3098827|NCT01486316|3821725|FG000|NOT COMPLETED|Overall Study||4
3098828|NCT01486316|3821726|FG001|NOT COMPLETED|Overall Study||3
3098829|NCT01486316|3821727|FG002|NOT COMPLETED|Overall Study||5
3098830|NCT01486316|3821728|FG003|NOT COMPLETED|Overall Study||2
3098831|NCT01486446|3821739|FG000|STARTED|Overall Study||7
3098832|NCT01486446|3821740|FG001|STARTED|Overall Study||1
3098833|NCT01486446|3821739|FG000|COMPLETED|Overall Study||6
3098834|NCT01486446|3821740|FG001|COMPLETED|Overall Study||1
3098835|NCT01486446|3821739|FG000|NOT COMPLETED|Overall Study||1
3098836|NCT01486446|3821740|FG001|NOT COMPLETED|Overall Study||0
3098837|NCT01486615|3821750|FG000|STARTED|Overall Study||20
3098838|NCT01486615|3821751|FG001|STARTED|Overall Study||20
3098839|NCT01486615|3821752|FG002|STARTED|Overall Study||20
3098840|NCT01486615|3821753|FG003|STARTED|Overall Study||20
3098841|NCT01486615|3821750|FG000|COMPLETED|Overall Study||20
3098842|NCT01486615|3821751|FG001|COMPLETED|Overall Study|observed till 2 hrs after premedication, not available after 24 hours as surgery was postponed|19
3098843|NCT01486615|3821752|FG002|COMPLETED|Overall Study|observed till 2 hrs after premedication, not available after 24 hours as surgery was postponed|18
3098844|NCT01486615|3821753|FG003|COMPLETED|Overall Study|observed till 2 hrs after premedication, not available after 24 hours as surgery was postponed|18
3098845|NCT01486615|3821750|FG000|NOT COMPLETED|Overall Study||0
3098846|NCT01486615|3821751|FG001|NOT COMPLETED|Overall Study||1
3098847|NCT01486615|3821752|FG002|NOT COMPLETED|Overall Study||2
3098848|NCT01486615|3821753|FG003|NOT COMPLETED|Overall Study||2
3098849|NCT01486758|3821765|FG000|STARTED|Overall Study||20
3098850|NCT01486758|3821766|FG001|STARTED|Overall Study||20
3098851|NCT01486758|3821765|FG000|COMPLETED|Overall Study||20
3098852|NCT01486758|3821766|FG001|COMPLETED|Overall Study||19
3098853|NCT01486758|3821765|FG000|NOT COMPLETED|Overall Study||0
3098854|NCT01486758|3821766|FG001|NOT COMPLETED|Overall Study||1
3098855|NCT01486784|3821779|FG000|STARTED|Overall Study||3
3098856|NCT01486784|3821780|FG001|STARTED|Overall Study||7
3098857|NCT01486784|3821781|FG002|STARTED|Overall Study||6
3098858|NCT01486784|3821782|FG003|STARTED|Overall Study||1
3098859|NCT01486784|3821783|FG004|STARTED|Overall Study||5
3098860|NCT01486784|3821784|FG005|STARTED|Overall Study||5
3098861|NCT01486784|3821779|FG000|Completed Cycle 1|Overall Study||2
3098862|NCT01486784|3821780|FG001|Completed Cycle 1|Overall Study||6
3098863|NCT01486784|3821781|FG002|Completed Cycle 1|Overall Study||3
3098864|NCT01486784|3821782|FG003|Completed Cycle 1|Overall Study||1
3098865|NCT01486784|3821783|FG004|Completed Cycle 1|Overall Study||3
3098866|NCT01486784|3821784|FG005|Completed Cycle 1|Overall Study||2
3098867|NCT01486784|3821779|FG000|Received Treatment|Overall Study||3
3098868|NCT01486784|3821780|FG001|Received Treatment|Overall Study||7
3290376|NCT02828644|4024307|FG001|STARTED|Overall Study||87
3290377|NCT02828644|4024306|FG000|COMPLETED|Overall Study||65
3290378|NCT02828644|4024307|FG001|COMPLETED|Overall Study||65
3290379|NCT02828644|4024306|FG000|NOT COMPLETED|Overall Study||23
3290380|NCT02828644|4024307|FG001|NOT COMPLETED|Overall Study||22
3290381|NCT02828917|4024314|FG000|STARTED|Overall Study||104
3290382|NCT02828917|4024314|FG000|COMPLETED|Overall Study||104
3290383|NCT02828917|4024314|FG000|NOT COMPLETED|Overall Study||0
3290384|NCT02829034|4024320|FG000|STARTED|Overall Study||14
3290385|NCT02829034|4024321|FG001|STARTED|Overall Study||8
3290386|NCT02829034|4024320|FG000|COMPLETED|Overall Study||9
3290387|NCT02829034|4024321|FG001|COMPLETED|Overall Study||6
3290388|NCT02829034|4024320|FG000|NOT COMPLETED|Overall Study||5
3290389|NCT02829034|4024321|FG001|NOT COMPLETED|Overall Study||2
3290390|NCT02829138|4024329|FG000|STARTED|Overall Study||29
3290391|NCT02829138|4024330|FG001|STARTED|Overall Study||28
3290392|NCT02829138|4024329|FG000|COMPLETED|Overall Study||28
3290393|NCT02829138|4024330|FG001|COMPLETED|Overall Study||28
3290394|NCT02829138|4024329|FG000|NOT COMPLETED|Overall Study||1
3290395|NCT02829138|4024330|FG001|NOT COMPLETED|Overall Study||0
3290396|NCT02829294|4024336|FG000|STARTED|Overall Study||19
3290397|NCT02829294|4024336|FG000|COMPLETED|Overall Study||19
3290398|NCT02829294|4024336|FG000|NOT COMPLETED|Overall Study||0
3290399|NCT02829307|4024342|FG000|STARTED|Overall Study||8
3290400|NCT02829307|4024342|FG000|COMPLETED|Overall Study||8
3290401|NCT02829307|4024342|FG000|NOT COMPLETED|Overall Study||0
3290402|NCT02829320|4024346|FG000|STARTED|Overall Study||28
3290403|NCT02829320|4024346|FG000|COMPLETED|Overall Study||28
3290404|NCT02829320|4024346|FG000|NOT COMPLETED|Overall Study||0
3290405|NCT02829463|4024359|FG000|STARTED|Overall Study||59
3290406|NCT02829463|4024360|FG001|STARTED|Overall Study||62
3290407|NCT02829463|4024359|FG000|COMPLETED|Overall Study||59
3290408|NCT02829463|4024360|FG001|COMPLETED|Overall Study||62
3290409|NCT02829463|4024359|FG000|NOT COMPLETED|Overall Study||0
3290410|NCT02829463|4024360|FG001|NOT COMPLETED|Overall Study||0
3290411|NCT02829775|4024366|FG000|STARTED|Overall Study||9
3290412|NCT02829775|4024366|FG000|COMPLETED|Overall Study||4
3290413|NCT02829775|4024366|FG000|NOT COMPLETED|Overall Study||5
3290417|NCT02829944|4024377|FG000|STARTED|Overall Study||44
3290418|NCT02829944|4024378|FG001|STARTED|Overall Study||40
3290419|NCT02829944|4024377|FG000|COMPLETED|Overall Study||38
3290420|NCT02829944|4024378|FG001|COMPLETED|Overall Study||33
3290421|NCT02829944|4024377|FG000|NOT COMPLETED|Overall Study||6
3290422|NCT02829944|4024378|FG001|NOT COMPLETED|Overall Study||7
3290423|NCT02829983|4024386|FG000|STARTED|Overall Study||20
3290424|NCT02829983|4024387|FG001|STARTED|Overall Study||20
3290425|NCT02829983|4024386|FG000|COMPLETED|Overall Study||20
3290426|NCT02829983|4024387|FG001|COMPLETED|Overall Study||20
3290427|NCT02829983|4024386|FG000|NOT COMPLETED|Overall Study||0
3290428|NCT02829983|4024387|FG001|NOT COMPLETED|Overall Study||0
3290429|NCT02829996|4024398|FG000|STARTED|Overall Study||39
3290430|NCT02829996|4024399|FG001|STARTED|Overall Study||39
3290431|NCT02829996|4024400|FG002|STARTED|Overall Study||40
3290432|NCT02829996|4024401|FG003|STARTED|Overall Study||41
3290433|NCT02829996|4024402|FG004|STARTED|Overall Study||42
3290434|NCT02829996|4024398|FG000|COMPLETED|Overall Study||38
3290435|NCT02829996|4024399|FG001|COMPLETED|Overall Study||39
3290436|NCT02829996|4024400|FG002|COMPLETED|Overall Study||40
3290437|NCT02829996|4024401|FG003|COMPLETED|Overall Study||41
3290438|NCT02829996|4024402|FG004|COMPLETED|Overall Study||42
3290439|NCT02829996|4024398|FG000|NOT COMPLETED|Overall Study||1
3290440|NCT02829996|4024399|FG001|NOT COMPLETED|Overall Study||0
3098869|NCT01486784|3821781|FG002|Received Treatment|Overall Study||5
3290441|NCT02829996|4024400|FG002|NOT COMPLETED|Overall Study||0
3290442|NCT02829996|4024401|FG003|NOT COMPLETED|Overall Study||0
3290443|NCT02829996|4024402|FG004|NOT COMPLETED|Overall Study||0
3290444|NCT02830074|4024416|FG000|STARTED|Overall Study||32
3098870|NCT01486784|3821782|FG003|Received Treatment|Overall Study||1
3098871|NCT01486784|3821783|FG004|Received Treatment|Overall Study||3
3098872|NCT01486784|3821784|FG005|Received Treatment|Overall Study||2
3098873|NCT01486784|3821779|FG000|COMPLETED|Overall Study||3
3098874|NCT01486784|3821780|FG001|COMPLETED|Overall Study||7
3098875|NCT01486784|3821781|FG002|COMPLETED|Overall Study||5
3098876|NCT01486784|3821782|FG003|COMPLETED|Overall Study||1
3098877|NCT01486784|3821783|FG004|COMPLETED|Overall Study||3
3098878|NCT01486784|3821784|FG005|COMPLETED|Overall Study||2
3098879|NCT01486784|3821779|FG000|NOT COMPLETED|Overall Study||0
3098880|NCT01486784|3821780|FG001|NOT COMPLETED|Overall Study||0
3098881|NCT01486784|3821781|FG002|NOT COMPLETED|Overall Study||1
3098882|NCT01486784|3821782|FG003|NOT COMPLETED|Overall Study||0
3098883|NCT01486784|3821783|FG004|NOT COMPLETED|Overall Study||2
3098884|NCT01486784|3821784|FG005|NOT COMPLETED|Overall Study||3
3098885|NCT01486810|3821798|FG000|STARTED|Overall Study||17
3098886|NCT01486810|3821798|FG000|COMPLETED|Overall Study||9
3098887|NCT01486810|3821798|FG000|NOT COMPLETED|Overall Study||8
3098888|NCT01486927|3821802|FG000|STARTED|Overall Study||174
3098889|NCT01486927|3821802|FG000|COMPLETED|Overall Study||161
3098890|NCT01486927|3821802|FG000|NOT COMPLETED|Overall Study||13
3098891|NCT01486966|3821815|FG000|STARTED|Overall Study||29
3098892|NCT01486966|3821816|FG001|STARTED|Overall Study||29
3098893|NCT01486966|3821815|FG000|COMPLETED|Overall Study||29
3098894|NCT01486966|3821816|FG001|COMPLETED|Overall Study||27
3098895|NCT01486966|3821815|FG000|NOT COMPLETED|Overall Study||0
3098896|NCT01486966|3821816|FG001|NOT COMPLETED|Overall Study||2
3098897|NCT01487161|3821826|FG000|STARTED|Overall Study||58
3098898|NCT01487161|3821827|FG001|STARTED|Overall Study||59
3098899|NCT01487161|3821828|FG002|STARTED|Overall Study||60
3098900|NCT01487161|3821829|FG003|STARTED|Overall Study||52
3098901|NCT01487161|3821826|FG000|COMPLETED|Overall Study||56
3098902|NCT01487161|3821827|FG001|COMPLETED|Overall Study||57
3098903|NCT01487161|3821828|FG002|COMPLETED|Overall Study||59
3098904|NCT01487161|3821829|FG003|COMPLETED|Overall Study||50
3098905|NCT01487161|3821826|FG000|NOT COMPLETED|Overall Study||2
3098906|NCT01487161|3821827|FG001|NOT COMPLETED|Overall Study||2
3098907|NCT01487161|3821828|FG002|NOT COMPLETED|Overall Study||1
3098908|NCT01487161|3821829|FG003|NOT COMPLETED|Overall Study||2
3098909|NCT01487200|3821848|FG000|STARTED|Overall Study||5
3098910|NCT01487200|3821849|FG001|STARTED|Overall Study||7
3098911|NCT01487200|3821850|FG002|STARTED|Overall Study||7
3098912|NCT01487200|3821851|FG003|STARTED|Overall Study||5
3290445|NCT02830074|4024417|FG001|STARTED|Overall Study||31
3290446|NCT02830074|4024416|FG000|COMPLETED|Overall Study||32
3290447|NCT02830074|4024417|FG001|COMPLETED|Overall Study||31
3290448|NCT02830074|4024416|FG000|NOT COMPLETED|Overall Study||0
3098913|NCT01487200|3821848|FG000|COMPLETED|Overall Study||5
3098914|NCT01487200|3821849|FG001|COMPLETED|Overall Study||6
3098915|NCT01487200|3821850|FG002|COMPLETED|Overall Study||7
3098916|NCT01487200|3821851|FG003|COMPLETED|Overall Study||5
3098917|NCT01487200|3821848|FG000|NOT COMPLETED|Overall Study||0
3098918|NCT01487200|3821849|FG001|NOT COMPLETED|Overall Study||1
3098919|NCT01487200|3821850|FG002|NOT COMPLETED|Overall Study||0
3098920|NCT01487200|3821851|FG003|NOT COMPLETED|Overall Study||0
3098921|NCT01487265|3821862|FG000|STARTED|Overall Study||37
3098922|NCT01487265|3821862|FG000|COMPLETED|Overall Study||0
3098923|NCT01487265|3821862|FG000|NOT COMPLETED|Overall Study||37
3098924|NCT01487525|3821868|FG000|STARTED|Overall Study||22
3098925|NCT01487525|3821869|FG001|STARTED|Overall Study||20
3098926|NCT01487525|3821868|FG000|COMPLETED|Overall Study||22
3098927|NCT01487525|3821869|FG001|COMPLETED|Overall Study||19
3098928|NCT01487525|3821868|FG000|NOT COMPLETED|Overall Study||0
3098929|NCT01487525|3821869|FG001|NOT COMPLETED|Overall Study||1
3098930|NCT01487577|3821875|FG000|STARTED|Overall Study||19
3098931|NCT01487577|3821875|FG000|COMPLETED|Overall Study|One participant became ineligible after signing consent, but before receiving protocol therapy.|18
3098932|NCT01487577|3821875|FG000|NOT COMPLETED|Overall Study||1
3098933|NCT01487668|3821881|FG000|STARTED|Overall Study||146
3098934|NCT01487668|3821882|FG001|STARTED|Overall Study||141
3098935|NCT01487668|3821881|FG000|COMPLETED|Overall Study||121
3098936|NCT01487668|3821882|FG001|COMPLETED|Overall Study||124
3098937|NCT01487668|3821881|FG000|NOT COMPLETED|Overall Study||25
3098938|NCT01487668|3821882|FG001|NOT COMPLETED|Overall Study||17
3098939|NCT01487863|3821892|FG000|STARTED|Overall Study||35
3098940|NCT01487863|3821893|FG001|STARTED|Overall Study||34
3098941|NCT01487863|3821892|FG000|Subjects Randomized (Efficacy Analysis)|Overall Study||35
3098942|NCT01487863|3821893|FG001|Subjects Randomized (Efficacy Analysis)|Overall Study||34
3098943|NCT01487863|3821892|FG000|Rcvd ≥1 Leukapheresis (Safety Analysis)|Overall Study||35
3098944|NCT01487863|3821893|FG001|Rcvd ≥1 Leukapheresis (Safety Analysis)|Overall Study||34
3098945|NCT01487863|3821892|FG000|COMPLETED|Overall Study||16
3098946|NCT01487863|3821893|FG001|COMPLETED|Overall Study||15
3098947|NCT01487863|3821892|FG000|NOT COMPLETED|Overall Study||19
3098948|NCT01487863|3821893|FG001|NOT COMPLETED|Overall Study||19
3098949|NCT01487954|3821901|FG000|STARTED|Overall Study||29
3098950|NCT01487954|3821902|FG001|STARTED|Overall Study||16
3098951|NCT01487954|3821901|FG000|Safety lead-in|Overall Study||10
3098952|NCT01487954|3821902|FG001|Safety lead-in|Overall Study|Only the first 10 patients in the alkaline group were analyzed, as that was the experimental group.|0
3098953|NCT01487954|3821901|FG000|COMPLETED|Overall Study||29
3098954|NCT01487954|3821902|FG001|COMPLETED|Overall Study||16
3098955|NCT01487954|3821901|FG000|NOT COMPLETED|Overall Study||0
3098956|NCT01487954|3821902|FG001|NOT COMPLETED|Overall Study||0
3098957|NCT01488019|3821910|FG000|STARTED|Overall Study||541
3098958|NCT01488019|3821911|FG001|STARTED|Overall Study||530
3098959|NCT01488019|3821910|FG000|COMPLETED|Overall Study||294
3098960|NCT01488019|3821911|FG001|COMPLETED|Overall Study||226
3098961|NCT01488019|3821910|FG000|NOT COMPLETED|Overall Study||247
3098962|NCT01488019|3821911|FG001|NOT COMPLETED|Overall Study||304
3098963|NCT01488071|3821921|FG000|STARTED|Overall Study|all-patients-treated set (APTS)|253
3098964|NCT01488071|3821922|FG001|STARTED|Overall Study|APTS|242
3098965|NCT01488071|3821921|FG000|COMPLETED|Overall Study||200
3098966|NCT01488071|3821922|FG001|COMPLETED|Overall Study||179
3098967|NCT01488071|3821921|FG000|NOT COMPLETED|Overall Study||53
3098968|NCT01488071|3821922|FG001|NOT COMPLETED|Overall Study||63
3098969|NCT01488097|3821928|FG000|STARTED|Overall Study||8
3098970|NCT01488097|3821928|FG000|Received Study Drug in Extension Study|Overall Study||8
3098971|NCT01488097|3821928|FG000|COMPLETED|Overall Study||7
3098972|NCT01488097|3821928|FG000|NOT COMPLETED|Overall Study||1
3098973|NCT01488188|3821934|FG000|STARTED|Overall Study||20
3098974|NCT01488188|3821935|FG001|STARTED|Overall Study||20
3098975|NCT01488188|3821934|FG000|COMPLETED|Overall Study||20
3098976|NCT01488188|3821935|FG001|COMPLETED|Overall Study||20
3098977|NCT01488188|3821934|FG000|NOT COMPLETED|Overall Study||0
3098978|NCT01488188|3821935|FG001|NOT COMPLETED|Overall Study||0
3098979|NCT01488279|3821943|FG000|STARTED|Overall Study||5
3098980|NCT01488279|3821944|FG001|STARTED|Overall Study||5
3098981|NCT01488279|3821943|FG000|COMPLETED|Overall Study||5
3098982|NCT01488279|3821944|FG001|COMPLETED|Overall Study||5
3098983|NCT01488279|3821943|FG000|NOT COMPLETED|Overall Study||0
3098984|NCT01488279|3821944|FG001|NOT COMPLETED|Overall Study||0
3098985|NCT01488318|3821953|FG000|STARTED|Overall Study||14
3098986|NCT01488318|3821953|FG000|COMPLETED|Overall Study||14
3098987|NCT01488318|3821953|FG000|NOT COMPLETED|Overall Study||0
3098988|NCT01488370|3821960|FG000|STARTED|Overall Study||22
3098989|NCT01488370|3821961|FG001|STARTED|Overall Study||23
3098990|NCT01488370|3821962|FG002|STARTED|Overall Study||20
3098991|NCT01488370|3821960|FG000|COMPLETED|Overall Study||22
3098992|NCT01488370|3821961|FG001|COMPLETED|Overall Study||22
3098993|NCT01488370|3821962|FG002|COMPLETED|Overall Study||19
3098994|NCT01488370|3821960|FG000|NOT COMPLETED|Overall Study||0
3098995|NCT01488370|3821961|FG001|NOT COMPLETED|Overall Study||1
3098996|NCT01488370|3821962|FG002|NOT COMPLETED|Overall Study||1
3098997|NCT01488409|3821972|FG000|STARTED|Overall Study||20
3098998|NCT01488409|3821973|FG001|STARTED|Overall Study||19
3098999|NCT01488409|3821972|FG000|COMPLETED|Overall Study||16
3099000|NCT01488409|3821973|FG001|COMPLETED|Overall Study||15
3099001|NCT01488409|3821972|FG000|NOT COMPLETED|Overall Study||4
3099002|NCT01488409|3821973|FG001|NOT COMPLETED|Overall Study||4
3099003|NCT01488448|3821981|FG000|STARTED|Overall Study||113
3099004|NCT01488448|3821982|FG001|STARTED|Overall Study||114
3099005|NCT01488448|3821981|FG000|COMPLETED|Overall Study||93
3099006|NCT01488448|3821982|FG001|COMPLETED|Overall Study||97
3099007|NCT01488448|3821981|FG000|NOT COMPLETED|Overall Study||20
3099008|NCT01488448|3821982|FG001|NOT COMPLETED|Overall Study||17
3099009|NCT01488487|3821990|FG000|STARTED|Overall Study||24
3099010|NCT01488487|3821990|FG000|Received Treatment|Overall Study||24
3099011|NCT01488487|3821990|FG000|COMPLETED|Overall Study||15
3099012|NCT01488487|3821990|FG000|NOT COMPLETED|Overall Study||9
3099013|NCT01488578|3821994|FG000|STARTED|Overall Study||11157
3099014|NCT01488578|3821994|FG000|COMPLETED|Overall Study||9321
3099015|NCT01488578|3821994|FG000|NOT COMPLETED|Overall Study||1836
3099016|NCT01488708|3822026|FG000|STARTED|Overall Study||940
3099017|NCT01488708|3822027|FG001|STARTED|Overall Study||578
3099018|NCT01488708|3822026|FG000|Received at Least 1 Dose of Study Drug|Overall Study||937
3099019|NCT01488708|3822027|FG001|Received at Least 1 Dose of Study Drug|Overall Study||578
3099020|NCT01488708|3822026|FG000|Participated in Follow Up|Overall Study||810
3099021|NCT01488708|3822027|FG001|Participated in Follow Up|Overall Study||526
3099022|NCT01488708|3822026|FG000|COMPLETED|Overall Study||0
3099023|NCT01488708|3822027|FG001|COMPLETED|Overall Study||0
3099024|NCT01488708|3822026|FG000|NOT COMPLETED|Overall Study||940
3099025|NCT01488708|3822027|FG001|NOT COMPLETED|Overall Study||578
3099026|NCT01488877|3822035|FG000|STARTED|Initial Randomization||1
3099027|NCT01488877|3822036|FG001|STARTED|Initial Randomization||5
3099028|NCT01488877|3822037|FG002|STARTED|Initial Randomization||0
3099029|NCT01488877|3822035|FG000|COMPLETED|Initial Randomization||1
3099030|NCT01488877|3822036|FG001|COMPLETED|Initial Randomization||5
3099031|NCT01488877|3822037|FG002|COMPLETED|Initial Randomization||0
3099032|NCT01488877|3822035|FG000|NOT COMPLETED|Initial Randomization||0
3099033|NCT01488877|3822036|FG001|NOT COMPLETED|Initial Randomization||0
3099034|NCT01488877|3822037|FG002|NOT COMPLETED|Initial Randomization||0
3099035|NCT01488877|3822035|FG000|STARTED|Re-randomization||0
3099036|NCT01488877|3822036|FG001|STARTED|Re-randomization||0
3099037|NCT01488877|3822037|FG002|STARTED|Re-randomization|Three participants were re-randomized from PF-03882845 3 mg arm.|3
3099038|NCT01488877|3822035|FG000|COMPLETED|Re-randomization||0
3099039|NCT01488877|3822036|FG001|COMPLETED|Re-randomization||0
3099040|NCT01488877|3822037|FG002|COMPLETED|Re-randomization||3
3099041|NCT01488877|3822035|FG000|NOT COMPLETED|Re-randomization||0
3099042|NCT01488877|3822036|FG001|NOT COMPLETED|Re-randomization||0
3099043|NCT01488877|3822037|FG002|NOT COMPLETED|Re-randomization||0
3099044|NCT01488890|3822048|FG000|STARTED|Overall Study||120
3099045|NCT01488890|3822049|FG001|STARTED|Overall Study||120
3099046|NCT01488890|3822050|FG002|STARTED|Overall Study||120
3099047|NCT01488890|3822051|FG003|STARTED|Overall Study||30
3099048|NCT01488890|3822048|FG000|Treated|Overall Study||120
3099049|NCT01488890|3822049|FG001|Treated|Overall Study||120
3099050|NCT01488890|3822050|FG002|Treated|Overall Study||119
3099051|NCT01488890|3822051|FG003|Treated|Overall Study||30
3099052|NCT01488890|3822048|FG000|COMPLETED|Overall Study||88
3099053|NCT01488890|3822049|FG001|COMPLETED|Overall Study||100
3099054|NCT01488890|3822050|FG002|COMPLETED|Overall Study||85
3290449|NCT02830074|4024417|FG001|NOT COMPLETED|Overall Study||0
3290450|NCT02830087|4024430|FG000|STARTED|Overall Study||4
3290451|NCT02830087|4024431|FG001|STARTED|Overall Study||4
3290452|NCT02830087|4024432|FG002|STARTED|Overall Study||4
3290453|NCT02830087|4024433|FG003|STARTED|Overall Study||3
3290454|NCT02830087|4024434|FG004|STARTED|Overall Study||3
3290455|NCT02830087|4024435|FG005|STARTED|Overall Study||3
3290456|NCT02830087|4024430|FG000|COMPLETED|Overall Study||0
3290457|NCT02830087|4024431|FG001|COMPLETED|Overall Study||0
3290458|NCT02830087|4024432|FG002|COMPLETED|Overall Study||0
3290459|NCT02830087|4024433|FG003|COMPLETED|Overall Study||0
3290460|NCT02830087|4024434|FG004|COMPLETED|Overall Study||0
3290461|NCT02830087|4024435|FG005|COMPLETED|Overall Study||0
3290462|NCT02830087|4024430|FG000|NOT COMPLETED|Overall Study||4
3290463|NCT02830087|4024431|FG001|NOT COMPLETED|Overall Study||4
3290464|NCT02830087|4024432|FG002|NOT COMPLETED|Overall Study||4
3099055|NCT01488890|3822051|FG003|COMPLETED|Overall Study||25
3099056|NCT01488890|3822048|FG000|NOT COMPLETED|Overall Study||32
3099057|NCT01488890|3822049|FG001|NOT COMPLETED|Overall Study||20
3099058|NCT01488890|3822050|FG002|NOT COMPLETED|Overall Study||35
3099059|NCT01488890|3822051|FG003|NOT COMPLETED|Overall Study||5
3099060|NCT01488994|3822067|FG000|STARTED|Overall Study||11
3099061|NCT01488994|3822068|FG001|STARTED|Overall Study||12
3099062|NCT01488994|3822067|FG000|COMPLETED|Overall Study||11
3099063|NCT01488994|3822068|FG001|COMPLETED|Overall Study||11
3099064|NCT01488994|3822067|FG000|NOT COMPLETED|Overall Study||0
3099065|NCT01488994|3822068|FG001|NOT COMPLETED|Overall Study||1
3099066|NCT01489020|3822085|FG000|STARTED|Overall Study||12
3099067|NCT01489020|3822086|FG001|STARTED|Overall Study||4
3099068|NCT01489020|3822087|FG002|STARTED|Overall Study||12
3099069|NCT01489020|3822088|FG003|STARTED|Overall Study||4
3099070|NCT01489020|3822089|FG004|STARTED|Overall Study||12
3099071|NCT01489020|3822090|FG005|STARTED|Overall Study||4
3099072|NCT01489020|3822085|FG000|COMPLETED|Overall Study||11
3099073|NCT01489020|3822086|FG001|COMPLETED|Overall Study||4
3099074|NCT01489020|3822087|FG002|COMPLETED|Overall Study||9
3099075|NCT01489020|3822088|FG003|COMPLETED|Overall Study||4
3099076|NCT01489020|3822089|FG004|COMPLETED|Overall Study||6
3099077|NCT01489020|3822090|FG005|COMPLETED|Overall Study||4
3099078|NCT01489020|3822085|FG000|NOT COMPLETED|Overall Study||1
3099079|NCT01489020|3822086|FG001|NOT COMPLETED|Overall Study||0
3099080|NCT01489020|3822087|FG002|NOT COMPLETED|Overall Study||3
3099081|NCT01489020|3822088|FG003|NOT COMPLETED|Overall Study||0
3099082|NCT01489020|3822089|FG004|NOT COMPLETED|Overall Study||6
3099083|NCT01489020|3822090|FG005|NOT COMPLETED|Overall Study||0
3099084|NCT01489111|3822110|FG000|STARTED|Overall Study||36
3099085|NCT01489111|3822110|FG000|COMPLETED|Overall Study||35
3099086|NCT01489111|3822110|FG000|NOT COMPLETED|Overall Study||1
3099087|NCT01489189|3822116|FG000|STARTED|Overall Study|Number of Eyes|191
3099088|NCT01489189|3822117|FG001|STARTED|Overall Study|Number of Eyes|203
3099089|NCT01489189|3822116|FG000|COMPLETED|Overall Study|Number of Eyes|160
3099090|NCT01489189|3822117|FG001|COMPLETED|Overall Study|Number of Eyes|168
3099091|NCT01489189|3822116|FG000|NOT COMPLETED|Overall Study||31
3099092|NCT01489189|3822117|FG001|NOT COMPLETED|Overall Study||35
3099093|NCT01489254|3822127|FG000|STARTED|Double-blind Part||355
3099094|NCT01489254|3822128|FG001|STARTED|Double-blind Part||357
3099095|NCT01489254|3822129|FG002|STARTED|Double-blind Part||84
3099096|NCT01489254|3822130|FG003|STARTED|Double-blind Part||0
3099097|NCT01489254|3822127|FG000|COMPLETED|Double-blind Part||330
3099098|NCT01489254|3822128|FG001|COMPLETED|Double-blind Part||324
3099099|NCT01489254|3822129|FG002|COMPLETED|Double-blind Part||81
3099100|NCT01489254|3822130|FG003|COMPLETED|Double-blind Part||0
3099101|NCT01489254|3822127|FG000|NOT COMPLETED|Double-blind Part||25
3099102|NCT01489254|3822128|FG001|NOT COMPLETED|Double-blind Part||33
3099103|NCT01489254|3822129|FG002|NOT COMPLETED|Double-blind Part||3
3099104|NCT01489254|3822130|FG003|NOT COMPLETED|Double-blind Part||0
3099105|NCT01489254|3822127|FG000|STARTED|Open-label Extension Part||0
3099106|NCT01489254|3822128|FG001|STARTED|Open-label Extension Part||0
3099107|NCT01489254|3822129|FG002|STARTED|Open-label Extension Part||0
3099108|NCT01489254|3822130|FG003|STARTED|Open-label Extension Part|735 completed the DB part, 729 were eligible to continue in the OL part, 1 opted not to continue|728
3099109|NCT01489254|3822127|FG000|COMPLETED|Open-label Extension Part||0
3099110|NCT01489254|3822128|FG001|COMPLETED|Open-label Extension Part||0
3099111|NCT01489254|3822129|FG002|COMPLETED|Open-label Extension Part||0
3290465|NCT02830087|4024433|FG003|NOT COMPLETED|Overall Study||3
3099112|NCT01489254|3822130|FG003|COMPLETED|Open-label Extension Part||670
3099113|NCT01489254|3822127|FG000|NOT COMPLETED|Open-label Extension Part||0
3099114|NCT01489254|3822128|FG001|NOT COMPLETED|Open-label Extension Part||0
3099115|NCT01489254|3822129|FG002|NOT COMPLETED|Open-label Extension Part||0
3099116|NCT01489254|3822130|FG003|NOT COMPLETED|Open-label Extension Part||58
3099117|NCT01489358|3822142|FG000|STARTED|Overall Study||5
3099118|NCT01489358|3822143|FG001|STARTED|Overall Study||10
3099119|NCT01489358|3822144|FG002|STARTED|Overall Study||10
3099120|NCT01489358|3822142|FG000|COMPLETED|Overall Study||5
3099121|NCT01489358|3822143|FG001|COMPLETED|Overall Study||10
3099122|NCT01489358|3822144|FG002|COMPLETED|Overall Study||8
3099123|NCT01489358|3822142|FG000|NOT COMPLETED|Overall Study||0
3099124|NCT01489358|3822143|FG001|NOT COMPLETED|Overall Study||0
3099125|NCT01489358|3822144|FG002|NOT COMPLETED|Overall Study||2
3099126|NCT01489527|3822154|FG000|STARTED|Overall Study||205
3099127|NCT01489527|3822155|FG001|STARTED|Overall Study||201
3099128|NCT01489527|3822154|FG000|COMPLETED|Overall Study||183
3099129|NCT01489527|3822155|FG001|COMPLETED|Overall Study||175
3099130|NCT01489527|3822154|FG000|NOT COMPLETED|Overall Study||22
3099131|NCT01489527|3822155|FG001|NOT COMPLETED|Overall Study||26
3099132|NCT01489579|3822163|FG000|STARTED|Overall Study||56
3099133|NCT01489579|3822164|FG001|STARTED|Overall Study||64
3099134|NCT01489579|3822163|FG000|COMPLETED|Overall Study||47
3099135|NCT01489579|3822164|FG001|COMPLETED|Overall Study||57
3099136|NCT01489579|3822163|FG000|NOT COMPLETED|Overall Study||9
3099137|NCT01489579|3822164|FG001|NOT COMPLETED|Overall Study||7
3099138|NCT01489670|3822172|FG000|STARTED|Overall Study||387
3099139|NCT01489670|3822172|FG000|COMPLETED|Overall Study||334
3099140|NCT01489670|3822172|FG000|NOT COMPLETED|Overall Study||53
3099141|NCT01489826|3822185|FG000|STARTED|Overall Study||3
3099142|NCT01489826|3822186|FG001|STARTED|Overall Study||3
3099143|NCT01489826|3822187|FG002|STARTED|Overall Study||3
3099144|NCT01489826|3822188|FG003|STARTED|Overall Study||7
3099145|NCT01489826|3822189|FG004|STARTED|Overall Study||3
3099146|NCT01489826|3822190|FG005|STARTED|Overall Study||3
3099147|NCT01489826|3822191|FG006|STARTED|Overall Study||9
3099148|NCT01489826|3822192|FG007|STARTED|Overall Study||3
3099149|NCT01489826|3822193|FG008|STARTED|Overall Study||6
3099150|NCT01489826|3822185|FG000|COMPLETED|Overall Study||3
3099151|NCT01489826|3822186|FG001|COMPLETED|Overall Study||3
3099152|NCT01489826|3822187|FG002|COMPLETED|Overall Study||3
3099153|NCT01489826|3822188|FG003|COMPLETED|Overall Study||7
3099154|NCT01489826|3822189|FG004|COMPLETED|Overall Study||3
3099155|NCT01489826|3822190|FG005|COMPLETED|Overall Study||3
3099156|NCT01489826|3822191|FG006|COMPLETED|Overall Study||9
3099157|NCT01489826|3822192|FG007|COMPLETED|Overall Study||3
3099158|NCT01489826|3822193|FG008|COMPLETED|Overall Study||6
3099159|NCT01489826|3822185|FG000|NOT COMPLETED|Overall Study||0
3099160|NCT01489826|3822186|FG001|NOT COMPLETED|Overall Study||0
3099161|NCT01489826|3822187|FG002|NOT COMPLETED|Overall Study||0
3099162|NCT01489826|3822188|FG003|NOT COMPLETED|Overall Study||0
3099163|NCT01489826|3822189|FG004|NOT COMPLETED|Overall Study||0
3099164|NCT01489826|3822190|FG005|NOT COMPLETED|Overall Study||0
3099165|NCT01489826|3822191|FG006|NOT COMPLETED|Overall Study||0
3099166|NCT01489826|3822192|FG007|NOT COMPLETED|Overall Study||0
3099167|NCT01489826|3822193|FG008|NOT COMPLETED|Overall Study||0
3099168|NCT01489891|3822223|FG000|STARTED|Overall Study||60
3099169|NCT01489891|3822224|FG001|STARTED|Overall Study||60
3099170|NCT01489891|3822223|FG000|COMPLETED|Overall Study||59
3099171|NCT01489891|3822224|FG001|COMPLETED|Overall Study||60
3099172|NCT01489891|3822223|FG000|NOT COMPLETED|Overall Study||1
3099173|NCT01489891|3822224|FG001|NOT COMPLETED|Overall Study||0
3099174|NCT01489956|3822232|FG000|STARTED|Overall Study|Ten of the 13 participants were considered evaluable.|13
3099175|NCT01489956|3822233|FG001|STARTED|Overall Study|Nine of the 10 participants receiving Immucothel alone had a response, so Montanide was not used.|0
3099176|NCT01489956|3822234|FG002|STARTED|Overall Study|These 6 subjects had Immucothel alone since Montanide was not needed for the 10 participants dosed.|6
3099177|NCT01489956|3822232|FG000|COMPLETED|Overall Study||12
3099178|NCT01489956|3822233|FG001|COMPLETED|Overall Study||0
3099179|NCT01489956|3822234|FG002|COMPLETED|Overall Study||5
3099180|NCT01489956|3822232|FG000|NOT COMPLETED|Overall Study||1
3099181|NCT01489956|3822233|FG001|NOT COMPLETED|Overall Study||0
3099182|NCT01489956|3822234|FG002|NOT COMPLETED|Overall Study||1
3099183|NCT01489969|3822245|FG000|STARTED|Overall Study||45
3099184|NCT01489969|3822246|FG001|STARTED|Overall Study||47
3099185|NCT01489969|3822247|FG002|STARTED|Overall Study||45
3099186|NCT01489969|3822245|FG000|COMPLETED|Overall Study||40
3099187|NCT01489969|3822246|FG001|COMPLETED|Overall Study||43
3099188|NCT01489969|3822247|FG002|COMPLETED|Overall Study||44
3099189|NCT01489969|3822245|FG000|NOT COMPLETED|Overall Study||5
3099190|NCT01489969|3822246|FG001|NOT COMPLETED|Overall Study||4
3099191|NCT01489969|3822247|FG002|NOT COMPLETED|Overall Study||1
3099192|NCT01490060|3822257|FG000|STARTED|Cycle 1||11
3099193|NCT01490060|3822258|FG001|STARTED|Cycle 1||13
3099194|NCT01490060|3822259|FG002|STARTED|Cycle 1||12
3099195|NCT01490060|3822260|FG003|STARTED|Cycle 1||11
3099196|NCT01490060|3822257|FG000|COMPLETED|Cycle 1||11
3099197|NCT01490060|3822258|FG001|COMPLETED|Cycle 1||12
3099198|NCT01490060|3822259|FG002|COMPLETED|Cycle 1||9
3099199|NCT01490060|3822260|FG003|COMPLETED|Cycle 1||8
3099200|NCT01490060|3822257|FG000|NOT COMPLETED|Cycle 1||0
3099201|NCT01490060|3822258|FG001|NOT COMPLETED|Cycle 1||1
3099202|NCT01490060|3822259|FG002|NOT COMPLETED|Cycle 1||3
3099203|NCT01490060|3822260|FG003|NOT COMPLETED|Cycle 1||3
3099204|NCT01490060|3822257|FG000|STARTED|Cycle 2||11
3099205|NCT01490060|3822258|FG001|STARTED|Cycle 2||12
3099206|NCT01490060|3822259|FG002|STARTED|Cycle 2||9
3099207|NCT01490060|3822260|FG003|STARTED|Cycle 2||8
3099208|NCT01490060|3822257|FG000|COMPLETED|Cycle 2||9
3099209|NCT01490060|3822258|FG001|COMPLETED|Cycle 2||11
3099210|NCT01490060|3822259|FG002|COMPLETED|Cycle 2||8
3099211|NCT01490060|3822260|FG003|COMPLETED|Cycle 2||8
3099212|NCT01490060|3822257|FG000|NOT COMPLETED|Cycle 2||2
3099213|NCT01490060|3822258|FG001|NOT COMPLETED|Cycle 2||1
3099214|NCT01490060|3822259|FG002|NOT COMPLETED|Cycle 2||1
3099215|NCT01490060|3822260|FG003|NOT COMPLETED|Cycle 2||0
3099216|NCT01490073|3822270|FG000|STARTED|Overall Study||12
3099217|NCT01490073|3822271|FG001|STARTED|Overall Study||12
3099218|NCT01490073|3822270|FG000|COMPLETED|Overall Study||12
3099219|NCT01490073|3822271|FG001|COMPLETED|Overall Study||12
3099220|NCT01490073|3822270|FG000|NOT COMPLETED|Overall Study||0
3099221|NCT01490073|3822271|FG001|NOT COMPLETED|Overall Study||0
3099222|NCT01490086|3822282|FG000|STARTED|Overall Study||58
3099223|NCT01490086|3822283|FG001|STARTED|Overall Study||59
3099224|NCT01490086|3822284|FG002|STARTED|Overall Study||58
3099225|NCT01490086|3822285|FG003|STARTED|Overall Study||20
3099226|NCT01490086|3822286|FG004|STARTED|Overall Study||39
3099227|NCT01490086|3822282|FG000|COMPLETED|Overall Study||50
3099228|NCT01490086|3822283|FG001|COMPLETED|Overall Study||44
3099229|NCT01490086|3822284|FG002|COMPLETED|Overall Study||51
3099230|NCT01490086|3822285|FG003|COMPLETED|Overall Study||13
3099231|NCT01490086|3822286|FG004|COMPLETED|Overall Study||28
3099232|NCT01490086|3822282|FG000|NOT COMPLETED|Overall Study||8
3099233|NCT01490086|3822283|FG001|NOT COMPLETED|Overall Study||15
3099234|NCT01490086|3822284|FG002|NOT COMPLETED|Overall Study||7
3099235|NCT01490086|3822285|FG003|NOT COMPLETED|Overall Study||7
3099236|NCT01490086|3822286|FG004|NOT COMPLETED|Overall Study||11
3099237|NCT01490125|3822298|FG000|STARTED|Period I||43
3099238|NCT01490125|3822299|FG001|STARTED|Period I||42
3099239|NCT01490125|3822300|FG002|STARTED|Period I||41
3099240|NCT01490125|3822301|FG003|STARTED|Period I||38
3099241|NCT01490125|3822302|FG004|STARTED|Period I||40
3099242|NCT01490125|3822303|FG005|STARTED|Period I||42
3099243|NCT01490125|3822298|FG000|COMPLETED|Period I||37
3099244|NCT01490125|3822299|FG001|COMPLETED|Period I||37
3099245|NCT01490125|3822300|FG002|COMPLETED|Period I||37
3099246|NCT01490125|3822301|FG003|COMPLETED|Period I||33
3099247|NCT01490125|3822302|FG004|COMPLETED|Period I||36
3099248|NCT01490125|3822303|FG005|COMPLETED|Period I||37
3099249|NCT01490125|3822298|FG000|NOT COMPLETED|Period I||6
3099250|NCT01490125|3822299|FG001|NOT COMPLETED|Period I||5
3099251|NCT01490125|3822300|FG002|NOT COMPLETED|Period I||4
3099252|NCT01490125|3822301|FG003|NOT COMPLETED|Period I||5
3099253|NCT01490125|3822302|FG004|NOT COMPLETED|Period I||4
3099254|NCT01490125|3822303|FG005|NOT COMPLETED|Period I||5
3099255|NCT01490125|3822298|FG000|STARTED|Period II||37
3099256|NCT01490125|3822299|FG001|STARTED|Period II||37
3099257|NCT01490125|3822300|FG002|STARTED|Period II||37
3099258|NCT01490125|3822301|FG003|STARTED|Period II||33
3099259|NCT01490125|3822302|FG004|STARTED|Period II||36
3099260|NCT01490125|3822303|FG005|STARTED|Period II||37
3099261|NCT01490125|3822298|FG000|COMPLETED|Period II||34
3099262|NCT01490125|3822299|FG001|COMPLETED|Period II||33
3099263|NCT01490125|3822300|FG002|COMPLETED|Period II||34
3099264|NCT01490125|3822301|FG003|COMPLETED|Period II||30
3099265|NCT01490125|3822302|FG004|COMPLETED|Period II||32
3099266|NCT01490125|3822303|FG005|COMPLETED|Period II||35
3099267|NCT01490125|3822298|FG000|NOT COMPLETED|Period II||3
3099268|NCT01490125|3822299|FG001|NOT COMPLETED|Period II||4
3099269|NCT01490125|3822300|FG002|NOT COMPLETED|Period II||3
3099270|NCT01490125|3822301|FG003|NOT COMPLETED|Period II||3
3099271|NCT01490125|3822302|FG004|NOT COMPLETED|Period II||4
3099272|NCT01490125|3822303|FG005|NOT COMPLETED|Period II||2
3099273|NCT01490125|3822298|FG000|STARTED|Period III||34
3099274|NCT01490125|3822299|FG001|STARTED|Period III||33
3099275|NCT01490125|3822300|FG002|STARTED|Period III||34
3099276|NCT01490125|3822301|FG003|STARTED|Period III||30
3099277|NCT01490125|3822302|FG004|STARTED|Period III||32
3099278|NCT01490125|3822303|FG005|STARTED|Period III||35
3099279|NCT01490125|3822298|FG000|COMPLETED|Period III||31
3099280|NCT01490125|3822299|FG001|COMPLETED|Period III||32
3099281|NCT01490125|3822300|FG002|COMPLETED|Period III||34
3099282|NCT01490125|3822301|FG003|COMPLETED|Period III||28
3099283|NCT01490125|3822302|FG004|COMPLETED|Period III||31
3099284|NCT01490125|3822303|FG005|COMPLETED|Period III||35
3099285|NCT01490125|3822298|FG000|NOT COMPLETED|Period III||3
3099286|NCT01490125|3822299|FG001|NOT COMPLETED|Period III||1
3099287|NCT01490125|3822300|FG002|NOT COMPLETED|Period III||0
3099288|NCT01490125|3822301|FG003|NOT COMPLETED|Period III||2
3099289|NCT01490125|3822302|FG004|NOT COMPLETED|Period III||1
3099290|NCT01490125|3822303|FG005|NOT COMPLETED|Period III||0
3099291|NCT01490151|3822311|FG000|STARTED|Overall Study||22
3099292|NCT01490151|3822311|FG000|COMPLETED|Overall Study||22
3099293|NCT01490151|3822311|FG000|NOT COMPLETED|Overall Study||0
3135342|NCT01706536|3860351|FG002|COMPLETED|Overall Study||49
3135343|NCT01706536|3860352|FG003|COMPLETED|Overall Study||53
3135344|NCT01706536|3860353|FG004|COMPLETED|Overall Study||57
3135345|NCT01706536|3860349|FG000|NOT COMPLETED|Overall Study||4
3135346|NCT01706536|3860350|FG001|NOT COMPLETED|Overall Study||4
3135347|NCT01706536|3860351|FG002|NOT COMPLETED|Overall Study||5
3135348|NCT01706536|3860352|FG003|NOT COMPLETED|Overall Study||4
3135349|NCT01706536|3860353|FG004|NOT COMPLETED|Overall Study||2
3135350|NCT01706549|3860366|FG000|STARTED|Overall Study||16
3135351|NCT01706549|3860366|FG000|COMPLETED|Overall Study||16
3135352|NCT01706549|3860366|FG000|NOT COMPLETED|Overall Study||0
3135353|NCT01706575|3860370|FG000|STARTED|Overall Study||76
3135354|NCT01706575|3860370|FG000|Treated|Overall Study||70
3135355|NCT01706575|3860370|FG000|COMPLETED|Overall Study||64
3099294|NCT01490294|3822321|FG000|STARTED|Overall Study||58
3099295|NCT01490294|3822322|FG001|STARTED|Overall Study||60
3099296|NCT01490294|3822323|FG002|STARTED|Overall Study||59
3099297|NCT01490294|3822324|FG003|STARTED|Overall Study||55
3099298|NCT01490294|3822321|FG000|Participant Received Treatment|Overall Study||54
3099299|NCT01490294|3822322|FG001|Participant Received Treatment|Overall Study||60
3099300|NCT01490294|3822323|FG002|Participant Received Treatment|Overall Study||58
3099301|NCT01490294|3822324|FG003|Participant Received Treatment|Overall Study||54
3099302|NCT01490294|3822321|FG000|COMPLETED|Overall Study||53
3099303|NCT01490294|3822322|FG001|COMPLETED|Overall Study||60
3099304|NCT01490294|3822323|FG002|COMPLETED|Overall Study||58
3099305|NCT01490294|3822324|FG003|COMPLETED|Overall Study||54
3099306|NCT01490294|3822321|FG000|NOT COMPLETED|Overall Study||5
3099307|NCT01490294|3822322|FG001|NOT COMPLETED|Overall Study||0
3099308|NCT01490294|3822323|FG002|NOT COMPLETED|Overall Study||1
3099309|NCT01490294|3822324|FG003|NOT COMPLETED|Overall Study||1
3099310|NCT01490359|3822336|FG000|STARTED|Overall Study||609
3099311|NCT01490359|3822337|FG001|STARTED|Overall Study||572
3099312|NCT01490359|3822336|FG000|Followed-up at 6 mo|Overall Study||558
3099313|NCT01490359|3822337|FG001|Followed-up at 6 mo|Overall Study||535
3099314|NCT01490359|3822336|FG000|Followed-up at 12 mo|Overall Study||569
3099315|NCT01490359|3822337|FG001|Followed-up at 12 mo|Overall Study||537
3099316|NCT01490359|3822336|FG000|COMPLETED|Overall Study||585
3099317|NCT01490359|3822337|FG001|COMPLETED|Overall Study||555
3099318|NCT01490359|3822336|FG000|NOT COMPLETED|Overall Study||24
3099319|NCT01490359|3822337|FG001|NOT COMPLETED|Overall Study||17
3099320|NCT01490450|3822348|FG000|STARTED|Period 1||41
3099321|NCT01490450|3822349|FG001|STARTED|Period 1||41
3099322|NCT01490450|3822350|FG002|STARTED|Period 1||42
3099323|NCT01490450|3822351|FG003|STARTED|Period 1||41
3099324|NCT01490450|3822348|FG000|COMPLETED|Period 1||38
3099325|NCT01490450|3822349|FG001|COMPLETED|Period 1||40
3099326|NCT01490450|3822350|FG002|COMPLETED|Period 1||38
3099327|NCT01490450|3822351|FG003|COMPLETED|Period 1||33
3099328|NCT01490450|3822348|FG000|NOT COMPLETED|Period 1||3
3099329|NCT01490450|3822349|FG001|NOT COMPLETED|Period 1||1
3099330|NCT01490450|3822350|FG002|NOT COMPLETED|Period 1||4
3099331|NCT01490450|3822351|FG003|NOT COMPLETED|Period 1||8
3099332|NCT01490450|3822348|FG000|STARTED|Period 2||38
3099333|NCT01490450|3822349|FG001|STARTED|Period 2||40
3099334|NCT01490450|3822350|FG002|STARTED|Period 2||37
3099335|NCT01490450|3822351|FG003|STARTED|Period 2||32
3099336|NCT01490450|3822348|FG000|COMPLETED|Period 2||36
3099337|NCT01490450|3822349|FG001|COMPLETED|Period 2||39
3099338|NCT01490450|3822350|FG002|COMPLETED|Period 2||37
3099339|NCT01490450|3822351|FG003|COMPLETED|Period 2||28
3099340|NCT01490450|3822348|FG000|NOT COMPLETED|Period 2||2
3099341|NCT01490450|3822349|FG001|NOT COMPLETED|Period 2||1
3099342|NCT01490450|3822350|FG002|NOT COMPLETED|Period 2||0
3099343|NCT01490450|3822351|FG003|NOT COMPLETED|Period 2||4
3099344|NCT01490580|3822366|FG000|STARTED|Overall Study||82
3099345|NCT01490580|3822367|FG001|STARTED|Overall Study||91
3099346|NCT01490580|3822366|FG000|COMPLETED|Overall Study||82
3099347|NCT01490580|3822367|FG001|COMPLETED|Overall Study||89
3099348|NCT01490580|3822366|FG000|NOT COMPLETED|Overall Study||0
3099349|NCT01490580|3822367|FG001|NOT COMPLETED|Overall Study||2
3099350|NCT01490632|3822382|FG000|STARTED|Part A: Initial Treatment Period||34
3099351|NCT01490632|3822383|FG001|STARTED|Part A: Initial Treatment Period||32
3099352|NCT01490632|3822384|FG002|STARTED|Part A: Initial Treatment Period||72
3290466|NCT02830087|4024434|FG004|NOT COMPLETED|Overall Study||3
3290467|NCT02830087|4024435|FG005|NOT COMPLETED|Overall Study||3
3290468|NCT02830438|4024449|FG000|STARTED|Overall Study||8
3290469|NCT02830438|4024449|FG000|COMPLETED|Overall Study||8
3290470|NCT02830438|4024449|FG000|NOT COMPLETED|Overall Study||0
3290471|NCT02830776|4024453|FG000|STARTED|Overall Study||15
3290472|NCT02830776|4024453|FG000|COMPLETED|Overall Study||14
3290473|NCT02830776|4024453|FG000|NOT COMPLETED|Overall Study||1
3290474|NCT02830880|4024458|FG000|STARTED|Overall Study||7
3290475|NCT02830880|4024458|FG000|Completed Visit After Cyle 1|Overall Study||7
3290476|NCT02830880|4024458|FG000|COMPLETED|Overall Study||4
3290477|NCT02830880|4024458|FG000|NOT COMPLETED|Overall Study||3
3290478|NCT02830893|4024464|FG000|STARTED|Overall Study||12
3290479|NCT02830893|4024465|FG001|STARTED|Overall Study||11
3290480|NCT02830893|4024464|FG000|COMPLETED|Overall Study||11
3290481|NCT02830893|4024465|FG001|COMPLETED|Overall Study||8
3290482|NCT02830893|4024464|FG000|NOT COMPLETED|Overall Study||1
3290483|NCT02830893|4024465|FG001|NOT COMPLETED|Overall Study||3
3290484|NCT02831257|4024471|FG000|STARTED|Overall Study||18
3290485|NCT02831257|4024471|FG000|COMPLETED|Overall Study||6
3290486|NCT02831257|4024471|FG000|NOT COMPLETED|Overall Study||12
3290487|NCT02831387|4024477|FG000|STARTED|Overall Study||23
3290488|NCT02831387|4024478|FG001|STARTED|Overall Study||24
3290489|NCT02831387|4024477|FG000|COMPLETED|Overall Study||22
3099353|NCT01490632|3822385|FG003|STARTED|Part A: Initial Treatment Period||64
3099354|NCT01490632|3822386|FG004|STARTED|Part A: Initial Treatment Period||69
3099355|NCT01490632|3822387|FG005|STARTED|Part A: Initial Treatment Period||0
3099356|NCT01490632|3822388|FG006|STARTED|Part A: Initial Treatment Period||0
3099357|NCT01490632|3822389|FG007|STARTED|Part A: Initial Treatment Period||0
3099358|NCT01490632|3822390|FG008|STARTED|Part A: Initial Treatment Period||0
3099359|NCT01490632|3822391|FG009|STARTED|Part A: Initial Treatment Period||0
3099360|NCT01490632|3822392|FG010|STARTED|Part A: Initial Treatment Period||0
3099361|NCT01490632|3822393|FG011|STARTED|Part A: Initial Treatment Period||0
3099362|NCT01490632|3822394|FG012|STARTED|Part A: Initial Treatment Period||0
3099363|NCT01490632|3822395|FG013|STARTED|Part A: Initial Treatment Period||0
3099364|NCT01490632|3822396|FG014|STARTED|Part A: Initial Treatment Period||0
3099365|NCT01490632|3822397|FG015|STARTED|Part A: Initial Treatment Period||0
3099366|NCT01490632|3822398|FG016|STARTED|Part A: Initial Treatment Period||0
3099367|NCT01490632|3822399|FG017|STARTED|Part A: Initial Treatment Period||0
3099368|NCT01490632|3822400|FG018|STARTED|Part A: Initial Treatment Period||0
3099369|NCT01490632|3822401|FG019|STARTED|Part A: Initial Treatment Period||0
3099370|NCT01490632|3822382|FG000|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||34
3099371|NCT01490632|3822383|FG001|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||32
3099372|NCT01490632|3822384|FG002|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||72
3099373|NCT01490632|3822385|FG003|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||64
3099374|NCT01490632|3822386|FG004|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||69
3099375|NCT01490632|3822387|FG005|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
3099376|NCT01490632|3822388|FG006|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
3099377|NCT01490632|3822389|FG007|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
3099378|NCT01490632|3822390|FG008|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
3099379|NCT01490632|3822391|FG009|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
3290490|NCT02831387|4024478|FG001|COMPLETED|Overall Study||22
3290491|NCT02831387|4024477|FG000|NOT COMPLETED|Overall Study||1
3290492|NCT02831387|4024478|FG001|NOT COMPLETED|Overall Study||2
3290493|NCT02831569|4024484|FG000|STARTED|Overall Study||80
3290494|NCT02831569|4024484|FG000|COMPLETED|Overall Study||80
3290495|NCT02831569|4024484|FG000|NOT COMPLETED|Overall Study||0
3099380|NCT01490632|3822392|FG010|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
3099381|NCT01490632|3822393|FG011|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
3099382|NCT01490632|3822394|FG012|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
3099383|NCT01490632|3822395|FG013|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
3099384|NCT01490632|3822396|FG014|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
3099385|NCT01490632|3822397|FG015|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
3099386|NCT01490632|3822398|FG016|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
3099387|NCT01490632|3822399|FG017|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
3099388|NCT01490632|3822400|FG018|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
3099389|NCT01490632|3822401|FG019|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
3099390|NCT01490632|3822382|FG000|COMPLETED|Part A: Initial Treatment Period||27
3099391|NCT01490632|3822383|FG001|COMPLETED|Part A: Initial Treatment Period||28
3099392|NCT01490632|3822384|FG002|COMPLETED|Part A: Initial Treatment Period||67
3099393|NCT01490632|3822385|FG003|COMPLETED|Part A: Initial Treatment Period||55
3099394|NCT01490632|3822386|FG004|COMPLETED|Part A: Initial Treatment Period|Includes participants who completed Part A, but discontinued per protocol using Part A PASI score.|52
3099395|NCT01490632|3822387|FG005|COMPLETED|Part A: Initial Treatment Period||0
3099396|NCT01490632|3822388|FG006|COMPLETED|Part A: Initial Treatment Period||0
3099397|NCT01490632|3822389|FG007|COMPLETED|Part A: Initial Treatment Period||0
3099398|NCT01490632|3822390|FG008|COMPLETED|Part A: Initial Treatment Period||0
3099399|NCT01490632|3822391|FG009|COMPLETED|Part A: Initial Treatment Period||0
3099400|NCT01490632|3822392|FG010|COMPLETED|Part A: Initial Treatment Period||0
3099401|NCT01490632|3822393|FG011|COMPLETED|Part A: Initial Treatment Period||0
3099402|NCT01490632|3822394|FG012|COMPLETED|Part A: Initial Treatment Period||0
3099403|NCT01490632|3822395|FG013|COMPLETED|Part A: Initial Treatment Period||0
3099404|NCT01490632|3822396|FG014|COMPLETED|Part A: Initial Treatment Period||0
3099405|NCT01490632|3822397|FG015|COMPLETED|Part A: Initial Treatment Period||0
3099406|NCT01490632|3822398|FG016|COMPLETED|Part A: Initial Treatment Period||0
3099407|NCT01490632|3822399|FG017|COMPLETED|Part A: Initial Treatment Period||0
3099408|NCT01490632|3822400|FG018|COMPLETED|Part A: Initial Treatment Period||0
3099409|NCT01490632|3822401|FG019|COMPLETED|Part A: Initial Treatment Period||0
3099410|NCT01490632|3822382|FG000|NOT COMPLETED|Part A: Initial Treatment Period||7
3099411|NCT01490632|3822383|FG001|NOT COMPLETED|Part A: Initial Treatment Period||4
3099412|NCT01490632|3822384|FG002|NOT COMPLETED|Part A: Initial Treatment Period||5
3099413|NCT01490632|3822385|FG003|NOT COMPLETED|Part A: Initial Treatment Period||9
3099414|NCT01490632|3822386|FG004|NOT COMPLETED|Part A: Initial Treatment Period||17
3099415|NCT01490632|3822387|FG005|NOT COMPLETED|Part A: Initial Treatment Period||0
3099416|NCT01490632|3822388|FG006|NOT COMPLETED|Part A: Initial Treatment Period||0
3099417|NCT01490632|3822389|FG007|NOT COMPLETED|Part A: Initial Treatment Period||0
3099418|NCT01490632|3822390|FG008|NOT COMPLETED|Part A: Initial Treatment Period||0
3099419|NCT01490632|3822391|FG009|NOT COMPLETED|Part A: Initial Treatment Period||0
3099420|NCT01490632|3822392|FG010|NOT COMPLETED|Part A: Initial Treatment Period||0
3099421|NCT01490632|3822393|FG011|NOT COMPLETED|Part A: Initial Treatment Period||0
3099422|NCT01490632|3822394|FG012|NOT COMPLETED|Part A: Initial Treatment Period||0
3290496|NCT02831660|4024488|FG000|STARTED|Overall Study||1
3290497|NCT02831660|4024488|FG000|COMPLETED|Overall Study||1
3290498|NCT02831660|4024488|FG000|NOT COMPLETED|Overall Study||0
3290499|NCT02831816|4024492|FG000|STARTED|Overall Study||640
3290500|NCT02831816|4024492|FG000|ZP|Overall Study||589
3099423|NCT01490632|3822395|FG013|NOT COMPLETED|Part A: Initial Treatment Period||0
3099424|NCT01490632|3822396|FG014|NOT COMPLETED|Part A: Initial Treatment Period||0
3099425|NCT01490632|3822397|FG015|NOT COMPLETED|Part A: Initial Treatment Period||0
3099426|NCT01490632|3822398|FG016|NOT COMPLETED|Part A: Initial Treatment Period||0
3099427|NCT01490632|3822399|FG017|NOT COMPLETED|Part A: Initial Treatment Period||0
3099428|NCT01490632|3822400|FG018|NOT COMPLETED|Part A: Initial Treatment Period||0
3099429|NCT01490632|3822401|FG019|NOT COMPLETED|Part A: Initial Treatment Period||0
3099430|NCT01490632|3822382|FG000|STARTED|Part B: Extension or Step-Up Period|See Recruitment Details for explanation of Part B participant assignment.|0
3099431|NCT01490632|3822383|FG001|STARTED|Part B: Extension or Step-Up Period|See Recruitment Details for explanation of Part B participant assignment.|0
3099432|NCT01490632|3822384|FG002|STARTED|Part B: Extension or Step-Up Period|See Recruitment Details for explanation of Part B participant assignment.|0
3099433|NCT01490632|3822385|FG003|STARTED|Part B: Extension or Step-Up Period|See Recruitment Details for explanation of Part B participant assignment.|0
3099434|NCT01490632|3822386|FG004|STARTED|Part B: Extension or Step-Up Period|See Recruitment Details for explanation of Part B participant assignment.|0
3099435|NCT01490632|3822387|FG005|STARTED|Part B: Extension or Step-Up Period|Part A participants randomized to 2 mg or 4 mg with a PASI ≥75 remained on 2 mg or 4 mg.|29
3099436|NCT01490632|3822388|FG006|STARTED|Part B: Extension or Step-Up Period|Part A participants randomized to 8 mg or 10 mg with a PASI ≥75 remained on 8 mg or 10 mg.|64
3099437|NCT01490632|3822389|FG007|STARTED|Part B: Extension or Step-Up Period|Placebo participants in Part A with a PASI <75 were re-randomized to 8 mg or 10 mg.|19
3099438|NCT01490632|3822390|FG008|STARTED|Part B: Extension or Step-Up Period|Part A participants randomized to 2 mg or 4 mg with a PASI ≥50 to <75 remained on 2 mg or 4 mg.|16
3099439|NCT01490632|3822391|FG009|STARTED|Part B: Extension or Step-Up Period|Part A participants randomized to 2 mg or 4 mg with a PASI <50 were re-randomized to 8 mg or 10 mg.|50
3099440|NCT01490632|3822392|FG010|STARTED|Part B: Extension or Step-Up Period|Part A 10 mg non-responders were discontinued from the study.|43
3099441|NCT01490632|3822393|FG011|STARTED|Part B: Extension or Step-Up Period|Part A participants randomized to Placebo remained on Placebo.|8
3099442|NCT01490632|3822394|FG012|STARTED|Part B: Extension or Step-Up Period||0
3099443|NCT01490632|3822395|FG013|STARTED|Part B: Extension or Step-Up Period||0
3099444|NCT01490632|3822396|FG014|STARTED|Part B: Extension or Step-Up Period||0
3099445|NCT01490632|3822397|FG015|STARTED|Part B: Extension or Step-Up Period||0
3099446|NCT01490632|3822398|FG016|STARTED|Part B: Extension or Step-Up Period||0
3099447|NCT01490632|3822399|FG017|STARTED|Part B: Extension or Step-Up Period||0
3099448|NCT01490632|3822400|FG018|STARTED|Part B: Extension or Step-Up Period||0
3099449|NCT01490632|3822401|FG019|STARTED|Part B: Extension or Step-Up Period||0
3099450|NCT01490632|3822382|FG000|COMPLETED|Part B: Extension or Step-Up Period||0
3099451|NCT01490632|3822383|FG001|COMPLETED|Part B: Extension or Step-Up Period||0
3099452|NCT01490632|3822384|FG002|COMPLETED|Part B: Extension or Step-Up Period||0
3099453|NCT01490632|3822385|FG003|COMPLETED|Part B: Extension or Step-Up Period||0
3099454|NCT01490632|3822386|FG004|COMPLETED|Part B: Extension or Step-Up Period||0
3099455|NCT01490632|3822387|FG005|COMPLETED|Part B: Extension or Step-Up Period||25
3099456|NCT01490632|3822388|FG006|COMPLETED|Part B: Extension or Step-Up Period||51
3099457|NCT01490632|3822389|FG007|COMPLETED|Part B: Extension or Step-Up Period||13
3099458|NCT01490632|3822390|FG008|COMPLETED|Part B: Extension or Step-Up Period||6
3099459|NCT01490632|3822391|FG009|COMPLETED|Part B: Extension or Step-Up Period||25
3099460|NCT01490632|3822392|FG010|COMPLETED|Part B: Extension or Step-Up Period||22
3099461|NCT01490632|3822393|FG011|COMPLETED|Part B: Extension or Step-Up Period||0
3099462|NCT01490632|3822394|FG012|COMPLETED|Part B: Extension or Step-Up Period||0
3099463|NCT01490632|3822395|FG013|COMPLETED|Part B: Extension or Step-Up Period||0
3099464|NCT01490632|3822396|FG014|COMPLETED|Part B: Extension or Step-Up Period||0
3099465|NCT01490632|3822397|FG015|COMPLETED|Part B: Extension or Step-Up Period||0
3099466|NCT01490632|3822398|FG016|COMPLETED|Part B: Extension or Step-Up Period||0
3099467|NCT01490632|3822399|FG017|COMPLETED|Part B: Extension or Step-Up Period||0
3099468|NCT01490632|3822400|FG018|COMPLETED|Part B: Extension or Step-Up Period||0
3099469|NCT01490632|3822401|FG019|COMPLETED|Part B: Extension or Step-Up Period||0
3099470|NCT01490632|3822382|FG000|NOT COMPLETED|Part B: Extension or Step-Up Period||0
3099471|NCT01490632|3822383|FG001|NOT COMPLETED|Part B: Extension or Step-Up Period||0
3099472|NCT01490632|3822384|FG002|NOT COMPLETED|Part B: Extension or Step-Up Period||0
3099473|NCT01490632|3822385|FG003|NOT COMPLETED|Part B: Extension or Step-Up Period||0
3099474|NCT01490632|3822386|FG004|NOT COMPLETED|Part B: Extension or Step-Up Period||0
3099475|NCT01490632|3822387|FG005|NOT COMPLETED|Part B: Extension or Step-Up Period||4
3099476|NCT01490632|3822388|FG006|NOT COMPLETED|Part B: Extension or Step-Up Period||13
3099477|NCT01490632|3822389|FG007|NOT COMPLETED|Part B: Extension or Step-Up Period||6
3099478|NCT01490632|3822390|FG008|NOT COMPLETED|Part B: Extension or Step-Up Period||10
3099479|NCT01490632|3822391|FG009|NOT COMPLETED|Part B: Extension or Step-Up Period||25
3099480|NCT01490632|3822392|FG010|NOT COMPLETED|Part B: Extension or Step-Up Period||21
3099481|NCT01490632|3822393|FG011|NOT COMPLETED|Part B: Extension or Step-Up Period||8
3099482|NCT01490632|3822394|FG012|NOT COMPLETED|Part B: Extension or Step-Up Period||0
3099483|NCT01490632|3822395|FG013|NOT COMPLETED|Part B: Extension or Step-Up Period||0
3099484|NCT01490632|3822396|FG014|NOT COMPLETED|Part B: Extension or Step-Up Period||0
3099485|NCT01490632|3822397|FG015|NOT COMPLETED|Part B: Extension or Step-Up Period||0
3099486|NCT01490632|3822398|FG016|NOT COMPLETED|Part B: Extension or Step-Up Period||0
3099487|NCT01490632|3822399|FG017|NOT COMPLETED|Part B: Extension or Step-Up Period||0
3099488|NCT01490632|3822400|FG018|NOT COMPLETED|Part B: Extension or Step-Up Period||0
3099489|NCT01490632|3822401|FG019|NOT COMPLETED|Part B: Extension or Step-Up Period||0
3099490|NCT01490632|3822382|FG000|STARTED|Part C: Washout or Step-Down Period||0
3099491|NCT01490632|3822383|FG001|STARTED|Part C: Washout or Step-Down Period||0
3099492|NCT01490632|3822384|FG002|STARTED|Part C: Washout or Step-Down Period||0
3099493|NCT01490632|3822385|FG003|STARTED|Part C: Washout or Step-Down Period||0
3099494|NCT01490632|3822386|FG004|STARTED|Part C: Washout or Step-Down Period|One participant completed Part B but discontinued without receiving a Part C treatment assignment.|0
3099495|NCT01490632|3822387|FG005|STARTED|Part C: Washout or Step-Down Period|Part A participants randomized to 2 mg or 4 mg with a PASI ≥75 remained on 2 mg or 4 mg.|0
3099496|NCT01490632|3822388|FG006|STARTED|Part C: Washout or Step-Down Period|Part A participants randomized to 8 mg or 10 mg with a PASI ≥75 remained on 8 mg or 10 mg.|0
3099497|NCT01490632|3822389|FG007|STARTED|Part C: Washout or Step-Down Period|Placebo participants in Part A with a PASI <75 were re-randomized to 8 mg or 10 mg.|0
3099498|NCT01490632|3822390|FG008|STARTED|Part C: Washout or Step-Down Period|Part A participants randomized to 2 mg or 4 mg with a PASI ≥50 to <75 remained on 2 mg or 4 mg.|0
3099499|NCT01490632|3822391|FG009|STARTED|Part C: Washout or Step-Down Period|Part A participants randomized to 2 mg or 4 mg with a PASI <50 were re-randomized to 8 mg or 10 mg.|0
3099500|NCT01490632|3822392|FG010|STARTED|Part C: Washout or Step-Down Period|Part A 10 mg non-responders were discontinued from the study.|0
3099501|NCT01490632|3822393|FG011|STARTED|Part C: Washout or Step-Down Period|Part A participants randomized to Placebo remained on Placebo.|0
3099502|NCT01490632|3822394|FG012|STARTED|Part C: Washout or Step-Down Period|Responders receiving 2 or 4 mg were re-randomized to receive placebo.|15
3099503|NCT01490632|3822395|FG013|STARTED|Part C: Washout or Step-Down Period|Responders receiving 2 or 4 mg were re-randomized to receive half of the dose from Part B.|16
3099504|NCT01490632|3822396|FG014|STARTED|Part C: Washout or Step-Down Period|Responders receiving 8 or 10 mg were re-randomized to receive placebo.|55
3099505|NCT01490632|3822397|FG015|STARTED|Part C: Washout or Step-Down Period|Responders receiving 8 or 10 mg were re-randomized to receive 4 mg.|55
3099506|NCT01490632|3822398|FG016|STARTED|Part C: Washout or Step-Down Period||0
3099507|NCT01490632|3822399|FG017|STARTED|Part C: Washout or Step-Down Period||0
3099508|NCT01490632|3822400|FG018|STARTED|Part C: Washout or Step-Down Period||0
3099509|NCT01490632|3822401|FG019|STARTED|Part C: Washout or Step-Down Period||0
3099510|NCT01490632|3822382|FG000|COMPLETED|Part C: Washout or Step-Down Period||0
3099511|NCT01490632|3822383|FG001|COMPLETED|Part C: Washout or Step-Down Period||0
3099512|NCT01490632|3822384|FG002|COMPLETED|Part C: Washout or Step-Down Period||0
3099513|NCT01490632|3822385|FG003|COMPLETED|Part C: Washout or Step-Down Period||0
3099514|NCT01490632|3822386|FG004|COMPLETED|Part C: Washout or Step-Down Period||0
3099515|NCT01490632|3822387|FG005|COMPLETED|Part C: Washout or Step-Down Period||0
3099516|NCT01490632|3822388|FG006|COMPLETED|Part C: Washout or Step-Down Period||0
3099517|NCT01490632|3822389|FG007|COMPLETED|Part C: Washout or Step-Down Period||0
3099518|NCT01490632|3822390|FG008|COMPLETED|Part C: Washout or Step-Down Period||0
3099519|NCT01490632|3822391|FG009|COMPLETED|Part C: Washout or Step-Down Period||0
3099520|NCT01490632|3822392|FG010|COMPLETED|Part C: Washout or Step-Down Period||0
3099521|NCT01490632|3822393|FG011|COMPLETED|Part C: Washout or Step-Down Period||0
3099522|NCT01490632|3822394|FG012|COMPLETED|Part C: Washout or Step-Down Period||10
3099523|NCT01490632|3822395|FG013|COMPLETED|Part C: Washout or Step-Down Period||6
3099524|NCT01490632|3822396|FG014|COMPLETED|Part C: Washout or Step-Down Period||37
3099525|NCT01490632|3822397|FG015|COMPLETED|Part C: Washout or Step-Down Period||18
3099526|NCT01490632|3822398|FG016|COMPLETED|Part C: Washout or Step-Down Period||0
3099527|NCT01490632|3822399|FG017|COMPLETED|Part C: Washout or Step-Down Period||0
3099528|NCT01490632|3822400|FG018|COMPLETED|Part C: Washout or Step-Down Period||0
3099529|NCT01490632|3822401|FG019|COMPLETED|Part C: Washout or Step-Down Period||0
3099530|NCT01490632|3822382|FG000|NOT COMPLETED|Part C: Washout or Step-Down Period||0
3099531|NCT01490632|3822383|FG001|NOT COMPLETED|Part C: Washout or Step-Down Period||0
3099532|NCT01490632|3822384|FG002|NOT COMPLETED|Part C: Washout or Step-Down Period||0
3099533|NCT01490632|3822385|FG003|NOT COMPLETED|Part C: Washout or Step-Down Period||0
3099534|NCT01490632|3822386|FG004|NOT COMPLETED|Part C: Washout or Step-Down Period||0
3290501|NCT02831816|4024492|FG000|CP|Overall Study||590
3290502|NCT02831816|4024492|FG000|Vehicle|Overall Study||131
3290503|NCT02831816|4024492|FG000|COMPLETED|Overall Study||640
3290504|NCT02831816|4024492|FG000|NOT COMPLETED|Overall Study||0
3290505|NCT02831855|4024503|FG000|STARTED|Open Label Phase (24 Weeks)||694
3099535|NCT01490632|3822387|FG005|NOT COMPLETED|Part C: Washout or Step-Down Period||0
3099536|NCT01490632|3822388|FG006|NOT COMPLETED|Part C: Washout or Step-Down Period||0
3099537|NCT01490632|3822389|FG007|NOT COMPLETED|Part C: Washout or Step-Down Period||0
3099538|NCT01490632|3822390|FG008|NOT COMPLETED|Part C: Washout or Step-Down Period||0
3099539|NCT01490632|3822391|FG009|NOT COMPLETED|Part C: Washout or Step-Down Period||0
3099540|NCT01490632|3822392|FG010|NOT COMPLETED|Part C: Washout or Step-Down Period||0
3099541|NCT01490632|3822393|FG011|NOT COMPLETED|Part C: Washout or Step-Down Period||0
3099542|NCT01490632|3822394|FG012|NOT COMPLETED|Part C: Washout or Step-Down Period||5
3099543|NCT01490632|3822395|FG013|NOT COMPLETED|Part C: Washout or Step-Down Period||10
3099544|NCT01490632|3822396|FG014|NOT COMPLETED|Part C: Washout or Step-Down Period||18
3099545|NCT01490632|3822397|FG015|NOT COMPLETED|Part C: Washout or Step-Down Period||37
3099546|NCT01490632|3822398|FG016|NOT COMPLETED|Part C: Washout or Step-Down Period||0
3099547|NCT01490632|3822399|FG017|NOT COMPLETED|Part C: Washout or Step-Down Period||0
3099548|NCT01490632|3822400|FG018|NOT COMPLETED|Part C: Washout or Step-Down Period||0
3290506|NCT02831855|4024504|FG001|STARTED|Open Label Phase (24 Weeks)||0
3099549|NCT01490632|3822401|FG019|NOT COMPLETED|Part C: Washout or Step-Down Period||0
3099550|NCT01490632|3822382|FG000|STARTED|Part D: Re-Treatment Period||0
3099551|NCT01490632|3822383|FG001|STARTED|Part D: Re-Treatment Period||0
3099552|NCT01490632|3822384|FG002|STARTED|Part D: Re-Treatment Period||0
3099553|NCT01490632|3822385|FG003|STARTED|Part D: Re-Treatment Period||0
3099554|NCT01490632|3822386|FG004|STARTED|Part D: Re-Treatment Period||0
3099555|NCT01490632|3822387|FG005|STARTED|Part D: Re-Treatment Period||0
3099556|NCT01490632|3822388|FG006|STARTED|Part D: Re-Treatment Period||0
3099557|NCT01490632|3822389|FG007|STARTED|Part D: Re-Treatment Period||0
3099558|NCT01490632|3822390|FG008|STARTED|Part D: Re-Treatment Period||0
3099559|NCT01490632|3822391|FG009|STARTED|Part D: Re-Treatment Period||0
3099560|NCT01490632|3822392|FG010|STARTED|Part D: Re-Treatment Period||0
3099561|NCT01490632|3822393|FG011|STARTED|Part D: Re-Treatment Period||0
3099562|NCT01490632|3822394|FG012|STARTED|Part D: Re-Treatment Period|Responders receiving 2 or 4 mg were re-randomized to receive placebo.|0
3099563|NCT01490632|3822395|FG013|STARTED|Part D: Re-Treatment Period|Responders receiving 2 or 4 mg were re-randomized to receive half of the dose from Part B.|0
3099564|NCT01490632|3822396|FG014|STARTED|Part D: Re-Treatment Period|Responders receiving 8 or 10 mg were re-randomized to receive placebo.|0
3099565|NCT01490632|3822397|FG015|STARTED|Part D: Re-Treatment Period|Responders receiving 8 or 10 mg were re-randomized to receive 4 mg.|0
3099566|NCT01490632|3822398|FG016|STARTED|Part D: Re-Treatment Period|Responders who experienced a relapse or flare proceeded for retreatment with 2 mg.|3
3099567|NCT01490632|3822399|FG017|STARTED|Part D: Re-Treatment Period|Responders who experienced a relapse or flare proceeded for retreatment with 4 mg.|13
3099568|NCT01490632|3822400|FG018|STARTED|Part D: Re-Treatment Period|Responders who experienced a relapse or flare proceeded for retreatment with 8 mg.|19
3099569|NCT01490632|3822401|FG019|STARTED|Part D: Re-Treatment Period|Responders who experienced a relapse or flare proceeded for retreatment with 10 mg.|37
3099570|NCT01490632|3822382|FG000|COMPLETED|Part D: Re-Treatment Period||0
3099571|NCT01490632|3822383|FG001|COMPLETED|Part D: Re-Treatment Period||0
3099572|NCT01490632|3822384|FG002|COMPLETED|Part D: Re-Treatment Period||0
3099573|NCT01490632|3822385|FG003|COMPLETED|Part D: Re-Treatment Period||0
3099574|NCT01490632|3822386|FG004|COMPLETED|Part D: Re-Treatment Period||0
3099575|NCT01490632|3822387|FG005|COMPLETED|Part D: Re-Treatment Period||0
3099576|NCT01490632|3822388|FG006|COMPLETED|Part D: Re-Treatment Period||0
3099577|NCT01490632|3822389|FG007|COMPLETED|Part D: Re-Treatment Period||0
3099578|NCT01490632|3822390|FG008|COMPLETED|Part D: Re-Treatment Period||0
3099579|NCT01490632|3822391|FG009|COMPLETED|Part D: Re-Treatment Period||0
3099580|NCT01490632|3822392|FG010|COMPLETED|Part D: Re-Treatment Period||0
3099581|NCT01490632|3822393|FG011|COMPLETED|Part D: Re-Treatment Period||0
3099582|NCT01490632|3822394|FG012|COMPLETED|Part D: Re-Treatment Period||0
3099583|NCT01490632|3822395|FG013|COMPLETED|Part D: Re-Treatment Period||0
3099584|NCT01490632|3822396|FG014|COMPLETED|Part D: Re-Treatment Period||0
3099585|NCT01490632|3822397|FG015|COMPLETED|Part D: Re-Treatment Period||0
3099586|NCT01490632|3822398|FG016|COMPLETED|Part D: Re-Treatment Period||3
3099587|NCT01490632|3822399|FG017|COMPLETED|Part D: Re-Treatment Period||8
3099588|NCT01490632|3822400|FG018|COMPLETED|Part D: Re-Treatment Period||12
3099589|NCT01490632|3822401|FG019|COMPLETED|Part D: Re-Treatment Period||30
3099590|NCT01490632|3822382|FG000|NOT COMPLETED|Part D: Re-Treatment Period||0
3099591|NCT01490632|3822383|FG001|NOT COMPLETED|Part D: Re-Treatment Period||0
3099592|NCT01490632|3822384|FG002|NOT COMPLETED|Part D: Re-Treatment Period||0
3099593|NCT01490632|3822385|FG003|NOT COMPLETED|Part D: Re-Treatment Period||0
3099594|NCT01490632|3822386|FG004|NOT COMPLETED|Part D: Re-Treatment Period||0
3099595|NCT01490632|3822387|FG005|NOT COMPLETED|Part D: Re-Treatment Period||0
3099596|NCT01490632|3822388|FG006|NOT COMPLETED|Part D: Re-Treatment Period||0
3099597|NCT01490632|3822389|FG007|NOT COMPLETED|Part D: Re-Treatment Period||0
3099598|NCT01490632|3822390|FG008|NOT COMPLETED|Part D: Re-Treatment Period||0
3099599|NCT01490632|3822391|FG009|NOT COMPLETED|Part D: Re-Treatment Period||0
3099600|NCT01490632|3822392|FG010|NOT COMPLETED|Part D: Re-Treatment Period||0
3099601|NCT01490632|3822393|FG011|NOT COMPLETED|Part D: Re-Treatment Period||0
3099602|NCT01490632|3822394|FG012|NOT COMPLETED|Part D: Re-Treatment Period||0
3099603|NCT01490632|3822395|FG013|NOT COMPLETED|Part D: Re-Treatment Period||0
3099604|NCT01490632|3822396|FG014|NOT COMPLETED|Part D: Re-Treatment Period||0
3099605|NCT01490632|3822397|FG015|NOT COMPLETED|Part D: Re-Treatment Period||0
3099606|NCT01490632|3822398|FG016|NOT COMPLETED|Part D: Re-Treatment Period||0
3099607|NCT01490632|3822399|FG017|NOT COMPLETED|Part D: Re-Treatment Period||5
3290507|NCT02831855|4024505|FG002|STARTED|Open Label Phase (24 Weeks)||0
3290508|NCT02831855|4024503|FG000|COMPLETED|Open Label Phase (24 Weeks)||623
3290509|NCT02831855|4024504|FG001|COMPLETED|Open Label Phase (24 Weeks)||0
3290510|NCT02831855|4024505|FG002|COMPLETED|Open Label Phase (24 Weeks)||0
3290511|NCT02831855|4024503|FG000|NOT COMPLETED|Open Label Phase (24 Weeks)||71
3290512|NCT02831855|4024504|FG001|NOT COMPLETED|Open Label Phase (24 Weeks)||0
3290513|NCT02831855|4024505|FG002|NOT COMPLETED|Open Label Phase (24 Weeks)||0
3290514|NCT02831855|4024503|FG000|STARTED|Double Blind Phase (24 Weeks)||0
3290515|NCT02831855|4024504|FG001|STARTED|Double Blind Phase (24 Weeks)|Only eligible participants from open label phase, were randomized into double blind phase.|267
3290516|NCT02831855|4024505|FG002|STARTED|Double Blind Phase (24 Weeks)|Only eligible participants from open label phase, were randomized into double blind phase. .|266
3099608|NCT01490632|3822400|FG018|NOT COMPLETED|Part D: Re-Treatment Period||7
3099609|NCT01490632|3822401|FG019|NOT COMPLETED|Part D: Re-Treatment Period||7
3099610|NCT01490684|3822444|FG000|STARTED|Overall Study||162
3099611|NCT01490684|3822444|FG000|COMPLETED|Overall Study||162
3099612|NCT01490684|3822444|FG000|NOT COMPLETED|Overall Study||0
3099613|NCT01490697|3822450|FG000|STARTED|Overall Study||16
3099614|NCT01490697|3822451|FG001|STARTED|Overall Study||18
3099615|NCT01490697|3822450|FG000|COMPLETED|Overall Study||15
3099616|NCT01490697|3822451|FG001|COMPLETED|Overall Study||16
3099617|NCT01490697|3822450|FG000|NOT COMPLETED|Overall Study||1
3099618|NCT01490697|3822451|FG001|NOT COMPLETED|Overall Study||2
3099619|NCT01490723|3822457|FG000|STARTED|Overall Study||20
3099620|NCT01490723|3822457|FG000|COMPLETED|Overall Study||20
3099621|NCT01490723|3822457|FG000|NOT COMPLETED|Overall Study||0
3099622|NCT01490788|3822461|FG000|STARTED|Overall Study||5
3099623|NCT01490788|3822462|FG001|STARTED|Overall Study||5
3099624|NCT01490788|3822463|FG002|STARTED|Overall Study||5
3099625|NCT01490788|3822464|FG003|STARTED|Overall Study||5
3099626|NCT01490788|3822465|FG004|STARTED|Overall Study||5
3099627|NCT01490788|3822466|FG005|STARTED|Overall Study||5
3099628|NCT01490788|3822461|FG000|COMPLETED|Overall Study||4
3099629|NCT01490788|3822462|FG001|COMPLETED|Overall Study||5
3099630|NCT01490788|3822463|FG002|COMPLETED|Overall Study||5
3099631|NCT01490788|3822464|FG003|COMPLETED|Overall Study||5
3099632|NCT01490788|3822465|FG004|COMPLETED|Overall Study||5
3099633|NCT01490788|3822466|FG005|COMPLETED|Overall Study||5
3099634|NCT01490788|3822461|FG000|NOT COMPLETED|Overall Study||1
3099635|NCT01490788|3822462|FG001|NOT COMPLETED|Overall Study||0
3099636|NCT01490788|3822463|FG002|NOT COMPLETED|Overall Study||0
3099637|NCT01490788|3822464|FG003|NOT COMPLETED|Overall Study||0
3099638|NCT01490788|3822465|FG004|NOT COMPLETED|Overall Study||0
3099639|NCT01490788|3822466|FG005|NOT COMPLETED|Overall Study||0
3099640|NCT01490814|3822476|FG000|STARTED|Overall Study|378 subjects randomized to Cryoballoon arm|378
3099641|NCT01490814|3822477|FG001|STARTED|Overall Study|384 subjects randomized to radiofrequency arm|384
3099642|NCT01490814|3822476|FG000|COMPLETED|Overall Study|374 received ablation|374
3099643|NCT01490814|3822477|FG001|COMPLETED|Overall Study|376 received ablation|376
3099644|NCT01490814|3822476|FG000|NOT COMPLETED|Overall Study||4
3099645|NCT01490814|3822477|FG001|NOT COMPLETED|Overall Study||8
3099646|NCT01490840|3822485|FG000|STARTED|Phase 1||94
3099647|NCT01490840|3822486|FG001|STARTED|Phase 1||84
3290517|NCT02831855|4024503|FG000|Treated|Double Blind Phase (24 Weeks)||0
3290518|NCT02831855|4024504|FG001|Treated|Double Blind Phase (24 Weeks)||264
3290519|NCT02831855|4024505|FG002|Treated|Double Blind Phase (24 Weeks)||266
3290520|NCT02831855|4024503|FG000|COMPLETED|Double Blind Phase (24 Weeks)||0
3290521|NCT02831855|4024504|FG001|COMPLETED|Double Blind Phase (24 Weeks)||238
3290522|NCT02831855|4024505|FG002|COMPLETED|Double Blind Phase (24 Weeks)||247
3099648|NCT01490840|3822485|FG000|Modified Full Analysis Set|Phase 1||56
3099649|NCT01490840|3822486|FG001|Modified Full Analysis Set|Phase 1||83
3099650|NCT01490840|3822485|FG000|COMPLETED|Phase 1||84
3099651|NCT01490840|3822486|FG001|COMPLETED|Phase 1||78
3099652|NCT01490840|3822485|FG000|NOT COMPLETED|Phase 1||10
3099653|NCT01490840|3822486|FG001|NOT COMPLETED|Phase 1||6
3099654|NCT01490840|3822485|FG000|STARTED|Phase 2|3 participants discontinued between phase 1 and phase 2|81
3099655|NCT01490840|3822486|FG001|STARTED|Phase 2|4 participants discontinued between phase 1 and phase 2|74
3099656|NCT01490840|3822485|FG000|COMPLETED|Phase 2||75
3099657|NCT01490840|3822486|FG001|COMPLETED|Phase 2||68
3099658|NCT01490840|3822485|FG000|NOT COMPLETED|Phase 2||6
3099659|NCT01490840|3822486|FG001|NOT COMPLETED|Phase 2||6
3099660|NCT01490866|3822492|FG000|STARTED|FOLFOX/Bevacizumab Treatment||70
3099661|NCT01490866|3822492|FG000|COMPLETED|FOLFOX/Bevacizumab Treatment||49
3099662|NCT01490866|3822492|FG000|NOT COMPLETED|FOLFOX/Bevacizumab Treatment||21
3099663|NCT01490866|3822492|FG000|STARTED|Axitinib Maintenance Therapy||49
3099664|NCT01490866|3822492|FG000|COMPLETED|Axitinib Maintenance Therapy|No protocol defined endpoint to Axitinib maintenance treatment.|0
3099665|NCT01490866|3822492|FG000|NOT COMPLETED|Axitinib Maintenance Therapy||49
3099666|NCT01490892|3822499|FG000|STARTED|Overall Study||219
3099667|NCT01490892|3822499|FG000|COMPLETED|Overall Study||219
3099668|NCT01490892|3822499|FG000|NOT COMPLETED|Overall Study||0
3099669|NCT01490918|3822506|FG000|STARTED|Overall Study||65
3099670|NCT01490918|3822507|FG001|STARTED|Overall Study||66
3099671|NCT01490918|3822508|FG002|STARTED|Overall Study||34
3290523|NCT02831855|4024503|FG000|NOT COMPLETED|Double Blind Phase (24 Weeks)||0
3290524|NCT02831855|4024504|FG001|NOT COMPLETED|Double Blind Phase (24 Weeks)||29
3290525|NCT02831855|4024505|FG002|NOT COMPLETED|Double Blind Phase (24 Weeks)||19
3290526|NCT02831998|4024515|FG000|STARTED|Overall Study||440
3290527|NCT02831998|4024515|FG000|ZP|Overall Study||400
3290528|NCT02831998|4024515|FG000|CP|Overall Study||400
3290529|NCT02831998|4024515|FG000|Vehicle|Overall Study||80
3290530|NCT02831998|4024515|FG000|COMPLETED|Overall Study||440
3290531|NCT02831998|4024515|FG000|NOT COMPLETED|Overall Study||0
3290532|NCT02832037|4024531|FG000|STARTED|Overall Study||85
3290533|NCT02832037|4024532|FG001|STARTED|Overall Study||84
3290534|NCT02832037|4024533|FG002|STARTED|Overall Study||85
3290535|NCT02832037|4024534|FG003|STARTED|Overall Study||85
3290536|NCT02832037|4024535|FG004|STARTED|Overall Study||170
3290537|NCT02832037|4024531|FG000|COMPLETED|Overall Study||66
3290538|NCT02832037|4024532|FG001|COMPLETED|Overall Study||72
3290539|NCT02832037|4024533|FG002|COMPLETED|Overall Study||77
3290540|NCT02832037|4024534|FG003|COMPLETED|Overall Study||78
3099672|NCT01490918|3822506|FG000|COMPLETED|Overall Study||52
3099673|NCT01490918|3822507|FG001|COMPLETED|Overall Study||52
3099674|NCT01490918|3822508|FG002|COMPLETED|Overall Study||22
3099675|NCT01490918|3822506|FG000|NOT COMPLETED|Overall Study||13
3099676|NCT01490918|3822507|FG001|NOT COMPLETED|Overall Study||14
3099677|NCT01490918|3822508|FG002|NOT COMPLETED|Overall Study||12
3099678|NCT01490931|3822520|FG000|STARTED|Overall Study||25
3099679|NCT01490931|3822520|FG000|COMPLETED|Overall Study||25
3099680|NCT01490931|3822520|FG000|NOT COMPLETED|Overall Study||0
3099681|NCT01491022|3822526|FG000|STARTED|Intervention 1||10
3099682|NCT01491022|3822527|FG001|STARTED|Intervention 1||12
3099683|NCT01491022|3822526|FG000|COMPLETED|Intervention 1||9
3099684|NCT01491022|3822527|FG001|COMPLETED|Intervention 1||11
3099685|NCT01491022|3822526|FG000|NOT COMPLETED|Intervention 1||1
3099686|NCT01491022|3822527|FG001|NOT COMPLETED|Intervention 1||1
3099687|NCT01491022|3822526|FG000|STARTED|2 Week Washout||9
3099688|NCT01491022|3822527|FG001|STARTED|2 Week Washout||11
3099689|NCT01491022|3822526|FG000|COMPLETED|2 Week Washout||9
3099690|NCT01491022|3822527|FG001|COMPLETED|2 Week Washout||11
3099691|NCT01491022|3822526|FG000|NOT COMPLETED|2 Week Washout||0
3099692|NCT01491022|3822527|FG001|NOT COMPLETED|2 Week Washout||0
3099693|NCT01491022|3822526|FG000|STARTED|Intervention 2||9
3099694|NCT01491022|3822527|FG001|STARTED|Intervention 2||11
3099695|NCT01491022|3822526|FG000|COMPLETED|Intervention 2||8
3099696|NCT01491022|3822527|FG001|COMPLETED|Intervention 2||11
3099697|NCT01491022|3822526|FG000|NOT COMPLETED|Intervention 2||1
3099698|NCT01491022|3822527|FG001|NOT COMPLETED|Intervention 2||0
3099699|NCT01491035|3822545|FG000|STARTED|Overall Study||6
3099700|NCT01491035|3822546|FG001|STARTED|Overall Study||6
3099701|NCT01491035|3822547|FG002|STARTED|Overall Study||6
3099702|NCT01491035|3822548|FG003|STARTED|Overall Study||6
3099703|NCT01491035|3822549|FG004|STARTED|Overall Study||6
3099704|NCT01491035|3822550|FG005|STARTED|Overall Study||6
3099705|NCT01491035|3822551|FG006|STARTED|Overall Study||6
3099706|NCT01491035|3822552|FG007|STARTED|Overall Study||6
3099707|NCT01491035|3822545|FG000|COMPLETED|Overall Study||6
3099708|NCT01491035|3822546|FG001|COMPLETED|Overall Study||6
3099709|NCT01491035|3822547|FG002|COMPLETED|Overall Study||6
3099710|NCT01491035|3822548|FG003|COMPLETED|Overall Study||6
3099711|NCT01491035|3822549|FG004|COMPLETED|Overall Study||5
3099712|NCT01491035|3822550|FG005|COMPLETED|Overall Study||6
3099713|NCT01491035|3822551|FG006|COMPLETED|Overall Study||6
3099714|NCT01491035|3822552|FG007|COMPLETED|Overall Study||6
3099715|NCT01491035|3822545|FG000|NOT COMPLETED|Overall Study||0
3099716|NCT01491035|3822546|FG001|NOT COMPLETED|Overall Study||0
3099717|NCT01491035|3822547|FG002|NOT COMPLETED|Overall Study||0
3099718|NCT01491035|3822548|FG003|NOT COMPLETED|Overall Study||0
3099719|NCT01491035|3822549|FG004|NOT COMPLETED|Overall Study||1
3099720|NCT01491035|3822550|FG005|NOT COMPLETED|Overall Study||0
3099721|NCT01491035|3822551|FG006|NOT COMPLETED|Overall Study||0
3099722|NCT01491035|3822552|FG007|NOT COMPLETED|Overall Study||0
3099723|NCT01491113|3822575|FG000|STARTED|Overall Study||6
3099724|NCT01491113|3822576|FG001|STARTED|Overall Study||6
3099725|NCT01491113|3822577|FG002|STARTED|Overall Study||6
3099726|NCT01491113|3822578|FG003|STARTED|Overall Study||6
3099727|NCT01491113|3822579|FG004|STARTED|Overall Study||6
3099728|NCT01491113|3822575|FG000|COMPLETED|Overall Study||6
3099729|NCT01491113|3822576|FG001|COMPLETED|Overall Study||6
3099730|NCT01491113|3822577|FG002|COMPLETED|Overall Study||6
3099731|NCT01491113|3822578|FG003|COMPLETED|Overall Study||6
3099732|NCT01491113|3822579|FG004|COMPLETED|Overall Study||6
3099733|NCT01491113|3822575|FG000|NOT COMPLETED|Overall Study||0
3099734|NCT01491113|3822576|FG001|NOT COMPLETED|Overall Study||0
3099735|NCT01491113|3822577|FG002|NOT COMPLETED|Overall Study||0
3099736|NCT01491113|3822578|FG003|NOT COMPLETED|Overall Study||0
3099737|NCT01491113|3822579|FG004|NOT COMPLETED|Overall Study||0
3099738|NCT01491178|3822593|FG000|STARTED|Overall Study|Started are the enrolled subjects who followed registration rule and for who eCRF was collected.|6443
3099739|NCT01491178|3822593|FG000|COMPLETED|Overall Study|Completed is defined as 104 weeks follow-up after enrollment.|3649
3099740|NCT01491178|3822593|FG000|NOT COMPLETED|Overall Study||2794
3099741|NCT01491490|3822599|FG000|STARTED|Overall Study||1
3099742|NCT01491490|3822600|FG001|STARTED|Overall Study||1
3099743|NCT01491490|3822599|FG000|COMPLETED|Overall Study||1
3099744|NCT01491490|3822600|FG001|COMPLETED|Overall Study||1
3099745|NCT01491490|3822599|FG000|NOT COMPLETED|Overall Study||0
3099746|NCT01491490|3822600|FG001|NOT COMPLETED|Overall Study||0
3099747|NCT01491607|3822610|FG000|STARTED|Overall Study||200
3099748|NCT01491607|3822610|FG000|COMPLETED|Overall Study||190
3099749|NCT01491607|3822610|FG000|NOT COMPLETED|Overall Study||10
3099750|NCT01491633|3822676|FG000|STARTED|Overall Study||5
3099751|NCT01491633|3822676|FG000|COMPLETED|Overall Study||0
3099752|NCT01491633|3822676|FG000|NOT COMPLETED|Overall Study||5
3099753|NCT01491672|3822683|FG000|STARTED|Overall Study||58
3099754|NCT01491672|3822684|FG001|STARTED|Overall Study|1 participant died prior to treatment initiation.|62
3099755|NCT01491672|3822685|FG002|STARTED|Overall Study||14
3099756|NCT01491672|3822683|FG000|Safety Set|Overall Study||58
3099757|NCT01491672|3822684|FG001|Safety Set|Overall Study||61
3099758|NCT01491672|3822685|FG002|Safety Set|Overall Study||14
3099759|NCT01491672|3822683|FG000|COMPLETED|Overall Study||2
3099760|NCT01491672|3822684|FG001|COMPLETED|Overall Study||2
3099761|NCT01491672|3822685|FG002|COMPLETED|Overall Study||3
3099762|NCT01491672|3822683|FG000|NOT COMPLETED|Overall Study||56
3099763|NCT01491672|3822684|FG001|NOT COMPLETED|Overall Study||60
3099764|NCT01491672|3822685|FG002|NOT COMPLETED|Overall Study||11
3099765|NCT01491737|3822697|FG000|STARTED|Overall Study||129
3099766|NCT01491737|3822698|FG001|STARTED|Overall Study||129
3099767|NCT01491737|3822697|FG000|Received at Least One Dose of Study Drug|Overall Study||127
3099768|NCT01491737|3822698|FG001|Received at Least One Dose of Study Drug|Overall Study||124
3099769|NCT01491737|3822697|FG000|Entered Follow-Up (Post-Treatment)|Overall Study||120
3099770|NCT01491737|3822698|FG001|Entered Follow-Up (Post-Treatment)|Overall Study||116
3099771|NCT01491737|3822697|FG000|COMPLETED|Overall Study||0
3099772|NCT01491737|3822698|FG001|COMPLETED|Overall Study||0
3099773|NCT01491737|3822697|FG000|NOT COMPLETED|Overall Study||129
3099774|NCT01491737|3822698|FG001|NOT COMPLETED|Overall Study||129
3099775|NCT01491802|3822704|FG000|STARTED|Overall Study||9
3099776|NCT01491802|3822705|FG001|STARTED|Overall Study||8
3099777|NCT01491802|3822704|FG000|COMPLETED|Overall Study||8
3099778|NCT01491802|3822705|FG001|COMPLETED|Overall Study||6
3099779|NCT01491802|3822704|FG000|NOT COMPLETED|Overall Study||1
3099780|NCT01491802|3822705|FG001|NOT COMPLETED|Overall Study||2
3099781|NCT01491841|3822712|FG000|STARTED|Overall Study||33
3099782|NCT01491841|3822712|FG000|COMPLETED|Overall Study||22
3099783|NCT01491841|3822712|FG000|NOT COMPLETED|Overall Study||11
3099784|NCT01491854|3822724|FG000|STARTED|Overall Study||130
3099785|NCT01491854|3822724|FG000|COMPLETED|Overall Study||0
3099786|NCT01491854|3822724|FG000|NOT COMPLETED|Overall Study||130
3099787|NCT01491919|3822731|FG000|STARTED|Overall Study||13
3099788|NCT01491919|3822732|FG001|STARTED|Overall Study||10
3099789|NCT01491919|3822733|FG002|STARTED|Overall Study||3
3099790|NCT01491919|3822731|FG000|COMPLETED|Overall Study||12
3099791|NCT01491919|3822732|FG001|COMPLETED|Overall Study||8
3099792|NCT01491919|3822733|FG002|COMPLETED|Overall Study||2
3099793|NCT01491919|3822731|FG000|NOT COMPLETED|Overall Study||1
3099794|NCT01491919|3822732|FG001|NOT COMPLETED|Overall Study||2
3099795|NCT01491919|3822733|FG002|NOT COMPLETED|Overall Study||1
3099796|NCT01491945|3822743|FG000|STARTED|Overall Study||76
3099797|NCT01491945|3822743|FG000|COMPLETED|Overall Study||25
3099798|NCT01491945|3822743|FG000|NOT COMPLETED|Overall Study||51
3099799|NCT01491958|3822750|FG000|STARTED|Overall Study||40
3099800|NCT01491958|3822751|FG001|STARTED|Overall Study||40
3099801|NCT01491958|3822750|FG000|COMPLETED|Overall Study||40
3099802|NCT01491958|3822751|FG001|COMPLETED|Overall Study||40
3099803|NCT01491958|3822750|FG000|NOT COMPLETED|Overall Study||0
3099804|NCT01491958|3822751|FG001|NOT COMPLETED|Overall Study||0
3099805|NCT01491984|3822758|FG000|STARTED|Overall Study||49
3099806|NCT01491984|3822759|FG001|STARTED|Overall Study||45
3099807|NCT01491984|3822758|FG000|COMPLETED|Overall Study||47
3099808|NCT01491984|3822759|FG001|COMPLETED|Overall Study||44
3099809|NCT01491984|3822758|FG000|NOT COMPLETED|Overall Study||2
3099810|NCT01491984|3822759|FG001|NOT COMPLETED|Overall Study||1
3099811|NCT01492088|3822768|FG000|STARTED|Overall Study||3
3099812|NCT01492088|3822769|FG001|STARTED|Overall Study||16
3099813|NCT01492088|3822770|FG002|STARTED|Overall Study||17
3099814|NCT01492088|3822768|FG000|COMPLETED|Overall Study||0
3099815|NCT01492088|3822769|FG001|COMPLETED|Overall Study||2
3099816|NCT01492088|3822770|FG002|COMPLETED|Overall Study||3
3099817|NCT01492088|3822768|FG000|NOT COMPLETED|Overall Study||3
3099818|NCT01492088|3822769|FG001|NOT COMPLETED|Overall Study||14
3099819|NCT01492088|3822770|FG002|NOT COMPLETED|Overall Study||14
3099820|NCT01492101|3822783|FG000|STARTED|Overall Study||429
3099821|NCT01492101|3822784|FG001|STARTED|Overall Study||423
3099822|NCT01492101|3822783|FG000|COMPLETED|Overall Study||92
3099823|NCT01492101|3822784|FG001|COMPLETED|Overall Study||81
3099824|NCT01492101|3822783|FG000|NOT COMPLETED|Overall Study||337
3099825|NCT01492101|3822784|FG001|NOT COMPLETED|Overall Study||342
3099826|NCT01492309|3822792|FG000|STARTED|Overall Study||11
3099827|NCT01492309|3822793|FG001|STARTED|Overall Study||11
3099828|NCT01492309|3822792|FG000|COMPLETED|Overall Study||11
3099829|NCT01492309|3822793|FG001|COMPLETED|Overall Study||11
3099830|NCT01492309|3822792|FG000|NOT COMPLETED|Overall Study||0
3099831|NCT01492309|3822793|FG001|NOT COMPLETED|Overall Study||0
3099832|NCT01492400|3822801|FG000|STARTED|Overall Study||181
3099833|NCT01492400|3822802|FG001|STARTED|Overall Study||182
3099834|NCT01492400|3822801|FG000|COMPLETED|Overall Study||165
3099835|NCT01492400|3822802|FG001|COMPLETED|Overall Study||166
3099836|NCT01492400|3822801|FG000|NOT COMPLETED|Overall Study||16
3099837|NCT01492400|3822802|FG001|NOT COMPLETED|Overall Study||16
3099838|NCT01492426|3822810|FG000|STARTED|Treatment||402
3099839|NCT01492426|3822811|FG001|STARTED|Treatment||200
3099840|NCT01492426|3822810|FG000|COMPLETED|Treatment||319
3099841|NCT01492426|3822811|FG001|COMPLETED|Treatment||160
3099842|NCT01492426|3822810|FG000|NOT COMPLETED|Treatment||83
3099843|NCT01492426|3822811|FG001|NOT COMPLETED|Treatment||40
3290541|NCT02832037|4024535|FG004|COMPLETED|Overall Study||151
3290542|NCT02832037|4024531|FG000|NOT COMPLETED|Overall Study||19
3290543|NCT02832037|4024532|FG001|NOT COMPLETED|Overall Study||12
3290544|NCT02832037|4024533|FG002|NOT COMPLETED|Overall Study||8
3290545|NCT02832037|4024534|FG003|NOT COMPLETED|Overall Study||7
3290546|NCT02832037|4024535|FG004|NOT COMPLETED|Overall Study||19
3290547|NCT02832115|4024549|FG000|STARTED|Overall Study||48
3099844|NCT01492426|3822810|FG000|STARTED|Follow-Up|This total number includes 319 who completed treatment plus 65 who rejoined for follow-up.|384
3099845|NCT01492426|3822811|FG001|STARTED|Follow-Up|This total number includes 160 who completed treatment plus 31 who rejoined for follow-up.|191
3099846|NCT01492426|3822810|FG000|COMPLETED|Follow-Up||359
3290548|NCT02832115|4024550|FG001|STARTED|Overall Study||52
3290549|NCT02832115|4024549|FG000|COMPLETED|Overall Study||48
3290550|NCT02832115|4024550|FG001|COMPLETED|Overall Study||52
3099847|NCT01492426|3822811|FG001|COMPLETED|Follow-Up||181
3099848|NCT01492426|3822810|FG000|NOT COMPLETED|Follow-Up||25
3099849|NCT01492426|3822811|FG001|NOT COMPLETED|Follow-Up||10
3099850|NCT01492439|3822823|FG000|STARTED|Overall Study||19
3099851|NCT01492439|3822824|FG001|STARTED|Overall Study||18
3099852|NCT01492439|3822823|FG000|Post-intervention|Overall Study||18
3099853|NCT01492439|3822824|FG001|Post-intervention|Overall Study||13
3099854|NCT01492439|3822823|FG000|COMPLETED|Overall Study||15
3099855|NCT01492439|3822824|FG001|COMPLETED|Overall Study||9
3099856|NCT01492439|3822823|FG000|NOT COMPLETED|Overall Study||4
3099857|NCT01492439|3822824|FG001|NOT COMPLETED|Overall Study||9
3099858|NCT01492582|3822832|FG000|STARTED|Overall Study|Consented to the vaccine arm (265 quadrivalent vaccine; 188 nonavalent vaccine)|453
3099859|NCT01492582|3822833|FG001|STARTED|Overall Study|Consented to the survey arm of the study|1046
3135356|NCT01706575|3860370|FG000|NOT COMPLETED|Overall Study||12
3290551|NCT02832115|4024549|FG000|NOT COMPLETED|Overall Study||0
3290552|NCT02832115|4024550|FG001|NOT COMPLETED|Overall Study||0
3290553|NCT02832154|4024556|FG000|STARTED|Overall Study||43
3290554|NCT02832154|4024556|FG000|COMPLETED|Overall Study||43
3290555|NCT02832154|4024556|FG000|NOT COMPLETED|Overall Study||0
3290556|NCT02832167|4024560|FG000|STARTED|Treatment Period 1||239
3290557|NCT02832167|4024560|FG000|COMPLETED|Treatment Period 1||110
3290558|NCT02832167|4024560|FG000|NOT COMPLETED|Treatment Period 1||129
3290559|NCT02832167|4024560|FG000|STARTED|Transition From Period 1 to Period 2||110
3290560|NCT02832167|4024560|FG000|COMPLETED|Transition From Period 1 to Period 2||103
3290561|NCT02832167|4024560|FG000|NOT COMPLETED|Transition From Period 1 to Period 2||7
3290562|NCT02832167|4024560|FG000|STARTED|Treatment Period 2||103
3290563|NCT02832167|4024560|FG000|COMPLETED|Treatment Period 2||20
3290564|NCT02832167|4024560|FG000|NOT COMPLETED|Treatment Period 2||83
3290565|NCT02832284|4024564|FG000|STARTED|Overall Study||23
3290566|NCT02832284|4024564|FG000|COMPLETED|Overall Study||23
3290567|NCT02832284|4024564|FG000|NOT COMPLETED|Overall Study||0
3290568|NCT02832375|4024570|FG000|STARTED|Overall Study||121
3290569|NCT02832375|4024571|FG001|STARTED|Overall Study||121
3290570|NCT02832375|4024570|FG000|COMPLETED|Overall Study||119
3290571|NCT02832375|4024571|FG001|COMPLETED|Overall Study||121
3290572|NCT02832375|4024570|FG000|NOT COMPLETED|Overall Study||2
3290573|NCT02832375|4024571|FG001|NOT COMPLETED|Overall Study||0
3290574|NCT02832622|4024578|FG000|STARTED|Overall Study||2169
3290575|NCT02832622|4024578|FG000|COMPLETED|Overall Study||433
3290576|NCT02832622|4024578|FG000|NOT COMPLETED|Overall Study||1736
3290577|NCT02832674|4024583|FG000|STARTED|Overall Study||72
3290578|NCT02832674|4024583|FG000|COMPLETED|Overall Study||67
3290579|NCT02832674|4024583|FG000|NOT COMPLETED|Overall Study||5
3290580|NCT02833077|4024589|FG000|STARTED|Overall Study||144
3290581|NCT02833077|4024590|FG001|STARTED|Overall Study||48
3290582|NCT02833077|4024589|FG000|Participants Treated|Overall Study||144
3290583|NCT02833077|4024590|FG001|Participants Treated|Overall Study||38
3290584|NCT02833077|4024589|FG000|COMPLETED|Overall Study||127
3290585|NCT02833077|4024590|FG001|COMPLETED|Overall Study|Includes participants who completed the study but did not receive the optional treatment.|40
3290586|NCT02833077|4024589|FG000|NOT COMPLETED|Overall Study||17
3290587|NCT02833077|4024590|FG001|NOT COMPLETED|Overall Study||8
3290588|NCT02833337|4024597|FG000|STARTED|Overall Study||180
3290589|NCT02833337|4024597|FG000|COMPLETED|Overall Study||180
3290590|NCT02833337|4024597|FG000|NOT COMPLETED|Overall Study||0
3290591|NCT02833350|4024608|FG000|STARTED|Overall Study||40
3290592|NCT02833350|4024609|FG001|STARTED|Overall Study||109
3290593|NCT02833350|4024610|FG002|STARTED|Overall Study||110
3290594|NCT02833350|4024611|FG003|STARTED|Overall Study||110
3290595|NCT02833350|4024612|FG004|STARTED|Overall Study||111
3290596|NCT02833350|4024613|FG005|STARTED|Overall Study||49
3290597|NCT02833350|4024614|FG006|STARTED|Overall Study||49
3290598|NCT02833350|4024608|FG000|Randomized|Overall Study||40
3290599|NCT02833350|4024609|FG001|Randomized|Overall Study||109
3290600|NCT02833350|4024610|FG002|Randomized|Overall Study||110
3290601|NCT02833350|4024611|FG003|Randomized|Overall Study||110
3290602|NCT02833350|4024612|FG004|Randomized|Overall Study||111
3290603|NCT02833350|4024613|FG005|Randomized|Overall Study||48
3290604|NCT02833350|4024614|FG006|Randomized|Overall Study||50
3290605|NCT02833350|4024608|FG000|COMPLETED|Overall Study||37
3290606|NCT02833350|4024609|FG001|COMPLETED|Overall Study||100
3290607|NCT02833350|4024610|FG002|COMPLETED|Overall Study||102
3290608|NCT02833350|4024611|FG003|COMPLETED|Overall Study||102
3290609|NCT02833350|4024612|FG004|COMPLETED|Overall Study||108
3290610|NCT02833350|4024613|FG005|COMPLETED|Overall Study||48
3290611|NCT02833350|4024614|FG006|COMPLETED|Overall Study||44
3290612|NCT02833350|4024608|FG000|NOT COMPLETED|Overall Study||3
3290613|NCT02833350|4024609|FG001|NOT COMPLETED|Overall Study||9
3290614|NCT02833350|4024610|FG002|NOT COMPLETED|Overall Study||8
3290615|NCT02833350|4024611|FG003|NOT COMPLETED|Overall Study||8
3290616|NCT02833350|4024612|FG004|NOT COMPLETED|Overall Study||3
3290617|NCT02833350|4024613|FG005|NOT COMPLETED|Overall Study||1
3290618|NCT02833350|4024614|FG006|NOT COMPLETED|Overall Study||5
3290619|NCT02833415|4024635|FG000|STARTED|Overall Study||20
3290620|NCT02833415|4024636|FG001|STARTED|Overall Study||20
3290621|NCT02833415|4024635|FG000|COMPLETED|Overall Study||18
3290622|NCT02833415|4024636|FG001|COMPLETED|Overall Study||17
3290623|NCT02833415|4024635|FG000|NOT COMPLETED|Overall Study||2
3290624|NCT02833415|4024636|FG001|NOT COMPLETED|Overall Study||3
3290625|NCT02833844|4024644|FG000|STARTED|Double-Blind Period||157
3290626|NCT02833844|4024645|FG001|STARTED|Double-Blind Period||310
3099860|NCT01492582|3822832|FG000|Received First Quadrivalent Vaccine Dose|Overall Study||254
3099861|NCT01492582|3822833|FG001|Received First Quadrivalent Vaccine Dose|Overall Study|Does not apply|0
3099862|NCT01492582|3822832|FG000|Received First Nonavalent Vaccine Dose|Overall Study||182
3099863|NCT01492582|3822833|FG001|Received First Nonavalent Vaccine Dose|Overall Study||0
3099864|NCT01492582|3822832|FG000|COMPLETED|Overall Study|Received 3 vaccine doses and completed Month 7 blood draw (224 quadrivalent; 160 nonavalent)|384
3099865|NCT01492582|3822833|FG001|COMPLETED|Overall Study|Returned evaluable survey|982
3099866|NCT01492582|3822832|FG000|NOT COMPLETED|Overall Study||69
3099867|NCT01492582|3822833|FG001|NOT COMPLETED|Overall Study||64
3099868|NCT01492673|3822856|FG000|STARTED|Overall Study||9
3099869|NCT01492673|3822856|FG000|COMPLETED|Overall Study||9
3099870|NCT01492673|3822856|FG000|NOT COMPLETED|Overall Study||0
3099871|NCT01492686|3822862|FG000|STARTED|Double-blind Phase||69
3099872|NCT01492686|3822863|FG001|STARTED|Double-blind Phase||68
3099873|NCT01492686|3822862|FG000|COMPLETED|Double-blind Phase||67
3099874|NCT01492686|3822863|FG001|COMPLETED|Double-blind Phase||60
3099875|NCT01492686|3822862|FG000|NOT COMPLETED|Double-blind Phase||2
3099876|NCT01492686|3822863|FG001|NOT COMPLETED|Double-blind Phase||8
3099877|NCT01492686|3822862|FG000|STARTED|Open-label Phase||65
3099878|NCT01492686|3822863|FG001|STARTED|Open-label Phase||58
3099879|NCT01492686|3822862|FG000|COMPLETED|Open-label Phase||53
3099880|NCT01492686|3822863|FG001|COMPLETED|Open-label Phase||40
3099881|NCT01492686|3822862|FG000|NOT COMPLETED|Open-label Phase||12
3099882|NCT01492686|3822863|FG001|NOT COMPLETED|Open-label Phase||18
3099883|NCT01493024|3822875|FG000|STARTED|Overall Study||30
3099884|NCT01493024|3822876|FG001|STARTED|Overall Study||12
3099885|NCT01493024|3822877|FG002|STARTED|Overall Study||24
3099886|NCT01493024|3822878|FG003|STARTED|Overall Study||24
3099887|NCT01493024|3822875|FG000|COMPLETED|Overall Study||30
3099888|NCT01493024|3822876|FG001|COMPLETED|Overall Study||12
3099889|NCT01493024|3822877|FG002|COMPLETED|Overall Study||24
3099890|NCT01493024|3822878|FG003|COMPLETED|Overall Study||24
3099891|NCT01493024|3822875|FG000|NOT COMPLETED|Overall Study||0
3099892|NCT01493024|3822876|FG001|NOT COMPLETED|Overall Study||0
3099893|NCT01493024|3822877|FG002|NOT COMPLETED|Overall Study||0
3099894|NCT01493024|3822878|FG003|NOT COMPLETED|Overall Study||0
3099895|NCT01493089|3822891|FG000|STARTED|Overall Study||122
3099896|NCT01493089|3822892|FG001|STARTED|Overall Study||117
3099897|NCT01493089|3822891|FG000|COMPLETED|Overall Study||119
3099898|NCT01493089|3822892|FG001|COMPLETED|Overall Study||114
3099899|NCT01493089|3822891|FG000|NOT COMPLETED|Overall Study||3
3099900|NCT01493089|3822892|FG001|NOT COMPLETED|Overall Study||3
3099901|NCT01493167|3822900|FG000|STARTED|Overall Study||97
3099902|NCT01493167|3822900|FG000|COMPLETED|Overall Study||97
3099903|NCT01493167|3822900|FG000|NOT COMPLETED|Overall Study||0
3099904|NCT01493180|3822906|FG000|STARTED|Overall Study||51
3099905|NCT01493180|3822907|FG001|STARTED|Overall Study||51
3099906|NCT01493180|3822906|FG000|COMPLETED|Overall Study||48
3099907|NCT01493180|3822907|FG001|COMPLETED|Overall Study||49
3099908|NCT01493180|3822906|FG000|NOT COMPLETED|Overall Study||3
3099909|NCT01493180|3822907|FG001|NOT COMPLETED|Overall Study||2
3099910|NCT01493284|3822913|FG000|STARTED|Overall Study||222
3099911|NCT01493284|3822913|FG000|COMPLETED|Overall Study||161
3099912|NCT01493284|3822913|FG000|NOT COMPLETED|Overall Study||61
3099913|NCT01493414|3822917|FG000|STARTED|Overall Study||2233
3099914|NCT01493414|3822917|FG000|COMPLETED|Overall Study||1283
3099915|NCT01493414|3822917|FG000|NOT COMPLETED|Overall Study||950
3099916|NCT01493427|3822925|FG000|STARTED|Overall Study||199
3099917|NCT01493427|3822925|FG000|COMPLETED|Overall Study||179
3099918|NCT01493427|3822925|FG000|NOT COMPLETED|Overall Study||20
3099919|NCT01493531|3822932|FG000|STARTED|Overall Study||204
3099920|NCT01493531|3822933|FG001|STARTED|Overall Study||200
3099921|NCT01493531|3822934|FG002|STARTED|Overall Study||206
3099922|NCT01493531|3822932|FG000|COMPLETED|Overall Study||163
3099923|NCT01493531|3822933|FG001|COMPLETED|Overall Study||150
3099924|NCT01493531|3822934|FG002|COMPLETED|Overall Study||158
3099925|NCT01493531|3822932|FG000|NOT COMPLETED|Overall Study||41
3099926|NCT01493531|3822933|FG001|NOT COMPLETED|Overall Study||50
3099927|NCT01493531|3822934|FG002|NOT COMPLETED|Overall Study||48
3099928|NCT01493557|3822945|FG000|STARTED|Not Randomized to Management Strategies||0
3099929|NCT01493557|3822946|FG001|STARTED|Not Randomized to Management Strategies||0
3099930|NCT01493557|3822947|FG002|STARTED|Not Randomized to Management Strategies||950
3099931|NCT01493557|3822945|FG000|Without Experiencing GIS|Not Randomized to Management Strategies||0
3099932|NCT01493557|3822946|FG001|Without Experiencing GIS|Not Randomized to Management Strategies||0
3099933|NCT01493557|3822947|FG002|Without Experiencing GIS|Not Randomized to Management Strategies|754 patients completed the trial.|854
3099934|NCT01493557|3822945|FG000|Reported GIS Prior to EOT Visit|Not Randomized to Management Strategies||0
3099935|NCT01493557|3822946|FG001|Reported GIS Prior to EOT Visit|Not Randomized to Management Strategies||0
3099936|NCT01493557|3822947|FG002|Reported GIS Prior to EOT Visit|Not Randomized to Management Strategies|32 patients completed the trial.|48
3099937|NCT01493557|3822945|FG000|Reported GIS Only at EOT Visit|Not Randomized to Management Strategies||0
3099938|NCT01493557|3822946|FG001|Reported GIS Only at EOT Visit|Not Randomized to Management Strategies||0
3099939|NCT01493557|3822947|FG002|Reported GIS Only at EOT Visit|Not Randomized to Management Strategies|26 patients completed (GIS resolved ) and 4 patients completed (GIS not resolved ) the trial.|48
3099940|NCT01493557|3822945|FG000|COMPLETED|Not Randomized to Management Strategies||0
3099941|NCT01493557|3822946|FG001|COMPLETED|Not Randomized to Management Strategies||0
3099942|NCT01493557|3822947|FG002|COMPLETED|Not Randomized to Management Strategies||816
3099943|NCT01493557|3822945|FG000|NOT COMPLETED|Not Randomized to Management Strategies||0
3099944|NCT01493557|3822946|FG001|NOT COMPLETED|Not Randomized to Management Strategies||0
3099945|NCT01493557|3822947|FG002|NOT COMPLETED|Not Randomized to Management Strategies||134
3099946|NCT01493557|3822945|FG000|STARTED|Randomized to Management Strategies||59
3099947|NCT01493557|3822946|FG001|STARTED|Randomized to Management Strategies||58
3099948|NCT01493557|3822947|FG002|STARTED|Randomized to Management Strategies||0
3099949|NCT01493557|3822945|FG000|COMPLETED|Randomized to Management Strategies||44
3099950|NCT01493557|3822946|FG001|COMPLETED|Randomized to Management Strategies||47
3099951|NCT01493557|3822947|FG002|COMPLETED|Randomized to Management Strategies||0
3099952|NCT01493557|3822945|FG000|NOT COMPLETED|Randomized to Management Strategies||15
3099953|NCT01493557|3822946|FG001|NOT COMPLETED|Randomized to Management Strategies||11
3099954|NCT01493557|3822947|FG002|NOT COMPLETED|Randomized to Management Strategies||0
3099955|NCT01493557|3822945|FG000|STARTED|Adding the Second Strategy||14
3099956|NCT01493557|3822946|FG001|STARTED|Adding the Second Strategy||15
3099957|NCT01493557|3822947|FG002|STARTED|Adding the Second Strategy||0
3099958|NCT01493557|3822945|FG000|COMPLETED|Adding the Second Strategy||12
3099959|NCT01493557|3822946|FG001|COMPLETED|Adding the Second Strategy||11
3099960|NCT01493557|3822947|FG002|COMPLETED|Adding the Second Strategy||0
3099961|NCT01493557|3822945|FG000|NOT COMPLETED|Adding the Second Strategy||2
3099962|NCT01493557|3822946|FG001|NOT COMPLETED|Adding the Second Strategy||4
3099963|NCT01493557|3822947|FG002|NOT COMPLETED|Adding the Second Strategy||0
3099964|NCT01493596|3822961|FG000|STARTED|Overall Study||8
3099965|NCT01493596|3822962|FG001|STARTED|Overall Study||8
3099966|NCT01493596|3822963|FG002|STARTED|Overall Study|Repeat of dose cohort because of incidences of hyperkalemia observed in cohort 2(a).|7
3099967|NCT01493596|3822964|FG003|STARTED|Overall Study||8
3099968|NCT01493596|3822965|FG004|STARTED|Overall Study||8
3099969|NCT01493596|3822966|FG005|STARTED|Overall Study||8
3099970|NCT01493596|3822967|FG006|STARTED|Overall Study||8
3099971|NCT01493596|3822961|FG000|COMPLETED|Overall Study||8
3099972|NCT01493596|3822962|FG001|COMPLETED|Overall Study||8
3099973|NCT01493596|3822963|FG002|COMPLETED|Overall Study||7
3099974|NCT01493596|3822964|FG003|COMPLETED|Overall Study||8
3099975|NCT01493596|3822965|FG004|COMPLETED|Overall Study||8
3099976|NCT01493596|3822966|FG005|COMPLETED|Overall Study||8
3099977|NCT01493596|3822967|FG006|COMPLETED|Overall Study||8
3099978|NCT01493596|3822961|FG000|NOT COMPLETED|Overall Study||0
3099979|NCT01493596|3822962|FG001|NOT COMPLETED|Overall Study||0
3099980|NCT01493596|3822963|FG002|NOT COMPLETED|Overall Study||0
3099981|NCT01493596|3822964|FG003|NOT COMPLETED|Overall Study||0
3099982|NCT01493596|3822965|FG004|NOT COMPLETED|Overall Study||0
3099983|NCT01493596|3822966|FG005|NOT COMPLETED|Overall Study||0
3099984|NCT01493596|3822967|FG006|NOT COMPLETED|Overall Study||0
3099985|NCT01493687|3822983|FG000|STARTED|Part A Vehicle Control (12 Weeks)||451
3099986|NCT01493687|3822984|FG001|STARTED|Part A Vehicle Control (12 Weeks)||232
3099987|NCT01493687|3822983|FG000|COMPLETED|Part A Vehicle Control (12 Weeks)||414
3099988|NCT01493687|3822984|FG001|COMPLETED|Part A Vehicle Control (12 Weeks)||210
3099989|NCT01493687|3822983|FG000|NOT COMPLETED|Part A Vehicle Control (12 Weeks)||37
3099990|NCT01493687|3822984|FG001|NOT COMPLETED|Part A Vehicle Control (12 Weeks)||22
3099991|NCT01493687|3822983|FG000|STARTED|Part B Long Term Active Control 40 Weeks|414 completed Part A. Then 2 discontinued (lack of efficacy, subject request) prior to Part B.|412
3099992|NCT01493687|3822984|FG001|STARTED|Part B Long Term Active Control 40 Weeks||210
3099993|NCT01493687|3822983|FG000|COMPLETED|Part B Long Term Active Control 40 Weeks||351
3099994|NCT01493687|3822984|FG001|COMPLETED|Part B Long Term Active Control 40 Weeks||175
3099995|NCT01493687|3822983|FG000|NOT COMPLETED|Part B Long Term Active Control 40 Weeks||61
3099996|NCT01493687|3822984|FG001|NOT COMPLETED|Part B Long Term Active Control 40 Weeks||35
3099997|NCT01493687|3822983|FG000|STARTED|Part C Safety Follow up (4 Weeks)|351 completed Part B. Then 1 discontinued (subject request) prior to Part C.|350
3099998|NCT01493687|3822984|FG001|STARTED|Part C Safety Follow up (4 Weeks)||175
3099999|NCT01493687|3822983|FG000|COMPLETED|Part C Safety Follow up (4 Weeks)||350
3100000|NCT01493687|3822984|FG001|COMPLETED|Part C Safety Follow up (4 Weeks)||174
3100001|NCT01493687|3822983|FG000|NOT COMPLETED|Part C Safety Follow up (4 Weeks)||0
3100002|NCT01493687|3822984|FG001|NOT COMPLETED|Part C Safety Follow up (4 Weeks)||1
3100003|NCT01493778|3822996|FG000|STARTED|Overall Study||60
3100004|NCT01493778|3822996|FG000|COMPLETED|Overall Study||52
3100005|NCT01493778|3822996|FG000|NOT COMPLETED|Overall Study||8
3100006|NCT01493947|3823011|FG000|STARTED|Period A Efficacy and Safety Data||478
3100007|NCT01493947|3823012|FG001|STARTED|Period A Efficacy and Safety Data||484
3100008|NCT01493947|3823011|FG000|COMPLETED|Period A Efficacy and Safety Data||446
3100009|NCT01493947|3823012|FG001|COMPLETED|Period A Efficacy and Safety Data||456
3100010|NCT01493947|3823011|FG000|NOT COMPLETED|Period A Efficacy and Safety Data||32
3100011|NCT01493947|3823012|FG001|NOT COMPLETED|Period A Efficacy and Safety Data||28
3100012|NCT01493947|3823011|FG000|STARTED|Period B Extension Period|Only 399 /446 subjects were eligible to enter in Period B (i.e IGA=0 or1 at end of Period A).|399
3100013|NCT01493947|3823012|FG001|STARTED|Period B Extension Period|358 / 456 subjects were eligible to enter in Period B (i.e IGA =0 or 1 at end of Period A).|358
3100014|NCT01493947|3823011|FG000|COMPLETED|Period B Extension Period||366
3100015|NCT01493947|3823012|FG001|COMPLETED|Period B Extension Period||326
3100016|NCT01493947|3823011|FG000|NOT COMPLETED|Period B Extension Period||33
3100017|NCT01493947|3823012|FG001|NOT COMPLETED|Period B Extension Period||32
3100018|NCT01493960|3823023|FG000|STARTED|Overall Study||87
3100019|NCT01493960|3823024|FG001|STARTED|Overall Study||44
3100020|NCT01493960|3823023|FG000|Received Study Drug|Overall Study||87
3100021|NCT01493960|3823024|FG001|Received Study Drug|Overall Study||43
3100022|NCT01493960|3823023|FG000|COMPLETED|Overall Study||55
3100023|NCT01493960|3823024|FG001|COMPLETED|Overall Study||26
3100024|NCT01493960|3823023|FG000|NOT COMPLETED|Overall Study||32
3100025|NCT01493960|3823024|FG001|NOT COMPLETED|Overall Study||18
3100026|NCT01494038|3823032|FG000|STARTED|Overall Study||477
3100027|NCT01494038|3823033|FG001|STARTED|Overall Study||479
3100028|NCT01494038|3823032|FG000|COMPLETED|Overall Study||389
3100029|NCT01494038|3823033|FG001|COMPLETED|Overall Study||396
3100030|NCT01494038|3823032|FG000|NOT COMPLETED|Overall Study||88
3100031|NCT01494038|3823033|FG001|NOT COMPLETED|Overall Study||83
3100032|NCT01494051|3823056|FG000|STARTED|Overall Study||6
3100033|NCT01494051|3823057|FG001|STARTED|Overall Study||7
3100034|NCT01494051|3823056|FG000|COMPLETED|Overall Study||6
3100035|NCT01494051|3823057|FG001|COMPLETED|Overall Study||7
3100036|NCT01494051|3823056|FG000|NOT COMPLETED|Overall Study||0
3100037|NCT01494051|3823057|FG001|NOT COMPLETED|Overall Study||0
3100038|NCT01494298|3823065|FG000|STARTED|Overall Study||56
3100039|NCT01494298|3823066|FG001|STARTED|Overall Study||55
3100040|NCT01494298|3823065|FG000|COMPLETED|Overall Study||54
3100041|NCT01494298|3823066|FG001|COMPLETED|Overall Study||47
3100042|NCT01494298|3823065|FG000|NOT COMPLETED|Overall Study||2
3100043|NCT01494298|3823066|FG001|NOT COMPLETED|Overall Study||8
3100044|NCT01494350|3823074|FG000|STARTED|Overall Study||50
3100045|NCT01494350|3823074|FG000|COMPLETED|Overall Study||49
3100046|NCT01494350|3823074|FG000|NOT COMPLETED|Overall Study||1
3100047|NCT01494467|3823080|FG000|STARTED|Part A Vehicle Control (12 Weeks)||459
3100048|NCT01494467|3823081|FG001|STARTED|Part A Vehicle Control (12 Weeks)||229
3100049|NCT01494467|3823080|FG000|COMPLETED|Part A Vehicle Control (12 Weeks)||429
3100050|NCT01494467|3823081|FG001|COMPLETED|Part A Vehicle Control (12 Weeks)||208
3100051|NCT01494467|3823080|FG000|NOT COMPLETED|Part A Vehicle Control (12 Weeks)||30
3100052|NCT01494467|3823081|FG001|NOT COMPLETED|Part A Vehicle Control (12 Weeks)||21
3100053|NCT01494467|3823080|FG000|STARTED|Part B Long Term Active Control 40 Weeks|429 completed Part A. Subsequently, one subject discontinued so only 428 entered Part B|428
3100054|NCT01494467|3823081|FG001|STARTED|Part B Long Term Active Control 40 Weeks||208
3100055|NCT01494467|3823080|FG000|COMPLETED|Part B Long Term Active Control 40 Weeks||353
3100056|NCT01494467|3823081|FG001|COMPLETED|Part B Long Term Active Control 40 Weeks||159
3100057|NCT01494467|3823080|FG000|NOT COMPLETED|Part B Long Term Active Control 40 Weeks||75
3100058|NCT01494467|3823081|FG001|NOT COMPLETED|Part B Long Term Active Control 40 Weeks||49
3100059|NCT01494467|3823080|FG000|STARTED|Part C Safety Follow up (4 Weeks)||353
3100060|NCT01494467|3823081|FG001|STARTED|Part C Safety Follow up (4 Weeks)||159
3100061|NCT01494467|3823080|FG000|COMPLETED|Part C Safety Follow up (4 Weeks)||353
3100062|NCT01494467|3823081|FG001|COMPLETED|Part C Safety Follow up (4 Weeks)||159
3100063|NCT01494467|3823080|FG000|NOT COMPLETED|Part C Safety Follow up (4 Weeks)||0
3100064|NCT01494467|3823081|FG001|NOT COMPLETED|Part C Safety Follow up (4 Weeks)||0
3100065|NCT01494506|3823096|FG000|STARTED|Overall Study|Started = Intent to Treat Population and includes all randomized participants|151
3100066|NCT01494506|3823097|FG001|STARTED|Overall Study||149
3100067|NCT01494506|3823098|FG002|STARTED|Overall Study||117
3100068|NCT01494506|3823096|FG000|Treated Population|Overall Study|Treated population: Patients who received at least 1 dose of study drug.|147
3100069|NCT01494506|3823097|FG001|Treated Population|Overall Study||134
3100070|NCT01494506|3823098|FG002|Treated Population|Overall Study|2 randomized Arm C patients did not receive study drug. 1 patient each in A and B received Arm C.|117
3100071|NCT01494506|3823096|FG000|COMPLETED|Overall Study|Completed = Subjects remaining on treatment at the time of the primary analysis data cut off.|3
3100072|NCT01494506|3823097|FG001|COMPLETED|Overall Study||6
3100073|NCT01494506|3823098|FG002|COMPLETED|Overall Study||14
3100074|NCT01494506|3823096|FG000|NOT COMPLETED|Overall Study||148
3100075|NCT01494506|3823097|FG001|NOT COMPLETED|Overall Study||143
3100076|NCT01494506|3823098|FG002|NOT COMPLETED|Overall Study||103
3100077|NCT01494532|3823114|FG000|STARTED|Overall Study||75
3100078|NCT01494532|3823115|FG001|STARTED|Overall Study||25
3100079|NCT01494532|3823116|FG002|STARTED|Overall Study||76
3100080|NCT01494532|3823117|FG003|STARTED|Overall Study||75
3100081|NCT01494532|3823118|FG004|STARTED|Overall Study||76
3100082|NCT01494532|3823119|FG005|STARTED|Overall Study||25
3100083|NCT01494532|3823114|FG000|COMPLETED|Overall Study||65
3100084|NCT01494532|3823115|FG001|COMPLETED|Overall Study||21
3100085|NCT01494532|3823116|FG002|COMPLETED|Overall Study||59
3100086|NCT01494532|3823117|FG003|COMPLETED|Overall Study||60
3100087|NCT01494532|3823118|FG004|COMPLETED|Overall Study||64
3100088|NCT01494532|3823119|FG005|COMPLETED|Overall Study||25
3100089|NCT01494532|3823114|FG000|NOT COMPLETED|Overall Study||10
3100090|NCT01494532|3823115|FG001|NOT COMPLETED|Overall Study||4
3100091|NCT01494532|3823116|FG002|NOT COMPLETED|Overall Study||17
3100092|NCT01494532|3823117|FG003|NOT COMPLETED|Overall Study||15
3100093|NCT01494532|3823118|FG004|NOT COMPLETED|Overall Study||12
3100094|NCT01494532|3823119|FG005|NOT COMPLETED|Overall Study||0
3100095|NCT01494545|3823134|FG000|STARTED|Overall Study||102
3100096|NCT01494545|3823134|FG000|COMPLETED|Overall Study||92
3100097|NCT01494545|3823134|FG000|NOT COMPLETED|Overall Study||10
3100098|NCT01494584|3823141|FG000|STARTED|Overall Study||5
3100099|NCT01494584|3823141|FG000|COMPLETED|Overall Study||4
3100100|NCT01494584|3823141|FG000|NOT COMPLETED|Overall Study||1
3100101|NCT01494610|3823164|FG000|STARTED|Period 1||31
3100102|NCT01494610|3823165|FG001|STARTED|Period 1||29
3100103|NCT01494610|3823164|FG000|COMPLETED|Period 1||30
3100104|NCT01494610|3823165|FG001|COMPLETED|Period 1||28
3100105|NCT01494610|3823164|FG000|NOT COMPLETED|Period 1||1
3100106|NCT01494610|3823165|FG001|NOT COMPLETED|Period 1||1
3100107|NCT01494610|3823164|FG000|STARTED|Period 2||30
3100108|NCT01494610|3823165|FG001|STARTED|Period 2||28
3100109|NCT01494610|3823164|FG000|COMPLETED|Period 2||30
3100110|NCT01494610|3823165|FG001|COMPLETED|Period 2||28
3100111|NCT01494610|3823164|FG000|NOT COMPLETED|Period 2||0
3100112|NCT01494610|3823165|FG001|NOT COMPLETED|Period 2||0
3100113|NCT01494610|3823164|FG000|STARTED|Period 3||30
3100114|NCT01494610|3823165|FG001|STARTED|Period 3||28
3100115|NCT01494610|3823164|FG000|COMPLETED|Period 3||28
3100116|NCT01494610|3823165|FG001|COMPLETED|Period 3||28
3100117|NCT01494610|3823164|FG000|NOT COMPLETED|Period 3||2
3100118|NCT01494610|3823165|FG001|NOT COMPLETED|Period 3||0
3100119|NCT01494610|3823164|FG000|STARTED|Period 4||28
3100120|NCT01494610|3823165|FG001|STARTED|Period 4||28
3100121|NCT01494610|3823164|FG000|COMPLETED|Period 4||27
3100122|NCT01494610|3823165|FG001|COMPLETED|Period 4||28
3100123|NCT01494610|3823164|FG000|NOT COMPLETED|Period 4||1
3100124|NCT01494610|3823165|FG001|NOT COMPLETED|Period 4||0
3100125|NCT01494649|3823179|FG000|STARTED|Overall Study||59
3100126|NCT01494649|3823180|FG001|STARTED|Overall Study||59
3100127|NCT01494649|3823179|FG000|COMPLETED|Overall Study||59
3290627|NCT02833844|4024644|FG000|Randomized and Treated|Double-Blind Period||157
3290628|NCT02833844|4024645|FG001|Randomized and Treated|Double-Blind Period||307
3290629|NCT02833844|4024644|FG000|COMPLETED|Double-Blind Period|completed double-blind period|155
3290630|NCT02833844|4024645|FG001|COMPLETED|Double-Blind Period|completed double-blind period|303
3290631|NCT02833844|4024644|FG000|NOT COMPLETED|Double-Blind Period||2
3290632|NCT02833844|4024645|FG001|NOT COMPLETED|Double-Blind Period||7
3290633|NCT02833844|4024644|FG000|STARTED|Open-Label Period|3 participants did not continue to open-label period|152
3290634|NCT02833844|4024645|FG001|STARTED|Open-Label Period||303
3290635|NCT02833844|4024644|FG000|Received Open-Label Study Drug|Open-Label Period||152
3290636|NCT02833844|4024645|FG001|Received Open-Label Study Drug|Open-Label Period||299
3290637|NCT02833844|4024644|FG000|COMPLETED|Open-Label Period||150
3290638|NCT02833844|4024645|FG001|COMPLETED|Open-Label Period||301
3290639|NCT02833844|4024644|FG000|NOT COMPLETED|Open-Label Period||2
3290640|NCT02833844|4024645|FG001|NOT COMPLETED|Open-Label Period||2
3290641|NCT02833857|4024653|FG000|STARTED|Overall Study||11
3290642|NCT02833857|4024653|FG000|COMPLETED|Overall Study||11
3290643|NCT02833857|4024653|FG000|NOT COMPLETED|Overall Study||0
3290644|NCT02833922|4024657|FG000|STARTED|Overall Study||718
3290645|NCT02833922|4024657|FG000|COMPLETED|Overall Study||336
3290646|NCT02833922|4024657|FG000|NOT COMPLETED|Overall Study||382
3290647|NCT02833948|4024663|FG000|STARTED|Overall Study||116
3290648|NCT02833948|4024664|FG001|STARTED|Overall Study||115
3290649|NCT02833948|4024663|FG000|COMPLETED|Overall Study||101
3290650|NCT02833948|4024664|FG001|COMPLETED|Overall Study||97
3290651|NCT02833948|4024663|FG000|NOT COMPLETED|Overall Study||15
3290652|NCT02833948|4024664|FG001|NOT COMPLETED|Overall Study||18
3290653|NCT02833974|4024676|FG000|STARTED|Overall Study||14
3290654|NCT02833974|4024677|FG001|STARTED|Overall Study||22
3290655|NCT02833974|4024676|FG000|COMPLETED|Overall Study||13
3290656|NCT02833974|4024677|FG001|COMPLETED|Overall Study||19
3290657|NCT02833974|4024676|FG000|NOT COMPLETED|Overall Study||1
3290658|NCT02833974|4024677|FG001|NOT COMPLETED|Overall Study||3
3290659|NCT02834247|4024687|FG000|STARTED|Dose Escalation Phase||8
3290660|NCT02834247|4024688|FG001|STARTED|Dose Escalation Phase||11
3290661|NCT02834247|4024689|FG002|STARTED|Dose Escalation Phase||5
3290662|NCT02834247|4024690|FG003|STARTED|Dose Escalation Phase||0
3290663|NCT02834247|4024687|FG000|COMPLETED|Dose Escalation Phase||0
3290664|NCT02834247|4024688|FG001|COMPLETED|Dose Escalation Phase||0
3290665|NCT02834247|4024689|FG002|COMPLETED|Dose Escalation Phase||0
3290666|NCT02834247|4024690|FG003|COMPLETED|Dose Escalation Phase||0
3290667|NCT02834247|4024687|FG000|NOT COMPLETED|Dose Escalation Phase||8
3290668|NCT02834247|4024688|FG001|NOT COMPLETED|Dose Escalation Phase||11
3290669|NCT02834247|4024689|FG002|NOT COMPLETED|Dose Escalation Phase||5
3290670|NCT02834247|4024690|FG003|NOT COMPLETED|Dose Escalation Phase||0
3290671|NCT02834247|4024687|FG000|STARTED|Dose Expansion Phase||0
3290672|NCT02834247|4024688|FG001|STARTED|Dose Expansion Phase||0
3290673|NCT02834247|4024689|FG002|STARTED|Dose Expansion Phase||0
3290674|NCT02834247|4024690|FG003|STARTED|Dose Expansion Phase||17
3290675|NCT02834247|4024687|FG000|COMPLETED|Dose Expansion Phase||0
3290676|NCT02834247|4024688|FG001|COMPLETED|Dose Expansion Phase||0
3290677|NCT02834247|4024689|FG002|COMPLETED|Dose Expansion Phase||0
3290678|NCT02834247|4024690|FG003|COMPLETED|Dose Expansion Phase||0
3290679|NCT02834247|4024687|FG000|NOT COMPLETED|Dose Expansion Phase||0
3290680|NCT02834247|4024688|FG001|NOT COMPLETED|Dose Expansion Phase||0
3290681|NCT02834247|4024689|FG002|NOT COMPLETED|Dose Expansion Phase||0
3290682|NCT02834247|4024690|FG003|NOT COMPLETED|Dose Expansion Phase||17
3290683|NCT02834390|4024704|FG000|STARTED|Induction Phase||4
3290684|NCT02834390|4024705|FG001|STARTED|Induction Phase||3
3100128|NCT01494649|3823180|FG001|COMPLETED|Overall Study||58
3100129|NCT01494649|3823179|FG000|NOT COMPLETED|Overall Study||0
3100130|NCT01494649|3823180|FG001|NOT COMPLETED|Overall Study||1
3100131|NCT01494753|3823190|FG000|STARTED|Day0-Day42||15
3100132|NCT01494753|3823191|FG001|STARTED|Day0-Day42||15
3100133|NCT01494753|3823190|FG000|COMPLETED|Day0-Day42||15
3100134|NCT01494753|3823191|FG001|COMPLETED|Day0-Day42||15
3100135|NCT01494753|3823190|FG000|NOT COMPLETED|Day0-Day42||0
3100136|NCT01494753|3823191|FG001|NOT COMPLETED|Day0-Day42||0
3100137|NCT01494753|3823190|FG000|STARTED|Day42-Day84||15
3100138|NCT01494753|3823191|FG001|STARTED|Day42-Day84||15
3100139|NCT01494753|3823190|FG000|COMPLETED|Day42-Day84||15
3100140|NCT01494753|3823191|FG001|COMPLETED|Day42-Day84||15
3100141|NCT01494753|3823190|FG000|NOT COMPLETED|Day42-Day84||0
3100142|NCT01494753|3823191|FG001|NOT COMPLETED|Day42-Day84||0
3100143|NCT01494818|3823199|FG000|STARTED|Overall Study||39
3100144|NCT01494818|3823200|FG001|STARTED|Overall Study||39
3100145|NCT01494818|3823199|FG000|COMPLETED|Overall Study||37
3100146|NCT01494818|3823200|FG001|COMPLETED|Overall Study||37
3100147|NCT01494818|3823199|FG000|NOT COMPLETED|Overall Study||2
3100148|NCT01494818|3823200|FG001|NOT COMPLETED|Overall Study||2
3100149|NCT01494922|3823206|FG000|STARTED|Overall Study||14
3100150|NCT01494922|3823206|FG000|COMPLETED|Overall Study||13
3100151|NCT01494922|3823206|FG000|NOT COMPLETED|Overall Study||1
3100152|NCT01494987|3823212|FG000|STARTED|Overall Study||216
3100153|NCT01494987|3823213|FG001|STARTED|Overall Study||215
3100154|NCT01494987|3823212|FG000|COMPLETED|Overall Study||188
3100155|NCT01494987|3823213|FG001|COMPLETED|Overall Study||187
3100156|NCT01494987|3823212|FG000|NOT COMPLETED|Overall Study||28
3100157|NCT01494987|3823213|FG001|NOT COMPLETED|Overall Study||28
3100158|NCT01495000|3823221|FG000|STARTED|Overall Study||124
3100159|NCT01495000|3823222|FG001|STARTED|Overall Study||126
3100160|NCT01495000|3823221|FG000|COMPLETED|Overall Study||111
3100161|NCT01495000|3823222|FG001|COMPLETED|Overall Study||114
3100162|NCT01495000|3823221|FG000|NOT COMPLETED|Overall Study||13
3100163|NCT01495000|3823222|FG001|NOT COMPLETED|Overall Study||12
3100164|NCT01495221|3823228|FG000|STARTED|Overall Study|First Patient enrolled December 2011.|9
3100165|NCT01495221|3823228|FG000|COMPLETED|Overall Study|Last patient enrolled May 2012.|9
3100166|NCT01495221|3823228|FG000|NOT COMPLETED|Overall Study||0
3100167|NCT01495286|3823232|FG000|STARTED|Overall Study||30
3100168|NCT01495286|3823232|FG000|COMPLETED|Overall Study||30
3100169|NCT01495286|3823232|FG000|NOT COMPLETED|Overall Study||0
3100170|NCT01495481|3823236|FG000|STARTED|Adenosine|Patients first received adenosine and then dexmedetomidine.|22
3100171|NCT01495481|3823236|FG000|COMPLETED|Adenosine||22
3100172|NCT01495481|3823236|FG000|NOT COMPLETED|Adenosine||0
3100173|NCT01495481|3823236|FG000|STARTED|Washout||22
3100174|NCT01495481|3823236|FG000|COMPLETED|Washout||22
3100175|NCT01495481|3823236|FG000|NOT COMPLETED|Washout||0
3100176|NCT01495481|3823236|FG000|STARTED|Dexmedetomidine||22
3100177|NCT01495481|3823236|FG000|COMPLETED|Dexmedetomidine||22
3100178|NCT01495481|3823236|FG000|NOT COMPLETED|Dexmedetomidine||0
3100179|NCT01495572|3823246|FG000|STARTED|Overall Study||0
3100180|NCT01495572|3823247|FG001|STARTED|Overall Study||5
3100181|NCT01495572|3823246|FG000|COMPLETED|Overall Study||0
3100182|NCT01495572|3823247|FG001|COMPLETED|Overall Study||5
3100183|NCT01495572|3823246|FG000|NOT COMPLETED|Overall Study||0
3100184|NCT01495572|3823247|FG001|NOT COMPLETED|Overall Study||0
3100185|NCT01495585|3823257|FG000|STARTED|Overall Study||4
3100186|NCT01495585|3823258|FG001|STARTED|Overall Study||6
3100187|NCT01495585|3823259|FG002|STARTED|Overall Study||4
3100188|NCT01495585|3823257|FG000|Open Label Lonafarnib 200 mg|Overall Study||2
3100189|NCT01495585|3823258|FG001|Open Label Lonafarnib 200 mg|Overall Study||0
3100190|NCT01495585|3823259|FG002|Open Label Lonafarnib 200 mg|Overall Study||0
3100191|NCT01495585|3823257|FG000|COMPLETED|Overall Study||4
3100192|NCT01495585|3823258|FG001|COMPLETED|Overall Study||6
3100193|NCT01495585|3823259|FG002|COMPLETED|Overall Study||4
3100194|NCT01495585|3823257|FG000|NOT COMPLETED|Overall Study||0
3100195|NCT01495585|3823258|FG001|NOT COMPLETED|Overall Study||0
3100196|NCT01495585|3823259|FG002|NOT COMPLETED|Overall Study||0
3100197|NCT01495689|3823269|FG000|STARTED|Overall Study||26
3100198|NCT01495689|3823270|FG001|STARTED|Overall Study||23
3100199|NCT01495689|3823269|FG000|COMPLETED|Overall Study||16
3100200|NCT01495689|3823270|FG001|COMPLETED|Overall Study||16
3100201|NCT01495689|3823269|FG000|NOT COMPLETED|Overall Study||10
3100202|NCT01495689|3823270|FG001|NOT COMPLETED|Overall Study||7
3100203|NCT01495702|3823278|FG000|STARTED|Randomized Phase||292
3100204|NCT01495702|3823279|FG001|STARTED|Randomized Phase||147
3100205|NCT01495702|3823278|FG000|COMPLETED|Randomized Phase||266
3100206|NCT01495702|3823279|FG001|COMPLETED|Randomized Phase||119
3100207|NCT01495702|3823278|FG000|NOT COMPLETED|Randomized Phase||26
3100208|NCT01495702|3823279|FG001|NOT COMPLETED|Randomized Phase||28
3100209|NCT01495702|3823278|FG000|STARTED|Extension Phase||26
3100210|NCT01495702|3823279|FG001|STARTED|Extension Phase||2
3100211|NCT01495702|3823278|FG000|COMPLETED|Extension Phase||26
3100212|NCT01495702|3823279|FG001|COMPLETED|Extension Phase||2
3100213|NCT01495702|3823278|FG000|NOT COMPLETED|Extension Phase||0
3100214|NCT01495702|3823279|FG001|NOT COMPLETED|Extension Phase||0
3100215|NCT01495793|3823286|FG000|STARTED|Overall Study||24
3100216|NCT01495793|3823286|FG000|COMPLETED|Overall Study||22
3100217|NCT01495793|3823286|FG000|NOT COMPLETED|Overall Study||2
3100218|NCT01495819|3823290|FG000|STARTED|Overall Study||34
3100219|NCT01495819|3823290|FG000|Nicotine 0.0125|Overall Study||31
3100220|NCT01495819|3823290|FG000|Nicotine 0.025|Overall Study||32
3100221|NCT01495819|3823290|FG000|Nicotine 0.05|Overall Study||33
3100222|NCT01495819|3823290|FG000|Nicotine 0.1|Overall Study||31
3100223|NCT01495819|3823290|FG000|NIcotine 0.2|Overall Study||33
3100224|NCT01495819|3823290|FG000|COMPLETED|Overall Study||30
3100225|NCT01495819|3823290|FG000|NOT COMPLETED|Overall Study||4
3100226|NCT01495858|3823302|FG000|STARTED|Overall Study||107
3100227|NCT01495858|3823303|FG001|STARTED|Overall Study||106
3100228|NCT01495858|3823304|FG002|STARTED|Overall Study||54
3100229|NCT01495858|3823302|FG000|COMPLETED|Overall Study||107
3100230|NCT01495858|3823303|FG001|COMPLETED|Overall Study||106
3100231|NCT01495858|3823304|FG002|COMPLETED|Overall Study||54
3100232|NCT01495858|3823302|FG000|NOT COMPLETED|Overall Study||0
3100233|NCT01495858|3823303|FG001|NOT COMPLETED|Overall Study||0
3100234|NCT01495858|3823304|FG002|NOT COMPLETED|Overall Study||0
3100235|NCT01495923|3823314|FG000|STARTED|Overall Study||73
3100236|NCT01495923|3823315|FG001|STARTED|Overall Study||72
3100237|NCT01495923|3823314|FG000|COMPLETED|Overall Study||73
3100238|NCT01495923|3823315|FG001|COMPLETED|Overall Study||72
3100239|NCT01495923|3823314|FG000|NOT COMPLETED|Overall Study||0
3100240|NCT01495923|3823315|FG001|NOT COMPLETED|Overall Study||0
3100241|NCT01495975|3823325|FG000|STARTED|Overall Study||15
3100242|NCT01495975|3823326|FG001|STARTED|Overall Study||14
3100243|NCT01495975|3823325|FG000|COMPLETED|Overall Study||14
3100244|NCT01495975|3823326|FG001|COMPLETED|Overall Study||14
3100245|NCT01495975|3823325|FG000|NOT COMPLETED|Overall Study||1
3100246|NCT01495975|3823326|FG001|NOT COMPLETED|Overall Study||0
3100247|NCT01496066|3823334|FG000|STARTED|Overall Study||403
3100248|NCT01496066|3823335|FG001|STARTED|Overall Study||197
3290685|NCT02834390|4024704|FG000|COMPLETED|Induction Phase||2
3290686|NCT02834390|4024705|FG001|COMPLETED|Induction Phase||1
3290687|NCT02834390|4024704|FG000|NOT COMPLETED|Induction Phase||2
3290688|NCT02834390|4024705|FG001|NOT COMPLETED|Induction Phase||2
3290689|NCT02834390|4024704|FG000|STARTED|Consolidation Phase||2
3290690|NCT02834390|4024705|FG001|STARTED|Consolidation Phase||1
3290691|NCT02834390|4024704|FG000|COMPLETED|Consolidation Phase||1
3290692|NCT02834390|4024705|FG001|COMPLETED|Consolidation Phase||0
3290693|NCT02834390|4024704|FG000|NOT COMPLETED|Consolidation Phase||1
3290694|NCT02834390|4024705|FG001|NOT COMPLETED|Consolidation Phase||1
3290695|NCT02834624|4024713|FG000|STARTED|Overall Study||15
3290696|NCT02834624|4024714|FG001|STARTED|Overall Study||15
3290697|NCT02834624|4024713|FG000|COMPLETED|Overall Study||15
3290698|NCT02834624|4024714|FG001|COMPLETED|Overall Study||15
3290699|NCT02834624|4024713|FG000|NOT COMPLETED|Overall Study||0
3290700|NCT02834624|4024714|FG001|NOT COMPLETED|Overall Study||0
3290701|NCT02834663|4024721|FG000|STARTED|Overall Study|Unit means the eye. One eye was included per patient|25
3290702|NCT02834663|4024721|FG000|COMPLETED|Overall Study|Unit means the eye. One eye was included per patient|25
3290703|NCT02834663|4024721|FG000|NOT COMPLETED|Overall Study||0
3290704|NCT02834806|4024739|FG000|STARTED|Overall Study||58
3290705|NCT02834806|4024739|FG000|COMPLETED|Overall Study||58
3290706|NCT02834806|4024739|FG000|NOT COMPLETED|Overall Study||0
3290707|NCT02834819|4024745|FG000|STARTED|Overall Study||9
3290708|NCT02834819|4024746|FG001|STARTED|Overall Study||9
3290709|NCT02834819|4024745|FG000|COMPLETED|Overall Study||4
3290710|NCT02834819|4024746|FG001|COMPLETED|Overall Study||9
3290711|NCT02834819|4024745|FG000|NOT COMPLETED|Overall Study||5
3290712|NCT02834819|4024746|FG001|NOT COMPLETED|Overall Study||0
3290713|NCT02835092|4024755|FG000|STARTED|Overall Study||66
3290714|NCT02835092|4024756|FG001|STARTED|Overall Study||65
3290715|NCT02835092|4024757|FG002|STARTED|Overall Study||67
3290716|NCT02835092|4024755|FG000|COMPLETED|Overall Study||63
3290717|NCT02835092|4024756|FG001|COMPLETED|Overall Study||57
3290718|NCT02835092|4024757|FG002|COMPLETED|Overall Study||64
3290719|NCT02835092|4024755|FG000|NOT COMPLETED|Overall Study||3
3290720|NCT02835092|4024756|FG001|NOT COMPLETED|Overall Study||8
3290721|NCT02835092|4024757|FG002|NOT COMPLETED|Overall Study||3
3290722|NCT02835274|4024767|FG000|STARTED|Overall Study||6
3290723|NCT02835274|4024768|FG001|STARTED|Overall Study||6
3290724|NCT02835274|4024767|FG000|COMPLETED|Overall Study||6
3290725|NCT02835274|4024768|FG001|COMPLETED|Overall Study||6
3290726|NCT02835274|4024767|FG000|NOT COMPLETED|Overall Study||0
3290727|NCT02835274|4024768|FG001|NOT COMPLETED|Overall Study||0
3290728|NCT02835339|4024776|FG000|STARTED|Overall Study||31
3290729|NCT02835339|4024777|FG001|STARTED|Overall Study||35
3290730|NCT02835339|4024776|FG000|COMPLETED|Overall Study||18
3290731|NCT02835339|4024777|FG001|COMPLETED|Overall Study||19
3290732|NCT02835339|4024776|FG000|NOT COMPLETED|Overall Study||13
3290733|NCT02835339|4024777|FG001|NOT COMPLETED|Overall Study||16
3290734|NCT02835495|4024785|FG000|STARTED|Overall Study|26 randomized, however, one had to withdraw pre-intervention initiation due to cancer diagnosis.|26
3290735|NCT02835495|4024786|FG001|STARTED|Overall Study||25
3290736|NCT02835495|4024785|FG000|Intervention Start|Overall Study||25
3290737|NCT02835495|4024786|FG001|Intervention Start|Overall Study||25
3290738|NCT02835495|4024785|FG000|COMPLETED|Overall Study||21
3290739|NCT02835495|4024786|FG001|COMPLETED|Overall Study||23
3290740|NCT02835495|4024785|FG000|NOT COMPLETED|Overall Study||5
3290741|NCT02835495|4024786|FG001|NOT COMPLETED|Overall Study||2
3290742|NCT02835625|4024796|FG000|STARTED|Overall Study||14734
3290743|NCT02835625|4024797|FG001|STARTED|Overall Study||14719
3290744|NCT02835625|4024796|FG000|COMPLETED|Overall Study||14734
3100249|NCT01496066|3823334|FG000|COMPLETED|Overall Study||391
3100250|NCT01496066|3823335|FG001|COMPLETED|Overall Study||188
3100251|NCT01496066|3823334|FG000|NOT COMPLETED|Overall Study||12
3100252|NCT01496066|3823335|FG001|NOT COMPLETED|Overall Study||9
3100253|NCT01496131|3823350|FG000|STARTED|Overall Study||14
3100254|NCT01496131|3823351|FG001|STARTED|Overall Study||14
3100255|NCT01496131|3823350|FG000|COMPLETED|Overall Study||14
3100256|NCT01496131|3823351|FG001|COMPLETED|Overall Study||14
3100257|NCT01496131|3823350|FG000|NOT COMPLETED|Overall Study||0
3100258|NCT01496131|3823351|FG001|NOT COMPLETED|Overall Study||0
3100259|NCT01496157|3823357|FG000|STARTED|Overall Study||13
3100260|NCT01496157|3823357|FG000|COMPLETED|Overall Study||13
3290745|NCT02835625|4024797|FG001|COMPLETED|Overall Study||14719
3290746|NCT02835625|4024796|FG000|NOT COMPLETED|Overall Study||0
3290747|NCT02835625|4024797|FG001|NOT COMPLETED|Overall Study||0
3290748|NCT02835677|4024804|FG000|STARTED|Overall Study||25
3290749|NCT02835677|4024804|FG000|COMPLETED|Overall Study||25
3290750|NCT02835677|4024804|FG000|NOT COMPLETED|Overall Study||0
3290751|NCT02835820|4024810|FG000|STARTED|Overall Study||7
3290752|NCT02835820|4024811|FG001|STARTED|Overall Study||10
3100261|NCT01496157|3823357|FG000|NOT COMPLETED|Overall Study||0
3100262|NCT01496183|3823363|FG000|STARTED|Overall Study||9
3100263|NCT01496183|3823364|FG001|STARTED|Overall Study||15
3100264|NCT01496183|3823363|FG000|COMPLETED|Overall Study||6
3100265|NCT01496183|3823364|FG001|COMPLETED|Overall Study||13
3100266|NCT01496183|3823363|FG000|NOT COMPLETED|Overall Study||3
3100267|NCT01496183|3823364|FG001|NOT COMPLETED|Overall Study||2
3100268|NCT01496248|3823371|FG000|STARTED|Overall Study||35
3100269|NCT01496248|3823371|FG000|COMPLETED|Overall Study||25
3100270|NCT01496248|3823371|FG000|NOT COMPLETED|Overall Study||10
3100271|NCT01496274|3823377|FG000|STARTED|Overall Study||40
3100272|NCT01496274|3823378|FG001|STARTED|Overall Study||23
3100273|NCT01496274|3823377|FG000|COMPLETED|Overall Study||37
3100274|NCT01496274|3823378|FG001|COMPLETED|Overall Study||18
3100275|NCT01496274|3823377|FG000|NOT COMPLETED|Overall Study||3
3100276|NCT01496274|3823378|FG001|NOT COMPLETED|Overall Study||5
3100277|NCT01496287|3823399|FG000|STARTED|Overall Study||70
3100278|NCT01496287|3823399|FG000|COMPLETED|Overall Study||64
3100279|NCT01496287|3823399|FG000|NOT COMPLETED|Overall Study||6
3290753|NCT02835820|4024810|FG000|Baseline Screen (OGTT)|Overall Study||7
3290754|NCT02835820|4024811|FG001|Baseline Screen (OGTT)|Overall Study||7
3290755|NCT02835820|4024810|FG000|COMPLETED|Overall Study||7
3290756|NCT02835820|4024811|FG001|COMPLETED|Overall Study||7
3290757|NCT02835820|4024810|FG000|NOT COMPLETED|Overall Study||0
3290758|NCT02835820|4024811|FG001|NOT COMPLETED|Overall Study||3
3290759|NCT02835846|4024817|FG000|STARTED|Overall Study||35
3290760|NCT02835846|4024817|FG000|COMPLETED|Overall Study||24
3290761|NCT02835846|4024817|FG000|NOT COMPLETED|Overall Study||11
3290762|NCT02836249|4024823|FG000|STARTED|Overall Study||123
3290763|NCT02836249|4024824|FG001|STARTED|Overall Study||58
3290764|NCT02836249|4024823|FG000|COMPLETED|Overall Study||0
3290765|NCT02836249|4024824|FG001|COMPLETED|Overall Study||0
3290766|NCT02836249|4024823|FG000|NOT COMPLETED|Overall Study||123
3290767|NCT02836249|4024824|FG001|NOT COMPLETED|Overall Study||58
3290768|NCT02836496|4024832|FG000|STARTED|Overall Study||54
3290769|NCT02836496|4024833|FG001|STARTED|Overall Study||54
3290770|NCT02836496|4024832|FG000|COMPLETED|Overall Study||52
3290771|NCT02836496|4024833|FG001|COMPLETED|Overall Study||52
3290772|NCT02836496|4024832|FG000|NOT COMPLETED|Overall Study||2
3290773|NCT02836496|4024833|FG001|NOT COMPLETED|Overall Study||2
3290774|NCT02836613|4024841|FG000|STARTED|Overall Study||80
3290775|NCT02836613|4024842|FG001|STARTED|Overall Study||80
3290776|NCT02836613|4024841|FG000|COMPLETED|Overall Study||79
3290777|NCT02836613|4024842|FG001|COMPLETED|Overall Study||77
3290778|NCT02836613|4024841|FG000|NOT COMPLETED|Overall Study||1
3290779|NCT02836613|4024842|FG001|NOT COMPLETED|Overall Study||3
3290780|NCT02836652|4024850|FG000|STARTED|Overall Study||35
3290781|NCT02836652|4024851|FG001|STARTED|Overall Study||37
3290782|NCT02836652|4024850|FG000|As-treated Population|Overall Study||31
3290783|NCT02836652|4024851|FG001|As-treated Population|Overall Study||34
3290784|NCT02836652|4024850|FG000|COMPLETED|Overall Study||17
3290785|NCT02836652|4024851|FG001|COMPLETED|Overall Study||18
3290786|NCT02836652|4024850|FG000|NOT COMPLETED|Overall Study||18
3290787|NCT02836652|4024851|FG001|NOT COMPLETED|Overall Study||19
3290788|NCT02836769|4024857|FG000|STARTED|Overall Study||35
3290789|NCT02836769|4024857|FG000|Received Intervention|Overall Study||30
3290790|NCT02836769|4024857|FG000|Completed Post-test Assessment|Overall Study||21
3290791|NCT02836769|4024857|FG000|COMPLETED|Overall Study||20
3290792|NCT02836769|4024857|FG000|NOT COMPLETED|Overall Study||15
3290793|NCT02836873|4024863|FG000|STARTED|Overall Study||157
3290794|NCT02836873|4024864|FG001|STARTED|Overall Study||155
3290795|NCT02836873|4024863|FG000|COMPLETED|Overall Study||152
3290796|NCT02836873|4024864|FG001|COMPLETED|Overall Study||144
3290797|NCT02836873|4024863|FG000|NOT COMPLETED|Overall Study||5
3290798|NCT02836873|4024864|FG001|NOT COMPLETED|Overall Study||11
3290799|NCT02836990|4024872|FG000|STARTED|Overall Study||50
3290800|NCT02836990|4024873|FG001|STARTED|Overall Study||55
3290801|NCT02836990|4024872|FG000|COMPLETED|Overall Study||50
3290802|NCT02836990|4024873|FG001|COMPLETED|Overall Study||55
3290803|NCT02836990|4024872|FG000|NOT COMPLETED|Overall Study||0
3290804|NCT02836990|4024873|FG001|NOT COMPLETED|Overall Study||0
3290805|NCT02837237|4024881|FG000|STARTED|Overall Study||11
3100280|NCT01496313|3823406|FG000|STARTED|Overall Study||40
3100281|NCT01496313|3823407|FG001|STARTED|Overall Study||41
3100282|NCT01496313|3823406|FG000|COMPLETED|Overall Study||35
3100283|NCT01496313|3823407|FG001|COMPLETED|Overall Study||26
3100284|NCT01496313|3823406|FG000|NOT COMPLETED|Overall Study||5
3100285|NCT01496313|3823407|FG001|NOT COMPLETED|Overall Study||15
3100286|NCT01496352|3823415|FG000|STARTED|Overall Study||24
3290806|NCT02837237|4024881|FG000|COMPLETED|Overall Study||11
3100287|NCT01496352|3823416|FG001|STARTED|Overall Study||6
3100288|NCT01496352|3823415|FG000|COMPLETED|Overall Study||24
3100289|NCT01496352|3823416|FG001|COMPLETED|Overall Study||6
3100290|NCT01496352|3823415|FG000|NOT COMPLETED|Overall Study||0
3100291|NCT01496352|3823416|FG001|NOT COMPLETED|Overall Study||0
3100292|NCT01496365|3823438|FG000|STARTED|Overall Study||112
3100293|NCT01496365|3823439|FG001|STARTED|Overall Study||56
3100294|NCT01496365|3823440|FG002|STARTED|Overall Study||57
3100295|NCT01496365|3823441|FG003|STARTED|Overall Study||57
3100296|NCT01496365|3823442|FG004|STARTED|Overall Study||57
3100297|NCT01496365|3823443|FG005|STARTED|Overall Study||56
3100298|NCT01496365|3823444|FG006|STARTED|Overall Study||57
3100299|NCT01496365|3823438|FG000|COMPLETED|Overall Study||97
3100300|NCT01496365|3823439|FG001|COMPLETED|Overall Study||41
3100301|NCT01496365|3823440|FG002|COMPLETED|Overall Study||51
3100302|NCT01496365|3823441|FG003|COMPLETED|Overall Study||53
3100303|NCT01496365|3823442|FG004|COMPLETED|Overall Study||44
3100304|NCT01496365|3823443|FG005|COMPLETED|Overall Study||46
3100305|NCT01496365|3823444|FG006|COMPLETED|Overall Study||51
3100306|NCT01496365|3823438|FG000|NOT COMPLETED|Overall Study||15
3100307|NCT01496365|3823439|FG001|NOT COMPLETED|Overall Study||15
3100308|NCT01496365|3823440|FG002|NOT COMPLETED|Overall Study||6
3100309|NCT01496365|3823441|FG003|NOT COMPLETED|Overall Study||4
3100310|NCT01496365|3823442|FG004|NOT COMPLETED|Overall Study||13
3100311|NCT01496365|3823443|FG005|NOT COMPLETED|Overall Study||10
3100312|NCT01496365|3823444|FG006|NOT COMPLETED|Overall Study||6
3100313|NCT01496430|3823463|FG000|STARTED|Overall Study||35
3100314|NCT01496430|3823464|FG001|STARTED|Overall Study||35
3100315|NCT01496430|3823465|FG002|STARTED|Overall Study||35
3100316|NCT01496430|3823463|FG000|COMPLETED|Overall Study||29
3100317|NCT01496430|3823464|FG001|COMPLETED|Overall Study||30
3100318|NCT01496430|3823465|FG002|COMPLETED|Overall Study||25
3100319|NCT01496430|3823463|FG000|NOT COMPLETED|Overall Study||6
3100320|NCT01496430|3823464|FG001|NOT COMPLETED|Overall Study||5
3100321|NCT01496430|3823465|FG002|NOT COMPLETED|Overall Study||10
3100322|NCT01496456|3823473|FG000|STARTED|Overall Study||17
3100323|NCT01496456|3823473|FG000|Baseline|Overall Study|Baseline group started with 16 patients.|16
3100324|NCT01496456|3823473|FG000|1-yr Recall|Overall Study||12
3100325|NCT01496456|3823473|FG000|2-yr Recall|Overall Study||10
3100326|NCT01496456|3823473|FG000|3-yr Final Recall|Overall Study||9
3100327|NCT01496456|3823473|FG000|COMPLETED|Overall Study||9
3100328|NCT01496456|3823473|FG000|NOT COMPLETED|Overall Study||8
3100329|NCT01496469|3823482|FG000|STARTED|Overall Study||60
3100330|NCT01496469|3823483|FG001|STARTED|Overall Study||61
3100331|NCT01496469|3823482|FG000|COMPLETED|Overall Study||50
3100332|NCT01496469|3823483|FG001|COMPLETED|Overall Study||53
3290807|NCT02837237|4024881|FG000|NOT COMPLETED|Overall Study||0
3290808|NCT02837328|4024887|FG000|STARTED|Overall Study||29
3290809|NCT02837328|4024888|FG001|STARTED|Overall Study||30
3290810|NCT02837328|4024887|FG000|COMPLETED|Overall Study||29
3290811|NCT02837328|4024888|FG001|COMPLETED|Overall Study||30
3290812|NCT02837328|4024887|FG000|NOT COMPLETED|Overall Study||0
3290813|NCT02837328|4024888|FG001|NOT COMPLETED|Overall Study||0
3290814|NCT02837731|4024896|FG000|STARTED|Allocation||102
3290815|NCT02837731|4024897|FG001|STARTED|Allocation||48
3290816|NCT02837731|4024896|FG000|COMPLETED|Allocation||83
3290817|NCT02837731|4024897|FG001|COMPLETED|Allocation||41
3290818|NCT02837731|4024896|FG000|NOT COMPLETED|Allocation||19
3290819|NCT02837731|4024897|FG001|NOT COMPLETED|Allocation||7
3290820|NCT02837731|4024896|FG000|STARTED|Follow-up||83
3290821|NCT02837731|4024897|FG001|STARTED|Follow-up||41
3290822|NCT02837731|4024896|FG000|COMPLETED|Follow-up||83
3290823|NCT02837731|4024897|FG001|COMPLETED|Follow-up||41
3290824|NCT02837731|4024896|FG000|NOT COMPLETED|Follow-up||0
3290825|NCT02837731|4024897|FG001|NOT COMPLETED|Follow-up||0
3290826|NCT02837731|4024896|FG000|STARTED|Analysis||83
3290827|NCT02837731|4024897|FG001|STARTED|Analysis||41
3290828|NCT02837731|4024896|FG000|COMPLETED|Analysis||83
3290829|NCT02837731|4024897|FG001|COMPLETED|Analysis||41
3290830|NCT02837731|4024896|FG000|NOT COMPLETED|Analysis||0
3290831|NCT02837731|4024897|FG001|NOT COMPLETED|Analysis||0
3290832|NCT02837744|4024903|FG000|STARTED|Overall Study||70
3100333|NCT01496469|3823482|FG000|NOT COMPLETED|Overall Study||10
3100334|NCT01496469|3823483|FG001|NOT COMPLETED|Overall Study||8
3100335|NCT01496612|3823489|FG000|STARTED|1st Intervention||3
3100336|NCT01496612|3823490|FG001|STARTED|1st Intervention||4
3100337|NCT01496612|3823489|FG000|COMPLETED|1st Intervention||1
3100338|NCT01496612|3823490|FG001|COMPLETED|1st Intervention||4
3100339|NCT01496612|3823489|FG000|NOT COMPLETED|1st Intervention||2
3100340|NCT01496612|3823490|FG001|NOT COMPLETED|1st Intervention||0
3100341|NCT01496612|3823489|FG000|STARTED|2nd Intervention||1
3100342|NCT01496612|3823490|FG001|STARTED|2nd Intervention||4
3100343|NCT01496612|3823489|FG000|COMPLETED|2nd Intervention||1
3100344|NCT01496612|3823490|FG001|COMPLETED|2nd Intervention||4
3100345|NCT01496612|3823489|FG000|NOT COMPLETED|2nd Intervention||0
3100346|NCT01496612|3823490|FG001|NOT COMPLETED|2nd Intervention||0
3100347|NCT01496807|3823498|FG000|STARTED|Overall Study||31
3100348|NCT01496807|3823498|FG000|COMPLETED|Overall Study||1
3290833|NCT02837744|4024903|FG000|COMPLETED|Overall Study||70
3290834|NCT02837744|4024903|FG000|NOT COMPLETED|Overall Study||0
3290835|NCT02837913|4024909|FG000|STARTED|Overall Study||10
3290836|NCT02837913|4024910|FG001|STARTED|Overall Study||9
3290837|NCT02837913|4024909|FG000|COMPLETED|Overall Study||10
3290838|NCT02837913|4024910|FG001|COMPLETED|Overall Study||9
3100349|NCT01496807|3823498|FG000|NOT COMPLETED|Overall Study||30
3100350|NCT01496846|3823508|FG000|STARTED|IANB Articaine (All Participants)||28
3100351|NCT01496846|3823509|FG001|STARTED|IANB Articaine (All Participants)||24
3100352|NCT01496846|3823510|FG002|STARTED|IANB Articaine (All Participants)||36
3100353|NCT01496846|3823511|FG003|STARTED|IANB Articaine (All Participants)||40
3100354|NCT01496846|3823512|FG004|STARTED|IANB Articaine (All Participants)||35
3100355|NCT01496846|3823513|FG005|STARTED|IANB Articaine (All Participants)||38
3100356|NCT01496846|3823508|FG000|COMPLETED|IANB Articaine (All Participants)||27
3100357|NCT01496846|3823509|FG001|COMPLETED|IANB Articaine (All Participants)||23
3100358|NCT01496846|3823510|FG002|COMPLETED|IANB Articaine (All Participants)||36
3100359|NCT01496846|3823511|FG003|COMPLETED|IANB Articaine (All Participants)||40
3100360|NCT01496846|3823512|FG004|COMPLETED|IANB Articaine (All Participants)||35
3100361|NCT01496846|3823513|FG005|COMPLETED|IANB Articaine (All Participants)||38
3100362|NCT01496846|3823508|FG000|NOT COMPLETED|IANB Articaine (All Participants)||1
3100363|NCT01496846|3823509|FG001|NOT COMPLETED|IANB Articaine (All Participants)||1
3100364|NCT01496846|3823510|FG002|NOT COMPLETED|IANB Articaine (All Participants)||0
3100365|NCT01496846|3823511|FG003|NOT COMPLETED|IANB Articaine (All Participants)||0
3100366|NCT01496846|3823512|FG004|NOT COMPLETED|IANB Articaine (All Participants)||0
3100367|NCT01496846|3823513|FG005|NOT COMPLETED|IANB Articaine (All Participants)||0
3100368|NCT01496846|3823508|FG000|STARTED|Supplemental Buccal Infiltration|No participants with successful IANB initially were brought forward to supplemental anesthetic|0
3100369|NCT01496846|3823509|FG001|STARTED|Supplemental Buccal Infiltration|No participants with successful IANB initially were brought forward to supplemental anesthetic|0
3100370|NCT01496846|3823510|FG002|STARTED|Supplemental Buccal Infiltration|Only after unsuccessful IANB.|36
3100371|NCT01496846|3823511|FG003|STARTED|Supplemental Buccal Infiltration|Only after unsuccessful IANB.|40
3100372|NCT01496846|3823512|FG004|STARTED|Supplemental Buccal Infiltration|Only after unsuccessful IANB.|35
3100373|NCT01496846|3823513|FG005|STARTED|Supplemental Buccal Infiltration|Only after unsuccessful IANB.|38
3100374|NCT01496846|3823508|FG000|COMPLETED|Supplemental Buccal Infiltration||0
3100375|NCT01496846|3823509|FG001|COMPLETED|Supplemental Buccal Infiltration||0
3100376|NCT01496846|3823510|FG002|COMPLETED|Supplemental Buccal Infiltration||36
3100377|NCT01496846|3823511|FG003|COMPLETED|Supplemental Buccal Infiltration||40
3100378|NCT01496846|3823512|FG004|COMPLETED|Supplemental Buccal Infiltration||35
3100379|NCT01496846|3823513|FG005|COMPLETED|Supplemental Buccal Infiltration||38
3100380|NCT01496846|3823508|FG000|NOT COMPLETED|Supplemental Buccal Infiltration||0
3100381|NCT01496846|3823509|FG001|NOT COMPLETED|Supplemental Buccal Infiltration||0
3100382|NCT01496846|3823510|FG002|NOT COMPLETED|Supplemental Buccal Infiltration||0
3100383|NCT01496846|3823511|FG003|NOT COMPLETED|Supplemental Buccal Infiltration||0
3100384|NCT01496846|3823512|FG004|NOT COMPLETED|Supplemental Buccal Infiltration||0
3100385|NCT01496846|3823513|FG005|NOT COMPLETED|Supplemental Buccal Infiltration||0
3100386|NCT01496885|3823524|FG000|STARTED|Overall Study||120
3100387|NCT01496885|3823524|FG000|COMPLETED|Overall Study||97
3100388|NCT01496885|3823524|FG000|NOT COMPLETED|Overall Study||23
3100389|NCT01497067|3823528|FG000|STARTED|Overall Study||657
3100390|NCT01497067|3823528|FG000|COMPLETED|Overall Study||575
3100391|NCT01497067|3823528|FG000|NOT COMPLETED|Overall Study||82
3135357|NCT01706588|3860379|FG000|STARTED|Overall Study||15
3135358|NCT01706588|3860380|FG001|STARTED|Overall Study||15
3135359|NCT01706588|3860381|FG002|STARTED|Overall Study||15
3135360|NCT01706588|3860382|FG003|STARTED|Overall Study||14
3135361|NCT01706588|3860383|FG004|STARTED|Overall Study||16
3135362|NCT01706588|3860379|FG000|COMPLETED|Overall Study||15
3135363|NCT01706588|3860380|FG001|COMPLETED|Overall Study||15
3135364|NCT01706588|3860381|FG002|COMPLETED|Overall Study||15
3290839|NCT02837913|4024909|FG000|NOT COMPLETED|Overall Study||0
3290840|NCT02837913|4024910|FG001|NOT COMPLETED|Overall Study||0
3290841|NCT02837952|4024918|FG000|STARTED|Overall Study||41
3290842|NCT02837952|4024919|FG001|STARTED|Overall Study||82
3290843|NCT02837952|4024918|FG000|COMPLETED|Overall Study||36
3290844|NCT02837952|4024919|FG001|COMPLETED|Overall Study||76
3290845|NCT02837952|4024918|FG000|NOT COMPLETED|Overall Study||5
3290846|NCT02837952|4024919|FG001|NOT COMPLETED|Overall Study||6
3290847|NCT02838017|4024927|FG000|STARTED|Overall Study||252
3290848|NCT02838017|4024928|FG001|STARTED|Overall Study||252
3290849|NCT02838017|4024927|FG000|COMPLETED|Overall Study||238
3290850|NCT02838017|4024928|FG001|COMPLETED|Overall Study||241
3290851|NCT02838017|4024927|FG000|NOT COMPLETED|Overall Study||14
3290852|NCT02838017|4024928|FG001|NOT COMPLETED|Overall Study||11
3290853|NCT02838134|4024936|FG000|STARTED|Overall Study||50
3290854|NCT02838134|4024937|FG001|STARTED|Overall Study||51
3290855|NCT02838134|4024936|FG000|COMPLETED|Overall Study||48
3290856|NCT02838134|4024937|FG001|COMPLETED|Overall Study||48
3290857|NCT02838134|4024936|FG000|NOT COMPLETED|Overall Study||2
3290858|NCT02838134|4024937|FG001|NOT COMPLETED|Overall Study||3
3290859|NCT02838407|4024943|FG000|STARTED|Overall Study||197
3290860|NCT02838407|4024943|FG000|COMPLETED|Overall Study||197
3290861|NCT02838407|4024943|FG000|NOT COMPLETED|Overall Study||0
3290862|NCT02838420|4024949|FG000|STARTED|Overall Study||125
3290863|NCT02838420|4024950|FG001|STARTED|Overall Study||62
3290864|NCT02838420|4024949|FG000|COMPLETED|Overall Study||0
3135365|NCT01706588|3860382|FG003|COMPLETED|Overall Study||14
3135366|NCT01706588|3860383|FG004|COMPLETED|Overall Study||16
3135367|NCT01706588|3860379|FG000|NOT COMPLETED|Overall Study||0
3135368|NCT01706588|3860380|FG001|NOT COMPLETED|Overall Study||0
3290865|NCT02838420|4024950|FG001|COMPLETED|Overall Study||0
3100392|NCT01497197|3823535|FG000|STARTED|Overall Study||89
3100393|NCT01497197|3823536|FG001|STARTED|Overall Study||85
3100394|NCT01497197|3823535|FG000|COMPLETED|Overall Study||72
3100395|NCT01497197|3823536|FG001|COMPLETED|Overall Study||70
3100396|NCT01497197|3823535|FG000|NOT COMPLETED|Overall Study||17
3100397|NCT01497197|3823536|FG001|NOT COMPLETED|Overall Study||15
3100398|NCT01497262|3823542|FG000|STARTED|Overall Study||162
3100399|NCT01497262|3823542|FG000|COMPLETED|Overall Study||151
3100400|NCT01497262|3823542|FG000|NOT COMPLETED|Overall Study||11
3100401|NCT01497275|3823546|FG000|STARTED|Overall Study||5
3100402|NCT01497275|3823546|FG000|COMPLETED|Overall Study||3
3100403|NCT01497275|3823546|FG000|NOT COMPLETED|Overall Study||2
3100404|NCT01497366|3823552|FG000|STARTED|Overall Study||263
3100405|NCT01497366|3823553|FG001|STARTED|Overall Study||264
3100406|NCT01497366|3823552|FG000|Randomized But Not Treated|Overall Study||7
3100407|NCT01497366|3823553|FG001|Randomized But Not Treated|Overall Study||21
3100408|NCT01497366|3823552|FG000|COMPLETED|Overall Study||224
3100409|NCT01497366|3823553|FG001|COMPLETED|Overall Study||176
3100410|NCT01497366|3823552|FG000|NOT COMPLETED|Overall Study||39
3100411|NCT01497366|3823553|FG001|NOT COMPLETED|Overall Study||88
3100412|NCT01497496|3823560|FG000|STARTED|Overall Study||29
3100413|NCT01497496|3823560|FG000|COMPLETED|Overall Study||29
3100414|NCT01497496|3823560|FG000|NOT COMPLETED|Overall Study||0
3100415|NCT01497613|3823566|FG000|STARTED|Overall Study||150
3100416|NCT01497613|3823567|FG001|STARTED|Overall Study||150
3100417|NCT01497613|3823566|FG000|COMPLETED|Overall Study||113
3100418|NCT01497613|3823567|FG001|COMPLETED|Overall Study||131
3100419|NCT01497613|3823566|FG000|NOT COMPLETED|Overall Study||37
3100420|NCT01497613|3823567|FG001|NOT COMPLETED|Overall Study||19
3100421|NCT01497665|3823573|FG000|STARTED|Overall Study||16
3100422|NCT01497665|3823573|FG000|Completed Effifcacy Assessment|Overall Study|Number of patients who completed efficacy assessment with CNS lesions per Overall RECIST 1.1.|10
3100423|NCT01497665|3823573|FG000|COMPLETED|Overall Study||16
3100424|NCT01497665|3823573|FG000|NOT COMPLETED|Overall Study||0
3100425|NCT01497756|3823577|FG000|STARTED|Overall Study||10
3100426|NCT01497756|3823577|FG000|COMPLETED|Overall Study||10
3100427|NCT01497756|3823577|FG000|NOT COMPLETED|Overall Study||0
3100428|NCT01497808|3823585|FG000|STARTED|Overall Study||6
3100429|NCT01497808|3823586|FG001|STARTED|Overall Study||4
3100430|NCT01497808|3823587|FG002|STARTED|Overall Study||6
3100431|NCT01497808|3823588|FG003|STARTED|Overall Study||6
3100432|NCT01497808|3823585|FG000|COMPLETED|Overall Study||6
3100433|NCT01497808|3823586|FG001|COMPLETED|Overall Study||4
3100434|NCT01497808|3823587|FG002|COMPLETED|Overall Study||6
3100435|NCT01497808|3823588|FG003|COMPLETED|Overall Study||6
3100436|NCT01497808|3823585|FG000|NOT COMPLETED|Overall Study||0
3100437|NCT01497808|3823586|FG001|NOT COMPLETED|Overall Study||0
3100438|NCT01497808|3823587|FG002|NOT COMPLETED|Overall Study||0
3100439|NCT01497808|3823588|FG003|NOT COMPLETED|Overall Study||0
3100440|NCT01497860|3823598|FG000|STARTED|Overall Study||12
3100441|NCT01497860|3823598|FG000|COMPLETED|Overall Study||12
3100442|NCT01497860|3823598|FG000|NOT COMPLETED|Overall Study||0
3100443|NCT01497899|3823606|FG000|STARTED|Double-Blind Phase||113
3100444|NCT01497899|3823607|FG001|STARTED|Double-Blind Phase||58
3100445|NCT01497899|3823608|FG002|STARTED|Double-Blind Phase||0
3100446|NCT01497899|3823609|FG003|STARTED|Double-Blind Phase||0
3100447|NCT01497899|3823606|FG000|COMPLETED|Double-Blind Phase||107
3100448|NCT01497899|3823607|FG001|COMPLETED|Double-Blind Phase||53
3100449|NCT01497899|3823608|FG002|COMPLETED|Double-Blind Phase||0
3100450|NCT01497899|3823609|FG003|COMPLETED|Double-Blind Phase||0
3100451|NCT01497899|3823606|FG000|NOT COMPLETED|Double-Blind Phase||6
3100452|NCT01497899|3823607|FG001|NOT COMPLETED|Double-Blind Phase||5
3100453|NCT01497899|3823608|FG002|NOT COMPLETED|Double-Blind Phase||0
3100454|NCT01497899|3823609|FG003|NOT COMPLETED|Double-Blind Phase||0
3100455|NCT01497899|3823606|FG000|STARTED|Open-Label Extension Phase|2 participants completed the Double-Blind Phase, but did not continue in the Open-Label Extension.|105
3100456|NCT01497899|3823607|FG001|STARTED|Open-Label Extension Phase||53
3100457|NCT01497899|3823608|FG002|STARTED|Open-Label Extension Phase|Participants enrolled from other Gilead-sponsored Study GS-US-299-0102.|70
3100458|NCT01497899|3823609|FG003|STARTED|Open-Label Extension Phase|Participants enrolled from other Gilead-sponsored Study GS-US-299-0102.|38
3100459|NCT01497899|3823606|FG000|COMPLETED|Open-Label Extension Phase||86
3100460|NCT01497899|3823607|FG001|COMPLETED|Open-Label Extension Phase||46
3100461|NCT01497899|3823608|FG002|COMPLETED|Open-Label Extension Phase||61
3100462|NCT01497899|3823609|FG003|COMPLETED|Open-Label Extension Phase||33
3100463|NCT01497899|3823606|FG000|NOT COMPLETED|Open-Label Extension Phase||19
3100464|NCT01497899|3823607|FG001|NOT COMPLETED|Open-Label Extension Phase||7
3100465|NCT01497899|3823608|FG002|NOT COMPLETED|Open-Label Extension Phase||9
3100466|NCT01497899|3823609|FG003|NOT COMPLETED|Open-Label Extension Phase||5
3100467|NCT01497938|3823618|FG000|STARTED|Overall Study||121
3100468|NCT01497938|3823619|FG001|STARTED|Overall Study||126
3100469|NCT01497938|3823618|FG000|COMPLETED|Overall Study||116
3100470|NCT01497938|3823619|FG001|COMPLETED|Overall Study||124
3100471|NCT01497938|3823618|FG000|NOT COMPLETED|Overall Study||5
3100472|NCT01497938|3823619|FG001|NOT COMPLETED|Overall Study||2
3100473|NCT01498068|3823627|FG000|STARTED|Overall Study||16
3100474|NCT01498068|3823628|FG001|STARTED|Overall Study||20
3100475|NCT01498068|3823627|FG000|COMPLETED|Overall Study||15
3100476|NCT01498068|3823628|FG001|COMPLETED|Overall Study||19
3100477|NCT01498068|3823627|FG000|NOT COMPLETED|Overall Study||1
3100478|NCT01498068|3823628|FG001|NOT COMPLETED|Overall Study||1
3100479|NCT01498120|3823634|FG000|STARTED|Overall Study||14
3100480|NCT01498120|3823634|FG000|COMPLETED|Overall Study||1
3100481|NCT01498120|3823634|FG000|NOT COMPLETED|Overall Study||13
3100482|NCT01498185|3823643|FG000|STARTED|Overall Study||13
3100483|NCT01498185|3823644|FG001|STARTED|Overall Study||13
3100484|NCT01498185|3823645|FG002|STARTED|Overall Study||15
3100485|NCT01498185|3823646|FG003|STARTED|Overall Study||14
3100486|NCT01498185|3823647|FG004|STARTED|Overall Study||15
3100487|NCT01498185|3823643|FG000|COMPLETED|Overall Study||12
3100488|NCT01498185|3823644|FG001|COMPLETED|Overall Study||12
3100489|NCT01498185|3823645|FG002|COMPLETED|Overall Study||15
3100490|NCT01498185|3823646|FG003|COMPLETED|Overall Study||11
3100491|NCT01498185|3823647|FG004|COMPLETED|Overall Study||12
3100492|NCT01498185|3823643|FG000|NOT COMPLETED|Overall Study||1
3100493|NCT01498185|3823644|FG001|NOT COMPLETED|Overall Study||1
3100494|NCT01498185|3823645|FG002|NOT COMPLETED|Overall Study||0
3100495|NCT01498185|3823646|FG003|NOT COMPLETED|Overall Study||3
3100496|NCT01498185|3823647|FG004|NOT COMPLETED|Overall Study||3
3100497|NCT01498289|3823665|FG000|STARTED|Overall Study||98
3100498|NCT01498289|3823666|FG001|STARTED|Overall Study||104
3100499|NCT01498289|3823665|FG000|Participants Assessed for AEs|Overall Study||91
3100500|NCT01498289|3823666|FG001|Participants Assessed for AEs|Overall Study||98
3100501|NCT01498289|3823665|FG000|COMPLETED|Overall Study||0
3100502|NCT01498289|3823666|FG001|COMPLETED|Overall Study||0
3100503|NCT01498289|3823665|FG000|NOT COMPLETED|Overall Study||98
3100504|NCT01498289|3823666|FG001|NOT COMPLETED|Overall Study||104
3100505|NCT01498419|3823680|FG000|STARTED|Overall Study||60
3100506|NCT01498419|3823681|FG001|STARTED|Overall Study||62
3100507|NCT01498419|3823682|FG002|STARTED|Overall Study||59
3100508|NCT01498419|3823683|FG003|STARTED|Overall Study||26
3100509|NCT01498419|3823680|FG000|COMPLETED|Overall Study||42
3290866|NCT02838420|4024949|FG000|NOT COMPLETED|Overall Study||125
3290867|NCT02838420|4024950|FG001|NOT COMPLETED|Overall Study||62
3290868|NCT02838628|4024958|FG000|STARTED|Treatment and Follow-up Period||84
3290869|NCT02838628|4024959|FG001|STARTED|Treatment and Follow-up Period||84
3290870|NCT02838628|4024958|FG000|COMPLETED|Treatment and Follow-up Period||84
3290871|NCT02838628|4024959|FG001|COMPLETED|Treatment and Follow-up Period||84
3290872|NCT02838628|4024958|FG000|NOT COMPLETED|Treatment and Follow-up Period||0
3290873|NCT02838628|4024959|FG001|NOT COMPLETED|Treatment and Follow-up Period||0
3290874|NCT02838628|4024958|FG000|STARTED|Recurrence Follow-up Period||36
3290875|NCT02838628|4024959|FG001|STARTED|Recurrence Follow-up Period||27
3290876|NCT02838628|4024958|FG000|COMPLETED|Recurrence Follow-up Period||16
3290877|NCT02838628|4024959|FG001|COMPLETED|Recurrence Follow-up Period||10
3290878|NCT02838628|4024958|FG000|NOT COMPLETED|Recurrence Follow-up Period||20
3290879|NCT02838628|4024959|FG001|NOT COMPLETED|Recurrence Follow-up Period||17
3290880|NCT02838901|4024968|FG000|STARTED|Overall Study||9
3290881|NCT02838901|4024969|FG001|STARTED|Overall Study||9
3290882|NCT02838901|4024968|FG000|COMPLETED|Overall Study||7
3290883|NCT02838901|4024969|FG001|COMPLETED|Overall Study||7
3290884|NCT02838901|4024968|FG000|NOT COMPLETED|Overall Study||2
3290885|NCT02838901|4024969|FG001|NOT COMPLETED|Overall Study||2
3290886|NCT02839200|4024983|FG000|STARTED|Overall Study||60
3290887|NCT02839200|4024984|FG001|STARTED|Overall Study||59
3290888|NCT02839200|4024985|FG002|STARTED|Overall Study||60
3290889|NCT02839200|4024986|FG003|STARTED|Overall Study||61
3290890|NCT02839200|4024987|FG004|STARTED|Overall Study||60
3290891|NCT02839200|4024988|FG005|STARTED|Overall Study||60
3290892|NCT02839200|4024983|FG000|COMPLETED|Overall Study||56
3290893|NCT02839200|4024984|FG001|COMPLETED|Overall Study||58
3290894|NCT02839200|4024985|FG002|COMPLETED|Overall Study||59
3290895|NCT02839200|4024986|FG003|COMPLETED|Overall Study||61
3290896|NCT02839200|4024987|FG004|COMPLETED|Overall Study||58
3290897|NCT02839200|4024988|FG005|COMPLETED|Overall Study||59
3290898|NCT02839200|4024983|FG000|NOT COMPLETED|Overall Study||4
3290899|NCT02839200|4024984|FG001|NOT COMPLETED|Overall Study||1
3290900|NCT02839200|4024985|FG002|NOT COMPLETED|Overall Study||1
3290901|NCT02839200|4024986|FG003|NOT COMPLETED|Overall Study||0
3290902|NCT02839200|4024987|FG004|NOT COMPLETED|Overall Study||2
3290903|NCT02839200|4024988|FG005|NOT COMPLETED|Overall Study||1
3290904|NCT02839330|4025006|FG000|STARTED|Overall Study||804
3290905|NCT02839330|4025007|FG001|STARTED|Overall Study||799
3290906|NCT02839330|4025008|FG002|STARTED|Overall Study||795
3290907|NCT02839330|4025009|FG003|STARTED|Overall Study||798
3290908|NCT02839330|4025006|FG000|Exposed|Overall Study||804
3290909|NCT02839330|4025007|FG001|Exposed|Overall Study||797
3290910|NCT02839330|4025008|FG002|Exposed|Overall Study||793
3290911|NCT02839330|4025009|FG003|Exposed|Overall Study||797
3290912|NCT02839330|4025006|FG000|COMPLETED|Overall Study||746
3290913|NCT02839330|4025007|FG001|COMPLETED|Overall Study||741
3290914|NCT02839330|4025008|FG002|COMPLETED|Overall Study||747
3290915|NCT02839330|4025009|FG003|COMPLETED|Overall Study||747
3290916|NCT02839330|4025006|FG000|NOT COMPLETED|Overall Study||58
3290917|NCT02839330|4025007|FG001|NOT COMPLETED|Overall Study||58
3290918|NCT02839330|4025008|FG002|NOT COMPLETED|Overall Study||48
3290919|NCT02839330|4025009|FG003|NOT COMPLETED|Overall Study||51
3290920|NCT02839681|4025020|FG000|STARTED|Overall Study||2
3100510|NCT01498419|3823681|FG001|COMPLETED|Overall Study||39
3100511|NCT01498419|3823682|FG002|COMPLETED|Overall Study||41
3100512|NCT01498419|3823683|FG003|COMPLETED|Overall Study||7
3100513|NCT01498419|3823680|FG000|NOT COMPLETED|Overall Study||18
3100514|NCT01498419|3823681|FG001|NOT COMPLETED|Overall Study||23
3100515|NCT01498419|3823682|FG002|NOT COMPLETED|Overall Study||18
3100516|NCT01498419|3823683|FG003|NOT COMPLETED|Overall Study||19
3100517|NCT01498445|3823699|FG000|STARTED|Overall Study||4
3100518|NCT01498445|3823700|FG001|STARTED|Overall Study||3
3100519|NCT01498445|3823701|FG002|STARTED|Overall Study||8
3100520|NCT01498445|3823702|FG003|STARTED|Overall Study||8
3100521|NCT01498445|3823703|FG004|STARTED|Overall Study||4
3100522|NCT01498445|3823704|FG005|STARTED|Overall Study||5
3100523|NCT01498445|3823699|FG000|COMPLETED|Overall Study||4
3100524|NCT01498445|3823700|FG001|COMPLETED|Overall Study||3
3100525|NCT01498445|3823701|FG002|COMPLETED|Overall Study||7
3100526|NCT01498445|3823702|FG003|COMPLETED|Overall Study||6
3100527|NCT01498445|3823703|FG004|COMPLETED|Overall Study||3
3100528|NCT01498445|3823704|FG005|COMPLETED|Overall Study||4
3100529|NCT01498445|3823699|FG000|NOT COMPLETED|Overall Study||0
3100530|NCT01498445|3823700|FG001|NOT COMPLETED|Overall Study||0
3100531|NCT01498445|3823701|FG002|NOT COMPLETED|Overall Study||1
3100532|NCT01498445|3823702|FG003|NOT COMPLETED|Overall Study||2
3100533|NCT01498445|3823703|FG004|NOT COMPLETED|Overall Study||1
3100534|NCT01498445|3823704|FG005|NOT COMPLETED|Overall Study||1
3100535|NCT01498458|3823718|FG000|STARTED|Overall Study|9 patients took part in the study of which 8 received pazopanib.|8
3100536|NCT01498458|3823718|FG000|COMPLETED|Overall Study|only 1 patient was in the study at the end. 7 left due to Adverse Events or Investigators Decision.|1
3100537|NCT01498458|3823718|FG000|NOT COMPLETED|Overall Study||7
3100538|NCT01498549|3823727|FG000|STARTED|Overall Study||39
3100539|NCT01498549|3823727|FG000|Atomoxetine 40 mg|Overall Study||39
3100540|NCT01498549|3823727|FG000|Atomoxetine 80 mg|Overall Study||37
3100541|NCT01498549|3823727|FG000|Sugar Pill 0 mg|Overall Study||36
3100542|NCT01498549|3823727|FG000|COMPLETED|Overall Study||35
3100543|NCT01498549|3823727|FG000|NOT COMPLETED|Overall Study||4
3100544|NCT01498575|3823738|FG000|STARTED|Overall Sample||610
3100545|NCT01498575|3823739|FG001|STARTED|Overall Sample||414
3100546|NCT01498575|3823738|FG000|COMPLETED|Overall Sample||550
3100547|NCT01498575|3823739|FG001|COMPLETED|Overall Sample||400
3100548|NCT01498575|3823738|FG000|NOT COMPLETED|Overall Sample||60
3100549|NCT01498575|3823739|FG001|NOT COMPLETED|Overall Sample||14
3100550|NCT01498575|3823738|FG000|STARTED|On the Road Driving Assessment (ODA)||128
3100551|NCT01498575|3823739|FG001|STARTED|On the Road Driving Assessment (ODA)||89
3100552|NCT01498575|3823738|FG000|COMPLETED|On the Road Driving Assessment (ODA)||86
3100553|NCT01498575|3823739|FG001|COMPLETED|On the Road Driving Assessment (ODA)||65
3100554|NCT01498575|3823738|FG000|NOT COMPLETED|On the Road Driving Assessment (ODA)||42
3100555|NCT01498575|3823739|FG001|NOT COMPLETED|On the Road Driving Assessment (ODA)||24
3100556|NCT01498588|3823745|FG000|STARTED|Overall Study||7
3100557|NCT01498588|3823745|FG000|COMPLETED|Overall Study||7
3100558|NCT01498588|3823745|FG000|NOT COMPLETED|Overall Study||0
3100559|NCT01498601|3823751|FG000|STARTED|Overall Study||51
3100560|NCT01498601|3823752|FG001|STARTED|Overall Study||32
3100561|NCT01498601|3823751|FG000|COMPLETED|Overall Study||51
3100562|NCT01498601|3823752|FG001|COMPLETED|Overall Study||32
3100563|NCT01498601|3823751|FG000|NOT COMPLETED|Overall Study||0
3100564|NCT01498601|3823752|FG001|NOT COMPLETED|Overall Study||0
3100565|NCT01498640|3823758|FG000|STARTED|Overall Study||52
3100566|NCT01498640|3823758|FG000|COMPLETED|Overall Study||47
3100567|NCT01498640|3823758|FG000|NOT COMPLETED|Overall Study||5
3100568|NCT01498653|3823768|FG000|STARTED|Overall Study||155
3100569|NCT01498653|3823769|FG001|STARTED|Overall Study||154
3100570|NCT01498653|3823768|FG000|COMPLETED|Overall Study||136
3100571|NCT01498653|3823769|FG001|COMPLETED|Overall Study||119
3100572|NCT01498653|3823768|FG000|NOT COMPLETED|Overall Study||19
3100573|NCT01498653|3823769|FG001|NOT COMPLETED|Overall Study||35
3100574|NCT01498679|3823777|FG000|STARTED|Overall Study||154
3100575|NCT01498679|3823778|FG001|STARTED|Overall Study||153
3100576|NCT01498679|3823777|FG000|COMPLETED|Overall Study||65
3100577|NCT01498679|3823778|FG001|COMPLETED|Overall Study||131
3100578|NCT01498679|3823777|FG000|NOT COMPLETED|Overall Study||89
3100579|NCT01498679|3823778|FG001|NOT COMPLETED|Overall Study||22
3100580|NCT01498692|3823784|FG000|STARTED|Overall Study||94
3100581|NCT01498692|3823784|FG000|COMPLETED|Overall Study||86
3100582|NCT01498692|3823784|FG000|NOT COMPLETED|Overall Study||8
3100583|NCT01498744|3823790|FG000|STARTED|Overall Study||22
3100584|NCT01498744|3823791|FG001|STARTED|Overall Study||31
3100585|NCT01498744|3823790|FG000|COMPLETED|Overall Study||22
3100586|NCT01498744|3823791|FG001|COMPLETED|Overall Study||31
3100587|NCT01498744|3823790|FG000|NOT COMPLETED|Overall Study||0
3100588|NCT01498744|3823791|FG001|NOT COMPLETED|Overall Study||0
3100589|NCT01498822|3823799|FG000|STARTED|Overall Study||175
3100590|NCT01498822|3823800|FG001|STARTED|Overall Study||178
3100591|NCT01498822|3823799|FG000|COMPLETED|Overall Study||121
3100592|NCT01498822|3823800|FG001|COMPLETED|Overall Study||122
3100593|NCT01498822|3823799|FG000|NOT COMPLETED|Overall Study||54
3100594|NCT01498822|3823800|FG001|NOT COMPLETED|Overall Study||56
3100595|NCT01498887|3823810|FG000|STARTED|Overall Study||200
3100596|NCT01498887|3823811|FG001|STARTED|Overall Study||147
3100597|NCT01498887|3823810|FG000|Safety Set|Overall Study||200
3100598|NCT01498887|3823811|FG001|Safety Set|Overall Study||147
3100599|NCT01498887|3823810|FG000|Intent-to-treat|Overall Study||185
3100600|NCT01498887|3823811|FG001|Intent-to-treat|Overall Study||135
3100601|NCT01498887|3823810|FG000|COMPLETED|Overall Study||184
3100602|NCT01498887|3823811|FG001|COMPLETED|Overall Study||136
3100603|NCT01498887|3823810|FG000|NOT COMPLETED|Overall Study||16
3100604|NCT01498887|3823811|FG001|NOT COMPLETED|Overall Study||11
3100605|NCT01498952|3823820|FG000|STARTED|Overall Study||3
3100606|NCT01498952|3823821|FG001|STARTED|Overall Study||3
3100607|NCT01498952|3823822|FG002|STARTED|Overall Study||0
3100608|NCT01498952|3823823|FG003|STARTED|Overall Study||0
3100609|NCT01498952|3823824|FG004|STARTED|Overall Study||0
3100610|NCT01498952|3823820|FG000|COMPLETED|Overall Study||1
3100611|NCT01498952|3823821|FG001|COMPLETED|Overall Study||1
3100612|NCT01498952|3823822|FG002|COMPLETED|Overall Study||0
3100613|NCT01498952|3823823|FG003|COMPLETED|Overall Study||0
3100614|NCT01498952|3823824|FG004|COMPLETED|Overall Study||0
3100615|NCT01498952|3823820|FG000|NOT COMPLETED|Overall Study||2
3100616|NCT01498952|3823821|FG001|NOT COMPLETED|Overall Study||2
3100617|NCT01498952|3823822|FG002|NOT COMPLETED|Overall Study||0
3100618|NCT01498952|3823823|FG003|NOT COMPLETED|Overall Study||0
3100619|NCT01498952|3823824|FG004|NOT COMPLETED|Overall Study||0
3100620|NCT01498978|3823837|FG000|STARTED|Overall Study||10
3100621|NCT01498978|3823837|FG000|COMPLETED|Overall Study||8
3100622|NCT01498978|3823837|FG000|NOT COMPLETED|Overall Study||2
3100623|NCT01499043|3823843|FG000|STARTED|Overall Study||6
3100624|NCT01499043|3823843|FG000|COMPLETED|Overall Study||0
3100625|NCT01499043|3823843|FG000|NOT COMPLETED|Overall Study||6
3100626|NCT01499082|3823854|FG000|STARTED|Overall Study||404
3100627|NCT01499082|3823855|FG001|STARTED|Overall Study||403
3100628|NCT01499082|3823854|FG000|Treated|Overall Study||404
3100629|NCT01499082|3823855|FG001|Treated|Overall Study||402
3100630|NCT01499082|3823854|FG000|Participated in Substudy|Overall Study|56 participants received adaptable dosing regimen and 53 participants received fixed dosing regimen|109
3100631|NCT01499082|3823855|FG001|Participated in Substudy|Overall Study||0
3100632|NCT01499082|3823854|FG000|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|404
3135369|NCT01706588|3860381|FG002|NOT COMPLETED|Overall Study||0
3135370|NCT01706588|3860382|FG003|NOT COMPLETED|Overall Study||0
3290921|NCT02839681|4025020|FG000|COMPLETED|Overall Study||0
3290922|NCT02839681|4025020|FG000|NOT COMPLETED|Overall Study||2
3290923|NCT02839746|4025024|FG000|STARTED|Overall Study||671
3290924|NCT02839746|4025024|FG000|COMPLETED|Overall Study||659
3290925|NCT02839746|4025024|FG000|NOT COMPLETED|Overall Study||12
3290926|NCT02839772|4025030|FG000|STARTED|Overall Study|Stratification was used. Clinic A enrolled 94 participants and Clinic B 99 participants|97
3290927|NCT02839772|4025031|FG001|STARTED|Overall Study||96
3290928|NCT02839772|4025030|FG000|COMPLETED|Overall Study|1 participant in Clinic B did not return for the 3 months post- intervention data collection.|96
3290929|NCT02839772|4025031|FG001|COMPLETED|Overall Study||96
3290930|NCT02839772|4025030|FG000|NOT COMPLETED|Overall Study||1
3290931|NCT02839772|4025031|FG001|NOT COMPLETED|Overall Study||0
3290932|NCT02839798|4025051|FG000|STARTED|Overall Study||6
3290933|NCT02839798|4025051|FG000|COMPLETED|Overall Study||4
3290934|NCT02839798|4025051|FG000|NOT COMPLETED|Overall Study||2
3290935|NCT02839876|4025057|FG000|STARTED|Overall Study||41
3290936|NCT02839876|4025058|FG001|STARTED|Overall Study||40
3290937|NCT02839876|4025057|FG000|COMPLETED|Overall Study||31
3290938|NCT02839876|4025058|FG001|COMPLETED|Overall Study||29
3290939|NCT02839876|4025057|FG000|NOT COMPLETED|Overall Study||10
3290940|NCT02839876|4025058|FG001|NOT COMPLETED|Overall Study||11
3290941|NCT02839889|4025066|FG000|STARTED|Randomization Period||2
3290942|NCT02839889|4025067|FG001|STARTED|Randomization Period||3
3290943|NCT02839889|4025066|FG000|COMPLETED|Randomization Period||2
3290944|NCT02839889|4025067|FG001|COMPLETED|Randomization Period||3
3290945|NCT02839889|4025066|FG000|NOT COMPLETED|Randomization Period||0
3290946|NCT02839889|4025067|FG001|NOT COMPLETED|Randomization Period||0
3290947|NCT02839889|4025066|FG000|STARTED|Open-Label Period||0
3290948|NCT02839889|4025067|FG001|STARTED|Open-Label Period||5
3290949|NCT02839889|4025066|FG000|COMPLETED|Open-Label Period||0
3290950|NCT02839889|4025067|FG001|COMPLETED|Open-Label Period||4
3290951|NCT02839889|4025066|FG000|NOT COMPLETED|Open-Label Period||0
3290952|NCT02839889|4025067|FG001|NOT COMPLETED|Open-Label Period||1
3290953|NCT02839902|4025075|FG000|STARTED|Overall Study||24
3290954|NCT02839902|4025076|FG001|STARTED|Overall Study||29
3290955|NCT02839902|4025075|FG000|COMPLETED|Overall Study||24
3290956|NCT02839902|4025076|FG001|COMPLETED|Overall Study||29
3290957|NCT02839902|4025075|FG000|NOT COMPLETED|Overall Study||0
3290958|NCT02839902|4025076|FG001|NOT COMPLETED|Overall Study||0
3290959|NCT02840097|4025085|FG000|STARTED|Overall Study||9
3290960|NCT02840097|4025086|FG001|STARTED|Overall Study||10
3290961|NCT02840097|4025087|FG002|STARTED|Overall Study||12
3290962|NCT02840097|4025085|FG000|COMPLETED|Overall Study||9
3290963|NCT02840097|4025086|FG001|COMPLETED|Overall Study||10
3290964|NCT02840097|4025087|FG002|COMPLETED|Overall Study||12
3290965|NCT02840097|4025085|FG000|NOT COMPLETED|Overall Study||0
3290966|NCT02840097|4025086|FG001|NOT COMPLETED|Overall Study||0
3290967|NCT02840097|4025087|FG002|NOT COMPLETED|Overall Study||0
3290968|NCT02840253|4025098|FG000|STARTED|Overall Study||23
3290969|NCT02840253|4025098|FG000|COMPLETED|Overall Study||19
3290970|NCT02840253|4025098|FG000|NOT COMPLETED|Overall Study||4
3290971|NCT02840461|4025105|FG000|STARTED|Overall Study||259
3290972|NCT02840461|4025106|FG001|STARTED|Overall Study||257
3290973|NCT02840461|4025107|FG002|STARTED|Overall Study||114
3290974|NCT02840461|4025105|FG000|COMPLETED|Overall Study||236
3290975|NCT02840461|4025106|FG001|COMPLETED|Overall Study||235
3290976|NCT02840461|4025107|FG002|COMPLETED|Overall Study||100
3290977|NCT02840461|4025105|FG000|NOT COMPLETED|Overall Study||23
3290978|NCT02840461|4025106|FG001|NOT COMPLETED|Overall Study||22
3100633|NCT01499082|3823855|FG001|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|400
3100634|NCT01499082|3823854|FG000|COMPLETED|Overall Study||359
3100635|NCT01499082|3823855|FG001|COMPLETED|Overall Study||355
3100636|NCT01499082|3823854|FG000|NOT COMPLETED|Overall Study||45
3100637|NCT01499082|3823855|FG001|NOT COMPLETED|Overall Study||48
3100638|NCT01499095|3823865|FG000|STARTED|Overall Study||404
3100639|NCT01499095|3823866|FG001|STARTED|Overall Study||407
3100640|NCT01499095|3823865|FG000|Treated|Overall Study||403
3100641|NCT01499095|3823866|FG001|Treated|Overall Study||406
3100642|NCT01499095|3823865|FG000|Participated in Substudy|Overall Study|45 participants received adaptable dosing regimen and 44 participants received fixed dosing regimen|89
3100643|NCT01499095|3823866|FG001|Participated in Substudy|Overall Study||0
3100644|NCT01499095|3823865|FG000|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|403
3100645|NCT01499095|3823866|FG001|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|405
3100646|NCT01499095|3823865|FG000|COMPLETED|Overall Study||315
3100647|NCT01499095|3823866|FG001|COMPLETED|Overall Study||314
3100648|NCT01499095|3823865|FG000|NOT COMPLETED|Overall Study||89
3100649|NCT01499095|3823866|FG001|NOT COMPLETED|Overall Study||93
3100650|NCT01499134|3823877|FG000|STARTED|Overall Study||9
3100651|NCT01499134|3823878|FG001|STARTED|Overall Study||8
3100652|NCT01499134|3823877|FG000|COMPLETED|Overall Study||9
3100653|NCT01499134|3823878|FG001|COMPLETED|Overall Study||7
3100654|NCT01499134|3823877|FG000|NOT COMPLETED|Overall Study||0
3100655|NCT01499134|3823878|FG001|NOT COMPLETED|Overall Study||1
3100656|NCT01499147|3823886|FG000|STARTED|Overall Study||33
3100657|NCT01499147|3823887|FG001|STARTED|Overall Study||17
3100658|NCT01499147|3823886|FG000|COMPLETED|Overall Study||18
3100659|NCT01499147|3823887|FG001|COMPLETED|Overall Study||12
3100660|NCT01499147|3823886|FG000|NOT COMPLETED|Overall Study||15
3100661|NCT01499147|3823887|FG001|NOT COMPLETED|Overall Study||5
3100662|NCT01499173|3823897|FG000|STARTED|Overall Study||101
3100663|NCT01499173|3823897|FG000|COMPLETED|Overall Study||64
3100664|NCT01499173|3823897|FG000|NOT COMPLETED|Overall Study||37
3100665|NCT01499199|3823902|FG000|STARTED|Overall Study||13
3100666|NCT01499199|3823902|FG000|COMPLETED|Overall Study||11
3100667|NCT01499199|3823902|FG000|NOT COMPLETED|Overall Study||2
3100668|NCT01499277|3823908|FG000|STARTED|Overall Study||506
3100669|NCT01499277|3823909|FG001|STARTED|Overall Study||255
3100670|NCT01499277|3823908|FG000|COMPLETED|Overall Study||459
3100671|NCT01499277|3823909|FG001|COMPLETED|Overall Study||223
3100672|NCT01499277|3823908|FG000|NOT COMPLETED|Overall Study||47
3100673|NCT01499277|3823909|FG001|NOT COMPLETED|Overall Study||32
3100674|NCT01499290|3823917|FG000|STARTED|Overall Study|Patients dosed in pooled protocols D4280C00001/D4280C00005 (NCT01499290/NCT01500239) agreed with FDA|529
3100675|NCT01499290|3823918|FG001|STARTED|Overall Study|Patients dosed in pooled protocols D4280C00001/D4280C00005 (NCT01499290/NCT01500239) agreed with FDA|529
3100676|NCT01499290|3823917|FG000|COMPLETED|Overall Study|(Numbers indicate patients who completed treatment)|474
3100677|NCT01499290|3823918|FG001|COMPLETED|Overall Study|(Numbers indicate patients who completed treatment)|494
3100678|NCT01499290|3823917|FG000|NOT COMPLETED|Overall Study||55
3100679|NCT01499290|3823918|FG001|NOT COMPLETED|Overall Study||35
3100680|NCT01499303|3823945|FG000|STARTED|Overall Study||21
3100681|NCT01499303|3823946|FG001|STARTED|Overall Study||47
3100682|NCT01499303|3823945|FG000|COMPLETED|Overall Study||18
3100683|NCT01499303|3823946|FG001|COMPLETED|Overall Study||40
3100684|NCT01499303|3823945|FG000|NOT COMPLETED|Overall Study||3
3100685|NCT01499303|3823946|FG001|NOT COMPLETED|Overall Study||7
3100686|NCT01499355|3823952|FG000|STARTED|Run-In Period||276
3100687|NCT01499355|3823953|FG001|STARTED|Run-In Period||0
3100688|NCT01499355|3823954|FG002|STARTED|Run-In Period||0
3100689|NCT01499355|3823955|FG003|STARTED|Run-In Period||0
3100690|NCT01499355|3823952|FG000|COMPLETED|Run-In Period||245
3100691|NCT01499355|3823953|FG001|COMPLETED|Run-In Period||0
3100692|NCT01499355|3823954|FG002|COMPLETED|Run-In Period||0
3100693|NCT01499355|3823955|FG003|COMPLETED|Run-In Period||0
3100694|NCT01499355|3823952|FG000|NOT COMPLETED|Run-In Period||31
3100695|NCT01499355|3823953|FG001|NOT COMPLETED|Run-In Period||0
3100696|NCT01499355|3823954|FG002|NOT COMPLETED|Run-In Period||0
3100697|NCT01499355|3823955|FG003|NOT COMPLETED|Run-In Period||0
3100698|NCT01499355|3823952|FG000|STARTED|Double-Blind Period||0
3100699|NCT01499355|3823953|FG001|STARTED|Double-Blind Period||63
3100700|NCT01499355|3823954|FG002|STARTED|Double-Blind Period||63
3100701|NCT01499355|3823955|FG003|STARTED|Double-Blind Period||62
3100702|NCT01499355|3823952|FG000|COMPLETED|Double-Blind Period||0
3100703|NCT01499355|3823953|FG001|COMPLETED|Double-Blind Period||40
3100704|NCT01499355|3823954|FG002|COMPLETED|Double-Blind Period||38
3100705|NCT01499355|3823955|FG003|COMPLETED|Double-Blind Period||39
3100706|NCT01499355|3823952|FG000|NOT COMPLETED|Double-Blind Period||0
3100707|NCT01499355|3823953|FG001|NOT COMPLETED|Double-Blind Period||23
3100708|NCT01499355|3823954|FG002|NOT COMPLETED|Double-Blind Period||25
3100709|NCT01499355|3823955|FG003|NOT COMPLETED|Double-Blind Period||23
3100710|NCT01499368|3823968|FG000|STARTED|Overall Study||165
3100711|NCT01499368|3823969|FG001|STARTED|Overall Study||163
3100712|NCT01499368|3823970|FG002|STARTED|Overall Study||167
3100713|NCT01499368|3823968|FG000|COMPLETED|Overall Study||138
3100714|NCT01499368|3823969|FG001|COMPLETED|Overall Study||145
3100715|NCT01499368|3823970|FG002|COMPLETED|Overall Study||146
3100716|NCT01499368|3823968|FG000|NOT COMPLETED|Overall Study||27
3100717|NCT01499368|3823969|FG001|NOT COMPLETED|Overall Study||18
3100718|NCT01499368|3823970|FG002|NOT COMPLETED|Overall Study||21
3100719|NCT01499498|3823978|FG000|STARTED|Overall Study||13
3100720|NCT01499498|3823978|FG000|COMPLETED|Overall Study||13
3100721|NCT01499498|3823978|FG000|NOT COMPLETED|Overall Study||0
3100722|NCT01499511|3823987|FG000|STARTED|Overall Study||885
3100723|NCT01499511|3823988|FG001|STARTED|Overall Study||833
3100724|NCT01499511|3823987|FG000|COMPLETED|Overall Study||884
3100725|NCT01499511|3823988|FG001|COMPLETED|Overall Study||833
3100726|NCT01499511|3823987|FG000|NOT COMPLETED|Overall Study||1
3100727|NCT01499511|3823988|FG001|NOT COMPLETED|Overall Study||0
3100728|NCT01499576|3823995|FG000|STARTED|Overall Study||126
3100729|NCT01499576|3823995|FG000|COMPLETED|Overall Study||105
3100730|NCT01499576|3823995|FG000|NOT COMPLETED|Overall Study||21
3100731|NCT01499654|3824000|FG000|STARTED|Overall Study||64
3100732|NCT01499654|3824000|FG000|COMPLETED|Overall Study||64
3100733|NCT01499654|3824000|FG000|NOT COMPLETED|Overall Study||0
3100734|NCT01499667|3824013|FG000|STARTED|Overall Study|"Started indicates randomized as well as safety population."|50
3100735|NCT01499667|3824014|FG001|STARTED|Overall Study||42
3100736|NCT01499667|3824015|FG002|STARTED|Overall Study||50
3100737|NCT01499667|3824013|FG000|Full Analysis Set (FAS)|Overall Study|One randomized patient did not receive natalizumub at screening, which was a requirement for FAS.|49
3100738|NCT01499667|3824014|FG001|Full Analysis Set (FAS)|Overall Study||42
3100739|NCT01499667|3824015|FG002|Full Analysis Set (FAS)|Overall Study||50
3100740|NCT01499667|3824013|FG000|Modified Full Analysis Set|Overall Study|mFAS included all FAS patients who completed 8 wks of fingolimod treatment with MRI scan|41
3100741|NCT01499667|3824014|FG001|Modified Full Analysis Set|Overall Study||29
3100742|NCT01499667|3824015|FG002|Modified Full Analysis Set|Overall Study||39
3100743|NCT01499667|3824013|FG000|COMPLETED|Overall Study||41
3100744|NCT01499667|3824014|FG001|COMPLETED|Overall Study||31
3100745|NCT01499667|3824015|FG002|COMPLETED|Overall Study||40
3100746|NCT01499667|3824013|FG000|NOT COMPLETED|Overall Study||9
3100747|NCT01499667|3824014|FG001|NOT COMPLETED|Overall Study||11
3100748|NCT01499667|3824015|FG002|NOT COMPLETED|Overall Study||10
3100749|NCT01499810|3824023|FG000|STARTED|Overall Study||53
3100750|NCT01499810|3824023|FG000|COMPLETED|Overall Study||41
3100751|NCT01499810|3824023|FG000|NOT COMPLETED|Overall Study||12
3100752|NCT01499849|3824030|FG000|STARTED|Overall Study|Number of randomized patients|266
3100753|NCT01499849|3824031|FG001|STARTED|Overall Study||266
3100754|NCT01499849|3824030|FG000|COMPLETED|Overall Study|Number of patients who completed 6 cycles|42
3100755|NCT01499849|3824031|FG001|COMPLETED|Overall Study||40
3100756|NCT01499849|3824030|FG000|NOT COMPLETED|Overall Study||224
3100757|NCT01499849|3824031|FG001|NOT COMPLETED|Overall Study||226
3100758|NCT01499862|3824037|FG000|STARTED|Overall Study||3
3100759|NCT01499862|3824037|FG000|COMPLETED|Overall Study||3
3100760|NCT01499862|3824037|FG000|NOT COMPLETED|Overall Study||0
3100761|NCT01499940|3824055|FG000|STARTED|Overall Study||9
3100762|NCT01499940|3824055|FG000|COMPLETED|Overall Study||0
3100763|NCT01499940|3824055|FG000|NOT COMPLETED|Overall Study||9
3100764|NCT01500031|3824059|FG000|STARTED|Overall Study||92
3100765|NCT01500031|3824059|FG000|COMPLETED|Overall Study||87
3100766|NCT01500031|3824059|FG000|NOT COMPLETED|Overall Study||5
3100767|NCT01500057|3824065|FG000|STARTED|Overall Study||31
3100768|NCT01500057|3824066|FG001|STARTED|Overall Study||35
3100769|NCT01500057|3824065|FG000|COMPLETED|Overall Study||25
3100770|NCT01500057|3824066|FG001|COMPLETED|Overall Study||31
3100771|NCT01500057|3824065|FG000|NOT COMPLETED|Overall Study||6
3100772|NCT01500057|3824066|FG001|NOT COMPLETED|Overall Study||4
3100773|NCT01500083|3824074|FG000|STARTED|Overall Study||16
3100774|NCT01500083|3824075|FG001|STARTED|Overall Study||74
3100775|NCT01500083|3824074|FG000|COMPLETED|Overall Study||4
3100776|NCT01500083|3824075|FG001|COMPLETED|Overall Study||31
3100777|NCT01500083|3824074|FG000|NOT COMPLETED|Overall Study||12
3100778|NCT01500083|3824075|FG001|NOT COMPLETED|Overall Study||43
3100779|NCT01500096|3824085|FG000|STARTED|Overall Study||32
3100780|NCT01500096|3824086|FG001|STARTED|Overall Study||17
3100781|NCT01500096|3824087|FG002|STARTED|Overall Study||31
3100782|NCT01500096|3824088|FG003|STARTED|Overall Study||16
3100783|NCT01500096|3824085|FG000|COMPLETED|Overall Study||31
3100784|NCT01500096|3824086|FG001|COMPLETED|Overall Study||17
3100785|NCT01500096|3824087|FG002|COMPLETED|Overall Study||31
3100786|NCT01500096|3824088|FG003|COMPLETED|Overall Study||14
3100787|NCT01500096|3824085|FG000|NOT COMPLETED|Overall Study||1
3100788|NCT01500096|3824086|FG001|NOT COMPLETED|Overall Study||0
3100789|NCT01500096|3824087|FG002|NOT COMPLETED|Overall Study||0
3100790|NCT01500096|3824088|FG003|NOT COMPLETED|Overall Study||2
3100791|NCT01500135|3824100|FG000|STARTED|Overall Study||100
3100792|NCT01500135|3824101|FG001|STARTED|Overall Study||50
3100793|NCT01500135|3824100|FG000|COMPLETED|Overall Study||83
3100794|NCT01500135|3824101|FG001|COMPLETED|Overall Study||39
3100795|NCT01500135|3824100|FG000|NOT COMPLETED|Overall Study||17
3100796|NCT01500135|3824101|FG001|NOT COMPLETED|Overall Study||11
3100797|NCT01500187|3824109|FG000|STARTED|Overall Study||23
3100798|NCT01500187|3824110|FG001|STARTED|Overall Study||15
3100799|NCT01500187|3824109|FG000|COMPLETED|Overall Study||17
3100800|NCT01500187|3824110|FG001|COMPLETED|Overall Study||15
3100801|NCT01500187|3824109|FG000|NOT COMPLETED|Overall Study||6
3100802|NCT01500187|3824110|FG001|NOT COMPLETED|Overall Study||0
3100803|NCT01500200|3824119|FG000|STARTED|Stage 1||98
3100804|NCT01500200|3824120|FG001|STARTED|Stage 1||24
3100805|NCT01500200|3824121|FG002|STARTED|Stage 1||19
3100806|NCT01500200|3824122|FG003|STARTED|Stage 1||0
3100807|NCT01500200|3824123|FG004|STARTED|Stage 1||0
3100808|NCT01500200|3824124|FG005|STARTED|Stage 1||0
3100809|NCT01500200|3824119|FG000|COMPLETED|Stage 1||90
3100810|NCT01500200|3824120|FG001|COMPLETED|Stage 1||18
3100811|NCT01500200|3824121|FG002|COMPLETED|Stage 1||13
3100812|NCT01500200|3824122|FG003|COMPLETED|Stage 1||0
3100813|NCT01500200|3824123|FG004|COMPLETED|Stage 1||0
3100814|NCT01500200|3824124|FG005|COMPLETED|Stage 1||0
3100815|NCT01500200|3824119|FG000|NOT COMPLETED|Stage 1||8
3100816|NCT01500200|3824120|FG001|NOT COMPLETED|Stage 1||6
3100817|NCT01500200|3824121|FG002|NOT COMPLETED|Stage 1||6
3100818|NCT01500200|3824122|FG003|NOT COMPLETED|Stage 1||0
3100819|NCT01500200|3824123|FG004|NOT COMPLETED|Stage 1||0
3100820|NCT01500200|3824124|FG005|NOT COMPLETED|Stage 1||0
3100821|NCT01500200|3824119|FG000|STARTED|Stage 2||0
3100822|NCT01500200|3824120|FG001|STARTED|Stage 2||0
3100823|NCT01500200|3824121|FG002|STARTED|Stage 2||0
3290979|NCT02840461|4025107|FG002|NOT COMPLETED|Overall Study||14
3290980|NCT02840474|4025118|FG000|STARTED|Overall Study||7
3290981|NCT02840474|4025119|FG001|STARTED|Overall Study||9
3290982|NCT02840474|4025118|FG000|Received Study Product|Overall Study||7
3290983|NCT02840474|4025119|FG001|Received Study Product|Overall Study||9
3290984|NCT02840474|4025118|FG000|COMPLETED|Overall Study||6
3290985|NCT02840474|4025119|FG001|COMPLETED|Overall Study||9
3290986|NCT02840474|4025118|FG000|NOT COMPLETED|Overall Study||1
3290987|NCT02840474|4025119|FG001|NOT COMPLETED|Overall Study||0
3290988|NCT02840721|4025125|FG000|STARTED|Treatment Period||50
3290989|NCT02840721|4025125|FG000|COMPLETED|Treatment Period||49
3290990|NCT02840721|4025125|FG000|NOT COMPLETED|Treatment Period||1
3290991|NCT02840721|4025125|FG000|STARTED|Follow-Up||49
3290992|NCT02840721|4025125|FG000|COMPLETED|Follow-Up||42
3290993|NCT02840721|4025125|FG000|NOT COMPLETED|Follow-Up||7
3290994|NCT02840916|4025131|FG000|STARTED|Overall Study||33
3290995|NCT02840916|4025132|FG001|STARTED|Overall Study||33
3290996|NCT02840916|4025131|FG000|COMPLETED|Overall Study||32
3290997|NCT02840916|4025132|FG001|COMPLETED|Overall Study||30
3290998|NCT02840916|4025131|FG000|NOT COMPLETED|Overall Study||1
3290999|NCT02840916|4025132|FG001|NOT COMPLETED|Overall Study||3
3291000|NCT02841033|4025138|FG000|STARTED|Overall Study||22
3291001|NCT02841033|4025138|FG000|COMPLETED|Overall Study||22
3291002|NCT02841033|4025138|FG000|NOT COMPLETED|Overall Study||0
3291003|NCT02841046|4025144|FG000|STARTED|Overall Study||25
3291004|NCT02841046|4025145|FG001|STARTED|Overall Study||25
3291005|NCT02841046|4025144|FG000|COMPLETED|Overall Study||25
3291006|NCT02841046|4025145|FG001|COMPLETED|Overall Study||25
3291007|NCT02841046|4025144|FG000|NOT COMPLETED|Overall Study||0
3291008|NCT02841046|4025145|FG001|NOT COMPLETED|Overall Study||0
3291009|NCT02841189|4025151|FG000|STARTED|Overall Study||100
3291010|NCT02841189|4025151|FG000|COMPLETED|Overall Study||65
3291011|NCT02841189|4025151|FG000|NOT COMPLETED|Overall Study||35
3291012|NCT02841241|4025155|FG000|STARTED|Overall Study||7
3291013|NCT02841241|4025155|FG000|COMPLETED|Overall Study||7
3291014|NCT02841241|4025155|FG000|NOT COMPLETED|Overall Study||0
3291015|NCT02841267|4025162|FG000|STARTED|Lead-in (Untreated)||4
3291016|NCT02841267|4025163|FG001|STARTED|Lead-in (Untreated)||7
3291017|NCT02841267|4025164|FG002|STARTED|Lead-in (Untreated)||8
3291018|NCT02841267|4025162|FG000|COMPLETED|Lead-in (Untreated)||4
3291019|NCT02841267|4025163|FG001|COMPLETED|Lead-in (Untreated)||7
3291020|NCT02841267|4025164|FG002|COMPLETED|Lead-in (Untreated)||8
3291021|NCT02841267|4025162|FG000|NOT COMPLETED|Lead-in (Untreated)||0
3291022|NCT02841267|4025163|FG001|NOT COMPLETED|Lead-in (Untreated)||0
3291023|NCT02841267|4025164|FG002|NOT COMPLETED|Lead-in (Untreated)||0
3291024|NCT02841267|4025162|FG000|STARTED|Treatment Period|Cohort 1 was invited to continue receiving 40mg/kg of study drug every 4 weeks for 28 weeks.|4
3291025|NCT02841267|4025163|FG001|STARTED|Treatment Period||7
3291026|NCT02841267|4025164|FG002|STARTED|Treatment Period||8
3291027|NCT02841267|4025162|FG000|COMPLETED|Treatment Period||4
3291028|NCT02841267|4025163|FG001|COMPLETED|Treatment Period||7
3291029|NCT02841267|4025164|FG002|COMPLETED|Treatment Period||8
3291030|NCT02841267|4025162|FG000|NOT COMPLETED|Treatment Period||0
3291031|NCT02841267|4025163|FG001|NOT COMPLETED|Treatment Period||0
3291032|NCT02841267|4025164|FG002|NOT COMPLETED|Treatment Period||0
3291033|NCT02841267|4025162|FG000|STARTED|Extension Study|Cohort 1 was invited to continue receiving 40mg/kg of study drug every 4 weeks for 28 weeks.|4
3291034|NCT02841267|4025163|FG001|STARTED|Extension Study|Cohort 2 was invited to continue receiving 40mg/kg of study drug every 4 weeks for 40 weeks.|6
3291035|NCT02841267|4025164|FG002|STARTED|Extension Study|Cohort 3 was invited to continue receiving 40mg/kg of study drug every 4 weeks for 24 weeks.|6
3291036|NCT02841267|4025162|FG000|COMPLETED|Extension Study||4
3291037|NCT02841267|4025163|FG001|COMPLETED|Extension Study||6
3291038|NCT02841267|4025164|FG002|COMPLETED|Extension Study||6
3291039|NCT02841267|4025162|FG000|NOT COMPLETED|Extension Study||0
3291040|NCT02841267|4025163|FG001|NOT COMPLETED|Extension Study||0
3291041|NCT02841267|4025164|FG002|NOT COMPLETED|Extension Study||0
3291042|NCT02841397|4025180|FG000|STARTED|Overall Study||50
3291043|NCT02841397|4025180|FG000|COMPLETED|Overall Study||48
3100824|NCT01500200|3824122|FG003|STARTED|Stage 2||20
3100825|NCT01500200|3824123|FG004|STARTED|Stage 2||23
3100826|NCT01500200|3824124|FG005|STARTED|Stage 2||22
3100827|NCT01500200|3824119|FG000|COMPLETED|Stage 2||0
3100828|NCT01500200|3824120|FG001|COMPLETED|Stage 2||0
3100829|NCT01500200|3824121|FG002|COMPLETED|Stage 2||0
3100830|NCT01500200|3824122|FG003|COMPLETED|Stage 2||20
3100831|NCT01500200|3824123|FG004|COMPLETED|Stage 2||18
3100832|NCT01500200|3824124|FG005|COMPLETED|Stage 2||18
3100833|NCT01500200|3824119|FG000|NOT COMPLETED|Stage 2||0
3100834|NCT01500200|3824120|FG001|NOT COMPLETED|Stage 2||0
3100835|NCT01500200|3824121|FG002|NOT COMPLETED|Stage 2||0
3100836|NCT01500200|3824122|FG003|NOT COMPLETED|Stage 2||0
3100837|NCT01500200|3824123|FG004|NOT COMPLETED|Stage 2||5
3100838|NCT01500200|3824124|FG005|NOT COMPLETED|Stage 2||4
3100839|NCT01500213|3824140|FG000|STARTED|Overall Study|Number of randomized patients|278
3100840|NCT01500213|3824141|FG001|STARTED|Overall Study||277
3100841|NCT01500213|3824140|FG000|COMPLETED|Overall Study|Number of patients who completed 6 cycles|61
3100842|NCT01500213|3824141|FG001|COMPLETED|Overall Study||53
3100843|NCT01500213|3824140|FG000|NOT COMPLETED|Overall Study||217
3100844|NCT01500213|3824141|FG001|NOT COMPLETED|Overall Study||224
3100845|NCT01500226|3824149|FG000|STARTED|Overall Study|Number of randomized patients|684
3100846|NCT01500226|3824150|FG001|STARTED|Overall Study||685
3100847|NCT01500226|3824149|FG000|COMPLETED|Overall Study|Number of patients who completed 6 cycles|185
3100848|NCT01500226|3824150|FG001|COMPLETED|Overall Study||191
3291044|NCT02841397|4025180|FG000|NOT COMPLETED|Overall Study||2
3291045|NCT02841449|4025186|FG000|STARTED|Overall Study||7
3291046|NCT02841449|4025187|FG001|STARTED|Overall Study||9
3291047|NCT02841449|4025186|FG000|COMPLETED|Overall Study||7
3100849|NCT01500226|3824149|FG000|NOT COMPLETED|Overall Study||499
3100850|NCT01500226|3824150|FG001|NOT COMPLETED|Overall Study||494
3100851|NCT01500252|3824158|FG000|STARTED|Overall Study||21
3100852|NCT01500252|3824159|FG001|STARTED|Overall Study||17
3100853|NCT01500252|3824158|FG000|One Years|Overall Study||20
3100854|NCT01500252|3824159|FG001|One Years|Overall Study||16
3100855|NCT01500252|3824158|FG000|Five Years|Overall Study||17
3100856|NCT01500252|3824159|FG001|Five Years|Overall Study||13
3100857|NCT01500252|3824158|FG000|Ten Years|Overall Study||12
3100858|NCT01500252|3824159|FG001|Ten Years|Overall Study||11
3100859|NCT01500252|3824158|FG000|COMPLETED|Overall Study|2 participants died within 5 years; 2 participants died between 5 & 10 years for a total of 4 deaths|12
3100860|NCT01500252|3824159|FG001|COMPLETED|Overall Study|2 participant deceased by 5 years; no further deaths between 5 & 10 years for a total of 2 deaths|11
3100861|NCT01500252|3824158|FG000|NOT COMPLETED|Overall Study||9
3100862|NCT01500252|3824159|FG001|NOT COMPLETED|Overall Study||6
3100863|NCT01500278|3824168|FG000|STARTED|Week 0 - Week 12||457
3100864|NCT01500278|3824169|FG001|STARTED|Week 0 - Week 12||458
3100865|NCT01500278|3824168|FG000|COMPLETED|Week 0 - Week 12||426
3100866|NCT01500278|3824169|FG001|COMPLETED|Week 0 - Week 12||428
3100867|NCT01500278|3824168|FG000|NOT COMPLETED|Week 0 - Week 12||31
3100868|NCT01500278|3824169|FG001|NOT COMPLETED|Week 0 - Week 12||30
3100869|NCT01500278|3824168|FG000|STARTED|Week 13 - Week 104||426
3100870|NCT01500278|3824169|FG001|STARTED|Week 13 - Week 104||428
3100871|NCT01500278|3824168|FG000|COMPLETED|Week 13 - Week 104||287
3100872|NCT01500278|3824169|FG001|COMPLETED|Week 13 - Week 104||302
3100873|NCT01500278|3824168|FG000|NOT COMPLETED|Week 13 - Week 104||139
3100874|NCT01500278|3824169|FG001|NOT COMPLETED|Week 13 - Week 104||126
3100875|NCT01500317|3824180|FG000|STARTED|Overall Study||13
3100876|NCT01500317|3824181|FG001|STARTED|Overall Study||12
3100877|NCT01500317|3824182|FG002|STARTED|Overall Study||13
3100878|NCT01500317|3824180|FG000|COMPLETED|Overall Study||10
3100879|NCT01500317|3824181|FG001|COMPLETED|Overall Study||10
3100880|NCT01500317|3824182|FG002|COMPLETED|Overall Study||13
3100881|NCT01500317|3824180|FG000|NOT COMPLETED|Overall Study||3
3100882|NCT01500317|3824181|FG001|NOT COMPLETED|Overall Study||2
3100883|NCT01500317|3824182|FG002|NOT COMPLETED|Overall Study||0
3100884|NCT01500382|3824194|FG000|STARTED|Treatment Period 1||1
3100885|NCT01500382|3824195|FG001|STARTED|Treatment Period 1||1
3100886|NCT01500382|3824196|FG002|STARTED|Treatment Period 1||1
3100887|NCT01500382|3824197|FG003|STARTED|Treatment Period 1||1
3100888|NCT01500382|3824194|FG000|COMPLETED|Treatment Period 1||1
3100889|NCT01500382|3824195|FG001|COMPLETED|Treatment Period 1||1
3100890|NCT01500382|3824196|FG002|COMPLETED|Treatment Period 1||1
3100891|NCT01500382|3824197|FG003|COMPLETED|Treatment Period 1||1
3100892|NCT01500382|3824194|FG000|NOT COMPLETED|Treatment Period 1||0
3100893|NCT01500382|3824195|FG001|NOT COMPLETED|Treatment Period 1||0
3100894|NCT01500382|3824196|FG002|NOT COMPLETED|Treatment Period 1||0
3100895|NCT01500382|3824197|FG003|NOT COMPLETED|Treatment Period 1||0
3100896|NCT01500382|3824194|FG000|STARTED|Washout Period||1
3100897|NCT01500382|3824195|FG001|STARTED|Washout Period||1
3100898|NCT01500382|3824196|FG002|STARTED|Washout Period||1
3100899|NCT01500382|3824197|FG003|STARTED|Washout Period||1
3100900|NCT01500382|3824194|FG000|COMPLETED|Washout Period||1
3100901|NCT01500382|3824195|FG001|COMPLETED|Washout Period||1
3100902|NCT01500382|3824196|FG002|COMPLETED|Washout Period||0
3100903|NCT01500382|3824197|FG003|COMPLETED|Washout Period||1
3100904|NCT01500382|3824194|FG000|NOT COMPLETED|Washout Period||0
3100905|NCT01500382|3824195|FG001|NOT COMPLETED|Washout Period||0
3100906|NCT01500382|3824196|FG002|NOT COMPLETED|Washout Period||1
3100907|NCT01500382|3824197|FG003|NOT COMPLETED|Washout Period||0
3100908|NCT01500382|3824194|FG000|STARTED|Treatment Period 2||1
3100909|NCT01500382|3824195|FG001|STARTED|Treatment Period 2||1
3100910|NCT01500382|3824196|FG002|STARTED|Treatment Period 2||0
3100911|NCT01500382|3824197|FG003|STARTED|Treatment Period 2||1
3100912|NCT01500382|3824194|FG000|COMPLETED|Treatment Period 2||1
3100913|NCT01500382|3824195|FG001|COMPLETED|Treatment Period 2||1
3100914|NCT01500382|3824196|FG002|COMPLETED|Treatment Period 2||0
3100915|NCT01500382|3824197|FG003|COMPLETED|Treatment Period 2||1
3100916|NCT01500382|3824194|FG000|NOT COMPLETED|Treatment Period 2||0
3100917|NCT01500382|3824195|FG001|NOT COMPLETED|Treatment Period 2||0
3100918|NCT01500382|3824196|FG002|NOT COMPLETED|Treatment Period 2||0
3100919|NCT01500382|3824197|FG003|NOT COMPLETED|Treatment Period 2||0
3100920|NCT01500434|3824207|FG000|STARTED|Overall Study||102
3100921|NCT01500434|3824207|FG000|COMPLETED|Overall Study||95
3100922|NCT01500434|3824207|FG000|NOT COMPLETED|Overall Study||7
3100923|NCT01500525|3824213|FG000|STARTED|Overall Study||286
3100924|NCT01500525|3824214|FG001|STARTED|Overall Study||301
3100925|NCT01500525|3824213|FG000|COMPLETED|Overall Study||286
3100926|NCT01500525|3824214|FG001|COMPLETED|Overall Study||301
3100927|NCT01500525|3824213|FG000|NOT COMPLETED|Overall Study||0
3100928|NCT01500525|3824214|FG001|NOT COMPLETED|Overall Study||0
3100929|NCT01500629|3824222|FG000|STARTED|Period 1 (Single Dose)||11
3100930|NCT01500629|3824223|FG001|STARTED|Period 1 (Single Dose)||10
3100931|NCT01500629|3824222|FG000|COMPLETED|Period 1 (Single Dose)||11
3100932|NCT01500629|3824223|FG001|COMPLETED|Period 1 (Single Dose)||10
3100933|NCT01500629|3824222|FG000|NOT COMPLETED|Period 1 (Single Dose)||0
3100934|NCT01500629|3824223|FG001|NOT COMPLETED|Period 1 (Single Dose)||0
3100935|NCT01500629|3824222|FG000|STARTED|Washout Period of 14 to 30 Days||11
3100936|NCT01500629|3824223|FG001|STARTED|Washout Period of 14 to 30 Days||10
3100937|NCT01500629|3824222|FG000|COMPLETED|Washout Period of 14 to 30 Days||10
3100938|NCT01500629|3824223|FG001|COMPLETED|Washout Period of 14 to 30 Days||10
3100939|NCT01500629|3824222|FG000|NOT COMPLETED|Washout Period of 14 to 30 Days||1
3100940|NCT01500629|3824223|FG001|NOT COMPLETED|Washout Period of 14 to 30 Days||0
3100941|NCT01500629|3824222|FG000|STARTED|Period 2 (Single Dose)||10
3100942|NCT01500629|3824223|FG001|STARTED|Period 2 (Single Dose)||10
3100943|NCT01500629|3824222|FG000|COMPLETED|Period 2 (Single Dose)||10
3100944|NCT01500629|3824223|FG001|COMPLETED|Period 2 (Single Dose)||10
3100945|NCT01500629|3824222|FG000|NOT COMPLETED|Period 2 (Single Dose)||0
3100946|NCT01500629|3824223|FG001|NOT COMPLETED|Period 2 (Single Dose)||0
3100947|NCT01500694|3824238|FG000|STARTED|Overall Study||131
3100948|NCT01500694|3824239|FG001|STARTED|Overall Study|Participants who received treatment were reported as Started.|83
3100949|NCT01500694|3824238|FG000|COMPLETED|Overall Study||79
3100950|NCT01500694|3824239|FG001|COMPLETED|Overall Study||54
3100951|NCT01500694|3824238|FG000|NOT COMPLETED|Overall Study||52
3100952|NCT01500694|3824239|FG001|NOT COMPLETED|Overall Study||29
3100953|NCT01500720|3824247|FG000|STARTED|Overall Study|Randomized|90
3100954|NCT01500720|3824248|FG001|STARTED|Overall Study|Randomized|89
3100955|NCT01500720|3824247|FG000|Treated|Overall Study||89
3100956|NCT01500720|3824248|FG001|Treated|Overall Study||88
3100957|NCT01500720|3824247|FG000|COMPLETED|Overall Study|Cancer progression,adverse event,consent withdrawal are considered as completed(defined in protocol)|85
3100958|NCT01500720|3824248|FG001|COMPLETED|Overall Study|Cancer progression,adverse event,consent withdrawal are considered as completed(defined in protocol)|80
3100959|NCT01500720|3824247|FG000|NOT COMPLETED|Overall Study||5
3100960|NCT01500720|3824248|FG001|NOT COMPLETED|Overall Study||9
3100961|NCT01500746|3824256|FG000|STARTED|Overall Study||4
3100962|NCT01500746|3824257|FG001|STARTED|Overall Study||4
3100963|NCT01500746|3824256|FG000|COMPLETED|Overall Study||4
3100964|NCT01500746|3824257|FG001|COMPLETED|Overall Study||4
3100965|NCT01500746|3824256|FG000|NOT COMPLETED|Overall Study||0
3100966|NCT01500746|3824257|FG001|NOT COMPLETED|Overall Study||0
3100967|NCT01500759|3824265|FG000|STARTED|Overall Study||3686
3100968|NCT01500759|3824266|FG001|STARTED|Overall Study||3190
3100969|NCT01500759|3824265|FG000|COMPLETED|Overall Study||3686
3100970|NCT01500759|3824266|FG001|COMPLETED|Overall Study||3190
3100971|NCT01500759|3824265|FG000|NOT COMPLETED|Overall Study||0
3100972|NCT01500759|3824266|FG001|NOT COMPLETED|Overall Study||0
3100973|NCT01501110|3824283|FG000|STARTED|Overall Study||34
3100974|NCT01501110|3824284|FG001|STARTED|Overall Study||34
3100975|NCT01501110|3824283|FG000|COMPLETED|Overall Study||34
3100976|NCT01501110|3824284|FG001|COMPLETED|Overall Study||33
3100977|NCT01501110|3824283|FG000|NOT COMPLETED|Overall Study||0
3100978|NCT01501110|3824284|FG001|NOT COMPLETED|Overall Study||1
3100979|NCT01501162|3824292|FG000|STARTED|Overall Study||65
3100980|NCT01501162|3824293|FG001|STARTED|Overall Study||65
3100981|NCT01501162|3824292|FG000|COMPLETED|Overall Study||57
3100982|NCT01501162|3824293|FG001|COMPLETED|Overall Study||60
3100983|NCT01501162|3824292|FG000|NOT COMPLETED|Overall Study||8
3100984|NCT01501162|3824293|FG001|NOT COMPLETED|Overall Study||5
3100985|NCT01501929|3824299|FG000|STARTED|First Intervention||8
3100986|NCT01501929|3824300|FG001|STARTED|First Intervention||17
3100987|NCT01501929|3824299|FG000|COMPLETED|First Intervention||8
3100988|NCT01501929|3824300|FG001|COMPLETED|First Intervention||17
3100989|NCT01501929|3824299|FG000|NOT COMPLETED|First Intervention||0
3100990|NCT01501929|3824300|FG001|NOT COMPLETED|First Intervention||0
3100991|NCT01501929|3824299|FG000|STARTED|Second Intervention||8
3100992|NCT01501929|3824300|FG001|STARTED|Second Intervention||17
3100993|NCT01501929|3824299|FG000|COMPLETED|Second Intervention||8
3100994|NCT01501929|3824300|FG001|COMPLETED|Second Intervention||17
3100995|NCT01501929|3824299|FG000|NOT COMPLETED|Second Intervention||0
3100996|NCT01501929|3824300|FG001|NOT COMPLETED|Second Intervention||0
3100997|NCT01502033|3824306|FG000|STARTED|Overall Study|Milestone (10 participants) met.|10
3100998|NCT01502033|3824306|FG000|COMPLETED|Overall Study|Milestone (10 participants) met|7
3100999|NCT01502033|3824306|FG000|NOT COMPLETED|Overall Study||3
3101000|NCT01502072|3824315|FG000|STARTED|Overall Study||14
3101001|NCT01502072|3824316|FG001|STARTED|Overall Study||10
3101002|NCT01502072|3824317|FG002|STARTED|Overall Study||20
3101003|NCT01502072|3824315|FG000|COMPLETED|Overall Study||13
3101004|NCT01502072|3824316|FG001|COMPLETED|Overall Study||9
3101005|NCT01502072|3824317|FG002|COMPLETED|Overall Study||20
3101006|NCT01502072|3824315|FG000|NOT COMPLETED|Overall Study||1
3101007|NCT01502072|3824316|FG001|NOT COMPLETED|Overall Study||1
3101008|NCT01502072|3824317|FG002|NOT COMPLETED|Overall Study||0
3101009|NCT01502228|3824325|FG000|STARTED|Overall Study||14
3101010|NCT01502228|3824325|FG000|COMPLETED|Overall Study||13
3101011|NCT01502228|3824325|FG000|NOT COMPLETED|Overall Study||1
3101012|NCT01502293|3824332|FG000|STARTED|Overall Study||30
3101013|NCT01502293|3824333|FG001|STARTED|Overall Study||17
3101014|NCT01502293|3824334|FG002|STARTED|Overall Study||4
3101015|NCT01502293|3824332|FG000|COMPLETED|Overall Study||5
3101016|NCT01502293|3824333|FG001|COMPLETED|Overall Study||0
3101017|NCT01502293|3824334|FG002|COMPLETED|Overall Study||0
3101018|NCT01502293|3824332|FG000|NOT COMPLETED|Overall Study||25
3101019|NCT01502293|3824333|FG001|NOT COMPLETED|Overall Study||17
3101020|NCT01502293|3824334|FG002|NOT COMPLETED|Overall Study||4
3101021|NCT01502306|3824348|FG000|STARTED|Overall Study||1004
3101022|NCT01502306|3824349|FG001|STARTED|Overall Study||1405
3101023|NCT01502306|3824350|FG002|STARTED|Overall Study||1407
3101024|NCT01502306|3824348|FG000|COMPLETED|Overall Study||1004
3101025|NCT01502306|3824349|FG001|COMPLETED|Overall Study||1405
3101026|NCT01502306|3824350|FG002|COMPLETED|Overall Study||1407
3101027|NCT01502306|3824348|FG000|NOT COMPLETED|Overall Study||0
3101028|NCT01502306|3824349|FG001|NOT COMPLETED|Overall Study||0
3101029|NCT01502306|3824350|FG002|NOT COMPLETED|Overall Study||0
3101030|NCT01502332|3824360|FG000|STARTED|Overall Study||157
3101031|NCT01502332|3824361|FG001|STARTED|Overall Study||163
3101032|NCT01502332|3824360|FG000|COMPLETED|Overall Study||157
3101033|NCT01502332|3824361|FG001|COMPLETED|Overall Study||163
3101034|NCT01502332|3824360|FG000|NOT COMPLETED|Overall Study||0
3101035|NCT01502332|3824361|FG001|NOT COMPLETED|Overall Study||0
3101036|NCT01502410|3824371|FG000|STARTED|Overall Study||10
3101037|NCT01502410|3824372|FG001|STARTED|Overall Study||10
3101038|NCT01502410|3824373|FG002|STARTED|Overall Study||0
3101039|NCT01502410|3824374|FG003|STARTED|Overall Study||0
3101040|NCT01502410|3824371|FG000|COMPLETED|Overall Study||0
3101041|NCT01502410|3824372|FG001|COMPLETED|Overall Study||0
3101042|NCT01502410|3824373|FG002|COMPLETED|Overall Study||0
3101043|NCT01502410|3824374|FG003|COMPLETED|Overall Study||0
3101044|NCT01502410|3824371|FG000|NOT COMPLETED|Overall Study||10
3101045|NCT01502410|3824372|FG001|NOT COMPLETED|Overall Study||10
3101046|NCT01502410|3824373|FG002|NOT COMPLETED|Overall Study||0
3101047|NCT01502410|3824374|FG003|NOT COMPLETED|Overall Study||0
3101048|NCT01502423|3824385|FG000|STARTED|Overall Study||31
3101049|NCT01502423|3824386|FG001|STARTED|Overall Study||30
3101050|NCT01502423|3824385|FG000|COMPLETED|Overall Study||31
3101051|NCT01502423|3824386|FG001|COMPLETED|Overall Study||29
3101052|NCT01502423|3824385|FG000|NOT COMPLETED|Overall Study||0
3101053|NCT01502423|3824386|FG001|NOT COMPLETED|Overall Study||1
3101054|NCT01502631|3824394|FG000|STARTED|Overall Study||30
3101055|NCT01502631|3824395|FG001|STARTED|Overall Study||31
3101056|NCT01502631|3824394|FG000|COMPLETED|Overall Study||10
3101057|NCT01502631|3824395|FG001|COMPLETED|Overall Study||11
3101058|NCT01502631|3824394|FG000|NOT COMPLETED|Overall Study||20
3101059|NCT01502631|3824395|FG001|NOT COMPLETED|Overall Study||20
3101060|NCT01502644|3824404|FG000|STARTED|Enrolled at Visit 1 After Pre-screening||81
3101061|NCT01502644|3824405|FG001|STARTED|Enrolled at Visit 1 After Pre-screening||0
3101062|NCT01502644|3824406|FG002|STARTED|Enrolled at Visit 1 After Pre-screening||0
3101063|NCT01502644|3824407|FG003|STARTED|Enrolled at Visit 1 After Pre-screening||0
3101064|NCT01502644|3824404|FG000|COMPLETED|Enrolled at Visit 1 After Pre-screening|Participants who completed Visit 1 were assigned to 1 of the 3 NA groups for remainder of the trial|72
3101065|NCT01502644|3824405|FG001|COMPLETED|Enrolled at Visit 1 After Pre-screening||0
3101066|NCT01502644|3824406|FG002|COMPLETED|Enrolled at Visit 1 After Pre-screening||0
3101067|NCT01502644|3824407|FG003|COMPLETED|Enrolled at Visit 1 After Pre-screening||0
3101068|NCT01502644|3824404|FG000|NOT COMPLETED|Enrolled at Visit 1 After Pre-screening||9
3101069|NCT01502644|3824405|FG001|NOT COMPLETED|Enrolled at Visit 1 After Pre-screening||0
3101070|NCT01502644|3824406|FG002|NOT COMPLETED|Enrolled at Visit 1 After Pre-screening||0
3101071|NCT01502644|3824407|FG003|NOT COMPLETED|Enrolled at Visit 1 After Pre-screening||0
3101072|NCT01502644|3824404|FG000|STARTED|Assigned to NA Groups||0
3101073|NCT01502644|3824405|FG001|STARTED|Assigned to NA Groups||30
3101074|NCT01502644|3824406|FG002|STARTED|Assigned to NA Groups||10
3101075|NCT01502644|3824407|FG003|STARTED|Assigned to NA Groups||32
3101076|NCT01502644|3824404|FG000|COMPLETED|Assigned to NA Groups||0
3101077|NCT01502644|3824405|FG001|COMPLETED|Assigned to NA Groups|Completed = completed at least 50% of the opioid treatment period (at least 10 weeks of treatment)|24
3101078|NCT01502644|3824406|FG002|COMPLETED|Assigned to NA Groups|Completed = completed at least 50% of the opioid treatment period (at least 10 weeks of treatment)|7
3101079|NCT01502644|3824407|FG003|COMPLETED|Assigned to NA Groups|Completed = completed at least 50% of the opioid treatment period (at least 10 weeks of treatment)|24
3101080|NCT01502644|3824404|FG000|NOT COMPLETED|Assigned to NA Groups||0
3101081|NCT01502644|3824405|FG001|NOT COMPLETED|Assigned to NA Groups||6
3101082|NCT01502644|3824406|FG002|NOT COMPLETED|Assigned to NA Groups||3
3101083|NCT01502644|3824407|FG003|NOT COMPLETED|Assigned to NA Groups||8
3101084|NCT01502709|3824417|FG000|STARTED|Overall Study||5
3101085|NCT01502709|3824418|FG001|STARTED|Overall Study||0
3101086|NCT01502709|3824417|FG000|COMPLETED|Overall Study||1
3101087|NCT01502709|3824418|FG001|COMPLETED|Overall Study||0
3101088|NCT01502709|3824417|FG000|NOT COMPLETED|Overall Study||4
3101089|NCT01502709|3824418|FG001|NOT COMPLETED|Overall Study||0
3101090|NCT01502761|3824429|FG000|STARTED|Overall Study||4
3101091|NCT01502761|3824430|FG001|STARTED|Overall Study||0
3101092|NCT01502761|3824431|FG002|STARTED|Overall Study||0
3101093|NCT01502761|3824432|FG003|STARTED|Overall Study||0
3101094|NCT01502761|3824429|FG000|COMPLETED|Overall Study||4
3101095|NCT01502761|3824430|FG001|COMPLETED|Overall Study||0
3101096|NCT01502761|3824431|FG002|COMPLETED|Overall Study||0
3101097|NCT01502761|3824432|FG003|COMPLETED|Overall Study||0
3101098|NCT01502761|3824429|FG000|NOT COMPLETED|Overall Study||0
3101099|NCT01502761|3824430|FG001|NOT COMPLETED|Overall Study||0
3101100|NCT01502761|3824431|FG002|NOT COMPLETED|Overall Study||0
3101101|NCT01502761|3824432|FG003|NOT COMPLETED|Overall Study||0
3101102|NCT01502787|3824442|FG000|STARTED|Overall Study||11
3101103|NCT01502787|3824443|FG001|STARTED|Overall Study||10
3101104|NCT01502787|3824442|FG000|COMPLETED|Overall Study||11
3101105|NCT01502787|3824443|FG001|COMPLETED|Overall Study||10
3101106|NCT01502787|3824442|FG000|NOT COMPLETED|Overall Study||0
3101107|NCT01502787|3824443|FG001|NOT COMPLETED|Overall Study||0
3101108|NCT01502813|3824453|FG000|STARTED|Overall Study||40
3101109|NCT01502813|3824453|FG000|COMPLETED|Overall Study||40
3101110|NCT01502813|3824453|FG000|NOT COMPLETED|Overall Study||0
3101111|NCT01502956|3824459|FG000|STARTED|Overall Study||192
3101112|NCT01502956|3824460|FG001|STARTED|Overall Study||194
3101113|NCT01502956|3824459|FG000|COMPLETED|Overall Study||168
3101114|NCT01502956|3824460|FG001|COMPLETED|Overall Study||168
3101115|NCT01502956|3824459|FG000|NOT COMPLETED|Overall Study||24
3101116|NCT01502956|3824460|FG001|NOT COMPLETED|Overall Study||26
3101117|NCT01503021|3824468|FG000|STARTED|Overall Study||360
3101118|NCT01503021|3824469|FG001|STARTED|Overall Study||358
3101119|NCT01503021|3824468|FG000|Dosed|Overall Study||351
3101120|NCT01503021|3824469|FG001|Dosed|Overall Study||352
3101121|NCT01503021|3824468|FG000|Completed Treatment|Overall Study||333
3101122|NCT01503021|3824469|FG001|Completed Treatment|Overall Study|One patient completed the treatment period but discontinued prior to completing the follow-up visit.|333
3101123|NCT01503021|3824468|FG000|COMPLETED|Overall Study||333
3101124|NCT01503021|3824469|FG001|COMPLETED|Overall Study||332
3101125|NCT01503021|3824468|FG000|NOT COMPLETED|Overall Study||27
3101126|NCT01503021|3824469|FG001|NOT COMPLETED|Overall Study||26
3101127|NCT01503164|3824482|FG000|STARTED|Overall Study||55
3101128|NCT01503164|3824483|FG001|STARTED|Overall Study||56
3101129|NCT01503164|3824482|FG000|COMPLETED|Overall Study||53
3101130|NCT01503164|3824483|FG001|COMPLETED|Overall Study||55
3101131|NCT01503164|3824482|FG000|NOT COMPLETED|Overall Study||2
3101132|NCT01503164|3824483|FG001|NOT COMPLETED|Overall Study||1
3101133|NCT01503229|3824489|FG000|STARTED|Overall Study||30
3101134|NCT01503229|3824489|FG000|COMPLETED|Overall Study||29
3101135|NCT01503229|3824489|FG000|NOT COMPLETED|Overall Study||1
3101136|NCT01503333|3824495|FG000|STARTED|Overall Study||777
3101137|NCT01503333|3824496|FG001|STARTED|Overall Study||766
3101138|NCT01503333|3824495|FG000|Completed Baseline|Overall Study||766
3101139|NCT01503333|3824496|FG001|Completed Baseline|Overall Study||753
3101140|NCT01503333|3824495|FG000|Completed Post-intervention|Overall Study||680
3101141|NCT01503333|3824496|FG001|Completed Post-intervention|Overall Study||706
3101142|NCT01503333|3824495|FG000|COMPLETED|Overall Study||437
3101143|NCT01503333|3824496|FG001|COMPLETED|Overall Study||461
3101144|NCT01503333|3824495|FG000|NOT COMPLETED|Overall Study||340
3101145|NCT01503333|3824496|FG001|NOT COMPLETED|Overall Study||305
3101146|NCT01503749|3824513|FG000|STARTED|Overall Study||3
3101147|NCT01503749|3824514|FG001|STARTED|Overall Study||3
3101148|NCT01503749|3824515|FG002|STARTED|Overall Study||3
3101149|NCT01503749|3824513|FG000|COMPLETED|Overall Study||3
3101150|NCT01503749|3824514|FG001|COMPLETED|Overall Study||3
3101151|NCT01503749|3824515|FG002|COMPLETED|Overall Study||3
3101152|NCT01503749|3824513|FG000|NOT COMPLETED|Overall Study||0
3101153|NCT01503749|3824514|FG001|NOT COMPLETED|Overall Study||0
3101154|NCT01503749|3824515|FG002|NOT COMPLETED|Overall Study||0
3101155|NCT01504204|3824525|FG000|STARTED|Overall Study||10
3101156|NCT01504204|3824526|FG001|STARTED|Overall Study||10
3101157|NCT01504204|3824525|FG000|COMPLETED|Overall Study||9
3101158|NCT01504204|3824526|FG001|COMPLETED|Overall Study||9
3101159|NCT01504204|3824525|FG000|NOT COMPLETED|Overall Study||1
3101160|NCT01504204|3824526|FG001|NOT COMPLETED|Overall Study||1
3101161|NCT01504412|3824537|FG000|STARTED|Overall Study||89
3101162|NCT01504412|3824538|FG001|STARTED|Overall Study||87
3101163|NCT01504412|3824539|FG002|STARTED|Overall Study||90
3101164|NCT01504412|3824540|FG003|STARTED|Overall Study||94
3101165|NCT01504412|3824541|FG004|STARTED|Overall Study||90
3101166|NCT01504412|3824537|FG000|COMPLETED|Overall Study||84
3101167|NCT01504412|3824538|FG001|COMPLETED|Overall Study||75
3101168|NCT01504412|3824539|FG002|COMPLETED|Overall Study||86
3101169|NCT01504412|3824540|FG003|COMPLETED|Overall Study||75
3101170|NCT01504412|3824541|FG004|COMPLETED|Overall Study||77
3101171|NCT01504412|3824537|FG000|NOT COMPLETED|Overall Study||5
3101172|NCT01504412|3824538|FG001|NOT COMPLETED|Overall Study||12
3101173|NCT01504412|3824539|FG002|NOT COMPLETED|Overall Study||4
3101174|NCT01504412|3824540|FG003|NOT COMPLETED|Overall Study||19
3101175|NCT01504412|3824541|FG004|NOT COMPLETED|Overall Study||13
3101176|NCT01504477|3824553|FG000|STARTED|Overall Study||6
3101177|NCT01504477|3824553|FG000|COMPLETED|Overall Study||6
3101178|NCT01504477|3824553|FG000|NOT COMPLETED|Overall Study||0
3101179|NCT01504672|3824559|FG000|STARTED|Overall Study||230
3101180|NCT01504672|3824560|FG001|STARTED|Overall Study||230
3101181|NCT01504672|3824559|FG000|COMPLETED|Overall Study||212
3101182|NCT01504672|3824560|FG001|COMPLETED|Overall Study||217
3101183|NCT01504672|3824559|FG000|NOT COMPLETED|Overall Study||18
3101184|NCT01504672|3824560|FG001|NOT COMPLETED|Overall Study||13
3135371|NCT01706588|3860383|FG004|NOT COMPLETED|Overall Study||0
3135372|NCT01706666|3860398|FG000|STARTED|Overall Study||1
3135373|NCT01706666|3860399|FG001|STARTED|Overall Study||1
3135374|NCT01706666|3860400|FG002|STARTED|Overall Study||1
3135375|NCT01706666|3860398|FG000|COMPLETED|Overall Study||1
3135376|NCT01706666|3860399|FG001|COMPLETED|Overall Study||1
3135377|NCT01706666|3860400|FG002|COMPLETED|Overall Study||1
3135378|NCT01706666|3860398|FG000|NOT COMPLETED|Overall Study||0
3135379|NCT01706666|3860399|FG001|NOT COMPLETED|Overall Study||0
3135380|NCT01706666|3860400|FG002|NOT COMPLETED|Overall Study||0
3135381|NCT01706770|3860410|FG000|STARTED|Overall Study||33
3135382|NCT01706770|3860411|FG001|STARTED|Overall Study||17
3135383|NCT01706770|3860410|FG000|COMPLETED|Overall Study||31
3135384|NCT01706770|3860411|FG001|COMPLETED|Overall Study||17
3135385|NCT01706770|3860410|FG000|NOT COMPLETED|Overall Study||2
3135386|NCT01706770|3860411|FG001|NOT COMPLETED|Overall Study||0
3135387|NCT01706822|3860417|FG000|STARTED|Overall Study||8
3135388|NCT01706822|3860417|FG000|COMPLETED|Overall Study||8
3135389|NCT01706822|3860417|FG000|NOT COMPLETED|Overall Study||0
3135390|NCT01706926|3860425|FG000|STARTED|Overall Study||81
3135391|NCT01706926|3860426|FG001|STARTED|Overall Study||81
3135392|NCT01706926|3860427|FG002|STARTED|Overall Study||85
3135393|NCT01706926|3860428|FG003|STARTED|Overall Study||79
3135394|NCT01706926|3860425|FG000|COMPLETED|Overall Study||75
3135395|NCT01706926|3860426|FG001|COMPLETED|Overall Study||77
3135396|NCT01706926|3860427|FG002|COMPLETED|Overall Study||79
3135397|NCT01706926|3860428|FG003|COMPLETED|Overall Study||74
3135398|NCT01706926|3860425|FG000|NOT COMPLETED|Overall Study||6
3135399|NCT01706926|3860426|FG001|NOT COMPLETED|Overall Study||4
3135400|NCT01706926|3860427|FG002|NOT COMPLETED|Overall Study||6
3135401|NCT01706926|3860428|FG003|NOT COMPLETED|Overall Study||5
3135402|NCT01706952|3860441|FG000|STARTED|Overall Study||45
3135403|NCT01706952|3860441|FG000|COMPLETED|Overall Study||37
3135404|NCT01706952|3860441|FG000|NOT COMPLETED|Overall Study||8
3135405|NCT01706965|3860449|FG000|STARTED|Overall Study||14
3135406|NCT01706965|3860450|FG001|STARTED|Overall Study||13
3135407|NCT01706965|3860449|FG000|COMPLETED|Overall Study||13
3135408|NCT01706965|3860450|FG001|COMPLETED|Overall Study||12
3135409|NCT01706965|3860449|FG000|NOT COMPLETED|Overall Study||1
3135410|NCT01706965|3860450|FG001|NOT COMPLETED|Overall Study||1
3135411|NCT01706978|3860458|FG000|STARTED|Overall Study||47
3135412|NCT01706978|3860459|FG001|STARTED|Overall Study||41
3135413|NCT01706978|3860458|FG000|COMPLETED|Overall Study||38
3135414|NCT01706978|3860459|FG001|COMPLETED|Overall Study||35
3135415|NCT01706978|3860458|FG000|NOT COMPLETED|Overall Study||9
3135416|NCT01706978|3860459|FG001|NOT COMPLETED|Overall Study||6
3135417|NCT01707004|3860465|FG000|STARTED|Overall Study||20
3135418|NCT01707004|3860465|FG000|COMPLETED|Overall Study|3 participants were not eligible to proceed to Bone Marrow Transplant due to significant infections.|17
3135419|NCT01707004|3860465|FG000|NOT COMPLETED|Overall Study||3
3135420|NCT01707030|3860472|FG000|STARTED|Overall Study||67
3135421|NCT01707030|3860473|FG001|STARTED|Overall Study||71
3135422|NCT01707030|3860472|FG000|COMPLETED|Overall Study||56
3135423|NCT01707030|3860473|FG001|COMPLETED|Overall Study||54
3135424|NCT01707030|3860472|FG000|NOT COMPLETED|Overall Study||11
3135425|NCT01707030|3860473|FG001|NOT COMPLETED|Overall Study||17
3135426|NCT01707043|3860485|FG000|STARTED|Overall Study||10
3135427|NCT01707043|3860486|FG001|STARTED|Overall Study||10
3135428|NCT01707043|3860485|FG000|COMPLETED|Overall Study||10
3135429|NCT01707043|3860486|FG001|COMPLETED|Overall Study||10
3135430|NCT01707043|3860485|FG000|NOT COMPLETED|Overall Study||0
3135431|NCT01707043|3860486|FG001|NOT COMPLETED|Overall Study||0
3135432|NCT01707095|3860494|FG000|STARTED|Overall Study||42
3135433|NCT01707095|3860495|FG001|STARTED|Overall Study||42
3135434|NCT01707095|3860494|FG000|COMPLETED|Overall Study||42
3135435|NCT01707095|3860495|FG001|COMPLETED|Overall Study||42
3135436|NCT01707095|3860494|FG000|NOT COMPLETED|Overall Study||0
3135437|NCT01707095|3860495|FG001|NOT COMPLETED|Overall Study||0
3135438|NCT01707108|3860501|FG000|STARTED|Overall Study||60
3135439|NCT01707108|3860501|FG000|1 Year|Overall Study||60
3135440|NCT01707108|3860501|FG000|COMPLETED|Overall Study||60
3135441|NCT01707108|3860501|FG000|NOT COMPLETED|Overall Study||0
3135442|NCT01707147|3860506|FG000|STARTED|Overall Study||3219
3135443|NCT01707147|3860506|FG000|COMPLETED|Overall Study||3119
3135444|NCT01707147|3860506|FG000|NOT COMPLETED|Overall Study||100
3135445|NCT01707225|3860510|FG000|STARTED|Overall Study||10
3135446|NCT01707225|3860510|FG000|COMPLETED|Overall Study||10
3135447|NCT01707225|3860510|FG000|NOT COMPLETED|Overall Study||0
3135448|NCT01707238|3860516|FG000|STARTED|Overall Study||48
3135449|NCT01707238|3860517|FG001|STARTED|Overall Study||52
3135450|NCT01707238|3860516|FG000|COMPLETED|Overall Study||48
3135451|NCT01707238|3860517|FG001|COMPLETED|Overall Study||52
3135452|NCT01707238|3860516|FG000|NOT COMPLETED|Overall Study||0
3135453|NCT01707238|3860517|FG001|NOT COMPLETED|Overall Study||0
3135454|NCT01707290|3860526|FG000|STARTED|Overall Study||121
3135455|NCT01707290|3860527|FG001|STARTED|Overall Study||4
3135456|NCT01707290|3860526|FG000|COMPLETED|Overall Study||35
3101185|NCT01504711|3824568|FG000|STARTED|Overall Study||30
3101186|NCT01504711|3824568|FG000|COMPLETED|Overall Study||27
3101187|NCT01504711|3824568|FG000|NOT COMPLETED|Overall Study||3
3101188|NCT01504841|3824575|FG000|STARTED|Overall Study||20
3101189|NCT01504841|3824576|FG001|STARTED|Overall Study||6
3101190|NCT01504841|3824577|FG002|STARTED|Overall Study|No enrollments occurred into Cohort 3 during the study.|0
3101191|NCT01504841|3824575|FG000|COMPLETED|Overall Study||19
3101192|NCT01504841|3824576|FG001|COMPLETED|Overall Study||5
3101193|NCT01504841|3824577|FG002|COMPLETED|Overall Study||0
3101194|NCT01504841|3824575|FG000|NOT COMPLETED|Overall Study||1
3101195|NCT01504841|3824576|FG001|NOT COMPLETED|Overall Study||1
3101196|NCT01504841|3824577|FG002|NOT COMPLETED|Overall Study||0
3101197|NCT01504854|3824586|FG000|STARTED|Overall Study||64
3101198|NCT01504854|3824587|FG001|STARTED|Overall Study||55
3101199|NCT01504854|3824586|FG000|COMPLETED|Overall Study||56
3101200|NCT01504854|3824587|FG001|COMPLETED|Overall Study||48
3101201|NCT01504854|3824586|FG000|NOT COMPLETED|Overall Study||8
3101202|NCT01504854|3824587|FG001|NOT COMPLETED|Overall Study||7
3101203|NCT01504867|3824595|FG000|STARTED|Overall Study||202
3101204|NCT01504867|3824596|FG001|STARTED|Overall Study||198
3101205|NCT01504867|3824595|FG000|COMPLETED|Overall Study||195
3101206|NCT01504867|3824596|FG001|COMPLETED|Overall Study||195
3101207|NCT01504867|3824595|FG000|NOT COMPLETED|Overall Study||7
3101208|NCT01504867|3824596|FG001|NOT COMPLETED|Overall Study||3
3101209|NCT01504958|3824605|FG000|STARTED|Overall Study|Baseline clinical, cognitive, and behavioral assessments: TMS-EMG measures, MRI scan, randomization.|10
3101210|NCT01504958|3824606|FG001|STARTED|Overall Study|Baseline clinical, cognitive, and behavioral assessments: TMS-EMG measures, MRI scan, randomization.|6
3101211|NCT01504958|3824607|FG002|STARTED|Overall Study|Baseline clinical, cognitive, and behavioral assessments: TMS-EMG measures, MRI scan, randomization.|6
3101212|NCT01504958|3824605|FG000|COMPLETED|Overall Study|1 Month Post-Treatment Follow Up|10
3101213|NCT01504958|3824606|FG001|COMPLETED|Overall Study|1 Month Post-Treatment Follow Up|6
3101214|NCT01504958|3824607|FG002|COMPLETED|Overall Study|1 Month Post-Treatment Follow Up|6
3101215|NCT01504958|3824605|FG000|NOT COMPLETED|Overall Study||0
3101216|NCT01504958|3824606|FG001|NOT COMPLETED|Overall Study||0
3101217|NCT01504958|3824607|FG002|NOT COMPLETED|Overall Study||0
3101218|NCT01504971|3824615|FG000|STARTED|Overall Study||95
3101219|NCT01504971|3824615|FG000|COMPLETED|Overall Study||82
3101220|NCT01504971|3824615|FG000|NOT COMPLETED|Overall Study||13
3101221|NCT01504997|3824623|FG000|STARTED|Overall Study||18
3101222|NCT01504997|3824623|FG000|COMPLETED|Overall Study||18
3101223|NCT01504997|3824623|FG000|NOT COMPLETED|Overall Study||0
3101224|NCT01505010|3824629|FG000|STARTED|Overall Study||9
3101225|NCT01505010|3824630|FG001|STARTED|Overall Study||8
3101226|NCT01505010|3824629|FG000|COMPLETED|Overall Study||9
3101227|NCT01505010|3824630|FG001|COMPLETED|Overall Study||6
3101228|NCT01505010|3824629|FG000|NOT COMPLETED|Overall Study||0
3101229|NCT01505010|3824630|FG001|NOT COMPLETED|Overall Study||2
3101230|NCT01505062|3824639|FG000|STARTED|Overall Study||3
3101231|NCT01505062|3824640|FG001|STARTED|Overall Study||3
3101232|NCT01505062|3824641|FG002|STARTED|Overall Study||3
3101233|NCT01505062|3824639|FG000|COMPLETED|Overall Study||3
3101234|NCT01505062|3824640|FG001|COMPLETED|Overall Study||3
3101235|NCT01505062|3824641|FG002|COMPLETED|Overall Study||3
3291048|NCT02841449|4025187|FG001|COMPLETED|Overall Study||9
3291049|NCT02841449|4025186|FG000|NOT COMPLETED|Overall Study||0
3291050|NCT02841449|4025187|FG001|NOT COMPLETED|Overall Study||0
3291051|NCT02841709|4025193|FG000|STARTED|1st Intervention||12
3291052|NCT02841709|4025194|FG001|STARTED|1st Intervention||11
3291053|NCT02841709|4025195|FG002|STARTED|1st Intervention||12
3291054|NCT02841709|4025196|FG003|STARTED|1st Intervention||12
3291055|NCT02841709|4025197|FG004|STARTED|1st Intervention||11
3291056|NCT02841709|4025193|FG000|COMPLETED|1st Intervention||12
3291057|NCT02841709|4025194|FG001|COMPLETED|1st Intervention||11
3291058|NCT02841709|4025195|FG002|COMPLETED|1st Intervention||12
3291059|NCT02841709|4025196|FG003|COMPLETED|1st Intervention||12
3291060|NCT02841709|4025197|FG004|COMPLETED|1st Intervention||11
3291061|NCT02841709|4025193|FG000|NOT COMPLETED|1st Intervention||0
3291062|NCT02841709|4025194|FG001|NOT COMPLETED|1st Intervention||0
3291063|NCT02841709|4025195|FG002|NOT COMPLETED|1st Intervention||0
3291064|NCT02841709|4025196|FG003|NOT COMPLETED|1st Intervention||0
3291065|NCT02841709|4025197|FG004|NOT COMPLETED|1st Intervention||0
3291066|NCT02841709|4025193|FG000|STARTED|Washout Period 1||12
3291067|NCT02841709|4025194|FG001|STARTED|Washout Period 1||11
3291068|NCT02841709|4025195|FG002|STARTED|Washout Period 1||12
3291069|NCT02841709|4025196|FG003|STARTED|Washout Period 1||12
3291070|NCT02841709|4025197|FG004|STARTED|Washout Period 1||11
3291071|NCT02841709|4025193|FG000|COMPLETED|Washout Period 1||12
3291072|NCT02841709|4025194|FG001|COMPLETED|Washout Period 1||11
3101236|NCT01505062|3824639|FG000|NOT COMPLETED|Overall Study||0
3101237|NCT01505062|3824640|FG001|NOT COMPLETED|Overall Study||0
3101238|NCT01505062|3824641|FG002|NOT COMPLETED|Overall Study||0
3101239|NCT01505114|3824653|FG000|STARTED|Overall Study||148
3101240|NCT01505114|3824654|FG001|STARTED|Overall Study||148
3101241|NCT01505114|3824655|FG002|STARTED|Overall Study||147
3101242|NCT01505114|3824656|FG003|STARTED|Overall Study||151
3291073|NCT02841709|4025195|FG002|COMPLETED|Washout Period 1||12
3291074|NCT02841709|4025196|FG003|COMPLETED|Washout Period 1||12
3291075|NCT02841709|4025197|FG004|COMPLETED|Washout Period 1||11
3291076|NCT02841709|4025193|FG000|NOT COMPLETED|Washout Period 1||0
3101243|NCT01505114|3824653|FG000|COMPLETED|Overall Study||123
3101244|NCT01505114|3824654|FG001|COMPLETED|Overall Study||135
3101245|NCT01505114|3824655|FG002|COMPLETED|Overall Study||129
3101246|NCT01505114|3824656|FG003|COMPLETED|Overall Study||128
3101247|NCT01505114|3824653|FG000|NOT COMPLETED|Overall Study||25
3101248|NCT01505114|3824654|FG001|NOT COMPLETED|Overall Study||13
3101249|NCT01505114|3824655|FG002|NOT COMPLETED|Overall Study||18
3101250|NCT01505114|3824656|FG003|NOT COMPLETED|Overall Study||23
3101251|NCT01505166|3824669|FG000|STARTED|Overall Study||3
3101252|NCT01505166|3824670|FG001|STARTED|Overall Study||0
3101253|NCT01505166|3824671|FG002|STARTED|Overall Study||0
3101254|NCT01505166|3824669|FG000|COMPLETED|Overall Study|"Completed means subject had successful Vigil manufacturing and had been given all the doses."|3
3101255|NCT01505166|3824670|FG001|COMPLETED|Overall Study||0
3101256|NCT01505166|3824671|FG002|COMPLETED|Overall Study||0
3101257|NCT01505166|3824669|FG000|NOT COMPLETED|Overall Study||0
3101258|NCT01505166|3824670|FG001|NOT COMPLETED|Overall Study||0
3101259|NCT01505166|3824671|FG002|NOT COMPLETED|Overall Study||0
3101260|NCT01505179|3824683|FG000|STARTED|Overall Study||6
3101261|NCT01505179|3824684|FG001|STARTED|Overall Study||4
3101262|NCT01505179|3824683|FG000|COMPLETED|Overall Study||6
3101263|NCT01505179|3824684|FG001|COMPLETED|Overall Study||4
3101264|NCT01505179|3824683|FG000|NOT COMPLETED|Overall Study||0
3101265|NCT01505179|3824684|FG001|NOT COMPLETED|Overall Study||0
3101266|NCT01505374|3824690|FG000|STARTED|Overall Study||30
3101267|NCT01505374|3824691|FG001|STARTED|Overall Study||30
3101268|NCT01505374|3824690|FG000|COMPLETED|Overall Study||29
3101269|NCT01505374|3824691|FG001|COMPLETED|Overall Study||30
3101270|NCT01505374|3824690|FG000|NOT COMPLETED|Overall Study||1
3101271|NCT01505374|3824691|FG001|NOT COMPLETED|Overall Study||0
3101272|NCT01505387|3824700|FG000|STARTED|Overall Study||25
3101273|NCT01505387|3824701|FG001|STARTED|Overall Study||25
3101274|NCT01505387|3824700|FG000|Treated|Overall Study||24
3101275|NCT01505387|3824701|FG001|Treated|Overall Study||24
3101276|NCT01505387|3824700|FG000|COMPLETED|Overall Study|1 subject not included in intention to treat population as violated inclusion criteria|23
3101277|NCT01505387|3824701|FG001|COMPLETED|Overall Study||24
3101278|NCT01505387|3824700|FG000|NOT COMPLETED|Overall Study||2
3101279|NCT01505387|3824701|FG001|NOT COMPLETED|Overall Study||1
3101280|NCT01505465|3824709|FG000|STARTED|Overall Study||25
3101281|NCT01505465|3824710|FG001|STARTED|Overall Study||25
3101282|NCT01505465|3824709|FG000|COMPLETED|Overall Study||19
3101283|NCT01505465|3824710|FG001|COMPLETED|Overall Study||18
3101284|NCT01505465|3824709|FG000|NOT COMPLETED|Overall Study||6
3101285|NCT01505465|3824710|FG001|NOT COMPLETED|Overall Study||7
3101286|NCT01505491|3824719|FG000|STARTED|Overall Study||67
3101287|NCT01505491|3824720|FG001|STARTED|Overall Study||62
3101288|NCT01505491|3824721|FG002|STARTED|Overall Study||64
3101289|NCT01505491|3824719|FG000|COMPLETED|Overall Study||65
3101290|NCT01505491|3824720|FG001|COMPLETED|Overall Study||61
3101291|NCT01505491|3824721|FG002|COMPLETED|Overall Study||59
3101292|NCT01505491|3824719|FG000|NOT COMPLETED|Overall Study||2
3101293|NCT01505491|3824720|FG001|NOT COMPLETED|Overall Study||1
3101294|NCT01505491|3824721|FG002|NOT COMPLETED|Overall Study||5
3101295|NCT01505530|3824732|FG000|STARTED|Overall Study||41
3101296|NCT01505530|3824733|FG001|STARTED|Overall Study||43
3101297|NCT01505530|3824734|FG002|STARTED|Overall Study||41
3101298|NCT01505530|3824732|FG000|Received At Least One Dose of Study Drug|Overall Study||41
3101299|NCT01505530|3824733|FG001|Received At Least One Dose of Study Drug|Overall Study||42
3101300|NCT01505530|3824734|FG002|Received At Least One Dose of Study Drug|Overall Study||41
3101301|NCT01505530|3824732|FG000|Completed One Cycle of Study Drug|Overall Study||29
3101302|NCT01505530|3824733|FG001|Completed One Cycle of Study Drug|Overall Study||27
3101303|NCT01505530|3824734|FG002|Completed One Cycle of Study Drug|Overall Study||31
3101304|NCT01505530|3824732|FG000|COMPLETED|Overall Study||0
3101305|NCT01505530|3824733|FG001|COMPLETED|Overall Study||0
3101306|NCT01505530|3824734|FG002|COMPLETED|Overall Study||0
3101307|NCT01505530|3824732|FG000|NOT COMPLETED|Overall Study||41
3101308|NCT01505530|3824733|FG001|NOT COMPLETED|Overall Study||43
3101309|NCT01505530|3824734|FG002|NOT COMPLETED|Overall Study||41
3101310|NCT01505608|3824744|FG000|STARTED|Phase I|Randomization to Arm A began in Phase 2. All patients in Phase I were enrolled to receive TPI 287.|0
3101311|NCT01505608|3824745|FG001|STARTED|Phase I||8
3101312|NCT01505608|3824744|FG000|COMPLETED|Phase I||0
3101313|NCT01505608|3824745|FG001|COMPLETED|Phase I||2
3101314|NCT01505608|3824744|FG000|NOT COMPLETED|Phase I||0
3101315|NCT01505608|3824745|FG001|NOT COMPLETED|Phase I||6
3101316|NCT01505608|3824744|FG000|STARTED|Phase II|Phase 2 was new enrollment, not the same patients from Phase 1.|2
3101317|NCT01505608|3824745|FG001|STARTED|Phase II|Phase 2 was new enrollment, not the same patients from Phase 1.|4
3101318|NCT01505608|3824744|FG000|COMPLETED|Phase II||0
3101319|NCT01505608|3824745|FG001|COMPLETED|Phase II||2
3101320|NCT01505608|3824744|FG000|NOT COMPLETED|Phase II||2
3101321|NCT01505608|3824745|FG001|NOT COMPLETED|Phase II||2
3101322|NCT01505634|3824757|FG000|STARTED|Overall Study||101
3101323|NCT01505634|3824758|FG001|STARTED|Overall Study||101
3101324|NCT01505634|3824759|FG002|STARTED|Overall Study||100
3101325|NCT01505634|3824757|FG000|Treated|Overall Study||99
3101326|NCT01505634|3824758|FG001|Treated|Overall Study||99
3101327|NCT01505634|3824759|FG002|Treated|Overall Study||100
3101328|NCT01505634|3824757|FG000|COMPLETED|Overall Study||92
3101329|NCT01505634|3824758|FG001|COMPLETED|Overall Study||91
3101330|NCT01505634|3824759|FG002|COMPLETED|Overall Study||94
3101331|NCT01505634|3824757|FG000|NOT COMPLETED|Overall Study||9
3101332|NCT01505634|3824758|FG001|NOT COMPLETED|Overall Study||10
3101333|NCT01505634|3824759|FG002|NOT COMPLETED|Overall Study||6
3101334|NCT01505647|3824769|FG000|STARTED|Day 1 Through Day 42 Follow-up||332
3101335|NCT01505647|3824770|FG001|STARTED|Day 1 Through Day 42 Follow-up||166
3101336|NCT01505647|3824769|FG000|Vaccinated|Day 1 Through Day 42 Follow-up||331
3101337|NCT01505647|3824770|FG001|Vaccinated|Day 1 Through Day 42 Follow-up||166
3101338|NCT01505647|3824769|FG000|COMPLETED|Day 1 Through Day 42 Follow-up||329
3101339|NCT01505647|3824770|FG001|COMPLETED|Day 1 Through Day 42 Follow-up||166
3101340|NCT01505647|3824769|FG000|NOT COMPLETED|Day 1 Through Day 42 Follow-up||3
3101341|NCT01505647|3824770|FG001|NOT COMPLETED|Day 1 Through Day 42 Follow-up||0
3101342|NCT01505647|3824769|FG000|STARTED|Day 43 Through Day 182 Follow-up||329
3101343|NCT01505647|3824770|FG001|STARTED|Day 43 Through Day 182 Follow-up||166
3101344|NCT01505647|3824769|FG000|COMPLETED|Day 43 Through Day 182 Follow-up||328
3101345|NCT01505647|3824770|FG001|COMPLETED|Day 43 Through Day 182 Follow-up||163
3101346|NCT01505647|3824769|FG000|NOT COMPLETED|Day 43 Through Day 182 Follow-up||1
3101347|NCT01505647|3824770|FG001|NOT COMPLETED|Day 43 Through Day 182 Follow-up||3
3101348|NCT01505673|3824778|FG000|STARTED|Overall Study||35
3101349|NCT01505673|3824779|FG001|STARTED|Overall Study||36
3101350|NCT01505673|3824778|FG000|COMPLETED|Overall Study||32
3101351|NCT01505673|3824779|FG001|COMPLETED|Overall Study||34
3101352|NCT01505673|3824778|FG000|NOT COMPLETED|Overall Study||3
3101353|NCT01505673|3824779|FG001|NOT COMPLETED|Overall Study||2
3101354|NCT01505764|3824787|FG000|STARTED|Overall Study||6
3101355|NCT01505764|3824788|FG001|STARTED|Overall Study||3
3101356|NCT01505764|3824787|FG000|COMPLETED|Overall Study||3
3101357|NCT01505764|3824788|FG001|COMPLETED|Overall Study||2
3101358|NCT01505764|3824787|FG000|NOT COMPLETED|Overall Study||3
3101359|NCT01505764|3824788|FG001|NOT COMPLETED|Overall Study||1
3101360|NCT01505868|3824800|FG000|STARTED|Overall Study||4
3101361|NCT01505868|3824801|FG001|STARTED|Overall Study||3
3101362|NCT01505868|3824802|FG002|STARTED|Overall Study||3
3163126|NCT01883427|3890584|FG000|NOT COMPLETED|Overall Study||0
3163127|NCT01883427|3890585|FG001|NOT COMPLETED|Overall Study||0
3163128|NCT01883440|3890593|FG000|STARTED|Overall Study||45
3163129|NCT01883440|3890594|FG001|STARTED|Overall Study||45
3291077|NCT02841709|4025194|FG001|NOT COMPLETED|Washout Period 1||0
3291078|NCT02841709|4025195|FG002|NOT COMPLETED|Washout Period 1||0
3291079|NCT02841709|4025196|FG003|NOT COMPLETED|Washout Period 1||0
3291080|NCT02841709|4025197|FG004|NOT COMPLETED|Washout Period 1||0
3291081|NCT02841709|4025193|FG000|STARTED|2nd Intervention||12
3291082|NCT02841709|4025194|FG001|STARTED|2nd Intervention||11
3291083|NCT02841709|4025195|FG002|STARTED|2nd Intervention||12
3291084|NCT02841709|4025196|FG003|STARTED|2nd Intervention||12
3291085|NCT02841709|4025197|FG004|STARTED|2nd Intervention||11
3291086|NCT02841709|4025193|FG000|COMPLETED|2nd Intervention||12
3291087|NCT02841709|4025194|FG001|COMPLETED|2nd Intervention||11
3291088|NCT02841709|4025195|FG002|COMPLETED|2nd Intervention||12
3291089|NCT02841709|4025196|FG003|COMPLETED|2nd Intervention||12
3291090|NCT02841709|4025197|FG004|COMPLETED|2nd Intervention||11
3291091|NCT02841709|4025193|FG000|NOT COMPLETED|2nd Intervention||0
3291092|NCT02841709|4025194|FG001|NOT COMPLETED|2nd Intervention||0
3291093|NCT02841709|4025195|FG002|NOT COMPLETED|2nd Intervention||0
3291094|NCT02841709|4025196|FG003|NOT COMPLETED|2nd Intervention||0
3291095|NCT02841709|4025197|FG004|NOT COMPLETED|2nd Intervention||0
3291096|NCT02841709|4025193|FG000|STARTED|Washout Period 2||12
3291097|NCT02841709|4025194|FG001|STARTED|Washout Period 2||11
3291098|NCT02841709|4025195|FG002|STARTED|Washout Period 2||12
3291099|NCT02841709|4025196|FG003|STARTED|Washout Period 2||12
3291100|NCT02841709|4025197|FG004|STARTED|Washout Period 2||11
3291101|NCT02841709|4025193|FG000|COMPLETED|Washout Period 2||12
3291102|NCT02841709|4025194|FG001|COMPLETED|Washout Period 2||11
3291103|NCT02841709|4025195|FG002|COMPLETED|Washout Period 2||12
3291104|NCT02841709|4025196|FG003|COMPLETED|Washout Period 2||12
3291105|NCT02841709|4025197|FG004|COMPLETED|Washout Period 2||11
3291106|NCT02841709|4025193|FG000|NOT COMPLETED|Washout Period 2||0
3291107|NCT02841709|4025194|FG001|NOT COMPLETED|Washout Period 2||0
3291108|NCT02841709|4025195|FG002|NOT COMPLETED|Washout Period 2||0
3291109|NCT02841709|4025196|FG003|NOT COMPLETED|Washout Period 2||0
3291110|NCT02841709|4025197|FG004|NOT COMPLETED|Washout Period 2||0
3291111|NCT02841709|4025193|FG000|STARTED|3rd Intervention||12
3291112|NCT02841709|4025194|FG001|STARTED|3rd Intervention||11
3291113|NCT02841709|4025195|FG002|STARTED|3rd Intervention||12
3291114|NCT02841709|4025196|FG003|STARTED|3rd Intervention||12
3163130|NCT01883440|3890593|FG000|COMPLETED|Overall Study||42
3163131|NCT01883440|3890594|FG001|COMPLETED|Overall Study||45
3163132|NCT01883440|3890593|FG000|NOT COMPLETED|Overall Study||3
3291115|NCT02841709|4025197|FG004|STARTED|3rd Intervention||11
3291116|NCT02841709|4025193|FG000|COMPLETED|3rd Intervention||12
3291117|NCT02841709|4025194|FG001|COMPLETED|3rd Intervention||11
3291118|NCT02841709|4025195|FG002|COMPLETED|3rd Intervention||12
3291119|NCT02841709|4025196|FG003|COMPLETED|3rd Intervention||12
3291120|NCT02841709|4025197|FG004|COMPLETED|3rd Intervention||11
3291121|NCT02841709|4025193|FG000|NOT COMPLETED|3rd Intervention||0
3101363|NCT01505868|3824803|FG003|STARTED|Overall Study||79
3101364|NCT01505868|3824804|FG004|STARTED|Overall Study||81
3163133|NCT01883440|3890594|FG001|NOT COMPLETED|Overall Study||0
3163134|NCT01883453|3890603|FG000|STARTED|Overall Study||73
3163135|NCT01883453|3890604|FG001|STARTED|Overall Study||73
3101365|NCT01505868|3824800|FG000|COMPLETED|Overall Study||3
3101366|NCT01505868|3824801|FG001|COMPLETED|Overall Study||3
3101367|NCT01505868|3824802|FG002|COMPLETED|Overall Study||3
3101368|NCT01505868|3824803|FG003|COMPLETED|Overall Study||79
3101369|NCT01505868|3824804|FG004|COMPLETED|Overall Study||81
3101370|NCT01505868|3824800|FG000|NOT COMPLETED|Overall Study||1
3101371|NCT01505868|3824801|FG001|NOT COMPLETED|Overall Study||0
3101372|NCT01505868|3824802|FG002|NOT COMPLETED|Overall Study||0
3101373|NCT01505868|3824803|FG003|NOT COMPLETED|Overall Study||0
3101374|NCT01505868|3824804|FG004|NOT COMPLETED|Overall Study||0
3101375|NCT01505881|3824818|FG000|STARTED|Overall Study||99
3101376|NCT01505881|3824819|FG001|STARTED|Overall Study||59
3101377|NCT01505881|3824818|FG000|COMPLETED|Overall Study||95
3101378|NCT01505881|3824819|FG001|COMPLETED|Overall Study||58
3101379|NCT01505881|3824818|FG000|NOT COMPLETED|Overall Study||4
3101380|NCT01505881|3824819|FG001|NOT COMPLETED|Overall Study||1
3101381|NCT01505933|3824828|FG000|STARTED|Overall Study||10
3101382|NCT01505933|3824829|FG001|STARTED|Overall Study||14
3101383|NCT01505933|3824828|FG000|COMPLETED|Overall Study||10
3101384|NCT01505933|3824829|FG001|COMPLETED|Overall Study||14
3101385|NCT01505933|3824828|FG000|NOT COMPLETED|Overall Study||0
3101386|NCT01505933|3824829|FG001|NOT COMPLETED|Overall Study||0
3101387|NCT01506193|3824838|FG000|STARTED|Overall Study||351
3101388|NCT01506193|3824839|FG001|STARTED|Overall Study||183
3101389|NCT01506193|3824840|FG002|STARTED|Overall Study||182
3101390|NCT01506193|3824838|FG000|COMPLETED|Overall Study||337
3101391|NCT01506193|3824839|FG001|COMPLETED|Overall Study||179
3101392|NCT01506193|3824840|FG002|COMPLETED|Overall Study||168
3101393|NCT01506193|3824838|FG000|NOT COMPLETED|Overall Study||14
3101394|NCT01506193|3824839|FG001|NOT COMPLETED|Overall Study||4
3101395|NCT01506193|3824840|FG002|NOT COMPLETED|Overall Study||14
3101396|NCT01506271|3824852|FG000|STARTED|Overall Study||118
3101397|NCT01506271|3824853|FG001|STARTED|Overall Study||116
3101398|NCT01506271|3824854|FG002|STARTED|Overall Study||117
3101399|NCT01506271|3824852|FG000|Treated|Overall Study||117
3101400|NCT01506271|3824853|FG001|Treated|Overall Study||116
3101401|NCT01506271|3824854|FG002|Treated|Overall Study||114
3291122|NCT02841709|4025194|FG001|NOT COMPLETED|3rd Intervention||0
3291123|NCT02841709|4025195|FG002|NOT COMPLETED|3rd Intervention||0
3291124|NCT02841709|4025196|FG003|NOT COMPLETED|3rd Intervention||0
3101402|NCT01506271|3824852|FG000|COMPLETED|Overall Study||114
3101403|NCT01506271|3824853|FG001|COMPLETED|Overall Study||109
3101404|NCT01506271|3824854|FG002|COMPLETED|Overall Study||114
3101405|NCT01506271|3824852|FG000|NOT COMPLETED|Overall Study||4
3101406|NCT01506271|3824853|FG001|NOT COMPLETED|Overall Study||7
3101407|NCT01506271|3824854|FG002|NOT COMPLETED|Overall Study||3
3291125|NCT02841709|4025197|FG004|NOT COMPLETED|3rd Intervention||0
3291126|NCT02841709|4025193|FG000|STARTED|Washout Period 3||12
3291127|NCT02841709|4025194|FG001|STARTED|Washout Period 3||11
3291128|NCT02841709|4025195|FG002|STARTED|Washout Period 3||12
3291129|NCT02841709|4025196|FG003|STARTED|Washout Period 3||12
3291130|NCT02841709|4025197|FG004|STARTED|Washout Period 3||11
3291131|NCT02841709|4025193|FG000|COMPLETED|Washout Period 3||12
3291132|NCT02841709|4025194|FG001|COMPLETED|Washout Period 3||11
3291133|NCT02841709|4025195|FG002|COMPLETED|Washout Period 3||12
3291134|NCT02841709|4025196|FG003|COMPLETED|Washout Period 3||12
3291135|NCT02841709|4025197|FG004|COMPLETED|Washout Period 3||11
3291136|NCT02841709|4025193|FG000|NOT COMPLETED|Washout Period 3||0
3291137|NCT02841709|4025194|FG001|NOT COMPLETED|Washout Period 3||0
3291138|NCT02841709|4025195|FG002|NOT COMPLETED|Washout Period 3||0
3291139|NCT02841709|4025196|FG003|NOT COMPLETED|Washout Period 3||0
3291140|NCT02841709|4025197|FG004|NOT COMPLETED|Washout Period 3||0
3291141|NCT02841709|4025193|FG000|STARTED|4th Intervention||12
3291142|NCT02841709|4025194|FG001|STARTED|4th Intervention||11
3291143|NCT02841709|4025195|FG002|STARTED|4th Intervention||12
3291144|NCT02841709|4025196|FG003|STARTED|4th Intervention||12
3291145|NCT02841709|4025197|FG004|STARTED|4th Intervention||11
3291146|NCT02841709|4025193|FG000|COMPLETED|4th Intervention||12
3291147|NCT02841709|4025194|FG001|COMPLETED|4th Intervention||11
3291148|NCT02841709|4025195|FG002|COMPLETED|4th Intervention||12
3291149|NCT02841709|4025196|FG003|COMPLETED|4th Intervention||12
3291150|NCT02841709|4025197|FG004|COMPLETED|4th Intervention||11
3291151|NCT02841709|4025193|FG000|NOT COMPLETED|4th Intervention||0
3291152|NCT02841709|4025194|FG001|NOT COMPLETED|4th Intervention||0
3291153|NCT02841709|4025195|FG002|NOT COMPLETED|4th Intervention||0
3291154|NCT02841709|4025196|FG003|NOT COMPLETED|4th Intervention||0
3291155|NCT02841709|4025197|FG004|NOT COMPLETED|4th Intervention||0
3291156|NCT02841709|4025193|FG000|STARTED|Washout Period 4||12
3291157|NCT02841709|4025194|FG001|STARTED|Washout Period 4||11
3291158|NCT02841709|4025195|FG002|STARTED|Washout Period 4||12
3291159|NCT02841709|4025196|FG003|STARTED|Washout Period 4||12
3291160|NCT02841709|4025197|FG004|STARTED|Washout Period 4||11
3291161|NCT02841709|4025193|FG000|COMPLETED|Washout Period 4||12
3291162|NCT02841709|4025194|FG001|COMPLETED|Washout Period 4||11
3291163|NCT02841709|4025195|FG002|COMPLETED|Washout Period 4||12
3291164|NCT02841709|4025196|FG003|COMPLETED|Washout Period 4||12
3291165|NCT02841709|4025197|FG004|COMPLETED|Washout Period 4||11
3101408|NCT01506323|3824864|FG000|STARTED|Overall Study||89
3101409|NCT01506323|3824865|FG001|STARTED|Overall Study||84
3101410|NCT01506323|3824864|FG000|Post-treatment Completers|Overall Study||69
3291166|NCT02841709|4025193|FG000|NOT COMPLETED|Washout Period 4||0
3291167|NCT02841709|4025194|FG001|NOT COMPLETED|Washout Period 4||0
3101411|NCT01506323|3824865|FG001|Post-treatment Completers|Overall Study||72
3101412|NCT01506323|3824864|FG000|Post-treatment Completed CAPS|Overall Study||68
3101413|NCT01506323|3824865|FG001|Post-treatment Completed CAPS|Overall Study||72
3101414|NCT01506323|3824864|FG000|COMPLETED|Overall Study||65
3101415|NCT01506323|3824865|FG001|COMPLETED|Overall Study||71
3101416|NCT01506323|3824864|FG000|NOT COMPLETED|Overall Study||24
3101417|NCT01506323|3824865|FG001|NOT COMPLETED|Overall Study||13
3101418|NCT01506362|3824876|FG000|STARTED|Overall Study||22
3101419|NCT01506362|3824876|FG000|COMPLETED|Overall Study||16
3101420|NCT01506362|3824876|FG000|NOT COMPLETED|Overall Study||6
3101421|NCT01506453|3824882|FG000|STARTED|Overall Study||25
3101422|NCT01506453|3824883|FG001|STARTED|Overall Study||26
3101423|NCT01506453|3824882|FG000|COMPLETED|Overall Study||25
3101424|NCT01506453|3824883|FG001|COMPLETED|Overall Study||24
3101425|NCT01506453|3824882|FG000|NOT COMPLETED|Overall Study||0
3101426|NCT01506453|3824883|FG001|NOT COMPLETED|Overall Study||2
3101427|NCT01506479|3824892|FG000|STARTED|Overall Study||40
3101428|NCT01506479|3824893|FG001|STARTED|Overall Study||43
3101429|NCT01506479|3824894|FG002|STARTED|Overall Study||45
3101430|NCT01506479|3824892|FG000|COMPLETED|Overall Study||37
3101431|NCT01506479|3824893|FG001|COMPLETED|Overall Study||38
3101432|NCT01506479|3824894|FG002|COMPLETED|Overall Study||42
3101433|NCT01506479|3824892|FG000|NOT COMPLETED|Overall Study||3
3101434|NCT01506479|3824893|FG001|NOT COMPLETED|Overall Study||5
3101435|NCT01506479|3824894|FG002|NOT COMPLETED|Overall Study||3
3101436|NCT01506596|3824904|FG000|STARTED|Overall Study||42
3101437|NCT01506596|3824904|FG000|COMPLETED|Overall Study|One enrolled patient had ineligible pathology after starting treatment; was removed from treatment.|41
3101438|NCT01506596|3824904|FG000|NOT COMPLETED|Overall Study||1
3101439|NCT01506609|3824914|FG000|STARTED|Overall Study||2
3101440|NCT01506609|3824915|FG001|STARTED|Overall Study||1
3101441|NCT01506609|3824916|FG002|STARTED|Overall Study||1
3101442|NCT01506609|3824917|FG003|STARTED|Overall Study||99
3101443|NCT01506609|3824918|FG004|STARTED|Overall Study||97
3101444|NCT01506609|3824919|FG005|STARTED|Overall Study||94
3101445|NCT01506609|3824914|FG000|COMPLETED|Overall Study||0
3101446|NCT01506609|3824915|FG001|COMPLETED|Overall Study||0
3101447|NCT01506609|3824916|FG002|COMPLETED|Overall Study||0
3101448|NCT01506609|3824917|FG003|COMPLETED|Overall Study||0
3101449|NCT01506609|3824918|FG004|COMPLETED|Overall Study||1
3101450|NCT01506609|3824919|FG005|COMPLETED|Overall Study||0
3101451|NCT01506609|3824914|FG000|NOT COMPLETED|Overall Study||2
3101452|NCT01506609|3824915|FG001|NOT COMPLETED|Overall Study||1
3101453|NCT01506609|3824916|FG002|NOT COMPLETED|Overall Study||1
3101454|NCT01506609|3824917|FG003|NOT COMPLETED|Overall Study||99
3101455|NCT01506609|3824918|FG004|NOT COMPLETED|Overall Study||96
3101456|NCT01506609|3824919|FG005|NOT COMPLETED|Overall Study||94
3101457|NCT01506726|3824932|FG000|STARTED|Overall Study||6
3101458|NCT01506726|3824933|FG001|STARTED|Overall Study||5
3101459|NCT01506726|3824932|FG000|COMPLETED|Overall Study||5
3101460|NCT01506726|3824933|FG001|COMPLETED|Overall Study||3
3101461|NCT01506726|3824932|FG000|NOT COMPLETED|Overall Study||1
3101462|NCT01506726|3824933|FG001|NOT COMPLETED|Overall Study||2
3101463|NCT01506882|3824941|FG000|STARTED|Overall Study||61
3101464|NCT01506882|3824942|FG001|STARTED|Overall Study||10
3101465|NCT01506882|3824941|FG000|COMPLETED|Overall Study||39
3101466|NCT01506882|3824942|FG001|COMPLETED|Overall Study||3
3101467|NCT01506882|3824941|FG000|NOT COMPLETED|Overall Study||22
3101468|NCT01506882|3824942|FG001|NOT COMPLETED|Overall Study||7
3101469|NCT01506908|3824952|FG000|STARTED|Overall Study||162
3101470|NCT01506908|3824953|FG001|STARTED|Overall Study||161
3101471|NCT01506908|3824952|FG000|COMPLETED|Overall Study||161
3101472|NCT01506908|3824953|FG001|COMPLETED|Overall Study||161
3101473|NCT01506908|3824952|FG000|NOT COMPLETED|Overall Study||1
3101474|NCT01506908|3824953|FG001|NOT COMPLETED|Overall Study||0
3101475|NCT01506947|3824961|FG000|STARTED|Overall Study||65
3101476|NCT01506947|3824961|FG000|COMPLETED|Overall Study||49
3101477|NCT01506947|3824961|FG000|NOT COMPLETED|Overall Study||16
3101478|NCT01506960|3824967|FG000|STARTED|Overall Study||64
3101479|NCT01506960|3824967|FG000|COMPLETED|Overall Study||17
3101480|NCT01506960|3824967|FG000|NOT COMPLETED|Overall Study||47
3101481|NCT01507051|3824977|FG000|STARTED|Overall Study||29
3101482|NCT01507051|3824978|FG001|STARTED|Overall Study||31
3291168|NCT02841709|4025195|FG002|NOT COMPLETED|Washout Period 4||0
3291169|NCT02841709|4025196|FG003|NOT COMPLETED|Washout Period 4||0
3291170|NCT02841709|4025197|FG004|NOT COMPLETED|Washout Period 4||0
3291171|NCT02841709|4025193|FG000|STARTED|5th Intervention||12
3291172|NCT02841709|4025194|FG001|STARTED|5th Intervention||11
3291173|NCT02841709|4025195|FG002|STARTED|5th Intervention||12
3291174|NCT02841709|4025196|FG003|STARTED|5th Intervention||12
3291175|NCT02841709|4025197|FG004|STARTED|5th Intervention||11
3101483|NCT01507051|3824979|FG002|STARTED|Overall Study||29
3101484|NCT01507051|3824980|FG003|STARTED|Overall Study||7
3101485|NCT01507051|3824977|FG000|Warfarin run-in Phase|Overall Study||28
3101486|NCT01507051|3824978|FG001|Warfarin run-in Phase|Overall Study||28
3101487|NCT01507051|3824979|FG002|Warfarin run-in Phase|Overall Study||0
3101488|NCT01507051|3824980|FG003|Warfarin run-in Phase|Overall Study|Safety Population: in RG4|7
3101489|NCT01507051|3824977|FG000|Received Placebo or Rivaroxaban|Overall Study|Safety Population: in RG1 and in RG4 (RG = Reporting Group for Safety Data)|28
3101490|NCT01507051|3824978|FG001|Received Placebo or Rivaroxaban|Overall Study|Safety Population: in RG2 and in RG4|28
3316733|NCT03118765|4050169|FG004|COMPLETED|Overall Study||28
3101491|NCT01507051|3824979|FG002|Received Placebo or Rivaroxaban|Overall Study|Safety Population: in RG3|28
3101492|NCT01507051|3824980|FG003|Received Placebo or Rivaroxaban|Overall Study||0
3101493|NCT01507051|3824977|FG000|COMPLETED|Overall Study||27
3101494|NCT01507051|3824978|FG001|COMPLETED|Overall Study||28
3101495|NCT01507051|3824979|FG002|COMPLETED|Overall Study||28
3101496|NCT01507051|3824980|FG003|COMPLETED|Overall Study||0
3101497|NCT01507051|3824977|FG000|NOT COMPLETED|Overall Study||2
3101498|NCT01507051|3824978|FG001|NOT COMPLETED|Overall Study||3
3101499|NCT01507051|3824979|FG002|NOT COMPLETED|Overall Study||1
3101500|NCT01507051|3824980|FG003|NOT COMPLETED|Overall Study||7
3101501|NCT01507090|3824990|FG000|STARTED|Overall Study||642
3101502|NCT01507090|3824990|FG000|COMPLETED|Overall Study||624
3101503|NCT01507090|3824990|FG000|NOT COMPLETED|Overall Study||18
3101504|NCT01507103|3825002|FG000|STARTED|Overall Study||41
3101505|NCT01507103|3825003|FG001|STARTED|Overall Study||41
3101506|NCT01507103|3825004|FG002|STARTED|Overall Study||42
3101507|NCT01507103|3825002|FG000|COMPLETED|Overall Study||41
3101508|NCT01507103|3825003|FG001|COMPLETED|Overall Study||41
3101509|NCT01507103|3825004|FG002|COMPLETED|Overall Study||42
3101510|NCT01507103|3825002|FG000|NOT COMPLETED|Overall Study||0
3101511|NCT01507103|3825003|FG001|NOT COMPLETED|Overall Study||0
3101512|NCT01507103|3825004|FG002|NOT COMPLETED|Overall Study||0
3101513|NCT01507155|3825012|FG000|STARTED|Overall Study||625
3101514|NCT01507155|3825013|FG001|STARTED|Overall Study||60
3101515|NCT01507155|3825012|FG000|COMPLETED|Overall Study||625
3101516|NCT01507155|3825013|FG001|COMPLETED|Overall Study||60
3101517|NCT01507155|3825012|FG000|NOT COMPLETED|Overall Study||0
3101518|NCT01507155|3825013|FG001|NOT COMPLETED|Overall Study||0
3101519|NCT01507181|3825020|FG000|STARTED|Overall Study||12
3101520|NCT01507181|3825021|FG001|STARTED|Overall Study||12
3101521|NCT01507181|3825020|FG000|COMPLETED|Overall Study||12
3101522|NCT01507181|3825021|FG001|COMPLETED|Overall Study||12
3101523|NCT01507181|3825020|FG000|NOT COMPLETED|Overall Study||0
3101524|NCT01507181|3825021|FG001|NOT COMPLETED|Overall Study||0
3101525|NCT01507220|3825029|FG000|STARTED|Overall Study||2
3101526|NCT01507220|3825030|FG001|STARTED|Overall Study||0
3101527|NCT01507220|3825029|FG000|COMPLETED|Overall Study||2
3101528|NCT01507220|3825030|FG001|COMPLETED|Overall Study||0
3101529|NCT01507220|3825029|FG000|NOT COMPLETED|Overall Study||0
3101530|NCT01507220|3825030|FG001|NOT COMPLETED|Overall Study||0
3101531|NCT01507246|3825038|FG000|STARTED|Overall Study||20
3101532|NCT01507246|3825039|FG001|STARTED|Overall Study||22
3291176|NCT02841709|4025193|FG000|COMPLETED|5th Intervention|Note: In total, 2 subjects did not complete Sequence 1.|10
3291177|NCT02841709|4025194|FG001|COMPLETED|5th Intervention||11
3291178|NCT02841709|4025195|FG002|COMPLETED|5th Intervention||12
3291179|NCT02841709|4025196|FG003|COMPLETED|5th Intervention||12
3291180|NCT02841709|4025197|FG004|COMPLETED|5th Intervention|Note: In total, 2 subjects did not complete Sequence 5.|9
3291181|NCT02841709|4025193|FG000|NOT COMPLETED|5th Intervention||2
3291182|NCT02841709|4025194|FG001|NOT COMPLETED|5th Intervention||0
3291183|NCT02841709|4025195|FG002|NOT COMPLETED|5th Intervention||0
3291184|NCT02841709|4025196|FG003|NOT COMPLETED|5th Intervention||0
3291185|NCT02841709|4025197|FG004|NOT COMPLETED|5th Intervention||2
3316734|NCT03118765|4050165|FG000|NOT COMPLETED|Overall Study||4
3316735|NCT03118765|4050166|FG001|NOT COMPLETED|Overall Study||2
3316736|NCT03118765|4050167|FG002|NOT COMPLETED|Overall Study||5
3316737|NCT03118765|4050168|FG003|NOT COMPLETED|Overall Study||3
3316738|NCT03118765|4050169|FG004|NOT COMPLETED|Overall Study||2
3316739|NCT03118843|4050182|FG000|STARTED|Overall Study||31
3316740|NCT03118843|4050182|FG000|COMPLETED|Overall Study||31
3316741|NCT03118843|4050182|FG000|NOT COMPLETED|Overall Study||0
3316742|NCT03118934|4050189|FG000|STARTED|Overall Study||34
3316743|NCT03118934|4050190|FG001|STARTED|Overall Study||31
3316744|NCT03118934|4050191|FG002|STARTED|Overall Study||34
3316745|NCT03118934|4050192|FG003|STARTED|Overall Study||29
3316746|NCT03118934|4050193|FG004|STARTED|Overall Study||29
3316747|NCT03118934|4050194|FG005|STARTED|Overall Study||25
3316748|NCT03118934|4050189|FG000|Safety Analysis Set|Overall Study||34
3316749|NCT03118934|4050190|FG001|Safety Analysis Set|Overall Study||29
3316750|NCT03118934|4050191|FG002|Safety Analysis Set|Overall Study||34
3316751|NCT03118934|4050192|FG003|Safety Analysis Set|Overall Study||29
3316752|NCT03118934|4050193|FG004|Safety Analysis Set|Overall Study||26
3316753|NCT03118934|4050194|FG005|Safety Analysis Set|Overall Study||25
3316754|NCT03118934|4050189|FG000|COMPLETED|Overall Study||34
3316755|NCT03118934|4050190|FG001|COMPLETED|Overall Study||30
3316756|NCT03118934|4050191|FG002|COMPLETED|Overall Study||33
3316757|NCT03118934|4050192|FG003|COMPLETED|Overall Study||28
3316758|NCT03118934|4050193|FG004|COMPLETED|Overall Study||27
3316759|NCT03118934|4050194|FG005|COMPLETED|Overall Study||23
3316760|NCT03118934|4050189|FG000|NOT COMPLETED|Overall Study||0
3316761|NCT03118934|4050190|FG001|NOT COMPLETED|Overall Study||1
3316762|NCT03118934|4050191|FG002|NOT COMPLETED|Overall Study||1
3316763|NCT03118934|4050192|FG003|NOT COMPLETED|Overall Study||1
3101533|NCT01507246|3825038|FG000|COMPLETED|Overall Study||18
3101534|NCT01507246|3825039|FG001|COMPLETED|Overall Study||21
3101535|NCT01507246|3825038|FG000|NOT COMPLETED|Overall Study||2
3101536|NCT01507246|3825039|FG001|NOT COMPLETED|Overall Study||1
3101537|NCT01507298|3825050|FG000|STARTED|Overall Study||1
3101538|NCT01507298|3825051|FG001|STARTED|Overall Study||20
3101539|NCT01507298|3825050|FG000|COMPLETED|Overall Study||1
3101540|NCT01507298|3825051|FG001|COMPLETED|Overall Study||14
3101541|NCT01507298|3825050|FG000|NOT COMPLETED|Overall Study||0
3101542|NCT01507298|3825051|FG001|NOT COMPLETED|Overall Study||6
3101543|NCT01507350|3825058|FG000|STARTED|Overall Study||9
3101544|NCT01507350|3825058|FG000|COMPLETED|Overall Study||9
3101545|NCT01507350|3825058|FG000|NOT COMPLETED|Overall Study||0
3101546|NCT01507493|3825064|FG000|STARTED|Overall Study||22
3101547|NCT01507493|3825065|FG001|STARTED|Overall Study||178
3101548|NCT01507493|3825064|FG000|COMPLETED|Overall Study||22
3101549|NCT01507493|3825065|FG001|COMPLETED|Overall Study||178
3101550|NCT01507493|3825064|FG000|NOT COMPLETED|Overall Study||0
3101551|NCT01507493|3825065|FG001|NOT COMPLETED|Overall Study||0
3101552|NCT01507662|3825073|FG000|STARTED|Overall Study||3898
3101553|NCT01507662|3825074|FG001|STARTED|Overall Study||3851
3101554|NCT01507662|3825073|FG000|COMPLETED|Overall Study||3082
3101555|NCT01507662|3825074|FG001|COMPLETED|Overall Study||3020
3101556|NCT01507662|3825073|FG000|NOT COMPLETED|Overall Study||816
3101557|NCT01507662|3825074|FG001|NOT COMPLETED|Overall Study||831
3101558|NCT01507688|3825082|FG000|STARTED|Baseline to 6 Month Assessment||129
3101559|NCT01507688|3825083|FG001|STARTED|Baseline to 6 Month Assessment||129
3101560|NCT01507688|3825082|FG000|COMPLETED|Baseline to 6 Month Assessment||113
3101561|NCT01507688|3825083|FG001|COMPLETED|Baseline to 6 Month Assessment||119
3101562|NCT01507688|3825082|FG000|NOT COMPLETED|Baseline to 6 Month Assessment||16
3101563|NCT01507688|3825083|FG001|NOT COMPLETED|Baseline to 6 Month Assessment||10
3101564|NCT01507688|3825082|FG000|STARTED|6 Month to 12 Month Assessment||113
3291186|NCT02841787|4025213|FG000|STARTED|Overall Study||12
3291187|NCT02841787|4025214|FG001|STARTED|Overall Study||23
3291188|NCT02841787|4025215|FG002|STARTED|Overall Study||12
3291189|NCT02841787|4025213|FG000|COMPLETED|Overall Study||9
3291190|NCT02841787|4025214|FG001|COMPLETED|Overall Study||19
3291191|NCT02841787|4025215|FG002|COMPLETED|Overall Study||12
3291192|NCT02841787|4025213|FG000|NOT COMPLETED|Overall Study||3
3291193|NCT02841787|4025214|FG001|NOT COMPLETED|Overall Study||4
3291194|NCT02841787|4025215|FG002|NOT COMPLETED|Overall Study||0
3291195|NCT02842060|4025225|FG000|STARTED|Overall Study||120
3291196|NCT02842060|4025226|FG001|STARTED|Overall Study||60
3291197|NCT02842060|4025225|FG000|COMPLETED|Overall Study||120
3291198|NCT02842060|4025226|FG001|COMPLETED|Overall Study||60
3291199|NCT02842060|4025225|FG000|NOT COMPLETED|Overall Study||0
3291200|NCT02842060|4025226|FG001|NOT COMPLETED|Overall Study||0
3291201|NCT02842073|4025232|FG000|STARTED|Overall Study||12
3291202|NCT02842073|4025232|FG000|COMPLETED|Overall Study||11
3291203|NCT02842073|4025232|FG000|NOT COMPLETED|Overall Study||1
3291204|NCT02842086|4025238|FG000|STARTED|Overall Study||2700
3291205|NCT02842086|4025239|FG001|STARTED|Overall Study||2699
3291206|NCT02842086|4025238|FG000|COMPLETED|Overall Study||2156
3291207|NCT02842086|4025239|FG001|COMPLETED|Overall Study||2206
3291208|NCT02842086|4025238|FG000|NOT COMPLETED|Overall Study||544
3291209|NCT02842086|4025239|FG001|NOT COMPLETED|Overall Study||493
3291210|NCT02842151|4025245|FG000|STARTED|Overall Study||150
3291211|NCT02842151|4025245|FG000|COMPLETED|Overall Study||148
3291212|NCT02842151|4025245|FG000|NOT COMPLETED|Overall Study||2
3291213|NCT02842242|4025253|FG000|STARTED|Overall Study||11
3291214|NCT02842242|4025254|FG001|STARTED|Overall Study||10
3291215|NCT02842242|4025253|FG000|COMPLETED|Overall Study||10
3291216|NCT02842242|4025254|FG001|COMPLETED|Overall Study||10
3291217|NCT02842242|4025253|FG000|NOT COMPLETED|Overall Study||1
3291218|NCT02842242|4025254|FG001|NOT COMPLETED|Overall Study||0
3291219|NCT02842736|4025260|FG000|STARTED|Overall Study|Treated|242
3291220|NCT02842736|4025260|FG000|Known Month 12 Outcome|Overall Study||230
3291221|NCT02842736|4025260|FG000|24 Month Visit Performed|Overall Study||210
3291222|NCT02842736|4025260|FG000|COMPLETED|Overall Study|36 Month Visit Completed|201
3291223|NCT02842736|4025260|FG000|NOT COMPLETED|Overall Study||41
3291224|NCT02842853|4025268|FG000|STARTED|Overall Study||902
3291225|NCT02842853|4025269|FG001|STARTED|Overall Study||895
3291226|NCT02842853|4025270|FG002|STARTED|Overall Study||906
3291227|NCT02842853|4025271|FG003|STARTED|Overall Study||641
3291228|NCT02842853|4025268|FG000|Vaccinated|Overall Study||895
3291229|NCT02842853|4025269|FG001|Vaccinated|Overall Study||886
3291230|NCT02842853|4025270|FG002|Vaccinated|Overall Study||900
3291231|NCT02842853|4025271|FG003|Vaccinated|Overall Study||636
3291232|NCT02842853|4025268|FG000|Safety Analysis Set (SafAS)|Overall Study||895
3291233|NCT02842853|4025269|FG001|Safety Analysis Set (SafAS)|Overall Study||883
3291234|NCT02842853|4025270|FG002|Safety Analysis Set (SafAS)|Overall Study||898
3291235|NCT02842853|4025271|FG003|Safety Analysis Set (SafAS)|Overall Study||635
3291236|NCT02842853|4025268|FG000|COMPLETED|Overall Study||879
3291237|NCT02842853|4025269|FG001|COMPLETED|Overall Study||861
3291238|NCT02842853|4025270|FG002|COMPLETED|Overall Study||885
3291239|NCT02842853|4025271|FG003|COMPLETED|Overall Study||617
3291240|NCT02842853|4025268|FG000|NOT COMPLETED|Overall Study||23
3291241|NCT02842853|4025269|FG001|NOT COMPLETED|Overall Study||34
3291242|NCT02842853|4025270|FG002|NOT COMPLETED|Overall Study||21
3291243|NCT02842853|4025271|FG003|NOT COMPLETED|Overall Study||24
3291244|NCT02842866|4025285|FG000|STARTED|Overall Study||451
3291245|NCT02842866|4025286|FG001|STARTED|Overall Study||455
3291246|NCT02842866|4025285|FG000|Vaccinated|Overall Study||448
3101565|NCT01507688|3825083|FG001|STARTED|6 Month to 12 Month Assessment||119
3101566|NCT01507688|3825082|FG000|COMPLETED|6 Month to 12 Month Assessment||108
3101567|NCT01507688|3825083|FG001|COMPLETED|6 Month to 12 Month Assessment||116
3101568|NCT01507688|3825082|FG000|NOT COMPLETED|6 Month to 12 Month Assessment||5
3291247|NCT02842866|4025286|FG001|Vaccinated|Overall Study||453
3291248|NCT02842866|4025285|FG000|COMPLETED|Overall Study||444
3101569|NCT01507688|3825083|FG001|NOT COMPLETED|6 Month to 12 Month Assessment||3
3101570|NCT01507779|3825091|FG000|STARTED|Overall Study||23
3101571|NCT01507779|3825092|FG001|STARTED|Overall Study||25
3101572|NCT01507779|3825091|FG000|COMPLETED|Overall Study||23
3101573|NCT01507779|3825092|FG001|COMPLETED|Overall Study||25
3101574|NCT01507779|3825091|FG000|NOT COMPLETED|Overall Study||0
3101575|NCT01507779|3825092|FG001|NOT COMPLETED|Overall Study||0
3101576|NCT01507831|3825102|FG000|STARTED|Overall Study|Randomized|788
3101577|NCT01507831|3825103|FG001|STARTED|Overall Study|Randomized|1553
3101578|NCT01507831|3825102|FG000|Treated|Overall Study||788
3101579|NCT01507831|3825103|FG001|Treated|Overall Study||1550
3101580|NCT01507831|3825102|FG000|COMPLETED|Overall Study||595
3101581|NCT01507831|3825103|FG001|COMPLETED|Overall Study||1113
3101582|NCT01507831|3825102|FG000|NOT COMPLETED|Overall Study||193
3101583|NCT01507831|3825103|FG001|NOT COMPLETED|Overall Study||440
3101584|NCT01507896|3825109|FG000|STARTED|Overall Study|30 unique participants had 40 surgeries planned (participants could have multiple surgeries).|30
3101585|NCT01507896|3825109|FG000|COMPLETED|Overall Study|28 unique participants had 38 surgeries (participants could have multiple surgeries).|28
3101586|NCT01507896|3825109|FG000|NOT COMPLETED|Overall Study||2
3101587|NCT01507987|3825122|FG000|STARTED|Overall Study||982
3101588|NCT01507987|3825123|FG001|STARTED|Overall Study||670
3101589|NCT01507987|3825124|FG002|STARTED|Overall Study||458
3101590|NCT01507987|3825125|FG003|STARTED|Overall Study||737
3101591|NCT01507987|3825122|FG000|COMPLETED|Overall Study||618
3291249|NCT02842866|4025286|FG001|COMPLETED|Overall Study||452
3291250|NCT02842866|4025285|FG000|NOT COMPLETED|Overall Study||7
3291251|NCT02842866|4025286|FG001|NOT COMPLETED|Overall Study||3
3291252|NCT02843178|4025296|FG000|STARTED|Overall Study||86
3291253|NCT02843178|4025297|FG001|STARTED|Overall Study||90
3291254|NCT02843178|4025298|FG002|STARTED|Overall Study||92
3291255|NCT02843178|4025299|FG003|STARTED|Overall Study||91
3291256|NCT02843178|4025296|FG000|COMPLETED|Overall Study||78
3291257|NCT02843178|4025297|FG001|COMPLETED|Overall Study||82
3291258|NCT02843178|4025298|FG002|COMPLETED|Overall Study||85
3291259|NCT02843178|4025299|FG003|COMPLETED|Overall Study||87
3291260|NCT02843178|4025296|FG000|NOT COMPLETED|Overall Study||8
3291261|NCT02843178|4025297|FG001|NOT COMPLETED|Overall Study||8
3291262|NCT02843178|4025298|FG002|NOT COMPLETED|Overall Study||7
3291263|NCT02843178|4025299|FG003|NOT COMPLETED|Overall Study||4
3291264|NCT02843529|4025311|FG000|STARTED|Overall Study||244
3291265|NCT02843529|4025312|FG001|STARTED|Overall Study||304
3291266|NCT02843529|4025311|FG000|COMPLETED|Overall Study||213
3291267|NCT02843529|4025312|FG001|COMPLETED|Overall Study||283
3291268|NCT02843529|4025311|FG000|NOT COMPLETED|Overall Study||31
3291269|NCT02843529|4025312|FG001|NOT COMPLETED|Overall Study||21
3291270|NCT02843659|4025321|FG000|STARTED|Overall Study||5
3291271|NCT02843659|4025322|FG001|STARTED|Overall Study||6
3291272|NCT02843659|4025323|FG002|STARTED|Overall Study||7
3291273|NCT02843659|4025321|FG000|COMPLETED|Overall Study||1
3291274|NCT02843659|4025322|FG001|COMPLETED|Overall Study||0
3291275|NCT02843659|4025323|FG002|COMPLETED|Overall Study||2
3291276|NCT02843659|4025321|FG000|NOT COMPLETED|Overall Study||4
3291277|NCT02843659|4025322|FG001|NOT COMPLETED|Overall Study||6
3291278|NCT02843659|4025323|FG002|NOT COMPLETED|Overall Study||5
3291279|NCT02844439|4025331|FG000|STARTED|Overall Study|"All Subjects with Glioblastoma:~24 subjects with EGFR-gene amplified + 16 subjects without EGFR gene-amplified nor EGFRvIII^pos"|40
3291280|NCT02844439|4025331|FG000|Subpopulation A (EGFR Gene Amplified Glioblastoma)|Overall Study||24
3291281|NCT02844439|4025331|FG000|Subpopulation B (EGFRvIII^Pos Glioblastoma)|Overall Study||11
3291282|NCT02844439|4025331|FG000|COMPLETED|Overall Study||0
3291283|NCT02844439|4025331|FG000|NOT COMPLETED|Overall Study||40
3291284|NCT02844543|4025342|FG000|STARTED|Overall Study||155
3291285|NCT02844543|4025342|FG000|COMPLETED|Overall Study||150
3291286|NCT02844543|4025342|FG000|NOT COMPLETED|Overall Study||5
3291287|NCT02844569|4025348|FG000|STARTED|Overall Study||12
3291288|NCT02844569|4025349|FG001|STARTED|Overall Study||12
3291289|NCT02844569|4025348|FG000|COMPLETED|Overall Study||12
3291290|NCT02844569|4025349|FG001|COMPLETED|Overall Study||12
3291291|NCT02844569|4025348|FG000|NOT COMPLETED|Overall Study||0
3291292|NCT02844569|4025349|FG001|NOT COMPLETED|Overall Study||0
3291293|NCT02844582|4025355|FG000|STARTED|Overall Study||2
3291294|NCT02844582|4025355|FG000|COMPLETED|Overall Study||2
3291295|NCT02844582|4025355|FG000|NOT COMPLETED|Overall Study||0
3291296|NCT02844920|4025359|FG000|STARTED|Overall Study||37
3291297|NCT02844920|4025359|FG000|Completed Without Evaluable Videos|Overall Study|Participants with completed the follow-up but without evaluable hysteroscopy videos|1
3291298|NCT02844920|4025359|FG000|Completed With Evaluable Videos|Overall Study|Participants with completed the follow-up and evaluable hysteroscopy videos|34
3291299|NCT02844920|4025359|FG000|Completed, Eval. Data, Opposing Fibroids|Overall Study|Participants with completed the follow-up, evaluable hysteroscopy videos, and opposing fibroids|6
3291300|NCT02844920|4025359|FG000|COMPLETED|Overall Study|Participants with completed the follow-up|35
3291301|NCT02844920|4025359|FG000|NOT COMPLETED|Overall Study||2
3291302|NCT02844998|4025366|FG000|STARTED|Overall Study||42
3291303|NCT02844998|4025367|FG001|STARTED|Overall Study||39
3291304|NCT02844998|4025368|FG002|STARTED|Overall Study||39
3291305|NCT02844998|4025366|FG000|COMPLETED|Overall Study||35
3291306|NCT02844998|4025367|FG001|COMPLETED|Overall Study||35
3291307|NCT02844998|4025368|FG002|COMPLETED|Overall Study||35
3291308|NCT02844998|4025366|FG000|NOT COMPLETED|Overall Study||7
3101592|NCT01507987|3825123|FG001|COMPLETED|Overall Study||335
3101593|NCT01507987|3825124|FG002|COMPLETED|Overall Study||252
3101594|NCT01507987|3825125|FG003|COMPLETED|Overall Study||480
3101595|NCT01507987|3825122|FG000|NOT COMPLETED|Overall Study||364
3101596|NCT01507987|3825123|FG001|NOT COMPLETED|Overall Study||335
3101597|NCT01507987|3825124|FG002|NOT COMPLETED|Overall Study||206
3101598|NCT01507987|3825125|FG003|NOT COMPLETED|Overall Study||257
3101599|NCT01508013|3825154|FG000|STARTED|Overall Study||214
3101600|NCT01508013|3825155|FG001|STARTED|Overall Study||229
3101601|NCT01508013|3825154|FG000|COMPLETED|Overall Study||182
3101602|NCT01508013|3825155|FG001|COMPLETED|Overall Study||206
3101603|NCT01508013|3825154|FG000|NOT COMPLETED|Overall Study||32
3101604|NCT01508013|3825155|FG001|NOT COMPLETED|Overall Study||23
3101605|NCT01508052|3825163|FG000|STARTED|Overall Study||20
3101606|NCT01508052|3825164|FG001|STARTED|Overall Study||20
3101607|NCT01508052|3825163|FG000|COMPLETED|Overall Study||20
3101608|NCT01508052|3825164|FG001|COMPLETED|Overall Study||20
3291309|NCT02844998|4025367|FG001|NOT COMPLETED|Overall Study||4
3291310|NCT02844998|4025368|FG002|NOT COMPLETED|Overall Study||4
3291311|NCT02845336|4025378|FG000|STARTED|Overall Study||6
3291312|NCT02845336|4025379|FG001|STARTED|Overall Study||1
3291313|NCT02845336|4025378|FG000|COMPLETED|Overall Study||1
3291314|NCT02845336|4025379|FG001|COMPLETED|Overall Study||0
3291315|NCT02845336|4025378|FG000|NOT COMPLETED|Overall Study||5
3291316|NCT02845336|4025379|FG001|NOT COMPLETED|Overall Study||1
3291317|NCT02845375|4025388|FG000|STARTED|Overall Study||13
3291318|NCT02845375|4025389|FG001|STARTED|Overall Study||14
3291319|NCT02845375|4025390|FG002|STARTED|Overall Study||13
3291320|NCT02845375|4025388|FG000|COMPLETED|Overall Study||12
3291321|NCT02845375|4025389|FG001|COMPLETED|Overall Study||12
3291322|NCT02845375|4025390|FG002|COMPLETED|Overall Study||12
3291323|NCT02845375|4025388|FG000|NOT COMPLETED|Overall Study||1
3291324|NCT02845375|4025389|FG001|NOT COMPLETED|Overall Study||2
3291325|NCT02845375|4025390|FG002|NOT COMPLETED|Overall Study||1
3291326|NCT02845674|4025400|FG000|STARTED|Overall Study||129
3291327|NCT02845674|4025401|FG001|STARTED|Overall Study||129
3291328|NCT02845674|4025400|FG000|COMPLETED|Overall Study||111
3291329|NCT02845674|4025401|FG001|COMPLETED|Overall Study||79
3291330|NCT02845674|4025400|FG000|NOT COMPLETED|Overall Study||18
3291331|NCT02845674|4025401|FG001|NOT COMPLETED|Overall Study||50
3291332|NCT02845700|4025409|FG000|STARTED|Baseline Appointment||6
3291333|NCT02845700|4025410|FG001|STARTED|Baseline Appointment||7
3291334|NCT02845700|4025409|FG000|COMPLETED|Baseline Appointment||6
3291335|NCT02845700|4025410|FG001|COMPLETED|Baseline Appointment||7
3291336|NCT02845700|4025409|FG000|NOT COMPLETED|Baseline Appointment||0
3291337|NCT02845700|4025410|FG001|NOT COMPLETED|Baseline Appointment||0
3291338|NCT02845700|4025409|FG000|STARTED|Intervention Session 1|1 participant withdrew after completing the Baseline Appointment|5
3291339|NCT02845700|4025410|FG001|STARTED|Intervention Session 1|1 participant withdrew after completing the Baseline Appointment|6
3291340|NCT02845700|4025409|FG000|COMPLETED|Intervention Session 1||5
3291341|NCT02845700|4025410|FG001|COMPLETED|Intervention Session 1||6
3291342|NCT02845700|4025409|FG000|NOT COMPLETED|Intervention Session 1||0
3291343|NCT02845700|4025410|FG001|NOT COMPLETED|Intervention Session 1||0
3291344|NCT02845700|4025409|FG000|STARTED|Intervention Session 2||5
3291345|NCT02845700|4025410|FG001|STARTED|Intervention Session 2||6
3291346|NCT02845700|4025409|FG000|COMPLETED|Intervention Session 2||5
3291347|NCT02845700|4025410|FG001|COMPLETED|Intervention Session 2||6
3291348|NCT02845700|4025409|FG000|NOT COMPLETED|Intervention Session 2||0
3291349|NCT02845700|4025410|FG001|NOT COMPLETED|Intervention Session 2||0
3291350|NCT02845700|4025409|FG000|STARTED|Month 1 Follow-Up|3 participants withdrew after completing the Intervention 2 Appointment|2
3291351|NCT02845700|4025410|FG001|STARTED|Month 1 Follow-Up|2 participants withdrew after completing the Intervention 2 Appointment|4
3291352|NCT02845700|4025409|FG000|COMPLETED|Month 1 Follow-Up||2
3291353|NCT02845700|4025410|FG001|COMPLETED|Month 1 Follow-Up||4
3291354|NCT02845700|4025409|FG000|NOT COMPLETED|Month 1 Follow-Up||0
3291355|NCT02845700|4025410|FG001|NOT COMPLETED|Month 1 Follow-Up||0
3291356|NCT02845752|4025418|FG000|STARTED|First Intervention (7 Days)||7
3291357|NCT02845752|4025419|FG001|STARTED|First Intervention (7 Days)||7
3291358|NCT02845752|4025418|FG000|COMPLETED|First Intervention (7 Days)||7
3291359|NCT02845752|4025419|FG001|COMPLETED|First Intervention (7 Days)||7
3291360|NCT02845752|4025418|FG000|NOT COMPLETED|First Intervention (7 Days)||0
3291361|NCT02845752|4025419|FG001|NOT COMPLETED|First Intervention (7 Days)||0
3291362|NCT02845752|4025418|FG000|STARTED|Washout (14 Days)||7
3291363|NCT02845752|4025419|FG001|STARTED|Washout (14 Days)||7
3291364|NCT02845752|4025418|FG000|COMPLETED|Washout (14 Days)||7
3291365|NCT02845752|4025419|FG001|COMPLETED|Washout (14 Days)||7
3291366|NCT02845752|4025418|FG000|NOT COMPLETED|Washout (14 Days)||0
3291367|NCT02845752|4025419|FG001|NOT COMPLETED|Washout (14 Days)||0
3291368|NCT02845752|4025418|FG000|STARTED|Second Intervention (7 Days)||7
3291369|NCT02845752|4025419|FG001|STARTED|Second Intervention (7 Days)||7
3291370|NCT02845752|4025418|FG000|COMPLETED|Second Intervention (7 Days)||7
3291371|NCT02845752|4025419|FG001|COMPLETED|Second Intervention (7 Days)||7
3291372|NCT02845752|4025418|FG000|NOT COMPLETED|Second Intervention (7 Days)||0
3291373|NCT02845752|4025419|FG001|NOT COMPLETED|Second Intervention (7 Days)||0
3291374|NCT02846233|4025427|FG000|STARTED|Overall Study||12
3291375|NCT02846233|4025428|FG001|STARTED|Overall Study||10
3291376|NCT02846233|4025427|FG000|COMPLETED|Overall Study||10
3101609|NCT01508052|3825163|FG000|NOT COMPLETED|Overall Study||0
3101610|NCT01508052|3825164|FG001|NOT COMPLETED|Overall Study||0
3101611|NCT01508117|3825170|FG000|STARTED|Overall Study||1
3101612|NCT01508117|3825170|FG000|COMPLETED|Overall Study||1
3101613|NCT01508117|3825170|FG000|NOT COMPLETED|Overall Study||0
3101614|NCT01508130|3825176|FG000|STARTED|Overall Study||493
3101615|NCT01508130|3825177|FG001|STARTED|Overall Study||142
3101616|NCT01508130|3825176|FG000|mTRT|Overall Study||493
3101617|NCT01508130|3825177|FG001|mTRT|Overall Study||142
3101618|NCT01508130|3825176|FG000|COMPLETED|Overall Study||266
3101619|NCT01508130|3825177|FG001|COMPLETED|Overall Study||73
3101620|NCT01508130|3825176|FG000|NOT COMPLETED|Overall Study||227
3101621|NCT01508130|3825177|FG001|NOT COMPLETED|Overall Study||69
3101622|NCT01508169|3825187|FG000|STARTED|Overall Study||47
3291377|NCT02846233|4025428|FG001|COMPLETED|Overall Study||8
3291378|NCT02846233|4025427|FG000|NOT COMPLETED|Overall Study||2
3291379|NCT02846233|4025428|FG001|NOT COMPLETED|Overall Study||2
3291380|NCT02846324|4025438|FG000|STARTED|Overall Study||9
3291381|NCT02846324|4025439|FG001|STARTED|Overall Study||6
3291382|NCT02846324|4025440|FG002|STARTED|Overall Study||14
3291383|NCT02846324|4025441|FG003|STARTED|Overall Study||10
3291384|NCT02846324|4025438|FG000|Completed Study Treatment|Overall Study||7
3291385|NCT02846324|4025439|FG001|Completed Study Treatment|Overall Study||5
3291386|NCT02846324|4025440|FG002|Completed Study Treatment|Overall Study||11
3291387|NCT02846324|4025441|FG003|Completed Study Treatment|Overall Study||10
3291388|NCT02846324|4025438|FG000|COMPLETED|Overall Study||7
3291389|NCT02846324|4025439|FG001|COMPLETED|Overall Study||6
3291390|NCT02846324|4025440|FG002|COMPLETED|Overall Study||10
3291391|NCT02846324|4025441|FG003|COMPLETED|Overall Study||10
3291392|NCT02846324|4025438|FG000|NOT COMPLETED|Overall Study||2
3291393|NCT02846324|4025439|FG001|NOT COMPLETED|Overall Study||0
3291394|NCT02846324|4025440|FG002|NOT COMPLETED|Overall Study||4
3291395|NCT02846324|4025441|FG003|NOT COMPLETED|Overall Study||0
3291396|NCT02846415|4025462|FG000|STARTED|Overall Study||18
3291397|NCT02846415|4025463|FG001|STARTED|Overall Study||12
3291398|NCT02846415|4025462|FG000|COMPLETED|Overall Study||15
3291399|NCT02846415|4025463|FG001|COMPLETED|Overall Study||11
3291400|NCT02846415|4025462|FG000|NOT COMPLETED|Overall Study||3
3291401|NCT02846415|4025463|FG001|NOT COMPLETED|Overall Study||1
3291402|NCT02846558|4025473|FG000|STARTED|Overall Study||15
3291403|NCT02846558|4025474|FG001|STARTED|Overall Study||12
3291404|NCT02846558|4025475|FG002|STARTED|Overall Study||14
3291405|NCT02846558|4025476|FG003|STARTED|Overall Study||13
3291406|NCT02846558|4025473|FG000|Baseline Study Visit|Overall Study||10
3291407|NCT02846558|4025474|FG001|Baseline Study Visit|Overall Study||9
3291408|NCT02846558|4025475|FG002|Baseline Study Visit|Overall Study||14
3291409|NCT02846558|4025476|FG003|Baseline Study Visit|Overall Study||12
3291410|NCT02846558|4025473|FG000|3 Month Study Visit|Overall Study||7
3291411|NCT02846558|4025474|FG001|3 Month Study Visit|Overall Study||8
3291412|NCT02846558|4025475|FG002|3 Month Study Visit|Overall Study||12
3291413|NCT02846558|4025476|FG003|3 Month Study Visit|Overall Study||11
3291414|NCT02846558|4025473|FG000|COMPLETED|Overall Study||7
3291415|NCT02846558|4025474|FG001|COMPLETED|Overall Study||8
3291416|NCT02846558|4025475|FG002|COMPLETED|Overall Study||12
3291417|NCT02846558|4025476|FG003|COMPLETED|Overall Study||11
3291418|NCT02846558|4025473|FG000|NOT COMPLETED|Overall Study||8
3291419|NCT02846558|4025474|FG001|NOT COMPLETED|Overall Study||4
3291420|NCT02846558|4025475|FG002|NOT COMPLETED|Overall Study||2
3291421|NCT02846558|4025476|FG003|NOT COMPLETED|Overall Study||2
3291422|NCT02846714|4025493|FG000|STARTED|Overall Study||42
3291423|NCT02846714|4025493|FG000|COMPLETED|Overall Study||36
3291424|NCT02846714|4025493|FG000|NOT COMPLETED|Overall Study||6
3291425|NCT02846740|4025499|FG000|STARTED|Overall Study||15
3291426|NCT02846740|4025500|FG001|STARTED|Overall Study||15
3291427|NCT02846740|4025499|FG000|COMPLETED|Overall Study||15
3291428|NCT02846740|4025500|FG001|COMPLETED|Overall Study||14
3291429|NCT02846740|4025499|FG000|NOT COMPLETED|Overall Study||0
3291430|NCT02846740|4025500|FG001|NOT COMPLETED|Overall Study||1
3291431|NCT02846779|4025509|FG000|STARTED|Overall Study||2000
3291432|NCT02846779|4025510|FG001|STARTED|Overall Study||2000
3291433|NCT02846779|4025511|FG002|STARTED|Overall Study||2000
3291434|NCT02846779|4025509|FG000|COMPLETED|Overall Study||1861
3291435|NCT02846779|4025510|FG001|COMPLETED|Overall Study||1873
3291436|NCT02846779|4025511|FG002|COMPLETED|Overall Study||1862
3291437|NCT02846779|4025509|FG000|NOT COMPLETED|Overall Study||139
3291438|NCT02846779|4025510|FG001|NOT COMPLETED|Overall Study||127
3291439|NCT02846779|4025511|FG002|NOT COMPLETED|Overall Study||138
3291440|NCT02846792|4025519|FG000|STARTED|Overall Study||5
3291441|NCT02846792|4025519|FG000|COMPLETED|Overall Study||5
3291442|NCT02846792|4025519|FG000|NOT COMPLETED|Overall Study||0
3291443|NCT02847169|4025523|FG000|STARTED|First Intervention (1 Week)||15
3291444|NCT02847169|4025524|FG001|STARTED|First Intervention (1 Week)||15
3101623|NCT01508169|3825188|FG001|STARTED|Overall Study||47
3291445|NCT02847169|4025523|FG000|COMPLETED|First Intervention (1 Week)||15
3291446|NCT02847169|4025524|FG001|COMPLETED|First Intervention (1 Week)||15
3291447|NCT02847169|4025523|FG000|NOT COMPLETED|First Intervention (1 Week)||0
3291448|NCT02847169|4025524|FG001|NOT COMPLETED|First Intervention (1 Week)||0
3291449|NCT02847169|4025523|FG000|STARTED|Second Intervention (1 Week)||15
3291450|NCT02847169|4025524|FG001|STARTED|Second Intervention (1 Week)||15
3291451|NCT02847169|4025523|FG000|COMPLETED|Second Intervention (1 Week)||15
3291452|NCT02847169|4025524|FG001|COMPLETED|Second Intervention (1 Week)||15
3316764|NCT03118934|4050193|FG004|NOT COMPLETED|Overall Study||2
3101624|NCT01508169|3825187|FG000|COMPLETED|Overall Study||44
3101625|NCT01508169|3825188|FG001|COMPLETED|Overall Study||45
3101626|NCT01508169|3825187|FG000|NOT COMPLETED|Overall Study||3
3101627|NCT01508169|3825188|FG001|NOT COMPLETED|Overall Study||2
3101628|NCT01508325|3825202|FG000|STARTED|Overall Study||93
3101629|NCT01508325|3825203|FG001|STARTED|Overall Study||93
3101630|NCT01508325|3825202|FG000|COMPLETED|Overall Study||75
3101631|NCT01508325|3825203|FG001|COMPLETED|Overall Study||72
3101632|NCT01508325|3825202|FG000|NOT COMPLETED|Overall Study||18
3101633|NCT01508325|3825203|FG001|NOT COMPLETED|Overall Study||21
3101634|NCT01508455|3825209|FG000|STARTED|Overall Study||6
3101635|NCT01508455|3825209|FG000|COMPLETED|Overall Study||6
3101636|NCT01508455|3825209|FG000|NOT COMPLETED|Overall Study||0
3101637|NCT01508650|3825215|FG000|STARTED|Overall Study||12
3101638|NCT01508650|3825216|FG001|STARTED|Overall Study||15
3101639|NCT01508650|3825215|FG000|COMPLETED|Overall Study||12
3101640|NCT01508650|3825216|FG001|COMPLETED|Overall Study||12
3101641|NCT01508650|3825215|FG000|NOT COMPLETED|Overall Study||0
3101642|NCT01508650|3825216|FG001|NOT COMPLETED|Overall Study||3
3101643|NCT01508676|3825224|FG000|STARTED|Phase I (2 Weeks)||18
3101644|NCT01508676|3825225|FG001|STARTED|Phase I (2 Weeks)||17
3101645|NCT01508676|3825224|FG000|COMPLETED|Phase I (2 Weeks)||16
3101646|NCT01508676|3825225|FG001|COMPLETED|Phase I (2 Weeks)||14
3101647|NCT01508676|3825224|FG000|NOT COMPLETED|Phase I (2 Weeks)||2
3101648|NCT01508676|3825225|FG001|NOT COMPLETED|Phase I (2 Weeks)||3
3101649|NCT01508676|3825224|FG000|STARTED|Washout Period (1 Week)||16
3101650|NCT01508676|3825225|FG001|STARTED|Washout Period (1 Week)||14
3101651|NCT01508676|3825224|FG000|COMPLETED|Washout Period (1 Week)||16
3101652|NCT01508676|3825225|FG001|COMPLETED|Washout Period (1 Week)||14
3101653|NCT01508676|3825224|FG000|NOT COMPLETED|Washout Period (1 Week)||0
3101654|NCT01508676|3825225|FG001|NOT COMPLETED|Washout Period (1 Week)||0
3101655|NCT01508676|3825224|FG000|STARTED|Phase II (2 Weeks)||16
3101656|NCT01508676|3825225|FG001|STARTED|Phase II (2 Weeks)||14
3101657|NCT01508676|3825224|FG000|COMPLETED|Phase II (2 Weeks)||15
3101658|NCT01508676|3825225|FG001|COMPLETED|Phase II (2 Weeks)||13
3101659|NCT01508676|3825224|FG000|NOT COMPLETED|Phase II (2 Weeks)||1
3101660|NCT01508676|3825225|FG001|NOT COMPLETED|Phase II (2 Weeks)||1
3101661|NCT01508702|3825234|FG000|STARTED|Overall Study||107
3101662|NCT01508702|3825235|FG001|STARTED|Overall Study||107
3101663|NCT01508702|3825234|FG000|COMPLETED|Overall Study||84
3101664|NCT01508702|3825235|FG001|COMPLETED|Overall Study||94
3101665|NCT01508702|3825234|FG000|NOT COMPLETED|Overall Study||23
3101666|NCT01508702|3825235|FG001|NOT COMPLETED|Overall Study||13
3101667|NCT01508832|3825243|FG000|STARTED|Overall Study||6
3101668|NCT01508832|3825244|FG001|STARTED|Overall Study||6
3101669|NCT01508832|3825243|FG000|COMPLETED|Overall Study||6
3101670|NCT01508832|3825244|FG001|COMPLETED|Overall Study||6
3101671|NCT01508832|3825243|FG000|NOT COMPLETED|Overall Study||0
3291453|NCT02847169|4025523|FG000|NOT COMPLETED|Second Intervention (1 Week)||0
3291454|NCT02847169|4025524|FG001|NOT COMPLETED|Second Intervention (1 Week)||0
3291455|NCT02847182|4025547|FG000|STARTED|Overall Study||119
3291456|NCT02847182|4025548|FG001|STARTED|Overall Study||61
3291457|NCT02847182|4025547|FG000|First Intervention (6 Months)|Overall Study||119
3291458|NCT02847182|4025548|FG001|First Intervention (6 Months)|Overall Study||61
3291459|NCT02847182|4025547|FG000|Second Intervention (6 Months)|Overall Study||61
3291460|NCT02847182|4025548|FG001|Second Intervention (6 Months)|Overall Study||119
3291461|NCT02847182|4025547|FG000|COMPLETED|Overall Study||119
3291462|NCT02847182|4025548|FG001|COMPLETED|Overall Study||60
3291463|NCT02847182|4025547|FG000|NOT COMPLETED|Overall Study||0
3291464|NCT02847182|4025548|FG001|NOT COMPLETED|Overall Study||1
3291465|NCT02847260|4025560|FG000|STARTED|Overall Study||39
3291466|NCT02847260|4025560|FG000|COMPLETED|Overall Study||32
3291467|NCT02847260|4025560|FG000|NOT COMPLETED|Overall Study||7
3291468|NCT02847494|4025566|FG000|STARTED|Overall Study||109
3291469|NCT02847494|4025567|FG001|STARTED|Overall Study||111
3291470|NCT02847494|4025566|FG000|COMPLETED|Overall Study||101
3291471|NCT02847494|4025567|FG001|COMPLETED|Overall Study||106
3291472|NCT02847494|4025566|FG000|NOT COMPLETED|Overall Study||8
3291473|NCT02847494|4025567|FG001|NOT COMPLETED|Overall Study||5
3291474|NCT02847650|4025575|FG000|STARTED|Overall Study||29
3291475|NCT02847650|4025576|FG001|STARTED|Overall Study||28
3291476|NCT02847650|4025575|FG000|COMPLETED|Overall Study||25
3291477|NCT02847650|4025576|FG001|COMPLETED|Overall Study||22
3291478|NCT02847650|4025575|FG000|NOT COMPLETED|Overall Study||4
3291479|NCT02847650|4025576|FG001|NOT COMPLETED|Overall Study||6
3291480|NCT02847858|4025584|FG000|STARTED|Overall Study||693
3291481|NCT02847858|4025585|FG001|STARTED|Overall Study||667
3291482|NCT02847858|4025584|FG000|COMPLETED|Overall Study||292
3291483|NCT02847858|4025585|FG001|COMPLETED|Overall Study||398
3291484|NCT02847858|4025584|FG000|NOT COMPLETED|Overall Study||401
3291485|NCT02847858|4025585|FG001|NOT COMPLETED|Overall Study||269
3291486|NCT02848079|4025596|FG000|STARTED|Overall Study||41
3291487|NCT02848079|4025596|FG000|Receieved Study Treatment|Overall Study||41
3291488|NCT02848079|4025596|FG000|Discontinued|Overall Study||41
3291489|NCT02848079|4025596|FG000|COMPLETED|Overall Study||41
3101672|NCT01508832|3825244|FG001|NOT COMPLETED|Overall Study||0
3101673|NCT01508910|3825253|FG000|STARTED|Randomization||57
3101674|NCT01508910|3825254|FG001|STARTED|Randomization||27
3101675|NCT01508910|3825255|FG002|STARTED|Randomization||28
3101676|NCT01508910|3825256|FG003|STARTED|Randomization|Participants not randomized into Not Injected arm, but some were re-assigned here during treatment.|0
3291490|NCT02848079|4025596|FG000|NOT COMPLETED|Overall Study||0
3101677|NCT01508910|3825253|FG000|COMPLETED|Randomization||57
3101678|NCT01508910|3825254|FG001|COMPLETED|Randomization||27
3101679|NCT01508910|3825255|FG002|COMPLETED|Randomization||28
3101680|NCT01508910|3825256|FG003|COMPLETED|Randomization||0
3101681|NCT01508910|3825253|FG000|NOT COMPLETED|Randomization||0
3101682|NCT01508910|3825254|FG001|NOT COMPLETED|Randomization||0
3101683|NCT01508910|3825255|FG002|NOT COMPLETED|Randomization||0
3101684|NCT01508910|3825256|FG003|NOT COMPLETED|Randomization||0
3101685|NCT01508910|3825253|FG000|STARTED|Treatment||50
3101686|NCT01508910|3825254|FG001|STARTED|Treatment||28
3101687|NCT01508910|3825255|FG002|STARTED|Treatment||28
3101688|NCT01508910|3825256|FG003|STARTED|Treatment|3 moved from Treatment (Tx) to Active Control (AC) Arm; 6 in Not injected Arm(4 from Tx ; 2 from AC)|6
3101689|NCT01508910|3825253|FG000|COMPLETED|Treatment||48
3101690|NCT01508910|3825254|FG001|COMPLETED|Treatment||24
3101691|NCT01508910|3825255|FG002|COMPLETED|Treatment||18
3101692|NCT01508910|3825256|FG003|COMPLETED|Treatment||3
3101693|NCT01508910|3825253|FG000|NOT COMPLETED|Treatment||2
3101694|NCT01508910|3825254|FG001|NOT COMPLETED|Treatment||4
3101695|NCT01508910|3825255|FG002|NOT COMPLETED|Treatment||10
3101696|NCT01508910|3825256|FG003|NOT COMPLETED|Treatment||3
3101697|NCT01508936|3825270|FG000|STARTED|Overall Study||102
3101698|NCT01508936|3825271|FG001|STARTED|Overall Study||409
3101699|NCT01508936|3825270|FG000|Randomized, Not Analyzed|Overall Study|Participants from two centers were omitted from all analyses.|4
3291491|NCT02848222|4025603|FG000|STARTED|Overall Study||25
3291492|NCT02848222|4025604|FG001|STARTED|Overall Study||18
3291493|NCT02848222|4025605|FG002|STARTED|Overall Study||17
3291494|NCT02848222|4025603|FG000|COMPLETED|Overall Study||18
3291495|NCT02848222|4025604|FG001|COMPLETED|Overall Study||17
3291496|NCT02848222|4025605|FG002|COMPLETED|Overall Study||17
3291497|NCT02848222|4025603|FG000|NOT COMPLETED|Overall Study||7
3291498|NCT02848222|4025604|FG001|NOT COMPLETED|Overall Study||1
3291499|NCT02848222|4025605|FG002|NOT COMPLETED|Overall Study||0
3291500|NCT02848313|4025615|FG000|STARTED|Overall Study||21
3291501|NCT02848313|4025616|FG001|STARTED|Overall Study||19
3291502|NCT02848313|4025615|FG000|COMPLETED|Overall Study||18
3291503|NCT02848313|4025616|FG001|COMPLETED|Overall Study||15
3291504|NCT02848313|4025615|FG000|NOT COMPLETED|Overall Study||3
3291505|NCT02848313|4025616|FG001|NOT COMPLETED|Overall Study||4
3291506|NCT02848326|4025628|FG000|STARTED|Treatment Period||186
3291507|NCT02848326|4025629|FG001|STARTED|Treatment Period||94
3291508|NCT02848326|4025630|FG002|STARTED|Treatment Period||185
3291509|NCT02848326|4025631|FG003|STARTED|Treatment Period||187
3291510|NCT02848326|4025632|FG004|STARTED|Treatment Period||89
3291511|NCT02848326|4025633|FG005|STARTED|Treatment Period||93
3291512|NCT02848326|4025628|FG000|Safety Population: Received Study Drug|Treatment Period||186
3291513|NCT02848326|4025629|FG001|Safety Population: Received Study Drug|Treatment Period||93
3291514|NCT02848326|4025630|FG002|Safety Population: Received Study Drug|Treatment Period||183
3291515|NCT02848326|4025631|FG003|Safety Population: Received Study Drug|Treatment Period||186
3291516|NCT02848326|4025632|FG004|Safety Population: Received Study Drug|Treatment Period||86
3291517|NCT02848326|4025633|FG005|Safety Population: Received Study Drug|Treatment Period||91
3291518|NCT02848326|4025628|FG000|COMPLETED|Treatment Period||148
3291519|NCT02848326|4025629|FG001|COMPLETED|Treatment Period||80
3291520|NCT02848326|4025630|FG002|COMPLETED|Treatment Period||149
3291521|NCT02848326|4025631|FG003|COMPLETED|Treatment Period||164
3291522|NCT02848326|4025632|FG004|COMPLETED|Treatment Period||70
3291523|NCT02848326|4025633|FG005|COMPLETED|Treatment Period||73
3291524|NCT02848326|4025628|FG000|NOT COMPLETED|Treatment Period||38
3291525|NCT02848326|4025629|FG001|NOT COMPLETED|Treatment Period||14
3291526|NCT02848326|4025630|FG002|NOT COMPLETED|Treatment Period||36
3291527|NCT02848326|4025631|FG003|NOT COMPLETED|Treatment Period||23
3291528|NCT02848326|4025632|FG004|NOT COMPLETED|Treatment Period||19
3291529|NCT02848326|4025633|FG005|NOT COMPLETED|Treatment Period||20
3291530|NCT02848326|4025628|FG000|STARTED|Safety Follow-up Period||161
3291531|NCT02848326|4025629|FG001|STARTED|Safety Follow-up Period||84
3291532|NCT02848326|4025630|FG002|STARTED|Safety Follow-up Period||156
3291533|NCT02848326|4025631|FG003|STARTED|Safety Follow-up Period||169
3291534|NCT02848326|4025632|FG004|STARTED|Safety Follow-up Period||77
3291535|NCT02848326|4025633|FG005|STARTED|Safety Follow-up Period||82
3291536|NCT02848326|4025628|FG000|COMPLETED|Safety Follow-up Period||157
3291537|NCT02848326|4025629|FG001|COMPLETED|Safety Follow-up Period||83
3291538|NCT02848326|4025630|FG002|COMPLETED|Safety Follow-up Period||153
3291539|NCT02848326|4025631|FG003|COMPLETED|Safety Follow-up Period||169
3291540|NCT02848326|4025632|FG004|COMPLETED|Safety Follow-up Period||76
3291541|NCT02848326|4025633|FG005|COMPLETED|Safety Follow-up Period||77
3291542|NCT02848326|4025628|FG000|NOT COMPLETED|Safety Follow-up Period||4
3291543|NCT02848326|4025629|FG001|NOT COMPLETED|Safety Follow-up Period||1
3291544|NCT02848326|4025630|FG002|NOT COMPLETED|Safety Follow-up Period||3
3291545|NCT02848326|4025631|FG003|NOT COMPLETED|Safety Follow-up Period||0
3291546|NCT02848326|4025632|FG004|NOT COMPLETED|Safety Follow-up Period||1
3291547|NCT02848326|4025633|FG005|NOT COMPLETED|Safety Follow-up Period||5
3291548|NCT02848599|4025649|FG000|STARTED|Overall Study||42
3291549|NCT02848599|4025650|FG001|STARTED|Overall Study||44
3291550|NCT02848599|4025649|FG000|COMPLETED|Overall Study||35
3135457|NCT01707290|3860527|FG001|COMPLETED|Overall Study||3
3291551|NCT02848599|4025650|FG001|COMPLETED|Overall Study||35
3291552|NCT02848599|4025649|FG000|NOT COMPLETED|Overall Study||7
3291553|NCT02848599|4025650|FG001|NOT COMPLETED|Overall Study||9
3291554|NCT02848651|4025658|FG000|STARTED|Overall Study||153
3291555|NCT02848651|4025658|FG000|Received Treatment|Overall Study||152
3101700|NCT01508936|3825271|FG001|Randomized, Not Analyzed|Overall Study|Participants from two centers were omitted from all analyses.|11
3101701|NCT01508936|3825270|FG000|Randomized|Overall Study||98
3101702|NCT01508936|3825271|FG001|Randomized|Overall Study||398
3101703|NCT01508936|3825270|FG000|Randomized, Not Treated|Overall Study||1
3101704|NCT01508936|3825271|FG001|Randomized, Not Treated|Overall Study||3
3101705|NCT01508936|3825270|FG000|Safety Analysis Set|Overall Study||97
3101706|NCT01508936|3825271|FG001|Safety Analysis Set|Overall Study||395
3101707|NCT01508936|3825270|FG000|Full Analysis Set|Overall Study||97
3101708|NCT01508936|3825271|FG001|Full Analysis Set|Overall Study||395
3101709|NCT01508936|3825270|FG000|FEV1 Subpopulation Analysis Set|Overall Study||91
3101710|NCT01508936|3825271|FG001|FEV1 Subpopulation Analysis Set|Overall Study||346
3101711|NCT01508936|3825270|FG000|COMPLETED|Overall Study||79
3101712|NCT01508936|3825271|FG001|COMPLETED|Overall Study||330
3101713|NCT01508936|3825270|FG000|NOT COMPLETED|Overall Study||23
3101714|NCT01508936|3825271|FG001|NOT COMPLETED|Overall Study||79
3101715|NCT01509040|3825280|FG000|STARTED|Overall Study||0
3101716|NCT01509040|3825281|FG001|STARTED|Overall Study||2
3101717|NCT01509040|3825282|FG002|STARTED|Overall Study||0
3101718|NCT01509040|3825280|FG000|COMPLETED|Overall Study||0
3101719|NCT01509040|3825281|FG001|COMPLETED|Overall Study||1
3291556|NCT02848651|4025658|FG000|COMPLETED|Overall Study||47
3291557|NCT02848651|4025658|FG000|NOT COMPLETED|Overall Study||106
3291558|NCT02848664|4025678|FG000|STARTED|Overall Study||11
3291559|NCT02848664|4025678|FG000|COMPLETED|Overall Study||7
3291560|NCT02848664|4025678|FG000|NOT COMPLETED|Overall Study||4
3291561|NCT02848729|4025688|FG000|STARTED|Overall Study||27
3291562|NCT02848729|4025689|FG001|STARTED|Overall Study||23
3291563|NCT02848729|4025688|FG000|Per Protocol Population|Overall Study||11
3291564|NCT02848729|4025689|FG001|Per Protocol Population|Overall Study||11
3291565|NCT02848729|4025688|FG000|Safety Population|Overall Study||27
3291566|NCT02848729|4025689|FG001|Safety Population|Overall Study||23
3291567|NCT02848729|4025688|FG000|COMPLETED|Overall Study||11
3291568|NCT02848729|4025689|FG001|COMPLETED|Overall Study||12
3291569|NCT02848729|4025688|FG000|NOT COMPLETED|Overall Study||16
3291570|NCT02848729|4025689|FG001|NOT COMPLETED|Overall Study||11
3291571|NCT02848833|4025702|FG000|STARTED|Overall Study||3368
3291572|NCT02848833|4025702|FG000|COMPLETED|Overall Study||3231
3291573|NCT02848833|4025702|FG000|NOT COMPLETED|Overall Study||137
3291574|NCT02849080|4025708|FG000|STARTED|Main Phase: 0 - 52 Weeks||253
3291575|NCT02849080|4025709|FG001|STARTED|Main Phase: 0 - 52 Weeks||251
3291576|NCT02849080|4025710|FG002|STARTED|Main Phase: 0 - 52 Weeks||0
3291577|NCT02849080|4025711|FG003|STARTED|Main Phase: 0 - 52 Weeks||0
3291578|NCT02849080|4025708|FG000|Exposed|Main Phase: 0 - 52 Weeks||253
3291579|NCT02849080|4025709|FG001|Exposed|Main Phase: 0 - 52 Weeks||250
3291580|NCT02849080|4025710|FG002|Exposed|Main Phase: 0 - 52 Weeks||0
3291581|NCT02849080|4025711|FG003|Exposed|Main Phase: 0 - 52 Weeks||0
3291582|NCT02849080|4025708|FG000|Full Analysis Set (FAS)|Main Phase: 0 - 52 Weeks||253
3291583|NCT02849080|4025709|FG001|Full Analysis Set (FAS)|Main Phase: 0 - 52 Weeks||251
3291584|NCT02849080|4025710|FG002|Full Analysis Set (FAS)|Main Phase: 0 - 52 Weeks||0
3291585|NCT02849080|4025711|FG003|Full Analysis Set (FAS)|Main Phase: 0 - 52 Weeks||0
3291586|NCT02849080|4025708|FG000|Safety Analysis Set (SAS)|Main Phase: 0 - 52 Weeks||253
3291587|NCT02849080|4025709|FG001|Safety Analysis Set (SAS)|Main Phase: 0 - 52 Weeks||250
3291588|NCT02849080|4025710|FG002|Safety Analysis Set (SAS)|Main Phase: 0 - 52 Weeks||0
3291589|NCT02849080|4025711|FG003|Safety Analysis Set (SAS)|Main Phase: 0 - 52 Weeks||0
3291590|NCT02849080|4025708|FG000|COMPLETED|Main Phase: 0 - 52 Weeks||241
3291591|NCT02849080|4025709|FG001|COMPLETED|Main Phase: 0 - 52 Weeks||244
3291592|NCT02849080|4025710|FG002|COMPLETED|Main Phase: 0 - 52 Weeks||0
3291593|NCT02849080|4025711|FG003|COMPLETED|Main Phase: 0 - 52 Weeks||0
3291594|NCT02849080|4025708|FG000|NOT COMPLETED|Main Phase: 0 - 52 Weeks||12
3291595|NCT02849080|4025709|FG001|NOT COMPLETED|Main Phase: 0 - 52 Weeks||7
3291596|NCT02849080|4025710|FG002|NOT COMPLETED|Main Phase: 0 - 52 Weeks||0
3291597|NCT02849080|4025711|FG003|NOT COMPLETED|Main Phase: 0 - 52 Weeks||0
3291598|NCT02849080|4025708|FG000|STARTED|Extension Phase: 53 - 104 Weeks|Participants who had provided consent to continue in the extension phase started in this period.|185
3291599|NCT02849080|4025709|FG001|STARTED|Extension Phase: 53 - 104 Weeks||0
3291600|NCT02849080|4025710|FG002|STARTED|Extension Phase: 53 - 104 Weeks|Participants who had provided consent to continue in the extension phase started in this period.|100
3291601|NCT02849080|4025711|FG003|STARTED|Extension Phase: 53 - 104 Weeks|Participants who had provided consent to continue in the extension phase started in this period.|98
3291602|NCT02849080|4025708|FG000|Exposed|Extension Phase: 53 - 104 Weeks||184
3291603|NCT02849080|4025709|FG001|Exposed|Extension Phase: 53 - 104 Weeks||0
3291604|NCT02849080|4025710|FG002|Exposed|Extension Phase: 53 - 104 Weeks||100
3291605|NCT02849080|4025711|FG003|Exposed|Extension Phase: 53 - 104 Weeks||97
3291606|NCT02849080|4025708|FG000|COMPLETED|Extension Phase: 53 - 104 Weeks||182
3291607|NCT02849080|4025709|FG001|COMPLETED|Extension Phase: 53 - 104 Weeks||0
3291608|NCT02849080|4025710|FG002|COMPLETED|Extension Phase: 53 - 104 Weeks||99
3291609|NCT02849080|4025711|FG003|COMPLETED|Extension Phase: 53 - 104 Weeks||98
3291610|NCT02849080|4025708|FG000|NOT COMPLETED|Extension Phase: 53 - 104 Weeks||3
3291611|NCT02849080|4025709|FG001|NOT COMPLETED|Extension Phase: 53 - 104 Weeks||0
3291612|NCT02849080|4025710|FG002|NOT COMPLETED|Extension Phase: 53 - 104 Weeks||1
3291613|NCT02849080|4025711|FG003|NOT COMPLETED|Extension Phase: 53 - 104 Weeks||0
3291614|NCT02849184|4025725|FG000|STARTED|Overall Study||40
3291615|NCT02849184|4025726|FG001|STARTED|Overall Study||42
3101720|NCT01509040|3825282|FG002|COMPLETED|Overall Study||0
3101721|NCT01509040|3825280|FG000|NOT COMPLETED|Overall Study||0
3101722|NCT01509040|3825281|FG001|NOT COMPLETED|Overall Study||1
3101723|NCT01509040|3825282|FG002|NOT COMPLETED|Overall Study||0
3101724|NCT01509079|3825299|FG000|STARTED|Overall Study||57
3101725|NCT01509079|3825300|FG001|STARTED|Overall Study||59
3101726|NCT01509079|3825299|FG000|COMPLETED|Overall Study||57
3101727|NCT01509079|3825300|FG001|COMPLETED|Overall Study||56
3101728|NCT01509079|3825299|FG000|NOT COMPLETED|Overall Study||0
3101729|NCT01509079|3825300|FG001|NOT COMPLETED|Overall Study||3
3101730|NCT01509105|3825306|FG000|STARTED|Overall Study||649
3101731|NCT01509105|3825306|FG000|COMPLETED|Overall Study||649
3101732|NCT01509105|3825306|FG000|NOT COMPLETED|Overall Study||0
3101733|NCT01509183|3825312|FG000|STARTED|Overall Study||250
3101734|NCT01509183|3825313|FG001|STARTED|Overall Study||245
3101735|NCT01509183|3825312|FG000|COMPLETED|Overall Study||141
3101736|NCT01509183|3825313|FG001|COMPLETED|Overall Study||134
3101737|NCT01509183|3825312|FG000|NOT COMPLETED|Overall Study||109
3101738|NCT01509183|3825313|FG001|NOT COMPLETED|Overall Study||111
3101739|NCT01509404|3825323|FG000|STARTED|Overall Study||20
3101740|NCT01509404|3825324|FG001|STARTED|Overall Study||20
3101741|NCT01509404|3825323|FG000|COMPLETED|Overall Study||20
3101742|NCT01509404|3825324|FG001|COMPLETED|Overall Study||20
3101743|NCT01509404|3825323|FG000|NOT COMPLETED|Overall Study||0
3101744|NCT01509404|3825324|FG001|NOT COMPLETED|Overall Study||0
3101745|NCT01509547|3825332|FG000|STARTED|Overall Study||77
3101746|NCT01509547|3825333|FG001|STARTED|Overall Study||80
3101747|NCT01509547|3825332|FG000|COMPLETED|Overall Study||42
3101748|NCT01509547|3825333|FG001|COMPLETED|Overall Study||41
3101749|NCT01509547|3825332|FG000|NOT COMPLETED|Overall Study||35
3101750|NCT01509547|3825333|FG001|NOT COMPLETED|Overall Study||39
3101751|NCT01509586|3825341|FG000|STARTED|Overall Study|Week 0|626
3101752|NCT01509586|3825342|FG001|STARTED|Overall Study|Week 0|610
3101753|NCT01509586|3825341|FG000|Week 3|Overall Study||574
3101754|NCT01509586|3825342|FG001|Week 3|Overall Study||585
3101755|NCT01509586|3825341|FG000|Week 6|Overall Study||551
3101756|NCT01509586|3825342|FG001|Week 6|Overall Study||585
3101757|NCT01509586|3825341|FG000|Week 10|Overall Study||537
3101758|NCT01509586|3825342|FG001|Week 10|Overall Study||574
3101759|NCT01509586|3825341|FG000|Week 14|Overall Study||528
3101760|NCT01509586|3825342|FG001|Week 14|Overall Study||566
3101761|NCT01509586|3825341|FG000|Week18|Overall Study||529
3101762|NCT01509586|3825342|FG001|Week18|Overall Study||555
3101763|NCT01509586|3825341|FG000|Week 32 (Month 6)|Overall Study||504
3101764|NCT01509586|3825342|FG001|Week 32 (Month 6)|Overall Study||523
3101765|NCT01509586|3825341|FG000|Week 46|Overall Study||483
3101766|NCT01509586|3825342|FG001|Week 46|Overall Study||494
3101767|NCT01509586|3825341|FG000|Week 58 (Month 12)|Overall Study||492
3101768|NCT01509586|3825342|FG001|Week 58 (Month 12)|Overall Study||499
3101769|NCT01509586|3825341|FG000|COMPLETED|Overall Study|final intent to treat sample|626
3101770|NCT01509586|3825342|FG001|COMPLETED|Overall Study|final intent to treat sample|610
3101771|NCT01509586|3825341|FG000|NOT COMPLETED|Overall Study||0
3101772|NCT01509586|3825342|FG001|NOT COMPLETED|Overall Study||0
3101773|NCT01509612|3825351|FG000|STARTED|Overall Study||47
3101774|NCT01509612|3825352|FG001|STARTED|Overall Study||51
3101775|NCT01509612|3825353|FG002|STARTED|Overall Study||52
3101776|NCT01509612|3825351|FG000|COMPLETED|Overall Study||47
3101777|NCT01509612|3825352|FG001|COMPLETED|Overall Study||51
3101778|NCT01509612|3825353|FG002|COMPLETED|Overall Study||52
3101779|NCT01509612|3825351|FG000|NOT COMPLETED|Overall Study||0
3101780|NCT01509612|3825352|FG001|NOT COMPLETED|Overall Study||0
3101781|NCT01509612|3825353|FG002|NOT COMPLETED|Overall Study||0
3101782|NCT01509625|3825364|FG000|STARTED|Overall Study||272
3101783|NCT01509625|3825364|FG000|COMPLETED|Overall Study||263
3101784|NCT01509625|3825364|FG000|NOT COMPLETED|Overall Study||9
3101785|NCT01509638|3825379|FG000|STARTED|Overall Study||23
3101786|NCT01509638|3825380|FG001|STARTED|Overall Study||26
3101787|NCT01509638|3825379|FG000|COMPLETED|Overall Study||20
3101788|NCT01509638|3825380|FG001|COMPLETED|Overall Study||24
3101789|NCT01509638|3825379|FG000|NOT COMPLETED|Overall Study||3
3101790|NCT01509638|3825380|FG001|NOT COMPLETED|Overall Study||2
3101791|NCT01509664|3825388|FG000|STARTED|Overall Study||49
3101792|NCT01509664|3825389|FG001|STARTED|Overall Study||49
3101793|NCT01509664|3825388|FG000|T2 Follow-up|Overall Study||45
3101794|NCT01509664|3825389|FG001|T2 Follow-up|Overall Study||38
3101795|NCT01509664|3825388|FG000|T3 Follow-up|Overall Study||40
3101796|NCT01509664|3825389|FG001|T3 Follow-up|Overall Study||33
3101797|NCT01509664|3825388|FG000|COMPLETED|Overall Study||34
3101798|NCT01509664|3825389|FG001|COMPLETED|Overall Study||28
3101799|NCT01509664|3825388|FG000|NOT COMPLETED|Overall Study||15
3101800|NCT01509664|3825389|FG001|NOT COMPLETED|Overall Study||21
3101801|NCT01509677|3825397|FG000|STARTED|Overall Study||79
3101802|NCT01509677|3825398|FG001|STARTED|Overall Study||79
3101803|NCT01509677|3825397|FG000|COMPLETED|Overall Study||76
3101804|NCT01509677|3825398|FG001|COMPLETED|Overall Study||73
3101805|NCT01509677|3825397|FG000|NOT COMPLETED|Overall Study||3
3101806|NCT01509677|3825398|FG001|NOT COMPLETED|Overall Study||6
3101807|NCT01509807|3825406|FG000|STARTED|Overall Study||16
3101808|NCT01509807|3825407|FG001|STARTED|Overall Study||17
3101809|NCT01509807|3825406|FG000|COMPLETED|Overall Study||15
3101810|NCT01509807|3825407|FG001|COMPLETED|Overall Study||16
3101811|NCT01509807|3825406|FG000|NOT COMPLETED|Overall Study||1
3101812|NCT01509807|3825407|FG001|NOT COMPLETED|Overall Study||1
3101813|NCT01509846|3825418|FG000|STARTED|Received Vaccination 1||5
3101814|NCT01509846|3825419|FG001|STARTED|Received Vaccination 1||20
3101815|NCT01509846|3825420|FG002|STARTED|Received Vaccination 1||20
3101816|NCT01509846|3825421|FG003|STARTED|Received Vaccination 1||20
3101817|NCT01509846|3825422|FG004|STARTED|Received Vaccination 1||17
3101818|NCT01509846|3825418|FG000|COMPLETED|Received Vaccination 1||5
3101819|NCT01509846|3825419|FG001|COMPLETED|Received Vaccination 1||20
3101820|NCT01509846|3825420|FG002|COMPLETED|Received Vaccination 1||20
3101821|NCT01509846|3825421|FG003|COMPLETED|Received Vaccination 1||20
3101822|NCT01509846|3825422|FG004|COMPLETED|Received Vaccination 1||17
3101823|NCT01509846|3825418|FG000|NOT COMPLETED|Received Vaccination 1||0
3101824|NCT01509846|3825419|FG001|NOT COMPLETED|Received Vaccination 1||0
3101825|NCT01509846|3825420|FG002|NOT COMPLETED|Received Vaccination 1||0
3101826|NCT01509846|3825421|FG003|NOT COMPLETED|Received Vaccination 1||0
3101827|NCT01509846|3825422|FG004|NOT COMPLETED|Received Vaccination 1||0
3101828|NCT01509846|3825418|FG000|STARTED|Received Vaccination 2||5
3101829|NCT01509846|3825419|FG001|STARTED|Received Vaccination 2||20
3101830|NCT01509846|3825420|FG002|STARTED|Received Vaccination 2||20
3101831|NCT01509846|3825421|FG003|STARTED|Received Vaccination 2||20
3101832|NCT01509846|3825422|FG004|STARTED|Received Vaccination 2||17
3101833|NCT01509846|3825418|FG000|COMPLETED|Received Vaccination 2||0
3101834|NCT01509846|3825419|FG001|COMPLETED|Received Vaccination 2||20
3101835|NCT01509846|3825420|FG002|COMPLETED|Received Vaccination 2||19
3101836|NCT01509846|3825421|FG003|COMPLETED|Received Vaccination 2||20
3101837|NCT01509846|3825422|FG004|COMPLETED|Received Vaccination 2||14
3101838|NCT01509846|3825418|FG000|NOT COMPLETED|Received Vaccination 2||5
3101839|NCT01509846|3825419|FG001|NOT COMPLETED|Received Vaccination 2||0
3101840|NCT01509846|3825420|FG002|NOT COMPLETED|Received Vaccination 2||1
3101841|NCT01509846|3825421|FG003|NOT COMPLETED|Received Vaccination 2||0
3101842|NCT01509846|3825422|FG004|NOT COMPLETED|Received Vaccination 2||3
3101843|NCT01509846|3825418|FG000|STARTED|Received Vaccination 3||0
3101844|NCT01509846|3825419|FG001|STARTED|Received Vaccination 3||20
3101845|NCT01509846|3825420|FG002|STARTED|Received Vaccination 3||19
3101846|NCT01509846|3825421|FG003|STARTED|Received Vaccination 3||20
3101847|NCT01509846|3825422|FG004|STARTED|Received Vaccination 3||14
3101848|NCT01509846|3825418|FG000|COMPLETED|Received Vaccination 3||0
3291616|NCT02849184|4025725|FG000|COMPLETED|Overall Study||40
3291617|NCT02849184|4025726|FG001|COMPLETED|Overall Study||42
3291618|NCT02849184|4025725|FG000|NOT COMPLETED|Overall Study||0
3291619|NCT02849184|4025726|FG001|NOT COMPLETED|Overall Study||0
3291620|NCT02849418|4025734|FG000|STARTED|Double-blinded (Up to 48 Weeks)||10
3291621|NCT02849418|4025735|FG001|STARTED|Double-blinded (Up to 48 Weeks)||11
3291622|NCT02849418|4025736|FG002|STARTED|Double-blinded (Up to 48 Weeks)||0
3291623|NCT02849418|4025737|FG003|STARTED|Double-blinded (Up to 48 Weeks)||0
3291624|NCT02849418|4025738|FG004|STARTED|Double-blinded (Up to 48 Weeks)||0
3291625|NCT02849418|4025739|FG005|STARTED|Double-blinded (Up to 48 Weeks)||0
3291626|NCT02849418|4025734|FG000|COMPLETED|Double-blinded (Up to 48 Weeks)||10
3291627|NCT02849418|4025735|FG001|COMPLETED|Double-blinded (Up to 48 Weeks)||11
3291628|NCT02849418|4025736|FG002|COMPLETED|Double-blinded (Up to 48 Weeks)||0
3291629|NCT02849418|4025737|FG003|COMPLETED|Double-blinded (Up to 48 Weeks)||0
3291630|NCT02849418|4025738|FG004|COMPLETED|Double-blinded (Up to 48 Weeks)||0
3291631|NCT02849418|4025739|FG005|COMPLETED|Double-blinded (Up to 48 Weeks)||0
3291632|NCT02849418|4025734|FG000|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
3291633|NCT02849418|4025735|FG001|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
3291634|NCT02849418|4025736|FG002|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
3291635|NCT02849418|4025737|FG003|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
3291636|NCT02849418|4025738|FG004|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
3291637|NCT02849418|4025739|FG005|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
3291638|NCT02849418|4025734|FG000|STARTED|Open-label(2nd Treatment-Week 12 to 48)||0
3291639|NCT02849418|4025735|FG001|STARTED|Open-label(2nd Treatment-Week 12 to 48)||0
3291640|NCT02849418|4025736|FG002|STARTED|Open-label(2nd Treatment-Week 12 to 48)||10
3291641|NCT02849418|4025737|FG003|STARTED|Open-label(2nd Treatment-Week 12 to 48)||6
3291642|NCT02849418|4025738|FG004|STARTED|Open-label(2nd Treatment-Week 12 to 48)||0
3291643|NCT02849418|4025739|FG005|STARTED|Open-label(2nd Treatment-Week 12 to 48)||0
3291644|NCT02849418|4025734|FG000|COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
3291645|NCT02849418|4025735|FG001|COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
3291646|NCT02849418|4025736|FG002|COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||10
3291647|NCT02849418|4025737|FG003|COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||6
3291648|NCT02849418|4025738|FG004|COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
3291649|NCT02849418|4025739|FG005|COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
3291650|NCT02849418|4025734|FG000|NOT COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
3291651|NCT02849418|4025735|FG001|NOT COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
3291652|NCT02849418|4025736|FG002|NOT COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
3291653|NCT02849418|4025737|FG003|NOT COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
3291654|NCT02849418|4025738|FG004|NOT COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
3291655|NCT02849418|4025739|FG005|NOT COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
3291656|NCT02849418|4025734|FG000|STARTED|Open-label(3rd Treatment-Week 12 to 48)||0
3291657|NCT02849418|4025735|FG001|STARTED|Open-label(3rd Treatment-Week 12 to 48)||0
3291658|NCT02849418|4025736|FG002|STARTED|Open-label(3rd Treatment-Week 12 to 48)||0
3101849|NCT01509846|3825419|FG001|COMPLETED|Received Vaccination 3||19
3101850|NCT01509846|3825420|FG002|COMPLETED|Received Vaccination 3||18
3101851|NCT01509846|3825421|FG003|COMPLETED|Received Vaccination 3||19
3101852|NCT01509846|3825422|FG004|COMPLETED|Received Vaccination 3||14
3291659|NCT02849418|4025737|FG003|STARTED|Open-label(3rd Treatment-Week 12 to 48)||0
3291660|NCT02849418|4025738|FG004|STARTED|Open-label(3rd Treatment-Week 12 to 48)||5
3291661|NCT02849418|4025739|FG005|STARTED|Open-label(3rd Treatment-Week 12 to 48)||3
3291662|NCT02849418|4025734|FG000|COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
3291663|NCT02849418|4025735|FG001|COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
3291664|NCT02849418|4025736|FG002|COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
3291665|NCT02849418|4025737|FG003|COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
3291666|NCT02849418|4025738|FG004|COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||5
3291667|NCT02849418|4025739|FG005|COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||3
3291668|NCT02849418|4025734|FG000|NOT COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
3291669|NCT02849418|4025735|FG001|NOT COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
3291670|NCT02849418|4025736|FG002|NOT COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
3291671|NCT02849418|4025737|FG003|NOT COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
3291672|NCT02849418|4025738|FG004|NOT COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
3291673|NCT02849418|4025739|FG005|NOT COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
3291674|NCT02849509|4025758|FG000|STARTED|Overall Study||379
3291675|NCT02849509|4025759|FG001|STARTED|Overall Study||591
3291676|NCT02849509|4025760|FG002|STARTED|Overall Study||343
3291677|NCT02849509|4025758|FG000|COMPLETED|Overall Study|Not prematurely discontinued from Pradaxa or VKA|289
3291678|NCT02849509|4025759|FG001|COMPLETED|Overall Study|Not prematurely discontinued from Pradaxa or VKA|425
3291679|NCT02849509|4025760|FG002|COMPLETED|Overall Study|Not prematurely discontinued from Pradaxa or VKA|258
3291680|NCT02849509|4025758|FG000|NOT COMPLETED|Overall Study||90
3291681|NCT02849509|4025759|FG001|NOT COMPLETED|Overall Study||166
3291682|NCT02849509|4025760|FG002|NOT COMPLETED|Overall Study||85
3291683|NCT02849678|4025772|FG000|STARTED|Overall Study||20
3291684|NCT02849678|4025773|FG001|STARTED|Overall Study||24
3291685|NCT02849678|4025772|FG000|COMPLETED|Overall Study||17
3291686|NCT02849678|4025773|FG001|COMPLETED|Overall Study||18
3291687|NCT02849678|4025772|FG000|NOT COMPLETED|Overall Study||3
3291688|NCT02849678|4025773|FG001|NOT COMPLETED|Overall Study||6
3291689|NCT02849704|4025781|FG000|STARTED|Washout Period - CP Subj on PERT - 3days||11
3291690|NCT02849704|4025782|FG001|STARTED|Washout Period - CP Subj on PERT - 3days||0
3291691|NCT02849704|4025781|FG000|COMPLETED|Washout Period - CP Subj on PERT - 3days||11
3291692|NCT02849704|4025782|FG001|COMPLETED|Washout Period - CP Subj on PERT - 3days||0
3291693|NCT02849704|4025781|FG000|NOT COMPLETED|Washout Period - CP Subj on PERT - 3days||0
3291694|NCT02849704|4025782|FG001|NOT COMPLETED|Washout Period - CP Subj on PERT - 3days||0
3291695|NCT02849704|4025781|FG000|STARTED|Baseline Assessments - All Subj - 7 Days||24
3291696|NCT02849704|4025782|FG001|STARTED|Baseline Assessments - All Subj - 7 Days||24
3291697|NCT02849704|4025781|FG000|COMPLETED|Baseline Assessments - All Subj - 7 Days||24
3291698|NCT02849704|4025782|FG001|COMPLETED|Baseline Assessments - All Subj - 7 Days||24
3291699|NCT02849704|4025781|FG000|NOT COMPLETED|Baseline Assessments - All Subj - 7 Days||0
3291700|NCT02849704|4025782|FG001|NOT COMPLETED|Baseline Assessments - All Subj - 7 Days||0
3291701|NCT02849704|4025781|FG000|STARTED|Assessment on PERT - CP Subj - 16 Days||24
3291702|NCT02849704|4025782|FG001|STARTED|Assessment on PERT - CP Subj - 16 Days||0
3291703|NCT02849704|4025781|FG000|COMPLETED|Assessment on PERT - CP Subj - 16 Days||21
3291704|NCT02849704|4025782|FG001|COMPLETED|Assessment on PERT - CP Subj - 16 Days||0
3291705|NCT02849704|4025781|FG000|NOT COMPLETED|Assessment on PERT - CP Subj - 16 Days||3
3291706|NCT02849704|4025782|FG001|NOT COMPLETED|Assessment on PERT - CP Subj - 16 Days||0
3291707|NCT02849938|4025794|FG000|STARTED|Overall Study||9
3291708|NCT02849938|4025795|FG001|STARTED|Overall Study||15
3291709|NCT02849938|4025794|FG000|COMPLETED|Overall Study||9
3291710|NCT02849938|4025795|FG001|COMPLETED|Overall Study||15
3291711|NCT02849938|4025794|FG000|NOT COMPLETED|Overall Study||0
3291712|NCT02849938|4025795|FG001|NOT COMPLETED|Overall Study||0
3291713|NCT02850068|4025801|FG000|STARTED|Overall Study||20
3291714|NCT02850068|4025801|FG000|COMPLETED|Overall Study||0
3291715|NCT02850068|4025801|FG000|NOT COMPLETED|Overall Study||20
3291716|NCT02850159|4025807|FG000|STARTED|Overall Study||16
3291717|NCT02850159|4025808|FG001|STARTED|Overall Study||16
3291718|NCT02850159|4025807|FG000|COMPLETED|Overall Study||16
3291719|NCT02850159|4025808|FG001|COMPLETED|Overall Study||16
3291720|NCT02850159|4025807|FG000|NOT COMPLETED|Overall Study||0
3291721|NCT02850159|4025808|FG001|NOT COMPLETED|Overall Study||0
3291722|NCT02850276|4025814|FG000|STARTED|Overall Study||76
3291723|NCT02850276|4025814|FG000|COMPLETED|Overall Study||15
3291724|NCT02850276|4025814|FG000|NOT COMPLETED|Overall Study||61
3291725|NCT02850601|4025821|FG000|STARTED|Overall Study||12
3291726|NCT02850601|4025822|FG001|STARTED|Overall Study||12
3291727|NCT02850601|4025821|FG000|COMPLETED|Overall Study||12
3291728|NCT02850601|4025822|FG001|COMPLETED|Overall Study||12
3291729|NCT02850601|4025821|FG000|NOT COMPLETED|Overall Study||0
3291730|NCT02850601|4025822|FG001|NOT COMPLETED|Overall Study||0
3291731|NCT02850965|4025830|FG000|STARTED|Overall Study||159
3291732|NCT02850965|4025831|FG001|STARTED|Overall Study||159
3291733|NCT02850965|4025830|FG000|Treated|Overall Study||159
3291734|NCT02850965|4025831|FG001|Treated|Overall Study||158
3291735|NCT02850965|4025830|FG000|COMPLETED|Overall Study||141
3291736|NCT02850965|4025831|FG001|COMPLETED|Overall Study||134
3291737|NCT02850965|4025830|FG000|NOT COMPLETED|Overall Study||18
3291738|NCT02850965|4025831|FG001|NOT COMPLETED|Overall Study||25
3101853|NCT01509846|3825418|FG000|NOT COMPLETED|Received Vaccination 3||0
3101854|NCT01509846|3825419|FG001|NOT COMPLETED|Received Vaccination 3||1
3101855|NCT01509846|3825420|FG002|NOT COMPLETED|Received Vaccination 3||1
3101856|NCT01509846|3825421|FG003|NOT COMPLETED|Received Vaccination 3||1
3101857|NCT01509846|3825422|FG004|NOT COMPLETED|Received Vaccination 3||0
3101858|NCT01509872|3825443|FG000|STARTED|Overall Study||26
3101859|NCT01509872|3825444|FG001|STARTED|Overall Study||24
3101860|NCT01509872|3825443|FG000|Post-Intervention Assessment|Overall Study||26
3101861|NCT01509872|3825444|FG001|Post-Intervention Assessment|Overall Study||24
3101862|NCT01509872|3825443|FG000|COMPLETED|Overall Study||25
3101863|NCT01509872|3825444|FG001|COMPLETED|Overall Study||24
3101864|NCT01509872|3825443|FG000|NOT COMPLETED|Overall Study||1
3101865|NCT01509872|3825444|FG001|NOT COMPLETED|Overall Study||0
3101866|NCT01509950|3825454|FG000|STARTED|Overall Study||7
3101867|NCT01509950|3825455|FG001|STARTED|Overall Study||8
3101868|NCT01509950|3825456|FG002|STARTED|Overall Study||0
3101869|NCT01509950|3825454|FG000|COMPLETED|Overall Study||7
3101870|NCT01509950|3825455|FG001|COMPLETED|Overall Study||8
3291739|NCT02850978|4025837|FG000|STARTED|Overall Study||1335
3101871|NCT01509950|3825456|FG002|COMPLETED|Overall Study||0
3291740|NCT02850978|4025837|FG000|Case Report Form (CRF) Collected|Overall Study||1308
3291741|NCT02850978|4025837|FG000|Treated|Overall Study||1308
3291742|NCT02850978|4025837|FG000|COMPLETED|Overall Study||909
3291743|NCT02850978|4025837|FG000|NOT COMPLETED|Overall Study||426
3291744|NCT02851069|4025841|FG000|STARTED|Overall Study||65
3291745|NCT02851069|4025841|FG000|COMPLETED|Overall Study||59
3291746|NCT02851069|4025841|FG000|NOT COMPLETED|Overall Study||6
3291747|NCT02851108|4025848|FG000|STARTED|Overall Study||50
3291748|NCT02851108|4025849|FG001|STARTED|Overall Study||50
3291749|NCT02851108|4025848|FG000|COMPLETED|Overall Study||42
3291750|NCT02851108|4025849|FG001|COMPLETED|Overall Study||49
3291751|NCT02851108|4025848|FG000|NOT COMPLETED|Overall Study||8
3291752|NCT02851108|4025849|FG001|NOT COMPLETED|Overall Study||1
3291753|NCT02851615|4025857|FG000|STARTED|Overall Study||27
3101872|NCT01509950|3825454|FG000|NOT COMPLETED|Overall Study||0
3101873|NCT01509950|3825455|FG001|NOT COMPLETED|Overall Study||0
3101874|NCT01509950|3825456|FG002|NOT COMPLETED|Overall Study||0
3101875|NCT01510028|3825466|FG000|STARTED|Overall Study||6
3101876|NCT01510028|3825467|FG001|STARTED|Overall Study||6
3101877|NCT01510028|3825468|FG002|STARTED|Overall Study||6
3101878|NCT01510028|3825469|FG003|STARTED|Overall Study||6
3101879|NCT01510028|3825466|FG000|COMPLETED|Overall Study||5
3101880|NCT01510028|3825467|FG001|COMPLETED|Overall Study||6
3101881|NCT01510028|3825468|FG002|COMPLETED|Overall Study||6
3101882|NCT01510028|3825469|FG003|COMPLETED|Overall Study||6
3101883|NCT01510028|3825466|FG000|NOT COMPLETED|Overall Study||1
3101884|NCT01510028|3825467|FG001|NOT COMPLETED|Overall Study||0
3101885|NCT01510028|3825468|FG002|NOT COMPLETED|Overall Study||0
3101886|NCT01510028|3825469|FG003|NOT COMPLETED|Overall Study||0
3101887|NCT01510145|3825481|FG000|STARTED|Overall Study||191
3101888|NCT01510145|3825481|FG000|COMPLETED|Overall Study||173
3101889|NCT01510145|3825481|FG000|NOT COMPLETED|Overall Study||18
3101890|NCT01510158|3825488|FG000|STARTED|Overall Study||202
3101891|NCT01510158|3825489|FG001|STARTED|Overall Study||203
3101892|NCT01510158|3825490|FG002|STARTED|Overall Study||202
3101893|NCT01510158|3825488|FG000|COMPLETED|Overall Study||151
3101894|NCT01510158|3825489|FG001|COMPLETED|Overall Study||150
3101895|NCT01510158|3825490|FG002|COMPLETED|Overall Study||152
3101896|NCT01510158|3825488|FG000|NOT COMPLETED|Overall Study||51
3101897|NCT01510158|3825489|FG001|NOT COMPLETED|Overall Study||53
3101898|NCT01510158|3825490|FG002|NOT COMPLETED|Overall Study||50
3101899|NCT01510327|3825498|FG000|STARTED|Overall Study||22
3101900|NCT01510327|3825498|FG000|COMPLETED|Overall Study||22
3101901|NCT01510327|3825498|FG000|NOT COMPLETED|Overall Study||0
3101902|NCT01510379|3825510|FG000|STARTED|Overall Study||49
3101903|NCT01510379|3825511|FG001|STARTED|Overall Study||51
3101904|NCT01510379|3825510|FG000|COMPLETED|Overall Study||49
3101905|NCT01510379|3825511|FG001|COMPLETED|Overall Study||51
3101906|NCT01510379|3825510|FG000|NOT COMPLETED|Overall Study||0
3101907|NCT01510379|3825511|FG001|NOT COMPLETED|Overall Study||0
3101908|NCT01510457|3825519|FG000|STARTED|Overall Study||17
3101909|NCT01510457|3825520|FG001|STARTED|Overall Study||29
3101910|NCT01510457|3825519|FG000|COMPLETED|Overall Study||12
3101911|NCT01510457|3825520|FG001|COMPLETED|Overall Study||26
3101912|NCT01510457|3825519|FG000|NOT COMPLETED|Overall Study||5
3101913|NCT01510457|3825520|FG001|NOT COMPLETED|Overall Study||3
3101914|NCT01510652|3825530|FG000|STARTED|Overall Study||719
3101915|NCT01510652|3825531|FG001|STARTED|Overall Study||355
3101916|NCT01510652|3825530|FG000|Baseline|Overall Study||718
3101917|NCT01510652|3825531|FG001|Baseline|Overall Study||348
3101918|NCT01510652|3825530|FG000|COMPLETED|Overall Study||627
3101919|NCT01510652|3825531|FG001|COMPLETED|Overall Study||288
3101920|NCT01510652|3825530|FG000|NOT COMPLETED|Overall Study||92
3101921|NCT01510652|3825531|FG001|NOT COMPLETED|Overall Study||67
3101922|NCT01510704|3825541|FG000|STARTED|Overall Study||54
3101923|NCT01510704|3825542|FG001|STARTED|Overall Study||58
3291754|NCT02851615|4025858|FG001|STARTED|Overall Study||31
3291755|NCT02851615|4025857|FG000|COMPLETED|Overall Study||26
3291756|NCT02851615|4025858|FG001|COMPLETED|Overall Study||27
3101924|NCT01510704|3825543|FG002|STARTED|Overall Study||50
3101925|NCT01510704|3825544|FG003|STARTED|Overall Study||53
3101926|NCT01510704|3825541|FG000|COMPLETED|Overall Study||54
3101927|NCT01510704|3825542|FG001|COMPLETED|Overall Study||58
3101928|NCT01510704|3825543|FG002|COMPLETED|Overall Study||50
3101929|NCT01510704|3825544|FG003|COMPLETED|Overall Study||53
3101930|NCT01510704|3825541|FG000|NOT COMPLETED|Overall Study||0
3101931|NCT01510704|3825542|FG001|NOT COMPLETED|Overall Study||0
3101932|NCT01510704|3825543|FG002|NOT COMPLETED|Overall Study||0
3101933|NCT01510704|3825544|FG003|NOT COMPLETED|Overall Study||0
3101934|NCT01510717|3825556|FG000|STARTED|Overall Study||155
3101935|NCT01510717|3825557|FG001|STARTED|Overall Study||165
3101936|NCT01510717|3825556|FG000|COMPLETED|Overall Study||153
3101937|NCT01510717|3825557|FG001|COMPLETED|Overall Study||160
3101938|NCT01510717|3825556|FG000|NOT COMPLETED|Overall Study||2
3101939|NCT01510717|3825557|FG001|NOT COMPLETED|Overall Study||5
3101940|NCT01510769|3825567|FG000|STARTED|Overall Study||106
3101941|NCT01510769|3825568|FG001|STARTED|Overall Study||109
3101942|NCT01510769|3825569|FG002|STARTED|Overall Study||109
3101943|NCT01510769|3825567|FG000|COMPLETED|Overall Study||79
3101944|NCT01510769|3825568|FG001|COMPLETED|Overall Study||84
3101945|NCT01510769|3825569|FG002|COMPLETED|Overall Study||87
3101946|NCT01510769|3825567|FG000|NOT COMPLETED|Overall Study||27
3101947|NCT01510769|3825568|FG001|NOT COMPLETED|Overall Study||25
3101948|NCT01510769|3825569|FG002|NOT COMPLETED|Overall Study||22
3101949|NCT01510834|3825577|FG000|STARTED|Overall Study||90
3101950|NCT01510834|3825577|FG000|COMPLETED|Overall Study||57
3101951|NCT01510834|3825577|FG000|NOT COMPLETED|Overall Study||33
3101952|NCT01510912|3825584|FG000|STARTED|Overall Study||602
3101953|NCT01510912|3825584|FG000|COMPLETED|Overall Study||360
3101954|NCT01510912|3825584|FG000|NOT COMPLETED|Overall Study||242
3101955|NCT01511016|3825590|FG000|STARTED|Overall Study||8
3101956|NCT01511016|3825591|FG001|STARTED|Overall Study||9
3101957|NCT01511016|3825590|FG000|COMPLETED|Overall Study||6
3101958|NCT01511016|3825591|FG001|COMPLETED|Overall Study||7
3101959|NCT01511016|3825590|FG000|NOT COMPLETED|Overall Study||2
3101960|NCT01511016|3825591|FG001|NOT COMPLETED|Overall Study||2
3101961|NCT01511055|3825598|FG000|STARTED|Overall Study||27
3101962|NCT01511055|3825598|FG000|COMPLETED|Overall Study||21
3101963|NCT01511055|3825598|FG000|NOT COMPLETED|Overall Study||6
3101964|NCT01511068|3825602|FG000|STARTED|Overall Study||2
3101965|NCT01511068|3825602|FG000|COMPLETED|Overall Study||2
3101966|NCT01511068|3825602|FG000|NOT COMPLETED|Overall Study||0
3101967|NCT01511107|3825608|FG000|STARTED|Overall Study|Randomized to the treatment group.|260
3101968|NCT01511107|3825609|FG001|STARTED|Overall Study|Randomized to the treatment group.|260
3101969|NCT01511107|3825608|FG000|COMPLETED|Overall Study|Completed - Assessed at a final visit in Sep or at the end of the respiratory season in Apr or May.|238
3101970|NCT01511107|3825609|FG001|COMPLETED|Overall Study|Completed - Assessed at a final visit in Sep or at the end of the respiratory season in Apr or May.|219
3101971|NCT01511107|3825608|FG000|NOT COMPLETED|Overall Study||22
3101972|NCT01511107|3825609|FG001|NOT COMPLETED|Overall Study||41
3101973|NCT01511250|3825625|FG000|STARTED|Overall Study||24
3101974|NCT01511250|3825626|FG001|STARTED|Overall Study||14
3101975|NCT01511250|3825627|FG002|STARTED|Overall Study||22
3101976|NCT01511250|3825628|FG003|STARTED|Overall Study||14
3101977|NCT01511250|3825629|FG004|STARTED|Overall Study||21
3101978|NCT01511250|3825630|FG005|STARTED|Overall Study||17
3101979|NCT01511250|3825631|FG006|STARTED|Overall Study||23
3101980|NCT01511250|3825632|FG007|STARTED|Overall Study||13
3101981|NCT01511250|3825633|FG008|STARTED|Overall Study||159
3101982|NCT01511250|3825634|FG009|STARTED|Overall Study||53
3101983|NCT01511250|3825625|FG000|COMPLETED|Overall Study||15
3101984|NCT01511250|3825626|FG001|COMPLETED|Overall Study||9
3101985|NCT01511250|3825627|FG002|COMPLETED|Overall Study||18
3101986|NCT01511250|3825628|FG003|COMPLETED|Overall Study||11
3101987|NCT01511250|3825629|FG004|COMPLETED|Overall Study||21
3101988|NCT01511250|3825630|FG005|COMPLETED|Overall Study||17
3101989|NCT01511250|3825631|FG006|COMPLETED|Overall Study||21
3101990|NCT01511250|3825632|FG007|COMPLETED|Overall Study||9
3101991|NCT01511250|3825633|FG008|COMPLETED|Overall Study||145
3101992|NCT01511250|3825634|FG009|COMPLETED|Overall Study||48
3101993|NCT01511250|3825625|FG000|NOT COMPLETED|Overall Study||9
3101994|NCT01511250|3825626|FG001|NOT COMPLETED|Overall Study||5
3101995|NCT01511250|3825627|FG002|NOT COMPLETED|Overall Study||4
3101996|NCT01511250|3825628|FG003|NOT COMPLETED|Overall Study||3
3101997|NCT01511250|3825629|FG004|NOT COMPLETED|Overall Study||0
3101998|NCT01511250|3825630|FG005|NOT COMPLETED|Overall Study||0
3101999|NCT01511250|3825631|FG006|NOT COMPLETED|Overall Study||2
3102000|NCT01511250|3825632|FG007|NOT COMPLETED|Overall Study||4
3102001|NCT01511250|3825633|FG008|NOT COMPLETED|Overall Study||14
3102002|NCT01511250|3825634|FG009|NOT COMPLETED|Overall Study||5
3135458|NCT01707290|3860526|FG000|NOT COMPLETED|Overall Study||86
3135459|NCT01707290|3860527|FG001|NOT COMPLETED|Overall Study||1
3135460|NCT01707368|3860536|FG000|STARTED|Overall Study||561
3135461|NCT01707368|3860536|FG000|COMPLETED|Overall Study||393
3135462|NCT01707368|3860536|FG000|NOT COMPLETED|Overall Study||168
3135463|NCT01707381|3860540|FG000|STARTED|Period 1||12
3135464|NCT01707381|3860541|FG001|STARTED|Period 1||13
3135465|NCT01707381|3860540|FG000|COMPLETED|Period 1||10
3135466|NCT01707381|3860541|FG001|COMPLETED|Period 1||11
3135467|NCT01707381|3860540|FG000|NOT COMPLETED|Period 1||2
3135468|NCT01707381|3860541|FG001|NOT COMPLETED|Period 1||2
3135469|NCT01707381|3860540|FG000|STARTED|Period 2||10
3135470|NCT01707381|3860541|FG001|STARTED|Period 2||11
3135471|NCT01707381|3860540|FG000|COMPLETED|Period 2||10
3135472|NCT01707381|3860541|FG001|COMPLETED|Period 2||11
3135473|NCT01707381|3860540|FG000|NOT COMPLETED|Period 2||0
3102003|NCT01511315|3825656|FG000|STARTED|Overall Study||36
3102004|NCT01511315|3825656|FG000|COMPLETED|Overall Study||32
3102005|NCT01511315|3825656|FG000|NOT COMPLETED|Overall Study||4
3102006|NCT01511419|3825662|FG000|STARTED|Dose 1||30
3102007|NCT01511419|3825663|FG001|STARTED|Dose 1||10
3102008|NCT01511419|3825662|FG000|COMPLETED|Dose 1||30
3102009|NCT01511419|3825663|FG001|COMPLETED|Dose 1||10
3102010|NCT01511419|3825662|FG000|NOT COMPLETED|Dose 1||0
3102011|NCT01511419|3825663|FG001|NOT COMPLETED|Dose 1||0
3102012|NCT01511419|3825662|FG000|STARTED|Dose 2||30
3102013|NCT01511419|3825663|FG001|STARTED|Dose 2||10
3102014|NCT01511419|3825662|FG000|COMPLETED|Dose 2||29
3102015|NCT01511419|3825663|FG001|COMPLETED|Dose 2||10
3102016|NCT01511419|3825662|FG000|NOT COMPLETED|Dose 2||1
3102017|NCT01511419|3825663|FG001|NOT COMPLETED|Dose 2||0
3102018|NCT01511445|3825695|FG000|STARTED|Overall Study|Patient enrollment started in December, 2011.|53
3102019|NCT01511445|3825696|FG001|STARTED|Overall Study|Patient enrollment started in December, 2011.|51
3102020|NCT01511445|3825695|FG000|Surgeries Completed|Overall Study|All surgeries were completed by October, 2013.|53
3102021|NCT01511445|3825696|FG001|Surgeries Completed|Overall Study|All surgeries were completed by October, 2013.|51
3102022|NCT01511445|3825695|FG000|Primary Completion October, 2014|Overall Study|1 was excluded Bechterew's disease. 1 protocol violation. 3 were lost to follow-up.|48
3102023|NCT01511445|3825696|FG001|Primary Completion October, 2014|Overall Study|3 protocol violations. 1 lost to follow-up.|47
3102024|NCT01511445|3825695|FG000|Follow-up Completion|Overall Study|Two year follow-up was completed in November, 2015|48
3102025|NCT01511445|3825696|FG001|Follow-up Completion|Overall Study|Two year follow-up was completed in November, 2015|47
3102026|NCT01511445|3825695|FG000|COMPLETED|Overall Study|Data analysis was completed in February, 2016|48
3102027|NCT01511445|3825696|FG001|COMPLETED|Overall Study|Data analysis was completed in February, 2016|47
3102028|NCT01511445|3825695|FG000|NOT COMPLETED|Overall Study||5
3102029|NCT01511445|3825696|FG001|NOT COMPLETED|Overall Study||4
3102030|NCT01511536|3825705|FG000|STARTED|Phase 1||3
3102031|NCT01511536|3825706|FG001|STARTED|Phase 1||7
3102032|NCT01511536|3825707|FG002|STARTED|Phase 1|Phase 1 and phase 2 are separate populations.|0
3102033|NCT01511536|3825705|FG000|COMPLETED|Phase 1|Cancer progression,adverse event,consent withdrawal are considered as completed(defined in protocol)|3
3102034|NCT01511536|3825706|FG001|COMPLETED|Phase 1|Cancer progression,adverse event,consent withdrawal are considered as completed(defined in protocol)|6
3102035|NCT01511536|3825707|FG002|COMPLETED|Phase 1||0
3102036|NCT01511536|3825705|FG000|NOT COMPLETED|Phase 1||0
3102037|NCT01511536|3825706|FG001|NOT COMPLETED|Phase 1||1
3102038|NCT01511536|3825707|FG002|NOT COMPLETED|Phase 1||0
3102039|NCT01511536|3825705|FG000|STARTED|Phase 2||0
3102040|NCT01511536|3825706|FG001|STARTED|Phase 2||0
3102041|NCT01511536|3825707|FG002|STARTED|Phase 2||27
3102042|NCT01511536|3825705|FG000|COMPLETED|Phase 2||0
3102043|NCT01511536|3825706|FG001|COMPLETED|Phase 2||0
3102044|NCT01511536|3825707|FG002|COMPLETED|Phase 2|Cancer progression,adverse event,consent withdrawal are considered as completed(defined in protocol)|18
3102045|NCT01511536|3825705|FG000|NOT COMPLETED|Phase 2||0
3102046|NCT01511536|3825706|FG001|NOT COMPLETED|Phase 2||0
3102047|NCT01511536|3825707|FG002|NOT COMPLETED|Phase 2||9
3102048|NCT01511640|3825719|FG000|STARTED|First Intervention (11-15 Days)||7
3102049|NCT01511640|3825720|FG001|STARTED|First Intervention (11-15 Days)||8
3102050|NCT01511640|3825721|FG002|STARTED|First Intervention (11-15 Days)||7
3102051|NCT01511640|3825722|FG003|STARTED|First Intervention (11-15 Days)||8
3102052|NCT01511640|3825719|FG000|COMPLETED|First Intervention (11-15 Days)||5
3102053|NCT01511640|3825720|FG001|COMPLETED|First Intervention (11-15 Days)||8
3102054|NCT01511640|3825721|FG002|COMPLETED|First Intervention (11-15 Days)||7
3102055|NCT01511640|3825722|FG003|COMPLETED|First Intervention (11-15 Days)||7
3102056|NCT01511640|3825719|FG000|NOT COMPLETED|First Intervention (11-15 Days)||2
3102057|NCT01511640|3825720|FG001|NOT COMPLETED|First Intervention (11-15 Days)||0
3102058|NCT01511640|3825721|FG002|NOT COMPLETED|First Intervention (11-15 Days)||0
3102059|NCT01511640|3825722|FG003|NOT COMPLETED|First Intervention (11-15 Days)||1
3102060|NCT01511640|3825719|FG000|STARTED|Washout (6-10 Days)||5
3102061|NCT01511640|3825720|FG001|STARTED|Washout (6-10 Days)||8
3102062|NCT01511640|3825721|FG002|STARTED|Washout (6-10 Days)||7
3102063|NCT01511640|3825722|FG003|STARTED|Washout (6-10 Days)||7
3102064|NCT01511640|3825719|FG000|COMPLETED|Washout (6-10 Days)||5
3102065|NCT01511640|3825720|FG001|COMPLETED|Washout (6-10 Days)||8
3102066|NCT01511640|3825721|FG002|COMPLETED|Washout (6-10 Days)||7
3102067|NCT01511640|3825722|FG003|COMPLETED|Washout (6-10 Days)||6
3102068|NCT01511640|3825719|FG000|NOT COMPLETED|Washout (6-10 Days)||0
3102069|NCT01511640|3825720|FG001|NOT COMPLETED|Washout (6-10 Days)||0
3102070|NCT01511640|3825721|FG002|NOT COMPLETED|Washout (6-10 Days)||0
3102071|NCT01511640|3825722|FG003|NOT COMPLETED|Washout (6-10 Days)||1
3102072|NCT01511640|3825719|FG000|STARTED|Third Intervention (11-15 Days)||5
3102073|NCT01511640|3825720|FG001|STARTED|Third Intervention (11-15 Days)||8
3102074|NCT01511640|3825721|FG002|STARTED|Third Intervention (11-15 Days)||7
3102075|NCT01511640|3825722|FG003|STARTED|Third Intervention (11-15 Days)||6
3102076|NCT01511640|3825719|FG000|COMPLETED|Third Intervention (11-15 Days)||4
3102077|NCT01511640|3825720|FG001|COMPLETED|Third Intervention (11-15 Days)||7
3102078|NCT01511640|3825721|FG002|COMPLETED|Third Intervention (11-15 Days)||7
3102079|NCT01511640|3825722|FG003|COMPLETED|Third Intervention (11-15 Days)||6
3102080|NCT01511640|3825719|FG000|NOT COMPLETED|Third Intervention (11-15 Days)||1
3102081|NCT01511640|3825720|FG001|NOT COMPLETED|Third Intervention (11-15 Days)||1
3102082|NCT01511640|3825721|FG002|NOT COMPLETED|Third Intervention (11-15 Days)||0
3102083|NCT01511640|3825722|FG003|NOT COMPLETED|Third Intervention (11-15 Days)||0
3102084|NCT01511809|3825734|FG000|STARTED|Overall Study||58
3102085|NCT01511809|3825735|FG001|STARTED|Overall Study||59
3291757|NCT02851615|4025857|FG000|NOT COMPLETED|Overall Study||1
3291758|NCT02851615|4025858|FG001|NOT COMPLETED|Overall Study||4
3291759|NCT02851823|4025865|FG000|STARTED|Overall Study||25
3291760|NCT02851823|4025865|FG000|1 Month|Overall Study||25
3291761|NCT02851823|4025865|FG000|3 Months|Overall Study||25
3291762|NCT02851823|4025865|FG000|COMPLETED|Overall Study||25
3291763|NCT02851823|4025865|FG000|NOT COMPLETED|Overall Study||0
3291764|NCT02852005|4025876|FG000|STARTED|Overall Study||4
3291765|NCT02852005|4025877|FG001|STARTED|Overall Study||4
3291766|NCT02852005|4025878|FG002|STARTED|Overall Study||6
3291767|NCT02852005|4025879|FG003|STARTED|Overall Study||6
3291768|NCT02852005|4025880|FG004|STARTED|Overall Study||7
3102086|NCT01511809|3825734|FG000|COMPLETED|Overall Study||51
3102087|NCT01511809|3825735|FG001|COMPLETED|Overall Study||52
3102088|NCT01511809|3825734|FG000|NOT COMPLETED|Overall Study||7
3102089|NCT01511809|3825735|FG001|NOT COMPLETED|Overall Study||7
3102090|NCT01511939|3825744|FG000|STARTED|Overall Study|Includes 1 subject who was also taking aspirin.|9
3102091|NCT01511939|3825745|FG001|STARTED|Overall Study|Includes one patient who was also taking aspirin.|5
3102092|NCT01511939|3825746|FG002|STARTED|Overall Study||8
3102093|NCT01511939|3825744|FG000|COMPLETED|Overall Study||7
3102094|NCT01511939|3825745|FG001|COMPLETED|Overall Study||4
3102095|NCT01511939|3825746|FG002|COMPLETED|Overall Study||8
3102096|NCT01511939|3825744|FG000|NOT COMPLETED|Overall Study||2
3102097|NCT01511939|3825745|FG001|NOT COMPLETED|Overall Study||1
3102098|NCT01511939|3825746|FG002|NOT COMPLETED|Overall Study||0
3102099|NCT01511978|3825756|FG000|STARTED|Overall Study||14
3102100|NCT01511978|3825757|FG001|STARTED|Overall Study||18
3102101|NCT01511978|3825756|FG000|COMPLETED|Overall Study||14
3102102|NCT01511978|3825757|FG001|COMPLETED|Overall Study||18
3102103|NCT01511978|3825756|FG000|NOT COMPLETED|Overall Study||0
3102104|NCT01511978|3825757|FG001|NOT COMPLETED|Overall Study||0
3102105|NCT01512108|3825767|FG000|STARTED|Overall Study||243
3102106|NCT01512108|3825768|FG001|STARTED|Overall Study||120
3102107|NCT01512108|3825767|FG000|Exposed|Overall Study|3 subjects withdrew prior to exposure to trial drug|240
3102108|NCT01512108|3825768|FG001|Exposed|Overall Study||120
3102109|NCT01512108|3825767|FG000|COMPLETED|Overall Study||221
3102110|NCT01512108|3825768|FG001|COMPLETED|Overall Study||111
3102111|NCT01512108|3825767|FG000|NOT COMPLETED|Overall Study||22
3102112|NCT01512108|3825768|FG001|NOT COMPLETED|Overall Study||9
3102113|NCT01512160|3825778|FG000|STARTED|Overall Study||22
3102114|NCT01512160|3825779|FG001|STARTED|Overall Study||23
3102115|NCT01512160|3825780|FG002|STARTED|Overall Study||22
3102116|NCT01512160|3825781|FG003|STARTED|Overall Study||23
3102117|NCT01512160|3825778|FG000|COMPLETED|Overall Study||20
3102118|NCT01512160|3825779|FG001|COMPLETED|Overall Study||23
3102119|NCT01512160|3825780|FG002|COMPLETED|Overall Study||22
3102120|NCT01512160|3825781|FG003|COMPLETED|Overall Study||22
3102121|NCT01512160|3825778|FG000|NOT COMPLETED|Overall Study||2
3102122|NCT01512160|3825779|FG001|NOT COMPLETED|Overall Study||0
3102123|NCT01512160|3825780|FG002|NOT COMPLETED|Overall Study||0
3102124|NCT01512160|3825781|FG003|NOT COMPLETED|Overall Study||1
3102125|NCT01512225|3825794|FG000|STARTED|Overall Study||45
3102126|NCT01512225|3825795|FG001|STARTED|Overall Study||45
3102127|NCT01512225|3825794|FG000|Provided Day 14 Volume|Overall Study||45
3102128|NCT01512225|3825795|FG001|Provided Day 14 Volume|Overall Study||40
3102129|NCT01512225|3825794|FG000|COMPLETED|Overall Study||45
3102130|NCT01512225|3825795|FG001|COMPLETED|Overall Study||45
3102131|NCT01512225|3825794|FG000|NOT COMPLETED|Overall Study||0
3102132|NCT01512225|3825795|FG001|NOT COMPLETED|Overall Study||0
3102133|NCT01512251|3825805|FG000|STARTED|Dose Level -1||3
3102134|NCT01512251|3825806|FG001|STARTED|Dose Level -1||5
3102135|NCT01512251|3825805|FG000|COMPLETED|Dose Level -1||3
3102136|NCT01512251|3825806|FG001|COMPLETED|Dose Level -1||5
3102137|NCT01512251|3825805|FG000|NOT COMPLETED|Dose Level -1||0
3102138|NCT01512251|3825806|FG001|NOT COMPLETED|Dose Level -1||0
3102139|NCT01512251|3825805|FG000|STARTED|Phase I, Dose 1||3
3102140|NCT01512251|3825806|FG001|STARTED|Phase I, Dose 1||5
3102141|NCT01512251|3825805|FG000|COMPLETED|Phase I, Dose 1||0
3102142|NCT01512251|3825806|FG001|COMPLETED|Phase I, Dose 1||0
3102143|NCT01512251|3825805|FG000|NOT COMPLETED|Phase I, Dose 1||3
3102144|NCT01512251|3825806|FG001|NOT COMPLETED|Phase I, Dose 1||5
3102145|NCT01512251|3825805|FG000|STARTED|Phase I, Dose 2||0
3102146|NCT01512251|3825806|FG001|STARTED|Phase I, Dose 2||0
3102147|NCT01512251|3825805|FG000|COMPLETED|Phase I, Dose 2||0
3102148|NCT01512251|3825806|FG001|COMPLETED|Phase I, Dose 2||0
3102149|NCT01512251|3825805|FG000|NOT COMPLETED|Phase I, Dose 2||0
3102150|NCT01512251|3825806|FG001|NOT COMPLETED|Phase I, Dose 2||0
3102151|NCT01512251|3825805|FG000|STARTED|Phase I, Dose 3||0
3102152|NCT01512251|3825806|FG001|STARTED|Phase I, Dose 3||0
3102153|NCT01512251|3825805|FG000|COMPLETED|Phase I, Dose 3||0
3102154|NCT01512251|3825806|FG001|COMPLETED|Phase I, Dose 3||0
3102155|NCT01512251|3825805|FG000|NOT COMPLETED|Phase I, Dose 3||0
3102156|NCT01512251|3825806|FG001|NOT COMPLETED|Phase I, Dose 3||0
3102157|NCT01512251|3825805|FG000|STARTED|Phase I, Dose 4||0
3102158|NCT01512251|3825806|FG001|STARTED|Phase I, Dose 4||0
3102159|NCT01512251|3825805|FG000|COMPLETED|Phase I, Dose 4||0
3102160|NCT01512251|3825806|FG001|COMPLETED|Phase I, Dose 4||0
3291769|NCT02852005|4025876|FG000|Month 0.5|Overall Study||3
3291770|NCT02852005|4025877|FG001|Month 0.5|Overall Study||4
3102161|NCT01512251|3825805|FG000|NOT COMPLETED|Phase I, Dose 4||0
3102162|NCT01512251|3825806|FG001|NOT COMPLETED|Phase I, Dose 4||0
3102163|NCT01512251|3825805|FG000|STARTED|Phase II||0
3102164|NCT01512251|3825806|FG001|STARTED|Phase II||0
3102165|NCT01512251|3825805|FG000|COMPLETED|Phase II||0
3102166|NCT01512251|3825806|FG001|COMPLETED|Phase II||0
3102167|NCT01512251|3825805|FG000|NOT COMPLETED|Phase II||0
3102168|NCT01512251|3825806|FG001|NOT COMPLETED|Phase II||0
3102169|NCT01512264|3825817|FG000|STARTED|Overall Study||7
3102170|NCT01512264|3825818|FG001|STARTED|Overall Study||7
3102171|NCT01512264|3825819|FG002|STARTED|Overall Study||7
3102172|NCT01512264|3825820|FG003|STARTED|Overall Study||7
3102173|NCT01512264|3825817|FG000|COMPLETED|Overall Study||7
3102174|NCT01512264|3825818|FG001|COMPLETED|Overall Study||7
3102175|NCT01512264|3825819|FG002|COMPLETED|Overall Study||7
3102176|NCT01512264|3825820|FG003|COMPLETED|Overall Study||6
3102177|NCT01512264|3825817|FG000|NOT COMPLETED|Overall Study||0
3102178|NCT01512264|3825818|FG001|NOT COMPLETED|Overall Study||0
3102179|NCT01512264|3825819|FG002|NOT COMPLETED|Overall Study||0
3102180|NCT01512264|3825820|FG003|NOT COMPLETED|Overall Study||1
3102181|NCT01512368|3825830|FG000|STARTED|Overall Study||63
3102182|NCT01512368|3825830|FG000|COMPLETED|Overall Study||60
3102183|NCT01512368|3825830|FG000|NOT COMPLETED|Overall Study||3
3102184|NCT01512446|3825836|FG000|STARTED|Overall Study||221
3102185|NCT01512446|3825837|FG001|STARTED|Overall Study||215
3102186|NCT01512446|3825836|FG000|Safety Analysis Set|Overall Study||197
3102187|NCT01512446|3825837|FG001|Safety Analysis Set|Overall Study||188
3102188|NCT01512446|3825836|FG000|COMPLETED|Overall Study||0
3102189|NCT01512446|3825837|FG001|COMPLETED|Overall Study||0
3102190|NCT01512446|3825836|FG000|NOT COMPLETED|Overall Study||221
3102191|NCT01512446|3825837|FG001|NOT COMPLETED|Overall Study||215
3102192|NCT01512667|3825845|FG000|STARTED|Overall Study||13
3102193|NCT01512667|3825846|FG001|STARTED|Overall Study||12
3102194|NCT01512667|3825845|FG000|Matched Participants|Overall Study||12
3102195|NCT01512667|3825846|FG001|Matched Participants|Overall Study||12
3102196|NCT01512667|3825845|FG000|Unmatched Participants|Overall Study|Participant was not matched to a healthy control participant.|1
3102197|NCT01512667|3825846|FG001|Unmatched Participants|Overall Study||0
3102198|NCT01512667|3825845|FG000|COMPLETED|Overall Study||13
3102199|NCT01512667|3825846|FG001|COMPLETED|Overall Study||12
3102200|NCT01512667|3825845|FG000|NOT COMPLETED|Overall Study||0
3102201|NCT01512667|3825846|FG001|NOT COMPLETED|Overall Study||0
3102202|NCT01512693|3825854|FG000|STARTED|Overall Study||8
3102203|NCT01512693|3825855|FG001|STARTED|Overall Study||9
3102204|NCT01512693|3825854|FG000|COMPLETED|Overall Study||8
3102205|NCT01512693|3825855|FG001|COMPLETED|Overall Study||8
3102206|NCT01512693|3825854|FG000|NOT COMPLETED|Overall Study||0
3102207|NCT01512693|3825855|FG001|NOT COMPLETED|Overall Study||1
3102208|NCT01512745|3825863|FG000|STARTED|Overall Study||176
3102209|NCT01512745|3825864|FG001|STARTED|Overall Study||91
3102210|NCT01512745|3825863|FG000|COMPLETED|Overall Study||136
3102211|NCT01512745|3825864|FG001|COMPLETED|Overall Study||71
3102212|NCT01512745|3825863|FG000|NOT COMPLETED|Overall Study||40
3102213|NCT01512745|3825864|FG001|NOT COMPLETED|Overall Study||20
3102214|NCT01512758|3825872|FG000|STARTED|Overall Study||30
3102215|NCT01512758|3825873|FG001|STARTED|Overall Study||6
3102216|NCT01512758|3825872|FG000|COMPLETED|Overall Study|Completed=Completed protocol-specified dosing and PK assessment.|30
3102217|NCT01512758|3825873|FG001|COMPLETED|Overall Study||6
3102218|NCT01512758|3825872|FG000|NOT COMPLETED|Overall Study||0
3102219|NCT01512758|3825873|FG001|NOT COMPLETED|Overall Study||0
3102220|NCT01512797|3825882|FG000|STARTED|Overall Study||16
3102221|NCT01512797|3825883|FG001|STARTED|Overall Study||16
3102222|NCT01512797|3825882|FG000|COMPLETED|Overall Study||16
3102223|NCT01512797|3825883|FG001|COMPLETED|Overall Study||16
3102224|NCT01512797|3825882|FG000|NOT COMPLETED|Overall Study||0
3102225|NCT01512797|3825883|FG001|NOT COMPLETED|Overall Study||0
3102226|NCT01512849|3825891|FG000|STARTED|Crossover Period 1||6
3102227|NCT01512849|3825892|FG001|STARTED|Crossover Period 1||6
3102228|NCT01512849|3825893|FG002|STARTED|Crossover Period 1||6
3102229|NCT01512849|3825894|FG003|STARTED|Crossover Period 1||6
3102230|NCT01512849|3825891|FG000|COMPLETED|Crossover Period 1||6
3102231|NCT01512849|3825892|FG001|COMPLETED|Crossover Period 1||6
3102232|NCT01512849|3825893|FG002|COMPLETED|Crossover Period 1||6
3102233|NCT01512849|3825894|FG003|COMPLETED|Crossover Period 1||6
3102234|NCT01512849|3825891|FG000|NOT COMPLETED|Crossover Period 1||0
3102235|NCT01512849|3825892|FG001|NOT COMPLETED|Crossover Period 1||0
3102236|NCT01512849|3825893|FG002|NOT COMPLETED|Crossover Period 1||0
3102237|NCT01512849|3825894|FG003|NOT COMPLETED|Crossover Period 1||0
3102238|NCT01512849|3825891|FG000|STARTED|Crossover Period 2||6
3102239|NCT01512849|3825892|FG001|STARTED|Crossover Period 2||6
3102240|NCT01512849|3825893|FG002|STARTED|Crossover Period 2||6
3102241|NCT01512849|3825894|FG003|STARTED|Crossover Period 2||6
3102242|NCT01512849|3825891|FG000|COMPLETED|Crossover Period 2||6
3102243|NCT01512849|3825892|FG001|COMPLETED|Crossover Period 2||6
3102244|NCT01512849|3825893|FG002|COMPLETED|Crossover Period 2||6
3102245|NCT01512849|3825894|FG003|COMPLETED|Crossover Period 2||6
3102246|NCT01512849|3825891|FG000|NOT COMPLETED|Crossover Period 2||0
3102247|NCT01512849|3825892|FG001|NOT COMPLETED|Crossover Period 2||0
3102248|NCT01512849|3825893|FG002|NOT COMPLETED|Crossover Period 2||0
3102249|NCT01512849|3825894|FG003|NOT COMPLETED|Crossover Period 2||0
3102250|NCT01512979|3825906|FG000|STARTED|Overall Study|Randomised and treated|159
3102251|NCT01512979|3825907|FG001|STARTED|Overall Study|Randomised and treated|157
3102252|NCT01512979|3825906|FG000|COMPLETED|Overall Study||140
3102253|NCT01512979|3825907|FG001|COMPLETED|Overall Study||135
3102254|NCT01512979|3825906|FG000|NOT COMPLETED|Overall Study||19
3102255|NCT01512979|3825907|FG001|NOT COMPLETED|Overall Study||22
3102256|NCT01513122|3825915|FG000|STARTED|Overall Study||102
3102257|NCT01513122|3825916|FG001|STARTED|Overall Study||108
3102258|NCT01513122|3825915|FG000|COMPLETED|Overall Study||91
3102259|NCT01513122|3825916|FG001|COMPLETED|Overall Study||105
3102260|NCT01513122|3825915|FG000|NOT COMPLETED|Overall Study||11
3102261|NCT01513122|3825916|FG001|NOT COMPLETED|Overall Study||3
3102262|NCT01513148|3825924|FG000|STARTED|Overall Study||16
3102263|NCT01513148|3825925|FG001|STARTED|Overall Study||16
3102264|NCT01513148|3825924|FG000|COMPLETED|Overall Study||14
3102265|NCT01513148|3825925|FG001|COMPLETED|Overall Study||14
3102266|NCT01513148|3825924|FG000|NOT COMPLETED|Overall Study||2
3102267|NCT01513148|3825925|FG001|NOT COMPLETED|Overall Study||2
3102268|NCT01513239|3825974|FG000|STARTED|Period 1: Main Phase|Randomized participants|397
3102269|NCT01513239|3825975|FG001|STARTED|Period 1: Main Phase|Randomized participants|407
3102270|NCT01513239|3825976|FG002|STARTED|Period 1: Main Phase|Randomized participants|399
3102271|NCT01513239|3825977|FG003|STARTED|Period 1: Main Phase||0
3102272|NCT01513239|3825978|FG004|STARTED|Period 1: Main Phase||0
3102273|NCT01513239|3825979|FG005|STARTED|Period 1: Main Phase||0
3102274|NCT01513239|3825974|FG000|Treated|Period 1: Main Phase|Treated participants|391
3102275|NCT01513239|3825975|FG001|Treated|Period 1: Main Phase|Treated participants|396
3102276|NCT01513239|3825976|FG002|Treated|Period 1: Main Phase|Treated participants|381
3102277|NCT01513239|3825977|FG003|Treated|Period 1: Main Phase||0
3102278|NCT01513239|3825978|FG004|Treated|Period 1: Main Phase||0
3102279|NCT01513239|3825979|FG005|Treated|Period 1: Main Phase||0
3102280|NCT01513239|3825974|FG000|All Participants as Treated|Period 1: Main Phase|One participant randomized to receive MK-3415A (MK-3415 plus MK-6072) received only MK-3415|390
3102281|NCT01513239|3825975|FG001|All Participants as Treated|Period 1: Main Phase|Treatment actually received|396
3102282|NCT01513239|3825976|FG002|All Participants as Treated|Period 1: Main Phase|Treatment actually received|381
3102283|NCT01513239|3825977|FG003|All Participants as Treated|Period 1: Main Phase||0
3102284|NCT01513239|3825978|FG004|All Participants as Treated|Period 1: Main Phase||0
3102285|NCT01513239|3825979|FG005|All Participants as Treated|Period 1: Main Phase||0
3102286|NCT01513239|3825974|FG000|COMPLETED|Period 1: Main Phase||322
3102287|NCT01513239|3825975|FG001|COMPLETED|Period 1: Main Phase||337
3102288|NCT01513239|3825976|FG002|COMPLETED|Period 1: Main Phase||311
3102289|NCT01513239|3825977|FG003|COMPLETED|Period 1: Main Phase||0
3102290|NCT01513239|3825978|FG004|COMPLETED|Period 1: Main Phase||0
3102291|NCT01513239|3825979|FG005|COMPLETED|Period 1: Main Phase||0
3102292|NCT01513239|3825974|FG000|NOT COMPLETED|Period 1: Main Phase||75
3102293|NCT01513239|3825975|FG001|NOT COMPLETED|Period 1: Main Phase||70
3102294|NCT01513239|3825976|FG002|NOT COMPLETED|Period 1: Main Phase||88
3102295|NCT01513239|3825977|FG003|NOT COMPLETED|Period 1: Main Phase||0
3102296|NCT01513239|3825978|FG004|NOT COMPLETED|Period 1: Main Phase||0
3102297|NCT01513239|3825979|FG005|NOT COMPLETED|Period 1: Main Phase||0
3102298|NCT01513239|3825974|FG000|STARTED|Period 2: 9 Month Extension Phase||0
3102299|NCT01513239|3825975|FG001|STARTED|Period 2: 9 Month Extension Phase||0
3102300|NCT01513239|3825976|FG002|STARTED|Period 2: 9 Month Extension Phase||0
3102301|NCT01513239|3825977|FG003|STARTED|Period 2: 9 Month Extension Phase||112
3102302|NCT01513239|3825978|FG004|STARTED|Period 2: 9 Month Extension Phase||100
3102303|NCT01513239|3825979|FG005|STARTED|Period 2: 9 Month Extension Phase||83
3102304|NCT01513239|3825974|FG000|COMPLETED|Period 2: 9 Month Extension Phase||0
3102305|NCT01513239|3825975|FG001|COMPLETED|Period 2: 9 Month Extension Phase||0
3102306|NCT01513239|3825976|FG002|COMPLETED|Period 2: 9 Month Extension Phase||0
3102307|NCT01513239|3825977|FG003|COMPLETED|Period 2: 9 Month Extension Phase||102
3102308|NCT01513239|3825978|FG004|COMPLETED|Period 2: 9 Month Extension Phase||90
3102309|NCT01513239|3825979|FG005|COMPLETED|Period 2: 9 Month Extension Phase||78
3102310|NCT01513239|3825974|FG000|NOT COMPLETED|Period 2: 9 Month Extension Phase||0
3102311|NCT01513239|3825975|FG001|NOT COMPLETED|Period 2: 9 Month Extension Phase||0
3102312|NCT01513239|3825976|FG002|NOT COMPLETED|Period 2: 9 Month Extension Phase||0
3102313|NCT01513239|3825977|FG003|NOT COMPLETED|Period 2: 9 Month Extension Phase||10
3102314|NCT01513239|3825978|FG004|NOT COMPLETED|Period 2: 9 Month Extension Phase||10
3102315|NCT01513239|3825979|FG005|NOT COMPLETED|Period 2: 9 Month Extension Phase||5
3102316|NCT01513291|3825993|FG000|STARTED|Treatment Period||120
3102317|NCT01513291|3825994|FG001|STARTED|Treatment Period||117
3102318|NCT01513291|3825995|FG002|STARTED|Treatment Period||0
3102319|NCT01513291|3825996|FG003|STARTED|Treatment Period||0
3102320|NCT01513291|3825997|FG004|STARTED|Treatment Period||0
3102321|NCT01513291|3825993|FG000|Treated|Treatment Period||120
3102322|NCT01513291|3825994|FG001|Treated|Treatment Period||115
3102323|NCT01513291|3825995|FG002|Treated|Treatment Period||0
3102324|NCT01513291|3825996|FG003|Treated|Treatment Period||0
3102325|NCT01513291|3825997|FG004|Treated|Treatment Period||0
3102326|NCT01513291|3825993|FG000|COMPLETED|Treatment Period||97
3102327|NCT01513291|3825994|FG001|COMPLETED|Treatment Period||101
3102328|NCT01513291|3825995|FG002|COMPLETED|Treatment Period||0
3102329|NCT01513291|3825996|FG003|COMPLETED|Treatment Period||0
3102330|NCT01513291|3825997|FG004|COMPLETED|Treatment Period||0
3102331|NCT01513291|3825993|FG000|NOT COMPLETED|Treatment Period||23
3102332|NCT01513291|3825994|FG001|NOT COMPLETED|Treatment Period||16
3102333|NCT01513291|3825995|FG002|NOT COMPLETED|Treatment Period||0
3102334|NCT01513291|3825996|FG003|NOT COMPLETED|Treatment Period||0
3102335|NCT01513291|3825997|FG004|NOT COMPLETED|Treatment Period||0
3102336|NCT01513291|3825993|FG000|STARTED|Run-out Period||0
3102337|NCT01513291|3825994|FG001|STARTED|Run-out Period||0
3102338|NCT01513291|3825995|FG002|STARTED|Run-out Period|These participants were pre-randomized from participants in the Treatment Period: MK-6096 group|50
3102339|NCT01513291|3825996|FG003|STARTED|Run-out Period|These participants were pre-randomized from participants in the Treatment Period: MK-6096 group|47
3102340|NCT01513291|3825997|FG004|STARTED|Run-out Period|These participants were completers from the Treatment Period: Placebo group|101
3102341|NCT01513291|3825993|FG000|COMPLETED|Run-out Period||0
3102342|NCT01513291|3825994|FG001|COMPLETED|Run-out Period||0
3102343|NCT01513291|3825995|FG002|COMPLETED|Run-out Period||50
3102344|NCT01513291|3825996|FG003|COMPLETED|Run-out Period||45
3102345|NCT01513291|3825997|FG004|COMPLETED|Run-out Period||101
3102346|NCT01513291|3825993|FG000|NOT COMPLETED|Run-out Period||0
3102347|NCT01513291|3825994|FG001|NOT COMPLETED|Run-out Period||0
3102348|NCT01513291|3825995|FG002|NOT COMPLETED|Run-out Period||0
3102349|NCT01513291|3825996|FG003|NOT COMPLETED|Run-out Period||2
3102350|NCT01513291|3825997|FG004|NOT COMPLETED|Run-out Period||0
3102351|NCT01513317|3826011|FG000|STARTED|Overall Study||50
3102352|NCT01513317|3826012|FG001|STARTED|Overall Study||26
3102353|NCT01513317|3826011|FG000|COMPLETED|Overall Study||16
3102354|NCT01513317|3826012|FG001|COMPLETED|Overall Study||2
3102355|NCT01513317|3826011|FG000|NOT COMPLETED|Overall Study||34
3102356|NCT01513317|3826012|FG001|NOT COMPLETED|Overall Study||24
3102357|NCT01513330|3826018|FG000|STARTED|SenSura Mio First,||64
3102358|NCT01513330|3826019|FG001|STARTED|SenSura Mio First,||58
3102359|NCT01513330|3826018|FG000|COMPLETED|SenSura Mio First,||60
3102360|NCT01513330|3826019|FG001|COMPLETED|SenSura Mio First,||56
3102361|NCT01513330|3826018|FG000|NOT COMPLETED|SenSura Mio First,||4
3102362|NCT01513330|3826019|FG001|NOT COMPLETED|SenSura Mio First,||2
3102363|NCT01513330|3826018|FG000|STARTED|Standard Care First,||60
3102364|NCT01513330|3826019|FG001|STARTED|Standard Care First,||56
3102365|NCT01513330|3826018|FG000|COMPLETED|Standard Care First,||56
3102366|NCT01513330|3826019|FG001|COMPLETED|Standard Care First,||52
3102367|NCT01513330|3826018|FG000|NOT COMPLETED|Standard Care First,||4
3102368|NCT01513330|3826019|FG001|NOT COMPLETED|Standard Care First,||4
3102369|NCT01513447|3826027|FG000|STARTED|Overall Study||3
3102370|NCT01513447|3826028|FG001|STARTED|Overall Study||5
3102371|NCT01513447|3826027|FG000|COMPLETED|Overall Study||3
3102372|NCT01513447|3826028|FG001|COMPLETED|Overall Study||5
3102373|NCT01513447|3826027|FG000|NOT COMPLETED|Overall Study||0
3102374|NCT01513447|3826028|FG001|NOT COMPLETED|Overall Study||0
3102375|NCT01513460|3826037|FG000|STARTED|Overall Study||258
3102376|NCT01513460|3826038|FG001|STARTED|Overall Study||258
3102377|NCT01513460|3826039|FG002|STARTED|Overall Study||257
3102378|NCT01513460|3826037|FG000|Full Analysis Set|Overall Study||257
3102379|NCT01513460|3826038|FG001|Full Analysis Set|Overall Study||258
3102380|NCT01513460|3826039|FG002|Full Analysis Set|Overall Study||257
3102381|NCT01513460|3826037|FG000|Per-protocol Set|Overall Study||196
3102382|NCT01513460|3826038|FG001|Per-protocol Set|Overall Study||186
3102383|NCT01513460|3826039|FG002|Per-protocol Set|Overall Study||166
3102384|NCT01513460|3826037|FG000|COMPLETED|Overall Study||229
3102385|NCT01513460|3826038|FG001|COMPLETED|Overall Study||226
3102386|NCT01513460|3826039|FG002|COMPLETED|Overall Study||201
3102387|NCT01513460|3826037|FG000|NOT COMPLETED|Overall Study||29
3102388|NCT01513460|3826038|FG001|NOT COMPLETED|Overall Study||32
3102389|NCT01513460|3826039|FG002|NOT COMPLETED|Overall Study||56
3102390|NCT01513473|3826051|FG000|STARTED|Main Trial (26 Weeks)||174
3102391|NCT01513473|3826052|FG001|STARTED|Main Trial (26 Weeks)|1 subject was randomised but withdrew before the drug exposure.|176
3102392|NCT01513473|3826051|FG000|Exposed|Main Trial (26 Weeks)||174
3102393|NCT01513473|3826052|FG001|Exposed|Main Trial (26 Weeks)||175
3102394|NCT01513473|3826051|FG000|COMPLETED|Main Trial (26 Weeks)||170
3102395|NCT01513473|3826052|FG001|COMPLETED|Main Trial (26 Weeks)||165
3102396|NCT01513473|3826051|FG000|NOT COMPLETED|Main Trial (26 Weeks)||4
3102397|NCT01513473|3826052|FG001|NOT COMPLETED|Main Trial (26 Weeks)||11
3291771|NCT02852005|4025878|FG002|Month 0.5|Overall Study||6
3291772|NCT02852005|4025879|FG003|Month 0.5|Overall Study||6
3291773|NCT02852005|4025880|FG004|Month 0.5|Overall Study||7
3291774|NCT02852005|4025876|FG000|Month 4.5|Overall Study||3
3291775|NCT02852005|4025877|FG001|Month 4.5|Overall Study||4
3291776|NCT02852005|4025878|FG002|Month 4.5|Overall Study||6
3291777|NCT02852005|4025879|FG003|Month 4.5|Overall Study||6
3291778|NCT02852005|4025880|FG004|Month 4.5|Overall Study||7
3291779|NCT02852005|4025876|FG000|Month 10|Overall Study||3
3291780|NCT02852005|4025877|FG001|Month 10|Overall Study||3
3102398|NCT01513473|3826051|FG000|STARTED|Extension Trial (26 Weeks)|18 subjects did not consent to participate in the extension trial.|152
3102399|NCT01513473|3826052|FG001|STARTED|Extension Trial (26 Weeks)|37 subjects did not consent to participate in the extension trial.|128
3102400|NCT01513473|3826051|FG000|COMPLETED|Extension Trial (26 Weeks)||151
3102401|NCT01513473|3826052|FG001|COMPLETED|Extension Trial (26 Weeks)||122
3102402|NCT01513473|3826051|FG000|NOT COMPLETED|Extension Trial (26 Weeks)||1
3102403|NCT01513473|3826052|FG001|NOT COMPLETED|Extension Trial (26 Weeks)||6
3102404|NCT01513538|3826058|FG000|STARTED|Overall Study||578
3102405|NCT01513538|3826058|FG000|COMPLETED|Overall Study||573
3102406|NCT01513538|3826058|FG000|NOT COMPLETED|Overall Study||5
3102407|NCT01513551|3826065|FG000|STARTED|Overall Study||230
3102408|NCT01513551|3826066|FG001|STARTED|Overall Study||231
3102409|NCT01513551|3826067|FG002|STARTED|Overall Study||231
3102410|NCT01513551|3826065|FG000|Vaccinated|Overall Study||230
3102411|NCT01513551|3826066|FG001|Vaccinated|Overall Study||231
3102412|NCT01513551|3826067|FG002|Vaccinated|Overall Study||230
3102413|NCT01513551|3826065|FG000|COMPLETED|Overall Study||226
3102414|NCT01513551|3826066|FG001|COMPLETED|Overall Study||225
3102415|NCT01513551|3826067|FG002|COMPLETED|Overall Study||226
3102416|NCT01513551|3826065|FG000|NOT COMPLETED|Overall Study||4
3102417|NCT01513551|3826066|FG001|NOT COMPLETED|Overall Study||6
3102418|NCT01513551|3826067|FG002|NOT COMPLETED|Overall Study||5
3102419|NCT01513590|3826077|FG000|STARTED|Overall Study||197
3102420|NCT01513590|3826078|FG001|STARTED|Overall Study||197
3102421|NCT01513590|3826077|FG000|Exposed|Overall Study|"One (1) subject was withdrawn prior to exposure due to non fulfilment of inclusion criteria"|196
3102422|NCT01513590|3826078|FG001|Exposed|Overall Study|"Two (2) subjects were withdrawn prior to exposure due to withdrawal of consent"|195
3102423|NCT01513590|3826077|FG000|COMPLETED|Overall Study||187
3102424|NCT01513590|3826078|FG001|COMPLETED|Overall Study||184
3102425|NCT01513590|3826077|FG000|NOT COMPLETED|Overall Study||10
3102426|NCT01513590|3826078|FG001|NOT COMPLETED|Overall Study||13
3102427|NCT01513759|3826084|FG000|STARTED|Overall Study||150
3102428|NCT01513759|3826084|FG000|At Least One Device Successfully Placed|Overall Study||149
3102429|NCT01513759|3826084|FG000|COMPLETED|Overall Study||145
3102430|NCT01513759|3826084|FG000|NOT COMPLETED|Overall Study||5
3102431|NCT01513902|3826091|FG000|STARTED|Overall Study||8
3102432|NCT01513902|3826092|FG001|STARTED|Overall Study||9
3102433|NCT01513902|3826093|FG002|STARTED|Overall Study||9
3102434|NCT01513902|3826091|FG000|COMPLETED|Overall Study||8
3102435|NCT01513902|3826092|FG001|COMPLETED|Overall Study||9
3102436|NCT01513902|3826093|FG002|COMPLETED|Overall Study||9
3102437|NCT01513902|3826091|FG000|NOT COMPLETED|Overall Study||0
3102438|NCT01513902|3826092|FG001|NOT COMPLETED|Overall Study||0
3102439|NCT01513902|3826093|FG002|NOT COMPLETED|Overall Study||0
3102440|NCT01513967|3826109|FG000|STARTED|Overall Study||4
3102441|NCT01513967|3826110|FG001|STARTED|Overall Study||4
3102442|NCT01513967|3826111|FG002|STARTED|Overall Study||4
3102443|NCT01513967|3826112|FG003|STARTED|Overall Study||6
3102444|NCT01513967|3826113|FG004|STARTED|Overall Study||4
3102445|NCT01513967|3826114|FG005|STARTED|Overall Study||4
3102446|NCT01513967|3826115|FG006|STARTED|Overall Study||5
3102447|NCT01513967|3826116|FG007|STARTED|Overall Study||8
3102448|NCT01513967|3826109|FG000|COMPLETED|Overall Study||4
3102449|NCT01513967|3826110|FG001|COMPLETED|Overall Study||4
3102450|NCT01513967|3826111|FG002|COMPLETED|Overall Study||4
3102451|NCT01513967|3826112|FG003|COMPLETED|Overall Study||6
3102452|NCT01513967|3826113|FG004|COMPLETED|Overall Study||4
3102453|NCT01513967|3826114|FG005|COMPLETED|Overall Study||3
3102454|NCT01513967|3826115|FG006|COMPLETED|Overall Study||3
3102455|NCT01513967|3826116|FG007|COMPLETED|Overall Study||6
3102456|NCT01513967|3826109|FG000|NOT COMPLETED|Overall Study||0
3102457|NCT01513967|3826110|FG001|NOT COMPLETED|Overall Study||0
3102458|NCT01513967|3826111|FG002|NOT COMPLETED|Overall Study||0
3102459|NCT01513967|3826112|FG003|NOT COMPLETED|Overall Study||0
3102460|NCT01513967|3826113|FG004|NOT COMPLETED|Overall Study||0
3102461|NCT01513967|3826114|FG005|NOT COMPLETED|Overall Study||1
3102462|NCT01513967|3826115|FG006|NOT COMPLETED|Overall Study||2
3102463|NCT01513967|3826116|FG007|NOT COMPLETED|Overall Study||2
3102464|NCT01514136|3826136|FG000|STARTED|Test Period 1; Test A|26 subjects tested Test A|25
3102465|NCT01514136|3826137|FG001|STARTED|Test Period 1; Test A||0
3102466|NCT01514136|3826138|FG002|STARTED|Test Period 1; Test A||0
3102467|NCT01514136|3826139|FG003|STARTED|Test Period 1; Test A||0
3102468|NCT01514136|3826140|FG004|STARTED|Test Period 1; Test A||0
3102469|NCT01514136|3826141|FG005|STARTED|Test Period 1; Test A||0
3102470|NCT01514136|3826142|FG006|STARTED|Test Period 1; Test A||0
3102471|NCT01514136|3826143|FG007|STARTED|Test Period 1; Test A||0
3102472|NCT01514136|3826136|FG000|COMPLETED|Test Period 1; Test A||22
3102473|NCT01514136|3826137|FG001|COMPLETED|Test Period 1; Test A||0
3102474|NCT01514136|3826138|FG002|COMPLETED|Test Period 1; Test A||0
3102475|NCT01514136|3826139|FG003|COMPLETED|Test Period 1; Test A||0
3102476|NCT01514136|3826140|FG004|COMPLETED|Test Period 1; Test A||0
3102477|NCT01514136|3826141|FG005|COMPLETED|Test Period 1; Test A||0
3102478|NCT01514136|3826142|FG006|COMPLETED|Test Period 1; Test A||0
3102479|NCT01514136|3826143|FG007|COMPLETED|Test Period 1; Test A||0
3102480|NCT01514136|3826136|FG000|NOT COMPLETED|Test Period 1; Test A||3
3102481|NCT01514136|3826137|FG001|NOT COMPLETED|Test Period 1; Test A||0
3102482|NCT01514136|3826138|FG002|NOT COMPLETED|Test Period 1; Test A||0
3102483|NCT01514136|3826139|FG003|NOT COMPLETED|Test Period 1; Test A||0
3102484|NCT01514136|3826140|FG004|NOT COMPLETED|Test Period 1; Test A||0
3102485|NCT01514136|3826141|FG005|NOT COMPLETED|Test Period 1; Test A||0
3102486|NCT01514136|3826142|FG006|NOT COMPLETED|Test Period 1; Test A||0
3102487|NCT01514136|3826143|FG007|NOT COMPLETED|Test Period 1; Test A||0
3102488|NCT01514136|3826136|FG000|STARTED|Test Period 1; Test B||0
3102489|NCT01514136|3826137|FG001|STARTED|Test Period 1; Test B|2 new subjects were entered the investigation|24
3102490|NCT01514136|3826138|FG002|STARTED|Test Period 1; Test B||0
3102491|NCT01514136|3826139|FG003|STARTED|Test Period 1; Test B||0
3102492|NCT01514136|3826140|FG004|STARTED|Test Period 1; Test B||0
3102493|NCT01514136|3826141|FG005|STARTED|Test Period 1; Test B||0
3102494|NCT01514136|3826142|FG006|STARTED|Test Period 1; Test B||0
3102495|NCT01514136|3826143|FG007|STARTED|Test Period 1; Test B||0
3102496|NCT01514136|3826136|FG000|COMPLETED|Test Period 1; Test B||0
3102497|NCT01514136|3826137|FG001|COMPLETED|Test Period 1; Test B||23
3102498|NCT01514136|3826138|FG002|COMPLETED|Test Period 1; Test B||0
3102499|NCT01514136|3826139|FG003|COMPLETED|Test Period 1; Test B||0
3102500|NCT01514136|3826140|FG004|COMPLETED|Test Period 1; Test B||0
3102501|NCT01514136|3826141|FG005|COMPLETED|Test Period 1; Test B||0
3102502|NCT01514136|3826142|FG006|COMPLETED|Test Period 1; Test B||0
3102503|NCT01514136|3826143|FG007|COMPLETED|Test Period 1; Test B||0
3102504|NCT01514136|3826136|FG000|NOT COMPLETED|Test Period 1; Test B||0
3102505|NCT01514136|3826137|FG001|NOT COMPLETED|Test Period 1; Test B||1
3102506|NCT01514136|3826138|FG002|NOT COMPLETED|Test Period 1; Test B||0
3102507|NCT01514136|3826139|FG003|NOT COMPLETED|Test Period 1; Test B||0
3102508|NCT01514136|3826140|FG004|NOT COMPLETED|Test Period 1; Test B||0
3102509|NCT01514136|3826141|FG005|NOT COMPLETED|Test Period 1; Test B||0
3102510|NCT01514136|3826142|FG006|NOT COMPLETED|Test Period 1; Test B||0
3102511|NCT01514136|3826143|FG007|NOT COMPLETED|Test Period 1; Test B||0
3102512|NCT01514136|3826136|FG000|STARTED|Test Period 1; Test C||0
3102513|NCT01514136|3826137|FG001|STARTED|Test Period 1; Test C||0
3102514|NCT01514136|3826138|FG002|STARTED|Test Period 1; Test C|1 new subject was included in the investigation|24
3102515|NCT01514136|3826139|FG003|STARTED|Test Period 1; Test C||0
3102516|NCT01514136|3826140|FG004|STARTED|Test Period 1; Test C||0
3102517|NCT01514136|3826141|FG005|STARTED|Test Period 1; Test C||0
3102518|NCT01514136|3826142|FG006|STARTED|Test Period 1; Test C||0
3102519|NCT01514136|3826143|FG007|STARTED|Test Period 1; Test C||0
3102520|NCT01514136|3826136|FG000|COMPLETED|Test Period 1; Test C||0
3102521|NCT01514136|3826137|FG001|COMPLETED|Test Period 1; Test C||0
3102522|NCT01514136|3826138|FG002|COMPLETED|Test Period 1; Test C||24
3102523|NCT01514136|3826139|FG003|COMPLETED|Test Period 1; Test C||0
3102524|NCT01514136|3826140|FG004|COMPLETED|Test Period 1; Test C||0
3102525|NCT01514136|3826141|FG005|COMPLETED|Test Period 1; Test C||0
3102526|NCT01514136|3826142|FG006|COMPLETED|Test Period 1; Test C||0
3102527|NCT01514136|3826143|FG007|COMPLETED|Test Period 1; Test C||0
3102528|NCT01514136|3826136|FG000|NOT COMPLETED|Test Period 1; Test C||0
3102529|NCT01514136|3826137|FG001|NOT COMPLETED|Test Period 1; Test C||0
3102530|NCT01514136|3826138|FG002|NOT COMPLETED|Test Period 1; Test C||0
3102531|NCT01514136|3826139|FG003|NOT COMPLETED|Test Period 1; Test C||0
3102532|NCT01514136|3826140|FG004|NOT COMPLETED|Test Period 1; Test C||0
3102533|NCT01514136|3826141|FG005|NOT COMPLETED|Test Period 1; Test C||0
3102534|NCT01514136|3826142|FG006|NOT COMPLETED|Test Period 1; Test C||0
3102535|NCT01514136|3826143|FG007|NOT COMPLETED|Test Period 1; Test C||0
3102536|NCT01514136|3826136|FG000|STARTED|Test Period 1; Test D||0
3102537|NCT01514136|3826137|FG001|STARTED|Test Period 1; Test D||0
3102538|NCT01514136|3826138|FG002|STARTED|Test Period 1; Test D||0
3102539|NCT01514136|3826139|FG003|STARTED|Test Period 1; Test D|The two subject that were on holiday after test A re-entered the investigation|26
3102540|NCT01514136|3826140|FG004|STARTED|Test Period 1; Test D||0
3102541|NCT01514136|3826141|FG005|STARTED|Test Period 1; Test D||0
3102542|NCT01514136|3826142|FG006|STARTED|Test Period 1; Test D||0
3102543|NCT01514136|3826143|FG007|STARTED|Test Period 1; Test D||0
3291781|NCT02852005|4025878|FG002|Month 10|Overall Study||6
3291782|NCT02852005|4025879|FG003|Month 10|Overall Study||5
3291783|NCT02852005|4025880|FG004|Month 10|Overall Study||7
3291784|NCT02852005|4025876|FG000|COMPLETED|Overall Study||3
3291785|NCT02852005|4025877|FG001|COMPLETED|Overall Study||4
3291786|NCT02852005|4025878|FG002|COMPLETED|Overall Study||6
3291787|NCT02852005|4025879|FG003|COMPLETED|Overall Study||6
3291788|NCT02852005|4025880|FG004|COMPLETED|Overall Study||6
3291789|NCT02852005|4025876|FG000|NOT COMPLETED|Overall Study||1
3102544|NCT01514136|3826136|FG000|COMPLETED|Test Period 1; Test D||0
3102545|NCT01514136|3826137|FG001|COMPLETED|Test Period 1; Test D||0
3102546|NCT01514136|3826138|FG002|COMPLETED|Test Period 1; Test D||0
3102547|NCT01514136|3826139|FG003|COMPLETED|Test Period 1; Test D||24
3102548|NCT01514136|3826140|FG004|COMPLETED|Test Period 1; Test D||0
3102549|NCT01514136|3826141|FG005|COMPLETED|Test Period 1; Test D||0
3102550|NCT01514136|3826142|FG006|COMPLETED|Test Period 1; Test D||0
3102551|NCT01514136|3826143|FG007|COMPLETED|Test Period 1; Test D||0
3102552|NCT01514136|3826136|FG000|NOT COMPLETED|Test Period 1; Test D||0
3102553|NCT01514136|3826137|FG001|NOT COMPLETED|Test Period 1; Test D||0
3102554|NCT01514136|3826138|FG002|NOT COMPLETED|Test Period 1; Test D||0
3102555|NCT01514136|3826139|FG003|NOT COMPLETED|Test Period 1; Test D||2
3102556|NCT01514136|3826140|FG004|NOT COMPLETED|Test Period 1; Test D||0
3102557|NCT01514136|3826141|FG005|NOT COMPLETED|Test Period 1; Test D||0
3102558|NCT01514136|3826142|FG006|NOT COMPLETED|Test Period 1; Test D||0
3102559|NCT01514136|3826143|FG007|NOT COMPLETED|Test Period 1; Test D||0
3102560|NCT01514136|3826136|FG000|STARTED|Test Period 2; Test A*||0
3102561|NCT01514136|3826137|FG001|STARTED|Test Period 2; Test A*||0
3102562|NCT01514136|3826138|FG002|STARTED|Test Period 2; Test A*||0
3102563|NCT01514136|3826139|FG003|STARTED|Test Period 2; Test A*||0
3102564|NCT01514136|3826140|FG004|STARTED|Test Period 2; Test A*|4 new subjects were included in the investigation|28
3102565|NCT01514136|3826141|FG005|STARTED|Test Period 2; Test A*||0
3102566|NCT01514136|3826142|FG006|STARTED|Test Period 2; Test A*||0
3102567|NCT01514136|3826143|FG007|STARTED|Test Period 2; Test A*||0
3291790|NCT02852005|4025877|FG001|NOT COMPLETED|Overall Study||0
3291791|NCT02852005|4025878|FG002|NOT COMPLETED|Overall Study||0
3291792|NCT02852005|4025879|FG003|NOT COMPLETED|Overall Study||0
3102568|NCT01514136|3826136|FG000|COMPLETED|Test Period 2; Test A*||0
3102569|NCT01514136|3826137|FG001|COMPLETED|Test Period 2; Test A*||0
3102570|NCT01514136|3826138|FG002|COMPLETED|Test Period 2; Test A*||0
3102571|NCT01514136|3826139|FG003|COMPLETED|Test Period 2; Test A*||0
3102572|NCT01514136|3826140|FG004|COMPLETED|Test Period 2; Test A*||26
3102573|NCT01514136|3826141|FG005|COMPLETED|Test Period 2; Test A*||0
3102574|NCT01514136|3826142|FG006|COMPLETED|Test Period 2; Test A*||0
3102575|NCT01514136|3826143|FG007|COMPLETED|Test Period 2; Test A*||0
3102576|NCT01514136|3826136|FG000|NOT COMPLETED|Test Period 2; Test A*||0
3102577|NCT01514136|3826137|FG001|NOT COMPLETED|Test Period 2; Test A*||0
3102578|NCT01514136|3826138|FG002|NOT COMPLETED|Test Period 2; Test A*||0
3102579|NCT01514136|3826139|FG003|NOT COMPLETED|Test Period 2; Test A*||0
3102580|NCT01514136|3826140|FG004|NOT COMPLETED|Test Period 2; Test A*||2
3102581|NCT01514136|3826141|FG005|NOT COMPLETED|Test Period 2; Test A*||0
3102582|NCT01514136|3826142|FG006|NOT COMPLETED|Test Period 2; Test A*||0
3102583|NCT01514136|3826143|FG007|NOT COMPLETED|Test Period 2; Test A*||0
3102584|NCT01514136|3826136|FG000|STARTED|Test Period 2; Test B*||0
3102585|NCT01514136|3826137|FG001|STARTED|Test Period 2; Test B*||0
3102586|NCT01514136|3826138|FG002|STARTED|Test Period 2; Test B*||0
3102587|NCT01514136|3826139|FG003|STARTED|Test Period 2; Test B*||0
3102588|NCT01514136|3826140|FG004|STARTED|Test Period 2; Test B*||0
3102589|NCT01514136|3826141|FG005|STARTED|Test Period 2; Test B*|Two subjects did not test test A*, but had a break and continued again on Test B*|28
3102590|NCT01514136|3826142|FG006|STARTED|Test Period 2; Test B*||0
3102591|NCT01514136|3826143|FG007|STARTED|Test Period 2; Test B*||0
3102592|NCT01514136|3826136|FG000|COMPLETED|Test Period 2; Test B*||0
3102593|NCT01514136|3826137|FG001|COMPLETED|Test Period 2; Test B*||0
3102594|NCT01514136|3826138|FG002|COMPLETED|Test Period 2; Test B*||0
3102595|NCT01514136|3826139|FG003|COMPLETED|Test Period 2; Test B*||0
3102596|NCT01514136|3826140|FG004|COMPLETED|Test Period 2; Test B*||0
3102597|NCT01514136|3826141|FG005|COMPLETED|Test Period 2; Test B*||26
3102598|NCT01514136|3826142|FG006|COMPLETED|Test Period 2; Test B*||0
3102599|NCT01514136|3826143|FG007|COMPLETED|Test Period 2; Test B*||0
3102600|NCT01514136|3826136|FG000|NOT COMPLETED|Test Period 2; Test B*||0
3102601|NCT01514136|3826137|FG001|NOT COMPLETED|Test Period 2; Test B*||0
3102602|NCT01514136|3826138|FG002|NOT COMPLETED|Test Period 2; Test B*||0
3102603|NCT01514136|3826139|FG003|NOT COMPLETED|Test Period 2; Test B*||0
3102604|NCT01514136|3826140|FG004|NOT COMPLETED|Test Period 2; Test B*||0
3102605|NCT01514136|3826141|FG005|NOT COMPLETED|Test Period 2; Test B*||2
3102606|NCT01514136|3826142|FG006|NOT COMPLETED|Test Period 2; Test B*||0
3102607|NCT01514136|3826143|FG007|NOT COMPLETED|Test Period 2; Test B*||0
3102608|NCT01514136|3826136|FG000|STARTED|Test Period 2; Test C*||0
3102609|NCT01514136|3826137|FG001|STARTED|Test Period 2; Test C*||0
3102610|NCT01514136|3826138|FG002|STARTED|Test Period 2; Test C*||0
3102611|NCT01514136|3826139|FG003|STARTED|Test Period 2; Test C*||0
3102612|NCT01514136|3826140|FG004|STARTED|Test Period 2; Test C*||0
3102613|NCT01514136|3826141|FG005|STARTED|Test Period 2; Test C*||0
3102614|NCT01514136|3826142|FG006|STARTED|Test Period 2; Test C*||26
3102615|NCT01514136|3826143|FG007|STARTED|Test Period 2; Test C*||0
3102616|NCT01514136|3826136|FG000|COMPLETED|Test Period 2; Test C*||0
3102617|NCT01514136|3826137|FG001|COMPLETED|Test Period 2; Test C*||0
3102618|NCT01514136|3826138|FG002|COMPLETED|Test Period 2; Test C*||0
3102619|NCT01514136|3826139|FG003|COMPLETED|Test Period 2; Test C*||0
3102620|NCT01514136|3826140|FG004|COMPLETED|Test Period 2; Test C*||0
3102621|NCT01514136|3826141|FG005|COMPLETED|Test Period 2; Test C*||0
3102622|NCT01514136|3826142|FG006|COMPLETED|Test Period 2; Test C*||23
3102623|NCT01514136|3826143|FG007|COMPLETED|Test Period 2; Test C*||0
3102624|NCT01514136|3826136|FG000|NOT COMPLETED|Test Period 2; Test C*||0
3102625|NCT01514136|3826137|FG001|NOT COMPLETED|Test Period 2; Test C*||0
3102626|NCT01514136|3826138|FG002|NOT COMPLETED|Test Period 2; Test C*||0
3102627|NCT01514136|3826139|FG003|NOT COMPLETED|Test Period 2; Test C*||0
3102628|NCT01514136|3826140|FG004|NOT COMPLETED|Test Period 2; Test C*||0
3102629|NCT01514136|3826141|FG005|NOT COMPLETED|Test Period 2; Test C*||0
3102630|NCT01514136|3826142|FG006|NOT COMPLETED|Test Period 2; Test C*||3
3102631|NCT01514136|3826143|FG007|NOT COMPLETED|Test Period 2; Test C*||0
3102632|NCT01514136|3826136|FG000|STARTED|Test Period; Test D*||0
3102633|NCT01514136|3826137|FG001|STARTED|Test Period; Test D*||0
3102634|NCT01514136|3826138|FG002|STARTED|Test Period; Test D*||0
3102635|NCT01514136|3826139|FG003|STARTED|Test Period; Test D*||0
3102636|NCT01514136|3826140|FG004|STARTED|Test Period; Test D*||0
3102637|NCT01514136|3826141|FG005|STARTED|Test Period; Test D*||0
3102638|NCT01514136|3826142|FG006|STARTED|Test Period; Test D*||0
3102639|NCT01514136|3826143|FG007|STARTED|Test Period; Test D*||23
3102640|NCT01514136|3826136|FG000|COMPLETED|Test Period; Test D*||0
3102641|NCT01514136|3826137|FG001|COMPLETED|Test Period; Test D*||0
3102642|NCT01514136|3826138|FG002|COMPLETED|Test Period; Test D*||0
3102643|NCT01514136|3826139|FG003|COMPLETED|Test Period; Test D*||0
3102644|NCT01514136|3826140|FG004|COMPLETED|Test Period; Test D*||0
3102645|NCT01514136|3826141|FG005|COMPLETED|Test Period; Test D*||0
3102646|NCT01514136|3826142|FG006|COMPLETED|Test Period; Test D*||0
3102647|NCT01514136|3826143|FG007|COMPLETED|Test Period; Test D*||23
3102648|NCT01514136|3826136|FG000|NOT COMPLETED|Test Period; Test D*||0
3102649|NCT01514136|3826137|FG001|NOT COMPLETED|Test Period; Test D*||0
3102650|NCT01514136|3826138|FG002|NOT COMPLETED|Test Period; Test D*||0
3102651|NCT01514136|3826139|FG003|NOT COMPLETED|Test Period; Test D*||0
3102652|NCT01514136|3826140|FG004|NOT COMPLETED|Test Period; Test D*||0
3102653|NCT01514136|3826141|FG005|NOT COMPLETED|Test Period; Test D*||0
3102654|NCT01514136|3826142|FG006|NOT COMPLETED|Test Period; Test D*||0
3102655|NCT01514136|3826143|FG007|NOT COMPLETED|Test Period; Test D*||0
3102656|NCT01514149|3826174|FG000|STARTED|Overall Study||15
3102657|NCT01514149|3826175|FG001|STARTED|Overall Study||15
3102658|NCT01514149|3826176|FG002|STARTED|Overall Study||14
3102659|NCT01514149|3826177|FG003|STARTED|Overall Study||14
3102660|NCT01514149|3826178|FG004|STARTED|Overall Study||15
3102661|NCT01514149|3826174|FG000|COMPLETED|Overall Study||12
3102662|NCT01514149|3826175|FG001|COMPLETED|Overall Study||14
3102663|NCT01514149|3826176|FG002|COMPLETED|Overall Study||11
3102664|NCT01514149|3826177|FG003|COMPLETED|Overall Study||13
3102665|NCT01514149|3826178|FG004|COMPLETED|Overall Study||14
3102666|NCT01514149|3826174|FG000|NOT COMPLETED|Overall Study||3
3102667|NCT01514149|3826175|FG001|NOT COMPLETED|Overall Study||1
3102668|NCT01514149|3826176|FG002|NOT COMPLETED|Overall Study||3
3102669|NCT01514149|3826177|FG003|NOT COMPLETED|Overall Study||1
3102670|NCT01514149|3826178|FG004|NOT COMPLETED|Overall Study||1
3102671|NCT01514162|3826190|FG000|STARTED|Overall Study||245
3102672|NCT01514162|3826190|FG000|COMPLETED|Overall Study||160
3102673|NCT01514162|3826190|FG000|NOT COMPLETED|Overall Study||85
3102674|NCT01514201|3826198|FG000|STARTED|PHASE I: Veliparib + Radiation Therapy||6
3102675|NCT01514201|3826199|FG001|STARTED|PHASE I: Veliparib + Radiation Therapy||6
3102676|NCT01514201|3826200|FG002|STARTED|PHASE I: Veliparib + Radiation Therapy||6
3102677|NCT01514201|3826201|FG003|STARTED|PHASE I: Veliparib + Radiation Therapy||0
3102678|NCT01514201|3826198|FG000|COMPLETED|PHASE I: Veliparib + Radiation Therapy||5
3102679|NCT01514201|3826199|FG001|COMPLETED|PHASE I: Veliparib + Radiation Therapy||6
3102680|NCT01514201|3826200|FG002|COMPLETED|PHASE I: Veliparib + Radiation Therapy||6
3102681|NCT01514201|3826201|FG003|COMPLETED|PHASE I: Veliparib + Radiation Therapy||0
3102682|NCT01514201|3826198|FG000|NOT COMPLETED|PHASE I: Veliparib + Radiation Therapy||1
3102683|NCT01514201|3826199|FG001|NOT COMPLETED|PHASE I: Veliparib + Radiation Therapy||0
3102684|NCT01514201|3826200|FG002|NOT COMPLETED|PHASE I: Veliparib + Radiation Therapy||0
3102685|NCT01514201|3826201|FG003|NOT COMPLETED|PHASE I: Veliparib + Radiation Therapy||0
3102686|NCT01514201|3826198|FG000|STARTED|PHASE I: Maintenance With Veliparib/TMZ||5
3102687|NCT01514201|3826199|FG001|STARTED|PHASE I: Maintenance With Veliparib/TMZ||6
3102688|NCT01514201|3826200|FG002|STARTED|PHASE I: Maintenance With Veliparib/TMZ||6
3102689|NCT01514201|3826201|FG003|STARTED|PHASE I: Maintenance With Veliparib/TMZ||0
3102690|NCT01514201|3826198|FG000|COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||0
3102691|NCT01514201|3826199|FG001|COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||0
3102692|NCT01514201|3826200|FG002|COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||0
3102693|NCT01514201|3826201|FG003|COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||0
3102694|NCT01514201|3826198|FG000|NOT COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||5
3102695|NCT01514201|3826199|FG001|NOT COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||6
3102696|NCT01514201|3826200|FG002|NOT COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||6
3102697|NCT01514201|3826201|FG003|NOT COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||0
3102698|NCT01514201|3826198|FG000|STARTED|PHASE II: Veliparib + Radiation Therapy||0
3102699|NCT01514201|3826199|FG001|STARTED|PHASE II: Veliparib + Radiation Therapy||0
3102700|NCT01514201|3826200|FG002|STARTED|PHASE II: Veliparib + Radiation Therapy||0
3102701|NCT01514201|3826201|FG003|STARTED|PHASE II: Veliparib + Radiation Therapy||47
3102702|NCT01514201|3826198|FG000|COMPLETED|PHASE II: Veliparib + Radiation Therapy||0
3102703|NCT01514201|3826199|FG001|COMPLETED|PHASE II: Veliparib + Radiation Therapy||0
3102704|NCT01514201|3826200|FG002|COMPLETED|PHASE II: Veliparib + Radiation Therapy||0
3102705|NCT01514201|3826201|FG003|COMPLETED|PHASE II: Veliparib + Radiation Therapy||35
3102706|NCT01514201|3826198|FG000|NOT COMPLETED|PHASE II: Veliparib + Radiation Therapy||0
3102707|NCT01514201|3826199|FG001|NOT COMPLETED|PHASE II: Veliparib + Radiation Therapy||0
3102708|NCT01514201|3826200|FG002|NOT COMPLETED|PHASE II: Veliparib + Radiation Therapy||0
3102709|NCT01514201|3826201|FG003|NOT COMPLETED|PHASE II: Veliparib + Radiation Therapy||12
3102710|NCT01514201|3826198|FG000|STARTED|PHASE II: Maintenance With Veliparib/TMZ||0
3102711|NCT01514201|3826199|FG001|STARTED|PHASE II: Maintenance With Veliparib/TMZ||0
3102712|NCT01514201|3826200|FG002|STARTED|PHASE II: Maintenance With Veliparib/TMZ||0
3102713|NCT01514201|3826201|FG003|STARTED|PHASE II: Maintenance With Veliparib/TMZ||35
3102714|NCT01514201|3826198|FG000|COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||0
3291793|NCT02852005|4025880|FG004|NOT COMPLETED|Overall Study||1
3291794|NCT02852265|4025896|FG000|STARTED|1-month Follow-up||10
3291795|NCT02852265|4025897|FG001|STARTED|1-month Follow-up||10
3291796|NCT02852265|4025896|FG000|COMPLETED|1-month Follow-up||10
3291797|NCT02852265|4025897|FG001|COMPLETED|1-month Follow-up||10
3291798|NCT02852265|4025896|FG000|NOT COMPLETED|1-month Follow-up||0
3291799|NCT02852265|4025897|FG001|NOT COMPLETED|1-month Follow-up||0
3291800|NCT02852265|4025896|FG000|STARTED|3-month Follow-up||10
3291801|NCT02852265|4025897|FG001|STARTED|3-month Follow-up||10
3291802|NCT02852265|4025896|FG000|COMPLETED|3-month Follow-up||9
3291803|NCT02852265|4025897|FG001|COMPLETED|3-month Follow-up||9
3291804|NCT02852265|4025896|FG000|NOT COMPLETED|3-month Follow-up||1
3291805|NCT02852265|4025897|FG001|NOT COMPLETED|3-month Follow-up||1
3291806|NCT02852265|4025896|FG000|STARTED|6-month Follow-up||9
3291807|NCT02852265|4025897|FG001|STARTED|6-month Follow-up||9
3291808|NCT02852265|4025896|FG000|COMPLETED|6-month Follow-up||9
3291809|NCT02852265|4025897|FG001|COMPLETED|6-month Follow-up||9
3291810|NCT02852265|4025896|FG000|NOT COMPLETED|6-month Follow-up||0
3291811|NCT02852265|4025897|FG001|NOT COMPLETED|6-month Follow-up||0
3102715|NCT01514201|3826199|FG001|COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||0
3102716|NCT01514201|3826200|FG002|COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||0
3102717|NCT01514201|3826201|FG003|COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||2
3102718|NCT01514201|3826198|FG000|NOT COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||0
3102719|NCT01514201|3826199|FG001|NOT COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||0
3102720|NCT01514201|3826200|FG002|NOT COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||0
3102721|NCT01514201|3826201|FG003|NOT COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||33
3102722|NCT01514240|3826223|FG000|STARTED|Overall Study||56
3102723|NCT01514240|3826224|FG001|STARTED|Overall Study||56
3102724|NCT01514240|3826223|FG000|COMPLETED|Overall Study||50
3102725|NCT01514240|3826224|FG001|COMPLETED|Overall Study||45
3102726|NCT01514240|3826223|FG000|NOT COMPLETED|Overall Study||6
3102727|NCT01514240|3826224|FG001|NOT COMPLETED|Overall Study||11
3102728|NCT01514279|3826233|FG000|STARTED|Overall Study||118
3102729|NCT01514279|3826234|FG001|STARTED|Overall Study||123
3102730|NCT01514279|3826235|FG002|STARTED|Overall Study||119
3102731|NCT01514279|3826233|FG000|COMPLETED|Overall Study||107
3102732|NCT01514279|3826234|FG001|COMPLETED|Overall Study||110
3102733|NCT01514279|3826235|FG002|COMPLETED|Overall Study||114
3102734|NCT01514279|3826233|FG000|NOT COMPLETED|Overall Study||11
3102735|NCT01514279|3826234|FG001|NOT COMPLETED|Overall Study||13
3102736|NCT01514279|3826235|FG002|NOT COMPLETED|Overall Study||5
3102737|NCT01514292|3826243|FG000|STARTED|Overall Study||72
3102738|NCT01514292|3826243|FG000|COMPLETED|Overall Study||72
3291812|NCT02852330|4025907|FG000|STARTED|Overall Study||20
3291813|NCT02852330|4025907|FG000|COMPLETED|Overall Study||20
3291814|NCT02852330|4025907|FG000|NOT COMPLETED|Overall Study||0
3291815|NCT02852434|4025913|FG000|STARTED|Overall Study||36
3291816|NCT02852434|4025914|FG001|STARTED|Overall Study||36
3291817|NCT02852434|4025913|FG000|COMPLETED|Overall Study||34
3291818|NCT02852434|4025914|FG001|COMPLETED|Overall Study||35
3291819|NCT02852434|4025913|FG000|NOT COMPLETED|Overall Study||2
3102739|NCT01514292|3826243|FG000|NOT COMPLETED|Overall Study||0
3102740|NCT01514318|3826247|FG000|STARTED|Overall Study||8
3102741|NCT01514318|3826247|FG000|COMPLETED|Overall Study||8
3102742|NCT01514318|3826247|FG000|NOT COMPLETED|Overall Study||0
3102743|NCT01514357|3826253|FG000|STARTED|Overall Study||12
3102744|NCT01514357|3826254|FG001|STARTED|Overall Study||0
3102745|NCT01514357|3826253|FG000|COMPLETED|Overall Study||8
3102746|NCT01514357|3826254|FG001|COMPLETED|Overall Study||0
3102747|NCT01514357|3826253|FG000|NOT COMPLETED|Overall Study||4
3102748|NCT01514357|3826254|FG001|NOT COMPLETED|Overall Study||0
3102749|NCT01514370|3826262|FG000|STARTED|Overall Study||40
3102750|NCT01514370|3826263|FG001|STARTED|Overall Study||40
3102751|NCT01514370|3826262|FG000|Safety Population|Overall Study|The Safety population consisted all randomized subjects who received at least 1 dose of study drug.|38
3102752|NCT01514370|3826263|FG001|Safety Population|Overall Study|The Safety population consisted all randomized subjects who received at least 1 dose of study drug.|40
3102753|NCT01514370|3826262|FG000|COMPLETED|Overall Study||29
3102754|NCT01514370|3826263|FG001|COMPLETED|Overall Study||24
3102755|NCT01514370|3826262|FG000|NOT COMPLETED|Overall Study||11
3102756|NCT01514370|3826263|FG001|NOT COMPLETED|Overall Study||16
3102757|NCT01514383|3826270|FG000|STARTED|Overall Study||34
3102758|NCT01514383|3826270|FG000|COMPLETED|Overall Study||34
3102759|NCT01514383|3826270|FG000|NOT COMPLETED|Overall Study||0
3102760|NCT01514396|3826275|FG000|STARTED|Overall Study||8
3102761|NCT01514396|3826275|FG000|COMPLETED|Overall Study||8
3102762|NCT01514396|3826275|FG000|NOT COMPLETED|Overall Study||0
3102763|NCT01514422|3826280|FG000|STARTED|Overall Study||20
3102764|NCT01514422|3826280|FG000|COMPLETED|Overall Study||19
3102765|NCT01514422|3826280|FG000|NOT COMPLETED|Overall Study||1
3102766|NCT01514448|3826286|FG000|STARTED|Overall Study||16
3102767|NCT01514448|3826287|FG001|STARTED|Overall Study||13
3102768|NCT01514448|3826286|FG000|Full Analysis Set (FAS)|Overall Study||12
3102769|NCT01514448|3826287|FG001|Full Analysis Set (FAS)|Overall Study||13
3102770|NCT01514448|3826286|FG000|COMPLETED|Overall Study||4
3102771|NCT01514448|3826287|FG001|COMPLETED|Overall Study||5
3102772|NCT01514448|3826286|FG000|NOT COMPLETED|Overall Study||12
3102773|NCT01514448|3826287|FG001|NOT COMPLETED|Overall Study||8
3102774|NCT01514461|3826297|FG000|STARTED|Overall Study||15
3102775|NCT01514461|3826298|FG001|STARTED|Overall Study||15
3102776|NCT01514461|3826299|FG002|STARTED|Overall Study||15
3102777|NCT01514461|3826297|FG000|COMPLETED|Overall Study||10
3102778|NCT01514461|3826298|FG001|COMPLETED|Overall Study||12
3102779|NCT01514461|3826299|FG002|COMPLETED|Overall Study||11
3102780|NCT01514461|3826297|FG000|NOT COMPLETED|Overall Study||5
3102781|NCT01514461|3826298|FG001|NOT COMPLETED|Overall Study||3
3102782|NCT01514461|3826299|FG002|NOT COMPLETED|Overall Study||4
3102783|NCT01514513|3826312|FG000|STARTED|Overall Study||21
3102784|NCT01514513|3826313|FG001|STARTED|Overall Study||21
3102785|NCT01514513|3826312|FG000|COMPLETED|Overall Study||20
3102786|NCT01514513|3826313|FG001|COMPLETED|Overall Study||20
3102787|NCT01514513|3826312|FG000|NOT COMPLETED|Overall Study||1
3102788|NCT01514513|3826313|FG001|NOT COMPLETED|Overall Study||1
3102789|NCT01514630|3826319|FG000|STARTED|Overall Study||14
3102790|NCT01514630|3826319|FG000|COMPLETED|Overall Study||11
3102791|NCT01514630|3826319|FG000|NOT COMPLETED|Overall Study||3
3102792|NCT01514682|3826325|FG000|STARTED|Overall Study||19
3102793|NCT01514682|3826326|FG001|STARTED|Overall Study||20
3291820|NCT02852434|4025914|FG001|NOT COMPLETED|Overall Study||1
3102794|NCT01514682|3826325|FG000|COMPLETED|Overall Study||13
3102795|NCT01514682|3826326|FG001|COMPLETED|Overall Study||14
3102796|NCT01514682|3826325|FG000|NOT COMPLETED|Overall Study||6
3102797|NCT01514682|3826326|FG001|NOT COMPLETED|Overall Study||6
3102798|NCT01514734|3826332|FG000|STARTED|Overall Study||9
3102799|NCT01514734|3826332|FG000|COMPLETED|Overall Study||9
3102800|NCT01514734|3826332|FG000|NOT COMPLETED|Overall Study||0
3102801|NCT01514760|3826336|FG000|STARTED|Overall Study||22
3102802|NCT01514760|3826336|FG000|COMPLETED|Overall Study||20
3102803|NCT01514760|3826336|FG000|NOT COMPLETED|Overall Study||2
3102804|NCT01514786|3826342|FG000|STARTED|Overall Study||286
3102805|NCT01514786|3826343|FG001|STARTED|Overall Study||284
3102806|NCT01514786|3826342|FG000|COMPLETED|Overall Study||286
3102807|NCT01514786|3826343|FG001|COMPLETED|Overall Study||284
3102808|NCT01514786|3826342|FG000|NOT COMPLETED|Overall Study||0
3102809|NCT01514786|3826343|FG001|NOT COMPLETED|Overall Study||0
3102810|NCT01514864|3826351|FG000|STARTED|Overall Study||9
3102811|NCT01514864|3826352|FG001|STARTED|Overall Study||5
3102812|NCT01514864|3826351|FG000|COMPLETED|Overall Study|Study was terminated; no patients completed study treatment|0
3102813|NCT01514864|3826352|FG001|COMPLETED|Overall Study||0
3102814|NCT01514864|3826351|FG000|NOT COMPLETED|Overall Study||9
3102815|NCT01514864|3826352|FG001|NOT COMPLETED|Overall Study||5
3102816|NCT01515046|3826359|FG000|STARTED|Overall Study||1
3102817|NCT01515046|3826359|FG000|COMPLETED|Overall Study||1
3102818|NCT01515046|3826359|FG000|NOT COMPLETED|Overall Study||0
3102819|NCT01515072|3826365|FG000|STARTED|Overall Study||166
3102820|NCT01515072|3826366|FG001|STARTED|Overall Study||155
3102821|NCT01515072|3826365|FG000|COMPLETED|Overall Study|There were 566 total organs transplanted and 248 kidneys transplanted in the No RIPC group.|166
3102822|NCT01515072|3826366|FG001|COMPLETED|Overall Study|There were 513 total organs transplanted and 235 kidneys transplanted in the RIPC group|155
3102823|NCT01515072|3826365|FG000|NOT COMPLETED|Overall Study||0
3102824|NCT01515072|3826366|FG001|NOT COMPLETED|Overall Study||0
3102825|NCT01515176|3826388|FG000|STARTED|Overall Study||4
3102826|NCT01515176|3826389|FG001|STARTED|Overall Study||32
3102827|NCT01515176|3826388|FG000|COMPLETED|Overall Study||4
3102828|NCT01515176|3826389|FG001|COMPLETED|Overall Study||32
3102829|NCT01515176|3826388|FG000|NOT COMPLETED|Overall Study||0
3102830|NCT01515176|3826389|FG001|NOT COMPLETED|Overall Study||0
3102831|NCT01515189|3826399|FG000|STARTED|Induction|Includes 1 subject who was randomized but not treated due to an Adverse Event before treatment|365
3102832|NCT01515189|3826400|FG001|STARTED|Induction||362
3102833|NCT01515189|3826399|FG000|COMPLETED|Induction||128
3102834|NCT01515189|3826400|FG001|COMPLETED|Induction||130
3102835|NCT01515189|3826399|FG000|NOT COMPLETED|Induction||237
3102836|NCT01515189|3826400|FG001|NOT COMPLETED|Induction||232
3102837|NCT01515189|3826399|FG000|STARTED|First Re-Induction Phase||23
3102838|NCT01515189|3826400|FG001|STARTED|First Re-Induction Phase||32
3102839|NCT01515189|3826399|FG000|COMPLETED|First Re-Induction Phase||9
3102840|NCT01515189|3826400|FG001|COMPLETED|First Re-Induction Phase||17
3102841|NCT01515189|3826399|FG000|NOT COMPLETED|First Re-Induction Phase||14
3102842|NCT01515189|3826400|FG001|NOT COMPLETED|First Re-Induction Phase||15
3102843|NCT01515306|3826408|FG000|STARTED|Overall Study||24
3102844|NCT01515306|3826409|FG001|STARTED|Overall Study||16
3102845|NCT01515306|3826408|FG000|Received at Least 1 Dose of Study Drug|Overall Study||24
3102846|NCT01515306|3826409|FG001|Received at Least 1 Dose of Study Drug|Overall Study||16
3102847|NCT01515306|3826408|FG000|Drug-Drug Interaction Population|Overall Study|Completed Cycle 1 Day 1 and Cycle 2 Day 1 treatment.|21
3102848|NCT01515306|3826409|FG001|Drug-Drug Interaction Population|Overall Study|Drug-drug interaction was only assessed in Part A.|0
3102849|NCT01515306|3826408|FG000|COMPLETED|Overall Study|Completed the required treatment in Cycle 1 Day 1 and Cycle 2 Day 1 and assessment.|12
3102850|NCT01515306|3826409|FG001|COMPLETED|Overall Study||2
3102851|NCT01515306|3826408|FG000|NOT COMPLETED|Overall Study||12
3102852|NCT01515306|3826409|FG001|NOT COMPLETED|Overall Study||14
3102853|NCT01515319|3826427|FG000|STARTED|Overall Study||3
3102854|NCT01515319|3826428|FG001|STARTED|Overall Study||3
3102855|NCT01515319|3826429|FG002|STARTED|Overall Study||6
3102856|NCT01515319|3826430|FG003|STARTED|Overall Study||6
3102857|NCT01515319|3826431|FG004|STARTED|Overall Study||6
3102858|NCT01515319|3826432|FG005|STARTED|Overall Study||6
3102859|NCT01515319|3826433|FG006|STARTED|Overall Study||10
3102860|NCT01515319|3826434|FG007|STARTED|Overall Study||6
3102861|NCT01515319|3826435|FG008|STARTED|Overall Study||14
3102862|NCT01515319|3826436|FG009|STARTED|Overall Study||8
3102863|NCT01515319|3826427|FG000|COMPLETED|Overall Study||3
3102864|NCT01515319|3826428|FG001|COMPLETED|Overall Study||3
3102865|NCT01515319|3826429|FG002|COMPLETED|Overall Study||6
3102866|NCT01515319|3826430|FG003|COMPLETED|Overall Study||6
3102867|NCT01515319|3826431|FG004|COMPLETED|Overall Study||6
3102868|NCT01515319|3826432|FG005|COMPLETED|Overall Study||6
3102869|NCT01515319|3826433|FG006|COMPLETED|Overall Study||9
3102870|NCT01515319|3826434|FG007|COMPLETED|Overall Study||6
3102871|NCT01515319|3826435|FG008|COMPLETED|Overall Study||9
3102872|NCT01515319|3826436|FG009|COMPLETED|Overall Study||8
3102873|NCT01515319|3826427|FG000|NOT COMPLETED|Overall Study||0
3102874|NCT01515319|3826428|FG001|NOT COMPLETED|Overall Study||0
3102875|NCT01515319|3826429|FG002|NOT COMPLETED|Overall Study||0
3102876|NCT01515319|3826430|FG003|NOT COMPLETED|Overall Study||0
3102877|NCT01515319|3826431|FG004|NOT COMPLETED|Overall Study||0
3102878|NCT01515319|3826432|FG005|NOT COMPLETED|Overall Study||0
3102879|NCT01515319|3826433|FG006|NOT COMPLETED|Overall Study||1
3102880|NCT01515319|3826434|FG007|NOT COMPLETED|Overall Study||0
3102881|NCT01515319|3826435|FG008|NOT COMPLETED|Overall Study||5
3102882|NCT01515319|3826436|FG009|NOT COMPLETED|Overall Study||0
3102883|NCT01515345|3826460|FG000|STARTED|Overall Study||665
3102884|NCT01515345|3826461|FG001|STARTED|Overall Study||343
3102885|NCT01515345|3826460|FG000|COMPLETED|Overall Study||664
3102886|NCT01515345|3826461|FG001|COMPLETED|Overall Study||343
3102887|NCT01515345|3826460|FG000|NOT COMPLETED|Overall Study||1
3102888|NCT01515345|3826461|FG001|NOT COMPLETED|Overall Study||0
3102889|NCT01515410|3826467|FG000|STARTED|Overall Study||19
3102890|NCT01515410|3826468|FG001|STARTED|Overall Study||15
3102891|NCT01515410|3826467|FG000|COMPLETED|Overall Study||19
3102892|NCT01515410|3826468|FG001|COMPLETED|Overall Study||15
3102893|NCT01515410|3826467|FG000|NOT COMPLETED|Overall Study||0
3102894|NCT01515410|3826468|FG001|NOT COMPLETED|Overall Study||0
3102895|NCT01515423|3826476|FG000|STARTED|Open Label Phase||1429
3102896|NCT01515423|3826477|FG001|STARTED|Open Label Phase||0
3102897|NCT01515423|3826478|FG002|STARTED|Open Label Phase||0
3102898|NCT01515423|3826476|FG000|COMPLETED|Open Label Phase||1016
3102899|NCT01515423|3826477|FG001|COMPLETED|Open Label Phase||0
3102900|NCT01515423|3826478|FG002|COMPLETED|Open Label Phase||0
3102901|NCT01515423|3826476|FG000|NOT COMPLETED|Open Label Phase||413
3102902|NCT01515423|3826477|FG001|NOT COMPLETED|Open Label Phase||0
3102903|NCT01515423|3826478|FG002|NOT COMPLETED|Open Label Phase||0
3102904|NCT01515423|3826476|FG000|STARTED|DOUBLE BLIND||0
3102905|NCT01515423|3826477|FG001|STARTED|DOUBLE BLIND||504
3102906|NCT01515423|3826478|FG002|STARTED|DOUBLE BLIND||512
3102907|NCT01515423|3826476|FG000|COMPLETED|DOUBLE BLIND||0
3102908|NCT01515423|3826477|FG001|COMPLETED|DOUBLE BLIND||422
3102909|NCT01515423|3826478|FG002|COMPLETED|DOUBLE BLIND||420
3102910|NCT01515423|3826476|FG000|NOT COMPLETED|DOUBLE BLIND||0
3102911|NCT01515423|3826477|FG001|NOT COMPLETED|DOUBLE BLIND||82
3102912|NCT01515423|3826478|FG002|NOT COMPLETED|DOUBLE BLIND||92
3102913|NCT01515475|3826489|FG000|STARTED|Overall Study||61
3102914|NCT01515475|3826490|FG001|STARTED|Overall Study||58
3102915|NCT01515475|3826491|FG002|STARTED|Overall Study||65
3102916|NCT01515475|3826492|FG003|STARTED|Overall Study||65
3102917|NCT01515475|3826489|FG000|COMPLETED|Overall Study||41
3102918|NCT01515475|3826490|FG001|COMPLETED|Overall Study||43
3102919|NCT01515475|3826491|FG002|COMPLETED|Overall Study||53
3102920|NCT01515475|3826492|FG003|COMPLETED|Overall Study||53
3102921|NCT01515475|3826489|FG000|NOT COMPLETED|Overall Study||20
3102922|NCT01515475|3826490|FG001|NOT COMPLETED|Overall Study||15
3102923|NCT01515475|3826491|FG002|NOT COMPLETED|Overall Study||12
3102924|NCT01515475|3826492|FG003|NOT COMPLETED|Overall Study||12
3102925|NCT01515488|3826504|FG000|STARTED|Overall Study||200
3102926|NCT01515488|3826505|FG001|STARTED|Overall Study||200
3102927|NCT01515488|3826504|FG000|COMPLETED|Overall Study||200
3102928|NCT01515488|3826505|FG001|COMPLETED|Overall Study||200
3102929|NCT01515488|3826504|FG000|NOT COMPLETED|Overall Study||0
3102930|NCT01515488|3826505|FG001|NOT COMPLETED|Overall Study||0
3102931|NCT01515540|3826513|FG000|STARTED|Overall Study||20
3102932|NCT01515540|3826514|FG001|STARTED|Overall Study||18
3102933|NCT01515540|3826513|FG000|COMPLETED|Overall Study||15
3102934|NCT01515540|3826514|FG001|COMPLETED|Overall Study||15
3102935|NCT01515540|3826513|FG000|NOT COMPLETED|Overall Study||5
3102936|NCT01515540|3826514|FG001|NOT COMPLETED|Overall Study||3
3102937|NCT01515566|3826522|FG000|STARTED|Overall Study||10
3102938|NCT01515566|3826523|FG001|STARTED|Overall Study||10
3102939|NCT01515566|3826522|FG000|COMPLETED|Overall Study||10
3102940|NCT01515566|3826523|FG001|COMPLETED|Overall Study||10
3102941|NCT01515566|3826522|FG000|NOT COMPLETED|Overall Study||0
3102942|NCT01515566|3826523|FG001|NOT COMPLETED|Overall Study||0
3102943|NCT01515657|3826529|FG000|STARTED|First Intervention||14
3102944|NCT01515657|3826530|FG001|STARTED|First Intervention||13
3102945|NCT01515657|3826531|FG002|STARTED|First Intervention||13
3102946|NCT01515657|3826529|FG000|COMPLETED|First Intervention||14
3102947|NCT01515657|3826530|FG001|COMPLETED|First Intervention||12
3102948|NCT01515657|3826531|FG002|COMPLETED|First Intervention||13
3102949|NCT01515657|3826529|FG000|NOT COMPLETED|First Intervention||0
3102950|NCT01515657|3826530|FG001|NOT COMPLETED|First Intervention||1
3102951|NCT01515657|3826531|FG002|NOT COMPLETED|First Intervention||0
3102952|NCT01515657|3826529|FG000|STARTED|Second Intervention||14
3102953|NCT01515657|3826530|FG001|STARTED|Second Intervention||12
3102954|NCT01515657|3826531|FG002|STARTED|Second Intervention||13
3102955|NCT01515657|3826529|FG000|COMPLETED|Second Intervention||14
3102956|NCT01515657|3826530|FG001|COMPLETED|Second Intervention||11
3102957|NCT01515657|3826531|FG002|COMPLETED|Second Intervention||13
3102958|NCT01515657|3826529|FG000|NOT COMPLETED|Second Intervention||0
3102959|NCT01515657|3826530|FG001|NOT COMPLETED|Second Intervention||1
3102960|NCT01515657|3826531|FG002|NOT COMPLETED|Second Intervention||0
3102961|NCT01515657|3826529|FG000|STARTED|Third Intervention||14
3102962|NCT01515657|3826530|FG001|STARTED|Third Intervention||11
3102963|NCT01515657|3826531|FG002|STARTED|Third Intervention||13
3102964|NCT01515657|3826529|FG000|COMPLETED|Third Intervention||13
3102965|NCT01515657|3826530|FG001|COMPLETED|Third Intervention||11
3102966|NCT01515657|3826531|FG002|COMPLETED|Third Intervention||13
3102967|NCT01515657|3826529|FG000|NOT COMPLETED|Third Intervention||1
3102968|NCT01515657|3826530|FG001|NOT COMPLETED|Third Intervention||0
3102969|NCT01515657|3826531|FG002|NOT COMPLETED|Third Intervention||0
3102970|NCT01515696|3826541|FG000|STARTED|Overall Study||47
3102971|NCT01515696|3826542|FG001|STARTED|Overall Study||49
3102972|NCT01515696|3826541|FG000|COMPLETED|Overall Study||39
3102973|NCT01515696|3826542|FG001|COMPLETED|Overall Study||39
3102974|NCT01515696|3826541|FG000|NOT COMPLETED|Overall Study||8
3102975|NCT01515696|3826542|FG001|NOT COMPLETED|Overall Study||10
3102976|NCT01515748|3826550|FG000|STARTED|Overall Study||264
3102977|NCT01515748|3826551|FG001|STARTED|Overall Study||266
3102978|NCT01515748|3826550|FG000|Treated|Overall Study||195
3102979|NCT01515748|3826551|FG001|Treated|Overall Study||241
3102980|NCT01515748|3826550|FG000|COMPLETED|Overall Study||144
3102981|NCT01515748|3826551|FG001|COMPLETED|Overall Study||131
3102982|NCT01515748|3826550|FG000|NOT COMPLETED|Overall Study||120
3102983|NCT01515748|3826551|FG001|NOT COMPLETED|Overall Study||135
3102984|NCT01515865|3826558|FG000|STARTED|Part A (Open-label)||98
3102985|NCT01515865|3826559|FG001|STARTED|Part A (Open-label)||0
3102986|NCT01515865|3826560|FG002|STARTED|Part A (Open-label)||0
3102987|NCT01515865|3826558|FG000|COMPLETED|Part A (Open-label)||95
3102988|NCT01515865|3826559|FG001|COMPLETED|Part A (Open-label)||0
3102989|NCT01515865|3826560|FG002|COMPLETED|Part A (Open-label)||0
3102990|NCT01515865|3826558|FG000|NOT COMPLETED|Part A (Open-label)||3
3102991|NCT01515865|3826559|FG001|NOT COMPLETED|Part A (Open-label)||0
3102992|NCT01515865|3826560|FG002|NOT COMPLETED|Part A (Open-label)||0
3102993|NCT01515865|3826558|FG000|STARTED|Part B (Open-label)|Twenty-four subjects from Part A did not meet the criteria required to be enrolled into Part B.|71
3102994|NCT01515865|3826559|FG001|STARTED|Part B (Open-label)||0
3102995|NCT01515865|3826560|FG002|STARTED|Part B (Open-label)||0
3102996|NCT01515865|3826558|FG000|COMPLETED|Part B (Open-label)||69
3102997|NCT01515865|3826559|FG001|COMPLETED|Part B (Open-label)||0
3102998|NCT01515865|3826560|FG002|COMPLETED|Part B (Open-label)||0
3102999|NCT01515865|3826558|FG000|NOT COMPLETED|Part B (Open-label)||2
3103000|NCT01515865|3826559|FG001|NOT COMPLETED|Part B (Open-label)||0
3103001|NCT01515865|3826560|FG002|NOT COMPLETED|Part B (Open-label)||0
3103002|NCT01515865|3826558|FG000|STARTED|Part C (Randomized)||0
3103003|NCT01515865|3826559|FG001|STARTED|Part C (Randomized)|A total of two subjects from Part B did not meet the criteria required to be enrolled into Part C.|33
3103004|NCT01515865|3826560|FG002|STARTED|Part C (Randomized)||34
3103005|NCT01515865|3826558|FG000|COMPLETED|Part C (Randomized)||0
3103006|NCT01515865|3826559|FG001|COMPLETED|Part C (Randomized)||33
3103007|NCT01515865|3826560|FG002|COMPLETED|Part C (Randomized)||34
3103008|NCT01515865|3826558|FG000|NOT COMPLETED|Part C (Randomized)||0
3103009|NCT01515865|3826559|FG001|NOT COMPLETED|Part C (Randomized)||0
3103010|NCT01515865|3826560|FG002|NOT COMPLETED|Part C (Randomized)||0
3103011|NCT01515891|3826568|FG000|STARTED|Overall Study||4
3103012|NCT01515891|3826568|FG000|COMPLETED|Overall Study||4
3103013|NCT01515891|3826568|FG000|NOT COMPLETED|Overall Study||0
3103014|NCT01515943|3826575|FG000|STARTED|Overall Study||75
3103015|NCT01515943|3826576|FG001|STARTED|Overall Study||85
3103016|NCT01515943|3826577|FG002|STARTED|Overall Study||44
3103017|NCT01515943|3826575|FG000|COMPLETED|Overall Study||69
3103018|NCT01515943|3826576|FG001|COMPLETED|Overall Study||69
3103019|NCT01515943|3826577|FG002|COMPLETED|Overall Study||31
3103020|NCT01515943|3826575|FG000|NOT COMPLETED|Overall Study||6
3103021|NCT01515943|3826576|FG001|NOT COMPLETED|Overall Study||16
3103022|NCT01515943|3826577|FG002|NOT COMPLETED|Overall Study||13
3103023|NCT01515956|3826587|FG000|STARTED|Overall Study||15
3103024|NCT01515956|3826587|FG000|COMPLETED|Overall Study||15
3103025|NCT01515956|3826587|FG000|NOT COMPLETED|Overall Study||0
3103026|NCT01515995|3826594|FG000|STARTED|Overall Study||25
3103027|NCT01515995|3826595|FG001|STARTED|Overall Study||25
3103028|NCT01515995|3826594|FG000|COMPLETED|Overall Study||22
3103029|NCT01515995|3826595|FG001|COMPLETED|Overall Study||21
3103030|NCT01515995|3826594|FG000|NOT COMPLETED|Overall Study||3
3103031|NCT01515995|3826595|FG001|NOT COMPLETED|Overall Study||4
3103032|NCT01516008|3826604|FG000|STARTED|Overall Study||114
3103033|NCT01516008|3826605|FG001|STARTED|Overall Study||121
3103034|NCT01516008|3826606|FG002|STARTED|Overall Study||117
3103035|NCT01516008|3826604|FG000|COMPLETED|Overall Study||69
3103036|NCT01516008|3826605|FG001|COMPLETED|Overall Study||105
3103037|NCT01516008|3826606|FG002|COMPLETED|Overall Study||99
3103038|NCT01516008|3826604|FG000|NOT COMPLETED|Overall Study||45
3103039|NCT01516008|3826605|FG001|NOT COMPLETED|Overall Study||16
3103040|NCT01516008|3826606|FG002|NOT COMPLETED|Overall Study||18
3103041|NCT01516268|3826616|FG000|STARTED|Overall Study||25
3103042|NCT01516268|3826617|FG001|STARTED|Overall Study||25
3103043|NCT01516268|3826616|FG000|COMPLETED|Overall Study||25
3103044|NCT01516268|3826617|FG001|COMPLETED|Overall Study||25
3103045|NCT01516268|3826616|FG000|NOT COMPLETED|Overall Study||0
3103046|NCT01516268|3826617|FG001|NOT COMPLETED|Overall Study||0
3103047|NCT01516424|3826625|FG000|STARTED|Overall Study|the patient number of randomization for Blonanserin Group|131
3103048|NCT01516424|3826626|FG001|STARTED|Overall Study|the patient number of randomization for Risperidone Group|136
3103049|NCT01516424|3826625|FG000|COMPLETED|Overall Study||96
3103050|NCT01516424|3826626|FG001|COMPLETED|Overall Study||114
3103051|NCT01516424|3826625|FG000|NOT COMPLETED|Overall Study||35
3103052|NCT01516424|3826626|FG001|NOT COMPLETED|Overall Study||22
3103053|NCT01516437|3826636|FG000|STARTED|Overall Study||24
3103054|NCT01516437|3826637|FG001|STARTED|Overall Study||24
3103055|NCT01516437|3826638|FG002|STARTED|Overall Study||15
3103056|NCT01516437|3826639|FG003|STARTED|Overall Study||7
3103057|NCT01516437|3826636|FG000|COMPLETED|Overall Study||24
3103058|NCT01516437|3826637|FG001|COMPLETED|Overall Study||24
3103059|NCT01516437|3826638|FG002|COMPLETED|Overall Study||14
3103060|NCT01516437|3826639|FG003|COMPLETED|Overall Study||6
3103061|NCT01516437|3826636|FG000|NOT COMPLETED|Overall Study||0
3103062|NCT01516437|3826637|FG001|NOT COMPLETED|Overall Study||0
3103063|NCT01516437|3826638|FG002|NOT COMPLETED|Overall Study||1
3103064|NCT01516437|3826639|FG003|NOT COMPLETED|Overall Study||1
3103065|NCT01516632|3826653|FG000|STARTED|Overall Study||101
3103066|NCT01516632|3826654|FG001|STARTED|Overall Study||63
3103067|NCT01516632|3826653|FG000|COMPLETED|Overall Study||77
3103068|NCT01516632|3826654|FG001|COMPLETED|Overall Study||48
3103069|NCT01516632|3826653|FG000|NOT COMPLETED|Overall Study||24
3103070|NCT01516632|3826654|FG001|NOT COMPLETED|Overall Study||15
3103071|NCT01516684|3826664|FG000|STARTED|Overall Study|"Overall number of units (trials) was used for measuring results with 170 trials.~Trials were randomized for each arm, not participants"|
3103072|NCT01516684|3826665|FG001|STARTED|Overall Study|"Overall number of units (trials) was used for measuring results with 170 trials.~Trials were randomized for each arm, not participants"|
3103073|NCT01516684|3826664|FG000|COMPLETED|Overall Study|Trials were randomized for each arm, not participants|
3103074|NCT01516684|3826665|FG001|COMPLETED|Overall Study|"Overall number of units (trials) completed was 152~Trials were randomized for each arm, not participants"|
3103075|NCT01516684|3826664|FG000|NOT COMPLETED|Overall Study||
3103076|NCT01516684|3826665|FG001|NOT COMPLETED|Overall Study||
3103077|NCT01516736|3826675|FG000|STARTED|Overall Study||155
3291821|NCT02852967|4025925|FG000|STARTED|Overall Study||23
3291822|NCT02852967|4025926|FG001|STARTED|Overall Study||22
3291823|NCT02852967|4025927|FG002|STARTED|Overall Study||21
3103078|NCT01516736|3826676|FG001|STARTED|Overall Study||153
3103079|NCT01516736|3826675|FG000|COMPLETED|Overall Study||135
3103080|NCT01516736|3826676|FG001|COMPLETED|Overall Study||140
3103081|NCT01516736|3826675|FG000|NOT COMPLETED|Overall Study||20
3103082|NCT01516736|3826676|FG001|NOT COMPLETED|Overall Study||13
3103083|NCT01516749|3826682|FG000|STARTED|Active Therapy||6
3103084|NCT01516749|3826682|FG000|COMPLETED|Active Therapy||5
3103085|NCT01516749|3826682|FG000|NOT COMPLETED|Active Therapy||1
3103086|NCT01516749|3826682|FG000|STARTED|Follow-up Off Therapy||5
3103087|NCT01516749|3826682|FG000|COMPLETED|Follow-up Off Therapy||4
3103088|NCT01516749|3826682|FG000|NOT COMPLETED|Follow-up Off Therapy||1
3103089|NCT01516879|3826688|FG000|STARTED|Overall Study||303
3103090|NCT01516879|3826689|FG001|STARTED|Overall Study||602
3103091|NCT01516879|3826688|FG000|Received Treatment|Overall Study||302
3103092|NCT01516879|3826689|FG001|Received Treatment|Overall Study||599
3103093|NCT01516879|3826688|FG000|COMPLETED|Overall Study||287
3103094|NCT01516879|3826689|FG001|COMPLETED|Overall Study||568
3103095|NCT01516879|3826688|FG000|NOT COMPLETED|Overall Study||16
3103096|NCT01516879|3826689|FG001|NOT COMPLETED|Overall Study||34
3103097|NCT01516892|3826695|FG000|STARTED|Overall Study||716
3103098|NCT01516892|3826695|FG000|COMPLETED|Overall Study||373
3103099|NCT01516892|3826695|FG000|NOT COMPLETED|Overall Study||343
3103100|NCT01516957|3826702|FG000|STARTED|Placebo-controlled Phase||55
3103101|NCT01516957|3826703|FG001|STARTED|Placebo-controlled Phase||57
3103102|NCT01516957|3826704|FG002|STARTED|Placebo-controlled Phase||56
3103103|NCT01516957|3826705|FG003|STARTED|Placebo-controlled Phase||0
3103104|NCT01516957|3826702|FG000|COMPLETED|Placebo-controlled Phase||52
3103105|NCT01516957|3826703|FG001|COMPLETED|Placebo-controlled Phase||53
3103106|NCT01516957|3826704|FG002|COMPLETED|Placebo-controlled Phase||51
3103107|NCT01516957|3826705|FG003|COMPLETED|Placebo-controlled Phase||0
3103108|NCT01516957|3826702|FG000|NOT COMPLETED|Placebo-controlled Phase||3
3103109|NCT01516957|3826703|FG001|NOT COMPLETED|Placebo-controlled Phase||4
3103110|NCT01516957|3826704|FG002|NOT COMPLETED|Placebo-controlled Phase||5
3103111|NCT01516957|3826705|FG003|NOT COMPLETED|Placebo-controlled Phase||0
3103112|NCT01516957|3826702|FG000|STARTED|Open-label Phase||0
3103113|NCT01516957|3826703|FG001|STARTED|Open-label Phase||0
3103114|NCT01516957|3826704|FG002|STARTED|Open-label Phase||0
3103115|NCT01516957|3826705|FG003|STARTED|Open-label Phase||156
3103116|NCT01516957|3826702|FG000|COMPLETED|Open-label Phase||0
3103117|NCT01516957|3826703|FG001|COMPLETED|Open-label Phase||0
3103118|NCT01516957|3826704|FG002|COMPLETED|Open-label Phase||0
3103119|NCT01516957|3826705|FG003|COMPLETED|Open-label Phase||0
3103120|NCT01516957|3826702|FG000|NOT COMPLETED|Open-label Phase||0
3103121|NCT01516957|3826703|FG001|NOT COMPLETED|Open-label Phase||0
3103122|NCT01516957|3826704|FG002|NOT COMPLETED|Open-label Phase||0
3103123|NCT01516957|3826705|FG003|NOT COMPLETED|Open-label Phase||156
3103124|NCT01516970|3826716|FG000|STARTED|Overall Study||159
3103125|NCT01516970|3826717|FG001|STARTED|Overall Study||153
3103126|NCT01516970|3826716|FG000|COMPLETED|Overall Study||141
3103127|NCT01516970|3826717|FG001|COMPLETED|Overall Study||132
3103128|NCT01516970|3826716|FG000|NOT COMPLETED|Overall Study||18
3103129|NCT01516970|3826717|FG001|NOT COMPLETED|Overall Study||21
3103130|NCT01517074|3826723|FG000|STARTED|Overall Study||5
3103131|NCT01517074|3826723|FG000|COMPLETED|Overall Study||5
3103132|NCT01517074|3826723|FG000|NOT COMPLETED|Overall Study||0
3103133|NCT01517178|3826732|FG000|STARTED|Period 1|One subject (who discontinued due to an adverse event) actually used New ostomy base plate.|16
3103134|NCT01517178|3826733|FG001|STARTED|Period 1||11
3103135|NCT01517178|3826732|FG000|COMPLETED|Period 1||12
3103136|NCT01517178|3826733|FG001|COMPLETED|Period 1||6
3291824|NCT02852967|4025928|FG003|STARTED|Overall Study||26
3291825|NCT02852967|4025929|FG004|STARTED|Overall Study||18
3291826|NCT02852967|4025925|FG000|Completed Period 1: Double-blind|Overall Study||14
3103137|NCT01517178|3826732|FG000|NOT COMPLETED|Period 1||4
3103138|NCT01517178|3826733|FG001|NOT COMPLETED|Period 1||5
3291827|NCT02852967|4025926|FG001|Completed Period 1: Double-blind|Overall Study||15
3291828|NCT02852967|4025927|FG002|Completed Period 1: Double-blind|Overall Study||17
3103139|NCT01517178|3826732|FG000|STARTED|Period 2|One subject discontinued during run-in and did not start period 2.|11
3103140|NCT01517178|3826733|FG001|STARTED|Period 2||6
3103141|NCT01517178|3826732|FG000|COMPLETED|Period 2||5
3103142|NCT01517178|3826733|FG001|COMPLETED|Period 2||4
3103143|NCT01517178|3826732|FG000|NOT COMPLETED|Period 2||6
3103144|NCT01517178|3826733|FG001|NOT COMPLETED|Period 2||2
3103145|NCT01517282|3826743|FG000|STARTED|Overall Study|One patient was randomized but did not receive study medication based on the investigator's decision|9
3103146|NCT01517282|3826744|FG001|STARTED|Overall Study||8
3103147|NCT01517282|3826745|FG002|STARTED|Overall Study|1 patient completed the trial, but received only 4 doses of medication and 2 MRIs due to pregnancy|9
3103148|NCT01517282|3826746|FG003|STARTED|Overall Study||6
3103149|NCT01517282|3826743|FG000|COMPLETED|Overall Study||8
3103150|NCT01517282|3826744|FG001|COMPLETED|Overall Study||7
3103151|NCT01517282|3826745|FG002|COMPLETED|Overall Study||8
3103152|NCT01517282|3826746|FG003|COMPLETED|Overall Study||5
3103153|NCT01517282|3826743|FG000|NOT COMPLETED|Overall Study||1
3103154|NCT01517282|3826744|FG001|NOT COMPLETED|Overall Study||1
3103155|NCT01517282|3826745|FG002|NOT COMPLETED|Overall Study||1
3103156|NCT01517282|3826746|FG003|NOT COMPLETED|Overall Study||1
3103157|NCT01517295|3826758|FG000|STARTED|Overall Study||16
3103158|NCT01517295|3826759|FG001|STARTED|Overall Study||14
3103159|NCT01517295|3826758|FG000|COMPLETED|Overall Study||15
3103160|NCT01517295|3826759|FG001|COMPLETED|Overall Study||14
3103161|NCT01517295|3826758|FG000|NOT COMPLETED|Overall Study||1
3103162|NCT01517295|3826759|FG001|NOT COMPLETED|Overall Study||0
3103163|NCT01517373|3826770|FG000|STARTED|Run-in Period||361
3103164|NCT01517373|3826771|FG001|STARTED|Run-in Period||0
3103165|NCT01517373|3826772|FG002|STARTED|Run-in Period||0
3103166|NCT01517373|3826773|FG003|STARTED|Run-in Period||0
3103167|NCT01517373|3826774|FG004|STARTED|Run-in Period||0
3103168|NCT01517373|3826775|FG005|STARTED|Run-in Period||0
3103169|NCT01517373|3826770|FG000|COMPLETED|Run-in Period||304
3103170|NCT01517373|3826771|FG001|COMPLETED|Run-in Period||0
3103171|NCT01517373|3826772|FG002|COMPLETED|Run-in Period||0
3103172|NCT01517373|3826773|FG003|COMPLETED|Run-in Period||0
3103173|NCT01517373|3826774|FG004|COMPLETED|Run-in Period||0
3103174|NCT01517373|3826775|FG005|COMPLETED|Run-in Period||0
3103175|NCT01517373|3826770|FG000|NOT COMPLETED|Run-in Period||57
3103176|NCT01517373|3826771|FG001|NOT COMPLETED|Run-in Period||0
3103177|NCT01517373|3826772|FG002|NOT COMPLETED|Run-in Period||0
3103178|NCT01517373|3826773|FG003|NOT COMPLETED|Run-in Period||0
3103179|NCT01517373|3826774|FG004|NOT COMPLETED|Run-in Period||0
3103180|NCT01517373|3826775|FG005|NOT COMPLETED|Run-in Period||0
3103181|NCT01517373|3826770|FG000|STARTED|Treatment Period||0
3103182|NCT01517373|3826771|FG001|STARTED|Treatment Period||61
3103183|NCT01517373|3826772|FG002|STARTED|Treatment Period||60
3103184|NCT01517373|3826773|FG003|STARTED|Treatment Period||61
3103185|NCT01517373|3826774|FG004|STARTED|Treatment Period||61
3103186|NCT01517373|3826775|FG005|STARTED|Treatment Period||61
3103187|NCT01517373|3826770|FG000|COMPLETED|Treatment Period||0
3103188|NCT01517373|3826771|FG001|COMPLETED|Treatment Period||57
3103189|NCT01517373|3826772|FG002|COMPLETED|Treatment Period||54
3103190|NCT01517373|3826773|FG003|COMPLETED|Treatment Period||54
3103191|NCT01517373|3826774|FG004|COMPLETED|Treatment Period||55
3103192|NCT01517373|3826775|FG005|COMPLETED|Treatment Period||54
3103193|NCT01517373|3826770|FG000|NOT COMPLETED|Treatment Period||0
3103194|NCT01517373|3826771|FG001|NOT COMPLETED|Treatment Period||4
3103195|NCT01517373|3826772|FG002|NOT COMPLETED|Treatment Period||6
3103196|NCT01517373|3826773|FG003|NOT COMPLETED|Treatment Period||7
3103197|NCT01517373|3826774|FG004|NOT COMPLETED|Treatment Period||6
3103198|NCT01517373|3826775|FG005|NOT COMPLETED|Treatment Period||7
3103199|NCT01517412|3826790|FG000|STARTED|Overall Study||225
3103200|NCT01517412|3826791|FG001|STARTED|Overall Study||226
3103201|NCT01517412|3826790|FG000|COMPLETED|Overall Study||189
3103202|NCT01517412|3826791|FG001|COMPLETED|Overall Study||202
3103203|NCT01517412|3826790|FG000|NOT COMPLETED|Overall Study||36
3103204|NCT01517412|3826791|FG001|NOT COMPLETED|Overall Study||24
3103205|NCT01517529|3826797|FG000|STARTED|Overall Study||10
3103206|NCT01517529|3826797|FG000|COMPLETED|Overall Study||10
3103207|NCT01517529|3826797|FG000|NOT COMPLETED|Overall Study||0
3103208|NCT01517750|3826805|FG000|STARTED|Overall Study||21
3103209|NCT01517750|3826806|FG001|STARTED|Overall Study||19
3103210|NCT01517750|3826807|FG002|STARTED|Overall Study||21
3103211|NCT01517750|3826808|FG003|STARTED|Overall Study||19
3103212|NCT01517750|3826805|FG000|COMPLETED|Overall Study||20
3103213|NCT01517750|3826806|FG001|COMPLETED|Overall Study||17
3103214|NCT01517750|3826807|FG002|COMPLETED|Overall Study||17
3103215|NCT01517750|3826808|FG003|COMPLETED|Overall Study||18
3103216|NCT01517750|3826805|FG000|NOT COMPLETED|Overall Study||1
3103217|NCT01517750|3826806|FG001|NOT COMPLETED|Overall Study||2
3103218|NCT01517750|3826807|FG002|NOT COMPLETED|Overall Study||4
3103219|NCT01517750|3826808|FG003|NOT COMPLETED|Overall Study||1
3135474|NCT01707381|3860541|FG001|NOT COMPLETED|Period 2||0
3135475|NCT01707420|3860549|FG000|STARTED|Overall Study||18
3135476|NCT01707420|3860550|FG001|STARTED|Overall Study||18
3135477|NCT01707420|3860549|FG000|COMPLETED|Overall Study||18
3291829|NCT02852967|4025928|FG003|Completed Period 1: Double-blind|Overall Study||16
3135478|NCT01707420|3860550|FG001|COMPLETED|Overall Study||18
3135479|NCT01707420|3860549|FG000|NOT COMPLETED|Overall Study||0
3103220|NCT01517867|3826824|FG000|STARTED|Overall Study||81
3103221|NCT01517867|3826825|FG001|STARTED|Overall Study||80
3103222|NCT01517867|3826824|FG000|COMPLETED|Overall Study||18
3103223|NCT01517867|3826825|FG001|COMPLETED|Overall Study||15
3103224|NCT01517867|3826824|FG000|NOT COMPLETED|Overall Study||63
3103225|NCT01517867|3826825|FG001|NOT COMPLETED|Overall Study||65
3103226|NCT01517893|3826833|FG000|STARTED|Overall Study||8
3103227|NCT01517893|3826834|FG001|STARTED|Overall Study||7
3103228|NCT01517893|3826833|FG000|COMPLETED|Overall Study||5
3103229|NCT01517893|3826834|FG001|COMPLETED|Overall Study||7
3103230|NCT01517893|3826833|FG000|NOT COMPLETED|Overall Study||3
3103231|NCT01517893|3826834|FG001|NOT COMPLETED|Overall Study||0
3103232|NCT01517984|3826843|FG000|STARTED|Overall Study||5
3103233|NCT01517984|3826844|FG001|STARTED|Overall Study||26
3103234|NCT01517984|3826845|FG002|STARTED|Overall Study||14
3103235|NCT01517984|3826846|FG003|STARTED|Overall Study||7
3103236|NCT01517984|3826843|FG000|COMPLETED|Overall Study||0
3103237|NCT01517984|3826844|FG001|COMPLETED|Overall Study||3
3103238|NCT01517984|3826845|FG002|COMPLETED|Overall Study||10
3103239|NCT01517984|3826846|FG003|COMPLETED|Overall Study||6
3103240|NCT01517984|3826843|FG000|NOT COMPLETED|Overall Study||5
3103241|NCT01517984|3826844|FG001|NOT COMPLETED|Overall Study||23
3103242|NCT01517984|3826845|FG002|NOT COMPLETED|Overall Study||4
3103243|NCT01517984|3826846|FG003|NOT COMPLETED|Overall Study||1
3103244|NCT01518153|3826853|FG000|STARTED|Stem Cell Transplant||16
3103245|NCT01518153|3826854|FG001|STARTED|Stem Cell Transplant||0
3103246|NCT01518153|3826855|FG002|STARTED|Stem Cell Transplant||0
3103247|NCT01518153|3826853|FG000|COMPLETED|Stem Cell Transplant||7
3103248|NCT01518153|3826854|FG001|COMPLETED|Stem Cell Transplant||0
3103249|NCT01518153|3826855|FG002|COMPLETED|Stem Cell Transplant||0
3103250|NCT01518153|3826853|FG000|NOT COMPLETED|Stem Cell Transplant||9
3103251|NCT01518153|3826854|FG001|NOT COMPLETED|Stem Cell Transplant||0
3103252|NCT01518153|3826855|FG002|NOT COMPLETED|Stem Cell Transplant||0
3103253|NCT01518153|3826853|FG000|STARTED|Donor Lymphocyte Infusion||0
3103254|NCT01518153|3826854|FG001|STARTED|Donor Lymphocyte Infusion||3
3103255|NCT01518153|3826855|FG002|STARTED|Donor Lymphocyte Infusion||4
3103256|NCT01518153|3826853|FG000|COMPLETED|Donor Lymphocyte Infusion||0
3103257|NCT01518153|3826854|FG001|COMPLETED|Donor Lymphocyte Infusion||1
3103258|NCT01518153|3826855|FG002|COMPLETED|Donor Lymphocyte Infusion||3
3103259|NCT01518153|3826853|FG000|NOT COMPLETED|Donor Lymphocyte Infusion||0
3103260|NCT01518153|3826854|FG001|NOT COMPLETED|Donor Lymphocyte Infusion||2
3103261|NCT01518153|3826855|FG002|NOT COMPLETED|Donor Lymphocyte Infusion||1
3103262|NCT01518192|3826866|FG000|STARTED|Overall Study||145
3103263|NCT01518192|3826867|FG001|STARTED|Overall Study||140
3103264|NCT01518192|3826868|FG002|STARTED|Overall Study||259
3103265|NCT01518192|3826866|FG000|COMPLETED|Overall Study||116
3103266|NCT01518192|3826867|FG001|COMPLETED|Overall Study||114
3103267|NCT01518192|3826868|FG002|COMPLETED|Overall Study||224
3103268|NCT01518192|3826866|FG000|NOT COMPLETED|Overall Study||29
3103269|NCT01518192|3826867|FG001|NOT COMPLETED|Overall Study||26
3103270|NCT01518192|3826868|FG002|NOT COMPLETED|Overall Study||35
3103271|NCT01518244|3826882|FG000|STARTED|Overall Study||50
3103272|NCT01518244|3826882|FG000|COMPLETED|Overall Study||47
3103273|NCT01518244|3826882|FG000|NOT COMPLETED|Overall Study||3
3103274|NCT01518257|3826888|FG000|STARTED|Overall Study||61
3103275|NCT01518257|3826889|FG001|STARTED|Overall Study||60
3103276|NCT01518257|3826888|FG000|COMPLETED|Overall Study||59
3103277|NCT01518257|3826889|FG001|COMPLETED|Overall Study||60
3103278|NCT01518257|3826888|FG000|NOT COMPLETED|Overall Study||2
3103279|NCT01518257|3826889|FG001|NOT COMPLETED|Overall Study||0
3103280|NCT01518270|3826895|FG000|STARTED|Overall Study||179
3103281|NCT01518270|3826895|FG000|COMPLETED|Overall Study||179
3103282|NCT01518270|3826895|FG000|NOT COMPLETED|Overall Study||0
3103283|NCT01518309|3826899|FG000|STARTED|Overall Study||39
3103284|NCT01518309|3826899|FG000|COMPLETED|Overall Study||0
3103285|NCT01518309|3826899|FG000|NOT COMPLETED|Overall Study||39
3103286|NCT01518322|3826903|FG000|STARTED|Overall Study||235
3103287|NCT01518322|3826903|FG000|COMPLETED|Overall Study||222
3103288|NCT01518322|3826903|FG000|NOT COMPLETED|Overall Study||13
3103289|NCT01518374|3826912|FG000|STARTED|Overall Study||1768
3103290|NCT01518374|3826912|FG000|COMPLETED|Overall Study||1761
3103291|NCT01518374|3826912|FG000|NOT COMPLETED|Overall Study||7
3103292|NCT01518530|3826916|FG000|STARTED|Active Treatment Period||10
3103293|NCT01518530|3826916|FG000|COMPLETED|Active Treatment Period||9
3103294|NCT01518530|3826916|FG000|NOT COMPLETED|Active Treatment Period||1
3103295|NCT01518530|3826916|FG000|STARTED|Post-Treatment Follow-up||9
3103296|NCT01518530|3826916|FG000|COMPLETED|Post-Treatment Follow-up||9
3103297|NCT01518530|3826916|FG000|NOT COMPLETED|Post-Treatment Follow-up||0
3103298|NCT01518699|3826926|FG000|STARTED|Period 1||10
3103299|NCT01518699|3826927|FG001|STARTED|Period 1||9
3103300|NCT01518699|3826928|FG002|STARTED|Period 1||9
3103301|NCT01518699|3826929|FG003|STARTED|Period 1||10
3103302|NCT01518699|3826930|FG004|STARTED|Period 1||10
3103303|NCT01518699|3826931|FG005|STARTED|Period 1||9
3103304|NCT01518699|3826926|FG000|COMPLETED|Period 1||10
3103305|NCT01518699|3826927|FG001|COMPLETED|Period 1||9
3103306|NCT01518699|3826928|FG002|COMPLETED|Period 1||9
3103307|NCT01518699|3826929|FG003|COMPLETED|Period 1||10
3103308|NCT01518699|3826930|FG004|COMPLETED|Period 1||10
3103309|NCT01518699|3826931|FG005|COMPLETED|Period 1||9
3103310|NCT01518699|3826926|FG000|NOT COMPLETED|Period 1||0
3103311|NCT01518699|3826927|FG001|NOT COMPLETED|Period 1||0
3103312|NCT01518699|3826928|FG002|NOT COMPLETED|Period 1||0
3103313|NCT01518699|3826929|FG003|NOT COMPLETED|Period 1||0
3103314|NCT01518699|3826930|FG004|NOT COMPLETED|Period 1||0
3103315|NCT01518699|3826931|FG005|NOT COMPLETED|Period 1||0
3103316|NCT01518699|3826926|FG000|STARTED|Period 2||10
3103317|NCT01518699|3826927|FG001|STARTED|Period 2||9
3103318|NCT01518699|3826928|FG002|STARTED|Period 2||9
3103319|NCT01518699|3826929|FG003|STARTED|Period 2||10
3103320|NCT01518699|3826930|FG004|STARTED|Period 2||10
3103321|NCT01518699|3826931|FG005|STARTED|Period 2||9
3103322|NCT01518699|3826926|FG000|COMPLETED|Period 2||8
3103323|NCT01518699|3826927|FG001|COMPLETED|Period 2||7
3103324|NCT01518699|3826928|FG002|COMPLETED|Period 2||9
3103325|NCT01518699|3826929|FG003|COMPLETED|Period 2||10
3103326|NCT01518699|3826930|FG004|COMPLETED|Period 2||10
3103327|NCT01518699|3826931|FG005|COMPLETED|Period 2||9
3103328|NCT01518699|3826926|FG000|NOT COMPLETED|Period 2||2
3103329|NCT01518699|3826927|FG001|NOT COMPLETED|Period 2||2
3103330|NCT01518699|3826928|FG002|NOT COMPLETED|Period 2||0
3103331|NCT01518699|3826929|FG003|NOT COMPLETED|Period 2||0
3103332|NCT01518699|3826930|FG004|NOT COMPLETED|Period 2||0
3103333|NCT01518699|3826931|FG005|NOT COMPLETED|Period 2||0
3103334|NCT01518699|3826926|FG000|STARTED|Period 3||8
3103335|NCT01518699|3826927|FG001|STARTED|Period 3||7
3103336|NCT01518699|3826928|FG002|STARTED|Period 3||9
3103337|NCT01518699|3826929|FG003|STARTED|Period 3||10
3103338|NCT01518699|3826930|FG004|STARTED|Period 3||10
3103339|NCT01518699|3826931|FG005|STARTED|Period 3||9
3103340|NCT01518699|3826926|FG000|COMPLETED|Period 3||8
3103341|NCT01518699|3826927|FG001|COMPLETED|Period 3||7
3103342|NCT01518699|3826928|FG002|COMPLETED|Period 3||9
3103343|NCT01518699|3826929|FG003|COMPLETED|Period 3||10
3103344|NCT01518699|3826930|FG004|COMPLETED|Period 3||10
3103345|NCT01518699|3826931|FG005|COMPLETED|Period 3||9
3103346|NCT01518699|3826926|FG000|NOT COMPLETED|Period 3||0
3103347|NCT01518699|3826927|FG001|NOT COMPLETED|Period 3||0
3103348|NCT01518699|3826928|FG002|NOT COMPLETED|Period 3||0
3103349|NCT01518699|3826929|FG003|NOT COMPLETED|Period 3||0
3103350|NCT01518699|3826930|FG004|NOT COMPLETED|Period 3||0
3103351|NCT01518699|3826931|FG005|NOT COMPLETED|Period 3||0
3103352|NCT01518868|3826939|FG000|STARTED|Overall Study||63
3103353|NCT01518868|3826940|FG001|STARTED|Overall Study||63
3103354|NCT01518868|3826939|FG000|COMPLETED|Overall Study||59
3103355|NCT01518868|3826940|FG001|COMPLETED|Overall Study||59
3103356|NCT01518868|3826939|FG000|NOT COMPLETED|Overall Study||4
3103357|NCT01518868|3826940|FG001|NOT COMPLETED|Overall Study||4
3103358|NCT01518946|3826948|FG000|STARTED|Open-label Phase||24
3103359|NCT01518946|3826949|FG001|STARTED|Open-label Phase||0
3103360|NCT01518946|3826950|FG002|STARTED|Open-label Phase||0
3103361|NCT01518946|3826948|FG000|COMPLETED|Open-label Phase||20
3103362|NCT01518946|3826949|FG001|COMPLETED|Open-label Phase||0
3103363|NCT01518946|3826950|FG002|COMPLETED|Open-label Phase||0
3103364|NCT01518946|3826948|FG000|NOT COMPLETED|Open-label Phase||4
3103365|NCT01518946|3826949|FG001|NOT COMPLETED|Open-label Phase||0
3103366|NCT01518946|3826950|FG002|NOT COMPLETED|Open-label Phase||0
3103367|NCT01518946|3826948|FG000|STARTED|Randomized Phase (First Intervention)||0
3103368|NCT01518946|3826949|FG001|STARTED|Randomized Phase (First Intervention)||10
3103369|NCT01518946|3826950|FG002|STARTED|Randomized Phase (First Intervention)||10
3103370|NCT01518946|3826948|FG000|COMPLETED|Randomized Phase (First Intervention)||0
3103371|NCT01518946|3826949|FG001|COMPLETED|Randomized Phase (First Intervention)||9
3103372|NCT01518946|3826950|FG002|COMPLETED|Randomized Phase (First Intervention)||10
3103373|NCT01518946|3826948|FG000|NOT COMPLETED|Randomized Phase (First Intervention)||0
3103374|NCT01518946|3826949|FG001|NOT COMPLETED|Randomized Phase (First Intervention)||1
3103375|NCT01518946|3826950|FG002|NOT COMPLETED|Randomized Phase (First Intervention)||0
3103376|NCT01518946|3826948|FG000|STARTED|Randomized Phase (Second Intervention)||0
3103377|NCT01518946|3826949|FG001|STARTED|Randomized Phase (Second Intervention)||9
3103378|NCT01518946|3826950|FG002|STARTED|Randomized Phase (Second Intervention)||10
3103379|NCT01518946|3826948|FG000|COMPLETED|Randomized Phase (Second Intervention)||0
3103380|NCT01518946|3826949|FG001|COMPLETED|Randomized Phase (Second Intervention)||9
3103381|NCT01518946|3826950|FG002|COMPLETED|Randomized Phase (Second Intervention)||10
3103382|NCT01518946|3826948|FG000|NOT COMPLETED|Randomized Phase (Second Intervention)||0
3103383|NCT01518946|3826949|FG001|NOT COMPLETED|Randomized Phase (Second Intervention)||0
3103384|NCT01518946|3826950|FG002|NOT COMPLETED|Randomized Phase (Second Intervention)||0
3103385|NCT01518972|3826959|FG000|STARTED|Overall Study||15
3103386|NCT01518972|3826960|FG001|STARTED|Overall Study||15
3103387|NCT01518972|3826959|FG000|COMPLETED|Overall Study||9
3103388|NCT01518972|3826960|FG001|COMPLETED|Overall Study||11
3103389|NCT01518972|3826959|FG000|NOT COMPLETED|Overall Study||6
3103390|NCT01518972|3826960|FG001|NOT COMPLETED|Overall Study||4
3103391|NCT01519063|3826968|FG000|STARTED|Overall Study||26
3103392|NCT01519063|3826969|FG001|STARTED|Overall Study||30
3103393|NCT01519063|3826968|FG000|COMPLETED|Overall Study||19
3103394|NCT01519063|3826969|FG001|COMPLETED|Overall Study||25
3103395|NCT01519063|3826968|FG000|NOT COMPLETED|Overall Study||7
3103396|NCT01519063|3826969|FG001|NOT COMPLETED|Overall Study||5
3103397|NCT01519089|3826977|FG000|STARTED|Overall Study||47
3103398|NCT01519089|3826978|FG001|STARTED|Overall Study||48
3103399|NCT01519089|3826977|FG000|Received Treatment|Overall Study||47
3103400|NCT01519089|3826978|FG001|Received Treatment|Overall Study||47
3103401|NCT01519089|3826977|FG000|COMPLETED|Overall Study||40
3103402|NCT01519089|3826978|FG001|COMPLETED|Overall Study||33
3103403|NCT01519089|3826977|FG000|NOT COMPLETED|Overall Study||7
3103404|NCT01519089|3826978|FG001|NOT COMPLETED|Overall Study||15
3103405|NCT01519167|3826988|FG000|STARTED|Overall Study||1
3103406|NCT01519167|3826989|FG001|STARTED|Overall Study||89
3103407|NCT01519167|3826988|FG000|COMPLETED|Overall Study||1
3103408|NCT01519167|3826989|FG001|COMPLETED|Overall Study||81
3103409|NCT01519167|3826988|FG000|NOT COMPLETED|Overall Study||0
3103410|NCT01519167|3826989|FG001|NOT COMPLETED|Overall Study||8
3103411|NCT01519206|3826995|FG000|STARTED|Overall Study||32
3103412|NCT01519206|3826995|FG000|COMPLETED|Overall Study||27
3103413|NCT01519206|3826995|FG000|NOT COMPLETED|Overall Study||5
3103414|NCT01519245|3827008|FG000|STARTED|Overall Study||24
3103415|NCT01519245|3827009|FG001|STARTED|Overall Study||20
3103416|NCT01519245|3827008|FG000|Received Pre-pump IV TXA|Overall Study|Two patients included in in the final analysis did not receive pre-pump IV TXA.|21
3103417|NCT01519245|3827009|FG001|Received Pre-pump IV TXA|Overall Study|All patients meeting inclusion criteria received appropriate dosing, as per protocol.|18
3103418|NCT01519245|3827008|FG000|Received Post-pump IV TXA|Overall Study|A break in protocol, dosing was given in the operating room at the surgeon's preference.|6
3103419|NCT01519245|3827009|FG001|Received Post-pump IV TXA|Overall Study|A break in protocol, dosing was given in the operating room at the surgeon's preference.|2
3103420|NCT01519245|3827008|FG000|COMPLETED|Overall Study||23
3103421|NCT01519245|3827009|FG001|COMPLETED|Overall Study||18
3103422|NCT01519245|3827008|FG000|NOT COMPLETED|Overall Study||1
3103423|NCT01519245|3827009|FG001|NOT COMPLETED|Overall Study||2
3103424|NCT01519271|3827019|FG000|STARTED|Phase 1||14
3103425|NCT01519271|3827020|FG001|STARTED|Phase 1||14
3103426|NCT01519271|3827019|FG000|COMPLETED|Phase 1||14
3103427|NCT01519271|3827020|FG001|COMPLETED|Phase 1|1 participant discontinued participation in the middle of phase 1.|13
3103428|NCT01519271|3827019|FG000|NOT COMPLETED|Phase 1||0
3103429|NCT01519271|3827020|FG001|NOT COMPLETED|Phase 1||1
3103430|NCT01519271|3827019|FG000|STARTED|Phase 2|2 participants discontinued after Phase 1|12
3103431|NCT01519271|3827020|FG001|STARTED|Phase 2||14
3103432|NCT01519271|3827019|FG000|COMPLETED|Phase 2||12
3103433|NCT01519271|3827020|FG001|COMPLETED|Phase 2||14
3103434|NCT01519271|3827019|FG000|NOT COMPLETED|Phase 2||0
3103435|NCT01519271|3827020|FG001|NOT COMPLETED|Phase 2||0
3103436|NCT01519284|3827033|FG000|STARTED|Overall Study||16
3103437|NCT01519284|3827034|FG001|STARTED|Overall Study||16
3103438|NCT01519284|3827035|FG002|STARTED|Overall Study||18
3103439|NCT01519284|3827036|FG003|STARTED|Overall Study||16
3103440|NCT01519284|3827037|FG004|STARTED|Overall Study||16
3103441|NCT01519284|3827033|FG000|COMPLETED|Overall Study||16
3103442|NCT01519284|3827034|FG001|COMPLETED|Overall Study||16
3103443|NCT01519284|3827035|FG002|COMPLETED|Overall Study||16
3103444|NCT01519284|3827036|FG003|COMPLETED|Overall Study||16
3103445|NCT01519284|3827037|FG004|COMPLETED|Overall Study||16
3103446|NCT01519284|3827033|FG000|NOT COMPLETED|Overall Study||0
3103447|NCT01519284|3827034|FG001|NOT COMPLETED|Overall Study||0
3103448|NCT01519284|3827035|FG002|NOT COMPLETED|Overall Study||2
3103449|NCT01519284|3827036|FG003|NOT COMPLETED|Overall Study||0
3103450|NCT01519284|3827037|FG004|NOT COMPLETED|Overall Study||0
3103451|NCT01519323|3827049|FG000|STARTED|Overall Study||3
3103452|NCT01519323|3827050|FG001|STARTED|Overall Study||3
3103453|NCT01519323|3827049|FG000|COMPLETED|Overall Study||0
3103454|NCT01519323|3827050|FG001|COMPLETED|Overall Study||0
3103455|NCT01519323|3827049|FG000|NOT COMPLETED|Overall Study||3
3103456|NCT01519323|3827050|FG001|NOT COMPLETED|Overall Study||3
3103457|NCT01519414|3827058|FG000|STARTED|Pre Cross-over||52
3103458|NCT01519414|3827059|FG001|STARTED|Pre Cross-over||26
3103459|NCT01519414|3827060|FG002|STARTED|Pre Cross-over||0
3103460|NCT01519414|3827058|FG000|COMPLETED|Pre Cross-over||52
3103461|NCT01519414|3827059|FG001|COMPLETED|Pre Cross-over||26
3103462|NCT01519414|3827060|FG002|COMPLETED|Pre Cross-over||0
3103463|NCT01519414|3827058|FG000|NOT COMPLETED|Pre Cross-over||0
3103464|NCT01519414|3827059|FG001|NOT COMPLETED|Pre Cross-over||0
3103465|NCT01519414|3827060|FG002|NOT COMPLETED|Pre Cross-over||0
3103466|NCT01519414|3827058|FG000|STARTED|Post Cross-over||52
3103467|NCT01519414|3827059|FG001|STARTED|Post Cross-over||14
3103468|NCT01519414|3827060|FG002|STARTED|Post Cross-over||12
3103469|NCT01519414|3827058|FG000|COMPLETED|Post Cross-over||52
3103470|NCT01519414|3827059|FG001|COMPLETED|Post Cross-over||14
3103471|NCT01519414|3827060|FG002|COMPLETED|Post Cross-over||12
3103472|NCT01519414|3827058|FG000|NOT COMPLETED|Post Cross-over||0
3103473|NCT01519414|3827059|FG001|NOT COMPLETED|Post Cross-over||0
3103474|NCT01519414|3827060|FG002|NOT COMPLETED|Post Cross-over||0
3103475|NCT01519427|3827071|FG000|STARTED|Overall Study||2
3103476|NCT01519427|3827071|FG000|COMPLETED|Overall Study||0
3103477|NCT01519427|3827071|FG000|NOT COMPLETED|Overall Study||2
3103478|NCT01519453|3827077|FG000|STARTED|Overall Study|Number of dyads (caregiver-child pairs) or 398 individuals|199
3103479|NCT01519453|3827078|FG001|STARTED|Overall Study|Number of dyads (caregiver-child pairs) or 398 individuals|199
3103480|NCT01519453|3827077|FG000|3 Month|Overall Study|Number of dyads (caregiver-child pairs) or 320 individuals|160
3103481|NCT01519453|3827078|FG001|3 Month|Overall Study|Number of dyads (caregiver-child pairs) or 362 individuals|181
3103482|NCT01519453|3827077|FG000|6 Month|Overall Study|Number of dyads (caregiver-child pairs) or 306 individuals|153
3103483|NCT01519453|3827078|FG001|6 Month|Overall Study|Number of dyads (caregiver-child pairs) or 350 individuals|175
3103484|NCT01519453|3827077|FG000|9 Month|Overall Study|Number of dyads (caregiver-child pairs) or 318 individuals|159
3103485|NCT01519453|3827078|FG001|9 Month|Overall Study|Number of dyads (caregiver-child pairs) or 332 individuals|166
3103486|NCT01519453|3827077|FG000|COMPLETED|Overall Study|Number of dyads (caregiver-child pairs) or 294 individuals|147
3103487|NCT01519453|3827078|FG001|COMPLETED|Overall Study|Number of dyads (caregiver-child pairs) or 326 individuals|163
3103488|NCT01519453|3827077|FG000|NOT COMPLETED|Overall Study||52
3103489|NCT01519453|3827078|FG001|NOT COMPLETED|Overall Study||36
3103490|NCT01519466|3827086|FG000|STARTED|Overall Study||33
3103491|NCT01519466|3827087|FG001|STARTED|Overall Study||16
3103492|NCT01519466|3827086|FG000|COMPLETED|Overall Study||33
3103493|NCT01519466|3827087|FG001|COMPLETED|Overall Study||16
3103494|NCT01519466|3827086|FG000|NOT COMPLETED|Overall Study||0
3103495|NCT01519466|3827087|FG001|NOT COMPLETED|Overall Study||0
3103496|NCT01519518|3827095|FG000|STARTED|Overall Study||914
3103497|NCT01519518|3827096|FG001|STARTED|Overall Study||915
3103498|NCT01519518|3827095|FG000|COMPLETED|Overall Study||907
3103499|NCT01519518|3827096|FG001|COMPLETED|Overall Study||905
3103500|NCT01519518|3827095|FG000|NOT COMPLETED|Overall Study||7
3103501|NCT01519518|3827096|FG001|NOT COMPLETED|Overall Study||10
3103502|NCT01519570|3827104|FG000|STARTED|Overall Study||500
3103503|NCT01519570|3827105|FG001|STARTED|Overall Study||2089
3103504|NCT01519570|3827104|FG000|COMPLETED|Overall Study||500
3103505|NCT01519570|3827105|FG001|COMPLETED|Overall Study||2089
3103506|NCT01519570|3827104|FG000|NOT COMPLETED|Overall Study||0
3103507|NCT01519570|3827105|FG001|NOT COMPLETED|Overall Study||0
3103508|NCT01519635|3827113|FG000|STARTED|Overall Study||12
3103509|NCT01519635|3827114|FG001|STARTED|Overall Study||12
3103510|NCT01519635|3827113|FG000|COMPLETED|Overall Study||11
3103511|NCT01519635|3827114|FG001|COMPLETED|Overall Study||9
3103512|NCT01519635|3827113|FG000|NOT COMPLETED|Overall Study||1
3103513|NCT01519635|3827114|FG001|NOT COMPLETED|Overall Study||3
3103514|NCT01519648|3827122|FG000|STARTED|Overall Study||502
3103515|NCT01519648|3827123|FG001|STARTED|Overall Study||306
3103516|NCT01519648|3827122|FG000|COMPLETED|Overall Study||502
3103517|NCT01519648|3827123|FG001|COMPLETED|Overall Study||306
3103518|NCT01519648|3827122|FG000|NOT COMPLETED|Overall Study||0
3103519|NCT01519648|3827123|FG001|NOT COMPLETED|Overall Study||0
3103520|NCT01519661|3827129|FG000|STARTED|Overall Study||157
3103521|NCT01519661|3827129|FG000|COMPLETED|Overall Study||96
3103522|NCT01519661|3827129|FG000|NOT COMPLETED|Overall Study||61
3103523|NCT01519674|3827137|FG000|STARTED|Overall Study||194
3103524|NCT01519674|3827138|FG001|STARTED|Overall Study||195
3103525|NCT01519674|3827139|FG002|STARTED|Overall Study||193
3103526|NCT01519674|3827137|FG000|Exposed|Overall Study||192
3103527|NCT01519674|3827138|FG001|Exposed|Overall Study||193
3103528|NCT01519674|3827139|FG002|Exposed|Overall Study||190
3103529|NCT01519674|3827137|FG000|COMPLETED|Overall Study||173
3103530|NCT01519674|3827138|FG001|COMPLETED|Overall Study||182
3291830|NCT02852967|4025929|FG004|Completed Period 1: Double-blind|Overall Study||10
3291831|NCT02852967|4025925|FG000|Completed Period 2: Open-label|Overall Study||11
3291832|NCT02852967|4025926|FG001|Completed Period 2: Open-label|Overall Study||8
3291833|NCT02852967|4025927|FG002|Completed Period 2: Open-label|Overall Study||13
3291834|NCT02852967|4025928|FG003|Completed Period 2: Open-label|Overall Study||11
3291835|NCT02852967|4025929|FG004|Completed Period 2: Open-label|Overall Study||14
3103531|NCT01519674|3827139|FG002|COMPLETED|Overall Study||181
3103532|NCT01519674|3827137|FG000|NOT COMPLETED|Overall Study||21
3103533|NCT01519674|3827138|FG001|NOT COMPLETED|Overall Study||13
3103534|NCT01519674|3827139|FG002|NOT COMPLETED|Overall Study||12
3103535|NCT01519700|3827151|FG000|STARTED|Overall Study||54
3103536|NCT01519700|3827152|FG001|STARTED|Overall Study||55
3103537|NCT01519700|3827153|FG002|STARTED|Overall Study||55
3103538|NCT01519700|3827154|FG003|STARTED|Overall Study||54
3103539|NCT01519700|3827151|FG000|Treated Cycle 1 EP2006|Overall Study||53
3103540|NCT01519700|3827152|FG001|Treated Cycle 1 EP2006|Overall Study||54
3103541|NCT01519700|3827153|FG002|Treated Cycle 1 EP2006|Overall Study||0
3103542|NCT01519700|3827154|FG003|Treated Cycle 1 EP2006|Overall Study||0
3103543|NCT01519700|3827151|FG000|Treated Cycle 1 Neupogen|Overall Study||0
3103544|NCT01519700|3827152|FG001|Treated Cycle 1 Neupogen|Overall Study||0
3103545|NCT01519700|3827153|FG002|Treated Cycle 1 Neupogen|Overall Study||55
3103546|NCT01519700|3827154|FG003|Treated Cycle 1 Neupogen|Overall Study||52
3103547|NCT01519700|3827151|FG000|Treated Cycle 2 EP2006|Overall Study||52
3103548|NCT01519700|3827152|FG001|Treated Cycle 2 EP2006|Overall Study||0
3103549|NCT01519700|3827153|FG002|Treated Cycle 2 EP2006|Overall Study||55
3103550|NCT01519700|3827154|FG003|Treated Cycle 2 EP2006|Overall Study||0
3103551|NCT01519700|3827151|FG000|Treated Cycle 2 Neupogen|Overall Study||0
3103552|NCT01519700|3827152|FG001|Treated Cycle 2 Neupogen|Overall Study||52
3103553|NCT01519700|3827153|FG002|Treated Cycle 2 Neupogen|Overall Study||0
3103554|NCT01519700|3827154|FG003|Treated Cycle 2 Neupogen|Overall Study||51
3103555|NCT01519700|3827151|FG000|Treated Cycle 3 EP2006|Overall Study||51
3103556|NCT01519700|3827152|FG001|Treated Cycle 3 EP2006|Overall Study||51
3103557|NCT01519700|3827153|FG002|Treated Cycle 3 EP2006|Overall Study||0
3103558|NCT01519700|3827154|FG003|Treated Cycle 3 EP2006|Overall Study||0
3103559|NCT01519700|3827151|FG000|Treated Cycle 3 Neupogen|Overall Study||0
3103560|NCT01519700|3827152|FG001|Treated Cycle 3 Neupogen|Overall Study||0
3103561|NCT01519700|3827153|FG002|Treated Cycle 3 Neupogen|Overall Study||54
3103562|NCT01519700|3827154|FG003|Treated Cycle 3 Neupogen|Overall Study||51
3103563|NCT01519700|3827151|FG000|Treated Cycle 4 EP2006|Overall Study||51
3103564|NCT01519700|3827152|FG001|Treated Cycle 4 EP2006|Overall Study||0
3103565|NCT01519700|3827153|FG002|Treated Cycle 4 EP2006|Overall Study||50
3103566|NCT01519700|3827154|FG003|Treated Cycle 4 EP2006|Overall Study||0
3103567|NCT01519700|3827151|FG000|Treated Cycle 4 Neupogen|Overall Study||0
3103568|NCT01519700|3827152|FG001|Treated Cycle 4 Neupogen|Overall Study||51
3103569|NCT01519700|3827153|FG002|Treated Cycle 4 Neupogen|Overall Study||0
3103570|NCT01519700|3827154|FG003|Treated Cycle 4 Neupogen|Overall Study||50
3103571|NCT01519700|3827151|FG000|Treated Cycle 5 EP2006|Overall Study||46
3103572|NCT01519700|3827152|FG001|Treated Cycle 5 EP2006|Overall Study||49
3103573|NCT01519700|3827153|FG002|Treated Cycle 5 EP2006|Overall Study||0
3103574|NCT01519700|3827154|FG003|Treated Cycle 5 EP2006|Overall Study||0
3103575|NCT01519700|3827151|FG000|Treated Cycle 5 Neupogen|Overall Study||0
3103576|NCT01519700|3827152|FG001|Treated Cycle 5 Neupogen|Overall Study||0
3103577|NCT01519700|3827153|FG002|Treated Cycle 5 Neupogen|Overall Study||48
3103578|NCT01519700|3827154|FG003|Treated Cycle 5 Neupogen|Overall Study||50
3103579|NCT01519700|3827151|FG000|Treated Cycle 6 EP2006|Overall Study||45
3103580|NCT01519700|3827152|FG001|Treated Cycle 6 EP2006|Overall Study||0
3103581|NCT01519700|3827153|FG002|Treated Cycle 6 EP2006|Overall Study||48
3103582|NCT01519700|3827154|FG003|Treated Cycle 6 EP2006|Overall Study||0
3103583|NCT01519700|3827151|FG000|Treated Cycle 6 Neupogen|Overall Study||0
3103584|NCT01519700|3827152|FG001|Treated Cycle 6 Neupogen|Overall Study||49
3103585|NCT01519700|3827153|FG002|Treated Cycle 6 Neupogen|Overall Study||0
3103586|NCT01519700|3827154|FG003|Treated Cycle 6 Neupogen|Overall Study||49
3291836|NCT02852967|4025925|FG000|COMPLETED|Overall Study||9
3291837|NCT02852967|4025926|FG001|COMPLETED|Overall Study||6
3291838|NCT02852967|4025927|FG002|COMPLETED|Overall Study||9
3291839|NCT02852967|4025928|FG003|COMPLETED|Overall Study||4
3291840|NCT02852967|4025929|FG004|COMPLETED|Overall Study||2
3291841|NCT02852967|4025925|FG000|NOT COMPLETED|Overall Study||14
3291842|NCT02852967|4025926|FG001|NOT COMPLETED|Overall Study||16
3291843|NCT02852967|4025927|FG002|NOT COMPLETED|Overall Study||12
3291844|NCT02852967|4025928|FG003|NOT COMPLETED|Overall Study||22
3291845|NCT02852967|4025929|FG004|NOT COMPLETED|Overall Study||16
3291846|NCT02853032|4025951|FG000|STARTED|Overall Study||60
3291847|NCT02853032|4025952|FG001|STARTED|Overall Study||59
3291848|NCT02853032|4025951|FG000|COMPLETED|Overall Study|"Evaluable = 10 or more irTMS sessions Completers = 15 or more irTMS sessions"|51
3291849|NCT02853032|4025952|FG001|COMPLETED|Overall Study|"Evaluable = 10 or more irTMS sessions Completers = 15 or more irTMS sessions"|56
3291850|NCT02853032|4025951|FG000|NOT COMPLETED|Overall Study||9
3291851|NCT02853032|4025952|FG001|NOT COMPLETED|Overall Study||3
3291852|NCT02853123|4025960|FG000|STARTED|Treatment Period 1||52
3291853|NCT02853123|4025961|FG001|STARTED|Treatment Period 1||54
3291854|NCT02853123|4025960|FG000|COMPLETED|Treatment Period 1||52
3291855|NCT02853123|4025961|FG001|COMPLETED|Treatment Period 1||51
3291856|NCT02853123|4025960|FG000|NOT COMPLETED|Treatment Period 1||0
3291857|NCT02853123|4025961|FG001|NOT COMPLETED|Treatment Period 1||3
3291858|NCT02853123|4025960|FG000|STARTED|Washout Period||52
3291859|NCT02853123|4025961|FG001|STARTED|Washout Period||51
3291860|NCT02853123|4025960|FG000|COMPLETED|Washout Period||51
3291861|NCT02853123|4025961|FG001|COMPLETED|Washout Period||48
3291862|NCT02853123|4025960|FG000|NOT COMPLETED|Washout Period||1
3291863|NCT02853123|4025961|FG001|NOT COMPLETED|Washout Period||3
3291864|NCT02853123|4025960|FG000|STARTED|Treatment Period 2||51
3291865|NCT02853123|4025961|FG001|STARTED|Treatment Period 2||48
3291866|NCT02853123|4025960|FG000|COMPLETED|Treatment Period 2||51
3291867|NCT02853123|4025961|FG001|COMPLETED|Treatment Period 2||48
3103587|NCT01519700|3827151|FG000|COMPLETED|Overall Study||45
3103588|NCT01519700|3827152|FG001|COMPLETED|Overall Study||49
3103589|NCT01519700|3827153|FG002|COMPLETED|Overall Study||48
3103590|NCT01519700|3827154|FG003|COMPLETED|Overall Study||47
3103591|NCT01519700|3827151|FG000|NOT COMPLETED|Overall Study||9
3103592|NCT01519700|3827152|FG001|NOT COMPLETED|Overall Study||6
3103593|NCT01519700|3827153|FG002|NOT COMPLETED|Overall Study||7
3103594|NCT01519700|3827154|FG003|NOT COMPLETED|Overall Study||7
3103595|NCT01519713|3827173|FG000|STARTED|Overall Study||194
3103596|NCT01519713|3827174|FG001|STARTED|Overall Study||2
3103597|NCT01519713|3827175|FG002|STARTED|Overall Study||4
3103598|NCT01519713|3827173|FG000|COMPLETED|Overall Study||194
3103599|NCT01519713|3827174|FG001|COMPLETED|Overall Study||2
3103600|NCT01519713|3827175|FG002|COMPLETED|Overall Study||4
3103601|NCT01519713|3827173|FG000|NOT COMPLETED|Overall Study||0
3103602|NCT01519713|3827174|FG001|NOT COMPLETED|Overall Study||0
3103603|NCT01519713|3827175|FG002|NOT COMPLETED|Overall Study||0
3103604|NCT01519765|3827185|FG000|STARTED|Overall Study||37
3103605|NCT01519765|3827186|FG001|STARTED|Overall Study||36
3103606|NCT01519765|3827185|FG000|COMPLETED|Overall Study||34
3103607|NCT01519765|3827186|FG001|COMPLETED|Overall Study||34
3103608|NCT01519765|3827185|FG000|NOT COMPLETED|Overall Study||3
3103609|NCT01519765|3827186|FG001|NOT COMPLETED|Overall Study||2
3103610|NCT01519778|3827193|FG000|STARTED|Overall Study||200
3103611|NCT01519778|3827193|FG000|COMPLETED|Overall Study||186
3103612|NCT01519778|3827193|FG000|NOT COMPLETED|Overall Study||14
3103613|NCT01519791|3827199|FG000|STARTED|Overall Study||219
3103614|NCT01519791|3827200|FG001|STARTED|Overall Study||660
3103615|NCT01519791|3827199|FG000|Completed Week 52|Overall Study||143
3103616|NCT01519791|3827200|FG001|Completed Week 52|Overall Study||500
3103617|NCT01519791|3827199|FG000|COMPLETED|Overall Study||67
3291868|NCT02853123|4025960|FG000|NOT COMPLETED|Treatment Period 2||0
3291869|NCT02853123|4025961|FG001|NOT COMPLETED|Treatment Period 2||0
3291870|NCT02853305|4025971|FG000|STARTED|Overall Study||351
3103618|NCT01519791|3827200|FG001|COMPLETED|Overall Study||292
3103619|NCT01519791|3827199|FG000|NOT COMPLETED|Overall Study||152
3103620|NCT01519791|3827200|FG001|NOT COMPLETED|Overall Study||368
3103621|NCT01519817|3827208|FG000|STARTED|Overall Study||4
3103622|NCT01519817|3827209|FG001|STARTED|Overall Study||3
3103623|NCT01519817|3827210|FG002|STARTED|Overall Study||16
3103624|NCT01519817|3827211|FG003|STARTED|Overall Study||11
3103625|NCT01519817|3827208|FG000|COMPLETED|Overall Study||3
3103626|NCT01519817|3827209|FG001|COMPLETED|Overall Study||3
3103627|NCT01519817|3827210|FG002|COMPLETED|Overall Study||16
3103628|NCT01519817|3827211|FG003|COMPLETED|Overall Study||10
3103629|NCT01519817|3827208|FG000|NOT COMPLETED|Overall Study||1
3103630|NCT01519817|3827209|FG001|NOT COMPLETED|Overall Study||0
3103631|NCT01519817|3827210|FG002|NOT COMPLETED|Overall Study||0
3103632|NCT01519817|3827211|FG003|NOT COMPLETED|Overall Study||1
3103633|NCT01519869|3827221|FG000|STARTED|Overall Study||28
3103634|NCT01519869|3827221|FG000|COMPLETED|Overall Study||27
3103635|NCT01519869|3827221|FG000|NOT COMPLETED|Overall Study||1
3103636|NCT01519882|3827227|FG000|STARTED|Overall Study||1
3103637|NCT01519882|3827228|FG001|STARTED|Overall Study||0
3103638|NCT01519882|3827227|FG000|COMPLETED|Overall Study||1
3103639|NCT01519882|3827228|FG001|COMPLETED|Overall Study||0
3103640|NCT01519882|3827227|FG000|NOT COMPLETED|Overall Study||0
3103641|NCT01519882|3827228|FG001|NOT COMPLETED|Overall Study||0
3103642|NCT01519921|3827236|FG000|STARTED|Overall Study||86
3103643|NCT01519921|3827237|FG001|STARTED|Overall Study||64
3103644|NCT01519921|3827236|FG000|COMPLETED|Overall Study||65
3103645|NCT01519921|3827237|FG001|COMPLETED|Overall Study||49
3103646|NCT01519921|3827236|FG000|NOT COMPLETED|Overall Study||21
3103647|NCT01519921|3827237|FG001|NOT COMPLETED|Overall Study||15
3103648|NCT01519934|3827243|FG000|STARTED|Overall Study||48
3103649|NCT01519934|3827243|FG000|COMPLETED|Overall Study||45
3103650|NCT01519934|3827243|FG000|NOT COMPLETED|Overall Study||3
3103651|NCT01519947|3827251|FG000|STARTED|Overall Study||19
3103652|NCT01519947|3827252|FG001|STARTED|Overall Study||11
3103653|NCT01519947|3827253|FG002|STARTED|Overall Study||15
3103654|NCT01519947|3827254|FG003|STARTED|Overall Study||42
3103655|NCT01519947|3827251|FG000|COMPLETED|Overall Study||17
3103656|NCT01519947|3827252|FG001|COMPLETED|Overall Study||7
3103657|NCT01519947|3827253|FG002|COMPLETED|Overall Study||8
3103658|NCT01519947|3827254|FG003|COMPLETED|Overall Study||34
3103659|NCT01519947|3827251|FG000|NOT COMPLETED|Overall Study||2
3103660|NCT01519947|3827252|FG001|NOT COMPLETED|Overall Study||4
3103661|NCT01519947|3827253|FG002|NOT COMPLETED|Overall Study||7
3103662|NCT01519947|3827254|FG003|NOT COMPLETED|Overall Study||8
3103663|NCT01520038|3827264|FG000|STARTED|Overall Study||2
3103664|NCT01520038|3827264|FG000|COMPLETED|Overall Study||1
3103665|NCT01520038|3827264|FG000|NOT COMPLETED|Overall Study||1
3103666|NCT01520207|3827270|FG000|STARTED|Overall Study||27
3103667|NCT01520207|3827271|FG001|STARTED|Overall Study||25
3103668|NCT01520207|3827270|FG000|COMPLETED|Overall Study||25
3103669|NCT01520207|3827271|FG001|COMPLETED|Overall Study||25
3103670|NCT01520207|3827270|FG000|NOT COMPLETED|Overall Study||2
3103671|NCT01520207|3827271|FG001|NOT COMPLETED|Overall Study||0
3103672|NCT01520324|3827277|FG000|STARTED|Overall Study||53
3103673|NCT01520324|3827277|FG000|COMPLETED|Overall Study||52
3103674|NCT01520324|3827277|FG000|NOT COMPLETED|Overall Study||1
3103675|NCT01520363|3827283|FG000|STARTED|Overall Study||26
3103676|NCT01520363|3827284|FG001|STARTED|Overall Study||26
3103677|NCT01520363|3827283|FG000|COMPLETED|Overall Study||24
3103678|NCT01520363|3827284|FG001|COMPLETED|Overall Study||26
3103679|NCT01520363|3827283|FG000|NOT COMPLETED|Overall Study||2
3103680|NCT01520363|3827284|FG001|NOT COMPLETED|Overall Study||0
3103681|NCT01520402|3827314|FG000|STARTED|Overall Study||35
3103682|NCT01520402|3827314|FG000|COMPLETED|Overall Study||30
3103683|NCT01520402|3827314|FG000|NOT COMPLETED|Overall Study||5
3103684|NCT01520454|3827329|FG000|STARTED|Overall Study||9
3103685|NCT01520454|3827330|FG001|STARTED|Overall Study||6
3103686|NCT01520454|3827331|FG002|STARTED|Overall Study||5
3103687|NCT01520454|3827332|FG003|STARTED|Overall Study||6
3103688|NCT01520454|3827329|FG000|COMPLETED|Overall Study||9
3103689|NCT01520454|3827330|FG001|COMPLETED|Overall Study||6
3103690|NCT01520454|3827331|FG002|COMPLETED|Overall Study||5
3103691|NCT01520454|3827332|FG003|COMPLETED|Overall Study||6
3103692|NCT01520454|3827329|FG000|NOT COMPLETED|Overall Study||0
3103693|NCT01520454|3827330|FG001|NOT COMPLETED|Overall Study||0
3103694|NCT01520454|3827331|FG002|NOT COMPLETED|Overall Study||0
3103695|NCT01520454|3827332|FG003|NOT COMPLETED|Overall Study||0
3103696|NCT01520506|3827345|FG000|STARTED|Overall Study||50
3103697|NCT01520506|3827345|FG000|COMPLETED|Overall Study||44
3103698|NCT01520506|3827345|FG000|NOT COMPLETED|Overall Study||6
3103699|NCT01520519|3827349|FG000|STARTED|Overall Study||40
3103700|NCT01520519|3827349|FG000|COMPLETED|Overall Study||40
3103701|NCT01520519|3827349|FG000|NOT COMPLETED|Overall Study||0
3103702|NCT01520532|3827353|FG000|STARTED|Overall Study|Subjects who underwent an ablation and had post-procedure MRI|60
3103703|NCT01520532|3827353|FG000|COMPLETED|Overall Study||60
3103704|NCT01520532|3827353|FG000|NOT COMPLETED|Overall Study||0
3103705|NCT01520558|3827360|FG000|STARTED|Overall Study||3
3103706|NCT01520558|3827361|FG001|STARTED|Overall Study||3
3103707|NCT01520558|3827362|FG002|STARTED|Overall Study||6
3103708|NCT01520558|3827360|FG000|COMPLETED|Overall Study||1
3103709|NCT01520558|3827361|FG001|COMPLETED|Overall Study||1
3103710|NCT01520558|3827362|FG002|COMPLETED|Overall Study||3
3103711|NCT01520558|3827360|FG000|NOT COMPLETED|Overall Study||2
3103712|NCT01520558|3827361|FG001|NOT COMPLETED|Overall Study||2
3103713|NCT01520558|3827362|FG002|NOT COMPLETED|Overall Study||3
3103714|NCT01520688|3827370|FG000|STARTED|Overall Study||4
3103715|NCT01520688|3827371|FG001|STARTED|Overall Study||4
3103716|NCT01520688|3827372|FG002|STARTED|Overall Study||4
3103717|NCT01520688|3827373|FG003|STARTED|Overall Study||5
3103718|NCT01520688|3827374|FG004|STARTED|Overall Study||5
3103719|NCT01520688|3827375|FG005|STARTED|Overall Study||5
3103720|NCT01520688|3827376|FG006|STARTED|Overall Study||5
3103721|NCT01520688|3827370|FG000|COMPLETED|Overall Study||4
3103722|NCT01520688|3827371|FG001|COMPLETED|Overall Study||2
3103723|NCT01520688|3827372|FG002|COMPLETED|Overall Study||4
3103724|NCT01520688|3827373|FG003|COMPLETED|Overall Study||4
3103725|NCT01520688|3827374|FG004|COMPLETED|Overall Study||4
3103726|NCT01520688|3827375|FG005|COMPLETED|Overall Study||5
3103727|NCT01520688|3827376|FG006|COMPLETED|Overall Study||0
3103728|NCT01520688|3827370|FG000|NOT COMPLETED|Overall Study||0
3103729|NCT01520688|3827371|FG001|NOT COMPLETED|Overall Study||2
3103730|NCT01520688|3827372|FG002|NOT COMPLETED|Overall Study||0
3103731|NCT01520688|3827373|FG003|NOT COMPLETED|Overall Study||1
3103732|NCT01520688|3827374|FG004|NOT COMPLETED|Overall Study||1
3103733|NCT01520688|3827375|FG005|NOT COMPLETED|Overall Study||0
3103734|NCT01520688|3827376|FG006|NOT COMPLETED|Overall Study||5
3103735|NCT01520727|3827393|FG000|STARTED|Overall Study||6
3103736|NCT01520727|3827394|FG001|STARTED|Overall Study||6
3103737|NCT01520727|3827395|FG002|STARTED|Overall Study||6
3103738|NCT01520727|3827396|FG003|STARTED|Overall Study||6
3103739|NCT01520727|3827397|FG004|STARTED|Overall Study||6
3103740|NCT01520727|3827398|FG005|STARTED|Overall Study||6
3103741|NCT01520727|3827399|FG006|STARTED|Overall Study||6
3103742|NCT01520727|3827400|FG007|STARTED|Overall Study||6
3103743|NCT01520727|3827401|FG008|STARTED|Overall Study||16
3103744|NCT01520727|3827393|FG000|COMPLETED|Overall Study||6
3103745|NCT01520727|3827394|FG001|COMPLETED|Overall Study||6
3103746|NCT01520727|3827395|FG002|COMPLETED|Overall Study||6
3103747|NCT01520727|3827396|FG003|COMPLETED|Overall Study||6
3103748|NCT01520727|3827397|FG004|COMPLETED|Overall Study||6
3103749|NCT01520727|3827398|FG005|COMPLETED|Overall Study||6
3103750|NCT01520727|3827399|FG006|COMPLETED|Overall Study||6
3103751|NCT01520727|3827400|FG007|COMPLETED|Overall Study||6
3103752|NCT01520727|3827401|FG008|COMPLETED|Overall Study||16
3103753|NCT01520727|3827393|FG000|NOT COMPLETED|Overall Study||0
3103754|NCT01520727|3827394|FG001|NOT COMPLETED|Overall Study||0
3103755|NCT01520727|3827395|FG002|NOT COMPLETED|Overall Study||0
3103756|NCT01520727|3827396|FG003|NOT COMPLETED|Overall Study||0
3103757|NCT01520727|3827397|FG004|NOT COMPLETED|Overall Study||0
3103758|NCT01520727|3827398|FG005|NOT COMPLETED|Overall Study||0
3103759|NCT01520727|3827399|FG006|NOT COMPLETED|Overall Study||0
3103760|NCT01520727|3827400|FG007|NOT COMPLETED|Overall Study||0
3103761|NCT01520727|3827401|FG008|NOT COMPLETED|Overall Study||0
3103762|NCT01520870|3827421|FG000|STARTED|Overall Study||49
3103763|NCT01520870|3827421|FG000|COMPLETED|Overall Study||47
3103764|NCT01520870|3827421|FG000|NOT COMPLETED|Overall Study||2
3103765|NCT01520909|3827427|FG000|STARTED|Part 1 (Randomized Period)||29
3103766|NCT01520909|3827428|FG001|STARTED|Part 1 (Randomized Period)||63
3103767|NCT01520909|3827429|FG002|STARTED|Part 1 (Randomized Period)||0
3103768|NCT01520909|3827427|FG000|COMPLETED|Part 1 (Randomized Period)||28
3103769|NCT01520909|3827428|FG001|COMPLETED|Part 1 (Randomized Period)||61
3103770|NCT01520909|3827429|FG002|COMPLETED|Part 1 (Randomized Period)||0
3103771|NCT01520909|3827427|FG000|NOT COMPLETED|Part 1 (Randomized Period)||1
3103772|NCT01520909|3827428|FG001|NOT COMPLETED|Part 1 (Randomized Period)||2
3103773|NCT01520909|3827429|FG002|NOT COMPLETED|Part 1 (Randomized Period)||0
3103774|NCT01520909|3827427|FG000|STARTED|Part 2 (Open-Label Period)-Eltrombopag||0
3103775|NCT01520909|3827428|FG001|STARTED|Part 2 (Open-Label Period)-Eltrombopag||0
3103776|NCT01520909|3827429|FG002|STARTED|Part 2 (Open-Label Period)-Eltrombopag|Two participants that completed Part 1 did not start Part 2 because of lack of efficacy.|87
3103777|NCT01520909|3827427|FG000|COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||0
3103778|NCT01520909|3827428|FG001|COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||0
3103779|NCT01520909|3827429|FG002|COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||80
3103780|NCT01520909|3827427|FG000|NOT COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||0
3103781|NCT01520909|3827428|FG001|NOT COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||0
3103782|NCT01520909|3827429|FG002|NOT COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||7
3103783|NCT01520922|3827451|FG000|STARTED|Treatment Phase||44
3103784|NCT01520922|3827452|FG001|STARTED|Treatment Phase||53
3103785|NCT01520922|3827451|FG000|COMPLETED|Treatment Phase|Completed 6 Cycles of Study Treatment|39
3103786|NCT01520922|3827452|FG001|COMPLETED|Treatment Phase|Completed 6 Cycles of Study Treatment|45
3103787|NCT01520922|3827451|FG000|NOT COMPLETED|Treatment Phase||5
3103788|NCT01520922|3827452|FG001|NOT COMPLETED|Treatment Phase||8
3103789|NCT01520922|3827451|FG000|STARTED|Follow up||44
3103790|NCT01520922|3827452|FG001|STARTED|Follow up||45
3103791|NCT01520922|3827451|FG000|COMPLETED|Follow up||44
3103792|NCT01520922|3827452|FG001|COMPLETED|Follow up||44
3103793|NCT01520922|3827451|FG000|NOT COMPLETED|Follow up||0
3103794|NCT01520922|3827452|FG001|NOT COMPLETED|Follow up||1
3103795|NCT01520922|3827451|FG000|STARTED|Survival Follow-up||21
3103796|NCT01520922|3827452|FG001|STARTED|Survival Follow-up||40
3103797|NCT01520922|3827451|FG000|COMPLETED|Survival Follow-up||20
3103798|NCT01520922|3827452|FG001|COMPLETED|Survival Follow-up||40
3103799|NCT01520922|3827451|FG000|NOT COMPLETED|Survival Follow-up||1
3103800|NCT01520922|3827452|FG001|NOT COMPLETED|Survival Follow-up||0
3103801|NCT01520987|3827466|FG000|STARTED|Overall Study||13
3103802|NCT01520987|3827467|FG001|STARTED|Overall Study||12
3103803|NCT01520987|3827468|FG002|STARTED|Overall Study||11
3103804|NCT01520987|3827469|FG003|STARTED|Overall Study||15
3103805|NCT01520987|3827470|FG004|STARTED|Overall Study||14
3103806|NCT01520987|3827471|FG005|STARTED|Overall Study||14
3103807|NCT01520987|3827472|FG006|STARTED|Overall Study||12
3103808|NCT01520987|3827473|FG007|STARTED|Overall Study||14
3103809|NCT01520987|3827466|FG000|Dosed|Overall Study||13
3103810|NCT01520987|3827467|FG001|Dosed|Overall Study||12
3103811|NCT01520987|3827468|FG002|Dosed|Overall Study||11
3103812|NCT01520987|3827469|FG003|Dosed|Overall Study||15
3103813|NCT01520987|3827470|FG004|Dosed|Overall Study||14
3103814|NCT01520987|3827471|FG005|Dosed|Overall Study||14
3103815|NCT01520987|3827472|FG006|Dosed|Overall Study||12
3103816|NCT01520987|3827473|FG007|Dosed|Overall Study||14
3103817|NCT01520987|3827466|FG000|COMPLETED|Overall Study||12
3103818|NCT01520987|3827467|FG001|COMPLETED|Overall Study||12
3103819|NCT01520987|3827468|FG002|COMPLETED|Overall Study||11
3103820|NCT01520987|3827469|FG003|COMPLETED|Overall Study||15
3103821|NCT01520987|3827470|FG004|COMPLETED|Overall Study||14
3103822|NCT01520987|3827471|FG005|COMPLETED|Overall Study||13
3103823|NCT01520987|3827472|FG006|COMPLETED|Overall Study||12
3103824|NCT01520987|3827473|FG007|COMPLETED|Overall Study||14
3103825|NCT01520987|3827466|FG000|NOT COMPLETED|Overall Study||1
3103826|NCT01520987|3827467|FG001|NOT COMPLETED|Overall Study||0
3103827|NCT01520987|3827468|FG002|NOT COMPLETED|Overall Study||0
3103828|NCT01520987|3827469|FG003|NOT COMPLETED|Overall Study||0
3103829|NCT01520987|3827470|FG004|NOT COMPLETED|Overall Study||0
3103830|NCT01520987|3827471|FG005|NOT COMPLETED|Overall Study||1
3103831|NCT01520987|3827472|FG006|NOT COMPLETED|Overall Study||0
3103832|NCT01520987|3827473|FG007|NOT COMPLETED|Overall Study||0
3103833|NCT01521026|3827491|FG000|STARTED|Overall Study||38
3103834|NCT01521026|3827492|FG001|STARTED|Overall Study||31
3103835|NCT01521026|3827491|FG000|COMPLETED|Overall Study||23
3103836|NCT01521026|3827492|FG001|COMPLETED|Overall Study||28
3103837|NCT01521026|3827491|FG000|NOT COMPLETED|Overall Study||15
3103838|NCT01521026|3827492|FG001|NOT COMPLETED|Overall Study||3
3103839|NCT01521117|3827498|FG000|STARTED|First Intervention (6 Weeks)||10
3103840|NCT01521117|3827499|FG001|STARTED|First Intervention (6 Weeks)||11
3103841|NCT01521117|3827498|FG000|COMPLETED|First Intervention (6 Weeks)||5
3103842|NCT01521117|3827499|FG001|COMPLETED|First Intervention (6 Weeks)||8
3103843|NCT01521117|3827498|FG000|NOT COMPLETED|First Intervention (6 Weeks)||5
3103844|NCT01521117|3827499|FG001|NOT COMPLETED|First Intervention (6 Weeks)||3
3103845|NCT01521117|3827498|FG000|STARTED|Washout (4 Weeks)||5
3103846|NCT01521117|3827499|FG001|STARTED|Washout (4 Weeks)||8
3103847|NCT01521117|3827498|FG000|COMPLETED|Washout (4 Weeks)||5
3103848|NCT01521117|3827499|FG001|COMPLETED|Washout (4 Weeks)||8
3103849|NCT01521117|3827498|FG000|NOT COMPLETED|Washout (4 Weeks)||0
3103850|NCT01521117|3827499|FG001|NOT COMPLETED|Washout (4 Weeks)||0
3103851|NCT01521117|3827498|FG000|STARTED|Second Intervention (6 Weeks)||5
3103852|NCT01521117|3827499|FG001|STARTED|Second Intervention (6 Weeks)||8
3103853|NCT01521117|3827498|FG000|COMPLETED|Second Intervention (6 Weeks)||5
3103854|NCT01521117|3827499|FG001|COMPLETED|Second Intervention (6 Weeks)||5
3103855|NCT01521117|3827498|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||0
3103856|NCT01521117|3827499|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||3
3103857|NCT01521260|3827507|FG000|STARTED|Overall Study||15
3103858|NCT01521260|3827508|FG001|STARTED|Overall Study||15
3103859|NCT01521260|3827507|FG000|COMPLETED|Overall Study||15
3103860|NCT01521260|3827508|FG001|COMPLETED|Overall Study||15
3103861|NCT01521260|3827507|FG000|NOT COMPLETED|Overall Study||0
3103862|NCT01521260|3827508|FG001|NOT COMPLETED|Overall Study||0
3103863|NCT01521364|3827514|FG000|STARTED|Linezolid Without Clarithromycin (1 wk)||7
3103864|NCT01521364|3827514|FG000|COMPLETED|Linezolid Without Clarithromycin (1 wk)||7
3103865|NCT01521364|3827514|FG000|NOT COMPLETED|Linezolid Without Clarithromycin (1 wk)||0
3103866|NCT01521364|3827514|FG000|STARTED|Linezolid + 250mg Claritromycin (wk 2&3)||7
3103867|NCT01521364|3827514|FG000|COMPLETED|Linezolid + 250mg Claritromycin (wk 2&3)||6
3103868|NCT01521364|3827514|FG000|NOT COMPLETED|Linezolid + 250mg Claritromycin (wk 2&3)||1
3103869|NCT01521364|3827514|FG000|STARTED|Linezolid + 500mg Claritromycin (wk 4&5)||6
3103870|NCT01521364|3827514|FG000|COMPLETED|Linezolid + 500mg Claritromycin (wk 4&5)||5
3103871|NCT01521364|3827514|FG000|NOT COMPLETED|Linezolid + 500mg Claritromycin (wk 4&5)||1
3103872|NCT01521494|3827530|FG000|STARTED|Overall Study||39
3103873|NCT01521494|3827531|FG001|STARTED|Overall Study||36
3103874|NCT01521494|3827532|FG002|STARTED|Overall Study||35
3103875|NCT01521494|3827533|FG003|STARTED|Overall Study||36
3103876|NCT01521494|3827534|FG004|STARTED|Overall Study||37
3103877|NCT01521494|3827530|FG000|COMPLETED|Overall Study||37
3103878|NCT01521494|3827531|FG001|COMPLETED|Overall Study||31
3103879|NCT01521494|3827532|FG002|COMPLETED|Overall Study||23
3103880|NCT01521494|3827533|FG003|COMPLETED|Overall Study||15
3103881|NCT01521494|3827534|FG004|COMPLETED|Overall Study||30
3103882|NCT01521494|3827530|FG000|NOT COMPLETED|Overall Study||2
3103883|NCT01521494|3827531|FG001|NOT COMPLETED|Overall Study||5
3103884|NCT01521494|3827532|FG002|NOT COMPLETED|Overall Study||12
3103885|NCT01521494|3827533|FG003|NOT COMPLETED|Overall Study||21
3103886|NCT01521494|3827534|FG004|NOT COMPLETED|Overall Study||7
3103887|NCT01521507|3827548|FG000|STARTED|Stage 1: Randomized Design||101
3103888|NCT01521507|3827549|FG001|STARTED|Stage 1: Randomized Design||99
3103889|NCT01521507|3827548|FG000|Received Initial Treatment (Tx)|Stage 1: Randomized Design||99
3103890|NCT01521507|3827549|FG001|Received Initial Treatment (Tx)|Stage 1: Randomized Design||98
3103891|NCT01521507|3827548|FG000|COMPLETED|Stage 1: Randomized Design||98
3103892|NCT01521507|3827549|FG001|COMPLETED|Stage 1: Randomized Design||94
3103893|NCT01521507|3827548|FG000|NOT COMPLETED|Stage 1: Randomized Design||3
3103894|NCT01521507|3827549|FG001|NOT COMPLETED|Stage 1: Randomized Design||5
3103895|NCT01521507|3827548|FG000|STARTED|Stage 2: Observational Design||98
3103896|NCT01521507|3827549|FG001|STARTED|Stage 2: Observational Design||94
3103897|NCT01521507|3827548|FG000|Received Crossover LipiFlow Tx|Stage 2: Observational Design||0
3103898|NCT01521507|3827549|FG001|Received Crossover LipiFlow Tx|Stage 2: Observational Design||93
3103899|NCT01521507|3827548|FG000|Received Only One LipiFlow Tx at 12 Mo|Stage 2: Observational Design||81
3103900|NCT01521507|3827549|FG001|Received Only One LipiFlow Tx at 12 Mo|Stage 2: Observational Design||82
3103901|NCT01521507|3827548|FG000|Received Other MGD Treatment at 12 Mo|Stage 2: Observational Design||11
3103902|NCT01521507|3827549|FG001|Received Other MGD Treatment at 12 Mo|Stage 2: Observational Design||9
3103903|NCT01521507|3827548|FG000|Received 2nd LipiFlow Tx at 12 Mo|Stage 2: Observational Design||2
3103904|NCT01521507|3827549|FG001|Received 2nd LipiFlow Tx at 12 Mo|Stage 2: Observational Design||1
3103905|NCT01521507|3827548|FG000|COMPLETED|Stage 2: Observational Design||94
3103906|NCT01521507|3827549|FG001|COMPLETED|Stage 2: Observational Design||92
3103907|NCT01521507|3827548|FG000|NOT COMPLETED|Stage 2: Observational Design||4
3103908|NCT01521507|3827549|FG001|NOT COMPLETED|Stage 2: Observational Design||2
3103909|NCT01521546|3827564|FG000|STARTED|Overall Study||22
3103910|NCT01521546|3827565|FG001|STARTED|Overall Study||20
3103911|NCT01521546|3827564|FG000|COMPLETED|Overall Study||20
3103912|NCT01521546|3827565|FG001|COMPLETED|Overall Study||20
3103913|NCT01521546|3827564|FG000|NOT COMPLETED|Overall Study||2
3103914|NCT01521546|3827565|FG001|NOT COMPLETED|Overall Study||0
3103915|NCT01521559|3827573|FG000|STARTED|Overall Study||92
3103916|NCT01521559|3827574|FG001|STARTED|Overall Study||91
3103917|NCT01521559|3827573|FG000|Completed Week 24|Overall Study||83
3103918|NCT01521559|3827574|FG001|Completed Week 24|Overall Study||85
3103919|NCT01521559|3827573|FG000|Completed Week 52|Overall Study||77
3103920|NCT01521559|3827574|FG001|Completed Week 52|Overall Study||73
3103921|NCT01521559|3827573|FG000|COMPLETED|Overall Study||77
3103922|NCT01521559|3827574|FG001|COMPLETED|Overall Study||73
3103923|NCT01521559|3827573|FG000|NOT COMPLETED|Overall Study||15
3103924|NCT01521559|3827574|FG001|NOT COMPLETED|Overall Study||18
3103925|NCT01521780|3827581|FG000|STARTED|Overall Study||9
3103926|NCT01521780|3827582|FG001|STARTED|Overall Study||1
3103927|NCT01521780|3827583|FG002|STARTED|Overall Study||2
3103928|NCT01521780|3827581|FG000|COMPLETED|Overall Study||9
3103929|NCT01521780|3827582|FG001|COMPLETED|Overall Study||1
3103930|NCT01521780|3827583|FG002|COMPLETED|Overall Study||2
3103931|NCT01521780|3827581|FG000|NOT COMPLETED|Overall Study||0
3103932|NCT01521780|3827582|FG001|NOT COMPLETED|Overall Study||0
3103933|NCT01521780|3827583|FG002|NOT COMPLETED|Overall Study||0
3103934|NCT01521845|3827594|FG000|STARTED|Overall Study||52
3103935|NCT01521845|3827595|FG001|STARTED|Overall Study||52
3103936|NCT01521845|3827594|FG000|COMPLETED|Overall Study||43
3103937|NCT01521845|3827595|FG001|COMPLETED|Overall Study||47
3103938|NCT01521845|3827594|FG000|NOT COMPLETED|Overall Study||9
3103939|NCT01521845|3827595|FG001|NOT COMPLETED|Overall Study||5
3103940|NCT01521871|3827603|FG000|STARTED|Overall Study||32
3103941|NCT01521871|3827604|FG001|STARTED|Overall Study||32
3103942|NCT01521871|3827603|FG000|COMPLETED|Overall Study||32
3103943|NCT01521871|3827604|FG001|COMPLETED|Overall Study||32
3103944|NCT01521871|3827603|FG000|NOT COMPLETED|Overall Study||0
3103945|NCT01521871|3827604|FG001|NOT COMPLETED|Overall Study||0
3103946|NCT01521884|3827610|FG000|STARTED|Overall Study||62
3103947|NCT01521884|3827610|FG000|COMPLETED|Overall Study||35
3103948|NCT01521884|3827610|FG000|NOT COMPLETED|Overall Study||27
3103949|NCT01521897|3827614|FG000|STARTED|Overall Study||1143
3103950|NCT01521897|3827614|FG000|COMPLETED|Overall Study||1120
3103951|NCT01521897|3827614|FG000|NOT COMPLETED|Overall Study||23
3103952|NCT01521923|3827622|FG000|STARTED|Overall Study||66
3103953|NCT01521923|3827623|FG001|STARTED|Overall Study||81
3103954|NCT01521923|3827624|FG002|STARTED|Overall Study||127
3103955|NCT01521923|3827625|FG003|STARTED|Overall Study||83
3103956|NCT01521923|3827622|FG000|COMPLETED|Overall Study||59
3103957|NCT01521923|3827623|FG001|COMPLETED|Overall Study||72
3103958|NCT01521923|3827624|FG002|COMPLETED|Overall Study||112
3103959|NCT01521923|3827625|FG003|COMPLETED|Overall Study||70
3103960|NCT01521923|3827622|FG000|NOT COMPLETED|Overall Study||7
3103961|NCT01521923|3827623|FG001|NOT COMPLETED|Overall Study||9
3103962|NCT01521923|3827624|FG002|NOT COMPLETED|Overall Study||15
3103963|NCT01521923|3827625|FG003|NOT COMPLETED|Overall Study||13
3103964|NCT01521949|3827638|FG000|STARTED|Overall Study||21
3103965|NCT01521949|3827638|FG000|COMPLETED|Overall Study||21
3103966|NCT01521949|3827638|FG000|NOT COMPLETED|Overall Study||0
3103967|NCT01522131|3827644|FG000|STARTED|Overall Study||16
3103968|NCT01522131|3827645|FG001|STARTED|Overall Study||17
3103969|NCT01522131|3827644|FG000|COMPLETED|Overall Study||14
3103970|NCT01522131|3827645|FG001|COMPLETED|Overall Study||17
3103971|NCT01522131|3827644|FG000|NOT COMPLETED|Overall Study||2
3103972|NCT01522131|3827645|FG001|NOT COMPLETED|Overall Study||0
3103973|NCT01522235|3827653|FG000|STARTED|Overall Study||3
3103974|NCT01522235|3827654|FG001|STARTED|Overall Study||3
3103975|NCT01522235|3827653|FG000|Randomized|Overall Study||2
3103976|NCT01522235|3827654|FG001|Randomized|Overall Study||3
3103977|NCT01522235|3827653|FG000|COMPLETED|Overall Study||2
3103978|NCT01522235|3827654|FG001|COMPLETED|Overall Study||2
3103979|NCT01522235|3827653|FG000|NOT COMPLETED|Overall Study||1
3103980|NCT01522235|3827654|FG001|NOT COMPLETED|Overall Study||1
3103981|NCT01522248|3827666|FG000|STARTED|Overall Study||10
3103982|NCT01522248|3827667|FG001|STARTED|Overall Study||10
3103983|NCT01522248|3827666|FG000|COMPLETED|Overall Study||9
3103984|NCT01522248|3827667|FG001|COMPLETED|Overall Study||10
3103985|NCT01522248|3827666|FG000|NOT COMPLETED|Overall Study||1
3103986|NCT01522248|3827667|FG001|NOT COMPLETED|Overall Study||0
3103987|NCT01522339|3827678|FG000|STARTED|Overall Study||15
3103988|NCT01522339|3827678|FG000|COMPLETED|Overall Study||15
3103989|NCT01522339|3827678|FG000|NOT COMPLETED|Overall Study||0
3103990|NCT01522391|3827685|FG000|STARTED|Overall Study||20
3103991|NCT01522391|3827686|FG001|STARTED|Overall Study||21
3103992|NCT01522391|3827685|FG000|COMPLETED|Overall Study||19
3103993|NCT01522391|3827686|FG001|COMPLETED|Overall Study||20
3103994|NCT01522391|3827685|FG000|NOT COMPLETED|Overall Study||1
3103995|NCT01522391|3827686|FG001|NOT COMPLETED|Overall Study||1
3103996|NCT01522404|3827694|FG000|STARTED|First Intervention (up to Week 29)||20
3103997|NCT01522404|3827695|FG001|STARTED|First Intervention (up to Week 29)||19
3103998|NCT01522404|3827694|FG000|COMPLETED|First Intervention (up to Week 29)||18
3103999|NCT01522404|3827695|FG001|COMPLETED|First Intervention (up to Week 29)||19
3104000|NCT01522404|3827694|FG000|NOT COMPLETED|First Intervention (up to Week 29)||2
3104001|NCT01522404|3827695|FG001|NOT COMPLETED|First Intervention (up to Week 29)||0
3104002|NCT01522404|3827694|FG000|STARTED|Second Intervention (up to Week 58)||18
3104003|NCT01522404|3827695|FG001|STARTED|Second Intervention (up to Week 58)||19
3104004|NCT01522404|3827694|FG000|COMPLETED|Second Intervention (up to Week 58)||17
3104005|NCT01522404|3827695|FG001|COMPLETED|Second Intervention (up to Week 58)||19
3104006|NCT01522404|3827694|FG000|NOT COMPLETED|Second Intervention (up to Week 58)||1
3104007|NCT01522404|3827695|FG001|NOT COMPLETED|Second Intervention (up to Week 58)||0
3104008|NCT01522417|3827712|FG000|STARTED|Overall Study||209
3104009|NCT01522417|3827713|FG001|STARTED|Overall Study||202
3104010|NCT01522417|3827714|FG002|STARTED|Overall Study|Randomization into the long tirofiban arm was initiated on 14 June 2013.|124
3104011|NCT01522417|3827712|FG000|COMPLETED|Overall Study||209
3104012|NCT01522417|3827713|FG001|COMPLETED|Overall Study||202
3104013|NCT01522417|3827714|FG002|COMPLETED|Overall Study|Randomization into the long tirofiban arm was completed on 1 February 2018.|124
3104014|NCT01522417|3827712|FG000|NOT COMPLETED|Overall Study||0
3104015|NCT01522417|3827713|FG001|NOT COMPLETED|Overall Study||0
3104016|NCT01522417|3827714|FG002|NOT COMPLETED|Overall Study||0
3104017|NCT01522443|3827724|FG000|STARTED|Overall Study||61
3104018|NCT01522443|3827725|FG001|STARTED|Overall Study||58
3104019|NCT01522443|3827724|FG000|COMPLETED|Overall Study||8
3104020|NCT01522443|3827725|FG001|COMPLETED|Overall Study||3
3104021|NCT01522443|3827724|FG000|NOT COMPLETED|Overall Study||53
3104022|NCT01522443|3827725|FG001|NOT COMPLETED|Overall Study||55
3104023|NCT01522456|3827731|FG000|STARTED|Overall Study||73
3104024|NCT01522456|3827731|FG000|COMPLETED|Overall Study||65
3104025|NCT01522456|3827731|FG000|NOT COMPLETED|Overall Study||8
3104026|NCT01522651|3827747|FG000|STARTED|Overall Study||26
3104027|NCT01522651|3827748|FG001|STARTED|Overall Study||27
3104028|NCT01522651|3827749|FG002|STARTED|Overall Study||26
3104029|NCT01522651|3827750|FG003|STARTED|Overall Study||28
3104030|NCT01522651|3827751|FG004|STARTED|Overall Study||27
3104031|NCT01522651|3827747|FG000|COMPLETED|Overall Study||17
3104032|NCT01522651|3827748|FG001|COMPLETED|Overall Study||19
3104033|NCT01522651|3827749|FG002|COMPLETED|Overall Study||22
3104034|NCT01522651|3827750|FG003|COMPLETED|Overall Study||20
3104035|NCT01522651|3827751|FG004|COMPLETED|Overall Study||21
3104036|NCT01522651|3827747|FG000|NOT COMPLETED|Overall Study||9
3104037|NCT01522651|3827748|FG001|NOT COMPLETED|Overall Study||8
3104038|NCT01522651|3827749|FG002|NOT COMPLETED|Overall Study||4
3104039|NCT01522651|3827750|FG003|NOT COMPLETED|Overall Study||8
3104040|NCT01522651|3827751|FG004|NOT COMPLETED|Overall Study||6
3104041|NCT01522703|3827765|FG000|STARTED|Overall Study||25
3104042|NCT01522703|3827766|FG001|STARTED|Overall Study||26
3104043|NCT01522703|3827765|FG000|COMPLETED|Overall Study||20
3104044|NCT01522703|3827766|FG001|COMPLETED|Overall Study||20
3104045|NCT01522703|3827765|FG000|NOT COMPLETED|Overall Study||5
3104046|NCT01522703|3827766|FG001|NOT COMPLETED|Overall Study||6
3104047|NCT01522755|3827772|FG000|STARTED|Overall Study||409
3104048|NCT01522755|3827772|FG000|COMPLETED|Overall Study||409
3104049|NCT01522755|3827772|FG000|NOT COMPLETED|Overall Study||0
3104050|NCT01522924|3827779|FG000|STARTED|Overall Study|There were 42 dental students in the intervention group.|42
3104051|NCT01522924|3827780|FG001|STARTED|Overall Study|There were 52 dental students in the control group.|52
3104052|NCT01522924|3827779|FG000|COMPLETED|Overall Study|There were 42 dental students who completed the second survey after the intervention.|42
3104053|NCT01522924|3827780|FG001|COMPLETED|Overall Study|There were 52 dental students who completed the second survey after the lecture.|52
3104054|NCT01522924|3827779|FG000|NOT COMPLETED|Overall Study||0
3104055|NCT01522924|3827780|FG001|NOT COMPLETED|Overall Study||0
3104056|NCT01522937|3827786|FG000|STARTED|Overall Study||146
3104057|NCT01522937|3827786|FG000|COMPLETED|Overall Study||146
3104058|NCT01522937|3827786|FG000|NOT COMPLETED|Overall Study||0
3104059|NCT01522950|3827793|FG000|STARTED|Overall Study||26
3104060|NCT01522950|3827794|FG001|STARTED|Overall Study||23
3104061|NCT01522950|3827795|FG002|STARTED|Overall Study||27
3104062|NCT01522950|3827793|FG000|COMPLETED|Overall Study||20
3104063|NCT01522950|3827794|FG001|COMPLETED|Overall Study||18
3104064|NCT01522950|3827795|FG002|COMPLETED|Overall Study||22
3104065|NCT01522950|3827793|FG000|NOT COMPLETED|Overall Study||6
3104066|NCT01522950|3827794|FG001|NOT COMPLETED|Overall Study||5
3104067|NCT01522950|3827795|FG002|NOT COMPLETED|Overall Study||5
3104068|NCT01522963|3827807|FG000|STARTED|Overall Study||24
3104069|NCT01522963|3827808|FG001|STARTED|Overall Study||25
3104070|NCT01522963|3827809|FG002|STARTED|Overall Study||25
3104071|NCT01522963|3827810|FG003|STARTED|Overall Study||24
3104072|NCT01522963|3827807|FG000|COMPLETED|Overall Study||22
3104073|NCT01522963|3827808|FG001|COMPLETED|Overall Study||22
3104074|NCT01522963|3827809|FG002|COMPLETED|Overall Study||22
3104075|NCT01522963|3827810|FG003|COMPLETED|Overall Study||18
3104076|NCT01522963|3827807|FG000|NOT COMPLETED|Overall Study||2
3104077|NCT01522963|3827808|FG001|NOT COMPLETED|Overall Study||3
3104078|NCT01522963|3827809|FG002|NOT COMPLETED|Overall Study||3
3104079|NCT01522963|3827810|FG003|NOT COMPLETED|Overall Study||6
3104080|NCT01523275|3827820|FG000|STARTED|Overall Study||6
3104081|NCT01523275|3827821|FG001|STARTED|Overall Study||9
3104082|NCT01523275|3827820|FG000|COMPLETED|Overall Study||4
3104083|NCT01523275|3827821|FG001|COMPLETED|Overall Study||7
3104084|NCT01523275|3827820|FG000|NOT COMPLETED|Overall Study||2
3104085|NCT01523275|3827821|FG001|NOT COMPLETED|Overall Study||2
3104086|NCT01523301|3827829|FG000|STARTED|Overall Study||184
3104087|NCT01523301|3827830|FG001|STARTED|Overall Study||196
3104088|NCT01523301|3827829|FG000|COMPLETED|Overall Study||149
3104089|NCT01523301|3827830|FG001|COMPLETED|Overall Study||164
3104090|NCT01523301|3827829|FG000|NOT COMPLETED|Overall Study||35
3104091|NCT01523301|3827830|FG001|NOT COMPLETED|Overall Study||32
3104092|NCT01523366|3827838|FG000|STARTED|Treatment Period 1||20
3104093|NCT01523366|3827839|FG001|STARTED|Treatment Period 1||20
3104094|NCT01523366|3827838|FG000|COMPLETED|Treatment Period 1||19
3104095|NCT01523366|3827839|FG001|COMPLETED|Treatment Period 1||20
3104096|NCT01523366|3827838|FG000|NOT COMPLETED|Treatment Period 1||1
3104097|NCT01523366|3827839|FG001|NOT COMPLETED|Treatment Period 1||0
3104098|NCT01523366|3827838|FG000|STARTED|Washout Period - 10-14 Days||19
3104099|NCT01523366|3827839|FG001|STARTED|Washout Period - 10-14 Days||20
3104100|NCT01523366|3827838|FG000|COMPLETED|Washout Period - 10-14 Days||19
3104101|NCT01523366|3827839|FG001|COMPLETED|Washout Period - 10-14 Days||20
3104102|NCT01523366|3827838|FG000|NOT COMPLETED|Washout Period - 10-14 Days||0
3104103|NCT01523366|3827839|FG001|NOT COMPLETED|Washout Period - 10-14 Days||0
3104104|NCT01523366|3827838|FG000|STARTED|Treatment Period 2||19
3104105|NCT01523366|3827839|FG001|STARTED|Treatment Period 2||20
3104106|NCT01523366|3827838|FG000|COMPLETED|Treatment Period 2||18
3104107|NCT01523366|3827839|FG001|COMPLETED|Treatment Period 2||20
3104108|NCT01523366|3827838|FG000|NOT COMPLETED|Treatment Period 2||1
3104109|NCT01523366|3827839|FG001|NOT COMPLETED|Treatment Period 2||0
3104110|NCT01523392|3827849|FG000|STARTED|Treatment Period 1||20
3104111|NCT01523392|3827850|FG001|STARTED|Treatment Period 1||14
3104112|NCT01523392|3827849|FG000|COMPLETED|Treatment Period 1||17
3104113|NCT01523392|3827850|FG001|COMPLETED|Treatment Period 1||14
3104114|NCT01523392|3827849|FG000|NOT COMPLETED|Treatment Period 1||3
3104115|NCT01523392|3827850|FG001|NOT COMPLETED|Treatment Period 1||0
3104116|NCT01523392|3827849|FG000|STARTED|Washout Period - 10 to 14 Days|1 patient did not complete 7-9 days of Period 1 treatment but continued in the Washout and Period 2|18
3104117|NCT01523392|3827850|FG001|STARTED|Washout Period - 10 to 14 Days||14
3104118|NCT01523392|3827849|FG000|COMPLETED|Washout Period - 10 to 14 Days||17
3104119|NCT01523392|3827850|FG001|COMPLETED|Washout Period - 10 to 14 Days||14
3104120|NCT01523392|3827849|FG000|NOT COMPLETED|Washout Period - 10 to 14 Days||1
3104121|NCT01523392|3827850|FG001|NOT COMPLETED|Washout Period - 10 to 14 Days||0
3104122|NCT01523392|3827849|FG000|STARTED|Treatment Period 2||17
3104123|NCT01523392|3827850|FG001|STARTED|Treatment Period 2||14
3104124|NCT01523392|3827849|FG000|COMPLETED|Treatment Period 2||17
3104125|NCT01523392|3827850|FG001|COMPLETED|Treatment Period 2||14
3104126|NCT01523392|3827849|FG000|NOT COMPLETED|Treatment Period 2||0
3104127|NCT01523392|3827850|FG001|NOT COMPLETED|Treatment Period 2||0
3104128|NCT01523457|3827860|FG000|STARTED|Overall Study||44
3104129|NCT01523457|3827861|FG001|STARTED|Overall Study||31
3104130|NCT01523457|3827860|FG000|COMPLETED|Overall Study||37
3104131|NCT01523457|3827861|FG001|COMPLETED|Overall Study||29
3104132|NCT01523457|3827860|FG000|NOT COMPLETED|Overall Study||7
3104133|NCT01523457|3827861|FG001|NOT COMPLETED|Overall Study||2
3104134|NCT01523496|3827871|FG000|STARTED|Overall Study|The supplementation group includes medium and high dose vitamin D supplementation|66
3104135|NCT01523496|3827872|FG001|STARTED|Overall Study||36
3104136|NCT01523496|3827873|FG002|STARTED|Overall Study|The supplementation group includes medium and high dose vitamin D supplementation|58
3104137|NCT01523496|3827874|FG003|STARTED|Overall Study||30
3104138|NCT01523496|3827871|FG000|COMPLETED|Overall Study||56
3104139|NCT01523496|3827872|FG001|COMPLETED|Overall Study||32
3104140|NCT01523496|3827873|FG002|COMPLETED|Overall Study||46
3104141|NCT01523496|3827874|FG003|COMPLETED|Overall Study||27
3104142|NCT01523496|3827871|FG000|NOT COMPLETED|Overall Study||10
3104143|NCT01523496|3827872|FG001|NOT COMPLETED|Overall Study||4
3104144|NCT01523496|3827873|FG002|NOT COMPLETED|Overall Study||12
3104145|NCT01523496|3827874|FG003|NOT COMPLETED|Overall Study||3
3104146|NCT01523587|3827890|FG000|STARTED|Overall Study||398
3104147|NCT01523587|3827891|FG001|STARTED|Overall Study||397
3104148|NCT01523587|3827890|FG000|Treated|Overall Study||392
3104149|NCT01523587|3827891|FG001|Treated|Overall Study||395
3104150|NCT01523587|3827890|FG000|COMPLETED|Overall Study||0
3104151|NCT01523587|3827891|FG001|COMPLETED|Overall Study||0
3104152|NCT01523587|3827890|FG000|NOT COMPLETED|Overall Study||398
3104153|NCT01523587|3827891|FG001|NOT COMPLETED|Overall Study||397
3104154|NCT01523613|3827900|FG000|STARTED|Overall Study|- 30 single restorations (30 R)|30
3104155|NCT01523613|3827901|FG001|STARTED|Overall Study|- 30 single restorations (30 F)|30
3104156|NCT01523613|3827902|FG002|STARTED|Overall Study|- 66 paired restorations (33R + 33F)|33
3104157|NCT01523613|3827900|FG000|COMPLETED|Overall Study|- 23 single restorations (23R)|23
3104158|NCT01523613|3827901|FG001|COMPLETED|Overall Study|- 25 single restorations (25F)|25
3104159|NCT01523613|3827902|FG002|COMPLETED|Overall Study|- 42 paired restorations (21R and 21F)|21
3104160|NCT01523613|3827900|FG000|NOT COMPLETED|Overall Study||7
3104161|NCT01523613|3827901|FG001|NOT COMPLETED|Overall Study||5
3104162|NCT01523613|3827902|FG002|NOT COMPLETED|Overall Study||12
3135480|NCT01707420|3860550|FG001|NOT COMPLETED|Overall Study||0
3135481|NCT01707472|3860561|FG000|STARTED|Overall Study||4
3135482|NCT01707472|3860562|FG001|STARTED|Overall Study||6
3135483|NCT01707472|3860563|FG002|STARTED|Overall Study||8
3135484|NCT01707472|3860561|FG000|COMPLETED|Overall Study||4
3135485|NCT01707472|3860562|FG001|COMPLETED|Overall Study||6
3135486|NCT01707472|3860563|FG002|COMPLETED|Overall Study||8
3135487|NCT01707472|3860561|FG000|NOT COMPLETED|Overall Study||0
3135488|NCT01707472|3860562|FG001|NOT COMPLETED|Overall Study||0
3135489|NCT01707472|3860563|FG002|NOT COMPLETED|Overall Study||0
3135490|NCT01707654|3860571|FG000|STARTED|Overall Study||9
3135491|NCT01707654|3860571|FG000|COMPLETED|Overall Study||9
3135492|NCT01707654|3860571|FG000|NOT COMPLETED|Overall Study||0
3135493|NCT01707667|3860577|FG000|STARTED|Period 1||7
3135494|NCT01707667|3860578|FG001|STARTED|Period 1||6
3135495|NCT01707667|3860577|FG000|COMPLETED|Period 1||6
3135496|NCT01707667|3860578|FG001|COMPLETED|Period 1||6
3135497|NCT01707667|3860577|FG000|NOT COMPLETED|Period 1||1
3135498|NCT01707667|3860578|FG001|NOT COMPLETED|Period 1||0
3135499|NCT01707667|3860577|FG000|STARTED|Period 2||6
3135500|NCT01707667|3860578|FG001|STARTED|Period 2||6
3135501|NCT01707667|3860577|FG000|COMPLETED|Period 2||6
3135502|NCT01707667|3860578|FG001|COMPLETED|Period 2||6
3135503|NCT01707667|3860577|FG000|NOT COMPLETED|Period 2||0
3135504|NCT01707667|3860578|FG001|NOT COMPLETED|Period 2||0
3135505|NCT01707693|3860586|FG000|STARTED|Overall Study Allocation||59
3135506|NCT01707693|3860587|FG001|STARTED|Overall Study Allocation||62
3135507|NCT01707693|3860586|FG000|COMPLETED|Overall Study Allocation||46
3135508|NCT01707693|3860587|FG001|COMPLETED|Overall Study Allocation||54
3135509|NCT01707693|3860586|FG000|NOT COMPLETED|Overall Study Allocation||13
3135510|NCT01707693|3860587|FG001|NOT COMPLETED|Overall Study Allocation||8
3135511|NCT01707693|3860586|FG000|STARTED|Time 3 Measures @ 6 Mth||46
3135512|NCT01707693|3860587|FG001|STARTED|Time 3 Measures @ 6 Mth||54
3135513|NCT01707693|3860586|FG000|COMPLETED|Time 3 Measures @ 6 Mth||46
3135514|NCT01707693|3860587|FG001|COMPLETED|Time 3 Measures @ 6 Mth||49
3135515|NCT01707693|3860586|FG000|NOT COMPLETED|Time 3 Measures @ 6 Mth||0
3135516|NCT01707693|3860587|FG001|NOT COMPLETED|Time 3 Measures @ 6 Mth||5
3135517|NCT01707992|3860597|FG000|STARTED|Placebo-Controlled Phase (24 Months)||740
3135518|NCT01707992|3860598|FG001|STARTED|Placebo-Controlled Phase (24 Months)||727
3135519|NCT01707992|3860599|FG002|STARTED|Placebo-Controlled Phase (24 Months)||732
3135520|NCT01707992|3860600|FG003|STARTED|Placebo-Controlled Phase (24 Months)||0
3135521|NCT01707992|3860601|FG004|STARTED|Placebo-Controlled Phase (24 Months)||0
3135522|NCT01707992|3860602|FG005|STARTED|Placebo-Controlled Phase (24 Months)||0
3135523|NCT01707992|3860597|FG000|COMPLETED|Placebo-Controlled Phase (24 Months)||596
3135524|NCT01707992|3860598|FG001|COMPLETED|Placebo-Controlled Phase (24 Months)||623
3135525|NCT01707992|3860599|FG002|COMPLETED|Placebo-Controlled Phase (24 Months)||532
3135526|NCT01707992|3860600|FG003|COMPLETED|Placebo-Controlled Phase (24 Months)||0
3135527|NCT01707992|3860601|FG004|COMPLETED|Placebo-Controlled Phase (24 Months)||0
3135528|NCT01707992|3860602|FG005|COMPLETED|Placebo-Controlled Phase (24 Months)||0
3135529|NCT01707992|3860597|FG000|NOT COMPLETED|Placebo-Controlled Phase (24 Months)||144
3135530|NCT01707992|3860598|FG001|NOT COMPLETED|Placebo-Controlled Phase (24 Months)||104
3135531|NCT01707992|3860599|FG002|NOT COMPLETED|Placebo-Controlled Phase (24 Months)||200
3135532|NCT01707992|3860600|FG003|NOT COMPLETED|Placebo-Controlled Phase (24 Months)||0
3135533|NCT01707992|3860601|FG004|NOT COMPLETED|Placebo-Controlled Phase (24 Months)||0
3135534|NCT01707992|3860602|FG005|NOT COMPLETED|Placebo-Controlled Phase (24 Months)||0
3135535|NCT01707992|3860597|FG000|STARTED|Active Treatment Phase (24 Months)||0
3135536|NCT01707992|3860598|FG001|STARTED|Active Treatment Phase (24 Months)||0
3135537|NCT01707992|3860599|FG002|STARTED|Active Treatment Phase (24 Months)||0
3135538|NCT01707992|3860600|FG003|STARTED|Active Treatment Phase (24 Months)||891
3135539|NCT01707992|3860601|FG004|STARTED|Active Treatment Phase (24 Months)||504
3135540|NCT01707992|3860602|FG005|STARTED|Active Treatment Phase (24 Months)||215
3135541|NCT01707992|3860597|FG000|COMPLETED|Active Treatment Phase (24 Months)||0
3135542|NCT01707992|3860598|FG001|COMPLETED|Active Treatment Phase (24 Months)||0
3135543|NCT01707992|3860599|FG002|COMPLETED|Active Treatment Phase (24 Months)||0
3135544|NCT01707992|3860600|FG003|COMPLETED|Active Treatment Phase (24 Months)||7
3104163|NCT01523704|3827912|FG000|STARTED|Overall Study|January 2012|636
3104164|NCT01523704|3827913|FG001|STARTED|Overall Study|January 2012|638
3104165|NCT01523704|3827912|FG000|COMPLETED|Overall Study|February 2016 (Enrollment: as of October 2013)|558
3104166|NCT01523704|3827913|FG001|COMPLETED|Overall Study|February 2016 (Enrollment: as of October 2013)|550
3104167|NCT01523704|3827912|FG000|NOT COMPLETED|Overall Study||78
3104168|NCT01523704|3827913|FG001|NOT COMPLETED|Overall Study||88
3104169|NCT01523743|3827920|FG000|STARTED|Period 1||63
3104170|NCT01523743|3827921|FG001|STARTED|Period 1||62
3104171|NCT01523743|3827920|FG000|COMPLETED|Period 1||53
3104172|NCT01523743|3827921|FG001|COMPLETED|Period 1||60
3104173|NCT01523743|3827920|FG000|NOT COMPLETED|Period 1||10
3104174|NCT01523743|3827921|FG001|NOT COMPLETED|Period 1||2
3104175|NCT01523743|3827920|FG000|STARTED|Period 2||53
3104176|NCT01523743|3827921|FG001|STARTED|Period 2||60
3104177|NCT01523743|3827920|FG000|COMPLETED|Period 2||52
3104178|NCT01523743|3827921|FG001|COMPLETED|Period 2||58
3104179|NCT01523743|3827920|FG000|NOT COMPLETED|Period 2||1
3104180|NCT01523743|3827921|FG001|NOT COMPLETED|Period 2||2
3104181|NCT01523756|3827927|FG000|STARTED|Baseline Period||11
3104182|NCT01523756|3827928|FG001|STARTED|Baseline Period||9
3104183|NCT01523756|3827927|FG000|COMPLETED|Baseline Period||11
3104184|NCT01523756|3827928|FG001|COMPLETED|Baseline Period||8
3104185|NCT01523756|3827927|FG000|NOT COMPLETED|Baseline Period||0
3104186|NCT01523756|3827928|FG001|NOT COMPLETED|Baseline Period||1
3104187|NCT01523756|3827927|FG000|STARTED|Test Period 1||11
3104188|NCT01523756|3827928|FG001|STARTED|Test Period 1||8
3104189|NCT01523756|3827927|FG000|COMPLETED|Test Period 1||10
3104190|NCT01523756|3827928|FG001|COMPLETED|Test Period 1||8
3104191|NCT01523756|3827927|FG000|NOT COMPLETED|Test Period 1||1
3104192|NCT01523756|3827928|FG001|NOT COMPLETED|Test Period 1||0
3104193|NCT01523756|3827927|FG000|STARTED|Test Period 2||10
3104194|NCT01523756|3827928|FG001|STARTED|Test Period 2||8
3104195|NCT01523756|3827927|FG000|COMPLETED|Test Period 2||10
3104196|NCT01523756|3827928|FG001|COMPLETED|Test Period 2||7
3104197|NCT01523756|3827927|FG000|NOT COMPLETED|Test Period 2||0
3104198|NCT01523756|3827928|FG001|NOT COMPLETED|Test Period 2||1
3104199|NCT01523782|3827939|FG000|STARTED|Overall Study||3
3104200|NCT01523782|3827940|FG001|STARTED|Overall Study||13
3104201|NCT01523782|3827941|FG002|STARTED|Overall Study||14
3104202|NCT01523782|3827939|FG000|COMPLETED|Overall Study||2
3104203|NCT01523782|3827940|FG001|COMPLETED|Overall Study||13
3104204|NCT01523782|3827941|FG002|COMPLETED|Overall Study||9
3104205|NCT01523782|3827939|FG000|NOT COMPLETED|Overall Study||1
3104206|NCT01523782|3827940|FG001|NOT COMPLETED|Overall Study||0
3104207|NCT01523782|3827941|FG002|NOT COMPLETED|Overall Study||5
3104208|NCT01523808|3827953|FG000|STARTED|Overall Study||3
3104209|NCT01523808|3827954|FG001|STARTED|Overall Study||3
3104210|NCT01523808|3827955|FG002|STARTED|Overall Study||3
3104211|NCT01523808|3827956|FG003|STARTED|Overall Study||3
3104212|NCT01523808|3827953|FG000|COMPLETED|Overall Study||0
3104213|NCT01523808|3827954|FG001|COMPLETED|Overall Study||3
3291871|NCT02853305|4025972|FG001|STARTED|Overall Study||307
3291872|NCT02853305|4025973|FG002|STARTED|Overall Study||352
3291873|NCT02853305|4025971|FG000|Treated|Overall Study|Includes 2 participants randomized to Pembrolizumab alone|349
3291874|NCT02853305|4025972|FG001|Treated|Overall Study||302
3291875|NCT02853305|4025973|FG002|Treated|Overall Study||342
3291876|NCT02853305|4025971|FG000|COMPLETED|Overall Study||0
3291877|NCT02853305|4025972|FG001|COMPLETED|Overall Study||0
3291878|NCT02853305|4025973|FG002|COMPLETED|Overall Study||0
3291879|NCT02853305|4025971|FG000|NOT COMPLETED|Overall Study||351
3291880|NCT02853305|4025972|FG001|NOT COMPLETED|Overall Study||307
3291881|NCT02853305|4025973|FG002|NOT COMPLETED|Overall Study||352
3291882|NCT02853318|4025981|FG000|STARTED|Overall Study||40
3291883|NCT02853318|4025981|FG000|COMPLETED|Overall Study||39
3291884|NCT02853318|4025981|FG000|NOT COMPLETED|Overall Study||1
3291885|NCT02853435|4025988|FG000|STARTED|Part 1a, Period 1 (3 Days)||9
3291886|NCT02853435|4025989|FG001|STARTED|Part 1a, Period 1 (3 Days)||9
3291887|NCT02853435|4025990|FG002|STARTED|Part 1a, Period 1 (3 Days)||8
3291888|NCT02853435|4025991|FG003|STARTED|Part 1a, Period 1 (3 Days)||0
3291889|NCT02853435|4025992|FG004|STARTED|Part 1a, Period 1 (3 Days)||0
3291890|NCT02853435|4025993|FG005|STARTED|Part 1a, Period 1 (3 Days)||0
3291891|NCT02853435|4025988|FG000|COMPLETED|Part 1a, Period 1 (3 Days)||9
3291892|NCT02853435|4025989|FG001|COMPLETED|Part 1a, Period 1 (3 Days)||9
3291893|NCT02853435|4025990|FG002|COMPLETED|Part 1a, Period 1 (3 Days)||8
3291894|NCT02853435|4025991|FG003|COMPLETED|Part 1a, Period 1 (3 Days)||0
3291895|NCT02853435|4025992|FG004|COMPLETED|Part 1a, Period 1 (3 Days)||0
3291896|NCT02853435|4025993|FG005|COMPLETED|Part 1a, Period 1 (3 Days)||0
3291897|NCT02853435|4025988|FG000|NOT COMPLETED|Part 1a, Period 1 (3 Days)||0
3291898|NCT02853435|4025989|FG001|NOT COMPLETED|Part 1a, Period 1 (3 Days)||0
3291899|NCT02853435|4025990|FG002|NOT COMPLETED|Part 1a, Period 1 (3 Days)||0
3104214|NCT01523808|3827955|FG002|COMPLETED|Overall Study||1
3104215|NCT01523808|3827956|FG003|COMPLETED|Overall Study||0
3104216|NCT01523808|3827953|FG000|NOT COMPLETED|Overall Study||3
3104217|NCT01523808|3827954|FG001|NOT COMPLETED|Overall Study||0
3104218|NCT01523808|3827955|FG002|NOT COMPLETED|Overall Study||2
3104219|NCT01523808|3827956|FG003|NOT COMPLETED|Overall Study||3
3104220|NCT01523821|3827978|FG000|STARTED|Overall Study||8
3104221|NCT01523821|3827979|FG001|STARTED|Overall Study||6
3104222|NCT01523821|3827980|FG002|STARTED|Overall Study||6
3104223|NCT01523821|3827978|FG000|COMPLETED|Overall Study||8
3104224|NCT01523821|3827979|FG001|COMPLETED|Overall Study||6
3104225|NCT01523821|3827980|FG002|COMPLETED|Overall Study||6
3104226|NCT01523821|3827978|FG000|NOT COMPLETED|Overall Study||0
3104227|NCT01523821|3827979|FG001|NOT COMPLETED|Overall Study||0
3104228|NCT01523821|3827980|FG002|NOT COMPLETED|Overall Study||0
3104229|NCT01523834|3827988|FG000|STARTED|Overall Study|Started Induction Phase|35
3104230|NCT01523834|3827988|FG000|Consolidation Phase|Overall Study|Started Consolidation Phase|7
3104231|NCT01523834|3827988|FG000|Maintenance Phase|Overall Study|Started Maintenance Phase|6
3104232|NCT01523834|3827988|FG000|COMPLETED|Overall Study||4
3104233|NCT01523834|3827988|FG000|NOT COMPLETED|Overall Study||31
3104234|NCT01523873|3827993|FG000|STARTED|Overall Study||35921
3104235|NCT01523873|3827993|FG000|Administered With Dotarem|Overall Study||35474
3104236|NCT01523873|3827993|FG000|COMPLETED|Overall Study||35499
3104237|NCT01523873|3827993|FG000|NOT COMPLETED|Overall Study||422
3104238|NCT01523886|3828001|FG000|STARTED|Overall Study||25
3104239|NCT01523886|3828002|FG001|STARTED|Overall Study||24
3104240|NCT01523886|3828001|FG000|COMPLETED|Overall Study||25
3104241|NCT01523886|3828002|FG001|COMPLETED|Overall Study||23
3104242|NCT01523886|3828001|FG000|NOT COMPLETED|Overall Study||0
3104243|NCT01523886|3828002|FG001|NOT COMPLETED|Overall Study||1
3104244|NCT01523899|3828010|FG000|STARTED|Overall Study||126
3104245|NCT01523899|3828011|FG001|STARTED|Overall Study||126
3104246|NCT01523899|3828010|FG000|COMPLETED|Overall Study||126
3104247|NCT01523899|3828011|FG001|COMPLETED|Overall Study||126
3163136|NCT01883453|3890603|FG000|COMPLETED|Overall Study||48
3163137|NCT01883453|3890604|FG001|COMPLETED|Overall Study||50
3163138|NCT01883453|3890603|FG000|NOT COMPLETED|Overall Study||25
3163139|NCT01883453|3890604|FG001|NOT COMPLETED|Overall Study||23
3163140|NCT01883492|3890612|FG000|STARTED|Overall Study||75
3163141|NCT01883492|3890613|FG001|STARTED|Overall Study||78
3163142|NCT01883492|3890612|FG000|COMPLETED|Overall Study||62
3163143|NCT01883492|3890613|FG001|COMPLETED|Overall Study||67
3163144|NCT01883492|3890612|FG000|NOT COMPLETED|Overall Study||13
3104248|NCT01523899|3828010|FG000|NOT COMPLETED|Overall Study||0
3104249|NCT01523899|3828011|FG001|NOT COMPLETED|Overall Study||0
3104250|NCT01523964|3828022|FG000|STARTED|Overall Study||31
3104251|NCT01523964|3828023|FG001|STARTED|Overall Study||30
3104252|NCT01523964|3828024|FG002|STARTED|Overall Study||16
3104253|NCT01523964|3828025|FG003|STARTED|Overall Study||15
3104254|NCT01523964|3828022|FG000|COMPLETED|Overall Study||31
3104255|NCT01523964|3828023|FG001|COMPLETED|Overall Study||30
3104256|NCT01523964|3828024|FG002|COMPLETED|Overall Study||16
3104257|NCT01523964|3828025|FG003|COMPLETED|Overall Study||15
3104258|NCT01523964|3828022|FG000|NOT COMPLETED|Overall Study||0
3104259|NCT01523964|3828023|FG001|NOT COMPLETED|Overall Study||0
3104260|NCT01523964|3828024|FG002|NOT COMPLETED|Overall Study||0
3104261|NCT01523964|3828025|FG003|NOT COMPLETED|Overall Study||0
3104262|NCT01524133|3828038|FG000|STARTED|Treatment Phase||71
3104263|NCT01524133|3828039|FG001|STARTED|Treatment Phase||69
3104264|NCT01524133|3828040|FG002|STARTED|Treatment Phase||67
3104265|NCT01524133|3828038|FG000|COMPLETED|Treatment Phase|Completed Both Assigned treatment|52
3104266|NCT01524133|3828039|FG001|COMPLETED|Treatment Phase|Completed Both Assigned Treatments|37
3104267|NCT01524133|3828040|FG002|COMPLETED|Treatment Phase|Completed both assigned treatments|31
3104268|NCT01524133|3828038|FG000|NOT COMPLETED|Treatment Phase||19
3104269|NCT01524133|3828039|FG001|NOT COMPLETED|Treatment Phase||32
3104270|NCT01524133|3828040|FG002|NOT COMPLETED|Treatment Phase||36
3104271|NCT01524133|3828038|FG000|STARTED|Overall Study 52 Weeks||71
3104272|NCT01524133|3828039|FG001|STARTED|Overall Study 52 Weeks||69
3104273|NCT01524133|3828040|FG002|STARTED|Overall Study 52 Weeks||67
3104274|NCT01524133|3828038|FG000|COMPLETED|Overall Study 52 Weeks||50
3104275|NCT01524133|3828039|FG001|COMPLETED|Overall Study 52 Weeks||49
3104276|NCT01524133|3828040|FG002|COMPLETED|Overall Study 52 Weeks||40
3104277|NCT01524133|3828038|FG000|NOT COMPLETED|Overall Study 52 Weeks||21
3104278|NCT01524133|3828039|FG001|NOT COMPLETED|Overall Study 52 Weeks||20
3104279|NCT01524133|3828040|FG002|NOT COMPLETED|Overall Study 52 Weeks||27
3104280|NCT01524198|3828050|FG000|STARTED|Overall Study||471
3104281|NCT01524198|3828051|FG001|STARTED|Overall Study||474
3104282|NCT01524198|3828050|FG000|COMPLETED|Overall Study||448
3104283|NCT01524198|3828051|FG001|COMPLETED|Overall Study||458
3104284|NCT01524198|3828050|FG000|NOT COMPLETED|Overall Study||23
3104285|NCT01524198|3828051|FG001|NOT COMPLETED|Overall Study||16
3104286|NCT01524224|3828065|FG000|STARTED|Overall Study||4
3104287|NCT01524224|3828066|FG001|STARTED|Overall Study||3
3104288|NCT01524224|3828067|FG002|STARTED|Overall Study||3
3104289|NCT01524224|3828068|FG003|STARTED|Overall Study||3
3104290|NCT01524224|3828069|FG004|STARTED|Overall Study||4
3104291|NCT01524224|3828070|FG005|STARTED|Overall Study||3
3104292|NCT01524224|3828071|FG006|STARTED|Overall Study||3
3104293|NCT01524224|3828072|FG007|STARTED|Overall Study||6
3104294|NCT01524224|3828065|FG000|Received at Least One Dose of Study Drug|Overall Study||4
3104295|NCT01524224|3828066|FG001|Received at Least One Dose of Study Drug|Overall Study||3
3104296|NCT01524224|3828067|FG002|Received at Least One Dose of Study Drug|Overall Study||3
3104297|NCT01524224|3828068|FG003|Received at Least One Dose of Study Drug|Overall Study||3
3104298|NCT01524224|3828069|FG004|Received at Least One Dose of Study Drug|Overall Study||4
3104299|NCT01524224|3828070|FG005|Received at Least One Dose of Study Drug|Overall Study||3
3104300|NCT01524224|3828071|FG006|Received at Least One Dose of Study Drug|Overall Study||3
3163145|NCT01883492|3890613|FG001|NOT COMPLETED|Overall Study||11
3163146|NCT01883635|3890621|FG000|STARTED|Overall Study||24
3104301|NCT01524224|3828072|FG007|Received at Least One Dose of Study Drug|Overall Study||6
3104302|NCT01524224|3828065|FG000|COMPLETED|Overall Study||1
3104303|NCT01524224|3828066|FG001|COMPLETED|Overall Study||2
3104304|NCT01524224|3828067|FG002|COMPLETED|Overall Study||1
3104305|NCT01524224|3828068|FG003|COMPLETED|Overall Study||1
3104306|NCT01524224|3828069|FG004|COMPLETED|Overall Study||0
3104307|NCT01524224|3828070|FG005|COMPLETED|Overall Study||1
3104308|NCT01524224|3828071|FG006|COMPLETED|Overall Study||0
3104309|NCT01524224|3828072|FG007|COMPLETED|Overall Study||0
3104310|NCT01524224|3828065|FG000|NOT COMPLETED|Overall Study||3
3104311|NCT01524224|3828066|FG001|NOT COMPLETED|Overall Study||1
3104312|NCT01524224|3828067|FG002|NOT COMPLETED|Overall Study||2
3104313|NCT01524224|3828068|FG003|NOT COMPLETED|Overall Study||2
3104314|NCT01524224|3828069|FG004|NOT COMPLETED|Overall Study||4
3104315|NCT01524224|3828070|FG005|NOT COMPLETED|Overall Study||2
3104316|NCT01524224|3828071|FG006|NOT COMPLETED|Overall Study||3
3104317|NCT01524224|3828072|FG007|NOT COMPLETED|Overall Study||6
3104318|NCT01524289|3828092|FG000|STARTED|Overall Study||204
3104319|NCT01524289|3828093|FG001|STARTED|Overall Study||102
3104320|NCT01524289|3828092|FG000|Treated|Overall Study||203
3104321|NCT01524289|3828093|FG001|Treated|Overall Study||102
3104322|NCT01524289|3828092|FG000|COMPLETED|Overall Study||174
3104323|NCT01524289|3828093|FG001|COMPLETED|Overall Study||88
3104324|NCT01524289|3828092|FG000|NOT COMPLETED|Overall Study||30
3104325|NCT01524289|3828093|FG001|NOT COMPLETED|Overall Study||14
3104326|NCT01524302|3828103|FG000|STARTED|Overall Study||6
3104327|NCT01524302|3828104|FG001|STARTED|Overall Study||6
3104328|NCT01524302|3828103|FG000|COMPLETED|Overall Study||6
3104329|NCT01524302|3828104|FG001|COMPLETED|Overall Study||6
3104330|NCT01524302|3828103|FG000|NOT COMPLETED|Overall Study||0
3104331|NCT01524302|3828104|FG001|NOT COMPLETED|Overall Study||0
3104332|NCT01524627|3828116|FG000|STARTED|Overall Study||22
3104333|NCT01524627|3828117|FG001|STARTED|Overall Study||21
3104334|NCT01524627|3828116|FG000|COMPLETED|Overall Study||21
3104335|NCT01524627|3828117|FG001|COMPLETED|Overall Study||19
3104336|NCT01524627|3828116|FG000|NOT COMPLETED|Overall Study||1
3104337|NCT01524627|3828117|FG001|NOT COMPLETED|Overall Study||2
3104338|NCT01524679|3828125|FG000|STARTED|Overall Study||112
3104339|NCT01524679|3828126|FG001|STARTED|Overall Study||58
3104340|NCT01524679|3828125|FG000|COMPLETED|Overall Study||89
3104341|NCT01524679|3828126|FG001|COMPLETED|Overall Study||49
3104342|NCT01524679|3828125|FG000|NOT COMPLETED|Overall Study||23
3104343|NCT01524679|3828126|FG001|NOT COMPLETED|Overall Study||9
3104344|NCT01524692|3828132|FG000|STARTED|Overall Study||35
3104345|NCT01524692|3828132|FG000|COMPLETED|Overall Study||32
3104346|NCT01524692|3828132|FG000|NOT COMPLETED|Overall Study||3
3104347|NCT01524770|3828137|FG000|STARTED|First Intervention||26
3104348|NCT01524770|3828138|FG001|STARTED|First Intervention||24
3104349|NCT01524770|3828137|FG000|Received at Least 1 Dose of Study Drug|First Intervention||26
3104350|NCT01524770|3828138|FG001|Received at Least 1 Dose of Study Drug|First Intervention||24
3104351|NCT01524770|3828137|FG000|COMPLETED|First Intervention||23
3104352|NCT01524770|3828138|FG001|COMPLETED|First Intervention||23
3104353|NCT01524770|3828137|FG000|NOT COMPLETED|First Intervention||3
3104354|NCT01524770|3828138|FG001|NOT COMPLETED|First Intervention||1
3104355|NCT01524770|3828137|FG000|STARTED|Washout Period of at Least 28 Days||23
3104356|NCT01524770|3828138|FG001|STARTED|Washout Period of at Least 28 Days||23
3104357|NCT01524770|3828137|FG000|COMPLETED|Washout Period of at Least 28 Days||23
3104358|NCT01524770|3828138|FG001|COMPLETED|Washout Period of at Least 28 Days||23
3104359|NCT01524770|3828137|FG000|NOT COMPLETED|Washout Period of at Least 28 Days||0
3104360|NCT01524770|3828138|FG001|NOT COMPLETED|Washout Period of at Least 28 Days||0
3104361|NCT01524770|3828137|FG000|STARTED|Second Intervention||23
3104362|NCT01524770|3828138|FG001|STARTED|Second Intervention||23
3104363|NCT01524770|3828137|FG000|COMPLETED|Second Intervention||23
3104364|NCT01524770|3828138|FG001|COMPLETED|Second Intervention||23
3104365|NCT01524770|3828137|FG000|NOT COMPLETED|Second Intervention||0
3104366|NCT01524770|3828138|FG001|NOT COMPLETED|Second Intervention||0
3104367|NCT01524783|3828146|FG000|STARTED|Blinded Period||205
3104368|NCT01524783|3828147|FG001|STARTED|Blinded Period||97
3104369|NCT01524783|3828148|FG002|STARTED|Blinded Period||0
3104370|NCT01524783|3828146|FG000|COMPLETED|Blinded Period||26
3104371|NCT01524783|3828147|FG001|COMPLETED|Blinded Period||6
3104372|NCT01524783|3828148|FG002|COMPLETED|Blinded Period||0
3104373|NCT01524783|3828146|FG000|NOT COMPLETED|Blinded Period||179
3104374|NCT01524783|3828147|FG001|NOT COMPLETED|Blinded Period||91
3104375|NCT01524783|3828148|FG002|NOT COMPLETED|Blinded Period||0
3104376|NCT01524783|3828146|FG000|STARTED|Open-label Period||26
3104377|NCT01524783|3828147|FG001|STARTED|Open-label Period||0
3104378|NCT01524783|3828148|FG002|STARTED|Open-label Period||6
3104379|NCT01524783|3828146|FG000|COMPLETED|Open-label Period||0
3104380|NCT01524783|3828147|FG001|COMPLETED|Open-label Period||0
3104381|NCT01524783|3828148|FG002|COMPLETED|Open-label Period||0
3104382|NCT01524783|3828146|FG000|NOT COMPLETED|Open-label Period||26
3104383|NCT01524783|3828147|FG001|NOT COMPLETED|Open-label Period||0
3104384|NCT01524783|3828148|FG002|NOT COMPLETED|Open-label Period||6
3104385|NCT01524796|3828160|FG000|STARTED|Overall Study||128
3104386|NCT01524796|3828160|FG000|COMPLETED|Overall Study||100
3104387|NCT01524796|3828160|FG000|NOT COMPLETED|Overall Study||28
3104388|NCT01524887|3828167|FG000|STARTED|Overall Study||85
3104389|NCT01524887|3828168|FG001|STARTED|Overall Study||90
3104390|NCT01524887|3828169|FG002|STARTED|Overall Study||86
3104391|NCT01524887|3828167|FG000|Received Treatment|Overall Study||83
3104392|NCT01524887|3828168|FG001|Received Treatment|Overall Study||85
3104393|NCT01524887|3828169|FG002|Received Treatment|Overall Study||83
3104394|NCT01524887|3828167|FG000|COMPLETED|Overall Study|No subject completed the study as Baxter Healthcare terminated the study early.|0
3104395|NCT01524887|3828168|FG001|COMPLETED|Overall Study|No subject completed the study as Baxter Healthcare terminated the study early.|0
3104396|NCT01524887|3828169|FG002|COMPLETED|Overall Study|No subject completed the study as Baxter Healthcare terminated the study early.|0
3104397|NCT01524887|3828167|FG000|NOT COMPLETED|Overall Study||85
3104398|NCT01524887|3828168|FG001|NOT COMPLETED|Overall Study||90
3104399|NCT01524887|3828169|FG002|NOT COMPLETED|Overall Study||86
3104400|NCT01524900|3828182|FG000|STARTED|Overall Study||49
3104401|NCT01524900|3828183|FG001|STARTED|Overall Study||246
3104402|NCT01524900|3828184|FG002|STARTED|Overall Study||30
3104403|NCT01524900|3828185|FG003|STARTED|Overall Study||22
3104404|NCT01524900|3828186|FG004|STARTED|Overall Study||40
3104405|NCT01524900|3828182|FG000|COMPLETED|Overall Study||43
3104406|NCT01524900|3828183|FG001|COMPLETED|Overall Study||232
3104407|NCT01524900|3828184|FG002|COMPLETED|Overall Study||29
3104408|NCT01524900|3828185|FG003|COMPLETED|Overall Study||21
3104409|NCT01524900|3828186|FG004|COMPLETED|Overall Study||40
3104410|NCT01524900|3828182|FG000|NOT COMPLETED|Overall Study||6
3104411|NCT01524900|3828183|FG001|NOT COMPLETED|Overall Study||14
3104412|NCT01524900|3828184|FG002|NOT COMPLETED|Overall Study||1
3104413|NCT01524900|3828185|FG003|NOT COMPLETED|Overall Study||1
3104414|NCT01524900|3828186|FG004|NOT COMPLETED|Overall Study||0
3104415|NCT01524913|3828202|FG000|STARTED|Overall Study||35
3104416|NCT01524913|3828203|FG001|STARTED|Overall Study||36
3104417|NCT01524913|3828204|FG002|STARTED|Overall Study||31
3104418|NCT01524913|3828202|FG000|COMPLETED|Overall Study||31
3104419|NCT01524913|3828203|FG001|COMPLETED|Overall Study||36
3104420|NCT01524913|3828204|FG002|COMPLETED|Overall Study||31
3104421|NCT01524913|3828202|FG000|NOT COMPLETED|Overall Study||4
3104422|NCT01524913|3828203|FG001|NOT COMPLETED|Overall Study||0
3104423|NCT01524913|3828204|FG002|NOT COMPLETED|Overall Study||0
3104424|NCT01524978|3828223|FG000|STARTED|Overall Study||62
3104425|NCT01524978|3828224|FG001|STARTED|Overall Study||4
3104426|NCT01524978|3828225|FG002|STARTED|Overall Study||10
3104427|NCT01524978|3828226|FG003|STARTED|Overall Study||27
3104428|NCT01524978|3828227|FG004|STARTED|Overall Study||9
3104429|NCT01524978|3828228|FG005|STARTED|Overall Study||9
3104430|NCT01524978|3828229|FG006|STARTED|Overall Study||26
3104431|NCT01524978|3828230|FG007|STARTED|Overall Study||12
3104432|NCT01524978|3828231|FG008|STARTED|Overall Study||12
3104433|NCT01524978|3828232|FG009|STARTED|Overall Study||9
3104434|NCT01524978|3828233|FG010|STARTED|Overall Study||28
3104435|NCT01524978|3828223|FG000|COMPLETED|Overall Study||0
3104436|NCT01524978|3828224|FG001|COMPLETED|Overall Study||0
3104437|NCT01524978|3828225|FG002|COMPLETED|Overall Study||0
3104438|NCT01524978|3828226|FG003|COMPLETED|Overall Study||0
3104439|NCT01524978|3828227|FG004|COMPLETED|Overall Study||0
3104440|NCT01524978|3828228|FG005|COMPLETED|Overall Study||0
3104441|NCT01524978|3828229|FG006|COMPLETED|Overall Study||0
3104442|NCT01524978|3828230|FG007|COMPLETED|Overall Study||0
3104443|NCT01524978|3828231|FG008|COMPLETED|Overall Study||0
3104444|NCT01524978|3828232|FG009|COMPLETED|Overall Study||0
3104445|NCT01524978|3828233|FG010|COMPLETED|Overall Study||0
3104446|NCT01524978|3828223|FG000|NOT COMPLETED|Overall Study||62
3104447|NCT01524978|3828224|FG001|NOT COMPLETED|Overall Study||4
3104448|NCT01524978|3828225|FG002|NOT COMPLETED|Overall Study||10
3104449|NCT01524978|3828226|FG003|NOT COMPLETED|Overall Study||27
3104450|NCT01524978|3828227|FG004|NOT COMPLETED|Overall Study||9
3104451|NCT01524978|3828228|FG005|NOT COMPLETED|Overall Study||9
3104452|NCT01524978|3828229|FG006|NOT COMPLETED|Overall Study||26
3104453|NCT01524978|3828230|FG007|NOT COMPLETED|Overall Study||12
3104454|NCT01524978|3828231|FG008|NOT COMPLETED|Overall Study||12
3104455|NCT01524978|3828232|FG009|NOT COMPLETED|Overall Study||9
3104456|NCT01524978|3828233|FG010|NOT COMPLETED|Overall Study||28
3104457|NCT01524991|3828248|FG000|STARTED|Overall Study||36
3104458|NCT01524991|3828248|FG000|COMPLETED|Overall Study||2
3104459|NCT01524991|3828248|FG000|NOT COMPLETED|Overall Study||34
3104460|NCT01525082|3828252|FG000|STARTED|Overall Study||20
3104461|NCT01525082|3828252|FG000|COMPLETED|Overall Study||19
3104462|NCT01525082|3828252|FG000|NOT COMPLETED|Overall Study||1
3104463|NCT01525173|3828261|FG000|STARTED|Overall Study||70
3104464|NCT01525173|3828262|FG001|STARTED|Overall Study||67
3104465|NCT01525173|3828261|FG000|COMPLETED|Overall Study||63
3104466|NCT01525173|3828262|FG001|COMPLETED|Overall Study||62
3104467|NCT01525173|3828261|FG000|NOT COMPLETED|Overall Study||7
3104468|NCT01525173|3828262|FG001|NOT COMPLETED|Overall Study||5
3104469|NCT01525225|3828268|FG000|STARTED|Enrollment||4
3104470|NCT01525225|3828268|FG000|COMPLETED|Enrollment||2
3104471|NCT01525225|3828268|FG000|NOT COMPLETED|Enrollment||2
3104472|NCT01525225|3828268|FG000|STARTED|Treated||2
3104473|NCT01525225|3828268|FG000|COMPLETED|Treated||2
3104474|NCT01525225|3828268|FG000|NOT COMPLETED|Treated||0
3104475|NCT01525238|3828275|FG000|STARTED|Overall Study||8
3104476|NCT01525238|3828276|FG001|STARTED|Overall Study||8
3104477|NCT01525238|3828277|FG002|STARTED|Overall Study||8
3104478|NCT01525238|3828275|FG000|COMPLETED|Overall Study||7
3104479|NCT01525238|3828276|FG001|COMPLETED|Overall Study||8
3104480|NCT01525238|3828277|FG002|COMPLETED|Overall Study||8
3104481|NCT01525238|3828275|FG000|NOT COMPLETED|Overall Study||1
3104482|NCT01525238|3828276|FG001|NOT COMPLETED|Overall Study||0
3104483|NCT01525238|3828277|FG002|NOT COMPLETED|Overall Study||0
3104484|NCT01525329|3828287|FG000|STARTED|Overall Study||4
3104485|NCT01525329|3828288|FG001|STARTED|Overall Study||14
3104486|NCT01525329|3828287|FG000|COMPLETED|Overall Study||4
3104487|NCT01525329|3828288|FG001|COMPLETED|Overall Study||14
3104488|NCT01525329|3828287|FG000|NOT COMPLETED|Overall Study||0
3104489|NCT01525329|3828288|FG001|NOT COMPLETED|Overall Study||0
3104490|NCT01525407|3828300|FG000|STARTED|Overall Study||41
3104491|NCT01525407|3828301|FG001|STARTED|Overall Study||42
3104492|NCT01525407|3828300|FG000|COMPLETED|Overall Study||38
3104493|NCT01525407|3828301|FG001|COMPLETED|Overall Study||38
3104494|NCT01525407|3828300|FG000|NOT COMPLETED|Overall Study||3
3104495|NCT01525407|3828301|FG001|NOT COMPLETED|Overall Study||4
3104496|NCT01525420|3828309|FG000|STARTED|Overall Study||59
3104497|NCT01525420|3828310|FG001|STARTED|Overall Study||62
3104498|NCT01525420|3828309|FG000|COMPLETED|Overall Study||43
3104499|NCT01525420|3828310|FG001|COMPLETED|Overall Study||38
3104500|NCT01525420|3828309|FG000|NOT COMPLETED|Overall Study||16
3104501|NCT01525420|3828310|FG001|NOT COMPLETED|Overall Study||24
3104502|NCT01525550|3828318|FG000|STARTED|Overall Study||61
3104503|NCT01525550|3828319|FG001|STARTED|Overall Study||45
3104504|NCT01525550|3828318|FG000|COMPLETED|Overall Study||0
3104505|NCT01525550|3828319|FG001|COMPLETED|Overall Study||0
3104506|NCT01525550|3828318|FG000|NOT COMPLETED|Overall Study||61
3104507|NCT01525550|3828319|FG001|NOT COMPLETED|Overall Study||45
3104508|NCT01525563|3828325|FG000|STARTED|Overall Study||1000
3104509|NCT01525563|3828325|FG000|End of Treatment|Overall Study|Only patients who had cycle regularization at end of treatment were allowed to continue.|910
3104510|NCT01525563|3828325|FG000|3 Months Follow-up|Overall Study|Only patients who had cycle regularization at end of treatment were allowed to continue.|838
3104511|NCT01525563|3828325|FG000|COMPLETED|Overall Study|6 Months Follow-up|788
3104512|NCT01525563|3828325|FG000|NOT COMPLETED|Overall Study||212
3104513|NCT01525589|3828332|FG000|STARTED|Overall Study||56
3104514|NCT01525589|3828333|FG001|STARTED|Overall Study||20
3163147|NCT01883635|3890622|FG001|STARTED|Overall Study||20
3163148|NCT01883635|3890621|FG000|COMPLETED|Overall Study||20
3163149|NCT01883635|3890622|FG001|COMPLETED|Overall Study||20
3104515|NCT01525589|3828334|FG002|STARTED|Overall Study||35
3104516|NCT01525589|3828332|FG000|COMPLETED|Overall Study||0
3104517|NCT01525589|3828333|FG001|COMPLETED|Overall Study||0
3104518|NCT01525589|3828334|FG002|COMPLETED|Overall Study||0
3104519|NCT01525589|3828332|FG000|NOT COMPLETED|Overall Study||56
3104520|NCT01525589|3828333|FG001|NOT COMPLETED|Overall Study||20
3104521|NCT01525589|3828334|FG002|NOT COMPLETED|Overall Study||35
3104522|NCT01525602|3828350|FG000|STARTED|Overall Study||9
3104523|NCT01525602|3828351|FG001|STARTED|Overall Study||3
3104524|NCT01525602|3828352|FG002|STARTED|Overall Study||3
3104525|NCT01525602|3828353|FG003|STARTED|Overall Study||6
3104526|NCT01525602|3828354|FG004|STARTED|Overall Study||33
3104527|NCT01525602|3828355|FG005|STARTED|Overall Study||7
3104528|NCT01525602|3828356|FG006|STARTED|Overall Study||6
3104529|NCT01525602|3828357|FG007|STARTED|Overall Study||7
3104530|NCT01525602|3828350|FG000|COMPLETED|Overall Study||0
3104531|NCT01525602|3828351|FG001|COMPLETED|Overall Study||0
3104532|NCT01525602|3828352|FG002|COMPLETED|Overall Study||0
3104533|NCT01525602|3828353|FG003|COMPLETED|Overall Study||0
3104534|NCT01525602|3828354|FG004|COMPLETED|Overall Study||0
3104535|NCT01525602|3828355|FG005|COMPLETED|Overall Study||0
3104536|NCT01525602|3828356|FG006|COMPLETED|Overall Study||0
3104537|NCT01525602|3828357|FG007|COMPLETED|Overall Study||0
3104538|NCT01525602|3828350|FG000|NOT COMPLETED|Overall Study||9
3104539|NCT01525602|3828351|FG001|NOT COMPLETED|Overall Study||3
3104540|NCT01525602|3828352|FG002|NOT COMPLETED|Overall Study||3
3104541|NCT01525602|3828353|FG003|NOT COMPLETED|Overall Study||6
3104542|NCT01525602|3828354|FG004|NOT COMPLETED|Overall Study||33
3104543|NCT01525602|3828355|FG005|NOT COMPLETED|Overall Study||7
3104544|NCT01525602|3828356|FG006|NOT COMPLETED|Overall Study||6
3104545|NCT01525602|3828357|FG007|NOT COMPLETED|Overall Study||7
3104546|NCT01525615|3828385|FG000|STARTED|Overall Study||132
3104547|NCT01525615|3828386|FG001|STARTED|Overall Study||133
3104548|NCT01525615|3828387|FG002|STARTED|Overall Study||139
3104549|NCT01525615|3828385|FG000|COMPLETED|Overall Study||118
3104550|NCT01525615|3828386|FG001|COMPLETED|Overall Study||126
3104551|NCT01525615|3828387|FG002|COMPLETED|Overall Study||133
3104552|NCT01525615|3828385|FG000|NOT COMPLETED|Overall Study||14
3104553|NCT01525615|3828386|FG001|NOT COMPLETED|Overall Study||7
3104554|NCT01525615|3828387|FG002|NOT COMPLETED|Overall Study||6
3104555|NCT01525628|3828400|FG000|STARTED|Overall Study||16
3104556|NCT01525628|3828401|FG001|STARTED|Overall Study||19
3104557|NCT01525628|3828402|FG002|STARTED|Overall Study||16
3104558|NCT01525628|3828403|FG003|STARTED|Overall Study||14
3104559|NCT01525628|3828404|FG004|STARTED|Overall Study||7
3104560|NCT01525628|3828400|FG000|COMPLETED|Overall Study||14
3104561|NCT01525628|3828401|FG001|COMPLETED|Overall Study||14
3104562|NCT01525628|3828402|FG002|COMPLETED|Overall Study||11
3104563|NCT01525628|3828403|FG003|COMPLETED|Overall Study||10
3104564|NCT01525628|3828404|FG004|COMPLETED|Overall Study||4
3104565|NCT01525628|3828400|FG000|NOT COMPLETED|Overall Study||2
3104566|NCT01525628|3828401|FG001|NOT COMPLETED|Overall Study||5
3104567|NCT01525628|3828402|FG002|NOT COMPLETED|Overall Study||5
3104568|NCT01525628|3828403|FG003|NOT COMPLETED|Overall Study||4
3104569|NCT01525628|3828404|FG004|NOT COMPLETED|Overall Study||3
3104570|NCT01525641|3828418|FG000|STARTED|Overall Study||615
3104571|NCT01525641|3828418|FG000|COMPLETED|Overall Study||435
3104572|NCT01525641|3828418|FG000|NOT COMPLETED|Overall Study||180
3104573|NCT01525667|3828425|FG000|STARTED|Overall Study||7
3104574|NCT01525667|3828426|FG001|STARTED|Overall Study||6
3104575|NCT01525667|3828427|FG002|STARTED|Overall Study||7
3104576|NCT01525667|3828425|FG000|COMPLETED|Overall Study||7
3104577|NCT01525667|3828426|FG001|COMPLETED|Overall Study||6
3104578|NCT01525667|3828427|FG002|COMPLETED|Overall Study||7
3104579|NCT01525667|3828425|FG000|NOT COMPLETED|Overall Study||0
3104580|NCT01525667|3828426|FG001|NOT COMPLETED|Overall Study||0
3104581|NCT01525667|3828427|FG002|NOT COMPLETED|Overall Study||0
3104582|NCT01525849|3828439|FG000|STARTED|Overall Study||76
3104583|NCT01525849|3828440|FG001|STARTED|Overall Study||75
3104584|NCT01525849|3828439|FG000|Treated|Overall Study|2 withdrew before treatment: 1 didn't want balloon dilation, 1 unrelated medical issue.|74
3104585|NCT01525849|3828440|FG001|Treated|Overall Study|14 withdrew before treatment: 8 didn't want FESS, 1 too busy, 2 medical issues, 3 excl. criteria.|61
3104586|NCT01525849|3828439|FG000|6-Months|Overall Study||73
3104587|NCT01525849|3828440|FG001|6-Months|Overall Study||60
3104588|NCT01525849|3828439|FG000|COMPLETED|Overall Study||71
3104589|NCT01525849|3828440|FG001|COMPLETED|Overall Study||59
3104590|NCT01525849|3828439|FG000|NOT COMPLETED|Overall Study||5
3104591|NCT01525849|3828440|FG001|NOT COMPLETED|Overall Study||16
3104592|NCT01525862|3828446|FG000|STARTED|Overall Study||21
3104593|NCT01525862|3828446|FG000|COMPLETED|Overall Study||21
3104594|NCT01525862|3828446|FG000|NOT COMPLETED|Overall Study||0
3104595|NCT01525875|3828452|FG000|STARTED|Placebo-controlled Period||22
3104596|NCT01525875|3828453|FG001|STARTED|Placebo-controlled Period||22
3104597|NCT01525875|3828452|FG000|COMPLETED|Placebo-controlled Period||21
3104598|NCT01525875|3828453|FG001|COMPLETED|Placebo-controlled Period||20
3104599|NCT01525875|3828452|FG000|NOT COMPLETED|Placebo-controlled Period||1
3104600|NCT01525875|3828453|FG001|NOT COMPLETED|Placebo-controlled Period||2
3104601|NCT01525875|3828452|FG000|STARTED|Open-label Period||21
3104602|NCT01525875|3828453|FG001|STARTED|Open-label Period||20
3104603|NCT01525875|3828452|FG000|COMPLETED|Open-label Period||21
3104604|NCT01525875|3828453|FG001|COMPLETED|Open-label Period||18
3104605|NCT01525875|3828452|FG000|NOT COMPLETED|Open-label Period||0
3104606|NCT01525875|3828453|FG001|NOT COMPLETED|Open-label Period||2
3104607|NCT01526057|3828462|FG000|STARTED|Overall Study||73
3104608|NCT01526057|3828463|FG001|STARTED|Overall Study||74
3104609|NCT01526057|3828464|FG002|STARTED|Overall Study||73
3104610|NCT01526057|3828462|FG000|COMPLETED|Overall Study||64
3104611|NCT01526057|3828463|FG001|COMPLETED|Overall Study||71
3104612|NCT01526057|3828464|FG002|COMPLETED|Overall Study||67
3104613|NCT01526057|3828462|FG000|NOT COMPLETED|Overall Study||9
3104614|NCT01526057|3828463|FG001|NOT COMPLETED|Overall Study||3
3104615|NCT01526057|3828464|FG002|NOT COMPLETED|Overall Study||6
3104616|NCT01526148|3828474|FG000|STARTED|Overall Study||18
3104617|NCT01526148|3828475|FG001|STARTED|Overall Study||24
3104618|NCT01526148|3828474|FG000|COMPLETED|Overall Study||4
3104619|NCT01526148|3828475|FG001|COMPLETED|Overall Study||11
3104620|NCT01526148|3828474|FG000|NOT COMPLETED|Overall Study||14
3104621|NCT01526148|3828475|FG001|NOT COMPLETED|Overall Study||13
3104622|NCT01526213|3828487|FG000|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
3104623|NCT01526213|3828488|FG001|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
3104624|NCT01526213|3828489|FG002|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
3104625|NCT01526213|3828490|FG003|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
3104626|NCT01526213|3828491|FG004|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
3104627|NCT01526213|3828492|FG005|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to (and completed) one of six sequences.|3
3104628|NCT01526213|3828487|FG000|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
3104629|NCT01526213|3828488|FG001|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
3104630|NCT01526213|3828489|FG002|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
3104631|NCT01526213|3828490|FG003|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
3104632|NCT01526213|3828491|FG004|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
3104633|NCT01526213|3828492|FG005|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
3104634|NCT01526213|3828487|FG000|NOT COMPLETED|Period 1 (5 Days)||0
3104635|NCT01526213|3828488|FG001|NOT COMPLETED|Period 1 (5 Days)||0
3104636|NCT01526213|3828489|FG002|NOT COMPLETED|Period 1 (5 Days)||0
3104637|NCT01526213|3828490|FG003|NOT COMPLETED|Period 1 (5 Days)||0
3104638|NCT01526213|3828491|FG004|NOT COMPLETED|Period 1 (5 Days)||0
3104639|NCT01526213|3828492|FG005|NOT COMPLETED|Period 1 (5 Days)||0
3104640|NCT01526213|3828487|FG000|STARTED|Washout 1 (10 Days)||3
3104641|NCT01526213|3828488|FG001|STARTED|Washout 1 (10 Days)||3
3104642|NCT01526213|3828489|FG002|STARTED|Washout 1 (10 Days)||3
3104643|NCT01526213|3828490|FG003|STARTED|Washout 1 (10 Days)||3
3104644|NCT01526213|3828491|FG004|STARTED|Washout 1 (10 Days)||3
3104645|NCT01526213|3828492|FG005|STARTED|Washout 1 (10 Days)||3
3104646|NCT01526213|3828487|FG000|COMPLETED|Washout 1 (10 Days)||3
3104647|NCT01526213|3828488|FG001|COMPLETED|Washout 1 (10 Days)||3
3104648|NCT01526213|3828489|FG002|COMPLETED|Washout 1 (10 Days)||3
3104649|NCT01526213|3828490|FG003|COMPLETED|Washout 1 (10 Days)||3
3104650|NCT01526213|3828491|FG004|COMPLETED|Washout 1 (10 Days)||3
3104651|NCT01526213|3828492|FG005|COMPLETED|Washout 1 (10 Days)||3
3104652|NCT01526213|3828487|FG000|NOT COMPLETED|Washout 1 (10 Days)||0
3104653|NCT01526213|3828488|FG001|NOT COMPLETED|Washout 1 (10 Days)||0
3104654|NCT01526213|3828489|FG002|NOT COMPLETED|Washout 1 (10 Days)||0
3104655|NCT01526213|3828490|FG003|NOT COMPLETED|Washout 1 (10 Days)||0
3104656|NCT01526213|3828491|FG004|NOT COMPLETED|Washout 1 (10 Days)||0
3104657|NCT01526213|3828492|FG005|NOT COMPLETED|Washout 1 (10 Days)||0
3104658|NCT01526213|3828487|FG000|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
3104659|NCT01526213|3828488|FG001|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
3104660|NCT01526213|3828489|FG002|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
3104661|NCT01526213|3828490|FG003|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
3104662|NCT01526213|3828491|FG004|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
3104663|NCT01526213|3828492|FG005|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
3104664|NCT01526213|3828487|FG000|COMPLETED|Period 2 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
3104665|NCT01526213|3828488|FG001|COMPLETED|Period 2 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
3104666|NCT01526213|3828489|FG002|COMPLETED|Period 2 (5 Days)|3-way crossover study. Each subject was his/her own control and underwent all 3 treatments.|3
3104667|NCT01526213|3828490|FG003|COMPLETED|Period 2 (5 Days)|3-way crossover study. Each subject was his/her own control and underwent all 3 treatments.|3
3104668|NCT01526213|3828491|FG004|COMPLETED|Period 2 (5 Days)|3-way crossover study. Each subject was his/her own control and underwent all 3 treatments.|3
3104669|NCT01526213|3828492|FG005|COMPLETED|Period 2 (5 Days)|3-way crossover study. Each subject was his/her own control and underwent all 3 treatments.|3
3104670|NCT01526213|3828487|FG000|NOT COMPLETED|Period 2 (5 Days)||0
3104671|NCT01526213|3828488|FG001|NOT COMPLETED|Period 2 (5 Days)||0
3163150|NCT01883635|3890621|FG000|NOT COMPLETED|Overall Study||4
3163151|NCT01883635|3890622|FG001|NOT COMPLETED|Overall Study||0
3163152|NCT01883856|3890632|FG000|STARTED|Overall Study||26
3163153|NCT01883856|3890633|FG001|STARTED|Overall Study||26
3163154|NCT01883856|3890632|FG000|COMPLETED|Overall Study||26
3163155|NCT01883856|3890633|FG001|COMPLETED|Overall Study||26
3163156|NCT01883856|3890632|FG000|NOT COMPLETED|Overall Study||0
3104672|NCT01526213|3828489|FG002|NOT COMPLETED|Period 2 (5 Days)||0
3104673|NCT01526213|3828490|FG003|NOT COMPLETED|Period 2 (5 Days)||0
3104674|NCT01526213|3828491|FG004|NOT COMPLETED|Period 2 (5 Days)||0
3104675|NCT01526213|3828492|FG005|NOT COMPLETED|Period 2 (5 Days)||0
3104676|NCT01526213|3828487|FG000|STARTED|Washout 2 (10 Days)||3
3104677|NCT01526213|3828488|FG001|STARTED|Washout 2 (10 Days)||3
3104678|NCT01526213|3828489|FG002|STARTED|Washout 2 (10 Days)||3
3104679|NCT01526213|3828490|FG003|STARTED|Washout 2 (10 Days)||3
3104680|NCT01526213|3828491|FG004|STARTED|Washout 2 (10 Days)||3
3104681|NCT01526213|3828492|FG005|STARTED|Washout 2 (10 Days)||3
3104682|NCT01526213|3828487|FG000|COMPLETED|Washout 2 (10 Days)||3
3104683|NCT01526213|3828488|FG001|COMPLETED|Washout 2 (10 Days)||3
3104684|NCT01526213|3828489|FG002|COMPLETED|Washout 2 (10 Days)||3
3104685|NCT01526213|3828490|FG003|COMPLETED|Washout 2 (10 Days)||3
3104686|NCT01526213|3828491|FG004|COMPLETED|Washout 2 (10 Days)||3
3104687|NCT01526213|3828492|FG005|COMPLETED|Washout 2 (10 Days)||3
3104688|NCT01526213|3828487|FG000|NOT COMPLETED|Washout 2 (10 Days)||0
3104689|NCT01526213|3828488|FG001|NOT COMPLETED|Washout 2 (10 Days)||0
3104690|NCT01526213|3828489|FG002|NOT COMPLETED|Washout 2 (10 Days)||0
3104691|NCT01526213|3828490|FG003|NOT COMPLETED|Washout 2 (10 Days)||0
3104692|NCT01526213|3828491|FG004|NOT COMPLETED|Washout 2 (10 Days)||0
3104693|NCT01526213|3828492|FG005|NOT COMPLETED|Washout 2 (10 Days)||0
3104694|NCT01526213|3828487|FG000|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
3104695|NCT01526213|3828488|FG001|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
3104696|NCT01526213|3828489|FG002|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
3104697|NCT01526213|3828490|FG003|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
3104698|NCT01526213|3828491|FG004|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
3104699|NCT01526213|3828492|FG005|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
3104700|NCT01526213|3828487|FG000|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
3104701|NCT01526213|3828488|FG001|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
3104702|NCT01526213|3828489|FG002|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
3104703|NCT01526213|3828490|FG003|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
3104704|NCT01526213|3828491|FG004|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
3104705|NCT01526213|3828492|FG005|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
3104706|NCT01526213|3828487|FG000|NOT COMPLETED|Period 3 (5 Days)||0
3104707|NCT01526213|3828488|FG001|NOT COMPLETED|Period 3 (5 Days)||0
3163157|NCT01883856|3890633|FG001|NOT COMPLETED|Overall Study||0
3104708|NCT01526213|3828489|FG002|NOT COMPLETED|Period 3 (5 Days)||0
3104709|NCT01526213|3828490|FG003|NOT COMPLETED|Period 3 (5 Days)||0
3104710|NCT01526213|3828491|FG004|NOT COMPLETED|Period 3 (5 Days)||0
3104711|NCT01526213|3828492|FG005|NOT COMPLETED|Period 3 (5 Days)||0
3104712|NCT01526343|3828503|FG000|STARTED|Overall Study||47
3104713|NCT01526343|3828503|FG000|COMPLETED|Overall Study||47
3104714|NCT01526343|3828503|FG000|NOT COMPLETED|Overall Study||0
3104715|NCT01526356|3828510|FG000|STARTED|Overall Study||59
3104716|NCT01526356|3828511|FG001|STARTED|Overall Study||63
3104717|NCT01526356|3828512|FG002|STARTED|Overall Study||57
3104718|NCT01526356|3828510|FG000|COMPLETED|Overall Study||51
3104719|NCT01526356|3828511|FG001|COMPLETED|Overall Study||53
3104720|NCT01526356|3828512|FG002|COMPLETED|Overall Study||45
3104721|NCT01526356|3828510|FG000|NOT COMPLETED|Overall Study||8
3104722|NCT01526356|3828511|FG001|NOT COMPLETED|Overall Study||10
3104723|NCT01526356|3828512|FG002|NOT COMPLETED|Overall Study||12
3104724|NCT01526538|3828524|FG000|STARTED|Overall Study||30
3104725|NCT01526538|3828525|FG001|STARTED|Overall Study||22
3104726|NCT01526538|3828524|FG000|COMPLETED|Overall Study||21
3104727|NCT01526538|3828525|FG001|COMPLETED|Overall Study||18
3104728|NCT01526538|3828524|FG000|NOT COMPLETED|Overall Study||9
3104729|NCT01526538|3828525|FG001|NOT COMPLETED|Overall Study||4
3104730|NCT01526551|3828533|FG000|STARTED|Overall Study||935
3104731|NCT01526551|3828533|FG000|COMPLETED|Overall Study||511
3104732|NCT01526551|3828533|FG000|NOT COMPLETED|Overall Study||424
3104733|NCT01526577|3828542|FG000|STARTED|Overall Study|1 more subject enrolled as a substitute for 1 withdrawn subject before the administration.|49
3104734|NCT01526577|3828543|FG001|STARTED|Overall Study||12
3104735|NCT01526577|3828544|FG002|STARTED|Overall Study|1 more subject enrolled as a substitute for 1 withdrawn subject before the administration.|33
3104736|NCT01526577|3828545|FG003|STARTED|Overall Study|1 more subject enrolled as a substitute for 1 withdrawn subject before the administration.|9
3104737|NCT01526577|3828546|FG004|STARTED|Overall Study|2 more subjects were enrolled as the substitutes for 2 withdrawn subjects before the administration.|10
3104738|NCT01526577|3828542|FG000|COMPLETED|Overall Study||48
3104739|NCT01526577|3828543|FG001|COMPLETED|Overall Study||12
3104740|NCT01526577|3828544|FG002|COMPLETED|Overall Study||32
3104741|NCT01526577|3828545|FG003|COMPLETED|Overall Study||8
3104742|NCT01526577|3828546|FG004|COMPLETED|Overall Study||8
3104743|NCT01526577|3828542|FG000|NOT COMPLETED|Overall Study||1
3104744|NCT01526577|3828543|FG001|NOT COMPLETED|Overall Study||0
3104745|NCT01526577|3828544|FG002|NOT COMPLETED|Overall Study||1
3104746|NCT01526577|3828545|FG003|NOT COMPLETED|Overall Study||1
3104747|NCT01526577|3828546|FG004|NOT COMPLETED|Overall Study||2
3104748|NCT01526629|3828554|FG000|STARTED|Overall Study||354
3104749|NCT01526629|3828554|FG000|COMPLETED|Overall Study||308
3104750|NCT01526629|3828554|FG000|NOT COMPLETED|Overall Study||46
3104751|NCT01526733|3828558|FG000|STARTED|Phase 1||12
3104752|NCT01526733|3828559|FG001|STARTED|Phase 1|One participant discontinued after receiving insulin-sham and before receiving insulin-rHuPH20.|13
3104753|NCT01526733|3828558|FG000|Received at Least 1 Dose of Study Drug|Phase 1||12
3104754|NCT01526733|3828559|FG001|Received at Least 1 Dose of Study Drug|Phase 1||13
3104755|NCT01526733|3828558|FG000|COMPLETED|Phase 1||10
3104756|NCT01526733|3828559|FG001|COMPLETED|Phase 1||12
3104757|NCT01526733|3828558|FG000|NOT COMPLETED|Phase 1||2
3104758|NCT01526733|3828559|FG001|NOT COMPLETED|Phase 1||1
3104759|NCT01526733|3828558|FG000|STARTED|Washout Period of 5 to 21 Days||10
3104760|NCT01526733|3828559|FG001|STARTED|Washout Period of 5 to 21 Days||12
3104761|NCT01526733|3828558|FG000|COMPLETED|Washout Period of 5 to 21 Days||10
3104762|NCT01526733|3828559|FG001|COMPLETED|Washout Period of 5 to 21 Days||12
3104763|NCT01526733|3828558|FG000|NOT COMPLETED|Washout Period of 5 to 21 Days||0
3104764|NCT01526733|3828559|FG001|NOT COMPLETED|Washout Period of 5 to 21 Days||0
3104765|NCT01526733|3828558|FG000|STARTED|Phase 2||10
3104766|NCT01526733|3828559|FG001|STARTED|Phase 2||12
3104767|NCT01526733|3828558|FG000|COMPLETED|Phase 2||10
3104768|NCT01526733|3828559|FG001|COMPLETED|Phase 2||12
3104769|NCT01526733|3828558|FG000|NOT COMPLETED|Phase 2||0
3104770|NCT01526733|3828559|FG001|NOT COMPLETED|Phase 2||0
3104771|NCT01526785|3828566|FG000|STARTED|Overall Study||113
3104772|NCT01526785|3828566|FG000|COMPLETED|Overall Study||100
3104773|NCT01526785|3828566|FG000|NOT COMPLETED|Overall Study||13
3104774|NCT01526889|3828572|FG000|STARTED|Treatment Period||18
3104775|NCT01526889|3828573|FG001|STARTED|Treatment Period||7
3104776|NCT01526889|3828572|FG000|COMPLETED|Treatment Period||16
3104777|NCT01526889|3828573|FG001|COMPLETED|Treatment Period||7
3104778|NCT01526889|3828572|FG000|NOT COMPLETED|Treatment Period||2
3104779|NCT01526889|3828573|FG001|NOT COMPLETED|Treatment Period||0
3104780|NCT01526889|3828572|FG000|STARTED|Treatment Extension Period||5
3104781|NCT01526889|3828573|FG001|STARTED|Treatment Extension Period||0
3104782|NCT01526889|3828572|FG000|COMPLETED|Treatment Extension Period||4
3104783|NCT01526889|3828573|FG001|COMPLETED|Treatment Extension Period||0
3104784|NCT01526889|3828572|FG000|NOT COMPLETED|Treatment Extension Period||1
3104785|NCT01526889|3828573|FG001|NOT COMPLETED|Treatment Extension Period||0
3291900|NCT02853435|4025991|FG003|NOT COMPLETED|Part 1a, Period 1 (3 Days)||0
3291901|NCT02853435|4025992|FG004|NOT COMPLETED|Part 1a, Period 1 (3 Days)||0
3104786|NCT01526902|3828579|FG000|STARTED|Overall Study||25
3104787|NCT01526902|3828580|FG001|STARTED|Overall Study||24
3104788|NCT01526902|3828579|FG000|COMPLETED|Overall Study||25
3104789|NCT01526902|3828580|FG001|COMPLETED|Overall Study||24
3104790|NCT01526902|3828579|FG000|NOT COMPLETED|Overall Study||0
3104791|NCT01526902|3828580|FG001|NOT COMPLETED|Overall Study||0
3291902|NCT02853435|4025993|FG005|NOT COMPLETED|Part 1a, Period 1 (3 Days)||0
3291903|NCT02853435|4025988|FG000|STARTED|Part 1a, Washout Period 1 (3 Days)||9
3291904|NCT02853435|4025989|FG001|STARTED|Part 1a, Washout Period 1 (3 Days)||9
3291905|NCT02853435|4025990|FG002|STARTED|Part 1a, Washout Period 1 (3 Days)||8
3291906|NCT02853435|4025991|FG003|STARTED|Part 1a, Washout Period 1 (3 Days)||0
3291907|NCT02853435|4025992|FG004|STARTED|Part 1a, Washout Period 1 (3 Days)||0
3291908|NCT02853435|4025993|FG005|STARTED|Part 1a, Washout Period 1 (3 Days)||0
3291909|NCT02853435|4025988|FG000|COMPLETED|Part 1a, Washout Period 1 (3 Days)||9
3291910|NCT02853435|4025989|FG001|COMPLETED|Part 1a, Washout Period 1 (3 Days)||9
3104792|NCT01526928|3828592|FG000|STARTED|Overall Study||38
3104793|NCT01526928|3828593|FG001|STARTED|Overall Study||19
3104794|NCT01526928|3828594|FG002|STARTED|Overall Study||209
3104795|NCT01526928|3828595|FG003|STARTED|Overall Study||245
3104796|NCT01526928|3828596|FG004|STARTED|Overall Study||95
3104797|NCT01526928|3828597|FG005|STARTED|Overall Study||6
3104798|NCT01526928|3828592|FG000|Started Phase 1|Overall Study||38
3104799|NCT01526928|3828593|FG001|Started Phase 1|Overall Study||19
3104800|NCT01526928|3828594|FG002|Started Phase 1|Overall Study||18
3104801|NCT01526928|3828595|FG003|Started Phase 1|Overall Study||17
3104802|NCT01526928|3828596|FG004|Started Phase 1|Overall Study||13
3104803|NCT01526928|3828597|FG005|Started Phase 1|Overall Study||6
3104804|NCT01526928|3828592|FG000|Started Phase 2|Overall Study||0
3104805|NCT01526928|3828593|FG001|Started Phase 2|Overall Study||0
3104806|NCT01526928|3828594|FG002|Started Phase 2|Overall Study||191
3104807|NCT01526928|3828595|FG003|Started Phase 2|Overall Study||228
3104808|NCT01526928|3828596|FG004|Started Phase 2|Overall Study||82
3104809|NCT01526928|3828597|FG005|Started Phase 2|Overall Study||0
3104810|NCT01526928|3828592|FG000|COMPLETED|Overall Study||0
3104811|NCT01526928|3828593|FG001|COMPLETED|Overall Study||0
3104812|NCT01526928|3828594|FG002|COMPLETED|Overall Study||0
3104813|NCT01526928|3828595|FG003|COMPLETED|Overall Study||0
3104814|NCT01526928|3828596|FG004|COMPLETED|Overall Study||0
3104815|NCT01526928|3828597|FG005|COMPLETED|Overall Study||0
3104816|NCT01526928|3828592|FG000|NOT COMPLETED|Overall Study||38
3104817|NCT01526928|3828593|FG001|NOT COMPLETED|Overall Study||19
3104818|NCT01526928|3828594|FG002|NOT COMPLETED|Overall Study||209
3104819|NCT01526928|3828595|FG003|NOT COMPLETED|Overall Study||245
3104820|NCT01526928|3828596|FG004|NOT COMPLETED|Overall Study||95
3104821|NCT01526928|3828597|FG005|NOT COMPLETED|Overall Study||6
3104822|NCT01527006|3828655|FG000|STARTED|Core Study||22
3104823|NCT01527006|3828656|FG001|STARTED|Core Study||28
3104824|NCT01527006|3828655|FG000|COMPLETED|Core Study||20
3104825|NCT01527006|3828656|FG001|COMPLETED|Core Study||22
3104826|NCT01527006|3828655|FG000|NOT COMPLETED|Core Study||2
3104827|NCT01527006|3828656|FG001|NOT COMPLETED|Core Study||6
3104828|NCT01527006|3828655|FG000|STARTED|Extension Phase|Of the 20 subjects who completed the Core Study, 19 subjects continued into the Extension Phase.|19
3104829|NCT01527006|3828656|FG001|STARTED|Extension Phase||22
3104830|NCT01527006|3828655|FG000|COMPLETED|Extension Phase||13
3104831|NCT01527006|3828656|FG001|COMPLETED|Extension Phase||14
3104832|NCT01527006|3828655|FG000|NOT COMPLETED|Extension Phase||6
3104833|NCT01527006|3828656|FG001|NOT COMPLETED|Extension Phase||8
3104834|NCT01527045|3828671|FG000|STARTED|Overall Study||30
3104835|NCT01527045|3828672|FG001|STARTED|Overall Study||5
3104836|NCT01527045|3828673|FG002|STARTED|Overall Study||12
3104837|NCT01527045|3828671|FG000|COMPLETED|Overall Study||29
3104838|NCT01527045|3828672|FG001|COMPLETED|Overall Study||5
3104839|NCT01527045|3828673|FG002|COMPLETED|Overall Study||12
3104840|NCT01527045|3828671|FG000|NOT COMPLETED|Overall Study||1
3104841|NCT01527045|3828672|FG001|NOT COMPLETED|Overall Study||0
3104842|NCT01527045|3828673|FG002|NOT COMPLETED|Overall Study||0
3104843|NCT01527110|3828681|FG000|STARTED|Overall Study||21
3104844|NCT01527110|3828681|FG000|COMPLETED|Overall Study||20
3104845|NCT01527110|3828681|FG000|NOT COMPLETED|Overall Study||1
3104846|NCT01527149|3828685|FG000|STARTED|Overall Study||37
3104847|NCT01527149|3828685|FG000|COMPLETED|Overall Study||35
3104848|NCT01527149|3828685|FG000|NOT COMPLETED|Overall Study||2
3104849|NCT01527162|3828689|FG000|STARTED|Overall Study||6
3104850|NCT01527162|3828690|FG001|STARTED|Overall Study||5
3104851|NCT01527162|3828689|FG000|COMPLETED|Overall Study||6
3104852|NCT01527162|3828690|FG001|COMPLETED|Overall Study||5
3104853|NCT01527162|3828689|FG000|NOT COMPLETED|Overall Study||0
3104854|NCT01527162|3828690|FG001|NOT COMPLETED|Overall Study||0
3104855|NCT01527357|3828700|FG000|STARTED|Overall Study||482
3104856|NCT01527357|3828701|FG001|STARTED|Overall Study||239
3104857|NCT01527357|3828700|FG000|Efficacy Population|Overall Study|Two participants did not receive study treatment.|480
3104858|NCT01527357|3828701|FG001|Efficacy Population|Overall Study||239
3104859|NCT01527357|3828700|FG000|COMPLETED|Overall Study||465
3104860|NCT01527357|3828701|FG001|COMPLETED|Overall Study||230
3104861|NCT01527357|3828700|FG000|NOT COMPLETED|Overall Study||17
3104862|NCT01527357|3828701|FG001|NOT COMPLETED|Overall Study||9
3104863|NCT01527370|3828707|FG000|STARTED|Overall Study||250
3104864|NCT01527370|3828707|FG000|COMPLETED|Overall Study||244
3104865|NCT01527370|3828707|FG000|NOT COMPLETED|Overall Study||6
3104866|NCT01527383|3828713|FG000|STARTED|Overall Study||292
3104867|NCT01527383|3828714|FG001|STARTED|Overall Study||62
3104868|NCT01527383|3828713|FG000|Vaccination 1 (Day 1)|Overall Study||291
3104869|NCT01527383|3828714|FG001|Vaccination 1 (Day 1)|Overall Study||62
3104870|NCT01527383|3828713|FG000|Vaccination 2 (~Day 30)|Overall Study||283
3291911|NCT02853435|4025990|FG002|COMPLETED|Part 1a, Washout Period 1 (3 Days)||8
3104871|NCT01527383|3828714|FG001|Vaccination 2 (~Day 30)|Overall Study||61
3104872|NCT01527383|3828713|FG000|Vaccination 3 (~Day 60)|Overall Study||278
3104873|NCT01527383|3828714|FG001|Vaccination 3 (~Day 60)|Overall Study||58
3104874|NCT01527383|3828713|FG000|Vaccination 4 (~Day 90)|Overall Study||277
3104875|NCT01527383|3828714|FG001|Vaccination 4 (~Day 90)|Overall Study||58
3104876|NCT01527383|3828713|FG000|COMPLETED|Overall Study||277
3104877|NCT01527383|3828714|FG001|COMPLETED|Overall Study||58
3104878|NCT01527383|3828713|FG000|NOT COMPLETED|Overall Study||15
3104879|NCT01527383|3828714|FG001|NOT COMPLETED|Overall Study||4
3104880|NCT01527487|3828722|FG000|STARTED|Overall Study|Includes 10 patients from safety lead-in.|54
3104881|NCT01527487|3828723|FG001|STARTED|Overall Study||22
3104882|NCT01527487|3828722|FG000|COMPLETED|Overall Study|Patients who completed 6 cycles plus surgery.|46
3104883|NCT01527487|3828723|FG001|COMPLETED|Overall Study||15
3104884|NCT01527487|3828722|FG000|NOT COMPLETED|Overall Study||8
3104885|NCT01527487|3828723|FG001|NOT COMPLETED|Overall Study||7
3104886|NCT01527500|3828738|FG000|STARTED|Part A||99
3104887|NCT01527500|3828739|FG001|STARTED|Part A||51
3104888|NCT01527500|3828738|FG000|COMPLETED|Part A||69
3104889|NCT01527500|3828739|FG001|COMPLETED|Part A||38
3104890|NCT01527500|3828738|FG000|NOT COMPLETED|Part A||30
3104891|NCT01527500|3828739|FG001|NOT COMPLETED|Part A||13
3104892|NCT01527500|3828738|FG000|STARTED|Part B||7
3104893|NCT01527500|3828739|FG001|STARTED|Part B||1
3104894|NCT01527500|3828738|FG000|COMPLETED|Part B||6
3104895|NCT01527500|3828739|FG001|COMPLETED|Part B||1
3104896|NCT01527500|3828738|FG000|NOT COMPLETED|Part B||1
3104897|NCT01527500|3828739|FG001|NOT COMPLETED|Part B||0
3104898|NCT01527513|3828757|FG000|STARTED|Double Blind Period (DB) - Part I||40
3104899|NCT01527513|3828758|FG001|STARTED|Double Blind Period (DB) - Part I||83
3104900|NCT01527513|3828757|FG000|Randomized|Double Blind Period (DB) - Part I||40
3104901|NCT01527513|3828758|FG001|Randomized|Double Blind Period (DB) - Part I||83
3104902|NCT01527513|3828757|FG000|Safety Population|Double Blind Period (DB) - Part I||40
3104903|NCT01527513|3828758|FG001|Safety Population|Double Blind Period (DB) - Part I||83
3104904|NCT01527513|3828757|FG000|Entered Maintenance Period|Double Blind Period (DB) - Part I||40
3104905|NCT01527513|3828758|FG001|Entered Maintenance Period|Double Blind Period (DB) - Part I||76
3104906|NCT01527513|3828757|FG000|Completed the Double Blind (DB)- Part I|Double Blind Period (DB) - Part I||37
3104907|NCT01527513|3828758|FG001|Completed the Double Blind (DB)- Part I|Double Blind Period (DB) - Part I||75
3104908|NCT01527513|3828757|FG000|Eligible for Open Label Period (OL)|Double Blind Period (DB) - Part I||37
3104909|NCT01527513|3828758|FG001|Eligible for Open Label Period (OL)|Double Blind Period (DB) - Part I||75
3104910|NCT01527513|3828757|FG000|Efficacy PP Population|Double Blind Period (DB) - Part I||37
3104911|NCT01527513|3828758|FG001|Efficacy PP Population|Double Blind Period (DB) - Part I||67
3104912|NCT01527513|3828757|FG000|Per-protocol (PP) Population|Double Blind Period (DB) - Part I||36
3104913|NCT01527513|3828758|FG001|Per-protocol (PP) Population|Double Blind Period (DB) - Part I||66
3104914|NCT01527513|3828757|FG000|COMPLETED|Double Blind Period (DB) - Part I||37
3104915|NCT01527513|3828758|FG001|COMPLETED|Double Blind Period (DB) - Part I||75
3104916|NCT01527513|3828757|FG000|NOT COMPLETED|Double Blind Period (DB) - Part I||3
3104917|NCT01527513|3828758|FG001|NOT COMPLETED|Double Blind Period (DB) - Part I||8
3104918|NCT01527513|3828757|FG000|STARTED|Eligible for 1-Year Open Label Period||0
3104919|NCT01527513|3828758|FG001|STARTED|Eligible for 1-Year Open Label Period|Participants that were eligible to participate in for 1-Year Open Label Period - Part II|112
3104920|NCT01527513|3828757|FG000|COMPLETED|Eligible for 1-Year Open Label Period||0
3104921|NCT01527513|3828758|FG001|COMPLETED|Eligible for 1-Year Open Label Period||95
3104922|NCT01527513|3828757|FG000|NOT COMPLETED|Eligible for 1-Year Open Label Period||0
3104923|NCT01527513|3828758|FG001|NOT COMPLETED|Eligible for 1-Year Open Label Period||17
3104924|NCT01527682|3828766|FG000|STARTED|Overall Study||37
3104925|NCT01527682|3828766|FG000|COMPLETED|Overall Study||29
3104926|NCT01527682|3828766|FG000|NOT COMPLETED|Overall Study||8
3104927|NCT01528033|3828772|FG000|STARTED|Primary Endpoint Assessment ITT||273
3104928|NCT01528033|3828773|FG001|STARTED|Primary Endpoint Assessment ITT||266
3104929|NCT01528033|3828772|FG000|COMPLETED|Primary Endpoint Assessment ITT||256
3104930|NCT01528033|3828773|FG001|COMPLETED|Primary Endpoint Assessment ITT||251
3104931|NCT01528033|3828772|FG000|NOT COMPLETED|Primary Endpoint Assessment ITT||17
3104932|NCT01528033|3828773|FG001|NOT COMPLETED|Primary Endpoint Assessment ITT||15
3104933|NCT01528033|3828772|FG000|STARTED|Follow Up||256
3104934|NCT01528033|3828773|FG001|STARTED|Follow Up||251
3104935|NCT01528033|3828772|FG000|COMPLETED|Follow Up||210
3104936|NCT01528033|3828773|FG001|COMPLETED|Follow Up||207
3104937|NCT01528033|3828772|FG000|NOT COMPLETED|Follow Up||46
3104938|NCT01528033|3828773|FG001|NOT COMPLETED|Follow Up||44
3104939|NCT01528072|3828779|FG000|STARTED|Overall Study||140
3104940|NCT01528072|3828779|FG000|COMPLETED|Overall Study||66
3104941|NCT01528072|3828779|FG000|NOT COMPLETED|Overall Study||74
3104942|NCT01528124|3828790|FG000|STARTED|Overall Study||6
3104943|NCT01528124|3828791|FG001|STARTED|Overall Study||6
3104944|NCT01528124|3828792|FG002|STARTED|Overall Study||6
3104945|NCT01528124|3828793|FG003|STARTED|Overall Study||6
3104946|NCT01528124|3828794|FG004|STARTED|Overall Study||5
3104947|NCT01528124|3828795|FG005|STARTED|Overall Study||6
3104948|NCT01528124|3828796|FG006|STARTED|Overall Study||6
3104949|NCT01528124|3828790|FG000|Received Study Drug|Overall Study||6
3104950|NCT01528124|3828791|FG001|Received Study Drug|Overall Study||6
3104951|NCT01528124|3828792|FG002|Received Study Drug|Overall Study||6
3104952|NCT01528124|3828793|FG003|Received Study Drug|Overall Study||6
3104953|NCT01528124|3828794|FG004|Received Study Drug|Overall Study||5
3104954|NCT01528124|3828795|FG005|Received Study Drug|Overall Study||6
3104955|NCT01528124|3828796|FG006|Received Study Drug|Overall Study||6
3104956|NCT01528124|3828790|FG000|COMPLETED|Overall Study||6
3104957|NCT01528124|3828791|FG001|COMPLETED|Overall Study||6
3104958|NCT01528124|3828792|FG002|COMPLETED|Overall Study||6
3104959|NCT01528124|3828793|FG003|COMPLETED|Overall Study||6
3104960|NCT01528124|3828794|FG004|COMPLETED|Overall Study||5
3104961|NCT01528124|3828795|FG005|COMPLETED|Overall Study||6
3104962|NCT01528124|3828796|FG006|COMPLETED|Overall Study||6
3104963|NCT01528124|3828790|FG000|NOT COMPLETED|Overall Study||0
3104964|NCT01528124|3828791|FG001|NOT COMPLETED|Overall Study||0
3104965|NCT01528124|3828792|FG002|NOT COMPLETED|Overall Study||0
3104966|NCT01528124|3828793|FG003|NOT COMPLETED|Overall Study||0
3104967|NCT01528124|3828794|FG004|NOT COMPLETED|Overall Study||0
3104968|NCT01528124|3828795|FG005|NOT COMPLETED|Overall Study||0
3104969|NCT01528124|3828796|FG006|NOT COMPLETED|Overall Study||0
3104970|NCT01528150|3828818|FG000|STARTED|Overall Study||466
3104971|NCT01528150|3828818|FG000|COMPLETED|Overall Study||422
3104972|NCT01528150|3828818|FG000|NOT COMPLETED|Overall Study||44
3104973|NCT01528215|3828824|FG000|STARTED|Enrollment to 1 Year Follow-up||59
3104974|NCT01528215|3828825|FG001|STARTED|Enrollment to 1 Year Follow-up||61
3104975|NCT01528215|3828824|FG000|COMPLETED|Enrollment to 1 Year Follow-up||55
3104976|NCT01528215|3828825|FG001|COMPLETED|Enrollment to 1 Year Follow-up||60
3104977|NCT01528215|3828824|FG000|NOT COMPLETED|Enrollment to 1 Year Follow-up||4
3104978|NCT01528215|3828825|FG001|NOT COMPLETED|Enrollment to 1 Year Follow-up||1
3104979|NCT01528215|3828824|FG000|STARTED|1 Year Follow-up to 5 Year Follow-up||55
3104980|NCT01528215|3828825|FG001|STARTED|1 Year Follow-up to 5 Year Follow-up||60
3104981|NCT01528215|3828824|FG000|COMPLETED|1 Year Follow-up to 5 Year Follow-up||40
3104982|NCT01528215|3828825|FG001|COMPLETED|1 Year Follow-up to 5 Year Follow-up||45
3104983|NCT01528215|3828824|FG000|NOT COMPLETED|1 Year Follow-up to 5 Year Follow-up||15
3104984|NCT01528215|3828825|FG001|NOT COMPLETED|1 Year Follow-up to 5 Year Follow-up||15
3104985|NCT01528228|3828833|FG000|STARTED|Overall Study||10
3104986|NCT01528228|3828834|FG001|STARTED|Overall Study||10
3104987|NCT01528228|3828833|FG000|COMPLETED|Overall Study||9
3104988|NCT01528228|3828834|FG001|COMPLETED|Overall Study||9
3104989|NCT01528228|3828833|FG000|NOT COMPLETED|Overall Study||1
3104990|NCT01528228|3828834|FG001|NOT COMPLETED|Overall Study||1
3104991|NCT01528254|3828842|FG000|STARTED|Overall Study||998
3104992|NCT01528254|3828843|FG001|STARTED|Overall Study||1003
3104993|NCT01528254|3828842|FG000|Safety Set|Overall Study||998
3104994|NCT01528254|3828843|FG001|Safety Set|Overall Study||1001
3104995|NCT01528254|3828842|FG000|Full Analysis Set (FAS)|Overall Study||983
3104996|NCT01528254|3828843|FG001|Full Analysis Set (FAS)|Overall Study||989
3104997|NCT01528254|3828842|FG000|Completed Treatment Period 1|Overall Study||458
3104998|NCT01528254|3828843|FG001|Completed Treatment Period 1|Overall Study||273
3104999|NCT01528254|3828842|FG000|Completed Treatment Period 2|Overall Study||244
3105000|NCT01528254|3828843|FG001|Completed Treatment Period 2|Overall Study||399
3105001|NCT01528254|3828842|FG000|Completed Treatment Period 3|Overall Study||109
3105002|NCT01528254|3828843|FG001|Completed Treatment Period 3|Overall Study||115
3105003|NCT01528254|3828842|FG000|COMPLETED|Overall Study||811
3105004|NCT01528254|3828843|FG001|COMPLETED|Overall Study||787
3105005|NCT01528254|3828842|FG000|NOT COMPLETED|Overall Study||187
3105006|NCT01528254|3828843|FG001|NOT COMPLETED|Overall Study||216
3105007|NCT01528319|3828850|FG000|STARTED|Overall Study||24
3105008|NCT01528319|3828850|FG000|12 Weeks After Surgery|Overall Study||24
3105009|NCT01528319|3828850|FG000|COMPLETED|Overall Study||23
3105010|NCT01528319|3828850|FG000|NOT COMPLETED|Overall Study||1
3105011|NCT01528332|3828856|FG000|STARTED|Overall Study||85
3105012|NCT01528332|3828857|FG001|STARTED|Overall Study||86
3105013|NCT01528332|3828856|FG000|COMPLETED|Overall Study||81
3105014|NCT01528332|3828857|FG001|COMPLETED|Overall Study||84
3105015|NCT01528332|3828856|FG000|NOT COMPLETED|Overall Study||4
3105016|NCT01528332|3828857|FG001|NOT COMPLETED|Overall Study||2
3105017|NCT01528345|3828865|FG000|STARTED|Overall Study||47
3105018|NCT01528345|3828866|FG001|STARTED|Overall Study||50
3105019|NCT01528345|3828865|FG000|COMPLETED|Overall Study||0
3105020|NCT01528345|3828866|FG001|COMPLETED|Overall Study||0
3105021|NCT01528345|3828865|FG000|NOT COMPLETED|Overall Study||47
3105022|NCT01528345|3828866|FG001|NOT COMPLETED|Overall Study||50
3105023|NCT01528592|3828872|FG000|STARTED|Overall Study||18
3105024|NCT01528592|3828872|FG000|COMPLETED|Overall Study||18
3105025|NCT01528592|3828872|FG000|NOT COMPLETED|Overall Study||0
3105026|NCT01528605|3828882|FG000|STARTED|Overall Study||28
3105027|NCT01528605|3828883|FG001|STARTED|Overall Study||28
3105028|NCT01528605|3828884|FG002|STARTED|Overall Study||28
3105029|NCT01528605|3828885|FG003|STARTED|Overall Study||28
3105030|NCT01528605|3828886|FG004|STARTED|Overall Study||28
3105031|NCT01528605|3828887|FG005|STARTED|Overall Study||28
3105032|NCT01528605|3828882|FG000|COMPLETED|Overall Study||26
3105033|NCT01528605|3828883|FG001|COMPLETED|Overall Study||28
3105034|NCT01528605|3828884|FG002|COMPLETED|Overall Study||27
3105035|NCT01528605|3828885|FG003|COMPLETED|Overall Study||27
3105036|NCT01528605|3828886|FG004|COMPLETED|Overall Study||28
3105037|NCT01528605|3828887|FG005|COMPLETED|Overall Study||28
3105038|NCT01528605|3828882|FG000|NOT COMPLETED|Overall Study||2
3105039|NCT01528605|3828883|FG001|NOT COMPLETED|Overall Study||0
3105040|NCT01528605|3828884|FG002|NOT COMPLETED|Overall Study||1
3105041|NCT01528605|3828885|FG003|NOT COMPLETED|Overall Study||1
3105042|NCT01528605|3828886|FG004|NOT COMPLETED|Overall Study||0
3105043|NCT01528605|3828887|FG005|NOT COMPLETED|Overall Study||0
3105044|NCT01528709|3828903|FG000|STARTED|Overall Study||86
3105045|NCT01528709|3828904|FG001|STARTED|Overall Study||87
3105046|NCT01528709|3828903|FG000|COMPLETED|Overall Study||73
3105047|NCT01528709|3828904|FG001|COMPLETED|Overall Study||72
3105048|NCT01528709|3828903|FG000|NOT COMPLETED|Overall Study||13
3105049|NCT01528709|3828904|FG001|NOT COMPLETED|Overall Study||15
3105050|NCT01528735|3828912|FG000|STARTED|Treatment Period 1: Faldap/Del/RBV||12
3105051|NCT01528735|3828913|FG001|STARTED|Treatment Period 1: Faldap/Del/RBV||13
3105052|NCT01528735|3828912|FG000|COMPLETED|Treatment Period 1: Faldap/Del/RBV||11
3105053|NCT01528735|3828913|FG001|COMPLETED|Treatment Period 1: Faldap/Del/RBV||12
3105054|NCT01528735|3828912|FG000|NOT COMPLETED|Treatment Period 1: Faldap/Del/RBV||1
3105055|NCT01528735|3828913|FG001|NOT COMPLETED|Treatment Period 1: Faldap/Del/RBV||1
3105056|NCT01528735|3828912|FG000|STARTED|Treatment Period 2: Faldap/PegIFN/RBV||11
3105057|NCT01528735|3828913|FG001|STARTED|Treatment Period 2: Faldap/PegIFN/RBV|One patient was treated with only PegIFN/RBV, as faldaprevir was discontinued due to adverse events|12
3105058|NCT01528735|3828912|FG000|COMPLETED|Treatment Period 2: Faldap/PegIFN/RBV||10
3105059|NCT01528735|3828913|FG001|COMPLETED|Treatment Period 2: Faldap/PegIFN/RBV||12
3105060|NCT01528735|3828912|FG000|NOT COMPLETED|Treatment Period 2: Faldap/PegIFN/RBV||1
3105061|NCT01528735|3828913|FG001|NOT COMPLETED|Treatment Period 2: Faldap/PegIFN/RBV||0
3105062|NCT01528787|3828925|FG000|STARTED|Overall Study||22
3105063|NCT01528787|3828926|FG001|STARTED|Overall Study||21
3105064|NCT01528787|3828927|FG002|STARTED|Overall Study||19
3105065|NCT01528787|3828928|FG003|STARTED|Overall Study||23
3105066|NCT01528787|3828925|FG000|COMPLETED|Overall Study||22
3105067|NCT01528787|3828926|FG001|COMPLETED|Overall Study||21
3105068|NCT01528787|3828927|FG002|COMPLETED|Overall Study||18
3105069|NCT01528787|3828928|FG003|COMPLETED|Overall Study||22
3105070|NCT01528787|3828925|FG000|NOT COMPLETED|Overall Study||0
3105071|NCT01528787|3828926|FG001|NOT COMPLETED|Overall Study||0
3105072|NCT01528787|3828927|FG002|NOT COMPLETED|Overall Study||1
3105073|NCT01528787|3828928|FG003|NOT COMPLETED|Overall Study||1
3105074|NCT01528878|3828938|FG000|STARTED|Overall Study||30
3105075|NCT01528878|3828938|FG000|COMPLETED|Overall Study||30
3105076|NCT01528878|3828938|FG000|NOT COMPLETED|Overall Study||0
3105077|NCT01528891|3828946|FG000|STARTED|Overall Study||200
3105078|NCT01528891|3828947|FG001|STARTED|Overall Study||200
3105079|NCT01528891|3828946|FG000|COMPLETED|Overall Study||200
3105080|NCT01528891|3828947|FG001|COMPLETED|Overall Study||200
3105081|NCT01528891|3828946|FG000|NOT COMPLETED|Overall Study||0
3105082|NCT01528891|3828947|FG001|NOT COMPLETED|Overall Study||0
3105083|NCT01528969|3828957|FG000|STARTED|Overall Study||37
3105084|NCT01528969|3828958|FG001|STARTED|Overall Study||38
3105085|NCT01528969|3828957|FG000|COMPLETED|Overall Study||35
3105086|NCT01528969|3828958|FG001|COMPLETED|Overall Study||38
3105087|NCT01528969|3828957|FG000|NOT COMPLETED|Overall Study||2
3105088|NCT01528969|3828958|FG001|NOT COMPLETED|Overall Study||0
3105089|NCT01529034|3828964|FG000|STARTED|Overall Study|Completed Study P261-401 and rolled over to Study P261-402|175
3105090|NCT01529034|3828964|FG000|Exposed|Overall Study|Treated at least 1 seizure cluster with USL261|161
3105091|NCT01529034|3828964|FG000|COMPLETED|Overall Study|Completed under initial protocol duration of 2 years; amended protocol open-ended duration|1
3105092|NCT01529034|3828964|FG000|NOT COMPLETED|Overall Study||174
3105093|NCT01529060|3828971|FG000|STARTED|Overall Study||10
3105094|NCT01529060|3828972|FG001|STARTED|Overall Study||10
3105095|NCT01529060|3828971|FG000|COMPLETED|Overall Study||10
3105096|NCT01529060|3828972|FG001|COMPLETED|Overall Study||10
3105097|NCT01529060|3828971|FG000|NOT COMPLETED|Overall Study||0
3105098|NCT01529060|3828972|FG001|NOT COMPLETED|Overall Study||0
3105099|NCT01529112|3828981|FG000|STARTED|Overall Study||89
3105100|NCT01529112|3828982|FG001|STARTED|Overall Study||46
3105101|NCT01529112|3828981|FG000|COMPLETED|Overall Study|On treatment=2, Discontinued treatment-continued follow-up=18 (data cut-off date 21 January 2014)|20
3105102|NCT01529112|3828982|FG001|COMPLETED|Overall Study|Discontinued treatment-continued follow-up=5 (data cut-off date 21 January 2014)|5
3105103|NCT01529112|3828981|FG000|NOT COMPLETED|Overall Study||69
3105104|NCT01529112|3828982|FG001|NOT COMPLETED|Overall Study||41
3105105|NCT01529203|3828988|FG000|STARTED|Overall Study||60
3105106|NCT01529203|3828988|FG000|COMPLETED|Overall Study||57
3105107|NCT01529203|3828988|FG000|NOT COMPLETED|Overall Study||3
3105108|NCT01529268|3828994|FG000|STARTED|Overall Study||88
3105109|NCT01529268|3828995|FG001|STARTED|Overall Study||81
3105110|NCT01529268|3828994|FG000|Completed 52-week Biopsy|Overall Study||71
3105111|NCT01529268|3828995|FG001|Completed 52-week Biopsy|Overall Study||75
3105112|NCT01529268|3828994|FG000|COMPLETED|Overall Study||76
3105113|NCT01529268|3828995|FG001|COMPLETED|Overall Study||78
3105114|NCT01529268|3828994|FG000|NOT COMPLETED|Overall Study||12
3105115|NCT01529268|3828995|FG001|NOT COMPLETED|Overall Study||3
3105116|NCT01529346|3829006|FG000|STARTED|Overall Study||55
3105117|NCT01529346|3829007|FG001|STARTED|Overall Study||54
3105118|NCT01529346|3829008|FG002|STARTED|Overall Study||54
3105119|NCT01529346|3829009|FG003|STARTED|Overall Study||36
3105120|NCT01529346|3829010|FG004|STARTED|Overall Study||36
3105121|NCT01529346|3829006|FG000|COMPLETED|Overall Study||53
3105122|NCT01529346|3829007|FG001|COMPLETED|Overall Study||53
3105123|NCT01529346|3829008|FG002|COMPLETED|Overall Study||52
3105124|NCT01529346|3829009|FG003|COMPLETED|Overall Study||36
3105125|NCT01529346|3829010|FG004|COMPLETED|Overall Study||36
3105126|NCT01529346|3829006|FG000|NOT COMPLETED|Overall Study||2
3105127|NCT01529346|3829007|FG001|NOT COMPLETED|Overall Study||1
3105128|NCT01529346|3829008|FG002|NOT COMPLETED|Overall Study||2
3105129|NCT01529346|3829009|FG003|NOT COMPLETED|Overall Study||0
3105130|NCT01529346|3829010|FG004|NOT COMPLETED|Overall Study||0
3105131|NCT01529385|3829025|FG000|STARTED|Overall Study||40
3105132|NCT01529385|3829026|FG001|STARTED|Overall Study||40
3105133|NCT01529385|3829025|FG000|Received Intervention|Overall Study|1 participant failed to show up to treatment allocation visit and was subsequently lost to follow up|39
3105134|NCT01529385|3829026|FG001|Received Intervention|Overall Study||40
3105135|NCT01529385|3829025|FG000|COMPLETED|Overall Study||38
3105136|NCT01529385|3829026|FG001|COMPLETED|Overall Study||39
3105137|NCT01529385|3829025|FG000|NOT COMPLETED|Overall Study||2
3105138|NCT01529385|3829026|FG001|NOT COMPLETED|Overall Study||1
3105139|NCT01529450|3829034|FG000|STARTED|Overall Study||3
3105140|NCT01529450|3829035|FG001|STARTED|Overall Study||8
3105141|NCT01529450|3829034|FG000|COMPLETED|Overall Study||3
3105142|NCT01529450|3829035|FG001|COMPLETED|Overall Study||6
3105143|NCT01529450|3829034|FG000|NOT COMPLETED|Overall Study||0
3105144|NCT01529450|3829035|FG001|NOT COMPLETED|Overall Study||2
3105145|NCT01529502|3829048|FG000|STARTED|Overall Study||2
3105146|NCT01529502|3829049|FG001|STARTED|Overall Study||3
3105147|NCT01529502|3829050|FG002|STARTED|Overall Study||2
3105148|NCT01529502|3829051|FG003|STARTED|Overall Study||3
3105149|NCT01529502|3829052|FG004|STARTED|Overall Study||2
3105150|NCT01529502|3829053|FG005|STARTED|Overall Study||2
3105151|NCT01529502|3829048|FG000|COMPLETED|Overall Study||2
3105152|NCT01529502|3829049|FG001|COMPLETED|Overall Study||3
3105153|NCT01529502|3829050|FG002|COMPLETED|Overall Study||2
3105154|NCT01529502|3829051|FG003|COMPLETED|Overall Study||1
3105155|NCT01529502|3829052|FG004|COMPLETED|Overall Study||2
3105156|NCT01529502|3829053|FG005|COMPLETED|Overall Study||2
3105157|NCT01529502|3829048|FG000|NOT COMPLETED|Overall Study||0
3105158|NCT01529502|3829049|FG001|NOT COMPLETED|Overall Study||0
3105159|NCT01529502|3829050|FG002|NOT COMPLETED|Overall Study||0
3105160|NCT01529502|3829051|FG003|NOT COMPLETED|Overall Study||2
3105161|NCT01529502|3829052|FG004|NOT COMPLETED|Overall Study||0
3105162|NCT01529502|3829053|FG005|NOT COMPLETED|Overall Study||0
3105163|NCT01529515|3829063|FG000|STARTED|TRANSITION PHASE||506
3105164|NCT01529515|3829064|FG001|STARTED|TRANSITION PHASE||0
3105165|NCT01529515|3829065|FG002|STARTED|TRANSITION PHASE||0
3105166|NCT01529515|3829066|FG003|STARTED|TRANSITION PHASE||0
3105167|NCT01529515|3829063|FG000|COMPLETED|TRANSITION PHASE||379
3105168|NCT01529515|3829064|FG001|COMPLETED|TRANSITION PHASE||0
3105169|NCT01529515|3829065|FG002|COMPLETED|TRANSITION PHASE||0
3105170|NCT01529515|3829066|FG003|COMPLETED|TRANSITION PHASE||0
3105171|NCT01529515|3829063|FG000|NOT COMPLETED|TRANSITION PHASE||127
3105172|NCT01529515|3829064|FG001|NOT COMPLETED|TRANSITION PHASE||0
3105173|NCT01529515|3829065|FG002|NOT COMPLETED|TRANSITION PHASE||0
3105174|NCT01529515|3829066|FG003|NOT COMPLETED|TRANSITION PHASE||0
3105175|NCT01529515|3829063|FG000|STARTED|MAINTENANCE PHASE||0
3105176|NCT01529515|3829064|FG001|STARTED|MAINTENANCE PHASE||379
3105177|NCT01529515|3829065|FG002|STARTED|MAINTENANCE PHASE||0
3105178|NCT01529515|3829066|FG003|STARTED|MAINTENANCE PHASE||0
3105179|NCT01529515|3829063|FG000|COMPLETED|MAINTENANCE PHASE||0
3105180|NCT01529515|3829064|FG001|COMPLETED|MAINTENANCE PHASE||305
3105181|NCT01529515|3829065|FG002|COMPLETED|MAINTENANCE PHASE||0
3105182|NCT01529515|3829066|FG003|COMPLETED|MAINTENANCE PHASE||0
3105183|NCT01529515|3829063|FG000|NOT COMPLETED|MAINTENANCE PHASE||0
3105184|NCT01529515|3829064|FG001|NOT COMPLETED|MAINTENANCE PHASE||74
3105185|NCT01529515|3829065|FG002|NOT COMPLETED|MAINTENANCE PHASE||0
3105186|NCT01529515|3829066|FG003|NOT COMPLETED|MAINTENANCE PHASE||0
3105187|NCT01529515|3829063|FG000|STARTED|DOUBLE BLIND PHASE||0
3105188|NCT01529515|3829064|FG001|STARTED|DOUBLE BLIND PHASE||0
3105189|NCT01529515|3829065|FG002|STARTED|DOUBLE BLIND PHASE||145
3105190|NCT01529515|3829066|FG003|STARTED|DOUBLE BLIND PHASE||160
3105191|NCT01529515|3829063|FG000|COMPLETED|DOUBLE BLIND PHASE||0
3105192|NCT01529515|3829064|FG001|COMPLETED|DOUBLE BLIND PHASE||0
3105193|NCT01529515|3829065|FG002|COMPLETED|DOUBLE BLIND PHASE||122
3105194|NCT01529515|3829066|FG003|COMPLETED|DOUBLE BLIND PHASE||148
3105195|NCT01529515|3829063|FG000|NOT COMPLETED|DOUBLE BLIND PHASE||0
3105196|NCT01529515|3829064|FG001|NOT COMPLETED|DOUBLE BLIND PHASE||0
3105197|NCT01529515|3829065|FG002|NOT COMPLETED|DOUBLE BLIND PHASE||23
3105198|NCT01529515|3829066|FG003|NOT COMPLETED|DOUBLE BLIND PHASE||12
3105199|NCT01529606|3829075|FG000|STARTED|Overall Study||55
3105200|NCT01529606|3829076|FG001|STARTED|Overall Study||47
3105201|NCT01529606|3829075|FG000|COMPLETED|Overall Study||34
3105202|NCT01529606|3829076|FG001|COMPLETED|Overall Study||29
3105203|NCT01529606|3829075|FG000|NOT COMPLETED|Overall Study||21
3105204|NCT01529606|3829076|FG001|NOT COMPLETED|Overall Study||18
3135545|NCT01707992|3860601|FG004|COMPLETED|Active Treatment Phase (24 Months)||10
3135546|NCT01707992|3860602|FG005|COMPLETED|Active Treatment Phase (24 Months)||0
3135547|NCT01707992|3860597|FG000|NOT COMPLETED|Active Treatment Phase (24 Months)||0
3135548|NCT01707992|3860598|FG001|NOT COMPLETED|Active Treatment Phase (24 Months)||0
3135549|NCT01707992|3860599|FG002|NOT COMPLETED|Active Treatment Phase (24 Months)||0
3135550|NCT01707992|3860600|FG003|NOT COMPLETED|Active Treatment Phase (24 Months)||884
3135551|NCT01707992|3860601|FG004|NOT COMPLETED|Active Treatment Phase (24 Months)||494
3135552|NCT01707992|3860602|FG005|NOT COMPLETED|Active Treatment Phase (24 Months)||215
3135553|NCT01708122|3860619|FG000|STARTED|Overall Study||27
3135554|NCT01708122|3860620|FG001|STARTED|Overall Study||26
3135555|NCT01708122|3860619|FG000|COMPLETED|Overall Study||27
3105205|NCT01529632|3829084|FG000|STARTED|Overall Study||90
3105206|NCT01529632|3829085|FG001|STARTED|Overall Study||103
3105207|NCT01529632|3829084|FG000|COMPLETED|Overall Study||87
3105208|NCT01529632|3829085|FG001|COMPLETED|Overall Study||100
3105209|NCT01529632|3829084|FG000|NOT COMPLETED|Overall Study||3
3105210|NCT01529632|3829085|FG001|NOT COMPLETED|Overall Study||3
3105211|NCT01529645|3829101|FG000|STARTED|Overall Study||42
3105212|NCT01529645|3829102|FG001|STARTED|Overall Study||42
3105213|NCT01529645|3829103|FG002|STARTED|Overall Study||42
3105214|NCT01529645|3829104|FG003|STARTED|Overall Study||42
3105215|NCT01529645|3829105|FG004|STARTED|Overall Study||42
3105216|NCT01529645|3829106|FG005|STARTED|Overall Study||42
3105217|NCT01529645|3829107|FG006|STARTED|Overall Study||42
3105218|NCT01529645|3829108|FG007|STARTED|Overall Study||42
3105219|NCT01529645|3829109|FG008|STARTED|Overall Study||42
3105220|NCT01529645|3829110|FG009|STARTED|Overall Study||42
3105221|NCT01529645|3829101|FG000|COMPLETED|Overall Study||40
3105222|NCT01529645|3829102|FG001|COMPLETED|Overall Study||41
3105223|NCT01529645|3829103|FG002|COMPLETED|Overall Study||40
3105224|NCT01529645|3829104|FG003|COMPLETED|Overall Study||40
3105225|NCT01529645|3829105|FG004|COMPLETED|Overall Study||40
3105226|NCT01529645|3829106|FG005|COMPLETED|Overall Study||41
3105227|NCT01529645|3829107|FG006|COMPLETED|Overall Study||40
3105228|NCT01529645|3829108|FG007|COMPLETED|Overall Study||42
3105229|NCT01529645|3829109|FG008|COMPLETED|Overall Study||41
3105230|NCT01529645|3829110|FG009|COMPLETED|Overall Study||42
3105231|NCT01529645|3829101|FG000|NOT COMPLETED|Overall Study||2
3105232|NCT01529645|3829102|FG001|NOT COMPLETED|Overall Study||1
3105233|NCT01529645|3829103|FG002|NOT COMPLETED|Overall Study||2
3105234|NCT01529645|3829104|FG003|NOT COMPLETED|Overall Study||2
3105235|NCT01529645|3829105|FG004|NOT COMPLETED|Overall Study||2
3105236|NCT01529645|3829106|FG005|NOT COMPLETED|Overall Study||1
3105237|NCT01529645|3829107|FG006|NOT COMPLETED|Overall Study||2
3105238|NCT01529645|3829108|FG007|NOT COMPLETED|Overall Study||0
3105239|NCT01529645|3829109|FG008|NOT COMPLETED|Overall Study||1
3105240|NCT01529645|3829110|FG009|NOT COMPLETED|Overall Study||0
3105241|NCT01529749|3829144|FG000|STARTED|Overall Study||12
3105242|NCT01529749|3829145|FG001|STARTED|Overall Study||12
3105243|NCT01529749|3829146|FG002|STARTED|Overall Study||12
3105244|NCT01529749|3829147|FG003|STARTED|Overall Study||12
3105245|NCT01529749|3829144|FG000|COMPLETED|Overall Study||12
3105246|NCT01529749|3829145|FG001|COMPLETED|Overall Study||10
3105247|NCT01529749|3829146|FG002|COMPLETED|Overall Study||10
3105248|NCT01529749|3829147|FG003|COMPLETED|Overall Study||10
3105249|NCT01529749|3829144|FG000|NOT COMPLETED|Overall Study||0
3105250|NCT01529749|3829145|FG001|NOT COMPLETED|Overall Study||2
3105251|NCT01529749|3829146|FG002|NOT COMPLETED|Overall Study||2
3105252|NCT01529749|3829147|FG003|NOT COMPLETED|Overall Study||2
3105253|NCT01529827|3829157|FG000|STARTED|Overall Study||94
3105254|NCT01529827|3829157|FG000|COMPLETED|Overall Study||94
3105255|NCT01529827|3829157|FG000|NOT COMPLETED|Overall Study||0
3105256|NCT01530178|3829163|FG000|STARTED|Overall Study||2
3105257|NCT01530178|3829164|FG001|STARTED|Overall Study||6
3105258|NCT01530178|3829163|FG000|COMPLETED|Overall Study||2
3105259|NCT01530178|3829164|FG001|COMPLETED|Overall Study||6
3105260|NCT01530178|3829163|FG000|NOT COMPLETED|Overall Study||0
3105261|NCT01530178|3829164|FG001|NOT COMPLETED|Overall Study||0
3105262|NCT01530243|3829178|FG000|STARTED|Overall Study||26
3105263|NCT01530243|3829179|FG001|STARTED|Overall Study||26
3105264|NCT01530243|3829180|FG002|STARTED|Overall Study||26
3105265|NCT01530243|3829181|FG003|STARTED|Overall Study||26
3105266|NCT01530243|3829178|FG000|COMPLETED|Overall Study||24
3105267|NCT01530243|3829179|FG001|COMPLETED|Overall Study||23
3105268|NCT01530243|3829180|FG002|COMPLETED|Overall Study||23
3105269|NCT01530243|3829181|FG003|COMPLETED|Overall Study||24
3105270|NCT01530243|3829178|FG000|NOT COMPLETED|Overall Study||2
3105271|NCT01530243|3829179|FG001|NOT COMPLETED|Overall Study||3
3105272|NCT01530243|3829180|FG002|NOT COMPLETED|Overall Study||3
3105273|NCT01530243|3829181|FG003|NOT COMPLETED|Overall Study||2
3105274|NCT01530256|3829192|FG000|STARTED|Overall Study||3
3105275|NCT01530256|3829192|FG000|COMPLETED|Overall Study||1
3105276|NCT01530256|3829192|FG000|NOT COMPLETED|Overall Study||2
3105277|NCT01530334|3829196|FG000|STARTED|Overall Study||61
3291912|NCT02853435|4025991|FG003|COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
3291913|NCT02853435|4025992|FG004|COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
3291914|NCT02853435|4025993|FG005|COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
3291915|NCT02853435|4025988|FG000|NOT COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
3291916|NCT02853435|4025989|FG001|NOT COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
3105278|NCT01530334|3829196|FG000|COMPLETED|Overall Study||10
3105279|NCT01530334|3829196|FG000|NOT COMPLETED|Overall Study||51
3105280|NCT01530399|3829206|FG000|STARTED|Overall Study||8
3105281|NCT01530399|3829207|FG001|STARTED|Overall Study||10
3105282|NCT01530399|3829208|FG002|STARTED|Overall Study||8
3105283|NCT01530399|3829209|FG003|STARTED|Overall Study||10
3291917|NCT02853435|4025990|FG002|NOT COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
3105284|NCT01530399|3829210|FG004|STARTED|Overall Study||6
3105285|NCT01530399|3829211|FG005|STARTED|Overall Study||7
3105286|NCT01530399|3829206|FG000|COMPLETED|Overall Study||7
3105287|NCT01530399|3829207|FG001|COMPLETED|Overall Study||8
3105288|NCT01530399|3829208|FG002|COMPLETED|Overall Study||7
3105289|NCT01530399|3829209|FG003|COMPLETED|Overall Study||10
3105290|NCT01530399|3829210|FG004|COMPLETED|Overall Study||6
3105291|NCT01530399|3829211|FG005|COMPLETED|Overall Study||6
3291918|NCT02853435|4025991|FG003|NOT COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
3291919|NCT02853435|4025992|FG004|NOT COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
3291920|NCT02853435|4025993|FG005|NOT COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
3291921|NCT02853435|4025988|FG000|STARTED|Part 1a, Period 2 (3 Days)||9
3291922|NCT02853435|4025989|FG001|STARTED|Part 1a, Period 2 (3 Days)||9
3291923|NCT02853435|4025990|FG002|STARTED|Part 1a, Period 2 (3 Days)||8
3291924|NCT02853435|4025991|FG003|STARTED|Part 1a, Period 2 (3 Days)||0
3291925|NCT02853435|4025992|FG004|STARTED|Part 1a, Period 2 (3 Days)||0
3105292|NCT01530399|3829206|FG000|NOT COMPLETED|Overall Study||1
3105293|NCT01530399|3829207|FG001|NOT COMPLETED|Overall Study||2
3105294|NCT01530399|3829208|FG002|NOT COMPLETED|Overall Study||1
3105295|NCT01530399|3829209|FG003|NOT COMPLETED|Overall Study||0
3105296|NCT01530399|3829210|FG004|NOT COMPLETED|Overall Study||0
3105297|NCT01530399|3829211|FG005|NOT COMPLETED|Overall Study||1
3105298|NCT01530464|3829227|FG000|STARTED|First Intervention (24h)||10
3105299|NCT01530464|3829228|FG001|STARTED|First Intervention (24h)||8
3105300|NCT01530464|3829227|FG000|COMPLETED|First Intervention (24h)||10
3105301|NCT01530464|3829228|FG001|COMPLETED|First Intervention (24h)||8
3105302|NCT01530464|3829227|FG000|NOT COMPLETED|First Intervention (24h)||0
3291926|NCT02853435|4025993|FG005|STARTED|Part 1a, Period 2 (3 Days)||0
3291927|NCT02853435|4025988|FG000|COMPLETED|Part 1a, Period 2 (3 Days)||9
3291928|NCT02853435|4025989|FG001|COMPLETED|Part 1a, Period 2 (3 Days)||9
3291929|NCT02853435|4025990|FG002|COMPLETED|Part 1a, Period 2 (3 Days)||8
3291930|NCT02853435|4025991|FG003|COMPLETED|Part 1a, Period 2 (3 Days)||0
3291931|NCT02853435|4025992|FG004|COMPLETED|Part 1a, Period 2 (3 Days)||0
3291932|NCT02853435|4025993|FG005|COMPLETED|Part 1a, Period 2 (3 Days)||0
3291933|NCT02853435|4025988|FG000|NOT COMPLETED|Part 1a, Period 2 (3 Days)||0
3291934|NCT02853435|4025989|FG001|NOT COMPLETED|Part 1a, Period 2 (3 Days)||0
3291935|NCT02853435|4025990|FG002|NOT COMPLETED|Part 1a, Period 2 (3 Days)||0
3291936|NCT02853435|4025991|FG003|NOT COMPLETED|Part 1a, Period 2 (3 Days)||0
3291937|NCT02853435|4025992|FG004|NOT COMPLETED|Part 1a, Period 2 (3 Days)||0
3291938|NCT02853435|4025993|FG005|NOT COMPLETED|Part 1a, Period 2 (3 Days)||0
3291939|NCT02853435|4025988|FG000|STARTED|Part 1a, Washout Period 2 (3 Days)||9
3291940|NCT02853435|4025989|FG001|STARTED|Part 1a, Washout Period 2 (3 Days)||9
3291941|NCT02853435|4025990|FG002|STARTED|Part 1a, Washout Period 2 (3 Days)||8
3291942|NCT02853435|4025991|FG003|STARTED|Part 1a, Washout Period 2 (3 Days)||0
3291943|NCT02853435|4025992|FG004|STARTED|Part 1a, Washout Period 2 (3 Days)||0
3291944|NCT02853435|4025993|FG005|STARTED|Part 1a, Washout Period 2 (3 Days)||0
3291945|NCT02853435|4025988|FG000|COMPLETED|Part 1a, Washout Period 2 (3 Days)||9
3291946|NCT02853435|4025989|FG001|COMPLETED|Part 1a, Washout Period 2 (3 Days)||9
3291947|NCT02853435|4025990|FG002|COMPLETED|Part 1a, Washout Period 2 (3 Days)||8
3291948|NCT02853435|4025991|FG003|COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
3291949|NCT02853435|4025992|FG004|COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
3291950|NCT02853435|4025993|FG005|COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
3291951|NCT02853435|4025988|FG000|NOT COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
3291952|NCT02853435|4025989|FG001|NOT COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
3291953|NCT02853435|4025990|FG002|NOT COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
3291954|NCT02853435|4025991|FG003|NOT COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
3291955|NCT02853435|4025992|FG004|NOT COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
3291956|NCT02853435|4025993|FG005|NOT COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
3291957|NCT02853435|4025988|FG000|STARTED|Part 1a, Period 3 (3 Days)||9
3291958|NCT02853435|4025989|FG001|STARTED|Part 1a, Period 3 (3 Days)||9
3291959|NCT02853435|4025990|FG002|STARTED|Part 1a, Period 3 (3 Days)||8
3291960|NCT02853435|4025991|FG003|STARTED|Part 1a, Period 3 (3 Days)||0
3291961|NCT02853435|4025992|FG004|STARTED|Part 1a, Period 3 (3 Days)||0
3291962|NCT02853435|4025993|FG005|STARTED|Part 1a, Period 3 (3 Days)||0
3291963|NCT02853435|4025988|FG000|COMPLETED|Part 1a, Period 3 (3 Days)||9
3291964|NCT02853435|4025989|FG001|COMPLETED|Part 1a, Period 3 (3 Days)||9
3291965|NCT02853435|4025990|FG002|COMPLETED|Part 1a, Period 3 (3 Days)||8
3291966|NCT02853435|4025991|FG003|COMPLETED|Part 1a, Period 3 (3 Days)||0
3291967|NCT02853435|4025992|FG004|COMPLETED|Part 1a, Period 3 (3 Days)||0
3291968|NCT02853435|4025993|FG005|COMPLETED|Part 1a, Period 3 (3 Days)||0
3291969|NCT02853435|4025988|FG000|NOT COMPLETED|Part 1a, Period 3 (3 Days)||0
3291970|NCT02853435|4025989|FG001|NOT COMPLETED|Part 1a, Period 3 (3 Days)||0
3291971|NCT02853435|4025990|FG002|NOT COMPLETED|Part 1a, Period 3 (3 Days)||0
3291972|NCT02853435|4025991|FG003|NOT COMPLETED|Part 1a, Period 3 (3 Days)||0
3291973|NCT02853435|4025992|FG004|NOT COMPLETED|Part 1a, Period 3 (3 Days)||0
3291974|NCT02853435|4025993|FG005|NOT COMPLETED|Part 1a, Period 3 (3 Days)||0
3291975|NCT02853435|4025988|FG000|STARTED|Part 2, Period 1 (3 Days)||0
3291976|NCT02853435|4025989|FG001|STARTED|Part 2, Period 1 (3 Days)||0
3291977|NCT02853435|4025990|FG002|STARTED|Part 2, Period 1 (3 Days)||0
3291978|NCT02853435|4025991|FG003|STARTED|Part 2, Period 1 (3 Days)||10
3291979|NCT02853435|4025992|FG004|STARTED|Part 2, Period 1 (3 Days)||0
3291980|NCT02853435|4025993|FG005|STARTED|Part 2, Period 1 (3 Days)||0
3291981|NCT02853435|4025988|FG000|COMPLETED|Part 2, Period 1 (3 Days)||0
3291982|NCT02853435|4025989|FG001|COMPLETED|Part 2, Period 1 (3 Days)||0
3291983|NCT02853435|4025990|FG002|COMPLETED|Part 2, Period 1 (3 Days)||0
3291984|NCT02853435|4025991|FG003|COMPLETED|Part 2, Period 1 (3 Days)||10
3291985|NCT02853435|4025992|FG004|COMPLETED|Part 2, Period 1 (3 Days)||0
3291986|NCT02853435|4025993|FG005|COMPLETED|Part 2, Period 1 (3 Days)||0
3105303|NCT01530464|3829228|FG001|NOT COMPLETED|First Intervention (24h)||0
3105304|NCT01530464|3829227|FG000|STARTED|Washout (24h)||10
3105305|NCT01530464|3829228|FG001|STARTED|Washout (24h)||8
3105306|NCT01530464|3829227|FG000|COMPLETED|Washout (24h)||10
3105307|NCT01530464|3829228|FG001|COMPLETED|Washout (24h)||8
3105308|NCT01530464|3829227|FG000|NOT COMPLETED|Washout (24h)||0
3105309|NCT01530464|3829228|FG001|NOT COMPLETED|Washout (24h)||0
3105310|NCT01530464|3829227|FG000|STARTED|Second Intervention (24h)||10
3105311|NCT01530464|3829228|FG001|STARTED|Second Intervention (24h)||8
3105312|NCT01530464|3829227|FG000|COMPLETED|Second Intervention (24h)||10
3105313|NCT01530464|3829228|FG001|COMPLETED|Second Intervention (24h)||8
3105314|NCT01530464|3829227|FG000|NOT COMPLETED|Second Intervention (24h)||0
3105315|NCT01530464|3829228|FG001|NOT COMPLETED|Second Intervention (24h)||0
3105316|NCT01530464|3829227|FG000|STARTED|Washout (24h)||10
3105317|NCT01530464|3829228|FG001|STARTED|Washout (24h)||8
3105318|NCT01530464|3829227|FG000|COMPLETED|Washout (24h)|1 subject withdrew consent and left due to family emergencies|9
3105319|NCT01530464|3829228|FG001|COMPLETED|Washout (24h)||8
3105320|NCT01530464|3829227|FG000|NOT COMPLETED|Washout (24h)||1
3105321|NCT01530464|3829228|FG001|NOT COMPLETED|Washout (24h)||0
3105322|NCT01530464|3829227|FG000|STARTED|Third Intervention (24h)||9
3291987|NCT02853435|4025988|FG000|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
3291988|NCT02853435|4025989|FG001|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
3291989|NCT02853435|4025990|FG002|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
3291990|NCT02853435|4025991|FG003|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
3291991|NCT02853435|4025992|FG004|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
3105323|NCT01530464|3829228|FG001|STARTED|Third Intervention (24h)||8
3105324|NCT01530464|3829227|FG000|COMPLETED|Third Intervention (24h)||9
3105325|NCT01530464|3829228|FG001|COMPLETED|Third Intervention (24h)||8
3105326|NCT01530464|3829227|FG000|NOT COMPLETED|Third Intervention (24h)||0
3105327|NCT01530464|3829228|FG001|NOT COMPLETED|Third Intervention (24h)||0
3105328|NCT01530464|3829227|FG000|STARTED|Washout (24h)||9
3105329|NCT01530464|3829228|FG001|STARTED|Washout (24h)||8
3105330|NCT01530464|3829227|FG000|COMPLETED|Washout (24h)||9
3105331|NCT01530464|3829228|FG001|COMPLETED|Washout (24h)|1 subject withdrew consent and left due to family emergencies|7
3105332|NCT01530464|3829227|FG000|NOT COMPLETED|Washout (24h)||0
3105333|NCT01530464|3829228|FG001|NOT COMPLETED|Washout (24h)||1
3105334|NCT01530477|3829242|FG000|STARTED|Overall Study|17 subjects consented to the Skeletal cohort only.|17
3105335|NCT01530477|3829243|FG001|STARTED|Overall Study|12 subjects consented to the Body Composition cohort only.|12
3105336|NCT01530477|3829244|FG002|STARTED|Overall Study|53 subjects consented to both the Skeletal and body Composition cohorts.|53
3105337|NCT01530477|3829242|FG000|COMPLETED|Overall Study|17 subjects completed imaging in the Skeletal cohort only.|17
3105338|NCT01530477|3829243|FG001|COMPLETED|Overall Study|12 subjects completed imaging in the Body Composition cohort only.|12
3105339|NCT01530477|3829244|FG002|COMPLETED|Overall Study|53 subjects completed the imaging in both the Skeletal and Body Composition cohorts.|53
3105340|NCT01530477|3829242|FG000|NOT COMPLETED|Overall Study||0
3105341|NCT01530477|3829243|FG001|NOT COMPLETED|Overall Study||0
3105342|NCT01530477|3829244|FG002|NOT COMPLETED|Overall Study||0
3105343|NCT01531153|3829253|FG000|STARTED|Overall Study||32
3105344|NCT01531153|3829254|FG001|STARTED|Overall Study||31
3105345|NCT01531153|3829255|FG002|STARTED|Overall Study||30
3105346|NCT01531153|3829253|FG000|COMPLETED|Overall Study||22
3105347|NCT01531153|3829254|FG001|COMPLETED|Overall Study||22
3105348|NCT01531153|3829255|FG002|COMPLETED|Overall Study||15
3105349|NCT01531153|3829253|FG000|NOT COMPLETED|Overall Study||10
3105350|NCT01531153|3829254|FG001|NOT COMPLETED|Overall Study||9
3105351|NCT01531153|3829255|FG002|NOT COMPLETED|Overall Study||15
3105352|NCT01531205|3829266|FG000|STARTED|Overall Study||2
3105353|NCT01531205|3829266|FG000|COMPLETED|Overall Study||1
3105354|NCT01531205|3829266|FG000|NOT COMPLETED|Overall Study||1
3105355|NCT01531335|3829274|FG000|STARTED|Overall Study||40
3105356|NCT01531335|3829275|FG001|STARTED|Overall Study||40
3105357|NCT01531335|3829274|FG000|COMPLETED|Overall Study||40
3105358|NCT01531335|3829275|FG001|COMPLETED|Overall Study||40
3105359|NCT01531335|3829274|FG000|NOT COMPLETED|Overall Study||0
3105360|NCT01531335|3829275|FG001|NOT COMPLETED|Overall Study||0
3105361|NCT01531374|3829284|FG000|STARTED|Overall Study||1285
3105362|NCT01531374|3829285|FG001|STARTED|Overall Study||373
3105363|NCT01531374|3829286|FG002|STARTED|Overall Study||1119
3105364|NCT01531374|3829284|FG000|COMPLETED|Overall Study||921
3105365|NCT01531374|3829285|FG001|COMPLETED|Overall Study||231
3105366|NCT01531374|3829286|FG002|COMPLETED|Overall Study||836
3105367|NCT01531374|3829284|FG000|NOT COMPLETED|Overall Study||364
3105368|NCT01531374|3829285|FG001|NOT COMPLETED|Overall Study||142
3105369|NCT01531374|3829286|FG002|NOT COMPLETED|Overall Study||283
3105370|NCT01531439|3829298|FG000|STARTED|Overall Study||41
3105371|NCT01531439|3829299|FG001|STARTED|Overall Study||43
3105372|NCT01531439|3829298|FG000|COMPLETED|Overall Study||37
3105373|NCT01531439|3829299|FG001|COMPLETED|Overall Study||42
3105374|NCT01531439|3829298|FG000|NOT COMPLETED|Overall Study||4
3105375|NCT01531439|3829299|FG001|NOT COMPLETED|Overall Study||1
3105376|NCT01531673|3829318|FG000|STARTED|Overall Study||33
3105377|NCT01531673|3829319|FG001|STARTED|Overall Study||8
3105378|NCT01531673|3829320|FG002|STARTED|Overall Study||8
3105379|NCT01531673|3829321|FG003|STARTED|Overall Study||18
3105380|NCT01531673|3829322|FG004|STARTED|Overall Study||8
3105381|NCT01531673|3829323|FG005|STARTED|Overall Study||19
3291992|NCT02853435|4025993|FG005|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
3105382|NCT01531673|3829324|FG006|STARTED|Overall Study||17
3105383|NCT01531673|3829325|FG007|STARTED|Overall Study||9
3105384|NCT01531673|3829326|FG008|STARTED|Overall Study||17
3105385|NCT01531673|3829327|FG009|STARTED|Overall Study||19
3105386|NCT01531673|3829328|FG010|STARTED|Overall Study||16
3105387|NCT01531673|3829329|FG011|STARTED|Overall Study||4
3105388|NCT01531673|3829330|FG012|STARTED|Overall Study||14
3105389|NCT01531673|3829318|FG000|COMPLETED|Overall Study||33
3105390|NCT01531673|3829319|FG001|COMPLETED|Overall Study||7
3105391|NCT01531673|3829320|FG002|COMPLETED|Overall Study||8
3105392|NCT01531673|3829321|FG003|COMPLETED|Overall Study||17
3105393|NCT01531673|3829322|FG004|COMPLETED|Overall Study||7
3105394|NCT01531673|3829323|FG005|COMPLETED|Overall Study||18
3105395|NCT01531673|3829324|FG006|COMPLETED|Overall Study||17
3105396|NCT01531673|3829325|FG007|COMPLETED|Overall Study||9
3105397|NCT01531673|3829326|FG008|COMPLETED|Overall Study||17
3105398|NCT01531673|3829327|FG009|COMPLETED|Overall Study||18
3105399|NCT01531673|3829328|FG010|COMPLETED|Overall Study||16
3105400|NCT01531673|3829329|FG011|COMPLETED|Overall Study||4
3105401|NCT01531673|3829330|FG012|COMPLETED|Overall Study||14
3105402|NCT01531673|3829318|FG000|NOT COMPLETED|Overall Study||0
3105403|NCT01531673|3829319|FG001|NOT COMPLETED|Overall Study||1
3105404|NCT01531673|3829320|FG002|NOT COMPLETED|Overall Study||0
3105405|NCT01531673|3829321|FG003|NOT COMPLETED|Overall Study||1
3105406|NCT01531673|3829322|FG004|NOT COMPLETED|Overall Study||1
3105407|NCT01531673|3829323|FG005|NOT COMPLETED|Overall Study||1
3105408|NCT01531673|3829324|FG006|NOT COMPLETED|Overall Study||0
3105409|NCT01531673|3829325|FG007|NOT COMPLETED|Overall Study||0
3105410|NCT01531673|3829326|FG008|NOT COMPLETED|Overall Study||0
3105411|NCT01531673|3829327|FG009|NOT COMPLETED|Overall Study||1
3105412|NCT01531673|3829328|FG010|NOT COMPLETED|Overall Study||0
3105413|NCT01531673|3829329|FG011|NOT COMPLETED|Overall Study||0
3105414|NCT01531673|3829330|FG012|NOT COMPLETED|Overall Study||0
3105415|NCT01531725|3829382|FG000|STARTED|Overall Study|5 patients with protocol violation were excluded.|202
3105416|NCT01531725|3829382|FG000|COMPLETED|Overall Study||197
3105417|NCT01531725|3829382|FG000|NOT COMPLETED|Overall Study||5
3105418|NCT01531738|3829388|FG000|STARTED|Overall Study||11
3105419|NCT01531738|3829389|FG001|STARTED|Overall Study||11
3105420|NCT01531738|3829388|FG000|COMPLETED|Overall Study||11
3105421|NCT01531738|3829389|FG001|COMPLETED|Overall Study||11
3105422|NCT01531738|3829388|FG000|NOT COMPLETED|Overall Study||0
3105423|NCT01531738|3829389|FG001|NOT COMPLETED|Overall Study||0
3105424|NCT01531803|3829397|FG000|STARTED|Overall Study||1
3105425|NCT01531803|3829398|FG001|STARTED|Overall Study||2
3105426|NCT01531803|3829397|FG000|COMPLETED|Overall Study||1
3105427|NCT01531803|3829398|FG001|COMPLETED|Overall Study||2
3105428|NCT01531803|3829397|FG000|NOT COMPLETED|Overall Study||0
3105429|NCT01531803|3829398|FG001|NOT COMPLETED|Overall Study||0
3105430|NCT01531894|3829404|FG000|STARTED|Overall Study||11
3105431|NCT01531894|3829404|FG000|COMPLETED|Overall Study||2
3105432|NCT01531894|3829404|FG000|NOT COMPLETED|Overall Study||9
3105433|NCT01531959|3829410|FG000|STARTED|Overall Study||68
3105434|NCT01531959|3829411|FG001|STARTED|Overall Study||68
3105435|NCT01531959|3829410|FG000|COMPLETED|Overall Study||66
3105436|NCT01531959|3829411|FG001|COMPLETED|Overall Study||66
3105437|NCT01531959|3829410|FG000|NOT COMPLETED|Overall Study||2
3105438|NCT01531959|3829411|FG001|NOT COMPLETED|Overall Study||2
3105439|NCT01531998|3829417|FG000|STARTED|Overall Study||11
3105440|NCT01531998|3829417|FG000|COMPLETED|Overall Study||8
3105441|NCT01531998|3829417|FG000|NOT COMPLETED|Overall Study||3
3105442|NCT01532089|3829423|FG000|STARTED|Overall Study||45
3105443|NCT01532089|3829424|FG001|STARTED|Overall Study||43
3105444|NCT01532089|3829423|FG000|COMPLETED|Overall Study||45
3105445|NCT01532089|3829424|FG001|COMPLETED|Overall Study||43
3105446|NCT01532089|3829423|FG000|NOT COMPLETED|Overall Study||0
3105447|NCT01532089|3829424|FG001|NOT COMPLETED|Overall Study||0
3105448|NCT01532128|3829435|FG000|STARTED|Overall Study||8
3105449|NCT01532128|3829436|FG001|STARTED|Overall Study||8
3105450|NCT01532128|3829437|FG002|STARTED|Overall Study||8
3105451|NCT01532128|3829435|FG000|COMPLETED|Overall Study||8
3105452|NCT01532128|3829436|FG001|COMPLETED|Overall Study||8
3105453|NCT01532128|3829437|FG002|COMPLETED|Overall Study||8
3105454|NCT01532128|3829435|FG000|NOT COMPLETED|Overall Study||0
3105455|NCT01532128|3829436|FG001|NOT COMPLETED|Overall Study||0
3105456|NCT01532128|3829437|FG002|NOT COMPLETED|Overall Study||0
3105457|NCT01532141|3829449|FG000|STARTED|Overall Study||9
3105458|NCT01532141|3829450|FG001|STARTED|Overall Study||8
3105459|NCT01532141|3829451|FG002|STARTED|Overall Study||8
3105460|NCT01532141|3829449|FG000|Period 1|Overall Study||9
3105461|NCT01532141|3829450|FG001|Period 1|Overall Study||8
3105462|NCT01532141|3829451|FG002|Period 1|Overall Study||8
3105463|NCT01532141|3829449|FG000|Period 2|Overall Study||8
3105464|NCT01532141|3829450|FG001|Period 2|Overall Study||8
3105465|NCT01532141|3829451|FG002|Period 2|Overall Study||8
3105466|NCT01532141|3829449|FG000|Period 3|Overall Study||8
3105467|NCT01532141|3829450|FG001|Period 3|Overall Study||8
3105468|NCT01532141|3829451|FG002|Period 3|Overall Study||8
3105469|NCT01532141|3829449|FG000|COMPLETED|Overall Study||8
3105470|NCT01532141|3829450|FG001|COMPLETED|Overall Study||8
3105471|NCT01532141|3829451|FG002|COMPLETED|Overall Study||8
3105472|NCT01532141|3829449|FG000|NOT COMPLETED|Overall Study||1
3105473|NCT01532141|3829450|FG001|NOT COMPLETED|Overall Study||0
3105474|NCT01532141|3829451|FG002|NOT COMPLETED|Overall Study||0
3105475|NCT01532349|3829462|FG000|STARTED|Overall Study||17
3105476|NCT01532349|3829463|FG001|STARTED|Overall Study||17
3105477|NCT01532349|3829462|FG000|COMPLETED|Overall Study||15
3105478|NCT01532349|3829463|FG001|COMPLETED|Overall Study||12
3105479|NCT01532349|3829462|FG000|NOT COMPLETED|Overall Study||2
3105480|NCT01532349|3829463|FG001|NOT COMPLETED|Overall Study||5
3105481|NCT01532388|3829471|FG000|STARTED|3-month Follow-up||101
3105482|NCT01532388|3829472|FG001|STARTED|3-month Follow-up||101
3105483|NCT01532388|3829471|FG000|COMPLETED|3-month Follow-up||33
3105484|NCT01532388|3829472|FG001|COMPLETED|3-month Follow-up||33
3105485|NCT01532388|3829471|FG000|NOT COMPLETED|3-month Follow-up||68
3105486|NCT01532388|3829472|FG001|NOT COMPLETED|3-month Follow-up||68
3105487|NCT01532388|3829471|FG000|STARTED|6-month Follow-up|All participants registered in the trial were contacted for follow-ups at 3, 6 and 12 months.|101
3105488|NCT01532388|3829472|FG001|STARTED|6-month Follow-up|All participants registered in the trial were contacted for follow-ups at 3, 6 and 12 months.|101
3105489|NCT01532388|3829471|FG000|COMPLETED|6-month Follow-up||27
3105490|NCT01532388|3829472|FG001|COMPLETED|6-month Follow-up||35
3105491|NCT01532388|3829471|FG000|NOT COMPLETED|6-month Follow-up||74
3105492|NCT01532388|3829472|FG001|NOT COMPLETED|6-month Follow-up||66
3105493|NCT01532388|3829471|FG000|STARTED|12-month Follow-up|All participants registered in the trial were contacted for follow-ups at 3, 6 and 12 months.|101
3105494|NCT01532388|3829472|FG001|STARTED|12-month Follow-up|All participants registered in the trial were contacted for follow-ups at 3, 6 and 12 months.|101
3105495|NCT01532388|3829471|FG000|COMPLETED|12-month Follow-up||32
3105496|NCT01532388|3829472|FG001|COMPLETED|12-month Follow-up||34
3105497|NCT01532388|3829471|FG000|NOT COMPLETED|12-month Follow-up||69
3105498|NCT01532388|3829472|FG001|NOT COMPLETED|12-month Follow-up||67
3105499|NCT01532414|3829481|FG000|STARTED|Overall Study||92
3105500|NCT01532414|3829482|FG001|STARTED|Overall Study|Up-titrated at 6 weeks from a starting dose of 12.5 mg due to morning testosterone <300 ng/dL|21
3105501|NCT01532414|3829483|FG002|STARTED|Overall Study||38
3105502|NCT01532414|3829481|FG000|COMPLETED|Overall Study||85
3105503|NCT01532414|3829482|FG001|COMPLETED|Overall Study||19
3105504|NCT01532414|3829483|FG002|COMPLETED|Overall Study||35
3105505|NCT01532414|3829481|FG000|NOT COMPLETED|Overall Study||7
3105506|NCT01532414|3829482|FG001|NOT COMPLETED|Overall Study||2
3105507|NCT01532414|3829483|FG002|NOT COMPLETED|Overall Study||3
3105508|NCT01532453|3829493|FG000|STARTED|Overall Study||81
3105509|NCT01532453|3829494|FG001|STARTED|Overall Study||160
3105510|NCT01532453|3829493|FG000|COMPLETED|Overall Study||54
3105511|NCT01532453|3829494|FG001|COMPLETED|Overall Study||90
3105512|NCT01532453|3829493|FG000|NOT COMPLETED|Overall Study||27
3105513|NCT01532453|3829494|FG001|NOT COMPLETED|Overall Study||70
3105514|NCT01532570|3829504|FG000|STARTED|Overall Study||11
3105515|NCT01532570|3829505|FG001|STARTED|Overall Study||2
3105516|NCT01532570|3829506|FG002|STARTED|Overall Study||1
3105517|NCT01532570|3829507|FG003|STARTED|Overall Study||4
3105518|NCT01532570|3829504|FG000|COMPLETED|Overall Study||10
3105519|NCT01532570|3829505|FG001|COMPLETED|Overall Study||1
3105520|NCT01532570|3829506|FG002|COMPLETED|Overall Study||1
3105521|NCT01532570|3829507|FG003|COMPLETED|Overall Study||4
3105522|NCT01532570|3829504|FG000|NOT COMPLETED|Overall Study||1
3105523|NCT01532570|3829505|FG001|NOT COMPLETED|Overall Study||1
3105524|NCT01532570|3829506|FG002|NOT COMPLETED|Overall Study||0
3105525|NCT01532570|3829507|FG003|NOT COMPLETED|Overall Study||0
3105526|NCT01532648|3829526|FG000|STARTED|Overall Study||255
3105527|NCT01532648|3829527|FG001|STARTED|Overall Study||255
3105528|NCT01532648|3829526|FG000|Safety Population|Overall Study||255
3105529|NCT01532648|3829527|FG001|Safety Population|Overall Study||255
3105530|NCT01532648|3829526|FG000|Intent-To-Treat Population|Overall Study||230
3105531|NCT01532648|3829527|FG001|Intent-To-Treat Population|Overall Study||228
3105532|NCT01532648|3829526|FG000|COMPLETED|Overall Study||219
3105533|NCT01532648|3829527|FG001|COMPLETED|Overall Study||238
3105534|NCT01532648|3829526|FG000|NOT COMPLETED|Overall Study||36
3105535|NCT01532648|3829527|FG001|NOT COMPLETED|Overall Study||17
3105536|NCT01532687|3829535|FG000|STARTED|Overall Study||29
3105537|NCT01532687|3829536|FG001|STARTED|Overall Study||25
3105538|NCT01532687|3829535|FG000|Crossover to Open-label Pazopanib|Overall Study||0
3105539|NCT01532687|3829536|FG001|Crossover to Open-label Pazopanib|Overall Study||14
3105540|NCT01532687|3829535|FG000|COMPLETED|Overall Study|Participants remain on treatment until time of progression and through the AE assessment period|15
3105541|NCT01532687|3829536|FG001|COMPLETED|Overall Study|Participants remain on treatment until time of progression|23
3105542|NCT01532687|3829535|FG000|NOT COMPLETED|Overall Study||14
3105543|NCT01532687|3829536|FG001|NOT COMPLETED|Overall Study||2
3105544|NCT01532700|3829544|FG000|STARTED|Overall Study||28
3105545|NCT01532700|3829544|FG000|COMPLETED|Overall Study||28
3105546|NCT01532700|3829544|FG000|NOT COMPLETED|Overall Study||0
3105547|NCT01532817|3829548|FG000|STARTED|Overall Study||30
3105548|NCT01532817|3829548|FG000|COMPLETED|Overall Study||30
3105549|NCT01532817|3829548|FG000|NOT COMPLETED|Overall Study||0
3105550|NCT01532830|3829552|FG000|STARTED|Overall Study||30
3105551|NCT01532830|3829552|FG000|COMPLETED|Overall Study||26
3105552|NCT01532830|3829552|FG000|NOT COMPLETED|Overall Study||4
3291993|NCT02853435|4025988|FG000|STARTED|Part 2, Washout Period 1 (3 Days)||0
3291994|NCT02853435|4025989|FG001|STARTED|Part 2, Washout Period 1 (3 Days)||0
3291995|NCT02853435|4025990|FG002|STARTED|Part 2, Washout Period 1 (3 Days)||0
3291996|NCT02853435|4025991|FG003|STARTED|Part 2, Washout Period 1 (3 Days)||10
3291997|NCT02853435|4025992|FG004|STARTED|Part 2, Washout Period 1 (3 Days)||0
3105553|NCT01532869|3829558|FG000|STARTED|Blinded-Treatment Period (Up to Week 24)||44
3105554|NCT01532869|3829559|FG001|STARTED|Blinded-Treatment Period (Up to Week 24)||43
3105555|NCT01532869|3829558|FG000|COMPLETED|Blinded-Treatment Period (Up to Week 24)|Number of participants who completed the first 24 weeks of full 48 weeks blinded-treatment period.|36
3105556|NCT01532869|3829559|FG001|COMPLETED|Blinded-Treatment Period (Up to Week 24)|Number of participants who completed the first 24 weeks of full 48 weeks blinded-treatment period.|35
3105557|NCT01532869|3829558|FG000|NOT COMPLETED|Blinded-Treatment Period (Up to Week 24)||8
3291998|NCT02853435|4025993|FG005|STARTED|Part 2, Washout Period 1 (3 Days)||0
3291999|NCT02853435|4025988|FG000|COMPLETED|Part 2, Washout Period 1 (3 Days)||0
3292000|NCT02853435|4025989|FG001|COMPLETED|Part 2, Washout Period 1 (3 Days)||0
3292001|NCT02853435|4025990|FG002|COMPLETED|Part 2, Washout Period 1 (3 Days)||0
3292002|NCT02853435|4025991|FG003|COMPLETED|Part 2, Washout Period 1 (3 Days)||10
3105558|NCT01532869|3829559|FG001|NOT COMPLETED|Blinded-Treatment Period (Up to Week 24)||8
3105559|NCT01532869|3829558|FG000|STARTED|Blinded-Treatment Period (Up to Week 48)||44
3105560|NCT01532869|3829559|FG001|STARTED|Blinded-Treatment Period (Up to Week 48)||43
3105561|NCT01532869|3829558|FG000|COMPLETED|Blinded-Treatment Period (Up to Week 48)|Number of participants who completed 48 weeks of blinded-treatment period.|33
3105562|NCT01532869|3829559|FG001|COMPLETED|Blinded-Treatment Period (Up to Week 48)|Number of participants who completed 48 weeks of blinded-treatment period.|30
3105563|NCT01532869|3829558|FG000|NOT COMPLETED|Blinded-Treatment Period (Up to Week 48)||11
3105564|NCT01532869|3829559|FG001|NOT COMPLETED|Blinded-Treatment Period (Up to Week 48)||13
3105565|NCT01532869|3829558|FG000|STARTED|Open-label Period (Week 48 to Week 96)|Two participants did not start the open label extension period.|31
3105566|NCT01532869|3829559|FG001|STARTED|Open-label Period (Week 48 to Week 96)||30
3105567|NCT01532869|3829558|FG000|COMPLETED|Open-label Period (Week 48 to Week 96)|Number of participants who completed study to Week 96.|24
3105568|NCT01532869|3829559|FG001|COMPLETED|Open-label Period (Week 48 to Week 96)|Number of participants who completed study to Week 96.|27
3105569|NCT01532869|3829558|FG000|NOT COMPLETED|Open-label Period (Week 48 to Week 96)||7
3105570|NCT01532869|3829559|FG001|NOT COMPLETED|Open-label Period (Week 48 to Week 96)||3
3105571|NCT01532908|3829572|FG000|STARTED|Overall Study||9
3105572|NCT01532908|3829573|FG001|STARTED|Overall Study||2
3105573|NCT01532908|3829572|FG000|Infused|Overall Study||9
3105574|NCT01532908|3829573|FG001|Infused|Overall Study||2
3105575|NCT01532908|3829572|FG000|Transplanted|Overall Study||8
3105576|NCT01532908|3829573|FG001|Transplanted|Overall Study||2
3105577|NCT01532908|3829572|FG000|COMPLETED|Overall Study||8
3105578|NCT01532908|3829573|FG001|COMPLETED|Overall Study||2
3105579|NCT01532908|3829572|FG000|NOT COMPLETED|Overall Study||1
3105580|NCT01532908|3829573|FG001|NOT COMPLETED|Overall Study||0
3105581|NCT01532921|3829579|FG000|STARTED|Overall Study||85
3105582|NCT01532921|3829579|FG000|Implantation Procedure|Overall Study||76
3105583|NCT01532921|3829579|FG000|Discharge|Overall Study||75
3105584|NCT01532921|3829579|FG000|6 Months Follow Up|Overall Study||68
3105585|NCT01532921|3829579|FG000|COMPLETED|Overall Study||69
3105586|NCT01532921|3829579|FG000|NOT COMPLETED|Overall Study||16
3105587|NCT01532934|3829589|FG000|STARTED|Overall Study||53
3105588|NCT01532934|3829590|FG001|STARTED|Overall Study||52
3105589|NCT01532934|3829589|FG000|COMPLETED|Overall Study||39
3105590|NCT01532934|3829590|FG001|COMPLETED|Overall Study||39
3105591|NCT01532934|3829589|FG000|NOT COMPLETED|Overall Study||14
3105592|NCT01532934|3829590|FG001|NOT COMPLETED|Overall Study||13
3105593|NCT01532973|3829607|FG000|STARTED|Part 1||6
3105594|NCT01532973|3829608|FG001|STARTED|Part 1||6
3105595|NCT01532973|3829609|FG002|STARTED|Part 1||6
3105596|NCT01532973|3829610|FG003|STARTED|Part 1|Planned panel not performed. No participants were enrolled.|0
3105597|NCT01532973|3829611|FG004|STARTED|Part 1||0
3105598|NCT01532973|3829612|FG005|STARTED|Part 1||0
3105599|NCT01532973|3829613|FG006|STARTED|Part 1||0
3105600|NCT01532973|3829614|FG007|STARTED|Part 1||0
3105601|NCT01532973|3829615|FG008|STARTED|Part 1||0
3105602|NCT01532973|3829616|FG009|STARTED|Part 1||0
3105603|NCT01532973|3829607|FG000|COMPLETED|Part 1||6
3105604|NCT01532973|3829608|FG001|COMPLETED|Part 1||6
3105605|NCT01532973|3829609|FG002|COMPLETED|Part 1||6
3105606|NCT01532973|3829610|FG003|COMPLETED|Part 1||0
3105607|NCT01532973|3829611|FG004|COMPLETED|Part 1||0
3105608|NCT01532973|3829612|FG005|COMPLETED|Part 1||0
3105609|NCT01532973|3829613|FG006|COMPLETED|Part 1||0
3105610|NCT01532973|3829614|FG007|COMPLETED|Part 1||0
3105611|NCT01532973|3829615|FG008|COMPLETED|Part 1||0
3105612|NCT01532973|3829616|FG009|COMPLETED|Part 1||0
3105613|NCT01532973|3829607|FG000|NOT COMPLETED|Part 1||0
3105614|NCT01532973|3829608|FG001|NOT COMPLETED|Part 1||0
3105615|NCT01532973|3829609|FG002|NOT COMPLETED|Part 1||0
3105616|NCT01532973|3829610|FG003|NOT COMPLETED|Part 1||0
3105617|NCT01532973|3829611|FG004|NOT COMPLETED|Part 1||0
3105618|NCT01532973|3829612|FG005|NOT COMPLETED|Part 1||0
3105619|NCT01532973|3829613|FG006|NOT COMPLETED|Part 1||0
3105620|NCT01532973|3829614|FG007|NOT COMPLETED|Part 1||0
3105621|NCT01532973|3829615|FG008|NOT COMPLETED|Part 1||0
3105622|NCT01532973|3829616|FG009|NOT COMPLETED|Part 1||0
3105623|NCT01532973|3829607|FG000|STARTED|Part 2||0
3105624|NCT01532973|3829608|FG001|STARTED|Part 2||0
3105625|NCT01532973|3829609|FG002|STARTED|Part 2||0
3105626|NCT01532973|3829610|FG003|STARTED|Part 2||0
3105627|NCT01532973|3829611|FG004|STARTED|Part 2||6
3105628|NCT01532973|3829612|FG005|STARTED|Part 2||6
3105629|NCT01532973|3829613|FG006|STARTED|Part 2||6
3105630|NCT01532973|3829614|FG007|STARTED|Part 2|Planned panel not performed. No participants were enrolled.|0
3105631|NCT01532973|3829615|FG008|STARTED|Part 2||0
3105632|NCT01532973|3829616|FG009|STARTED|Part 2||0
3105633|NCT01532973|3829607|FG000|COMPLETED|Part 2||0
3105634|NCT01532973|3829608|FG001|COMPLETED|Part 2||0
3105635|NCT01532973|3829609|FG002|COMPLETED|Part 2||0
3105636|NCT01532973|3829610|FG003|COMPLETED|Part 2||0
3105637|NCT01532973|3829611|FG004|COMPLETED|Part 2||6
3105638|NCT01532973|3829612|FG005|COMPLETED|Part 2||6
3105639|NCT01532973|3829613|FG006|COMPLETED|Part 2||6
3105640|NCT01532973|3829614|FG007|COMPLETED|Part 2||0
3105641|NCT01532973|3829615|FG008|COMPLETED|Part 2||0
3105642|NCT01532973|3829616|FG009|COMPLETED|Part 2||0
3105643|NCT01532973|3829607|FG000|NOT COMPLETED|Part 2||0
3105644|NCT01532973|3829608|FG001|NOT COMPLETED|Part 2||0
3105645|NCT01532973|3829609|FG002|NOT COMPLETED|Part 2||0
3105646|NCT01532973|3829610|FG003|NOT COMPLETED|Part 2||0
3105647|NCT01532973|3829611|FG004|NOT COMPLETED|Part 2||0
3105648|NCT01532973|3829612|FG005|NOT COMPLETED|Part 2||0
3105649|NCT01532973|3829613|FG006|NOT COMPLETED|Part 2||0
3105650|NCT01532973|3829614|FG007|NOT COMPLETED|Part 2||0
3105651|NCT01532973|3829615|FG008|NOT COMPLETED|Part 2||0
3105652|NCT01532973|3829616|FG009|NOT COMPLETED|Part 2||0
3105653|NCT01532973|3829607|FG000|STARTED|Part 3||0
3105654|NCT01532973|3829608|FG001|STARTED|Part 3||0
3105655|NCT01532973|3829609|FG002|STARTED|Part 3||0
3105656|NCT01532973|3829610|FG003|STARTED|Part 3||0
3105657|NCT01532973|3829611|FG004|STARTED|Part 3||0
3105658|NCT01532973|3829612|FG005|STARTED|Part 3||0
3105659|NCT01532973|3829613|FG006|STARTED|Part 3||0
3105660|NCT01532973|3829614|FG007|STARTED|Part 3||0
3105661|NCT01532973|3829615|FG008|STARTED|Part 3||6
3105662|NCT01532973|3829616|FG009|STARTED|Part 3||6
3105663|NCT01532973|3829607|FG000|COMPLETED|Part 3||0
3105664|NCT01532973|3829608|FG001|COMPLETED|Part 3||0
3105665|NCT01532973|3829609|FG002|COMPLETED|Part 3||0
3105666|NCT01532973|3829610|FG003|COMPLETED|Part 3||0
3105667|NCT01532973|3829611|FG004|COMPLETED|Part 3||0
3105668|NCT01532973|3829612|FG005|COMPLETED|Part 3||0
3105669|NCT01532973|3829613|FG006|COMPLETED|Part 3||0
3105670|NCT01532973|3829614|FG007|COMPLETED|Part 3||0
3105671|NCT01532973|3829615|FG008|COMPLETED|Part 3||6
3105672|NCT01532973|3829616|FG009|COMPLETED|Part 3||6
3105673|NCT01532973|3829607|FG000|NOT COMPLETED|Part 3||0
3105674|NCT01532973|3829608|FG001|NOT COMPLETED|Part 3||0
3105675|NCT01532973|3829609|FG002|NOT COMPLETED|Part 3||0
3105676|NCT01532973|3829610|FG003|NOT COMPLETED|Part 3||0
3105677|NCT01532973|3829611|FG004|NOT COMPLETED|Part 3||0
3105678|NCT01532973|3829612|FG005|NOT COMPLETED|Part 3||0
3105679|NCT01532973|3829613|FG006|NOT COMPLETED|Part 3||0
3105680|NCT01532973|3829614|FG007|NOT COMPLETED|Part 3||0
3105681|NCT01532973|3829615|FG008|NOT COMPLETED|Part 3||0
3105682|NCT01532973|3829616|FG009|NOT COMPLETED|Part 3||0
3105683|NCT01532986|3829642|FG000|STARTED|Overall Study||166
3105684|NCT01532986|3829643|FG001|STARTED|Overall Study||162
3105685|NCT01532986|3829642|FG000|COMPLETED|Overall Study||143
3105686|NCT01532986|3829643|FG001|COMPLETED|Overall Study||138
3105687|NCT01532986|3829642|FG000|NOT COMPLETED|Overall Study||23
3105688|NCT01532986|3829643|FG001|NOT COMPLETED|Overall Study||24
3105689|NCT01532999|3829652|FG000|STARTED|Overall Study||96
3105690|NCT01532999|3829653|FG001|STARTED|Overall Study||95
3105691|NCT01532999|3829652|FG000|COMPLETED|Overall Study||65
3105692|NCT01532999|3829653|FG001|COMPLETED|Overall Study||77
3105693|NCT01532999|3829652|FG000|NOT COMPLETED|Overall Study||31
3105694|NCT01532999|3829653|FG001|NOT COMPLETED|Overall Study||18
3105695|NCT01533038|3829661|FG000|STARTED|Overall Study||45
3105696|NCT01533038|3829662|FG001|STARTED|Overall Study||35
3105697|NCT01533038|3829661|FG000|COMPLETED|Overall Study||45
3105698|NCT01533038|3829662|FG001|COMPLETED|Overall Study||34
3105699|NCT01533038|3829661|FG000|NOT COMPLETED|Overall Study||0
3105700|NCT01533038|3829662|FG001|NOT COMPLETED|Overall Study||1
3105701|NCT01533077|3829672|FG000|STARTED|Overall Study||5
3105702|NCT01533077|3829673|FG001|STARTED|Overall Study||5
3105703|NCT01533077|3829674|FG002|STARTED|Overall Study||4
3105704|NCT01533077|3829675|FG003|STARTED|Overall Study||4
3105705|NCT01533077|3829672|FG000|BIA 9-1067 50 mg|Overall Study||5
3105706|NCT01533077|3829673|FG001|BIA 9-1067 50 mg|Overall Study||5
3105707|NCT01533077|3829674|FG002|BIA 9-1067 50 mg|Overall Study||4
3105708|NCT01533077|3829675|FG003|BIA 9-1067 50 mg|Overall Study||4
3105709|NCT01533077|3829672|FG000|Sinemet® 100/25|Overall Study||4
3105710|NCT01533077|3829673|FG001|Sinemet® 100/25|Overall Study||5
3105711|NCT01533077|3829674|FG002|Sinemet® 100/25|Overall Study||4
3105712|NCT01533077|3829675|FG003|Sinemet® 100/25|Overall Study||4
3105713|NCT01533077|3829672|FG000|BIA 9-1067 50 mg + Sinemet® 100/25|Overall Study||4
3105714|NCT01533077|3829673|FG001|BIA 9-1067 50 mg + Sinemet® 100/25|Overall Study||4
3105715|NCT01533077|3829674|FG002|BIA 9-1067 50 mg + Sinemet® 100/25|Overall Study||4
3105716|NCT01533077|3829675|FG003|BIA 9-1067 50 mg + Sinemet® 100/25|Overall Study||4
3105717|NCT01533077|3829672|FG000|Sinemet® 100/25 1 h After the BIA 9-1067|Overall Study||5
3105718|NCT01533077|3829673|FG001|Sinemet® 100/25 1 h After the BIA 9-1067|Overall Study||5
3105719|NCT01533077|3829674|FG002|Sinemet® 100/25 1 h After the BIA 9-1067|Overall Study||4
3105720|NCT01533077|3829675|FG003|Sinemet® 100/25 1 h After the BIA 9-1067|Overall Study||4
3105721|NCT01533077|3829672|FG000|COMPLETED|Overall Study||4
3105722|NCT01533077|3829673|FG001|COMPLETED|Overall Study||4
3105723|NCT01533077|3829674|FG002|COMPLETED|Overall Study||4
3105724|NCT01533077|3829675|FG003|COMPLETED|Overall Study||4
3105725|NCT01533077|3829672|FG000|NOT COMPLETED|Overall Study||1
3105726|NCT01533077|3829673|FG001|NOT COMPLETED|Overall Study||1
3105727|NCT01533077|3829674|FG002|NOT COMPLETED|Overall Study||0
3105728|NCT01533077|3829675|FG003|NOT COMPLETED|Overall Study||0
3105729|NCT01533116|3829689|FG000|STARTED|Overall Study||14
3105730|NCT01533116|3829690|FG001|STARTED|Overall Study||13
3105731|NCT01533116|3829691|FG002|STARTED|Overall Study||13
3105732|NCT01533116|3829692|FG003|STARTED|Overall Study||12
3105733|NCT01533116|3829689|FG000|COMPLETED|Overall Study||12
3105734|NCT01533116|3829690|FG001|COMPLETED|Overall Study||12
3105735|NCT01533116|3829691|FG002|COMPLETED|Overall Study||12
3105736|NCT01533116|3829692|FG003|COMPLETED|Overall Study||12
3105737|NCT01533116|3829689|FG000|NOT COMPLETED|Overall Study||2
3105738|NCT01533116|3829690|FG001|NOT COMPLETED|Overall Study||1
3105739|NCT01533116|3829691|FG002|NOT COMPLETED|Overall Study||1
3105740|NCT01533116|3829692|FG003|NOT COMPLETED|Overall Study||0
3105741|NCT01533181|3829704|FG000|STARTED|Overall Study||15
3105742|NCT01533181|3829705|FG001|STARTED|Overall Study||29
3105743|NCT01533181|3829704|FG000|COMPLETED|Overall Study||14
3105744|NCT01533181|3829705|FG001|COMPLETED|Overall Study||28
3105745|NCT01533181|3829704|FG000|NOT COMPLETED|Overall Study||1
3105746|NCT01533181|3829705|FG001|NOT COMPLETED|Overall Study||1
3105747|NCT01533207|3829713|FG000|STARTED|Overall Study||20
3105748|NCT01533207|3829714|FG001|STARTED|Overall Study||18
3105749|NCT01533207|3829713|FG000|COMPLETED|Overall Study||20
3105750|NCT01533207|3829714|FG001|COMPLETED|Overall Study||18
3105751|NCT01533207|3829713|FG000|NOT COMPLETED|Overall Study||0
3105752|NCT01533207|3829714|FG001|NOT COMPLETED|Overall Study||0
3105753|NCT01533246|3829720|FG000|STARTED|Overall Study||17
3105754|NCT01533246|3829720|FG000|COMPLETED|Overall Study||15
3105755|NCT01533246|3829720|FG000|NOT COMPLETED|Overall Study||2
3105756|NCT01533259|3829724|FG000|STARTED|Overall Study||48
3105757|NCT01533259|3829724|FG000|COMPLETED|Overall Study||48
3105758|NCT01533259|3829724|FG000|NOT COMPLETED|Overall Study||0
3105759|NCT01533428|3829730|FG000|STARTED|Overall Study||186
3105760|NCT01533428|3829731|FG001|STARTED|Overall Study||183
3105761|NCT01533428|3829730|FG000|COMPLETED|Overall Study||177
3105762|NCT01533428|3829731|FG001|COMPLETED|Overall Study||175
3105763|NCT01533428|3829730|FG000|NOT COMPLETED|Overall Study||9
3105764|NCT01533428|3829731|FG001|NOT COMPLETED|Overall Study||8
3105765|NCT01533493|3829739|FG000|STARTED|Overall Study||12
3105766|NCT01533493|3829740|FG001|STARTED|Overall Study||14
3105767|NCT01533493|3829739|FG000|COMPLETED|Overall Study||7
3105768|NCT01533493|3829740|FG001|COMPLETED|Overall Study||11
3105769|NCT01533493|3829739|FG000|NOT COMPLETED|Overall Study||5
3105770|NCT01533493|3829740|FG001|NOT COMPLETED|Overall Study||3
3105771|NCT01533597|3829748|FG000|STARTED|Overall Study||35
3105772|NCT01533597|3829749|FG001|STARTED|Overall Study||35
3105773|NCT01533597|3829748|FG000|COMPLETED|Overall Study||29
3105774|NCT01533597|3829749|FG001|COMPLETED|Overall Study||25
3105775|NCT01533597|3829748|FG000|NOT COMPLETED|Overall Study||6
3105776|NCT01533597|3829749|FG001|NOT COMPLETED|Overall Study||10
3105777|NCT01533688|3829758|FG000|STARTED|Overall Study||71
3105778|NCT01533688|3829759|FG001|STARTED|Overall Study||70
3105779|NCT01533688|3829760|FG002|STARTED|Overall Study||71
3105780|NCT01533688|3829758|FG000|COMPLETED|Overall Study||63
3105781|NCT01533688|3829759|FG001|COMPLETED|Overall Study||60
3105782|NCT01533688|3829760|FG002|COMPLETED|Overall Study||63
3105783|NCT01533688|3829758|FG000|NOT COMPLETED|Overall Study||8
3105784|NCT01533688|3829759|FG001|NOT COMPLETED|Overall Study||10
3105785|NCT01533688|3829760|FG002|NOT COMPLETED|Overall Study||8
3105786|NCT01533922|3829770|FG000|STARTED|Overall Study||59
3105787|NCT01533922|3829771|FG001|STARTED|Overall Study||59
3105788|NCT01533922|3829772|FG002|STARTED|Overall Study||60
3105789|NCT01533922|3829773|FG003|STARTED|Overall Study||58
3105790|NCT01533922|3829774|FG004|STARTED|Overall Study||59
3105791|NCT01533922|3829770|FG000|Received Placebo|Overall Study||0
3105792|NCT01533922|3829771|FG001|Received Placebo|Overall Study||49
3105793|NCT01533922|3829772|FG002|Received Placebo|Overall Study||57
3105794|NCT01533922|3829773|FG003|Received Placebo|Overall Study||57
3105795|NCT01533922|3829774|FG004|Received Placebo|Overall Study||59
3105796|NCT01533922|3829770|FG000|Received Olo 5|Overall Study||51
3105797|NCT01533922|3829771|FG001|Received Olo 5|Overall Study||52
3105798|NCT01533922|3829772|FG002|Received Olo 5|Overall Study||57
3105799|NCT01533922|3829773|FG003|Received Olo 5|Overall Study||57
3105800|NCT01533922|3829774|FG004|Received Olo 5|Overall Study||0
3105801|NCT01533922|3829770|FG000|Received Tio 5|Overall Study||54
3105802|NCT01533922|3829771|FG001|Received Tio 5|Overall Study||58
3105803|NCT01533922|3829772|FG002|Received Tio 5|Overall Study||59
3105804|NCT01533922|3829773|FG003|Received Tio 5|Overall Study|One patient received Tio 5 instead of Olo 5 by mistake.|1
3105805|NCT01533922|3829774|FG004|Received Tio 5|Overall Study||54
3105806|NCT01533922|3829770|FG000|Received Tio+Olo 2.5/5|Overall Study||59
3105807|NCT01533922|3829771|FG001|Received Tio+Olo 2.5/5|Overall Study||0
3105808|NCT01533922|3829772|FG002|Received Tio+Olo 2.5/5|Overall Study||52
3105809|NCT01533922|3829773|FG003|Received Tio+Olo 2.5/5|Overall Study||55
3105810|NCT01533922|3829774|FG004|Received Tio+Olo 2.5/5|Overall Study||56
3105811|NCT01533922|3829770|FG000|Received Tio+Olo 5/5|Overall Study||58
3105812|NCT01533922|3829771|FG001|Received Tio+Olo 5/5|Overall Study||59
3105813|NCT01533922|3829772|FG002|Received Tio+Olo 5/5|Overall Study||0
3105814|NCT01533922|3829773|FG003|Received Tio+Olo 5/5|Overall Study||53
3105815|NCT01533922|3829774|FG004|Received Tio+Olo 5/5|Overall Study||56
3105816|NCT01533922|3829770|FG000|COMPLETED|Overall Study|Completed all treatment arms|49
3105817|NCT01533922|3829771|FG001|COMPLETED|Overall Study|Completed all treatment arms|47
3105818|NCT01533922|3829772|FG002|COMPLETED|Overall Study|Completed all treatment arms|50
3105819|NCT01533922|3829773|FG003|COMPLETED|Overall Study|Completed all treatment arms|53
3105820|NCT01533922|3829774|FG004|COMPLETED|Overall Study|Completed all treatment arms|53
3105821|NCT01533922|3829770|FG000|NOT COMPLETED|Overall Study||10
3105822|NCT01533922|3829771|FG001|NOT COMPLETED|Overall Study||12
3105823|NCT01533922|3829772|FG002|NOT COMPLETED|Overall Study||10
3105824|NCT01533922|3829773|FG003|NOT COMPLETED|Overall Study||5
3105825|NCT01533922|3829774|FG004|NOT COMPLETED|Overall Study||6
3105826|NCT01533935|3829786|FG000|STARTED|Overall Study||58
3105827|NCT01533935|3829787|FG001|STARTED|Overall Study||58
3105828|NCT01533935|3829788|FG002|STARTED|Overall Study||58
3105829|NCT01533935|3829789|FG003|STARTED|Overall Study||59
3105830|NCT01533935|3829790|FG004|STARTED|Overall Study||58
3105831|NCT01533935|3829786|FG000|Received Placebo|Overall Study||0
3105832|NCT01533935|3829787|FG001|Received Placebo|Overall Study||47
3105833|NCT01533935|3829788|FG002|Received Placebo|Overall Study||52
3105834|NCT01533935|3829789|FG003|Received Placebo|Overall Study||57
3105835|NCT01533935|3829790|FG004|Received Placebo|Overall Study||58
3105836|NCT01533935|3829786|FG000|Received Olo 5|Overall Study||52
3105837|NCT01533935|3829787|FG001|Received Olo 5|Overall Study||52
3105838|NCT01533935|3829788|FG002|Received Olo 5|Overall Study||55
3105839|NCT01533935|3829789|FG003|Received Olo 5|Overall Study||59
3105840|NCT01533935|3829790|FG004|Received Olo 5|Overall Study||0
3105841|NCT01533935|3829786|FG000|Received Tio 5|Overall Study||54
3105842|NCT01533935|3829787|FG001|Received Tio 5|Overall Study||54
3105843|NCT01533935|3829788|FG002|Received Tio 5|Overall Study||58
3105844|NCT01533935|3829789|FG003|Received Tio 5|Overall Study||0
3105845|NCT01533935|3829790|FG004|Received Tio 5|Overall Study||52
3105846|NCT01533935|3829786|FG000|Received Tio+Olo 2.5/5|Overall Study||58
3105847|NCT01533935|3829787|FG001|Received Tio+Olo 2.5/5|Overall Study||0
3105848|NCT01533935|3829788|FG002|Received Tio+Olo 2.5/5|Overall Study||49
3105849|NCT01533935|3829789|FG003|Received Tio+Olo 2.5/5|Overall Study||56
3105850|NCT01533935|3829790|FG004|Received Tio+Olo 2.5/5|Overall Study||56
3105851|NCT01533935|3829786|FG000|Received Tio+Olo 5/5|Overall Study||56
3105852|NCT01533935|3829787|FG001|Received Tio+Olo 5/5|Overall Study||58
3105853|NCT01533935|3829788|FG002|Received Tio+Olo 5/5|Overall Study|One patient received Tio+Olo 5/5 instead of Tio+Olo 2.5/5 by mistake.|1
3105854|NCT01533935|3829789|FG003|Received Tio+Olo 5/5|Overall Study||54
3105855|NCT01533935|3829790|FG004|Received Tio+Olo 5/5|Overall Study||55
3105856|NCT01533935|3829786|FG000|COMPLETED|Overall Study|All treatment periods|52
3105857|NCT01533935|3829787|FG001|COMPLETED|Overall Study|All treatment periods|45
3105858|NCT01533935|3829788|FG002|COMPLETED|Overall Study|All treatment periods|50
3105859|NCT01533935|3829789|FG003|COMPLETED|Overall Study|All treatment periods|52
3105860|NCT01533935|3829790|FG004|COMPLETED|Overall Study|All treatment periods|50
3105861|NCT01533935|3829786|FG000|NOT COMPLETED|Overall Study||6
3105862|NCT01533935|3829787|FG001|NOT COMPLETED|Overall Study||13
3105863|NCT01533935|3829788|FG002|NOT COMPLETED|Overall Study||8
3105864|NCT01533935|3829789|FG003|NOT COMPLETED|Overall Study||7
3105865|NCT01533935|3829790|FG004|NOT COMPLETED|Overall Study||8
3105866|NCT01533948|3829802|FG000|STARTED|Overall Study||25
3105867|NCT01533948|3829802|FG000|COMPLETED|Overall Study||25
3105868|NCT01533948|3829802|FG000|NOT COMPLETED|Overall Study||0
3105869|NCT01533974|3829808|FG000|STARTED|Overall Study||224
3105870|NCT01533974|3829809|FG001|STARTED|Overall Study||226
3105871|NCT01533974|3829808|FG000|COMPLETED|Overall Study||173
3105872|NCT01533974|3829809|FG001|COMPLETED|Overall Study||176
3105873|NCT01533974|3829808|FG000|NOT COMPLETED|Overall Study||51
3105874|NCT01533974|3829809|FG001|NOT COMPLETED|Overall Study||50
3105875|NCT01534013|3829817|FG000|STARTED|Overall Study||8
3105876|NCT01534013|3829818|FG001|STARTED|Overall Study||6
3105877|NCT01534013|3829817|FG000|COMPLETED|Overall Study||6
3105878|NCT01534013|3829818|FG001|COMPLETED|Overall Study||6
3105879|NCT01534013|3829817|FG000|NOT COMPLETED|Overall Study||2
3105880|NCT01534013|3829818|FG001|NOT COMPLETED|Overall Study||0
3105881|NCT01534052|3829824|FG000|STARTED|Overall Study||52
3105882|NCT01534052|3829824|FG000|Treatment Received|Overall Study||52
3105883|NCT01534052|3829824|FG000|COMPLETED|Overall Study||52
3105884|NCT01534052|3829824|FG000|NOT COMPLETED|Overall Study||0
3105885|NCT01534078|3829828|FG000|STARTED|Overall Study||34
3105886|NCT01534078|3829828|FG000|COMPLETED|Overall Study||32
3105887|NCT01534078|3829828|FG000|NOT COMPLETED|Overall Study||2
3105888|NCT01534182|3829834|FG000|STARTED|Overall Study||230
3105889|NCT01534182|3829835|FG001|STARTED|Overall Study||68
3105890|NCT01534182|3829834|FG000|Safety Set|Overall Study||230
3105891|NCT01534182|3829835|FG001|Safety Set|Overall Study||64
3105892|NCT01534182|3829834|FG000|Full Analysis Set|Overall Study||229
3105893|NCT01534182|3829835|FG001|Full Analysis Set|Overall Study||62
3105894|NCT01534182|3829834|FG000|COMPLETED|Overall Study||218
3105895|NCT01534182|3829835|FG001|COMPLETED|Overall Study||58
3105896|NCT01534182|3829834|FG000|NOT COMPLETED|Overall Study||12
3105897|NCT01534182|3829835|FG001|NOT COMPLETED|Overall Study||10
3105898|NCT01534195|3829844|FG000|STARTED|Overall Study||5
3105899|NCT01534195|3829845|FG001|STARTED|Overall Study||6
3105900|NCT01534195|3829844|FG000|COMPLETED|Overall Study||4
3105901|NCT01534195|3829845|FG001|COMPLETED|Overall Study||5
3105902|NCT01534195|3829844|FG000|NOT COMPLETED|Overall Study||1
3105903|NCT01534195|3829845|FG001|NOT COMPLETED|Overall Study||1
3105904|NCT01534208|3829853|FG000|STARTED|Overall Study||216
3105905|NCT01534208|3829854|FG001|STARTED|Overall Study||283
3105906|NCT01534208|3829853|FG000|COMPLETED|Overall Study||159
3105907|NCT01534208|3829854|FG001|COMPLETED|Overall Study||234
3105908|NCT01534208|3829853|FG000|NOT COMPLETED|Overall Study||57
3105909|NCT01534208|3829854|FG001|NOT COMPLETED|Overall Study||49
3105910|NCT01534260|3829862|FG000|STARTED|Overall Study||17
3105911|NCT01534260|3829863|FG001|STARTED|Overall Study||20
3105912|NCT01534260|3829862|FG000|COMPLETED|Overall Study||1
3105913|NCT01534260|3829863|FG001|COMPLETED|Overall Study||0
3105914|NCT01534260|3829862|FG000|NOT COMPLETED|Overall Study||16
3105915|NCT01534260|3829863|FG001|NOT COMPLETED|Overall Study||20
3105916|NCT01534273|3829873|FG000|STARTED|Period 1||3
3105917|NCT01534273|3829874|FG001|STARTED|Period 1||6
3105918|NCT01534273|3829875|FG002|STARTED|Period 1||2
3105919|NCT01534273|3829876|FG003|STARTED|Period 1||7
3105920|NCT01534273|3829877|FG004|STARTED|Period 1||3
3105921|NCT01534273|3829878|FG005|STARTED|Period 1||3
3105922|NCT01534273|3829879|FG006|STARTED|Period 1||6
3105923|NCT01534273|3829873|FG000|Received at Least 1 Dose of Study Drug|Period 1||3
3105924|NCT01534273|3829874|FG001|Received at Least 1 Dose of Study Drug|Period 1||6
3105925|NCT01534273|3829875|FG002|Received at Least 1 Dose of Study Drug|Period 1||2
3105926|NCT01534273|3829876|FG003|Received at Least 1 Dose of Study Drug|Period 1||7
3105927|NCT01534273|3829877|FG004|Received at Least 1 Dose of Study Drug|Period 1||3
3105928|NCT01534273|3829878|FG005|Received at Least 1 Dose of Study Drug|Period 1||3
3105929|NCT01534273|3829879|FG006|Received at Least 1 Dose of Study Drug|Period 1||6
3105930|NCT01534273|3829873|FG000|COMPLETED|Period 1||3
3105931|NCT01534273|3829874|FG001|COMPLETED|Period 1||6
3105932|NCT01534273|3829875|FG002|COMPLETED|Period 1||2
3105933|NCT01534273|3829876|FG003|COMPLETED|Period 1||6
3105934|NCT01534273|3829877|FG004|COMPLETED|Period 1||3
3105935|NCT01534273|3829878|FG005|COMPLETED|Period 1||3
3105936|NCT01534273|3829879|FG006|COMPLETED|Period 1||6
3105937|NCT01534273|3829873|FG000|NOT COMPLETED|Period 1||0
3105938|NCT01534273|3829874|FG001|NOT COMPLETED|Period 1||0
3105939|NCT01534273|3829875|FG002|NOT COMPLETED|Period 1||0
3105940|NCT01534273|3829876|FG003|NOT COMPLETED|Period 1||1
3105941|NCT01534273|3829877|FG004|NOT COMPLETED|Period 1||0
3105942|NCT01534273|3829878|FG005|NOT COMPLETED|Period 1||0
3105943|NCT01534273|3829879|FG006|NOT COMPLETED|Period 1||0
3105944|NCT01534273|3829873|FG000|STARTED|Period 2|Participants in Cohort A participated in only 1 treatment period.|0
3105945|NCT01534273|3829874|FG001|STARTED|Period 2|Participants in Cohort A participated in only 1 treatment period.|0
3105946|NCT01534273|3829875|FG002|STARTED|Period 2||2
3105947|NCT01534273|3829876|FG003|STARTED|Period 2||6
3105948|NCT01534273|3829877|FG004|STARTED|Period 2|Participants in Cohort C participated in only 1 treatment period.|0
3105949|NCT01534273|3829878|FG005|STARTED|Period 2|Participants in Cohort C participated in only 1 treatment period.|0
3105950|NCT01534273|3829879|FG006|STARTED|Period 2|Participants in Cohort C participated in only 1 treatment period.|0
3105951|NCT01534273|3829873|FG000|COMPLETED|Period 2||0
3105952|NCT01534273|3829874|FG001|COMPLETED|Period 2||0
3105953|NCT01534273|3829875|FG002|COMPLETED|Period 2||2
3105954|NCT01534273|3829876|FG003|COMPLETED|Period 2||6
3105955|NCT01534273|3829877|FG004|COMPLETED|Period 2||0
3105956|NCT01534273|3829878|FG005|COMPLETED|Period 2||0
3105957|NCT01534273|3829879|FG006|COMPLETED|Period 2||0
3105958|NCT01534273|3829873|FG000|NOT COMPLETED|Period 2||0
3105959|NCT01534273|3829874|FG001|NOT COMPLETED|Period 2||0
3105960|NCT01534273|3829875|FG002|NOT COMPLETED|Period 2||0
3105961|NCT01534273|3829876|FG003|NOT COMPLETED|Period 2||0
3105962|NCT01534273|3829877|FG004|NOT COMPLETED|Period 2||0
3105963|NCT01534273|3829878|FG005|NOT COMPLETED|Period 2||0
3105964|NCT01534273|3829879|FG006|NOT COMPLETED|Period 2||0
3105965|NCT01534351|3829903|FG000|STARTED|Overall Study||1
3105966|NCT01534351|3829904|FG001|STARTED|Overall Study||0
3105967|NCT01534351|3829905|FG002|STARTED|Overall Study||0
3105968|NCT01534351|3829903|FG000|COMPLETED|Overall Study||0
3105969|NCT01534351|3829904|FG001|COMPLETED|Overall Study||0
3105970|NCT01534351|3829905|FG002|COMPLETED|Overall Study||0
3105971|NCT01534351|3829903|FG000|NOT COMPLETED|Overall Study||1
3105972|NCT01534351|3829904|FG001|NOT COMPLETED|Overall Study||0
3105973|NCT01534351|3829905|FG002|NOT COMPLETED|Overall Study||0
3105974|NCT01534416|3829915|FG000|STARTED|Overall Study||68
3105975|NCT01534416|3829916|FG001|STARTED|Overall Study||64
3105976|NCT01534416|3829915|FG000|COMPLETED|Overall Study||68
3105977|NCT01534416|3829916|FG001|COMPLETED|Overall Study||64
3105978|NCT01534416|3829915|FG000|NOT COMPLETED|Overall Study||0
3105979|NCT01534416|3829916|FG001|NOT COMPLETED|Overall Study||0
3105980|NCT01534520|3829934|FG000|STARTED|Overall Study||30
3105981|NCT01534520|3829935|FG001|STARTED|Overall Study||29
3105982|NCT01534520|3829934|FG000|COMPLETED|Overall Study||30
3105983|NCT01534520|3829935|FG001|COMPLETED|Overall Study|1 subject withdrew consent at time of uterine sound attempt due to intolerable pain|28
3105984|NCT01534520|3829934|FG000|NOT COMPLETED|Overall Study||0
3105985|NCT01534520|3829935|FG001|NOT COMPLETED|Overall Study||1
3105986|NCT01534533|3829949|FG000|STARTED|Overall Study||48
3105987|NCT01534533|3829950|FG001|STARTED|Overall Study||48
3105988|NCT01534533|3829951|FG002|STARTED|Overall Study||48
3105989|NCT01534533|3829952|FG003|STARTED|Overall Study||48
3105990|NCT01534533|3829949|FG000|COMPLETED|Overall Study||40
3105991|NCT01534533|3829950|FG001|COMPLETED|Overall Study||45
3105992|NCT01534533|3829951|FG002|COMPLETED|Overall Study||40
3105993|NCT01534533|3829952|FG003|COMPLETED|Overall Study||44
3105994|NCT01534533|3829949|FG000|NOT COMPLETED|Overall Study||8
3105995|NCT01534533|3829950|FG001|NOT COMPLETED|Overall Study||3
3105996|NCT01534533|3829951|FG002|NOT COMPLETED|Overall Study||8
3105997|NCT01534533|3829952|FG003|NOT COMPLETED|Overall Study||4
3105998|NCT01534637|3829964|FG000|STARTED|Overall Study||22
3105999|NCT01534637|3829964|FG000|COMPLETED|Overall Study||13
3106000|NCT01534637|3829964|FG000|NOT COMPLETED|Overall Study||9
3106001|NCT01534663|3829970|FG000|STARTED|Overall Study||14
3106002|NCT01534663|3829971|FG001|STARTED|Overall Study||17
3106003|NCT01534663|3829970|FG000|COMPLETED|Overall Study||12
3106004|NCT01534663|3829971|FG001|COMPLETED|Overall Study||14
3106005|NCT01534663|3829970|FG000|NOT COMPLETED|Overall Study||2
3106006|NCT01534663|3829971|FG001|NOT COMPLETED|Overall Study||3
3106007|NCT01534689|3829977|FG000|STARTED|Overall Study||105
3106008|NCT01534689|3829977|FG000|COMPLETED|Overall Study||105
3106009|NCT01534689|3829977|FG000|NOT COMPLETED|Overall Study||0
3106010|NCT01534897|3829981|FG000|STARTED|Overall Study||10
3106011|NCT01534897|3829981|FG000|Day 25 Iodine-131 Scan|Overall Study||10
3106012|NCT01534897|3829981|FG000|Day 37 Iodine-131 Treatment|Overall Study||6
3106013|NCT01534897|3829981|FG000|COMPLETED|Overall Study||10
3106014|NCT01534897|3829981|FG000|NOT COMPLETED|Overall Study||0
3106015|NCT01534910|3829988|FG000|STARTED|Overall Study||33
3106016|NCT01534910|3829989|FG001|STARTED|Overall Study||32
3106017|NCT01534910|3829988|FG000|COMPLETED|Overall Study||29
3106018|NCT01534910|3829989|FG001|COMPLETED|Overall Study||28
3106019|NCT01534910|3829988|FG000|NOT COMPLETED|Overall Study||4
3106020|NCT01534910|3829989|FG001|NOT COMPLETED|Overall Study||4
3106021|NCT01534962|3830001|FG000|STARTED|Overall Study||67
3106022|NCT01534962|3830002|FG001|STARTED|Overall Study||60
3106023|NCT01534962|3830003|FG002|STARTED|Overall Study||58
3106024|NCT01534962|3830004|FG003|STARTED|Overall Study||56
3106025|NCT01534962|3830001|FG000|COMPLETED|Overall Study||30
3106026|NCT01534962|3830002|FG001|COMPLETED|Overall Study||34
3106027|NCT01534962|3830003|FG002|COMPLETED|Overall Study||34
3106028|NCT01534962|3830004|FG003|COMPLETED|Overall Study||24
3106029|NCT01534962|3830001|FG000|NOT COMPLETED|Overall Study||37
3106030|NCT01534962|3830002|FG001|NOT COMPLETED|Overall Study||26
3106031|NCT01534962|3830003|FG002|NOT COMPLETED|Overall Study||24
3106032|NCT01534962|3830004|FG003|NOT COMPLETED|Overall Study||32
3106033|NCT01534975|3830018|FG000|STARTED|Overall Study||136
3106034|NCT01534975|3830019|FG001|STARTED|Overall Study||133
3106035|NCT01534975|3830020|FG002|STARTED|Overall Study||160
3106036|NCT01534975|3830021|FG003|STARTED|Overall Study||84
3106037|NCT01534975|3830018|FG000|COMPLETED|Overall Study||136
3106038|NCT01534975|3830019|FG001|COMPLETED|Overall Study||133
3106039|NCT01534975|3830020|FG002|COMPLETED|Overall Study||160
3106040|NCT01534975|3830021|FG003|COMPLETED|Overall Study||84
3106041|NCT01534975|3830018|FG000|NOT COMPLETED|Overall Study||0
3106042|NCT01534975|3830019|FG001|NOT COMPLETED|Overall Study||0
3106043|NCT01534975|3830020|FG002|NOT COMPLETED|Overall Study||0
3106044|NCT01534975|3830021|FG003|NOT COMPLETED|Overall Study||0
3106045|NCT01535001|3830033|FG000|STARTED|Overall Study||50
3106046|NCT01535001|3830034|FG001|STARTED|Overall Study||50
3106047|NCT01535001|3830033|FG000|COMPLETED|Overall Study||47
3106048|NCT01535001|3830034|FG001|COMPLETED|Overall Study||44
3106049|NCT01535001|3830033|FG000|NOT COMPLETED|Overall Study||3
3106050|NCT01535001|3830034|FG001|NOT COMPLETED|Overall Study||6
3106051|NCT01535014|3830044|FG000|STARTED|Overall Study||210
3106052|NCT01535014|3830045|FG001|STARTED|Overall Study||200
3106053|NCT01535014|3830046|FG002|STARTED|Overall Study||50
3106054|NCT01535014|3830047|FG003|STARTED|Overall Study||33
3106055|NCT01535014|3830044|FG000|COMPLETED|Overall Study||208
3106056|NCT01535014|3830045|FG001|COMPLETED|Overall Study||194
3106057|NCT01535014|3830046|FG002|COMPLETED|Overall Study||49
3106058|NCT01535014|3830047|FG003|COMPLETED|Overall Study||33
3106059|NCT01535014|3830044|FG000|NOT COMPLETED|Overall Study||2
3106060|NCT01535014|3830045|FG001|NOT COMPLETED|Overall Study||6
3106061|NCT01535014|3830046|FG002|NOT COMPLETED|Overall Study||1
3106062|NCT01535014|3830047|FG003|NOT COMPLETED|Overall Study||0
3106063|NCT01535040|3830057|FG000|STARTED|Overall Study||65
3106064|NCT01535040|3830058|FG001|STARTED|Overall Study||65
3106065|NCT01535040|3830057|FG000|COMPLETED|Overall Study||35
3106066|NCT01535040|3830058|FG001|COMPLETED|Overall Study||44
3106067|NCT01535040|3830057|FG000|NOT COMPLETED|Overall Study||30
3106068|NCT01535040|3830058|FG001|NOT COMPLETED|Overall Study||21
3106069|NCT01535053|3830066|FG000|STARTED|Overall Study||29
3106070|NCT01535053|3830067|FG001|STARTED|Overall Study||28
3106071|NCT01535053|3830066|FG000|COMPLETED|Overall Study|treated for 3 cycles after hCG <5mIU/ml or until biologic,disease progression, unacceptable toxicity|28
3106072|NCT01535053|3830067|FG001|COMPLETED|Overall Study|treated for 3 cycles after hCG <5mIU/ml or until biologic,disease progression, unacceptable toxicity|26
3106073|NCT01535053|3830066|FG000|NOT COMPLETED|Overall Study||1
3106074|NCT01535053|3830067|FG001|NOT COMPLETED|Overall Study||2
3106075|NCT01535118|3830073|FG000|STARTED|Overall Study||2765
3106076|NCT01535118|3830073|FG000|COMPLETED|Overall Study||2765
3106077|NCT01535118|3830073|FG000|NOT COMPLETED|Overall Study||0
3106078|NCT01535222|3830083|FG000|STARTED|Overall Study||3
3106079|NCT01535222|3830084|FG001|STARTED|Overall Study||3
3106080|NCT01535222|3830085|FG002|STARTED|Overall Study|Patient randomized but did not meet inclusion/exclusion criteria and did not receive study drug|7
3106081|NCT01535222|3830086|FG003|STARTED|Overall Study||6
3106082|NCT01535222|3830087|FG004|STARTED|Overall Study||6
3106083|NCT01535222|3830088|FG005|STARTED|Overall Study||8
3106084|NCT01535222|3830083|FG000|COMPLETED|Overall Study||3
3106085|NCT01535222|3830084|FG001|COMPLETED|Overall Study||3
3106086|NCT01535222|3830085|FG002|COMPLETED|Overall Study||6
3106087|NCT01535222|3830086|FG003|COMPLETED|Overall Study||6
3106088|NCT01535222|3830087|FG004|COMPLETED|Overall Study||6
3106089|NCT01535222|3830088|FG005|COMPLETED|Overall Study||8
3106090|NCT01535222|3830083|FG000|NOT COMPLETED|Overall Study||0
3106091|NCT01535222|3830084|FG001|NOT COMPLETED|Overall Study||0
3106092|NCT01535222|3830085|FG002|NOT COMPLETED|Overall Study||1
3106093|NCT01535222|3830086|FG003|NOT COMPLETED|Overall Study||0
3106094|NCT01535222|3830087|FG004|NOT COMPLETED|Overall Study||0
3106095|NCT01535222|3830088|FG005|NOT COMPLETED|Overall Study||0
3106096|NCT01535235|3830104|FG000|STARTED|Overall Study||16
3106097|NCT01535235|3830105|FG001|STARTED|Overall Study||15
3106098|NCT01535235|3830104|FG000|COMPLETED|Overall Study||15
3106099|NCT01535235|3830105|FG001|COMPLETED|Overall Study||15
3106100|NCT01535235|3830104|FG000|NOT COMPLETED|Overall Study||1
3106101|NCT01535235|3830105|FG001|NOT COMPLETED|Overall Study||0
3106102|NCT01535261|3830111|FG000|STARTED|Overall Study||357
3106103|NCT01535261|3830111|FG000|COMPLETED|Overall Study||307
3106104|NCT01535261|3830111|FG000|NOT COMPLETED|Overall Study||50
3106105|NCT01535287|3830117|FG000|STARTED|Overall Study||70
3106106|NCT01535287|3830118|FG001|STARTED|Overall Study||70
3106107|NCT01535287|3830117|FG000|COMPLETED|Overall Study||65
3106108|NCT01535287|3830118|FG001|COMPLETED|Overall Study||64
3106109|NCT01535287|3830117|FG000|NOT COMPLETED|Overall Study||5
3106110|NCT01535287|3830118|FG001|NOT COMPLETED|Overall Study||6
3106111|NCT01535326|3830127|FG000|STARTED|Overall Study||90
3106112|NCT01535326|3830128|FG001|STARTED|Overall Study||90
3106113|NCT01535326|3830129|FG002|STARTED|Overall Study||90
3106114|NCT01535326|3830127|FG000|COMPLETED|Overall Study||90
3106115|NCT01535326|3830128|FG001|COMPLETED|Overall Study||90
3106116|NCT01535326|3830129|FG002|COMPLETED|Overall Study||90
3106117|NCT01535326|3830127|FG000|NOT COMPLETED|Overall Study||0
3106118|NCT01535326|3830128|FG001|NOT COMPLETED|Overall Study||0
3106119|NCT01535326|3830129|FG002|NOT COMPLETED|Overall Study||0
3106120|NCT01535365|3830142|FG000|STARTED|Overall Study||31
3106121|NCT01535365|3830143|FG001|STARTED|Overall Study||29
3106122|NCT01535365|3830142|FG000|COMPLETED|Overall Study||31
3106123|NCT01535365|3830143|FG001|COMPLETED|Overall Study||29
3106124|NCT01535365|3830142|FG000|NOT COMPLETED|Overall Study||0
3106125|NCT01535365|3830143|FG001|NOT COMPLETED|Overall Study||0
3106126|NCT01535443|3830151|FG000|STARTED|Overall Study||35
3106127|NCT01535443|3830151|FG000|COMPLETED|Overall Study||32
3106128|NCT01535443|3830151|FG000|NOT COMPLETED|Overall Study||3
3106129|NCT01535560|3830158|FG000|STARTED|Overall Study||274
3106130|NCT01535560|3830159|FG001|STARTED|Overall Study||275
3106131|NCT01535560|3830158|FG000|COMPLETED|Overall Study||237
3106132|NCT01535560|3830159|FG001|COMPLETED|Overall Study||179
3106133|NCT01535560|3830158|FG000|NOT COMPLETED|Overall Study||37
3106134|NCT01535560|3830159|FG001|NOT COMPLETED|Overall Study||96
3106135|NCT01535573|3830168|FG000|STARTED|Overall Study||21
3106136|NCT01535573|3830169|FG001|STARTED|Overall Study||44
3106137|NCT01535573|3830170|FG002|STARTED|Overall Study||43
3292003|NCT02853435|4025992|FG004|COMPLETED|Part 2, Washout Period 1 (3 Days)||0
3292004|NCT02853435|4025993|FG005|COMPLETED|Part 2, Washout Period 1 (3 Days)||0
3292005|NCT02853435|4025988|FG000|NOT COMPLETED|Part 2, Washout Period 1 (3 Days)||0
3292006|NCT02853435|4025989|FG001|NOT COMPLETED|Part 2, Washout Period 1 (3 Days)||0
3292007|NCT02853435|4025990|FG002|NOT COMPLETED|Part 2, Washout Period 1 (3 Days)||0
3292008|NCT02853435|4025991|FG003|NOT COMPLETED|Part 2, Washout Period 1 (3 Days)||0
3292009|NCT02853435|4025992|FG004|NOT COMPLETED|Part 2, Washout Period 1 (3 Days)||0
3292010|NCT02853435|4025993|FG005|NOT COMPLETED|Part 2, Washout Period 1 (3 Days)||0
3292011|NCT02853435|4025988|FG000|STARTED|Part 2, Period 2 (3 Days)||0
3292012|NCT02853435|4025989|FG001|STARTED|Part 2, Period 2 (3 Days)||0
3292013|NCT02853435|4025990|FG002|STARTED|Part 2, Period 2 (3 Days)||0
3292014|NCT02853435|4025991|FG003|STARTED|Part 2, Period 2 (3 Days)||10
3292015|NCT02853435|4025992|FG004|STARTED|Part 2, Period 2 (3 Days)||0
3292016|NCT02853435|4025993|FG005|STARTED|Part 2, Period 2 (3 Days)||0
3292017|NCT02853435|4025988|FG000|COMPLETED|Part 2, Period 2 (3 Days)||0
3292018|NCT02853435|4025989|FG001|COMPLETED|Part 2, Period 2 (3 Days)||0
3292019|NCT02853435|4025990|FG002|COMPLETED|Part 2, Period 2 (3 Days)||0
3292020|NCT02853435|4025991|FG003|COMPLETED|Part 2, Period 2 (3 Days)||10
3292021|NCT02853435|4025992|FG004|COMPLETED|Part 2, Period 2 (3 Days)||0
3292022|NCT02853435|4025993|FG005|COMPLETED|Part 2, Period 2 (3 Days)||0
3292023|NCT02853435|4025988|FG000|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
3292024|NCT02853435|4025989|FG001|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
3106138|NCT01535573|3830168|FG000|COMPLETED|Overall Study||13
3106139|NCT01535573|3830169|FG001|COMPLETED|Overall Study||23
3106140|NCT01535573|3830170|FG002|COMPLETED|Overall Study||24
3106141|NCT01535573|3830168|FG000|NOT COMPLETED|Overall Study||8
3106142|NCT01535573|3830169|FG001|NOT COMPLETED|Overall Study||21
3106143|NCT01535573|3830170|FG002|NOT COMPLETED|Overall Study||19
3106144|NCT01535599|3830180|FG000|STARTED|Overall Study||347
3106145|NCT01535599|3830181|FG001|STARTED|Overall Study||346
3106146|NCT01535599|3830180|FG000|COMPLETED|Overall Study||297
3106147|NCT01535599|3830181|FG001|COMPLETED|Overall Study||250
3106148|NCT01535599|3830180|FG000|NOT COMPLETED|Overall Study||50
3106149|NCT01535599|3830181|FG001|NOT COMPLETED|Overall Study||96
3106150|NCT01535638|3830187|FG000|STARTED|Treatment 1 (Single Dose)||3
3106151|NCT01535638|3830188|FG001|STARTED|Treatment 1 (Single Dose)||3
3106152|NCT01535638|3830189|FG002|STARTED|Treatment 1 (Single Dose)||3
3106153|NCT01535638|3830190|FG003|STARTED|Treatment 1 (Single Dose)||3
3106154|NCT01535638|3830191|FG004|STARTED|Treatment 1 (Single Dose)||3
3106155|NCT01535638|3830192|FG005|STARTED|Treatment 1 (Single Dose)||3
3106156|NCT01535638|3830187|FG000|COMPLETED|Treatment 1 (Single Dose)||3
3106157|NCT01535638|3830188|FG001|COMPLETED|Treatment 1 (Single Dose)||3
3106158|NCT01535638|3830189|FG002|COMPLETED|Treatment 1 (Single Dose)||3
3106159|NCT01535638|3830190|FG003|COMPLETED|Treatment 1 (Single Dose)||3
3106160|NCT01535638|3830191|FG004|COMPLETED|Treatment 1 (Single Dose)||3
3106161|NCT01535638|3830192|FG005|COMPLETED|Treatment 1 (Single Dose)||2
3106162|NCT01535638|3830187|FG000|NOT COMPLETED|Treatment 1 (Single Dose)||0
3106163|NCT01535638|3830188|FG001|NOT COMPLETED|Treatment 1 (Single Dose)||0
3106164|NCT01535638|3830189|FG002|NOT COMPLETED|Treatment 1 (Single Dose)||0
3106165|NCT01535638|3830190|FG003|NOT COMPLETED|Treatment 1 (Single Dose)||0
3106166|NCT01535638|3830191|FG004|NOT COMPLETED|Treatment 1 (Single Dose)||0
3106167|NCT01535638|3830192|FG005|NOT COMPLETED|Treatment 1 (Single Dose)||1
3106168|NCT01535638|3830187|FG000|STARTED|Treatment 2 (Single Dose)||3
3106169|NCT01535638|3830188|FG001|STARTED|Treatment 2 (Single Dose)||3
3106170|NCT01535638|3830189|FG002|STARTED|Treatment 2 (Single Dose)||3
3106171|NCT01535638|3830190|FG003|STARTED|Treatment 2 (Single Dose)||3
3106172|NCT01535638|3830191|FG004|STARTED|Treatment 2 (Single Dose)||3
3106173|NCT01535638|3830192|FG005|STARTED|Treatment 2 (Single Dose)||2
3106174|NCT01535638|3830187|FG000|COMPLETED|Treatment 2 (Single Dose)||3
3106175|NCT01535638|3830188|FG001|COMPLETED|Treatment 2 (Single Dose)||3
3106176|NCT01535638|3830189|FG002|COMPLETED|Treatment 2 (Single Dose)||3
3106177|NCT01535638|3830190|FG003|COMPLETED|Treatment 2 (Single Dose)||3
3106178|NCT01535638|3830191|FG004|COMPLETED|Treatment 2 (Single Dose)||3
3106179|NCT01535638|3830192|FG005|COMPLETED|Treatment 2 (Single Dose)||2
3106180|NCT01535638|3830187|FG000|NOT COMPLETED|Treatment 2 (Single Dose)||0
3106181|NCT01535638|3830188|FG001|NOT COMPLETED|Treatment 2 (Single Dose)||0
3106182|NCT01535638|3830189|FG002|NOT COMPLETED|Treatment 2 (Single Dose)||0
3106183|NCT01535638|3830190|FG003|NOT COMPLETED|Treatment 2 (Single Dose)||0
3106184|NCT01535638|3830191|FG004|NOT COMPLETED|Treatment 2 (Single Dose)||0
3106185|NCT01535638|3830192|FG005|NOT COMPLETED|Treatment 2 (Single Dose)||0
3106186|NCT01535638|3830187|FG000|STARTED|Treatment 3 (Single Dose)||3
3106187|NCT01535638|3830188|FG001|STARTED|Treatment 3 (Single Dose)||3
3106188|NCT01535638|3830189|FG002|STARTED|Treatment 3 (Single Dose)||3
3106189|NCT01535638|3830190|FG003|STARTED|Treatment 3 (Single Dose)||3
3106190|NCT01535638|3830191|FG004|STARTED|Treatment 3 (Single Dose)||3
3106191|NCT01535638|3830192|FG005|STARTED|Treatment 3 (Single Dose)||2
3106192|NCT01535638|3830187|FG000|COMPLETED|Treatment 3 (Single Dose)||3
3106193|NCT01535638|3830188|FG001|COMPLETED|Treatment 3 (Single Dose)||3
3106194|NCT01535638|3830189|FG002|COMPLETED|Treatment 3 (Single Dose)||3
3106195|NCT01535638|3830190|FG003|COMPLETED|Treatment 3 (Single Dose)||2
3106196|NCT01535638|3830191|FG004|COMPLETED|Treatment 3 (Single Dose)||3
3106197|NCT01535638|3830192|FG005|COMPLETED|Treatment 3 (Single Dose)||2
3106198|NCT01535638|3830187|FG000|NOT COMPLETED|Treatment 3 (Single Dose)||0
3106199|NCT01535638|3830188|FG001|NOT COMPLETED|Treatment 3 (Single Dose)||0
3106200|NCT01535638|3830189|FG002|NOT COMPLETED|Treatment 3 (Single Dose)||0
3106201|NCT01535638|3830190|FG003|NOT COMPLETED|Treatment 3 (Single Dose)||1
3106202|NCT01535638|3830191|FG004|NOT COMPLETED|Treatment 3 (Single Dose)||0
3106203|NCT01535638|3830192|FG005|NOT COMPLETED|Treatment 3 (Single Dose)||0
3106204|NCT01535664|3830201|FG000|STARTED|Overall Study||20
3106205|NCT01535664|3830201|FG000|COMPLETED|Overall Study||20
3106206|NCT01535664|3830201|FG000|NOT COMPLETED|Overall Study||0
3106207|NCT01535729|3830209|FG000|STARTED|Overall Study||465
3106208|NCT01535729|3830209|FG000|Treated|Overall Study||385
3106209|NCT01535729|3830209|FG000|COMPLETED|Overall Study||49
3106210|NCT01535729|3830209|FG000|NOT COMPLETED|Overall Study||416
3106211|NCT01535924|3830219|FG000|STARTED|Overall Study||3
3106212|NCT01535924|3830220|FG001|STARTED|Overall Study||3
3106213|NCT01535924|3830221|FG002|STARTED|Overall Study||3
3106214|NCT01535924|3830222|FG003|STARTED|Overall Study||4
3106215|NCT01535924|3830223|FG004|STARTED|Overall Study||6
3106216|NCT01535924|3830224|FG005|STARTED|Overall Study||7
3106217|NCT01535924|3830219|FG000|COMPLETED|Overall Study||3
3106218|NCT01535924|3830220|FG001|COMPLETED|Overall Study||3
3106219|NCT01535924|3830221|FG002|COMPLETED|Overall Study||3
3106220|NCT01535924|3830222|FG003|COMPLETED|Overall Study||4
3106221|NCT01535924|3830223|FG004|COMPLETED|Overall Study||6
3106222|NCT01535924|3830224|FG005|COMPLETED|Overall Study||7
3106223|NCT01535924|3830219|FG000|NOT COMPLETED|Overall Study||0
3106224|NCT01535924|3830220|FG001|NOT COMPLETED|Overall Study||0
3106225|NCT01535924|3830221|FG002|NOT COMPLETED|Overall Study||0
3106226|NCT01535924|3830222|FG003|NOT COMPLETED|Overall Study||0
3106227|NCT01535924|3830223|FG004|NOT COMPLETED|Overall Study||0
3106228|NCT01535924|3830224|FG005|NOT COMPLETED|Overall Study||0
3106229|NCT01535937|3830241|FG000|STARTED|Overall Study||27
3106230|NCT01535937|3830242|FG001|STARTED|Overall Study||28
3106231|NCT01535937|3830241|FG000|COMPLETED|Overall Study||27
3106232|NCT01535937|3830242|FG001|COMPLETED|Overall Study||28
3106233|NCT01535937|3830241|FG000|NOT COMPLETED|Overall Study||0
3106234|NCT01535937|3830242|FG001|NOT COMPLETED|Overall Study||0
3106235|NCT01535976|3830250|FG000|STARTED|Overall Study||27
3106236|NCT01535976|3830251|FG001|STARTED|Overall Study||27
3106237|NCT01535976|3830250|FG000|COMPLETED|Overall Study||26
3106238|NCT01535976|3830251|FG001|COMPLETED|Overall Study||26
3106239|NCT01535976|3830250|FG000|NOT COMPLETED|Overall Study||1
3106240|NCT01535976|3830251|FG001|NOT COMPLETED|Overall Study||1
3106241|NCT01536067|3830257|FG000|STARTED|Overall Study||3
3106242|NCT01536067|3830257|FG000|COMPLETED|Overall Study||2
3106243|NCT01536067|3830257|FG000|NOT COMPLETED|Overall Study||1
3106244|NCT01536093|3830263|FG000|STARTED|Overall Study||24
3106245|NCT01536093|3830264|FG001|STARTED|Overall Study||24
3106246|NCT01536093|3830263|FG000|COMPLETED|Overall Study||21
3106247|NCT01536093|3830264|FG001|COMPLETED|Overall Study||21
3106248|NCT01536093|3830263|FG000|NOT COMPLETED|Overall Study||3
3106249|NCT01536093|3830264|FG001|NOT COMPLETED|Overall Study||3
3135556|NCT01708122|3860620|FG001|COMPLETED|Overall Study||26
3135557|NCT01708122|3860619|FG000|NOT COMPLETED|Overall Study||0
3135558|NCT01708122|3860620|FG001|NOT COMPLETED|Overall Study||0
3135559|NCT01708161|3860632|FG000|STARTED|Overall Study||4
3135560|NCT01708161|3860633|FG001|STARTED|Overall Study||10
3135561|NCT01708161|3860634|FG002|STARTED|Overall Study||10
3135562|NCT01708161|3860635|FG003|STARTED|Overall Study||16
3292025|NCT02853435|4025990|FG002|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
3292026|NCT02853435|4025991|FG003|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
3292027|NCT02853435|4025992|FG004|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
3292028|NCT02853435|4025993|FG005|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
3292029|NCT02853435|4025988|FG000|STARTED|Part 3, Period 1 (3 Days)||0
3292030|NCT02853435|4025989|FG001|STARTED|Part 3, Period 1 (3 Days)||0
3292031|NCT02853435|4025990|FG002|STARTED|Part 3, Period 1 (3 Days)||0
3292032|NCT02853435|4025991|FG003|STARTED|Part 3, Period 1 (3 Days)||0
3292033|NCT02853435|4025992|FG004|STARTED|Part 3, Period 1 (3 Days)||10
3292034|NCT02853435|4025993|FG005|STARTED|Part 3, Period 1 (3 Days)||2
3292035|NCT02853435|4025988|FG000|COMPLETED|Part 3, Period 1 (3 Days)||0
3292036|NCT02853435|4025989|FG001|COMPLETED|Part 3, Period 1 (3 Days)||0
3292037|NCT02853435|4025990|FG002|COMPLETED|Part 3, Period 1 (3 Days)||0
3292038|NCT02853435|4025991|FG003|COMPLETED|Part 3, Period 1 (3 Days)||0
3292039|NCT02853435|4025992|FG004|COMPLETED|Part 3, Period 1 (3 Days)||10
3292040|NCT02853435|4025993|FG005|COMPLETED|Part 3, Period 1 (3 Days)||2
3292041|NCT02853435|4025988|FG000|NOT COMPLETED|Part 3, Period 1 (3 Days)||0
3292042|NCT02853435|4025989|FG001|NOT COMPLETED|Part 3, Period 1 (3 Days)||0
3292043|NCT02853435|4025990|FG002|NOT COMPLETED|Part 3, Period 1 (3 Days)||0
3292044|NCT02853435|4025991|FG003|NOT COMPLETED|Part 3, Period 1 (3 Days)||0
3135563|NCT01708161|3860636|FG004|STARTED|Overall Study||6
3135564|NCT01708161|3860637|FG005|STARTED|Overall Study||1
3135565|NCT01708161|3860632|FG000|COMPLETED|Overall Study||0
3135566|NCT01708161|3860633|FG001|COMPLETED|Overall Study||0
3135567|NCT01708161|3860634|FG002|COMPLETED|Overall Study||0
3135568|NCT01708161|3860635|FG003|COMPLETED|Overall Study||0
3135569|NCT01708161|3860636|FG004|COMPLETED|Overall Study||0
3135570|NCT01708161|3860637|FG005|COMPLETED|Overall Study||0
3135571|NCT01708161|3860632|FG000|NOT COMPLETED|Overall Study||4
3135572|NCT01708161|3860633|FG001|NOT COMPLETED|Overall Study||10
3135573|NCT01708161|3860634|FG002|NOT COMPLETED|Overall Study||10
3135574|NCT01708161|3860635|FG003|NOT COMPLETED|Overall Study||16
3135575|NCT01708161|3860636|FG004|NOT COMPLETED|Overall Study||6
3135576|NCT01708161|3860637|FG005|NOT COMPLETED|Overall Study||1
3135577|NCT01708174|3860654|FG000|STARTED|Treatment Period||2
3135578|NCT01708174|3860655|FG001|STARTED|Treatment Period||16
3135579|NCT01708174|3860656|FG002|STARTED|Treatment Period||4
3135580|NCT01708174|3860654|FG000|Pharmacokinetic Analysis Set|Treatment Period||2
3135581|NCT01708174|3860655|FG001|Pharmacokinetic Analysis Set|Treatment Period||13
3135582|NCT01708174|3860656|FG002|Pharmacokinetic Analysis Set|Treatment Period||0
3135583|NCT01708174|3860654|FG000|COMPLETED|Treatment Period||1
3135584|NCT01708174|3860655|FG001|COMPLETED|Treatment Period||14
3135585|NCT01708174|3860656|FG002|COMPLETED|Treatment Period||3
3135586|NCT01708174|3860654|FG000|NOT COMPLETED|Treatment Period||1
3135587|NCT01708174|3860655|FG001|NOT COMPLETED|Treatment Period||2
3135588|NCT01708174|3860656|FG002|NOT COMPLETED|Treatment Period||1
3135589|NCT01708174|3860654|FG000|STARTED|Survival Follow-up||1
3135590|NCT01708174|3860655|FG001|STARTED|Survival Follow-up||10
3135591|NCT01708174|3860656|FG002|STARTED|Survival Follow-up||0
3135592|NCT01708174|3860654|FG000|COMPLETED|Survival Follow-up||1
3135593|NCT01708174|3860655|FG001|COMPLETED|Survival Follow-up||10
3135594|NCT01708174|3860656|FG002|COMPLETED|Survival Follow-up||0
3135595|NCT01708174|3860654|FG000|NOT COMPLETED|Survival Follow-up||0
3135596|NCT01708174|3860655|FG001|NOT COMPLETED|Survival Follow-up||0
3135597|NCT01708174|3860656|FG002|NOT COMPLETED|Survival Follow-up||0
3135598|NCT01708187|3860667|FG000|STARTED|Overall Study||1
3135599|NCT01708187|3860668|FG001|STARTED|Overall Study||1
3135600|NCT01708187|3860667|FG000|COMPLETED|Overall Study||1
3135601|NCT01708187|3860668|FG001|COMPLETED|Overall Study||0
3135602|NCT01708187|3860667|FG000|NOT COMPLETED|Overall Study||0
3135603|NCT01708187|3860668|FG001|NOT COMPLETED|Overall Study||1
3135604|NCT01708213|3860674|FG000|STARTED|Overall Study||72
3135605|NCT01708213|3860674|FG000|COMPLETED|Overall Study||71
3135606|NCT01708213|3860674|FG000|NOT COMPLETED|Overall Study||1
3135607|NCT01708278|3860684|FG000|STARTED|Overall Study||1
3135608|NCT01708278|3860685|FG001|STARTED|Overall Study||2
3135609|NCT01708278|3860686|FG002|STARTED|Overall Study||2
3135610|NCT01708278|3860687|FG003|STARTED|Overall Study||2
3135611|NCT01708278|3860688|FG004|STARTED|Overall Study||1
3135612|NCT01708278|3860689|FG005|STARTED|Overall Study||1
3135613|NCT01708278|3860684|FG000|COMPLETED|Overall Study||1
3106250|NCT01536119|3830272|FG000|STARTED|Overall Study|(107*2= 214) (107 mothers and 107 fathers)|214
3106251|NCT01536119|3830273|FG001|STARTED|Overall Study|(107*2=214) (107 mothers and 107 fathers)|214
3106252|NCT01536119|3830272|FG000|COMPLETED|Overall Study|104 Mothers + 93 fathers = 197 participants 3 mothers + 14 fathers = 17 did not complete the study|197
3106253|NCT01536119|3830273|FG001|COMPLETED|Overall Study|105 mothers + 95 fathers = 200 participants 2 mothers + 12 fathers = 14 did not complete the study|200
3106254|NCT01536119|3830272|FG000|NOT COMPLETED|Overall Study||17
3106255|NCT01536119|3830273|FG001|NOT COMPLETED|Overall Study||14
3106256|NCT01536145|3830279|FG000|STARTED|Overall Study||3
3106257|NCT01536145|3830280|FG001|STARTED|Overall Study||4
3106258|NCT01536145|3830281|FG002|STARTED|Overall Study||3
3106259|NCT01536145|3830282|FG003|STARTED|Overall Study||3
3106260|NCT01536145|3830283|FG004|STARTED|Overall Study||4
3106261|NCT01536145|3830284|FG005|STARTED|Overall Study||3
3106262|NCT01536145|3830285|FG006|STARTED|Overall Study||3
3106263|NCT01536145|3830286|FG007|STARTED|Overall Study||4
3106264|NCT01536145|3830287|FG008|STARTED|Overall Study||3
3106265|NCT01536145|3830288|FG009|STARTED|Overall Study||7
3106266|NCT01536145|3830289|FG010|STARTED|Overall Study||10
3106267|NCT01536145|3830279|FG000|COMPLETED|Overall Study||0
3106268|NCT01536145|3830280|FG001|COMPLETED|Overall Study||0
3106269|NCT01536145|3830281|FG002|COMPLETED|Overall Study||1
3106270|NCT01536145|3830282|FG003|COMPLETED|Overall Study||1
3106271|NCT01536145|3830283|FG004|COMPLETED|Overall Study||2
3106272|NCT01536145|3830284|FG005|COMPLETED|Overall Study||0
3106273|NCT01536145|3830285|FG006|COMPLETED|Overall Study||1
3106274|NCT01536145|3830286|FG007|COMPLETED|Overall Study||0
3106275|NCT01536145|3830287|FG008|COMPLETED|Overall Study||0
3106276|NCT01536145|3830288|FG009|COMPLETED|Overall Study||1
3106277|NCT01536145|3830289|FG010|COMPLETED|Overall Study||0
3106278|NCT01536145|3830279|FG000|NOT COMPLETED|Overall Study||3
3106279|NCT01536145|3830280|FG001|NOT COMPLETED|Overall Study||4
3106280|NCT01536145|3830281|FG002|NOT COMPLETED|Overall Study||2
3106281|NCT01536145|3830282|FG003|NOT COMPLETED|Overall Study||2
3106282|NCT01536145|3830283|FG004|NOT COMPLETED|Overall Study||2
3106283|NCT01536145|3830284|FG005|NOT COMPLETED|Overall Study||3
3106284|NCT01536145|3830285|FG006|NOT COMPLETED|Overall Study||2
3106285|NCT01536145|3830286|FG007|NOT COMPLETED|Overall Study||4
3106286|NCT01536145|3830287|FG008|NOT COMPLETED|Overall Study||3
3106287|NCT01536145|3830288|FG009|NOT COMPLETED|Overall Study||6
3106288|NCT01536145|3830289|FG010|NOT COMPLETED|Overall Study||10
3106289|NCT01536171|3830320|FG000|STARTED|Overall Study||22
3106290|NCT01536171|3830320|FG000|COMPLETED|Overall Study||21
3106291|NCT01536171|3830320|FG000|NOT COMPLETED|Overall Study||1
3106292|NCT01536184|3830327|FG000|STARTED|Overall Study||8
3106293|NCT01536184|3830328|FG001|STARTED|Overall Study||4
3106294|NCT01536184|3830327|FG000|COMPLETED|Overall Study||8
3106295|NCT01536184|3830328|FG001|COMPLETED|Overall Study||4
3106296|NCT01536184|3830327|FG000|NOT COMPLETED|Overall Study||0
3106297|NCT01536184|3830328|FG001|NOT COMPLETED|Overall Study||0
3106298|NCT01536197|3830336|FG000|STARTED|Overall Study||23
3106299|NCT01536197|3830337|FG001|STARTED|Overall Study||10
3106300|NCT01536197|3830336|FG000|COMPLETED|Overall Study||23
3106301|NCT01536197|3830337|FG001|COMPLETED|Overall Study||10
3106302|NCT01536197|3830336|FG000|NOT COMPLETED|Overall Study||0
3106303|NCT01536197|3830337|FG001|NOT COMPLETED|Overall Study||0
3106304|NCT01536262|3830346|FG000|STARTED|Overall Study||41
3106305|NCT01536262|3830347|FG001|STARTED|Overall Study||40
3106306|NCT01536262|3830348|FG002|STARTED|Overall Study||41
3106307|NCT01536262|3830346|FG000|COMPLETED|Overall Study||33
3106308|NCT01536262|3830347|FG001|COMPLETED|Overall Study||38
3106309|NCT01536262|3830348|FG002|COMPLETED|Overall Study||39
3106310|NCT01536262|3830346|FG000|NOT COMPLETED|Overall Study||8
3106311|NCT01536262|3830347|FG001|NOT COMPLETED|Overall Study||2
3106312|NCT01536262|3830348|FG002|NOT COMPLETED|Overall Study||2
3106313|NCT01536366|3830359|FG000|STARTED|Overall Study||14
3106314|NCT01536366|3830360|FG001|STARTED|Overall Study||13
3106315|NCT01536366|3830359|FG000|BIA 9-1067 + Repaglinide|Overall Study||14
3106316|NCT01536366|3830360|FG001|BIA 9-1067 + Repaglinide|Overall Study||10
3106317|NCT01536366|3830359|FG000|Repaglinide|Overall Study||14
3106318|NCT01536366|3830360|FG001|Repaglinide|Overall Study||13
3106319|NCT01536366|3830359|FG000|Follow-up|Overall Study||13
3106320|NCT01536366|3830360|FG001|Follow-up|Overall Study||9
3106321|NCT01536366|3830359|FG000|COMPLETED|Overall Study||1
3106322|NCT01536366|3830360|FG001|COMPLETED|Overall Study||9
3106323|NCT01536366|3830359|FG000|NOT COMPLETED|Overall Study||13
3106324|NCT01536366|3830360|FG001|NOT COMPLETED|Overall Study||4
3106325|NCT01536379|3830368|FG000|STARTED|Overall Study||13
3106326|NCT01536379|3830369|FG001|STARTED|Overall Study||12
3106327|NCT01536379|3830368|FG000|COMPLETED|Overall Study||11
3106328|NCT01536379|3830369|FG001|COMPLETED|Overall Study||9
3106329|NCT01536379|3830368|FG000|NOT COMPLETED|Overall Study||2
3106330|NCT01536379|3830369|FG001|NOT COMPLETED|Overall Study||3
3106331|NCT01536392|3830377|FG000|STARTED|Overall Study||41
3106332|NCT01536392|3830378|FG001|STARTED|Overall Study||34
3106333|NCT01536392|3830377|FG000|COMPLETED|Overall Study||28
3106334|NCT01536392|3830378|FG001|COMPLETED|Overall Study||19
3106335|NCT01536392|3830377|FG000|NOT COMPLETED|Overall Study||13
3106336|NCT01536392|3830378|FG001|NOT COMPLETED|Overall Study||15
3106337|NCT01536405|3830386|FG000|STARTED|Randomization to Visit 1 (Vaccination 1)||706
3106338|NCT01536405|3830387|FG001|STARTED|Randomization to Visit 1 (Vaccination 1)||706
3135614|NCT01708278|3860685|FG001|COMPLETED|Overall Study||2
3106339|NCT01536405|3830386|FG000|COMPLETED|Randomization to Visit 1 (Vaccination 1)||698
3106340|NCT01536405|3830387|FG001|COMPLETED|Randomization to Visit 1 (Vaccination 1)||702
3106341|NCT01536405|3830386|FG000|NOT COMPLETED|Randomization to Visit 1 (Vaccination 1)||8
3106342|NCT01536405|3830387|FG001|NOT COMPLETED|Randomization to Visit 1 (Vaccination 1)||4
3106343|NCT01536405|3830386|FG000|STARTED|Visit 1 (Vaccination 1) to Visit 2||698
3106344|NCT01536405|3830387|FG001|STARTED|Visit 1 (Vaccination 1) to Visit 2||702
3106345|NCT01536405|3830386|FG000|Received Vaccination 1|Visit 1 (Vaccination 1) to Visit 2||698
3106346|NCT01536405|3830387|FG001|Received Vaccination 1|Visit 1 (Vaccination 1) to Visit 2||702
3106347|NCT01536405|3830386|FG000|COMPLETED|Visit 1 (Vaccination 1) to Visit 2||666
3106348|NCT01536405|3830387|FG001|COMPLETED|Visit 1 (Vaccination 1) to Visit 2||662
3106349|NCT01536405|3830386|FG000|NOT COMPLETED|Visit 1 (Vaccination 1) to Visit 2||32
3106350|NCT01536405|3830387|FG001|NOT COMPLETED|Visit 1 (Vaccination 1) to Visit 2||40
3106351|NCT01536405|3830386|FG000|STARTED|Visit 2 to Visit 3 (Vaccination 2)||666
3106352|NCT01536405|3830387|FG001|STARTED|Visit 2 to Visit 3 (Vaccination 2)||662
3106353|NCT01536405|3830386|FG000|COMPLETED|Visit 2 to Visit 3 (Vaccination 2)||635
3106354|NCT01536405|3830387|FG001|COMPLETED|Visit 2 to Visit 3 (Vaccination 2)||634
3106355|NCT01536405|3830386|FG000|NOT COMPLETED|Visit 2 to Visit 3 (Vaccination 2)||31
3106356|NCT01536405|3830387|FG001|NOT COMPLETED|Visit 2 to Visit 3 (Vaccination 2)||28
3106357|NCT01536405|3830386|FG000|STARTED|Visit 3 (Vaccination 2) to Visit 4||635
3106358|NCT01536405|3830387|FG001|STARTED|Visit 3 (Vaccination 2) to Visit 4||634
3106359|NCT01536405|3830386|FG000|Received Vaccination 2|Visit 3 (Vaccination 2) to Visit 4||634
3106360|NCT01536405|3830387|FG001|Received Vaccination 2|Visit 3 (Vaccination 2) to Visit 4||632
3106361|NCT01536405|3830386|FG000|COMPLETED|Visit 3 (Vaccination 2) to Visit 4||615
3106362|NCT01536405|3830387|FG001|COMPLETED|Visit 3 (Vaccination 2) to Visit 4||618
3106363|NCT01536405|3830386|FG000|NOT COMPLETED|Visit 3 (Vaccination 2) to Visit 4||20
3106364|NCT01536405|3830387|FG001|NOT COMPLETED|Visit 3 (Vaccination 2) to Visit 4||16
3106365|NCT01536405|3830386|FG000|STARTED|Visit 4 to Extended Study Follow-up||615
3106366|NCT01536405|3830387|FG001|STARTED|Visit 4 to Extended Study Follow-up||618
3106367|NCT01536405|3830386|FG000|COMPLETED|Visit 4 to Extended Study Follow-up||595
3106368|NCT01536405|3830387|FG001|COMPLETED|Visit 4 to Extended Study Follow-up||595
3106369|NCT01536405|3830386|FG000|NOT COMPLETED|Visit 4 to Extended Study Follow-up||20
3106370|NCT01536405|3830387|FG001|NOT COMPLETED|Visit 4 to Extended Study Follow-up||23
3106371|NCT01536418|3830395|FG000|STARTED|Overall Study||127
3106372|NCT01536418|3830396|FG001|STARTED|Overall Study||126
3106373|NCT01536418|3830395|FG000|COMPLETED|Overall Study||58
3106374|NCT01536418|3830396|FG001|COMPLETED|Overall Study||60
3106375|NCT01536418|3830395|FG000|NOT COMPLETED|Overall Study||69
3106376|NCT01536418|3830396|FG001|NOT COMPLETED|Overall Study||66
3106377|NCT01536496|3830405|FG000|STARTED|Overall Study||57
3106378|NCT01536496|3830406|FG001|STARTED|Overall Study||57
3106379|NCT01536496|3830405|FG000|COMPLETED|Overall Study||55
3106380|NCT01536496|3830406|FG001|COMPLETED|Overall Study||56
3106381|NCT01536496|3830405|FG000|NOT COMPLETED|Overall Study||2
3106382|NCT01536496|3830406|FG001|NOT COMPLETED|Overall Study||1
3106383|NCT01536535|3830416|FG000|STARTED|Overall Study||178
3106384|NCT01536535|3830417|FG001|STARTED|Overall Study||250
3106385|NCT01536535|3830416|FG000|COMPLETED|Overall Study|Patients either completed week 52 visit or had early colectomy or had additional therapy.|163
3106386|NCT01536535|3830417|FG001|COMPLETED|Overall Study|Patients either completed week 52 visit or had early colectomy or had additional therapy.|237
3106387|NCT01536535|3830416|FG000|NOT COMPLETED|Overall Study||15
3106388|NCT01536535|3830417|FG001|NOT COMPLETED|Overall Study||13
3106389|NCT01536561|3830424|FG000|STARTED|Dosimetric and Therapeutic Treatment||59
3106390|NCT01536561|3830424|FG000|COMPLETED|Dosimetric and Therapeutic Treatment||0
3106391|NCT01536561|3830424|FG000|NOT COMPLETED|Dosimetric and Therapeutic Treatment||59
3106392|NCT01536561|3830424|FG000|STARTED|Long-Term Follow-Up||13
3106393|NCT01536561|3830424|FG000|COMPLETED|Long-Term Follow-Up||13
3106394|NCT01536561|3830424|FG000|NOT COMPLETED|Long-Term Follow-Up||0
3106395|NCT01536574|3830433|FG000|STARTED|Overall Study||162
3106396|NCT01536574|3830434|FG001|STARTED|Overall Study||133
3106397|NCT01536574|3830433|FG000|COMPLETED|Overall Study||156
3106398|NCT01536574|3830434|FG001|COMPLETED|Overall Study||126
3106399|NCT01536574|3830433|FG000|NOT COMPLETED|Overall Study||6
3106400|NCT01536574|3830434|FG001|NOT COMPLETED|Overall Study||7
3106401|NCT01536587|3830440|FG000|STARTED|Overall Study||32
3106402|NCT01536587|3830440|FG000|COMPLETED|Overall Study||30
3106403|NCT01536587|3830440|FG000|NOT COMPLETED|Overall Study||2
3106404|NCT01536704|3830444|FG000|STARTED|Period 1||12
3106405|NCT01536704|3830445|FG001|STARTED|Period 1||12
3106406|NCT01536704|3830446|FG002|STARTED|Period 1||13
3106407|NCT01536704|3830447|FG003|STARTED|Period 1||13
3106408|NCT01536704|3830444|FG000|COMPLETED|Period 1||12
3106409|NCT01536704|3830445|FG001|COMPLETED|Period 1||12
3106410|NCT01536704|3830446|FG002|COMPLETED|Period 1||13
3106411|NCT01536704|3830447|FG003|COMPLETED|Period 1||13
3106412|NCT01536704|3830444|FG000|NOT COMPLETED|Period 1||0
3106413|NCT01536704|3830445|FG001|NOT COMPLETED|Period 1||0
3106414|NCT01536704|3830446|FG002|NOT COMPLETED|Period 1||0
3106415|NCT01536704|3830447|FG003|NOT COMPLETED|Period 1||0
3106416|NCT01536704|3830444|FG000|STARTED|Washout Period 1||12
3106417|NCT01536704|3830445|FG001|STARTED|Washout Period 1||12
3106418|NCT01536704|3830446|FG002|STARTED|Washout Period 1||13
3106419|NCT01536704|3830447|FG003|STARTED|Washout Period 1||13
3106420|NCT01536704|3830444|FG000|COMPLETED|Washout Period 1||11
3106421|NCT01536704|3830445|FG001|COMPLETED|Washout Period 1||10
3106422|NCT01536704|3830446|FG002|COMPLETED|Washout Period 1||13
3106423|NCT01536704|3830447|FG003|COMPLETED|Washout Period 1||13
3106424|NCT01536704|3830444|FG000|NOT COMPLETED|Washout Period 1||1
3106425|NCT01536704|3830445|FG001|NOT COMPLETED|Washout Period 1||2
3106426|NCT01536704|3830446|FG002|NOT COMPLETED|Washout Period 1||0
3106427|NCT01536704|3830447|FG003|NOT COMPLETED|Washout Period 1||0
3106428|NCT01536704|3830444|FG000|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1|13
3106429|NCT01536704|3830445|FG001|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1|11
3106430|NCT01536704|3830446|FG002|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1|10
3106431|NCT01536704|3830447|FG003|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1|13
3106432|NCT01536704|3830444|FG000|COMPLETED|Period 2||13
3106433|NCT01536704|3830445|FG001|COMPLETED|Period 2||11
3106434|NCT01536704|3830446|FG002|COMPLETED|Period 2||10
3106435|NCT01536704|3830447|FG003|COMPLETED|Period 2||13
3106436|NCT01536704|3830444|FG000|NOT COMPLETED|Period 2||0
3106437|NCT01536704|3830445|FG001|NOT COMPLETED|Period 2||0
3106438|NCT01536704|3830446|FG002|NOT COMPLETED|Period 2||0
3106439|NCT01536704|3830447|FG003|NOT COMPLETED|Period 2||0
3106440|NCT01536704|3830444|FG000|STARTED|Washout Period 2||13
3106441|NCT01536704|3830445|FG001|STARTED|Washout Period 2||11
3106442|NCT01536704|3830446|FG002|STARTED|Washout Period 2||10
3106443|NCT01536704|3830447|FG003|STARTED|Washout Period 2||13
3106444|NCT01536704|3830444|FG000|COMPLETED|Washout Period 2||12
3106445|NCT01536704|3830445|FG001|COMPLETED|Washout Period 2||11
3106446|NCT01536704|3830446|FG002|COMPLETED|Washout Period 2||10
3106447|NCT01536704|3830447|FG003|COMPLETED|Washout Period 2||12
3106448|NCT01536704|3830444|FG000|NOT COMPLETED|Washout Period 2||1
3106449|NCT01536704|3830445|FG001|NOT COMPLETED|Washout Period 2||0
3106450|NCT01536704|3830446|FG002|NOT COMPLETED|Washout Period 2||0
3106451|NCT01536704|3830447|FG003|NOT COMPLETED|Washout Period 2||1
3106452|NCT01536704|3830444|FG000|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2|10
3106453|NCT01536704|3830445|FG001|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2|12
3106454|NCT01536704|3830446|FG002|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2|12
3106455|NCT01536704|3830447|FG003|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2|11
3106456|NCT01536704|3830444|FG000|COMPLETED|Period 3||10
3106457|NCT01536704|3830445|FG001|COMPLETED|Period 3||12
3106458|NCT01536704|3830446|FG002|COMPLETED|Period 3||12
3106459|NCT01536704|3830447|FG003|COMPLETED|Period 3||10
3106460|NCT01536704|3830444|FG000|NOT COMPLETED|Period 3||0
3106461|NCT01536704|3830445|FG001|NOT COMPLETED|Period 3||0
3106462|NCT01536704|3830446|FG002|NOT COMPLETED|Period 3||0
3106463|NCT01536704|3830447|FG003|NOT COMPLETED|Period 3||1
3106464|NCT01536704|3830444|FG000|STARTED|Washout Period 3||10
3106465|NCT01536704|3830445|FG001|STARTED|Washout Period 3||12
3106466|NCT01536704|3830446|FG002|STARTED|Washout Period 3||12
3106467|NCT01536704|3830447|FG003|STARTED|Washout Period 3||10
3106468|NCT01536704|3830444|FG000|COMPLETED|Washout Period 3||10
3106469|NCT01536704|3830445|FG001|COMPLETED|Washout Period 3||12
3106470|NCT01536704|3830446|FG002|COMPLETED|Washout Period 3||11
3106471|NCT01536704|3830447|FG003|COMPLETED|Washout Period 3||10
3106472|NCT01536704|3830444|FG000|NOT COMPLETED|Washout Period 3||0
3106473|NCT01536704|3830445|FG001|NOT COMPLETED|Washout Period 3||0
3106474|NCT01536704|3830446|FG002|NOT COMPLETED|Washout Period 3||1
3106475|NCT01536704|3830447|FG003|NOT COMPLETED|Washout Period 3||0
3106476|NCT01536704|3830444|FG000|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3|12
3106477|NCT01536704|3830445|FG001|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3|11
3106478|NCT01536704|3830446|FG002|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3|10
3106479|NCT01536704|3830447|FG003|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3|10
3106480|NCT01536704|3830444|FG000|COMPLETED|Period 4||12
3106481|NCT01536704|3830445|FG001|COMPLETED|Period 4||11
3106482|NCT01536704|3830446|FG002|COMPLETED|Period 4||10
3106483|NCT01536704|3830447|FG003|COMPLETED|Period 4||10
3106484|NCT01536704|3830444|FG000|NOT COMPLETED|Period 4||0
3106485|NCT01536704|3830445|FG001|NOT COMPLETED|Period 4||0
3106486|NCT01536704|3830446|FG002|NOT COMPLETED|Period 4||0
3106487|NCT01536704|3830447|FG003|NOT COMPLETED|Period 4||0
3106488|NCT01536795|3830463|FG000|STARTED|Overall Study||24
3106489|NCT01536795|3830464|FG001|STARTED|Overall Study||24
3106490|NCT01536795|3830463|FG000|COMPLETED|Overall Study||23
3106491|NCT01536795|3830464|FG001|COMPLETED|Overall Study||22
3106492|NCT01536795|3830463|FG000|NOT COMPLETED|Overall Study||1
3106493|NCT01536795|3830464|FG001|NOT COMPLETED|Overall Study||2
3106494|NCT01536860|3830470|FG000|STARTED|First Intervention (1 Day)||4
3106495|NCT01536860|3830471|FG001|STARTED|First Intervention (1 Day)||4
3106496|NCT01536860|3830472|FG002|STARTED|First Intervention (1 Day)||4
3106497|NCT01536860|3830470|FG000|COMPLETED|First Intervention (1 Day)||4
3106498|NCT01536860|3830471|FG001|COMPLETED|First Intervention (1 Day)||4
3106499|NCT01536860|3830472|FG002|COMPLETED|First Intervention (1 Day)||4
3106500|NCT01536860|3830470|FG000|NOT COMPLETED|First Intervention (1 Day)||0
3106501|NCT01536860|3830471|FG001|NOT COMPLETED|First Intervention (1 Day)||0
3106502|NCT01536860|3830472|FG002|NOT COMPLETED|First Intervention (1 Day)||0
3106503|NCT01536860|3830470|FG000|STARTED|Washout Period (3 Days)||4
3106504|NCT01536860|3830471|FG001|STARTED|Washout Period (3 Days)||4
3106505|NCT01536860|3830472|FG002|STARTED|Washout Period (3 Days)||4
3106506|NCT01536860|3830470|FG000|COMPLETED|Washout Period (3 Days)||4
3106507|NCT01536860|3830471|FG001|COMPLETED|Washout Period (3 Days)||4
3106508|NCT01536860|3830472|FG002|COMPLETED|Washout Period (3 Days)||4
3106509|NCT01536860|3830470|FG000|NOT COMPLETED|Washout Period (3 Days)||0
3106510|NCT01536860|3830471|FG001|NOT COMPLETED|Washout Period (3 Days)||0
3106511|NCT01536860|3830472|FG002|NOT COMPLETED|Washout Period (3 Days)||0
3106512|NCT01536860|3830470|FG000|STARTED|Second Intervention (1 Day)||4
3106513|NCT01536860|3830471|FG001|STARTED|Second Intervention (1 Day)||4
3106514|NCT01536860|3830472|FG002|STARTED|Second Intervention (1 Day)||4
3106515|NCT01536860|3830470|FG000|COMPLETED|Second Intervention (1 Day)||4
3106516|NCT01536860|3830471|FG001|COMPLETED|Second Intervention (1 Day)||4
3106517|NCT01536860|3830472|FG002|COMPLETED|Second Intervention (1 Day)||4
3106518|NCT01536860|3830470|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
3106519|NCT01536860|3830471|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
3106520|NCT01536860|3830472|FG002|NOT COMPLETED|Second Intervention (1 Day)||0
3106521|NCT01536860|3830470|FG000|STARTED|Washout Period (3 Days)||4
3106522|NCT01536860|3830471|FG001|STARTED|Washout Period (3 Days)||4
3106523|NCT01536860|3830472|FG002|STARTED|Washout Period (3 Days)||4
3106524|NCT01536860|3830470|FG000|COMPLETED|Washout Period (3 Days)||3
3106525|NCT01536860|3830471|FG001|COMPLETED|Washout Period (3 Days)||4
3106526|NCT01536860|3830472|FG002|COMPLETED|Washout Period (3 Days)||4
3106527|NCT01536860|3830470|FG000|NOT COMPLETED|Washout Period (3 Days)||1
3106528|NCT01536860|3830471|FG001|NOT COMPLETED|Washout Period (3 Days)||0
3106529|NCT01536860|3830472|FG002|NOT COMPLETED|Washout Period (3 Days)||0
3106530|NCT01536860|3830470|FG000|STARTED|Third Intervention (1 Day)||3
3106531|NCT01536860|3830471|FG001|STARTED|Third Intervention (1 Day)||4
3106532|NCT01536860|3830472|FG002|STARTED|Third Intervention (1 Day)||4
3106533|NCT01536860|3830470|FG000|COMPLETED|Third Intervention (1 Day)||3
3106534|NCT01536860|3830471|FG001|COMPLETED|Third Intervention (1 Day)||4
3106535|NCT01536860|3830472|FG002|COMPLETED|Third Intervention (1 Day)||4
3106536|NCT01536860|3830470|FG000|NOT COMPLETED|Third Intervention (1 Day)||0
3106537|NCT01536860|3830471|FG001|NOT COMPLETED|Third Intervention (1 Day)||0
3106538|NCT01536860|3830472|FG002|NOT COMPLETED|Third Intervention (1 Day)||0
3106539|NCT01536886|3830484|FG000|STARTED|Overall Study||141
3106540|NCT01536886|3830485|FG001|STARTED|Overall Study||135
3106541|NCT01536886|3830486|FG002|STARTED|Overall Study||49
3106542|NCT01536886|3830487|FG003|STARTED|Overall Study||51
3106543|NCT01536886|3830484|FG000|COMPLETED|Overall Study||136
3106544|NCT01536886|3830485|FG001|COMPLETED|Overall Study||127
3106545|NCT01536886|3830486|FG002|COMPLETED|Overall Study||47
3106546|NCT01536886|3830487|FG003|COMPLETED|Overall Study||48
3106547|NCT01536886|3830484|FG000|NOT COMPLETED|Overall Study||5
3106548|NCT01536886|3830485|FG001|NOT COMPLETED|Overall Study||8
3106549|NCT01536886|3830486|FG002|NOT COMPLETED|Overall Study||2
3106550|NCT01536886|3830487|FG003|NOT COMPLETED|Overall Study||3
3106551|NCT01536938|3830500|FG000|STARTED|Overall Study||100
3106552|NCT01536938|3830501|FG001|STARTED|Overall Study||101
3106553|NCT01536938|3830502|FG002|STARTED|Overall Study||101
3106554|NCT01536938|3830500|FG000|COMPLETED|Overall Study||94
3106555|NCT01536938|3830501|FG001|COMPLETED|Overall Study||94
3106556|NCT01536938|3830502|FG002|COMPLETED|Overall Study||93
3106557|NCT01536938|3830500|FG000|NOT COMPLETED|Overall Study||6
3106558|NCT01536938|3830501|FG001|NOT COMPLETED|Overall Study||7
3106559|NCT01536938|3830502|FG002|NOT COMPLETED|Overall Study||8
3106560|NCT01536951|3830512|FG000|STARTED|First Intervention and Washout Period 1||3
3106561|NCT01536951|3830513|FG001|STARTED|First Intervention and Washout Period 1||3
3106562|NCT01536951|3830514|FG002|STARTED|First Intervention and Washout Period 1||3
3106563|NCT01536951|3830515|FG003|STARTED|First Intervention and Washout Period 1||8
3106564|NCT01536951|3830516|FG004|STARTED|First Intervention and Washout Period 1||9
3106565|NCT01536951|3830517|FG005|STARTED|First Intervention and Washout Period 1||9
3106566|NCT01536951|3830518|FG006|STARTED|First Intervention and Washout Period 1||9
3106567|NCT01536951|3830519|FG007|STARTED|First Intervention and Washout Period 1||9
3106568|NCT01536951|3830520|FG008|STARTED|First Intervention and Washout Period 1||9
3106569|NCT01536951|3830512|FG000|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1|Across all reporting groups, study drug is LY3009104, moxifloxacin, or placebo.|3
3106570|NCT01536951|3830513|FG001|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||3
3106571|NCT01536951|3830514|FG002|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||3
3106572|NCT01536951|3830515|FG003|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||8
3106573|NCT01536951|3830516|FG004|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||9
3106574|NCT01536951|3830517|FG005|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||9
3106575|NCT01536951|3830518|FG006|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||9
3106576|NCT01536951|3830519|FG007|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||9
3106577|NCT01536951|3830520|FG008|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||9
3106578|NCT01536951|3830512|FG000|COMPLETED|First Intervention and Washout Period 1||3
3106579|NCT01536951|3830513|FG001|COMPLETED|First Intervention and Washout Period 1||3
3106580|NCT01536951|3830514|FG002|COMPLETED|First Intervention and Washout Period 1||2
3106581|NCT01536951|3830515|FG003|COMPLETED|First Intervention and Washout Period 1||8
3106582|NCT01536951|3830516|FG004|COMPLETED|First Intervention and Washout Period 1||9
3106583|NCT01536951|3830517|FG005|COMPLETED|First Intervention and Washout Period 1||9
3106584|NCT01536951|3830518|FG006|COMPLETED|First Intervention and Washout Period 1||9
3106585|NCT01536951|3830519|FG007|COMPLETED|First Intervention and Washout Period 1||9
3106586|NCT01536951|3830520|FG008|COMPLETED|First Intervention and Washout Period 1||9
3106587|NCT01536951|3830512|FG000|NOT COMPLETED|First Intervention and Washout Period 1||0
3106588|NCT01536951|3830513|FG001|NOT COMPLETED|First Intervention and Washout Period 1||0
3106589|NCT01536951|3830514|FG002|NOT COMPLETED|First Intervention and Washout Period 1||1
3106590|NCT01536951|3830515|FG003|NOT COMPLETED|First Intervention and Washout Period 1||0
3106591|NCT01536951|3830516|FG004|NOT COMPLETED|First Intervention and Washout Period 1||0
3106592|NCT01536951|3830517|FG005|NOT COMPLETED|First Intervention and Washout Period 1||0
3106593|NCT01536951|3830518|FG006|NOT COMPLETED|First Intervention and Washout Period 1||0
3106594|NCT01536951|3830519|FG007|NOT COMPLETED|First Intervention and Washout Period 1||0
3106595|NCT01536951|3830520|FG008|NOT COMPLETED|First Intervention and Washout Period 1||0
3106596|NCT01536951|3830512|FG000|STARTED|Second Intervention and Washout Period 2||3
3106597|NCT01536951|3830513|FG001|STARTED|Second Intervention and Washout Period 2||3
3106598|NCT01536951|3830514|FG002|STARTED|Second Intervention and Washout Period 2||2
3106599|NCT01536951|3830515|FG003|STARTED|Second Intervention and Washout Period 2||8
3106600|NCT01536951|3830516|FG004|STARTED|Second Intervention and Washout Period 2||9
3106601|NCT01536951|3830517|FG005|STARTED|Second Intervention and Washout Period 2||9
3106602|NCT01536951|3830518|FG006|STARTED|Second Intervention and Washout Period 2||9
3106603|NCT01536951|3830519|FG007|STARTED|Second Intervention and Washout Period 2||9
3106604|NCT01536951|3830520|FG008|STARTED|Second Intervention and Washout Period 2||9
3106605|NCT01536951|3830512|FG000|COMPLETED|Second Intervention and Washout Period 2||3
3106606|NCT01536951|3830513|FG001|COMPLETED|Second Intervention and Washout Period 2||3
3106607|NCT01536951|3830514|FG002|COMPLETED|Second Intervention and Washout Period 2||2
3106608|NCT01536951|3830515|FG003|COMPLETED|Second Intervention and Washout Period 2||8
3106609|NCT01536951|3830516|FG004|COMPLETED|Second Intervention and Washout Period 2||9
3106610|NCT01536951|3830517|FG005|COMPLETED|Second Intervention and Washout Period 2||9
3106611|NCT01536951|3830518|FG006|COMPLETED|Second Intervention and Washout Period 2||9
3106612|NCT01536951|3830519|FG007|COMPLETED|Second Intervention and Washout Period 2||8
3106613|NCT01536951|3830520|FG008|COMPLETED|Second Intervention and Washout Period 2||9
3106614|NCT01536951|3830512|FG000|NOT COMPLETED|Second Intervention and Washout Period 2||0
3106615|NCT01536951|3830513|FG001|NOT COMPLETED|Second Intervention and Washout Period 2||0
3106616|NCT01536951|3830514|FG002|NOT COMPLETED|Second Intervention and Washout Period 2||0
3106617|NCT01536951|3830515|FG003|NOT COMPLETED|Second Intervention and Washout Period 2||0
3106618|NCT01536951|3830516|FG004|NOT COMPLETED|Second Intervention and Washout Period 2||0
3106619|NCT01536951|3830517|FG005|NOT COMPLETED|Second Intervention and Washout Period 2||0
3106620|NCT01536951|3830518|FG006|NOT COMPLETED|Second Intervention and Washout Period 2||0
3106621|NCT01536951|3830519|FG007|NOT COMPLETED|Second Intervention and Washout Period 2||1
3106622|NCT01536951|3830520|FG008|NOT COMPLETED|Second Intervention and Washout Period 2||0
3106623|NCT01536951|3830512|FG000|STARTED|Third Intervention||3
3106624|NCT01536951|3830513|FG001|STARTED|Third Intervention||3
3106625|NCT01536951|3830514|FG002|STARTED|Third Intervention||2
3106626|NCT01536951|3830515|FG003|STARTED|Third Intervention||8
3106627|NCT01536951|3830516|FG004|STARTED|Third Intervention||9
3106628|NCT01536951|3830517|FG005|STARTED|Third Intervention||9
3106629|NCT01536951|3830518|FG006|STARTED|Third Intervention||9
3106630|NCT01536951|3830519|FG007|STARTED|Third Intervention||8
3106631|NCT01536951|3830520|FG008|STARTED|Third Intervention||9
3106632|NCT01536951|3830512|FG000|COMPLETED|Third Intervention||3
3106633|NCT01536951|3830513|FG001|COMPLETED|Third Intervention||3
3106634|NCT01536951|3830514|FG002|COMPLETED|Third Intervention||2
3106635|NCT01536951|3830515|FG003|COMPLETED|Third Intervention||8
3106636|NCT01536951|3830516|FG004|COMPLETED|Third Intervention||9
3106637|NCT01536951|3830517|FG005|COMPLETED|Third Intervention||9
3106638|NCT01536951|3830518|FG006|COMPLETED|Third Intervention||9
3106639|NCT01536951|3830519|FG007|COMPLETED|Third Intervention||8
3106640|NCT01536951|3830520|FG008|COMPLETED|Third Intervention||9
3106641|NCT01536951|3830512|FG000|NOT COMPLETED|Third Intervention||0
3106642|NCT01536951|3830513|FG001|NOT COMPLETED|Third Intervention||0
3106643|NCT01536951|3830514|FG002|NOT COMPLETED|Third Intervention||0
3106644|NCT01536951|3830515|FG003|NOT COMPLETED|Third Intervention||0
3106645|NCT01536951|3830516|FG004|NOT COMPLETED|Third Intervention||0
3106646|NCT01536951|3830517|FG005|NOT COMPLETED|Third Intervention||0
3106647|NCT01536951|3830518|FG006|NOT COMPLETED|Third Intervention||0
3106648|NCT01536951|3830519|FG007|NOT COMPLETED|Third Intervention||0
3106649|NCT01536951|3830520|FG008|NOT COMPLETED|Third Intervention||0
3106650|NCT01537029|3830543|FG000|STARTED|Overall Study||15
3106651|NCT01537029|3830543|FG000|COMPLETED|Overall Study||15
3106652|NCT01537029|3830543|FG000|NOT COMPLETED|Overall Study||0
3106653|NCT01537042|3830549|FG000|STARTED|Overall Study||10
3106654|NCT01537042|3830550|FG001|STARTED|Overall Study||20
3106655|NCT01537042|3830549|FG000|COMPLETED|Overall Study||10
3106656|NCT01537042|3830550|FG001|COMPLETED|Overall Study||15
3106657|NCT01537042|3830549|FG000|NOT COMPLETED|Overall Study||0
3106658|NCT01537042|3830550|FG001|NOT COMPLETED|Overall Study||5
3106659|NCT01537068|3830562|FG000|STARTED|Overall Study||30
3106660|NCT01537068|3830563|FG001|STARTED|Overall Study||29
3106661|NCT01537068|3830562|FG000|COMPLETED|Overall Study||26
3106662|NCT01537068|3830563|FG001|COMPLETED|Overall Study||26
3106663|NCT01537068|3830562|FG000|NOT COMPLETED|Overall Study||4
3106664|NCT01537068|3830563|FG001|NOT COMPLETED|Overall Study||3
3106665|NCT01537081|3830572|FG000|STARTED|Overall Study||1123
3106666|NCT01537081|3830573|FG001|STARTED|Overall Study||1124
3106667|NCT01537081|3830574|FG002|STARTED|Overall Study||563
3106668|NCT01537081|3830572|FG000|Safety Population|Overall Study||1122
3106669|NCT01537081|3830573|FG001|Safety Population|Overall Study||1122
3106670|NCT01537081|3830574|FG002|Safety Population|Overall Study||561
3106671|NCT01537081|3830572|FG000|Modified Intent to Treat Population|Overall Study||1106
3106672|NCT01537081|3830573|FG001|Modified Intent to Treat Population|Overall Study||1109
3106673|NCT01537081|3830574|FG002|Modified Intent to Treat Population|Overall Study||556
3106674|NCT01537081|3830572|FG000|COMPLETED|Overall Study||1084
3106675|NCT01537081|3830573|FG001|COMPLETED|Overall Study||1086
3106676|NCT01537081|3830574|FG002|COMPLETED|Overall Study||547
3106677|NCT01537081|3830572|FG000|NOT COMPLETED|Overall Study||39
3106678|NCT01537081|3830573|FG001|NOT COMPLETED|Overall Study||38
3106679|NCT01537081|3830574|FG002|NOT COMPLETED|Overall Study||16
3106680|NCT01537120|3830583|FG000|STARTED|Enrolled||25
3106681|NCT01537120|3830583|FG000|COMPLETED|Enrolled||25
3106682|NCT01537120|3830583|FG000|NOT COMPLETED|Enrolled||0
3106683|NCT01537120|3830583|FG000|STARTED|8 Weeks Washout||25
3106684|NCT01537120|3830583|FG000|COMPLETED|8 Weeks Washout||24
3106685|NCT01537120|3830583|FG000|NOT COMPLETED|8 Weeks Washout||1
3106686|NCT01537120|3830583|FG000|STARTED|3 Weeks Placebo||24
3106687|NCT01537120|3830583|FG000|COMPLETED|3 Weeks Placebo||23
3106688|NCT01537120|3830583|FG000|NOT COMPLETED|3 Weeks Placebo||1
3106689|NCT01537120|3830583|FG000|STARTED|12 Weeks Vildagliptin||23
3106690|NCT01537120|3830583|FG000|COMPLETED|12 Weeks Vildagliptin||23
3106691|NCT01537120|3830583|FG000|NOT COMPLETED|12 Weeks Vildagliptin||0
3106692|NCT01537133|3830593|FG000|STARTED|Overall Study||28
3106693|NCT01537133|3830594|FG001|STARTED|Overall Study||14
3106694|NCT01537133|3830595|FG002|STARTED|Overall Study||21
3106695|NCT01537133|3830596|FG003|STARTED|Overall Study||21
3106696|NCT01537133|3830593|FG000|COMPLETED|Overall Study||25
3106697|NCT01537133|3830594|FG001|COMPLETED|Overall Study||14
3106698|NCT01537133|3830595|FG002|COMPLETED|Overall Study||21
3106699|NCT01537133|3830596|FG003|COMPLETED|Overall Study||21
3106700|NCT01537133|3830593|FG000|NOT COMPLETED|Overall Study||3
3106701|NCT01537133|3830594|FG001|NOT COMPLETED|Overall Study||0
3106702|NCT01537133|3830595|FG002|NOT COMPLETED|Overall Study||0
3106703|NCT01537133|3830596|FG003|NOT COMPLETED|Overall Study||0
3106704|NCT01537185|3830608|FG000|STARTED|Overall Study||10
3106705|NCT01537185|3830609|FG001|STARTED|Overall Study||12
3106706|NCT01537185|3830610|FG002|STARTED|Overall Study||10
3106707|NCT01537185|3830611|FG003|STARTED|Overall Study||10
3106708|NCT01537185|3830608|FG000|COMPLETED|Overall Study||7
3106709|NCT01537185|3830609|FG001|COMPLETED|Overall Study||6
3106710|NCT01537185|3830610|FG002|COMPLETED|Overall Study||4
3106711|NCT01537185|3830611|FG003|COMPLETED|Overall Study||8
3106712|NCT01537185|3830608|FG000|NOT COMPLETED|Overall Study||3
3106713|NCT01537185|3830609|FG001|NOT COMPLETED|Overall Study||6
3106714|NCT01537185|3830610|FG002|NOT COMPLETED|Overall Study||6
3106715|NCT01537185|3830611|FG003|NOT COMPLETED|Overall Study||2
3106716|NCT01537198|3830623|FG000|STARTED|Overall Study||617
3106717|NCT01537198|3830623|FG000|COMPLETED|Overall Study||463
3106718|NCT01537198|3830623|FG000|NOT COMPLETED|Overall Study||154
3106719|NCT01537211|3830629|FG000|STARTED|Overall Study||4
3106720|NCT01537211|3830630|FG001|STARTED|Overall Study||6
3106721|NCT01537211|3830629|FG000|COMPLETED|Overall Study||4
3106722|NCT01537211|3830630|FG001|COMPLETED|Overall Study||5
3106723|NCT01537211|3830629|FG000|NOT COMPLETED|Overall Study||0
3106724|NCT01537211|3830630|FG001|NOT COMPLETED|Overall Study||1
3106725|NCT01537302|3830640|FG000|STARTED|Overall Study||100
3106726|NCT01537302|3830640|FG000|COMPLETED|Overall Study||100
3106727|NCT01537302|3830640|FG000|NOT COMPLETED|Overall Study||0
3106728|NCT01537315|3830646|FG000|STARTED|Overall Study||1
3106729|NCT01537315|3830647|FG001|STARTED|Overall Study||7
3106730|NCT01537315|3830646|FG000|COMPLETED|Overall Study||1
3106731|NCT01537315|3830647|FG001|COMPLETED|Overall Study||7
3106732|NCT01537315|3830646|FG000|NOT COMPLETED|Overall Study||0
3106733|NCT01537315|3830647|FG001|NOT COMPLETED|Overall Study||0
3106734|NCT01537367|3830656|FG000|STARTED|Overall Study||615
3106735|NCT01537367|3830657|FG001|STARTED|Overall Study||610
3106736|NCT01537367|3830658|FG002|STARTED|Overall Study||613
3106737|NCT01537367|3830656|FG000|COMPLETED|Overall Study|All participants who were enrolled were followed for routine HIV clinic attendance via clinic EMR.|615
3106738|NCT01537367|3830657|FG001|COMPLETED|Overall Study|All participants who were enrolled were followed for routine HIV clinic attendance via clinic EMR.|610
3106739|NCT01537367|3830658|FG002|COMPLETED|Overall Study|All participants who were enrolled were followed for routine HIV clinic attendance via clinic EMR.|613
3106740|NCT01537367|3830656|FG000|NOT COMPLETED|Overall Study||0
3106741|NCT01537367|3830657|FG001|NOT COMPLETED|Overall Study||0
3106742|NCT01537367|3830658|FG002|NOT COMPLETED|Overall Study||0
3106743|NCT01537393|3830668|FG000|STARTED|Overall Study||707
3106744|NCT01537393|3830669|FG001|STARTED|Overall Study||698
3106745|NCT01537393|3830668|FG000|COMPLETED|Overall Study||553
3106746|NCT01537393|3830669|FG001|COMPLETED|Overall Study||507
3106747|NCT01537393|3830668|FG000|NOT COMPLETED|Overall Study||154
3106748|NCT01537393|3830669|FG001|NOT COMPLETED|Overall Study||191
3106749|NCT01537419|3830677|FG000|STARTED|Overall Study||63
3106750|NCT01537419|3830678|FG001|STARTED|Overall Study||66
3106751|NCT01537419|3830677|FG000|COMPLETED|Overall Study||52
3106752|NCT01537419|3830678|FG001|COMPLETED|Overall Study||54
3106753|NCT01537419|3830677|FG000|NOT COMPLETED|Overall Study||11
3106754|NCT01537419|3830678|FG001|NOT COMPLETED|Overall Study||12
3106755|NCT01537432|3830686|FG000|STARTED|Overall Study||24
3106756|NCT01537432|3830687|FG001|STARTED|Overall Study||12
3106757|NCT01537432|3830686|FG000|COMPLETED|Overall Study||18
3106758|NCT01537432|3830687|FG001|COMPLETED|Overall Study||10
3106759|NCT01537432|3830686|FG000|NOT COMPLETED|Overall Study||6
3106760|NCT01537432|3830687|FG001|NOT COMPLETED|Overall Study||2
3106761|NCT01537549|3830693|FG000|STARTED|Overall Study||11
3106762|NCT01537549|3830693|FG000|COMPLETED|Overall Study||8
3106763|NCT01537549|3830693|FG000|NOT COMPLETED|Overall Study||3
3106764|NCT01537666|3830703|FG000|STARTED|Overall Study|2 of these 6 also received a single 250 mg IV dose of vancomycin at least 72 hours after AeroVanc.|6
3106765|NCT01537666|3830704|FG001|STARTED|Overall Study|2 of these 6 also received a single 250 mg IV dose of vancomycin at least 72 hours after AeroVanc.|6
3106766|NCT01537666|3830705|FG002|STARTED|Overall Study|2 of these 6 also received a single 250 mg IV dose of vancomycin at least 72 hours after AeroVanc.|6
3106767|NCT01537666|3830706|FG003|STARTED|Overall Study|5 of 7 patients received a 32 mg dose of AeroVanc followed by a dose of 80 mg at least 1 week later.|7
3106768|NCT01537666|3830703|FG000|COMPLETED|Overall Study||6
3106769|NCT01537666|3830704|FG001|COMPLETED|Overall Study||6
3106770|NCT01537666|3830705|FG002|COMPLETED|Overall Study||6
3106771|NCT01537666|3830706|FG003|COMPLETED|Overall Study|1 patient withdrew after a 32 mg dose and was replaced by a patient who only received an 80 mg dose.|7
3106772|NCT01537666|3830703|FG000|NOT COMPLETED|Overall Study||0
3106773|NCT01537666|3830704|FG001|NOT COMPLETED|Overall Study||0
3106774|NCT01537666|3830705|FG002|NOT COMPLETED|Overall Study||0
3106775|NCT01537666|3830706|FG003|NOT COMPLETED|Overall Study||0
3106776|NCT01537783|3830728|FG000|STARTED|Overall Study||25
3106777|NCT01537783|3830729|FG001|STARTED|Overall Study||25
3106778|NCT01537783|3830728|FG000|COMPLETED|Overall Study||14
3106779|NCT01537783|3830729|FG001|COMPLETED|Overall Study||23
3106780|NCT01537783|3830728|FG000|NOT COMPLETED|Overall Study||11
3106781|NCT01537783|3830729|FG001|NOT COMPLETED|Overall Study||2
3106782|NCT01537835|3830738|FG000|STARTED|Overall Study||37
3106783|NCT01537835|3830739|FG001|STARTED|Overall Study||37
3106784|NCT01537835|3830740|FG002|STARTED|Overall Study||35
3106785|NCT01537835|3830738|FG000|COMPLETED|Overall Study||37
3106786|NCT01537835|3830739|FG001|COMPLETED|Overall Study||37
3106787|NCT01537835|3830740|FG002|COMPLETED|Overall Study||35
3106788|NCT01537835|3830738|FG000|NOT COMPLETED|Overall Study||0
3106789|NCT01537835|3830739|FG001|NOT COMPLETED|Overall Study||0
3106790|NCT01537835|3830740|FG002|NOT COMPLETED|Overall Study||0
3106791|NCT01537887|3830748|FG000|STARTED|Period 1||12
3106792|NCT01537887|3830749|FG001|STARTED|Period 1||12
3106793|NCT01537887|3830750|FG002|STARTED|Period 1||12
3106794|NCT01537887|3830751|FG003|STARTED|Period 1||12
3106795|NCT01537887|3830752|FG004|STARTED|Period 1||12
3106796|NCT01537887|3830753|FG005|STARTED|Period 1||12
3106797|NCT01537887|3830748|FG000|Received at Least 1 Dose of Study Drug|Period 1||12
3106798|NCT01537887|3830749|FG001|Received at Least 1 Dose of Study Drug|Period 1||12
3106799|NCT01537887|3830750|FG002|Received at Least 1 Dose of Study Drug|Period 1||11
3106800|NCT01537887|3830751|FG003|Received at Least 1 Dose of Study Drug|Period 1||12
3106801|NCT01537887|3830752|FG004|Received at Least 1 Dose of Study Drug|Period 1||12
3106802|NCT01537887|3830753|FG005|Received at Least 1 Dose of Study Drug|Period 1||12
3106803|NCT01537887|3830748|FG000|COMPLETED|Period 1||12
3106804|NCT01537887|3830749|FG001|COMPLETED|Period 1||12
3106805|NCT01537887|3830750|FG002|COMPLETED|Period 1||11
3106806|NCT01537887|3830751|FG003|COMPLETED|Period 1||12
3106807|NCT01537887|3830752|FG004|COMPLETED|Period 1||11
3106808|NCT01537887|3830753|FG005|COMPLETED|Period 1||11
3106809|NCT01537887|3830748|FG000|NOT COMPLETED|Period 1||0
3106810|NCT01537887|3830749|FG001|NOT COMPLETED|Period 1||0
3106811|NCT01537887|3830750|FG002|NOT COMPLETED|Period 1||1
3106812|NCT01537887|3830751|FG003|NOT COMPLETED|Period 1||0
3106813|NCT01537887|3830752|FG004|NOT COMPLETED|Period 1||1
3106814|NCT01537887|3830753|FG005|NOT COMPLETED|Period 1||1
3106815|NCT01537887|3830748|FG000|STARTED|Period 2||12
3106816|NCT01537887|3830749|FG001|STARTED|Period 2||12
3106817|NCT01537887|3830750|FG002|STARTED|Period 2||11
3106818|NCT01537887|3830751|FG003|STARTED|Period 2||12
3106819|NCT01537887|3830752|FG004|STARTED|Period 2||11
3106820|NCT01537887|3830753|FG005|STARTED|Period 2||11
3106821|NCT01537887|3830748|FG000|COMPLETED|Period 2||12
3106822|NCT01537887|3830749|FG001|COMPLETED|Period 2||11
3106823|NCT01537887|3830750|FG002|COMPLETED|Period 2||11
3106824|NCT01537887|3830751|FG003|COMPLETED|Period 2||12
3106825|NCT01537887|3830752|FG004|COMPLETED|Period 2||11
3106826|NCT01537887|3830753|FG005|COMPLETED|Period 2||11
3106827|NCT01537887|3830748|FG000|NOT COMPLETED|Period 2||0
3106828|NCT01537887|3830749|FG001|NOT COMPLETED|Period 2||1
3106829|NCT01537887|3830750|FG002|NOT COMPLETED|Period 2||0
3106830|NCT01537887|3830751|FG003|NOT COMPLETED|Period 2||0
3106831|NCT01537887|3830752|FG004|NOT COMPLETED|Period 2||0
3106832|NCT01537887|3830753|FG005|NOT COMPLETED|Period 2||0
3106833|NCT01537887|3830748|FG000|STARTED|Period 3||12
3106834|NCT01537887|3830749|FG001|STARTED|Period 3||11
3106835|NCT01537887|3830750|FG002|STARTED|Period 3||11
3106836|NCT01537887|3830751|FG003|STARTED|Period 3||12
3106837|NCT01537887|3830752|FG004|STARTED|Period 3||11
3106838|NCT01537887|3830753|FG005|STARTED|Period 3||11
3106839|NCT01537887|3830748|FG000|COMPLETED|Period 3||12
3106840|NCT01537887|3830749|FG001|COMPLETED|Period 3||10
3106841|NCT01537887|3830750|FG002|COMPLETED|Period 3||10
3106842|NCT01537887|3830751|FG003|COMPLETED|Period 3||12
3106843|NCT01537887|3830752|FG004|COMPLETED|Period 3||11
3106844|NCT01537887|3830753|FG005|COMPLETED|Period 3||11
3106845|NCT01537887|3830748|FG000|NOT COMPLETED|Period 3||0
3106846|NCT01537887|3830749|FG001|NOT COMPLETED|Period 3||1
3106847|NCT01537887|3830750|FG002|NOT COMPLETED|Period 3||1
3106848|NCT01537887|3830751|FG003|NOT COMPLETED|Period 3||0
3106849|NCT01537887|3830752|FG004|NOT COMPLETED|Period 3||0
3106850|NCT01537887|3830753|FG005|NOT COMPLETED|Period 3||0
3106851|NCT01537900|3830761|FG000|STARTED|Overall Study||4
3106852|NCT01537900|3830761|FG000|COMPLETED|Overall Study||4
3106853|NCT01537900|3830761|FG000|NOT COMPLETED|Overall Study||0
3106854|NCT01537926|3830767|FG000|STARTED|Overall Study||29
3106855|NCT01537926|3830768|FG001|STARTED|Overall Study||13
3106856|NCT01537926|3830767|FG000|COMPLETED|Overall Study||24
3106857|NCT01537926|3830768|FG001|COMPLETED|Overall Study||11
3106858|NCT01537926|3830767|FG000|NOT COMPLETED|Overall Study||5
3106859|NCT01537926|3830768|FG001|NOT COMPLETED|Overall Study||2
3106860|NCT01538199|3830781|FG000|STARTED|Overall Study||10
3106861|NCT01538199|3830782|FG001|STARTED|Overall Study||11
3106862|NCT01538199|3830783|FG002|STARTED|Overall Study||4
3106863|NCT01538199|3830784|FG003|STARTED|Overall Study||3
3106864|NCT01538199|3830781|FG000|COMPLETED|Overall Study|"1 completed study but was excluded as a completer from analyses because started a new treatment"|8
3106865|NCT01538199|3830782|FG001|COMPLETED|Overall Study|"1 completed study but was excluded as a completer from analyses because started a new treatment"|8
3106866|NCT01538199|3830783|FG002|COMPLETED|Overall Study|1 non-completer included in analyses because only missed follow up, completed all treatment visits.|3
3106867|NCT01538199|3830784|FG003|COMPLETED|Overall Study|Completer excluded from analyses because determined to be not eligible at end of study.|1
3106868|NCT01538199|3830781|FG000|NOT COMPLETED|Overall Study||2
3106869|NCT01538199|3830782|FG001|NOT COMPLETED|Overall Study||3
3106870|NCT01538199|3830783|FG002|NOT COMPLETED|Overall Study||1
3106871|NCT01538199|3830784|FG003|NOT COMPLETED|Overall Study||2
3106872|NCT01538472|3830801|FG000|STARTED|Overall Study||40
3106873|NCT01538472|3830801|FG000|COMPLETED|Overall Study||36
3106874|NCT01538472|3830801|FG000|NOT COMPLETED|Overall Study||4
3106875|NCT01538615|3830807|FG000|STARTED|Overall Study||162
3106876|NCT01538615|3830808|FG001|STARTED|Overall Study||158
3106877|NCT01538615|3830807|FG000|COMPLETED|Overall Study||140
3106878|NCT01538615|3830808|FG001|COMPLETED|Overall Study||146
3106879|NCT01538615|3830807|FG000|NOT COMPLETED|Overall Study||22
3106880|NCT01538615|3830808|FG001|NOT COMPLETED|Overall Study||12
3106881|NCT01538628|3830816|FG000|STARTED|Overall Study||149
3106882|NCT01538628|3830817|FG001|STARTED|Overall Study||73
3106883|NCT01538628|3830816|FG000|COMPLETED|Overall Study||148
3106884|NCT01538628|3830817|FG001|COMPLETED|Overall Study||71
3106885|NCT01538628|3830816|FG000|NOT COMPLETED|Overall Study||1
3106886|NCT01538628|3830817|FG001|NOT COMPLETED|Overall Study||2
3106887|NCT01538719|3830826|FG000|STARTED|Overall Study||7
3106888|NCT01538719|3830827|FG001|STARTED|Overall Study||12
3106889|NCT01538719|3830826|FG000|COMPLETED|Overall Study||5
3106890|NCT01538719|3830827|FG001|COMPLETED|Overall Study||12
3106891|NCT01538719|3830826|FG000|NOT COMPLETED|Overall Study||2
3106892|NCT01538719|3830827|FG001|NOT COMPLETED|Overall Study||0
3106893|NCT01538745|3830835|FG000|STARTED|Overall Study||24
3106894|NCT01538745|3830836|FG001|STARTED|Overall Study||21
3106895|NCT01538745|3830835|FG000|COMPLETED|Overall Study||24
3106896|NCT01538745|3830836|FG001|COMPLETED|Overall Study||21
3106897|NCT01538745|3830835|FG000|NOT COMPLETED|Overall Study||0
3106898|NCT01538745|3830836|FG001|NOT COMPLETED|Overall Study||0
3106899|NCT01538862|3830842|FG000|STARTED|Overall Study||7
3106900|NCT01538862|3830842|FG000|COMPLETED|Overall Study||7
3106901|NCT01538862|3830842|FG000|NOT COMPLETED|Overall Study||0
3106902|NCT01539070|3830849|FG000|STARTED|Overall Study||168
3106903|NCT01539070|3830850|FG001|STARTED|Overall Study||138
3106904|NCT01539070|3830849|FG000|COMPLETED|Overall Study||109
3106905|NCT01539070|3830850|FG001|COMPLETED|Overall Study||99
3106906|NCT01539070|3830849|FG000|NOT COMPLETED|Overall Study||59
3106907|NCT01539070|3830850|FG001|NOT COMPLETED|Overall Study||39
3106908|NCT01539083|3830856|FG000|STARTED|Before Randomization (VCD Induction)||256
3106909|NCT01539083|3830857|FG001|STARTED|Before Randomization (VCD Induction)||0
3106910|NCT01539083|3830858|FG002|STARTED|Before Randomization (VCD Induction)||0
3106911|NCT01539083|3830856|FG000|Treated|Before Randomization (VCD Induction)||254
3106912|NCT01539083|3830857|FG001|Treated|Before Randomization (VCD Induction)||0
3106913|NCT01539083|3830858|FG002|Treated|Before Randomization (VCD Induction)||0
3106914|NCT01539083|3830856|FG000|COMPLETED|Before Randomization (VCD Induction)||203
3106915|NCT01539083|3830857|FG001|COMPLETED|Before Randomization (VCD Induction)||0
3106916|NCT01539083|3830858|FG002|COMPLETED|Before Randomization (VCD Induction)||0
3106917|NCT01539083|3830856|FG000|NOT COMPLETED|Before Randomization (VCD Induction)||53
3106918|NCT01539083|3830857|FG001|NOT COMPLETED|Before Randomization (VCD Induction)||0
3106919|NCT01539083|3830858|FG002|NOT COMPLETED|Before Randomization (VCD Induction)||0
3106920|NCT01539083|3830856|FG000|STARTED|After Randomization (TP and VTP)||0
3106921|NCT01539083|3830857|FG001|STARTED|After Randomization (TP and VTP)|Participants who completed induction phase were randomized for the consolidated treatment.|100
3106922|NCT01539083|3830858|FG002|STARTED|After Randomization (TP and VTP)|Participants who completed induction phase were randomized for the consolidation treatment phase.|103
3106923|NCT01539083|3830856|FG000|Safety Population|After Randomization (TP and VTP)||0
3106924|NCT01539083|3830857|FG001|Safety Population|After Randomization (TP and VTP)|One participant was randomized but not treated. Hence, was not included in safety population.|99
3106925|NCT01539083|3830858|FG002|Safety Population|After Randomization (TP and VTP)||103
3106926|NCT01539083|3830856|FG000|COMPLETED|After Randomization (TP and VTP)||0
3106927|NCT01539083|3830857|FG001|COMPLETED|After Randomization (TP and VTP)||79
3106928|NCT01539083|3830858|FG002|COMPLETED|After Randomization (TP and VTP)||80
3106929|NCT01539083|3830856|FG000|NOT COMPLETED|After Randomization (TP and VTP)||0
3106930|NCT01539083|3830857|FG001|NOT COMPLETED|After Randomization (TP and VTP)||21
3106931|NCT01539083|3830858|FG002|NOT COMPLETED|After Randomization (TP and VTP)||23
3106932|NCT01539135|3830867|FG000|STARTED|Overall Study||43
3106933|NCT01539135|3830868|FG001|STARTED|Overall Study||37
3106934|NCT01539135|3830867|FG000|COMPLETED|Overall Study||43
3106935|NCT01539135|3830868|FG001|COMPLETED|Overall Study||37
3106936|NCT01539135|3830867|FG000|NOT COMPLETED|Overall Study||0
3106937|NCT01539135|3830868|FG001|NOT COMPLETED|Overall Study||0
3106938|NCT01539239|3830876|FG000|STARTED|Overall Study||369
3106939|NCT01539239|3830877|FG001|STARTED|Overall Study||187
3106940|NCT01539239|3830876|FG000|COMPLETED|Overall Study||357
3106941|NCT01539239|3830877|FG001|COMPLETED|Overall Study||170
3106942|NCT01539239|3830876|FG000|NOT COMPLETED|Overall Study||12
3106943|NCT01539239|3830877|FG001|NOT COMPLETED|Overall Study||17
3106944|NCT01539291|3830886|FG000|STARTED|Study GS-US-312-0116|Started = Randomized in Study GS-US-312-0116.|106
3106945|NCT01539291|3830887|FG001|STARTED|Study GS-US-312-0116|Started = Randomized in Study GS-US-312-0116.|4
3106946|NCT01539291|3830888|FG002|STARTED|Study GS-US-312-0116|Started = Randomized in Study GS-US-312-0116.|42
3106947|NCT01539291|3830889|FG003|STARTED|Study GS-US-312-0116|Started = Randomized in Study GS-US-312-0116.|44
3106948|NCT01539291|3830886|FG000|COMPLETED|Study GS-US-312-0116|Completed = Met Primary Endpoint (reason as determined by investigator) or finished study period.|81
3106949|NCT01539291|3830887|FG001|COMPLETED|Study GS-US-312-0116|Completed = Met Primary Endpoint (reason as determined by investigator) or finished study period.|4
3106950|NCT01539291|3830888|FG002|COMPLETED|Study GS-US-312-0116|Completed = Met Primary Endpoint (reason as determined by investigator) or finished study period.|42
3106951|NCT01539291|3830889|FG003|COMPLETED|Study GS-US-312-0116|Completed = Met Primary Endpoint (reason as determined by investigator) or finished study period.|44
3106952|NCT01539291|3830886|FG000|NOT COMPLETED|Study GS-US-312-0116||25
3106953|NCT01539291|3830887|FG001|NOT COMPLETED|Study GS-US-312-0116||0
3106954|NCT01539291|3830888|FG002|NOT COMPLETED|Study GS-US-312-0116||0
3106955|NCT01539291|3830889|FG003|NOT COMPLETED|Study GS-US-312-0116||0
3106956|NCT01539291|3830886|FG000|STARTED|Study GS-US-312-0117|Started = Completed GS-US-312-0116 and Enrolled in GS-US-312-0117.|71
3106957|NCT01539291|3830887|FG001|STARTED|Study GS-US-312-0117|Started = Completed GS-US-312-0116 and Enrolled in GS-US-312-0117.|4
3106958|NCT01539291|3830888|FG002|STARTED|Study GS-US-312-0117|Started = Completed GS-US-312-0116 and Enrolled in GS-US-312-0117.|42
3106959|NCT01539291|3830889|FG003|STARTED|Study GS-US-312-0117|Started = Completed GS-US-312-0116 and Enrolled in GS-US-312-0117.|44
3106960|NCT01539291|3830886|FG000|COMPLETED|Study GS-US-312-0117|Completed = Met Primary Endpoint (reason as determined by investigator) or finished study period.|30
3106961|NCT01539291|3830887|FG001|COMPLETED|Study GS-US-312-0117|Completed = Met Primary Endpoint (reason as determined by investigator) or finished study period.|2
3106962|NCT01539291|3830888|FG002|COMPLETED|Study GS-US-312-0117|Completed = Met Primary Endpoint (reason as determined by investigator) or finished study period.|20
3106963|NCT01539291|3830889|FG003|COMPLETED|Study GS-US-312-0117|Completed = Met Primary Endpoint (reason as determined by investigator) or finished study period.|18
3106964|NCT01539291|3830886|FG000|NOT COMPLETED|Study GS-US-312-0117||41
3106965|NCT01539291|3830887|FG001|NOT COMPLETED|Study GS-US-312-0117||2
3106966|NCT01539291|3830888|FG002|NOT COMPLETED|Study GS-US-312-0117||22
3106967|NCT01539291|3830889|FG003|NOT COMPLETED|Study GS-US-312-0117||26
3106968|NCT01539317|3830908|FG000|STARTED|Overall Study||25
3106969|NCT01539317|3830909|FG001|STARTED|Overall Study||25
3106970|NCT01539317|3830908|FG000|COMPLETED|Overall Study||24
3106971|NCT01539317|3830909|FG001|COMPLETED|Overall Study||25
3106972|NCT01539317|3830908|FG000|NOT COMPLETED|Overall Study||1
3106973|NCT01539317|3830909|FG001|NOT COMPLETED|Overall Study||0
3106974|NCT01539512|3830920|FG000|STARTED|Overall Study||110
3106975|NCT01539512|3830921|FG001|STARTED|Overall Study||110
3106976|NCT01539512|3830920|FG000|COMPLETED|Overall Study|Completed=reached primary efficacy endpoint (progressive disease or death) or finished study period.|87
3106977|NCT01539512|3830921|FG001|COMPLETED|Overall Study|Completed=reached primary efficacy endpoint (progressive disease or death) or finished study period.|97
3106978|NCT01539512|3830920|FG000|NOT COMPLETED|Overall Study||23
3106979|NCT01539512|3830921|FG001|NOT COMPLETED|Overall Study||13
3106980|NCT01539525|3830930|FG000|STARTED|Overall Study||145
3106981|NCT01539525|3830931|FG001|STARTED|Overall Study||143
3106982|NCT01539525|3830932|FG002|STARTED|Overall Study||151
3106983|NCT01539525|3830930|FG000|COMPLETED|Overall Study||125
3106984|NCT01539525|3830931|FG001|COMPLETED|Overall Study||127
3106985|NCT01539525|3830932|FG002|COMPLETED|Overall Study||134
3106986|NCT01539525|3830930|FG000|NOT COMPLETED|Overall Study||20
3106987|NCT01539525|3830931|FG001|NOT COMPLETED|Overall Study||16
3106988|NCT01539525|3830932|FG002|NOT COMPLETED|Overall Study||17
3106989|NCT01539538|3830945|FG000|STARTED|Overall Study||177
3106990|NCT01539538|3830946|FG001|STARTED|Overall Study||180
3106991|NCT01539538|3830945|FG000|COMPLETED|Overall Study||146
3106992|NCT01539538|3830946|FG001|COMPLETED|Overall Study||136
3106993|NCT01539538|3830945|FG000|NOT COMPLETED|Overall Study||31
3106994|NCT01539538|3830946|FG001|NOT COMPLETED|Overall Study||44
3106995|NCT01539642|3830954|FG000|STARTED|Overall Study||114
3106996|NCT01539642|3830955|FG001|STARTED|Overall Study||58
3106997|NCT01539642|3830954|FG000|COMPLETED|Overall Study||78
3106998|NCT01539642|3830955|FG001|COMPLETED|Overall Study||27
3106999|NCT01539642|3830954|FG000|NOT COMPLETED|Overall Study||36
3107000|NCT01539642|3830955|FG001|NOT COMPLETED|Overall Study||31
3107001|NCT01539694|3830961|FG000|STARTED|Overall Study||63
3107002|NCT01539694|3830962|FG001|STARTED|Overall Study||63
3107003|NCT01539694|3830961|FG000|COMPLETED|Overall Study||62
3107004|NCT01539694|3830962|FG001|COMPLETED|Overall Study||62
3107005|NCT01539694|3830961|FG000|NOT COMPLETED|Overall Study||1
3107006|NCT01539694|3830962|FG001|NOT COMPLETED|Overall Study||1
3107007|NCT01539759|3830970|FG000|STARTED|Overall Study||56
3107008|NCT01539759|3830971|FG001|STARTED|Overall Study||56
3107009|NCT01539759|3830970|FG000|Had Successful IUD Placement|Overall Study||34
3107010|NCT01539759|3830971|FG001|Had Successful IUD Placement|Overall Study||53
3107011|NCT01539759|3830970|FG000|IUD Expulsion|Overall Study||1
3107012|NCT01539759|3830971|FG001|IUD Expulsion|Overall Study||4
3107013|NCT01539759|3830970|FG000|IUD Removal|Overall Study||2
3107014|NCT01539759|3830971|FG001|IUD Removal|Overall Study||7
3107015|NCT01539759|3830970|FG000|IUD in Place at 6 Months Posptartum|Overall Study||32
3107016|NCT01539759|3830971|FG001|IUD in Place at 6 Months Posptartum|Overall Study||40
3107017|NCT01539759|3830970|FG000|COMPLETED|Overall Study||50
3107018|NCT01539759|3830971|FG001|COMPLETED|Overall Study||48
3107019|NCT01539759|3830970|FG000|NOT COMPLETED|Overall Study||6
3107020|NCT01539759|3830971|FG001|NOT COMPLETED|Overall Study||8
3107021|NCT01539837|3830980|FG000|STARTED|Overall Study||8
3107022|NCT01539837|3830981|FG001|STARTED|Overall Study||7
3107023|NCT01539837|3830982|FG002|STARTED|Overall Study||7
3107024|NCT01539837|3830980|FG000|COMPLETED|Overall Study||8
3107025|NCT01539837|3830981|FG001|COMPLETED|Overall Study||6
3107026|NCT01539837|3830982|FG002|COMPLETED|Overall Study||5
3107027|NCT01539837|3830980|FG000|NOT COMPLETED|Overall Study||0
3107028|NCT01539837|3830981|FG001|NOT COMPLETED|Overall Study||1
3107029|NCT01539837|3830982|FG002|NOT COMPLETED|Overall Study||2
3107030|NCT01539863|3830992|FG000|STARTED|Overall Study||166
3107031|NCT01539863|3830993|FG001|STARTED|Overall Study||162
3107032|NCT01539863|3830992|FG000|COMPLETED|Overall Study||161
3107033|NCT01539863|3830993|FG001|COMPLETED|Overall Study||158
3107034|NCT01539863|3830992|FG000|NOT COMPLETED|Overall Study||5
3107035|NCT01539863|3830993|FG001|NOT COMPLETED|Overall Study||4
3107036|NCT01539980|3830999|FG000|STARTED|Overall Study||30
3107037|NCT01539980|3830999|FG000|COMPLETED|Overall Study||30
3107038|NCT01539980|3830999|FG000|NOT COMPLETED|Overall Study||0
3107039|NCT01540045|3831003|FG000|STARTED|Overall Study||40
3107040|NCT01540045|3831003|FG000|COMPLETED|Overall Study||40
3107041|NCT01540045|3831003|FG000|NOT COMPLETED|Overall Study||0
3107042|NCT01540071|3831028|FG000|STARTED|Overall Study||38
3107043|NCT01540071|3831028|FG000|COMPLETED|Overall Study||38
3107044|NCT01540071|3831028|FG000|NOT COMPLETED|Overall Study||0
3107045|NCT01540162|3831035|FG000|STARTED|Overall Study||30
3107046|NCT01540162|3831036|FG001|STARTED|Overall Study||32
3107047|NCT01540162|3831035|FG000|COMPLETED|Overall Study||30
3107048|NCT01540162|3831036|FG001|COMPLETED|Overall Study||32
3107049|NCT01540162|3831035|FG000|NOT COMPLETED|Overall Study||0
3107050|NCT01540162|3831036|FG001|NOT COMPLETED|Overall Study||0
3107051|NCT01540266|3831048|FG000|STARTED|Overall Study||63
3107052|NCT01540266|3831049|FG001|STARTED|Overall Study||42
3107053|NCT01540266|3831050|FG002|STARTED|Overall Study||60
3107054|NCT01540266|3831051|FG003|STARTED|Overall Study||38
3107055|NCT01540266|3831052|FG004|STARTED|Overall Study||20
3107056|NCT01540266|3831053|FG005|STARTED|Overall Study||19
3107057|NCT01540266|3831048|FG000|COMPLETED|Overall Study||57
3107058|NCT01540266|3831049|FG001|COMPLETED|Overall Study||41
3107059|NCT01540266|3831050|FG002|COMPLETED|Overall Study||59
3107060|NCT01540266|3831051|FG003|COMPLETED|Overall Study||38
3107061|NCT01540266|3831052|FG004|COMPLETED|Overall Study||20
3107062|NCT01540266|3831053|FG005|COMPLETED|Overall Study||19
3107063|NCT01540266|3831048|FG000|NOT COMPLETED|Overall Study||6
3107064|NCT01540266|3831049|FG001|NOT COMPLETED|Overall Study||1
3107065|NCT01540266|3831050|FG002|NOT COMPLETED|Overall Study||1
3107066|NCT01540266|3831051|FG003|NOT COMPLETED|Overall Study||0
3107067|NCT01540266|3831052|FG004|NOT COMPLETED|Overall Study||0
3107068|NCT01540266|3831053|FG005|NOT COMPLETED|Overall Study||0
3107069|NCT01540370|3831067|FG000|STARTED|Overall Study||102
3107070|NCT01540370|3831067|FG000|COMPLETED|Overall Study||100
3107071|NCT01540370|3831067|FG000|NOT COMPLETED|Overall Study||2
3107072|NCT01540409|3831073|FG000|STARTED|Overall Study||6
3107073|NCT01540409|3831074|FG001|STARTED|Overall Study||6
3107074|NCT01540409|3831073|FG000|COMPLETED|Overall Study||6
3107075|NCT01540409|3831074|FG001|COMPLETED|Overall Study||6
3107076|NCT01540409|3831073|FG000|NOT COMPLETED|Overall Study||0
3107077|NCT01540409|3831074|FG001|NOT COMPLETED|Overall Study||0
3107078|NCT01540474|3831087|FG000|STARTED|Vaccination Period||10
3107079|NCT01540474|3831088|FG001|STARTED|Vaccination Period||10
3107080|NCT01540474|3831089|FG002|STARTED|Vaccination Period||10
3107081|NCT01540474|3831090|FG003|STARTED|Vaccination Period||0
3107082|NCT01540474|3831087|FG000|COMPLETED|Vaccination Period||10
3107083|NCT01540474|3831088|FG001|COMPLETED|Vaccination Period||9
3107084|NCT01540474|3831089|FG002|COMPLETED|Vaccination Period||10
3107085|NCT01540474|3831090|FG003|COMPLETED|Vaccination Period||0
3107086|NCT01540474|3831087|FG000|NOT COMPLETED|Vaccination Period||0
3107087|NCT01540474|3831088|FG001|NOT COMPLETED|Vaccination Period||1
3107088|NCT01540474|3831089|FG002|NOT COMPLETED|Vaccination Period||0
3107089|NCT01540474|3831090|FG003|NOT COMPLETED|Vaccination Period||0
3107090|NCT01540474|3831087|FG000|STARTED|Malaria Challenge||10
3107091|NCT01540474|3831088|FG001|STARTED|Malaria Challenge||9
3107092|NCT01540474|3831089|FG002|STARTED|Malaria Challenge||10
3107093|NCT01540474|3831090|FG003|STARTED|Malaria Challenge||6
3107094|NCT01540474|3831087|FG000|COMPLETED|Malaria Challenge||10
3107095|NCT01540474|3831088|FG001|COMPLETED|Malaria Challenge||9
3107096|NCT01540474|3831089|FG002|COMPLETED|Malaria Challenge||10
3107097|NCT01540474|3831090|FG003|COMPLETED|Malaria Challenge||5
3107098|NCT01540474|3831087|FG000|NOT COMPLETED|Malaria Challenge||0
3107099|NCT01540474|3831088|FG001|NOT COMPLETED|Malaria Challenge||0
3107100|NCT01540474|3831089|FG002|NOT COMPLETED|Malaria Challenge||0
3107101|NCT01540474|3831090|FG003|NOT COMPLETED|Malaria Challenge||1
3107102|NCT01540487|3831103|FG000|STARTED|Overall Study||24
3107103|NCT01540487|3831104|FG001|STARTED|Overall Study||24
3107104|NCT01540487|3831103|FG000|COMPLETED|Overall Study||23
3107105|NCT01540487|3831104|FG001|COMPLETED|Overall Study||24
3107106|NCT01540487|3831103|FG000|NOT COMPLETED|Overall Study||1
3107107|NCT01540487|3831104|FG001|NOT COMPLETED|Overall Study||0
3107108|NCT01540513|3831114|FG000|STARTED|Overall Study||12
3107109|NCT01540513|3831114|FG000|COMPLETED|Overall Study||12
3107110|NCT01540513|3831114|FG000|NOT COMPLETED|Overall Study||0
3107111|NCT01540565|3831118|FG000|STARTED|Overall Study||52
3107112|NCT01540565|3831118|FG000|COMPLETED|Overall Study||50
3107113|NCT01540565|3831118|FG000|NOT COMPLETED|Overall Study||2
3107114|NCT01540773|3831122|FG000|STARTED|First Intervention||8
3107115|NCT01540773|3831123|FG001|STARTED|First Intervention||8
3107116|NCT01540773|3831122|FG000|COMPLETED|First Intervention||8
3107117|NCT01540773|3831123|FG001|COMPLETED|First Intervention||8
3107118|NCT01540773|3831122|FG000|NOT COMPLETED|First Intervention||0
3107119|NCT01540773|3831123|FG001|NOT COMPLETED|First Intervention||0
3107120|NCT01540773|3831122|FG000|STARTED|Wash Out Period of 1 Week||8
3107121|NCT01540773|3831123|FG001|STARTED|Wash Out Period of 1 Week||8
3107122|NCT01540773|3831122|FG000|COMPLETED|Wash Out Period of 1 Week||8
3107123|NCT01540773|3831123|FG001|COMPLETED|Wash Out Period of 1 Week||8
3107124|NCT01540773|3831122|FG000|NOT COMPLETED|Wash Out Period of 1 Week||0
3107125|NCT01540773|3831123|FG001|NOT COMPLETED|Wash Out Period of 1 Week||0
3107126|NCT01540773|3831122|FG000|STARTED|Second Intervention||8
3107127|NCT01540773|3831123|FG001|STARTED|Second Intervention||8
3107128|NCT01540773|3831122|FG000|COMPLETED|Second Intervention||8
3107129|NCT01540773|3831123|FG001|COMPLETED|Second Intervention||8
3107130|NCT01540773|3831122|FG000|NOT COMPLETED|Second Intervention||0
3107131|NCT01540773|3831123|FG001|NOT COMPLETED|Second Intervention||0
3107132|NCT01540825|3831142|FG000|STARTED|Overall Study||20
3107133|NCT01540825|3831143|FG001|STARTED|Overall Study||6
3107134|NCT01540825|3831144|FG002|STARTED|Overall Study||6
3107135|NCT01540825|3831145|FG003|STARTED|Overall Study||6
3107136|NCT01540825|3831146|FG004|STARTED|Overall Study||6
3107137|NCT01540825|3831147|FG005|STARTED|Overall Study||6
3107138|NCT01540825|3831148|FG006|STARTED|Overall Study||6
3107139|NCT01540825|3831149|FG007|STARTED|Overall Study||6
3107140|NCT01540825|3831150|FG008|STARTED|Overall Study||6
3107141|NCT01540825|3831151|FG009|STARTED|Overall Study||6
3107142|NCT01540825|3831152|FG010|STARTED|Overall Study||6
3107143|NCT01540825|3831142|FG000|COMPLETED|Overall Study||20
3107144|NCT01540825|3831143|FG001|COMPLETED|Overall Study||6
3107145|NCT01540825|3831144|FG002|COMPLETED|Overall Study||6
3107146|NCT01540825|3831145|FG003|COMPLETED|Overall Study||6
3107147|NCT01540825|3831146|FG004|COMPLETED|Overall Study||6
3107148|NCT01540825|3831147|FG005|COMPLETED|Overall Study||6
3107149|NCT01540825|3831148|FG006|COMPLETED|Overall Study||6
3107150|NCT01540825|3831149|FG007|COMPLETED|Overall Study||6
3107151|NCT01540825|3831150|FG008|COMPLETED|Overall Study||6
3107152|NCT01540825|3831151|FG009|COMPLETED|Overall Study||6
3107153|NCT01540825|3831152|FG010|COMPLETED|Overall Study||6
3107154|NCT01540825|3831142|FG000|NOT COMPLETED|Overall Study||0
3107155|NCT01540825|3831143|FG001|NOT COMPLETED|Overall Study||0
3107156|NCT01540825|3831144|FG002|NOT COMPLETED|Overall Study||0
3107157|NCT01540825|3831145|FG003|NOT COMPLETED|Overall Study||0
3107158|NCT01540825|3831146|FG004|NOT COMPLETED|Overall Study||0
3107159|NCT01540825|3831147|FG005|NOT COMPLETED|Overall Study||0
3107160|NCT01540825|3831148|FG006|NOT COMPLETED|Overall Study||0
3107161|NCT01540825|3831149|FG007|NOT COMPLETED|Overall Study||0
3107162|NCT01540825|3831150|FG008|NOT COMPLETED|Overall Study||0
3107163|NCT01540825|3831151|FG009|NOT COMPLETED|Overall Study||0
3107164|NCT01540825|3831152|FG010|NOT COMPLETED|Overall Study||0
3107165|NCT01540838|3831188|FG000|STARTED|Overall Study||188
3107166|NCT01540838|3831189|FG001|STARTED|Overall Study||187
3107167|NCT01540838|3831188|FG000|COMPLETED|Overall Study||166
3107168|NCT01540838|3831189|FG001|COMPLETED|Overall Study||164
3107169|NCT01540838|3831188|FG000|NOT COMPLETED|Overall Study||22
3107170|NCT01540838|3831189|FG001|NOT COMPLETED|Overall Study||23
3107171|NCT01540851|3831197|FG000|STARTED|Overall Study||154
3107172|NCT01540851|3831198|FG001|STARTED|Overall Study||154
3107173|NCT01540851|3831197|FG000|COMPLETED|Overall Study||133
3107174|NCT01540851|3831198|FG001|COMPLETED|Overall Study||136
3107175|NCT01540851|3831197|FG000|NOT COMPLETED|Overall Study||21
3107176|NCT01540851|3831198|FG001|NOT COMPLETED|Overall Study||18
3107177|NCT01540981|3831208|FG000|STARTED|Overall Study||6
3107178|NCT01540981|3831209|FG001|STARTED|Overall Study||6
3107179|NCT01540981|3831208|FG000|COMPLETED|Overall Study||5
3107180|NCT01540981|3831209|FG001|COMPLETED|Overall Study||6
3107181|NCT01540981|3831208|FG000|NOT COMPLETED|Overall Study||1
3107182|NCT01540981|3831209|FG001|NOT COMPLETED|Overall Study||0
3107183|NCT01541215|3831217|FG000|STARTED|Treatment Period (52 Weeks)||66
3107184|NCT01541215|3831218|FG001|STARTED|Treatment Period (52 Weeks)||69
3107185|NCT01541215|3831217|FG000|Exposed|Treatment Period (52 Weeks)||66
3107186|NCT01541215|3831218|FG001|Exposed|Treatment Period (52 Weeks)||68
3107187|NCT01541215|3831217|FG000|COMPLETED|Treatment Period (52 Weeks)||56
3107188|NCT01541215|3831218|FG001|COMPLETED|Treatment Period (52 Weeks)||53
3107189|NCT01541215|3831217|FG000|NOT COMPLETED|Treatment Period (52 Weeks)||10
3107190|NCT01541215|3831218|FG001|NOT COMPLETED|Treatment Period (52 Weeks)||16
3107191|NCT01541215|3831217|FG000|STARTED|Follow up 1 (Weeks 53-104)|Subjects who attended safety follow up visit at week 104 were included.|52
3107192|NCT01541215|3831218|FG001|STARTED|Follow up 1 (Weeks 53-104)|Follow up was not planned for the subjects who received placebo.|0
3107193|NCT01541215|3831217|FG000|COMPLETED|Follow up 1 (Weeks 53-104)||50
3107194|NCT01541215|3831218|FG001|COMPLETED|Follow up 1 (Weeks 53-104)||0
3107195|NCT01541215|3831217|FG000|NOT COMPLETED|Follow up 1 (Weeks 53-104)||2
3107196|NCT01541215|3831218|FG001|NOT COMPLETED|Follow up 1 (Weeks 53-104)||0
3107197|NCT01541215|3831217|FG000|STARTED|Follow up 2 (Weeks 105-156)|Subjects who attended safety follow up visit at week 156 were included.|48
3107198|NCT01541215|3831218|FG001|STARTED|Follow up 2 (Weeks 105-156)||0
3107199|NCT01541215|3831217|FG000|COMPLETED|Follow up 2 (Weeks 105-156)||48
3107200|NCT01541215|3831218|FG001|COMPLETED|Follow up 2 (Weeks 105-156)||0
3107201|NCT01541215|3831217|FG000|NOT COMPLETED|Follow up 2 (Weeks 105-156)||0
3107202|NCT01541215|3831218|FG001|NOT COMPLETED|Follow up 2 (Weeks 105-156)||0
3107203|NCT01541254|3831228|FG000|STARTED|Overall Study||36
3107204|NCT01541254|3831228|FG000|COMPLETED|Overall Study||30
3107205|NCT01541254|3831228|FG000|NOT COMPLETED|Overall Study||6
3107206|NCT01541358|3831232|FG000|STARTED|Overall Study||2
3107207|NCT01541358|3831232|FG000|COMPLETED|Overall Study||2
3107208|NCT01541358|3831232|FG000|NOT COMPLETED|Overall Study||0
3107209|NCT01541371|3831237|FG000|STARTED|Overall Study||403
3107210|NCT01541371|3831237|FG000|Full Analysis Set|Overall Study||394
3107211|NCT01541371|3831237|FG000|COMPLETED|Overall Study||326
3107212|NCT01541371|3831237|FG000|NOT COMPLETED|Overall Study||77
3107213|NCT01541384|3831248|FG000|STARTED|Overall Study||40
3107214|NCT01541384|3831249|FG001|STARTED|Overall Study||40
3107215|NCT01541384|3831250|FG002|STARTED|Overall Study||40
3107216|NCT01541384|3831248|FG000|COMPLETED|Overall Study||40
3107217|NCT01541384|3831249|FG001|COMPLETED|Overall Study||39
3107218|NCT01541384|3831250|FG002|COMPLETED|Overall Study||38
3107219|NCT01541384|3831248|FG000|NOT COMPLETED|Overall Study||0
3107220|NCT01541384|3831249|FG001|NOT COMPLETED|Overall Study||1
3107221|NCT01541384|3831250|FG002|NOT COMPLETED|Overall Study||2
3107222|NCT01541553|3831260|FG000|STARTED|Overall Study||167
3107223|NCT01541553|3831261|FG001|STARTED|Overall Study||162
3107224|NCT01541553|3831260|FG000|COMPLETED|Overall Study||155
3107225|NCT01541553|3831261|FG001|COMPLETED|Overall Study||148
3107226|NCT01541553|3831260|FG000|NOT COMPLETED|Overall Study||12
3107227|NCT01541553|3831261|FG001|NOT COMPLETED|Overall Study||14
3107228|NCT01541644|3831267|FG000|STARTED|Overall Study||27
3107229|NCT01541644|3831267|FG000|COMPLETED|Overall Study||24
3107230|NCT01541644|3831267|FG000|NOT COMPLETED|Overall Study||3
3107231|NCT01541735|3831273|FG000|STARTED|Overall Study||7
3107232|NCT01541735|3831274|FG001|STARTED|Overall Study||7
3107233|NCT01541735|3831273|FG000|COMPLETED|Overall Study||7
3107234|NCT01541735|3831274|FG001|COMPLETED|Overall Study||7
3107235|NCT01541735|3831273|FG000|NOT COMPLETED|Overall Study||0
3107236|NCT01541735|3831274|FG001|NOT COMPLETED|Overall Study||0
3107237|NCT01541748|3831280|FG000|STARTED|Overall Study|74 subjects were consented; however, 5 were screen failures and 1 did not receive the study device.|74
3107238|NCT01541748|3831280|FG000|COMPLETED|Overall Study||43
3107239|NCT01541748|3831280|FG000|NOT COMPLETED|Overall Study||31
3107240|NCT01541826|3831296|FG000|STARTED|Overall Study||28
3107241|NCT01541826|3831297|FG001|STARTED|Overall Study||28
3107242|NCT01541826|3831298|FG002|STARTED|Overall Study||6
3107243|NCT01541826|3831296|FG000|COMPLETED|Overall Study||24
3107244|NCT01541826|3831297|FG001|COMPLETED|Overall Study||25
3107245|NCT01541826|3831298|FG002|COMPLETED|Overall Study||6
3107246|NCT01541826|3831296|FG000|NOT COMPLETED|Overall Study||4
3107247|NCT01541826|3831297|FG001|NOT COMPLETED|Overall Study||3
3107248|NCT01541826|3831298|FG002|NOT COMPLETED|Overall Study||0
3107249|NCT01541865|3831306|FG000|STARTED|Overall Study||146
3107250|NCT01541865|3831306|FG000|COMPLETED|Overall Study||124
3107251|NCT01541865|3831306|FG000|NOT COMPLETED|Overall Study||22
3107252|NCT01541891|3831312|FG000|STARTED|Overall Study||15
3107253|NCT01541891|3831313|FG001|STARTED|Overall Study||15
3107254|NCT01541891|3831312|FG000|COMPLETED|Overall Study||14
3107255|NCT01541891|3831313|FG001|COMPLETED|Overall Study||14
3107256|NCT01541891|3831312|FG000|NOT COMPLETED|Overall Study||1
3107257|NCT01541891|3831313|FG001|NOT COMPLETED|Overall Study||1
3107258|NCT01541917|3831324|FG000|STARTED|Overall Study||144
3107259|NCT01541917|3831325|FG001|STARTED|Overall Study||145
3107260|NCT01541917|3831324|FG000|COMPLETED|Overall Study||129
3107261|NCT01541917|3831325|FG001|COMPLETED|Overall Study||136
3107262|NCT01541917|3831324|FG000|NOT COMPLETED|Overall Study||15
3107263|NCT01541917|3831325|FG001|NOT COMPLETED|Overall Study||9
3107264|NCT01541930|3831334|FG000|STARTED|Overall Study||21
3107265|NCT01541930|3831334|FG000|COMPLETED|Overall Study||20
3107266|NCT01541930|3831334|FG000|NOT COMPLETED|Overall Study||1
3107267|NCT01541969|3831351|FG000|STARTED|Double-blind (0-12 Weeks)||50
3107268|NCT01541969|3831352|FG001|STARTED|Double-blind (0-12 Weeks)||50
3107269|NCT01541969|3831351|FG000|COMPLETED|Double-blind (0-12 Weeks)||44
3107270|NCT01541969|3831352|FG001|COMPLETED|Double-blind (0-12 Weeks)||48
3107271|NCT01541969|3831351|FG000|NOT COMPLETED|Double-blind (0-12 Weeks)||6
3107272|NCT01541969|3831352|FG001|NOT COMPLETED|Double-blind (0-12 Weeks)||2
3107273|NCT01541969|3831351|FG000|STARTED|Open Label Extension (12-36 Weeks)||44
3107274|NCT01541969|3831352|FG001|STARTED|Open Label Extension (12-36 Weeks)||48
3107275|NCT01541969|3831351|FG000|COMPLETED|Open Label Extension (12-36 Weeks)||33
3107276|NCT01541969|3831352|FG001|COMPLETED|Open Label Extension (12-36 Weeks)||35
3107277|NCT01541969|3831351|FG000|NOT COMPLETED|Open Label Extension (12-36 Weeks)||11
3107278|NCT01541969|3831352|FG001|NOT COMPLETED|Open Label Extension (12-36 Weeks)||13
3107279|NCT01542034|3831363|FG000|STARTED|Overall Study||256
3107280|NCT01542034|3831364|FG001|STARTED|Overall Study||250
3107281|NCT01542034|3831363|FG000|Received Treatment|Overall Study||256
3107282|NCT01542034|3831364|FG001|Received Treatment|Overall Study||249
3107283|NCT01542034|3831363|FG000|COMPLETED|Overall Study|Participants who completed long-term follow-up 24 weeks after the last treatment|226
3107284|NCT01542034|3831364|FG001|COMPLETED|Overall Study|Participants who completed long-term follow-up 24 weeks after the last treatment|227
3107285|NCT01542034|3831363|FG000|NOT COMPLETED|Overall Study||30
3107286|NCT01542034|3831364|FG001|NOT COMPLETED|Overall Study||23
3107287|NCT01542125|3831372|FG000|STARTED|Overall Study||140
3107288|NCT01542125|3831373|FG001|STARTED|Overall Study||141
3107289|NCT01542125|3831372|FG000|COMPLETED|Overall Study||140
3107290|NCT01542125|3831373|FG001|COMPLETED|Overall Study||141
3107291|NCT01542125|3831372|FG000|NOT COMPLETED|Overall Study||0
3107292|NCT01542125|3831373|FG001|NOT COMPLETED|Overall Study||0
3107293|NCT01542229|3831381|FG000|STARTED|Overall Study||68
3107294|NCT01542229|3831382|FG001|STARTED|Overall Study||66
3107295|NCT01542229|3831381|FG000|COMPLETED|Overall Study||45
3107296|NCT01542229|3831382|FG001|COMPLETED|Overall Study||30
3107297|NCT01542229|3831381|FG000|NOT COMPLETED|Overall Study||23
3107298|NCT01542229|3831382|FG001|NOT COMPLETED|Overall Study||36
3107299|NCT01542255|3831389|FG000|STARTED|Overall Study||7
3107300|NCT01542255|3831389|FG000|Analyzed for Time to Progression|Overall Study||7
3107301|NCT01542255|3831389|FG000|COMPLETED|Overall Study||7
3107302|NCT01542255|3831389|FG000|NOT COMPLETED|Overall Study||0
3135615|NCT01708278|3860686|FG002|COMPLETED|Overall Study||2
3135616|NCT01708278|3860687|FG003|COMPLETED|Overall Study||2
3135617|NCT01708278|3860688|FG004|COMPLETED|Overall Study||1
3135618|NCT01708278|3860689|FG005|COMPLETED|Overall Study||1
3135619|NCT01708278|3860684|FG000|NOT COMPLETED|Overall Study||0
3135620|NCT01708278|3860685|FG001|NOT COMPLETED|Overall Study||0
3135621|NCT01708278|3860686|FG002|NOT COMPLETED|Overall Study||0
3135622|NCT01708278|3860687|FG003|NOT COMPLETED|Overall Study||0
3135623|NCT01708278|3860688|FG004|NOT COMPLETED|Overall Study||0
3135624|NCT01708278|3860689|FG005|NOT COMPLETED|Overall Study||0
3135625|NCT01708291|3860705|FG000|STARTED|Overall Study||21
3135626|NCT01708291|3860706|FG001|STARTED|Overall Study||21
3135627|NCT01708291|3860705|FG000|COMPLETED|Overall Study||19
3135628|NCT01708291|3860706|FG001|COMPLETED|Overall Study||20
3135629|NCT01708291|3860705|FG000|NOT COMPLETED|Overall Study||2
3135630|NCT01708291|3860706|FG001|NOT COMPLETED|Overall Study||1
3135631|NCT01708317|3860712|FG000|STARTED|2010 Control Period|# of ED patients eligible for ACASI, had it been available, in control period|3929
3135632|NCT01708317|3860712|FG000|COMPLETED|2010 Control Period||3929
3135633|NCT01708317|3860712|FG000|NOT COMPLETED|2010 Control Period||0
3135634|NCT01708317|3860712|FG000|STARTED|Initial Education Period|# of ED patients eligible for ACASI, had it been available, in initial education period|982
3135635|NCT01708317|3860712|FG000|COMPLETED|Initial Education Period||982
3135636|NCT01708317|3860712|FG000|NOT COMPLETED|Initial Education Period||0
3135637|NCT01708317|3860712|FG000|STARTED|ACASI + Education Period|# of ED patients eligible for ACASI in the period the ACASI was actually available.|2601
3135638|NCT01708317|3860712|FG000|COMPLETED|ACASI + Education Period||2601
3135639|NCT01708317|3860712|FG000|NOT COMPLETED|ACASI + Education Period||0
3135640|NCT01708317|3860712|FG000|STARTED|Final Education Period|# of ED patients eligible for ACASI, had it been available, in final education period|909
3135641|NCT01708317|3860712|FG000|COMPLETED|Final Education Period||909
3135642|NCT01708317|3860712|FG000|NOT COMPLETED|Final Education Period||0
3135643|NCT01708525|3860719|FG000|STARTED|Overall Study||2
3135644|NCT01708525|3860719|FG000|COMPLETED|Overall Study||2
3135645|NCT01708525|3860719|FG000|NOT COMPLETED|Overall Study||0
3135646|NCT01708590|3860727|FG000|STARTED|Induction Phase||222
3135647|NCT01708590|3860728|FG001|STARTED|Induction Phase||219
3135648|NCT01708590|3860729|FG002|STARTED|Induction Phase||220
3135649|NCT01708590|3860730|FG003|STARTED|Induction Phase||0
3135650|NCT01708590|3860731|FG004|STARTED|Induction Phase||0
3135651|NCT01708590|3860732|FG005|STARTED|Induction Phase||0
3135652|NCT01708590|3860733|FG006|STARTED|Induction Phase||0
3135653|NCT01708590|3860727|FG000|COMPLETED|Induction Phase||212
3135654|NCT01708590|3860728|FG001|COMPLETED|Induction Phase||212
3107303|NCT01542307|3831394|FG000|STARTED|Overall Study|Each subject inhaled Oxygen for 30 minutes in blinded fashion for 2 of the 4 migraine attacks|22
3107304|NCT01542307|3831395|FG001|STARTED|Overall Study|Each subject inhaled Medical Air for 30 minutes in blinded fashion for 2 of the 4 migraine attacks|22
3107305|NCT01542307|3831394|FG000|COMPLETED|Overall Study||22
3107306|NCT01542307|3831395|FG001|COMPLETED|Overall Study||22
3107307|NCT01542307|3831394|FG000|NOT COMPLETED|Overall Study||0
3107308|NCT01542307|3831395|FG001|NOT COMPLETED|Overall Study||0
3107309|NCT01542372|3831401|FG000|STARTED|Overall Study||11
3107310|NCT01542372|3831402|FG001|STARTED|Overall Study||11
3107311|NCT01542372|3831401|FG000|COMPLETED|Overall Study||11
3107312|NCT01542372|3831402|FG001|COMPLETED|Overall Study||11
3107313|NCT01542372|3831401|FG000|NOT COMPLETED|Overall Study||0
3107314|NCT01542372|3831402|FG001|NOT COMPLETED|Overall Study||0
3107315|NCT01542398|3831409|FG000|STARTED|Overall Study||79
3107316|NCT01542398|3831410|FG001|STARTED|Overall Study||80
3107317|NCT01542398|3831409|FG000|Post-Intervention Assessment|Overall Study||78
3107318|NCT01542398|3831410|FG001|Post-Intervention Assessment|Overall Study||80
3107319|NCT01542398|3831409|FG000|COMPLETED|Overall Study||71
3107320|NCT01542398|3831410|FG001|COMPLETED|Overall Study||67
3107321|NCT01542398|3831409|FG000|NOT COMPLETED|Overall Study||8
3107322|NCT01542398|3831410|FG001|NOT COMPLETED|Overall Study||13
3107323|NCT01542502|3831418|FG000|STARTED|Overall Study||6
3107324|NCT01542502|3831419|FG001|STARTED|Overall Study||6
3107325|NCT01542502|3831418|FG000|COMPLETED|Overall Study||6
3107326|NCT01542502|3831419|FG001|COMPLETED|Overall Study||6
3107327|NCT01542502|3831418|FG000|NOT COMPLETED|Overall Study||0
3107328|NCT01542502|3831419|FG001|NOT COMPLETED|Overall Study||0
3107329|NCT01542528|3831428|FG000|STARTED|Overall Study||61
3107330|NCT01542528|3831429|FG001|STARTED|Overall Study||56
3107331|NCT01542528|3831428|FG000|COMPLETED|Overall Study||49
3107332|NCT01542528|3831429|FG001|COMPLETED|Overall Study||49
3107333|NCT01542528|3831428|FG000|NOT COMPLETED|Overall Study||12
3107334|NCT01542528|3831429|FG001|NOT COMPLETED|Overall Study||7
3107335|NCT01542541|3831437|FG000|STARTED|Overall Study||38
3107336|NCT01542541|3831438|FG001|STARTED|Overall Study||30
3107337|NCT01542541|3831437|FG000|COMPLETED|Overall Study||30
3107338|NCT01542541|3831438|FG001|COMPLETED|Overall Study||30
3107339|NCT01542541|3831437|FG000|NOT COMPLETED|Overall Study||8
3107340|NCT01542541|3831438|FG001|NOT COMPLETED|Overall Study||0
3107341|NCT01542632|3831450|FG000|STARTED|Overall Study||25
3107342|NCT01542632|3831451|FG001|STARTED|Overall Study||25
3107343|NCT01542632|3831452|FG002|STARTED|Overall Study||24
3107344|NCT01542632|3831453|FG003|STARTED|Overall Study||21
3107345|NCT01542632|3831454|FG004|STARTED|Overall Study||21
3107346|NCT01542632|3831455|FG005|STARTED|Overall Study||24
3107347|NCT01542632|3831450|FG000|COMPLETED|Overall Study||25
3107348|NCT01542632|3831451|FG001|COMPLETED|Overall Study||24
3107349|NCT01542632|3831452|FG002|COMPLETED|Overall Study||23
3107350|NCT01542632|3831453|FG003|COMPLETED|Overall Study||19
3107351|NCT01542632|3831454|FG004|COMPLETED|Overall Study||17
3107352|NCT01542632|3831455|FG005|COMPLETED|Overall Study||24
3107353|NCT01542632|3831450|FG000|NOT COMPLETED|Overall Study||0
3107354|NCT01542632|3831451|FG001|NOT COMPLETED|Overall Study||1
3107355|NCT01542632|3831452|FG002|NOT COMPLETED|Overall Study||1
3107356|NCT01542632|3831453|FG003|NOT COMPLETED|Overall Study||2
3107357|NCT01542632|3831454|FG004|NOT COMPLETED|Overall Study||4
3107358|NCT01542632|3831455|FG005|NOT COMPLETED|Overall Study||0
3107359|NCT01542645|3831476|FG000|STARTED|Overall Study||82
3107360|NCT01542645|3831477|FG001|STARTED|Overall Study||82
3107361|NCT01542645|3831476|FG000|COMPLETED|Overall Study||77
3107362|NCT01542645|3831477|FG001|COMPLETED|Overall Study||79
3107363|NCT01542645|3831476|FG000|NOT COMPLETED|Overall Study||5
3107364|NCT01542645|3831477|FG001|NOT COMPLETED|Overall Study||3
3107365|NCT01542684|3831487|FG000|STARTED|Overall Study||8
3107366|NCT01542684|3831487|FG000|COMPLETED|Overall Study||8
3107367|NCT01542684|3831487|FG000|NOT COMPLETED|Overall Study||0
3107368|NCT01542788|3831493|FG000|STARTED|Overall Study||209
3107369|NCT01542788|3831494|FG001|STARTED|Overall Study||71
3107370|NCT01542788|3831493|FG000|Randomized and Treated|Overall Study||207
3107371|NCT01542788|3831494|FG001|Randomized and Treated|Overall Study||71
3107372|NCT01542788|3831493|FG000|COMPLETED|Overall Study||154
3107373|NCT01542788|3831494|FG001|COMPLETED|Overall Study||0
3107374|NCT01542788|3831493|FG000|NOT COMPLETED|Overall Study||55
3107375|NCT01542788|3831494|FG001|NOT COMPLETED|Overall Study||71
3107376|NCT01542957|3831502|FG000|STARTED|End of Therapy||65
3107377|NCT01542957|3831503|FG001|STARTED|End of Therapy||63
3107378|NCT01542957|3831502|FG000|COMPLETED|End of Therapy||53
3107379|NCT01542957|3831503|FG001|COMPLETED|End of Therapy||53
3107380|NCT01542957|3831502|FG000|NOT COMPLETED|End of Therapy||12
3107381|NCT01542957|3831503|FG001|NOT COMPLETED|End of Therapy||10
3107382|NCT01542957|3831502|FG000|STARTED|3-month Follow-up||53
3107383|NCT01542957|3831503|FG001|STARTED|3-month Follow-up||53
3107384|NCT01542957|3831502|FG000|COMPLETED|3-month Follow-up||50
3107385|NCT01542957|3831503|FG001|COMPLETED|3-month Follow-up||45
3107386|NCT01542957|3831502|FG000|NOT COMPLETED|3-month Follow-up||3
3107387|NCT01542957|3831503|FG001|NOT COMPLETED|3-month Follow-up||8
3107388|NCT01542957|3831502|FG000|STARTED|12-month Follow-up||53
3107389|NCT01542957|3831503|FG001|STARTED|12-month Follow-up||53
3107390|NCT01542957|3831502|FG000|COMPLETED|12-month Follow-up||37
3107391|NCT01542957|3831503|FG001|COMPLETED|12-month Follow-up||40
3107392|NCT01542957|3831502|FG000|NOT COMPLETED|12-month Follow-up||16
3107393|NCT01542957|3831503|FG001|NOT COMPLETED|12-month Follow-up||13
3107394|NCT01543074|3831513|FG000|STARTED|Overall Study||5
3107395|NCT01543074|3831514|FG001|STARTED|Overall Study||7
3107396|NCT01543074|3831515|FG002|STARTED|Overall Study||5
3107397|NCT01543074|3831516|FG003|STARTED|Overall Study||6
3107398|NCT01543074|3831513|FG000|COMPLETED|Overall Study||5
3107399|NCT01543074|3831514|FG001|COMPLETED|Overall Study||7
3107400|NCT01543074|3831515|FG002|COMPLETED|Overall Study||5
3107401|NCT01543074|3831516|FG003|COMPLETED|Overall Study||6
3107402|NCT01543074|3831513|FG000|NOT COMPLETED|Overall Study||0
3107403|NCT01543074|3831514|FG001|NOT COMPLETED|Overall Study||0
3107404|NCT01543074|3831515|FG002|NOT COMPLETED|Overall Study||0
3107405|NCT01543074|3831516|FG003|NOT COMPLETED|Overall Study||0
3107406|NCT01543087|3831536|FG000|STARTED|Stage 1 (48 Months)||70
3107407|NCT01543087|3831537|FG001|STARTED|Stage 1 (48 Months)||103
3107408|NCT01543087|3831538|FG002|STARTED|Stage 1 (48 Months)||277
3107409|NCT01543087|3831539|FG003|STARTED|Stage 1 (48 Months)||116
3107410|NCT01543087|3831540|FG004|STARTED|Stage 1 (48 Months)||86
3107411|NCT01543087|3831541|FG005|STARTED|Stage 1 (48 Months)||46
3107412|NCT01543087|3831536|FG000|Safety Population|Stage 1 (48 Months)||70
3107413|NCT01543087|3831537|FG001|Safety Population|Stage 1 (48 Months)||101
3107414|NCT01543087|3831538|FG002|Safety Population|Stage 1 (48 Months)||277
3107415|NCT01543087|3831539|FG003|Safety Population|Stage 1 (48 Months)||116
3107416|NCT01543087|3831540|FG004|Safety Population|Stage 1 (48 Months)||86
3107417|NCT01543087|3831541|FG005|Safety Population|Stage 1 (48 Months)||46
3107418|NCT01543087|3831536|FG000|COMPLETED|Stage 1 (48 Months)||56
3107419|NCT01543087|3831537|FG001|COMPLETED|Stage 1 (48 Months)||93
3107420|NCT01543087|3831538|FG002|COMPLETED|Stage 1 (48 Months)||237
3107421|NCT01543087|3831539|FG003|COMPLETED|Stage 1 (48 Months)||108
3107422|NCT01543087|3831540|FG004|COMPLETED|Stage 1 (48 Months)||83
3107423|NCT01543087|3831541|FG005|COMPLETED|Stage 1 (48 Months)||46
3107424|NCT01543087|3831536|FG000|NOT COMPLETED|Stage 1 (48 Months)||14
3107425|NCT01543087|3831537|FG001|NOT COMPLETED|Stage 1 (48 Months)||10
3107426|NCT01543087|3831538|FG002|NOT COMPLETED|Stage 1 (48 Months)||40
3107427|NCT01543087|3831539|FG003|NOT COMPLETED|Stage 1 (48 Months)||8
3107428|NCT01543087|3831540|FG004|NOT COMPLETED|Stage 1 (48 Months)||3
3107429|NCT01543087|3831541|FG005|NOT COMPLETED|Stage 1 (48 Months)||0
3107430|NCT01543087|3831536|FG000|STARTED|Booster Stage (26 Months)|Group1 participants (primary study B1971015)were not invited to participate in Booster stage (BS).|0
3107431|NCT01543087|3831537|FG001|STARTED|Booster Stage (26 Months)|BS was optional for eligible participants. Not all participants completing stage 1 continued to BS.|60
3107432|NCT01543087|3831538|FG002|STARTED|Booster Stage (26 Months)|BS was optional for eligible participants. Not all participants completing stage 1 continued to BS.|92
3107433|NCT01543087|3831539|FG003|STARTED|Booster Stage (26 Months)|BS was optional for eligible participants. Not all participants completing stage 1 continued to BS.|64
3107434|NCT01543087|3831540|FG004|STARTED|Booster Stage (26 Months)|BS was optional for eligible participants. Not all participants completing stage 1 continued to BS.|56
3107435|NCT01543087|3831541|FG005|STARTED|Booster Stage (26 Months)|BS was optional for eligible participants. Not all participants completing stage 1 continued to BS.|32
3107436|NCT01543087|3831536|FG000|Vaccinated|Booster Stage (26 Months)||0
3107437|NCT01543087|3831537|FG001|Vaccinated|Booster Stage (26 Months)||59
3107438|NCT01543087|3831538|FG002|Vaccinated|Booster Stage (26 Months)||92
3107439|NCT01543087|3831539|FG003|Vaccinated|Booster Stage (26 Months)||64
3107440|NCT01543087|3831540|FG004|Vaccinated|Booster Stage (26 Months)||54
3107441|NCT01543087|3831541|FG005|Vaccinated|Booster Stage (26 Months)||32
3107442|NCT01543087|3831536|FG000|COMPLETED|Booster Stage (26 Months)||0
3107443|NCT01543087|3831537|FG001|COMPLETED|Booster Stage (26 Months)||59
3107444|NCT01543087|3831538|FG002|COMPLETED|Booster Stage (26 Months)||91
3107445|NCT01543087|3831539|FG003|COMPLETED|Booster Stage (26 Months)||64
3107446|NCT01543087|3831540|FG004|COMPLETED|Booster Stage (26 Months)||54
3107447|NCT01543087|3831541|FG005|COMPLETED|Booster Stage (26 Months)||32
3107448|NCT01543087|3831536|FG000|NOT COMPLETED|Booster Stage (26 Months)||0
3107449|NCT01543087|3831537|FG001|NOT COMPLETED|Booster Stage (26 Months)||1
3107450|NCT01543087|3831538|FG002|NOT COMPLETED|Booster Stage (26 Months)||1
3107451|NCT01543087|3831539|FG003|NOT COMPLETED|Booster Stage (26 Months)||0
3107452|NCT01543087|3831540|FG004|NOT COMPLETED|Booster Stage (26 Months)||2
3107453|NCT01543087|3831541|FG005|NOT COMPLETED|Booster Stage (26 Months)||0
3107454|NCT01543152|3831582|FG000|STARTED|Overall Study||3
3107455|NCT01543152|3831583|FG001|STARTED|Overall Study||6
3107456|NCT01543152|3831584|FG002|STARTED|Overall Study||11
3107457|NCT01543152|3831585|FG003|STARTED|Overall Study||3
3107458|NCT01543152|3831586|FG004|STARTED|Overall Study||3
3107459|NCT01543152|3831582|FG000|COMPLETED|Overall Study||3
3107460|NCT01543152|3831583|FG001|COMPLETED|Overall Study||4
3107461|NCT01543152|3831584|FG002|COMPLETED|Overall Study||11
3107462|NCT01543152|3831585|FG003|COMPLETED|Overall Study||3
3107463|NCT01543152|3831586|FG004|COMPLETED|Overall Study||3
3107464|NCT01543152|3831582|FG000|NOT COMPLETED|Overall Study||0
3107465|NCT01543152|3831583|FG001|NOT COMPLETED|Overall Study||2
3107466|NCT01543152|3831584|FG002|NOT COMPLETED|Overall Study||0
3107467|NCT01543152|3831585|FG003|NOT COMPLETED|Overall Study||0
3107468|NCT01543152|3831586|FG004|NOT COMPLETED|Overall Study||0
3107469|NCT01543178|3831601|FG000|STARTED|Open-label Period|2583 subjects entered the open-label period, but 4 received no rifaximin; 2579 received rifaximin.|2583
3107470|NCT01543178|3831602|FG001|STARTED|Open-label Period|The double-blind rifaximin arm/group is not applicable to the open-label period.|0
3107471|NCT01543178|3831603|FG002|STARTED|Open-label Period|The double-blind placebo arm/group is not applicable to the open-label period.|0
3107472|NCT01543178|3831601|FG000|COMPLETED|Open-label Period||636
3107473|NCT01543178|3831602|FG001|COMPLETED|Open-label Period||0
3107474|NCT01543178|3831603|FG002|COMPLETED|Open-label Period||0
3107475|NCT01543178|3831601|FG000|NOT COMPLETED|Open-label Period||1947
3107476|NCT01543178|3831602|FG001|NOT COMPLETED|Open-label Period||0
3107477|NCT01543178|3831603|FG002|NOT COMPLETED|Open-label Period||0
3107478|NCT01543178|3831601|FG000|STARTED|Double-blind Period|The open-label rifaximin arm/group is not applicable to the double-blind period.|0
3107479|NCT01543178|3831602|FG001|STARTED|Double-blind Period|636 subjects had recurrence in open-label period; 328 randomized to rifaximin.|328
3107480|NCT01543178|3831603|FG002|STARTED|Double-blind Period|636 subjects had recurrence in open-label period; 308 randomized to placebo.|308
3107481|NCT01543178|3831601|FG000|COMPLETED|Double-blind Period||0
3107482|NCT01543178|3831602|FG001|COMPLETED|Double-blind Period|295 completed 1st double-blind retreatment and 284 completed 2nd double-blind retreatment.|284
3107483|NCT01543178|3831603|FG002|COMPLETED|Double-blind Period|283 completed 1st double-blind retreatment and 271 completed 2nd double-blind retreatment.|271
3107484|NCT01543178|3831601|FG000|NOT COMPLETED|Double-blind Period||0
3107485|NCT01543178|3831602|FG001|NOT COMPLETED|Double-blind Period||44
3107486|NCT01543178|3831603|FG002|NOT COMPLETED|Double-blind Period||37
3107487|NCT01543204|3831610|FG000|STARTED|Overall Study||64
3107488|NCT01543204|3831610|FG000|COMPLETED|Overall Study||56
3107489|NCT01543204|3831610|FG000|NOT COMPLETED|Overall Study||8
3107490|NCT01543490|3831620|FG000|STARTED|Overall Study||368
3107491|NCT01543490|3831621|FG001|STARTED|Overall Study||190
3107492|NCT01543490|3831620|FG000|COMPLETED|Overall Study||352
3107493|NCT01543490|3831621|FG001|COMPLETED|Overall Study||185
3107494|NCT01543490|3831620|FG000|NOT COMPLETED|Overall Study||16
3107495|NCT01543490|3831621|FG001|NOT COMPLETED|Overall Study||5
3107496|NCT01543503|3831629|FG000|STARTED|Overall Study||426
3107497|NCT01543503|3831630|FG001|STARTED|Overall Study||798
3107498|NCT01543503|3831629|FG000|COMPLETED|Overall Study||350
3107499|NCT01543503|3831630|FG001|COMPLETED|Overall Study||711
3107500|NCT01543503|3831629|FG000|NOT COMPLETED|Overall Study||76
3107501|NCT01543503|3831630|FG001|NOT COMPLETED|Overall Study||87
3107502|NCT01543568|3831636|FG000|STARTED|Overall Study||46
3107503|NCT01543568|3831636|FG000|COMPLETED|Overall Study||45
3107504|NCT01543568|3831636|FG000|NOT COMPLETED|Overall Study||1
3107505|NCT01543581|3831640|FG000|STARTED|Overall Study||1
3107506|NCT01543581|3831641|FG001|STARTED|Overall Study||0
3107507|NCT01543581|3831640|FG000|COMPLETED|Overall Study||1
3107508|NCT01543581|3831641|FG001|COMPLETED|Overall Study||0
3107509|NCT01543581|3831640|FG000|NOT COMPLETED|Overall Study||0
3107510|NCT01543581|3831641|FG001|NOT COMPLETED|Overall Study||0
3107511|NCT01543607|3831647|FG000|STARTED|Overall Study||1
3107512|NCT01543607|3831647|FG000|COMPLETED|Overall Study||1
3107513|NCT01543607|3831647|FG000|NOT COMPLETED|Overall Study||0
3107514|NCT01543685|3831656|FG000|STARTED|Overall Study||93
3107515|NCT01543685|3831657|FG001|STARTED|Overall Study||91
3107516|NCT01543685|3831658|FG002|STARTED|Overall Study||91
3107517|NCT01543685|3831659|FG003|STARTED|Overall Study||93
3107518|NCT01543685|3831660|FG004|STARTED|Overall Study||94
3107519|NCT01543685|3831656|FG000|COMPLETED|Overall Study||90
3107520|NCT01543685|3831657|FG001|COMPLETED|Overall Study||88
3107521|NCT01543685|3831658|FG002|COMPLETED|Overall Study||89
3107522|NCT01543685|3831659|FG003|COMPLETED|Overall Study||93
3107523|NCT01543685|3831660|FG004|COMPLETED|Overall Study||90
3107524|NCT01543685|3831656|FG000|NOT COMPLETED|Overall Study||3
3107525|NCT01543685|3831657|FG001|NOT COMPLETED|Overall Study||3
3107526|NCT01543685|3831658|FG002|NOT COMPLETED|Overall Study||2
3107527|NCT01543685|3831659|FG003|NOT COMPLETED|Overall Study||0
3107528|NCT01543685|3831660|FG004|NOT COMPLETED|Overall Study||4
3107529|NCT01543776|3831674|FG000|STARTED|Overall Study||36
3107530|NCT01543776|3831675|FG001|STARTED|Overall Study||36
3107531|NCT01543776|3831674|FG000|COMPLETED|Overall Study||34
3107532|NCT01543776|3831675|FG001|COMPLETED|Overall Study||34
3107533|NCT01543776|3831674|FG000|NOT COMPLETED|Overall Study||2
3107534|NCT01543776|3831675|FG001|NOT COMPLETED|Overall Study||2
3107535|NCT01543828|3831683|FG000|STARTED|Treatment 1||20
3107536|NCT01543828|3831684|FG001|STARTED|Treatment 1||20
3107537|NCT01543828|3831683|FG000|COMPLETED|Treatment 1||20
3107538|NCT01543828|3831684|FG001|COMPLETED|Treatment 1||20
3107539|NCT01543828|3831683|FG000|NOT COMPLETED|Treatment 1||0
3107540|NCT01543828|3831684|FG001|NOT COMPLETED|Treatment 1||0
3107541|NCT01543828|3831683|FG000|STARTED|Treatment 2||20
3107542|NCT01543828|3831684|FG001|STARTED|Treatment 2|1 participant completed treatment 1, had an adverse event, and did not receive treatment 2.|19
3107543|NCT01543828|3831683|FG000|COMPLETED|Treatment 2||19
3107544|NCT01543828|3831684|FG001|COMPLETED|Treatment 2||19
3107545|NCT01543828|3831683|FG000|NOT COMPLETED|Treatment 2||1
3107546|NCT01543828|3831684|FG001|NOT COMPLETED|Treatment 2||0
3107547|NCT01543958|3831692|FG000|STARTED|Overall Study||40
3107548|NCT01543958|3831692|FG000|COMPLETED|Overall Study||36
3107549|NCT01543958|3831692|FG000|NOT COMPLETED|Overall Study||4
3107550|NCT01544023|3831696|FG000|STARTED|Overall Study|retrospective|207
3107551|NCT01544023|3831696|FG000|COMPLETED|Overall Study||207
3107552|NCT01544023|3831696|FG000|NOT COMPLETED|Overall Study||0
3107553|NCT01544062|3831702|FG000|STARTED|Overall Study||33
3107554|NCT01544062|3831703|FG001|STARTED|Overall Study||35
3107555|NCT01544062|3831702|FG000|COMPLETED|Overall Study||33
3107556|NCT01544062|3831703|FG001|COMPLETED|Overall Study||35
3107557|NCT01544062|3831702|FG000|NOT COMPLETED|Overall Study||0
3107558|NCT01544062|3831703|FG001|NOT COMPLETED|Overall Study||0
3107559|NCT01544088|3831712|FG000|STARTED|Overall Study||98
3107560|NCT01544088|3831713|FG001|STARTED|Overall Study||100
3107561|NCT01544088|3831712|FG000|COMPLETED|Overall Study||61
3107562|NCT01544088|3831713|FG001|COMPLETED|Overall Study||79
3107563|NCT01544088|3831712|FG000|NOT COMPLETED|Overall Study||37
3107564|NCT01544088|3831713|FG001|NOT COMPLETED|Overall Study||21
3107565|NCT01544114|3831722|FG000|STARTED|Overall Study||4
3107566|NCT01544114|3831723|FG001|STARTED|Overall Study||20
3107567|NCT01544114|3831724|FG002|STARTED|Overall Study||22
3107568|NCT01544114|3831722|FG000|COMPLETED|Overall Study|completed study and received 6 months of study drug|3
3107569|NCT01544114|3831723|FG001|COMPLETED|Overall Study|completed study and received 6 months of study drug|16
3107570|NCT01544114|3831724|FG002|COMPLETED|Overall Study|completed study and received 6 months of study drug|17
3107571|NCT01544114|3831722|FG000|NOT COMPLETED|Overall Study||1
3107572|NCT01544114|3831723|FG001|NOT COMPLETED|Overall Study||4
3107573|NCT01544114|3831724|FG002|NOT COMPLETED|Overall Study||5
3107574|NCT01544153|3831738|FG000|STARTED|Overall Study||1337
3107575|NCT01544153|3831739|FG001|STARTED|Overall Study||1324
3107576|NCT01544153|3831740|FG002|STARTED|Overall Study||1314
3107577|NCT01544153|3831741|FG003|STARTED|Overall Study||1317
3107578|NCT01544153|3831738|FG000|COMPLETED|Overall Study||1337
3107579|NCT01544153|3831739|FG001|COMPLETED|Overall Study||1323
3107580|NCT01544153|3831740|FG002|COMPLETED|Overall Study||1313
3107581|NCT01544153|3831741|FG003|COMPLETED|Overall Study||1317
3107582|NCT01544153|3831738|FG000|NOT COMPLETED|Overall Study||0
3107583|NCT01544153|3831739|FG001|NOT COMPLETED|Overall Study||1
3107584|NCT01544153|3831740|FG002|NOT COMPLETED|Overall Study||1
3107585|NCT01544153|3831741|FG003|NOT COMPLETED|Overall Study||0
3107586|NCT01544166|3831751|FG000|STARTED|Overall Study||44
3107587|NCT01544166|3831751|FG000|COMPLETED|Overall Study||44
3107588|NCT01544166|3831751|FG000|NOT COMPLETED|Overall Study||0
3107589|NCT01544179|3831760|FG000|STARTED|Overall Study||133
3107590|NCT01544179|3831761|FG001|STARTED|Overall Study||132
3107591|NCT01544179|3831760|FG000|Received Treatment|Overall Study||132
3107592|NCT01544179|3831761|FG001|Received Treatment|Overall Study||132
3107593|NCT01544179|3831760|FG000|Did Not Receive Treatment|Overall Study||1
3107594|NCT01544179|3831761|FG001|Did Not Receive Treatment|Overall Study||0
3107595|NCT01544179|3831760|FG000|COMPLETED|Overall Study|Patients are ongoing in the study|70
3107596|NCT01544179|3831761|FG001|COMPLETED|Overall Study|Patients are ongoing in the study|86
3107597|NCT01544179|3831760|FG000|NOT COMPLETED|Overall Study||63
3107598|NCT01544179|3831761|FG001|NOT COMPLETED|Overall Study||46
3107599|NCT01544309|3831769|FG000|STARTED|Overall Study||524
3107600|NCT01544309|3831770|FG001|STARTED|Overall Study||525
3107601|NCT01544309|3831769|FG000|COMPLETED|Overall Study||504
3107602|NCT01544309|3831770|FG001|COMPLETED|Overall Study||514
3107603|NCT01544309|3831769|FG000|NOT COMPLETED|Overall Study||20
3107604|NCT01544309|3831770|FG001|NOT COMPLETED|Overall Study||11
3107605|NCT01544335|3831778|FG000|STARTED|Overall Study||191
3107606|NCT01544335|3831778|FG000|COMPLETED|Overall Study||138
3107607|NCT01544335|3831778|FG000|NOT COMPLETED|Overall Study||53
3107608|NCT01544348|3831790|FG000|STARTED|Overall Study||17
3107609|NCT01544348|3831791|FG001|STARTED|Overall Study||6
3292045|NCT02853435|4025992|FG004|NOT COMPLETED|Part 3, Period 1 (3 Days)||0
3292046|NCT02853435|4025993|FG005|NOT COMPLETED|Part 3, Period 1 (3 Days)||0
3292047|NCT02853435|4025988|FG000|STARTED|Part 3, Washout Period 1 (3 Days)||0
3107610|NCT01544348|3831792|FG002|STARTED|Overall Study||3
3107611|NCT01544348|3831793|FG003|STARTED|Overall Study||3
3107612|NCT01544348|3831794|FG004|STARTED|Overall Study||16
3107613|NCT01544348|3831795|FG005|STARTED|Overall Study||19
3107614|NCT01544348|3831796|FG006|STARTED|Overall Study||14
3107615|NCT01544348|3831797|FG007|STARTED|Overall Study||8
3107616|NCT01544348|3831790|FG000|Treated|Overall Study||17
3107617|NCT01544348|3831791|FG001|Treated|Overall Study||6
3107618|NCT01544348|3831792|FG002|Treated|Overall Study||3
3107619|NCT01544348|3831793|FG003|Treated|Overall Study||3
3107620|NCT01544348|3831794|FG004|Treated|Overall Study||15
3107621|NCT01544348|3831795|FG005|Treated|Overall Study||18
3107622|NCT01544348|3831796|FG006|Treated|Overall Study||14
3107623|NCT01544348|3831797|FG007|Treated|Overall Study||8
3107624|NCT01544348|3831790|FG000|COMPLETED|Overall Study||15
3107625|NCT01544348|3831791|FG001|COMPLETED|Overall Study||6
3107626|NCT01544348|3831792|FG002|COMPLETED|Overall Study||3
3107627|NCT01544348|3831793|FG003|COMPLETED|Overall Study||3
3107628|NCT01544348|3831794|FG004|COMPLETED|Overall Study||15
3107629|NCT01544348|3831795|FG005|COMPLETED|Overall Study||16
3107630|NCT01544348|3831796|FG006|COMPLETED|Overall Study||12
3107631|NCT01544348|3831797|FG007|COMPLETED|Overall Study||8
3107632|NCT01544348|3831790|FG000|NOT COMPLETED|Overall Study||2
3107633|NCT01544348|3831791|FG001|NOT COMPLETED|Overall Study||0
3107634|NCT01544348|3831792|FG002|NOT COMPLETED|Overall Study||0
3107635|NCT01544348|3831793|FG003|NOT COMPLETED|Overall Study||0
3107636|NCT01544348|3831794|FG004|NOT COMPLETED|Overall Study||1
3107637|NCT01544348|3831795|FG005|NOT COMPLETED|Overall Study||3
3107638|NCT01544348|3831796|FG006|NOT COMPLETED|Overall Study||2
3107639|NCT01544348|3831797|FG007|NOT COMPLETED|Overall Study||0
3107640|NCT01544361|3831827|FG000|STARTED|Overall Study||8
3107641|NCT01544361|3831828|FG001|STARTED|Overall Study||6
3107642|NCT01544361|3831829|FG002|STARTED|Overall Study||6
3107643|NCT01544361|3831830|FG003|STARTED|Overall Study||6
3107644|NCT01544361|3831831|FG004|STARTED|Overall Study||6
3107645|NCT01544361|3831827|FG000|COMPLETED|Overall Study||8
3107646|NCT01544361|3831828|FG001|COMPLETED|Overall Study||6
3107647|NCT01544361|3831829|FG002|COMPLETED|Overall Study||6
3107648|NCT01544361|3831830|FG003|COMPLETED|Overall Study||6
3107649|NCT01544361|3831831|FG004|COMPLETED|Overall Study||6
3107650|NCT01544361|3831827|FG000|NOT COMPLETED|Overall Study||0
3107651|NCT01544361|3831828|FG001|NOT COMPLETED|Overall Study||0
3107652|NCT01544361|3831829|FG002|NOT COMPLETED|Overall Study||0
3107653|NCT01544361|3831830|FG003|NOT COMPLETED|Overall Study||0
3107654|NCT01544361|3831831|FG004|NOT COMPLETED|Overall Study||0
3107655|NCT01544478|3831843|FG000|STARTED|Overall Study||1030
3107656|NCT01544478|3831843|FG000|Vaccination 1|Overall Study||1030
3107657|NCT01544478|3831843|FG000|Vaccination 2|Overall Study||1026
3107658|NCT01544478|3831843|FG000|Vaccination 3|Overall Study||1019
3107659|NCT01544478|3831843|FG000|COMPLETED|Overall Study||912
3107660|NCT01544478|3831843|FG000|NOT COMPLETED|Overall Study||118
3107661|NCT01544491|3831849|FG000|STARTED|Overall Study||52
3107662|NCT01544491|3831850|FG001|STARTED|Overall Study||54
3107663|NCT01544491|3831849|FG000|COMPLETED|Overall Study||47
3107664|NCT01544491|3831850|FG001|COMPLETED|Overall Study||51
3107665|NCT01544491|3831849|FG000|NOT COMPLETED|Overall Study||5
3107666|NCT01544491|3831850|FG001|NOT COMPLETED|Overall Study||3
3107667|NCT01544582|3831859|FG000|STARTED|Screening/Eligibility||713
3107668|NCT01544582|3831860|FG001|STARTED|Screening/Eligibility||0
3107669|NCT01544582|3831861|FG002|STARTED|Screening/Eligibility||0
3107670|NCT01544582|3831862|FG003|STARTED|Screening/Eligibility||0
3107671|NCT01544582|3831859|FG000|Analysis Population|Screening/Eligibility||679
3107672|NCT01544582|3831860|FG001|Analysis Population|Screening/Eligibility||0
3107673|NCT01544582|3831861|FG002|Analysis Population|Screening/Eligibility||0
3107674|NCT01544582|3831862|FG003|Analysis Population|Screening/Eligibility||0
3107675|NCT01544582|3831859|FG000|COMPLETED|Screening/Eligibility|Completed means met criteria for Analysis Population|679
3107676|NCT01544582|3831860|FG001|COMPLETED|Screening/Eligibility||0
3107677|NCT01544582|3831861|FG002|COMPLETED|Screening/Eligibility||0
3107678|NCT01544582|3831862|FG003|COMPLETED|Screening/Eligibility||0
3107679|NCT01544582|3831859|FG000|NOT COMPLETED|Screening/Eligibility||34
3107680|NCT01544582|3831860|FG001|NOT COMPLETED|Screening/Eligibility||0
3107681|NCT01544582|3831861|FG002|NOT COMPLETED|Screening/Eligibility||0
3107682|NCT01544582|3831862|FG003|NOT COMPLETED|Screening/Eligibility||0
3107683|NCT01544582|3831859|FG000|STARTED|Analysis Population|Analysis Population was grouped into Boceprevir+PR, Telaprevir+PR, or PR Alone|0
3107684|NCT01544582|3831860|FG001|STARTED|Analysis Population||298
3107685|NCT01544582|3831861|FG002|STARTED|Analysis Population||307
3107686|NCT01544582|3831862|FG003|STARTED|Analysis Population||74
3107687|NCT01544582|3831859|FG000|COMPLETED|Analysis Population||0
3107688|NCT01544582|3831860|FG001|COMPLETED|Analysis Population||180
3107689|NCT01544582|3831861|FG002|COMPLETED|Analysis Population||205
3107690|NCT01544582|3831862|FG003|COMPLETED|Analysis Population||35
3107691|NCT01544582|3831859|FG000|NOT COMPLETED|Analysis Population||0
3107692|NCT01544582|3831860|FG001|NOT COMPLETED|Analysis Population||118
3107693|NCT01544582|3831861|FG002|NOT COMPLETED|Analysis Population||102
3107694|NCT01544582|3831862|FG003|NOT COMPLETED|Analysis Population||39
3107695|NCT01544595|3831881|FG000|STARTED|Status at Week 68||301
3107696|NCT01544595|3831882|FG001|STARTED|Status at Week 68||363
3107697|NCT01544595|3831883|FG002|STARTED|Status at Week 68||150
3107698|NCT01544595|3831884|FG003|STARTED|Status at Week 68||181
3107699|NCT01544595|3831885|FG004|STARTED|Status at Week 68|These patients were not in the study arms at this time point.|0
3107700|NCT01544595|3831886|FG005|STARTED|Status at Week 68|These patients were not in the study arms at this time point.|0
3107701|NCT01544595|3831881|FG000|COMPLETED|Status at Week 68||262
3107702|NCT01544595|3831882|FG001|COMPLETED|Status at Week 68||346
3107703|NCT01544595|3831883|FG002|COMPLETED|Status at Week 68||87
3107704|NCT01544595|3831884|FG003|COMPLETED|Status at Week 68||130
3107705|NCT01544595|3831885|FG004|COMPLETED|Status at Week 68|These patients were not in the study arms at this time point.|0
3107706|NCT01544595|3831886|FG005|COMPLETED|Status at Week 68|These patients were not in the study arms at this time point.|0
3107707|NCT01544595|3831881|FG000|NOT COMPLETED|Status at Week 68||39
3107708|NCT01544595|3831882|FG001|NOT COMPLETED|Status at Week 68||17
3107709|NCT01544595|3831883|FG002|NOT COMPLETED|Status at Week 68||63
3107710|NCT01544595|3831884|FG003|NOT COMPLETED|Status at Week 68||51
3107711|NCT01544595|3831885|FG004|NOT COMPLETED|Status at Week 68||0
3107712|NCT01544595|3831886|FG005|NOT COMPLETED|Status at Week 68||0
3107713|NCT01544595|3831881|FG000|STARTED|Status at Week 156||301
3107714|NCT01544595|3831882|FG001|STARTED|Status at Week 156||363
3107715|NCT01544595|3831883|FG002|STARTED|Status at Week 156||150
3107716|NCT01544595|3831884|FG003|STARTED|Status at Week 156||181
3107717|NCT01544595|3831885|FG004|STARTED|Status at Week 156||98
3107718|NCT01544595|3831886|FG005|STARTED|Status at Week 156||53
3107719|NCT01544595|3831881|FG000|COMPLETED|Status at Week 156||184
3107720|NCT01544595|3831882|FG001|COMPLETED|Status at Week 156||285
3107721|NCT01544595|3831883|FG002|COMPLETED|Status at Week 156||10
3107722|NCT01544595|3831884|FG003|COMPLETED|Status at Week 156||15
3107723|NCT01544595|3831885|FG004|COMPLETED|Status at Week 156||60
3107724|NCT01544595|3831886|FG005|COMPLETED|Status at Week 156||38
3107725|NCT01544595|3831881|FG000|NOT COMPLETED|Status at Week 156||117
3107726|NCT01544595|3831882|FG001|NOT COMPLETED|Status at Week 156||78
3107727|NCT01544595|3831883|FG002|NOT COMPLETED|Status at Week 156||140
3107728|NCT01544595|3831884|FG003|NOT COMPLETED|Status at Week 156||166
3107729|NCT01544595|3831885|FG004|NOT COMPLETED|Status at Week 156||38
3107730|NCT01544595|3831886|FG005|NOT COMPLETED|Status at Week 156||15
3107731|NCT01544920|3831906|FG000|STARTED|Overall Study||368
3107732|NCT01544920|3831907|FG001|STARTED|Overall Study||369
3107733|NCT01544920|3831906|FG000|COMPLETED|Overall Study||349
3107734|NCT01544920|3831907|FG001|COMPLETED|Overall Study||346
3107735|NCT01544920|3831906|FG000|NOT COMPLETED|Overall Study||19
3107736|NCT01544920|3831907|FG001|NOT COMPLETED|Overall Study||23
3107737|NCT01544998|3831915|FG000|STARTED|First Intervention (3 Hours)||26
3107738|NCT01544998|3831916|FG001|STARTED|First Intervention (3 Hours)||15
3107739|NCT01544998|3831915|FG000|COMPLETED|First Intervention (3 Hours)||26
3107740|NCT01544998|3831916|FG001|COMPLETED|First Intervention (3 Hours)||15
3107741|NCT01544998|3831915|FG000|NOT COMPLETED|First Intervention (3 Hours)||0
3107742|NCT01544998|3831916|FG001|NOT COMPLETED|First Intervention (3 Hours)||0
3107743|NCT01544998|3831915|FG000|STARTED|Washout (1 Week)||26
3107744|NCT01544998|3831916|FG001|STARTED|Washout (1 Week)||15
3107745|NCT01544998|3831915|FG000|COMPLETED|Washout (1 Week)||26
3107746|NCT01544998|3831916|FG001|COMPLETED|Washout (1 Week)||15
3107747|NCT01544998|3831915|FG000|NOT COMPLETED|Washout (1 Week)||0
3107748|NCT01544998|3831916|FG001|NOT COMPLETED|Washout (1 Week)||0
3107749|NCT01544998|3831915|FG000|STARTED|Second Intervention (3 Hours)||26
3107750|NCT01544998|3831916|FG001|STARTED|Second Intervention (3 Hours)||15
3107751|NCT01544998|3831915|FG000|COMPLETED|Second Intervention (3 Hours)||26
3107752|NCT01544998|3831916|FG001|COMPLETED|Second Intervention (3 Hours)||15
3107753|NCT01544998|3831915|FG000|NOT COMPLETED|Second Intervention (3 Hours)||0
3107754|NCT01544998|3831916|FG001|NOT COMPLETED|Second Intervention (3 Hours)||0
3107755|NCT01545076|3831924|FG000|STARTED|IgPro10 Restabilization Period||208
3107756|NCT01545076|3831925|FG001|STARTED|IgPro10 Restabilization Period||0
3107757|NCT01545076|3831926|FG002|STARTED|IgPro10 Restabilization Period||0
3107758|NCT01545076|3831927|FG003|STARTED|IgPro10 Restabilization Period||0
3107759|NCT01545076|3831928|FG004|STARTED|IgPro10 Restabilization Period||0
3107760|NCT01545076|3831924|FG000|COMPLETED|IgPro10 Restabilization Period||172
3107761|NCT01545076|3831925|FG001|COMPLETED|IgPro10 Restabilization Period||0
3107762|NCT01545076|3831926|FG002|COMPLETED|IgPro10 Restabilization Period||0
3107763|NCT01545076|3831927|FG003|COMPLETED|IgPro10 Restabilization Period||0
3107764|NCT01545076|3831928|FG004|COMPLETED|IgPro10 Restabilization Period||0
3107765|NCT01545076|3831924|FG000|NOT COMPLETED|IgPro10 Restabilization Period||36
3107766|NCT01545076|3831925|FG001|NOT COMPLETED|IgPro10 Restabilization Period||0
3107767|NCT01545076|3831926|FG002|NOT COMPLETED|IgPro10 Restabilization Period||0
3107768|NCT01545076|3831927|FG003|NOT COMPLETED|IgPro10 Restabilization Period||0
3107769|NCT01545076|3831928|FG004|NOT COMPLETED|IgPro10 Restabilization Period||0
3107770|NCT01545076|3831924|FG000|STARTED|IgPro20 Subcutaneous Treatment Period||0
3107771|NCT01545076|3831925|FG001|STARTED|IgPro20 Subcutaneous Treatment Period||58
3107772|NCT01545076|3831926|FG002|STARTED|IgPro20 Subcutaneous Treatment Period||57
3107773|NCT01545076|3831927|FG003|STARTED|IgPro20 Subcutaneous Treatment Period||57
3107774|NCT01545076|3831928|FG004|STARTED|IgPro20 Subcutaneous Treatment Period||0
3107775|NCT01545076|3831924|FG000|COMPLETED|IgPro20 Subcutaneous Treatment Period||0
3107776|NCT01545076|3831925|FG001|COMPLETED|IgPro20 Subcutaneous Treatment Period||39
3107777|NCT01545076|3831926|FG002|COMPLETED|IgPro20 Subcutaneous Treatment Period||36
3107778|NCT01545076|3831927|FG003|COMPLETED|IgPro20 Subcutaneous Treatment Period||21
3107779|NCT01545076|3831928|FG004|COMPLETED|IgPro20 Subcutaneous Treatment Period||0
3107780|NCT01545076|3831924|FG000|NOT COMPLETED|IgPro20 Subcutaneous Treatment Period||0
3107781|NCT01545076|3831925|FG001|NOT COMPLETED|IgPro20 Subcutaneous Treatment Period||19
3107782|NCT01545076|3831926|FG002|NOT COMPLETED|IgPro20 Subcutaneous Treatment Period||21
3107783|NCT01545076|3831927|FG003|NOT COMPLETED|IgPro20 Subcutaneous Treatment Period||36
3107784|NCT01545076|3831928|FG004|NOT COMPLETED|IgPro20 Subcutaneous Treatment Period||0
3107785|NCT01545076|3831924|FG000|STARTED|IgPro10 Rescue Period||0
3107786|NCT01545076|3831925|FG001|STARTED|IgPro10 Rescue Period||0
3107787|NCT01545076|3831926|FG002|STARTED|IgPro10 Rescue Period||0
3107788|NCT01545076|3831927|FG003|STARTED|IgPro10 Rescue Period||0
3107789|NCT01545076|3831928|FG004|STARTED|IgPro10 Rescue Period||60
3107790|NCT01545076|3831924|FG000|COMPLETED|IgPro10 Rescue Period||0
3107791|NCT01545076|3831925|FG001|COMPLETED|IgPro10 Rescue Period||0
3107792|NCT01545076|3831926|FG002|COMPLETED|IgPro10 Rescue Period||0
3107793|NCT01545076|3831927|FG003|COMPLETED|IgPro10 Rescue Period||0
3107794|NCT01545076|3831928|FG004|COMPLETED|IgPro10 Rescue Period||60
3107795|NCT01545076|3831924|FG000|NOT COMPLETED|IgPro10 Rescue Period||0
3107796|NCT01545076|3831925|FG001|NOT COMPLETED|IgPro10 Rescue Period||0
3107797|NCT01545076|3831926|FG002|NOT COMPLETED|IgPro10 Rescue Period||0
3107798|NCT01545076|3831927|FG003|NOT COMPLETED|IgPro10 Rescue Period||0
3107799|NCT01545076|3831928|FG004|NOT COMPLETED|IgPro10 Rescue Period||0
3107800|NCT01545141|3831945|FG000|STARTED|Overall Study||2
3107801|NCT01545141|3831946|FG001|STARTED|Overall Study||3
3107802|NCT01545141|3831947|FG002|STARTED|Overall Study||3
3107803|NCT01545141|3831948|FG003|STARTED|Overall Study||7
3107804|NCT01545141|3831945|FG000|COMPLETED|Overall Study||2
3107805|NCT01545141|3831946|FG001|COMPLETED|Overall Study||3
3107806|NCT01545141|3831947|FG002|COMPLETED|Overall Study||3
3107807|NCT01545141|3831948|FG003|COMPLETED|Overall Study||7
3107808|NCT01545141|3831945|FG000|NOT COMPLETED|Overall Study||0
3107809|NCT01545141|3831946|FG001|NOT COMPLETED|Overall Study||0
3107810|NCT01545141|3831947|FG002|NOT COMPLETED|Overall Study||0
3107811|NCT01545141|3831948|FG003|NOT COMPLETED|Overall Study||0
3107812|NCT01545193|3831959|FG000|STARTED|Overall Study||150
3107813|NCT01545193|3831960|FG001|STARTED|Overall Study||150
3107814|NCT01545193|3831959|FG000|COMPLETED|Overall Study||150
3107815|NCT01545193|3831960|FG001|COMPLETED|Overall Study||149
3107816|NCT01545193|3831959|FG000|NOT COMPLETED|Overall Study||0
3107817|NCT01545193|3831960|FG001|NOT COMPLETED|Overall Study||1
3107818|NCT01545232|3831968|FG000|STARTED|Overall Study||338
3107819|NCT01545232|3831969|FG001|STARTED|Overall Study||342
3107820|NCT01545232|3831968|FG000|COMPLETED|Overall Study||338
3107821|NCT01545232|3831969|FG001|COMPLETED|Overall Study||342
3107822|NCT01545232|3831968|FG000|NOT COMPLETED|Overall Study||0
3107823|NCT01545232|3831969|FG001|NOT COMPLETED|Overall Study||0
3107824|NCT01545336|3831979|FG000|STARTED|Overall Study||12
3107825|NCT01545336|3831980|FG001|STARTED|Overall Study||6
3107826|NCT01545336|3831979|FG000|COMPLETED|Overall Study||12
3107827|NCT01545336|3831980|FG001|COMPLETED|Overall Study||6
3107828|NCT01545336|3831979|FG000|NOT COMPLETED|Overall Study||0
3107829|NCT01545336|3831980|FG001|NOT COMPLETED|Overall Study||0
3107830|NCT01545375|3831990|FG000|STARTED|Overall Study||900
3107831|NCT01545375|3831991|FG001|STARTED|Overall Study||903
3107832|NCT01545375|3831990|FG000|COMPLETED|Overall Study||803
3107833|NCT01545375|3831991|FG001|COMPLETED|Overall Study||813
3107834|NCT01545375|3831990|FG000|NOT COMPLETED|Overall Study||97
3107835|NCT01545375|3831991|FG001|NOT COMPLETED|Overall Study||90
3107836|NCT01545388|3832000|FG000|STARTED|Overall Study||138
3107837|NCT01545388|3832001|FG001|STARTED|Overall Study||133
3107838|NCT01545388|3832002|FG002|STARTED|Overall Study||66
3107839|NCT01545388|3832000|FG000|COMPLETED|Overall Study||130
3107840|NCT01545388|3832001|FG001|COMPLETED|Overall Study||122
3107841|NCT01545388|3832002|FG002|COMPLETED|Overall Study||58
3107842|NCT01545388|3832000|FG000|NOT COMPLETED|Overall Study||8
3107843|NCT01545388|3832001|FG001|NOT COMPLETED|Overall Study||11
3163158|NCT01883895|3890639|FG000|STARTED|Overall Study||34
3292048|NCT02853435|4025989|FG001|STARTED|Part 3, Washout Period 1 (3 Days)||0
3292049|NCT02853435|4025990|FG002|STARTED|Part 3, Washout Period 1 (3 Days)||0
3292050|NCT02853435|4025991|FG003|STARTED|Part 3, Washout Period 1 (3 Days)||0
3292051|NCT02853435|4025992|FG004|STARTED|Part 3, Washout Period 1 (3 Days)||10
3292052|NCT02853435|4025993|FG005|STARTED|Part 3, Washout Period 1 (3 Days)||2
3292053|NCT02853435|4025988|FG000|COMPLETED|Part 3, Washout Period 1 (3 Days)||0
3163159|NCT01883895|3890639|FG000|COMPLETED|Overall Study||32
3163160|NCT01883895|3890639|FG000|NOT COMPLETED|Overall Study||2
3292054|NCT02853435|4025989|FG001|COMPLETED|Part 3, Washout Period 1 (3 Days)||0
3292055|NCT02853435|4025990|FG002|COMPLETED|Part 3, Washout Period 1 (3 Days)||0
3292056|NCT02853435|4025991|FG003|COMPLETED|Part 3, Washout Period 1 (3 Days)||0
3292057|NCT02853435|4025992|FG004|COMPLETED|Part 3, Washout Period 1 (3 Days)||10
3292058|NCT02853435|4025993|FG005|COMPLETED|Part 3, Washout Period 1 (3 Days)||2
3292059|NCT02853435|4025988|FG000|NOT COMPLETED|Part 3, Washout Period 1 (3 Days)||0
3292060|NCT02853435|4025989|FG001|NOT COMPLETED|Part 3, Washout Period 1 (3 Days)||0
3292061|NCT02853435|4025990|FG002|NOT COMPLETED|Part 3, Washout Period 1 (3 Days)||0
3292062|NCT02853435|4025991|FG003|NOT COMPLETED|Part 3, Washout Period 1 (3 Days)||0
3292063|NCT02853435|4025992|FG004|NOT COMPLETED|Part 3, Washout Period 1 (3 Days)||0
3292064|NCT02853435|4025993|FG005|NOT COMPLETED|Part 3, Washout Period 1 (3 Days)||0
3292065|NCT02853435|4025988|FG000|STARTED|Part 3, Period 2 (3 Days)||0
3292066|NCT02853435|4025989|FG001|STARTED|Part 3, Period 2 (3 Days)||0
3292067|NCT02853435|4025990|FG002|STARTED|Part 3, Period 2 (3 Days)||0
3292068|NCT02853435|4025991|FG003|STARTED|Part 3, Period 2 (3 Days)||0
3292069|NCT02853435|4025992|FG004|STARTED|Part 3, Period 2 (3 Days)||10
3292070|NCT02853435|4025993|FG005|STARTED|Part 3, Period 2 (3 Days)||2
3292071|NCT02853435|4025988|FG000|COMPLETED|Part 3, Period 2 (3 Days)||0
3292072|NCT02853435|4025989|FG001|COMPLETED|Part 3, Period 2 (3 Days)||0
3292073|NCT02853435|4025990|FG002|COMPLETED|Part 3, Period 2 (3 Days)||0
3292074|NCT02853435|4025991|FG003|COMPLETED|Part 3, Period 2 (3 Days)||0
3292075|NCT02853435|4025992|FG004|COMPLETED|Part 3, Period 2 (3 Days)||10
3292076|NCT02853435|4025993|FG005|COMPLETED|Part 3, Period 2 (3 Days)||2
3292077|NCT02853435|4025988|FG000|NOT COMPLETED|Part 3, Period 2 (3 Days)||0
3292078|NCT02853435|4025989|FG001|NOT COMPLETED|Part 3, Period 2 (3 Days)||0
3292079|NCT02853435|4025990|FG002|NOT COMPLETED|Part 3, Period 2 (3 Days)||0
3292080|NCT02853435|4025991|FG003|NOT COMPLETED|Part 3, Period 2 (3 Days)||0
3292081|NCT02853435|4025992|FG004|NOT COMPLETED|Part 3, Period 2 (3 Days)||0
3292082|NCT02853435|4025993|FG005|NOT COMPLETED|Part 3, Period 2 (3 Days)||0
3292083|NCT02853435|4025988|FG000|STARTED|Part 3, Washout Period 2 (3 Days)||0
3292084|NCT02853435|4025989|FG001|STARTED|Part 3, Washout Period 2 (3 Days)||0
3292085|NCT02853435|4025990|FG002|STARTED|Part 3, Washout Period 2 (3 Days)||0
3292086|NCT02853435|4025991|FG003|STARTED|Part 3, Washout Period 2 (3 Days)||0
3292087|NCT02853435|4025992|FG004|STARTED|Part 3, Washout Period 2 (3 Days)||10
3292088|NCT02853435|4025993|FG005|STARTED|Part 3, Washout Period 2 (3 Days)||2
3292089|NCT02853435|4025988|FG000|COMPLETED|Part 3, Washout Period 2 (3 Days)||0
3107844|NCT01545388|3832002|FG002|NOT COMPLETED|Overall Study||8
3107845|NCT01545583|3832019|FG000|STARTED|Overall Study||12
3107846|NCT01545583|3832020|FG001|STARTED|Overall Study||2
3107847|NCT01545583|3832021|FG002|STARTED|Overall Study||6
3107848|NCT01545583|3832022|FG003|STARTED|Overall Study||6
3107849|NCT01545583|3832023|FG004|STARTED|Overall Study||6
3107850|NCT01545583|3832024|FG005|STARTED|Overall Study||6
3107851|NCT01545583|3832025|FG006|STARTED|Overall Study||6
3107852|NCT01545583|3832026|FG007|STARTED|Overall Study||6
3107853|NCT01545583|3832027|FG008|STARTED|Overall Study||6
3107854|NCT01545583|3832019|FG000|Received at Least 1 Dose of Study Drug|Overall Study||12
3107855|NCT01545583|3832020|FG001|Received at Least 1 Dose of Study Drug|Overall Study||2
3107856|NCT01545583|3832021|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
3107857|NCT01545583|3832022|FG003|Received at Least 1 Dose of Study Drug|Overall Study||6
3107858|NCT01545583|3832023|FG004|Received at Least 1 Dose of Study Drug|Overall Study||6
3107859|NCT01545583|3832024|FG005|Received at Least 1 Dose of Study Drug|Overall Study||6
3107860|NCT01545583|3832025|FG006|Received at Least 1 Dose of Study Drug|Overall Study||6
3107861|NCT01545583|3832026|FG007|Received at Least 1 Dose of Study Drug|Overall Study||6
3107862|NCT01545583|3832027|FG008|Received at Least 1 Dose of Study Drug|Overall Study||6
3107863|NCT01545583|3832019|FG000|COMPLETED|Overall Study||12
3107864|NCT01545583|3832020|FG001|COMPLETED|Overall Study||2
3107865|NCT01545583|3832021|FG002|COMPLETED|Overall Study||6
3107866|NCT01545583|3832022|FG003|COMPLETED|Overall Study||6
3107867|NCT01545583|3832023|FG004|COMPLETED|Overall Study||6
3107868|NCT01545583|3832024|FG005|COMPLETED|Overall Study||6
3107869|NCT01545583|3832025|FG006|COMPLETED|Overall Study||6
3107870|NCT01545583|3832026|FG007|COMPLETED|Overall Study||6
3107871|NCT01545583|3832027|FG008|COMPLETED|Overall Study||6
3107872|NCT01545583|3832019|FG000|NOT COMPLETED|Overall Study||0
3107873|NCT01545583|3832020|FG001|NOT COMPLETED|Overall Study||0
3107874|NCT01545583|3832021|FG002|NOT COMPLETED|Overall Study||0
3107875|NCT01545583|3832022|FG003|NOT COMPLETED|Overall Study||0
3107876|NCT01545583|3832023|FG004|NOT COMPLETED|Overall Study||0
3107877|NCT01545583|3832024|FG005|NOT COMPLETED|Overall Study||0
3107878|NCT01545583|3832025|FG006|NOT COMPLETED|Overall Study||0
3107879|NCT01545583|3832026|FG007|NOT COMPLETED|Overall Study||0
3107880|NCT01545583|3832027|FG008|NOT COMPLETED|Overall Study||0
3107881|NCT01545700|3832060|FG000|STARTED|Overall Study||34
3107882|NCT01545700|3832061|FG001|STARTED|Overall Study||33
3107883|NCT01545700|3832062|FG002|STARTED|Overall Study||33
3107884|NCT01545700|3832063|FG003|STARTED|Overall Study||34
3107885|NCT01545700|3832064|FG004|STARTED|Overall Study||33
3107886|NCT01545700|3832065|FG005|STARTED|Overall Study||33
3107887|NCT01545700|3832060|FG000|COMPLETED|Overall Study||33
3107888|NCT01545700|3832061|FG001|COMPLETED|Overall Study||32
3107889|NCT01545700|3832062|FG002|COMPLETED|Overall Study||31
3107890|NCT01545700|3832063|FG003|COMPLETED|Overall Study||34
3107891|NCT01545700|3832064|FG004|COMPLETED|Overall Study||32
3107892|NCT01545700|3832065|FG005|COMPLETED|Overall Study||33
3107893|NCT01545700|3832060|FG000|NOT COMPLETED|Overall Study||1
3107894|NCT01545700|3832061|FG001|NOT COMPLETED|Overall Study||1
3107895|NCT01545700|3832062|FG002|NOT COMPLETED|Overall Study||2
3107896|NCT01545700|3832063|FG003|NOT COMPLETED|Overall Study||0
3107897|NCT01545700|3832064|FG004|NOT COMPLETED|Overall Study||1
3107898|NCT01545700|3832065|FG005|NOT COMPLETED|Overall Study||0
3107899|NCT01545765|3832099|FG000|STARTED|Overall Study||31
3107900|NCT01545765|3832099|FG000|COMPLETED|Overall Study||31
3107901|NCT01545765|3832099|FG000|NOT COMPLETED|Overall Study||0
3107902|NCT01545817|3832106|FG000|STARTED|Pazopanib||74
3107903|NCT01545817|3832107|FG001|STARTED|Pazopanib||0
3107904|NCT01545817|3832106|FG000|COMPLETED|Pazopanib||0
3107905|NCT01545817|3832107|FG001|COMPLETED|Pazopanib||0
3107906|NCT01545817|3832106|FG000|NOT COMPLETED|Pazopanib||74
3107907|NCT01545817|3832107|FG001|NOT COMPLETED|Pazopanib||0
3107908|NCT01545817|3832106|FG000|STARTED|Everolimus||0
3107909|NCT01545817|3832107|FG001|STARTED|Everolimus||38
3107910|NCT01545817|3832106|FG000|COMPLETED|Everolimus||0
3107911|NCT01545817|3832107|FG001|COMPLETED|Everolimus||0
3107912|NCT01545817|3832106|FG000|NOT COMPLETED|Everolimus||0
3107913|NCT01545817|3832107|FG001|NOT COMPLETED|Everolimus||38
3107914|NCT01545843|3832118|FG000|STARTED|Overall Study||19
3107915|NCT01545843|3832119|FG001|STARTED|Overall Study||24
3107916|NCT01545843|3832120|FG002|STARTED|Overall Study||25
3107917|NCT01545843|3832118|FG000|COMPLETED|Overall Study||16
3107918|NCT01545843|3832119|FG001|COMPLETED|Overall Study||17
3107919|NCT01545843|3832120|FG002|COMPLETED|Overall Study||21
3107920|NCT01545843|3832118|FG000|NOT COMPLETED|Overall Study||3
3107921|NCT01545843|3832119|FG001|NOT COMPLETED|Overall Study||7
3107922|NCT01545843|3832120|FG002|NOT COMPLETED|Overall Study||4
3107923|NCT01545934|3832133|FG000|STARTED|Overall Study||132
3107924|NCT01545934|3832134|FG001|STARTED|Overall Study||132
3107925|NCT01545934|3832133|FG000|COMPLETED|Overall Study||127
3107926|NCT01545934|3832134|FG001|COMPLETED|Overall Study||129
3107927|NCT01545934|3832133|FG000|NOT COMPLETED|Overall Study||5
3107928|NCT01545934|3832134|FG001|NOT COMPLETED|Overall Study||3
3107929|NCT01546038|3832147|FG000|STARTED|Overall Study||17
3107930|NCT01546038|3832148|FG001|STARTED|Overall Study||6
3107931|NCT01546038|3832149|FG002|STARTED|Overall Study||4
3107932|NCT01546038|3832150|FG003|STARTED|Overall Study||3
3107933|NCT01546038|3832151|FG004|STARTED|Overall Study||16
3107934|NCT01546038|3832152|FG005|STARTED|Overall Study||6
3107935|NCT01546038|3832153|FG006|STARTED|Overall Study||71
3107936|NCT01546038|3832154|FG007|STARTED|Overall Study||88
3107937|NCT01546038|3832155|FG008|STARTED|Overall Study||44
3107938|NCT01546038|3832147|FG000|Received Treatment|Overall Study||17
3107939|NCT01546038|3832148|FG001|Received Treatment|Overall Study||6
3107940|NCT01546038|3832149|FG002|Received Treatment|Overall Study||4
3107941|NCT01546038|3832150|FG003|Received Treatment|Overall Study||3
3107942|NCT01546038|3832151|FG004|Received Treatment|Overall Study||16
3107943|NCT01546038|3832152|FG005|Received Treatment|Overall Study||6
3107944|NCT01546038|3832153|FG006|Received Treatment|Overall Study||69
3107945|NCT01546038|3832154|FG007|Received Treatment|Overall Study||84
3107946|NCT01546038|3832155|FG008|Received Treatment|Overall Study||41
3107947|NCT01546038|3832147|FG000|COMPLETED|Overall Study||1
3107948|NCT01546038|3832148|FG001|COMPLETED|Overall Study||0
3107949|NCT01546038|3832149|FG002|COMPLETED|Overall Study||0
3107950|NCT01546038|3832150|FG003|COMPLETED|Overall Study||0
3107951|NCT01546038|3832151|FG004|COMPLETED|Overall Study||6
3107952|NCT01546038|3832152|FG005|COMPLETED|Overall Study||2
3107953|NCT01546038|3832153|FG006|COMPLETED|Overall Study||18
3107954|NCT01546038|3832154|FG007|COMPLETED|Overall Study||4
3107955|NCT01546038|3832155|FG008|COMPLETED|Overall Study||1
3107956|NCT01546038|3832147|FG000|NOT COMPLETED|Overall Study||16
3107957|NCT01546038|3832148|FG001|NOT COMPLETED|Overall Study||6
3107958|NCT01546038|3832149|FG002|NOT COMPLETED|Overall Study||4
3107959|NCT01546038|3832150|FG003|NOT COMPLETED|Overall Study||3
3107960|NCT01546038|3832151|FG004|NOT COMPLETED|Overall Study||10
3107961|NCT01546038|3832152|FG005|NOT COMPLETED|Overall Study||4
3107962|NCT01546038|3832153|FG006|NOT COMPLETED|Overall Study||53
3107963|NCT01546038|3832154|FG007|NOT COMPLETED|Overall Study||84
3107964|NCT01546038|3832155|FG008|NOT COMPLETED|Overall Study||43
3107965|NCT01546142|3832207|FG000|STARTED|Overall Study||258
3107966|NCT01546142|3832208|FG001|STARTED|Overall Study||258
3107967|NCT01546142|3832207|FG000|Received Treatment|Overall Study||257
3292090|NCT02853435|4025989|FG001|COMPLETED|Part 3, Washout Period 2 (3 Days)||0
3292091|NCT02853435|4025990|FG002|COMPLETED|Part 3, Washout Period 2 (3 Days)||0
3292092|NCT02853435|4025991|FG003|COMPLETED|Part 3, Washout Period 2 (3 Days)||0
3292093|NCT02853435|4025992|FG004|COMPLETED|Part 3, Washout Period 2 (3 Days)||9
3292094|NCT02853435|4025993|FG005|COMPLETED|Part 3, Washout Period 2 (3 Days)||2
3292095|NCT02853435|4025988|FG000|NOT COMPLETED|Part 3, Washout Period 2 (3 Days)||0
3292096|NCT02853435|4025989|FG001|NOT COMPLETED|Part 3, Washout Period 2 (3 Days)||0
3292097|NCT02853435|4025990|FG002|NOT COMPLETED|Part 3, Washout Period 2 (3 Days)||0
3292098|NCT02853435|4025991|FG003|NOT COMPLETED|Part 3, Washout Period 2 (3 Days)||0
3292099|NCT02853435|4025992|FG004|NOT COMPLETED|Part 3, Washout Period 2 (3 Days)||1
3292100|NCT02853435|4025993|FG005|NOT COMPLETED|Part 3, Washout Period 2 (3 Days)||0
3292101|NCT02853435|4025988|FG000|STARTED|Part 3, Period 3 (3 Days)||0
3292102|NCT02853435|4025989|FG001|STARTED|Part 3, Period 3 (3 Days)||0
3292103|NCT02853435|4025990|FG002|STARTED|Part 3, Period 3 (3 Days)||0
3292104|NCT02853435|4025991|FG003|STARTED|Part 3, Period 3 (3 Days)||0
3292105|NCT02853435|4025992|FG004|STARTED|Part 3, Period 3 (3 Days)||9
3292106|NCT02853435|4025993|FG005|STARTED|Part 3, Period 3 (3 Days)||2
3292107|NCT02853435|4025988|FG000|COMPLETED|Part 3, Period 3 (3 Days)||0
3292108|NCT02853435|4025989|FG001|COMPLETED|Part 3, Period 3 (3 Days)||0
3292109|NCT02853435|4025990|FG002|COMPLETED|Part 3, Period 3 (3 Days)||0
3292110|NCT02853435|4025991|FG003|COMPLETED|Part 3, Period 3 (3 Days)||0
3292111|NCT02853435|4025992|FG004|COMPLETED|Part 3, Period 3 (3 Days)||9
3292112|NCT02853435|4025993|FG005|COMPLETED|Part 3, Period 3 (3 Days)||2
3292113|NCT02853435|4025988|FG000|NOT COMPLETED|Part 3, Period 3 (3 Days)||0
3292114|NCT02853435|4025989|FG001|NOT COMPLETED|Part 3, Period 3 (3 Days)||0
3292115|NCT02853435|4025990|FG002|NOT COMPLETED|Part 3, Period 3 (3 Days)||0
3292116|NCT02853435|4025991|FG003|NOT COMPLETED|Part 3, Period 3 (3 Days)||0
3292117|NCT02853435|4025992|FG004|NOT COMPLETED|Part 3, Period 3 (3 Days)||0
3292118|NCT02853435|4025993|FG005|NOT COMPLETED|Part 3, Period 3 (3 Days)||0
3292119|NCT02853760|4026023|FG000|STARTED|First Intervention (3 Hours)||7
3292120|NCT02853760|4026024|FG001|STARTED|First Intervention (3 Hours)||10
3292121|NCT02853760|4026025|FG002|STARTED|First Intervention (3 Hours)||7
3292122|NCT02853760|4026026|FG003|STARTED|First Intervention (3 Hours)||8
3292123|NCT02853760|4026027|FG004|STARTED|First Intervention (3 Hours)||8
3292124|NCT02853760|4026028|FG005|STARTED|First Intervention (3 Hours)||7
3292125|NCT02853760|4026023|FG000|COMPLETED|First Intervention (3 Hours)||7
3292126|NCT02853760|4026024|FG001|COMPLETED|First Intervention (3 Hours)||10
3292127|NCT02853760|4026025|FG002|COMPLETED|First Intervention (3 Hours)||7
3292128|NCT02853760|4026026|FG003|COMPLETED|First Intervention (3 Hours)||8
3292129|NCT02853760|4026027|FG004|COMPLETED|First Intervention (3 Hours)||8
3292130|NCT02853760|4026028|FG005|COMPLETED|First Intervention (3 Hours)||7
3292131|NCT02853760|4026023|FG000|NOT COMPLETED|First Intervention (3 Hours)||0
3292132|NCT02853760|4026024|FG001|NOT COMPLETED|First Intervention (3 Hours)||0
3292133|NCT02853760|4026025|FG002|NOT COMPLETED|First Intervention (3 Hours)||0
3292134|NCT02853760|4026026|FG003|NOT COMPLETED|First Intervention (3 Hours)||0
3292135|NCT02853760|4026027|FG004|NOT COMPLETED|First Intervention (3 Hours)||0
3292136|NCT02853760|4026028|FG005|NOT COMPLETED|First Intervention (3 Hours)||0
3292137|NCT02853760|4026023|FG000|STARTED|Washout (1 Week)||7
3292138|NCT02853760|4026024|FG001|STARTED|Washout (1 Week)||10
3292139|NCT02853760|4026025|FG002|STARTED|Washout (1 Week)||7
3292140|NCT02853760|4026026|FG003|STARTED|Washout (1 Week)||8
3292141|NCT02853760|4026027|FG004|STARTED|Washout (1 Week)||8
3292142|NCT02853760|4026028|FG005|STARTED|Washout (1 Week)||7
3292143|NCT02853760|4026023|FG000|COMPLETED|Washout (1 Week)||7
3292144|NCT02853760|4026024|FG001|COMPLETED|Washout (1 Week)||10
3292145|NCT02853760|4026025|FG002|COMPLETED|Washout (1 Week)||6
3292146|NCT02853760|4026026|FG003|COMPLETED|Washout (1 Week)||6
3292147|NCT02853760|4026027|FG004|COMPLETED|Washout (1 Week)||8
3292148|NCT02853760|4026028|FG005|COMPLETED|Washout (1 Week)||5
3292149|NCT02853760|4026023|FG000|NOT COMPLETED|Washout (1 Week)||0
3107968|NCT01546142|3832208|FG001|Received Treatment|Overall Study||257
3107969|NCT01546142|3832207|FG000|COMPLETED|Overall Study|Participants who completed long-term follow-up 24 weeks after the last treatment|214
3107970|NCT01546142|3832208|FG001|COMPLETED|Overall Study|Participants who completed long-term follow-up 24 weeks after the last treatment|224
3107971|NCT01546142|3832207|FG000|NOT COMPLETED|Overall Study||44
3107972|NCT01546142|3832208|FG001|NOT COMPLETED|Overall Study||34
3107973|NCT01546155|3832214|FG000|STARTED|Overall Study||11
3107974|NCT01546155|3832214|FG000|COMPLETED|Overall Study||8
3107975|NCT01546155|3832214|FG000|NOT COMPLETED|Overall Study||3
3107976|NCT01546168|3832220|FG000|STARTED|Overall Study||55
3107977|NCT01546168|3832221|FG001|STARTED|Overall Study||33
3107978|NCT01546168|3832220|FG000|COMPLETED|Overall Study||51
3107979|NCT01546168|3832221|FG001|COMPLETED|Overall Study||33
3107980|NCT01546168|3832220|FG000|NOT COMPLETED|Overall Study||4
3107981|NCT01546168|3832221|FG001|NOT COMPLETED|Overall Study||0
3107982|NCT01546194|3832229|FG000|STARTED|Overall Study||100
3107983|NCT01546194|3832230|FG001|STARTED|Overall Study||100
3107984|NCT01546194|3832229|FG000|COMPLETED|Overall Study||64
3107985|NCT01546194|3832230|FG001|COMPLETED|Overall Study||65
3107986|NCT01546194|3832229|FG000|NOT COMPLETED|Overall Study||36
3107987|NCT01546194|3832230|FG001|NOT COMPLETED|Overall Study||35
3107988|NCT01546285|3832236|FG000|STARTED|Overall Study||66
3107989|NCT01546285|3832236|FG000|COMPLETED|Overall Study||66
3107990|NCT01546285|3832236|FG000|NOT COMPLETED|Overall Study||0
3107991|NCT01546402|3832244|FG000|STARTED|Overall Study||10
3107992|NCT01546402|3832245|FG001|STARTED|Overall Study||10
3107993|NCT01546402|3832244|FG000|COMPLETED|Overall Study||10
3107994|NCT01546402|3832245|FG001|COMPLETED|Overall Study||10
3107995|NCT01546402|3832244|FG000|NOT COMPLETED|Overall Study||0
3107996|NCT01546402|3832245|FG001|NOT COMPLETED|Overall Study||0
3107997|NCT01546454|3832251|FG000|STARTED|Natural Menstrual Cycle||4
3292150|NCT02853760|4026024|FG001|NOT COMPLETED|Washout (1 Week)||0
3292151|NCT02853760|4026025|FG002|NOT COMPLETED|Washout (1 Week)||1
3292152|NCT02853760|4026026|FG003|NOT COMPLETED|Washout (1 Week)||2
3292153|NCT02853760|4026027|FG004|NOT COMPLETED|Washout (1 Week)||0
3292154|NCT02853760|4026028|FG005|NOT COMPLETED|Washout (1 Week)||2
3292155|NCT02853760|4026023|FG000|STARTED|Second Intervention (3 Hours)||7
3292156|NCT02853760|4026024|FG001|STARTED|Second Intervention (3 Hours)||10
3292157|NCT02853760|4026025|FG002|STARTED|Second Intervention (3 Hours)||6
3292158|NCT02853760|4026026|FG003|STARTED|Second Intervention (3 Hours)||6
3292159|NCT02853760|4026027|FG004|STARTED|Second Intervention (3 Hours)||8
3292160|NCT02853760|4026028|FG005|STARTED|Second Intervention (3 Hours)||5
3292161|NCT02853760|4026023|FG000|COMPLETED|Second Intervention (3 Hours)||7
3292162|NCT02853760|4026024|FG001|COMPLETED|Second Intervention (3 Hours)||10
3292163|NCT02853760|4026025|FG002|COMPLETED|Second Intervention (3 Hours)||6
3292164|NCT02853760|4026026|FG003|COMPLETED|Second Intervention (3 Hours)||6
3292165|NCT02853760|4026027|FG004|COMPLETED|Second Intervention (3 Hours)||8
3292166|NCT02853760|4026028|FG005|COMPLETED|Second Intervention (3 Hours)||5
3292167|NCT02853760|4026023|FG000|NOT COMPLETED|Second Intervention (3 Hours)||0
3292168|NCT02853760|4026024|FG001|NOT COMPLETED|Second Intervention (3 Hours)||0
3292169|NCT02853760|4026025|FG002|NOT COMPLETED|Second Intervention (3 Hours)||0
3292170|NCT02853760|4026026|FG003|NOT COMPLETED|Second Intervention (3 Hours)||0
3292171|NCT02853760|4026027|FG004|NOT COMPLETED|Second Intervention (3 Hours)||0
3292172|NCT02853760|4026028|FG005|NOT COMPLETED|Second Intervention (3 Hours)||0
3292173|NCT02853760|4026023|FG000|STARTED|Washout (1 Week)||7
3292174|NCT02853760|4026024|FG001|STARTED|Washout (1 Week)||10
3292175|NCT02853760|4026025|FG002|STARTED|Washout (1 Week)||6
3292176|NCT02853760|4026026|FG003|STARTED|Washout (1 Week)||6
3292177|NCT02853760|4026027|FG004|STARTED|Washout (1 Week)||8
3292178|NCT02853760|4026028|FG005|STARTED|Washout (1 Week)||5
3292179|NCT02853760|4026023|FG000|COMPLETED|Washout (1 Week)||7
3292180|NCT02853760|4026024|FG001|COMPLETED|Washout (1 Week)||10
3292181|NCT02853760|4026025|FG002|COMPLETED|Washout (1 Week)||6
3292182|NCT02853760|4026026|FG003|COMPLETED|Washout (1 Week)||6
3292183|NCT02853760|4026027|FG004|COMPLETED|Washout (1 Week)||8
3292184|NCT02853760|4026028|FG005|COMPLETED|Washout (1 Week)||5
3292185|NCT02853760|4026023|FG000|NOT COMPLETED|Washout (1 Week)||0
3292186|NCT02853760|4026024|FG001|NOT COMPLETED|Washout (1 Week)||0
3292187|NCT02853760|4026025|FG002|NOT COMPLETED|Washout (1 Week)||0
3292188|NCT02853760|4026026|FG003|NOT COMPLETED|Washout (1 Week)||0
3292189|NCT02853760|4026027|FG004|NOT COMPLETED|Washout (1 Week)||0
3292190|NCT02853760|4026028|FG005|NOT COMPLETED|Washout (1 Week)||0
3292191|NCT02853760|4026023|FG000|STARTED|Third Intervention (3 Hours)||7
3292192|NCT02853760|4026024|FG001|STARTED|Third Intervention (3 Hours)||10
3292193|NCT02853760|4026025|FG002|STARTED|Third Intervention (3 Hours)||6
3292194|NCT02853760|4026026|FG003|STARTED|Third Intervention (3 Hours)||6
3292195|NCT02853760|4026027|FG004|STARTED|Third Intervention (3 Hours)||8
3292196|NCT02853760|4026028|FG005|STARTED|Third Intervention (3 Hours)||5
3292197|NCT02853760|4026023|FG000|COMPLETED|Third Intervention (3 Hours)||7
3292198|NCT02853760|4026024|FG001|COMPLETED|Third Intervention (3 Hours)||10
3292199|NCT02853760|4026025|FG002|COMPLETED|Third Intervention (3 Hours)||6
3292200|NCT02853760|4026026|FG003|COMPLETED|Third Intervention (3 Hours)||6
3292201|NCT02853760|4026027|FG004|COMPLETED|Third Intervention (3 Hours)||8
3292202|NCT02853760|4026028|FG005|COMPLETED|Third Intervention (3 Hours)||5
3292203|NCT02853760|4026023|FG000|NOT COMPLETED|Third Intervention (3 Hours)||0
3107998|NCT01546454|3832251|FG000|COMPLETED|Natural Menstrual Cycle||4
3107999|NCT01546454|3832251|FG000|NOT COMPLETED|Natural Menstrual Cycle||0
3108000|NCT01546454|3832251|FG000|STARTED|Oral Contraceptive Cycle||4
3108001|NCT01546454|3832251|FG000|COMPLETED|Oral Contraceptive Cycle||4
3108002|NCT01546454|3832251|FG000|NOT COMPLETED|Oral Contraceptive Cycle||0
3108003|NCT01546454|3832251|FG000|STARTED|Eligard Treatment||4
3108004|NCT01546454|3832251|FG000|COMPLETED|Eligard Treatment||4
3108005|NCT01546454|3832251|FG000|NOT COMPLETED|Eligard Treatment||0
3108006|NCT01546454|3832251|FG000|STARTED|Estrogen/Progesterone Replacement Cycle||4
3108007|NCT01546454|3832251|FG000|COMPLETED|Estrogen/Progesterone Replacement Cycle||4
3108008|NCT01546454|3832251|FG000|NOT COMPLETED|Estrogen/Progesterone Replacement Cycle||0
3108009|NCT01546519|3832261|FG000|STARTED|Overall Study||9
3292204|NCT02853760|4026024|FG001|NOT COMPLETED|Third Intervention (3 Hours)||0
3292205|NCT02853760|4026025|FG002|NOT COMPLETED|Third Intervention (3 Hours)||0
3292206|NCT02853760|4026026|FG003|NOT COMPLETED|Third Intervention (3 Hours)||0
3292207|NCT02853760|4026027|FG004|NOT COMPLETED|Third Intervention (3 Hours)||0
3292208|NCT02853760|4026028|FG005|NOT COMPLETED|Third Intervention (3 Hours)||0
3292209|NCT02853929|4026038|FG000|STARTED|Overall Study||270
3292210|NCT02853929|4026039|FG001|STARTED|Overall Study||281
3292211|NCT02853929|4026038|FG000|Vaccinated|Overall Study||263
3292212|NCT02853929|4026039|FG001|Vaccinated|Overall Study||277
3292213|NCT02853929|4026038|FG000|COMPLETED|Overall Study||259
3292214|NCT02853929|4026039|FG001|COMPLETED|Overall Study||277
3292215|NCT02853929|4026038|FG000|NOT COMPLETED|Overall Study||11
3292216|NCT02853929|4026039|FG001|NOT COMPLETED|Overall Study||4
3292217|NCT02854059|4026047|FG000|STARTED|Overall Study||2
3292218|NCT02854059|4026048|FG001|STARTED|Overall Study||0
3292219|NCT02854059|4026047|FG000|COMPLETED|Overall Study||2
3292220|NCT02854059|4026048|FG001|COMPLETED|Overall Study||0
3292221|NCT02854059|4026047|FG000|NOT COMPLETED|Overall Study||0
3292222|NCT02854059|4026048|FG001|NOT COMPLETED|Overall Study||0
3292223|NCT02854527|4026064|FG000|STARTED|Overall Study||3
3292224|NCT02854527|4026065|FG001|STARTED|Overall Study||3
3292225|NCT02854527|4026066|FG002|STARTED|Overall Study||3
3292226|NCT02854527|4026067|FG003|STARTED|Overall Study||3
3292227|NCT02854527|4026068|FG004|STARTED|Overall Study||3
3292228|NCT02854527|4026069|FG005|STARTED|Overall Study||3
3292229|NCT02854527|4026070|FG006|STARTED|Overall Study||3
3292230|NCT02854527|4026071|FG007|STARTED|Overall Study||3
3292231|NCT02854527|4026072|FG008|STARTED|Overall Study||3
3292232|NCT02854527|4026073|FG009|STARTED|Overall Study||3
3292233|NCT02854527|4026064|FG000|Received R1|Overall Study||3
3292234|NCT02854527|4026065|FG001|Received R1|Overall Study||3
3292235|NCT02854527|4026066|FG002|Received R1|Overall Study||3
3292236|NCT02854527|4026067|FG003|Received R1|Overall Study||2
3292237|NCT02854527|4026068|FG004|Received R1|Overall Study||2
3292238|NCT02854527|4026069|FG005|Received R1|Overall Study||3
3292239|NCT02854527|4026070|FG006|Received R1|Overall Study||3
3292240|NCT02854527|4026071|FG007|Received R1|Overall Study||3
3292241|NCT02854527|4026072|FG008|Received R1|Overall Study||3
3292242|NCT02854527|4026073|FG009|Received R1|Overall Study||3
3292243|NCT02854527|4026064|FG000|Received R2|Overall Study||3
3292244|NCT02854527|4026065|FG001|Received R2|Overall Study||3
3292245|NCT02854527|4026066|FG002|Received R2|Overall Study||3
3292246|NCT02854527|4026067|FG003|Received R2|Overall Study||3
3292247|NCT02854527|4026068|FG004|Received R2|Overall Study||3
3292248|NCT02854527|4026069|FG005|Received R2|Overall Study||3
3292249|NCT02854527|4026070|FG006|Received R2|Overall Study||3
3292250|NCT02854527|4026071|FG007|Received R2|Overall Study||3
3292251|NCT02854527|4026072|FG008|Received R2|Overall Study||3
3292252|NCT02854527|4026073|FG009|Received R2|Overall Study||3
3292253|NCT02854527|4026064|FG000|Received R3|Overall Study||3
3292254|NCT02854527|4026065|FG001|Received R3|Overall Study||3
3292255|NCT02854527|4026066|FG002|Received R3|Overall Study||3
3292256|NCT02854527|4026067|FG003|Received R3|Overall Study||2
3292257|NCT02854527|4026068|FG004|Received R3|Overall Study||3
3292258|NCT02854527|4026069|FG005|Received R3|Overall Study||3
3292259|NCT02854527|4026070|FG006|Received R3|Overall Study||3
3292260|NCT02854527|4026071|FG007|Received R3|Overall Study||3
3292261|NCT02854527|4026072|FG008|Received R3|Overall Study||3
3292262|NCT02854527|4026073|FG009|Received R3|Overall Study||3
3292263|NCT02854527|4026064|FG000|Received R4|Overall Study||3
3292264|NCT02854527|4026065|FG001|Received R4|Overall Study||3
3292265|NCT02854527|4026066|FG002|Received R4|Overall Study||3
3292266|NCT02854527|4026067|FG003|Received R4|Overall Study||2
3292267|NCT02854527|4026068|FG004|Received R4|Overall Study||3
3292268|NCT02854527|4026069|FG005|Received R4|Overall Study||3
3292269|NCT02854527|4026070|FG006|Received R4|Overall Study||3
3292270|NCT02854527|4026071|FG007|Received R4|Overall Study||3
3292271|NCT02854527|4026072|FG008|Received R4|Overall Study||3
3292272|NCT02854527|4026073|FG009|Received R4|Overall Study||3
3292273|NCT02854527|4026064|FG000|Received T|Overall Study||3
3292274|NCT02854527|4026065|FG001|Received T|Overall Study||3
3292275|NCT02854527|4026066|FG002|Received T|Overall Study||3
3292276|NCT02854527|4026067|FG003|Received T|Overall Study||2
3292277|NCT02854527|4026068|FG004|Received T|Overall Study||2
3292278|NCT02854527|4026069|FG005|Received T|Overall Study||3
3292279|NCT02854527|4026070|FG006|Received T|Overall Study||3
3292280|NCT02854527|4026071|FG007|Received T|Overall Study||3
3292281|NCT02854527|4026072|FG008|Received T|Overall Study||3
3292282|NCT02854527|4026073|FG009|Received T|Overall Study||3
3292283|NCT02854527|4026064|FG000|COMPLETED|Overall Study||3
3292284|NCT02854527|4026065|FG001|COMPLETED|Overall Study||3
3292285|NCT02854527|4026066|FG002|COMPLETED|Overall Study||3
3108010|NCT01546519|3832262|FG001|STARTED|Overall Study||8
3108011|NCT01546519|3832263|FG002|STARTED|Overall Study||8
3108012|NCT01546519|3832264|FG003|STARTED|Overall Study||6
3108013|NCT01546519|3832261|FG000|Safety-Evaluable Participants|Overall Study||9
3108014|NCT01546519|3832262|FG001|Safety-Evaluable Participants|Overall Study||8
3108015|NCT01546519|3832263|FG002|Safety-Evaluable Participants|Overall Study||8
3108016|NCT01546519|3832264|FG003|Safety-Evaluable Participants|Overall Study||6
3108017|NCT01546519|3832261|FG000|COMPLETED|Overall Study||0
3108018|NCT01546519|3832262|FG001|COMPLETED|Overall Study||0
3108019|NCT01546519|3832263|FG002|COMPLETED|Overall Study||0
3108020|NCT01546519|3832264|FG003|COMPLETED|Overall Study||0
3108021|NCT01546519|3832261|FG000|NOT COMPLETED|Overall Study||9
3108022|NCT01546519|3832262|FG001|NOT COMPLETED|Overall Study||8
3108023|NCT01546519|3832263|FG002|NOT COMPLETED|Overall Study||8
3108024|NCT01546519|3832264|FG003|NOT COMPLETED|Overall Study||6
3108025|NCT01546623|3832280|FG000|STARTED|Overall Study||82
3108026|NCT01546623|3832281|FG001|STARTED|Overall Study||80
3108027|NCT01546623|3832280|FG000|Received Study Drug|Overall Study||81
3108028|NCT01546623|3832281|FG001|Received Study Drug|Overall Study||79
3108029|NCT01546623|3832280|FG000|COMPLETED|Overall Study||76
3108030|NCT01546623|3832281|FG001|COMPLETED|Overall Study||74
3108031|NCT01546623|3832280|FG000|NOT COMPLETED|Overall Study||6
3108032|NCT01546623|3832281|FG001|NOT COMPLETED|Overall Study||6
3108033|NCT01546636|3832289|FG000|STARTED|Overall Study||36
3108034|NCT01546636|3832290|FG001|STARTED|Overall Study||34
3108035|NCT01546636|3832289|FG000|COMPLETED|Overall Study||36
3108036|NCT01546636|3832290|FG001|COMPLETED|Overall Study||34
3108037|NCT01546636|3832289|FG000|NOT COMPLETED|Overall Study||0
3108038|NCT01546636|3832290|FG001|NOT COMPLETED|Overall Study||0
3108039|NCT01546649|3832298|FG000|STARTED|Overall Study||83
3108040|NCT01546649|3832299|FG001|STARTED|Overall Study||84
3108041|NCT01546649|3832298|FG000|COMPLETED|Overall Study||75
3108042|NCT01546649|3832299|FG001|COMPLETED|Overall Study||75
3108043|NCT01546649|3832298|FG000|NOT COMPLETED|Overall Study||8
3108044|NCT01546649|3832299|FG001|NOT COMPLETED|Overall Study||9
3108045|NCT01546675|3832307|FG000|STARTED|Overall Study||1
3108046|NCT01546675|3832308|FG001|STARTED|Overall Study||1
3108047|NCT01546675|3832307|FG000|COMPLETED|Overall Study||1
3108048|NCT01546675|3832308|FG001|COMPLETED|Overall Study||1
3108049|NCT01546675|3832307|FG000|NOT COMPLETED|Overall Study||0
3108050|NCT01546675|3832308|FG001|NOT COMPLETED|Overall Study||0
3108051|NCT01546688|3832316|FG000|STARTED|Overall Study||18
3108052|NCT01546688|3832317|FG001|STARTED|Overall Study||33
3108053|NCT01546688|3832316|FG000|COMPLETED|Overall Study||15
3108054|NCT01546688|3832317|FG001|COMPLETED|Overall Study||28
3108055|NCT01546688|3832316|FG000|NOT COMPLETED|Overall Study||3
3108056|NCT01546688|3832317|FG001|NOT COMPLETED|Overall Study||5
3108057|NCT01546857|3832325|FG000|STARTED|Overall Study||14
3108058|NCT01546857|3832326|FG001|STARTED|Overall Study||20
3108059|NCT01546857|3832325|FG000|COMPLETED|Overall Study||12
3108060|NCT01546857|3832326|FG001|COMPLETED|Overall Study||17
3108061|NCT01546857|3832325|FG000|NOT COMPLETED|Overall Study||2
3108062|NCT01546857|3832326|FG001|NOT COMPLETED|Overall Study||3
3108063|NCT01546922|3832333|FG000|STARTED|First Period of 10 Weeks||30
3108064|NCT01546922|3832334|FG001|STARTED|First Period of 10 Weeks||30
3108065|NCT01546922|3832333|FG000|COMPLETED|First Period of 10 Weeks||25
3108066|NCT01546922|3832334|FG001|COMPLETED|First Period of 10 Weeks||28
3108067|NCT01546922|3832333|FG000|NOT COMPLETED|First Period of 10 Weeks||5
3108068|NCT01546922|3832334|FG001|NOT COMPLETED|First Period of 10 Weeks||2
3108069|NCT01546922|3832333|FG000|STARTED|Second Period of 10 Weeks||25
3108070|NCT01546922|3832334|FG001|STARTED|Second Period of 10 Weeks||28
3108071|NCT01546922|3832333|FG000|COMPLETED|Second Period of 10 Weeks||22
3108072|NCT01546922|3832334|FG001|COMPLETED|Second Period of 10 Weeks||25
3108073|NCT01546922|3832333|FG000|NOT COMPLETED|Second Period of 10 Weeks||3
3108074|NCT01546922|3832334|FG001|NOT COMPLETED|Second Period of 10 Weeks||3
3108075|NCT01547000|3832342|FG000|STARTED|Overall Study||18
3108076|NCT01547000|3832343|FG001|STARTED|Overall Study||16
3108077|NCT01547000|3832342|FG000|COMPLETED|Overall Study||18
3108078|NCT01547000|3832343|FG001|COMPLETED|Overall Study||16
3292286|NCT02854527|4026067|FG003|COMPLETED|Overall Study||2
3292287|NCT02854527|4026068|FG004|COMPLETED|Overall Study||2
3292288|NCT02854527|4026069|FG005|COMPLETED|Overall Study||3
3292289|NCT02854527|4026070|FG006|COMPLETED|Overall Study||3
3292290|NCT02854527|4026071|FG007|COMPLETED|Overall Study||3
3292291|NCT02854527|4026072|FG008|COMPLETED|Overall Study||3
3292292|NCT02854527|4026073|FG009|COMPLETED|Overall Study||3
3292293|NCT02854527|4026064|FG000|NOT COMPLETED|Overall Study||0
3292294|NCT02854527|4026065|FG001|NOT COMPLETED|Overall Study||0
3292295|NCT02854527|4026066|FG002|NOT COMPLETED|Overall Study||0
3292296|NCT02854527|4026067|FG003|NOT COMPLETED|Overall Study||1
3292297|NCT02854527|4026068|FG004|NOT COMPLETED|Overall Study||1
3292298|NCT02854527|4026069|FG005|NOT COMPLETED|Overall Study||0
3292299|NCT02854527|4026070|FG006|NOT COMPLETED|Overall Study||0
3292300|NCT02854527|4026071|FG007|NOT COMPLETED|Overall Study||0
3292301|NCT02854527|4026072|FG008|NOT COMPLETED|Overall Study||0
3292302|NCT02854527|4026073|FG009|NOT COMPLETED|Overall Study||0
3292303|NCT02854540|4026085|FG000|STARTED|Overall Study||13
3108079|NCT01547000|3832342|FG000|NOT COMPLETED|Overall Study||0
3108080|NCT01547000|3832343|FG001|NOT COMPLETED|Overall Study||0
3108081|NCT01547130|3832351|FG000|STARTED|Overall Study||74
3108082|NCT01547130|3832352|FG001|STARTED|Overall Study||73
3108083|NCT01547130|3832351|FG000|COMPLETED|Overall Study||65
3108084|NCT01547130|3832352|FG001|COMPLETED|Overall Study||68
3108085|NCT01547130|3832351|FG000|NOT COMPLETED|Overall Study||9
3108086|NCT01547130|3832352|FG001|NOT COMPLETED|Overall Study||5
3108087|NCT01547247|3832368|FG000|STARTED|Overall Study||104
3108088|NCT01547247|3832369|FG001|STARTED|Overall Study||104
3108089|NCT01547247|3832368|FG000|COMPLETED|Overall Study||98
3108090|NCT01547247|3832369|FG001|COMPLETED|Overall Study||98
3108091|NCT01547247|3832368|FG000|NOT COMPLETED|Overall Study||6
3108092|NCT01547247|3832369|FG001|NOT COMPLETED|Overall Study||6
3108093|NCT01547286|3832375|FG000|STARTED|Overall Study||7
3108094|NCT01547286|3832375|FG000|COMPLETED|Overall Study||5
3108095|NCT01547286|3832375|FG000|NOT COMPLETED|Overall Study||2
3108096|NCT01547299|3832382|FG000|STARTED|Overall Study||25
3108097|NCT01547299|3832383|FG001|STARTED|Overall Study||27
3108098|NCT01547299|3832382|FG000|COMPLETED|Overall Study||23
3108099|NCT01547299|3832383|FG001|COMPLETED|Overall Study||25
3108100|NCT01547299|3832382|FG000|NOT COMPLETED|Overall Study||2
3108101|NCT01547299|3832383|FG001|NOT COMPLETED|Overall Study||2
3108102|NCT01547390|3832391|FG000|STARTED|Overall Study||27
3108103|NCT01547390|3832392|FG001|STARTED|Overall Study||26
3108104|NCT01547390|3832391|FG000|COMPLETED|Overall Study||14
3108105|NCT01547390|3832392|FG001|COMPLETED|Overall Study||16
3108106|NCT01547390|3832391|FG000|NOT COMPLETED|Overall Study||13
3108107|NCT01547390|3832392|FG001|NOT COMPLETED|Overall Study||10
3108108|NCT01547598|3832400|FG000|STARTED|Overall Study||67
3108109|NCT01547598|3832401|FG001|STARTED|Overall Study||68
3163161|NCT01883986|3890645|FG000|STARTED|Overall Study|Allocated to intervention arm|20
3163162|NCT01883986|3890646|FG001|STARTED|Overall Study|Allocated to usual care arm|20
3163163|NCT01883986|3890645|FG000|Did Not Complete Study|Overall Study||3
3163164|NCT01883986|3890646|FG001|Did Not Complete Study|Overall Study|Did not completed study|1
3163165|NCT01883986|3890645|FG000|COMPLETED|Overall Study|Received allocated intervention|17
3163166|NCT01883986|3890646|FG001|COMPLETED|Overall Study|Completed study|19
3163167|NCT01883986|3890645|FG000|NOT COMPLETED|Overall Study||3
3292304|NCT02854540|4026085|FG000|COMPLETED|Overall Study||11
3292305|NCT02854540|4026085|FG000|NOT COMPLETED|Overall Study||2
3292306|NCT02854605|4026094|FG000|STARTED|Overall Study||56
3292307|NCT02854605|4026095|FG001|STARTED|Overall Study||56
3292308|NCT02854605|4026096|FG002|STARTED|Overall Study||28
3292309|NCT02854605|4026094|FG000|COMPLETED|Overall Study||53
3292310|NCT02854605|4026095|FG001|COMPLETED|Overall Study||49
3292311|NCT02854605|4026096|FG002|COMPLETED|Overall Study||24
3292312|NCT02854605|4026094|FG000|NOT COMPLETED|Overall Study||3
3292313|NCT02854605|4026095|FG001|NOT COMPLETED|Overall Study||7
3292314|NCT02854605|4026096|FG002|NOT COMPLETED|Overall Study||4
3292315|NCT02854631|4026106|FG000|STARTED|Overall Study||52
3292316|NCT02854631|4026107|FG001|STARTED|Overall Study||52
3292317|NCT02854631|4026106|FG000|COMPLETED|Overall Study||26
3292318|NCT02854631|4026107|FG001|COMPLETED|Overall Study||37
3292319|NCT02854631|4026106|FG000|NOT COMPLETED|Overall Study||26
3292320|NCT02854631|4026107|FG001|NOT COMPLETED|Overall Study||15
3292321|NCT02854800|4026116|FG000|STARTED|Overall Study||32
3292322|NCT02854800|4026117|FG001|STARTED|Overall Study||28
3292323|NCT02854800|4026118|FG002|STARTED|Overall Study||14
3292324|NCT02854800|4026116|FG000|COMPLETED|Overall Study||12
3292325|NCT02854800|4026117|FG001|COMPLETED|Overall Study||15
3292326|NCT02854800|4026118|FG002|COMPLETED|Overall Study||8
3292327|NCT02854800|4026116|FG000|NOT COMPLETED|Overall Study||20
3292328|NCT02854800|4026117|FG001|NOT COMPLETED|Overall Study||13
3292329|NCT02854800|4026118|FG002|NOT COMPLETED|Overall Study||6
3292330|NCT02855060|4026131|FG000|STARTED|Overall Study||22
3292331|NCT02855060|4026132|FG001|STARTED|Overall Study||28
3292332|NCT02855060|4026131|FG000|COMPLETED|Overall Study||20
3292333|NCT02855060|4026132|FG001|COMPLETED|Overall Study||23
3292334|NCT02855060|4026131|FG000|NOT COMPLETED|Overall Study||2
3292335|NCT02855060|4026132|FG001|NOT COMPLETED|Overall Study||5
3292336|NCT02855086|4026140|FG000|STARTED|Overall Study||2
3292337|NCT02855086|4026141|FG001|STARTED|Overall Study||1
3292338|NCT02855086|4026140|FG000|COMPLETED|Overall Study||2
3292339|NCT02855086|4026141|FG001|COMPLETED|Overall Study||1
3292340|NCT02855086|4026140|FG000|NOT COMPLETED|Overall Study||0
3292341|NCT02855086|4026141|FG001|NOT COMPLETED|Overall Study||0
3292342|NCT02855164|4026155|FG000|STARTED|Parts A + B (Randomized Set)||14
3292343|NCT02855164|4026156|FG001|STARTED|Parts A + B (Randomized Set)||16
3292344|NCT02855164|4026157|FG002|STARTED|Parts A + B (Randomized Set)||37
3292345|NCT02855164|4026158|FG003|STARTED|Parts A + B (Randomized Set)||85
3292346|NCT02855164|4026159|FG004|STARTED|Parts A + B (Randomized Set)||46
3292347|NCT02855164|4026160|FG005|STARTED|Parts A + B (Randomized Set)||0
3292348|NCT02855164|4026161|FG006|STARTED|Parts A + B (Randomized Set)||0
3292349|NCT02855164|4026162|FG007|STARTED|Parts A + B (Randomized Set)||0
3292350|NCT02855164|4026155|FG000|COMPLETED|Parts A + B (Randomized Set)||14
3292351|NCT02855164|4026156|FG001|COMPLETED|Parts A + B (Randomized Set)||16
3292352|NCT02855164|4026157|FG002|COMPLETED|Parts A + B (Randomized Set)||36
3292353|NCT02855164|4026158|FG003|COMPLETED|Parts A + B (Randomized Set)||77
3292354|NCT02855164|4026159|FG004|COMPLETED|Parts A + B (Randomized Set)||45
3292355|NCT02855164|4026160|FG005|COMPLETED|Parts A + B (Randomized Set)||0
3292356|NCT02855164|4026161|FG006|COMPLETED|Parts A + B (Randomized Set)||0
3108110|NCT01547598|3832400|FG000|COMPLETED|Overall Study||61
3108111|NCT01547598|3832401|FG001|COMPLETED|Overall Study||63
3108112|NCT01547598|3832400|FG000|NOT COMPLETED|Overall Study||6
3108113|NCT01547598|3832401|FG001|NOT COMPLETED|Overall Study||5
3108114|NCT01547715|3832411|FG000|STARTED|Overall Study||60
3108115|NCT01547715|3832412|FG001|STARTED|Overall Study||60
3108116|NCT01547715|3832413|FG002|STARTED|Overall Study||60
3108117|NCT01547715|3832411|FG000|COMPLETED|Overall Study||60
3108118|NCT01547715|3832412|FG001|COMPLETED|Overall Study||60
3108119|NCT01547715|3832413|FG002|COMPLETED|Overall Study||60
3108120|NCT01547715|3832411|FG000|NOT COMPLETED|Overall Study||0
3108121|NCT01547715|3832412|FG001|NOT COMPLETED|Overall Study||0
3108122|NCT01547715|3832413|FG002|NOT COMPLETED|Overall Study||0
3108123|NCT01547780|3832426|FG000|STARTED|Baseline PET Scan||12
3108124|NCT01547780|3832427|FG001|STARTED|Baseline PET Scan||0
3108125|NCT01547780|3832428|FG002|STARTED|Baseline PET Scan||19
3108126|NCT01547780|3832429|FG003|STARTED|Baseline PET Scan||19
3108127|NCT01547780|3832426|FG000|COMPLETED|Baseline PET Scan||9
3108128|NCT01547780|3832427|FG001|COMPLETED|Baseline PET Scan||0
3108129|NCT01547780|3832428|FG002|COMPLETED|Baseline PET Scan||17
3108130|NCT01547780|3832429|FG003|COMPLETED|Baseline PET Scan||19
3108131|NCT01547780|3832426|FG000|NOT COMPLETED|Baseline PET Scan||3
3108132|NCT01547780|3832427|FG001|NOT COMPLETED|Baseline PET Scan||0
3108133|NCT01547780|3832428|FG002|NOT COMPLETED|Baseline PET Scan||2
3108134|NCT01547780|3832429|FG003|NOT COMPLETED|Baseline PET Scan||0
3108135|NCT01547780|3832426|FG000|STARTED|Repeat PET Scan||0
3108136|NCT01547780|3832427|FG001|STARTED|Repeat PET Scan||4
3108137|NCT01547780|3832428|FG002|STARTED|Repeat PET Scan||0
3108138|NCT01547780|3832429|FG003|STARTED|Repeat PET Scan||0
3108139|NCT01547780|3832426|FG000|COMPLETED|Repeat PET Scan||0
3108140|NCT01547780|3832427|FG001|COMPLETED|Repeat PET Scan||4
3108141|NCT01547780|3832428|FG002|COMPLETED|Repeat PET Scan||0
3108142|NCT01547780|3832429|FG003|COMPLETED|Repeat PET Scan||0
3108143|NCT01547780|3832426|FG000|NOT COMPLETED|Repeat PET Scan||0
3108144|NCT01547780|3832427|FG001|NOT COMPLETED|Repeat PET Scan||0
3108145|NCT01547780|3832428|FG002|NOT COMPLETED|Repeat PET Scan||0
3108146|NCT01547780|3832429|FG003|NOT COMPLETED|Repeat PET Scan||0
3108147|NCT01547806|3832439|FG000|STARTED|Overall Study||49
3108148|NCT01547806|3832439|FG000|COMPLETED|Overall Study||49
3108149|NCT01547806|3832439|FG000|NOT COMPLETED|Overall Study||0
3108150|NCT01548040|3832446|FG000|STARTED|Overall Study||56
3108151|NCT01548040|3832447|FG001|STARTED|Overall Study||55
3108152|NCT01548040|3832446|FG000|COMPLETED|Overall Study||43
3108153|NCT01548040|3832447|FG001|COMPLETED|Overall Study||45
3108154|NCT01548040|3832446|FG000|NOT COMPLETED|Overall Study||13
3108155|NCT01548040|3832447|FG001|NOT COMPLETED|Overall Study||10
3108156|NCT01548287|3832457|FG000|STARTED|Screening||19
3292357|NCT02855164|4026162|FG007|COMPLETED|Parts A + B (Randomized Set)||0
3292358|NCT02855164|4026155|FG000|NOT COMPLETED|Parts A + B (Randomized Set)||0
3292359|NCT02855164|4026156|FG001|NOT COMPLETED|Parts A + B (Randomized Set)||0
3292360|NCT02855164|4026157|FG002|NOT COMPLETED|Parts A + B (Randomized Set)||1
3292361|NCT02855164|4026158|FG003|NOT COMPLETED|Parts A + B (Randomized Set)||8
3292362|NCT02855164|4026159|FG004|NOT COMPLETED|Parts A + B (Randomized Set)||1
3292363|NCT02855164|4026160|FG005|NOT COMPLETED|Parts A + B (Randomized Set)||0
3292364|NCT02855164|4026161|FG006|NOT COMPLETED|Parts A + B (Randomized Set)||0
3292365|NCT02855164|4026162|FG007|NOT COMPLETED|Parts A + B (Randomized Set)||0
3292366|NCT02855164|4026155|FG000|STARTED|Part C (Randomized Set)||0
3292367|NCT02855164|4026156|FG001|STARTED|Part C (Randomized Set)||0
3292368|NCT02855164|4026157|FG002|STARTED|Part C (Randomized Set)||0
3292369|NCT02855164|4026158|FG003|STARTED|Part C (Randomized Set)||0
3292370|NCT02855164|4026159|FG004|STARTED|Part C (Randomized Set)||0
3292371|NCT02855164|4026160|FG005|STARTED|Part C (Randomized Set)||50
3292372|NCT02855164|4026161|FG006|STARTED|Part C (Randomized Set)||51
3292373|NCT02855164|4026162|FG007|STARTED|Part C (Randomized Set)||51
3292374|NCT02855164|4026155|FG000|COMPLETED|Part C (Randomized Set)||0
3292375|NCT02855164|4026156|FG001|COMPLETED|Part C (Randomized Set)||0
3292376|NCT02855164|4026157|FG002|COMPLETED|Part C (Randomized Set)||0
3292377|NCT02855164|4026158|FG003|COMPLETED|Part C (Randomized Set)||0
3292378|NCT02855164|4026159|FG004|COMPLETED|Part C (Randomized Set)||0
3292379|NCT02855164|4026160|FG005|COMPLETED|Part C (Randomized Set)||38
3292380|NCT02855164|4026161|FG006|COMPLETED|Part C (Randomized Set)||37
3292381|NCT02855164|4026162|FG007|COMPLETED|Part C (Randomized Set)||44
3292382|NCT02855164|4026155|FG000|NOT COMPLETED|Part C (Randomized Set)||0
3292383|NCT02855164|4026156|FG001|NOT COMPLETED|Part C (Randomized Set)||0
3292384|NCT02855164|4026157|FG002|NOT COMPLETED|Part C (Randomized Set)||0
3292385|NCT02855164|4026158|FG003|NOT COMPLETED|Part C (Randomized Set)||0
3292386|NCT02855164|4026159|FG004|NOT COMPLETED|Part C (Randomized Set)||0
3292387|NCT02855164|4026160|FG005|NOT COMPLETED|Part C (Randomized Set)||12
3292388|NCT02855164|4026161|FG006|NOT COMPLETED|Part C (Randomized Set)||14
3292389|NCT02855164|4026162|FG007|NOT COMPLETED|Part C (Randomized Set)||7
3292390|NCT02855281|4026200|FG000|STARTED|Overall Study||50
3292391|NCT02855281|4026200|FG000|COMPLETED|Overall Study||50
3292392|NCT02855281|4026200|FG000|NOT COMPLETED|Overall Study||0
3292393|NCT02855359|4026210|FG000|STARTED|Overall Study||11
3108157|NCT01548287|3832458|FG001|STARTED|Screening||22
3108158|NCT01548287|3832459|FG002|STARTED|Screening||20
3108159|NCT01548287|3832460|FG003|STARTED|Screening||20
3108160|NCT01548287|3832461|FG004|STARTED|Screening||83
3108161|NCT01548287|3832457|FG000|COMPLETED|Screening||19
3108162|NCT01548287|3832458|FG001|COMPLETED|Screening||22
3108163|NCT01548287|3832459|FG002|COMPLETED|Screening||20
3108164|NCT01548287|3832460|FG003|COMPLETED|Screening||20
3108165|NCT01548287|3832461|FG004|COMPLETED|Screening||0
3108166|NCT01548287|3832457|FG000|NOT COMPLETED|Screening||0
3108167|NCT01548287|3832458|FG001|NOT COMPLETED|Screening||0
3108168|NCT01548287|3832459|FG002|NOT COMPLETED|Screening||0
3108169|NCT01548287|3832460|FG003|NOT COMPLETED|Screening||0
3108170|NCT01548287|3832461|FG004|NOT COMPLETED|Screening||83
3108171|NCT01548287|3832457|FG000|STARTED|Randomized Period||19
3108172|NCT01548287|3832458|FG001|STARTED|Randomized Period||22
3108173|NCT01548287|3832459|FG002|STARTED|Randomized Period||20
3108174|NCT01548287|3832460|FG003|STARTED|Randomized Period||20
3108175|NCT01548287|3832461|FG004|STARTED|Randomized Period||0
3108176|NCT01548287|3832457|FG000|COMPLETED|Randomized Period||19
3108177|NCT01548287|3832458|FG001|COMPLETED|Randomized Period||20
3108178|NCT01548287|3832459|FG002|COMPLETED|Randomized Period||13
3108179|NCT01548287|3832460|FG003|COMPLETED|Randomized Period||20
3108180|NCT01548287|3832461|FG004|COMPLETED|Randomized Period||0
3108181|NCT01548287|3832457|FG000|NOT COMPLETED|Randomized Period||0
3108182|NCT01548287|3832458|FG001|NOT COMPLETED|Randomized Period||2
3108183|NCT01548287|3832459|FG002|NOT COMPLETED|Randomized Period||7
3108184|NCT01548287|3832460|FG003|NOT COMPLETED|Randomized Period||0
3108185|NCT01548287|3832461|FG004|NOT COMPLETED|Randomized Period||0
3108186|NCT01548339|3832473|FG000|STARTED|Overall Study||44
3108187|NCT01548339|3832474|FG001|STARTED|Overall Study||42
3108188|NCT01548339|3832473|FG000|COMPLETED|Overall Study||38
3108189|NCT01548339|3832474|FG001|COMPLETED|Overall Study||41
3108190|NCT01548339|3832473|FG000|NOT COMPLETED|Overall Study||6
3108191|NCT01548339|3832474|FG001|NOT COMPLETED|Overall Study||1
3108192|NCT01548404|3832482|FG000|STARTED|Overall Study||54
3108193|NCT01548404|3832483|FG001|STARTED|Overall Study||55
3163168|NCT01883986|3890646|FG001|NOT COMPLETED|Overall Study||1
3163169|NCT01883999|3890652|FG000|STARTED|Overall Study||64
3163170|NCT01883999|3890652|FG000|COMPLETED|Overall Study||61
3163171|NCT01883999|3890652|FG000|NOT COMPLETED|Overall Study||3
3163172|NCT01884025|3890658|FG000|STARTED|Overall Study||13
3292394|NCT02855359|4026211|FG001|STARTED|Overall Study||13
3292395|NCT02855359|4026212|FG002|STARTED|Overall Study||0
3292396|NCT02855359|4026213|FG003|STARTED|Overall Study||0
3292397|NCT02855359|4026210|FG000|COMPLETED|Overall Study||0
3292398|NCT02855359|4026211|FG001|COMPLETED|Overall Study||0
3292399|NCT02855359|4026212|FG002|COMPLETED|Overall Study||0
3292400|NCT02855359|4026213|FG003|COMPLETED|Overall Study||0
3292401|NCT02855359|4026210|FG000|NOT COMPLETED|Overall Study||11
3292402|NCT02855359|4026211|FG001|NOT COMPLETED|Overall Study||13
3292403|NCT02855359|4026212|FG002|NOT COMPLETED|Overall Study||0
3292404|NCT02855359|4026213|FG003|NOT COMPLETED|Overall Study||0
3292405|NCT02855437|4026221|FG000|STARTED|Phase 1||23
3292406|NCT02855437|4026222|FG001|STARTED|Phase 1||21
3292407|NCT02855437|4026221|FG000|COMPLETED|Phase 1||21
3292408|NCT02855437|4026222|FG001|COMPLETED|Phase 1||19
3292409|NCT02855437|4026221|FG000|NOT COMPLETED|Phase 1||2
3292410|NCT02855437|4026222|FG001|NOT COMPLETED|Phase 1||2
3292411|NCT02855437|4026221|FG000|STARTED|Crossover Period (Same Day)||21
3292412|NCT02855437|4026222|FG001|STARTED|Crossover Period (Same Day)||19
3292413|NCT02855437|4026221|FG000|COMPLETED|Crossover Period (Same Day)||21
3292414|NCT02855437|4026222|FG001|COMPLETED|Crossover Period (Same Day)||19
3292415|NCT02855437|4026221|FG000|NOT COMPLETED|Crossover Period (Same Day)||0
3292416|NCT02855437|4026222|FG001|NOT COMPLETED|Crossover Period (Same Day)||0
3292417|NCT02855437|4026221|FG000|STARTED|Phase 2||21
3292418|NCT02855437|4026222|FG001|STARTED|Phase 2||19
3292419|NCT02855437|4026221|FG000|COMPLETED|Phase 2||20
3292420|NCT02855437|4026222|FG001|COMPLETED|Phase 2||18
3292421|NCT02855437|4026221|FG000|NOT COMPLETED|Phase 2||1
3292422|NCT02855437|4026222|FG001|NOT COMPLETED|Phase 2||1
3292423|NCT02855450|4026231|FG000|STARTED|Overall Study||40
3292424|NCT02855450|4026232|FG001|STARTED|Overall Study||20
3292425|NCT02855450|4026231|FG000|COMPLETED|Overall Study||35
3292426|NCT02855450|4026232|FG001|COMPLETED|Overall Study||20
3292427|NCT02855450|4026231|FG000|NOT COMPLETED|Overall Study||5
3292428|NCT02855450|4026232|FG001|NOT COMPLETED|Overall Study||0
3292429|NCT02855541|4026238|FG000|STARTED|Overall Study||25
3292430|NCT02855541|4026238|FG000|COMPLETED|Overall Study||21
3292431|NCT02855541|4026238|FG000|NOT COMPLETED|Overall Study||4
3292432|NCT02855567|4026244|FG000|STARTED|Overall Study||54
3292433|NCT02855567|4026245|FG001|STARTED|Overall Study||56
3292434|NCT02855567|4026244|FG000|COMPLETED|Overall Study||54
3292435|NCT02855567|4026245|FG001|COMPLETED|Overall Study||56
3292436|NCT02855567|4026244|FG000|NOT COMPLETED|Overall Study||0
3292437|NCT02855567|4026245|FG001|NOT COMPLETED|Overall Study||0
3292438|NCT02856035|4026251|FG000|STARTED|Overall Study||4
3292439|NCT02856035|4026251|FG000|COMPLETED|Overall Study||4
3292440|NCT02856035|4026251|FG000|NOT COMPLETED|Overall Study||0
3292441|NCT02856282|4026255|FG000|STARTED|Overall Study||46
3292442|NCT02856282|4026255|FG000|COMPLETED|Overall Study||45
3292443|NCT02856282|4026255|FG000|NOT COMPLETED|Overall Study||1
3108194|NCT01548404|3832482|FG000|COMPLETED|Overall Study||24
3108195|NCT01548404|3832483|FG001|COMPLETED|Overall Study||41
3108196|NCT01548404|3832482|FG000|NOT COMPLETED|Overall Study||30
3108197|NCT01548404|3832483|FG001|NOT COMPLETED|Overall Study||14
3292444|NCT02856490|4026262|FG000|STARTED|Overall Study||2
3292445|NCT02856490|4026263|FG001|STARTED|Overall Study||2
3108198|NCT01548417|3832492|FG000|STARTED|Overall Study||28
3108199|NCT01548417|3832493|FG001|STARTED|Overall Study||28
3108200|NCT01548417|3832492|FG000|COMPLETED|Overall Study||28
3163173|NCT01884025|3890659|FG001|STARTED|Overall Study||14
3108201|NCT01548417|3832493|FG001|COMPLETED|Overall Study||26
3108202|NCT01548417|3832492|FG000|NOT COMPLETED|Overall Study||0
3108203|NCT01548417|3832493|FG001|NOT COMPLETED|Overall Study||2
3108204|NCT01548573|3832499|FG000|STARTED|Overall Study||19
3108205|NCT01548573|3832499|FG000|COMPLETED|Overall Study||14
3108206|NCT01548573|3832499|FG000|NOT COMPLETED|Overall Study||5
3108207|NCT01548599|3832506|FG000|STARTED|Overall Study||72
3108208|NCT01548599|3832507|FG001|STARTED|Overall Study||68
3108209|NCT01548599|3832506|FG000|COMPLETED|Overall Study||66
3108210|NCT01548599|3832507|FG001|COMPLETED|Overall Study||66
3108211|NCT01548599|3832506|FG000|NOT COMPLETED|Overall Study||6
3108212|NCT01548599|3832507|FG001|NOT COMPLETED|Overall Study||2
3108213|NCT01548638|3832516|FG000|STARTED|Overall Study||13
3108214|NCT01548638|3832516|FG000|COMPLETED|Overall Study||9
3108215|NCT01548638|3832516|FG000|NOT COMPLETED|Overall Study||4
3108216|NCT01548690|3832525|FG000|STARTED|Overall Study||9
3108217|NCT01548690|3832526|FG001|STARTED|Overall Study||10
3108218|NCT01548690|3832527|FG002|STARTED|Overall Study||13
3108219|NCT01548690|3832528|FG003|STARTED|Overall Study||15
3108220|NCT01548690|3832525|FG000|Evaluable (72 Hours on Infusion)|Overall Study||6
3108221|NCT01548690|3832526|FG001|Evaluable (72 Hours on Infusion)|Overall Study||6
3108222|NCT01548690|3832527|FG002|Evaluable (72 Hours on Infusion)|Overall Study||12
3108223|NCT01548690|3832528|FG003|Evaluable (72 Hours on Infusion)|Overall Study||12
3108224|NCT01548690|3832525|FG000|COMPLETED|Overall Study||9
3108225|NCT01548690|3832526|FG001|COMPLETED|Overall Study||7
3108226|NCT01548690|3832527|FG002|COMPLETED|Overall Study||8
3108227|NCT01548690|3832528|FG003|COMPLETED|Overall Study||10
3108228|NCT01548690|3832525|FG000|NOT COMPLETED|Overall Study||0
3108229|NCT01548690|3832526|FG001|NOT COMPLETED|Overall Study||3
3108230|NCT01548690|3832527|FG002|NOT COMPLETED|Overall Study||5
3108231|NCT01548690|3832528|FG003|NOT COMPLETED|Overall Study||5
3108232|NCT01548742|3832543|FG000|STARTED|Overall Study||58
3108233|NCT01548742|3832544|FG001|STARTED|Overall Study||58
3108234|NCT01548742|3832543|FG000|COMPLETED|Overall Study||45
3108235|NCT01548742|3832544|FG001|COMPLETED|Overall Study||54
3163174|NCT01884025|3890658|FG000|COMPLETED|Overall Study||10
3163175|NCT01884025|3890659|FG001|COMPLETED|Overall Study||10
3163176|NCT01884025|3890658|FG000|NOT COMPLETED|Overall Study||3
3163177|NCT01884025|3890659|FG001|NOT COMPLETED|Overall Study||4
3163178|NCT01884064|3890667|FG000|STARTED|Overall Study||12
3163179|NCT01884064|3890668|FG001|STARTED|Overall Study||5
3163180|NCT01884064|3890667|FG000|COMPLETED|Overall Study||12
3163181|NCT01884064|3890668|FG001|COMPLETED|Overall Study||5
3163182|NCT01884064|3890667|FG000|NOT COMPLETED|Overall Study||0
3163183|NCT01884064|3890668|FG001|NOT COMPLETED|Overall Study||0
3163184|NCT01884311|3890674|FG000|STARTED|Overall Study||38
3163185|NCT01884311|3890674|FG000|COMPLETED|Overall Study||33
3163186|NCT01884311|3890674|FG000|NOT COMPLETED|Overall Study||5
3163187|NCT01884337|3890683|FG000|STARTED|Treatment||326
3163188|NCT01884337|3890684|FG001|STARTED|Treatment||172
3163189|NCT01884337|3890683|FG000|Continuing Into Follow-up Period|Treatment||324
3163190|NCT01884337|3890684|FG001|Continuing Into Follow-up Period|Treatment||171
3163191|NCT01884337|3890683|FG000|COMPLETED|Treatment||322
3163192|NCT01884337|3890684|FG001|COMPLETED|Treatment||170
3163193|NCT01884337|3890683|FG000|NOT COMPLETED|Treatment||4
3163194|NCT01884337|3890684|FG001|NOT COMPLETED|Treatment||2
3163195|NCT01884337|3890683|FG000|STARTED|Follow-up Period||324
3163196|NCT01884337|3890684|FG001|STARTED|Follow-up Period||171
3163197|NCT01884337|3890683|FG000|COMPLETED|Follow-up Period||323
3163198|NCT01884337|3890684|FG001|COMPLETED|Follow-up Period||170
3163199|NCT01884337|3890683|FG000|NOT COMPLETED|Follow-up Period||1
3163200|NCT01884337|3890684|FG001|NOT COMPLETED|Follow-up Period||1
3163201|NCT01884350|3890692|FG000|STARTED|Primary Efficacy Analysis Set (24 Weeks)||583
3163202|NCT01884350|3890693|FG001|STARTED|Primary Efficacy Analysis Set (24 Weeks)||579
3163203|NCT01884350|3890694|FG002|STARTED|Primary Efficacy Analysis Set (24 Weeks)|Participants were not randomized to this arm until after initial 24-week period|0
3163204|NCT01884350|3890692|FG000|Safety Analysis Set|Primary Efficacy Analysis Set (24 Weeks)||604
3163205|NCT01884350|3890693|FG001|Safety Analysis Set|Primary Efficacy Analysis Set (24 Weeks)||558
3163206|NCT01884350|3890694|FG002|Safety Analysis Set|Primary Efficacy Analysis Set (24 Weeks)||0
3163207|NCT01884350|3890692|FG000|COMPLETED|Primary Efficacy Analysis Set (24 Weeks)||529
3163208|NCT01884350|3890693|FG001|COMPLETED|Primary Efficacy Analysis Set (24 Weeks)||525
3163209|NCT01884350|3890694|FG002|COMPLETED|Primary Efficacy Analysis Set (24 Weeks)||0
3163210|NCT01884350|3890692|FG000|NOT COMPLETED|Primary Efficacy Analysis Set (24 Weeks)||54
3163211|NCT01884350|3890693|FG001|NOT COMPLETED|Primary Efficacy Analysis Set (24 Weeks)||54
3163212|NCT01884350|3890694|FG002|NOT COMPLETED|Primary Efficacy Analysis Set (24 Weeks)||0
3163213|NCT01884350|3890692|FG000|STARTED|Primary Efficacy Analysis Set (48 Weeks)||583
3292446|NCT02856490|4026264|FG002|STARTED|Overall Study||2
3292447|NCT02856490|4026262|FG000|COMPLETED|Overall Study||2
3292448|NCT02856490|4026263|FG001|COMPLETED|Overall Study||2
3292449|NCT02856490|4026264|FG002|COMPLETED|Overall Study||2
3292450|NCT02856490|4026262|FG000|NOT COMPLETED|Overall Study||0
3292451|NCT02856490|4026263|FG001|NOT COMPLETED|Overall Study||0
3108236|NCT01548742|3832543|FG000|NOT COMPLETED|Overall Study||13
3108237|NCT01548742|3832544|FG001|NOT COMPLETED|Overall Study||4
3108238|NCT01548768|3832556|FG000|STARTED|Overall Study||8
3108239|NCT01548768|3832557|FG001|STARTED|Overall Study||4
3108240|NCT01548768|3832558|FG002|STARTED|Overall Study||16
3108241|NCT01548768|3832559|FG003|STARTED|Overall Study||121
3292452|NCT02856490|4026264|FG002|NOT COMPLETED|Overall Study||0
3292453|NCT02856555|4026275|FG000|STARTED|Overall Study||51
3292454|NCT02856555|4026276|FG001|STARTED|Overall Study||50
3292455|NCT02856555|4026277|FG002|STARTED|Overall Study||26
3292456|NCT02856555|4026275|FG000|COMPLETED|Overall Study||46
3292457|NCT02856555|4026276|FG001|COMPLETED|Overall Study||46
3292458|NCT02856555|4026277|FG002|COMPLETED|Overall Study||26
3292459|NCT02856555|4026275|FG000|NOT COMPLETED|Overall Study||5
3292460|NCT02856555|4026276|FG001|NOT COMPLETED|Overall Study||4
3292461|NCT02856555|4026277|FG002|NOT COMPLETED|Overall Study||0
3292462|NCT02856802|4026287|FG000|STARTED|Double-Blind Treatment Period 1|4 of 54 randomized subjects did not start; 2 had no migraines, 1 withdrew, 1 lost to follow-up.|50
3292463|NCT02856802|4026288|FG001|STARTED|Double-Blind Treatment Period 1|10 of 53 randomized subjects did not start; 6 had no migraines, 3 withdrew, 1 sponsor terminated.|43
3108242|NCT01548768|3832556|FG000|COMPLETED|Overall Study||7
3108243|NCT01548768|3832557|FG001|COMPLETED|Overall Study||2
3108244|NCT01548768|3832558|FG002|COMPLETED|Overall Study||15
3108245|NCT01548768|3832559|FG003|COMPLETED|Overall Study||117
3108246|NCT01548768|3832556|FG000|NOT COMPLETED|Overall Study||1
3108247|NCT01548768|3832557|FG001|NOT COMPLETED|Overall Study||2
3108248|NCT01548768|3832558|FG002|NOT COMPLETED|Overall Study||1
3108249|NCT01548768|3832559|FG003|NOT COMPLETED|Overall Study||4
3108250|NCT01548833|3832571|FG000|STARTED|Overall Study||39
3108251|NCT01548833|3832571|FG000|COMPLETED|Overall Study||39
3108252|NCT01548833|3832571|FG000|NOT COMPLETED|Overall Study||0
3108253|NCT01548885|3832579|FG000|STARTED|Overall Study||146
3108254|NCT01548885|3832579|FG000|COMPLETED|Overall Study||146
3108255|NCT01548885|3832579|FG000|NOT COMPLETED|Overall Study||0
3108256|NCT01549002|3832585|FG000|STARTED|Overall Study||10
3108257|NCT01549002|3832586|FG001|STARTED|Overall Study||10
3108258|NCT01549002|3832585|FG000|COMPLETED|Overall Study||10
3108259|NCT01549002|3832586|FG001|COMPLETED|Overall Study||6
3108260|NCT01549002|3832585|FG000|NOT COMPLETED|Overall Study||0
3108261|NCT01549002|3832586|FG001|NOT COMPLETED|Overall Study||4
3108262|NCT01549041|3832594|FG000|STARTED|Overall Study||12
3108263|NCT01549041|3832595|FG001|STARTED|Overall Study||18
3108264|NCT01549041|3832594|FG000|COMPLETED|Overall Study||10
3108265|NCT01549041|3832595|FG001|COMPLETED|Overall Study||10
3108266|NCT01549041|3832594|FG000|NOT COMPLETED|Overall Study||2
3108267|NCT01549041|3832595|FG001|NOT COMPLETED|Overall Study||8
3108268|NCT01549223|3832603|FG000|STARTED|Overall Study||30
3108269|NCT01549223|3832604|FG001|STARTED|Overall Study||30
3108270|NCT01549223|3832603|FG000|COMPLETED|Overall Study||30
3108271|NCT01549223|3832604|FG001|COMPLETED|Overall Study||30
3108272|NCT01549223|3832603|FG000|NOT COMPLETED|Overall Study||0
3108273|NCT01549223|3832604|FG001|NOT COMPLETED|Overall Study||0
3108274|NCT01549275|3832612|FG000|STARTED|Overall Study||76
3108275|NCT01549275|3832613|FG001|STARTED|Overall Study||29
3108276|NCT01549275|3832612|FG000|COMPLETED|Overall Study||75
3292464|NCT02856802|4026287|FG000|COMPLETED|Double-Blind Treatment Period 1||48
3292465|NCT02856802|4026288|FG001|COMPLETED|Double-Blind Treatment Period 1||38
3292466|NCT02856802|4026287|FG000|NOT COMPLETED|Double-Blind Treatment Period 1||2
3292467|NCT02856802|4026288|FG001|NOT COMPLETED|Double-Blind Treatment Period 1||5
3292468|NCT02856802|4026287|FG000|STARTED|Double-Blind Treatment Period 2|6 of 43 re-randomized subjects did not start; 5 had no migraines, for 1 protocol deviation.|37
3292469|NCT02856802|4026288|FG001|STARTED|Double-Blind Treatment Period 2|5 of 43 re-randomized subjects did not start; 4 had no migraines, for 1 prohibited drug use.|38
3292470|NCT02856802|4026287|FG000|COMPLETED|Double-Blind Treatment Period 2||36
3292471|NCT02856802|4026288|FG001|COMPLETED|Double-Blind Treatment Period 2||38
3292472|NCT02856802|4026287|FG000|NOT COMPLETED|Double-Blind Treatment Period 2||1
3292473|NCT02856802|4026288|FG001|NOT COMPLETED|Double-Blind Treatment Period 2||0
3292474|NCT02856828|4026300|FG000|STARTED|Overall Study||2
3292475|NCT02856828|4026301|FG001|STARTED|Overall Study||3
3292476|NCT02856828|4026300|FG000|COMPLETED|Overall Study||2
3292477|NCT02856828|4026301|FG001|COMPLETED|Overall Study||3
3292478|NCT02856828|4026300|FG000|NOT COMPLETED|Overall Study||0
3292479|NCT02856828|4026301|FG001|NOT COMPLETED|Overall Study||0
3292480|NCT02856880|4026315|FG000|STARTED|Overall Study||45
3292481|NCT02856880|4026315|FG000|Received Test Zinc-IPMP|Overall Study||44
3292482|NCT02856880|4026315|FG000|Received Test Zinc Non-IPMP|Overall Study||44
3292483|NCT02856880|4026315|FG000|Received Positive Control|Overall Study||45
3292484|NCT02856880|4026315|FG000|Received Non-SLS Negative Control|Overall Study||44
3292485|NCT02856880|4026315|FG000|Received SLS Negative Control|Overall Study||44
3292486|NCT02856880|4026315|FG000|COMPLETED|Overall Study||44
3292487|NCT02856880|4026315|FG000|NOT COMPLETED|Overall Study||1
3292488|NCT02857283|4026336|FG000|STARTED|First Exposure||8
3292489|NCT02857283|4026337|FG001|STARTED|First Exposure||7
3292490|NCT02857283|4026336|FG000|COMPLETED|First Exposure||7
3292491|NCT02857283|4026337|FG001|COMPLETED|First Exposure||7
3292492|NCT02857283|4026336|FG000|NOT COMPLETED|First Exposure||1
3292493|NCT02857283|4026337|FG001|NOT COMPLETED|First Exposure||0
3108277|NCT01549275|3832613|FG001|COMPLETED|Overall Study||29
3108278|NCT01549275|3832612|FG000|NOT COMPLETED|Overall Study||1
3108279|NCT01549275|3832613|FG001|NOT COMPLETED|Overall Study||0
3108280|NCT01549314|3832626|FG000|STARTED|Overall Study|1 subject signed the consent form but dropped out prior to any study procedures or data collection.|27
3108281|NCT01549314|3832627|FG001|STARTED|Overall Study||26
3292494|NCT02857283|4026336|FG000|STARTED|Washout (2 Weeks)||7
3292495|NCT02857283|4026337|FG001|STARTED|Washout (2 Weeks)||7
3292496|NCT02857283|4026336|FG000|COMPLETED|Washout (2 Weeks)||7
3108282|NCT01549314|3832628|FG002|STARTED|Overall Study||26
3108283|NCT01549314|3832626|FG000|COMPLETED|Overall Study||23
3108284|NCT01549314|3832627|FG001|COMPLETED|Overall Study||21
3108285|NCT01549314|3832628|FG002|COMPLETED|Overall Study||24
3108286|NCT01549314|3832626|FG000|NOT COMPLETED|Overall Study||4
3108287|NCT01549314|3832627|FG001|NOT COMPLETED|Overall Study||5
3108288|NCT01549314|3832628|FG002|NOT COMPLETED|Overall Study||2
3108289|NCT01549340|3832636|FG000|STARTED|Overall Study|Advised to receive AIT|8790
3108290|NCT01549340|3832636|FG000|Started AIT|Overall Study||3182
3108291|NCT01549340|3832636|FG000|COMPLETED|Overall Study|Completed 5 years of AIT|385
3108292|NCT01549340|3832636|FG000|NOT COMPLETED|Overall Study||8405
3135655|NCT01708590|3860729|FG002|COMPLETED|Induction Phase||209
3135656|NCT01708590|3860730|FG003|COMPLETED|Induction Phase||0
3135657|NCT01708590|3860731|FG004|COMPLETED|Induction Phase||0
3135658|NCT01708590|3860732|FG005|COMPLETED|Induction Phase||0
3135659|NCT01708590|3860733|FG006|COMPLETED|Induction Phase||0
3135660|NCT01708590|3860727|FG000|NOT COMPLETED|Induction Phase||10
3135661|NCT01708590|3860728|FG001|NOT COMPLETED|Induction Phase||7
3135662|NCT01708590|3860729|FG002|NOT COMPLETED|Induction Phase||11
3135663|NCT01708590|3860730|FG003|NOT COMPLETED|Induction Phase||0
3135664|NCT01708590|3860731|FG004|NOT COMPLETED|Induction Phase||0
3135665|NCT01708590|3860732|FG005|NOT COMPLETED|Induction Phase||0
3135666|NCT01708590|3860733|FG006|NOT COMPLETED|Induction Phase||0
3135667|NCT01708590|3860727|FG000|STARTED|Withdrawal Phase||0
3135668|NCT01708590|3860728|FG001|STARTED|Withdrawal Phase||0
3135669|NCT01708590|3860729|FG002|STARTED|Withdrawal Phase||0
3135670|NCT01708590|3860730|FG003|STARTED|Withdrawal Phase||59
3135671|NCT01708590|3860731|FG004|STARTED|Withdrawal Phase||57
3135672|NCT01708590|3860732|FG005|STARTED|Withdrawal Phase||84
3135673|NCT01708590|3860733|FG006|STARTED|Withdrawal Phase||83
3135674|NCT01708590|3860727|FG000|COMPLETED|Withdrawal Phase||0
3135675|NCT01708590|3860728|FG001|COMPLETED|Withdrawal Phase||0
3135676|NCT01708590|3860729|FG002|COMPLETED|Withdrawal Phase||0
3135677|NCT01708590|3860730|FG003|COMPLETED|Withdrawal Phase||6
3135678|NCT01708590|3860731|FG004|COMPLETED|Withdrawal Phase||45
3135679|NCT01708590|3860732|FG005|COMPLETED|Withdrawal Phase||2
3135680|NCT01708590|3860733|FG006|COMPLETED|Withdrawal Phase||74
3135681|NCT01708590|3860727|FG000|NOT COMPLETED|Withdrawal Phase||0
3135682|NCT01708590|3860728|FG001|NOT COMPLETED|Withdrawal Phase||0
3135683|NCT01708590|3860729|FG002|NOT COMPLETED|Withdrawal Phase||0
3135684|NCT01708590|3860730|FG003|NOT COMPLETED|Withdrawal Phase||53
3135685|NCT01708590|3860731|FG004|NOT COMPLETED|Withdrawal Phase||12
3135686|NCT01708590|3860732|FG005|NOT COMPLETED|Withdrawal Phase||82
3135687|NCT01708590|3860733|FG006|NOT COMPLETED|Withdrawal Phase||9
3135688|NCT01708603|3860750|FG000|STARTED|Overall Study||612
3135689|NCT01708603|3860751|FG001|STARTED|Overall Study||610
3135690|NCT01708603|3860752|FG002|STARTED|Overall Study||300
3135691|NCT01708603|3860753|FG003|STARTED|Overall Study||309
3135692|NCT01708603|3860750|FG000|COMPLETED|Overall Study||597
3135693|NCT01708603|3860751|FG001|COMPLETED|Overall Study||588
3135694|NCT01708603|3860752|FG002|COMPLETED|Overall Study||291
3135695|NCT01708603|3860753|FG003|COMPLETED|Overall Study||300
3135696|NCT01708603|3860750|FG000|NOT COMPLETED|Overall Study||15
3292497|NCT02857283|4026337|FG001|COMPLETED|Washout (2 Weeks)||7
3292498|NCT02857283|4026336|FG000|NOT COMPLETED|Washout (2 Weeks)||0
3292499|NCT02857283|4026337|FG001|NOT COMPLETED|Washout (2 Weeks)||0
3292500|NCT02857283|4026336|FG000|STARTED|Second Exposure||7
3292501|NCT02857283|4026337|FG001|STARTED|Second Exposure||7
3292502|NCT02857283|4026336|FG000|COMPLETED|Second Exposure||7
3292503|NCT02857283|4026337|FG001|COMPLETED|Second Exposure||7
3292504|NCT02857283|4026336|FG000|NOT COMPLETED|Second Exposure||0
3292505|NCT02857283|4026337|FG001|NOT COMPLETED|Second Exposure||0
3292506|NCT02857816|4026344|FG000|STARTED|Overall Study||154
3292507|NCT02857816|4026344|FG000|Subjects Qualified and Treated With PTNM|Overall Study||120
3292508|NCT02857816|4026344|FG000|COMPLETED|Overall Study||116
3292509|NCT02857816|4026344|FG000|NOT COMPLETED|Overall Study||38
3292510|NCT02858050|4026351|FG000|STARTED|Overall Study||20
3292511|NCT02858050|4026352|FG001|STARTED|Overall Study||20
3292512|NCT02858050|4026351|FG000|COMPLETED|Overall Study||20
3292513|NCT02858050|4026352|FG001|COMPLETED|Overall Study||20
3292514|NCT02858050|4026351|FG000|NOT COMPLETED|Overall Study||0
3292515|NCT02858050|4026352|FG001|NOT COMPLETED|Overall Study||0
3316765|NCT03118934|4050194|FG005|NOT COMPLETED|Overall Study||2
3316766|NCT03118947|4050204|FG000|STARTED|Overall Study||78
3316767|NCT03118947|4050204|FG000|COMPLETED|Overall Study||49
3316768|NCT03118947|4050204|FG000|NOT COMPLETED|Overall Study||29
3316769|NCT03119025|4050208|FG000|STARTED|Overall Study||10
3316770|NCT03119025|4050208|FG000|COMPLETED|Overall Study||10
3316771|NCT03119025|4050208|FG000|NOT COMPLETED|Overall Study||0
3316772|NCT03119168|4050214|FG000|STARTED|Overall Study||129
3316773|NCT03119168|4050215|FG001|STARTED|Overall Study||139
3135697|NCT01708603|3860751|FG001|NOT COMPLETED|Overall Study||22
3135698|NCT01708603|3860752|FG002|NOT COMPLETED|Overall Study||9
3135699|NCT01708603|3860753|FG003|NOT COMPLETED|Overall Study||9
3135700|NCT01708629|3860772|FG000|STARTED|Overall Study||624
3135701|NCT01708629|3860773|FG001|STARTED|Overall Study||629
3316774|NCT03119168|4050214|FG000|COMPLETED|Overall Study||129
3316775|NCT03119168|4050215|FG001|COMPLETED|Overall Study||139
3316776|NCT03119168|4050214|FG000|NOT COMPLETED|Overall Study||0
3316777|NCT03119168|4050215|FG001|NOT COMPLETED|Overall Study||0
3316778|NCT03119181|4050225|FG000|STARTED|Overall Study||19
3316779|NCT03119181|4050226|FG001|STARTED|Overall Study||21
3108293|NCT01549392|3832647|FG000|STARTED|Overall Study||3
3108294|NCT01549392|3832648|FG001|STARTED|Overall Study||0
3108295|NCT01549392|3832647|FG000|COMPLETED|Overall Study||2
3108296|NCT01549392|3832648|FG001|COMPLETED|Overall Study||0
3108297|NCT01549392|3832647|FG000|NOT COMPLETED|Overall Study||1
3292516|NCT02858076|4026360|FG000|STARTED|Overall Study||100
3292517|NCT02858076|4026361|FG001|STARTED|Overall Study||105
3292518|NCT02858076|4026360|FG000|COMPLETED|Overall Study||90
3292519|NCT02858076|4026361|FG001|COMPLETED|Overall Study||87
3292520|NCT02858076|4026360|FG000|NOT COMPLETED|Overall Study||10
3292521|NCT02858076|4026361|FG001|NOT COMPLETED|Overall Study||18
3292522|NCT02858154|4026369|FG000|STARTED|HFNC 3-4 Hours||9
3292523|NCT02858154|4026369|FG000|COMPLETED|HFNC 3-4 Hours||9
3292524|NCT02858154|4026369|FG000|NOT COMPLETED|HFNC 3-4 Hours||0
3292525|NCT02858154|4026369|FG000|STARTED|Clinically Ordered PSG/Low Flow Oxygen||9
3292526|NCT02858154|4026369|FG000|COMPLETED|Clinically Ordered PSG/Low Flow Oxygen||9
3292527|NCT02858154|4026369|FG000|NOT COMPLETED|Clinically Ordered PSG/Low Flow Oxygen||0
3292528|NCT02858180|4026376|FG000|STARTED|Overall Study||10
3292529|NCT02858180|4026377|FG001|STARTED|Overall Study||5
3292530|NCT02858180|4026376|FG000|COMPLETED|Overall Study|Completed a 12-week course of therapy.|10
3292531|NCT02858180|4026377|FG001|COMPLETED|Overall Study|Completed a 12-week course of therapy.|3
3292532|NCT02858180|4026376|FG000|NOT COMPLETED|Overall Study||0
3292533|NCT02858180|4026377|FG001|NOT COMPLETED|Overall Study||2
3292534|NCT02858349|4026383|FG000|STARTED|Overall Study||10
3292535|NCT02858349|4026383|FG000|COMPLETED|Overall Study||10
3292536|NCT02858349|4026383|FG000|NOT COMPLETED|Overall Study||0
3292537|NCT02858362|4026390|FG000|STARTED|Overall Study||30
3292538|NCT02858362|4026391|FG001|STARTED|Overall Study||10
3292539|NCT02858362|4026392|FG002|STARTED|Overall Study||3
3292540|NCT02858362|4026390|FG000|Did Not Enter Extension Phase|Overall Study||1
3292541|NCT02858362|4026391|FG001|Did Not Enter Extension Phase|Overall Study||2
3292542|NCT02858362|4026392|FG002|Did Not Enter Extension Phase|Overall Study||0
3292543|NCT02858362|4026390|FG000|COMPLETED|Overall Study||28
3292544|NCT02858362|4026391|FG001|COMPLETED|Overall Study||9
3292545|NCT02858362|4026392|FG002|COMPLETED|Overall Study||0
3292546|NCT02858362|4026390|FG000|NOT COMPLETED|Overall Study||2
3292547|NCT02858362|4026391|FG001|NOT COMPLETED|Overall Study||1
3292548|NCT02858362|4026392|FG002|NOT COMPLETED|Overall Study||3
3292549|NCT02858401|4026412|FG000|STARTED|Overall Study||6
3292550|NCT02858401|4026413|FG001|STARTED|Overall Study||6
3292551|NCT02858401|4026414|FG002|STARTED|Overall Study||6
3292552|NCT02858401|4026415|FG003|STARTED|Overall Study||6
3292553|NCT02858401|4026416|FG004|STARTED|Overall Study||6
3292554|NCT02858401|4026417|FG005|STARTED|Overall Study||6
3292555|NCT02858401|4026418|FG006|STARTED|Overall Study||12
3292556|NCT02858401|4026412|FG000|COMPLETED|Overall Study||6
3292557|NCT02858401|4026413|FG001|COMPLETED|Overall Study||5
3292558|NCT02858401|4026414|FG002|COMPLETED|Overall Study||6
3292559|NCT02858401|4026415|FG003|COMPLETED|Overall Study||6
3292560|NCT02858401|4026416|FG004|COMPLETED|Overall Study||6
3292561|NCT02858401|4026417|FG005|COMPLETED|Overall Study||5
3292562|NCT02858401|4026418|FG006|COMPLETED|Overall Study||12
3292563|NCT02858401|4026412|FG000|NOT COMPLETED|Overall Study||0
3292564|NCT02858401|4026413|FG001|NOT COMPLETED|Overall Study||1
3292565|NCT02858401|4026414|FG002|NOT COMPLETED|Overall Study||0
3292566|NCT02858401|4026415|FG003|NOT COMPLETED|Overall Study||0
3292567|NCT02858401|4026416|FG004|NOT COMPLETED|Overall Study||0
3292568|NCT02858401|4026417|FG005|NOT COMPLETED|Overall Study||1
3292569|NCT02858401|4026418|FG006|NOT COMPLETED|Overall Study||0
3292570|NCT02858440|4026443|FG000|STARTED|Overall Study||235
3292571|NCT02858440|4026443|FG000|COMPLETED|Overall Study||223
3292572|NCT02858440|4026443|FG000|NOT COMPLETED|Overall Study||12
3292573|NCT02858492|4026451|FG000|STARTED|Overall Study||3
3292574|NCT02858492|4026452|FG001|STARTED|Overall Study||15
3292575|NCT02858492|4026453|FG002|STARTED|Overall Study||5
3292576|NCT02858492|4026454|FG003|STARTED|Overall Study||28
3292577|NCT02858492|4026451|FG000|COMPLETED|Overall Study||3
3292578|NCT02858492|4026452|FG001|COMPLETED|Overall Study||14
3292579|NCT02858492|4026453|FG002|COMPLETED|Overall Study||5
3292580|NCT02858492|4026454|FG003|COMPLETED|Overall Study||22
3292581|NCT02858492|4026451|FG000|NOT COMPLETED|Overall Study||0
3292582|NCT02858492|4026452|FG001|NOT COMPLETED|Overall Study||1
3292583|NCT02858492|4026453|FG002|NOT COMPLETED|Overall Study||0
3292584|NCT02858492|4026454|FG003|NOT COMPLETED|Overall Study||6
3292585|NCT02858713|4026468|FG000|STARTED|Overall Study||68
3292586|NCT02858713|4026469|FG001|STARTED|Overall Study||66
3292587|NCT02858713|4026468|FG000|COMPLETED|Overall Study||61
3292588|NCT02858713|4026469|FG001|COMPLETED|Overall Study||61
3292589|NCT02858713|4026468|FG000|NOT COMPLETED|Overall Study||7
3292590|NCT02858713|4026469|FG001|NOT COMPLETED|Overall Study||5
3292591|NCT02858726|4026483|FG000|STARTED|Overall Study||44
3292592|NCT02858726|4026484|FG001|STARTED|Overall Study||42
3292593|NCT02858726|4026485|FG002|STARTED|Overall Study||44
3292594|NCT02858726|4026486|FG003|STARTED|Overall Study||45
3292595|NCT02858726|4026483|FG000|COMPLETED|Overall Study||39
3292596|NCT02858726|4026484|FG001|COMPLETED|Overall Study||35
3292597|NCT02858726|4026485|FG002|COMPLETED|Overall Study||33
3292598|NCT02858726|4026486|FG003|COMPLETED|Overall Study||42
3292599|NCT02858726|4026483|FG000|NOT COMPLETED|Overall Study||5
3292600|NCT02858726|4026484|FG001|NOT COMPLETED|Overall Study||7
3292601|NCT02858726|4026485|FG002|NOT COMPLETED|Overall Study||11
3108298|NCT01549392|3832648|FG001|NOT COMPLETED|Overall Study||0
3108299|NCT01549405|3832656|FG000|STARTED|Overall Study||20
3108300|NCT01549405|3832657|FG001|STARTED|Overall Study||20
3108301|NCT01549405|3832656|FG000|COMPLETED|Overall Study||20
3108302|NCT01549405|3832657|FG001|COMPLETED|Overall Study||20
3108303|NCT01549405|3832656|FG000|NOT COMPLETED|Overall Study||0
3108304|NCT01549405|3832657|FG001|NOT COMPLETED|Overall Study||0
3108305|NCT01549587|3832667|FG000|STARTED|Overall Study||373
3108306|NCT01549587|3832668|FG001|STARTED|Overall Study||373
3108307|NCT01549587|3832667|FG000|COMPLETED|Overall Study||334
3108308|NCT01549587|3832668|FG001|COMPLETED|Overall Study||336
3108309|NCT01549587|3832667|FG000|NOT COMPLETED|Overall Study||39
3108310|NCT01549587|3832668|FG001|NOT COMPLETED|Overall Study||37
3108311|NCT01549613|3832676|FG000|STARTED|Overall Study||50
3108312|NCT01549613|3832677|FG001|STARTED|Overall Study||50
3108313|NCT01549613|3832676|FG000|COMPLETED|Overall Study||39
3108314|NCT01549613|3832677|FG001|COMPLETED|Overall Study||39
3108315|NCT01549613|3832676|FG000|NOT COMPLETED|Overall Study||11
3108316|NCT01549613|3832677|FG001|NOT COMPLETED|Overall Study||11
3108317|NCT01549652|3832686|FG000|STARTED|Overall Study||27
3108318|NCT01549652|3832687|FG001|STARTED|Overall Study||30
3108319|NCT01549652|3832688|FG002|STARTED|Overall Study||40
3108320|NCT01549652|3832689|FG003|STARTED|Overall Study||36
3108321|NCT01549652|3832686|FG000|COMPLETED|Overall Study||15
3108322|NCT01549652|3832687|FG001|COMPLETED|Overall Study||18
3108323|NCT01549652|3832688|FG002|COMPLETED|Overall Study||23
3108324|NCT01549652|3832689|FG003|COMPLETED|Overall Study||25
3108325|NCT01549652|3832686|FG000|NOT COMPLETED|Overall Study||12
3108326|NCT01549652|3832687|FG001|NOT COMPLETED|Overall Study||12
3108327|NCT01549652|3832688|FG002|NOT COMPLETED|Overall Study||17
3108328|NCT01549652|3832689|FG003|NOT COMPLETED|Overall Study||11
3108329|NCT01549860|3832697|FG000|STARTED|Overall Study||40
3108330|NCT01549860|3832698|FG001|STARTED|Overall Study||41
3108331|NCT01549860|3832697|FG000|COMPLETED|Overall Study||38
3108332|NCT01549860|3832698|FG001|COMPLETED|Overall Study||40
3108333|NCT01549860|3832697|FG000|NOT COMPLETED|Overall Study||2
3108334|NCT01549860|3832698|FG001|NOT COMPLETED|Overall Study||1
3108335|NCT01549873|3832706|FG000|STARTED|Overall Study||15
3108336|NCT01549873|3832707|FG001|STARTED|Overall Study||15
3108337|NCT01549873|3832706|FG000|COMPLETED|Overall Study||15
3108338|NCT01549873|3832707|FG001|COMPLETED|Overall Study||14
3108339|NCT01549873|3832706|FG000|NOT COMPLETED|Overall Study||0
3108340|NCT01549873|3832707|FG001|NOT COMPLETED|Overall Study||1
3108341|NCT01549886|3832715|FG000|STARTED|Overall Study||2
3108342|NCT01549886|3832716|FG001|STARTED|Overall Study||3
3108343|NCT01549886|3832715|FG000|COMPLETED|Overall Study||0
3108344|NCT01549886|3832716|FG001|COMPLETED|Overall Study||0
3108345|NCT01549886|3832715|FG000|NOT COMPLETED|Overall Study||2
3108346|NCT01549886|3832716|FG001|NOT COMPLETED|Overall Study||3
3108347|NCT01549925|3832726|FG000|STARTED|Overall Study||25
3292602|NCT02858726|4026486|FG003|NOT COMPLETED|Overall Study||3
3292603|NCT02859142|4026502|FG000|STARTED|Overall Study||61
3292604|NCT02859142|4026503|FG001|STARTED|Overall Study||61
3292605|NCT02859142|4026502|FG000|COMPLETED|Overall Study||57
3292606|NCT02859142|4026503|FG001|COMPLETED|Overall Study||52
3292607|NCT02859142|4026502|FG000|NOT COMPLETED|Overall Study||4
3292608|NCT02859142|4026503|FG001|NOT COMPLETED|Overall Study||9
3292609|NCT02859246|4026509|FG000|STARTED|Overall Study|15 subjects were enrolled into study|15
3292610|NCT02859246|4026509|FG000|COMPLETED|Overall Study|10 subjects completed the study|10
3292611|NCT02859246|4026509|FG000|NOT COMPLETED|Overall Study||5
3292612|NCT02859324|4026517|FG000|STARTED|Overall Study||7
3292613|NCT02859324|4026518|FG001|STARTED|Overall Study||9
3292614|NCT02859324|4026519|FG002|STARTED|Overall Study||5
3292615|NCT02859324|4026517|FG000|COMPLETED|Overall Study||0
3292616|NCT02859324|4026518|FG001|COMPLETED|Overall Study||0
3292617|NCT02859324|4026519|FG002|COMPLETED|Overall Study||0
3292618|NCT02859324|4026517|FG000|NOT COMPLETED|Overall Study||7
3292619|NCT02859324|4026518|FG001|NOT COMPLETED|Overall Study||9
3292620|NCT02859324|4026519|FG002|NOT COMPLETED|Overall Study||5
3292621|NCT02859441|4026527|FG000|STARTED|Overall Study||3
3292622|NCT02859441|4026527|FG000|COMPLETED|Overall Study||3
3292623|NCT02859441|4026527|FG000|NOT COMPLETED|Overall Study||0
3292624|NCT02859454|4026548|FG000|STARTED|Overall Study||13
3292625|NCT02859454|4026548|FG000|COMPLETED|Overall Study||12
3292626|NCT02859454|4026548|FG000|NOT COMPLETED|Overall Study||1
3292627|NCT02859597|4026557|FG000|STARTED|Overall Study|started Dec 2016|22
3292628|NCT02859597|4026558|FG001|STARTED|Overall Study|Started Dec 2016|19
3292629|NCT02859597|4026557|FG000|COMPLETED|Overall Study|September 2018|22
3292630|NCT02859597|4026558|FG001|COMPLETED|Overall Study|September 2018|19
3292631|NCT02859597|4026557|FG000|NOT COMPLETED|Overall Study||0
3292632|NCT02859597|4026558|FG001|NOT COMPLETED|Overall Study||0
3292633|NCT02860130|4026568|FG000|STARTED|Overall Study||17
3292634|NCT02860130|4026569|FG001|STARTED|Overall Study||17
3108348|NCT01549925|3832727|FG001|STARTED|Overall Study||25
3108349|NCT01549925|3832726|FG000|COMPLETED|Overall Study||25
3108350|NCT01549925|3832727|FG001|COMPLETED|Overall Study||25
3108351|NCT01549925|3832726|FG000|NOT COMPLETED|Overall Study||0
3108352|NCT01549925|3832727|FG001|NOT COMPLETED|Overall Study||0
3108353|NCT01549951|3832733|FG000|STARTED|Overall Study||50
3108354|NCT01549951|3832733|FG000|Primary Reason Off Study Treatment|Overall Study||50
3108355|NCT01549951|3832733|FG000|COMPLETED|Overall Study||0
3108356|NCT01549951|3832733|FG000|NOT COMPLETED|Overall Study||50
3108357|NCT01549964|3832741|FG000|STARTED|24-Week Treatment Period||132
3108358|NCT01549964|3832742|FG001|STARTED|24-Week Treatment Period||260
3108359|NCT01549964|3832743|FG002|STARTED|24-Week Treatment Period||263
3108360|NCT01549964|3832744|FG003|STARTED|24-Week Treatment Period||261
3108361|NCT01549964|3832741|FG000|Safety Analysis Set=Received Treatment|24-Week Treatment Period||132
3108362|NCT01549964|3832742|FG001|Safety Analysis Set=Received Treatment|24-Week Treatment Period||260
3108363|NCT01549964|3832743|FG002|Safety Analysis Set=Received Treatment|24-Week Treatment Period||263
3108364|NCT01549964|3832744|FG003|Safety Analysis Set=Received Treatment|24-Week Treatment Period||260
3108365|NCT01549964|3832741|FG000|COMPLETED|24-Week Treatment Period||71
3108366|NCT01549964|3832742|FG001|COMPLETED|24-Week Treatment Period||149
3108367|NCT01549964|3832743|FG002|COMPLETED|24-Week Treatment Period||147
3108368|NCT01549964|3832744|FG003|COMPLETED|24-Week Treatment Period||140
3108369|NCT01549964|3832741|FG000|NOT COMPLETED|24-Week Treatment Period||61
3108370|NCT01549964|3832742|FG001|NOT COMPLETED|24-Week Treatment Period||111
3108371|NCT01549964|3832743|FG002|NOT COMPLETED|24-Week Treatment Period||116
3108372|NCT01549964|3832744|FG003|NOT COMPLETED|24-Week Treatment Period||121
3108373|NCT01549964|3832741|FG000|STARTED|80-Week Extension Period||66
3108374|NCT01549964|3832742|FG001|STARTED|80-Week Extension Period||138
3108375|NCT01549964|3832743|FG002|STARTED|80-Week Extension Period||140
3108376|NCT01549964|3832744|FG003|STARTED|80-Week Extension Period||137
3108377|NCT01549964|3832741|FG000|COMPLETED|80-Week Extension Period||0
3108378|NCT01549964|3832742|FG001|COMPLETED|80-Week Extension Period||0
3108379|NCT01549964|3832743|FG002|COMPLETED|80-Week Extension Period||0
3108380|NCT01549964|3832744|FG003|COMPLETED|80-Week Extension Period||0
3108381|NCT01549964|3832741|FG000|NOT COMPLETED|80-Week Extension Period||66
3108382|NCT01549964|3832742|FG001|NOT COMPLETED|80-Week Extension Period||138
3108383|NCT01549964|3832743|FG002|NOT COMPLETED|80-Week Extension Period||140
3108384|NCT01549964|3832744|FG003|NOT COMPLETED|80-Week Extension Period||137
3108385|NCT01550224|3832756|FG000|STARTED|Overall Study||3
3108386|NCT01550224|3832757|FG001|STARTED|Overall Study||20
3108387|NCT01550224|3832756|FG000|COMPLETED|Overall Study||3
3108388|NCT01550224|3832757|FG001|COMPLETED|Overall Study||20
3108389|NCT01550224|3832756|FG000|NOT COMPLETED|Overall Study||0
3108390|NCT01550224|3832757|FG001|NOT COMPLETED|Overall Study||0
3108391|NCT01550289|3832765|FG000|STARTED|Overall Study||128
3108392|NCT01550289|3832766|FG001|STARTED|Overall Study||61
3108393|NCT01550289|3832765|FG000|COMPLETED|Overall Study||115
3108394|NCT01550289|3832766|FG001|COMPLETED|Overall Study||57
3108395|NCT01550289|3832765|FG000|NOT COMPLETED|Overall Study||13
3108396|NCT01550289|3832766|FG001|NOT COMPLETED|Overall Study||4
3108397|NCT01550341|3832776|FG000|STARTED|Overall Study||32
3108398|NCT01550341|3832777|FG001|STARTED|Overall Study||18
3108399|NCT01550341|3832776|FG000|COMPLETED|Overall Study||32
3108400|NCT01550341|3832777|FG001|COMPLETED|Overall Study||18
3108401|NCT01550341|3832776|FG000|NOT COMPLETED|Overall Study||0
3108402|NCT01550341|3832777|FG001|NOT COMPLETED|Overall Study||0
3108403|NCT01550367|3832783|FG000|STARTED|Overall Study||30
3108404|NCT01550367|3832783|FG000|1200 mg/d HCQ|Overall Study||13
3108405|NCT01550367|3832783|FG000|600 mg/d HCQ|Overall Study||17
3108406|NCT01550367|3832783|FG000|COMPLETED|Overall Study||30
3108407|NCT01550367|3832783|FG000|NOT COMPLETED|Overall Study||0
3108408|NCT01550471|3832792|FG000|STARTED|Run-In Period (3 Weeks)||3
3108409|NCT01550471|3832793|FG001|STARTED|Run-In Period (3 Weeks)||4
3108410|NCT01550471|3832794|FG002|STARTED|Run-In Period (3 Weeks)||3
3108411|NCT01550471|3832795|FG003|STARTED|Run-In Period (3 Weeks)||4
3108412|NCT01550471|3832796|FG004|STARTED|Run-In Period (3 Weeks)||4
3108413|NCT01550471|3832797|FG005|STARTED|Run-In Period (3 Weeks)||4
3108414|NCT01550471|3832792|FG000|COMPLETED|Run-In Period (3 Weeks)||3
3108415|NCT01550471|3832793|FG001|COMPLETED|Run-In Period (3 Weeks)||4
3108416|NCT01550471|3832794|FG002|COMPLETED|Run-In Period (3 Weeks)||3
3108417|NCT01550471|3832795|FG003|COMPLETED|Run-In Period (3 Weeks)||4
3108418|NCT01550471|3832796|FG004|COMPLETED|Run-In Period (3 Weeks)||4
3108419|NCT01550471|3832797|FG005|COMPLETED|Run-In Period (3 Weeks)||4
3108420|NCT01550471|3832792|FG000|NOT COMPLETED|Run-In Period (3 Weeks)||0
3108421|NCT01550471|3832793|FG001|NOT COMPLETED|Run-In Period (3 Weeks)||0
3108422|NCT01550471|3832794|FG002|NOT COMPLETED|Run-In Period (3 Weeks)||0
3108423|NCT01550471|3832795|FG003|NOT COMPLETED|Run-In Period (3 Weeks)||0
3108424|NCT01550471|3832796|FG004|NOT COMPLETED|Run-In Period (3 Weeks)||0
3108425|NCT01550471|3832797|FG005|NOT COMPLETED|Run-In Period (3 Weeks)||0
3108426|NCT01550471|3832792|FG000|STARTED|First Treatment Period (3 Weeks)||3
3108427|NCT01550471|3832793|FG001|STARTED|First Treatment Period (3 Weeks)||4
3108428|NCT01550471|3832794|FG002|STARTED|First Treatment Period (3 Weeks)||3
3108429|NCT01550471|3832795|FG003|STARTED|First Treatment Period (3 Weeks)||4
3108430|NCT01550471|3832796|FG004|STARTED|First Treatment Period (3 Weeks)||4
3108431|NCT01550471|3832797|FG005|STARTED|First Treatment Period (3 Weeks)||4
3108432|NCT01550471|3832792|FG000|COMPLETED|First Treatment Period (3 Weeks)||3
3108433|NCT01550471|3832793|FG001|COMPLETED|First Treatment Period (3 Weeks)||4
3108434|NCT01550471|3832794|FG002|COMPLETED|First Treatment Period (3 Weeks)||3
3108435|NCT01550471|3832795|FG003|COMPLETED|First Treatment Period (3 Weeks)||4
3108436|NCT01550471|3832796|FG004|COMPLETED|First Treatment Period (3 Weeks)||4
3108437|NCT01550471|3832797|FG005|COMPLETED|First Treatment Period (3 Weeks)||4
3108438|NCT01550471|3832792|FG000|NOT COMPLETED|First Treatment Period (3 Weeks)||0
3108439|NCT01550471|3832793|FG001|NOT COMPLETED|First Treatment Period (3 Weeks)||0
3108440|NCT01550471|3832794|FG002|NOT COMPLETED|First Treatment Period (3 Weeks)||0
3108441|NCT01550471|3832795|FG003|NOT COMPLETED|First Treatment Period (3 Weeks)||0
3108442|NCT01550471|3832796|FG004|NOT COMPLETED|First Treatment Period (3 Weeks)||0
3108443|NCT01550471|3832797|FG005|NOT COMPLETED|First Treatment Period (3 Weeks)||0
3108444|NCT01550471|3832792|FG000|STARTED|First Wash Out Period (3 Weeks)||3
3108445|NCT01550471|3832793|FG001|STARTED|First Wash Out Period (3 Weeks)||4
3108446|NCT01550471|3832794|FG002|STARTED|First Wash Out Period (3 Weeks)||3
3108447|NCT01550471|3832795|FG003|STARTED|First Wash Out Period (3 Weeks)||4
3108448|NCT01550471|3832796|FG004|STARTED|First Wash Out Period (3 Weeks)||4
3108449|NCT01550471|3832797|FG005|STARTED|First Wash Out Period (3 Weeks)||4
3108450|NCT01550471|3832792|FG000|COMPLETED|First Wash Out Period (3 Weeks)||3
3108451|NCT01550471|3832793|FG001|COMPLETED|First Wash Out Period (3 Weeks)||4
3108452|NCT01550471|3832794|FG002|COMPLETED|First Wash Out Period (3 Weeks)||3
3108453|NCT01550471|3832795|FG003|COMPLETED|First Wash Out Period (3 Weeks)||4
3108454|NCT01550471|3832796|FG004|COMPLETED|First Wash Out Period (3 Weeks)||4
3108455|NCT01550471|3832797|FG005|COMPLETED|First Wash Out Period (3 Weeks)||4
3108456|NCT01550471|3832792|FG000|NOT COMPLETED|First Wash Out Period (3 Weeks)||0
3108457|NCT01550471|3832793|FG001|NOT COMPLETED|First Wash Out Period (3 Weeks)||0
3108458|NCT01550471|3832794|FG002|NOT COMPLETED|First Wash Out Period (3 Weeks)||0
3108459|NCT01550471|3832795|FG003|NOT COMPLETED|First Wash Out Period (3 Weeks)||0
3108460|NCT01550471|3832796|FG004|NOT COMPLETED|First Wash Out Period (3 Weeks)||0
3108461|NCT01550471|3832797|FG005|NOT COMPLETED|First Wash Out Period (3 Weeks)||0
3108462|NCT01550471|3832792|FG000|STARTED|Second Treatment Period (3 Weeks)||3
3108463|NCT01550471|3832793|FG001|STARTED|Second Treatment Period (3 Weeks)||4
3108464|NCT01550471|3832794|FG002|STARTED|Second Treatment Period (3 Weeks)||3
3108465|NCT01550471|3832795|FG003|STARTED|Second Treatment Period (3 Weeks)||4
3108466|NCT01550471|3832796|FG004|STARTED|Second Treatment Period (3 Weeks)||4
3108467|NCT01550471|3832797|FG005|STARTED|Second Treatment Period (3 Weeks)||4
3108468|NCT01550471|3832792|FG000|COMPLETED|Second Treatment Period (3 Weeks)||3
3108469|NCT01550471|3832793|FG001|COMPLETED|Second Treatment Period (3 Weeks)||4
3108470|NCT01550471|3832794|FG002|COMPLETED|Second Treatment Period (3 Weeks)||3
3108471|NCT01550471|3832795|FG003|COMPLETED|Second Treatment Period (3 Weeks)||4
3108472|NCT01550471|3832796|FG004|COMPLETED|Second Treatment Period (3 Weeks)||4
3108473|NCT01550471|3832797|FG005|COMPLETED|Second Treatment Period (3 Weeks)||4
3108474|NCT01550471|3832792|FG000|NOT COMPLETED|Second Treatment Period (3 Weeks)||0
3292635|NCT02860130|4026568|FG000|COMPLETED|Overall Study||10
3292636|NCT02860130|4026569|FG001|COMPLETED|Overall Study||8
3292637|NCT02860130|4026568|FG000|NOT COMPLETED|Overall Study||7
3292638|NCT02860130|4026569|FG001|NOT COMPLETED|Overall Study||9
3292639|NCT02860286|4026577|FG000|STARTED|Overall Study||13
3292640|NCT02860286|4026578|FG001|STARTED|Overall Study||61
3292641|NCT02860286|4026577|FG000|COMPLETED|Overall Study||13
3292642|NCT02860286|4026578|FG001|COMPLETED|Overall Study||61
3292643|NCT02860286|4026577|FG000|NOT COMPLETED|Overall Study||0
3292644|NCT02860286|4026578|FG001|NOT COMPLETED|Overall Study||0
3292645|NCT02860507|4026595|FG000|STARTED|Overall Study||25
3292646|NCT02860507|4026596|FG001|STARTED|Overall Study||25
3292647|NCT02860507|4026595|FG000|COMPLETED|Overall Study||25
3292648|NCT02860507|4026596|FG001|COMPLETED|Overall Study||25
3292649|NCT02860507|4026595|FG000|NOT COMPLETED|Overall Study||0
3292650|NCT02860507|4026596|FG001|NOT COMPLETED|Overall Study||0
3292651|NCT02860546|4026602|FG000|STARTED|Overall Study||18
3292652|NCT02860546|4026602|FG000|COMPLETED|Overall Study||0
3292653|NCT02860546|4026602|FG000|NOT COMPLETED|Overall Study||18
3292654|NCT02860845|4026608|FG000|STARTED|Overall Study||24
3292655|NCT02860845|4026609|FG001|STARTED|Overall Study||24
3292656|NCT02860845|4026608|FG000|Analyzed Patients|Overall Study||22
3292657|NCT02860845|4026609|FG001|Analyzed Patients|Overall Study||23
3292658|NCT02860845|4026608|FG000|COMPLETED|Overall Study||22
3292659|NCT02860845|4026609|FG001|COMPLETED|Overall Study||23
3292660|NCT02860845|4026608|FG000|NOT COMPLETED|Overall Study||2
3292661|NCT02860845|4026609|FG001|NOT COMPLETED|Overall Study||1
3292662|NCT02860988|4026621|FG000|STARTED|Overall Study||201
3292663|NCT02860988|4026622|FG001|STARTED|Overall Study||200
3292664|NCT02860988|4026621|FG000|COMPLETED|Overall Study||117
3292665|NCT02860988|4026622|FG001|COMPLETED|Overall Study||94
3292666|NCT02860988|4026621|FG000|NOT COMPLETED|Overall Study||84
3292667|NCT02860988|4026622|FG001|NOT COMPLETED|Overall Study||106
3292668|NCT02861118|4026630|FG000|STARTED|Overall Study||194
3292669|NCT02861118|4026631|FG001|STARTED|Overall Study||116
3292670|NCT02861118|4026630|FG000|COMPLETED|Overall Study||194
3292671|NCT02861118|4026631|FG001|COMPLETED|Overall Study||116
3292672|NCT02861118|4026630|FG000|NOT COMPLETED|Overall Study||0
3292673|NCT02861118|4026631|FG001|NOT COMPLETED|Overall Study||0
3292674|NCT02861131|4026641|FG000|STARTED|Overall Study||100
3292675|NCT02861131|4026642|FG001|STARTED|Overall Study||100
3292676|NCT02861131|4026641|FG000|COMPLETED|Overall Study||100
3292677|NCT02861131|4026642|FG001|COMPLETED|Overall Study||100
3292678|NCT02861131|4026641|FG000|NOT COMPLETED|Overall Study||0
3292679|NCT02861131|4026642|FG001|NOT COMPLETED|Overall Study||0
3292680|NCT02861534|4026650|FG000|STARTED|Overall Study||2526
3292681|NCT02861534|4026651|FG001|STARTED|Overall Study||2524
3292682|NCT02861534|4026650|FG000|Treated|Overall Study||2519
3292683|NCT02861534|4026651|FG001|Treated|Overall Study||2515
3292684|NCT02861534|4026650|FG000|COMPLETED|Overall Study||1952
3292685|NCT02861534|4026651|FG001|COMPLETED|Overall Study||1937
3292686|NCT02861534|4026650|FG000|NOT COMPLETED|Overall Study||574
3292687|NCT02861534|4026651|FG001|NOT COMPLETED|Overall Study||587
3108475|NCT01550471|3832793|FG001|NOT COMPLETED|Second Treatment Period (3 Weeks)||0
3108476|NCT01550471|3832794|FG002|NOT COMPLETED|Second Treatment Period (3 Weeks)||0
3108477|NCT01550471|3832795|FG003|NOT COMPLETED|Second Treatment Period (3 Weeks)||0
3108478|NCT01550471|3832796|FG004|NOT COMPLETED|Second Treatment Period (3 Weeks)||0
3108479|NCT01550471|3832797|FG005|NOT COMPLETED|Second Treatment Period (3 Weeks)||0
3108480|NCT01550471|3832792|FG000|STARTED|Second Wash Out Period (3 Weeks)||3
3108481|NCT01550471|3832793|FG001|STARTED|Second Wash Out Period (3 Weeks)||4
3108482|NCT01550471|3832794|FG002|STARTED|Second Wash Out Period (3 Weeks)||3
3108483|NCT01550471|3832795|FG003|STARTED|Second Wash Out Period (3 Weeks)||4
3108484|NCT01550471|3832796|FG004|STARTED|Second Wash Out Period (3 Weeks)||4
3108485|NCT01550471|3832797|FG005|STARTED|Second Wash Out Period (3 Weeks)||4
3108486|NCT01550471|3832792|FG000|COMPLETED|Second Wash Out Period (3 Weeks)||3
3108487|NCT01550471|3832793|FG001|COMPLETED|Second Wash Out Period (3 Weeks)||4
3108488|NCT01550471|3832794|FG002|COMPLETED|Second Wash Out Period (3 Weeks)||3
3108489|NCT01550471|3832795|FG003|COMPLETED|Second Wash Out Period (3 Weeks)||4
3108490|NCT01550471|3832796|FG004|COMPLETED|Second Wash Out Period (3 Weeks)||4
3292688|NCT02861586|4026665|FG000|STARTED|Overall Study||51
3292689|NCT02861586|4026666|FG001|STARTED|Overall Study||18
3292690|NCT02861586|4026667|FG002|STARTED|Overall Study||47
3292691|NCT02861586|4026668|FG003|STARTED|Overall Study||16
3292692|NCT02861586|4026669|FG004|STARTED|Overall Study||47
3292693|NCT02861586|4026670|FG005|STARTED|Overall Study||50
3292694|NCT02861586|4026671|FG006|STARTED|Overall Study||18
3292695|NCT02861586|4026672|FG007|STARTED|Overall Study||16
3292696|NCT02861586|4026665|FG000|COMPLETED|Overall Study||47
3292697|NCT02861586|4026666|FG001|COMPLETED|Overall Study||15
3292698|NCT02861586|4026667|FG002|COMPLETED|Overall Study||46
3292699|NCT02861586|4026668|FG003|COMPLETED|Overall Study||16
3292700|NCT02861586|4026669|FG004|COMPLETED|Overall Study||47
3292701|NCT02861586|4026670|FG005|COMPLETED|Overall Study||45
3292702|NCT02861586|4026671|FG006|COMPLETED|Overall Study||17
3292703|NCT02861586|4026672|FG007|COMPLETED|Overall Study||16
3292704|NCT02861586|4026665|FG000|NOT COMPLETED|Overall Study||4
3292705|NCT02861586|4026666|FG001|NOT COMPLETED|Overall Study||3
3292706|NCT02861586|4026667|FG002|NOT COMPLETED|Overall Study||1
3292707|NCT02861586|4026668|FG003|NOT COMPLETED|Overall Study||0
3292708|NCT02861586|4026669|FG004|NOT COMPLETED|Overall Study||0
3292709|NCT02861586|4026670|FG005|NOT COMPLETED|Overall Study||5
3292710|NCT02861586|4026671|FG006|NOT COMPLETED|Overall Study||1
3292711|NCT02861586|4026672|FG007|NOT COMPLETED|Overall Study||0
3292712|NCT02861664|4026697|FG000|STARTED|Overall Study||67
3292713|NCT02861664|4026698|FG001|STARTED|Overall Study||68
3292714|NCT02861664|4026697|FG000|COMPLETED|Overall Study||67
3292715|NCT02861664|4026698|FG001|COMPLETED|Overall Study||67
3292716|NCT02861664|4026697|FG000|NOT COMPLETED|Overall Study||0
3292717|NCT02861664|4026698|FG001|NOT COMPLETED|Overall Study||1
3292718|NCT02861807|4026706|FG000|STARTED|Overall Study||47
3292719|NCT02861807|4026707|FG001|STARTED|Overall Study||37
3292720|NCT02861807|4026706|FG000|Attended Post-treatment Assessment|Overall Study||34
3292721|NCT02861807|4026707|FG001|Attended Post-treatment Assessment|Overall Study||18
3292722|NCT02861807|4026706|FG000|Attended 2-month Follow-up|Overall Study||32
3292723|NCT02861807|4026707|FG001|Attended 2-month Follow-up|Overall Study||20
3292724|NCT02861807|4026706|FG000|COMPLETED|Overall Study||35
3292725|NCT02861807|4026707|FG001|COMPLETED|Overall Study||23
3292726|NCT02861807|4026706|FG000|NOT COMPLETED|Overall Study||12
3292727|NCT02861807|4026707|FG001|NOT COMPLETED|Overall Study||14
3292728|NCT02861937|4026716|FG000|STARTED|Overall Study||10
3292729|NCT02861937|4026717|FG001|STARTED|Overall Study||12
3292730|NCT02861937|4026718|FG002|STARTED|Overall Study||12
3292731|NCT02861937|4026716|FG000|COMPLETED|Overall Study||10
3292732|NCT02861937|4026717|FG001|COMPLETED|Overall Study||12
3292733|NCT02861937|4026718|FG002|COMPLETED|Overall Study||12
3292734|NCT02861937|4026716|FG000|NOT COMPLETED|Overall Study||0
3292735|NCT02861937|4026717|FG001|NOT COMPLETED|Overall Study||0
3292736|NCT02861937|4026718|FG002|NOT COMPLETED|Overall Study||0
3292737|NCT02862080|4026729|FG000|STARTED|7 Days Before Any Intervention||1
3292738|NCT02862080|4026730|FG001|STARTED|7 Days Before Any Intervention||1
3292739|NCT02862080|4026731|FG002|STARTED|7 Days Before Any Intervention||1
3292740|NCT02862080|4026732|FG003|STARTED|7 Days Before Any Intervention||1
3292741|NCT02862080|4026729|FG000|COMPLETED|7 Days Before Any Intervention||1
3292742|NCT02862080|4026730|FG001|COMPLETED|7 Days Before Any Intervention||1
3292743|NCT02862080|4026731|FG002|COMPLETED|7 Days Before Any Intervention||1
3292744|NCT02862080|4026732|FG003|COMPLETED|7 Days Before Any Intervention||1
3292745|NCT02862080|4026729|FG000|NOT COMPLETED|7 Days Before Any Intervention||0
3292746|NCT02862080|4026730|FG001|NOT COMPLETED|7 Days Before Any Intervention||0
3292747|NCT02862080|4026731|FG002|NOT COMPLETED|7 Days Before Any Intervention||0
3292748|NCT02862080|4026732|FG003|NOT COMPLETED|7 Days Before Any Intervention||0
3292749|NCT02862080|4026729|FG000|STARTED|3 Days Before Any Intervention||1
3292750|NCT02862080|4026730|FG001|STARTED|3 Days Before Any Intervention||1
3292751|NCT02862080|4026731|FG002|STARTED|3 Days Before Any Intervention||1
3292752|NCT02862080|4026732|FG003|STARTED|3 Days Before Any Intervention||1
3292753|NCT02862080|4026729|FG000|COMPLETED|3 Days Before Any Intervention||1
3292754|NCT02862080|4026730|FG001|COMPLETED|3 Days Before Any Intervention||1
3292755|NCT02862080|4026731|FG002|COMPLETED|3 Days Before Any Intervention||1
3292756|NCT02862080|4026732|FG003|COMPLETED|3 Days Before Any Intervention||1
3292757|NCT02862080|4026729|FG000|NOT COMPLETED|3 Days Before Any Intervention||0
3108491|NCT01550471|3832797|FG005|COMPLETED|Second Wash Out Period (3 Weeks)||3
3108492|NCT01550471|3832792|FG000|NOT COMPLETED|Second Wash Out Period (3 Weeks)||0
3108493|NCT01550471|3832793|FG001|NOT COMPLETED|Second Wash Out Period (3 Weeks)||0
3108494|NCT01550471|3832794|FG002|NOT COMPLETED|Second Wash Out Period (3 Weeks)||0
3108495|NCT01550471|3832795|FG003|NOT COMPLETED|Second Wash Out Period (3 Weeks)||0
3108496|NCT01550471|3832796|FG004|NOT COMPLETED|Second Wash Out Period (3 Weeks)||0
3108497|NCT01550471|3832797|FG005|NOT COMPLETED|Second Wash Out Period (3 Weeks)||1
3108498|NCT01550471|3832792|FG000|STARTED|Third Treatment Period (3 Weeks)||3
3108499|NCT01550471|3832793|FG001|STARTED|Third Treatment Period (3 Weeks)||4
3108500|NCT01550471|3832794|FG002|STARTED|Third Treatment Period (3 Weeks)||3
3108501|NCT01550471|3832795|FG003|STARTED|Third Treatment Period (3 Weeks)||4
3108502|NCT01550471|3832796|FG004|STARTED|Third Treatment Period (3 Weeks)||4
3108503|NCT01550471|3832797|FG005|STARTED|Third Treatment Period (3 Weeks)||3
3108504|NCT01550471|3832792|FG000|COMPLETED|Third Treatment Period (3 Weeks)||3
3108505|NCT01550471|3832793|FG001|COMPLETED|Third Treatment Period (3 Weeks)||4
3108506|NCT01550471|3832794|FG002|COMPLETED|Third Treatment Period (3 Weeks)||3
3108507|NCT01550471|3832795|FG003|COMPLETED|Third Treatment Period (3 Weeks)||4
3108508|NCT01550471|3832796|FG004|COMPLETED|Third Treatment Period (3 Weeks)||4
3108509|NCT01550471|3832797|FG005|COMPLETED|Third Treatment Period (3 Weeks)||3
3108510|NCT01550471|3832792|FG000|NOT COMPLETED|Third Treatment Period (3 Weeks)||0
3292758|NCT02862080|4026730|FG001|NOT COMPLETED|3 Days Before Any Intervention||0
3292759|NCT02862080|4026731|FG002|NOT COMPLETED|3 Days Before Any Intervention||0
3292760|NCT02862080|4026732|FG003|NOT COMPLETED|3 Days Before Any Intervention||0
3292761|NCT02862080|4026729|FG000|STARTED|Intervention 1 (1 Week)||1
3292762|NCT02862080|4026730|FG001|STARTED|Intervention 1 (1 Week)||1
3292763|NCT02862080|4026731|FG002|STARTED|Intervention 1 (1 Week)||1
3292764|NCT02862080|4026732|FG003|STARTED|Intervention 1 (1 Week)||1
3292765|NCT02862080|4026729|FG000|COMPLETED|Intervention 1 (1 Week)||1
3292766|NCT02862080|4026730|FG001|COMPLETED|Intervention 1 (1 Week)||1
3292767|NCT02862080|4026731|FG002|COMPLETED|Intervention 1 (1 Week)||1
3292768|NCT02862080|4026732|FG003|COMPLETED|Intervention 1 (1 Week)||1
3292769|NCT02862080|4026729|FG000|NOT COMPLETED|Intervention 1 (1 Week)||0
3292770|NCT02862080|4026730|FG001|NOT COMPLETED|Intervention 1 (1 Week)||0
3292771|NCT02862080|4026731|FG002|NOT COMPLETED|Intervention 1 (1 Week)||0
3292772|NCT02862080|4026732|FG003|NOT COMPLETED|Intervention 1 (1 Week)||0
3292773|NCT02862080|4026729|FG000|STARTED|Washout (1 Week)||1
3292774|NCT02862080|4026730|FG001|STARTED|Washout (1 Week)||1
3292775|NCT02862080|4026731|FG002|STARTED|Washout (1 Week)||1
3292776|NCT02862080|4026732|FG003|STARTED|Washout (1 Week)||1
3292777|NCT02862080|4026729|FG000|COMPLETED|Washout (1 Week)||1
3292778|NCT02862080|4026730|FG001|COMPLETED|Washout (1 Week)||1
3292779|NCT02862080|4026731|FG002|COMPLETED|Washout (1 Week)||1
3292780|NCT02862080|4026732|FG003|COMPLETED|Washout (1 Week)||1
3292781|NCT02862080|4026729|FG000|NOT COMPLETED|Washout (1 Week)||0
3292782|NCT02862080|4026730|FG001|NOT COMPLETED|Washout (1 Week)||0
3292783|NCT02862080|4026731|FG002|NOT COMPLETED|Washout (1 Week)||0
3292784|NCT02862080|4026732|FG003|NOT COMPLETED|Washout (1 Week)||0
3292785|NCT02862080|4026729|FG000|STARTED|Intervention 2 (1 Week)||1
3292786|NCT02862080|4026730|FG001|STARTED|Intervention 2 (1 Week)||1
3292787|NCT02862080|4026731|FG002|STARTED|Intervention 2 (1 Week)||1
3292788|NCT02862080|4026732|FG003|STARTED|Intervention 2 (1 Week)||1
3292789|NCT02862080|4026729|FG000|COMPLETED|Intervention 2 (1 Week)||1
3292790|NCT02862080|4026730|FG001|COMPLETED|Intervention 2 (1 Week)||1
3292791|NCT02862080|4026731|FG002|COMPLETED|Intervention 2 (1 Week)||1
3292792|NCT02862080|4026732|FG003|COMPLETED|Intervention 2 (1 Week)||1
3292793|NCT02862080|4026729|FG000|NOT COMPLETED|Intervention 2 (1 Week)||0
3292794|NCT02862080|4026730|FG001|NOT COMPLETED|Intervention 2 (1 Week)||0
3292795|NCT02862080|4026731|FG002|NOT COMPLETED|Intervention 2 (1 Week)||0
3292796|NCT02862080|4026732|FG003|NOT COMPLETED|Intervention 2 (1 Week)||0
3292797|NCT02862080|4026729|FG000|STARTED|Washout (1 Week)||1
3292798|NCT02862080|4026730|FG001|STARTED|Washout (1 Week)||1
3292799|NCT02862080|4026731|FG002|STARTED|Washout (1 Week)||1
3292800|NCT02862080|4026732|FG003|STARTED|Washout (1 Week)||1
3292801|NCT02862080|4026729|FG000|COMPLETED|Washout (1 Week)||1
3292802|NCT02862080|4026730|FG001|COMPLETED|Washout (1 Week)||1
3292803|NCT02862080|4026731|FG002|COMPLETED|Washout (1 Week)||1
3292804|NCT02862080|4026732|FG003|COMPLETED|Washout (1 Week)||1
3292805|NCT02862080|4026729|FG000|NOT COMPLETED|Washout (1 Week)||0
3292806|NCT02862080|4026730|FG001|NOT COMPLETED|Washout (1 Week)||0
3292807|NCT02862080|4026731|FG002|NOT COMPLETED|Washout (1 Week)||0
3292808|NCT02862080|4026732|FG003|NOT COMPLETED|Washout (1 Week)||0
3292809|NCT02862080|4026729|FG000|STARTED|Intervention 1 Again (1 Week)||1
3292810|NCT02862080|4026730|FG001|STARTED|Intervention 1 Again (1 Week)||1
3292811|NCT02862080|4026731|FG002|STARTED|Intervention 1 Again (1 Week)||1
3292812|NCT02862080|4026732|FG003|STARTED|Intervention 1 Again (1 Week)||1
3292813|NCT02862080|4026729|FG000|COMPLETED|Intervention 1 Again (1 Week)||1
3292814|NCT02862080|4026730|FG001|COMPLETED|Intervention 1 Again (1 Week)||1
3292815|NCT02862080|4026731|FG002|COMPLETED|Intervention 1 Again (1 Week)||1
3292816|NCT02862080|4026732|FG003|COMPLETED|Intervention 1 Again (1 Week)||1
3292817|NCT02862080|4026729|FG000|NOT COMPLETED|Intervention 1 Again (1 Week)||0
3292818|NCT02862080|4026730|FG001|NOT COMPLETED|Intervention 1 Again (1 Week)||0
3292819|NCT02862080|4026731|FG002|NOT COMPLETED|Intervention 1 Again (1 Week)||0
3292820|NCT02862080|4026732|FG003|NOT COMPLETED|Intervention 1 Again (1 Week)||0
3108511|NCT01550471|3832793|FG001|NOT COMPLETED|Third Treatment Period (3 Weeks)||0
3108512|NCT01550471|3832794|FG002|NOT COMPLETED|Third Treatment Period (3 Weeks)||0
3108513|NCT01550471|3832795|FG003|NOT COMPLETED|Third Treatment Period (3 Weeks)||0
3108514|NCT01550471|3832796|FG004|NOT COMPLETED|Third Treatment Period (3 Weeks)||0
3108515|NCT01550471|3832797|FG005|NOT COMPLETED|Third Treatment Period (3 Weeks)||0
3108516|NCT01550471|3832792|FG000|STARTED|Third Wash Out Period (3 Weeks)||3
3108517|NCT01550471|3832793|FG001|STARTED|Third Wash Out Period (3 Weeks)||4
3108518|NCT01550471|3832794|FG002|STARTED|Third Wash Out Period (3 Weeks)||3
3108519|NCT01550471|3832795|FG003|STARTED|Third Wash Out Period (3 Weeks)||4
3108520|NCT01550471|3832796|FG004|STARTED|Third Wash Out Period (3 Weeks)||4
3108521|NCT01550471|3832797|FG005|STARTED|Third Wash Out Period (3 Weeks)||3
3108522|NCT01550471|3832792|FG000|COMPLETED|Third Wash Out Period (3 Weeks)||3
3108523|NCT01550471|3832793|FG001|COMPLETED|Third Wash Out Period (3 Weeks)||4
3108524|NCT01550471|3832794|FG002|COMPLETED|Third Wash Out Period (3 Weeks)||3
3108525|NCT01550471|3832795|FG003|COMPLETED|Third Wash Out Period (3 Weeks)||4
3108526|NCT01550471|3832796|FG004|COMPLETED|Third Wash Out Period (3 Weeks)||4
3292821|NCT02862106|4026748|FG000|STARTED|Overall Study||183
3292822|NCT02862106|4026749|FG001|STARTED|Overall Study||26
3292823|NCT02862106|4026748|FG000|COMPLETED|Overall Study||145
3292824|NCT02862106|4026749|FG001|COMPLETED|Overall Study||20
3292825|NCT02862106|4026748|FG000|NOT COMPLETED|Overall Study||38
3292826|NCT02862106|4026749|FG001|NOT COMPLETED|Overall Study||6
3292827|NCT02862535|4026765|FG000|STARTED|Overall Study||9
3292828|NCT02862535|4026766|FG001|STARTED|Overall Study||6
3292829|NCT02862535|4026767|FG002|STARTED|Overall Study||10
3292830|NCT02862535|4026768|FG003|STARTED|Overall Study||11
3292831|NCT02862535|4026765|FG000|COMPLETED|Overall Study||0
3292832|NCT02862535|4026766|FG001|COMPLETED|Overall Study||0
3292833|NCT02862535|4026767|FG002|COMPLETED|Overall Study||0
3292834|NCT02862535|4026768|FG003|COMPLETED|Overall Study||0
3292835|NCT02862535|4026765|FG000|NOT COMPLETED|Overall Study||9
3292836|NCT02862535|4026766|FG001|NOT COMPLETED|Overall Study||6
3292837|NCT02862535|4026767|FG002|NOT COMPLETED|Overall Study||10
3292838|NCT02862535|4026768|FG003|NOT COMPLETED|Overall Study||11
3292839|NCT02862548|4026780|FG000|STARTED|Open-Label Phase||26
3292840|NCT02862548|4026781|FG001|STARTED|Open-Label Phase||25
3292841|NCT02862548|4026780|FG000|COMPLETED|Open-Label Phase||26
3292842|NCT02862548|4026781|FG001|COMPLETED|Open-Label Phase||24
3292843|NCT02862548|4026780|FG000|NOT COMPLETED|Open-Label Phase||0
3292844|NCT02862548|4026781|FG001|NOT COMPLETED|Open-Label Phase||1
3292845|NCT02862548|4026780|FG000|STARTED|Open-Label Extension Phase||26
3292846|NCT02862548|4026781|FG001|STARTED|Open-Label Extension Phase||24
3292847|NCT02862548|4026780|FG000|COMPLETED|Open-Label Extension Phase||0
3292848|NCT02862548|4026781|FG001|COMPLETED|Open-Label Extension Phase||0
3292849|NCT02862548|4026780|FG000|NOT COMPLETED|Open-Label Extension Phase||26
3292850|NCT02862548|4026781|FG001|NOT COMPLETED|Open-Label Extension Phase||24
3292851|NCT02862574|4026790|FG000|STARTED|Double-Blind Treatment Period||5
3292852|NCT02862574|4026791|FG001|STARTED|Double-Blind Treatment Period||5
3292853|NCT02862574|4026792|FG002|STARTED|Double-Blind Treatment Period||5
3292854|NCT02862574|4026790|FG000|COMPLETED|Double-Blind Treatment Period||2
3292855|NCT02862574|4026791|FG001|COMPLETED|Double-Blind Treatment Period||3
3292856|NCT02862574|4026792|FG002|COMPLETED|Double-Blind Treatment Period||1
3292857|NCT02862574|4026790|FG000|NOT COMPLETED|Double-Blind Treatment Period||3
3292858|NCT02862574|4026791|FG001|NOT COMPLETED|Double-Blind Treatment Period||2
3292859|NCT02862574|4026792|FG002|NOT COMPLETED|Double-Blind Treatment Period||4
3292860|NCT02862574|4026790|FG000|STARTED|Open-Label Treatment Period||2
3292861|NCT02862574|4026791|FG001|STARTED|Open-Label Treatment Period||3
3292862|NCT02862574|4026792|FG002|STARTED|Open-Label Treatment Period||1
3292863|NCT02862574|4026790|FG000|COMPLETED|Open-Label Treatment Period||0
3292864|NCT02862574|4026791|FG001|COMPLETED|Open-Label Treatment Period||0
3292865|NCT02862574|4026792|FG002|COMPLETED|Open-Label Treatment Period||0
3292866|NCT02862574|4026790|FG000|NOT COMPLETED|Open-Label Treatment Period||2
3292867|NCT02862574|4026791|FG001|NOT COMPLETED|Open-Label Treatment Period||3
3292868|NCT02862574|4026792|FG002|NOT COMPLETED|Open-Label Treatment Period||1
3292869|NCT02862600|4026801|FG000|STARTED|Period 1--Perhexiline-low Target Range|First subject underwent baseline functional assessment and perhexiline dosing on August 22, 2016|35
3292870|NCT02862600|4026801|FG000|COMPLETED|Period 1--Perhexiline-low Target Range|Study terminated on April 26, 2017 due to lack of efficacy.|22
3292871|NCT02862600|4026801|FG000|NOT COMPLETED|Period 1--Perhexiline-low Target Range||13
3292872|NCT02862600|4026801|FG000|STARTED|Period 2--Perhexiline-high Target Range|First subject completed Period 1 and moved into Period 2 perhexiline dosing on October 17, 2016|22
3292873|NCT02862600|4026801|FG000|COMPLETED|Period 2--Perhexiline-high Target Range|Study terminated on April 26, 2017 due to lack of efficacy in first 15 subjects completing Period 2.|15
3292874|NCT02862600|4026801|FG000|NOT COMPLETED|Period 2--Perhexiline-high Target Range||7
3292875|NCT02862730|4026807|FG000|STARTED|Tslim Training Visit (2 Weeks)||4
3292876|NCT02862730|4026808|FG001|STARTED|Tslim Training Visit (2 Weeks)||1
3292877|NCT02862730|4026809|FG002|STARTED|Tslim Training Visit (2 Weeks)||8
3292878|NCT02862730|4026810|FG003|STARTED|Tslim Training Visit (2 Weeks)||5
3292879|NCT02862730|4026811|FG004|STARTED|Tslim Training Visit (2 Weeks)||5
3292880|NCT02862730|4026812|FG005|STARTED|Tslim Training Visit (2 Weeks)||1
3292881|NCT02862730|4026813|FG006|STARTED|Tslim Training Visit (2 Weeks)||1
3292882|NCT02862730|4026807|FG000|COMPLETED|Tslim Training Visit (2 Weeks)||4
3292883|NCT02862730|4026808|FG001|COMPLETED|Tslim Training Visit (2 Weeks)||1
3108527|NCT01550471|3832797|FG005|COMPLETED|Third Wash Out Period (3 Weeks)||3
3108528|NCT01550471|3832792|FG000|NOT COMPLETED|Third Wash Out Period (3 Weeks)||0
3108529|NCT01550471|3832793|FG001|NOT COMPLETED|Third Wash Out Period (3 Weeks)||0
3108530|NCT01550471|3832794|FG002|NOT COMPLETED|Third Wash Out Period (3 Weeks)||0
3108531|NCT01550471|3832795|FG003|NOT COMPLETED|Third Wash Out Period (3 Weeks)||0
3108532|NCT01550471|3832796|FG004|NOT COMPLETED|Third Wash Out Period (3 Weeks)||0
3108533|NCT01550471|3832797|FG005|NOT COMPLETED|Third Wash Out Period (3 Weeks)||0
3108534|NCT01550549|3832806|FG000|STARTED|Overall Study||151
3108535|NCT01550549|3832806|FG000|COMPLETED|Overall Study||151
3108536|NCT01550549|3832806|FG000|NOT COMPLETED|Overall Study||0
3108537|NCT01550705|3832816|FG000|STARTED|Overall Study||11
3108538|NCT01550705|3832816|FG000|COMPLETED|Overall Study||10
3108539|NCT01550705|3832816|FG000|NOT COMPLETED|Overall Study||1
3292884|NCT02862730|4026809|FG002|COMPLETED|Tslim Training Visit (2 Weeks)||7
3292885|NCT02862730|4026810|FG003|COMPLETED|Tslim Training Visit (2 Weeks)||5
3292886|NCT02862730|4026811|FG004|COMPLETED|Tslim Training Visit (2 Weeks)||5
3292887|NCT02862730|4026812|FG005|COMPLETED|Tslim Training Visit (2 Weeks)||1
3292888|NCT02862730|4026813|FG006|COMPLETED|Tslim Training Visit (2 Weeks)||1
3292889|NCT02862730|4026807|FG000|NOT COMPLETED|Tslim Training Visit (2 Weeks)||0
3292890|NCT02862730|4026808|FG001|NOT COMPLETED|Tslim Training Visit (2 Weeks)||0
3292891|NCT02862730|4026809|FG002|NOT COMPLETED|Tslim Training Visit (2 Weeks)||1
3292892|NCT02862730|4026810|FG003|NOT COMPLETED|Tslim Training Visit (2 Weeks)||0
3292893|NCT02862730|4026811|FG004|NOT COMPLETED|Tslim Training Visit (2 Weeks)||0
3292894|NCT02862730|4026812|FG005|NOT COMPLETED|Tslim Training Visit (2 Weeks)||0
3292895|NCT02862730|4026813|FG006|NOT COMPLETED|Tslim Training Visit (2 Weeks)||0
3292896|NCT02862730|4026807|FG000|STARTED|First Rest Period (1-12 Weeks)||4
3292897|NCT02862730|4026808|FG001|STARTED|First Rest Period (1-12 Weeks)||1
3292898|NCT02862730|4026809|FG002|STARTED|First Rest Period (1-12 Weeks)||7
3292899|NCT02862730|4026810|FG003|STARTED|First Rest Period (1-12 Weeks)||5
3292900|NCT02862730|4026811|FG004|STARTED|First Rest Period (1-12 Weeks)||5
3292901|NCT02862730|4026812|FG005|STARTED|First Rest Period (1-12 Weeks)||1
3292902|NCT02862730|4026813|FG006|STARTED|First Rest Period (1-12 Weeks)||1
3292903|NCT02862730|4026807|FG000|COMPLETED|First Rest Period (1-12 Weeks)||4
3292904|NCT02862730|4026808|FG001|COMPLETED|First Rest Period (1-12 Weeks)||1
3292905|NCT02862730|4026809|FG002|COMPLETED|First Rest Period (1-12 Weeks)||7
3292906|NCT02862730|4026810|FG003|COMPLETED|First Rest Period (1-12 Weeks)||5
3292907|NCT02862730|4026811|FG004|COMPLETED|First Rest Period (1-12 Weeks)||5
3292908|NCT02862730|4026812|FG005|COMPLETED|First Rest Period (1-12 Weeks)||1
3292909|NCT02862730|4026813|FG006|COMPLETED|First Rest Period (1-12 Weeks)||1
3292910|NCT02862730|4026807|FG000|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
3292911|NCT02862730|4026808|FG001|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
3292912|NCT02862730|4026809|FG002|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
3292913|NCT02862730|4026810|FG003|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
3292914|NCT02862730|4026811|FG004|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
3292915|NCT02862730|4026812|FG005|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
3292916|NCT02862730|4026813|FG006|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
3292917|NCT02862730|4026807|FG000|STARTED|First Intervention (84 Hours)||4
3292918|NCT02862730|4026808|FG001|STARTED|First Intervention (84 Hours)||1
3292919|NCT02862730|4026809|FG002|STARTED|First Intervention (84 Hours)||7
3292920|NCT02862730|4026810|FG003|STARTED|First Intervention (84 Hours)||5
3292921|NCT02862730|4026811|FG004|STARTED|First Intervention (84 Hours)||5
3292922|NCT02862730|4026812|FG005|STARTED|First Intervention (84 Hours)||1
3292923|NCT02862730|4026813|FG006|STARTED|First Intervention (84 Hours)||1
3292924|NCT02862730|4026807|FG000|COMPLETED|First Intervention (84 Hours)||4
3292925|NCT02862730|4026808|FG001|COMPLETED|First Intervention (84 Hours)||1
3292926|NCT02862730|4026809|FG002|COMPLETED|First Intervention (84 Hours)||7
3292927|NCT02862730|4026810|FG003|COMPLETED|First Intervention (84 Hours)||5
3292928|NCT02862730|4026811|FG004|COMPLETED|First Intervention (84 Hours)||5
3292929|NCT02862730|4026812|FG005|COMPLETED|First Intervention (84 Hours)||1
3292930|NCT02862730|4026813|FG006|COMPLETED|First Intervention (84 Hours)||1
3292931|NCT02862730|4026807|FG000|NOT COMPLETED|First Intervention (84 Hours)||0
3292932|NCT02862730|4026808|FG001|NOT COMPLETED|First Intervention (84 Hours)||0
3292933|NCT02862730|4026809|FG002|NOT COMPLETED|First Intervention (84 Hours)||0
3292934|NCT02862730|4026810|FG003|NOT COMPLETED|First Intervention (84 Hours)||0
3292935|NCT02862730|4026811|FG004|NOT COMPLETED|First Intervention (84 Hours)||0
3292936|NCT02862730|4026812|FG005|NOT COMPLETED|First Intervention (84 Hours)||0
3292937|NCT02862730|4026813|FG006|NOT COMPLETED|First Intervention (84 Hours)||0
3292938|NCT02862730|4026807|FG000|STARTED|Second Rest Period (7-45 Days)||4
3292939|NCT02862730|4026808|FG001|STARTED|Second Rest Period (7-45 Days)||1
3292940|NCT02862730|4026809|FG002|STARTED|Second Rest Period (7-45 Days)||7
3292941|NCT02862730|4026810|FG003|STARTED|Second Rest Period (7-45 Days)||5
3292942|NCT02862730|4026811|FG004|STARTED|Second Rest Period (7-45 Days)||5
3108540|NCT01550731|3832822|FG000|STARTED|Overall Study||205
3108541|NCT01550731|3832823|FG001|STARTED|Overall Study||209
3108542|NCT01550731|3832822|FG000|COMPLETED|Overall Study||205
3108543|NCT01550731|3832823|FG001|COMPLETED|Overall Study||209
3108544|NCT01550731|3832822|FG000|NOT COMPLETED|Overall Study||0
3108545|NCT01550731|3832823|FG001|NOT COMPLETED|Overall Study||0
3108546|NCT01550744|3832829|FG000|STARTED|Open-Label||478
3108547|NCT01550744|3832830|FG001|STARTED|Open-Label||0
3108548|NCT01550744|3832831|FG002|STARTED|Open-Label||0
3108549|NCT01550744|3832829|FG000|COMPLETED|Open-Label||378
3108550|NCT01550744|3832830|FG001|COMPLETED|Open-Label||0
3108551|NCT01550744|3832831|FG002|COMPLETED|Open-Label||0
3108552|NCT01550744|3832829|FG000|NOT COMPLETED|Open-Label||100
3108553|NCT01550744|3832830|FG001|NOT COMPLETED|Open-Label||0
3108554|NCT01550744|3832831|FG002|NOT COMPLETED|Open-Label||0
3108555|NCT01550744|3832829|FG000|STARTED|Double-Blind||0
3108556|NCT01550744|3832830|FG001|STARTED|Double-Blind||76
3108557|NCT01550744|3832831|FG002|STARTED|Double-Blind||302
3108558|NCT01550744|3832829|FG000|COMPLETED|Double-Blind||0
3108559|NCT01550744|3832830|FG001|COMPLETED|Double-Blind||59
3108560|NCT01550744|3832831|FG002|COMPLETED|Double-Blind||235
3108561|NCT01550744|3832829|FG000|NOT COMPLETED|Double-Blind||0
3108562|NCT01550744|3832830|FG001|NOT COMPLETED|Double-Blind||17
3108563|NCT01550744|3832831|FG002|NOT COMPLETED|Double-Blind||67
3108564|NCT01550757|3832842|FG000|STARTED|Overall Study||56
3108565|NCT01550757|3832843|FG001|STARTED|Overall Study||52
3108566|NCT01550757|3832844|FG002|STARTED|Overall Study||130
3108567|NCT01550757|3832845|FG003|STARTED|Overall Study||144
3108568|NCT01550757|3832842|FG000|COMPLETED|Overall Study||33
3108569|NCT01550757|3832843|FG001|COMPLETED|Overall Study||38
3108570|NCT01550757|3832844|FG002|COMPLETED|Overall Study||85
3108571|NCT01550757|3832845|FG003|COMPLETED|Overall Study||90
3108572|NCT01550757|3832842|FG000|NOT COMPLETED|Overall Study||23
3108573|NCT01550757|3832843|FG001|NOT COMPLETED|Overall Study||14
3108574|NCT01550757|3832844|FG002|NOT COMPLETED|Overall Study||45
3108575|NCT01550757|3832845|FG003|NOT COMPLETED|Overall Study||54
3108576|NCT01550809|3832857|FG000|STARTED|Overall Study|Six patients started with the tBolus, the others with the iBolus, according to a crossover design.|6
3108577|NCT01550809|3832858|FG001|STARTED|Overall Study|Six patients started with the iBolus, the others with the tBolus, according to a crossover design.|6
3108578|NCT01550809|3832857|FG000|COMPLETED|Overall Study||6
3108579|NCT01550809|3832858|FG001|COMPLETED|Overall Study||6
3108580|NCT01550809|3832857|FG000|NOT COMPLETED|Overall Study||0
3108581|NCT01550809|3832858|FG001|NOT COMPLETED|Overall Study||0
3108582|NCT01550952|3832864|FG000|STARTED|Overall Study||10
3108583|NCT01550952|3832864|FG000|COMPLETED|Overall Study||10
3108584|NCT01550952|3832864|FG000|NOT COMPLETED|Overall Study||0
3292943|NCT02862730|4026812|FG005|STARTED|Second Rest Period (7-45 Days)||1
3292944|NCT02862730|4026813|FG006|STARTED|Second Rest Period (7-45 Days)||1
3292945|NCT02862730|4026807|FG000|COMPLETED|Second Rest Period (7-45 Days)||4
3292946|NCT02862730|4026808|FG001|COMPLETED|Second Rest Period (7-45 Days)||1
3292947|NCT02862730|4026809|FG002|COMPLETED|Second Rest Period (7-45 Days)||7
3292948|NCT02862730|4026810|FG003|COMPLETED|Second Rest Period (7-45 Days)||5
3292949|NCT02862730|4026811|FG004|COMPLETED|Second Rest Period (7-45 Days)||5
3292950|NCT02862730|4026812|FG005|COMPLETED|Second Rest Period (7-45 Days)||1
3292951|NCT02862730|4026813|FG006|COMPLETED|Second Rest Period (7-45 Days)||1
3292952|NCT02862730|4026807|FG000|NOT COMPLETED|Second Rest Period (7-45 Days)||0
3292953|NCT02862730|4026808|FG001|NOT COMPLETED|Second Rest Period (7-45 Days)||0
3292954|NCT02862730|4026809|FG002|NOT COMPLETED|Second Rest Period (7-45 Days)||0
3292955|NCT02862730|4026810|FG003|NOT COMPLETED|Second Rest Period (7-45 Days)||0
3292956|NCT02862730|4026811|FG004|NOT COMPLETED|Second Rest Period (7-45 Days)||0
3292957|NCT02862730|4026812|FG005|NOT COMPLETED|Second Rest Period (7-45 Days)||0
3292958|NCT02862730|4026813|FG006|NOT COMPLETED|Second Rest Period (7-45 Days)||0
3292959|NCT02862730|4026807|FG000|STARTED|Second Intervention (84 Hours)||4
3292960|NCT02862730|4026808|FG001|STARTED|Second Intervention (84 Hours)||1
3292961|NCT02862730|4026809|FG002|STARTED|Second Intervention (84 Hours)||7
3292962|NCT02862730|4026810|FG003|STARTED|Second Intervention (84 Hours)||5
3292963|NCT02862730|4026811|FG004|STARTED|Second Intervention (84 Hours)||5
3292964|NCT02862730|4026812|FG005|STARTED|Second Intervention (84 Hours)||1
3292965|NCT02862730|4026813|FG006|STARTED|Second Intervention (84 Hours)||1
3292966|NCT02862730|4026807|FG000|COMPLETED|Second Intervention (84 Hours)||3
3292967|NCT02862730|4026808|FG001|COMPLETED|Second Intervention (84 Hours)||1
3292968|NCT02862730|4026809|FG002|COMPLETED|Second Intervention (84 Hours)||7
3292969|NCT02862730|4026810|FG003|COMPLETED|Second Intervention (84 Hours)||5
3292970|NCT02862730|4026811|FG004|COMPLETED|Second Intervention (84 Hours)||5
3292971|NCT02862730|4026812|FG005|COMPLETED|Second Intervention (84 Hours)||1
3292972|NCT02862730|4026813|FG006|COMPLETED|Second Intervention (84 Hours)||1
3292973|NCT02862730|4026807|FG000|NOT COMPLETED|Second Intervention (84 Hours)||1
3292974|NCT02862730|4026808|FG001|NOT COMPLETED|Second Intervention (84 Hours)||0
3292975|NCT02862730|4026809|FG002|NOT COMPLETED|Second Intervention (84 Hours)||0
3292976|NCT02862730|4026810|FG003|NOT COMPLETED|Second Intervention (84 Hours)||0
3292977|NCT02862730|4026811|FG004|NOT COMPLETED|Second Intervention (84 Hours)||0
3292978|NCT02862730|4026812|FG005|NOT COMPLETED|Second Intervention (84 Hours)||0
3108585|NCT01550965|3832868|FG000|STARTED|Overall Study||463
3108586|NCT01550965|3832868|FG000|COMPLETED|Overall Study||353
3108587|NCT01550965|3832868|FG000|NOT COMPLETED|Overall Study||110
3108588|NCT01551030|3832873|FG000|STARTED|Overall Study||19
3108589|NCT01551030|3832873|FG000|COMPLETED|Overall Study||19
3108590|NCT01551030|3832873|FG000|NOT COMPLETED|Overall Study||0
3108591|NCT01551056|3832879|FG000|STARTED|Overall Study||46
3108592|NCT01551056|3832880|FG001|STARTED|Overall Study||45
3108593|NCT01551056|3832879|FG000|COMPLETED|Overall Study||44
3108594|NCT01551056|3832880|FG001|COMPLETED|Overall Study||45
3108595|NCT01551056|3832879|FG000|NOT COMPLETED|Overall Study||2
3108596|NCT01551056|3832880|FG001|NOT COMPLETED|Overall Study||0
3108597|NCT01551095|3832886|FG000|STARTED|Overall Study||7
3108598|NCT01551095|3832886|FG000|COMPLETED|Overall Study||7
3108599|NCT01551095|3832886|FG000|NOT COMPLETED|Overall Study||0
3108600|NCT01551173|3832892|FG000|STARTED|Overall Study|"Started indicates randomized"|218
3108601|NCT01551173|3832893|FG001|STARTED|Overall Study||218
3108602|NCT01551173|3832892|FG000|Full Analysis Set (FAS)|Overall Study|Patients took at least 1 dose of study drug & had at least 1 post-randomization efficacy parameter|210
3108603|NCT01551173|3832893|FG001|Full Analysis Set (FAS)|Overall Study||214
3108604|NCT01551173|3832892|FG000|COMPLETED|Overall Study||190
3108605|NCT01551173|3832893|FG001|COMPLETED|Overall Study||186
3108606|NCT01551173|3832892|FG000|NOT COMPLETED|Overall Study||28
3108607|NCT01551173|3832893|FG001|NOT COMPLETED|Overall Study||32
3108608|NCT01551186|3832902|FG000|STARTED|Overall Study||50
3108609|NCT01551186|3832903|FG001|STARTED|Overall Study||53
3108610|NCT01551186|3832902|FG000|COMPLETED|Overall Study||30
3292979|NCT02862730|4026813|FG006|NOT COMPLETED|Second Intervention (84 Hours)||0
3292980|NCT02862730|4026807|FG000|STARTED|Third Rest Period (7-45 Days)||3
3292981|NCT02862730|4026808|FG001|STARTED|Third Rest Period (7-45 Days)||1
3292982|NCT02862730|4026809|FG002|STARTED|Third Rest Period (7-45 Days)||7
3292983|NCT02862730|4026810|FG003|STARTED|Third Rest Period (7-45 Days)||5
3292984|NCT02862730|4026811|FG004|STARTED|Third Rest Period (7-45 Days)||5
3292985|NCT02862730|4026812|FG005|STARTED|Third Rest Period (7-45 Days)||1
3292986|NCT02862730|4026813|FG006|STARTED|Third Rest Period (7-45 Days)||1
3292987|NCT02862730|4026807|FG000|COMPLETED|Third Rest Period (7-45 Days)||3
3292988|NCT02862730|4026808|FG001|COMPLETED|Third Rest Period (7-45 Days)||1
3292989|NCT02862730|4026809|FG002|COMPLETED|Third Rest Period (7-45 Days)||6
3292990|NCT02862730|4026810|FG003|COMPLETED|Third Rest Period (7-45 Days)||5
3292991|NCT02862730|4026811|FG004|COMPLETED|Third Rest Period (7-45 Days)||4
3292992|NCT02862730|4026812|FG005|COMPLETED|Third Rest Period (7-45 Days)||1
3292993|NCT02862730|4026813|FG006|COMPLETED|Third Rest Period (7-45 Days)||1
3292994|NCT02862730|4026807|FG000|NOT COMPLETED|Third Rest Period (7-45 Days)||0
3292995|NCT02862730|4026808|FG001|NOT COMPLETED|Third Rest Period (7-45 Days)||0
3292996|NCT02862730|4026809|FG002|NOT COMPLETED|Third Rest Period (7-45 Days)||1
3292997|NCT02862730|4026810|FG003|NOT COMPLETED|Third Rest Period (7-45 Days)||0
3292998|NCT02862730|4026811|FG004|NOT COMPLETED|Third Rest Period (7-45 Days)||1
3292999|NCT02862730|4026812|FG005|NOT COMPLETED|Third Rest Period (7-45 Days)||0
3293000|NCT02862730|4026813|FG006|NOT COMPLETED|Third Rest Period (7-45 Days)||0
3293001|NCT02862730|4026807|FG000|STARTED|Third Intervention (84 Hours)||3
3293002|NCT02862730|4026808|FG001|STARTED|Third Intervention (84 Hours)||1
3293003|NCT02862730|4026809|FG002|STARTED|Third Intervention (84 Hours)||6
3293004|NCT02862730|4026810|FG003|STARTED|Third Intervention (84 Hours)||5
3293005|NCT02862730|4026811|FG004|STARTED|Third Intervention (84 Hours)||4
3293006|NCT02862730|4026812|FG005|STARTED|Third Intervention (84 Hours)||1
3293007|NCT02862730|4026813|FG006|STARTED|Third Intervention (84 Hours)||1
3293008|NCT02862730|4026807|FG000|COMPLETED|Third Intervention (84 Hours)||3
3293009|NCT02862730|4026808|FG001|COMPLETED|Third Intervention (84 Hours)||1
3293010|NCT02862730|4026809|FG002|COMPLETED|Third Intervention (84 Hours)||6
3293011|NCT02862730|4026810|FG003|COMPLETED|Third Intervention (84 Hours)||4
3293012|NCT02862730|4026811|FG004|COMPLETED|Third Intervention (84 Hours)||4
3293013|NCT02862730|4026812|FG005|COMPLETED|Third Intervention (84 Hours)||1
3293014|NCT02862730|4026813|FG006|COMPLETED|Third Intervention (84 Hours)||1
3293015|NCT02862730|4026807|FG000|NOT COMPLETED|Third Intervention (84 Hours)||0
3293016|NCT02862730|4026808|FG001|NOT COMPLETED|Third Intervention (84 Hours)||0
3293017|NCT02862730|4026809|FG002|NOT COMPLETED|Third Intervention (84 Hours)||0
3293018|NCT02862730|4026810|FG003|NOT COMPLETED|Third Intervention (84 Hours)||1
3293019|NCT02862730|4026811|FG004|NOT COMPLETED|Third Intervention (84 Hours)||0
3293020|NCT02862730|4026812|FG005|NOT COMPLETED|Third Intervention (84 Hours)||0
3293021|NCT02862730|4026813|FG006|NOT COMPLETED|Third Intervention (84 Hours)||0
3293022|NCT02862730|4026807|FG000|STARTED|Fourth Rest Period (7-45 Days)||3
3293023|NCT02862730|4026808|FG001|STARTED|Fourth Rest Period (7-45 Days)||1
3293024|NCT02862730|4026809|FG002|STARTED|Fourth Rest Period (7-45 Days)||6
3293025|NCT02862730|4026810|FG003|STARTED|Fourth Rest Period (7-45 Days)||4
3293026|NCT02862730|4026811|FG004|STARTED|Fourth Rest Period (7-45 Days)||4
3293027|NCT02862730|4026812|FG005|STARTED|Fourth Rest Period (7-45 Days)||1
3293028|NCT02862730|4026813|FG006|STARTED|Fourth Rest Period (7-45 Days)||1
3293029|NCT02862730|4026807|FG000|COMPLETED|Fourth Rest Period (7-45 Days)||3
3293030|NCT02862730|4026808|FG001|COMPLETED|Fourth Rest Period (7-45 Days)||1
3293031|NCT02862730|4026809|FG002|COMPLETED|Fourth Rest Period (7-45 Days)||6
3293032|NCT02862730|4026810|FG003|COMPLETED|Fourth Rest Period (7-45 Days)||4
3293033|NCT02862730|4026811|FG004|COMPLETED|Fourth Rest Period (7-45 Days)||4
3293034|NCT02862730|4026812|FG005|COMPLETED|Fourth Rest Period (7-45 Days)||1
3293035|NCT02862730|4026813|FG006|COMPLETED|Fourth Rest Period (7-45 Days)||1
3293036|NCT02862730|4026807|FG000|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0
3293037|NCT02862730|4026808|FG001|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0
3293038|NCT02862730|4026809|FG002|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0
3293039|NCT02862730|4026810|FG003|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0
3293040|NCT02862730|4026811|FG004|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0
3293041|NCT02862730|4026812|FG005|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0
3293042|NCT02862730|4026813|FG006|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0
3293043|NCT02862730|4026807|FG000|STARTED|Fourth Intervention (84 Hours)||3
3108611|NCT01551186|3832903|FG001|COMPLETED|Overall Study||40
3108612|NCT01551186|3832902|FG000|NOT COMPLETED|Overall Study||20
3108613|NCT01551186|3832903|FG001|NOT COMPLETED|Overall Study||13
3108614|NCT01551199|3832909|FG000|STARTED|Overall Study||7
3108615|NCT01551199|3832909|FG000|COMPLETED|Overall Study||2
3108616|NCT01551199|3832909|FG000|NOT COMPLETED|Overall Study||5
3108617|NCT01551212|3832915|FG000|STARTED|Overall Study||171
3108618|NCT01551212|3832916|FG001|STARTED|Overall Study||168
3108619|NCT01551212|3832915|FG000|Full Anylsis Set (FAS)|Overall Study||169
3108620|NCT01551212|3832916|FG001|Full Anylsis Set (FAS)|Overall Study||164
3108621|NCT01551212|3832915|FG000|Safety Set|Overall Study||169
3108622|NCT01551212|3832916|FG001|Safety Set|Overall Study||164
3108623|NCT01551212|3832915|FG000|Per Protocol Set (PP)|Overall Study||110
3108624|NCT01551212|3832916|FG001|Per Protocol Set (PP)|Overall Study||101
3108625|NCT01551212|3832915|FG000|COMPLETED|Overall Study||166
3108626|NCT01551212|3832916|FG001|COMPLETED|Overall Study||148
3108627|NCT01551212|3832915|FG000|NOT COMPLETED|Overall Study||5
3108628|NCT01551212|3832916|FG001|NOT COMPLETED|Overall Study||20
3108629|NCT01551264|3832924|FG000|STARTED|Overall Study||70
3108630|NCT01551264|3832925|FG001|STARTED|Overall Study||69
3108631|NCT01551264|3832924|FG000|Started Bracing|Overall Study||69
3108632|NCT01551264|3832925|FG001|Started Bracing|Overall Study||67
3108633|NCT01551264|3832924|FG000|Data for at Least One Follow-up After Brace Discontinuation Ascertained|Overall Study|Attended at least one visit within one year after discontinuing bracing|44
3108634|NCT01551264|3832925|FG001|Data for at Least One Follow-up After Brace Discontinuation Ascertained|Overall Study|Attended at least one visit within one year after discontinuing bracing|55
3108635|NCT01551264|3832924|FG000|COMPLETED|Overall Study|Attended 60 month follow-up visit|38
3108636|NCT01551264|3832925|FG001|COMPLETED|Overall Study|Attended 36 month follow-up visit|41
3108637|NCT01551264|3832924|FG000|NOT COMPLETED|Overall Study||32
3108638|NCT01551264|3832925|FG001|NOT COMPLETED|Overall Study||28
3108639|NCT01551303|3832933|FG000|STARTED|Overall Study||25
3108640|NCT01551303|3832934|FG001|STARTED|Overall Study||22
3293044|NCT02862730|4026808|FG001|STARTED|Fourth Intervention (84 Hours)||1
3293045|NCT02862730|4026809|FG002|STARTED|Fourth Intervention (84 Hours)||6
3293046|NCT02862730|4026810|FG003|STARTED|Fourth Intervention (84 Hours)||4
3293047|NCT02862730|4026811|FG004|STARTED|Fourth Intervention (84 Hours)||4
3293048|NCT02862730|4026812|FG005|STARTED|Fourth Intervention (84 Hours)||1
3293049|NCT02862730|4026813|FG006|STARTED|Fourth Intervention (84 Hours)||1
3293050|NCT02862730|4026807|FG000|COMPLETED|Fourth Intervention (84 Hours)||3
3293051|NCT02862730|4026808|FG001|COMPLETED|Fourth Intervention (84 Hours)||1
3293052|NCT02862730|4026809|FG002|COMPLETED|Fourth Intervention (84 Hours)||6
3293053|NCT02862730|4026810|FG003|COMPLETED|Fourth Intervention (84 Hours)||4
3293054|NCT02862730|4026811|FG004|COMPLETED|Fourth Intervention (84 Hours)||4
3293055|NCT02862730|4026812|FG005|COMPLETED|Fourth Intervention (84 Hours)||1
3293056|NCT02862730|4026813|FG006|COMPLETED|Fourth Intervention (84 Hours)||1
3293057|NCT02862730|4026807|FG000|NOT COMPLETED|Fourth Intervention (84 Hours)||0
3293058|NCT02862730|4026808|FG001|NOT COMPLETED|Fourth Intervention (84 Hours)||0
3293059|NCT02862730|4026809|FG002|NOT COMPLETED|Fourth Intervention (84 Hours)||0
3293060|NCT02862730|4026810|FG003|NOT COMPLETED|Fourth Intervention (84 Hours)||0
3293061|NCT02862730|4026811|FG004|NOT COMPLETED|Fourth Intervention (84 Hours)||0
3293062|NCT02862730|4026812|FG005|NOT COMPLETED|Fourth Intervention (84 Hours)||0
3293063|NCT02862730|4026813|FG006|NOT COMPLETED|Fourth Intervention (84 Hours)||0
3293064|NCT02862912|4026830|FG000|STARTED|Overall Study||23
3293065|NCT02862912|4026831|FG001|STARTED|Overall Study||20
3293066|NCT02862912|4026830|FG000|COMPLETED|Overall Study||22
3293067|NCT02862912|4026831|FG001|COMPLETED|Overall Study||20
3293068|NCT02862912|4026830|FG000|NOT COMPLETED|Overall Study||1
3293069|NCT02862912|4026831|FG001|NOT COMPLETED|Overall Study||0
3293070|NCT02863198|4026841|FG000|STARTED|Overall Study||60
3293071|NCT02863198|4026842|FG001|STARTED|Overall Study||60
3293072|NCT02863198|4026841|FG000|COMPLETED|Overall Study||60
3293073|NCT02863198|4026842|FG001|COMPLETED|Overall Study||60
3293074|NCT02863198|4026841|FG000|NOT COMPLETED|Overall Study||0
3293075|NCT02863198|4026842|FG001|NOT COMPLETED|Overall Study||0
3293076|NCT02863263|4026850|FG000|STARTED|Overall Study||3
3293077|NCT02863263|4026851|FG001|STARTED|Overall Study||2
3293078|NCT02863263|4026850|FG000|COMPLETED|Overall Study||2
3293079|NCT02863263|4026851|FG001|COMPLETED|Overall Study||1
3293080|NCT02863263|4026850|FG000|NOT COMPLETED|Overall Study||1
3293081|NCT02863263|4026851|FG001|NOT COMPLETED|Overall Study||1
3293082|NCT02863289|4026857|FG000|STARTED|Overall Study|Study started on 01/11/2016, with 118 study participants.|118
3293083|NCT02863289|4026857|FG000|COMPLETED|Overall Study|Study completed on 01/03/2017, 35 study participants have returned the questionnaire.|35
3293084|NCT02863289|4026857|FG000|NOT COMPLETED|Overall Study||83
3293085|NCT02863328|4026864|FG000|STARTED|Overall Study||411
3293086|NCT02863328|4026865|FG001|STARTED|Overall Study||410
3293087|NCT02863328|4026864|FG000|Full Analysis Set (FAS)|Overall Study||411
3293088|NCT02863328|4026865|FG001|Full Analysis Set (FAS)|Overall Study||410
3293089|NCT02863328|4026864|FG000|Safety Analysis Set (SAS)|Overall Study||410
3293090|NCT02863328|4026865|FG001|Safety Analysis Set (SAS)|Overall Study||409
3293091|NCT02863328|4026864|FG000|COMPLETED|Overall Study||400
3293092|NCT02863328|4026865|FG001|COMPLETED|Overall Study||387
3293093|NCT02863328|4026864|FG000|NOT COMPLETED|Overall Study||11
3293094|NCT02863328|4026865|FG001|NOT COMPLETED|Overall Study||23
3293095|NCT02863354|4026873|FG000|STARTED|Year 1||23
3293096|NCT02863354|4026874|FG001|STARTED|Year 1||20
3108641|NCT01551303|3832933|FG000|COMPLETED|Overall Study||21
3108642|NCT01551303|3832934|FG001|COMPLETED|Overall Study||15
3108643|NCT01551303|3832933|FG000|NOT COMPLETED|Overall Study||4
3108644|NCT01551303|3832934|FG001|NOT COMPLETED|Overall Study||7
3108645|NCT01551355|3832946|FG000|STARTED|Overall Study||622
3108646|NCT01551355|3832947|FG001|STARTED|Overall Study||594
3108647|NCT01551355|3832948|FG002|STARTED|Overall Study||493
3108648|NCT01551355|3832949|FG003|STARTED|Overall Study||435
3108649|NCT01551355|3832950|FG004|STARTED|Overall Study||64
3108650|NCT01551355|3832951|FG005|STARTED|Overall Study||71
3108651|NCT01551355|3832946|FG000|COMPLETED|Overall Study||571
3108652|NCT01551355|3832947|FG001|COMPLETED|Overall Study||545
3108653|NCT01551355|3832948|FG002|COMPLETED|Overall Study||459
3293097|NCT02863354|4026873|FG000|COMPLETED|Year 1||19
3293098|NCT02863354|4026874|FG001|COMPLETED|Year 1||18
3293099|NCT02863354|4026873|FG000|NOT COMPLETED|Year 1||4
3293100|NCT02863354|4026874|FG001|NOT COMPLETED|Year 1||2
3293101|NCT02863354|4026873|FG000|STARTED|Year 2||19
3293102|NCT02863354|4026874|FG001|STARTED|Year 2||18
3293103|NCT02863354|4026873|FG000|COMPLETED|Year 2||17
3293104|NCT02863354|4026874|FG001|COMPLETED|Year 2||16
3293105|NCT02863354|4026873|FG000|NOT COMPLETED|Year 2||2
3293106|NCT02863354|4026874|FG001|NOT COMPLETED|Year 2||2
3293107|NCT02863419|4026883|FG000|STARTED|Overall Study||285
3293108|NCT02863419|4026884|FG001|STARTED|Overall Study||284
3293109|NCT02863419|4026885|FG002|STARTED|Overall Study||142
3293110|NCT02863419|4026883|FG000|Full Analysis Set (FAS)|Overall Study||285
3293111|NCT02863419|4026884|FG001|Full Analysis Set (FAS)|Overall Study||284
3293112|NCT02863419|4026885|FG002|Full Analysis Set (FAS)|Overall Study||142
3293113|NCT02863419|4026883|FG000|Safety Analysis Set (SAS)|Overall Study||285
3293114|NCT02863419|4026884|FG001|Safety Analysis Set (SAS)|Overall Study||284
3293115|NCT02863419|4026885|FG002|Safety Analysis Set (SAS)|Overall Study||142
3293116|NCT02863419|4026883|FG000|COMPLETED|Overall Study||277
3293117|NCT02863419|4026884|FG001|COMPLETED|Overall Study||274
3293118|NCT02863419|4026885|FG002|COMPLETED|Overall Study||134
3293119|NCT02863419|4026883|FG000|NOT COMPLETED|Overall Study||8
3293120|NCT02863419|4026884|FG001|NOT COMPLETED|Overall Study||10
3293121|NCT02863419|4026885|FG002|NOT COMPLETED|Overall Study||8
3293122|NCT02863575|4026896|FG000|STARTED|Overall Study||161
3293123|NCT02863575|4026897|FG001|STARTED|Overall Study||161
3293124|NCT02863575|4026898|FG002|STARTED|Overall Study||52
3293125|NCT02863575|4026896|FG000|COMPLETED|Overall Study||160
3293126|NCT02863575|4026897|FG001|COMPLETED|Overall Study||159
3293127|NCT02863575|4026898|FG002|COMPLETED|Overall Study||51
3293128|NCT02863575|4026896|FG000|NOT COMPLETED|Overall Study||1
3293129|NCT02863575|4026897|FG001|NOT COMPLETED|Overall Study||2
3293130|NCT02863575|4026898|FG002|NOT COMPLETED|Overall Study||1
3293131|NCT02864069|4026909|FG000|STARTED|Overall Study||18
3293132|NCT02864069|4026910|FG001|STARTED|Overall Study||13
3293133|NCT02864069|4026911|FG002|STARTED|Overall Study||21
3293134|NCT02864069|4026909|FG000|COMPLETED|Overall Study||12
3293135|NCT02864069|4026910|FG001|COMPLETED|Overall Study||5
3293136|NCT02864069|4026911|FG002|COMPLETED|Overall Study||13
3293137|NCT02864069|4026909|FG000|NOT COMPLETED|Overall Study||6
3293138|NCT02864069|4026910|FG001|NOT COMPLETED|Overall Study||8
3293139|NCT02864069|4026911|FG002|NOT COMPLETED|Overall Study||8
3293140|NCT02864082|4026921|FG000|STARTED|Overall Study||10
3293141|NCT02864082|4026922|FG001|STARTED|Overall Study||9
3293142|NCT02864082|4026921|FG000|COMPLETED|Overall Study||7
3293143|NCT02864082|4026922|FG001|COMPLETED|Overall Study||5
3293144|NCT02864082|4026921|FG000|NOT COMPLETED|Overall Study||3
3293145|NCT02864082|4026922|FG001|NOT COMPLETED|Overall Study||4
3293146|NCT02864316|4026944|FG000|STARTED|Overall Study||2
3293147|NCT02864316|4026945|FG001|STARTED|Overall Study||2
3293148|NCT02864316|4026944|FG000|COMPLETED|Overall Study||0
3293149|NCT02864316|4026945|FG001|COMPLETED|Overall Study||0
3293150|NCT02864316|4026944|FG000|NOT COMPLETED|Overall Study||2
3293151|NCT02864316|4026945|FG001|NOT COMPLETED|Overall Study||2
3293152|NCT02864342|4026953|FG000|STARTED|Overall Study||70
3293153|NCT02864342|4026954|FG001|STARTED|Overall Study||68
3293154|NCT02864342|4026953|FG000|Full Analysis Set (FAS)|Overall Study||70
3293155|NCT02864342|4026954|FG001|Full Analysis Set (FAS)|Overall Study||67
3293156|NCT02864342|4026953|FG000|COMPLETED|Overall Study||55
3293157|NCT02864342|4026954|FG001|COMPLETED|Overall Study||49
3293158|NCT02864342|4026953|FG000|NOT COMPLETED|Overall Study||15
3293159|NCT02864342|4026954|FG001|NOT COMPLETED|Overall Study||19
3293160|NCT02864355|4026963|FG000|STARTED|Overall Study||25
3293161|NCT02864355|4026964|FG001|STARTED|Overall Study||28
3293162|NCT02864355|4026963|FG000|COMPLETED|Overall Study||23
3293163|NCT02864355|4026964|FG001|COMPLETED|Overall Study||25
3293164|NCT02864355|4026963|FG000|NOT COMPLETED|Overall Study||2
3293165|NCT02864355|4026964|FG001|NOT COMPLETED|Overall Study||3
3293166|NCT02864368|4026975|FG000|STARTED|Overall Study||4
3293167|NCT02864368|4026976|FG001|STARTED|Overall Study||1
3293168|NCT02864368|4026977|FG002|STARTED|Overall Study||6
3293169|NCT02864368|4026978|FG003|STARTED|Overall Study||8
3293170|NCT02864368|4026979|FG004|STARTED|Overall Study||8
3293171|NCT02864368|4026975|FG000|COMPLETED|Overall Study||4
3108654|NCT01551355|3832949|FG003|COMPLETED|Overall Study||411
3108655|NCT01551355|3832950|FG004|COMPLETED|Overall Study||55
3108656|NCT01551355|3832951|FG005|COMPLETED|Overall Study||65
3108657|NCT01551355|3832946|FG000|NOT COMPLETED|Overall Study||51
3293172|NCT02864368|4026976|FG001|COMPLETED|Overall Study||1
3293173|NCT02864368|4026977|FG002|COMPLETED|Overall Study||6
3293174|NCT02864368|4026978|FG003|COMPLETED|Overall Study||8
3293175|NCT02864368|4026979|FG004|COMPLETED|Overall Study||8
3293176|NCT02864368|4026975|FG000|NOT COMPLETED|Overall Study||0
3108658|NCT01551355|3832947|FG001|NOT COMPLETED|Overall Study||49
3108659|NCT01551355|3832948|FG002|NOT COMPLETED|Overall Study||34
3108660|NCT01551355|3832949|FG003|NOT COMPLETED|Overall Study||24
3108661|NCT01551355|3832950|FG004|NOT COMPLETED|Overall Study||9
3108662|NCT01551355|3832951|FG005|NOT COMPLETED|Overall Study||6
3108663|NCT01551420|3832961|FG000|STARTED|In-laboratory (Part A)||39
3108664|NCT01551420|3832962|FG001|STARTED|In-laboratory (Part A)||13
3293177|NCT02864368|4026976|FG001|NOT COMPLETED|Overall Study||0
3293178|NCT02864368|4026977|FG002|NOT COMPLETED|Overall Study||0
3293179|NCT02864368|4026978|FG003|NOT COMPLETED|Overall Study||0
3293180|NCT02864368|4026979|FG004|NOT COMPLETED|Overall Study||0
3293181|NCT02864381|4026998|FG000|STARTED|Overall Study||72
3293182|NCT02864381|4026999|FG001|STARTED|Overall Study||72
3293183|NCT02864381|4026998|FG000|COMPLETED|Overall Study||0
3293184|NCT02864381|4026999|FG001|COMPLETED|Overall Study||0
3293185|NCT02864381|4026998|FG000|NOT COMPLETED|Overall Study||72
3293186|NCT02864381|4026999|FG001|NOT COMPLETED|Overall Study||72
3293187|NCT02864394|4027007|FG000|STARTED|Overall Study||213
3293188|NCT02864394|4027008|FG001|STARTED|Overall Study||212
3293189|NCT02864394|4027007|FG000|Treated|Overall Study||213
3293190|NCT02864394|4027008|FG001|Treated|Overall Study||198
3293191|NCT02864394|4027007|FG000|COMPLETED|Overall Study||0
3293192|NCT02864394|4027008|FG001|COMPLETED|Overall Study||0
3293193|NCT02864394|4027007|FG000|NOT COMPLETED|Overall Study||213
3293194|NCT02864394|4027008|FG001|NOT COMPLETED|Overall Study||212
3293195|NCT02864706|4027016|FG000|STARTED|Overall Study||48
3293196|NCT02864706|4027017|FG001|STARTED|Overall Study||47
3293197|NCT02864706|4027016|FG000|Safety Set|Overall Study||48
3293198|NCT02864706|4027017|FG001|Safety Set|Overall Study||47
3293199|NCT02864706|4027016|FG000|Intent to Treat|Overall Study||46
3293200|NCT02864706|4027017|FG001|Intent to Treat|Overall Study||47
3293201|NCT02864706|4027016|FG000|COMPLETED|Overall Study||48
3293202|NCT02864706|4027017|FG001|COMPLETED|Overall Study||47
3293203|NCT02864706|4027016|FG000|NOT COMPLETED|Overall Study||0
3293204|NCT02864706|4027017|FG001|NOT COMPLETED|Overall Study||0
3293205|NCT02864732|4027025|FG000|STARTED|Overall Study||15
3293206|NCT02864732|4027026|FG001|STARTED|Overall Study||15
3293207|NCT02864732|4027025|FG000|COMPLETED|Overall Study||13
3293208|NCT02864732|4027026|FG001|COMPLETED|Overall Study||13
3293209|NCT02864732|4027025|FG000|NOT COMPLETED|Overall Study||2
3293210|NCT02864732|4027026|FG001|NOT COMPLETED|Overall Study||2
3293211|NCT02865187|4027035|FG000|STARTED|Overall Study||33
3293212|NCT02865187|4027036|FG001|STARTED|Overall Study||14
3293213|NCT02865187|4027035|FG000|Visit 2 - at 3 Months|Overall Study||23
3293214|NCT02865187|4027036|FG001|Visit 2 - at 3 Months|Overall Study||7
3293215|NCT02865187|4027035|FG000|COMPLETED|Overall Study||20
3293216|NCT02865187|4027036|FG001|COMPLETED|Overall Study||7
3293217|NCT02865187|4027035|FG000|NOT COMPLETED|Overall Study||13
3293218|NCT02865187|4027036|FG001|NOT COMPLETED|Overall Study||7
3293219|NCT02865343|4027044|FG000|STARTED|Overall Study||6
3293220|NCT02865343|4027045|FG001|STARTED|Overall Study||5
3293221|NCT02865343|4027044|FG000|COMPLETED|Overall Study||6
3293222|NCT02865343|4027045|FG001|COMPLETED|Overall Study||3
3293223|NCT02865343|4027044|FG000|NOT COMPLETED|Overall Study||0
3293224|NCT02865343|4027045|FG001|NOT COMPLETED|Overall Study||2
3293225|NCT02865434|4027064|FG000|STARTED|Overall Study||3
3293226|NCT02865434|4027065|FG001|STARTED|Overall Study||3
3293227|NCT02865434|4027066|FG002|STARTED|Overall Study||3
3293228|NCT02865434|4027067|FG003|STARTED|Overall Study||3
3293229|NCT02865434|4027068|FG004|STARTED|Overall Study||3
3293230|NCT02865434|4027069|FG005|STARTED|Overall Study||3
3293231|NCT02865434|4027070|FG006|STARTED|Overall Study||3
3293232|NCT02865434|4027071|FG007|STARTED|Overall Study||3
3293233|NCT02865434|4027072|FG008|STARTED|Overall Study||3
3293234|NCT02865434|4027073|FG009|STARTED|Overall Study||6
3293235|NCT02865434|4027074|FG010|STARTED|Overall Study||6
3293236|NCT02865434|4027064|FG000|COMPLETED|Overall Study||3
3293237|NCT02865434|4027065|FG001|COMPLETED|Overall Study||3
3293238|NCT02865434|4027066|FG002|COMPLETED|Overall Study||3
3293239|NCT02865434|4027067|FG003|COMPLETED|Overall Study||3
3293240|NCT02865434|4027068|FG004|COMPLETED|Overall Study||3
3293241|NCT02865434|4027069|FG005|COMPLETED|Overall Study||3
3293242|NCT02865434|4027070|FG006|COMPLETED|Overall Study||3
3293243|NCT02865434|4027071|FG007|COMPLETED|Overall Study||3
3293244|NCT02865434|4027072|FG008|COMPLETED|Overall Study||3
3293245|NCT02865434|4027073|FG009|COMPLETED|Overall Study||6
3293246|NCT02865434|4027074|FG010|COMPLETED|Overall Study||6
3293247|NCT02865434|4027064|FG000|NOT COMPLETED|Overall Study||0
3293248|NCT02865434|4027065|FG001|NOT COMPLETED|Overall Study||0
3293249|NCT02865434|4027066|FG002|NOT COMPLETED|Overall Study||0
3293250|NCT02865434|4027067|FG003|NOT COMPLETED|Overall Study||0
3293251|NCT02865434|4027068|FG004|NOT COMPLETED|Overall Study||0
3293252|NCT02865434|4027069|FG005|NOT COMPLETED|Overall Study||0
3293253|NCT02865434|4027070|FG006|NOT COMPLETED|Overall Study||0
3293254|NCT02865434|4027071|FG007|NOT COMPLETED|Overall Study||0
3293255|NCT02865434|4027072|FG008|NOT COMPLETED|Overall Study||0
3293256|NCT02865434|4027073|FG009|NOT COMPLETED|Overall Study||0
3293257|NCT02865434|4027074|FG010|NOT COMPLETED|Overall Study||0
3293258|NCT02865499|4027104|FG000|STARTED|Baseline||8
3108665|NCT01551420|3832961|FG000|COMPLETED|In-laboratory (Part A)||33
3108666|NCT01551420|3832962|FG001|COMPLETED|In-laboratory (Part A)||11
3108667|NCT01551420|3832961|FG000|NOT COMPLETED|In-laboratory (Part A)||6
3108668|NCT01551420|3832962|FG001|NOT COMPLETED|In-laboratory (Part A)||2
3108669|NCT01551420|3832961|FG000|STARTED|Screened for Part B Eligibility||33
3108670|NCT01551420|3832962|FG001|STARTED|Screened for Part B Eligibility||11
3108671|NCT01551420|3832961|FG000|COMPLETED|Screened for Part B Eligibility||24
3108672|NCT01551420|3832962|FG001|COMPLETED|Screened for Part B Eligibility||8
3108673|NCT01551420|3832961|FG000|NOT COMPLETED|Screened for Part B Eligibility||9
3108674|NCT01551420|3832962|FG001|NOT COMPLETED|Screened for Part B Eligibility||3
3108675|NCT01551420|3832961|FG000|STARTED|Home Use (Part B)||24
3108676|NCT01551420|3832962|FG001|STARTED|Home Use (Part B)||8
3163214|NCT01884350|3890693|FG001|STARTED|Primary Efficacy Analysis Set (48 Weeks)|After 24 weeks participants were randomized to continue AEP or stop AEP and revert to SOC.|263
3171754|NCT01936948|3898955|FG002|STARTED|Overall Study||237
3171755|NCT01936948|3898956|FG003|STARTED|Overall Study||233
3293259|NCT02865499|4027104|FG000|COMPLETED|Baseline||6
3293260|NCT02865499|4027104|FG000|NOT COMPLETED|Baseline||2
3293261|NCT02865499|4027104|FG000|STARTED|8 Weeks||6
3293262|NCT02865499|4027104|FG000|COMPLETED|8 Weeks||6
3293263|NCT02865499|4027104|FG000|NOT COMPLETED|8 Weeks||0
3293264|NCT02865499|4027104|FG000|STARTED|12 Weeks||6
3293265|NCT02865499|4027104|FG000|COMPLETED|12 Weeks||6
3293266|NCT02865499|4027104|FG000|NOT COMPLETED|12 Weeks||0
3293267|NCT02865538|4027113|FG000|STARTED|Overall Study||18
3293268|NCT02865538|4027114|FG001|STARTED|Overall Study||15
3293269|NCT02865538|4027115|FG002|STARTED|Overall Study||15
3293270|NCT02865538|4027116|FG003|STARTED|Overall Study||15
3293271|NCT02865538|4027117|FG004|STARTED|Overall Study||13
3293272|NCT02865538|4027113|FG000|COMPLETED|Overall Study||17
3293273|NCT02865538|4027114|FG001|COMPLETED|Overall Study||15
3293274|NCT02865538|4027115|FG002|COMPLETED|Overall Study||14
3293275|NCT02865538|4027116|FG003|COMPLETED|Overall Study||15
3293276|NCT02865538|4027117|FG004|COMPLETED|Overall Study||13
3293277|NCT02865538|4027113|FG000|NOT COMPLETED|Overall Study||1
3293278|NCT02865538|4027114|FG001|NOT COMPLETED|Overall Study||0
3293279|NCT02865538|4027115|FG002|NOT COMPLETED|Overall Study||1
3293280|NCT02865538|4027116|FG003|NOT COMPLETED|Overall Study||0
3293281|NCT02865538|4027117|FG004|NOT COMPLETED|Overall Study||0
3293282|NCT02865590|4027131|FG000|STARTED|Overall Study||8
3293283|NCT02865590|4027132|FG001|STARTED|Overall Study||8
3293284|NCT02865590|4027131|FG000|COMPLETED|Overall Study||8
3293285|NCT02865590|4027132|FG001|COMPLETED|Overall Study||8
3293286|NCT02865590|4027131|FG000|NOT COMPLETED|Overall Study||0
3293287|NCT02865590|4027132|FG001|NOT COMPLETED|Overall Study||0
3293288|NCT02865720|4027140|FG000|STARTED|Overall Study||0
3293289|NCT02865720|4027141|FG001|STARTED|Overall Study||8
3293290|NCT02865720|4027140|FG000|COMPLETED|Overall Study||0
3293291|NCT02865720|4027141|FG001|COMPLETED|Overall Study||8
3293292|NCT02865720|4027140|FG000|NOT COMPLETED|Overall Study||0
3293293|NCT02865720|4027141|FG001|NOT COMPLETED|Overall Study||0
3293294|NCT02865811|4027146|FG000|STARTED|Overall Study||26
3293295|NCT02865811|4027146|FG000|COMPLETED|Overall Study||26
3293296|NCT02865811|4027146|FG000|NOT COMPLETED|Overall Study||0
3293297|NCT02866175|4027153|FG000|STARTED|Overall Study||751
3293298|NCT02866175|4027154|FG001|STARTED|Overall Study||755
3293299|NCT02866175|4027153|FG000|COMPLETED|Overall Study||616
3293300|NCT02866175|4027154|FG001|COMPLETED|Overall Study||580
3293301|NCT02866175|4027153|FG000|NOT COMPLETED|Overall Study||135
3293302|NCT02866175|4027154|FG001|NOT COMPLETED|Overall Study||175
3293303|NCT02866643|4027163|FG000|STARTED|Overall Study||48
3293304|NCT02866643|4027164|FG001|STARTED|Overall Study||47
3293305|NCT02866643|4027163|FG000|Intent-to-Treat (ITT) Population|Overall Study||38
3293306|NCT02866643|4027164|FG001|Intent-to-Treat (ITT) Population|Overall Study||39
3293307|NCT02866643|4027163|FG000|Per Protocol Population|Overall Study||35
3293308|NCT02866643|4027164|FG001|Per Protocol Population|Overall Study||35
3293309|NCT02866643|4027163|FG000|COMPLETED|Overall Study||35
3293310|NCT02866643|4027164|FG001|COMPLETED|Overall Study||35
3293311|NCT02866643|4027163|FG000|NOT COMPLETED|Overall Study||13
3293312|NCT02866643|4027164|FG001|NOT COMPLETED|Overall Study||12
3293313|NCT02866695|4027170|FG000|STARTED|Overall Study||20
3293314|NCT02866695|4027170|FG000|COMPLETED|Overall Study||18
3293315|NCT02866695|4027170|FG000|NOT COMPLETED|Overall Study||2
3293316|NCT02866942|4027174|FG000|STARTED|Overall Study||479
3293317|NCT02866942|4027174|FG000|COMPLETED|Overall Study||478
3293318|NCT02866942|4027174|FG000|NOT COMPLETED|Overall Study||1
3293319|NCT02867059|4027180|FG000|STARTED|Overall Study||7
3293320|NCT02867059|4027181|FG001|STARTED|Overall Study||10
3293321|NCT02867059|4027180|FG000|COMPLETED|Overall Study||7
3293322|NCT02867059|4027181|FG001|COMPLETED|Overall Study||8
3293323|NCT02867059|4027180|FG000|NOT COMPLETED|Overall Study||0
3293324|NCT02867059|4027181|FG001|NOT COMPLETED|Overall Study||2
3293325|NCT02867150|4027187|FG000|STARTED|Overall Study||58
3293326|NCT02867150|4027187|FG000|COMPLETED|Overall Study||58
3293327|NCT02867150|4027187|FG000|NOT COMPLETED|Overall Study||0
3293328|NCT02867163|4027191|FG000|STARTED|Overall Study||25
3293329|NCT02867163|4027191|FG000|COMPLETED|Overall Study||25
3293330|NCT02867163|4027191|FG000|NOT COMPLETED|Overall Study||0
3293331|NCT02867202|4027197|FG000|STARTED|Overall Study||83
3293332|NCT02867202|4027198|FG001|STARTED|Overall Study||88
3293333|NCT02867202|4027197|FG000|COMPLETED|Overall Study||62
3108677|NCT01551420|3832961|FG000|COMPLETED|Home Use (Part B)||18
3293334|NCT02867202|4027198|FG001|COMPLETED|Overall Study||56
3108678|NCT01551420|3832962|FG001|COMPLETED|Home Use (Part B)||7
3108679|NCT01551420|3832961|FG000|NOT COMPLETED|Home Use (Part B)||6
3108680|NCT01551420|3832962|FG001|NOT COMPLETED|Home Use (Part B)||1
3108681|NCT01551550|3832970|FG000|STARTED|Overall Study||41
3108682|NCT01551550|3832971|FG001|STARTED|Overall Study||41
3108683|NCT01551550|3832970|FG000|COMPLETED|Overall Study||41
3108684|NCT01551550|3832971|FG001|COMPLETED|Overall Study||40
3108685|NCT01551550|3832970|FG000|NOT COMPLETED|Overall Study||0
3293335|NCT02867202|4027197|FG000|NOT COMPLETED|Overall Study||21
3293336|NCT02867202|4027198|FG001|NOT COMPLETED|Overall Study||32
3293337|NCT02867605|4027204|FG000|STARTED|Overall Study||20
3293338|NCT02867605|4027204|FG000|COMPLETED|Overall Study||20
3293339|NCT02867605|4027204|FG000|NOT COMPLETED|Overall Study||0
3293340|NCT02867618|4027221|FG000|STARTED|Overall Study||11
3293341|NCT02867618|4027221|FG000|COMPLETED|Overall Study||11
3293342|NCT02867618|4027221|FG000|NOT COMPLETED|Overall Study||0
3293343|NCT02867709|4027228|FG000|STARTED|Treatment Period||563
3293344|NCT02867709|4027229|FG001|STARTED|Treatment Period||561
3293345|NCT02867709|4027230|FG002|STARTED|Treatment Period||562
3293346|NCT02867709|4027228|FG000|Safety Population: Received Study Drug|Treatment Period||499
3293347|NCT02867709|4027229|FG001|Safety Population: Received Study Drug|Treatment Period||478
3293348|NCT02867709|4027230|FG002|Safety Population: Received Study Drug|Treatment Period||488
3293349|NCT02867709|4027228|FG000|COMPLETED|Treatment Period||493
3293350|NCT02867709|4027229|FG001|COMPLETED|Treatment Period||474
3293351|NCT02867709|4027230|FG002|COMPLETED|Treatment Period||487
3293352|NCT02867709|4027228|FG000|NOT COMPLETED|Treatment Period||70
3293353|NCT02867709|4027229|FG001|NOT COMPLETED|Treatment Period||87
3293354|NCT02867709|4027230|FG002|NOT COMPLETED|Treatment Period||75
3293355|NCT02867709|4027228|FG000|STARTED|Safety Follow-up Period||493
3293356|NCT02867709|4027229|FG001|STARTED|Safety Follow-up Period||474
3293357|NCT02867709|4027230|FG002|STARTED|Safety Follow-up Period||487
3293358|NCT02867709|4027228|FG000|COMPLETED|Safety Follow-up Period||482
3293359|NCT02867709|4027229|FG001|COMPLETED|Safety Follow-up Period||459
3293360|NCT02867709|4027230|FG002|COMPLETED|Safety Follow-up Period||473
3293361|NCT02867709|4027228|FG000|NOT COMPLETED|Safety Follow-up Period||11
3293362|NCT02867709|4027229|FG001|NOT COMPLETED|Safety Follow-up Period||15
3293363|NCT02867709|4027230|FG002|NOT COMPLETED|Safety Follow-up Period||14
3293364|NCT02867995|4027240|FG000|STARTED|Overall Study|Total patients consented|9
3293365|NCT02867995|4027241|FG001|STARTED|Overall Study|Total patients consented|30
3293366|NCT02867995|4027240|FG000|COMPLETED|Overall Study|Total patients completed|9
3293367|NCT02867995|4027241|FG001|COMPLETED|Overall Study|Total patients completed|27
3293368|NCT02867995|4027240|FG000|NOT COMPLETED|Overall Study||0
3293369|NCT02867995|4027241|FG001|NOT COMPLETED|Overall Study||3
3293370|NCT02868216|4027253|FG000|STARTED|Overall Study||43
3293371|NCT02868216|4027254|FG001|STARTED|Overall Study||47
3293372|NCT02868216|4027253|FG000|COMPLETED|Overall Study||35
3293373|NCT02868216|4027254|FG001|COMPLETED|Overall Study||41
3293374|NCT02868216|4027253|FG000|NOT COMPLETED|Overall Study||8
3293375|NCT02868216|4027254|FG001|NOT COMPLETED|Overall Study||6
3293376|NCT02868229|4027264|FG000|STARTED|Overall Study||12
3293377|NCT02868229|4027265|FG001|STARTED|Overall Study||16
3293378|NCT02868229|4027266|FG002|STARTED|Overall Study||16
3293379|NCT02868229|4027267|FG003|STARTED|Overall Study||17
3293380|NCT02868229|4027264|FG000|Intent to Treat (ITT) Population|Overall Study||12
3293381|NCT02868229|4027265|FG001|Intent to Treat (ITT) Population|Overall Study||16
3293382|NCT02868229|4027266|FG002|Intent to Treat (ITT) Population|Overall Study||16
3293383|NCT02868229|4027267|FG003|Intent to Treat (ITT) Population|Overall Study||17
3293384|NCT02868229|4027264|FG000|Pharmacodynamic (PD) Population|Overall Study||12
3293385|NCT02868229|4027265|FG001|Pharmacodynamic (PD) Population|Overall Study||16
3293386|NCT02868229|4027266|FG002|Pharmacodynamic (PD) Population|Overall Study||13
3293387|NCT02868229|4027267|FG003|Pharmacodynamic (PD) Population|Overall Study||12
3293388|NCT02868229|4027264|FG000|Pharmacokinetic (PK) Population|Overall Study||12
3293389|NCT02868229|4027265|FG001|Pharmacokinetic (PK) Population|Overall Study||16
3293390|NCT02868229|4027266|FG002|Pharmacokinetic (PK) Population|Overall Study||16
3293391|NCT02868229|4027267|FG003|Pharmacokinetic (PK) Population|Overall Study||17
3293392|NCT02868229|4027264|FG000|Safety Analysis Population|Overall Study||12
3293393|NCT02868229|4027265|FG001|Safety Analysis Population|Overall Study||16
3293394|NCT02868229|4027266|FG002|Safety Analysis Population|Overall Study||16
3293395|NCT02868229|4027267|FG003|Safety Analysis Population|Overall Study||17
3293396|NCT02868229|4027264|FG000|Maximum Tolerated Dose (MTD) Population|Overall Study||12
3293397|NCT02868229|4027265|FG001|Maximum Tolerated Dose (MTD) Population|Overall Study||16
3293398|NCT02868229|4027266|FG002|Maximum Tolerated Dose (MTD) Population|Overall Study||16
3293399|NCT02868229|4027267|FG003|Maximum Tolerated Dose (MTD) Population|Overall Study||16
3293400|NCT02868229|4027264|FG000|COMPLETED|Overall Study||11
3293401|NCT02868229|4027265|FG001|COMPLETED|Overall Study||16
3293402|NCT02868229|4027266|FG002|COMPLETED|Overall Study||15
3293403|NCT02868229|4027267|FG003|COMPLETED|Overall Study||12
3293404|NCT02868229|4027264|FG000|NOT COMPLETED|Overall Study||1
3293405|NCT02868229|4027265|FG001|NOT COMPLETED|Overall Study||0
3293406|NCT02868229|4027266|FG002|NOT COMPLETED|Overall Study||1
3293407|NCT02868229|4027267|FG003|NOT COMPLETED|Overall Study||5
3293408|NCT02868242|4027282|FG000|STARTED|Overall Study||19
3108686|NCT01551550|3832971|FG001|NOT COMPLETED|Overall Study||1
3108687|NCT01551693|3832979|FG000|STARTED|Overall Study||1
3108688|NCT01551693|3832980|FG001|STARTED|Overall Study||2
3108689|NCT01551693|3832979|FG000|COMPLETED|Overall Study||0
3108690|NCT01551693|3832980|FG001|COMPLETED|Overall Study||0
3108691|NCT01551693|3832979|FG000|NOT COMPLETED|Overall Study||1
3108692|NCT01551693|3832980|FG001|NOT COMPLETED|Overall Study||2
3108693|NCT01551745|3832986|FG000|STARTED|Overall Study||5
3108694|NCT01551745|3832986|FG000|COMPLETED|Overall Study|"Completed means subject had been given all manufactured doses"|2
3108695|NCT01551745|3832986|FG000|NOT COMPLETED|Overall Study||3
3108696|NCT01551758|3832992|FG000|STARTED|Overall Study||1403
3108697|NCT01551758|3832993|FG001|STARTED|Overall Study||1396
3108698|NCT01551758|3832992|FG000|COMPLETED|Overall Study||1309
3108699|NCT01551758|3832993|FG001|COMPLETED|Overall Study||1291
3108700|NCT01551758|3832992|FG000|NOT COMPLETED|Overall Study||94
3108701|NCT01551758|3832993|FG001|NOT COMPLETED|Overall Study||105
3108702|NCT01551888|3833003|FG000|STARTED|Period 1||12
3108703|NCT01551888|3833004|FG001|STARTED|Period 1||12
3108704|NCT01551888|3833003|FG000|COMPLETED|Period 1||12
3108705|NCT01551888|3833004|FG001|COMPLETED|Period 1||12
3108706|NCT01551888|3833003|FG000|NOT COMPLETED|Period 1||0
3108707|NCT01551888|3833004|FG001|NOT COMPLETED|Period 1||0
3108708|NCT01551888|3833003|FG000|STARTED|Period 2||12
3108709|NCT01551888|3833004|FG001|STARTED|Period 2||12
3108710|NCT01551888|3833003|FG000|COMPLETED|Period 2||12
3108711|NCT01551888|3833004|FG001|COMPLETED|Period 2||12
3108712|NCT01551888|3833003|FG000|NOT COMPLETED|Period 2||0
3108713|NCT01551888|3833004|FG001|NOT COMPLETED|Period 2||0
3108714|NCT01551979|3833012|FG000|STARTED|Overall Study||10
3108715|NCT01551979|3833013|FG001|STARTED|Overall Study||7
3108716|NCT01551979|3833012|FG000|Last Day of Treatment (After 5 Days)|Overall Study||10
3108717|NCT01551979|3833013|FG001|Last Day of Treatment (After 5 Days)|Overall Study||7
3108718|NCT01551979|3833012|FG000|1 Week Post Treatment|Overall Study||10
3108719|NCT01551979|3833013|FG001|1 Week Post Treatment|Overall Study||6
3293409|NCT02868242|4027282|FG000|COMPLETED|Overall Study||19
3293410|NCT02868242|4027282|FG000|NOT COMPLETED|Overall Study||0
3293411|NCT02868281|4027290|FG000|STARTED|Overall Study||252
3293412|NCT02868281|4027291|FG001|STARTED|Overall Study||278
3293413|NCT02868281|4027290|FG000|COMPLETED|Overall Study||209
3293414|NCT02868281|4027291|FG001|COMPLETED|Overall Study||234
3293415|NCT02868281|4027290|FG000|NOT COMPLETED|Overall Study||43
3293416|NCT02868281|4027291|FG001|NOT COMPLETED|Overall Study||44
3293417|NCT02868554|4027300|FG000|STARTED|Overall Study||10
3293418|NCT02868554|4027301|FG001|STARTED|Overall Study||12
3293419|NCT02868554|4027302|FG002|STARTED|Overall Study||12
3293420|NCT02868554|4027300|FG000|COMPLETED|Overall Study||7
3293421|NCT02868554|4027301|FG001|COMPLETED|Overall Study||12
3293422|NCT02868554|4027302|FG002|COMPLETED|Overall Study||11
3293423|NCT02868554|4027300|FG000|NOT COMPLETED|Overall Study||3
3293424|NCT02868554|4027301|FG001|NOT COMPLETED|Overall Study||0
3293425|NCT02868554|4027302|FG002|NOT COMPLETED|Overall Study||1
3293426|NCT02869295|4027315|FG000|STARTED|Overall Study||4
3293427|NCT02869295|4027316|FG001|STARTED|Overall Study||11
3293428|NCT02869295|4027317|FG002|STARTED|Overall Study||6
3293429|NCT02869295|4027318|FG003|STARTED|Overall Study||6
3293430|NCT02869295|4027319|FG004|STARTED|Overall Study||1
3293431|NCT02869295|4027315|FG000|COMPLETED|Overall Study||0
3293432|NCT02869295|4027316|FG001|COMPLETED|Overall Study||0
3293433|NCT02869295|4027317|FG002|COMPLETED|Overall Study||0
3293434|NCT02869295|4027318|FG003|COMPLETED|Overall Study||0
3293435|NCT02869295|4027319|FG004|COMPLETED|Overall Study||0
3293436|NCT02869295|4027315|FG000|NOT COMPLETED|Overall Study||4
3293437|NCT02869295|4027316|FG001|NOT COMPLETED|Overall Study||11
3293438|NCT02869295|4027317|FG002|NOT COMPLETED|Overall Study||6
3293439|NCT02869295|4027318|FG003|NOT COMPLETED|Overall Study||6
3293440|NCT02869295|4027319|FG004|NOT COMPLETED|Overall Study||1
3293441|NCT02869334|4027333|FG000|STARTED|Overall Study||10
3293442|NCT02869334|4027334|FG001|STARTED|Overall Study||10
3293443|NCT02869334|4027333|FG000|COMPLETED|Overall Study||2
3293444|NCT02869334|4027334|FG001|COMPLETED|Overall Study||3
3293445|NCT02869334|4027333|FG000|NOT COMPLETED|Overall Study||8
3293446|NCT02869334|4027334|FG001|NOT COMPLETED|Overall Study||7
3293447|NCT02869438|4027342|FG000|STARTED|Overall Study||118
3293448|NCT02869438|4027343|FG001|STARTED|Overall Study||115
3293449|NCT02869438|4027342|FG000|COMPLETED|Overall Study||115
3293450|NCT02869438|4027343|FG001|COMPLETED|Overall Study||113
3293451|NCT02869438|4027342|FG000|NOT COMPLETED|Overall Study||3
3293452|NCT02869438|4027343|FG001|NOT COMPLETED|Overall Study||2
3293453|NCT02869451|4027349|FG000|STARTED|Overall Study||5
3293454|NCT02869451|4027349|FG000|COMPLETED|Overall Study||5
3293455|NCT02869451|4027349|FG000|NOT COMPLETED|Overall Study||0
3293456|NCT02869893|4027353|FG000|STARTED|Overall Study||57
3293457|NCT02869893|4027353|FG000|COMPLETED|Overall Study||50
3293458|NCT02869893|4027353|FG000|NOT COMPLETED|Overall Study||7
3108720|NCT01551979|3833012|FG000|COMPLETED|Overall Study||8
3108721|NCT01551979|3833013|FG001|COMPLETED|Overall Study||5
3108722|NCT01551979|3833012|FG000|NOT COMPLETED|Overall Study||2
3108723|NCT01551979|3833013|FG001|NOT COMPLETED|Overall Study||2
3108724|NCT01552057|3833021|FG000|STARTED|Overall Study||196
3108725|NCT01552057|3833022|FG001|STARTED|Overall Study||197
3108726|NCT01552057|3833021|FG000|Received at Least 1 Dose of Study Drug|Overall Study||194
3108727|NCT01552057|3833022|FG001|Received at Least 1 Dose of Study Drug|Overall Study||196
3293459|NCT02870101|4027358|FG000|STARTED|Overall Study||2767
3293460|NCT02870101|4027358|FG000|COMPLETED|Overall Study||2598
3293461|NCT02870101|4027358|FG000|NOT COMPLETED|Overall Study||169
3108728|NCT01552057|3833021|FG000|COMPLETED|Overall Study||166
3108729|NCT01552057|3833022|FG001|COMPLETED|Overall Study||149
3108730|NCT01552057|3833021|FG000|NOT COMPLETED|Overall Study||30
3108731|NCT01552057|3833022|FG001|NOT COMPLETED|Overall Study||48
3108732|NCT01552213|3833030|FG000|STARTED|Overall Study||50
3108733|NCT01552213|3833031|FG001|STARTED|Overall Study||45
3108734|NCT01552213|3833030|FG000|Analyzed|Overall Study||42
3108735|NCT01552213|3833031|FG001|Analyzed|Overall Study||41
3108736|NCT01552213|3833030|FG000|COMPLETED|Overall Study||37
3108737|NCT01552213|3833031|FG001|COMPLETED|Overall Study||37
3108738|NCT01552213|3833030|FG000|NOT COMPLETED|Overall Study||13
3108739|NCT01552213|3833031|FG001|NOT COMPLETED|Overall Study||8
3108740|NCT01552343|3833039|FG000|STARTED|Overall Study||29
3108741|NCT01552343|3833040|FG001|STARTED|Overall Study||27
3108742|NCT01552343|3833039|FG000|COMPLETED|Overall Study||29
3108743|NCT01552343|3833040|FG001|COMPLETED|Overall Study||27
3108744|NCT01552343|3833039|FG000|NOT COMPLETED|Overall Study||0
3108745|NCT01552343|3833040|FG001|NOT COMPLETED|Overall Study||0
3108746|NCT01552369|3833057|FG000|STARTED|Overall Study||100
3108747|NCT01552369|3833058|FG001|STARTED|Overall Study||105
3108748|NCT01552369|3833057|FG000|One Year|Overall Study||100
3108749|NCT01552369|3833058|FG001|One Year|Overall Study||105
3108750|NCT01552369|3833057|FG000|Final Follow up|Overall Study||92
3108751|NCT01552369|3833058|FG001|Final Follow up|Overall Study||96
3108752|NCT01552369|3833057|FG000|COMPLETED|Overall Study||92
3108753|NCT01552369|3833058|FG001|COMPLETED|Overall Study||96
3108754|NCT01552369|3833057|FG000|NOT COMPLETED|Overall Study||8
3293462|NCT02870205|4027377|FG000|STARTED|Overall Study||294
3293463|NCT02870205|4027378|FG001|STARTED|Overall Study||294
3293464|NCT02870205|4027379|FG002|STARTED|Overall Study||294
3293465|NCT02870205|4027380|FG003|STARTED|Overall Study||294
3293466|NCT02870205|4027377|FG000|COMPLETED|Overall Study||284
3293467|NCT02870205|4027378|FG001|COMPLETED|Overall Study||289
3293468|NCT02870205|4027379|FG002|COMPLETED|Overall Study||287
3293469|NCT02870205|4027380|FG003|COMPLETED|Overall Study||287
3293470|NCT02870205|4027377|FG000|NOT COMPLETED|Overall Study||10
3293471|NCT02870205|4027378|FG001|NOT COMPLETED|Overall Study||5
3293472|NCT02870205|4027379|FG002|NOT COMPLETED|Overall Study||7
3293473|NCT02870205|4027380|FG003|NOT COMPLETED|Overall Study||7
3293474|NCT02870283|4027393|FG000|STARTED|Overall Study||38
3293475|NCT02870283|4027394|FG001|STARTED|Overall Study||35
3293476|NCT02870283|4027395|FG002|STARTED|Overall Study||34
3293477|NCT02870283|4027393|FG000|COMPLETED|Overall Study||35
3293478|NCT02870283|4027394|FG001|COMPLETED|Overall Study||26
3293479|NCT02870283|4027395|FG002|COMPLETED|Overall Study||15
3293480|NCT02870283|4027393|FG000|NOT COMPLETED|Overall Study||3
3293481|NCT02870283|4027394|FG001|NOT COMPLETED|Overall Study||9
3293482|NCT02870283|4027395|FG002|NOT COMPLETED|Overall Study||19
3293483|NCT02870309|4027403|FG000|STARTED|Overall Study||4
3293484|NCT02870309|4027403|FG000|COMPLETED|Overall Study||4
3293485|NCT02870309|4027403|FG000|NOT COMPLETED|Overall Study||0
3293486|NCT02870920|4027409|FG000|STARTED|Overall Study||61
3293487|NCT02870920|4027410|FG001|STARTED|Overall Study||119
3293488|NCT02870920|4027409|FG000|COMPLETED|Overall Study||61
3293489|NCT02870920|4027410|FG001|COMPLETED|Overall Study||119
3293490|NCT02870920|4027409|FG000|NOT COMPLETED|Overall Study||0
3293491|NCT02870920|4027410|FG001|NOT COMPLETED|Overall Study||0
3293492|NCT02870933|4027418|FG000|STARTED|Overall Study||15
3293493|NCT02870933|4027419|FG001|STARTED|Overall Study||15
3293494|NCT02870933|4027418|FG000|COMPLETED|Overall Study||13
3293495|NCT02870933|4027419|FG001|COMPLETED|Overall Study||13
3293496|NCT02870933|4027418|FG000|NOT COMPLETED|Overall Study||2
3293497|NCT02870933|4027419|FG001|NOT COMPLETED|Overall Study||2
3293498|NCT02870972|4027431|FG000|STARTED|Overall Study||18
3293499|NCT02870972|4027432|FG001|STARTED|Overall Study||14
3293500|NCT02870972|4027433|FG002|STARTED|Overall Study||14
3293501|NCT02870972|4027434|FG003|STARTED|Overall Study||7
3293502|NCT02870972|4027435|FG004|STARTED|Overall Study||22
3293503|NCT02870972|4027431|FG000|COMPLETED|Overall Study||17
3293504|NCT02870972|4027432|FG001|COMPLETED|Overall Study||14
3293505|NCT02870972|4027433|FG002|COMPLETED|Overall Study||14
3293506|NCT02870972|4027434|FG003|COMPLETED|Overall Study||7
3293507|NCT02870972|4027435|FG004|COMPLETED|Overall Study||22
3293508|NCT02870972|4027431|FG000|NOT COMPLETED|Overall Study||1
3293509|NCT02870972|4027432|FG001|NOT COMPLETED|Overall Study||0
3293510|NCT02870972|4027433|FG002|NOT COMPLETED|Overall Study||0
3293511|NCT02870972|4027434|FG003|NOT COMPLETED|Overall Study||0
3293512|NCT02870972|4027435|FG004|NOT COMPLETED|Overall Study||0
3293513|NCT02871011|4027451|FG000|STARTED|Overall Study||7
3293514|NCT02871011|4027452|FG001|STARTED|Overall Study||13
3293515|NCT02871011|4027451|FG000|COMPLETED|Overall Study||7
3293516|NCT02871011|4027452|FG001|COMPLETED|Overall Study||13
3293517|NCT02871011|4027451|FG000|NOT COMPLETED|Overall Study||0
3293518|NCT02871011|4027452|FG001|NOT COMPLETED|Overall Study||0
3108755|NCT01552369|3833058|FG001|NOT COMPLETED|Overall Study||9
3108756|NCT01552408|3833068|FG000|STARTED|Overall Study||20
3108757|NCT01552408|3833069|FG001|STARTED|Overall Study||20
3108758|NCT01552408|3833068|FG000|COMPLETED|Overall Study||16
3293519|NCT02871128|4027461|FG000|STARTED|Overall Study||20
3293520|NCT02871128|4027462|FG001|STARTED|Overall Study||20
3293521|NCT02871128|4027463|FG002|STARTED|Overall Study||16
3293522|NCT02871128|4027461|FG000|COMPLETED|Overall Study||20
3293523|NCT02871128|4027462|FG001|COMPLETED|Overall Study||19
3293524|NCT02871128|4027463|FG002|COMPLETED|Overall Study||15
3108759|NCT01552408|3833069|FG001|COMPLETED|Overall Study||18
3108760|NCT01552408|3833068|FG000|NOT COMPLETED|Overall Study||4
3108761|NCT01552408|3833069|FG001|NOT COMPLETED|Overall Study||2
3108762|NCT01552603|3833076|FG000|STARTED|Overall Study||14
3108763|NCT01552603|3833076|FG000|COMPLETED|Overall Study||13
3108764|NCT01552603|3833076|FG000|NOT COMPLETED|Overall Study||1
3108765|NCT01552681|3833082|FG000|STARTED|Overall Study||33
3108766|NCT01552681|3833083|FG001|STARTED|Overall Study||19
3108767|NCT01552681|3833082|FG000|COMPLETED|Overall Study||28
3108768|NCT01552681|3833083|FG001|COMPLETED|Overall Study||18
3108769|NCT01552681|3833082|FG000|NOT COMPLETED|Overall Study||5
3108770|NCT01552681|3833083|FG001|NOT COMPLETED|Overall Study||1
3293525|NCT02871128|4027461|FG000|NOT COMPLETED|Overall Study||0
3293526|NCT02871128|4027462|FG001|NOT COMPLETED|Overall Study||1
3293527|NCT02871128|4027463|FG002|NOT COMPLETED|Overall Study||1
3293528|NCT02871375|4027471|FG000|STARTED|Period 1, First 14 Days of Wear||89
3293529|NCT02871375|4027472|FG001|STARTED|Period 1, First 14 Days of Wear||77
3293530|NCT02871375|4027471|FG000|COMPLETED|Period 1, First 14 Days of Wear||89
3293531|NCT02871375|4027472|FG001|COMPLETED|Period 1, First 14 Days of Wear||76
3293532|NCT02871375|4027471|FG000|NOT COMPLETED|Period 1, First 14 Days of Wear||0
3293533|NCT02871375|4027472|FG001|NOT COMPLETED|Period 1, First 14 Days of Wear||1
3293534|NCT02871375|4027471|FG000|STARTED|Period 2, Second 14 Days of Wear||89
3293535|NCT02871375|4027472|FG001|STARTED|Period 2, Second 14 Days of Wear||76
3293536|NCT02871375|4027471|FG000|COMPLETED|Period 2, Second 14 Days of Wear||89
3293537|NCT02871375|4027472|FG001|COMPLETED|Period 2, Second 14 Days of Wear||76
3293538|NCT02871375|4027471|FG000|NOT COMPLETED|Period 2, Second 14 Days of Wear||0
3293539|NCT02871375|4027472|FG001|NOT COMPLETED|Period 2, Second 14 Days of Wear||0
3293540|NCT02871440|4027483|FG000|STARTED|Overall Study||12
3293541|NCT02871440|4027484|FG001|STARTED|Overall Study||13
3293542|NCT02871440|4027485|FG002|STARTED|Overall Study||15
3293543|NCT02871440|4027483|FG000|COMPLETED|Overall Study||12
3293544|NCT02871440|4027484|FG001|COMPLETED|Overall Study||13
3293545|NCT02871440|4027485|FG002|COMPLETED|Overall Study||15
3293546|NCT02871440|4027483|FG000|NOT COMPLETED|Overall Study||0
3293547|NCT02871440|4027484|FG001|NOT COMPLETED|Overall Study||0
3293548|NCT02871440|4027485|FG002|NOT COMPLETED|Overall Study||0
3293549|NCT02871479|4027499|FG000|STARTED|Overall Study||36
3293550|NCT02871479|4027500|FG001|STARTED|Overall Study||24
3293551|NCT02871479|4027501|FG002|STARTED|Overall Study||11
3293552|NCT02871479|4027499|FG000|COMPLETED|Overall Study||33
3293553|NCT02871479|4027500|FG001|COMPLETED|Overall Study||21
3293554|NCT02871479|4027501|FG002|COMPLETED|Overall Study||11
3293555|NCT02871479|4027499|FG000|NOT COMPLETED|Overall Study||3
3293556|NCT02871479|4027500|FG001|NOT COMPLETED|Overall Study||3
3293557|NCT02871479|4027501|FG002|NOT COMPLETED|Overall Study||0
3293558|NCT02871492|4027512|FG000|STARTED|Overall Study||73
3293559|NCT02871492|4027513|FG001|STARTED|Overall Study||73
3293560|NCT02871492|4027514|FG002|STARTED|Overall Study||77
3293561|NCT02871492|4027512|FG000|COMPLETED|Overall Study||67
3293562|NCT02871492|4027513|FG001|COMPLETED|Overall Study||70
3293563|NCT02871492|4027514|FG002|COMPLETED|Overall Study||71
3293564|NCT02871492|4027512|FG000|NOT COMPLETED|Overall Study||6
3293565|NCT02871492|4027513|FG001|NOT COMPLETED|Overall Study||3
3293566|NCT02871492|4027514|FG002|NOT COMPLETED|Overall Study||6
3293567|NCT02871570|4027524|FG000|STARTED|Overall Study||8
3293568|NCT02871570|4027525|FG001|STARTED|Overall Study||8
3293569|NCT02871570|4027524|FG000|COMPLETED|Overall Study||8
3293570|NCT02871570|4027525|FG001|COMPLETED|Overall Study||8
3293571|NCT02871570|4027524|FG000|NOT COMPLETED|Overall Study||0
3293572|NCT02871570|4027525|FG001|NOT COMPLETED|Overall Study||0
3293573|NCT02871635|4027533|FG000|STARTED|Overall Study||72
3293574|NCT02871635|4027534|FG001|STARTED|Overall Study||75
3293575|NCT02871635|4027533|FG000|COMPLETED|Overall Study||54
3293576|NCT02871635|4027534|FG001|COMPLETED|Overall Study||56
3293577|NCT02871635|4027533|FG000|NOT COMPLETED|Overall Study||18
3293578|NCT02871635|4027534|FG001|NOT COMPLETED|Overall Study||19
3293579|NCT02871739|4027546|FG000|STARTED|Overall Study||6
3293580|NCT02871739|4027547|FG001|STARTED|Overall Study||6
3293581|NCT02871739|4027548|FG002|STARTED|Overall Study||4
3293582|NCT02871739|4027549|FG003|STARTED|Overall Study||7
3293583|NCT02871739|4027546|FG000|Completed First SPI|Overall Study||3
3293584|NCT02871739|4027547|FG001|Completed First SPI|Overall Study||5
3293585|NCT02871739|4027548|FG002|Completed First SPI|Overall Study||4
3293586|NCT02871739|4027549|FG003|Completed First SPI|Overall Study||6
3293587|NCT02871739|4027546|FG000|Completed Second SPI|Overall Study||3
3293588|NCT02871739|4027547|FG001|Completed Second SPI|Overall Study||4
3293589|NCT02871739|4027548|FG002|Completed Second SPI|Overall Study||4
3293590|NCT02871739|4027549|FG003|Completed Second SPI|Overall Study||5
3293591|NCT02871739|4027546|FG000|Complete Final Survey|Overall Study||3
3293592|NCT02871739|4027547|FG001|Complete Final Survey|Overall Study||4
3293593|NCT02871739|4027548|FG002|Complete Final Survey|Overall Study||4
3293594|NCT02871739|4027549|FG003|Complete Final Survey|Overall Study||5
3293595|NCT02871739|4027546|FG000|COMPLETED|Overall Study||3
3293596|NCT02871739|4027547|FG001|COMPLETED|Overall Study||4
3293597|NCT02871739|4027548|FG002|COMPLETED|Overall Study||4
3108771|NCT01552694|3833091|FG000|STARTED|Overall Study||18
3293598|NCT02871739|4027549|FG003|COMPLETED|Overall Study||5
3293599|NCT02871739|4027546|FG000|NOT COMPLETED|Overall Study||3
3293600|NCT02871739|4027547|FG001|NOT COMPLETED|Overall Study||2
3293601|NCT02871739|4027548|FG002|NOT COMPLETED|Overall Study||0
3108772|NCT01552694|3833092|FG001|STARTED|Overall Study||20
3108773|NCT01552694|3833091|FG000|COMPLETED|Overall Study||18
3108774|NCT01552694|3833092|FG001|COMPLETED|Overall Study||18
3108775|NCT01552694|3833091|FG000|NOT COMPLETED|Overall Study||0
3108776|NCT01552694|3833092|FG001|NOT COMPLETED|Overall Study||2
3108777|NCT01552772|3833098|FG000|STARTED|Overall Study||60
3108778|NCT01552772|3833098|FG000|COMPLETED|Overall Study|Participants who completed the Day 28 visit were defined as completers for the trial.|56
3108779|NCT01552772|3833098|FG000|NOT COMPLETED|Overall Study||4
3108780|NCT01552876|3833103|FG000|STARTED|Overall Study||20
3108781|NCT01552876|3833104|FG001|STARTED|Overall Study||20
3108782|NCT01552876|3833103|FG000|COMPLETED|Overall Study||20
3108783|NCT01552876|3833104|FG001|COMPLETED|Overall Study||20
3108784|NCT01552876|3833103|FG000|NOT COMPLETED|Overall Study||0
3108785|NCT01552876|3833104|FG001|NOT COMPLETED|Overall Study||0
3108786|NCT01552889|3833118|FG000|STARTED|Overall Study||101
3108787|NCT01552889|3833119|FG001|STARTED|Overall Study||100
3108788|NCT01552889|3833118|FG000|COMPLETED|Overall Study||90
3108789|NCT01552889|3833119|FG001|COMPLETED|Overall Study||95
3108790|NCT01552889|3833118|FG000|NOT COMPLETED|Overall Study||11
3108791|NCT01552889|3833119|FG001|NOT COMPLETED|Overall Study||5
3108792|NCT01552902|3833130|FG000|STARTED|Overall Study||110
3108793|NCT01552902|3833131|FG001|STARTED|Overall Study||218
3108794|NCT01552902|3833132|FG002|STARTED|Overall Study||219
3108795|NCT01552902|3833130|FG000|COMPLETED|Overall Study||97
3108796|NCT01552902|3833131|FG001|COMPLETED|Overall Study||181
3108797|NCT01552902|3833132|FG002|COMPLETED|Overall Study||186
3108798|NCT01552902|3833130|FG000|NOT COMPLETED|Overall Study||13
3108799|NCT01552902|3833131|FG001|NOT COMPLETED|Overall Study||37
3108800|NCT01552902|3833132|FG002|NOT COMPLETED|Overall Study||33
3108801|NCT01552915|3833143|FG000|STARTED|Overall Study|This population is from the Safety Set. Two randomized subjects were not dosed and were excluded.|91
3108802|NCT01552915|3833144|FG001|STARTED|Overall Study|This population is from the Safety Set. Two randomized subjects were not dosed and were excluded.|184
3108803|NCT01552915|3833145|FG002|STARTED|Overall Study|This population is from the Safety Set. One randomized subject was not dosed and was excluded.|184
3108804|NCT01552915|3833143|FG000|COMPLETED|Overall Study||68
3108805|NCT01552915|3833144|FG001|COMPLETED|Overall Study||155
3108806|NCT01552915|3833145|FG002|COMPLETED|Overall Study||157
3108807|NCT01552915|3833143|FG000|NOT COMPLETED|Overall Study||23
3108808|NCT01552915|3833144|FG001|NOT COMPLETED|Overall Study||29
3108809|NCT01552915|3833145|FG002|NOT COMPLETED|Overall Study||27
3108810|NCT01552928|3833157|FG000|STARTED|Period 1||14
3108811|NCT01552928|3833158|FG001|STARTED|Period 1||15
3108812|NCT01552928|3833159|FG002|STARTED|Period 1||15
3108813|NCT01552928|3833160|FG003|STARTED|Period 1||16
3108814|NCT01552928|3833157|FG000|COMPLETED|Period 1||14
3108815|NCT01552928|3833158|FG001|COMPLETED|Period 1||15
3108816|NCT01552928|3833159|FG002|COMPLETED|Period 1||15
3108817|NCT01552928|3833160|FG003|COMPLETED|Period 1||16
3108818|NCT01552928|3833157|FG000|NOT COMPLETED|Period 1||0
3108819|NCT01552928|3833158|FG001|NOT COMPLETED|Period 1||0
3108820|NCT01552928|3833159|FG002|NOT COMPLETED|Period 1||0
3108821|NCT01552928|3833160|FG003|NOT COMPLETED|Period 1||0
3108822|NCT01552928|3833157|FG000|STARTED|Period 2||14
3108823|NCT01552928|3833158|FG001|STARTED|Period 2||15
3108824|NCT01552928|3833159|FG002|STARTED|Period 2||15
3108825|NCT01552928|3833160|FG003|STARTED|Period 2||16
3108826|NCT01552928|3833157|FG000|COMPLETED|Period 2||14
3108827|NCT01552928|3833158|FG001|COMPLETED|Period 2||15
3108828|NCT01552928|3833159|FG002|COMPLETED|Period 2||15
3108829|NCT01552928|3833160|FG003|COMPLETED|Period 2||16
3108830|NCT01552928|3833157|FG000|NOT COMPLETED|Period 2||0
3108831|NCT01552928|3833158|FG001|NOT COMPLETED|Period 2||0
3108832|NCT01552928|3833159|FG002|NOT COMPLETED|Period 2||0
3108833|NCT01552928|3833160|FG003|NOT COMPLETED|Period 2||0
3108834|NCT01552928|3833157|FG000|STARTED|Period 3||14
3108835|NCT01552928|3833158|FG001|STARTED|Period 3||15
3108836|NCT01552928|3833159|FG002|STARTED|Period 3||15
3108837|NCT01552928|3833160|FG003|STARTED|Period 3||16
3108838|NCT01552928|3833157|FG000|COMPLETED|Period 3||14
3108839|NCT01552928|3833158|FG001|COMPLETED|Period 3||15
3108840|NCT01552928|3833159|FG002|COMPLETED|Period 3||14
3108841|NCT01552928|3833160|FG003|COMPLETED|Period 3||16
3108842|NCT01552928|3833157|FG000|NOT COMPLETED|Period 3||0
3108843|NCT01552928|3833158|FG001|NOT COMPLETED|Period 3||0
3108844|NCT01552928|3833159|FG002|NOT COMPLETED|Period 3||1
3108845|NCT01552928|3833160|FG003|NOT COMPLETED|Period 3||0
3108846|NCT01552928|3833157|FG000|STARTED|Period 4||14
3108847|NCT01552928|3833158|FG001|STARTED|Period 4||15
3108848|NCT01552928|3833159|FG002|STARTED|Period 4||14
3108849|NCT01552928|3833160|FG003|STARTED|Period 4||16
3108850|NCT01552928|3833157|FG000|COMPLETED|Period 4||14
3108851|NCT01552928|3833158|FG001|COMPLETED|Period 4||15
3108852|NCT01552928|3833159|FG002|COMPLETED|Period 4||14
3108853|NCT01552928|3833160|FG003|COMPLETED|Period 4||16
3108854|NCT01552928|3833157|FG000|NOT COMPLETED|Period 4||0
3108855|NCT01552928|3833158|FG001|NOT COMPLETED|Period 4||0
3108856|NCT01552928|3833159|FG002|NOT COMPLETED|Period 4||0
3108857|NCT01552928|3833160|FG003|NOT COMPLETED|Period 4||0
3108858|NCT01552954|3833179|FG000|STARTED|Overall Study|A total of 13 patients were withdrawn from 269 patients. The remained 256 patients were randomized.|131
3108859|NCT01552954|3833180|FG001|STARTED|Overall Study||125
3108860|NCT01552954|3833179|FG000|COMPLETED|Overall Study||126
3108861|NCT01552954|3833180|FG001|COMPLETED|Overall Study||119
3108862|NCT01552954|3833179|FG000|NOT COMPLETED|Overall Study||5
3108863|NCT01552954|3833180|FG001|NOT COMPLETED|Overall Study||6
3108864|NCT01553058|3833189|FG000|STARTED|Overall Study||33
3108865|NCT01553058|3833190|FG001|STARTED|Overall Study||31
3108866|NCT01553058|3833191|FG002|STARTED|Overall Study||33
3108867|NCT01553058|3833189|FG000|COMPLETED|Overall Study||32
3108868|NCT01553058|3833190|FG001|COMPLETED|Overall Study||30
3108869|NCT01553058|3833191|FG002|COMPLETED|Overall Study||30
3108870|NCT01553058|3833189|FG000|NOT COMPLETED|Overall Study||1
3108871|NCT01553058|3833190|FG001|NOT COMPLETED|Overall Study||1
3108872|NCT01553058|3833191|FG002|NOT COMPLETED|Overall Study||3
3108873|NCT01553084|3833206|FG000|STARTED|Overall Study||241
3108874|NCT01553084|3833207|FG001|STARTED|Overall Study||421
3108875|NCT01553084|3833208|FG002|STARTED|Overall Study||424
3108876|NCT01553084|3833206|FG000|COMPLETED|Overall Study||226
3108877|NCT01553084|3833207|FG001|COMPLETED|Overall Study||408
3108878|NCT01553084|3833208|FG002|COMPLETED|Overall Study||389
3108879|NCT01553084|3833206|FG000|NOT COMPLETED|Overall Study||15
3108880|NCT01553084|3833207|FG001|NOT COMPLETED|Overall Study||13
3108881|NCT01553084|3833208|FG002|NOT COMPLETED|Overall Study||35
3108882|NCT01553136|3833220|FG000|STARTED|Overall Study||64
3108883|NCT01553136|3833221|FG001|STARTED|Overall Study||67
3108884|NCT01553136|3833220|FG000|Completed Treatment|Overall Study||55
3108885|NCT01553136|3833221|FG001|Completed Treatment|Overall Study||52
3108886|NCT01553136|3833220|FG000|COMPLETED|Overall Study||48
3108887|NCT01553136|3833221|FG001|COMPLETED|Overall Study||45
3108888|NCT01553136|3833220|FG000|NOT COMPLETED|Overall Study||16
3108889|NCT01553136|3833221|FG001|NOT COMPLETED|Overall Study||22
3108890|NCT01553188|3833231|FG000|STARTED|Overall Study||3
3108891|NCT01553188|3833232|FG001|STARTED|Overall Study||6
3108892|NCT01553188|3833233|FG002|STARTED|Overall Study||16
3108893|NCT01553188|3833234|FG003|STARTED|Overall Study||11
3108894|NCT01553188|3833231|FG000|COMPLETED|Overall Study||2
3293602|NCT02871739|4027549|FG003|NOT COMPLETED|Overall Study||2
3316780|NCT03119181|4050225|FG000|COMPLETED|Overall Study||19
3316781|NCT03119181|4050226|FG001|COMPLETED|Overall Study||21
3316782|NCT03119181|4050225|FG000|NOT COMPLETED|Overall Study||0
3316783|NCT03119181|4050226|FG001|NOT COMPLETED|Overall Study||0
3316784|NCT03119389|4050234|FG000|STARTED|Overall Study||6791
3316785|NCT03119389|4050235|FG001|STARTED|Overall Study||7627
3316786|NCT03119389|4050234|FG000|COMPLETED|Overall Study||6791
3316787|NCT03119389|4050235|FG001|COMPLETED|Overall Study||7627
3316788|NCT03119389|4050234|FG000|NOT COMPLETED|Overall Study||0
3316789|NCT03119389|4050235|FG001|NOT COMPLETED|Overall Study||0
3316790|NCT03119571|4050245|FG000|STARTED|Overall Study||31
3316791|NCT03119571|4050246|FG001|STARTED|Overall Study||34
3316792|NCT03119571|4050245|FG000|COMPLETED|Overall Study||31
3316793|NCT03119571|4050246|FG001|COMPLETED|Overall Study||34
3316794|NCT03119571|4050245|FG000|NOT COMPLETED|Overall Study||0
3316795|NCT03119571|4050246|FG001|NOT COMPLETED|Overall Study||0
3316796|NCT03119610|4050254|FG000|STARTED|Overall Study||13
3316797|NCT03119610|4050255|FG001|STARTED|Overall Study||10
3316798|NCT03119610|4050254|FG000|COMPLETED|Overall Study||12
3316799|NCT03119610|4050255|FG001|COMPLETED|Overall Study||9
3316800|NCT03119610|4050254|FG000|NOT COMPLETED|Overall Study||1
3316801|NCT03119610|4050255|FG001|NOT COMPLETED|Overall Study||1
3316802|NCT03119649|4050266|FG000|STARTED|Overall Study||11
3316803|NCT03119649|4050267|FG001|STARTED|Overall Study||10
3316804|NCT03119649|4050268|FG002|STARTED|Overall Study||10
3316805|NCT03119649|4050269|FG003|STARTED|Overall Study||14
3316806|NCT03119649|4050270|FG004|STARTED|Overall Study||14
3316807|NCT03119649|4050266|FG000|COMPLETED|Overall Study||11
3316808|NCT03119649|4050267|FG001|COMPLETED|Overall Study||10
3316809|NCT03119649|4050268|FG002|COMPLETED|Overall Study||10
3316810|NCT03119649|4050269|FG003|COMPLETED|Overall Study||14
3316811|NCT03119649|4050270|FG004|COMPLETED|Overall Study||14
3316812|NCT03119649|4050266|FG000|NOT COMPLETED|Overall Study||0
3316813|NCT03119649|4050267|FG001|NOT COMPLETED|Overall Study||0
3316814|NCT03119649|4050268|FG002|NOT COMPLETED|Overall Study||0
3316815|NCT03119649|4050269|FG003|NOT COMPLETED|Overall Study||0
3316816|NCT03119649|4050270|FG004|NOT COMPLETED|Overall Study||0
3316817|NCT03119688|4050286|FG000|STARTED|Overall Study||48
3316818|NCT03119688|4050286|FG000|COMPLETED|Overall Study||44
3316819|NCT03119688|4050286|FG000|NOT COMPLETED|Overall Study||4
3316820|NCT03119701|4050305|FG000|STARTED|6-day Dosing||29
3316821|NCT03119701|4050306|FG001|STARTED|6-day Dosing||11
3316822|NCT03119701|4050305|FG000|COMPLETED|6-day Dosing||22
3316823|NCT03119701|4050306|FG001|COMPLETED|6-day Dosing||8
3316824|NCT03119701|4050305|FG000|NOT COMPLETED|6-day Dosing||7
3316825|NCT03119701|4050306|FG001|NOT COMPLETED|6-day Dosing||3
3316826|NCT03119701|4050305|FG000|STARTED|Mid-term (Final) Follow-up at D90|3 patients who discontinued study drug due to adverse events were also followed up.|25
3316827|NCT03119701|4050306|FG001|STARTED|Mid-term (Final) Follow-up at D90|2 patients who did not receive 6 doses were also followed up.|10
3316828|NCT03119701|4050305|FG000|COMPLETED|Mid-term (Final) Follow-up at D90||22
3316829|NCT03119701|4050306|FG001|COMPLETED|Mid-term (Final) Follow-up at D90||9
3316830|NCT03119701|4050305|FG000|NOT COMPLETED|Mid-term (Final) Follow-up at D90||3
3108895|NCT01553188|3833232|FG001|COMPLETED|Overall Study||5
3108896|NCT01553188|3833233|FG002|COMPLETED|Overall Study||14
3108897|NCT01553188|3833234|FG003|COMPLETED|Overall Study||11
3108898|NCT01553188|3833231|FG000|NOT COMPLETED|Overall Study||1
3108899|NCT01553188|3833232|FG001|NOT COMPLETED|Overall Study||1
3108900|NCT01553188|3833233|FG002|NOT COMPLETED|Overall Study||2
3108901|NCT01553188|3833234|FG003|NOT COMPLETED|Overall Study||0
3108902|NCT01553201|3833249|FG000|STARTED|Overall Study||15
3108903|NCT01553201|3833250|FG001|STARTED|Overall Study||15
3108904|NCT01553201|3833249|FG000|COMPLETED|Overall Study||15
3108905|NCT01553201|3833250|FG001|COMPLETED|Overall Study||15
3108906|NCT01553201|3833249|FG000|NOT COMPLETED|Overall Study||0
3108907|NCT01553201|3833250|FG001|NOT COMPLETED|Overall Study||0
3108908|NCT01553279|3833258|FG000|STARTED|Part 1 (Infant Vaccinations)||142
3108909|NCT01553279|3833259|FG001|STARTED|Part 1 (Infant Vaccinations)||142
3108910|NCT01553279|3833258|FG000|COMPLETED|Part 1 (Infant Vaccinations)||140
3108911|NCT01553279|3833259|FG001|COMPLETED|Part 1 (Infant Vaccinations)||141
3108912|NCT01553279|3833258|FG000|NOT COMPLETED|Part 1 (Infant Vaccinations)||2
3108913|NCT01553279|3833259|FG001|NOT COMPLETED|Part 1 (Infant Vaccinations)||1
3108914|NCT01553279|3833258|FG000|STARTED|Interim Period||140
3108915|NCT01553279|3833259|FG001|STARTED|Interim Period||141
3108916|NCT01553279|3833258|FG000|COMPLETED|Interim Period||137
3108917|NCT01553279|3833259|FG001|COMPLETED|Interim Period||139
3108918|NCT01553279|3833258|FG000|NOT COMPLETED|Interim Period||3
3108919|NCT01553279|3833259|FG001|NOT COMPLETED|Interim Period||2
3108920|NCT01553279|3833258|FG000|STARTED|Period 2: Toddler Vaccinations||137
3108921|NCT01553279|3833259|FG001|STARTED|Period 2: Toddler Vaccinations||139
3108922|NCT01553279|3833258|FG000|COMPLETED|Period 2: Toddler Vaccinations||134
3108923|NCT01553279|3833259|FG001|COMPLETED|Period 2: Toddler Vaccinations||132
3108924|NCT01553279|3833258|FG000|NOT COMPLETED|Period 2: Toddler Vaccinations||3
3108925|NCT01553279|3833259|FG001|NOT COMPLETED|Period 2: Toddler Vaccinations||7
3108926|NCT01553292|3833266|FG000|STARTED|Overall Study||21
3108927|NCT01553292|3833266|FG000|COMPLETED|Overall Study||21
3108928|NCT01553292|3833266|FG000|NOT COMPLETED|Overall Study||0
3108929|NCT01553318|3833274|FG000|STARTED|Overall Study||24
3108930|NCT01553318|3833275|FG001|STARTED|Overall Study||27
3108931|NCT01553318|3833274|FG000|COMPLETED|Overall Study||21
3108932|NCT01553318|3833275|FG001|COMPLETED|Overall Study||25
3108933|NCT01553318|3833274|FG000|NOT COMPLETED|Overall Study||3
3108934|NCT01553318|3833275|FG001|NOT COMPLETED|Overall Study||2
3108935|NCT01553539|3833283|FG000|STARTED|Overall Study||20
3108936|NCT01553539|3833283|FG000|COMPLETED|Overall Study||20
3108937|NCT01553539|3833283|FG000|NOT COMPLETED|Overall Study||0
3108938|NCT01553591|3833290|FG000|STARTED|Overall Study||429
3108939|NCT01553591|3833291|FG001|STARTED|Overall Study||426
3108940|NCT01553591|3833292|FG002|STARTED|Overall Study||427
3108941|NCT01553591|3833290|FG000|Attended Week 12 Visit|Overall Study||341
3108942|NCT01553591|3833291|FG001|Attended Week 12 Visit|Overall Study||330
3108943|NCT01553591|3833292|FG002|Attended Week 12 Visit|Overall Study||342
3108944|NCT01553591|3833290|FG000|Attended Week 26 Visit|Overall Study||289
3108945|NCT01553591|3833291|FG001|Attended Week 26 Visit|Overall Study||291
3108946|NCT01553591|3833292|FG002|Attended Week 26 Visit|Overall Study||290
3108947|NCT01553591|3833290|FG000|COMPLETED|Overall Study||257
3108948|NCT01553591|3833291|FG001|COMPLETED|Overall Study||257
3108949|NCT01553591|3833292|FG002|COMPLETED|Overall Study||269
3108950|NCT01553591|3833290|FG000|NOT COMPLETED|Overall Study||172
3108951|NCT01553591|3833291|FG001|NOT COMPLETED|Overall Study||169
3108952|NCT01553591|3833292|FG002|NOT COMPLETED|Overall Study||158
3108953|NCT01553708|3833302|FG000|STARTED|Overall Study||17
3108954|NCT01553708|3833303|FG001|STARTED|Overall Study||17
3108955|NCT01553708|3833302|FG000|COMPLETED|Overall Study||17
3108956|NCT01553708|3833303|FG001|COMPLETED|Overall Study||17
3108957|NCT01553708|3833302|FG000|NOT COMPLETED|Overall Study||0
3108958|NCT01553708|3833303|FG001|NOT COMPLETED|Overall Study||0
3108959|NCT01553747|3833312|FG000|STARTED|Overall Study||381
3293603|NCT02872012|4027564|FG000|STARTED|Overall Study||4
3293604|NCT02872012|4027565|FG001|STARTED|Overall Study||7
3293605|NCT02872012|4027566|FG002|STARTED|Overall Study||4
3293606|NCT02872012|4027567|FG003|STARTED|Overall Study||3
3293607|NCT02872012|4027568|FG004|STARTED|Overall Study||5
3293608|NCT02872012|4027564|FG000|COMPLETED|Overall Study||3
3293609|NCT02872012|4027565|FG001|COMPLETED|Overall Study||7
3293610|NCT02872012|4027566|FG002|COMPLETED|Overall Study||4
3293611|NCT02872012|4027567|FG003|COMPLETED|Overall Study||3
3293612|NCT02872012|4027568|FG004|COMPLETED|Overall Study||5
3293613|NCT02872012|4027564|FG000|NOT COMPLETED|Overall Study||1
3293614|NCT02872012|4027565|FG001|NOT COMPLETED|Overall Study||0
3293615|NCT02872012|4027566|FG002|NOT COMPLETED|Overall Study||0
3293616|NCT02872012|4027567|FG003|NOT COMPLETED|Overall Study||0
3293617|NCT02872012|4027568|FG004|NOT COMPLETED|Overall Study||0
3293618|NCT02872103|4027584|FG000|STARTED|Cycle 1||83
3293619|NCT02872103|4027585|FG001|STARTED|Cycle 1||39
3293620|NCT02872103|4027584|FG000|COMPLETED|Cycle 1||83
3293621|NCT02872103|4027585|FG001|COMPLETED|Cycle 1||38
3293622|NCT02872103|4027584|FG000|NOT COMPLETED|Cycle 1||0
3293623|NCT02872103|4027585|FG001|NOT COMPLETED|Cycle 1||1
3293624|NCT02872103|4027584|FG000|STARTED|Cycle 2-4||83
3293625|NCT02872103|4027585|FG001|STARTED|Cycle 2-4|1 subject withdrawn in Cycle 1|38
3108960|NCT01553747|3833313|FG001|STARTED|Overall Study||383
3108961|NCT01553747|3833314|FG002|STARTED|Overall Study||382
3108962|NCT01553747|3833312|FG000|Attended Week 12 Visit|Overall Study||296
3108963|NCT01553747|3833313|FG001|Attended Week 12 Visit|Overall Study||301
3108964|NCT01553747|3833314|FG002|Attended Week 12 Visit|Overall Study||312
3108965|NCT01553747|3833312|FG000|Attended Week 26 Visit|Overall Study||259
3108966|NCT01553747|3833313|FG001|Attended Week 26 Visit|Overall Study||271
3108967|NCT01553747|3833314|FG002|Attended Week 26 Visit|Overall Study||278
3108968|NCT01553747|3833312|FG000|Participated in Blinded-Placebo Period|Overall Study||246
3108969|NCT01553747|3833313|FG001|Participated in Blinded-Placebo Period|Overall Study||253
3108970|NCT01553747|3833314|FG002|Participated in Blinded-Placebo Period|Overall Study||272
3108971|NCT01553747|3833312|FG000|COMPLETED|Overall Study||250
3108972|NCT01553747|3833313|FG001|COMPLETED|Overall Study||264
3108973|NCT01553747|3833314|FG002|COMPLETED|Overall Study||273
3108974|NCT01553747|3833312|FG000|NOT COMPLETED|Overall Study||131
3108975|NCT01553747|3833313|FG001|NOT COMPLETED|Overall Study||119
3108976|NCT01553747|3833314|FG002|NOT COMPLETED|Overall Study||109
3108977|NCT01553851|3833325|FG000|STARTED|Overall Study||20
3108978|NCT01553851|3833325|FG000|COMPLETED|Overall Study||17
3108979|NCT01553851|3833325|FG000|NOT COMPLETED|Overall Study||3
3108980|NCT01553916|3833329|FG000|STARTED|Overall Study||19
3108981|NCT01553916|3833329|FG000|COMPLETED|Overall Study||16
3108982|NCT01553916|3833329|FG000|NOT COMPLETED|Overall Study||3
3108983|NCT01554176|3833335|FG000|STARTED|Treatment Phase||65
3108984|NCT01554176|3833336|FG001|STARTED|Treatment Phase||64
3108985|NCT01554176|3833337|FG002|STARTED|Treatment Phase||0
3108986|NCT01554176|3833338|FG003|STARTED|Treatment Phase||0
3108987|NCT01554176|3833339|FG004|STARTED|Treatment Phase||0
3108988|NCT01554176|3833335|FG000|Treated|Treatment Phase||64
3108989|NCT01554176|3833336|FG001|Treated|Treatment Phase||64
3108990|NCT01554176|3833337|FG002|Treated|Treatment Phase||0
3108991|NCT01554176|3833338|FG003|Treated|Treatment Phase||0
3108992|NCT01554176|3833339|FG004|Treated|Treatment Phase||0
3108993|NCT01554176|3833335|FG000|COMPLETED|Treatment Phase||57
3108994|NCT01554176|3833336|FG001|COMPLETED|Treatment Phase||59
3108995|NCT01554176|3833337|FG002|COMPLETED|Treatment Phase||0
3108996|NCT01554176|3833338|FG003|COMPLETED|Treatment Phase||0
3108997|NCT01554176|3833339|FG004|COMPLETED|Treatment Phase||0
3108998|NCT01554176|3833335|FG000|NOT COMPLETED|Treatment Phase||8
3108999|NCT01554176|3833336|FG001|NOT COMPLETED|Treatment Phase||5
3109000|NCT01554176|3833337|FG002|NOT COMPLETED|Treatment Phase||0
3109001|NCT01554176|3833338|FG003|NOT COMPLETED|Treatment Phase||0
3109002|NCT01554176|3833339|FG004|NOT COMPLETED|Treatment Phase||0
3109003|NCT01554176|3833335|FG000|STARTED|Run-out Phase||0
3109004|NCT01554176|3833336|FG001|STARTED|Run-out Phase||0
3109005|NCT01554176|3833337|FG002|STARTED|Run-out Phase||29
3109006|NCT01554176|3833338|FG003|STARTED|Run-out Phase||28
3109007|NCT01554176|3833339|FG004|STARTED|Run-out Phase||59
3109008|NCT01554176|3833335|FG000|Treated|Run-out Phase||0
3109009|NCT01554176|3833336|FG001|Treated|Run-out Phase||0
3109010|NCT01554176|3833337|FG002|Treated|Run-out Phase||29
3109011|NCT01554176|3833338|FG003|Treated|Run-out Phase||28
3109012|NCT01554176|3833339|FG004|Treated|Run-out Phase||59
3109013|NCT01554176|3833335|FG000|COMPLETED|Run-out Phase||0
3109014|NCT01554176|3833336|FG001|COMPLETED|Run-out Phase||0
3109015|NCT01554176|3833337|FG002|COMPLETED|Run-out Phase||29
3109016|NCT01554176|3833338|FG003|COMPLETED|Run-out Phase||27
3109017|NCT01554176|3833339|FG004|COMPLETED|Run-out Phase||59
3109018|NCT01554176|3833335|FG000|NOT COMPLETED|Run-out Phase||0
3109019|NCT01554176|3833336|FG001|NOT COMPLETED|Run-out Phase||0
3109020|NCT01554176|3833337|FG002|NOT COMPLETED|Run-out Phase||0
3109021|NCT01554176|3833338|FG003|NOT COMPLETED|Run-out Phase||1
3109022|NCT01554176|3833339|FG004|NOT COMPLETED|Run-out Phase||0
3109023|NCT01554241|3833355|FG000|STARTED|Overall Study||23
3109024|NCT01554241|3833356|FG001|STARTED|Overall Study||20
3109025|NCT01554241|3833357|FG002|STARTED|Overall Study||24
3109026|NCT01554241|3833358|FG003|STARTED|Overall Study||14
3109027|NCT01554241|3833355|FG000|COMPLETED|Overall Study||20
3109028|NCT01554241|3833356|FG001|COMPLETED|Overall Study||19
3109029|NCT01554241|3833357|FG002|COMPLETED|Overall Study||20
3109030|NCT01554241|3833358|FG003|COMPLETED|Overall Study||13
3109031|NCT01554241|3833355|FG000|NOT COMPLETED|Overall Study||3
3109032|NCT01554241|3833356|FG001|NOT COMPLETED|Overall Study||1
3109033|NCT01554241|3833357|FG002|NOT COMPLETED|Overall Study||4
3109034|NCT01554241|3833358|FG003|NOT COMPLETED|Overall Study||1
3109035|NCT01554371|3833371|FG000|STARTED|Overall Study||3
3109036|NCT01554371|3833372|FG001|STARTED|Overall Study||3
3109037|NCT01554371|3833373|FG002|STARTED|Overall Study||38
3109038|NCT01554371|3833371|FG000|COMPLETED|Overall Study||3
3109039|NCT01554371|3833372|FG001|COMPLETED|Overall Study||3
3109040|NCT01554371|3833373|FG002|COMPLETED|Overall Study||38
3109041|NCT01554371|3833371|FG000|NOT COMPLETED|Overall Study||0
3109042|NCT01554371|3833372|FG001|NOT COMPLETED|Overall Study||0
3109043|NCT01554371|3833373|FG002|NOT COMPLETED|Overall Study||0
3109044|NCT01554488|3833386|FG000|STARTED|Overall Study||13
3109045|NCT01554488|3833387|FG001|STARTED|Overall Study||12
3109046|NCT01554488|3833386|FG000|COMPLETED|Overall Study||12
3109047|NCT01554488|3833387|FG001|COMPLETED|Overall Study||9
3109048|NCT01554488|3833386|FG000|NOT COMPLETED|Overall Study||1
3109049|NCT01554488|3833387|FG001|NOT COMPLETED|Overall Study||3
3109050|NCT01554514|3833393|FG000|STARTED|Overall Study||19
3109051|NCT01554514|3833393|FG000|COMPLETED|Overall Study||17
3109052|NCT01554514|3833393|FG000|NOT COMPLETED|Overall Study||2
3109053|NCT01554527|3833400|FG000|STARTED|Overall Study||34
3109054|NCT01554527|3833401|FG001|STARTED|Overall Study||38
3109055|NCT01554527|3833402|FG002|STARTED|Overall Study||33
3109056|NCT01554527|3833400|FG000|Crossed Over to Control|Overall Study||0
3109057|NCT01554527|3833401|FG001|Crossed Over to Control|Overall Study||0
3109058|NCT01554527|3833402|FG002|Crossed Over to Control|Overall Study||2
3109059|NCT01554527|3833400|FG000|Had CPAP Titration|Overall Study|No control group members received CPAP (definitionally)|0
3293626|NCT02872103|4027584|FG000|COMPLETED|Cycle 2-4||81
3293627|NCT02872103|4027585|FG001|COMPLETED|Cycle 2-4||37
3293628|NCT02872103|4027584|FG000|NOT COMPLETED|Cycle 2-4||2
3293629|NCT02872103|4027585|FG001|NOT COMPLETED|Cycle 2-4||1
3293630|NCT02872142|4027593|FG000|STARTED|Overall Study||12
3293631|NCT02872142|4027593|FG000|COMPLETED|Overall Study||6
3109060|NCT01554527|3833401|FG001|Had CPAP Titration|Overall Study||38
3109061|NCT01554527|3833402|FG002|Had CPAP Titration|Overall Study||30
3109062|NCT01554527|3833400|FG000|Initiated CPAP Treatment at Home|Overall Study||0
3109063|NCT01554527|3833401|FG001|Initiated CPAP Treatment at Home|Overall Study||38
3109064|NCT01554527|3833402|FG002|Initiated CPAP Treatment at Home|Overall Study||28
3109065|NCT01554527|3833400|FG000|Completed as a Control|Overall Study||33
3109066|NCT01554527|3833401|FG001|Completed as a Control|Overall Study||0
3109067|NCT01554527|3833402|FG002|Completed as a Control|Overall Study||1
3109068|NCT01554527|3833400|FG000|COMPLETED|Overall Study||33
3109069|NCT01554527|3833401|FG001|COMPLETED|Overall Study||38
3109070|NCT01554527|3833402|FG002|COMPLETED|Overall Study||25
3109071|NCT01554527|3833400|FG000|NOT COMPLETED|Overall Study||1
3109072|NCT01554527|3833401|FG001|NOT COMPLETED|Overall Study||0
3109073|NCT01554527|3833402|FG002|NOT COMPLETED|Overall Study||8
3109074|NCT01554579|3833413|FG000|STARTED|Overall Study||86
3109075|NCT01554579|3833414|FG001|STARTED|Overall Study||85
3109076|NCT01554579|3833413|FG000|COMPLETED|Overall Study||76
3109077|NCT01554579|3833414|FG001|COMPLETED|Overall Study||58
3109078|NCT01554579|3833413|FG000|NOT COMPLETED|Overall Study||10
3109079|NCT01554579|3833414|FG001|NOT COMPLETED|Overall Study||27
3109080|NCT01554618|3833423|FG000|STARTED|Randomized Through Start of Treatment||59
3109081|NCT01554618|3833424|FG001|STARTED|Randomized Through Start of Treatment||24
3109082|NCT01554618|3833423|FG000|COMPLETED|Randomized Through Start of Treatment||58
3109083|NCT01554618|3833424|FG001|COMPLETED|Randomized Through Start of Treatment||24
3109084|NCT01554618|3833423|FG000|NOT COMPLETED|Randomized Through Start of Treatment||1
3109085|NCT01554618|3833424|FG001|NOT COMPLETED|Randomized Through Start of Treatment||0
3109086|NCT01554618|3833423|FG000|STARTED|Controlled Assessment Period||58
3109087|NCT01554618|3833424|FG001|STARTED|Controlled Assessment Period||24
3109088|NCT01554618|3833423|FG000|COMPLETED|Controlled Assessment Period||50
3109089|NCT01554618|3833424|FG001|COMPLETED|Controlled Assessment Period||23
3109090|NCT01554618|3833423|FG000|NOT COMPLETED|Controlled Assessment Period||8
3109091|NCT01554618|3833424|FG001|NOT COMPLETED|Controlled Assessment Period||1
3109092|NCT01554618|3833423|FG000|STARTED|Open-Label Extension Period|1 patient who was noncompliant with study medication did not enter the open-label extension period|49
3109093|NCT01554618|3833424|FG001|STARTED|Open-Label Extension Period||23
3109094|NCT01554618|3833423|FG000|COMPLETED|Open-Label Extension Period||46
3109095|NCT01554618|3833424|FG001|COMPLETED|Open-Label Extension Period||18
3109096|NCT01554618|3833423|FG000|NOT COMPLETED|Open-Label Extension Period||3
3109097|NCT01554618|3833424|FG001|NOT COMPLETED|Open-Label Extension Period||5
3109098|NCT01554683|3833434|FG000|STARTED|Overall Study||2
3109099|NCT01554683|3833435|FG001|STARTED|Overall Study||1
3109100|NCT01554683|3833436|FG002|STARTED|Overall Study||3
3109101|NCT01554683|3833437|FG003|STARTED|Overall Study||2
3109102|NCT01554683|3833438|FG004|STARTED|Overall Study||1
3109103|NCT01554683|3833439|FG005|STARTED|Overall Study||0
3109104|NCT01554683|3833434|FG000|COMPLETED|Overall Study||2
3109105|NCT01554683|3833435|FG001|COMPLETED|Overall Study||1
3109106|NCT01554683|3833436|FG002|COMPLETED|Overall Study||3
3109107|NCT01554683|3833437|FG003|COMPLETED|Overall Study||2
3109108|NCT01554683|3833438|FG004|COMPLETED|Overall Study||1
3109109|NCT01554683|3833439|FG005|COMPLETED|Overall Study||0
3109110|NCT01554683|3833434|FG000|NOT COMPLETED|Overall Study||0
3109111|NCT01554683|3833435|FG001|NOT COMPLETED|Overall Study||0
3109112|NCT01554683|3833436|FG002|NOT COMPLETED|Overall Study||0
3109113|NCT01554683|3833437|FG003|NOT COMPLETED|Overall Study||0
3109114|NCT01554683|3833438|FG004|NOT COMPLETED|Overall Study||0
3109115|NCT01554683|3833439|FG005|NOT COMPLETED|Overall Study||0
3109116|NCT01554891|3833450|FG000|STARTED|Overall Study||105
3109117|NCT01554891|3833451|FG001|STARTED|Overall Study||120
3109118|NCT01554891|3833452|FG002|STARTED|Overall Study||57
3109119|NCT01554891|3833450|FG000|COMPLETED|Overall Study||98
3109120|NCT01554891|3833451|FG001|COMPLETED|Overall Study||115
3109121|NCT01554891|3833452|FG002|COMPLETED|Overall Study||55
3109122|NCT01554891|3833450|FG000|NOT COMPLETED|Overall Study||7
3293632|NCT02872142|4027593|FG000|NOT COMPLETED|Overall Study||6
3293633|NCT02872285|4027599|FG000|STARTED|Overall Study||22
3293634|NCT02872285|4027600|FG001|STARTED|Overall Study||11
3293635|NCT02872285|4027599|FG000|COMPLETED|Overall Study||17
3293636|NCT02872285|4027600|FG001|COMPLETED|Overall Study||9
3293637|NCT02872285|4027599|FG000|NOT COMPLETED|Overall Study||5
3293638|NCT02872285|4027600|FG001|NOT COMPLETED|Overall Study||2
3293639|NCT02872311|4027611|FG000|STARTED|Overall Study||59
3293640|NCT02872311|4027612|FG001|STARTED|Overall Study||60
3109123|NCT01554891|3833451|FG001|NOT COMPLETED|Overall Study||5
3109124|NCT01554891|3833452|FG002|NOT COMPLETED|Overall Study||2
3109125|NCT01554904|3833460|FG000|STARTED|Overall Study||18
3109126|NCT01554904|3833460|FG000|Home Sleep Study 1|Overall Study|After informed consent signed.|18
3109127|NCT01554904|3833460|FG000|Start 6 Weeks of Facial Training|Overall Study|1 participant was found to have obstructive sleep apnea on the home sleep study #1|17
3293641|NCT02872311|4027613|FG002|STARTED|Overall Study||20
3293642|NCT02872311|4027614|FG003|STARTED|Overall Study||20
3293643|NCT02872311|4027615|FG004|STARTED|Overall Study||20
3109128|NCT01554904|3833460|FG000|Complete 6 Weeks of Facial Training|Overall Study|3 subjects withdrew during training|14
3109129|NCT01554904|3833460|FG000|Home Sleep Study 2|Overall Study||14
3109130|NCT01554904|3833460|FG000|COMPLETED|Overall Study||14
3109131|NCT01554904|3833460|FG000|NOT COMPLETED|Overall Study||4
3109132|NCT01554982|3833464|FG000|STARTED|Overall Study||168
3109133|NCT01554982|3833464|FG000|Received Drug|Overall Study||166
3109134|NCT01554982|3833464|FG000|COMPLETED|Overall Study||125
3109135|NCT01554982|3833464|FG000|NOT COMPLETED|Overall Study||43
3109136|NCT01555125|3833471|FG000|STARTED|Induction Period||59
3109137|NCT01555125|3833472|FG001|STARTED|Induction Period||59
3109138|NCT01555125|3833473|FG002|STARTED|Induction Period||0
3109139|NCT01555125|3833474|FG003|STARTED|Induction Period||0
3109140|NCT01555125|3833475|FG004|STARTED|Induction Period||59
3109141|NCT01555125|3833471|FG000|COMPLETED|Induction Period||58
3109142|NCT01555125|3833472|FG001|COMPLETED|Induction Period||56
3109143|NCT01555125|3833473|FG002|COMPLETED|Induction Period||0
3109144|NCT01555125|3833474|FG003|COMPLETED|Induction Period||0
3109145|NCT01555125|3833475|FG004|COMPLETED|Induction Period||56
3109146|NCT01555125|3833471|FG000|NOT COMPLETED|Induction Period||1
3109147|NCT01555125|3833472|FG001|NOT COMPLETED|Induction Period||3
3109148|NCT01555125|3833473|FG002|NOT COMPLETED|Induction Period||0
3109149|NCT01555125|3833474|FG003|NOT COMPLETED|Induction Period||0
3109150|NCT01555125|3833475|FG004|NOT COMPLETED|Induction Period||3
3109151|NCT01555125|3833471|FG000|STARTED|Maintenance Period||58
3109152|NCT01555125|3833472|FG001|STARTED|Maintenance Period||56
3109153|NCT01555125|3833473|FG002|STARTED|Maintenance Period||29
3109154|NCT01555125|3833474|FG003|STARTED|Maintenance Period||27
3109155|NCT01555125|3833475|FG004|STARTED|Maintenance Period||0
3109156|NCT01555125|3833471|FG000|COMPLETED|Maintenance Period||48
3109157|NCT01555125|3833472|FG001|COMPLETED|Maintenance Period||52
3109158|NCT01555125|3833473|FG002|COMPLETED|Maintenance Period||25
3109159|NCT01555125|3833474|FG003|COMPLETED|Maintenance Period||25
3109160|NCT01555125|3833475|FG004|COMPLETED|Maintenance Period||0
3109161|NCT01555125|3833471|FG000|NOT COMPLETED|Maintenance Period||10
3109162|NCT01555125|3833472|FG001|NOT COMPLETED|Maintenance Period||4
3109163|NCT01555125|3833473|FG002|NOT COMPLETED|Maintenance Period||4
3109164|NCT01555125|3833474|FG003|NOT COMPLETED|Maintenance Period||2
3109165|NCT01555125|3833475|FG004|NOT COMPLETED|Maintenance Period||0
3109166|NCT01555125|3833471|FG000|STARTED|Extension||46
3109167|NCT01555125|3833472|FG001|STARTED|Extension||51
3109168|NCT01555125|3833473|FG002|STARTED|Extension||23
3109169|NCT01555125|3833474|FG003|STARTED|Extension||23
3109170|NCT01555125|3833475|FG004|STARTED|Extension||0
3109171|NCT01555125|3833471|FG000|COMPLETED|Extension||1
3109172|NCT01555125|3833472|FG001|COMPLETED|Extension||0
3109173|NCT01555125|3833473|FG002|COMPLETED|Extension||0
3109174|NCT01555125|3833474|FG003|COMPLETED|Extension||1
3109175|NCT01555125|3833475|FG004|COMPLETED|Extension||0
3109176|NCT01555125|3833471|FG000|NOT COMPLETED|Extension||45
3109177|NCT01555125|3833472|FG001|NOT COMPLETED|Extension||51
3109178|NCT01555125|3833473|FG002|NOT COMPLETED|Extension||23
3293644|NCT02872311|4027611|FG000|COMPLETED|Overall Study||55
3293645|NCT02872311|4027612|FG001|COMPLETED|Overall Study||58
3293646|NCT02872311|4027613|FG002|COMPLETED|Overall Study||19
3293647|NCT02872311|4027614|FG003|COMPLETED|Overall Study||20
3293648|NCT02872311|4027615|FG004|COMPLETED|Overall Study||20
3293649|NCT02872311|4027611|FG000|NOT COMPLETED|Overall Study||4
3109179|NCT01555125|3833474|FG003|NOT COMPLETED|Extension||22
3109180|NCT01555125|3833475|FG004|NOT COMPLETED|Extension||0
3109181|NCT01555125|3833471|FG000|STARTED|Follow-Up Period||36
3109182|NCT01555125|3833472|FG001|STARTED|Follow-Up Period||31
3109183|NCT01555125|3833473|FG002|STARTED|Follow-Up Period||19
3109184|NCT01555125|3833474|FG003|STARTED|Follow-Up Period||18
3109185|NCT01555125|3833475|FG004|STARTED|Follow-Up Period||0
3109186|NCT01555125|3833471|FG000|COMPLETED|Follow-Up Period||32
3109187|NCT01555125|3833472|FG001|COMPLETED|Follow-Up Period||30
3109188|NCT01555125|3833473|FG002|COMPLETED|Follow-Up Period||18
3109189|NCT01555125|3833474|FG003|COMPLETED|Follow-Up Period||17
3109190|NCT01555125|3833475|FG004|COMPLETED|Follow-Up Period||0
3109191|NCT01555125|3833471|FG000|NOT COMPLETED|Follow-Up Period||4
3109192|NCT01555125|3833472|FG001|NOT COMPLETED|Follow-Up Period||1
3109193|NCT01555125|3833473|FG002|NOT COMPLETED|Follow-Up Period||1
3109194|NCT01555125|3833474|FG003|NOT COMPLETED|Follow-Up Period||1
3109195|NCT01555125|3833475|FG004|NOT COMPLETED|Follow-Up Period||0
3109196|NCT01555138|3833492|FG000|STARTED|Overall Study||293
3109197|NCT01555138|3833493|FG001|STARTED|Overall Study||288
3109198|NCT01555138|3833492|FG000|COMPLETED|Overall Study||246
3109199|NCT01555138|3833493|FG001|COMPLETED|Overall Study||250
3109200|NCT01555138|3833492|FG000|NOT COMPLETED|Overall Study||47
3109201|NCT01555138|3833493|FG001|NOT COMPLETED|Overall Study||38
3109202|NCT01555151|3833503|FG000|STARTED|Overall Study||188
3293650|NCT02872311|4027612|FG001|NOT COMPLETED|Overall Study||2
3293651|NCT02872311|4027613|FG002|NOT COMPLETED|Overall Study||1
3293652|NCT02872311|4027614|FG003|NOT COMPLETED|Overall Study||0
3293653|NCT02872311|4027615|FG004|NOT COMPLETED|Overall Study||0
3293654|NCT02872857|4027645|FG000|STARTED|Phase 1||15
3293655|NCT02872857|4027646|FG001|STARTED|Phase 1||15
3293656|NCT02872857|4027647|FG002|STARTED|Phase 1||0
3293657|NCT02872857|4027648|FG003|STARTED|Phase 1||0
3109203|NCT01555151|3833504|FG001|STARTED|Overall Study||181
3109204|NCT01555151|3833505|FG002|STARTED|Overall Study||184
3109205|NCT01555151|3833506|FG003|STARTED|Overall Study||186
3109206|NCT01555151|3833503|FG000|Safety Set (SAF)|Overall Study||186
3109207|NCT01555151|3833504|FG001|Safety Set (SAF)|Overall Study||180
3109208|NCT01555151|3833505|FG002|Safety Set (SAF)|Overall Study||183
3109209|NCT01555151|3833506|FG003|Safety Set (SAF)|Overall Study||186
3109210|NCT01555151|3833503|FG000|COMPLETED|Overall Study||175
3109211|NCT01555151|3833504|FG001|COMPLETED|Overall Study||173
3109212|NCT01555151|3833505|FG002|COMPLETED|Overall Study||178
3109213|NCT01555151|3833506|FG003|COMPLETED|Overall Study||176
3109214|NCT01555151|3833503|FG000|NOT COMPLETED|Overall Study||13
3109215|NCT01555151|3833504|FG001|NOT COMPLETED|Overall Study||8
3109216|NCT01555151|3833505|FG002|NOT COMPLETED|Overall Study||6
3109217|NCT01555151|3833506|FG003|NOT COMPLETED|Overall Study||10
3109218|NCT01555164|3833519|FG000|STARTED|Overall Study||222
3109219|NCT01555164|3833520|FG001|STARTED|Overall Study||220
3109220|NCT01555164|3833519|FG000|COMPLETED|Overall Study||182
3109221|NCT01555164|3833520|FG001|COMPLETED|Overall Study||185
3109222|NCT01555164|3833519|FG000|NOT COMPLETED|Overall Study||40
3109223|NCT01555164|3833520|FG001|NOT COMPLETED|Overall Study||35
3109224|NCT01555463|3833528|FG000|STARTED|Treatment||483
3109225|NCT01555463|3833529|FG001|STARTED|Treatment||478
3109226|NCT01555463|3833528|FG000|COMPLETED|Treatment||419
3109227|NCT01555463|3833529|FG001|COMPLETED|Treatment||399
3109228|NCT01555463|3833528|FG000|NOT COMPLETED|Treatment||64
3109229|NCT01555463|3833529|FG001|NOT COMPLETED|Treatment||79
3109230|NCT01555463|3833528|FG000|STARTED|Follow up|Treatment completers and non-completers were asked to participate in the follow-up phase.|447
3109231|NCT01555463|3833529|FG001|STARTED|Follow up|Treatment completers and non-completers were asked to participate in the follow-up phase.|439
3109232|NCT01555463|3833528|FG000|COMPLETED|Follow up||409
3109233|NCT01555463|3833529|FG001|COMPLETED|Follow up||394
3109234|NCT01555463|3833528|FG000|NOT COMPLETED|Follow up||38
3109235|NCT01555463|3833529|FG001|NOT COMPLETED|Follow up||45
3109236|NCT01555541|3833535|FG000|STARTED|Salvage Response Assessment||19
3109237|NCT01555541|3833535|FG000|COMPLETED|Salvage Response Assessment||19
3109238|NCT01555541|3833535|FG000|NOT COMPLETED|Salvage Response Assessment||0
3109239|NCT01555541|3833535|FG000|STARTED|OVA Treatment||19
3109240|NCT01555541|3833535|FG000|COMPLETED|OVA Treatment||19
3109241|NCT01555541|3833535|FG000|NOT COMPLETED|OVA Treatment||0
3109242|NCT01555541|3833535|FG000|STARTED|Autologous Stem Cell Transplantation|7 patients didn't move forward due to non-response/progression on last line of therapy prior to ASCT|12
3109243|NCT01555541|3833535|FG000|COMPLETED|Autologous Stem Cell Transplantation||12
3109244|NCT01555541|3833535|FG000|NOT COMPLETED|Autologous Stem Cell Transplantation||0
3109245|NCT01555567|3833544|FG000|STARTED|12 Week||12
3109246|NCT01555567|3833545|FG001|STARTED|12 Week||13
3109247|NCT01555567|3833546|FG002|STARTED|12 Week||9
3109248|NCT01555567|3833547|FG003|STARTED|12 Week||9
3109249|NCT01555567|3833544|FG000|COMPLETED|12 Week||11
3109250|NCT01555567|3833545|FG001|COMPLETED|12 Week||12
3109251|NCT01555567|3833546|FG002|COMPLETED|12 Week||8
3109252|NCT01555567|3833547|FG003|COMPLETED|12 Week||9
3109253|NCT01555567|3833544|FG000|NOT COMPLETED|12 Week||1
3109254|NCT01555567|3833545|FG001|NOT COMPLETED|12 Week||1
3109255|NCT01555567|3833546|FG002|NOT COMPLETED|12 Week||1
3109256|NCT01555567|3833547|FG003|NOT COMPLETED|12 Week||0
3109257|NCT01555567|3833544|FG000|STARTED|Return to Activity||11
3109258|NCT01555567|3833545|FG001|STARTED|Return to Activity||12
3109259|NCT01555567|3833546|FG002|STARTED|Return to Activity||8
3109260|NCT01555567|3833547|FG003|STARTED|Return to Activity||9
3109261|NCT01555567|3833544|FG000|COMPLETED|Return to Activity||10
3109262|NCT01555567|3833545|FG001|COMPLETED|Return to Activity||10
3109263|NCT01555567|3833546|FG002|COMPLETED|Return to Activity||8
3109264|NCT01555567|3833547|FG003|COMPLETED|Return to Activity||8
3109265|NCT01555567|3833544|FG000|NOT COMPLETED|Return to Activity||1
3109266|NCT01555567|3833545|FG001|NOT COMPLETED|Return to Activity||2
3109267|NCT01555567|3833546|FG002|NOT COMPLETED|Return to Activity||0
3109268|NCT01555567|3833547|FG003|NOT COMPLETED|Return to Activity||1
3109269|NCT01555671|3833559|FG000|STARTED|Overall Study||125
3109270|NCT01555671|3833560|FG001|STARTED|Overall Study||125
3109271|NCT01555671|3833559|FG000|COMPLETED|Overall Study||105
3109272|NCT01555671|3833560|FG001|COMPLETED|Overall Study||100
3109273|NCT01555671|3833559|FG000|NOT COMPLETED|Overall Study||20
3109274|NCT01555671|3833560|FG001|NOT COMPLETED|Overall Study||25
3109275|NCT01555697|3833576|FG000|STARTED|Overall Study||10
3109276|NCT01555697|3833577|FG001|STARTED|Overall Study||10
3109277|NCT01555697|3833578|FG002|STARTED|Overall Study||10
3109278|NCT01555697|3833579|FG003|STARTED|Overall Study||10
3109279|NCT01555697|3833580|FG004|STARTED|Overall Study||10
3109280|NCT01555697|3833581|FG005|STARTED|Overall Study||10
3109281|NCT01555697|3833582|FG006|STARTED|Overall Study||10
3109282|NCT01555697|3833583|FG007|STARTED|Overall Study||10
3109283|NCT01555697|3833576|FG000|6 Hours Lab Testing Day 1|Overall Study||10
3109284|NCT01555697|3833577|FG001|6 Hours Lab Testing Day 1|Overall Study||10
3109285|NCT01555697|3833578|FG002|6 Hours Lab Testing Day 1|Overall Study||10
3109286|NCT01555697|3833579|FG003|6 Hours Lab Testing Day 1|Overall Study||10
3109287|NCT01555697|3833580|FG004|6 Hours Lab Testing Day 1|Overall Study||10
3109288|NCT01555697|3833581|FG005|6 Hours Lab Testing Day 1|Overall Study||10
3109289|NCT01555697|3833582|FG006|6 Hours Lab Testing Day 1|Overall Study||10
3109290|NCT01555697|3833583|FG007|6 Hours Lab Testing Day 1|Overall Study||10
3109291|NCT01555697|3833576|FG000|Approx 7 Day Washout|Overall Study||10
3109292|NCT01555697|3833577|FG001|Approx 7 Day Washout|Overall Study||10
3109293|NCT01555697|3833578|FG002|Approx 7 Day Washout|Overall Study||10
3109294|NCT01555697|3833579|FG003|Approx 7 Day Washout|Overall Study||10
3109295|NCT01555697|3833580|FG004|Approx 7 Day Washout|Overall Study||10
3109296|NCT01555697|3833581|FG005|Approx 7 Day Washout|Overall Study||10
3109297|NCT01555697|3833582|FG006|Approx 7 Day Washout|Overall Study||10
3109298|NCT01555697|3833583|FG007|Approx 7 Day Washout|Overall Study||10
3109299|NCT01555697|3833576|FG000|6 Hours Lab Testing Day 2|Overall Study||10
3109300|NCT01555697|3833577|FG001|6 Hours Lab Testing Day 2|Overall Study||10
3109301|NCT01555697|3833578|FG002|6 Hours Lab Testing Day 2|Overall Study||10
3109302|NCT01555697|3833579|FG003|6 Hours Lab Testing Day 2|Overall Study||10
3109303|NCT01555697|3833580|FG004|6 Hours Lab Testing Day 2|Overall Study||10
3109304|NCT01555697|3833581|FG005|6 Hours Lab Testing Day 2|Overall Study||10
3109305|NCT01555697|3833582|FG006|6 Hours Lab Testing Day 2|Overall Study||10
3109306|NCT01555697|3833583|FG007|6 Hours Lab Testing Day 2|Overall Study||10
3109307|NCT01555697|3833576|FG000|COMPLETED|Overall Study||10
3109308|NCT01555697|3833577|FG001|COMPLETED|Overall Study||10
3109309|NCT01555697|3833578|FG002|COMPLETED|Overall Study||10
3109310|NCT01555697|3833579|FG003|COMPLETED|Overall Study||10
3109311|NCT01555697|3833580|FG004|COMPLETED|Overall Study||10
3109312|NCT01555697|3833581|FG005|COMPLETED|Overall Study||10
3109313|NCT01555697|3833582|FG006|COMPLETED|Overall Study||10
3109314|NCT01555697|3833583|FG007|COMPLETED|Overall Study||10
3109315|NCT01555697|3833576|FG000|NOT COMPLETED|Overall Study||0
3109316|NCT01555697|3833577|FG001|NOT COMPLETED|Overall Study||0
3109317|NCT01555697|3833578|FG002|NOT COMPLETED|Overall Study||0
3109318|NCT01555697|3833579|FG003|NOT COMPLETED|Overall Study||0
3109319|NCT01555697|3833580|FG004|NOT COMPLETED|Overall Study||0
3109320|NCT01555697|3833581|FG005|NOT COMPLETED|Overall Study||0
3109321|NCT01555697|3833582|FG006|NOT COMPLETED|Overall Study||0
3109322|NCT01555697|3833583|FG007|NOT COMPLETED|Overall Study||0
3109323|NCT01555762|3833595|FG000|STARTED|Overall Study||402
3109324|NCT01555762|3833595|FG000|Safety Population|Overall Study||383
3109325|NCT01555762|3833595|FG000|Efficacy Population|Overall Study||358
3109326|NCT01555762|3833595|FG000|COMPLETED|Overall Study||128
3109327|NCT01555762|3833595|FG000|NOT COMPLETED|Overall Study||274
3109328|NCT01555931|3833601|FG000|STARTED|Overall Study||17
3109329|NCT01555931|3833602|FG001|STARTED|Overall Study||18
3109330|NCT01555931|3833601|FG000|COMPLETED|Overall Study||15
3109331|NCT01555931|3833602|FG001|COMPLETED|Overall Study||13
3109332|NCT01555931|3833601|FG000|NOT COMPLETED|Overall Study||2
3109333|NCT01555931|3833602|FG001|NOT COMPLETED|Overall Study||5
3109334|NCT01555957|3833610|FG000|STARTED|Overall Study||20
3109335|NCT01555957|3833611|FG001|STARTED|Overall Study||20
3109336|NCT01555957|3833610|FG000|COMPLETED|Overall Study||20
3109337|NCT01555957|3833611|FG001|COMPLETED|Overall Study||20
3109338|NCT01555957|3833610|FG000|NOT COMPLETED|Overall Study||0
3109339|NCT01555957|3833611|FG001|NOT COMPLETED|Overall Study||0
3109340|NCT01555983|3833617|FG000|STARTED|Overall Study||9
3109341|NCT01555983|3833618|FG001|STARTED|Overall Study||7
3109342|NCT01555983|3833619|FG002|STARTED|Overall Study||7
3109343|NCT01555983|3833620|FG003|STARTED|Overall Study||7
3109344|NCT01555983|3833621|FG004|STARTED|Overall Study||5
3109345|NCT01555983|3833622|FG005|STARTED|Overall Study||7
3109346|NCT01555983|3833617|FG000|COMPLETED|Overall Study|One subject only finished the placebo session, then dropped out of study|8
3109347|NCT01555983|3833618|FG001|COMPLETED|Overall Study||7
3109348|NCT01555983|3833619|FG002|COMPLETED|Overall Study||7
3109349|NCT01555983|3833620|FG003|COMPLETED|Overall Study||7
3109350|NCT01555983|3833621|FG004|COMPLETED|Overall Study|One subject complete 6.7%THC and placebo sessions, then dropped out|4
3109351|NCT01555983|3833622|FG005|COMPLETED|Overall Study|One subject completed the 6.7%THC session, then dropped out.|6
3109352|NCT01555983|3833617|FG000|NOT COMPLETED|Overall Study||1
3109353|NCT01555983|3833618|FG001|NOT COMPLETED|Overall Study||0
3109354|NCT01555983|3833619|FG002|NOT COMPLETED|Overall Study||0
3109355|NCT01555983|3833620|FG003|NOT COMPLETED|Overall Study||0
3109356|NCT01555983|3833621|FG004|NOT COMPLETED|Overall Study||1
3109357|NCT01555983|3833622|FG005|NOT COMPLETED|Overall Study||1
3109358|NCT01556061|3833632|FG000|STARTED|Overall Study||25
3109359|NCT01556061|3833633|FG001|STARTED|Overall Study||25
3109360|NCT01556061|3833632|FG000|COMPLETED|Overall Study||25
3109361|NCT01556061|3833633|FG001|COMPLETED|Overall Study||25
3109362|NCT01556061|3833632|FG000|NOT COMPLETED|Overall Study||0
3109363|NCT01556061|3833633|FG001|NOT COMPLETED|Overall Study||0
3109364|NCT01556100|3833641|FG000|STARTED|Overall Study||40
3109365|NCT01556100|3833641|FG000|COMPLETED|Overall Study||34
3109366|NCT01556100|3833641|FG000|NOT COMPLETED|Overall Study||6
3109367|NCT01556165|3833647|FG000|STARTED|Overall Study||65
3109368|NCT01556165|3833648|FG001|STARTED|Overall Study||65
3109369|NCT01556165|3833647|FG000|COMPLETED|Overall Study||53
3109370|NCT01556165|3833648|FG001|COMPLETED|Overall Study||58
3109371|NCT01556165|3833647|FG000|NOT COMPLETED|Overall Study||12
3109372|NCT01556165|3833648|FG001|NOT COMPLETED|Overall Study||7
3109373|NCT01556204|3833656|FG000|STARTED|Overall Study||35
3109374|NCT01556204|3833657|FG001|STARTED|Overall Study||38
3109375|NCT01556204|3833656|FG000|COMPLETED|Overall Study||35
3109376|NCT01556204|3833657|FG001|COMPLETED|Overall Study||38
3109377|NCT01556204|3833656|FG000|NOT COMPLETED|Overall Study||0
3109378|NCT01556204|3833657|FG001|NOT COMPLETED|Overall Study||0
3109379|NCT01556347|3833663|FG000|STARTED|Induction Immunotherapy||2
3109380|NCT01556347|3833663|FG000|COMPLETED|Induction Immunotherapy||2
3109381|NCT01556347|3833663|FG000|NOT COMPLETED|Induction Immunotherapy||0
3109382|NCT01556347|3833663|FG000|STARTED|Bortezomib Treatment Phase||2
3109383|NCT01556347|3833663|FG000|COMPLETED|Bortezomib Treatment Phase||2
3109384|NCT01556347|3833663|FG000|NOT COMPLETED|Bortezomib Treatment Phase||0
3109385|NCT01556347|3833663|FG000|STARTED|Recovery Phase||2
3109386|NCT01556347|3833663|FG000|COMPLETED|Recovery Phase||2
3109387|NCT01556347|3833663|FG000|NOT COMPLETED|Recovery Phase||0
3135702|NCT01708629|3860774|FG002|STARTED|Overall Study||313
3135703|NCT01708629|3860775|FG003|STARTED|Overall Study||315
3135704|NCT01708629|3860772|FG000|COMPLETED|Overall Study||608
3135705|NCT01708629|3860773|FG001|COMPLETED|Overall Study||604
3135706|NCT01708629|3860774|FG002|COMPLETED|Overall Study||303
3135707|NCT01708629|3860775|FG003|COMPLETED|Overall Study||301
3135708|NCT01708629|3860772|FG000|NOT COMPLETED|Overall Study||16
3135709|NCT01708629|3860773|FG001|NOT COMPLETED|Overall Study||25
3135710|NCT01708629|3860774|FG002|NOT COMPLETED|Overall Study||10
3135711|NCT01708629|3860775|FG003|NOT COMPLETED|Overall Study||14
3135712|NCT01708902|3860792|FG000|STARTED|Overall Study||147
3135713|NCT01708902|3860793|FG001|STARTED|Overall Study||145
3135714|NCT01708902|3860794|FG002|STARTED|Overall Study||144
3135715|NCT01708902|3860795|FG003|STARTED|Overall Study||147
3135716|NCT01708902|3860796|FG004|STARTED|Overall Study||147
3135717|NCT01708902|3860797|FG005|STARTED|Overall Study||71
3135718|NCT01708902|3860798|FG006|STARTED|Overall Study||72
3135719|NCT01708902|3860792|FG000|COMPLETED|Overall Study||130
3135720|NCT01708902|3860793|FG001|COMPLETED|Overall Study||137
3135721|NCT01708902|3860794|FG002|COMPLETED|Overall Study||127
3135722|NCT01708902|3860795|FG003|COMPLETED|Overall Study||137
3135723|NCT01708902|3860796|FG004|COMPLETED|Overall Study||131
3135724|NCT01708902|3860797|FG005|COMPLETED|Overall Study||64
3135725|NCT01708902|3860798|FG006|COMPLETED|Overall Study||65
3135726|NCT01708902|3860792|FG000|NOT COMPLETED|Overall Study||17
3135727|NCT01708902|3860793|FG001|NOT COMPLETED|Overall Study||8
3135728|NCT01708902|3860794|FG002|NOT COMPLETED|Overall Study||17
3135729|NCT01708902|3860795|FG003|NOT COMPLETED|Overall Study||10
3135730|NCT01708902|3860796|FG004|NOT COMPLETED|Overall Study||16
3135731|NCT01708902|3860797|FG005|NOT COMPLETED|Overall Study||7
3135732|NCT01708902|3860798|FG006|NOT COMPLETED|Overall Study||7
3135733|NCT01708915|3860821|FG000|STARTED|Overall Study||204
3135734|NCT01708915|3860822|FG001|STARTED|Overall Study||201
3135735|NCT01708915|3860823|FG002|STARTED|Overall Study||198
3135736|NCT01708915|3860824|FG003|STARTED|Overall Study||202
3135737|NCT01708915|3860821|FG000|COMPLETED|Overall Study||118
3135738|NCT01708915|3860822|FG001|COMPLETED|Overall Study||139
3135739|NCT01708915|3860823|FG002|COMPLETED|Overall Study||152
3135740|NCT01708915|3860824|FG003|COMPLETED|Overall Study||169
3135741|NCT01708915|3860821|FG000|NOT COMPLETED|Overall Study||86
3135742|NCT01708915|3860822|FG001|NOT COMPLETED|Overall Study||62
3135743|NCT01708915|3860823|FG002|NOT COMPLETED|Overall Study||46
3135744|NCT01708915|3860824|FG003|NOT COMPLETED|Overall Study||33
3135745|NCT01708941|3860838|FG000|STARTED|Overall Study||21
3135746|NCT01708941|3860839|FG001|STARTED|Overall Study||23
3135747|NCT01708941|3860840|FG002|STARTED|Overall Study||22
3135748|NCT01708941|3860841|FG003|STARTED|Overall Study||22
3135749|NCT01708941|3860838|FG000|Eligible and Started Treatment|Overall Study||18
3135750|NCT01708941|3860839|FG001|Eligible and Started Treatment|Overall Study||22
3135751|NCT01708941|3860840|FG002|Eligible and Started Treatment|Overall Study||19
3135752|NCT01708941|3860841|FG003|Eligible and Started Treatment|Overall Study||22
3135753|NCT01708941|3860838|FG000|COMPLETED|Overall Study||3
3135754|NCT01708941|3860839|FG001|COMPLETED|Overall Study||5
3135755|NCT01708941|3860840|FG002|COMPLETED|Overall Study||3
3135756|NCT01708941|3860841|FG003|COMPLETED|Overall Study||4
3135757|NCT01708941|3860838|FG000|NOT COMPLETED|Overall Study||18
3135758|NCT01708941|3860839|FG001|NOT COMPLETED|Overall Study||18
3135759|NCT01708941|3860840|FG002|NOT COMPLETED|Overall Study||19
3135760|NCT01708941|3860841|FG003|NOT COMPLETED|Overall Study||18
3135761|NCT01708954|3860854|FG000|STARTED|Step 1||42
3135762|NCT01708954|3860855|FG001|STARTED|Step 1||40
3135763|NCT01708954|3860856|FG002|STARTED|Step 1||43
3135764|NCT01708954|3860854|FG000|Started Protocol Therapy|Step 1||40
3135765|NCT01708954|3860855|FG001|Started Protocol Therapy|Step 1||40
3135766|NCT01708954|3860856|FG002|Started Protocol Therapy|Step 1||39
3135767|NCT01708954|3860854|FG000|Eligible and Treated|Step 1||38
3135768|NCT01708954|3860855|FG001|Eligible and Treated|Step 1||38
3135769|NCT01708954|3860856|FG002|Eligible and Treated|Step 1||35
3135770|NCT01708954|3860854|FG000|Patients With MET Status Data Available|Step 1||30
3135771|NCT01708954|3860855|FG001|Patients With MET Status Data Available|Step 1||32
3135772|NCT01708954|3860856|FG002|Patients With MET Status Data Available|Step 1||24
3135773|NCT01708954|3860854|FG000|COMPLETED|Step 1|Treatment continued until progressive disease or unacceptable toxicity.|0
3135774|NCT01708954|3860855|FG001|COMPLETED|Step 1|Treatment continued until progressive disease or unacceptable toxicity.|0
3135775|NCT01708954|3860856|FG002|COMPLETED|Step 1|Treatment continued until progressive disease or unacceptable toxicity.|0
3135776|NCT01708954|3860854|FG000|NOT COMPLETED|Step 1||42
3135777|NCT01708954|3860855|FG001|NOT COMPLETED|Step 1||40
3135778|NCT01708954|3860856|FG002|NOT COMPLETED|Step 1||43
3135779|NCT01708954|3860854|FG000|STARTED|Step 2|Only patients with disease progression in Step 1 are eligible to register to Step 2.|13
3135780|NCT01708954|3860855|FG001|STARTED|Step 2|Only patients with disease progression in Step 1 are eligible to register to Step 2.|7
3135781|NCT01708954|3860856|FG002|STARTED|Step 2|Only patients with disease progression on Arms A and B were allowed to register to Step 2.|0
3109388|NCT01556425|3833695|FG000|STARTED|Overall Study||25
3109389|NCT01556425|3833696|FG001|STARTED|Overall Study||23
3109390|NCT01556425|3833697|FG002|STARTED|Overall Study||18
3109391|NCT01556425|3833698|FG003|STARTED|Overall Study||18
3109392|NCT01556425|3833695|FG000|COMPLETED|Overall Study||25
3109393|NCT01556425|3833696|FG001|COMPLETED|Overall Study||23
3109394|NCT01556425|3833697|FG002|COMPLETED|Overall Study||18
3109395|NCT01556425|3833698|FG003|COMPLETED|Overall Study||18
3109396|NCT01556425|3833695|FG000|NOT COMPLETED|Overall Study||0
3109397|NCT01556425|3833696|FG001|NOT COMPLETED|Overall Study||0
3109398|NCT01556425|3833697|FG002|NOT COMPLETED|Overall Study||0
3109399|NCT01556425|3833698|FG003|NOT COMPLETED|Overall Study||0
3109400|NCT01556438|3833710|FG000|STARTED|Overall Study||4
3109401|NCT01556438|3833711|FG001|STARTED|Overall Study||12
3109402|NCT01556438|3833710|FG000|Received at Least 1 Dose of Study Drug|Overall Study|100 mg tabalumab IV|4
3109403|NCT01556438|3833711|FG001|Received at Least 1 Dose of Study Drug|Overall Study|300 mg tabalumab IV|12
3109404|NCT01556438|3833710|FG000|Received BTZ IV|Overall Study||4
3109405|NCT01556438|3833711|FG001|Received BTZ IV|Overall Study||4
3109406|NCT01556438|3833710|FG000|Received BTZ SC|Overall Study||0
3109407|NCT01556438|3833711|FG001|Received BTZ SC|Overall Study||8
3109408|NCT01556438|3833710|FG000|COMPLETED|Overall Study||0
3109409|NCT01556438|3833711|FG001|COMPLETED|Overall Study||1
3109410|NCT01556438|3833710|FG000|NOT COMPLETED|Overall Study||4
3109411|NCT01556438|3833711|FG001|NOT COMPLETED|Overall Study||11
3109412|NCT01556451|3833725|FG000|STARTED|Overall Study||180
3109413|NCT01556451|3833725|FG000|COMPLETED|Overall Study||180
3109414|NCT01556451|3833725|FG000|NOT COMPLETED|Overall Study||0
3109415|NCT01556581|3833731|FG000|STARTED|Overall Study||61
3109416|NCT01556581|3833732|FG001|STARTED|Overall Study||58
3109417|NCT01556581|3833731|FG000|COMPLETED|Overall Study||61
3109418|NCT01556581|3833732|FG001|COMPLETED|Overall Study||58
3109419|NCT01556581|3833731|FG000|NOT COMPLETED|Overall Study||0
3109420|NCT01556581|3833732|FG001|NOT COMPLETED|Overall Study||0
3109421|NCT01556594|3833741|FG000|STARTED|Overall Study||10
3109422|NCT01556594|3833742|FG001|STARTED|Overall Study||2
3109423|NCT01556594|3833743|FG002|STARTED|Overall Study||6
3109424|NCT01556594|3833741|FG000|COMPLETED|Overall Study||10
3109425|NCT01556594|3833742|FG001|COMPLETED|Overall Study||2
3109426|NCT01556594|3833743|FG002|COMPLETED|Overall Study||6
3109427|NCT01556594|3833741|FG000|NOT COMPLETED|Overall Study||0
3109428|NCT01556594|3833742|FG001|NOT COMPLETED|Overall Study||0
3109429|NCT01556594|3833743|FG002|NOT COMPLETED|Overall Study||0
3109430|NCT01556633|3833755|FG000|STARTED|Overall Study||10
3109431|NCT01556633|3833756|FG001|STARTED|Overall Study||6
3109432|NCT01556633|3833755|FG000|COMPLETED|Overall Study||10
3109433|NCT01556633|3833756|FG001|COMPLETED|Overall Study||6
3109434|NCT01556633|3833755|FG000|NOT COMPLETED|Overall Study||0
3109435|NCT01556633|3833756|FG001|NOT COMPLETED|Overall Study||0
3109436|NCT01556724|3833767|FG000|STARTED|Overall Study||16
3109437|NCT01556724|3833768|FG001|STARTED|Overall Study||14
3109438|NCT01556724|3833767|FG000|COMPLETED|Overall Study||16
3109439|NCT01556724|3833768|FG001|COMPLETED|Overall Study||14
3109440|NCT01556724|3833767|FG000|NOT COMPLETED|Overall Study||0
3109441|NCT01556724|3833768|FG001|NOT COMPLETED|Overall Study||0
3109442|NCT01556763|3833780|FG000|STARTED|Overall Study||4
3109443|NCT01556763|3833781|FG001|STARTED|Overall Study||9
3109444|NCT01556763|3833782|FG002|STARTED|Overall Study||8
3109445|NCT01556763|3833780|FG000|COMPLETED|Overall Study||4
3109446|NCT01556763|3833781|FG001|COMPLETED|Overall Study||8
3109447|NCT01556763|3833782|FG002|COMPLETED|Overall Study||8
3109448|NCT01556763|3833780|FG000|NOT COMPLETED|Overall Study||0
3109449|NCT01556763|3833781|FG001|NOT COMPLETED|Overall Study||1
3109450|NCT01556763|3833782|FG002|NOT COMPLETED|Overall Study||0
3109451|NCT01556906|3833792|FG000|STARTED|Overall Study||6
3109452|NCT01556906|3833792|FG000|COMPLETED|Overall Study||6
3109453|NCT01556906|3833792|FG000|NOT COMPLETED|Overall Study||0
3109454|NCT01556932|3833796|FG000|STARTED|Baseline First Treatment||13
3109455|NCT01556932|3833797|FG001|STARTED|Baseline First Treatment||9
3109456|NCT01556932|3833796|FG000|Recieved|Baseline First Treatment||13
3109457|NCT01556932|3833797|FG001|Recieved|Baseline First Treatment||9
3109458|NCT01556932|3833796|FG000|COMPLETED|Baseline First Treatment||13
3109459|NCT01556932|3833797|FG001|COMPLETED|Baseline First Treatment||9
3109460|NCT01556932|3833796|FG000|NOT COMPLETED|Baseline First Treatment||0
3109461|NCT01556932|3833797|FG001|NOT COMPLETED|Baseline First Treatment||0
3109462|NCT01556932|3833796|FG000|STARTED|Time Point 60 Minutes|1 subject withdrew and never started second treatment.|13
3109463|NCT01556932|3833797|FG001|STARTED|Time Point 60 Minutes|1 subject withdrew and never started second treatment.|9
3109464|NCT01556932|3833796|FG000|Recieved|Time Point 60 Minutes||12
3109465|NCT01556932|3833797|FG001|Recieved|Time Point 60 Minutes||8
3109466|NCT01556932|3833796|FG000|COMPLETED|Time Point 60 Minutes||12
3109467|NCT01556932|3833797|FG001|COMPLETED|Time Point 60 Minutes||8
3109468|NCT01556932|3833796|FG000|NOT COMPLETED|Time Point 60 Minutes||1
3109469|NCT01556932|3833797|FG001|NOT COMPLETED|Time Point 60 Minutes||1
3109470|NCT01556932|3833796|FG000|STARTED|Second Treament||12
3109471|NCT01556932|3833797|FG001|STARTED|Second Treament||8
3109472|NCT01556932|3833796|FG000|Recieved|Second Treament||12
3109473|NCT01556932|3833797|FG001|Recieved|Second Treament||8
3109474|NCT01556932|3833796|FG000|COMPLETED|Second Treament||12
3109475|NCT01556932|3833797|FG001|COMPLETED|Second Treament||8
3109476|NCT01556932|3833796|FG000|NOT COMPLETED|Second Treament||0
3109477|NCT01556932|3833797|FG001|NOT COMPLETED|Second Treament||0
3109478|NCT01556997|3833805|FG000|STARTED|Overall Study||279
3109479|NCT01556997|3833806|FG001|STARTED|Overall Study||280
3109480|NCT01556997|3833807|FG002|STARTED|Overall Study||278
3109481|NCT01556997|3833805|FG000|COMPLETED|Overall Study||253
3109482|NCT01556997|3833806|FG001|COMPLETED|Overall Study||252
3109483|NCT01556997|3833807|FG002|COMPLETED|Overall Study||246
3109484|NCT01556997|3833805|FG000|NOT COMPLETED|Overall Study||26
3109485|NCT01556997|3833806|FG001|NOT COMPLETED|Overall Study||28
3109486|NCT01556997|3833807|FG002|NOT COMPLETED|Overall Study||32
3109487|NCT01557166|3833817|FG000|STARTED|Overall Study||180
3109488|NCT01557166|3833818|FG001|STARTED|Overall Study||179
3109489|NCT01557166|3833817|FG000|Exposed|Overall Study||176
3109490|NCT01557166|3833818|FG001|Exposed|Overall Study||179
3109491|NCT01557166|3833817|FG000|COMPLETED|Overall Study||134
3109492|NCT01557166|3833818|FG001|COMPLETED|Overall Study||142
3109493|NCT01557166|3833817|FG000|NOT COMPLETED|Overall Study||46
3109494|NCT01557166|3833818|FG001|NOT COMPLETED|Overall Study||37
3109495|NCT01557244|3833829|FG000|STARTED|Active Comparator/Efficacy Phase:12Weeks||42
3109496|NCT01557244|3833830|FG001|STARTED|Active Comparator/Efficacy Phase:12Weeks||42
3109497|NCT01557244|3833831|FG002|STARTED|Active Comparator/Efficacy Phase:12Weeks||40
3109498|NCT01557244|3833832|FG003|STARTED|Active Comparator/Efficacy Phase:12Weeks||0
3109499|NCT01557244|3833833|FG004|STARTED|Active Comparator/Efficacy Phase:12Weeks||0
3109500|NCT01557244|3833834|FG005|STARTED|Active Comparator/Efficacy Phase:12Weeks||28
3109501|NCT01557244|3833835|FG006|STARTED|Active Comparator/Efficacy Phase:12Weeks||29
3109502|NCT01557244|3833829|FG000|Treated|Active Comparator/Efficacy Phase:12Weeks||42
3109503|NCT01557244|3833830|FG001|Treated|Active Comparator/Efficacy Phase:12Weeks||42
3109504|NCT01557244|3833831|FG002|Treated|Active Comparator/Efficacy Phase:12Weeks||40
3109505|NCT01557244|3833832|FG003|Treated|Active Comparator/Efficacy Phase:12Weeks||0
3109506|NCT01557244|3833833|FG004|Treated|Active Comparator/Efficacy Phase:12Weeks||0
3109507|NCT01557244|3833834|FG005|Treated|Active Comparator/Efficacy Phase:12Weeks||28
3109508|NCT01557244|3833835|FG006|Treated|Active Comparator/Efficacy Phase:12Weeks||29
3109509|NCT01557244|3833829|FG000|COMPLETED|Active Comparator/Efficacy Phase:12Weeks||33
3109510|NCT01557244|3833830|FG001|COMPLETED|Active Comparator/Efficacy Phase:12Weeks||40
3109511|NCT01557244|3833831|FG002|COMPLETED|Active Comparator/Efficacy Phase:12Weeks||36
3109512|NCT01557244|3833832|FG003|COMPLETED|Active Comparator/Efficacy Phase:12Weeks||0
3109513|NCT01557244|3833833|FG004|COMPLETED|Active Comparator/Efficacy Phase:12Weeks||0
3109514|NCT01557244|3833834|FG005|COMPLETED|Active Comparator/Efficacy Phase:12Weeks||21
3109515|NCT01557244|3833835|FG006|COMPLETED|Active Comparator/Efficacy Phase:12Weeks||28
3109516|NCT01557244|3833829|FG000|NOT COMPLETED|Active Comparator/Efficacy Phase:12Weeks||9
3109517|NCT01557244|3833830|FG001|NOT COMPLETED|Active Comparator/Efficacy Phase:12Weeks||2
3109518|NCT01557244|3833831|FG002|NOT COMPLETED|Active Comparator/Efficacy Phase:12Weeks||4
3109519|NCT01557244|3833832|FG003|NOT COMPLETED|Active Comparator/Efficacy Phase:12Weeks||0
3109520|NCT01557244|3833833|FG004|NOT COMPLETED|Active Comparator/Efficacy Phase:12Weeks||0
3109521|NCT01557244|3833834|FG005|NOT COMPLETED|Active Comparator/Efficacy Phase:12Weeks||7
3109522|NCT01557244|3833835|FG006|NOT COMPLETED|Active Comparator/Efficacy Phase:12Weeks||1
3109523|NCT01557244|3833829|FG000|STARTED|Safety Extension Phase: 12 Weeks||33
3109524|NCT01557244|3833830|FG001|STARTED|Safety Extension Phase: 12 Weeks||40
3109525|NCT01557244|3833831|FG002|STARTED|Safety Extension Phase: 12 Weeks|Did not receive oxybutynin in safety extension phase.|0
3109526|NCT01557244|3833832|FG003|STARTED|Safety Extension Phase: 12 Weeks|Allocated from oxybutynin arm to this arm by investigator in safety extension phase.|16
3109527|NCT01557244|3833833|FG004|STARTED|Safety Extension Phase: 12 Weeks|Allocated from oxybutynin arm to this arm by investigator in safety extension phase.|20
3109528|NCT01557244|3833834|FG005|STARTED|Safety Extension Phase: 12 Weeks||21
3109529|NCT01557244|3833835|FG006|STARTED|Safety Extension Phase: 12 Weeks||28
3109530|NCT01557244|3833829|FG000|Treated|Safety Extension Phase: 12 Weeks||30
3109531|NCT01557244|3833830|FG001|Treated|Safety Extension Phase: 12 Weeks||37
3109532|NCT01557244|3833831|FG002|Treated|Safety Extension Phase: 12 Weeks||0
3109533|NCT01557244|3833832|FG003|Treated|Safety Extension Phase: 12 Weeks||16
3109534|NCT01557244|3833833|FG004|Treated|Safety Extension Phase: 12 Weeks||20
3109535|NCT01557244|3833834|FG005|Treated|Safety Extension Phase: 12 Weeks||20
3109536|NCT01557244|3833835|FG006|Treated|Safety Extension Phase: 12 Weeks||28
3109537|NCT01557244|3833829|FG000|COMPLETED|Safety Extension Phase: 12 Weeks||30
3109538|NCT01557244|3833830|FG001|COMPLETED|Safety Extension Phase: 12 Weeks||36
3109539|NCT01557244|3833831|FG002|COMPLETED|Safety Extension Phase: 12 Weeks||0
3109540|NCT01557244|3833832|FG003|COMPLETED|Safety Extension Phase: 12 Weeks||15
3109541|NCT01557244|3833833|FG004|COMPLETED|Safety Extension Phase: 12 Weeks||20
3109542|NCT01557244|3833834|FG005|COMPLETED|Safety Extension Phase: 12 Weeks||20
3109543|NCT01557244|3833835|FG006|COMPLETED|Safety Extension Phase: 12 Weeks||28
3109544|NCT01557244|3833829|FG000|NOT COMPLETED|Safety Extension Phase: 12 Weeks||3
3109545|NCT01557244|3833830|FG001|NOT COMPLETED|Safety Extension Phase: 12 Weeks||4
3109546|NCT01557244|3833831|FG002|NOT COMPLETED|Safety Extension Phase: 12 Weeks||0
3109547|NCT01557244|3833832|FG003|NOT COMPLETED|Safety Extension Phase: 12 Weeks||1
3109548|NCT01557244|3833833|FG004|NOT COMPLETED|Safety Extension Phase: 12 Weeks||0
3109549|NCT01557244|3833834|FG005|NOT COMPLETED|Safety Extension Phase: 12 Weeks||1
3109550|NCT01557244|3833835|FG006|NOT COMPLETED|Safety Extension Phase: 12 Weeks||0
3109551|NCT01557283|3833863|FG000|STARTED|Overall Study||140
3109552|NCT01557283|3833863|FG000|COMPLETED|Overall Study||96
3109553|NCT01557283|3833863|FG000|NOT COMPLETED|Overall Study||44
3109554|NCT01557322|3833869|FG000|STARTED|Overall Study||211
3109555|NCT01557322|3833870|FG001|STARTED|Overall Study||1543
3109556|NCT01557322|3833869|FG000|COMPLETED|Overall Study||211
3109557|NCT01557322|3833870|FG001|COMPLETED|Overall Study||1543
3109558|NCT01557322|3833869|FG000|NOT COMPLETED|Overall Study||0
3109559|NCT01557322|3833870|FG001|NOT COMPLETED|Overall Study||0
3109560|NCT01557348|3833878|FG000|STARTED|Overall Study||604
3109561|NCT01557348|3833879|FG001|STARTED|Overall Study||507
3109562|NCT01557348|3833878|FG000|Safety Population|Overall Study||604
3109563|NCT01557348|3833879|FG001|Safety Population|Overall Study||507
3109564|NCT01557348|3833878|FG000|COMPLETED|Overall Study||524
3109565|NCT01557348|3833879|FG001|COMPLETED|Overall Study||417
3109566|NCT01557348|3833878|FG000|NOT COMPLETED|Overall Study||80
3109567|NCT01557348|3833879|FG001|NOT COMPLETED|Overall Study||90
3293658|NCT02872857|4027645|FG000|COMPLETED|Phase 1||15
3293659|NCT02872857|4027646|FG001|COMPLETED|Phase 1||15
3293660|NCT02872857|4027647|FG002|COMPLETED|Phase 1||0
3293661|NCT02872857|4027648|FG003|COMPLETED|Phase 1||0
3293662|NCT02872857|4027645|FG000|NOT COMPLETED|Phase 1||0
3109568|NCT01557400|3833886|FG000|STARTED|Overall Study||94
3109569|NCT01557400|3833886|FG000|Received at Least 1 Dose of Study Drug|Overall Study||94
3109570|NCT01557400|3833886|FG000|COMPLETED|Overall Study||37
3109571|NCT01557400|3833886|FG000|NOT COMPLETED|Overall Study||57
3109572|NCT01557452|3833890|FG000|STARTED|Overall Study||1
3109573|NCT01557452|3833890|FG000|COMPLETED|Overall Study||1
3109574|NCT01557452|3833890|FG000|NOT COMPLETED|Overall Study||0
3109575|NCT01557504|3833897|FG000|STARTED|Overall Study||13
3109576|NCT01557504|3833898|FG001|STARTED|Overall Study||12
3109577|NCT01557504|3833897|FG000|COMPLETED|Overall Study||12
3109578|NCT01557504|3833898|FG001|COMPLETED|Overall Study||12
3109579|NCT01557504|3833897|FG000|NOT COMPLETED|Overall Study||1
3109580|NCT01557504|3833898|FG001|NOT COMPLETED|Overall Study||0
3109581|NCT01557517|3833912|FG000|STARTED|Overall Study||19
3109582|NCT01557517|3833913|FG001|STARTED|Overall Study||21
3109583|NCT01557517|3833912|FG000|COMPLETED|Overall Study||17
3109584|NCT01557517|3833913|FG001|COMPLETED|Overall Study||17
3109585|NCT01557517|3833912|FG000|NOT COMPLETED|Overall Study||2
3109586|NCT01557517|3833913|FG001|NOT COMPLETED|Overall Study||4
3109587|NCT01557569|3833928|FG000|STARTED|Overall Study|Those who received at least one dose of medication|6
3109588|NCT01557569|3833929|FG001|STARTED|Overall Study|Those who received at least one dose of medication|7
3109589|NCT01557569|3833928|FG000|Completed 2-wk Residential Stay|Overall Study||3
3109590|NCT01557569|3833929|FG001|Completed 2-wk Residential Stay|Overall Study||1
3109591|NCT01557569|3833928|FG000|COMPLETED|Overall Study||1
3109592|NCT01557569|3833929|FG001|COMPLETED|Overall Study||0
3109593|NCT01557569|3833928|FG000|NOT COMPLETED|Overall Study||5
3109594|NCT01557569|3833929|FG001|NOT COMPLETED|Overall Study||7
3109595|NCT01557582|3833935|FG000|STARTED|Overall Study||103
3109596|NCT01557582|3833935|FG000|COMPLETED|Overall Study||97
3109597|NCT01557582|3833935|FG000|NOT COMPLETED|Overall Study||6
3109598|NCT01557595|3833939|FG000|STARTED|Overall Study||22
3109599|NCT01557595|3833939|FG000|COMPLETED|Overall Study||14
3109600|NCT01557595|3833939|FG000|NOT COMPLETED|Overall Study||8
3109601|NCT01557699|3833946|FG000|STARTED|Overall Study||20
3109602|NCT01557699|3833947|FG001|STARTED|Overall Study||20
3109603|NCT01557699|3833948|FG002|STARTED|Overall Study||20
3109604|NCT01557699|3833946|FG000|COMPLETED|Overall Study||20
3109605|NCT01557699|3833947|FG001|COMPLETED|Overall Study||20
3109606|NCT01557699|3833948|FG002|COMPLETED|Overall Study||20
3109607|NCT01557699|3833946|FG000|NOT COMPLETED|Overall Study||0
3109608|NCT01557699|3833947|FG001|NOT COMPLETED|Overall Study||0
3109609|NCT01557699|3833948|FG002|NOT COMPLETED|Overall Study||0
3109610|NCT01557751|3833959|FG000|STARTED|Overall Study||156
3109611|NCT01557751|3833959|FG000|COMPLETED|Overall Study||153
3109612|NCT01557751|3833959|FG000|NOT COMPLETED|Overall Study||3
3109613|NCT01557790|3833963|FG000|STARTED|Overall Study||5
3109614|NCT01557790|3833963|FG000|COMPLETED|Overall Study||4
3109615|NCT01557790|3833963|FG000|NOT COMPLETED|Overall Study||1
3109616|NCT01557842|3833969|FG000|STARTED|Overall Study||9
3109617|NCT01557842|3833970|FG001|STARTED|Overall Study||6
3109618|NCT01557842|3833969|FG000|COMPLETED|Overall Study||0
3109619|NCT01557842|3833970|FG001|COMPLETED|Overall Study||0
3109620|NCT01557842|3833969|FG000|NOT COMPLETED|Overall Study||9
3109621|NCT01557842|3833970|FG001|NOT COMPLETED|Overall Study||6
3109622|NCT01557868|3833978|FG000|STARTED|Overall Study||103
3109623|NCT01557868|3833979|FG001|STARTED|Overall Study||95
3109624|NCT01557868|3833978|FG000|COMPLETED|Overall Study||76
3109625|NCT01557868|3833979|FG001|COMPLETED|Overall Study||65
3109626|NCT01557868|3833978|FG000|NOT COMPLETED|Overall Study||27
3109627|NCT01557868|3833979|FG001|NOT COMPLETED|Overall Study||30
3109628|NCT01557894|3833987|FG000|STARTED|Overall Study||38
3109629|NCT01557894|3833988|FG001|STARTED|Overall Study||38
3109630|NCT01557894|3833987|FG000|COMPLETED|Overall Study||35
3109631|NCT01557894|3833988|FG001|COMPLETED|Overall Study||33
3109632|NCT01557894|3833987|FG000|NOT COMPLETED|Overall Study||3
3109633|NCT01557894|3833988|FG001|NOT COMPLETED|Overall Study||5
3109634|NCT01557920|3833995|FG000|STARTED|Overall Study||9
3109635|NCT01557920|3833996|FG001|STARTED|Overall Study||9
3109636|NCT01557920|3833995|FG000|COMPLETED|Overall Study||6
3109637|NCT01557920|3833996|FG001|COMPLETED|Overall Study||6
3109638|NCT01557920|3833995|FG000|NOT COMPLETED|Overall Study||3
3293663|NCT02872857|4027646|FG001|NOT COMPLETED|Phase 1||0
3109639|NCT01557920|3833996|FG001|NOT COMPLETED|Overall Study||3
3109640|NCT01557946|3834031|FG000|STARTED|Overall Study||20
3109641|NCT01557946|3834032|FG001|STARTED|Overall Study||12
3109642|NCT01557946|3834031|FG000|COMPLETED|Overall Study|20 consented and scanned - 1 subject's data not used due to ongoing neurological condition.|17
3109643|NCT01557946|3834032|FG001|COMPLETED|Overall Study|2 subjects with unusable imaging data.|12
3109644|NCT01557946|3834031|FG000|NOT COMPLETED|Overall Study||3
3109645|NCT01557946|3834032|FG001|NOT COMPLETED|Overall Study||0
3109646|NCT01557959|3834037|FG000|STARTED|Overall Study||45
3109647|NCT01557959|3834037|FG000|COMPLETED|Overall Study||45
3109648|NCT01557959|3834037|FG000|NOT COMPLETED|Overall Study||0
3109649|NCT01558063|3834049|FG000|STARTED|Overall Study||5
3109650|NCT01558063|3834050|FG001|STARTED|Overall Study||6
3109651|NCT01558063|3834051|FG002|STARTED|Overall Study||8
3109652|NCT01558063|3834052|FG003|STARTED|Overall Study||5
3109653|NCT01558063|3834053|FG004|STARTED|Overall Study||9
3109654|NCT01558063|3834054|FG005|STARTED|Overall Study||5
3109655|NCT01558063|3834049|FG000|COMPLETED|Overall Study||5
3109656|NCT01558063|3834050|FG001|COMPLETED|Overall Study||6
3109657|NCT01558063|3834051|FG002|COMPLETED|Overall Study||8
3109658|NCT01558063|3834052|FG003|COMPLETED|Overall Study||5
3109659|NCT01558063|3834053|FG004|COMPLETED|Overall Study||9
3109660|NCT01558063|3834054|FG005|COMPLETED|Overall Study||5
3109661|NCT01558063|3834049|FG000|NOT COMPLETED|Overall Study||0
3109662|NCT01558063|3834050|FG001|NOT COMPLETED|Overall Study||0
3109663|NCT01558063|3834051|FG002|NOT COMPLETED|Overall Study||0
3109664|NCT01558063|3834052|FG003|NOT COMPLETED|Overall Study||0
3109665|NCT01558063|3834053|FG004|NOT COMPLETED|Overall Study||0
3109666|NCT01558063|3834054|FG005|NOT COMPLETED|Overall Study||0
3109667|NCT01558089|3834063|FG000|STARTED|Overall Study||76
3109668|NCT01558089|3834063|FG000|COMPLETED|Overall Study||63
3109669|NCT01558089|3834063|FG000|NOT COMPLETED|Overall Study||13
3109670|NCT01558128|3834067|FG000|STARTED|Overall Study||1
3109671|NCT01558128|3834067|FG000|COMPLETED|Overall Study||1
3109672|NCT01558128|3834067|FG000|NOT COMPLETED|Overall Study||0
3109673|NCT01558271|3834074|FG000|STARTED|Overall Study||281
3109674|NCT01558271|3834075|FG001|STARTED|Overall Study||70
3109675|NCT01558271|3834076|FG002|STARTED|Overall Study||141
3109676|NCT01558271|3834074|FG000|Received at Least 1 Dose of Study Drug|Overall Study||280
3109677|NCT01558271|3834075|FG001|Received at Least 1 Dose of Study Drug|Overall Study||70
3109678|NCT01558271|3834076|FG002|Received at Least 1 Dose of Study Drug|Overall Study||137
3109679|NCT01558271|3834074|FG000|Completed 26 Weeks|Overall Study||271
3109680|NCT01558271|3834075|FG001|Completed 26 Weeks|Overall Study||63
3109681|NCT01558271|3834076|FG002|Completed 26 Weeks|Overall Study||128
3109682|NCT01558271|3834074|FG000|COMPLETED|Overall Study||263
3109683|NCT01558271|3834075|FG001|COMPLETED|Overall Study||59
3109684|NCT01558271|3834076|FG002|COMPLETED|Overall Study||124
3109685|NCT01558271|3834074|FG000|NOT COMPLETED|Overall Study||18
3109686|NCT01558271|3834075|FG001|NOT COMPLETED|Overall Study||11
3109687|NCT01558271|3834076|FG002|NOT COMPLETED|Overall Study||17
3109688|NCT01558297|3834091|FG000|STARTED|Overall Study||30
3109689|NCT01558297|3834092|FG001|STARTED|Overall Study||29
3109690|NCT01558297|3834093|FG002|STARTED|Overall Study||30
3109691|NCT01558297|3834091|FG000|COMPLETED|Overall Study||28
3109692|NCT01558297|3834092|FG001|COMPLETED|Overall Study||27
3109693|NCT01558297|3834093|FG002|COMPLETED|Overall Study||29
3109694|NCT01558297|3834091|FG000|NOT COMPLETED|Overall Study||2
3109695|NCT01558297|3834092|FG001|NOT COMPLETED|Overall Study||2
3109696|NCT01558297|3834093|FG002|NOT COMPLETED|Overall Study||1
3109697|NCT01558596|3834103|FG000|STARTED|Overall Study||104
3109698|NCT01558596|3834104|FG001|STARTED|Overall Study||101
3109699|NCT01558596|3834103|FG000|COMPLETED|Overall Study||101
3109700|NCT01558596|3834104|FG001|COMPLETED|Overall Study||100
3109701|NCT01558596|3834103|FG000|NOT COMPLETED|Overall Study||3
3109702|NCT01558596|3834104|FG001|NOT COMPLETED|Overall Study||1
3109703|NCT01558635|3834110|FG000|STARTED|Overall Study||17
3109704|NCT01558635|3834110|FG000|Treated|Overall Study||17
3109705|NCT01558635|3834110|FG000|Discharge /1 Month Post-procedure|Overall Study||15
3109706|NCT01558635|3834110|FG000|3 Months Post-procedure|Overall Study||14
3109707|NCT01558635|3834110|FG000|6 Months Post-procedure|Overall Study||14
3109708|NCT01558635|3834110|FG000|COMPLETED|Overall Study||11
3109709|NCT01558635|3834110|FG000|NOT COMPLETED|Overall Study||6
3109710|NCT01558661|3834121|FG000|STARTED|Overall Study||33
3109711|NCT01558661|3834121|FG000|First Stage|Overall Study||18
3109712|NCT01558661|3834121|FG000|Second Stage|Overall Study||15
3109713|NCT01558661|3834121|FG000|COMPLETED|Overall Study||33
3109714|NCT01558661|3834121|FG000|NOT COMPLETED|Overall Study||0
3293664|NCT02872857|4027647|FG002|NOT COMPLETED|Phase 1||0
3293665|NCT02872857|4027648|FG003|NOT COMPLETED|Phase 1||0
3293666|NCT02872857|4027645|FG000|STARTED|Phase 2||0
3293667|NCT02872857|4027646|FG001|STARTED|Phase 2||0
3293668|NCT02872857|4027647|FG002|STARTED|Phase 2||15
3293669|NCT02872857|4027648|FG003|STARTED|Phase 2||15
3293670|NCT02872857|4027645|FG000|COMPLETED|Phase 2||0
3293671|NCT02872857|4027646|FG001|COMPLETED|Phase 2||0
3109715|NCT01558674|3834127|FG000|STARTED|Part 1||11
3109716|NCT01558674|3834128|FG001|STARTED|Part 1||0
3109717|NCT01558674|3834127|FG000|COMPLETED|Part 1||0
3109718|NCT01558674|3834128|FG001|COMPLETED|Part 1||0
3109719|NCT01558674|3834127|FG000|NOT COMPLETED|Part 1||11
3109720|NCT01558674|3834128|FG001|NOT COMPLETED|Part 1||0
3293672|NCT02872857|4027647|FG002|COMPLETED|Phase 2||15
3293673|NCT02872857|4027648|FG003|COMPLETED|Phase 2||15
3109721|NCT01558674|3834127|FG000|STARTED|Part 2||0
3109722|NCT01558674|3834128|FG001|STARTED|Part 2||0
3109723|NCT01558674|3834127|FG000|COMPLETED|Part 2||0
3109724|NCT01558674|3834128|FG001|COMPLETED|Part 2||0
3109725|NCT01558674|3834127|FG000|NOT COMPLETED|Part 2||0
3109726|NCT01558674|3834128|FG001|NOT COMPLETED|Part 2||0
3109727|NCT01558700|3834149|FG000|STARTED|Overall Study||19
3109728|NCT01558700|3834150|FG001|STARTED|Overall Study||21
3109729|NCT01558700|3834149|FG000|COMPLETED|Overall Study||19
3109730|NCT01558700|3834150|FG001|COMPLETED|Overall Study||21
3109731|NCT01558700|3834149|FG000|NOT COMPLETED|Overall Study||0
3109732|NCT01558700|3834150|FG001|NOT COMPLETED|Overall Study||0
3109733|NCT01558739|3834156|FG000|STARTED|Overall Study||48
3109734|NCT01558739|3834156|FG000|COMPLETED|Overall Study||31
3109735|NCT01558739|3834156|FG000|NOT COMPLETED|Overall Study||17
3109736|NCT01558752|3834162|FG000|STARTED|Overall Study||42
3109737|NCT01558752|3834163|FG001|STARTED|Overall Study||46
3109738|NCT01558752|3834162|FG000|COMPLETED|Overall Study||40
3109739|NCT01558752|3834163|FG001|COMPLETED|Overall Study||46
3109740|NCT01558752|3834162|FG000|NOT COMPLETED|Overall Study||2
3109741|NCT01558752|3834163|FG001|NOT COMPLETED|Overall Study||0
3109742|NCT01558791|3834171|FG000|STARTED|Overall Study||607
3109743|NCT01558791|3834172|FG001|STARTED|Overall Study||629
3109744|NCT01558791|3834171|FG000|COMPLETED|Overall Study||607
3109745|NCT01558791|3834172|FG001|COMPLETED|Overall Study||629
3109746|NCT01558791|3834171|FG000|NOT COMPLETED|Overall Study||0
3109747|NCT01558791|3834172|FG001|NOT COMPLETED|Overall Study||0
3109748|NCT01559012|3834182|FG000|STARTED|Overall Study||6
3109749|NCT01559012|3834183|FG001|STARTED|Overall Study|1 more patient added to randomization list to reach the pre-assignment number of treated patients|7
3109750|NCT01559012|3834182|FG000|COMPLETED|Overall Study||6
3109751|NCT01559012|3834183|FG001|COMPLETED|Overall Study|Patient N. 2 withdrew from study for alleged side effects at day 1 of placebo cycle.|6
3109752|NCT01559012|3834182|FG000|NOT COMPLETED|Overall Study||0
3109753|NCT01559012|3834183|FG001|NOT COMPLETED|Overall Study||1
3109754|NCT01559064|3834207|FG000|STARTED|Overall Study||16
3109755|NCT01559064|3834208|FG001|STARTED|Overall Study||40
3109756|NCT01559064|3834209|FG002|STARTED|Overall Study||59
3109757|NCT01559064|3834207|FG000|COMPLETED|Overall Study||15
3109758|NCT01559064|3834208|FG001|COMPLETED|Overall Study||39
3109759|NCT01559064|3834209|FG002|COMPLETED|Overall Study||57
3109760|NCT01559064|3834207|FG000|NOT COMPLETED|Overall Study||1
3109761|NCT01559064|3834208|FG001|NOT COMPLETED|Overall Study||1
3109762|NCT01559064|3834209|FG002|NOT COMPLETED|Overall Study||2
3109763|NCT01559090|3834220|FG000|STARTED|Stage I||6
3109764|NCT01559090|3834221|FG001|STARTED|Stage I||5
3109765|NCT01559090|3834222|FG002|STARTED|Stage I||6
3109766|NCT01559090|3834220|FG000|COMPLETED|Stage I||4
3109767|NCT01559090|3834221|FG001|COMPLETED|Stage I||3
3109768|NCT01559090|3834222|FG002|COMPLETED|Stage I||3
3109769|NCT01559090|3834220|FG000|NOT COMPLETED|Stage I||2
3109770|NCT01559090|3834221|FG001|NOT COMPLETED|Stage I||2
3109771|NCT01559090|3834222|FG002|NOT COMPLETED|Stage I||3
3109772|NCT01559090|3834220|FG000|STARTED|Stage II||4
3109773|NCT01559090|3834221|FG001|STARTED|Stage II||3
3109774|NCT01559090|3834222|FG002|STARTED|Stage II|One subject who completed Stage I did not agree to participate in Stage II|2
3109775|NCT01559090|3834220|FG000|COMPLETED|Stage II||3
3109776|NCT01559090|3834221|FG001|COMPLETED|Stage II||3
3109777|NCT01559090|3834222|FG002|COMPLETED|Stage II||2
3109778|NCT01559090|3834220|FG000|NOT COMPLETED|Stage II||1
3109779|NCT01559090|3834221|FG001|NOT COMPLETED|Stage II||0
3109780|NCT01559090|3834222|FG002|NOT COMPLETED|Stage II||0
3109781|NCT01559116|3834230|FG000|STARTED|Overall Study|Randomised|219
3109782|NCT01559116|3834230|FG000|COMPLETED|Overall Study|Completed all 4 treatment periods|193
3109783|NCT01559116|3834230|FG000|NOT COMPLETED|Overall Study||26
3109784|NCT01559129|3834249|FG000|STARTED|Treatment Phase||12
3109785|NCT01559129|3834250|FG001|STARTED|Treatment Phase||11
3109786|NCT01559129|3834249|FG000|Received Treatment|Treatment Phase||12
3109787|NCT01559129|3834250|FG001|Received Treatment|Treatment Phase||10
3109788|NCT01559129|3834249|FG000|COMPLETED|Treatment Phase||7
3109789|NCT01559129|3834250|FG001|COMPLETED|Treatment Phase||4
3109790|NCT01559129|3834249|FG000|NOT COMPLETED|Treatment Phase||5
3109791|NCT01559129|3834250|FG001|NOT COMPLETED|Treatment Phase||7
3109792|NCT01559129|3834249|FG000|STARTED|Open-label Extension Period|One participant elected not to enter the Extension Phase.|6
3109793|NCT01559129|3834250|FG001|STARTED|Open-label Extension Period|Two participants elected not to enter the Extension Phase.|2
3109794|NCT01559129|3834249|FG000|COMPLETED|Open-label Extension Period||0
3109795|NCT01559129|3834250|FG001|COMPLETED|Open-label Extension Period||0
3109796|NCT01559129|3834249|FG000|NOT COMPLETED|Open-label Extension Period||6
3109797|NCT01559129|3834250|FG001|NOT COMPLETED|Open-label Extension Period||2
3109798|NCT01559259|3834267|FG000|STARTED|Overall Study||30
3109799|NCT01559259|3834268|FG001|STARTED|Overall Study||90
3109800|NCT01559259|3834269|FG002|STARTED|Overall Study||93
3109801|NCT01559259|3834270|FG003|STARTED|Overall Study||89
3109802|NCT01559259|3834271|FG004|STARTED|Overall Study||92
3109803|NCT01559259|3834267|FG000|COMPLETED|Overall Study||30
3109804|NCT01559259|3834268|FG001|COMPLETED|Overall Study||89
3109805|NCT01559259|3834269|FG002|COMPLETED|Overall Study||92
3109806|NCT01559259|3834270|FG003|COMPLETED|Overall Study||88
3109807|NCT01559259|3834271|FG004|COMPLETED|Overall Study||92
3109808|NCT01559259|3834267|FG000|NOT COMPLETED|Overall Study||0
3109809|NCT01559259|3834268|FG001|NOT COMPLETED|Overall Study||1
3109810|NCT01559259|3834269|FG002|NOT COMPLETED|Overall Study||1
3109811|NCT01559259|3834270|FG003|NOT COMPLETED|Overall Study||1
3109812|NCT01559259|3834271|FG004|NOT COMPLETED|Overall Study||0
3109813|NCT01559311|3834286|FG000|STARTED|Overall Study|Enrollment & Baseline|30
3109814|NCT01559311|3834287|FG001|STARTED|Overall Study|Enrollment & Baseline|34
3109815|NCT01559311|3834288|FG002|STARTED|Overall Study|Enrollment & Baseline|34
3109816|NCT01559311|3834286|FG000|Implant|Overall Study||28
3109817|NCT01559311|3834287|FG001|Implant|Overall Study||34
3109818|NCT01559311|3834288|FG002|Implant|Overall Study||32
3109819|NCT01559311|3834286|FG000|1-Month|Overall Study||27
3109820|NCT01559311|3834287|FG001|1-Month|Overall Study||34
3109821|NCT01559311|3834288|FG002|1-Month|Overall Study||29
3109822|NCT01559311|3834286|FG000|3-Month|Overall Study||27
3109823|NCT01559311|3834287|FG001|3-Month|Overall Study||34
3109824|NCT01559311|3834288|FG002|3-Month|Overall Study||29
3109825|NCT01559311|3834286|FG000|6-Month|Overall Study||27
3109826|NCT01559311|3834287|FG001|6-Month|Overall Study||33
3109827|NCT01559311|3834288|FG002|6-Month|Overall Study||28
3109828|NCT01559311|3834286|FG000|COMPLETED|Overall Study|12-Month|27
3109829|NCT01559311|3834287|FG001|COMPLETED|Overall Study|12-Month|28
3109830|NCT01559311|3834288|FG002|COMPLETED|Overall Study|12-Month|26
3109831|NCT01559311|3834286|FG000|NOT COMPLETED|Overall Study||3
3109832|NCT01559311|3834287|FG001|NOT COMPLETED|Overall Study||6
3109833|NCT01559311|3834288|FG002|NOT COMPLETED|Overall Study||8
3109834|NCT01559389|3834298|FG000|STARTED|Overall Study||69
3109835|NCT01559389|3834299|FG001|STARTED|Overall Study||69
3109836|NCT01559389|3834298|FG000|COMPLETED|Overall Study||49
3109837|NCT01559389|3834299|FG001|COMPLETED|Overall Study||49
3109838|NCT01559389|3834298|FG000|NOT COMPLETED|Overall Study||20
3109839|NCT01559389|3834299|FG001|NOT COMPLETED|Overall Study||20
3109840|NCT01559454|3834311|FG000|STARTED|Overall Study||9
3109841|NCT01559454|3834312|FG001|STARTED|Overall Study||10
3109842|NCT01559454|3834311|FG000|COMPLETED|Overall Study||6
3109843|NCT01559454|3834312|FG001|COMPLETED|Overall Study||4
3109844|NCT01559454|3834311|FG000|NOT COMPLETED|Overall Study||3
3109845|NCT01559454|3834312|FG001|NOT COMPLETED|Overall Study||6
3109846|NCT01559506|3834320|FG000|STARTED|Overall Study||20
3109847|NCT01559506|3834321|FG001|STARTED|Overall Study||21
3109848|NCT01559506|3834320|FG000|COMPLETED|Overall Study||20
3109849|NCT01559506|3834321|FG001|COMPLETED|Overall Study||18
3109850|NCT01559506|3834320|FG000|NOT COMPLETED|Overall Study||0
3109851|NCT01559506|3834321|FG001|NOT COMPLETED|Overall Study||3
3109852|NCT01559649|3834329|FG000|STARTED|Overall Study||269
3109853|NCT01559649|3834330|FG001|STARTED|Overall Study|Started with 10 nurses. As an RN dropped out due to scheduling, etc, RN replaced with another RN|15
3109854|NCT01559649|3834329|FG000|COMPLETED|Overall Study|Screening not completed in 11, VFSS not completed in 2, 6 excluded from analysis. N=250 analyzed|250
3109855|NCT01559649|3834330|FG001|COMPLETED|Overall Study||9
3109856|NCT01559649|3834329|FG000|NOT COMPLETED|Overall Study||19
3109857|NCT01559649|3834330|FG001|NOT COMPLETED|Overall Study||6
3109858|NCT01559675|3834339|FG000|STARTED|Overall Study||58
3109859|NCT01559675|3834340|FG001|STARTED|Overall Study||63
3109860|NCT01559675|3834339|FG000|COMPLETED|Overall Study||43
3109861|NCT01559675|3834340|FG001|COMPLETED|Overall Study||49
3109862|NCT01559675|3834339|FG000|NOT COMPLETED|Overall Study||15
3109863|NCT01559675|3834340|FG001|NOT COMPLETED|Overall Study||14
3109864|NCT01559844|3834346|FG000|STARTED|Overall Study||61
3109865|NCT01559844|3834346|FG000|COMPLETED|Overall Study||36
3109866|NCT01559844|3834346|FG000|NOT COMPLETED|Overall Study||25
3109867|NCT01559857|3834352|FG000|STARTED|Overall Study||19
3109868|NCT01559857|3834353|FG001|STARTED|Overall Study||18
3109869|NCT01559857|3834352|FG000|COMPLETED|Overall Study||19
3109870|NCT01559857|3834353|FG001|COMPLETED|Overall Study||18
3109871|NCT01559857|3834352|FG000|NOT COMPLETED|Overall Study||0
3109872|NCT01559857|3834353|FG001|NOT COMPLETED|Overall Study||0
3109873|NCT01559922|3834363|FG000|STARTED|Overall Study||50
3109874|NCT01559922|3834364|FG001|STARTED|Overall Study||97
3109875|NCT01559922|3834363|FG000|COMPLETED|Overall Study||46
3109876|NCT01559922|3834364|FG001|COMPLETED|Overall Study||87
3109877|NCT01559922|3834363|FG000|NOT COMPLETED|Overall Study||4
3109878|NCT01559922|3834364|FG001|NOT COMPLETED|Overall Study||10
3109879|NCT01559935|3834370|FG000|STARTED|Car Phase||72
3109880|NCT01559935|3834370|FG000|COMPLETED|Car Phase||58
3109881|NCT01559935|3834370|FG000|NOT COMPLETED|Car Phase||14
3109882|NCT01559935|3834370|FG000|STARTED|BiRD Phase||58
3109883|NCT01559935|3834370|FG000|COMPLETED|BiRD Phase||54
3109884|NCT01559935|3834370|FG000|NOT COMPLETED|BiRD Phase||4
3109885|NCT01559935|3834370|FG000|STARTED|Maintenance Phase||54
3109886|NCT01559935|3834370|FG000|COMPLETED|Maintenance Phase||0
3109887|NCT01559935|3834370|FG000|NOT COMPLETED|Maintenance Phase||54
3109888|NCT01559948|3834376|FG000|STARTED|Overall Study||15
3109889|NCT01559948|3834377|FG001|STARTED|Overall Study||15
3109890|NCT01559948|3834376|FG000|COMPLETED|Overall Study||15
3109891|NCT01559948|3834377|FG001|COMPLETED|Overall Study||15
3109892|NCT01559948|3834376|FG000|NOT COMPLETED|Overall Study||0
3109893|NCT01559948|3834377|FG001|NOT COMPLETED|Overall Study||0
3109894|NCT01560143|3834387|FG000|STARTED|Overall Study||12
3109895|NCT01560143|3834387|FG000|COMPLETED|Overall Study||12
3109896|NCT01560143|3834387|FG000|NOT COMPLETED|Overall Study||0
3109897|NCT01560234|3834399|FG000|STARTED|Overall Study||16
3109898|NCT01560234|3834400|FG001|STARTED|Overall Study||4
3109899|NCT01560234|3834401|FG002|STARTED|Overall Study||4
3109900|NCT01560234|3834402|FG003|STARTED|Overall Study||3
3109901|NCT01560234|3834403|FG004|STARTED|Overall Study||4
3109902|NCT01560234|3834404|FG005|STARTED|Overall Study||4
3109903|NCT01560234|3834405|FG006|STARTED|Overall Study||4
3109904|NCT01560234|3834406|FG007|STARTED|Overall Study||8
3109905|NCT01560234|3834399|FG000|COMPLETED|Overall Study||13
3109906|NCT01560234|3834400|FG001|COMPLETED|Overall Study||4
3109907|NCT01560234|3834401|FG002|COMPLETED|Overall Study||3
3109908|NCT01560234|3834402|FG003|COMPLETED|Overall Study||3
3109909|NCT01560234|3834403|FG004|COMPLETED|Overall Study||4
3109910|NCT01560234|3834404|FG005|COMPLETED|Overall Study||2
3109911|NCT01560234|3834405|FG006|COMPLETED|Overall Study||4
3109912|NCT01560234|3834406|FG007|COMPLETED|Overall Study||6
3109913|NCT01560234|3834399|FG000|NOT COMPLETED|Overall Study||3
3109914|NCT01560234|3834400|FG001|NOT COMPLETED|Overall Study||0
3109915|NCT01560234|3834401|FG002|NOT COMPLETED|Overall Study||1
3109916|NCT01560234|3834402|FG003|NOT COMPLETED|Overall Study||0
3109917|NCT01560234|3834403|FG004|NOT COMPLETED|Overall Study||0
3109918|NCT01560234|3834404|FG005|NOT COMPLETED|Overall Study||2
3109919|NCT01560234|3834405|FG006|NOT COMPLETED|Overall Study||0
3109920|NCT01560234|3834406|FG007|NOT COMPLETED|Overall Study||2
3109921|NCT01560260|3834424|FG000|STARTED|Overall Study||20
3109922|NCT01560260|3834424|FG000|COMPLETED|Overall Study||20
3109923|NCT01560260|3834424|FG000|NOT COMPLETED|Overall Study||0
3109924|NCT01560286|3834430|FG000|STARTED|Overall Study||24
3109925|NCT01560286|3834430|FG000|COMPLETED|Overall Study||24
3109926|NCT01560286|3834430|FG000|NOT COMPLETED|Overall Study||0
3109927|NCT01560377|3834434|FG000|STARTED|Overall Study||147
3109928|NCT01560377|3834434|FG000|Eligible for Analysis|Overall Study||139
3109929|NCT01560377|3834434|FG000|COMPLETED|Overall Study||147
3109930|NCT01560377|3834434|FG000|NOT COMPLETED|Overall Study||0
3109931|NCT01560403|3834440|FG000|STARTED|Overall Study||5
3109932|NCT01560403|3834441|FG001|STARTED|Overall Study||9
3109933|NCT01560403|3834440|FG000|COMPLETED|Overall Study||5
3109934|NCT01560403|3834441|FG001|COMPLETED|Overall Study||8
3109935|NCT01560403|3834440|FG000|NOT COMPLETED|Overall Study||0
3109936|NCT01560403|3834441|FG001|NOT COMPLETED|Overall Study||1
3109937|NCT01560416|3834449|FG000|STARTED|Randomized Phase||15
3109938|NCT01560416|3834450|FG001|STARTED|Randomized Phase||35
3109939|NCT01560416|3834449|FG000|COMPLETED|Randomized Phase||8
3109940|NCT01560416|3834450|FG001|COMPLETED|Randomized Phase||35
3109941|NCT01560416|3834449|FG000|NOT COMPLETED|Randomized Phase||7
3109942|NCT01560416|3834450|FG001|NOT COMPLETED|Randomized Phase||0
3109943|NCT01560416|3834449|FG000|STARTED|Crossover Phase||7
3109944|NCT01560416|3834450|FG001|STARTED|Crossover Phase||0
3109945|NCT01560416|3834449|FG000|COMPLETED|Crossover Phase||7
3109946|NCT01560416|3834450|FG001|COMPLETED|Crossover Phase||0
3109947|NCT01560416|3834449|FG000|NOT COMPLETED|Crossover Phase||0
3109948|NCT01560416|3834450|FG001|NOT COMPLETED|Crossover Phase||0
3109949|NCT01560429|3834460|FG000|STARTED|Overall Study||26
3109950|NCT01560429|3834461|FG001|STARTED|Overall Study||26
3109951|NCT01560429|3834460|FG000|COMPLETED|Overall Study||23
3109952|NCT01560429|3834461|FG001|COMPLETED|Overall Study||20
3109953|NCT01560429|3834460|FG000|NOT COMPLETED|Overall Study||3
3109954|NCT01560429|3834461|FG001|NOT COMPLETED|Overall Study||6
3109955|NCT01560624|3834471|FG000|STARTED|Overall Study||346
3109956|NCT01560624|3834472|FG001|STARTED|Overall Study||344
3109957|NCT01560624|3834471|FG000|Clinical Worsening Event|Overall Study||91
3109958|NCT01560624|3834472|FG001|Clinical Worsening Event|Overall Study||133
3109959|NCT01560624|3834471|FG000|Early Discontinuation From Treatment|Overall Study||107
3109960|NCT01560624|3834472|FG001|Early Discontinuation From Treatment|Overall Study||56
3109961|NCT01560624|3834471|FG000|COMPLETED|Overall Study||148
3109962|NCT01560624|3834472|FG001|COMPLETED|Overall Study||155
3109963|NCT01560624|3834471|FG000|NOT COMPLETED|Overall Study||198
3109964|NCT01560624|3834472|FG001|NOT COMPLETED|Overall Study||189
3109965|NCT01560780|3834480|FG000|STARTED|Overall Study||42
3109966|NCT01560780|3834481|FG001|STARTED|Overall Study||42
3109967|NCT01560780|3834480|FG000|Clinical Follow-Up at 12 Months|Overall Study||42
3109968|NCT01560780|3834481|FG001|Clinical Follow-Up at 12 Months|Overall Study||42
3109969|NCT01560780|3834480|FG000|Completed Study Drug for 12 Months|Overall Study||27
3109970|NCT01560780|3834481|FG001|Completed Study Drug for 12 Months|Overall Study||27
3109971|NCT01560780|3834480|FG000|COMPLETED|Overall Study||29
3109972|NCT01560780|3834481|FG001|COMPLETED|Overall Study||30
3109973|NCT01560780|3834480|FG000|NOT COMPLETED|Overall Study||13
3109974|NCT01560780|3834481|FG001|NOT COMPLETED|Overall Study||12
3109975|NCT01560819|3834489|FG000|STARTED|Overall Study||10
3109976|NCT01560819|3834490|FG001|STARTED|Overall Study||10
3109977|NCT01560819|3834489|FG000|COMPLETED|Overall Study||9
3109978|NCT01560819|3834490|FG001|COMPLETED|Overall Study||10
3109979|NCT01560819|3834489|FG000|NOT COMPLETED|Overall Study||1
3109980|NCT01560819|3834490|FG001|NOT COMPLETED|Overall Study||0
3109981|NCT01560871|3834496|FG000|STARTED|Overall Study||9
3109982|NCT01560871|3834497|FG001|STARTED|Overall Study||7
3109983|NCT01560871|3834496|FG000|COMPLETED|Overall Study||3
3109984|NCT01560871|3834497|FG001|COMPLETED|Overall Study||5
3109985|NCT01560871|3834496|FG000|NOT COMPLETED|Overall Study||6
3109986|NCT01560871|3834497|FG001|NOT COMPLETED|Overall Study||2
3109987|NCT01560923|3834506|FG000|STARTED|Overall Study||24
3109988|NCT01560923|3834507|FG001|STARTED|Overall Study||22
3109989|NCT01560923|3834506|FG000|COMPLETED|Overall Study||24
3109990|NCT01560923|3834507|FG001|COMPLETED|Overall Study||22
3109991|NCT01560923|3834506|FG000|NOT COMPLETED|Overall Study||0
3109992|NCT01560923|3834507|FG001|NOT COMPLETED|Overall Study||0
3109993|NCT01560949|3834513|FG000|STARTED|Systemic Phase: mFOLFIRINOX||33
3109994|NCT01560949|3834513|FG000|COMPLETED|Systemic Phase: mFOLFIRINOX||27
3109995|NCT01560949|3834513|FG000|NOT COMPLETED|Systemic Phase: mFOLFIRINOX||6
3109996|NCT01560949|3834513|FG000|STARTED|Chemoradiation Phase: With Gemcitabine||23
3109997|NCT01560949|3834513|FG000|COMPLETED|Chemoradiation Phase: With Gemcitabine||23
3109998|NCT01560949|3834513|FG000|NOT COMPLETED|Chemoradiation Phase: With Gemcitabine||0
3109999|NCT01560949|3834513|FG000|STARTED|Surgery Phase||18
3110000|NCT01560949|3834513|FG000|COMPLETED|Surgery Phase||15
3110001|NCT01560949|3834513|FG000|NOT COMPLETED|Surgery Phase||3
3110002|NCT01560975|3834521|FG000|STARTED|Overall Study||10
3110003|NCT01560975|3834521|FG000|COMPLETED|Overall Study||10
3110004|NCT01560975|3834521|FG000|NOT COMPLETED|Overall Study||0
3110005|NCT01560988|3834529|FG000|STARTED|First Intervention (Six Weeks)||32
3110006|NCT01560988|3834530|FG001|STARTED|First Intervention (Six Weeks)||30
3110007|NCT01560988|3834529|FG000|COMPLETED|First Intervention (Six Weeks)||22
3110008|NCT01560988|3834530|FG001|COMPLETED|First Intervention (Six Weeks)||26
3110009|NCT01560988|3834529|FG000|NOT COMPLETED|First Intervention (Six Weeks)||10
3110010|NCT01560988|3834530|FG001|NOT COMPLETED|First Intervention (Six Weeks)||4
3110011|NCT01560988|3834529|FG000|STARTED|Washout (Six Weeks)||22
3110012|NCT01560988|3834530|FG001|STARTED|Washout (Six Weeks)||26
3110013|NCT01560988|3834529|FG000|COMPLETED|Washout (Six Weeks)||20
3110014|NCT01560988|3834530|FG001|COMPLETED|Washout (Six Weeks)||24
3110015|NCT01560988|3834529|FG000|NOT COMPLETED|Washout (Six Weeks)||2
3110016|NCT01560988|3834530|FG001|NOT COMPLETED|Washout (Six Weeks)||2
3110017|NCT01560988|3834529|FG000|STARTED|Second Intervention (Six Weeks)||20
3110018|NCT01560988|3834530|FG001|STARTED|Second Intervention (Six Weeks)||24
3110019|NCT01560988|3834529|FG000|COMPLETED|Second Intervention (Six Weeks)||18
3110020|NCT01560988|3834530|FG001|COMPLETED|Second Intervention (Six Weeks)||22
3110021|NCT01560988|3834529|FG000|NOT COMPLETED|Second Intervention (Six Weeks)||2
3110022|NCT01560988|3834530|FG001|NOT COMPLETED|Second Intervention (Six Weeks)||2
3110023|NCT01561053|3834545|FG000|STARTED|Overall Study||86
3110024|NCT01561053|3834546|FG001|STARTED|Overall Study||92
3110025|NCT01561053|3834547|FG002|STARTED|Overall Study||82
3110026|NCT01561053|3834548|FG003|STARTED|Overall Study||87
3110027|NCT01561053|3834545|FG000|Patients With Baseline MMSE:18-21|Overall Study||47
3110028|NCT01561053|3834546|FG001|Patients With Baseline MMSE:18-21|Overall Study||40
3110029|NCT01561053|3834547|FG002|Patients With Baseline MMSE:18-21|Overall Study||47
3110030|NCT01561053|3834548|FG003|Patients With Baseline MMSE:18-21|Overall Study||42
3110031|NCT01561053|3834545|FG000|Patients With Baseline MMSE:22-26|Overall Study||39
3110032|NCT01561053|3834546|FG001|Patients With Baseline MMSE:22-26|Overall Study||52
3110033|NCT01561053|3834547|FG002|Patients With Baseline MMSE:22-26|Overall Study||35
3110034|NCT01561053|3834548|FG003|Patients With Baseline MMSE:22-26|Overall Study||45
3110035|NCT01561053|3834545|FG000|Randomized Not Treated|Overall Study||8
3110036|NCT01561053|3834546|FG001|Randomized Not Treated|Overall Study||6
3110037|NCT01561053|3834547|FG002|Randomized Not Treated|Overall Study||4
3110038|NCT01561053|3834548|FG003|Randomized Not Treated|Overall Study||7
3110039|NCT01561053|3834545|FG000|Evaluable Subjects|Overall Study||78
3110040|NCT01561053|3834546|FG001|Evaluable Subjects|Overall Study||86
3110041|NCT01561053|3834547|FG002|Evaluable Subjects|Overall Study||78
3110042|NCT01561053|3834548|FG003|Evaluable Subjects|Overall Study||80
3110043|NCT01561053|3834545|FG000|COMPLETED|Overall Study||51
3110044|NCT01561053|3834546|FG001|COMPLETED|Overall Study||56
3110045|NCT01561053|3834547|FG002|COMPLETED|Overall Study||61
3110046|NCT01561053|3834548|FG003|COMPLETED|Overall Study||64
3110047|NCT01561053|3834545|FG000|NOT COMPLETED|Overall Study||35
3110048|NCT01561053|3834546|FG001|NOT COMPLETED|Overall Study||36
3110049|NCT01561053|3834547|FG002|NOT COMPLETED|Overall Study||21
3110050|NCT01561053|3834548|FG003|NOT COMPLETED|Overall Study||23
3110051|NCT01561079|3834559|FG000|STARTED|Overall Study||127
3110052|NCT01561079|3834559|FG000|COMPLETED|Overall Study||49
3110053|NCT01561079|3834559|FG000|NOT COMPLETED|Overall Study||78
3110054|NCT01561300|3834602|FG000|STARTED|Run in on Placebo||15
3110055|NCT01561300|3834603|FG001|STARTED|Run in on Placebo||15
3110056|NCT01561300|3834602|FG000|COMPLETED|Run in on Placebo||14
3110057|NCT01561300|3834603|FG001|COMPLETED|Run in on Placebo||15
3110058|NCT01561300|3834602|FG000|NOT COMPLETED|Run in on Placebo||1
3110059|NCT01561300|3834603|FG001|NOT COMPLETED|Run in on Placebo||0
3110060|NCT01561300|3834602|FG000|STARTED|First Intervention||14
3110061|NCT01561300|3834603|FG001|STARTED|First Intervention||15
3110062|NCT01561300|3834602|FG000|COMPLETED|First Intervention||14
3110063|NCT01561300|3834603|FG001|COMPLETED|First Intervention||15
3110064|NCT01561300|3834602|FG000|NOT COMPLETED|First Intervention||0
3110065|NCT01561300|3834603|FG001|NOT COMPLETED|First Intervention||0
3110066|NCT01561300|3834602|FG000|STARTED|Washout on Placebo||14
3110067|NCT01561300|3834603|FG001|STARTED|Washout on Placebo||15
3110068|NCT01561300|3834602|FG000|COMPLETED|Washout on Placebo||14
3110069|NCT01561300|3834603|FG001|COMPLETED|Washout on Placebo||15
3110070|NCT01561300|3834602|FG000|NOT COMPLETED|Washout on Placebo||0
3110071|NCT01561300|3834603|FG001|NOT COMPLETED|Washout on Placebo||0
3110072|NCT01561300|3834602|FG000|STARTED|Second Intervention||14
3110073|NCT01561300|3834603|FG001|STARTED|Second Intervention||15
3110074|NCT01561300|3834602|FG000|COMPLETED|Second Intervention||14
3110075|NCT01561300|3834603|FG001|COMPLETED|Second Intervention||15
3110076|NCT01561300|3834602|FG000|NOT COMPLETED|Second Intervention||0
3110077|NCT01561300|3834603|FG001|NOT COMPLETED|Second Intervention||0
3110078|NCT01561313|3834612|FG000|STARTED|Overall Study||33
3110079|NCT01561313|3834613|FG001|STARTED|Overall Study||31
3110080|NCT01561313|3834612|FG000|COMPLETED|Overall Study||31
3110081|NCT01561313|3834613|FG001|COMPLETED|Overall Study||31
3110082|NCT01561313|3834612|FG000|NOT COMPLETED|Overall Study||2
3110083|NCT01561313|3834613|FG001|NOT COMPLETED|Overall Study||0
3110084|NCT01561469|3834621|FG000|STARTED|Overall Study||101
3110085|NCT01561469|3834622|FG001|STARTED|Overall Study||87
3110086|NCT01561469|3834621|FG000|COMPLETED|Overall Study||101
3110087|NCT01561469|3834622|FG001|COMPLETED|Overall Study||87
3110088|NCT01561469|3834621|FG000|NOT COMPLETED|Overall Study||0
3110089|NCT01561469|3834622|FG001|NOT COMPLETED|Overall Study||0
3110090|NCT01561560|3834628|FG000|STARTED|First Two Weeks of Wear||60
3110091|NCT01561560|3834629|FG001|STARTED|First Two Weeks of Wear||61
3110092|NCT01561560|3834628|FG000|COMPLETED|First Two Weeks of Wear||60
3110093|NCT01561560|3834629|FG001|COMPLETED|First Two Weeks of Wear||59
3110094|NCT01561560|3834628|FG000|NOT COMPLETED|First Two Weeks of Wear||0
3110095|NCT01561560|3834629|FG001|NOT COMPLETED|First Two Weeks of Wear||2
3110096|NCT01561560|3834628|FG000|STARTED|Second Two Weeks of Wear||60
3110097|NCT01561560|3834629|FG001|STARTED|Second Two Weeks of Wear||59
3110098|NCT01561560|3834628|FG000|COMPLETED|Second Two Weeks of Wear||60
3110099|NCT01561560|3834629|FG001|COMPLETED|Second Two Weeks of Wear||58
3110100|NCT01561560|3834628|FG000|NOT COMPLETED|Second Two Weeks of Wear||0
3110101|NCT01561560|3834629|FG001|NOT COMPLETED|Second Two Weeks of Wear||1
3110102|NCT01561703|3834637|FG000|STARTED|Overall Study||28
3110103|NCT01561703|3834638|FG001|STARTED|Overall Study||30
3110104|NCT01561703|3834637|FG000|COMPLETED|Overall Study||20
3110105|NCT01561703|3834638|FG001|COMPLETED|Overall Study||24
3110106|NCT01561703|3834637|FG000|NOT COMPLETED|Overall Study||8
3110107|NCT01561703|3834638|FG001|NOT COMPLETED|Overall Study||6
3110108|NCT01561716|3834650|FG000|STARTED|Overall Study||5
3110109|NCT01561716|3834651|FG001|STARTED|Overall Study||5
3110110|NCT01561716|3834652|FG002|STARTED|Overall Study||5
3110111|NCT01561716|3834653|FG003|STARTED|Overall Study||5
3110112|NCT01561716|3834654|FG004|STARTED|Overall Study||5
3110113|NCT01561716|3834655|FG005|STARTED|Overall Study||5
3110114|NCT01561716|3834650|FG000|COMPLETED|Overall Study||5
3110115|NCT01561716|3834651|FG001|COMPLETED|Overall Study||5
3110116|NCT01561716|3834652|FG002|COMPLETED|Overall Study||5
3110117|NCT01561716|3834653|FG003|COMPLETED|Overall Study||5
3110118|NCT01561716|3834654|FG004|COMPLETED|Overall Study||5
3110119|NCT01561716|3834655|FG005|COMPLETED|Overall Study||5
3110120|NCT01561716|3834650|FG000|NOT COMPLETED|Overall Study||0
3110121|NCT01561716|3834651|FG001|NOT COMPLETED|Overall Study||0
3110122|NCT01561716|3834652|FG002|NOT COMPLETED|Overall Study||0
3110123|NCT01561716|3834653|FG003|NOT COMPLETED|Overall Study||0
3110124|NCT01561716|3834654|FG004|NOT COMPLETED|Overall Study||0
3110125|NCT01561716|3834655|FG005|NOT COMPLETED|Overall Study||0
3110126|NCT01561755|3834671|FG000|STARTED|Overall Study||6
3110127|NCT01561755|3834672|FG001|STARTED|Overall Study||6
3110128|NCT01561755|3834671|FG000|COMPLETED|Overall Study||6
3110129|NCT01561755|3834672|FG001|COMPLETED|Overall Study||5
3110130|NCT01561755|3834671|FG000|NOT COMPLETED|Overall Study||0
3110131|NCT01561755|3834672|FG001|NOT COMPLETED|Overall Study||1
3110132|NCT01561833|3834678|FG000|STARTED|Overall Study||12
3110133|NCT01561833|3834678|FG000|COMPLETED|Overall Study||12
3110134|NCT01561833|3834678|FG000|NOT COMPLETED|Overall Study||0
3110135|NCT01561898|3834686|FG000|STARTED|Overall Study||7
3110136|NCT01561898|3834687|FG001|STARTED|Overall Study||92
3110137|NCT01561898|3834688|FG002|STARTED|Overall Study||97
3110138|NCT01561898|3834689|FG003|STARTED|Overall Study||32
3110139|NCT01561898|3834686|FG000|COMPLETED|Overall Study||5
3110140|NCT01561898|3834687|FG001|COMPLETED|Overall Study||51
3110141|NCT01561898|3834688|FG002|COMPLETED|Overall Study||53
3110142|NCT01561898|3834689|FG003|COMPLETED|Overall Study||12
3110143|NCT01561898|3834686|FG000|NOT COMPLETED|Overall Study||2
3110144|NCT01561898|3834687|FG001|NOT COMPLETED|Overall Study||41
3110145|NCT01561898|3834688|FG002|NOT COMPLETED|Overall Study||44
3110146|NCT01561898|3834689|FG003|NOT COMPLETED|Overall Study||20
3110147|NCT01561963|3834697|FG000|STARTED|Overall Study||21
3110148|NCT01561963|3834697|FG000|Received Period 1 Treatment|Overall Study||21
3110149|NCT01561963|3834697|FG000|Received Period 2 Treatment|Overall Study||20
3110150|NCT01561963|3834697|FG000|Received Period 3 Treatment|Overall Study||20
3110151|NCT01561963|3834697|FG000|COMPLETED|Overall Study||20
3110152|NCT01561963|3834697|FG000|NOT COMPLETED|Overall Study||1
3110153|NCT01561976|3834712|FG000|STARTED|Period 1||5
3110154|NCT01561976|3834713|FG001|STARTED|Period 1||5
3110155|NCT01561976|3834714|FG002|STARTED|Period 1||5
3110156|NCT01561976|3834715|FG003|STARTED|Period 1||5
3110157|NCT01561976|3834716|FG004|STARTED|Period 1||5
3110158|NCT01561976|3834717|FG005|STARTED|Period 1||5
3110159|NCT01561976|3834712|FG000|COMPLETED|Period 1||5
3110160|NCT01561976|3834713|FG001|COMPLETED|Period 1||5
3110161|NCT01561976|3834714|FG002|COMPLETED|Period 1||4
3110162|NCT01561976|3834715|FG003|COMPLETED|Period 1||5
3110163|NCT01561976|3834716|FG004|COMPLETED|Period 1||5
3110164|NCT01561976|3834717|FG005|COMPLETED|Period 1||5
3110165|NCT01561976|3834712|FG000|NOT COMPLETED|Period 1||0
3110166|NCT01561976|3834713|FG001|NOT COMPLETED|Period 1||0
3110167|NCT01561976|3834714|FG002|NOT COMPLETED|Period 1||1
3110168|NCT01561976|3834715|FG003|NOT COMPLETED|Period 1||0
3110169|NCT01561976|3834716|FG004|NOT COMPLETED|Period 1||0
3110170|NCT01561976|3834717|FG005|NOT COMPLETED|Period 1||0
3110171|NCT01561976|3834712|FG000|STARTED|Washout Period 1 (7 Days)||5
3110172|NCT01561976|3834713|FG001|STARTED|Washout Period 1 (7 Days)||5
3110173|NCT01561976|3834714|FG002|STARTED|Washout Period 1 (7 Days)||4
3110174|NCT01561976|3834715|FG003|STARTED|Washout Period 1 (7 Days)||5
3110175|NCT01561976|3834716|FG004|STARTED|Washout Period 1 (7 Days)||5
3110176|NCT01561976|3834717|FG005|STARTED|Washout Period 1 (7 Days)||5
3110177|NCT01561976|3834712|FG000|COMPLETED|Washout Period 1 (7 Days)||5
3110178|NCT01561976|3834713|FG001|COMPLETED|Washout Period 1 (7 Days)||5
3110179|NCT01561976|3834714|FG002|COMPLETED|Washout Period 1 (7 Days)||4
3110180|NCT01561976|3834715|FG003|COMPLETED|Washout Period 1 (7 Days)||4
3110181|NCT01561976|3834716|FG004|COMPLETED|Washout Period 1 (7 Days)||5
3110182|NCT01561976|3834717|FG005|COMPLETED|Washout Period 1 (7 Days)||4
3110183|NCT01561976|3834712|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0
3110184|NCT01561976|3834713|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0
3110185|NCT01561976|3834714|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||0
3110186|NCT01561976|3834715|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||1
3110187|NCT01561976|3834716|FG004|NOT COMPLETED|Washout Period 1 (7 Days)||0
3110188|NCT01561976|3834717|FG005|NOT COMPLETED|Washout Period 1 (7 Days)||1
3110189|NCT01561976|3834712|FG000|STARTED|Period 2||5
3110190|NCT01561976|3834713|FG001|STARTED|Period 2||5
3110191|NCT01561976|3834714|FG002|STARTED|Period 2||4
3110192|NCT01561976|3834715|FG003|STARTED|Period 2||4
3110193|NCT01561976|3834716|FG004|STARTED|Period 2||5
3110194|NCT01561976|3834717|FG005|STARTED|Period 2||4
3110195|NCT01561976|3834712|FG000|COMPLETED|Period 2||5
3110196|NCT01561976|3834713|FG001|COMPLETED|Period 2||5
3110197|NCT01561976|3834714|FG002|COMPLETED|Period 2||4
3110198|NCT01561976|3834715|FG003|COMPLETED|Period 2||4
3110199|NCT01561976|3834716|FG004|COMPLETED|Period 2||5
3110200|NCT01561976|3834717|FG005|COMPLETED|Period 2||4
3110201|NCT01561976|3834712|FG000|NOT COMPLETED|Period 2||0
3110202|NCT01561976|3834713|FG001|NOT COMPLETED|Period 2||0
3110203|NCT01561976|3834714|FG002|NOT COMPLETED|Period 2||0
3110204|NCT01561976|3834715|FG003|NOT COMPLETED|Period 2||0
3110205|NCT01561976|3834716|FG004|NOT COMPLETED|Period 2||0
3110206|NCT01561976|3834717|FG005|NOT COMPLETED|Period 2||0
3110207|NCT01561976|3834712|FG000|STARTED|Washout Period 2 (7 Days)||5
3110208|NCT01561976|3834713|FG001|STARTED|Washout Period 2 (7 Days)||5
3110209|NCT01561976|3834714|FG002|STARTED|Washout Period 2 (7 Days)||4
3110210|NCT01561976|3834715|FG003|STARTED|Washout Period 2 (7 Days)||4
3110211|NCT01561976|3834716|FG004|STARTED|Washout Period 2 (7 Days)||5
3110212|NCT01561976|3834717|FG005|STARTED|Washout Period 2 (7 Days)||4
3110213|NCT01561976|3834712|FG000|COMPLETED|Washout Period 2 (7 Days)||4
3110214|NCT01561976|3834713|FG001|COMPLETED|Washout Period 2 (7 Days)||5
3110215|NCT01561976|3834714|FG002|COMPLETED|Washout Period 2 (7 Days)||3
3110216|NCT01561976|3834715|FG003|COMPLETED|Washout Period 2 (7 Days)||4
3110217|NCT01561976|3834716|FG004|COMPLETED|Washout Period 2 (7 Days)||5
3110218|NCT01561976|3834717|FG005|COMPLETED|Washout Period 2 (7 Days)||4
3110219|NCT01561976|3834712|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||1
3110220|NCT01561976|3834713|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0
3110221|NCT01561976|3834714|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||1
3110222|NCT01561976|3834715|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||0
3110223|NCT01561976|3834716|FG004|NOT COMPLETED|Washout Period 2 (7 Days)||0
3110224|NCT01561976|3834717|FG005|NOT COMPLETED|Washout Period 2 (7 Days)||0
3110225|NCT01561976|3834712|FG000|STARTED|Period 3||4
3110226|NCT01561976|3834713|FG001|STARTED|Period 3||5
3110227|NCT01561976|3834714|FG002|STARTED|Period 3||3
3110228|NCT01561976|3834715|FG003|STARTED|Period 3||4
3110229|NCT01561976|3834716|FG004|STARTED|Period 3||5
3110230|NCT01561976|3834717|FG005|STARTED|Period 3||4
3110231|NCT01561976|3834712|FG000|COMPLETED|Period 3||4
3110232|NCT01561976|3834713|FG001|COMPLETED|Period 3||5
3110233|NCT01561976|3834714|FG002|COMPLETED|Period 3||3
3110234|NCT01561976|3834715|FG003|COMPLETED|Period 3||4
3110235|NCT01561976|3834716|FG004|COMPLETED|Period 3||5
3110236|NCT01561976|3834717|FG005|COMPLETED|Period 3||4
3110237|NCT01561976|3834712|FG000|NOT COMPLETED|Period 3||0
3110238|NCT01561976|3834713|FG001|NOT COMPLETED|Period 3||0
3110239|NCT01561976|3834714|FG002|NOT COMPLETED|Period 3||0
3110240|NCT01561976|3834715|FG003|NOT COMPLETED|Period 3||0
3110241|NCT01561976|3834716|FG004|NOT COMPLETED|Period 3||0
3110242|NCT01561976|3834717|FG005|NOT COMPLETED|Period 3||0
3110243|NCT01562028|3834727|FG000|STARTED|Overall Study||37
3110244|NCT01562028|3834728|FG001|STARTED|Overall Study||72
3110245|NCT01562028|3834727|FG000|COMPLETED|Overall Study||34
3110246|NCT01562028|3834728|FG001|COMPLETED|Overall Study||70
3110247|NCT01562028|3834727|FG000|NOT COMPLETED|Overall Study||3
3110248|NCT01562028|3834728|FG001|NOT COMPLETED|Overall Study||2
3110249|NCT01562041|3834734|FG000|STARTED|Overall Study||14
3110250|NCT01562041|3834734|FG000|COMPLETED|Overall Study||14
3110251|NCT01562041|3834734|FG000|NOT COMPLETED|Overall Study||0
3110252|NCT01562132|3834740|FG000|STARTED|Overall Study||3
3110253|NCT01562132|3834741|FG001|STARTED|Overall Study||3
3110254|NCT01562132|3834740|FG000|COMPLETED|Overall Study||3
3110255|NCT01562132|3834741|FG001|COMPLETED|Overall Study||3
3110256|NCT01562132|3834740|FG000|NOT COMPLETED|Overall Study||0
3110257|NCT01562132|3834741|FG001|NOT COMPLETED|Overall Study||0
3110258|NCT01562275|3834760|FG000|STARTED|Stage 1||3
3110259|NCT01562275|3834761|FG001|STARTED|Stage 1||7
3110260|NCT01562275|3834762|FG002|STARTED|Stage 1||3
3110261|NCT01562275|3834763|FG003|STARTED|Stage 1||4
3110262|NCT01562275|3834764|FG004|STARTED|Stage 1||4
3110263|NCT01562275|3834765|FG005|STARTED|Stage 1||4
3110264|NCT01562275|3834766|FG006|STARTED|Stage 1||3
3110265|NCT01562275|3834767|FG007|STARTED|Stage 1||7
3110266|NCT01562275|3834768|FG008|STARTED|Stage 1||3
3110267|NCT01562275|3834769|FG009|STARTED|Stage 1||7
3110268|NCT01562275|3834770|FG010|STARTED|Stage 1||3
3110269|NCT01562275|3834771|FG011|STARTED|Stage 1||0
3110270|NCT01562275|3834772|FG012|STARTED|Stage 1||0
3110271|NCT01562275|3834760|FG000|COMPLETED|Stage 1||0
3110272|NCT01562275|3834761|FG001|COMPLETED|Stage 1||0
3110273|NCT01562275|3834762|FG002|COMPLETED|Stage 1||0
3110274|NCT01562275|3834763|FG003|COMPLETED|Stage 1||0
3110275|NCT01562275|3834764|FG004|COMPLETED|Stage 1||0
3110276|NCT01562275|3834765|FG005|COMPLETED|Stage 1||0
3110277|NCT01562275|3834766|FG006|COMPLETED|Stage 1||0
3110278|NCT01562275|3834767|FG007|COMPLETED|Stage 1||0
3110279|NCT01562275|3834768|FG008|COMPLETED|Stage 1||0
3110280|NCT01562275|3834769|FG009|COMPLETED|Stage 1||0
3110281|NCT01562275|3834770|FG010|COMPLETED|Stage 1||0
3110282|NCT01562275|3834771|FG011|COMPLETED|Stage 1||0
3110283|NCT01562275|3834772|FG012|COMPLETED|Stage 1||0
3110284|NCT01562275|3834760|FG000|NOT COMPLETED|Stage 1||3
3110285|NCT01562275|3834761|FG001|NOT COMPLETED|Stage 1||7
3110286|NCT01562275|3834762|FG002|NOT COMPLETED|Stage 1||3
3110287|NCT01562275|3834763|FG003|NOT COMPLETED|Stage 1||4
3110288|NCT01562275|3834764|FG004|NOT COMPLETED|Stage 1||4
3110289|NCT01562275|3834765|FG005|NOT COMPLETED|Stage 1||4
3110290|NCT01562275|3834766|FG006|NOT COMPLETED|Stage 1||3
3110291|NCT01562275|3834767|FG007|NOT COMPLETED|Stage 1||7
3110292|NCT01562275|3834768|FG008|NOT COMPLETED|Stage 1||3
3110293|NCT01562275|3834769|FG009|NOT COMPLETED|Stage 1||7
3110294|NCT01562275|3834770|FG010|NOT COMPLETED|Stage 1||3
3110295|NCT01562275|3834771|FG011|NOT COMPLETED|Stage 1||0
3110296|NCT01562275|3834772|FG012|NOT COMPLETED|Stage 1||0
3110297|NCT01562275|3834760|FG000|STARTED|Stage 2||0
3110298|NCT01562275|3834761|FG001|STARTED|Stage 2||0
3110299|NCT01562275|3834762|FG002|STARTED|Stage 2||0
3110300|NCT01562275|3834763|FG003|STARTED|Stage 2||0
3110301|NCT01562275|3834764|FG004|STARTED|Stage 2||0
3110302|NCT01562275|3834765|FG005|STARTED|Stage 2||0
3110303|NCT01562275|3834766|FG006|STARTED|Stage 2||0
3110304|NCT01562275|3834767|FG007|STARTED|Stage 2||0
3110305|NCT01562275|3834768|FG008|STARTED|Stage 2||0
3110306|NCT01562275|3834769|FG009|STARTED|Stage 2||0
3110307|NCT01562275|3834770|FG010|STARTED|Stage 2||0
3110308|NCT01562275|3834771|FG011|STARTED|Stage 2||14
3110309|NCT01562275|3834772|FG012|STARTED|Stage 2||5
3110310|NCT01562275|3834760|FG000|COMPLETED|Stage 2||0
3110311|NCT01562275|3834761|FG001|COMPLETED|Stage 2||0
3110312|NCT01562275|3834762|FG002|COMPLETED|Stage 2||0
3110313|NCT01562275|3834763|FG003|COMPLETED|Stage 2||0
3110314|NCT01562275|3834764|FG004|COMPLETED|Stage 2||0
3110315|NCT01562275|3834765|FG005|COMPLETED|Stage 2||0
3110316|NCT01562275|3834766|FG006|COMPLETED|Stage 2||0
3110317|NCT01562275|3834767|FG007|COMPLETED|Stage 2||0
3110318|NCT01562275|3834768|FG008|COMPLETED|Stage 2||0
3110319|NCT01562275|3834769|FG009|COMPLETED|Stage 2||0
3110320|NCT01562275|3834770|FG010|COMPLETED|Stage 2||0
3110321|NCT01562275|3834771|FG011|COMPLETED|Stage 2||0
3110322|NCT01562275|3834772|FG012|COMPLETED|Stage 2||0
3110323|NCT01562275|3834760|FG000|NOT COMPLETED|Stage 2||0
3110324|NCT01562275|3834761|FG001|NOT COMPLETED|Stage 2||0
3110325|NCT01562275|3834762|FG002|NOT COMPLETED|Stage 2||0
3110326|NCT01562275|3834763|FG003|NOT COMPLETED|Stage 2||0
3110327|NCT01562275|3834764|FG004|NOT COMPLETED|Stage 2||0
3110328|NCT01562275|3834765|FG005|NOT COMPLETED|Stage 2||0
3110329|NCT01562275|3834766|FG006|NOT COMPLETED|Stage 2||0
3110330|NCT01562275|3834767|FG007|NOT COMPLETED|Stage 2||0
3110331|NCT01562275|3834768|FG008|NOT COMPLETED|Stage 2||0
3110332|NCT01562275|3834769|FG009|NOT COMPLETED|Stage 2||0
3110333|NCT01562275|3834770|FG010|NOT COMPLETED|Stage 2||0
3110334|NCT01562275|3834771|FG011|NOT COMPLETED|Stage 2||14
3110335|NCT01562275|3834772|FG012|NOT COMPLETED|Stage 2||5
3110336|NCT01562314|3834804|FG000|STARTED|Overall Study||29
3110337|NCT01562314|3834805|FG001|STARTED|Overall Study||31
3110338|NCT01562314|3834804|FG000|Received at Least 1 Dose of Study Drug|Overall Study||29
3110339|NCT01562314|3834805|FG001|Received at Least 1 Dose of Study Drug|Overall Study||31
3110340|NCT01562314|3834804|FG000|Intent-to-Treat (ITT) Analysis Set|Overall Study||29
3110341|NCT01562314|3834805|FG001|Intent-to-Treat (ITT) Analysis Set|Overall Study||31
3110342|NCT01562314|3834804|FG000|Per Protocol (PP) Analysis Set|Overall Study||17
3110343|NCT01562314|3834805|FG001|Per Protocol (PP) Analysis Set|Overall Study||27
3110344|NCT01562314|3834804|FG000|COMPLETED|Overall Study||16
3110345|NCT01562314|3834805|FG001|COMPLETED|Overall Study||23
3110346|NCT01562314|3834804|FG000|NOT COMPLETED|Overall Study||13
3110347|NCT01562314|3834805|FG001|NOT COMPLETED|Overall Study||8
3110348|NCT01562327|3834811|FG000|STARTED|Overall Study||50
3110349|NCT01562327|3834811|FG000|COMPLETED|Overall Study||42
3110350|NCT01562327|3834811|FG000|NOT COMPLETED|Overall Study||8
3110351|NCT01562379|3834821|FG000|STARTED|Overall Study||1438
3110352|NCT01562379|3834822|FG001|STARTED|Overall Study||1492
3110353|NCT01562379|3834823|FG002|STARTED|Overall Study||851
3110354|NCT01562379|3834824|FG003|STARTED|Overall Study||843
3110355|NCT01562379|3834825|FG004|STARTED|Overall Study||825
3110356|NCT01562379|3834821|FG000|COMPLETED|Overall Study||1312
3110357|NCT01562379|3834822|FG001|COMPLETED|Overall Study||1395
3110358|NCT01562379|3834823|FG002|COMPLETED|Overall Study||789
3110359|NCT01562379|3834824|FG003|COMPLETED|Overall Study||786
3110360|NCT01562379|3834825|FG004|COMPLETED|Overall Study||785
3110361|NCT01562379|3834821|FG000|NOT COMPLETED|Overall Study||126
3110362|NCT01562379|3834822|FG001|NOT COMPLETED|Overall Study||97
3110363|NCT01562379|3834823|FG002|NOT COMPLETED|Overall Study||62
3110364|NCT01562379|3834824|FG003|NOT COMPLETED|Overall Study||57
3110365|NCT01562379|3834825|FG004|NOT COMPLETED|Overall Study||40
3110366|NCT01562444|3834840|FG000|STARTED|Overall Study||48
3110367|NCT01562444|3834841|FG001|STARTED|Overall Study||51
3110368|NCT01562444|3834842|FG002|STARTED|Overall Study||106
3110369|NCT01562444|3834840|FG000|COMPLETED|Overall Study||43
3110370|NCT01562444|3834841|FG001|COMPLETED|Overall Study||49
3110371|NCT01562444|3834842|FG002|COMPLETED|Overall Study||99
3110372|NCT01562444|3834840|FG000|NOT COMPLETED|Overall Study||5
3110373|NCT01562444|3834841|FG001|NOT COMPLETED|Overall Study||2
3110374|NCT01562444|3834842|FG002|NOT COMPLETED|Overall Study||7
3110375|NCT01562548|3834854|FG000|STARTED|Overall Study||25
3110376|NCT01562548|3834855|FG001|STARTED|Overall Study||15
3110377|NCT01562548|3834856|FG002|STARTED|Overall Study||25
3110378|NCT01562548|3834857|FG003|STARTED|Overall Study||14
3110379|NCT01562548|3834854|FG000|COMPLETED|Overall Study||25
3110380|NCT01562548|3834855|FG001|COMPLETED|Overall Study||15
3110381|NCT01562548|3834856|FG002|COMPLETED|Overall Study||24
3110382|NCT01562548|3834857|FG003|COMPLETED|Overall Study||14
3110383|NCT01562548|3834854|FG000|NOT COMPLETED|Overall Study||0
3110384|NCT01562548|3834855|FG001|NOT COMPLETED|Overall Study||0
3110385|NCT01562548|3834856|FG002|NOT COMPLETED|Overall Study||1
3110386|NCT01562548|3834857|FG003|NOT COMPLETED|Overall Study||0
3135782|NCT01708954|3860854|FG000|COMPLETED|Step 2|Treatment continued until progressive disease or unacceptable toxicity.|0
3135783|NCT01708954|3860855|FG001|COMPLETED|Step 2|Treatment continued until progressive disease or unacceptable toxicity.|0
3135784|NCT01708954|3860856|FG002|COMPLETED|Step 2||0
3135785|NCT01708954|3860854|FG000|NOT COMPLETED|Step 2||13
3135786|NCT01708954|3860855|FG001|NOT COMPLETED|Step 2||7
3135787|NCT01708954|3860856|FG002|NOT COMPLETED|Step 2||0
3135788|NCT01708967|3860867|FG000|STARTED|Overall Study||50
3135789|NCT01708967|3860868|FG001|STARTED|Overall Study||50
3135790|NCT01708967|3860867|FG000|COMPLETED|Overall Study||50
3135791|NCT01708967|3860868|FG001|COMPLETED|Overall Study||43
3135792|NCT01708967|3860867|FG000|NOT COMPLETED|Overall Study||0
3135793|NCT01708967|3860868|FG001|NOT COMPLETED|Overall Study||7
3135794|NCT01709032|3860874|FG000|STARTED|Overall Study||9
3135795|NCT01709032|3860874|FG000|COMPLETED|Overall Study||6
3135796|NCT01709032|3860874|FG000|NOT COMPLETED|Overall Study||3
3135797|NCT01709084|3860881|FG000|STARTED|Overall Study||213
3135798|NCT01709084|3860882|FG001|STARTED|Overall Study||213
3135799|NCT01709084|3860881|FG000|Treated|Overall Study||213
3135800|NCT01709084|3860882|FG001|Treated|Overall Study||211
3135801|NCT01709084|3860881|FG000|COMPLETED|Overall Study||197
3135802|NCT01709084|3860882|FG001|COMPLETED|Overall Study||198
3135803|NCT01709084|3860881|FG000|NOT COMPLETED|Overall Study||16
3135804|NCT01709084|3860882|FG001|NOT COMPLETED|Overall Study||15
3135805|NCT01709110|3860890|FG000|STARTED|Overall Study||683
3135806|NCT01709110|3860891|FG001|STARTED|Overall Study||683
3135807|NCT01709110|3860890|FG000|Received at Least One Dose of Study Drug|Overall Study||680
3135808|NCT01709110|3860891|FG001|Received at Least One Dose of Study Drug|Overall Study||680
3135809|NCT01709110|3860890|FG000|COMPLETED|Overall Study||498
3135810|NCT01709110|3860891|FG001|COMPLETED|Overall Study||515
3135811|NCT01709110|3860890|FG000|NOT COMPLETED|Overall Study||185
3135812|NCT01709110|3860891|FG001|NOT COMPLETED|Overall Study||168
3135813|NCT01709149|3860900|FG000|STARTED|Open-label Lead-in Phase||711
3135814|NCT01709149|3860901|FG001|STARTED|Open-label Lead-in Phase||0
3135815|NCT01709149|3860902|FG002|STARTED|Open-label Lead-in Phase||0
3135816|NCT01709149|3860900|FG000|COMPLETED|Open-label Lead-in Phase||596
3135817|NCT01709149|3860901|FG001|COMPLETED|Open-label Lead-in Phase||0
3135818|NCT01709149|3860902|FG002|COMPLETED|Open-label Lead-in Phase||0
3135819|NCT01709149|3860900|FG000|NOT COMPLETED|Open-label Lead-in Phase||115
3135820|NCT01709149|3860901|FG001|NOT COMPLETED|Open-label Lead-in Phase||0
3135821|NCT01709149|3860902|FG002|NOT COMPLETED|Open-label Lead-in Phase||0
3135822|NCT01709149|3860900|FG000|STARTED|Double-blind, Placebo-controlled Phase||0
3135823|NCT01709149|3860901|FG001|STARTED|Double-blind, Placebo-controlled Phase||295
3135824|NCT01709149|3860902|FG002|STARTED|Double-blind, Placebo-controlled Phase||301
3135825|NCT01709149|3860900|FG000|COMPLETED|Double-blind, Placebo-controlled Phase||0
3135826|NCT01709149|3860901|FG001|COMPLETED|Double-blind, Placebo-controlled Phase||269
3135827|NCT01709149|3860902|FG002|COMPLETED|Double-blind, Placebo-controlled Phase||204
3135828|NCT01709149|3860900|FG000|NOT COMPLETED|Double-blind, Placebo-controlled Phase||0
3135829|NCT01709149|3860901|FG001|NOT COMPLETED|Double-blind, Placebo-controlled Phase||26
3135830|NCT01709149|3860902|FG002|NOT COMPLETED|Double-blind, Placebo-controlled Phase||97
3135831|NCT01709162|3860911|FG000|STARTED|Overall Study|Randomized|18
3135832|NCT01709162|3860912|FG001|STARTED|Overall Study|Randomized|5
3135833|NCT01709162|3860911|FG000|Received Treatment|Overall Study||18
3135834|NCT01709162|3860912|FG001|Received Treatment|Overall Study||4
3135835|NCT01709162|3860911|FG000|Still Receiving Treatment|Overall Study||0
3135836|NCT01709162|3860912|FG001|Still Receiving Treatment|Overall Study||0
3135837|NCT01709162|3860911|FG000|COMPLETED|Overall Study|Completed treatment as per protocol|12
3135838|NCT01709162|3860912|FG001|COMPLETED|Overall Study|Completed treatment as per protocol|0
3135839|NCT01709162|3860911|FG000|NOT COMPLETED|Overall Study||6
3135840|NCT01709162|3860912|FG001|NOT COMPLETED|Overall Study||5
3135841|NCT01709227|3860920|FG000|STARTED|Overall Study||32
3135842|NCT01709227|3860921|FG001|STARTED|Overall Study||41
3135843|NCT01709227|3860920|FG000|COMPLETED|Overall Study||31
3135844|NCT01709227|3860921|FG001|COMPLETED|Overall Study||32
3110387|NCT01562613|3834869|FG000|STARTED|Overall Study||533
3110388|NCT01562613|3834869|FG000|COMPLETED|Overall Study||529
3110389|NCT01562613|3834869|FG000|NOT COMPLETED|Overall Study||4
3110390|NCT01562678|3834875|FG000|STARTED|Overall Study||14
3110391|NCT01562678|3834876|FG001|STARTED|Overall Study||14
3110392|NCT01562678|3834875|FG000|COMPLETED|Overall Study||8
3110393|NCT01562678|3834876|FG001|COMPLETED|Overall Study||12
3110394|NCT01562678|3834875|FG000|NOT COMPLETED|Overall Study||6
3110395|NCT01562678|3834876|FG001|NOT COMPLETED|Overall Study||2
3110396|NCT01562743|3834882|FG000|STARTED|Overall Study||185
3110397|NCT01562743|3834882|FG000|COMPLETED|Overall Study||133
3110398|NCT01562743|3834882|FG000|NOT COMPLETED|Overall Study||52
3110399|NCT01562756|3834886|FG000|STARTED|Overall Study||6
3110400|NCT01562756|3834886|FG000|COMPLETED|Overall Study||6
3110401|NCT01562756|3834886|FG000|NOT COMPLETED|Overall Study||0
3110402|NCT01562782|3834892|FG000|STARTED|Overall Study||19
3110403|NCT01562782|3834893|FG001|STARTED|Overall Study||20
3110404|NCT01562782|3834892|FG000|COMPLETED|Overall Study||15
3110405|NCT01562782|3834893|FG001|COMPLETED|Overall Study||15
3110406|NCT01562782|3834892|FG000|NOT COMPLETED|Overall Study||4
3110407|NCT01562782|3834893|FG001|NOT COMPLETED|Overall Study||5
3110408|NCT01562873|3834899|FG000|STARTED|Overall Study||21
3110409|NCT01562873|3834900|FG001|STARTED|Overall Study|The observed number of objective responses in Cohort A was not sufficient for Cohort B to open.|0
3110410|NCT01562873|3834899|FG000|COMPLETED|Overall Study||0
3110411|NCT01562873|3834900|FG001|COMPLETED|Overall Study||0
3110412|NCT01562873|3834899|FG000|NOT COMPLETED|Overall Study||21
3110413|NCT01562873|3834900|FG001|NOT COMPLETED|Overall Study||0
3110414|NCT01562886|3834904|FG000|STARTED|Overall Study||14
3110415|NCT01562886|3834904|FG000|COMPLETED|Overall Study||13
3110416|NCT01562886|3834904|FG000|NOT COMPLETED|Overall Study||1
3110417|NCT01563003|3834910|FG000|STARTED|Overall Study||16
3110418|NCT01563003|3834911|FG001|STARTED|Overall Study||15
3110419|NCT01563003|3834910|FG000|COMPLETED|Overall Study||16
3110420|NCT01563003|3834911|FG001|COMPLETED|Overall Study||15
3110421|NCT01563003|3834910|FG000|NOT COMPLETED|Overall Study||0
3110422|NCT01563003|3834911|FG001|NOT COMPLETED|Overall Study||0
3110423|NCT01563029|3834922|FG000|STARTED|Overall Study||119
3110424|NCT01563029|3834923|FG001|STARTED|Overall Study||118
3110425|NCT01563029|3834924|FG002|STARTED|Overall Study||120
3110426|NCT01563029|3834925|FG003|STARTED|Overall Study||118
3110427|NCT01563029|3834926|FG004|STARTED|Overall Study||118
3110428|NCT01563029|3834922|FG000|COMPLETED|Overall Study||66
3110429|NCT01563029|3834923|FG001|COMPLETED|Overall Study||94
3110430|NCT01563029|3834924|FG002|COMPLETED|Overall Study||87
3110431|NCT01563029|3834925|FG003|COMPLETED|Overall Study||85
3110432|NCT01563029|3834926|FG004|COMPLETED|Overall Study||89
3110433|NCT01563029|3834922|FG000|NOT COMPLETED|Overall Study||53
3110434|NCT01563029|3834923|FG001|NOT COMPLETED|Overall Study||24
3110435|NCT01563029|3834924|FG002|NOT COMPLETED|Overall Study||33
3110436|NCT01563029|3834925|FG003|NOT COMPLETED|Overall Study||33
3110437|NCT01563029|3834926|FG004|NOT COMPLETED|Overall Study||29
3110438|NCT01563055|3834939|FG000|STARTED|Overall Study||10
3110439|NCT01563055|3834939|FG000|COMPLETED|Overall Study||10
3110440|NCT01563055|3834939|FG000|NOT COMPLETED|Overall Study||0
3110441|NCT01563081|3834948|FG000|STARTED|Overall Study||30
3110442|NCT01563081|3834949|FG001|STARTED|Overall Study||30
3110443|NCT01563081|3834948|FG000|COMPLETED|Overall Study||30
3110444|NCT01563081|3834949|FG001|COMPLETED|Overall Study||30
3110445|NCT01563081|3834948|FG000|NOT COMPLETED|Overall Study||0
3110446|NCT01563081|3834949|FG001|NOT COMPLETED|Overall Study||0
3110447|NCT01563172|3834959|FG000|STARTED|Overall Study||65
3110448|NCT01563172|3834959|FG000|Experimental Dentifrice 0.5g/2 Min|Overall Study||59
3110449|NCT01563172|3834959|FG000|Experimental Dentifrice 0.5g/45 Sec|Overall Study||59
3110450|NCT01563172|3834959|FG000|Experimental Dentifrice 1.5g/ 2min|Overall Study||58
3110451|NCT01563172|3834959|FG000|Experimental Dentifrice 1.5g/ 45 Sec|Overall Study||58
3110452|NCT01563172|3834959|FG000|Control Dentifrice|Overall Study||60
3110453|NCT01563172|3834959|FG000|COMPLETED|Overall Study||52
3110454|NCT01563172|3834959|FG000|NOT COMPLETED|Overall Study||13
3110455|NCT01563185|3834974|FG000|STARTED|Overall Study||12
3110456|NCT01563185|3834974|FG000|COMPLETED|Overall Study||10
3110457|NCT01563185|3834974|FG000|NOT COMPLETED|Overall Study||2
3110458|NCT01563198|3834978|FG000|STARTED|Baseline||49733
3110459|NCT01563198|3834978|FG000|COMPLETED|Baseline||49733
3110460|NCT01563198|3834978|FG000|NOT COMPLETED|Baseline||0
3110461|NCT01563198|3834978|FG000|STARTED|After Training||47979
3110462|NCT01563198|3834978|FG000|COMPLETED|After Training||47979
3110463|NCT01563198|3834978|FG000|NOT COMPLETED|After Training||0
3110464|NCT01563237|3834982|FG000|STARTED|Overall Study||64
3110465|NCT01563237|3834983|FG001|STARTED|Overall Study||5
3110466|NCT01563237|3834982|FG000|COMPLETED|Overall Study||54
3110467|NCT01563237|3834983|FG001|COMPLETED|Overall Study||5
3110468|NCT01563237|3834982|FG000|NOT COMPLETED|Overall Study||10
3110469|NCT01563237|3834983|FG001|NOT COMPLETED|Overall Study||0
3110470|NCT01563354|3834991|FG000|STARTED|Core Phase||41
3110471|NCT01563354|3834992|FG001|STARTED|Core Phase||42
3110472|NCT01563354|3834993|FG002|STARTED|Core Phase||41
3110473|NCT01563354|3834991|FG000|Entered Extension Phase|Core Phase||12
3110474|NCT01563354|3834992|FG001|Entered Extension Phase|Core Phase||14
3110475|NCT01563354|3834993|FG002|Entered Extension Phase|Core Phase||15
3110476|NCT01563354|3834991|FG000|COMPLETED|Core Phase||12
3110477|NCT01563354|3834992|FG001|COMPLETED|Core Phase||14
3110478|NCT01563354|3834993|FG002|COMPLETED|Core Phase||15
3110479|NCT01563354|3834991|FG000|NOT COMPLETED|Core Phase||29
3110480|NCT01563354|3834992|FG001|NOT COMPLETED|Core Phase||28
3110481|NCT01563354|3834993|FG002|NOT COMPLETED|Core Phase||26
3110482|NCT01563354|3834991|FG000|STARTED|Extension Phase|Criteria to enter Extension: continued clinical benefit and no unacceptable toxicity|12
3110483|NCT01563354|3834992|FG001|STARTED|Extension Phase|Criteria to enter Extension: continued clinical benefit and no unacceptable toxicity|14
3110484|NCT01563354|3834993|FG002|STARTED|Extension Phase||15
3110485|NCT01563354|3834991|FG000|COMPLETED|Extension Phase||0
3110486|NCT01563354|3834992|FG001|COMPLETED|Extension Phase||0
3110487|NCT01563354|3834993|FG002|COMPLETED|Extension Phase||0
3110488|NCT01563354|3834991|FG000|NOT COMPLETED|Extension Phase||12
3110489|NCT01563354|3834992|FG001|NOT COMPLETED|Extension Phase||14
3110490|NCT01563354|3834993|FG002|NOT COMPLETED|Extension Phase||15
3110491|NCT01563406|3835005|FG000|STARTED|Overall Study|194 hubs|60
3110492|NCT01563406|3835006|FG001|STARTED|Overall Study|102 hubs|30
3110493|NCT01563406|3835007|FG002|STARTED|Overall Study|101 hubs|30
3110494|NCT01563406|3835008|FG003|STARTED|Overall Study|112 hubs|29
3110495|NCT01563406|3835005|FG000|COMPLETED|Overall Study|194 hubs|60
3110496|NCT01563406|3835006|FG001|COMPLETED|Overall Study|102 hubs|30
3110497|NCT01563406|3835007|FG002|COMPLETED|Overall Study|101 hubs|30
3110498|NCT01563406|3835008|FG003|COMPLETED|Overall Study|112 hubs|29
3110499|NCT01563406|3835005|FG000|NOT COMPLETED|Overall Study||0
3110500|NCT01563406|3835006|FG001|NOT COMPLETED|Overall Study||0
3110501|NCT01563406|3835007|FG002|NOT COMPLETED|Overall Study||0
3110502|NCT01563406|3835008|FG003|NOT COMPLETED|Overall Study||0
3110503|NCT01563536|3835024|FG000|STARTED|Overall Study||6
3110504|NCT01563536|3835025|FG001|STARTED|Overall Study||6
3110505|NCT01563536|3835024|FG000|COMPLETED|Overall Study||5
3110506|NCT01563536|3835025|FG001|COMPLETED|Overall Study||4
3110507|NCT01563536|3835024|FG000|NOT COMPLETED|Overall Study||1
3110508|NCT01563536|3835025|FG001|NOT COMPLETED|Overall Study||2
3110509|NCT01563913|3835033|FG000|STARTED|Overall Study||15
3110510|NCT01563913|3835034|FG001|STARTED|Overall Study||15
3110511|NCT01563913|3835033|FG000|COMPLETED|Overall Study||13
3110512|NCT01563913|3835034|FG001|COMPLETED|Overall Study||15
3110513|NCT01563913|3835033|FG000|NOT COMPLETED|Overall Study||2
3110514|NCT01563913|3835034|FG001|NOT COMPLETED|Overall Study||0
3110515|NCT01563978|3835042|FG000|STARTED|Overall Study|Patients who received treatment.|68
3110516|NCT01563978|3835043|FG001|STARTED|Overall Study|Patients who received treatment.|67
3110517|NCT01563978|3835042|FG000|Randomised But Did Not Receive Treatment|Overall Study||0
3110518|NCT01563978|3835043|FG001|Randomised But Did Not Receive Treatment|Overall Study||0
3110519|NCT01563978|3835042|FG000|COMPLETED|Overall Study||64
3110520|NCT01563978|3835043|FG001|COMPLETED|Overall Study||65
3110521|NCT01563978|3835042|FG000|NOT COMPLETED|Overall Study||4
3110522|NCT01563978|3835043|FG001|NOT COMPLETED|Overall Study||2
3110523|NCT01564277|3835051|FG000|STARTED|Overall Study||12
3110524|NCT01564277|3835052|FG001|STARTED|Overall Study||12
3110525|NCT01564277|3835051|FG000|COMPLETED|Overall Study||11
3110526|NCT01564277|3835052|FG001|COMPLETED|Overall Study||11
3110527|NCT01564277|3835051|FG000|NOT COMPLETED|Overall Study||1
3110528|NCT01564277|3835052|FG001|NOT COMPLETED|Overall Study||1
3110529|NCT01564394|3835060|FG000|STARTED|Overall Study|Prostate cancer survivors n=20, family n=10. Only survivors were randomized.|30
3110530|NCT01564394|3835061|FG001|STARTED|Overall Study|Prostate cancer survivors n=20, family n=10. Only survivors were randomized.|30
3110531|NCT01564394|3835060|FG000|COMPLETED|Overall Study|Prostate cancer survivors n=16, family n=8.|24
3110532|NCT01564394|3835061|FG001|COMPLETED|Overall Study|Prostate cancer survivors n=13, family n=7.|20
3110533|NCT01564394|3835060|FG000|NOT COMPLETED|Overall Study||6
3110534|NCT01564394|3835061|FG001|NOT COMPLETED|Overall Study||10
3110535|NCT01564407|3835072|FG000|STARTED|Overall Study||4
3110536|NCT01564407|3835073|FG001|STARTED|Overall Study||5
3110537|NCT01564407|3835074|FG002|STARTED|Overall Study||4
3110538|NCT01564407|3835075|FG003|STARTED|Overall Study||2
3110539|NCT01564407|3835076|FG004|STARTED|Overall Study||0
3110540|NCT01564407|3835072|FG000|COMPLETED|Overall Study||4
3110541|NCT01564407|3835073|FG001|COMPLETED|Overall Study||3
3110542|NCT01564407|3835074|FG002|COMPLETED|Overall Study||4
3110543|NCT01564407|3835075|FG003|COMPLETED|Overall Study||1
3110544|NCT01564407|3835076|FG004|COMPLETED|Overall Study||0
3110545|NCT01564407|3835072|FG000|NOT COMPLETED|Overall Study||0
3110546|NCT01564407|3835073|FG001|NOT COMPLETED|Overall Study||2
3110547|NCT01564407|3835074|FG002|NOT COMPLETED|Overall Study||0
3110548|NCT01564407|3835075|FG003|NOT COMPLETED|Overall Study||1
3110549|NCT01564407|3835076|FG004|NOT COMPLETED|Overall Study||0
3110550|NCT01564459|3835100|FG000|STARTED|Run-In||12
3110551|NCT01564459|3835101|FG001|STARTED|Run-In|1 participant randomized to placebo arm received MK-6096 10 mg|87
3110552|NCT01564459|3835102|FG002|STARTED|Run-In|1 participant randomized to placebo arm received MK-6096 10 mg|83
3110553|NCT01564459|3835100|FG000|COMPLETED|Run-In||0
3110554|NCT01564459|3835101|FG001|COMPLETED|Run-In||87
3110555|NCT01564459|3835102|FG002|COMPLETED|Run-In||83
3110556|NCT01564459|3835100|FG000|NOT COMPLETED|Run-In||12
3110557|NCT01564459|3835101|FG001|NOT COMPLETED|Run-In||0
3110558|NCT01564459|3835102|FG002|NOT COMPLETED|Run-In||0
3110559|NCT01564459|3835100|FG000|STARTED|Double-blind Treatment||0
3110560|NCT01564459|3835101|FG001|STARTED|Double-blind Treatment|1 participant randomized to placebo arm received MK-6096 10 mg|87
3110561|NCT01564459|3835102|FG002|STARTED|Double-blind Treatment|1 participant randomized to placebo arm received MK-6096 10 mg|83
3163215|NCT01884350|3890694|FG002|STARTED|Primary Efficacy Analysis Set (48 Weeks)|After 24 weeks participants were randomized to continue AEP or stop AEP and revert to SOC.|261
3163216|NCT01884350|3890692|FG000|Safety Analysis Set|Primary Efficacy Analysis Set (48 Weeks)||604
3163217|NCT01884350|3890693|FG001|Safety Analysis Set|Primary Efficacy Analysis Set (48 Weeks)||308
3293674|NCT02872857|4027645|FG000|NOT COMPLETED|Phase 2||0
3293675|NCT02872857|4027646|FG001|NOT COMPLETED|Phase 2||0
3293676|NCT02872857|4027647|FG002|NOT COMPLETED|Phase 2||0
3293677|NCT02872857|4027648|FG003|NOT COMPLETED|Phase 2||0
3293678|NCT02872909|4027656|FG000|STARTED|Overall Study||32
3293679|NCT02872909|4027657|FG001|STARTED|Overall Study||18
3293680|NCT02872909|4027656|FG000|COMPLETED|Overall Study||32
3293681|NCT02872909|4027657|FG001|COMPLETED|Overall Study||18
3293682|NCT02872909|4027656|FG000|NOT COMPLETED|Overall Study||0
3293683|NCT02872909|4027657|FG001|NOT COMPLETED|Overall Study||0
3293684|NCT02872935|4027665|FG000|STARTED|Overall Study||11
3293685|NCT02872935|4027666|FG001|STARTED|Overall Study||11
3293686|NCT02872935|4027665|FG000|COMPLETED|Overall Study||11
3293687|NCT02872935|4027666|FG001|COMPLETED|Overall Study|One subject consented but did no proceed with the study.|10
3293688|NCT02872935|4027665|FG000|NOT COMPLETED|Overall Study||0
3293689|NCT02872935|4027666|FG001|NOT COMPLETED|Overall Study||1
3293690|NCT02873104|4027674|FG000|STARTED|Overall Study||47
3293691|NCT02873104|4027675|FG001|STARTED|Overall Study||23
3110562|NCT01564459|3835100|FG000|COMPLETED|Double-blind Treatment||0
3110563|NCT01564459|3835101|FG001|COMPLETED|Double-blind Treatment||87
3110564|NCT01564459|3835102|FG002|COMPLETED|Double-blind Treatment||82
3110565|NCT01564459|3835100|FG000|NOT COMPLETED|Double-blind Treatment||0
3110566|NCT01564459|3835101|FG001|NOT COMPLETED|Double-blind Treatment||0
3110567|NCT01564459|3835102|FG002|NOT COMPLETED|Double-blind Treatment||1
3110568|NCT01564485|3835115|FG000|STARTED|Overall Study||92
3110569|NCT01564485|3835116|FG001|STARTED|Overall Study||101
3110570|NCT01564485|3835115|FG000|COMPLETED|Overall Study||84
3110571|NCT01564485|3835116|FG001|COMPLETED|Overall Study||78
3110572|NCT01564485|3835115|FG000|NOT COMPLETED|Overall Study||8
3110573|NCT01564485|3835116|FG001|NOT COMPLETED|Overall Study||23
3110574|NCT01564628|3835122|FG000|STARTED|Overall Study||185
3110575|NCT01564628|3835123|FG001|STARTED|Overall Study||58
3110576|NCT01564628|3835124|FG002|STARTED|Overall Study||63
3110577|NCT01564628|3835122|FG000|COMPLETED|Overall Study||181
3110578|NCT01564628|3835123|FG001|COMPLETED|Overall Study||56
3110579|NCT01564628|3835124|FG002|COMPLETED|Overall Study||61
3110580|NCT01564628|3835122|FG000|NOT COMPLETED|Overall Study||4
3110581|NCT01564628|3835123|FG001|NOT COMPLETED|Overall Study||2
3110582|NCT01564628|3835124|FG002|NOT COMPLETED|Overall Study||2
3110583|NCT01564654|3835128|FG000|STARTED|Overall Study|106 knees (bilateral)|89
3110584|NCT01564654|3835128|FG000|COMPLETED|Overall Study|106 knees (bilateral)|89
3110585|NCT01564654|3835128|FG000|NOT COMPLETED|Overall Study||0
3110586|NCT01564693|3835135|FG000|STARTED|Overall Study|Originally we planned to study 4 patients. We expanded to 9 to improve consistency of the results.|9
3110587|NCT01564693|3835136|FG001|STARTED|Overall Study||4
3110588|NCT01564693|3835137|FG002|STARTED|Overall Study|Only 2 patients were found necessary to give statistical relevance to the patients' results.|2
3110589|NCT01564693|3835135|FG000|COMPLETED|Overall Study||9
3110590|NCT01564693|3835136|FG001|COMPLETED|Overall Study||4
3110591|NCT01564693|3835137|FG002|COMPLETED|Overall Study||2
3110592|NCT01564693|3835135|FG000|NOT COMPLETED|Overall Study||0
3110593|NCT01564693|3835136|FG001|NOT COMPLETED|Overall Study||0
3110594|NCT01564693|3835137|FG002|NOT COMPLETED|Overall Study||0
3110595|NCT01564706|3835145|FG000|STARTED|Overall Study||9
3110596|NCT01564706|3835145|FG000|COMPLETED|Overall Study||9
3110597|NCT01564706|3835145|FG000|NOT COMPLETED|Overall Study||0
3110598|NCT01564758|3835149|FG000|STARTED|Overall Study||99
3110599|NCT01564758|3835149|FG000|COMPLETED|Overall Study||85
3110600|NCT01564758|3835149|FG000|NOT COMPLETED|Overall Study||14
3110601|NCT01564784|3835155|FG000|STARTED|Overall Study|Treated (164 randomized)|164
3110602|NCT01564784|3835156|FG001|STARTED|Overall Study|Treated (162 randomized)|143
3110603|NCT01564784|3835155|FG000|COMPLETED|Overall Study||30
3110604|NCT01564784|3835156|FG001|COMPLETED|Overall Study||10
3110605|NCT01564784|3835155|FG000|NOT COMPLETED|Overall Study||134
3110606|NCT01564784|3835156|FG001|NOT COMPLETED|Overall Study||133
3110607|NCT01564862|3835165|FG000|STARTED|Overall Study||198
3110608|NCT01564862|3835166|FG001|STARTED|Overall Study||210
3110609|NCT01564862|3835167|FG002|STARTED|Overall Study||194
3110610|NCT01564862|3835165|FG000|Received Treatment|Overall Study||196
3293692|NCT02873104|4027674|FG000|COMPLETED|Overall Study||46
3110611|NCT01564862|3835166|FG001|Received Treatment|Overall Study||207
3110612|NCT01564862|3835167|FG002|Received Treatment|Overall Study||191
3110613|NCT01564862|3835165|FG000|COMPLETED|Overall Study||168
3110614|NCT01564862|3835166|FG001|COMPLETED|Overall Study||176
3110615|NCT01564862|3835167|FG002|COMPLETED|Overall Study||164
3110616|NCT01564862|3835165|FG000|NOT COMPLETED|Overall Study||30
3110617|NCT01564862|3835166|FG001|NOT COMPLETED|Overall Study||34
3110618|NCT01564862|3835167|FG002|NOT COMPLETED|Overall Study||30
3110619|NCT01564914|3835177|FG000|STARTED|Overall Study||16
3110620|NCT01564914|3835178|FG001|STARTED|Overall Study||6
3110621|NCT01564914|3835177|FG000|COMPLETED|Overall Study||16
3110622|NCT01564914|3835178|FG001|COMPLETED|Overall Study||6
3110623|NCT01564914|3835177|FG000|NOT COMPLETED|Overall Study||0
3110624|NCT01564914|3835178|FG001|NOT COMPLETED|Overall Study||0
3110625|NCT01564953|3835187|FG000|STARTED|Overall Study||143
3293693|NCT02873104|4027675|FG001|COMPLETED|Overall Study||23
3110626|NCT01564953|3835187|FG000|COMPLETED|Overall Study||143
3110627|NCT01564953|3835187|FG000|NOT COMPLETED|Overall Study||0
3110628|NCT01565083|3835197|FG000|STARTED|Overall Study||106
3110629|NCT01565083|3835198|FG001|STARTED|Overall Study||107
3110630|NCT01565083|3835197|FG000|COMPLETED|Overall Study||73
3110631|NCT01565083|3835198|FG001|COMPLETED|Overall Study||68
3110632|NCT01565083|3835197|FG000|NOT COMPLETED|Overall Study||33
3110633|NCT01565083|3835198|FG001|NOT COMPLETED|Overall Study||39
3110634|NCT01565148|3835208|FG000|STARTED|Overall Study||47
3110635|NCT01565148|3835209|FG001|STARTED|Overall Study||46
3110636|NCT01565148|3835210|FG002|STARTED|Overall Study||47
3110637|NCT01565148|3835211|FG003|STARTED|Overall Study||45
3110638|NCT01565148|3835208|FG000|COMPLETED|Overall Study||32
3110639|NCT01565148|3835209|FG001|COMPLETED|Overall Study||31
3110640|NCT01565148|3835210|FG002|COMPLETED|Overall Study||40
3110641|NCT01565148|3835211|FG003|COMPLETED|Overall Study||32
3110642|NCT01565148|3835208|FG000|NOT COMPLETED|Overall Study||15
3110643|NCT01565148|3835209|FG001|NOT COMPLETED|Overall Study||15
3110644|NCT01565148|3835210|FG002|NOT COMPLETED|Overall Study||7
3110645|NCT01565148|3835211|FG003|NOT COMPLETED|Overall Study||13
3110646|NCT01565291|3835227|FG000|STARTED|Overall Study||16
3110647|NCT01565291|3835228|FG001|STARTED|Overall Study||16
3110648|NCT01565291|3835227|FG000|COMPLETED|Overall Study||15
3110649|NCT01565291|3835228|FG001|COMPLETED|Overall Study||16
3110650|NCT01565291|3835227|FG000|NOT COMPLETED|Overall Study||1
3110651|NCT01565291|3835228|FG001|NOT COMPLETED|Overall Study||0
3110652|NCT01565330|3835238|FG000|STARTED|Overall Study||5
3110653|NCT01565330|3835239|FG001|STARTED|Overall Study||4
3110654|NCT01565330|3835240|FG002|STARTED|Overall Study||4
3110655|NCT01565330|3835241|FG003|STARTED|Overall Study||7
3110656|NCT01565330|3835238|FG000|COMPLETED|Overall Study||5
3110657|NCT01565330|3835239|FG001|COMPLETED|Overall Study||4
3110658|NCT01565330|3835240|FG002|COMPLETED|Overall Study||4
3110659|NCT01565330|3835241|FG003|COMPLETED|Overall Study||7
3110660|NCT01565330|3835238|FG000|NOT COMPLETED|Overall Study||0
3110661|NCT01565330|3835239|FG001|NOT COMPLETED|Overall Study||0
3110662|NCT01565330|3835240|FG002|NOT COMPLETED|Overall Study||0
3110663|NCT01565330|3835241|FG003|NOT COMPLETED|Overall Study||0
3110664|NCT01565343|3835255|FG000|STARTED|Overall Study||11
3110665|NCT01565343|3835256|FG001|STARTED|Overall Study||4
3110666|NCT01565343|3835257|FG002|STARTED|Overall Study||10
3110667|NCT01565343|3835255|FG000|COMPLETED|Overall Study||10
3110668|NCT01565343|3835256|FG001|COMPLETED|Overall Study||4
3110669|NCT01565343|3835257|FG002|COMPLETED|Overall Study||10
3110670|NCT01565343|3835255|FG000|NOT COMPLETED|Overall Study||1
3110671|NCT01565343|3835256|FG001|NOT COMPLETED|Overall Study||0
3110672|NCT01565343|3835257|FG002|NOT COMPLETED|Overall Study||0
3110673|NCT01565356|3835264|FG000|STARTED|Overall Study||41
3110674|NCT01565356|3835264|FG000|COMPLETED|Overall Study||41
3110675|NCT01565356|3835264|FG000|NOT COMPLETED|Overall Study||0
3110676|NCT01565369|3835268|FG000|STARTED|Overall Study||35
3110677|NCT01565369|3835268|FG000|COMPLETED|Overall Study||35
3110678|NCT01565369|3835268|FG000|NOT COMPLETED|Overall Study||0
3110679|NCT01565382|3835273|FG000|STARTED|Overall Study||40
3110680|NCT01565382|3835274|FG001|STARTED|Overall Study||7
3110681|NCT01565382|3835273|FG000|COMPLETED|Overall Study||40
3110682|NCT01565382|3835274|FG001|COMPLETED|Overall Study||7
3110683|NCT01565382|3835273|FG000|NOT COMPLETED|Overall Study||0
3110684|NCT01565382|3835274|FG001|NOT COMPLETED|Overall Study||0
3110685|NCT01565499|3835279|FG000|STARTED|Overall Study||83
3110686|NCT01565499|3835279|FG000|COMPLETED|Overall Study||75
3110687|NCT01565499|3835279|FG000|NOT COMPLETED|Overall Study||8
3110688|NCT01565538|3835285|FG000|STARTED|Overall Study||61
3110689|NCT01565538|3835286|FG001|STARTED|Overall Study||62
3110690|NCT01565538|3835285|FG000|COMPLETED|Overall Study||61
3110691|NCT01565538|3835286|FG001|COMPLETED|Overall Study||62
3110692|NCT01565538|3835285|FG000|NOT COMPLETED|Overall Study||0
3110693|NCT01565538|3835286|FG001|NOT COMPLETED|Overall Study||0
3110694|NCT01565551|3835294|FG000|STARTED|Overall Study||586
3110695|NCT01565551|3835295|FG001|STARTED|Overall Study||51
3110696|NCT01565551|3835294|FG000|Clinical/Demographics|Overall Study||586
3110697|NCT01565551|3835295|FG001|Clinical/Demographics|Overall Study||51
3110698|NCT01565551|3835294|FG000|Biospecimens/Biomarkers|Overall Study||479
3110699|NCT01565551|3835295|FG001|Biospecimens/Biomarkers|Overall Study||22
3110700|NCT01565551|3835294|FG000|Neuroimaging|Overall Study||233
3110701|NCT01565551|3835295|FG001|Neuroimaging|Overall Study||25
3110702|NCT01565551|3835294|FG000|6-Month Outcomes|Overall Study||412
3110703|NCT01565551|3835295|FG001|6-Month Outcomes|Overall Study||30
3110704|NCT01565551|3835294|FG000|COMPLETED|Overall Study||586
3110705|NCT01565551|3835295|FG001|COMPLETED|Overall Study||51
3110706|NCT01565551|3835294|FG000|NOT COMPLETED|Overall Study||0
3110707|NCT01565551|3835295|FG001|NOT COMPLETED|Overall Study||0
3110708|NCT01565564|3835303|FG000|STARTED|Overall Study||344
3110709|NCT01565564|3835304|FG001|STARTED|Overall Study||362
3110710|NCT01565564|3835303|FG000|COMPLETED|Overall Study||339
3110711|NCT01565564|3835304|FG001|COMPLETED|Overall Study||361
3110712|NCT01565564|3835303|FG000|NOT COMPLETED|Overall Study||5
3110713|NCT01565564|3835304|FG001|NOT COMPLETED|Overall Study||1
3110714|NCT01565616|3835310|FG000|STARTED|Overall Study||22
3110715|NCT01565616|3835310|FG000|First Component: 5 Related Donors|Overall Study||5
3110716|NCT01565616|3835310|FG000|Second Component: Related or Unrelated|Overall Study||17
3110717|NCT01565616|3835310|FG000|COMPLETED|Overall Study||22
3110718|NCT01565616|3835310|FG000|NOT COMPLETED|Overall Study||0
3110719|NCT01565642|3835316|FG000|STARTED|Overall Study||151
3110720|NCT01565642|3835317|FG001|STARTED|Overall Study||151
3110721|NCT01565642|3835316|FG000|COMPLETED|Overall Study||149
3110722|NCT01565642|3835317|FG001|COMPLETED|Overall Study||150
3110723|NCT01565642|3835316|FG000|NOT COMPLETED|Overall Study||2
3110724|NCT01565642|3835317|FG001|NOT COMPLETED|Overall Study||1
3110725|NCT01565668|3835325|FG000|STARTED|Overall Study||38
3110726|NCT01565668|3835326|FG001|STARTED|Overall Study||38
3110727|NCT01565668|3835325|FG000|Completed Treatment Per Protocol|Overall Study||0
3110728|NCT01565668|3835326|FG001|Completed Treatment Per Protocol|Overall Study||0
3110729|NCT01565668|3835325|FG000|Started 30-day Follow-up|Overall Study||37
3110730|NCT01565668|3835326|FG001|Started 30-day Follow-up|Overall Study||37
3110731|NCT01565668|3835325|FG000|Completed 30-day Follow-up|Overall Study||11
3110732|NCT01565668|3835326|FG001|Completed 30-day Follow-up|Overall Study||5
3110733|NCT01565668|3835325|FG000|Started Long-term Follow-up|Overall Study||36
3110734|NCT01565668|3835326|FG001|Started Long-term Follow-up|Overall Study||33
3110735|NCT01565668|3835325|FG000|Completed Long-term Follow-up|Overall Study||0
3110736|NCT01565668|3835326|FG001|Completed Long-term Follow-up|Overall Study||0
3110737|NCT01565668|3835325|FG000|COMPLETED|Overall Study||0
3110738|NCT01565668|3835326|FG001|COMPLETED|Overall Study||0
3110739|NCT01565668|3835325|FG000|NOT COMPLETED|Overall Study||38
3110740|NCT01565668|3835326|FG001|NOT COMPLETED|Overall Study||38
3110741|NCT01565694|3835332|FG000|STARTED|Dose-Titration Period||76
3110742|NCT01565694|3835332|FG000|COMPLETED|Dose-Titration Period||62
3110743|NCT01565694|3835332|FG000|NOT COMPLETED|Dose-Titration Period||14
3110744|NCT01565694|3835332|FG000|STARTED|Fixed-Dose Assessment Period||62
3110745|NCT01565694|3835332|FG000|COMPLETED|Fixed-Dose Assessment Period||58
3110746|NCT01565694|3835332|FG000|NOT COMPLETED|Fixed-Dose Assessment Period||4
3110747|NCT01565707|3835340|FG000|STARTED|Overall Study||75
3110748|NCT01565707|3835341|FG001|STARTED|Overall Study||73
3110749|NCT01565707|3835342|FG002|STARTED|Overall Study||19
3110750|NCT01565707|3835343|FG003|STARTED|Overall Study||22
3110751|NCT01565707|3835340|FG000|Treated|Overall Study||73
3110752|NCT01565707|3835341|FG001|Treated|Overall Study||73
3110753|NCT01565707|3835342|FG002|Treated|Overall Study||19
3110754|NCT01565707|3835343|FG003|Treated|Overall Study||22
3110755|NCT01565707|3835340|FG000|COMPLETED|Overall Study||66
3110756|NCT01565707|3835341|FG001|COMPLETED|Overall Study||65
3110757|NCT01565707|3835342|FG002|COMPLETED|Overall Study||16
3110758|NCT01565707|3835343|FG003|COMPLETED|Overall Study||17
3110759|NCT01565707|3835340|FG000|NOT COMPLETED|Overall Study||9
3110760|NCT01565707|3835341|FG001|NOT COMPLETED|Overall Study||8
3110761|NCT01565707|3835342|FG002|NOT COMPLETED|Overall Study||3
3110762|NCT01565707|3835343|FG003|NOT COMPLETED|Overall Study||5
3110763|NCT01565850|3835362|FG000|STARTED|Overall Study||103
3110764|NCT01565850|3835363|FG001|STARTED|Overall Study||50
3110765|NCT01565850|3835362|FG000|COMPLETED|Overall Study||83
3110766|NCT01565850|3835363|FG001|COMPLETED|Overall Study||42
3110767|NCT01565850|3835362|FG000|NOT COMPLETED|Overall Study||20
3110768|NCT01565850|3835363|FG001|NOT COMPLETED|Overall Study||8
3110769|NCT01565889|3835375|FG000|STARTED|Part A||12
3110770|NCT01565889|3835376|FG001|STARTED|Part A||4
3110771|NCT01565889|3835377|FG002|STARTED|Part A||8
3110772|NCT01565889|3835378|FG003|STARTED|Part A||7
3110773|NCT01565889|3835379|FG004|STARTED|Part A||7
3110774|NCT01565889|3835380|FG005|STARTED|Part A||0
3110775|NCT01565889|3835375|FG000|COMPLETED|Part A|3 participants from this group continued in the Part B: SOF+PEG+RBV group.|11
3110776|NCT01565889|3835376|FG001|COMPLETED|Part A|No participants from this group continued in the Part B: SOF+PEG+RBV group.|4
3110777|NCT01565889|3835377|FG002|COMPLETED|Part A|3 participants from this group continued in the Part B: SOF+PEG+RBV group.|8
3110778|NCT01565889|3835378|FG003|COMPLETED|Part A|2 participants from this group continued in the Part B: SOF+PEG+RBV group.|7
3110779|NCT01565889|3835379|FG004|COMPLETED|Part A|1 participant from this group continued in the Part B: SOF+PEG+RBV group.|7
3110780|NCT01565889|3835380|FG005|COMPLETED|Part A||0
3110781|NCT01565889|3835375|FG000|NOT COMPLETED|Part A||1
3110782|NCT01565889|3835376|FG001|NOT COMPLETED|Part A||0
3110783|NCT01565889|3835377|FG002|NOT COMPLETED|Part A||0
3110784|NCT01565889|3835378|FG003|NOT COMPLETED|Part A||0
3110785|NCT01565889|3835379|FG004|NOT COMPLETED|Part A||0
3110786|NCT01565889|3835380|FG005|NOT COMPLETED|Part A||0
3110787|NCT01565889|3835375|FG000|STARTED|Part B||0
3110788|NCT01565889|3835376|FG001|STARTED|Part B||0
3110789|NCT01565889|3835377|FG002|STARTED|Part B||0
3110790|NCT01565889|3835378|FG003|STARTED|Part B||0
3110791|NCT01565889|3835379|FG004|STARTED|Part B||0
3110792|NCT01565889|3835380|FG005|STARTED|Part B|9 participants in this group transferred from a Part A cohort, and 14 participants joined the study.|23
3110793|NCT01565889|3835375|FG000|COMPLETED|Part B||0
3110794|NCT01565889|3835376|FG001|COMPLETED|Part B||0
3110795|NCT01565889|3835377|FG002|COMPLETED|Part B||0
3110796|NCT01565889|3835378|FG003|COMPLETED|Part B||0
3110797|NCT01565889|3835379|FG004|COMPLETED|Part B||0
3110798|NCT01565889|3835380|FG005|COMPLETED|Part B||19
3110799|NCT01565889|3835375|FG000|NOT COMPLETED|Part B||0
3110800|NCT01565889|3835376|FG001|NOT COMPLETED|Part B||0
3110801|NCT01565889|3835377|FG002|NOT COMPLETED|Part B||0
3110802|NCT01565889|3835378|FG003|NOT COMPLETED|Part B||0
3110803|NCT01565889|3835379|FG004|NOT COMPLETED|Part B||0
3110804|NCT01565889|3835380|FG005|NOT COMPLETED|Part B||4
3110805|NCT01565902|3835399|FG000|STARTED|Overall Study||8
3110806|NCT01565902|3835400|FG001|STARTED|Overall Study||8
3110807|NCT01565902|3835401|FG002|STARTED|Overall Study||8
3110808|NCT01565902|3835402|FG003|STARTED|Overall Study||16
3110809|NCT01565902|3835399|FG000|COMPLETED|Overall Study||8
3110810|NCT01565902|3835400|FG001|COMPLETED|Overall Study||8
3110811|NCT01565902|3835401|FG002|COMPLETED|Overall Study||8
3110812|NCT01565902|3835402|FG003|COMPLETED|Overall Study||16
3110813|NCT01565902|3835399|FG000|NOT COMPLETED|Overall Study||0
3110814|NCT01565902|3835400|FG001|NOT COMPLETED|Overall Study||0
3110815|NCT01565902|3835401|FG002|NOT COMPLETED|Overall Study||0
3110816|NCT01565902|3835402|FG003|NOT COMPLETED|Overall Study||0
3110817|NCT01565928|3835415|FG000|STARTED|Overall Study||22
3110818|NCT01565928|3835415|FG000|COMPLETED|Overall Study||0
3110819|NCT01565928|3835415|FG000|NOT COMPLETED|Overall Study||22
3110820|NCT01565941|3835424|FG000|STARTED|Overall Study||360
3110821|NCT01565941|3835425|FG001|STARTED|Overall Study||353
3110822|NCT01565941|3835424|FG000|COMPLETED|Overall Study||349
3110823|NCT01565941|3835425|FG001|COMPLETED|Overall Study||349
3110824|NCT01565941|3835424|FG000|NOT COMPLETED|Overall Study||11
3110825|NCT01565941|3835425|FG001|NOT COMPLETED|Overall Study||4
3110826|NCT01565980|3835435|FG000|STARTED|Overall Study||20
3110827|NCT01565980|3835436|FG001|STARTED|Overall Study|Three patients had started the intervention protocol at the time of study withdrawal.|20
3110828|NCT01565980|3835435|FG000|COMPLETED|Overall Study||16
3110829|NCT01565980|3835436|FG001|COMPLETED|Overall Study||16
3110830|NCT01565980|3835435|FG000|NOT COMPLETED|Overall Study||4
3110831|NCT01565980|3835436|FG001|NOT COMPLETED|Overall Study||4
3110832|NCT01565993|3835448|FG000|STARTED|Overall Study||66
3110833|NCT01565993|3835449|FG001|STARTED|Overall Study|3 patients were excluded for failing to meet the inclusion criteria|42
3110834|NCT01565993|3835448|FG000|COMPLETED|Overall Study|A total of 105 polypectomies were performed on 98 patients|66
3110835|NCT01565993|3835449|FG001|COMPLETED|Overall Study||39
3110836|NCT01565993|3835448|FG000|NOT COMPLETED|Overall Study||0
3110837|NCT01565993|3835449|FG001|NOT COMPLETED|Overall Study||3
3110838|NCT01566084|3835457|FG000|STARTED|Overall Study||7
3110839|NCT01566084|3835458|FG001|STARTED|Overall Study||10
3110840|NCT01566084|3835457|FG000|COMPLETED|Overall Study||7
3110841|NCT01566084|3835458|FG001|COMPLETED|Overall Study||10
3110842|NCT01566084|3835457|FG000|NOT COMPLETED|Overall Study||0
3110843|NCT01566084|3835458|FG001|NOT COMPLETED|Overall Study||0
3110844|NCT01566162|3835472|FG000|STARTED|Overall Study||191
3110845|NCT01566162|3835472|FG000|COMPLETED|Overall Study||155
3110846|NCT01566162|3835472|FG000|NOT COMPLETED|Overall Study||36
3110847|NCT01566214|3835478|FG000|STARTED|Overall Study||6
3110848|NCT01566214|3835479|FG001|STARTED|Overall Study||6
3110849|NCT01566214|3835478|FG000|COMPLETED|Overall Study||3
3110850|NCT01566214|3835479|FG001|COMPLETED|Overall Study||6
3110851|NCT01566214|3835478|FG000|NOT COMPLETED|Overall Study||3
3110852|NCT01566214|3835479|FG001|NOT COMPLETED|Overall Study||0
3110853|NCT01566331|3835487|FG000|STARTED|Overall Study||40
3110854|NCT01566331|3835488|FG001|STARTED|Overall Study||40
3110855|NCT01566331|3835487|FG000|COMPLETED|Overall Study||40
3110856|NCT01566331|3835488|FG001|COMPLETED|Overall Study||40
3110857|NCT01566331|3835487|FG000|NOT COMPLETED|Overall Study||0
3110858|NCT01566331|3835488|FG001|NOT COMPLETED|Overall Study||0
3110859|NCT01566409|3835496|FG000|STARTED|Overall Study||49
3110860|NCT01566409|3835497|FG001|STARTED|Overall Study||53
3110861|NCT01566409|3835496|FG000|COMPLETED|Overall Study||47
3110862|NCT01566409|3835497|FG001|COMPLETED|Overall Study||48
3110863|NCT01566409|3835496|FG000|NOT COMPLETED|Overall Study||2
3110864|NCT01566409|3835497|FG001|NOT COMPLETED|Overall Study||5
3110865|NCT01566435|3835503|FG000|STARTED|ACF Induction Therapy||30
3110866|NCT01566435|3835503|FG000|COMPLETED|ACF Induction Therapy||30
3110867|NCT01566435|3835503|FG000|NOT COMPLETED|ACF Induction Therapy||0
3110868|NCT01566435|3835503|FG000|STARTED|ACF Definitive Chemoradiation-cisplatin||28
3110869|NCT01566435|3835503|FG000|COMPLETED|ACF Definitive Chemoradiation-cisplatin||27
3110870|NCT01566435|3835503|FG000|NOT COMPLETED|ACF Definitive Chemoradiation-cisplatin||1
3110871|NCT01566435|3835503|FG000|STARTED|ACF Definitive Chemoradiation-cetuximab||2
3110872|NCT01566435|3835503|FG000|COMPLETED|ACF Definitive Chemoradiation-cetuximab||2
3110873|NCT01566435|3835503|FG000|NOT COMPLETED|ACF Definitive Chemoradiation-cetuximab||0
3110874|NCT01566448|3835511|FG000|STARTED|Overall Study||30
3110875|NCT01566448|3835511|FG000|COMPLETED|Overall Study||30
3110876|NCT01566448|3835511|FG000|NOT COMPLETED|Overall Study||0
3110877|NCT01566461|3835517|FG000|STARTED|IN.PACT SFA I Phase||99
3110878|NCT01566461|3835518|FG001|STARTED|IN.PACT SFA I Phase||51
3110879|NCT01566461|3835517|FG000|COMPLETED|IN.PACT SFA I Phase||88
3110880|NCT01566461|3835518|FG001|COMPLETED|IN.PACT SFA I Phase||49
3110881|NCT01566461|3835517|FG000|NOT COMPLETED|IN.PACT SFA I Phase||11
3110882|NCT01566461|3835518|FG001|NOT COMPLETED|IN.PACT SFA I Phase||2
3110883|NCT01566461|3835517|FG000|STARTED|IN.PACT SFA II Phase||121
3110884|NCT01566461|3835518|FG001|STARTED|IN.PACT SFA II Phase||60
3110885|NCT01566461|3835517|FG000|COMPLETED|IN.PACT SFA II Phase||109
3110886|NCT01566461|3835518|FG001|COMPLETED|IN.PACT SFA II Phase||55
3110887|NCT01566461|3835517|FG000|NOT COMPLETED|IN.PACT SFA II Phase||12
3110888|NCT01566461|3835518|FG001|NOT COMPLETED|IN.PACT SFA II Phase||5
3293694|NCT02873104|4027674|FG000|NOT COMPLETED|Overall Study||1
3293695|NCT02873104|4027675|FG001|NOT COMPLETED|Overall Study||0
3293696|NCT02873208|4027681|FG000|STARTED|Overall Study||265
3293697|NCT02873208|4027681|FG000|COMPLETED|Overall Study||167
3110889|NCT01566500|3835524|FG000|STARTED|Overall Study||140
3110890|NCT01566500|3835524|FG000|COMPLETED|Overall Study||140
3110891|NCT01566500|3835524|FG000|NOT COMPLETED|Overall Study||0
3110892|NCT01566526|3835528|FG000|STARTED|Overall Study||26
3110893|NCT01566526|3835528|FG000|COMPLETED|Overall Study||26
3110894|NCT01566526|3835528|FG000|NOT COMPLETED|Overall Study||0
3110895|NCT01566539|3835540|FG000|STARTED|Main Study Period||101
3110896|NCT01566539|3835541|FG001|STARTED|Main Study Period||100
3110897|NCT01566539|3835542|FG002|STARTED|Main Study Period||104
3110898|NCT01566539|3835543|FG003|STARTED|Main Study Period||0
3110899|NCT01566539|3835544|FG004|STARTED|Main Study Period||40
3110900|NCT01566539|3835545|FG005|STARTED|Main Study Period||43
3110901|NCT01566539|3835546|FG006|STARTED|Main Study Period||30
3110902|NCT01566539|3835547|FG007|STARTED|Main Study Period||30
3110903|NCT01566539|3835548|FG008|STARTED|Main Study Period||1
3110904|NCT01566539|3835540|FG000|COMPLETED|Main Study Period||100
3110905|NCT01566539|3835541|FG001|COMPLETED|Main Study Period||100
3110906|NCT01566539|3835542|FG002|COMPLETED|Main Study Period||104
3110907|NCT01566539|3835543|FG003|COMPLETED|Main Study Period||0
3110908|NCT01566539|3835544|FG004|COMPLETED|Main Study Period||40
3110909|NCT01566539|3835545|FG005|COMPLETED|Main Study Period||40
3110910|NCT01566539|3835546|FG006|COMPLETED|Main Study Period||30
3110911|NCT01566539|3835547|FG007|COMPLETED|Main Study Period||30
3110912|NCT01566539|3835548|FG008|COMPLETED|Main Study Period||1
3110913|NCT01566539|3835540|FG000|NOT COMPLETED|Main Study Period||1
3110914|NCT01566539|3835541|FG001|NOT COMPLETED|Main Study Period||0
3110915|NCT01566539|3835542|FG002|NOT COMPLETED|Main Study Period||0
3110916|NCT01566539|3835543|FG003|NOT COMPLETED|Main Study Period||0
3110917|NCT01566539|3835544|FG004|NOT COMPLETED|Main Study Period||0
3110918|NCT01566539|3835545|FG005|NOT COMPLETED|Main Study Period||3
3110919|NCT01566539|3835546|FG006|NOT COMPLETED|Main Study Period||0
3110920|NCT01566539|3835547|FG007|NOT COMPLETED|Main Study Period||0
3110921|NCT01566539|3835548|FG008|NOT COMPLETED|Main Study Period||0
3110922|NCT01566539|3835540|FG000|STARTED|Within Subject Group||0
3110923|NCT01566539|3835541|FG001|STARTED|Within Subject Group||0
3110924|NCT01566539|3835542|FG002|STARTED|Within Subject Group||0
3110925|NCT01566539|3835543|FG003|STARTED|Within Subject Group|Participants can move from Healthy Volunteers-AVP, OT and Placebo groups to the within subject group|156
3110926|NCT01566539|3835544|FG004|STARTED|Within Subject Group||0
3110927|NCT01566539|3835545|FG005|STARTED|Within Subject Group||0
3110928|NCT01566539|3835546|FG006|STARTED|Within Subject Group||0
3110929|NCT01566539|3835547|FG007|STARTED|Within Subject Group||0
3110930|NCT01566539|3835548|FG008|STARTED|Within Subject Group||0
3110931|NCT01566539|3835540|FG000|COMPLETED|Within Subject Group||0
3110932|NCT01566539|3835541|FG001|COMPLETED|Within Subject Group||0
3110933|NCT01566539|3835542|FG002|COMPLETED|Within Subject Group||0
3110934|NCT01566539|3835543|FG003|COMPLETED|Within Subject Group|Participants can move from Healthy Volunteers-AVP, OT and Placebo groups to the within subject group|153
3110935|NCT01566539|3835544|FG004|COMPLETED|Within Subject Group||0
3110936|NCT01566539|3835545|FG005|COMPLETED|Within Subject Group||0
3110937|NCT01566539|3835546|FG006|COMPLETED|Within Subject Group||0
3110938|NCT01566539|3835547|FG007|COMPLETED|Within Subject Group||0
3110939|NCT01566539|3835548|FG008|COMPLETED|Within Subject Group||0
3110940|NCT01566539|3835540|FG000|NOT COMPLETED|Within Subject Group||0
3110941|NCT01566539|3835541|FG001|NOT COMPLETED|Within Subject Group||0
3110942|NCT01566539|3835542|FG002|NOT COMPLETED|Within Subject Group||0
3110943|NCT01566539|3835543|FG003|NOT COMPLETED|Within Subject Group||3
3110944|NCT01566539|3835544|FG004|NOT COMPLETED|Within Subject Group||0
3110945|NCT01566539|3835545|FG005|NOT COMPLETED|Within Subject Group||0
3110946|NCT01566539|3835546|FG006|NOT COMPLETED|Within Subject Group||0
3110947|NCT01566539|3835547|FG007|NOT COMPLETED|Within Subject Group||0
3110948|NCT01566539|3835548|FG008|NOT COMPLETED|Within Subject Group||0
3110949|NCT01566604|3835572|FG000|STARTED|Overall Study||306
3110950|NCT01566604|3835573|FG001|STARTED|Overall Study||154
3110951|NCT01566604|3835572|FG000|Safety Set|Overall Study||305
3110952|NCT01566604|3835573|FG001|Safety Set|Overall Study||154
3110953|NCT01566604|3835572|FG000|Full Analysis Set (FAS)|Overall Study||305
3110954|NCT01566604|3835573|FG001|Full Analysis Set (FAS)|Overall Study||154
3110955|NCT01566604|3835572|FG000|FAS, Serial Spirometry Subgroup|Overall Study||134
3110956|NCT01566604|3835573|FG001|FAS, Serial Spirometry Subgroup|Overall Study||58
3110957|NCT01566604|3835572|FG000|COMPLETED|Overall Study||282
3110958|NCT01566604|3835573|FG001|COMPLETED|Overall Study||143
3110959|NCT01566604|3835572|FG000|NOT COMPLETED|Overall Study||24
3110960|NCT01566604|3835573|FG001|NOT COMPLETED|Overall Study||11
3110961|NCT01566630|3835581|FG000|STARTED|Overall Study||2
3110962|NCT01566630|3835582|FG001|STARTED|Overall Study||1
3110963|NCT01566630|3835581|FG000|COMPLETED|Overall Study||2
3110964|NCT01566630|3835582|FG001|COMPLETED|Overall Study||1
3110965|NCT01566630|3835581|FG000|NOT COMPLETED|Overall Study||0
3110966|NCT01566630|3835582|FG001|NOT COMPLETED|Overall Study||0
3110967|NCT01566682|3835594|FG000|STARTED|Overall Study||420
3110968|NCT01566682|3835594|FG000|COMPLETED|Overall Study||374
3110969|NCT01566682|3835594|FG000|NOT COMPLETED|Overall Study||46
3110970|NCT01566721|3835600|FG000|STARTED|Treatment Period||1867
3110971|NCT01566721|3835601|FG001|STARTED|Treatment Period||710
3110972|NCT01566721|3835600|FG000|COMPLETED|Treatment Period||1670
3110973|NCT01566721|3835601|FG001|COMPLETED|Treatment Period||652
3110974|NCT01566721|3835600|FG000|NOT COMPLETED|Treatment Period||197
3110975|NCT01566721|3835601|FG001|NOT COMPLETED|Treatment Period||58
3135845|NCT01709227|3860920|FG000|NOT COMPLETED|Overall Study||1
3110976|NCT01566721|3835600|FG000|STARTED|Safety Follow-up|Participants who discontinued treatment were allowed to join the SFU Period.|1865
3110977|NCT01566721|3835601|FG001|STARTED|Safety Follow-up|Participants who discontinued treatment were allowed to join the SFU Period.|708
3110978|NCT01566721|3835600|FG000|COMPLETED|Safety Follow-up||1318
3110979|NCT01566721|3835601|FG001|COMPLETED|Safety Follow-up||501
3110980|NCT01566721|3835600|FG000|NOT COMPLETED|Safety Follow-up||547
3110981|NCT01566721|3835601|FG001|NOT COMPLETED|Safety Follow-up||207
3110982|NCT01566773|3835614|FG000|STARTED|Overall Study||140
3110983|NCT01566773|3835614|FG000|GP MDI 18 µg BID|Overall Study||64
3110984|NCT01566773|3835614|FG000|GP MDI 9 µg BID|Overall Study||64
3110985|NCT01566773|3835614|FG000|GP MDI 4.6 µg BID|Overall Study||62
3110986|NCT01566773|3835614|FG000|GP MDI 2.4 µg BID|Overall Study||64
3110987|NCT01566773|3835614|FG000|GP MDI 1.2 µg BID|Overall Study||57
3110988|NCT01566773|3835614|FG000|GP MDI 0.6 µg BID|Overall Study||59
3110989|NCT01566773|3835614|FG000|Placebo MDI|Overall Study||62
3110990|NCT01566773|3835614|FG000|Spiriva® Handihaler®|Overall Study||62
3110991|NCT01566773|3835614|FG000|COMPLETED|Overall Study||110
3110992|NCT01566773|3835614|FG000|NOT COMPLETED|Overall Study||30
3110993|NCT01566838|3835636|FG000|STARTED|Overall Study||41
3110994|NCT01566838|3835637|FG001|STARTED|Overall Study||42
3110995|NCT01566838|3835636|FG000|COMPLETED|Overall Study||38
3110996|NCT01566838|3835637|FG001|COMPLETED|Overall Study||42
3110997|NCT01566838|3835636|FG000|NOT COMPLETED|Overall Study||3
3110998|NCT01566838|3835637|FG001|NOT COMPLETED|Overall Study||0
3110999|NCT01566981|3835645|FG000|STARTED|Overall Study||58
3111000|NCT01566981|3835646|FG001|STARTED|Overall Study||62
3111001|NCT01566981|3835645|FG000|COMPLETED|Overall Study||53
3111002|NCT01566981|3835646|FG001|COMPLETED|Overall Study||54
3111003|NCT01566981|3835645|FG000|NOT COMPLETED|Overall Study||5
3111004|NCT01566981|3835646|FG001|NOT COMPLETED|Overall Study||8
3111005|NCT01567020|3835658|FG000|STARTED|Overall Study||28
3111006|NCT01567020|3835659|FG001|STARTED|Overall Study||46
3111007|NCT01567020|3835660|FG002|STARTED|Overall Study||20
3111008|NCT01567020|3835661|FG003|STARTED|Overall Study||11
3111009|NCT01567020|3835658|FG000|COMPLETED|Overall Study||21
3111010|NCT01567020|3835659|FG001|COMPLETED|Overall Study||41
3111011|NCT01567020|3835660|FG002|COMPLETED|Overall Study||18
3111012|NCT01567020|3835661|FG003|COMPLETED|Overall Study||10
3111013|NCT01567020|3835658|FG000|NOT COMPLETED|Overall Study||7
3111014|NCT01567020|3835659|FG001|NOT COMPLETED|Overall Study||5
3111015|NCT01567020|3835660|FG002|NOT COMPLETED|Overall Study||2
3111016|NCT01567020|3835661|FG003|NOT COMPLETED|Overall Study||1
3111017|NCT01567085|3835671|FG000|STARTED|Overall Study||80
3111018|NCT01567085|3835671|FG000|Received at Least 1 Dose of Study Drug|Overall Study||80
3111019|NCT01567085|3835671|FG000|COMPLETED|Overall Study||60
3111020|NCT01567085|3835671|FG000|NOT COMPLETED|Overall Study||20
3111021|NCT01567150|3835677|FG000|STARTED|Overall Study||21
3111022|NCT01567150|3835678|FG001|STARTED|Overall Study||18
3111023|NCT01567150|3835677|FG000|COMPLETED|Overall Study||19
3111024|NCT01567150|3835678|FG001|COMPLETED|Overall Study||16
3111025|NCT01567150|3835677|FG000|NOT COMPLETED|Overall Study||2
3111026|NCT01567150|3835678|FG001|NOT COMPLETED|Overall Study||2
3111027|NCT01567163|3835684|FG000|STARTED|Overall Study||22
3111028|NCT01567163|3835684|FG000|Received at Least 1 Dose of Study Drug|Overall Study||22
3111029|NCT01567163|3835684|FG000|Drug-Drug Interaction Population|Overall Study|Completed Cycle 1, Day 1 and Cycle 2, Day 1 treatment with required assessments.|18
3111030|NCT01567163|3835684|FG000|COMPLETED|Overall Study||18
3111031|NCT01567163|3835684|FG000|NOT COMPLETED|Overall Study||4
3111032|NCT01567306|3835699|FG000|STARTED|Overall Study||27
3111033|NCT01567306|3835700|FG001|STARTED|Overall Study||25
3111034|NCT01567306|3835701|FG002|STARTED|Overall Study||24
3111035|NCT01567306|3835702|FG003|STARTED|Overall Study||24
3111036|NCT01567306|3835703|FG004|STARTED|Overall Study||25
3111037|NCT01567306|3835704|FG005|STARTED|Overall Study||26
3111038|NCT01567306|3835699|FG000|COMPLETED|Overall Study||24
3111039|NCT01567306|3835700|FG001|COMPLETED|Overall Study||23
3111040|NCT01567306|3835701|FG002|COMPLETED|Overall Study||24
3111041|NCT01567306|3835702|FG003|COMPLETED|Overall Study||19
3111042|NCT01567306|3835703|FG004|COMPLETED|Overall Study||18
3111043|NCT01567306|3835704|FG005|COMPLETED|Overall Study||23
3111044|NCT01567306|3835699|FG000|NOT COMPLETED|Overall Study||3
3111045|NCT01567306|3835700|FG001|NOT COMPLETED|Overall Study||2
3111046|NCT01567306|3835701|FG002|NOT COMPLETED|Overall Study||0
3111047|NCT01567306|3835702|FG003|NOT COMPLETED|Overall Study||5
3111048|NCT01567306|3835703|FG004|NOT COMPLETED|Overall Study||7
3111049|NCT01567306|3835704|FG005|NOT COMPLETED|Overall Study||3
3111050|NCT01567371|3835718|FG000|STARTED|Overall Study||30
3111051|NCT01567371|3835718|FG000|COMPLETED|Overall Study||30
3111052|NCT01567371|3835718|FG000|NOT COMPLETED|Overall Study||0
3111053|NCT01567462|3835724|FG000|STARTED|Overall Study||45
3111054|NCT01567462|3835725|FG001|STARTED|Overall Study||45
3111055|NCT01567462|3835724|FG000|COMPLETED|Overall Study||41
3111056|NCT01567462|3835725|FG001|COMPLETED|Overall Study||38
3111057|NCT01567462|3835724|FG000|NOT COMPLETED|Overall Study||4
3111058|NCT01567462|3835725|FG001|NOT COMPLETED|Overall Study||7
3111059|NCT01567527|3835733|FG000|STARTED|Conversion Phase.||466
3111060|NCT01567527|3835734|FG001|STARTED|Conversion Phase.|There were no subjects in this reporting group in this phase of the study.|0
3111061|NCT01567527|3835735|FG002|STARTED|Conversion Phase.|There were no subjects in this reporting group in this phase of the study.|0
3135846|NCT01709227|3860921|FG001|NOT COMPLETED|Overall Study||9
3111062|NCT01567527|3835736|FG003|STARTED|Conversion Phase.|There were no subjects in this reporting group in this phase of the study.|0
3111063|NCT01567527|3835737|FG004|STARTED|Conversion Phase.|There were no subjects in this reporting group in this phase of the study.|0
3111064|NCT01567527|3835733|FG000|COMPLETED|Conversion Phase.||367
3111065|NCT01567527|3835734|FG001|COMPLETED|Conversion Phase.||0
3111066|NCT01567527|3835735|FG002|COMPLETED|Conversion Phase.||0
3111067|NCT01567527|3835736|FG003|COMPLETED|Conversion Phase.||0
3111068|NCT01567527|3835737|FG004|COMPLETED|Conversion Phase.||0
3111069|NCT01567527|3835733|FG000|NOT COMPLETED|Conversion Phase.||99
3111070|NCT01567527|3835734|FG001|NOT COMPLETED|Conversion Phase.||0
3111071|NCT01567527|3835735|FG002|NOT COMPLETED|Conversion Phase.||0
3111072|NCT01567527|3835736|FG003|NOT COMPLETED|Conversion Phase.||0
3111073|NCT01567527|3835737|FG004|NOT COMPLETED|Conversion Phase.||0
3111074|NCT01567527|3835733|FG000|STARTED|Oral Aripiprazole Stabilization Phase.|There were no subjects in this reporting group in this phase of the study.|0
3111075|NCT01567527|3835734|FG001|STARTED|Oral Aripiprazole Stabilization Phase.|265 of the 632 subjects who started this phase entered the Oral Stabilization Phase directly.|632
3111076|NCT01567527|3835735|FG002|STARTED|Oral Aripiprazole Stabilization Phase.|There were no subjects in this reporting group in this phase of the study.|0
3111077|NCT01567527|3835736|FG003|STARTED|Oral Aripiprazole Stabilization Phase.|There were no subjects in this reporting group in this phase of the study.|0
3111078|NCT01567527|3835737|FG004|STARTED|Oral Aripiprazole Stabilization Phase.|There were no subjects in this reporting group in this phase of the study.|0
3111079|NCT01567527|3835733|FG000|COMPLETED|Oral Aripiprazole Stabilization Phase.||0
3111080|NCT01567527|3835734|FG001|COMPLETED|Oral Aripiprazole Stabilization Phase.||425
3111081|NCT01567527|3835735|FG002|COMPLETED|Oral Aripiprazole Stabilization Phase.||0
3111082|NCT01567527|3835736|FG003|COMPLETED|Oral Aripiprazole Stabilization Phase.||0
3111083|NCT01567527|3835737|FG004|COMPLETED|Oral Aripiprazole Stabilization Phase.||0
3111084|NCT01567527|3835733|FG000|NOT COMPLETED|Oral Aripiprazole Stabilization Phase.||0
3111085|NCT01567527|3835734|FG001|NOT COMPLETED|Oral Aripiprazole Stabilization Phase.||207
3111086|NCT01567527|3835735|FG002|NOT COMPLETED|Oral Aripiprazole Stabilization Phase.||0
3111087|NCT01567527|3835736|FG003|NOT COMPLETED|Oral Aripiprazole Stabilization Phase.||0
3111088|NCT01567527|3835737|FG004|NOT COMPLETED|Oral Aripiprazole Stabilization Phase.||0
3111089|NCT01567527|3835733|FG000|STARTED|IM Depot Stabilization.|There were no subjects in this reporting group in this phase of the study.|0
3111090|NCT01567527|3835734|FG001|STARTED|IM Depot Stabilization.|There were no subjects in this reporting group in this phase of the study.|0
3111091|NCT01567527|3835735|FG002|STARTED|IM Depot Stabilization.||425
3111092|NCT01567527|3835736|FG003|STARTED|IM Depot Stabilization.|There were no subjects in this reporting group in this phase of the study.|0
3111093|NCT01567527|3835737|FG004|STARTED|IM Depot Stabilization.|There were no subjects in this reporting group in this phase of the study.|0
3111094|NCT01567527|3835733|FG000|COMPLETED|IM Depot Stabilization.||0
3111095|NCT01567527|3835734|FG001|COMPLETED|IM Depot Stabilization.||0
3111096|NCT01567527|3835735|FG002|COMPLETED|IM Depot Stabilization.||266
3111097|NCT01567527|3835736|FG003|COMPLETED|IM Depot Stabilization.||0
3111098|NCT01567527|3835737|FG004|COMPLETED|IM Depot Stabilization.||0
3111099|NCT01567527|3835733|FG000|NOT COMPLETED|IM Depot Stabilization.||0
3111100|NCT01567527|3835734|FG001|NOT COMPLETED|IM Depot Stabilization.||0
3111101|NCT01567527|3835735|FG002|NOT COMPLETED|IM Depot Stabilization.||159
3111102|NCT01567527|3835736|FG003|NOT COMPLETED|IM Depot Stabilization.||0
3111103|NCT01567527|3835737|FG004|NOT COMPLETED|IM Depot Stabilization.||0
3111104|NCT01567527|3835733|FG000|STARTED|Double-blind, Placebo-controlled Phase||0
3111105|NCT01567527|3835734|FG001|STARTED|Double-blind, Placebo-controlled Phase||0
3111106|NCT01567527|3835735|FG002|STARTED|Double-blind, Placebo-controlled Phase|Subjects were randomized to Aripiprazole IM Depot and placebo groups in this phase of the study|0
3111107|NCT01567527|3835736|FG003|STARTED|Double-blind, Placebo-controlled Phase||133
3111108|NCT01567527|3835737|FG004|STARTED|Double-blind, Placebo-controlled Phase||133
3111109|NCT01567527|3835733|FG000|COMPLETED|Double-blind, Placebo-controlled Phase||0
3111110|NCT01567527|3835734|FG001|COMPLETED|Double-blind, Placebo-controlled Phase||0
3111111|NCT01567527|3835735|FG002|COMPLETED|Double-blind, Placebo-controlled Phase||0
3111112|NCT01567527|3835736|FG003|COMPLETED|Double-blind, Placebo-controlled Phase||64
3111113|NCT01567527|3835737|FG004|COMPLETED|Double-blind, Placebo-controlled Phase||38
3111114|NCT01567527|3835733|FG000|NOT COMPLETED|Double-blind, Placebo-controlled Phase||0
3111115|NCT01567527|3835734|FG001|NOT COMPLETED|Double-blind, Placebo-controlled Phase||0
3111116|NCT01567527|3835735|FG002|NOT COMPLETED|Double-blind, Placebo-controlled Phase||0
3111117|NCT01567527|3835736|FG003|NOT COMPLETED|Double-blind, Placebo-controlled Phase||69
3111118|NCT01567527|3835737|FG004|NOT COMPLETED|Double-blind, Placebo-controlled Phase||95
3111119|NCT01567826|3835748|FG000|STARTED|Overall Study||43
3111120|NCT01567826|3835749|FG001|STARTED|Overall Study||44
3111121|NCT01567826|3835748|FG000|COMPLETED|Overall Study||40
3111122|NCT01567826|3835749|FG001|COMPLETED|Overall Study||42
3111123|NCT01567826|3835748|FG000|NOT COMPLETED|Overall Study||3
3111124|NCT01567826|3835749|FG001|NOT COMPLETED|Overall Study||2
3111125|NCT01567839|3835757|FG000|STARTED|Overall Study||60
3111126|NCT01567839|3835757|FG000|COMPLETED|Overall Study||60
3111127|NCT01567839|3835757|FG000|NOT COMPLETED|Overall Study||0
3111128|NCT01567852|3835767|FG000|STARTED|Overall Study||8
3111129|NCT01567852|3835768|FG001|STARTED|Overall Study||12
3111130|NCT01567852|3835767|FG000|COMPLETED|Overall Study||4
3111131|NCT01567852|3835768|FG001|COMPLETED|Overall Study||5
3111132|NCT01567852|3835767|FG000|NOT COMPLETED|Overall Study||4
3111133|NCT01567852|3835768|FG001|NOT COMPLETED|Overall Study||7
3111134|NCT01567865|3835778|FG000|STARTED|Enrolled and Vaccinated (Day 0)||163
3111135|NCT01567865|3835779|FG001|STARTED|Enrolled and Vaccinated (Day 0)||220
3111136|NCT01567865|3835780|FG002|STARTED|Enrolled and Vaccinated (Day 0)||211
3111137|NCT01567865|3835781|FG003|STARTED|Enrolled and Vaccinated (Day 0)||224
3111138|NCT01567865|3835778|FG000|COMPLETED|Enrolled and Vaccinated (Day 0)||163
3111139|NCT01567865|3835779|FG001|COMPLETED|Enrolled and Vaccinated (Day 0)||220
3111140|NCT01567865|3835780|FG002|COMPLETED|Enrolled and Vaccinated (Day 0)||211
3111141|NCT01567865|3835781|FG003|COMPLETED|Enrolled and Vaccinated (Day 0)||224
3111142|NCT01567865|3835778|FG000|NOT COMPLETED|Enrolled and Vaccinated (Day 0)||0
3111143|NCT01567865|3835779|FG001|NOT COMPLETED|Enrolled and Vaccinated (Day 0)||0
3111144|NCT01567865|3835780|FG002|NOT COMPLETED|Enrolled and Vaccinated (Day 0)||0
3111145|NCT01567865|3835781|FG003|NOT COMPLETED|Enrolled and Vaccinated (Day 0)||0
3111146|NCT01567865|3835778|FG000|STARTED|Evaluated for Immunogenicity||163
3111147|NCT01567865|3835779|FG001|STARTED|Evaluated for Immunogenicity||220
3111148|NCT01567865|3835780|FG002|STARTED|Evaluated for Immunogenicity||211
3111149|NCT01567865|3835781|FG003|STARTED|Evaluated for Immunogenicity||224
3111150|NCT01567865|3835778|FG000|COMPLETED|Evaluated for Immunogenicity||146
3111151|NCT01567865|3835779|FG001|COMPLETED|Evaluated for Immunogenicity||195
3111152|NCT01567865|3835780|FG002|COMPLETED|Evaluated for Immunogenicity||192
3111153|NCT01567865|3835781|FG003|COMPLETED|Evaluated for Immunogenicity||194
3111154|NCT01567865|3835778|FG000|NOT COMPLETED|Evaluated for Immunogenicity||17
3111155|NCT01567865|3835779|FG001|NOT COMPLETED|Evaluated for Immunogenicity||25
3111156|NCT01567865|3835780|FG002|NOT COMPLETED|Evaluated for Immunogenicity||19
3111157|NCT01567865|3835781|FG003|NOT COMPLETED|Evaluated for Immunogenicity||30
3111158|NCT01567891|3835792|FG000|STARTED|Overall Study||9
3111159|NCT01567891|3835792|FG000|Received T-cell|Overall Study||6
3111160|NCT01567891|3835792|FG000|COMPLETED|Overall Study||6
3111161|NCT01567891|3835792|FG000|NOT COMPLETED|Overall Study||3
3111162|NCT01567943|3835807|FG000|STARTED|Overall Study||40
3111163|NCT01567943|3835808|FG001|STARTED|Overall Study||39
3111164|NCT01567943|3835809|FG002|STARTED|Overall Study||44
3111165|NCT01567943|3835807|FG000|COMPLETED|Overall Study||26
3111166|NCT01567943|3835808|FG001|COMPLETED|Overall Study||29
3111167|NCT01567943|3835809|FG002|COMPLETED|Overall Study||44
3111168|NCT01567943|3835807|FG000|NOT COMPLETED|Overall Study||14
3111169|NCT01567943|3835808|FG001|NOT COMPLETED|Overall Study||10
3111170|NCT01567943|3835809|FG002|NOT COMPLETED|Overall Study||0
3111171|NCT01568008|3835815|FG000|STARTED|Overall Study||933
3111172|NCT01568008|3835815|FG000|COMPLETED|Overall Study||699
3111173|NCT01568008|3835815|FG000|NOT COMPLETED|Overall Study||234
3111174|NCT01568021|3835819|FG000|STARTED|Overall Study||99
3111175|NCT01568021|3835819|FG000|COMPLETED|Overall Study||83
3111176|NCT01568021|3835819|FG000|NOT COMPLETED|Overall Study||16
3111177|NCT01568034|3835823|FG000|STARTED|Overall Study||2
3111178|NCT01568034|3835824|FG001|STARTED|Overall Study||2
3111179|NCT01568034|3835825|FG002|STARTED|Overall Study||3
3111180|NCT01568034|3835826|FG003|STARTED|Overall Study||3
3111181|NCT01568034|3835823|FG000|25 mg BIA 9-1067|Overall Study||2
3111182|NCT01568034|3835824|FG001|25 mg BIA 9-1067|Overall Study||2
3111183|NCT01568034|3835825|FG002|25 mg BIA 9-1067|Overall Study||3
3111184|NCT01568034|3835826|FG003|25 mg BIA 9-1067|Overall Study||3
3111185|NCT01568034|3835823|FG000|50 mg BIA 9-1067|Overall Study||2
3111186|NCT01568034|3835824|FG001|50 mg BIA 9-1067|Overall Study||2
3111187|NCT01568034|3835825|FG002|50 mg BIA 9-1067|Overall Study||3
3111188|NCT01568034|3835826|FG003|50 mg BIA 9-1067|Overall Study||3
3111189|NCT01568034|3835823|FG000|100 mg BIA 9-1067|Overall Study||2
3111190|NCT01568034|3835824|FG001|100 mg BIA 9-1067|Overall Study||2
3111191|NCT01568034|3835825|FG002|100 mg BIA 9-1067|Overall Study||3
3111192|NCT01568034|3835826|FG003|100 mg BIA 9-1067|Overall Study||3
3111193|NCT01568034|3835823|FG000|Placebo|Overall Study||1
3111194|NCT01568034|3835824|FG001|Placebo|Overall Study||2
3111195|NCT01568034|3835825|FG002|Placebo|Overall Study||3
3111196|NCT01568034|3835826|FG003|Placebo|Overall Study||3
3111197|NCT01568034|3835823|FG000|COMPLETED|Overall Study||1
3111198|NCT01568034|3835824|FG001|COMPLETED|Overall Study||2
3111199|NCT01568034|3835825|FG002|COMPLETED|Overall Study||3
3111200|NCT01568034|3835826|FG003|COMPLETED|Overall Study||3
3111201|NCT01568034|3835823|FG000|NOT COMPLETED|Overall Study||1
3111202|NCT01568034|3835824|FG001|NOT COMPLETED|Overall Study||0
3111203|NCT01568034|3835825|FG002|NOT COMPLETED|Overall Study||0
3111204|NCT01568034|3835826|FG003|NOT COMPLETED|Overall Study||0
3111205|NCT01568047|3835840|FG000|STARTED|Overall Study||10
3111206|NCT01568047|3835841|FG001|STARTED|Overall Study||10
3111207|NCT01568047|3835842|FG002|STARTED|Overall Study||10
3111208|NCT01568047|3835843|FG003|STARTED|Overall Study||10
3111209|NCT01568047|3835840|FG000|COMPLETED|Overall Study||9
3111210|NCT01568047|3835841|FG001|COMPLETED|Overall Study||9
3111211|NCT01568047|3835842|FG002|COMPLETED|Overall Study||9
3111212|NCT01568047|3835843|FG003|COMPLETED|Overall Study||9
3111213|NCT01568047|3835840|FG000|NOT COMPLETED|Overall Study||1
3111214|NCT01568047|3835841|FG001|NOT COMPLETED|Overall Study||1
3111215|NCT01568047|3835842|FG002|NOT COMPLETED|Overall Study||1
3111216|NCT01568047|3835843|FG003|NOT COMPLETED|Overall Study||1
3111217|NCT01568073|3835858|FG000|STARTED|Overall Study||121
3111218|NCT01568073|3835859|FG001|STARTED|Overall Study||122
3111219|NCT01568073|3835860|FG002|STARTED|Overall Study||122
3111220|NCT01568073|3835861|FG003|STARTED|Overall Study||119
3111221|NCT01568073|3835862|FG004|STARTED|Overall Study||116
3111222|NCT01568073|3835858|FG000|COMPLETED|Overall Study||110
3111223|NCT01568073|3835859|FG001|COMPLETED|Overall Study||107
3111224|NCT01568073|3835860|FG002|COMPLETED|Overall Study||110
3111225|NCT01568073|3835861|FG003|COMPLETED|Overall Study||108
3111226|NCT01568073|3835862|FG004|COMPLETED|Overall Study||107
3111227|NCT01568073|3835858|FG000|NOT COMPLETED|Overall Study||11
3111228|NCT01568073|3835859|FG001|NOT COMPLETED|Overall Study||15
3111229|NCT01568073|3835860|FG002|NOT COMPLETED|Overall Study||12
3111230|NCT01568073|3835861|FG003|NOT COMPLETED|Overall Study||11
3111231|NCT01568073|3835862|FG004|NOT COMPLETED|Overall Study||9
3111232|NCT01568112|3835878|FG000|STARTED|Overall Study||44
3111233|NCT01568112|3835879|FG001|STARTED|Overall Study||44
3111234|NCT01568112|3835880|FG002|STARTED|Overall Study||43
3111235|NCT01568112|3835881|FG003|STARTED|Overall Study||42
3111236|NCT01568112|3835878|FG000|COMPLETED|Overall Study||39
3111237|NCT01568112|3835879|FG001|COMPLETED|Overall Study||36
3111238|NCT01568112|3835880|FG002|COMPLETED|Overall Study||36
3111239|NCT01568112|3835881|FG003|COMPLETED|Overall Study||30
3111240|NCT01568112|3835878|FG000|NOT COMPLETED|Overall Study||5
3111241|NCT01568112|3835879|FG001|NOT COMPLETED|Overall Study||8
3111242|NCT01568112|3835880|FG002|NOT COMPLETED|Overall Study||7
3111243|NCT01568112|3835881|FG003|NOT COMPLETED|Overall Study||12
3111244|NCT01568255|3835894|FG000|STARTED|Overall Study||5
3111245|NCT01568255|3835895|FG001|STARTED|Overall Study||6
3111246|NCT01568255|3835894|FG000|COMPLETED|Overall Study||5
3111247|NCT01568255|3835895|FG001|COMPLETED|Overall Study||6
3111248|NCT01568255|3835894|FG000|NOT COMPLETED|Overall Study||0
3111249|NCT01568255|3835895|FG001|NOT COMPLETED|Overall Study||0
3111250|NCT01568320|3835901|FG000|STARTED|Overall Study||73
3111251|NCT01568320|3835901|FG000|5-Year|Overall Study|Patients eligible for Follow-up at 5 year|36
3111252|NCT01568320|3835901|FG000|COMPLETED|Overall Study||32
3111253|NCT01568320|3835901|FG000|NOT COMPLETED|Overall Study||41
3111254|NCT01568424|3835905|FG000|STARTED|Overall Study||25
3111255|NCT01568424|3835905|FG000|COMPLETED|Overall Study||25
3111256|NCT01568424|3835905|FG000|NOT COMPLETED|Overall Study||0
3111257|NCT01568528|3835912|FG000|STARTED|Overall Study||19
3111258|NCT01568528|3835913|FG001|STARTED|Overall Study||11
3111259|NCT01568528|3835914|FG002|STARTED|Overall Study||9
3111260|NCT01568528|3835912|FG000|COMPLETED|Overall Study||19
3111261|NCT01568528|3835913|FG001|COMPLETED|Overall Study||11
3111262|NCT01568528|3835914|FG002|COMPLETED|Overall Study||9
3111263|NCT01568528|3835912|FG000|NOT COMPLETED|Overall Study||0
3111264|NCT01568528|3835913|FG001|NOT COMPLETED|Overall Study||0
3111265|NCT01568528|3835914|FG002|NOT COMPLETED|Overall Study||0
3135847|NCT01709305|3860928|FG000|STARTED|Phase 1||5570
3135848|NCT01709305|3860929|FG001|STARTED|Phase 1||0
3135849|NCT01709305|3860930|FG002|STARTED|Phase 1||0
3135850|NCT01709305|3860931|FG003|STARTED|Phase 1||0
3135851|NCT01709305|3860932|FG004|STARTED|Phase 1||0
3135852|NCT01709305|3860928|FG000|COMPLETED|Phase 1||4933
3135853|NCT01709305|3860929|FG001|COMPLETED|Phase 1||0
3135854|NCT01709305|3860930|FG002|COMPLETED|Phase 1||0
3135855|NCT01709305|3860931|FG003|COMPLETED|Phase 1||0
3135856|NCT01709305|3860932|FG004|COMPLETED|Phase 1||0
3135857|NCT01709305|3860928|FG000|NOT COMPLETED|Phase 1||637
3135858|NCT01709305|3860929|FG001|NOT COMPLETED|Phase 1||0
3135859|NCT01709305|3860930|FG002|NOT COMPLETED|Phase 1||0
3135860|NCT01709305|3860931|FG003|NOT COMPLETED|Phase 1||0
3135861|NCT01709305|3860932|FG004|NOT COMPLETED|Phase 1||0
3135862|NCT01709305|3860928|FG000|STARTED|Phase 2||0
3135863|NCT01709305|3860929|FG001|STARTED|Phase 2||552
3135864|NCT01709305|3860930|FG002|STARTED|Phase 2||550
3135865|NCT01709305|3860931|FG003|STARTED|Phase 2||556
3135866|NCT01709305|3860932|FG004|STARTED|Phase 2||554
3135867|NCT01709305|3860928|FG000|COMPLETED|Phase 2||0
3135868|NCT01709305|3860929|FG001|COMPLETED|Phase 2||500
3135869|NCT01709305|3860930|FG002|COMPLETED|Phase 2||505
3135870|NCT01709305|3860931|FG003|COMPLETED|Phase 2||508
3135871|NCT01709305|3860932|FG004|COMPLETED|Phase 2||507
3135872|NCT01709305|3860928|FG000|NOT COMPLETED|Phase 2||0
3135873|NCT01709305|3860929|FG001|NOT COMPLETED|Phase 2||52
3135874|NCT01709305|3860930|FG002|NOT COMPLETED|Phase 2||45
3135875|NCT01709305|3860931|FG003|NOT COMPLETED|Phase 2||48
3135876|NCT01709305|3860932|FG004|NOT COMPLETED|Phase 2||47
3135877|NCT01709383|3860949|FG000|STARTED|Overall Study||24
3135878|NCT01709383|3860950|FG001|STARTED|Overall Study||14
3135879|NCT01709383|3860949|FG000|Completed Treatment|Overall Study||24
3135880|NCT01709383|3860950|FG001|Completed Treatment|Overall Study||14
3135881|NCT01709383|3860949|FG000|Completed Follow-ups|Overall Study||23
3135882|NCT01709383|3860950|FG001|Completed Follow-ups|Overall Study||14
3135883|NCT01709383|3860949|FG000|Included in Analysis|Overall Study||22
3135884|NCT01709383|3860950|FG001|Included in Analysis|Overall Study||13
3135885|NCT01709383|3860949|FG000|COMPLETED|Overall Study||23
3135886|NCT01709383|3860950|FG001|COMPLETED|Overall Study||14
3135887|NCT01709383|3860949|FG000|NOT COMPLETED|Overall Study||1
3135888|NCT01709383|3860950|FG001|NOT COMPLETED|Overall Study||0
3135889|NCT01709409|3860960|FG000|STARTED|Overall Study||43
3135890|NCT01709409|3860961|FG001|STARTED|Overall Study||45
3135891|NCT01709409|3860960|FG000|COMPLETED|Overall Study||42
3135892|NCT01709409|3860961|FG001|COMPLETED|Overall Study||45
3135893|NCT01709409|3860960|FG000|NOT COMPLETED|Overall Study||1
3135894|NCT01709409|3860961|FG001|NOT COMPLETED|Overall Study||0
3135895|NCT01709422|3860969|FG000|STARTED|Overall Study||70
3135896|NCT01709422|3860970|FG001|STARTED|Overall Study||70
3135897|NCT01709422|3860969|FG000|COMPLETED|Overall Study||70
3111266|NCT01568593|3835924|FG000|STARTED|Overall Study||48
3111267|NCT01568593|3835925|FG001|STARTED|Overall Study||45
3111268|NCT01568593|3835924|FG000|COMPLETED|Overall Study||41
3111269|NCT01568593|3835925|FG001|COMPLETED|Overall Study||42
3111270|NCT01568593|3835924|FG000|NOT COMPLETED|Overall Study||7
3111271|NCT01568593|3835925|FG001|NOT COMPLETED|Overall Study||3
3111272|NCT01568606|3835931|FG000|STARTED|Overall Study||20
3111273|NCT01568606|3835931|FG000|COMPLETED|Overall Study||20
3111274|NCT01568606|3835931|FG000|NOT COMPLETED|Overall Study||0
3111275|NCT01568827|3835937|FG000|STARTED|First Intervention (6 Days)||5
3111276|NCT01568827|3835938|FG001|STARTED|First Intervention (6 Days)||5
3111277|NCT01568827|3835937|FG000|COMPLETED|First Intervention (6 Days)||5
3111278|NCT01568827|3835938|FG001|COMPLETED|First Intervention (6 Days)||5
3111279|NCT01568827|3835937|FG000|NOT COMPLETED|First Intervention (6 Days)||0
3111280|NCT01568827|3835938|FG001|NOT COMPLETED|First Intervention (6 Days)||0
3111281|NCT01568827|3835937|FG000|STARTED|Washout (2 Days)||5
3111282|NCT01568827|3835938|FG001|STARTED|Washout (2 Days)||5
3111283|NCT01568827|3835937|FG000|COMPLETED|Washout (2 Days)||5
3111284|NCT01568827|3835938|FG001|COMPLETED|Washout (2 Days)||5
3111285|NCT01568827|3835937|FG000|NOT COMPLETED|Washout (2 Days)||0
3293698|NCT02873208|4027681|FG000|NOT COMPLETED|Overall Study||98
3293699|NCT02873221|4027688|FG000|STARTED|Treatment Period||417
3293700|NCT02873221|4027689|FG001|STARTED|Treatment Period||417
3293701|NCT02873221|4027690|FG002|STARTED|Treatment Period||420
3293702|NCT02873221|4027688|FG000|Safety Population: Received Study Drug|Treatment Period||417
3293703|NCT02873221|4027689|FG001|Safety Population: Received Study Drug|Treatment Period||404
3111286|NCT01568827|3835938|FG001|NOT COMPLETED|Washout (2 Days)||0
3111287|NCT01568827|3835937|FG000|STARTED|Intervention 2 (5 Days)||5
3111288|NCT01568827|3835938|FG001|STARTED|Intervention 2 (5 Days)||5
3111289|NCT01568827|3835937|FG000|COMPLETED|Intervention 2 (5 Days)||5
3111290|NCT01568827|3835938|FG001|COMPLETED|Intervention 2 (5 Days)||5
3111291|NCT01568827|3835937|FG000|NOT COMPLETED|Intervention 2 (5 Days)||0
3111292|NCT01568827|3835938|FG001|NOT COMPLETED|Intervention 2 (5 Days)||0
3111293|NCT01568866|3835946|FG000|STARTED|Overall Study||465
3111294|NCT01568866|3835947|FG001|STARTED|Overall Study||464
3111295|NCT01568866|3835946|FG000|Received Treatment|Overall Study||456
3111296|NCT01568866|3835947|FG001|Received Treatment|Overall Study||463
3111297|NCT01568866|3835946|FG000|COMPLETED|Overall Study|Indicates participants still receiving treatment|27
3111298|NCT01568866|3835947|FG001|COMPLETED|Overall Study|Indicates participants still receiving treatment|48
3111299|NCT01568866|3835946|FG000|NOT COMPLETED|Overall Study||438
3111300|NCT01568866|3835947|FG001|NOT COMPLETED|Overall Study||416
3111301|NCT01568892|3835955|FG000|STARTED|Double-blind Phase||14
3111302|NCT01568892|3835956|FG001|STARTED|Double-blind Phase||16
3111303|NCT01568892|3835955|FG000|COMPLETED|Double-blind Phase||14
3111304|NCT01568892|3835956|FG001|COMPLETED|Double-blind Phase||16
3111305|NCT01568892|3835955|FG000|NOT COMPLETED|Double-blind Phase||0
3111306|NCT01568892|3835956|FG001|NOT COMPLETED|Double-blind Phase||0
3111307|NCT01568892|3835955|FG000|STARTED|Open-label Phase|One participant completing the DB Phase withdrew on Day 8 and did not enter the Open-label Phase.|13
3111308|NCT01568892|3835956|FG001|STARTED|Open-label Phase||16
3111309|NCT01568892|3835955|FG000|COMPLETED|Open-label Phase||7
3111310|NCT01568892|3835956|FG001|COMPLETED|Open-label Phase||13
3111311|NCT01568892|3835955|FG000|NOT COMPLETED|Open-label Phase||6
3111312|NCT01568892|3835956|FG001|NOT COMPLETED|Open-label Phase||3
3111313|NCT01568905|3835966|FG000|STARTED|Overall Study||13
3111314|NCT01568905|3835967|FG001|STARTED|Overall Study||11
3111315|NCT01568905|3835968|FG002|STARTED|Overall Study||12
3111316|NCT01568905|3835966|FG000|COMPLETED|Overall Study||12
3111317|NCT01568905|3835967|FG001|COMPLETED|Overall Study||11
3111318|NCT01568905|3835968|FG002|COMPLETED|Overall Study||12
3111319|NCT01568905|3835966|FG000|NOT COMPLETED|Overall Study||1
3111320|NCT01568905|3835967|FG001|NOT COMPLETED|Overall Study||0
3111321|NCT01568905|3835968|FG002|NOT COMPLETED|Overall Study||0
3111322|NCT01568944|3835978|FG000|STARTED|Overall Study||8
3111323|NCT01568944|3835979|FG001|STARTED|Overall Study||10
3111324|NCT01568944|3835978|FG000|COMPLETED|Overall Study||8
3111325|NCT01568944|3835979|FG001|COMPLETED|Overall Study||10
3111326|NCT01568944|3835978|FG000|NOT COMPLETED|Overall Study||0
3111327|NCT01568944|3835979|FG001|NOT COMPLETED|Overall Study||0
3111328|NCT01569022|3835985|FG000|STARTED|First Intervention||21
3111329|NCT01569022|3835986|FG001|STARTED|First Intervention||21
3111330|NCT01569022|3835985|FG000|COMPLETED|First Intervention||19
3111331|NCT01569022|3835986|FG001|COMPLETED|First Intervention||20
3293704|NCT02873221|4027690|FG002|Safety Population: Received Study Drug|Treatment Period||409
3293705|NCT02873221|4027688|FG000|COMPLETED|Treatment Period||329
3111332|NCT01569022|3835985|FG000|NOT COMPLETED|First Intervention||2
3111333|NCT01569022|3835986|FG001|NOT COMPLETED|First Intervention||1
3111334|NCT01569022|3835985|FG000|STARTED|Second Intervention||19
3111335|NCT01569022|3835986|FG001|STARTED|Second Intervention||20
3111336|NCT01569022|3835985|FG000|COMPLETED|Second Intervention||17
3111337|NCT01569022|3835986|FG001|COMPLETED|Second Intervention||18
3111338|NCT01569022|3835985|FG000|NOT COMPLETED|Second Intervention||2
3111339|NCT01569022|3835986|FG001|NOT COMPLETED|Second Intervention||2
3111340|NCT01569074|3835999|FG000|STARTED|Overall Study|Patients who received treatment|31
3111341|NCT01569074|3836000|FG001|STARTED|Overall Study|Patients who received treatment|33
3111342|NCT01569074|3836001|FG002|STARTED|Overall Study|Patients who received treatment|33
3293706|NCT02873221|4027689|FG001|COMPLETED|Treatment Period||291
3111343|NCT01569074|3836002|FG003|STARTED|Overall Study|Patients who received treatment|33
3111344|NCT01569074|3836003|FG004|STARTED|Overall Study|Patients who received treatment|33
3111345|NCT01569074|3835999|FG000|Randomised But Did Not Receive Treatment|Overall Study||0
3111346|NCT01569074|3836000|FG001|Randomised But Did Not Receive Treatment|Overall Study||0
3111347|NCT01569074|3836001|FG002|Randomised But Did Not Receive Treatment|Overall Study||0
3111348|NCT01569074|3836002|FG003|Randomised But Did Not Receive Treatment|Overall Study||0
3111349|NCT01569074|3836003|FG004|Randomised But Did Not Receive Treatment|Overall Study||0
3111350|NCT01569074|3835999|FG000|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|24
3111351|NCT01569074|3836000|FG001|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|24
3111352|NCT01569074|3836001|FG002|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|21
3111353|NCT01569074|3836002|FG003|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|25
3111354|NCT01569074|3836003|FG004|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|25
3111355|NCT01569074|3835999|FG000|NOT COMPLETED|Overall Study||7
3111356|NCT01569074|3836000|FG001|NOT COMPLETED|Overall Study||9
3111357|NCT01569074|3836001|FG002|NOT COMPLETED|Overall Study||12
3111358|NCT01569074|3836002|FG003|NOT COMPLETED|Overall Study||8
3111359|NCT01569074|3836003|FG004|NOT COMPLETED|Overall Study||8
3111360|NCT01569087|3836022|FG000|STARTED|Overall Study||21
3111361|NCT01569087|3836023|FG001|STARTED|Overall Study||20
3111362|NCT01569087|3836024|FG002|STARTED|Overall Study||19
3111363|NCT01569087|3836022|FG000|COMPLETED|Overall Study||20
3111364|NCT01569087|3836023|FG001|COMPLETED|Overall Study||20
3111365|NCT01569087|3836024|FG002|COMPLETED|Overall Study||18
3111366|NCT01569087|3836022|FG000|NOT COMPLETED|Overall Study||1
3111367|NCT01569087|3836023|FG001|NOT COMPLETED|Overall Study||0
3111368|NCT01569087|3836024|FG002|NOT COMPLETED|Overall Study||1
3111369|NCT01569126|3836038|FG000|STARTED|Overall Study||8
3111370|NCT01569126|3836039|FG001|STARTED|Overall Study||8
3111371|NCT01569126|3836040|FG002|STARTED|Overall Study||8
3111372|NCT01569126|3836041|FG003|STARTED|Overall Study||8
3111373|NCT01569126|3836042|FG004|STARTED|Overall Study||12
3111374|NCT01569126|3836043|FG005|STARTED|Overall Study||12
3111375|NCT01569126|3836038|FG000|Received at Least 1 Dose of Study Drug|Overall Study||8
3111376|NCT01569126|3836039|FG001|Received at Least 1 Dose of Study Drug|Overall Study||8
3111377|NCT01569126|3836040|FG002|Received at Least 1 Dose of Study Drug|Overall Study||8
3111378|NCT01569126|3836041|FG003|Received at Least 1 Dose of Study Drug|Overall Study||8
3111379|NCT01569126|3836042|FG004|Received at Least 1 Dose of Study Drug|Overall Study||12
3111380|NCT01569126|3836043|FG005|Received at Least 1 Dose of Study Drug|Overall Study||12
3111381|NCT01569126|3836038|FG000|COMPLETED|Overall Study||8
3111382|NCT01569126|3836039|FG001|COMPLETED|Overall Study||8
3111383|NCT01569126|3836040|FG002|COMPLETED|Overall Study||8
3111384|NCT01569126|3836041|FG003|COMPLETED|Overall Study||8
3111385|NCT01569126|3836042|FG004|COMPLETED|Overall Study||12
3111386|NCT01569126|3836043|FG005|COMPLETED|Overall Study||12
3111387|NCT01569126|3836038|FG000|NOT COMPLETED|Overall Study||0
3111388|NCT01569126|3836039|FG001|NOT COMPLETED|Overall Study||0
3111389|NCT01569126|3836040|FG002|NOT COMPLETED|Overall Study||0
3111390|NCT01569126|3836041|FG003|NOT COMPLETED|Overall Study||0
3111391|NCT01569126|3836042|FG004|NOT COMPLETED|Overall Study||0
3111392|NCT01569126|3836043|FG005|NOT COMPLETED|Overall Study||0
3111393|NCT01569152|3836064|FG000|STARTED|Phase IIa, Period 1||41
3111394|NCT01569152|3836065|FG001|STARTED|Phase IIa, Period 1||41
3111395|NCT01569152|3836066|FG002|STARTED|Phase IIa, Period 1||0
3111396|NCT01569152|3836064|FG000|COMPLETED|Phase IIa, Period 1||20
3111397|NCT01569152|3836065|FG001|COMPLETED|Phase IIa, Period 1||9
3111398|NCT01569152|3836066|FG002|COMPLETED|Phase IIa, Period 1||0
3111399|NCT01569152|3836064|FG000|NOT COMPLETED|Phase IIa, Period 1||21
3111400|NCT01569152|3836065|FG001|NOT COMPLETED|Phase IIa, Period 1||32
3111401|NCT01569152|3836066|FG002|NOT COMPLETED|Phase IIa, Period 1||0
3111402|NCT01569152|3836064|FG000|STARTED|Safety Extension, Period 3||0
3111403|NCT01569152|3836065|FG001|STARTED|Safety Extension, Period 3||0
3111404|NCT01569152|3836066|FG002|STARTED|Safety Extension, Period 3|Includes 29 completers and 26 early escapees from Base Study Phase IIa|55
3111405|NCT01569152|3836064|FG000|COMPLETED|Safety Extension, Period 3||0
3111406|NCT01569152|3836065|FG001|COMPLETED|Safety Extension, Period 3||0
3111407|NCT01569152|3836066|FG002|COMPLETED|Safety Extension, Period 3||0
3111408|NCT01569152|3836064|FG000|NOT COMPLETED|Safety Extension, Period 3||0
3111409|NCT01569152|3836065|FG001|NOT COMPLETED|Safety Extension, Period 3||0
3111410|NCT01569152|3836066|FG002|NOT COMPLETED|Safety Extension, Period 3||55
3111411|NCT01569191|3836075|FG000|STARTED|Overall Study||11
3111412|NCT01569191|3836076|FG001|STARTED|Overall Study||7
3111413|NCT01569191|3836075|FG000|COMPLETED|Overall Study||11
3111414|NCT01569191|3836076|FG001|COMPLETED|Overall Study||7
3111415|NCT01569191|3836075|FG000|NOT COMPLETED|Overall Study||0
3111416|NCT01569191|3836076|FG001|NOT COMPLETED|Overall Study||0
3111417|NCT01569295|3836088|FG000|STARTED|Overall Study||207
3111418|NCT01569295|3836089|FG001|STARTED|Overall Study||209
3111419|NCT01569295|3836088|FG000|Long-Term Follow-up|Overall Study||109
3111420|NCT01569295|3836089|FG001|Long-Term Follow-up|Overall Study||161
3111421|NCT01569295|3836088|FG000|COMPLETED|Overall Study||0
3111422|NCT01569295|3836089|FG001|COMPLETED|Overall Study||0
3111423|NCT01569295|3836088|FG000|NOT COMPLETED|Overall Study||207
3111424|NCT01569295|3836089|FG001|NOT COMPLETED|Overall Study||209
3111425|NCT01569438|3836098|FG000|STARTED|Overall Study||52
3111426|NCT01569438|3836099|FG001|STARTED|Overall Study||55
3111427|NCT01569438|3836098|FG000|Treated|Overall Study||51
3111428|NCT01569438|3836099|FG001|Treated|Overall Study||54
3111429|NCT01569438|3836098|FG000|Titration Set|Overall Study||38
3111430|NCT01569438|3836099|FG001|Titration Set|Overall Study||36
3111431|NCT01569438|3836098|FG000|COMPLETED|Overall Study||45
3111432|NCT01569438|3836099|FG001|COMPLETED|Overall Study||33
3111433|NCT01569438|3836098|FG000|NOT COMPLETED|Overall Study||7
3111434|NCT01569438|3836099|FG001|NOT COMPLETED|Overall Study||22
3111435|NCT01569451|3836107|FG000|STARTED|Overall Study||26
3111436|NCT01569451|3836108|FG001|STARTED|Overall Study||27
3111437|NCT01569451|3836107|FG000|COMPLETED|Overall Study||12
3111438|NCT01569451|3836108|FG001|COMPLETED|Overall Study||14
3111439|NCT01569451|3836107|FG000|NOT COMPLETED|Overall Study||14
3111440|NCT01569451|3836108|FG001|NOT COMPLETED|Overall Study||13
3111441|NCT01569464|3836118|FG000|STARTED|Overall Study||101
3111442|NCT01569464|3836119|FG001|STARTED|Overall Study||49
3111443|NCT01569464|3836118|FG000|COMPLETED|Overall Study||91
3111444|NCT01569464|3836119|FG001|COMPLETED|Overall Study||44
3111445|NCT01569464|3836118|FG000|NOT COMPLETED|Overall Study||10
3111446|NCT01569464|3836119|FG001|NOT COMPLETED|Overall Study||5
3111447|NCT01569529|3836129|FG000|STARTED|Overall Study||2676
3111448|NCT01569529|3836130|FG001|STARTED|Overall Study||394
3111449|NCT01569529|3836129|FG000|COMPLETED|Overall Study||2676
3111450|NCT01569529|3836130|FG001|COMPLETED|Overall Study||394
3111451|NCT01569529|3836129|FG000|NOT COMPLETED|Overall Study||0
3111452|NCT01569529|3836130|FG001|NOT COMPLETED|Overall Study||0
3111453|NCT01569568|3836138|FG000|STARTED|Overall Study||20
3111454|NCT01569568|3836139|FG001|STARTED|Overall Study||29
3111455|NCT01569568|3836138|FG000|COMPLETED|Overall Study||20
3111456|NCT01569568|3836139|FG001|COMPLETED|Overall Study||27
3111457|NCT01569568|3836138|FG000|NOT COMPLETED|Overall Study||0
3111458|NCT01569568|3836139|FG001|NOT COMPLETED|Overall Study||2
3111459|NCT01569594|3836145|FG000|STARTED|Overall Study||230
3111460|NCT01569594|3836145|FG000|COMPLETED|Overall Study||163
3111461|NCT01569594|3836145|FG000|NOT COMPLETED|Overall Study||67
3111462|NCT01569607|3836151|FG000|STARTED|Overall Study||11
3111463|NCT01569607|3836152|FG001|STARTED|Overall Study||11
3111464|NCT01569607|3836151|FG000|COMPLETED|Overall Study||10
3111465|NCT01569607|3836152|FG001|COMPLETED|Overall Study||10
3111466|NCT01569607|3836151|FG000|NOT COMPLETED|Overall Study||1
3111467|NCT01569607|3836152|FG001|NOT COMPLETED|Overall Study||1
3111468|NCT01569737|3836158|FG000|STARTED|Overall Study||98
3111469|NCT01569737|3836158|FG000|COMPLETED|Overall Study||95
3111470|NCT01569737|3836158|FG000|NOT COMPLETED|Overall Study||3
3111471|NCT01569763|3836164|FG000|STARTED|Overall Study||102
3111472|NCT01569763|3836165|FG001|STARTED|Overall Study||51
3111473|NCT01569763|3836164|FG000|Treated|Overall Study||102
3111474|NCT01569763|3836165|FG001|Treated|Overall Study||51
3111475|NCT01569763|3836164|FG000|COMPLETED|Overall Study|Completed 12 Months of Follow-up|99
3111476|NCT01569763|3836165|FG001|COMPLETED|Overall Study|Completed 12 Months of Follow-up|44
3111477|NCT01569763|3836164|FG000|NOT COMPLETED|Overall Study||3
3111478|NCT01569763|3836165|FG001|NOT COMPLETED|Overall Study||7
3111479|NCT01569815|3836175|FG000|STARTED|Overall Study||8
3111480|NCT01569815|3836176|FG001|STARTED|Overall Study||8
3111481|NCT01569815|3836177|FG002|STARTED|Overall Study||8
3111482|NCT01569815|3836178|FG003|STARTED|Overall Study||8
3111483|NCT01569815|3836175|FG000|COMPLETED|Overall Study||8
3111484|NCT01569815|3836176|FG001|COMPLETED|Overall Study||8
3111485|NCT01569815|3836177|FG002|COMPLETED|Overall Study||8
3111486|NCT01569815|3836178|FG003|COMPLETED|Overall Study||8
3111487|NCT01569815|3836175|FG000|NOT COMPLETED|Overall Study||0
3111488|NCT01569815|3836176|FG001|NOT COMPLETED|Overall Study||0
3111489|NCT01569815|3836177|FG002|NOT COMPLETED|Overall Study||0
3111490|NCT01569815|3836178|FG003|NOT COMPLETED|Overall Study||0
3111491|NCT01569828|3836191|FG000|STARTED|Overall Study||6
3111492|NCT01569828|3836192|FG001|STARTED|Overall Study||6
3111493|NCT01569828|3836191|FG000|COMPLETED|Overall Study||6
3111494|NCT01569828|3836192|FG001|COMPLETED|Overall Study||6
3111495|NCT01569828|3836191|FG000|NOT COMPLETED|Overall Study||0
3111496|NCT01569828|3836192|FG001|NOT COMPLETED|Overall Study||0
3111497|NCT01569841|3836199|FG000|STARTED|Period A (6 Weeks)||12
3111498|NCT01569841|3836200|FG001|STARTED|Period A (6 Weeks)||12
3111499|NCT01569841|3836199|FG000|Exposed|Period A (6 Weeks)||12
3111500|NCT01569841|3836200|FG001|Exposed|Period A (6 Weeks)||12
3111501|NCT01569841|3836199|FG000|COMPLETED|Period A (6 Weeks)||12
3111502|NCT01569841|3836200|FG001|COMPLETED|Period A (6 Weeks)||11
3111503|NCT01569841|3836199|FG000|NOT COMPLETED|Period A (6 Weeks)||0
3111504|NCT01569841|3836200|FG001|NOT COMPLETED|Period A (6 Weeks)||1
3111505|NCT01569841|3836199|FG000|STARTED|Period B (6 Weeks)||12
3111506|NCT01569841|3836200|FG001|STARTED|Period B (6 Weeks)||11
3111507|NCT01569841|3836199|FG000|Exposed|Period B (6 Weeks)||12
3111508|NCT01569841|3836200|FG001|Exposed|Period B (6 Weeks)||11
3111509|NCT01569841|3836199|FG000|COMPLETED|Period B (6 Weeks)||12
3111510|NCT01569841|3836200|FG001|COMPLETED|Period B (6 Weeks)||11
3111511|NCT01569841|3836199|FG000|NOT COMPLETED|Period B (6 Weeks)||0
3111512|NCT01569841|3836200|FG001|NOT COMPLETED|Period B (6 Weeks)||0
3111513|NCT01570036|3836210|FG000|STARTED|Overall Study||136
3111514|NCT01570036|3836211|FG001|STARTED|Overall Study||139
3111515|NCT01570036|3836210|FG000|Primary Vaccine Series Completed|Overall Study||121
3111516|NCT01570036|3836211|FG001|Primary Vaccine Series Completed|Overall Study||132
3111517|NCT01570036|3836210|FG000|Booster Series Completed|Overall Study||40
3111518|NCT01570036|3836211|FG001|Booster Series Completed|Overall Study||30
3111519|NCT01570036|3836210|FG000|COMPLETED|Overall Study||18
3111520|NCT01570036|3836211|FG001|COMPLETED|Overall Study||17
3111521|NCT01570036|3836210|FG000|NOT COMPLETED|Overall Study||118
3111522|NCT01570036|3836211|FG001|NOT COMPLETED|Overall Study||122
3111523|NCT01570192|3836219|FG000|STARTED|Overall Study||13
3111524|NCT01570192|3836220|FG001|STARTED|Overall Study||30
3111525|NCT01570192|3836219|FG000|COMPLETED|Overall Study||6
3111526|NCT01570192|3836220|FG001|COMPLETED|Overall Study||17
3111527|NCT01570192|3836219|FG000|NOT COMPLETED|Overall Study||7
3111528|NCT01570192|3836220|FG001|NOT COMPLETED|Overall Study||13
3111529|NCT01570244|3836231|FG000|STARTED|Microgynon||16
3111530|NCT01570244|3836231|FG000|COMPLETED|Microgynon||16
3111531|NCT01570244|3836231|FG000|NOT COMPLETED|Microgynon||0
3111532|NCT01570244|3836231|FG000|STARTED|Microgynon+Faldaprevir||16
3111533|NCT01570244|3836231|FG000|COMPLETED|Microgynon+Faldaprevir||15
3111534|NCT01570244|3836231|FG000|NOT COMPLETED|Microgynon+Faldaprevir||1
3111535|NCT01570283|3836240|FG000|STARTED|Cohort 1: Dose Level 1||1
3111536|NCT01570283|3836241|FG001|STARTED|Cohort 1: Dose Level 1||3
3111537|NCT01570283|3836242|FG002|STARTED|Cohort 1: Dose Level 1||0
3111538|NCT01570283|3836243|FG003|STARTED|Cohort 1: Dose Level 1||0
3111539|NCT01570283|3836244|FG004|STARTED|Cohort 1: Dose Level 1||0
3111540|NCT01570283|3836245|FG005|STARTED|Cohort 1: Dose Level 1||0
3111541|NCT01570283|3836240|FG000|COMPLETED|Cohort 1: Dose Level 1||1
3111542|NCT01570283|3836241|FG001|COMPLETED|Cohort 1: Dose Level 1||1
3111543|NCT01570283|3836242|FG002|COMPLETED|Cohort 1: Dose Level 1||0
3111544|NCT01570283|3836243|FG003|COMPLETED|Cohort 1: Dose Level 1||0
3111545|NCT01570283|3836244|FG004|COMPLETED|Cohort 1: Dose Level 1||0
3111546|NCT01570283|3836245|FG005|COMPLETED|Cohort 1: Dose Level 1||0
3111547|NCT01570283|3836240|FG000|NOT COMPLETED|Cohort 1: Dose Level 1||0
3111548|NCT01570283|3836241|FG001|NOT COMPLETED|Cohort 1: Dose Level 1||2
3111549|NCT01570283|3836242|FG002|NOT COMPLETED|Cohort 1: Dose Level 1||0
3111550|NCT01570283|3836243|FG003|NOT COMPLETED|Cohort 1: Dose Level 1||0
3111551|NCT01570283|3836244|FG004|NOT COMPLETED|Cohort 1: Dose Level 1||0
3111552|NCT01570283|3836245|FG005|NOT COMPLETED|Cohort 1: Dose Level 1||0
3111553|NCT01570283|3836240|FG000|STARTED|Cohort 2: Dose Level 2||0
3111554|NCT01570283|3836241|FG001|STARTED|Cohort 2: Dose Level 2||0
3111555|NCT01570283|3836242|FG002|STARTED|Cohort 2: Dose Level 2||2
3111556|NCT01570283|3836243|FG003|STARTED|Cohort 2: Dose Level 2||2
3111557|NCT01570283|3836244|FG004|STARTED|Cohort 2: Dose Level 2||0
3111558|NCT01570283|3836245|FG005|STARTED|Cohort 2: Dose Level 2||0
3111559|NCT01570283|3836240|FG000|COMPLETED|Cohort 2: Dose Level 2||0
3111560|NCT01570283|3836241|FG001|COMPLETED|Cohort 2: Dose Level 2||0
3111561|NCT01570283|3836242|FG002|COMPLETED|Cohort 2: Dose Level 2||1
3111562|NCT01570283|3836243|FG003|COMPLETED|Cohort 2: Dose Level 2||1
3111563|NCT01570283|3836244|FG004|COMPLETED|Cohort 2: Dose Level 2||0
3111564|NCT01570283|3836245|FG005|COMPLETED|Cohort 2: Dose Level 2||0
3111565|NCT01570283|3836240|FG000|NOT COMPLETED|Cohort 2: Dose Level 2||0
3111566|NCT01570283|3836241|FG001|NOT COMPLETED|Cohort 2: Dose Level 2||0
3111567|NCT01570283|3836242|FG002|NOT COMPLETED|Cohort 2: Dose Level 2||1
3111568|NCT01570283|3836243|FG003|NOT COMPLETED|Cohort 2: Dose Level 2||1
3111569|NCT01570283|3836244|FG004|NOT COMPLETED|Cohort 2: Dose Level 2||0
3111570|NCT01570283|3836245|FG005|NOT COMPLETED|Cohort 2: Dose Level 2||0
3111571|NCT01570283|3836240|FG000|STARTED|Cohort 3: Dose Level 3||0
3111572|NCT01570283|3836241|FG001|STARTED|Cohort 3: Dose Level 3||0
3111573|NCT01570283|3836242|FG002|STARTED|Cohort 3: Dose Level 3||0
3111574|NCT01570283|3836243|FG003|STARTED|Cohort 3: Dose Level 3||0
3111575|NCT01570283|3836244|FG004|STARTED|Cohort 3: Dose Level 3||1
3111576|NCT01570283|3836245|FG005|STARTED|Cohort 3: Dose Level 3||12
3111577|NCT01570283|3836240|FG000|COMPLETED|Cohort 3: Dose Level 3||0
3111578|NCT01570283|3836241|FG001|COMPLETED|Cohort 3: Dose Level 3||0
3111579|NCT01570283|3836242|FG002|COMPLETED|Cohort 3: Dose Level 3||0
3111580|NCT01570283|3836243|FG003|COMPLETED|Cohort 3: Dose Level 3||0
3111581|NCT01570283|3836244|FG004|COMPLETED|Cohort 3: Dose Level 3||1
3111582|NCT01570283|3836245|FG005|COMPLETED|Cohort 3: Dose Level 3||10
3111583|NCT01570283|3836240|FG000|NOT COMPLETED|Cohort 3: Dose Level 3||0
3111584|NCT01570283|3836241|FG001|NOT COMPLETED|Cohort 3: Dose Level 3||0
3111585|NCT01570283|3836242|FG002|NOT COMPLETED|Cohort 3: Dose Level 3||0
3111586|NCT01570283|3836243|FG003|NOT COMPLETED|Cohort 3: Dose Level 3||0
3111587|NCT01570283|3836244|FG004|NOT COMPLETED|Cohort 3: Dose Level 3||0
3111588|NCT01570283|3836245|FG005|NOT COMPLETED|Cohort 3: Dose Level 3||2
3111589|NCT01570309|3836261|FG000|STARTED|Overall Study||48
3111590|NCT01570309|3836262|FG001|STARTED|Overall Study||48
3111591|NCT01570309|3836261|FG000|COMPLETED|Overall Study||45
3111592|NCT01570309|3836262|FG001|COMPLETED|Overall Study||45
3111593|NCT01570309|3836261|FG000|NOT COMPLETED|Overall Study||3
3111594|NCT01570309|3836262|FG001|NOT COMPLETED|Overall Study||3
3111595|NCT01570348|3836272|FG000|STARTED|Overall Study||2
3111596|NCT01570348|3836272|FG000|COMPLETED|Overall Study||2
3111597|NCT01570348|3836272|FG000|NOT COMPLETED|Overall Study||0
3111598|NCT01570361|3836278|FG000|STARTED|Overall Study||128
3111599|NCT01570361|3836279|FG001|STARTED|Overall Study||127
3111600|NCT01570361|3836278|FG000|Received Study Treatment|Overall Study||102
3111601|NCT01570361|3836279|FG001|Received Study Treatment|Overall Study||123
3111602|NCT01570361|3836278|FG000|Cross-over (AAD Therapy to RF Ablation)|Overall Study||0
3111603|NCT01570361|3836279|FG001|Cross-over (AAD Therapy to RF Ablation)|Overall Study||15
3111604|NCT01570361|3836278|FG000|AAD Therapy Only|Overall Study||0
3111605|NCT01570361|3836279|FG001|AAD Therapy Only|Overall Study||108
3111606|NCT01570361|3836278|FG000|COMPLETED|Overall Study||46
3111607|NCT01570361|3836279|FG001|COMPLETED|Overall Study||52
3111608|NCT01570361|3836278|FG000|NOT COMPLETED|Overall Study||82
3111609|NCT01570361|3836279|FG001|NOT COMPLETED|Overall Study||75
3111610|NCT01570387|3836292|FG000|STARTED|Overall Study||6
3111611|NCT01570387|3836293|FG001|STARTED|Overall Study||3
3111612|NCT01570387|3836294|FG002|STARTED|Overall Study||6
3111613|NCT01570387|3836295|FG003|STARTED|Overall Study||12
3111614|NCT01570387|3836292|FG000|Dose Limiting Toxicity|Overall Study||0
3111615|NCT01570387|3836293|FG001|Dose Limiting Toxicity|Overall Study||0
3111616|NCT01570387|3836294|FG002|Dose Limiting Toxicity|Overall Study||6
3111617|NCT01570387|3836295|FG003|Dose Limiting Toxicity|Overall Study||12
3111618|NCT01570387|3836292|FG000|Response to Maximal Tolerated Dose|Overall Study||0
3111619|NCT01570387|3836293|FG001|Response to Maximal Tolerated Dose|Overall Study||0
3111620|NCT01570387|3836294|FG002|Response to Maximal Tolerated Dose|Overall Study||3
3111621|NCT01570387|3836295|FG003|Response to Maximal Tolerated Dose|Overall Study||6
3111622|NCT01570387|3836292|FG000|COMPLETED|Overall Study||5
3111623|NCT01570387|3836293|FG001|COMPLETED|Overall Study||3
3111624|NCT01570387|3836294|FG002|COMPLETED|Overall Study||6
3111625|NCT01570387|3836295|FG003|COMPLETED|Overall Study||10
3111626|NCT01570387|3836292|FG000|NOT COMPLETED|Overall Study||1
3111627|NCT01570387|3836293|FG001|NOT COMPLETED|Overall Study||0
3111628|NCT01570387|3836294|FG002|NOT COMPLETED|Overall Study||0
3111629|NCT01570387|3836295|FG003|NOT COMPLETED|Overall Study||2
3111630|NCT01570491|3836304|FG000|STARTED|Overall Study||19
3111631|NCT01570491|3836305|FG001|STARTED|Overall Study||19
3111632|NCT01570491|3836304|FG000|COMPLETED|Overall Study||14
3111633|NCT01570491|3836305|FG001|COMPLETED|Overall Study||18
3111634|NCT01570491|3836304|FG000|NOT COMPLETED|Overall Study||5
3111635|NCT01570491|3836305|FG001|NOT COMPLETED|Overall Study||1
3111636|NCT01570686|3836313|FG000|STARTED|Overall Study||296
3111637|NCT01570686|3836314|FG001|STARTED|Overall Study||294
3111638|NCT01570686|3836313|FG000|Safety and Full Analysis Set (FAS)|Overall Study|One patient was mis-randomized and never received study drug. Hence not included in Safety or FAS.|295
3111639|NCT01570686|3836314|FG001|Safety and Full Analysis Set (FAS)|Overall Study||294
3111640|NCT01570686|3836313|FG000|COMPLETED|Overall Study||274
3111641|NCT01570686|3836314|FG001|COMPLETED|Overall Study||278
3111642|NCT01570686|3836313|FG000|NOT COMPLETED|Overall Study||22
3111643|NCT01570686|3836314|FG001|NOT COMPLETED|Overall Study||16
3111644|NCT01570751|3836322|FG000|STARTED|Period A (16 Weeks)||73
3111645|NCT01570751|3836323|FG001|STARTED|Period A (16 Weeks)||72
3111646|NCT01570751|3836322|FG000|Exposed|Period A (16 Weeks)||73
3111647|NCT01570751|3836323|FG001|Exposed|Period A (16 Weeks)||72
3111648|NCT01570751|3836322|FG000|COMPLETED|Period A (16 Weeks)||70
3111649|NCT01570751|3836323|FG001|COMPLETED|Period A (16 Weeks)||67
3111650|NCT01570751|3836322|FG000|NOT COMPLETED|Period A (16 Weeks)||3
3111651|NCT01570751|3836323|FG001|NOT COMPLETED|Period A (16 Weeks)||5
3111652|NCT01570751|3836322|FG000|STARTED|Period B (16 Weeks)||70
3111653|NCT01570751|3836323|FG001|STARTED|Period B (16 Weeks)||67
3111654|NCT01570751|3836322|FG000|Exposed|Period B (16 Weeks)||70
3111655|NCT01570751|3836323|FG001|Exposed|Period B (16 Weeks)||67
3111656|NCT01570751|3836322|FG000|COMPLETED|Period B (16 Weeks)||69
3111657|NCT01570751|3836323|FG001|COMPLETED|Period B (16 Weeks)||66
3111658|NCT01570751|3836322|FG000|NOT COMPLETED|Period B (16 Weeks)||1
3111659|NCT01570751|3836323|FG001|NOT COMPLETED|Period B (16 Weeks)||1
3111660|NCT01570829|3836333|FG000|STARTED|Overall Study||164
3111661|NCT01570829|3836334|FG001|STARTED|Overall Study||167
3111662|NCT01570829|3836333|FG000|COMPLETED|Overall Study||164
3111663|NCT01570829|3836334|FG001|COMPLETED|Overall Study||167
3111664|NCT01570829|3836333|FG000|NOT COMPLETED|Overall Study||0
3111665|NCT01570829|3836334|FG001|NOT COMPLETED|Overall Study||0
3111666|NCT01570868|3836342|FG000|STARTED|Overall Study||43
3111667|NCT01570868|3836343|FG001|STARTED|Overall Study||8
3111668|NCT01570868|3836342|FG000|COMPLETED|Overall Study||0
3111669|NCT01570868|3836343|FG001|COMPLETED|Overall Study||0
3111670|NCT01570868|3836342|FG000|NOT COMPLETED|Overall Study||43
3111671|NCT01570868|3836343|FG001|NOT COMPLETED|Overall Study||8
3111672|NCT01571232|3836355|FG000|STARTED|Overall Study||10
3111673|NCT01571232|3836356|FG001|STARTED|Overall Study||10
3111674|NCT01571232|3836355|FG000|COMPLETED|Overall Study||9
3111675|NCT01571232|3836356|FG001|COMPLETED|Overall Study||9
3111676|NCT01571232|3836355|FG000|NOT COMPLETED|Overall Study||1
3111677|NCT01571232|3836356|FG001|NOT COMPLETED|Overall Study||1
3111678|NCT01571284|3836363|FG000|STARTED|Overall Study||781
3111679|NCT01571284|3836363|FG000|Safety Population|Overall Study||779
3111680|NCT01571284|3836363|FG000|COMPLETED|Overall Study|403 participants with DP and 209 with adverse events were considered as completed.|612
3111681|NCT01571284|3836363|FG000|NOT COMPLETED|Overall Study||169
3111682|NCT01571362|3836367|FG000|STARTED|Open-Label Conversion + Titration Period||410
3111683|NCT01571362|3836368|FG001|STARTED|Open-Label Conversion + Titration Period|This phase commenced after the Open-Label Period.|0
3111684|NCT01571362|3836369|FG002|STARTED|Open-Label Conversion + Titration Period|This phase commenced after the Open-Label Period.|0
3111685|NCT01571362|3836367|FG000|COMPLETED|Open-Label Conversion + Titration Period||281
3111686|NCT01571362|3836368|FG001|COMPLETED|Open-Label Conversion + Titration Period|This phase commenced after the Open-Label Period.|0
3293707|NCT02873221|4027690|FG002|COMPLETED|Treatment Period||315
3293708|NCT02873221|4027688|FG000|NOT COMPLETED|Treatment Period||88
3293709|NCT02873221|4027689|FG001|NOT COMPLETED|Treatment Period||126
3293710|NCT02873221|4027690|FG002|NOT COMPLETED|Treatment Period||105
3293711|NCT02873221|4027688|FG000|STARTED|Safety Follow-up Period||350
3293712|NCT02873221|4027689|FG001|STARTED|Safety Follow-up Period||356
3293713|NCT02873221|4027690|FG002|STARTED|Safety Follow-up Period||364
3293714|NCT02873221|4027688|FG000|COMPLETED|Safety Follow-up Period||343
3293715|NCT02873221|4027689|FG001|COMPLETED|Safety Follow-up Period||339
3293716|NCT02873221|4027690|FG002|COMPLETED|Safety Follow-up Period||350
3293717|NCT02873221|4027688|FG000|NOT COMPLETED|Safety Follow-up Period||7
3293718|NCT02873221|4027689|FG001|NOT COMPLETED|Safety Follow-up Period||17
3293719|NCT02873221|4027690|FG002|NOT COMPLETED|Safety Follow-up Period||14
3293720|NCT02873286|4027703|FG000|STARTED|Main Study||78
3293721|NCT02873286|4027704|FG001|STARTED|Main Study||89
3293722|NCT02873286|4027705|FG002|STARTED|Main Study||80
3293723|NCT02873286|4027706|FG003|STARTED|Main Study||90
3293724|NCT02873286|4027707|FG004|STARTED|Main Study||83
3293725|NCT02873286|4027703|FG000|COMPLETED|Main Study||76
3293726|NCT02873286|4027704|FG001|COMPLETED|Main Study||84
3293727|NCT02873286|4027705|FG002|COMPLETED|Main Study||78
3293728|NCT02873286|4027706|FG003|COMPLETED|Main Study||89
3293729|NCT02873286|4027707|FG004|COMPLETED|Main Study||81
3293730|NCT02873286|4027703|FG000|NOT COMPLETED|Main Study||2
3293731|NCT02873286|4027704|FG001|NOT COMPLETED|Main Study||5
3293732|NCT02873286|4027705|FG002|NOT COMPLETED|Main Study||2
3293733|NCT02873286|4027706|FG003|NOT COMPLETED|Main Study||1
3293734|NCT02873286|4027707|FG004|NOT COMPLETED|Main Study||2
3293735|NCT02873286|4027703|FG000|STARTED|Booster Substudy||43
3293736|NCT02873286|4027704|FG001|STARTED|Booster Substudy||0
3293737|NCT02873286|4027705|FG002|STARTED|Booster Substudy||45
3293738|NCT02873286|4027706|FG003|STARTED|Booster Substudy||0
3293739|NCT02873286|4027707|FG004|STARTED|Booster Substudy||0
3293740|NCT02873286|4027703|FG000|COMPLETED|Booster Substudy||43
3293741|NCT02873286|4027704|FG001|COMPLETED|Booster Substudy||0
3293742|NCT02873286|4027705|FG002|COMPLETED|Booster Substudy||45
3293743|NCT02873286|4027706|FG003|COMPLETED|Booster Substudy||0
3293744|NCT02873286|4027707|FG004|COMPLETED|Booster Substudy||0
3293745|NCT02873286|4027703|FG000|NOT COMPLETED|Booster Substudy||0
3111687|NCT01571362|3836369|FG002|COMPLETED|Open-Label Conversion + Titration Period|This phase commenced after the Open-Label Period.|0
3111688|NCT01571362|3836367|FG000|NOT COMPLETED|Open-Label Conversion + Titration Period||129
3111689|NCT01571362|3836368|FG001|NOT COMPLETED|Open-Label Conversion + Titration Period||0
3111690|NCT01571362|3836369|FG002|NOT COMPLETED|Open-Label Conversion + Titration Period||0
3111691|NCT01571362|3836367|FG000|STARTED|Double-Blind Treatment Period|This phase preceded the Double-Blind Treatment Period.|0
3111692|NCT01571362|3836368|FG001|STARTED|Double-Blind Treatment Period||134
3111693|NCT01571362|3836369|FG002|STARTED|Double-Blind Treatment Period||146
3111694|NCT01571362|3836367|FG000|COMPLETED|Double-Blind Treatment Period|This phase preceded the Double-Blind Treatment Period.|0
3111695|NCT01571362|3836368|FG001|COMPLETED|Double-Blind Treatment Period||81
3111696|NCT01571362|3836369|FG002|COMPLETED|Double-Blind Treatment Period||107
3111697|NCT01571362|3836367|FG000|NOT COMPLETED|Double-Blind Treatment Period||0
3111698|NCT01571362|3836368|FG001|NOT COMPLETED|Double-Blind Treatment Period||53
3111699|NCT01571362|3836369|FG002|NOT COMPLETED|Double-Blind Treatment Period||39
3111700|NCT01571427|3836379|FG000|STARTED|Overall Study||41
3111701|NCT01571427|3836380|FG001|STARTED|Overall Study||42
3111702|NCT01571427|3836379|FG000|COMPLETED|Overall Study||41
3111703|NCT01571427|3836380|FG001|COMPLETED|Overall Study||42
3111704|NCT01571427|3836379|FG000|NOT COMPLETED|Overall Study||0
3111705|NCT01571427|3836380|FG001|NOT COMPLETED|Overall Study||0
3111706|NCT01571453|3836388|FG000|STARTED|Overall Study||211
3111707|NCT01571453|3836389|FG001|STARTED|Overall Study||226
3111708|NCT01571453|3836388|FG000|COMPLETED|Overall Study||173
3111709|NCT01571453|3836389|FG001|COMPLETED|Overall Study||164
3111710|NCT01571453|3836388|FG000|NOT COMPLETED|Overall Study||38
3111711|NCT01571453|3836389|FG001|NOT COMPLETED|Overall Study||62
3111712|NCT01571557|3836395|FG000|STARTED|Overall Study||573
3111713|NCT01571557|3836395|FG000|COMPLETED|Overall Study||573
3111714|NCT01571557|3836395|FG000|NOT COMPLETED|Overall Study||0
3111715|NCT01571596|3836402|FG000|STARTED|Overall Study||21
3111716|NCT01571596|3836403|FG001|STARTED|Overall Study||1
3111717|NCT01571596|3836404|FG002|STARTED|Overall Study||1
3111718|NCT01571596|3836402|FG000|COMPLETED|Overall Study||19
3111719|NCT01571596|3836403|FG001|COMPLETED|Overall Study||0
3111720|NCT01571596|3836404|FG002|COMPLETED|Overall Study||0
3111721|NCT01571596|3836402|FG000|NOT COMPLETED|Overall Study||2
3111722|NCT01571596|3836403|FG001|NOT COMPLETED|Overall Study||1
3111723|NCT01571596|3836404|FG002|NOT COMPLETED|Overall Study||1
3111724|NCT01572038|3836414|FG000|STARTED|Overall Study|All participants who were enrolled in the study.|1436
3293746|NCT02873286|4027704|FG001|NOT COMPLETED|Booster Substudy||0
3293747|NCT02873286|4027705|FG002|NOT COMPLETED|Booster Substudy||0
3293748|NCT02873286|4027706|FG003|NOT COMPLETED|Booster Substudy||0
3111725|NCT01572038|3836414|FG000|Received at Least One Dose of Study Drug|Overall Study||1436
3111726|NCT01572038|3836414|FG000|COMPLETED|Overall Study||445
3111727|NCT01572038|3836414|FG000|NOT COMPLETED|Overall Study||991
3111728|NCT01572298|3836442|FG000|STARTED|Overall Study||14
3111729|NCT01572298|3836443|FG001|STARTED|Overall Study||13
3293749|NCT02873286|4027707|FG004|NOT COMPLETED|Booster Substudy||0
3293750|NCT02873338|4027722|FG000|STARTED|Overall Study||26
3111730|NCT01572298|3836442|FG000|COMPLETED|Overall Study||12
3111731|NCT01572298|3836443|FG001|COMPLETED|Overall Study||12
3111732|NCT01572298|3836442|FG000|NOT COMPLETED|Overall Study||2
3111733|NCT01572298|3836443|FG001|NOT COMPLETED|Overall Study||1
3111734|NCT01572389|3836453|FG000|STARTED|Overall Study||136
3111735|NCT01572389|3836454|FG001|STARTED|Overall Study||89
3293751|NCT02873338|4027723|FG001|STARTED|Overall Study||25
3293752|NCT02873338|4027724|FG002|STARTED|Overall Study||24
3293753|NCT02873338|4027722|FG000|COMPLETED|Overall Study||8
3293754|NCT02873338|4027723|FG001|COMPLETED|Overall Study||4
3293755|NCT02873338|4027724|FG002|COMPLETED|Overall Study||6
3293756|NCT02873338|4027722|FG000|NOT COMPLETED|Overall Study||18
3111736|NCT01572389|3836453|FG000|COMPLETED|Overall Study||90
3111737|NCT01572389|3836454|FG001|COMPLETED|Overall Study||68
3111738|NCT01572389|3836453|FG000|NOT COMPLETED|Overall Study||46
3111739|NCT01572389|3836454|FG001|NOT COMPLETED|Overall Study||21
3111740|NCT01572428|3836462|FG000|STARTED|Overall Study||402
3111741|NCT01572428|3836463|FG001|STARTED|Overall Study||402
3111742|NCT01572428|3836462|FG000|COMPLETED|Overall Study||399
3111743|NCT01572428|3836463|FG001|COMPLETED|Overall Study||401
3111744|NCT01572428|3836462|FG000|NOT COMPLETED|Overall Study||3
3111745|NCT01572428|3836463|FG001|NOT COMPLETED|Overall Study||1
3111746|NCT01572727|3836471|FG000|STARTED|Overall Study||207
3111747|NCT01572727|3836472|FG001|STARTED|Overall Study||209
3111748|NCT01572727|3836471|FG000|Pts With Treatment + Safety Assessment|Overall Study|patients who received study treatment and had at least one post-baseline safety assessment|202
3111749|NCT01572727|3836472|FG001|Pts With Treatment + Safety Assessment|Overall Study|patients who received study treatment and had at least one post-baseline safety assessment|201
3111750|NCT01572727|3836471|FG000|COMPLETED|Overall Study||0
3111751|NCT01572727|3836472|FG001|COMPLETED|Overall Study||0
3111752|NCT01572727|3836471|FG000|NOT COMPLETED|Overall Study||207
3111753|NCT01572727|3836472|FG001|NOT COMPLETED|Overall Study||209
3111754|NCT01572740|3836480|FG000|STARTED|Overall Study||127
3111755|NCT01572740|3836481|FG001|STARTED|Overall Study||130
3111756|NCT01572740|3836480|FG000|COMPLETED|Overall Study||121
3111757|NCT01572740|3836481|FG001|COMPLETED|Overall Study||125
3111758|NCT01572740|3836480|FG000|NOT COMPLETED|Overall Study||6
3111759|NCT01572740|3836481|FG001|NOT COMPLETED|Overall Study||5
3111760|NCT01572792|3836492|FG000|STARTED|Lead-in Study||337
3111761|NCT01572792|3836493|FG001|STARTED|Lead-in Study||338
3111762|NCT01572792|3836494|FG002|STARTED|Lead-in Study||338
3111763|NCT01572792|3836495|FG003|STARTED|Lead-in Study||340
3111764|NCT01572792|3836496|FG004|STARTED|Lead-in Study||339
3111765|NCT01572792|3836492|FG000|COMPLETED|Lead-in Study||236
3111766|NCT01572792|3836493|FG001|COMPLETED|Lead-in Study||272
3111767|NCT01572792|3836494|FG002|COMPLETED|Lead-in Study||276
3111768|NCT01572792|3836495|FG003|COMPLETED|Lead-in Study||268
3111769|NCT01572792|3836496|FG004|COMPLETED|Lead-in Study||270
3111770|NCT01572792|3836492|FG000|NOT COMPLETED|Lead-in Study||101
3111771|NCT01572792|3836493|FG001|NOT COMPLETED|Lead-in Study||66
3111772|NCT01572792|3836494|FG002|NOT COMPLETED|Lead-in Study||62
3111773|NCT01572792|3836495|FG003|NOT COMPLETED|Lead-in Study||72
3111774|NCT01572792|3836496|FG004|NOT COMPLETED|Lead-in Study||69
3111775|NCT01572792|3836492|FG000|STARTED|Extension Study||146
3111776|NCT01572792|3836493|FG001|STARTED|Extension Study||184
3111777|NCT01572792|3836494|FG002|STARTED|Extension Study||205
3111778|NCT01572792|3836495|FG003|STARTED|Extension Study||194
3111779|NCT01572792|3836496|FG004|STARTED|Extension Study||192
3111780|NCT01572792|3836492|FG000|COMPLETED|Extension Study||121
3111781|NCT01572792|3836493|FG001|COMPLETED|Extension Study||155
3111782|NCT01572792|3836494|FG002|COMPLETED|Extension Study||179
3111783|NCT01572792|3836495|FG003|COMPLETED|Extension Study||165
3111784|NCT01572792|3836496|FG004|COMPLETED|Extension Study||160
3111785|NCT01572792|3836492|FG000|NOT COMPLETED|Extension Study||25
3111786|NCT01572792|3836493|FG001|NOT COMPLETED|Extension Study||29
3111787|NCT01572792|3836494|FG002|NOT COMPLETED|Extension Study||26
3111788|NCT01572792|3836495|FG003|NOT COMPLETED|Extension Study||29
3111789|NCT01572792|3836496|FG004|NOT COMPLETED|Extension Study||32
3111790|NCT01572844|3836509|FG000|STARTED|Overall Study||3
3111791|NCT01572844|3836510|FG001|STARTED|Overall Study||3
3111792|NCT01572844|3836509|FG000|COMPLETED|Overall Study||2
3111793|NCT01572844|3836510|FG001|COMPLETED|Overall Study||2
3111794|NCT01572844|3836509|FG000|NOT COMPLETED|Overall Study||1
3111795|NCT01572844|3836510|FG001|NOT COMPLETED|Overall Study||1
3111796|NCT01572909|3836521|FG000|STARTED|Overall Study||152
3111797|NCT01572909|3836522|FG001|STARTED|Overall Study||148
3293757|NCT02873338|4027723|FG001|NOT COMPLETED|Overall Study||21
3293758|NCT02873338|4027724|FG002|NOT COMPLETED|Overall Study||18
3293759|NCT02873377|4027734|FG000|STARTED|Period 1: Enrollment||65
3293760|NCT02873377|4027735|FG001|STARTED|Period 1: Enrollment||69
3293761|NCT02873377|4027734|FG000|COMPLETED|Period 1: Enrollment||65
3111798|NCT01572909|3836521|FG000|COMPLETED|Overall Study||120
3111799|NCT01572909|3836522|FG001|COMPLETED|Overall Study||123
3111800|NCT01572909|3836521|FG000|NOT COMPLETED|Overall Study||32
3111801|NCT01572909|3836522|FG001|NOT COMPLETED|Overall Study||25
3111802|NCT01572922|3836530|FG000|STARTED|Overall Study||142
3111803|NCT01572922|3836530|FG000|COMPLETED|Overall Study||139
3111804|NCT01572922|3836530|FG000|NOT COMPLETED|Overall Study||3
3111805|NCT01572948|3836541|FG000|STARTED|Overall Study||11
3111806|NCT01572948|3836542|FG001|STARTED|Overall Study||16
3111807|NCT01572948|3836541|FG000|COMPLETED|Overall Study||10
3111808|NCT01572948|3836542|FG001|COMPLETED|Overall Study||15
3111809|NCT01572948|3836541|FG000|NOT COMPLETED|Overall Study||1
3111810|NCT01572948|3836542|FG001|NOT COMPLETED|Overall Study||1
3111811|NCT01573000|3836554|FG000|STARTED|Dosimetric and Therapeutic Treatment||42
3111812|NCT01573000|3836555|FG001|STARTED|Dosimetric and Therapeutic Treatment||36
3111813|NCT01573000|3836554|FG000|COMPLETED|Dosimetric and Therapeutic Treatment|These participants completed 2 years of follow up and enrolled in BEX104526.|7
3111814|NCT01573000|3836555|FG001|COMPLETED|Dosimetric and Therapeutic Treatment|These participants completed 2 years of follow up and enrolled in BEX104526.|1
3111815|NCT01573000|3836554|FG000|NOT COMPLETED|Dosimetric and Therapeutic Treatment||35
3111816|NCT01573000|3836555|FG001|NOT COMPLETED|Dosimetric and Therapeutic Treatment||35
3111817|NCT01573000|3836554|FG000|STARTED|Crossover Phase||0
3111818|NCT01573000|3836555|FG001|STARTED|Crossover Phase|19 of 36 par. randomized to receive Unlabeled TST crossed over to receive TST and Iodine I 131 TST.|19
3293762|NCT02873377|4027735|FG001|COMPLETED|Period 1: Enrollment||69
3293763|NCT02873377|4027734|FG000|NOT COMPLETED|Period 1: Enrollment||0
3293764|NCT02873377|4027735|FG001|NOT COMPLETED|Period 1: Enrollment||0
3111819|NCT01573000|3836554|FG000|COMPLETED|Crossover Phase||0
3111820|NCT01573000|3836555|FG001|COMPLETED|Crossover Phase|This participant completed 2 years of follow up and enrolled in BEX104526.|1
3111821|NCT01573000|3836554|FG000|NOT COMPLETED|Crossover Phase||0
3111822|NCT01573000|3836555|FG001|NOT COMPLETED|Crossover Phase||18
3111823|NCT01573000|3836554|FG000|STARTED|Long-Term Follow-Up|14 of the 35 participants withdrawing from Study BEX104515 enrolled in long-term follow-up study.|14
3111824|NCT01573000|3836555|FG001|STARTED|Long-Term Follow-Up|5 of the 35 participants withdrawing from Study BEX104515 enrolled in long-term follow-up study.|5
3111825|NCT01573000|3836554|FG000|COMPLETED|Long-Term Follow-Up||11
3111826|NCT01573000|3836555|FG001|COMPLETED|Long-Term Follow-Up|One participant who received crossover treatment was lost to follow up.|4
3111827|NCT01573000|3836554|FG000|NOT COMPLETED|Long-Term Follow-Up||3
3111828|NCT01573000|3836555|FG001|NOT COMPLETED|Long-Term Follow-Up||1
3111829|NCT01573052|3836567|FG000|STARTED|Overall Study||9
3111830|NCT01573052|3836568|FG001|STARTED|Overall Study||17
3111831|NCT01573052|3836567|FG000|COMPLETED|Overall Study||6
3111832|NCT01573052|3836568|FG001|COMPLETED|Overall Study||11
3111833|NCT01573052|3836567|FG000|NOT COMPLETED|Overall Study||3
3111834|NCT01573052|3836568|FG001|NOT COMPLETED|Overall Study||6
3111835|NCT01573169|3836577|FG000|STARTED|Overall Study||38
3111836|NCT01573169|3836578|FG001|STARTED|Overall Study||35
3111837|NCT01573169|3836577|FG000|COMPLETED|Overall Study||38
3111838|NCT01573169|3836578|FG001|COMPLETED|Overall Study||35
3111839|NCT01573169|3836577|FG000|NOT COMPLETED|Overall Study||0
3111840|NCT01573169|3836578|FG001|NOT COMPLETED|Overall Study||0
3111841|NCT01573260|3836586|FG000|STARTED|Overall Study||18
3111842|NCT01573260|3836587|FG001|STARTED|Overall Study||15
3111843|NCT01573260|3836586|FG000|COMPLETED|Overall Study||18
3111844|NCT01573260|3836587|FG001|COMPLETED|Overall Study||15
3111845|NCT01573260|3836586|FG000|NOT COMPLETED|Overall Study||0
3111846|NCT01573260|3836587|FG001|NOT COMPLETED|Overall Study||0
3111847|NCT01573273|3836599|FG000|STARTED|TSST : Trier Social Stress Task||24
3111848|NCT01573273|3836600|FG001|STARTED|TSST : Trier Social Stress Task||25
3111849|NCT01573273|3836601|FG002|STARTED|TSST : Trier Social Stress Task||0
3111850|NCT01573273|3836602|FG003|STARTED|TSST : Trier Social Stress Task||0
3111851|NCT01573273|3836603|FG004|STARTED|TSST : Trier Social Stress Task||0
3111852|NCT01573273|3836604|FG005|STARTED|TSST : Trier Social Stress Task||0
3111853|NCT01573273|3836605|FG006|STARTED|TSST : Trier Social Stress Task||32
3111854|NCT01573273|3836606|FG007|STARTED|TSST : Trier Social Stress Task||31
3111855|NCT01573273|3836607|FG008|STARTED|TSST : Trier Social Stress Task||0
3111856|NCT01573273|3836608|FG009|STARTED|TSST : Trier Social Stress Task||0
3111857|NCT01573273|3836609|FG010|STARTED|TSST : Trier Social Stress Task||0
3111858|NCT01573273|3836610|FG011|STARTED|TSST : Trier Social Stress Task||0
3111859|NCT01573273|3836599|FG000|COMPLETED|TSST : Trier Social Stress Task||24
3111860|NCT01573273|3836600|FG001|COMPLETED|TSST : Trier Social Stress Task||25
3111861|NCT01573273|3836601|FG002|COMPLETED|TSST : Trier Social Stress Task||0
3111862|NCT01573273|3836602|FG003|COMPLETED|TSST : Trier Social Stress Task||0
3111863|NCT01573273|3836603|FG004|COMPLETED|TSST : Trier Social Stress Task||0
3111864|NCT01573273|3836604|FG005|COMPLETED|TSST : Trier Social Stress Task||0
3111865|NCT01573273|3836605|FG006|COMPLETED|TSST : Trier Social Stress Task||32
3111866|NCT01573273|3836606|FG007|COMPLETED|TSST : Trier Social Stress Task||31
3111867|NCT01573273|3836607|FG008|COMPLETED|TSST : Trier Social Stress Task||0
3111868|NCT01573273|3836608|FG009|COMPLETED|TSST : Trier Social Stress Task||0
3111869|NCT01573273|3836609|FG010|COMPLETED|TSST : Trier Social Stress Task||0
3111870|NCT01573273|3836610|FG011|COMPLETED|TSST : Trier Social Stress Task||0
3111871|NCT01573273|3836599|FG000|NOT COMPLETED|TSST : Trier Social Stress Task||0
3111872|NCT01573273|3836600|FG001|NOT COMPLETED|TSST : Trier Social Stress Task||0
3111873|NCT01573273|3836601|FG002|NOT COMPLETED|TSST : Trier Social Stress Task||0
3111874|NCT01573273|3836602|FG003|NOT COMPLETED|TSST : Trier Social Stress Task||0
3111875|NCT01573273|3836603|FG004|NOT COMPLETED|TSST : Trier Social Stress Task||0
3111876|NCT01573273|3836604|FG005|NOT COMPLETED|TSST : Trier Social Stress Task||0
3111877|NCT01573273|3836605|FG006|NOT COMPLETED|TSST : Trier Social Stress Task||0
3111878|NCT01573273|3836606|FG007|NOT COMPLETED|TSST : Trier Social Stress Task||0
3111879|NCT01573273|3836607|FG008|NOT COMPLETED|TSST : Trier Social Stress Task||0
3111880|NCT01573273|3836608|FG009|NOT COMPLETED|TSST : Trier Social Stress Task||0
3111881|NCT01573273|3836609|FG010|NOT COMPLETED|TSST : Trier Social Stress Task||0
3293765|NCT02873377|4027734|FG000|STARTED|Period Title 2: 3 Months Follow up||65
3111882|NCT01573273|3836610|FG011|NOT COMPLETED|TSST : Trier Social Stress Task||0
3111883|NCT01573273|3836599|FG000|STARTED|MRI 1||0
3111884|NCT01573273|3836600|FG001|STARTED|MRI 1||0
3111885|NCT01573273|3836601|FG002|STARTED|MRI 1||19
3111886|NCT01573273|3836602|FG003|STARTED|MRI 1||23
3111887|NCT01573273|3836603|FG004|STARTED|MRI 1||0
3111888|NCT01573273|3836604|FG005|STARTED|MRI 1||0
3111889|NCT01573273|3836605|FG006|STARTED|MRI 1||0
3111890|NCT01573273|3836606|FG007|STARTED|MRI 1||0
3111891|NCT01573273|3836607|FG008|STARTED|MRI 1||28
3111892|NCT01573273|3836608|FG009|STARTED|MRI 1||29
3111893|NCT01573273|3836609|FG010|STARTED|MRI 1||0
3111894|NCT01573273|3836610|FG011|STARTED|MRI 1||0
3111895|NCT01573273|3836599|FG000|COMPLETED|MRI 1||0
3111896|NCT01573273|3836600|FG001|COMPLETED|MRI 1||0
3111897|NCT01573273|3836601|FG002|COMPLETED|MRI 1||19
3111898|NCT01573273|3836602|FG003|COMPLETED|MRI 1||23
3111899|NCT01573273|3836603|FG004|COMPLETED|MRI 1||0
3111900|NCT01573273|3836604|FG005|COMPLETED|MRI 1||0
3111901|NCT01573273|3836605|FG006|COMPLETED|MRI 1||0
3111902|NCT01573273|3836606|FG007|COMPLETED|MRI 1||0
3111903|NCT01573273|3836607|FG008|COMPLETED|MRI 1||28
3111904|NCT01573273|3836608|FG009|COMPLETED|MRI 1||29
3111905|NCT01573273|3836609|FG010|COMPLETED|MRI 1||0
3111906|NCT01573273|3836610|FG011|COMPLETED|MRI 1||0
3111907|NCT01573273|3836599|FG000|NOT COMPLETED|MRI 1||0
3111908|NCT01573273|3836600|FG001|NOT COMPLETED|MRI 1||0
3111909|NCT01573273|3836601|FG002|NOT COMPLETED|MRI 1||0
3111910|NCT01573273|3836602|FG003|NOT COMPLETED|MRI 1||0
3111911|NCT01573273|3836603|FG004|NOT COMPLETED|MRI 1||0
3111912|NCT01573273|3836604|FG005|NOT COMPLETED|MRI 1||0
3111913|NCT01573273|3836605|FG006|NOT COMPLETED|MRI 1||0
3111914|NCT01573273|3836606|FG007|NOT COMPLETED|MRI 1||0
3111915|NCT01573273|3836607|FG008|NOT COMPLETED|MRI 1||0
3111916|NCT01573273|3836608|FG009|NOT COMPLETED|MRI 1||0
3111917|NCT01573273|3836609|FG010|NOT COMPLETED|MRI 1||0
3111918|NCT01573273|3836610|FG011|NOT COMPLETED|MRI 1||0
3111919|NCT01573273|3836599|FG000|STARTED|MRI 2||0
3111920|NCT01573273|3836600|FG001|STARTED|MRI 2||0
3111921|NCT01573273|3836601|FG002|STARTED|MRI 2||0
3111922|NCT01573273|3836602|FG003|STARTED|MRI 2||0
3111923|NCT01573273|3836603|FG004|STARTED|MRI 2||23
3111924|NCT01573273|3836604|FG005|STARTED|MRI 2||18
3111925|NCT01573273|3836605|FG006|STARTED|MRI 2||0
3111926|NCT01573273|3836606|FG007|STARTED|MRI 2||0
3111927|NCT01573273|3836607|FG008|STARTED|MRI 2||0
3111928|NCT01573273|3836608|FG009|STARTED|MRI 2||0
3111929|NCT01573273|3836609|FG010|STARTED|MRI 2||27
3111930|NCT01573273|3836610|FG011|STARTED|MRI 2||28
3111931|NCT01573273|3836599|FG000|COMPLETED|MRI 2||0
3111932|NCT01573273|3836600|FG001|COMPLETED|MRI 2||0
3111933|NCT01573273|3836601|FG002|COMPLETED|MRI 2||0
3111934|NCT01573273|3836602|FG003|COMPLETED|MRI 2||0
3111935|NCT01573273|3836603|FG004|COMPLETED|MRI 2||23
3111936|NCT01573273|3836604|FG005|COMPLETED|MRI 2||18
3111937|NCT01573273|3836605|FG006|COMPLETED|MRI 2||0
3111938|NCT01573273|3836606|FG007|COMPLETED|MRI 2||0
3111939|NCT01573273|3836607|FG008|COMPLETED|MRI 2||0
3111940|NCT01573273|3836608|FG009|COMPLETED|MRI 2||0
3111941|NCT01573273|3836609|FG010|COMPLETED|MRI 2||27
3111942|NCT01573273|3836610|FG011|COMPLETED|MRI 2||28
3111943|NCT01573273|3836599|FG000|NOT COMPLETED|MRI 2||0
3111944|NCT01573273|3836600|FG001|NOT COMPLETED|MRI 2||0
3111945|NCT01573273|3836601|FG002|NOT COMPLETED|MRI 2||0
3111946|NCT01573273|3836602|FG003|NOT COMPLETED|MRI 2||0
3111947|NCT01573273|3836603|FG004|NOT COMPLETED|MRI 2||0
3111948|NCT01573273|3836604|FG005|NOT COMPLETED|MRI 2||0
3111949|NCT01573273|3836605|FG006|NOT COMPLETED|MRI 2||0
3111950|NCT01573273|3836606|FG007|NOT COMPLETED|MRI 2||0
3111951|NCT01573273|3836607|FG008|NOT COMPLETED|MRI 2||0
3111952|NCT01573273|3836608|FG009|NOT COMPLETED|MRI 2||0
3111953|NCT01573273|3836609|FG010|NOT COMPLETED|MRI 2||0
3111954|NCT01573273|3836610|FG011|NOT COMPLETED|MRI 2||0
3111955|NCT01573325|3836636|FG000|STARTED|Overall Study||50
3111956|NCT01573325|3836636|FG000|COMPLETED|Overall Study||50
3111957|NCT01573325|3836636|FG000|NOT COMPLETED|Overall Study||0
3111958|NCT01573442|3836643|FG000|STARTED|Overall Study||113
3111959|NCT01573442|3836644|FG001|STARTED|Overall Study||114
3111960|NCT01573442|3836643|FG000|COMPLETED|Overall Study||104
3111961|NCT01573442|3836644|FG001|COMPLETED|Overall Study||104
3111962|NCT01573442|3836643|FG000|NOT COMPLETED|Overall Study||9
3111963|NCT01573442|3836644|FG001|NOT COMPLETED|Overall Study||10
3111964|NCT01573533|3836650|FG000|STARTED|Overall Study||9
3111965|NCT01573533|3836650|FG000|COMPLETED|Overall Study||9
3111966|NCT01573533|3836650|FG000|NOT COMPLETED|Overall Study||0
3111967|NCT01573572|3836654|FG000|STARTED|Overall Study||131
3111968|NCT01573572|3836654|FG000|COMPLETED|Overall Study||103
3111969|NCT01573572|3836654|FG000|NOT COMPLETED|Overall Study||28
3111970|NCT01573624|3836658|FG000|STARTED|Period 1 : Treatment Period 1 (14 Days)||64
3111971|NCT01573624|3836659|FG001|STARTED|Period 1 : Treatment Period 1 (14 Days)||62
3111972|NCT01573624|3836660|FG002|STARTED|Period 1 : Treatment Period 1 (14 Days)||60
3111973|NCT01573624|3836661|FG003|STARTED|Period 1 : Treatment Period 1 (14 Days)||63
3111974|NCT01573624|3836662|FG004|STARTED|Period 1 : Treatment Period 1 (14 Days)||58
3111975|NCT01573624|3836663|FG005|STARTED|Period 1 : Treatment Period 1 (14 Days)||55
3111976|NCT01573624|3836664|FG006|STARTED|Period 1 : Treatment Period 1 (14 Days)||59
3111977|NCT01573624|3836658|FG000|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||58
3111978|NCT01573624|3836659|FG001|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||59
3111979|NCT01573624|3836660|FG002|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||51
3111980|NCT01573624|3836661|FG003|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||61
3111981|NCT01573624|3836662|FG004|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||56
3111982|NCT01573624|3836663|FG005|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||51
3111983|NCT01573624|3836664|FG006|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||57
3111984|NCT01573624|3836658|FG000|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||6
3111985|NCT01573624|3836659|FG001|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||3
3111986|NCT01573624|3836660|FG002|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||9
3111987|NCT01573624|3836661|FG003|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||2
3111988|NCT01573624|3836662|FG004|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||2
3111989|NCT01573624|3836663|FG005|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||4
3111990|NCT01573624|3836664|FG006|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||2
3111991|NCT01573624|3836658|FG000|STARTED|Period 2 : Washout Period 1 (12-14 Days)||58
3111992|NCT01573624|3836659|FG001|STARTED|Period 2 : Washout Period 1 (12-14 Days)||59
3111993|NCT01573624|3836660|FG002|STARTED|Period 2 : Washout Period 1 (12-14 Days)||51
3111994|NCT01573624|3836661|FG003|STARTED|Period 2 : Washout Period 1 (12-14 Days)||61
3111995|NCT01573624|3836662|FG004|STARTED|Period 2 : Washout Period 1 (12-14 Days)||56
3111996|NCT01573624|3836663|FG005|STARTED|Period 2 : Washout Period 1 (12-14 Days)||51
3111997|NCT01573624|3836664|FG006|STARTED|Period 2 : Washout Period 1 (12-14 Days)||57
3111998|NCT01573624|3836658|FG000|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||57
3111999|NCT01573624|3836659|FG001|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||58
3112000|NCT01573624|3836660|FG002|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||48
3112001|NCT01573624|3836661|FG003|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||56
3112002|NCT01573624|3836662|FG004|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||56
3112003|NCT01573624|3836663|FG005|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||48
3112004|NCT01573624|3836664|FG006|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||55
3112005|NCT01573624|3836658|FG000|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||1
3112006|NCT01573624|3836659|FG001|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||1
3112007|NCT01573624|3836660|FG002|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||3
3112008|NCT01573624|3836661|FG003|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||5
3112009|NCT01573624|3836662|FG004|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||0
3112010|NCT01573624|3836663|FG005|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||3
3112011|NCT01573624|3836664|FG006|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||2
3112012|NCT01573624|3836658|FG000|STARTED|Period 3 : Treatment Period 2 (14 Days)||57
3112013|NCT01573624|3836659|FG001|STARTED|Period 3 : Treatment Period 2 (14 Days)||58
3112014|NCT01573624|3836660|FG002|STARTED|Period 3 : Treatment Period 2 (14 Days)||48
3112015|NCT01573624|3836661|FG003|STARTED|Period 3 : Treatment Period 2 (14 Days)||56
3112016|NCT01573624|3836662|FG004|STARTED|Period 3 : Treatment Period 2 (14 Days)||56
3112017|NCT01573624|3836663|FG005|STARTED|Period 3 : Treatment Period 2 (14 Days)||48
3112018|NCT01573624|3836664|FG006|STARTED|Period 3 : Treatment Period 2 (14 Days)||55
3112019|NCT01573624|3836658|FG000|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||50
3112020|NCT01573624|3836659|FG001|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||52
3112021|NCT01573624|3836660|FG002|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||45
3112022|NCT01573624|3836661|FG003|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||55
3112023|NCT01573624|3836662|FG004|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||53
3112024|NCT01573624|3836663|FG005|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||43
3112025|NCT01573624|3836664|FG006|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||55
3112026|NCT01573624|3836658|FG000|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||7
3112027|NCT01573624|3836659|FG001|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||6
3112028|NCT01573624|3836660|FG002|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||3
3112029|NCT01573624|3836661|FG003|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||1
3112030|NCT01573624|3836662|FG004|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||3
3112031|NCT01573624|3836663|FG005|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||5
3112032|NCT01573624|3836664|FG006|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||0
3112033|NCT01573624|3836658|FG000|STARTED|Period 4 : Washout Period 2 (12-14 Days)||50
3112034|NCT01573624|3836659|FG001|STARTED|Period 4 : Washout Period 2 (12-14 Days)||52
3112035|NCT01573624|3836660|FG002|STARTED|Period 4 : Washout Period 2 (12-14 Days)||45
3112036|NCT01573624|3836661|FG003|STARTED|Period 4 : Washout Period 2 (12-14 Days)||55
3112037|NCT01573624|3836662|FG004|STARTED|Period 4 : Washout Period 2 (12-14 Days)||53
3112038|NCT01573624|3836663|FG005|STARTED|Period 4 : Washout Period 2 (12-14 Days)||43
3112039|NCT01573624|3836664|FG006|STARTED|Period 4 : Washout Period 2 (12-14 Days)||55
3112040|NCT01573624|3836658|FG000|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||49
3112041|NCT01573624|3836659|FG001|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||48
3112042|NCT01573624|3836660|FG002|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||43
3112043|NCT01573624|3836661|FG003|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||53
3112044|NCT01573624|3836662|FG004|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||52
3112045|NCT01573624|3836663|FG005|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||41
3112046|NCT01573624|3836664|FG006|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||52
3112047|NCT01573624|3836658|FG000|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||1
3112048|NCT01573624|3836659|FG001|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||4
3112049|NCT01573624|3836660|FG002|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||2
3112050|NCT01573624|3836661|FG003|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||2
3135898|NCT01709422|3860970|FG001|COMPLETED|Overall Study||70
3112051|NCT01573624|3836662|FG004|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||1
3112052|NCT01573624|3836663|FG005|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||2
3112053|NCT01573624|3836664|FG006|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||3
3112054|NCT01573624|3836658|FG000|STARTED|Period 5 : Treatment Period 3 (14 Days)||49
3112055|NCT01573624|3836659|FG001|STARTED|Period 5 : Treatment Period 3 (14 Days)||48
3112056|NCT01573624|3836660|FG002|STARTED|Period 5 : Treatment Period 3 (14 Days)||43
3112057|NCT01573624|3836661|FG003|STARTED|Period 5 : Treatment Period 3 (14 Days)||53
3112058|NCT01573624|3836662|FG004|STARTED|Period 5 : Treatment Period 3 (14 Days)||52
3112059|NCT01573624|3836663|FG005|STARTED|Period 5 : Treatment Period 3 (14 Days)||41
3112060|NCT01573624|3836664|FG006|STARTED|Period 5 : Treatment Period 3 (14 Days)||52
3112061|NCT01573624|3836658|FG000|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||46
3112062|NCT01573624|3836659|FG001|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||47
3112063|NCT01573624|3836660|FG002|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||43
3112064|NCT01573624|3836661|FG003|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||53
3112065|NCT01573624|3836662|FG004|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||51
3112066|NCT01573624|3836663|FG005|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||39
3112067|NCT01573624|3836664|FG006|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||48
3112068|NCT01573624|3836658|FG000|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||3
3112069|NCT01573624|3836659|FG001|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||1
3112070|NCT01573624|3836660|FG002|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||0
3112071|NCT01573624|3836661|FG003|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||0
3112072|NCT01573624|3836662|FG004|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||1
3112073|NCT01573624|3836663|FG005|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||2
3112074|NCT01573624|3836664|FG006|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||4
3112075|NCT01573624|3836658|FG000|STARTED|Period 6 : Follow-up Period (7 Days)||46
3112076|NCT01573624|3836659|FG001|STARTED|Period 6 : Follow-up Period (7 Days)||47
3112077|NCT01573624|3836660|FG002|STARTED|Period 6 : Follow-up Period (7 Days)||43
3112078|NCT01573624|3836661|FG003|STARTED|Period 6 : Follow-up Period (7 Days)||53
3112079|NCT01573624|3836662|FG004|STARTED|Period 6 : Follow-up Period (7 Days)||51
3112080|NCT01573624|3836663|FG005|STARTED|Period 6 : Follow-up Period (7 Days)||39
3112081|NCT01573624|3836664|FG006|STARTED|Period 6 : Follow-up Period (7 Days)||48
3112082|NCT01573624|3836658|FG000|COMPLETED|Period 6 : Follow-up Period (7 Days)||45
3112083|NCT01573624|3836659|FG001|COMPLETED|Period 6 : Follow-up Period (7 Days)||47
3112084|NCT01573624|3836660|FG002|COMPLETED|Period 6 : Follow-up Period (7 Days)||43
3112085|NCT01573624|3836661|FG003|COMPLETED|Period 6 : Follow-up Period (7 Days)||53
3112086|NCT01573624|3836662|FG004|COMPLETED|Period 6 : Follow-up Period (7 Days)||49
3112087|NCT01573624|3836663|FG005|COMPLETED|Period 6 : Follow-up Period (7 Days)||38
3112088|NCT01573624|3836664|FG006|COMPLETED|Period 6 : Follow-up Period (7 Days)||48
3112089|NCT01573624|3836658|FG000|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||1
3112090|NCT01573624|3836659|FG001|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||0
3112091|NCT01573624|3836660|FG002|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||0
3112092|NCT01573624|3836661|FG003|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||0
3112093|NCT01573624|3836662|FG004|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||2
3112094|NCT01573624|3836663|FG005|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||1
3112095|NCT01573624|3836664|FG006|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||0
3112096|NCT01573702|3836686|FG000|STARTED|Overall Study||25
3112097|NCT01573702|3836686|FG000|COMPLETED|Overall Study||25
3112098|NCT01573702|3836686|FG000|NOT COMPLETED|Overall Study||0
3112099|NCT01573767|3836695|FG000|STARTED|Overall Study||115
3112100|NCT01573767|3836696|FG001|STARTED|Overall Study||114
3112101|NCT01573767|3836697|FG002|STARTED|Overall Study||113
3112102|NCT01573767|3836698|FG003|STARTED|Overall Study||114
3112103|NCT01573767|3836695|FG000|COMPLETED|Overall Study||93
3112104|NCT01573767|3836696|FG001|COMPLETED|Overall Study||93
3112105|NCT01573767|3836697|FG002|COMPLETED|Overall Study||99
3112106|NCT01573767|3836698|FG003|COMPLETED|Overall Study||90
3112107|NCT01573767|3836695|FG000|NOT COMPLETED|Overall Study||22
3112108|NCT01573767|3836696|FG001|NOT COMPLETED|Overall Study||21
3112109|NCT01573767|3836697|FG002|NOT COMPLETED|Overall Study||14
3112110|NCT01573767|3836698|FG003|NOT COMPLETED|Overall Study||24
3112111|NCT01573910|3836710|FG000|STARTED|Overall Study||489
3112112|NCT01573910|3836711|FG001|STARTED|Overall Study||493
3112113|NCT01573910|3836710|FG000|COMPLETED|Overall Study||469
3112114|NCT01573910|3836711|FG001|COMPLETED|Overall Study||476
3112115|NCT01573910|3836710|FG000|NOT COMPLETED|Overall Study||20
3112116|NCT01573910|3836711|FG001|NOT COMPLETED|Overall Study||17
3112117|NCT01573949|3836717|FG000|STARTED|Overall Study||7
3112118|NCT01573949|3836717|FG000|COMPLETED|Overall Study||7
3112119|NCT01573949|3836717|FG000|NOT COMPLETED|Overall Study||0
3112120|NCT01574079|3836723|FG000|STARTED|Overall Study||18
3112121|NCT01574079|3836724|FG001|STARTED|Overall Study||15
3112122|NCT01574079|3836723|FG000|COMPLETED|Overall Study||17
3112123|NCT01574079|3836724|FG001|COMPLETED|Overall Study||13
3112124|NCT01574079|3836723|FG000|NOT COMPLETED|Overall Study||1
3112125|NCT01574079|3836724|FG001|NOT COMPLETED|Overall Study||2
3112126|NCT01574105|3836732|FG000|STARTED|Overall Study||29
3112127|NCT01574105|3836733|FG001|STARTED|Overall Study||37
3112128|NCT01574105|3836732|FG000|COMPLETED|Overall Study||29
3112129|NCT01574105|3836733|FG001|COMPLETED|Overall Study||37
3112130|NCT01574105|3836732|FG000|NOT COMPLETED|Overall Study||0
3112131|NCT01574105|3836733|FG001|NOT COMPLETED|Overall Study||0
3112132|NCT01574144|3836739|FG000|STARTED|Overall Study||70
3112133|NCT01574144|3836739|FG000|COMPLETED|Overall Study||70
3112134|NCT01574144|3836739|FG000|NOT COMPLETED|Overall Study||0
3112135|NCT01574157|3836746|FG000|STARTED|Overall Study||35
3112136|NCT01574157|3836747|FG001|STARTED|Overall Study||39
3112137|NCT01574157|3836746|FG000|Month 3|Overall Study||31
3112138|NCT01574157|3836747|FG001|Month 3|Overall Study||33
3112139|NCT01574157|3836746|FG000|COMPLETED|Overall Study||31
3112140|NCT01574157|3836747|FG001|COMPLETED|Overall Study||31
3112141|NCT01574157|3836746|FG000|NOT COMPLETED|Overall Study||4
3112142|NCT01574157|3836747|FG001|NOT COMPLETED|Overall Study||8
3112143|NCT01574183|3836759|FG000|STARTED|Overall Study||41
3112144|NCT01574183|3836760|FG001|STARTED|Overall Study||35
3112145|NCT01574183|3836759|FG000|COMPLETED|Overall Study||14
3112146|NCT01574183|3836760|FG001|COMPLETED|Overall Study||17
3112147|NCT01574183|3836759|FG000|NOT COMPLETED|Overall Study||27
3112148|NCT01574183|3836760|FG001|NOT COMPLETED|Overall Study||18
3112149|NCT01574248|3836770|FG000|STARTED|Overall Study||15
3112150|NCT01574248|3836771|FG001|STARTED|Overall Study||18
3112151|NCT01574248|3836770|FG000|COMPLETED|Overall Study||12
3112152|NCT01574248|3836771|FG001|COMPLETED|Overall Study||18
3112153|NCT01574248|3836770|FG000|NOT COMPLETED|Overall Study||3
3112154|NCT01574248|3836771|FG001|NOT COMPLETED|Overall Study||0
3112155|NCT01574287|3836777|FG000|STARTED|Overall Study||4
3112156|NCT01574287|3836777|FG000|COMPLETED|Overall Study||4
3112157|NCT01574287|3836777|FG000|NOT COMPLETED|Overall Study||0
3112158|NCT01574326|3836783|FG000|STARTED|Overall Study||51
3112159|NCT01574326|3836784|FG001|STARTED|Overall Study||50
3112160|NCT01574326|3836783|FG000|Treated|Overall Study||51
3112161|NCT01574326|3836784|FG001|Treated|Overall Study||49
3112162|NCT01574326|3836783|FG000|COMPLETED|Overall Study||35
3112163|NCT01574326|3836784|FG001|COMPLETED|Overall Study||31
3112164|NCT01574326|3836783|FG000|NOT COMPLETED|Overall Study||16
3112165|NCT01574326|3836784|FG001|NOT COMPLETED|Overall Study||19
3112166|NCT01574352|3836797|FG000|STARTED|Overall Study|59 participants where randomized, but 4 dropped out prior to baseline measurements.|55
3112167|NCT01574352|3836798|FG001|STARTED|Overall Study|56 participants where randomized, but 5 dropped out prior to baseline measurements.|51
3112168|NCT01574352|3836797|FG000|COMPLETED|Overall Study|Participated in the last follow up measurement.|48
3112169|NCT01574352|3836798|FG001|COMPLETED|Overall Study|Participated in the last follow up measurement.|38
3112170|NCT01574352|3836797|FG000|NOT COMPLETED|Overall Study||7
3112171|NCT01574352|3836798|FG001|NOT COMPLETED|Overall Study||13
3112172|NCT01574612|3836804|FG000|STARTED|Overall Study|patients who were identified as having the appropriate medical history of herpes labialis|54
3112173|NCT01574612|3836804|FG000|COMPLETED|Overall Study||46
3112174|NCT01574612|3836804|FG000|NOT COMPLETED|Overall Study||8
3112175|NCT01574651|3836810|FG000|STARTED|Overall Study||476
3112176|NCT01574651|3836811|FG001|STARTED|Overall Study||458
3112177|NCT01574651|3836810|FG000|Full Analysis Set (FAS)|Overall Study||476
3112178|NCT01574651|3836811|FG001|Full Analysis Set (FAS)|Overall Study||458
3112179|NCT01574651|3836810|FG000|Per Protocol Set (PPS)|Overall Study||373
3112180|NCT01574651|3836811|FG001|Per Protocol Set (PPS)|Overall Study||374
3112181|NCT01574651|3836810|FG000|COMPLETED|Overall Study||415
3112182|NCT01574651|3836811|FG001|COMPLETED|Overall Study||406
3112183|NCT01574651|3836810|FG000|NOT COMPLETED|Overall Study||61
3112184|NCT01574651|3836811|FG001|NOT COMPLETED|Overall Study||52
3112185|NCT01574703|3836821|FG000|STARTED|Overall Study||1192
3112186|NCT01574703|3836822|FG001|STARTED|Overall Study||1166
3112187|NCT01574703|3836823|FG002|STARTED|Overall Study||1116
3112188|NCT01574703|3836824|FG003|STARTED|Overall Study||1121
3112189|NCT01574703|3836821|FG000|COMPLETED|Overall Study||1067
3112190|NCT01574703|3836822|FG001|COMPLETED|Overall Study||1054
3112191|NCT01574703|3836823|FG002|COMPLETED|Overall Study||1011
3112192|NCT01574703|3836824|FG003|COMPLETED|Overall Study||1007
3112193|NCT01574703|3836821|FG000|NOT COMPLETED|Overall Study||125
3112194|NCT01574703|3836822|FG001|NOT COMPLETED|Overall Study||112
3112195|NCT01574703|3836823|FG002|NOT COMPLETED|Overall Study||105
3112196|NCT01574703|3836824|FG003|NOT COMPLETED|Overall Study||114
3112197|NCT01574716|3836839|FG000|STARTED|Part 1||3
3112198|NCT01574716|3836840|FG001|STARTED|Part 1||4
3112199|NCT01574716|3836841|FG002|STARTED|Part 1||9
3112200|NCT01574716|3836842|FG003|STARTED|Part 1||0
3112201|NCT01574716|3836843|FG004|STARTED|Part 1||0
3112202|NCT01574716|3836839|FG000|COMPLETED|Part 1||0
3112203|NCT01574716|3836840|FG001|COMPLETED|Part 1||0
3112204|NCT01574716|3836841|FG002|COMPLETED|Part 1||0
3112205|NCT01574716|3836842|FG003|COMPLETED|Part 1||0
3112206|NCT01574716|3836843|FG004|COMPLETED|Part 1||0
3112207|NCT01574716|3836839|FG000|NOT COMPLETED|Part 1||3
3112208|NCT01574716|3836840|FG001|NOT COMPLETED|Part 1||4
3112209|NCT01574716|3836841|FG002|NOT COMPLETED|Part 1||9
3112210|NCT01574716|3836842|FG003|NOT COMPLETED|Part 1||0
3112211|NCT01574716|3836843|FG004|NOT COMPLETED|Part 1||0
3112212|NCT01574716|3836839|FG000|STARTED|Part 2||0
3112213|NCT01574716|3836840|FG001|STARTED|Part 2||0
3112214|NCT01574716|3836841|FG002|STARTED|Part 2||0
3112215|NCT01574716|3836842|FG003|STARTED|Part 2||139
3112216|NCT01574716|3836843|FG004|STARTED|Part 2||70
3112217|NCT01574716|3836839|FG000|Treated Participants|Part 2||0
3112218|NCT01574716|3836840|FG001|Treated Participants|Part 2||0
3112219|NCT01574716|3836841|FG002|Treated Participants|Part 2||0
3112220|NCT01574716|3836842|FG003|Treated Participants|Part 2||140
3112221|NCT01574716|3836843|FG004|Treated Participants|Part 2||67
3112222|NCT01574716|3836839|FG000|COMPLETED|Part 2||0
3112223|NCT01574716|3836840|FG001|COMPLETED|Part 2||0
3112224|NCT01574716|3836841|FG002|COMPLETED|Part 2||0
3112225|NCT01574716|3836842|FG003|COMPLETED|Part 2||2
3112226|NCT01574716|3836843|FG004|COMPLETED|Part 2||0
3112227|NCT01574716|3836839|FG000|NOT COMPLETED|Part 2||0
3112228|NCT01574716|3836840|FG001|NOT COMPLETED|Part 2||0
3112229|NCT01574716|3836841|FG002|NOT COMPLETED|Part 2||0
3112230|NCT01574716|3836842|FG003|NOT COMPLETED|Part 2||137
3112231|NCT01574716|3836843|FG004|NOT COMPLETED|Part 2||70
3112232|NCT01574807|3836852|FG000|STARTED|First Appointment||50
3112233|NCT01574807|3836853|FG001|STARTED|First Appointment||50
3112234|NCT01574807|3836852|FG000|COMPLETED|First Appointment||50
3112235|NCT01574807|3836853|FG001|COMPLETED|First Appointment||50
3112236|NCT01574807|3836852|FG000|NOT COMPLETED|First Appointment||0
3112237|NCT01574807|3836853|FG001|NOT COMPLETED|First Appointment||0
3112238|NCT01574807|3836852|FG000|STARTED|Wash Out Period 2 Weeks||50
3112239|NCT01574807|3836853|FG001|STARTED|Wash Out Period 2 Weeks||50
3112240|NCT01574807|3836852|FG000|COMPLETED|Wash Out Period 2 Weeks||50
3112241|NCT01574807|3836853|FG001|COMPLETED|Wash Out Period 2 Weeks||50
3112242|NCT01574807|3836852|FG000|NOT COMPLETED|Wash Out Period 2 Weeks||0
3112243|NCT01574807|3836853|FG001|NOT COMPLETED|Wash Out Period 2 Weeks||0
3112244|NCT01574807|3836852|FG000|STARTED|Second Appointment||50
3112245|NCT01574807|3836853|FG001|STARTED|Second Appointment||50
3112246|NCT01574807|3836852|FG000|COMPLETED|Second Appointment||50
3112247|NCT01574807|3836853|FG001|COMPLETED|Second Appointment||50
3112248|NCT01574807|3836852|FG000|NOT COMPLETED|Second Appointment||0
3112249|NCT01574807|3836853|FG001|NOT COMPLETED|Second Appointment||0
3112250|NCT01575054|3836860|FG000|STARTED|Overall Study||233
3112251|NCT01575054|3836861|FG001|STARTED|Overall Study||235
3112252|NCT01575054|3836860|FG000|COMPLETED|Overall Study||204
3112253|NCT01575054|3836861|FG001|COMPLETED|Overall Study||209
3112254|NCT01575054|3836860|FG000|NOT COMPLETED|Overall Study||29
3112255|NCT01575054|3836861|FG001|NOT COMPLETED|Overall Study||26
3112256|NCT01575080|3836867|FG000|STARTED|Overall Study||102
3112257|NCT01575080|3836867|FG000|COMPLETED|Overall Study||102
3112258|NCT01575080|3836867|FG000|NOT COMPLETED|Overall Study||0
3112259|NCT01575106|3836871|FG000|STARTED|Overall Study||38
3112260|NCT01575106|3836871|FG000|COMPLETED|Overall Study||24
3112261|NCT01575106|3836871|FG000|NOT COMPLETED|Overall Study||14
3112262|NCT01575197|3836879|FG000|STARTED|Overall Study||152
3112263|NCT01575197|3836880|FG001|STARTED|Overall Study||152
3112264|NCT01575197|3836881|FG002|STARTED|Overall Study||152
3112265|NCT01575197|3836879|FG000|COMPLETED|Overall Study||149
3112266|NCT01575197|3836880|FG001|COMPLETED|Overall Study||143
3112267|NCT01575197|3836881|FG002|COMPLETED|Overall Study||146
3112268|NCT01575197|3836879|FG000|NOT COMPLETED|Overall Study||3
3112269|NCT01575197|3836880|FG001|NOT COMPLETED|Overall Study||9
3112270|NCT01575197|3836881|FG002|NOT COMPLETED|Overall Study||6
3293766|NCT02873377|4027735|FG001|STARTED|Period Title 2: 3 Months Follow up||69
3293767|NCT02873377|4027734|FG000|COMPLETED|Period Title 2: 3 Months Follow up||43
3293768|NCT02873377|4027735|FG001|COMPLETED|Period Title 2: 3 Months Follow up||47
3317237|NCT03124771|4050772|FG000|STARTED|Overall Study||132
3112271|NCT01575275|3836889|FG000|STARTED|Overall Study||8
3112272|NCT01575275|3836889|FG000|COMPLETED|Overall Study||8
3112273|NCT01575275|3836889|FG000|NOT COMPLETED|Overall Study||0
3112274|NCT01575522|3836893|FG000|STARTED|Overall Study||22
3112275|NCT01575522|3836893|FG000|COMPLETED|Overall Study||22
3112276|NCT01575522|3836893|FG000|NOT COMPLETED|Overall Study||0
3112277|NCT01575561|3836900|FG000|STARTED|Overall Study||377
3112278|NCT01575561|3836900|FG000|COMPLETED|Overall Study||338
3112279|NCT01575561|3836900|FG000|NOT COMPLETED|Overall Study||39
3112280|NCT01575756|3836904|FG000|STARTED|Treatment Period 1||11
3112281|NCT01575756|3836905|FG001|STARTED|Treatment Period 1||11
3112282|NCT01575756|3836904|FG000|COMPLETED|Treatment Period 1||11
3112283|NCT01575756|3836905|FG001|COMPLETED|Treatment Period 1||11
3112284|NCT01575756|3836904|FG000|NOT COMPLETED|Treatment Period 1||0
3112285|NCT01575756|3836905|FG001|NOT COMPLETED|Treatment Period 1||0
3112286|NCT01575756|3836904|FG000|STARTED|Treatment Period 2||11
3112287|NCT01575756|3836905|FG001|STARTED|Treatment Period 2||11
3112288|NCT01575756|3836904|FG000|COMPLETED|Treatment Period 2||11
3112289|NCT01575756|3836905|FG001|COMPLETED|Treatment Period 2||11
3112290|NCT01575756|3836904|FG000|NOT COMPLETED|Treatment Period 2||0
3112291|NCT01575756|3836905|FG001|NOT COMPLETED|Treatment Period 2||0
3112292|NCT01575769|3836912|FG000|STARTED|Overall Study||41
3112293|NCT01575769|3836912|FG000|COMPLETED|Overall Study||0
3112294|NCT01575769|3836912|FG000|NOT COMPLETED|Overall Study||41
3112295|NCT01575808|3836920|FG000|STARTED|Overall Study||103
3112296|NCT01575808|3836921|FG001|STARTED|Overall Study||68
3112297|NCT01575808|3836920|FG000|COMPLETED|Overall Study|Study ongoing. All 103 assessed for primary invasiveness endpoints,100 for primary efficacy endpoint|100
3112298|NCT01575808|3836921|FG001|COMPLETED|Overall Study||68
3112299|NCT01575808|3836920|FG000|NOT COMPLETED|Overall Study||3
3112300|NCT01575808|3836921|FG001|NOT COMPLETED|Overall Study||0
3112301|NCT01575834|3836931|FG000|STARTED|Overall Study||3591
3112302|NCT01575834|3836932|FG001|STARTED|Overall Study||3589
3112303|NCT01575834|3836931|FG000|Received Double-blind Treatment|Overall Study|Six participants received a dose of romosozumab in error during the double-blind period.|3582
3112304|NCT01575834|3836932|FG001|Received Double-blind Treatment|Overall Study||3575
3112305|NCT01575834|3836931|FG000|Completed Double-blind Period|Overall Study||3205
3112306|NCT01575834|3836932|FG001|Completed Double-blind Period|Overall Study||3185
3112307|NCT01575834|3836931|FG000|Completed 24-month Study Period|Overall Study||3032
3112308|NCT01575834|3836932|FG001|Completed 24-month Study Period|Overall Study||2994
3112309|NCT01575834|3836931|FG000|COMPLETED|Overall Study|Completed 36-month study period|2892
3112310|NCT01575834|3836932|FG001|COMPLETED|Overall Study|Completed 36-month study period|2851
3112311|NCT01575834|3836931|FG000|NOT COMPLETED|Overall Study||699
3112312|NCT01575834|3836932|FG001|NOT COMPLETED|Overall Study||738
3112313|NCT01575860|3836942|FG000|STARTED|Overall Study||8
3112314|NCT01575860|3836942|FG000|COMPLETED|Overall Study||6
3112315|NCT01575860|3836942|FG000|NOT COMPLETED|Overall Study||2
3112316|NCT01575873|3836951|FG000|STARTED|Overall Study||145
3112317|NCT01575873|3836952|FG001|STARTED|Overall Study||145
3112318|NCT01575873|3836953|FG002|STARTED|Overall Study||252
3112319|NCT01575873|3836954|FG003|STARTED|Overall Study||253
3112320|NCT01575873|3836951|FG000|Received Study Drug|Overall Study|Participants who received oral risedronate|140
3112321|NCT01575873|3836952|FG001|Received Study Drug|Overall Study|Participants who received subcutaneous denosumab|142
3112322|NCT01575873|3836953|FG002|Received Study Drug|Overall Study|Participants who received oral risedronate|246
3112323|NCT01575873|3836954|FG003|Received Study Drug|Overall Study|Participants who received subcutaneous denosumab|251
3112324|NCT01575873|3836951|FG000|COMPLETED|Overall Study||117
3112325|NCT01575873|3836952|FG001|COMPLETED|Overall Study||109
3112326|NCT01575873|3836953|FG002|COMPLETED|Overall Study||178
3112327|NCT01575873|3836954|FG003|COMPLETED|Overall Study||186
3112328|NCT01575873|3836951|FG000|NOT COMPLETED|Overall Study||28
3112329|NCT01575873|3836952|FG001|NOT COMPLETED|Overall Study||36
3112330|NCT01575873|3836953|FG002|NOT COMPLETED|Overall Study||74
3112331|NCT01575873|3836954|FG003|NOT COMPLETED|Overall Study||67
3112332|NCT01575899|3836965|FG000|STARTED|Overall Study||73
3112333|NCT01575899|3836966|FG001|STARTED|Overall Study||73
3112334|NCT01575899|3836967|FG002|STARTED|Overall Study|Included patients still with Hp infection after previous therapy without levofloxacin and Augmentin.|62
3112335|NCT01575899|3836965|FG000|COMPLETED|Overall Study||68
3112336|NCT01575899|3836966|FG001|COMPLETED|Overall Study||68
3112337|NCT01575899|3836967|FG002|COMPLETED|Overall Study||60
3112338|NCT01575899|3836965|FG000|NOT COMPLETED|Overall Study||5
3112339|NCT01575899|3836966|FG001|NOT COMPLETED|Overall Study||5
3112340|NCT01575899|3836967|FG002|NOT COMPLETED|Overall Study||2
3112341|NCT01575912|3836980|FG000|STARTED|Overall Study||30
3112342|NCT01575912|3836981|FG001|STARTED|Overall Study||32
3112343|NCT01575912|3836982|FG002|STARTED|Overall Study||30
3112344|NCT01575912|3836980|FG000|COMPLETED|Overall Study||30
3112345|NCT01575912|3836981|FG001|COMPLETED|Overall Study||32
3112346|NCT01575912|3836982|FG002|COMPLETED|Overall Study||30
3112347|NCT01575912|3836980|FG000|NOT COMPLETED|Overall Study||0
3112348|NCT01575912|3836981|FG001|NOT COMPLETED|Overall Study||0
3112349|NCT01575912|3836982|FG002|NOT COMPLETED|Overall Study||0
3135899|NCT01709422|3860969|FG000|NOT COMPLETED|Overall Study||0
3135900|NCT01709422|3860970|FG001|NOT COMPLETED|Overall Study||0
3135901|NCT01709474|3860980|FG000|STARTED|Overall Study||3
3135902|NCT01709474|3860981|FG001|STARTED|Overall Study||4
3135903|NCT01709474|3860980|FG000|COMPLETED|Overall Study||3
3135904|NCT01709474|3860981|FG001|COMPLETED|Overall Study||4
3135905|NCT01709474|3860980|FG000|NOT COMPLETED|Overall Study||0
3135906|NCT01709474|3860981|FG001|NOT COMPLETED|Overall Study||0
3135907|NCT01709500|3860989|FG000|STARTED|Overall Study||167
3135908|NCT01709500|3860990|FG001|STARTED|Overall Study||82
3135909|NCT01709500|3860989|FG000|Treated|Overall Study||167
3135910|NCT01709500|3860990|FG001|Treated|Overall Study||81
3135911|NCT01709500|3860989|FG000|COMPLETED|Overall Study||0
3135912|NCT01709500|3860990|FG001|COMPLETED|Overall Study||0
3135913|NCT01709500|3860989|FG000|NOT COMPLETED|Overall Study||167
3135914|NCT01709500|3860990|FG001|NOT COMPLETED|Overall Study||82
3136808|NCT01715805|3862076|FG003|STARTED|Placebo + ADT Lead-in Period||0
3136809|NCT01715805|3862073|FG000|COMPLETED|Placebo + ADT Lead-in Period||807
3136810|NCT01715805|3862074|FG001|COMPLETED|Placebo + ADT Lead-in Period||0
3136811|NCT01715805|3862075|FG002|COMPLETED|Placebo + ADT Lead-in Period||0
3136812|NCT01715805|3862076|FG003|COMPLETED|Placebo + ADT Lead-in Period||0
3136813|NCT01715805|3862073|FG000|NOT COMPLETED|Placebo + ADT Lead-in Period||215
3136814|NCT01715805|3862074|FG001|NOT COMPLETED|Placebo + ADT Lead-in Period||0
3136815|NCT01715805|3862075|FG002|NOT COMPLETED|Placebo + ADT Lead-in Period||0
3136816|NCT01715805|3862076|FG003|NOT COMPLETED|Placebo + ADT Lead-in Period||0
3136817|NCT01715805|3862073|FG000|STARTED|Double-Blind or Continued Treatment||0
3136818|NCT01715805|3862074|FG001|STARTED|Double-Blind or Continued Treatment||261
3136819|NCT01715805|3862075|FG002|STARTED|Double-Blind or Continued Treatment||269
3136820|NCT01715805|3862076|FG003|STARTED|Double-Blind or Continued Treatment||270
3136821|NCT01715805|3862073|FG000|Double-Blind Safety Population|Double-Blind or Continued Treatment||0
3136822|NCT01715805|3862074|FG001|Double-Blind Safety Population|Double-Blind or Continued Treatment||258
3136823|NCT01715805|3862075|FG002|Double-Blind Safety Population|Double-Blind or Continued Treatment||269
3136824|NCT01715805|3862076|FG003|Double-Blind Safety Population|Double-Blind or Continued Treatment||0
3136825|NCT01715805|3862073|FG000|COMPLETED|Double-Blind or Continued Treatment||0
3136826|NCT01715805|3862074|FG001|COMPLETED|Double-Blind or Continued Treatment||222
3136827|NCT01715805|3862075|FG002|COMPLETED|Double-Blind or Continued Treatment||213
3136828|NCT01715805|3862076|FG003|COMPLETED|Double-Blind or Continued Treatment||222
3136829|NCT01715805|3862073|FG000|NOT COMPLETED|Double-Blind or Continued Treatment||0
3171756|NCT01936948|3898953|FG000|Crossover|Overall Study||31
3112350|NCT01576003|3836993|FG000|STARTED|Overall Study||2
3112351|NCT01576003|3836994|FG001|STARTED|Overall Study||3
3112352|NCT01576003|3836995|FG002|STARTED|Overall Study||4
3112353|NCT01576003|3836993|FG000|COMPLETED|Overall Study||1
3112354|NCT01576003|3836994|FG001|COMPLETED|Overall Study||1
3112355|NCT01576003|3836995|FG002|COMPLETED|Overall Study||4
3112356|NCT01576003|3836993|FG000|NOT COMPLETED|Overall Study||1
3112357|NCT01576003|3836994|FG001|NOT COMPLETED|Overall Study||2
3112358|NCT01576003|3836995|FG002|NOT COMPLETED|Overall Study||0
3112359|NCT01576016|3837005|FG000|STARTED|Lead Safety||920
3112360|NCT01576016|3837006|FG001|STARTED|Lead Safety||0
3112361|NCT01576016|3837005|FG000|COMPLETED|Lead Safety||647
3112362|NCT01576016|3837006|FG001|COMPLETED|Lead Safety||0
3112363|NCT01576016|3837005|FG000|NOT COMPLETED|Lead Safety||273
3112364|NCT01576016|3837006|FG001|NOT COMPLETED|Lead Safety||0
3112365|NCT01576016|3837005|FG000|STARTED|MRI Safety||0
3112366|NCT01576016|3837006|FG001|STARTED|MRI Safety|255 enrollments includes 30 supplemental scans performed in Australia using the same scan protocol.|255
3112367|NCT01576016|3837005|FG000|COMPLETED|MRI Safety||0
3112368|NCT01576016|3837006|FG001|COMPLETED|MRI Safety||181
3112369|NCT01576016|3837005|FG000|NOT COMPLETED|MRI Safety||0
3112370|NCT01576016|3837006|FG001|NOT COMPLETED|MRI Safety||74
3112371|NCT01576042|3837016|FG000|STARTED|Overall Study||13
3112372|NCT01576042|3837017|FG001|STARTED|Overall Study||14
3112373|NCT01576042|3837016|FG000|Switched to the Other Arm|Overall Study||5
3112374|NCT01576042|3837017|FG001|Switched to the Other Arm|Overall Study||1
3112375|NCT01576042|3837016|FG000|COMPLETED|Overall Study||11
3112376|NCT01576042|3837017|FG001|COMPLETED|Overall Study||14
3112377|NCT01576042|3837016|FG000|NOT COMPLETED|Overall Study||2
3112378|NCT01576042|3837017|FG001|NOT COMPLETED|Overall Study||0
3112379|NCT01576055|3837025|FG000|STARTED|Overall Study||197
3112380|NCT01576055|3837026|FG001|STARTED|Overall Study||70
3112381|NCT01576055|3837025|FG000|COMPLETED|Overall Study||178
3112382|NCT01576055|3837026|FG001|COMPLETED|Overall Study||64
3112383|NCT01576055|3837025|FG000|NOT COMPLETED|Overall Study||19
3112384|NCT01576055|3837026|FG001|NOT COMPLETED|Overall Study||6
3112385|NCT01576120|3837034|FG000|STARTED|Overall Study||21
3112386|NCT01576120|3837035|FG001|STARTED|Overall Study||19
3112387|NCT01576120|3837034|FG000|COMPLETED|Overall Study||21
3112388|NCT01576120|3837035|FG001|COMPLETED|Overall Study||19
3112389|NCT01576120|3837034|FG000|NOT COMPLETED|Overall Study||0
3112390|NCT01576120|3837035|FG001|NOT COMPLETED|Overall Study||0
3112391|NCT01576146|3837041|FG000|STARTED|Extension Period 1||30
3112392|NCT01576146|3837041|FG000|COMPLETED|Extension Period 1||20
3112393|NCT01576146|3837041|FG000|NOT COMPLETED|Extension Period 1||10
3112394|NCT01576146|3837041|FG000|STARTED|Extension Period 2|Three participants who completed Extension Period 1 did not enroll in Period 2|17
3112395|NCT01576146|3837041|FG000|COMPLETED|Extension Period 2||0
3112396|NCT01576146|3837041|FG000|NOT COMPLETED|Extension Period 2||17
3112397|NCT01576159|3837049|FG000|STARTED|Overall Study||12
3112398|NCT01576159|3837050|FG001|STARTED|Overall Study||12
3112399|NCT01576159|3837051|FG002|STARTED|Overall Study||12
3112400|NCT01576159|3837052|FG003|STARTED|Overall Study||12
3112401|NCT01576159|3837049|FG000|COMPLETED|Overall Study||11
3112402|NCT01576159|3837050|FG001|COMPLETED|Overall Study||11
3112403|NCT01576159|3837051|FG002|COMPLETED|Overall Study||11
3112404|NCT01576159|3837052|FG003|COMPLETED|Overall Study||11
3112405|NCT01576159|3837049|FG000|NOT COMPLETED|Overall Study||1
3112406|NCT01576159|3837050|FG001|NOT COMPLETED|Overall Study||1
3112407|NCT01576159|3837051|FG002|NOT COMPLETED|Overall Study||1
3112408|NCT01576159|3837052|FG003|NOT COMPLETED|Overall Study||1
3112409|NCT01576172|3837071|FG000|STARTED|Overall Study||79
3112410|NCT01576172|3837072|FG001|STARTED|Overall Study||80
3112411|NCT01576172|3837071|FG000|COMPLETED|Overall Study||74
3112412|NCT01576172|3837072|FG001|COMPLETED|Overall Study||79
3112413|NCT01576172|3837071|FG000|NOT COMPLETED|Overall Study||5
3112414|NCT01576172|3837072|FG001|NOT COMPLETED|Overall Study||1
3112415|NCT01576276|3837082|FG000|STARTED|Overall Study||22
3112416|NCT01576276|3837083|FG001|STARTED|Overall Study||29
3112417|NCT01576276|3837082|FG000|COMPLETED|Overall Study||14
3112418|NCT01576276|3837083|FG001|COMPLETED|Overall Study||18
3112419|NCT01576276|3837082|FG000|NOT COMPLETED|Overall Study||8
3112420|NCT01576276|3837083|FG001|NOT COMPLETED|Overall Study||11
3112421|NCT01576341|3837090|FG000|STARTED|Overall Study||417
3112422|NCT01576341|3837090|FG000|COMPLETED|Overall Study||324
3112423|NCT01576341|3837090|FG000|NOT COMPLETED|Overall Study||93
3112424|NCT01576367|3837097|FG000|STARTED|Overall Study||17
3112425|NCT01576367|3837097|FG000|COMPLETED|Overall Study||14
3112426|NCT01576367|3837097|FG000|NOT COMPLETED|Overall Study||3
3112427|NCT01576406|3837107|FG000|STARTED|Overall Study||11
3112428|NCT01576406|3837108|FG001|STARTED|Overall Study||15
3112429|NCT01576406|3837109|FG002|STARTED|Overall Study||20
3112430|NCT01576406|3837110|FG003|STARTED|Overall Study||10
3112431|NCT01576406|3837111|FG004|STARTED|Overall Study||16
3112432|NCT01576406|3837112|FG005|STARTED|Overall Study||16
3112433|NCT01576406|3837107|FG000|COMPLETED|Overall Study||5
3112434|NCT01576406|3837108|FG001|COMPLETED|Overall Study||7
3112435|NCT01576406|3837109|FG002|COMPLETED|Overall Study||4
3112436|NCT01576406|3837110|FG003|COMPLETED|Overall Study||1
3112437|NCT01576406|3837111|FG004|COMPLETED|Overall Study||8
3112438|NCT01576406|3837112|FG005|COMPLETED|Overall Study||4
3112439|NCT01576406|3837107|FG000|NOT COMPLETED|Overall Study||6
3112440|NCT01576406|3837108|FG001|NOT COMPLETED|Overall Study||8
3112441|NCT01576406|3837109|FG002|NOT COMPLETED|Overall Study||16
3112442|NCT01576406|3837110|FG003|NOT COMPLETED|Overall Study||9
3112443|NCT01576406|3837111|FG004|NOT COMPLETED|Overall Study||8
3112444|NCT01576406|3837112|FG005|NOT COMPLETED|Overall Study||12
3112445|NCT01576471|3837128|FG000|STARTED|Overall Study||125
3112446|NCT01576471|3837129|FG001|STARTED|Overall Study||125
3112447|NCT01576471|3837128|FG000|COMPLETED|Overall Study||117
3112448|NCT01576471|3837129|FG001|COMPLETED|Overall Study||116
3112449|NCT01576471|3837128|FG000|NOT COMPLETED|Overall Study||8
3112450|NCT01576471|3837129|FG001|NOT COMPLETED|Overall Study||9
3112451|NCT01576484|3837137|FG000|STARTED|Overall Study||12
3112452|NCT01576484|3837138|FG001|STARTED|Overall Study||46
3112453|NCT01576484|3837137|FG000|COMPLETED|Overall Study||7
3112454|NCT01576484|3837138|FG001|COMPLETED|Overall Study||27
3112455|NCT01576484|3837137|FG000|NOT COMPLETED|Overall Study||5
3112456|NCT01576484|3837138|FG001|NOT COMPLETED|Overall Study||19
3112457|NCT01576523|3837152|FG000|STARTED|Dosing Period 1||3
3112458|NCT01576523|3837153|FG001|STARTED|Dosing Period 1||3
3112459|NCT01576523|3837154|FG002|STARTED|Dosing Period 1||3
3112460|NCT01576523|3837155|FG003|STARTED|Dosing Period 1||3
3112461|NCT01576523|3837156|FG004|STARTED|Dosing Period 1||3
3112462|NCT01576523|3837157|FG005|STARTED|Dosing Period 1||3
3112463|NCT01576523|3837152|FG000|COMPLETED|Dosing Period 1||3
3112464|NCT01576523|3837153|FG001|COMPLETED|Dosing Period 1||3
3112465|NCT01576523|3837154|FG002|COMPLETED|Dosing Period 1||3
3112466|NCT01576523|3837155|FG003|COMPLETED|Dosing Period 1||3
3112467|NCT01576523|3837156|FG004|COMPLETED|Dosing Period 1||3
3112468|NCT01576523|3837157|FG005|COMPLETED|Dosing Period 1||3
3112469|NCT01576523|3837152|FG000|NOT COMPLETED|Dosing Period 1||0
3112470|NCT01576523|3837153|FG001|NOT COMPLETED|Dosing Period 1||0
3112471|NCT01576523|3837154|FG002|NOT COMPLETED|Dosing Period 1||0
3112472|NCT01576523|3837155|FG003|NOT COMPLETED|Dosing Period 1||0
3112473|NCT01576523|3837156|FG004|NOT COMPLETED|Dosing Period 1||0
3112474|NCT01576523|3837157|FG005|NOT COMPLETED|Dosing Period 1||0
3112475|NCT01576523|3837152|FG000|STARTED|Dosing Period 2||3
3112476|NCT01576523|3837153|FG001|STARTED|Dosing Period 2||3
3112477|NCT01576523|3837154|FG002|STARTED|Dosing Period 2||3
3112478|NCT01576523|3837155|FG003|STARTED|Dosing Period 2||3
3112479|NCT01576523|3837156|FG004|STARTED|Dosing Period 2||3
3112480|NCT01576523|3837157|FG005|STARTED|Dosing Period 2||3
3112481|NCT01576523|3837152|FG000|COMPLETED|Dosing Period 2||3
3112482|NCT01576523|3837153|FG001|COMPLETED|Dosing Period 2||3
3112483|NCT01576523|3837154|FG002|COMPLETED|Dosing Period 2||3
3112484|NCT01576523|3837155|FG003|COMPLETED|Dosing Period 2||3
3112485|NCT01576523|3837156|FG004|COMPLETED|Dosing Period 2||3
3112486|NCT01576523|3837157|FG005|COMPLETED|Dosing Period 2||3
3112487|NCT01576523|3837152|FG000|NOT COMPLETED|Dosing Period 2||0
3112488|NCT01576523|3837153|FG001|NOT COMPLETED|Dosing Period 2||0
3112489|NCT01576523|3837154|FG002|NOT COMPLETED|Dosing Period 2||0
3112490|NCT01576523|3837155|FG003|NOT COMPLETED|Dosing Period 2||0
3112491|NCT01576523|3837156|FG004|NOT COMPLETED|Dosing Period 2||0
3112492|NCT01576523|3837157|FG005|NOT COMPLETED|Dosing Period 2||0
3112493|NCT01576536|3837166|FG000|STARTED|Overall Study||117
3112494|NCT01576536|3837166|FG000|COMPLETED|Overall Study||117
3112495|NCT01576536|3837166|FG000|NOT COMPLETED|Overall Study||0
3112496|NCT01576588|3837170|FG000|STARTED|Overall Study||25
3112497|NCT01576588|3837170|FG000|COMPLETED|Overall Study||23
3112498|NCT01576588|3837170|FG000|NOT COMPLETED|Overall Study||2
3112499|NCT01576705|3837179|FG000|STARTED|Overall Study||43
3112500|NCT01576705|3837180|FG001|STARTED|Overall Study||45
3112501|NCT01576705|3837181|FG002|STARTED|Overall Study||43
3112502|NCT01576705|3837182|FG003|STARTED|Overall Study||44
3112503|NCT01576705|3837179|FG000|COMPLETED|Overall Study||40
3112504|NCT01576705|3837180|FG001|COMPLETED|Overall Study||37
3112505|NCT01576705|3837181|FG002|COMPLETED|Overall Study||38
3112506|NCT01576705|3837182|FG003|COMPLETED|Overall Study||41
3112507|NCT01576705|3837179|FG000|NOT COMPLETED|Overall Study||3
3112508|NCT01576705|3837180|FG001|NOT COMPLETED|Overall Study||8
3112509|NCT01576705|3837181|FG002|NOT COMPLETED|Overall Study||5
3112510|NCT01576705|3837182|FG003|NOT COMPLETED|Overall Study||3
3112511|NCT01576718|3837198|FG000|STARTED|Pre-Assignment Period (Run-In Placebo)||889
3112512|NCT01576718|3837199|FG001|STARTED|Pre-Assignment Period (Run-In Placebo)||0
3112513|NCT01576718|3837200|FG002|STARTED|Pre-Assignment Period (Run-In Placebo)||0
3112514|NCT01576718|3837201|FG003|STARTED|Pre-Assignment Period (Run-In Placebo)||0
3112515|NCT01576718|3837202|FG004|STARTED|Pre-Assignment Period (Run-In Placebo)||0
3112516|NCT01576718|3837203|FG005|STARTED|Pre-Assignment Period (Run-In Placebo)||0
3112517|NCT01576718|3837204|FG006|STARTED|Pre-Assignment Period (Run-In Placebo)||0
3112518|NCT01576718|3837198|FG000|COMPLETED|Pre-Assignment Period (Run-In Placebo)|Participants randomized into the Treatment Period|640
3112519|NCT01576718|3837199|FG001|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
3112520|NCT01576718|3837200|FG002|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
3112521|NCT01576718|3837201|FG003|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
3112522|NCT01576718|3837202|FG004|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
3112523|NCT01576718|3837203|FG005|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
3112524|NCT01576718|3837204|FG006|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
3112525|NCT01576718|3837198|FG000|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||249
3112526|NCT01576718|3837199|FG001|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
3112527|NCT01576718|3837200|FG002|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
3112528|NCT01576718|3837201|FG003|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
3112529|NCT01576718|3837202|FG004|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
3112530|NCT01576718|3837203|FG005|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
3112531|NCT01576718|3837204|FG006|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
3112532|NCT01576718|3837198|FG000|STARTED|Treatment Period||0
3112533|NCT01576718|3837199|FG001|STARTED|Treatment Period||107
3112534|NCT01576718|3837200|FG002|STARTED|Treatment Period||107
3112535|NCT01576718|3837201|FG003|STARTED|Treatment Period||106
3112536|NCT01576718|3837202|FG004|STARTED|Treatment Period||107
3112537|NCT01576718|3837203|FG005|STARTED|Treatment Period||106
3112538|NCT01576718|3837204|FG006|STARTED|Treatment Period||107
3112539|NCT01576718|3837198|FG000|Safety Population|Treatment Period||0
3112540|NCT01576718|3837199|FG001|Safety Population|Treatment Period||107
3112541|NCT01576718|3837200|FG002|Safety Population|Treatment Period||107
3112542|NCT01576718|3837201|FG003|Safety Population|Treatment Period||106
3112543|NCT01576718|3837202|FG004|Safety Population|Treatment Period||107
3112544|NCT01576718|3837203|FG005|Safety Population|Treatment Period||106
3112545|NCT01576718|3837204|FG006|Safety Population|Treatment Period||106
3112546|NCT01576718|3837198|FG000|Efficacy Population (Full Analysis Set)|Treatment Period||0
3112547|NCT01576718|3837199|FG001|Efficacy Population (Full Analysis Set)|Treatment Period||107
3112548|NCT01576718|3837200|FG002|Efficacy Population (Full Analysis Set)|Treatment Period||106
3112549|NCT01576718|3837201|FG003|Efficacy Population (Full Analysis Set)|Treatment Period||102
3112550|NCT01576718|3837202|FG004|Efficacy Population (Full Analysis Set)|Treatment Period||107
3112551|NCT01576718|3837203|FG005|Efficacy Population (Full Analysis Set)|Treatment Period||105
3112552|NCT01576718|3837204|FG006|Efficacy Population (Full Analysis Set)|Treatment Period||103
3112553|NCT01576718|3837198|FG000|COMPLETED|Treatment Period||0
3112554|NCT01576718|3837199|FG001|COMPLETED|Treatment Period||82
3112555|NCT01576718|3837200|FG002|COMPLETED|Treatment Period||87
3112556|NCT01576718|3837201|FG003|COMPLETED|Treatment Period||75
3112557|NCT01576718|3837202|FG004|COMPLETED|Treatment Period||80
3112558|NCT01576718|3837203|FG005|COMPLETED|Treatment Period||58
3112559|NCT01576718|3837204|FG006|COMPLETED|Treatment Period||77
3112560|NCT01576718|3837198|FG000|NOT COMPLETED|Treatment Period||0
3112561|NCT01576718|3837199|FG001|NOT COMPLETED|Treatment Period||25
3112562|NCT01576718|3837200|FG002|NOT COMPLETED|Treatment Period||20
3112563|NCT01576718|3837201|FG003|NOT COMPLETED|Treatment Period||31
3112564|NCT01576718|3837202|FG004|NOT COMPLETED|Treatment Period||27
3112565|NCT01576718|3837203|FG005|NOT COMPLETED|Treatment Period||48
3112566|NCT01576718|3837204|FG006|NOT COMPLETED|Treatment Period||30
3112567|NCT01576783|3837220|FG000|STARTED|Overall Study||189
3112568|NCT01576783|3837221|FG001|STARTED|Overall Study||188
3112569|NCT01576783|3837220|FG000|COMPLETED|Overall Study||169
3112570|NCT01576783|3837221|FG001|COMPLETED|Overall Study||171
3112571|NCT01576783|3837220|FG000|NOT COMPLETED|Overall Study||20
3293769|NCT02873377|4027734|FG000|NOT COMPLETED|Period Title 2: 3 Months Follow up||22
3293770|NCT02873377|4027735|FG001|NOT COMPLETED|Period Title 2: 3 Months Follow up||22
3293771|NCT02873377|4027734|FG000|STARTED|Period Title 3: 6 Months Follow up||65
3293772|NCT02873377|4027735|FG001|STARTED|Period Title 3: 6 Months Follow up||69
3293773|NCT02873377|4027734|FG000|COMPLETED|Period Title 3: 6 Months Follow up||50
3293774|NCT02873377|4027735|FG001|COMPLETED|Period Title 3: 6 Months Follow up||46
3293775|NCT02873377|4027734|FG000|NOT COMPLETED|Period Title 3: 6 Months Follow up||15
3293776|NCT02873377|4027735|FG001|NOT COMPLETED|Period Title 3: 6 Months Follow up||23
3293777|NCT02873429|4027744|FG000|STARTED|Baseline||109
3293778|NCT02873429|4027745|FG001|STARTED|Baseline||100
3293779|NCT02873429|4027744|FG000|COMPLETED|Baseline||109
3293780|NCT02873429|4027745|FG001|COMPLETED|Baseline||100
3293781|NCT02873429|4027744|FG000|NOT COMPLETED|Baseline||0
3293782|NCT02873429|4027745|FG001|NOT COMPLETED|Baseline||0
3293783|NCT02873429|4027744|FG000|STARTED|6-8 Weeks|4 CAM participants not eligible to complete follow ups because they did not continue treatment.|105
3293784|NCT02873429|4027745|FG001|STARTED|6-8 Weeks|2 Con. participants not eligible to complete follow ups because they did not continue treatment.|98
3293785|NCT02873429|4027744|FG000|COMPLETED|6-8 Weeks||95
3293786|NCT02873429|4027745|FG001|COMPLETED|6-8 Weeks||97
3293787|NCT02873429|4027744|FG000|NOT COMPLETED|6-8 Weeks||10
3293788|NCT02873429|4027745|FG001|NOT COMPLETED|6-8 Weeks||1
3293789|NCT02873429|4027744|FG000|STARTED|16 Weeks|10 CAM participants Missed 6-8 week but are eligible for 16 week|105
3293790|NCT02873429|4027745|FG001|STARTED|16 Weeks|1 Conv. participant Missed 6-8 week but was eligible for 16 week|98
3293791|NCT02873429|4027744|FG000|COMPLETED|16 Weeks||100
3293792|NCT02873429|4027745|FG001|COMPLETED|16 Weeks||96
3293793|NCT02873429|4027744|FG000|NOT COMPLETED|16 Weeks||5
3293794|NCT02873429|4027745|FG001|NOT COMPLETED|16 Weeks||2
3293795|NCT02873481|4027753|FG000|STARTED|Overall Study||15
3293796|NCT02873481|4027754|FG001|STARTED|Overall Study||17
3293797|NCT02873481|4027753|FG000|COMPLETED|Overall Study||15
3293798|NCT02873481|4027754|FG001|COMPLETED|Overall Study||17
3293799|NCT02873481|4027753|FG000|NOT COMPLETED|Overall Study||0
3293800|NCT02873481|4027754|FG001|NOT COMPLETED|Overall Study||0
3293801|NCT02873585|4027760|FG000|STARTED|Overall Study||32
3293802|NCT02873585|4027760|FG000|COMPLETED|Overall Study||32
3293803|NCT02873585|4027760|FG000|NOT COMPLETED|Overall Study||0
3293804|NCT02873689|4027770|FG000|STARTED|Overall Study||109
3293805|NCT02873689|4027771|FG001|STARTED|Overall Study||108
3293806|NCT02873689|4027770|FG000|Treated|Overall Study||108
3293807|NCT02873689|4027771|FG001|Treated|Overall Study||107
3293808|NCT02873689|4027770|FG000|COMPLETED|Overall Study||102
3293809|NCT02873689|4027771|FG001|COMPLETED|Overall Study||103
3112572|NCT01576783|3837221|FG001|NOT COMPLETED|Overall Study||17
3112573|NCT01576809|3837227|FG000|STARTED|Overall Study||51
3112574|NCT01576809|3837227|FG000|COMPLETED|Overall Study||51
3112575|NCT01576809|3837227|FG000|NOT COMPLETED|Overall Study||0
3112576|NCT01576874|3837233|FG000|STARTED|Overall Study||72
3112577|NCT01576874|3837234|FG001|STARTED|Overall Study||72
3112578|NCT01576874|3837233|FG000|COMPLETED|Overall Study||72
3112579|NCT01576874|3837234|FG001|COMPLETED|Overall Study||72
3112580|NCT01576874|3837233|FG000|NOT COMPLETED|Overall Study||0
3112581|NCT01576874|3837234|FG001|NOT COMPLETED|Overall Study||0
3112582|NCT01576939|3837240|FG000|STARTED|Overall Study||30
3112583|NCT01576939|3837240|FG000|COMPLETED|Overall Study||30
3112584|NCT01576939|3837240|FG000|NOT COMPLETED|Overall Study||0
3112585|NCT01576952|3837246|FG000|STARTED|Overall Study||180
3112586|NCT01576952|3837247|FG001|STARTED|Overall Study||88
3112587|NCT01576952|3837246|FG000|Safety Population|Overall Study||169
3112588|NCT01576952|3837247|FG001|Safety Population|Overall Study||85
3112589|NCT01576952|3837246|FG000|mITT Population|Overall Study||168
3112590|NCT01576952|3837247|FG001|mITT Population|Overall Study||85
3112591|NCT01576952|3837246|FG000|COMPLETED|Overall Study||139
3112592|NCT01576952|3837247|FG001|COMPLETED|Overall Study||33
3112593|NCT01576952|3837246|FG000|NOT COMPLETED|Overall Study||41
3112594|NCT01576952|3837247|FG001|NOT COMPLETED|Overall Study||55
3112595|NCT01577108|3837255|FG000|STARTED|Overall Study||54
3112596|NCT01577108|3837256|FG001|STARTED|Overall Study||56
3112597|NCT01577108|3837255|FG000|COMPLETED|Overall Study||49
3112598|NCT01577108|3837256|FG001|COMPLETED|Overall Study||50
3112599|NCT01577108|3837255|FG000|NOT COMPLETED|Overall Study||5
3112600|NCT01577108|3837256|FG001|NOT COMPLETED|Overall Study||6
3112601|NCT01577160|3837262|FG000|STARTED|Overall Study||353
3112602|NCT01577160|3837262|FG000|COMPLETED|Overall Study||255
3112603|NCT01577160|3837262|FG000|NOT COMPLETED|Overall Study||98
3112604|NCT01577186|3837266|FG000|STARTED|Overall Study||480
3112605|NCT01577186|3837266|FG000|COMPLETED|Overall Study||350
3112606|NCT01577186|3837266|FG000|NOT COMPLETED|Overall Study||130
3112607|NCT01577238|3837272|FG000|STARTED|Overall Study||127
3112608|NCT01577238|3837273|FG001|STARTED|Overall Study||123
3112609|NCT01577238|3837272|FG000|COMPLETED|Overall Study||117
3112610|NCT01577238|3837273|FG001|COMPLETED|Overall Study||111
3112611|NCT01577238|3837272|FG000|NOT COMPLETED|Overall Study||10
3112612|NCT01577238|3837273|FG001|NOT COMPLETED|Overall Study||12
3112613|NCT01577329|3837281|FG000|STARTED|Overall Study||19
3112614|NCT01577329|3837282|FG001|STARTED|Overall Study||22
3112615|NCT01577329|3837281|FG000|COMPLETED|Overall Study||16
3112616|NCT01577329|3837282|FG001|COMPLETED|Overall Study||22
3112617|NCT01577329|3837281|FG000|NOT COMPLETED|Overall Study||3
3112618|NCT01577329|3837282|FG001|NOT COMPLETED|Overall Study||0
3112619|NCT01577381|3837292|FG000|STARTED|Overall Study||2
3112620|NCT01577381|3837293|FG001|STARTED|Overall Study||3
3112621|NCT01577381|3837294|FG002|STARTED|Overall Study||3
3293810|NCT02873689|4027770|FG000|NOT COMPLETED|Overall Study||7
3293811|NCT02873689|4027771|FG001|NOT COMPLETED|Overall Study||5
3293812|NCT02873702|4027779|FG000|STARTED|Healing Period (up to Week 8)||20
3293813|NCT02873702|4027780|FG001|STARTED|Healing Period (up to Week 8)||17
3293814|NCT02873702|4027781|FG002|STARTED|Healing Period (up to Week 8)||0
3293815|NCT02873702|4027782|FG003|STARTED|Healing Period (up to Week 8)||0
3293816|NCT02873702|4027779|FG000|COMPLETED|Healing Period (up to Week 8)||19
3293817|NCT02873702|4027780|FG001|COMPLETED|Healing Period (up to Week 8)||16
3293818|NCT02873702|4027781|FG002|COMPLETED|Healing Period (up to Week 8)||0
3293819|NCT02873702|4027782|FG003|COMPLETED|Healing Period (up to Week 8)||0
3293820|NCT02873702|4027779|FG000|NOT COMPLETED|Healing Period (up to Week 8)||1
3293821|NCT02873702|4027780|FG001|NOT COMPLETED|Healing Period (up to Week 8)||1
3293822|NCT02873702|4027781|FG002|NOT COMPLETED|Healing Period (up to Week 8)||0
3293823|NCT02873702|4027782|FG003|NOT COMPLETED|Healing Period (up to Week 8)||0
3293824|NCT02873702|4027779|FG000|STARTED|Maintenance Period (up to Month 6)||0
3293825|NCT02873702|4027780|FG001|STARTED|Maintenance Period (up to Month 6)||0
3293826|NCT02873702|4027781|FG002|STARTED|Maintenance Period (up to Month 6)||8
3293827|NCT02873702|4027782|FG003|STARTED|Maintenance Period (up to Month 6)||8
3293828|NCT02873702|4027779|FG000|COMPLETED|Maintenance Period (up to Month 6)||0
3293829|NCT02873702|4027780|FG001|COMPLETED|Maintenance Period (up to Month 6)||0
3293830|NCT02873702|4027781|FG002|COMPLETED|Maintenance Period (up to Month 6)||1
3293831|NCT02873702|4027782|FG003|COMPLETED|Maintenance Period (up to Month 6)||6
3293832|NCT02873702|4027779|FG000|NOT COMPLETED|Maintenance Period (up to Month 6)||0
3293833|NCT02873702|4027780|FG001|NOT COMPLETED|Maintenance Period (up to Month 6)||0
3293834|NCT02873702|4027781|FG002|NOT COMPLETED|Maintenance Period (up to Month 6)||7
3293835|NCT02873702|4027782|FG003|NOT COMPLETED|Maintenance Period (up to Month 6)||2
3293836|NCT02873754|4027792|FG000|STARTED|Overall Study||11
3112622|NCT01577381|3837295|FG003|STARTED|Overall Study||2
3112623|NCT01577381|3837292|FG000|COMPLETED|Overall Study||0
3112624|NCT01577381|3837293|FG001|COMPLETED|Overall Study||0
3112625|NCT01577381|3837294|FG002|COMPLETED|Overall Study||0
3112626|NCT01577381|3837295|FG003|COMPLETED|Overall Study||0
3112627|NCT01577381|3837292|FG000|NOT COMPLETED|Overall Study||2
3112628|NCT01577381|3837293|FG001|NOT COMPLETED|Overall Study||3
3112629|NCT01577381|3837294|FG002|NOT COMPLETED|Overall Study||3
3112630|NCT01577381|3837295|FG003|NOT COMPLETED|Overall Study||2
3112631|NCT01577537|3837307|FG000|STARTED|Overall Study||128
3112632|NCT01577537|3837308|FG001|STARTED|Overall Study||123
3112633|NCT01577537|3837307|FG000|COMPLETED|Overall Study||120
3112634|NCT01577537|3837308|FG001|COMPLETED|Overall Study||116
3112635|NCT01577537|3837307|FG000|NOT COMPLETED|Overall Study||8
3112636|NCT01577537|3837308|FG001|NOT COMPLETED|Overall Study||7
3112637|NCT01577706|3837314|FG000|STARTED|First Intervention (1 Day)||3
3112638|NCT01577706|3837315|FG001|STARTED|First Intervention (1 Day)||1
3112639|NCT01577706|3837316|FG002|STARTED|First Intervention (1 Day)||3
3112640|NCT01577706|3837314|FG000|COMPLETED|First Intervention (1 Day)||3
3112641|NCT01577706|3837315|FG001|COMPLETED|First Intervention (1 Day)||1
3112642|NCT01577706|3837316|FG002|COMPLETED|First Intervention (1 Day)||3
3112643|NCT01577706|3837314|FG000|NOT COMPLETED|First Intervention (1 Day)||0
3112644|NCT01577706|3837315|FG001|NOT COMPLETED|First Intervention (1 Day)||0
3112645|NCT01577706|3837316|FG002|NOT COMPLETED|First Intervention (1 Day)||0
3112646|NCT01577706|3837314|FG000|STARTED|Washout (at Least 1 Week)||3
3112647|NCT01577706|3837315|FG001|STARTED|Washout (at Least 1 Week)||1
3112648|NCT01577706|3837316|FG002|STARTED|Washout (at Least 1 Week)||3
3112649|NCT01577706|3837314|FG000|COMPLETED|Washout (at Least 1 Week)||3
3112650|NCT01577706|3837315|FG001|COMPLETED|Washout (at Least 1 Week)||1
3112651|NCT01577706|3837316|FG002|COMPLETED|Washout (at Least 1 Week)||3
3112652|NCT01577706|3837314|FG000|NOT COMPLETED|Washout (at Least 1 Week)||0
3112653|NCT01577706|3837315|FG001|NOT COMPLETED|Washout (at Least 1 Week)||0
3112654|NCT01577706|3837316|FG002|NOT COMPLETED|Washout (at Least 1 Week)||0
3112655|NCT01577706|3837314|FG000|STARTED|Second Intervention (1 Day)||3
3112656|NCT01577706|3837315|FG001|STARTED|Second Intervention (1 Day)||1
3112657|NCT01577706|3837316|FG002|STARTED|Second Intervention (1 Day)||3
3112658|NCT01577706|3837314|FG000|COMPLETED|Second Intervention (1 Day)||3
3112659|NCT01577706|3837315|FG001|COMPLETED|Second Intervention (1 Day)||1
3112660|NCT01577706|3837316|FG002|COMPLETED|Second Intervention (1 Day)||3
3112661|NCT01577706|3837314|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
3112662|NCT01577706|3837315|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
3112663|NCT01577706|3837316|FG002|NOT COMPLETED|Second Intervention (1 Day)||0
3112664|NCT01577706|3837314|FG000|STARTED|Washout (at Least 1 Week)||3
3112665|NCT01577706|3837315|FG001|STARTED|Washout (at Least 1 Week)||1
3112666|NCT01577706|3837316|FG002|STARTED|Washout (at Least 1 Week)||3
3112667|NCT01577706|3837314|FG000|COMPLETED|Washout (at Least 1 Week)||3
3112668|NCT01577706|3837315|FG001|COMPLETED|Washout (at Least 1 Week)||1
3112669|NCT01577706|3837316|FG002|COMPLETED|Washout (at Least 1 Week)||3
3112670|NCT01577706|3837314|FG000|NOT COMPLETED|Washout (at Least 1 Week)||0
3112671|NCT01577706|3837315|FG001|NOT COMPLETED|Washout (at Least 1 Week)||0
3112672|NCT01577706|3837316|FG002|NOT COMPLETED|Washout (at Least 1 Week)||0
3112673|NCT01577706|3837314|FG000|STARTED|Third Intervention (1 Day)||3
3112674|NCT01577706|3837315|FG001|STARTED|Third Intervention (1 Day)||1
3112675|NCT01577706|3837316|FG002|STARTED|Third Intervention (1 Day)||3
3112676|NCT01577706|3837314|FG000|COMPLETED|Third Intervention (1 Day)||3
3112677|NCT01577706|3837315|FG001|COMPLETED|Third Intervention (1 Day)||1
3112678|NCT01577706|3837316|FG002|COMPLETED|Third Intervention (1 Day)||3
3112679|NCT01577706|3837314|FG000|NOT COMPLETED|Third Intervention (1 Day)||0
3112680|NCT01577706|3837315|FG001|NOT COMPLETED|Third Intervention (1 Day)||0
3112681|NCT01577706|3837316|FG002|NOT COMPLETED|Third Intervention (1 Day)||0
3112682|NCT01577732|3837324|FG000|STARTED|Overall Study||300
3112683|NCT01577732|3837324|FG000|COMPLETED|Overall Study||300
3112684|NCT01577732|3837324|FG000|NOT COMPLETED|Overall Study||0
3112685|NCT01577745|3837334|FG000|STARTED|Overall Study||3
3112686|NCT01577745|3837335|FG001|STARTED|Overall Study||3
3112687|NCT01577745|3837336|FG002|STARTED|Overall Study||3
3112688|NCT01577745|3837337|FG003|STARTED|Overall Study||6
3112689|NCT01577745|3837338|FG004|STARTED|Overall Study||5
3112690|NCT01577745|3837339|FG005|STARTED|Overall Study||5
3112691|NCT01577745|3837334|FG000|COMPLETED|Overall Study||0
3112692|NCT01577745|3837335|FG001|COMPLETED|Overall Study||0
3112693|NCT01577745|3837336|FG002|COMPLETED|Overall Study||1
3112694|NCT01577745|3837337|FG003|COMPLETED|Overall Study||0
3112695|NCT01577745|3837338|FG004|COMPLETED|Overall Study||0
3112696|NCT01577745|3837339|FG005|COMPLETED|Overall Study||1
3112697|NCT01577745|3837334|FG000|NOT COMPLETED|Overall Study||3
3112698|NCT01577745|3837335|FG001|NOT COMPLETED|Overall Study||3
3112699|NCT01577745|3837336|FG002|NOT COMPLETED|Overall Study||2
3112700|NCT01577745|3837337|FG003|NOT COMPLETED|Overall Study||6
3112701|NCT01577745|3837338|FG004|NOT COMPLETED|Overall Study||5
3112702|NCT01577745|3837339|FG005|NOT COMPLETED|Overall Study||4
3112703|NCT01577758|3837358|FG000|STARTED|Dose Escalation Phase||2
3112704|NCT01577758|3837359|FG001|STARTED|Dose Escalation Phase||2
3112705|NCT01577758|3837360|FG002|STARTED|Dose Escalation Phase||2
3112706|NCT01577758|3837361|FG003|STARTED|Dose Escalation Phase||2
3112707|NCT01577758|3837362|FG004|STARTED|Dose Escalation Phase||6
3112708|NCT01577758|3837363|FG005|STARTED|Dose Escalation Phase||4
3112709|NCT01577758|3837364|FG006|STARTED|Dose Escalation Phase||1
3112710|NCT01577758|3837365|FG007|STARTED|Dose Escalation Phase||0
3112711|NCT01577758|3837358|FG000|COMPLETED|Dose Escalation Phase||0
3112712|NCT01577758|3837359|FG001|COMPLETED|Dose Escalation Phase||0
3112713|NCT01577758|3837360|FG002|COMPLETED|Dose Escalation Phase||0
3112714|NCT01577758|3837361|FG003|COMPLETED|Dose Escalation Phase||0
3112715|NCT01577758|3837362|FG004|COMPLETED|Dose Escalation Phase||0
3112716|NCT01577758|3837363|FG005|COMPLETED|Dose Escalation Phase||0
3112717|NCT01577758|3837364|FG006|COMPLETED|Dose Escalation Phase||0
3112718|NCT01577758|3837365|FG007|COMPLETED|Dose Escalation Phase||0
3112719|NCT01577758|3837358|FG000|NOT COMPLETED|Dose Escalation Phase||2
3112720|NCT01577758|3837359|FG001|NOT COMPLETED|Dose Escalation Phase||2
3112721|NCT01577758|3837360|FG002|NOT COMPLETED|Dose Escalation Phase||2
3112722|NCT01577758|3837361|FG003|NOT COMPLETED|Dose Escalation Phase||2
3112723|NCT01577758|3837362|FG004|NOT COMPLETED|Dose Escalation Phase||6
3112724|NCT01577758|3837363|FG005|NOT COMPLETED|Dose Escalation Phase||4
3112725|NCT01577758|3837364|FG006|NOT COMPLETED|Dose Escalation Phase||1
3112726|NCT01577758|3837365|FG007|NOT COMPLETED|Dose Escalation Phase||0
3112727|NCT01577758|3837358|FG000|STARTED|mCRC Expansion Phase||0
3112728|NCT01577758|3837359|FG001|STARTED|mCRC Expansion Phase||0
3112729|NCT01577758|3837360|FG002|STARTED|mCRC Expansion Phase||0
3112730|NCT01577758|3837361|FG003|STARTED|mCRC Expansion Phase||0
3112731|NCT01577758|3837362|FG004|STARTED|mCRC Expansion Phase||0
3112732|NCT01577758|3837363|FG005|STARTED|mCRC Expansion Phase||0
3112733|NCT01577758|3837364|FG006|STARTED|mCRC Expansion Phase||0
3112734|NCT01577758|3837365|FG007|STARTED|mCRC Expansion Phase||25
3112735|NCT01577758|3837358|FG000|COMPLETED|mCRC Expansion Phase||0
3112736|NCT01577758|3837359|FG001|COMPLETED|mCRC Expansion Phase||0
3112737|NCT01577758|3837360|FG002|COMPLETED|mCRC Expansion Phase||0
3112738|NCT01577758|3837361|FG003|COMPLETED|mCRC Expansion Phase||0
3112739|NCT01577758|3837362|FG004|COMPLETED|mCRC Expansion Phase||0
3112740|NCT01577758|3837363|FG005|COMPLETED|mCRC Expansion Phase||0
3112741|NCT01577758|3837364|FG006|COMPLETED|mCRC Expansion Phase||0
3112742|NCT01577758|3837365|FG007|COMPLETED|mCRC Expansion Phase||0
3112743|NCT01577758|3837358|FG000|NOT COMPLETED|mCRC Expansion Phase||0
3112744|NCT01577758|3837359|FG001|NOT COMPLETED|mCRC Expansion Phase||0
3112745|NCT01577758|3837360|FG002|NOT COMPLETED|mCRC Expansion Phase||0
3112746|NCT01577758|3837361|FG003|NOT COMPLETED|mCRC Expansion Phase||0
3112747|NCT01577758|3837362|FG004|NOT COMPLETED|mCRC Expansion Phase||0
3112748|NCT01577758|3837363|FG005|NOT COMPLETED|mCRC Expansion Phase||0
3112749|NCT01577758|3837364|FG006|NOT COMPLETED|mCRC Expansion Phase||0
3112750|NCT01577758|3837365|FG007|NOT COMPLETED|mCRC Expansion Phase||25
3112751|NCT01577966|3837385|FG000|STARTED|Overall Study||9
3112752|NCT01577966|3837385|FG000|COMPLETED|Overall Study||9
3112753|NCT01577966|3837385|FG000|NOT COMPLETED|Overall Study||0
3112754|NCT01578031|3837393|FG000|STARTED|Overall Study||129
3112755|NCT01578031|3837394|FG001|STARTED|Overall Study||69
3112756|NCT01578031|3837395|FG002|STARTED|Overall Study||12
3112757|NCT01578031|3837396|FG003|STARTED|Overall Study||30
3112758|NCT01578031|3837393|FG000|COMPLETED|Overall Study|Follow-up obtained only in subjects with average PAP use at least 4 hr/day|67
3112759|NCT01578031|3837394|FG001|COMPLETED|Overall Study|Follow-up obtained only in subjects with average PAP use at least 4 hr/day|35
3112760|NCT01578031|3837395|FG002|COMPLETED|Overall Study|Only baseline data collected|12
3112761|NCT01578031|3837396|FG003|COMPLETED|Overall Study|Only baseline data collected|30
3112762|NCT01578031|3837393|FG000|NOT COMPLETED|Overall Study||62
3112763|NCT01578031|3837394|FG001|NOT COMPLETED|Overall Study||34
3112764|NCT01578031|3837395|FG002|NOT COMPLETED|Overall Study||0
3112765|NCT01578031|3837396|FG003|NOT COMPLETED|Overall Study||0
3112766|NCT01578044|3837406|FG000|STARTED|Overall Study||6
3112767|NCT01578044|3837407|FG001|STARTED|Overall Study||6
3112768|NCT01578044|3837406|FG000|COMPLETED|Overall Study||6
3112769|NCT01578044|3837407|FG001|COMPLETED|Overall Study||6
3112770|NCT01578044|3837406|FG000|NOT COMPLETED|Overall Study||0
3112771|NCT01578044|3837407|FG001|NOT COMPLETED|Overall Study||0
3112772|NCT01578187|3837413|FG000|STARTED|Label Comprehension Phase||63
3112773|NCT01578187|3837413|FG000|COMPLETED|Label Comprehension Phase||63
3112774|NCT01578187|3837413|FG000|NOT COMPLETED|Label Comprehension Phase||0
3112775|NCT01578187|3837413|FG000|STARTED|Usability Phase||48
3112776|NCT01578187|3837413|FG000|COMPLETED|Usability Phase||47
3112777|NCT01578187|3837413|FG000|NOT COMPLETED|Usability Phase||1
3112778|NCT01578239|3837421|FG000|STARTED|Treatment Period||117
3112779|NCT01578239|3837422|FG001|STARTED|Treatment Period||114
3112780|NCT01578239|3837421|FG000|Full Analysis Set (FAS)|Treatment Period||117
3112781|NCT01578239|3837422|FG001|Full Analysis Set (FAS)|Treatment Period||114
3112782|NCT01578239|3837421|FG000|Safety Analysis Set (SAF)|Treatment Period||111
3112783|NCT01578239|3837422|FG001|Safety Analysis Set (SAF)|Treatment Period||112
3112784|NCT01578239|3837421|FG000|FAS-Entered Long-term Follow-up|Treatment Period||101
3112785|NCT01578239|3837422|FG001|FAS-Entered Long-term Follow-up|Treatment Period||99
3112786|NCT01578239|3837421|FG000|COMPLETED|Treatment Period||50
3112787|NCT01578239|3837422|FG001|COMPLETED|Treatment Period||13
3112788|NCT01578239|3837421|FG000|NOT COMPLETED|Treatment Period||67
3112789|NCT01578239|3837422|FG001|NOT COMPLETED|Treatment Period||101
3112790|NCT01578239|3837421|FG000|STARTED|Long-term Follow-Up Period|FAS-Entered long-term follow-up|101
3112791|NCT01578239|3837422|FG001|STARTED|Long-term Follow-Up Period|FAS-Entered long-term follow-up|99
3112792|NCT01578239|3837421|FG000|COMPLETED|Long-term Follow-Up Period||24
3112793|NCT01578239|3837422|FG001|COMPLETED|Long-term Follow-Up Period||19
3112794|NCT01578239|3837421|FG000|NOT COMPLETED|Long-term Follow-Up Period||77
3112795|NCT01578239|3837422|FG001|NOT COMPLETED|Long-term Follow-Up Period||80
3112796|NCT01578278|3837432|FG000|STARTED|Overall Study||152
3112797|NCT01578278|3837433|FG001|STARTED|Overall Study||152
3112798|NCT01578278|3837434|FG002|STARTED|Overall Study||154
3112799|NCT01578278|3837435|FG003|STARTED|Overall Study||148
3112800|NCT01578278|3837432|FG000|COMPLETED|Overall Study||148
3112801|NCT01578278|3837433|FG001|COMPLETED|Overall Study||150
3112802|NCT01578278|3837434|FG002|COMPLETED|Overall Study||150
3112803|NCT01578278|3837435|FG003|COMPLETED|Overall Study||139
3112804|NCT01578278|3837432|FG000|NOT COMPLETED|Overall Study||4
3112805|NCT01578278|3837433|FG001|NOT COMPLETED|Overall Study||2
3112806|NCT01578278|3837434|FG002|NOT COMPLETED|Overall Study||4
3112807|NCT01578278|3837435|FG003|NOT COMPLETED|Overall Study||9
3112808|NCT01578317|3837447|FG000|STARTED|Overall Study||22
3112809|NCT01578317|3837448|FG001|STARTED|Overall Study||21
3112810|NCT01578317|3837447|FG000|Analysis Population|Overall Study||22
3112811|NCT01578317|3837448|FG001|Analysis Population|Overall Study||20
3112812|NCT01578317|3837447|FG000|COMPLETED|Overall Study||22
3112813|NCT01578317|3837448|FG001|COMPLETED|Overall Study||20
3112814|NCT01578317|3837447|FG000|NOT COMPLETED|Overall Study||0
3112815|NCT01578317|3837448|FG001|NOT COMPLETED|Overall Study||1
3112816|NCT01578330|3837454|FG000|STARTED|Overall Study||42
3112817|NCT01578330|3837454|FG000|Per Protocol Population|Overall Study||35
3112818|NCT01578330|3837454|FG000|COMPLETED|Overall Study||35
3112819|NCT01578330|3837454|FG000|NOT COMPLETED|Overall Study||7
3112820|NCT01578486|3837458|FG000|STARTED|Overall Study||13
3112821|NCT01578486|3837458|FG000|COMPLETED|Overall Study||8
3112822|NCT01578486|3837458|FG000|NOT COMPLETED|Overall Study||5
3112823|NCT01578499|3837464|FG000|STARTED|Overall Study||66
3112824|NCT01578499|3837465|FG001|STARTED|Overall Study||65
3112825|NCT01578499|3837464|FG000|Safety Population: Treated|Overall Study||66
3112826|NCT01578499|3837465|FG001|Safety Population: Treated|Overall Study||62
3112827|NCT01578499|3837464|FG000|Intent to Treat Population: CD30+|Overall Study||64
3112828|NCT01578499|3837465|FG001|Intent to Treat Population: CD30+|Overall Study||64
3112829|NCT01578499|3837464|FG000|COMPLETED|Overall Study||32
3112830|NCT01578499|3837465|FG001|COMPLETED|Overall Study||22
3112831|NCT01578499|3837464|FG000|NOT COMPLETED|Overall Study||34
3112832|NCT01578499|3837465|FG001|NOT COMPLETED|Overall Study||43
3112833|NCT01578551|3837477|FG000|STARTED|Overall Study||19
3112834|NCT01578551|3837478|FG001|STARTED|Overall Study||6
3112835|NCT01578551|3837477|FG000|COMPLETED|Overall Study||18
3112836|NCT01578551|3837478|FG001|COMPLETED|Overall Study||6
3112837|NCT01578551|3837477|FG000|NOT COMPLETED|Overall Study||1
3112838|NCT01578551|3837478|FG001|NOT COMPLETED|Overall Study||0
3112839|NCT01578577|3837488|FG000|STARTED|Overall Study||305
3112840|NCT01578577|3837489|FG001|STARTED|Overall Study||302
3112841|NCT01578577|3837490|FG002|STARTED|Overall Study||313
3112842|NCT01578577|3837488|FG000|COMPLETED|Overall Study||254
3112843|NCT01578577|3837489|FG001|COMPLETED|Overall Study||262
3112844|NCT01578577|3837490|FG002|COMPLETED|Overall Study||278
3112845|NCT01578577|3837488|FG000|NOT COMPLETED|Overall Study||51
3112846|NCT01578577|3837489|FG001|NOT COMPLETED|Overall Study||40
3112847|NCT01578577|3837490|FG002|NOT COMPLETED|Overall Study||35
3112848|NCT01578707|3837510|FG000|STARTED|Overall Study||196
3112849|NCT01578707|3837511|FG001|STARTED|Overall Study||195
3112850|NCT01578707|3837510|FG000|COMPLETED|Overall Study||196
3112851|NCT01578707|3837511|FG001|COMPLETED|Overall Study||195
3112852|NCT01578707|3837510|FG000|NOT COMPLETED|Overall Study||0
3112853|NCT01578707|3837511|FG001|NOT COMPLETED|Overall Study||0
3112854|NCT01578772|3837517|FG000|STARTED|Overall Study||17
3112855|NCT01578772|3837517|FG000|COMPLETED|Overall Study||17
3112856|NCT01578772|3837517|FG000|NOT COMPLETED|Overall Study||0
3112857|NCT01578850|3837524|FG000|STARTED|Period 1|491 participants were enrolled in open-label treatment but 2 did not receive study medication.|489
3112858|NCT01578850|3837525|FG001|STARTED|Period 1||0
3112859|NCT01578850|3837526|FG002|STARTED|Period 1||0
3112860|NCT01578850|3837524|FG000|COMPLETED|Period 1||452
3112861|NCT01578850|3837525|FG001|COMPLETED|Period 1||0
3112862|NCT01578850|3837526|FG002|COMPLETED|Period 1||0
3112863|NCT01578850|3837524|FG000|NOT COMPLETED|Period 1||37
3112864|NCT01578850|3837525|FG001|NOT COMPLETED|Period 1||0
3112865|NCT01578850|3837526|FG002|NOT COMPLETED|Period 1||0
3112866|NCT01578850|3837524|FG000|STARTED|Period 2||0
3112867|NCT01578850|3837525|FG001|STARTED|Period 2|Two participants in ETN did not receive treatment.|167
3293837|NCT02873754|4027792|FG000|COMPLETED|Overall Study||5
3293838|NCT02873754|4027792|FG000|NOT COMPLETED|Overall Study||6
3293839|NCT02873923|4027796|FG000|STARTED|Overall Study||2846
3293840|NCT02873923|4027796|FG000|COMPLETED|Overall Study||2846
3293841|NCT02873923|4027796|FG000|NOT COMPLETED|Overall Study||0
3293842|NCT02873936|4027803|FG000|STARTED|Overall Study||148
3293843|NCT02873936|4027804|FG001|STARTED|Overall Study||153
3293844|NCT02873936|4027805|FG002|STARTED|Overall Study||148
3293845|NCT02873936|4027803|FG000|COMPLETED|Overall Study||135
3293846|NCT02873936|4027804|FG001|COMPLETED|Overall Study||130
3293847|NCT02873936|4027805|FG002|COMPLETED|Overall Study||116
3293848|NCT02873936|4027803|FG000|NOT COMPLETED|Overall Study||13
3293849|NCT02873936|4027804|FG001|NOT COMPLETED|Overall Study||23
3293850|NCT02873936|4027805|FG002|NOT COMPLETED|Overall Study||32
3293851|NCT02874066|4027813|FG000|STARTED|Overall Study||46
3293852|NCT02874066|4027813|FG000|COMPLETED|Overall Study||46
3293853|NCT02874066|4027813|FG000|NOT COMPLETED|Overall Study||0
3293854|NCT02874092|4027819|FG000|STARTED|Overall Study||7
3293855|NCT02874092|4027820|FG001|STARTED|Overall Study||2
3293856|NCT02874092|4027819|FG000|COMPLETED|Overall Study||7
3112868|NCT01578850|3837526|FG002|STARTED|Period 2|One participants in PBO did not receive treatment.|176
3112869|NCT01578850|3837524|FG000|COMPLETED|Period 2||0
3293857|NCT02874092|4027820|FG001|COMPLETED|Overall Study||2
3112870|NCT01578850|3837525|FG001|COMPLETED|Period 2||154
3112871|NCT01578850|3837526|FG002|COMPLETED|Period 2||162
3293858|NCT02874092|4027819|FG000|NOT COMPLETED|Overall Study||0
3112872|NCT01578850|3837524|FG000|NOT COMPLETED|Period 2||0
3112873|NCT01578850|3837525|FG001|NOT COMPLETED|Period 2||13
3112874|NCT01578850|3837526|FG002|NOT COMPLETED|Period 2||14
3112875|NCT01578902|3837534|FG000|STARTED|Overall Study||84
3112876|NCT01578902|3837534|FG000|COMPLETED|Overall Study||84
3112877|NCT01578902|3837534|FG000|NOT COMPLETED|Overall Study||0
3112878|NCT01578980|3837541|FG000|STARTED|Overall Study||20
3112879|NCT01578980|3837541|FG000|COMPLETED|Overall Study||20
3112880|NCT01578980|3837541|FG000|NOT COMPLETED|Overall Study||0
3112881|NCT01578993|3837545|FG000|STARTED|Overall Study||101
3112882|NCT01578993|3837545|FG000|COMPLETED|Overall Study||101
3112883|NCT01578993|3837545|FG000|NOT COMPLETED|Overall Study||0
3112884|NCT01579006|3837549|FG000|STARTED|Overall Study||184
3112885|NCT01579006|3837549|FG000|COMPLETED|Overall Study||151
3112886|NCT01579006|3837549|FG000|NOT COMPLETED|Overall Study||33
3112887|NCT01579045|3837553|FG000|STARTED|Overall Study||24
3112888|NCT01579045|3837553|FG000|COMPLETED|Overall Study||24
3112889|NCT01579045|3837553|FG000|NOT COMPLETED|Overall Study||0
3112890|NCT01579084|3837575|FG000|STARTED|Overall Study||8
3112891|NCT01579084|3837576|FG001|STARTED|Overall Study||8
3112892|NCT01579084|3837577|FG002|STARTED|Overall Study||8
3112893|NCT01579084|3837578|FG003|STARTED|Overall Study||8
3112894|NCT01579084|3837579|FG004|STARTED|Overall Study||8
3112895|NCT01579084|3837580|FG005|STARTED|Overall Study||8
3112896|NCT01579084|3837581|FG006|STARTED|Overall Study||4
3112897|NCT01579084|3837582|FG007|STARTED|Overall Study||4
3112898|NCT01579084|3837583|FG008|STARTED|Overall Study||4
3112899|NCT01579084|3837584|FG009|STARTED|Overall Study||4
3112900|NCT01579084|3837575|FG000|COMPLETED|Overall Study||8
3112901|NCT01579084|3837576|FG001|COMPLETED|Overall Study||8
3112902|NCT01579084|3837577|FG002|COMPLETED|Overall Study||8
3112903|NCT01579084|3837578|FG003|COMPLETED|Overall Study||8
3112904|NCT01579084|3837579|FG004|COMPLETED|Overall Study||8
3112905|NCT01579084|3837580|FG005|COMPLETED|Overall Study||8
3112906|NCT01579084|3837581|FG006|COMPLETED|Overall Study||4
3112907|NCT01579084|3837582|FG007|COMPLETED|Overall Study||4
3112908|NCT01579084|3837583|FG008|COMPLETED|Overall Study||4
3112909|NCT01579084|3837584|FG009|COMPLETED|Overall Study||4
3112910|NCT01579084|3837575|FG000|NOT COMPLETED|Overall Study||0
3112911|NCT01579084|3837576|FG001|NOT COMPLETED|Overall Study||0
3112912|NCT01579084|3837577|FG002|NOT COMPLETED|Overall Study||0
3112913|NCT01579084|3837578|FG003|NOT COMPLETED|Overall Study||0
3112914|NCT01579084|3837579|FG004|NOT COMPLETED|Overall Study||0
3112915|NCT01579084|3837580|FG005|NOT COMPLETED|Overall Study||0
3112916|NCT01579084|3837581|FG006|NOT COMPLETED|Overall Study||0
3112917|NCT01579084|3837582|FG007|NOT COMPLETED|Overall Study||0
3112918|NCT01579084|3837583|FG008|NOT COMPLETED|Overall Study||0
3112919|NCT01579084|3837584|FG009|NOT COMPLETED|Overall Study||0
3112920|NCT01579162|3837605|FG000|STARTED|Overall Study||16
3112921|NCT01579162|3837606|FG001|STARTED|Overall Study||8
3112922|NCT01579162|3837607|FG002|STARTED|Overall Study||8
3112923|NCT01579162|3837608|FG003|STARTED|Overall Study||8
3112924|NCT01579162|3837609|FG004|STARTED|Overall Study||8
3112925|NCT01579162|3837605|FG000|COMPLETED|Overall Study||16
3112926|NCT01579162|3837606|FG001|COMPLETED|Overall Study||8
3112927|NCT01579162|3837607|FG002|COMPLETED|Overall Study||8
3112928|NCT01579162|3837608|FG003|COMPLETED|Overall Study||8
3112929|NCT01579162|3837609|FG004|COMPLETED|Overall Study||8
3112930|NCT01579162|3837605|FG000|NOT COMPLETED|Overall Study||0
3112931|NCT01579162|3837606|FG001|NOT COMPLETED|Overall Study||0
3112932|NCT01579162|3837607|FG002|NOT COMPLETED|Overall Study||0
3112933|NCT01579162|3837608|FG003|NOT COMPLETED|Overall Study||0
3112934|NCT01579162|3837609|FG004|NOT COMPLETED|Overall Study||0
3112935|NCT01579214|3837624|FG000|STARTED|Overall Study||45
3112936|NCT01579214|3837625|FG001|STARTED|Overall Study||138
3112937|NCT01579214|3837624|FG000|COMPLETED|Overall Study||45
3112938|NCT01579214|3837625|FG001|COMPLETED|Overall Study||138
3112939|NCT01579214|3837624|FG000|NOT COMPLETED|Overall Study||0
3112940|NCT01579214|3837625|FG001|NOT COMPLETED|Overall Study||0
3112941|NCT01579305|3837633|FG000|STARTED|Overall Study|Subjects that signed Informed Consent, passed screening criteria, and were randomized.|139
3112942|NCT01579305|3837634|FG001|STARTED|Overall Study|Subjects that signed Informed Consent, passed screening criteria, and were randomized.|142
3112943|NCT01579305|3837633|FG000|Discontinued Before Treatment|Overall Study||0
3112944|NCT01579305|3837634|FG001|Discontinued Before Treatment|Overall Study||1
3112945|NCT01579305|3837633|FG000|Continued After Treatment|Overall Study||139
3112946|NCT01579305|3837634|FG001|Continued After Treatment|Overall Study||141
3112947|NCT01579305|3837633|FG000|COMPLETED|Overall Study||118
3112948|NCT01579305|3837634|FG001|COMPLETED|Overall Study||115
3112949|NCT01579305|3837633|FG000|NOT COMPLETED|Overall Study||21
3112950|NCT01579305|3837634|FG001|NOT COMPLETED|Overall Study||27
3112951|NCT01579318|3837640|FG000|STARTED|Overall Study||2
3112952|NCT01579318|3837640|FG000|COMPLETED|Overall Study||1
3112953|NCT01579318|3837640|FG000|NOT COMPLETED|Overall Study||1
3112954|NCT01579474|3837650|FG000|STARTED|Overall Study||44
3112955|NCT01579474|3837651|FG001|STARTED|Overall Study||43
3112956|NCT01579474|3837652|FG002|STARTED|Overall Study||29
3112957|NCT01579474|3837653|FG003|STARTED|Overall Study||3
3112958|NCT01579474|3837654|FG004|STARTED|Overall Study||10
3112959|NCT01579474|3837655|FG005|STARTED|Overall Study||2
3112960|NCT01579474|3837650|FG000|COMPLETED|Overall Study||41
3112961|NCT01579474|3837651|FG001|COMPLETED|Overall Study||30
3112962|NCT01579474|3837652|FG002|COMPLETED|Overall Study||27
3112963|NCT01579474|3837653|FG003|COMPLETED|Overall Study||3
3112964|NCT01579474|3837654|FG004|COMPLETED|Overall Study||9
3112965|NCT01579474|3837655|FG005|COMPLETED|Overall Study||1
3112966|NCT01579474|3837650|FG000|NOT COMPLETED|Overall Study||3
3112967|NCT01579474|3837651|FG001|NOT COMPLETED|Overall Study||13
3112968|NCT01579474|3837652|FG002|NOT COMPLETED|Overall Study||2
3112969|NCT01579474|3837653|FG003|NOT COMPLETED|Overall Study||0
3112970|NCT01579474|3837654|FG004|NOT COMPLETED|Overall Study||1
3112971|NCT01579474|3837655|FG005|NOT COMPLETED|Overall Study||1
3112972|NCT01579513|3837670|FG000|STARTED|Primary Hospitalization||91
3112973|NCT01579513|3837671|FG001|STARTED|Primary Hospitalization||99
3112974|NCT01579513|3837670|FG000|COMPLETED|Primary Hospitalization||81
3112975|NCT01579513|3837671|FG001|COMPLETED|Primary Hospitalization||95
3112976|NCT01579513|3837670|FG000|NOT COMPLETED|Primary Hospitalization||10
3112977|NCT01579513|3837671|FG001|NOT COMPLETED|Primary Hospitalization||4
3112978|NCT01579513|3837670|FG000|STARTED|1 Year Neurodevelopmental Follow up||81
3112979|NCT01579513|3837671|FG001|STARTED|1 Year Neurodevelopmental Follow up||95
3112980|NCT01579513|3837670|FG000|COMPLETED|1 Year Neurodevelopmental Follow up||61
3112981|NCT01579513|3837671|FG001|COMPLETED|1 Year Neurodevelopmental Follow up||68
3112982|NCT01579513|3837670|FG000|NOT COMPLETED|1 Year Neurodevelopmental Follow up||20
3112983|NCT01579513|3837671|FG001|NOT COMPLETED|1 Year Neurodevelopmental Follow up||27
3112984|NCT01579565|3837679|FG000|STARTED|Randomized||207
3112985|NCT01579565|3837680|FG001|STARTED|Randomized||209
3112986|NCT01579565|3837679|FG000|COMPLETED|Randomized||202
3112987|NCT01579565|3837680|FG001|COMPLETED|Randomized||204
3112988|NCT01579565|3837679|FG000|NOT COMPLETED|Randomized||5
3112989|NCT01579565|3837680|FG001|NOT COMPLETED|Randomized||5
3112990|NCT01579565|3837679|FG000|STARTED|Treated||202
3112991|NCT01579565|3837680|FG001|STARTED|Treated||204
3112992|NCT01579565|3837679|FG000|COMPLETED|Treated||200
3112993|NCT01579565|3837680|FG001|COMPLETED|Treated||201
3112994|NCT01579565|3837679|FG000|NOT COMPLETED|Treated||2
3112995|NCT01579565|3837680|FG001|NOT COMPLETED|Treated||3
3112996|NCT01579578|3837690|FG000|STARTED|Overall Study||13
3112997|NCT01579578|3837691|FG001|STARTED|Overall Study||12
3112998|NCT01579578|3837690|FG000|Ongoing|Overall Study||3
3112999|NCT01579578|3837691|FG001|Ongoing|Overall Study||0
3113000|NCT01579578|3837690|FG000|COMPLETED|Overall Study||0
3113001|NCT01579578|3837691|FG001|COMPLETED|Overall Study||0
3113002|NCT01579578|3837690|FG000|NOT COMPLETED|Overall Study||13
3113003|NCT01579578|3837691|FG001|NOT COMPLETED|Overall Study||12
3113004|NCT01579669|3837699|FG000|STARTED|Overall Study||170
3113005|NCT01579669|3837700|FG001|STARTED|Overall Study||41
3113006|NCT01579669|3837699|FG000|COMPLETED|Overall Study||134
3113007|NCT01579669|3837700|FG001|COMPLETED|Overall Study||41
3113008|NCT01579669|3837699|FG000|NOT COMPLETED|Overall Study||36
3113009|NCT01579669|3837700|FG001|NOT COMPLETED|Overall Study||0
3113010|NCT01579747|3837708|FG000|STARTED|Overall Study||12
3113011|NCT01579747|3837709|FG001|STARTED|Overall Study||12
3113012|NCT01579747|3837708|FG000|COMPLETED|Overall Study||12
3113013|NCT01579747|3837709|FG001|COMPLETED|Overall Study||12
3113014|NCT01579747|3837708|FG000|NOT COMPLETED|Overall Study||0
3113015|NCT01579747|3837709|FG001|NOT COMPLETED|Overall Study||0
3113016|NCT01579812|3837715|FG000|STARTED|Overall Study||90
3113017|NCT01579812|3837715|FG000|COMPLETED|Overall Study||38
3113018|NCT01579812|3837715|FG000|NOT COMPLETED|Overall Study||52
3113019|NCT01579916|3837724|FG000|STARTED|Overall Study||242
3113020|NCT01579916|3837725|FG001|STARTED|Overall Study||61
3113021|NCT01579916|3837724|FG000|COMPLETED|Overall Study||234
3113022|NCT01579916|3837725|FG001|COMPLETED|Overall Study||59
3113023|NCT01579916|3837724|FG000|NOT COMPLETED|Overall Study||8
3113024|NCT01579916|3837725|FG001|NOT COMPLETED|Overall Study||2
3113025|NCT01580020|3837733|FG000|STARTED|Overall Study||52
3113026|NCT01580020|3837734|FG001|STARTED|Overall Study||40
3113027|NCT01580020|3837735|FG002|STARTED|Overall Study||61
3113028|NCT01580020|3837736|FG003|STARTED|Overall Study||22
3113029|NCT01580020|3837733|FG000|COMPLETED|Overall Study||51
3113030|NCT01580020|3837734|FG001|COMPLETED|Overall Study||33
3113031|NCT01580020|3837735|FG002|COMPLETED|Overall Study||57
3113032|NCT01580020|3837736|FG003|COMPLETED|Overall Study||20
3113033|NCT01580020|3837733|FG000|NOT COMPLETED|Overall Study||1
3113034|NCT01580020|3837734|FG001|NOT COMPLETED|Overall Study||7
3113035|NCT01580020|3837735|FG002|NOT COMPLETED|Overall Study||4
3113036|NCT01580020|3837736|FG003|NOT COMPLETED|Overall Study||2
3113037|NCT01580072|3837749|FG000|STARTED|Overall Study||28
3113038|NCT01580072|3837750|FG001|STARTED|Overall Study||37
3113039|NCT01580072|3837751|FG002|STARTED|Overall Study||0
3113040|NCT01580072|3837749|FG000|COMPLETED|Overall Study||16
3113041|NCT01580072|3837750|FG001|COMPLETED|Overall Study||28
3113042|NCT01580072|3837751|FG002|COMPLETED|Overall Study||0
3113043|NCT01580072|3837749|FG000|NOT COMPLETED|Overall Study||12
3113044|NCT01580072|3837750|FG001|NOT COMPLETED|Overall Study||9
3113045|NCT01580072|3837751|FG002|NOT COMPLETED|Overall Study||0
3113046|NCT01580098|3837761|FG000|STARTED|Overall Study||76
3113047|NCT01580098|3837762|FG001|STARTED|Overall Study||114
3113048|NCT01580098|3837763|FG002|STARTED|Overall Study||3
3113049|NCT01580098|3837761|FG000|COMPLETED|Overall Study||61
3113050|NCT01580098|3837762|FG001|COMPLETED|Overall Study||101
3113051|NCT01580098|3837763|FG002|COMPLETED|Overall Study|Due to high age and bad health conditions no patients finished (nursing)|0
3113052|NCT01580098|3837761|FG000|NOT COMPLETED|Overall Study||15
3113053|NCT01580098|3837762|FG001|NOT COMPLETED|Overall Study||13
3113054|NCT01580098|3837763|FG002|NOT COMPLETED|Overall Study||3
3113055|NCT01580293|3837777|FG000|STARTED|Part A_Main Trial||20
3113056|NCT01580293|3837778|FG001|STARTED|Part A_Main Trial||114
3113057|NCT01580293|3837779|FG002|STARTED|Part A_Main Trial|Participants in Part B were not counted for Part A|0
3113058|NCT01580293|3837777|FG000|COMPLETED|Part A_Main Trial||18
3113059|NCT01580293|3837778|FG001|COMPLETED|Part A_Main Trial||108
3113060|NCT01580293|3837779|FG002|COMPLETED|Part A_Main Trial||0
3113061|NCT01580293|3837777|FG000|NOT COMPLETED|Part A_Main Trial||2
3113062|NCT01580293|3837778|FG001|NOT COMPLETED|Part A_Main Trial||6
3113063|NCT01580293|3837779|FG002|NOT COMPLETED|Part A_Main Trial||0
3113064|NCT01580293|3837777|FG000|STARTED|Part A_Extension|Not all participants from main trial entered extension or remained in the same arm.|14
3113065|NCT01580293|3837778|FG001|STARTED|Part A_Extension|Not all participants from main trial entered extension or remained in the same arm.|107
3113066|NCT01580293|3837779|FG002|STARTED|Part A_Extension|Participants in Part B were not counted for part A|0
3113067|NCT01580293|3837777|FG000|COMPLETED|Part A_Extension||14
3113068|NCT01580293|3837778|FG001|COMPLETED|Part A_Extension||95
3113069|NCT01580293|3837779|FG002|COMPLETED|Part A_Extension||0
3113070|NCT01580293|3837777|FG000|NOT COMPLETED|Part A_Extension||0
3113071|NCT01580293|3837778|FG001|NOT COMPLETED|Part A_Extension||12
3113072|NCT01580293|3837779|FG002|NOT COMPLETED|Part A_Extension||0
3113073|NCT01580293|3837777|FG000|STARTED|Part B|Time in Part A for 8 participants coming from Part A was not counted in part B.|0
3113074|NCT01580293|3837778|FG001|STARTED|Part B|Time in Part A for 8 participants coming from Part A was not counted in part B.|0
3113075|NCT01580293|3837779|FG002|STARTED|Part B|11 participants were enrolled in Part B only, 8 participants switched from Part A to Part B.|19
3113076|NCT01580293|3837777|FG000|COMPLETED|Part B||0
3113077|NCT01580293|3837778|FG001|COMPLETED|Part B||0
3113078|NCT01580293|3837779|FG002|COMPLETED|Part B||17
3113079|NCT01580293|3837777|FG000|NOT COMPLETED|Part B||0
3113080|NCT01580293|3837778|FG001|NOT COMPLETED|Part B||0
3113081|NCT01580293|3837779|FG002|NOT COMPLETED|Part B||2
3113082|NCT01580306|3837810|FG000|STARTED|Overall Study||8
3113083|NCT01580306|3837811|FG001|STARTED|Overall Study||8
3113084|NCT01580306|3837812|FG002|STARTED|Overall Study||8
3113085|NCT01580306|3837813|FG003|STARTED|Overall Study||8
3113086|NCT01580306|3837810|FG000|COMPLETED|Overall Study||8
3113087|NCT01580306|3837811|FG001|COMPLETED|Overall Study||8
3113088|NCT01580306|3837812|FG002|COMPLETED|Overall Study||8
3113089|NCT01580306|3837813|FG003|COMPLETED|Overall Study||8
3113090|NCT01580306|3837810|FG000|NOT COMPLETED|Overall Study||0
3113091|NCT01580306|3837811|FG001|NOT COMPLETED|Overall Study||0
3113092|NCT01580306|3837812|FG002|NOT COMPLETED|Overall Study||0
3113093|NCT01580306|3837813|FG003|NOT COMPLETED|Overall Study||0
3113094|NCT01580410|3837825|FG000|STARTED|Overall Study||68
3113095|NCT01580410|3837826|FG001|STARTED|Overall Study||68
3113096|NCT01580410|3837825|FG000|COMPLETED|Overall Study||57
3113097|NCT01580410|3837826|FG001|COMPLETED|Overall Study||60
3113098|NCT01580410|3837825|FG000|NOT COMPLETED|Overall Study||11
3113099|NCT01580410|3837826|FG001|NOT COMPLETED|Overall Study||8
3113100|NCT01580423|3837832|FG000|STARTED|First Intervention||8
3113101|NCT01580423|3837833|FG001|STARTED|First Intervention||8
3113102|NCT01580423|3837832|FG000|COMPLETED|First Intervention||8
3113103|NCT01580423|3837833|FG001|COMPLETED|First Intervention||8
3113104|NCT01580423|3837832|FG000|NOT COMPLETED|First Intervention||0
3113105|NCT01580423|3837833|FG001|NOT COMPLETED|First Intervention||0
3113106|NCT01580423|3837832|FG000|STARTED|Second Intervention||8
3113107|NCT01580423|3837833|FG001|STARTED|Second Intervention||8
3113108|NCT01580423|3837832|FG000|COMPLETED|Second Intervention||8
3113109|NCT01580423|3837833|FG001|COMPLETED|Second Intervention||8
3113110|NCT01580423|3837832|FG000|NOT COMPLETED|Second Intervention||0
3113111|NCT01580423|3837833|FG001|NOT COMPLETED|Second Intervention||0
3113112|NCT01580488|3837840|FG000|STARTED|Overall Study||24
3113113|NCT01580488|3837840|FG000|COMPLETED|Overall Study||23
3113114|NCT01580488|3837840|FG000|NOT COMPLETED|Overall Study||1
3113115|NCT01580592|3837857|FG000|STARTED|Overall Study||10
3113116|NCT01580592|3837858|FG001|STARTED|Overall Study||9
3113117|NCT01580592|3837859|FG002|STARTED|Overall Study||12
3113118|NCT01580592|3837857|FG000|COMPLETED|Overall Study||10
3113119|NCT01580592|3837858|FG001|COMPLETED|Overall Study||9
3113120|NCT01580592|3837859|FG002|COMPLETED|Overall Study||12
3113121|NCT01580592|3837857|FG000|NOT COMPLETED|Overall Study||0
3113122|NCT01580592|3837858|FG001|NOT COMPLETED|Overall Study||0
3113123|NCT01580592|3837859|FG002|NOT COMPLETED|Overall Study||0
3113124|NCT01580618|3837869|FG000|STARTED|Overall Study||8
3113125|NCT01580618|3837870|FG001|STARTED|Overall Study||12
3113126|NCT01580618|3837869|FG000|COMPLETED|Overall Study|One patient was switched from the normal saline to TNKase arm at attending physician request.|7
3113127|NCT01580618|3837870|FG001|COMPLETED|Overall Study||12
3113128|NCT01580618|3837869|FG000|NOT COMPLETED|Overall Study||1
3113129|NCT01580618|3837870|FG001|NOT COMPLETED|Overall Study||0
3113130|NCT01580670|3837876|FG000|STARTED|Induction Period (Week 0 to 14)||14
3113131|NCT01580670|3837876|FG000|COMPLETED|Induction Period (Week 0 to 14)||14
3113132|NCT01580670|3837876|FG000|NOT COMPLETED|Induction Period (Week 0 to 14)||0
3113133|NCT01580670|3837876|FG000|STARTED|Maintenance Period (Week 14 to 54)||14
3113134|NCT01580670|3837876|FG000|COMPLETED|Maintenance Period (Week 14 to 54)||12
3113135|NCT01580670|3837876|FG000|NOT COMPLETED|Maintenance Period (Week 14 to 54)||2
3113136|NCT01580904|3837882|FG000|STARTED|Overall Study||51
3113137|NCT01580904|3837883|FG001|STARTED|Overall Study||49
3113138|NCT01580904|3837882|FG000|COMPLETED|Overall Study||47
3113139|NCT01580904|3837883|FG001|COMPLETED|Overall Study||42
3113140|NCT01580904|3837882|FG000|NOT COMPLETED|Overall Study||4
3113141|NCT01580904|3837883|FG001|NOT COMPLETED|Overall Study||7
3113142|NCT01580969|3837893|FG000|STARTED|Overall Study||6
3113143|NCT01580969|3837894|FG001|STARTED|Overall Study||3
3113144|NCT01580969|3837895|FG002|STARTED|Overall Study||13
3113145|NCT01580969|3837893|FG000|COMPLETED|Overall Study||3
3113146|NCT01580969|3837894|FG001|COMPLETED|Overall Study||3
3113147|NCT01580969|3837895|FG002|COMPLETED|Overall Study||13
3113148|NCT01580969|3837893|FG000|NOT COMPLETED|Overall Study||3
3113149|NCT01580969|3837894|FG001|NOT COMPLETED|Overall Study||0
3113150|NCT01580969|3837895|FG002|NOT COMPLETED|Overall Study||0
3293859|NCT02874092|4027820|FG001|NOT COMPLETED|Overall Study||0
3293860|NCT02874404|4027825|FG000|STARTED|Overall Study||13
3113151|NCT01580995|3837905|FG000|STARTED|Overall Study||10
3113152|NCT01580995|3837906|FG001|STARTED|Overall Study||9
3113153|NCT01580995|3837905|FG000|COMPLETED|Overall Study||8
3113154|NCT01580995|3837906|FG001|COMPLETED|Overall Study||7
3113155|NCT01580995|3837905|FG000|NOT COMPLETED|Overall Study||2
3113156|NCT01580995|3837906|FG001|NOT COMPLETED|Overall Study||2
3113157|NCT01581008|3837914|FG000|STARTED|Overall Study||17
3113158|NCT01581008|3837915|FG001|STARTED|Overall Study||13
3113159|NCT01581008|3837914|FG000|COMPLETED|Overall Study||16
3113160|NCT01581008|3837915|FG001|COMPLETED|Overall Study||7
3113161|NCT01581008|3837914|FG000|NOT COMPLETED|Overall Study||1
3113162|NCT01581008|3837915|FG001|NOT COMPLETED|Overall Study||6
3113163|NCT01581021|3837924|FG000|STARTED|Overall Study||29
3113164|NCT01581021|3837925|FG001|STARTED|Overall Study||29
3113165|NCT01581021|3837924|FG000|COMPLETED|Overall Study||19
3113166|NCT01581021|3837925|FG001|COMPLETED|Overall Study||18
3113167|NCT01581021|3837924|FG000|NOT COMPLETED|Overall Study||10
3113168|NCT01581021|3837925|FG001|NOT COMPLETED|Overall Study||11
3113169|NCT01581281|3837934|FG000|STARTED|Overall Study||145
3113170|NCT01581281|3837935|FG001|STARTED|Overall Study||72
3113171|NCT01581281|3837936|FG002|STARTED|Overall Study||144
3113172|NCT01581281|3837934|FG000|COMPLETED|Overall Study||130
3113173|NCT01581281|3837935|FG001|COMPLETED|Overall Study||66
3113174|NCT01581281|3837936|FG002|COMPLETED|Overall Study||132
3113175|NCT01581281|3837934|FG000|NOT COMPLETED|Overall Study||15
3113176|NCT01581281|3837935|FG001|NOT COMPLETED|Overall Study||6
3113177|NCT01581281|3837936|FG002|NOT COMPLETED|Overall Study||12
3113178|NCT01581307|3837945|FG000|STARTED|Overall Study||9
3113179|NCT01581307|3837945|FG000|COMPLETED|Overall Study||8
3113180|NCT01581307|3837945|FG000|NOT COMPLETED|Overall Study||1
3113181|NCT01581437|3837949|FG000|STARTED|Overall Study||78
3113182|NCT01581437|3837949|FG000|COMPLETED|Overall Study||78
3113183|NCT01581437|3837949|FG000|NOT COMPLETED|Overall Study||0
3113184|NCT01581541|3837957|FG000|STARTED|Overall Study||1
3113185|NCT01581541|3837958|FG001|STARTED|Overall Study||1
3113186|NCT01581541|3837959|FG002|STARTED|Overall Study||1
3113187|NCT01581541|3837960|FG003|STARTED|Overall Study||1
3113188|NCT01581541|3837961|FG004|STARTED|Overall Study||2
3113189|NCT01581541|3837962|FG005|STARTED|Overall Study||3
3113190|NCT01581541|3837963|FG006|STARTED|Overall Study||1
3113191|NCT01581541|3837964|FG007|STARTED|Overall Study||2
3113192|NCT01581541|3837965|FG008|STARTED|Overall Study||1
3113193|NCT01581541|3837966|FG009|STARTED|Overall Study||3
3113194|NCT01581541|3837967|FG010|STARTED|Overall Study||1
3113195|NCT01581541|3837957|FG000|COMPLETED|Overall Study||1
3113196|NCT01581541|3837958|FG001|COMPLETED|Overall Study||1
3113197|NCT01581541|3837959|FG002|COMPLETED|Overall Study||1
3113198|NCT01581541|3837960|FG003|COMPLETED|Overall Study||1
3113199|NCT01581541|3837961|FG004|COMPLETED|Overall Study||2
3113200|NCT01581541|3837962|FG005|COMPLETED|Overall Study||3
3113201|NCT01581541|3837963|FG006|COMPLETED|Overall Study||1
3113202|NCT01581541|3837964|FG007|COMPLETED|Overall Study||2
3113203|NCT01581541|3837965|FG008|COMPLETED|Overall Study||1
3113204|NCT01581541|3837966|FG009|COMPLETED|Overall Study||3
3113205|NCT01581541|3837967|FG010|COMPLETED|Overall Study||1
3113206|NCT01581541|3837957|FG000|NOT COMPLETED|Overall Study||0
3113207|NCT01581541|3837958|FG001|NOT COMPLETED|Overall Study||0
3113208|NCT01581541|3837959|FG002|NOT COMPLETED|Overall Study||0
3113209|NCT01581541|3837960|FG003|NOT COMPLETED|Overall Study||0
3113210|NCT01581541|3837961|FG004|NOT COMPLETED|Overall Study||0
3113211|NCT01581541|3837962|FG005|NOT COMPLETED|Overall Study||0
3113212|NCT01581541|3837963|FG006|NOT COMPLETED|Overall Study||0
3113213|NCT01581541|3837964|FG007|NOT COMPLETED|Overall Study||0
3113214|NCT01581541|3837965|FG008|NOT COMPLETED|Overall Study||0
3113215|NCT01581541|3837966|FG009|NOT COMPLETED|Overall Study||0
3113216|NCT01581541|3837967|FG010|NOT COMPLETED|Overall Study||0
3113217|NCT01581593|3837992|FG000|STARTED|Overall Study||45
3113218|NCT01581593|3837992|FG000|COMPLETED|Overall Study||44
3113219|NCT01581593|3837992|FG000|NOT COMPLETED|Overall Study||1
3113220|NCT01581619|3838000|FG000|STARTED|Overall Study||54
3113221|NCT01581619|3838000|FG000|COMPLETED|Overall Study||52
3113222|NCT01581619|3838000|FG000|NOT COMPLETED|Overall Study||2
3113223|NCT01581658|3838010|FG000|STARTED|Overall Study||8
3113224|NCT01581658|3838011|FG001|STARTED|Overall Study||8
3113225|NCT01581658|3838012|FG002|STARTED|Overall Study||8
3293861|NCT02874404|4027825|FG000|COMPLETED|Overall Study||13
3113226|NCT01581658|3838013|FG003|STARTED|Overall Study||8
3113227|NCT01581658|3838010|FG000|COMPLETED|Overall Study||8
3113228|NCT01581658|3838011|FG001|COMPLETED|Overall Study||8
3113229|NCT01581658|3838012|FG002|COMPLETED|Overall Study||8
3113230|NCT01581658|3838013|FG003|COMPLETED|Overall Study||8
3113231|NCT01581658|3838010|FG000|NOT COMPLETED|Overall Study||0
3113232|NCT01581658|3838011|FG001|NOT COMPLETED|Overall Study||0
3113233|NCT01581658|3838012|FG002|NOT COMPLETED|Overall Study||0
3113234|NCT01581658|3838013|FG003|NOT COMPLETED|Overall Study||0
3113235|NCT01581684|3838033|FG000|STARTED|Overall Study||14
3113236|NCT01581684|3838034|FG001|STARTED|Overall Study||6
3113237|NCT01581684|3838035|FG002|STARTED|Overall Study||6
3113238|NCT01581684|3838036|FG003|STARTED|Overall Study||6
3113239|NCT01581684|3838037|FG004|STARTED|Overall Study||6
3113240|NCT01581684|3838038|FG005|STARTED|Overall Study||6
3113241|NCT01581684|3838039|FG006|STARTED|Overall Study||6
3113242|NCT01581684|3838040|FG007|STARTED|Overall Study||6
3113243|NCT01581684|3838041|FG008|STARTED|Overall Study||1
3113244|NCT01581684|3838042|FG009|STARTED|Overall Study||5
3113245|NCT01581684|3838033|FG000|COMPLETED|Overall Study||14
3113246|NCT01581684|3838034|FG001|COMPLETED|Overall Study||6
3113247|NCT01581684|3838035|FG002|COMPLETED|Overall Study||6
3113248|NCT01581684|3838036|FG003|COMPLETED|Overall Study||6
3113249|NCT01581684|3838037|FG004|COMPLETED|Overall Study||6
3113250|NCT01581684|3838038|FG005|COMPLETED|Overall Study||6
3113251|NCT01581684|3838039|FG006|COMPLETED|Overall Study||6
3113252|NCT01581684|3838040|FG007|COMPLETED|Overall Study||6
3113253|NCT01581684|3838041|FG008|COMPLETED|Overall Study||0
3113254|NCT01581684|3838042|FG009|COMPLETED|Overall Study||5
3113255|NCT01581684|3838033|FG000|NOT COMPLETED|Overall Study||0
3113256|NCT01581684|3838034|FG001|NOT COMPLETED|Overall Study||0
3113257|NCT01581684|3838035|FG002|NOT COMPLETED|Overall Study||0
3113258|NCT01581684|3838036|FG003|NOT COMPLETED|Overall Study||0
3113259|NCT01581684|3838037|FG004|NOT COMPLETED|Overall Study||0
3113260|NCT01581684|3838038|FG005|NOT COMPLETED|Overall Study||0
3113261|NCT01581684|3838039|FG006|NOT COMPLETED|Overall Study||0
3113262|NCT01581684|3838040|FG007|NOT COMPLETED|Overall Study||0
3113263|NCT01581684|3838041|FG008|NOT COMPLETED|Overall Study||1
3113264|NCT01581684|3838042|FG009|NOT COMPLETED|Overall Study||0
3113265|NCT01581710|3838075|FG000|STARTED|First Intervention (14days)||18
3113266|NCT01581710|3838076|FG001|STARTED|First Intervention (14days)||14
3113267|NCT01581710|3838075|FG000|COMPLETED|First Intervention (14days)||18
3113268|NCT01581710|3838076|FG001|COMPLETED|First Intervention (14days)||14
3113269|NCT01581710|3838075|FG000|NOT COMPLETED|First Intervention (14days)||0
3113270|NCT01581710|3838076|FG001|NOT COMPLETED|First Intervention (14days)||0
3113271|NCT01581710|3838075|FG000|STARTED|Washout Period (14days)||18
3113272|NCT01581710|3838076|FG001|STARTED|Washout Period (14days)||14
3113273|NCT01581710|3838075|FG000|COMPLETED|Washout Period (14days)||18
3113274|NCT01581710|3838076|FG001|COMPLETED|Washout Period (14days)||14
3113275|NCT01581710|3838075|FG000|NOT COMPLETED|Washout Period (14days)||0
3113276|NCT01581710|3838076|FG001|NOT COMPLETED|Washout Period (14days)||0
3113277|NCT01581710|3838075|FG000|STARTED|Second Intervention (14days)||18
3113278|NCT01581710|3838076|FG001|STARTED|Second Intervention (14days)||14
3113279|NCT01581710|3838075|FG000|COMPLETED|Second Intervention (14days)||18
3113280|NCT01581710|3838076|FG001|COMPLETED|Second Intervention (14days)||12
3113281|NCT01581710|3838075|FG000|NOT COMPLETED|Second Intervention (14days)||0
3113282|NCT01581710|3838076|FG001|NOT COMPLETED|Second Intervention (14days)||2
3113283|NCT01581931|3838086|FG000|STARTED|First Period||16
3113284|NCT01581931|3838087|FG001|STARTED|First Period||16
3113285|NCT01581931|3838086|FG000|COMPLETED|First Period||16
3113286|NCT01581931|3838087|FG001|COMPLETED|First Period||16
3113287|NCT01581931|3838086|FG000|NOT COMPLETED|First Period||0
3113288|NCT01581931|3838087|FG001|NOT COMPLETED|First Period||0
3113289|NCT01581931|3838086|FG000|STARTED|Washout||16
3113290|NCT01581931|3838087|FG001|STARTED|Washout||16
3113291|NCT01581931|3838086|FG000|COMPLETED|Washout||16
3113292|NCT01581931|3838087|FG001|COMPLETED|Washout||15
3113293|NCT01581931|3838086|FG000|NOT COMPLETED|Washout||0
3113294|NCT01581931|3838087|FG001|NOT COMPLETED|Washout||1
3113295|NCT01581931|3838086|FG000|STARTED|Second Period||16
3113296|NCT01581931|3838087|FG001|STARTED|Second Period||15
3113297|NCT01581931|3838086|FG000|COMPLETED|Second Period||16
3113298|NCT01581931|3838087|FG001|COMPLETED|Second Period||15
3113299|NCT01581931|3838086|FG000|NOT COMPLETED|Second Period||0
3113300|NCT01581931|3838087|FG001|NOT COMPLETED|Second Period||0
3113301|NCT01581970|3838093|FG000|STARTED|Overall Study||7
3113302|NCT01581970|3838093|FG000|COMPLETED|Overall Study||7
3113303|NCT01581970|3838093|FG000|NOT COMPLETED|Overall Study||0
3113304|NCT01582009|3838097|FG000|STARTED|Overall Study||26
3113305|NCT01582009|3838097|FG000|COMPLETED|Overall Study||24
3113306|NCT01582009|3838097|FG000|NOT COMPLETED|Overall Study||2
3113307|NCT01582061|3838103|FG000|STARTED|Overall Study||49
3113308|NCT01582061|3838104|FG001|STARTED|Overall Study||55
3113309|NCT01582061|3838103|FG000|COMPLETED|Overall Study||21
3113310|NCT01582061|3838104|FG001|COMPLETED|Overall Study||19
3113311|NCT01582061|3838103|FG000|NOT COMPLETED|Overall Study||28
3113312|NCT01582061|3838104|FG001|NOT COMPLETED|Overall Study||36
3113313|NCT01582139|3838122|FG000|STARTED|Overall Study||6
3113314|NCT01582139|3838123|FG001|STARTED|Overall Study||6
3113315|NCT01582139|3838122|FG000|COMPLETED|Overall Study||6
3113316|NCT01582139|3838123|FG001|COMPLETED|Overall Study||6
3113317|NCT01582139|3838122|FG000|NOT COMPLETED|Overall Study||0
3113318|NCT01582139|3838123|FG001|NOT COMPLETED|Overall Study||0
3113319|NCT01582152|3838131|FG000|STARTED|Overall Study||6
3113320|NCT01582152|3838132|FG001|STARTED|Overall Study||6
3113321|NCT01582152|3838131|FG000|COMPLETED|Overall Study||0
3113322|NCT01582152|3838132|FG001|COMPLETED|Overall Study||0
3113323|NCT01582152|3838131|FG000|NOT COMPLETED|Overall Study||6
3113324|NCT01582152|3838132|FG001|NOT COMPLETED|Overall Study||6
3113325|NCT01582178|3838140|FG000|STARTED|Overall Study||106
3113326|NCT01582178|3838141|FG001|STARTED|Overall Study||106
3113327|NCT01582178|3838140|FG000|COMPLETED|Overall Study||100
3113328|NCT01582178|3838141|FG001|COMPLETED|Overall Study||101
3113329|NCT01582178|3838140|FG000|NOT COMPLETED|Overall Study||6
3113330|NCT01582178|3838141|FG001|NOT COMPLETED|Overall Study||5
3135915|NCT01709513|3860999|FG000|STARTED|Overall Study||63
3135916|NCT01709513|3861000|FG001|STARTED|Overall Study||125
3135917|NCT01709513|3861001|FG002|STARTED|Overall Study||126
3135918|NCT01709513|3860999|FG000|Treated|Overall Study||63
3135919|NCT01709513|3861000|FG001|Treated|Overall Study||124
3135920|NCT01709513|3861001|FG002|Treated|Overall Study||126
3135921|NCT01709513|3860999|FG000|COMPLETED|Overall Study||42
3135922|NCT01709513|3861000|FG001|COMPLETED|Overall Study||82
3135923|NCT01709513|3861001|FG002|COMPLETED|Overall Study||96
3135924|NCT01709513|3860999|FG000|NOT COMPLETED|Overall Study||21
3135925|NCT01709513|3861000|FG001|NOT COMPLETED|Overall Study||43
3135926|NCT01709513|3861001|FG002|NOT COMPLETED|Overall Study||30
3135927|NCT01709578|3861015|FG000|STARTED|Overall Study||181
3135928|NCT01709578|3861016|FG001|STARTED|Overall Study||181
3135929|NCT01709578|3861017|FG002|STARTED|Overall Study||184
3135930|NCT01709578|3861015|FG000|COMPLETED|Overall Study||101
3135931|NCT01709578|3861016|FG001|COMPLETED|Overall Study||125
3135932|NCT01709578|3861017|FG002|COMPLETED|Overall Study||133
3135933|NCT01709578|3861015|FG000|NOT COMPLETED|Overall Study||80
3135934|NCT01709578|3861016|FG001|NOT COMPLETED|Overall Study||56
3135935|NCT01709578|3861017|FG002|NOT COMPLETED|Overall Study||51
3135936|NCT01709695|3861027|FG000|STARTED|Overall Study||13
3135937|NCT01709695|3861028|FG001|STARTED|Overall Study||14
3135938|NCT01709695|3861027|FG000|COMPLETED|Overall Study||12
3135939|NCT01709695|3861028|FG001|COMPLETED|Overall Study||13
3135940|NCT01709695|3861027|FG000|NOT COMPLETED|Overall Study||1
3135941|NCT01709695|3861028|FG001|NOT COMPLETED|Overall Study||1
3135942|NCT01709708|3861036|FG000|STARTED|Overall Study||27
3135943|NCT01709708|3861037|FG001|STARTED|Overall Study||14
3135944|NCT01709708|3861036|FG000|COMPLETED|Overall Study||26
3135945|NCT01709708|3861037|FG001|COMPLETED|Overall Study||12
3135946|NCT01709708|3861036|FG000|NOT COMPLETED|Overall Study||1
3135947|NCT01709708|3861037|FG001|NOT COMPLETED|Overall Study||2
3135948|NCT01709721|3861047|FG000|STARTED|Open Label Phase||41
3135949|NCT01709721|3861048|FG001|STARTED|Open Label Phase||40
3135950|NCT01709721|3861049|FG002|STARTED|Open Label Phase||72
3135951|NCT01709721|3861047|FG000|COMPLETED|Open Label Phase||41
3135952|NCT01709721|3861048|FG001|COMPLETED|Open Label Phase||40
3135953|NCT01709721|3861049|FG002|COMPLETED|Open Label Phase||0
3135954|NCT01709721|3861047|FG000|NOT COMPLETED|Open Label Phase||0
3135955|NCT01709721|3861048|FG001|NOT COMPLETED|Open Label Phase||0
3135956|NCT01709721|3861049|FG002|NOT COMPLETED|Open Label Phase||72
3135957|NCT01709721|3861047|FG000|STARTED|Randomized Phase||41
3135958|NCT01709721|3861048|FG001|STARTED|Randomized Phase||40
3135959|NCT01709721|3861049|FG002|STARTED|Randomized Phase||0
3293862|NCT02874404|4027825|FG000|NOT COMPLETED|Overall Study||0
3293863|NCT02874534|4027832|FG000|STARTED|Overall Study||31
3293864|NCT02874534|4027833|FG001|STARTED|Overall Study||26
3293865|NCT02874534|4027832|FG000|COMPLETED|Overall Study||23
3293866|NCT02874534|4027833|FG001|COMPLETED|Overall Study||15
3293867|NCT02874534|4027832|FG000|NOT COMPLETED|Overall Study||8
3293868|NCT02874534|4027833|FG001|NOT COMPLETED|Overall Study||11
3293869|NCT02874794|4027841|FG000|STARTED|Overall Study||233
3293870|NCT02874794|4027842|FG001|STARTED|Overall Study||232
3293871|NCT02874794|4027841|FG000|COMPLETED|Overall Study||226
3293872|NCT02874794|4027842|FG001|COMPLETED|Overall Study||221
3293873|NCT02874794|4027841|FG000|NOT COMPLETED|Overall Study||7
3293874|NCT02874794|4027842|FG001|NOT COMPLETED|Overall Study||11
3293875|NCT02874846|4027853|FG000|STARTED|Overall Study||8
3293876|NCT02874846|4027854|FG001|STARTED|Overall Study||4
3293877|NCT02874846|4027853|FG000|COMPLETED|Overall Study||8
3293878|NCT02874846|4027854|FG001|COMPLETED|Overall Study||4
3293879|NCT02874846|4027853|FG000|NOT COMPLETED|Overall Study||0
3293880|NCT02874846|4027854|FG001|NOT COMPLETED|Overall Study||0
3293881|NCT02874924|4027864|FG000|STARTED|Overall Study||14
3293882|NCT02874924|4027865|FG001|STARTED|Overall Study||14
3293883|NCT02874924|4027866|FG002|STARTED|Overall Study||6
3293884|NCT02874924|4027864|FG000|COMPLETED|Overall Study||11
3293885|NCT02874924|4027865|FG001|COMPLETED|Overall Study||14
3293886|NCT02874924|4027866|FG002|COMPLETED|Overall Study||6
3293887|NCT02874924|4027864|FG000|NOT COMPLETED|Overall Study||3
3135960|NCT01709721|3861047|FG000|COMPLETED|Randomized Phase||38
3135961|NCT01709721|3861048|FG001|COMPLETED|Randomized Phase||34
3135962|NCT01709721|3861049|FG002|COMPLETED|Randomized Phase||0
3135963|NCT01709721|3861047|FG000|NOT COMPLETED|Randomized Phase||3
3135964|NCT01709721|3861048|FG001|NOT COMPLETED|Randomized Phase||6
3135965|NCT01709721|3861049|FG002|NOT COMPLETED|Randomized Phase||0
3135966|NCT01709747|3861057|FG000|STARTED|Overall Study||364
3135967|NCT01709747|3861057|FG000|COMPLETED|Overall Study||287
3135968|NCT01709747|3861057|FG000|NOT COMPLETED|Overall Study||77
3135969|NCT01709786|3861062|FG000|STARTED|Overall Study||88
3293888|NCT02874924|4027865|FG001|NOT COMPLETED|Overall Study||0
3293889|NCT02874924|4027866|FG002|NOT COMPLETED|Overall Study||0
3113331|NCT01582243|3838147|FG000|STARTED|Overall Study||40
3113332|NCT01582243|3838147|FG000|COMPLETED|Overall Study||37
3113333|NCT01582243|3838147|FG000|NOT COMPLETED|Overall Study||3
3113334|NCT01582282|3838154|FG000|STARTED|Overall Study||15
3113335|NCT01582282|3838155|FG001|STARTED|Overall Study||14
3113336|NCT01582282|3838156|FG002|STARTED|Overall Study||8
3113337|NCT01582282|3838154|FG000|COMPLETED|Overall Study||13
3113338|NCT01582282|3838155|FG001|COMPLETED|Overall Study||12
3113339|NCT01582282|3838156|FG002|COMPLETED|Overall Study||8
3113340|NCT01582282|3838154|FG000|NOT COMPLETED|Overall Study||2
3113341|NCT01582282|3838155|FG001|NOT COMPLETED|Overall Study||2
3113342|NCT01582282|3838156|FG002|NOT COMPLETED|Overall Study||0
3113343|NCT01582308|3838164|FG000|STARTED|Period 1||2
3113344|NCT01582308|3838165|FG001|STARTED|Period 1||2
3113345|NCT01582308|3838166|FG002|STARTED|Period 1||2
3113346|NCT01582308|3838167|FG003|STARTED|Period 1||2
3113347|NCT01582308|3838168|FG004|STARTED|Period 1|Includes replacement for a participant who discontinued after period 1|3
3113348|NCT01582308|3838169|FG005|STARTED|Period 1||2
3113349|NCT01582308|3838170|FG006|STARTED|Period 1|Includes replacement for a participant who discontinued during period 1|3
3113350|NCT01582308|3838171|FG007|STARTED|Period 1||2
3113351|NCT01582308|3838172|FG008|STARTED|Period 1||2
3113352|NCT01582308|3838173|FG009|STARTED|Period 1||2
3113353|NCT01582308|3838164|FG000|COMPLETED|Period 1||2
3113354|NCT01582308|3838165|FG001|COMPLETED|Period 1||2
3113355|NCT01582308|3838166|FG002|COMPLETED|Period 1||2
3113356|NCT01582308|3838167|FG003|COMPLETED|Period 1||2
3113357|NCT01582308|3838168|FG004|COMPLETED|Period 1||3
3113358|NCT01582308|3838169|FG005|COMPLETED|Period 1||2
3113359|NCT01582308|3838170|FG006|COMPLETED|Period 1||2
3113360|NCT01582308|3838171|FG007|COMPLETED|Period 1||2
3113361|NCT01582308|3838172|FG008|COMPLETED|Period 1||2
3113362|NCT01582308|3838173|FG009|COMPLETED|Period 1||2
3113363|NCT01582308|3838164|FG000|NOT COMPLETED|Period 1||0
3113364|NCT01582308|3838165|FG001|NOT COMPLETED|Period 1||0
3113365|NCT01582308|3838166|FG002|NOT COMPLETED|Period 1||0
3113366|NCT01582308|3838167|FG003|NOT COMPLETED|Period 1||0
3113367|NCT01582308|3838168|FG004|NOT COMPLETED|Period 1||0
3113368|NCT01582308|3838169|FG005|NOT COMPLETED|Period 1||0
3113369|NCT01582308|3838170|FG006|NOT COMPLETED|Period 1||1
3113370|NCT01582308|3838171|FG007|NOT COMPLETED|Period 1||0
3113371|NCT01582308|3838172|FG008|NOT COMPLETED|Period 1||0
3113372|NCT01582308|3838173|FG009|NOT COMPLETED|Period 1||0
3113373|NCT01582308|3838164|FG000|STARTED|10-day Washout Following Period 1||2
3113374|NCT01582308|3838165|FG001|STARTED|10-day Washout Following Period 1||2
3113375|NCT01582308|3838166|FG002|STARTED|10-day Washout Following Period 1||2
3113376|NCT01582308|3838167|FG003|STARTED|10-day Washout Following Period 1||2
3113377|NCT01582308|3838168|FG004|STARTED|10-day Washout Following Period 1||3
3113378|NCT01582308|3838169|FG005|STARTED|10-day Washout Following Period 1||2
3113379|NCT01582308|3838170|FG006|STARTED|10-day Washout Following Period 1||2
3113380|NCT01582308|3838171|FG007|STARTED|10-day Washout Following Period 1||2
3113381|NCT01582308|3838172|FG008|STARTED|10-day Washout Following Period 1||2
3113382|NCT01582308|3838173|FG009|STARTED|10-day Washout Following Period 1||2
3113383|NCT01582308|3838164|FG000|COMPLETED|10-day Washout Following Period 1||2
3113384|NCT01582308|3838165|FG001|COMPLETED|10-day Washout Following Period 1||2
3113385|NCT01582308|3838166|FG002|COMPLETED|10-day Washout Following Period 1||2
3113386|NCT01582308|3838167|FG003|COMPLETED|10-day Washout Following Period 1||2
3113387|NCT01582308|3838168|FG004|COMPLETED|10-day Washout Following Period 1||2
3113388|NCT01582308|3838169|FG005|COMPLETED|10-day Washout Following Period 1||2
3113389|NCT01582308|3838170|FG006|COMPLETED|10-day Washout Following Period 1||2
3113390|NCT01582308|3838171|FG007|COMPLETED|10-day Washout Following Period 1||2
3113391|NCT01582308|3838172|FG008|COMPLETED|10-day Washout Following Period 1||2
3113392|NCT01582308|3838173|FG009|COMPLETED|10-day Washout Following Period 1||2
3113393|NCT01582308|3838164|FG000|NOT COMPLETED|10-day Washout Following Period 1||0
3113394|NCT01582308|3838165|FG001|NOT COMPLETED|10-day Washout Following Period 1||0
3113395|NCT01582308|3838166|FG002|NOT COMPLETED|10-day Washout Following Period 1||0
3113396|NCT01582308|3838167|FG003|NOT COMPLETED|10-day Washout Following Period 1||0
3113397|NCT01582308|3838168|FG004|NOT COMPLETED|10-day Washout Following Period 1||1
3113398|NCT01582308|3838169|FG005|NOT COMPLETED|10-day Washout Following Period 1||0
3113399|NCT01582308|3838170|FG006|NOT COMPLETED|10-day Washout Following Period 1||0
3113400|NCT01582308|3838171|FG007|NOT COMPLETED|10-day Washout Following Period 1||0
3113401|NCT01582308|3838172|FG008|NOT COMPLETED|10-day Washout Following Period 1||0
3113402|NCT01582308|3838173|FG009|NOT COMPLETED|10-day Washout Following Period 1||0
3113403|NCT01582308|3838164|FG000|STARTED|Period 2||2
3113404|NCT01582308|3838165|FG001|STARTED|Period 2||2
3113405|NCT01582308|3838166|FG002|STARTED|Period 2||2
3113406|NCT01582308|3838167|FG003|STARTED|Period 2||2
3113407|NCT01582308|3838168|FG004|STARTED|Period 2||2
3113408|NCT01582308|3838169|FG005|STARTED|Period 2||2
3113409|NCT01582308|3838170|FG006|STARTED|Period 2||2
3113410|NCT01582308|3838171|FG007|STARTED|Period 2||2
3113411|NCT01582308|3838172|FG008|STARTED|Period 2||2
3113412|NCT01582308|3838173|FG009|STARTED|Period 2||2
3113413|NCT01582308|3838164|FG000|COMPLETED|Period 2||2
3113414|NCT01582308|3838165|FG001|COMPLETED|Period 2||2
3113415|NCT01582308|3838166|FG002|COMPLETED|Period 2||2
3113416|NCT01582308|3838167|FG003|COMPLETED|Period 2||2
3113417|NCT01582308|3838168|FG004|COMPLETED|Period 2||2
3113418|NCT01582308|3838169|FG005|COMPLETED|Period 2||2
3113419|NCT01582308|3838170|FG006|COMPLETED|Period 2||2
3113420|NCT01582308|3838171|FG007|COMPLETED|Period 2||2
3113421|NCT01582308|3838172|FG008|COMPLETED|Period 2||2
3113422|NCT01582308|3838173|FG009|COMPLETED|Period 2||2
3113423|NCT01582308|3838164|FG000|NOT COMPLETED|Period 2||0
3113424|NCT01582308|3838165|FG001|NOT COMPLETED|Period 2||0
3113425|NCT01582308|3838166|FG002|NOT COMPLETED|Period 2||0
3113426|NCT01582308|3838167|FG003|NOT COMPLETED|Period 2||0
3113427|NCT01582308|3838168|FG004|NOT COMPLETED|Period 2||0
3113428|NCT01582308|3838169|FG005|NOT COMPLETED|Period 2||0
3113429|NCT01582308|3838170|FG006|NOT COMPLETED|Period 2||0
3113430|NCT01582308|3838171|FG007|NOT COMPLETED|Period 2||0
3113431|NCT01582308|3838172|FG008|NOT COMPLETED|Period 2||0
3113432|NCT01582308|3838173|FG009|NOT COMPLETED|Period 2||0
3113433|NCT01582308|3838164|FG000|STARTED|10-day Washout Following Period 2||2
3113434|NCT01582308|3838165|FG001|STARTED|10-day Washout Following Period 2||2
3113435|NCT01582308|3838166|FG002|STARTED|10-day Washout Following Period 2||2
3113436|NCT01582308|3838167|FG003|STARTED|10-day Washout Following Period 2||2
3113437|NCT01582308|3838168|FG004|STARTED|10-day Washout Following Period 2||2
3113438|NCT01582308|3838169|FG005|STARTED|10-day Washout Following Period 2||2
3113439|NCT01582308|3838170|FG006|STARTED|10-day Washout Following Period 2||2
3113440|NCT01582308|3838171|FG007|STARTED|10-day Washout Following Period 2||2
3113441|NCT01582308|3838172|FG008|STARTED|10-day Washout Following Period 2||2
3113442|NCT01582308|3838173|FG009|STARTED|10-day Washout Following Period 2||2
3113443|NCT01582308|3838164|FG000|COMPLETED|10-day Washout Following Period 2||2
3113444|NCT01582308|3838165|FG001|COMPLETED|10-day Washout Following Period 2||2
3113445|NCT01582308|3838166|FG002|COMPLETED|10-day Washout Following Period 2||2
3113446|NCT01582308|3838167|FG003|COMPLETED|10-day Washout Following Period 2||2
3113447|NCT01582308|3838168|FG004|COMPLETED|10-day Washout Following Period 2||2
3113448|NCT01582308|3838169|FG005|COMPLETED|10-day Washout Following Period 2||2
3113449|NCT01582308|3838170|FG006|COMPLETED|10-day Washout Following Period 2||2
3113450|NCT01582308|3838171|FG007|COMPLETED|10-day Washout Following Period 2||2
3113451|NCT01582308|3838172|FG008|COMPLETED|10-day Washout Following Period 2||2
3113452|NCT01582308|3838173|FG009|COMPLETED|10-day Washout Following Period 2||2
3113453|NCT01582308|3838164|FG000|NOT COMPLETED|10-day Washout Following Period 2||0
3113454|NCT01582308|3838165|FG001|NOT COMPLETED|10-day Washout Following Period 2||0
3113455|NCT01582308|3838166|FG002|NOT COMPLETED|10-day Washout Following Period 2||0
3113456|NCT01582308|3838167|FG003|NOT COMPLETED|10-day Washout Following Period 2||0
3113457|NCT01582308|3838168|FG004|NOT COMPLETED|10-day Washout Following Period 2||0
3113458|NCT01582308|3838169|FG005|NOT COMPLETED|10-day Washout Following Period 2||0
3113459|NCT01582308|3838170|FG006|NOT COMPLETED|10-day Washout Following Period 2||0
3113460|NCT01582308|3838171|FG007|NOT COMPLETED|10-day Washout Following Period 2||0
3113461|NCT01582308|3838172|FG008|NOT COMPLETED|10-day Washout Following Period 2||0
3113462|NCT01582308|3838173|FG009|NOT COMPLETED|10-day Washout Following Period 2||0
3113463|NCT01582308|3838164|FG000|STARTED|Period 3||2
3113464|NCT01582308|3838165|FG001|STARTED|Period 3||2
3113465|NCT01582308|3838166|FG002|STARTED|Period 3||2
3113466|NCT01582308|3838167|FG003|STARTED|Period 3||2
3113467|NCT01582308|3838168|FG004|STARTED|Period 3||2
3113468|NCT01582308|3838169|FG005|STARTED|Period 3||2
3113469|NCT01582308|3838170|FG006|STARTED|Period 3||2
3113470|NCT01582308|3838171|FG007|STARTED|Period 3||2
3113471|NCT01582308|3838172|FG008|STARTED|Period 3||2
3113472|NCT01582308|3838173|FG009|STARTED|Period 3||2
3113473|NCT01582308|3838164|FG000|COMPLETED|Period 3||2
3113474|NCT01582308|3838165|FG001|COMPLETED|Period 3||2
3113475|NCT01582308|3838166|FG002|COMPLETED|Period 3||2
3113476|NCT01582308|3838167|FG003|COMPLETED|Period 3||2
3113477|NCT01582308|3838168|FG004|COMPLETED|Period 3||2
3113478|NCT01582308|3838169|FG005|COMPLETED|Period 3||2
3113479|NCT01582308|3838170|FG006|COMPLETED|Period 3||2
3113480|NCT01582308|3838171|FG007|COMPLETED|Period 3||2
3113481|NCT01582308|3838172|FG008|COMPLETED|Period 3||2
3113482|NCT01582308|3838173|FG009|COMPLETED|Period 3||2
3113483|NCT01582308|3838164|FG000|NOT COMPLETED|Period 3||0
3113484|NCT01582308|3838165|FG001|NOT COMPLETED|Period 3||0
3113485|NCT01582308|3838166|FG002|NOT COMPLETED|Period 3||0
3113486|NCT01582308|3838167|FG003|NOT COMPLETED|Period 3||0
3113487|NCT01582308|3838168|FG004|NOT COMPLETED|Period 3||0
3113488|NCT01582308|3838169|FG005|NOT COMPLETED|Period 3||0
3113489|NCT01582308|3838170|FG006|NOT COMPLETED|Period 3||0
3113490|NCT01582308|3838171|FG007|NOT COMPLETED|Period 3||0
3113491|NCT01582308|3838172|FG008|NOT COMPLETED|Period 3||0
3113492|NCT01582308|3838173|FG009|NOT COMPLETED|Period 3||0
3113493|NCT01582308|3838164|FG000|STARTED|10-day Washout Following Period 3||2
3113494|NCT01582308|3838165|FG001|STARTED|10-day Washout Following Period 3||2
3113495|NCT01582308|3838166|FG002|STARTED|10-day Washout Following Period 3||2
3113496|NCT01582308|3838167|FG003|STARTED|10-day Washout Following Period 3||2
3113497|NCT01582308|3838168|FG004|STARTED|10-day Washout Following Period 3||2
3113498|NCT01582308|3838169|FG005|STARTED|10-day Washout Following Period 3||2
3113499|NCT01582308|3838170|FG006|STARTED|10-day Washout Following Period 3||2
3113500|NCT01582308|3838171|FG007|STARTED|10-day Washout Following Period 3||2
3113501|NCT01582308|3838172|FG008|STARTED|10-day Washout Following Period 3||2
3113502|NCT01582308|3838173|FG009|STARTED|10-day Washout Following Period 3||2
3113503|NCT01582308|3838164|FG000|COMPLETED|10-day Washout Following Period 3||2
3113504|NCT01582308|3838165|FG001|COMPLETED|10-day Washout Following Period 3||2
3113505|NCT01582308|3838166|FG002|COMPLETED|10-day Washout Following Period 3||2
3113506|NCT01582308|3838167|FG003|COMPLETED|10-day Washout Following Period 3||2
3113507|NCT01582308|3838168|FG004|COMPLETED|10-day Washout Following Period 3||2
3113508|NCT01582308|3838169|FG005|COMPLETED|10-day Washout Following Period 3||2
3113509|NCT01582308|3838170|FG006|COMPLETED|10-day Washout Following Period 3||2
3113510|NCT01582308|3838171|FG007|COMPLETED|10-day Washout Following Period 3||2
3113511|NCT01582308|3838172|FG008|COMPLETED|10-day Washout Following Period 3||2
3113512|NCT01582308|3838173|FG009|COMPLETED|10-day Washout Following Period 3||2
3113513|NCT01582308|3838164|FG000|NOT COMPLETED|10-day Washout Following Period 3||0
3113514|NCT01582308|3838165|FG001|NOT COMPLETED|10-day Washout Following Period 3||0
3113515|NCT01582308|3838166|FG002|NOT COMPLETED|10-day Washout Following Period 3||0
3113516|NCT01582308|3838167|FG003|NOT COMPLETED|10-day Washout Following Period 3||0
3113517|NCT01582308|3838168|FG004|NOT COMPLETED|10-day Washout Following Period 3||0
3113518|NCT01582308|3838169|FG005|NOT COMPLETED|10-day Washout Following Period 3||0
3113519|NCT01582308|3838170|FG006|NOT COMPLETED|10-day Washout Following Period 3||0
3113520|NCT01582308|3838171|FG007|NOT COMPLETED|10-day Washout Following Period 3||0
3113521|NCT01582308|3838172|FG008|NOT COMPLETED|10-day Washout Following Period 3||0
3113522|NCT01582308|3838173|FG009|NOT COMPLETED|10-day Washout Following Period 3||0
3113523|NCT01582308|3838164|FG000|STARTED|Period 4||2
3113524|NCT01582308|3838165|FG001|STARTED|Period 4||2
3113525|NCT01582308|3838166|FG002|STARTED|Period 4||2
3113526|NCT01582308|3838167|FG003|STARTED|Period 4||2
3113527|NCT01582308|3838168|FG004|STARTED|Period 4||2
3113528|NCT01582308|3838169|FG005|STARTED|Period 4||2
3113529|NCT01582308|3838170|FG006|STARTED|Period 4||2
3113530|NCT01582308|3838171|FG007|STARTED|Period 4||2
3113531|NCT01582308|3838172|FG008|STARTED|Period 4||2
3113532|NCT01582308|3838173|FG009|STARTED|Period 4||2
3113533|NCT01582308|3838164|FG000|COMPLETED|Period 4||1
3113534|NCT01582308|3838165|FG001|COMPLETED|Period 4||2
3113535|NCT01582308|3838166|FG002|COMPLETED|Period 4||2
3113536|NCT01582308|3838167|FG003|COMPLETED|Period 4||2
3293890|NCT02875028|4027876|FG000|STARTED|First Intervention (24 Hours)||8
3293891|NCT02875028|4027877|FG001|STARTED|First Intervention (24 Hours)||8
3293892|NCT02875028|4027876|FG000|COMPLETED|First Intervention (24 Hours)||8
3293893|NCT02875028|4027877|FG001|COMPLETED|First Intervention (24 Hours)||8
3293894|NCT02875028|4027876|FG000|NOT COMPLETED|First Intervention (24 Hours)||0
3293895|NCT02875028|4027877|FG001|NOT COMPLETED|First Intervention (24 Hours)||0
3293896|NCT02875028|4027876|FG000|STARTED|Washout Period||8
3293897|NCT02875028|4027877|FG001|STARTED|Washout Period||8
3113537|NCT01582308|3838168|FG004|COMPLETED|Period 4||2
3113538|NCT01582308|3838169|FG005|COMPLETED|Period 4||1
3113539|NCT01582308|3838170|FG006|COMPLETED|Period 4||2
3113540|NCT01582308|3838171|FG007|COMPLETED|Period 4||2
3113541|NCT01582308|3838172|FG008|COMPLETED|Period 4||2
3113542|NCT01582308|3838173|FG009|COMPLETED|Period 4||1
3113543|NCT01582308|3838164|FG000|NOT COMPLETED|Period 4||1
3113544|NCT01582308|3838165|FG001|NOT COMPLETED|Period 4||0
3113545|NCT01582308|3838166|FG002|NOT COMPLETED|Period 4||0
3113546|NCT01582308|3838167|FG003|NOT COMPLETED|Period 4||0
3113547|NCT01582308|3838168|FG004|NOT COMPLETED|Period 4||0
3113548|NCT01582308|3838169|FG005|NOT COMPLETED|Period 4||1
3113549|NCT01582308|3838170|FG006|NOT COMPLETED|Period 4||0
3113550|NCT01582308|3838171|FG007|NOT COMPLETED|Period 4||0
3113551|NCT01582308|3838172|FG008|NOT COMPLETED|Period 4||0
3113552|NCT01582308|3838173|FG009|NOT COMPLETED|Period 4||1
3113553|NCT01582308|3838164|FG000|STARTED|10-day Washout Following Period 4||1
3113554|NCT01582308|3838165|FG001|STARTED|10-day Washout Following Period 4||2
3113555|NCT01582308|3838166|FG002|STARTED|10-day Washout Following Period 4||2
3113556|NCT01582308|3838167|FG003|STARTED|10-day Washout Following Period 4||2
3113557|NCT01582308|3838168|FG004|STARTED|10-day Washout Following Period 4||2
3113558|NCT01582308|3838169|FG005|STARTED|10-day Washout Following Period 4||1
3113559|NCT01582308|3838170|FG006|STARTED|10-day Washout Following Period 4||2
3113560|NCT01582308|3838171|FG007|STARTED|10-day Washout Following Period 4||2
3113561|NCT01582308|3838172|FG008|STARTED|10-day Washout Following Period 4||2
3113562|NCT01582308|3838173|FG009|STARTED|10-day Washout Following Period 4||1
3113563|NCT01582308|3838164|FG000|COMPLETED|10-day Washout Following Period 4||1
3113564|NCT01582308|3838165|FG001|COMPLETED|10-day Washout Following Period 4||2
3113565|NCT01582308|3838166|FG002|COMPLETED|10-day Washout Following Period 4||2
3113566|NCT01582308|3838167|FG003|COMPLETED|10-day Washout Following Period 4||2
3113567|NCT01582308|3838168|FG004|COMPLETED|10-day Washout Following Period 4||2
3113568|NCT01582308|3838169|FG005|COMPLETED|10-day Washout Following Period 4||1
3113569|NCT01582308|3838170|FG006|COMPLETED|10-day Washout Following Period 4||2
3113570|NCT01582308|3838171|FG007|COMPLETED|10-day Washout Following Period 4||2
3113571|NCT01582308|3838172|FG008|COMPLETED|10-day Washout Following Period 4||2
3113572|NCT01582308|3838173|FG009|COMPLETED|10-day Washout Following Period 4||1
3113573|NCT01582308|3838164|FG000|NOT COMPLETED|10-day Washout Following Period 4||0
3113574|NCT01582308|3838165|FG001|NOT COMPLETED|10-day Washout Following Period 4||0
3113575|NCT01582308|3838166|FG002|NOT COMPLETED|10-day Washout Following Period 4||0
3113576|NCT01582308|3838167|FG003|NOT COMPLETED|10-day Washout Following Period 4||0
3113577|NCT01582308|3838168|FG004|NOT COMPLETED|10-day Washout Following Period 4||0
3113578|NCT01582308|3838169|FG005|NOT COMPLETED|10-day Washout Following Period 4||0
3113579|NCT01582308|3838170|FG006|NOT COMPLETED|10-day Washout Following Period 4||0
3113580|NCT01582308|3838171|FG007|NOT COMPLETED|10-day Washout Following Period 4||0
3113581|NCT01582308|3838172|FG008|NOT COMPLETED|10-day Washout Following Period 4||0
3113582|NCT01582308|3838173|FG009|NOT COMPLETED|10-day Washout Following Period 4||0
3113583|NCT01582308|3838164|FG000|STARTED|Period 5||1
3113584|NCT01582308|3838165|FG001|STARTED|Period 5||2
3113585|NCT01582308|3838166|FG002|STARTED|Period 5||2
3113586|NCT01582308|3838167|FG003|STARTED|Period 5||2
3113587|NCT01582308|3838168|FG004|STARTED|Period 5||2
3113588|NCT01582308|3838169|FG005|STARTED|Period 5||1
3113589|NCT01582308|3838170|FG006|STARTED|Period 5||2
3113590|NCT01582308|3838171|FG007|STARTED|Period 5||2
3113591|NCT01582308|3838172|FG008|STARTED|Period 5||2
3113592|NCT01582308|3838173|FG009|STARTED|Period 5||1
3113593|NCT01582308|3838164|FG000|COMPLETED|Period 5||1
3113594|NCT01582308|3838165|FG001|COMPLETED|Period 5||2
3113595|NCT01582308|3838166|FG002|COMPLETED|Period 5||2
3113596|NCT01582308|3838167|FG003|COMPLETED|Period 5||2
3113597|NCT01582308|3838168|FG004|COMPLETED|Period 5||2
3113598|NCT01582308|3838169|FG005|COMPLETED|Period 5||1
3113599|NCT01582308|3838170|FG006|COMPLETED|Period 5||2
3113600|NCT01582308|3838171|FG007|COMPLETED|Period 5||2
3113601|NCT01582308|3838172|FG008|COMPLETED|Period 5||2
3113602|NCT01582308|3838173|FG009|COMPLETED|Period 5||1
3113603|NCT01582308|3838164|FG000|NOT COMPLETED|Period 5||0
3113604|NCT01582308|3838165|FG001|NOT COMPLETED|Period 5||0
3113605|NCT01582308|3838166|FG002|NOT COMPLETED|Period 5||0
3113606|NCT01582308|3838167|FG003|NOT COMPLETED|Period 5||0
3113607|NCT01582308|3838168|FG004|NOT COMPLETED|Period 5||0
3113608|NCT01582308|3838169|FG005|NOT COMPLETED|Period 5||0
3113609|NCT01582308|3838170|FG006|NOT COMPLETED|Period 5||0
3113610|NCT01582308|3838171|FG007|NOT COMPLETED|Period 5||0
3113611|NCT01582308|3838172|FG008|NOT COMPLETED|Period 5||0
3113612|NCT01582308|3838173|FG009|NOT COMPLETED|Period 5||0
3113613|NCT01582451|3838188|FG000|STARTED|Overall Study||307
3113614|NCT01582451|3838189|FG001|STARTED|Overall Study||159
3113615|NCT01582451|3838188|FG000|Received at Least 1 Dose of Study Drug|Overall Study||305
3113616|NCT01582451|3838189|FG001|Received at Least 1 Dose of Study Drug|Overall Study||159
3113617|NCT01582451|3838188|FG000|COMPLETED|Overall Study||275
3113618|NCT01582451|3838189|FG001|COMPLETED|Overall Study||139
3113619|NCT01582451|3838188|FG000|NOT COMPLETED|Overall Study||32
3113620|NCT01582451|3838189|FG001|NOT COMPLETED|Overall Study||20
3113621|NCT01582477|3838197|FG000|STARTED|Overall Study||12
3113622|NCT01582477|3838198|FG001|STARTED|Overall Study||12
3113623|NCT01582477|3838197|FG000|COMPLETED|Overall Study||12
3113624|NCT01582477|3838198|FG001|COMPLETED|Overall Study||12
3113625|NCT01582477|3838197|FG000|NOT COMPLETED|Overall Study||0
3113626|NCT01582477|3838198|FG001|NOT COMPLETED|Overall Study||0
3113627|NCT01582490|3838206|FG000|STARTED|Overall Study||9
3113628|NCT01582490|3838207|FG001|STARTED|Overall Study||10
3113629|NCT01582490|3838206|FG000|COMPLETED|Overall Study||8
3113630|NCT01582490|3838207|FG001|COMPLETED|Overall Study||9
3113631|NCT01582490|3838206|FG000|NOT COMPLETED|Overall Study||1
3113632|NCT01582490|3838207|FG001|NOT COMPLETED|Overall Study||1
3113633|NCT01582789|3838215|FG000|STARTED|First Intervention (14 Days)||34
3113634|NCT01582789|3838216|FG001|STARTED|First Intervention (14 Days)||27
3113635|NCT01582789|3838215|FG000|COMPLETED|First Intervention (14 Days)||34
3113636|NCT01582789|3838216|FG001|COMPLETED|First Intervention (14 Days)||27
3113637|NCT01582789|3838215|FG000|NOT COMPLETED|First Intervention (14 Days)||0
3113638|NCT01582789|3838216|FG001|NOT COMPLETED|First Intervention (14 Days)||0
3113639|NCT01582789|3838215|FG000|STARTED|Second Intervention (14 Days)||34
3113640|NCT01582789|3838216|FG001|STARTED|Second Intervention (14 Days)||27
3113641|NCT01582789|3838215|FG000|COMPLETED|Second Intervention (14 Days)||33
3113642|NCT01582789|3838216|FG001|COMPLETED|Second Intervention (14 Days)||27
3113643|NCT01582789|3838215|FG000|NOT COMPLETED|Second Intervention (14 Days)||1
3113644|NCT01582789|3838216|FG001|NOT COMPLETED|Second Intervention (14 Days)||0
3113645|NCT01582854|3838226|FG000|STARTED|Overall Study||248
3113646|NCT01582854|3838227|FG001|STARTED|Overall Study||255
3113647|NCT01582854|3838226|FG000|COMPLETED|Overall Study||212
3293898|NCT02875028|4027876|FG000|COMPLETED|Washout Period||8
3293899|NCT02875028|4027877|FG001|COMPLETED|Washout Period||7
3293900|NCT02875028|4027876|FG000|NOT COMPLETED|Washout Period||0
3293901|NCT02875028|4027877|FG001|NOT COMPLETED|Washout Period||1
3293902|NCT02875028|4027876|FG000|STARTED|Second Intervention (24 Hours)||8
3293903|NCT02875028|4027877|FG001|STARTED|Second Intervention (24 Hours)||7
3293904|NCT02875028|4027876|FG000|COMPLETED|Second Intervention (24 Hours)||8
3293905|NCT02875028|4027877|FG001|COMPLETED|Second Intervention (24 Hours)||7
3293906|NCT02875028|4027876|FG000|NOT COMPLETED|Second Intervention (24 Hours)||0
3293907|NCT02875028|4027877|FG001|NOT COMPLETED|Second Intervention (24 Hours)||0
3293908|NCT02875080|4027888|FG000|STARTED|Overall Study||6
3293909|NCT02875080|4027889|FG001|STARTED|Overall Study||6
3293910|NCT02875080|4027890|FG002|STARTED|Overall Study||6
3293911|NCT02875080|4027888|FG000|COMPLETED|Overall Study||4
3293912|NCT02875080|4027889|FG001|COMPLETED|Overall Study||6
3293913|NCT02875080|4027890|FG002|COMPLETED|Overall Study||6
3293914|NCT02875080|4027888|FG000|NOT COMPLETED|Overall Study||2
3293915|NCT02875080|4027889|FG001|NOT COMPLETED|Overall Study||0
3113648|NCT01582854|3838227|FG001|COMPLETED|Overall Study||221
3113649|NCT01582854|3838226|FG000|NOT COMPLETED|Overall Study||36
3113650|NCT01582854|3838227|FG001|NOT COMPLETED|Overall Study||34
3113651|NCT01582880|3838233|FG000|STARTED|Overall Study||1
3113652|NCT01582880|3838233|FG000|COMPLETED|Overall Study||1
3113653|NCT01582880|3838233|FG000|NOT COMPLETED|Overall Study||0
3113654|NCT01582945|3838237|FG000|STARTED|Overall Study||14
3113655|NCT01582945|3838237|FG000|COMPLETED|Overall Study||12
3113656|NCT01582945|3838237|FG000|NOT COMPLETED|Overall Study||2
3113657|NCT01582971|3838243|FG000|STARTED|Overall Study||128
3113658|NCT01582971|3838244|FG001|STARTED|Overall Study||128
3113659|NCT01582971|3838243|FG000|COMPLETED|Overall Study||89
3113660|NCT01582971|3838244|FG001|COMPLETED|Overall Study||91
3113661|NCT01582971|3838243|FG000|NOT COMPLETED|Overall Study||39
3113662|NCT01582971|3838244|FG001|NOT COMPLETED|Overall Study||37
3113663|NCT01583101|3838258|FG000|STARTED|Overall Study||1076
3113664|NCT01583101|3838259|FG001|STARTED|Overall Study||1161
3113665|NCT01583101|3838258|FG000|COMPLETED|Overall Study||1076
3113666|NCT01583101|3838259|FG001|COMPLETED|Overall Study||1161
3113667|NCT01583101|3838258|FG000|NOT COMPLETED|Overall Study||0
3113668|NCT01583101|3838259|FG001|NOT COMPLETED|Overall Study||0
3113669|NCT01583166|3838267|FG000|STARTED|Overall Study||45
3113670|NCT01583166|3838268|FG001|STARTED|Overall Study||45
3113671|NCT01583166|3838267|FG000|COMPLETED|Overall Study||41
3113672|NCT01583166|3838268|FG001|COMPLETED|Overall Study||39
3113673|NCT01583166|3838267|FG000|NOT COMPLETED|Overall Study||4
3113674|NCT01583166|3838268|FG001|NOT COMPLETED|Overall Study||6
3113675|NCT01583179|3838276|FG000|STARTED|Overall Study||14
3113676|NCT01583179|3838277|FG001|STARTED|Overall Study||12
3113677|NCT01583179|3838276|FG000|COMPLETED|Overall Study||13
3113678|NCT01583179|3838277|FG001|COMPLETED|Overall Study||10
3113679|NCT01583179|3838276|FG000|NOT COMPLETED|Overall Study||1
3113680|NCT01583179|3838277|FG001|NOT COMPLETED|Overall Study||2
3113681|NCT01583218|3838285|FG000|STARTED|Overall Study||3759
3113682|NCT01583218|3838286|FG001|STARTED|Overall Study||3754
3113683|NCT01583218|3838285|FG000|COMPLETED|Overall Study||3470
3113684|NCT01583218|3838286|FG001|COMPLETED|Overall Study||3471
3113685|NCT01583218|3838285|FG000|NOT COMPLETED|Overall Study||289
3113686|NCT01583218|3838286|FG001|NOT COMPLETED|Overall Study||283
3113687|NCT01583296|3838294|FG000|STARTED|Overall Study||27
3113688|NCT01583296|3838295|FG001|STARTED|Overall Study||26
3113689|NCT01583296|3838294|FG000|COMPLETED|Overall Study||16
3113690|NCT01583296|3838295|FG001|COMPLETED|Overall Study||16
3113691|NCT01583296|3838294|FG000|NOT COMPLETED|Overall Study||11
3113692|NCT01583296|3838295|FG001|NOT COMPLETED|Overall Study||10
3113693|NCT01583374|3838304|FG000|STARTED|Placebo-controlled Phase (Week 0-24)||164
3113694|NCT01583374|3838305|FG001|STARTED|Placebo-controlled Phase (Week 0-24)||163
3113695|NCT01583374|3838306|FG002|STARTED|Placebo-controlled Phase (Week 0-24)||163
3113696|NCT01583374|3838307|FG003|STARTED|Placebo-controlled Phase (Week 0-24)||0
3113697|NCT01583374|3838308|FG004|STARTED|Placebo-controlled Phase (Week 0-24)||0
3113698|NCT01583374|3838309|FG005|STARTED|Placebo-controlled Phase (Week 0-24)||0
3113699|NCT01583374|3838310|FG006|STARTED|Placebo-controlled Phase (Week 0-24)||0
3113700|NCT01583374|3838311|FG007|STARTED|Placebo-controlled Phase (Week 0-24)||0
3113701|NCT01583374|3838312|FG008|STARTED|Placebo-controlled Phase (Week 0-24)||0
3113702|NCT01583374|3838304|FG000|Received Treatment|Placebo-controlled Phase (Week 0-24)||164
3113703|NCT01583374|3838305|FG001|Received Treatment|Placebo-controlled Phase (Week 0-24)||163
3113704|NCT01583374|3838306|FG002|Received Treatment|Placebo-controlled Phase (Week 0-24)||163
3113705|NCT01583374|3838307|FG003|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
3113706|NCT01583374|3838308|FG004|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
3113707|NCT01583374|3838309|FG005|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
3113708|NCT01583374|3838310|FG006|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
3113709|NCT01583374|3838311|FG007|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
3113710|NCT01583374|3838312|FG008|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
3113711|NCT01583374|3838304|FG000|Completed Week 16|Placebo-controlled Phase (Week 0-24)||150
3113712|NCT01583374|3838305|FG001|Completed Week 16|Placebo-controlled Phase (Week 0-24)||151
3113713|NCT01583374|3838306|FG002|Completed Week 16|Placebo-controlled Phase (Week 0-24)||144
3113714|NCT01583374|3838307|FG003|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
3113715|NCT01583374|3838308|FG004|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
3113716|NCT01583374|3838309|FG005|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
3113717|NCT01583374|3838310|FG006|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
3113718|NCT01583374|3838311|FG007|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
3113719|NCT01583374|3838312|FG008|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
3113720|NCT01583374|3838304|FG000|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)|One participant who escaped early did not complete Week 24|51
3113721|NCT01583374|3838305|FG001|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||49
3113722|NCT01583374|3838306|FG002|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)|One participant who escaped early did not complete Week 24|49
3113723|NCT01583374|3838307|FG003|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
3113724|NCT01583374|3838308|FG004|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
3113725|NCT01583374|3838309|FG005|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
3113726|NCT01583374|3838310|FG006|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
3113727|NCT01583374|3838311|FG007|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
3113728|NCT01583374|3838312|FG008|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
3113729|NCT01583374|3838304|FG000|COMPLETED|Placebo-controlled Phase (Week 0-24)|Completed = participants who completed the Placebo-controlled Phase|145
3113730|NCT01583374|3838305|FG001|COMPLETED|Placebo-controlled Phase (Week 0-24)|Completed = participants who completed the Placebo-controlled Phase|147
3113731|NCT01583374|3838306|FG002|COMPLETED|Placebo-controlled Phase (Week 0-24)|Completed = participants who completed the Placebo-controlled Phase|138
3113732|NCT01583374|3838307|FG003|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
3113733|NCT01583374|3838308|FG004|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
3113734|NCT01583374|3838309|FG005|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
3113735|NCT01583374|3838310|FG006|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
3293916|NCT02875080|4027890|FG002|NOT COMPLETED|Overall Study||0
3293917|NCT02875340|4027898|FG000|STARTED|Overall Study||8
3293918|NCT02875340|4027898|FG000|COMPLETED|Overall Study|No patients completed 6 months of continuous treatment|0
3293919|NCT02875340|4027898|FG000|NOT COMPLETED|Overall Study||8
3293920|NCT02875366|4027910|FG000|STARTED|Overall Study||36
3293921|NCT02875366|4027911|FG001|STARTED|Overall Study||34
3293922|NCT02875366|4027910|FG000|COMPLETED|Overall Study||36
3293923|NCT02875366|4027911|FG001|COMPLETED|Overall Study||31
3293924|NCT02875366|4027910|FG000|NOT COMPLETED|Overall Study||0
3113736|NCT01583374|3838311|FG007|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
3113737|NCT01583374|3838312|FG008|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
3113738|NCT01583374|3838304|FG000|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||19
3113739|NCT01583374|3838305|FG001|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||16
3113740|NCT01583374|3838306|FG002|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||25
3113741|NCT01583374|3838307|FG003|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
3113742|NCT01583374|3838308|FG004|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
3113743|NCT01583374|3838309|FG005|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
3113744|NCT01583374|3838310|FG006|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
3113745|NCT01583374|3838311|FG007|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
3113746|NCT01583374|3838312|FG008|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
3113747|NCT01583374|3838304|FG000|STARTED|Extension Phase (Weeks 24 to 52)||0
3113748|NCT01583374|3838305|FG001|STARTED|Extension Phase (Weeks 24 to 52)||74
3113749|NCT01583374|3838306|FG002|STARTED|Extension Phase (Weeks 24 to 52)||65
3113750|NCT01583374|3838307|FG003|STARTED|Extension Phase (Weeks 24 to 52)||47
3113751|NCT01583374|3838308|FG004|STARTED|Extension Phase (Weeks 24 to 52)||91
3113752|NCT01583374|3838309|FG005|STARTED|Extension Phase (Weeks 24 to 52)||48
3113753|NCT01583374|3838310|FG006|STARTED|Extension Phase (Weeks 24 to 52)||48
3113754|NCT01583374|3838311|FG007|STARTED|Extension Phase (Weeks 24 to 52)||25
3113755|NCT01583374|3838312|FG008|STARTED|Extension Phase (Weeks 24 to 52)||23
3113756|NCT01583374|3838304|FG000|COMPLETED|Extension Phase (Weeks 24 to 52)||0
3113757|NCT01583374|3838305|FG001|COMPLETED|Extension Phase (Weeks 24 to 52)||69
3113758|NCT01583374|3838306|FG002|COMPLETED|Extension Phase (Weeks 24 to 52)||61
3113759|NCT01583374|3838307|FG003|COMPLETED|Extension Phase (Weeks 24 to 52)||41
3113760|NCT01583374|3838308|FG004|COMPLETED|Extension Phase (Weeks 24 to 52)||85
3293925|NCT02875366|4027911|FG001|NOT COMPLETED|Overall Study||3
3293926|NCT02875392|4027919|FG000|STARTED|Overall Study||28
3293927|NCT02875392|4027920|FG001|STARTED|Overall Study||29
3293928|NCT02875392|4027919|FG000|COMPLETED|Overall Study||21
3293929|NCT02875392|4027920|FG001|COMPLETED|Overall Study||21
3293930|NCT02875392|4027919|FG000|NOT COMPLETED|Overall Study||7
3293931|NCT02875392|4027920|FG001|NOT COMPLETED|Overall Study||8
3293932|NCT02875613|4027926|FG000|STARTED|Overall Study||5
3293933|NCT02875613|4027926|FG000|COMPLETED|Overall Study||4
3293934|NCT02875613|4027926|FG000|NOT COMPLETED|Overall Study||1
3293935|NCT02875834|4027934|FG000|STARTED|Open-label Phase||267
3293936|NCT02875834|4027935|FG001|STARTED|Open-label Phase||0
3293937|NCT02875834|4027936|FG002|STARTED|Open-label Phase||0
3293938|NCT02875834|4027937|FG003|STARTED|Open-label Phase||0
3293939|NCT02875834|4027934|FG000|COMPLETED|Open-label Phase||260
3293940|NCT02875834|4027935|FG001|COMPLETED|Open-label Phase||0
3293941|NCT02875834|4027936|FG002|COMPLETED|Open-label Phase||0
3293942|NCT02875834|4027937|FG003|COMPLETED|Open-label Phase||0
3293943|NCT02875834|4027934|FG000|NOT COMPLETED|Open-label Phase||7
3293944|NCT02875834|4027935|FG001|NOT COMPLETED|Open-label Phase||0
3293945|NCT02875834|4027936|FG002|NOT COMPLETED|Open-label Phase||0
3293946|NCT02875834|4027937|FG003|NOT COMPLETED|Open-label Phase||0
3293947|NCT02875834|4027934|FG000|STARTED|Randomized Treatment Phase|No subjects were randomized in 10g TID group in RTP.|0
3293948|NCT02875834|4027935|FG001|STARTED|Randomized Treatment Phase|99 subjects were randomized in 5g QD group in RTP.|99
3293949|NCT02875834|4027936|FG002|STARTED|Randomized Treatment Phase|99 subjects were randomized in 10g QD group in RTP.|99
3293950|NCT02875834|4027937|FG003|STARTED|Randomized Treatment Phase|50 subjects were randomized in placebo group in RTP.|50
3293951|NCT02875834|4027934|FG000|COMPLETED|Randomized Treatment Phase||0
3293952|NCT02875834|4027935|FG001|COMPLETED|Randomized Treatment Phase||85
3293953|NCT02875834|4027936|FG002|COMPLETED|Randomized Treatment Phase||88
3293954|NCT02875834|4027937|FG003|COMPLETED|Randomized Treatment Phase||41
3293955|NCT02875834|4027934|FG000|NOT COMPLETED|Randomized Treatment Phase||0
3293956|NCT02875834|4027935|FG001|NOT COMPLETED|Randomized Treatment Phase||14
3293957|NCT02875834|4027936|FG002|NOT COMPLETED|Randomized Treatment Phase||11
3293958|NCT02875834|4027937|FG003|NOT COMPLETED|Randomized Treatment Phase||9
3293959|NCT02875977|4027949|FG000|STARTED|Overall Study||100
3293960|NCT02875977|4027950|FG001|STARTED|Overall Study||100
3293961|NCT02875977|4027949|FG000|COMPLETED|Overall Study||58
3293962|NCT02875977|4027950|FG001|COMPLETED|Overall Study||71
3293963|NCT02875977|4027949|FG000|NOT COMPLETED|Overall Study||42
3293964|NCT02875977|4027950|FG001|NOT COMPLETED|Overall Study||29
3293965|NCT02876055|4027959|FG000|STARTED|Overall Study||42
3293966|NCT02876055|4027960|FG001|STARTED|Overall Study||41
3293967|NCT02876055|4027961|FG002|STARTED|Overall Study||42
3113761|NCT01583374|3838309|FG005|COMPLETED|Extension Phase (Weeks 24 to 52)||43
3113762|NCT01583374|3838310|FG006|COMPLETED|Extension Phase (Weeks 24 to 52)||43
3113763|NCT01583374|3838311|FG007|COMPLETED|Extension Phase (Weeks 24 to 52)||22
3113764|NCT01583374|3838312|FG008|COMPLETED|Extension Phase (Weeks 24 to 52)||21
3113765|NCT01583374|3838304|FG000|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||0
3113766|NCT01583374|3838305|FG001|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||5
3113767|NCT01583374|3838306|FG002|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||4
3113768|NCT01583374|3838307|FG003|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||6
3113769|NCT01583374|3838308|FG004|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||6
3113770|NCT01583374|3838309|FG005|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||5
3113771|NCT01583374|3838310|FG006|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||5
3113772|NCT01583374|3838311|FG007|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||3
3113773|NCT01583374|3838312|FG008|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||2
3113774|NCT01583374|3838304|FG000|STARTED|Long-Term Extension Phase Weeks 52-260||0
3113775|NCT01583374|3838305|FG001|STARTED|Long-Term Extension Phase Weeks 52-260||66
3113776|NCT01583374|3838306|FG002|STARTED|Long-Term Extension Phase Weeks 52-260||61
3113777|NCT01583374|3838307|FG003|STARTED|Long-Term Extension Phase Weeks 52-260||35
3113778|NCT01583374|3838308|FG004|STARTED|Long-Term Extension Phase Weeks 52-260||81
3113779|NCT01583374|3838309|FG005|STARTED|Long-Term Extension Phase Weeks 52-260||39
3113780|NCT01583374|3838310|FG006|STARTED|Long-Term Extension Phase Weeks 52-260||38
3113781|NCT01583374|3838311|FG007|STARTED|Long-Term Extension Phase Weeks 52-260||21
3113782|NCT01583374|3838312|FG008|STARTED|Long-Term Extension Phase Weeks 52-260||20
3113783|NCT01583374|3838304|FG000|COMPLETED|Long-Term Extension Phase Weeks 52-260||0
3113784|NCT01583374|3838305|FG001|COMPLETED|Long-Term Extension Phase Weeks 52-260||40
3113785|NCT01583374|3838306|FG002|COMPLETED|Long-Term Extension Phase Weeks 52-260||41
3113786|NCT01583374|3838307|FG003|COMPLETED|Long-Term Extension Phase Weeks 52-260||22
3113787|NCT01583374|3838308|FG004|COMPLETED|Long-Term Extension Phase Weeks 52-260||50
3113788|NCT01583374|3838309|FG005|COMPLETED|Long-Term Extension Phase Weeks 52-260||22
3113789|NCT01583374|3838310|FG006|COMPLETED|Long-Term Extension Phase Weeks 52-260||20
3113790|NCT01583374|3838311|FG007|COMPLETED|Long-Term Extension Phase Weeks 52-260||12
3113791|NCT01583374|3838312|FG008|COMPLETED|Long-Term Extension Phase Weeks 52-260||10
3113792|NCT01583374|3838304|FG000|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||0
3113793|NCT01583374|3838305|FG001|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||26
3113794|NCT01583374|3838306|FG002|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||20
3113795|NCT01583374|3838307|FG003|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||13
3113796|NCT01583374|3838308|FG004|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||31
3113797|NCT01583374|3838309|FG005|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||17
3113798|NCT01583374|3838310|FG006|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||18
3113799|NCT01583374|3838311|FG007|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||9
3113800|NCT01583374|3838312|FG008|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||10
3113801|NCT01583452|3838333|FG000|STARTED|Overall Study||21
3113802|NCT01583452|3838334|FG001|STARTED|Overall Study||20
3113803|NCT01583452|3838333|FG000|COMPLETED|Overall Study||21
3113804|NCT01583452|3838334|FG001|COMPLETED|Overall Study||20
3113805|NCT01583452|3838333|FG000|NOT COMPLETED|Overall Study||0
3113806|NCT01583452|3838334|FG001|NOT COMPLETED|Overall Study||0
3113807|NCT01583530|3838349|FG000|STARTED|Overall Study||19
3113808|NCT01583530|3838350|FG001|STARTED|Overall Study||20
3113809|NCT01583530|3838351|FG002|STARTED|Overall Study||20
3113810|NCT01583530|3838352|FG003|STARTED|Overall Study||19
3113811|NCT01583530|3838353|FG004|STARTED|Overall Study||20
3113812|NCT01583530|3838354|FG005|STARTED|Overall Study||20
3113813|NCT01583530|3838349|FG000|COMPLETED|Overall Study||19
3113814|NCT01583530|3838350|FG001|COMPLETED|Overall Study||17
3113815|NCT01583530|3838351|FG002|COMPLETED|Overall Study||20
3113816|NCT01583530|3838352|FG003|COMPLETED|Overall Study||18
3113817|NCT01583530|3838353|FG004|COMPLETED|Overall Study||15
3113818|NCT01583530|3838354|FG005|COMPLETED|Overall Study||17
3113819|NCT01583530|3838349|FG000|NOT COMPLETED|Overall Study||0
3113820|NCT01583530|3838350|FG001|NOT COMPLETED|Overall Study||3
3113821|NCT01583530|3838351|FG002|NOT COMPLETED|Overall Study||0
3113822|NCT01583530|3838352|FG003|NOT COMPLETED|Overall Study||1
3113823|NCT01583530|3838353|FG004|NOT COMPLETED|Overall Study||5
3113824|NCT01583530|3838354|FG005|NOT COMPLETED|Overall Study||3
3113825|NCT01583543|3838371|FG000|STARTED|Overall Study||12
3113826|NCT01583543|3838371|FG000|COMPLETED|Overall Study||12
3113827|NCT01583543|3838371|FG000|NOT COMPLETED|Overall Study||0
3113828|NCT01583686|3838383|FG000|STARTED|Overall Study||3
3113829|NCT01583686|3838384|FG001|STARTED|Overall Study||3
3113830|NCT01583686|3838385|FG002|STARTED|Overall Study||3
3113831|NCT01583686|3838386|FG003|STARTED|Overall Study||3
3113832|NCT01583686|3838387|FG004|STARTED|Overall Study||3
3113833|NCT01583686|3838383|FG000|COMPLETED|Overall Study||3
3113834|NCT01583686|3838384|FG001|COMPLETED|Overall Study||3
3113835|NCT01583686|3838385|FG002|COMPLETED|Overall Study||3
3113836|NCT01583686|3838386|FG003|COMPLETED|Overall Study||3
3113837|NCT01583686|3838387|FG004|COMPLETED|Overall Study||3
3113838|NCT01583686|3838383|FG000|NOT COMPLETED|Overall Study||0
3113839|NCT01583686|3838384|FG001|NOT COMPLETED|Overall Study||0
3113840|NCT01583686|3838385|FG002|NOT COMPLETED|Overall Study||0
3113841|NCT01583686|3838386|FG003|NOT COMPLETED|Overall Study||0
3113842|NCT01583686|3838387|FG004|NOT COMPLETED|Overall Study||0
3113843|NCT01583868|3838404|FG000|STARTED|Overall Study||108
3113844|NCT01583868|3838405|FG001|STARTED|Overall Study||108
3113845|NCT01583868|3838404|FG000|COMPLETED|Overall Study||104
3113846|NCT01583868|3838405|FG001|COMPLETED|Overall Study||104
3113847|NCT01583868|3838404|FG000|NOT COMPLETED|Overall Study||4
3113848|NCT01583868|3838405|FG001|NOT COMPLETED|Overall Study||4
3113849|NCT01583894|3838415|FG000|STARTED|Overall Study||828
3113850|NCT01583894|3838415|FG000|COMPLETED|Overall Study||813
3113851|NCT01583894|3838415|FG000|NOT COMPLETED|Overall Study||15
3113852|NCT01583985|3838421|FG000|STARTED|Overall Study||120
3113853|NCT01583985|3838422|FG001|STARTED|Overall Study||120
3113854|NCT01583985|3838421|FG000|Included in Primary Analysis|Overall Study||119
3113855|NCT01583985|3838422|FG001|Included in Primary Analysis|Overall Study||119
3113856|NCT01583985|3838421|FG000|COMPLETED|Overall Study||117
3113857|NCT01583985|3838422|FG001|COMPLETED|Overall Study||117
3113858|NCT01583985|3838421|FG000|NOT COMPLETED|Overall Study||3
3113859|NCT01583985|3838422|FG001|NOT COMPLETED|Overall Study||3
3113860|NCT01584024|3838428|FG000|STARTED|Overall Study||42
3113861|NCT01584024|3838428|FG000|COMPLETED|Overall Study||29
3113862|NCT01584024|3838428|FG000|NOT COMPLETED|Overall Study||13
3113863|NCT01584232|3838435|FG000|STARTED|Overall Study||181
3113864|NCT01584232|3838436|FG001|STARTED|Overall Study||180
3113865|NCT01584232|3838435|FG000|Received at Least 1 Dose of Study Drug|Overall Study||181
3113866|NCT01584232|3838436|FG001|Received at Least 1 Dose of Study Drug|Overall Study||180
3113867|NCT01584232|3838435|FG000|COMPLETED|Overall Study||173
3113868|NCT01584232|3838436|FG001|COMPLETED|Overall Study||177
3113869|NCT01584232|3838435|FG000|NOT COMPLETED|Overall Study||8
3113870|NCT01584232|3838436|FG001|NOT COMPLETED|Overall Study||3
3113871|NCT01584388|3838442|FG000|STARTED|Overall Study||30
3113872|NCT01584388|3838442|FG000|COMPLETED|Overall Study||30
3113873|NCT01584388|3838442|FG000|NOT COMPLETED|Overall Study||0
3113874|NCT01584440|3838462|FG000|STARTED|Stage 1 (5 Weeks)||93
3113875|NCT01584440|3838463|FG001|STARTED|Stage 1 (5 Weeks)||127
3113876|NCT01584440|3838464|FG002|STARTED|Stage 1 (5 Weeks)||0
3113877|NCT01584440|3838465|FG003|STARTED|Stage 1 (5 Weeks)||0
3113878|NCT01584440|3838466|FG004|STARTED|Stage 1 (5 Weeks)||0
3113879|NCT01584440|3838462|FG000|COMPLETED|Stage 1 (5 Weeks)||83
3113880|NCT01584440|3838463|FG001|COMPLETED|Stage 1 (5 Weeks)||119
3113881|NCT01584440|3838464|FG002|COMPLETED|Stage 1 (5 Weeks)||0
3113882|NCT01584440|3838465|FG003|COMPLETED|Stage 1 (5 Weeks)||0
3113883|NCT01584440|3838466|FG004|COMPLETED|Stage 1 (5 Weeks)||0
3113884|NCT01584440|3838462|FG000|NOT COMPLETED|Stage 1 (5 Weeks)||10
3113885|NCT01584440|3838463|FG001|NOT COMPLETED|Stage 1 (5 Weeks)||8
3113886|NCT01584440|3838464|FG002|NOT COMPLETED|Stage 1 (5 Weeks)||0
3113887|NCT01584440|3838465|FG003|NOT COMPLETED|Stage 1 (5 Weeks)||0
3113888|NCT01584440|3838466|FG004|NOT COMPLETED|Stage 1 (5 Weeks)||0
3113889|NCT01584440|3838462|FG000|STARTED|Stage 2 (5 Weeks)||0
3113890|NCT01584440|3838463|FG001|STARTED|Stage 2 (5 Weeks)||0
3113891|NCT01584440|3838464|FG002|STARTED|Stage 2 (5 Weeks)||83
3113892|NCT01584440|3838465|FG003|STARTED|Stage 2 (5 Weeks)||59
3113893|NCT01584440|3838466|FG004|STARTED|Stage 2 (5 Weeks)||60
3113894|NCT01584440|3838462|FG000|COMPLETED|Stage 2 (5 Weeks)||0
3113895|NCT01584440|3838463|FG001|COMPLETED|Stage 2 (5 Weeks)||0
3113896|NCT01584440|3838464|FG002|COMPLETED|Stage 2 (5 Weeks)||80
3113897|NCT01584440|3838465|FG003|COMPLETED|Stage 2 (5 Weeks)||55
3113898|NCT01584440|3838466|FG004|COMPLETED|Stage 2 (5 Weeks)||59
3113899|NCT01584440|3838462|FG000|NOT COMPLETED|Stage 2 (5 Weeks)||0
3113900|NCT01584440|3838463|FG001|NOT COMPLETED|Stage 2 (5 Weeks)||0
3113901|NCT01584440|3838464|FG002|NOT COMPLETED|Stage 2 (5 Weeks)||3
3113902|NCT01584440|3838465|FG003|NOT COMPLETED|Stage 2 (5 Weeks)||4
3113903|NCT01584440|3838466|FG004|NOT COMPLETED|Stage 2 (5 Weeks)||1
3113904|NCT01584479|3838483|FG000|STARTED|Overall Study||732
3113905|NCT01584479|3838484|FG001|STARTED|Overall Study||1686
3113906|NCT01584479|3838485|FG002|STARTED|Overall Study||852
3113907|NCT01584479|3838486|FG003|STARTED|Overall Study||1847
3113908|NCT01584479|3838483|FG000|COMPLETED|Overall Study||732
3113909|NCT01584479|3838484|FG001|COMPLETED|Overall Study||1686
3113910|NCT01584479|3838485|FG002|COMPLETED|Overall Study||852
3113911|NCT01584479|3838486|FG003|COMPLETED|Overall Study||1847
3113912|NCT01584479|3838483|FG000|NOT COMPLETED|Overall Study||0
3113913|NCT01584479|3838484|FG001|NOT COMPLETED|Overall Study||0
3113914|NCT01584479|3838485|FG002|NOT COMPLETED|Overall Study||0
3113915|NCT01584479|3838486|FG003|NOT COMPLETED|Overall Study||0
3113916|NCT01584518|3838498|FG000|STARTED|Overall Study||25
3113917|NCT01584518|3838499|FG001|STARTED|Overall Study||25
3113918|NCT01584518|3838498|FG000|COMPLETED|Overall Study||25
3113919|NCT01584518|3838499|FG001|COMPLETED|Overall Study||25
3113920|NCT01584518|3838498|FG000|NOT COMPLETED|Overall Study||0
3113921|NCT01584518|3838499|FG001|NOT COMPLETED|Overall Study||0
3113922|NCT01584544|3838510|FG000|STARTED|Overall Study||3
3113923|NCT01584544|3838511|FG001|STARTED|Overall Study||6
3113924|NCT01584544|3838512|FG002|STARTED|Overall Study||6
3113925|NCT01584544|3838513|FG003|STARTED|Overall Study||3
3113926|NCT01584544|3838514|FG004|STARTED|Overall Study||6
3113927|NCT01584544|3838510|FG000|COMPLETED|Overall Study||3
3113928|NCT01584544|3838511|FG001|COMPLETED|Overall Study||6
3113929|NCT01584544|3838512|FG002|COMPLETED|Overall Study||6
3113930|NCT01584544|3838513|FG003|COMPLETED|Overall Study||3
3113931|NCT01584544|3838514|FG004|COMPLETED|Overall Study||6
3113932|NCT01584544|3838510|FG000|NOT COMPLETED|Overall Study||0
3113933|NCT01584544|3838511|FG001|NOT COMPLETED|Overall Study||0
3113934|NCT01584544|3838512|FG002|NOT COMPLETED|Overall Study||0
3113935|NCT01584544|3838513|FG003|NOT COMPLETED|Overall Study||0
3113936|NCT01584544|3838514|FG004|NOT COMPLETED|Overall Study||0
3113937|NCT01584609|3838528|FG000|STARTED|Overall Study||98
3113938|NCT01584609|3838529|FG001|STARTED|Overall Study||100
3113939|NCT01584609|3838528|FG000|COMPLETED|Overall Study||86
3113940|NCT01584609|3838529|FG001|COMPLETED|Overall Study||96
3113941|NCT01584609|3838528|FG000|NOT COMPLETED|Overall Study||12
3113942|NCT01584609|3838529|FG001|NOT COMPLETED|Overall Study||4
3113943|NCT01584648|3838537|FG000|STARTED|Overall Study||211
3113944|NCT01584648|3838538|FG001|STARTED|Overall Study||212
3113945|NCT01584648|3838537|FG000|Safety Set|Overall Study||209
3113946|NCT01584648|3838538|FG001|Safety Set|Overall Study||211
3113947|NCT01584648|3838537|FG000|Crossover Population|Overall Study||0
3113948|NCT01584648|3838538|FG001|Crossover Population|Overall Study||28
3113949|NCT01584648|3838537|FG000|COMPLETED|Overall Study||0
3113950|NCT01584648|3838538|FG001|COMPLETED|Overall Study||0
3113951|NCT01584648|3838537|FG000|NOT COMPLETED|Overall Study||211
3113952|NCT01584648|3838538|FG001|NOT COMPLETED|Overall Study||212
3113953|NCT01584843|3838551|FG000|STARTED|First Treatment Period||3
3113954|NCT01584843|3838552|FG001|STARTED|First Treatment Period||4
3113955|NCT01584843|3838553|FG002|STARTED|First Treatment Period||3
3113956|NCT01584843|3838554|FG003|STARTED|First Treatment Period||10
3113957|NCT01584843|3838555|FG004|STARTED|First Treatment Period||10
3113958|NCT01584843|3838556|FG005|STARTED|First Treatment Period||11
3113959|NCT01584843|3838551|FG000|COMPLETED|First Treatment Period||3
3113960|NCT01584843|3838552|FG001|COMPLETED|First Treatment Period||4
3113961|NCT01584843|3838553|FG002|COMPLETED|First Treatment Period||2
3113962|NCT01584843|3838554|FG003|COMPLETED|First Treatment Period||10
3113963|NCT01584843|3838555|FG004|COMPLETED|First Treatment Period||10
3113964|NCT01584843|3838556|FG005|COMPLETED|First Treatment Period||9
3113965|NCT01584843|3838551|FG000|NOT COMPLETED|First Treatment Period||0
3113966|NCT01584843|3838552|FG001|NOT COMPLETED|First Treatment Period||0
3113967|NCT01584843|3838553|FG002|NOT COMPLETED|First Treatment Period||1
3113968|NCT01584843|3838554|FG003|NOT COMPLETED|First Treatment Period||0
3113969|NCT01584843|3838555|FG004|NOT COMPLETED|First Treatment Period||0
3113970|NCT01584843|3838556|FG005|NOT COMPLETED|First Treatment Period||2
3113971|NCT01584843|3838551|FG000|STARTED|Second Treatment Period||2
3113972|NCT01584843|3838552|FG001|STARTED|Second Treatment Period||1
3113973|NCT01584843|3838553|FG002|STARTED|Second Treatment Period||2
3113974|NCT01584843|3838554|FG003|STARTED|Second Treatment Period||6
3113975|NCT01584843|3838555|FG004|STARTED|Second Treatment Period||3
3113976|NCT01584843|3838556|FG005|STARTED|Second Treatment Period||1
3113977|NCT01584843|3838551|FG000|COMPLETED|Second Treatment Period||2
3113978|NCT01584843|3838552|FG001|COMPLETED|Second Treatment Period||1
3113979|NCT01584843|3838553|FG002|COMPLETED|Second Treatment Period||2
3113980|NCT01584843|3838554|FG003|COMPLETED|Second Treatment Period||6
3113981|NCT01584843|3838555|FG004|COMPLETED|Second Treatment Period||3
3113982|NCT01584843|3838556|FG005|COMPLETED|Second Treatment Period||0
3113983|NCT01584843|3838551|FG000|NOT COMPLETED|Second Treatment Period||0
3113984|NCT01584843|3838552|FG001|NOT COMPLETED|Second Treatment Period||0
3293968|NCT02876055|4027959|FG000|COMPLETED|Overall Study||42
3293969|NCT02876055|4027960|FG001|COMPLETED|Overall Study||41
3293970|NCT02876055|4027961|FG002|COMPLETED|Overall Study||42
3293971|NCT02876055|4027959|FG000|NOT COMPLETED|Overall Study||0
3293972|NCT02876055|4027960|FG001|NOT COMPLETED|Overall Study||0
3293973|NCT02876055|4027961|FG002|NOT COMPLETED|Overall Study||0
3293974|NCT02876159|4027971|FG000|STARTED|Overall Study||10
3293975|NCT02876159|4027972|FG001|STARTED|Overall Study||10
3293976|NCT02876159|4027971|FG000|COMPLETED|Overall Study||10
3293977|NCT02876159|4027972|FG001|COMPLETED|Overall Study||10
3293978|NCT02876159|4027971|FG000|NOT COMPLETED|Overall Study||0
3293979|NCT02876159|4027972|FG001|NOT COMPLETED|Overall Study||0
3293980|NCT02876575|4027981|FG000|STARTED|Overall Study||48
3293981|NCT02876575|4027981|FG000|COMPLETED|Overall Study||48
3293982|NCT02876575|4027981|FG000|NOT COMPLETED|Overall Study||0
3293983|NCT02876601|4027990|FG000|STARTED|First Intervention (24 Hours)||8
3293984|NCT02876601|4027991|FG001|STARTED|First Intervention (24 Hours)||8
3293985|NCT02876601|4027992|FG002|STARTED|First Intervention (24 Hours)||2
3293986|NCT02876601|4027993|FG003|STARTED|First Intervention (24 Hours)||2
3293987|NCT02876601|4027990|FG000|COMPLETED|First Intervention (24 Hours)||8
3293988|NCT02876601|4027991|FG001|COMPLETED|First Intervention (24 Hours)||8
3293989|NCT02876601|4027992|FG002|COMPLETED|First Intervention (24 Hours)||2
3293990|NCT02876601|4027993|FG003|COMPLETED|First Intervention (24 Hours)||2
3293991|NCT02876601|4027990|FG000|NOT COMPLETED|First Intervention (24 Hours)||0
3293992|NCT02876601|4027991|FG001|NOT COMPLETED|First Intervention (24 Hours)||0
3293993|NCT02876601|4027992|FG002|NOT COMPLETED|First Intervention (24 Hours)||0
3293994|NCT02876601|4027993|FG003|NOT COMPLETED|First Intervention (24 Hours)||0
3293995|NCT02876601|4027990|FG000|STARTED|Washout (Minimum of 6 Weeks)||8
3293996|NCT02876601|4027991|FG001|STARTED|Washout (Minimum of 6 Weeks)||8
3293997|NCT02876601|4027992|FG002|STARTED|Washout (Minimum of 6 Weeks)||2
3293998|NCT02876601|4027993|FG003|STARTED|Washout (Minimum of 6 Weeks)||2
3293999|NCT02876601|4027990|FG000|COMPLETED|Washout (Minimum of 6 Weeks)||8
3294000|NCT02876601|4027991|FG001|COMPLETED|Washout (Minimum of 6 Weeks)||8
3294001|NCT02876601|4027992|FG002|COMPLETED|Washout (Minimum of 6 Weeks)||1
3294002|NCT02876601|4027993|FG003|COMPLETED|Washout (Minimum of 6 Weeks)||2
3294003|NCT02876601|4027990|FG000|NOT COMPLETED|Washout (Minimum of 6 Weeks)||0
3294004|NCT02876601|4027991|FG001|NOT COMPLETED|Washout (Minimum of 6 Weeks)||0
3113985|NCT01584843|3838553|FG002|NOT COMPLETED|Second Treatment Period||0
3113986|NCT01584843|3838554|FG003|NOT COMPLETED|Second Treatment Period||0
3113987|NCT01584843|3838555|FG004|NOT COMPLETED|Second Treatment Period||0
3113988|NCT01584843|3838556|FG005|NOT COMPLETED|Second Treatment Period||1
3113989|NCT01585025|3838575|FG000|STARTED|Overall Study||10
3113990|NCT01585025|3838576|FG001|STARTED|Overall Study||13
3113991|NCT01585025|3838577|FG002|STARTED|Overall Study||12
3113992|NCT01585025|3838575|FG000|COMPLETED|Overall Study||10
3113993|NCT01585025|3838576|FG001|COMPLETED|Overall Study||10
3113994|NCT01585025|3838577|FG002|COMPLETED|Overall Study||8
3113995|NCT01585025|3838575|FG000|NOT COMPLETED|Overall Study||0
3113996|NCT01585025|3838576|FG001|NOT COMPLETED|Overall Study||3
3113997|NCT01585025|3838577|FG002|NOT COMPLETED|Overall Study||4
3113998|NCT01585038|3838587|FG000|STARTED|Overall Study||20
3113999|NCT01585038|3838588|FG001|STARTED|Overall Study||20
3114000|NCT01585038|3838587|FG000|COMPLETED|Overall Study||18
3114001|NCT01585038|3838588|FG001|COMPLETED|Overall Study||18
3114002|NCT01585038|3838587|FG000|NOT COMPLETED|Overall Study||2
3114003|NCT01585038|3838588|FG001|NOT COMPLETED|Overall Study||2
3114004|NCT01585129|3838596|FG000|STARTED|Overall Study||41
3114005|NCT01585129|3838597|FG001|STARTED|Overall Study||39
3114006|NCT01585129|3838596|FG000|COMPLETED|Overall Study||41
3114007|NCT01585129|3838597|FG001|COMPLETED|Overall Study||39
3114008|NCT01585129|3838596|FG000|NOT COMPLETED|Overall Study||0
3114009|NCT01585129|3838597|FG001|NOT COMPLETED|Overall Study||0
3114010|NCT01585155|3838603|FG000|STARTED|Overall Study||21
3114011|NCT01585155|3838603|FG000|COMPLETED|Overall Study||16
3114012|NCT01585155|3838603|FG000|NOT COMPLETED|Overall Study||5
3114013|NCT01585168|3838609|FG000|STARTED|Overall Study||18
3114014|NCT01585168|3838610|FG001|STARTED|Overall Study||18
3114015|NCT01585168|3838611|FG002|STARTED|Overall Study||16
3114016|NCT01585168|3838612|FG003|STARTED|Overall Study||19
3114017|NCT01585168|3838609|FG000|COMPLETED|Overall Study||15
3114018|NCT01585168|3838610|FG001|COMPLETED|Overall Study||17
3114019|NCT01585168|3838611|FG002|COMPLETED|Overall Study||15
3114020|NCT01585168|3838612|FG003|COMPLETED|Overall Study||18
3114021|NCT01585168|3838609|FG000|NOT COMPLETED|Overall Study||3
3114022|NCT01585168|3838610|FG001|NOT COMPLETED|Overall Study||1
3114023|NCT01585168|3838611|FG002|NOT COMPLETED|Overall Study||1
3114024|NCT01585168|3838612|FG003|NOT COMPLETED|Overall Study||1
3114025|NCT01585194|3838620|FG000|STARTED|Overall Study||39
3114026|NCT01585194|3838620|FG000|COMPLETED|Overall Study||35
3114027|NCT01585194|3838620|FG000|NOT COMPLETED|Overall Study||4
3114028|NCT01585207|3838624|FG000|STARTED|Overall Study||4
3114029|NCT01585207|3838624|FG000|COMPLETED|Overall Study||4
3114030|NCT01585207|3838624|FG000|NOT COMPLETED|Overall Study||0
3114031|NCT01585246|3838633|FG000|STARTED|Overall Study||3
3114032|NCT01585246|3838634|FG001|STARTED|Overall Study||4
3114033|NCT01585246|3838635|FG002|STARTED|Overall Study||20
3114034|NCT01585246|3838636|FG003|STARTED|Overall Study||10
3114035|NCT01585246|3838637|FG004|STARTED|Overall Study||11
3114036|NCT01585246|3838633|FG000|COMPLETED|Overall Study||3
3114037|NCT01585246|3838634|FG001|COMPLETED|Overall Study||3
3114038|NCT01585246|3838635|FG002|COMPLETED|Overall Study||16
3114039|NCT01585246|3838636|FG003|COMPLETED|Overall Study||6
3114040|NCT01585246|3838637|FG004|COMPLETED|Overall Study||9
3114041|NCT01585246|3838633|FG000|NOT COMPLETED|Overall Study||0
3114042|NCT01585246|3838634|FG001|NOT COMPLETED|Overall Study||1
3114043|NCT01585246|3838635|FG002|NOT COMPLETED|Overall Study||4
3114044|NCT01585246|3838636|FG003|NOT COMPLETED|Overall Study||4
3114045|NCT01585246|3838637|FG004|NOT COMPLETED|Overall Study||2
3114046|NCT01585272|3838652|FG000|STARTED|Overall Study||121
3114047|NCT01585272|3838652|FG000|Safety Set|Overall Study|Subjects received 3 mg bid Exelon caps for more than 4 weeks & used at least 1 dose of Exelon patch.|102
3114048|NCT01585272|3838652|FG000|Exelon Patch 5 cm2|Overall Study||114
3114049|NCT01585272|3838652|FG000|Exelon Patch 10 cm2|Overall Study||96
3114050|NCT01585272|3838652|FG000|COMPLETED|Overall Study||82
3114051|NCT01585272|3838652|FG000|NOT COMPLETED|Overall Study||39
3114052|NCT01585298|3838656|FG000|STARTED|Overall Study||6998
3114053|NCT01585298|3838656|FG000|COMPLETED|Overall Study||6961
3114054|NCT01585298|3838656|FG000|NOT COMPLETED|Overall Study||37
3114055|NCT01585324|3838660|FG000|STARTED|Overall Study||30
3114056|NCT01585324|3838660|FG000|COMPLETED|Overall Study||30
3114057|NCT01585324|3838660|FG000|NOT COMPLETED|Overall Study||0
3114058|NCT01585428|3838668|FG000|STARTED|Overall Study||18
3114059|NCT01585428|3838669|FG001|STARTED|Overall Study||11
3114060|NCT01585428|3838668|FG000|COMPLETED|Overall Study||17
3114061|NCT01585428|3838669|FG001|COMPLETED|Overall Study||11
3114062|NCT01585428|3838668|FG000|NOT COMPLETED|Overall Study||1
3114063|NCT01585428|3838669|FG001|NOT COMPLETED|Overall Study||0
3114064|NCT01585441|3838678|FG000|STARTED|Overall Study||3
3114065|NCT01585441|3838679|FG001|STARTED|Overall Study||3
3114066|NCT01585441|3838678|FG000|Month 3|Overall Study|One participant was not evaluated at Month 3 but at the final visit due to study terminating early.|2
3114067|NCT01585441|3838679|FG001|Month 3|Overall Study||3
3114068|NCT01585441|3838678|FG000|Received Finasteride at Month 3|Overall Study||2
3114069|NCT01585441|3838679|FG001|Received Finasteride at Month 3|Overall Study||2
3114070|NCT01585441|3838678|FG000|Final Study Safety Visit|Overall Study||3
3114071|NCT01585441|3838679|FG001|Final Study Safety Visit|Overall Study|A final study visit was not required for the placebo participant who completed the study at Month 3.|2
3114072|NCT01585441|3838678|FG000|COMPLETED|Overall Study|Defined as completing the Month 3 masked phase of the study and/or the final safety visit|3
3114073|NCT01585441|3838679|FG001|COMPLETED|Overall Study|Defined as completing the Month 3 masked phase of the study and/or the final safety visit|3
3114074|NCT01585441|3838678|FG000|NOT COMPLETED|Overall Study||0
3114075|NCT01585441|3838679|FG001|NOT COMPLETED|Overall Study||0
3114076|NCT01585558|3838688|FG000|STARTED|Overall Study||62
3114077|NCT01585558|3838689|FG001|STARTED|Overall Study||69
3114078|NCT01585558|3838690|FG002|STARTED|Overall Study||49
3114079|NCT01585558|3838688|FG000|COMPLETED|Overall Study||49
3114080|NCT01585558|3838689|FG001|COMPLETED|Overall Study||57
3114081|NCT01585558|3838690|FG002|COMPLETED|Overall Study||34
3114082|NCT01585558|3838688|FG000|NOT COMPLETED|Overall Study||13
3114083|NCT01585558|3838689|FG001|NOT COMPLETED|Overall Study||12
3114084|NCT01585558|3838690|FG002|NOT COMPLETED|Overall Study||15
3114085|NCT01585584|3838698|FG000|STARTED|Overall Study||10
3114086|NCT01585584|3838698|FG000|COMPLETED|Overall Study||6
3114087|NCT01585584|3838698|FG000|NOT COMPLETED|Overall Study||4
3114088|NCT01585597|3838702|FG000|STARTED|Overall Study||20
3114089|NCT01585597|3838702|FG000|COMPLETED|Overall Study||20
3114090|NCT01585597|3838702|FG000|NOT COMPLETED|Overall Study||0
3114091|NCT01585766|3838712|FG000|STARTED|Overall Study||7
3114092|NCT01585766|3838713|FG001|STARTED|Overall Study||5
3114093|NCT01585766|3838714|FG002|STARTED|Overall Study||3
3114094|NCT01585766|3838715|FG003|STARTED|Overall Study||4
3114095|NCT01585766|3838716|FG004|STARTED|Overall Study||3
3114096|NCT01585766|3838717|FG005|STARTED|Overall Study||6
3114097|NCT01585766|3838712|FG000|COMPLETED|Overall Study||7
3114098|NCT01585766|3838713|FG001|COMPLETED|Overall Study||3
3114099|NCT01585766|3838714|FG002|COMPLETED|Overall Study||1
3114100|NCT01585766|3838715|FG003|COMPLETED|Overall Study||4
3114101|NCT01585766|3838716|FG004|COMPLETED|Overall Study||3
3114102|NCT01585766|3838717|FG005|COMPLETED|Overall Study||6
3114103|NCT01585766|3838712|FG000|NOT COMPLETED|Overall Study||0
3114104|NCT01585766|3838713|FG001|NOT COMPLETED|Overall Study||2
3114105|NCT01585766|3838714|FG002|NOT COMPLETED|Overall Study||2
3114106|NCT01585766|3838715|FG003|NOT COMPLETED|Overall Study||0
3114107|NCT01585766|3838716|FG004|NOT COMPLETED|Overall Study||0
3114108|NCT01585766|3838717|FG005|NOT COMPLETED|Overall Study||0
3114109|NCT01585779|3838740|FG000|STARTED|Overall Study||36
3114110|NCT01585779|3838741|FG001|STARTED|Overall Study||28
3114111|NCT01585779|3838740|FG000|COMPLETED|Overall Study||26
3114112|NCT01585779|3838741|FG001|COMPLETED|Overall Study||21
3114113|NCT01585779|3838740|FG000|NOT COMPLETED|Overall Study||10
3114114|NCT01585779|3838741|FG001|NOT COMPLETED|Overall Study||7
3114115|NCT01585831|3838750|FG000|STARTED|Overall Study||28
3114116|NCT01585831|3838751|FG001|STARTED|Overall Study||20
3114117|NCT01585831|3838750|FG000|COMPLETED|Overall Study||26
3114118|NCT01585831|3838751|FG001|COMPLETED|Overall Study||18
3114119|NCT01585831|3838750|FG000|NOT COMPLETED|Overall Study||2
3114120|NCT01585831|3838751|FG001|NOT COMPLETED|Overall Study||2
3114121|NCT01585961|3838757|FG000|STARTED|Overall Study||511
3114122|NCT01585961|3838757|FG000|Safety|Overall Study|Patients ablated with study catheter|508
3114123|NCT01585961|3838757|FG000|COMPLETED|Overall Study||478
3114124|NCT01585961|3838757|FG000|NOT COMPLETED|Overall Study||33
3114125|NCT01585987|3838763|FG000|STARTED|Randomized||57
3114126|NCT01585987|3838764|FG001|STARTED|Randomized||57
3114127|NCT01585987|3838763|FG000|COMPLETED|Randomized||57
3114128|NCT01585987|3838764|FG001|COMPLETED|Randomized||51
3114129|NCT01585987|3838763|FG000|NOT COMPLETED|Randomized||0
3114130|NCT01585987|3838764|FG001|NOT COMPLETED|Randomized||6
3114131|NCT01585987|3838763|FG000|STARTED|Treated||57
3114132|NCT01585987|3838764|FG001|STARTED|Treated||51
3114133|NCT01585987|3838763|FG000|COMPLETED|Treated||3
3114134|NCT01585987|3838764|FG001|COMPLETED|Treated||2
3114135|NCT01585987|3838763|FG000|NOT COMPLETED|Treated||54
3114136|NCT01585987|3838764|FG001|NOT COMPLETED|Treated||49
3114137|NCT01586026|3838771|FG000|STARTED|Overall Study||350
3114138|NCT01586026|3838772|FG001|STARTED|Overall Study||414
3114139|NCT01586026|3838773|FG002|STARTED|Overall Study||271
3114140|NCT01586026|3838771|FG000|COMPLETED|Overall Study||350
3114141|NCT01586026|3838772|FG001|COMPLETED|Overall Study||414
3114142|NCT01586026|3838773|FG002|COMPLETED|Overall Study||271
3114143|NCT01586026|3838771|FG000|NOT COMPLETED|Overall Study||0
3114144|NCT01586026|3838772|FG001|NOT COMPLETED|Overall Study||0
3114145|NCT01586026|3838773|FG002|NOT COMPLETED|Overall Study||0
3114146|NCT01586039|3838785|FG000|STARTED|Overall Study||8
3114147|NCT01586039|3838786|FG001|STARTED|Overall Study||9
3114148|NCT01586039|3838787|FG002|STARTED|Overall Study||8
3114149|NCT01586039|3838788|FG003|STARTED|Overall Study||8
3114150|NCT01586039|3838785|FG000|COMPLETED|Overall Study||8
3114151|NCT01586039|3838786|FG001|COMPLETED|Overall Study||8
3114152|NCT01586039|3838787|FG002|COMPLETED|Overall Study||8
3114153|NCT01586039|3838788|FG003|COMPLETED|Overall Study||8
3114154|NCT01586039|3838785|FG000|NOT COMPLETED|Overall Study||0
3114155|NCT01586039|3838786|FG001|NOT COMPLETED|Overall Study||1
3114156|NCT01586039|3838787|FG002|NOT COMPLETED|Overall Study||0
3114157|NCT01586039|3838788|FG003|NOT COMPLETED|Overall Study||0
3114158|NCT01586091|3838801|FG000|STARTED|Overall Study|9 Caucasian and 9 Asian participants, each received Levocetiricine, fexofenadine and Placebo.|6
3114159|NCT01586091|3838802|FG001|STARTED|Overall Study|9 Caucasian and 9 Asian participants, each received Levocetiricine, fexofenadine and Placebo.|6
3114160|NCT01586091|3838803|FG002|STARTED|Overall Study||6
3114161|NCT01586091|3838801|FG000|COMPLETED|Overall Study|9 Caucasian and 9 Asian participants, each received Levocetiricine, fexofenadine and Placebo.|6
3135970|NCT01709786|3861062|FG000|COMPLETED|Overall Study||88
3114162|NCT01586091|3838802|FG001|COMPLETED|Overall Study|9 Caucasian and 9 Asian participants, each received Levocetiricine, fexofenadine and Placebo.|6
3114163|NCT01586091|3838803|FG002|COMPLETED|Overall Study||6
3114164|NCT01586091|3838801|FG000|NOT COMPLETED|Overall Study||0
3114165|NCT01586091|3838802|FG001|NOT COMPLETED|Overall Study||0
3114166|NCT01586091|3838803|FG002|NOT COMPLETED|Overall Study||0
3114167|NCT01586156|3838817|FG000|STARTED|Overall Study||10
3114168|NCT01586156|3838818|FG001|STARTED|Overall Study||10
3114169|NCT01586156|3838819|FG002|STARTED|Overall Study||10
3114170|NCT01586156|3838817|FG000|COMPLETED|Overall Study||10
3114171|NCT01586156|3838818|FG001|COMPLETED|Overall Study||9
3114172|NCT01586156|3838819|FG002|COMPLETED|Overall Study||10
3114173|NCT01586156|3838817|FG000|NOT COMPLETED|Overall Study||0
3114174|NCT01586156|3838818|FG001|NOT COMPLETED|Overall Study||1
3114175|NCT01586156|3838819|FG002|NOT COMPLETED|Overall Study||0
3114176|NCT01586195|3838827|FG000|STARTED|Overall Study||31
3114177|NCT01586195|3838827|FG000|COMPLETED|Overall Study||5
3114178|NCT01586195|3838827|FG000|NOT COMPLETED|Overall Study||26
3114179|NCT01586312|3838833|FG000|STARTED|Overall Study||15
3114180|NCT01586312|3838834|FG001|STARTED|Overall Study||15
3114181|NCT01586312|3838833|FG000|COMPLETED|Overall Study||15
3114182|NCT01586312|3838834|FG001|COMPLETED|Overall Study||15
3114183|NCT01586312|3838833|FG000|NOT COMPLETED|Overall Study||0
3114184|NCT01586312|3838834|FG001|NOT COMPLETED|Overall Study||0
3114185|NCT01586338|3838840|FG000|STARTED|Overall Study||237
3114186|NCT01586338|3838840|FG000|COMPLETED|Overall Study||229
3114187|NCT01586338|3838840|FG000|NOT COMPLETED|Overall Study||8
3114188|NCT01586364|3838844|FG000|STARTED|Overall Study||301
3114189|NCT01586364|3838844|FG000|COMPLETED|Overall Study||184
3114190|NCT01586364|3838844|FG000|NOT COMPLETED|Overall Study||117
3114191|NCT01586624|3838856|FG000|STARTED|Overall Study||6
3114192|NCT01586624|3838857|FG001|STARTED|Overall Study||6
3114193|NCT01586624|3838858|FG002|STARTED|Overall Study||6
3114194|NCT01586624|3838859|FG003|STARTED|Overall Study||7
3114195|NCT01586624|3838860|FG004|STARTED|Overall Study||9
3114196|NCT01586624|3838861|FG005|STARTED|Overall Study||8
3114197|NCT01586624|3838862|FG006|STARTED|Overall Study||8
3114198|NCT01586624|3838863|FG007|STARTED|Overall Study||11
3114199|NCT01586624|3838856|FG000|COMPLETED|Overall Study||2
3114200|NCT01586624|3838857|FG001|COMPLETED|Overall Study||2
3114201|NCT01586624|3838858|FG002|COMPLETED|Overall Study||1
3114202|NCT01586624|3838859|FG003|COMPLETED|Overall Study||0
3114203|NCT01586624|3838860|FG004|COMPLETED|Overall Study||1
3114204|NCT01586624|3838861|FG005|COMPLETED|Overall Study||0
3114205|NCT01586624|3838862|FG006|COMPLETED|Overall Study||0
3114206|NCT01586624|3838863|FG007|COMPLETED|Overall Study||1
3114207|NCT01586624|3838856|FG000|NOT COMPLETED|Overall Study||4
3114208|NCT01586624|3838857|FG001|NOT COMPLETED|Overall Study||4
3114209|NCT01586624|3838858|FG002|NOT COMPLETED|Overall Study||5
3114210|NCT01586624|3838859|FG003|NOT COMPLETED|Overall Study||7
3114211|NCT01586624|3838860|FG004|NOT COMPLETED|Overall Study||8
3114212|NCT01586624|3838861|FG005|NOT COMPLETED|Overall Study||8
3114213|NCT01586624|3838862|FG006|NOT COMPLETED|Overall Study||8
3114214|NCT01586624|3838863|FG007|NOT COMPLETED|Overall Study||10
3114215|NCT01586741|3838885|FG000|STARTED|Overall Study||28
3114216|NCT01586741|3838886|FG001|STARTED|Overall Study||29
3114217|NCT01586741|3838887|FG002|STARTED|Overall Study||32
3114218|NCT01586741|3838885|FG000|COMPLETED|Overall Study||27
3114219|NCT01586741|3838886|FG001|COMPLETED|Overall Study||29
3114220|NCT01586741|3838887|FG002|COMPLETED|Overall Study||30
3114221|NCT01586741|3838885|FG000|NOT COMPLETED|Overall Study||1
3114222|NCT01586741|3838886|FG001|NOT COMPLETED|Overall Study||0
3114223|NCT01586741|3838887|FG002|NOT COMPLETED|Overall Study||2
3114224|NCT01586806|3838898|FG000|STARTED|Overall Study||65
3114225|NCT01586806|3838899|FG001|STARTED|Overall Study||65
3114226|NCT01586806|3838900|FG002|STARTED|Overall Study||65
3114227|NCT01586806|3838898|FG000|COMPLETED|Overall Study||62
3114228|NCT01586806|3838899|FG001|COMPLETED|Overall Study||61
3114229|NCT01586806|3838900|FG002|COMPLETED|Overall Study||63
3114230|NCT01586806|3838898|FG000|NOT COMPLETED|Overall Study||3
3114231|NCT01586806|3838899|FG001|NOT COMPLETED|Overall Study||4
3114232|NCT01586806|3838900|FG002|NOT COMPLETED|Overall Study||2
3114233|NCT01586819|3838910|FG000|STARTED|Overall Study||12
3114234|NCT01586819|3838911|FG001|STARTED|Overall Study||14
3114235|NCT01586819|3838910|FG000|COMPLETED|Overall Study||11
3114236|NCT01586819|3838911|FG001|COMPLETED|Overall Study||14
3114237|NCT01586819|3838910|FG000|NOT COMPLETED|Overall Study||1
3114238|NCT01586819|3838911|FG001|NOT COMPLETED|Overall Study||0
3114239|NCT01586871|3838920|FG000|STARTED|Overall Study||560
3114240|NCT01586871|3838921|FG001|STARTED|Overall Study||554
3114241|NCT01586871|3838922|FG002|STARTED|Overall Study||33
3114242|NCT01586871|3838920|FG000|COMPLETED|Overall Study||560
3114243|NCT01586871|3838921|FG001|COMPLETED|Overall Study||554
3114244|NCT01586871|3838922|FG002|COMPLETED|Overall Study||33
3114245|NCT01586871|3838920|FG000|NOT COMPLETED|Overall Study||0
3114246|NCT01586871|3838921|FG001|NOT COMPLETED|Overall Study||0
3114247|NCT01586871|3838922|FG002|NOT COMPLETED|Overall Study||0
3114248|NCT01586897|3838932|FG000|STARTED|Overall Study||26
3114249|NCT01586897|3838933|FG001|STARTED|Overall Study||26
3114250|NCT01586897|3838932|FG000|COMPLETED|Overall Study||26
3114251|NCT01586897|3838933|FG001|COMPLETED|Overall Study||26
3114252|NCT01586897|3838932|FG000|NOT COMPLETED|Overall Study||0
3114253|NCT01586897|3838933|FG001|NOT COMPLETED|Overall Study||0
3114254|NCT01586910|3838943|FG000|STARTED|Overall Study||879
3114255|NCT01586910|3838944|FG001|STARTED|Overall Study||867
3114256|NCT01586910|3838943|FG000|COMPLETED|Overall Study||864
3114257|NCT01586910|3838944|FG001|COMPLETED|Overall Study||796
3114258|NCT01586910|3838943|FG000|NOT COMPLETED|Overall Study||15
3114259|NCT01586910|3838944|FG001|NOT COMPLETED|Overall Study||71
3114260|NCT01586962|3838952|FG000|STARTED|Overall Study||56
3114261|NCT01586962|3838952|FG000|COMPLETED|Overall Study||56
3114262|NCT01586962|3838952|FG000|NOT COMPLETED|Overall Study||0
3114263|NCT01586975|3838959|FG000|STARTED|Overall Study||15
3114264|NCT01586975|3838960|FG001|STARTED|Overall Study||32
3114265|NCT01586975|3838961|FG002|STARTED|Overall Study||46
3114266|NCT01586975|3838959|FG000|COMPLETED|Overall Study||15
3114267|NCT01586975|3838960|FG001|COMPLETED|Overall Study||32
3114268|NCT01586975|3838961|FG002|COMPLETED|Overall Study||46
3114269|NCT01586975|3838959|FG000|NOT COMPLETED|Overall Study||0
3114270|NCT01586975|3838960|FG001|NOT COMPLETED|Overall Study||0
3114271|NCT01586975|3838961|FG002|NOT COMPLETED|Overall Study||0
3114272|NCT01587001|3838971|FG000|STARTED|Overall Study||14
3114273|NCT01587001|3838972|FG001|STARTED|Overall Study||3
3114274|NCT01587001|3838971|FG000|COMPLETED|Overall Study||8
3114275|NCT01587001|3838972|FG001|COMPLETED|Overall Study||2
3114276|NCT01587001|3838971|FG000|NOT COMPLETED|Overall Study||6
3114277|NCT01587001|3838972|FG001|NOT COMPLETED|Overall Study||1
3114278|NCT01587014|3838979|FG000|STARTED|Overall Study||26
3114279|NCT01587014|3838979|FG000|COMPLETED|Overall Study||24
3114280|NCT01587014|3838979|FG000|NOT COMPLETED|Overall Study||2
3114281|NCT01587027|3838985|FG000|STARTED|First Intervention (1 Day)||8
3114282|NCT01587027|3838986|FG001|STARTED|First Intervention (1 Day)||8
3114283|NCT01587027|3838985|FG000|COMPLETED|First Intervention (1 Day)||8
3114284|NCT01587027|3838986|FG001|COMPLETED|First Intervention (1 Day)||8
3114285|NCT01587027|3838985|FG000|NOT COMPLETED|First Intervention (1 Day)||0
3114286|NCT01587027|3838986|FG001|NOT COMPLETED|First Intervention (1 Day)||0
3114287|NCT01587027|3838985|FG000|STARTED|Washout (1 Day)||8
3114288|NCT01587027|3838986|FG001|STARTED|Washout (1 Day)||8
3114289|NCT01587027|3838985|FG000|COMPLETED|Washout (1 Day)||8
3114290|NCT01587027|3838986|FG001|COMPLETED|Washout (1 Day)||8
3114291|NCT01587027|3838985|FG000|NOT COMPLETED|Washout (1 Day)||0
3114292|NCT01587027|3838986|FG001|NOT COMPLETED|Washout (1 Day)||0
3114293|NCT01587027|3838985|FG000|STARTED|Second Intervention (1 Day)||8
3114294|NCT01587027|3838986|FG001|STARTED|Second Intervention (1 Day)||8
3114295|NCT01587027|3838985|FG000|COMPLETED|Second Intervention (1 Day)||8
3114296|NCT01587027|3838986|FG001|COMPLETED|Second Intervention (1 Day)||8
3114297|NCT01587027|3838985|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
3114298|NCT01587027|3838986|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
3114299|NCT01587027|3838985|FG000|STARTED|Washout (1 Day)||8
3114300|NCT01587027|3838986|FG001|STARTED|Washout (1 Day)||8
3114301|NCT01587027|3838985|FG000|COMPLETED|Washout (1 Day)||8
3114302|NCT01587027|3838986|FG001|COMPLETED|Washout (1 Day)||8
3114303|NCT01587027|3838985|FG000|NOT COMPLETED|Washout (1 Day)||0
3114304|NCT01587027|3838986|FG001|NOT COMPLETED|Washout (1 Day)||0
3114305|NCT01587027|3838985|FG000|STARTED|Third Intervention (1 Day)||8
3114306|NCT01587027|3838986|FG001|STARTED|Third Intervention (1 Day)||8
3114307|NCT01587027|3838985|FG000|COMPLETED|Third Intervention (1 Day)||8
3114308|NCT01587027|3838986|FG001|COMPLETED|Third Intervention (1 Day)||8
3114309|NCT01587027|3838985|FG000|NOT COMPLETED|Third Intervention (1 Day)||0
3114310|NCT01587027|3838986|FG001|NOT COMPLETED|Third Intervention (1 Day)||0
3114311|NCT01587027|3838985|FG000|STARTED|Discharge (1 Day)||8
3114312|NCT01587027|3838986|FG001|STARTED|Discharge (1 Day)||8
3114313|NCT01587027|3838985|FG000|COMPLETED|Discharge (1 Day)||8
3114314|NCT01587027|3838986|FG001|COMPLETED|Discharge (1 Day)||8
3114315|NCT01587027|3838985|FG000|NOT COMPLETED|Discharge (1 Day)||0
3114316|NCT01587027|3838986|FG001|NOT COMPLETED|Discharge (1 Day)||0
3114317|NCT01587040|3838996|FG000|STARTED|Overall Study||17
3114318|NCT01587040|3838997|FG001|STARTED|Overall Study||3
3114319|NCT01587040|3838998|FG002|STARTED|Overall Study||37
3114320|NCT01587040|3838999|FG003|STARTED|Overall Study||4
3114321|NCT01587040|3838996|FG000|COMPLETED|Overall Study||0
3114322|NCT01587040|3838997|FG001|COMPLETED|Overall Study||0
3114323|NCT01587040|3838998|FG002|COMPLETED|Overall Study||0
3114324|NCT01587040|3838999|FG003|COMPLETED|Overall Study||0
3114325|NCT01587040|3838996|FG000|NOT COMPLETED|Overall Study||17
3114326|NCT01587040|3838997|FG001|NOT COMPLETED|Overall Study||3
3114327|NCT01587040|3838998|FG002|NOT COMPLETED|Overall Study||37
3114328|NCT01587040|3838999|FG003|NOT COMPLETED|Overall Study||4
3114329|NCT01587079|3839009|FG000|STARTED|Overall Study||159
3114330|NCT01587079|3839009|FG000|COMPLETED|Overall Study||120
3114331|NCT01587079|3839009|FG000|NOT COMPLETED|Overall Study||39
3114332|NCT01587105|3839045|FG000|STARTED|Overall Study||150
3114333|NCT01587105|3839046|FG001|STARTED|Overall Study||181
3114334|NCT01587105|3839045|FG000|COMPLETED|Overall Study||144
3114335|NCT01587105|3839046|FG001|COMPLETED|Overall Study||138
3114336|NCT01587105|3839045|FG000|NOT COMPLETED|Overall Study||6
3114337|NCT01587105|3839046|FG001|NOT COMPLETED|Overall Study||43
3114338|NCT01587118|3839052|FG000|STARTED|Overall Study|31 signed consent and 18 were deemed eligible and initiated treatment with adjunctive asenapine.|18
3114339|NCT01587118|3839052|FG000|COMPLETED|Overall Study||11
3114340|NCT01587118|3839052|FG000|NOT COMPLETED|Overall Study||7
3114341|NCT01587274|3839059|FG000|STARTED|Overall Study||108
3114342|NCT01587274|3839060|FG001|STARTED|Overall Study||108
3114343|NCT01587274|3839061|FG002|STARTED|Overall Study||107
3114344|NCT01587274|3839059|FG000|COMPLETED|Overall Study||104
3114345|NCT01587274|3839060|FG001|COMPLETED|Overall Study||103
3114346|NCT01587274|3839061|FG002|COMPLETED|Overall Study||104
3114347|NCT01587274|3839059|FG000|NOT COMPLETED|Overall Study||4
3114348|NCT01587274|3839060|FG001|NOT COMPLETED|Overall Study||5
3114349|NCT01587274|3839061|FG002|NOT COMPLETED|Overall Study||3
3114350|NCT01587651|3839072|FG000|STARTED|Overall Study||34
3114351|NCT01587651|3839073|FG001|STARTED|Overall Study||41
3114352|NCT01587651|3839074|FG002|STARTED|Overall Study||35
3114353|NCT01587651|3839072|FG000|COMPLETED|Overall Study||34
3114354|NCT01587651|3839073|FG001|COMPLETED|Overall Study||38
3114355|NCT01587651|3839074|FG002|COMPLETED|Overall Study||34
3114356|NCT01587651|3839072|FG000|NOT COMPLETED|Overall Study||0
3114357|NCT01587651|3839073|FG001|NOT COMPLETED|Overall Study||3
3114358|NCT01587651|3839074|FG002|NOT COMPLETED|Overall Study||1
3114359|NCT01587703|3839101|FG000|STARTED|Part1 QD(Median Exposure of 1.38months)||3
3114360|NCT01587703|3839102|FG001|STARTED|Part1 QD(Median Exposure of 1.38months)||4
3114361|NCT01587703|3839103|FG002|STARTED|Part1 QD(Median Exposure of 1.38months)||1
3114362|NCT01587703|3839104|FG003|STARTED|Part1 QD(Median Exposure of 1.38months)||3
3114363|NCT01587703|3839105|FG004|STARTED|Part1 QD(Median Exposure of 1.38months)||4
3114364|NCT01587703|3839106|FG005|STARTED|Part1 QD(Median Exposure of 1.38months)||9
3114365|NCT01587703|3839107|FG006|STARTED|Part1 QD(Median Exposure of 1.38months)||32
3114366|NCT01587703|3839108|FG007|STARTED|Part1 QD(Median Exposure of 1.38months)||9
3114367|NCT01587703|3839109|FG008|STARTED|Part1 QD(Median Exposure of 1.38months)||0
3114368|NCT01587703|3839110|FG009|STARTED|Part1 QD(Median Exposure of 1.38months)||0
3114369|NCT01587703|3839111|FG010|STARTED|Part1 QD(Median Exposure of 1.38months)||0
3114370|NCT01587703|3839112|FG011|STARTED|Part1 QD(Median Exposure of 1.38months)||0
3114371|NCT01587703|3839113|FG012|STARTED|Part1 QD(Median Exposure of 1.38months)||0
3114372|NCT01587703|3839114|FG013|STARTED|Part1 QD(Median Exposure of 1.38months)||0
3114373|NCT01587703|3839115|FG014|STARTED|Part1 QD(Median Exposure of 1.38months)||0
3114374|NCT01587703|3839116|FG015|STARTED|Part1 QD(Median Exposure of 1.38months)||0
3114375|NCT01587703|3839117|FG016|STARTED|Part1 QD(Median Exposure of 1.38months)||0
3114376|NCT01587703|3839118|FG017|STARTED|Part1 QD(Median Exposure of 1.38months)||0
3114377|NCT01587703|3839119|FG018|STARTED|Part1 QD(Median Exposure of 1.38months)||0
3114378|NCT01587703|3839101|FG000|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
3114379|NCT01587703|3839102|FG001|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
3114380|NCT01587703|3839103|FG002|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
3114381|NCT01587703|3839104|FG003|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
3114382|NCT01587703|3839105|FG004|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
3114383|NCT01587703|3839106|FG005|COMPLETED|Part1 QD(Median Exposure of 1.38months)||1
3114384|NCT01587703|3839107|FG006|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
3114385|NCT01587703|3839108|FG007|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
3114386|NCT01587703|3839109|FG008|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
3114387|NCT01587703|3839110|FG009|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
3114388|NCT01587703|3839111|FG010|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
3114389|NCT01587703|3839112|FG011|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
3114390|NCT01587703|3839113|FG012|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
3114391|NCT01587703|3839114|FG013|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
3114392|NCT01587703|3839115|FG014|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
3114393|NCT01587703|3839116|FG015|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
3114394|NCT01587703|3839117|FG016|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
3114395|NCT01587703|3839118|FG017|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
3114396|NCT01587703|3839119|FG018|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
3114397|NCT01587703|3839101|FG000|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||3
3114398|NCT01587703|3839102|FG001|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||4
3294005|NCT02876601|4027992|FG002|NOT COMPLETED|Washout (Minimum of 6 Weeks)||1
3294006|NCT02876601|4027993|FG003|NOT COMPLETED|Washout (Minimum of 6 Weeks)||0
3294007|NCT02876601|4027990|FG000|STARTED|Second Intervention (24 Hours)||8
3294008|NCT02876601|4027991|FG001|STARTED|Second Intervention (24 Hours)||8
3294009|NCT02876601|4027992|FG002|STARTED|Second Intervention (24 Hours)||1
3294010|NCT02876601|4027993|FG003|STARTED|Second Intervention (24 Hours)||2
3294011|NCT02876601|4027990|FG000|COMPLETED|Second Intervention (24 Hours)||8
3294012|NCT02876601|4027991|FG001|COMPLETED|Second Intervention (24 Hours)||8
3294013|NCT02876601|4027992|FG002|COMPLETED|Second Intervention (24 Hours)||1
3294014|NCT02876601|4027993|FG003|COMPLETED|Second Intervention (24 Hours)||2
3294015|NCT02876601|4027990|FG000|NOT COMPLETED|Second Intervention (24 Hours)||0
3294016|NCT02876601|4027991|FG001|NOT COMPLETED|Second Intervention (24 Hours)||0
3294017|NCT02876601|4027992|FG002|NOT COMPLETED|Second Intervention (24 Hours)||0
3294018|NCT02876601|4027993|FG003|NOT COMPLETED|Second Intervention (24 Hours)||0
3294019|NCT02876757|4028040|FG000|STARTED|Overall Study||93197
3294020|NCT02876757|4028041|FG001|STARTED|Overall Study||93197
3294021|NCT02876757|4028040|FG000|COMPLETED|Overall Study||93197
3294022|NCT02876757|4028041|FG001|COMPLETED|Overall Study||93197
3294023|NCT02876757|4028040|FG000|NOT COMPLETED|Overall Study||0
3294024|NCT02876757|4028041|FG001|NOT COMPLETED|Overall Study||0
3294025|NCT02876887|4028049|FG000|STARTED|Overall Study||23
3294026|NCT02876887|4028050|FG001|STARTED|Overall Study||21
3294027|NCT02876887|4028049|FG000|COMPLETED|Overall Study||19
3294028|NCT02876887|4028050|FG001|COMPLETED|Overall Study||21
3294029|NCT02876887|4028049|FG000|NOT COMPLETED|Overall Study||4
3114399|NCT01587703|3839103|FG002|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||1
3114400|NCT01587703|3839104|FG003|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||3
3114401|NCT01587703|3839105|FG004|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||4
3114402|NCT01587703|3839106|FG005|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||8
3114403|NCT01587703|3839107|FG006|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||32
3114404|NCT01587703|3839108|FG007|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||9
3114405|NCT01587703|3839109|FG008|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
3114406|NCT01587703|3839110|FG009|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
3114407|NCT01587703|3839111|FG010|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
3114408|NCT01587703|3839112|FG011|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
3114409|NCT01587703|3839113|FG012|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
3114410|NCT01587703|3839114|FG013|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
3114411|NCT01587703|3839115|FG014|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
3114412|NCT01587703|3839116|FG015|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
3114413|NCT01587703|3839117|FG016|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
3114414|NCT01587703|3839118|FG017|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
3114415|NCT01587703|3839119|FG018|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
3114416|NCT01587703|3839101|FG000|STARTED|Part1 BID(Median Exposure of 1.41months)||0
3114417|NCT01587703|3839102|FG001|STARTED|Part1 BID(Median Exposure of 1.41months)||0
3114418|NCT01587703|3839103|FG002|STARTED|Part1 BID(Median Exposure of 1.41months)||0
3114419|NCT01587703|3839104|FG003|STARTED|Part1 BID(Median Exposure of 1.41months)||0
3114420|NCT01587703|3839105|FG004|STARTED|Part1 BID(Median Exposure of 1.41months)||0
3114421|NCT01587703|3839106|FG005|STARTED|Part1 BID(Median Exposure of 1.41months)||0
3114422|NCT01587703|3839107|FG006|STARTED|Part1 BID(Median Exposure of 1.41months)||0
3114423|NCT01587703|3839108|FG007|STARTED|Part1 BID(Median Exposure of 1.41months)||0
3114424|NCT01587703|3839109|FG008|STARTED|Part1 BID(Median Exposure of 1.41months)||4
3114425|NCT01587703|3839110|FG009|STARTED|Part1 BID(Median Exposure of 1.41months)||10
3114426|NCT01587703|3839111|FG010|STARTED|Part1 BID(Median Exposure of 1.41months)||5
3114427|NCT01587703|3839112|FG011|STARTED|Part1 BID(Median Exposure of 1.41months)||0
3114428|NCT01587703|3839113|FG012|STARTED|Part1 BID(Median Exposure of 1.41months)||0
3114429|NCT01587703|3839114|FG013|STARTED|Part1 BID(Median Exposure of 1.41months)||0
3114430|NCT01587703|3839115|FG014|STARTED|Part1 BID(Median Exposure of 1.41months)||0
3114431|NCT01587703|3839116|FG015|STARTED|Part1 BID(Median Exposure of 1.41months)||0
3294030|NCT02876887|4028050|FG001|NOT COMPLETED|Overall Study||0
3294031|NCT02876900|4028059|FG000|STARTED|Overall Study||205
3294032|NCT02876900|4028060|FG001|STARTED|Overall Study||206
3294033|NCT02876900|4028061|FG002|STARTED|Overall Study||206
3294034|NCT02876900|4028059|FG000|COMPLETED|Overall Study||166
3114432|NCT01587703|3839117|FG016|STARTED|Part1 BID(Median Exposure of 1.41months)||0
3114433|NCT01587703|3839118|FG017|STARTED|Part1 BID(Median Exposure of 1.41months)||0
3114434|NCT01587703|3839119|FG018|STARTED|Part1 BID(Median Exposure of 1.41months)||0
3114435|NCT01587703|3839101|FG000|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
3114436|NCT01587703|3839102|FG001|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
3114437|NCT01587703|3839103|FG002|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
3114438|NCT01587703|3839104|FG003|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
3114439|NCT01587703|3839105|FG004|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
3114440|NCT01587703|3839106|FG005|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
3114441|NCT01587703|3839107|FG006|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
3114442|NCT01587703|3839108|FG007|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
3114443|NCT01587703|3839109|FG008|COMPLETED|Part1 BID(Median Exposure of 1.41months)||1
3114444|NCT01587703|3839110|FG009|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
3114445|NCT01587703|3839111|FG010|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
3114446|NCT01587703|3839112|FG011|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
3114447|NCT01587703|3839113|FG012|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
3114448|NCT01587703|3839114|FG013|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
3114449|NCT01587703|3839115|FG014|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
3114450|NCT01587703|3839116|FG015|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
3114451|NCT01587703|3839117|FG016|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
3114452|NCT01587703|3839118|FG017|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
3114453|NCT01587703|3839119|FG018|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
3114454|NCT01587703|3839101|FG000|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
3114455|NCT01587703|3839102|FG001|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
3114456|NCT01587703|3839103|FG002|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
3114457|NCT01587703|3839104|FG003|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
3114458|NCT01587703|3839105|FG004|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
3114459|NCT01587703|3839106|FG005|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
3114460|NCT01587703|3839107|FG006|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
3114461|NCT01587703|3839108|FG007|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
3114462|NCT01587703|3839109|FG008|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||3
3114463|NCT01587703|3839110|FG009|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||10
3114464|NCT01587703|3839111|FG010|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||5
3294035|NCT02876900|4028060|FG001|COMPLETED|Overall Study||158
3114465|NCT01587703|3839112|FG011|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
3114466|NCT01587703|3839113|FG012|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
3114467|NCT01587703|3839114|FG013|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
3114468|NCT01587703|3839115|FG014|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
3114469|NCT01587703|3839116|FG015|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
3114470|NCT01587703|3839117|FG016|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
3114471|NCT01587703|3839118|FG017|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
3114472|NCT01587703|3839119|FG018|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
3114473|NCT01587703|3839101|FG000|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
3114474|NCT01587703|3839102|FG001|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
3114475|NCT01587703|3839103|FG002|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
3114476|NCT01587703|3839104|FG003|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
3114477|NCT01587703|3839105|FG004|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
3114478|NCT01587703|3839106|FG005|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
3114479|NCT01587703|3839107|FG006|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
3114480|NCT01587703|3839108|FG007|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
3114481|NCT01587703|3839109|FG008|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
3114482|NCT01587703|3839110|FG009|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
3114483|NCT01587703|3839111|FG010|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
3114484|NCT01587703|3839112|FG011|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
3114485|NCT01587703|3839113|FG012|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
3114486|NCT01587703|3839114|FG013|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
3114487|NCT01587703|3839115|FG014|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
3114488|NCT01587703|3839116|FG015|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
3114489|NCT01587703|3839117|FG016|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
3114490|NCT01587703|3839118|FG017|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||5
3114491|NCT01587703|3839119|FG018|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||5
3114492|NCT01587703|3839101|FG000|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
3114493|NCT01587703|3839102|FG001|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
3114494|NCT01587703|3839103|FG002|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
3114495|NCT01587703|3839104|FG003|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
3114496|NCT01587703|3839105|FG004|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
3114497|NCT01587703|3839106|FG005|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
3114498|NCT01587703|3839107|FG006|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
3114499|NCT01587703|3839108|FG007|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
3114500|NCT01587703|3839109|FG008|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
3114501|NCT01587703|3839110|FG009|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
3114502|NCT01587703|3839111|FG010|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
3114503|NCT01587703|3839112|FG011|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
3114504|NCT01587703|3839113|FG012|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
3114505|NCT01587703|3839114|FG013|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
3114506|NCT01587703|3839115|FG014|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
3114507|NCT01587703|3839116|FG015|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
3114508|NCT01587703|3839117|FG016|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
3114509|NCT01587703|3839118|FG017|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||5
3114510|NCT01587703|3839119|FG018|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||5
3114511|NCT01587703|3839101|FG000|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
3114512|NCT01587703|3839102|FG001|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
3114513|NCT01587703|3839103|FG002|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
3114514|NCT01587703|3839104|FG003|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
3114515|NCT01587703|3839105|FG004|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
3114516|NCT01587703|3839106|FG005|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
3114517|NCT01587703|3839107|FG006|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
3114518|NCT01587703|3839108|FG007|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
3114519|NCT01587703|3839109|FG008|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
3114520|NCT01587703|3839110|FG009|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
3114521|NCT01587703|3839111|FG010|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
3114522|NCT01587703|3839112|FG011|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
3114523|NCT01587703|3839113|FG012|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
3114524|NCT01587703|3839114|FG013|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
3114525|NCT01587703|3839115|FG014|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
3114526|NCT01587703|3839116|FG015|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
3114527|NCT01587703|3839117|FG016|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
3114528|NCT01587703|3839118|FG017|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
3114529|NCT01587703|3839119|FG018|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
3114530|NCT01587703|3839101|FG000|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
3114531|NCT01587703|3839102|FG001|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
3114532|NCT01587703|3839103|FG002|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
3114533|NCT01587703|3839104|FG003|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
3114534|NCT01587703|3839105|FG004|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
3114535|NCT01587703|3839106|FG005|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
3114536|NCT01587703|3839107|FG006|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
3114537|NCT01587703|3839108|FG007|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
3114538|NCT01587703|3839109|FG008|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
3114539|NCT01587703|3839110|FG009|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
3114540|NCT01587703|3839111|FG010|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
3114541|NCT01587703|3839112|FG011|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
3114542|NCT01587703|3839113|FG012|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
3114543|NCT01587703|3839114|FG013|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
3114544|NCT01587703|3839115|FG014|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
3114545|NCT01587703|3839116|FG015|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
3114546|NCT01587703|3839117|FG016|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
3114547|NCT01587703|3839118|FG017|STARTED|Substudy-P2, Week1Day3 to Week2Day1||5
3114548|NCT01587703|3839119|FG018|STARTED|Substudy-P2, Week1Day3 to Week2Day1||5
3114549|NCT01587703|3839101|FG000|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
3114550|NCT01587703|3839102|FG001|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
3114551|NCT01587703|3839103|FG002|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
3114552|NCT01587703|3839104|FG003|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
3114553|NCT01587703|3839105|FG004|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
3114554|NCT01587703|3839106|FG005|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
3114555|NCT01587703|3839107|FG006|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
3114556|NCT01587703|3839108|FG007|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
3114557|NCT01587703|3839109|FG008|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
3114558|NCT01587703|3839110|FG009|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
3114559|NCT01587703|3839111|FG010|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
3114560|NCT01587703|3839112|FG011|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
3114561|NCT01587703|3839113|FG012|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
3114562|NCT01587703|3839114|FG013|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
3114563|NCT01587703|3839115|FG014|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
3114564|NCT01587703|3839116|FG015|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
3114565|NCT01587703|3839117|FG016|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
3114566|NCT01587703|3839118|FG017|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||5
3294036|NCT02876900|4028061|FG002|COMPLETED|Overall Study||162
3294037|NCT02876900|4028059|FG000|NOT COMPLETED|Overall Study||39
3294038|NCT02876900|4028060|FG001|NOT COMPLETED|Overall Study||48
3294039|NCT02876900|4028061|FG002|NOT COMPLETED|Overall Study||44
3294040|NCT02876926|4028072|FG000|STARTED|Overall Study||21
3294041|NCT02876926|4028073|FG001|STARTED|Overall Study||22
3294042|NCT02876926|4028074|FG002|STARTED|Overall Study||22
3294043|NCT02876926|4028072|FG000|COMPLETED|Overall Study||3
3294044|NCT02876926|4028073|FG001|COMPLETED|Overall Study||3
3294045|NCT02876926|4028074|FG002|COMPLETED|Overall Study||2
3294046|NCT02876926|4028072|FG000|NOT COMPLETED|Overall Study||18
3294047|NCT02876926|4028073|FG001|NOT COMPLETED|Overall Study||19
3294048|NCT02876926|4028074|FG002|NOT COMPLETED|Overall Study||20
3294049|NCT02877004|4028085|FG000|STARTED|Overall Study||20
3294050|NCT02877004|4028086|FG001|STARTED|Overall Study||20
3294051|NCT02877004|4028087|FG002|STARTED|Overall Study||20
3294052|NCT02877004|4028085|FG000|COMPLETED|Overall Study||20
3294053|NCT02877004|4028086|FG001|COMPLETED|Overall Study||20
3294054|NCT02877004|4028087|FG002|COMPLETED|Overall Study||19
3294055|NCT02877004|4028085|FG000|NOT COMPLETED|Overall Study||0
3294056|NCT02877004|4028086|FG001|NOT COMPLETED|Overall Study||0
3294057|NCT02877004|4028087|FG002|NOT COMPLETED|Overall Study||1
3294058|NCT02877082|4028095|FG000|STARTED|Overall Study||5
3294059|NCT02877082|4028095|FG000|COMPLETED|Overall Study||0
3294060|NCT02877082|4028095|FG000|NOT COMPLETED|Overall Study||5
3294061|NCT02877095|4028101|FG000|STARTED|Overall Study|First patient enrolled 1/9/17.|20
3294062|NCT02877095|4028102|FG001|STARTED|Overall Study||20
3294063|NCT02877095|4028101|FG000|COMPLETED|Overall Study||20
3294064|NCT02877095|4028102|FG001|COMPLETED|Overall Study||20
3294065|NCT02877095|4028101|FG000|NOT COMPLETED|Overall Study||0
3294066|NCT02877095|4028102|FG001|NOT COMPLETED|Overall Study||0
3294067|NCT02877485|4028110|FG000|STARTED|Overall Study||22
3294068|NCT02877485|4028111|FG001|STARTED|Overall Study||20
3294069|NCT02877485|4028110|FG000|COMPLETED|Overall Study||22
3294070|NCT02877485|4028111|FG001|COMPLETED|Overall Study||20
3294071|NCT02877485|4028110|FG000|NOT COMPLETED|Overall Study||0
3294072|NCT02877485|4028111|FG001|NOT COMPLETED|Overall Study||0
3294073|NCT02877680|4028120|FG000|STARTED|Overall Study||55
3294074|NCT02877680|4028121|FG001|STARTED|Overall Study||25
3294075|NCT02877680|4028120|FG000|COMPLETED|Overall Study||54
3294076|NCT02877680|4028121|FG001|COMPLETED|Overall Study||24
3294077|NCT02877680|4028120|FG000|NOT COMPLETED|Overall Study||1
3294078|NCT02877680|4028121|FG001|NOT COMPLETED|Overall Study||1
3294079|NCT02877927|4028133|FG000|STARTED|Overall Study||368
3294080|NCT02877927|4028134|FG001|STARTED|Overall Study||367
3294081|NCT02877927|4028133|FG000|COMPLETED|Overall Study||314
3294082|NCT02877927|4028134|FG001|COMPLETED|Overall Study||310
3294083|NCT02877927|4028133|FG000|NOT COMPLETED|Overall Study||54
3294084|NCT02877927|4028134|FG001|NOT COMPLETED|Overall Study||57
3294085|NCT02878057|4028140|FG000|STARTED|Overall Study||30
3294086|NCT02878057|4028140|FG000|COMPLETED|Overall Study||26
3294087|NCT02878057|4028140|FG000|NOT COMPLETED|Overall Study||4
3294088|NCT02878213|4028144|FG000|STARTED|Overall Study||39
3294089|NCT02878213|4028144|FG000|COMPLETED|Overall Study||36
3294090|NCT02878213|4028144|FG000|NOT COMPLETED|Overall Study||3
3114567|NCT01587703|3839119|FG018|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||5
3114568|NCT01587703|3839101|FG000|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
3114569|NCT01587703|3839102|FG001|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
3114570|NCT01587703|3839103|FG002|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
3114571|NCT01587703|3839104|FG003|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
3114572|NCT01587703|3839105|FG004|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
3114573|NCT01587703|3839106|FG005|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
3114574|NCT01587703|3839107|FG006|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
3114575|NCT01587703|3839108|FG007|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
3114576|NCT01587703|3839109|FG008|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
3114577|NCT01587703|3839110|FG009|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
3114578|NCT01587703|3839111|FG010|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
3114579|NCT01587703|3839112|FG011|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
3114580|NCT01587703|3839113|FG012|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
3114581|NCT01587703|3839114|FG013|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
3114582|NCT01587703|3839115|FG014|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
3114583|NCT01587703|3839116|FG015|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
3114584|NCT01587703|3839117|FG016|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
3114585|NCT01587703|3839118|FG017|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
3114586|NCT01587703|3839119|FG018|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
3114587|NCT01587703|3839101|FG000|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
3114588|NCT01587703|3839102|FG001|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
3114589|NCT01587703|3839103|FG002|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
3114590|NCT01587703|3839104|FG003|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
3114591|NCT01587703|3839105|FG004|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
3114592|NCT01587703|3839106|FG005|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
3114593|NCT01587703|3839107|FG006|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
3114594|NCT01587703|3839108|FG007|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
3114595|NCT01587703|3839109|FG008|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
3114596|NCT01587703|3839110|FG009|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
3114597|NCT01587703|3839111|FG010|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
3114598|NCT01587703|3839112|FG011|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
3114599|NCT01587703|3839113|FG012|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
3114600|NCT01587703|3839114|FG013|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
3114601|NCT01587703|3839115|FG014|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
3114602|NCT01587703|3839116|FG015|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
3114603|NCT01587703|3839117|FG016|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
3114604|NCT01587703|3839118|FG017|STARTED|Substudy-P3, Week2Day1 to Week2Day3||5
3114605|NCT01587703|3839119|FG018|STARTED|Substudy-P3, Week2Day1 to Week2Day3||5
3114606|NCT01587703|3839101|FG000|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
3114607|NCT01587703|3839102|FG001|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
3114608|NCT01587703|3839103|FG002|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
3114609|NCT01587703|3839104|FG003|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
3114610|NCT01587703|3839105|FG004|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
3114611|NCT01587703|3839106|FG005|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
3114612|NCT01587703|3839107|FG006|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
3114613|NCT01587703|3839108|FG007|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
3114614|NCT01587703|3839109|FG008|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
3114615|NCT01587703|3839110|FG009|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
3114616|NCT01587703|3839111|FG010|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
3114617|NCT01587703|3839112|FG011|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
3114618|NCT01587703|3839113|FG012|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
3114619|NCT01587703|3839114|FG013|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
3114620|NCT01587703|3839115|FG014|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
3114621|NCT01587703|3839116|FG015|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
3114622|NCT01587703|3839117|FG016|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
3114623|NCT01587703|3839118|FG017|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||5
3114624|NCT01587703|3839119|FG018|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||5
3114625|NCT01587703|3839101|FG000|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
3114626|NCT01587703|3839102|FG001|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
3114627|NCT01587703|3839103|FG002|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
3114628|NCT01587703|3839104|FG003|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
3114629|NCT01587703|3839105|FG004|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
3114630|NCT01587703|3839106|FG005|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
3114631|NCT01587703|3839107|FG006|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
3114632|NCT01587703|3839108|FG007|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
3114633|NCT01587703|3839109|FG008|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
3114634|NCT01587703|3839110|FG009|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
3114635|NCT01587703|3839111|FG010|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
3114636|NCT01587703|3839112|FG011|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
3114637|NCT01587703|3839113|FG012|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
3114638|NCT01587703|3839114|FG013|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
3114639|NCT01587703|3839115|FG014|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
3114640|NCT01587703|3839116|FG015|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
3114641|NCT01587703|3839117|FG016|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
3114642|NCT01587703|3839118|FG017|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
3114643|NCT01587703|3839119|FG018|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
3114644|NCT01587703|3839101|FG000|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
3114645|NCT01587703|3839102|FG001|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
3114646|NCT01587703|3839103|FG002|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
3114647|NCT01587703|3839104|FG003|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
3114648|NCT01587703|3839105|FG004|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
3114649|NCT01587703|3839106|FG005|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
3114650|NCT01587703|3839107|FG006|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
3114651|NCT01587703|3839108|FG007|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
3114652|NCT01587703|3839109|FG008|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
3114653|NCT01587703|3839110|FG009|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
3114654|NCT01587703|3839111|FG010|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
3114655|NCT01587703|3839112|FG011|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
3114656|NCT01587703|3839113|FG012|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
3114657|NCT01587703|3839114|FG013|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
3114658|NCT01587703|3839115|FG014|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
3114659|NCT01587703|3839116|FG015|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
3114660|NCT01587703|3839117|FG016|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
3114661|NCT01587703|3839118|FG017|STARTED|Substudy-P4,Maximum Exposure of 5.5month||5
3114662|NCT01587703|3839119|FG018|STARTED|Substudy-P4,Maximum Exposure of 5.5month||5
3114663|NCT01587703|3839101|FG000|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
3114664|NCT01587703|3839102|FG001|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
3114665|NCT01587703|3839103|FG002|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
3114666|NCT01587703|3839104|FG003|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
3114667|NCT01587703|3839105|FG004|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
3114668|NCT01587703|3839106|FG005|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
3114669|NCT01587703|3839107|FG006|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
3114670|NCT01587703|3839108|FG007|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
3114671|NCT01587703|3839109|FG008|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
3114672|NCT01587703|3839110|FG009|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
3114673|NCT01587703|3839111|FG010|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
3114674|NCT01587703|3839112|FG011|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
3114675|NCT01587703|3839113|FG012|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
3114676|NCT01587703|3839114|FG013|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
3114677|NCT01587703|3839115|FG014|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
3114678|NCT01587703|3839116|FG015|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
3114679|NCT01587703|3839117|FG016|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
3114680|NCT01587703|3839118|FG017|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
3114681|NCT01587703|3839119|FG018|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
3114682|NCT01587703|3839101|FG000|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
3114683|NCT01587703|3839102|FG001|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
3114684|NCT01587703|3839103|FG002|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
3114685|NCT01587703|3839104|FG003|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
3114686|NCT01587703|3839105|FG004|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
3114687|NCT01587703|3839106|FG005|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
3114688|NCT01587703|3839107|FG006|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
3114689|NCT01587703|3839108|FG007|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
3114690|NCT01587703|3839109|FG008|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
3114691|NCT01587703|3839110|FG009|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
3114692|NCT01587703|3839111|FG010|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
3114693|NCT01587703|3839112|FG011|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
3114694|NCT01587703|3839113|FG012|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
3114695|NCT01587703|3839114|FG013|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
3114696|NCT01587703|3839115|FG014|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
3114697|NCT01587703|3839116|FG015|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
3114698|NCT01587703|3839117|FG016|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
3114699|NCT01587703|3839118|FG017|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||5
3114700|NCT01587703|3839119|FG018|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||5
3114701|NCT01587703|3839101|FG000|STARTED|Part2(Median Exposure of 1.41 Months)||0
3114702|NCT01587703|3839102|FG001|STARTED|Part2(Median Exposure of 1.41 Months)||0
3114703|NCT01587703|3839103|FG002|STARTED|Part2(Median Exposure of 1.41 Months)||0
3114704|NCT01587703|3839104|FG003|STARTED|Part2(Median Exposure of 1.41 Months)||0
3114705|NCT01587703|3839105|FG004|STARTED|Part2(Median Exposure of 1.41 Months)||0
3114706|NCT01587703|3839106|FG005|STARTED|Part2(Median Exposure of 1.41 Months)||0
3114707|NCT01587703|3839107|FG006|STARTED|Part2(Median Exposure of 1.41 Months)||0
3114708|NCT01587703|3839108|FG007|STARTED|Part2(Median Exposure of 1.41 Months)||0
3114709|NCT01587703|3839109|FG008|STARTED|Part2(Median Exposure of 1.41 Months)||0
3114710|NCT01587703|3839110|FG009|STARTED|Part2(Median Exposure of 1.41 Months)||0
3114711|NCT01587703|3839111|FG010|STARTED|Part2(Median Exposure of 1.41 Months)||0
3114712|NCT01587703|3839112|FG011|STARTED|Part2(Median Exposure of 1.41 Months)||12
3114713|NCT01587703|3839113|FG012|STARTED|Part2(Median Exposure of 1.41 Months)||14
3114714|NCT01587703|3839114|FG013|STARTED|Part2(Median Exposure of 1.41 Months)||23
3114715|NCT01587703|3839115|FG014|STARTED|Part2(Median Exposure of 1.41 Months)||19
3114716|NCT01587703|3839116|FG015|STARTED|Part2(Median Exposure of 1.41 Months)||21
3114717|NCT01587703|3839117|FG016|STARTED|Part2(Median Exposure of 1.41 Months)||13
3114718|NCT01587703|3839118|FG017|STARTED|Part2(Median Exposure of 1.41 Months)||0
3114719|NCT01587703|3839119|FG018|STARTED|Part2(Median Exposure of 1.41 Months)||0
3114720|NCT01587703|3839101|FG000|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
3114721|NCT01587703|3839102|FG001|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
3114722|NCT01587703|3839103|FG002|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
3114723|NCT01587703|3839104|FG003|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
3114724|NCT01587703|3839105|FG004|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
3114725|NCT01587703|3839106|FG005|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
3114726|NCT01587703|3839107|FG006|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
3114727|NCT01587703|3839108|FG007|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
3114728|NCT01587703|3839109|FG008|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
3114729|NCT01587703|3839110|FG009|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
3114730|NCT01587703|3839111|FG010|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
3114731|NCT01587703|3839112|FG011|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
3114732|NCT01587703|3839113|FG012|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
3114733|NCT01587703|3839114|FG013|COMPLETED|Part2(Median Exposure of 1.41 Months)||1
3114734|NCT01587703|3839115|FG014|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
3114735|NCT01587703|3839116|FG015|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
3114736|NCT01587703|3839117|FG016|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
3114737|NCT01587703|3839118|FG017|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
3114738|NCT01587703|3839119|FG018|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
3114739|NCT01587703|3839101|FG000|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
3114740|NCT01587703|3839102|FG001|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
3114741|NCT01587703|3839103|FG002|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
3114742|NCT01587703|3839104|FG003|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
3114743|NCT01587703|3839105|FG004|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
3114744|NCT01587703|3839106|FG005|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
3114745|NCT01587703|3839107|FG006|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
3114746|NCT01587703|3839108|FG007|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
3114747|NCT01587703|3839109|FG008|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
3114748|NCT01587703|3839110|FG009|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
3114749|NCT01587703|3839111|FG010|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
3114750|NCT01587703|3839112|FG011|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||12
3114751|NCT01587703|3839113|FG012|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||14
3114752|NCT01587703|3839114|FG013|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||22
3114753|NCT01587703|3839115|FG014|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||19
3114754|NCT01587703|3839116|FG015|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||21
3114755|NCT01587703|3839117|FG016|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||13
3114756|NCT01587703|3839118|FG017|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
3114757|NCT01587703|3839119|FG018|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
3114758|NCT01587885|3839178|FG000|STARTED|Treatment Period 1||26
3114759|NCT01587885|3839179|FG001|STARTED|Treatment Period 1||22
3114760|NCT01587885|3839178|FG000|COMPLETED|Treatment Period 1||26
3114761|NCT01587885|3839179|FG001|COMPLETED|Treatment Period 1||19
3114762|NCT01587885|3839178|FG000|NOT COMPLETED|Treatment Period 1||0
3114763|NCT01587885|3839179|FG001|NOT COMPLETED|Treatment Period 1||3
3114764|NCT01587885|3839178|FG000|STARTED|Treatment Period 2||26
3114765|NCT01587885|3839179|FG001|STARTED|Treatment Period 2||19
3114766|NCT01587885|3839178|FG000|COMPLETED|Treatment Period 2||26
3114767|NCT01587885|3839179|FG001|COMPLETED|Treatment Period 2||19
3114768|NCT01587885|3839178|FG000|NOT COMPLETED|Treatment Period 2||0
3114769|NCT01587885|3839179|FG001|NOT COMPLETED|Treatment Period 2||0
3114770|NCT01587898|3839190|FG000|STARTED|Overall Study||18
3114771|NCT01587898|3839191|FG001|STARTED|Overall Study||17
3114772|NCT01587898|3839192|FG002|STARTED|Overall Study||18
3114773|NCT01587898|3839193|FG003|STARTED|Overall Study||19
3114774|NCT01587898|3839190|FG000|COMPLETED|Overall Study||14
3114775|NCT01587898|3839191|FG001|COMPLETED|Overall Study||12
3114776|NCT01587898|3839192|FG002|COMPLETED|Overall Study||16
3114777|NCT01587898|3839193|FG003|COMPLETED|Overall Study||17
3114778|NCT01587898|3839190|FG000|NOT COMPLETED|Overall Study||4
3114779|NCT01587898|3839191|FG001|NOT COMPLETED|Overall Study||5
3114780|NCT01587898|3839192|FG002|NOT COMPLETED|Overall Study||2
3114781|NCT01587898|3839193|FG003|NOT COMPLETED|Overall Study||2
3114782|NCT01587924|3839210|FG000|STARTED|Overall Study||21
3114783|NCT01587924|3839211|FG001|STARTED|Overall Study||21
3114784|NCT01587924|3839212|FG002|STARTED|Overall Study||21
3114785|NCT01587924|3839213|FG003|STARTED|Overall Study||20
3114786|NCT01587924|3839210|FG000|COMPLETED|Overall Study||17
3114787|NCT01587924|3839211|FG001|COMPLETED|Overall Study||17
3114788|NCT01587924|3839212|FG002|COMPLETED|Overall Study||17
3114789|NCT01587924|3839213|FG003|COMPLETED|Overall Study||19
3114790|NCT01587924|3839210|FG000|NOT COMPLETED|Overall Study||4
3114791|NCT01587924|3839211|FG001|NOT COMPLETED|Overall Study||4
3114792|NCT01587924|3839212|FG002|NOT COMPLETED|Overall Study||4
3114793|NCT01587924|3839213|FG003|NOT COMPLETED|Overall Study||1
3114794|NCT01587950|3839223|FG000|STARTED|Period 1||12
3114795|NCT01587950|3839223|FG000|Received 5% KNO3 Solution (5 Minutes)|Period 1||5
3114796|NCT01587950|3839223|FG000|Received 5% KNO3 Solution (2 Minutes)|Period 1||3
3114797|NCT01587950|3839223|FG000|Received Sterile Water (2 Minutes)|Period 1||2
3114798|NCT01587950|3839223|FG000|Received 5% KNO3 Solution (10 Minutes)|Period 1||4
3114799|NCT01587950|3839223|FG000|Received 2.5% KNO3 Solution (2 Minutes)|Period 1||4
3114800|NCT01587950|3839223|FG000|Received 2.5% KNO3 Solution (10 Minutes)|Period 1||3
3114801|NCT01587950|3839223|FG000|Received Sterile Water (10 Minutes)|Period 1||5
3114802|NCT01587950|3839223|FG000|Received 2.5% KNO3 Solution (5 Minutes)|Period 1||5
3114803|NCT01587950|3839223|FG000|Received Sterile Water (5 Minutes)|Period 1||5
3114804|NCT01587950|3839223|FG000|COMPLETED|Period 1||12
3114805|NCT01587950|3839223|FG000|NOT COMPLETED|Period 1||0
3114806|NCT01587950|3839223|FG000|STARTED|Washout 1||12
3114807|NCT01587950|3839223|FG000|COMPLETED|Washout 1||12
3114808|NCT01587950|3839223|FG000|NOT COMPLETED|Washout 1||0
3114809|NCT01587950|3839223|FG000|STARTED|Period 2||12
3114810|NCT01587950|3839223|FG000|Received Sterile Water (2 Minutes)|Period 2||8
3114811|NCT01587950|3839223|FG000|Received 5% KNO3 Solution (10 Minutes)|Period 2||4
3114812|NCT01587950|3839223|FG000|Received 2.5% KNO3 Solution (5 Minutes)|Period 2||2
3114813|NCT01587950|3839223|FG000|Received 2.5% KNO3 Solution (10 Minutes)|Period 2||6
3114814|NCT01587950|3839223|FG000|Received 5% KNO3 Solution (2 Minutes)|Period 2||6
3114815|NCT01587950|3839223|FG000|Received Sterile Water (5 Minutes)|Period 2||2
3114816|NCT01587950|3839223|FG000|Received 2.5% KNO3 Solution (2 Minutes)|Period 2||4
3114817|NCT01587950|3839223|FG000|Received Sterile Water (10 Minutes)|Period 2||2
3114818|NCT01587950|3839223|FG000|Received 5% KNO3 Solution (5 Minutes)|Period 2||2
3114819|NCT01587950|3839223|FG000|COMPLETED|Period 2||12
3114820|NCT01587950|3839223|FG000|NOT COMPLETED|Period 2||0
3114821|NCT01587950|3839223|FG000|STARTED|Washout 2||12
3114822|NCT01587950|3839223|FG000|COMPLETED|Washout 2||12
3114823|NCT01587950|3839223|FG000|NOT COMPLETED|Washout 2||0
3114824|NCT01587950|3839223|FG000|STARTED|Period 3||12
3114825|NCT01587950|3839223|FG000|Received 2.5% KNO3 Solution (2 Minutes)|Period 3||4
3114826|NCT01587950|3839223|FG000|Received Sterile Water (10 Minutes)|Period 3||5
3114827|NCT01587950|3839223|FG000|Received Sterile Water (2 Minutes)|Period 3||2
3114828|NCT01587950|3839223|FG000|Received 5% KNO3 Solution (10 Minutes)|Period 3||4
3114829|NCT01587950|3839223|FG000|Received Sterile Water (5 Minutes)|Period 3||5
3114830|NCT01587950|3839223|FG000|Received 5% KNO3 Solution (5 Minutes)|Period 3||5
3114831|NCT01587950|3839223|FG000|Received 5% KNO3 Solution (2 Minutes)|Period 3||3
3114832|NCT01587950|3839223|FG000|Received 2.5% KNO3 Solution (10 Minutes)|Period 3||3
3114833|NCT01587950|3839223|FG000|Received 2.5% KNO3 Solution (5 Minutes)|Period 3||5
3114834|NCT01587950|3839223|FG000|COMPLETED|Period 3||12
3114835|NCT01587950|3839223|FG000|NOT COMPLETED|Period 3||0
3114836|NCT01587989|3839238|FG000|STARTED|12-Week Open-Label Run-In Period||77
3114837|NCT01587989|3839239|FG001|STARTED|12-Week Open-Label Run-In Period||0
3114838|NCT01587989|3839240|FG002|STARTED|12-Week Open-Label Run-In Period||0
3114839|NCT01587989|3839238|FG000|COMPLETED|12-Week Open-Label Run-In Period||65
3114840|NCT01587989|3839239|FG001|COMPLETED|12-Week Open-Label Run-In Period||0
3114841|NCT01587989|3839240|FG002|COMPLETED|12-Week Open-Label Run-In Period||0
3114842|NCT01587989|3839238|FG000|NOT COMPLETED|12-Week Open-Label Run-In Period||12
3114843|NCT01587989|3839239|FG001|NOT COMPLETED|12-Week Open-Label Run-In Period||0
3114844|NCT01587989|3839240|FG002|NOT COMPLETED|12-Week Open-Label Run-In Period||0
3114845|NCT01587989|3839238|FG000|STARTED|Randomized Study Treatment||0
3114846|NCT01587989|3839239|FG001|STARTED|Randomized Study Treatment||32
3114847|NCT01587989|3839240|FG002|STARTED|Randomized Study Treatment||33
3114848|NCT01587989|3839238|FG000|COMPLETED|Randomized Study Treatment||0
3114849|NCT01587989|3839239|FG001|COMPLETED|Randomized Study Treatment||30
3114850|NCT01587989|3839240|FG002|COMPLETED|Randomized Study Treatment||32
3114851|NCT01587989|3839238|FG000|NOT COMPLETED|Randomized Study Treatment||0
3114852|NCT01587989|3839239|FG001|NOT COMPLETED|Randomized Study Treatment||2
3114853|NCT01587989|3839240|FG002|NOT COMPLETED|Randomized Study Treatment||1
3114854|NCT01588106|3839248|FG000|STARTED|Overall Study||78
3114855|NCT01588106|3839249|FG001|STARTED|Overall Study||76
3114856|NCT01588106|3839248|FG000|COMPLETED|Overall Study||73
3114857|NCT01588106|3839249|FG001|COMPLETED|Overall Study||72
3114858|NCT01588106|3839248|FG000|NOT COMPLETED|Overall Study||5
3114859|NCT01588106|3839249|FG001|NOT COMPLETED|Overall Study||4
3114860|NCT01588158|3839257|FG000|STARTED|Overall Study||4
3114861|NCT01588158|3839258|FG001|STARTED|Overall Study||3
3114862|NCT01588158|3839257|FG000|COMPLETED|Overall Study||4
3114863|NCT01588158|3839258|FG001|COMPLETED|Overall Study||3
3114864|NCT01588158|3839257|FG000|NOT COMPLETED|Overall Study||0
3114865|NCT01588158|3839258|FG001|NOT COMPLETED|Overall Study||0
3114866|NCT01588184|3839270|FG000|STARTED|Overall Study||11
3114867|NCT01588184|3839271|FG001|STARTED|Overall Study||41
3114868|NCT01588184|3839272|FG002|STARTED|Overall Study||7
3114869|NCT01588184|3839273|FG003|STARTED|Overall Study||6
3114870|NCT01588184|3839274|FG004|STARTED|Overall Study||16
3114871|NCT01588184|3839275|FG005|STARTED|Overall Study||14
3114872|NCT01588184|3839270|FG000|COMPLETED|Overall Study||8
3114873|NCT01588184|3839271|FG001|COMPLETED|Overall Study||28
3114874|NCT01588184|3839272|FG002|COMPLETED|Overall Study||5
3114875|NCT01588184|3839273|FG003|COMPLETED|Overall Study||3
3114876|NCT01588184|3839274|FG004|COMPLETED|Overall Study||14
3114877|NCT01588184|3839275|FG005|COMPLETED|Overall Study||10
3114878|NCT01588184|3839270|FG000|NOT COMPLETED|Overall Study||3
3114879|NCT01588184|3839271|FG001|NOT COMPLETED|Overall Study||13
3114880|NCT01588184|3839272|FG002|NOT COMPLETED|Overall Study||2
3114881|NCT01588184|3839273|FG003|NOT COMPLETED|Overall Study||3
3114882|NCT01588184|3839274|FG004|NOT COMPLETED|Overall Study||2
3114883|NCT01588184|3839275|FG005|NOT COMPLETED|Overall Study||4
3114884|NCT01588197|3839291|FG000|STARTED|Overall Study||10
3114885|NCT01588197|3839292|FG001|STARTED|Overall Study||10
3114886|NCT01588197|3839291|FG000|COMPLETED|Overall Study||9
3114887|NCT01588197|3839292|FG001|COMPLETED|Overall Study||9
3114888|NCT01588197|3839291|FG000|NOT COMPLETED|Overall Study||1
3114889|NCT01588197|3839292|FG001|NOT COMPLETED|Overall Study||1
3114890|NCT01588236|3839301|FG000|STARTED|Overall Study||92
3114891|NCT01588236|3839302|FG001|STARTED|Overall Study||94
3114892|NCT01588236|3839303|FG002|STARTED|Overall Study||94
3114893|NCT01588236|3839301|FG000|COMPLETED|Overall Study||76
3114894|NCT01588236|3839302|FG001|COMPLETED|Overall Study||66
3114895|NCT01588236|3839303|FG002|COMPLETED|Overall Study||69
3114896|NCT01588236|3839301|FG000|NOT COMPLETED|Overall Study||16
3114897|NCT01588236|3839302|FG001|NOT COMPLETED|Overall Study||28
3114898|NCT01588236|3839303|FG002|NOT COMPLETED|Overall Study||25
3114899|NCT01588353|3839314|FG000|STARTED|Step1||6
3114900|NCT01588353|3839315|FG001|STARTED|Step1||0
3114901|NCT01588353|3839316|FG002|STARTED|Step1||0
3114902|NCT01588353|3839314|FG000|COMPLETED|Step1||6
3114903|NCT01588353|3839315|FG001|COMPLETED|Step1||0
3114904|NCT01588353|3839316|FG002|COMPLETED|Step1||0
3114905|NCT01588353|3839314|FG000|NOT COMPLETED|Step1||0
3114906|NCT01588353|3839315|FG001|NOT COMPLETED|Step1||0
3114907|NCT01588353|3839316|FG002|NOT COMPLETED|Step1||0
3114908|NCT01588353|3839314|FG000|STARTED|Step2||0
3114909|NCT01588353|3839315|FG001|STARTED|Step2||71
3114910|NCT01588353|3839316|FG002|STARTED|Step2||0
3114911|NCT01588353|3839314|FG000|COMPLETED|Step2||0
3114912|NCT01588353|3839315|FG001|COMPLETED|Step2||70
3114913|NCT01588353|3839316|FG002|COMPLETED|Step2||0
3114914|NCT01588353|3839314|FG000|NOT COMPLETED|Step2||0
3114915|NCT01588353|3839315|FG001|NOT COMPLETED|Step2||1
3114916|NCT01588353|3839316|FG002|NOT COMPLETED|Step2||0
3114917|NCT01588353|3839314|FG000|STARTED|Step3||0
3114918|NCT01588353|3839315|FG001|STARTED|Step3||0
3114919|NCT01588353|3839316|FG002|STARTED|Step3||25
3114920|NCT01588353|3839314|FG000|COMPLETED|Step3||0
3114921|NCT01588353|3839315|FG001|COMPLETED|Step3||0
3114922|NCT01588353|3839316|FG002|COMPLETED|Step3||23
3114923|NCT01588353|3839314|FG000|NOT COMPLETED|Step3||0
3114924|NCT01588353|3839315|FG001|NOT COMPLETED|Step3||0
3114925|NCT01588353|3839316|FG002|NOT COMPLETED|Step3||2
3114926|NCT01588366|3839328|FG000|STARTED|Overall Study||2
3294091|NCT02878330|4028151|FG000|STARTED|Overall Study||484
3294092|NCT02878330|4028152|FG001|STARTED|Overall Study||969
3294093|NCT02878330|4028151|FG000|COMPLETED|Overall Study||455
3294094|NCT02878330|4028152|FG001|COMPLETED|Overall Study||913
3294095|NCT02878330|4028151|FG000|NOT COMPLETED|Overall Study||29
3294096|NCT02878330|4028152|FG001|NOT COMPLETED|Overall Study||56
3294097|NCT02878382|4028159|FG000|STARTED|Overall Study|total 20 patients.split-scalp: 20 split -scalp received CAL-PDT and the other 20 received C-PDT|20
3294098|NCT02878382|4028160|FG001|STARTED|Overall Study|otal 20 patients.split-scalp: 20 split -scalp received CAL-PDT and the other 20 received C-PDT|20
3294099|NCT02878382|4028159|FG000|COMPLETED|Overall Study||20
3294100|NCT02878382|4028160|FG001|COMPLETED|Overall Study||20
3294101|NCT02878382|4028159|FG000|NOT COMPLETED|Overall Study||0
3294102|NCT02878382|4028160|FG001|NOT COMPLETED|Overall Study||0
3114927|NCT01588366|3839329|FG001|STARTED|Overall Study||7
3114928|NCT01588366|3839330|FG002|STARTED|Overall Study||2
3114929|NCT01588366|3839331|FG003|STARTED|Overall Study||7
3114930|NCT01588366|3839332|FG004|STARTED|Overall Study||3
3114931|NCT01588366|3839333|FG005|STARTED|Overall Study||9
3114932|NCT01588366|3839328|FG000|Received at Least One Dose of Study Drug|Overall Study||2
3114933|NCT01588366|3839329|FG001|Received at Least One Dose of Study Drug|Overall Study||7
3114934|NCT01588366|3839330|FG002|Received at Least One Dose of Study Drug|Overall Study||2
3294103|NCT02878486|4028170|FG000|STARTED|Overall Study||3
3294104|NCT02878486|4028171|FG001|STARTED|Overall Study||3
3294105|NCT02878486|4028170|FG000|COMPLETED|Overall Study||3
3294106|NCT02878486|4028171|FG001|COMPLETED|Overall Study||3
3294107|NCT02878486|4028170|FG000|NOT COMPLETED|Overall Study||0
3114935|NCT01588366|3839331|FG003|Received at Least One Dose of Study Drug|Overall Study||7
3114936|NCT01588366|3839332|FG004|Received at Least One Dose of Study Drug|Overall Study||3
3114937|NCT01588366|3839333|FG005|Received at Least One Dose of Study Drug|Overall Study||9
3114938|NCT01588366|3839328|FG000|COMPLETED|Overall Study||2
3114939|NCT01588366|3839329|FG001|COMPLETED|Overall Study||6
3114940|NCT01588366|3839330|FG002|COMPLETED|Overall Study||2
3114941|NCT01588366|3839331|FG003|COMPLETED|Overall Study||6
3114942|NCT01588366|3839332|FG004|COMPLETED|Overall Study||3
3114943|NCT01588366|3839333|FG005|COMPLETED|Overall Study||7
3114944|NCT01588366|3839328|FG000|NOT COMPLETED|Overall Study||0
3114945|NCT01588366|3839329|FG001|NOT COMPLETED|Overall Study||1
3114946|NCT01588366|3839330|FG002|NOT COMPLETED|Overall Study||0
3114947|NCT01588366|3839331|FG003|NOT COMPLETED|Overall Study||1
3114948|NCT01588366|3839332|FG004|NOT COMPLETED|Overall Study||0
3294108|NCT02878486|4028171|FG001|NOT COMPLETED|Overall Study||0
3294109|NCT02878590|4028177|FG000|STARTED|Overall Study||12
3294110|NCT02878590|4028177|FG000|COMPLETED|Overall Study||10
3294111|NCT02878590|4028177|FG000|NOT COMPLETED|Overall Study||2
3114949|NCT01588366|3839333|FG005|NOT COMPLETED|Overall Study||2
3114950|NCT01588405|3839349|FG000|STARTED|Overall Study||33
3114951|NCT01588405|3839349|FG000|COMPLETED|Overall Study||31
3114952|NCT01588405|3839349|FG000|NOT COMPLETED|Overall Study||2
3114953|NCT01588418|3839356|FG000|STARTED|Overall Study||11
3114954|NCT01588418|3839357|FG001|STARTED|Overall Study||4
3114955|NCT01588418|3839356|FG000|COMPLETED|Overall Study||11
3114956|NCT01588418|3839357|FG001|COMPLETED|Overall Study||4
3114957|NCT01588418|3839356|FG000|NOT COMPLETED|Overall Study||0
3114958|NCT01588418|3839357|FG001|NOT COMPLETED|Overall Study||0
3114959|NCT01588444|3839365|FG000|STARTED|Overall Study||20
3114960|NCT01588444|3839366|FG001|STARTED|Overall Study||20
3114961|NCT01588444|3839365|FG000|COMPLETED|Overall Study||20
3114962|NCT01588444|3839366|FG001|COMPLETED|Overall Study||20
3114963|NCT01588444|3839365|FG000|NOT COMPLETED|Overall Study||0
3114964|NCT01588444|3839366|FG001|NOT COMPLETED|Overall Study||0
3114965|NCT01588457|3839374|FG000|STARTED|Randomization 1||53
3114966|NCT01588457|3839375|FG001|STARTED|Randomization 1||59
3114967|NCT01588457|3839376|FG002|STARTED|Randomization 1|No subject assigned during first randomization to monotherapy|0
3114968|NCT01588457|3839377|FG003|STARTED|Randomization 1|No subject assigned during first randomization to monotherapy|0
3114969|NCT01588457|3839374|FG000|COMPLETED|Randomization 1||30
3114970|NCT01588457|3839375|FG001|COMPLETED|Randomization 1||43
3114971|NCT01588457|3839376|FG002|COMPLETED|Randomization 1||0
3114972|NCT01588457|3839377|FG003|COMPLETED|Randomization 1||0
3114973|NCT01588457|3839374|FG000|NOT COMPLETED|Randomization 1||23
3114974|NCT01588457|3839375|FG001|NOT COMPLETED|Randomization 1||16
3114975|NCT01588457|3839376|FG002|NOT COMPLETED|Randomization 1||0
3114976|NCT01588457|3839377|FG003|NOT COMPLETED|Randomization 1||0
3114977|NCT01588457|3839374|FG000|STARTED|Randomization 2|Some subjects who completed the first randomization had QTP or LTG added to regimen|21
3114978|NCT01588457|3839375|FG001|STARTED|Randomization 2|Some subjects who completed the first randomization had QTP or LTG added to regimen|31
3114979|NCT01588457|3839376|FG002|STARTED|Randomization 2|Assignment of Quetiapine plus monotherapy for symptoms of depression|17
3114980|NCT01588457|3839377|FG003|STARTED|Randomization 2|Assignment of Lamotrigine plus monotherapy for symptoms of depression|18
3114981|NCT01588457|3839374|FG000|COMPLETED|Randomization 2||1
3114982|NCT01588457|3839375|FG001|COMPLETED|Randomization 2||3
3114983|NCT01588457|3839376|FG002|COMPLETED|Randomization 2||12
3114984|NCT01588457|3839377|FG003|COMPLETED|Randomization 2||13
3114985|NCT01588457|3839374|FG000|NOT COMPLETED|Randomization 2||20
3114986|NCT01588457|3839375|FG001|NOT COMPLETED|Randomization 2||28
3294112|NCT02878603|4028183|FG000|STARTED|Overall Study||29
3294113|NCT02878603|4028184|FG001|STARTED|Overall Study||75
3294114|NCT02878603|4028183|FG000|COMPLETED|Overall Study||23
3294115|NCT02878603|4028184|FG001|COMPLETED|Overall Study||70
3294116|NCT02878603|4028183|FG000|NOT COMPLETED|Overall Study||6
3294117|NCT02878603|4028184|FG001|NOT COMPLETED|Overall Study||5
3294118|NCT02879032|4028190|FG000|STARTED|Overall Study||130
3294119|NCT02879032|4028190|FG000|COMPLETED|Overall Study||130
3294120|NCT02879032|4028190|FG000|NOT COMPLETED|Overall Study||0
3294121|NCT02879318|4028198|FG000|STARTED|Overall Study||61
3294122|NCT02879318|4028199|FG001|STARTED|Overall Study||119
3294123|NCT02879318|4028198|FG000|COMPLETED|Overall Study||61
3294124|NCT02879318|4028199|FG001|COMPLETED|Overall Study||119
3294125|NCT02879318|4028198|FG000|NOT COMPLETED|Overall Study||0
3294126|NCT02879318|4028199|FG001|NOT COMPLETED|Overall Study||0
3294127|NCT02879383|4028209|FG000|STARTED|First 24 Weeks||39
3294128|NCT02879383|4028210|FG001|STARTED|First 24 Weeks||37
3294129|NCT02879383|4028211|FG002|STARTED|First 24 Weeks||17
3294130|NCT02879383|4028212|FG003|STARTED|First 24 Weeks||16
3294131|NCT02879383|4028209|FG000|COMPLETED|First 24 Weeks||39
3294132|NCT02879383|4028210|FG001|COMPLETED|First 24 Weeks||36
3294133|NCT02879383|4028211|FG002|COMPLETED|First 24 Weeks||17
3294134|NCT02879383|4028212|FG003|COMPLETED|First 24 Weeks||16
3294135|NCT02879383|4028209|FG000|NOT COMPLETED|First 24 Weeks||0
3294136|NCT02879383|4028210|FG001|NOT COMPLETED|First 24 Weeks||1
3294137|NCT02879383|4028211|FG002|NOT COMPLETED|First 24 Weeks||0
3294138|NCT02879383|4028212|FG003|NOT COMPLETED|First 24 Weeks||0
3294139|NCT02879383|4028209|FG000|STARTED|Second 24 Weeks (Crossover for Sham)||33
3294140|NCT02879383|4028210|FG001|STARTED|Second 24 Weeks (Crossover for Sham)||0
3294141|NCT02879383|4028211|FG002|STARTED|Second 24 Weeks (Crossover for Sham)||4
3294142|NCT02879383|4028212|FG003|STARTED|Second 24 Weeks (Crossover for Sham)||0
3294143|NCT02879383|4028209|FG000|COMPLETED|Second 24 Weeks (Crossover for Sham)||33
3294144|NCT02879383|4028210|FG001|COMPLETED|Second 24 Weeks (Crossover for Sham)||0
3114987|NCT01588457|3839376|FG002|NOT COMPLETED|Randomization 2||5
3114988|NCT01588457|3839377|FG003|NOT COMPLETED|Randomization 2||5
3114989|NCT01588470|3839397|FG000|STARTED|Overall Study|First enrolled April 2007|130
3114990|NCT01588470|3839397|FG000|COMPLETED|Overall Study|Completed Dec. 2011|50
3114991|NCT01588470|3839397|FG000|NOT COMPLETED|Overall Study||80
3294145|NCT02879383|4028211|FG002|COMPLETED|Second 24 Weeks (Crossover for Sham)||4
3294146|NCT02879383|4028212|FG003|COMPLETED|Second 24 Weeks (Crossover for Sham)||0
3294147|NCT02879383|4028209|FG000|NOT COMPLETED|Second 24 Weeks (Crossover for Sham)||0
3294148|NCT02879383|4028210|FG001|NOT COMPLETED|Second 24 Weeks (Crossover for Sham)||0
3294149|NCT02879383|4028211|FG002|NOT COMPLETED|Second 24 Weeks (Crossover for Sham)||0
3294150|NCT02879383|4028212|FG003|NOT COMPLETED|Second 24 Weeks (Crossover for Sham)||0
3294151|NCT02879578|4028227|FG000|STARTED|Overall Study||33
3294152|NCT02879578|4028228|FG001|STARTED|Overall Study||41
3294153|NCT02879578|4028229|FG002|STARTED|Overall Study||81
3114992|NCT01588496|3839409|FG000|STARTED|Overall Study||8
3114993|NCT01588496|3839410|FG001|STARTED|Overall Study||17
3114994|NCT01588496|3839411|FG002|STARTED|Overall Study||33
3114995|NCT01588496|3839409|FG000|Received Treatment|Overall Study||8
3114996|NCT01588496|3839410|FG001|Received Treatment|Overall Study||16
3114997|NCT01588496|3839411|FG002|Received Treatment|Overall Study||33
3114998|NCT01588496|3839409|FG000|COMPLETED|Overall Study||8
3114999|NCT01588496|3839410|FG001|COMPLETED|Overall Study||16
3115000|NCT01588496|3839411|FG002|COMPLETED|Overall Study||33
3115001|NCT01588496|3839409|FG000|NOT COMPLETED|Overall Study||0
3115002|NCT01588496|3839410|FG001|NOT COMPLETED|Overall Study||1
3115003|NCT01588496|3839411|FG002|NOT COMPLETED|Overall Study||0
3135971|NCT01709786|3861062|FG000|NOT COMPLETED|Overall Study||0
3135972|NCT01709799|3861071|FG000|STARTED|Overall Study||25
3135973|NCT01709799|3861072|FG001|STARTED|Overall Study||21
3135974|NCT01709799|3861073|FG002|STARTED|Overall Study||18
3135975|NCT01709799|3861071|FG000|COMPLETED|Overall Study||22
3135976|NCT01709799|3861072|FG001|COMPLETED|Overall Study||18
3135977|NCT01709799|3861073|FG002|COMPLETED|Overall Study||15
3135978|NCT01709799|3861071|FG000|NOT COMPLETED|Overall Study||3
3135979|NCT01709799|3861072|FG001|NOT COMPLETED|Overall Study||3
3135980|NCT01709799|3861073|FG002|NOT COMPLETED|Overall Study||3
3135981|NCT01709838|3861081|FG000|STARTED|Overall Study||134
3135982|NCT01709838|3861081|FG000|COMPLETED|Overall Study||67
3135983|NCT01709838|3861081|FG000|NOT COMPLETED|Overall Study||67
3135984|NCT01709864|3861089|FG000|STARTED|Overall Study||222
3135985|NCT01709864|3861090|FG001|STARTED|Overall Study||219
3135986|NCT01709864|3861089|FG000|Full Analysis Set (FAS)|Overall Study|FAS included all randomized patients who received at least one dose of trial drug.|222
3135987|NCT01709864|3861090|FG001|Full Analysis Set (FAS)|Overall Study|FAS included all randomized patients who received at least one dose of trial drug.|216
3135988|NCT01709864|3861089|FG000|Per Protocol Set (PPS)|Overall Study|PPS included all patients in the FAS who did not have any major protocol deviations.|204
3135989|NCT01709864|3861090|FG001|Per Protocol Set (PPS)|Overall Study|PPS included all patients in the FAS who did not have any major protocol deviations.|201
3135990|NCT01709864|3861089|FG000|COMPLETED|Overall Study||215
3135991|NCT01709864|3861090|FG001|COMPLETED|Overall Study||208
3135992|NCT01709864|3861089|FG000|NOT COMPLETED|Overall Study||7
3135993|NCT01709864|3861090|FG001|NOT COMPLETED|Overall Study||11
3135994|NCT01709903|3861098|FG000|STARTED|Overall Study|Randomized set|372
3135995|NCT01709903|3861099|FG001|STARTED|Overall Study|Randomized set|372
3135996|NCT01709903|3861098|FG000|COMPLETED|Overall Study||343
3135997|NCT01709903|3861099|FG001|COMPLETED|Overall Study||333
3135998|NCT01709903|3861098|FG000|NOT COMPLETED|Overall Study||29
3135999|NCT01709903|3861099|FG001|NOT COMPLETED|Overall Study||39
3136000|NCT01709981|3861107|FG000|STARTED|Overall Study||141
3136001|NCT01709981|3861108|FG001|STARTED|Overall Study||139
3136002|NCT01709981|3861107|FG000|COMPLETED|Overall Study||141
3136003|NCT01709981|3861108|FG001|COMPLETED|Overall Study||139
3136004|NCT01709981|3861107|FG000|NOT COMPLETED|Overall Study||0
3136005|NCT01709981|3861108|FG001|NOT COMPLETED|Overall Study||0
3136006|NCT01710020|3861114|FG000|STARTED|Period 1||12
3136007|NCT01710020|3861114|FG000|COMPLETED|Period 1||11
3136008|NCT01710020|3861114|FG000|NOT COMPLETED|Period 1||1
3136009|NCT01710020|3861114|FG000|STARTED|Washout Period (at Least 14 Days)||11
3136010|NCT01710020|3861114|FG000|COMPLETED|Washout Period (at Least 14 Days)||11
3136011|NCT01710020|3861114|FG000|NOT COMPLETED|Washout Period (at Least 14 Days)||0
3136012|NCT01710020|3861114|FG000|STARTED|Period 2||11
3136013|NCT01710020|3861114|FG000|COMPLETED|Period 2||11
3136014|NCT01710020|3861114|FG000|NOT COMPLETED|Period 2||0
3294154|NCT02879578|4028227|FG000|Safety Analysis Set|Overall Study||33
3294155|NCT02879578|4028228|FG001|Safety Analysis Set|Overall Study||40
3294156|NCT02879578|4028229|FG002|Safety Analysis Set|Overall Study||79
3294157|NCT02879578|4028227|FG000|COMPLETED|Overall Study||23
3294158|NCT02879578|4028228|FG001|COMPLETED|Overall Study||32
3294159|NCT02879578|4028229|FG002|COMPLETED|Overall Study||49
3294160|NCT02879578|4028227|FG000|NOT COMPLETED|Overall Study||10
3294161|NCT02879578|4028228|FG001|NOT COMPLETED|Overall Study||9
3294162|NCT02879578|4028229|FG002|NOT COMPLETED|Overall Study||32
3294163|NCT02879747|4028240|FG000|STARTED|Overall Study||27
3294164|NCT02879747|4028241|FG001|STARTED|Overall Study||38
3294165|NCT02879747|4028242|FG002|STARTED|Overall Study||33
3294166|NCT02879747|4028240|FG000|COMPLETED|Overall Study||23
3294167|NCT02879747|4028241|FG001|COMPLETED|Overall Study||32
3294168|NCT02879747|4028242|FG002|COMPLETED|Overall Study||31
3294169|NCT02879747|4028240|FG000|NOT COMPLETED|Overall Study||4
3294170|NCT02879747|4028241|FG001|NOT COMPLETED|Overall Study||6
3294171|NCT02879747|4028242|FG002|NOT COMPLETED|Overall Study||2
3294172|NCT02879812|4028261|FG000|STARTED|Overall Study||23370
3294173|NCT02879812|4028262|FG001|STARTED|Overall Study||22480
3294174|NCT02879812|4028261|FG000|COMPLETED|Overall Study||22153
3294175|NCT02879812|4028262|FG001|COMPLETED|Overall Study||21029
3294176|NCT02879812|4028261|FG000|NOT COMPLETED|Overall Study||1217
3294177|NCT02879812|4028262|FG001|NOT COMPLETED|Overall Study||1451
3136015|NCT01710033|3861124|FG000|STARTED|Stage 1||6
3136016|NCT01710033|3861125|FG001|STARTED|Stage 1||6
3136017|NCT01710033|3861126|FG002|STARTED|Stage 1||6
3136018|NCT01710033|3861127|FG003|STARTED|Stage 1||6
3136019|NCT01710033|3861128|FG004|STARTED|Stage 1||0
3294178|NCT02879994|4028268|FG000|STARTED|Overall Study||11
3294179|NCT02879994|4028268|FG000|COMPLETED|Overall Study||0
3294180|NCT02879994|4028268|FG000|NOT COMPLETED|Overall Study||11
3294181|NCT02880137|4028272|FG000|STARTED|Overall Study||36
3294182|NCT02880137|4028272|FG000|COMPLETED|Overall Study||36
3115004|NCT01588509|3839421|FG000|STARTED|Overall Study||30
3115005|NCT01588509|3839422|FG001|STARTED|Overall Study||30
3115006|NCT01588509|3839421|FG000|Received Treatment|Overall Study||30
3115007|NCT01588509|3839422|FG001|Received Treatment|Overall Study||30
3115008|NCT01588509|3839421|FG000|COMPLETED|Overall Study||29
3115009|NCT01588509|3839422|FG001|COMPLETED|Overall Study||30
3115010|NCT01588509|3839421|FG000|NOT COMPLETED|Overall Study||1
3115011|NCT01588509|3839422|FG001|NOT COMPLETED|Overall Study||0
3115012|NCT01588548|3839434|FG000|STARTED|Overall Study||3
3115013|NCT01588548|3839435|FG001|STARTED|Overall Study||7
3115014|NCT01588548|3839436|FG002|STARTED|Overall Study||6
3115015|NCT01588548|3839437|FG003|STARTED|Overall Study||7
3115016|NCT01588548|3839438|FG004|STARTED|Overall Study||6
3115017|NCT01588548|3839439|FG005|STARTED|Overall Study||6
3115018|NCT01588548|3839434|FG000|Cycle 1 Day 21|Overall Study||3
3115019|NCT01588548|3839435|FG001|Cycle 1 Day 21|Overall Study||5
3115020|NCT01588548|3839436|FG002|Cycle 1 Day 21|Overall Study||2
3115021|NCT01588548|3839437|FG003|Cycle 1 Day 21|Overall Study||5
3115022|NCT01588548|3839438|FG004|Cycle 1 Day 21|Overall Study||3
3115023|NCT01588548|3839439|FG005|Cycle 1 Day 21|Overall Study||3
3115024|NCT01588548|3839434|FG000|COMPLETED|Overall Study||0
3115025|NCT01588548|3839435|FG001|COMPLETED|Overall Study||0
3115026|NCT01588548|3839436|FG002|COMPLETED|Overall Study||0
3115027|NCT01588548|3839437|FG003|COMPLETED|Overall Study||0
3115028|NCT01588548|3839438|FG004|COMPLETED|Overall Study||0
3115029|NCT01588548|3839439|FG005|COMPLETED|Overall Study||0
3115030|NCT01588548|3839434|FG000|NOT COMPLETED|Overall Study||3
3115031|NCT01588548|3839435|FG001|NOT COMPLETED|Overall Study||7
3115032|NCT01588548|3839436|FG002|NOT COMPLETED|Overall Study||6
3115033|NCT01588548|3839437|FG003|NOT COMPLETED|Overall Study||7
3115034|NCT01588548|3839438|FG004|NOT COMPLETED|Overall Study||6
3115035|NCT01588548|3839439|FG005|NOT COMPLETED|Overall Study||6
3115036|NCT01588561|3839453|FG000|STARTED|Overall Study||14
3115037|NCT01588561|3839454|FG001|STARTED|Overall Study||1
3115038|NCT01588561|3839453|FG000|First Injection (Visit 1)|Overall Study||14
3115039|NCT01588561|3839454|FG001|First Injection (Visit 1)|Overall Study||1
3115040|NCT01588561|3839453|FG000|Rest Period|Overall Study||14
3115041|NCT01588561|3839454|FG001|Rest Period|Overall Study||1
3115042|NCT01588561|3839453|FG000|Second Injection (Visit 2)|Overall Study||14
3115043|NCT01588561|3839454|FG001|Second Injection (Visit 2)|Overall Study||1
3115044|NCT01588561|3839453|FG000|COMPLETED|Overall Study||14
3115045|NCT01588561|3839454|FG001|COMPLETED|Overall Study||1
3115046|NCT01588561|3839453|FG000|NOT COMPLETED|Overall Study||0
3115047|NCT01588561|3839454|FG001|NOT COMPLETED|Overall Study||0
3115048|NCT01588821|3839460|FG000|STARTED|Overall Study||37
3115049|NCT01588821|3839460|FG000|COMPLETED|Overall Study||37
3115050|NCT01588821|3839460|FG000|NOT COMPLETED|Overall Study||0
3115051|NCT01588951|3839468|FG000|STARTED|Overall Study||2
3115052|NCT01588951|3839469|FG001|STARTED|Overall Study||2
3115053|NCT01588951|3839470|FG002|STARTED|Overall Study||6
3115054|NCT01588951|3839468|FG000|COMPLETED|Overall Study||2
3115055|NCT01588951|3839469|FG001|COMPLETED|Overall Study||2
3115056|NCT01588951|3839470|FG002|COMPLETED|Overall Study||5
3115057|NCT01588951|3839468|FG000|NOT COMPLETED|Overall Study||0
3115058|NCT01588951|3839469|FG001|NOT COMPLETED|Overall Study||0
3115059|NCT01588951|3839470|FG002|NOT COMPLETED|Overall Study||1
3115060|NCT01588990|3839478|FG000|STARTED|Phase A||128
3115061|NCT01588990|3839478|FG000|COMPLETED|Phase A|A total of 58 participants had disease progression in Phase A and ended Phase A.|58
3115062|NCT01588990|3839478|FG000|NOT COMPLETED|Phase A||70
3115063|NCT01588990|3839478|FG000|STARTED|Phase B|Of 58 participants who had documented disease progression in Phase A, 53 entered in Phase B.|53
3115064|NCT01588990|3839478|FG000|COMPLETED|Phase B|A total of 37 participants had disease progression in Phase B and ended Phase B.|37
3115065|NCT01588990|3839478|FG000|NOT COMPLETED|Phase B||16
3115066|NCT01589094|3839486|FG000|STARTED|Overall Study||51
3115067|NCT01589094|3839486|FG000|COMPLETED|Overall Study||49
3115068|NCT01589094|3839486|FG000|NOT COMPLETED|Overall Study||2
3115069|NCT01589185|3839495|FG000|STARTED|Overall Study||6
3115070|NCT01589185|3839496|FG001|STARTED|Overall Study||8
3115071|NCT01589185|3839497|FG002|STARTED|Overall Study||10
3115072|NCT01589185|3839498|FG003|STARTED|Overall Study||8
3115073|NCT01589185|3839499|FG004|STARTED|Overall Study||16
3115074|NCT01589185|3839495|FG000|COMPLETED|Overall Study||4
3115075|NCT01589185|3839496|FG001|COMPLETED|Overall Study||6
3115076|NCT01589185|3839497|FG002|COMPLETED|Overall Study||6
3115077|NCT01589185|3839498|FG003|COMPLETED|Overall Study||5
3115078|NCT01589185|3839499|FG004|COMPLETED|Overall Study||15
3115079|NCT01589185|3839495|FG000|NOT COMPLETED|Overall Study||2
3115080|NCT01589185|3839496|FG001|NOT COMPLETED|Overall Study||2
3115081|NCT01589185|3839497|FG002|NOT COMPLETED|Overall Study||4
3115082|NCT01589185|3839498|FG003|NOT COMPLETED|Overall Study||3
3115083|NCT01589185|3839499|FG004|NOT COMPLETED|Overall Study||1
3115084|NCT01589237|3839516|FG000|STARTED|Part A (52 Weeks)|"Started = Full analysis set/safety set"|11
3115085|NCT01589237|3839517|FG001|STARTED|Part A (52 Weeks)||12
3115086|NCT01589237|3839518|FG002|STARTED|Part A (52 Weeks)||10
3115087|NCT01589237|3839519|FG003|STARTED|Part A (52 Weeks)||5
3115088|NCT01589237|3839516|FG000|COMPLETED|Part A (52 Weeks)||9
3115089|NCT01589237|3839517|FG001|COMPLETED|Part A (52 Weeks)||9
3115090|NCT01589237|3839518|FG002|COMPLETED|Part A (52 Weeks)||8
3115091|NCT01589237|3839519|FG003|COMPLETED|Part A (52 Weeks)||5
3115092|NCT01589237|3839516|FG000|NOT COMPLETED|Part A (52 Weeks)||2
3115093|NCT01589237|3839517|FG001|NOT COMPLETED|Part A (52 Weeks)||3
3115094|NCT01589237|3839518|FG002|NOT COMPLETED|Part A (52 Weeks)||2
3115095|NCT01589237|3839519|FG003|NOT COMPLETED|Part A (52 Weeks)||0
3115096|NCT01589237|3839516|FG000|STARTED|Part B (Planned for 78 Week-terminated)||5
3115097|NCT01589237|3839517|FG001|STARTED|Part B (Planned for 78 Week-terminated)||6
3115098|NCT01589237|3839518|FG002|STARTED|Part B (Planned for 78 Week-terminated)||4
3115099|NCT01589237|3839519|FG003|STARTED|Part B (Planned for 78 Week-terminated)||4
3115100|NCT01589237|3839516|FG000|COMPLETED|Part B (Planned for 78 Week-terminated)||0
3115101|NCT01589237|3839517|FG001|COMPLETED|Part B (Planned for 78 Week-terminated)||0
3115102|NCT01589237|3839518|FG002|COMPLETED|Part B (Planned for 78 Week-terminated)||0
3115103|NCT01589237|3839519|FG003|COMPLETED|Part B (Planned for 78 Week-terminated)||0
3115104|NCT01589237|3839516|FG000|NOT COMPLETED|Part B (Planned for 78 Week-terminated)||5
3115105|NCT01589237|3839517|FG001|NOT COMPLETED|Part B (Planned for 78 Week-terminated)||6
3115106|NCT01589237|3839518|FG002|NOT COMPLETED|Part B (Planned for 78 Week-terminated)||4
3115107|NCT01589237|3839519|FG003|NOT COMPLETED|Part B (Planned for 78 Week-terminated)||4
3115108|NCT01589263|3839535|FG000|STARTED|Overall Study||9
3115109|NCT01589263|3839536|FG001|STARTED|Overall Study||12
3115110|NCT01589263|3839535|FG000|COMPLETED|Overall Study||9
3115111|NCT01589263|3839536|FG001|COMPLETED|Overall Study||12
3115112|NCT01589263|3839535|FG000|NOT COMPLETED|Overall Study||0
3115113|NCT01589263|3839536|FG001|NOT COMPLETED|Overall Study||0
3115114|NCT01589302|3839542|FG000|STARTED|Overall Study||154
3115115|NCT01589302|3839542|FG000|Del17p Patients|Overall Study||76
3115116|NCT01589302|3839542|FG000|Non-Del17p Patients|Overall Study||76
3115117|NCT01589302|3839542|FG000|COMPLETED|Overall Study||152
3115118|NCT01589302|3839542|FG000|NOT COMPLETED|Overall Study||2
3115119|NCT01589315|3839547|FG000|STARTED|Overall Study||17
3115120|NCT01589315|3839547|FG000|COMPLETED|Overall Study||16
3115121|NCT01589315|3839547|FG000|NOT COMPLETED|Overall Study||1
3115122|NCT01589445|3839551|FG000|STARTED|001 (Pioglitazone) -3 Months||77
3115123|NCT01589445|3839551|FG000|COMPLETED|001 (Pioglitazone) -3 Months|dropped out 7 patients|70
3115124|NCT01589445|3839551|FG000|NOT COMPLETED|001 (Pioglitazone) -3 Months||7
3115125|NCT01589445|3839551|FG000|STARTED|002 (Metformin)-3 Months|70 patients participated for trial of drug 002.|70
3115126|NCT01589445|3839551|FG000|COMPLETED|002 (Metformin)-3 Months|61 patients completed the drug 002.9 patients dropped out.|61
3115127|NCT01589445|3839551|FG000|NOT COMPLETED|002 (Metformin)-3 Months||9
3115128|NCT01589484|3839559|FG000|STARTED|Overall Study||104
3115129|NCT01589484|3839559|FG000|COMPLETED|Overall Study||100
3115130|NCT01589484|3839559|FG000|NOT COMPLETED|Overall Study||4
3115131|NCT01589497|3839568|FG000|STARTED|Overall Study||18
3115132|NCT01589497|3839569|FG001|STARTED|Overall Study||17
3115133|NCT01589497|3839570|FG002|STARTED|Overall Study||16
3115134|NCT01589497|3839571|FG003|STARTED|Overall Study||18
3115135|NCT01589497|3839568|FG000|COMPLETED|Overall Study|1 participant who completed study but had insufficient sputum volume was excluded from the analyses|17
3115136|NCT01589497|3839569|FG001|COMPLETED|Overall Study|1 participant who completed study but had insufficient sputum volume was excluded from the analyses|16
3115137|NCT01589497|3839570|FG002|COMPLETED|Overall Study||15
3115138|NCT01589497|3839571|FG003|COMPLETED|Overall Study||17
3115139|NCT01589497|3839568|FG000|NOT COMPLETED|Overall Study||1
3115140|NCT01589497|3839569|FG001|NOT COMPLETED|Overall Study||1
3115141|NCT01589497|3839570|FG002|NOT COMPLETED|Overall Study||1
3294183|NCT02880137|4028272|FG000|NOT COMPLETED|Overall Study||0
3294184|NCT02880176|4028278|FG000|STARTED|Overall Study||23
3294185|NCT02880176|4028279|FG001|STARTED|Overall Study||11
3294186|NCT02880176|4028278|FG000|Underwent Cystectomy|Overall Study||22
3294187|NCT02880176|4028279|FG001|Underwent Cystectomy|Overall Study||11
3294188|NCT02880176|4028278|FG000|Collected Postop Step Data|Overall Study||22
3294189|NCT02880176|4028279|FG001|Collected Postop Step Data|Overall Study||11
3294190|NCT02880176|4028278|FG000|Responded to 30 Day Survey|Overall Study||20
3294191|NCT02880176|4028279|FG001|Responded to 30 Day Survey|Overall Study||9
3294192|NCT02880176|4028278|FG000|COMPLETED|Overall Study||20
3294193|NCT02880176|4028279|FG001|COMPLETED|Overall Study||9
3294194|NCT02880176|4028278|FG000|NOT COMPLETED|Overall Study||3
3294195|NCT02880176|4028279|FG001|NOT COMPLETED|Overall Study||2
3294196|NCT02880189|4028285|FG000|STARTED|Overall Study||21
3294197|NCT02880189|4028285|FG000|COMPLETED|Overall Study||21
3294198|NCT02880189|4028285|FG000|NOT COMPLETED|Overall Study||0
3294199|NCT02880228|4028289|FG000|STARTED|Overall Study||11
3294200|NCT02880228|4028289|FG000|COMPLETED|Overall Study||11
3294201|NCT02880228|4028289|FG000|NOT COMPLETED|Overall Study||0
3294202|NCT02880254|4028295|FG000|STARTED|Overall Study||13
3294203|NCT02880254|4028296|FG001|STARTED|Overall Study||14
3294204|NCT02880254|4028295|FG000|COMPLETED|Overall Study||4
3294205|NCT02880254|4028296|FG001|COMPLETED|Overall Study||4
3294206|NCT02880254|4028295|FG000|NOT COMPLETED|Overall Study||9
3294207|NCT02880254|4028296|FG001|NOT COMPLETED|Overall Study||10
3294208|NCT02880475|4028304|FG000|STARTED|Overall Study||13
3294209|NCT02880475|4028305|FG001|STARTED|Overall Study||17
3294210|NCT02880475|4028304|FG000|COMPLETED|Overall Study||13
3294211|NCT02880475|4028305|FG001|COMPLETED|Overall Study||17
3294212|NCT02880475|4028304|FG000|NOT COMPLETED|Overall Study||0
3294213|NCT02880475|4028305|FG001|NOT COMPLETED|Overall Study||0
3294214|NCT02880514|4028313|FG000|STARTED|Overall Study|A total of 50 subjects with one sinus side assigned to the treatment group|50
3316831|NCT03119701|4050306|FG001|NOT COMPLETED|Mid-term (Final) Follow-up at D90||1
3115142|NCT01589497|3839571|FG003|NOT COMPLETED|Overall Study||1
3115143|NCT01589510|3839586|FG000|STARTED|Overall Study||419
3115144|NCT01589510|3839586|FG000|COMPLETED|Overall Study||386
3115145|NCT01589510|3839586|FG000|NOT COMPLETED|Overall Study||33
3115146|NCT01589601|3839592|FG000|STARTED|Overall Study||75
3115147|NCT01589601|3839593|FG001|STARTED|Overall Study||75
3115148|NCT01589601|3839592|FG000|COMPLETED|Overall Study||28
3115149|NCT01589601|3839593|FG001|COMPLETED|Overall Study||26
3115150|NCT01589601|3839592|FG000|NOT COMPLETED|Overall Study||47
3115151|NCT01589601|3839593|FG001|NOT COMPLETED|Overall Study||49
3115152|NCT01589653|3839601|FG000|STARTED|Overall Study||76
3115153|NCT01589653|3839602|FG001|STARTED|Overall Study||79
3115154|NCT01589653|3839601|FG000|Exposed|Overall Study||76
3115155|NCT01589653|3839602|FG001|Exposed|Overall Study||78
3115156|NCT01589653|3839601|FG000|COMPLETED|Overall Study||69
3115157|NCT01589653|3839602|FG001|COMPLETED|Overall Study||68
3115158|NCT01589653|3839601|FG000|NOT COMPLETED|Overall Study||7
3115159|NCT01589653|3839602|FG001|NOT COMPLETED|Overall Study||11
3115160|NCT01589770|3839610|FG000|STARTED|Overall Study||67
3115161|NCT01589770|3839611|FG001|STARTED|Overall Study||61
3115162|NCT01589770|3839610|FG000|COMPLETED|Overall Study||59
3115163|NCT01589770|3839611|FG001|COMPLETED|Overall Study||56
3115164|NCT01589770|3839610|FG000|NOT COMPLETED|Overall Study||8
3115165|NCT01589770|3839611|FG001|NOT COMPLETED|Overall Study||5
3115166|NCT01589822|3839620|FG000|STARTED|Overall Study||84
3115167|NCT01589822|3839621|FG001|STARTED|Overall Study||89
3115168|NCT01589822|3839622|FG002|STARTED|Overall Study||41
3115169|NCT01589822|3839620|FG000|COMPLETED|Overall Study||80
3115170|NCT01589822|3839621|FG001|COMPLETED|Overall Study||86
3115171|NCT01589822|3839622|FG002|COMPLETED|Overall Study||40
3115172|NCT01589822|3839620|FG000|NOT COMPLETED|Overall Study||4
3115173|NCT01589822|3839621|FG001|NOT COMPLETED|Overall Study||3
3115174|NCT01589822|3839622|FG002|NOT COMPLETED|Overall Study||1
3115175|NCT01589978|3839632|FG000|STARTED|Overall Study||2681
3115176|NCT01589978|3839632|FG000|COMPLETED|Overall Study||2681
3115177|NCT01589978|3839632|FG000|NOT COMPLETED|Overall Study||0
3115178|NCT01590017|3839637|FG000|STARTED|Overall Study||41
3115179|NCT01590017|3839637|FG000|COMPLETED|Overall Study||37
3115180|NCT01590017|3839637|FG000|NOT COMPLETED|Overall Study||4
3115181|NCT01590082|3839643|FG000|STARTED|Overall Study||11
3115182|NCT01590082|3839644|FG001|STARTED|Overall Study||1
3115183|NCT01590082|3839643|FG000|COMPLETED|Overall Study||9
3115184|NCT01590082|3839644|FG001|COMPLETED|Overall Study||1
3115185|NCT01590082|3839643|FG000|NOT COMPLETED|Overall Study||2
3115186|NCT01590082|3839644|FG001|NOT COMPLETED|Overall Study||0
3115187|NCT01590212|3839653|FG000|STARTED|Overall Study||12
3115188|NCT01590212|3839654|FG001|STARTED|Overall Study||9
3115189|NCT01590212|3839655|FG002|STARTED|Overall Study||14
3115190|NCT01590212|3839653|FG000|Baseline (Pre-intervention)|Overall Study|withdrew=2|10
3115191|NCT01590212|3839654|FG001|Baseline (Pre-intervention)|Overall Study||9
3115192|NCT01590212|3839655|FG002|Baseline (Pre-intervention)|Overall Study|failed contact=2|12
3115193|NCT01590212|3839653|FG000|Post-intervention|Overall Study|failed contact=3|7
3115194|NCT01590212|3839654|FG001|Post-intervention|Overall Study|failed contact=2; withdrew=1|6
3115195|NCT01590212|3839655|FG002|Post-intervention|Overall Study|failed contact=1|10
3115196|NCT01590212|3839653|FG000|COMPLETED|Overall Study|Includes 2 contacted who failed contact at post-intervention data collection point|9
3115197|NCT01590212|3839654|FG001|COMPLETED|Overall Study||5
3115198|NCT01590212|3839655|FG002|COMPLETED|Overall Study||9
3115199|NCT01590212|3839653|FG000|NOT COMPLETED|Overall Study||3
3115200|NCT01590212|3839654|FG001|NOT COMPLETED|Overall Study||4
3115201|NCT01590212|3839655|FG002|NOT COMPLETED|Overall Study||5
3115202|NCT01590238|3839664|FG000|STARTED|Overall Study||15
3115203|NCT01590238|3839664|FG000|COMPLETED|Overall Study||13
3115204|NCT01590238|3839664|FG000|NOT COMPLETED|Overall Study||2
3115205|NCT01590264|3839668|FG000|STARTED|Overall Study||5
3115206|NCT01590264|3839668|FG000|COMPLETED|Overall Study||5
3115207|NCT01590264|3839668|FG000|NOT COMPLETED|Overall Study||0
3115208|NCT01590433|3839674|FG000|STARTED|Overall Study||127
3115209|NCT01590433|3839675|FG001|STARTED|Overall Study||55
3115210|NCT01590433|3839674|FG000|COMPLETED|Overall Study||75
3115211|NCT01590433|3839675|FG001|COMPLETED|Overall Study||33
3115212|NCT01590433|3839674|FG000|NOT COMPLETED|Overall Study||52
3115213|NCT01590433|3839675|FG001|NOT COMPLETED|Overall Study||22
3115214|NCT01590550|3839681|FG000|STARTED|Overall Study||18
3115215|NCT01590550|3839681|FG000|COMPLETED|Overall Study||18
3115216|NCT01590550|3839681|FG000|NOT COMPLETED|Overall Study||0
3115217|NCT01590563|3839686|FG000|STARTED|Overall Study||15
3115218|NCT01590563|3839686|FG000|COMPLETED|Overall Study||14
3115219|NCT01590563|3839686|FG000|NOT COMPLETED|Overall Study||1
3115220|NCT01590758|3839693|FG000|STARTED|Overall Study||85
3115221|NCT01590758|3839694|FG001|STARTED|Overall Study||104
3115222|NCT01590758|3839693|FG000|COMPLETED|Overall Study||80
3115223|NCT01590758|3839694|FG001|COMPLETED|Overall Study||97
3115224|NCT01590758|3839693|FG000|NOT COMPLETED|Overall Study||5
3115225|NCT01590758|3839694|FG001|NOT COMPLETED|Overall Study||7
3115226|NCT01590771|3839702|FG000|STARTED|Overall Study||249
3115227|NCT01590771|3839703|FG001|STARTED|Overall Study||249
3115228|NCT01590771|3839702|FG000|COMPLETED|Overall Study||230
3115229|NCT01590771|3839703|FG001|COMPLETED|Overall Study||210
3115230|NCT01590771|3839702|FG000|NOT COMPLETED|Overall Study||19
3115231|NCT01590771|3839703|FG001|NOT COMPLETED|Overall Study||39
3115232|NCT01590797|3839711|FG000|STARTED|Overall Study||234
3115233|NCT01590797|3839712|FG001|STARTED|Overall Study||233
3115234|NCT01590797|3839711|FG000|COMPLETED|Overall Study||217
3115235|NCT01590797|3839712|FG001|COMPLETED|Overall Study||217
3115236|NCT01590797|3839711|FG000|NOT COMPLETED|Overall Study||17
3115237|NCT01590797|3839712|FG001|NOT COMPLETED|Overall Study||16
3115238|NCT01590810|3839723|FG000|STARTED|Overall Study||8
3115239|NCT01590810|3839724|FG001|STARTED|Overall Study||8
3115240|NCT01590810|3839725|FG002|STARTED|Overall Study||8
3115241|NCT01590810|3839726|FG003|STARTED|Overall Study||8
3115242|NCT01590810|3839727|FG004|STARTED|Overall Study||2
3115243|NCT01590810|3839723|FG000|COMPLETED|Overall Study||8
3115244|NCT01590810|3839724|FG001|COMPLETED|Overall Study||7
3115245|NCT01590810|3839725|FG002|COMPLETED|Overall Study||7
3115246|NCT01590810|3839726|FG003|COMPLETED|Overall Study||8
3115247|NCT01590810|3839727|FG004|COMPLETED|Overall Study||2
3115248|NCT01590810|3839723|FG000|NOT COMPLETED|Overall Study||0
3115249|NCT01590810|3839724|FG001|NOT COMPLETED|Overall Study||1
3115250|NCT01590810|3839725|FG002|NOT COMPLETED|Overall Study||1
3115251|NCT01590810|3839726|FG003|NOT COMPLETED|Overall Study||0
3115252|NCT01590810|3839727|FG004|NOT COMPLETED|Overall Study||0
3115253|NCT01590875|3839762|FG000|STARTED|Overall Study||10
3115254|NCT01590875|3839763|FG001|STARTED|Overall Study||10
3115255|NCT01590875|3839762|FG000|COMPLETED|Overall Study||10
3115256|NCT01590875|3839763|FG001|COMPLETED|Overall Study||10
3115257|NCT01590875|3839762|FG000|NOT COMPLETED|Overall Study||0
3115258|NCT01590875|3839763|FG001|NOT COMPLETED|Overall Study||0
3115259|NCT01590888|3839774|FG000|STARTED|Overall Study||36
3115260|NCT01590888|3839775|FG001|STARTED|Overall Study||38
3115261|NCT01590888|3839776|FG002|STARTED|Overall Study||35
3115262|NCT01590888|3839774|FG000|COMPLETED|Overall Study||32
3115263|NCT01590888|3839775|FG001|COMPLETED|Overall Study||38
3115264|NCT01590888|3839776|FG002|COMPLETED|Overall Study||34
3115265|NCT01590888|3839774|FG000|NOT COMPLETED|Overall Study||4
3115266|NCT01590888|3839775|FG001|NOT COMPLETED|Overall Study||0
3115267|NCT01590888|3839776|FG002|NOT COMPLETED|Overall Study||1
3115268|NCT01590979|3839786|FG000|STARTED|Overall Study||27
3115269|NCT01590979|3839787|FG001|STARTED|Overall Study||27
3115270|NCT01590979|3839786|FG000|COMPLETED|Overall Study||27
3115271|NCT01590979|3839787|FG001|COMPLETED|Overall Study||27
3115272|NCT01590979|3839786|FG000|NOT COMPLETED|Overall Study||0
3115273|NCT01590979|3839787|FG001|NOT COMPLETED|Overall Study||0
3115274|NCT01591005|3839797|FG000|STARTED|Overall Study||53
3115275|NCT01591005|3839798|FG001|STARTED|Overall Study||53
3115276|NCT01591005|3839799|FG002|STARTED|Overall Study||68
3115277|NCT01591005|3839800|FG003|STARTED|Overall Study||68
3115278|NCT01591005|3839797|FG000|COMPLETED|Overall Study||53
3115279|NCT01591005|3839798|FG001|COMPLETED|Overall Study||53
3115280|NCT01591005|3839799|FG002|COMPLETED|Overall Study||68
3115281|NCT01591005|3839800|FG003|COMPLETED|Overall Study||68
3115282|NCT01591005|3839797|FG000|NOT COMPLETED|Overall Study||0
3115283|NCT01591005|3839798|FG001|NOT COMPLETED|Overall Study||0
3115284|NCT01591005|3839799|FG002|NOT COMPLETED|Overall Study||0
3115285|NCT01591005|3839800|FG003|NOT COMPLETED|Overall Study||0
3115286|NCT01591018|3839812|FG000|STARTED|Overall Study||60
3115287|NCT01591018|3839813|FG001|STARTED|Overall Study||60
3115288|NCT01591018|3839812|FG000|COMPLETED|Overall Study||60
3115289|NCT01591018|3839813|FG001|COMPLETED|Overall Study||60
3115290|NCT01591018|3839812|FG000|NOT COMPLETED|Overall Study||0
3115291|NCT01591018|3839813|FG001|NOT COMPLETED|Overall Study||0
3115292|NCT01591044|3839822|FG000|STARTED|Overall Study||101
3115293|NCT01591044|3839823|FG001|STARTED|Overall Study||100
3115294|NCT01591044|3839824|FG002|STARTED|Overall Study||100
3115295|NCT01591044|3839822|FG000|COMPLETED|Overall Study||94
3115296|NCT01591044|3839823|FG001|COMPLETED|Overall Study||91
3115297|NCT01591044|3839824|FG002|COMPLETED|Overall Study||96
3115298|NCT01591044|3839822|FG000|NOT COMPLETED|Overall Study||7
3115299|NCT01591044|3839823|FG001|NOT COMPLETED|Overall Study||9
3115300|NCT01591044|3839824|FG002|NOT COMPLETED|Overall Study||4
3115301|NCT01591161|3839834|FG000|STARTED|Overall Study||245
3115302|NCT01591161|3839835|FG001|STARTED|Overall Study||124
3115303|NCT01591161|3839834|FG000|COMPLETED|Overall Study||174
3115304|NCT01591161|3839835|FG001|COMPLETED|Overall Study||68
3115305|NCT01591161|3839834|FG000|NOT COMPLETED|Overall Study||71
3115306|NCT01591161|3839835|FG001|NOT COMPLETED|Overall Study||56
3115307|NCT01591317|3839844|FG000|STARTED|Overall Study||10
3115308|NCT01591317|3839845|FG001|STARTED|Overall Study||10
3115309|NCT01591317|3839846|FG002|STARTED|Overall Study||10
3115310|NCT01591317|3839844|FG000|COMPLETED|Overall Study||10
3115311|NCT01591317|3839845|FG001|COMPLETED|Overall Study||10
3115312|NCT01591317|3839846|FG002|COMPLETED|Overall Study||10
3115313|NCT01591317|3839844|FG000|NOT COMPLETED|Overall Study||0
3115314|NCT01591317|3839845|FG001|NOT COMPLETED|Overall Study||0
3115315|NCT01591317|3839846|FG002|NOT COMPLETED|Overall Study||0
3115316|NCT01591330|3839859|FG000|STARTED|Period 1||8
3115317|NCT01591330|3839860|FG001|STARTED|Period 1||9
3115318|NCT01591330|3839861|FG002|STARTED|Period 1||9
3115319|NCT01591330|3839862|FG003|STARTED|Period 1||9
3115320|NCT01591330|3839859|FG000|Received at Least 1 Dose of Study Drug|Period 1||8
3115321|NCT01591330|3839860|FG001|Received at Least 1 Dose of Study Drug|Period 1||9
3115322|NCT01591330|3839861|FG002|Received at Least 1 Dose of Study Drug|Period 1||9
3115323|NCT01591330|3839862|FG003|Received at Least 1 Dose of Study Drug|Period 1||9
3115324|NCT01591330|3839859|FG000|COMPLETED|Period 1||7
3115325|NCT01591330|3839860|FG001|COMPLETED|Period 1||9
3115326|NCT01591330|3839861|FG002|COMPLETED|Period 1||9
3115327|NCT01591330|3839862|FG003|COMPLETED|Period 1||9
3115328|NCT01591330|3839859|FG000|NOT COMPLETED|Period 1||1
3115329|NCT01591330|3839860|FG001|NOT COMPLETED|Period 1||0
3115330|NCT01591330|3839861|FG002|NOT COMPLETED|Period 1||0
3115331|NCT01591330|3839862|FG003|NOT COMPLETED|Period 1||0
3115332|NCT01591330|3839859|FG000|STARTED|Washout of at Least 3 Days||7
3115333|NCT01591330|3839860|FG001|STARTED|Washout of at Least 3 Days||9
3115334|NCT01591330|3839861|FG002|STARTED|Washout of at Least 3 Days||9
3115335|NCT01591330|3839862|FG003|STARTED|Washout of at Least 3 Days||9
3115336|NCT01591330|3839859|FG000|COMPLETED|Washout of at Least 3 Days||6
3115337|NCT01591330|3839860|FG001|COMPLETED|Washout of at Least 3 Days||9
3115338|NCT01591330|3839861|FG002|COMPLETED|Washout of at Least 3 Days||9
3115339|NCT01591330|3839862|FG003|COMPLETED|Washout of at Least 3 Days||9
3115340|NCT01591330|3839859|FG000|NOT COMPLETED|Washout of at Least 3 Days||1
3115341|NCT01591330|3839860|FG001|NOT COMPLETED|Washout of at Least 3 Days||0
3115342|NCT01591330|3839861|FG002|NOT COMPLETED|Washout of at Least 3 Days||0
3115343|NCT01591330|3839862|FG003|NOT COMPLETED|Washout of at Least 3 Days||0
3115344|NCT01591330|3839859|FG000|STARTED|Period 2||6
3115345|NCT01591330|3839860|FG001|STARTED|Period 2||9
3115346|NCT01591330|3839861|FG002|STARTED|Period 2||9
3115347|NCT01591330|3839862|FG003|STARTED|Period 2||9
3115348|NCT01591330|3839859|FG000|COMPLETED|Period 2||5
3115349|NCT01591330|3839860|FG001|COMPLETED|Period 2||9
3115350|NCT01591330|3839861|FG002|COMPLETED|Period 2||9
3115351|NCT01591330|3839862|FG003|COMPLETED|Period 2||9
3115352|NCT01591330|3839859|FG000|NOT COMPLETED|Period 2||1
3115353|NCT01591330|3839860|FG001|NOT COMPLETED|Period 2||0
3115354|NCT01591330|3839861|FG002|NOT COMPLETED|Period 2||0
3115355|NCT01591330|3839862|FG003|NOT COMPLETED|Period 2||0
3115356|NCT01591330|3839859|FG000|STARTED|Washout of at Least 3 Days||5
3115357|NCT01591330|3839860|FG001|STARTED|Washout of at Least 3 Days||9
3115358|NCT01591330|3839861|FG002|STARTED|Washout of at Least 3 Days||9
3115359|NCT01591330|3839862|FG003|STARTED|Washout of at Least 3 Days||9
3115360|NCT01591330|3839859|FG000|COMPLETED|Washout of at Least 3 Days||5
3115361|NCT01591330|3839860|FG001|COMPLETED|Washout of at Least 3 Days||9
3115362|NCT01591330|3839861|FG002|COMPLETED|Washout of at Least 3 Days||9
3115363|NCT01591330|3839862|FG003|COMPLETED|Washout of at Least 3 Days||9
3115364|NCT01591330|3839859|FG000|NOT COMPLETED|Washout of at Least 3 Days||0
3115365|NCT01591330|3839860|FG001|NOT COMPLETED|Washout of at Least 3 Days||0
3115366|NCT01591330|3839861|FG002|NOT COMPLETED|Washout of at Least 3 Days||0
3115367|NCT01591330|3839862|FG003|NOT COMPLETED|Washout of at Least 3 Days||0
3115368|NCT01591330|3839859|FG000|STARTED|Period 3||5
3115369|NCT01591330|3839860|FG001|STARTED|Period 3||9
3115370|NCT01591330|3839861|FG002|STARTED|Period 3||9
3115371|NCT01591330|3839862|FG003|STARTED|Period 3||9
3115372|NCT01591330|3839859|FG000|COMPLETED|Period 3||5
3115373|NCT01591330|3839860|FG001|COMPLETED|Period 3||9
3115374|NCT01591330|3839861|FG002|COMPLETED|Period 3||9
3115375|NCT01591330|3839862|FG003|COMPLETED|Period 3||9
3115376|NCT01591330|3839859|FG000|NOT COMPLETED|Period 3||0
3115377|NCT01591330|3839860|FG001|NOT COMPLETED|Period 3||0
3115378|NCT01591330|3839861|FG002|NOT COMPLETED|Period 3||0
3294215|NCT02880514|4028314|FG001|STARTED|Overall Study|A total of 50 subjects with one sinus side assigned to the control group|50
3294216|NCT02880514|4028313|FG000|COMPLETED|Overall Study||50
3294217|NCT02880514|4028314|FG001|COMPLETED|Overall Study||50
3294218|NCT02880514|4028313|FG000|NOT COMPLETED|Overall Study||0
3294219|NCT02880514|4028314|FG001|NOT COMPLETED|Overall Study||0
3294220|NCT02880761|4028323|FG000|STARTED|Overall Study||103
3294221|NCT02880761|4028324|FG001|STARTED|Overall Study||106
3294222|NCT02880761|4028323|FG000|COMPLETED|Overall Study||87
3294223|NCT02880761|4028324|FG001|COMPLETED|Overall Study||85
3294224|NCT02880761|4028323|FG000|NOT COMPLETED|Overall Study||16
3294225|NCT02880761|4028324|FG001|NOT COMPLETED|Overall Study||21
3294226|NCT02880852|4028330|FG000|STARTED|Overall Study||20
3294227|NCT02880852|4028330|FG000|COMPLETED|Overall Study||20
3294228|NCT02880852|4028330|FG000|NOT COMPLETED|Overall Study||0
3294229|NCT02880865|4028336|FG000|STARTED|Overall Study||314
3294230|NCT02880865|4028337|FG001|STARTED|Overall Study||314
3294231|NCT02880865|4028336|FG000|Received MMR Dose 1|Overall Study||314
3294232|NCT02880865|4028337|FG001|Received MMR Dose 1|Overall Study||314
3294233|NCT02880865|4028336|FG000|Received CD-JEV|Overall Study||314
3294234|NCT02880865|4028337|FG001|Received CD-JEV|Overall Study||309
3294235|NCT02880865|4028336|FG000|Received MMR Dose 2|Overall Study||313
3294236|NCT02880865|4028337|FG001|Received MMR Dose 2|Overall Study||311
3294237|NCT02880865|4028336|FG000|COMPLETED|Overall Study||313
3294238|NCT02880865|4028337|FG001|COMPLETED|Overall Study||311
3294239|NCT02880865|4028336|FG000|NOT COMPLETED|Overall Study||1
3294240|NCT02880865|4028337|FG001|NOT COMPLETED|Overall Study||3
3294241|NCT02881008|4028370|FG000|STARTED|Overall Study||8
3294242|NCT02881008|4028371|FG001|STARTED|Overall Study||8
3294243|NCT02881008|4028372|FG002|STARTED|Overall Study||8
3294244|NCT02881008|4028373|FG003|STARTED|Overall Study||8
3294245|NCT02881008|4028374|FG004|STARTED|Overall Study||8
3115379|NCT01591330|3839862|FG003|NOT COMPLETED|Period 3||0
3115380|NCT01591330|3839859|FG000|STARTED|Washout of at Least 3 Days||5
3115381|NCT01591330|3839860|FG001|STARTED|Washout of at Least 3 Days||9
3115382|NCT01591330|3839861|FG002|STARTED|Washout of at Least 3 Days||9
3294246|NCT02881008|4028375|FG005|STARTED|Overall Study||8
3294247|NCT02881008|4028370|FG000|COMPLETED|Overall Study||8
3115383|NCT01591330|3839862|FG003|STARTED|Washout of at Least 3 Days||9
3115384|NCT01591330|3839859|FG000|COMPLETED|Washout of at Least 3 Days||5
3115385|NCT01591330|3839860|FG001|COMPLETED|Washout of at Least 3 Days||9
3115386|NCT01591330|3839861|FG002|COMPLETED|Washout of at Least 3 Days||9
3115387|NCT01591330|3839862|FG003|COMPLETED|Washout of at Least 3 Days||9
3115388|NCT01591330|3839859|FG000|NOT COMPLETED|Washout of at Least 3 Days||0
3115389|NCT01591330|3839860|FG001|NOT COMPLETED|Washout of at Least 3 Days||0
3115390|NCT01591330|3839861|FG002|NOT COMPLETED|Washout of at Least 3 Days||0
3115391|NCT01591330|3839862|FG003|NOT COMPLETED|Washout of at Least 3 Days||0
3115392|NCT01591330|3839859|FG000|STARTED|Period 4||5
3115393|NCT01591330|3839860|FG001|STARTED|Period 4||9
3115394|NCT01591330|3839861|FG002|STARTED|Period 4||9
3115395|NCT01591330|3839862|FG003|STARTED|Period 4||9
3115396|NCT01591330|3839859|FG000|COMPLETED|Period 4||5
3115397|NCT01591330|3839860|FG001|COMPLETED|Period 4||9
3115398|NCT01591330|3839861|FG002|COMPLETED|Period 4||9
3115399|NCT01591330|3839862|FG003|COMPLETED|Period 4||9
3115400|NCT01591330|3839859|FG000|NOT COMPLETED|Period 4||0
3115401|NCT01591330|3839860|FG001|NOT COMPLETED|Period 4||0
3115402|NCT01591330|3839861|FG002|NOT COMPLETED|Period 4||0
3115403|NCT01591330|3839862|FG003|NOT COMPLETED|Period 4||0
3115404|NCT01591382|3839874|FG000|STARTED|Overall Study||32
3115405|NCT01591382|3839875|FG001|STARTED|Overall Study||32
3115406|NCT01591382|3839874|FG000|COMPLETED|Overall Study||29
3115407|NCT01591382|3839875|FG001|COMPLETED|Overall Study||30
3115408|NCT01591382|3839874|FG000|NOT COMPLETED|Overall Study||3
3115409|NCT01591382|3839875|FG001|NOT COMPLETED|Overall Study||2
3115410|NCT01591408|3839883|FG000|STARTED|Overall Study||36
3115411|NCT01591408|3839884|FG001|STARTED|Overall Study||32
3115412|NCT01591408|3839883|FG000|COMPLETED|Overall Study||24
3115413|NCT01591408|3839884|FG001|COMPLETED|Overall Study||24
3115414|NCT01591408|3839883|FG000|NOT COMPLETED|Overall Study||12
3115415|NCT01591408|3839884|FG001|NOT COMPLETED|Overall Study||8
3115416|NCT01591460|3839890|FG000|STARTED|Overall Study|Those with elevated (Week 12) or detectable (Week 24) virus discontinued due to the Futility Rule.|165
3115417|NCT01591460|3839890|FG000|COMPLETED|Overall Study|The number who completed PEG-IFN, as scheduled according to response-guided treatment, is presented.|139
3115418|NCT01591460|3839890|FG000|NOT COMPLETED|Overall Study||26
3115419|NCT01591499|3839902|FG000|STARTED|Baseline Visit||33
3115420|NCT01591499|3839903|FG001|STARTED|Baseline Visit||39
3115421|NCT01591499|3839904|FG002|STARTED|Baseline Visit||31
3115422|NCT01591499|3839905|FG003|STARTED|Baseline Visit||39
3115423|NCT01591499|3839902|FG000|COMPLETED|Baseline Visit||33
3115424|NCT01591499|3839903|FG001|COMPLETED|Baseline Visit||37
3115425|NCT01591499|3839904|FG002|COMPLETED|Baseline Visit||31
3115426|NCT01591499|3839905|FG003|COMPLETED|Baseline Visit||37
3115427|NCT01591499|3839902|FG000|NOT COMPLETED|Baseline Visit||0
3115428|NCT01591499|3839903|FG001|NOT COMPLETED|Baseline Visit||2
3115429|NCT01591499|3839904|FG002|NOT COMPLETED|Baseline Visit||0
3115430|NCT01591499|3839905|FG003|NOT COMPLETED|Baseline Visit||2
3115431|NCT01591499|3839902|FG000|STARTED|First Intervention (up to 24 Days)||33
3115432|NCT01591499|3839903|FG001|STARTED|First Intervention (up to 24 Days)||37
3115433|NCT01591499|3839904|FG002|STARTED|First Intervention (up to 24 Days)||31
3115434|NCT01591499|3839905|FG003|STARTED|First Intervention (up to 24 Days)||37
3115435|NCT01591499|3839902|FG000|COMPLETED|First Intervention (up to 24 Days)||33
3115436|NCT01591499|3839903|FG001|COMPLETED|First Intervention (up to 24 Days)||37
3115437|NCT01591499|3839904|FG002|COMPLETED|First Intervention (up to 24 Days)||31
3115438|NCT01591499|3839905|FG003|COMPLETED|First Intervention (up to 24 Days)||37
3115439|NCT01591499|3839902|FG000|NOT COMPLETED|First Intervention (up to 24 Days)||0
3115440|NCT01591499|3839903|FG001|NOT COMPLETED|First Intervention (up to 24 Days)||0
3115441|NCT01591499|3839904|FG002|NOT COMPLETED|First Intervention (up to 24 Days)||0
3115442|NCT01591499|3839905|FG003|NOT COMPLETED|First Intervention (up to 24 Days)||0
3115443|NCT01591499|3839902|FG000|STARTED|Second Intervention (up to 24 Days)||33
3115444|NCT01591499|3839903|FG001|STARTED|Second Intervention (up to 24 Days)||37
3115445|NCT01591499|3839904|FG002|STARTED|Second Intervention (up to 24 Days)||31
3115446|NCT01591499|3839905|FG003|STARTED|Second Intervention (up to 24 Days)||37
3115447|NCT01591499|3839902|FG000|COMPLETED|Second Intervention (up to 24 Days)||27
3115448|NCT01591499|3839903|FG001|COMPLETED|Second Intervention (up to 24 Days)||34
3115449|NCT01591499|3839904|FG002|COMPLETED|Second Intervention (up to 24 Days)||28
3115450|NCT01591499|3839905|FG003|COMPLETED|Second Intervention (up to 24 Days)||34
3115451|NCT01591499|3839902|FG000|NOT COMPLETED|Second Intervention (up to 24 Days)||6
3115452|NCT01591499|3839903|FG001|NOT COMPLETED|Second Intervention (up to 24 Days)||3
3115453|NCT01591499|3839904|FG002|NOT COMPLETED|Second Intervention (up to 24 Days)||3
3115454|NCT01591499|3839905|FG003|NOT COMPLETED|Second Intervention (up to 24 Days)||3
3115455|NCT01591616|3839929|FG000|STARTED|Overall Study||16
3115456|NCT01591616|3839929|FG000|COMPLETED|Overall Study||15
3115457|NCT01591616|3839929|FG000|NOT COMPLETED|Overall Study||1
3115458|NCT01591655|3840070|FG000|STARTED|Overall Study||240
3115459|NCT01591655|3840071|FG001|STARTED|Overall Study||120
3115460|NCT01591655|3840070|FG000|COMPLETED|Overall Study||168
3115461|NCT01591655|3840071|FG001|COMPLETED|Overall Study||57
3115462|NCT01591655|3840070|FG000|NOT COMPLETED|Overall Study||72
3115463|NCT01591655|3840071|FG001|NOT COMPLETED|Overall Study||63
3115464|NCT01591681|3840077|FG000|STARTED|Overall Study||49
3115465|NCT01591681|3840077|FG000|COMPLETED|Overall Study||45
3115466|NCT01591681|3840077|FG000|NOT COMPLETED|Overall Study||4
3115467|NCT01591733|3840083|FG000|STARTED|Overall Study||48
3115468|NCT01591733|3840083|FG000|COMPLETED|Overall Study||48
3115469|NCT01591733|3840083|FG000|NOT COMPLETED|Overall Study||0
3115470|NCT01591746|3840091|FG000|STARTED|Overall Study||68
3115471|NCT01591746|3840092|FG001|STARTED|Overall Study||63
3115472|NCT01591746|3840091|FG000|COMPLETED|Overall Study||68
3115473|NCT01591746|3840092|FG001|COMPLETED|Overall Study||63
3115474|NCT01591746|3840091|FG000|NOT COMPLETED|Overall Study||0
3115475|NCT01591746|3840092|FG001|NOT COMPLETED|Overall Study||0
3115476|NCT01591785|3840100|FG000|STARTED|Overall Study||30
3115477|NCT01591785|3840101|FG001|STARTED|Overall Study||30
3115478|NCT01591785|3840100|FG000|COMPLETED|Overall Study||26
3115479|NCT01591785|3840101|FG001|COMPLETED|Overall Study||28
3115480|NCT01591785|3840100|FG000|NOT COMPLETED|Overall Study||4
3115481|NCT01591785|3840101|FG001|NOT COMPLETED|Overall Study||2
3115482|NCT01591837|3840109|FG000|STARTED|Overall Study||60
3115483|NCT01591837|3840110|FG001|STARTED|Overall Study||60
3115484|NCT01591837|3840109|FG000|COMPLETED|Overall Study||60
3115485|NCT01591837|3840110|FG001|COMPLETED|Overall Study||60
3115486|NCT01591837|3840109|FG000|NOT COMPLETED|Overall Study||0
3115487|NCT01591837|3840110|FG001|NOT COMPLETED|Overall Study||0
3115488|NCT01591863|3840116|FG000|STARTED|Overall Study||38
3115489|NCT01591863|3840116|FG000|COMPLETED|Overall Study||24
3115490|NCT01591863|3840116|FG000|NOT COMPLETED|Overall Study||14
3294248|NCT02881008|4028371|FG001|COMPLETED|Overall Study||8
3294249|NCT02881008|4028372|FG002|COMPLETED|Overall Study||8
3294250|NCT02881008|4028373|FG003|COMPLETED|Overall Study||8
3294251|NCT02881008|4028374|FG004|COMPLETED|Overall Study||8
3294252|NCT02881008|4028375|FG005|COMPLETED|Overall Study||8
3294253|NCT02881008|4028370|FG000|NOT COMPLETED|Overall Study||0
3294254|NCT02881008|4028371|FG001|NOT COMPLETED|Overall Study||0
3294255|NCT02881008|4028372|FG002|NOT COMPLETED|Overall Study||0
3294256|NCT02881008|4028373|FG003|NOT COMPLETED|Overall Study||0
3294257|NCT02881008|4028374|FG004|NOT COMPLETED|Overall Study||0
3294258|NCT02881008|4028375|FG005|NOT COMPLETED|Overall Study||0
3294259|NCT02881047|4028392|FG000|STARTED|Overall Study||8
3294260|NCT02881047|4028392|FG000|COMPLETED|Overall Study||6
3294261|NCT02881047|4028392|FG000|NOT COMPLETED|Overall Study||2
3294262|NCT02881112|4028396|FG000|STARTED|Overall Study||180
3294263|NCT02881112|4028396|FG000|COMPLETED|Overall Study||152
3294264|NCT02881112|4028396|FG000|NOT COMPLETED|Overall Study||28
3294265|NCT02881567|4028400|FG000|STARTED|Overall Study||41
3294266|NCT02881567|4028400|FG000|COMPLETED|Overall Study||23
3294267|NCT02881567|4028400|FG000|NOT COMPLETED|Overall Study||18
3294268|NCT02881658|4028406|FG000|STARTED|Overall Study||100
3294269|NCT02881658|4028407|FG001|STARTED|Overall Study||101
3294270|NCT02881658|4028406|FG000|COMPLETED|Overall Study||98
3294271|NCT02881658|4028407|FG001|COMPLETED|Overall Study||96
3294272|NCT02881658|4028406|FG000|NOT COMPLETED|Overall Study||2
3294273|NCT02881658|4028407|FG001|NOT COMPLETED|Overall Study||5
3294274|NCT02881775|4028415|FG000|STARTED|Baseline||11
3294275|NCT02881775|4028416|FG001|STARTED|Baseline||9
3294276|NCT02881775|4028415|FG000|COMPLETED|Baseline||11
3294277|NCT02881775|4028416|FG001|COMPLETED|Baseline||9
3294278|NCT02881775|4028415|FG000|NOT COMPLETED|Baseline||0
3294279|NCT02881775|4028416|FG001|NOT COMPLETED|Baseline||0
3294280|NCT02881775|4028415|FG000|STARTED|First Intervention (1-hr Session)|Two participants dropped out prior to First Intervention (1-hr Session).|9
3294281|NCT02881775|4028416|FG001|STARTED|First Intervention (1-hr Session)|Two participants dropped out prior to First Intervention (1-hr Session).|7
3294282|NCT02881775|4028415|FG000|COMPLETED|First Intervention (1-hr Session)||9
3294283|NCT02881775|4028416|FG001|COMPLETED|First Intervention (1-hr Session)||7
3294284|NCT02881775|4028415|FG000|NOT COMPLETED|First Intervention (1-hr Session)||0
3294285|NCT02881775|4028416|FG001|NOT COMPLETED|First Intervention (1-hr Session)||0
3294286|NCT02881775|4028415|FG000|STARTED|Washout (1 Week)||9
3294287|NCT02881775|4028416|FG001|STARTED|Washout (1 Week)||7
3294288|NCT02881775|4028415|FG000|COMPLETED|Washout (1 Week)||9
3294289|NCT02881775|4028416|FG001|COMPLETED|Washout (1 Week)||7
3294290|NCT02881775|4028415|FG000|NOT COMPLETED|Washout (1 Week)||0
3294291|NCT02881775|4028416|FG001|NOT COMPLETED|Washout (1 Week)||0
3294292|NCT02881775|4028415|FG000|STARTED|Second Intervention (1-Hour Session)||9
3294293|NCT02881775|4028416|FG001|STARTED|Second Intervention (1-Hour Session)||7
3294294|NCT02881775|4028415|FG000|COMPLETED|Second Intervention (1-Hour Session)||9
3294295|NCT02881775|4028416|FG001|COMPLETED|Second Intervention (1-Hour Session)||7
3294296|NCT02881775|4028415|FG000|NOT COMPLETED|Second Intervention (1-Hour Session)||0
3294297|NCT02881775|4028416|FG001|NOT COMPLETED|Second Intervention (1-Hour Session)||0
3294298|NCT02881840|4028422|FG000|STARTED|Overall Study||6
3294299|NCT02881840|4028422|FG000|COMPLETED|Overall Study||6
3294300|NCT02881840|4028422|FG000|NOT COMPLETED|Overall Study||0
3294301|NCT02881957|4028428|FG000|STARTED|Overall Study||136
3294302|NCT02881957|4028429|FG001|STARTED|Overall Study||138
3115491|NCT01592006|3840120|FG000|STARTED|Overall Study||3
3115492|NCT01592006|3840120|FG000|COMPLETED|Overall Study||3
3115493|NCT01592006|3840120|FG000|NOT COMPLETED|Overall Study||0
3115494|NCT01592045|3840126|FG000|STARTED|Overall Study||14
3115495|NCT01592045|3840127|FG001|STARTED|Overall Study||14
3115496|NCT01592045|3840126|FG000|Completed Course 1|Overall Study||13
3115497|NCT01592045|3840127|FG001|Completed Course 1|Overall Study||14
3115498|NCT01592045|3840126|FG000|Completed Course 2|Overall Study||13
3294303|NCT02881957|4028428|FG000|COMPLETED|Overall Study||133
3294304|NCT02881957|4028429|FG001|COMPLETED|Overall Study||134
3294305|NCT02881957|4028428|FG000|NOT COMPLETED|Overall Study||3
3115499|NCT01592045|3840127|FG001|Completed Course 2|Overall Study||13
3115500|NCT01592045|3840126|FG000|Completed Course 3|Overall Study||11
3115501|NCT01592045|3840127|FG001|Completed Course 3|Overall Study||13
3115502|NCT01592045|3840126|FG000|Completed Course 4|Overall Study||11
3115503|NCT01592045|3840127|FG001|Completed Course 4|Overall Study||12
3115504|NCT01592045|3840126|FG000|Completed Course 5|Overall Study||9
3115505|NCT01592045|3840127|FG001|Completed Course 5|Overall Study||12
3115506|NCT01592045|3840126|FG000|COMPLETED|Overall Study||9
3115507|NCT01592045|3840127|FG001|COMPLETED|Overall Study||12
3115508|NCT01592045|3840126|FG000|NOT COMPLETED|Overall Study||5
3115509|NCT01592045|3840127|FG001|NOT COMPLETED|Overall Study||2
3115510|NCT01592071|3840133|FG000|STARTED|Overall Study||120
3115511|NCT01592071|3840133|FG000|COMPLETED|Overall Study||120
3115512|NCT01592071|3840133|FG000|NOT COMPLETED|Overall Study||0
3115513|NCT01592240|3840144|FG000|STARTED|Overall Study||50
3115514|NCT01592240|3840145|FG001|STARTED|Overall Study||50
3115515|NCT01592240|3840146|FG002|STARTED|Overall Study||52
3115516|NCT01592240|3840147|FG003|STARTED|Overall Study||50
3115517|NCT01592240|3840148|FG004|STARTED|Overall Study||51
3115518|NCT01592240|3840149|FG005|STARTED|Overall Study||50
3115519|NCT01592240|3840150|FG006|STARTED|Overall Study||51
3115520|NCT01592240|3840144|FG000|COMPLETED|Overall Study||47
3115521|NCT01592240|3840145|FG001|COMPLETED|Overall Study||39
3115522|NCT01592240|3840146|FG002|COMPLETED|Overall Study||45
3115523|NCT01592240|3840147|FG003|COMPLETED|Overall Study||47
3115524|NCT01592240|3840148|FG004|COMPLETED|Overall Study||44
3115525|NCT01592240|3840149|FG005|COMPLETED|Overall Study||47
3115526|NCT01592240|3840150|FG006|COMPLETED|Overall Study||48
3115527|NCT01592240|3840144|FG000|NOT COMPLETED|Overall Study||3
3115528|NCT01592240|3840145|FG001|NOT COMPLETED|Overall Study||11
3115529|NCT01592240|3840146|FG002|NOT COMPLETED|Overall Study||7
3115530|NCT01592240|3840147|FG003|NOT COMPLETED|Overall Study||3
3115531|NCT01592240|3840148|FG004|NOT COMPLETED|Overall Study||7
3115532|NCT01592240|3840149|FG005|NOT COMPLETED|Overall Study||3
3115533|NCT01592240|3840150|FG006|NOT COMPLETED|Overall Study||3
3115534|NCT01592292|3840173|FG000|STARTED|Overall Study||46
3115535|NCT01592292|3840174|FG001|STARTED|Overall Study||20
3115536|NCT01592292|3840175|FG002|STARTED|Overall Study||13
3294306|NCT02881957|4028429|FG001|NOT COMPLETED|Overall Study||4
3294307|NCT02881996|4028437|FG000|STARTED|Overall Study||45
3294308|NCT02881996|4028438|FG001|STARTED|Overall Study||45
3294309|NCT02881996|4028437|FG000|COMPLETED|Overall Study||39
3294310|NCT02881996|4028438|FG001|COMPLETED|Overall Study||43
3294311|NCT02881996|4028437|FG000|NOT COMPLETED|Overall Study||6
3294312|NCT02881996|4028438|FG001|NOT COMPLETED|Overall Study||2
3294313|NCT02882152|4028446|FG000|STARTED|Overall Study||20
3294314|NCT02882152|4028447|FG001|STARTED|Overall Study||20
3294315|NCT02882152|4028446|FG000|COMPLETED|Overall Study||19
3294316|NCT02882152|4028447|FG001|COMPLETED|Overall Study||20
3294317|NCT02882152|4028446|FG000|NOT COMPLETED|Overall Study||1
3294318|NCT02882152|4028447|FG001|NOT COMPLETED|Overall Study||0
3294319|NCT02882178|4028453|FG000|STARTED|Overall Study||18
3294320|NCT02882178|4028453|FG000|COMPLETED|Overall Study||18
3294321|NCT02882178|4028453|FG000|NOT COMPLETED|Overall Study||0
3294322|NCT02882633|4028459|FG000|STARTED|Overall Study||25
3294323|NCT02882633|4028460|FG001|STARTED|Overall Study||25
3294324|NCT02882633|4028459|FG000|COMPLETED|Overall Study||23
3294325|NCT02882633|4028460|FG001|COMPLETED|Overall Study||25
3294326|NCT02882633|4028459|FG000|NOT COMPLETED|Overall Study||2
3294327|NCT02882633|4028460|FG001|NOT COMPLETED|Overall Study||0
3294328|NCT02882711|4028466|FG000|STARTED|Overall Study||6
3294329|NCT02882711|4028466|FG000|COMPLETED|Overall Study||2
3294330|NCT02882711|4028466|FG000|NOT COMPLETED|Overall Study||4
3294331|NCT02882854|4028472|FG000|STARTED|Overall Study||40
3294332|NCT02882854|4028473|FG001|STARTED|Overall Study||44
3294333|NCT02882854|4028472|FG000|COMPLETED|Overall Study||39
3294334|NCT02882854|4028473|FG001|COMPLETED|Overall Study||41
3294335|NCT02882854|4028472|FG000|NOT COMPLETED|Overall Study||1
3294336|NCT02882854|4028473|FG001|NOT COMPLETED|Overall Study||3
3294337|NCT02883244|4028481|FG000|STARTED|Overall Study||24
3294338|NCT02883244|4028482|FG001|STARTED|Overall Study||26
3294339|NCT02883244|4028481|FG000|COMPLETED|Overall Study||24
3294340|NCT02883244|4028482|FG001|COMPLETED|Overall Study||25
3294341|NCT02883244|4028481|FG000|NOT COMPLETED|Overall Study||0
3294342|NCT02883244|4028482|FG001|NOT COMPLETED|Overall Study||1
3294343|NCT02883400|4028490|FG000|STARTED|Overall Study||22
3294344|NCT02883400|4028491|FG001|STARTED|Overall Study||8
3294345|NCT02883400|4028490|FG000|COMPLETED|Overall Study||22
3294346|NCT02883400|4028491|FG001|COMPLETED|Overall Study||8
3294347|NCT02883400|4028490|FG000|NOT COMPLETED|Overall Study||0
3294348|NCT02883400|4028491|FG001|NOT COMPLETED|Overall Study||0
3294349|NCT02883452|4028503|FG000|STARTED|Overall Study|This cohort is only for Part 1.|13
3115537|NCT01592292|3840176|FG003|STARTED|Overall Study||11
3115538|NCT01592292|3840173|FG000|Intention to Treat (ITT) Set|Overall Study|Excluding primary effect evaluation omission.|34
3115539|NCT01592292|3840174|FG001|Intention to Treat (ITT) Set|Overall Study||13
3294350|NCT02883452|4028504|FG001|STARTED|Overall Study|This cohort is only for Part 1.|11
3294351|NCT02883452|4028505|FG002|STARTED|Overall Study|This cohort is only for Part 1.|12
3294352|NCT02883452|4028506|FG003|STARTED|Overall Study|This cohort is only for Part 1.|8
3294353|NCT02883452|4028507|FG004|STARTED|Overall Study|This arm is for Part 2. All of the patients in Part 2 were screened only for Part 2.|66
3316832|NCT03119831|4050315|FG000|STARTED|Overall Study||14
3115540|NCT01592292|3840175|FG002|Intention to Treat (ITT) Set|Overall Study||10
3115541|NCT01592292|3840176|FG003|Intention to Treat (ITT) Set|Overall Study||8
3115542|NCT01592292|3840173|FG000|Standard Population Set (SPS)|Overall Study|Excluding participants with change of administration drug or suspension of drug administration.|31
3115543|NCT01592292|3840174|FG001|Standard Population Set (SPS)|Overall Study||10
3115544|NCT01592292|3840175|FG002|Standard Population Set (SPS)|Overall Study||7
3115545|NCT01592292|3840176|FG003|Standard Population Set (SPS)|Overall Study||7
3115546|NCT01592292|3840173|FG000|COMPLETED|Overall Study|Participants who completed 12 months visit.|40
3115547|NCT01592292|3840174|FG001|COMPLETED|Overall Study||15
3115548|NCT01592292|3840175|FG002|COMPLETED|Overall Study||10
3115549|NCT01592292|3840176|FG003|COMPLETED|Overall Study||10
3115550|NCT01592292|3840173|FG000|NOT COMPLETED|Overall Study||6
3115551|NCT01592292|3840174|FG001|NOT COMPLETED|Overall Study||5
3115552|NCT01592292|3840175|FG002|NOT COMPLETED|Overall Study||3
3115553|NCT01592292|3840176|FG003|NOT COMPLETED|Overall Study||1
3115554|NCT01592344|3840184|FG000|STARTED|Overall Study||45
3115555|NCT01592344|3840185|FG001|STARTED|Overall Study||49
3115556|NCT01592344|3840184|FG000|COMPLETED|Overall Study||41
3115557|NCT01592344|3840185|FG001|COMPLETED|Overall Study||44
3115558|NCT01592344|3840184|FG000|NOT COMPLETED|Overall Study||4
3115559|NCT01592344|3840185|FG001|NOT COMPLETED|Overall Study||5
3115560|NCT01592396|3840193|FG000|STARTED|Overall Study||10
3115561|NCT01592396|3840194|FG001|STARTED|Overall Study||10
3115562|NCT01592396|3840193|FG000|COMPLETED|Overall Study||10
3115563|NCT01592396|3840194|FG001|COMPLETED|Overall Study||10
3115564|NCT01592396|3840193|FG000|NOT COMPLETED|Overall Study||0
3115565|NCT01592396|3840194|FG001|NOT COMPLETED|Overall Study||0
3115566|NCT01592409|3840203|FG000|STARTED|Overall Study||67
3115567|NCT01592409|3840204|FG001|STARTED|Overall Study||32
3115568|NCT01592409|3840203|FG000|COMPLETED|Overall Study||67
3115569|NCT01592409|3840204|FG001|COMPLETED|Overall Study||31
3115570|NCT01592409|3840203|FG000|NOT COMPLETED|Overall Study||0
3115571|NCT01592409|3840204|FG001|NOT COMPLETED|Overall Study||1
3115572|NCT01592435|3840210|FG000|STARTED|Overall Study||76
3115573|NCT01592435|3840210|FG000|COMPLETED|Overall Study||76
3115574|NCT01592435|3840210|FG000|NOT COMPLETED|Overall Study||0
3115575|NCT01592500|3840220|FG000|STARTED|Overall Study|Randomized Participants|14
3115576|NCT01592500|3840221|FG001|STARTED|Overall Study||15
3115577|NCT01592500|3840222|FG002|STARTED|Overall Study||14
3115578|NCT01592500|3840223|FG003|STARTED|Overall Study|Randomized Participants|13
3115579|NCT01592500|3840220|FG000|COMPLETED|Overall Study||13
3115580|NCT01592500|3840221|FG001|COMPLETED|Overall Study||15
3115581|NCT01592500|3840222|FG002|COMPLETED|Overall Study||14
3115582|NCT01592500|3840223|FG003|COMPLETED|Overall Study||11
3115583|NCT01592500|3840220|FG000|NOT COMPLETED|Overall Study||1
3115584|NCT01592500|3840221|FG001|NOT COMPLETED|Overall Study||0
3115585|NCT01592500|3840222|FG002|NOT COMPLETED|Overall Study||0
3115586|NCT01592500|3840223|FG003|NOT COMPLETED|Overall Study||2
3115587|NCT01592695|3840235|FG000|STARTED|Overall Study||31
3115588|NCT01592695|3840236|FG001|STARTED|Overall Study||32
3115589|NCT01592695|3840235|FG000|COMPLETED|Overall Study||23
3115590|NCT01592695|3840236|FG001|COMPLETED|Overall Study||28
3115591|NCT01592695|3840235|FG000|NOT COMPLETED|Overall Study||8
3115592|NCT01592695|3840236|FG001|NOT COMPLETED|Overall Study||4
3115593|NCT01592708|3840244|FG000|STARTED|Overall Study||96
3115594|NCT01592708|3840245|FG001|STARTED|Overall Study||137
3115595|NCT01592708|3840244|FG000|COMPLETED|Overall Study||93
3115596|NCT01592708|3840245|FG001|COMPLETED|Overall Study||137
3115597|NCT01592708|3840244|FG000|NOT COMPLETED|Overall Study||3
3115598|NCT01592708|3840245|FG001|NOT COMPLETED|Overall Study||0
3115599|NCT01592747|3840257|FG000|STARTED|Overall Study|Based on Randomized Population|160
3115600|NCT01592747|3840258|FG001|STARTED|Overall Study|Based on Randomized Population|161
3115601|NCT01592747|3840259|FG002|STARTED|Overall Study|Based on Randomized Population|158
3115602|NCT01592747|3840257|FG000|COMPLETED|Overall Study||44
3115603|NCT01592747|3840258|FG001|COMPLETED|Overall Study||50
3115604|NCT01592747|3840259|FG002|COMPLETED|Overall Study||50
3115605|NCT01592747|3840257|FG000|NOT COMPLETED|Overall Study||116
3115606|NCT01592747|3840258|FG001|NOT COMPLETED|Overall Study||111
3115607|NCT01592747|3840259|FG002|NOT COMPLETED|Overall Study||108
3115608|NCT01592760|3840271|FG000|STARTED|Perioperative to Discharge||90
3115609|NCT01592760|3840272|FG001|STARTED|Perioperative to Discharge||90
3115610|NCT01592760|3840273|FG002|STARTED|Perioperative to Discharge||45
3115611|NCT01592760|3840271|FG000|COMPLETED|Perioperative to Discharge||90
3115612|NCT01592760|3840272|FG001|COMPLETED|Perioperative to Discharge||90
3115613|NCT01592760|3840273|FG002|COMPLETED|Perioperative to Discharge||45
3115614|NCT01592760|3840271|FG000|NOT COMPLETED|Perioperative to Discharge||0
3115615|NCT01592760|3840272|FG001|NOT COMPLETED|Perioperative to Discharge||0
3115616|NCT01592760|3840273|FG002|NOT COMPLETED|Perioperative to Discharge||0
3294354|NCT02883452|4028508|FG005|STARTED|Overall Study|This arm is for Part 2. All of the patients in Part 2 were screened only for Part 2.|65
3294355|NCT02883452|4028503|FG000|COMPLETED|Overall Study||8
3294356|NCT02883452|4028504|FG001|COMPLETED|Overall Study||9
3294357|NCT02883452|4028505|FG002|COMPLETED|Overall Study||7
3294358|NCT02883452|4028506|FG003|COMPLETED|Overall Study||6
3294359|NCT02883452|4028507|FG004|COMPLETED|Overall Study||55
3294360|NCT02883452|4028508|FG005|COMPLETED|Overall Study||50
3294361|NCT02883452|4028503|FG000|NOT COMPLETED|Overall Study||5
3115617|NCT01592760|3840271|FG000|STARTED|24-hour Follow-Up||90
3115618|NCT01592760|3840272|FG001|STARTED|24-hour Follow-Up||90
3115619|NCT01592760|3840273|FG002|STARTED|24-hour Follow-Up||45
3115620|NCT01592760|3840271|FG000|COMPLETED|24-hour Follow-Up||86
3115621|NCT01592760|3840272|FG001|COMPLETED|24-hour Follow-Up||87
3115622|NCT01592760|3840273|FG002|COMPLETED|24-hour Follow-Up||43
3115623|NCT01592760|3840271|FG000|NOT COMPLETED|24-hour Follow-Up||4
3115624|NCT01592760|3840272|FG001|NOT COMPLETED|24-hour Follow-Up||3
3115625|NCT01592760|3840273|FG002|NOT COMPLETED|24-hour Follow-Up||2
3115626|NCT01592773|3840284|FG000|STARTED|Overall Study|All enrolled patients received at least 1 dose of investigational product (Safety Population).|747
3115627|NCT01592773|3840284|FG000|COMPLETED|Overall Study||81
3115628|NCT01592773|3840284|FG000|NOT COMPLETED|Overall Study||666
3115629|NCT01592786|3840288|FG000|STARTED|Overall Study|Participants in the Safety Population are being presented.|903
3115630|NCT01592786|3840288|FG000|COMPLETED|Overall Study||765
3115631|NCT01592786|3840288|FG000|NOT COMPLETED|Overall Study||138
3115632|NCT01592799|3840292|FG000|STARTED|Overall Study||501
3115633|NCT01592799|3840292|FG000|COMPLETED|Overall Study||501
3115634|NCT01592799|3840292|FG000|NOT COMPLETED|Overall Study||0
3115635|NCT01592851|3840300|FG000|STARTED|Overall Study||56
3115636|NCT01592851|3840301|FG001|STARTED|Overall Study||57
3115637|NCT01592851|3840300|FG000|COMPLETED|Overall Study||56
3115638|NCT01592851|3840301|FG001|COMPLETED|Overall Study||57
3115639|NCT01592851|3840300|FG000|NOT COMPLETED|Overall Study||0
3115640|NCT01592851|3840301|FG001|NOT COMPLETED|Overall Study||0
3115641|NCT01592864|3840309|FG000|STARTED|Overall Study||60
3115642|NCT01592864|3840310|FG001|STARTED|Overall Study||58
3115643|NCT01592864|3840309|FG000|COMPLETED|Overall Study||60
3115644|NCT01592864|3840310|FG001|COMPLETED|Overall Study||57
3115645|NCT01592864|3840309|FG000|NOT COMPLETED|Overall Study||0
3115646|NCT01592864|3840310|FG001|NOT COMPLETED|Overall Study||1
3115647|NCT01593020|3840318|FG000|STARTED|Overall Study||28
3115648|NCT01593020|3840319|FG001|STARTED|Overall Study||23
3115649|NCT01593020|3840318|FG000|COMPLETED|Overall Study||26
3115650|NCT01593020|3840319|FG001|COMPLETED|Overall Study||21
3115651|NCT01593020|3840318|FG000|NOT COMPLETED|Overall Study||2
3115652|NCT01593020|3840319|FG001|NOT COMPLETED|Overall Study||2
3115653|NCT01593215|3840327|FG000|STARTED|Overall Study||25
3115654|NCT01593215|3840328|FG001|STARTED|Overall Study||25
3115655|NCT01593215|3840327|FG000|COMPLETED|Overall Study||24
3115656|NCT01593215|3840328|FG001|COMPLETED|Overall Study||25
3115657|NCT01593215|3840327|FG000|NOT COMPLETED|Overall Study||1
3115658|NCT01593215|3840328|FG001|NOT COMPLETED|Overall Study||0
3115659|NCT01593592|3840336|FG000|STARTED|Overall Study||35
3115660|NCT01593592|3840337|FG001|STARTED|Overall Study||35
3115661|NCT01593592|3840336|FG000|COMPLETED|Overall Study||35
3115662|NCT01593592|3840337|FG001|COMPLETED|Overall Study||35
3115663|NCT01593592|3840336|FG000|NOT COMPLETED|Overall Study||0
3115664|NCT01593592|3840337|FG001|NOT COMPLETED|Overall Study||0
3115665|NCT01593670|3840343|FG000|STARTED|Overall Study||9
3115666|NCT01593670|3840343|FG000|COMPLETED|Overall Study||9
3115667|NCT01593670|3840343|FG000|NOT COMPLETED|Overall Study||0
3115668|NCT01593696|3840351|FG000|STARTED|Dose Escalation||16
3115669|NCT01593696|3840352|FG001|STARTED|Dose Escalation||5
3294362|NCT02883452|4028504|FG001|NOT COMPLETED|Overall Study||2
3294363|NCT02883452|4028505|FG002|NOT COMPLETED|Overall Study||5
3294364|NCT02883452|4028506|FG003|NOT COMPLETED|Overall Study||2
3294365|NCT02883452|4028507|FG004|NOT COMPLETED|Overall Study||11
3294366|NCT02883452|4028508|FG005|NOT COMPLETED|Overall Study||15
3294367|NCT02884089|4028523|FG000|STARTED|Period 1||11
3294368|NCT02884089|4028524|FG001|STARTED|Period 1||11
3294369|NCT02884089|4028525|FG002|STARTED|Period 1||9
3294370|NCT02884089|4028526|FG003|STARTED|Period 1||9
3294371|NCT02884089|4028523|FG000|Received at Least One Dose of Study Drug|Period 1||11
3294372|NCT02884089|4028524|FG001|Received at Least One Dose of Study Drug|Period 1||11
3294373|NCT02884089|4028525|FG002|Received at Least One Dose of Study Drug|Period 1||9
3294374|NCT02884089|4028526|FG003|Received at Least One Dose of Study Drug|Period 1||9
3294375|NCT02884089|4028523|FG000|COMPLETED|Period 1||9
3294376|NCT02884089|4028524|FG001|COMPLETED|Period 1||9
3294377|NCT02884089|4028525|FG002|COMPLETED|Period 1||9
3294378|NCT02884089|4028526|FG003|COMPLETED|Period 1||9
3294379|NCT02884089|4028523|FG000|NOT COMPLETED|Period 1||2
3294380|NCT02884089|4028524|FG001|NOT COMPLETED|Period 1||2
3294381|NCT02884089|4028525|FG002|NOT COMPLETED|Period 1||0
3294382|NCT02884089|4028526|FG003|NOT COMPLETED|Period 1||0
3294383|NCT02884089|4028523|FG000|STARTED|Washout Period 1||9
3294384|NCT02884089|4028524|FG001|STARTED|Washout Period 1||9
3294385|NCT02884089|4028525|FG002|STARTED|Washout Period 1||9
3294386|NCT02884089|4028526|FG003|STARTED|Washout Period 1||9
3294387|NCT02884089|4028523|FG000|COMPLETED|Washout Period 1||9
3294388|NCT02884089|4028524|FG001|COMPLETED|Washout Period 1||7
3294389|NCT02884089|4028525|FG002|COMPLETED|Washout Period 1||9
3294390|NCT02884089|4028526|FG003|COMPLETED|Washout Period 1||8
3294391|NCT02884089|4028523|FG000|NOT COMPLETED|Washout Period 1||0
3294392|NCT02884089|4028524|FG001|NOT COMPLETED|Washout Period 1||2
3115670|NCT01593696|3840353|FG002|STARTED|Dose Escalation||0
3115671|NCT01593696|3840354|FG003|STARTED|Dose Escalation||0
3115672|NCT01593696|3840351|FG000|Prior Transplant|Dose Escalation||7
3115673|NCT01593696|3840352|FG001|Prior Transplant|Dose Escalation||1
3294393|NCT02884089|4028525|FG002|NOT COMPLETED|Washout Period 1||0
3294394|NCT02884089|4028526|FG003|NOT COMPLETED|Washout Period 1||1
3294395|NCT02884089|4028523|FG000|STARTED|Period 2||9
3294396|NCT02884089|4028524|FG001|STARTED|Period 2||7
3115674|NCT01593696|3840353|FG002|Prior Transplant|Dose Escalation||0
3115675|NCT01593696|3840354|FG003|Prior Transplant|Dose Escalation||0
3115676|NCT01593696|3840351|FG000|No Prior Transplant|Dose Escalation||9
3115677|NCT01593696|3840352|FG001|No Prior Transplant|Dose Escalation||4
3115678|NCT01593696|3840353|FG002|No Prior Transplant|Dose Escalation||0
3115679|NCT01593696|3840354|FG003|No Prior Transplant|Dose Escalation||0
3115680|NCT01593696|3840351|FG000|COMPLETED|Dose Escalation||14
3115681|NCT01593696|3840352|FG001|COMPLETED|Dose Escalation||5
3115682|NCT01593696|3840353|FG002|COMPLETED|Dose Escalation||0
3115683|NCT01593696|3840354|FG003|COMPLETED|Dose Escalation||0
3115684|NCT01593696|3840351|FG000|NOT COMPLETED|Dose Escalation||2
3115685|NCT01593696|3840352|FG001|NOT COMPLETED|Dose Escalation||0
3115686|NCT01593696|3840353|FG002|NOT COMPLETED|Dose Escalation||0
3115687|NCT01593696|3840354|FG003|NOT COMPLETED|Dose Escalation||0
3115688|NCT01593696|3840351|FG000|STARTED|Dose Expansion||0
3115689|NCT01593696|3840352|FG001|STARTED|Dose Expansion||0
3115690|NCT01593696|3840353|FG002|STARTED|Dose Expansion||16
3115691|NCT01593696|3840354|FG003|STARTED|Dose Expansion||16
3115692|NCT01593696|3840351|FG000|COMPLETED|Dose Expansion||0
3115693|NCT01593696|3840352|FG001|COMPLETED|Dose Expansion||0
3115694|NCT01593696|3840353|FG002|COMPLETED|Dose Expansion||15
3115695|NCT01593696|3840354|FG003|COMPLETED|Dose Expansion||16
3115696|NCT01593696|3840351|FG000|NOT COMPLETED|Dose Expansion||0
3115697|NCT01593696|3840352|FG001|NOT COMPLETED|Dose Expansion||0
3115698|NCT01593696|3840353|FG002|NOT COMPLETED|Dose Expansion||1
3115699|NCT01593696|3840354|FG003|NOT COMPLETED|Dose Expansion||0
3115700|NCT01593722|3840366|FG000|STARTED|Overall Study||6
3115701|NCT01593722|3840367|FG001|STARTED|Overall Study||6
3115702|NCT01593722|3840366|FG000|COMPLETED|Overall Study||6
3115703|NCT01593722|3840367|FG001|COMPLETED|Overall Study||6
3115704|NCT01593722|3840366|FG000|NOT COMPLETED|Overall Study||0
3115705|NCT01593722|3840367|FG001|NOT COMPLETED|Overall Study||0
3115706|NCT01593748|3840377|FG000|STARTED|Overall Study||45
3115707|NCT01593748|3840378|FG001|STARTED|Overall Study||45
3115708|NCT01593748|3840377|FG000|COMPLETED|Overall Study||45
3115709|NCT01593748|3840378|FG001|COMPLETED|Overall Study||45
3115710|NCT01593748|3840377|FG000|NOT COMPLETED|Overall Study||0
3115711|NCT01593748|3840378|FG001|NOT COMPLETED|Overall Study||0
3115712|NCT01593787|3840387|FG000|STARTED|Overall Study||6
3115713|NCT01593787|3840388|FG001|STARTED|Overall Study||8
3115714|NCT01593787|3840389|FG002|STARTED|Overall Study||18
3115715|NCT01593787|3840387|FG000|COMPLETED|Overall Study||5
3115716|NCT01593787|3840388|FG001|COMPLETED|Overall Study||8
3115717|NCT01593787|3840389|FG002|COMPLETED|Overall Study||18
3115718|NCT01593787|3840387|FG000|NOT COMPLETED|Overall Study||1
3115719|NCT01593787|3840388|FG001|NOT COMPLETED|Overall Study||0
3294397|NCT02884089|4028525|FG002|STARTED|Period 2||9
3294398|NCT02884089|4028526|FG003|STARTED|Period 2||8
3294399|NCT02884089|4028523|FG000|COMPLETED|Period 2||8
3294400|NCT02884089|4028524|FG001|COMPLETED|Period 2||7
3294401|NCT02884089|4028525|FG002|COMPLETED|Period 2||9
3294402|NCT02884089|4028526|FG003|COMPLETED|Period 2||8
3294403|NCT02884089|4028523|FG000|NOT COMPLETED|Period 2||1
3294404|NCT02884089|4028524|FG001|NOT COMPLETED|Period 2||0
3294405|NCT02884089|4028525|FG002|NOT COMPLETED|Period 2||0
3294406|NCT02884089|4028526|FG003|NOT COMPLETED|Period 2||0
3294407|NCT02884089|4028523|FG000|STARTED|Washout Period 2||8
3294408|NCT02884089|4028524|FG001|STARTED|Washout Period 2||7
3294409|NCT02884089|4028525|FG002|STARTED|Washout Period 2||9
3294410|NCT02884089|4028526|FG003|STARTED|Washout Period 2||8
3294411|NCT02884089|4028523|FG000|COMPLETED|Washout Period 2||8
3294412|NCT02884089|4028524|FG001|COMPLETED|Washout Period 2||7
3294413|NCT02884089|4028525|FG002|COMPLETED|Washout Period 2||9
3294414|NCT02884089|4028526|FG003|COMPLETED|Washout Period 2||8
3294415|NCT02884089|4028523|FG000|NOT COMPLETED|Washout Period 2||0
3294416|NCT02884089|4028524|FG001|NOT COMPLETED|Washout Period 2||0
3294417|NCT02884089|4028525|FG002|NOT COMPLETED|Washout Period 2||0
3294418|NCT02884089|4028526|FG003|NOT COMPLETED|Washout Period 2||0
3294419|NCT02884089|4028523|FG000|STARTED|Period 3||8
3294420|NCT02884089|4028524|FG001|STARTED|Period 3||7
3294421|NCT02884089|4028525|FG002|STARTED|Period 3||9
3294422|NCT02884089|4028526|FG003|STARTED|Period 3||8
3294423|NCT02884089|4028523|FG000|COMPLETED|Period 3||8
3294424|NCT02884089|4028524|FG001|COMPLETED|Period 3||7
3294425|NCT02884089|4028525|FG002|COMPLETED|Period 3||8
3294426|NCT02884089|4028526|FG003|COMPLETED|Period 3||8
3294427|NCT02884089|4028523|FG000|NOT COMPLETED|Period 3||0
3294428|NCT02884089|4028524|FG001|NOT COMPLETED|Period 3||0
3294429|NCT02884089|4028525|FG002|NOT COMPLETED|Period 3||1
3294430|NCT02884089|4028526|FG003|NOT COMPLETED|Period 3||0
3294431|NCT02884089|4028523|FG000|STARTED|Washout Period 3||8
3294432|NCT02884089|4028524|FG001|STARTED|Washout Period 3||7
3294433|NCT02884089|4028525|FG002|STARTED|Washout Period 3||8
3294434|NCT02884089|4028526|FG003|STARTED|Washout Period 3||8
3115720|NCT01593787|3840389|FG002|NOT COMPLETED|Overall Study||0
3115721|NCT01593852|3840401|FG000|STARTED|Overall Study||68
3115722|NCT01593852|3840402|FG001|STARTED|Overall Study||68
3115723|NCT01593852|3840401|FG000|COMPLETED|Overall Study||68
3294435|NCT02884089|4028523|FG000|COMPLETED|Washout Period 3||8
3294436|NCT02884089|4028524|FG001|COMPLETED|Washout Period 3||7
3294437|NCT02884089|4028525|FG002|COMPLETED|Washout Period 3||7
3294438|NCT02884089|4028526|FG003|COMPLETED|Washout Period 3||7
3294439|NCT02884089|4028523|FG000|NOT COMPLETED|Washout Period 3||0
3294440|NCT02884089|4028524|FG001|NOT COMPLETED|Washout Period 3||0
3115724|NCT01593852|3840402|FG001|COMPLETED|Overall Study||68
3115725|NCT01593852|3840401|FG000|NOT COMPLETED|Overall Study||0
3115726|NCT01593852|3840402|FG001|NOT COMPLETED|Overall Study||0
3115727|NCT01593917|3840408|FG000|STARTED|Overall Study||329
3115728|NCT01593917|3840408|FG000|COMPLETED|Overall Study||159
3115729|NCT01593917|3840408|FG000|NOT COMPLETED|Overall Study||170
3115730|NCT01594125|3840417|FG000|STARTED|Overall Study||4
3115731|NCT01594125|3840418|FG001|STARTED|Overall Study||12
3115732|NCT01594125|3840419|FG002|STARTED|Overall Study||3
3115733|NCT01594125|3840420|FG003|STARTED|Overall Study||4
3115734|NCT01594125|3840421|FG004|STARTED|Overall Study||7
3115735|NCT01594125|3840417|FG000|COMPLETED|Overall Study||0
3115736|NCT01594125|3840418|FG001|COMPLETED|Overall Study||0
3115737|NCT01594125|3840419|FG002|COMPLETED|Overall Study||0
3115738|NCT01594125|3840420|FG003|COMPLETED|Overall Study||0
3115739|NCT01594125|3840421|FG004|COMPLETED|Overall Study||0
3115740|NCT01594125|3840417|FG000|NOT COMPLETED|Overall Study||4
3115741|NCT01594125|3840418|FG001|NOT COMPLETED|Overall Study||12
3115742|NCT01594125|3840419|FG002|NOT COMPLETED|Overall Study||3
3115743|NCT01594125|3840420|FG003|NOT COMPLETED|Overall Study||4
3115744|NCT01594125|3840421|FG004|NOT COMPLETED|Overall Study||7
3115745|NCT01594281|3840436|FG000|STARTED|Interventional Core Phase||36
3115746|NCT01594281|3840437|FG001|STARTED|Interventional Core Phase||36
3115747|NCT01594281|3840438|FG002|STARTED|Interventional Core Phase||36
3115748|NCT01594281|3840436|FG000|Full Analysis Set (FAS)|Interventional Core Phase||35
3115749|NCT01594281|3840437|FG001|Full Analysis Set (FAS)|Interventional Core Phase||35
3115750|NCT01594281|3840438|FG002|Full Analysis Set (FAS)|Interventional Core Phase||36
3115751|NCT01594281|3840436|FG000|COMPLETED|Interventional Core Phase||29
3115752|NCT01594281|3840437|FG001|COMPLETED|Interventional Core Phase||26
3115753|NCT01594281|3840438|FG002|COMPLETED|Interventional Core Phase||28
3115754|NCT01594281|3840436|FG000|NOT COMPLETED|Interventional Core Phase||7
3115755|NCT01594281|3840437|FG001|NOT COMPLETED|Interventional Core Phase||10
3115756|NCT01594281|3840438|FG002|NOT COMPLETED|Interventional Core Phase||8
3115757|NCT01594281|3840436|FG000|STARTED|Non-Interventional Follow Up Phase|1 patient exited after completing Core Phase and did not start the Follow-Up Phase|28
3115758|NCT01594281|3840437|FG001|STARTED|Non-Interventional Follow Up Phase|5 patients exited after completing Core Phase and did not start the Follow-Up Phase|21
3115759|NCT01594281|3840438|FG002|STARTED|Non-Interventional Follow Up Phase|3 patients exited after completing Core Phase and did not start the Follow-Up Phase|25
3115760|NCT01594281|3840436|FG000|Follow Up Set (FUS)|Non-Interventional Follow Up Phase||28
3115761|NCT01594281|3840437|FG001|Follow Up Set (FUS)|Non-Interventional Follow Up Phase||20
3115762|NCT01594281|3840438|FG002|Follow Up Set (FUS)|Non-Interventional Follow Up Phase||25
3115763|NCT01594281|3840436|FG000|COMPLETED|Non-Interventional Follow Up Phase||25
3115764|NCT01594281|3840437|FG001|COMPLETED|Non-Interventional Follow Up Phase||19
3115765|NCT01594281|3840438|FG002|COMPLETED|Non-Interventional Follow Up Phase||23
3115766|NCT01594281|3840436|FG000|NOT COMPLETED|Non-Interventional Follow Up Phase||3
3115767|NCT01594281|3840437|FG001|NOT COMPLETED|Non-Interventional Follow Up Phase||2
3115768|NCT01594281|3840438|FG002|NOT COMPLETED|Non-Interventional Follow Up Phase||2
3115769|NCT01594294|3840451|FG000|STARTED|Overall Study||39
3115770|NCT01594294|3840452|FG001|STARTED|Overall Study||40
3115771|NCT01594294|3840451|FG000|COMPLETED|Overall Study||36
3115772|NCT01594294|3840452|FG001|COMPLETED|Overall Study||36
3115773|NCT01594294|3840451|FG000|NOT COMPLETED|Overall Study||3
3115774|NCT01594294|3840452|FG001|NOT COMPLETED|Overall Study||4
3115775|NCT01594333|3840460|FG000|STARTED|Overall Study||2391
3115776|NCT01594333|3840461|FG001|STARTED|Overall Study||2395
3115777|NCT01594333|3840460|FG000|COMPLETED|Overall Study||2230
3115778|NCT01594333|3840461|FG001|COMPLETED|Overall Study||2244
3115779|NCT01594333|3840460|FG000|NOT COMPLETED|Overall Study||161
3115780|NCT01594333|3840461|FG001|NOT COMPLETED|Overall Study||151
3115781|NCT01594385|3840469|FG000|STARTED|Overall Study||17
3115782|NCT01594385|3840470|FG001|STARTED|Overall Study||13
3115783|NCT01594385|3840469|FG000|COMPLETED|Overall Study||17
3115784|NCT01594385|3840470|FG001|COMPLETED|Overall Study||13
3115785|NCT01594385|3840469|FG000|NOT COMPLETED|Overall Study||0
3115786|NCT01594385|3840470|FG001|NOT COMPLETED|Overall Study||0
3115787|NCT01594411|3840480|FG000|STARTED|Overall Study||251
3115788|NCT01594411|3840480|FG000|COMPLETED|Overall Study||249
3115789|NCT01594411|3840480|FG000|NOT COMPLETED|Overall Study||2
3115790|NCT01594424|3840487|FG000|STARTED|Overall Study||10
3115791|NCT01594424|3840487|FG000|COMPLETED|Overall Study||8
3115792|NCT01594424|3840487|FG000|NOT COMPLETED|Overall Study||2
3115793|NCT01594476|3840493|FG000|STARTED|Overall Study||101
3115794|NCT01594476|3840494|FG001|STARTED|Overall Study||100
3115795|NCT01594476|3840493|FG000|Received Intervention|Overall Study||66
3115796|NCT01594476|3840494|FG001|Received Intervention|Overall Study||73
3115797|NCT01594476|3840493|FG000|Excluded After Allocation|Overall Study||1
3115798|NCT01594476|3840494|FG001|Excluded After Allocation|Overall Study||3
3115799|NCT01594476|3840493|FG000|IUD Removal|Overall Study||3
3115800|NCT01594476|3840494|FG001|IUD Removal|Overall Study||5
3294441|NCT02884089|4028525|FG002|NOT COMPLETED|Washout Period 3||1
3294442|NCT02884089|4028526|FG003|NOT COMPLETED|Washout Period 3||1
3294443|NCT02884089|4028523|FG000|STARTED|Period 4||8
3294444|NCT02884089|4028524|FG001|STARTED|Period 4||7
3294445|NCT02884089|4028525|FG002|STARTED|Period 4||7
3294446|NCT02884089|4028526|FG003|STARTED|Period 4||7
3115801|NCT01594476|3840493|FG000|IUD Expulsion|Overall Study||2
3294447|NCT02884089|4028523|FG000|COMPLETED|Period 4||7
3294448|NCT02884089|4028524|FG001|COMPLETED|Period 4||6
3115802|NCT01594476|3840494|FG001|IUD Expulsion|Overall Study||0
3115803|NCT01594476|3840493|FG000|Pregnant|Overall Study||2
3115804|NCT01594476|3840494|FG001|Pregnant|Overall Study||5
3115805|NCT01594476|3840493|FG000|COMPLETED|Overall Study||100
3115806|NCT01594476|3840494|FG001|COMPLETED|Overall Study||97
3115807|NCT01594476|3840493|FG000|NOT COMPLETED|Overall Study||1
3115808|NCT01594476|3840494|FG001|NOT COMPLETED|Overall Study||3
3115809|NCT01594515|3840514|FG000|STARTED|Overall Study||6
3115810|NCT01594515|3840515|FG001|STARTED|Overall Study||6
3115811|NCT01594515|3840516|FG002|STARTED|Overall Study||6
3115812|NCT01594515|3840517|FG003|STARTED|Overall Study||6
3115813|NCT01594515|3840518|FG004|STARTED|Overall Study||6
3115814|NCT01594515|3840519|FG005|STARTED|Overall Study||6
3115815|NCT01594515|3840520|FG006|STARTED|Overall Study||6
3115816|NCT01594515|3840521|FG007|STARTED|Overall Study||6
3294449|NCT02884089|4028525|FG002|COMPLETED|Period 4||7
3294450|NCT02884089|4028526|FG003|COMPLETED|Period 4||7
3294451|NCT02884089|4028523|FG000|NOT COMPLETED|Period 4||1
3294452|NCT02884089|4028524|FG001|NOT COMPLETED|Period 4||1
3294453|NCT02884089|4028525|FG002|NOT COMPLETED|Period 4||0
3294454|NCT02884089|4028526|FG003|NOT COMPLETED|Period 4||0
3294455|NCT02884089|4028523|FG000|STARTED|Follow-up Visit||7
3294456|NCT02884089|4028524|FG001|STARTED|Follow-up Visit||6
3294457|NCT02884089|4028525|FG002|STARTED|Follow-up Visit||7
3294458|NCT02884089|4028526|FG003|STARTED|Follow-up Visit||7
3294459|NCT02884089|4028523|FG000|COMPLETED|Follow-up Visit||6
3294460|NCT02884089|4028524|FG001|COMPLETED|Follow-up Visit||6
3294461|NCT02884089|4028525|FG002|COMPLETED|Follow-up Visit||7
3294462|NCT02884089|4028526|FG003|COMPLETED|Follow-up Visit||6
3294463|NCT02884089|4028523|FG000|NOT COMPLETED|Follow-up Visit||1
3294464|NCT02884089|4028524|FG001|NOT COMPLETED|Follow-up Visit||0
3294465|NCT02884089|4028525|FG002|NOT COMPLETED|Follow-up Visit||0
3294466|NCT02884089|4028526|FG003|NOT COMPLETED|Follow-up Visit||1
3294467|NCT02884414|4028536|FG000|STARTED|Overall Study||56
3294468|NCT02884414|4028536|FG000|COMPLETED|Overall Study||56
3294469|NCT02884414|4028536|FG000|NOT COMPLETED|Overall Study||0
3294470|NCT02884427|4028543|FG000|STARTED|Overall Study||48
3294471|NCT02884427|4028544|FG001|STARTED|Overall Study||52
3294472|NCT02884427|4028545|FG002|STARTED|Overall Study||50
3294473|NCT02884427|4028543|FG000|COMPLETED|Overall Study||48
3294474|NCT02884427|4028544|FG001|COMPLETED|Overall Study||52
3294475|NCT02884427|4028545|FG002|COMPLETED|Overall Study||50
3294476|NCT02884427|4028543|FG000|NOT COMPLETED|Overall Study||0
3294477|NCT02884427|4028544|FG001|NOT COMPLETED|Overall Study||0
3294478|NCT02884427|4028545|FG002|NOT COMPLETED|Overall Study||0
3294479|NCT02884492|4028555|FG000|STARTED|Overall Study||7
3294480|NCT02884492|4028556|FG001|STARTED|Overall Study||10
3294481|NCT02884492|4028555|FG000|COMPLETED|Overall Study||7
3294482|NCT02884492|4028556|FG001|COMPLETED|Overall Study||10
3294483|NCT02884492|4028555|FG000|NOT COMPLETED|Overall Study||0
3294484|NCT02884492|4028556|FG001|NOT COMPLETED|Overall Study||0
3294485|NCT02885012|4028564|FG000|STARTED|Overall Study||1
3294486|NCT02885012|4028565|FG001|STARTED|Overall Study||2
3294487|NCT02885012|4028564|FG000|COMPLETED|Overall Study||1
3294488|NCT02885012|4028565|FG001|COMPLETED|Overall Study||2
3294489|NCT02885012|4028564|FG000|NOT COMPLETED|Overall Study||0
3294490|NCT02885012|4028565|FG001|NOT COMPLETED|Overall Study||0
3294491|NCT02885025|4028575|FG000|STARTED|Overall Study||16
3294492|NCT02885025|4028576|FG001|STARTED|Overall Study||14
3294493|NCT02885025|4028577|FG002|STARTED|Overall Study||9
3294494|NCT02885025|4028578|FG003|STARTED|Overall Study||8
3294495|NCT02885025|4028575|FG000|COMPLETED|Overall Study||16
3294496|NCT02885025|4028576|FG001|COMPLETED|Overall Study||12
3294497|NCT02885025|4028577|FG002|COMPLETED|Overall Study||9
3294498|NCT02885025|4028578|FG003|COMPLETED|Overall Study||8
3294499|NCT02885025|4028575|FG000|NOT COMPLETED|Overall Study||0
3294500|NCT02885025|4028576|FG001|NOT COMPLETED|Overall Study||2
3294501|NCT02885025|4028577|FG002|NOT COMPLETED|Overall Study||0
3294502|NCT02885025|4028578|FG003|NOT COMPLETED|Overall Study||0
3294503|NCT02885181|4028596|FG000|STARTED|Overall Study||20
3294504|NCT02885181|4028597|FG001|STARTED|Overall Study||20
3294505|NCT02885181|4028598|FG002|STARTED|Overall Study||21
3294506|NCT02885181|4028599|FG003|STARTED|Overall Study||22
3294507|NCT02885181|4028596|FG000|COMPLETED|Overall Study||20
3294508|NCT02885181|4028597|FG001|COMPLETED|Overall Study||19
3294509|NCT02885181|4028598|FG002|COMPLETED|Overall Study||21
3294510|NCT02885181|4028599|FG003|COMPLETED|Overall Study||19
3294511|NCT02885181|4028596|FG000|NOT COMPLETED|Overall Study||0
3294512|NCT02885181|4028597|FG001|NOT COMPLETED|Overall Study||1
3294513|NCT02885181|4028598|FG002|NOT COMPLETED|Overall Study||0
3294514|NCT02885181|4028599|FG003|NOT COMPLETED|Overall Study||3
3294515|NCT02885246|4028613|FG000|STARTED|Overall Study||1839
3294516|NCT02885246|4028613|FG000|COMPLETED|Overall Study||1839
3294517|NCT02885246|4028613|FG000|NOT COMPLETED|Overall Study||0
3316833|NCT03119831|4050316|FG001|STARTED|Overall Study||14
3316834|NCT03119831|4050317|FG002|STARTED|Overall Study||14
3316835|NCT03119831|4050315|FG000|COMPLETED|Overall Study||14
3316836|NCT03119831|4050316|FG001|COMPLETED|Overall Study||14
3316837|NCT03119831|4050317|FG002|COMPLETED|Overall Study||14
3316838|NCT03119831|4050315|FG000|NOT COMPLETED|Overall Study||0
3316839|NCT03119831|4050316|FG001|NOT COMPLETED|Overall Study||0
3316840|NCT03119831|4050317|FG002|NOT COMPLETED|Overall Study||0
3316841|NCT03120013|4050328|FG000|STARTED|First Intervention (2 Weeks)||10
3115817|NCT01594515|3840522|FG008|STARTED|Overall Study||6
3115818|NCT01594515|3840523|FG009|STARTED|Overall Study||16
3115819|NCT01594515|3840514|FG000|COMPLETED|Overall Study||6
3115820|NCT01594515|3840515|FG001|COMPLETED|Overall Study||6
3115821|NCT01594515|3840516|FG002|COMPLETED|Overall Study||6
3115822|NCT01594515|3840517|FG003|COMPLETED|Overall Study||6
3115823|NCT01594515|3840518|FG004|COMPLETED|Overall Study||6
3115824|NCT01594515|3840519|FG005|COMPLETED|Overall Study||6
3115825|NCT01594515|3840520|FG006|COMPLETED|Overall Study||6
3115826|NCT01594515|3840521|FG007|COMPLETED|Overall Study||6
3115827|NCT01594515|3840522|FG008|COMPLETED|Overall Study||6
3115828|NCT01594515|3840523|FG009|COMPLETED|Overall Study||16
3115829|NCT01594515|3840514|FG000|NOT COMPLETED|Overall Study||0
3115830|NCT01594515|3840515|FG001|NOT COMPLETED|Overall Study||0
3115831|NCT01594515|3840516|FG002|NOT COMPLETED|Overall Study||0
3115832|NCT01594515|3840517|FG003|NOT COMPLETED|Overall Study||0
3115833|NCT01594515|3840518|FG004|NOT COMPLETED|Overall Study||0
3115834|NCT01594515|3840519|FG005|NOT COMPLETED|Overall Study||0
3115835|NCT01594515|3840520|FG006|NOT COMPLETED|Overall Study||0
3115836|NCT01594515|3840521|FG007|NOT COMPLETED|Overall Study||0
3115837|NCT01594515|3840522|FG008|NOT COMPLETED|Overall Study||0
3115838|NCT01594515|3840523|FG009|NOT COMPLETED|Overall Study||0
3115839|NCT01594528|3840548|FG000|STARTED|Overall Study||16
3115840|NCT01594528|3840549|FG001|STARTED|Overall Study||17
3115841|NCT01594528|3840550|FG002|STARTED|Overall Study||16
3115842|NCT01594528|3840548|FG000|COMPLETED|Overall Study||16
3115843|NCT01594528|3840549|FG001|COMPLETED|Overall Study||17
3115844|NCT01594528|3840550|FG002|COMPLETED|Overall Study||16
3115845|NCT01594528|3840548|FG000|NOT COMPLETED|Overall Study||0
3115846|NCT01594528|3840549|FG001|NOT COMPLETED|Overall Study||0
3115847|NCT01594528|3840550|FG002|NOT COMPLETED|Overall Study||0
3115848|NCT01594749|3840558|FG000|STARTED|Overall Study||507
3115849|NCT01594749|3840559|FG001|STARTED|Overall Study||508
3115850|NCT01594749|3840558|FG000|Treated|Overall Study||503
3115851|NCT01594749|3840559|FG001|Treated|Overall Study||498
3115852|NCT01594749|3840558|FG000|COMPLETED|Overall Study||485
3115853|NCT01594749|3840559|FG001|COMPLETED|Overall Study||490
3115854|NCT01594749|3840558|FG000|NOT COMPLETED|Overall Study||22
3115855|NCT01594749|3840559|FG001|NOT COMPLETED|Overall Study||18
3115856|NCT01594762|3840567|FG000|STARTED|Overall Study||97
3115857|NCT01594762|3840568|FG001|STARTED|Overall Study||103
3115858|NCT01594762|3840567|FG000|COMPLETED|Overall Study||86
3115859|NCT01594762|3840568|FG001|COMPLETED|Overall Study||93
3115860|NCT01594762|3840567|FG000|NOT COMPLETED|Overall Study||11
3294518|NCT02885350|4028621|FG000|STARTED|Overall Study||20
3294519|NCT02885350|4028622|FG001|STARTED|Overall Study||20
3294520|NCT02885350|4028623|FG002|STARTED|Overall Study||20
3294521|NCT02885350|4028624|FG003|STARTED|Overall Study||20
3294522|NCT02885350|4028621|FG000|COMPLETED|Overall Study||20
3294523|NCT02885350|4028622|FG001|COMPLETED|Overall Study||20
3294524|NCT02885350|4028623|FG002|COMPLETED|Overall Study||20
3294525|NCT02885350|4028624|FG003|COMPLETED|Overall Study||20
3294526|NCT02885350|4028621|FG000|NOT COMPLETED|Overall Study||0
3294527|NCT02885350|4028622|FG001|NOT COMPLETED|Overall Study||0
3294528|NCT02885350|4028623|FG002|NOT COMPLETED|Overall Study||0
3294529|NCT02885350|4028624|FG003|NOT COMPLETED|Overall Study||0
3294530|NCT02885506|4028644|FG000|STARTED|Part A||6
3294531|NCT02885506|4028645|FG001|STARTED|Part A||6
3294532|NCT02885506|4028646|FG002|STARTED|Part A||6
3294533|NCT02885506|4028647|FG003|STARTED|Part A||6
3294534|NCT02885506|4028648|FG004|STARTED|Part A||6
3294535|NCT02885506|4028649|FG005|STARTED|Part A||6
3294536|NCT02885506|4028650|FG006|STARTED|Part A||6
3294537|NCT02885506|4028651|FG007|STARTED|Part A||14
3294538|NCT02885506|4028652|FG008|STARTED|Part A||0
3294539|NCT02885506|4028653|FG009|STARTED|Part A||0
3294540|NCT02885506|4028644|FG000|COMPLETED|Part A||6
3294541|NCT02885506|4028645|FG001|COMPLETED|Part A||6
3294542|NCT02885506|4028646|FG002|COMPLETED|Part A||6
3294543|NCT02885506|4028647|FG003|COMPLETED|Part A||6
3294544|NCT02885506|4028648|FG004|COMPLETED|Part A||6
3294545|NCT02885506|4028649|FG005|COMPLETED|Part A||6
3294546|NCT02885506|4028650|FG006|COMPLETED|Part A||6
3294547|NCT02885506|4028651|FG007|COMPLETED|Part A||14
3294548|NCT02885506|4028652|FG008|COMPLETED|Part A||0
3294549|NCT02885506|4028653|FG009|COMPLETED|Part A||0
3294550|NCT02885506|4028644|FG000|NOT COMPLETED|Part A||0
3294551|NCT02885506|4028645|FG001|NOT COMPLETED|Part A||0
3294552|NCT02885506|4028646|FG002|NOT COMPLETED|Part A||0
3294553|NCT02885506|4028647|FG003|NOT COMPLETED|Part A||0
3294554|NCT02885506|4028648|FG004|NOT COMPLETED|Part A||0
3294555|NCT02885506|4028649|FG005|NOT COMPLETED|Part A||0
3294556|NCT02885506|4028650|FG006|NOT COMPLETED|Part A||0
3294557|NCT02885506|4028651|FG007|NOT COMPLETED|Part A||0
3294558|NCT02885506|4028652|FG008|NOT COMPLETED|Part A||0
3294559|NCT02885506|4028653|FG009|NOT COMPLETED|Part A||0
3294560|NCT02885506|4028644|FG000|STARTED|Part B||0
3294561|NCT02885506|4028645|FG001|STARTED|Part B||0
3294562|NCT02885506|4028646|FG002|STARTED|Part B||0
3294563|NCT02885506|4028647|FG003|STARTED|Part B||0
3115861|NCT01594762|3840568|FG001|NOT COMPLETED|Overall Study||10
3115862|NCT01594827|3840576|FG000|STARTED|Overall Study||14
3115863|NCT01594827|3840577|FG001|STARTED|Overall Study||15
3115864|NCT01594827|3840576|FG000|COMPLETED|Overall Study||10
3294564|NCT02885506|4028648|FG004|STARTED|Part B||0
3294565|NCT02885506|4028649|FG005|STARTED|Part B||0
3294566|NCT02885506|4028650|FG006|STARTED|Part B||0
3294567|NCT02885506|4028651|FG007|STARTED|Part B||0
3294568|NCT02885506|4028652|FG008|STARTED|Part B||4
3115865|NCT01594827|3840577|FG001|COMPLETED|Overall Study||15
3115866|NCT01594827|3840576|FG000|NOT COMPLETED|Overall Study||4
3115867|NCT01594827|3840577|FG001|NOT COMPLETED|Overall Study||0
3115868|NCT01594853|3840587|FG000|STARTED|Overall Study||16
3115869|NCT01594853|3840588|FG001|STARTED|Overall Study||15
3115870|NCT01594853|3840587|FG000|COMPLETED|Overall Study||14
3115871|NCT01594853|3840588|FG001|COMPLETED|Overall Study||12
3115872|NCT01594853|3840587|FG000|NOT COMPLETED|Overall Study||2
3115873|NCT01594853|3840588|FG001|NOT COMPLETED|Overall Study||3
3115874|NCT01594931|3840597|FG000|STARTED|Overall Study||160
3115875|NCT01594931|3840598|FG001|STARTED|Overall Study||157
3115876|NCT01594931|3840599|FG002|STARTED|Overall Study|One randomized subject was not treated.|160
3115877|NCT01594931|3840597|FG000|COMPLETED|Overall Study||131
3115878|NCT01594931|3840598|FG001|COMPLETED|Overall Study||145
3115879|NCT01594931|3840599|FG002|COMPLETED|Overall Study||146
3115880|NCT01594931|3840597|FG000|NOT COMPLETED|Overall Study||29
3115881|NCT01594931|3840598|FG001|NOT COMPLETED|Overall Study||12
3115882|NCT01594931|3840599|FG002|NOT COMPLETED|Overall Study||14
3115883|NCT01594970|3840610|FG000|STARTED|Overall Study||295
3115884|NCT01594970|3840611|FG001|STARTED|Overall Study||248
3115885|NCT01594970|3840612|FG002|STARTED|Overall Study||257
3115886|NCT01594970|3840610|FG000|COMPLETED|Overall Study||220
3115887|NCT01594970|3840611|FG001|COMPLETED|Overall Study||166
3115888|NCT01594970|3840612|FG002|COMPLETED|Overall Study||191
3115889|NCT01594970|3840610|FG000|NOT COMPLETED|Overall Study||75
3115890|NCT01594970|3840611|FG001|NOT COMPLETED|Overall Study||82
3115891|NCT01594970|3840612|FG002|NOT COMPLETED|Overall Study||66
3115892|NCT01595282|3840622|FG000|STARTED|Overall Study||47
3115893|NCT01595282|3840623|FG001|STARTED|Overall Study||47
3115894|NCT01595282|3840622|FG000|COMPLETED|Overall Study||47
3115895|NCT01595282|3840623|FG001|COMPLETED|Overall Study||47
3115896|NCT01595282|3840622|FG000|NOT COMPLETED|Overall Study||0
3115897|NCT01595282|3840623|FG001|NOT COMPLETED|Overall Study||0
3136020|NCT01710033|3861124|FG000|COMPLETED|Stage 1||6
3136021|NCT01710033|3861125|FG001|COMPLETED|Stage 1||6
3136022|NCT01710033|3861126|FG002|COMPLETED|Stage 1||6
3136023|NCT01710033|3861127|FG003|COMPLETED|Stage 1||6
3136024|NCT01710033|3861128|FG004|COMPLETED|Stage 1||0
3136025|NCT01710033|3861124|FG000|NOT COMPLETED|Stage 1||0
3136026|NCT01710033|3861125|FG001|NOT COMPLETED|Stage 1||0
3136027|NCT01710033|3861126|FG002|NOT COMPLETED|Stage 1||0
3136028|NCT01710033|3861127|FG003|NOT COMPLETED|Stage 1||0
3136029|NCT01710033|3861128|FG004|NOT COMPLETED|Stage 1||0
3136030|NCT01710033|3861124|FG000|STARTED|Stage 2||0
3136031|NCT01710033|3861125|FG001|STARTED|Stage 2||0
3136032|NCT01710033|3861126|FG002|STARTED|Stage 2||0
3136033|NCT01710033|3861127|FG003|STARTED|Stage 2||0
3136034|NCT01710033|3861128|FG004|STARTED|Stage 2||4
3136035|NCT01710033|3861124|FG000|COMPLETED|Stage 2||0
3136036|NCT01710033|3861125|FG001|COMPLETED|Stage 2||0
3136037|NCT01710033|3861126|FG002|COMPLETED|Stage 2||0
3136038|NCT01710033|3861127|FG003|COMPLETED|Stage 2||0
3136039|NCT01710033|3861128|FG004|COMPLETED|Stage 2||3
3136040|NCT01710033|3861124|FG000|NOT COMPLETED|Stage 2||0
3136041|NCT01710033|3861125|FG001|NOT COMPLETED|Stage 2||0
3136042|NCT01710033|3861126|FG002|NOT COMPLETED|Stage 2||0
3136043|NCT01710033|3861127|FG003|NOT COMPLETED|Stage 2||0
3136044|NCT01710033|3861128|FG004|NOT COMPLETED|Stage 2||1
3136045|NCT01710046|3861143|FG000|STARTED|Overall Study||9
3136046|NCT01710046|3861144|FG001|STARTED|Overall Study||3
3136047|NCT01710046|3861143|FG000|COMPLETED|Overall Study||8
3136048|NCT01710046|3861144|FG001|COMPLETED|Overall Study||3
3136049|NCT01710046|3861143|FG000|NOT COMPLETED|Overall Study||1
3136050|NCT01710046|3861144|FG001|NOT COMPLETED|Overall Study||0
3136051|NCT01710137|3861152|FG000|STARTED|Overall Study||89
3136052|NCT01710137|3861153|FG001|STARTED|Overall Study||90
3136053|NCT01710137|3861152|FG000|COMPLETED|Overall Study||65
3136054|NCT01710137|3861153|FG001|COMPLETED|Overall Study||76
3136055|NCT01710137|3861152|FG000|NOT COMPLETED|Overall Study||24
3136056|NCT01710137|3861153|FG001|NOT COMPLETED|Overall Study||14
3136057|NCT01710254|3861159|FG000|STARTED|Overall Study||30
3136058|NCT01710254|3861159|FG000|COMPLETED|Overall Study||30
3136059|NCT01710254|3861159|FG000|NOT COMPLETED|Overall Study||0
3136060|NCT01710306|3861165|FG000|STARTED|Overall Study||86
3136061|NCT01710306|3861166|FG001|STARTED|Overall Study||85
3136062|NCT01710306|3861165|FG000|COMPLETED|Overall Study||68
3136063|NCT01710306|3861166|FG001|COMPLETED|Overall Study||55
3136064|NCT01710306|3861165|FG000|NOT COMPLETED|Overall Study||18
3136065|NCT01710306|3861166|FG001|NOT COMPLETED|Overall Study||30
3136066|NCT01710332|3861175|FG000|STARTED|Overall Study||6
3136067|NCT01710332|3861176|FG001|STARTED|Overall Study||6
3136068|NCT01710332|3861175|FG000|COMPLETED|Overall Study||6
3136069|NCT01710332|3861176|FG001|COMPLETED|Overall Study||6
3136070|NCT01710332|3861175|FG000|NOT COMPLETED|Overall Study||0
3136071|NCT01710332|3861176|FG001|NOT COMPLETED|Overall Study||0
3136072|NCT01710345|3861185|FG000|STARTED|Overall Study|41 patients were randomized to sufentanil 20 mcg, one patient not dosed due to damaged medication.|40
3136073|NCT01710345|3861186|FG001|STARTED|Overall Study||40
3136074|NCT01710345|3861187|FG002|STARTED|Overall Study||20
3136075|NCT01710345|3861185|FG000|COMPLETED|Overall Study||37
3136076|NCT01710345|3861186|FG001|COMPLETED|Overall Study||35
3136077|NCT01710345|3861187|FG002|COMPLETED|Overall Study||19
3136078|NCT01710345|3861185|FG000|NOT COMPLETED|Overall Study||3
3136079|NCT01710345|3861186|FG001|NOT COMPLETED|Overall Study||5
3136080|NCT01710345|3861187|FG002|NOT COMPLETED|Overall Study||1
3115898|NCT01595386|3840631|FG000|STARTED|Overall Study||21
3115899|NCT01595386|3840632|FG001|STARTED|Overall Study||19
3115900|NCT01595386|3840631|FG000|COMPLETED|Overall Study||21
3115901|NCT01595386|3840632|FG001|COMPLETED|Overall Study||19
3115902|NCT01595386|3840631|FG000|NOT COMPLETED|Overall Study||0
3115903|NCT01595386|3840632|FG001|NOT COMPLETED|Overall Study||0
3115904|NCT01595438|3840640|FG000|STARTED|Overall Study||516
3115905|NCT01595438|3840641|FG001|STARTED|Overall Study||517
3115906|NCT01595438|3840640|FG000|COMPLETED|Overall Study||473
3115907|NCT01595438|3840641|FG001|COMPLETED|Overall Study||476
3115908|NCT01595438|3840640|FG000|NOT COMPLETED|Overall Study||43
3115909|NCT01595438|3840641|FG001|NOT COMPLETED|Overall Study||41
3115910|NCT01595516|3840650|FG000|STARTED|Overall Study||16
3115911|NCT01595516|3840651|FG001|STARTED|Overall Study||16
3115912|NCT01595516|3840652|FG002|STARTED|Overall Study||12
3115913|NCT01595516|3840650|FG000|COMPLETED|Overall Study||16
3115914|NCT01595516|3840651|FG001|COMPLETED|Overall Study||16
3115915|NCT01595516|3840652|FG002|COMPLETED|Overall Study||12
3115916|NCT01595516|3840650|FG000|NOT COMPLETED|Overall Study||0
3115917|NCT01595516|3840651|FG001|NOT COMPLETED|Overall Study||0
3115918|NCT01595516|3840652|FG002|NOT COMPLETED|Overall Study||0
3115919|NCT01595529|3840676|FG000|STARTED|Overall Study||348
3115920|NCT01595529|3840677|FG001|STARTED|Overall Study||345
3115921|NCT01595529|3840676|FG000|Treated|Overall Study||337
3115922|NCT01595529|3840677|FG001|Treated|Overall Study||340
3115923|NCT01595529|3840676|FG000|Evaluated for Primary Endpoint, ITT|Overall Study||328
3115924|NCT01595529|3840677|FG001|Evaluated for Primary Endpoint, ITT|Overall Study||336
3115925|NCT01595529|3840676|FG000|ITT Without Treatment Failure|Overall Study||326
3115926|NCT01595529|3840677|FG001|ITT Without Treatment Failure|Overall Study||322
3115927|NCT01595529|3840676|FG000|ITT With Stool Sample at TOC|Overall Study||298
3115928|NCT01595529|3840677|FG001|ITT With Stool Sample at TOC|Overall Study||310
3115929|NCT01595529|3840676|FG000|Per-protocol, Completed 80% of Dose|Overall Study||308
3115930|NCT01595529|3840677|FG001|Per-protocol, Completed 80% of Dose|Overall Study||314
3115931|NCT01595529|3840676|FG000|Per-protocol Without Treatment Failure|Overall Study||306
3115932|NCT01595529|3840677|FG001|Per-protocol Without Treatment Failure|Overall Study||305
3115933|NCT01595529|3840676|FG000|Per-protocol With Stool Sample at TOC|Overall Study||280
3115934|NCT01595529|3840677|FG001|Per-protocol With Stool Sample at TOC|Overall Study||289
3115935|NCT01595529|3840676|FG000|Completed All Milestones|Overall Study||318
3115936|NCT01595529|3840677|FG001|Completed All Milestones|Overall Study||318
3115937|NCT01595529|3840676|FG000|COMPLETED|Overall Study||324
3115938|NCT01595529|3840677|FG001|COMPLETED|Overall Study||325
3115939|NCT01595529|3840676|FG000|NOT COMPLETED|Overall Study||24
3115940|NCT01595529|3840677|FG001|NOT COMPLETED|Overall Study||20
3115941|NCT01595646|3840686|FG000|STARTED|Overall Study||13
3115942|NCT01595646|3840687|FG001|STARTED|Overall Study||12
3115943|NCT01595646|3840688|FG002|STARTED|Overall Study||12
3115944|NCT01595646|3840686|FG000|COMPLETED|Overall Study||12
3115945|NCT01595646|3840687|FG001|COMPLETED|Overall Study||12
3115946|NCT01595646|3840688|FG002|COMPLETED|Overall Study||12
3115947|NCT01595646|3840686|FG000|NOT COMPLETED|Overall Study||1
3115948|NCT01595646|3840687|FG001|NOT COMPLETED|Overall Study||0
3115949|NCT01595646|3840688|FG002|NOT COMPLETED|Overall Study||0
3115950|NCT01595854|3840704|FG000|STARTED|Overall Study||8
3115951|NCT01595854|3840705|FG001|STARTED|Overall Study||4
3115952|NCT01595854|3840706|FG002|STARTED|Overall Study||8
3115953|NCT01595854|3840707|FG003|STARTED|Overall Study||4
3115954|NCT01595854|3840708|FG004|STARTED|Overall Study||12
3115955|NCT01595854|3840704|FG000|COMPLETED|Overall Study||8
3115956|NCT01595854|3840705|FG001|COMPLETED|Overall Study||4
3115957|NCT01595854|3840706|FG002|COMPLETED|Overall Study||8
3115958|NCT01595854|3840707|FG003|COMPLETED|Overall Study||4
3115959|NCT01595854|3840708|FG004|COMPLETED|Overall Study||12
3115960|NCT01595854|3840704|FG000|NOT COMPLETED|Overall Study||0
3115961|NCT01595854|3840705|FG001|NOT COMPLETED|Overall Study||0
3115962|NCT01595854|3840706|FG002|NOT COMPLETED|Overall Study||0
3115963|NCT01595854|3840707|FG003|NOT COMPLETED|Overall Study||0
3115964|NCT01595854|3840708|FG004|NOT COMPLETED|Overall Study||0
3294569|NCT02885506|4028653|FG009|STARTED|Part B||4
3294570|NCT02885506|4028644|FG000|COMPLETED|Part B||0
3294571|NCT02885506|4028645|FG001|COMPLETED|Part B||0
3294572|NCT02885506|4028646|FG002|COMPLETED|Part B||0
3294573|NCT02885506|4028647|FG003|COMPLETED|Part B||0
3294574|NCT02885506|4028648|FG004|COMPLETED|Part B||0
3294575|NCT02885506|4028649|FG005|COMPLETED|Part B||0
3115965|NCT01596062|3840729|FG000|STARTED|Overall Study||3
3115966|NCT01596062|3840730|FG001|STARTED|Overall Study||6
3115967|NCT01596062|3840731|FG002|STARTED|Overall Study||7
3115968|NCT01596062|3840729|FG000|COMPLETED|Overall Study||2
3115969|NCT01596062|3840730|FG001|COMPLETED|Overall Study||6
3115970|NCT01596062|3840731|FG002|COMPLETED|Overall Study||4
3115971|NCT01596062|3840729|FG000|NOT COMPLETED|Overall Study||1
3115972|NCT01596062|3840730|FG001|NOT COMPLETED|Overall Study||0
3115973|NCT01596062|3840731|FG002|NOT COMPLETED|Overall Study||3
3115974|NCT01596088|3840739|FG000|STARTED|Overall Study||2
3115975|NCT01596088|3840739|FG000|COMPLETED|Overall Study||2
3115976|NCT01596088|3840739|FG000|NOT COMPLETED|Overall Study||0
3294576|NCT02885506|4028650|FG006|COMPLETED|Part B||0
3294577|NCT02885506|4028651|FG007|COMPLETED|Part B||0
3294578|NCT02885506|4028652|FG008|COMPLETED|Part B||4
3294579|NCT02885506|4028653|FG009|COMPLETED|Part B||4
3294580|NCT02885506|4028644|FG000|NOT COMPLETED|Part B||0
3294581|NCT02885506|4028645|FG001|NOT COMPLETED|Part B||0
3115977|NCT01596127|3840743|FG000|STARTED|Overall Study||4
3115978|NCT01596127|3840743|FG000|COMPLETED|Overall Study||3
3115979|NCT01596127|3840743|FG000|NOT COMPLETED|Overall Study||1
3115980|NCT01596231|3840749|FG000|STARTED|Overall Study||10
3115981|NCT01596231|3840750|FG001|STARTED|Overall Study||10
3115982|NCT01596231|3840749|FG000|COMPLETED|Overall Study||10
3294582|NCT02885506|4028646|FG002|NOT COMPLETED|Part B||0
3294583|NCT02885506|4028647|FG003|NOT COMPLETED|Part B||0
3294584|NCT02885506|4028648|FG004|NOT COMPLETED|Part B||0
3115983|NCT01596231|3840750|FG001|COMPLETED|Overall Study||10
3115984|NCT01596231|3840749|FG000|NOT COMPLETED|Overall Study||0
3115985|NCT01596231|3840750|FG001|NOT COMPLETED|Overall Study||0
3115986|NCT01596283|3840758|FG000|STARTED|Overall Study||69
3115987|NCT01596283|3840759|FG001|STARTED|Overall Study||66
3115988|NCT01596283|3840758|FG000|COMPLETED|Overall Study||69
3115989|NCT01596283|3840759|FG001|COMPLETED|Overall Study||66
3115990|NCT01596283|3840758|FG000|NOT COMPLETED|Overall Study||0
3115991|NCT01596283|3840759|FG001|NOT COMPLETED|Overall Study||0
3115992|NCT01596335|3840769|FG000|STARTED|Overall Study||16
3115993|NCT01596335|3840770|FG001|STARTED|Overall Study||15
3115994|NCT01596335|3840769|FG000|COMPLETED|Overall Study||11
3115995|NCT01596335|3840770|FG001|COMPLETED|Overall Study||6
3115996|NCT01596335|3840769|FG000|NOT COMPLETED|Overall Study||5
3115997|NCT01596335|3840770|FG001|NOT COMPLETED|Overall Study||9
3115998|NCT01596504|3840779|FG000|STARTED|Overall Study||48
3115999|NCT01596504|3840780|FG001|STARTED|Overall Study||47
3116000|NCT01596504|3840781|FG002|STARTED|Overall Study||47
3116001|NCT01596504|3840779|FG000|COMPLETED|Overall Study||46
3116002|NCT01596504|3840780|FG001|COMPLETED|Overall Study||44
3116003|NCT01596504|3840781|FG002|COMPLETED|Overall Study||46
3116004|NCT01596504|3840779|FG000|NOT COMPLETED|Overall Study||2
3116005|NCT01596504|3840780|FG001|NOT COMPLETED|Overall Study||3
3116006|NCT01596504|3840781|FG002|NOT COMPLETED|Overall Study||1
3116007|NCT01596582|3840792|FG000|STARTED|Overall Study||172
3116008|NCT01596582|3840793|FG001|STARTED|Overall Study||180
3116009|NCT01596582|3840792|FG000|COMPLETED|Overall Study||168
3116010|NCT01596582|3840793|FG001|COMPLETED|Overall Study||173
3116011|NCT01596582|3840792|FG000|NOT COMPLETED|Overall Study||4
3116012|NCT01596582|3840793|FG001|NOT COMPLETED|Overall Study||7
3116013|NCT01596595|3840806|FG000|STARTED|Overall Study||1779
3116014|NCT01596595|3840806|FG000|COMPLETED|Overall Study||814
3116015|NCT01596595|3840806|FG000|NOT COMPLETED|Overall Study||965
3116016|NCT01596699|3840812|FG000|STARTED|Overall Study||10
3116017|NCT01596699|3840813|FG001|STARTED|Overall Study||6
3116018|NCT01596699|3840812|FG000|COMPLETED|Overall Study||10
3116019|NCT01596699|3840813|FG001|COMPLETED|Overall Study||6
3116020|NCT01596699|3840812|FG000|NOT COMPLETED|Overall Study||0
3116021|NCT01596699|3840813|FG001|NOT COMPLETED|Overall Study||0
3116022|NCT01596751|3840828|FG000|STARTED|Overall Study||5
3116023|NCT01596751|3840829|FG001|STARTED|Overall Study||4
3116024|NCT01596751|3840830|FG002|STARTED|Overall Study||3
3116025|NCT01596751|3840831|FG003|STARTED|Overall Study||6
3116026|NCT01596751|3840832|FG004|STARTED|Overall Study||4
3116027|NCT01596751|3840833|FG005|STARTED|Overall Study||6
3116028|NCT01596751|3840834|FG006|STARTED|Overall Study||17
3116029|NCT01596751|3840835|FG007|STARTED|Overall Study||22
3116030|NCT01596751|3840828|FG000|COMPLETED|Overall Study||5
3116031|NCT01596751|3840829|FG001|COMPLETED|Overall Study||4
3116032|NCT01596751|3840830|FG002|COMPLETED|Overall Study||3
3116033|NCT01596751|3840831|FG003|COMPLETED|Overall Study||6
3116034|NCT01596751|3840832|FG004|COMPLETED|Overall Study||4
3116035|NCT01596751|3840833|FG005|COMPLETED|Overall Study||6
3116036|NCT01596751|3840834|FG006|COMPLETED|Overall Study||17
3116037|NCT01596751|3840835|FG007|COMPLETED|Overall Study||22
3116038|NCT01596751|3840828|FG000|NOT COMPLETED|Overall Study||0
3116039|NCT01596751|3840829|FG001|NOT COMPLETED|Overall Study||0
3116040|NCT01596751|3840830|FG002|NOT COMPLETED|Overall Study||0
3116041|NCT01596751|3840831|FG003|NOT COMPLETED|Overall Study||0
3116042|NCT01596751|3840832|FG004|NOT COMPLETED|Overall Study||0
3116043|NCT01596751|3840833|FG005|NOT COMPLETED|Overall Study||0
3116044|NCT01596751|3840834|FG006|NOT COMPLETED|Overall Study||0
3294585|NCT02885506|4028649|FG005|NOT COMPLETED|Part B||0
3294586|NCT02885506|4028650|FG006|NOT COMPLETED|Part B||0
3294587|NCT02885506|4028651|FG007|NOT COMPLETED|Part B||0
3294588|NCT02885506|4028652|FG008|NOT COMPLETED|Part B||0
3294589|NCT02885506|4028653|FG009|NOT COMPLETED|Part B||0
3294590|NCT02885636|4028679|FG000|STARTED|Overall Study||15
3294591|NCT02885636|4028680|FG001|STARTED|Overall Study||15
3294592|NCT02885636|4028679|FG000|COMPLETED|Overall Study||15
3294593|NCT02885636|4028680|FG001|COMPLETED|Overall Study||15
3294594|NCT02885636|4028679|FG000|NOT COMPLETED|Overall Study||0
3294595|NCT02885636|4028680|FG001|NOT COMPLETED|Overall Study||0
3116045|NCT01596751|3840835|FG007|NOT COMPLETED|Overall Study||0
3116046|NCT01596842|3840855|FG000|STARTED|Overall Study||10
3116047|NCT01596842|3840856|FG001|STARTED|Overall Study||7
3116048|NCT01596842|3840855|FG000|COMPLETED|Overall Study||8
3116049|NCT01596842|3840856|FG001|COMPLETED|Overall Study||7
3116050|NCT01596842|3840855|FG000|NOT COMPLETED|Overall Study||2
3116051|NCT01596842|3840856|FG001|NOT COMPLETED|Overall Study||0
3116052|NCT01596972|3840864|FG000|STARTED|Overall Study||25
3294596|NCT02886234|4028688|FG000|STARTED|Overall Study||20
3294597|NCT02886234|4028689|FG001|STARTED|Overall Study||24
3294598|NCT02886234|4028688|FG000|COMPLETED|Overall Study||20
3294599|NCT02886234|4028689|FG001|COMPLETED|Overall Study||22
3116053|NCT01596972|3840865|FG001|STARTED|Overall Study||26
3116054|NCT01596972|3840864|FG000|COMPLETED|Overall Study||24
3116055|NCT01596972|3840865|FG001|COMPLETED|Overall Study||12
3116056|NCT01596972|3840864|FG000|NOT COMPLETED|Overall Study||1
3116057|NCT01596972|3840865|FG001|NOT COMPLETED|Overall Study||14
3116058|NCT01597050|3840873|FG000|STARTED|Overall Study||36
3116059|NCT01597050|3840874|FG001|STARTED|Overall Study||18
3116060|NCT01597050|3840873|FG000|COMPLETED|Overall Study||35
3116061|NCT01597050|3840874|FG001|COMPLETED|Overall Study||18
3116062|NCT01597050|3840873|FG000|NOT COMPLETED|Overall Study||1
3116063|NCT01597050|3840874|FG001|NOT COMPLETED|Overall Study||0
3116064|NCT01597128|3840882|FG000|STARTED|Overall Study||18
3116065|NCT01597128|3840883|FG001|STARTED|Overall Study||17
3116066|NCT01597128|3840882|FG000|COMPLETED|Overall Study||18
3116067|NCT01597128|3840883|FG001|COMPLETED|Overall Study||17
3116068|NCT01597128|3840882|FG000|NOT COMPLETED|Overall Study||0
3116069|NCT01597128|3840883|FG001|NOT COMPLETED|Overall Study||0
3116070|NCT01597141|3840891|FG000|STARTED|Overall Study||50
3116071|NCT01597141|3840892|FG001|STARTED|Overall Study||50
3116072|NCT01597141|3840891|FG000|COMPLETED|Overall Study||50
3116073|NCT01597141|3840892|FG001|COMPLETED|Overall Study||50
3116074|NCT01597141|3840891|FG000|NOT COMPLETED|Overall Study||0
3116075|NCT01597141|3840892|FG001|NOT COMPLETED|Overall Study||0
3116076|NCT01597193|3840907|FG000|STARTED|Stage 1: Dose Escalation (141 Days)||7
3116077|NCT01597193|3840908|FG001|STARTED|Stage 1: Dose Escalation (141 Days)||8
3116078|NCT01597193|3840909|FG002|STARTED|Stage 1: Dose Escalation (141 Days)||0
3116079|NCT01597193|3840910|FG003|STARTED|Stage 1: Dose Escalation (141 Days)||0
3116080|NCT01597193|3840911|FG004|STARTED|Stage 1: Dose Escalation (141 Days)||0
3116081|NCT01597193|3840912|FG005|STARTED|Stage 1: Dose Escalation (141 Days)||0
3116082|NCT01597193|3840913|FG006|STARTED|Stage 1: Dose Escalation (141 Days)||0
3116083|NCT01597193|3840907|FG000|COMPLETED|Stage 1: Dose Escalation (141 Days)||0
3116084|NCT01597193|3840908|FG001|COMPLETED|Stage 1: Dose Escalation (141 Days)||0
3116085|NCT01597193|3840909|FG002|COMPLETED|Stage 1: Dose Escalation (141 Days)||0
3116086|NCT01597193|3840910|FG003|COMPLETED|Stage 1: Dose Escalation (141 Days)||0
3294600|NCT02886234|4028688|FG000|NOT COMPLETED|Overall Study||0
3294601|NCT02886234|4028689|FG001|NOT COMPLETED|Overall Study||2
3294602|NCT02886338|4028695|FG000|STARTED|Overall Study||10
3294603|NCT02886338|4028695|FG000|COMPLETED|Overall Study||9
3294604|NCT02886338|4028695|FG000|NOT COMPLETED|Overall Study||1
3294605|NCT02886494|4028701|FG000|STARTED|Overall Study||60
3294606|NCT02886494|4028702|FG001|STARTED|Overall Study||20
3294607|NCT02886494|4028701|FG000|COMPLETED|Overall Study||43
3294608|NCT02886494|4028702|FG001|COMPLETED|Overall Study||16
3294609|NCT02886494|4028701|FG000|NOT COMPLETED|Overall Study||17
3294610|NCT02886494|4028702|FG001|NOT COMPLETED|Overall Study||4
3294611|NCT02886624|4028711|FG000|STARTED|8-week Treatment||30
3294612|NCT02886624|4028711|FG000|COMPLETED|8-week Treatment||30
3294613|NCT02886624|4028711|FG000|NOT COMPLETED|8-week Treatment||0
3294614|NCT02886624|4028711|FG000|STARTED|12-week Post Treatment Follow-up||30
3294615|NCT02886624|4028711|FG000|COMPLETED|12-week Post Treatment Follow-up||29
3294616|NCT02886624|4028711|FG000|NOT COMPLETED|12-week Post Treatment Follow-up||1
3294617|NCT02886624|4028711|FG000|STARTED|48-week Post Treatment Follow-up||29
3294618|NCT02886624|4028711|FG000|COMPLETED|48-week Post Treatment Follow-up||28
3294619|NCT02886624|4028711|FG000|NOT COMPLETED|48-week Post Treatment Follow-up||1
3294620|NCT02886702|4028718|FG000|STARTED|Overall Study||284
3294621|NCT02886702|4028719|FG001|STARTED|Overall Study||286
3294622|NCT02886702|4028720|FG002|STARTED|Overall Study||285
3294623|NCT02886702|4028718|FG000|Modified Intent-to Treat (mITT)|Overall Study||263
3294624|NCT02886702|4028719|FG001|Modified Intent-to Treat (mITT)|Overall Study||266
3294625|NCT02886702|4028720|FG002|Modified Intent-to Treat (mITT)|Overall Study||275
3294626|NCT02886702|4028718|FG000|Per-Protocol Population (PP)|Overall Study||208
3294627|NCT02886702|4028719|FG001|Per-Protocol Population (PP)|Overall Study||209
3294628|NCT02886702|4028720|FG002|Per-Protocol Population (PP)|Overall Study||201
3294629|NCT02886702|4028718|FG000|COMPLETED|Overall Study||236
3294630|NCT02886702|4028719|FG001|COMPLETED|Overall Study||235
3294631|NCT02886702|4028720|FG002|COMPLETED|Overall Study||232
3294632|NCT02886702|4028718|FG000|NOT COMPLETED|Overall Study||48
3294633|NCT02886702|4028719|FG001|NOT COMPLETED|Overall Study||51
3294634|NCT02886702|4028720|FG002|NOT COMPLETED|Overall Study||53
3294635|NCT02886715|4028731|FG000|STARTED|Overall Study||442
3294636|NCT02886715|4028732|FG001|STARTED|Overall Study||445
3294637|NCT02886715|4028733|FG002|STARTED|Overall Study||223
3294638|NCT02886715|4028731|FG000|Modified ITT (mITT)|Overall Study||421
3294639|NCT02886715|4028732|FG001|Modified ITT (mITT)|Overall Study||418
3294640|NCT02886715|4028733|FG002|Modified ITT (mITT)|Overall Study||217
3294641|NCT02886715|4028731|FG000|Per Protocol (PP) Population|Overall Study||346
3294642|NCT02886715|4028732|FG001|Per Protocol (PP) Population|Overall Study||351
3294643|NCT02886715|4028733|FG002|Per Protocol (PP) Population|Overall Study||176
3294644|NCT02886715|4028731|FG000|COMPLETED|Overall Study||378
3294645|NCT02886715|4028732|FG001|COMPLETED|Overall Study||390
3294646|NCT02886715|4028733|FG002|COMPLETED|Overall Study||203
3294647|NCT02886715|4028731|FG000|NOT COMPLETED|Overall Study||64
3294648|NCT02886715|4028732|FG001|NOT COMPLETED|Overall Study||55
3294649|NCT02886715|4028733|FG002|NOT COMPLETED|Overall Study||20
3294650|NCT02886728|4028745|FG000|STARTED|Overall Study||417
3294651|NCT02886728|4028746|FG001|STARTED|Overall Study||207
3116087|NCT01597193|3840911|FG004|COMPLETED|Stage 1: Dose Escalation (141 Days)||0
3116088|NCT01597193|3840912|FG005|COMPLETED|Stage 1: Dose Escalation (141 Days)||0
3116089|NCT01597193|3840913|FG006|COMPLETED|Stage 1: Dose Escalation (141 Days)||0
3116090|NCT01597193|3840907|FG000|NOT COMPLETED|Stage 1: Dose Escalation (141 Days)||7
3116091|NCT01597193|3840908|FG001|NOT COMPLETED|Stage 1: Dose Escalation (141 Days)||8
3116092|NCT01597193|3840909|FG002|NOT COMPLETED|Stage 1: Dose Escalation (141 Days)||0
3116093|NCT01597193|3840910|FG003|NOT COMPLETED|Stage 1: Dose Escalation (141 Days)||0
3116094|NCT01597193|3840911|FG004|NOT COMPLETED|Stage 1: Dose Escalation (141 Days)||0
3116095|NCT01597193|3840912|FG005|NOT COMPLETED|Stage 1: Dose Escalation (141 Days)||0
3116096|NCT01597193|3840913|FG006|NOT COMPLETED|Stage 1: Dose Escalation (141 Days)||0
3116097|NCT01597193|3840907|FG000|STARTED|Stage 2: Dose Expansion (1067 Days)||0
3116098|NCT01597193|3840908|FG001|STARTED|Stage 2: Dose Expansion (1067 Days)||0
3116099|NCT01597193|3840909|FG002|STARTED|Stage 2: Dose Expansion (1067 Days)||14
3116100|NCT01597193|3840910|FG003|STARTED|Stage 2: Dose Expansion (1067 Days)||20
3116101|NCT01597193|3840911|FG004|STARTED|Stage 2: Dose Expansion (1067 Days)||16
3116102|NCT01597193|3840912|FG005|STARTED|Stage 2: Dose Expansion (1067 Days)||23
3116103|NCT01597193|3840913|FG006|STARTED|Stage 2: Dose Expansion (1067 Days)||11
3116104|NCT01597193|3840907|FG000|COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
3116105|NCT01597193|3840908|FG001|COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
3116106|NCT01597193|3840909|FG002|COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
3116107|NCT01597193|3840910|FG003|COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
3116108|NCT01597193|3840911|FG004|COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
3116109|NCT01597193|3840912|FG005|COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
3116110|NCT01597193|3840913|FG006|COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
3116111|NCT01597193|3840907|FG000|NOT COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
3116112|NCT01597193|3840908|FG001|NOT COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
3116113|NCT01597193|3840909|FG002|NOT COMPLETED|Stage 2: Dose Expansion (1067 Days)||14
3116114|NCT01597193|3840910|FG003|NOT COMPLETED|Stage 2: Dose Expansion (1067 Days)||20
3116115|NCT01597193|3840911|FG004|NOT COMPLETED|Stage 2: Dose Expansion (1067 Days)||16
3116116|NCT01597193|3840912|FG005|NOT COMPLETED|Stage 2: Dose Expansion (1067 Days)||23
3116117|NCT01597193|3840913|FG006|NOT COMPLETED|Stage 2: Dose Expansion (1067 Days)||11
3116118|NCT01597245|3840938|FG000|STARTED|Induction Period (Week 0 - Week 12)||168
3116119|NCT01597245|3840939|FG001|STARTED|Induction Period (Week 0 - Week 12)||358
3116120|NCT01597245|3840940|FG002|STARTED|Induction Period (Week 0 - Week 12)||347
3116121|NCT01597245|3840941|FG003|STARTED|Induction Period (Week 0 - Week 12)||351
3116122|NCT01597245|3840942|FG004|STARTED|Induction Period (Week 0 - Week 12)||0
3116123|NCT01597245|3840943|FG005|STARTED|Induction Period (Week 0 - Week 12)||0
3294652|NCT02886728|4028747|FG002|STARTED|Overall Study||210
3294653|NCT02886728|4028748|FG003|STARTED|Overall Study||418
3294654|NCT02886728|4028745|FG000|COMPLETED|Overall Study||345
3294655|NCT02886728|4028746|FG001|COMPLETED|Overall Study||175
3294656|NCT02886728|4028747|FG002|COMPLETED|Overall Study||174
3294657|NCT02886728|4028748|FG003|COMPLETED|Overall Study||331
3294658|NCT02886728|4028745|FG000|NOT COMPLETED|Overall Study||72
3294659|NCT02886728|4028746|FG001|NOT COMPLETED|Overall Study||32
3294660|NCT02886728|4028747|FG002|NOT COMPLETED|Overall Study||36
3294661|NCT02886728|4028748|FG003|NOT COMPLETED|Overall Study||87
3294662|NCT02886923|4028758|FG000|STARTED|Period 1||12
3294663|NCT02886923|4028759|FG001|STARTED|Period 1||11
3294664|NCT02886923|4028758|FG000|COMPLETED|Period 1||12
3294665|NCT02886923|4028759|FG001|COMPLETED|Period 1||11
3294666|NCT02886923|4028758|FG000|NOT COMPLETED|Period 1||0
3294667|NCT02886923|4028759|FG001|NOT COMPLETED|Period 1||0
3294668|NCT02886923|4028758|FG000|STARTED|Period 2||12
3294669|NCT02886923|4028759|FG001|STARTED|Period 2||11
3294670|NCT02886923|4028758|FG000|COMPLETED|Period 2||12
3294671|NCT02886923|4028759|FG001|COMPLETED|Period 2||11
3294672|NCT02886923|4028758|FG000|NOT COMPLETED|Period 2||0
3294673|NCT02886923|4028759|FG001|NOT COMPLETED|Period 2||0
3294674|NCT02887183|4028765|FG000|STARTED|Overall Study||795
3294675|NCT02887183|4028765|FG000|Full Analysis Set|Overall Study||794
3294676|NCT02887183|4028765|FG000|COMPLETED|Overall Study||654
3294677|NCT02887183|4028765|FG000|NOT COMPLETED|Overall Study||141
3294678|NCT02887404|4028771|FG000|STARTED|Overall Study||150
3294679|NCT02887404|4028772|FG001|STARTED|Overall Study||149
3294680|NCT02887404|4028771|FG000|COMPLETED|Overall Study||150
3294681|NCT02887404|4028772|FG001|COMPLETED|Overall Study||149
3294682|NCT02887404|4028771|FG000|NOT COMPLETED|Overall Study||0
3294683|NCT02887404|4028772|FG001|NOT COMPLETED|Overall Study||0
3294684|NCT02887521|4028781|FG000|STARTED|Overall Study||4
3294685|NCT02887521|4028782|FG001|STARTED|Overall Study||5
3294686|NCT02887521|4028781|FG000|COMPLETED|Overall Study||4
3294687|NCT02887521|4028782|FG001|COMPLETED|Overall Study||2
3294688|NCT02887521|4028781|FG000|NOT COMPLETED|Overall Study||0
3294689|NCT02887521|4028782|FG001|NOT COMPLETED|Overall Study||3
3294690|NCT02887989|4028790|FG000|STARTED|Overall Study||70
3294691|NCT02887989|4028791|FG001|STARTED|Overall Study||70
3294692|NCT02887989|4028790|FG000|COMPLETED|Overall Study||61
3294693|NCT02887989|4028791|FG001|COMPLETED|Overall Study||59
3294694|NCT02887989|4028790|FG000|NOT COMPLETED|Overall Study||9
3294695|NCT02887989|4028791|FG001|NOT COMPLETED|Overall Study||11
3294696|NCT02888080|4028799|FG000|STARTED|Overall Study||20
3294697|NCT02888080|4028800|FG001|STARTED|Overall Study||20
3294698|NCT02888080|4028799|FG000|COMPLETED|Overall Study||18
3294699|NCT02888080|4028800|FG001|COMPLETED|Overall Study||15
3294700|NCT02888080|4028799|FG000|NOT COMPLETED|Overall Study||2
3116124|NCT01597245|3840944|FG006|STARTED|Induction Period (Week 0 - Week 12)||0
3116125|NCT01597245|3840945|FG007|STARTED|Induction Period (Week 0 - Week 12)||0
3116126|NCT01597245|3840946|FG008|STARTED|Induction Period (Week 0 - Week 12)||0
3116127|NCT01597245|3840947|FG009|STARTED|Induction Period (Week 0 - Week 12)||0
3116128|NCT01597245|3840948|FG010|STARTED|Induction Period (Week 0 - Week 12)||0
3116129|NCT01597245|3840949|FG011|STARTED|Induction Period (Week 0 - Week 12)||0
3116130|NCT01597245|3840950|FG012|STARTED|Induction Period (Week 0 - Week 12)||0
3116131|NCT01597245|3840951|FG013|STARTED|Induction Period (Week 0 - Week 12)||0
3116132|NCT01597245|3840952|FG014|STARTED|Induction Period (Week 0 - Week 12)||0
3116133|NCT01597245|3840953|FG015|STARTED|Induction Period (Week 0 - Week 12)||0
3116134|NCT01597245|3840954|FG016|STARTED|Induction Period (Week 0 - Week 12)||0
3116135|NCT01597245|3840955|FG017|STARTED|Induction Period (Week 0 - Week 12)||0
3116136|NCT01597245|3840956|FG018|STARTED|Induction Period (Week 0 - Week 12)||0
3116137|NCT01597245|3840957|FG019|STARTED|Induction Period (Week 0 - Week 12)||0
3294701|NCT02888080|4028800|FG001|NOT COMPLETED|Overall Study||5
3294702|NCT02888093|4028808|FG000|STARTED|Overall Study||22
3294703|NCT02888093|4028809|FG001|STARTED|Overall Study||22
3294704|NCT02888093|4028808|FG000|COMPLETED|Overall Study||20
3294705|NCT02888093|4028809|FG001|COMPLETED|Overall Study||20
3294706|NCT02888093|4028808|FG000|NOT COMPLETED|Overall Study||2
3294707|NCT02888093|4028809|FG001|NOT COMPLETED|Overall Study||2
3294708|NCT02888106|4028823|FG000|STARTED|Overall Study||15
3294709|NCT02888106|4028824|FG001|STARTED|Overall Study||15
3294710|NCT02888106|4028825|FG002|STARTED|Overall Study||15
3294711|NCT02888106|4028826|FG003|STARTED|Overall Study||15
3294712|NCT02888106|4028827|FG004|STARTED|Overall Study||15
3294713|NCT02888106|4028828|FG005|STARTED|Overall Study||15
3294714|NCT02888106|4028823|FG000|COMPLETED|Overall Study||10
3294715|NCT02888106|4028824|FG001|COMPLETED|Overall Study||13
3294716|NCT02888106|4028825|FG002|COMPLETED|Overall Study||15
3294717|NCT02888106|4028826|FG003|COMPLETED|Overall Study||13
3294718|NCT02888106|4028827|FG004|COMPLETED|Overall Study||14
3294719|NCT02888106|4028828|FG005|COMPLETED|Overall Study||14
3294720|NCT02888106|4028823|FG000|NOT COMPLETED|Overall Study||5
3294721|NCT02888106|4028824|FG001|NOT COMPLETED|Overall Study||2
3294722|NCT02888106|4028825|FG002|NOT COMPLETED|Overall Study||0
3294723|NCT02888106|4028826|FG003|NOT COMPLETED|Overall Study||2
3294724|NCT02888106|4028827|FG004|NOT COMPLETED|Overall Study||1
3294725|NCT02888106|4028828|FG005|NOT COMPLETED|Overall Study||1
3294726|NCT02888171|4028850|FG000|STARTED|Overall Study||30
3294727|NCT02888171|4028851|FG001|STARTED|Overall Study||30
3294728|NCT02888171|4028850|FG000|COMPLETED|Overall Study||25
3294729|NCT02888171|4028851|FG001|COMPLETED|Overall Study||26
3294730|NCT02888171|4028850|FG000|NOT COMPLETED|Overall Study||5
3294731|NCT02888171|4028851|FG001|NOT COMPLETED|Overall Study||4
3294732|NCT02888665|4028860|FG000|STARTED|Overall Study||3
3294733|NCT02888665|4028861|FG001|STARTED|Overall Study||3
3294734|NCT02888665|4028862|FG002|STARTED|Overall Study||31
3294735|NCT02888665|4028860|FG000|COMPLETED|Overall Study||3
3294736|NCT02888665|4028861|FG001|COMPLETED|Overall Study||3
3294737|NCT02888665|4028862|FG002|COMPLETED|Overall Study||31
3294738|NCT02888665|4028860|FG000|NOT COMPLETED|Overall Study||0
3294739|NCT02888665|4028861|FG001|NOT COMPLETED|Overall Study||0
3294740|NCT02888665|4028862|FG002|NOT COMPLETED|Overall Study||0
3294741|NCT02888691|4028871|FG000|STARTED|First Intervention Period||7
3294742|NCT02888691|4028872|FG001|STARTED|First Intervention Period||7
3294743|NCT02888691|4028871|FG000|COMPLETED|First Intervention Period||6
3294744|NCT02888691|4028872|FG001|COMPLETED|First Intervention Period||7
3294745|NCT02888691|4028871|FG000|NOT COMPLETED|First Intervention Period||1
3294746|NCT02888691|4028872|FG001|NOT COMPLETED|First Intervention Period||0
3294747|NCT02888691|4028871|FG000|STARTED|Second Intervention Period|This is a cross-over study. Therefore starters does not necessarily equal completers of period 1.|7
3294748|NCT02888691|4028872|FG001|STARTED|Second Intervention Period||5
3294749|NCT02888691|4028871|FG000|COMPLETED|Second Intervention Period||7
3294750|NCT02888691|4028872|FG001|COMPLETED|Second Intervention Period||3
3294751|NCT02888691|4028871|FG000|NOT COMPLETED|Second Intervention Period||0
3294752|NCT02888691|4028872|FG001|NOT COMPLETED|Second Intervention Period||2
3294753|NCT02888756|4028881|FG000|STARTED|Vaccination Period||16
3294754|NCT02888756|4028882|FG001|STARTED|Vaccination Period||9
3294755|NCT02888756|4028883|FG002|STARTED|Vaccination Period||8
3294756|NCT02888756|4028881|FG000|COMPLETED|Vaccination Period||16
3294757|NCT02888756|4028882|FG001|COMPLETED|Vaccination Period||9
3294758|NCT02888756|4028883|FG002|COMPLETED|Vaccination Period||8
3294759|NCT02888756|4028881|FG000|NOT COMPLETED|Vaccination Period||0
3294760|NCT02888756|4028882|FG001|NOT COMPLETED|Vaccination Period||0
3294761|NCT02888756|4028883|FG002|NOT COMPLETED|Vaccination Period||0
3294762|NCT02888756|4028881|FG000|STARTED|Analytical Treatment Interruption||15
3294763|NCT02888756|4028882|FG001|STARTED|Analytical Treatment Interruption||9
3294764|NCT02888756|4028883|FG002|STARTED|Analytical Treatment Interruption||8
3294765|NCT02888756|4028881|FG000|COMPLETED|Analytical Treatment Interruption||5
3294766|NCT02888756|4028882|FG001|COMPLETED|Analytical Treatment Interruption||3
3294767|NCT02888756|4028883|FG002|COMPLETED|Analytical Treatment Interruption||3
3294768|NCT02888756|4028881|FG000|NOT COMPLETED|Analytical Treatment Interruption||10
3294769|NCT02888756|4028882|FG001|NOT COMPLETED|Analytical Treatment Interruption||6
3294770|NCT02888756|4028883|FG002|NOT COMPLETED|Analytical Treatment Interruption||5
3294771|NCT02889289|4028891|FG000|STARTED|Overall Study||1
3116138|NCT01597245|3840958|FG020|STARTED|Induction Period (Week 0 - Week 12)||0
3116139|NCT01597245|3840938|FG000|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||167
3116140|NCT01597245|3840939|FG001|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||357
3116141|NCT01597245|3840940|FG002|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||347
3116142|NCT01597245|3840941|FG003|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||350
3294772|NCT02889289|4028891|FG000|COMPLETED|Overall Study||1
3294773|NCT02889289|4028891|FG000|NOT COMPLETED|Overall Study||0
3294774|NCT02889393|4028897|FG000|STARTED|Overall Study||3
3294775|NCT02889393|4028898|FG001|STARTED|Overall Study||3
3294776|NCT02889393|4028897|FG000|COMPLETED|Overall Study||3
3294777|NCT02889393|4028898|FG001|COMPLETED|Overall Study||3
3294778|NCT02889393|4028897|FG000|NOT COMPLETED|Overall Study||0
3294779|NCT02889393|4028898|FG001|NOT COMPLETED|Overall Study||0
3294780|NCT02889510|4028905|FG000|STARTED|Overall Study||35
3294781|NCT02889510|4028906|FG001|STARTED|Overall Study||37
3294782|NCT02889510|4028905|FG000|COMPLETED|Overall Study||27
3294783|NCT02889510|4028906|FG001|COMPLETED|Overall Study||32
3294784|NCT02889510|4028905|FG000|NOT COMPLETED|Overall Study||8
3294785|NCT02889510|4028906|FG001|NOT COMPLETED|Overall Study||5
3294786|NCT02889562|4028914|FG000|STARTED|Overall Study||28
3294787|NCT02889562|4028915|FG001|STARTED|Overall Study||28
3294788|NCT02889562|4028914|FG000|COMPLETED|Overall Study||28
3294789|NCT02889562|4028915|FG001|COMPLETED|Overall Study||26
3294790|NCT02889562|4028914|FG000|NOT COMPLETED|Overall Study||0
3294791|NCT02889562|4028915|FG001|NOT COMPLETED|Overall Study||2
3294792|NCT02889796|4028925|FG000|STARTED|Overall Study||477
3294793|NCT02889796|4028926|FG001|STARTED|Overall Study||480
3294794|NCT02889796|4028927|FG002|STARTED|Overall Study||325
3294795|NCT02889796|4028928|FG003|STARTED|Overall Study||190
3294796|NCT02889796|4028929|FG004|STARTED|Overall Study||191
3294797|NCT02889796|4028930|FG005|STARTED|Overall Study||96
3294798|NCT02889796|4028925|FG000|COMPLETED|Overall Study||424
3294799|NCT02889796|4028926|FG001|COMPLETED|Overall Study||422
3294800|NCT02889796|4028927|FG002|COMPLETED|Overall Study||281
3294801|NCT02889796|4028928|FG003|COMPLETED|Overall Study||181
3294802|NCT02889796|4028929|FG004|COMPLETED|Overall Study||185
3294803|NCT02889796|4028930|FG005|COMPLETED|Overall Study|Completed 24 weeks of placebo treatment and not rerandomized to Filgotinib 200 mg or 100 mg groups|24
3294804|NCT02889796|4028925|FG000|NOT COMPLETED|Overall Study||53
3294805|NCT02889796|4028926|FG001|NOT COMPLETED|Overall Study||58
3294806|NCT02889796|4028927|FG002|NOT COMPLETED|Overall Study||44
3294807|NCT02889796|4028928|FG003|NOT COMPLETED|Overall Study||9
3294808|NCT02889796|4028929|FG004|NOT COMPLETED|Overall Study||6
3294809|NCT02889796|4028930|FG005|NOT COMPLETED|Overall Study||72
3294810|NCT02889861|4028953|FG000|STARTED|Overall Study||3
3294811|NCT02889861|4028953|FG000|COMPLETED|Overall Study||1
3294812|NCT02889861|4028953|FG000|NOT COMPLETED|Overall Study||2
3294813|NCT02889900|4028962|FG000|STARTED|Overall Study||62
3294814|NCT02889900|4028962|FG000|Received Treatment|Overall Study||60
3294815|NCT02889900|4028962|FG000|COMPLETED|Overall Study|Patients ongoing in study at primary analysis data cut off (DCO)|5
3294816|NCT02889900|4028962|FG000|NOT COMPLETED|Overall Study||57
3294817|NCT02890303|4028966|FG000|STARTED|Overall Study||100
3294818|NCT02890303|4028966|FG000|COMPLETED|Overall Study||100
3294819|NCT02890303|4028966|FG000|NOT COMPLETED|Overall Study||0
3294820|NCT02890381|4028972|FG000|STARTED|Overall Study||11
3294821|NCT02890381|4028973|FG001|STARTED|Overall Study||6
3294822|NCT02890381|4028972|FG000|COMPLETED|Overall Study||11
3294823|NCT02890381|4028973|FG001|COMPLETED|Overall Study||6
3294824|NCT02890381|4028972|FG000|NOT COMPLETED|Overall Study||0
3294825|NCT02890381|4028973|FG001|NOT COMPLETED|Overall Study||0
3294826|NCT02890992|4028987|FG000|STARTED|12 Weeks Open-Label Dose Finding Period||4
3294827|NCT02890992|4028988|FG001|STARTED|12 Weeks Open-Label Dose Finding Period||6
3294828|NCT02890992|4028989|FG002|STARTED|12 Weeks Open-Label Dose Finding Period||4
3294829|NCT02890992|4028990|FG003|STARTED|12 Weeks Open-Label Dose Finding Period||6
3294830|NCT02890992|4028991|FG004|STARTED|12 Weeks Open-Label Dose Finding Period||6
3294831|NCT02890992|4028992|FG005|STARTED|12 Weeks Open-Label Dose Finding Period||5
3294832|NCT02890992|4028993|FG006|STARTED|12 Weeks Open-Label Dose Finding Period||6
3294833|NCT02890992|4028994|FG007|STARTED|12 Weeks Open-Label Dose Finding Period||5
3294834|NCT02890992|4028987|FG000|Treated|12 Weeks Open-Label Dose Finding Period||4
3294835|NCT02890992|4028988|FG001|Treated|12 Weeks Open-Label Dose Finding Period||6
3294836|NCT02890992|4028989|FG002|Treated|12 Weeks Open-Label Dose Finding Period||4
3294837|NCT02890992|4028990|FG003|Treated|12 Weeks Open-Label Dose Finding Period||6
3294838|NCT02890992|4028991|FG004|Treated|12 Weeks Open-Label Dose Finding Period||6
3294839|NCT02890992|4028992|FG005|Treated|12 Weeks Open-Label Dose Finding Period||5
3294840|NCT02890992|4028993|FG006|Treated|12 Weeks Open-Label Dose Finding Period||6
3294841|NCT02890992|4028994|FG007|Treated|12 Weeks Open-Label Dose Finding Period||5
3294842|NCT02890992|4028987|FG000|COMPLETED|12 Weeks Open-Label Dose Finding Period|Out of 4 participants, 3 participants entered into the open-label extension (OLE) period.|4
3294843|NCT02890992|4028988|FG001|COMPLETED|12 Weeks Open-Label Dose Finding Period||6
3294844|NCT02890992|4028989|FG002|COMPLETED|12 Weeks Open-Label Dose Finding Period||4
3294845|NCT02890992|4028990|FG003|COMPLETED|12 Weeks Open-Label Dose Finding Period||6
3294846|NCT02890992|4028991|FG004|COMPLETED|12 Weeks Open-Label Dose Finding Period||6
3294847|NCT02890992|4028992|FG005|COMPLETED|12 Weeks Open-Label Dose Finding Period||5
3294848|NCT02890992|4028993|FG006|COMPLETED|12 Weeks Open-Label Dose Finding Period||6
3116143|NCT01597245|3840942|FG004|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
3116144|NCT01597245|3840943|FG005|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
3116145|NCT01597245|3840944|FG006|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
3116146|NCT01597245|3840945|FG007|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
3116147|NCT01597245|3840946|FG008|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
3116148|NCT01597245|3840947|FG009|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
3116149|NCT01597245|3840948|FG010|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
3116150|NCT01597245|3840949|FG011|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
3116151|NCT01597245|3840950|FG012|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
3116152|NCT01597245|3840951|FG013|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
3116153|NCT01597245|3840952|FG014|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
3116154|NCT01597245|3840953|FG015|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
3116155|NCT01597245|3840954|FG016|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
3116156|NCT01597245|3840955|FG017|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
3116157|NCT01597245|3840956|FG018|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
3116158|NCT01597245|3840957|FG019|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
3116159|NCT01597245|3840958|FG020|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
3116160|NCT01597245|3840938|FG000|COMPLETED|Induction Period (Week 0 - Week 12)||158
3116161|NCT01597245|3840939|FG001|COMPLETED|Induction Period (Week 0 - Week 12)|1 participant randomized to maintenance period but did not receive a dose in the maintenance period.|333
3116162|NCT01597245|3840940|FG002|COMPLETED|Induction Period (Week 0 - Week 12)||328
3116163|NCT01597245|3840941|FG003|COMPLETED|Induction Period (Week 0 - Week 12)|2 participants discontinued after IND completion and prior to randomizing into maintenance period.|342
3116164|NCT01597245|3840942|FG004|COMPLETED|Induction Period (Week 0 - Week 12)||0
3116165|NCT01597245|3840943|FG005|COMPLETED|Induction Period (Week 0 - Week 12)||0
3116166|NCT01597245|3840944|FG006|COMPLETED|Induction Period (Week 0 - Week 12)||0
3116167|NCT01597245|3840945|FG007|COMPLETED|Induction Period (Week 0 - Week 12)||0
3116168|NCT01597245|3840946|FG008|COMPLETED|Induction Period (Week 0 - Week 12)||0
3116169|NCT01597245|3840947|FG009|COMPLETED|Induction Period (Week 0 - Week 12)||0
3116170|NCT01597245|3840948|FG010|COMPLETED|Induction Period (Week 0 - Week 12)||0
3116171|NCT01597245|3840949|FG011|COMPLETED|Induction Period (Week 0 - Week 12)||0
3116172|NCT01597245|3840950|FG012|COMPLETED|Induction Period (Week 0 - Week 12)||0
3116173|NCT01597245|3840951|FG013|COMPLETED|Induction Period (Week 0 - Week 12)||0
3116174|NCT01597245|3840952|FG014|COMPLETED|Induction Period (Week 0 - Week 12)||0
3116175|NCT01597245|3840953|FG015|COMPLETED|Induction Period (Week 0 - Week 12)||0
3116176|NCT01597245|3840954|FG016|COMPLETED|Induction Period (Week 0 - Week 12)||0
3116177|NCT01597245|3840955|FG017|COMPLETED|Induction Period (Week 0 - Week 12)||0
3116178|NCT01597245|3840956|FG018|COMPLETED|Induction Period (Week 0 - Week 12)||0
3116179|NCT01597245|3840957|FG019|COMPLETED|Induction Period (Week 0 - Week 12)||0
3116180|NCT01597245|3840958|FG020|COMPLETED|Induction Period (Week 0 - Week 12)||0
3116181|NCT01597245|3840938|FG000|NOT COMPLETED|Induction Period (Week 0 - Week 12)||10
3294849|NCT02890992|4028994|FG007|COMPLETED|12 Weeks Open-Label Dose Finding Period||5
3294850|NCT02890992|4028987|FG000|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0
3294851|NCT02890992|4028988|FG001|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0
3294852|NCT02890992|4028989|FG002|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0
3294853|NCT02890992|4028990|FG003|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0
3294854|NCT02890992|4028991|FG004|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0
3294855|NCT02890992|4028992|FG005|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0
3294856|NCT02890992|4028993|FG006|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0
3294857|NCT02890992|4028994|FG007|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0
3294858|NCT02890992|4028987|FG000|STARTED|130 Weeks Open-Label Extension Period|3 participants from Open-Label Dose Finding Period (OLDFI) entered in OLE period.|3
3294859|NCT02890992|4028988|FG001|STARTED|130 Weeks Open-Label Extension Period||6
3294860|NCT02890992|4028989|FG002|STARTED|130 Weeks Open-Label Extension Period||4
3294861|NCT02890992|4028990|FG003|STARTED|130 Weeks Open-Label Extension Period||6
3294862|NCT02890992|4028991|FG004|STARTED|130 Weeks Open-Label Extension Period||6
3294863|NCT02890992|4028992|FG005|STARTED|130 Weeks Open-Label Extension Period||5
3294864|NCT02890992|4028993|FG006|STARTED|130 Weeks Open-Label Extension Period||6
3294865|NCT02890992|4028994|FG007|STARTED|130 Weeks Open-Label Extension Period||5
3294866|NCT02890992|4028987|FG000|Treated|130 Weeks Open-Label Extension Period||3
3294867|NCT02890992|4028988|FG001|Treated|130 Weeks Open-Label Extension Period||6
3294868|NCT02890992|4028989|FG002|Treated|130 Weeks Open-Label Extension Period||4
3294869|NCT02890992|4028990|FG003|Treated|130 Weeks Open-Label Extension Period||6
3294870|NCT02890992|4028991|FG004|Treated|130 Weeks Open-Label Extension Period||6
3294871|NCT02890992|4028992|FG005|Treated|130 Weeks Open-Label Extension Period||5
3294872|NCT02890992|4028993|FG006|Treated|130 Weeks Open-Label Extension Period||5
3294873|NCT02890992|4028994|FG007|Treated|130 Weeks Open-Label Extension Period||4
3294874|NCT02890992|4028987|FG000|COMPLETED|130 Weeks Open-Label Extension Period||3
3294875|NCT02890992|4028988|FG001|COMPLETED|130 Weeks Open-Label Extension Period||3
3294876|NCT02890992|4028989|FG002|COMPLETED|130 Weeks Open-Label Extension Period||4
3294877|NCT02890992|4028990|FG003|COMPLETED|130 Weeks Open-Label Extension Period||6
3294878|NCT02890992|4028991|FG004|COMPLETED|130 Weeks Open-Label Extension Period||6
3294879|NCT02890992|4028992|FG005|COMPLETED|130 Weeks Open-Label Extension Period||5
3294880|NCT02890992|4028993|FG006|COMPLETED|130 Weeks Open-Label Extension Period||5
3294881|NCT02890992|4028994|FG007|COMPLETED|130 Weeks Open-Label Extension Period||4
3294882|NCT02890992|4028987|FG000|NOT COMPLETED|130 Weeks Open-Label Extension Period||0
3294883|NCT02890992|4028988|FG001|NOT COMPLETED|130 Weeks Open-Label Extension Period||3
3294884|NCT02890992|4028989|FG002|NOT COMPLETED|130 Weeks Open-Label Extension Period||0
3294885|NCT02890992|4028990|FG003|NOT COMPLETED|130 Weeks Open-Label Extension Period||0
3294886|NCT02890992|4028991|FG004|NOT COMPLETED|130 Weeks Open-Label Extension Period||0
3294887|NCT02890992|4028992|FG005|NOT COMPLETED|130 Weeks Open-Label Extension Period||0
3294888|NCT02890992|4028993|FG006|NOT COMPLETED|130 Weeks Open-Label Extension Period||1
3294889|NCT02890992|4028994|FG007|NOT COMPLETED|130 Weeks Open-Label Extension Period||1
3294890|NCT02891070|4029021|FG000|STARTED|Overall Study||110
3294891|NCT02891070|4029022|FG001|STARTED|Overall Study||114
3294892|NCT02891070|4029021|FG000|COMPLETED|Overall Study||100
3294893|NCT02891070|4029022|FG001|COMPLETED|Overall Study||106
3294894|NCT02891070|4029021|FG000|NOT COMPLETED|Overall Study||10
3294895|NCT02891070|4029022|FG001|NOT COMPLETED|Overall Study||8
3294896|NCT02891174|4029030|FG000|STARTED|First Intervention (24 Hours)||20
3294897|NCT02891174|4029031|FG001|STARTED|First Intervention (24 Hours)||23
3294898|NCT02891174|4029030|FG000|Received First Intervention|First Intervention (24 Hours)||19
3294899|NCT02891174|4029031|FG001|Received First Intervention|First Intervention (24 Hours)||18
3294900|NCT02891174|4029030|FG000|COMPLETED|First Intervention (24 Hours)||17
3294901|NCT02891174|4029031|FG001|COMPLETED|First Intervention (24 Hours)||10
3294902|NCT02891174|4029030|FG000|NOT COMPLETED|First Intervention (24 Hours)||3
3294903|NCT02891174|4029031|FG001|NOT COMPLETED|First Intervention (24 Hours)||13
3294904|NCT02891174|4029030|FG000|STARTED|Second Intervention (24 Hours)||17
3294905|NCT02891174|4029031|FG001|STARTED|Second Intervention (24 Hours)||10
3294906|NCT02891174|4029030|FG000|COMPLETED|Second Intervention (24 Hours)||11
3294907|NCT02891174|4029031|FG001|COMPLETED|Second Intervention (24 Hours)||3
3294908|NCT02891174|4029030|FG000|NOT COMPLETED|Second Intervention (24 Hours)||6
3294909|NCT02891174|4029031|FG001|NOT COMPLETED|Second Intervention (24 Hours)||7
3294910|NCT02891200|4029043|FG000|STARTED|Overall Study||145
3294911|NCT02891200|4029044|FG001|STARTED|Overall Study||147
3294912|NCT02891200|4029043|FG000|COMPLETED|Overall Study||103
3294913|NCT02891200|4029044|FG001|COMPLETED|Overall Study||98
3294914|NCT02891200|4029043|FG000|NOT COMPLETED|Overall Study||42
3294915|NCT02891200|4029044|FG001|NOT COMPLETED|Overall Study||49
3294916|NCT02891408|4029057|FG000|STARTED|Overall Study||10
3294917|NCT02891408|4029058|FG001|STARTED|Overall Study||10
3294918|NCT02891408|4029059|FG002|STARTED|Overall Study||14
3294919|NCT02891408|4029060|FG003|STARTED|Overall Study||10
3294920|NCT02891408|4029061|FG004|STARTED|Overall Study||10
3294921|NCT02891408|4029062|FG005|STARTED|Overall Study||10
3294922|NCT02891408|4029063|FG006|STARTED|Overall Study||10
3294923|NCT02891408|4029057|FG000|COMPLETED|Overall Study||10
3294924|NCT02891408|4029058|FG001|COMPLETED|Overall Study||10
3294925|NCT02891408|4029059|FG002|COMPLETED|Overall Study||13
3294926|NCT02891408|4029060|FG003|COMPLETED|Overall Study||10
3294927|NCT02891408|4029061|FG004|COMPLETED|Overall Study||10
3294928|NCT02891408|4029062|FG005|COMPLETED|Overall Study||10
3294929|NCT02891408|4029063|FG006|COMPLETED|Overall Study||10
3294930|NCT02891408|4029057|FG000|NOT COMPLETED|Overall Study||0
3294931|NCT02891408|4029058|FG001|NOT COMPLETED|Overall Study||0
3294932|NCT02891408|4029059|FG002|NOT COMPLETED|Overall Study||1
3294933|NCT02891408|4029060|FG003|NOT COMPLETED|Overall Study||0
3294934|NCT02891408|4029061|FG004|NOT COMPLETED|Overall Study||0
3294935|NCT02891408|4029062|FG005|NOT COMPLETED|Overall Study||0
3294936|NCT02891408|4029063|FG006|NOT COMPLETED|Overall Study||0
3294937|NCT02891629|4029091|FG000|STARTED|Overall Study||10
3294938|NCT02891629|4029092|FG001|STARTED|Overall Study||5
3294939|NCT02891629|4029091|FG000|COMPLETED|Overall Study||10
3294940|NCT02891629|4029092|FG001|COMPLETED|Overall Study||4
3294941|NCT02891629|4029091|FG000|NOT COMPLETED|Overall Study||0
3294942|NCT02891629|4029092|FG001|NOT COMPLETED|Overall Study||1
3294943|NCT02891681|4029101|FG000|STARTED|Overall Study||39
3294944|NCT02891681|4029102|FG001|STARTED|Overall Study||1
3294945|NCT02891681|4029103|FG002|STARTED|Overall Study||1
3294946|NCT02891681|4029101|FG000|COMPLETED|Overall Study||36
3294947|NCT02891681|4029102|FG001|COMPLETED|Overall Study||1
3294948|NCT02891681|4029103|FG002|COMPLETED|Overall Study||0
3294949|NCT02891681|4029101|FG000|NOT COMPLETED|Overall Study||3
3294950|NCT02891681|4029102|FG001|NOT COMPLETED|Overall Study||0
3294951|NCT02891681|4029103|FG002|NOT COMPLETED|Overall Study||1
3294952|NCT02891850|4029113|FG000|STARTED|Overall Study||111
3294953|NCT02891850|4029114|FG001|STARTED|Overall Study||114
3294954|NCT02891850|4029113|FG000|COMPLETED|Overall Study||104
3294955|NCT02891850|4029114|FG001|COMPLETED|Overall Study||107
3294956|NCT02891850|4029113|FG000|NOT COMPLETED|Overall Study||7
3294957|NCT02891850|4029114|FG001|NOT COMPLETED|Overall Study||7
3294958|NCT02891863|4029120|FG000|STARTED|Overall Study||9
3294959|NCT02891863|4029120|FG000|COMPLETED|Overall Study||9
3294960|NCT02891863|4029120|FG000|NOT COMPLETED|Overall Study||0
3294961|NCT02891915|4029126|FG000|STARTED|Overall Study||192
3116182|NCT01597245|3840939|FG001|NOT COMPLETED|Induction Period (Week 0 - Week 12)||25
3116183|NCT01597245|3840940|FG002|NOT COMPLETED|Induction Period (Week 0 - Week 12)||19
3116184|NCT01597245|3840941|FG003|NOT COMPLETED|Induction Period (Week 0 - Week 12)||9
3116185|NCT01597245|3840942|FG004|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
3116186|NCT01597245|3840943|FG005|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
3116187|NCT01597245|3840944|FG006|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
3116188|NCT01597245|3840945|FG007|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
3116189|NCT01597245|3840946|FG008|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
3116190|NCT01597245|3840947|FG009|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
3116191|NCT01597245|3840948|FG010|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
3116192|NCT01597245|3840949|FG011|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
3116193|NCT01597245|3840950|FG012|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
3116194|NCT01597245|3840951|FG013|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
3116195|NCT01597245|3840952|FG014|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
3116196|NCT01597245|3840953|FG015|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
3116197|NCT01597245|3840954|FG016|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
3116198|NCT01597245|3840955|FG017|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
3116199|NCT01597245|3840956|FG018|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
3116200|NCT01597245|3840957|FG019|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
3116201|NCT01597245|3840958|FG020|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
3116202|NCT01597245|3840938|FG000|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|0
3116203|NCT01597245|3840939|FG001|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|0
3116204|NCT01597245|3840940|FG002|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|0
3116205|NCT01597245|3840941|FG003|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|0
3116206|NCT01597245|3840942|FG004|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|176
3136081|NCT01710358|3861198|FG000|STARTED|Treatment Period Part A (Weeks 0 to 24)||489
3294962|NCT02891915|4029127|FG001|STARTED|Overall Study||193
3294963|NCT02891915|4029126|FG000|COMPLETED|Overall Study||179
3294964|NCT02891915|4029127|FG001|COMPLETED|Overall Study||181
3294965|NCT02891915|4029126|FG000|NOT COMPLETED|Overall Study||13
3294966|NCT02891915|4029127|FG001|NOT COMPLETED|Overall Study||12
3294967|NCT02892019|4029135|FG000|STARTED|Overall Study||41
3294968|NCT02892019|4029136|FG001|STARTED|Overall Study||39
3294969|NCT02892019|4029135|FG000|COMPLETED|Overall Study||40
3294970|NCT02892019|4029136|FG001|COMPLETED|Overall Study||36
3294971|NCT02892019|4029135|FG000|NOT COMPLETED|Overall Study||1
3294972|NCT02892019|4029136|FG001|NOT COMPLETED|Overall Study||3
3294973|NCT02892110|4029144|FG000|STARTED|Overall Study||35
3294974|NCT02892110|4029145|FG001|STARTED|Overall Study||37
3294975|NCT02892110|4029144|FG000|COMPLETED|Overall Study||22
3294976|NCT02892110|4029145|FG001|COMPLETED|Overall Study||25
3294977|NCT02892110|4029144|FG000|NOT COMPLETED|Overall Study||13
3294978|NCT02892110|4029145|FG001|NOT COMPLETED|Overall Study||12
3294979|NCT02892344|4029153|FG000|STARTED|Overall Study||398
3294980|NCT02892344|4029154|FG001|STARTED|Overall Study||404
3294981|NCT02892344|4029153|FG000|Full Analysis Set|Overall Study||395
3294982|NCT02892344|4029154|FG001|Full Analysis Set|Overall Study||399
3294983|NCT02892344|4029153|FG000|COMPLETED|Overall Study||394
3294984|NCT02892344|4029154|FG001|COMPLETED|Overall Study||383
3294985|NCT02892344|4029153|FG000|NOT COMPLETED|Overall Study||4
3294986|NCT02892344|4029154|FG001|NOT COMPLETED|Overall Study||21
3294987|NCT02892409|4029162|FG000|STARTED|Overall Study||15
3294988|NCT02892409|4029163|FG001|STARTED|Overall Study||15
3294989|NCT02892409|4029162|FG000|COMPLETED|Overall Study||12
3294990|NCT02892409|4029163|FG001|COMPLETED|Overall Study||14
3294991|NCT02892409|4029162|FG000|NOT COMPLETED|Overall Study||3
3294992|NCT02892409|4029163|FG001|NOT COMPLETED|Overall Study||1
3294993|NCT02892422|4029169|FG000|STARTED|Overall Study|528 participants were enrolled, 524 from study 16159A and 4 from study 16323A|528
3294994|NCT02892422|4029169|FG000|COMPLETED|Overall Study||318
3294995|NCT02892422|4029169|FG000|NOT COMPLETED|Overall Study||210
3294996|NCT02892448|4029176|FG000|STARTED|Overall Study||12
3294997|NCT02892448|4029177|FG001|STARTED|Overall Study||12
3294998|NCT02892448|4029178|FG002|STARTED|Overall Study||11
3294999|NCT02892448|4029176|FG000|COMPLETED|Overall Study||10
3295000|NCT02892448|4029177|FG001|COMPLETED|Overall Study||10
3295001|NCT02892448|4029178|FG002|COMPLETED|Overall Study||10
3295002|NCT02892448|4029176|FG000|NOT COMPLETED|Overall Study||2
3295003|NCT02892448|4029177|FG001|NOT COMPLETED|Overall Study||2
3295004|NCT02892448|4029178|FG002|NOT COMPLETED|Overall Study||1
3295005|NCT02892513|4029188|FG000|STARTED|Overall Study||28
3295006|NCT02892513|4029189|FG001|STARTED|Overall Study|did not receive allocated intervention = 1 (withdrew per participant request)|25
3295007|NCT02892513|4029188|FG000|COMPLETED|Overall Study|Discontinued intervention early = 5; excluded from analysis = 0|28
3295008|NCT02892513|4029189|FG001|COMPLETED|Overall Study|Discontinued intervention early = 6; excluded from analysis = 1|24
3295009|NCT02892513|4029188|FG000|NOT COMPLETED|Overall Study||0
3295010|NCT02892513|4029189|FG001|NOT COMPLETED|Overall Study||1
3295011|NCT02892734|4029195|FG000|STARTED|Treatment on Study||3
3295012|NCT02892734|4029195|FG000|Completed 1st Cycle/Response at 12 Weeks|Treatment on Study||1
3116207|NCT01597245|3840943|FG005|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|187
3116208|NCT01597245|3840944|FG006|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|181
3116209|NCT01597245|3840945|FG007|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|3
3116210|NCT01597245|3840946|FG008|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|155
3116211|NCT01597245|3840947|FG009|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|132
3116212|NCT01597245|3840948|FG010|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|200
3116213|NCT01597245|3840949|FG011|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|75
3116214|NCT01597245|3840950|FG012|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|49
3116215|NCT01597245|3840951|FG013|STARTED|Maintenance Period (Week 12 to Week 60)||0
3116216|NCT01597245|3840952|FG014|STARTED|Maintenance Period (Week 12 to Week 60)||0
3116217|NCT01597245|3840953|FG015|STARTED|Maintenance Period (Week 12 to Week 60)||0
3116218|NCT01597245|3840954|FG016|STARTED|Maintenance Period (Week 12 to Week 60)||0
3116219|NCT01597245|3840955|FG017|STARTED|Maintenance Period (Week 12 to Week 60)||0
3116220|NCT01597245|3840956|FG018|STARTED|Maintenance Period (Week 12 to Week 60)||0
3116221|NCT01597245|3840957|FG019|STARTED|Maintenance Period (Week 12 to Week 60)||0
3116222|NCT01597245|3840958|FG020|STARTED|Maintenance Period (Week 12 to Week 60)||0
3116223|NCT01597245|3840938|FG000|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
3116224|NCT01597245|3840939|FG001|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
3116225|NCT01597245|3840940|FG002|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
3116226|NCT01597245|3840941|FG003|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
3116227|NCT01597245|3840942|FG004|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||176
3116228|NCT01597245|3840943|FG005|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||187
3116229|NCT01597245|3840944|FG006|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||181
3116230|NCT01597245|3840945|FG007|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||3
3116231|NCT01597245|3840946|FG008|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||155
3116232|NCT01597245|3840947|FG009|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||132
3116233|NCT01597245|3840948|FG010|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||200
3116234|NCT01597245|3840949|FG011|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||75
3116235|NCT01597245|3840950|FG012|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||49
3116236|NCT01597245|3840951|FG013|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
3116237|NCT01597245|3840952|FG014|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
3116238|NCT01597245|3840953|FG015|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
3116239|NCT01597245|3840954|FG016|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
3116240|NCT01597245|3840955|FG017|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
3116241|NCT01597245|3840956|FG018|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
3116242|NCT01597245|3840957|FG019|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
3116243|NCT01597245|3840958|FG020|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
3116244|NCT01597245|3840938|FG000|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
3116245|NCT01597245|3840939|FG001|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
3116246|NCT01597245|3840940|FG002|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
3116247|NCT01597245|3840941|FG003|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
3116248|NCT01597245|3840942|FG004|COMPLETED|Maintenance Period (Week 12 to Week 60)||15
3116249|NCT01597245|3840943|FG005|COMPLETED|Maintenance Period (Week 12 to Week 60)||149
3116250|NCT01597245|3840944|FG006|COMPLETED|Maintenance Period (Week 12 to Week 60)||92
3116251|NCT01597245|3840945|FG007|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
3116252|NCT01597245|3840946|FG008|COMPLETED|Maintenance Period (Week 12 to Week 60)||135
3116253|NCT01597245|3840947|FG009|COMPLETED|Maintenance Period (Week 12 to Week 60)||11
3116254|NCT01597245|3840948|FG010|COMPLETED|Maintenance Period (Week 12 to Week 60)||178
3116255|NCT01597245|3840949|FG011|COMPLETED|Maintenance Period (Week 12 to Week 60)||56
3116256|NCT01597245|3840950|FG012|COMPLETED|Maintenance Period (Week 12 to Week 60)||37
3116257|NCT01597245|3840951|FG013|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
3116258|NCT01597245|3840952|FG014|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
3116259|NCT01597245|3840953|FG015|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
3116260|NCT01597245|3840954|FG016|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
3116261|NCT01597245|3840955|FG017|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
3116262|NCT01597245|3840956|FG018|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
3116263|NCT01597245|3840957|FG019|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
3116264|NCT01597245|3840958|FG020|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
3116265|NCT01597245|3840938|FG000|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
3116266|NCT01597245|3840939|FG001|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
3116267|NCT01597245|3840940|FG002|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
3116268|NCT01597245|3840941|FG003|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
3116269|NCT01597245|3840942|FG004|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||161
3116270|NCT01597245|3840943|FG005|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||38
3116271|NCT01597245|3840944|FG006|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||89
3116272|NCT01597245|3840945|FG007|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||3
3116273|NCT01597245|3840946|FG008|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||20
3116274|NCT01597245|3840947|FG009|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||121
3116275|NCT01597245|3840948|FG010|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||22
3116276|NCT01597245|3840949|FG011|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||19
3116277|NCT01597245|3840950|FG012|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||12
3116278|NCT01597245|3840951|FG013|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
3116279|NCT01597245|3840952|FG014|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
3116280|NCT01597245|3840953|FG015|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
3116281|NCT01597245|3840954|FG016|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
3116282|NCT01597245|3840955|FG017|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
3116283|NCT01597245|3840956|FG018|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
3116284|NCT01597245|3840957|FG019|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
3116285|NCT01597245|3840958|FG020|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
3116286|NCT01597245|3840938|FG000|STARTED|Long Term Extension (Week 60 - Week 264)||0
3116287|NCT01597245|3840939|FG001|STARTED|Long Term Extension (Week 60 - Week 264)||0
3116288|NCT01597245|3840940|FG002|STARTED|Long Term Extension (Week 60 - Week 264)||0
3116289|NCT01597245|3840941|FG003|STARTED|Long Term Extension (Week 60 - Week 264)||0
3116290|NCT01597245|3840942|FG004|STARTED|Long Term Extension (Week 60 - Week 264)|Includes participants who started the long-term extension period.|0
3116291|NCT01597245|3840943|FG005|STARTED|Long Term Extension (Week 60 - Week 264)|Includes participants who started the long-term extension period.|0
3116292|NCT01597245|3840944|FG006|STARTED|Long Term Extension (Week 60 - Week 264)|Includes participants who started the long-term extension period.|0
3116293|NCT01597245|3840945|FG007|STARTED|Long Term Extension (Week 60 - Week 264)||0
3116294|NCT01597245|3840946|FG008|STARTED|Long Term Extension (Week 60 - Week 264)|Includes participants who started the long-term extension period.|0
3116295|NCT01597245|3840947|FG009|STARTED|Long Term Extension (Week 60 - Week 264)|Includes participants who started the long-term extension period.|0
3116296|NCT01597245|3840948|FG010|STARTED|Long Term Extension (Week 60 - Week 264)|Includes participants who started the long-term extension period.|0
3116297|NCT01597245|3840949|FG011|STARTED|Long Term Extension (Week 60 - Week 264)|Includes participants who started the long-term extension period.|0
3116298|NCT01597245|3840950|FG012|STARTED|Long Term Extension (Week 60 - Week 264)|Includes participants who started the long-term extension period.|0
3116299|NCT01597245|3840951|FG013|STARTED|Long Term Extension (Week 60 - Week 264)|Participants who received placebo at the start of the long-term extension period.|26
3116300|NCT01597245|3840952|FG014|STARTED|Long Term Extension (Week 60 - Week 264)|Participants received ixe at the start of the long-term extension.|979
3116301|NCT01597245|3840953|FG015|STARTED|Long Term Extension (Week 60 - Week 264)|Participants received ixe in all dosing regimens, including participants who switched PBO to ixe.|1002
3116302|NCT01597245|3840954|FG016|STARTED|Long Term Extension (Week 60 - Week 264)||0
3116303|NCT01597245|3840955|FG017|STARTED|Long Term Extension (Week 60 - Week 264)||0
3116304|NCT01597245|3840956|FG018|STARTED|Long Term Extension (Week 60 - Week 264)||0
3116305|NCT01597245|3840957|FG019|STARTED|Long Term Extension (Week 60 - Week 264)||0
3116306|NCT01597245|3840958|FG020|STARTED|Long Term Extension (Week 60 - Week 264)||0
3116307|NCT01597245|3840938|FG000|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
3116308|NCT01597245|3840939|FG001|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
3116309|NCT01597245|3840940|FG002|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
3116310|NCT01597245|3840941|FG003|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
3116311|NCT01597245|3840942|FG004|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
3116312|NCT01597245|3840943|FG005|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
3116313|NCT01597245|3840944|FG006|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
3116314|NCT01597245|3840945|FG007|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
3116315|NCT01597245|3840946|FG008|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
3116316|NCT01597245|3840947|FG009|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
3116317|NCT01597245|3840948|FG010|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
3116318|NCT01597245|3840949|FG011|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
3116319|NCT01597245|3840950|FG012|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
3116320|NCT01597245|3840951|FG013|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
3116321|NCT01597245|3840952|FG014|COMPLETED|Long Term Extension (Week 60 - Week 264)||754
3116322|NCT01597245|3840953|FG015|COMPLETED|Long Term Extension (Week 60 - Week 264)||774
3116323|NCT01597245|3840954|FG016|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
3116324|NCT01597245|3840955|FG017|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
3116325|NCT01597245|3840956|FG018|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
3116326|NCT01597245|3840957|FG019|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
3116327|NCT01597245|3840958|FG020|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
3116328|NCT01597245|3840938|FG000|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
3116329|NCT01597245|3840939|FG001|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
3116330|NCT01597245|3840940|FG002|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
3116331|NCT01597245|3840941|FG003|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
3116332|NCT01597245|3840942|FG004|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
3116333|NCT01597245|3840943|FG005|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
3116334|NCT01597245|3840944|FG006|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
3116335|NCT01597245|3840945|FG007|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
3116336|NCT01597245|3840946|FG008|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
3116337|NCT01597245|3840947|FG009|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
3116338|NCT01597245|3840948|FG010|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
3116339|NCT01597245|3840949|FG011|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
3116340|NCT01597245|3840950|FG012|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
3116341|NCT01597245|3840951|FG013|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||26
3116342|NCT01597245|3840952|FG014|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||225
3116343|NCT01597245|3840953|FG015|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||228
3116344|NCT01597245|3840954|FG016|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
3116345|NCT01597245|3840955|FG017|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
3116346|NCT01597245|3840956|FG018|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
3116347|NCT01597245|3840957|FG019|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
3116348|NCT01597245|3840958|FG020|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
3116349|NCT01597245|3840938|FG000|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
3116350|NCT01597245|3840939|FG001|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
3116351|NCT01597245|3840940|FG002|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
3116352|NCT01597245|3840941|FG003|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
3116353|NCT01597245|3840942|FG004|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
3116354|NCT01597245|3840943|FG005|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
3116355|NCT01597245|3840944|FG006|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
3116356|NCT01597245|3840945|FG007|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
3116357|NCT01597245|3840946|FG008|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
3116358|NCT01597245|3840947|FG009|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
3116359|NCT01597245|3840948|FG010|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
3116360|NCT01597245|3840949|FG011|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
3116361|NCT01597245|3840950|FG012|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
3116362|NCT01597245|3840951|FG013|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
3116363|NCT01597245|3840952|FG014|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|0
3116364|NCT01597245|3840953|FG015|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|0
3116365|NCT01597245|3840954|FG016|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|16
3116366|NCT01597245|3840955|FG017|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|6
3116367|NCT01597245|3840956|FG018|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|24
3116368|NCT01597245|3840957|FG019|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|656
3116369|NCT01597245|3840958|FG020|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|248
3116370|NCT01597245|3840938|FG000|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
3116371|NCT01597245|3840939|FG001|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
3116372|NCT01597245|3840940|FG002|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
3116373|NCT01597245|3840941|FG003|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
3116374|NCT01597245|3840942|FG004|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
3116375|NCT01597245|3840943|FG005|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
3116376|NCT01597245|3840944|FG006|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
3116377|NCT01597245|3840945|FG007|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
3116378|NCT01597245|3840946|FG008|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
3116379|NCT01597245|3840947|FG009|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
3116380|NCT01597245|3840948|FG010|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
3116381|NCT01597245|3840949|FG011|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
3116382|NCT01597245|3840950|FG012|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
3116383|NCT01597245|3840951|FG013|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
3116384|NCT01597245|3840952|FG014|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
3116385|NCT01597245|3840953|FG015|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
3116386|NCT01597245|3840954|FG016|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
3116387|NCT01597245|3840955|FG017|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
3116388|NCT01597245|3840956|FG018|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||14
3116389|NCT01597245|3840957|FG019|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||489
3116390|NCT01597245|3840958|FG020|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||212
3116391|NCT01597245|3840938|FG000|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
3116392|NCT01597245|3840939|FG001|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
3116393|NCT01597245|3840940|FG002|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
3116394|NCT01597245|3840941|FG003|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
3116395|NCT01597245|3840942|FG004|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
3116396|NCT01597245|3840943|FG005|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
3116397|NCT01597245|3840944|FG006|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
3116398|NCT01597245|3840945|FG007|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
3116399|NCT01597245|3840946|FG008|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
3116400|NCT01597245|3840947|FG009|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
3116401|NCT01597245|3840948|FG010|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
3116402|NCT01597245|3840949|FG011|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
3116403|NCT01597245|3840950|FG012|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
3116404|NCT01597245|3840951|FG013|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
3116405|NCT01597245|3840952|FG014|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
3116406|NCT01597245|3840953|FG015|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
3116407|NCT01597245|3840954|FG016|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||16
3116408|NCT01597245|3840955|FG017|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||6
3116409|NCT01597245|3840956|FG018|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||10
3116410|NCT01597245|3840957|FG019|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||167
3116411|NCT01597245|3840958|FG020|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||36
3116412|NCT01597258|3840991|FG000|STARTED|Overall Study||2029
3116413|NCT01597258|3840991|FG000|COMPLETED|Overall Study||2028
3116414|NCT01597258|3840991|FG000|NOT COMPLETED|Overall Study||1
3116415|NCT01597375|3840995|FG000|STARTED|First Intervention (4 Weeks)||23
3116416|NCT01597375|3840996|FG001|STARTED|First Intervention (4 Weeks)||23
3116417|NCT01597375|3840995|FG000|COMPLETED|First Intervention (4 Weeks)||21
3116418|NCT01597375|3840996|FG001|COMPLETED|First Intervention (4 Weeks)||22
3116419|NCT01597375|3840995|FG000|NOT COMPLETED|First Intervention (4 Weeks)||2
3116420|NCT01597375|3840996|FG001|NOT COMPLETED|First Intervention (4 Weeks)||1
3116421|NCT01597375|3840995|FG000|STARTED|Washout (2 Weeks)||21
3116422|NCT01597375|3840996|FG001|STARTED|Washout (2 Weeks)||22
3116423|NCT01597375|3840995|FG000|COMPLETED|Washout (2 Weeks)||20
3116424|NCT01597375|3840996|FG001|COMPLETED|Washout (2 Weeks)||22
3116425|NCT01597375|3840995|FG000|NOT COMPLETED|Washout (2 Weeks)||1
3116426|NCT01597375|3840996|FG001|NOT COMPLETED|Washout (2 Weeks)||0
3116427|NCT01597375|3840995|FG000|STARTED|Second Intervention||20
3116428|NCT01597375|3840996|FG001|STARTED|Second Intervention||22
3116429|NCT01597375|3840995|FG000|COMPLETED|Second Intervention||19
3116430|NCT01597375|3840996|FG001|COMPLETED|Second Intervention||21
3116431|NCT01597375|3840995|FG000|NOT COMPLETED|Second Intervention||1
3116432|NCT01597375|3840996|FG001|NOT COMPLETED|Second Intervention||1
3116433|NCT01597440|3841005|FG000|STARTED|Overall Study||1
3116434|NCT01597440|3841006|FG001|STARTED|Overall Study||0
3116435|NCT01597440|3841005|FG000|COMPLETED|Overall Study||1
3116436|NCT01597440|3841006|FG001|COMPLETED|Overall Study||0
3116437|NCT01597440|3841005|FG000|NOT COMPLETED|Overall Study||0
3116438|NCT01597440|3841006|FG001|NOT COMPLETED|Overall Study||0
3116439|NCT01597479|3841016|FG000|STARTED|Overall Study||26
3116440|NCT01597479|3841017|FG001|STARTED|Overall Study||26
3116441|NCT01597479|3841016|FG000|COMPLETED|Overall Study||24
3116442|NCT01597479|3841017|FG001|COMPLETED|Overall Study||26
3116443|NCT01597479|3841016|FG000|NOT COMPLETED|Overall Study||2
3116444|NCT01597479|3841017|FG001|NOT COMPLETED|Overall Study||0
3116445|NCT01597492|3841026|FG000|STARTED|Overall Study||34
3116446|NCT01597492|3841027|FG001|STARTED|Overall Study||45
3116447|NCT01597492|3841026|FG000|COMPLETED|Overall Study||28
3116448|NCT01597492|3841027|FG001|COMPLETED|Overall Study||41
3116449|NCT01597492|3841026|FG000|NOT COMPLETED|Overall Study||6
3116450|NCT01597492|3841027|FG001|NOT COMPLETED|Overall Study||4
3116451|NCT01597505|3841035|FG000|STARTED|Overall Study|Randomized participants|308
3116452|NCT01597505|3841036|FG001|STARTED|Overall Study|Randomized participants|298
3116453|NCT01597505|3841035|FG000|Treated|Overall Study|One participant was instead randomized to vancomycin|305
3116454|NCT01597505|3841036|FG001|Treated|Overall Study||286
3116455|NCT01597505|3841035|FG000|COMPLETED|Overall Study||264
3116456|NCT01597505|3841036|FG001|COMPLETED|Overall Study||265
3116457|NCT01597505|3841035|FG000|NOT COMPLETED|Overall Study||44
3116458|NCT01597505|3841036|FG001|NOT COMPLETED|Overall Study||33
3116459|NCT01597557|3841045|FG000|STARTED|Overall Study||132
3116460|NCT01597557|3841046|FG001|STARTED|Overall Study||129
3116461|NCT01597557|3841045|FG000|COMPLETED|Overall Study||128
3116462|NCT01597557|3841046|FG001|COMPLETED|Overall Study||126
3116463|NCT01597557|3841045|FG000|NOT COMPLETED|Overall Study||4
3116464|NCT01597557|3841046|FG001|NOT COMPLETED|Overall Study||3
3116465|NCT01597596|3841054|FG000|STARTED|Overall Study||1
3116466|NCT01597596|3841055|FG001|STARTED|Overall Study||3
3116467|NCT01597596|3841054|FG000|COMPLETED|Overall Study||0
3116468|NCT01597596|3841055|FG001|COMPLETED|Overall Study||2
3116469|NCT01597596|3841054|FG000|NOT COMPLETED|Overall Study||1
3116470|NCT01597596|3841055|FG001|NOT COMPLETED|Overall Study||1
3116471|NCT01597622|3841061|FG000|STARTED|Overall Study||142
3116472|NCT01597622|3841061|FG000|COMPLETED|Overall Study||104
3116473|NCT01597622|3841061|FG000|NOT COMPLETED|Overall Study||38
3116474|NCT01597635|3841068|FG000|STARTED|Part A||5
3116475|NCT01597635|3841069|FG001|STARTED|Part A||0
3116476|NCT01597635|3841070|FG002|STARTED|Part A||0
3116477|NCT01597635|3841068|FG000|COMPLETED|Part A||2
3116478|NCT01597635|3841069|FG001|COMPLETED|Part A||0
3116479|NCT01597635|3841070|FG002|COMPLETED|Part A||0
3116480|NCT01597635|3841068|FG000|NOT COMPLETED|Part A||3
3116481|NCT01597635|3841069|FG001|NOT COMPLETED|Part A||0
3116482|NCT01597635|3841070|FG002|NOT COMPLETED|Part A||0
3116483|NCT01597635|3841068|FG000|STARTED|Part B||0
3116484|NCT01597635|3841069|FG001|STARTED|Part B||20
3116485|NCT01597635|3841070|FG002|STARTED|Part B||19
3116486|NCT01597635|3841068|FG000|COMPLETED|Part B||0
3116487|NCT01597635|3841069|FG001|COMPLETED|Part B||14
3116488|NCT01597635|3841070|FG002|COMPLETED|Part B||15
3116489|NCT01597635|3841068|FG000|NOT COMPLETED|Part B||0
3116490|NCT01597635|3841069|FG001|NOT COMPLETED|Part B||6
3116491|NCT01597635|3841070|FG002|NOT COMPLETED|Part B||4
3116492|NCT01597687|3841082|FG000|STARTED|Overall Study||76
3116493|NCT01597687|3841083|FG001|STARTED|Overall Study||89
3116494|NCT01597687|3841084|FG002|STARTED|Overall Study||147
3116495|NCT01597687|3841082|FG000|COMPLETED|Overall Study||76
3116496|NCT01597687|3841083|FG001|COMPLETED|Overall Study||89
3116497|NCT01597687|3841084|FG002|COMPLETED|Overall Study||147
3116498|NCT01597687|3841082|FG000|NOT COMPLETED|Overall Study||0
3116499|NCT01597687|3841083|FG001|NOT COMPLETED|Overall Study||0
3116500|NCT01597687|3841084|FG002|NOT COMPLETED|Overall Study||0
3116501|NCT01597791|3841110|FG000|STARTED|Overall Study||28
3116502|NCT01597791|3841111|FG001|STARTED|Overall Study||28
3116503|NCT01597791|3841110|FG000|COMPLETED|Overall Study||20
3116504|NCT01597791|3841111|FG001|COMPLETED|Overall Study||18
3116505|NCT01597791|3841110|FG000|NOT COMPLETED|Overall Study||8
3116506|NCT01597791|3841111|FG001|NOT COMPLETED|Overall Study||10
3116507|NCT01597843|3841120|FG000|STARTED|Overall Study||79
3116508|NCT01597843|3841121|FG001|STARTED|Overall Study||122
3116509|NCT01597843|3841122|FG002|STARTED|Overall Study||81
3116510|NCT01597843|3841120|FG000|Survey 1 Responses|Overall Study||45
3116511|NCT01597843|3841121|FG001|Survey 1 Responses|Overall Study||71
3116512|NCT01597843|3841122|FG002|Survey 1 Responses|Overall Study||59
3116513|NCT01597843|3841120|FG000|Survey 2 Responses|Overall Study||52
3116514|NCT01597843|3841121|FG001|Survey 2 Responses|Overall Study||42
3116515|NCT01597843|3841122|FG002|Survey 2 Responses|Overall Study||58
3116516|NCT01597843|3841120|FG000|Survey 3 Responses|Overall Study||65
3116517|NCT01597843|3841121|FG001|Survey 3 Responses|Overall Study||56
3116518|NCT01597843|3841122|FG002|Survey 3 Responses|Overall Study||76
3116519|NCT01597843|3841120|FG000|COMPLETED|Overall Study||79
3116520|NCT01597843|3841121|FG001|COMPLETED|Overall Study||122
3116521|NCT01597843|3841122|FG002|COMPLETED|Overall Study||81
3116522|NCT01597843|3841120|FG000|NOT COMPLETED|Overall Study||0
3116523|NCT01597843|3841121|FG001|NOT COMPLETED|Overall Study||0
3116524|NCT01597843|3841122|FG002|NOT COMPLETED|Overall Study||0
3116525|NCT01597856|3841133|FG000|STARTED|Overall Study||85
3116526|NCT01597856|3841134|FG001|STARTED|Overall Study||87
3116527|NCT01597856|3841135|FG002|STARTED|Overall Study||174
3116528|NCT01597856|3841133|FG000|Week 4 Follow-up|Overall Study||62
3116529|NCT01597856|3841134|FG001|Week 4 Follow-up|Overall Study||67
3116530|NCT01597856|3841135|FG002|Week 4 Follow-up|Overall Study||129
3116531|NCT01597856|3841133|FG000|COMPLETED|Overall Study||63
3116532|NCT01597856|3841134|FG001|COMPLETED|Overall Study||61
3116533|NCT01597856|3841135|FG002|COMPLETED|Overall Study||120
3116534|NCT01597856|3841133|FG000|NOT COMPLETED|Overall Study||22
3116535|NCT01597856|3841134|FG001|NOT COMPLETED|Overall Study||26
3116536|NCT01597856|3841135|FG002|NOT COMPLETED|Overall Study||54
3116537|NCT01597908|3841146|FG000|STARTED|Randomized Phase||352
3116538|NCT01597908|3841147|FG001|STARTED|Randomized Phase||352
3116539|NCT01597908|3841148|FG002|STARTED|Randomized Phase||0
3116540|NCT01597908|3841146|FG000|Safety Set|Randomized Phase||350
3116541|NCT01597908|3841147|FG001|Safety Set|Randomized Phase||349
3116542|NCT01597908|3841148|FG002|Safety Set|Randomized Phase||0
3116543|NCT01597908|3841146|FG000|COMPLETED|Randomized Phase||1
3116544|NCT01597908|3841147|FG001|COMPLETED|Randomized Phase||0
3116545|NCT01597908|3841148|FG002|COMPLETED|Randomized Phase||0
3116546|NCT01597908|3841146|FG000|NOT COMPLETED|Randomized Phase||351
3116547|NCT01597908|3841147|FG001|NOT COMPLETED|Randomized Phase||352
3116548|NCT01597908|3841148|FG002|NOT COMPLETED|Randomized Phase||0
3116549|NCT01597908|3841146|FG000|STARTED|Crossover Phase||0
3116550|NCT01597908|3841147|FG001|STARTED|Crossover Phase||0
3116551|NCT01597908|3841148|FG002|STARTED|Crossover Phase||34
3116552|NCT01597908|3841146|FG000|COMPLETED|Crossover Phase||0
3116553|NCT01597908|3841147|FG001|COMPLETED|Crossover Phase||0
3116554|NCT01597908|3841148|FG002|COMPLETED|Crossover Phase||0
3116555|NCT01597908|3841146|FG000|NOT COMPLETED|Crossover Phase||0
3116556|NCT01597908|3841147|FG001|NOT COMPLETED|Crossover Phase||0
3116557|NCT01597908|3841148|FG002|NOT COMPLETED|Crossover Phase||34
3116558|NCT01597973|3841159|FG000|STARTED|Overall Study||234
3116559|NCT01597973|3841160|FG001|STARTED|Overall Study||230
3116560|NCT01597973|3841159|FG000|Began First Dose|Overall Study||230
3116561|NCT01597973|3841160|FG001|Began First Dose|Overall Study||228
3116562|NCT01597973|3841159|FG000|COMPLETED|Overall Study||214
3116563|NCT01597973|3841160|FG001|COMPLETED|Overall Study||211
3116564|NCT01597973|3841159|FG000|NOT COMPLETED|Overall Study||20
3116565|NCT01597973|3841160|FG001|NOT COMPLETED|Overall Study||19
3116566|NCT01598064|3841170|FG000|STARTED|Overall Study||25
3116567|NCT01598064|3841171|FG001|STARTED|Overall Study||24
3116568|NCT01598064|3841170|FG000|COMPLETED|Overall Study||25
3116569|NCT01598064|3841171|FG001|COMPLETED|Overall Study||24
3116570|NCT01598064|3841170|FG000|NOT COMPLETED|Overall Study||0
3116571|NCT01598064|3841171|FG001|NOT COMPLETED|Overall Study||0
3116572|NCT01598090|3841182|FG000|STARTED|Treatment Period||27
3116573|NCT01598090|3841183|FG001|STARTED|Treatment Period||411
3116574|NCT01598090|3841184|FG002|STARTED|Treatment Period||206
3116575|NCT01598090|3841182|FG000|COMPLETED|Treatment Period||16
3116576|NCT01598090|3841183|FG001|COMPLETED|Treatment Period||339
3116577|NCT01598090|3841184|FG002|COMPLETED|Treatment Period||171
3116578|NCT01598090|3841182|FG000|NOT COMPLETED|Treatment Period||11
3116579|NCT01598090|3841183|FG001|NOT COMPLETED|Treatment Period||72
3116580|NCT01598090|3841184|FG002|NOT COMPLETED|Treatment Period||35
3116581|NCT01598090|3841182|FG000|STARTED|Follow-up Period|Includes 10 participants who re-joined from treatment period to follow-up period.|26
3116582|NCT01598090|3841183|FG001|STARTED|Follow-up Period|Includes 60 participants who re-joined from treatment period to follow-up period.|399
3116583|NCT01598090|3841184|FG002|STARTED|Follow-up Period|Includes 28 participants who re-joined from treatment period to follow-up period.|199
3116584|NCT01598090|3841182|FG000|COMPLETED|Follow-up Period||21
3116585|NCT01598090|3841183|FG001|COMPLETED|Follow-up Period||364
3116586|NCT01598090|3841184|FG002|COMPLETED|Follow-up Period||171
3116587|NCT01598090|3841182|FG000|NOT COMPLETED|Follow-up Period||5
3116588|NCT01598090|3841183|FG001|NOT COMPLETED|Follow-up Period||35
3116589|NCT01598090|3841184|FG002|NOT COMPLETED|Follow-up Period||28
3116590|NCT01598129|3841195|FG000|STARTED|Overall Study||12
3116591|NCT01598129|3841195|FG000|COMPLETED|Overall Study||3
3116592|NCT01598129|3841195|FG000|NOT COMPLETED|Overall Study||9
3116593|NCT01598194|3841202|FG000|STARTED|Overall Study||30
3116594|NCT01598194|3841203|FG001|STARTED|Overall Study||30
3116595|NCT01598194|3841202|FG000|2 Passes With 25G for Cytology|Overall Study||30
3116596|NCT01598194|3841203|FG001|2 Passes With 25G for Cytology|Overall Study||30
3116597|NCT01598194|3841202|FG000|1 Pass With 22Gpc for Cytology|Overall Study|1 participant's pass could not be performed|29
3116598|NCT01598194|3841203|FG001|1 Pass With 22Gpc for Cytology|Overall Study||30
3116599|NCT01598194|3841202|FG000|1 Pass With 22Gpc for Histology|Overall Study|3 participants passes could not be performed|27
3116600|NCT01598194|3841203|FG001|1 Pass With 22Gpc for Histology|Overall Study|1 participant's pass could not be performed|29
3116601|NCT01598194|3841202|FG000|COMPLETED|Overall Study||30
3116602|NCT01598194|3841203|FG001|COMPLETED|Overall Study||30
3116603|NCT01598194|3841202|FG000|NOT COMPLETED|Overall Study||0
3116604|NCT01598194|3841203|FG001|NOT COMPLETED|Overall Study||0
3116605|NCT01598207|3841215|FG000|STARTED|Overall Study||7
3116606|NCT01598207|3841216|FG001|STARTED|Overall Study||6
3116607|NCT01598207|3841215|FG000|COMPLETED|Overall Study||6
3116608|NCT01598207|3841216|FG001|COMPLETED|Overall Study||6
3116609|NCT01598207|3841215|FG000|NOT COMPLETED|Overall Study||1
3116610|NCT01598207|3841216|FG001|NOT COMPLETED|Overall Study||0
3116611|NCT01598298|3841224|FG000|STARTED|Overall Study||150
3116612|NCT01598298|3841225|FG001|STARTED|Overall Study||149
3116613|NCT01598298|3841224|FG000|Patients Evaluable for Primary Endpoint|Overall Study||127
3116614|NCT01598298|3841225|FG001|Patients Evaluable for Primary Endpoint|Overall Study||128
3116615|NCT01598298|3841224|FG000|Patients Evaluable for Adverse Events|Overall Study||138
3116616|NCT01598298|3841225|FG001|Patients Evaluable for Adverse Events|Overall Study||141
3116617|NCT01598298|3841224|FG000|COMPLETED|Overall Study||110
3116618|NCT01598298|3841225|FG001|COMPLETED|Overall Study||108
3116619|NCT01598298|3841224|FG000|NOT COMPLETED|Overall Study||40
3116620|NCT01598298|3841225|FG001|NOT COMPLETED|Overall Study||41
3116621|NCT01598311|3841233|FG000|STARTED|Overall Study||303
3116622|NCT01598311|3841234|FG001|STARTED|Overall Study||305
3116623|NCT01598311|3841233|FG000|Treated|Overall Study||294
3116624|NCT01598311|3841234|FG001|Treated|Overall Study||301
3116625|NCT01598311|3841233|FG000|Treated and Confirmed CDAD|Overall Study||285
3116626|NCT01598311|3841234|FG001|Treated and Confirmed CDAD|Overall Study||292
3116627|NCT01598311|3841233|FG000|COMPLETED|Overall Study||256
3116628|NCT01598311|3841234|FG001|COMPLETED|Overall Study||244
3116629|NCT01598311|3841233|FG000|NOT COMPLETED|Overall Study||47
3116630|NCT01598311|3841234|FG001|NOT COMPLETED|Overall Study||61
3116631|NCT01598350|3841240|FG000|STARTED|Overall Study||6
3116632|NCT01598350|3841240|FG000|COMPLETED|Overall Study||6
3116633|NCT01598350|3841240|FG000|NOT COMPLETED|Overall Study||0
3116634|NCT01598428|3841244|FG000|STARTED|Overall Study||20
3116635|NCT01598428|3841244|FG000|COMPLETED|Overall Study||20
3116636|NCT01598428|3841244|FG000|NOT COMPLETED|Overall Study||0
3116637|NCT01598506|3841249|FG000|STARTED|Overall Study||22
3116638|NCT01598506|3841249|FG000|COMPLETED|Overall Study||20
3116639|NCT01598506|3841249|FG000|NOT COMPLETED|Overall Study||2
3116640|NCT01598532|3841254|FG000|STARTED|Overall Study||22
3116641|NCT01598532|3841254|FG000|COMPLETED|Overall Study||11
3116642|NCT01598532|3841254|FG000|NOT COMPLETED|Overall Study||11
3116643|NCT01598545|3841261|FG000|STARTED|Overall Study||20
3116644|NCT01598545|3841261|FG000|COMPLETED|Overall Study||20
3116645|NCT01598545|3841261|FG000|NOT COMPLETED|Overall Study||0
3116646|NCT01598610|3841265|FG000|STARTED|Overall Study||220
3116647|NCT01598610|3841265|FG000|COMPLETED|Overall Study||219
3116648|NCT01598610|3841265|FG000|NOT COMPLETED|Overall Study||1
3116649|NCT01598662|3841271|FG000|STARTED|Overall Study||11
3116650|NCT01598662|3841272|FG001|STARTED|Overall Study||21
3116651|NCT01598662|3841271|FG000|Patients Who Received IUD|Overall Study|Subjects did not return at 6 weeks for IUD insertion.|0
3116652|NCT01598662|3841272|FG001|Patients Who Received IUD|Overall Study||18
3116653|NCT01598662|3841271|FG000|Patients Returned for 6 wk Postpartum|Overall Study||0
3116654|NCT01598662|3841272|FG001|Patients Returned for 6 wk Postpartum|Overall Study||2
3116655|NCT01598662|3841271|FG000|COMPLETED|Overall Study||0
3116656|NCT01598662|3841272|FG001|COMPLETED|Overall Study||0
3116657|NCT01598662|3841271|FG000|NOT COMPLETED|Overall Study||11
3295013|NCT02892734|4029195|FG000|Went on to Start Cycle 2|Treatment on Study||1
3295014|NCT02892734|4029195|FG000|COMPLETED|Treatment on Study||1
3295015|NCT02892734|4029195|FG000|NOT COMPLETED|Treatment on Study||2
3295016|NCT02892734|4029195|FG000|STARTED|Follow up for 2 Years||3
3295017|NCT02892734|4029195|FG000|COMPLETED|Follow up for 2 Years||0
3295018|NCT02892734|4029195|FG000|NOT COMPLETED|Follow up for 2 Years||3
3295019|NCT02892760|4029199|FG000|STARTED|Overall Study||17
3295020|NCT02892760|4029199|FG000|Received Intervention|Overall Study||15
3116658|NCT01598662|3841272|FG001|NOT COMPLETED|Overall Study||21
3116659|NCT01598701|3841280|FG000|STARTED|Overall Study||50
3116660|NCT01598701|3841281|FG001|STARTED|Overall Study||50
3116661|NCT01598701|3841280|FG000|COMPLETED|Overall Study||45
3116662|NCT01598701|3841281|FG001|COMPLETED|Overall Study||41
3116663|NCT01598701|3841280|FG000|NOT COMPLETED|Overall Study||5
3116664|NCT01598701|3841281|FG001|NOT COMPLETED|Overall Study||9
3116665|NCT01598740|3841289|FG000|STARTED|Period 1||9
3116666|NCT01598740|3841290|FG001|STARTED|Period 1||9
3116667|NCT01598740|3841289|FG000|COMPLETED|Period 1||9
3116668|NCT01598740|3841290|FG001|COMPLETED|Period 1||9
3116669|NCT01598740|3841289|FG000|NOT COMPLETED|Period 1||0
3116670|NCT01598740|3841290|FG001|NOT COMPLETED|Period 1||0
3116671|NCT01598740|3841289|FG000|STARTED|Period 2|1 subject discontinued during the washout period prior to starting treatment period 2.|8
3116672|NCT01598740|3841290|FG001|STARTED|Period 2||9
3116673|NCT01598740|3841289|FG000|COMPLETED|Period 2||7
3116674|NCT01598740|3841290|FG001|COMPLETED|Period 2||9
3116675|NCT01598740|3841289|FG000|NOT COMPLETED|Period 2||1
3116676|NCT01598740|3841290|FG001|NOT COMPLETED|Period 2||0
3116677|NCT01598753|3841301|FG000|STARTED|Overall Study||37
3116678|NCT01598753|3841302|FG001|STARTED|Overall Study||31
3116679|NCT01598753|3841303|FG002|STARTED|Overall Study||32
3116680|NCT01598753|3841304|FG003|STARTED|Overall Study||34
3116681|NCT01598753|3841301|FG000|COMPLETED|Overall Study||25
3116682|NCT01598753|3841302|FG001|COMPLETED|Overall Study||16
3116683|NCT01598753|3841303|FG002|COMPLETED|Overall Study||24
3116684|NCT01598753|3841304|FG003|COMPLETED|Overall Study||19
3116685|NCT01598753|3841301|FG000|NOT COMPLETED|Overall Study||12
3116686|NCT01598753|3841302|FG001|NOT COMPLETED|Overall Study||15
3116687|NCT01598753|3841303|FG002|NOT COMPLETED|Overall Study||8
3116688|NCT01598753|3841304|FG003|NOT COMPLETED|Overall Study||15
3116689|NCT01598779|3841314|FG000|STARTED|Overall Study||150
3116690|NCT01598779|3841314|FG000|COMPLETED|Overall Study||150
3116691|NCT01598779|3841314|FG000|NOT COMPLETED|Overall Study||0
3116692|NCT01598831|3841320|FG000|STARTED|Overall Study||402
3116693|NCT01598831|3841321|FG001|STARTED|Overall Study||414
3116694|NCT01598831|3841320|FG000|Received at Least 1 Dose Study Treatment|Overall Study||395
3116695|NCT01598831|3841321|FG001|Received at Least 1 Dose Study Treatment|Overall Study||405
3116696|NCT01598831|3841320|FG000|COMPLETED|Overall Study||283
3116697|NCT01598831|3841321|FG001|COMPLETED|Overall Study||278
3116698|NCT01598831|3841320|FG000|NOT COMPLETED|Overall Study||119
3116699|NCT01598831|3841321|FG001|NOT COMPLETED|Overall Study||136
3116700|NCT01598896|3841329|FG000|STARTED|Overall Study||3
3116701|NCT01598896|3841330|FG001|STARTED|Overall Study||4
3116702|NCT01598896|3841329|FG000|COMPLETED|Overall Study||3
3116703|NCT01598896|3841330|FG001|COMPLETED|Overall Study||2
3116704|NCT01598896|3841329|FG000|NOT COMPLETED|Overall Study||0
3116705|NCT01598896|3841330|FG001|NOT COMPLETED|Overall Study||2
3116706|NCT01598922|3841338|FG000|STARTED|Overall Study||37
3116707|NCT01598922|3841339|FG001|STARTED|Overall Study||40
3116708|NCT01598922|3841338|FG000|COMPLETED|Overall Study||34
3116709|NCT01598922|3841339|FG001|COMPLETED|Overall Study||30
3116710|NCT01598922|3841338|FG000|NOT COMPLETED|Overall Study||3
3116711|NCT01598922|3841339|FG001|NOT COMPLETED|Overall Study||10
3116712|NCT01598987|3841345|FG000|STARTED|Baseline to Month 12||56
3116713|NCT01598987|3841345|FG000|COMPLETED|Baseline to Month 12||50
3116714|NCT01598987|3841345|FG000|NOT COMPLETED|Baseline to Month 12||6
3116715|NCT01598987|3841345|FG000|STARTED|Baseline to 24 Month||56
3116716|NCT01598987|3841345|FG000|COMPLETED|Baseline to 24 Month||48
3116717|NCT01598987|3841345|FG000|NOT COMPLETED|Baseline to 24 Month||8
3116718|NCT01599104|3841359|FG000|STARTED|Overall Study||387
3116719|NCT01599104|3841360|FG001|STARTED|Overall Study||385
3116720|NCT01599104|3841361|FG002|STARTED|Overall Study||389
3116721|NCT01599104|3841359|FG000|COMPLETED|Overall Study||371
3116722|NCT01599104|3841360|FG001|COMPLETED|Overall Study||371
3116723|NCT01599104|3841361|FG002|COMPLETED|Overall Study||363
3116724|NCT01599104|3841359|FG000|NOT COMPLETED|Overall Study||16
3116725|NCT01599104|3841360|FG001|NOT COMPLETED|Overall Study||14
3116726|NCT01599104|3841361|FG002|NOT COMPLETED|Overall Study||26
3116727|NCT01599234|3841371|FG000|STARTED|Overall Study||167
3116728|NCT01599234|3841372|FG001|STARTED|Overall Study||170
3116729|NCT01599234|3841371|FG000|COMPLETED|Overall Study||150
3116730|NCT01599234|3841372|FG001|COMPLETED|Overall Study||155
3116731|NCT01599234|3841371|FG000|NOT COMPLETED|Overall Study||17
3116732|NCT01599234|3841372|FG001|NOT COMPLETED|Overall Study||15
3116733|NCT01599286|3841380|FG000|STARTED|Overall Study||24
3116734|NCT01599286|3841381|FG001|STARTED|Overall Study||23
3116735|NCT01599286|3841380|FG000|COMPLETED|Overall Study||24
3116736|NCT01599286|3841381|FG001|COMPLETED|Overall Study||23
3116737|NCT01599286|3841380|FG000|NOT COMPLETED|Overall Study||0
3116738|NCT01599286|3841381|FG001|NOT COMPLETED|Overall Study||0
3116739|NCT01599325|3841387|FG000|STARTED|Primary Parent Phase||72
3295021|NCT02892760|4029199|FG000|COMPLETED|Overall Study||14
3116740|NCT01599325|3841387|FG000|Intent to Treat (ITT) Population|Primary Parent Phase|Includes all participants who were enrolled into the study|72
3116741|NCT01599325|3841387|FG000|Pharmacokinetic (PK) Population|Primary Parent Phase|Includes all participants with evaluable azacitidine plasma PK profiles.|12
3116742|NCT01599325|3841387|FG000|COMPLETED|Primary Parent Phase|Participants still on study treatment at time of study closure|15
3116743|NCT01599325|3841387|FG000|NOT COMPLETED|Primary Parent Phase||57
3116744|NCT01599325|3841387|FG000|STARTED|Extension Phase||15
3116745|NCT01599325|3841387|FG000|COMPLETED|Extension Phase||0
3116746|NCT01599325|3841387|FG000|NOT COMPLETED|Extension Phase||15
3116747|NCT01599585|3841394|FG000|STARTED|Overall Study||62
3116748|NCT01599585|3841395|FG001|STARTED|Overall Study||59
3116749|NCT01599585|3841394|FG000|COMPLETED|Overall Study||40
3116750|NCT01599585|3841395|FG001|COMPLETED|Overall Study||42
3116751|NCT01599585|3841394|FG000|NOT COMPLETED|Overall Study||22
3116752|NCT01599585|3841395|FG001|NOT COMPLETED|Overall Study||17
3116753|NCT01599637|3841404|FG000|STARTED|Overall Study|" started indicates randomized safety, pharmacodynamics and pharmocokinetics set"|20
3116754|NCT01599637|3841405|FG001|STARTED|Overall Study||10
3116755|NCT01599637|3841406|FG002|STARTED|Overall Study||10
3116756|NCT01599637|3841404|FG000|COMPLETED|Overall Study||19
3116757|NCT01599637|3841405|FG001|COMPLETED|Overall Study||8
3116758|NCT01599637|3841406|FG002|COMPLETED|Overall Study||10
3116759|NCT01599637|3841404|FG000|NOT COMPLETED|Overall Study||1
3116760|NCT01599637|3841405|FG001|NOT COMPLETED|Overall Study||2
3116761|NCT01599637|3841406|FG002|NOT COMPLETED|Overall Study||0
3116762|NCT01599650|3841419|FG000|STARTED|Overall Study||183
3116763|NCT01599650|3841420|FG001|STARTED|Overall Study||180
3116764|NCT01599650|3841421|FG002|STARTED|Overall Study||92
3116765|NCT01599650|3841419|FG000|Completed 6 Mos|Overall Study||174
3116766|NCT01599650|3841420|FG001|Completed 6 Mos|Overall Study||170
3116767|NCT01599650|3841421|FG002|Completed 6 Mos|Overall Study||80
3116768|NCT01599650|3841419|FG000|COMPLETED|Overall Study||161
3116769|NCT01599650|3841420|FG001|COMPLETED|Overall Study||154
3116770|NCT01599650|3841421|FG002|COMPLETED|Overall Study||65
3116771|NCT01599650|3841419|FG000|NOT COMPLETED|Overall Study||22
3116772|NCT01599650|3841420|FG001|NOT COMPLETED|Overall Study||26
3116773|NCT01599650|3841421|FG002|NOT COMPLETED|Overall Study||27
3116774|NCT01599741|3841431|FG000|STARTED|Overall Study||51
3116775|NCT01599741|3841431|FG000|Collected Dose and Image Information|Overall Study||48
3116776|NCT01599741|3841431|FG000|COMPLETED|Overall Study||48
3116777|NCT01599741|3841431|FG000|NOT COMPLETED|Overall Study||3
3116778|NCT01599754|3841437|FG000|STARTED|Overall Study||363
3116779|NCT01599754|3841438|FG001|STARTED|Overall Study||361
3116780|NCT01599754|3841437|FG000|Treated|Overall Study||360
3116781|NCT01599754|3841438|FG001|Treated|Overall Study||360
3116782|NCT01599754|3841437|FG000|COMPLETED|Overall Study||0
3116783|NCT01599754|3841438|FG001|COMPLETED|Overall Study||1
3116784|NCT01599754|3841437|FG000|NOT COMPLETED|Overall Study||363
3116785|NCT01599754|3841438|FG001|NOT COMPLETED|Overall Study||360
3116786|NCT01599793|3841444|FG000|STARTED|Overall Study||19
3116787|NCT01599793|3841444|FG000|COMPLETED|Overall Study||17
3116788|NCT01599793|3841444|FG000|NOT COMPLETED|Overall Study||2
3116789|NCT01599806|3841450|FG000|STARTED|Overall Study||516
3116790|NCT01599806|3841451|FG001|STARTED|Overall Study||517
3116791|NCT01599806|3841450|FG000|COMPLETED|Overall Study||473
3116792|NCT01599806|3841451|FG001|COMPLETED|Overall Study||476
3116793|NCT01599806|3841450|FG000|NOT COMPLETED|Overall Study||43
3116794|NCT01599806|3841451|FG001|NOT COMPLETED|Overall Study||41
3116795|NCT01599832|3841457|FG000|STARTED|Overall Study||20
3116796|NCT01599832|3841457|FG000|COMPLETED|Overall Study||20
3116797|NCT01599832|3841457|FG000|NOT COMPLETED|Overall Study||0
3116798|NCT01600014|3841461|FG000|STARTED|1. Cycle & Observation Period D1 to W52|Subjects completing W52 without having been administered a 2nd cycle are counted as completers.|450
3116799|NCT01600014|3841462|FG001|STARTED|1. Cycle & Observation Period D1 to W52||0
3116800|NCT01600014|3841461|FG000|COMPLETED|1. Cycle & Observation Period D1 to W52||162
3116801|NCT01600014|3841462|FG001|COMPLETED|1. Cycle & Observation Period D1 to W52||0
3116802|NCT01600014|3841461|FG000|NOT COMPLETED|1. Cycle & Observation Period D1 to W52||288
3116803|NCT01600014|3841462|FG001|NOT COMPLETED|1. Cycle & Observation Period D1 to W52||0
3116804|NCT01600014|3841461|FG000|STARTED|2. Cycle Recalcitrant Subgroup W8 to W52||92
3116805|NCT01600014|3841462|FG001|STARTED|2. Cycle Recalcitrant Subgroup W8 to W52||49
3116806|NCT01600014|3841461|FG000|COMPLETED|2. Cycle Recalcitrant Subgroup W8 to W52||80
3116807|NCT01600014|3841462|FG001|COMPLETED|2. Cycle Recalcitrant Subgroup W8 to W52||39
3116808|NCT01600014|3841461|FG000|NOT COMPLETED|2. Cycle Recalcitrant Subgroup W8 to W52||12
3116809|NCT01600014|3841462|FG001|NOT COMPLETED|2. Cycle Recalcitrant Subgroup W8 to W52||10
3116810|NCT01600014|3841461|FG000|STARTED|2. Cycl Recurrent Subgroup W26/44 to W52||42
3116811|NCT01600014|3841462|FG001|STARTED|2. Cycl Recurrent Subgroup W26/44 to W52||20
3116812|NCT01600014|3841461|FG000|COMPLETED|2. Cycl Recurrent Subgroup W26/44 to W52||39
3116813|NCT01600014|3841462|FG001|COMPLETED|2. Cycl Recurrent Subgroup W26/44 to W52||20
3116814|NCT01600014|3841461|FG000|NOT COMPLETED|2. Cycl Recurrent Subgroup W26/44 to W52||3
3116815|NCT01600014|3841462|FG001|NOT COMPLETED|2. Cycl Recurrent Subgroup W26/44 to W52||0
3116816|NCT01600053|3841480|FG000|STARTED|Overall Study||11
3116817|NCT01600053|3841480|FG000|COMPLETED|Overall Study||0
3116818|NCT01600053|3841480|FG000|NOT COMPLETED|Overall Study||11
3116819|NCT01600092|3841486|FG000|STARTED|Overall Study||513
3116820|NCT01600092|3841487|FG001|STARTED|Overall Study||507
3136082|NCT01710358|3861199|FG001|STARTED|Treatment Period Part A (Weeks 0 to 24)||488
3116821|NCT01600092|3841486|FG000|Received at Least 1 Vaccination|Overall Study|1 participant received RotaTeq™ existing formulation as their first vaccination|510
3116822|NCT01600092|3841487|FG001|Received at Least 1 Vaccination|Overall Study||504
3116823|NCT01600092|3841486|FG000|Received All 3 Vaccinations|Overall Study||500
3116824|NCT01600092|3841487|FG001|Received All 3 Vaccinations|Overall Study||494
3116825|NCT01600092|3841486|FG000|COMPLETED|Overall Study||495
3116826|NCT01600092|3841487|FG001|COMPLETED|Overall Study||491
3116827|NCT01600092|3841486|FG000|NOT COMPLETED|Overall Study||18
3116828|NCT01600092|3841487|FG001|NOT COMPLETED|Overall Study||16
3116829|NCT01600105|3841495|FG000|STARTED|Total Participants||255
3116830|NCT01600105|3841496|FG001|STARTED|Total Participants||21
3116831|NCT01600105|3841495|FG000|COMPLETED|Total Participants||214
3116832|NCT01600105|3841496|FG001|COMPLETED|Total Participants||11
3116833|NCT01600105|3841495|FG000|NOT COMPLETED|Total Participants||41
3116834|NCT01600105|3841496|FG001|NOT COMPLETED|Total Participants||10
3116835|NCT01600105|3841495|FG000|STARTED|Sub Study I||19
3116836|NCT01600105|3841496|FG001|STARTED|Sub Study I||21
3116837|NCT01600105|3841495|FG000|COMPLETED|Sub Study I||19
3116838|NCT01600105|3841496|FG001|COMPLETED|Sub Study I||11
3116839|NCT01600105|3841495|FG000|NOT COMPLETED|Sub Study I||0
3116840|NCT01600105|3841496|FG001|NOT COMPLETED|Sub Study I||10
3116841|NCT01600105|3841495|FG000|STARTED|Sub Study II||65
3116842|NCT01600105|3841496|FG001|STARTED|Sub Study II||0
3116843|NCT01600105|3841495|FG000|COMPLETED|Sub Study II||60
3116844|NCT01600105|3841496|FG001|COMPLETED|Sub Study II||0
3116845|NCT01600105|3841495|FG000|NOT COMPLETED|Sub Study II||5
3116846|NCT01600105|3841496|FG001|NOT COMPLETED|Sub Study II||0
3116847|NCT01600105|3841495|FG000|STARTED|Sub Study III||39
3116848|NCT01600105|3841496|FG001|STARTED|Sub Study III||0
3116849|NCT01600105|3841495|FG000|COMPLETED|Sub Study III||34
3116850|NCT01600105|3841496|FG001|COMPLETED|Sub Study III||0
3116851|NCT01600105|3841495|FG000|NOT COMPLETED|Sub Study III||5
3116852|NCT01600105|3841496|FG001|NOT COMPLETED|Sub Study III||0
3116853|NCT01600105|3841495|FG000|STARTED|Sub Study IV||41
3116854|NCT01600105|3841496|FG001|STARTED|Sub Study IV||8
3116855|NCT01600105|3841495|FG000|COMPLETED|Sub Study IV||41
3116856|NCT01600105|3841496|FG001|COMPLETED|Sub Study IV||8
3116857|NCT01600105|3841495|FG000|NOT COMPLETED|Sub Study IV||0
3116858|NCT01600105|3841496|FG001|NOT COMPLETED|Sub Study IV||0
3116859|NCT01600105|3841495|FG000|STARTED|Sub Study V||52
3116860|NCT01600105|3841496|FG001|STARTED|Sub Study V||0
3116861|NCT01600105|3841495|FG000|COMPLETED|Sub Study V||50
3116862|NCT01600105|3841496|FG001|COMPLETED|Sub Study V||0
3116863|NCT01600105|3841495|FG000|NOT COMPLETED|Sub Study V||2
3116864|NCT01600105|3841496|FG001|NOT COMPLETED|Sub Study V||0
3116865|NCT01600170|3841508|FG000|STARTED|Period 1|Participants were assigned atorvastatin for 12 wks followed by a washout and then placebo.|6
3116866|NCT01600170|3841509|FG001|STARTED|Period 1|Participants were assigned placebo for 12 wks followed by a washout and then atorvastatin.|5
3116867|NCT01600170|3841508|FG000|COMPLETED|Period 1||6
3116868|NCT01600170|3841509|FG001|COMPLETED|Period 1||5
3116869|NCT01600170|3841508|FG000|NOT COMPLETED|Period 1||0
3116870|NCT01600170|3841509|FG001|NOT COMPLETED|Period 1||0
3116871|NCT01600170|3841508|FG000|STARTED|Period 2|These 6 were on atorvastatin in period 1 and on placebo in Period 2.|6
3116872|NCT01600170|3841509|FG001|STARTED|Period 2|These 5 were on placebo in Period 1 and on Atorvastatin in Period 2.|5
3116873|NCT01600170|3841508|FG000|COMPLETED|Period 2|One subject moved away from the area due to job responsibilities and dropped out of study.|5
3116874|NCT01600170|3841509|FG001|COMPLETED|Period 2||5
3116875|NCT01600170|3841508|FG000|NOT COMPLETED|Period 2||1
3116876|NCT01600170|3841509|FG001|NOT COMPLETED|Period 2||0
3116877|NCT01600222|3841517|FG000|STARTED|Overall Study||37
3116878|NCT01600222|3841517|FG000|COMPLETED|Overall Study||35
3116879|NCT01600222|3841517|FG000|NOT COMPLETED|Overall Study||2
3116880|NCT01600287|3841524|FG000|STARTED|Overall Study||20
3116881|NCT01600287|3841525|FG001|STARTED|Overall Study||20
3116882|NCT01600287|3841524|FG000|COMPLETED|Overall Study||20
3116883|NCT01600287|3841525|FG001|COMPLETED|Overall Study||20
3116884|NCT01600287|3841524|FG000|NOT COMPLETED|Overall Study||0
3116885|NCT01600287|3841525|FG001|NOT COMPLETED|Overall Study||0
3116886|NCT01600326|3841533|FG000|STARTED|Overall Study||15
3116887|NCT01600326|3841534|FG001|STARTED|Overall Study||15
3116888|NCT01600326|3841533|FG000|Primary Outcome Measure Data Collection|Overall Study||15
3116889|NCT01600326|3841534|FG001|Primary Outcome Measure Data Collection|Overall Study||15
3116890|NCT01600326|3841533|FG000|COMPLETED|Overall Study||14
3116891|NCT01600326|3841534|FG001|COMPLETED|Overall Study||14
3116892|NCT01600326|3841533|FG000|NOT COMPLETED|Overall Study||1
3116893|NCT01600326|3841534|FG001|NOT COMPLETED|Overall Study||1
3116894|NCT01600482|3841542|FG000|STARTED|Overall Study||148
3116895|NCT01600482|3841543|FG001|STARTED|Overall Study|Last 26 patients allocated to CELT ACD|59
3116896|NCT01600482|3841542|FG000|COMPLETED|Overall Study|Last 26 patients allocated to CELT ACD|148
3116897|NCT01600482|3841543|FG001|COMPLETED|Overall Study||59
3116898|NCT01600482|3841542|FG000|NOT COMPLETED|Overall Study||0
3116899|NCT01600482|3841543|FG001|NOT COMPLETED|Overall Study||0
3116900|NCT01600495|3841551|FG000|STARTED|Overall Study|We start with the prediction of collecting 20 patients in the treated group|23
3116901|NCT01600495|3841552|FG001|STARTED|Overall Study|We start with the prediction of collecting 20 control patients|23
3116902|NCT01600495|3841551|FG000|COMPLETED|Overall Study|We finished the job with 23 patients for each group (treated and control)|23
3116903|NCT01600495|3841552|FG001|COMPLETED|Overall Study|We finished the job with 23 patients for each group (treated and control)|23
3116904|NCT01600495|3841551|FG000|NOT COMPLETED|Overall Study||0
3116905|NCT01600495|3841552|FG001|NOT COMPLETED|Overall Study||0
3116906|NCT01600586|3841561|FG000|STARTED|Overall Study||49
3116907|NCT01600586|3841562|FG001|STARTED|Overall Study||51
3116908|NCT01600586|3841561|FG000|COMPLETED|Overall Study||46
3116909|NCT01600586|3841562|FG001|COMPLETED|Overall Study||48
3116910|NCT01600586|3841561|FG000|NOT COMPLETED|Overall Study||3
3116911|NCT01600586|3841562|FG001|NOT COMPLETED|Overall Study||3
3116912|NCT01600638|3841575|FG000|STARTED|Overall Study||25
3116913|NCT01600638|3841575|FG000|COMPLETED|Overall Study||25
3116914|NCT01600638|3841575|FG000|NOT COMPLETED|Overall Study||0
3116915|NCT01600677|3841581|FG000|STARTED|Overall Study||7
3116916|NCT01600677|3841582|FG001|STARTED|Overall Study||4
3116917|NCT01600677|3841581|FG000|COMPLETED|Overall Study||7
3116918|NCT01600677|3841582|FG001|COMPLETED|Overall Study||4
3116919|NCT01600677|3841581|FG000|NOT COMPLETED|Overall Study||0
3116920|NCT01600677|3841582|FG001|NOT COMPLETED|Overall Study||0
3116921|NCT01600703|3841588|FG000|STARTED|First Intervention||7
3116922|NCT01600703|3841589|FG001|STARTED|First Intervention||8
3116923|NCT01600703|3841588|FG000|COMPLETED|First Intervention||7
3116924|NCT01600703|3841589|FG001|COMPLETED|First Intervention||8
3116925|NCT01600703|3841588|FG000|NOT COMPLETED|First Intervention||0
3116926|NCT01600703|3841589|FG001|NOT COMPLETED|First Intervention||0
3116927|NCT01600703|3841588|FG000|STARTED|Second Intervention||7
3116928|NCT01600703|3841589|FG001|STARTED|Second Intervention||8
3116929|NCT01600703|3841588|FG000|COMPLETED|Second Intervention||7
3116930|NCT01600703|3841589|FG001|COMPLETED|Second Intervention||8
3116931|NCT01600703|3841588|FG000|NOT COMPLETED|Second Intervention||0
3116932|NCT01600703|3841589|FG001|NOT COMPLETED|Second Intervention||0
3116933|NCT01600716|3841597|FG000|STARTED|Overall Study||66
3116934|NCT01600716|3841598|FG001|STARTED|Overall Study||78
3116935|NCT01600716|3841597|FG000|COMPLETED|Overall Study||59
3116936|NCT01600716|3841598|FG001|COMPLETED|Overall Study||71
3116937|NCT01600716|3841597|FG000|NOT COMPLETED|Overall Study||7
3116938|NCT01600716|3841598|FG001|NOT COMPLETED|Overall Study||7
3116939|NCT01600729|3841606|FG000|STARTED|Overall Study||66
3116940|NCT01600729|3841606|FG000|COMPLETED|Overall Study||65
3116941|NCT01600729|3841606|FG000|NOT COMPLETED|Overall Study||1
3116942|NCT01600885|3841610|FG000|STARTED|First Period||10
3116943|NCT01600885|3841611|FG001|STARTED|First Period||9
3116944|NCT01600885|3841610|FG000|COMPLETED|First Period||8
3116945|NCT01600885|3841611|FG001|COMPLETED|First Period||8
3116946|NCT01600885|3841610|FG000|NOT COMPLETED|First Period||2
3116947|NCT01600885|3841611|FG001|NOT COMPLETED|First Period||1
3116948|NCT01600885|3841610|FG000|STARTED|Wash Out Period||8
3116949|NCT01600885|3841611|FG001|STARTED|Wash Out Period||8
3116950|NCT01600885|3841610|FG000|COMPLETED|Wash Out Period||8
3116951|NCT01600885|3841611|FG001|COMPLETED|Wash Out Period||8
3116952|NCT01600885|3841610|FG000|NOT COMPLETED|Wash Out Period||0
3116953|NCT01600885|3841611|FG001|NOT COMPLETED|Wash Out Period||0
3116954|NCT01600885|3841610|FG000|STARTED|Second Period||8
3116955|NCT01600885|3841611|FG001|STARTED|Second Period||8
3116956|NCT01600885|3841610|FG000|COMPLETED|Second Period||8
3116957|NCT01600885|3841611|FG001|COMPLETED|Second Period||8
3116958|NCT01600885|3841610|FG000|NOT COMPLETED|Second Period||0
3116959|NCT01600885|3841611|FG001|NOT COMPLETED|Second Period||0
3116960|NCT01600950|3841617|FG000|STARTED|Period 1||10
3116961|NCT01600950|3841618|FG001|STARTED|Period 1||10
3116962|NCT01600950|3841617|FG000|COMPLETED|Period 1||10
3116963|NCT01600950|3841618|FG001|COMPLETED|Period 1||10
3116964|NCT01600950|3841617|FG000|NOT COMPLETED|Period 1||0
3116965|NCT01600950|3841618|FG001|NOT COMPLETED|Period 1||0
3116966|NCT01600950|3841617|FG000|STARTED|Period 2||10
3116967|NCT01600950|3841618|FG001|STARTED|Period 2||10
3116968|NCT01600950|3841617|FG000|COMPLETED|Period 2||10
3116969|NCT01600950|3841618|FG001|COMPLETED|Period 2||10
3116970|NCT01600950|3841617|FG000|NOT COMPLETED|Period 2||0
3116971|NCT01600950|3841618|FG001|NOT COMPLETED|Period 2||0
3116972|NCT01601067|3841626|FG000|STARTED|Overall Study||63
3116973|NCT01601067|3841627|FG001|STARTED|Overall Study||56
3116974|NCT01601067|3841626|FG000|COMPLETED|Overall Study||30
3116975|NCT01601067|3841627|FG001|COMPLETED|Overall Study||34
3116976|NCT01601067|3841626|FG000|NOT COMPLETED|Overall Study||33
3116977|NCT01601067|3841627|FG001|NOT COMPLETED|Overall Study||22
3116978|NCT01601132|3841633|FG000|STARTED|Overall Study||30
3116979|NCT01601132|3841633|FG000|COMPLETED|Overall Study||28
3116980|NCT01601132|3841633|FG000|NOT COMPLETED|Overall Study||2
3116981|NCT01601236|3841646|FG000|STARTED|Overall Study||7
3116982|NCT01601236|3841647|FG001|STARTED|Overall Study||3
3116983|NCT01601236|3841648|FG002|STARTED|Overall Study||14
3116984|NCT01601236|3841649|FG003|STARTED|Overall Study||6
3116985|NCT01601236|3841650|FG004|STARTED|Overall Study||3
3116986|NCT01601236|3841651|FG005|STARTED|Overall Study||1
3116987|NCT01601236|3841646|FG000|COMPLETED|Overall Study||2
3116988|NCT01601236|3841647|FG001|COMPLETED|Overall Study||2
3116989|NCT01601236|3841648|FG002|COMPLETED|Overall Study||8
3116990|NCT01601236|3841649|FG003|COMPLETED|Overall Study||4
3116991|NCT01601236|3841650|FG004|COMPLETED|Overall Study||0
3116992|NCT01601236|3841651|FG005|COMPLETED|Overall Study||0
3116993|NCT01601236|3841646|FG000|NOT COMPLETED|Overall Study||5
3116994|NCT01601236|3841647|FG001|NOT COMPLETED|Overall Study||1
3116995|NCT01601236|3841648|FG002|NOT COMPLETED|Overall Study||6
3116996|NCT01601236|3841649|FG003|NOT COMPLETED|Overall Study||2
3116997|NCT01601236|3841650|FG004|NOT COMPLETED|Overall Study||3
3116998|NCT01601236|3841651|FG005|NOT COMPLETED|Overall Study||1
3116999|NCT01601431|3841662|FG000|STARTED|Overall Study||223
3117000|NCT01601431|3841663|FG001|STARTED|Overall Study||217
3117001|NCT01601431|3841662|FG000|COMPLETED|Overall Study||211
3117002|NCT01601431|3841663|FG001|COMPLETED|Overall Study||214
3117003|NCT01601431|3841662|FG000|NOT COMPLETED|Overall Study||12
3117004|NCT01601431|3841663|FG001|NOT COMPLETED|Overall Study||3
3117005|NCT01601470|3841669|FG000|STARTED|Period 1 - Sildenafil||28
3117006|NCT01601470|3841669|FG000|PK Analysis Set|Period 1 - Sildenafil||28
3117007|NCT01601470|3841669|FG000|Safety Set|Period 1 - Sildenafil||28
3117008|NCT01601470|3841669|FG000|COMPLETED|Period 1 - Sildenafil||28
3117009|NCT01601470|3841669|FG000|NOT COMPLETED|Period 1 - Sildenafil||0
3117010|NCT01601470|3841669|FG000|STARTED|Period 2 - LCZ696||28
3117011|NCT01601470|3841669|FG000|PK Analysis Set|Period 2 - LCZ696||27
3117012|NCT01601470|3841669|FG000|Safety Set|Period 2 - LCZ696||27
3117013|NCT01601470|3841669|FG000|COMPLETED|Period 2 - LCZ696||27
3117014|NCT01601470|3841669|FG000|NOT COMPLETED|Period 2 - LCZ696||1
3117015|NCT01601470|3841669|FG000|STARTED|Period 3 - LCZ696+Sildenafil||27
3117016|NCT01601470|3841669|FG000|PK Analysis Set|Period 3 - LCZ696+Sildenafil||27
3117017|NCT01601470|3841669|FG000|Safety Set|Period 3 - LCZ696+Sildenafil||27
3117018|NCT01601470|3841669|FG000|COMPLETED|Period 3 - LCZ696+Sildenafil||27
3117019|NCT01601470|3841669|FG000|NOT COMPLETED|Period 3 - LCZ696+Sildenafil||0
3117020|NCT01601496|3841675|FG000|STARTED|Overall Study|Enrolled|117
3117021|NCT01601496|3841675|FG000|COMPLETED|Overall Study|Completed 12-M F/up|102
3117022|NCT01601496|3841675|FG000|NOT COMPLETED|Overall Study||15
3117023|NCT01601535|3841685|FG000|STARTED|Phase 1||6
3117024|NCT01601535|3841686|FG001|STARTED|Phase 1||6
3117025|NCT01601535|3841687|FG002|STARTED|Phase 1||6
3117026|NCT01601535|3841688|FG003|STARTED|Phase 1||4
3117027|NCT01601535|3841689|FG004|STARTED|Phase 1||0
3117028|NCT01601535|3841690|FG005|STARTED|Phase 1||0
3117029|NCT01601535|3841685|FG000|COMPLETED|Phase 1||0
3117030|NCT01601535|3841686|FG001|COMPLETED|Phase 1||0
3117031|NCT01601535|3841687|FG002|COMPLETED|Phase 1||1
3117032|NCT01601535|3841688|FG003|COMPLETED|Phase 1||0
3117033|NCT01601535|3841689|FG004|COMPLETED|Phase 1||0
3117034|NCT01601535|3841690|FG005|COMPLETED|Phase 1||0
3117035|NCT01601535|3841685|FG000|NOT COMPLETED|Phase 1||6
3117036|NCT01601535|3841686|FG001|NOT COMPLETED|Phase 1||6
3117037|NCT01601535|3841687|FG002|NOT COMPLETED|Phase 1||5
3117038|NCT01601535|3841688|FG003|NOT COMPLETED|Phase 1||4
3117039|NCT01601535|3841689|FG004|NOT COMPLETED|Phase 1||0
3117040|NCT01601535|3841690|FG005|NOT COMPLETED|Phase 1||0
3117041|NCT01601535|3841685|FG000|STARTED|Phase 2||0
3117042|NCT01601535|3841686|FG001|STARTED|Phase 2||0
3117043|NCT01601535|3841687|FG002|STARTED|Phase 2||0
3117044|NCT01601535|3841688|FG003|STARTED|Phase 2||0
3117045|NCT01601535|3841689|FG004|STARTED|Phase 2||20
3117046|NCT01601535|3841690|FG005|STARTED|Phase 2||12
3117047|NCT01601535|3841685|FG000|COMPLETED|Phase 2||0
3117048|NCT01601535|3841686|FG001|COMPLETED|Phase 2||0
3117049|NCT01601535|3841687|FG002|COMPLETED|Phase 2||0
3117050|NCT01601535|3841688|FG003|COMPLETED|Phase 2||0
3117051|NCT01601535|3841689|FG004|COMPLETED|Phase 2||1
3117052|NCT01601535|3841690|FG005|COMPLETED|Phase 2||0
3117053|NCT01601535|3841685|FG000|NOT COMPLETED|Phase 2||0
3117054|NCT01601535|3841686|FG001|NOT COMPLETED|Phase 2||0
3117055|NCT01601535|3841687|FG002|NOT COMPLETED|Phase 2||0
3117056|NCT01601535|3841688|FG003|NOT COMPLETED|Phase 2||0
3117057|NCT01601535|3841689|FG004|NOT COMPLETED|Phase 2||19
3117058|NCT01601535|3841690|FG005|NOT COMPLETED|Phase 2||12
3117059|NCT01601626|3841716|FG000|STARTED|Overall Study||24
3117060|NCT01601626|3841717|FG001|STARTED|Overall Study||24
3117061|NCT01601626|3841718|FG002|STARTED|Overall Study||23
3117062|NCT01601626|3841716|FG000|COMPLETED|Overall Study||21
3117063|NCT01601626|3841717|FG001|COMPLETED|Overall Study||19
3117064|NCT01601626|3841718|FG002|COMPLETED|Overall Study||21
3117065|NCT01601626|3841716|FG000|NOT COMPLETED|Overall Study||3
3117066|NCT01601626|3841717|FG001|NOT COMPLETED|Overall Study||5
3117067|NCT01601626|3841718|FG002|NOT COMPLETED|Overall Study||2
3136083|NCT01710358|3861200|FG002|STARTED|Treatment Period Part A (Weeks 0 to 24)||330
3136084|NCT01710358|3861198|FG000|Received at Least 1 Dose of Study Drug|Treatment Period Part A (Weeks 0 to 24)||488
3136085|NCT01710358|3861199|FG001|Received at Least 1 Dose of Study Drug|Treatment Period Part A (Weeks 0 to 24)||487
3136086|NCT01710358|3861200|FG002|Received at Least 1 Dose of Study Drug|Treatment Period Part A (Weeks 0 to 24)||330
3136087|NCT01710358|3861198|FG000|Rescued|Treatment Period Part A (Weeks 0 to 24)||128
3136088|NCT01710358|3861199|FG001|Rescued|Treatment Period Part A (Weeks 0 to 24)||35
3136089|NCT01710358|3861200|FG002|Rescued|Treatment Period Part A (Weeks 0 to 24)||40
3136090|NCT01710358|3861198|FG000|COMPLETED|Treatment Period Part A (Weeks 0 to 24)|Includes all participants rescued during Part A.|438
3136091|NCT01710358|3861199|FG001|COMPLETED|Treatment Period Part A (Weeks 0 to 24)|Includes all participants rescued during Part A.|459
3136092|NCT01710358|3861200|FG002|COMPLETED|Treatment Period Part A (Weeks 0 to 24)|Includes all participants rescued during Part A.|307
3136093|NCT01710358|3861198|FG000|NOT COMPLETED|Treatment Period Part A (Weeks 0 to 24)||51
3136094|NCT01710358|3861199|FG001|NOT COMPLETED|Treatment Period Part A (Weeks 0 to 24)||29
3136095|NCT01710358|3861200|FG002|NOT COMPLETED|Treatment Period Part A (Weeks 0 to 24)||23
3136096|NCT01710358|3861198|FG000|STARTED|Treatment Period Part B (Weeks 24 to 52)|Excludes participants rescued during Part A.|310
3136097|NCT01710358|3861199|FG001|STARTED|Treatment Period Part B (Weeks 24 to 52)|Excludes participants rescued during Part A.|424
3136830|NCT01715805|3862074|FG001|NOT COMPLETED|Double-Blind or Continued Treatment||39
3117068|NCT01601652|3841726|FG000|STARTED|Overall Study||12
3117069|NCT01601652|3841726|FG000|COMPLETED|Overall Study||11
3117070|NCT01601652|3841726|FG000|NOT COMPLETED|Overall Study||1
3117071|NCT01601691|3841730|FG000|STARTED|Overall Study||10
3117072|NCT01601691|3841730|FG000|COMPLETED|Overall Study||10
3117073|NCT01601691|3841730|FG000|NOT COMPLETED|Overall Study||0
3117074|NCT01601704|3841736|FG000|STARTED|Overall Study||4456
3117075|NCT01601704|3841737|FG001|STARTED|Overall Study||4454
3117076|NCT01601704|3841736|FG000|Treated|Overall Study||4455
3117077|NCT01601704|3841737|FG001|Treated|Overall Study||4450
3117078|NCT01601704|3841736|FG000|COMPLETED|Overall Study||4455
3117079|NCT01601704|3841737|FG001|COMPLETED|Overall Study||4450
3117080|NCT01601704|3841736|FG000|NOT COMPLETED|Overall Study||1
3117081|NCT01601704|3841737|FG001|NOT COMPLETED|Overall Study||4
3117082|NCT01601782|3841743|FG000|STARTED|Overall Study||16
3117083|NCT01601782|3841743|FG000|COMPLETED|Overall Study||16
3117084|NCT01601782|3841743|FG000|NOT COMPLETED|Overall Study||0
3117085|NCT01601821|3841749|FG000|STARTED|Overall Study||125
3117086|NCT01601821|3841750|FG001|STARTED|Overall Study||120
3117087|NCT01601821|3841749|FG000|COMPLETED|Overall Study||96
3117088|NCT01601821|3841750|FG001|COMPLETED|Overall Study||91
3117089|NCT01601821|3841749|FG000|NOT COMPLETED|Overall Study||29
3117090|NCT01601821|3841750|FG001|NOT COMPLETED|Overall Study||29
3117091|NCT01601847|3841758|FG000|STARTED|Overall Study||153
3117092|NCT01601847|3841759|FG001|STARTED|Overall Study||147
3117093|NCT01601847|3841758|FG000|COMPLETED|Overall Study||140
3117094|NCT01601847|3841759|FG001|COMPLETED|Overall Study||137
3117095|NCT01601847|3841758|FG000|NOT COMPLETED|Overall Study||13
3117096|NCT01601847|3841759|FG001|NOT COMPLETED|Overall Study||10
3117097|NCT01601860|3841767|FG000|STARTED|Overall Study||40
3117098|NCT01601860|3841768|FG001|STARTED|Overall Study||40
3117099|NCT01601860|3841767|FG000|COMPLETED|Overall Study||19
3117100|NCT01601860|3841768|FG001|COMPLETED|Overall Study||31
3117101|NCT01601860|3841767|FG000|NOT COMPLETED|Overall Study||21
3117102|NCT01601860|3841768|FG001|NOT COMPLETED|Overall Study||9
3117103|NCT01601873|3841777|FG000|STARTED|Overall Study||50
3117104|NCT01601873|3841778|FG001|STARTED|Overall Study||47
3117105|NCT01601873|3841777|FG000|COMPLETED|Overall Study||48
3117106|NCT01601873|3841778|FG001|COMPLETED|Overall Study||44
3117107|NCT01601873|3841777|FG000|NOT COMPLETED|Overall Study||2
3117108|NCT01601873|3841778|FG001|NOT COMPLETED|Overall Study||3
3117109|NCT01601977|3841784|FG000|STARTED|Overall Study|5 patients consented for study participation but did not attend for study assessments.|10
3117110|NCT01601977|3841784|FG000|COMPLETED|Overall Study||10
3117111|NCT01601977|3841784|FG000|NOT COMPLETED|Overall Study||0
3117112|NCT01602068|3841792|FG000|STARTED|Overall Study|Day before surgery|23
3117113|NCT01602068|3841793|FG001|STARTED|Overall Study|Day before surgery|22
3117114|NCT01602068|3841792|FG000|COMPLETED|Overall Study||23
3117115|NCT01602068|3841793|FG001|COMPLETED|Overall Study||22
3117116|NCT01602068|3841792|FG000|NOT COMPLETED|Overall Study||0
3117117|NCT01602068|3841793|FG001|NOT COMPLETED|Overall Study||0
3117118|NCT01602120|3841803|FG000|STARTED|Overall Study||29
3117119|NCT01602120|3841804|FG001|STARTED|Overall Study||60
3117120|NCT01602120|3841805|FG002|STARTED|Overall Study||17
3117121|NCT01602120|3841806|FG003|STARTED|Overall Study||53
3117122|NCT01602120|3841803|FG000|COMPLETED|Overall Study||0
3117123|NCT01602120|3841804|FG001|COMPLETED|Overall Study||0
3117124|NCT01602120|3841805|FG002|COMPLETED|Overall Study||0
3117125|NCT01602120|3841806|FG003|COMPLETED|Overall Study||0
3117126|NCT01602120|3841803|FG000|NOT COMPLETED|Overall Study||29
3117127|NCT01602120|3841804|FG001|NOT COMPLETED|Overall Study||60
3117128|NCT01602120|3841805|FG002|NOT COMPLETED|Overall Study||17
3117129|NCT01602120|3841806|FG003|NOT COMPLETED|Overall Study||53
3117130|NCT01602172|3841821|FG000|STARTED|Overall Study||37
3117131|NCT01602172|3841822|FG001|STARTED|Overall Study||23
3117132|NCT01602172|3841823|FG002|STARTED|Overall Study||22
3117133|NCT01602172|3841821|FG000|COMPLETED|Overall Study||32
3117134|NCT01602172|3841822|FG001|COMPLETED|Overall Study||17
3117135|NCT01602172|3841823|FG002|COMPLETED|Overall Study||22
3117136|NCT01602172|3841821|FG000|NOT COMPLETED|Overall Study||5
3117137|NCT01602172|3841822|FG001|NOT COMPLETED|Overall Study||6
3117138|NCT01602172|3841823|FG002|NOT COMPLETED|Overall Study||0
3117139|NCT01602224|3841840|FG000|STARTED|Overall Study||74
3117140|NCT01602224|3841841|FG001|STARTED|Overall Study||74
3117141|NCT01602224|3841842|FG002|STARTED|Overall Study||72
3117142|NCT01602224|3841840|FG000|Received at Least 1 Dose of Study Drug|Overall Study||73
3117143|NCT01602224|3841841|FG001|Received at Least 1 Dose of Study Drug|Overall Study||74
3117144|NCT01602224|3841842|FG002|Received at Least 1 Dose of Study Drug|Overall Study||72
3117145|NCT01602224|3841840|FG000|COMPLETED|Overall Study||66
3117146|NCT01602224|3841841|FG001|COMPLETED|Overall Study||66
3117147|NCT01602224|3841842|FG002|COMPLETED|Overall Study||66
3117148|NCT01602224|3841840|FG000|NOT COMPLETED|Overall Study||8
3117149|NCT01602224|3841841|FG001|NOT COMPLETED|Overall Study||8
3117150|NCT01602224|3841842|FG002|NOT COMPLETED|Overall Study||6
3117151|NCT01602315|3841859|FG000|STARTED|Overall Study||16
3117152|NCT01602315|3841860|FG001|STARTED|Overall Study||5
3117153|NCT01602315|3841861|FG002|STARTED|Overall Study||18
3117154|NCT01602315|3841862|FG003|STARTED|Overall Study||6
3117155|NCT01602315|3841863|FG004|STARTED|Overall Study||71
3117156|NCT01602315|3841864|FG005|STARTED|Overall Study||35
3117157|NCT01602315|3841865|FG006|STARTED|Overall Study||29
3117158|NCT01602315|3841859|FG000|COMPLETED|Overall Study||0
3117159|NCT01602315|3841860|FG001|COMPLETED|Overall Study||0
3117160|NCT01602315|3841861|FG002|COMPLETED|Overall Study||0
3117161|NCT01602315|3841862|FG003|COMPLETED|Overall Study||0
3117162|NCT01602315|3841863|FG004|COMPLETED|Overall Study||0
3117163|NCT01602315|3841864|FG005|COMPLETED|Overall Study||0
3117164|NCT01602315|3841865|FG006|COMPLETED|Overall Study||0
3117165|NCT01602315|3841859|FG000|NOT COMPLETED|Overall Study||16
3117166|NCT01602315|3841860|FG001|NOT COMPLETED|Overall Study||5
3117167|NCT01602315|3841861|FG002|NOT COMPLETED|Overall Study||18
3117168|NCT01602315|3841862|FG003|NOT COMPLETED|Overall Study||6
3117169|NCT01602315|3841863|FG004|NOT COMPLETED|Overall Study||71
3117170|NCT01602315|3841864|FG005|NOT COMPLETED|Overall Study||35
3117171|NCT01602315|3841865|FG006|NOT COMPLETED|Overall Study||29
3117172|NCT01602341|3841903|FG000|STARTED|Overall Study||44
3117173|NCT01602341|3841904|FG001|STARTED|Overall Study||42
3117174|NCT01602341|3841903|FG000|COMPLETED|Overall Study||44
3117175|NCT01602341|3841904|FG001|COMPLETED|Overall Study||41
3117176|NCT01602341|3841903|FG000|NOT COMPLETED|Overall Study||0
3117177|NCT01602341|3841904|FG001|NOT COMPLETED|Overall Study||1
3117178|NCT01602380|3841916|FG000|STARTED|Overall Study||230
3117179|NCT01602380|3841917|FG001|STARTED|Overall Study||232
3117180|NCT01602380|3841916|FG000|COMPLETED|Overall Study|Completed: number of patients ongoing in the study at data cut-off for the primary analysis|137
3117181|NCT01602380|3841917|FG001|COMPLETED|Overall Study|Completed: number of patients ongoing in the study at data cut-off for the primary analysis|131
3117182|NCT01602380|3841916|FG000|NOT COMPLETED|Overall Study||93
3117183|NCT01602380|3841917|FG001|NOT COMPLETED|Overall Study||101
3117184|NCT01602419|3841923|FG000|STARTED|Overall Study||120
3117185|NCT01602419|3841923|FG000|SAF Population|Overall Study||111
3117186|NCT01602419|3841923|FG000|ITT Population|Overall Study||102
3117187|NCT01602419|3841923|FG000|EFF Population|Overall Study||91
3117188|NCT01602419|3841923|FG000|COMPLETED|Overall Study||91
3117189|NCT01602419|3841923|FG000|NOT COMPLETED|Overall Study||29
3117190|NCT01602484|3841970|FG000|STARTED|Overall Study||25
3117191|NCT01602484|3841971|FG001|STARTED|Overall Study||25
3117192|NCT01602484|3841970|FG000|COMPLETED|Overall Study||25
3117193|NCT01602484|3841971|FG001|COMPLETED|Overall Study||24
3117194|NCT01602484|3841970|FG000|NOT COMPLETED|Overall Study||0
3117195|NCT01602484|3841971|FG001|NOT COMPLETED|Overall Study||1
3117196|NCT01602510|3841977|FG000|STARTED|Open Label Phase||420
3117197|NCT01602510|3841978|FG001|STARTED|Open Label Phase||0
3117198|NCT01602510|3841979|FG002|STARTED|Open Label Phase||0
3117199|NCT01602510|3841977|FG000|COMPLETED|Open Label Phase||117
3117200|NCT01602510|3841978|FG001|COMPLETED|Open Label Phase||0
3117201|NCT01602510|3841979|FG002|COMPLETED|Open Label Phase||0
3117202|NCT01602510|3841977|FG000|NOT COMPLETED|Open Label Phase||303
3117203|NCT01602510|3841978|FG001|NOT COMPLETED|Open Label Phase||0
3117204|NCT01602510|3841979|FG002|NOT COMPLETED|Open Label Phase||0
3117205|NCT01602510|3841977|FG000|STARTED|Randomized Phase||0
3117206|NCT01602510|3841978|FG001|STARTED|Randomized Phase||133
3117207|NCT01602510|3841979|FG002|STARTED|Randomized Phase||131
3117208|NCT01602510|3841977|FG000|COMPLETED|Randomized Phase||0
3117209|NCT01602510|3841978|FG001|COMPLETED|Randomized Phase||59
3117210|NCT01602510|3841979|FG002|COMPLETED|Randomized Phase||58
3117211|NCT01602510|3841977|FG000|NOT COMPLETED|Randomized Phase||0
3117212|NCT01602510|3841978|FG001|NOT COMPLETED|Randomized Phase||74
3117213|NCT01602510|3841979|FG002|NOT COMPLETED|Randomized Phase||73
3117214|NCT01602549|3841987|FG000|STARTED|Overall Study||19
3117215|NCT01602549|3841988|FG001|STARTED|Overall Study||38
3117216|NCT01602549|3841987|FG000|COMPLETED|Overall Study||18
3117217|NCT01602549|3841988|FG001|COMPLETED|Overall Study||37
3117218|NCT01602549|3841987|FG000|NOT COMPLETED|Overall Study||1
3117219|NCT01602549|3841988|FG001|NOT COMPLETED|Overall Study||1
3117220|NCT01602562|3841998|FG000|STARTED|Overall Study||21
3117221|NCT01602562|3841999|FG001|STARTED|Overall Study||19
3117222|NCT01602562|3841998|FG000|COMPLETED|Overall Study||16
3117223|NCT01602562|3841999|FG001|COMPLETED|Overall Study||16
3117224|NCT01602562|3841998|FG000|NOT COMPLETED|Overall Study||5
3117225|NCT01602562|3841999|FG001|NOT COMPLETED|Overall Study||3
3117226|NCT01602614|3842010|FG000|STARTED|Overall Study||0
3117227|NCT01602614|3842011|FG001|STARTED|Overall Study||10
3117228|NCT01602614|3842012|FG002|STARTED|Overall Study||8
3117229|NCT01602614|3842013|FG003|STARTED|Overall Study||0
3117230|NCT01602614|3842010|FG000|COMPLETED|Overall Study||0
3117231|NCT01602614|3842011|FG001|COMPLETED|Overall Study||10
3117232|NCT01602614|3842012|FG002|COMPLETED|Overall Study||8
3117233|NCT01602614|3842013|FG003|COMPLETED|Overall Study||0
3117234|NCT01602614|3842010|FG000|NOT COMPLETED|Overall Study||0
3117235|NCT01602614|3842011|FG001|NOT COMPLETED|Overall Study||0
3117236|NCT01602614|3842012|FG002|NOT COMPLETED|Overall Study||0
3117237|NCT01602614|3842013|FG003|NOT COMPLETED|Overall Study||0
3117238|NCT01602679|3842029|FG000|STARTED|Overall Study||4
3117239|NCT01602679|3842030|FG001|STARTED|Overall Study||3
3117240|NCT01602679|3842029|FG000|COMPLETED|Overall Study||4
3117241|NCT01602679|3842030|FG001|COMPLETED|Overall Study||3
3117242|NCT01602679|3842029|FG000|NOT COMPLETED|Overall Study||0
3117243|NCT01602679|3842030|FG001|NOT COMPLETED|Overall Study||0
3117244|NCT01602692|3842038|FG000|STARTED|Overall Study||20
3117245|NCT01602692|3842039|FG001|STARTED|Overall Study||20
3117246|NCT01602692|3842038|FG000|COMPLETED|Overall Study||20
3117247|NCT01602692|3842039|FG001|COMPLETED|Overall Study||20
3117248|NCT01602692|3842038|FG000|NOT COMPLETED|Overall Study||0
3117249|NCT01602692|3842039|FG001|NOT COMPLETED|Overall Study||0
3117250|NCT01602731|3842049|FG000|STARTED|Overall Study||45
3117251|NCT01602731|3842049|FG000|Cognitive Impairment|Overall Study|After repeat cognitive testing, additional 1 patient had no cognitive impairment and did not proceed|44
3117252|NCT01602731|3842049|FG000|Poor Medication Adherence|Overall Study|24 out of 35 patients who completed 1-month pill counts had medication adherence <88%.|24
3117253|NCT01602731|3842049|FG000|COMPLETED|Overall Study||15
3117254|NCT01602731|3842049|FG000|NOT COMPLETED|Overall Study||30
3117255|NCT01602744|3842057|FG000|STARTED|Overall Study||176
3117256|NCT01602744|3842058|FG001|STARTED|Overall Study||183
3117257|NCT01602744|3842057|FG000|COMPLETED|Overall Study||146
3117258|NCT01602744|3842058|FG001|COMPLETED|Overall Study||160
3117259|NCT01602744|3842057|FG000|NOT COMPLETED|Overall Study||30
3117260|NCT01602744|3842058|FG001|NOT COMPLETED|Overall Study||23
3117261|NCT01602965|3842066|FG000|STARTED|Overall Study||20
3117262|NCT01602965|3842067|FG001|STARTED|Overall Study||20
3117263|NCT01602965|3842066|FG000|COMPLETED|Overall Study||16
3117264|NCT01602965|3842067|FG001|COMPLETED|Overall Study||18
3117265|NCT01602965|3842066|FG000|NOT COMPLETED|Overall Study||4
3117266|NCT01602965|3842067|FG001|NOT COMPLETED|Overall Study||2
3117267|NCT01603056|3842075|FG000|STARTED|Overall Study||413
3117268|NCT01603056|3842076|FG001|STARTED|Overall Study||204
3117269|NCT01603056|3842075|FG000|COMPLETED|Overall Study||379
3117270|NCT01603056|3842076|FG001|COMPLETED|Overall Study||190
3117271|NCT01603056|3842075|FG000|NOT COMPLETED|Overall Study||34
3117272|NCT01603056|3842076|FG001|NOT COMPLETED|Overall Study||14
3117273|NCT01603082|3842084|FG000|STARTED|Overall Study|Randomized|51
3117274|NCT01603082|3842085|FG001|STARTED|Overall Study|Randomized|49
3117275|NCT01603082|3842084|FG000|COMPLETED|Overall Study|Completed the study.|49
3117276|NCT01603082|3842085|FG001|COMPLETED|Overall Study|Completed the study|48
3117277|NCT01603082|3842084|FG000|NOT COMPLETED|Overall Study||2
3117278|NCT01603082|3842085|FG001|NOT COMPLETED|Overall Study||1
3117279|NCT01603277|3842093|FG000|STARTED|Overall Study||78
3117280|NCT01603277|3842094|FG001|STARTED|Overall Study||82
3117281|NCT01603277|3842093|FG000|COMPLETED|Overall Study||64
3117282|NCT01603277|3842094|FG001|COMPLETED|Overall Study||64
3117283|NCT01603277|3842093|FG000|NOT COMPLETED|Overall Study||14
3117284|NCT01603277|3842094|FG001|NOT COMPLETED|Overall Study||18
3117285|NCT01603355|3842100|FG000|STARTED|Overall Study||3
3117286|NCT01603355|3842100|FG000|COMPLETED|Overall Study||1
3117287|NCT01603355|3842100|FG000|NOT COMPLETED|Overall Study||2
3117288|NCT01603368|3842106|FG000|STARTED|Overall Study||68
3117289|NCT01603368|3842107|FG001|STARTED|Overall Study||66
3117290|NCT01603368|3842106|FG000|COMPLETED|Overall Study||68
3117291|NCT01603368|3842107|FG001|COMPLETED|Overall Study||66
3117292|NCT01603368|3842106|FG000|NOT COMPLETED|Overall Study||0
3117293|NCT01603368|3842107|FG001|NOT COMPLETED|Overall Study||0
3117294|NCT01603420|3842115|FG000|STARTED|Overall Study||1
3117295|NCT01603420|3842116|FG001|STARTED|Overall Study||1
3117296|NCT01603420|3842115|FG000|COMPLETED|Overall Study||1
3117297|NCT01603420|3842116|FG001|COMPLETED|Overall Study||1
3117298|NCT01603420|3842115|FG000|NOT COMPLETED|Overall Study||0
3117299|NCT01603420|3842116|FG001|NOT COMPLETED|Overall Study||0
3117300|NCT01603459|3842125|FG000|STARTED|Overall Study||155
3117301|NCT01603459|3842125|FG000|COMPLETED|Overall Study||137
3117302|NCT01603459|3842125|FG000|NOT COMPLETED|Overall Study||18
3117303|NCT01603602|3842150|FG000|STARTED|Overall Study||77
3117304|NCT01603602|3842151|FG001|STARTED|Overall Study||78
3117305|NCT01603602|3842152|FG002|STARTED|Overall Study||80
3117306|NCT01603602|3842150|FG000|COMPLETED|Overall Study||75
3117307|NCT01603602|3842151|FG001|COMPLETED|Overall Study||78
3117308|NCT01603602|3842152|FG002|COMPLETED|Overall Study||79
3117309|NCT01603602|3842150|FG000|NOT COMPLETED|Overall Study||2
3117310|NCT01603602|3842151|FG001|NOT COMPLETED|Overall Study||0
3117311|NCT01603602|3842152|FG002|NOT COMPLETED|Overall Study||1
3117312|NCT01603615|3842160|FG000|STARTED|Overall Study||220
3117313|NCT01603615|3842160|FG000|Safety Population (Treated)|Overall Study||213
3117314|NCT01603615|3842160|FG000|COMPLETED|Overall Study||186
3117315|NCT01603615|3842160|FG000|NOT COMPLETED|Overall Study||34
3117316|NCT01603628|3842167|FG000|STARTED|Overall Study||128
3117317|NCT01603628|3842168|FG001|STARTED|Overall Study||126
3117318|NCT01603628|3842169|FG002|STARTED|Overall Study||130
3117319|NCT01603628|3842167|FG000|Safety Population: Received Treatment|Overall Study||128
3117320|NCT01603628|3842168|FG001|Safety Population: Received Treatment|Overall Study||126
3117321|NCT01603628|3842169|FG002|Safety Population: Received Treatment|Overall Study||128
3117322|NCT01603628|3842167|FG000|COMPLETED|Overall Study||125
3117323|NCT01603628|3842168|FG001|COMPLETED|Overall Study||123
3117324|NCT01603628|3842169|FG002|COMPLETED|Overall Study||128
3117325|NCT01603628|3842167|FG000|NOT COMPLETED|Overall Study||3
3117326|NCT01603628|3842168|FG001|NOT COMPLETED|Overall Study||3
3117327|NCT01603628|3842169|FG002|NOT COMPLETED|Overall Study||2
3117328|NCT01603641|3842177|FG000|STARTED|Overall Study||370
3117329|NCT01603641|3842177|FG000|Safety Population (Treated)|Overall Study||367
3117330|NCT01603641|3842177|FG000|Modified Intent-to-treat Population|Overall Study||366
3117331|NCT01603641|3842177|FG000|COMPLETED|Overall Study||335
3117332|NCT01603641|3842177|FG000|NOT COMPLETED|Overall Study||35
3117333|NCT01603875|3842184|FG000|STARTED|Overall Study||35
3117334|NCT01603875|3842185|FG001|STARTED|Overall Study||35
3117335|NCT01603875|3842186|FG002|STARTED|Overall Study||35
3117336|NCT01603875|3842184|FG000|COMPLETED|Overall Study||28
3117337|NCT01603875|3842185|FG001|COMPLETED|Overall Study||27
3117338|NCT01603875|3842186|FG002|COMPLETED|Overall Study||26
3117339|NCT01603875|3842184|FG000|NOT COMPLETED|Overall Study||7
3117340|NCT01603875|3842185|FG001|NOT COMPLETED|Overall Study||8
3117341|NCT01603875|3842186|FG002|NOT COMPLETED|Overall Study||9
3117342|NCT01603940|3842196|FG000|STARTED|Overall Study||16
3117343|NCT01603940|3842197|FG001|STARTED|Overall Study||14
3117344|NCT01603940|3842196|FG000|COMPLETED|Overall Study||16
3117345|NCT01603940|3842197|FG001|COMPLETED|Overall Study||14
3117346|NCT01603940|3842196|FG000|NOT COMPLETED|Overall Study||0
3117347|NCT01603940|3842197|FG001|NOT COMPLETED|Overall Study||0
3117348|NCT01604109|3842205|FG000|STARTED|Overall Study||150
3117349|NCT01604109|3842206|FG001|STARTED|Overall Study||146
3117350|NCT01604109|3842205|FG000|COMPLETED|Overall Study||117
3117351|NCT01604109|3842206|FG001|COMPLETED|Overall Study||112
3117352|NCT01604109|3842205|FG000|NOT COMPLETED|Overall Study||33
3117353|NCT01604109|3842206|FG001|NOT COMPLETED|Overall Study||34
3117354|NCT01604122|3842214|FG000|STARTED|Overall Study||60
3117355|NCT01604122|3842215|FG001|STARTED|Overall Study||32
3117356|NCT01604122|3842214|FG000|COMPLETED|Overall Study||60
3117357|NCT01604122|3842215|FG001|COMPLETED|Overall Study||32
3117358|NCT01604122|3842214|FG000|NOT COMPLETED|Overall Study||0
3117359|NCT01604122|3842215|FG001|NOT COMPLETED|Overall Study||0
3117360|NCT01604265|3842224|FG000|STARTED|Overall Study||34
3117361|NCT01604265|3842225|FG001|STARTED|Overall Study||32
3117362|NCT01604265|3842224|FG000|COMPLETED|Overall Study||32
3117363|NCT01604265|3842225|FG001|COMPLETED|Overall Study||32
3117364|NCT01604265|3842224|FG000|NOT COMPLETED|Overall Study||2
3117365|NCT01604265|3842225|FG001|NOT COMPLETED|Overall Study||0
3117366|NCT01604278|3842233|FG000|STARTED|Overall Study||226
3117367|NCT01604278|3842234|FG001|STARTED|Overall Study||223
3117368|NCT01604278|3842233|FG000|Safety Set|Overall Study||226
3117369|NCT01604278|3842234|FG001|Safety Set|Overall Study|Two randomized participants who did not receive study drug were excluded from this set.|221
3117370|NCT01604278|3842233|FG000|Full Analysis Set|Overall Study||226
3117371|NCT01604278|3842234|FG001|Full Analysis Set|Overall Study|Three randomized participants excluded: 2 who did not receive study drug; 1 with a major deviation.|220
3117372|NCT01604278|3842233|FG000|COMPLETED|Overall Study||212
3117373|NCT01604278|3842234|FG001|COMPLETED|Overall Study||210
3295022|NCT02892760|4029199|FG000|NOT COMPLETED|Overall Study||3
3295023|NCT02893878|4029206|FG000|STARTED|Overall Study||13861
3295024|NCT02893878|4029207|FG001|STARTED|Overall Study||2295
3117374|NCT01604278|3842233|FG000|NOT COMPLETED|Overall Study||14
3117375|NCT01604278|3842234|FG001|NOT COMPLETED|Overall Study||13
3117376|NCT01604291|3842244|FG000|STARTED|Overall Study||311
3117377|NCT01604291|3842245|FG001|STARTED|Overall Study||443
3117378|NCT01604291|3842246|FG002|STARTED|Overall Study||193
3117379|NCT01604291|3842247|FG003|STARTED|Overall Study||44
3117380|NCT01604291|3842244|FG000|COMPLETED|Overall Study||311
3117381|NCT01604291|3842245|FG001|COMPLETED|Overall Study||443
3117382|NCT01604291|3842246|FG002|COMPLETED|Overall Study||193
3117383|NCT01604291|3842247|FG003|COMPLETED|Overall Study||44
3117384|NCT01604291|3842244|FG000|NOT COMPLETED|Overall Study||0
3117385|NCT01604291|3842245|FG001|NOT COMPLETED|Overall Study||0
3117386|NCT01604291|3842246|FG002|NOT COMPLETED|Overall Study||0
3117387|NCT01604291|3842247|FG003|NOT COMPLETED|Overall Study||0
3117388|NCT01604343|3842268|FG000|STARTED|Prior to W52 Administration(Through W52)||556
3117389|NCT01604343|3842269|FG001|STARTED|Prior to W52 Administration(Through W52)||0
3117390|NCT01604343|3842270|FG002|STARTED|Prior to W52 Administration(Through W52)||557
3117391|NCT01604343|3842271|FG003|STARTED|Prior to W52 Administration(Through W52)||0
3117392|NCT01604343|3842272|FG004|STARTED|Prior to W52 Administration(Through W52)||557
3117393|NCT01604343|3842268|FG000|Participants Re-randomized at Week 18|Prior to W52 Administration(Through W52)|Out of 187, 95 were re-randomized to sirukumab 50 mg and 92 were re-randomized to 100 mg group.|187
3117394|NCT01604343|3842269|FG001|Participants Re-randomized at Week 18|Prior to W52 Administration(Through W52)||0
3117395|NCT01604343|3842270|FG002|Participants Re-randomized at Week 18|Prior to W52 Administration(Through W52)||0
3117396|NCT01604343|3842271|FG003|Participants Re-randomized at Week 18|Prior to W52 Administration(Through W52)||0
3117397|NCT01604343|3842272|FG004|Participants Re-randomized at Week 18|Prior to W52 Administration(Through W52)||0
3117398|NCT01604343|3842268|FG000|Participants Re-randomized at Week 40|Prior to W52 Administration(Through W52)|Out of 24, 12 were re-randomized to sirukumab 50 mg and 12 were re-randomized to 100 mg group.|24
3117399|NCT01604343|3842269|FG001|Participants Re-randomized at Week 40|Prior to W52 Administration(Through W52)||0
3117400|NCT01604343|3842270|FG002|Participants Re-randomized at Week 40|Prior to W52 Administration(Through W52)||0
3117401|NCT01604343|3842271|FG003|Participants Re-randomized at Week 40|Prior to W52 Administration(Through W52)||0
3117402|NCT01604343|3842272|FG004|Participants Re-randomized at Week 40|Prior to W52 Administration(Through W52)||0
3117403|NCT01604343|3842268|FG000|COMPLETED|Prior to W52 Administration(Through W52)||458
3117404|NCT01604343|3842269|FG001|COMPLETED|Prior to W52 Administration(Through W52)||0
3117405|NCT01604343|3842270|FG002|COMPLETED|Prior to W52 Administration(Through W52)||481
3117406|NCT01604343|3842271|FG003|COMPLETED|Prior to W52 Administration(Through W52)||0
3117407|NCT01604343|3842272|FG004|COMPLETED|Prior to W52 Administration(Through W52)||470
3117408|NCT01604343|3842268|FG000|NOT COMPLETED|Prior to W52 Administration(Through W52)||98
3117409|NCT01604343|3842269|FG001|NOT COMPLETED|Prior to W52 Administration(Through W52)||0
3117410|NCT01604343|3842270|FG002|NOT COMPLETED|Prior to W52 Administration(Through W52)||76
3117411|NCT01604343|3842271|FG003|NOT COMPLETED|Prior to W52 Administration(Through W52)||0
3295025|NCT02893878|4029208|FG002|STARTED|Overall Study||3178
3117412|NCT01604343|3842272|FG004|NOT COMPLETED|Prior to W52 Administration(Through W52)||87
3117413|NCT01604343|3842268|FG000|STARTED|Week 52 to Week 104||0
3117414|NCT01604343|3842269|FG001|STARTED|Week 52 to Week 104|Participants re-randomized at Week 18 (95), 40 (12) and 52 were included|243
3117415|NCT01604343|3842270|FG002|STARTED|Week 52 to Week 104||481
3117416|NCT01604343|3842271|FG003|STARTED|Week 52 to Week 104|Participants re-randomized at Week 18 (92), 40 (12) and 52 were included|241
3117417|NCT01604343|3842272|FG004|STARTED|Week 52 to Week 104||470
3117418|NCT01604343|3842268|FG000|Treated|Week 52 to Week 104||0
3117419|NCT01604343|3842269|FG001|Treated|Week 52 to Week 104||242
3117420|NCT01604343|3842270|FG002|Treated|Week 52 to Week 104||481
3117421|NCT01604343|3842271|FG003|Treated|Week 52 to Week 104||241
3117422|NCT01604343|3842272|FG004|Treated|Week 52 to Week 104||470
3117423|NCT01604343|3842268|FG000|COMPLETED|Week 52 to Week 104||0
3117424|NCT01604343|3842269|FG001|COMPLETED|Week 52 to Week 104||200
3117425|NCT01604343|3842270|FG002|COMPLETED|Week 52 to Week 104||414
3117426|NCT01604343|3842271|FG003|COMPLETED|Week 52 to Week 104||195
3117427|NCT01604343|3842272|FG004|COMPLETED|Week 52 to Week 104||429
3117428|NCT01604343|3842268|FG000|NOT COMPLETED|Week 52 to Week 104||0
3117429|NCT01604343|3842269|FG001|NOT COMPLETED|Week 52 to Week 104||43
3117430|NCT01604343|3842270|FG002|NOT COMPLETED|Week 52 to Week 104||67
3117431|NCT01604343|3842271|FG003|NOT COMPLETED|Week 52 to Week 104||46
3117432|NCT01604343|3842272|FG004|NOT COMPLETED|Week 52 to Week 104||41
3117433|NCT01604343|3842268|FG000|STARTED|Safety Follow-up Period (Week 104-120)||109
3117434|NCT01604343|3842269|FG001|STARTED|Safety Follow-up Period (Week 104-120)||27
3117435|NCT01604343|3842270|FG002|STARTED|Safety Follow-up Period (Week 104-120)||105
3117436|NCT01604343|3842271|FG003|STARTED|Safety Follow-up Period (Week 104-120)||36
3117437|NCT01604343|3842272|FG004|STARTED|Safety Follow-up Period (Week 104-120)||114
3117438|NCT01604343|3842268|FG000|Safety Population|Safety Follow-up Period (Week 104-120)||109
3117439|NCT01604343|3842269|FG001|Safety Population|Safety Follow-up Period (Week 104-120)||26
3117440|NCT01604343|3842270|FG002|Safety Population|Safety Follow-up Period (Week 104-120)||105
3117441|NCT01604343|3842271|FG003|Safety Population|Safety Follow-up Period (Week 104-120)||36
3117442|NCT01604343|3842272|FG004|Safety Population|Safety Follow-up Period (Week 104-120)||114
3117443|NCT01604343|3842268|FG000|COMPLETED|Safety Follow-up Period (Week 104-120)||79
3117444|NCT01604343|3842269|FG001|COMPLETED|Safety Follow-up Period (Week 104-120)||20
3117445|NCT01604343|3842270|FG002|COMPLETED|Safety Follow-up Period (Week 104-120)||72
3117446|NCT01604343|3842271|FG003|COMPLETED|Safety Follow-up Period (Week 104-120)||26
3117447|NCT01604343|3842272|FG004|COMPLETED|Safety Follow-up Period (Week 104-120)||85
3117448|NCT01604343|3842268|FG000|NOT COMPLETED|Safety Follow-up Period (Week 104-120)||30
3117449|NCT01604343|3842269|FG001|NOT COMPLETED|Safety Follow-up Period (Week 104-120)||7
3117450|NCT01604343|3842270|FG002|NOT COMPLETED|Safety Follow-up Period (Week 104-120)||33
3117451|NCT01604343|3842271|FG003|NOT COMPLETED|Safety Follow-up Period (Week 104-120)||10
3117452|NCT01604343|3842272|FG004|NOT COMPLETED|Safety Follow-up Period (Week 104-120)||29
3117453|NCT01604408|3842284|FG000|STARTED|Treatment Period 1||102
3117454|NCT01604408|3842285|FG001|STARTED|Treatment Period 1||99
3117455|NCT01604408|3842284|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 1||102
3117456|NCT01604408|3842285|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 1||99
3117457|NCT01604408|3842284|FG000|COMPLETED|Treatment Period 1||102
3117458|NCT01604408|3842285|FG001|COMPLETED|Treatment Period 1||98
3117459|NCT01604408|3842284|FG000|NOT COMPLETED|Treatment Period 1||0
3117460|NCT01604408|3842285|FG001|NOT COMPLETED|Treatment Period 1||1
3117461|NCT01604408|3842284|FG000|STARTED|Treatment Period 2||102
3117462|NCT01604408|3842285|FG001|STARTED|Treatment Period 2||98
3117463|NCT01604408|3842284|FG000|COMPLETED|Treatment Period 2||100
3117464|NCT01604408|3842285|FG001|COMPLETED|Treatment Period 2||96
3117465|NCT01604408|3842284|FG000|NOT COMPLETED|Treatment Period 2||2
3117466|NCT01604408|3842285|FG001|NOT COMPLETED|Treatment Period 2||2
3117467|NCT01604408|3842284|FG000|STARTED|Treatment Period 3||100
3117468|NCT01604408|3842285|FG001|STARTED|Treatment Period 3||96
3117469|NCT01604408|3842284|FG000|COMPLETED|Treatment Period 3||95
3117470|NCT01604408|3842285|FG001|COMPLETED|Treatment Period 3||91
3117471|NCT01604408|3842284|FG000|NOT COMPLETED|Treatment Period 3||5
3117472|NCT01604408|3842285|FG001|NOT COMPLETED|Treatment Period 3||5
3117473|NCT01604408|3842284|FG000|STARTED|Treatment Period 4||95
3117474|NCT01604408|3842285|FG001|STARTED|Treatment Period 4||91
3117475|NCT01604408|3842284|FG000|COMPLETED|Treatment Period 4||92
3117476|NCT01604408|3842285|FG001|COMPLETED|Treatment Period 4||89
3117477|NCT01604408|3842284|FG000|NOT COMPLETED|Treatment Period 4||3
3117478|NCT01604408|3842285|FG001|NOT COMPLETED|Treatment Period 4||2
3117479|NCT01604408|3842284|FG000|STARTED|Treatment Period 5||92
3117480|NCT01604408|3842285|FG001|STARTED|Treatment Period 5||89
3117481|NCT01604408|3842284|FG000|COMPLETED|Treatment Period 5||88
3117482|NCT01604408|3842285|FG001|COMPLETED|Treatment Period 5||89
3117483|NCT01604408|3842284|FG000|NOT COMPLETED|Treatment Period 5||4
3117484|NCT01604408|3842285|FG001|NOT COMPLETED|Treatment Period 5||0
3117485|NCT01604408|3842284|FG000|STARTED|Treatment Period 6||88
3117486|NCT01604408|3842285|FG001|STARTED|Treatment Period 6||89
3117487|NCT01604408|3842284|FG000|COMPLETED|Treatment Period 6||86
3117488|NCT01604408|3842285|FG001|COMPLETED|Treatment Period 6||87
3117489|NCT01604408|3842284|FG000|NOT COMPLETED|Treatment Period 6||2
3117490|NCT01604408|3842285|FG001|NOT COMPLETED|Treatment Period 6||2
3117491|NCT01604408|3842284|FG000|STARTED|Observation Period||86
3117492|NCT01604408|3842285|FG001|STARTED|Observation Period||87
3117493|NCT01604408|3842284|FG000|COMPLETED|Observation Period||85
3117494|NCT01604408|3842285|FG001|COMPLETED|Observation Period||84
3117495|NCT01604408|3842284|FG000|NOT COMPLETED|Observation Period||1
3117496|NCT01604408|3842285|FG001|NOT COMPLETED|Observation Period||3
3117497|NCT01604772|3842291|FG000|STARTED|Overall Study||16
3117498|NCT01604772|3842291|FG000|COMPLETED|Overall Study||16
3117499|NCT01604772|3842291|FG000|NOT COMPLETED|Overall Study||0
3117500|NCT01604785|3842298|FG000|STARTED|Overall Study||37
3117501|NCT01604785|3842299|FG001|STARTED|Overall Study||37
3117502|NCT01604785|3842298|FG000|COMPLETED|Overall Study||30
3117503|NCT01604785|3842299|FG001|COMPLETED|Overall Study||36
3117504|NCT01604785|3842298|FG000|NOT COMPLETED|Overall Study||7
3117505|NCT01604785|3842299|FG001|NOT COMPLETED|Overall Study||1
3117506|NCT01604824|3842309|FG000|STARTED|Double-blind (DB) Period||6
3117507|NCT01604824|3842310|FG001|STARTED|Double-blind (DB) Period||7
3117508|NCT01604824|3842311|FG002|STARTED|Double-blind (DB) Period||5
3117509|NCT01604824|3842312|FG003|STARTED|Double-blind (DB) Period||5
3117510|NCT01604824|3842313|FG004|STARTED|Double-blind (DB) Period||0
3117511|NCT01604824|3842314|FG005|STARTED|Double-blind (DB) Period||0
3117512|NCT01604824|3842309|FG000|Completed DB Period (Day 99)|Double-blind (DB) Period||6
3117513|NCT01604824|3842310|FG001|Completed DB Period (Day 99)|Double-blind (DB) Period||7
3117514|NCT01604824|3842311|FG002|Completed DB Period (Day 99)|Double-blind (DB) Period||5
3117515|NCT01604824|3842312|FG003|Completed DB Period (Day 99)|Double-blind (DB) Period||5
3117516|NCT01604824|3842313|FG004|Completed DB Period (Day 99)|Double-blind (DB) Period||0
3117517|NCT01604824|3842314|FG005|Completed DB Period (Day 99)|Double-blind (DB) Period||0
3117518|NCT01604824|3842309|FG000|Completed DB Follow-up (Day 155)|Double-blind (DB) Period||6
3117519|NCT01604824|3842310|FG001|Completed DB Follow-up (Day 155)|Double-blind (DB) Period||7
3117520|NCT01604824|3842311|FG002|Completed DB Follow-up (Day 155)|Double-blind (DB) Period||5
3117521|NCT01604824|3842312|FG003|Completed DB Follow-up (Day 155)|Double-blind (DB) Period||5
3117522|NCT01604824|3842313|FG004|Completed DB Follow-up (Day 155)|Double-blind (DB) Period||0
3117523|NCT01604824|3842314|FG005|Completed DB Follow-up (Day 155)|Double-blind (DB) Period||0
3117524|NCT01604824|3842309|FG000|COMPLETED|Double-blind (DB) Period||6
3117525|NCT01604824|3842310|FG001|COMPLETED|Double-blind (DB) Period||7
3117526|NCT01604824|3842311|FG002|COMPLETED|Double-blind (DB) Period||5
3117527|NCT01604824|3842312|FG003|COMPLETED|Double-blind (DB) Period||5
3117528|NCT01604824|3842313|FG004|COMPLETED|Double-blind (DB) Period||0
3117529|NCT01604824|3842314|FG005|COMPLETED|Double-blind (DB) Period||0
3117530|NCT01604824|3842309|FG000|NOT COMPLETED|Double-blind (DB) Period||0
3117531|NCT01604824|3842310|FG001|NOT COMPLETED|Double-blind (DB) Period||0
3117532|NCT01604824|3842311|FG002|NOT COMPLETED|Double-blind (DB) Period||0
3117533|NCT01604824|3842312|FG003|NOT COMPLETED|Double-blind (DB) Period||0
3117534|NCT01604824|3842313|FG004|NOT COMPLETED|Double-blind (DB) Period||0
3117535|NCT01604824|3842314|FG005|NOT COMPLETED|Double-blind (DB) Period||0
3117536|NCT01604824|3842309|FG000|STARTED|Open-label Extension (OLE) Period||0
3117537|NCT01604824|3842310|FG001|STARTED|Open-label Extension (OLE) Period||0
3117538|NCT01604824|3842311|FG002|STARTED|Open-label Extension (OLE) Period||0
3117539|NCT01604824|3842312|FG003|STARTED|Open-label Extension (OLE) Period||0
3117540|NCT01604824|3842313|FG004|STARTED|Open-label Extension (OLE) Period|Completed DB Period (Day 99)|13
3117541|NCT01604824|3842314|FG005|STARTED|Open-label Extension (OLE) Period|Completed DB follow-up (Day 155)|10
3117542|NCT01604824|3842309|FG000|Started Open-label Extension Period|Open-label Extension (OLE) Period||0
3117543|NCT01604824|3842310|FG001|Started Open-label Extension Period|Open-label Extension (OLE) Period||0
3117544|NCT01604824|3842311|FG002|Started Open-label Extension Period|Open-label Extension (OLE) Period||0
3117545|NCT01604824|3842312|FG003|Started Open-label Extension Period|Open-label Extension (OLE) Period||0
3117546|NCT01604824|3842313|FG004|Started Open-label Extension Period|Open-label Extension (OLE) Period|Two subjects chose not to enter OLE period|11
3117547|NCT01604824|3842314|FG005|Started Open-label Extension Period|Open-label Extension (OLE) Period||10
3117548|NCT01604824|3842309|FG000|Completed Study|Open-label Extension (OLE) Period||0
3117549|NCT01604824|3842310|FG001|Completed Study|Open-label Extension (OLE) Period||0
3117550|NCT01604824|3842311|FG002|Completed Study|Open-label Extension (OLE) Period||0
3117551|NCT01604824|3842312|FG003|Completed Study|Open-label Extension (OLE) Period||0
3117552|NCT01604824|3842313|FG004|Completed Study|Open-label Extension (OLE) Period||10
3117553|NCT01604824|3842314|FG005|Completed Study|Open-label Extension (OLE) Period||10
3117554|NCT01604824|3842309|FG000|COMPLETED|Open-label Extension (OLE) Period||0
3117555|NCT01604824|3842310|FG001|COMPLETED|Open-label Extension (OLE) Period||0
3117556|NCT01604824|3842311|FG002|COMPLETED|Open-label Extension (OLE) Period||0
3117557|NCT01604824|3842312|FG003|COMPLETED|Open-label Extension (OLE) Period||0
3117558|NCT01604824|3842313|FG004|COMPLETED|Open-label Extension (OLE) Period||10
3117559|NCT01604824|3842314|FG005|COMPLETED|Open-label Extension (OLE) Period||10
3117560|NCT01604824|3842309|FG000|NOT COMPLETED|Open-label Extension (OLE) Period||0
3117561|NCT01604824|3842310|FG001|NOT COMPLETED|Open-label Extension (OLE) Period||0
3117562|NCT01604824|3842311|FG002|NOT COMPLETED|Open-label Extension (OLE) Period||0
3117563|NCT01604824|3842312|FG003|NOT COMPLETED|Open-label Extension (OLE) Period||0
3117564|NCT01604824|3842313|FG004|NOT COMPLETED|Open-label Extension (OLE) Period||3
3117565|NCT01604824|3842314|FG005|NOT COMPLETED|Open-label Extension (OLE) Period||0
3117566|NCT01604850|3842328|FG000|STARTED|Overall Study||103
3117567|NCT01604850|3842329|FG001|STARTED|Overall Study||99
3117568|NCT01604850|3842328|FG000|Enrolled and Treated|Overall Study||103
3117569|NCT01604850|3842329|FG001|Enrolled and Treated|Overall Study||98
3117570|NCT01604850|3842328|FG000|COMPLETED|Overall Study||51
3117571|NCT01604850|3842329|FG001|COMPLETED|Overall Study||69
3117572|NCT01604850|3842328|FG000|NOT COMPLETED|Overall Study||52
3117573|NCT01604850|3842329|FG001|NOT COMPLETED|Overall Study||30
3117574|NCT01604941|3842337|FG000|STARTED|Overall Study||11
3117575|NCT01604941|3842338|FG001|STARTED|Overall Study||4
3117576|NCT01604941|3842339|FG002|STARTED|Overall Study||3
3117577|NCT01604941|3842340|FG003|STARTED|Overall Study||3
3117578|NCT01604941|3842341|FG004|STARTED|Overall Study||4
3117579|NCT01604941|3842342|FG005|STARTED|Overall Study||7
3117580|NCT01604941|3842337|FG000|COMPLETED|Overall Study||0
3117581|NCT01604941|3842338|FG001|COMPLETED|Overall Study||0
3117582|NCT01604941|3842339|FG002|COMPLETED|Overall Study||0
3117583|NCT01604941|3842340|FG003|COMPLETED|Overall Study||0
3117584|NCT01604941|3842341|FG004|COMPLETED|Overall Study||3
3117585|NCT01604941|3842342|FG005|COMPLETED|Overall Study||0
3117586|NCT01604941|3842337|FG000|NOT COMPLETED|Overall Study||11
3117587|NCT01604941|3842338|FG001|NOT COMPLETED|Overall Study||4
3117588|NCT01604941|3842339|FG002|NOT COMPLETED|Overall Study||3
3117589|NCT01604941|3842340|FG003|NOT COMPLETED|Overall Study||3
3117590|NCT01604941|3842341|FG004|NOT COMPLETED|Overall Study||1
3117591|NCT01604941|3842342|FG005|NOT COMPLETED|Overall Study||7
3117592|NCT01605032|3842348|FG000|STARTED|Overall Study||19
3117593|NCT01605032|3842348|FG000|COMPLETED|Overall Study||18
3117594|NCT01605032|3842348|FG000|NOT COMPLETED|Overall Study||1
3117595|NCT01605071|3842354|FG000|STARTED|Overall Study||27
3117596|NCT01605071|3842355|FG001|STARTED|Overall Study||26
3117597|NCT01605071|3842354|FG000|COMPLETED|Overall Study||24
3117598|NCT01605071|3842355|FG001|COMPLETED|Overall Study||24
3117599|NCT01605071|3842354|FG000|NOT COMPLETED|Overall Study||3
3117600|NCT01605071|3842355|FG001|NOT COMPLETED|Overall Study||2
3117601|NCT01605097|3842363|FG000|STARTED|Overall Study|One patient consented but was ineligible due to lack of lesion visible on mpMRI|26
3117602|NCT01605097|3842363|FG000|COMPLETED|Overall Study||25
3117603|NCT01605097|3842363|FG000|NOT COMPLETED|Overall Study||1
3117604|NCT01605136|3842370|FG000|STARTED|Study Period||48
3117605|NCT01605136|3842371|FG001|STARTED|Study Period||45
3117606|NCT01605136|3842370|FG000|COMPLETED|Study Period||45
3117607|NCT01605136|3842371|FG001|COMPLETED|Study Period||42
3117608|NCT01605136|3842370|FG000|NOT COMPLETED|Study Period||3
3117609|NCT01605136|3842371|FG001|NOT COMPLETED|Study Period||3
3117610|NCT01605136|3842370|FG000|STARTED|Safety Follow-Up Period||45
3117611|NCT01605136|3842371|FG001|STARTED|Safety Follow-Up Period||42
3117612|NCT01605136|3842370|FG000|COMPLETED|Safety Follow-Up Period||44
3117613|NCT01605136|3842371|FG001|COMPLETED|Safety Follow-Up Period||40
3117614|NCT01605136|3842370|FG000|NOT COMPLETED|Safety Follow-Up Period||1
3117615|NCT01605136|3842371|FG001|NOT COMPLETED|Safety Follow-Up Period||2
3117616|NCT01605227|3842379|FG000|STARTED|Overall Study||682
3117617|NCT01605227|3842380|FG001|STARTED|Overall Study||346
3117618|NCT01605227|3842379|FG000|COMPLETED|Overall Study||61
3117619|NCT01605227|3842380|FG001|COMPLETED|Overall Study||17
3117620|NCT01605227|3842379|FG000|NOT COMPLETED|Overall Study||621
3117621|NCT01605227|3842380|FG001|NOT COMPLETED|Overall Study||329
3117622|NCT01605292|3842388|FG000|STARTED|Overall Study||351
3117623|NCT01605292|3842389|FG001|STARTED|Overall Study||347
3117624|NCT01605292|3842388|FG000|COMPLETED|Overall Study||351
3117625|NCT01605292|3842389|FG001|COMPLETED|Overall Study||347
3117626|NCT01605292|3842388|FG000|NOT COMPLETED|Overall Study||0
3117627|NCT01605292|3842389|FG001|NOT COMPLETED|Overall Study||0
3117628|NCT01605396|3842397|FG000|STARTED|Overall Study||40
3117629|NCT01605396|3842398|FG001|STARTED|Overall Study||40
3117630|NCT01605396|3842397|FG000|Treated|Overall Study||39
3117631|NCT01605396|3842398|FG001|Treated|Overall Study||40
3117632|NCT01605396|3842397|FG000|COMPLETED|Overall Study||0
3117633|NCT01605396|3842398|FG001|COMPLETED|Overall Study||0
3117634|NCT01605396|3842397|FG000|NOT COMPLETED|Overall Study||40
3117635|NCT01605396|3842398|FG001|NOT COMPLETED|Overall Study||40
3117636|NCT01605435|3842404|FG000|STARTED|Overall Study||2
3117637|NCT01605435|3842405|FG001|STARTED|Overall Study||3
3117638|NCT01605435|3842404|FG000|COMPLETED|Overall Study||2
3117639|NCT01605435|3842405|FG001|COMPLETED|Overall Study||3
3117640|NCT01605435|3842404|FG000|NOT COMPLETED|Overall Study||0
3117641|NCT01605435|3842405|FG001|NOT COMPLETED|Overall Study||0
3117642|NCT01605461|3842422|FG000|STARTED|Overall Study||12
3117643|NCT01605461|3842422|FG000|COMPLETED|Overall Study||8
3117644|NCT01605461|3842422|FG000|NOT COMPLETED|Overall Study||4
3117645|NCT01605539|3842428|FG000|STARTED|Overall Study||3
3117646|NCT01605539|3842429|FG001|STARTED|Overall Study||3
3117647|NCT01605539|3842430|FG002|STARTED|Overall Study||4
3117648|NCT01605539|3842428|FG000|COMPLETED|Overall Study||3
3117649|NCT01605539|3842429|FG001|COMPLETED|Overall Study||2
3117650|NCT01605539|3842430|FG002|COMPLETED|Overall Study||4
3117651|NCT01605539|3842428|FG000|NOT COMPLETED|Overall Study||0
3117652|NCT01605539|3842429|FG001|NOT COMPLETED|Overall Study||1
3117653|NCT01605539|3842430|FG002|NOT COMPLETED|Overall Study||0
3117654|NCT01605552|3842441|FG000|STARTED|Overall Study||13
3117655|NCT01605552|3842442|FG001|STARTED|Overall Study||16
3117656|NCT01605552|3842441|FG000|COMPLETED|Overall Study|4 dropped out before the first BtB visit; it is unlikely that the treatment was the cause of dropout|7
3117657|NCT01605552|3842442|FG001|COMPLETED|Overall Study||14
3117658|NCT01605552|3842441|FG000|NOT COMPLETED|Overall Study||6
3117659|NCT01605552|3842442|FG001|NOT COMPLETED|Overall Study||2
3117660|NCT01605669|3842448|FG000|STARTED|Overall Study||50
3117661|NCT01605669|3842448|FG000|COMPLETED|Overall Study||50
3117662|NCT01605669|3842448|FG000|NOT COMPLETED|Overall Study||0
3117663|NCT01605799|3842455|FG000|STARTED|Overall Study||17
3117664|NCT01605799|3842456|FG001|STARTED|Overall Study||16
3117665|NCT01605799|3842455|FG000|COMPLETED|Overall Study||15
3117666|NCT01605799|3842456|FG001|COMPLETED|Overall Study||15
3117667|NCT01605799|3842455|FG000|NOT COMPLETED|Overall Study||2
3117668|NCT01605799|3842456|FG001|NOT COMPLETED|Overall Study||1
3117669|NCT01605825|3842464|FG000|STARTED|Overall Study||55
3117670|NCT01605825|3842465|FG001|STARTED|Overall Study||28
3117671|NCT01605825|3842464|FG000|COMPLETED|Overall Study||45
3117672|NCT01605825|3842465|FG001|COMPLETED|Overall Study||25
3117673|NCT01605825|3842464|FG000|NOT COMPLETED|Overall Study||10
3117674|NCT01605825|3842465|FG001|NOT COMPLETED|Overall Study||3
3117675|NCT01605877|3842471|FG000|STARTED|Overall Study||64
3117676|NCT01605877|3842471|FG000|COMPLETED|Overall Study||63
3117677|NCT01605877|3842471|FG000|NOT COMPLETED|Overall Study||1
3117678|NCT01605890|3842493|FG000|STARTED|Overall Study||30
3117679|NCT01605890|3842493|FG000|COMPLETED|Overall Study||28
3117680|NCT01605890|3842493|FG000|NOT COMPLETED|Overall Study||2
3117681|NCT01605903|3842499|FG000|STARTED|Overall Study||345
3117682|NCT01605903|3842500|FG001|STARTED|Overall Study||343
3117683|NCT01605903|3842499|FG000|COMPLETED|Overall Study||345
3117684|NCT01605903|3842500|FG001|COMPLETED|Overall Study||343
3117685|NCT01605903|3842499|FG000|NOT COMPLETED|Overall Study||0
3117686|NCT01605903|3842500|FG001|NOT COMPLETED|Overall Study||0
3117687|NCT01605916|3842511|FG000|STARTED|Overall Study||4
3117688|NCT01605916|3842512|FG001|STARTED|Overall Study||4
3117689|NCT01605916|3842513|FG002|STARTED|Overall Study||4
3117690|NCT01605916|3842514|FG003|STARTED|Overall Study||6
3117691|NCT01605916|3842515|FG004|STARTED|Overall Study||7
3117692|NCT01605916|3842511|FG000|COMPLETED|Overall Study||0
3117693|NCT01605916|3842512|FG001|COMPLETED|Overall Study||0
3117694|NCT01605916|3842513|FG002|COMPLETED|Overall Study|Subject ongoing the study at data cut off|1
3117695|NCT01605916|3842514|FG003|COMPLETED|Overall Study||0
3117696|NCT01605916|3842515|FG004|COMPLETED|Overall Study|Subject ongoing the study at data cut off|1
3117697|NCT01605916|3842511|FG000|NOT COMPLETED|Overall Study||4
3117698|NCT01605916|3842512|FG001|NOT COMPLETED|Overall Study||4
3117699|NCT01605916|3842513|FG002|NOT COMPLETED|Overall Study||3
3117700|NCT01605916|3842514|FG003|NOT COMPLETED|Overall Study||6
3117701|NCT01605916|3842515|FG004|NOT COMPLETED|Overall Study||6
3117702|NCT01605942|3842530|FG000|STARTED|Overall Study||6
3117703|NCT01605942|3842531|FG001|STARTED|Overall Study||2
3117704|NCT01605942|3842530|FG000|COMPLETED|Overall Study||6
3117705|NCT01605942|3842531|FG001|COMPLETED|Overall Study||2
3117706|NCT01605942|3842530|FG000|NOT COMPLETED|Overall Study||0
3117707|NCT01605942|3842531|FG001|NOT COMPLETED|Overall Study||0
3117708|NCT01606007|3842540|FG000|STARTED|Overall Study||176
3117709|NCT01606007|3842541|FG001|STARTED|Overall Study||179
3117710|NCT01606007|3842542|FG002|STARTED|Overall Study||179
3117711|NCT01606007|3842540|FG000|COMPLETED|Overall Study||161
3117712|NCT01606007|3842541|FG001|COMPLETED|Overall Study||160
3117713|NCT01606007|3842542|FG002|COMPLETED|Overall Study||169
3117714|NCT01606007|3842540|FG000|NOT COMPLETED|Overall Study||15
3117715|NCT01606007|3842541|FG001|NOT COMPLETED|Overall Study||19
3117716|NCT01606007|3842542|FG002|NOT COMPLETED|Overall Study||10
3117717|NCT01606124|3842552|FG000|STARTED|Overall Study||19
3117718|NCT01606124|3842553|FG001|STARTED|Overall Study||20
3117719|NCT01606124|3842552|FG000|COMPLETED|Overall Study||19
3117720|NCT01606124|3842553|FG001|COMPLETED|Overall Study||20
3117721|NCT01606124|3842552|FG000|NOT COMPLETED|Overall Study||0
3117722|NCT01606124|3842553|FG001|NOT COMPLETED|Overall Study||0
3117723|NCT01606137|3842559|FG000|STARTED|Overall Study||507
3117724|NCT01606137|3842559|FG000|COMPLETED|Overall Study||245
3117725|NCT01606137|3842559|FG000|NOT COMPLETED|Overall Study||262
3117726|NCT01606176|3842565|FG000|STARTED|Overall Study||36
3117727|NCT01606176|3842566|FG001|STARTED|Overall Study||34
3117728|NCT01606176|3842565|FG000|COMPLETED|Overall Study||32
3117729|NCT01606176|3842566|FG001|COMPLETED|Overall Study||31
3117730|NCT01606176|3842565|FG000|NOT COMPLETED|Overall Study||4
3117731|NCT01606176|3842566|FG001|NOT COMPLETED|Overall Study||3
3117732|NCT01606189|3842572|FG000|STARTED|First Intenvention (14-20 Days)||8
3117733|NCT01606189|3842573|FG001|STARTED|First Intenvention (14-20 Days)||8
3117734|NCT01606189|3842574|FG002|STARTED|First Intenvention (14-20 Days)||8
3117735|NCT01606189|3842575|FG003|STARTED|First Intenvention (14-20 Days)||8
3117736|NCT01606189|3842576|FG004|STARTED|First Intenvention (14-20 Days)||8
3117737|NCT01606189|3842577|FG005|STARTED|First Intenvention (14-20 Days)||8
3117738|NCT01606189|3842572|FG000|COMPLETED|First Intenvention (14-20 Days)||8
3117739|NCT01606189|3842573|FG001|COMPLETED|First Intenvention (14-20 Days)||8
3117740|NCT01606189|3842574|FG002|COMPLETED|First Intenvention (14-20 Days)||8
3117741|NCT01606189|3842575|FG003|COMPLETED|First Intenvention (14-20 Days)||8
3117742|NCT01606189|3842576|FG004|COMPLETED|First Intenvention (14-20 Days)||8
3117743|NCT01606189|3842577|FG005|COMPLETED|First Intenvention (14-20 Days)||8
3117744|NCT01606189|3842572|FG000|NOT COMPLETED|First Intenvention (14-20 Days)||0
3117745|NCT01606189|3842573|FG001|NOT COMPLETED|First Intenvention (14-20 Days)||0
3117746|NCT01606189|3842574|FG002|NOT COMPLETED|First Intenvention (14-20 Days)||0
3117747|NCT01606189|3842575|FG003|NOT COMPLETED|First Intenvention (14-20 Days)||0
3117748|NCT01606189|3842576|FG004|NOT COMPLETED|First Intenvention (14-20 Days)||0
3117749|NCT01606189|3842577|FG005|NOT COMPLETED|First Intenvention (14-20 Days)||0
3117750|NCT01606189|3842572|FG000|STARTED|Second Intenvention (14-20 Days)||8
3117751|NCT01606189|3842573|FG001|STARTED|Second Intenvention (14-20 Days)||8
3117752|NCT01606189|3842574|FG002|STARTED|Second Intenvention (14-20 Days)||8
3117753|NCT01606189|3842575|FG003|STARTED|Second Intenvention (14-20 Days)||8
3117754|NCT01606189|3842576|FG004|STARTED|Second Intenvention (14-20 Days)||8
3117755|NCT01606189|3842577|FG005|STARTED|Second Intenvention (14-20 Days)||8
3117756|NCT01606189|3842572|FG000|COMPLETED|Second Intenvention (14-20 Days)||8
3117757|NCT01606189|3842573|FG001|COMPLETED|Second Intenvention (14-20 Days)||8
3117758|NCT01606189|3842574|FG002|COMPLETED|Second Intenvention (14-20 Days)||8
3117759|NCT01606189|3842575|FG003|COMPLETED|Second Intenvention (14-20 Days)||8
3117760|NCT01606189|3842576|FG004|COMPLETED|Second Intenvention (14-20 Days)||8
3117761|NCT01606189|3842577|FG005|COMPLETED|Second Intenvention (14-20 Days)||7
3117762|NCT01606189|3842572|FG000|NOT COMPLETED|Second Intenvention (14-20 Days)||0
3117763|NCT01606189|3842573|FG001|NOT COMPLETED|Second Intenvention (14-20 Days)||0
3117764|NCT01606189|3842574|FG002|NOT COMPLETED|Second Intenvention (14-20 Days)||0
3117765|NCT01606189|3842575|FG003|NOT COMPLETED|Second Intenvention (14-20 Days)||0
3117766|NCT01606189|3842576|FG004|NOT COMPLETED|Second Intenvention (14-20 Days)||0
3117767|NCT01606189|3842577|FG005|NOT COMPLETED|Second Intenvention (14-20 Days)||1
3117768|NCT01606189|3842572|FG000|STARTED|Third Intenvention (14-20 Days)||8
3117769|NCT01606189|3842573|FG001|STARTED|Third Intenvention (14-20 Days)||8
3117770|NCT01606189|3842574|FG002|STARTED|Third Intenvention (14-20 Days)||8
3117771|NCT01606189|3842575|FG003|STARTED|Third Intenvention (14-20 Days)||8
3117772|NCT01606189|3842576|FG004|STARTED|Third Intenvention (14-20 Days)||8
3117773|NCT01606189|3842577|FG005|STARTED|Third Intenvention (14-20 Days)||7
3117774|NCT01606189|3842572|FG000|COMPLETED|Third Intenvention (14-20 Days)||8
3117775|NCT01606189|3842573|FG001|COMPLETED|Third Intenvention (14-20 Days)||8
3117776|NCT01606189|3842574|FG002|COMPLETED|Third Intenvention (14-20 Days)||8
3117777|NCT01606189|3842575|FG003|COMPLETED|Third Intenvention (14-20 Days)||8
3117778|NCT01606189|3842576|FG004|COMPLETED|Third Intenvention (14-20 Days)||8
3117779|NCT01606189|3842577|FG005|COMPLETED|Third Intenvention (14-20 Days)||6
3117780|NCT01606189|3842572|FG000|NOT COMPLETED|Third Intenvention (14-20 Days)||0
3117781|NCT01606189|3842573|FG001|NOT COMPLETED|Third Intenvention (14-20 Days)||0
3117782|NCT01606189|3842574|FG002|NOT COMPLETED|Third Intenvention (14-20 Days)||0
3117783|NCT01606189|3842575|FG003|NOT COMPLETED|Third Intenvention (14-20 Days)||0
3117784|NCT01606189|3842576|FG004|NOT COMPLETED|Third Intenvention (14-20 Days)||0
3117785|NCT01606189|3842577|FG005|NOT COMPLETED|Third Intenvention (14-20 Days)||1
3117786|NCT01606202|3842587|FG000|STARTED|Overall Study||56
3117787|NCT01606202|3842588|FG001|STARTED|Overall Study||60
3117788|NCT01606202|3842587|FG000|COMPLETED|Overall Study||49
3117789|NCT01606202|3842588|FG001|COMPLETED|Overall Study||57
3117790|NCT01606202|3842587|FG000|NOT COMPLETED|Overall Study||7
3117791|NCT01606202|3842588|FG001|NOT COMPLETED|Overall Study||3
3117792|NCT01606228|3842594|FG000|STARTED|Overall Study||188
3117793|NCT01606228|3842594|FG000|COMPLETED|Overall Study||159
3117794|NCT01606228|3842594|FG000|NOT COMPLETED|Overall Study||29
3117795|NCT01606254|3842602|FG000|STARTED|Overall Study||14
3117796|NCT01606254|3842603|FG001|STARTED|Overall Study||14
3117797|NCT01606254|3842604|FG002|STARTED|Overall Study||14
3117798|NCT01606254|3842605|FG003|STARTED|Overall Study||14
3117799|NCT01606254|3842602|FG000|COMPLETED|Overall Study||12
3117800|NCT01606254|3842603|FG001|COMPLETED|Overall Study||10
3117801|NCT01606254|3842604|FG002|COMPLETED|Overall Study||14
3117802|NCT01606254|3842605|FG003|COMPLETED|Overall Study||11
3117803|NCT01606254|3842602|FG000|NOT COMPLETED|Overall Study||2
3117804|NCT01606254|3842603|FG001|NOT COMPLETED|Overall Study||4
3117805|NCT01606254|3842604|FG002|NOT COMPLETED|Overall Study||0
3117806|NCT01606254|3842605|FG003|NOT COMPLETED|Overall Study||3
3117807|NCT01606306|3842621|FG000|STARTED|Overall Study||50
3117808|NCT01606306|3842622|FG001|STARTED|Overall Study||49
3117809|NCT01606306|3842623|FG002|STARTED|Overall Study||51
3117810|NCT01606306|3842624|FG003|STARTED|Overall Study||51
3117811|NCT01606306|3842625|FG004|STARTED|Overall Study||52
3117812|NCT01606306|3842626|FG005|STARTED|Overall Study||47
3117813|NCT01606306|3842621|FG000|Completed First Treatment Period|Overall Study||43
3117814|NCT01606306|3842622|FG001|Completed First Treatment Period|Overall Study||47
3117815|NCT01606306|3842623|FG002|Completed First Treatment Period|Overall Study||47
3117816|NCT01606306|3842624|FG003|Completed First Treatment Period|Overall Study||45
3117817|NCT01606306|3842625|FG004|Completed First Treatment Period|Overall Study||47
3117818|NCT01606306|3842626|FG005|Completed First Treatment Period|Overall Study||44
3117819|NCT01606306|3842621|FG000|Completed Second Treatment Period|Overall Study||41
3117820|NCT01606306|3842622|FG001|Completed Second Treatment Period|Overall Study||38
3117821|NCT01606306|3842623|FG002|Completed Second Treatment Period|Overall Study||43
3295026|NCT02893878|4029206|FG000|COMPLETED|Overall Study||13861
3117822|NCT01606306|3842624|FG003|Completed Second Treatment Period|Overall Study||44
3117823|NCT01606306|3842625|FG004|Completed Second Treatment Period|Overall Study||46
3117824|NCT01606306|3842626|FG005|Completed Second Treatment Period|Overall Study||41
3117825|NCT01606306|3842621|FG000|Completed Third Treatment Period|Overall Study||35
3117826|NCT01606306|3842622|FG001|Completed Third Treatment Period|Overall Study||39
3117827|NCT01606306|3842623|FG002|Completed Third Treatment Period|Overall Study||37
3117828|NCT01606306|3842624|FG003|Completed Third Treatment Period|Overall Study||38
3117829|NCT01606306|3842625|FG004|Completed Third Treatment Period|Overall Study||41
3117830|NCT01606306|3842626|FG005|Completed Third Treatment Period|Overall Study||36
3117831|NCT01606306|3842621|FG000|COMPLETED|Overall Study||35
3117832|NCT01606306|3842622|FG001|COMPLETED|Overall Study||39
3117833|NCT01606306|3842623|FG002|COMPLETED|Overall Study||37
3117834|NCT01606306|3842624|FG003|COMPLETED|Overall Study||38
3117835|NCT01606306|3842625|FG004|COMPLETED|Overall Study||41
3117836|NCT01606306|3842626|FG005|COMPLETED|Overall Study||36
3117837|NCT01606306|3842621|FG000|NOT COMPLETED|Overall Study||15
3117838|NCT01606306|3842622|FG001|NOT COMPLETED|Overall Study||10
3117839|NCT01606306|3842623|FG002|NOT COMPLETED|Overall Study||14
3117840|NCT01606306|3842624|FG003|NOT COMPLETED|Overall Study||13
3117841|NCT01606306|3842625|FG004|NOT COMPLETED|Overall Study||11
3117842|NCT01606306|3842626|FG005|NOT COMPLETED|Overall Study||11
3117843|NCT01606319|3842634|FG000|STARTED|Overall Study||150
3117844|NCT01606319|3842635|FG001|STARTED|Overall Study||150
3117845|NCT01606319|3842634|FG000|COMPLETED|Overall Study||116
3117846|NCT01606319|3842635|FG001|COMPLETED|Overall Study||110
3117847|NCT01606319|3842634|FG000|NOT COMPLETED|Overall Study||34
3117848|NCT01606319|3842635|FG001|NOT COMPLETED|Overall Study||40
3117849|NCT01606670|3842641|FG000|STARTED|Overall Study||93
3117850|NCT01606670|3842641|FG000|Safety Set|Overall Study||93
3117851|NCT01606670|3842641|FG000|Full Analysis Set|Overall Study||70
3117852|NCT01606670|3842641|FG000|COMPLETED|Overall Study||77
3117853|NCT01606670|3842641|FG000|NOT COMPLETED|Overall Study||16
3117854|NCT01606735|3842648|FG000|STARTED|Overall Study||58
3117855|NCT01606735|3842649|FG001|STARTED|Overall Study||56
3117856|NCT01606735|3842650|FG002|STARTED|Overall Study||58
3117857|NCT01606735|3842648|FG000|COMPLETED|Overall Study||58
3117858|NCT01606735|3842649|FG001|COMPLETED|Overall Study||56
3117859|NCT01606735|3842650|FG002|COMPLETED|Overall Study||58
3117860|NCT01606735|3842648|FG000|NOT COMPLETED|Overall Study||0
3117861|NCT01606735|3842649|FG001|NOT COMPLETED|Overall Study||0
3117862|NCT01606735|3842650|FG002|NOT COMPLETED|Overall Study||0
3117863|NCT01606748|3842660|FG000|STARTED|Overall Study||18
3117864|NCT01606748|3842661|FG001|STARTED|Overall Study||17
3117865|NCT01606748|3842660|FG000|Received at Least 1 Dose of Study Drug|Overall Study||18
3117866|NCT01606748|3842661|FG001|Received at Least 1 Dose of Study Drug|Overall Study||17
3117867|NCT01606748|3842660|FG000|COMPLETED|Overall Study||15
3117868|NCT01606748|3842661|FG001|COMPLETED|Overall Study||17
3117869|NCT01606748|3842660|FG000|NOT COMPLETED|Overall Study||3
3117870|NCT01606748|3842661|FG001|NOT COMPLETED|Overall Study||0
3117871|NCT01606761|3842682|FG000|STARTED|Prior to Week 24||294
3117872|NCT01606761|3842683|FG001|STARTED|Prior to Week 24||292
3117873|NCT01606761|3842684|FG002|STARTED|Prior to Week 24||292
3117874|NCT01606761|3842685|FG003|STARTED|Prior to Week 24||0
3117875|NCT01606761|3842686|FG004|STARTED|Prior to Week 24||0
3117876|NCT01606761|3842682|FG000|Participants Re-randomized at Week 18|Prior to Week 24|Out of 94, 46 were re-randomized to sirukumab 50 mg and 48 were re-randomized to 100 mg group.|94
3117877|NCT01606761|3842683|FG001|Participants Re-randomized at Week 18|Prior to Week 24||0
3117878|NCT01606761|3842684|FG002|Participants Re-randomized at Week 18|Prior to Week 24||0
3117879|NCT01606761|3842685|FG003|Participants Re-randomized at Week 18|Prior to Week 24||0
3117880|NCT01606761|3842686|FG004|Participants Re-randomized at Week 18|Prior to Week 24||0
3117881|NCT01606761|3842682|FG000|COMPLETED|Prior to Week 24||252
3117882|NCT01606761|3842683|FG001|COMPLETED|Prior to Week 24||237
3117883|NCT01606761|3842684|FG002|COMPLETED|Prior to Week 24||245
3117884|NCT01606761|3842685|FG003|COMPLETED|Prior to Week 24||0
3117885|NCT01606761|3842686|FG004|COMPLETED|Prior to Week 24||0
3117886|NCT01606761|3842682|FG000|NOT COMPLETED|Prior to Week 24||42
3117887|NCT01606761|3842683|FG001|NOT COMPLETED|Prior to Week 24||55
3117888|NCT01606761|3842684|FG002|NOT COMPLETED|Prior to Week 24||47
3117889|NCT01606761|3842685|FG003|NOT COMPLETED|Prior to Week 24||0
3117890|NCT01606761|3842686|FG004|NOT COMPLETED|Prior to Week 24||0
3117891|NCT01606761|3842682|FG000|STARTED|Week 24 to Week 52||0
3117892|NCT01606761|3842683|FG001|STARTED|Week 24 to Week 52||237
3117893|NCT01606761|3842684|FG002|STARTED|Week 24 to Week 52||245
3117894|NCT01606761|3842685|FG003|STARTED|Week 24 to Week 52|Participants re-randomized at Week 18 (46) and Week 24 (80) were included.|126
3117895|NCT01606761|3842686|FG004|STARTED|Week 24 to Week 52|Participants re-randomized at Week 18 (48) and Week 24 (78) were included.|126
3295027|NCT02893878|4029207|FG001|COMPLETED|Overall Study||2295
3295028|NCT02893878|4029208|FG002|COMPLETED|Overall Study||3178
3295029|NCT02893878|4029206|FG000|NOT COMPLETED|Overall Study||0
3117896|NCT01606761|3842682|FG000|Treated|Week 24 to Week 52||0
3117897|NCT01606761|3842683|FG001|Treated|Week 24 to Week 52||237
3117898|NCT01606761|3842684|FG002|Treated|Week 24 to Week 52||245
3117899|NCT01606761|3842685|FG003|Treated|Week 24 to Week 52||124
3117900|NCT01606761|3842686|FG004|Treated|Week 24 to Week 52||126
3117901|NCT01606761|3842682|FG000|COMPLETED|Week 24 to Week 52||0
3117902|NCT01606761|3842683|FG001|COMPLETED|Week 24 to Week 52||204
3117903|NCT01606761|3842684|FG002|COMPLETED|Week 24 to Week 52||212
3117904|NCT01606761|3842685|FG003|COMPLETED|Week 24 to Week 52||109
3117905|NCT01606761|3842686|FG004|COMPLETED|Week 24 to Week 52||106
3117906|NCT01606761|3842682|FG000|NOT COMPLETED|Week 24 to Week 52||0
3117907|NCT01606761|3842683|FG001|NOT COMPLETED|Week 24 to Week 52||33
3117908|NCT01606761|3842684|FG002|NOT COMPLETED|Week 24 to Week 52||33
3295030|NCT02893878|4029207|FG001|NOT COMPLETED|Overall Study||0
3295031|NCT02893878|4029208|FG002|NOT COMPLETED|Overall Study||0
3117909|NCT01606761|3842685|FG003|NOT COMPLETED|Week 24 to Week 52||17
3295032|NCT02894502|4029222|FG000|STARTED|Baseline||155
3117910|NCT01606761|3842686|FG004|NOT COMPLETED|Week 24 to Week 52||20
3117911|NCT01606761|3842682|FG000|STARTED|Safety Follow-up Period (Week 52-68)||28
3117912|NCT01606761|3842683|FG001|STARTED|Safety Follow-up Period (Week 52-68)||65
3295033|NCT02894502|4029223|FG001|STARTED|Baseline||177
3295034|NCT02894502|4029224|FG002|STARTED|Baseline||178
3117913|NCT01606761|3842684|FG002|STARTED|Safety Follow-up Period (Week 52-68)||62
3117914|NCT01606761|3842685|FG003|STARTED|Safety Follow-up Period (Week 52-68)||9
3117915|NCT01606761|3842686|FG004|STARTED|Safety Follow-up Period (Week 52-68)||19
3117916|NCT01606761|3842682|FG000|Safety Population|Safety Follow-up Period (Week 52-68)||28
3117917|NCT01606761|3842683|FG001|Safety Population|Safety Follow-up Period (Week 52-68)||65
3117918|NCT01606761|3842684|FG002|Safety Population|Safety Follow-up Period (Week 52-68)||62
3117919|NCT01606761|3842685|FG003|Safety Population|Safety Follow-up Period (Week 52-68)||7
3117920|NCT01606761|3842686|FG004|Safety Population|Safety Follow-up Period (Week 52-68)||19
3117921|NCT01606761|3842682|FG000|COMPLETED|Safety Follow-up Period (Week 52-68)||24
3117922|NCT01606761|3842683|FG001|COMPLETED|Safety Follow-up Period (Week 52-68)||55
3117923|NCT01606761|3842684|FG002|COMPLETED|Safety Follow-up Period (Week 52-68)||45
3117924|NCT01606761|3842685|FG003|COMPLETED|Safety Follow-up Period (Week 52-68)||7
3117925|NCT01606761|3842686|FG004|COMPLETED|Safety Follow-up Period (Week 52-68)||11
3117926|NCT01606761|3842682|FG000|NOT COMPLETED|Safety Follow-up Period (Week 52-68)||4
3117927|NCT01606761|3842683|FG001|NOT COMPLETED|Safety Follow-up Period (Week 52-68)||10
3117928|NCT01606761|3842684|FG002|NOT COMPLETED|Safety Follow-up Period (Week 52-68)||17
3117929|NCT01606761|3842685|FG003|NOT COMPLETED|Safety Follow-up Period (Week 52-68)||2
3117930|NCT01606761|3842686|FG004|NOT COMPLETED|Safety Follow-up Period (Week 52-68)||8
3117931|NCT01606787|3842703|FG000|STARTED|Overall Study||105
3117932|NCT01606787|3842704|FG001|STARTED|Overall Study||105
3117933|NCT01606787|3842703|FG000|COMPLETED|Overall Study||101
3117934|NCT01606787|3842704|FG001|COMPLETED|Overall Study||98
3117935|NCT01606787|3842703|FG000|NOT COMPLETED|Overall Study||4
3117936|NCT01606787|3842704|FG001|NOT COMPLETED|Overall Study||7
3117937|NCT01606800|3842712|FG000|STARTED|Overall Study||22
3117938|NCT01606800|3842713|FG001|STARTED|Overall Study||23
3117939|NCT01606800|3842712|FG000|Treated|Overall Study||22
3117940|NCT01606800|3842713|FG001|Treated|Overall Study||23
3117941|NCT01606800|3842712|FG000|COMPLETED|Overall Study||17
3117942|NCT01606800|3842713|FG001|COMPLETED|Overall Study||21
3117943|NCT01606800|3842712|FG000|NOT COMPLETED|Overall Study||5
3117944|NCT01606800|3842713|FG001|NOT COMPLETED|Overall Study||2
3117945|NCT01606852|3842721|FG000|STARTED|Overall Study||7
3117946|NCT01606852|3842722|FG001|STARTED|Overall Study||8
3117947|NCT01606852|3842721|FG000|COMPLETED|Overall Study||7
3117948|NCT01606852|3842722|FG001|COMPLETED|Overall Study||8
3117949|NCT01606852|3842721|FG000|NOT COMPLETED|Overall Study||0
3117950|NCT01606852|3842722|FG001|NOT COMPLETED|Overall Study||0
3117951|NCT01607073|3842728|FG000|STARTED|Overall Study||2
3117952|NCT01607073|3842728|FG000|COMPLETED|Overall Study||1
3117953|NCT01607073|3842728|FG000|NOT COMPLETED|Overall Study||1
3117954|NCT01607112|3842737|FG000|STARTED|Overall Study||60
3117955|NCT01607112|3842738|FG001|STARTED|Overall Study||59
3117956|NCT01607112|3842737|FG000|COMPLETED|Overall Study||60
3117957|NCT01607112|3842738|FG001|COMPLETED|Overall Study||59
3117958|NCT01607112|3842737|FG000|NOT COMPLETED|Overall Study||0
3117959|NCT01607112|3842738|FG001|NOT COMPLETED|Overall Study||0
3117960|NCT01607203|3842750|FG000|STARTED|Overall Study||59
3117961|NCT01607203|3842751|FG001|STARTED|Overall Study||61
3117962|NCT01607203|3842750|FG000|COMPLETED|Overall Study||59
3117963|NCT01607203|3842751|FG001|COMPLETED|Overall Study||61
3117964|NCT01607203|3842750|FG000|NOT COMPLETED|Overall Study||0
3117965|NCT01607203|3842751|FG001|NOT COMPLETED|Overall Study||0
3117966|NCT01607255|3842761|FG000|STARTED|Overall Study||161
3117967|NCT01607255|3842762|FG001|STARTED|Overall Study||160
3117968|NCT01607255|3842763|FG002|STARTED|Overall Study||159
3117969|NCT01607255|3842761|FG000|COMPLETED|Overall Study||161
3117970|NCT01607255|3842762|FG001|COMPLETED|Overall Study||160
3117971|NCT01607255|3842763|FG002|COMPLETED|Overall Study||159
3117972|NCT01607255|3842761|FG000|NOT COMPLETED|Overall Study||0
3117973|NCT01607255|3842762|FG001|NOT COMPLETED|Overall Study||0
3117974|NCT01607255|3842763|FG002|NOT COMPLETED|Overall Study||0
3117975|NCT01607346|3842771|FG000|STARTED|Overall Study||10
3117976|NCT01607346|3842771|FG000|COMPLETED|Overall Study||7
3117977|NCT01607346|3842771|FG000|NOT COMPLETED|Overall Study||3
3117978|NCT01607398|3842777|FG000|STARTED|Overall Study||28
3117979|NCT01607398|3842778|FG001|STARTED|Overall Study||28
3117980|NCT01607398|3842777|FG000|COMPLETED|Overall Study||26
3117981|NCT01607398|3842778|FG001|COMPLETED|Overall Study||26
3117982|NCT01607398|3842777|FG000|NOT COMPLETED|Overall Study||2
3117983|NCT01607398|3842778|FG001|NOT COMPLETED|Overall Study||2
3117984|NCT01607411|3842784|FG000|STARTED|Period I||14
3117985|NCT01607411|3842785|FG001|STARTED|Period I||13
3117986|NCT01607411|3842786|FG002|STARTED|Period I||14
3117987|NCT01607411|3842787|FG003|STARTED|Period I||14
3117988|NCT01607411|3842784|FG000|COMPLETED|Period I||14
3117989|NCT01607411|3842785|FG001|COMPLETED|Period I||13
3295035|NCT02894502|4029222|FG000|COMPLETED|Baseline||128
3117990|NCT01607411|3842786|FG002|COMPLETED|Period I||14
3117991|NCT01607411|3842787|FG003|COMPLETED|Period I||14
3117992|NCT01607411|3842784|FG000|NOT COMPLETED|Period I||0
3117993|NCT01607411|3842785|FG001|NOT COMPLETED|Period I||0
3295036|NCT02894502|4029223|FG001|COMPLETED|Baseline||145
3117994|NCT01607411|3842786|FG002|NOT COMPLETED|Period I||0
3117995|NCT01607411|3842787|FG003|NOT COMPLETED|Period I||0
3117996|NCT01607411|3842784|FG000|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|14
3117997|NCT01607411|3842785|FG001|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|14
3117998|NCT01607411|3842786|FG002|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|13
3117999|NCT01607411|3842787|FG003|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|14
3118000|NCT01607411|3842784|FG000|COMPLETED|Period II||14
3118001|NCT01607411|3842785|FG001|COMPLETED|Period II||14
3118002|NCT01607411|3842786|FG002|COMPLETED|Period II||13
3118003|NCT01607411|3842787|FG003|COMPLETED|Period II||14
3118004|NCT01607411|3842784|FG000|NOT COMPLETED|Period II||0
3118005|NCT01607411|3842785|FG001|NOT COMPLETED|Period II||0
3118006|NCT01607411|3842786|FG002|NOT COMPLETED|Period II||0
3118007|NCT01607411|3842787|FG003|NOT COMPLETED|Period II||0
3118008|NCT01607411|3842784|FG000|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|14
3118009|NCT01607411|3842785|FG001|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|14
3118010|NCT01607411|3842786|FG002|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|14
3118011|NCT01607411|3842787|FG003|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|13
3118012|NCT01607411|3842784|FG000|COMPLETED|Period III||14
3118013|NCT01607411|3842785|FG001|COMPLETED|Period III||14
3118014|NCT01607411|3842786|FG002|COMPLETED|Period III||14
3118015|NCT01607411|3842787|FG003|COMPLETED|Period III||13
3118016|NCT01607411|3842784|FG000|NOT COMPLETED|Period III||0
3118017|NCT01607411|3842785|FG001|NOT COMPLETED|Period III||0
3118018|NCT01607411|3842786|FG002|NOT COMPLETED|Period III||0
3118019|NCT01607411|3842787|FG003|NOT COMPLETED|Period III||0
3118020|NCT01607411|3842784|FG000|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|13
3118021|NCT01607411|3842785|FG001|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|14
3118022|NCT01607411|3842786|FG002|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|14
3118023|NCT01607411|3842787|FG003|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|14
3118024|NCT01607411|3842784|FG000|COMPLETED|Period IV||13
3118025|NCT01607411|3842785|FG001|COMPLETED|Period IV||14
3118026|NCT01607411|3842786|FG002|COMPLETED|Period IV||14
3118027|NCT01607411|3842787|FG003|COMPLETED|Period IV||14
3118028|NCT01607411|3842784|FG000|NOT COMPLETED|Period IV||0
3118029|NCT01607411|3842785|FG001|NOT COMPLETED|Period IV||0
3118030|NCT01607411|3842786|FG002|NOT COMPLETED|Period IV||0
3118031|NCT01607411|3842787|FG003|NOT COMPLETED|Period IV||0
3118032|NCT01607450|3842804|FG000|STARTED|Overall Study||6
3118033|NCT01607450|3842805|FG001|STARTED|Overall Study||8
3118034|NCT01607450|3842806|FG002|STARTED|Overall Study||7
3118035|NCT01607450|3842807|FG003|STARTED|Overall Study||11
3118036|NCT01607450|3842808|FG004|STARTED|Overall Study||1
3118037|NCT01607450|3842809|FG005|STARTED|Overall Study||0
3118038|NCT01607450|3842810|FG006|STARTED|Overall Study||0
3118039|NCT01607450|3842804|FG000|COMPLETED|Overall Study||6
3118040|NCT01607450|3842805|FG001|COMPLETED|Overall Study||8
3118041|NCT01607450|3842806|FG002|COMPLETED|Overall Study||7
3118042|NCT01607450|3842807|FG003|COMPLETED|Overall Study||11
3118043|NCT01607450|3842808|FG004|COMPLETED|Overall Study||1
3118044|NCT01607450|3842809|FG005|COMPLETED|Overall Study||0
3118045|NCT01607450|3842810|FG006|COMPLETED|Overall Study||0
3118046|NCT01607450|3842804|FG000|NOT COMPLETED|Overall Study||0
3118047|NCT01607450|3842805|FG001|NOT COMPLETED|Overall Study||0
3118048|NCT01607450|3842806|FG002|NOT COMPLETED|Overall Study||0
3118049|NCT01607450|3842807|FG003|NOT COMPLETED|Overall Study||0
3118050|NCT01607450|3842808|FG004|NOT COMPLETED|Overall Study||0
3118051|NCT01607450|3842809|FG005|NOT COMPLETED|Overall Study||0
3118052|NCT01607450|3842810|FG006|NOT COMPLETED|Overall Study||0
3118053|NCT01607476|3842834|FG000|STARTED|Overall Study||25
3118054|NCT01607476|3842835|FG001|STARTED|Overall Study||30
3118055|NCT01607476|3842836|FG002|STARTED|Overall Study||33
3118056|NCT01607476|3842834|FG000|COMPLETED|Overall Study||24
3118057|NCT01607476|3842835|FG001|COMPLETED|Overall Study||30
3118058|NCT01607476|3842836|FG002|COMPLETED|Overall Study||30
3118059|NCT01607476|3842834|FG000|NOT COMPLETED|Overall Study||1
3118060|NCT01607476|3842835|FG001|NOT COMPLETED|Overall Study||0
3118061|NCT01607476|3842836|FG002|NOT COMPLETED|Overall Study||3
3118062|NCT01607554|3842844|FG000|STARTED|Overall Study||2
3118063|NCT01607554|3842844|FG000|COMPLETED|Overall Study||0
3118064|NCT01607554|3842844|FG000|NOT COMPLETED|Overall Study||2
3118065|NCT01607593|3842848|FG000|STARTED|Overall Study||122
3118066|NCT01607593|3842848|FG000|COMPLETED|Overall Study||29
3118067|NCT01607593|3842848|FG000|NOT COMPLETED|Overall Study||93
3118068|NCT01607645|3842854|FG000|STARTED|Overall Study||4
3118069|NCT01607645|3842855|FG001|STARTED|Overall Study||3
3118070|NCT01607645|3842854|FG000|COMPLETED|Overall Study||4
3118071|NCT01607645|3842855|FG001|COMPLETED|Overall Study||3
3118072|NCT01607645|3842854|FG000|NOT COMPLETED|Overall Study||0
3118073|NCT01607645|3842855|FG001|NOT COMPLETED|Overall Study||0
3136098|NCT01710358|3861200|FG002|STARTED|Treatment Period Part B (Weeks 24 to 52)|Excludes participants rescued during Part A.|267
3136831|NCT01715805|3862075|FG002|NOT COMPLETED|Double-Blind or Continued Treatment||56
3171757|NCT01936948|3898954|FG001|Crossover|Overall Study||27
3295037|NCT02894502|4029224|FG002|COMPLETED|Baseline||133
3118074|NCT01607658|3842865|FG000|STARTED|Overall Study||65
3118075|NCT01607658|3842866|FG001|STARTED|Overall Study||67
3118076|NCT01607658|3842867|FG002|STARTED|Overall Study||58
3118077|NCT01607658|3842868|FG003|STARTED|Overall Study||63
3118078|NCT01607658|3842865|FG000|COMPLETED|Overall Study||56
3118079|NCT01607658|3842866|FG001|COMPLETED|Overall Study||56
3118080|NCT01607658|3842867|FG002|COMPLETED|Overall Study||47
3118081|NCT01607658|3842868|FG003|COMPLETED|Overall Study||52
3118082|NCT01607658|3842865|FG000|NOT COMPLETED|Overall Study||9
3295038|NCT02894502|4029222|FG000|NOT COMPLETED|Baseline||27
3295039|NCT02894502|4029223|FG001|NOT COMPLETED|Baseline||32
3118083|NCT01607658|3842866|FG001|NOT COMPLETED|Overall Study||11
3118084|NCT01607658|3842867|FG002|NOT COMPLETED|Overall Study||11
3118085|NCT01607658|3842868|FG003|NOT COMPLETED|Overall Study||11
3118086|NCT01607853|3842878|FG000|STARTED|Overall Study||24
3118087|NCT01607853|3842878|FG000|COMPLETED|Overall Study||24
3118088|NCT01607853|3842878|FG000|NOT COMPLETED|Overall Study||0
3118089|NCT01607892|3842890|FG000|STARTED|Overall Study||58
3118090|NCT01607892|3842891|FG001|STARTED|Overall Study||27
3118091|NCT01607892|3842892|FG002|STARTED|Overall Study||81
3118092|NCT01607892|3842893|FG003|STARTED|Overall Study||95
3118093|NCT01607892|3842894|FG004|STARTED|Overall Study||24
3118094|NCT01607892|3842890|FG000|COMPLETED|Overall Study||0
3118095|NCT01607892|3842891|FG001|COMPLETED|Overall Study||0
3118096|NCT01607892|3842892|FG002|COMPLETED|Overall Study||0
3118097|NCT01607892|3842893|FG003|COMPLETED|Overall Study||0
3118098|NCT01607892|3842894|FG004|COMPLETED|Overall Study||0
3118099|NCT01607892|3842890|FG000|NOT COMPLETED|Overall Study||58
3118100|NCT01607892|3842891|FG001|NOT COMPLETED|Overall Study||27
3118101|NCT01607892|3842892|FG002|NOT COMPLETED|Overall Study||81
3118102|NCT01607892|3842893|FG003|NOT COMPLETED|Overall Study||95
3118103|NCT01607892|3842894|FG004|NOT COMPLETED|Overall Study||24
3118104|NCT01607905|3842927|FG000|STARTED|Overall Study||60
3118105|NCT01607905|3842928|FG001|STARTED|Overall Study||20
3118106|NCT01607905|3842929|FG002|STARTED|Overall Study||21
3118107|NCT01607905|3842930|FG003|STARTED|Overall Study||21
3118108|NCT01607905|3842931|FG004|STARTED|Overall Study||7
3118109|NCT01607905|3842932|FG005|STARTED|Overall Study||15
3118110|NCT01607905|3842933|FG006|STARTED|Overall Study||47
3118111|NCT01607905|3842927|FG000|Received Study Drug|Overall Study||59
3118112|NCT01607905|3842928|FG001|Received Study Drug|Overall Study||20
3118113|NCT01607905|3842929|FG002|Received Study Drug|Overall Study||21
3118114|NCT01607905|3842930|FG003|Received Study Drug|Overall Study||21
3118115|NCT01607905|3842931|FG004|Received Study Drug|Overall Study||6
3118116|NCT01607905|3842932|FG005|Received Study Drug|Overall Study||15
3118117|NCT01607905|3842933|FG006|Received Study Drug|Overall Study||47
3118118|NCT01607905|3842927|FG000|Low Dose (<30 mg/m^2)|Overall Study||16
3118119|NCT01607905|3842928|FG001|Low Dose (<30 mg/m^2)|Overall Study||5
3118120|NCT01607905|3842929|FG002|Low Dose (<30 mg/m^2)|Overall Study||3
3118121|NCT01607905|3842930|FG003|Low Dose (<30 mg/m^2)|Overall Study||0
3118122|NCT01607905|3842931|FG004|Low Dose (<30 mg/m^2)|Overall Study||0
3118123|NCT01607905|3842932|FG005|Low Dose (<30 mg/m^2)|Overall Study||2
3118124|NCT01607905|3842933|FG006|Low Dose (<30 mg/m^2)|Overall Study||8
3118125|NCT01607905|3842927|FG000|Medium Dose (>=30 mg/m^2 and <55 mg/m^2)|Overall Study||27
3118126|NCT01607905|3842928|FG001|Medium Dose (>=30 mg/m^2 and <55 mg/m^2)|Overall Study||11
3118127|NCT01607905|3842929|FG002|Medium Dose (>=30 mg/m^2 and <55 mg/m^2)|Overall Study||15
3118128|NCT01607905|3842930|FG003|Medium Dose (>=30 mg/m^2 and <55 mg/m^2)|Overall Study||8
3118129|NCT01607905|3842931|FG004|Medium Dose (>=30 mg/m^2 and <55 mg/m^2)|Overall Study||6
3118130|NCT01607905|3842932|FG005|Medium Dose (>=30 mg/m^2 and <55 mg/m^2)|Overall Study||3
3118131|NCT01607905|3842933|FG006|Medium Dose (>=30 mg/m^2 and <55 mg/m^2)|Overall Study||21
3118132|NCT01607905|3842927|FG000|High Dose (>= 55 mg/m^2)|Overall Study||16
3118133|NCT01607905|3842928|FG001|High Dose (>= 55 mg/m^2)|Overall Study||4
3118134|NCT01607905|3842929|FG002|High Dose (>= 55 mg/m^2)|Overall Study||3
3118135|NCT01607905|3842930|FG003|High Dose (>= 55 mg/m^2)|Overall Study||13
3118136|NCT01607905|3842931|FG004|High Dose (>= 55 mg/m^2)|Overall Study||0
3118137|NCT01607905|3842932|FG005|High Dose (>= 55 mg/m^2)|Overall Study||10
3118138|NCT01607905|3842933|FG006|High Dose (>= 55 mg/m^2)|Overall Study||18
3118139|NCT01607905|3842927|FG000|COMPLETED|Overall Study||0
3118140|NCT01607905|3842928|FG001|COMPLETED|Overall Study||0
3118141|NCT01607905|3842929|FG002|COMPLETED|Overall Study||0
3118142|NCT01607905|3842930|FG003|COMPLETED|Overall Study||0
3118143|NCT01607905|3842931|FG004|COMPLETED|Overall Study||0
3118144|NCT01607905|3842932|FG005|COMPLETED|Overall Study||0
3118145|NCT01607905|3842933|FG006|COMPLETED|Overall Study||0
3118146|NCT01607905|3842927|FG000|NOT COMPLETED|Overall Study||60
3118147|NCT01607905|3842928|FG001|NOT COMPLETED|Overall Study||20
3118148|NCT01607905|3842929|FG002|NOT COMPLETED|Overall Study||21
3118149|NCT01607905|3842930|FG003|NOT COMPLETED|Overall Study||21
3118150|NCT01607905|3842931|FG004|NOT COMPLETED|Overall Study||7
3118151|NCT01607905|3842932|FG005|NOT COMPLETED|Overall Study||15
3118152|NCT01607905|3842933|FG006|NOT COMPLETED|Overall Study||47
3118153|NCT01607957|3842993|FG000|STARTED|Overall Study||534
3118154|NCT01607957|3842994|FG001|STARTED|Overall Study||266
3118155|NCT01607957|3842993|FG000|Treated|Overall Study||533
3118156|NCT01607957|3842994|FG001|Treated|Overall Study||265
3295040|NCT02894502|4029224|FG002|NOT COMPLETED|Baseline||45
3118157|NCT01607957|3842993|FG000|COMPLETED|Overall Study||162
3118158|NCT01607957|3842994|FG001|COMPLETED|Overall Study||51
3295041|NCT02894502|4029222|FG000|STARTED|First Follow up||128
3118159|NCT01607957|3842993|FG000|NOT COMPLETED|Overall Study||372
3118160|NCT01607957|3842994|FG001|NOT COMPLETED|Overall Study||215
3118161|NCT01608061|3843002|FG000|STARTED|Blinded Period||21
3118162|NCT01608061|3843003|FG001|STARTED|Blinded Period||21
3118163|NCT01608061|3843002|FG000|COMPLETED|Blinded Period||21
3118164|NCT01608061|3843003|FG001|COMPLETED|Blinded Period||21
3118165|NCT01608061|3843002|FG000|NOT COMPLETED|Blinded Period||0
3118166|NCT01608061|3843003|FG001|NOT COMPLETED|Blinded Period||0
3118167|NCT01608061|3843002|FG000|STARTED|Long Term Follow-Up||21
3118168|NCT01608061|3843003|FG001|STARTED|Long Term Follow-Up||21
3118169|NCT01608061|3843002|FG000|COMPLETED|Long Term Follow-Up||14
3118170|NCT01608061|3843003|FG001|COMPLETED|Long Term Follow-Up||16
3118171|NCT01608061|3843002|FG000|NOT COMPLETED|Long Term Follow-Up||7
3118172|NCT01608061|3843003|FG001|NOT COMPLETED|Long Term Follow-Up||5
3118173|NCT01608061|3843002|FG000|STARTED|Extension Period||14
3118174|NCT01608061|3843003|FG001|STARTED|Extension Period||16
3118175|NCT01608061|3843002|FG000|COMPLETED|Extension Period||14
3118176|NCT01608061|3843003|FG001|COMPLETED|Extension Period||14
3118177|NCT01608061|3843002|FG000|NOT COMPLETED|Extension Period||0
3118178|NCT01608061|3843003|FG001|NOT COMPLETED|Extension Period||2
3118179|NCT01608087|3843013|FG000|STARTED|Overall Study||30
3118180|NCT01608087|3843014|FG001|STARTED|Overall Study||30
3118181|NCT01608087|3843015|FG002|STARTED|Overall Study||31
3118182|NCT01608087|3843013|FG000|COMPLETED|Overall Study||30
3118183|NCT01608087|3843014|FG001|COMPLETED|Overall Study||28
3118184|NCT01608087|3843015|FG002|COMPLETED|Overall Study||31
3118185|NCT01608087|3843013|FG000|NOT COMPLETED|Overall Study||0
3118186|NCT01608087|3843014|FG001|NOT COMPLETED|Overall Study||2
3118187|NCT01608087|3843015|FG002|NOT COMPLETED|Overall Study||0
3118188|NCT01608100|3843023|FG000|STARTED|Overall Study||1101
3118189|NCT01608100|3843023|FG000|COMPLETED|Overall Study||1101
3118190|NCT01608100|3843023|FG000|NOT COMPLETED|Overall Study||0
3118191|NCT01608295|3843049|FG000|STARTED|Overall Study||26
3118192|NCT01608295|3843050|FG001|STARTED|Overall Study||30
3118193|NCT01608295|3843049|FG000|COMPLETED|Overall Study||20
3118194|NCT01608295|3843050|FG001|COMPLETED|Overall Study||25
3118195|NCT01608295|3843049|FG000|NOT COMPLETED|Overall Study||6
3118196|NCT01608295|3843050|FG001|NOT COMPLETED|Overall Study||5
3118197|NCT01608308|3843061|FG000|STARTED|Overall Study||31
3118198|NCT01608308|3843062|FG001|STARTED|Overall Study||31
3118199|NCT01608308|3843061|FG000|COMPLETED|Overall Study||31
3118200|NCT01608308|3843062|FG001|COMPLETED|Overall Study||29
3118201|NCT01608308|3843061|FG000|NOT COMPLETED|Overall Study||0
3118202|NCT01608308|3843062|FG001|NOT COMPLETED|Overall Study||2
3118203|NCT01608321|3843070|FG000|STARTED|Overall Study||13
3118204|NCT01608321|3843071|FG001|STARTED|Overall Study||4
3118205|NCT01608321|3843070|FG000|COMPLETED|Overall Study||12
3118206|NCT01608321|3843071|FG001|COMPLETED|Overall Study||4
3118207|NCT01608321|3843070|FG000|NOT COMPLETED|Overall Study||1
3118208|NCT01608321|3843071|FG001|NOT COMPLETED|Overall Study||0
3118209|NCT01608490|3843079|FG000|STARTED|Overall Study||158
3118210|NCT01608490|3843080|FG001|STARTED|Overall Study||157
3118211|NCT01608490|3843079|FG000|COMPLETED|Overall Study||141
3118212|NCT01608490|3843080|FG001|COMPLETED|Overall Study||142
3118213|NCT01608490|3843079|FG000|NOT COMPLETED|Overall Study||17
3118214|NCT01608490|3843080|FG001|NOT COMPLETED|Overall Study||15
3118215|NCT01608659|3843086|FG000|STARTED|Overall Study||110
3118216|NCT01608659|3843086|FG000|COMPLETED|Overall Study||94
3118217|NCT01608659|3843086|FG000|NOT COMPLETED|Overall Study||16
3118218|NCT01608672|3843090|FG000|STARTED|Overall Study||207
3118219|NCT01608672|3843090|FG000|COMPLETED|Overall Study||207
3118220|NCT01608672|3843090|FG000|NOT COMPLETED|Overall Study||0
3118221|NCT01608724|3843094|FG000|STARTED|Overall Study|One patient was excluded because the Informed Consent Form was destroyed by site staff by mistake.|1423
3118222|NCT01608724|3843094|FG000|Treated|Overall Study||1361
3118223|NCT01608724|3843094|FG000|COMPLETED|Overall Study||1180
3118224|NCT01608724|3843094|FG000|NOT COMPLETED|Overall Study||243
3118225|NCT01608815|3843101|FG000|STARTED|Overall Study||188
3118226|NCT01608815|3843102|FG001|STARTED|Overall Study||7
3118227|NCT01608815|3843103|FG002|STARTED|Overall Study||5
3118228|NCT01608815|3843101|FG000|COMPLETED|Overall Study||188
3118229|NCT01608815|3843102|FG001|COMPLETED|Overall Study||7
3118230|NCT01608815|3843103|FG002|COMPLETED|Overall Study||5
3118231|NCT01608815|3843101|FG000|NOT COMPLETED|Overall Study||0
3118232|NCT01608815|3843102|FG001|NOT COMPLETED|Overall Study||0
3118233|NCT01608815|3843103|FG002|NOT COMPLETED|Overall Study||0
3118234|NCT01608971|3843114|FG000|STARTED|Overall Study||15
3118235|NCT01608971|3843115|FG001|STARTED|Overall Study||15
3118236|NCT01608971|3843114|FG000|COMPLETED|Overall Study||15
3118237|NCT01608971|3843115|FG001|COMPLETED|Overall Study||15
3118238|NCT01608971|3843114|FG000|NOT COMPLETED|Overall Study||0
3118239|NCT01608971|3843115|FG001|NOT COMPLETED|Overall Study||0
3118240|NCT01609010|3843125|FG000|STARTED|Overall Study||156
3118241|NCT01609010|3843126|FG001|STARTED|Overall Study||157
3118242|NCT01609010|3843125|FG000|Entering Cycle 2|Overall Study||120
3118243|NCT01609010|3843126|FG001|Entering Cycle 2|Overall Study||124
3118244|NCT01609010|3843125|FG000|COMPLETED|Overall Study||113
3118245|NCT01609010|3843126|FG001|COMPLETED|Overall Study||120
3118246|NCT01609010|3843125|FG000|NOT COMPLETED|Overall Study||43
3118247|NCT01609010|3843126|FG001|NOT COMPLETED|Overall Study||37
3118248|NCT01609023|3843132|FG000|STARTED|Overall Study||67
3118249|NCT01609023|3843132|FG000|COMPLETED|Overall Study||34
3118250|NCT01609023|3843132|FG000|NOT COMPLETED|Overall Study||33
3118251|NCT01609062|3843138|FG000|STARTED|Primary Phase||15
3118252|NCT01609062|3843139|FG001|STARTED|Primary Phase||10
3118253|NCT01609062|3843138|FG000|COMPLETED|Primary Phase||15
3118254|NCT01609062|3843139|FG001|COMPLETED|Primary Phase||10
3118255|NCT01609062|3843138|FG000|NOT COMPLETED|Primary Phase||0
3118256|NCT01609062|3843139|FG001|NOT COMPLETED|Primary Phase||0
3118257|NCT01609062|3843138|FG000|STARTED|Extension Phase||15
3118258|NCT01609062|3843139|FG001|STARTED|Extension Phase||10
3118259|NCT01609062|3843138|FG000|COMPLETED|Extension Phase||0
3118260|NCT01609062|3843139|FG001|COMPLETED|Extension Phase|EAP = Expanded Access Program|0
3118261|NCT01609062|3843138|FG000|NOT COMPLETED|Extension Phase||15
3118262|NCT01609062|3843139|FG001|NOT COMPLETED|Extension Phase||10
3118263|NCT01609218|3843146|FG000|STARTED|Period 1||13
3118264|NCT01609218|3843147|FG001|STARTED|Period 1||14
3118265|NCT01609218|3843146|FG000|Received LY2140023|Period 1||13
3118266|NCT01609218|3843147|FG001|Received LY2140023|Period 1||14
3118267|NCT01609218|3843146|FG000|Received Activated Charcoal|Period 1|Participants in this treatment sequence did not receive activated charcoal during Period 1.|0
3118268|NCT01609218|3843147|FG001|Received Activated Charcoal|Period 1|Two participants discontinued after receiving LY2140023 but prior to receiving activated charcoal.|12
3118269|NCT01609218|3843146|FG000|COMPLETED|Period 1||10
3118270|NCT01609218|3843147|FG001|COMPLETED|Period 1||8
3118271|NCT01609218|3843146|FG000|NOT COMPLETED|Period 1||3
3118272|NCT01609218|3843147|FG001|NOT COMPLETED|Period 1||6
3118273|NCT01609218|3843146|FG000|STARTED|Period 2||10
3118274|NCT01609218|3843147|FG001|STARTED|Period 2|One participant did not complete Period 1 but did continue onto Period 2.|9
3118275|NCT01609218|3843146|FG000|Received LY2140023|Period 2||10
3118276|NCT01609218|3843147|FG001|Received LY2140023|Period 2||9
3118277|NCT01609218|3843146|FG000|Received Activated Charcoal|Period 2||9
3118278|NCT01609218|3843147|FG001|Received Activated Charcoal|Period 2|Participants in this treatment sequence did not receive activated charcoal during Period 2.|0
3118279|NCT01609218|3843146|FG000|COMPLETED|Period 2||9
3118280|NCT01609218|3843147|FG001|COMPLETED|Period 2||9
3118281|NCT01609218|3843146|FG000|NOT COMPLETED|Period 2||1
3118282|NCT01609218|3843147|FG001|NOT COMPLETED|Period 2||0
3118283|NCT01609257|3843155|FG000|STARTED|Overall Study||67
3118284|NCT01609257|3843156|FG001|STARTED|Overall Study||65
3118285|NCT01609257|3843155|FG000|Received 2 Doses|Overall Study||63
3118286|NCT01609257|3843156|FG001|Received 2 Doses|Overall Study||64
3118287|NCT01609257|3843155|FG000|Received Challenge Product|Overall Study||56
3118288|NCT01609257|3843156|FG001|Received Challenge Product|Overall Study||53
3118289|NCT01609257|3843155|FG000|COMPLETED|Overall Study||61
3118290|NCT01609257|3843156|FG001|COMPLETED|Overall Study||57
3118291|NCT01609257|3843155|FG000|NOT COMPLETED|Overall Study||6
3118292|NCT01609257|3843156|FG001|NOT COMPLETED|Overall Study||8
3118293|NCT01609296|3843165|FG000|STARTED|Overall Study||1406
3118294|NCT01609296|3843165|FG000|COMPLETED|Overall Study||918
3118295|NCT01609296|3843165|FG000|NOT COMPLETED|Overall Study||488
3118296|NCT01609348|3843175|FG000|STARTED|Overall Study||3
3118297|NCT01609348|3843176|FG001|STARTED|Overall Study||2
3118298|NCT01609348|3843175|FG000|COMPLETED|Overall Study||3
3118299|NCT01609348|3843176|FG001|COMPLETED|Overall Study||2
3118300|NCT01609348|3843175|FG000|NOT COMPLETED|Overall Study||0
3118301|NCT01609348|3843176|FG001|NOT COMPLETED|Overall Study||0
3118302|NCT01609478|3843185|FG000|STARTED|Overall Study||111
3118303|NCT01609478|3843186|FG001|STARTED|Overall Study||108
3118304|NCT01609478|3843187|FG002|STARTED|Overall Study||116
3118305|NCT01609478|3843185|FG000|Full Analysis Set (FAS)|Overall Study||110
3118306|NCT01609478|3843186|FG001|Full Analysis Set (FAS)|Overall Study||108
3118307|NCT01609478|3843187|FG002|Full Analysis Set (FAS)|Overall Study||115
3118308|NCT01609478|3843185|FG000|COMPLETED|Overall Study||104
3118309|NCT01609478|3843186|FG001|COMPLETED|Overall Study||106
3118310|NCT01609478|3843187|FG002|COMPLETED|Overall Study||107
3118311|NCT01609478|3843185|FG000|NOT COMPLETED|Overall Study||7
3118312|NCT01609478|3843186|FG001|NOT COMPLETED|Overall Study||2
3118313|NCT01609478|3843187|FG002|NOT COMPLETED|Overall Study||9
3118314|NCT01609543|3843195|FG000|STARTED|Overall Study||62
3118315|NCT01609543|3843195|FG000|COMPLETED|Overall Study||20
3118316|NCT01609543|3843195|FG000|NOT COMPLETED|Overall Study||42
3118317|NCT01609556|3843216|FG000|STARTED|Dose Escalation: Maximum 101.3 Weeks||2
3118318|NCT01609556|3843217|FG001|STARTED|Dose Escalation: Maximum 101.3 Weeks||1
3118319|NCT01609556|3843218|FG002|STARTED|Dose Escalation: Maximum 101.3 Weeks||1
3118320|NCT01609556|3843219|FG003|STARTED|Dose Escalation: Maximum 101.3 Weeks||1
3118321|NCT01609556|3843220|FG004|STARTED|Dose Escalation: Maximum 101.3 Weeks||9
3118322|NCT01609556|3843221|FG005|STARTED|Dose Escalation: Maximum 101.3 Weeks||18
3118323|NCT01609556|3843222|FG006|STARTED|Dose Escalation: Maximum 101.3 Weeks||7
3118324|NCT01609556|3843223|FG007|STARTED|Dose Escalation: Maximum 101.3 Weeks||5
3118325|NCT01609556|3843224|FG008|STARTED|Dose Escalation: Maximum 101.3 Weeks||5
3118326|NCT01609556|3843225|FG009|STARTED|Dose Escalation: Maximum 101.3 Weeks||4
3118327|NCT01609556|3843226|FG010|STARTED|Dose Escalation: Maximum 101.3 Weeks||9
3118328|NCT01609556|3843227|FG011|STARTED|Dose Escalation: Maximum 101.3 Weeks||7
3118329|NCT01609556|3843228|FG012|STARTED|Dose Escalation: Maximum 101.3 Weeks||0
3118330|NCT01609556|3843229|FG013|STARTED|Dose Escalation: Maximum 101.3 Weeks||0
3118331|NCT01609556|3843230|FG014|STARTED|Dose Escalation: Maximum 101.3 Weeks||0
3118332|NCT01609556|3843231|FG015|STARTED|Dose Escalation: Maximum 101.3 Weeks||0
3118333|NCT01609556|3843216|FG000|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||2
3118334|NCT01609556|3843217|FG001|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||1
3118335|NCT01609556|3843218|FG002|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||1
3118336|NCT01609556|3843219|FG003|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||1
3118337|NCT01609556|3843220|FG004|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||9
3118338|NCT01609556|3843221|FG005|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||18
3118339|NCT01609556|3843222|FG006|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||7
3118340|NCT01609556|3843223|FG007|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||5
3118341|NCT01609556|3843224|FG008|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||5
3118342|NCT01609556|3843225|FG009|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||4
3118343|NCT01609556|3843226|FG010|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||9
3118344|NCT01609556|3843227|FG011|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||7
3118345|NCT01609556|3843228|FG012|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||0
3118346|NCT01609556|3843229|FG013|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||0
3118347|NCT01609556|3843230|FG014|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||0
3118348|NCT01609556|3843231|FG015|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||0
3118349|NCT01609556|3843216|FG000|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
3118350|NCT01609556|3843217|FG001|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
3118351|NCT01609556|3843218|FG002|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
3118352|NCT01609556|3843219|FG003|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
3118353|NCT01609556|3843220|FG004|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
3118354|NCT01609556|3843221|FG005|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
3118355|NCT01609556|3843222|FG006|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
3118356|NCT01609556|3843223|FG007|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
3118357|NCT01609556|3843224|FG008|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
3118358|NCT01609556|3843225|FG009|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
3118359|NCT01609556|3843226|FG010|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
3118360|NCT01609556|3843227|FG011|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
3118361|NCT01609556|3843228|FG012|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
3118362|NCT01609556|3843229|FG013|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
3118363|NCT01609556|3843230|FG014|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
3118364|NCT01609556|3843231|FG015|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
3118365|NCT01609556|3843216|FG000|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||2
3118366|NCT01609556|3843217|FG001|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||1
3118367|NCT01609556|3843218|FG002|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||1
3118368|NCT01609556|3843219|FG003|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||1
3118369|NCT01609556|3843220|FG004|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||9
3118370|NCT01609556|3843221|FG005|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||18
3118371|NCT01609556|3843222|FG006|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||7
3118372|NCT01609556|3843223|FG007|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||5
3118373|NCT01609556|3843224|FG008|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||5
3118374|NCT01609556|3843225|FG009|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||4
3118375|NCT01609556|3843226|FG010|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||9
3118376|NCT01609556|3843227|FG011|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||7
3118377|NCT01609556|3843228|FG012|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
3118378|NCT01609556|3843229|FG013|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
3118379|NCT01609556|3843230|FG014|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
3118380|NCT01609556|3843231|FG015|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
3118381|NCT01609556|3843216|FG000|STARTED|Dose Expansion: Maximum 124 Weeks||0
3118382|NCT01609556|3843217|FG001|STARTED|Dose Expansion: Maximum 124 Weeks||0
3118383|NCT01609556|3843218|FG002|STARTED|Dose Expansion: Maximum 124 Weeks||0
3118384|NCT01609556|3843219|FG003|STARTED|Dose Expansion: Maximum 124 Weeks||0
3118385|NCT01609556|3843220|FG004|STARTED|Dose Expansion: Maximum 124 Weeks||0
3118386|NCT01609556|3843221|FG005|STARTED|Dose Expansion: Maximum 124 Weeks||0
3118387|NCT01609556|3843222|FG006|STARTED|Dose Expansion: Maximum 124 Weeks||0
3118388|NCT01609556|3843223|FG007|STARTED|Dose Expansion: Maximum 124 Weeks||0
3118389|NCT01609556|3843224|FG008|STARTED|Dose Expansion: Maximum 124 Weeks||0
3118390|NCT01609556|3843225|FG009|STARTED|Dose Expansion: Maximum 124 Weeks||0
3118391|NCT01609556|3843226|FG010|STARTED|Dose Expansion: Maximum 124 Weeks||0
3118392|NCT01609556|3843227|FG011|STARTED|Dose Expansion: Maximum 124 Weeks||0
3118393|NCT01609556|3843228|FG012|STARTED|Dose Expansion: Maximum 124 Weeks||46
3118394|NCT01609556|3843229|FG013|STARTED|Dose Expansion: Maximum 124 Weeks||24
3118395|NCT01609556|3843230|FG014|STARTED|Dose Expansion: Maximum 124 Weeks||27
3118396|NCT01609556|3843231|FG015|STARTED|Dose Expansion: Maximum 124 Weeks||40
3118397|NCT01609556|3843216|FG000|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
3118398|NCT01609556|3843217|FG001|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
3118399|NCT01609556|3843218|FG002|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
3118400|NCT01609556|3843219|FG003|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
3118401|NCT01609556|3843220|FG004|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
3118402|NCT01609556|3843221|FG005|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
3118403|NCT01609556|3843222|FG006|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
3118404|NCT01609556|3843223|FG007|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
3118405|NCT01609556|3843224|FG008|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
3118406|NCT01609556|3843225|FG009|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
3118407|NCT01609556|3843226|FG010|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
3118408|NCT01609556|3843227|FG011|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
3118409|NCT01609556|3843228|FG012|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
3118410|NCT01609556|3843229|FG013|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
3118411|NCT01609556|3843230|FG014|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
3118412|NCT01609556|3843231|FG015|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
3118413|NCT01609556|3843216|FG000|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0
3118414|NCT01609556|3843217|FG001|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0
3118415|NCT01609556|3843218|FG002|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0
3118416|NCT01609556|3843219|FG003|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0
3118417|NCT01609556|3843220|FG004|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0
3118418|NCT01609556|3843221|FG005|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0
3118419|NCT01609556|3843222|FG006|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0
3118420|NCT01609556|3843223|FG007|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0
3118421|NCT01609556|3843224|FG008|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0
3118422|NCT01609556|3843225|FG009|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0
3118423|NCT01609556|3843226|FG010|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0
3118424|NCT01609556|3843227|FG011|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0
3118425|NCT01609556|3843228|FG012|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||46
3118426|NCT01609556|3843229|FG013|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||24
3118427|NCT01609556|3843230|FG014|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||27
3118428|NCT01609556|3843231|FG015|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||40
3118429|NCT01609582|3843274|FG000|STARTED|Overall Study||1603
3118430|NCT01609582|3843275|FG001|STARTED|Overall Study||1604
3118431|NCT01609582|3843274|FG000|Treated|Overall Study||1603
3118432|NCT01609582|3843275|FG001|Treated|Overall Study||1601
3118433|NCT01609582|3843274|FG000|COMPLETED|Overall Study||0
3118434|NCT01609582|3843275|FG001|COMPLETED|Overall Study||0
3118435|NCT01609582|3843274|FG000|NOT COMPLETED|Overall Study||1603
3118436|NCT01609582|3843275|FG001|NOT COMPLETED|Overall Study||1604
3118437|NCT01609933|3843281|FG000|STARTED|Overall Study||32
3118438|NCT01609933|3843281|FG000|COMPLETED|Overall Study||28
3118439|NCT01609933|3843281|FG000|NOT COMPLETED|Overall Study||4
3118440|NCT01610011|3843289|FG000|STARTED|Overall Study||19
3118441|NCT01610011|3843290|FG001|STARTED|Overall Study||2
3118442|NCT01610011|3843289|FG000|COMPLETED|Overall Study||9
3118443|NCT01610011|3843290|FG001|COMPLETED|Overall Study||2
3118444|NCT01610011|3843289|FG000|NOT COMPLETED|Overall Study||10
3118445|NCT01610011|3843290|FG001|NOT COMPLETED|Overall Study||0
3118446|NCT01610037|3843299|FG000|STARTED|All Patients||407
3118447|NCT01610037|3843300|FG001|STARTED|All Patients||405
3118448|NCT01610037|3843301|FG002|STARTED|All Patients||404
3118449|NCT01610037|3843299|FG000|Randomized Set (RAN)|All Patients||407
3118450|NCT01610037|3843300|FG001|Randomized Set (RAN)|All Patients||405
3118451|NCT01610037|3843301|FG002|Randomized Set (RAN)|All Patients||404
3118452|NCT01610037|3843299|FG000|Full Analysis Set (FAS)|All Patients||407
3118453|NCT01610037|3843300|FG001|Full Analysis Set (FAS)|All Patients||405
3118454|NCT01610037|3843301|FG002|Full Analysis Set (FAS)|All Patients||403
3118455|NCT01610037|3843299|FG000|COMPLETED|All Patients||348
3118456|NCT01610037|3843300|FG001|COMPLETED|All Patients||354
3118457|NCT01610037|3843301|FG002|COMPLETED|All Patients||320
3118458|NCT01610037|3843299|FG000|NOT COMPLETED|All Patients||59
3118459|NCT01610037|3843300|FG001|NOT COMPLETED|All Patients||51
3118460|NCT01610037|3843301|FG002|NOT COMPLETED|All Patients||84
3118461|NCT01610037|3843299|FG000|STARTED|Treatment and Follow up Period||407
3118462|NCT01610037|3843300|FG001|STARTED|Treatment and Follow up Period||405
3118463|NCT01610037|3843301|FG002|STARTED|Treatment and Follow up Period||404
3118464|NCT01610037|3843299|FG000|COMPLETED|Treatment and Follow up Period||382
3118465|NCT01610037|3843300|FG001|COMPLETED|Treatment and Follow up Period||377
3118466|NCT01610037|3843301|FG002|COMPLETED|Treatment and Follow up Period||378
3118467|NCT01610037|3843299|FG000|NOT COMPLETED|Treatment and Follow up Period||25
3118468|NCT01610037|3843300|FG001|NOT COMPLETED|Treatment and Follow up Period||28
3118469|NCT01610037|3843301|FG002|NOT COMPLETED|Treatment and Follow up Period||26
3118470|NCT01610063|3843311|FG000|STARTED|Overall Study||114
3118471|NCT01610063|3843312|FG001|STARTED|Overall Study||113
3118472|NCT01610063|3843311|FG000|Baseline|Overall Study||114
3118473|NCT01610063|3843312|FG001|Baseline|Overall Study||113
3118474|NCT01610063|3843311|FG000|Completed 2-week|Overall Study||97
3118475|NCT01610063|3843312|FG001|Completed 2-week|Overall Study||105
3118476|NCT01610063|3843311|FG000|Completed 4-week|Overall Study||86
3118477|NCT01610063|3843312|FG001|Completed 4-week|Overall Study||98
3118478|NCT01610063|3843311|FG000|Completed 8-week|Overall Study||72
3118479|NCT01610063|3843312|FG001|Completed 8-week|Overall Study||93
3118480|NCT01610063|3843311|FG000|COMPLETED|Overall Study||72
3118481|NCT01610063|3843312|FG001|COMPLETED|Overall Study||93
3118482|NCT01610063|3843311|FG000|NOT COMPLETED|Overall Study||42
3118483|NCT01610063|3843312|FG001|NOT COMPLETED|Overall Study||20
3118484|NCT01610076|3843320|FG000|STARTED|Overall Study||103
3118485|NCT01610076|3843321|FG001|STARTED|Overall Study||105
3118486|NCT01610076|3843320|FG000|COMPLETED|Overall Study||100
3118487|NCT01610076|3843321|FG001|COMPLETED|Overall Study||100
3118488|NCT01610076|3843320|FG000|NOT COMPLETED|Overall Study||3
3118489|NCT01610076|3843321|FG001|NOT COMPLETED|Overall Study||5
3118490|NCT01610154|3843328|FG000|STARTED|Overall Study||85
3118491|NCT01610154|3843328|FG000|COMPLETED|Overall Study||84
3118492|NCT01610154|3843328|FG000|NOT COMPLETED|Overall Study||1
3118493|NCT01610167|3843337|FG000|STARTED|Overall Study||52
3118494|NCT01610167|3843338|FG001|STARTED|Overall Study||49
3118495|NCT01610167|3843339|FG002|STARTED|Overall Study||50
3118496|NCT01610167|3843337|FG000|COMPLETED|Overall Study||52
3118497|NCT01610167|3843338|FG001|COMPLETED|Overall Study||49
3118498|NCT01610167|3843339|FG002|COMPLETED|Overall Study||48
3118499|NCT01610167|3843337|FG000|NOT COMPLETED|Overall Study||0
3118500|NCT01610167|3843338|FG001|NOT COMPLETED|Overall Study||0
3118501|NCT01610167|3843339|FG002|NOT COMPLETED|Overall Study||2
3118502|NCT01610206|3843349|FG000|STARTED|Overall Study||73
3118503|NCT01610206|3843350|FG001|STARTED|Overall Study||75
3118504|NCT01610206|3843349|FG000|COMPLETED|Overall Study||63
3118505|NCT01610206|3843350|FG001|COMPLETED|Overall Study||45
3118506|NCT01610206|3843349|FG000|NOT COMPLETED|Overall Study||10
3118507|NCT01610206|3843350|FG001|NOT COMPLETED|Overall Study||30
3118508|NCT01610271|3843358|FG000|STARTED|Overall Study||150
3118509|NCT01610271|3843359|FG001|STARTED|Overall Study||150
3118510|NCT01610271|3843358|FG000|COMPLETED|Overall Study||148
3118511|NCT01610271|3843359|FG001|COMPLETED|Overall Study||146
3118512|NCT01610271|3843358|FG000|NOT COMPLETED|Overall Study||2
3118513|NCT01610271|3843359|FG001|NOT COMPLETED|Overall Study||4
3118514|NCT01610284|3843369|FG000|STARTED|Randomization Phase||576
3118515|NCT01610284|3843370|FG001|STARTED|Randomization Phase||571
3118516|NCT01610284|3843369|FG000|Safety Set (SS)|Randomization Phase||573
3118517|NCT01610284|3843370|FG001|Safety Set (SS)|Randomization Phase||570
3118518|NCT01610284|3843369|FG000|COMPLETED|Randomization Phase||574
3118519|NCT01610284|3843370|FG001|COMPLETED|Randomization Phase||569
3118520|NCT01610284|3843369|FG000|NOT COMPLETED|Randomization Phase||2
3118521|NCT01610284|3843370|FG001|NOT COMPLETED|Randomization Phase||2
3118522|NCT01610284|3843369|FG000|STARTED|Treatment Phase||574
3118523|NCT01610284|3843370|FG001|STARTED|Treatment Phase||569
3118524|NCT01610284|3843369|FG000|BKM120 Pharmacokinetic Analysis Set|Treatment Phase||93
3118525|NCT01610284|3843370|FG001|BKM120 Pharmacokinetic Analysis Set|Treatment Phase||0
3118526|NCT01610284|3843369|FG000|Full Pharmacokinetic Analysis Set (FPAS)|Treatment Phase||35
3118527|NCT01610284|3843370|FG001|Full Pharmacokinetic Analysis Set (FPAS)|Treatment Phase||0
3118528|NCT01610284|3843369|FG000|COMPLETED|Treatment Phase||0
3118529|NCT01610284|3843370|FG001|COMPLETED|Treatment Phase||0
3118530|NCT01610284|3843369|FG000|NOT COMPLETED|Treatment Phase||574
3118531|NCT01610284|3843370|FG001|NOT COMPLETED|Treatment Phase||569
3118532|NCT01610284|3843369|FG000|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|89
3118533|NCT01610284|3843370|FG001|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|29
3118534|NCT01610284|3843369|FG000|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
3118535|NCT01610284|3843370|FG001|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
3118536|NCT01610284|3843369|FG000|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||89
3118537|NCT01610284|3843370|FG001|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||29
3118538|NCT01610297|3843376|FG000|STARTED|Overall Study||27
3118539|NCT01610297|3843376|FG000|COMPLETED|Overall Study||26
3118540|NCT01610297|3843376|FG000|NOT COMPLETED|Overall Study||1
3118541|NCT01610336|3843391|FG000|STARTED|Overall Study||5
3118542|NCT01610336|3843392|FG001|STARTED|Overall Study||7
3118543|NCT01610336|3843393|FG002|STARTED|Overall Study||6
3118544|NCT01610336|3843394|FG003|STARTED|Overall Study||7
3118545|NCT01610336|3843395|FG004|STARTED|Overall Study||4
3118546|NCT01610336|3843396|FG005|STARTED|Overall Study||12
3118547|NCT01610336|3843397|FG006|STARTED|Overall Study||5
3118548|NCT01610336|3843398|FG007|STARTED|Overall Study||7
3118549|NCT01610336|3843399|FG008|STARTED|Overall Study||8
3118550|NCT01610336|3843400|FG009|STARTED|Overall Study||53
3118551|NCT01610336|3843401|FG010|STARTED|Overall Study||47
3118552|NCT01610336|3843391|FG000|COMPLETED|Overall Study||0
3118553|NCT01610336|3843392|FG001|COMPLETED|Overall Study||0
3118554|NCT01610336|3843393|FG002|COMPLETED|Overall Study||0
3118555|NCT01610336|3843394|FG003|COMPLETED|Overall Study||0
3118556|NCT01610336|3843395|FG004|COMPLETED|Overall Study||0
3118557|NCT01610336|3843396|FG005|COMPLETED|Overall Study||0
3118558|NCT01610336|3843397|FG006|COMPLETED|Overall Study||0
3118559|NCT01610336|3843398|FG007|COMPLETED|Overall Study||0
3118560|NCT01610336|3843399|FG008|COMPLETED|Overall Study||0
3118561|NCT01610336|3843400|FG009|COMPLETED|Overall Study||0
3118562|NCT01610336|3843401|FG010|COMPLETED|Overall Study||0
3118563|NCT01610336|3843391|FG000|NOT COMPLETED|Overall Study||5
3118564|NCT01610336|3843392|FG001|NOT COMPLETED|Overall Study||7
3118565|NCT01610336|3843393|FG002|NOT COMPLETED|Overall Study||6
3118566|NCT01610336|3843394|FG003|NOT COMPLETED|Overall Study||7
3118567|NCT01610336|3843395|FG004|NOT COMPLETED|Overall Study||4
3118568|NCT01610336|3843396|FG005|NOT COMPLETED|Overall Study||12
3118569|NCT01610336|3843397|FG006|NOT COMPLETED|Overall Study||5
3118570|NCT01610336|3843398|FG007|NOT COMPLETED|Overall Study||7
3118571|NCT01610336|3843399|FG008|NOT COMPLETED|Overall Study||8
3118572|NCT01610336|3843400|FG009|NOT COMPLETED|Overall Study||53
3118573|NCT01610336|3843401|FG010|NOT COMPLETED|Overall Study||47
3118574|NCT01610414|3843431|FG000|STARTED|Study Start - Month 13||922
3118575|NCT01610414|3843432|FG001|STARTED|Study Start - Month 13||924
3118576|NCT01610414|3843431|FG000|COMPLETED|Study Start - Month 13||807
3118577|NCT01610414|3843432|FG001|COMPLETED|Study Start - Month 13||795
3118578|NCT01610414|3843431|FG000|NOT COMPLETED|Study Start - Month 13||115
3118579|NCT01610414|3843432|FG001|NOT COMPLETED|Study Start - Month 13||129
3118580|NCT01610414|3843431|FG000|STARTED|Month 13 - Month 25||922
3118581|NCT01610414|3843432|FG001|STARTED|Month 13 - Month 25||924
3118582|NCT01610414|3843431|FG000|COMPLETED|Month 13 - Month 25||857
3118583|NCT01610414|3843432|FG001|COMPLETED|Month 13 - Month 25||854
3118584|NCT01610414|3843431|FG000|NOT COMPLETED|Month 13 - Month 25||65
3118585|NCT01610414|3843432|FG001|NOT COMPLETED|Month 13 - Month 25||70
3118586|NCT01610414|3843431|FG000|STARTED|After Month 25||922
3118587|NCT01610414|3843432|FG001|STARTED|After Month 25||924
3118588|NCT01610414|3843431|FG000|COMPLETED|After Month 25||874
3118589|NCT01610414|3843432|FG001|COMPLETED|After Month 25||871
3118590|NCT01610414|3843431|FG000|NOT COMPLETED|After Month 25||48
3118591|NCT01610414|3843432|FG001|NOT COMPLETED|After Month 25||53
3118592|NCT01610427|3843439|FG000|STARTED|Overall Study||22
3118593|NCT01610427|3843439|FG000|COMPLETED|Overall Study||22
3118594|NCT01610427|3843439|FG000|NOT COMPLETED|Overall Study||0
3118595|NCT01610453|3843443|FG000|STARTED|Overall Study||150
3118596|NCT01610453|3843443|FG000|COMPLETED|Overall Study||150
3118597|NCT01610453|3843443|FG000|NOT COMPLETED|Overall Study||0
3118598|NCT01610492|3843448|FG000|STARTED|Overall Study||14
3118599|NCT01610492|3843448|FG000|COMPLETED|Overall Study||8
3118600|NCT01610492|3843448|FG000|NOT COMPLETED|Overall Study||6
3118601|NCT01610557|3843456|FG000|STARTED|36-Week Randomized Crossover Phase|Participants randomly assigned to Grp 1: 14 unilateral and 2 bilateral (left eye assigned to Grp 3)|16
3118602|NCT01610557|3843457|FG001|STARTED|36-Week Randomized Crossover Phase|Participants randomly assigned to Grp 2: 12 unilateral and 1 bilateral (left eye assigned to Grp 4)|13
3118603|NCT01610557|3843458|FG002|STARTED|36-Week Randomized Crossover Phase|Participants randomly assigned to Grp 3: 13 unilateral and 1 bilateral (left eye assigned to Grp 1)|14
3118604|NCT01610557|3843459|FG003|STARTED|36-Week Randomized Crossover Phase|Participants randomly assigned to Grp 4: 11 unilateral and 2 bilateral (left eye assigned to Grp 2)|13
3118605|NCT01610557|3843460|FG004|STARTED|36-Week Randomized Crossover Phase|Not applicable for 36-week double-masked randomized crossover phase|0
3118606|NCT01610557|3843456|FG000|COMPLETED|36-Week Randomized Crossover Phase||16
3118607|NCT01610557|3843457|FG001|COMPLETED|36-Week Randomized Crossover Phase|Unilateral participant unable to return for visits after Wk 4 due to recovery from an adverse event|12
3118608|NCT01610557|3843458|FG002|COMPLETED|36-Week Randomized Crossover Phase||14
3118609|NCT01610557|3843459|FG003|COMPLETED|36-Week Randomized Crossover Phase||13
3118610|NCT01610557|3843460|FG004|COMPLETED|36-Week Randomized Crossover Phase|Not applicable for 36-week double-masked randomized crossover phase|0
3118611|NCT01610557|3843456|FG000|NOT COMPLETED|36-Week Randomized Crossover Phase||0
3118612|NCT01610557|3843457|FG001|NOT COMPLETED|36-Week Randomized Crossover Phase||1
3118613|NCT01610557|3843458|FG002|NOT COMPLETED|36-Week Randomized Crossover Phase||0
3118614|NCT01610557|3843459|FG003|NOT COMPLETED|36-Week Randomized Crossover Phase||0
3118615|NCT01610557|3843460|FG004|NOT COMPLETED|36-Week Randomized Crossover Phase||0
3118616|NCT01610557|3843456|FG000|STARTED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
3118617|NCT01610557|3843457|FG001|STARTED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
3118618|NCT01610557|3843458|FG002|STARTED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
3118619|NCT01610557|3843459|FG003|STARTED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
3118620|NCT01610557|3843460|FG004|STARTED|Post-36-Week Extension Phase||55
3118621|NCT01610557|3843456|FG000|COMPLETED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
3118622|NCT01610557|3843457|FG001|COMPLETED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
3118623|NCT01610557|3843458|FG002|COMPLETED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
3118624|NCT01610557|3843459|FG003|COMPLETED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
3118625|NCT01610557|3843460|FG004|COMPLETED|Post-36-Week Extension Phase|2 bilateral participants withdrew before their first post-36-week extension visit|52
3118626|NCT01610557|3843456|FG000|NOT COMPLETED|Post-36-Week Extension Phase||0
3118627|NCT01610557|3843457|FG001|NOT COMPLETED|Post-36-Week Extension Phase||0
3118628|NCT01610557|3843458|FG002|NOT COMPLETED|Post-36-Week Extension Phase||0
3118629|NCT01610557|3843459|FG003|NOT COMPLETED|Post-36-Week Extension Phase||0
3118630|NCT01610557|3843460|FG004|NOT COMPLETED|Post-36-Week Extension Phase||3
3118631|NCT01610570|3843475|FG000|STARTED|Ph I >/= 12 mo. Children & Adolescents||0
3118632|NCT01610570|3843476|FG001|STARTED|Ph I >/= 12 mo. Children & Adolescents||2
3118633|NCT01610570|3843477|FG002|STARTED|Ph I >/= 12 mo. Children & Adolescents||0
3118634|NCT01610570|3843478|FG003|STARTED|Ph I >/= 12 mo. Children & Adolescents||0
3118635|NCT01610570|3843475|FG000|COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
3118636|NCT01610570|3843476|FG001|COMPLETED|Ph I >/= 12 mo. Children & Adolescents||2
3118637|NCT01610570|3843477|FG002|COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
3118638|NCT01610570|3843478|FG003|COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
3118639|NCT01610570|3843475|FG000|NOT COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
3118640|NCT01610570|3843476|FG001|NOT COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
3118641|NCT01610570|3843477|FG002|NOT COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
3118642|NCT01610570|3843478|FG003|NOT COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
3118643|NCT01610570|3843475|FG000|STARTED|Ph II >/= 18yrs of Age at Enrollment||0
3118644|NCT01610570|3843476|FG001|STARTED|Ph II >/= 18yrs of Age at Enrollment||0
3118645|NCT01610570|3843477|FG002|STARTED|Ph II >/= 18yrs of Age at Enrollment||0
3118646|NCT01610570|3843478|FG003|STARTED|Ph II >/= 18yrs of Age at Enrollment||6
3118647|NCT01610570|3843475|FG000|COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
3118648|NCT01610570|3843476|FG001|COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
3118649|NCT01610570|3843477|FG002|COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
3118650|NCT01610570|3843478|FG003|COMPLETED|Ph II >/= 18yrs of Age at Enrollment||6
3118651|NCT01610570|3843475|FG000|NOT COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
3118652|NCT01610570|3843476|FG001|NOT COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
3118653|NCT01610570|3843477|FG002|NOT COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
3118654|NCT01610570|3843478|FG003|NOT COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
3118655|NCT01610570|3843475|FG000|STARTED|Ph II >/= 12 mo. & </=17yrs||0
3118656|NCT01610570|3843476|FG001|STARTED|Ph II >/= 12 mo. & </=17yrs||0
3118657|NCT01610570|3843477|FG002|STARTED|Ph II >/= 12 mo. & </=17yrs||0
3118658|NCT01610570|3843478|FG003|STARTED|Ph II >/= 12 mo. & </=17yrs||0
3118659|NCT01610570|3843475|FG000|COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
3118660|NCT01610570|3843476|FG001|COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
3118661|NCT01610570|3843477|FG002|COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
3118662|NCT01610570|3843478|FG003|COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
3118663|NCT01610570|3843475|FG000|NOT COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
3118664|NCT01610570|3843476|FG001|NOT COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
3118665|NCT01610570|3843477|FG002|NOT COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
3118666|NCT01610570|3843478|FG003|NOT COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
3118667|NCT01610596|3843496|FG000|STARTED|Overall Study||36
3118668|NCT01610596|3843497|FG001|STARTED|Overall Study||36
3118669|NCT01610596|3843496|FG000|COMPLETED|Overall Study||36
3118670|NCT01610596|3843497|FG001|COMPLETED|Overall Study||35
3118671|NCT01610596|3843496|FG000|NOT COMPLETED|Overall Study||0
3118672|NCT01610596|3843497|FG001|NOT COMPLETED|Overall Study||1
3118673|NCT01610687|3843503|FG000|STARTED|Overall Study||137
3118674|NCT01610687|3843503|FG000|COMPLETED|Overall Study||70
3118675|NCT01610687|3843503|FG000|NOT COMPLETED|Overall Study||67
3118676|NCT01610700|3843509|FG000|STARTED|Overall Study||80
3118677|NCT01610700|3843510|FG001|STARTED|Overall Study||80
3118678|NCT01610700|3843509|FG000|COMPLETED|Overall Study||77
3118679|NCT01610700|3843510|FG001|COMPLETED|Overall Study||77
3118680|NCT01610700|3843509|FG000|NOT COMPLETED|Overall Study||3
3118681|NCT01610700|3843510|FG001|NOT COMPLETED|Overall Study||3
3118682|NCT01610713|3843519|FG000|STARTED|Overall Study||77
3118683|NCT01610713|3843520|FG001|STARTED|Overall Study||77
3118684|NCT01610713|3843519|FG000|COMPLETED|Overall Study||71
3118685|NCT01610713|3843520|FG001|COMPLETED|Overall Study||76
3118686|NCT01610713|3843519|FG000|NOT COMPLETED|Overall Study||6
3118687|NCT01610713|3843520|FG001|NOT COMPLETED|Overall Study||1
3118688|NCT01610752|3843529|FG000|STARTED|Overall Study||18
3118689|NCT01610752|3843530|FG001|STARTED|Overall Study||19
3118690|NCT01610752|3843531|FG002|STARTED|Overall Study||17
3118691|NCT01610752|3843529|FG000|COMPLETED|Overall Study||18
3118692|NCT01610752|3843530|FG001|COMPLETED|Overall Study||19
3118693|NCT01610752|3843531|FG002|COMPLETED|Overall Study||13
3118694|NCT01610752|3843529|FG000|NOT COMPLETED|Overall Study||0
3118695|NCT01610752|3843530|FG001|NOT COMPLETED|Overall Study||0
3118696|NCT01610752|3843531|FG002|NOT COMPLETED|Overall Study||4
3118697|NCT01610791|3843539|FG000|STARTED|Overall Study||121
3118698|NCT01610791|3843539|FG000|COMPLETED|Overall Study||100
3118699|NCT01610791|3843539|FG000|NOT COMPLETED|Overall Study||21
3118700|NCT01611090|3843545|FG000|STARTED|Randomized Period||289
3118701|NCT01611090|3843546|FG001|STARTED|Randomized Period||289
3118702|NCT01611090|3843547|FG002|STARTED|Randomized Period||0
3118703|NCT01611090|3843545|FG000|Treated|Randomized Period||287
3118704|NCT01611090|3843546|FG001|Treated|Randomized Period||287
3118705|NCT01611090|3843547|FG002|Treated|Randomized Period||0
3118706|NCT01611090|3843545|FG000|COMPLETED|Randomized Period||259
3118707|NCT01611090|3843546|FG001|COMPLETED|Randomized Period||260
3118708|NCT01611090|3843547|FG002|COMPLETED|Randomized Period||0
3118709|NCT01611090|3843545|FG000|NOT COMPLETED|Randomized Period||30
3118710|NCT01611090|3843546|FG001|NOT COMPLETED|Randomized Period||29
3118711|NCT01611090|3843547|FG002|NOT COMPLETED|Randomized Period||0
3118712|NCT01611090|3843545|FG000|STARTED|Cross Over (Placebo to Ibrutinib)||0
3118713|NCT01611090|3843546|FG001|STARTED|Cross Over (Placebo to Ibrutinib)||0
3118714|NCT01611090|3843547|FG002|STARTED|Cross Over (Placebo to Ibrutinib)||183
3118715|NCT01611090|3843545|FG000|Treated|Cross Over (Placebo to Ibrutinib)||0
3118716|NCT01611090|3843546|FG001|Treated|Cross Over (Placebo to Ibrutinib)||0
3118717|NCT01611090|3843547|FG002|Treated|Cross Over (Placebo to Ibrutinib)||183
3118718|NCT01611090|3843545|FG000|COMPLETED|Cross Over (Placebo to Ibrutinib)||0
3118719|NCT01611090|3843546|FG001|COMPLETED|Cross Over (Placebo to Ibrutinib)||0
3118720|NCT01611090|3843547|FG002|COMPLETED|Cross Over (Placebo to Ibrutinib)||178
3118721|NCT01611090|3843545|FG000|NOT COMPLETED|Cross Over (Placebo to Ibrutinib)||0
3118722|NCT01611090|3843546|FG001|NOT COMPLETED|Cross Over (Placebo to Ibrutinib)||0
3118723|NCT01611090|3843547|FG002|NOT COMPLETED|Cross Over (Placebo to Ibrutinib)||5
3118724|NCT01611155|3843556|FG000|STARTED|Overall Study||25
3118725|NCT01611155|3843557|FG001|STARTED|Overall Study||25
3118726|NCT01611155|3843556|FG000|Received Treatment|Overall Study||25
3118727|NCT01611155|3843557|FG001|Received Treatment|Overall Study||25
3118728|NCT01611155|3843556|FG000|COMPLETED|Overall Study||16
3118729|NCT01611155|3843557|FG001|COMPLETED|Overall Study||18
3118730|NCT01611155|3843556|FG000|NOT COMPLETED|Overall Study||9
3118731|NCT01611155|3843557|FG001|NOT COMPLETED|Overall Study||7
3118732|NCT01611194|3843565|FG000|STARTED|Overall Study||36
3118733|NCT01611194|3843566|FG001|STARTED|Overall Study||35
3118734|NCT01611194|3843565|FG000|COMPLETED|Overall Study||36
3118735|NCT01611194|3843566|FG001|COMPLETED|Overall Study||32
3118736|NCT01611194|3843565|FG000|NOT COMPLETED|Overall Study||0
3118737|NCT01611194|3843566|FG001|NOT COMPLETED|Overall Study||3
3118738|NCT01611259|3843572|FG000|STARTED|Overall Study||48
3118739|NCT01611259|3843572|FG000|COMPLETED|Overall Study||34
3118740|NCT01611259|3843572|FG000|NOT COMPLETED|Overall Study||14
3118741|NCT01611298|3843576|FG000|STARTED|Overall Study||7
3118742|NCT01611298|3843576|FG000|COMPLETED|Overall Study||5
3118743|NCT01611298|3843576|FG000|NOT COMPLETED|Overall Study||2
3118744|NCT01611454|3843582|FG000|STARTED|Overall Study||58
3118745|NCT01611454|3843583|FG001|STARTED|Overall Study||48
3118746|NCT01611454|3843582|FG000|COMPLETED|Overall Study||40
3118747|NCT01611454|3843583|FG001|COMPLETED|Overall Study||38
3118748|NCT01611454|3843582|FG000|NOT COMPLETED|Overall Study||18
3118749|NCT01611454|3843583|FG001|NOT COMPLETED|Overall Study||10
3118750|NCT01611558|3843593|FG000|STARTED|Induction Phase||40
3118751|NCT01611558|3843593|FG000|COMPLETED|Induction Phase||2
3118752|NCT01611558|3843593|FG000|NOT COMPLETED|Induction Phase||38
3118753|NCT01611558|3843593|FG000|STARTED|Maintenance Phase||2
3118754|NCT01611558|3843593|FG000|COMPLETED|Maintenance Phase||0
3118755|NCT01611558|3843593|FG000|NOT COMPLETED|Maintenance Phase||2
3118756|NCT01611571|3843601|FG000|STARTED|Overall Study||11
3118757|NCT01611571|3843602|FG001|STARTED|Overall Study||10
3118758|NCT01611571|3843603|FG002|STARTED|Overall Study||10
3118759|NCT01611571|3843601|FG000|COMPLETED|Overall Study||10
3118760|NCT01611571|3843602|FG001|COMPLETED|Overall Study||10
3118761|NCT01611571|3843603|FG002|COMPLETED|Overall Study||9
3118762|NCT01611571|3843601|FG000|NOT COMPLETED|Overall Study||1
3118763|NCT01611571|3843602|FG001|NOT COMPLETED|Overall Study||0
3118764|NCT01611571|3843603|FG002|NOT COMPLETED|Overall Study||1
3118765|NCT01611662|3843611|FG000|STARTED|Overall Study||32
3118766|NCT01611662|3843611|FG000|COMPLETED|Overall Study||31
3118767|NCT01611662|3843611|FG000|NOT COMPLETED|Overall Study||1
3118768|NCT01611779|3843615|FG000|STARTED|Overall Study||5
3118769|NCT01611779|3843615|FG000|COMPLETED|Overall Study||5
3118770|NCT01611779|3843615|FG000|NOT COMPLETED|Overall Study||0
3118771|NCT01611792|3843621|FG000|STARTED|Initial Period: Time 0||29
3118772|NCT01611792|3843622|FG001|STARTED|Initial Period: Time 0||29
3118773|NCT01611792|3843621|FG000|COMPLETED|Initial Period: Time 0||17
3118774|NCT01611792|3843622|FG001|COMPLETED|Initial Period: Time 0||20
3118775|NCT01611792|3843621|FG000|NOT COMPLETED|Initial Period: Time 0||12
3118776|NCT01611792|3843622|FG001|NOT COMPLETED|Initial Period: Time 0||9
3118777|NCT01611792|3843621|FG000|STARTED|Follow-up: at 11 Weeks||17
3118778|NCT01611792|3843622|FG001|STARTED|Follow-up: at 11 Weeks||20
3118779|NCT01611792|3843621|FG000|COMPLETED|Follow-up: at 11 Weeks||17
3118780|NCT01611792|3843622|FG001|COMPLETED|Follow-up: at 11 Weeks||20
3118781|NCT01611792|3843621|FG000|NOT COMPLETED|Follow-up: at 11 Weeks||0
3118782|NCT01611792|3843622|FG001|NOT COMPLETED|Follow-up: at 11 Weeks||0
3118783|NCT01611792|3843621|FG000|STARTED|Followup: at 6 Months||17
3118784|NCT01611792|3843622|FG001|STARTED|Followup: at 6 Months||20
3118785|NCT01611792|3843621|FG000|COMPLETED|Followup: at 6 Months||11
3118786|NCT01611792|3843622|FG001|COMPLETED|Followup: at 6 Months||7
3118787|NCT01611792|3843621|FG000|NOT COMPLETED|Followup: at 6 Months||6
3118788|NCT01611792|3843622|FG001|NOT COMPLETED|Followup: at 6 Months||13
3118789|NCT01611857|3843631|FG000|STARTED|Overall Study|Three dose levels of tivantinib (120 mg, 240 mg, and 360 mg) were evaluated to determine the MTD.|15
3118790|NCT01611857|3843632|FG001|STARTED|Overall Study||34
3118791|NCT01611857|3843631|FG000|Tivantinib 120 mg|Overall Study||5
3118792|NCT01611857|3843632|FG001|Tivantinib 120 mg|Overall Study||0
3118793|NCT01611857|3843631|FG000|Tivantinib 240 mg|Overall Study||3
3118794|NCT01611857|3843632|FG001|Tivantinib 240 mg|Overall Study||0
3118795|NCT01611857|3843631|FG000|Tivantinib 360 mg|Overall Study||7
3118796|NCT01611857|3843632|FG001|Tivantinib 360 mg|Overall Study|Two participants withdrew prior to receiving drug.|32
3118797|NCT01611857|3843631|FG000|COMPLETED|Overall Study||15
3118798|NCT01611857|3843632|FG001|COMPLETED|Overall Study||32
3118799|NCT01611857|3843631|FG000|NOT COMPLETED|Overall Study||0
3118800|NCT01611857|3843632|FG001|NOT COMPLETED|Overall Study||2
3118801|NCT01611935|3843642|FG000|STARTED|Overall Study||50
3118802|NCT01611935|3843643|FG001|STARTED|Overall Study||51
3118803|NCT01611935|3843642|FG000|COMPLETED|Overall Study||49
3118804|NCT01611935|3843643|FG001|COMPLETED|Overall Study||51
3118805|NCT01611935|3843642|FG000|NOT COMPLETED|Overall Study||1
3118806|NCT01611935|3843643|FG001|NOT COMPLETED|Overall Study||0
3118807|NCT01611948|3843651|FG000|STARTED|Overall Study||32
3118808|NCT01611948|3843652|FG001|STARTED|Overall Study||38
3118809|NCT01611948|3843651|FG000|COMPLETED|Overall Study||18
3118810|NCT01611948|3843652|FG001|COMPLETED|Overall Study||26
3118811|NCT01611948|3843651|FG000|NOT COMPLETED|Overall Study||14
3118812|NCT01611948|3843652|FG001|NOT COMPLETED|Overall Study||12
3118813|NCT01611974|3843661|FG000|STARTED|Overall Study||40
3118814|NCT01611974|3843662|FG001|STARTED|Overall Study||40
3118815|NCT01611974|3843663|FG002|STARTED|Overall Study||40
3118816|NCT01611974|3843661|FG000|COMPLETED|Overall Study||25
3118817|NCT01611974|3843662|FG001|COMPLETED|Overall Study||25
3118818|NCT01611974|3843663|FG002|COMPLETED|Overall Study||24
3118819|NCT01611974|3843661|FG000|NOT COMPLETED|Overall Study||15
3118820|NCT01611974|3843662|FG001|NOT COMPLETED|Overall Study||15
3118821|NCT01611974|3843663|FG002|NOT COMPLETED|Overall Study||16
3118822|NCT01612000|3843675|FG000|STARTED|Overall Study||84
3118823|NCT01612000|3843676|FG001|STARTED|Overall Study||86
3118824|NCT01612000|3843677|FG002|STARTED|Overall Study||85
3118825|NCT01612000|3843678|FG003|STARTED|Overall Study||86
3118826|NCT01612000|3843675|FG000|COMPLETED|Overall Study||75
3118827|NCT01612000|3843676|FG001|COMPLETED|Overall Study||81
3118828|NCT01612000|3843677|FG002|COMPLETED|Overall Study||78
3118829|NCT01612000|3843678|FG003|COMPLETED|Overall Study||76
3118830|NCT01612000|3843675|FG000|NOT COMPLETED|Overall Study||9
3118831|NCT01612000|3843676|FG001|NOT COMPLETED|Overall Study||5
3118832|NCT01612000|3843677|FG002|NOT COMPLETED|Overall Study||7
3118833|NCT01612000|3843678|FG003|NOT COMPLETED|Overall Study||10
3118834|NCT01612156|3843690|FG000|STARTED|Overall Study||42
3118835|NCT01612156|3843691|FG001|STARTED|Overall Study||48
3118836|NCT01612156|3843690|FG000|COMPLETED|Overall Study|Contraindication to urodynamics (urinary tract infection) diagnosed after randomization|40
3118837|NCT01612156|3843691|FG001|COMPLETED|Overall Study||48
3118838|NCT01612156|3843690|FG000|NOT COMPLETED|Overall Study||2
3118839|NCT01612156|3843691|FG001|NOT COMPLETED|Overall Study||0
3118840|NCT01612221|3843699|FG000|STARTED|Overall Study||50
3118841|NCT01612221|3843700|FG001|STARTED|Overall Study||50
3118842|NCT01612221|3843699|FG000|COMPLETED|Overall Study||50
3118843|NCT01612221|3843700|FG001|COMPLETED|Overall Study||50
3118844|NCT01612221|3843699|FG000|NOT COMPLETED|Overall Study||0
3118845|NCT01612221|3843700|FG001|NOT COMPLETED|Overall Study||0
3118846|NCT01612494|3843708|FG000|STARTED|Overall Study||21
3118847|NCT01612494|3843709|FG001|STARTED|Overall Study||23
3118848|NCT01612494|3843708|FG000|COMPLETED|Overall Study||21
3118849|NCT01612494|3843709|FG001|COMPLETED|Overall Study||23
3118850|NCT01612494|3843708|FG000|NOT COMPLETED|Overall Study||0
3295042|NCT02894502|4029223|FG001|STARTED|First Follow up||145
3295043|NCT02894502|4029224|FG002|STARTED|First Follow up||133
3295044|NCT02894502|4029222|FG000|COMPLETED|First Follow up||94
3295045|NCT02894502|4029223|FG001|COMPLETED|First Follow up||114
3295046|NCT02894502|4029224|FG002|COMPLETED|First Follow up||93
3295047|NCT02894502|4029222|FG000|NOT COMPLETED|First Follow up||34
3118851|NCT01612494|3843709|FG001|NOT COMPLETED|Overall Study||0
3118852|NCT01612546|3843715|FG000|STARTED|Overall Study||10
3118853|NCT01612546|3843715|FG000|COMPLETED|Overall Study||10
3118854|NCT01612546|3843715|FG000|NOT COMPLETED|Overall Study||0
3118855|NCT01612676|3843723|FG000|STARTED|Overall Study||6
3118856|NCT01612676|3843724|FG001|STARTED|Overall Study||7
3118857|NCT01612676|3843725|FG002|STARTED|Overall Study||5
3118858|NCT01612676|3843726|FG003|STARTED|Overall Study||13
3118859|NCT01612676|3843723|FG000|Dosed|Overall Study||5
3118860|NCT01612676|3843724|FG001|Dosed|Overall Study||7
3118861|NCT01612676|3843725|FG002|Dosed|Overall Study||5
3118862|NCT01612676|3843726|FG003|Dosed|Overall Study||13
3118863|NCT01612676|3843723|FG000|COMPLETED|Overall Study||4
3118864|NCT01612676|3843724|FG001|COMPLETED|Overall Study||3
3118865|NCT01612676|3843725|FG002|COMPLETED|Overall Study||4
3118866|NCT01612676|3843726|FG003|COMPLETED|Overall Study||10
3118867|NCT01612676|3843723|FG000|NOT COMPLETED|Overall Study||2
3118868|NCT01612676|3843724|FG001|NOT COMPLETED|Overall Study||4
3118869|NCT01612676|3843725|FG002|NOT COMPLETED|Overall Study||1
3118870|NCT01612676|3843726|FG003|NOT COMPLETED|Overall Study||3
3118871|NCT01612702|3843740|FG000|STARTED|Overall Study||146
3118872|NCT01612702|3843741|FG001|STARTED|Overall Study||145
3118873|NCT01612702|3843740|FG000|COMPLETED|Overall Study||135
3118874|NCT01612702|3843741|FG001|COMPLETED|Overall Study||134
3118875|NCT01612702|3843740|FG000|NOT COMPLETED|Overall Study||11
3118876|NCT01612702|3843741|FG001|NOT COMPLETED|Overall Study||11
3118877|NCT01612767|3843747|FG000|STARTED|Overall Study||329
3118878|NCT01612767|3843747|FG000|COMPLETED|Overall Study||287
3118879|NCT01612767|3843747|FG000|NOT COMPLETED|Overall Study||42
3118880|NCT01612780|3843772|FG000|STARTED|Overall Study||82
3118881|NCT01612780|3843772|FG000|COMPLETED|Overall Study||76
3118882|NCT01612780|3843772|FG000|NOT COMPLETED|Overall Study||6
3118883|NCT01612793|3843778|FG000|STARTED|Overall Study||2
3118884|NCT01612793|3843779|FG001|STARTED|Overall Study||2
3118885|NCT01612793|3843778|FG000|COMPLETED|Overall Study||2
3118886|NCT01612793|3843779|FG001|COMPLETED|Overall Study||2
3118887|NCT01612793|3843778|FG000|NOT COMPLETED|Overall Study||0
3118888|NCT01612793|3843779|FG001|NOT COMPLETED|Overall Study||0
3118889|NCT01612858|3843787|FG000|STARTED|Overall Study||16
3118890|NCT01612858|3843788|FG001|STARTED|Overall Study||4
3118891|NCT01612858|3843787|FG000|COMPLETED|Overall Study||11
3118892|NCT01612858|3843788|FG001|COMPLETED|Overall Study||3
3118893|NCT01612858|3843787|FG000|NOT COMPLETED|Overall Study||5
3295048|NCT02894502|4029223|FG001|NOT COMPLETED|First Follow up||31
3118894|NCT01612858|3843788|FG001|NOT COMPLETED|Overall Study||1
3118895|NCT01612884|3843796|FG000|STARTED|Overall Study||19
3118896|NCT01612884|3843797|FG001|STARTED|Overall Study||18
3118897|NCT01612884|3843796|FG000|COMPLETED|Overall Study||19
3118898|NCT01612884|3843797|FG001|COMPLETED|Overall Study||18
3118899|NCT01612884|3843796|FG000|NOT COMPLETED|Overall Study||0
3118900|NCT01612884|3843797|FG001|NOT COMPLETED|Overall Study||0
3118901|NCT01613014|3843805|FG000|STARTED|Overall Study||75
3118902|NCT01613014|3843806|FG001|STARTED|Overall Study||75
3118903|NCT01613014|3843805|FG000|COMPLETED|Overall Study||57
3118904|NCT01613014|3843806|FG001|COMPLETED|Overall Study||63
3118905|NCT01613014|3843805|FG000|NOT COMPLETED|Overall Study||18
3118906|NCT01613014|3843806|FG001|NOT COMPLETED|Overall Study||12
3118907|NCT01613027|3843812|FG000|STARTED|Overall Study||135
3118908|NCT01613027|3843812|FG000|COMPLETED|Overall Study||127
3118909|NCT01613027|3843812|FG000|NOT COMPLETED|Overall Study||8
3118910|NCT01613118|3843820|FG000|STARTED|Double-blind||13
3118911|NCT01613118|3843821|FG001|STARTED|Double-blind||26
3118912|NCT01613118|3843822|FG002|STARTED|Double-blind||34
3118913|NCT01613118|3843823|FG003|STARTED|Double-blind||36
3118914|NCT01613118|3843820|FG000|COMPLETED|Double-blind||13
3118915|NCT01613118|3843821|FG001|COMPLETED|Double-blind||23
3118916|NCT01613118|3843822|FG002|COMPLETED|Double-blind||32
3118917|NCT01613118|3843823|FG003|COMPLETED|Double-blind||35
3118918|NCT01613118|3843820|FG000|NOT COMPLETED|Double-blind||0
3118919|NCT01613118|3843821|FG001|NOT COMPLETED|Double-blind||3
3118920|NCT01613118|3843822|FG002|NOT COMPLETED|Double-blind||2
3118921|NCT01613118|3843823|FG003|NOT COMPLETED|Double-blind||1
3118922|NCT01613118|3843820|FG000|STARTED|Open-label Extension|Arm includes subjects from the Irbesartan Arm in the Double-blind period.|21
3118923|NCT01613118|3843821|FG001|STARTED|Open-label Extension|Arm includes subjects from the Irbesartan Arm in the Double-blind period.|42
3118924|NCT01613118|3843822|FG002|STARTED|Open-label Extension|Arm includes subjects from the Irbesartan Arm in the Double-blind period.|40
3118925|NCT01613118|3843823|FG003|STARTED|Open-label Extension||0
3118926|NCT01613118|3843820|FG000|COMPLETED|Open-label Extension|OLE ongoing|0
3118927|NCT01613118|3843821|FG001|COMPLETED|Open-label Extension|OLE ongoing|0
3118928|NCT01613118|3843822|FG002|COMPLETED|Open-label Extension|OLE ongoing|0
3118929|NCT01613118|3843823|FG003|COMPLETED|Open-label Extension||0
3118930|NCT01613118|3843820|FG000|NOT COMPLETED|Open-label Extension||21
3118931|NCT01613118|3843821|FG001|NOT COMPLETED|Open-label Extension||42
3118932|NCT01613118|3843822|FG002|NOT COMPLETED|Open-label Extension||40
3118933|NCT01613118|3843823|FG003|NOT COMPLETED|Open-label Extension||0
3118934|NCT01613131|3843836|FG000|STARTED|Overall Study||20
3118935|NCT01613131|3843837|FG001|STARTED|Overall Study||18
3118936|NCT01613131|3843836|FG000|COMPLETED|Overall Study||17
3118937|NCT01613131|3843837|FG001|COMPLETED|Overall Study||13
3118938|NCT01613131|3843836|FG000|NOT COMPLETED|Overall Study||3
3118939|NCT01613131|3843837|FG001|NOT COMPLETED|Overall Study||5
3118940|NCT01613222|3843843|FG000|STARTED|Overall Study||63
3118941|NCT01613222|3843843|FG000|COMPLETED|Overall Study||51
3118942|NCT01613222|3843843|FG000|NOT COMPLETED|Overall Study||12
3118943|NCT01613248|3843862|FG000|STARTED|Overall Study||139
3118944|NCT01613248|3843863|FG001|STARTED|Overall Study||138
3118945|NCT01613248|3843864|FG002|STARTED|Overall Study||139
3118946|NCT01613248|3843865|FG003|STARTED|Overall Study||139
3118947|NCT01613248|3843866|FG004|STARTED|Overall Study||139
3118948|NCT01613248|3843867|FG005|STARTED|Overall Study||140
3118949|NCT01613248|3843862|FG000|COMPLETED|Overall Study||110
3118950|NCT01613248|3843863|FG001|COMPLETED|Overall Study||104
3118951|NCT01613248|3843864|FG002|COMPLETED|Overall Study||106
3118952|NCT01613248|3843865|FG003|COMPLETED|Overall Study||101
3118953|NCT01613248|3843866|FG004|COMPLETED|Overall Study||104
3118954|NCT01613248|3843867|FG005|COMPLETED|Overall Study||102
3118955|NCT01613248|3843862|FG000|NOT COMPLETED|Overall Study||29
3118956|NCT01613248|3843863|FG001|NOT COMPLETED|Overall Study||34
3118957|NCT01613248|3843864|FG002|NOT COMPLETED|Overall Study||33
3118958|NCT01613248|3843865|FG003|NOT COMPLETED|Overall Study||38
3118959|NCT01613248|3843866|FG004|NOT COMPLETED|Overall Study||35
3118960|NCT01613248|3843867|FG005|NOT COMPLETED|Overall Study||38
3118961|NCT01613313|3843885|FG000|STARTED|Overall Study||2
3118962|NCT01613313|3843886|FG001|STARTED|Overall Study||4
3118963|NCT01613313|3843887|FG002|STARTED|Overall Study||4
3118964|NCT01613313|3843888|FG003|STARTED|Overall Study||4
3118965|NCT01613313|3843885|FG000|COMPLETED|Overall Study||2
3118966|NCT01613313|3843886|FG001|COMPLETED|Overall Study||4
3118967|NCT01613313|3843887|FG002|COMPLETED|Overall Study||4
3118968|NCT01613313|3843888|FG003|COMPLETED|Overall Study||4
3118969|NCT01613313|3843885|FG000|NOT COMPLETED|Overall Study||0
3118970|NCT01613313|3843886|FG001|NOT COMPLETED|Overall Study||0
3118971|NCT01613313|3843887|FG002|NOT COMPLETED|Overall Study||0
3118972|NCT01613313|3843888|FG003|NOT COMPLETED|Overall Study||0
3118973|NCT01613326|3843900|FG000|STARTED|Overall Study||327
3118974|NCT01613326|3843901|FG001|STARTED|Overall Study||330
3118975|NCT01613326|3843900|FG000|COMPLETED|Overall Study||314
3118976|NCT01613326|3843901|FG001|COMPLETED|Overall Study||316
3118977|NCT01613326|3843900|FG000|NOT COMPLETED|Overall Study||13
3118978|NCT01613326|3843901|FG001|NOT COMPLETED|Overall Study||14
3118979|NCT01613339|3843909|FG000|STARTED|Overall Study||24
3118980|NCT01613339|3843910|FG001|STARTED|Overall Study||22
3118981|NCT01613339|3843909|FG000|COMPLETED|Overall Study||21
3295049|NCT02894502|4029224|FG002|NOT COMPLETED|First Follow up||40
3295050|NCT02894502|4029222|FG000|STARTED|Second Follow up||94
3295051|NCT02894502|4029223|FG001|STARTED|Second Follow up||114
3295052|NCT02894502|4029224|FG002|STARTED|Second Follow up||93
3295053|NCT02894502|4029222|FG000|COMPLETED|Second Follow up||79
3118982|NCT01613339|3843910|FG001|COMPLETED|Overall Study||21
3118983|NCT01613339|3843909|FG000|NOT COMPLETED|Overall Study||3
3118984|NCT01613339|3843910|FG001|NOT COMPLETED|Overall Study||1
3118985|NCT01613378|3843915|FG000|STARTED|Overall Study||200
3118986|NCT01613378|3843915|FG000|COMPLETED|Overall Study||161
3118987|NCT01613378|3843915|FG000|NOT COMPLETED|Overall Study||39
3118988|NCT01613417|3843921|FG000|STARTED|First Injection||113
3118989|NCT01613417|3843922|FG001|STARTED|First Injection||116
3118990|NCT01613417|3843921|FG000|COMPLETED|First Injection||113
3118991|NCT01613417|3843922|FG001|COMPLETED|First Injection||116
3118992|NCT01613417|3843921|FG000|NOT COMPLETED|First Injection||0
3118993|NCT01613417|3843922|FG001|NOT COMPLETED|First Injection||0
3118994|NCT01613417|3843921|FG000|STARTED|Washout (no Second Injection/MRI)||113
3118995|NCT01613417|3843922|FG001|STARTED|Washout (no Second Injection/MRI)||116
3118996|NCT01613417|3843921|FG000|COMPLETED|Washout (no Second Injection/MRI)||100
3118997|NCT01613417|3843922|FG001|COMPLETED|Washout (no Second Injection/MRI)||109
3118998|NCT01613417|3843921|FG000|NOT COMPLETED|Washout (no Second Injection/MRI)||13
3118999|NCT01613417|3843922|FG001|NOT COMPLETED|Washout (no Second Injection/MRI)||7
3119000|NCT01613417|3843921|FG000|STARTED|Second Injection||100
3119001|NCT01613417|3843922|FG001|STARTED|Second Injection||109
3119002|NCT01613417|3843921|FG000|COMPLETED|Second Injection||100
3119003|NCT01613417|3843922|FG001|COMPLETED|Second Injection||109
3119004|NCT01613417|3843921|FG000|NOT COMPLETED|Second Injection||0
3119005|NCT01613417|3843922|FG001|NOT COMPLETED|Second Injection||0
3119006|NCT01613599|3843938|FG000|STARTED|Overall Study||97
3119007|NCT01613599|3843938|FG000|COMPLETED|Overall Study||72
3119008|NCT01613599|3843938|FG000|NOT COMPLETED|Overall Study||25
3119009|NCT01613716|3843942|FG000|STARTED|Overall Study||30
3119010|NCT01613716|3843942|FG000|COMPLETED|Overall Study||23
3119011|NCT01613716|3843942|FG000|NOT COMPLETED|Overall Study||7
3119012|NCT01613768|3843946|FG000|STARTED|Overall Study||29
3119013|NCT01613768|3843946|FG000|COMPLETED|Overall Study||29
3119014|NCT01613768|3843946|FG000|NOT COMPLETED|Overall Study||0
3119015|NCT01614093|3843951|FG000|STARTED|Overall Study||17
3119016|NCT01614093|3843951|FG000|COMPLETED|Overall Study||16
3119017|NCT01614093|3843951|FG000|NOT COMPLETED|Overall Study||1
3119018|NCT01614210|3843956|FG000|STARTED|Overall Study||52
3119019|NCT01614210|3843956|FG000|COMPLETED|Overall Study||52
3119020|NCT01614210|3843956|FG000|NOT COMPLETED|Overall Study||0
3119021|NCT01614249|3843962|FG000|STARTED|Overall Study|Participants received every two-weeks supply and monitored regularly on cell-phone and face-to-face.|107
3119022|NCT01614249|3843963|FG001|STARTED|Overall Study|Participants received every two-week supply and monitored regularly on cell-phone and face-to-face.|109
3119023|NCT01614249|3843962|FG000|At Week-4|Overall Study|Participants received every two-week supply and monitored regularly on cell-phone and face-to-face.|98
3119024|NCT01614249|3843963|FG001|At Week-4|Overall Study|Participants received every two-week supply and monitored regularly on cell-phone and face-to-face.|92
3119025|NCT01614249|3843962|FG000|At Week-8 (End of Study Period)|Overall Study|End of study data collected for all participants who completed the 8-week trial period.|96
3119026|NCT01614249|3843963|FG001|At Week-8 (End of Study Period)|Overall Study|End of study data collected for all participants who completed the 8-week trial period.|86
3119027|NCT01614249|3843962|FG000|COMPLETED|Overall Study|End of study data analyzed for only participants who completed the 8-week trial period.|96
3119028|NCT01614249|3843963|FG001|COMPLETED|Overall Study|End of study data analyzed for only participants who completed the 8-week trial period.|86
3119029|NCT01614249|3843962|FG000|NOT COMPLETED|Overall Study||11
3295054|NCT02894502|4029223|FG001|COMPLETED|Second Follow up||96
3295055|NCT02894502|4029224|FG002|COMPLETED|Second Follow up||79
3295056|NCT02894502|4029222|FG000|NOT COMPLETED|Second Follow up||15
3295057|NCT02894502|4029223|FG001|NOT COMPLETED|Second Follow up||18
3119030|NCT01614249|3843963|FG001|NOT COMPLETED|Overall Study||23
3119031|NCT01614392|3843971|FG000|STARTED|Overall Study||25
3119032|NCT01614392|3843972|FG001|STARTED|Overall Study||27
3119033|NCT01614392|3843971|FG000|COMPLETED|Overall Study||24
3119034|NCT01614392|3843972|FG001|COMPLETED|Overall Study||24
3119035|NCT01614392|3843971|FG000|NOT COMPLETED|Overall Study||1
3119036|NCT01614392|3843972|FG001|NOT COMPLETED|Overall Study||3
3119037|NCT01614457|3843980|FG000|STARTED|Overall Study||34
3119038|NCT01614457|3843981|FG001|STARTED|Overall Study||35
3119039|NCT01614457|3843980|FG000|COMPLETED|Overall Study||32
3119040|NCT01614457|3843981|FG001|COMPLETED|Overall Study||35
3119041|NCT01614457|3843980|FG000|NOT COMPLETED|Overall Study||2
3119042|NCT01614457|3843981|FG001|NOT COMPLETED|Overall Study||0
3119043|NCT01614470|3843989|FG000|STARTED|Part 1: Treatment Period 1 (8 Weeks)||20
3119044|NCT01614470|3843990|FG001|STARTED|Part 1: Treatment Period 1 (8 Weeks)||19
3119045|NCT01614470|3843991|FG002|STARTED|Part 1: Treatment Period 1 (8 Weeks)||0
3119046|NCT01614470|3843989|FG000|COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||18
3119047|NCT01614470|3843990|FG001|COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||18
3119048|NCT01614470|3843991|FG002|COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||0
3119049|NCT01614470|3843989|FG000|NOT COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||2
3119050|NCT01614470|3843990|FG001|NOT COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||1
3119051|NCT01614470|3843991|FG002|NOT COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||0
3119052|NCT01614470|3843989|FG000|STARTED|Part 1: Washout Period (4 to 8 Weeks)||18
3119053|NCT01614470|3843990|FG001|STARTED|Part 1: Washout Period (4 to 8 Weeks)||18
3119054|NCT01614470|3843991|FG002|STARTED|Part 1: Washout Period (4 to 8 Weeks)||0
3119055|NCT01614470|3843989|FG000|COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||18
3119056|NCT01614470|3843990|FG001|COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||18
3119057|NCT01614470|3843991|FG002|COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||0
3119058|NCT01614470|3843989|FG000|NOT COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||0
3119059|NCT01614470|3843990|FG001|NOT COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||0
3119060|NCT01614470|3843991|FG002|NOT COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||0
3119061|NCT01614470|3843989|FG000|STARTED|Part 1: Treatment Period 2 (8 Weeks)||18
3119062|NCT01614470|3843990|FG001|STARTED|Part 1: Treatment Period 2 (8 Weeks)||18
3295058|NCT02894502|4029224|FG002|NOT COMPLETED|Second Follow up||14
3295059|NCT02894502|4029222|FG000|STARTED|Third Follow up||79
3119063|NCT01614470|3843991|FG002|STARTED|Part 1: Treatment Period 2 (8 Weeks)||0
3119064|NCT01614470|3843989|FG000|COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||18
3119065|NCT01614470|3843990|FG001|COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||18
3119066|NCT01614470|3843991|FG002|COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||0
3119067|NCT01614470|3843989|FG000|NOT COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||0
3119068|NCT01614470|3843990|FG001|NOT COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||0
3119069|NCT01614470|3843991|FG002|NOT COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||0
3119070|NCT01614470|3843989|FG000|STARTED|Part 2: Open-label Period (16 Weeks)||0
3119071|NCT01614470|3843990|FG001|STARTED|Part 2: Open-label Period (16 Weeks)||0
3119072|NCT01614470|3843991|FG002|STARTED|Part 2: Open-label Period (16 Weeks)||36
3119073|NCT01614470|3843989|FG000|COMPLETED|Part 2: Open-label Period (16 Weeks)||0
3119074|NCT01614470|3843990|FG001|COMPLETED|Part 2: Open-label Period (16 Weeks)||0
3119075|NCT01614470|3843991|FG002|COMPLETED|Part 2: Open-label Period (16 Weeks)||36
3119076|NCT01614470|3843989|FG000|NOT COMPLETED|Part 2: Open-label Period (16 Weeks)||0
3119077|NCT01614470|3843990|FG001|NOT COMPLETED|Part 2: Open-label Period (16 Weeks)||0
3119078|NCT01614470|3843991|FG002|NOT COMPLETED|Part 2: Open-label Period (16 Weeks)||0
3119079|NCT01614509|3844002|FG000|STARTED|Overall Study||24
3119080|NCT01614509|3844003|FG001|STARTED|Overall Study||21
3119081|NCT01614509|3844002|FG000|COMPLETED|Overall Study||23
3119082|NCT01614509|3844003|FG001|COMPLETED|Overall Study||18
3119083|NCT01614509|3844002|FG000|NOT COMPLETED|Overall Study||1
3119084|NCT01614509|3844003|FG001|NOT COMPLETED|Overall Study||3
3136099|NCT01710358|3861198|FG000|Received at Least 1 Dose of Study Drug|Treatment Period Part B (Weeks 24 to 52)|Participants originally randomized to placebo received baricitinib during Part B.|306
3136100|NCT01710358|3861199|FG001|Received at Least 1 Dose of Study Drug|Treatment Period Part B (Weeks 24 to 52)||424
3136101|NCT01710358|3861200|FG002|Received at Least 1 Dose of Study Drug|Treatment Period Part B (Weeks 24 to 52)||267
3136102|NCT01710358|3861198|FG000|Rescued|Treatment Period Part B (Weeks 24 to 52)||5
3136103|NCT01710358|3861199|FG001|Rescued|Treatment Period Part B (Weeks 24 to 52)||8
3136104|NCT01710358|3861200|FG002|Rescued|Treatment Period Part B (Weeks 24 to 52)||11
3136105|NCT01710358|3861198|FG000|COMPLETED|Treatment Period Part B (Weeks 24 to 52)|Includes all participants rescued during Part B.|294
3136106|NCT01710358|3861199|FG001|COMPLETED|Treatment Period Part B (Weeks 24 to 52)|Includes all participants rescued during Part B.|402
3136107|NCT01710358|3861200|FG002|COMPLETED|Treatment Period Part B (Weeks 24 to 52)|Includes all participants rescued during Part B.|252
3136108|NCT01710358|3861198|FG000|NOT COMPLETED|Treatment Period Part B (Weeks 24 to 52)||16
3136109|NCT01710358|3861199|FG001|NOT COMPLETED|Treatment Period Part B (Weeks 24 to 52)||22
3136110|NCT01710358|3861200|FG002|NOT COMPLETED|Treatment Period Part B (Weeks 24 to 52)||15
3136111|NCT01710358|3861198|FG000|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
3136112|NCT01710358|3861199|FG001|STARTED|Rescue Period|Baricitinib 4 mg administered PO QD through Week 52. Participants continued background MTX therapy.|227
3136113|NCT01710358|3861200|FG002|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
3136114|NCT01710358|3861198|FG000|COMPLETED|Rescue Period||0
3136115|NCT01710358|3861199|FG001|COMPLETED|Rescue Period||196
3136116|NCT01710358|3861200|FG002|COMPLETED|Rescue Period||0
3136117|NCT01710358|3861198|FG000|NOT COMPLETED|Rescue Period||0
3136118|NCT01710358|3861199|FG001|NOT COMPLETED|Rescue Period||31
3136119|NCT01710358|3861200|FG002|NOT COMPLETED|Rescue Period||0
3136120|NCT01710358|3861198|FG000|STARTED|Follow-up Period|Participants from treatment who entered the post-treatment follow-up period.|33
3136121|NCT01710358|3861199|FG001|STARTED|Follow-up Period|Rescued participants who entered post-treatment follow-up are included in Baricitinib 4mg follow up.|76
3136122|NCT01710358|3861200|FG002|STARTED|Follow-up Period|Participants from treatment who entered the post-treatment follow-up period.|20
3136123|NCT01710358|3861198|FG000|COMPLETED|Follow-up Period||33
3136124|NCT01710358|3861199|FG001|COMPLETED|Follow-up Period||76
3136125|NCT01710358|3861200|FG002|COMPLETED|Follow-up Period||20
3136126|NCT01710358|3861198|FG000|NOT COMPLETED|Follow-up Period||0
3136127|NCT01710358|3861199|FG001|NOT COMPLETED|Follow-up Period||0
3136128|NCT01710358|3861200|FG002|NOT COMPLETED|Follow-up Period||0
3136129|NCT01710501|3861224|FG000|STARTED|Overall Study||29
3136130|NCT01710501|3861225|FG001|STARTED|Overall Study||28
3136131|NCT01710501|3861226|FG002|STARTED|Overall Study||30
3136132|NCT01710501|3861224|FG000|COMPLETED|Overall Study||27
3136133|NCT01710501|3861225|FG001|COMPLETED|Overall Study||28
3136134|NCT01710501|3861226|FG002|COMPLETED|Overall Study||30
3136135|NCT01710501|3861224|FG000|NOT COMPLETED|Overall Study||2
3136136|NCT01710501|3861225|FG001|NOT COMPLETED|Overall Study||0
3136137|NCT01710501|3861226|FG002|NOT COMPLETED|Overall Study||0
3136138|NCT01710514|3861236|FG000|STARTED|Overall Study||54
3136139|NCT01710514|3861237|FG001|STARTED|Overall Study||54
3136140|NCT01710514|3861236|FG000|Intent-To-Treat (ITT) Analysis Set|Overall Study|All randomised subjects were included in the Intent-To-Treat (ITT) analysis set.|54
3136141|NCT01710514|3861237|FG001|Intent-To-Treat (ITT) Analysis Set|Overall Study|All randomised subjects were included in the ITT analysis set.|54
3136142|NCT01710514|3861236|FG000|Full Analysis Set (FAS)|Overall Study|All randomised and exposed subjects with at least one completed primary efficacy assessment.|46
3136143|NCT01710514|3861237|FG001|Full Analysis Set (FAS)|Overall Study|All randomised and exposed subjects with at least one completed primary efficacy assessment.|48
3136144|NCT01710514|3861236|FG000|FAS With Embryo Transfer (ET)|Overall Study|Data on pregnancy was reported for the subjects with embryo transfer.|43
3119085|NCT01614574|3844009|FG000|STARTED|Overall Study||6
3119086|NCT01614574|3844009|FG000|COMPLETED|Overall Study||6
3119087|NCT01614574|3844009|FG000|NOT COMPLETED|Overall Study||0
3119088|NCT01614600|3844013|FG000|STARTED|Overall Study||88
3119089|NCT01614600|3844013|FG000|COMPLETED|Overall Study||84
3119090|NCT01614600|3844013|FG000|NOT COMPLETED|Overall Study||4
3119091|NCT01614613|3844017|FG000|STARTED|Overall Study||146
3119092|NCT01614613|3844017|FG000|COMPLETED|Overall Study||146
3119093|NCT01614613|3844017|FG000|NOT COMPLETED|Overall Study||0
3119094|NCT01614743|3844024|FG000|STARTED|Overall Study||4
3119095|NCT01614743|3844025|FG001|STARTED|Overall Study||5
3119096|NCT01614743|3844024|FG000|COMPLETED|Overall Study||3
3119097|NCT01614743|3844025|FG001|COMPLETED|Overall Study|Subject in the placebo group (5) also received the treatment (IncobotulinumtoxinA) at Visit 5.|5
3119098|NCT01614743|3844024|FG000|NOT COMPLETED|Overall Study||1
3119099|NCT01614743|3844025|FG001|NOT COMPLETED|Overall Study||0
3119100|NCT01614769|3844031|FG000|STARTED|Period 1||2
3119101|NCT01614769|3844032|FG001|STARTED|Period 1||1
3119102|NCT01614769|3844033|FG002|STARTED|Period 1||2
3119103|NCT01614769|3844034|FG003|STARTED|Period 1||2
3119104|NCT01614769|3844035|FG004|STARTED|Period 1||1
3119105|NCT01614769|3844036|FG005|STARTED|Period 1||2
3119106|NCT01614769|3844031|FG000|COMPLETED|Period 1||1
3119107|NCT01614769|3844032|FG001|COMPLETED|Period 1||1
3119108|NCT01614769|3844033|FG002|COMPLETED|Period 1||2
3119109|NCT01614769|3844034|FG003|COMPLETED|Period 1||0
3119110|NCT01614769|3844035|FG004|COMPLETED|Period 1||1
3119111|NCT01614769|3844036|FG005|COMPLETED|Period 1||1
3119112|NCT01614769|3844031|FG000|NOT COMPLETED|Period 1||1
3119113|NCT01614769|3844032|FG001|NOT COMPLETED|Period 1||0
3119114|NCT01614769|3844033|FG002|NOT COMPLETED|Period 1||0
3119115|NCT01614769|3844034|FG003|NOT COMPLETED|Period 1||2
3119116|NCT01614769|3844035|FG004|NOT COMPLETED|Period 1||0
3119117|NCT01614769|3844036|FG005|NOT COMPLETED|Period 1||1
3119118|NCT01614769|3844031|FG000|STARTED|7-Day Washout||1
3119119|NCT01614769|3844032|FG001|STARTED|7-Day Washout||1
3119120|NCT01614769|3844033|FG002|STARTED|7-Day Washout||2
3119121|NCT01614769|3844034|FG003|STARTED|7-Day Washout||0
3119122|NCT01614769|3844035|FG004|STARTED|7-Day Washout||1
3119123|NCT01614769|3844036|FG005|STARTED|7-Day Washout||1
3119124|NCT01614769|3844031|FG000|COMPLETED|7-Day Washout||1
3119125|NCT01614769|3844032|FG001|COMPLETED|7-Day Washout||1
3119126|NCT01614769|3844033|FG002|COMPLETED|7-Day Washout||2
3119127|NCT01614769|3844034|FG003|COMPLETED|7-Day Washout||0
3119128|NCT01614769|3844035|FG004|COMPLETED|7-Day Washout||1
3119129|NCT01614769|3844036|FG005|COMPLETED|7-Day Washout||1
3119130|NCT01614769|3844031|FG000|NOT COMPLETED|7-Day Washout||0
3119131|NCT01614769|3844032|FG001|NOT COMPLETED|7-Day Washout||0
3119132|NCT01614769|3844033|FG002|NOT COMPLETED|7-Day Washout||0
3119133|NCT01614769|3844034|FG003|NOT COMPLETED|7-Day Washout||0
3119134|NCT01614769|3844035|FG004|NOT COMPLETED|7-Day Washout||0
3119135|NCT01614769|3844036|FG005|NOT COMPLETED|7-Day Washout||0
3119136|NCT01614769|3844031|FG000|STARTED|Period 2||1
3119137|NCT01614769|3844032|FG001|STARTED|Period 2||1
3119138|NCT01614769|3844033|FG002|STARTED|Period 2||2
3119139|NCT01614769|3844034|FG003|STARTED|Period 2||0
3119140|NCT01614769|3844035|FG004|STARTED|Period 2||1
3119141|NCT01614769|3844036|FG005|STARTED|Period 2||1
3119142|NCT01614769|3844031|FG000|COMPLETED|Period 2||1
3119143|NCT01614769|3844032|FG001|COMPLETED|Period 2||1
3119144|NCT01614769|3844033|FG002|COMPLETED|Period 2||2
3119145|NCT01614769|3844034|FG003|COMPLETED|Period 2||0
3119146|NCT01614769|3844035|FG004|COMPLETED|Period 2||1
3119147|NCT01614769|3844036|FG005|COMPLETED|Period 2||1
3119148|NCT01614769|3844031|FG000|NOT COMPLETED|Period 2||0
3119149|NCT01614769|3844032|FG001|NOT COMPLETED|Period 2||0
3119150|NCT01614769|3844033|FG002|NOT COMPLETED|Period 2||0
3119151|NCT01614769|3844034|FG003|NOT COMPLETED|Period 2||0
3119152|NCT01614769|3844035|FG004|NOT COMPLETED|Period 2||0
3119153|NCT01614769|3844036|FG005|NOT COMPLETED|Period 2||0
3119154|NCT01614769|3844031|FG000|STARTED|7-Day Washout||1
3119155|NCT01614769|3844032|FG001|STARTED|7-Day Washout||1
3119156|NCT01614769|3844033|FG002|STARTED|7-Day Washout||2
3119157|NCT01614769|3844034|FG003|STARTED|7-Day Washout||0
3119158|NCT01614769|3844035|FG004|STARTED|7-Day Washout||1
3119159|NCT01614769|3844036|FG005|STARTED|7-Day Washout||1
3119160|NCT01614769|3844031|FG000|COMPLETED|7-Day Washout||1
3119161|NCT01614769|3844032|FG001|COMPLETED|7-Day Washout||1
3119162|NCT01614769|3844033|FG002|COMPLETED|7-Day Washout||2
3119163|NCT01614769|3844034|FG003|COMPLETED|7-Day Washout||0
3119164|NCT01614769|3844035|FG004|COMPLETED|7-Day Washout||1
3119165|NCT01614769|3844036|FG005|COMPLETED|7-Day Washout||1
3119166|NCT01614769|3844031|FG000|NOT COMPLETED|7-Day Washout||0
3119167|NCT01614769|3844032|FG001|NOT COMPLETED|7-Day Washout||0
3119168|NCT01614769|3844033|FG002|NOT COMPLETED|7-Day Washout||0
3119169|NCT01614769|3844034|FG003|NOT COMPLETED|7-Day Washout||0
3119170|NCT01614769|3844035|FG004|NOT COMPLETED|7-Day Washout||0
3119171|NCT01614769|3844036|FG005|NOT COMPLETED|7-Day Washout||0
3119172|NCT01614769|3844031|FG000|STARTED|Period 3||1
3119173|NCT01614769|3844032|FG001|STARTED|Period 3||1
3119174|NCT01614769|3844033|FG002|STARTED|Period 3||2
3119175|NCT01614769|3844034|FG003|STARTED|Period 3||0
3119176|NCT01614769|3844035|FG004|STARTED|Period 3||1
3119177|NCT01614769|3844036|FG005|STARTED|Period 3||1
3119178|NCT01614769|3844031|FG000|COMPLETED|Period 3||1
3119179|NCT01614769|3844032|FG001|COMPLETED|Period 3||1
3119180|NCT01614769|3844033|FG002|COMPLETED|Period 3||1
3119181|NCT01614769|3844034|FG003|COMPLETED|Period 3||0
3119182|NCT01614769|3844035|FG004|COMPLETED|Period 3||1
3119183|NCT01614769|3844036|FG005|COMPLETED|Period 3||1
3119184|NCT01614769|3844031|FG000|NOT COMPLETED|Period 3||0
3119185|NCT01614769|3844032|FG001|NOT COMPLETED|Period 3||0
3119186|NCT01614769|3844033|FG002|NOT COMPLETED|Period 3||1
3295060|NCT02894502|4029223|FG001|STARTED|Third Follow up||96
3295061|NCT02894502|4029224|FG002|STARTED|Third Follow up||79
3295062|NCT02894502|4029222|FG000|COMPLETED|Third Follow up||73
3295063|NCT02894502|4029223|FG001|COMPLETED|Third Follow up||89
3295064|NCT02894502|4029224|FG002|COMPLETED|Third Follow up||76
3119187|NCT01614769|3844034|FG003|NOT COMPLETED|Period 3||0
3119188|NCT01614769|3844035|FG004|NOT COMPLETED|Period 3||0
3119189|NCT01614769|3844036|FG005|NOT COMPLETED|Period 3||0
3119190|NCT01614795|3844048|FG000|STARTED|Overall Study||11
3119191|NCT01614795|3844049|FG001|STARTED|Overall Study||12
3119192|NCT01614795|3844050|FG002|STARTED|Overall Study||11
3119193|NCT01614795|3844051|FG003|STARTED|Overall Study||12
3119194|NCT01614795|3844048|FG000|COMPLETED|Overall Study||0
3119195|NCT01614795|3844049|FG001|COMPLETED|Overall Study||0
3119196|NCT01614795|3844050|FG002|COMPLETED|Overall Study||0
3119197|NCT01614795|3844051|FG003|COMPLETED|Overall Study||0
3119198|NCT01614795|3844048|FG000|NOT COMPLETED|Overall Study||11
3119199|NCT01614795|3844049|FG001|NOT COMPLETED|Overall Study||12
3119200|NCT01614795|3844050|FG002|NOT COMPLETED|Overall Study||11
3119201|NCT01614795|3844051|FG003|NOT COMPLETED|Overall Study||12
3119202|NCT01614821|3844062|FG000|STARTED|Overall Study||63
3119203|NCT01614821|3844062|FG000|COMPLETED|Overall Study||63
3119204|NCT01614821|3844062|FG000|NOT COMPLETED|Overall Study||0
3119205|NCT01614847|3844068|FG000|STARTED|Day 1|Four subjects chosen at random received Drop A (hyaluronate) during Day 1.|4
3119206|NCT01614847|3844069|FG001|STARTED|Day 1|The other 4 subjects, not to Group 1, received Drop B (saline) on Day 1.|4
3119207|NCT01614847|3844068|FG000|COMPLETED|Day 1||4
3119208|NCT01614847|3844069|FG001|COMPLETED|Day 1|See Arm 1 comments.|4
3119209|NCT01614847|3844068|FG000|NOT COMPLETED|Day 1||0
3119210|NCT01614847|3844069|FG001|NOT COMPLETED|Day 1||0
3119211|NCT01614847|3844068|FG000|STARTED|Day 2 (24 Hours Later)|On Day 2, these subject will received Drop B (normal saline).|4
3119212|NCT01614847|3844069|FG001|STARTED|Day 2 (24 Hours Later)|On Day 2, these subjects received Drop A (hyaluronate).|4
3119213|NCT01614847|3844068|FG000|COMPLETED|Day 2 (24 Hours Later)||4
3119214|NCT01614847|3844069|FG001|COMPLETED|Day 2 (24 Hours Later)||4
3119215|NCT01614847|3844068|FG000|NOT COMPLETED|Day 2 (24 Hours Later)||0
3119216|NCT01614847|3844069|FG001|NOT COMPLETED|Day 2 (24 Hours Later)||0
3119217|NCT01614886|3844082|FG000|STARTED|Overall Study||107
3119218|NCT01614886|3844083|FG001|STARTED|Overall Study||109
3119219|NCT01614886|3844082|FG000|Safety Population (SAF)|Overall Study||107
3119220|NCT01614886|3844083|FG001|Safety Population (SAF)|Overall Study||108
3119221|NCT01614886|3844082|FG000|Full Analysis Set (FAS)|Overall Study||104
3119222|NCT01614886|3844083|FG001|Full Analysis Set (FAS)|Overall Study||105
3119223|NCT01614886|3844082|FG000|COMPLETED|Overall Study||87
3119224|NCT01614886|3844083|FG001|COMPLETED|Overall Study||83
3119225|NCT01614886|3844082|FG000|NOT COMPLETED|Overall Study||20
3119226|NCT01614886|3844083|FG001|NOT COMPLETED|Overall Study||26
3119227|NCT01614899|3844092|FG000|STARTED|Overall Study||150
3119228|NCT01614899|3844093|FG001|STARTED|Overall Study||155
3119229|NCT01614899|3844094|FG002|STARTED|Overall Study||152
3119230|NCT01614899|3844092|FG000|COMPLETED|Overall Study||106
3119231|NCT01614899|3844093|FG001|COMPLETED|Overall Study||116
3119232|NCT01614899|3844094|FG002|COMPLETED|Overall Study||110
3119233|NCT01614899|3844092|FG000|NOT COMPLETED|Overall Study||44
3119234|NCT01614899|3844093|FG001|NOT COMPLETED|Overall Study||39
3119235|NCT01614899|3844094|FG002|NOT COMPLETED|Overall Study||42
3119236|NCT01614912|3844102|FG000|STARTED|Overall Study||284
3119237|NCT01614912|3844102|FG000|COMPLETED|Overall Study||159
3119238|NCT01614912|3844102|FG000|NOT COMPLETED|Overall Study||125
3119239|NCT01614925|3844108|FG000|STARTED|Overall Study||18
3119240|NCT01614925|3844109|FG001|STARTED|Overall Study||17
3119241|NCT01614925|3844108|FG000|COMPLETED|Overall Study||14
3119242|NCT01614925|3844109|FG001|COMPLETED|Overall Study||15
3119243|NCT01614925|3844108|FG000|NOT COMPLETED|Overall Study||4
3119244|NCT01614925|3844109|FG001|NOT COMPLETED|Overall Study||2
3119245|NCT01615120|3844117|FG000|STARTED|Overall Study||38
3119246|NCT01615120|3844118|FG001|STARTED|Overall Study||39
3119247|NCT01615120|3844117|FG000|COMPLETED|Overall Study||23
3119248|NCT01615120|3844118|FG001|COMPLETED|Overall Study||19
3119249|NCT01615120|3844117|FG000|NOT COMPLETED|Overall Study||15
3119250|NCT01615120|3844118|FG001|NOT COMPLETED|Overall Study||20
3119251|NCT01615198|3844126|FG000|STARTED|Overall Study||296
3119252|NCT01615198|3844127|FG001|STARTED|Overall Study||292
3119253|NCT01615198|3844126|FG000|Full Analysis Set|Overall Study||296
3119254|NCT01615198|3844127|FG001|Full Analysis Set|Overall Study||292
3119255|NCT01615198|3844126|FG000|Ambulatory BP Monitoring (ABPM) Subset|Overall Study||154
3119256|NCT01615198|3844127|FG001|Ambulatory BP Monitoring (ABPM) Subset|Overall Study||157
3119257|NCT01615198|3844126|FG000|Safety Set|Overall Study||296
3119258|NCT01615198|3844127|FG001|Safety Set|Overall Study||292
3119259|NCT01615198|3844126|FG000|ABPM Dipper Status Subset|Overall Study||82
3119260|NCT01615198|3844127|FG001|ABPM Dipper Status Subset|Overall Study||84
3119261|NCT01615198|3844126|FG000|COMPLETED|Overall Study||272
3119262|NCT01615198|3844127|FG001|COMPLETED|Overall Study||273
3119263|NCT01615198|3844126|FG000|NOT COMPLETED|Overall Study||24
3295065|NCT02894502|4029222|FG000|NOT COMPLETED|Third Follow up||6
3119264|NCT01615198|3844127|FG001|NOT COMPLETED|Overall Study||19
3119265|NCT01615263|3844135|FG000|STARTED|Overall Study||20
3119266|NCT01615263|3844136|FG001|STARTED|Overall Study||20
3119267|NCT01615263|3844135|FG000|COMPLETED|Overall Study||20
3119268|NCT01615263|3844136|FG001|COMPLETED|Overall Study||18
3119269|NCT01615263|3844135|FG000|NOT COMPLETED|Overall Study||0
3119270|NCT01615263|3844136|FG001|NOT COMPLETED|Overall Study||2
3119271|NCT01615328|3844144|FG000|STARTED|Overall Study||42
3119272|NCT01615328|3844145|FG001|STARTED|Overall Study||43
3119273|NCT01615328|3844144|FG000|COMPLETED|Overall Study||39
3119274|NCT01615328|3844145|FG001|COMPLETED|Overall Study||38
3119275|NCT01615328|3844144|FG000|NOT COMPLETED|Overall Study||3
3119276|NCT01615328|3844145|FG001|NOT COMPLETED|Overall Study||5
3119277|NCT01615367|3844157|FG000|STARTED|Overall Study||19
3119278|NCT01615367|3844158|FG001|STARTED|Overall Study||19
3119279|NCT01615367|3844157|FG000|COMPLETED|Overall Study||14
3119280|NCT01615367|3844158|FG001|COMPLETED|Overall Study|11 TAU participants chose to participate in NEW Tx after the completion of the waitlist period.|13
3119281|NCT01615367|3844157|FG000|NOT COMPLETED|Overall Study||5
3119282|NCT01615367|3844158|FG001|NOT COMPLETED|Overall Study||6
3119283|NCT01615484|3844166|FG000|STARTED|Overall Study||0
3119284|NCT01615484|3844167|FG001|STARTED|Overall Study||24
3119285|NCT01615484|3844166|FG000|COMPLETED|Overall Study||0
3119286|NCT01615484|3844167|FG001|COMPLETED|Overall Study||24
3119287|NCT01615484|3844166|FG000|NOT COMPLETED|Overall Study||0
3119288|NCT01615484|3844167|FG001|NOT COMPLETED|Overall Study||0
3119289|NCT01615731|3844175|FG000|STARTED|Overall Study||24
3119290|NCT01615731|3844176|FG001|STARTED|Overall Study||26
3119291|NCT01615731|3844175|FG000|COMPLETED|Overall Study||21
3119292|NCT01615731|3844176|FG001|COMPLETED|Overall Study||24
3119293|NCT01615731|3844175|FG000|NOT COMPLETED|Overall Study||3
3119294|NCT01615731|3844176|FG001|NOT COMPLETED|Overall Study||2
3119295|NCT01615809|3844182|FG000|STARTED|Overall Study|basal visit|32
3119296|NCT01615809|3844182|FG000|COMPLETED|Overall Study||22
3119297|NCT01615809|3844182|FG000|NOT COMPLETED|Overall Study||10
3119298|NCT01615822|3844189|FG000|STARTED|Period 1||8
3119299|NCT01615822|3844190|FG001|STARTED|Period 1||11
3119300|NCT01615822|3844191|FG002|STARTED|Period 1||6
3119301|NCT01615822|3844189|FG000|COMPLETED|Period 1||7
3119302|NCT01615822|3844190|FG001|COMPLETED|Period 1||9
3119303|NCT01615822|3844191|FG002|COMPLETED|Period 1||6
3119304|NCT01615822|3844189|FG000|NOT COMPLETED|Period 1||1
3119305|NCT01615822|3844190|FG001|NOT COMPLETED|Period 1||2
3119306|NCT01615822|3844191|FG002|NOT COMPLETED|Period 1||0
3119307|NCT01615822|3844189|FG000|STARTED|Period 2||7
3119308|NCT01615822|3844190|FG001|STARTED|Period 2||9
3119309|NCT01615822|3844191|FG002|STARTED|Period 2||6
3119310|NCT01615822|3844189|FG000|COMPLETED|Period 2||7
3295066|NCT02894502|4029223|FG001|NOT COMPLETED|Third Follow up||7
3295067|NCT02894502|4029224|FG002|NOT COMPLETED|Third Follow up||3
3295068|NCT02894840|4029239|FG000|STARTED|Overall Study||20
3295069|NCT02894840|4029240|FG001|STARTED|Overall Study||20
3295070|NCT02894840|4029241|FG002|STARTED|Overall Study||200
3295071|NCT02894840|4029242|FG003|STARTED|Overall Study||100
3295072|NCT02894840|4029239|FG000|COMPLETED|Overall Study||19
3295073|NCT02894840|4029240|FG001|COMPLETED|Overall Study||20
3119311|NCT01615822|3844190|FG001|COMPLETED|Period 2||8
3119312|NCT01615822|3844191|FG002|COMPLETED|Period 2||4
3119313|NCT01615822|3844189|FG000|NOT COMPLETED|Period 2||0
3119314|NCT01615822|3844190|FG001|NOT COMPLETED|Period 2||1
3119315|NCT01615822|3844191|FG002|NOT COMPLETED|Period 2||2
3119316|NCT01615939|3844204|FG000|STARTED|Overall Study||13
3119317|NCT01615939|3844205|FG001|STARTED|Overall Study||4
3119318|NCT01615939|3844204|FG000|COMPLETED|Overall Study||8
3119319|NCT01615939|3844205|FG001|COMPLETED|Overall Study||4
3119320|NCT01615939|3844204|FG000|NOT COMPLETED|Overall Study||5
3119321|NCT01615939|3844205|FG001|NOT COMPLETED|Overall Study||0
3119322|NCT01616056|3844211|FG000|STARTED|Overall Study||20
3119323|NCT01616056|3844211|FG000|COMPLETED|Overall Study||19
3119324|NCT01616056|3844211|FG000|NOT COMPLETED|Overall Study||1
3119325|NCT01616082|3844217|FG000|STARTED|Overall Study||19
3119326|NCT01616082|3844218|FG001|STARTED|Overall Study||20
3119327|NCT01616082|3844217|FG000|COMPLETED|Overall Study||19
3119328|NCT01616082|3844218|FG001|COMPLETED|Overall Study||18
3119329|NCT01616082|3844217|FG000|NOT COMPLETED|Overall Study||0
3119330|NCT01616082|3844218|FG001|NOT COMPLETED|Overall Study||2
3119331|NCT01616160|3844225|FG000|STARTED|Overall Study||11
3119332|NCT01616160|3844225|FG000|COMPLETED|Overall Study||9
3119333|NCT01616160|3844225|FG000|NOT COMPLETED|Overall Study||2
3119334|NCT01616173|3844232|FG000|STARTED|Overall Study||27
3119335|NCT01616173|3844233|FG001|STARTED|Overall Study||26
3119336|NCT01616173|3844234|FG002|STARTED|Overall Study||27
3119337|NCT01616173|3844232|FG000|COMPLETED|Overall Study||27
3119338|NCT01616173|3844233|FG001|COMPLETED|Overall Study||24
3119339|NCT01616173|3844234|FG002|COMPLETED|Overall Study||27
3119340|NCT01616173|3844232|FG000|NOT COMPLETED|Overall Study||0
3119341|NCT01616173|3844233|FG001|NOT COMPLETED|Overall Study||2
3119342|NCT01616173|3844234|FG002|NOT COMPLETED|Overall Study||0
3119343|NCT01616459|3844246|FG000|STARTED|Overall Study||240
3119344|NCT01616459|3844247|FG001|STARTED|Overall Study||240
3119345|NCT01616459|3844248|FG002|STARTED|Overall Study||230
3119346|NCT01616459|3844249|FG003|STARTED|Overall Study||241
3119347|NCT01616459|3844246|FG000|COMPLETED|Overall Study||236
3119348|NCT01616459|3844247|FG001|COMPLETED|Overall Study||223
3119349|NCT01616459|3844248|FG002|COMPLETED|Overall Study||220
3119350|NCT01616459|3844249|FG003|COMPLETED|Overall Study||233
3119351|NCT01616459|3844246|FG000|NOT COMPLETED|Overall Study||4
3119352|NCT01616459|3844247|FG001|NOT COMPLETED|Overall Study||17
3119353|NCT01616459|3844248|FG002|NOT COMPLETED|Overall Study||10
3119354|NCT01616459|3844249|FG003|NOT COMPLETED|Overall Study||8
3119355|NCT01616563|3844264|FG000|STARTED|Overall Study||293
3119356|NCT01616563|3844264|FG000|COMPLETED|Overall Study||253
3119357|NCT01616563|3844264|FG000|NOT COMPLETED|Overall Study||40
3119358|NCT01616576|3844271|FG000|STARTED|Overall Study||18
3119359|NCT01616576|3844272|FG001|STARTED|Overall Study||18
3119360|NCT01616576|3844271|FG000|COMPLETED|Overall Study||18
3119361|NCT01616576|3844272|FG001|COMPLETED|Overall Study||18
3119362|NCT01616576|3844271|FG000|NOT COMPLETED|Overall Study||0
3119363|NCT01616576|3844272|FG001|NOT COMPLETED|Overall Study||0
3119364|NCT01616654|3844286|FG000|STARTED|Overall Study||61
3119365|NCT01616654|3844287|FG001|STARTED|Overall Study||61
3119366|NCT01616654|3844288|FG002|STARTED|Overall Study||60
3119367|NCT01616654|3844289|FG003|STARTED|Overall Study||61
3119368|NCT01616654|3844290|FG004|STARTED|Overall Study||61
3119369|NCT01616654|3844286|FG000|COMPLETED|Overall Study||56
3119370|NCT01616654|3844287|FG001|COMPLETED|Overall Study||53
3119371|NCT01616654|3844288|FG002|COMPLETED|Overall Study||50
3119372|NCT01616654|3844289|FG003|COMPLETED|Overall Study||53
3119373|NCT01616654|3844290|FG004|COMPLETED|Overall Study||49
3119374|NCT01616654|3844286|FG000|NOT COMPLETED|Overall Study||5
3119375|NCT01616654|3844287|FG001|NOT COMPLETED|Overall Study||8
3119376|NCT01616654|3844288|FG002|NOT COMPLETED|Overall Study||10
3119377|NCT01616654|3844289|FG003|NOT COMPLETED|Overall Study||8
3119378|NCT01616654|3844290|FG004|NOT COMPLETED|Overall Study||12
3119379|NCT01616693|3844307|FG000|STARTED|Evaluated for Safety||155
3119380|NCT01616693|3844308|FG001|STARTED|Evaluated for Safety||155
3119381|NCT01616693|3844309|FG002|STARTED|Evaluated for Safety||155
3119382|NCT01616693|3844310|FG003|STARTED|Evaluated for Safety||155
3119383|NCT01616693|3844307|FG000|COMPLETED|Evaluated for Safety||154
3119384|NCT01616693|3844308|FG001|COMPLETED|Evaluated for Safety||155
3119385|NCT01616693|3844309|FG002|COMPLETED|Evaluated for Safety||154
3119386|NCT01616693|3844310|FG003|COMPLETED|Evaluated for Safety||155
3119387|NCT01616693|3844307|FG000|NOT COMPLETED|Evaluated for Safety||1
3119388|NCT01616693|3844308|FG001|NOT COMPLETED|Evaluated for Safety||0
3119389|NCT01616693|3844309|FG002|NOT COMPLETED|Evaluated for Safety||1
3119390|NCT01616693|3844310|FG003|NOT COMPLETED|Evaluated for Safety||0
3119391|NCT01616693|3844307|FG000|STARTED|Received Both Vaccines||154
3119392|NCT01616693|3844308|FG001|STARTED|Received Both Vaccines||155
3119393|NCT01616693|3844309|FG002|STARTED|Received Both Vaccines||154
3119394|NCT01616693|3844310|FG003|STARTED|Received Both Vaccines||155
3119395|NCT01616693|3844307|FG000|COMPLETED|Received Both Vaccines||141
3119396|NCT01616693|3844308|FG001|COMPLETED|Received Both Vaccines||145
3119397|NCT01616693|3844309|FG002|COMPLETED|Received Both Vaccines||142
3119398|NCT01616693|3844310|FG003|COMPLETED|Received Both Vaccines||136
3119399|NCT01616693|3844307|FG000|NOT COMPLETED|Received Both Vaccines||13
3119400|NCT01616693|3844308|FG001|NOT COMPLETED|Received Both Vaccines||10
3119401|NCT01616693|3844309|FG002|NOT COMPLETED|Received Both Vaccines||12
3119402|NCT01616693|3844310|FG003|NOT COMPLETED|Received Both Vaccines||19
3119403|NCT01616693|3844307|FG000|STARTED|Blood Analyzed for Immunogenicity||141
3119404|NCT01616693|3844308|FG001|STARTED|Blood Analyzed for Immunogenicity||145
3119405|NCT01616693|3844309|FG002|STARTED|Blood Analyzed for Immunogenicity||142
3119406|NCT01616693|3844310|FG003|STARTED|Blood Analyzed for Immunogenicity||136
3119407|NCT01616693|3844307|FG000|COMPLETED|Blood Analyzed for Immunogenicity||137
3119408|NCT01616693|3844308|FG001|COMPLETED|Blood Analyzed for Immunogenicity||143
3119409|NCT01616693|3844309|FG002|COMPLETED|Blood Analyzed for Immunogenicity||136
3119410|NCT01616693|3844310|FG003|COMPLETED|Blood Analyzed for Immunogenicity||135
3119411|NCT01616693|3844307|FG000|NOT COMPLETED|Blood Analyzed for Immunogenicity||4
3119412|NCT01616693|3844308|FG001|NOT COMPLETED|Blood Analyzed for Immunogenicity||2
3119413|NCT01616693|3844309|FG002|NOT COMPLETED|Blood Analyzed for Immunogenicity||6
3119414|NCT01616693|3844310|FG003|NOT COMPLETED|Blood Analyzed for Immunogenicity||1
3119415|NCT01616771|3844324|FG000|STARTED|Macintosh Laryngoscopy for 5 Sec||23
3119416|NCT01616771|3844324|FG000|COMPLETED|Macintosh Laryngoscopy for 5 Sec||23
3119417|NCT01616771|3844324|FG000|NOT COMPLETED|Macintosh Laryngoscopy for 5 Sec||0
3119418|NCT01616771|3844324|FG000|STARTED|GVL Selected by Weight for 5 Sec||23
3119419|NCT01616771|3844324|FG000|COMPLETED|GVL Selected by Weight for 5 Sec||23
3119420|NCT01616771|3844324|FG000|NOT COMPLETED|GVL Selected by Weight for 5 Sec||0
3119421|NCT01616771|3844324|FG000|STARTED|Smaller Sized GVL for 5 Sec|Four of 23 patients could not be evaluated by smaller sized GVL, because there was no smaller one.|23
3119422|NCT01616771|3844324|FG000|COMPLETED|Smaller Sized GVL for 5 Sec||19
3119423|NCT01616771|3844324|FG000|NOT COMPLETED|Smaller Sized GVL for 5 Sec||4
3119424|NCT01616953|3844335|FG000|STARTED|Overall Study||10
3119425|NCT01616953|3844336|FG001|STARTED|Overall Study||8
3119426|NCT01616953|3844335|FG000|Implant Placement Surgery|Overall Study||9
3119427|NCT01616953|3844336|FG001|Implant Placement Surgery|Overall Study||8
3119428|NCT01616953|3844335|FG000|Implant Uncovery|Overall Study||8
3119429|NCT01616953|3844336|FG001|Implant Uncovery|Overall Study||8
3119430|NCT01616953|3844335|FG000|6 Months Post-loading|Overall Study||8
3119431|NCT01616953|3844336|FG001|6 Months Post-loading|Overall Study||8
3119432|NCT01616953|3844335|FG000|COMPLETED|Overall Study||8
3119433|NCT01616953|3844336|FG001|COMPLETED|Overall Study||8
3119434|NCT01616953|3844335|FG000|NOT COMPLETED|Overall Study||2
3119435|NCT01616953|3844336|FG001|NOT COMPLETED|Overall Study||0
3119436|NCT01617005|3844342|FG000|STARTED|Overall Study||50
3119437|NCT01617005|3844342|FG000|COMPLETED|Overall Study||48
3119438|NCT01617005|3844342|FG000|NOT COMPLETED|Overall Study||2
3119439|NCT01617070|3844346|FG000|STARTED|LNAA (4 Weeks)||10
3119440|NCT01617070|3844346|FG000|COMPLETED|LNAA (4 Weeks)||10
3119441|NCT01617070|3844346|FG000|NOT COMPLETED|LNAA (4 Weeks)||0
3119442|NCT01617070|3844346|FG000|STARTED|Washout (4 Weeks)||10
3119443|NCT01617070|3844346|FG000|COMPLETED|Washout (4 Weeks)||10
3119444|NCT01617070|3844346|FG000|NOT COMPLETED|Washout (4 Weeks)||0
3119445|NCT01617070|3844346|FG000|STARTED|BH4 Therapy (4 Weeks)||10
3119446|NCT01617070|3844346|FG000|COMPLETED|BH4 Therapy (4 Weeks)||10
3119447|NCT01617070|3844346|FG000|NOT COMPLETED|BH4 Therapy (4 Weeks)||0
3119448|NCT01617070|3844346|FG000|STARTED|BH4 and LNAA (4 Weeks)||10
3119449|NCT01617070|3844346|FG000|COMPLETED|BH4 and LNAA (4 Weeks)||9
3119450|NCT01617070|3844346|FG000|NOT COMPLETED|BH4 and LNAA (4 Weeks)||1
3119451|NCT01617083|3844359|FG000|STARTED|Overall Study||18
3119452|NCT01617083|3844360|FG001|STARTED|Overall Study||14
3119453|NCT01617083|3844361|FG002|STARTED|Overall Study||15
3119454|NCT01617083|3844359|FG000|COMPLETED|Overall Study||18
3119455|NCT01617083|3844360|FG001|COMPLETED|Overall Study||14
3119456|NCT01617083|3844361|FG002|COMPLETED|Overall Study||15
3119457|NCT01617083|3844359|FG000|NOT COMPLETED|Overall Study||0
3119458|NCT01617083|3844360|FG001|NOT COMPLETED|Overall Study||0
3119459|NCT01617083|3844361|FG002|NOT COMPLETED|Overall Study||0
3119460|NCT01617148|3844368|FG000|STARTED|Overall Study||26
3119461|NCT01617148|3844368|FG000|COMPLETED|Overall Study||26
3119462|NCT01617148|3844368|FG000|NOT COMPLETED|Overall Study||0
3119463|NCT01617369|3844373|FG000|STARTED|Overall Study||12
3119464|NCT01617369|3844373|FG000|COMPLETED|Overall Study||12
3119465|NCT01617369|3844373|FG000|NOT COMPLETED|Overall Study||0
3119466|NCT01617421|3844379|FG000|STARTED|Overall Study||18
3119467|NCT01617421|3844379|FG000|COMPLETED|Overall Study||12
3119468|NCT01617421|3844379|FG000|NOT COMPLETED|Overall Study||6
3119469|NCT01617434|3844385|FG000|STARTED|Overall Study||226
3119470|NCT01617434|3844386|FG001|STARTED|Overall Study||225
3119471|NCT01617434|3844385|FG000|Exposed|Overall Study||225
3119472|NCT01617434|3844386|FG001|Exposed|Overall Study||225
3119473|NCT01617434|3844385|FG000|COMPLETED|Overall Study||191
3119474|NCT01617434|3844386|FG001|COMPLETED|Overall Study||174
3119475|NCT01617434|3844385|FG000|NOT COMPLETED|Overall Study||35
3119476|NCT01617434|3844386|FG001|NOT COMPLETED|Overall Study||51
3119477|NCT01617447|3844394|FG000|STARTED|Overall Study||47
3119478|NCT01617447|3844395|FG001|STARTED|Overall Study||45
3119479|NCT01617447|3844394|FG000|COMPLETED|Overall Study||47
3119480|NCT01617447|3844395|FG001|COMPLETED|Overall Study||42
3119481|NCT01617447|3844394|FG000|NOT COMPLETED|Overall Study||0
3119482|NCT01617447|3844395|FG001|NOT COMPLETED|Overall Study||3
3119483|NCT01617460|3844401|FG000|STARTED|Overall Study||86
3119484|NCT01617460|3844401|FG000|COMPLETED|Overall Study||46
3119485|NCT01617460|3844401|FG000|NOT COMPLETED|Overall Study||40
3119486|NCT01617577|3844407|FG000|STARTED|Overall Study||5
3119487|NCT01617577|3844408|FG001|STARTED|Overall Study||3
3119488|NCT01617577|3844407|FG000|COMPLETED|Overall Study||5
3119489|NCT01617577|3844408|FG001|COMPLETED|Overall Study||3
3119490|NCT01617577|3844407|FG000|NOT COMPLETED|Overall Study||0
3119491|NCT01617577|3844408|FG001|NOT COMPLETED|Overall Study||0
3119492|NCT01617603|3844418|FG000|STARTED|Overall Study||20
3119493|NCT01617603|3844419|FG001|STARTED|Overall Study||21
3119494|NCT01617603|3844420|FG002|STARTED|Overall Study||21
3119495|NCT01617603|3844418|FG000|COMPLETED|Overall Study||17
3119496|NCT01617603|3844419|FG001|COMPLETED|Overall Study||19
3119497|NCT01617603|3844420|FG002|COMPLETED|Overall Study||20
3119498|NCT01617603|3844418|FG000|NOT COMPLETED|Overall Study||3
3119499|NCT01617603|3844419|FG001|NOT COMPLETED|Overall Study||2
3119500|NCT01617603|3844420|FG002|NOT COMPLETED|Overall Study||1
3119501|NCT01617629|3844428|FG000|STARTED|Overall Study||9
3119502|NCT01617629|3844428|FG000|COMPLETED|Overall Study||3
3119503|NCT01617629|3844428|FG000|NOT COMPLETED|Overall Study||6
3119504|NCT01617655|3844434|FG000|STARTED|Overall Study|Randomized|35
3119505|NCT01617655|3844435|FG001|STARTED|Overall Study|Randomized|72
3119506|NCT01617655|3844434|FG000|Treated|Overall Study||35
3119507|NCT01617655|3844435|FG001|Treated|Overall Study||72
3119508|NCT01617655|3844434|FG000|COMPLETED|Overall Study||26
3119509|NCT01617655|3844435|FG001|COMPLETED|Overall Study||43
3119510|NCT01617655|3844434|FG000|NOT COMPLETED|Overall Study||9
3119511|NCT01617655|3844435|FG001|NOT COMPLETED|Overall Study||29
3119512|NCT01617668|3844445|FG000|STARTED|Overall Study||51
3119513|NCT01617668|3844446|FG001|STARTED|Overall Study|54 patients were randomized and only 50 received study treatment.|50
3119514|NCT01617668|3844447|FG002|STARTED|Overall Study||55
3119515|NCT01617668|3844448|FG003|STARTED|Overall Study|55 patients were randomized and only 53 received study treatment.|53
3119516|NCT01617668|3844445|FG000|Randomized Patients|Overall Study||51
3119517|NCT01617668|3844446|FG001|Randomized Patients|Overall Study||54
3119518|NCT01617668|3844447|FG002|Randomized Patients|Overall Study||55
3119519|NCT01617668|3844448|FG003|Randomized Patients|Overall Study||55
3119520|NCT01617668|3844445|FG000|COMPLETED|Overall Study||38
3119521|NCT01617668|3844446|FG001|COMPLETED|Overall Study||41
3119522|NCT01617668|3844447|FG002|COMPLETED|Overall Study||32
3119523|NCT01617668|3844448|FG003|COMPLETED|Overall Study||38
3119524|NCT01617668|3844445|FG000|NOT COMPLETED|Overall Study||13
3119525|NCT01617668|3844446|FG001|NOT COMPLETED|Overall Study||9
3119526|NCT01617668|3844447|FG002|NOT COMPLETED|Overall Study||23
3119527|NCT01617668|3844448|FG003|NOT COMPLETED|Overall Study||15
3119528|NCT01617681|3844466|FG000|STARTED|Period 1 Double Blind||32
3119529|NCT01617681|3844467|FG001|STARTED|Period 1 Double Blind||31
3119530|NCT01617681|3844468|FG002|STARTED|Period 1 Double Blind||33
3119531|NCT01617681|3844469|FG003|STARTED|Period 1 Double Blind||31
3119532|NCT01617681|3844470|FG004|STARTED|Period 1 Double Blind||0
3119533|NCT01617681|3844466|FG000|Full Analysis Set (FAS)|Period 1 Double Blind||31
3119534|NCT01617681|3844467|FG001|Full Analysis Set (FAS)|Period 1 Double Blind||31
3119535|NCT01617681|3844468|FG002|Full Analysis Set (FAS)|Period 1 Double Blind||33
3119536|NCT01617681|3844469|FG003|Full Analysis Set (FAS)|Period 1 Double Blind||31
3119537|NCT01617681|3844470|FG004|Full Analysis Set (FAS)|Period 1 Double Blind||0
3119538|NCT01617681|3844466|FG000|COMPLETED|Period 1 Double Blind||29
3119539|NCT01617681|3844467|FG001|COMPLETED|Period 1 Double Blind||30
3119540|NCT01617681|3844468|FG002|COMPLETED|Period 1 Double Blind||32
3119541|NCT01617681|3844469|FG003|COMPLETED|Period 1 Double Blind||29
3119542|NCT01617681|3844470|FG004|COMPLETED|Period 1 Double Blind||0
3119543|NCT01617681|3844466|FG000|NOT COMPLETED|Period 1 Double Blind||3
3119544|NCT01617681|3844467|FG001|NOT COMPLETED|Period 1 Double Blind||1
3119545|NCT01617681|3844468|FG002|NOT COMPLETED|Period 1 Double Blind||1
3119546|NCT01617681|3844469|FG003|NOT COMPLETED|Period 1 Double Blind||2
3119547|NCT01617681|3844470|FG004|NOT COMPLETED|Period 1 Double Blind||0
3119548|NCT01617681|3844466|FG000|STARTED|Period 2 Open Label||0
3119549|NCT01617681|3844467|FG001|STARTED|Period 2 Open Label||0
3119550|NCT01617681|3844468|FG002|STARTED|Period 2 Open Label||0
3119551|NCT01617681|3844469|FG003|STARTED|Period 2 Open Label||0
3119552|NCT01617681|3844470|FG004|STARTED|Period 2 Open Label||120
3119553|NCT01617681|3844466|FG000|COMPLETED|Period 2 Open Label||0
3119554|NCT01617681|3844467|FG001|COMPLETED|Period 2 Open Label||0
3295074|NCT02894840|4029241|FG002|COMPLETED|Overall Study||197
3295075|NCT02894840|4029242|FG003|COMPLETED|Overall Study||100
3295076|NCT02894840|4029239|FG000|NOT COMPLETED|Overall Study||1
3295077|NCT02894840|4029240|FG001|NOT COMPLETED|Overall Study||0
3295078|NCT02894840|4029241|FG002|NOT COMPLETED|Overall Study||3
3295079|NCT02894840|4029242|FG003|NOT COMPLETED|Overall Study||0
3295080|NCT02895035|4029257|FG000|STARTED|Overall Study||23
3295081|NCT02895035|4029258|FG001|STARTED|Overall Study||36
3295082|NCT02895035|4029257|FG000|COMPLETED|Overall Study||18
3295083|NCT02895035|4029258|FG001|COMPLETED|Overall Study||24
3295084|NCT02895035|4029257|FG000|NOT COMPLETED|Overall Study||5
3295085|NCT02895035|4029258|FG001|NOT COMPLETED|Overall Study||12
3119555|NCT01617681|3844468|FG002|COMPLETED|Period 2 Open Label||0
3119556|NCT01617681|3844469|FG003|COMPLETED|Period 2 Open Label||0
3119557|NCT01617681|3844470|FG004|COMPLETED|Period 2 Open Label||114
3119558|NCT01617681|3844466|FG000|NOT COMPLETED|Period 2 Open Label||0
3119559|NCT01617681|3844467|FG001|NOT COMPLETED|Period 2 Open Label||0
3119560|NCT01617681|3844468|FG002|NOT COMPLETED|Period 2 Open Label||0
3119561|NCT01617681|3844469|FG003|NOT COMPLETED|Period 2 Open Label||0
3295086|NCT02895100|4029268|FG000|STARTED|Overall Study||25
3295087|NCT02895100|4029269|FG001|STARTED|Overall Study||25
3295088|NCT02895100|4029270|FG002|STARTED|Overall Study||23
3295089|NCT02895100|4029271|FG003|STARTED|Overall Study||25
3295090|NCT02895100|4029268|FG000|COMPLETED|Overall Study||14
3295091|NCT02895100|4029269|FG001|COMPLETED|Overall Study||14
3295092|NCT02895100|4029270|FG002|COMPLETED|Overall Study||15
3295093|NCT02895100|4029271|FG003|COMPLETED|Overall Study||15
3295094|NCT02895100|4029268|FG000|NOT COMPLETED|Overall Study||11
3295095|NCT02895100|4029269|FG001|NOT COMPLETED|Overall Study||11
3295096|NCT02895100|4029270|FG002|NOT COMPLETED|Overall Study||8
3295097|NCT02895100|4029271|FG003|NOT COMPLETED|Overall Study||10
3295098|NCT02895295|4029284|FG000|STARTED|Overall Study||384
3295099|NCT02895295|4029285|FG001|STARTED|Overall Study||410
3295100|NCT02895295|4029286|FG002|STARTED|Overall Study||391
3295101|NCT02895295|4029284|FG000|COMPLETED|Overall Study||313
3295102|NCT02895295|4029285|FG001|COMPLETED|Overall Study||316
3295103|NCT02895295|4029286|FG002|COMPLETED|Overall Study||299
3295104|NCT02895295|4029284|FG000|NOT COMPLETED|Overall Study||71
3295105|NCT02895295|4029285|FG001|NOT COMPLETED|Overall Study||94
3295106|NCT02895295|4029286|FG002|NOT COMPLETED|Overall Study||92
3295107|NCT02895347|4029296|FG000|STARTED|Overall Study||20
3295108|NCT02895347|4029297|FG001|STARTED|Overall Study||20
3295109|NCT02895347|4029296|FG000|COMPLETED|Overall Study||17
3295110|NCT02895347|4029297|FG001|COMPLETED|Overall Study||19
3295111|NCT02895347|4029296|FG000|NOT COMPLETED|Overall Study||3
3295112|NCT02895347|4029297|FG001|NOT COMPLETED|Overall Study||1
3295113|NCT02895360|4029310|FG000|STARTED|Phase 1 - 30 mg/m² Cohort||4
3295114|NCT02895360|4029311|FG001|STARTED|Phase 1 - 30 mg/m² Cohort||0
3295115|NCT02895360|4029312|FG002|STARTED|Phase 1 - 30 mg/m² Cohort||0
3295116|NCT02895360|4029313|FG003|STARTED|Phase 1 - 30 mg/m² Cohort||0
3295117|NCT02895360|4029314|FG004|STARTED|Phase 1 - 30 mg/m² Cohort||0
3295118|NCT02895360|4029315|FG005|STARTED|Phase 1 - 30 mg/m² Cohort||0
3295119|NCT02895360|4029310|FG000|COMPLETED|Phase 1 - 30 mg/m² Cohort||0
3295120|NCT02895360|4029311|FG001|COMPLETED|Phase 1 - 30 mg/m² Cohort||0
3295121|NCT02895360|4029312|FG002|COMPLETED|Phase 1 - 30 mg/m² Cohort||0
3295122|NCT02895360|4029313|FG003|COMPLETED|Phase 1 - 30 mg/m² Cohort||0
3295123|NCT02895360|4029314|FG004|COMPLETED|Phase 1 - 30 mg/m² Cohort||0
3119562|NCT01617681|3844470|FG004|NOT COMPLETED|Period 2 Open Label||6
3119563|NCT01617967|3844485|FG000|STARTED|Overall Study||4
3119564|NCT01617967|3844486|FG001|STARTED|Overall Study||3
3119565|NCT01617967|3844487|FG002|STARTED|Overall Study||3
3119566|NCT01617967|3844488|FG003|STARTED|Overall Study||7
3119567|NCT01617967|3844489|FG004|STARTED|Overall Study||3
3119568|NCT01617967|3844490|FG005|STARTED|Overall Study||9
3119569|NCT01617967|3844485|FG000|COMPLETED|Overall Study||3
3119570|NCT01617967|3844486|FG001|COMPLETED|Overall Study||3
3119571|NCT01617967|3844487|FG002|COMPLETED|Overall Study||3
3119572|NCT01617967|3844488|FG003|COMPLETED|Overall Study||6
3119573|NCT01617967|3844489|FG004|COMPLETED|Overall Study||3
3119574|NCT01617967|3844490|FG005|COMPLETED|Overall Study||8
3119575|NCT01617967|3844485|FG000|NOT COMPLETED|Overall Study||1
3119576|NCT01617967|3844486|FG001|NOT COMPLETED|Overall Study||0
3119577|NCT01617967|3844487|FG002|NOT COMPLETED|Overall Study||0
3119578|NCT01617967|3844488|FG003|NOT COMPLETED|Overall Study||1
3119579|NCT01617967|3844489|FG004|NOT COMPLETED|Overall Study||0
3119580|NCT01617967|3844490|FG005|NOT COMPLETED|Overall Study||1
3119581|NCT01618019|3844507|FG000|STARTED|Overall Study||55
3119582|NCT01618019|3844508|FG001|STARTED|Overall Study||54
3119583|NCT01618019|3844507|FG000|COMPLETED|Overall Study||41
3119584|NCT01618019|3844508|FG001|COMPLETED|Overall Study||40
3119585|NCT01618019|3844507|FG000|NOT COMPLETED|Overall Study||14
3119586|NCT01618019|3844508|FG001|NOT COMPLETED|Overall Study||14
3119587|NCT01618162|3844516|FG000|STARTED|Overall Study||289
3119588|NCT01618162|3844517|FG001|STARTED|Overall Study||146
3119589|NCT01618162|3844516|FG000|Exposed|Overall Study||288
3119590|NCT01618162|3844517|FG001|Exposed|Overall Study||146
3119591|NCT01618162|3844516|FG000|COMPLETED|Overall Study||251
3119592|NCT01618162|3844517|FG001|COMPLETED|Overall Study||111
3119593|NCT01618162|3844516|FG000|NOT COMPLETED|Overall Study||38
3119594|NCT01618162|3844517|FG001|NOT COMPLETED|Overall Study||35
3119595|NCT01618214|3844525|FG000|STARTED|Overall Study||172
3119596|NCT01618214|3844526|FG001|STARTED|Overall Study||172
3119597|NCT01618214|3844525|FG000|Exposed|Overall Study||172
3119598|NCT01618214|3844526|FG001|Exposed|Overall Study||172
3119599|NCT01618214|3844525|FG000|COMPLETED|Overall Study||162
3119600|NCT01618214|3844526|FG001|COMPLETED|Overall Study||159
3119601|NCT01618214|3844525|FG000|NOT COMPLETED|Overall Study||10
3119602|NCT01618214|3844526|FG001|NOT COMPLETED|Overall Study||13
3119603|NCT01618227|3844534|FG000|STARTED|Overall Study||2
3119604|NCT01618227|3844535|FG001|STARTED|Overall Study||2
3119605|NCT01618227|3844534|FG000|COMPLETED|Overall Study||2
3119606|NCT01618227|3844535|FG001|COMPLETED|Overall Study||0
3119607|NCT01618227|3844534|FG000|NOT COMPLETED|Overall Study||0
3119608|NCT01618227|3844535|FG001|NOT COMPLETED|Overall Study||2
3119609|NCT01618240|3844541|FG000|STARTED|Overall Study||30
3119610|NCT01618240|3844541|FG000|COMPLETED|Overall Study||30
3119611|NCT01618240|3844541|FG000|NOT COMPLETED|Overall Study||0
3119612|NCT01618266|3844545|FG000|STARTED|Overall Study||375
3119613|NCT01618266|3844545|FG000|COMPLETED|Overall Study||279
3119614|NCT01618266|3844545|FG000|NOT COMPLETED|Overall Study||96
3119615|NCT01618305|3844551|FG000|STARTED|Overall Study||202
3119616|NCT01618305|3844552|FG001|STARTED|Overall Study||206
3119617|NCT01618305|3844551|FG000|COMPLETED|Overall Study||187
3119618|NCT01618305|3844552|FG001|COMPLETED|Overall Study||196
3119619|NCT01618305|3844551|FG000|NOT COMPLETED|Overall Study||15
3119620|NCT01618305|3844552|FG001|NOT COMPLETED|Overall Study||10
3119621|NCT01618344|3844562|FG000|STARTED|Overall Study||32
3119622|NCT01618344|3844562|FG000|COMPLETED|Overall Study||23
3119623|NCT01618344|3844562|FG000|NOT COMPLETED|Overall Study||9
3119624|NCT01618422|3844568|FG000|STARTED|Overall Study||114
3119625|NCT01618422|3844569|FG001|STARTED|Overall Study||111
3119626|NCT01618422|3844568|FG000|COMPLETED|Overall Study||114
3119627|NCT01618422|3844569|FG001|COMPLETED|Overall Study||111
3119628|NCT01618422|3844568|FG000|NOT COMPLETED|Overall Study||0
3119629|NCT01618422|3844569|FG001|NOT COMPLETED|Overall Study||0
3119630|NCT01618669|3844577|FG000|STARTED|Overall Study||578
3119631|NCT01618669|3844578|FG001|STARTED|Overall Study||569
3119632|NCT01618669|3844577|FG000|Received Treatment|Overall Study||575
3119633|NCT01618669|3844578|FG001|Received Treatment|Overall Study||567
3119634|NCT01618669|3844577|FG000|COMPLETED|Overall Study||544
3119635|NCT01618669|3844578|FG001|COMPLETED|Overall Study||546
3119636|NCT01618669|3844577|FG000|NOT COMPLETED|Overall Study||34
3119637|NCT01618669|3844578|FG001|NOT COMPLETED|Overall Study||23
3119638|NCT01618695|3844600|FG000|STARTED|Core Phase||177
3119639|NCT01618695|3844601|FG001|STARTED|Core Phase||176
3119640|NCT01618695|3844602|FG002|STARTED|Core Phase||177
3119641|NCT01618695|3844603|FG003|STARTED|Core Phase||180
3119642|NCT01618695|3844600|FG000|Treated (Safety Analysis Set)|Core Phase||176
3119643|NCT01618695|3844601|FG001|Treated (Safety Analysis Set)|Core Phase||176
3119644|NCT01618695|3844602|FG002|Treated (Safety Analysis Set)|Core Phase||175
3119645|NCT01618695|3844603|FG003|Treated (Safety Analysis Set)|Core Phase||180
3119646|NCT01618695|3844600|FG000|COMPLETED|Core Phase||152
3119647|NCT01618695|3844601|FG001|COMPLETED|Core Phase||156
3119648|NCT01618695|3844602|FG002|COMPLETED|Core Phase||147
3119649|NCT01618695|3844603|FG003|COMPLETED|Core Phase||144
3119650|NCT01618695|3844600|FG000|NOT COMPLETED|Core Phase||25
3119651|NCT01618695|3844601|FG001|NOT COMPLETED|Core Phase||20
3119652|NCT01618695|3844602|FG002|NOT COMPLETED|Core Phase||30
3119653|NCT01618695|3844603|FG003|NOT COMPLETED|Core Phase||36
3119654|NCT01618695|3844600|FG000|STARTED|Extension Phase|Participants who completed Core Phase and gave consent, entered the Extension Phase.|151
3119655|NCT01618695|3844601|FG001|STARTED|Extension Phase||156
3119656|NCT01618695|3844602|FG002|STARTED|Extension Phase|Participants who completed Core Phase and gave consent, entered the Extension Phase.|146
3119657|NCT01618695|3844603|FG003|STARTED|Extension Phase|Participants who completed Core Phase and gave consent, entered the Extension Phase.|143
3119658|NCT01618695|3844600|FG000|COMPLETED|Extension Phase||56
3119659|NCT01618695|3844601|FG001|COMPLETED|Extension Phase||40
3119660|NCT01618695|3844602|FG002|COMPLETED|Extension Phase||54
3119661|NCT01618695|3844603|FG003|COMPLETED|Extension Phase||46
3119662|NCT01618695|3844600|FG000|NOT COMPLETED|Extension Phase||95
3119663|NCT01618695|3844601|FG001|NOT COMPLETED|Extension Phase||116
3119664|NCT01618695|3844602|FG002|NOT COMPLETED|Extension Phase||92
3119665|NCT01618695|3844603|FG003|NOT COMPLETED|Extension Phase||97
3119666|NCT01618708|3844616|FG000|STARTED|Overall Study||175
3119667|NCT01618708|3844617|FG001|STARTED|Overall Study||182
3119668|NCT01618708|3844616|FG000|Treated|Overall Study||172
3119669|NCT01618708|3844617|FG001|Treated|Overall Study||180
3119670|NCT01618708|3844616|FG000|COMPLETED|Overall Study||131
3119671|NCT01618708|3844617|FG001|COMPLETED|Overall Study||136
3119672|NCT01618708|3844616|FG000|NOT COMPLETED|Overall Study||44
3119673|NCT01618708|3844617|FG001|NOT COMPLETED|Overall Study||46
3119674|NCT01618838|3844624|FG000|STARTED|Overall Study||4
3119675|NCT01618838|3844624|FG000|COMPLETED|Overall Study||0
3119676|NCT01618838|3844624|FG000|NOT COMPLETED|Overall Study||4
3119677|NCT01618864|3844629|FG000|STARTED|Overall Study||23
3119678|NCT01618864|3844629|FG000|Completed 2 Weeks|Overall Study||19
3119679|NCT01618864|3844629|FG000|COMPLETED|Overall Study|Completed 4 weeks and 8 weeks of treatment|19
3119680|NCT01618864|3844629|FG000|NOT COMPLETED|Overall Study||4
3119681|NCT01618916|3844644|FG000|STARTED|Overall Study||12
3119682|NCT01618916|3844645|FG001|STARTED|Overall Study||10
3119683|NCT01618916|3844646|FG002|STARTED|Overall Study||11
3119684|NCT01618916|3844647|FG003|STARTED|Overall Study||9
3119685|NCT01618916|3844648|FG004|STARTED|Overall Study||5
3119686|NCT01618916|3844649|FG005|STARTED|Overall Study||4
3119687|NCT01618916|3844644|FG000|Received At Least 1 Dose of Study Drug|Overall Study||12
3119688|NCT01618916|3844645|FG001|Received At Least 1 Dose of Study Drug|Overall Study||10
3119689|NCT01618916|3844646|FG002|Received At Least 1 Dose of Study Drug|Overall Study||11
3119690|NCT01618916|3844647|FG003|Received At Least 1 Dose of Study Drug|Overall Study||9
3119691|NCT01618916|3844648|FG004|Received At Least 1 Dose of Study Drug|Overall Study||5
3119692|NCT01618916|3844649|FG005|Received At Least 1 Dose of Study Drug|Overall Study||4
3119693|NCT01618916|3844644|FG000|COMPLETED|Overall Study||10
3119694|NCT01618916|3844645|FG001|COMPLETED|Overall Study||9
3119695|NCT01618916|3844646|FG002|COMPLETED|Overall Study||10
3119696|NCT01618916|3844647|FG003|COMPLETED|Overall Study||7
3119697|NCT01618916|3844648|FG004|COMPLETED|Overall Study||4
3119698|NCT01618916|3844649|FG005|COMPLETED|Overall Study||4
3119699|NCT01618916|3844644|FG000|NOT COMPLETED|Overall Study||2
3119700|NCT01618916|3844645|FG001|NOT COMPLETED|Overall Study||1
3119701|NCT01618916|3844646|FG002|NOT COMPLETED|Overall Study||1
3119702|NCT01618916|3844647|FG003|NOT COMPLETED|Overall Study||2
3119703|NCT01618916|3844648|FG004|NOT COMPLETED|Overall Study||1
3119704|NCT01618916|3844649|FG005|NOT COMPLETED|Overall Study||0
3119705|NCT01618942|3844664|FG000|STARTED|Overall Study||50
3119706|NCT01618942|3844665|FG001|STARTED|Overall Study||50
3119707|NCT01618942|3844664|FG000|COMPLETED|Overall Study||50
3119708|NCT01618942|3844665|FG001|COMPLETED|Overall Study||50
3119709|NCT01618942|3844664|FG000|NOT COMPLETED|Overall Study||0
3119710|NCT01618942|3844665|FG001|NOT COMPLETED|Overall Study||0
3119711|NCT01618955|3844675|FG000|STARTED|Overall Study||20
3119712|NCT01618955|3844676|FG001|STARTED|Overall Study||30
3119713|NCT01618955|3844677|FG002|STARTED|Overall Study||31
3119714|NCT01618955|3844678|FG003|STARTED|Overall Study||20
3119715|NCT01618955|3844675|FG000|COMPLETED|Overall Study||20
3119716|NCT01618955|3844676|FG001|COMPLETED|Overall Study||30
3119717|NCT01618955|3844677|FG002|COMPLETED|Overall Study||31
3119718|NCT01618955|3844678|FG003|COMPLETED|Overall Study||20
3119719|NCT01618955|3844675|FG000|NOT COMPLETED|Overall Study||0
3119720|NCT01618955|3844676|FG001|NOT COMPLETED|Overall Study||0
3119721|NCT01618955|3844677|FG002|NOT COMPLETED|Overall Study||0
3119722|NCT01618955|3844678|FG003|NOT COMPLETED|Overall Study||0
3119723|NCT01618968|3844692|FG000|STARTED|Overall Study||13
3119724|NCT01618968|3844693|FG001|STARTED|Overall Study||12
3119725|NCT01618968|3844694|FG002|STARTED|Overall Study||12
3119726|NCT01618968|3844695|FG003|STARTED|Overall Study||12
3119727|NCT01618968|3844692|FG000|Received Treatment A|Overall Study||12
3119728|NCT01618968|3844693|FG001|Received Treatment A|Overall Study||12
3119729|NCT01618968|3844694|FG002|Received Treatment A|Overall Study||12
3119730|NCT01618968|3844695|FG003|Received Treatment A|Overall Study||11
3119731|NCT01618968|3844692|FG000|Received Treatment B|Overall Study||13
3119732|NCT01618968|3844693|FG001|Received Treatment B|Overall Study||12
3119733|NCT01618968|3844694|FG002|Received Treatment B|Overall Study||12
3119734|NCT01618968|3844695|FG003|Received Treatment B|Overall Study||12
3119735|NCT01618968|3844692|FG000|Received Treatment C|Overall Study||12
3119736|NCT01618968|3844693|FG001|Received Treatment C|Overall Study||12
3119737|NCT01618968|3844694|FG002|Received Treatment C|Overall Study||12
3119738|NCT01618968|3844695|FG003|Received Treatment C|Overall Study||11
3119739|NCT01618968|3844692|FG000|COMPLETED|Overall Study||12
3119740|NCT01618968|3844693|FG001|COMPLETED|Overall Study||12
3119741|NCT01618968|3844694|FG002|COMPLETED|Overall Study||12
3119742|NCT01618968|3844695|FG003|COMPLETED|Overall Study||11
3119743|NCT01618968|3844692|FG000|NOT COMPLETED|Overall Study||1
3119744|NCT01618968|3844693|FG001|NOT COMPLETED|Overall Study||0
3119745|NCT01618968|3844694|FG002|NOT COMPLETED|Overall Study||0
3119746|NCT01618968|3844695|FG003|NOT COMPLETED|Overall Study||1
3119747|NCT01619059|3844706|FG000|STARTED|Short-Term (ST) Treatment Period||162
3119748|NCT01619059|3844707|FG001|STARTED|Short-Term (ST) Treatment Period||153
3119749|NCT01619059|3844706|FG000|COMPLETED|Short-Term (ST) Treatment Period||156
3119750|NCT01619059|3844707|FG001|COMPLETED|Short-Term (ST) Treatment Period||142
3119751|NCT01619059|3844706|FG000|NOT COMPLETED|Short-Term (ST) Treatment Period||6
3119752|NCT01619059|3844707|FG001|NOT COMPLETED|Short-Term (ST) Treatment Period||11
3119753|NCT01619059|3844706|FG000|STARTED|Long-Term (LT) Treatment Period||155
3119754|NCT01619059|3844707|FG001|STARTED|Long-Term (LT) Treatment Period||142
3119755|NCT01619059|3844706|FG000|COMPLETED|Long-Term (LT) Treatment Period||147
3119756|NCT01619059|3844707|FG001|COMPLETED|Long-Term (LT) Treatment Period||133
3119757|NCT01619059|3844706|FG000|NOT COMPLETED|Long-Term (LT) Treatment Period||8
3119758|NCT01619059|3844707|FG001|NOT COMPLETED|Long-Term (LT) Treatment Period||9
3119762|NCT01619410|3844719|FG000|STARTED|Overall Study||14
3119763|NCT01619410|3844720|FG001|STARTED|Overall Study||11
3119764|NCT01619410|3844719|FG000|COMPLETED|Overall Study||7
3119765|NCT01619410|3844720|FG001|COMPLETED|Overall Study||7
3119766|NCT01619410|3844719|FG000|NOT COMPLETED|Overall Study||7
3119767|NCT01619410|3844720|FG001|NOT COMPLETED|Overall Study||4
3119768|NCT01619423|3844730|FG000|STARTED|Part 1 (Dose Escalation)||0
3119769|NCT01619423|3844731|FG001|STARTED|Part 1 (Dose Escalation)||5
3119770|NCT01619423|3844732|FG002|STARTED|Part 1 (Dose Escalation)||3
3119771|NCT01619423|3844733|FG003|STARTED|Part 1 (Dose Escalation)||5
3119772|NCT01619423|3844730|FG000|COMPLETED|Part 1 (Dose Escalation)||0
3119773|NCT01619423|3844731|FG001|COMPLETED|Part 1 (Dose Escalation)||3
3119774|NCT01619423|3844732|FG002|COMPLETED|Part 1 (Dose Escalation)||3
3119775|NCT01619423|3844733|FG003|COMPLETED|Part 1 (Dose Escalation)||5
3119776|NCT01619423|3844730|FG000|NOT COMPLETED|Part 1 (Dose Escalation)||0
3119777|NCT01619423|3844731|FG001|NOT COMPLETED|Part 1 (Dose Escalation)||2
3119778|NCT01619423|3844732|FG002|NOT COMPLETED|Part 1 (Dose Escalation)||0
3119779|NCT01619423|3844733|FG003|NOT COMPLETED|Part 1 (Dose Escalation)||0
3119780|NCT01619423|3844730|FG000|STARTED|Part 2a||15
3119781|NCT01619423|3844731|FG001|STARTED|Part 2a||13
3119782|NCT01619423|3844732|FG002|STARTED|Part 2a||0
3119783|NCT01619423|3844733|FG003|STARTED|Part 2a||11
3119784|NCT01619423|3844730|FG000|COMPLETED|Part 2a||15
3119785|NCT01619423|3844731|FG001|COMPLETED|Part 2a||13
3119786|NCT01619423|3844732|FG002|COMPLETED|Part 2a||0
3119787|NCT01619423|3844733|FG003|COMPLETED|Part 2a||11
3119788|NCT01619423|3844730|FG000|NOT COMPLETED|Part 2a||0
3119789|NCT01619423|3844731|FG001|NOT COMPLETED|Part 2a||0
3119790|NCT01619423|3844732|FG002|NOT COMPLETED|Part 2a||0
3119791|NCT01619423|3844733|FG003|NOT COMPLETED|Part 2a||0
3119792|NCT01619423|3844730|FG000|STARTED|Part 2b||45
3119793|NCT01619423|3844731|FG001|STARTED|Part 2b||44
3119794|NCT01619423|3844732|FG002|STARTED|Part 2b||45
3119795|NCT01619423|3844733|FG003|STARTED|Part 2b||0
3119796|NCT01619423|3844730|FG000|COMPLETED|Part 2b||45
3119797|NCT01619423|3844731|FG001|COMPLETED|Part 2b||44
3119798|NCT01619423|3844732|FG002|COMPLETED|Part 2b||45
3119799|NCT01619423|3844733|FG003|COMPLETED|Part 2b||0
3119800|NCT01619423|3844730|FG000|NOT COMPLETED|Part 2b||0
3119801|NCT01619423|3844731|FG001|NOT COMPLETED|Part 2b||0
3119802|NCT01619423|3844732|FG002|NOT COMPLETED|Part 2b||0
3119803|NCT01619423|3844733|FG003|NOT COMPLETED|Part 2b||0
3119804|NCT01619579|3844746|FG000|STARTED|Overall Study||5
3119805|NCT01619579|3844747|FG001|STARTED|Overall Study||17
3119806|NCT01619579|3844746|FG000|COMPLETED|Overall Study||5
3119807|NCT01619579|3844747|FG001|COMPLETED|Overall Study||14
3119808|NCT01619579|3844746|FG000|NOT COMPLETED|Overall Study||0
3119809|NCT01619579|3844747|FG001|NOT COMPLETED|Overall Study||3
3119810|NCT01619774|3844753|FG000|STARTED|Overall Study||23
3119811|NCT01619774|3844753|FG000|COMPLETED|Overall Study||23
3119812|NCT01619774|3844753|FG000|NOT COMPLETED|Overall Study||0
3119813|NCT01619787|3844759|FG000|STARTED|Overall Study||217
3119814|NCT01619787|3844759|FG000|COMPLETED|Overall Study||212
3119815|NCT01619787|3844759|FG000|NOT COMPLETED|Overall Study||5
3119816|NCT01619839|3844770|FG000|STARTED|Overall Study||48
3119817|NCT01619839|3844771|FG001|STARTED|Overall Study||31
3119818|NCT01619839|3844772|FG002|STARTED|Overall Study||18
3119819|NCT01619839|3844773|FG003|STARTED|Overall Study||10
3119820|NCT01619839|3844774|FG004|STARTED|Overall Study||106
3119821|NCT01619839|3844770|FG000|COMPLETED|Overall Study||43
3119822|NCT01619839|3844771|FG001|COMPLETED|Overall Study||27
3119823|NCT01619839|3844772|FG002|COMPLETED|Overall Study||17
3119824|NCT01619839|3844773|FG003|COMPLETED|Overall Study||9
3119825|NCT01619839|3844774|FG004|COMPLETED|Overall Study||97
3119826|NCT01619839|3844770|FG000|NOT COMPLETED|Overall Study||5
3119827|NCT01619839|3844771|FG001|NOT COMPLETED|Overall Study||4
3119828|NCT01619839|3844772|FG002|NOT COMPLETED|Overall Study||1
3119829|NCT01619839|3844773|FG003|NOT COMPLETED|Overall Study||1
3119830|NCT01619839|3844774|FG004|NOT COMPLETED|Overall Study||9
3119831|NCT01619852|3844785|FG000|STARTED|24 Hour Assessment||75
3119832|NCT01619852|3844786|FG001|STARTED|24 Hour Assessment||75
3119833|NCT01619852|3844785|FG000|COMPLETED|24 Hour Assessment||74
3119834|NCT01619852|3844786|FG001|COMPLETED|24 Hour Assessment||74
3119835|NCT01619852|3844785|FG000|NOT COMPLETED|24 Hour Assessment||1
3119836|NCT01619852|3844786|FG001|NOT COMPLETED|24 Hour Assessment||1
3119837|NCT01619852|3844785|FG000|STARTED|3 Month Follow up||74
3119838|NCT01619852|3844786|FG001|STARTED|3 Month Follow up||74
3119839|NCT01619852|3844785|FG000|COMPLETED|3 Month Follow up||43
3119840|NCT01619852|3844786|FG001|COMPLETED|3 Month Follow up||40
3119841|NCT01619852|3844785|FG000|NOT COMPLETED|3 Month Follow up||31
3119842|NCT01619852|3844786|FG001|NOT COMPLETED|3 Month Follow up||34
3119843|NCT01619865|3844793|FG000|STARTED|Overall Study||223
3119844|NCT01619865|3844793|FG000|COMPLETED|Overall Study||219
3119845|NCT01619865|3844793|FG000|NOT COMPLETED|Overall Study||4
3119846|NCT01619878|3844798|FG000|STARTED|6 Week Follow-up Phase||20
3119847|NCT01619878|3844798|FG000|COMPLETED|6 Week Follow-up Phase||19
3119848|NCT01619878|3844798|FG000|NOT COMPLETED|6 Week Follow-up Phase||1
3119849|NCT01619878|3844798|FG000|STARTED|Follow-up at 12 Months of Age||20
3119850|NCT01619878|3844798|FG000|COMPLETED|Follow-up at 12 Months of Age||17
3119851|NCT01619878|3844798|FG000|NOT COMPLETED|Follow-up at 12 Months of Age||3
3119852|NCT01619982|3844804|FG000|STARTED|Overall Study||20
3119853|NCT01619982|3844805|FG001|STARTED|Overall Study||12
3119854|NCT01619982|3844804|FG000|COMPLETED|Overall Study||20
3119855|NCT01619982|3844805|FG001|COMPLETED|Overall Study||12
3119856|NCT01619982|3844804|FG000|NOT COMPLETED|Overall Study||0
3119857|NCT01619982|3844805|FG001|NOT COMPLETED|Overall Study||0
3119858|NCT01620047|3844818|FG000|STARTED|Overall Study||20
3119859|NCT01620047|3844819|FG001|STARTED|Overall Study||20
3119860|NCT01620047|3844820|FG002|STARTED|Overall Study||20
3119861|NCT01620047|3844818|FG000|COMPLETED|Overall Study||20
3119862|NCT01620047|3844819|FG001|COMPLETED|Overall Study||20
3119863|NCT01620047|3844820|FG002|COMPLETED|Overall Study||20
3119864|NCT01620047|3844818|FG000|NOT COMPLETED|Overall Study||0
3119865|NCT01620047|3844819|FG001|NOT COMPLETED|Overall Study||0
3119866|NCT01620047|3844820|FG002|NOT COMPLETED|Overall Study||0
3119867|NCT01620060|3844828|FG000|STARTED|Overall Study||105
3119868|NCT01620060|3844828|FG000|COMPLETED|Overall Study||90
3119869|NCT01620060|3844828|FG000|NOT COMPLETED|Overall Study||15
3119870|NCT01620086|3844834|FG000|STARTED|Overall Study||13
3119871|NCT01620086|3844835|FG001|STARTED|Overall Study||11
3119872|NCT01620086|3844836|FG002|STARTED|Overall Study||2
3119873|NCT01620086|3844834|FG000|COMPLETED|Overall Study||8
3119874|NCT01620086|3844835|FG001|COMPLETED|Overall Study||4
3119875|NCT01620086|3844836|FG002|COMPLETED|Overall Study||2
3119876|NCT01620086|3844834|FG000|NOT COMPLETED|Overall Study||5
3119877|NCT01620086|3844835|FG001|NOT COMPLETED|Overall Study||7
3119878|NCT01620086|3844836|FG002|NOT COMPLETED|Overall Study||0
3119879|NCT01620138|3844847|FG000|STARTED|Overall Study||12
3119880|NCT01620138|3844848|FG001|STARTED|Overall Study||9
3119881|NCT01620138|3844847|FG000|COMPLETED|Overall Study||6
3119882|NCT01620138|3844848|FG001|COMPLETED|Overall Study||9
3119883|NCT01620138|3844847|FG000|NOT COMPLETED|Overall Study||6
3119884|NCT01620138|3844848|FG001|NOT COMPLETED|Overall Study||0
3119885|NCT01620177|3844854|FG000|STARTED|Overall Study||98
3119886|NCT01620177|3844854|FG000|COMPLETED|Overall Study||19
3119887|NCT01620177|3844854|FG000|NOT COMPLETED|Overall Study||79
3119888|NCT01620190|3844871|FG000|STARTED|Overall Study||26
3119889|NCT01620190|3844871|FG000|COMPLETED|Overall Study||26
3119890|NCT01620190|3844871|FG000|NOT COMPLETED|Overall Study||0
3119891|NCT01620216|3844882|FG000|STARTED|Overall Study||4
3119892|NCT01620216|3844883|FG001|STARTED|Overall Study||2
3119893|NCT01620216|3844884|FG002|STARTED|Overall Study||6
3119894|NCT01620216|3844885|FG003|STARTED|Overall Study||0
3119895|NCT01620216|3844886|FG004|STARTED|Overall Study||0
3119896|NCT01620216|3844887|FG005|STARTED|Overall Study||0
3119897|NCT01620216|3844888|FG006|STARTED|Overall Study||0
3119898|NCT01620216|3844882|FG000|COMPLETED|Overall Study||4
3119899|NCT01620216|3844883|FG001|COMPLETED|Overall Study||2
3119900|NCT01620216|3844884|FG002|COMPLETED|Overall Study||6
3119901|NCT01620216|3844885|FG003|COMPLETED|Overall Study||0
3119902|NCT01620216|3844886|FG004|COMPLETED|Overall Study||0
3119903|NCT01620216|3844887|FG005|COMPLETED|Overall Study||0
3119904|NCT01620216|3844888|FG006|COMPLETED|Overall Study||0
3119905|NCT01620216|3844882|FG000|NOT COMPLETED|Overall Study||0
3119906|NCT01620216|3844883|FG001|NOT COMPLETED|Overall Study||0
3119907|NCT01620216|3844884|FG002|NOT COMPLETED|Overall Study||0
3119908|NCT01620216|3844885|FG003|NOT COMPLETED|Overall Study||0
3119909|NCT01620216|3844886|FG004|NOT COMPLETED|Overall Study||0
3119910|NCT01620216|3844887|FG005|NOT COMPLETED|Overall Study||0
3119911|NCT01620216|3844888|FG006|NOT COMPLETED|Overall Study||0
3119912|NCT01620255|3844909|FG000|STARTED|Overall Study||73
3119913|NCT01620255|3844910|FG001|STARTED|Overall Study||71
3119914|NCT01620255|3844911|FG002|STARTED|Overall Study||70
3119915|NCT01620255|3844912|FG003|STARTED|Overall Study||73
3119916|NCT01620255|3844913|FG004|STARTED|Overall Study||70
3119917|NCT01620255|3844909|FG000|Treated|Overall Study||73
3119918|NCT01620255|3844910|FG001|Treated|Overall Study||71
3119919|NCT01620255|3844911|FG002|Treated|Overall Study||70
3119920|NCT01620255|3844912|FG003|Treated|Overall Study||73
3119921|NCT01620255|3844913|FG004|Treated|Overall Study||70
3119922|NCT01620255|3844909|FG000|COMPLETED|Overall Study||69
3119923|NCT01620255|3844910|FG001|COMPLETED|Overall Study||65
3119924|NCT01620255|3844911|FG002|COMPLETED|Overall Study||68
3119925|NCT01620255|3844912|FG003|COMPLETED|Overall Study||70
3119926|NCT01620255|3844913|FG004|COMPLETED|Overall Study||64
3119927|NCT01620255|3844909|FG000|NOT COMPLETED|Overall Study||4
3119928|NCT01620255|3844910|FG001|NOT COMPLETED|Overall Study||6
3119929|NCT01620255|3844911|FG002|NOT COMPLETED|Overall Study||2
3119930|NCT01620255|3844912|FG003|NOT COMPLETED|Overall Study||3
3119931|NCT01620255|3844913|FG004|NOT COMPLETED|Overall Study||6
3119932|NCT01620489|3844927|FG000|STARTED|Overall Study||140
3119933|NCT01620489|3844928|FG001|STARTED|Overall Study||139
3119934|NCT01620489|3844927|FG000|Exposed|Overall Study||140
3119935|NCT01620489|3844928|FG001|Exposed|Overall Study|2 subjects did not take trial product|137
3119936|NCT01620489|3844927|FG000|COMPLETED|Overall Study||105
3119937|NCT01620489|3844928|FG001|COMPLETED|Overall Study|2 subjects did not take trial product|105
3119938|NCT01620489|3844927|FG000|NOT COMPLETED|Overall Study||35
3119939|NCT01620489|3844928|FG001|NOT COMPLETED|Overall Study||34
3119940|NCT01620528|3844937|FG000|STARTED|Treatment Period||374
3119941|NCT01620528|3844938|FG001|STARTED|Treatment Period||249
3119942|NCT01620528|3844939|FG002|STARTED|Treatment Period|1 subject did not receive study drug|249
3119943|NCT01620528|3844937|FG000|COMPLETED|Treatment Period||274
3119944|NCT01620528|3844938|FG001|COMPLETED|Treatment Period||196
3119945|NCT01620528|3844939|FG002|COMPLETED|Treatment Period||183
3119946|NCT01620528|3844937|FG000|NOT COMPLETED|Treatment Period||100
3119947|NCT01620528|3844938|FG001|NOT COMPLETED|Treatment Period||53
3119948|NCT01620528|3844939|FG002|NOT COMPLETED|Treatment Period||66
3119949|NCT01620528|3844937|FG000|STARTED|Post-Treatment Follow-Up Period|elected to enter the PTFU Period|68
3119950|NCT01620528|3844938|FG001|STARTED|Post-Treatment Follow-Up Period|elected to enter the PTFU Period|48
3119951|NCT01620528|3844939|FG002|STARTED|Post-Treatment Follow-Up Period|elected to enter the PTFU Period|51
3119952|NCT01620528|3844937|FG000|Completed PTFU Month 6|Post-Treatment Follow-Up Period||46
3119953|NCT01620528|3844938|FG001|Completed PTFU Month 6|Post-Treatment Follow-Up Period|Met criteria (reported a post-treatment menses, met the DXA criteria, and had a PTFU Month 6 visit).|26
3119954|NCT01620528|3844939|FG002|Completed PTFU Month 6|Post-Treatment Follow-Up Period|Met criteria (reported a post-treatment menses, met the DXA criteria, and had a PTFU Month 6 visit).|18
3119955|NCT01620528|3844937|FG000|Completed PTFU Month 12|Post-Treatment Follow-Up Period||2
3119956|NCT01620528|3844938|FG001|Completed PTFU Month 12|Post-Treatment Follow-Up Period||5
3119957|NCT01620528|3844939|FG002|Completed PTFU Month 12|Post-Treatment Follow-Up Period||19
3119958|NCT01620528|3844937|FG000|COMPLETED|Post-Treatment Follow-Up Period||48
3119959|NCT01620528|3844938|FG001|COMPLETED|Post-Treatment Follow-Up Period||31
3119960|NCT01620528|3844939|FG002|COMPLETED|Post-Treatment Follow-Up Period||37
3119961|NCT01620528|3844937|FG000|NOT COMPLETED|Post-Treatment Follow-Up Period||20
3119962|NCT01620528|3844938|FG001|NOT COMPLETED|Post-Treatment Follow-Up Period||17
3119963|NCT01620528|3844939|FG002|NOT COMPLETED|Post-Treatment Follow-Up Period||14
3119964|NCT01620567|3844949|FG000|STARTED|Overall Study||23
3119965|NCT01620567|3844950|FG001|STARTED|Overall Study||25
3119966|NCT01620567|3844949|FG000|COMPLETED|Overall Study||20
3119967|NCT01620567|3844950|FG001|COMPLETED|Overall Study||20
3119968|NCT01620567|3844949|FG000|NOT COMPLETED|Overall Study||3
3119969|NCT01620567|3844950|FG001|NOT COMPLETED|Overall Study||5
3119970|NCT01620593|3844961|FG000|STARTED|Overall Study||21
3119971|NCT01620593|3844962|FG001|STARTED|Overall Study||20
3119972|NCT01620593|3844961|FG000|COMPLETED|Overall Study||17
3119973|NCT01620593|3844962|FG001|COMPLETED|Overall Study||19
3119974|NCT01620593|3844961|FG000|NOT COMPLETED|Overall Study||4
3119975|NCT01620593|3844962|FG001|NOT COMPLETED|Overall Study||1
3119976|NCT01620658|3844971|FG000|STARTED|Overall Study||59
3119977|NCT01620658|3844972|FG001|STARTED|Overall Study||74
3119978|NCT01620658|3844973|FG002|STARTED|Overall Study||64
3119979|NCT01620658|3844971|FG000|COMPLETED|Overall Study||35
3119980|NCT01620658|3844972|FG001|COMPLETED|Overall Study||45
3119981|NCT01620658|3844973|FG002|COMPLETED|Overall Study||44
3119982|NCT01620658|3844971|FG000|NOT COMPLETED|Overall Study||24
3119983|NCT01620658|3844972|FG001|NOT COMPLETED|Overall Study||29
3119984|NCT01620658|3844973|FG002|NOT COMPLETED|Overall Study||20
3119985|NCT01620762|3844990|FG000|STARTED|Overall Study||468
3119986|NCT01620762|3844991|FG001|STARTED|Overall Study||470
3119987|NCT01620762|3844992|FG002|STARTED|Overall Study||470
3119988|NCT01620762|3844990|FG000|COMPLETED|Overall Study||420
3119989|NCT01620762|3844991|FG001|COMPLETED|Overall Study||412
3119990|NCT01620762|3844992|FG002|COMPLETED|Overall Study||417
3119991|NCT01620762|3844990|FG000|NOT COMPLETED|Overall Study||48
3119992|NCT01620762|3844991|FG001|NOT COMPLETED|Overall Study||58
3119993|NCT01620762|3844992|FG002|NOT COMPLETED|Overall Study||53
3119994|NCT01620983|3845003|FG000|STARTED|Overall Study||130
3119995|NCT01620983|3845004|FG001|STARTED|Overall Study||135
3119996|NCT01620983|3845005|FG002|STARTED|Overall Study||137
3119997|NCT01620983|3845003|FG000|COMPLETED|Overall Study||111
3119998|NCT01620983|3845004|FG001|COMPLETED|Overall Study||113
3119999|NCT01620983|3845005|FG002|COMPLETED|Overall Study||122
3120000|NCT01620983|3845003|FG000|NOT COMPLETED|Overall Study||19
3120001|NCT01620983|3845004|FG001|NOT COMPLETED|Overall Study||22
3120002|NCT01620983|3845005|FG002|NOT COMPLETED|Overall Study||15
3120003|NCT01621009|3845017|FG000|STARTED|Overall Study||113
3120004|NCT01621009|3845018|FG001|STARTED|Overall Study||116
3120005|NCT01621009|3845019|FG002|STARTED|Overall Study||121
3120006|NCT01621009|3845020|FG003|STARTED|Overall Study||113
3120007|NCT01621009|3845017|FG000|COMPLETED|Overall Study||70
3120008|NCT01621009|3845018|FG001|COMPLETED|Overall Study||65
3120009|NCT01621009|3845019|FG002|COMPLETED|Overall Study||58
3120010|NCT01621009|3845020|FG003|COMPLETED|Overall Study||60
3120011|NCT01621009|3845017|FG000|NOT COMPLETED|Overall Study||43
3120012|NCT01621009|3845018|FG001|NOT COMPLETED|Overall Study||51
3120013|NCT01621009|3845019|FG002|NOT COMPLETED|Overall Study||63
3120014|NCT01621009|3845020|FG003|NOT COMPLETED|Overall Study||53
3120015|NCT01621126|3845028|FG000|STARTED|Overall Study||40
3120016|NCT01621126|3845028|FG000|COMPLETED|Overall Study||34
3120017|NCT01621126|3845028|FG000|NOT COMPLETED|Overall Study||6
3120018|NCT01621178|3845035|FG000|STARTED|Overall Study||194
3120019|NCT01621178|3845036|FG001|STARTED|Overall Study||190
3120020|NCT01621178|3845037|FG002|STARTED|Overall Study||193
3120021|NCT01621178|3845035|FG000|Received at Least One Dose of Study Drug|Overall Study||194
3120022|NCT01621178|3845036|FG001|Received at Least One Dose of Study Drug|Overall Study||190
3120023|NCT01621178|3845037|FG002|Received at Least One Dose of Study Drug|Overall Study||192
3120024|NCT01621178|3845035|FG000|Modified Intent to Treat Population|Overall Study||186
3120025|NCT01621178|3845036|FG001|Modified Intent to Treat Population|Overall Study||180
3120026|NCT01621178|3845037|FG002|Modified Intent to Treat Population|Overall Study||183
3120027|NCT01621178|3845035|FG000|COMPLETED|Overall Study||163
3120028|NCT01621178|3845036|FG001|COMPLETED|Overall Study||160
3120029|NCT01621178|3845037|FG002|COMPLETED|Overall Study||157
3120030|NCT01621178|3845035|FG000|NOT COMPLETED|Overall Study||31
3120031|NCT01621178|3845036|FG001|NOT COMPLETED|Overall Study||30
3120032|NCT01621178|3845037|FG002|NOT COMPLETED|Overall Study||36
3120033|NCT01621191|3845049|FG000|STARTED|Overall Study||149
3120034|NCT01621191|3845049|FG000|Received at Least 1 Dose of Study Drug|Overall Study||149
3120035|NCT01621191|3845049|FG000|Had at Least 1 Post-Baseline Observation|Overall Study||148
3120036|NCT01621191|3845049|FG000|COMPLETED|Overall Study||124
3120037|NCT01621191|3845049|FG000|NOT COMPLETED|Overall Study||25
3120038|NCT01621230|3845056|FG000|STARTED|Overall Study||154
3120039|NCT01621230|3845057|FG001|STARTED|Overall Study||156
3120040|NCT01621230|3845056|FG000|COMPLETED|Overall Study||154
3120041|NCT01621230|3845057|FG001|COMPLETED|Overall Study||156
3120042|NCT01621230|3845056|FG000|NOT COMPLETED|Overall Study||0
3120043|NCT01621230|3845057|FG001|NOT COMPLETED|Overall Study||0
3120044|NCT01621477|3845066|FG000|STARTED|Overall Study||17
3120045|NCT01621477|3845066|FG000|COMPLETED|Overall Study||17
3120046|NCT01621477|3845066|FG000|NOT COMPLETED|Overall Study||0
3136145|NCT01710514|3861237|FG001|FAS With Embryo Transfer (ET)|Overall Study|Data on pregnancy was reported for the subjects with embryo transfer.|47
3136146|NCT01710514|3861236|FG000|Safety Analysis Set|Overall Study|All subjects received at least one dose of Investigational Medicinal Product (IMP).|54
3136147|NCT01710514|3861237|FG001|Safety Analysis Set|Overall Study|All subjects received at least one dose of IMP.|54
3136148|NCT01710514|3861236|FG000|COMPLETED|Overall Study||47
3136149|NCT01710514|3861237|FG001|COMPLETED|Overall Study||47
3136150|NCT01710514|3861236|FG000|NOT COMPLETED|Overall Study||7
3136151|NCT01710514|3861237|FG001|NOT COMPLETED|Overall Study||7
3136152|NCT01710527|3861246|FG000|STARTED|Period 1: Intervention Period 1||16
3136153|NCT01710527|3861247|FG001|STARTED|Period 1: Intervention Period 1||16
3136154|NCT01710527|3861246|FG000|COMPLETED|Period 1: Intervention Period 1||16
3136155|NCT01710527|3861247|FG001|COMPLETED|Period 1: Intervention Period 1||16
3136156|NCT01710527|3861246|FG000|NOT COMPLETED|Period 1: Intervention Period 1||0
3136157|NCT01710527|3861247|FG001|NOT COMPLETED|Period 1: Intervention Period 1||0
3136158|NCT01710527|3861246|FG000|STARTED|Period 2: Washout Period (7 Days)||16
3136159|NCT01710527|3861247|FG001|STARTED|Period 2: Washout Period (7 Days)||16
3136160|NCT01710527|3861246|FG000|COMPLETED|Period 2: Washout Period (7 Days)||16
3136161|NCT01710527|3861247|FG001|COMPLETED|Period 2: Washout Period (7 Days)||15
3136162|NCT01710527|3861246|FG000|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
3136163|NCT01710527|3861247|FG001|NOT COMPLETED|Period 2: Washout Period (7 Days)||1
3136164|NCT01710527|3861246|FG000|STARTED|Period 3: Intervention Period 2||16
3136165|NCT01710527|3861247|FG001|STARTED|Period 3: Intervention Period 2||15
3136166|NCT01710527|3861246|FG000|COMPLETED|Period 3: Intervention Period 2||16
3136167|NCT01710527|3861247|FG001|COMPLETED|Period 3: Intervention Period 2||15
3136168|NCT01710527|3861246|FG000|NOT COMPLETED|Period 3: Intervention Period 2||0
3136169|NCT01710527|3861247|FG001|NOT COMPLETED|Period 3: Intervention Period 2||0
3136170|NCT01710657|3861256|FG000|STARTED|Overall Study||184
3136171|NCT01710657|3861257|FG001|STARTED|Overall Study||183
3136172|NCT01710657|3861258|FG002|STARTED|Overall Study||180
3136173|NCT01710657|3861256|FG000|Titration Period (4 Weeks)|Overall Study||184
3136174|NCT01710657|3861257|FG001|Titration Period (4 Weeks)|Overall Study||183
3136175|NCT01710657|3861258|FG002|Titration Period (4 Weeks)|Overall Study||180
3136176|NCT01710657|3861256|FG000|Maintenance Period (12 Weeks)|Overall Study||176
3136177|NCT01710657|3861257|FG001|Maintenance Period (12 Weeks)|Overall Study||175
3136178|NCT01710657|3861258|FG002|Maintenance Period (12 Weeks)|Overall Study||168
3136179|NCT01710657|3861256|FG000|COMPLETED|Overall Study||166
3136180|NCT01710657|3861257|FG001|COMPLETED|Overall Study||171
3136181|NCT01710657|3861258|FG002|COMPLETED|Overall Study||148
3136182|NCT01710657|3861256|FG000|NOT COMPLETED|Overall Study||18
3136183|NCT01710657|3861257|FG001|NOT COMPLETED|Overall Study||12
3136184|NCT01710657|3861258|FG002|NOT COMPLETED|Overall Study||32
3136185|NCT01710709|3861266|FG000|STARTED|Overall Study||464
3136186|NCT01710709|3861266|FG000|COMPLETED|Overall Study||291
3136187|NCT01710709|3861266|FG000|NOT COMPLETED|Overall Study||173
3136188|NCT01710787|3861274|FG000|STARTED|Overall Study||44
3136189|NCT01710787|3861275|FG001|STARTED|Overall Study||44
3136190|NCT01710787|3861276|FG002|STARTED|Overall Study||22
3295124|NCT02895360|4029315|FG005|COMPLETED|Phase 1 - 30 mg/m² Cohort||0
3295125|NCT02895360|4029310|FG000|NOT COMPLETED|Phase 1 - 30 mg/m² Cohort||4
3295126|NCT02895360|4029311|FG001|NOT COMPLETED|Phase 1 - 30 mg/m² Cohort||0
3120047|NCT01621490|3845079|FG000|STARTED|Overall Study||41
3120048|NCT01621490|3845080|FG001|STARTED|Overall Study||44
3120049|NCT01621490|3845081|FG002|STARTED|Overall Study||11
3120050|NCT01621490|3845082|FG003|STARTED|Overall Study||10
3120051|NCT01621490|3845083|FG004|STARTED|Overall Study||6
3120052|NCT01621490|3845084|FG005|STARTED|Overall Study||25
3120053|NCT01621490|3845085|FG006|STARTED|Overall Study||11
3120054|NCT01621490|3845086|FG007|STARTED|Overall Study||10
3120055|NCT01621490|3845087|FG008|STARTED|Overall Study||10
3120056|NCT01621490|3845079|FG000|COMPLETED|Overall Study||0
3120057|NCT01621490|3845080|FG001|COMPLETED|Overall Study||0
3120058|NCT01621490|3845081|FG002|COMPLETED|Overall Study||0
3120059|NCT01621490|3845082|FG003|COMPLETED|Overall Study||1
3120060|NCT01621490|3845083|FG004|COMPLETED|Overall Study||0
3120061|NCT01621490|3845084|FG005|COMPLETED|Overall Study||1
3120062|NCT01621490|3845085|FG006|COMPLETED|Overall Study||0
3120063|NCT01621490|3845086|FG007|COMPLETED|Overall Study||0
3120064|NCT01621490|3845087|FG008|COMPLETED|Overall Study||2
3120065|NCT01621490|3845079|FG000|NOT COMPLETED|Overall Study||41
3120066|NCT01621490|3845080|FG001|NOT COMPLETED|Overall Study||44
3120067|NCT01621490|3845081|FG002|NOT COMPLETED|Overall Study||11
3120068|NCT01621490|3845082|FG003|NOT COMPLETED|Overall Study||9
3120069|NCT01621490|3845083|FG004|NOT COMPLETED|Overall Study||6
3120070|NCT01621490|3845084|FG005|NOT COMPLETED|Overall Study||24
3120071|NCT01621490|3845085|FG006|NOT COMPLETED|Overall Study||11
3120072|NCT01621490|3845086|FG007|NOT COMPLETED|Overall Study||10
3120073|NCT01621490|3845087|FG008|NOT COMPLETED|Overall Study||8
3120074|NCT01621542|3845206|FG000|STARTED|Overall Study||5
3120075|NCT01621542|3845207|FG001|STARTED|Overall Study||5
3120076|NCT01621542|3845208|FG002|STARTED|Overall Study||6
3120077|NCT01621542|3845209|FG003|STARTED|Overall Study||28
3120078|NCT01621542|3845210|FG004|STARTED|Overall Study||9
3120079|NCT01621542|3845211|FG005|STARTED|Overall Study||9
3120080|NCT01621542|3845206|FG000|COMPLETED|Overall Study||0
3120081|NCT01621542|3845207|FG001|COMPLETED|Overall Study||0
3120082|NCT01621542|3845208|FG002|COMPLETED|Overall Study||0
3120083|NCT01621542|3845209|FG003|COMPLETED|Overall Study||0
3120084|NCT01621542|3845210|FG004|COMPLETED|Overall Study||0
3120085|NCT01621542|3845211|FG005|COMPLETED|Overall Study||0
3120086|NCT01621542|3845206|FG000|NOT COMPLETED|Overall Study||5
3120087|NCT01621542|3845207|FG001|NOT COMPLETED|Overall Study||5
3120088|NCT01621542|3845208|FG002|NOT COMPLETED|Overall Study||6
3120089|NCT01621542|3845209|FG003|NOT COMPLETED|Overall Study||28
3120090|NCT01621542|3845210|FG004|NOT COMPLETED|Overall Study||9
3120091|NCT01621542|3845211|FG005|NOT COMPLETED|Overall Study||9
3120092|NCT01621633|3845229|FG000|STARTED|Overall Study||8
3120093|NCT01621633|3845230|FG001|STARTED|Overall Study||8
3120094|NCT01621633|3845231|FG002|STARTED|Overall Study||8
3120095|NCT01621633|3845232|FG003|STARTED|Overall Study||8
3120096|NCT01621633|3845229|FG000|COMPLETED|Overall Study||8
3120097|NCT01621633|3845230|FG001|COMPLETED|Overall Study||8
3120098|NCT01621633|3845231|FG002|COMPLETED|Overall Study||8
3120099|NCT01621633|3845232|FG003|COMPLETED|Overall Study||8
3120100|NCT01621633|3845229|FG000|NOT COMPLETED|Overall Study||0
3120101|NCT01621633|3845230|FG001|NOT COMPLETED|Overall Study||0
3120102|NCT01621633|3845231|FG002|NOT COMPLETED|Overall Study||0
3120103|NCT01621633|3845232|FG003|NOT COMPLETED|Overall Study||0
3120104|NCT01621672|3845244|FG000|STARTED|Overall Study||25
3120105|NCT01621672|3845245|FG001|STARTED|Overall Study||17
3120106|NCT01621672|3845244|FG000|COMPLETED|Overall Study||25
3120107|NCT01621672|3845245|FG001|COMPLETED|Overall Study||17
3120108|NCT01621672|3845244|FG000|NOT COMPLETED|Overall Study||0
3120109|NCT01621672|3845245|FG001|NOT COMPLETED|Overall Study||0
3120110|NCT01621776|3845254|FG000|STARTED|Overall Study||41
3120111|NCT01621776|3845255|FG001|STARTED|Overall Study||40
3120112|NCT01621776|3845256|FG002|STARTED|Overall Study||18
3120113|NCT01621776|3845254|FG000|COMPLETED|Overall Study||41
3120114|NCT01621776|3845255|FG001|COMPLETED|Overall Study||40
3120115|NCT01621776|3845256|FG002|COMPLETED|Overall Study||18
3120116|NCT01621776|3845254|FG000|NOT COMPLETED|Overall Study||0
3120117|NCT01621776|3845255|FG001|NOT COMPLETED|Overall Study||0
3120118|NCT01621776|3845256|FG002|NOT COMPLETED|Overall Study||0
3120119|NCT01621802|3845270|FG000|STARTED|Overall Study||802
3120120|NCT01621802|3845271|FG001|STARTED|Overall Study||298
3120121|NCT01621802|3845272|FG002|STARTED|Overall Study||796
3120122|NCT01621802|3845273|FG003|STARTED|Overall Study||303
3120123|NCT01621802|3845274|FG004|STARTED|Overall Study||1319
3120124|NCT01621802|3845275|FG005|STARTED|Overall Study||489
3120125|NCT01621802|3845270|FG000|COMPLETED|Overall Study||755
3120126|NCT01621802|3845271|FG001|COMPLETED|Overall Study||275
3120127|NCT01621802|3845272|FG002|COMPLETED|Overall Study||763
3120128|NCT01621802|3845273|FG003|COMPLETED|Overall Study||292
3120129|NCT01621802|3845274|FG004|COMPLETED|Overall Study||1284
3120130|NCT01621802|3845275|FG005|COMPLETED|Overall Study||477
3120131|NCT01621802|3845270|FG000|NOT COMPLETED|Overall Study||47
3120132|NCT01621802|3845271|FG001|NOT COMPLETED|Overall Study||23
3120133|NCT01621802|3845272|FG002|NOT COMPLETED|Overall Study||33
3120134|NCT01621802|3845273|FG003|NOT COMPLETED|Overall Study||11
3120135|NCT01621802|3845274|FG004|NOT COMPLETED|Overall Study||35
3120136|NCT01621802|3845275|FG005|NOT COMPLETED|Overall Study||12
3120137|NCT01621880|3845294|FG000|STARTED|Overall Study||58
3120138|NCT01621880|3845295|FG001|STARTED|Overall Study||54
3120139|NCT01621880|3845294|FG000|COMPLETED|Overall Study||48
3120140|NCT01621880|3845295|FG001|COMPLETED|Overall Study||49
3120141|NCT01621880|3845294|FG000|NOT COMPLETED|Overall Study||10
3120142|NCT01621880|3845295|FG001|NOT COMPLETED|Overall Study||5
3120143|NCT01622010|3845304|FG000|STARTED|Overall Study||18
3120144|NCT01622010|3845305|FG001|STARTED|Overall Study||12
3120145|NCT01622010|3845304|FG000|COMPLETED|Overall Study||12
3120146|NCT01622010|3845305|FG001|COMPLETED|Overall Study||8
3120147|NCT01622010|3845304|FG000|NOT COMPLETED|Overall Study||6
3120148|NCT01622010|3845305|FG001|NOT COMPLETED|Overall Study||4
3120149|NCT01622231|3845313|FG000|STARTED|Overall Study||61
3120150|NCT01622231|3845313|FG000|COMPLETED|Overall Study||59
3120151|NCT01622231|3845313|FG000|NOT COMPLETED|Overall Study||2
3120152|NCT01622257|3845320|FG000|STARTED|Overall Study||66
3120153|NCT01622257|3845321|FG001|STARTED|Overall Study||66
3120154|NCT01622257|3845322|FG002|STARTED|Overall Study||66
3120155|NCT01622257|3845320|FG000|COMPLETED|Overall Study||66
3120156|NCT01622257|3845321|FG001|COMPLETED|Overall Study||66
3120157|NCT01622257|3845322|FG002|COMPLETED|Overall Study||66
3120158|NCT01622257|3845320|FG000|NOT COMPLETED|Overall Study||0
3120159|NCT01622257|3845321|FG001|NOT COMPLETED|Overall Study||0
3120160|NCT01622257|3845322|FG002|NOT COMPLETED|Overall Study||0
3120161|NCT01622296|3845330|FG000|STARTED|First Intervention||10
3120162|NCT01622296|3845331|FG001|STARTED|First Intervention||10
3120163|NCT01622296|3845330|FG000|COMPLETED|First Intervention||10
3120164|NCT01622296|3845331|FG001|COMPLETED|First Intervention||10
3120165|NCT01622296|3845330|FG000|NOT COMPLETED|First Intervention||0
3120166|NCT01622296|3845331|FG001|NOT COMPLETED|First Intervention||0
3120167|NCT01622296|3845330|FG000|STARTED|Washout Period of at Least 1 Week||10
3120168|NCT01622296|3845331|FG001|STARTED|Washout Period of at Least 1 Week||10
3120169|NCT01622296|3845330|FG000|COMPLETED|Washout Period of at Least 1 Week||10
3120170|NCT01622296|3845331|FG001|COMPLETED|Washout Period of at Least 1 Week||10
3120171|NCT01622296|3845330|FG000|NOT COMPLETED|Washout Period of at Least 1 Week||0
3120172|NCT01622296|3845331|FG001|NOT COMPLETED|Washout Period of at Least 1 Week||0
3120173|NCT01622296|3845330|FG000|STARTED|Second Intervention||10
3120174|NCT01622296|3845331|FG001|STARTED|Second Intervention||10
3120175|NCT01622296|3845330|FG000|COMPLETED|Second Intervention||10
3120176|NCT01622296|3845331|FG001|COMPLETED|Second Intervention||10
3120177|NCT01622296|3845330|FG000|NOT COMPLETED|Second Intervention||0
3120178|NCT01622296|3845331|FG001|NOT COMPLETED|Second Intervention||0
3120179|NCT01622348|3845339|FG000|STARTED|Overall Study||15
3120180|NCT01622348|3845340|FG001|STARTED|Overall Study||14
3120181|NCT01622348|3845341|FG002|STARTED|Overall Study||15
3120182|NCT01622348|3845339|FG000|COMPLETED|Overall Study||14
3120183|NCT01622348|3845340|FG001|COMPLETED|Overall Study||14
3120184|NCT01622348|3845341|FG002|COMPLETED|Overall Study||14
3120185|NCT01622348|3845339|FG000|NOT COMPLETED|Overall Study||1
3120186|NCT01622348|3845340|FG001|NOT COMPLETED|Overall Study||0
3120187|NCT01622348|3845341|FG002|NOT COMPLETED|Overall Study||1
3120188|NCT01622543|3845351|FG000|STARTED|Overall Study||51
3120189|NCT01622543|3845352|FG001|STARTED|Overall Study||52
3120190|NCT01622543|3845351|FG000|COMPLETED|Overall Study||51
3120191|NCT01622543|3845352|FG001|COMPLETED|Overall Study||52
3120192|NCT01622543|3845351|FG000|NOT COMPLETED|Overall Study||0
3120193|NCT01622543|3845352|FG001|NOT COMPLETED|Overall Study||0
3120194|NCT01622569|3845362|FG000|STARTED|Double-Blind Treatment Phase (Wks 1-16)||82
3120195|NCT01622569|3845363|FG001|STARTED|Double-Blind Treatment Phase (Wks 1-16)||81
3120196|NCT01622569|3845364|FG002|STARTED|Double-Blind Treatment Phase (Wks 1-16)||80
3120197|NCT01622569|3845365|FG003|STARTED|Double-Blind Treatment Phase (Wks 1-16)||80
3120198|NCT01622569|3845362|FG000|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||70
3120199|NCT01622569|3845363|FG001|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||75
3120200|NCT01622569|3845364|FG002|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||71
3120201|NCT01622569|3845365|FG003|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||76
3120202|NCT01622569|3845362|FG000|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||12
3120203|NCT01622569|3845363|FG001|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||6
3120204|NCT01622569|3845364|FG002|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||9
3120205|NCT01622569|3845365|FG003|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||4
3120206|NCT01622569|3845362|FG000|STARTED|Open-Label Extension Phase (Wks 17-24)||68
3120207|NCT01622569|3845363|FG001|STARTED|Open-Label Extension Phase (Wks 17-24)||72
3120208|NCT01622569|3845364|FG002|STARTED|Open-Label Extension Phase (Wks 17-24)||67
3120209|NCT01622569|3845365|FG003|STARTED|Open-Label Extension Phase (Wks 17-24)||75
3120210|NCT01622569|3845362|FG000|COMPLETED|Open-Label Extension Phase (Wks 17-24)||67
3120211|NCT01622569|3845363|FG001|COMPLETED|Open-Label Extension Phase (Wks 17-24)||70
3120212|NCT01622569|3845364|FG002|COMPLETED|Open-Label Extension Phase (Wks 17-24)||64
3120213|NCT01622569|3845365|FG003|COMPLETED|Open-Label Extension Phase (Wks 17-24)||73
3120214|NCT01622569|3845362|FG000|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||1
3120215|NCT01622569|3845363|FG001|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||2
3120216|NCT01622569|3845364|FG002|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||3
3120217|NCT01622569|3845365|FG003|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||2
3120218|NCT01622660|3845385|FG000|STARTED|Overall Study||2
3120219|NCT01622660|3845385|FG000|COMPLETED|Overall Study||1
3120220|NCT01622660|3845385|FG000|NOT COMPLETED|Overall Study||1
3120221|NCT01622673|3845395|FG000|STARTED|Treatment Period 1||4
3120222|NCT01622673|3845396|FG001|STARTED|Treatment Period 1||5
3120223|NCT01622673|3845397|FG002|STARTED|Treatment Period 1||4
3120224|NCT01622673|3845398|FG003|STARTED|Treatment Period 1||6
3120225|NCT01622673|3845399|FG004|STARTED|Treatment Period 1||4
3120226|NCT01622673|3845400|FG005|STARTED|Treatment Period 1||4
3120227|NCT01622673|3845395|FG000|COMPLETED|Treatment Period 1||4
3120228|NCT01622673|3845396|FG001|COMPLETED|Treatment Period 1||4
3120229|NCT01622673|3845397|FG002|COMPLETED|Treatment Period 1||4
3120230|NCT01622673|3845398|FG003|COMPLETED|Treatment Period 1||5
3120231|NCT01622673|3845399|FG004|COMPLETED|Treatment Period 1||4
3120232|NCT01622673|3845400|FG005|COMPLETED|Treatment Period 1||4
3120233|NCT01622673|3845395|FG000|NOT COMPLETED|Treatment Period 1||0
3120234|NCT01622673|3845396|FG001|NOT COMPLETED|Treatment Period 1||1
3120235|NCT01622673|3845397|FG002|NOT COMPLETED|Treatment Period 1||0
3120236|NCT01622673|3845398|FG003|NOT COMPLETED|Treatment Period 1||1
3120237|NCT01622673|3845399|FG004|NOT COMPLETED|Treatment Period 1||0
3120238|NCT01622673|3845400|FG005|NOT COMPLETED|Treatment Period 1||0
3120239|NCT01622673|3845395|FG000|STARTED|Treatment Period 2||4
3120240|NCT01622673|3845396|FG001|STARTED|Treatment Period 2||4
3120241|NCT01622673|3845397|FG002|STARTED|Treatment Period 2||4
3120242|NCT01622673|3845398|FG003|STARTED|Treatment Period 2||5
3120243|NCT01622673|3845399|FG004|STARTED|Treatment Period 2||4
3120244|NCT01622673|3845400|FG005|STARTED|Treatment Period 2||4
3120245|NCT01622673|3845395|FG000|COMPLETED|Treatment Period 2||4
3120246|NCT01622673|3845396|FG001|COMPLETED|Treatment Period 2||4
3120247|NCT01622673|3845397|FG002|COMPLETED|Treatment Period 2||4
3120248|NCT01622673|3845398|FG003|COMPLETED|Treatment Period 2||4
3120249|NCT01622673|3845399|FG004|COMPLETED|Treatment Period 2||4
3120250|NCT01622673|3845400|FG005|COMPLETED|Treatment Period 2||4
3120251|NCT01622673|3845395|FG000|NOT COMPLETED|Treatment Period 2||0
3120252|NCT01622673|3845396|FG001|NOT COMPLETED|Treatment Period 2||0
3120253|NCT01622673|3845397|FG002|NOT COMPLETED|Treatment Period 2||0
3120254|NCT01622673|3845398|FG003|NOT COMPLETED|Treatment Period 2||1
3120255|NCT01622673|3845399|FG004|NOT COMPLETED|Treatment Period 2||0
3120256|NCT01622673|3845400|FG005|NOT COMPLETED|Treatment Period 2||0
3120257|NCT01622673|3845395|FG000|STARTED|Treatment Period 3||4
3120258|NCT01622673|3845396|FG001|STARTED|Treatment Period 3||4
3120259|NCT01622673|3845397|FG002|STARTED|Treatment Period 3||4
3120260|NCT01622673|3845398|FG003|STARTED|Treatment Period 3||4
3120261|NCT01622673|3845399|FG004|STARTED|Treatment Period 3||4
3120262|NCT01622673|3845400|FG005|STARTED|Treatment Period 3||4
3120263|NCT01622673|3845395|FG000|COMPLETED|Treatment Period 3||4
3120264|NCT01622673|3845396|FG001|COMPLETED|Treatment Period 3||3
3120265|NCT01622673|3845397|FG002|COMPLETED|Treatment Period 3||4
3120266|NCT01622673|3845398|FG003|COMPLETED|Treatment Period 3||4
3120267|NCT01622673|3845399|FG004|COMPLETED|Treatment Period 3||4
3120268|NCT01622673|3845400|FG005|COMPLETED|Treatment Period 3||4
3120269|NCT01622673|3845395|FG000|NOT COMPLETED|Treatment Period 3||0
3120270|NCT01622673|3845396|FG001|NOT COMPLETED|Treatment Period 3||1
3120271|NCT01622673|3845397|FG002|NOT COMPLETED|Treatment Period 3||0
3120272|NCT01622673|3845398|FG003|NOT COMPLETED|Treatment Period 3||0
3120273|NCT01622673|3845399|FG004|NOT COMPLETED|Treatment Period 3||0
3120274|NCT01622673|3845400|FG005|NOT COMPLETED|Treatment Period 3||0
3120275|NCT01622673|3845395|FG000|STARTED|Treatment Period 4||4
3120276|NCT01622673|3845396|FG001|STARTED|Treatment Period 4||3
3120277|NCT01622673|3845397|FG002|STARTED|Treatment Period 4||4
3120278|NCT01622673|3845398|FG003|STARTED|Treatment Period 4||4
3120279|NCT01622673|3845399|FG004|STARTED|Treatment Period 4||4
3120280|NCT01622673|3845400|FG005|STARTED|Treatment Period 4||4
3120281|NCT01622673|3845395|FG000|COMPLETED|Treatment Period 4||4
3120282|NCT01622673|3845396|FG001|COMPLETED|Treatment Period 4||3
3120283|NCT01622673|3845397|FG002|COMPLETED|Treatment Period 4||4
3120284|NCT01622673|3845398|FG003|COMPLETED|Treatment Period 4||4
3120285|NCT01622673|3845399|FG004|COMPLETED|Treatment Period 4||4
3120286|NCT01622673|3845400|FG005|COMPLETED|Treatment Period 4||4
3120287|NCT01622673|3845395|FG000|NOT COMPLETED|Treatment Period 4||0
3120288|NCT01622673|3845396|FG001|NOT COMPLETED|Treatment Period 4||0
3120289|NCT01622673|3845397|FG002|NOT COMPLETED|Treatment Period 4||0
3120290|NCT01622673|3845398|FG003|NOT COMPLETED|Treatment Period 4||0
3120291|NCT01622673|3845399|FG004|NOT COMPLETED|Treatment Period 4||0
3120292|NCT01622673|3845400|FG005|NOT COMPLETED|Treatment Period 4||0
3120293|NCT01622673|3845395|FG000|STARTED|Treatment Period 5||4
3120294|NCT01622673|3845396|FG001|STARTED|Treatment Period 5||3
3120295|NCT01622673|3845397|FG002|STARTED|Treatment Period 5||4
3120296|NCT01622673|3845398|FG003|STARTED|Treatment Period 5||4
3120297|NCT01622673|3845399|FG004|STARTED|Treatment Period 5||4
3120298|NCT01622673|3845400|FG005|STARTED|Treatment Period 5||4
3120299|NCT01622673|3845395|FG000|COMPLETED|Treatment Period 5||4
3120300|NCT01622673|3845396|FG001|COMPLETED|Treatment Period 5||3
3120301|NCT01622673|3845397|FG002|COMPLETED|Treatment Period 5||4
3120302|NCT01622673|3845398|FG003|COMPLETED|Treatment Period 5||4
3120303|NCT01622673|3845399|FG004|COMPLETED|Treatment Period 5||4
3120304|NCT01622673|3845400|FG005|COMPLETED|Treatment Period 5||4
3120305|NCT01622673|3845395|FG000|NOT COMPLETED|Treatment Period 5||0
3120306|NCT01622673|3845396|FG001|NOT COMPLETED|Treatment Period 5||0
3120307|NCT01622673|3845397|FG002|NOT COMPLETED|Treatment Period 5||0
3120308|NCT01622673|3845398|FG003|NOT COMPLETED|Treatment Period 5||0
3120309|NCT01622673|3845399|FG004|NOT COMPLETED|Treatment Period 5||0
3120310|NCT01622673|3845400|FG005|NOT COMPLETED|Treatment Period 5||0
3120311|NCT01622699|3845421|FG000|STARTED|Overall Study||213
3120312|NCT01622699|3845422|FG001|STARTED|Overall Study||217
3120313|NCT01622699|3845421|FG000|COMPLETED|Overall Study||213
3120314|NCT01622699|3845422|FG001|COMPLETED|Overall Study||217
3120315|NCT01622699|3845421|FG000|NOT COMPLETED|Overall Study||0
3120316|NCT01622699|3845422|FG001|NOT COMPLETED|Overall Study||0
3120317|NCT01623037|3845428|FG000|STARTED|Overall Study||15
3120318|NCT01623037|3845428|FG000|COMPLETED|Overall Study||15
3120319|NCT01623037|3845428|FG000|NOT COMPLETED|Overall Study||0
3120320|NCT01623050|3845434|FG000|STARTED|Overall Study||36
3120321|NCT01623050|3845434|FG000|Treated|Overall Study||34
3120322|NCT01623050|3845434|FG000|COMPLETED|Overall Study||27
3120323|NCT01623050|3845434|FG000|NOT COMPLETED|Overall Study||9
3120324|NCT01623115|3845440|FG000|STARTED|Overall Study|Randomized|163
3120325|NCT01623115|3845441|FG001|STARTED|Overall Study|Randomized|323
3120326|NCT01623115|3845440|FG000|Treated|Overall Study||163
3120327|NCT01623115|3845441|FG001|Treated|Overall Study||322
3120328|NCT01623115|3845440|FG000|COMPLETED|Overall Study||130
3120329|NCT01623115|3845441|FG001|COMPLETED|Overall Study||246
3120330|NCT01623115|3845440|FG000|NOT COMPLETED|Overall Study||33
3120331|NCT01623115|3845441|FG001|NOT COMPLETED|Overall Study||77
3120332|NCT01623154|3845447|FG000|STARTED|Overall Study||99
3120333|NCT01623154|3845447|FG000|Available for Analysis|Overall Study||95
3120334|NCT01623154|3845447|FG000|COMPLETED|Overall Study||95
3120335|NCT01623154|3845447|FG000|NOT COMPLETED|Overall Study||4
3120336|NCT01623167|3845456|FG000|STARTED|Overall Study||30
3120337|NCT01623167|3845457|FG001|STARTED|Overall Study||31
3120338|NCT01623167|3845458|FG002|STARTED|Overall Study||31
3120339|NCT01623167|3845456|FG000|COMPLETED|Overall Study||13
3120340|NCT01623167|3845457|FG001|COMPLETED|Overall Study||17
3120341|NCT01623167|3845458|FG002|COMPLETED|Overall Study||18
3120342|NCT01623167|3845456|FG000|NOT COMPLETED|Overall Study||17
3120343|NCT01623167|3845457|FG001|NOT COMPLETED|Overall Study||14
3120344|NCT01623167|3845458|FG002|NOT COMPLETED|Overall Study||13
3120345|NCT01623271|3845466|FG000|STARTED|Overall Study||5
3120346|NCT01623271|3845466|FG000|COMPLETED|Overall Study||3
3120347|NCT01623271|3845466|FG000|NOT COMPLETED|Overall Study||2
3120348|NCT01623310|3845470|FG000|STARTED|Overall Study||223
3120349|NCT01623310|3845470|FG000|COMPLETED|Overall Study||144
3120350|NCT01623310|3845470|FG000|NOT COMPLETED|Overall Study||79
3120351|NCT01623323|3845474|FG000|STARTED|Overall Study||705
3120352|NCT01623323|3845474|FG000|COMPLETED|Overall Study||601
3120353|NCT01623323|3845474|FG000|NOT COMPLETED|Overall Study||104
3120354|NCT01623466|3845480|FG000|STARTED|Overall Study||18
3120355|NCT01623466|3845481|FG001|STARTED|Overall Study||18
3120356|NCT01623466|3845480|FG000|COMPLETED|Overall Study||17
3120357|NCT01623466|3845481|FG001|COMPLETED|Overall Study||18
3120358|NCT01623466|3845480|FG000|NOT COMPLETED|Overall Study||1
3120359|NCT01623466|3845481|FG001|NOT COMPLETED|Overall Study||0
3120360|NCT01623479|3845487|FG000|STARTED|Overall Study||585
3120361|NCT01623479|3845487|FG000|COMPLETED|Overall Study||585
3120362|NCT01623479|3845487|FG000|NOT COMPLETED|Overall Study||0
3120363|NCT01623531|3845493|FG000|STARTED|Overall Study||31
3120364|NCT01623531|3845494|FG001|STARTED|Overall Study||31
3120365|NCT01623531|3845493|FG000|COMPLETED|Overall Study||27
3120366|NCT01623531|3845494|FG001|COMPLETED|Overall Study||29
3120367|NCT01623531|3845493|FG000|NOT COMPLETED|Overall Study||4
3120368|NCT01623531|3845494|FG001|NOT COMPLETED|Overall Study||2
3120369|NCT01623596|3845505|FG000|STARTED|Overall Study||436
3120370|NCT01623596|3845506|FG001|STARTED|Overall Study||439
3120371|NCT01623596|3845505|FG000|On Randomized Treatment|Overall Study||352
3120372|NCT01623596|3845506|FG001|On Randomized Treatment|Overall Study||125
3120373|NCT01623596|3845505|FG000|On Switched Treatment|Overall Study||22
3120374|NCT01623596|3845506|FG001|On Switched Treatment|Overall Study||214
3120375|NCT01623596|3845505|FG000|COMPLETED|Overall Study||374
3120376|NCT01623596|3845506|FG001|COMPLETED|Overall Study||339
3120377|NCT01623596|3845505|FG000|NOT COMPLETED|Overall Study||62
3120378|NCT01623596|3845506|FG001|NOT COMPLETED|Overall Study||100
3120379|NCT01623739|3845516|FG000|STARTED|Overall Study||19
3120380|NCT01623739|3845517|FG001|STARTED|Overall Study||19
3120381|NCT01623739|3845516|FG000|COMPLETED|Overall Study||17
3120382|NCT01623739|3845517|FG001|COMPLETED|Overall Study||15
3120383|NCT01623739|3845516|FG000|NOT COMPLETED|Overall Study||2
3120384|NCT01623739|3845517|FG001|NOT COMPLETED|Overall Study||4
3120385|NCT01623752|3845527|FG000|STARTED|Phase 1 (78 Weeks)||1378
3120386|NCT01623752|3845528|FG001|STARTED|Phase 1 (78 Weeks)||440
3120387|NCT01623752|3845529|FG002|STARTED|Phase 1 (78 Weeks)||3
3120388|NCT01623752|3845527|FG000|COMPLETED|Phase 1 (78 Weeks)||747
3120389|NCT01623752|3845528|FG001|COMPLETED|Phase 1 (78 Weeks)||233
3120390|NCT01623752|3845529|FG002|COMPLETED|Phase 1 (78 Weeks)||1
3120391|NCT01623752|3845527|FG000|NOT COMPLETED|Phase 1 (78 Weeks)||631
3120392|NCT01623752|3845528|FG001|NOT COMPLETED|Phase 1 (78 Weeks)||207
3120393|NCT01623752|3845529|FG002|NOT COMPLETED|Phase 1 (78 Weeks)||2
3120394|NCT01623752|3845527|FG000|STARTED|Phase 2 (78 Weeks)|Participants only who consented to continue in Period 2.|291
3120395|NCT01623752|3845528|FG001|STARTED|Phase 2 (78 Weeks)|Participants only who consented to continue in Period 2.|116
3120396|NCT01623752|3845529|FG002|STARTED|Phase 2 (78 Weeks)|Participants only who consented to continue in Period 2.|0
3120397|NCT01623752|3845527|FG000|COMPLETED|Phase 2 (78 Weeks)||225
3120398|NCT01623752|3845528|FG001|COMPLETED|Phase 2 (78 Weeks)||98
3120399|NCT01623752|3845529|FG002|COMPLETED|Phase 2 (78 Weeks)||0
3120400|NCT01623752|3845527|FG000|NOT COMPLETED|Phase 2 (78 Weeks)||66
3120401|NCT01623752|3845528|FG001|NOT COMPLETED|Phase 2 (78 Weeks)||18
3120402|NCT01623752|3845529|FG002|NOT COMPLETED|Phase 2 (78 Weeks)||0
3120403|NCT01623830|3845540|FG000|STARTED|Overall Study||45
3120404|NCT01623830|3845541|FG001|STARTED|Overall Study||44
3120405|NCT01623830|3845540|FG000|COMPLETED|Overall Study||38
3120406|NCT01623830|3845541|FG001|COMPLETED|Overall Study||35
3120407|NCT01623830|3845540|FG000|NOT COMPLETED|Overall Study||7
3120408|NCT01623830|3845541|FG001|NOT COMPLETED|Overall Study||9
3120409|NCT01623869|3845547|FG000|STARTED|Overall Study||16
3120410|NCT01623869|3845547|FG000|COMPLETED|Overall Study||16
3120411|NCT01623869|3845547|FG000|NOT COMPLETED|Overall Study||0
3120412|NCT01624090|3845555|FG000|STARTED|Overall Study||2
3120413|NCT01624090|3845556|FG001|STARTED|Overall Study||2
3120414|NCT01624090|3845557|FG002|STARTED|Overall Study||10
3120415|NCT01624090|3845558|FG003|STARTED|Overall Study||2
3120416|NCT01624090|3845555|FG000|COMPLETED|Overall Study||2
3120417|NCT01624090|3845556|FG001|COMPLETED|Overall Study||0
3120418|NCT01624090|3845557|FG002|COMPLETED|Overall Study||3
3120419|NCT01624090|3845558|FG003|COMPLETED|Overall Study||2
3120420|NCT01624090|3845555|FG000|NOT COMPLETED|Overall Study||0
3120421|NCT01624090|3845556|FG001|NOT COMPLETED|Overall Study||2
3120422|NCT01624090|3845557|FG002|NOT COMPLETED|Overall Study||7
3120423|NCT01624090|3845558|FG003|NOT COMPLETED|Overall Study||0
3120424|NCT01624142|3845570|FG000|STARTED|Overall Study||106
3120425|NCT01624142|3845571|FG001|STARTED|Overall Study||194
3120426|NCT01624142|3845570|FG000|COMPLETED|Overall Study||74
3120427|NCT01624142|3845571|FG001|COMPLETED|Overall Study||178
3120428|NCT01624142|3845570|FG000|NOT COMPLETED|Overall Study||32
3120429|NCT01624142|3845571|FG001|NOT COMPLETED|Overall Study||16
3120430|NCT01624168|3845581|FG000|STARTED|Overall Study||19
3120431|NCT01624168|3845582|FG001|STARTED|Overall Study||28
3120432|NCT01624168|3845583|FG002|STARTED|Overall Study||28
3120433|NCT01624168|3845581|FG000|COMPLETED|Overall Study||15
3120434|NCT01624168|3845582|FG001|COMPLETED|Overall Study||16
3120435|NCT01624168|3845583|FG002|COMPLETED|Overall Study||22
3120436|NCT01624168|3845581|FG000|NOT COMPLETED|Overall Study||4
3120437|NCT01624168|3845582|FG001|NOT COMPLETED|Overall Study||12
3120438|NCT01624168|3845583|FG002|NOT COMPLETED|Overall Study||6
3120439|NCT01624194|3845593|FG000|STARTED|Overall Study||16
3120440|NCT01624194|3845594|FG001|STARTED|Overall Study||18
3120441|NCT01624194|3845593|FG000|COMPLETED|Overall Study||14
3120442|NCT01624194|3845594|FG001|COMPLETED|Overall Study||18
3120443|NCT01624194|3845593|FG000|NOT COMPLETED|Overall Study||2
3120444|NCT01624194|3845594|FG001|NOT COMPLETED|Overall Study||0
3120445|NCT01624233|3845601|FG000|STARTED|Period 2 - Induction||91
3120446|NCT01624233|3845601|FG000|Received at Least 1 Dose of Study Drug|Period 2 - Induction||91
3120447|NCT01624233|3845601|FG000|Erythrodermic Psoriasis (Ps)|Period 2 - Induction||8
3120448|NCT01624233|3845601|FG000|Pustular Ps|Period 2 - Induction||5
3120449|NCT01624233|3845601|FG000|Plaque Ps|Period 2 - Induction||78
3120450|NCT01624233|3845601|FG000|COMPLETED|Period 2 - Induction||90
3120451|NCT01624233|3845601|FG000|NOT COMPLETED|Period 2 - Induction||1
3120452|NCT01624233|3845601|FG000|STARTED|Period 3 - Maintenance||90
3120453|NCT01624233|3845601|FG000|Received at Least 1 Dose of Study Drug|Period 3 - Maintenance||90
3120454|NCT01624233|3845601|FG000|COMPLETED|Period 3 - Maintenance||83
3120455|NCT01624233|3845601|FG000|NOT COMPLETED|Period 3 - Maintenance||7
3120456|NCT01624233|3845601|FG000|STARTED|Period 4 - Drug Free Period|Only responders in participants with plaque Ps moved to the Drug Free Period 4.|70
3120457|NCT01624233|3845601|FG000|Adverse Event|Period 4 - Drug Free Period|1 participant who discontinued due to adverse event is included in the participants who relapsed.|1
3120458|NCT01624233|3845601|FG000|Physician Decision|Period 4 - Drug Free Period|1 participant who discontinued due to physician decision is included in the participants relapsed.|1
3120459|NCT01624233|3845601|FG000|COMPLETED|Period 4 - Drug Free Period||9
3120460|NCT01624233|3845601|FG000|NOT COMPLETED|Period 4 - Drug Free Period||61
3120461|NCT01624233|3845601|FG000|STARTED|Period 5 - Retreatment Period|Period 5 included (participants with erythrodermic Ps or pustular Ps) or Period 4 completers.|80
3120462|NCT01624233|3845601|FG000|COMPLETED|Period 5 - Retreatment Period||70
3120463|NCT01624233|3845601|FG000|NOT COMPLETED|Period 5 - Retreatment Period||10
3120464|NCT01624233|3845601|FG000|STARTED|Period 6: Follow-up|Period 6 included participants received a dose of drug and exhibited the required neutrophil count.|88
3120465|NCT01624233|3845601|FG000|COMPLETED|Period 6: Follow-up||79
3120466|NCT01624233|3845601|FG000|NOT COMPLETED|Period 6: Follow-up||9
3120467|NCT01624259|3845611|FG000|STARTED|Overall Study||299
3120468|NCT01624259|3845612|FG001|STARTED|Overall Study||300
3120469|NCT01624259|3845611|FG000|Received at Least One Dose of Study Drug|Overall Study||299
3120470|NCT01624259|3845612|FG001|Received at Least One Dose of Study Drug|Overall Study||300
3120471|NCT01624259|3845611|FG000|COMPLETED|Overall Study|Completed the study on study treatment|269
3120472|NCT01624259|3845612|FG001|COMPLETED|Overall Study|Completed the study on study treatment|269
3120473|NCT01624259|3845611|FG000|NOT COMPLETED|Overall Study||30
3120474|NCT01624259|3845612|FG001|NOT COMPLETED|Overall Study||31
3120475|NCT01624350|3845620|FG000|STARTED|Overall Study||100
3120476|NCT01624350|3845620|FG000|COMPLETED|Overall Study||75
3120477|NCT01624350|3845620|FG000|NOT COMPLETED|Overall Study||25
3120478|NCT01624363|3845640|FG000|STARTED|Overall Study||341
3120479|NCT01624363|3845640|FG000|COMPLETED|Overall Study||341
3120480|NCT01624363|3845640|FG000|NOT COMPLETED|Overall Study||0
3120481|NCT01624467|3845644|FG000|STARTED|Overall Study||75
3120482|NCT01624467|3845644|FG000|Received at Least One Dose of Study Drug|Overall Study||75
3120483|NCT01624467|3845644|FG000|COMPLETED|Overall Study||44
3120484|NCT01624467|3845644|FG000|NOT COMPLETED|Overall Study||31
3120485|NCT01624506|3845652|FG000|STARTED|Overall Study||530
3120486|NCT01624506|3845653|FG001|STARTED|Overall Study||230
3120487|NCT01624506|3845652|FG000|COMPLETED|Overall Study||465
3120488|NCT01624506|3845653|FG001|COMPLETED|Overall Study||213
3120489|NCT01624506|3845652|FG000|NOT COMPLETED|Overall Study||65
3120490|NCT01624506|3845653|FG001|NOT COMPLETED|Overall Study||17
3120491|NCT01624662|3845663|FG000|STARTED|Double-Blind Treatment Phase (Wks 1-16)||80
3120492|NCT01624662|3845664|FG001|STARTED|Double-Blind Treatment Phase (Wks 1-16)||81
3120493|NCT01624662|3845665|FG002|STARTED|Double-Blind Treatment Phase (Wks 1-16)||80
3120494|NCT01624662|3845666|FG003|STARTED|Double-Blind Treatment Phase (Wks 1-16)||82
3120495|NCT01624662|3845663|FG000|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||70
3120496|NCT01624662|3845664|FG001|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||78
3120497|NCT01624662|3845665|FG002|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||76
3120498|NCT01624662|3845666|FG003|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||82
3120499|NCT01624662|3845663|FG000|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||10
3120500|NCT01624662|3845664|FG001|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||3
3120501|NCT01624662|3845665|FG002|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||4
3120502|NCT01624662|3845666|FG003|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||0
3120503|NCT01624662|3845663|FG000|STARTED|Open-Label Extension Phase (Wks 17-24)||70
3120504|NCT01624662|3845664|FG001|STARTED|Open-Label Extension Phase (Wks 17-24)||78
3120505|NCT01624662|3845665|FG002|STARTED|Open-Label Extension Phase (Wks 17-24)||72
3120506|NCT01624662|3845666|FG003|STARTED|Open-Label Extension Phase (Wks 17-24)||79
3120507|NCT01624662|3845663|FG000|COMPLETED|Open-Label Extension Phase (Wks 17-24)||69
3120508|NCT01624662|3845664|FG001|COMPLETED|Open-Label Extension Phase (Wks 17-24)||76
3120509|NCT01624662|3845665|FG002|COMPLETED|Open-Label Extension Phase (Wks 17-24)||71
3120510|NCT01624662|3845666|FG003|COMPLETED|Open-Label Extension Phase (Wks 17-24)||78
3120511|NCT01624662|3845663|FG000|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||1
3120512|NCT01624662|3845664|FG001|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||2
3120513|NCT01624662|3845665|FG002|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||1
3120514|NCT01624662|3845666|FG003|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||1
3120515|NCT01624870|3845687|FG000|STARTED|Overall Study|provided informed consent|200
3120516|NCT01624870|3845687|FG000|COMPLETED|Overall Study|Completed 6 month follow up|173
3120517|NCT01624870|3845687|FG000|NOT COMPLETED|Overall Study||27
3120518|NCT01624740|3845695|FG000|STARTED|First Intervention (3-4 Days)||9
3120519|NCT01624740|3845696|FG001|STARTED|First Intervention (3-4 Days)||9
3120520|NCT01624740|3845695|FG000|COMPLETED|First Intervention (3-4 Days)||9
3120521|NCT01624740|3845696|FG001|COMPLETED|First Intervention (3-4 Days)||9
3120522|NCT01624740|3845695|FG000|NOT COMPLETED|First Intervention (3-4 Days)||0
3120523|NCT01624740|3845696|FG001|NOT COMPLETED|First Intervention (3-4 Days)||0
3120524|NCT01624740|3845695|FG000|STARTED|Washout (1 Hour)||9
3120525|NCT01624740|3845696|FG001|STARTED|Washout (1 Hour)||9
3120526|NCT01624740|3845695|FG000|COMPLETED|Washout (1 Hour)||9
3120527|NCT01624740|3845696|FG001|COMPLETED|Washout (1 Hour)||9
3120528|NCT01624740|3845695|FG000|NOT COMPLETED|Washout (1 Hour)||0
3120529|NCT01624740|3845696|FG001|NOT COMPLETED|Washout (1 Hour)||0
3120530|NCT01624740|3845695|FG000|STARTED|Second Intervention (3-4 Days)||9
3120531|NCT01624740|3845696|FG001|STARTED|Second Intervention (3-4 Days)||9
3120532|NCT01624740|3845695|FG000|COMPLETED|Second Intervention (3-4 Days)||8
3120533|NCT01624740|3845696|FG001|COMPLETED|Second Intervention (3-4 Days)||9
3120534|NCT01624740|3845695|FG000|NOT COMPLETED|Second Intervention (3-4 Days)||1
3120535|NCT01624740|3845696|FG001|NOT COMPLETED|Second Intervention (3-4 Days)||0
3120536|NCT01624948|3845705|FG000|STARTED|Overall Study||20
3120537|NCT01624948|3845706|FG001|STARTED|Overall Study||20
3120538|NCT01624948|3845705|FG000|COMPLETED|Overall Study||20
3120539|NCT01624948|3845706|FG001|COMPLETED|Overall Study||20
3120540|NCT01624948|3845705|FG000|NOT COMPLETED|Overall Study||0
3120541|NCT01624948|3845706|FG001|NOT COMPLETED|Overall Study||0
3120542|NCT01624974|3845718|FG000|STARTED|Period III of Treatment (4 Weeks)||54
3120543|NCT01624974|3845719|FG001|STARTED|Period III of Treatment (4 Weeks)||53
3120544|NCT01624974|3845718|FG000|COMPLETED|Period III of Treatment (4 Weeks)||47
3120545|NCT01624974|3845719|FG001|COMPLETED|Period III of Treatment (4 Weeks)||45
3120546|NCT01624974|3845718|FG000|NOT COMPLETED|Period III of Treatment (4 Weeks)||7
3120547|NCT01624974|3845719|FG001|NOT COMPLETED|Period III of Treatment (4 Weeks)||8
3120548|NCT01624974|3845718|FG000|STARTED|Period IV Washout (4 Weeks)||47
3120549|NCT01624974|3845719|FG001|STARTED|Period IV Washout (4 Weeks)||45
3120550|NCT01624974|3845718|FG000|COMPLETED|Period IV Washout (4 Weeks)||44
3120551|NCT01624974|3845719|FG001|COMPLETED|Period IV Washout (4 Weeks)||42
3120552|NCT01624974|3845718|FG000|NOT COMPLETED|Period IV Washout (4 Weeks)||3
3120553|NCT01624974|3845719|FG001|NOT COMPLETED|Period IV Washout (4 Weeks)||3
3120554|NCT01624974|3845718|FG000|STARTED|Period V of Treatment (4 Weeks)||44
3120555|NCT01624974|3845719|FG001|STARTED|Period V of Treatment (4 Weeks)||42
3120556|NCT01624974|3845718|FG000|COMPLETED|Period V of Treatment (4 Weeks)||39
3120557|NCT01624974|3845719|FG001|COMPLETED|Period V of Treatment (4 Weeks)||42
3120558|NCT01624974|3845718|FG000|NOT COMPLETED|Period V of Treatment (4 Weeks)||5
3120559|NCT01624974|3845719|FG001|NOT COMPLETED|Period V of Treatment (4 Weeks)||0
3120560|NCT01625000|3845731|FG000|STARTED|Overall Study||126
3120561|NCT01625000|3845732|FG001|STARTED|Overall Study||133
3120562|NCT01625000|3845733|FG002|STARTED|Overall Study||67
3120563|NCT01625000|3845734|FG003|STARTED|Overall Study||56
3120564|NCT01625000|3845735|FG004|STARTED|Overall Study||126
3120565|NCT01625000|3845731|FG000|COMPLETED|Overall Study||74
3120566|NCT01625000|3845732|FG001|COMPLETED|Overall Study||81
3120567|NCT01625000|3845733|FG002|COMPLETED|Overall Study||34
3120568|NCT01625000|3845734|FG003|COMPLETED|Overall Study||37
3120569|NCT01625000|3845735|FG004|COMPLETED|Overall Study||71
3120570|NCT01625000|3845731|FG000|NOT COMPLETED|Overall Study||52
3120571|NCT01625000|3845732|FG001|NOT COMPLETED|Overall Study||52
3120572|NCT01625000|3845733|FG002|NOT COMPLETED|Overall Study||33
3120573|NCT01625000|3845734|FG003|NOT COMPLETED|Overall Study||19
3120574|NCT01625000|3845735|FG004|NOT COMPLETED|Overall Study||55
3120575|NCT01625013|3845747|FG000|STARTED|Overall Study||51
3120576|NCT01625013|3845747|FG000|COMPLETED|Overall Study||48
3120577|NCT01625013|3845747|FG000|NOT COMPLETED|Overall Study||3
3120578|NCT01625091|3845754|FG000|STARTED|Intervention||96
3120579|NCT01625091|3845755|FG001|STARTED|Intervention||98
3120580|NCT01625091|3845754|FG000|2 Months|Intervention||90
3120581|NCT01625091|3845755|FG001|2 Months|Intervention||93
3120582|NCT01625091|3845754|FG000|4 Months|Intervention||85
3120583|NCT01625091|3845755|FG001|4 Months|Intervention||87
3120584|NCT01625091|3845754|FG000|COMPLETED|Intervention||85
3120585|NCT01625091|3845755|FG001|COMPLETED|Intervention||87
3120586|NCT01625091|3845754|FG000|NOT COMPLETED|Intervention||11
3120587|NCT01625091|3845755|FG001|NOT COMPLETED|Intervention||11
3120588|NCT01625091|3845754|FG000|STARTED|Post-intervention||85
3120589|NCT01625091|3845755|FG001|STARTED|Post-intervention||87
3120590|NCT01625091|3845754|FG000|7 Months|Post-intervention||81
3120591|NCT01625091|3845755|FG001|7 Months|Post-intervention||85
3120592|NCT01625091|3845754|FG000|COMPLETED|Post-intervention||81
3120593|NCT01625091|3845755|FG001|COMPLETED|Post-intervention||85
3120594|NCT01625091|3845754|FG000|NOT COMPLETED|Post-intervention||4
3120595|NCT01625091|3845755|FG001|NOT COMPLETED|Post-intervention||2
3120596|NCT01625104|3845763|FG000|STARTED|Overall Study||448
3120597|NCT01625104|3845764|FG001|STARTED|Overall Study||434
3120598|NCT01625104|3845763|FG000|COMPLETED|Overall Study||448
3120599|NCT01625104|3845764|FG001|COMPLETED|Overall Study||434
3120600|NCT01625104|3845763|FG000|NOT COMPLETED|Overall Study||0
3120601|NCT01625104|3845764|FG001|NOT COMPLETED|Overall Study||0
3120602|NCT01625169|3845770|FG000|STARTED|Overall Study||9
3120603|NCT01625169|3845770|FG000|COMPLETED|Overall Study||9
3120604|NCT01625169|3845770|FG000|NOT COMPLETED|Overall Study||0
3120605|NCT01625182|3845776|FG000|STARTED|Overall Study||54
3120606|NCT01625182|3845777|FG001|STARTED|Overall Study||52
3120607|NCT01625182|3845776|FG000|COMPLETED|Overall Study||34
3120608|NCT01625182|3845777|FG001|COMPLETED|Overall Study||41
3120609|NCT01625182|3845776|FG000|NOT COMPLETED|Overall Study||20
3120610|NCT01625182|3845777|FG001|NOT COMPLETED|Overall Study||11
3120611|NCT01625221|3845784|FG000|STARTED|Overall Study||35
3120612|NCT01625221|3845784|FG000|COMPLETED|Overall Study||28
3120613|NCT01625221|3845784|FG000|NOT COMPLETED|Overall Study||7
3120614|NCT01625338|3845791|FG000|STARTED|Overall Study||114
3120615|NCT01625338|3845792|FG001|STARTED|Overall Study||200
3120616|NCT01625338|3845793|FG002|STARTED|Overall Study||220
3120617|NCT01625338|3845791|FG000|COMPLETED|Overall Study||82
3120618|NCT01625338|3845792|FG001|COMPLETED|Overall Study||156
3120619|NCT01625338|3845793|FG002|COMPLETED|Overall Study||181
3120620|NCT01625338|3845791|FG000|NOT COMPLETED|Overall Study||32
3120621|NCT01625338|3845792|FG001|NOT COMPLETED|Overall Study||44
3120622|NCT01625338|3845793|FG002|NOT COMPLETED|Overall Study||39
3120623|NCT01625377|3845803|FG000|STARTED|Overall Study|"Started indicates randomized patients."|95
3120624|NCT01625377|3845804|FG001|STARTED|Overall Study||93
3120625|NCT01625377|3845803|FG000|Safety Set of Population|Overall Study||94
3120626|NCT01625377|3845804|FG001|Safety Set of Population|Overall Study||90
3120627|NCT01625377|3845803|FG000|Intent to Treat Population|Overall Study||93
3120628|NCT01625377|3845804|FG001|Intent to Treat Population|Overall Study||90
3120629|NCT01625377|3845803|FG000|COMPLETED|Overall Study||88
3120630|NCT01625377|3845804|FG001|COMPLETED|Overall Study||71
3120631|NCT01625377|3845803|FG000|NOT COMPLETED|Overall Study||7
3120632|NCT01625377|3845804|FG001|NOT COMPLETED|Overall Study||22
3120633|NCT01625416|3845812|FG000|STARTED|Overall Study||60
3120634|NCT01625416|3845813|FG001|STARTED|Overall Study||61
3120635|NCT01625416|3845812|FG000|COMPLETED|Overall Study||51
3120636|NCT01625416|3845813|FG001|COMPLETED|Overall Study||54
3120637|NCT01625416|3845812|FG000|NOT COMPLETED|Overall Study||9
3120638|NCT01625416|3845813|FG001|NOT COMPLETED|Overall Study||7
3120639|NCT01625455|3845822|FG000|STARTED|Overall Study||2
3120640|NCT01625455|3845823|FG001|STARTED|Overall Study||3
3120641|NCT01625455|3845822|FG000|COMPLETED|Overall Study||2
3120642|NCT01625455|3845823|FG001|COMPLETED|Overall Study||3
3120643|NCT01625455|3845822|FG000|NOT COMPLETED|Overall Study||0
3120644|NCT01625455|3845823|FG001|NOT COMPLETED|Overall Study||0
3120645|NCT01625507|3845829|FG000|STARTED|Overall Study||73
3120646|NCT01625507|3845829|FG000|COMPLETED|Overall Study||63
3120647|NCT01625507|3845829|FG000|NOT COMPLETED|Overall Study||10
3120648|NCT01625689|3845836|FG000|STARTED|Overall Study||150
3120649|NCT01625689|3845837|FG001|STARTED|Overall Study||150
3120650|NCT01625689|3845836|FG000|COMPLETED|Overall Study||148
3120651|NCT01625689|3845837|FG001|COMPLETED|Overall Study||149
3120652|NCT01625689|3845836|FG000|NOT COMPLETED|Overall Study||2
3120653|NCT01625689|3845837|FG001|NOT COMPLETED|Overall Study||1
3120654|NCT01625845|3845845|FG000|STARTED|Overall Study||10
3120655|NCT01625845|3845846|FG001|STARTED|Overall Study||6
3120656|NCT01625845|3845845|FG000|COMPLETED|Overall Study||5
3120657|NCT01625845|3845846|FG001|COMPLETED|Overall Study||3
3120658|NCT01625845|3845845|FG000|NOT COMPLETED|Overall Study||5
3120659|NCT01625845|3845846|FG001|NOT COMPLETED|Overall Study||3
3120660|NCT01625897|3845854|FG000|STARTED|Overall Study||83
3120661|NCT01625897|3845855|FG001|STARTED|Overall Study||42
3120662|NCT01625897|3845854|FG000|COMPLETED|Overall Study||31
3120663|NCT01625897|3845855|FG001|COMPLETED|Overall Study||28
3120664|NCT01625897|3845854|FG000|NOT COMPLETED|Overall Study||52
3120665|NCT01625897|3845855|FG001|NOT COMPLETED|Overall Study||14
3120666|NCT01625910|3845863|FG000|STARTED|Overall Study||35
3120667|NCT01625910|3845864|FG001|STARTED|Overall Study||37
3120668|NCT01625910|3845863|FG000|COMPLETED|Overall Study||32
3120669|NCT01625910|3845864|FG001|COMPLETED|Overall Study||33
3120670|NCT01625910|3845863|FG000|NOT COMPLETED|Overall Study||3
3120671|NCT01625910|3845864|FG001|NOT COMPLETED|Overall Study||4
3120672|NCT01625923|3845872|FG000|STARTED|Overall Study||3
3120673|NCT01625923|3845872|FG000|COMPLETED|Overall Study||3
3120674|NCT01625923|3845872|FG000|NOT COMPLETED|Overall Study||0
3120675|NCT01625988|3845879|FG000|STARTED|Overall Study|One participant was randomized inappropriately and was discontinued before start of study treatment.|108
3120676|NCT01625988|3845880|FG001|STARTED|Overall Study||110
3120677|NCT01625988|3845879|FG000|Received at Least One Dose of Study Drug|Overall Study||107
3120678|NCT01625988|3845880|FG001|Received at Least One Dose of Study Drug|Overall Study||110
3120679|NCT01625988|3845879|FG000|COMPLETED|Overall Study||94
3120680|NCT01625988|3845880|FG001|COMPLETED|Overall Study||97
3120681|NCT01625988|3845879|FG000|NOT COMPLETED|Overall Study||14
3120682|NCT01625988|3845880|FG001|NOT COMPLETED|Overall Study||13
3120683|NCT01626079|3845891|FG000|STARTED|Overall Study||302
3120684|NCT01626079|3845892|FG001|STARTED|Overall Study||312
3120685|NCT01626079|3845891|FG000|COMPLETED|Overall Study||135
3120686|NCT01626079|3845892|FG001|COMPLETED|Overall Study||96
3120687|NCT01626079|3845891|FG000|NOT COMPLETED|Overall Study||167
3120688|NCT01626079|3845892|FG001|NOT COMPLETED|Overall Study||216
3120689|NCT01626092|3845899|FG000|STARTED|Overall Study||3
3120690|NCT01626092|3845899|FG000|COMPLETED|Overall Study||3
3120691|NCT01626092|3845899|FG000|NOT COMPLETED|Overall Study||0
3120692|NCT01626118|3845907|FG000|STARTED|Overall Study||94
3120693|NCT01626118|3845908|FG001|STARTED|Overall Study||93
3120694|NCT01626118|3845909|FG002|STARTED|Overall Study||92
3120695|NCT01626118|3845910|FG003|STARTED|Overall Study||94
3120696|NCT01626118|3845907|FG000|COMPLETED|Overall Study||92
3120697|NCT01626118|3845908|FG001|COMPLETED|Overall Study||91
3120698|NCT01626118|3845909|FG002|COMPLETED|Overall Study||90
3120699|NCT01626118|3845910|FG003|COMPLETED|Overall Study||91
3120700|NCT01626118|3845907|FG000|NOT COMPLETED|Overall Study||2
3120701|NCT01626118|3845908|FG001|NOT COMPLETED|Overall Study||2
3120702|NCT01626118|3845909|FG002|NOT COMPLETED|Overall Study||2
3120703|NCT01626118|3845910|FG003|NOT COMPLETED|Overall Study||3
3120704|NCT01626352|3845920|FG000|STARTED|Overall Study||22
3120705|NCT01626352|3845920|FG000|COMPLETED|Overall Study||12
3120706|NCT01626352|3845920|FG000|NOT COMPLETED|Overall Study||10
3120707|NCT01626391|3845929|FG000|STARTED|Overall Study||5
3120708|NCT01626391|3845930|FG001|STARTED|Overall Study||4
3120709|NCT01626391|3845929|FG000|COMPLETED|Overall Study||3
3120710|NCT01626391|3845930|FG001|COMPLETED|Overall Study||4
3120711|NCT01626391|3845929|FG000|NOT COMPLETED|Overall Study||2
3120712|NCT01626391|3845930|FG001|NOT COMPLETED|Overall Study||0
3120713|NCT01626456|3845938|FG000|STARTED|Overall Study||110
3120714|NCT01626456|3845939|FG001|STARTED|Overall Study||368
3120715|NCT01626456|3845938|FG000|COMPLETED|Overall Study||75
3120716|NCT01626456|3845939|FG001|COMPLETED|Overall Study||251
3120717|NCT01626456|3845938|FG000|NOT COMPLETED|Overall Study||35
3120718|NCT01626456|3845939|FG001|NOT COMPLETED|Overall Study||117
3120719|NCT01626495|3845954|FG000|STARTED|Overall Study|Number of enrolled subjects|73
3120720|NCT01626495|3845954|FG000|Intervention|Overall Study||62
3120721|NCT01626495|3845954|FG000|COMPLETED|Overall Study|Follow up phase completed as per protocol|21
3120722|NCT01626495|3845954|FG000|NOT COMPLETED|Overall Study||52
3120723|NCT01626664|3845960|FG000|STARTED|Randomization Period||47
3120724|NCT01626664|3845961|FG001|STARTED|Randomization Period||24
3120725|NCT01626664|3845962|FG002|STARTED|Randomization Period||0
3120726|NCT01626664|3845960|FG000|COMPLETED|Randomization Period||47
3120727|NCT01626664|3845961|FG001|COMPLETED|Randomization Period||24
3120728|NCT01626664|3845962|FG002|COMPLETED|Randomization Period||0
3120729|NCT01626664|3845960|FG000|NOT COMPLETED|Randomization Period||0
3120730|NCT01626664|3845961|FG001|NOT COMPLETED|Randomization Period||0
3120731|NCT01626664|3845962|FG002|NOT COMPLETED|Randomization Period||0
3120732|NCT01626664|3845960|FG000|STARTED|Crossover Period||0
3120733|NCT01626664|3845961|FG001|STARTED|Crossover Period||0
3120734|NCT01626664|3845962|FG002|STARTED|Crossover Period||18
3120735|NCT01626664|3845960|FG000|COMPLETED|Crossover Period||0
3120736|NCT01626664|3845961|FG001|COMPLETED|Crossover Period||0
3120737|NCT01626664|3845962|FG002|COMPLETED|Crossover Period||18
3120738|NCT01626664|3845960|FG000|NOT COMPLETED|Crossover Period||0
3120739|NCT01626664|3845961|FG001|NOT COMPLETED|Crossover Period||0
3120740|NCT01626664|3845962|FG002|NOT COMPLETED|Crossover Period||0
3120741|NCT01626690|3845971|FG000|STARTED|Overall Study||49
3120742|NCT01626690|3845972|FG001|STARTED|Overall Study||51
3120743|NCT01626690|3845971|FG000|COMPLETED|Overall Study||47
3120744|NCT01626690|3845972|FG001|COMPLETED|Overall Study||51
3120745|NCT01626690|3845971|FG000|NOT COMPLETED|Overall Study||2
3120746|NCT01626690|3845972|FG001|NOT COMPLETED|Overall Study||0
3120747|NCT01626820|3845982|FG000|STARTED|Overall Study||56
3120748|NCT01626820|3845983|FG001|STARTED|Overall Study||57
3120749|NCT01626820|3845982|FG000|COMPLETED|Overall Study||56
3120750|NCT01626820|3845983|FG001|COMPLETED|Overall Study||57
3120751|NCT01626820|3845982|FG000|NOT COMPLETED|Overall Study||0
3120752|NCT01626820|3845983|FG001|NOT COMPLETED|Overall Study||0
3120753|NCT01626859|3845993|FG000|STARTED|Overall Study||11
3120754|NCT01626859|3845994|FG001|STARTED|Overall Study||16
3120755|NCT01626859|3845995|FG002|STARTED|Overall Study||11
3120756|NCT01626859|3845993|FG000|COMPLETED|Overall Study||9
3120757|NCT01626859|3845994|FG001|COMPLETED|Overall Study||8
3120758|NCT01626859|3845995|FG002|COMPLETED|Overall Study||7
3120759|NCT01626859|3845993|FG000|NOT COMPLETED|Overall Study||2
3120760|NCT01626859|3845994|FG001|NOT COMPLETED|Overall Study||8
3120761|NCT01626859|3845995|FG002|NOT COMPLETED|Overall Study||4
3120762|NCT01626872|3846006|FG000|STARTED|Overall Study||81
3120763|NCT01626872|3846007|FG001|STARTED|Overall Study||109
3120764|NCT01626872|3846008|FG002|STARTED|Overall Study||58
3120765|NCT01626872|3846006|FG000|COMPLETED|Overall Study||29
3120766|NCT01626872|3846007|FG001|COMPLETED|Overall Study||43
3120767|NCT01626872|3846008|FG002|COMPLETED|Overall Study||34
3120768|NCT01626872|3846006|FG000|NOT COMPLETED|Overall Study||52
3120769|NCT01626872|3846007|FG001|NOT COMPLETED|Overall Study||66
3120770|NCT01626872|3846008|FG002|NOT COMPLETED|Overall Study||24
3120771|NCT01626885|3846016|FG000|STARTED|Overall Study||42
3120772|NCT01626885|3846016|FG000|COMPLETED|Overall Study||30
3120773|NCT01626885|3846016|FG000|NOT COMPLETED|Overall Study||12
3120774|NCT01626989|3846020|FG000|STARTED|Screening Period||44
3120775|NCT01626989|3846021|FG001|STARTED|Screening Period||0
3120776|NCT01626989|3846022|FG002|STARTED|Screening Period||0
3120777|NCT01626989|3846020|FG000|COMPLETED|Screening Period||27
3120778|NCT01626989|3846021|FG001|COMPLETED|Screening Period||0
3120779|NCT01626989|3846022|FG002|COMPLETED|Screening Period||0
3120780|NCT01626989|3846020|FG000|NOT COMPLETED|Screening Period||17
3120781|NCT01626989|3846021|FG001|NOT COMPLETED|Screening Period||0
3120782|NCT01626989|3846022|FG002|NOT COMPLETED|Screening Period||0
3120783|NCT01626989|3846020|FG000|STARTED|Fist Intervention (Night 1)||0
3120784|NCT01626989|3846021|FG001|STARTED|Fist Intervention (Night 1)||15
3120785|NCT01626989|3846022|FG002|STARTED|Fist Intervention (Night 1)||12
3120786|NCT01626989|3846020|FG000|COMPLETED|Fist Intervention (Night 1)||0
3120787|NCT01626989|3846021|FG001|COMPLETED|Fist Intervention (Night 1)||15
3120788|NCT01626989|3846022|FG002|COMPLETED|Fist Intervention (Night 1)||12
3120789|NCT01626989|3846020|FG000|NOT COMPLETED|Fist Intervention (Night 1)||0
3120790|NCT01626989|3846021|FG001|NOT COMPLETED|Fist Intervention (Night 1)||0
3120791|NCT01626989|3846022|FG002|NOT COMPLETED|Fist Intervention (Night 1)||0
3120792|NCT01626989|3846020|FG000|STARTED|Second Intervention (Night 2)||0
3120793|NCT01626989|3846021|FG001|STARTED|Second Intervention (Night 2)||15
3120794|NCT01626989|3846022|FG002|STARTED|Second Intervention (Night 2)||12
3120795|NCT01626989|3846020|FG000|COMPLETED|Second Intervention (Night 2)||0
3120796|NCT01626989|3846021|FG001|COMPLETED|Second Intervention (Night 2)||15
3120797|NCT01626989|3846022|FG002|COMPLETED|Second Intervention (Night 2)||12
3120798|NCT01626989|3846020|FG000|NOT COMPLETED|Second Intervention (Night 2)||0
3120799|NCT01626989|3846021|FG001|NOT COMPLETED|Second Intervention (Night 2)||0
3120800|NCT01626989|3846022|FG002|NOT COMPLETED|Second Intervention (Night 2)||0
3120801|NCT01627002|3846033|FG000|STARTED|Overall Study||4
3120802|NCT01627002|3846034|FG001|STARTED|Overall Study||4
3120803|NCT01627002|3846035|FG002|STARTED|Overall Study||4
3120804|NCT01627002|3846036|FG003|STARTED|Overall Study||4
3120805|NCT01627002|3846037|FG004|STARTED|Overall Study||2
3120806|NCT01627002|3846038|FG005|STARTED|Overall Study||9
3120807|NCT01627002|3846039|FG006|STARTED|Overall Study||10
3120808|NCT01627002|3846040|FG007|STARTED|Overall Study||5
3120809|NCT01627002|3846041|FG008|STARTED|Overall Study||7
3120810|NCT01627002|3846033|FG000|COMPLETED|Overall Study||4
3120811|NCT01627002|3846034|FG001|COMPLETED|Overall Study||4
3120812|NCT01627002|3846035|FG002|COMPLETED|Overall Study||4
3120813|NCT01627002|3846036|FG003|COMPLETED|Overall Study||4
3120814|NCT01627002|3846037|FG004|COMPLETED|Overall Study||2
3120815|NCT01627002|3846038|FG005|COMPLETED|Overall Study||9
3120816|NCT01627002|3846039|FG006|COMPLETED|Overall Study||10
3120817|NCT01627002|3846040|FG007|COMPLETED|Overall Study||5
3120818|NCT01627002|3846041|FG008|COMPLETED|Overall Study||7
3120819|NCT01627002|3846033|FG000|NOT COMPLETED|Overall Study||0
3120820|NCT01627002|3846034|FG001|NOT COMPLETED|Overall Study||0
3120821|NCT01627002|3846035|FG002|NOT COMPLETED|Overall Study||0
3120822|NCT01627002|3846036|FG003|NOT COMPLETED|Overall Study||0
3120823|NCT01627002|3846037|FG004|NOT COMPLETED|Overall Study||0
3120824|NCT01627002|3846038|FG005|NOT COMPLETED|Overall Study||0
3120825|NCT01627002|3846039|FG006|NOT COMPLETED|Overall Study||0
3120826|NCT01627002|3846040|FG007|NOT COMPLETED|Overall Study||0
3120827|NCT01627002|3846041|FG008|NOT COMPLETED|Overall Study||0
3120828|NCT01627067|3846068|FG000|STARTED|Overall Study||23
3120829|NCT01627067|3846068|FG000|COMPLETED|Overall Study||22
3120830|NCT01627067|3846068|FG000|NOT COMPLETED|Overall Study||1
3120831|NCT01627249|3846077|FG000|STARTED|Overall Study||224
3120832|NCT01627249|3846078|FG001|STARTED|Overall Study||218
3120833|NCT01627249|3846079|FG002|STARTED|Overall Study||218
3120834|NCT01627249|3846077|FG000|COMPLETED|Overall Study||208
3120835|NCT01627249|3846078|FG001|COMPLETED|Overall Study||206
3120836|NCT01627249|3846079|FG002|COMPLETED|Overall Study||206
3120837|NCT01627249|3846077|FG000|NOT COMPLETED|Overall Study||16
3120838|NCT01627249|3846078|FG001|NOT COMPLETED|Overall Study||12
3120839|NCT01627249|3846079|FG002|NOT COMPLETED|Overall Study||12
3120840|NCT01627288|3846091|FG000|STARTED|Overall Study||3
3120841|NCT01627288|3846092|FG001|STARTED|Overall Study||3
3120842|NCT01627288|3846093|FG002|STARTED|Overall Study||6
3120843|NCT01627288|3846094|FG003|STARTED|Overall Study||0
3120844|NCT01627288|3846091|FG000|COMPLETED|Overall Study||3
3120845|NCT01627288|3846092|FG001|COMPLETED|Overall Study||3
3120846|NCT01627288|3846093|FG002|COMPLETED|Overall Study||6
3120847|NCT01627288|3846094|FG003|COMPLETED|Overall Study||0
3120848|NCT01627288|3846091|FG000|NOT COMPLETED|Overall Study||0
3120849|NCT01627288|3846092|FG001|NOT COMPLETED|Overall Study||0
3120850|NCT01627288|3846093|FG002|NOT COMPLETED|Overall Study||0
3120851|NCT01627288|3846094|FG003|NOT COMPLETED|Overall Study||0
3120852|NCT01627327|3846108|FG000|STARTED|Overall Study||310
3120853|NCT01627327|3846109|FG001|STARTED|Overall Study||313
3120854|NCT01627327|3846108|FG000|COMPLETED|Overall Study||291
3120855|NCT01627327|3846109|FG001|COMPLETED|Overall Study||274
3120856|NCT01627327|3846108|FG000|NOT COMPLETED|Overall Study||19
3120857|NCT01627327|3846109|FG001|NOT COMPLETED|Overall Study||39
3120858|NCT01627340|3846117|FG000|STARTED|Overall Study||416
3120859|NCT01627340|3846118|FG001|STARTED|Overall Study||258
3120860|NCT01627340|3846117|FG000|COMPLETED|Overall Study||404
3120861|NCT01627340|3846118|FG001|COMPLETED|Overall Study||254
3120862|NCT01627340|3846117|FG000|NOT COMPLETED|Overall Study||12
3120863|NCT01627340|3846118|FG001|NOT COMPLETED|Overall Study||4
3120864|NCT01627574|3846128|FG000|STARTED|Overall Study||142
3120865|NCT01627574|3846129|FG001|STARTED|Overall Study||130
3120866|NCT01627574|3846128|FG000|COMPLETED|Overall Study||121
3120867|NCT01627574|3846129|FG001|COMPLETED|Overall Study||112
3120868|NCT01627574|3846128|FG000|NOT COMPLETED|Overall Study||21
3120869|NCT01627574|3846129|FG001|NOT COMPLETED|Overall Study||18
3120870|NCT01627691|3846135|FG000|STARTED|Overall Study||250
3120871|NCT01627691|3846135|FG000|Primary Endpoint (30days)|Overall Study||239
3120872|NCT01627691|3846135|FG000|COMPLETED|Overall Study||232
3120873|NCT01627691|3846135|FG000|NOT COMPLETED|Overall Study||18
3120874|NCT01627782|3846143|FG000|STARTED|Overall Study||17
3120875|NCT01627782|3846144|FG001|STARTED|Overall Study||18
3120876|NCT01627782|3846145|FG002|STARTED|Overall Study||16
3120877|NCT01627782|3846146|FG003|STARTED|Overall Study||17
3120878|NCT01627782|3846143|FG000|Treated|Overall Study||16
3120879|NCT01627782|3846144|FG001|Treated|Overall Study||18
3120880|NCT01627782|3846145|FG002|Treated|Overall Study||16
3120881|NCT01627782|3846146|FG003|Treated|Overall Study||17
3120882|NCT01627782|3846143|FG000|COMPLETED|Overall Study||1
3120883|NCT01627782|3846144|FG001|COMPLETED|Overall Study||12
3120884|NCT01627782|3846145|FG002|COMPLETED|Overall Study||1
3120885|NCT01627782|3846146|FG003|COMPLETED|Overall Study||11
3120886|NCT01627782|3846143|FG000|NOT COMPLETED|Overall Study||16
3120887|NCT01627782|3846144|FG001|NOT COMPLETED|Overall Study||6
3120888|NCT01627782|3846145|FG002|NOT COMPLETED|Overall Study||15
3120889|NCT01627782|3846146|FG003|NOT COMPLETED|Overall Study||6
3120890|NCT01627860|3846160|FG000|STARTED|Overall Study||35
3120891|NCT01627860|3846161|FG001|STARTED|Overall Study||20
3120892|NCT01627860|3846160|FG000|COMPLETED|Overall Study||23
3120893|NCT01627860|3846161|FG001|COMPLETED|Overall Study||14
3120894|NCT01627860|3846160|FG000|NOT COMPLETED|Overall Study||12
3120895|NCT01627860|3846161|FG001|NOT COMPLETED|Overall Study||6
3120896|NCT01628016|3846170|FG000|STARTED|Pretraining to Posttraining||27
3120897|NCT01628016|3846171|FG001|STARTED|Pretraining to Posttraining||27
3120898|NCT01628016|3846172|FG002|STARTED|Pretraining to Posttraining||23
3120899|NCT01628016|3846170|FG000|COMPLETED|Pretraining to Posttraining||27
3120900|NCT01628016|3846171|FG001|COMPLETED|Pretraining to Posttraining||27
3120901|NCT01628016|3846172|FG002|COMPLETED|Pretraining to Posttraining||23
3120902|NCT01628016|3846170|FG000|NOT COMPLETED|Pretraining to Posttraining||0
3120903|NCT01628016|3846171|FG001|NOT COMPLETED|Pretraining to Posttraining||0
3120904|NCT01628016|3846172|FG002|NOT COMPLETED|Pretraining to Posttraining||0
3120905|NCT01628016|3846170|FG000|STARTED|Posttraining to 5 Follow-ups||27
3120906|NCT01628016|3846171|FG001|STARTED|Posttraining to 5 Follow-ups||27
3120907|NCT01628016|3846172|FG002|STARTED|Posttraining to 5 Follow-ups||23
3120908|NCT01628016|3846170|FG000|COMPLETED|Posttraining to 5 Follow-ups||23
3120909|NCT01628016|3846171|FG001|COMPLETED|Posttraining to 5 Follow-ups||20
3120910|NCT01628016|3846172|FG002|COMPLETED|Posttraining to 5 Follow-ups||18
3120911|NCT01628016|3846170|FG000|NOT COMPLETED|Posttraining to 5 Follow-ups||4
3120912|NCT01628016|3846171|FG001|NOT COMPLETED|Posttraining to 5 Follow-ups||7
3120913|NCT01628016|3846172|FG002|NOT COMPLETED|Posttraining to 5 Follow-ups||5
3120914|NCT01628042|3846186|FG000|STARTED|Overall Study||8
3120915|NCT01628042|3846187|FG001|STARTED|Overall Study||8
3120916|NCT01628042|3846188|FG002|STARTED|Overall Study||8
3120917|NCT01628042|3846189|FG003|STARTED|Overall Study||8
3120918|NCT01628042|3846186|FG000|COMPLETED|Overall Study||8
3120919|NCT01628042|3846187|FG001|COMPLETED|Overall Study||8
3120920|NCT01628042|3846188|FG002|COMPLETED|Overall Study||8
3120921|NCT01628042|3846189|FG003|COMPLETED|Overall Study||8
3120922|NCT01628042|3846186|FG000|NOT COMPLETED|Overall Study||0
3120923|NCT01628042|3846187|FG001|NOT COMPLETED|Overall Study||0
3120924|NCT01628042|3846188|FG002|NOT COMPLETED|Overall Study||0
3120925|NCT01628042|3846189|FG003|NOT COMPLETED|Overall Study||0
3120926|NCT01628107|3846199|FG000|STARTED|Overall Study||414
3120927|NCT01628107|3846199|FG000|Treated|Overall Study||406
3120928|NCT01628107|3846199|FG000|COMPLETED|Overall Study||295
3120929|NCT01628107|3846199|FG000|NOT COMPLETED|Overall Study||119
3120930|NCT01628120|3846203|FG000|STARTED|Overall Study||173
3120931|NCT01628120|3846203|FG000|Treated|Overall Study||170
3120932|NCT01628120|3846203|FG000|COMPLETED|Overall Study||129
3120933|NCT01628120|3846203|FG000|NOT COMPLETED|Overall Study||44
3120934|NCT01628159|3846207|FG000|STARTED|Overall Study||657
3120935|NCT01628159|3846207|FG000|COMPLETED|Overall Study||493
3120936|NCT01628159|3846207|FG000|NOT COMPLETED|Overall Study||164
3120937|NCT01628198|3846211|FG000|STARTED|Overall Study||38
3120938|NCT01628198|3846211|FG000|COMPLETED|Overall Study||20
3120939|NCT01628198|3846211|FG000|NOT COMPLETED|Overall Study||18
3120940|NCT01628250|3846217|FG000|STARTED|Overall Study||49
3120941|NCT01628250|3846218|FG001|STARTED|Overall Study||50
3120942|NCT01628250|3846217|FG000|COMPLETED|Overall Study||49
3120943|NCT01628250|3846218|FG001|COMPLETED|Overall Study||50
3120944|NCT01628250|3846217|FG000|NOT COMPLETED|Overall Study||0
3120945|NCT01628250|3846218|FG001|NOT COMPLETED|Overall Study||0
3120946|NCT01628367|3846226|FG000|STARTED|Overall Study||16
3120947|NCT01628367|3846227|FG001|STARTED|Overall Study||16
3120948|NCT01628367|3846226|FG000|COMPLETED|Overall Study||15
3120949|NCT01628367|3846227|FG001|COMPLETED|Overall Study||16
3120950|NCT01628367|3846226|FG000|NOT COMPLETED|Overall Study||1
3120951|NCT01628367|3846227|FG001|NOT COMPLETED|Overall Study||0
3120952|NCT01628393|3846236|FG000|STARTED|Placebo-controlled Treatment Period||88
3120953|NCT01628393|3846237|FG001|STARTED|Placebo-controlled Treatment Period||87
3120954|NCT01628393|3846238|FG002|STARTED|Placebo-controlled Treatment Period||83
3120955|NCT01628393|3846239|FG003|STARTED|Placebo-controlled Treatment Period||0
3120956|NCT01628393|3846240|FG004|STARTED|Placebo-controlled Treatment Period||0
3120957|NCT01628393|3846236|FG000|COMPLETED|Placebo-controlled Treatment Period||85
3120958|NCT01628393|3846237|FG001|COMPLETED|Placebo-controlled Treatment Period||85
3120959|NCT01628393|3846238|FG002|COMPLETED|Placebo-controlled Treatment Period||82
3120960|NCT01628393|3846239|FG003|COMPLETED|Placebo-controlled Treatment Period||0
3120961|NCT01628393|3846240|FG004|COMPLETED|Placebo-controlled Treatment Period||0
3120962|NCT01628393|3846236|FG000|NOT COMPLETED|Placebo-controlled Treatment Period||3
3120963|NCT01628393|3846237|FG001|NOT COMPLETED|Placebo-controlled Treatment Period||2
3120964|NCT01628393|3846238|FG002|NOT COMPLETED|Placebo-controlled Treatment Period||1
3120965|NCT01628393|3846239|FG003|NOT COMPLETED|Placebo-controlled Treatment Period||0
3120966|NCT01628393|3846240|FG004|NOT COMPLETED|Placebo-controlled Treatment Period||0
3120967|NCT01628393|3846236|FG000|STARTED|Blinded Active Extension Period||0
3120968|NCT01628393|3846237|FG001|STARTED|Blinded Active Extension Period||85
3120969|NCT01628393|3846238|FG002|STARTED|Blinded Active Extension Period||81
3120970|NCT01628393|3846239|FG003|STARTED|Blinded Active Extension Period||41
3120971|NCT01628393|3846240|FG004|STARTED|Blinded Active Extension Period||42
3120972|NCT01628393|3846236|FG000|COMPLETED|Blinded Active Extension Period||0
3120973|NCT01628393|3846237|FG001|COMPLETED|Blinded Active Extension Period||75
3120974|NCT01628393|3846238|FG002|COMPLETED|Blinded Active Extension Period||75
3120975|NCT01628393|3846239|FG003|COMPLETED|Blinded Active Extension Period||37
3120976|NCT01628393|3846240|FG004|COMPLETED|Blinded Active Extension Period||36
3120977|NCT01628393|3846236|FG000|NOT COMPLETED|Blinded Active Extension Period||0
3120978|NCT01628393|3846237|FG001|NOT COMPLETED|Blinded Active Extension Period||10
3120979|NCT01628393|3846238|FG002|NOT COMPLETED|Blinded Active Extension Period||6
3120980|NCT01628393|3846239|FG003|NOT COMPLETED|Blinded Active Extension Period||4
3120981|NCT01628393|3846240|FG004|NOT COMPLETED|Blinded Active Extension Period||6
3120982|NCT01628510|3846256|FG000|STARTED|Overall Study||51
3120983|NCT01628510|3846257|FG001|STARTED|Overall Study||49
3120984|NCT01628510|3846256|FG000|COMPLETED|Overall Study||48
3120985|NCT01628510|3846257|FG001|COMPLETED|Overall Study||44
3120986|NCT01628510|3846256|FG000|NOT COMPLETED|Overall Study||3
3120987|NCT01628510|3846257|FG001|NOT COMPLETED|Overall Study||5
3136191|NCT01710787|3861274|FG000|COMPLETED|Overall Study||44
3136192|NCT01710787|3861275|FG001|COMPLETED|Overall Study||44
3136193|NCT01710787|3861276|FG002|COMPLETED|Overall Study||22
3136194|NCT01710787|3861274|FG000|NOT COMPLETED|Overall Study||0
3136195|NCT01710787|3861275|FG001|NOT COMPLETED|Overall Study||0
3136196|NCT01710787|3861276|FG002|NOT COMPLETED|Overall Study||0
3136197|NCT01710800|3861284|FG000|STARTED|Overall Study|63 patients consented to be part of the study|63
3136198|NCT01710800|3861284|FG000|Received PPI Intervention|Overall Study||44
3136199|NCT01710800|3861284|FG000|Received Placebo Intervention|Overall Study||45
3295127|NCT02895360|4029312|FG002|NOT COMPLETED|Phase 1 - 30 mg/m² Cohort||0
3295128|NCT02895360|4029313|FG003|NOT COMPLETED|Phase 1 - 30 mg/m² Cohort||0
3295129|NCT02895360|4029314|FG004|NOT COMPLETED|Phase 1 - 30 mg/m² Cohort||0
3295130|NCT02895360|4029315|FG005|NOT COMPLETED|Phase 1 - 30 mg/m² Cohort||0
3295131|NCT02895360|4029310|FG000|STARTED|Phase 1 - 45 mg/m² Cohort||0
3295132|NCT02895360|4029311|FG001|STARTED|Phase 1 - 45 mg/m² Cohort||3
3295133|NCT02895360|4029312|FG002|STARTED|Phase 1 - 45 mg/m² Cohort||0
3295134|NCT02895360|4029313|FG003|STARTED|Phase 1 - 45 mg/m² Cohort||0
3295135|NCT02895360|4029314|FG004|STARTED|Phase 1 - 45 mg/m² Cohort||0
3295136|NCT02895360|4029315|FG005|STARTED|Phase 1 - 45 mg/m² Cohort||0
3295137|NCT02895360|4029310|FG000|COMPLETED|Phase 1 - 45 mg/m² Cohort||0
3120988|NCT01628523|3846265|FG000|STARTED|Overall Study||219
3120989|NCT01628523|3846265|FG000|COMPLETED|Overall Study||219
3120990|NCT01628523|3846265|FG000|NOT COMPLETED|Overall Study||0
3120991|NCT01628549|3846274|FG000|STARTED|Overall Study||73
3120992|NCT01628549|3846275|FG001|STARTED|Overall Study||76
3120993|NCT01628549|3846276|FG002|STARTED|Overall Study||70
3120994|NCT01628549|3846277|FG003|STARTED|Overall Study||66
3120995|NCT01628549|3846274|FG000|COMPLETED|Overall Study||64
3120996|NCT01628549|3846275|FG001|COMPLETED|Overall Study||64
3120997|NCT01628549|3846276|FG002|COMPLETED|Overall Study||60
3120998|NCT01628549|3846277|FG003|COMPLETED|Overall Study||57
3120999|NCT01628549|3846274|FG000|NOT COMPLETED|Overall Study||9
3121000|NCT01628549|3846275|FG001|NOT COMPLETED|Overall Study||12
3121001|NCT01628549|3846276|FG002|NOT COMPLETED|Overall Study||10
3121002|NCT01628549|3846277|FG003|NOT COMPLETED|Overall Study||9
3121003|NCT01628588|3846287|FG000|STARTED|Overall Study||854
3121004|NCT01628588|3846287|FG000|COMPLETED|Overall Study||838
3121005|NCT01628588|3846287|FG000|NOT COMPLETED|Overall Study||16
3121006|NCT01628601|3846291|FG000|STARTED|Overall Study||392
3121007|NCT01628601|3846291|FG000|COMPLETED|Overall Study||351
3121008|NCT01628601|3846291|FG000|NOT COMPLETED|Overall Study||41
3121009|NCT01628614|3846295|FG000|STARTED|Overall Study||4812
3121010|NCT01628614|3846295|FG000|COMPLETED|Overall Study||3037
3121011|NCT01628614|3846295|FG000|NOT COMPLETED|Overall Study||1775
3121012|NCT01628692|3846305|FG000|STARTED|Overall Study||53
3121013|NCT01628692|3846306|FG001|STARTED|Overall Study||23
3121014|NCT01628692|3846307|FG002|STARTED|Overall Study||51
3121015|NCT01628692|3846308|FG003|STARTED|Overall Study||20
3121016|NCT01628692|3846309|FG004|STARTED|Overall Study||12
3121017|NCT01628692|3846310|FG005|STARTED|Overall Study||9
3121018|NCT01628692|3846305|FG000|COMPLETED|Overall Study||46
3121019|NCT01628692|3846306|FG001|COMPLETED|Overall Study||17
3121020|NCT01628692|3846307|FG002|COMPLETED|Overall Study||43
3121021|NCT01628692|3846308|FG003|COMPLETED|Overall Study||19
3121022|NCT01628692|3846309|FG004|COMPLETED|Overall Study||8
3121023|NCT01628692|3846310|FG005|COMPLETED|Overall Study||0
3121024|NCT01628692|3846305|FG000|NOT COMPLETED|Overall Study||7
3121025|NCT01628692|3846306|FG001|NOT COMPLETED|Overall Study||6
3121026|NCT01628692|3846307|FG002|NOT COMPLETED|Overall Study||8
3121027|NCT01628692|3846308|FG003|NOT COMPLETED|Overall Study||1
3121028|NCT01628692|3846309|FG004|NOT COMPLETED|Overall Study||4
3121029|NCT01628692|3846310|FG005|NOT COMPLETED|Overall Study||9
3121030|NCT01628718|3846329|FG000|STARTED|Overall Study||60
3121031|NCT01628718|3846330|FG001|STARTED|Overall Study||62
3121032|NCT01628718|3846329|FG000|COMPLETED|Overall Study||33
3121033|NCT01628718|3846330|FG001|COMPLETED|Overall Study||37
3121034|NCT01628718|3846329|FG000|NOT COMPLETED|Overall Study||27
3121035|NCT01628718|3846330|FG001|NOT COMPLETED|Overall Study||25
3121036|NCT01628848|3846338|FG000|STARTED|Overall Study||87
3121037|NCT01628848|3846339|FG001|STARTED|Overall Study||87
3121038|NCT01628848|3846338|FG000|COMPLETED|Overall Study||75
3121039|NCT01628848|3846339|FG001|COMPLETED|Overall Study||73
3121040|NCT01628848|3846338|FG000|NOT COMPLETED|Overall Study||12
3121041|NCT01628848|3846339|FG001|NOT COMPLETED|Overall Study||14
3121042|NCT01628874|3846347|FG000|STARTED|Overall Study||34
3121043|NCT01628874|3846348|FG001|STARTED|Overall Study||32
3121044|NCT01628874|3846347|FG000|COMPLETED|Overall Study||29
3121045|NCT01628874|3846348|FG001|COMPLETED|Overall Study||29
3121046|NCT01628874|3846347|FG000|NOT COMPLETED|Overall Study||5
3121047|NCT01628874|3846348|FG001|NOT COMPLETED|Overall Study||3
3121048|NCT01628913|3846356|FG000|STARTED|Overall Study||31
3121049|NCT01628913|3846357|FG001|STARTED|Overall Study||31
3121050|NCT01628913|3846356|FG000|COMPLETED|Overall Study||0
3121051|NCT01628913|3846357|FG001|COMPLETED|Overall Study||0
3121052|NCT01628913|3846356|FG000|NOT COMPLETED|Overall Study||31
3121053|NCT01628913|3846357|FG001|NOT COMPLETED|Overall Study||31
3121054|NCT01628926|3846366|FG000|STARTED|Overall Study||168
3121055|NCT01628926|3846367|FG001|STARTED|Overall Study||167
3121056|NCT01628926|3846368|FG002|STARTED|Overall Study||85
3121057|NCT01628926|3846366|FG000|COMPLETED|Overall Study||142
3121058|NCT01628926|3846367|FG001|COMPLETED|Overall Study||144
3121059|NCT01628926|3846368|FG002|COMPLETED|Overall Study||68
3121060|NCT01628926|3846366|FG000|NOT COMPLETED|Overall Study||26
3121061|NCT01628926|3846367|FG001|NOT COMPLETED|Overall Study||23
3121062|NCT01628926|3846368|FG002|NOT COMPLETED|Overall Study||17
3121063|NCT01628965|3846377|FG000|STARTED|Overall Study||143
3121064|NCT01628965|3846377|FG000|COMPLETED|Overall Study||94
3121065|NCT01628965|3846377|FG000|NOT COMPLETED|Overall Study||49
3121066|NCT01629134|3846381|FG000|STARTED|Overall Study||62
3121067|NCT01629134|3846381|FG000|COMPLETED|Overall Study||62
3121068|NCT01629134|3846381|FG000|NOT COMPLETED|Overall Study||0
3121069|NCT01629290|3846385|FG000|STARTED|Overall Study||15
3121070|NCT01629290|3846385|FG000|COMPLETED|Overall Study||15
3121071|NCT01629290|3846385|FG000|NOT COMPLETED|Overall Study||0
3121072|NCT01629381|3846397|FG000|STARTED|Overall Study||122
3121073|NCT01629381|3846398|FG001|STARTED|Overall Study||119
3121074|NCT01629381|3846397|FG000|COMPLETED|Overall Study||120
3121075|NCT01629381|3846398|FG001|COMPLETED|Overall Study||114
3121076|NCT01629381|3846397|FG000|NOT COMPLETED|Overall Study||2
3121077|NCT01629381|3846398|FG001|NOT COMPLETED|Overall Study||5
3121078|NCT01629563|3846410|FG000|STARTED|Overall Study||228
3121079|NCT01629563|3846411|FG001|STARTED|Overall Study|2 subjects randomised to 10mg received 5mg treatment in error (FAS 1: 10mg, Safety Set: 5mg)|223
3121080|NCT01629563|3846410|FG000|Safety Population|Overall Study||230
3121081|NCT01629563|3846411|FG001|Safety Population|Overall Study||221
3121082|NCT01629563|3846410|FG000|Started Treatment Course 2|Overall Study||213
3121083|NCT01629563|3846411|FG001|Started Treatment Course 2|Overall Study||207
3121084|NCT01629563|3846410|FG000|Started Treatment Course 3|Overall Study||191
3121085|NCT01629563|3846411|FG001|Started Treatment Course 3|Overall Study||190
3295138|NCT02895360|4029311|FG001|COMPLETED|Phase 1 - 45 mg/m² Cohort||0
3295139|NCT02895360|4029312|FG002|COMPLETED|Phase 1 - 45 mg/m² Cohort||0
3295140|NCT02895360|4029313|FG003|COMPLETED|Phase 1 - 45 mg/m² Cohort||0
3295141|NCT02895360|4029314|FG004|COMPLETED|Phase 1 - 45 mg/m² Cohort||0
3295142|NCT02895360|4029315|FG005|COMPLETED|Phase 1 - 45 mg/m² Cohort||0
3295143|NCT02895360|4029310|FG000|NOT COMPLETED|Phase 1 - 45 mg/m² Cohort||0
3295144|NCT02895360|4029311|FG001|NOT COMPLETED|Phase 1 - 45 mg/m² Cohort||3
3295145|NCT02895360|4029312|FG002|NOT COMPLETED|Phase 1 - 45 mg/m² Cohort||0
3295146|NCT02895360|4029313|FG003|NOT COMPLETED|Phase 1 - 45 mg/m² Cohort||0
3121086|NCT01629563|3846410|FG000|Started Treatment Course 4|Overall Study||178
3121087|NCT01629563|3846411|FG001|Started Treatment Course 4|Overall Study||176
3121088|NCT01629563|3846410|FG000|COMPLETED|Overall Study||167
3121089|NCT01629563|3846411|FG001|COMPLETED|Overall Study||170
3121090|NCT01629563|3846410|FG000|NOT COMPLETED|Overall Study||61
3121091|NCT01629563|3846411|FG001|NOT COMPLETED|Overall Study||53
3121092|NCT01629589|3846419|FG000|STARTED|Overall Study||212
3121093|NCT01629589|3846420|FG001|STARTED|Overall Study||211
3121094|NCT01629589|3846419|FG000|COMPLETED|Overall Study|A participant received the Boostrix vaccine. Study data reported for the Boostrix vaccine group.|204
3121095|NCT01629589|3846420|FG001|COMPLETED|Overall Study||204
3121096|NCT01629589|3846419|FG000|NOT COMPLETED|Overall Study||8
3121097|NCT01629589|3846420|FG001|NOT COMPLETED|Overall Study||7
3121098|NCT01629615|3846426|FG000|STARTED|Overall Study||50
3121099|NCT01629615|3846426|FG000|COMPLETED|Overall Study||50
3121100|NCT01629615|3846426|FG000|NOT COMPLETED|Overall Study||0
3121101|NCT01629667|3846433|FG000|STARTED|Overall Study||59
3121102|NCT01629667|3846434|FG001|STARTED|Overall Study||58
3121103|NCT01629667|3846435|FG002|STARTED|Overall Study||59
3121104|NCT01629667|3846433|FG000|Randomized and Treated|Overall Study||57
3121105|NCT01629667|3846434|FG001|Randomized and Treated|Overall Study||57
3121106|NCT01629667|3846435|FG002|Randomized and Treated|Overall Study||59
3121107|NCT01629667|3846433|FG000|COMPLETED|Overall Study||12
3121108|NCT01629667|3846434|FG001|COMPLETED|Overall Study||17
3121109|NCT01629667|3846435|FG002|COMPLETED|Overall Study||14
3121110|NCT01629667|3846433|FG000|NOT COMPLETED|Overall Study||47
3121111|NCT01629667|3846434|FG001|NOT COMPLETED|Overall Study||41
3121112|NCT01629667|3846435|FG002|NOT COMPLETED|Overall Study||45
3121113|NCT01629693|3846447|FG000|STARTED|Overall Study||193
3121114|NCT01629693|3846448|FG001|STARTED|Overall Study||188
3121115|NCT01629693|3846447|FG000|COMPLETED|Overall Study||188
3121116|NCT01629693|3846448|FG001|COMPLETED|Overall Study||178
3121117|NCT01629693|3846447|FG000|NOT COMPLETED|Overall Study||5
3121118|NCT01629693|3846448|FG001|NOT COMPLETED|Overall Study||10
3121119|NCT01629706|3846454|FG000|STARTED|Phase 1 PureVision||44
3121120|NCT01629706|3846454|FG000|COMPLETED|Phase 1 PureVision||35
3121121|NCT01629706|3846454|FG000|NOT COMPLETED|Phase 1 PureVision||9
3121122|NCT01629706|3846454|FG000|STARTED|Phase 2 Habitual|Phase 2 enrolled 48 new participants, plus 10 participants from Phase 1|58
3121123|NCT01629706|3846454|FG000|COMPLETED|Phase 2 Habitual||48
3121124|NCT01629706|3846454|FG000|NOT COMPLETED|Phase 2 Habitual||10
3121125|NCT01629771|3846464|FG000|STARTED|Overall Study||36
3121126|NCT01629771|3846465|FG001|STARTED|Overall Study||36
3121127|NCT01629771|3846464|FG000|COMPLETED|Overall Study||36
3121128|NCT01629771|3846465|FG001|COMPLETED|Overall Study||36
3121129|NCT01629771|3846464|FG000|NOT COMPLETED|Overall Study||0
3121130|NCT01629771|3846465|FG001|NOT COMPLETED|Overall Study||0
3121131|NCT01629784|3846471|FG000|STARTED|Overall Study||31
3121132|NCT01629784|3846471|FG000|COMPLETED|Overall Study||25
3121133|NCT01629784|3846471|FG000|NOT COMPLETED|Overall Study||6
3121134|NCT01629797|3846478|FG000|STARTED|Overall Study||100
3121135|NCT01629797|3846478|FG000|COMPLETED|Overall Study||82
3121136|NCT01629797|3846478|FG000|NOT COMPLETED|Overall Study||18
3121137|NCT01629823|3846488|FG000|STARTED|Trial Period||66
3121138|NCT01629823|3846489|FG001|STARTED|Trial Period||69
3121139|NCT01629823|3846490|FG002|STARTED|Trial Period||59
3121140|NCT01629823|3846488|FG000|COMPLETED|Trial Period||53
3121141|NCT01629823|3846489|FG001|COMPLETED|Trial Period||56
3121142|NCT01629823|3846490|FG002|COMPLETED|Trial Period||49
3121143|NCT01629823|3846488|FG000|NOT COMPLETED|Trial Period||13
3121144|NCT01629823|3846489|FG001|NOT COMPLETED|Trial Period||13
3121145|NCT01629823|3846490|FG002|NOT COMPLETED|Trial Period||10
3295147|NCT02895360|4029314|FG004|NOT COMPLETED|Phase 1 - 45 mg/m² Cohort||0
3295148|NCT02895360|4029315|FG005|NOT COMPLETED|Phase 1 - 45 mg/m² Cohort||0
3295149|NCT02895360|4029310|FG000|STARTED|Phase 1 - 70 mg/m² Cohort||0
3295150|NCT02895360|4029311|FG001|STARTED|Phase 1 - 70 mg/m² Cohort||0
3295151|NCT02895360|4029312|FG002|STARTED|Phase 1 - 70 mg/m² Cohort||9
3295152|NCT02895360|4029313|FG003|STARTED|Phase 1 - 70 mg/m² Cohort||0
3295153|NCT02895360|4029314|FG004|STARTED|Phase 1 - 70 mg/m² Cohort||0
3295154|NCT02895360|4029315|FG005|STARTED|Phase 1 - 70 mg/m² Cohort||0
3295155|NCT02895360|4029310|FG000|COMPLETED|Phase 1 - 70 mg/m² Cohort||0
3295156|NCT02895360|4029311|FG001|COMPLETED|Phase 1 - 70 mg/m² Cohort||0
3121146|NCT01629823|3846488|FG000|STARTED|Washout Period||54
3121147|NCT01629823|3846489|FG001|STARTED|Washout Period||57
3121148|NCT01629823|3846490|FG002|STARTED|Washout Period||50
3121149|NCT01629823|3846488|FG000|COMPLETED|Washout Period||51
3121150|NCT01629823|3846489|FG001|COMPLETED|Washout Period||51
3121151|NCT01629823|3846490|FG002|COMPLETED|Washout Period||50
3121152|NCT01629823|3846488|FG000|NOT COMPLETED|Washout Period||3
3121153|NCT01629823|3846489|FG001|NOT COMPLETED|Washout Period||6
3121154|NCT01629823|3846490|FG002|NOT COMPLETED|Washout Period||0
3121155|NCT01629862|3846500|FG000|STARTED|Overall Study||28
3121156|NCT01629862|3846501|FG001|STARTED|Overall Study||25
3121157|NCT01629862|3846500|FG000|COMPLETED|Overall Study||26
3121158|NCT01629862|3846501|FG001|COMPLETED|Overall Study||23
3121159|NCT01629862|3846500|FG000|NOT COMPLETED|Overall Study||2
3121160|NCT01629862|3846501|FG001|NOT COMPLETED|Overall Study||2
3121161|NCT01629953|3846509|FG000|STARTED|Overall Study||65
3121162|NCT01629953|3846510|FG001|STARTED|Overall Study||75
3121163|NCT01629953|3846509|FG000|COMPLETED|Overall Study||52
3121164|NCT01629953|3846510|FG001|COMPLETED|Overall Study||60
3121165|NCT01629953|3846509|FG000|NOT COMPLETED|Overall Study||13
3121166|NCT01629953|3846510|FG001|NOT COMPLETED|Overall Study||15
3121167|NCT01629966|3846519|FG000|STARTED|Overall Study||221
3121168|NCT01629966|3846520|FG001|STARTED|Overall Study||227
3121169|NCT01629966|3846521|FG002|STARTED|Overall Study||225
3121170|NCT01629966|3846519|FG000|COMPLETED|Overall Study||180
3121171|NCT01629966|3846520|FG001|COMPLETED|Overall Study||175
3121172|NCT01629966|3846521|FG002|COMPLETED|Overall Study||159
3121173|NCT01629966|3846519|FG000|NOT COMPLETED|Overall Study||41
3121174|NCT01629966|3846520|FG001|NOT COMPLETED|Overall Study||52
3121175|NCT01629966|3846521|FG002|NOT COMPLETED|Overall Study||66
3121176|NCT01630109|3846532|FG000|STARTED|Overall Study||1
3121177|NCT01630109|3846533|FG001|STARTED|Overall Study||1
3121178|NCT01630109|3846534|FG002|STARTED|Overall Study||3
3121179|NCT01630109|3846532|FG000|COMPLETED|Overall Study||1
3121180|NCT01630109|3846533|FG001|COMPLETED|Overall Study||1
3121181|NCT01630109|3846534|FG002|COMPLETED|Overall Study||3
3121182|NCT01630109|3846532|FG000|NOT COMPLETED|Overall Study||0
3121183|NCT01630109|3846533|FG001|NOT COMPLETED|Overall Study||0
3121184|NCT01630109|3846534|FG002|NOT COMPLETED|Overall Study||0
3121185|NCT01630135|3846550|FG000|STARTED|Overall Study||131
3121186|NCT01630135|3846551|FG001|STARTED|Overall Study||130
3121187|NCT01630135|3846550|FG000|COMPLETED|Overall Study||131
3121188|NCT01630135|3846551|FG001|COMPLETED|Overall Study||128
3121189|NCT01630135|3846550|FG000|NOT COMPLETED|Overall Study||0
3121190|NCT01630135|3846551|FG001|NOT COMPLETED|Overall Study||2
3121191|NCT01630200|3846559|FG000|STARTED|Overall Study||40
3121192|NCT01630200|3846560|FG001|STARTED|Overall Study||40
3121193|NCT01630200|3846559|FG000|COMPLETED|Overall Study||33
3121194|NCT01630200|3846560|FG001|COMPLETED|Overall Study||34
3121195|NCT01630200|3846559|FG000|NOT COMPLETED|Overall Study||7
3121196|NCT01630200|3846560|FG001|NOT COMPLETED|Overall Study||6
3121197|NCT01630616|3846572|FG000|STARTED|Overall Study||5
3121198|NCT01630616|3846573|FG001|STARTED|Overall Study||3
3121199|NCT01630616|3846574|FG002|STARTED|Overall Study||3
3121200|NCT01630616|3846575|FG003|STARTED|Overall Study||12
3121201|NCT01630616|3846576|FG004|STARTED|Overall Study||6
3121202|NCT01630616|3846577|FG005|STARTED|Overall Study||2
3121203|NCT01630616|3846572|FG000|COMPLETED|Overall Study||5
3121204|NCT01630616|3846573|FG001|COMPLETED|Overall Study||3
3121205|NCT01630616|3846574|FG002|COMPLETED|Overall Study||3
3121206|NCT01630616|3846575|FG003|COMPLETED|Overall Study||9
3121207|NCT01630616|3846576|FG004|COMPLETED|Overall Study||6
3121208|NCT01630616|3846577|FG005|COMPLETED|Overall Study||2
3121209|NCT01630616|3846572|FG000|NOT COMPLETED|Overall Study||0
3121210|NCT01630616|3846573|FG001|NOT COMPLETED|Overall Study||0
3121211|NCT01630616|3846574|FG002|NOT COMPLETED|Overall Study||0
3121212|NCT01630616|3846575|FG003|NOT COMPLETED|Overall Study||3
3121213|NCT01630616|3846576|FG004|NOT COMPLETED|Overall Study||0
3121214|NCT01630616|3846577|FG005|NOT COMPLETED|Overall Study||0
3121215|NCT01630694|3846596|FG000|STARTED|Overall Study||12
3121216|NCT01630694|3846597|FG001|STARTED|Overall Study||16
3121217|NCT01630694|3846596|FG000|COMPLETED|Overall Study||12
3121218|NCT01630694|3846597|FG001|COMPLETED|Overall Study||16
3121219|NCT01630694|3846596|FG000|NOT COMPLETED|Overall Study||0
3121220|NCT01630694|3846597|FG001|NOT COMPLETED|Overall Study||0
3121221|NCT01630811|3846603|FG000|STARTED|First Intervention (8 Weeks)||7
3121222|NCT01630811|3846604|FG001|STARTED|First Intervention (8 Weeks)||6
3121223|NCT01630811|3846603|FG000|COMPLETED|First Intervention (8 Weeks)||7
3121224|NCT01630811|3846604|FG001|COMPLETED|First Intervention (8 Weeks)||6
3121225|NCT01630811|3846603|FG000|NOT COMPLETED|First Intervention (8 Weeks)||0
3121226|NCT01630811|3846604|FG001|NOT COMPLETED|First Intervention (8 Weeks)||0
3121227|NCT01630811|3846603|FG000|STARTED|Washout (4 Weeks)||7
3121228|NCT01630811|3846604|FG001|STARTED|Washout (4 Weeks)||6
3121229|NCT01630811|3846603|FG000|COMPLETED|Washout (4 Weeks)||7
3121230|NCT01630811|3846604|FG001|COMPLETED|Washout (4 Weeks)||6
3121231|NCT01630811|3846603|FG000|NOT COMPLETED|Washout (4 Weeks)||0
3121232|NCT01630811|3846604|FG001|NOT COMPLETED|Washout (4 Weeks)||0
3121233|NCT01630811|3846603|FG000|STARTED|Second Intervention (8 Weeks)||7
3121234|NCT01630811|3846604|FG001|STARTED|Second Intervention (8 Weeks)||6
3121235|NCT01630811|3846603|FG000|COMPLETED|Second Intervention (8 Weeks)||6
3121236|NCT01630811|3846604|FG001|COMPLETED|Second Intervention (8 Weeks)||6
3121237|NCT01630811|3846603|FG000|NOT COMPLETED|Second Intervention (8 Weeks)||1
3121238|NCT01630811|3846604|FG001|NOT COMPLETED|Second Intervention (8 Weeks)||0
3121239|NCT01630811|3846603|FG000|STARTED|Second Washout (4 Weeks)||6
3295157|NCT02895360|4029312|FG002|COMPLETED|Phase 1 - 70 mg/m² Cohort||0
3295158|NCT02895360|4029313|FG003|COMPLETED|Phase 1 - 70 mg/m² Cohort||0
3295159|NCT02895360|4029314|FG004|COMPLETED|Phase 1 - 70 mg/m² Cohort||0
3295160|NCT02895360|4029315|FG005|COMPLETED|Phase 1 - 70 mg/m² Cohort||0
3295161|NCT02895360|4029310|FG000|NOT COMPLETED|Phase 1 - 70 mg/m² Cohort||0
3295162|NCT02895360|4029311|FG001|NOT COMPLETED|Phase 1 - 70 mg/m² Cohort||0
3295163|NCT02895360|4029312|FG002|NOT COMPLETED|Phase 1 - 70 mg/m² Cohort||9
3295164|NCT02895360|4029313|FG003|NOT COMPLETED|Phase 1 - 70 mg/m² Cohort||0
3295165|NCT02895360|4029314|FG004|NOT COMPLETED|Phase 1 - 70 mg/m² Cohort||0
3295166|NCT02895360|4029315|FG005|NOT COMPLETED|Phase 1 - 70 mg/m² Cohort||0
3295167|NCT02895360|4029310|FG000|STARTED|Phase 1 - 90 mg/m² Cohort||0
3295168|NCT02895360|4029311|FG001|STARTED|Phase 1 - 90 mg/m² Cohort||0
3121240|NCT01630811|3846604|FG001|STARTED|Second Washout (4 Weeks)||6
3121241|NCT01630811|3846603|FG000|COMPLETED|Second Washout (4 Weeks)||6
3121242|NCT01630811|3846604|FG001|COMPLETED|Second Washout (4 Weeks)||6
3121243|NCT01630811|3846603|FG000|NOT COMPLETED|Second Washout (4 Weeks)||0
3121244|NCT01630811|3846604|FG001|NOT COMPLETED|Second Washout (4 Weeks)||0
3121245|NCT01630889|3846612|FG000|STARTED|Overall Study||15
3121246|NCT01630889|3846612|FG000|Received at Least 1 Dose of Study Drug|Overall Study||15
3121247|NCT01630889|3846612|FG000|COMPLETED|Overall Study||5
3121248|NCT01630889|3846612|FG000|NOT COMPLETED|Overall Study||10
3121249|NCT01631071|3846618|FG000|STARTED|Overall Study||55
3121250|NCT01631071|3846619|FG001|STARTED|Overall Study||55
3121251|NCT01631071|3846618|FG000|COMPLETED|Overall Study||55
3121252|NCT01631071|3846619|FG001|COMPLETED|Overall Study||55
3121253|NCT01631071|3846618|FG000|NOT COMPLETED|Overall Study||0
3121254|NCT01631071|3846619|FG001|NOT COMPLETED|Overall Study||0
3121255|NCT01631110|3846627|FG000|STARTED|Overall Study||55
3121256|NCT01631110|3846628|FG001|STARTED|Overall Study||55
3121257|NCT01631110|3846627|FG000|COMPLETED|Overall Study||55
3121258|NCT01631110|3846628|FG001|COMPLETED|Overall Study||55
3121259|NCT01631110|3846627|FG000|NOT COMPLETED|Overall Study||0
3121260|NCT01631110|3846628|FG001|NOT COMPLETED|Overall Study||0
3121261|NCT01631149|3846636|FG000|STARTED|Overall Study||12
3121262|NCT01631149|3846637|FG001|STARTED|Overall Study||12
3121263|NCT01631149|3846636|FG000|COMPLETED|Overall Study||12
3121264|NCT01631149|3846637|FG001|COMPLETED|Overall Study||12
3121265|NCT01631149|3846636|FG000|NOT COMPLETED|Overall Study||0
3121266|NCT01631149|3846637|FG001|NOT COMPLETED|Overall Study||0
3121267|NCT01631188|3846643|FG000|STARTED|Overall Study||100
3121268|NCT01631188|3846643|FG000|COMPLETED|Overall Study||25
3121269|NCT01631188|3846643|FG000|NOT COMPLETED|Overall Study||75
3121270|NCT01631214|3846649|FG000|STARTED|Overall Study||2047
3121271|NCT01631214|3846650|FG001|STARTED|Overall Study||2046
3121272|NCT01631214|3846649|FG000|Received Double-blind Treatment|Overall Study||2040
3121273|NCT01631214|3846650|FG001|Received Double-blind Treatment|Overall Study||2038
3121274|NCT01631214|3846649|FG000|Completed Double-blind Period|Overall Study||1823
3121275|NCT01631214|3846650|FG001|Completed Double-blind Period|Overall Study||1831
3121276|NCT01631214|3846649|FG000|Completed Primary Analysis Period|Overall Study||1576
3295169|NCT02895360|4029312|FG002|STARTED|Phase 1 - 90 mg/m² Cohort||0
3295170|NCT02895360|4029313|FG003|STARTED|Phase 1 - 90 mg/m² Cohort||4
3295171|NCT02895360|4029314|FG004|STARTED|Phase 1 - 90 mg/m² Cohort||0
3295172|NCT02895360|4029315|FG005|STARTED|Phase 1 - 90 mg/m² Cohort||0
3295173|NCT02895360|4029310|FG000|COMPLETED|Phase 1 - 90 mg/m² Cohort||0
3295174|NCT02895360|4029311|FG001|COMPLETED|Phase 1 - 90 mg/m² Cohort||0
3295175|NCT02895360|4029312|FG002|COMPLETED|Phase 1 - 90 mg/m² Cohort||0
3295176|NCT02895360|4029313|FG003|COMPLETED|Phase 1 - 90 mg/m² Cohort||0
3295177|NCT02895360|4029314|FG004|COMPLETED|Phase 1 - 90 mg/m² Cohort||0
3295178|NCT02895360|4029315|FG005|COMPLETED|Phase 1 - 90 mg/m² Cohort||0
3295179|NCT02895360|4029310|FG000|NOT COMPLETED|Phase 1 - 90 mg/m² Cohort||0
3295180|NCT02895360|4029311|FG001|NOT COMPLETED|Phase 1 - 90 mg/m² Cohort||0
3295181|NCT02895360|4029312|FG002|NOT COMPLETED|Phase 1 - 90 mg/m² Cohort||0
3295182|NCT02895360|4029313|FG003|NOT COMPLETED|Phase 1 - 90 mg/m² Cohort||4
3295183|NCT02895360|4029314|FG004|NOT COMPLETED|Phase 1 - 90 mg/m² Cohort||0
3295184|NCT02895360|4029315|FG005|NOT COMPLETED|Phase 1 - 90 mg/m² Cohort||0
3295185|NCT02895360|4029310|FG000|STARTED|Phase 2a||0
3295186|NCT02895360|4029311|FG001|STARTED|Phase 2a||0
3295187|NCT02895360|4029312|FG002|STARTED|Phase 2a||0
3295188|NCT02895360|4029313|FG003|STARTED|Phase 2a||0
3121277|NCT01631214|3846650|FG001|Completed Primary Analysis Period|Overall Study||1574
3121278|NCT01631214|3846649|FG000|COMPLETED|Overall Study||1503
3121279|NCT01631214|3846650|FG001|COMPLETED|Overall Study||1523
3121280|NCT01631214|3846649|FG000|NOT COMPLETED|Overall Study||544
3121281|NCT01631214|3846650|FG001|NOT COMPLETED|Overall Study||523
3121282|NCT01631227|3846660|FG000|STARTED|Overall Study||333
3121283|NCT01631227|3846661|FG001|STARTED|Overall Study||332
3121284|NCT01631227|3846660|FG000|Safety Subject Sample|Overall Study|1 patient was randomized by mistake and never received study medication.|332
3121285|NCT01631227|3846661|FG001|Safety Subject Sample|Overall Study||332
3121286|NCT01631227|3846660|FG000|Full Analysis Set Population|Overall Study|2 patients not eligible for the Full Analysis Set due to missing post-baseline efficacy measurement|330
3121287|NCT01631227|3846661|FG001|Full Analysis Set Population|Overall Study|1 patient not eligible for the Full Analysis Set due to missing post-baseline efficacy measurement|331
3121288|NCT01631227|3846660|FG000|COMPLETED|Overall Study||303
3121289|NCT01631227|3846661|FG001|COMPLETED|Overall Study||310
3121290|NCT01631227|3846660|FG000|NOT COMPLETED|Overall Study||30
3121291|NCT01631227|3846661|FG001|NOT COMPLETED|Overall Study||22
3121292|NCT01631331|3846667|FG000|STARTED|Overall Study||15
3121293|NCT01631331|3846667|FG000|COMPLETED|Overall Study||11
3121294|NCT01631331|3846667|FG000|NOT COMPLETED|Overall Study||4
3121295|NCT01631435|3846672|FG000|STARTED|Overall Study||75
3121296|NCT01631435|3846672|FG000|COMPLETED|Overall Study||66
3121297|NCT01631435|3846672|FG000|NOT COMPLETED|Overall Study||9
3121298|NCT01631474|3846682|FG000|STARTED|Overall Study||72
3121299|NCT01631474|3846683|FG001|STARTED|Overall Study||76
3121300|NCT01631474|3846684|FG002|STARTED|Overall Study||70
3121301|NCT01631474|3846685|FG003|STARTED|Overall Study||70
3121302|NCT01631474|3846686|FG004|STARTED|Overall Study||75
3121303|NCT01631474|3846682|FG000|COMPLETED|Overall Study||58
3121304|NCT01631474|3846683|FG001|COMPLETED|Overall Study||64
3121305|NCT01631474|3846684|FG002|COMPLETED|Overall Study||61
3121306|NCT01631474|3846685|FG003|COMPLETED|Overall Study||59
3121307|NCT01631474|3846686|FG004|COMPLETED|Overall Study||62
3121308|NCT01631474|3846682|FG000|NOT COMPLETED|Overall Study||14
3121309|NCT01631474|3846683|FG001|NOT COMPLETED|Overall Study||12
3121310|NCT01631474|3846684|FG002|NOT COMPLETED|Overall Study||9
3121311|NCT01631474|3846685|FG003|NOT COMPLETED|Overall Study||11
3121312|NCT01631474|3846686|FG004|NOT COMPLETED|Overall Study||13
3121313|NCT01631552|3846702|FG000|STARTED|Overall Study||83
3121314|NCT01631552|3846703|FG001|STARTED|Overall Study||420
3121315|NCT01631552|3846704|FG002|STARTED|Overall Study||9
3121316|NCT01631552|3846705|FG003|STARTED|Overall Study||3
3121317|NCT01631552|3846702|FG000|Enrolled and Treated|Overall Study||81
3121318|NCT01631552|3846703|FG001|Enrolled and Treated|Overall Study||402
3121319|NCT01631552|3846704|FG002|Enrolled and Treated|Overall Study||9
3121320|NCT01631552|3846705|FG003|Enrolled and Treated|Overall Study||3
3121321|NCT01631552|3846702|FG000|COMPLETED|Overall Study||81
3121322|NCT01631552|3846703|FG001|COMPLETED|Overall Study||400
3121323|NCT01631552|3846704|FG002|COMPLETED|Overall Study||9
3121324|NCT01631552|3846705|FG003|COMPLETED|Overall Study||3
3121325|NCT01631552|3846702|FG000|NOT COMPLETED|Overall Study||2
3121326|NCT01631552|3846703|FG001|NOT COMPLETED|Overall Study||20
3121327|NCT01631552|3846704|FG002|NOT COMPLETED|Overall Study||0
3121328|NCT01631552|3846705|FG003|NOT COMPLETED|Overall Study||0
3121329|NCT01631630|3846719|FG000|STARTED|Overall Study||8
3121330|NCT01631630|3846720|FG001|STARTED|Overall Study||8
3121331|NCT01631630|3846719|FG000|COMPLETED|Overall Study||5
3121332|NCT01631630|3846720|FG001|COMPLETED|Overall Study||8
3121333|NCT01631630|3846719|FG000|NOT COMPLETED|Overall Study||3
3121334|NCT01631630|3846720|FG001|NOT COMPLETED|Overall Study||0
3121335|NCT01631656|3846728|FG000|STARTED|Overall Study||5
3121336|NCT01631656|3846729|FG001|STARTED|Overall Study||5
3121337|NCT01631656|3846728|FG000|COMPLETED|Overall Study||5
3121338|NCT01631656|3846729|FG001|COMPLETED|Overall Study||5
3121339|NCT01631656|3846728|FG000|NOT COMPLETED|Overall Study||0
3121340|NCT01631656|3846729|FG001|NOT COMPLETED|Overall Study||0
3121341|NCT01631682|3846739|FG000|STARTED|Overall Study||55
3121342|NCT01631682|3846740|FG001|STARTED|Overall Study||66
3121343|NCT01631682|3846741|FG002|STARTED|Overall Study||44
3121344|NCT01631682|3846742|FG003|STARTED|Overall Study||7
3121345|NCT01631682|3846739|FG000|COMPLETED|Overall Study||24
3295189|NCT02895360|4029314|FG004|STARTED|Phase 2a||11
3295190|NCT02895360|4029315|FG005|STARTED|Phase 2a||12
3295191|NCT02895360|4029310|FG000|COMPLETED|Phase 2a||0
3295192|NCT02895360|4029311|FG001|COMPLETED|Phase 2a||0
3295193|NCT02895360|4029312|FG002|COMPLETED|Phase 2a||0
3295194|NCT02895360|4029313|FG003|COMPLETED|Phase 2a||0
3295195|NCT02895360|4029314|FG004|COMPLETED|Phase 2a||0
3295196|NCT02895360|4029315|FG005|COMPLETED|Phase 2a||0
3295197|NCT02895360|4029310|FG000|NOT COMPLETED|Phase 2a||0
3295198|NCT02895360|4029311|FG001|NOT COMPLETED|Phase 2a||0
3295199|NCT02895360|4029312|FG002|NOT COMPLETED|Phase 2a||0
3295200|NCT02895360|4029313|FG003|NOT COMPLETED|Phase 2a||0
3295201|NCT02895360|4029314|FG004|NOT COMPLETED|Phase 2a||11
3295202|NCT02895360|4029315|FG005|NOT COMPLETED|Phase 2a||12
3295203|NCT02895945|4029349|FG000|STARTED|Overall Study||7
3295204|NCT02895945|4029350|FG001|STARTED|Overall Study||1
3295205|NCT02895945|4029349|FG000|SAS|Overall Study||7
3121346|NCT01631682|3846740|FG001|COMPLETED|Overall Study||21
3121347|NCT01631682|3846741|FG002|COMPLETED|Overall Study||13
3121348|NCT01631682|3846742|FG003|COMPLETED|Overall Study||5
3121349|NCT01631682|3846739|FG000|NOT COMPLETED|Overall Study||31
3121350|NCT01631682|3846740|FG001|NOT COMPLETED|Overall Study||45
3121351|NCT01631682|3846741|FG002|NOT COMPLETED|Overall Study||31
3121352|NCT01631682|3846742|FG003|NOT COMPLETED|Overall Study||2
3121353|NCT01631747|3846754|FG000|STARTED|Randomization Through End of Pregnancy||141
3121354|NCT01631747|3846755|FG001|STARTED|Randomization Through End of Pregnancy||140
3121355|NCT01631747|3846754|FG000|COMPLETED|Randomization Through End of Pregnancy||140
3121356|NCT01631747|3846755|FG001|COMPLETED|Randomization Through End of Pregnancy||140
3121357|NCT01631747|3846754|FG000|NOT COMPLETED|Randomization Through End of Pregnancy||1
3121358|NCT01631747|3846755|FG001|NOT COMPLETED|Randomization Through End of Pregnancy||0
3121359|NCT01631747|3846754|FG000|STARTED|Live Birth||140
3121360|NCT01631747|3846755|FG001|STARTED|Live Birth||140
3121361|NCT01631747|3846754|FG000|COMPLETED|Live Birth||136
3121362|NCT01631747|3846755|FG001|COMPLETED|Live Birth||139
3121363|NCT01631747|3846754|FG000|NOT COMPLETED|Live Birth||4
3295206|NCT02895945|4029350|FG001|SAS|Overall Study||1
3121364|NCT01631747|3846755|FG001|NOT COMPLETED|Live Birth||1
3121365|NCT01631747|3846754|FG000|STARTED|One Year Infant Outcomes||136
3121366|NCT01631747|3846755|FG001|STARTED|One Year Infant Outcomes||139
3121367|NCT01631747|3846754|FG000|COMPLETED|One Year Infant Outcomes||123
3121368|NCT01631747|3846755|FG001|COMPLETED|One Year Infant Outcomes||130
3121369|NCT01631747|3846754|FG000|NOT COMPLETED|One Year Infant Outcomes||13
3121370|NCT01631747|3846755|FG001|NOT COMPLETED|One Year Infant Outcomes||9
3121371|NCT01631812|3846762|FG000|STARTED|Overall Study||130
3121372|NCT01631812|3846762|FG000|COMPLETED|Overall Study||93
3121373|NCT01631812|3846762|FG000|NOT COMPLETED|Overall Study||37
3121374|NCT01631825|3846766|FG000|STARTED|Overall Study||321
3121375|NCT01631825|3846766|FG000|COMPLETED|Overall Study||256
3121376|NCT01631825|3846766|FG000|NOT COMPLETED|Overall Study||65
3121377|NCT01631864|3846772|FG000|STARTED|Overall Study||50
3121378|NCT01631864|3846773|FG001|STARTED|Overall Study||48
3121379|NCT01631864|3846772|FG000|COMPLETED|Overall Study||48
3121380|NCT01631864|3846773|FG001|COMPLETED|Overall Study||44
3121381|NCT01631864|3846772|FG000|NOT COMPLETED|Overall Study||2
3121382|NCT01631864|3846773|FG001|NOT COMPLETED|Overall Study||4
3121383|NCT01631929|3846781|FG000|STARTED|Overall Study||6
3121384|NCT01631929|3846782|FG001|STARTED|Overall Study||6
3121385|NCT01631929|3846781|FG000|COMPLETED|Overall Study||6
3121386|NCT01631929|3846782|FG001|COMPLETED|Overall Study||6
3121387|NCT01631929|3846781|FG000|NOT COMPLETED|Overall Study||0
3121388|NCT01631929|3846782|FG001|NOT COMPLETED|Overall Study||0
3121389|NCT01632150|3846788|FG000|STARTED|Overall Study||40
3121390|NCT01632150|3846788|FG000|Received Cyclophosphamide|Overall Study||11
3121391|NCT01632150|3846788|FG000|COMPLETED|Overall Study|Completed=still receiving treatment|0
3121392|NCT01632150|3846788|FG000|NOT COMPLETED|Overall Study||40
3121393|NCT01632202|3846797|FG000|STARTED|Overall Study||1
3121394|NCT01632202|3846798|FG001|STARTED|Overall Study||7
3121395|NCT01632202|3846797|FG000|COMPLETED|Overall Study||1
3121396|NCT01632202|3846798|FG001|COMPLETED|Overall Study||7
3121397|NCT01632202|3846797|FG000|NOT COMPLETED|Overall Study||0
3121398|NCT01632202|3846798|FG001|NOT COMPLETED|Overall Study||0
3121399|NCT01632215|3846806|FG000|STARTED|Overall Study||20
3121400|NCT01632215|3846807|FG001|STARTED|Overall Study||20
3121401|NCT01632215|3846806|FG000|COMPLETED|Overall Study||18
3121402|NCT01632215|3846807|FG001|COMPLETED|Overall Study||19
3121403|NCT01632215|3846806|FG000|NOT COMPLETED|Overall Study||2
3121404|NCT01632215|3846807|FG001|NOT COMPLETED|Overall Study||1
3121405|NCT01632241|3846815|FG000|STARTED|Double-blinded (Up to Week 52)||165
3121406|NCT01632241|3846816|FG001|STARTED|Double-blinded (Up to Week 52)||331
3121407|NCT01632241|3846815|FG000|COMPLETED|Double-blinded (Up to Week 52)||121
3121408|NCT01632241|3846816|FG001|COMPLETED|Double-blinded (Up to Week 52)||252
3121409|NCT01632241|3846815|FG000|NOT COMPLETED|Double-blinded (Up to Week 52)||44
3121410|NCT01632241|3846816|FG001|NOT COMPLETED|Double-blinded (Up to Week 52)||79
3121411|NCT01632241|3846815|FG000|STARTED|Open-label (Week 52 to Week 76)|As the OL phase was optional, participants did not choose to enter the OL Phase.|117
3121412|NCT01632241|3846816|FG001|STARTED|Open-label (Week 52 to Week 76)|As the OL phase was optional, participants did not choose to enter the OL Phase.|242
3121413|NCT01632241|3846815|FG000|COMPLETED|Open-label (Week 52 to Week 76)||107
3121414|NCT01632241|3846816|FG001|COMPLETED|Open-label (Week 52 to Week 76)||220
3121415|NCT01632241|3846815|FG000|NOT COMPLETED|Open-label (Week 52 to Week 76)||10
3121416|NCT01632241|3846816|FG001|NOT COMPLETED|Open-label (Week 52 to Week 76)||22
3121417|NCT01632267|3846828|FG000|STARTED|Overall Study||104
3121418|NCT01632267|3846828|FG000|COMPLETED|Overall Study||97
3121419|NCT01632267|3846828|FG000|NOT COMPLETED|Overall Study||7
3121420|NCT01632280|3846834|FG000|STARTED|Overall Study||6
3121421|NCT01632280|3846835|FG001|STARTED|Overall Study||6
3121422|NCT01632280|3846834|FG000|COMPLETED|Overall Study||5
3121423|NCT01632280|3846835|FG001|COMPLETED|Overall Study||6
3121424|NCT01632280|3846834|FG000|NOT COMPLETED|Overall Study||1
3121425|NCT01632280|3846835|FG001|NOT COMPLETED|Overall Study||0
3121426|NCT01632306|3846843|FG000|STARTED|Overall Study||3
3121427|NCT01632306|3846844|FG001|STARTED|Overall Study||10
3121428|NCT01632306|3846845|FG002|STARTED|Overall Study||0
3121429|NCT01632306|3846843|FG000|Received at Least One Dose of Study Drug|Overall Study||3
3121430|NCT01632306|3846844|FG001|Received at Least One Dose of Study Drug|Overall Study||10
3121431|NCT01632306|3846845|FG002|Received at Least One Dose of Study Drug|Overall Study||0
3121432|NCT01632306|3846843|FG000|COMPLETED|Overall Study||2
3121433|NCT01632306|3846844|FG001|COMPLETED|Overall Study||10
3121434|NCT01632306|3846845|FG002|COMPLETED|Overall Study||0
3121435|NCT01632306|3846843|FG000|NOT COMPLETED|Overall Study||1
3121436|NCT01632306|3846844|FG001|NOT COMPLETED|Overall Study||0
3121437|NCT01632306|3846845|FG002|NOT COMPLETED|Overall Study||0
3121438|NCT01632345|3846856|FG000|STARTED|Randomized Participants||41
3121439|NCT01632345|3846857|FG001|STARTED|Randomized Participants||43
3121440|NCT01632345|3846858|FG002|STARTED|Randomized Participants||42
3121441|NCT01632345|3846859|FG003|STARTED|Randomized Participants||41
3121442|NCT01632345|3846860|FG004|STARTED|Randomized Participants||43
3121443|NCT01632345|3846861|FG005|STARTED|Randomized Participants||66
3121444|NCT01632345|3846862|FG006|STARTED|Randomized Participants||66
3121445|NCT01632345|3846856|FG000|COMPLETED|Randomized Participants||41
3121446|NCT01632345|3846857|FG001|COMPLETED|Randomized Participants||43
3121447|NCT01632345|3846858|FG002|COMPLETED|Randomized Participants||42
3121448|NCT01632345|3846859|FG003|COMPLETED|Randomized Participants||41
3121449|NCT01632345|3846860|FG004|COMPLETED|Randomized Participants||43
3121450|NCT01632345|3846861|FG005|COMPLETED|Randomized Participants||66
3121451|NCT01632345|3846862|FG006|COMPLETED|Randomized Participants||66
3121452|NCT01632345|3846856|FG000|NOT COMPLETED|Randomized Participants||0
3121453|NCT01632345|3846857|FG001|NOT COMPLETED|Randomized Participants||0
3121454|NCT01632345|3846858|FG002|NOT COMPLETED|Randomized Participants||0
3121455|NCT01632345|3846859|FG003|NOT COMPLETED|Randomized Participants||0
3121456|NCT01632345|3846860|FG004|NOT COMPLETED|Randomized Participants||0
3121457|NCT01632345|3846861|FG005|NOT COMPLETED|Randomized Participants||0
3121458|NCT01632345|3846862|FG006|NOT COMPLETED|Randomized Participants||0
3121459|NCT01632345|3846856|FG000|STARTED|Treatment: Part I||41
3121460|NCT01632345|3846857|FG001|STARTED|Treatment: Part I||43
3121461|NCT01632345|3846858|FG002|STARTED|Treatment: Part I||42
3121462|NCT01632345|3846859|FG003|STARTED|Treatment: Part I||41
3121463|NCT01632345|3846860|FG004|STARTED|Treatment: Part I||43
3121464|NCT01632345|3846861|FG005|STARTED|Treatment: Part I|Participants in Part II did not participate in Part I.|0
3121465|NCT01632345|3846862|FG006|STARTED|Treatment: Part I|Participants in Part II did not participate in Part I.|0
3121466|NCT01632345|3846856|FG000|Treated|Treatment: Part I||40
3121467|NCT01632345|3846857|FG001|Treated|Treatment: Part I||43
3121468|NCT01632345|3846858|FG002|Treated|Treatment: Part I||42
3121469|NCT01632345|3846859|FG003|Treated|Treatment: Part I||41
3121470|NCT01632345|3846860|FG004|Treated|Treatment: Part I||43
3121471|NCT01632345|3846861|FG005|Treated|Treatment: Part I||0
3121472|NCT01632345|3846862|FG006|Treated|Treatment: Part I||0
3121473|NCT01632345|3846856|FG000|COMPLETED|Treatment: Part I||29
3121474|NCT01632345|3846857|FG001|COMPLETED|Treatment: Part I||28
3121475|NCT01632345|3846858|FG002|COMPLETED|Treatment: Part I||32
3121476|NCT01632345|3846859|FG003|COMPLETED|Treatment: Part I||33
3121477|NCT01632345|3846860|FG004|COMPLETED|Treatment: Part I||30
3121478|NCT01632345|3846861|FG005|COMPLETED|Treatment: Part I||0
3121479|NCT01632345|3846862|FG006|COMPLETED|Treatment: Part I||0
3121480|NCT01632345|3846856|FG000|NOT COMPLETED|Treatment: Part I||12
3121481|NCT01632345|3846857|FG001|NOT COMPLETED|Treatment: Part I||15
3121482|NCT01632345|3846858|FG002|NOT COMPLETED|Treatment: Part I||10
3121483|NCT01632345|3846859|FG003|NOT COMPLETED|Treatment: Part I||8
3121484|NCT01632345|3846860|FG004|NOT COMPLETED|Treatment: Part I||13
3121485|NCT01632345|3846861|FG005|NOT COMPLETED|Treatment: Part I||0
3121486|NCT01632345|3846862|FG006|NOT COMPLETED|Treatment: Part I||0
3121487|NCT01632345|3846856|FG000|STARTED|Treatment: Part II|Participants in Part I did not continue in Part II.|0
3121488|NCT01632345|3846857|FG001|STARTED|Treatment: Part II|Participants in Part I did not continue in Part II.|0
3121489|NCT01632345|3846858|FG002|STARTED|Treatment: Part II|Participants in Part I did not continue in Part II.|0
3121490|NCT01632345|3846859|FG003|STARTED|Treatment: Part II|Participants in Part I did not continue in Part II.|0
3121491|NCT01632345|3846860|FG004|STARTED|Treatment: Part II|Participants in Part I did not continue in Part II.|0
3121492|NCT01632345|3846861|FG005|STARTED|Treatment: Part II|66 new participants enrolled at 100 mg dose in Part II.|66
3121493|NCT01632345|3846862|FG006|STARTED|Treatment: Part II|66 new participants enrolled at efavirenz treatment in Part II.|66
3121494|NCT01632345|3846856|FG000|Treated|Treatment: Part II||0
3121495|NCT01632345|3846857|FG001|Treated|Treatment: Part II||0
3121496|NCT01632345|3846858|FG002|Treated|Treatment: Part II||0
3121497|NCT01632345|3846859|FG003|Treated|Treatment: Part II||0
3121498|NCT01632345|3846860|FG004|Treated|Treatment: Part II||0
3121499|NCT01632345|3846861|FG005|Treated|Treatment: Part II||66
3121500|NCT01632345|3846862|FG006|Treated|Treatment: Part II||66
3121501|NCT01632345|3846856|FG000|COMPLETED|Treatment: Part II||0
3121502|NCT01632345|3846857|FG001|COMPLETED|Treatment: Part II||0
3121503|NCT01632345|3846858|FG002|COMPLETED|Treatment: Part II||0
3121504|NCT01632345|3846859|FG003|COMPLETED|Treatment: Part II||0
3121505|NCT01632345|3846860|FG004|COMPLETED|Treatment: Part II||0
3121506|NCT01632345|3846861|FG005|COMPLETED|Treatment: Part II||55
3121507|NCT01632345|3846862|FG006|COMPLETED|Treatment: Part II||55
3121508|NCT01632345|3846856|FG000|NOT COMPLETED|Treatment: Part II||0
3121509|NCT01632345|3846857|FG001|NOT COMPLETED|Treatment: Part II||0
3121510|NCT01632345|3846858|FG002|NOT COMPLETED|Treatment: Part II||0
3121511|NCT01632345|3846859|FG003|NOT COMPLETED|Treatment: Part II||0
3121512|NCT01632345|3846860|FG004|NOT COMPLETED|Treatment: Part II||0
3121513|NCT01632345|3846861|FG005|NOT COMPLETED|Treatment: Part II||11
3121514|NCT01632345|3846862|FG006|NOT COMPLETED|Treatment: Part II||11
3121515|NCT01632423|3846877|FG000|STARTED|Overall Study||10337
3121516|NCT01632423|3846877|FG000|COMPLETED|Overall Study||10091
3121517|NCT01632423|3846877|FG000|NOT COMPLETED|Overall Study||246
3121518|NCT01632566|3846886|FG000|STARTED|Overall Study||8
3121519|NCT01632566|3846887|FG001|STARTED|Overall Study||10
3121520|NCT01632566|3846888|FG002|STARTED|Overall Study||9
3121521|NCT01632566|3846889|FG003|STARTED|Overall Study||6
3121522|NCT01632566|3846890|FG004|STARTED|Overall Study||6
3121523|NCT01632566|3846886|FG000|Received at Least One Dose LY3031207|Overall Study||8
3121524|NCT01632566|3846887|FG001|Received at Least One Dose LY3031207|Overall Study||10
3121525|NCT01632566|3846888|FG002|Received at Least One Dose LY3031207|Overall Study||9
3121526|NCT01632566|3846889|FG003|Received at Least One Dose LY3031207|Overall Study||0
3121527|NCT01632566|3846890|FG004|Received at Least One Dose LY3031207|Overall Study||0
3121528|NCT01632566|3846886|FG000|Received at Least One Dose Simvastatin|Overall Study||0
3121529|NCT01632566|3846887|FG001|Received at Least One Dose Simvastatin|Overall Study||10
3121530|NCT01632566|3846888|FG002|Received at Least One Dose Simvastatin|Overall Study||9
3121531|NCT01632566|3846889|FG003|Received at Least One Dose Simvastatin|Overall Study||4
3121532|NCT01632566|3846890|FG004|Received at Least One Dose Simvastatin|Overall Study||4
3121533|NCT01632566|3846886|FG000|COMPLETED|Overall Study||8
3121534|NCT01632566|3846887|FG001|COMPLETED|Overall Study||7
3121535|NCT01632566|3846888|FG002|COMPLETED|Overall Study||0
3121536|NCT01632566|3846889|FG003|COMPLETED|Overall Study||4
3121537|NCT01632566|3846890|FG004|COMPLETED|Overall Study||4
3121538|NCT01632566|3846886|FG000|NOT COMPLETED|Overall Study||0
3121539|NCT01632566|3846887|FG001|NOT COMPLETED|Overall Study||3
3121540|NCT01632566|3846888|FG002|NOT COMPLETED|Overall Study||9
3121541|NCT01632566|3846889|FG003|NOT COMPLETED|Overall Study||2
3121542|NCT01632566|3846890|FG004|NOT COMPLETED|Overall Study||2
3121543|NCT01632579|3846906|FG000|STARTED|Period 1 (First Intervention)||2
3121544|NCT01632579|3846907|FG001|STARTED|Period 1 (First Intervention)||6
3121545|NCT01632579|3846908|FG002|STARTED|Period 1 (First Intervention)||2
3121546|NCT01632579|3846909|FG003|STARTED|Period 1 (First Intervention)||2
3121547|NCT01632579|3846910|FG004|STARTED|Period 1 (First Intervention)||6
3121548|NCT01632579|3846911|FG005|STARTED|Period 1 (First Intervention)||2
3121549|NCT01632579|3846912|FG006|STARTED|Period 1 (First Intervention)||2
3121550|NCT01632579|3846913|FG007|STARTED|Period 1 (First Intervention)||6
3121551|NCT01632579|3846914|FG008|STARTED|Period 1 (First Intervention)||2
3121552|NCT01632579|3846906|FG000|Received at Least 1 Dose|Period 1 (First Intervention)||2
3121553|NCT01632579|3846907|FG001|Received at Least 1 Dose|Period 1 (First Intervention)||6
3121554|NCT01632579|3846908|FG002|Received at Least 1 Dose|Period 1 (First Intervention)||2
3121555|NCT01632579|3846909|FG003|Received at Least 1 Dose|Period 1 (First Intervention)||2
3121556|NCT01632579|3846910|FG004|Received at Least 1 Dose|Period 1 (First Intervention)||6
3121557|NCT01632579|3846911|FG005|Received at Least 1 Dose|Period 1 (First Intervention)||2
3121558|NCT01632579|3846912|FG006|Received at Least 1 Dose|Period 1 (First Intervention)||2
3121559|NCT01632579|3846913|FG007|Received at Least 1 Dose|Period 1 (First Intervention)||6
3121560|NCT01632579|3846914|FG008|Received at Least 1 Dose|Period 1 (First Intervention)||2
3121561|NCT01632579|3846906|FG000|COMPLETED|Period 1 (First Intervention)||2
3121562|NCT01632579|3846907|FG001|COMPLETED|Period 1 (First Intervention)||6
3121563|NCT01632579|3846908|FG002|COMPLETED|Period 1 (First Intervention)||2
3121564|NCT01632579|3846909|FG003|COMPLETED|Period 1 (First Intervention)||2
3121565|NCT01632579|3846910|FG004|COMPLETED|Period 1 (First Intervention)||6
3121566|NCT01632579|3846911|FG005|COMPLETED|Period 1 (First Intervention)||2
3121567|NCT01632579|3846912|FG006|COMPLETED|Period 1 (First Intervention)||2
3121568|NCT01632579|3846913|FG007|COMPLETED|Period 1 (First Intervention)||6
3121569|NCT01632579|3846914|FG008|COMPLETED|Period 1 (First Intervention)||2
3121570|NCT01632579|3846906|FG000|NOT COMPLETED|Period 1 (First Intervention)||0
3121571|NCT01632579|3846907|FG001|NOT COMPLETED|Period 1 (First Intervention)||0
3121572|NCT01632579|3846908|FG002|NOT COMPLETED|Period 1 (First Intervention)||0
3121573|NCT01632579|3846909|FG003|NOT COMPLETED|Period 1 (First Intervention)||0
3121574|NCT01632579|3846910|FG004|NOT COMPLETED|Period 1 (First Intervention)||0
3121575|NCT01632579|3846911|FG005|NOT COMPLETED|Period 1 (First Intervention)||0
3121576|NCT01632579|3846912|FG006|NOT COMPLETED|Period 1 (First Intervention)||0
3121577|NCT01632579|3846913|FG007|NOT COMPLETED|Period 1 (First Intervention)||0
3121578|NCT01632579|3846914|FG008|NOT COMPLETED|Period 1 (First Intervention)||0
3121579|NCT01632579|3846906|FG000|STARTED|Washout Period||2
3121580|NCT01632579|3846907|FG001|STARTED|Washout Period||6
3121581|NCT01632579|3846908|FG002|STARTED|Washout Period||2
3121582|NCT01632579|3846909|FG003|STARTED|Washout Period||2
3121583|NCT01632579|3846910|FG004|STARTED|Washout Period||6
3121584|NCT01632579|3846911|FG005|STARTED|Washout Period||2
3121585|NCT01632579|3846912|FG006|STARTED|Washout Period||2
3121586|NCT01632579|3846913|FG007|STARTED|Washout Period||6
3121587|NCT01632579|3846914|FG008|STARTED|Washout Period||2
3121588|NCT01632579|3846906|FG000|COMPLETED|Washout Period||1
3121589|NCT01632579|3846907|FG001|COMPLETED|Washout Period||6
3121590|NCT01632579|3846908|FG002|COMPLETED|Washout Period||2
3121591|NCT01632579|3846909|FG003|COMPLETED|Washout Period||2
3121592|NCT01632579|3846910|FG004|COMPLETED|Washout Period||6
3121593|NCT01632579|3846911|FG005|COMPLETED|Washout Period||2
3121594|NCT01632579|3846912|FG006|COMPLETED|Washout Period||2
3121595|NCT01632579|3846913|FG007|COMPLETED|Washout Period||6
3121596|NCT01632579|3846914|FG008|COMPLETED|Washout Period||2
3121597|NCT01632579|3846906|FG000|NOT COMPLETED|Washout Period||1
3121598|NCT01632579|3846907|FG001|NOT COMPLETED|Washout Period||0
3121599|NCT01632579|3846908|FG002|NOT COMPLETED|Washout Period||0
3121600|NCT01632579|3846909|FG003|NOT COMPLETED|Washout Period||0
3121601|NCT01632579|3846910|FG004|NOT COMPLETED|Washout Period||0
3121602|NCT01632579|3846911|FG005|NOT COMPLETED|Washout Period||0
3121603|NCT01632579|3846912|FG006|NOT COMPLETED|Washout Period||0
3121604|NCT01632579|3846913|FG007|NOT COMPLETED|Washout Period||0
3121605|NCT01632579|3846914|FG008|NOT COMPLETED|Washout Period||0
3121606|NCT01632579|3846906|FG000|STARTED|Period 2 (Second Intervention)||1
3121607|NCT01632579|3846907|FG001|STARTED|Period 2 (Second Intervention)||6
3121608|NCT01632579|3846908|FG002|STARTED|Period 2 (Second Intervention)||2
3121609|NCT01632579|3846909|FG003|STARTED|Period 2 (Second Intervention)||2
3121610|NCT01632579|3846910|FG004|STARTED|Period 2 (Second Intervention)||6
3121611|NCT01632579|3846911|FG005|STARTED|Period 2 (Second Intervention)||2
3121612|NCT01632579|3846912|FG006|STARTED|Period 2 (Second Intervention)||2
3121613|NCT01632579|3846913|FG007|STARTED|Period 2 (Second Intervention)||6
3121614|NCT01632579|3846914|FG008|STARTED|Period 2 (Second Intervention)||2
3121615|NCT01632579|3846906|FG000|Received at Least 1 Dose|Period 2 (Second Intervention)||1
3121616|NCT01632579|3846907|FG001|Received at Least 1 Dose|Period 2 (Second Intervention)||6
3121617|NCT01632579|3846908|FG002|Received at Least 1 Dose|Period 2 (Second Intervention)||2
3121618|NCT01632579|3846909|FG003|Received at Least 1 Dose|Period 2 (Second Intervention)||2
3121619|NCT01632579|3846910|FG004|Received at Least 1 Dose|Period 2 (Second Intervention)||6
3121620|NCT01632579|3846911|FG005|Received at Least 1 Dose|Period 2 (Second Intervention)||2
3121621|NCT01632579|3846912|FG006|Received at Least 1 Dose|Period 2 (Second Intervention)||2
3121622|NCT01632579|3846913|FG007|Received at Least 1 Dose|Period 2 (Second Intervention)||6
3121623|NCT01632579|3846914|FG008|Received at Least 1 Dose|Period 2 (Second Intervention)||2
3121624|NCT01632579|3846906|FG000|COMPLETED|Period 2 (Second Intervention)||0
3121625|NCT01632579|3846907|FG001|COMPLETED|Period 2 (Second Intervention)||6
3121626|NCT01632579|3846908|FG002|COMPLETED|Period 2 (Second Intervention)||2
3121627|NCT01632579|3846909|FG003|COMPLETED|Period 2 (Second Intervention)||2
3121628|NCT01632579|3846910|FG004|COMPLETED|Period 2 (Second Intervention)||6
3121629|NCT01632579|3846911|FG005|COMPLETED|Period 2 (Second Intervention)||2
3121630|NCT01632579|3846912|FG006|COMPLETED|Period 2 (Second Intervention)||2
3121631|NCT01632579|3846913|FG007|COMPLETED|Period 2 (Second Intervention)||6
3121632|NCT01632579|3846914|FG008|COMPLETED|Period 2 (Second Intervention)||2
3121633|NCT01632579|3846906|FG000|NOT COMPLETED|Period 2 (Second Intervention)||1
3121634|NCT01632579|3846907|FG001|NOT COMPLETED|Period 2 (Second Intervention)||0
3121635|NCT01632579|3846908|FG002|NOT COMPLETED|Period 2 (Second Intervention)||0
3121636|NCT01632579|3846909|FG003|NOT COMPLETED|Period 2 (Second Intervention)||0
3121637|NCT01632579|3846910|FG004|NOT COMPLETED|Period 2 (Second Intervention)||0
3121638|NCT01632579|3846911|FG005|NOT COMPLETED|Period 2 (Second Intervention)||0
3121639|NCT01632579|3846912|FG006|NOT COMPLETED|Period 2 (Second Intervention)||0
3121640|NCT01632579|3846913|FG007|NOT COMPLETED|Period 2 (Second Intervention)||0
3121641|NCT01632579|3846914|FG008|NOT COMPLETED|Period 2 (Second Intervention)||0
3121642|NCT01632579|3846906|FG000|STARTED|Washout Period||0
3121643|NCT01632579|3846907|FG001|STARTED|Washout Period||6
3121644|NCT01632579|3846908|FG002|STARTED|Washout Period||2
3121645|NCT01632579|3846909|FG003|STARTED|Washout Period||2
3121646|NCT01632579|3846910|FG004|STARTED|Washout Period||6
3121647|NCT01632579|3846911|FG005|STARTED|Washout Period||2
3121648|NCT01632579|3846912|FG006|STARTED|Washout Period||2
3121649|NCT01632579|3846913|FG007|STARTED|Washout Period||6
3121650|NCT01632579|3846914|FG008|STARTED|Washout Period||2
3121651|NCT01632579|3846906|FG000|COMPLETED|Washout Period||0
3121652|NCT01632579|3846907|FG001|COMPLETED|Washout Period||6
3121653|NCT01632579|3846908|FG002|COMPLETED|Washout Period||2
3121654|NCT01632579|3846909|FG003|COMPLETED|Washout Period||2
3121655|NCT01632579|3846910|FG004|COMPLETED|Washout Period||6
3121656|NCT01632579|3846911|FG005|COMPLETED|Washout Period||2
3121657|NCT01632579|3846912|FG006|COMPLETED|Washout Period||2
3121658|NCT01632579|3846913|FG007|COMPLETED|Washout Period||6
3121659|NCT01632579|3846914|FG008|COMPLETED|Washout Period||2
3121660|NCT01632579|3846906|FG000|NOT COMPLETED|Washout Period||0
3121661|NCT01632579|3846907|FG001|NOT COMPLETED|Washout Period||0
3121662|NCT01632579|3846908|FG002|NOT COMPLETED|Washout Period||0
3121663|NCT01632579|3846909|FG003|NOT COMPLETED|Washout Period||0
3121664|NCT01632579|3846910|FG004|NOT COMPLETED|Washout Period||0
3121665|NCT01632579|3846911|FG005|NOT COMPLETED|Washout Period||0
3121666|NCT01632579|3846912|FG006|NOT COMPLETED|Washout Period||0
3121667|NCT01632579|3846913|FG007|NOT COMPLETED|Washout Period||0
3121668|NCT01632579|3846914|FG008|NOT COMPLETED|Washout Period||0
3121669|NCT01632579|3846906|FG000|STARTED|Period 3 (Third Intervention)||0
3121670|NCT01632579|3846907|FG001|STARTED|Period 3 (Third Intervention)||6
3121671|NCT01632579|3846908|FG002|STARTED|Period 3 (Third Intervention)||2
3121672|NCT01632579|3846909|FG003|STARTED|Period 3 (Third Intervention)||2
3121673|NCT01632579|3846910|FG004|STARTED|Period 3 (Third Intervention)||6
3121674|NCT01632579|3846911|FG005|STARTED|Period 3 (Third Intervention)||2
3121675|NCT01632579|3846912|FG006|STARTED|Period 3 (Third Intervention)||2
3121676|NCT01632579|3846913|FG007|STARTED|Period 3 (Third Intervention)||6
3121677|NCT01632579|3846914|FG008|STARTED|Period 3 (Third Intervention)||2
3121678|NCT01632579|3846906|FG000|Received at Least 1 Dose|Period 3 (Third Intervention)||0
3121679|NCT01632579|3846907|FG001|Received at Least 1 Dose|Period 3 (Third Intervention)||6
3121680|NCT01632579|3846908|FG002|Received at Least 1 Dose|Period 3 (Third Intervention)||2
3121681|NCT01632579|3846909|FG003|Received at Least 1 Dose|Period 3 (Third Intervention)||2
3121682|NCT01632579|3846910|FG004|Received at Least 1 Dose|Period 3 (Third Intervention)||6
3121683|NCT01632579|3846911|FG005|Received at Least 1 Dose|Period 3 (Third Intervention)||2
3121684|NCT01632579|3846912|FG006|Received at Least 1 Dose|Period 3 (Third Intervention)||2
3121685|NCT01632579|3846913|FG007|Received at Least 1 Dose|Period 3 (Third Intervention)||6
3121686|NCT01632579|3846914|FG008|Received at Least 1 Dose|Period 3 (Third Intervention)||2
3121687|NCT01632579|3846906|FG000|COMPLETED|Period 3 (Third Intervention)||0
3121688|NCT01632579|3846907|FG001|COMPLETED|Period 3 (Third Intervention)||6
3121689|NCT01632579|3846908|FG002|COMPLETED|Period 3 (Third Intervention)||2
3121690|NCT01632579|3846909|FG003|COMPLETED|Period 3 (Third Intervention)||2
3121691|NCT01632579|3846910|FG004|COMPLETED|Period 3 (Third Intervention)||6
3121692|NCT01632579|3846911|FG005|COMPLETED|Period 3 (Third Intervention)||2
3121693|NCT01632579|3846912|FG006|COMPLETED|Period 3 (Third Intervention)||2
3121694|NCT01632579|3846913|FG007|COMPLETED|Period 3 (Third Intervention)||6
3121695|NCT01632579|3846914|FG008|COMPLETED|Period 3 (Third Intervention)||2
3121696|NCT01632579|3846906|FG000|NOT COMPLETED|Period 3 (Third Intervention)||0
3121697|NCT01632579|3846907|FG001|NOT COMPLETED|Period 3 (Third Intervention)||0
3121698|NCT01632579|3846908|FG002|NOT COMPLETED|Period 3 (Third Intervention)||0
3121699|NCT01632579|3846909|FG003|NOT COMPLETED|Period 3 (Third Intervention)||0
3121700|NCT01632579|3846910|FG004|NOT COMPLETED|Period 3 (Third Intervention)||0
3121701|NCT01632579|3846911|FG005|NOT COMPLETED|Period 3 (Third Intervention)||0
3121702|NCT01632579|3846912|FG006|NOT COMPLETED|Period 3 (Third Intervention)||0
3121703|NCT01632579|3846913|FG007|NOT COMPLETED|Period 3 (Third Intervention)||0
3121704|NCT01632579|3846914|FG008|NOT COMPLETED|Period 3 (Third Intervention)||0
3121705|NCT01632683|3846940|FG000|STARTED|Overall Study||548
3121706|NCT01632683|3846941|FG001|STARTED|Overall Study||552
3121707|NCT01632683|3846940|FG000|COMPLETED|Overall Study||548
3121708|NCT01632683|3846941|FG001|COMPLETED|Overall Study||552
3121709|NCT01632683|3846940|FG000|NOT COMPLETED|Overall Study||0
3121710|NCT01632683|3846941|FG001|NOT COMPLETED|Overall Study||0
3121711|NCT01632709|3846951|FG000|STARTED|Overall Study||4
3121712|NCT01632709|3846952|FG001|STARTED|Overall Study||3
3121713|NCT01632709|3846953|FG002|STARTED|Overall Study||5
3121714|NCT01632709|3846954|FG003|STARTED|Overall Study||4
3121715|NCT01632709|3846951|FG000|Completed Visit 2 (Received Injection)|Overall Study||4
3121716|NCT01632709|3846952|FG001|Completed Visit 2 (Received Injection)|Overall Study||2
3121717|NCT01632709|3846953|FG002|Completed Visit 2 (Received Injection)|Overall Study||5
3121718|NCT01632709|3846954|FG003|Completed Visit 2 (Received Injection)|Overall Study||3
3121719|NCT01632709|3846951|FG000|COMPLETED|Overall Study||2
3121720|NCT01632709|3846952|FG001|COMPLETED|Overall Study||2
3121721|NCT01632709|3846953|FG002|COMPLETED|Overall Study||5
3121722|NCT01632709|3846954|FG003|COMPLETED|Overall Study||3
3121723|NCT01632709|3846951|FG000|NOT COMPLETED|Overall Study||2
3121724|NCT01632709|3846952|FG001|NOT COMPLETED|Overall Study||1
3121725|NCT01632709|3846953|FG002|NOT COMPLETED|Overall Study||0
3121726|NCT01632709|3846954|FG003|NOT COMPLETED|Overall Study||1
3121727|NCT01632735|3846964|FG000|STARTED|Overall Study||40
3121728|NCT01632735|3846965|FG001|STARTED|Overall Study||40
3121729|NCT01632735|3846964|FG000|COMPLETED|Overall Study||36
3121730|NCT01632735|3846965|FG001|COMPLETED|Overall Study||37
3121731|NCT01632735|3846964|FG000|NOT COMPLETED|Overall Study||4
3121732|NCT01632735|3846965|FG001|NOT COMPLETED|Overall Study||3
3121733|NCT01632800|3846971|FG000|STARTED|Overall Study||26
3121734|NCT01632800|3846971|FG000|COMPLETED|Overall Study||25
3121735|NCT01632800|3846971|FG000|NOT COMPLETED|Overall Study||1
3121736|NCT01632878|3846977|FG000|STARTED|Screening||1531
3121737|NCT01632878|3846977|FG000|COMPLETED|Screening||1263
3121738|NCT01632878|3846977|FG000|NOT COMPLETED|Screening||268
3121739|NCT01632878|3846977|FG000|STARTED|Treatment||1263
3121740|NCT01632878|3846977|FG000|COMPLETED|Treatment||1105
3121741|NCT01632878|3846977|FG000|NOT COMPLETED|Treatment||158
3121742|NCT01632891|3846983|FG000|STARTED|Overall Study||26
3121743|NCT01632891|3846984|FG001|STARTED|Overall Study||26
3121744|NCT01632891|3846983|FG000|COMPLETED|Overall Study||25
3121745|NCT01632891|3846984|FG001|COMPLETED|Overall Study||25
3121746|NCT01632891|3846983|FG000|NOT COMPLETED|Overall Study||1
3121747|NCT01632891|3846984|FG001|NOT COMPLETED|Overall Study||1
3121748|NCT01632904|3846996|FG000|STARTED|Overall Study||54
3121749|NCT01632904|3846997|FG001|STARTED|Overall Study||56
3121750|NCT01632904|3846996|FG000|COMPLETED|Overall Study|Patients still in the study as of data cutoff, 27MAR2014.|47
3121751|NCT01632904|3846997|FG001|COMPLETED|Overall Study|Patients still in the study as of 27MAR2014, including those who crossed over to ruxolitinib|50
3121752|NCT01632904|3846996|FG000|NOT COMPLETED|Overall Study||7
3121753|NCT01632904|3846997|FG001|NOT COMPLETED|Overall Study||6
3121754|NCT01632995|3847003|FG000|STARTED|Pre-screening to Enrollment Period||1069
3121755|NCT01632995|3847003|FG000|COMPLETED|Pre-screening to Enrollment Period||557
3121756|NCT01632995|3847003|FG000|NOT COMPLETED|Pre-screening to Enrollment Period||512
3121757|NCT01632995|3847003|FG000|STARTED|Main Study Follow-up Period||557
3121758|NCT01632995|3847003|FG000|COMPLETED|Main Study Follow-up Period||437
3121759|NCT01632995|3847003|FG000|NOT COMPLETED|Main Study Follow-up Period||120
3121760|NCT01633060|3847011|FG000|STARTED|Randomization Phase|All randomized patients|289
3121761|NCT01633060|3847012|FG001|STARTED|Randomization Phase|All randomized patients|143
3121762|NCT01633060|3847011|FG000|COMPLETED|Randomization Phase||288
3121763|NCT01633060|3847012|FG001|COMPLETED|Randomization Phase||140
3121764|NCT01633060|3847011|FG000|NOT COMPLETED|Randomization Phase||1
3121765|NCT01633060|3847012|FG001|NOT COMPLETED|Randomization Phase||3
3121766|NCT01633060|3847011|FG000|STARTED|Treatment Phase||288
3121767|NCT01633060|3847012|FG001|STARTED|Treatment Phase||140
3121768|NCT01633060|3847011|FG000|FAS - ctDNA PIK3CA Mutant|Treatment Phase||100
3121769|NCT01633060|3847012|FG001|FAS - ctDNA PIK3CA Mutant|Treatment Phase||35
3121770|NCT01633060|3847011|FG000|FAS - ctDNA PIK3CA Non-mutant|Treatment Phase||132
3121771|NCT01633060|3847012|FG001|FAS - ctDNA PIK3CA Non-mutant|Treatment Phase||81
3121772|NCT01633060|3847011|FG000|Safety Set (SS)|Treatment Phase||288
3121773|NCT01633060|3847012|FG001|Safety Set (SS)|Treatment Phase||140
3121774|NCT01633060|3847011|FG000|Pharmacokinetic Analysis Set (PAS)|Treatment Phase||63
3121775|NCT01633060|3847012|FG001|Pharmacokinetic Analysis Set (PAS)|Treatment Phase||0
3121776|NCT01633060|3847011|FG000|COMPLETED|Treatment Phase||0
3121777|NCT01633060|3847012|FG001|COMPLETED|Treatment Phase||0
3121778|NCT01633060|3847011|FG000|NOT COMPLETED|Treatment Phase||288
3121779|NCT01633060|3847012|FG001|NOT COMPLETED|Treatment Phase||140
3121780|NCT01633060|3847011|FG000|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|16
3121781|NCT01633060|3847012|FG001|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|2
3121782|NCT01633060|3847011|FG000|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
3121783|NCT01633060|3847012|FG001|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
3121784|NCT01633060|3847011|FG000|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||16
3121785|NCT01633060|3847012|FG001|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||2
3121786|NCT01633112|3847022|FG000|STARTED|Overall Study||352
3121787|NCT01633112|3847023|FG001|STARTED|Overall Study||370
3121788|NCT01633112|3847024|FG002|STARTED|Overall Study||342
3121789|NCT01633112|3847022|FG000|COMPLETED|Overall Study||299
3121790|NCT01633112|3847023|FG001|COMPLETED|Overall Study||310
3121791|NCT01633112|3847024|FG002|COMPLETED|Overall Study||250
3121792|NCT01633112|3847022|FG000|NOT COMPLETED|Overall Study||53
3121793|NCT01633112|3847023|FG001|NOT COMPLETED|Overall Study||60
3121794|NCT01633112|3847024|FG002|NOT COMPLETED|Overall Study||92
3121795|NCT01633320|3847035|FG000|STARTED|Overall Study||132
3121796|NCT01633320|3847036|FG001|STARTED|Overall Study||68
3121797|NCT01633320|3847035|FG000|COMPLETED|Overall Study||132
3121798|NCT01633320|3847036|FG001|COMPLETED|Overall Study||68
3121799|NCT01633320|3847035|FG000|NOT COMPLETED|Overall Study||0
3121800|NCT01633320|3847036|FG001|NOT COMPLETED|Overall Study||0
3121801|NCT01633398|3847044|FG000|STARTED|Overall Study||4779
3121802|NCT01633398|3847045|FG001|STARTED|Overall Study||1550
3121803|NCT01633398|3847044|FG000|COMPLETED|Overall Study||4779
3121804|NCT01633398|3847045|FG001|COMPLETED|Overall Study||1550
3121805|NCT01633398|3847044|FG000|NOT COMPLETED|Overall Study||0
3121806|NCT01633398|3847045|FG001|NOT COMPLETED|Overall Study||0
3295207|NCT02895945|4029349|FG000|FAS|Overall Study||7
3295208|NCT02895945|4029350|FG001|FAS|Overall Study||0
3295209|NCT02895945|4029349|FG000|COMPLETED|Overall Study||5
3295210|NCT02895945|4029350|FG001|COMPLETED|Overall Study||0
3295211|NCT02895945|4029349|FG000|NOT COMPLETED|Overall Study||2
3295212|NCT02895945|4029350|FG001|NOT COMPLETED|Overall Study||1
3295213|NCT02896075|4029356|FG000|STARTED|Overall Study||40
3295214|NCT02896075|4029356|FG000|Leg Soreness|Overall Study||40
3295215|NCT02896075|4029356|FG000|COMPLETED|Overall Study||40
3295216|NCT02896075|4029356|FG000|NOT COMPLETED|Overall Study||0
3295217|NCT02896127|4029365|FG000|STARTED|COMPLETED WEEK 52||305
3295218|NCT02896127|4029366|FG001|STARTED|COMPLETED WEEK 52|Includes participants originally assigned to placebo and switched to AIN457150 mg after Wk 16.|153
3295219|NCT02896127|4029365|FG000|COMPLETED|COMPLETED WEEK 52||278
3295220|NCT02896127|4029366|FG001|COMPLETED|COMPLETED WEEK 52||142
3295221|NCT02896127|4029365|FG000|NOT COMPLETED|COMPLETED WEEK 52||27
3295222|NCT02896127|4029366|FG001|NOT COMPLETED|COMPLETED WEEK 52||11
3295223|NCT02896127|4029365|FG000|STARTED|COMPLETED POST-TREATMENT FOLLOW UP|Participants enter follow-up if they exited before Wk 52 Thus numbers different from previous period|280
3295224|NCT02896127|4029366|FG001|STARTED|COMPLETED POST-TREATMENT FOLLOW UP|Participants enter follow-up if they exited before Wk 52 Thus numbers different from previous period|139
3295225|NCT02896127|4029365|FG000|COMPLETED|COMPLETED POST-TREATMENT FOLLOW UP|Participants enter follow-up if they exited before Wk 52 Thus numbers different from previous period|276
3295226|NCT02896127|4029366|FG001|COMPLETED|COMPLETED POST-TREATMENT FOLLOW UP|Participants enter follow-up if they exited before Wk 52 Thus numbers different from previous period|134
3295227|NCT02896127|4029365|FG000|NOT COMPLETED|COMPLETED POST-TREATMENT FOLLOW UP||4
3295228|NCT02896127|4029366|FG001|NOT COMPLETED|COMPLETED POST-TREATMENT FOLLOW UP||5
3295229|NCT02896296|4029372|FG000|STARTED|Overall Study||208
3295230|NCT02896296|4029372|FG000|COMPLETED|Overall Study||166
3295231|NCT02896296|4029372|FG000|NOT COMPLETED|Overall Study||42
3295232|NCT02896361|4029376|FG000|STARTED|First Intervention (2 Weeks)||9
3295233|NCT02896361|4029377|FG001|STARTED|First Intervention (2 Weeks)||10
3295234|NCT02896361|4029378|FG002|STARTED|First Intervention (2 Weeks)||8
3295235|NCT02896361|4029376|FG000|COMPLETED|First Intervention (2 Weeks)||9
3295236|NCT02896361|4029377|FG001|COMPLETED|First Intervention (2 Weeks)||10
3295237|NCT02896361|4029378|FG002|COMPLETED|First Intervention (2 Weeks)||8
3295238|NCT02896361|4029376|FG000|NOT COMPLETED|First Intervention (2 Weeks)||0
3295239|NCT02896361|4029377|FG001|NOT COMPLETED|First Intervention (2 Weeks)||0
3295240|NCT02896361|4029378|FG002|NOT COMPLETED|First Intervention (2 Weeks)||0
3295241|NCT02896361|4029376|FG000|STARTED|Second Intervention (2 Weeks)||9
3295242|NCT02896361|4029377|FG001|STARTED|Second Intervention (2 Weeks)||10
3295243|NCT02896361|4029378|FG002|STARTED|Second Intervention (2 Weeks)||8
3295244|NCT02896361|4029376|FG000|COMPLETED|Second Intervention (2 Weeks)||9
3295245|NCT02896361|4029377|FG001|COMPLETED|Second Intervention (2 Weeks)||10
3295246|NCT02896361|4029378|FG002|COMPLETED|Second Intervention (2 Weeks)||8
3295247|NCT02896361|4029376|FG000|NOT COMPLETED|Second Intervention (2 Weeks)||0
3295248|NCT02896361|4029377|FG001|NOT COMPLETED|Second Intervention (2 Weeks)||0
3295249|NCT02896361|4029378|FG002|NOT COMPLETED|Second Intervention (2 Weeks)||0
3295250|NCT02896361|4029376|FG000|STARTED|Third Intervention (2 Weeks)||9
3295251|NCT02896361|4029377|FG001|STARTED|Third Intervention (2 Weeks)||10
3295252|NCT02896361|4029378|FG002|STARTED|Third Intervention (2 Weeks)||8
3295253|NCT02896361|4029376|FG000|COMPLETED|Third Intervention (2 Weeks)||8
3295254|NCT02896361|4029377|FG001|COMPLETED|Third Intervention (2 Weeks)||9
3295255|NCT02896361|4029378|FG002|COMPLETED|Third Intervention (2 Weeks)||8
3295256|NCT02896361|4029376|FG000|NOT COMPLETED|Third Intervention (2 Weeks)||1
3121807|NCT01633788|3847055|FG000|STARTED|Overall Study||57
3295257|NCT02896361|4029377|FG001|NOT COMPLETED|Third Intervention (2 Weeks)||1
3121808|NCT01633788|3847056|FG001|STARTED|Overall Study||58
3121809|NCT01633788|3847057|FG002|STARTED|Overall Study||59
3121810|NCT01633788|3847058|FG003|STARTED|Overall Study||58
3121811|NCT01633788|3847055|FG000|COMPLETED|Overall Study||50
3121812|NCT01633788|3847056|FG001|COMPLETED|Overall Study||50
3121813|NCT01633788|3847057|FG002|COMPLETED|Overall Study||49
3121814|NCT01633788|3847058|FG003|COMPLETED|Overall Study||45
3121815|NCT01633788|3847055|FG000|NOT COMPLETED|Overall Study||7
3121816|NCT01633788|3847056|FG001|NOT COMPLETED|Overall Study||8
3121817|NCT01633788|3847057|FG002|NOT COMPLETED|Overall Study||10
3121818|NCT01633788|3847058|FG003|NOT COMPLETED|Overall Study||13
3121819|NCT01633827|3847068|FG000|STARTED|First Intervention||11
3121820|NCT01633827|3847069|FG001|STARTED|First Intervention||11
3121821|NCT01633827|3847068|FG000|COMPLETED|First Intervention||11
3121822|NCT01633827|3847069|FG001|COMPLETED|First Intervention||11
3121823|NCT01633827|3847068|FG000|NOT COMPLETED|First Intervention||0
3121824|NCT01633827|3847069|FG001|NOT COMPLETED|First Intervention||0
3121825|NCT01633827|3847068|FG000|STARTED|Washout Period||11
3121826|NCT01633827|3847069|FG001|STARTED|Washout Period||11
3121827|NCT01633827|3847068|FG000|COMPLETED|Washout Period||11
3121828|NCT01633827|3847069|FG001|COMPLETED|Washout Period||11
3121829|NCT01633827|3847068|FG000|NOT COMPLETED|Washout Period||0
3121830|NCT01633827|3847069|FG001|NOT COMPLETED|Washout Period||0
3121831|NCT01633827|3847068|FG000|STARTED|Second Intervention||11
3121832|NCT01633827|3847069|FG001|STARTED|Second Intervention||11
3121833|NCT01633827|3847068|FG000|COMPLETED|Second Intervention||11
3121834|NCT01633827|3847069|FG001|COMPLETED|Second Intervention||11
3121835|NCT01633827|3847068|FG000|NOT COMPLETED|Second Intervention||0
3121836|NCT01633827|3847069|FG001|NOT COMPLETED|Second Intervention||0
3121837|NCT01633853|3847084|FG000|STARTED|Overall Study||104
3121838|NCT01633853|3847085|FG001|STARTED|Overall Study||100
3121839|NCT01633853|3847084|FG000|COMPLETED|Overall Study||104
3121840|NCT01633853|3847085|FG001|COMPLETED|Overall Study||100
3121841|NCT01633853|3847084|FG000|NOT COMPLETED|Overall Study||0
3121842|NCT01633853|3847085|FG001|NOT COMPLETED|Overall Study||0
3121843|NCT01633892|3847092|FG000|STARTED|Overall Study||5
3121844|NCT01633892|3847092|FG000|COMPLETED|Overall Study||5
3121845|NCT01633892|3847092|FG000|NOT COMPLETED|Overall Study||0
3121846|NCT01633944|3847098|FG000|STARTED|Open-label Titration Phase||752
3121847|NCT01633944|3847099|FG001|STARTED|Open-label Titration Phase||0
3121848|NCT01633944|3847100|FG002|STARTED|Open-label Titration Phase||0
3121849|NCT01633944|3847098|FG000|COMPLETED|Open-label Titration Phase||462
3121850|NCT01633944|3847099|FG001|COMPLETED|Open-label Titration Phase||0
3121851|NCT01633944|3847100|FG002|COMPLETED|Open-label Titration Phase||0
3121852|NCT01633944|3847098|FG000|NOT COMPLETED|Open-label Titration Phase||290
3121853|NCT01633944|3847099|FG001|NOT COMPLETED|Open-label Titration Phase||0
3121854|NCT01633944|3847100|FG002|NOT COMPLETED|Open-label Titration Phase||0
3121855|NCT01633944|3847098|FG000|STARTED|Double-blind Treatment Phase|All subjects completing OL titration in the previous period were randomized to a DB treatment.|0
3121856|NCT01633944|3847099|FG001|STARTED|Double-blind Treatment Phase|Subjects were randomized to DB treatment after completing OL titration in the previous period.|230
3121857|NCT01633944|3847100|FG002|STARTED|Double-blind Treatment Phase|Subjects were randomized to DB treatment after completing OL titration in the previous period.|232
3121858|NCT01633944|3847098|FG000|COMPLETED|Double-blind Treatment Phase||0
3121859|NCT01633944|3847099|FG001|COMPLETED|Double-blind Treatment Phase||176
3121860|NCT01633944|3847100|FG002|COMPLETED|Double-blind Treatment Phase||174
3121861|NCT01633944|3847098|FG000|NOT COMPLETED|Double-blind Treatment Phase||0
3121862|NCT01633944|3847099|FG001|NOT COMPLETED|Double-blind Treatment Phase||54
3121863|NCT01633944|3847100|FG002|NOT COMPLETED|Double-blind Treatment Phase||58
3121864|NCT01634048|3847110|FG000|STARTED|Overall Study||21
3121865|NCT01634048|3847111|FG001|STARTED|Overall Study||18
3121866|NCT01634048|3847110|FG000|COMPLETED|Overall Study||15
3121867|NCT01634048|3847111|FG001|COMPLETED|Overall Study||15
3121868|NCT01634048|3847110|FG000|NOT COMPLETED|Overall Study||6
3121869|NCT01634048|3847111|FG001|NOT COMPLETED|Overall Study||3
3121870|NCT01634100|3847117|FG000|STARTED|Overall Study||3
3121871|NCT01634100|3847118|FG001|STARTED|Overall Study||3
3121872|NCT01634100|3847119|FG002|STARTED|Overall Study||3
3121873|NCT01634100|3847120|FG003|STARTED|Overall Study||3
3121874|NCT01634100|3847121|FG004|STARTED|Overall Study||3
3121875|NCT01634100|3847122|FG005|STARTED|Overall Study||3
3121876|NCT01634100|3847117|FG000|Received Empa Alone|Overall Study||3
3121877|NCT01634100|3847118|FG001|Received Empa Alone|Overall Study||3
3121878|NCT01634100|3847119|FG002|Received Empa Alone|Overall Study||3
3295258|NCT02896361|4029378|FG002|NOT COMPLETED|Third Intervention (2 Weeks)||0
3295259|NCT02896400|4029406|FG000|STARTED|Baseline||66
3295260|NCT02896400|4029407|FG001|STARTED|Baseline||66
3295261|NCT02896400|4029408|FG002|STARTED|Baseline||66
3295262|NCT02896400|4029409|FG003|STARTED|Baseline||66
3295263|NCT02896400|4029410|FG004|STARTED|Baseline||66
3295264|NCT02896400|4029411|FG005|STARTED|Baseline||66
3295265|NCT02896400|4029412|FG006|STARTED|Baseline||66
3295266|NCT02896400|4029413|FG007|STARTED|Baseline||66
3295267|NCT02896400|4029414|FG008|STARTED|Baseline||66
3295268|NCT02896400|4029415|FG009|STARTED|Baseline||66
3121879|NCT01634100|3847120|FG003|Received Empa Alone|Overall Study||3
3121880|NCT01634100|3847121|FG004|Received Empa Alone|Overall Study||3
3295269|NCT02896400|4029416|FG010|STARTED|Baseline||66
3295270|NCT02896400|4029417|FG011|STARTED|Baseline||66
3121881|NCT01634100|3847122|FG005|Received Empa Alone|Overall Study||3
3121882|NCT01634100|3847117|FG000|Received Empa + Rifampicin|Overall Study||3
3121883|NCT01634100|3847118|FG001|Received Empa + Rifampicin|Overall Study||3
3121884|NCT01634100|3847119|FG002|Received Empa + Rifampicin|Overall Study||3
3121885|NCT01634100|3847120|FG003|Received Empa + Rifampicin|Overall Study||3
3121886|NCT01634100|3847121|FG004|Received Empa + Rifampicin|Overall Study||3
3121887|NCT01634100|3847122|FG005|Received Empa + Rifampicin|Overall Study||3
3121888|NCT01634100|3847117|FG000|Received Empa + Probenecid|Overall Study||2
3121889|NCT01634100|3847118|FG001|Received Empa + Probenecid|Overall Study||3
3121890|NCT01634100|3847119|FG002|Received Empa + Probenecid|Overall Study||2
3121891|NCT01634100|3847120|FG003|Received Empa + Probenecid|Overall Study||3
3121892|NCT01634100|3847121|FG004|Received Empa + Probenecid|Overall Study||3
3121893|NCT01634100|3847122|FG005|Received Empa + Probenecid|Overall Study||3
3121894|NCT01634100|3847117|FG000|COMPLETED|Overall Study||2
3121895|NCT01634100|3847118|FG001|COMPLETED|Overall Study||3
3121896|NCT01634100|3847119|FG002|COMPLETED|Overall Study||2
3121897|NCT01634100|3847120|FG003|COMPLETED|Overall Study||3
3121898|NCT01634100|3847121|FG004|COMPLETED|Overall Study||3
3121899|NCT01634100|3847122|FG005|COMPLETED|Overall Study||3
3121900|NCT01634100|3847117|FG000|NOT COMPLETED|Overall Study||1
3121901|NCT01634100|3847118|FG001|NOT COMPLETED|Overall Study||0
3121902|NCT01634100|3847119|FG002|NOT COMPLETED|Overall Study||1
3121903|NCT01634100|3847120|FG003|NOT COMPLETED|Overall Study||0
3121904|NCT01634100|3847121|FG004|NOT COMPLETED|Overall Study||0
3121905|NCT01634100|3847122|FG005|NOT COMPLETED|Overall Study||0
3121906|NCT01634113|3847133|FG000|STARTED|Overall Study||34
3121907|NCT01634113|3847134|FG001|STARTED|Overall Study||36
3121908|NCT01634113|3847135|FG002|STARTED|Overall Study||32
3121909|NCT01634113|3847133|FG000|COMPLETED|Overall Study||34
3121910|NCT01634113|3847134|FG001|COMPLETED|Overall Study||36
3121911|NCT01634113|3847135|FG002|COMPLETED|Overall Study||31
3121912|NCT01634113|3847133|FG000|NOT COMPLETED|Overall Study||0
3121913|NCT01634113|3847134|FG001|NOT COMPLETED|Overall Study||0
3121914|NCT01634113|3847135|FG002|NOT COMPLETED|Overall Study||1
3121915|NCT01634139|3847146|FG000|STARTED|Overall Study||132
3121916|NCT01634139|3847147|FG001|STARTED|Overall Study||136
3121917|NCT01634139|3847148|FG002|STARTED|Overall Study||135
3121918|NCT01634139|3847146|FG000|COMPLETED|Overall Study||122
3121919|NCT01634139|3847147|FG001|COMPLETED|Overall Study||130
3121920|NCT01634139|3847148|FG002|COMPLETED|Overall Study||130
3121921|NCT01634139|3847146|FG000|NOT COMPLETED|Overall Study||10
3121922|NCT01634139|3847147|FG001|NOT COMPLETED|Overall Study||6
3121923|NCT01634139|3847148|FG002|NOT COMPLETED|Overall Study||5
3121924|NCT01634152|3847159|FG000|STARTED|Overall Study||134
3121925|NCT01634152|3847160|FG001|STARTED|Overall Study||137
3121926|NCT01634152|3847161|FG002|STARTED|Overall Study||130
3121927|NCT01634152|3847159|FG000|COMPLETED|Overall Study||130
3121928|NCT01634152|3847160|FG001|COMPLETED|Overall Study||136
3121929|NCT01634152|3847161|FG002|COMPLETED|Overall Study||126
3121930|NCT01634152|3847159|FG000|NOT COMPLETED|Overall Study||4
3121931|NCT01634152|3847160|FG001|NOT COMPLETED|Overall Study||1
3121932|NCT01634152|3847161|FG002|NOT COMPLETED|Overall Study||4
3121933|NCT01634165|3847169|FG000|STARTED|Period 1||6
3121934|NCT01634165|3847170|FG001|STARTED|Period 1||6
3121935|NCT01634165|3847171|FG002|STARTED|Period 1||6
3121936|NCT01634165|3847172|FG003|STARTED|Period 1||6
3295271|NCT02896400|4029418|FG012|STARTED|Baseline||66
3295272|NCT02896400|4029419|FG013|STARTED|Baseline||66
3295273|NCT02896400|4029420|FG014|STARTED|Baseline||66
3295274|NCT02896400|4029421|FG015|STARTED|Baseline||66
3295275|NCT02896400|4029406|FG000|COMPLETED|Baseline||66
3295276|NCT02896400|4029407|FG001|COMPLETED|Baseline||66
3295277|NCT02896400|4029408|FG002|COMPLETED|Baseline||66
3295278|NCT02896400|4029409|FG003|COMPLETED|Baseline||66
3295279|NCT02896400|4029410|FG004|COMPLETED|Baseline||66
3295280|NCT02896400|4029411|FG005|COMPLETED|Baseline||66
3295281|NCT02896400|4029412|FG006|COMPLETED|Baseline||66
3295282|NCT02896400|4029413|FG007|COMPLETED|Baseline||66
3295283|NCT02896400|4029414|FG008|COMPLETED|Baseline||66
3295284|NCT02896400|4029415|FG009|COMPLETED|Baseline||66
3295285|NCT02896400|4029416|FG010|COMPLETED|Baseline||66
3295286|NCT02896400|4029417|FG011|COMPLETED|Baseline||66
3295287|NCT02896400|4029418|FG012|COMPLETED|Baseline||66
3295288|NCT02896400|4029419|FG013|COMPLETED|Baseline||66
3295289|NCT02896400|4029420|FG014|COMPLETED|Baseline||66
3295290|NCT02896400|4029421|FG015|COMPLETED|Baseline||66
3295291|NCT02896400|4029406|FG000|NOT COMPLETED|Baseline||0
3295292|NCT02896400|4029407|FG001|NOT COMPLETED|Baseline||0
3121937|NCT01634165|3847169|FG000|Received at Least 1 Dose of Study Drug|Period 1||6
3121938|NCT01634165|3847170|FG001|Received at Least 1 Dose of Study Drug|Period 1||6
3121939|NCT01634165|3847171|FG002|Received at Least 1 Dose of Study Drug|Period 1||6
3121940|NCT01634165|3847172|FG003|Received at Least 1 Dose of Study Drug|Period 1||6
3121941|NCT01634165|3847169|FG000|COMPLETED|Period 1||6
3121942|NCT01634165|3847170|FG001|COMPLETED|Period 1||6
3295293|NCT02896400|4029408|FG002|NOT COMPLETED|Baseline||0
3295294|NCT02896400|4029409|FG003|NOT COMPLETED|Baseline||0
3295295|NCT02896400|4029410|FG004|NOT COMPLETED|Baseline||0
3295296|NCT02896400|4029411|FG005|NOT COMPLETED|Baseline||0
3295297|NCT02896400|4029412|FG006|NOT COMPLETED|Baseline||0
3295298|NCT02896400|4029413|FG007|NOT COMPLETED|Baseline||0
3295299|NCT02896400|4029414|FG008|NOT COMPLETED|Baseline||0
3295300|NCT02896400|4029415|FG009|NOT COMPLETED|Baseline||0
3295301|NCT02896400|4029416|FG010|NOT COMPLETED|Baseline||0
3121943|NCT01634165|3847171|FG002|COMPLETED|Period 1||6
3121944|NCT01634165|3847172|FG003|COMPLETED|Period 1||6
3121945|NCT01634165|3847169|FG000|NOT COMPLETED|Period 1||0
3121946|NCT01634165|3847170|FG001|NOT COMPLETED|Period 1||0
3121947|NCT01634165|3847171|FG002|NOT COMPLETED|Period 1||0
3121948|NCT01634165|3847172|FG003|NOT COMPLETED|Period 1||0
3121949|NCT01634165|3847169|FG000|STARTED|Period 2||6
3121950|NCT01634165|3847170|FG001|STARTED|Period 2||6
3121951|NCT01634165|3847171|FG002|STARTED|Period 2||6
3121952|NCT01634165|3847172|FG003|STARTED|Period 2||6
3121953|NCT01634165|3847169|FG000|COMPLETED|Period 2||6
3121954|NCT01634165|3847170|FG001|COMPLETED|Period 2||5
3121955|NCT01634165|3847171|FG002|COMPLETED|Period 2||6
3121956|NCT01634165|3847172|FG003|COMPLETED|Period 2||6
3121957|NCT01634165|3847169|FG000|NOT COMPLETED|Period 2||0
3121958|NCT01634165|3847170|FG001|NOT COMPLETED|Period 2||1
3121959|NCT01634165|3847171|FG002|NOT COMPLETED|Period 2||0
3121960|NCT01634165|3847172|FG003|NOT COMPLETED|Period 2||0
3121961|NCT01634165|3847169|FG000|STARTED|Period 3||6
3121962|NCT01634165|3847170|FG001|STARTED|Period 3||5
3121963|NCT01634165|3847171|FG002|STARTED|Period 3||6
3121964|NCT01634165|3847172|FG003|STARTED|Period 3||6
3121965|NCT01634165|3847169|FG000|COMPLETED|Period 3||6
3121966|NCT01634165|3847170|FG001|COMPLETED|Period 3||5
3121967|NCT01634165|3847171|FG002|COMPLETED|Period 3||6
3121968|NCT01634165|3847172|FG003|COMPLETED|Period 3||6
3121969|NCT01634165|3847169|FG000|NOT COMPLETED|Period 3||0
3121970|NCT01634165|3847170|FG001|NOT COMPLETED|Period 3||0
3121971|NCT01634165|3847171|FG002|NOT COMPLETED|Period 3||0
3121972|NCT01634165|3847172|FG003|NOT COMPLETED|Period 3||0
3121973|NCT01634165|3847169|FG000|STARTED|Period 4||6
3121974|NCT01634165|3847170|FG001|STARTED|Period 4||5
3121975|NCT01634165|3847171|FG002|STARTED|Period 4||6
3121976|NCT01634165|3847172|FG003|STARTED|Period 4||6
3121977|NCT01634165|3847169|FG000|COMPLETED|Period 4||6
3121978|NCT01634165|3847170|FG001|COMPLETED|Period 4||5
3121979|NCT01634165|3847171|FG002|COMPLETED|Period 4||6
3121980|NCT01634165|3847172|FG003|COMPLETED|Period 4||6
3121981|NCT01634165|3847169|FG000|NOT COMPLETED|Period 4||0
3121982|NCT01634165|3847170|FG001|NOT COMPLETED|Period 4||0
3121983|NCT01634165|3847171|FG002|NOT COMPLETED|Period 4||0
3121984|NCT01634165|3847172|FG003|NOT COMPLETED|Period 4||0
3121985|NCT01634178|3847182|FG000|STARTED|Treatment Period 1||23
3121986|NCT01634178|3847183|FG001|STARTED|Treatment Period 1||23
3121987|NCT01634178|3847182|FG000|COMPLETED|Treatment Period 1||23
3121988|NCT01634178|3847183|FG001|COMPLETED|Treatment Period 1||22
3121989|NCT01634178|3847182|FG000|NOT COMPLETED|Treatment Period 1||0
3121990|NCT01634178|3847183|FG001|NOT COMPLETED|Treatment Period 1||1
3121991|NCT01634178|3847182|FG000|STARTED|Treatment Period 2||23
3121992|NCT01634178|3847183|FG001|STARTED|Treatment Period 2||22
3121993|NCT01634178|3847182|FG000|COMPLETED|Treatment Period 2||22
3121994|NCT01634178|3847183|FG001|COMPLETED|Treatment Period 2||22
3121995|NCT01634178|3847182|FG000|NOT COMPLETED|Treatment Period 2||1
3121996|NCT01634178|3847183|FG001|NOT COMPLETED|Treatment Period 2||0
3121997|NCT01634191|3847194|FG000|STARTED|Overall Study||18
3121998|NCT01634191|3847195|FG001|STARTED|Overall Study||18
3121999|NCT01634191|3847194|FG000|COMPLETED|Overall Study||18
3122000|NCT01634191|3847195|FG001|COMPLETED|Overall Study||18
3122001|NCT01634191|3847194|FG000|NOT COMPLETED|Overall Study||0
3122002|NCT01634191|3847195|FG001|NOT COMPLETED|Overall Study||0
3122003|NCT01634243|3847214|FG000|STARTED|Overall Study||21
3122004|NCT01634243|3847215|FG001|STARTED|Overall Study||43
3122005|NCT01634243|3847214|FG000|COMPLETED|Overall Study||15
3122006|NCT01634243|3847215|FG001|COMPLETED|Overall Study||38
3122007|NCT01634243|3847214|FG000|NOT COMPLETED|Overall Study||6
3122008|NCT01634243|3847215|FG001|NOT COMPLETED|Overall Study||5
3122009|NCT01634256|3847223|FG000|STARTED|Overall Study||30
3122010|NCT01634256|3847224|FG001|STARTED|Overall Study||30
3122011|NCT01634256|3847223|FG000|COMPLETED|Overall Study||26
3122012|NCT01634256|3847224|FG001|COMPLETED|Overall Study||22
3122013|NCT01634256|3847223|FG000|NOT COMPLETED|Overall Study||4
3122014|NCT01634256|3847224|FG001|NOT COMPLETED|Overall Study||8
3122015|NCT01634269|3847230|FG000|STARTED|Overall Study||20
3122016|NCT01634269|3847230|FG000|30 Days|Overall Study||20
3122017|NCT01634269|3847230|FG000|6 Month|Overall Study||20
3122018|NCT01634269|3847230|FG000|12 Month|Overall Study||20
3122019|NCT01634269|3847230|FG000|24 Month|Overall Study||18
3122020|NCT01634269|3847230|FG000|COMPLETED|Overall Study||18
3122021|NCT01634269|3847230|FG000|NOT COMPLETED|Overall Study||2
3122022|NCT01634360|3847242|FG000|STARTED|Overall Study||49
3122023|NCT01634360|3847243|FG001|STARTED|Overall Study||136
3122024|NCT01634360|3847242|FG000|COMPLETED|Overall Study||0
3122025|NCT01634360|3847243|FG001|COMPLETED|Overall Study||0
3122026|NCT01634360|3847242|FG000|NOT COMPLETED|Overall Study||49
3122027|NCT01634360|3847243|FG001|NOT COMPLETED|Overall Study||136
3122028|NCT01634555|3847249|FG000|STARTED|Overall Study||29
3122029|NCT01634555|3847249|FG000|Received at Least 1 Dose of Study Drug|Overall Study||29
3122030|NCT01634555|3847249|FG000|Drug-Drug Interaction (DDI) Population|Overall Study|Completed the required treatment in Cycle 1, Day 1 and Cycle 2, Day 1.|25
3122031|NCT01634555|3847249|FG000|COMPLETED|Overall Study|Completed the required treatment and assessment.|25
3122032|NCT01634555|3847249|FG000|NOT COMPLETED|Overall Study||4
3122033|NCT01634620|3847254|FG000|STARTED|Overall Study||200
3122034|NCT01634620|3847254|FG000|COMPLETED|Overall Study||200
3122035|NCT01634620|3847254|FG000|NOT COMPLETED|Overall Study||0
3122036|NCT01634659|3847265|FG000|STARTED|Period 1 - First 8 Days of Wear||155
3122037|NCT01634659|3847266|FG001|STARTED|Period 1 - First 8 Days of Wear||158
3122038|NCT01634659|3847265|FG000|COMPLETED|Period 1 - First 8 Days of Wear||155
3122039|NCT01634659|3847266|FG001|COMPLETED|Period 1 - First 8 Days of Wear||158
3122040|NCT01634659|3847265|FG000|NOT COMPLETED|Period 1 - First 8 Days of Wear||0
3122041|NCT01634659|3847266|FG001|NOT COMPLETED|Period 1 - First 8 Days of Wear||0
3122042|NCT01634659|3847265|FG000|STARTED|Period 2 - Second 8 Days of Wear||155
3122043|NCT01634659|3847266|FG001|STARTED|Period 2 - Second 8 Days of Wear||158
3122044|NCT01634659|3847265|FG000|COMPLETED|Period 2 - Second 8 Days of Wear||152
3122045|NCT01634659|3847266|FG001|COMPLETED|Period 2 - Second 8 Days of Wear||158
3122046|NCT01634659|3847265|FG000|NOT COMPLETED|Period 2 - Second 8 Days of Wear||3
3122047|NCT01634659|3847266|FG001|NOT COMPLETED|Period 2 - Second 8 Days of Wear||0
3122048|NCT01634854|3847274|FG000|STARTED|Overall Study||64
3122049|NCT01634854|3847275|FG001|STARTED|Overall Study||66
3122050|NCT01634854|3847274|FG000|COMPLETED|Overall Study||62
3122051|NCT01634854|3847275|FG001|COMPLETED|Overall Study||59
3122052|NCT01634854|3847274|FG000|NOT COMPLETED|Overall Study||2
3122053|NCT01634854|3847275|FG001|NOT COMPLETED|Overall Study||7
3122054|NCT01635062|3847283|FG000|STARTED|Overall Study||9
3122055|NCT01635062|3847284|FG001|STARTED|Overall Study||9
3122056|NCT01635062|3847283|FG000|Sodium Restriction Baseline Visit|Overall Study||9
3122057|NCT01635062|3847284|FG001|Sodium Restriction Baseline Visit|Overall Study||9
3122058|NCT01635062|3847283|FG000|Sodium Loading Baseline Visit|Overall Study||9
3122059|NCT01635062|3847284|FG001|Sodium Loading Baseline Visit|Overall Study||9
3122060|NCT01635062|3847283|FG000|Post-randomization Sodium Restriction|Overall Study||9
3122061|NCT01635062|3847284|FG001|Post-randomization Sodium Restriction|Overall Study||9
3122062|NCT01635062|3847283|FG000|Post-Randomization Sodium Loaded|Overall Study||9
3122063|NCT01635062|3847284|FG001|Post-Randomization Sodium Loaded|Overall Study||9
3122064|NCT01635062|3847283|FG000|COMPLETED|Overall Study||9
3122065|NCT01635062|3847284|FG001|COMPLETED|Overall Study||9
3122066|NCT01635062|3847283|FG000|NOT COMPLETED|Overall Study||0
3122067|NCT01635062|3847284|FG001|NOT COMPLETED|Overall Study||0
3122068|NCT01635101|3847297|FG000|STARTED|Overall Study||61
3122069|NCT01635101|3847298|FG001|STARTED|Overall Study||67
3122070|NCT01635101|3847299|FG002|STARTED|Overall Study||69
3122071|NCT01635101|3847297|FG000|Safety Population|Overall Study||61
3122072|NCT01635101|3847298|FG001|Safety Population|Overall Study||67
3122073|NCT01635101|3847299|FG002|Safety Population|Overall Study||69
3122074|NCT01635101|3847297|FG000|Modified Intent to Treat (mITT)|Overall Study||61
3122075|NCT01635101|3847298|FG001|Modified Intent to Treat (mITT)|Overall Study||67
3122076|NCT01635101|3847299|FG002|Modified Intent to Treat (mITT)|Overall Study||69
3122077|NCT01635101|3847297|FG000|Pharmacokinetics Evaluable Population|Overall Study||50
3122078|NCT01635101|3847298|FG001|Pharmacokinetics Evaluable Population|Overall Study||59
3122079|NCT01635101|3847299|FG002|Pharmacokinetics Evaluable Population|Overall Study||58
3122080|NCT01635101|3847297|FG000|COMPLETED|Overall Study||52
3122081|NCT01635101|3847298|FG001|COMPLETED|Overall Study||55
3122082|NCT01635101|3847299|FG002|COMPLETED|Overall Study||52
3122083|NCT01635101|3847297|FG000|NOT COMPLETED|Overall Study||9
3122084|NCT01635101|3847298|FG001|NOT COMPLETED|Overall Study||12
3122085|NCT01635101|3847299|FG002|NOT COMPLETED|Overall Study||17
3122086|NCT01635153|3847312|FG000|STARTED|Overall Study||72
3122087|NCT01635153|3847313|FG001|STARTED|Overall Study||79
3122088|NCT01635153|3847312|FG000|COMPLETED|Overall Study||32
3122089|NCT01635153|3847313|FG001|COMPLETED|Overall Study||36
3122090|NCT01635153|3847312|FG000|NOT COMPLETED|Overall Study||40
3122091|NCT01635153|3847313|FG001|NOT COMPLETED|Overall Study||43
3136200|NCT01710800|3861284|FG000|COMPLETED|Overall Study|22 drop outs(consented but did not participate, refused 2nd intervention)|41
3136201|NCT01710800|3861284|FG000|NOT COMPLETED|Overall Study||22
3136202|NCT01710839|3861292|FG000|STARTED|Overall Study||24
3136203|NCT01710839|3861293|FG001|STARTED|Overall Study||6
3136204|NCT01710839|3861292|FG000|COMPLETED|Overall Study||23
3136205|NCT01710839|3861293|FG001|COMPLETED|Overall Study||0
3136206|NCT01710839|3861292|FG000|NOT COMPLETED|Overall Study||1
3136207|NCT01710839|3861293|FG001|NOT COMPLETED|Overall Study||6
3136208|NCT01710891|3861301|FG000|STARTED|Overall Study||95
3136209|NCT01710891|3861302|FG001|STARTED|Overall Study||103
3136210|NCT01710891|3861301|FG000|COMPLETED|Overall Study||95
3136211|NCT01710891|3861302|FG001|COMPLETED|Overall Study||103
3136212|NCT01710891|3861301|FG000|NOT COMPLETED|Overall Study||0
3136213|NCT01710891|3861302|FG001|NOT COMPLETED|Overall Study||0
3136214|NCT01711177|3861311|FG000|STARTED|Overall Study||10
3136215|NCT01711177|3861312|FG001|STARTED|Overall Study||3
3136216|NCT01711177|3861313|FG002|STARTED|Overall Study||3
3136217|NCT01711177|3861311|FG000|COMPLETED|Overall Study||10
3136218|NCT01711177|3861312|FG001|COMPLETED|Overall Study||3
3136219|NCT01711177|3861313|FG002|COMPLETED|Overall Study||3
3136220|NCT01711177|3861311|FG000|NOT COMPLETED|Overall Study||0
3136221|NCT01711177|3861312|FG001|NOT COMPLETED|Overall Study||0
3136222|NCT01711177|3861313|FG002|NOT COMPLETED|Overall Study||0
3136223|NCT01711216|3861321|FG000|STARTED|Overall Study||999
3136224|NCT01711216|3861321|FG000|COMPLETED|Overall Study||782
3136225|NCT01711216|3861321|FG000|NOT COMPLETED|Overall Study||217
3136226|NCT01711294|3861328|FG000|STARTED|Overall Study||121
3136227|NCT01711294|3861329|FG001|STARTED|Overall Study||65
3136228|NCT01711294|3861330|FG002|STARTED|Overall Study||64
3136229|NCT01711294|3861328|FG000|COMPLETED|Overall Study||121
3122092|NCT01635218|3847322|FG000|STARTED|Overall Study||44
3122093|NCT01635218|3847323|FG001|STARTED|Overall Study||46
3122094|NCT01635218|3847324|FG002|STARTED|Overall Study||43
3122095|NCT01635218|3847322|FG000|COMPLETED|Overall Study||41
3122096|NCT01635218|3847323|FG001|COMPLETED|Overall Study||39
3122097|NCT01635218|3847324|FG002|COMPLETED|Overall Study||37
3122098|NCT01635218|3847322|FG000|NOT COMPLETED|Overall Study||3
3122099|NCT01635218|3847323|FG001|NOT COMPLETED|Overall Study||7
3122100|NCT01635218|3847324|FG002|NOT COMPLETED|Overall Study||6
3122101|NCT01635244|3847335|FG000|STARTED|Overall Study||18
3122102|NCT01635244|3847336|FG001|STARTED|Overall Study||22
3122103|NCT01635244|3847337|FG002|STARTED|Overall Study||20
3122104|NCT01635244|3847335|FG000|COMPLETED|Overall Study||17
3122105|NCT01635244|3847336|FG001|COMPLETED|Overall Study||21
3122106|NCT01635244|3847337|FG002|COMPLETED|Overall Study||18
3122107|NCT01635244|3847335|FG000|NOT COMPLETED|Overall Study||1
3122108|NCT01635244|3847336|FG001|NOT COMPLETED|Overall Study||1
3122109|NCT01635244|3847337|FG002|NOT COMPLETED|Overall Study||2
3122110|NCT01635283|3847345|FG000|STARTED|Overall Study||5
3122111|NCT01635283|3847345|FG000|COMPLETED|Overall Study||1
3122112|NCT01635283|3847345|FG000|NOT COMPLETED|Overall Study||4
3122113|NCT01635439|3847354|FG000|STARTED|Overall Study||100
3122114|NCT01635439|3847355|FG001|STARTED|Overall Study||100
3122115|NCT01635439|3847354|FG000|COMPLETED|Overall Study||100
3122116|NCT01635439|3847355|FG001|COMPLETED|Overall Study||100
3122117|NCT01635439|3847354|FG000|NOT COMPLETED|Overall Study||0
3122118|NCT01635439|3847355|FG001|NOT COMPLETED|Overall Study||0
3122119|NCT01635504|3847361|FG000|STARTED|Overall Study||5
3122120|NCT01635504|3847361|FG000|COMPLETED|Overall Study||5
3122121|NCT01635504|3847361|FG000|NOT COMPLETED|Overall Study||0
3122122|NCT01635764|3847370|FG000|STARTED|Overall Study||508
3122123|NCT01635764|3847370|FG000|COMPLETED|Overall Study||235
3122124|NCT01635764|3847370|FG000|NOT COMPLETED|Overall Study||273
3122125|NCT01635855|3847381|FG000|STARTED|Overall Study||117
3122126|NCT01635855|3847381|FG000|COMPLETED|Overall Study||113
3122127|NCT01635855|3847381|FG000|NOT COMPLETED|Overall Study||4
3122128|NCT01635881|3847385|FG000|STARTED|Overall Study||60
3122129|NCT01635881|3847385|FG000|COMPLETED|Overall Study||60
3122130|NCT01635881|3847385|FG000|NOT COMPLETED|Overall Study||0
3122131|NCT01635920|3847391|FG000|STARTED|Overall Study||125
3122132|NCT01635920|3847392|FG001|STARTED|Overall Study||126
3122133|NCT01635920|3847391|FG000|COMPLETED|Overall Study||122
3122134|NCT01635920|3847392|FG001|COMPLETED|Overall Study||125
3122135|NCT01635920|3847391|FG000|NOT COMPLETED|Overall Study||3
3122136|NCT01635920|3847392|FG001|NOT COMPLETED|Overall Study||1
3122137|NCT01635933|3847401|FG000|STARTED|Overall Study||178
3122138|NCT01635933|3847402|FG001|STARTED|Overall Study||185
3122139|NCT01635933|3847401|FG000|COMPLETED|Overall Study||176
3122140|NCT01635933|3847402|FG001|COMPLETED|Overall Study||177
3122141|NCT01635933|3847401|FG000|NOT COMPLETED|Overall Study||2
3122142|NCT01635933|3847402|FG001|NOT COMPLETED|Overall Study||8
3122143|NCT01635998|3847410|FG000|STARTED|Overall Study||28
3122144|NCT01635998|3847411|FG001|STARTED|Overall Study||22
3122145|NCT01635998|3847410|FG000|COMPLETED|Overall Study||24
3122146|NCT01635998|3847411|FG001|COMPLETED|Overall Study||15
3122147|NCT01635998|3847410|FG000|NOT COMPLETED|Overall Study||4
3122148|NCT01635998|3847411|FG001|NOT COMPLETED|Overall Study||7
3122149|NCT01636063|3847419|FG000|STARTED|Overall Study||21
3122150|NCT01636063|3847420|FG001|STARTED|Overall Study||21
3122151|NCT01636063|3847419|FG000|COMPLETED|Overall Study||21
3122152|NCT01636063|3847420|FG001|COMPLETED|Overall Study||21
3122153|NCT01636063|3847419|FG000|NOT COMPLETED|Overall Study||0
3122154|NCT01636063|3847420|FG001|NOT COMPLETED|Overall Study||0
3122155|NCT01636076|3847428|FG000|STARTED|Overall Study||316
3122156|NCT01636076|3847429|FG001|STARTED|Overall Study||313
3122157|NCT01636076|3847428|FG000|COMPLETED|Overall Study||299
3122158|NCT01636076|3847429|FG001|COMPLETED|Overall Study||288
3122159|NCT01636076|3847428|FG000|NOT COMPLETED|Overall Study||17
3122160|NCT01636076|3847429|FG001|NOT COMPLETED|Overall Study||25
3122161|NCT01636102|3847444|FG000|STARTED|Overall Study||63
3122162|NCT01636102|3847445|FG001|STARTED|Overall Study||63
3122163|NCT01636102|3847444|FG000|COMPLETED|Overall Study||63
3122164|NCT01636102|3847445|FG001|COMPLETED|Overall Study||63
3122165|NCT01636102|3847444|FG000|NOT COMPLETED|Overall Study||0
3122166|NCT01636102|3847445|FG001|NOT COMPLETED|Overall Study||0
3122167|NCT01636206|3847454|FG000|STARTED|Overall Study||111
3122168|NCT01636206|3847455|FG001|STARTED|Overall Study||221
3122169|NCT01636206|3847454|FG000|COMPLETED|Overall Study||92
3122170|NCT01636206|3847455|FG001|COMPLETED|Overall Study||170
3122171|NCT01636206|3847454|FG000|NOT COMPLETED|Overall Study||19
3122172|NCT01636206|3847455|FG001|NOT COMPLETED|Overall Study||51
3122173|NCT01636258|3847463|FG000|STARTED|Overall Study||13
3122174|NCT01636258|3847464|FG001|STARTED|Overall Study||14
3122175|NCT01636258|3847463|FG000|COMPLETED|Overall Study||12
3122176|NCT01636258|3847464|FG001|COMPLETED|Overall Study||14
3122177|NCT01636258|3847463|FG000|NOT COMPLETED|Overall Study||1
3122178|NCT01636258|3847464|FG001|NOT COMPLETED|Overall Study||0
3122179|NCT01636284|3847471|FG000|STARTED|Overall Study||16
3122180|NCT01636284|3847471|FG000|COMPLETED|Overall Study||16
3122181|NCT01636284|3847471|FG000|NOT COMPLETED|Overall Study||0
3122182|NCT01636297|3847478|FG000|STARTED|Overall Study||40
3122183|NCT01636297|3847479|FG001|STARTED|Overall Study||40
3122184|NCT01636297|3847480|FG002|STARTED|Overall Study||20
3122185|NCT01636297|3847478|FG000|COMPLETED|Overall Study||36
3122186|NCT01636297|3847479|FG001|COMPLETED|Overall Study||36
3122187|NCT01636297|3847480|FG002|COMPLETED|Overall Study||19
3122188|NCT01636297|3847478|FG000|NOT COMPLETED|Overall Study||4
3122189|NCT01636297|3847479|FG001|NOT COMPLETED|Overall Study||4
3122190|NCT01636297|3847480|FG002|NOT COMPLETED|Overall Study||1
3122191|NCT01636362|3847490|FG000|STARTED|Overall Study||45
3122192|NCT01636362|3847490|FG000|COMPLETED|Overall Study||37
3122193|NCT01636362|3847490|FG000|NOT COMPLETED|Overall Study||8
3122194|NCT01636414|3847497|FG000|STARTED|Overall Study||64
3122195|NCT01636414|3847498|FG001|STARTED|Overall Study||66
3122196|NCT01636414|3847499|FG002|STARTED|Overall Study||74
3122197|NCT01636414|3847497|FG000|COMPLETED|Overall Study||61
3122198|NCT01636414|3847498|FG001|COMPLETED|Overall Study||60
3122199|NCT01636414|3847499|FG002|COMPLETED|Overall Study||65
3122200|NCT01636414|3847497|FG000|NOT COMPLETED|Overall Study||3
3122201|NCT01636414|3847498|FG001|NOT COMPLETED|Overall Study||6
3122202|NCT01636414|3847499|FG002|NOT COMPLETED|Overall Study||9
3122203|NCT01636453|3847507|FG000|STARTED|Overall Study||120
3122204|NCT01636453|3847507|FG000|COMPLETED|Overall Study||112
3122205|NCT01636453|3847507|FG000|NOT COMPLETED|Overall Study||8
3122206|NCT01636661|3847513|FG000|STARTED|Overall Study||5
3122207|NCT01636661|3847514|FG001|STARTED|Overall Study||6
3122208|NCT01636661|3847513|FG000|COMPLETED|Overall Study||5
3122209|NCT01636661|3847514|FG001|COMPLETED|Overall Study||6
3122210|NCT01636661|3847513|FG000|NOT COMPLETED|Overall Study||0
3122211|NCT01636661|3847514|FG001|NOT COMPLETED|Overall Study||0
3122212|NCT01636687|3847523|FG000|STARTED|Induction Period||61
3122213|NCT01636687|3847524|FG001|STARTED|Induction Period||60
3122214|NCT01636687|3847525|FG002|STARTED|Induction Period||0
3122215|NCT01636687|3847526|FG003|STARTED|Induction Period||0
3122216|NCT01636687|3847527|FG004|STARTED|Induction Period||61
3122217|NCT01636687|3847523|FG000|COMPLETED|Induction Period||58
3122218|NCT01636687|3847524|FG001|COMPLETED|Induction Period||60
3122219|NCT01636687|3847525|FG002|COMPLETED|Induction Period||0
3122220|NCT01636687|3847526|FG003|COMPLETED|Induction Period||0
3122221|NCT01636687|3847527|FG004|COMPLETED|Induction Period||59
3122222|NCT01636687|3847523|FG000|NOT COMPLETED|Induction Period||3
3122223|NCT01636687|3847524|FG001|NOT COMPLETED|Induction Period||0
3122224|NCT01636687|3847525|FG002|NOT COMPLETED|Induction Period||0
3122225|NCT01636687|3847526|FG003|NOT COMPLETED|Induction Period||0
3122226|NCT01636687|3847527|FG004|NOT COMPLETED|Induction Period||2
3122227|NCT01636687|3847523|FG000|STARTED|Maintenance Period||58
3122228|NCT01636687|3847524|FG001|STARTED|Maintenance Period||60
3122229|NCT01636687|3847525|FG002|STARTED|Maintenance Period||28
3122230|NCT01636687|3847526|FG003|STARTED|Maintenance Period||28
3122231|NCT01636687|3847527|FG004|STARTED|Maintenance Period||3
3122232|NCT01636687|3847523|FG000|COMPLETED|Maintenance Period||50
3122233|NCT01636687|3847524|FG001|COMPLETED|Maintenance Period||58
3122234|NCT01636687|3847525|FG002|COMPLETED|Maintenance Period||26
3122235|NCT01636687|3847526|FG003|COMPLETED|Maintenance Period||28
3122236|NCT01636687|3847527|FG004|COMPLETED|Maintenance Period||1
3122237|NCT01636687|3847523|FG000|NOT COMPLETED|Maintenance Period||8
3122238|NCT01636687|3847524|FG001|NOT COMPLETED|Maintenance Period||2
3122239|NCT01636687|3847525|FG002|NOT COMPLETED|Maintenance Period||2
3122240|NCT01636687|3847526|FG003|NOT COMPLETED|Maintenance Period||0
3122241|NCT01636687|3847527|FG004|NOT COMPLETED|Maintenance Period||2
3122242|NCT01636687|3847523|FG000|STARTED|Extension Period||47
3122243|NCT01636687|3847524|FG001|STARTED|Extension Period||54
3122244|NCT01636687|3847525|FG002|STARTED|Extension Period||25
3122245|NCT01636687|3847526|FG003|STARTED|Extension Period||28
3122246|NCT01636687|3847527|FG004|STARTED|Extension Period||0
3122247|NCT01636687|3847523|FG000|COMPLETED|Extension Period||0
3122248|NCT01636687|3847524|FG001|COMPLETED|Extension Period||0
3122249|NCT01636687|3847525|FG002|COMPLETED|Extension Period||0
3122250|NCT01636687|3847526|FG003|COMPLETED|Extension Period||0
3122251|NCT01636687|3847527|FG004|COMPLETED|Extension Period||0
3122252|NCT01636687|3847523|FG000|NOT COMPLETED|Extension Period||47
3122253|NCT01636687|3847524|FG001|NOT COMPLETED|Extension Period||54
3122254|NCT01636687|3847525|FG002|NOT COMPLETED|Extension Period||25
3122255|NCT01636687|3847526|FG003|NOT COMPLETED|Extension Period||28
3122256|NCT01636687|3847527|FG004|NOT COMPLETED|Extension Period||0
3122257|NCT01636687|3847523|FG000|STARTED|Follow-up Period||38
3122258|NCT01636687|3847524|FG001|STARTED|Follow-up Period||45
3122259|NCT01636687|3847525|FG002|STARTED|Follow-up Period||21
3122260|NCT01636687|3847526|FG003|STARTED|Follow-up Period||20
3122261|NCT01636687|3847527|FG004|STARTED|Follow-up Period||2
3122262|NCT01636687|3847523|FG000|COMPLETED|Follow-up Period||37
3122263|NCT01636687|3847524|FG001|COMPLETED|Follow-up Period||45
3122264|NCT01636687|3847525|FG002|COMPLETED|Follow-up Period||21
3122265|NCT01636687|3847526|FG003|COMPLETED|Follow-up Period||20
3122266|NCT01636687|3847527|FG004|COMPLETED|Follow-up Period||1
3122267|NCT01636687|3847523|FG000|NOT COMPLETED|Follow-up Period||1
3122268|NCT01636687|3847524|FG001|NOT COMPLETED|Follow-up Period||0
3122269|NCT01636687|3847525|FG002|NOT COMPLETED|Follow-up Period||0
3122270|NCT01636687|3847526|FG003|NOT COMPLETED|Follow-up Period||0
3122271|NCT01636687|3847527|FG004|NOT COMPLETED|Follow-up Period||1
3122272|NCT01636713|3847548|FG000|STARTED|Overall Study||193
3122273|NCT01636713|3847549|FG001|STARTED|Overall Study||194
3122274|NCT01636713|3847550|FG002|STARTED|Overall Study||193
3122275|NCT01636713|3847548|FG000|COMPLETED|Overall Study||161
3122276|NCT01636713|3847549|FG001|COMPLETED|Overall Study||166
3122277|NCT01636713|3847550|FG002|COMPLETED|Overall Study||170
3122278|NCT01636713|3847548|FG000|NOT COMPLETED|Overall Study||32
3122279|NCT01636713|3847549|FG001|NOT COMPLETED|Overall Study||28
3122280|NCT01636713|3847550|FG002|NOT COMPLETED|Overall Study||23
3122281|NCT01636765|3847558|FG000|STARTED|Overall Study||104
3122282|NCT01636765|3847558|FG000|COMPLETED|Overall Study||104
3122283|NCT01636765|3847558|FG000|NOT COMPLETED|Overall Study||0
3122284|NCT01636778|3847562|FG000|STARTED|Pre-Antiviral Treatment Period (Part 1)||45
3122285|NCT01636778|3847563|FG001|STARTED|Pre-Antiviral Treatment Period (Part 1)||0
3122286|NCT01636778|3847564|FG002|STARTED|Pre-Antiviral Treatment Period (Part 1)||0
3122287|NCT01636778|3847562|FG000|COMPLETED|Pre-Antiviral Treatment Period (Part 1)||41
3122288|NCT01636778|3847563|FG001|COMPLETED|Pre-Antiviral Treatment Period (Part 1)||0
3122289|NCT01636778|3847564|FG002|COMPLETED|Pre-Antiviral Treatment Period (Part 1)||0
3122290|NCT01636778|3847562|FG000|NOT COMPLETED|Pre-Antiviral Treatment Period (Part 1)||4
3122291|NCT01636778|3847563|FG001|NOT COMPLETED|Pre-Antiviral Treatment Period (Part 1)||0
3122292|NCT01636778|3847564|FG002|NOT COMPLETED|Pre-Antiviral Treatment Period (Part 1)||0
3122293|NCT01636778|3847562|FG000|STARTED|Antiviral Treatment Period (Part 2)||0
3122294|NCT01636778|3847563|FG001|STARTED|Antiviral Treatment Period (Part 2)||41
3122295|NCT01636778|3847564|FG002|STARTED|Antiviral Treatment Period (Part 2)||0
3122296|NCT01636778|3847562|FG000|COMPLETED|Antiviral Treatment Period (Part 2)||0
3122297|NCT01636778|3847563|FG001|COMPLETED|Antiviral Treatment Period (Part 2)||31
3122298|NCT01636778|3847564|FG002|COMPLETED|Antiviral Treatment Period (Part 2)||0
3122299|NCT01636778|3847562|FG000|NOT COMPLETED|Antiviral Treatment Period (Part 2)||0
3122300|NCT01636778|3847563|FG001|NOT COMPLETED|Antiviral Treatment Period (Part 2)||10
3122301|NCT01636778|3847564|FG002|NOT COMPLETED|Antiviral Treatment Period (Part 2)||0
3122302|NCT01636778|3847562|FG000|STARTED|Follow-up Period After Part 2||0
3122303|NCT01636778|3847563|FG001|STARTED|Follow-up Period After Part 2||0
3122304|NCT01636778|3847564|FG002|STARTED|Follow-up Period After Part 2||41
3122305|NCT01636778|3847562|FG000|COMPLETED|Follow-up Period After Part 2||0
3122306|NCT01636778|3847563|FG001|COMPLETED|Follow-up Period After Part 2||0
3122307|NCT01636778|3847564|FG002|COMPLETED|Follow-up Period After Part 2||37
3122308|NCT01636778|3847562|FG000|NOT COMPLETED|Follow-up Period After Part 2||0
3122309|NCT01636778|3847563|FG001|NOT COMPLETED|Follow-up Period After Part 2||0
3122310|NCT01636778|3847564|FG002|NOT COMPLETED|Follow-up Period After Part 2||4
3122311|NCT01636882|3847572|FG000|STARTED|Overall Study||16
3122312|NCT01636882|3847572|FG000|COMPLETED|Overall Study||16
3122313|NCT01636882|3847572|FG000|NOT COMPLETED|Overall Study||0
3122314|NCT01636934|3847578|FG000|STARTED|Overall Study||25
3122315|NCT01636934|3847579|FG001|STARTED|Overall Study||24
3122316|NCT01636934|3847578|FG000|COMPLETED|Overall Study||19
3122317|NCT01636934|3847579|FG001|COMPLETED|Overall Study||21
3122318|NCT01636934|3847578|FG000|NOT COMPLETED|Overall Study||6
3122319|NCT01636934|3847579|FG001|NOT COMPLETED|Overall Study||3
3122320|NCT01636947|3847587|FG000|STARTED|Overall Study||244
3122321|NCT01636947|3847588|FG001|STARTED|Overall Study||250
3122322|NCT01636947|3847587|FG000|Treated|Overall Study||242
3122323|NCT01636947|3847588|FG001|Treated|Overall Study||248
3122324|NCT01636947|3847587|FG000|COMPLETED|Overall Study||232
3122325|NCT01636947|3847588|FG001|COMPLETED|Overall Study||239
3122326|NCT01636947|3847587|FG000|NOT COMPLETED|Overall Study||12
3122327|NCT01636947|3847588|FG001|NOT COMPLETED|Overall Study||11
3122328|NCT01636960|3847594|FG000|STARTED|Induction Phase||9
3122329|NCT01636960|3847594|FG000|COMPLETED|Induction Phase|Participants continuing into Maintenance Phase|7
3122330|NCT01636960|3847594|FG000|NOT COMPLETED|Induction Phase||2
3122331|NCT01636960|3847594|FG000|STARTED|Maintenance Phase||7
3122332|NCT01636960|3847594|FG000|COMPLETED|Maintenance Phase||0
3122333|NCT01636960|3847594|FG000|NOT COMPLETED|Maintenance Phase||7
3122334|NCT01636986|3847600|FG000|STARTED|Overall Study||30
3122335|NCT01636986|3847601|FG001|STARTED|Overall Study||32
3122336|NCT01636986|3847600|FG000|COMPLETED|Overall Study||30
3122337|NCT01636986|3847601|FG001|COMPLETED|Overall Study||30
3122338|NCT01636986|3847600|FG000|NOT COMPLETED|Overall Study||0
3122339|NCT01636986|3847601|FG001|NOT COMPLETED|Overall Study||2
3122340|NCT01637077|3847609|FG000|STARTED|Overall Study||23
3122341|NCT01637077|3847610|FG001|STARTED|Overall Study||23
3122342|NCT01637077|3847609|FG000|COMPLETED|Overall Study||19
3122343|NCT01637077|3847610|FG001|COMPLETED|Overall Study||22
3122344|NCT01637077|3847609|FG000|NOT COMPLETED|Overall Study||4
3122345|NCT01637077|3847610|FG001|NOT COMPLETED|Overall Study||1
3122346|NCT01637090|3847616|FG000|STARTED|Overall Study||3
3122347|NCT01637090|3847616|FG000|COMPLETED|Overall Study||0
3122348|NCT01637090|3847616|FG000|NOT COMPLETED|Overall Study||3
3122349|NCT01637142|3847620|FG000|STARTED|Treatment Period 1||18
3122350|NCT01637142|3847620|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 1||18
3122351|NCT01637142|3847620|FG000|COMPLETED|Treatment Period 1||18
3122352|NCT01637142|3847620|FG000|NOT COMPLETED|Treatment Period 1||0
3122353|NCT01637142|3847620|FG000|STARTED|Washout Period (at Least 3 Days)||18
3122354|NCT01637142|3847620|FG000|COMPLETED|Washout Period (at Least 3 Days)||17
3122355|NCT01637142|3847620|FG000|NOT COMPLETED|Washout Period (at Least 3 Days)||1
3122356|NCT01637142|3847620|FG000|STARTED|Treatment Period 2||17
3122357|NCT01637142|3847620|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 2||17
3122358|NCT01637142|3847620|FG000|COMPLETED|Treatment Period 2||17
3122359|NCT01637142|3847620|FG000|NOT COMPLETED|Treatment Period 2||0
3122360|NCT01637246|3847626|FG000|STARTED|Overall Study||4385
3122361|NCT01637246|3847626|FG000|COMPLETED|Overall Study||2246
3122362|NCT01637246|3847626|FG000|NOT COMPLETED|Overall Study||2139
3122363|NCT01637272|3847630|FG000|STARTED|Overall Study||43
3122364|NCT01637272|3847630|FG000|Completed sc Phase|Overall Study||33
3122365|NCT01637272|3847630|FG000|Completed Core Phase (sc + LAR)|Overall Study||31
3122366|NCT01637272|3847630|FG000|Entered Extension Phase|Overall Study||27
3122367|NCT01637272|3847630|FG000|Completed Core But Did no Enter Ext..|Overall Study||4
3122368|NCT01637272|3847630|FG000|COMPLETED|Overall Study||23
3122369|NCT01637272|3847630|FG000|NOT COMPLETED|Overall Study||20
3122370|NCT01637402|3847649|FG000|STARTED|Standard Dose Regimen||41
3122371|NCT01637402|3847650|FG001|STARTED|Standard Dose Regimen|Escalated dose not introduced as treatment option until after Week 12 evaluation|0
3122372|NCT01637402|3847649|FG000|COMPLETED|Standard Dose Regimen||38
3122373|NCT01637402|3847650|FG001|COMPLETED|Standard Dose Regimen||0
3122374|NCT01637402|3847649|FG000|NOT COMPLETED|Standard Dose Regimen||3
3122375|NCT01637402|3847650|FG001|NOT COMPLETED|Standard Dose Regimen||0
3122376|NCT01637402|3847649|FG000|STARTED|Week 12 Evaluation||38
3122377|NCT01637402|3847650|FG001|STARTED|Week 12 Evaluation|Escalated dose not introduced as treatment option until after Week 12 evaluation|0
3122378|NCT01637402|3847649|FG000|COMPLETED|Week 12 Evaluation||32
3122379|NCT01637402|3847650|FG001|COMPLETED|Week 12 Evaluation||0
3122380|NCT01637402|3847649|FG000|NOT COMPLETED|Week 12 Evaluation||6
3122381|NCT01637402|3847650|FG001|NOT COMPLETED|Week 12 Evaluation||0
3122382|NCT01637402|3847649|FG000|STARTED|Treatment Regiments Post Week 12|Patients continuing on standard dose|14
3122383|NCT01637402|3847650|FG001|STARTED|Treatment Regiments Post Week 12|Patients who progressed after decline on standard dose|18
3122384|NCT01637402|3847649|FG000|COMPLETED|Treatment Regiments Post Week 12||5
3122385|NCT01637402|3847650|FG001|COMPLETED|Treatment Regiments Post Week 12||14
3122386|NCT01637402|3847649|FG000|NOT COMPLETED|Treatment Regiments Post Week 12||9
3122387|NCT01637402|3847650|FG001|NOT COMPLETED|Treatment Regiments Post Week 12||4
3122388|NCT01637584|3847677|FG000|STARTED|Overall Study||20
3122389|NCT01637584|3847678|FG001|STARTED|Overall Study||20
3122390|NCT01637584|3847677|FG000|COMPLETED|Overall Study||19
3122391|NCT01637584|3847678|FG001|COMPLETED|Overall Study||17
3122392|NCT01637584|3847677|FG000|NOT COMPLETED|Overall Study||1
3122393|NCT01637584|3847678|FG001|NOT COMPLETED|Overall Study||3
3122394|NCT01637623|3847688|FG000|STARTED|Overall Study||29
3122395|NCT01637623|3847689|FG001|STARTED|Overall Study||30
3122396|NCT01637623|3847690|FG002|STARTED|Overall Study||28
3122397|NCT01637623|3847688|FG000|Received Intervention|Overall Study||28
3122398|NCT01637623|3847689|FG001|Received Intervention|Overall Study||30
3122399|NCT01637623|3847690|FG002|Received Intervention|Overall Study||27
3122400|NCT01637623|3847688|FG000|Did Not Receive Intervention|Overall Study||1
3122401|NCT01637623|3847689|FG001|Did Not Receive Intervention|Overall Study||0
3122402|NCT01637623|3847690|FG002|Did Not Receive Intervention|Overall Study||1
3122403|NCT01637623|3847688|FG000|Analyzed|Overall Study||28
3122404|NCT01637623|3847689|FG001|Analyzed|Overall Study||30
3122405|NCT01637623|3847690|FG002|Analyzed|Overall Study||28
3122406|NCT01637623|3847688|FG000|COMPLETED|Overall Study||28
3122407|NCT01637623|3847689|FG001|COMPLETED|Overall Study||30
3122408|NCT01637623|3847690|FG002|COMPLETED|Overall Study||25
3122409|NCT01637623|3847688|FG000|NOT COMPLETED|Overall Study||1
3122410|NCT01637623|3847689|FG001|NOT COMPLETED|Overall Study||0
3122411|NCT01637623|3847690|FG002|NOT COMPLETED|Overall Study||3
3122412|NCT01637870|3847698|FG000|STARTED|Overall Study||110
3122413|NCT01637870|3847698|FG000|COMPLETED|Overall Study||110
3122414|NCT01637870|3847698|FG000|NOT COMPLETED|Overall Study||0
3122415|NCT01637922|3847704|FG000|STARTED|Overall Study||15
3122416|NCT01637922|3847705|FG001|STARTED|Overall Study||19
3122417|NCT01637922|3847704|FG000|COMPLETED|Overall Study||13
3122418|NCT01637922|3847705|FG001|COMPLETED|Overall Study||14
3122419|NCT01637922|3847704|FG000|NOT COMPLETED|Overall Study||2
3122420|NCT01637922|3847705|FG001|NOT COMPLETED|Overall Study||5
3122421|NCT01637935|3847714|FG000|STARTED|Overall Study||34181
3122422|NCT01637935|3847715|FG001|STARTED|Overall Study||158918
3122423|NCT01637935|3847714|FG000|COMPLETED|Overall Study||34181
3122424|NCT01637935|3847715|FG001|COMPLETED|Overall Study||158918
3122425|NCT01637935|3847714|FG000|NOT COMPLETED|Overall Study||0
3122426|NCT01637935|3847715|FG001|NOT COMPLETED|Overall Study||0
3122427|NCT01637961|3847721|FG000|STARTED|Overall Study||23
3122428|NCT01637961|3847721|FG000|COMPLETED|Overall Study|Eligible and treated patients.|21
3122429|NCT01637961|3847721|FG000|NOT COMPLETED|Overall Study||2
3122430|NCT01638000|3847733|FG000|STARTED|Overall Study||943
3122431|NCT01638000|3847734|FG001|STARTED|Overall Study||944
3122432|NCT01638000|3847733|FG000|Received at Least 1 Double-Blind Dose|Overall Study||936
3122433|NCT01638000|3847734|FG001|Received at Least 1 Double-Blind Dose|Overall Study||934
3122434|NCT01638000|3847733|FG000|COMPLETED|Overall Study||883
3122435|NCT01638000|3847734|FG001|COMPLETED|Overall Study||873
3122436|NCT01638000|3847733|FG000|NOT COMPLETED|Overall Study||60
3122437|NCT01638000|3847734|FG001|NOT COMPLETED|Overall Study||71
3122438|NCT01638013|3847743|FG000|STARTED|Overall Study||201
3122439|NCT01638013|3847744|FG001|STARTED|Overall Study||225
3122440|NCT01638013|3847745|FG002|STARTED|Overall Study||417
3122441|NCT01638013|3847743|FG000|COMPLETED|Overall Study||70
3122442|NCT01638013|3847744|FG001|COMPLETED|Overall Study||147
3122443|NCT01638013|3847745|FG002|COMPLETED|Overall Study||296
3122444|NCT01638013|3847743|FG000|NOT COMPLETED|Overall Study||131
3122445|NCT01638013|3847744|FG001|NOT COMPLETED|Overall Study||78
3122446|NCT01638013|3847745|FG002|NOT COMPLETED|Overall Study||121
3122447|NCT01638052|3847759|FG000|STARTED|Overall Study||28
3122448|NCT01638052|3847760|FG001|STARTED|Overall Study||28
3122449|NCT01638052|3847759|FG000|COMPLETED|Overall Study||28
3122450|NCT01638052|3847760|FG001|COMPLETED|Overall Study||28
3122451|NCT01638052|3847759|FG000|NOT COMPLETED|Overall Study||0
3122452|NCT01638052|3847760|FG001|NOT COMPLETED|Overall Study||0
3122453|NCT01638312|3847768|FG000|STARTED|Overall Study||20
3122454|NCT01638312|3847769|FG001|STARTED|Overall Study||30
3122455|NCT01638312|3847768|FG000|COMPLETED|Overall Study||20
3122456|NCT01638312|3847769|FG001|COMPLETED|Overall Study||30
3122457|NCT01638312|3847768|FG000|NOT COMPLETED|Overall Study||0
3122458|NCT01638312|3847769|FG001|NOT COMPLETED|Overall Study||0
3122459|NCT01638390|3847775|FG000|STARTED|Overall Study|enrolled|357
3122460|NCT01638390|3847775|FG000|COMPLETED|Overall Study|treated eyes|336
3122461|NCT01638390|3847775|FG000|NOT COMPLETED|Overall Study||21
3122462|NCT01638416|3847788|FG000|STARTED|Overall Study||2490
3122463|NCT01638416|3847789|FG001|STARTED|Overall Study||2504
3122464|NCT01638416|3847788|FG000|COMPLETED|Overall Study||2457
3122465|NCT01638416|3847789|FG001|COMPLETED|Overall Study||2462
3122466|NCT01638416|3847788|FG000|NOT COMPLETED|Overall Study||33
3122467|NCT01638416|3847789|FG001|NOT COMPLETED|Overall Study||42
3122468|NCT01638429|3847796|FG000|STARTED|Overall Study||12
3122469|NCT01638429|3847796|FG000|Pre-treatment Testing|Overall Study||11
3122470|NCT01638429|3847796|FG000|Antibiotic Treatment|Overall Study||11
3122471|NCT01638429|3847796|FG000|Post-treatment Testing|Overall Study||11
3122472|NCT01638429|3847796|FG000|COMPLETED|Overall Study||11
3122473|NCT01638429|3847796|FG000|NOT COMPLETED|Overall Study||1
3122474|NCT01638468|3847804|FG000|STARTED|Overall Study||7
3122475|NCT01638468|3847804|FG000|COMPLETED|Overall Study||7
3122476|NCT01638468|3847804|FG000|NOT COMPLETED|Overall Study||0
3122477|NCT01638507|3847808|FG000|STARTED|Overall Study||230
3122478|NCT01638507|3847808|FG000|COMPLETED|Overall Study||224
3122479|NCT01638507|3847808|FG000|NOT COMPLETED|Overall Study||6
3122480|NCT01638546|3847816|FG000|STARTED|Overall Study||52
3122481|NCT01638546|3847817|FG001|STARTED|Overall Study||45
3122482|NCT01638546|3847816|FG000|COMPLETED|Overall Study||51
3122483|NCT01638546|3847817|FG001|COMPLETED|Overall Study||42
3122484|NCT01638546|3847816|FG000|NOT COMPLETED|Overall Study||1
3122485|NCT01638546|3847817|FG001|NOT COMPLETED|Overall Study||3
3122486|NCT01638559|3847825|FG000|STARTED|Overall Study||88
3122487|NCT01638559|3847825|FG000|COMPLETED|Overall Study|Completion through the time of the primary endpoint (outcome).|85
3122488|NCT01638559|3847825|FG000|NOT COMPLETED|Overall Study||3
3122489|NCT01638819|3847842|FG000|STARTED|Overall Study||15
3122490|NCT01638819|3847843|FG001|STARTED|Overall Study||15
3122491|NCT01638819|3847842|FG000|First Intervention (8 Weeks)|Overall Study||15
3122492|NCT01638819|3847843|FG001|First Intervention (8 Weeks)|Overall Study||15
3122493|NCT01638819|3847842|FG000|Second Intervention (24 Weeks)|Overall Study||14
3122494|NCT01638819|3847843|FG001|Second Intervention (24 Weeks)|Overall Study||15
3122495|NCT01638819|3847842|FG000|COMPLETED|Overall Study||14
3122496|NCT01638819|3847843|FG001|COMPLETED|Overall Study||15
3122497|NCT01638819|3847842|FG000|NOT COMPLETED|Overall Study||1
3122498|NCT01638819|3847843|FG001|NOT COMPLETED|Overall Study||0
3122499|NCT01639001|3847850|FG000|STARTED|Overall Study||104
3122500|NCT01639001|3847851|FG001|STARTED|Overall Study||103
3122501|NCT01639001|3847850|FG000|Treated|Overall Study||104
3122502|NCT01639001|3847851|FG001|Treated|Overall Study||101
3122503|NCT01639001|3847850|FG000|COMPLETED|Overall Study||29
3122504|NCT01639001|3847851|FG001|COMPLETED|Overall Study||26
3122505|NCT01639001|3847850|FG000|NOT COMPLETED|Overall Study||75
3122506|NCT01639001|3847851|FG001|NOT COMPLETED|Overall Study||77
3122507|NCT01639040|3847861|FG000|STARTED|Overall Study||10
3122508|NCT01639040|3847862|FG001|STARTED|Overall Study||21
3122509|NCT01639040|3847861|FG000|COMPLETED|Overall Study||9
3122510|NCT01639040|3847862|FG001|COMPLETED|Overall Study||21
3122511|NCT01639040|3847861|FG000|NOT COMPLETED|Overall Study||1
3122512|NCT01639040|3847862|FG001|NOT COMPLETED|Overall Study||0
3122513|NCT01639144|3847873|FG000|STARTED|Overall Study||260
3122514|NCT01639144|3847874|FG001|STARTED|Overall Study||255
3122515|NCT01639144|3847873|FG000|COMPLETED|Overall Study||250
3122516|NCT01639144|3847874|FG001|COMPLETED|Overall Study||250
3122517|NCT01639144|3847873|FG000|NOT COMPLETED|Overall Study||10
3122518|NCT01639144|3847874|FG001|NOT COMPLETED|Overall Study||5
3122519|NCT01639157|3847880|FG000|STARTED|Overall Study||4
3122520|NCT01639157|3847881|FG001|STARTED|Overall Study||5
3122521|NCT01639157|3847880|FG000|COMPLETED|Overall Study||4
3122522|NCT01639157|3847881|FG001|COMPLETED|Overall Study||5
3122523|NCT01639157|3847880|FG000|NOT COMPLETED|Overall Study||0
3122524|NCT01639157|3847881|FG001|NOT COMPLETED|Overall Study||0
3122525|NCT01639222|3847887|FG000|STARTED|Overall Study||55
3122526|NCT01639222|3847887|FG000|COMPLETED|Overall Study||55
3122527|NCT01639222|3847887|FG000|NOT COMPLETED|Overall Study||0
3122528|NCT01639339|3847895|FG000|STARTED|Double-blind Period (Up to Week 104)||224
3122529|NCT01639339|3847896|FG001|STARTED|Double-blind Period (Up to Week 104)||224
3122530|NCT01639339|3847895|FG000|COMPLETED|Double-blind Period (Up to Week 104)||170
3122531|NCT01639339|3847896|FG001|COMPLETED|Double-blind Period (Up to Week 104)||186
3122532|NCT01639339|3847895|FG000|NOT COMPLETED|Double-blind Period (Up to Week 104)||54
3122533|NCT01639339|3847896|FG001|NOT COMPLETED|Double-blind Period (Up to Week 104)||38
3122534|NCT01639339|3847895|FG000|STARTED|Open-label Period (Up to Week 28)|Of the 356 participants who completed the double-blind period, 279 were eligible for open-label treatment. As enrolling into the open-label period was optional, only 257 participants enrolled, of whom 255 started open-label treatment.|123
3122535|NCT01639339|3847896|FG001|STARTED|Open-label Period (Up to Week 28)||132
3122536|NCT01639339|3847895|FG000|COMPLETED|Open-label Period (Up to Week 28)||122
3122537|NCT01639339|3847896|FG001|COMPLETED|Open-label Period (Up to Week 28)||124
3122538|NCT01639339|3847895|FG000|NOT COMPLETED|Open-label Period (Up to Week 28)||1
3122539|NCT01639339|3847896|FG001|NOT COMPLETED|Open-label Period (Up to Week 28)||8
3122540|NCT01639352|3847906|FG000|STARTED|Overall Study||20
3122541|NCT01639352|3847906|FG000|COMPLETED|Overall Study||20
3122542|NCT01639352|3847906|FG000|NOT COMPLETED|Overall Study||0
3122543|NCT01639443|3847912|FG000|STARTED|Overall Study|These individuals opted into Fast-tracked group and were consented.|180
3122544|NCT01639443|3847913|FG001|STARTED|Overall Study|These individuals opted to not participate in Fast-tracked group, and were not consented.|4855
3122545|NCT01639443|3847912|FG000|COMPLETED|Overall Study|Intervention is limited to appointment booking, and all completed.|180
3122546|NCT01639443|3847913|FG001|COMPLETED|Overall Study|These individuals all booked appointments using typical booking.|4855
3122547|NCT01639443|3847912|FG000|NOT COMPLETED|Overall Study||0
3122548|NCT01639443|3847913|FG001|NOT COMPLETED|Overall Study||0
3122549|NCT01639469|3847921|FG000|STARTED|Overall Study||89
3122550|NCT01639469|3847922|FG001|STARTED|Overall Study||80
3122551|NCT01639469|3847921|FG000|COMPLETED|Overall Study||84
3122552|NCT01639469|3847922|FG001|COMPLETED|Overall Study||77
3122553|NCT01639469|3847921|FG000|NOT COMPLETED|Overall Study||5
3122554|NCT01639469|3847922|FG001|NOT COMPLETED|Overall Study||3
3122555|NCT01639495|3847928|FG000|STARTED|Overall Study|Patients who signed the informed consent.|148
3122556|NCT01639495|3847928|FG000|Safety Cohort|Overall Study||144
3122557|NCT01639495|3847928|FG000|Primary Effectiveness Cohort|Overall Study||138
3122558|NCT01639495|3847928|FG000|COMPLETED|Overall Study||132
3122559|NCT01639495|3847928|FG000|NOT COMPLETED|Overall Study||16
3122560|NCT01639560|3847934|FG000|STARTED|Overall Study||45
3122561|NCT01639560|3847935|FG001|STARTED|Overall Study||48
3122562|NCT01639560|3847934|FG000|End of Treatment|Overall Study||28
3122563|NCT01639560|3847935|FG001|End of Treatment|Overall Study||20
3122564|NCT01639560|3847934|FG000|COMPLETED|Overall Study||26
3122565|NCT01639560|3847935|FG001|COMPLETED|Overall Study||19
3122566|NCT01639560|3847934|FG000|NOT COMPLETED|Overall Study||19
3122567|NCT01639560|3847935|FG001|NOT COMPLETED|Overall Study||29
3122568|NCT01639599|3847944|FG000|STARTED|Overall Study||50
3122569|NCT01639599|3847945|FG001|STARTED|Overall Study||50
3122570|NCT01639599|3847946|FG002|STARTED|Overall Study||50
3122571|NCT01639599|3847944|FG000|COMPLETED|Overall Study||50
3122572|NCT01639599|3847945|FG001|COMPLETED|Overall Study||49
3122573|NCT01639599|3847946|FG002|COMPLETED|Overall Study||50
3122574|NCT01639599|3847944|FG000|NOT COMPLETED|Overall Study||0
3122575|NCT01639599|3847945|FG001|NOT COMPLETED|Overall Study||1
3122576|NCT01639599|3847946|FG002|NOT COMPLETED|Overall Study||0
3122577|NCT01639664|3847956|FG000|STARTED|Overall Study||63
3122578|NCT01639664|3847957|FG001|STARTED|Overall Study||52
3122579|NCT01639664|3847956|FG000|COMPLETED|Overall Study||63
3122580|NCT01639664|3847957|FG001|COMPLETED|Overall Study||52
3122581|NCT01639664|3847956|FG000|NOT COMPLETED|Overall Study||0
3122582|NCT01639664|3847957|FG001|NOT COMPLETED|Overall Study||0
3122583|NCT01639703|3847964|FG000|STARTED|Overall Study||96
3122584|NCT01639703|3847964|FG000|COMPLETED|Overall Study||84
3122585|NCT01639703|3847964|FG000|NOT COMPLETED|Overall Study||12
3122586|NCT01639729|3847980|FG000|STARTED|Overall Study||4
3122587|NCT01639729|3847981|FG001|STARTED|Overall Study||4
3122588|NCT01639729|3847982|FG002|STARTED|Overall Study||4
3122589|NCT01639729|3847983|FG003|STARTED|Overall Study||5
3122590|NCT01639729|3847984|FG004|STARTED|Overall Study||4
3122591|NCT01639729|3847985|FG005|STARTED|Overall Study||4
3122592|NCT01639729|3847980|FG000|COMPLETED|Overall Study||3
3122593|NCT01639729|3847981|FG001|COMPLETED|Overall Study||4
3122594|NCT01639729|3847982|FG002|COMPLETED|Overall Study||3
3122595|NCT01639729|3847983|FG003|COMPLETED|Overall Study||4
3122596|NCT01639729|3847984|FG004|COMPLETED|Overall Study||4
3122597|NCT01639729|3847985|FG005|COMPLETED|Overall Study||4
3122598|NCT01639729|3847980|FG000|NOT COMPLETED|Overall Study||1
3122599|NCT01639729|3847981|FG001|NOT COMPLETED|Overall Study||0
3122600|NCT01639729|3847982|FG002|NOT COMPLETED|Overall Study||1
3122601|NCT01639729|3847983|FG003|NOT COMPLETED|Overall Study||1
3122602|NCT01639729|3847984|FG004|NOT COMPLETED|Overall Study||0
3122603|NCT01639729|3847985|FG005|NOT COMPLETED|Overall Study||0
3122604|NCT01639742|3847995|FG000|STARTED|Overall Study||18
3122605|NCT01639742|3847995|FG000|COMPLETED|Overall Study||0
3122606|NCT01639742|3847995|FG000|NOT COMPLETED|Overall Study||18
3122607|NCT01639755|3847999|FG000|STARTED|Overall Study||19
3122608|NCT01639755|3847999|FG000|COMPLETED|Overall Study||0
3122609|NCT01639755|3847999|FG000|NOT COMPLETED|Overall Study||19
3122610|NCT01639833|3848005|FG000|STARTED|Overall Study||45
3122611|NCT01639833|3848006|FG001|STARTED|Overall Study||45
3122612|NCT01639833|3848005|FG000|COMPLETED|Overall Study||39
3122613|NCT01639833|3848006|FG001|COMPLETED|Overall Study||41
3122614|NCT01639833|3848005|FG000|NOT COMPLETED|Overall Study||6
3122615|NCT01639833|3848006|FG001|NOT COMPLETED|Overall Study||4
3122616|NCT01639872|3848014|FG000|STARTED|Overall Study||24
3122617|NCT01639872|3848015|FG001|STARTED|Overall Study||25
3122618|NCT01639872|3848014|FG000|COMPLETED|Overall Study||14
3122619|NCT01639872|3848015|FG001|COMPLETED|Overall Study||20
3122620|NCT01639872|3848014|FG000|NOT COMPLETED|Overall Study||10
3122621|NCT01639872|3848015|FG001|NOT COMPLETED|Overall Study||5
3122622|NCT01640054|3848021|FG000|STARTED|Overall Study|Patients who received treatment|115
3122623|NCT01640054|3848021|FG000|Did Not Receive Treatment|Overall Study||0
3122624|NCT01640054|3848021|FG000|COMPLETED|Overall Study|Number of patients on treatment when the study was stopped.|109
3122625|NCT01640054|3848021|FG000|NOT COMPLETED|Overall Study||6
3122626|NCT01640171|3848025|FG000|STARTED|Overall Study||57
3122627|NCT01640171|3848025|FG000|COMPLETED|Overall Study||57
3122628|NCT01640171|3848025|FG000|NOT COMPLETED|Overall Study||0
3122629|NCT01640184|3848033|FG000|STARTED|Overall Study||34
3122630|NCT01640184|3848034|FG001|STARTED|Overall Study||23
3122631|NCT01640184|3848035|FG002|STARTED|Overall Study||22
3122632|NCT01640184|3848033|FG000|COMPLETED|Overall Study||26
3122633|NCT01640184|3848034|FG001|COMPLETED|Overall Study||21
3122634|NCT01640184|3848035|FG002|COMPLETED|Overall Study||20
3122635|NCT01640184|3848033|FG000|NOT COMPLETED|Overall Study||8
3122636|NCT01640184|3848034|FG001|NOT COMPLETED|Overall Study||2
3122637|NCT01640184|3848035|FG002|NOT COMPLETED|Overall Study||2
3122638|NCT01640197|3848048|FG000|STARTED|Overall Study||30
3122639|NCT01640197|3848049|FG001|STARTED|Overall Study||30
3122640|NCT01640197|3848048|FG000|COMPLETED|Overall Study||30
3122641|NCT01640197|3848049|FG001|COMPLETED|Overall Study||30
3122642|NCT01640197|3848048|FG000|NOT COMPLETED|Overall Study||0
3122643|NCT01640197|3848049|FG001|NOT COMPLETED|Overall Study||0
3122644|NCT01640249|3848062|FG000|STARTED|Period 1||3
3122645|NCT01640249|3848063|FG001|STARTED|Period 1||2
3122646|NCT01640249|3848064|FG002|STARTED|Period 1||2
3122647|NCT01640249|3848065|FG003|STARTED|Period 1||2
3122648|NCT01640249|3848066|FG004|STARTED|Period 1||2
3122649|NCT01640249|3848067|FG005|STARTED|Period 1||5
3122650|NCT01640249|3848068|FG006|STARTED|Period 1||2
3122651|NCT01640249|3848062|FG000|Received at Least 1 Dose of Study Drug|Period 1||3
3122652|NCT01640249|3848063|FG001|Received at Least 1 Dose of Study Drug|Period 1||2
3122653|NCT01640249|3848064|FG002|Received at Least 1 Dose of Study Drug|Period 1||2
3122654|NCT01640249|3848065|FG003|Received at Least 1 Dose of Study Drug|Period 1||2
3122655|NCT01640249|3848066|FG004|Received at Least 1 Dose of Study Drug|Period 1||2
3122656|NCT01640249|3848067|FG005|Received at Least 1 Dose of Study Drug|Period 1||5
3122657|NCT01640249|3848068|FG006|Received at Least 1 Dose of Study Drug|Period 1||2
3122658|NCT01640249|3848062|FG000|COMPLETED|Period 1||2
3122659|NCT01640249|3848063|FG001|COMPLETED|Period 1||2
3122660|NCT01640249|3848064|FG002|COMPLETED|Period 1||2
3122661|NCT01640249|3848065|FG003|COMPLETED|Period 1||2
3122662|NCT01640249|3848066|FG004|COMPLETED|Period 1||2
3122663|NCT01640249|3848067|FG005|COMPLETED|Period 1||4
3122664|NCT01640249|3848068|FG006|COMPLETED|Period 1||2
3122665|NCT01640249|3848062|FG000|NOT COMPLETED|Period 1||1
3122666|NCT01640249|3848063|FG001|NOT COMPLETED|Period 1||0
3122667|NCT01640249|3848064|FG002|NOT COMPLETED|Period 1||0
3122668|NCT01640249|3848065|FG003|NOT COMPLETED|Period 1||0
3122669|NCT01640249|3848066|FG004|NOT COMPLETED|Period 1||0
3122670|NCT01640249|3848067|FG005|NOT COMPLETED|Period 1||1
3122671|NCT01640249|3848068|FG006|NOT COMPLETED|Period 1||0
3122672|NCT01640249|3848062|FG000|STARTED|Period 2||2
3122673|NCT01640249|3848063|FG001|STARTED|Period 2||2
3122674|NCT01640249|3848064|FG002|STARTED|Period 2||2
3122675|NCT01640249|3848065|FG003|STARTED|Period 2||2
3122676|NCT01640249|3848066|FG004|STARTED|Period 2||2
3122677|NCT01640249|3848067|FG005|STARTED|Period 2||4
3122678|NCT01640249|3848068|FG006|STARTED|Period 2||2
3122679|NCT01640249|3848062|FG000|COMPLETED|Period 2||2
3122680|NCT01640249|3848063|FG001|COMPLETED|Period 2||2
3122681|NCT01640249|3848064|FG002|COMPLETED|Period 2||2
3122682|NCT01640249|3848065|FG003|COMPLETED|Period 2||2
3122683|NCT01640249|3848066|FG004|COMPLETED|Period 2||2
3122684|NCT01640249|3848067|FG005|COMPLETED|Period 2||4
3122685|NCT01640249|3848068|FG006|COMPLETED|Period 2||2
3122686|NCT01640249|3848062|FG000|NOT COMPLETED|Period 2||0
3122687|NCT01640249|3848063|FG001|NOT COMPLETED|Period 2||0
3122688|NCT01640249|3848064|FG002|NOT COMPLETED|Period 2||0
3122689|NCT01640249|3848065|FG003|NOT COMPLETED|Period 2||0
3122690|NCT01640249|3848066|FG004|NOT COMPLETED|Period 2||0
3122691|NCT01640249|3848067|FG005|NOT COMPLETED|Period 2||0
3122692|NCT01640249|3848068|FG006|NOT COMPLETED|Period 2||0
3122693|NCT01640249|3848062|FG000|STARTED|Period 3||2
3122694|NCT01640249|3848063|FG001|STARTED|Period 3||2
3122695|NCT01640249|3848064|FG002|STARTED|Period 3||2
3122696|NCT01640249|3848065|FG003|STARTED|Period 3||2
3122697|NCT01640249|3848066|FG004|STARTED|Period 3|Cohort 2 was planned for only 2 dosing periods.|0
3122698|NCT01640249|3848067|FG005|STARTED|Period 3|Cohort 2 was planned for only 2 dosing periods.|0
3122699|NCT01640249|3848068|FG006|STARTED|Period 3|Cohort 2 was planned for only 2 dosing periods.|0
3122700|NCT01640249|3848062|FG000|COMPLETED|Period 3||2
3122701|NCT01640249|3848063|FG001|COMPLETED|Period 3||2
3122702|NCT01640249|3848064|FG002|COMPLETED|Period 3||2
3122703|NCT01640249|3848065|FG003|COMPLETED|Period 3||1
3122704|NCT01640249|3848066|FG004|COMPLETED|Period 3||0
3122705|NCT01640249|3848067|FG005|COMPLETED|Period 3||0
3122706|NCT01640249|3848068|FG006|COMPLETED|Period 3||0
3122707|NCT01640249|3848062|FG000|NOT COMPLETED|Period 3||0
3122708|NCT01640249|3848063|FG001|NOT COMPLETED|Period 3||0
3122709|NCT01640249|3848064|FG002|NOT COMPLETED|Period 3||0
3122710|NCT01640249|3848065|FG003|NOT COMPLETED|Period 3||1
3122711|NCT01640249|3848066|FG004|NOT COMPLETED|Period 3||0
3122712|NCT01640249|3848067|FG005|NOT COMPLETED|Period 3||0
3122713|NCT01640249|3848068|FG006|NOT COMPLETED|Period 3||0
3122714|NCT01640288|3848089|FG000|STARTED|Overall Study||100
3122715|NCT01640288|3848090|FG001|STARTED|Overall Study||71
3122716|NCT01640288|3848089|FG000|Received Allocated Intervention|Overall Study|74 rec'd the gas (inc. 4 images were not obtained due to equipment failure = 70)|70
3122717|NCT01640288|3848090|FG001|Received Allocated Intervention|Overall Study|53 rec'd the gas (exc. 1 images not obtained due to equipment failure, 4 poor images = 48 )|48
3122718|NCT01640288|3848089|FG000|Did Not Receive Allocated Intervention|Overall Study||26
3122719|NCT01640288|3848090|FG001|Did Not Receive Allocated Intervention|Overall Study||18
3122720|NCT01640288|3848089|FG000|COMPLETED|Overall Study|One subject was lost to followup but rec'd the gas and images were obtained|70
3122721|NCT01640288|3848090|FG001|COMPLETED|Overall Study||48
3122722|NCT01640288|3848089|FG000|NOT COMPLETED|Overall Study||30
3122723|NCT01640288|3848090|FG001|NOT COMPLETED|Overall Study||23
3122724|NCT01640314|3848099|FG000|STARTED|Overall Study||63
3122725|NCT01640314|3848100|FG001|STARTED|Overall Study||63
3122726|NCT01640314|3848099|FG000|COMPLETED|Overall Study||63
3122727|NCT01640314|3848100|FG001|COMPLETED|Overall Study||62
3122728|NCT01640314|3848099|FG000|NOT COMPLETED|Overall Study||0
3122729|NCT01640314|3848100|FG001|NOT COMPLETED|Overall Study||1
3122730|NCT01640327|3848108|FG000|STARTED|Overall Study||63
3122731|NCT01640327|3848109|FG001|STARTED|Overall Study||63
3122732|NCT01640327|3848108|FG000|COMPLETED|Overall Study||63
3122733|NCT01640327|3848109|FG001|COMPLETED|Overall Study||63
3122734|NCT01640327|3848108|FG000|NOT COMPLETED|Overall Study||0
3122735|NCT01640327|3848109|FG001|NOT COMPLETED|Overall Study||0
3295302|NCT02896400|4029417|FG011|NOT COMPLETED|Baseline||0
3295303|NCT02896400|4029418|FG012|NOT COMPLETED|Baseline||0
3295304|NCT02896400|4029419|FG013|NOT COMPLETED|Baseline||0
3295305|NCT02896400|4029420|FG014|NOT COMPLETED|Baseline||0
3295306|NCT02896400|4029421|FG015|NOT COMPLETED|Baseline||0
3295307|NCT02896400|4029406|FG000|STARTED|1 Month Follow-up||66
3295308|NCT02896400|4029407|FG001|STARTED|1 Month Follow-up||66
3295309|NCT02896400|4029408|FG002|STARTED|1 Month Follow-up||66
3295310|NCT02896400|4029409|FG003|STARTED|1 Month Follow-up||66
3295311|NCT02896400|4029410|FG004|STARTED|1 Month Follow-up||66
3295312|NCT02896400|4029411|FG005|STARTED|1 Month Follow-up||66
3295313|NCT02896400|4029412|FG006|STARTED|1 Month Follow-up||66
3295314|NCT02896400|4029413|FG007|STARTED|1 Month Follow-up||66
3295315|NCT02896400|4029414|FG008|STARTED|1 Month Follow-up||66
3295316|NCT02896400|4029415|FG009|STARTED|1 Month Follow-up||66
3295317|NCT02896400|4029416|FG010|STARTED|1 Month Follow-up||66
3295318|NCT02896400|4029417|FG011|STARTED|1 Month Follow-up||66
3295319|NCT02896400|4029418|FG012|STARTED|1 Month Follow-up||66
3295320|NCT02896400|4029419|FG013|STARTED|1 Month Follow-up||66
3295321|NCT02896400|4029420|FG014|STARTED|1 Month Follow-up||66
3295322|NCT02896400|4029421|FG015|STARTED|1 Month Follow-up||66
3295323|NCT02896400|4029406|FG000|COMPLETED|1 Month Follow-up||59
3295324|NCT02896400|4029407|FG001|COMPLETED|1 Month Follow-up||59
3295325|NCT02896400|4029408|FG002|COMPLETED|1 Month Follow-up||61
3295326|NCT02896400|4029409|FG003|COMPLETED|1 Month Follow-up||58
3295327|NCT02896400|4029410|FG004|COMPLETED|1 Month Follow-up||57
3295328|NCT02896400|4029411|FG005|COMPLETED|1 Month Follow-up||60
3295329|NCT02896400|4029412|FG006|COMPLETED|1 Month Follow-up||61
3295330|NCT02896400|4029413|FG007|COMPLETED|1 Month Follow-up||60
3295331|NCT02896400|4029414|FG008|COMPLETED|1 Month Follow-up||62
3295332|NCT02896400|4029415|FG009|COMPLETED|1 Month Follow-up||59
3295333|NCT02896400|4029416|FG010|COMPLETED|1 Month Follow-up||61
3295334|NCT02896400|4029417|FG011|COMPLETED|1 Month Follow-up||61
3295335|NCT02896400|4029418|FG012|COMPLETED|1 Month Follow-up||63
3295336|NCT02896400|4029419|FG013|COMPLETED|1 Month Follow-up||62
3295337|NCT02896400|4029420|FG014|COMPLETED|1 Month Follow-up||65
3295338|NCT02896400|4029421|FG015|COMPLETED|1 Month Follow-up||63
3295339|NCT02896400|4029406|FG000|NOT COMPLETED|1 Month Follow-up||7
3295340|NCT02896400|4029407|FG001|NOT COMPLETED|1 Month Follow-up||7
3295341|NCT02896400|4029408|FG002|NOT COMPLETED|1 Month Follow-up||5
3295342|NCT02896400|4029409|FG003|NOT COMPLETED|1 Month Follow-up||8
3295343|NCT02896400|4029410|FG004|NOT COMPLETED|1 Month Follow-up||9
3295344|NCT02896400|4029411|FG005|NOT COMPLETED|1 Month Follow-up||6
3295345|NCT02896400|4029412|FG006|NOT COMPLETED|1 Month Follow-up||5
3295346|NCT02896400|4029413|FG007|NOT COMPLETED|1 Month Follow-up||6
3295347|NCT02896400|4029414|FG008|NOT COMPLETED|1 Month Follow-up||4
3295348|NCT02896400|4029415|FG009|NOT COMPLETED|1 Month Follow-up||7
3295349|NCT02896400|4029416|FG010|NOT COMPLETED|1 Month Follow-up||5
3295350|NCT02896400|4029417|FG011|NOT COMPLETED|1 Month Follow-up||5
3295351|NCT02896400|4029418|FG012|NOT COMPLETED|1 Month Follow-up||3
3295352|NCT02896400|4029419|FG013|NOT COMPLETED|1 Month Follow-up||4
3295353|NCT02896400|4029420|FG014|NOT COMPLETED|1 Month Follow-up||1
3295354|NCT02896400|4029421|FG015|NOT COMPLETED|1 Month Follow-up||3
3295355|NCT02896400|4029406|FG000|STARTED|3 Month Follow-up||66
3295356|NCT02896400|4029407|FG001|STARTED|3 Month Follow-up||66
3295357|NCT02896400|4029408|FG002|STARTED|3 Month Follow-up||66
3295358|NCT02896400|4029409|FG003|STARTED|3 Month Follow-up||66
3295359|NCT02896400|4029410|FG004|STARTED|3 Month Follow-up||66
3295360|NCT02896400|4029411|FG005|STARTED|3 Month Follow-up||66
3295361|NCT02896400|4029412|FG006|STARTED|3 Month Follow-up||66
3295362|NCT02896400|4029413|FG007|STARTED|3 Month Follow-up||66
3295363|NCT02896400|4029414|FG008|STARTED|3 Month Follow-up||66
3295364|NCT02896400|4029415|FG009|STARTED|3 Month Follow-up||66
3295365|NCT02896400|4029416|FG010|STARTED|3 Month Follow-up||66
3295366|NCT02896400|4029417|FG011|STARTED|3 Month Follow-up||66
3122736|NCT01640340|3848117|FG000|STARTED|Overall Study||20
3295367|NCT02896400|4029418|FG012|STARTED|3 Month Follow-up||66
3295368|NCT02896400|4029419|FG013|STARTED|3 Month Follow-up||66
3295369|NCT02896400|4029420|FG014|STARTED|3 Month Follow-up||66
3122737|NCT01640340|3848118|FG001|STARTED|Overall Study||20
3122738|NCT01640340|3848117|FG000|Overall Complete Response Rate|Overall Study||20
3122739|NCT01640340|3848118|FG001|Overall Complete Response Rate|Overall Study||20
3122740|NCT01640340|3848117|FG000|COMPLETED|Overall Study||20
3122741|NCT01640340|3848118|FG001|COMPLETED|Overall Study||20
3122742|NCT01640340|3848117|FG000|NOT COMPLETED|Overall Study||0
3122743|NCT01640340|3848118|FG001|NOT COMPLETED|Overall Study||0
3122744|NCT01640353|3848124|FG000|STARTED|Overall Study||194
3122745|NCT01640353|3848124|FG000|Treated|Overall Study||172
3122746|NCT01640353|3848124|FG000|Month 1|Overall Study||171
3122747|NCT01640353|3848124|FG000|Month 3|Overall Study||169
3122748|NCT01640353|3848124|FG000|Month 6|Overall Study||168
3122749|NCT01640353|3848124|FG000|Month 12|Overall Study||160
3122750|NCT01640353|3848124|FG000|Month 18|Overall Study||150
3122751|NCT01640353|3848124|FG000|COMPLETED|Overall Study||149
3122752|NCT01640353|3848124|FG000|NOT COMPLETED|Overall Study||45
3122753|NCT01640366|3848128|FG000|STARTED|Overall Study||200
3122754|NCT01640366|3848128|FG000|Day 21 Follow-up|Overall Study||185
3122755|NCT01640366|3848128|FG000|Day 42 Follow-up|Overall Study||177
3122756|NCT01640366|3848128|FG000|Day 90 Follow-up|Overall Study||178
3122757|NCT01640366|3848128|FG000|COMPLETED|Overall Study||178
3122758|NCT01640366|3848128|FG000|NOT COMPLETED|Overall Study||22
3295370|NCT02896400|4029421|FG015|STARTED|3 Month Follow-up||65
3295371|NCT02896400|4029406|FG000|COMPLETED|3 Month Follow-up||60
3295372|NCT02896400|4029407|FG001|COMPLETED|3 Month Follow-up||63
3295373|NCT02896400|4029408|FG002|COMPLETED|3 Month Follow-up||60
3295374|NCT02896400|4029409|FG003|COMPLETED|3 Month Follow-up||55
3295375|NCT02896400|4029410|FG004|COMPLETED|3 Month Follow-up||54
3122759|NCT01640379|3848136|FG000|STARTED|Overall Study||149
3122760|NCT01640379|3848137|FG001|STARTED|Overall Study||137
3163218|NCT01884350|3890694|FG002|Safety Analysis Set|Primary Efficacy Analysis Set (48 Weeks)||223
3295376|NCT02896400|4029411|FG005|COMPLETED|3 Month Follow-up||60
3295377|NCT02896400|4029412|FG006|COMPLETED|3 Month Follow-up||62
3295378|NCT02896400|4029413|FG007|COMPLETED|3 Month Follow-up||63
3295379|NCT02896400|4029414|FG008|COMPLETED|3 Month Follow-up||60
3295380|NCT02896400|4029415|FG009|COMPLETED|3 Month Follow-up||61
3295381|NCT02896400|4029416|FG010|COMPLETED|3 Month Follow-up||60
3295382|NCT02896400|4029417|FG011|COMPLETED|3 Month Follow-up||60
3295383|NCT02896400|4029418|FG012|COMPLETED|3 Month Follow-up||63
3295384|NCT02896400|4029419|FG013|COMPLETED|3 Month Follow-up||60
3295385|NCT02896400|4029420|FG014|COMPLETED|3 Month Follow-up||62
3295386|NCT02896400|4029421|FG015|COMPLETED|3 Month Follow-up||63
3295387|NCT02896400|4029406|FG000|NOT COMPLETED|3 Month Follow-up||6
3295388|NCT02896400|4029407|FG001|NOT COMPLETED|3 Month Follow-up||3
3295389|NCT02896400|4029408|FG002|NOT COMPLETED|3 Month Follow-up||6
3295390|NCT02896400|4029409|FG003|NOT COMPLETED|3 Month Follow-up||11
3295391|NCT02896400|4029410|FG004|NOT COMPLETED|3 Month Follow-up||12
3295392|NCT02896400|4029411|FG005|NOT COMPLETED|3 Month Follow-up||6
3295393|NCT02896400|4029412|FG006|NOT COMPLETED|3 Month Follow-up||4
3295394|NCT02896400|4029413|FG007|NOT COMPLETED|3 Month Follow-up||3
3295395|NCT02896400|4029414|FG008|NOT COMPLETED|3 Month Follow-up||6
3295396|NCT02896400|4029415|FG009|NOT COMPLETED|3 Month Follow-up||5
3295397|NCT02896400|4029416|FG010|NOT COMPLETED|3 Month Follow-up||6
3295398|NCT02896400|4029417|FG011|NOT COMPLETED|3 Month Follow-up||6
3295399|NCT02896400|4029418|FG012|NOT COMPLETED|3 Month Follow-up||3
3295400|NCT02896400|4029419|FG013|NOT COMPLETED|3 Month Follow-up||6
3295401|NCT02896400|4029420|FG014|NOT COMPLETED|3 Month Follow-up||4
3295402|NCT02896400|4029421|FG015|NOT COMPLETED|3 Month Follow-up||2
3295403|NCT02896400|4029406|FG000|STARTED|Biochemical Verification at 3 Months||60
3295404|NCT02896400|4029407|FG001|STARTED|Biochemical Verification at 3 Months||63
3295405|NCT02896400|4029408|FG002|STARTED|Biochemical Verification at 3 Months||60
3295406|NCT02896400|4029409|FG003|STARTED|Biochemical Verification at 3 Months||55
3295407|NCT02896400|4029410|FG004|STARTED|Biochemical Verification at 3 Months||54
3295408|NCT02896400|4029411|FG005|STARTED|Biochemical Verification at 3 Months||60
3295409|NCT02896400|4029412|FG006|STARTED|Biochemical Verification at 3 Months||62
3163219|NCT01884350|3890692|FG000|COMPLETED|Primary Efficacy Analysis Set (48 Weeks)||503
3163220|NCT01884350|3890693|FG001|COMPLETED|Primary Efficacy Analysis Set (48 Weeks)||250
3163221|NCT01884350|3890694|FG002|COMPLETED|Primary Efficacy Analysis Set (48 Weeks)||250
3163222|NCT01884350|3890692|FG000|NOT COMPLETED|Primary Efficacy Analysis Set (48 Weeks)||80
3163223|NCT01884350|3890693|FG001|NOT COMPLETED|Primary Efficacy Analysis Set (48 Weeks)||13
3163224|NCT01884350|3890694|FG002|NOT COMPLETED|Primary Efficacy Analysis Set (48 Weeks)||11
3163225|NCT01884519|3890706|FG000|STARTED|Overall Study||60
3163226|NCT01884519|3890707|FG001|STARTED|Overall Study||60
3295410|NCT02896400|4029413|FG007|STARTED|Biochemical Verification at 3 Months||63
3295411|NCT02896400|4029414|FG008|STARTED|Biochemical Verification at 3 Months||60
3295412|NCT02896400|4029415|FG009|STARTED|Biochemical Verification at 3 Months||61
3295413|NCT02896400|4029416|FG010|STARTED|Biochemical Verification at 3 Months||60
3295414|NCT02896400|4029417|FG011|STARTED|Biochemical Verification at 3 Months||60
3295415|NCT02896400|4029418|FG012|STARTED|Biochemical Verification at 3 Months||63
3295416|NCT02896400|4029419|FG013|STARTED|Biochemical Verification at 3 Months||60
3295417|NCT02896400|4029420|FG014|STARTED|Biochemical Verification at 3 Months||62
3295418|NCT02896400|4029421|FG015|STARTED|Biochemical Verification at 3 Months||63
3295419|NCT02896400|4029406|FG000|COMPLETED|Biochemical Verification at 3 Months||14
3163227|NCT01884519|3890706|FG000|COMPLETED|Overall Study||60
3295420|NCT02896400|4029407|FG001|COMPLETED|Biochemical Verification at 3 Months||15
3295421|NCT02896400|4029408|FG002|COMPLETED|Biochemical Verification at 3 Months||13
3122761|NCT01640379|3848136|FG000|COMPLETED|Overall Study||135
3122762|NCT01640379|3848137|FG001|COMPLETED|Overall Study||125
3122763|NCT01640379|3848136|FG000|NOT COMPLETED|Overall Study||14
3122764|NCT01640379|3848137|FG001|NOT COMPLETED|Overall Study||12
3122765|NCT01640548|3848144|FG000|STARTED|Overall Study||309
3122766|NCT01640548|3848144|FG000|COMPLETED|Overall Study||309
3122767|NCT01640548|3848144|FG000|NOT COMPLETED|Overall Study||0
3122768|NCT01640808|3848150|FG000|STARTED|Overall Study||309
3122769|NCT01640808|3848151|FG001|STARTED|Overall Study||307
3122770|NCT01640808|3848150|FG000|Subjects Received Treatment|Overall Study||305
3122771|NCT01640808|3848151|FG001|Subjects Received Treatment|Overall Study||305
3122772|NCT01640808|3848150|FG000|COMPLETED|Overall Study||251
3122773|NCT01640808|3848151|FG001|COMPLETED|Overall Study||291
3122774|NCT01640808|3848150|FG000|NOT COMPLETED|Overall Study||58
3122775|NCT01640808|3848151|FG001|NOT COMPLETED|Overall Study||16
3122776|NCT01640834|3848160|FG000|STARTED|Overall Study||8
3122777|NCT01640834|3848161|FG001|STARTED|Overall Study||8
3122778|NCT01640834|3848162|FG002|STARTED|Overall Study||4
3122779|NCT01640834|3848160|FG000|Received at Least 1 Dose of Study Drug|Overall Study||8
3122780|NCT01640834|3848161|FG001|Received at Least 1 Dose of Study Drug|Overall Study||8
3122781|NCT01640834|3848162|FG002|Received at Least 1 Dose of Study Drug|Overall Study||4
3122782|NCT01640834|3848160|FG000|COMPLETED|Overall Study||8
3122783|NCT01640834|3848161|FG001|COMPLETED|Overall Study||8
3122784|NCT01640834|3848162|FG002|COMPLETED|Overall Study||4
3122785|NCT01640834|3848160|FG000|NOT COMPLETED|Overall Study||0
3122786|NCT01640834|3848161|FG001|NOT COMPLETED|Overall Study||0
3122787|NCT01640834|3848162|FG002|NOT COMPLETED|Overall Study||0
3122788|NCT01640873|3848174|FG000|STARTED|Overall Study||22
3122789|NCT01640873|3848175|FG001|STARTED|Overall Study||11
3122790|NCT01640873|3848174|FG000|COMPLETED|Overall Study||20
3122791|NCT01640873|3848175|FG001|COMPLETED|Overall Study||10
3122792|NCT01640873|3848174|FG000|NOT COMPLETED|Overall Study||2
3122793|NCT01640873|3848175|FG001|NOT COMPLETED|Overall Study||1
3122794|NCT01640925|3848183|FG000|STARTED|Overall Study||175
3122795|NCT01640925|3848184|FG001|STARTED|Overall Study||175
3122796|NCT01640925|3848183|FG000|COMPLETED|Overall Study||161
3122797|NCT01640925|3848184|FG001|COMPLETED|Overall Study||164
3122798|NCT01640925|3848183|FG000|NOT COMPLETED|Overall Study||14
3122799|NCT01640925|3848184|FG001|NOT COMPLETED|Overall Study||11
3295422|NCT02896400|4029409|FG003|COMPLETED|Biochemical Verification at 3 Months||14
3295423|NCT02896400|4029410|FG004|COMPLETED|Biochemical Verification at 3 Months||9
3295424|NCT02896400|4029411|FG005|COMPLETED|Biochemical Verification at 3 Months||11
3295425|NCT02896400|4029412|FG006|COMPLETED|Biochemical Verification at 3 Months||11
3295426|NCT02896400|4029413|FG007|COMPLETED|Biochemical Verification at 3 Months||14
3295427|NCT02896400|4029414|FG008|COMPLETED|Biochemical Verification at 3 Months||15
3295428|NCT02896400|4029415|FG009|COMPLETED|Biochemical Verification at 3 Months||8
3295429|NCT02896400|4029416|FG010|COMPLETED|Biochemical Verification at 3 Months||5
3295430|NCT02896400|4029417|FG011|COMPLETED|Biochemical Verification at 3 Months||19
3295431|NCT02896400|4029418|FG012|COMPLETED|Biochemical Verification at 3 Months||10
3295432|NCT02896400|4029419|FG013|COMPLETED|Biochemical Verification at 3 Months||12
3295433|NCT02896400|4029420|FG014|COMPLETED|Biochemical Verification at 3 Months||7
3295434|NCT02896400|4029421|FG015|COMPLETED|Biochemical Verification at 3 Months||6
3295435|NCT02896400|4029406|FG000|NOT COMPLETED|Biochemical Verification at 3 Months||46
3295436|NCT02896400|4029407|FG001|NOT COMPLETED|Biochemical Verification at 3 Months||48
3295437|NCT02896400|4029408|FG002|NOT COMPLETED|Biochemical Verification at 3 Months||47
3295438|NCT02896400|4029409|FG003|NOT COMPLETED|Biochemical Verification at 3 Months||41
3295439|NCT02896400|4029410|FG004|NOT COMPLETED|Biochemical Verification at 3 Months||45
3295440|NCT02896400|4029411|FG005|NOT COMPLETED|Biochemical Verification at 3 Months||49
3295441|NCT02896400|4029412|FG006|NOT COMPLETED|Biochemical Verification at 3 Months||51
3295442|NCT02896400|4029413|FG007|NOT COMPLETED|Biochemical Verification at 3 Months||49
3295443|NCT02896400|4029414|FG008|NOT COMPLETED|Biochemical Verification at 3 Months||45
3295444|NCT02896400|4029415|FG009|NOT COMPLETED|Biochemical Verification at 3 Months||53
3295445|NCT02896400|4029416|FG010|NOT COMPLETED|Biochemical Verification at 3 Months||55
3295446|NCT02896400|4029417|FG011|NOT COMPLETED|Biochemical Verification at 3 Months||41
3295447|NCT02896400|4029418|FG012|NOT COMPLETED|Biochemical Verification at 3 Months||53
3295448|NCT02896400|4029419|FG013|NOT COMPLETED|Biochemical Verification at 3 Months||48
3295449|NCT02896400|4029420|FG014|NOT COMPLETED|Biochemical Verification at 3 Months||55
3295450|NCT02896400|4029421|FG015|NOT COMPLETED|Biochemical Verification at 3 Months||57
3295451|NCT02896569|4029449|FG000|STARTED|Overall Study||25
3295452|NCT02896569|4029450|FG001|STARTED|Overall Study||24
3295453|NCT02896569|4029449|FG000|COMPLETED|Overall Study||21
3295454|NCT02896569|4029450|FG001|COMPLETED|Overall Study||19
3295455|NCT02896569|4029449|FG000|NOT COMPLETED|Overall Study||4
3295456|NCT02896569|4029450|FG001|NOT COMPLETED|Overall Study||5
3295457|NCT02896595|4029458|FG000|STARTED|Overall Study||50
3295458|NCT02896595|4029459|FG001|STARTED|Overall Study||50
3122800|NCT01640951|3848198|FG000|STARTED|Overall Study||77
3122801|NCT01640951|3848199|FG001|STARTED|Overall Study||75
3122802|NCT01640951|3848200|FG002|STARTED|Overall Study||168
3122803|NCT01640951|3848201|FG003|STARTED|Overall Study||55
3122804|NCT01640951|3848202|FG004|STARTED|Overall Study||95
3122805|NCT01640951|3848203|FG005|STARTED|Overall Study||60
3122806|NCT01640951|3848204|FG006|STARTED|Overall Study||112
3122807|NCT01640951|3848205|FG007|STARTED|Overall Study||33
3122808|NCT01640951|3848198|FG000|COMPLETED|Overall Study||31
3122809|NCT01640951|3848199|FG001|COMPLETED|Overall Study||60
3122810|NCT01640951|3848200|FG002|COMPLETED|Overall Study||126
3122811|NCT01640951|3848201|FG003|COMPLETED|Overall Study||10
3122812|NCT01640951|3848202|FG004|COMPLETED|Overall Study||82
3122813|NCT01640951|3848203|FG005|COMPLETED|Overall Study||13
3122814|NCT01640951|3848204|FG006|COMPLETED|Overall Study||94
3122815|NCT01640951|3848205|FG007|COMPLETED|Overall Study||17
3122816|NCT01640951|3848198|FG000|NOT COMPLETED|Overall Study||46
3122817|NCT01640951|3848199|FG001|NOT COMPLETED|Overall Study||15
3122818|NCT01640951|3848200|FG002|NOT COMPLETED|Overall Study||42
3122819|NCT01640951|3848201|FG003|NOT COMPLETED|Overall Study||45
3122820|NCT01640951|3848202|FG004|NOT COMPLETED|Overall Study||13
3122821|NCT01640951|3848203|FG005|NOT COMPLETED|Overall Study||47
3122822|NCT01640951|3848204|FG006|NOT COMPLETED|Overall Study||18
3122823|NCT01640951|3848205|FG007|NOT COMPLETED|Overall Study||16
3122824|NCT01640964|3848228|FG000|STARTED|Overall Study||20
3122825|NCT01640964|3848229|FG001|STARTED|Overall Study||20
3122826|NCT01640964|3848230|FG002|STARTED|Overall Study||6
3122827|NCT01640964|3848228|FG000|COMPLETED|Overall Study||19
3122828|NCT01640964|3848229|FG001|COMPLETED|Overall Study||19
3122829|NCT01640964|3848230|FG002|COMPLETED|Overall Study||3
3122830|NCT01640964|3848228|FG000|NOT COMPLETED|Overall Study||1
3122831|NCT01640964|3848229|FG001|NOT COMPLETED|Overall Study||1
3122832|NCT01640964|3848230|FG002|NOT COMPLETED|Overall Study||3
3122833|NCT01641042|3848241|FG000|STARTED|Overall Study||43
3122834|NCT01641042|3848242|FG001|STARTED|Overall Study||43
3122835|NCT01641042|3848241|FG000|COMPLETED|Overall Study||43
3122836|NCT01641042|3848242|FG001|COMPLETED|Overall Study||43
3122837|NCT01641042|3848241|FG000|NOT COMPLETED|Overall Study||0
3122838|NCT01641042|3848242|FG001|NOT COMPLETED|Overall Study||0
3122839|NCT01641081|3848248|FG000|STARTED|Period 1||18
3122840|NCT01641081|3848249|FG001|STARTED|Period 1||18
3122841|NCT01641081|3848250|FG002|STARTED|Period 1||15
3122842|NCT01641081|3848251|FG003|STARTED|Period 1||22
3295459|NCT02896595|4029458|FG000|COMPLETED|Overall Study||50
3295460|NCT02896595|4029459|FG001|COMPLETED|Overall Study||50
3295461|NCT02896595|4029458|FG000|NOT COMPLETED|Overall Study||0
3295462|NCT02896595|4029459|FG001|NOT COMPLETED|Overall Study||0
3295463|NCT02896907|4029465|FG000|STARTED|Overall Study||8
3295464|NCT02896907|4029465|FG000|COMPLETED|Overall Study||8
3295465|NCT02896907|4029465|FG000|NOT COMPLETED|Overall Study||0
3295466|NCT02897115|4029471|FG000|STARTED|Overall Study||14
3295467|NCT02897115|4029472|FG001|STARTED|Overall Study||8
3295468|NCT02897115|4029471|FG000|COMPLETED|Overall Study||3
3295469|NCT02897115|4029472|FG001|COMPLETED|Overall Study||0
3295470|NCT02897115|4029471|FG000|NOT COMPLETED|Overall Study||11
3295471|NCT02897115|4029472|FG001|NOT COMPLETED|Overall Study||8
3295472|NCT02897141|4029480|FG000|STARTED|Overall Study||40
3295473|NCT02897141|4029481|FG001|STARTED|Overall Study||40
3295474|NCT02897141|4029480|FG000|COMPLETED|Overall Study||38
3295475|NCT02897141|4029481|FG001|COMPLETED|Overall Study||39
3295476|NCT02897141|4029480|FG000|NOT COMPLETED|Overall Study||2
3295477|NCT02897141|4029481|FG001|NOT COMPLETED|Overall Study||1
3295478|NCT02897349|4029500|FG000|STARTED|Overall Study||102
3295479|NCT02897349|4029501|FG001|STARTED|Overall Study||104
3295480|NCT02897349|4029500|FG000|COMPLETED|Overall Study||97
3295481|NCT02897349|4029501|FG001|COMPLETED|Overall Study||98
3295482|NCT02897349|4029500|FG000|NOT COMPLETED|Overall Study||5
3295483|NCT02897349|4029501|FG001|NOT COMPLETED|Overall Study||6
3295484|NCT02898077|4029509|FG000|STARTED|Overall Study||294
3295485|NCT02898077|4029510|FG001|STARTED|Overall Study||146
3295486|NCT02898077|4029509|FG000|Received at Least 1 Dose of Study Drug|Overall Study||293
3295487|NCT02898077|4029510|FG001|Received at Least 1 Dose of Study Drug|Overall Study||145
3295488|NCT02898077|4029509|FG000|COMPLETED|Overall Study||199
3295489|NCT02898077|4029510|FG001|COMPLETED|Overall Study||116
3295490|NCT02898077|4029509|FG000|NOT COMPLETED|Overall Study||95
3295491|NCT02898077|4029510|FG001|NOT COMPLETED|Overall Study||30
3295492|NCT02898103|4029518|FG000|STARTED|Overall Study||4
3295493|NCT02898103|4029519|FG001|STARTED|Overall Study||3
3295494|NCT02898103|4029518|FG000|COMPLETED|Overall Study||4
3295495|NCT02898103|4029519|FG001|COMPLETED|Overall Study||3
3295496|NCT02898103|4029518|FG000|NOT COMPLETED|Overall Study||0
3295497|NCT02898103|4029519|FG001|NOT COMPLETED|Overall Study||0
3295498|NCT02898116|4029529|FG000|STARTED|Overall Study||2
3295499|NCT02898116|4029529|FG000|COMPLETED|Overall Study||0
3295500|NCT02898116|4029529|FG000|NOT COMPLETED|Overall Study||2
3295501|NCT02898259|4029538|FG000|STARTED|Overall Study||3
3295502|NCT02898259|4029539|FG001|STARTED|Overall Study||3
3122843|NCT01641081|3848252|FG004|STARTED|Period 1||17
3122844|NCT01641081|3848253|FG005|STARTED|Period 1||19
3295503|NCT02898259|4029540|FG002|STARTED|Overall Study||6
3295504|NCT02898259|4029541|FG003|STARTED|Overall Study||7
3295505|NCT02898259|4029542|FG004|STARTED|Overall Study||0
3295506|NCT02898259|4029538|FG000|COMPLETED|Overall Study||2
3295507|NCT02898259|4029539|FG001|COMPLETED|Overall Study||2
3295508|NCT02898259|4029540|FG002|COMPLETED|Overall Study||1
3295509|NCT02898259|4029541|FG003|COMPLETED|Overall Study||6
3295510|NCT02898259|4029542|FG004|COMPLETED|Overall Study||0
3295511|NCT02898259|4029538|FG000|NOT COMPLETED|Overall Study||1
3295512|NCT02898259|4029539|FG001|NOT COMPLETED|Overall Study||1
3122845|NCT01641081|3848254|FG006|STARTED|Period 1||19
3122846|NCT01641081|3848255|FG007|STARTED|Period 1||17
3122847|NCT01641081|3848256|FG008|STARTED|Period 1||15
3122848|NCT01641081|3848257|FG009|STARTED|Period 1||14
3122849|NCT01641081|3848248|FG000|COMPLETED|Period 1||17
3122850|NCT01641081|3848249|FG001|COMPLETED|Period 1||18
3122851|NCT01641081|3848250|FG002|COMPLETED|Period 1||15
3122852|NCT01641081|3848251|FG003|COMPLETED|Period 1||22
3122853|NCT01641081|3848252|FG004|COMPLETED|Period 1||16
3122854|NCT01641081|3848253|FG005|COMPLETED|Period 1||19
3122855|NCT01641081|3848254|FG006|COMPLETED|Period 1||18
3122856|NCT01641081|3848255|FG007|COMPLETED|Period 1||14
3122857|NCT01641081|3848256|FG008|COMPLETED|Period 1||15
3122858|NCT01641081|3848257|FG009|COMPLETED|Period 1||14
3122859|NCT01641081|3848248|FG000|NOT COMPLETED|Period 1||1
3122860|NCT01641081|3848249|FG001|NOT COMPLETED|Period 1||0
3122861|NCT01641081|3848250|FG002|NOT COMPLETED|Period 1||0
3122862|NCT01641081|3848251|FG003|NOT COMPLETED|Period 1||0
3122863|NCT01641081|3848252|FG004|NOT COMPLETED|Period 1||1
3122864|NCT01641081|3848253|FG005|NOT COMPLETED|Period 1||0
3122865|NCT01641081|3848254|FG006|NOT COMPLETED|Period 1||1
3122866|NCT01641081|3848255|FG007|NOT COMPLETED|Period 1||3
3122867|NCT01641081|3848256|FG008|NOT COMPLETED|Period 1||0
3122868|NCT01641081|3848257|FG009|NOT COMPLETED|Period 1||0
3122869|NCT01641081|3848248|FG000|STARTED|Period 2||17
3122870|NCT01641081|3848249|FG001|STARTED|Period 2||18
3122871|NCT01641081|3848250|FG002|STARTED|Period 2||15
3122872|NCT01641081|3848251|FG003|STARTED|Period 2||22
3122873|NCT01641081|3848252|FG004|STARTED|Period 2||16
3122874|NCT01641081|3848253|FG005|STARTED|Period 2||19
3122875|NCT01641081|3848254|FG006|STARTED|Period 2||18
3122876|NCT01641081|3848255|FG007|STARTED|Period 2||14
3122877|NCT01641081|3848256|FG008|STARTED|Period 2||15
3122878|NCT01641081|3848257|FG009|STARTED|Period 2||14
3122879|NCT01641081|3848248|FG000|COMPLETED|Period 2||16
3122880|NCT01641081|3848249|FG001|COMPLETED|Period 2||18
3122881|NCT01641081|3848250|FG002|COMPLETED|Period 2||15
3122882|NCT01641081|3848251|FG003|COMPLETED|Period 2||21
3122883|NCT01641081|3848252|FG004|COMPLETED|Period 2||16
3122884|NCT01641081|3848253|FG005|COMPLETED|Period 2||18
3122885|NCT01641081|3848254|FG006|COMPLETED|Period 2||16
3122886|NCT01641081|3848255|FG007|COMPLETED|Period 2||14
3122887|NCT01641081|3848256|FG008|COMPLETED|Period 2||15
3122888|NCT01641081|3848257|FG009|COMPLETED|Period 2||14
3122889|NCT01641081|3848248|FG000|NOT COMPLETED|Period 2||1
3122890|NCT01641081|3848249|FG001|NOT COMPLETED|Period 2||0
3122891|NCT01641081|3848250|FG002|NOT COMPLETED|Period 2||0
3122892|NCT01641081|3848251|FG003|NOT COMPLETED|Period 2||1
3122893|NCT01641081|3848252|FG004|NOT COMPLETED|Period 2||0
3122894|NCT01641081|3848253|FG005|NOT COMPLETED|Period 2||1
3122895|NCT01641081|3848254|FG006|NOT COMPLETED|Period 2||2
3122896|NCT01641081|3848255|FG007|NOT COMPLETED|Period 2||0
3122897|NCT01641081|3848256|FG008|NOT COMPLETED|Period 2||0
3122898|NCT01641081|3848257|FG009|NOT COMPLETED|Period 2||0
3122899|NCT01641081|3848248|FG000|STARTED|Period 3||16
3122900|NCT01641081|3848249|FG001|STARTED|Period 3||18
3122901|NCT01641081|3848250|FG002|STARTED|Period 3||15
3122902|NCT01641081|3848251|FG003|STARTED|Period 3||21
3122903|NCT01641081|3848252|FG004|STARTED|Period 3||16
3295513|NCT02898259|4029540|FG002|NOT COMPLETED|Overall Study||5
3295514|NCT02898259|4029541|FG003|NOT COMPLETED|Overall Study||1
3295515|NCT02898259|4029542|FG004|NOT COMPLETED|Overall Study||0
3295516|NCT02898454|4029553|FG000|STARTED|Overall Study||153
3295517|NCT02898454|4029554|FG001|STARTED|Overall Study||145
3295518|NCT02898454|4029555|FG002|STARTED|Overall Study||150
3295519|NCT02898454|4029553|FG000|Intent-to-Treat (ITT) Population|Overall Study||153
3295520|NCT02898454|4029554|FG001|Intent-to-Treat (ITT) Population|Overall Study||145
3295521|NCT02898454|4029555|FG002|Intent-to-Treat (ITT) Population|Overall Study||150
3295522|NCT02898454|4029553|FG000|Treated|Overall Study||152
3295523|NCT02898454|4029554|FG001|Treated|Overall Study||145
3295524|NCT02898454|4029555|FG002|Treated|Overall Study||150
3295525|NCT02898454|4029553|FG000|Safety Population|Overall Study|2 participants randomized to placebo received 1 dose of dupilumab:counted in 300 mg q2w then q4w arm|150
3295526|NCT02898454|4029554|FG001|Safety Population|Overall Study|1 randomized to dupilumab q2w arm received 1dose of placebo: counted in 300 mg q2w then q4w arm.|148
3295527|NCT02898454|4029555|FG002|Safety Population|Overall Study||149
3295528|NCT02898454|4029553|FG000|COMPLETED|Overall Study||136
3295529|NCT02898454|4029554|FG001|COMPLETED|Overall Study||140
3295530|NCT02898454|4029555|FG002|COMPLETED|Overall Study||144
3122904|NCT01641081|3848253|FG005|STARTED|Period 3||18
3122905|NCT01641081|3848254|FG006|STARTED|Period 3||16
3122906|NCT01641081|3848255|FG007|STARTED|Period 3||14
3122907|NCT01641081|3848256|FG008|STARTED|Period 3||15
3122908|NCT01641081|3848257|FG009|STARTED|Period 3||14
3122909|NCT01641081|3848248|FG000|COMPLETED|Period 3||16
3122910|NCT01641081|3848249|FG001|COMPLETED|Period 3||18
3122911|NCT01641081|3848250|FG002|COMPLETED|Period 3||14
3122912|NCT01641081|3848251|FG003|COMPLETED|Period 3||21
3122913|NCT01641081|3848252|FG004|COMPLETED|Period 3||16
3122914|NCT01641081|3848253|FG005|COMPLETED|Period 3||18
3122915|NCT01641081|3848254|FG006|COMPLETED|Period 3||16
3122916|NCT01641081|3848255|FG007|COMPLETED|Period 3||14
3122917|NCT01641081|3848256|FG008|COMPLETED|Period 3||14
3122918|NCT01641081|3848257|FG009|COMPLETED|Period 3||14
3122919|NCT01641081|3848248|FG000|NOT COMPLETED|Period 3||0
3122920|NCT01641081|3848249|FG001|NOT COMPLETED|Period 3||0
3122921|NCT01641081|3848250|FG002|NOT COMPLETED|Period 3||1
3122922|NCT01641081|3848251|FG003|NOT COMPLETED|Period 3||0
3122923|NCT01641081|3848252|FG004|NOT COMPLETED|Period 3||0
3122924|NCT01641081|3848253|FG005|NOT COMPLETED|Period 3||0
3122925|NCT01641081|3848254|FG006|NOT COMPLETED|Period 3||0
3122926|NCT01641081|3848255|FG007|NOT COMPLETED|Period 3||0
3122927|NCT01641081|3848256|FG008|NOT COMPLETED|Period 3||1
3122928|NCT01641081|3848257|FG009|NOT COMPLETED|Period 3||0
3122929|NCT01641081|3848248|FG000|STARTED|Period 4||16
3122930|NCT01641081|3848249|FG001|STARTED|Period 4||18
3122931|NCT01641081|3848250|FG002|STARTED|Period 4||14
3122932|NCT01641081|3848251|FG003|STARTED|Period 4||21
3122933|NCT01641081|3848252|FG004|STARTED|Period 4||16
3122934|NCT01641081|3848253|FG005|STARTED|Period 4||18
3122935|NCT01641081|3848254|FG006|STARTED|Period 4||16
3122936|NCT01641081|3848255|FG007|STARTED|Period 4||14
3122937|NCT01641081|3848256|FG008|STARTED|Period 4||14
3122938|NCT01641081|3848257|FG009|STARTED|Period 4||14
3122939|NCT01641081|3848248|FG000|COMPLETED|Period 4||16
3122940|NCT01641081|3848249|FG001|COMPLETED|Period 4||17
3122941|NCT01641081|3848250|FG002|COMPLETED|Period 4||14
3122942|NCT01641081|3848251|FG003|COMPLETED|Period 4||20
3122943|NCT01641081|3848252|FG004|COMPLETED|Period 4||16
3122944|NCT01641081|3848253|FG005|COMPLETED|Period 4||18
3122945|NCT01641081|3848254|FG006|COMPLETED|Period 4||16
3122946|NCT01641081|3848255|FG007|COMPLETED|Period 4||14
3122947|NCT01641081|3848256|FG008|COMPLETED|Period 4||14
3122948|NCT01641081|3848257|FG009|COMPLETED|Period 4||14
3122949|NCT01641081|3848248|FG000|NOT COMPLETED|Period 4||0
3122950|NCT01641081|3848249|FG001|NOT COMPLETED|Period 4||1
3122951|NCT01641081|3848250|FG002|NOT COMPLETED|Period 4||0
3122952|NCT01641081|3848251|FG003|NOT COMPLETED|Period 4||1
3122953|NCT01641081|3848252|FG004|NOT COMPLETED|Period 4||0
3122954|NCT01641081|3848253|FG005|NOT COMPLETED|Period 4||0
3122955|NCT01641081|3848254|FG006|NOT COMPLETED|Period 4||0
3122956|NCT01641081|3848255|FG007|NOT COMPLETED|Period 4||0
3122957|NCT01641081|3848256|FG008|NOT COMPLETED|Period 4||0
3122958|NCT01641081|3848257|FG009|NOT COMPLETED|Period 4||0
3122959|NCT01641081|3848248|FG000|STARTED|Period 5||16
3122960|NCT01641081|3848249|FG001|STARTED|Period 5||17
3122961|NCT01641081|3848250|FG002|STARTED|Period 5||14
3122962|NCT01641081|3848251|FG003|STARTED|Period 5||20
3122963|NCT01641081|3848252|FG004|STARTED|Period 5||16
3122964|NCT01641081|3848253|FG005|STARTED|Period 5||18
3122965|NCT01641081|3848254|FG006|STARTED|Period 5||16
3122966|NCT01641081|3848255|FG007|STARTED|Period 5||14
3122967|NCT01641081|3848256|FG008|STARTED|Period 5||14
3122968|NCT01641081|3848257|FG009|STARTED|Period 5||14
3122969|NCT01641081|3848248|FG000|COMPLETED|Period 5||16
3122970|NCT01641081|3848249|FG001|COMPLETED|Period 5||17
3122971|NCT01641081|3848250|FG002|COMPLETED|Period 5||12
3122972|NCT01641081|3848251|FG003|COMPLETED|Period 5||20
3122973|NCT01641081|3848252|FG004|COMPLETED|Period 5||16
3122974|NCT01641081|3848253|FG005|COMPLETED|Period 5||18
3122975|NCT01641081|3848254|FG006|COMPLETED|Period 5||16
3122976|NCT01641081|3848255|FG007|COMPLETED|Period 5||14
3122977|NCT01641081|3848256|FG008|COMPLETED|Period 5||14
3122978|NCT01641081|3848257|FG009|COMPLETED|Period 5||14
3122979|NCT01641081|3848248|FG000|NOT COMPLETED|Period 5||0
3122980|NCT01641081|3848249|FG001|NOT COMPLETED|Period 5||0
3122981|NCT01641081|3848250|FG002|NOT COMPLETED|Period 5||2
3122982|NCT01641081|3848251|FG003|NOT COMPLETED|Period 5||0
3122983|NCT01641081|3848252|FG004|NOT COMPLETED|Period 5||0
3122984|NCT01641081|3848253|FG005|NOT COMPLETED|Period 5||0
3122985|NCT01641081|3848254|FG006|NOT COMPLETED|Period 5||0
3122986|NCT01641081|3848255|FG007|NOT COMPLETED|Period 5||0
3122987|NCT01641081|3848256|FG008|NOT COMPLETED|Period 5||0
3122988|NCT01641081|3848257|FG009|NOT COMPLETED|Period 5||0
3122989|NCT01641120|3848269|FG000|STARTED|25 Gauge Needle Weeks 1, 4, 5||20
3122990|NCT01641120|3848269|FG000|COMPLETED|25 Gauge Needle Weeks 1, 4, 5||20
3122991|NCT01641120|3848269|FG000|NOT COMPLETED|25 Gauge Needle Weeks 1, 4, 5||0
3122992|NCT01641120|3848269|FG000|STARTED|30 Gauge Needle Weeks 2 and 3||20
3122993|NCT01641120|3848269|FG000|COMPLETED|30 Gauge Needle Weeks 2 and 3||20
3122994|NCT01641120|3848269|FG000|NOT COMPLETED|30 Gauge Needle Weeks 2 and 3||0
3122995|NCT01641133|3848279|FG000|STARTED|Overall Study||97
3122996|NCT01641133|3848280|FG001|STARTED|Overall Study||99
3122997|NCT01641133|3848281|FG002|STARTED|Overall Study||98
3122998|NCT01641133|3848279|FG000|COMPLETED|Overall Study||87
3122999|NCT01641133|3848280|FG001|COMPLETED|Overall Study||90
3123000|NCT01641133|3848281|FG002|COMPLETED|Overall Study||90
3123001|NCT01641133|3848279|FG000|NOT COMPLETED|Overall Study||10
3123002|NCT01641133|3848280|FG001|NOT COMPLETED|Overall Study||9
3123003|NCT01641133|3848281|FG002|NOT COMPLETED|Overall Study||8
3123004|NCT01641159|3848291|FG000|STARTED|Overall Study||35
3123005|NCT01641159|3848292|FG001|STARTED|Overall Study||27
3123006|NCT01641159|3848291|FG000|COMPLETED|Overall Study||33
3123007|NCT01641159|3848292|FG001|COMPLETED|Overall Study||25
3123008|NCT01641159|3848291|FG000|NOT COMPLETED|Overall Study||2
3123009|NCT01641159|3848292|FG001|NOT COMPLETED|Overall Study||2
3123010|NCT01641198|3848301|FG000|STARTED|After 12 Months of Function||20
3123011|NCT01641198|3848302|FG001|STARTED|After 12 Months of Function||19
3123012|NCT01641198|3848303|FG002|STARTED|After 12 Months of Function||19
3123013|NCT01641198|3848301|FG000|COMPLETED|After 12 Months of Function|Participants: 3 interval violation, 1 protocol violation. Implants: 13 bone loss not measurable|16
3123014|NCT01641198|3848302|FG001|COMPLETED|After 12 Months of Function|Participants: 2 interval violation, 1 adverse event. Implants: 3 bone loss not measurable|16
3123015|NCT01641198|3848303|FG002|COMPLETED|After 12 Months of Function|Participants: 2 interval violation. Implants: 3 bone loss not measurable|17
3123016|NCT01641198|3848301|FG000|NOT COMPLETED|After 12 Months of Function||4
3123017|NCT01641198|3848302|FG001|NOT COMPLETED|After 12 Months of Function||3
3123018|NCT01641198|3848303|FG002|NOT COMPLETED|After 12 Months of Function||2
3123019|NCT01641198|3848301|FG000|STARTED|After 24 Months of Function||16
3123020|NCT01641198|3848302|FG001|STARTED|After 24 Months of Function||16
3123021|NCT01641198|3848303|FG002|STARTED|After 24 Months of Function||17
3123022|NCT01641198|3848301|FG000|COMPLETED|After 24 Months of Function|Participants: 4 interval violation. Implants: 3 bone loss not measurable|12
3123023|NCT01641198|3848302|FG001|COMPLETED|After 24 Months of Function|Participants: 9 interval violation|7
3123024|NCT01641198|3848303|FG002|COMPLETED|After 24 Months of Function|Participants: 6 interval violation. Implants: 2 bone loss not measurable|11
3123025|NCT01641198|3848301|FG000|NOT COMPLETED|After 24 Months of Function||4
3123026|NCT01641198|3848302|FG001|NOT COMPLETED|After 24 Months of Function||9
3123027|NCT01641198|3848303|FG002|NOT COMPLETED|After 24 Months of Function||6
3123028|NCT01641198|3848301|FG000|STARTED|At 15-20 Years of Function||12
3123029|NCT01641198|3848302|FG001|STARTED|At 15-20 Years of Function||7
3123030|NCT01641198|3848303|FG002|STARTED|At 15-20 Years of Function||11
3123031|NCT01641198|3848301|FG000|COMPLETED|At 15-20 Years of Function|Participants: 5 interval violation, 1 death|6
3123032|NCT01641198|3848302|FG001|COMPLETED|At 15-20 Years of Function|Participants: 1 interval violation|6
3123033|NCT01641198|3848303|FG002|COMPLETED|At 15-20 Years of Function|Participants: 1 interval violation, 1 death|9
3123034|NCT01641198|3848301|FG000|NOT COMPLETED|At 15-20 Years of Function||6
3123035|NCT01641198|3848302|FG001|NOT COMPLETED|At 15-20 Years of Function||1
3123036|NCT01641198|3848303|FG002|NOT COMPLETED|At 15-20 Years of Function||2
3123037|NCT01641237|3848312|FG000|STARTED|Period I||16
3123038|NCT01641237|3848313|FG001|STARTED|Period I||16
3123039|NCT01641237|3848314|FG002|STARTED|Period I||15
3123040|NCT01641237|3848315|FG003|STARTED|Period I||15
3123041|NCT01641237|3848312|FG000|COMPLETED|Period I||16
3123042|NCT01641237|3848313|FG001|COMPLETED|Period I||16
3123043|NCT01641237|3848314|FG002|COMPLETED|Period I||15
3123044|NCT01641237|3848315|FG003|COMPLETED|Period I||15
3123045|NCT01641237|3848312|FG000|NOT COMPLETED|Period I||0
3123046|NCT01641237|3848313|FG001|NOT COMPLETED|Period I||0
3123047|NCT01641237|3848314|FG002|NOT COMPLETED|Period I||0
3123048|NCT01641237|3848315|FG003|NOT COMPLETED|Period I||0
3123049|NCT01641237|3848312|FG000|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|15
3123050|NCT01641237|3848313|FG001|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|16
3123051|NCT01641237|3848314|FG002|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|16
3295531|NCT02898454|4029553|FG000|NOT COMPLETED|Overall Study||17
3295532|NCT02898454|4029554|FG001|NOT COMPLETED|Overall Study||5
3295533|NCT02898454|4029555|FG002|NOT COMPLETED|Overall Study||6
3295534|NCT02898597|4029570|FG000|STARTED|Overall Study||25
3295535|NCT02898597|4029571|FG001|STARTED|Overall Study||24
3295536|NCT02898597|4029570|FG000|COMPLETED|Overall Study||21
3295537|NCT02898597|4029571|FG001|COMPLETED|Overall Study||12
3295538|NCT02898597|4029570|FG000|NOT COMPLETED|Overall Study||4
3123052|NCT01641237|3848315|FG003|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|15
3123053|NCT01641237|3848312|FG000|COMPLETED|Period II||14
3123054|NCT01641237|3848313|FG001|COMPLETED|Period II||16
3123055|NCT01641237|3848314|FG002|COMPLETED|Period II||16
3123056|NCT01641237|3848315|FG003|COMPLETED|Period II||15
3123057|NCT01641237|3848312|FG000|NOT COMPLETED|Period II||1
3123058|NCT01641237|3848313|FG001|NOT COMPLETED|Period II||0
3123059|NCT01641237|3848314|FG002|NOT COMPLETED|Period II||0
3123060|NCT01641237|3848315|FG003|NOT COMPLETED|Period II||0
3123061|NCT01641237|3848312|FG000|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|16
3123062|NCT01641237|3848313|FG001|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|14
3123063|NCT01641237|3848314|FG002|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|15
3295539|NCT02898597|4029571|FG001|NOT COMPLETED|Overall Study||12
3295540|NCT02898662|4029579|FG000|STARTED|Overall Study||40
3295541|NCT02898662|4029580|FG001|STARTED|Overall Study||41
3295542|NCT02898662|4029579|FG000|Completed Treatment|Overall Study||25
3295543|NCT02898662|4029580|FG001|Completed Treatment|Overall Study||29
3295544|NCT02898662|4029579|FG000|COMPLETED|Overall Study||11
3295545|NCT02898662|4029580|FG001|COMPLETED|Overall Study||13
3295546|NCT02898662|4029579|FG000|NOT COMPLETED|Overall Study||29
3295547|NCT02898662|4029580|FG001|NOT COMPLETED|Overall Study||28
3295548|NCT02898740|4029588|FG000|STARTED|Overall Study||21
3295549|NCT02898740|4029589|FG001|STARTED|Overall Study||19
3295550|NCT02898740|4029588|FG000|COMPLETED|Overall Study||21
3295551|NCT02898740|4029589|FG001|COMPLETED|Overall Study||19
3295552|NCT02898740|4029588|FG000|NOT COMPLETED|Overall Study||0
3295553|NCT02898740|4029589|FG001|NOT COMPLETED|Overall Study||0
3295554|NCT02898974|4029597|FG000|STARTED|Overall Study||13
3295555|NCT02898974|4029598|FG001|STARTED|Overall Study||9
3295556|NCT02898974|4029597|FG000|COMPLETED|Overall Study||13
3295557|NCT02898974|4029598|FG001|COMPLETED|Overall Study||9
3295558|NCT02898974|4029597|FG000|NOT COMPLETED|Overall Study||0
3295559|NCT02898974|4029598|FG001|NOT COMPLETED|Overall Study||0
3295560|NCT02899156|4029606|FG000|STARTED|Overall Study||11
3295561|NCT02899156|4029607|FG001|STARTED|Overall Study||11
3295562|NCT02899156|4029606|FG000|COMPLETED|Overall Study||10
3123064|NCT01641237|3848315|FG003|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|16
3123065|NCT01641237|3848312|FG000|COMPLETED|Period III||15
3123066|NCT01641237|3848313|FG001|COMPLETED|Period III||14
3123067|NCT01641237|3848314|FG002|COMPLETED|Period III||15
3123068|NCT01641237|3848315|FG003|COMPLETED|Period III||16
3123069|NCT01641237|3848312|FG000|NOT COMPLETED|Period III||1
3123070|NCT01641237|3848313|FG001|NOT COMPLETED|Period III||0
3123071|NCT01641237|3848314|FG002|NOT COMPLETED|Period III||0
3123072|NCT01641237|3848315|FG003|NOT COMPLETED|Period III||0
3123073|NCT01641237|3848312|FG000|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|15
3123074|NCT01641237|3848313|FG001|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|15
3123075|NCT01641237|3848314|FG002|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|15
3123076|NCT01641237|3848315|FG003|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|15
3123077|NCT01641237|3848312|FG000|COMPLETED|Period IV||15
3123078|NCT01641237|3848313|FG001|COMPLETED|Period IV||15
3123079|NCT01641237|3848314|FG002|COMPLETED|Period IV||15
3123080|NCT01641237|3848315|FG003|COMPLETED|Period IV||15
3123081|NCT01641237|3848312|FG000|NOT COMPLETED|Period IV||0
3123082|NCT01641237|3848313|FG001|NOT COMPLETED|Period IV||0
3123083|NCT01641237|3848314|FG002|NOT COMPLETED|Period IV||0
3123084|NCT01641237|3848315|FG003|NOT COMPLETED|Period IV||0
3136230|NCT01711294|3861329|FG001|COMPLETED|Overall Study||65
3136231|NCT01711294|3861330|FG002|COMPLETED|Overall Study||64
3136232|NCT01711294|3861328|FG000|NOT COMPLETED|Overall Study||0
3136233|NCT01711294|3861329|FG001|NOT COMPLETED|Overall Study||0
3136234|NCT01711294|3861330|FG002|NOT COMPLETED|Overall Study||0
3136235|NCT01711359|3861341|FG000|STARTED|Treatment Period||213
3136236|NCT01711359|3861342|FG001|STARTED|Treatment Period||160
3136237|NCT01711359|3861343|FG002|STARTED|Treatment Period||215
3136238|NCT01711359|3861341|FG000|Received at Least One Dose of Study Drug|Treatment Period||210
3136239|NCT01711359|3861342|FG001|Received at Least One Dose of Study Drug|Treatment Period||159
3136240|NCT01711359|3861343|FG002|Received at Least One Dose of Study Drug|Treatment Period||215
3136241|NCT01711359|3861341|FG000|Rescued|Treatment Period||26
3136242|NCT01711359|3861342|FG001|Rescued|Treatment Period||7
3136243|NCT01711359|3861343|FG002|Rescued|Treatment Period||6
3136244|NCT01711359|3861341|FG000|COMPLETED|Treatment Period||161
3136245|NCT01711359|3861342|FG001|COMPLETED|Treatment Period||136
3136246|NCT01711359|3861343|FG002|COMPLETED|Treatment Period||173
3136247|NCT01711359|3861341|FG000|NOT COMPLETED|Treatment Period||52
3136248|NCT01711359|3861342|FG001|NOT COMPLETED|Treatment Period||24
3136249|NCT01711359|3861343|FG002|NOT COMPLETED|Treatment Period||42
3136250|NCT01711359|3861341|FG000|STARTED|Follow Up|Participants from treatment who entered the post-treatment follow-up period.|25
3136251|NCT01711359|3861342|FG001|STARTED|Follow Up|Participants from treatment who entered the post-treatment follow-up period.|15
3136252|NCT01711359|3861343|FG002|STARTED|Follow Up|Participants from treatment and rescue who entered the post-treatment follow-up period.|28
3136253|NCT01711359|3861341|FG000|COMPLETED|Follow Up||0
3136254|NCT01711359|3861342|FG001|COMPLETED|Follow Up||0
3136255|NCT01711359|3861343|FG002|COMPLETED|Follow Up||0
3136256|NCT01711359|3861341|FG000|NOT COMPLETED|Follow Up||25
3136257|NCT01711359|3861342|FG001|NOT COMPLETED|Follow Up||15
3136258|NCT01711359|3861343|FG002|NOT COMPLETED|Follow Up||28
3136259|NCT01711372|3861358|FG000|STARTED|Overall Study||66
3136260|NCT01711372|3861359|FG001|STARTED|Overall Study||47
3136261|NCT01711372|3861358|FG000|COMPLETED|Overall Study||66
3136262|NCT01711372|3861359|FG001|COMPLETED|Overall Study||47
3136263|NCT01711372|3861358|FG000|NOT COMPLETED|Overall Study||0
3136264|NCT01711372|3861359|FG001|NOT COMPLETED|Overall Study||0
3136265|NCT01711424|3861364|FG000|STARTED|Overall Study||1209
3136266|NCT01711424|3861364|FG000|COMPLETED|Overall Study||1209
3136267|NCT01711424|3861364|FG000|NOT COMPLETED|Overall Study||0
3136268|NCT01711619|3861370|FG000|STARTED|Overall Study||56
3136269|NCT01711619|3861371|FG001|STARTED|Overall Study||60
3136270|NCT01711619|3861370|FG000|COMPLETED|Overall Study||38
3136271|NCT01711619|3861371|FG001|COMPLETED|Overall Study||36
3136272|NCT01711619|3861370|FG000|NOT COMPLETED|Overall Study||18
3136273|NCT01711619|3861371|FG001|NOT COMPLETED|Overall Study||24
3136274|NCT01711645|3861377|FG000|STARTED|Overall Study||55
3136275|NCT01711645|3861377|FG000|COMPLETED|Overall Study||36
3136276|NCT01711645|3861377|FG000|NOT COMPLETED|Overall Study||19
3136277|NCT01711658|3861383|FG000|STARTED|Overall Study||64
3136278|NCT01711658|3861384|FG001|STARTED|Overall Study||63
3136279|NCT01711658|3861383|FG000|Participants Who Started Protocol Treatment|Overall Study||59
3136280|NCT01711658|3861384|FG001|Participants Who Started Protocol Treatment|Overall Study||60
3136281|NCT01711658|3861383|FG000|COMPLETED|Overall Study||64
3136282|NCT01711658|3861384|FG001|COMPLETED|Overall Study||63
3136283|NCT01711658|3861383|FG000|NOT COMPLETED|Overall Study||0
3136284|NCT01711658|3861384|FG001|NOT COMPLETED|Overall Study||0
3136285|NCT01711736|3861392|FG000|STARTED|Overall Study||299
3136286|NCT01711736|3861393|FG001|STARTED|Overall Study||302
3136287|NCT01711736|3861392|FG000|COMPLETED|Overall Study|Up to Day 180|287
3136288|NCT01711736|3861393|FG001|COMPLETED|Overall Study|Up to Day 180|294
3136289|NCT01711736|3861392|FG000|NOT COMPLETED|Overall Study||12
3136290|NCT01711736|3861393|FG001|NOT COMPLETED|Overall Study||8
3136291|NCT01711853|3861400|FG000|STARTED|Overall Study||19
3136292|NCT01711853|3861400|FG000|COMPLETED|Overall Study||16
3136293|NCT01711853|3861400|FG000|NOT COMPLETED|Overall Study||3
3136294|NCT01711866|3861404|FG000|STARTED|Overall Study||87
3123085|NCT01641367|3848331|FG000|STARTED|Cohorts||287
3123086|NCT01641367|3848332|FG001|STARTED|Cohorts||74
3123087|NCT01641367|3848333|FG002|STARTED|Cohorts||72
3123088|NCT01641367|3848334|FG003|STARTED|Cohorts||8
3123089|NCT01641367|3848335|FG004|STARTED|Cohorts||70
3123090|NCT01641367|3848336|FG005|STARTED|Cohorts||34
3123091|NCT01641367|3848337|FG006|STARTED|Cohorts||0
3123092|NCT01641367|3848338|FG007|STARTED|Cohorts||0
3123093|NCT01641367|3848331|FG000|Followed 72 Weeks on Step 1/2|Cohorts||211
3123094|NCT01641367|3848332|FG001|Followed 72 Weeks on Step 1/2|Cohorts||60
3123095|NCT01641367|3848333|FG002|Followed 72 Weeks on Step 1/2|Cohorts||60
3123096|NCT01641367|3848334|FG003|Followed 72 Weeks on Step 1/2|Cohorts||6
3123097|NCT01641367|3848335|FG004|Followed 72 Weeks on Step 1/2|Cohorts||52
3123098|NCT01641367|3848336|FG005|Followed 72 Weeks on Step 1/2|Cohorts||30
3123099|NCT01641367|3848337|FG006|Followed 72 Weeks on Step 1/2|Cohorts||0
3123100|NCT01641367|3848338|FG007|Followed 72 Weeks on Step 1/2|Cohorts||0
3123101|NCT01641367|3848331|FG000|COMPLETED|Cohorts||253
3123102|NCT01641367|3848332|FG001|COMPLETED|Cohorts||73
3123103|NCT01641367|3848333|FG002|COMPLETED|Cohorts||68
3123104|NCT01641367|3848334|FG003|COMPLETED|Cohorts||8
3123105|NCT01641367|3848335|FG004|COMPLETED|Cohorts||67
3123106|NCT01641367|3848336|FG005|COMPLETED|Cohorts||33
3123107|NCT01641367|3848337|FG006|COMPLETED|Cohorts||0
3123108|NCT01641367|3848338|FG007|COMPLETED|Cohorts||0
3123109|NCT01641367|3848331|FG000|NOT COMPLETED|Cohorts||34
3123110|NCT01641367|3848332|FG001|NOT COMPLETED|Cohorts||1
3163228|NCT01884519|3890707|FG001|COMPLETED|Overall Study||60
3163229|NCT01884519|3890706|FG000|NOT COMPLETED|Overall Study||0
3295563|NCT02899156|4029607|FG001|COMPLETED|Overall Study||10
3295564|NCT02899156|4029606|FG000|NOT COMPLETED|Overall Study||1
3295565|NCT02899156|4029607|FG001|NOT COMPLETED|Overall Study||1
3295566|NCT02899195|4029613|FG000|STARTED|Concurrent Durvalumab||55
3295567|NCT02899195|4029613|FG000|COMPLETED|Concurrent Durvalumab||44
3295568|NCT02899195|4029613|FG000|NOT COMPLETED|Concurrent Durvalumab||11
3295569|NCT02899195|4029613|FG000|STARTED|Maintenance Durvalumab||44
3295570|NCT02899195|4029613|FG000|COMPLETED|Maintenance Durvalumab||10
3163230|NCT01884519|3890707|FG001|NOT COMPLETED|Overall Study||0
3163231|NCT01884545|3890725|FG000|STARTED|Overall Study||50
3163232|NCT01884545|3890726|FG001|STARTED|Overall Study||49
3163233|NCT01884545|3890727|FG002|STARTED|Overall Study||49
3295571|NCT02899195|4029613|FG000|NOT COMPLETED|Maintenance Durvalumab||34
3295584|NCT02899338|4029628|FG000|STARTED|Overall Study||81
3295585|NCT02899338|4029629|FG001|STARTED|Overall Study||81
3295586|NCT02899338|4029628|FG000|COMPLETED|Overall Study||78
3295587|NCT02899338|4029629|FG001|COMPLETED|Overall Study||79
3295588|NCT02899338|4029628|FG000|NOT COMPLETED|Overall Study||3
3295589|NCT02899338|4029629|FG001|NOT COMPLETED|Overall Study||2
3295590|NCT02899377|4029637|FG000|STARTED|Overall Study||13
3295591|NCT02899377|4029638|FG001|STARTED|Overall Study||12
3295592|NCT02899377|4029637|FG000|COMPLETED|Overall Study||12
3295593|NCT02899377|4029638|FG001|COMPLETED|Overall Study||12
3295594|NCT02899377|4029637|FG000|NOT COMPLETED|Overall Study||1
3295595|NCT02899377|4029638|FG001|NOT COMPLETED|Overall Study||0
3295596|NCT02899650|4029649|FG000|STARTED|Overall Study||15
3295597|NCT02899650|4029650|FG001|STARTED|Overall Study||10
3295598|NCT02899650|4029651|FG002|STARTED|Overall Study||14
3295599|NCT02899650|4029652|FG003|STARTED|Overall Study|We were not able to recruit older unfit adults so this group was dropped from the study.|0
3295600|NCT02899650|4029649|FG000|COMPLETED|Overall Study||15
3295601|NCT02899650|4029650|FG001|COMPLETED|Overall Study||10
3295602|NCT02899650|4029651|FG002|COMPLETED|Overall Study||14
3295603|NCT02899650|4029652|FG003|COMPLETED|Overall Study||0
3295604|NCT02899650|4029649|FG000|NOT COMPLETED|Overall Study||0
3295605|NCT02899650|4029650|FG001|NOT COMPLETED|Overall Study||0
3295606|NCT02899650|4029651|FG002|NOT COMPLETED|Overall Study||0
3295607|NCT02899650|4029652|FG003|NOT COMPLETED|Overall Study||0
3295608|NCT02899689|4029663|FG000|STARTED|Overall Study||209
3295609|NCT02899689|4029664|FG001|STARTED|Overall Study||210
3295610|NCT02899689|4029663|FG000|COMPLETED|Overall Study||209
3295611|NCT02899689|4029664|FG001|COMPLETED|Overall Study||208
3295612|NCT02899689|4029663|FG000|NOT COMPLETED|Overall Study||0
3295613|NCT02899689|4029664|FG001|NOT COMPLETED|Overall Study||2
3295614|NCT02899884|4029670|FG000|STARTED|Overall Study||3765
3295615|NCT02899884|4029670|FG000|COMPLETED|Overall Study||3765
3295616|NCT02899884|4029670|FG000|NOT COMPLETED|Overall Study||0
3295617|NCT02899962|4029674|FG000|STARTED|Open-label Phase||650
3295618|NCT02899962|4029675|FG001|STARTED|Open-label Phase||0
3295619|NCT02899962|4029676|FG002|STARTED|Open-label Phase||0
3123111|NCT01641367|3848333|FG002|NOT COMPLETED|Cohorts||4
3123112|NCT01641367|3848334|FG003|NOT COMPLETED|Cohorts||0
3163234|NCT01884545|3890728|FG003|STARTED|Overall Study||52
3295620|NCT02899962|4029674|FG000|COMPLETED|Open-label Phase||623
3123113|NCT01641367|3848335|FG004|NOT COMPLETED|Cohorts||3
3123114|NCT01641367|3848336|FG005|NOT COMPLETED|Cohorts||1
3123115|NCT01641367|3848337|FG006|NOT COMPLETED|Cohorts||0
3123116|NCT01641367|3848338|FG007|NOT COMPLETED|Cohorts||0
3123117|NCT01641367|3848331|FG000|STARTED|Randomized Adherence Intervention||0
3123118|NCT01641367|3848332|FG001|STARTED|Randomized Adherence Intervention||0
3123119|NCT01641367|3848333|FG002|STARTED|Randomized Adherence Intervention||0
3123120|NCT01641367|3848334|FG003|STARTED|Randomized Adherence Intervention||0
3123121|NCT01641367|3848335|FG004|STARTED|Randomized Adherence Intervention||0
3123122|NCT01641367|3848336|FG005|STARTED|Randomized Adherence Intervention||0
3123123|NCT01641367|3848337|FG006|STARTED|Randomized Adherence Intervention||257
3123124|NCT01641367|3848338|FG007|STARTED|Randomized Adherence Intervention||264
3123125|NCT01641367|3848331|FG000|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||0
3123126|NCT01641367|3848332|FG001|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||0
3123127|NCT01641367|3848333|FG002|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||0
3123128|NCT01641367|3848334|FG003|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||0
3123129|NCT01641367|3848335|FG004|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||0
3123130|NCT01641367|3848336|FG005|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||0
3123131|NCT01641367|3848337|FG006|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||196
3123132|NCT01641367|3848338|FG007|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||202
3123133|NCT01641367|3848331|FG000|COMPLETED|Randomized Adherence Intervention||0
3123134|NCT01641367|3848332|FG001|COMPLETED|Randomized Adherence Intervention||0
3123135|NCT01641367|3848333|FG002|COMPLETED|Randomized Adherence Intervention||0
3123136|NCT01641367|3848334|FG003|COMPLETED|Randomized Adherence Intervention||0
3123137|NCT01641367|3848335|FG004|COMPLETED|Randomized Adherence Intervention||0
3123138|NCT01641367|3848336|FG005|COMPLETED|Randomized Adherence Intervention||0
3123139|NCT01641367|3848337|FG006|COMPLETED|Randomized Adherence Intervention||238
3123140|NCT01641367|3848338|FG007|COMPLETED|Randomized Adherence Intervention||240
3123141|NCT01641367|3848331|FG000|NOT COMPLETED|Randomized Adherence Intervention||0
3123142|NCT01641367|3848332|FG001|NOT COMPLETED|Randomized Adherence Intervention||0
3123143|NCT01641367|3848333|FG002|NOT COMPLETED|Randomized Adherence Intervention||0
3123144|NCT01641367|3848334|FG003|NOT COMPLETED|Randomized Adherence Intervention||0
3123145|NCT01641367|3848335|FG004|NOT COMPLETED|Randomized Adherence Intervention||0
3123146|NCT01641367|3848336|FG005|NOT COMPLETED|Randomized Adherence Intervention||0
3123147|NCT01641367|3848337|FG006|NOT COMPLETED|Randomized Adherence Intervention||19
3123148|NCT01641367|3848338|FG007|NOT COMPLETED|Randomized Adherence Intervention||24
3123149|NCT01641380|3848363|FG000|STARTED|First Injection Cycle||50
3123150|NCT01641380|3848364|FG001|STARTED|First Injection Cycle||50
3123151|NCT01641380|3848363|FG000|COMPLETED|First Injection Cycle||43
3123152|NCT01641380|3848364|FG001|COMPLETED|First Injection Cycle||44
3123153|NCT01641380|3848363|FG000|NOT COMPLETED|First Injection Cycle||7
3123154|NCT01641380|3848364|FG001|NOT COMPLETED|First Injection Cycle||6
3123155|NCT01641380|3848363|FG000|STARTED|Second Injection Cycle||43
3123156|NCT01641380|3848364|FG001|STARTED|Second Injection Cycle||44
3123157|NCT01641380|3848363|FG000|COMPLETED|Second Injection Cycle||39
3123158|NCT01641380|3848364|FG001|COMPLETED|Second Injection Cycle||38
3123159|NCT01641380|3848363|FG000|NOT COMPLETED|Second Injection Cycle||4
3123160|NCT01641380|3848364|FG001|NOT COMPLETED|Second Injection Cycle||6
3123161|NCT01641380|3848363|FG000|STARTED|Third Injection Cycle||39
3123162|NCT01641380|3848364|FG001|STARTED|Third Injection Cycle||38
3123163|NCT01641380|3848363|FG000|COMPLETED|Third Injection Cycle||36
3123164|NCT01641380|3848364|FG001|COMPLETED|Third Injection Cycle||33
3123165|NCT01641380|3848363|FG000|NOT COMPLETED|Third Injection Cycle||3
3123166|NCT01641380|3848364|FG001|NOT COMPLETED|Third Injection Cycle||5
3123167|NCT01641445|3848373|FG000|STARTED|Overall Study||41
3123168|NCT01641445|3848374|FG001|STARTED|Overall Study||41
3123169|NCT01641445|3848373|FG000|COMPLETED|Overall Study||31
3123170|NCT01641445|3848374|FG001|COMPLETED|Overall Study||36
3123171|NCT01641445|3848373|FG000|NOT COMPLETED|Overall Study||10
3123172|NCT01641445|3848374|FG001|NOT COMPLETED|Overall Study||5
3123173|NCT01641471|3848382|FG000|STARTED|Overall Study||58
3123174|NCT01641471|3848383|FG001|STARTED|Overall Study||58
3123175|NCT01641471|3848382|FG000|COMPLETED|Overall Study||35
3123176|NCT01641471|3848383|FG001|COMPLETED|Overall Study||31
3123177|NCT01641471|3848382|FG000|NOT COMPLETED|Overall Study||23
3123178|NCT01641471|3848383|FG001|NOT COMPLETED|Overall Study||27
3123179|NCT01641640|3848389|FG000|STARTED|Overall Study||328
3123180|NCT01641640|3848389|FG000|Enrolled and Treated|Overall Study||327
3123181|NCT01641640|3848389|FG000|COMPLETED|Overall Study||292
3123182|NCT01641640|3848389|FG000|NOT COMPLETED|Overall Study||36
3123183|NCT01641653|3848395|FG000|STARTED|Overall Study||30
3123184|NCT01641653|3848396|FG001|STARTED|Overall Study||30
3123185|NCT01641653|3848395|FG000|COMPLETED|Overall Study||30
3123186|NCT01641653|3848396|FG001|COMPLETED|Overall Study||30
3123187|NCT01641653|3848395|FG000|NOT COMPLETED|Overall Study||0
3123188|NCT01641653|3848396|FG001|NOT COMPLETED|Overall Study||0
3123189|NCT01641692|3848405|FG000|STARTED|Treatment Period 1||42
3123190|NCT01641692|3848406|FG001|STARTED|Treatment Period 1||45
3123191|NCT01641692|3848407|FG002|STARTED|Treatment Period 1||51
3123192|NCT01641692|3848408|FG003|STARTED|Treatment Period 1||41
3123193|NCT01641692|3848409|FG004|STARTED|Treatment Period 1||43
3123194|NCT01641692|3848410|FG005|STARTED|Treatment Period 1||39
3123195|NCT01641692|3848411|FG006|STARTED|Treatment Period 1||38
3123196|NCT01641692|3848412|FG007|STARTED|Treatment Period 1||51
3123197|NCT01641692|3848405|FG000|COMPLETED|Treatment Period 1||40
3123198|NCT01641692|3848406|FG001|COMPLETED|Treatment Period 1||45
3123199|NCT01641692|3848407|FG002|COMPLETED|Treatment Period 1||50
3123200|NCT01641692|3848408|FG003|COMPLETED|Treatment Period 1||41
3123201|NCT01641692|3848409|FG004|COMPLETED|Treatment Period 1||39
3123202|NCT01641692|3848410|FG005|COMPLETED|Treatment Period 1||37
3123203|NCT01641692|3848411|FG006|COMPLETED|Treatment Period 1||38
3123204|NCT01641692|3848412|FG007|COMPLETED|Treatment Period 1||48
3123205|NCT01641692|3848405|FG000|NOT COMPLETED|Treatment Period 1||2
3123206|NCT01641692|3848406|FG001|NOT COMPLETED|Treatment Period 1||0
3123207|NCT01641692|3848407|FG002|NOT COMPLETED|Treatment Period 1||1
3123208|NCT01641692|3848408|FG003|NOT COMPLETED|Treatment Period 1||0
3123209|NCT01641692|3848409|FG004|NOT COMPLETED|Treatment Period 1||4
3123210|NCT01641692|3848410|FG005|NOT COMPLETED|Treatment Period 1||2
3123211|NCT01641692|3848411|FG006|NOT COMPLETED|Treatment Period 1||0
3123212|NCT01641692|3848412|FG007|NOT COMPLETED|Treatment Period 1||3
3123213|NCT01641692|3848405|FG000|STARTED|Washout Period 1 (12-14 Days)||40
3123214|NCT01641692|3848406|FG001|STARTED|Washout Period 1 (12-14 Days)||45
3123215|NCT01641692|3848407|FG002|STARTED|Washout Period 1 (12-14 Days)||50
3123216|NCT01641692|3848408|FG003|STARTED|Washout Period 1 (12-14 Days)||41
3123217|NCT01641692|3848409|FG004|STARTED|Washout Period 1 (12-14 Days)||39
3123218|NCT01641692|3848410|FG005|STARTED|Washout Period 1 (12-14 Days)||37
3123219|NCT01641692|3848411|FG006|STARTED|Washout Period 1 (12-14 Days)||38
3123220|NCT01641692|3848412|FG007|STARTED|Washout Period 1 (12-14 Days)||48
3123221|NCT01641692|3848405|FG000|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|36
3123222|NCT01641692|3848406|FG001|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|44
3123223|NCT01641692|3848407|FG002|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|47
3123224|NCT01641692|3848408|FG003|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|39
3123225|NCT01641692|3848409|FG004|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|35
3123226|NCT01641692|3848410|FG005|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|37
3123227|NCT01641692|3848411|FG006|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|36
3123228|NCT01641692|3848412|FG007|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|47
3123229|NCT01641692|3848405|FG000|NOT COMPLETED|Washout Period 1 (12-14 Days)||4
3123230|NCT01641692|3848406|FG001|NOT COMPLETED|Washout Period 1 (12-14 Days)||1
3123231|NCT01641692|3848407|FG002|NOT COMPLETED|Washout Period 1 (12-14 Days)||3
3123232|NCT01641692|3848408|FG003|NOT COMPLETED|Washout Period 1 (12-14 Days)||2
3123233|NCT01641692|3848409|FG004|NOT COMPLETED|Washout Period 1 (12-14 Days)||4
3123234|NCT01641692|3848410|FG005|NOT COMPLETED|Washout Period 1 (12-14 Days)||0
3123235|NCT01641692|3848411|FG006|NOT COMPLETED|Washout Period 1 (12-14 Days)||2
3123236|NCT01641692|3848412|FG007|NOT COMPLETED|Washout Period 1 (12-14 Days)||1
3123237|NCT01641692|3848405|FG000|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|33
3123238|NCT01641692|3848406|FG001|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|46
3123239|NCT01641692|3848407|FG002|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|40
3123240|NCT01641692|3848408|FG003|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|41
3123241|NCT01641692|3848409|FG004|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|37
3123242|NCT01641692|3848410|FG005|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|45
3123243|NCT01641692|3848411|FG006|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|43
3123244|NCT01641692|3848412|FG007|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|36
3123245|NCT01641692|3848405|FG000|COMPLETED|Treatment Period 2||30
3123246|NCT01641692|3848406|FG001|COMPLETED|Treatment Period 2||46
3123247|NCT01641692|3848407|FG002|COMPLETED|Treatment Period 2||40
3123248|NCT01641692|3848408|FG003|COMPLETED|Treatment Period 2||41
3123249|NCT01641692|3848409|FG004|COMPLETED|Treatment Period 2||37
3123250|NCT01641692|3848410|FG005|COMPLETED|Treatment Period 2||43
3123251|NCT01641692|3848411|FG006|COMPLETED|Treatment Period 2||43
3123252|NCT01641692|3848412|FG007|COMPLETED|Treatment Period 2||35
3123253|NCT01641692|3848405|FG000|NOT COMPLETED|Treatment Period 2||3
3123254|NCT01641692|3848406|FG001|NOT COMPLETED|Treatment Period 2||0
3123255|NCT01641692|3848407|FG002|NOT COMPLETED|Treatment Period 2||0
3123256|NCT01641692|3848408|FG003|NOT COMPLETED|Treatment Period 2||0
3123257|NCT01641692|3848409|FG004|NOT COMPLETED|Treatment Period 2||0
3123258|NCT01641692|3848410|FG005|NOT COMPLETED|Treatment Period 2||2
3123259|NCT01641692|3848411|FG006|NOT COMPLETED|Treatment Period 2||0
3123260|NCT01641692|3848412|FG007|NOT COMPLETED|Treatment Period 2||1
3123261|NCT01641692|3848405|FG000|STARTED|Washout Period 2 (12-14 Days)||30
3123262|NCT01641692|3848406|FG001|STARTED|Washout Period 2 (12-14 Days)||46
3123263|NCT01641692|3848407|FG002|STARTED|Washout Period 2 (12-14 Days)||40
3123264|NCT01641692|3848408|FG003|STARTED|Washout Period 2 (12-14 Days)||41
3123265|NCT01641692|3848409|FG004|STARTED|Washout Period 2 (12-14 Days)||37
3123266|NCT01641692|3848410|FG005|STARTED|Washout Period 2 (12-14 Days)||43
3123267|NCT01641692|3848411|FG006|STARTED|Washout Period 2 (12-14 Days)||43
3123268|NCT01641692|3848412|FG007|STARTED|Washout Period 2 (12-14 Days)||35
3123269|NCT01641692|3848405|FG000|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|30
3123270|NCT01641692|3848406|FG001|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|46
3123271|NCT01641692|3848407|FG002|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|39
3123272|NCT01641692|3848408|FG003|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|41
3123273|NCT01641692|3848409|FG004|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|34
3123274|NCT01641692|3848410|FG005|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|42
3123275|NCT01641692|3848411|FG006|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|42
3123276|NCT01641692|3848412|FG007|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|34
3123277|NCT01641692|3848405|FG000|NOT COMPLETED|Washout Period 2 (12-14 Days)||0
3123278|NCT01641692|3848406|FG001|NOT COMPLETED|Washout Period 2 (12-14 Days)||0
3123279|NCT01641692|3848407|FG002|NOT COMPLETED|Washout Period 2 (12-14 Days)||1
3123280|NCT01641692|3848408|FG003|NOT COMPLETED|Washout Period 2 (12-14 Days)||0
3123281|NCT01641692|3848409|FG004|NOT COMPLETED|Washout Period 2 (12-14 Days)||3
3123282|NCT01641692|3848410|FG005|NOT COMPLETED|Washout Period 2 (12-14 Days)||1
3123283|NCT01641692|3848411|FG006|NOT COMPLETED|Washout Period 2 (12-14 Days)||1
3123284|NCT01641692|3848412|FG007|NOT COMPLETED|Washout Period 2 (12-14 Days)||1
3123285|NCT01641692|3848405|FG000|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|43
3123286|NCT01641692|3848406|FG001|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|33
3123287|NCT01641692|3848407|FG002|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|38
3123288|NCT01641692|3848408|FG003|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|42
3123289|NCT01641692|3848409|FG004|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|40
3123290|NCT01641692|3848410|FG005|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|39
3123291|NCT01641692|3848411|FG006|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|35
3123292|NCT01641692|3848412|FG007|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|38
3123293|NCT01641692|3848405|FG000|COMPLETED|Treatment Period 3||43
3123294|NCT01641692|3848406|FG001|COMPLETED|Treatment Period 3||32
3123295|NCT01641692|3848407|FG002|COMPLETED|Treatment Period 3||37
3123296|NCT01641692|3848408|FG003|COMPLETED|Treatment Period 3||42
3123297|NCT01641692|3848409|FG004|COMPLETED|Treatment Period 3||40
3123298|NCT01641692|3848410|FG005|COMPLETED|Treatment Period 3||39
3123299|NCT01641692|3848411|FG006|COMPLETED|Treatment Period 3||33
3123300|NCT01641692|3848412|FG007|COMPLETED|Treatment Period 3||38
3123301|NCT01641692|3848405|FG000|NOT COMPLETED|Treatment Period 3||0
3123302|NCT01641692|3848406|FG001|NOT COMPLETED|Treatment Period 3||1
3123303|NCT01641692|3848407|FG002|NOT COMPLETED|Treatment Period 3||1
3123304|NCT01641692|3848408|FG003|NOT COMPLETED|Treatment Period 3||0
3123305|NCT01641692|3848409|FG004|NOT COMPLETED|Treatment Period 3||0
3123306|NCT01641692|3848410|FG005|NOT COMPLETED|Treatment Period 3||0
3123307|NCT01641692|3848411|FG006|NOT COMPLETED|Treatment Period 3||2
3123308|NCT01641692|3848412|FG007|NOT COMPLETED|Treatment Period 3||0
3123309|NCT01641692|3848405|FG000|STARTED|Washout Period 3 or Follow-up||43
3123310|NCT01641692|3848406|FG001|STARTED|Washout Period 3 or Follow-up||32
3123311|NCT01641692|3848407|FG002|STARTED|Washout Period 3 or Follow-up||37
3123312|NCT01641692|3848408|FG003|STARTED|Washout Period 3 or Follow-up||42
3123313|NCT01641692|3848409|FG004|STARTED|Washout Period 3 or Follow-up||40
3123314|NCT01641692|3848410|FG005|STARTED|Washout Period 3 or Follow-up||39
3123315|NCT01641692|3848411|FG006|STARTED|Washout Period 3 or Follow-up||33
3123316|NCT01641692|3848412|FG007|STARTED|Washout Period 3 or Follow-up||38
3123317|NCT01641692|3848405|FG000|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|42
3123318|NCT01641692|3848406|FG001|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|32
3123319|NCT01641692|3848407|FG002|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|36
3123320|NCT01641692|3848408|FG003|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|41
3123321|NCT01641692|3848409|FG004|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|40
3123322|NCT01641692|3848410|FG005|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|37
3123323|NCT01641692|3848411|FG006|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|32
3136295|NCT01711866|3861404|FG000|COMPLETED|Overall Study||79
3123324|NCT01641692|3848412|FG007|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|38
3123325|NCT01641692|3848405|FG000|NOT COMPLETED|Washout Period 3 or Follow-up||1
3123326|NCT01641692|3848406|FG001|NOT COMPLETED|Washout Period 3 or Follow-up||0
3123327|NCT01641692|3848407|FG002|NOT COMPLETED|Washout Period 3 or Follow-up||1
3123328|NCT01641692|3848408|FG003|NOT COMPLETED|Washout Period 3 or Follow-up||1
3123329|NCT01641692|3848409|FG004|NOT COMPLETED|Washout Period 3 or Follow-up||0
3123330|NCT01641692|3848410|FG005|NOT COMPLETED|Washout Period 3 or Follow-up||2
3123331|NCT01641692|3848411|FG006|NOT COMPLETED|Washout Period 3 or Follow-up||1
3123332|NCT01641692|3848412|FG007|NOT COMPLETED|Washout Period 3 or Follow-up||0
3123333|NCT01641809|3848435|FG000|STARTED|Induction Phase (Day 1 to Week 24)||60
3123334|NCT01641809|3848436|FG001|STARTED|Induction Phase (Day 1 to Week 24)||60
3123335|NCT01641809|3848437|FG002|STARTED|Induction Phase (Day 1 to Week 24)||61
3123336|NCT01641809|3848438|FG003|STARTED|Induction Phase (Day 1 to Week 24)||62
3123337|NCT01641809|3848435|FG000|COMPLETED|Induction Phase (Day 1 to Week 24)||52
3123338|NCT01641809|3848436|FG001|COMPLETED|Induction Phase (Day 1 to Week 24)||53
3123339|NCT01641809|3848437|FG002|COMPLETED|Induction Phase (Day 1 to Week 24)||55
3123340|NCT01641809|3848438|FG003|COMPLETED|Induction Phase (Day 1 to Week 24)||47
3123341|NCT01641809|3848435|FG000|NOT COMPLETED|Induction Phase (Day 1 to Week 24)||8
3123342|NCT01641809|3848436|FG001|NOT COMPLETED|Induction Phase (Day 1 to Week 24)||7
3123343|NCT01641809|3848437|FG002|NOT COMPLETED|Induction Phase (Day 1 to Week 24)||6
3123344|NCT01641809|3848438|FG003|NOT COMPLETED|Induction Phase (Day 1 to Week 24)||15
3123345|NCT01641809|3848435|FG000|STARTED|Maintenance Phase (Week 24 to Week 96)||52
3123346|NCT01641809|3848436|FG001|STARTED|Maintenance Phase (Week 24 to Week 96)||53
3123347|NCT01641809|3848437|FG002|STARTED|Maintenance Phase (Week 24 to Week 96)||55
3123348|NCT01641809|3848438|FG003|STARTED|Maintenance Phase (Week 24 to Week 96)||47
3123349|NCT01641809|3848435|FG000|COMPLETED|Maintenance Phase (Week 24 to Week 96)||46
3123350|NCT01641809|3848436|FG001|COMPLETED|Maintenance Phase (Week 24 to Week 96)||48
3123351|NCT01641809|3848437|FG002|COMPLETED|Maintenance Phase (Week 24 to Week 96)||52
3123352|NCT01641809|3848438|FG003|COMPLETED|Maintenance Phase (Week 24 to Week 96)||41
3123353|NCT01641809|3848435|FG000|NOT COMPLETED|Maintenance Phase (Week 24 to Week 96)||6
3123354|NCT01641809|3848436|FG001|NOT COMPLETED|Maintenance Phase (Week 24 to Week 96)||5
3136296|NCT01711866|3861404|FG000|NOT COMPLETED|Overall Study||8
3163235|NCT01884545|3890725|FG000|COMPLETED|Overall Study||37
3163236|NCT01884545|3890726|FG001|COMPLETED|Overall Study||31
3163237|NCT01884545|3890727|FG002|COMPLETED|Overall Study||35
3163238|NCT01884545|3890728|FG003|COMPLETED|Overall Study||43
3163239|NCT01884545|3890725|FG000|NOT COMPLETED|Overall Study||13
3163240|NCT01884545|3890726|FG001|NOT COMPLETED|Overall Study||18
3163241|NCT01884545|3890727|FG002|NOT COMPLETED|Overall Study||14
3163242|NCT01884545|3890728|FG003|NOT COMPLETED|Overall Study||9
3163243|NCT01884571|3890738|FG000|STARTED|Overall Study||31
3163244|NCT01884571|3890738|FG000|COMPLETED|Overall Study||23
3163245|NCT01884571|3890738|FG000|NOT COMPLETED|Overall Study||8
3163246|NCT01884597|3890745|FG000|STARTED|Overall Study||5
3295621|NCT02899962|4029675|FG001|COMPLETED|Open-label Phase||0
3163247|NCT01884597|3890746|FG001|STARTED|Overall Study||3
3163248|NCT01884597|3890747|FG002|STARTED|Overall Study||16
3163249|NCT01884597|3890745|FG000|COMPLETED|Overall Study||4
3163250|NCT01884597|3890746|FG001|COMPLETED|Overall Study||2
3163251|NCT01884597|3890747|FG002|COMPLETED|Overall Study||15
3163252|NCT01884597|3890745|FG000|NOT COMPLETED|Overall Study||1
3163253|NCT01884597|3890746|FG001|NOT COMPLETED|Overall Study||1
3163254|NCT01884597|3890747|FG002|NOT COMPLETED|Overall Study||1
3163255|NCT01884675|3890763|FG000|STARTED|Overall Study||16
3163256|NCT01884675|3890764|FG001|STARTED|Overall Study||17
3163257|NCT01884675|3890763|FG000|COMPLETED|Overall Study||13
3163258|NCT01884675|3890764|FG001|COMPLETED|Overall Study||15
3163259|NCT01884675|3890763|FG000|NOT COMPLETED|Overall Study||3
3163260|NCT01884675|3890764|FG001|NOT COMPLETED|Overall Study||2
3163261|NCT01884688|3890772|FG000|STARTED|Overall Study||3
3163262|NCT01884688|3890772|FG000|COMPLETED|Overall Study||1
3163263|NCT01884688|3890772|FG000|NOT COMPLETED|Overall Study||2
3163264|NCT01884844|3890778|FG000|STARTED|Overall Study||16
3163265|NCT01884844|3890779|FG001|STARTED|Overall Study||17
3163266|NCT01884844|3890778|FG000|COMPLETED|Overall Study||13
3163267|NCT01884844|3890779|FG001|COMPLETED|Overall Study||12
3163268|NCT01884844|3890778|FG000|NOT COMPLETED|Overall Study||3
3163269|NCT01884844|3890779|FG001|NOT COMPLETED|Overall Study||5
3163270|NCT01885000|3890787|FG000|STARTED|Overall Study||48
3163271|NCT01885000|3890788|FG001|STARTED|Overall Study||44
3163272|NCT01885000|3890787|FG000|COMPLETED|Overall Study||46
3163273|NCT01885000|3890788|FG001|COMPLETED|Overall Study||42
3163274|NCT01885000|3890787|FG000|NOT COMPLETED|Overall Study||2
3163275|NCT01885000|3890788|FG001|NOT COMPLETED|Overall Study||2
3163276|NCT01885104|3890796|FG000|STARTED|Overall Study||31
3163277|NCT01885104|3890797|FG001|STARTED|Overall Study||34
3163278|NCT01885104|3890796|FG000|COMPLETED|Overall Study||29
3163279|NCT01885104|3890797|FG001|COMPLETED|Overall Study||33
3163280|NCT01885104|3890796|FG000|NOT COMPLETED|Overall Study||2
3163281|NCT01885104|3890797|FG001|NOT COMPLETED|Overall Study||1
3163282|NCT01885117|3890805|FG000|STARTED|Overall Study||61
3163283|NCT01885117|3890806|FG001|STARTED|Overall Study||64
3163284|NCT01885117|3890805|FG000|COMPLETED|Overall Study||61
3295622|NCT02899962|4029676|FG002|COMPLETED|Open-label Phase||0
3123355|NCT01641809|3848437|FG002|NOT COMPLETED|Maintenance Phase (Week 24 to Week 96)||3
3123356|NCT01641809|3848438|FG003|NOT COMPLETED|Maintenance Phase (Week 24 to Week 96)||6
3123357|NCT01641809|3848435|FG000|STARTED|Open-label (Week 96 to Week 324)||46
3123358|NCT01641809|3848436|FG001|STARTED|Open-label (Week 96 to Week 324)|1 participant completed study as per protocol at Week 96 and opted to not enter open-label phase|47
3123359|NCT01641809|3848437|FG002|STARTED|Open-label (Week 96 to Week 324)|1 participant completed study as per protocol at Week 96 and opted to not enter open-label phase|51
3123360|NCT01641809|3848438|FG003|STARTED|Open-label (Week 96 to Week 324)|Participants completed study at Week 96 and did not enter open-label phase|0
3123361|NCT01641809|3848435|FG000|COMPLETED|Open-label (Week 96 to Week 324)||30
3123362|NCT01641809|3848436|FG001|COMPLETED|Open-label (Week 96 to Week 324)||35
3123363|NCT01641809|3848437|FG002|COMPLETED|Open-label (Week 96 to Week 324)||43
3123364|NCT01641809|3848438|FG003|COMPLETED|Open-label (Week 96 to Week 324)||0
3123365|NCT01641809|3848435|FG000|NOT COMPLETED|Open-label (Week 96 to Week 324)||16
3123366|NCT01641809|3848436|FG001|NOT COMPLETED|Open-label (Week 96 to Week 324)||12
3123367|NCT01641809|3848437|FG002|NOT COMPLETED|Open-label (Week 96 to Week 324)||8
3123368|NCT01641809|3848438|FG003|NOT COMPLETED|Open-label (Week 96 to Week 324)||0
3123369|NCT01641822|3848458|FG000|STARTED|Run-in Phase||107
3123370|NCT01641822|3848459|FG001|STARTED|Run-in Phase||0
3123371|NCT01641822|3848460|FG002|STARTED|Run-in Phase||0
3123372|NCT01641822|3848458|FG000|COMPLETED|Run-in Phase|3 participants who completed the TIS Run-In Phase did not continue to the Comparative Phase.|93
3123373|NCT01641822|3848459|FG001|COMPLETED|Run-in Phase||0
3123374|NCT01641822|3848460|FG002|COMPLETED|Run-in Phase||0
3123375|NCT01641822|3848458|FG000|NOT COMPLETED|Run-in Phase||14
3123376|NCT01641822|3848459|FG001|NOT COMPLETED|Run-in Phase||0
3123377|NCT01641822|3848460|FG002|NOT COMPLETED|Run-in Phase||0
3123378|NCT01641822|3848458|FG000|STARTED|Comparative Phase|Participants continuing into the Comparative Phase were randomized to the AZLI or Placebo group.|0
3123379|NCT01641822|3848459|FG001|STARTED|Comparative Phase||43
3123380|NCT01641822|3848460|FG002|STARTED|Comparative Phase||47
3123381|NCT01641822|3848458|FG000|Received Randomized Study Drug Treatment|Comparative Phase||0
3123382|NCT01641822|3848459|FG001|Received Randomized Study Drug Treatment|Comparative Phase||42
3123383|NCT01641822|3848460|FG002|Received Randomized Study Drug Treatment|Comparative Phase||46
3123384|NCT01641822|3848458|FG000|COMPLETED|Comparative Phase||0
3123385|NCT01641822|3848459|FG001|COMPLETED|Comparative Phase||37
3123386|NCT01641822|3848460|FG002|COMPLETED|Comparative Phase||37
3123387|NCT01641822|3848458|FG000|NOT COMPLETED|Comparative Phase||0
3123388|NCT01641822|3848459|FG001|NOT COMPLETED|Comparative Phase||6
3123389|NCT01641822|3848460|FG002|NOT COMPLETED|Comparative Phase||10
3123390|NCT01641835|3848467|FG000|STARTED|Overall Study||303
3123391|NCT01641835|3848467|FG000|COMPLETED|Overall Study||303
3123392|NCT01641835|3848467|FG000|NOT COMPLETED|Overall Study||0
3123393|NCT01641861|3848473|FG000|STARTED|Overall Study||246
3123394|NCT01641861|3848474|FG001|STARTED|Overall Study||242
3123395|NCT01641861|3848473|FG000|COMPLETED|Overall Study||211
3123396|NCT01641861|3848474|FG001|COMPLETED|Overall Study||217
3123397|NCT01641861|3848473|FG000|NOT COMPLETED|Overall Study||35
3123398|NCT01641861|3848474|FG001|NOT COMPLETED|Overall Study||25
3123399|NCT01641900|3848482|FG000|STARTED|Overall Study||28
3123400|NCT01641900|3848483|FG001|STARTED|Overall Study||31
3123401|NCT01641900|3848482|FG000|Completed Placebo Intervention|Overall Study|n=1,assigned to placebo intervention first, completed the session and dropped out of the study.|27
3123402|NCT01641900|3848483|FG001|Completed Placebo Intervention|Overall Study|n=2,both assigned to placebo intervention first, completed the session and dropped out of the study.|29
3123403|NCT01641900|3848482|FG000|Completed Drug Intervention|Overall Study|n=1,assigned to drug intervention first, completed the session and dropped out of the study.|26
3123404|NCT01641900|3848483|FG001|Completed Drug Intervention|Overall Study||29
3123405|NCT01641900|3848482|FG000|COMPLETED|Overall Study||26
3123406|NCT01641900|3848483|FG001|COMPLETED|Overall Study||29
3123407|NCT01641900|3848482|FG000|NOT COMPLETED|Overall Study||2
3123408|NCT01641900|3848483|FG001|NOT COMPLETED|Overall Study||2
3123409|NCT01641926|3848495|FG000|STARTED|Overall Study||143
3123410|NCT01641926|3848496|FG001|STARTED|Overall Study||145
3123411|NCT01641926|3848497|FG002|STARTED|Overall Study||57
3123412|NCT01641926|3848498|FG003|STARTED|Overall Study||57
3123413|NCT01641926|3848495|FG000|Treated (All Participants as Treated)|Overall Study||142
3123414|NCT01641926|3848496|FG001|Treated (All Participants as Treated)|Overall Study||144
3123415|NCT01641926|3848497|FG002|Treated (All Participants as Treated)|Overall Study||56
3123416|NCT01641926|3848498|FG003|Treated (All Participants as Treated)|Overall Study||57
3123417|NCT01641926|3848495|FG000|COMPLETED|Overall Study||115
3123418|NCT01641926|3848496|FG001|COMPLETED|Overall Study||130
3123419|NCT01641926|3848497|FG002|COMPLETED|Overall Study||46
3123420|NCT01641926|3848498|FG003|COMPLETED|Overall Study||53
3123421|NCT01641926|3848495|FG000|NOT COMPLETED|Overall Study||28
3123422|NCT01641926|3848496|FG001|NOT COMPLETED|Overall Study||15
3123423|NCT01641926|3848497|FG002|NOT COMPLETED|Overall Study||11
3123424|NCT01641926|3848498|FG003|NOT COMPLETED|Overall Study||4
3123425|NCT01641939|3848511|FG000|STARTED|Overall Study||117
3123426|NCT01641939|3848512|FG001|STARTED|Overall Study||228
3123427|NCT01641939|3848513|FG002|STARTED|Overall Study||70
3123428|NCT01641939|3848511|FG000|Stage 1|Overall Study||37
3123429|NCT01641939|3848512|FG001|Stage 1|Overall Study||75
3123430|NCT01641939|3848513|FG002|Stage 1|Overall Study||70
3123431|NCT01641939|3848511|FG000|Stage 2|Overall Study||80
3123432|NCT01641939|3848512|FG001|Stage 2|Overall Study||153
3123433|NCT01641939|3848513|FG002|Stage 2|Overall Study||0
3123434|NCT01641939|3848511|FG000|COMPLETED|Overall Study||0
3123435|NCT01641939|3848512|FG001|COMPLETED|Overall Study||0
3123436|NCT01641939|3848513|FG002|COMPLETED|Overall Study||0
3123437|NCT01641939|3848511|FG000|NOT COMPLETED|Overall Study||117
3123438|NCT01641939|3848512|FG001|NOT COMPLETED|Overall Study||228
3123439|NCT01641939|3848513|FG002|NOT COMPLETED|Overall Study||70
3123440|NCT01641952|3848523|FG000|STARTED|Overall Study||505
3123441|NCT01641952|3848523|FG000|Treated|Overall Study||504
3123442|NCT01641952|3848523|FG000|COMPLETED|Overall Study||471
3123443|NCT01641952|3848523|FG000|NOT COMPLETED|Overall Study||34
3123444|NCT01641978|3848527|FG000|STARTED|Overall Study||125
3123445|NCT01641978|3848527|FG000|COMPLETED|Overall Study||125
3123446|NCT01641978|3848527|FG000|NOT COMPLETED|Overall Study||0
3123447|NCT01641991|3848539|FG000|STARTED|Overall Study||82
3123448|NCT01641991|3848540|FG001|STARTED|Overall Study||82
3123449|NCT01641991|3848541|FG002|STARTED|Overall Study||82
3123450|NCT01641991|3848542|FG003|STARTED|Overall Study||82
3123451|NCT01641991|3848539|FG000|COMPLETED|Overall Study||73
3123452|NCT01641991|3848540|FG001|COMPLETED|Overall Study||74
3123453|NCT01641991|3848541|FG002|COMPLETED|Overall Study||65
3123454|NCT01641991|3848542|FG003|COMPLETED|Overall Study||66
3123455|NCT01641991|3848539|FG000|NOT COMPLETED|Overall Study||9
3123456|NCT01641991|3848540|FG001|NOT COMPLETED|Overall Study||8
3123457|NCT01641991|3848541|FG002|NOT COMPLETED|Overall Study||17
3123458|NCT01641991|3848542|FG003|NOT COMPLETED|Overall Study||16
3123459|NCT01642056|3848557|FG000|STARTED|First Intervention||10
3123460|NCT01642056|3848558|FG001|STARTED|First Intervention||10
3123461|NCT01642056|3848557|FG000|COMPLETED|First Intervention||9
3123462|NCT01642056|3848558|FG001|COMPLETED|First Intervention||10
3123463|NCT01642056|3848557|FG000|NOT COMPLETED|First Intervention||1
3123464|NCT01642056|3848558|FG001|NOT COMPLETED|First Intervention||0
3123465|NCT01642056|3848557|FG000|STARTED|Second Intervention||9
3123466|NCT01642056|3848558|FG001|STARTED|Second Intervention||10
3123467|NCT01642056|3848557|FG000|COMPLETED|Second Intervention||8
3123468|NCT01642056|3848558|FG001|COMPLETED|Second Intervention||8
3123469|NCT01642056|3848557|FG000|NOT COMPLETED|Second Intervention||1
3123470|NCT01642056|3848558|FG001|NOT COMPLETED|Second Intervention||2
3123471|NCT01642082|3848564|FG000|STARTED|Overall Study||28
3123472|NCT01642082|3848564|FG000|COMPLETED|Overall Study||28
3123473|NCT01642082|3848564|FG000|NOT COMPLETED|Overall Study||0
3123474|NCT01642147|3848577|FG000|STARTED|Overall Study||30
3123475|NCT01642147|3848578|FG001|STARTED|Overall Study||30
3123476|NCT01642147|3848577|FG000|COMPLETED|Overall Study||30
3123477|NCT01642147|3848578|FG001|COMPLETED|Overall Study||30
3123478|NCT01642147|3848577|FG000|NOT COMPLETED|Overall Study||0
3123479|NCT01642147|3848578|FG001|NOT COMPLETED|Overall Study||0
3123480|NCT01642212|3848586|FG000|STARTED|Single-blind Baseline||119
3123481|NCT01642212|3848587|FG001|STARTED|Single-blind Baseline||0
3163285|NCT01885117|3890806|FG001|COMPLETED|Overall Study||64
3163286|NCT01885117|3890805|FG000|NOT COMPLETED|Overall Study||0
3163287|NCT01885117|3890806|FG001|NOT COMPLETED|Overall Study||0
3163288|NCT01885182|3890814|FG000|STARTED|Overall Study||117
3295623|NCT02899962|4029674|FG000|NOT COMPLETED|Open-label Phase||27
3295624|NCT02899962|4029675|FG001|NOT COMPLETED|Open-label Phase||0
3295625|NCT02899962|4029676|FG002|NOT COMPLETED|Open-label Phase||0
3295626|NCT02899962|4029674|FG000|STARTED|Maintenance Phase||0
3295627|NCT02899962|4029675|FG001|STARTED|Maintenance Phase||272
3295628|NCT02899962|4029676|FG002|STARTED|Maintenance Phase||273
3295629|NCT02899962|4029674|FG000|COMPLETED|Maintenance Phase||0
3295630|NCT02899962|4029675|FG001|COMPLETED|Maintenance Phase||131
3295631|NCT02899962|4029676|FG002|COMPLETED|Maintenance Phase||120
3295632|NCT02899962|4029674|FG000|NOT COMPLETED|Maintenance Phase||0
3295633|NCT02899962|4029675|FG001|NOT COMPLETED|Maintenance Phase||141
3295634|NCT02899962|4029676|FG002|NOT COMPLETED|Maintenance Phase||153
3295635|NCT02899988|4029687|FG000|STARTED|Induction Period (16 Weeks)||52
3295636|NCT02899988|4029688|FG001|STARTED|Induction Period (16 Weeks)||51
3295637|NCT02899988|4029689|FG002|STARTED|Induction Period (16 Weeks)||51
3295638|NCT02899988|4029690|FG003|STARTED|Induction Period (16 Weeks)||51
3295639|NCT02899988|4029691|FG004|STARTED|Induction Period (16 Weeks)||0
3295640|NCT02899988|4029692|FG005|STARTED|Induction Period (16 Weeks)||0
3295641|NCT02899988|4029693|FG006|STARTED|Induction Period (16 Weeks)||0
3295642|NCT02899988|4029694|FG007|STARTED|Induction Period (16 Weeks)||0
3295643|NCT02899988|4029695|FG008|STARTED|Induction Period (16 Weeks)||0
3295644|NCT02899988|4029696|FG009|STARTED|Induction Period (16 Weeks)||0
3295645|NCT02899988|4029697|FG010|STARTED|Induction Period (16 Weeks)||0
3295646|NCT02899988|4029687|FG000|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||52
3295647|NCT02899988|4029688|FG001|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||51
3295648|NCT02899988|4029689|FG002|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||51
3295649|NCT02899988|4029690|FG003|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||51
3295650|NCT02899988|4029691|FG004|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
3295651|NCT02899988|4029692|FG005|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
3295652|NCT02899988|4029693|FG006|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
3295653|NCT02899988|4029694|FG007|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
3295654|NCT02899988|4029695|FG008|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
3163289|NCT01885182|3890815|FG001|STARTED|Overall Study||115
3123482|NCT01642212|3848588|FG002|STARTED|Single-blind Baseline||0
3123483|NCT01642212|3848589|FG003|STARTED|Single-blind Baseline||0
3123484|NCT01642212|3848590|FG004|STARTED|Single-blind Baseline||0
3123485|NCT01642212|3848586|FG000|COMPLETED|Single-blind Baseline||93
3123486|NCT01642212|3848587|FG001|COMPLETED|Single-blind Baseline||0
3123487|NCT01642212|3848588|FG002|COMPLETED|Single-blind Baseline||0
3123488|NCT01642212|3848589|FG003|COMPLETED|Single-blind Baseline||0
3123489|NCT01642212|3848590|FG004|COMPLETED|Single-blind Baseline||0
3123490|NCT01642212|3848586|FG000|NOT COMPLETED|Single-blind Baseline||26
3123491|NCT01642212|3848587|FG001|NOT COMPLETED|Single-blind Baseline||0
3123492|NCT01642212|3848588|FG002|NOT COMPLETED|Single-blind Baseline||0
3123493|NCT01642212|3848589|FG003|NOT COMPLETED|Single-blind Baseline||0
3123494|NCT01642212|3848590|FG004|NOT COMPLETED|Single-blind Baseline||0
3123495|NCT01642212|3848586|FG000|STARTED|Double-blind Treatment||0
3123496|NCT01642212|3848587|FG001|STARTED|Double-blind Treatment||42
3123497|NCT01642212|3848588|FG002|STARTED|Double-blind Treatment||51
3123498|NCT01642212|3848589|FG003|STARTED|Double-blind Treatment||0
3123499|NCT01642212|3848590|FG004|STARTED|Double-blind Treatment||0
3295655|NCT02899988|4029696|FG009|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
3295656|NCT02899988|4029697|FG010|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
3295657|NCT02899988|4029687|FG000|COMPLETED|Induction Period (16 Weeks)||50
3295658|NCT02899988|4029688|FG001|COMPLETED|Induction Period (16 Weeks)||49
3295659|NCT02899988|4029689|FG002|COMPLETED|Induction Period (16 Weeks)||51
3295660|NCT02899988|4029690|FG003|COMPLETED|Induction Period (16 Weeks)||49
3295661|NCT02899988|4029691|FG004|COMPLETED|Induction Period (16 Weeks)||0
3295662|NCT02899988|4029692|FG005|COMPLETED|Induction Period (16 Weeks)||0
3123500|NCT01642212|3848586|FG000|COMPLETED|Double-blind Treatment||0
3123501|NCT01642212|3848587|FG001|COMPLETED|Double-blind Treatment||39
3123502|NCT01642212|3848588|FG002|COMPLETED|Double-blind Treatment||49
3123503|NCT01642212|3848589|FG003|COMPLETED|Double-blind Treatment||0
3123504|NCT01642212|3848590|FG004|COMPLETED|Double-blind Treatment||0
3123505|NCT01642212|3848586|FG000|NOT COMPLETED|Double-blind Treatment||0
3123506|NCT01642212|3848587|FG001|NOT COMPLETED|Double-blind Treatment||3
3123507|NCT01642212|3848588|FG002|NOT COMPLETED|Double-blind Treatment||2
3123508|NCT01642212|3848589|FG003|NOT COMPLETED|Double-blind Treatment||0
3123509|NCT01642212|3848590|FG004|NOT COMPLETED|Double-blind Treatment||0
3123510|NCT01642212|3848586|FG000|STARTED|Open-label Extension||0
3123511|NCT01642212|3848587|FG001|STARTED|Open-label Extension||0
3123512|NCT01642212|3848588|FG002|STARTED|Open-label Extension||0
3123513|NCT01642212|3848589|FG003|STARTED|Open-label Extension|Two participants completed double-blind treatment but did not enter the open-label extension.|37
3123514|NCT01642212|3848590|FG004|STARTED|Open-label Extension|Four participants completed double-blind treatment but did not enter the open-label extension.|45
3123515|NCT01642212|3848586|FG000|COMPLETED|Open-label Extension||0
3123516|NCT01642212|3848587|FG001|COMPLETED|Open-label Extension||0
3123517|NCT01642212|3848588|FG002|COMPLETED|Open-label Extension||0
3123518|NCT01642212|3848589|FG003|COMPLETED|Open-label Extension||27
3123519|NCT01642212|3848590|FG004|COMPLETED|Open-label Extension||37
3123520|NCT01642212|3848586|FG000|NOT COMPLETED|Open-label Extension||0
3123521|NCT01642212|3848587|FG001|NOT COMPLETED|Open-label Extension||0
3295663|NCT02899988|4029693|FG006|COMPLETED|Induction Period (16 Weeks)||0
3295664|NCT02899988|4029694|FG007|COMPLETED|Induction Period (16 Weeks)||0
3295665|NCT02899988|4029695|FG008|COMPLETED|Induction Period (16 Weeks)||0
3295666|NCT02899988|4029696|FG009|COMPLETED|Induction Period (16 Weeks)||0
3295667|NCT02899988|4029697|FG010|COMPLETED|Induction Period (16 Weeks)||0
3295668|NCT02899988|4029687|FG000|NOT COMPLETED|Induction Period (16 Weeks)||2
3295669|NCT02899988|4029688|FG001|NOT COMPLETED|Induction Period (16 Weeks)||2
3295670|NCT02899988|4029689|FG002|NOT COMPLETED|Induction Period (16 Weeks)||0
3295671|NCT02899988|4029690|FG003|NOT COMPLETED|Induction Period (16 Weeks)||2
3295672|NCT02899988|4029691|FG004|NOT COMPLETED|Induction Period (16 Weeks)||0
3295673|NCT02899988|4029692|FG005|NOT COMPLETED|Induction Period (16 Weeks)||0
3295674|NCT02899988|4029693|FG006|NOT COMPLETED|Induction Period (16 Weeks)||0
3295675|NCT02899988|4029694|FG007|NOT COMPLETED|Induction Period (16 Weeks)||0
3295676|NCT02899988|4029695|FG008|NOT COMPLETED|Induction Period (16 Weeks)||0
3295677|NCT02899988|4029696|FG009|NOT COMPLETED|Induction Period (16 Weeks)||0
3295678|NCT02899988|4029697|FG010|NOT COMPLETED|Induction Period (16 Weeks)||0
3295679|NCT02899988|4029687|FG000|STARTED|Maintenance Period (88 Weeks)|No participants received placebo during maintenance period.|0
3295680|NCT02899988|4029688|FG001|STARTED|Maintenance Period (88 Weeks)|No participants received 30 mg mirikizumab Q8W in both induction and maintenance.|0
3295681|NCT02899988|4029689|FG002|STARTED|Maintenance Period (88 Weeks)|No participants received 100 mg mirikizumab Q8W in both induction and maintenance.|0
3295682|NCT02899988|4029690|FG003|STARTED|Maintenance Period (88 Weeks)||0
3295683|NCT02899988|4029691|FG004|STARTED|Maintenance Period (88 Weeks)|Participants received 30 mg mirikizumab Q8W during induction period.|15
3295684|NCT02899988|4029692|FG005|STARTED|Maintenance Period (88 Weeks)|Participants received 100 mg mirikizumab Q8W during induction period.|30
3295685|NCT02899988|4029693|FG006|STARTED|Maintenance Period (88 Weeks)|Participants received 300 mg mirikizumab Q8W during induction period.|34
3295686|NCT02899988|4029694|FG007|STARTED|Maintenance Period (88 Weeks)|Participants received placebo during induction period.|50
3295687|NCT02899988|4029695|FG008|STARTED|Maintenance Period (88 Weeks)|Participants received 30 mg mirikizumab Q8W during induction arm.|34
3295688|NCT02899988|4029696|FG009|STARTED|Maintenance Period (88 Weeks)|Participants received 100 mg mirikizumab Q8W during induction arm.|21
3123522|NCT01642212|3848588|FG002|NOT COMPLETED|Open-label Extension||0
3123523|NCT01642212|3848589|FG003|NOT COMPLETED|Open-label Extension||10
3123524|NCT01642212|3848590|FG004|NOT COMPLETED|Open-label Extension||8
3123525|NCT01642238|3848598|FG000|STARTED|First Intervention (1 Day)||7
3123526|NCT01642238|3848599|FG001|STARTED|First Intervention (1 Day)||8
3123527|NCT01642238|3848598|FG000|COMPLETED|First Intervention (1 Day)||7
3123528|NCT01642238|3848599|FG001|COMPLETED|First Intervention (1 Day)||8
3123529|NCT01642238|3848598|FG000|NOT COMPLETED|First Intervention (1 Day)||0
3123530|NCT01642238|3848599|FG001|NOT COMPLETED|First Intervention (1 Day)||0
3123531|NCT01642238|3848598|FG000|STARTED|Washout (1-2 Weeks)||7
3123532|NCT01642238|3848599|FG001|STARTED|Washout (1-2 Weeks)||8
3123533|NCT01642238|3848598|FG000|COMPLETED|Washout (1-2 Weeks)||7
3123534|NCT01642238|3848599|FG001|COMPLETED|Washout (1-2 Weeks)||8
3123535|NCT01642238|3848598|FG000|NOT COMPLETED|Washout (1-2 Weeks)||0
3123536|NCT01642238|3848599|FG001|NOT COMPLETED|Washout (1-2 Weeks)||0
3123537|NCT01642238|3848598|FG000|STARTED|Second Intervention (1 Day)||7
3123538|NCT01642238|3848599|FG001|STARTED|Second Intervention (1 Day)||8
3123539|NCT01642238|3848598|FG000|COMPLETED|Second Intervention (1 Day)||7
3123540|NCT01642238|3848599|FG001|COMPLETED|Second Intervention (1 Day)||8
3123541|NCT01642238|3848598|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
3123542|NCT01642238|3848599|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
3123543|NCT01642251|3848608|FG000|STARTED|Overall Study||3
3123544|NCT01642251|3848609|FG001|STARTED|Overall Study||6
3123545|NCT01642251|3848610|FG002|STARTED|Overall Study||75
3123546|NCT01642251|3848611|FG003|STARTED|Overall Study||72
3123547|NCT01642251|3848608|FG000|Started Protocol Therapy|Overall Study||3
3123548|NCT01642251|3848609|FG001|Started Protocol Therapy|Overall Study||6
3123549|NCT01642251|3848610|FG002|Started Protocol Therapy|Overall Study||66
3123550|NCT01642251|3848611|FG003|Started Protocol Therapy|Overall Study||66
3123551|NCT01642251|3848608|FG000|Eligible|Overall Study||3
3123552|NCT01642251|3848609|FG001|Eligible|Overall Study||6
3123553|NCT01642251|3848610|FG002|Eligible|Overall Study||72
3123554|NCT01642251|3848611|FG003|Eligible|Overall Study||69
3123555|NCT01642251|3848608|FG000|Eligible and Treated|Overall Study||3
3123556|NCT01642251|3848609|FG001|Eligible and Treated|Overall Study||6
3295689|NCT02899988|4029697|FG010|STARTED|Maintenance Period (88 Weeks)|Participants received 300 mg mirikizumab Q8W during induction arm.|15
3295690|NCT02899988|4029687|FG000|Rescue Participants|Maintenance Period (88 Weeks)||0
3295691|NCT02899988|4029688|FG001|Rescue Participants|Maintenance Period (88 Weeks)||0
3295692|NCT02899988|4029689|FG002|Rescue Participants|Maintenance Period (88 Weeks)||0
3295693|NCT02899988|4029690|FG003|Rescue Participants|Maintenance Period (88 Weeks)|In PRN not regaining ≥ PASI 90 after 3 consecutive doses of drug or have < PASI 50 after 1 dose.|10
3295694|NCT02899988|4029691|FG004|Rescue Participants|Maintenance Period (88 Weeks)||0
3295695|NCT02899988|4029692|FG005|Rescue Participants|Maintenance Period (88 Weeks)||0
3295696|NCT02899988|4029693|FG006|Rescue Participants|Maintenance Period (88 Weeks)||0
3295697|NCT02899988|4029694|FG007|Rescue Participants|Maintenance Period (88 Weeks)||0
3295698|NCT02899988|4029695|FG008|Rescue Participants|Maintenance Period (88 Weeks)||0
3295699|NCT02899988|4029696|FG009|Rescue Participants|Maintenance Period (88 Weeks)||0
3295700|NCT02899988|4029697|FG010|Rescue Participants|Maintenance Period (88 Weeks)||0
3295701|NCT02899988|4029687|FG000|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||0
3295702|NCT02899988|4029688|FG001|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||0
3295703|NCT02899988|4029689|FG002|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||0
3295704|NCT02899988|4029690|FG003|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||13
3295705|NCT02899988|4029691|FG004|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||9
3295706|NCT02899988|4029692|FG005|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||18
3295707|NCT02899988|4029693|FG006|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||26
3295708|NCT02899988|4029694|FG007|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||42
3295709|NCT02899988|4029695|FG008|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||24
3295710|NCT02899988|4029696|FG009|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||17
3295711|NCT02899988|4029697|FG010|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||0
3295712|NCT02899988|4029687|FG000|COMPLETED|Maintenance Period (88 Weeks)||0
3295713|NCT02899988|4029688|FG001|COMPLETED|Maintenance Period (88 Weeks)||0
3295714|NCT02899988|4029689|FG002|COMPLETED|Maintenance Period (88 Weeks)||0
3295715|NCT02899988|4029690|FG003|COMPLETED|Maintenance Period (88 Weeks)||0
3295716|NCT02899988|4029691|FG004|COMPLETED|Maintenance Period (88 Weeks)||13
3295717|NCT02899988|4029692|FG005|COMPLETED|Maintenance Period (88 Weeks)||27
3295718|NCT02899988|4029693|FG006|COMPLETED|Maintenance Period (88 Weeks)||30
3295719|NCT02899988|4029694|FG007|COMPLETED|Maintenance Period (88 Weeks)||45
3295720|NCT02899988|4029695|FG008|COMPLETED|Maintenance Period (88 Weeks)||30
3295721|NCT02899988|4029696|FG009|COMPLETED|Maintenance Period (88 Weeks)||19
3295722|NCT02899988|4029697|FG010|COMPLETED|Maintenance Period (88 Weeks)||13
3295723|NCT02899988|4029687|FG000|NOT COMPLETED|Maintenance Period (88 Weeks)||0
3295724|NCT02899988|4029688|FG001|NOT COMPLETED|Maintenance Period (88 Weeks)||0
3295725|NCT02899988|4029689|FG002|NOT COMPLETED|Maintenance Period (88 Weeks)||0
3295726|NCT02899988|4029690|FG003|NOT COMPLETED|Maintenance Period (88 Weeks)||0
3295727|NCT02899988|4029691|FG004|NOT COMPLETED|Maintenance Period (88 Weeks)||2
3295728|NCT02899988|4029692|FG005|NOT COMPLETED|Maintenance Period (88 Weeks)||3
3295729|NCT02899988|4029693|FG006|NOT COMPLETED|Maintenance Period (88 Weeks)||4
3295730|NCT02899988|4029694|FG007|NOT COMPLETED|Maintenance Period (88 Weeks)||5
3123557|NCT01642251|3848610|FG002|Eligible and Treated|Overall Study||64
3123558|NCT01642251|3848611|FG003|Eligible and Treated|Overall Study||64
3123559|NCT01642251|3848608|FG000|COMPLETED|Overall Study||3
3123560|NCT01642251|3848609|FG001|COMPLETED|Overall Study||6
3123561|NCT01642251|3848610|FG002|COMPLETED|Overall Study||53
3123562|NCT01642251|3848611|FG003|COMPLETED|Overall Study||49
3123563|NCT01642251|3848608|FG000|NOT COMPLETED|Overall Study||0
3123564|NCT01642251|3848609|FG001|NOT COMPLETED|Overall Study||0
3123565|NCT01642251|3848610|FG002|NOT COMPLETED|Overall Study||22
3123566|NCT01642251|3848611|FG003|NOT COMPLETED|Overall Study||23
3123567|NCT01642277|3848622|FG000|STARTED|Overall Study||74
3123568|NCT01642277|3848623|FG001|STARTED|Overall Study||60
3123569|NCT01642277|3848622|FG000|COMPLETED|Overall Study||50
3123570|NCT01642277|3848623|FG001|COMPLETED|Overall Study||60
3123571|NCT01642277|3848622|FG000|NOT COMPLETED|Overall Study||24
3123572|NCT01642277|3848623|FG001|NOT COMPLETED|Overall Study||0
3123573|NCT01642407|3848630|FG000|STARTED|Part 1 (Screening Till Week 16)||6
3123574|NCT01642407|3848630|FG000|COMPLETED|Part 1 (Screening Till Week 16)||3
3123575|NCT01642407|3848630|FG000|NOT COMPLETED|Part 1 (Screening Till Week 16)||3
3123576|NCT01642407|3848630|FG000|STARTED|Part 2(Week17 to Maximum of 119.6 Weeks)||3
3123577|NCT01642407|3848630|FG000|COMPLETED|Part 2(Week17 to Maximum of 119.6 Weeks)||1
3123578|NCT01642407|3848630|FG000|NOT COMPLETED|Part 2(Week17 to Maximum of 119.6 Weeks)||2
3123579|NCT01642485|3848634|FG000|STARTED|Period 1, Day 1|crossover so all subjects had this treatment|4
3123580|NCT01642485|3848635|FG001|STARTED|Period 1, Day 1||4
3123581|NCT01642485|3848636|FG002|STARTED|Period 1, Day 1||4
3123582|NCT01642485|3848637|FG003|STARTED|Period 1, Day 1||4
3123583|NCT01642485|3848638|FG004|STARTED|Period 1, Day 1||4
3123584|NCT01642485|3848639|FG005|STARTED|Period 1, Day 1||4
3123585|NCT01642485|3848640|FG006|STARTED|Period 1, Day 1||4
3123586|NCT01642485|3848641|FG007|STARTED|Period 1, Day 1||4
3123587|NCT01642485|3848634|FG000|COMPLETED|Period 1, Day 1||4
3123588|NCT01642485|3848635|FG001|COMPLETED|Period 1, Day 1||4
3123589|NCT01642485|3848636|FG002|COMPLETED|Period 1, Day 1||4
3123590|NCT01642485|3848637|FG003|COMPLETED|Period 1, Day 1||4
3123591|NCT01642485|3848638|FG004|COMPLETED|Period 1, Day 1||4
3123592|NCT01642485|3848639|FG005|COMPLETED|Period 1, Day 1||4
3123593|NCT01642485|3848640|FG006|COMPLETED|Period 1, Day 1||4
3123594|NCT01642485|3848641|FG007|COMPLETED|Period 1, Day 1||4
3123595|NCT01642485|3848634|FG000|NOT COMPLETED|Period 1, Day 1||0
3123596|NCT01642485|3848635|FG001|NOT COMPLETED|Period 1, Day 1||0
3123597|NCT01642485|3848636|FG002|NOT COMPLETED|Period 1, Day 1||0
3123598|NCT01642485|3848637|FG003|NOT COMPLETED|Period 1, Day 1||0
3123599|NCT01642485|3848638|FG004|NOT COMPLETED|Period 1, Day 1||0
3123600|NCT01642485|3848639|FG005|NOT COMPLETED|Period 1, Day 1||0
3123601|NCT01642485|3848640|FG006|NOT COMPLETED|Period 1, Day 1||0
3123602|NCT01642485|3848641|FG007|NOT COMPLETED|Period 1, Day 1||0
3123603|NCT01642485|3848634|FG000|STARTED|Period 1, Day 2||4
3123604|NCT01642485|3848635|FG001|STARTED|Period 1, Day 2||4
3123605|NCT01642485|3848636|FG002|STARTED|Period 1, Day 2||4
3123606|NCT01642485|3848637|FG003|STARTED|Period 1, Day 2||4
3123607|NCT01642485|3848638|FG004|STARTED|Period 1, Day 2||4
3123608|NCT01642485|3848639|FG005|STARTED|Period 1, Day 2||4
3123609|NCT01642485|3848640|FG006|STARTED|Period 1, Day 2||4
3123610|NCT01642485|3848641|FG007|STARTED|Period 1, Day 2||4
3123611|NCT01642485|3848634|FG000|COMPLETED|Period 1, Day 2||4
3123612|NCT01642485|3848635|FG001|COMPLETED|Period 1, Day 2||4
3123613|NCT01642485|3848636|FG002|COMPLETED|Period 1, Day 2||4
3123614|NCT01642485|3848637|FG003|COMPLETED|Period 1, Day 2||4
3123615|NCT01642485|3848638|FG004|COMPLETED|Period 1, Day 2||4
3123616|NCT01642485|3848639|FG005|COMPLETED|Period 1, Day 2||4
3123617|NCT01642485|3848640|FG006|COMPLETED|Period 1, Day 2||4
3123618|NCT01642485|3848641|FG007|COMPLETED|Period 1, Day 2||4
3123619|NCT01642485|3848634|FG000|NOT COMPLETED|Period 1, Day 2||0
3123620|NCT01642485|3848635|FG001|NOT COMPLETED|Period 1, Day 2||0
3123621|NCT01642485|3848636|FG002|NOT COMPLETED|Period 1, Day 2||0
3123622|NCT01642485|3848637|FG003|NOT COMPLETED|Period 1, Day 2||0
3123623|NCT01642485|3848638|FG004|NOT COMPLETED|Period 1, Day 2||0
3123624|NCT01642485|3848639|FG005|NOT COMPLETED|Period 1, Day 2||0
3123625|NCT01642485|3848640|FG006|NOT COMPLETED|Period 1, Day 2||0
3123626|NCT01642485|3848641|FG007|NOT COMPLETED|Period 1, Day 2||0
3123627|NCT01642485|3848634|FG000|STARTED|Period 1, Day 3||4
3123628|NCT01642485|3848635|FG001|STARTED|Period 1, Day 3||4
3123629|NCT01642485|3848636|FG002|STARTED|Period 1, Day 3||4
3123630|NCT01642485|3848637|FG003|STARTED|Period 1, Day 3||4
3123631|NCT01642485|3848638|FG004|STARTED|Period 1, Day 3||4
3123632|NCT01642485|3848639|FG005|STARTED|Period 1, Day 3||4
3123633|NCT01642485|3848640|FG006|STARTED|Period 1, Day 3||4
3123634|NCT01642485|3848641|FG007|STARTED|Period 1, Day 3||4
3123635|NCT01642485|3848634|FG000|COMPLETED|Period 1, Day 3||4
3123636|NCT01642485|3848635|FG001|COMPLETED|Period 1, Day 3||4
3123637|NCT01642485|3848636|FG002|COMPLETED|Period 1, Day 3||4
3123638|NCT01642485|3848637|FG003|COMPLETED|Period 1, Day 3||4
3123639|NCT01642485|3848638|FG004|COMPLETED|Period 1, Day 3||4
3123640|NCT01642485|3848639|FG005|COMPLETED|Period 1, Day 3||4
3123641|NCT01642485|3848640|FG006|COMPLETED|Period 1, Day 3||4
3123642|NCT01642485|3848641|FG007|COMPLETED|Period 1, Day 3||4
3123643|NCT01642485|3848634|FG000|NOT COMPLETED|Period 1, Day 3||0
3123644|NCT01642485|3848635|FG001|NOT COMPLETED|Period 1, Day 3||0
3123645|NCT01642485|3848636|FG002|NOT COMPLETED|Period 1, Day 3||0
3123646|NCT01642485|3848637|FG003|NOT COMPLETED|Period 1, Day 3||0
3123647|NCT01642485|3848638|FG004|NOT COMPLETED|Period 1, Day 3||0
3123648|NCT01642485|3848639|FG005|NOT COMPLETED|Period 1, Day 3||0
3123649|NCT01642485|3848640|FG006|NOT COMPLETED|Period 1, Day 3||0
3123650|NCT01642485|3848641|FG007|NOT COMPLETED|Period 1, Day 3||0
3123651|NCT01642485|3848634|FG000|STARTED|Period 2, Day 1||4
3123652|NCT01642485|3848635|FG001|STARTED|Period 2, Day 1||4
3123653|NCT01642485|3848636|FG002|STARTED|Period 2, Day 1||4
3123654|NCT01642485|3848637|FG003|STARTED|Period 2, Day 1||4
3123655|NCT01642485|3848638|FG004|STARTED|Period 2, Day 1||4
3123656|NCT01642485|3848639|FG005|STARTED|Period 2, Day 1||4
3123657|NCT01642485|3848640|FG006|STARTED|Period 2, Day 1||4
3123658|NCT01642485|3848641|FG007|STARTED|Period 2, Day 1||4
3123659|NCT01642485|3848634|FG000|COMPLETED|Period 2, Day 1||4
3123660|NCT01642485|3848635|FG001|COMPLETED|Period 2, Day 1||4
3123661|NCT01642485|3848636|FG002|COMPLETED|Period 2, Day 1||4
3123662|NCT01642485|3848637|FG003|COMPLETED|Period 2, Day 1||4
3123663|NCT01642485|3848638|FG004|COMPLETED|Period 2, Day 1||4
3123664|NCT01642485|3848639|FG005|COMPLETED|Period 2, Day 1||4
3123665|NCT01642485|3848640|FG006|COMPLETED|Period 2, Day 1||4
3123666|NCT01642485|3848641|FG007|COMPLETED|Period 2, Day 1||4
3123667|NCT01642485|3848634|FG000|NOT COMPLETED|Period 2, Day 1||0
3123668|NCT01642485|3848635|FG001|NOT COMPLETED|Period 2, Day 1||0
3123669|NCT01642485|3848636|FG002|NOT COMPLETED|Period 2, Day 1||0
3123670|NCT01642485|3848637|FG003|NOT COMPLETED|Period 2, Day 1||0
3123671|NCT01642485|3848638|FG004|NOT COMPLETED|Period 2, Day 1||0
3123672|NCT01642485|3848639|FG005|NOT COMPLETED|Period 2, Day 1||0
3123673|NCT01642485|3848640|FG006|NOT COMPLETED|Period 2, Day 1||0
3123674|NCT01642485|3848641|FG007|NOT COMPLETED|Period 2, Day 1||0
3123675|NCT01642485|3848634|FG000|STARTED|Period 2, Day 2||4
3123676|NCT01642485|3848635|FG001|STARTED|Period 2, Day 2||4
3123677|NCT01642485|3848636|FG002|STARTED|Period 2, Day 2||4
3123678|NCT01642485|3848637|FG003|STARTED|Period 2, Day 2||4
3123679|NCT01642485|3848638|FG004|STARTED|Period 2, Day 2||4
3123680|NCT01642485|3848639|FG005|STARTED|Period 2, Day 2||4
3123681|NCT01642485|3848640|FG006|STARTED|Period 2, Day 2||4
3123682|NCT01642485|3848641|FG007|STARTED|Period 2, Day 2||4
3123683|NCT01642485|3848634|FG000|COMPLETED|Period 2, Day 2||4
3123684|NCT01642485|3848635|FG001|COMPLETED|Period 2, Day 2||4
3123685|NCT01642485|3848636|FG002|COMPLETED|Period 2, Day 2||4
3123686|NCT01642485|3848637|FG003|COMPLETED|Period 2, Day 2||4
3123687|NCT01642485|3848638|FG004|COMPLETED|Period 2, Day 2||4
3123688|NCT01642485|3848639|FG005|COMPLETED|Period 2, Day 2||4
3123689|NCT01642485|3848640|FG006|COMPLETED|Period 2, Day 2||4
3123690|NCT01642485|3848641|FG007|COMPLETED|Period 2, Day 2||4
3123691|NCT01642485|3848634|FG000|NOT COMPLETED|Period 2, Day 2||0
3123692|NCT01642485|3848635|FG001|NOT COMPLETED|Period 2, Day 2||0
3123693|NCT01642485|3848636|FG002|NOT COMPLETED|Period 2, Day 2||0
3123694|NCT01642485|3848637|FG003|NOT COMPLETED|Period 2, Day 2||0
3123695|NCT01642485|3848638|FG004|NOT COMPLETED|Period 2, Day 2||0
3123696|NCT01642485|3848639|FG005|NOT COMPLETED|Period 2, Day 2||0
3123697|NCT01642485|3848640|FG006|NOT COMPLETED|Period 2, Day 2||0
3123698|NCT01642485|3848641|FG007|NOT COMPLETED|Period 2, Day 2||0
3123699|NCT01642485|3848634|FG000|STARTED|Period 2, Day 3||4
3123700|NCT01642485|3848635|FG001|STARTED|Period 2, Day 3||4
3123701|NCT01642485|3848636|FG002|STARTED|Period 2, Day 3||4
3123702|NCT01642485|3848637|FG003|STARTED|Period 2, Day 3||4
3123703|NCT01642485|3848638|FG004|STARTED|Period 2, Day 3||4
3123704|NCT01642485|3848639|FG005|STARTED|Period 2, Day 3||4
3123705|NCT01642485|3848640|FG006|STARTED|Period 2, Day 3||4
3123706|NCT01642485|3848641|FG007|STARTED|Period 2, Day 3||4
3123707|NCT01642485|3848634|FG000|COMPLETED|Period 2, Day 3||4
3123708|NCT01642485|3848635|FG001|COMPLETED|Period 2, Day 3||4
3123709|NCT01642485|3848636|FG002|COMPLETED|Period 2, Day 3||4
3123710|NCT01642485|3848637|FG003|COMPLETED|Period 2, Day 3||4
3123711|NCT01642485|3848638|FG004|COMPLETED|Period 2, Day 3||4
3123712|NCT01642485|3848639|FG005|COMPLETED|Period 2, Day 3||4
3123713|NCT01642485|3848640|FG006|COMPLETED|Period 2, Day 3||4
3123714|NCT01642485|3848641|FG007|COMPLETED|Period 2, Day 3||4
3123715|NCT01642485|3848634|FG000|NOT COMPLETED|Period 2, Day 3||0
3123716|NCT01642485|3848635|FG001|NOT COMPLETED|Period 2, Day 3||0
3123717|NCT01642485|3848636|FG002|NOT COMPLETED|Period 2, Day 3||0
3123718|NCT01642485|3848637|FG003|NOT COMPLETED|Period 2, Day 3||0
3123719|NCT01642485|3848638|FG004|NOT COMPLETED|Period 2, Day 3||0
3123720|NCT01642485|3848639|FG005|NOT COMPLETED|Period 2, Day 3||0
3123721|NCT01642485|3848640|FG006|NOT COMPLETED|Period 2, Day 3||0
3123722|NCT01642485|3848641|FG007|NOT COMPLETED|Period 2, Day 3||0
3123723|NCT01642589|3848661|FG000|STARTED|Overall Study||200
3123724|NCT01642589|3848662|FG001|STARTED|Overall Study||100
3123725|NCT01642589|3848661|FG000|COMPLETED|Overall Study||199
3123726|NCT01642589|3848662|FG001|COMPLETED|Overall Study||99
3123727|NCT01642589|3848661|FG000|NOT COMPLETED|Overall Study||1
3123728|NCT01642589|3848662|FG001|NOT COMPLETED|Overall Study||1
3123729|NCT01642602|3848668|FG000|STARTED|Overall Study||104
3123730|NCT01642602|3848668|FG000|COMPLETED|Overall Study||102
3123731|NCT01642602|3848668|FG000|NOT COMPLETED|Overall Study||2
3123732|NCT01642615|3848672|FG000|STARTED|Open Label Maintenance Phase||63
3123733|NCT01642615|3848673|FG001|STARTED|Open Label Maintenance Phase||0
3123734|NCT01642615|3848674|FG002|STARTED|Open Label Maintenance Phase||0
3123735|NCT01642615|3848672|FG000|Safety Analysis Set|Open Label Maintenance Phase||62
3123736|NCT01642615|3848673|FG001|Safety Analysis Set|Open Label Maintenance Phase||0
3123737|NCT01642615|3848674|FG002|Safety Analysis Set|Open Label Maintenance Phase||0
3123738|NCT01642615|3848672|FG000|COMPLETED|Open Label Maintenance Phase||58
3123739|NCT01642615|3848673|FG001|COMPLETED|Open Label Maintenance Phase||0
3123740|NCT01642615|3848674|FG002|COMPLETED|Open Label Maintenance Phase||0
3123741|NCT01642615|3848672|FG000|NOT COMPLETED|Open Label Maintenance Phase||5
3123742|NCT01642615|3848673|FG001|NOT COMPLETED|Open Label Maintenance Phase||0
3123743|NCT01642615|3848674|FG002|NOT COMPLETED|Open Label Maintenance Phase||0
3123744|NCT01642615|3848672|FG000|STARTED|Double Blind Maintenance Phase||0
3123745|NCT01642615|3848673|FG001|STARTED|Double Blind Maintenance Phase||25
3123746|NCT01642615|3848674|FG002|STARTED|Double Blind Maintenance Phase||26
3123747|NCT01642615|3848672|FG000|COMPLETED|Double Blind Maintenance Phase||0
3123748|NCT01642615|3848673|FG001|COMPLETED|Double Blind Maintenance Phase||18
3123749|NCT01642615|3848674|FG002|COMPLETED|Double Blind Maintenance Phase||20
3123750|NCT01642615|3848672|FG000|NOT COMPLETED|Double Blind Maintenance Phase||0
3123751|NCT01642615|3848673|FG001|NOT COMPLETED|Double Blind Maintenance Phase||7
3123752|NCT01642615|3848674|FG002|NOT COMPLETED|Double Blind Maintenance Phase||6
3123753|NCT01642914|3848685|FG000|STARTED|Overall Study||173
3123754|NCT01642914|3848686|FG001|STARTED|Overall Study||154
3123755|NCT01642914|3848687|FG002|STARTED|Overall Study||160
3123756|NCT01642914|3848685|FG000|COMPLETED|Overall Study||127
3123757|NCT01642914|3848686|FG001|COMPLETED|Overall Study||122
3123758|NCT01642914|3848687|FG002|COMPLETED|Overall Study||120
3123759|NCT01642914|3848685|FG000|NOT COMPLETED|Overall Study||46
3123760|NCT01642914|3848686|FG001|NOT COMPLETED|Overall Study||32
3123761|NCT01642914|3848687|FG002|NOT COMPLETED|Overall Study||40
3123762|NCT01643044|3848699|FG000|STARTED|Overall Study||24
3123763|NCT01643044|3848700|FG001|STARTED|Overall Study||24
3123764|NCT01643044|3848699|FG000|COMPLETED|Overall Study||20
3123765|NCT01643044|3848700|FG001|COMPLETED|Overall Study||19
3123766|NCT01643044|3848699|FG000|NOT COMPLETED|Overall Study||4
3123767|NCT01643044|3848700|FG001|NOT COMPLETED|Overall Study||5
3123768|NCT01643213|3848708|FG000|STARTED|Overall Study||13
3123769|NCT01643213|3848709|FG001|STARTED|Overall Study||14
3123770|NCT01643213|3848708|FG000|COMPLETED|Overall Study||12
3123771|NCT01643213|3848709|FG001|COMPLETED|Overall Study||14
3123772|NCT01643213|3848708|FG000|NOT COMPLETED|Overall Study||1
3123773|NCT01643213|3848709|FG001|NOT COMPLETED|Overall Study||0
3123774|NCT01643382|3848717|FG000|STARTED|Overall Study||30
3123775|NCT01643382|3848718|FG001|STARTED|Overall Study||30
3123776|NCT01643382|3848717|FG000|COMPLETED|Overall Study||30
3123777|NCT01643382|3848718|FG001|COMPLETED|Overall Study||30
3123778|NCT01643382|3848717|FG000|NOT COMPLETED|Overall Study||0
3123779|NCT01643382|3848718|FG001|NOT COMPLETED|Overall Study||0
3123780|NCT01643408|3848724|FG000|STARTED|Overall Study||30
3123781|NCT01643408|3848724|FG000|COMPLETED|Overall Study||16
3123782|NCT01643408|3848724|FG000|NOT COMPLETED|Overall Study||14
3295731|NCT02899988|4029695|FG008|NOT COMPLETED|Maintenance Period (88 Weeks)||4
3295732|NCT02899988|4029696|FG009|NOT COMPLETED|Maintenance Period (88 Weeks)||2
3295733|NCT02899988|4029697|FG010|NOT COMPLETED|Maintenance Period (88 Weeks)||2
3295734|NCT02899988|4029687|FG000|STARTED|Follow-Up (16 Weeks)||0
3295735|NCT02899988|4029688|FG001|STARTED|Follow-Up (16 Weeks)||0
3123783|NCT01643473|3848730|FG000|STARTED|Overall Study||21
3123784|NCT01643473|3848731|FG001|STARTED|Overall Study||21
3123785|NCT01643473|3848730|FG000|COMPLETED|Overall Study||20
3123786|NCT01643473|3848731|FG001|COMPLETED|Overall Study||21
3123787|NCT01643473|3848730|FG000|NOT COMPLETED|Overall Study||1
3123788|NCT01643473|3848731|FG001|NOT COMPLETED|Overall Study||0
3123789|NCT01643616|3848739|FG000|STARTED|Overall Study||125
3123790|NCT01643616|3848740|FG001|STARTED|Overall Study||125
3123791|NCT01643616|3848739|FG000|COMPLETED|Overall Study||125
3123792|NCT01643616|3848740|FG001|COMPLETED|Overall Study||125
3123793|NCT01643616|3848739|FG000|NOT COMPLETED|Overall Study||0
3123794|NCT01643616|3848740|FG001|NOT COMPLETED|Overall Study||0
3123795|NCT01643668|3848746|FG000|STARTED|Overall Study||34
3123796|NCT01643668|3848746|FG000|COMPLETED|Overall Study||33
3123797|NCT01643668|3848746|FG000|NOT COMPLETED|Overall Study||1
3123798|NCT01643707|3848752|FG000|STARTED|Overall Study||858
3123799|NCT01643707|3848753|FG001|STARTED|Overall Study||484
3123800|NCT01643707|3848752|FG000|COMPLETED|Overall Study||823
3123801|NCT01643707|3848753|FG001|COMPLETED|Overall Study||470
3123802|NCT01643707|3848752|FG000|NOT COMPLETED|Overall Study||35
3123803|NCT01643707|3848753|FG001|NOT COMPLETED|Overall Study||14
3123804|NCT01643772|3848766|FG000|STARTED|Overall Study||15
3123805|NCT01643772|3848767|FG001|STARTED|Overall Study||15
3123806|NCT01643772|3848768|FG002|STARTED|Overall Study||15
3123807|NCT01643772|3848769|FG003|STARTED|Overall Study||16
3123808|NCT01643772|3848766|FG000|COMPLETED|Overall Study||15
3123809|NCT01643772|3848767|FG001|COMPLETED|Overall Study||15
3123810|NCT01643772|3848768|FG002|COMPLETED|Overall Study||15
3123811|NCT01643772|3848769|FG003|COMPLETED|Overall Study||14
3123812|NCT01643772|3848766|FG000|NOT COMPLETED|Overall Study||0
3295736|NCT02899988|4029689|FG002|STARTED|Follow-Up (16 Weeks)||0
3295737|NCT02899988|4029690|FG003|STARTED|Follow-Up (16 Weeks)||0
3295738|NCT02899988|4029691|FG004|STARTED|Follow-Up (16 Weeks)|Not all participants that completed maintenance period continued to follow-up period.|2
3295739|NCT02899988|4029692|FG005|STARTED|Follow-Up (16 Weeks)|Not all participants that completed maintenance period continued to follow-up period.|4
3123813|NCT01643772|3848767|FG001|NOT COMPLETED|Overall Study||0
3123814|NCT01643772|3848768|FG002|NOT COMPLETED|Overall Study||0
3123815|NCT01643772|3848769|FG003|NOT COMPLETED|Overall Study||2
3123816|NCT01643798|3848781|FG000|STARTED|Pretreatment 1 and Stimulation||7
3123817|NCT01643798|3848782|FG001|STARTED|Pretreatment 1 and Stimulation||8
3123818|NCT01643798|3848781|FG000|COMPLETED|Pretreatment 1 and Stimulation||6
3123819|NCT01643798|3848782|FG001|COMPLETED|Pretreatment 1 and Stimulation||8
3123820|NCT01643798|3848781|FG000|NOT COMPLETED|Pretreatment 1 and Stimulation||1
3123821|NCT01643798|3848782|FG001|NOT COMPLETED|Pretreatment 1 and Stimulation||0
3123822|NCT01643798|3848781|FG000|STARTED|Pretreatment 2 and Stimulation||6
3123823|NCT01643798|3848782|FG001|STARTED|Pretreatment 2 and Stimulation||8
3123824|NCT01643798|3848781|FG000|COMPLETED|Pretreatment 2 and Stimulation||6
3123825|NCT01643798|3848782|FG001|COMPLETED|Pretreatment 2 and Stimulation||8
3123826|NCT01643798|3848781|FG000|NOT COMPLETED|Pretreatment 2 and Stimulation||0
3123827|NCT01643798|3848782|FG001|NOT COMPLETED|Pretreatment 2 and Stimulation||0
3123828|NCT01643850|3848802|FG000|STARTED|Overall Study||5
3123829|NCT01643850|3848803|FG001|STARTED|Overall Study||2
3123830|NCT01643850|3848804|FG002|STARTED|Overall Study||8
3123831|NCT01643850|3848805|FG003|STARTED|Overall Study||3
3123832|NCT01643850|3848806|FG004|STARTED|Overall Study||3
3123833|NCT01643850|3848807|FG005|STARTED|Overall Study||3
3123834|NCT01643850|3848808|FG006|STARTED|Overall Study||4
3123835|NCT01643850|3848809|FG007|STARTED|Overall Study||4
3123836|NCT01643850|3848810|FG008|STARTED|Overall Study||4
3123837|NCT01643850|3848802|FG000|COMPLETED|Overall Study||5
3123838|NCT01643850|3848803|FG001|COMPLETED|Overall Study||2
3123839|NCT01643850|3848804|FG002|COMPLETED|Overall Study||7
3123840|NCT01643850|3848805|FG003|COMPLETED|Overall Study||3
3123841|NCT01643850|3848806|FG004|COMPLETED|Overall Study||0
3123842|NCT01643850|3848807|FG005|COMPLETED|Overall Study||3
3123843|NCT01643850|3848808|FG006|COMPLETED|Overall Study||3
3123844|NCT01643850|3848809|FG007|COMPLETED|Overall Study||4
3123845|NCT01643850|3848810|FG008|COMPLETED|Overall Study||3
3123846|NCT01643850|3848802|FG000|NOT COMPLETED|Overall Study||0
3123847|NCT01643850|3848803|FG001|NOT COMPLETED|Overall Study||0
3123848|NCT01643850|3848804|FG002|NOT COMPLETED|Overall Study||1
3123849|NCT01643850|3848805|FG003|NOT COMPLETED|Overall Study||0
3123850|NCT01643850|3848806|FG004|NOT COMPLETED|Overall Study||3
3123851|NCT01643850|3848807|FG005|NOT COMPLETED|Overall Study||0
3123852|NCT01643850|3848808|FG006|NOT COMPLETED|Overall Study||1
3123853|NCT01643850|3848809|FG007|NOT COMPLETED|Overall Study||0
3123854|NCT01643850|3848810|FG008|NOT COMPLETED|Overall Study||1
3123855|NCT01643876|3848876|FG000|STARTED|Overall Study||48
3123856|NCT01643876|3848876|FG000|COMPLETED|Overall Study||48
3123857|NCT01643876|3848876|FG000|NOT COMPLETED|Overall Study||0
3123858|NCT01643902|3848880|FG000|STARTED|Overall Study||20
3123859|NCT01643902|3848880|FG000|COMPLETED|Overall Study||20
3123860|NCT01643902|3848880|FG000|NOT COMPLETED|Overall Study||0
3123861|NCT01643928|3848890|FG000|STARTED|Overall Study||58
3123862|NCT01643928|3848891|FG001|STARTED|Overall Study||32
3123863|NCT01643928|3848892|FG002|STARTED|Overall Study||33
3123864|NCT01643928|3848893|FG003|STARTED|Overall Study||30
3123865|NCT01643928|3848894|FG004|STARTED|Overall Study||30
3123866|NCT01643928|3848890|FG000|COMPLETED|Overall Study||48
3123867|NCT01643928|3848891|FG001|COMPLETED|Overall Study||30
3123868|NCT01643928|3848892|FG002|COMPLETED|Overall Study||30
3123869|NCT01643928|3848893|FG003|COMPLETED|Overall Study||27
3123870|NCT01643928|3848894|FG004|COMPLETED|Overall Study||28
3123871|NCT01643928|3848890|FG000|NOT COMPLETED|Overall Study||10
3123872|NCT01643928|3848891|FG001|NOT COMPLETED|Overall Study||2
3123873|NCT01643928|3848892|FG002|NOT COMPLETED|Overall Study||3
3123874|NCT01643928|3848893|FG003|NOT COMPLETED|Overall Study||3
3123875|NCT01643928|3848894|FG004|NOT COMPLETED|Overall Study||2
3123876|NCT01644058|3848935|FG000|STARTED|Overall Study||18
3123877|NCT01644058|3848935|FG000|COMPLETED|Overall Study||18
3123878|NCT01644058|3848935|FG000|NOT COMPLETED|Overall Study||0
3123879|NCT01644149|3848942|FG000|STARTED|Overall Study||43
3123880|NCT01644149|3848943|FG001|STARTED|Overall Study||40
3123881|NCT01644149|3848942|FG000|COMPLETED|Overall Study|One subject discontinued prior to vaccination. 28 day serum samples not obtained from 3 subjects.|39
3123882|NCT01644149|3848943|FG001|COMPLETED|Overall Study|28 day serum samples were not obtained from one NS subject.|39
3123883|NCT01644149|3848942|FG000|NOT COMPLETED|Overall Study||4
3123884|NCT01644149|3848943|FG001|NOT COMPLETED|Overall Study||1
3123885|NCT01644175|3848952|FG000|STARTED|Overall Study|Randomized|107
3123886|NCT01644175|3848953|FG001|STARTED|Overall Study|Randomized|209
3123887|NCT01644175|3848952|FG000|Treated|Overall Study||107
3123888|NCT01644175|3848953|FG001|Treated|Overall Study||207
3123889|NCT01644175|3848952|FG000|COMPLETED|Overall Study||75
3123890|NCT01644175|3848953|FG001|COMPLETED|Overall Study||156
3123891|NCT01644175|3848952|FG000|NOT COMPLETED|Overall Study||32
3123892|NCT01644175|3848953|FG001|NOT COMPLETED|Overall Study||53
3123893|NCT01644188|3848961|FG000|STARTED|Overall Study|Randomized|479
3123894|NCT01644188|3848962|FG001|STARTED|Overall Study|Randomized|241
3123895|NCT01644188|3848961|FG000|Treated|Overall Study||479
3123896|NCT01644188|3848962|FG001|Treated|Overall Study||241
3123897|NCT01644188|3848961|FG000|COMPLETED|Overall Study||357
3123898|NCT01644188|3848962|FG001|COMPLETED|Overall Study||166
3123899|NCT01644188|3848961|FG000|NOT COMPLETED|Overall Study||122
3123900|NCT01644188|3848962|FG001|NOT COMPLETED|Overall Study||75
3123901|NCT01644240|3848971|FG000|STARTED|Overall Study||6
3123902|NCT01644240|3848972|FG001|STARTED|Overall Study||4
3123903|NCT01644240|3848973|FG002|STARTED|Overall Study||6
3123904|NCT01644240|3848971|FG000|COMPLETED|Overall Study||6
3123905|NCT01644240|3848972|FG001|COMPLETED|Overall Study||4
3123906|NCT01644240|3848973|FG002|COMPLETED|Overall Study||6
3123907|NCT01644240|3848971|FG000|NOT COMPLETED|Overall Study||0
3123908|NCT01644240|3848972|FG001|NOT COMPLETED|Overall Study||0
3123909|NCT01644240|3848973|FG002|NOT COMPLETED|Overall Study||0
3123910|NCT01644292|3848981|FG000|STARTED|Overall Study||2
3123911|NCT01644292|3848981|FG000|COMPLETED|Overall Study||2
3123912|NCT01644292|3848981|FG000|NOT COMPLETED|Overall Study||0
3123913|NCT01644331|3848987|FG000|STARTED|Overall Study||129
3123914|NCT01644331|3848988|FG001|STARTED|Overall Study||128
3123915|NCT01644331|3848987|FG000|COMPLETED|Overall Study||118
3123916|NCT01644331|3848988|FG001|COMPLETED|Overall Study||118
3123917|NCT01644331|3848987|FG000|NOT COMPLETED|Overall Study||11
3123918|NCT01644331|3848988|FG001|NOT COMPLETED|Overall Study||10
3123919|NCT01644396|3848994|FG000|STARTED|Overall Study||50
3123920|NCT01644396|3848994|FG000|COMPLETED|Overall Study||50
3123921|NCT01644396|3848994|FG000|NOT COMPLETED|Overall Study||0
3123922|NCT01644474|3849001|FG000|STARTED|Overall Study|Randomized|51
3123923|NCT01644474|3849002|FG001|STARTED|Overall Study|Randomized|52
3123924|NCT01644474|3849001|FG000|Treated|Overall Study||51
3123925|NCT01644474|3849002|FG001|Treated|Overall Study||52
3123926|NCT01644474|3849001|FG000|COMPLETED|Overall Study||44
3123927|NCT01644474|3849002|FG001|COMPLETED|Overall Study||44
3123928|NCT01644474|3849001|FG000|NOT COMPLETED|Overall Study||7
3123929|NCT01644474|3849002|FG001|NOT COMPLETED|Overall Study||8
3123930|NCT01644500|3849011|FG000|STARTED|Overall Study||244
3123931|NCT01644500|3849012|FG001|STARTED|Overall Study||248
3123932|NCT01644500|3849013|FG002|STARTED|Overall Study||245
3123933|NCT01644500|3849011|FG000|Received at Least One Dose of Study Drug|Overall Study||244
3123934|NCT01644500|3849012|FG001|Received at Least One Dose of Study Drug|Overall Study||248
3123935|NCT01644500|3849013|FG002|Received at Least One Dose of Study Drug|Overall Study||243
3123936|NCT01644500|3849011|FG000|Modified Intent-to-treat Population|Overall Study||239
3123937|NCT01644500|3849012|FG001|Modified Intent-to-treat Population|Overall Study||239
3123938|NCT01644500|3849013|FG002|Modified Intent-to-treat Population|Overall Study||242
3123939|NCT01644500|3849011|FG000|COMPLETED|Overall Study||222
3123940|NCT01644500|3849012|FG001|COMPLETED|Overall Study||224
3123941|NCT01644500|3849013|FG002|COMPLETED|Overall Study||230
3123942|NCT01644500|3849011|FG000|NOT COMPLETED|Overall Study||22
3123943|NCT01644500|3849012|FG001|NOT COMPLETED|Overall Study||24
3123944|NCT01644500|3849013|FG002|NOT COMPLETED|Overall Study||15
3123945|NCT01644565|3849021|FG000|STARTED|Overall Study||5
3123946|NCT01644565|3849022|FG001|STARTED|Overall Study||5
3123947|NCT01644565|3849023|FG002|STARTED|Overall Study||5
3123948|NCT01644565|3849024|FG003|STARTED|Overall Study||5
3123949|NCT01644565|3849025|FG004|STARTED|Overall Study||5
3123950|NCT01644565|3849026|FG005|STARTED|Overall Study||7
3123951|NCT01644565|3849027|FG006|STARTED|Overall Study||7
3123952|NCT01644565|3849028|FG007|STARTED|Overall Study||10
3123953|NCT01644565|3849029|FG008|STARTED|Overall Study||8
3123954|NCT01644565|3849021|FG000|COMPLETED|Overall Study||4
3123955|NCT01644565|3849022|FG001|COMPLETED|Overall Study||5
3123956|NCT01644565|3849023|FG002|COMPLETED|Overall Study||5
3123957|NCT01644565|3849024|FG003|COMPLETED|Overall Study||4
3123958|NCT01644565|3849025|FG004|COMPLETED|Overall Study||4
3123959|NCT01644565|3849026|FG005|COMPLETED|Overall Study||7
3123960|NCT01644565|3849027|FG006|COMPLETED|Overall Study||7
3123961|NCT01644565|3849028|FG007|COMPLETED|Overall Study||8
3123962|NCT01644565|3849029|FG008|COMPLETED|Overall Study||7
3123963|NCT01644565|3849021|FG000|NOT COMPLETED|Overall Study||1
3123964|NCT01644565|3849022|FG001|NOT COMPLETED|Overall Study||0
3123965|NCT01644565|3849023|FG002|NOT COMPLETED|Overall Study||0
3123966|NCT01644565|3849024|FG003|NOT COMPLETED|Overall Study||1
3123967|NCT01644565|3849025|FG004|NOT COMPLETED|Overall Study||1
3123968|NCT01644565|3849026|FG005|NOT COMPLETED|Overall Study||0
3123969|NCT01644565|3849027|FG006|NOT COMPLETED|Overall Study||0
3123970|NCT01644565|3849028|FG007|NOT COMPLETED|Overall Study||2
3123971|NCT01644565|3849029|FG008|NOT COMPLETED|Overall Study||1
3123972|NCT01644617|3849052|FG000|STARTED|Overall Study||42
3123973|NCT01644617|3849053|FG001|STARTED|Overall Study||41
3123974|NCT01644617|3849054|FG002|STARTED|Overall Study||41
3123975|NCT01644617|3849052|FG000|COMPLETED|Overall Study||36
3123976|NCT01644617|3849053|FG001|COMPLETED|Overall Study||36
3123977|NCT01644617|3849054|FG002|COMPLETED|Overall Study||34
3123978|NCT01644617|3849052|FG000|NOT COMPLETED|Overall Study||6
3123979|NCT01644617|3849053|FG001|NOT COMPLETED|Overall Study||5
3123980|NCT01644617|3849054|FG002|NOT COMPLETED|Overall Study||7
3123981|NCT01644643|3849066|FG000|STARTED|Overall Study||15
3123982|NCT01644643|3849067|FG001|STARTED|Overall Study||12
3123983|NCT01644643|3849068|FG002|STARTED|Overall Study||153
3123984|NCT01644643|3849069|FG003|STARTED|Overall Study||153
3123985|NCT01644643|3849066|FG000|COMPLETED|Overall Study||13
3123986|NCT01644643|3849067|FG001|COMPLETED|Overall Study||12
3123987|NCT01644643|3849068|FG002|COMPLETED|Overall Study||148
3123988|NCT01644643|3849069|FG003|COMPLETED|Overall Study||143
3123989|NCT01644643|3849066|FG000|NOT COMPLETED|Overall Study||2
3123990|NCT01644643|3849067|FG001|NOT COMPLETED|Overall Study||0
3123991|NCT01644643|3849068|FG002|NOT COMPLETED|Overall Study||5
3123992|NCT01644643|3849069|FG003|NOT COMPLETED|Overall Study||10
3123993|NCT01644695|3849085|FG000|STARTED|Overall Study||85
3123994|NCT01644695|3849085|FG000|COMPLETED|Overall Study||85
3123995|NCT01644695|3849085|FG000|NOT COMPLETED|Overall Study||0
3123996|NCT01644734|3849089|FG000|STARTED|Overall Study|Patients with documentation of treatment.|1282
3123997|NCT01644734|3849089|FG000|COMPLETED|Overall Study||1016
3123998|NCT01644734|3849089|FG000|NOT COMPLETED|Overall Study||266
3123999|NCT01644890|3849095|FG000|STARTED|Overall Study||218
3295740|NCT02899988|4029693|FG006|STARTED|Follow-Up (16 Weeks)|Not all participants that completed maintenance period continued to follow-up period.|3
3295741|NCT02899988|4029694|FG007|STARTED|Follow-Up (16 Weeks)|Not all participants that completed maintenance period continued to follow-up period.|3
3295742|NCT02899988|4029695|FG008|STARTED|Follow-Up (16 Weeks)|Not all participants that completed maintenance period continued to follow-up period.|6
3295743|NCT02899988|4029696|FG009|STARTED|Follow-Up (16 Weeks)|Not all participants that completed maintenance period continued to follow-up period.|2
3124000|NCT01644890|3849096|FG001|STARTED|Overall Study||218
3124001|NCT01644890|3849095|FG000|COMPLETED|Overall Study||2
3124002|NCT01644890|3849096|FG001|COMPLETED|Overall Study||3
3124003|NCT01644890|3849095|FG000|NOT COMPLETED|Overall Study||216
3124004|NCT01644890|3849096|FG001|NOT COMPLETED|Overall Study||215
3124005|NCT01645059|3849102|FG000|STARTED|Overall Study||129
3124006|NCT01645059|3849102|FG000|COMPLETED|Overall Study||129
3124007|NCT01645059|3849102|FG000|NOT COMPLETED|Overall Study||0
3124008|NCT01645098|3849113|FG000|STARTED|Overall Study||24
3124009|NCT01645098|3849114|FG001|STARTED|Overall Study||29
3124010|NCT01645098|3849113|FG000|COMPLETED|Overall Study||24
3124011|NCT01645098|3849114|FG001|COMPLETED|Overall Study||29
3124012|NCT01645098|3849113|FG000|NOT COMPLETED|Overall Study||0
3124013|NCT01645098|3849114|FG001|NOT COMPLETED|Overall Study||0
3124014|NCT01645111|3849120|FG000|STARTED|Overall Study||50
3124015|NCT01645111|3849120|FG000|COMPLETED|Overall Study||35
3124016|NCT01645111|3849120|FG000|NOT COMPLETED|Overall Study||15
3124017|NCT01645176|3849124|FG000|STARTED|Overall Study||21
3124018|NCT01645176|3849124|FG000|COMPLETED|Overall Study||16
3124019|NCT01645176|3849124|FG000|NOT COMPLETED|Overall Study||5
3124020|NCT01645280|3849133|FG000|STARTED|Overall Study|16 participants in placebo group early escaped to receive Ustekinmab; included in safety population.|55
3124021|NCT01645280|3849134|FG001|STARTED|Overall Study||54
3124022|NCT01645280|3849135|FG002|STARTED|Overall Study||55
3124023|NCT01645280|3849136|FG003|STARTED|Overall Study||54
3124024|NCT01645280|3849137|FG004|STARTED|Overall Study||55
3124025|NCT01645280|3849133|FG000|COMPLETED|Overall Study||49
3124026|NCT01645280|3849134|FG001|COMPLETED|Overall Study||51
3124027|NCT01645280|3849135|FG002|COMPLETED|Overall Study||49
3124028|NCT01645280|3849136|FG003|COMPLETED|Overall Study||48
3124029|NCT01645280|3849137|FG004|COMPLETED|Overall Study||47
3124030|NCT01645280|3849133|FG000|NOT COMPLETED|Overall Study||6
3124031|NCT01645280|3849134|FG001|NOT COMPLETED|Overall Study||3
3124032|NCT01645280|3849135|FG002|NOT COMPLETED|Overall Study||6
3124033|NCT01645280|3849136|FG003|NOT COMPLETED|Overall Study||6
3124034|NCT01645280|3849137|FG004|NOT COMPLETED|Overall Study||8
3124035|NCT01645306|3849153|FG000|STARTED|Overall Study||51
3124036|NCT01645306|3849154|FG001|STARTED|Overall Study||54
3124037|NCT01645306|3849155|FG002|STARTED|Overall Study||53
3124038|NCT01645306|3849153|FG000|COMPLETED|Overall Study||49
3124039|NCT01645306|3849154|FG001|COMPLETED|Overall Study||50
3124040|NCT01645306|3849155|FG002|COMPLETED|Overall Study||48
3124041|NCT01645306|3849153|FG000|NOT COMPLETED|Overall Study||2
3124042|NCT01645306|3849154|FG001|NOT COMPLETED|Overall Study||4
3124043|NCT01645306|3849155|FG002|NOT COMPLETED|Overall Study||5
3124044|NCT01645735|3849165|FG000|STARTED|Overall Study||32
3124045|NCT01645735|3849166|FG001|STARTED|Overall Study||17
3124046|NCT01645735|3849165|FG000|COMPLETED|Overall Study||28
3124047|NCT01645735|3849166|FG001|COMPLETED|Overall Study||16
3124048|NCT01645735|3849165|FG000|NOT COMPLETED|Overall Study||4
3124049|NCT01645735|3849166|FG001|NOT COMPLETED|Overall Study||1
3124050|NCT01645930|3849173|FG000|STARTED|Overall Study||43
3124051|NCT01645930|3849173|FG000|COMPLETED|Overall Study||0
3124052|NCT01645930|3849173|FG000|NOT COMPLETED|Overall Study||43
3124053|NCT01646021|3849179|FG000|STARTED|Overall Study||139
3124054|NCT01646021|3849180|FG001|STARTED|Overall Study||141
3124055|NCT01646021|3849179|FG000|Treated|Overall Study||139
3124056|NCT01646021|3849180|FG001|Treated|Overall Study||139
3124057|NCT01646021|3849179|FG000|COMPLETED|Overall Study||0
3295744|NCT02899988|4029697|FG010|STARTED|Follow-Up (16 Weeks)|Not all participants that completed maintenance period continued to follow-up period.|0
3295745|NCT02899988|4029687|FG000|COMPLETED|Follow-Up (16 Weeks)||0
3295746|NCT02899988|4029688|FG001|COMPLETED|Follow-Up (16 Weeks)||0
3295747|NCT02899988|4029689|FG002|COMPLETED|Follow-Up (16 Weeks)||0
3295748|NCT02899988|4029690|FG003|COMPLETED|Follow-Up (16 Weeks)||0
3295749|NCT02899988|4029691|FG004|COMPLETED|Follow-Up (16 Weeks)||2
3295750|NCT02899988|4029692|FG005|COMPLETED|Follow-Up (16 Weeks)||4
3295751|NCT02899988|4029693|FG006|COMPLETED|Follow-Up (16 Weeks)||3
3295752|NCT02899988|4029694|FG007|COMPLETED|Follow-Up (16 Weeks)||3
3295753|NCT02899988|4029695|FG008|COMPLETED|Follow-Up (16 Weeks)||6
3295754|NCT02899988|4029696|FG009|COMPLETED|Follow-Up (16 Weeks)||2
3295755|NCT02899988|4029697|FG010|COMPLETED|Follow-Up (16 Weeks)||0
3295756|NCT02899988|4029687|FG000|NOT COMPLETED|Follow-Up (16 Weeks)||0
3295757|NCT02899988|4029688|FG001|NOT COMPLETED|Follow-Up (16 Weeks)||0
3295758|NCT02899988|4029689|FG002|NOT COMPLETED|Follow-Up (16 Weeks)||0
3295759|NCT02899988|4029690|FG003|NOT COMPLETED|Follow-Up (16 Weeks)||0
3295760|NCT02899988|4029691|FG004|NOT COMPLETED|Follow-Up (16 Weeks)||0
3295761|NCT02899988|4029692|FG005|NOT COMPLETED|Follow-Up (16 Weeks)||0
3295762|NCT02899988|4029693|FG006|NOT COMPLETED|Follow-Up (16 Weeks)||0
3295763|NCT02899988|4029694|FG007|NOT COMPLETED|Follow-Up (16 Weeks)||0
3295764|NCT02899988|4029695|FG008|NOT COMPLETED|Follow-Up (16 Weeks)||0
3295765|NCT02899988|4029696|FG009|NOT COMPLETED|Follow-Up (16 Weeks)||0
3124058|NCT01646021|3849180|FG001|COMPLETED|Overall Study||0
3124059|NCT01646021|3849179|FG000|NOT COMPLETED|Overall Study||139
3124060|NCT01646021|3849180|FG001|NOT COMPLETED|Overall Study||141
3124061|NCT01646073|3849188|FG000|STARTED|Period A (12 Weeks)||87
3124062|NCT01646073|3849189|FG001|STARTED|Period A (12 Weeks)||338
3124063|NCT01646073|3849188|FG000|COMPLETED|Period A (12 Weeks)||85
3295766|NCT02899988|4029697|FG010|NOT COMPLETED|Follow-Up (16 Weeks)||0
3295767|NCT02900092|4029729|FG000|STARTED|Overall Study||10
3295768|NCT02900092|4029729|FG000|COMPLETED|Overall Study||9
3295769|NCT02900092|4029729|FG000|NOT COMPLETED|Overall Study||1
3295770|NCT02900170|4029733|FG000|STARTED|Overall Study||8
3295771|NCT02900170|4029733|FG000|COMPLETED|Overall Study||0
3295772|NCT02900170|4029733|FG000|NOT COMPLETED|Overall Study||8
3295773|NCT02900378|4029739|FG000|STARTED|Randomization (Visit 2)||310
3295774|NCT02900378|4029740|FG001|STARTED|Randomization (Visit 2)||311
3295775|NCT02900378|4029739|FG000|COMPLETED|Randomization (Visit 2)||287
3124064|NCT01646073|3849189|FG001|COMPLETED|Period A (12 Weeks)||333
3124065|NCT01646073|3849188|FG000|NOT COMPLETED|Period A (12 Weeks)||2
3124066|NCT01646073|3849189|FG001|NOT COMPLETED|Period A (12 Weeks)||5
3124067|NCT01646073|3849188|FG000|STARTED|Period B (12 Weeks)||85
3124068|NCT01646073|3849189|FG001|STARTED|Period B (12 Weeks)||333
3124069|NCT01646073|3849188|FG000|COMPLETED|Period B (12 Weeks)||84
3124070|NCT01646073|3849189|FG001|COMPLETED|Period B (12 Weeks)||320
3124071|NCT01646073|3849188|FG000|NOT COMPLETED|Period B (12 Weeks)||1
3124072|NCT01646073|3849189|FG001|NOT COMPLETED|Period B (12 Weeks)||13
3124073|NCT01646125|3849200|FG000|STARTED|Overall Study||31
3124074|NCT01646125|3849201|FG001|STARTED|Overall Study||28
3124075|NCT01646125|3849200|FG000|COMPLETED|Overall Study||0
3124076|NCT01646125|3849201|FG001|COMPLETED|Overall Study||0
3124077|NCT01646125|3849200|FG000|NOT COMPLETED|Overall Study||31
3124078|NCT01646125|3849201|FG001|NOT COMPLETED|Overall Study||28
3124079|NCT01646138|3849213|FG000|STARTED|Overall Study||5
3124080|NCT01646138|3849214|FG001|STARTED|Overall Study||4
3124081|NCT01646138|3849215|FG002|STARTED|Overall Study||5
3124082|NCT01646138|3849216|FG003|STARTED|Overall Study||19
3124083|NCT01646138|3849217|FG004|STARTED|Overall Study||15
3124084|NCT01646138|3849213|FG000|COMPLETED|Overall Study||5
3124085|NCT01646138|3849214|FG001|COMPLETED|Overall Study||4
3124086|NCT01646138|3849215|FG002|COMPLETED|Overall Study||5
3124087|NCT01646138|3849216|FG003|COMPLETED|Overall Study||19
3124088|NCT01646138|3849217|FG004|COMPLETED|Overall Study||13
3124089|NCT01646138|3849213|FG000|NOT COMPLETED|Overall Study||0
3124090|NCT01646138|3849214|FG001|NOT COMPLETED|Overall Study||0
3124091|NCT01646138|3849215|FG002|NOT COMPLETED|Overall Study||0
3124092|NCT01646138|3849216|FG003|NOT COMPLETED|Overall Study||0
3124093|NCT01646138|3849217|FG004|NOT COMPLETED|Overall Study||2
3124094|NCT01646151|3849229|FG000|STARTED|Overall Study||2580
3124095|NCT01646151|3849229|FG000|COMPLETED|Overall Study||2410
3124096|NCT01646151|3849229|FG000|NOT COMPLETED|Overall Study||170
3124097|NCT01646177|3849237|FG000|STARTED|Blinded Induction Dosing (Week 0-12)||193
3295776|NCT02900378|4029740|FG001|COMPLETED|Randomization (Visit 2)||283
3295777|NCT02900378|4029739|FG000|NOT COMPLETED|Randomization (Visit 2)||23
3295778|NCT02900378|4029740|FG001|NOT COMPLETED|Randomization (Visit 2)||28
3295779|NCT02900378|4029739|FG000|STARTED|Treatment Phase||309
3295780|NCT02900378|4029740|FG001|STARTED|Treatment Phase||310
3295781|NCT02900378|4029739|FG000|Full Analysis Set|Treatment Phase||302
3295782|NCT02900378|4029740|FG001|Full Analysis Set|Treatment Phase||302
3295783|NCT02900378|4029739|FG000|COMPLETED|Treatment Phase||309
3295784|NCT02900378|4029740|FG001|COMPLETED|Treatment Phase||310
3295785|NCT02900378|4029739|FG000|NOT COMPLETED|Treatment Phase||0
3295786|NCT02900378|4029740|FG001|NOT COMPLETED|Treatment Phase||0
3295787|NCT02901054|4029746|FG000|STARTED|Overall Study|19 consented, 3 withdrew prior to intervention, 1 received study drug but surgery was cancelled.|19
3295788|NCT02901054|4029746|FG000|COMPLETED|Overall Study||15
3295789|NCT02901054|4029746|FG000|NOT COMPLETED|Overall Study||4
3295790|NCT02901080|4029750|FG000|STARTED|Overall Study||161
3295791|NCT02901080|4029750|FG000|COMPLETED|Overall Study||112
3295792|NCT02901080|4029750|FG000|NOT COMPLETED|Overall Study||49
3295793|NCT02901249|4029756|FG000|STARTED|Overall Study||68
3295794|NCT02901249|4029756|FG000|COMPLETED|Overall Study|Primary and secondary outcomes are assessed just at the end of the protocol, not at each step|43
3295795|NCT02901249|4029756|FG000|NOT COMPLETED|Overall Study||25
3295796|NCT02901275|4029760|FG000|STARTED|Overall Study||29
3295797|NCT02901275|4029760|FG000|Placebo + Placebo|Overall Study||29
3295798|NCT02901275|4029760|FG000|Hydromorphone (Oral) 4mg + Placebo|Overall Study||29
3295799|NCT02901275|4029760|FG000|Hydromorphone (Oral) 4mg + Dronabinol (Oral) 2.5mg|Overall Study||29
3295800|NCT02901275|4029760|FG000|Hydromorphone (Oral) 4mg + Dronabinol (Oral) 5mg|Overall Study||29
3295801|NCT02901275|4029760|FG000|Hydromorphone (Oral) 4mg + Dronabinol (Oral) 10mg|Overall Study||29
3295802|NCT02901275|4029760|FG000|COMPLETED|Overall Study||29
3295803|NCT02901275|4029760|FG000|NOT COMPLETED|Overall Study||0
3295804|NCT02901431|4029780|FG000|STARTED|PK Part||12
3295805|NCT02901431|4029781|FG001|STARTED|PK Part||11
3295806|NCT02901431|4029782|FG002|STARTED|PK Part||15
3124098|NCT01646177|3849238|FG001|STARTED|Blinded Induction Dosing (Week 0-12)||382
3124099|NCT01646177|3849239|FG002|STARTED|Blinded Induction Dosing (Week 0-12)||386
3124100|NCT01646177|3849240|FG003|STARTED|Blinded Induction Dosing (Week 0-12)||385
3124101|NCT01646177|3849241|FG004|STARTED|Blinded Induction Dosing (Week 0-12)||0
3124102|NCT01646177|3849242|FG005|STARTED|Blinded Induction Dosing (Week 0-12)||0
3124103|NCT01646177|3849243|FG006|STARTED|Blinded Induction Dosing (Week 0-12)||0
3124104|NCT01646177|3849244|FG007|STARTED|Blinded Induction Dosing (Week 0-12)||0
3124105|NCT01646177|3849245|FG008|STARTED|Blinded Induction Dosing (Week 0-12)||0
3124106|NCT01646177|3849246|FG009|STARTED|Blinded Induction Dosing (Week 0-12)||0
3124107|NCT01646177|3849247|FG010|STARTED|Blinded Induction Dosing (Week 0-12)||0
3124108|NCT01646177|3849248|FG011|STARTED|Blinded Induction Dosing (Week 0-12)||0
3124109|NCT01646177|3849237|FG000|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||193
3124110|NCT01646177|3849238|FG001|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||382
3124111|NCT01646177|3849239|FG002|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||382
3124112|NCT01646177|3849240|FG003|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||384
3124113|NCT01646177|3849241|FG004|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||0
3124114|NCT01646177|3849242|FG005|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||0
3124115|NCT01646177|3849243|FG006|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||0
3124116|NCT01646177|3849244|FG007|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||0
3124117|NCT01646177|3849245|FG008|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||0
3124118|NCT01646177|3849246|FG009|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||0
3124119|NCT01646177|3849247|FG010|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||0
3124120|NCT01646177|3849248|FG011|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||0
3124121|NCT01646177|3849237|FG000|COMPLETED|Blinded Induction Dosing (Week 0-12)||183
3124122|NCT01646177|3849238|FG001|COMPLETED|Blinded Induction Dosing (Week 0-12)||369
3124123|NCT01646177|3849239|FG002|COMPLETED|Blinded Induction Dosing (Week 0-12)||360
3124124|NCT01646177|3849240|FG003|COMPLETED|Blinded Induction Dosing (Week 0-12)||363
3124125|NCT01646177|3849241|FG004|COMPLETED|Blinded Induction Dosing (Week 0-12)||0
3124126|NCT01646177|3849242|FG005|COMPLETED|Blinded Induction Dosing (Week 0-12)||0
3124127|NCT01646177|3849243|FG006|COMPLETED|Blinded Induction Dosing (Week 0-12)||0
3124128|NCT01646177|3849244|FG007|COMPLETED|Blinded Induction Dosing (Week 0-12)||0
3124129|NCT01646177|3849245|FG008|COMPLETED|Blinded Induction Dosing (Week 0-12)||0
3124130|NCT01646177|3849246|FG009|COMPLETED|Blinded Induction Dosing (Week 0-12)||0
3124131|NCT01646177|3849247|FG010|COMPLETED|Blinded Induction Dosing (Week 0-12)||0
3124132|NCT01646177|3849248|FG011|COMPLETED|Blinded Induction Dosing (Week 0-12)||0
3124133|NCT01646177|3849237|FG000|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||10
3124134|NCT01646177|3849238|FG001|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||13
3124135|NCT01646177|3849239|FG002|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||26
3124136|NCT01646177|3849240|FG003|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||22
3124137|NCT01646177|3849241|FG004|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||0
3124138|NCT01646177|3849242|FG005|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||0
3124139|NCT01646177|3849243|FG006|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||0
3124140|NCT01646177|3849244|FG007|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||0
3295807|NCT02901431|4029783|FG003|STARTED|PK Part||0
3295808|NCT02901431|4029784|FG004|STARTED|PK Part||0
3295809|NCT02901431|4029785|FG005|STARTED|PK Part||0
3295810|NCT02901431|4029786|FG006|STARTED|PK Part||0
3295811|NCT02901431|4029787|FG007|STARTED|PK Part||0
3295812|NCT02901431|4029788|FG008|STARTED|PK Part||0
3295813|NCT02901431|4029789|FG009|STARTED|PK Part||0
3295814|NCT02901431|4029790|FG010|STARTED|PK Part||0
3295815|NCT02901431|4029791|FG011|STARTED|PK Part||0
3295816|NCT02901431|4029792|FG012|STARTED|PK Part||0
3295817|NCT02901431|4029780|FG000|COMPLETED|PK Part||5
3295818|NCT02901431|4029781|FG001|COMPLETED|PK Part||5
3295819|NCT02901431|4029782|FG002|COMPLETED|PK Part||6
3295820|NCT02901431|4029783|FG003|COMPLETED|PK Part||0
3295821|NCT02901431|4029784|FG004|COMPLETED|PK Part||0
3295822|NCT02901431|4029785|FG005|COMPLETED|PK Part||0
3295823|NCT02901431|4029786|FG006|COMPLETED|PK Part||0
3295824|NCT02901431|4029787|FG007|COMPLETED|PK Part||0
3295825|NCT02901431|4029788|FG008|COMPLETED|PK Part||0
3295826|NCT02901431|4029789|FG009|COMPLETED|PK Part||0
3295827|NCT02901431|4029790|FG010|COMPLETED|PK Part||0
3295828|NCT02901431|4029791|FG011|COMPLETED|PK Part||0
3295829|NCT02901431|4029792|FG012|COMPLETED|PK Part||0
3295830|NCT02901431|4029780|FG000|NOT COMPLETED|PK Part||7
3295831|NCT02901431|4029781|FG001|NOT COMPLETED|PK Part||6
3295832|NCT02901431|4029782|FG002|NOT COMPLETED|PK Part||9
3295833|NCT02901431|4029783|FG003|NOT COMPLETED|PK Part||0
3295834|NCT02901431|4029784|FG004|NOT COMPLETED|PK Part||0
3295835|NCT02901431|4029785|FG005|NOT COMPLETED|PK Part||0
3295836|NCT02901431|4029786|FG006|NOT COMPLETED|PK Part||0
3295837|NCT02901431|4029787|FG007|NOT COMPLETED|PK Part||0
3295838|NCT02901431|4029788|FG008|NOT COMPLETED|PK Part||0
3295839|NCT02901431|4029789|FG009|NOT COMPLETED|PK Part||0
3295840|NCT02901431|4029790|FG010|NOT COMPLETED|PK Part||0
3295841|NCT02901431|4029791|FG011|NOT COMPLETED|PK Part||0
3295842|NCT02901431|4029792|FG012|NOT COMPLETED|PK Part||0
3295843|NCT02901431|4029780|FG000|STARTED|Main Treatment Part||0
3295844|NCT02901431|4029781|FG001|STARTED|Main Treatment Part||0
3295845|NCT02901431|4029782|FG002|STARTED|Main Treatment Part||0
3295846|NCT02901431|4029783|FG003|STARTED|Main Treatment Part||112
3295847|NCT02901431|4029784|FG004|STARTED|Main Treatment Part||57
3295848|NCT02901431|4029785|FG005|STARTED|Main Treatment Part||66
3295849|NCT02901431|4029786|FG006|STARTED|Main Treatment Part||66
3295850|NCT02901431|4029787|FG007|STARTED|Main Treatment Part||7
3295851|NCT02901431|4029788|FG008|STARTED|Main Treatment Part||0
3124141|NCT01646177|3849245|FG008|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||0
3124142|NCT01646177|3849246|FG009|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||0
3124143|NCT01646177|3849247|FG010|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||0
3124144|NCT01646177|3849248|FG011|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||0
3124145|NCT01646177|3849237|FG000|STARTED|Long-Term Extension Period (Week 12-264)|Participants completed prior period then proceeded to IXE80Q4W long-term extension period.|0
3124146|NCT01646177|3849238|FG001|STARTED|Long-Term Extension Period (Week 12-264)|Participants completed prior period then proceeded to IXE80Q4W long-term extension period.|0
3124147|NCT01646177|3849239|FG002|STARTED|Long-Term Extension Period (Week 12-264)|Participants completed prior period then proceeded to IXE80Q4W long-term extension period.|0
3124148|NCT01646177|3849240|FG003|STARTED|Long-Term Extension Period (Week 12-264)|Participants completed prior period then proceeded to IXE80Q4W long-term extension period.|0
3124149|NCT01646177|3849241|FG004|STARTED|Long-Term Extension Period (Week 12-264)|Participants completed prior period then proceeded to IXE80Q4W long-term extension period.|183
3124150|NCT01646177|3849242|FG005|STARTED|Long-Term Extension Period (Week 12-264)|Participants completed prior period then proceeded to IXE80Q4W long-term extension period.|369
3124151|NCT01646177|3849243|FG006|STARTED|Long-Term Extension Period (Week 12-264)|Participants completed prior period then proceeded to IXE80Q4W long-term extension period.|360
3124152|NCT01646177|3849244|FG007|STARTED|Long-Term Extension Period (Week 12-264)|Participants completed prior period then proceeded to IXE80Q4W long-term extension period.|362
3124153|NCT01646177|3849245|FG008|STARTED|Long-Term Extension Period (Week 12-264)||0
3124154|NCT01646177|3849246|FG009|STARTED|Long-Term Extension Period (Week 12-264)||0
3124155|NCT01646177|3849247|FG010|STARTED|Long-Term Extension Period (Week 12-264)||0
3124156|NCT01646177|3849248|FG011|STARTED|Long-Term Extension Period (Week 12-264)||0
3124157|NCT01646177|3849237|FG000|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||0
3124158|NCT01646177|3849238|FG001|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||0
3124159|NCT01646177|3849239|FG002|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||0
3136297|NCT01711879|3861410|FG000|STARTED|Overall Study||3
3295852|NCT02901431|4029789|FG009|STARTED|Main Treatment Part||0
3295853|NCT02901431|4029790|FG010|STARTED|Main Treatment Part||0
3295854|NCT02901431|4029791|FG011|STARTED|Main Treatment Part||0
3295855|NCT02901431|4029792|FG012|STARTED|Main Treatment Part||0
3295856|NCT02901431|4029780|FG000|COMPLETED|Main Treatment Part||0
3295857|NCT02901431|4029781|FG001|COMPLETED|Main Treatment Part||0
3295858|NCT02901431|4029782|FG002|COMPLETED|Main Treatment Part||0
3295859|NCT02901431|4029783|FG003|COMPLETED|Main Treatment Part||86
3295860|NCT02901431|4029784|FG004|COMPLETED|Main Treatment Part||50
3295861|NCT02901431|4029785|FG005|COMPLETED|Main Treatment Part||54
3295862|NCT02901431|4029786|FG006|COMPLETED|Main Treatment Part||55
3295863|NCT02901431|4029787|FG007|COMPLETED|Main Treatment Part||7
3295864|NCT02901431|4029788|FG008|COMPLETED|Main Treatment Part||0
3295865|NCT02901431|4029789|FG009|COMPLETED|Main Treatment Part||0
3295866|NCT02901431|4029790|FG010|COMPLETED|Main Treatment Part||0
3295867|NCT02901431|4029791|FG011|COMPLETED|Main Treatment Part||0
3295868|NCT02901431|4029792|FG012|COMPLETED|Main Treatment Part||0
3295869|NCT02901431|4029780|FG000|NOT COMPLETED|Main Treatment Part||0
3295870|NCT02901431|4029781|FG001|NOT COMPLETED|Main Treatment Part||0
3295871|NCT02901431|4029782|FG002|NOT COMPLETED|Main Treatment Part||0
3295872|NCT02901431|4029783|FG003|NOT COMPLETED|Main Treatment Part||26
3295873|NCT02901431|4029784|FG004|NOT COMPLETED|Main Treatment Part||7
3295874|NCT02901431|4029785|FG005|NOT COMPLETED|Main Treatment Part||12
3295875|NCT02901431|4029786|FG006|NOT COMPLETED|Main Treatment Part||11
3295876|NCT02901431|4029787|FG007|NOT COMPLETED|Main Treatment Part||0
3295877|NCT02901431|4029788|FG008|NOT COMPLETED|Main Treatment Part||0
3295878|NCT02901431|4029789|FG009|NOT COMPLETED|Main Treatment Part||0
3295879|NCT02901431|4029790|FG010|NOT COMPLETED|Main Treatment Part||0
3295880|NCT02901431|4029791|FG011|NOT COMPLETED|Main Treatment Part||0
3295881|NCT02901431|4029792|FG012|NOT COMPLETED|Main Treatment Part||0
3295882|NCT02901431|4029780|FG000|STARTED|Open Label Part||0
3295883|NCT02901431|4029781|FG001|STARTED|Open Label Part||0
3295884|NCT02901431|4029782|FG002|STARTED|Open Label Part||0
3295885|NCT02901431|4029783|FG003|STARTED|Open Label Part||0
3295886|NCT02901431|4029784|FG004|STARTED|Open Label Part||0
3295887|NCT02901431|4029785|FG005|STARTED|Open Label Part||0
3295888|NCT02901431|4029786|FG006|STARTED|Open Label Part||0
3295889|NCT02901431|4029787|FG007|STARTED|Open Label Part||0
3295890|NCT02901431|4029788|FG008|STARTED|Open Label Part||68
3295891|NCT02901431|4029789|FG009|STARTED|Open Label Part||35
3295892|NCT02901431|4029790|FG010|STARTED|Open Label Part||40
3295893|NCT02901431|4029791|FG011|STARTED|Open Label Part||46
3295894|NCT02901431|4029792|FG012|STARTED|Open Label Part||5
3295895|NCT02901431|4029780|FG000|COMPLETED|Open Label Part||0
3295896|NCT02901431|4029781|FG001|COMPLETED|Open Label Part||0
3295897|NCT02901431|4029782|FG002|COMPLETED|Open Label Part||0
3295898|NCT02901431|4029783|FG003|COMPLETED|Open Label Part||0
3295899|NCT02901431|4029784|FG004|COMPLETED|Open Label Part||0
3295900|NCT02901431|4029785|FG005|COMPLETED|Open Label Part||0
3295901|NCT02901431|4029786|FG006|COMPLETED|Open Label Part||0
3295902|NCT02901431|4029787|FG007|COMPLETED|Open Label Part||0
3295903|NCT02901431|4029788|FG008|COMPLETED|Open Label Part||20
3295904|NCT02901431|4029789|FG009|COMPLETED|Open Label Part||11
3295905|NCT02901431|4029790|FG010|COMPLETED|Open Label Part||11
3295906|NCT02901431|4029791|FG011|COMPLETED|Open Label Part||7
3295907|NCT02901431|4029792|FG012|COMPLETED|Open Label Part||2
3295908|NCT02901431|4029780|FG000|NOT COMPLETED|Open Label Part||0
3124160|NCT01646177|3849240|FG003|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||0
3124161|NCT01646177|3849241|FG004|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||183
3124162|NCT01646177|3849242|FG005|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||369
3124163|NCT01646177|3849243|FG006|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||360
3124164|NCT01646177|3849244|FG007|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||362
3124165|NCT01646177|3849245|FG008|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||0
3124166|NCT01646177|3849246|FG009|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||0
3124167|NCT01646177|3849247|FG010|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||0
3124168|NCT01646177|3849248|FG011|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||0
3124169|NCT01646177|3849237|FG000|COMPLETED|Long-Term Extension Period (Week 12-264)||0
3124170|NCT01646177|3849238|FG001|COMPLETED|Long-Term Extension Period (Week 12-264)||0
3124171|NCT01646177|3849239|FG002|COMPLETED|Long-Term Extension Period (Week 12-264)||0
3124172|NCT01646177|3849240|FG003|COMPLETED|Long-Term Extension Period (Week 12-264)||0
3124173|NCT01646177|3849241|FG004|COMPLETED|Long-Term Extension Period (Week 12-264)||135
3124174|NCT01646177|3849242|FG005|COMPLETED|Long-Term Extension Period (Week 12-264)||256
3124175|NCT01646177|3849243|FG006|COMPLETED|Long-Term Extension Period (Week 12-264)||244
3124176|NCT01646177|3849244|FG007|COMPLETED|Long-Term Extension Period (Week 12-264)||255
3124177|NCT01646177|3849245|FG008|COMPLETED|Long-Term Extension Period (Week 12-264)||0
3124178|NCT01646177|3849246|FG009|COMPLETED|Long-Term Extension Period (Week 12-264)||0
3124179|NCT01646177|3849247|FG010|COMPLETED|Long-Term Extension Period (Week 12-264)||0
3124180|NCT01646177|3849248|FG011|COMPLETED|Long-Term Extension Period (Week 12-264)||0
3124181|NCT01646177|3849237|FG000|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
3124182|NCT01646177|3849238|FG001|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
3124183|NCT01646177|3849239|FG002|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
3124184|NCT01646177|3849240|FG003|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
3124185|NCT01646177|3849241|FG004|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||48
3124186|NCT01646177|3849242|FG005|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||113
3124187|NCT01646177|3849243|FG006|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||116
3124188|NCT01646177|3849244|FG007|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||107
3124189|NCT01646177|3849245|FG008|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
3124190|NCT01646177|3849246|FG009|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
3124191|NCT01646177|3849247|FG010|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
3124192|NCT01646177|3849248|FG011|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
3124193|NCT01646177|3849237|FG000|STARTED|Follow-Up Period (Minimum of 12 Weeks)||0
3124194|NCT01646177|3849238|FG001|STARTED|Follow-Up Period (Minimum of 12 Weeks)||0
3124195|NCT01646177|3849239|FG002|STARTED|Follow-Up Period (Minimum of 12 Weeks)||0
3124196|NCT01646177|3849240|FG003|STARTED|Follow-Up Period (Minimum of 12 Weeks)||0
3124197|NCT01646177|3849241|FG004|STARTED|Follow-Up Period (Minimum of 12 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|0
3124198|NCT01646177|3849242|FG005|STARTED|Follow-Up Period (Minimum of 12 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|0
3124199|NCT01646177|3849243|FG006|STARTED|Follow-Up Period (Minimum of 12 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|0
3124200|NCT01646177|3849244|FG007|STARTED|Follow-Up Period (Minimum of 12 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|0
3124201|NCT01646177|3849245|FG008|STARTED|Follow-Up Period (Minimum of 12 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|157
3295909|NCT02901431|4029781|FG001|NOT COMPLETED|Open Label Part||0
3295910|NCT02901431|4029782|FG002|NOT COMPLETED|Open Label Part||0
3295911|NCT02901431|4029783|FG003|NOT COMPLETED|Open Label Part||0
3295912|NCT02901431|4029784|FG004|NOT COMPLETED|Open Label Part||0
3295913|NCT02901431|4029785|FG005|NOT COMPLETED|Open Label Part||0
3295914|NCT02901431|4029786|FG006|NOT COMPLETED|Open Label Part||0
3295915|NCT02901431|4029787|FG007|NOT COMPLETED|Open Label Part||0
3295916|NCT02901431|4029788|FG008|NOT COMPLETED|Open Label Part||48
3295917|NCT02901431|4029789|FG009|NOT COMPLETED|Open Label Part||24
3295918|NCT02901431|4029790|FG010|NOT COMPLETED|Open Label Part||29
3295919|NCT02901431|4029791|FG011|NOT COMPLETED|Open Label Part||39
3295920|NCT02901431|4029792|FG012|NOT COMPLETED|Open Label Part||3
3316842|NCT03120013|4050329|FG001|STARTED|First Intervention (2 Weeks)||11
3316843|NCT03120013|4050328|FG000|Received Intervention|First Intervention (2 Weeks)||10
3316844|NCT03120013|4050329|FG001|Received Intervention|First Intervention (2 Weeks)||11
3316845|NCT03120013|4050328|FG000|COMPLETED|First Intervention (2 Weeks)||10
3316846|NCT03120013|4050329|FG001|COMPLETED|First Intervention (2 Weeks)||10
3316847|NCT03120013|4050328|FG000|NOT COMPLETED|First Intervention (2 Weeks)||0
3316848|NCT03120013|4050329|FG001|NOT COMPLETED|First Intervention (2 Weeks)||1
3316849|NCT03120013|4050328|FG000|STARTED|Washout (6 Months)||10
3316850|NCT03120013|4050329|FG001|STARTED|Washout (6 Months)||10
3316851|NCT03120013|4050328|FG000|COMPLETED|Washout (6 Months)||10
3316852|NCT03120013|4050329|FG001|COMPLETED|Washout (6 Months)||10
3316853|NCT03120013|4050328|FG000|NOT COMPLETED|Washout (6 Months)||0
3316854|NCT03120013|4050329|FG001|NOT COMPLETED|Washout (6 Months)||0
3316855|NCT03120013|4050328|FG000|STARTED|Second Intervention (2 Weeks)||10
3124202|NCT01646177|3849246|FG009|STARTED|Follow-Up Period (Minimum of 12 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|309
3124203|NCT01646177|3849247|FG010|STARTED|Follow-Up Period (Minimum of 12 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|305
3124204|NCT01646177|3849248|FG011|STARTED|Follow-Up Period (Minimum of 12 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|313
3124205|NCT01646177|3849237|FG000|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||0
3124206|NCT01646177|3849238|FG001|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||0
3124207|NCT01646177|3849239|FG002|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||0
3124208|NCT01646177|3849240|FG003|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||0
3124209|NCT01646177|3849241|FG004|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||0
3124210|NCT01646177|3849242|FG005|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||0
3295921|NCT02901899|4029817|FG000|STARTED|Reached 1st Response Assessment||45
3295922|NCT02901899|4029817|FG000|Registered|Reached 1st Response Assessment||45
3295923|NCT02901899|4029817|FG000|Started Treatment|Reached 1st Response Assessment||43
3295924|NCT02901899|4029817|FG000|Attempted 2 Cycles of Treatment/Reached First Response|Reached 1st Response Assessment||37
3295925|NCT02901899|4029817|FG000|COMPLETED|Reached 1st Response Assessment||37
3295926|NCT02901899|4029817|FG000|NOT COMPLETED|Reached 1st Response Assessment||8
3295927|NCT02901899|4029817|FG000|STARTED|Continued Treatment After 1st Response||37
3295928|NCT02901899|4029817|FG000|Went on to Start Cycle 3|Continued Treatment After 1st Response||21
3295929|NCT02901899|4029817|FG000|COMPLETED|Continued Treatment After 1st Response||21
3295930|NCT02901899|4029817|FG000|NOT COMPLETED|Continued Treatment After 1st Response||16
3295931|NCT02901899|4029817|FG000|STARTED|Follow up|All patients who receive at least one dose of study drug go into the follow up period.|43
3295932|NCT02901899|4029817|FG000|COMPLETED|Follow up||27
3295933|NCT02901899|4029817|FG000|NOT COMPLETED|Follow up||16
3295934|NCT02901951|4029821|FG000|STARTED|Overall Study||103
3295935|NCT02901951|4029821|FG000|COMPLETED|Overall Study||103
3295936|NCT02901951|4029821|FG000|NOT COMPLETED|Overall Study||0
3295937|NCT02902081|4029825|FG000|STARTED|Overall Study||38
3295938|NCT02902081|4029825|FG000|COMPLETED|Overall Study||38
3295939|NCT02902081|4029825|FG000|NOT COMPLETED|Overall Study||0
3316856|NCT03120013|4050329|FG001|STARTED|Second Intervention (2 Weeks)||10
3316857|NCT03120013|4050328|FG000|COMPLETED|Second Intervention (2 Weeks)||10
3316858|NCT03120013|4050329|FG001|COMPLETED|Second Intervention (2 Weeks)||10
3316859|NCT03120013|4050328|FG000|NOT COMPLETED|Second Intervention (2 Weeks)||0
3316860|NCT03120013|4050329|FG001|NOT COMPLETED|Second Intervention (2 Weeks)||0
3316861|NCT03120351|4050337|FG000|STARTED|Overall Study||40
3316862|NCT03120351|4050338|FG001|STARTED|Overall Study||40
3316863|NCT03120351|4050337|FG000|COMPLETED|Overall Study||39
3316864|NCT03120351|4050338|FG001|COMPLETED|Overall Study||39
3316865|NCT03120351|4050337|FG000|NOT COMPLETED|Overall Study||1
3316866|NCT03120351|4050338|FG001|NOT COMPLETED|Overall Study||1
3317238|NCT03124771|4050772|FG000|COMPLETED|Overall Study||132
3317239|NCT03124771|4050772|FG000|NOT COMPLETED|Overall Study||0
3317240|NCT03124784|4050776|FG000|STARTED|Overall Study||27
3317241|NCT03124784|4050776|FG000|COMPLETED|Overall Study||25
3317242|NCT03124784|4050776|FG000|NOT COMPLETED|Overall Study||2
3317243|NCT03124797|4050780|FG000|STARTED|Overall Study||18
3317244|NCT03124797|4050780|FG000|COMPLETED|Overall Study||18
3317245|NCT03124797|4050780|FG000|NOT COMPLETED|Overall Study||0
3317246|NCT03124823|4050784|FG000|STARTED|Overall Study||11
3317247|NCT03124823|4050784|FG000|COMPLETED|Overall Study||11
3317248|NCT03124823|4050784|FG000|NOT COMPLETED|Overall Study||0
3317249|NCT03124836|4050788|FG000|STARTED|Overall Study||28
3317250|NCT03124836|4050788|FG000|COMPLETED|Overall Study||28
3317251|NCT03124836|4050788|FG000|NOT COMPLETED|Overall Study||0
3317252|NCT03124901|4050792|FG000|STARTED|Overall Study||147
3317253|NCT03124901|4050792|FG000|COMPLETED|Overall Study||147
3317254|NCT03124901|4050792|FG000|NOT COMPLETED|Overall Study||0
3317255|NCT03124927|4050796|FG000|STARTED|Overall Study||25
3317256|NCT03124927|4050796|FG000|COMPLETED|Overall Study||25
3317257|NCT03124927|4050796|FG000|NOT COMPLETED|Overall Study||0
3317258|NCT03124966|4050800|FG000|STARTED|Overall Study||118
3317259|NCT03124966|4050800|FG000|COMPLETED|Overall Study||118
3317260|NCT03124966|4050800|FG000|NOT COMPLETED|Overall Study||0
3317261|NCT03124979|4050804|FG000|STARTED|Overall Study||13
3317262|NCT03124979|4050804|FG000|COMPLETED|Overall Study||13
3317263|NCT03124979|4050804|FG000|NOT COMPLETED|Overall Study||0
3317264|NCT03125005|4050808|FG000|STARTED|Overall Study||51
3317265|NCT03125005|4050808|FG000|COMPLETED|Overall Study||51
3317266|NCT03125005|4050808|FG000|NOT COMPLETED|Overall Study||0
3317267|NCT03125018|4050812|FG000|STARTED|Overall Study||13
3317268|NCT03125018|4050812|FG000|COMPLETED|Overall Study||13
3317269|NCT03125018|4050812|FG000|NOT COMPLETED|Overall Study||0
3317270|NCT03125031|4050816|FG000|STARTED|Overall Study||44
3317271|NCT03125031|4050817|FG001|STARTED|Overall Study||44
3317272|NCT03125031|4050816|FG000|COMPLETED|Overall Study||44
3317273|NCT03125031|4050817|FG001|COMPLETED|Overall Study||44
3317274|NCT03125031|4050816|FG000|NOT COMPLETED|Overall Study||0
3317275|NCT03125031|4050817|FG001|NOT COMPLETED|Overall Study||0
3317276|NCT03125200|4050829|FG000|STARTED|Overall Study||2
3317277|NCT03125200|4050830|FG001|STARTED|Overall Study||2
3317278|NCT03125200|4050831|FG002|STARTED|Overall Study||2
3317279|NCT03125200|4050832|FG003|STARTED|Overall Study||5
3124211|NCT01646177|3849243|FG006|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||0
3124212|NCT01646177|3849244|FG007|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||0
3124213|NCT01646177|3849245|FG008|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||157
3124214|NCT01646177|3849246|FG009|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||309
3124215|NCT01646177|3849247|FG010|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||305
3124216|NCT01646177|3849248|FG011|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||313
3124217|NCT01646177|3849237|FG000|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
3124218|NCT01646177|3849238|FG001|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
3124219|NCT01646177|3849239|FG002|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
3124220|NCT01646177|3849240|FG003|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
3124221|NCT01646177|3849241|FG004|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
3124222|NCT01646177|3849242|FG005|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
3124223|NCT01646177|3849243|FG006|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
3124224|NCT01646177|3849244|FG007|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
3124225|NCT01646177|3849245|FG008|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||126
3124226|NCT01646177|3849246|FG009|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||233
3124227|NCT01646177|3849247|FG010|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||225
3124228|NCT01646177|3849248|FG011|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||230
3124229|NCT01646177|3849237|FG000|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
3295940|NCT02902146|4029835|FG000|STARTED|Overall Study||381
3295941|NCT02902146|4029836|FG001|STARTED|Overall Study||376
3295942|NCT02902146|4029835|FG000|COMPLETED|Overall Study||381
3295943|NCT02902146|4029836|FG001|COMPLETED|Overall Study||376
3295944|NCT02902146|4029835|FG000|NOT COMPLETED|Overall Study||0
3295945|NCT02902146|4029836|FG001|NOT COMPLETED|Overall Study||0
3295946|NCT02902172|4029844|FG000|STARTED|Overall Study||16
3295947|NCT02902172|4029845|FG001|STARTED|Overall Study||20
3295948|NCT02902172|4029844|FG000|COMPLETED|Overall Study||16
3295949|NCT02902172|4029845|FG001|COMPLETED|Overall Study||20
3295950|NCT02902172|4029844|FG000|NOT COMPLETED|Overall Study||0
3295951|NCT02902172|4029845|FG001|NOT COMPLETED|Overall Study||0
3295952|NCT02902237|4029852|FG000|STARTED|Overall Study||17
3295953|NCT02902237|4029852|FG000|COMPLETED|Overall Study|STUDY INITIATION: 2017 03 29, 1st Patient In, STUDY COMPLETION: 2019 11 05, Date of Study End|17
3295954|NCT02902237|4029852|FG000|NOT COMPLETED|Overall Study||0
3295955|NCT02902770|4029866|FG000|STARTED|Overall Study||50
3295956|NCT02902770|4029867|FG001|STARTED|Overall Study||50
3295957|NCT02902770|4029868|FG002|STARTED|Overall Study||50
3295958|NCT02902770|4029866|FG000|COMPLETED|Overall Study||50
3295959|NCT02902770|4029867|FG001|COMPLETED|Overall Study||50
3295960|NCT02902770|4029868|FG002|COMPLETED|Overall Study||50
3295961|NCT02902770|4029866|FG000|NOT COMPLETED|Overall Study||0
3295962|NCT02902770|4029867|FG001|NOT COMPLETED|Overall Study||0
3295963|NCT02902770|4029868|FG002|NOT COMPLETED|Overall Study||0
3295964|NCT02902809|4029876|FG000|STARTED|Overall Study||28
3295965|NCT02902809|4029876|FG000|Treatment Received|Overall Study||28
3295966|NCT02902809|4029876|FG000|Treatment Completed|Overall Study||2
3295967|NCT02902809|4029876|FG000|COMPLETED|Overall Study||0
3295968|NCT02902809|4029876|FG000|NOT COMPLETED|Overall Study||28
3295969|NCT02902913|4029880|FG000|STARTED|Overall Study||9
3295970|NCT02902913|4029880|FG000|First Intervention (1 Day)|Overall Study||9
3295971|NCT02902913|4029880|FG000|Washout (7 Days)|Overall Study||9
3295972|NCT02902913|4029880|FG000|Second Intervention (1 Day)|Overall Study||9
3295973|NCT02902913|4029880|FG000|Washout (7 Days)|Overall Study||9
3295974|NCT02902913|4029880|FG000|Third Intervention (1 Day)|Overall Study||9
3295975|NCT02902913|4029880|FG000|Washout (7 Days)|Overall Study||9
3295976|NCT02902913|4029880|FG000|Ibuprofen (400mg)|Overall Study||9
3295977|NCT02902913|4029880|FG000|COMPLETED|Overall Study||9
3295978|NCT02902913|4029880|FG000|NOT COMPLETED|Overall Study||0
3295979|NCT02902965|4029888|FG000|STARTED|Overall Study||74
3295980|NCT02902965|4029888|FG000|COMPLETED|Overall Study||64
3295981|NCT02902965|4029888|FG000|NOT COMPLETED|Overall Study||10
3295982|NCT02903030|4029895|FG000|STARTED|First Intervention (8 Weeks)||8
3295983|NCT02903030|4029896|FG001|STARTED|First Intervention (8 Weeks)||5
3295984|NCT02903030|4029895|FG000|Received Intervention|First Intervention (8 Weeks)||6
3295985|NCT02903030|4029896|FG001|Received Intervention|First Intervention (8 Weeks)||4
3295986|NCT02903030|4029895|FG000|COMPLETED|First Intervention (8 Weeks)||6
3295987|NCT02903030|4029896|FG001|COMPLETED|First Intervention (8 Weeks)||4
3295988|NCT02903030|4029895|FG000|NOT COMPLETED|First Intervention (8 Weeks)||2
3295989|NCT02903030|4029896|FG001|NOT COMPLETED|First Intervention (8 Weeks)||1
3295990|NCT02903030|4029895|FG000|STARTED|Washout (3 Weeks)||6
3295991|NCT02903030|4029896|FG001|STARTED|Washout (3 Weeks)||4
3295992|NCT02903030|4029895|FG000|COMPLETED|Washout (3 Weeks)||6
3295993|NCT02903030|4029896|FG001|COMPLETED|Washout (3 Weeks)||4
3295994|NCT02903030|4029895|FG000|NOT COMPLETED|Washout (3 Weeks)||0
3295995|NCT02903030|4029896|FG001|NOT COMPLETED|Washout (3 Weeks)||0
3295996|NCT02903030|4029895|FG000|STARTED|Second Intervention (8 Weeks)||6
3295997|NCT02903030|4029896|FG001|STARTED|Second Intervention (8 Weeks)||4
3295998|NCT02903030|4029895|FG000|COMPLETED|Second Intervention (8 Weeks)||6
3295999|NCT02903030|4029896|FG001|COMPLETED|Second Intervention (8 Weeks)||4
3296000|NCT02903030|4029895|FG000|NOT COMPLETED|Second Intervention (8 Weeks)||0
3296001|NCT02903030|4029896|FG001|NOT COMPLETED|Second Intervention (8 Weeks)||0
3124230|NCT01646177|3849238|FG001|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
3124231|NCT01646177|3849239|FG002|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
3124232|NCT01646177|3849240|FG003|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
3124233|NCT01646177|3849241|FG004|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
3124234|NCT01646177|3849242|FG005|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
3124235|NCT01646177|3849243|FG006|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
3124236|NCT01646177|3849244|FG007|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
3124237|NCT01646177|3849245|FG008|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||31
3124238|NCT01646177|3849246|FG009|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||76
3124239|NCT01646177|3849247|FG010|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||80
3124240|NCT01646177|3849248|FG011|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||83
3124241|NCT01646203|3849271|FG000|STARTED|Overall Study||2
3124242|NCT01646203|3849272|FG001|STARTED|Overall Study||5
3124243|NCT01646203|3849273|FG002|STARTED|Overall Study||7
3124244|NCT01646203|3849271|FG000|Received at Least One Dose of Study Drug|Overall Study||2
3124245|NCT01646203|3849272|FG001|Received at Least One Dose of Study Drug|Overall Study||5
3124246|NCT01646203|3849273|FG002|Received at Least One Dose of Study Drug|Overall Study||7
3124247|NCT01646203|3849271|FG000|COMPLETED|Overall Study||0
3296002|NCT02903121|4029907|FG000|STARTED|Overall Study||57
3296003|NCT02903121|4029908|FG001|STARTED|Overall Study||52
3296004|NCT02903121|4029907|FG000|COMPLETED|Overall Study||34
3296005|NCT02903121|4029908|FG001|COMPLETED|Overall Study||38
3296006|NCT02903121|4029907|FG000|NOT COMPLETED|Overall Study||23
3296007|NCT02903121|4029908|FG001|NOT COMPLETED|Overall Study||14
3296008|NCT02903238|4029914|FG000|STARTED|Overall Study||21
3296009|NCT02903238|4029914|FG000|COMPLETED|Overall Study||17
3296010|NCT02903238|4029914|FG000|NOT COMPLETED|Overall Study||4
3296011|NCT02903368|4029921|FG000|STARTED|Overall Study||59
3296012|NCT02903368|4029922|FG001|STARTED|Overall Study||59
3296013|NCT02903368|4029921|FG000|COMPLETED|Overall Study||55
3296014|NCT02903368|4029922|FG001|COMPLETED|Overall Study||59
3296015|NCT02903368|4029921|FG000|NOT COMPLETED|Overall Study||4
3296016|NCT02903368|4029922|FG001|NOT COMPLETED|Overall Study||0
3296017|NCT02903394|4029933|FG000|STARTED|Overall Study||5
3296018|NCT02903394|4029934|FG001|STARTED|Overall Study||50
3296019|NCT02903394|4029933|FG000|COMPLETED|Overall Study||5
3296020|NCT02903394|4029934|FG001|COMPLETED|Overall Study||50
3296021|NCT02903394|4029933|FG000|NOT COMPLETED|Overall Study||0
3296022|NCT02903394|4029934|FG001|NOT COMPLETED|Overall Study||0
3296023|NCT02903407|4029943|FG000|STARTED|Overall Study||4
3296024|NCT02903407|4029944|FG001|STARTED|Overall Study||3
3296025|NCT02903407|4029943|FG000|COMPLETED|Overall Study||4
3296026|NCT02903407|4029944|FG001|COMPLETED|Overall Study||3
3296027|NCT02903407|4029943|FG000|NOT COMPLETED|Overall Study||0
3296028|NCT02903407|4029944|FG001|NOT COMPLETED|Overall Study||0
3296029|NCT02903420|4029950|FG000|STARTED|Overall Study||28
3296030|NCT02903420|4029950|FG000|COMPLETED|Overall Study||25
3296031|NCT02903420|4029950|FG000|NOT COMPLETED|Overall Study||3
3296032|NCT02903446|4029956|FG000|STARTED|Overall Study||10
3296033|NCT02903446|4029957|FG001|STARTED|Overall Study||10
3296034|NCT02903446|4029956|FG000|COMPLETED|Overall Study||10
3296035|NCT02903446|4029957|FG001|COMPLETED|Overall Study||10
3296036|NCT02903446|4029956|FG000|NOT COMPLETED|Overall Study||0
3296037|NCT02903446|4029957|FG001|NOT COMPLETED|Overall Study||0
3296038|NCT02903511|4029965|FG000|STARTED|Overall Study||26
3296039|NCT02903511|4029966|FG001|STARTED|Overall Study||25
3296040|NCT02903511|4029965|FG000|Received Intervention|Overall Study||25
3296041|NCT02903511|4029966|FG001|Received Intervention|Overall Study||25
3296042|NCT02903511|4029965|FG000|COMPLETED|Overall Study||22
3296043|NCT02903511|4029966|FG001|COMPLETED|Overall Study||23
3296044|NCT02903511|4029965|FG000|NOT COMPLETED|Overall Study||4
3296045|NCT02903511|4029966|FG001|NOT COMPLETED|Overall Study||2
3296046|NCT02903836|4029975|FG000|STARTED|Overall Study||74
3296047|NCT02903836|4029976|FG001|STARTED|Overall Study||73
3296048|NCT02903836|4029977|FG002|STARTED|Overall Study||77
3296049|NCT02903836|4029975|FG000|COMPLETED|Overall Study||71
3296050|NCT02903836|4029976|FG001|COMPLETED|Overall Study||69
3296051|NCT02903836|4029977|FG002|COMPLETED|Overall Study||73
3296052|NCT02903836|4029975|FG000|NOT COMPLETED|Overall Study||3
3296053|NCT02903836|4029976|FG001|NOT COMPLETED|Overall Study||4
3296054|NCT02903836|4029977|FG002|NOT COMPLETED|Overall Study||4
3296055|NCT02903966|4029987|FG000|STARTED|Part A (Day 1 to 43)||12
3296056|NCT02903966|4029988|FG001|STARTED|Part A (Day 1 to 43)||24
3296057|NCT02903966|4029987|FG000|COMPLETED|Part A (Day 1 to 43)||11
3296058|NCT02903966|4029988|FG001|COMPLETED|Part A (Day 1 to 43)||24
3296059|NCT02903966|4029987|FG000|NOT COMPLETED|Part A (Day 1 to 43)||1
3296060|NCT02903966|4029988|FG001|NOT COMPLETED|Part A (Day 1 to 43)||0
3296061|NCT02903966|4029987|FG000|STARTED|Part B (Day 44 to 112)||11
3296062|NCT02903966|4029988|FG001|STARTED|Part B (Day 44 to 112)||24
3296063|NCT02903966|4029987|FG000|COMPLETED|Part B (Day 44 to 112)||11
3296064|NCT02903966|4029988|FG001|COMPLETED|Part B (Day 44 to 112)||22
3296065|NCT02903966|4029987|FG000|NOT COMPLETED|Part B (Day 44 to 112)||0
3296066|NCT02903966|4029988|FG001|NOT COMPLETED|Part B (Day 44 to 112)||2
3296067|NCT02904057|4030002|FG000|STARTED|Overall Study||19
3296068|NCT02904057|4030003|FG001|STARTED|Overall Study||10
3296069|NCT02904057|4030002|FG000|COMPLETED|Overall Study||19
3296070|NCT02904057|4030003|FG001|COMPLETED|Overall Study||10
3296071|NCT02904057|4030002|FG000|NOT COMPLETED|Overall Study||0
3124248|NCT01646203|3849272|FG001|COMPLETED|Overall Study||3
3124249|NCT01646203|3849273|FG002|COMPLETED|Overall Study||6
3124250|NCT01646203|3849271|FG000|NOT COMPLETED|Overall Study||2
3124251|NCT01646203|3849272|FG001|NOT COMPLETED|Overall Study||2
3124252|NCT01646203|3849273|FG002|NOT COMPLETED|Overall Study||1
3124253|NCT01646216|3849288|FG000|STARTED|Overall Study||17
3124254|NCT01646216|3849289|FG001|STARTED|Overall Study||17
3124255|NCT01646216|3849288|FG000|COMPLETED|Overall Study||6
3124256|NCT01646216|3849289|FG001|COMPLETED|Overall Study||4
3124257|NCT01646216|3849288|FG000|NOT COMPLETED|Overall Study||11
3124258|NCT01646216|3849289|FG001|NOT COMPLETED|Overall Study||13
3124259|NCT01646255|3849301|FG000|STARTED|Overall Study||172
3124260|NCT01646255|3849302|FG001|STARTED|Overall Study||174
3124261|NCT01646255|3849301|FG000|COMPLETED|Overall Study||151
3124262|NCT01646255|3849302|FG001|COMPLETED|Overall Study||160
3124263|NCT01646255|3849301|FG000|NOT COMPLETED|Overall Study||21
3124264|NCT01646255|3849302|FG001|NOT COMPLETED|Overall Study||14
3124265|NCT01646268|3849311|FG000|STARTED|Overall Study||124
3124266|NCT01646268|3849312|FG001|STARTED|Overall Study||123
3124267|NCT01646268|3849311|FG000|COMPLETED|Overall Study||113
3124268|NCT01646268|3849312|FG001|COMPLETED|Overall Study||107
3124269|NCT01646268|3849311|FG000|NOT COMPLETED|Overall Study||11
3124270|NCT01646268|3849312|FG001|NOT COMPLETED|Overall Study||16
3124271|NCT01646320|3849320|FG000|STARTED|Short-term Period (Day 1 to Week 24)||160
3124272|NCT01646320|3849321|FG001|STARTED|Short-term Period (Day 1 to Week 24)||160
3296072|NCT02904057|4030003|FG001|NOT COMPLETED|Overall Study||0
3296073|NCT02904096|4030011|FG000|STARTED|Overall Study||130
3296074|NCT02904096|4030012|FG001|STARTED|Overall Study||126
3296075|NCT02904096|4030011|FG000|COMPLETED|Overall Study||111
3296076|NCT02904096|4030012|FG001|COMPLETED|Overall Study||105
3296077|NCT02904096|4030011|FG000|NOT COMPLETED|Overall Study||19
3296078|NCT02904096|4030012|FG001|NOT COMPLETED|Overall Study||21
3296079|NCT02904200|4030018|FG000|STARTED|Overall Study|One pat. early terminated on own decision, due to travelling distance between home and hospital.|2
3296080|NCT02904200|4030019|FG001|STARTED|Overall Study|No statistical evaluation was performed because only 2 subjects were included in one arm.|0
3296081|NCT02904200|4030018|FG000|COMPLETED|Overall Study||1
3296082|NCT02904200|4030019|FG001|COMPLETED|Overall Study||0
3296083|NCT02904200|4030018|FG000|NOT COMPLETED|Overall Study||1
3296084|NCT02904200|4030019|FG001|NOT COMPLETED|Overall Study||0
3296085|NCT02904226|4030031|FG000|STARTED|Overall Study||40
3296086|NCT02904226|4030032|FG001|STARTED|Overall Study||31
3296087|NCT02904226|4030033|FG002|STARTED|Overall Study||30
3296088|NCT02904226|4030034|FG003|STARTED|Overall Study||100
3296089|NCT02904226|4030035|FG004|STARTED|Overall Study||11
3296090|NCT02904226|4030036|FG005|STARTED|Overall Study||0
3296091|NCT02904226|4030037|FG006|STARTED|Overall Study||6
3296092|NCT02904226|4030038|FG007|STARTED|Overall Study||0
3296093|NCT02904226|4030031|FG000|COMPLETED|Overall Study||0
3296094|NCT02904226|4030032|FG001|COMPLETED|Overall Study||2
3296095|NCT02904226|4030033|FG002|COMPLETED|Overall Study||0
3296096|NCT02904226|4030034|FG003|COMPLETED|Overall Study||4
3296097|NCT02904226|4030035|FG004|COMPLETED|Overall Study||0
3296098|NCT02904226|4030036|FG005|COMPLETED|Overall Study||0
3296099|NCT02904226|4030037|FG006|COMPLETED|Overall Study||0
3296100|NCT02904226|4030038|FG007|COMPLETED|Overall Study||0
3296101|NCT02904226|4030031|FG000|NOT COMPLETED|Overall Study||40
3296102|NCT02904226|4030032|FG001|NOT COMPLETED|Overall Study||29
3296103|NCT02904226|4030033|FG002|NOT COMPLETED|Overall Study||30
3296104|NCT02904226|4030034|FG003|NOT COMPLETED|Overall Study||96
3296105|NCT02904226|4030035|FG004|NOT COMPLETED|Overall Study||11
3296106|NCT02904226|4030036|FG005|NOT COMPLETED|Overall Study||0
3296107|NCT02904226|4030037|FG006|NOT COMPLETED|Overall Study||6
3296108|NCT02904226|4030038|FG007|NOT COMPLETED|Overall Study||0
3296109|NCT02904265|4030056|FG000|STARTED|Overall Study|Study closed due to only 3 participants recruited|1
3296110|NCT02904265|4030057|FG001|STARTED|Overall Study|Study closed due to only 3 participants recruited|2
3296111|NCT02904265|4030056|FG000|COMPLETED|Overall Study||0
3296112|NCT02904265|4030057|FG001|COMPLETED|Overall Study||0
3296113|NCT02904265|4030056|FG000|NOT COMPLETED|Overall Study||1
3296114|NCT02904265|4030057|FG001|NOT COMPLETED|Overall Study||2
3296115|NCT02904512|4030065|FG000|STARTED|Overall Study||9
3296116|NCT02904512|4030066|FG001|STARTED|Overall Study||7
3296117|NCT02904512|4030065|FG000|COMPLETED|Overall Study||6
3296118|NCT02904512|4030066|FG001|COMPLETED|Overall Study||7
3296119|NCT02904512|4030065|FG000|NOT COMPLETED|Overall Study||3
3296120|NCT02904512|4030066|FG001|NOT COMPLETED|Overall Study||0
3296121|NCT02904902|4030072|FG000|STARTED|Overall Study||15
3296122|NCT02904902|4030072|FG000|COMPLETED|Overall Study||14
3124273|NCT01646320|3849320|FG000|COMPLETED|Short-term Period (Day 1 to Week 24)||148
3296123|NCT02904902|4030072|FG000|NOT COMPLETED|Overall Study||1
3296124|NCT02904915|4030078|FG000|STARTED|Overall Study||25
3296125|NCT02904915|4030079|FG001|STARTED|Overall Study||25
3296126|NCT02904915|4030078|FG000|COMPLETED|Overall Study||25
3296127|NCT02904915|4030079|FG001|COMPLETED|Overall Study||25
3296128|NCT02904915|4030078|FG000|NOT COMPLETED|Overall Study||0
3296129|NCT02904915|4030079|FG001|NOT COMPLETED|Overall Study||0
3296130|NCT02904954|4030087|FG000|STARTED|Neoadjuvant (Preoperative) to Surgery||30
3296131|NCT02904954|4030088|FG001|STARTED|Neoadjuvant (Preoperative) to Surgery||30
3296132|NCT02904954|4030087|FG000|COMPLETED|Neoadjuvant (Preoperative) to Surgery|30 participants completed 2 neoadjuvant cycles. Surgical resection was not performed in 4 participants.|26
3124274|NCT01646320|3849321|FG001|COMPLETED|Short-term Period (Day 1 to Week 24)||153
3124275|NCT01646320|3849320|FG000|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||12
3124276|NCT01646320|3849321|FG001|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||7
3124277|NCT01646320|3849320|FG000|STARTED|Long-term Period (Weeks 24 to 52)||147
3124278|NCT01646320|3849321|FG001|STARTED|Long-term Period (Weeks 24 to 52)||147
3124279|NCT01646320|3849320|FG000|COMPLETED|Long-term Period (Weeks 24 to 52)||141
3124280|NCT01646320|3849321|FG001|COMPLETED|Long-term Period (Weeks 24 to 52)||140
3124281|NCT01646320|3849320|FG000|NOT COMPLETED|Long-term Period (Weeks 24 to 52)||6
3124282|NCT01646320|3849321|FG001|NOT COMPLETED|Long-term Period (Weeks 24 to 52)||7
3124283|NCT01646346|3849327|FG000|STARTED|Overall Study||46
3124284|NCT01646346|3849327|FG000|COMPLETED|Overall Study||46
3124285|NCT01646346|3849327|FG000|NOT COMPLETED|Overall Study||0
3124286|NCT01646385|3849333|FG000|STARTED|Overall Study||3529
3124287|NCT01646385|3849334|FG001|STARTED|Overall Study||2864
3124288|NCT01646385|3849333|FG000|COMPLETED|Overall Study|Completed refers to participants who continued up to last follow-up.|2691
3124289|NCT01646385|3849334|FG001|COMPLETED|Overall Study|Completed refers to participants who continued up to last follow-up.|1993
3124290|NCT01646385|3849333|FG000|NOT COMPLETED|Overall Study||838
3124291|NCT01646385|3849334|FG001|NOT COMPLETED|Overall Study||871
3124292|NCT01646398|3849342|FG000|STARTED|Overall Study||382
3124293|NCT01646398|3849343|FG001|STARTED|Overall Study||382
3124294|NCT01646398|3849342|FG000|COMPLETED|Overall Study||381
3124295|NCT01646398|3849343|FG001|COMPLETED|Overall Study||382
3296133|NCT02904954|4030088|FG001|COMPLETED|Neoadjuvant (Preoperative) to Surgery|30 participants completed the first neoadjuvant Durvalumab cycle combined with SBRT. Three subjects did not receive the 2nd cycle. Surgical resection was not performed in 4 participants.|26
3296134|NCT02904954|4030087|FG000|NOT COMPLETED|Neoadjuvant (Preoperative) to Surgery||4
3296135|NCT02904954|4030088|FG001|NOT COMPLETED|Neoadjuvant (Preoperative) to Surgery||4
3296136|NCT02904954|4030087|FG000|STARTED|Adjuvant Durvalumab||26
3296137|NCT02904954|4030088|FG001|STARTED|Adjuvant Durvalumab||26
3296138|NCT02904954|4030087|FG000|COMPLETED|Adjuvant Durvalumab||5
3296139|NCT02904954|4030088|FG001|COMPLETED|Adjuvant Durvalumab||10
3296140|NCT02904954|4030087|FG000|NOT COMPLETED|Adjuvant Durvalumab||21
3296141|NCT02904954|4030088|FG001|NOT COMPLETED|Adjuvant Durvalumab||16
3296142|NCT02905006|4030102|FG000|STARTED|Overall Study||42
3296143|NCT02905006|4030103|FG001|STARTED|Overall Study||39
3296144|NCT02905006|4030104|FG002|STARTED|Overall Study||43
3296145|NCT02905006|4030105|FG003|STARTED|Overall Study||40
3296146|NCT02905006|4030106|FG004|STARTED|Overall Study||43
3296147|NCT02905006|4030107|FG005|STARTED|Overall Study||43
3296148|NCT02905006|4030102|FG000|Completed Treatment Period|Overall Study||37
3296149|NCT02905006|4030103|FG001|Completed Treatment Period|Overall Study||36
3296150|NCT02905006|4030104|FG002|Completed Treatment Period|Overall Study||38
3296151|NCT02905006|4030105|FG003|Completed Treatment Period|Overall Study||34
3296152|NCT02905006|4030106|FG004|Completed Treatment Period|Overall Study||40
3296153|NCT02905006|4030107|FG005|Completed Treatment Period|Overall Study||39
3296154|NCT02905006|4030102|FG000|Enrolled in Extension Study (PS0011)|Overall Study||38
3296155|NCT02905006|4030103|FG001|Enrolled in Extension Study (PS0011)|Overall Study||35
3296156|NCT02905006|4030104|FG002|Enrolled in Extension Study (PS0011)|Overall Study||39
3296157|NCT02905006|4030105|FG003|Enrolled in Extension Study (PS0011)|Overall Study||38
3296158|NCT02905006|4030106|FG004|Enrolled in Extension Study (PS0011)|Overall Study||42
3296159|NCT02905006|4030107|FG005|Enrolled in Extension Study (PS0011)|Overall Study||40
3296160|NCT02905006|4030102|FG000|Entered Safety Follow-up Period|Overall Study||4
3296161|NCT02905006|4030103|FG001|Entered Safety Follow-up Period|Overall Study||4
3296162|NCT02905006|4030104|FG002|Entered Safety Follow-up Period|Overall Study||4
3296163|NCT02905006|4030105|FG003|Entered Safety Follow-up Period|Overall Study||2
3296164|NCT02905006|4030106|FG004|Entered Safety Follow-up Period|Overall Study||1
3296165|NCT02905006|4030107|FG005|Entered Safety Follow-up Period|Overall Study||3
3296166|NCT02905006|4030102|FG000|COMPLETED|Overall Study||37
3296167|NCT02905006|4030103|FG001|COMPLETED|Overall Study||36
3296168|NCT02905006|4030104|FG002|COMPLETED|Overall Study||38
3296169|NCT02905006|4030105|FG003|COMPLETED|Overall Study||34
3296170|NCT02905006|4030106|FG004|COMPLETED|Overall Study||40
3296171|NCT02905006|4030107|FG005|COMPLETED|Overall Study||39
3296172|NCT02905006|4030102|FG000|NOT COMPLETED|Overall Study||5
3296173|NCT02905006|4030103|FG001|NOT COMPLETED|Overall Study||3
3296174|NCT02905006|4030104|FG002|NOT COMPLETED|Overall Study||5
3296175|NCT02905006|4030105|FG003|NOT COMPLETED|Overall Study||6
3296176|NCT02905006|4030106|FG004|NOT COMPLETED|Overall Study||3
3296177|NCT02905006|4030107|FG005|NOT COMPLETED|Overall Study||4
3296178|NCT02905149|4030147|FG000|STARTED|Overall Study||30
3296179|NCT02905149|4030148|FG001|STARTED|Overall Study||30
3296180|NCT02905149|4030147|FG000|COMPLETED|Overall Study||28
3296181|NCT02905149|4030148|FG001|COMPLETED|Overall Study||30
3296182|NCT02905149|4030147|FG000|NOT COMPLETED|Overall Study||2
3296183|NCT02905149|4030148|FG001|NOT COMPLETED|Overall Study||0
3296184|NCT02905266|4030156|FG000|STARTED|Treatment Phase Part 1||53
3296185|NCT02905266|4030157|FG001|STARTED|Treatment Phase Part 1||53
3296186|NCT02905266|4030156|FG000|COMPLETED|Treatment Phase Part 1||24
3296187|NCT02905266|4030157|FG001|COMPLETED|Treatment Phase Part 1||30
3296188|NCT02905266|4030156|FG000|NOT COMPLETED|Treatment Phase Part 1||29
3296189|NCT02905266|4030157|FG001|NOT COMPLETED|Treatment Phase Part 1||23
3124296|NCT01646398|3849342|FG000|NOT COMPLETED|Overall Study||1
3124297|NCT01646398|3849343|FG001|NOT COMPLETED|Overall Study||0
3124298|NCT01646645|3849349|FG000|STARTED|Overall Study||58
3296190|NCT02905266|4030156|FG000|STARTED|Transition From Part 1 to Part 2||24
3296191|NCT02905266|4030157|FG001|STARTED|Transition From Part 1 to Part 2||30
3296192|NCT02905266|4030156|FG000|COMPLETED|Transition From Part 1 to Part 2||20
3296193|NCT02905266|4030157|FG001|COMPLETED|Transition From Part 1 to Part 2||22
3296194|NCT02905266|4030156|FG000|NOT COMPLETED|Transition From Part 1 to Part 2||4
3296195|NCT02905266|4030157|FG001|NOT COMPLETED|Transition From Part 1 to Part 2||8
3296196|NCT02905266|4030156|FG000|STARTED|Maintenance Phase Part 2||20
3296197|NCT02905266|4030157|FG001|STARTED|Maintenance Phase Part 2||22
3296198|NCT02905266|4030156|FG000|COMPLETED|Maintenance Phase Part 2||8
3296199|NCT02905266|4030157|FG001|COMPLETED|Maintenance Phase Part 2||14
3296200|NCT02905266|4030156|FG000|NOT COMPLETED|Maintenance Phase Part 2||12
3296201|NCT02905266|4030157|FG001|NOT COMPLETED|Maintenance Phase Part 2||8
3296202|NCT02905331|4030165|FG000|STARTED|Placebo Controlled Period(Week[wk] 0-16)||16
3296203|NCT02905331|4030166|FG001|STARTED|Placebo Controlled Period(Week[wk] 0-16)||62
3296204|NCT02905331|4030167|FG002|STARTED|Placebo Controlled Period(Week[wk] 0-16)||0
3296205|NCT02905331|4030165|FG000|COMPLETED|Placebo Controlled Period(Week[wk] 0-16)||13
3296206|NCT02905331|4030166|FG001|COMPLETED|Placebo Controlled Period(Week[wk] 0-16)||61
3296207|NCT02905331|4030167|FG002|COMPLETED|Placebo Controlled Period(Week[wk] 0-16)||0
3296208|NCT02905331|4030165|FG000|NOT COMPLETED|Placebo Controlled Period(Week[wk] 0-16)||3
3296209|NCT02905331|4030166|FG001|NOT COMPLETED|Placebo Controlled Period(Week[wk] 0-16)||1
3296210|NCT02905331|4030167|FG002|NOT COMPLETED|Placebo Controlled Period(Week[wk] 0-16)||0
3296211|NCT02905331|4030165|FG000|STARTED|Active Treatment and Follow up (wk16-40)||0
3296212|NCT02905331|4030166|FG001|STARTED|Active Treatment and Follow up (wk16-40)||61
3296213|NCT02905331|4030167|FG002|STARTED|Active Treatment and Follow up (wk16-40)||13
3296214|NCT02905331|4030165|FG000|COMPLETED|Active Treatment and Follow up (wk16-40)||0
3296215|NCT02905331|4030166|FG001|COMPLETED|Active Treatment and Follow up (wk16-40)||53
3296216|NCT02905331|4030167|FG002|COMPLETED|Active Treatment and Follow up (wk16-40)||13
3296217|NCT02905331|4030165|FG000|NOT COMPLETED|Active Treatment and Follow up (wk16-40)||0
3296218|NCT02905331|4030166|FG001|NOT COMPLETED|Active Treatment and Follow up (wk16-40)||8
3296219|NCT02905331|4030167|FG002|NOT COMPLETED|Active Treatment and Follow up (wk16-40)||0
3296220|NCT02905435|4030175|FG000|STARTED|Overall Study||14
3296221|NCT02905435|4030175|FG000|COMPLETED|Overall Study||7
3296222|NCT02905435|4030175|FG000|NOT COMPLETED|Overall Study||7
3296223|NCT02905825|4030180|FG000|STARTED|Overall Study||53
3296224|NCT02905825|4030180|FG000|COMPLETED|Overall Study||41
3296225|NCT02905825|4030180|FG000|NOT COMPLETED|Overall Study||12
3296226|NCT02905981|4030184|FG000|STARTED|Overall Study||1
3296227|NCT02905981|4030184|FG000|COMPLETED|Overall Study||0
3296228|NCT02905981|4030184|FG000|NOT COMPLETED|Overall Study||1
3296229|NCT02906358|4030190|FG000|STARTED|Overall Study||58
3296230|NCT02906358|4030191|FG001|STARTED|Overall Study||53
3296231|NCT02906358|4030190|FG000|Completed 3 Month Measures|Overall Study||36
3296232|NCT02906358|4030191|FG001|Completed 3 Month Measures|Overall Study||33
3296233|NCT02906358|4030190|FG000|COMPLETED|Overall Study||36
3296234|NCT02906358|4030191|FG001|COMPLETED|Overall Study||31
3296235|NCT02906358|4030190|FG000|NOT COMPLETED|Overall Study||22
3296236|NCT02906358|4030191|FG001|NOT COMPLETED|Overall Study||22
3296237|NCT02906566|4030199|FG000|STARTED|Overall Study||24
3296238|NCT02906566|4030200|FG001|STARTED|Overall Study||10
3296239|NCT02906566|4030199|FG000|COMPLETED|Overall Study||21
3296240|NCT02906566|4030200|FG001|COMPLETED|Overall Study||10
3296241|NCT02906566|4030199|FG000|NOT COMPLETED|Overall Study||3
3296242|NCT02906566|4030200|FG001|NOT COMPLETED|Overall Study||0
3296243|NCT02906579|4030208|FG000|STARTED|Overall Study||11
3296244|NCT02906579|4030208|FG000|Completed Cycle 1 (Placebo)|Overall Study||11
3296245|NCT02906579|4030208|FG000|Completed Cycle 2 (10 mg IW-1973)|Overall Study||11
3296246|NCT02906579|4030208|FG000|Completed Cycle 3 (20 mg IW-1973)|Overall Study||11
3296247|NCT02906579|4030208|FG000|Completed Cycle 4 (30 mg IW-1973)|Overall Study||10
3296248|NCT02906579|4030208|FG000|Completed Cycle 5 (40 mg IW-1973)|Overall Study||9
3296249|NCT02906579|4030208|FG000|Completed Cycle 6 (50 mg IW-1973)|Overall Study||9
3296250|NCT02906579|4030208|FG000|COMPLETED|Overall Study||9
3296251|NCT02906579|4030208|FG000|NOT COMPLETED|Overall Study||2
3296252|NCT02906644|4030230|FG000|STARTED|First 2 Weeks||31
3296253|NCT02906644|4030231|FG001|STARTED|First 2 Weeks||30
3296254|NCT02906644|4030230|FG000|COMPLETED|First 2 Weeks||30
3296255|NCT02906644|4030231|FG001|COMPLETED|First 2 Weeks||27
3296256|NCT02906644|4030230|FG000|NOT COMPLETED|First 2 Weeks||1
3296257|NCT02906644|4030231|FG001|NOT COMPLETED|First 2 Weeks||3
3296258|NCT02906644|4030230|FG000|STARTED|Weeks 3 to 14|All participants receiving active Lorcaserin plus nicotine patches starting at the 2nd study visit.|30
3296259|NCT02906644|4030231|FG001|STARTED|Weeks 3 to 14|All participants receiving active Lorcaserin plus nicotine patches starting at the 2nd study visit.|27
3296260|NCT02906644|4030230|FG000|Final Study Visit|Weeks 3 to 14|All participants receiving only 1 week of 14mg & 1 week of 7mg nicotine patches at this visit.|17
3296261|NCT02906644|4030231|FG001|Final Study Visit|Weeks 3 to 14|All participants receiving only 1 week of 14mg & 1 week of 7mg nicotine patches at this visit.|20
3296262|NCT02906644|4030230|FG000|Follow-up (6 Months Post Quit Day)|Weeks 3 to 14||14
3296263|NCT02906644|4030231|FG001|Follow-up (6 Months Post Quit Day)|Weeks 3 to 14||16
3296264|NCT02906644|4030230|FG000|COMPLETED|Weeks 3 to 14||14
3296265|NCT02906644|4030231|FG001|COMPLETED|Weeks 3 to 14||16
3296266|NCT02906644|4030230|FG000|NOT COMPLETED|Weeks 3 to 14||16
3296267|NCT02906644|4030231|FG001|NOT COMPLETED|Weeks 3 to 14||11
3124299|NCT01646645|3849349|FG000|COMPLETED|Overall Study||28
3124300|NCT01646645|3849349|FG000|NOT COMPLETED|Overall Study||30
3124301|NCT01646671|3849356|FG000|STARTED|Overall Study||3
3124302|NCT01646671|3849357|FG001|STARTED|Overall Study||11
3124303|NCT01646671|3849358|FG002|STARTED|Overall Study||21
3124304|NCT01646671|3849356|FG000|COMPLETED|Overall Study||3
3124305|NCT01646671|3849357|FG001|COMPLETED|Overall Study||11
3124306|NCT01646671|3849358|FG002|COMPLETED|Overall Study||21
3124307|NCT01646671|3849356|FG000|NOT COMPLETED|Overall Study||0
3124308|NCT01646671|3849357|FG001|NOT COMPLETED|Overall Study||0
3296268|NCT02906670|4030248|FG000|STARTED|Cohort 1, QW||1
3296269|NCT02906670|4030249|FG001|STARTED|Cohort 1, QW||0
3296270|NCT02906670|4030250|FG002|STARTED|Cohort 1, QW||0
3296271|NCT02906670|4030251|FG003|STARTED|Cohort 1, QW||0
3296272|NCT02906670|4030252|FG004|STARTED|Cohort 1, QW||0
3296273|NCT02906670|4030253|FG005|STARTED|Cohort 1, QW||0
3296274|NCT02906670|4030254|FG006|STARTED|Cohort 1, QW||0
3296275|NCT02906670|4030255|FG007|STARTED|Cohort 1, QW||0
3296276|NCT02906670|4030256|FG008|STARTED|Cohort 1, QW||0
3296277|NCT02906670|4030257|FG009|STARTED|Cohort 1, QW||0
3296278|NCT02906670|4030248|FG000|COMPLETED|Cohort 1, QW||0
3296279|NCT02906670|4030249|FG001|COMPLETED|Cohort 1, QW||0
3296280|NCT02906670|4030250|FG002|COMPLETED|Cohort 1, QW||0
3296281|NCT02906670|4030251|FG003|COMPLETED|Cohort 1, QW||0
3296282|NCT02906670|4030252|FG004|COMPLETED|Cohort 1, QW||0
3296283|NCT02906670|4030253|FG005|COMPLETED|Cohort 1, QW||0
3296284|NCT02906670|4030254|FG006|COMPLETED|Cohort 1, QW||0
3296285|NCT02906670|4030255|FG007|COMPLETED|Cohort 1, QW||0
3296286|NCT02906670|4030256|FG008|COMPLETED|Cohort 1, QW||0
3296287|NCT02906670|4030257|FG009|COMPLETED|Cohort 1, QW||0
3296288|NCT02906670|4030248|FG000|NOT COMPLETED|Cohort 1, QW||1
3296289|NCT02906670|4030249|FG001|NOT COMPLETED|Cohort 1, QW||0
3296290|NCT02906670|4030250|FG002|NOT COMPLETED|Cohort 1, QW||0
3296291|NCT02906670|4030251|FG003|NOT COMPLETED|Cohort 1, QW||0
3296292|NCT02906670|4030252|FG004|NOT COMPLETED|Cohort 1, QW||0
3296293|NCT02906670|4030253|FG005|NOT COMPLETED|Cohort 1, QW||0
3296294|NCT02906670|4030254|FG006|NOT COMPLETED|Cohort 1, QW||0
3296295|NCT02906670|4030255|FG007|NOT COMPLETED|Cohort 1, QW||0
3296296|NCT02906670|4030256|FG008|NOT COMPLETED|Cohort 1, QW||0
3296297|NCT02906670|4030257|FG009|NOT COMPLETED|Cohort 1, QW||0
3296298|NCT02906670|4030248|FG000|STARTED|Cohort 2, QW||0
3296299|NCT02906670|4030249|FG001|STARTED|Cohort 2, QW||1
3296300|NCT02906670|4030250|FG002|STARTED|Cohort 2, QW||0
3296301|NCT02906670|4030251|FG003|STARTED|Cohort 2, QW||0
3296302|NCT02906670|4030252|FG004|STARTED|Cohort 2, QW||0
3296303|NCT02906670|4030253|FG005|STARTED|Cohort 2, QW||0
3296304|NCT02906670|4030254|FG006|STARTED|Cohort 2, QW||0
3296305|NCT02906670|4030255|FG007|STARTED|Cohort 2, QW||0
3296306|NCT02906670|4030256|FG008|STARTED|Cohort 2, QW||0
3296307|NCT02906670|4030257|FG009|STARTED|Cohort 2, QW||0
3296308|NCT02906670|4030248|FG000|COMPLETED|Cohort 2, QW||0
3296309|NCT02906670|4030249|FG001|COMPLETED|Cohort 2, QW||0
3296310|NCT02906670|4030250|FG002|COMPLETED|Cohort 2, QW||0
3296311|NCT02906670|4030251|FG003|COMPLETED|Cohort 2, QW||0
3296312|NCT02906670|4030252|FG004|COMPLETED|Cohort 2, QW||0
3296313|NCT02906670|4030253|FG005|COMPLETED|Cohort 2, QW||0
3296314|NCT02906670|4030254|FG006|COMPLETED|Cohort 2, QW||0
3296315|NCT02906670|4030255|FG007|COMPLETED|Cohort 2, QW||0
3296316|NCT02906670|4030256|FG008|COMPLETED|Cohort 2, QW||0
3296317|NCT02906670|4030257|FG009|COMPLETED|Cohort 2, QW||0
3296318|NCT02906670|4030248|FG000|NOT COMPLETED|Cohort 2, QW||0
3296319|NCT02906670|4030249|FG001|NOT COMPLETED|Cohort 2, QW||1
3296320|NCT02906670|4030250|FG002|NOT COMPLETED|Cohort 2, QW||0
3296321|NCT02906670|4030251|FG003|NOT COMPLETED|Cohort 2, QW||0
3296322|NCT02906670|4030252|FG004|NOT COMPLETED|Cohort 2, QW||0
3296323|NCT02906670|4030253|FG005|NOT COMPLETED|Cohort 2, QW||0
3296324|NCT02906670|4030254|FG006|NOT COMPLETED|Cohort 2, QW||0
3296325|NCT02906670|4030255|FG007|NOT COMPLETED|Cohort 2, QW||0
3296326|NCT02906670|4030256|FG008|NOT COMPLETED|Cohort 2, QW||0
3296327|NCT02906670|4030257|FG009|NOT COMPLETED|Cohort 2, QW||0
3296328|NCT02906670|4030248|FG000|STARTED|Cohort 3, QW||0
3296329|NCT02906670|4030249|FG001|STARTED|Cohort 3, QW||0
3296330|NCT02906670|4030250|FG002|STARTED|Cohort 3, QW||4
3296331|NCT02906670|4030251|FG003|STARTED|Cohort 3, QW||0
3296332|NCT02906670|4030252|FG004|STARTED|Cohort 3, QW||0
3296333|NCT02906670|4030253|FG005|STARTED|Cohort 3, QW||0
3296334|NCT02906670|4030254|FG006|STARTED|Cohort 3, QW||0
3296335|NCT02906670|4030255|FG007|STARTED|Cohort 3, QW||0
3296336|NCT02906670|4030256|FG008|STARTED|Cohort 3, QW||0
3296337|NCT02906670|4030257|FG009|STARTED|Cohort 3, QW||0
3296338|NCT02906670|4030248|FG000|COMPLETED|Cohort 3, QW||0
3296339|NCT02906670|4030249|FG001|COMPLETED|Cohort 3, QW||0
3296340|NCT02906670|4030250|FG002|COMPLETED|Cohort 3, QW||0
3296341|NCT02906670|4030251|FG003|COMPLETED|Cohort 3, QW||0
3296342|NCT02906670|4030252|FG004|COMPLETED|Cohort 3, QW||0
3296343|NCT02906670|4030253|FG005|COMPLETED|Cohort 3, QW||0
3296344|NCT02906670|4030254|FG006|COMPLETED|Cohort 3, QW||0
3296345|NCT02906670|4030255|FG007|COMPLETED|Cohort 3, QW||0
3296346|NCT02906670|4030256|FG008|COMPLETED|Cohort 3, QW||0
3296347|NCT02906670|4030257|FG009|COMPLETED|Cohort 3, QW||0
3296348|NCT02906670|4030248|FG000|NOT COMPLETED|Cohort 3, QW||0
3296349|NCT02906670|4030249|FG001|NOT COMPLETED|Cohort 3, QW||0
3296350|NCT02906670|4030250|FG002|NOT COMPLETED|Cohort 3, QW||4
3296351|NCT02906670|4030251|FG003|NOT COMPLETED|Cohort 3, QW||0
3124309|NCT01646671|3849358|FG002|NOT COMPLETED|Overall Study||0
3124310|NCT01646762|3849368|FG000|STARTED|Overall Study||13
3124311|NCT01646762|3849368|FG000|COMPLETED|Overall Study||13
3124312|NCT01646762|3849368|FG000|NOT COMPLETED|Overall Study||0
3124313|NCT01646814|3849374|FG000|STARTED|Overall Study||121
3124314|NCT01646814|3849375|FG001|STARTED|Overall Study||126
3124315|NCT01646814|3849374|FG000|COMPLETED|Overall Study||110
3124316|NCT01646814|3849375|FG001|COMPLETED|Overall Study||120
3124317|NCT01646814|3849374|FG000|NOT COMPLETED|Overall Study||11
3124318|NCT01646814|3849375|FG001|NOT COMPLETED|Overall Study||6
3124319|NCT01646827|3849383|FG000|STARTED|Overall Study||18
3124320|NCT01646827|3849384|FG001|STARTED|Overall Study||19
3124321|NCT01646827|3849383|FG000|COMPLETED|Overall Study||16
3124322|NCT01646827|3849384|FG001|COMPLETED|Overall Study||14
3124323|NCT01646827|3849383|FG000|NOT COMPLETED|Overall Study||2
3124324|NCT01646827|3849384|FG001|NOT COMPLETED|Overall Study||5
3124325|NCT01647217|3849392|FG000|STARTED|Overall Study||8
3124326|NCT01647217|3849393|FG001|STARTED|Overall Study||9
3124327|NCT01647217|3849392|FG000|COMPLETED|Overall Study||7
3124328|NCT01647217|3849393|FG001|COMPLETED|Overall Study||8
3124329|NCT01647217|3849392|FG000|NOT COMPLETED|Overall Study||1
3124330|NCT01647217|3849393|FG001|NOT COMPLETED|Overall Study||1
3124331|NCT01647282|3849403|FG000|STARTED|Overall Study||30
3124332|NCT01647282|3849404|FG001|STARTED|Overall Study||30
3124333|NCT01647282|3849403|FG000|COMPLETED|Overall Study||23
3124334|NCT01647282|3849404|FG001|COMPLETED|Overall Study||25
3124335|NCT01647282|3849403|FG000|NOT COMPLETED|Overall Study||7
3124336|NCT01647282|3849404|FG001|NOT COMPLETED|Overall Study||5
3124337|NCT01647438|3849412|FG000|STARTED|Overall Study||32
3124338|NCT01647438|3849413|FG001|STARTED|Overall Study||31
3124339|NCT01647438|3849412|FG000|COMPLETED|Overall Study||32
3124340|NCT01647438|3849413|FG001|COMPLETED|Overall Study||31
3124341|NCT01647438|3849412|FG000|NOT COMPLETED|Overall Study||0
3124342|NCT01647438|3849413|FG001|NOT COMPLETED|Overall Study||0
3124343|NCT01647464|3849419|FG000|STARTED|Overall Study||10
3124344|NCT01647464|3849419|FG000|COMPLETED|Overall Study||10
3124345|NCT01647464|3849419|FG000|NOT COMPLETED|Overall Study||0
3124346|NCT01647516|3849426|FG000|STARTED|Induction Period (IP)||66
3124347|NCT01647516|3849427|FG001|STARTED|Induction Period (IP)||66
3124348|NCT01647516|3849428|FG002|STARTED|Induction Period (IP)||67
3124349|NCT01647516|3849429|FG003|STARTED|Induction Period (IP)||0
3124350|NCT01647516|3849430|FG004|STARTED|Induction Period (IP)||0
3124351|NCT01647516|3849431|FG005|STARTED|Induction Period (IP)||0
3124352|NCT01647516|3849426|FG000|Received Study Drug|Induction Period (IP)||65
3124353|NCT01647516|3849427|FG001|Received Study Drug|Induction Period (IP)||65
3124354|NCT01647516|3849428|FG002|Received Study Drug|Induction Period (IP)||67
3124355|NCT01647516|3849429|FG003|Received Study Drug|Induction Period (IP)||0
3124356|NCT01647516|3849430|FG004|Received Study Drug|Induction Period (IP)||0
3124357|NCT01647516|3849431|FG005|Received Study Drug|Induction Period (IP)||0
3124358|NCT01647516|3849426|FG000|COMPLETED|Induction Period (IP)||60
3124359|NCT01647516|3849427|FG001|COMPLETED|Induction Period (IP)||63
3124360|NCT01647516|3849428|FG002|COMPLETED|Induction Period (IP)||63
3124361|NCT01647516|3849429|FG003|COMPLETED|Induction Period (IP)||0
3124362|NCT01647516|3849430|FG004|COMPLETED|Induction Period (IP)||0
3124363|NCT01647516|3849431|FG005|COMPLETED|Induction Period (IP)||0
3124364|NCT01647516|3849426|FG000|NOT COMPLETED|Induction Period (IP)||6
3124365|NCT01647516|3849427|FG001|NOT COMPLETED|Induction Period (IP)||3
3124366|NCT01647516|3849428|FG002|NOT COMPLETED|Induction Period (IP)||4
3124367|NCT01647516|3849429|FG003|NOT COMPLETED|Induction Period (IP)||0
3124368|NCT01647516|3849430|FG004|NOT COMPLETED|Induction Period (IP)||0
3124369|NCT01647516|3849431|FG005|NOT COMPLETED|Induction Period (IP)||0
3124370|NCT01647516|3849426|FG000|STARTED|Maintenance Period (MP)|The MP includes participants who were responders at week 8.|25
3124371|NCT01647516|3849427|FG001|STARTED|Maintenance Period (MP)|The MP includes participants who were responders at week 8.|36
3124372|NCT01647516|3849428|FG002|STARTED|Maintenance Period (MP)|The MP includes participants who were responders at week 8.|42
3124373|NCT01647516|3849429|FG003|STARTED|Maintenance Period (MP)||0
3124374|NCT01647516|3849430|FG004|STARTED|Maintenance Period (MP)||0
3124375|NCT01647516|3849431|FG005|STARTED|Maintenance Period (MP)||0
3124376|NCT01647516|3849426|FG000|COMPLETED|Maintenance Period (MP)||21
3124377|NCT01647516|3849427|FG001|COMPLETED|Maintenance Period (MP)||30
3124378|NCT01647516|3849428|FG002|COMPLETED|Maintenance Period (MP)||40
3124379|NCT01647516|3849429|FG003|COMPLETED|Maintenance Period (MP)||0
3124380|NCT01647516|3849430|FG004|COMPLETED|Maintenance Period (MP)||0
3124381|NCT01647516|3849431|FG005|COMPLETED|Maintenance Period (MP)||0
3124382|NCT01647516|3849426|FG000|NOT COMPLETED|Maintenance Period (MP)||4
3124383|NCT01647516|3849427|FG001|NOT COMPLETED|Maintenance Period (MP)||6
3296352|NCT02906670|4030252|FG004|NOT COMPLETED|Cohort 3, QW||0
3296353|NCT02906670|4030253|FG005|NOT COMPLETED|Cohort 3, QW||0
3296354|NCT02906670|4030254|FG006|NOT COMPLETED|Cohort 3, QW||0
3296355|NCT02906670|4030255|FG007|NOT COMPLETED|Cohort 3, QW||0
3296356|NCT02906670|4030256|FG008|NOT COMPLETED|Cohort 3, QW||0
3296357|NCT02906670|4030257|FG009|NOT COMPLETED|Cohort 3, QW||0
3296358|NCT02906670|4030248|FG000|STARTED|Cohort 4, Q2W||0
3296359|NCT02906670|4030249|FG001|STARTED|Cohort 4, Q2W||0
3296360|NCT02906670|4030250|FG002|STARTED|Cohort 4, Q2W||0
3296361|NCT02906670|4030251|FG003|STARTED|Cohort 4, Q2W||0
3296362|NCT02906670|4030252|FG004|STARTED|Cohort 4, Q2W||0
3296363|NCT02906670|4030253|FG005|STARTED|Cohort 4, Q2W||3
3124384|NCT01647516|3849428|FG002|NOT COMPLETED|Maintenance Period (MP)||2
3124385|NCT01647516|3849429|FG003|NOT COMPLETED|Maintenance Period (MP)||0
3124386|NCT01647516|3849430|FG004|NOT COMPLETED|Maintenance Period (MP)||0
3124387|NCT01647516|3849431|FG005|NOT COMPLETED|Maintenance Period (MP)||0
3124388|NCT01647516|3849426|FG000|STARTED|Open-Label Period||0
3124389|NCT01647516|3849427|FG001|STARTED|Open-Label Period||0
3124390|NCT01647516|3849428|FG002|STARTED|Open-Label Period||0
3124391|NCT01647516|3849429|FG003|STARTED|Open-Label Period|"The participants were:~non-responders at Week 8,completed the MP or had disease relapse during MP"|55
3124392|NCT01647516|3849430|FG004|STARTED|Open-Label Period|"The participants were:~non-responders at Week 8,completed the MP or had disease relapse during MP"|56
3124393|NCT01647516|3849431|FG005|STARTED|Open-Label Period|"The participants were:~non-responders at Week 8,completed the MP or had disease relapse during MP"|59
3124394|NCT01647516|3849426|FG000|COMPLETED|Open-Label Period||0
3124395|NCT01647516|3849427|FG001|COMPLETED|Open-Label Period||0
3124396|NCT01647516|3849428|FG002|COMPLETED|Open-Label Period||0
3124397|NCT01647516|3849429|FG003|COMPLETED|Open-Label Period||6
3124398|NCT01647516|3849430|FG004|COMPLETED|Open-Label Period||5
3124399|NCT01647516|3849431|FG005|COMPLETED|Open-Label Period||3
3124400|NCT01647516|3849426|FG000|NOT COMPLETED|Open-Label Period||0
3124401|NCT01647516|3849427|FG001|NOT COMPLETED|Open-Label Period||0
3124402|NCT01647516|3849428|FG002|NOT COMPLETED|Open-Label Period||0
3124403|NCT01647516|3849429|FG003|NOT COMPLETED|Open-Label Period||49
3124404|NCT01647516|3849430|FG004|NOT COMPLETED|Open-Label Period||51
3124405|NCT01647516|3849431|FG005|NOT COMPLETED|Open-Label Period||56
3124406|NCT01647542|3849449|FG000|STARTED|Overall Study||131
3124407|NCT01647542|3849450|FG001|STARTED|Overall Study||131
3124408|NCT01647542|3849451|FG002|STARTED|Overall Study||131
3124409|NCT01647542|3849449|FG000|COMPLETED|Overall Study||55
3124410|NCT01647542|3849450|FG001|COMPLETED|Overall Study||58
3124411|NCT01647542|3849451|FG002|COMPLETED|Overall Study||59
3124412|NCT01647542|3849449|FG000|NOT COMPLETED|Overall Study||76
3124413|NCT01647542|3849450|FG001|NOT COMPLETED|Overall Study||73
3124414|NCT01647542|3849451|FG002|NOT COMPLETED|Overall Study||72
3124415|NCT01647581|3849461|FG000|STARTED|Overall Study||547
3124416|NCT01647581|3849462|FG001|STARTED|Overall Study||551
3124417|NCT01647581|3849461|FG000|COMPLETED|Overall Study||530
3124418|NCT01647581|3849462|FG001|COMPLETED|Overall Study||520
3124419|NCT01647581|3849461|FG000|NOT COMPLETED|Overall Study||17
3124420|NCT01647581|3849462|FG001|NOT COMPLETED|Overall Study||31
3124421|NCT01647711|3849473|FG000|STARTED|Overall Study||6
3124422|NCT01647711|3849474|FG001|STARTED|Overall Study||3
3124423|NCT01647711|3849475|FG002|STARTED|Overall Study||9
3124424|NCT01647711|3849476|FG003|STARTED|Overall Study||11
3124425|NCT01647711|3849477|FG004|STARTED|Overall Study||6
3124426|NCT01647711|3849473|FG000|COMPLETED|Overall Study||0
3124427|NCT01647711|3849474|FG001|COMPLETED|Overall Study||0
3124428|NCT01647711|3849475|FG002|COMPLETED|Overall Study||0
3124429|NCT01647711|3849476|FG003|COMPLETED|Overall Study||0
3124430|NCT01647711|3849477|FG004|COMPLETED|Overall Study||0
3124431|NCT01647711|3849473|FG000|NOT COMPLETED|Overall Study||6
3124432|NCT01647711|3849474|FG001|NOT COMPLETED|Overall Study||3
3124433|NCT01647711|3849475|FG002|NOT COMPLETED|Overall Study||9
3124434|NCT01647711|3849476|FG003|NOT COMPLETED|Overall Study||11
3124435|NCT01647711|3849477|FG004|NOT COMPLETED|Overall Study||6
3124436|NCT01647737|3849493|FG000|STARTED|Overall Study||30
3124437|NCT01647737|3849494|FG001|STARTED|Overall Study||30
3124438|NCT01647737|3849493|FG000|COMPLETED|Overall Study||26
3124439|NCT01647737|3849494|FG001|COMPLETED|Overall Study||25
3124440|NCT01647737|3849493|FG000|NOT COMPLETED|Overall Study||4
3124441|NCT01647737|3849494|FG001|NOT COMPLETED|Overall Study||5
3124442|NCT01647945|3849504|FG000|STARTED|Overall Study||6
3124443|NCT01647945|3849505|FG001|STARTED|Overall Study||6
3124444|NCT01647945|3849506|FG002|STARTED|Overall Study||5
3124445|NCT01647945|3849507|FG003|STARTED|Overall Study||6
3124446|NCT01647945|3849504|FG000|COMPLETED|Overall Study||6
3124447|NCT01647945|3849505|FG001|COMPLETED|Overall Study||6
3124448|NCT01647945|3849506|FG002|COMPLETED|Overall Study||3
3124449|NCT01647945|3849507|FG003|COMPLETED|Overall Study||5
3124450|NCT01647945|3849504|FG000|NOT COMPLETED|Overall Study||0
3124451|NCT01647945|3849505|FG001|NOT COMPLETED|Overall Study||0
3124452|NCT01647945|3849506|FG002|NOT COMPLETED|Overall Study||2
3124453|NCT01647945|3849507|FG003|NOT COMPLETED|Overall Study||1
3124454|NCT01647958|3849519|FG000|STARTED|Initial Study||41
3124455|NCT01647958|3849520|FG001|STARTED|Initial Study||24
3124456|NCT01647958|3849519|FG000|COMPLETED|Initial Study||39
3124457|NCT01647958|3849520|FG001|COMPLETED|Initial Study||21
3124458|NCT01647958|3849519|FG000|NOT COMPLETED|Initial Study||2
3124459|NCT01647958|3849520|FG001|NOT COMPLETED|Initial Study||3
3124460|NCT01647958|3849519|FG000|STARTED|Continuation Phase||39
3124461|NCT01647958|3849520|FG001|STARTED|Continuation Phase||21
3124462|NCT01647958|3849519|FG000|COMPLETED|Continuation Phase|Treatment-arm patients received TIF procedure during Initial Study phase|0
3124463|NCT01647958|3849520|FG001|COMPLETED|Continuation Phase|21 Control patients received TIF crossover procedure following 6-month follow-up visit.|21
3124464|NCT01647958|3849519|FG000|NOT COMPLETED|Continuation Phase||39
3124465|NCT01647958|3849520|FG001|NOT COMPLETED|Continuation Phase||0
3124466|NCT01647958|3849519|FG000|STARTED|Extended Follow-up Phase|Treatment and Control/Crossover patients were combined into 1 cohort for this follow up. 39+21=60|60
3124467|NCT01647958|3849520|FG001|STARTED|Extended Follow-up Phase|Treatment and Control/Crossover patients combined into 1 cohort for this period=60, 0 under Control|0
3124468|NCT01647958|3849519|FG000|COMPLETED|Extended Follow-up Phase|The 8 lost to follow up patients are of the combined Treatment and Control cohort of 52 patients|52
3124469|NCT01647958|3849520|FG001|COMPLETED|Extended Follow-up Phase||0
3124470|NCT01647958|3849519|FG000|NOT COMPLETED|Extended Follow-up Phase||8
3124471|NCT01647958|3849520|FG001|NOT COMPLETED|Extended Follow-up Phase||0
3124472|NCT01648101|3849538|FG000|STARTED|Titration Phase (4 Weeks)||25
3124473|NCT01648101|3849539|FG001|STARTED|Titration Phase (4 Weeks)||26
3124474|NCT01648101|3849540|FG002|STARTED|Titration Phase (4 Weeks)||24
3124475|NCT01648101|3849538|FG000|COMPLETED|Titration Phase (4 Weeks)||23
3124476|NCT01648101|3849539|FG001|COMPLETED|Titration Phase (4 Weeks)||23
3124477|NCT01648101|3849540|FG002|COMPLETED|Titration Phase (4 Weeks)||18
3124478|NCT01648101|3849538|FG000|NOT COMPLETED|Titration Phase (4 Weeks)||2
3124479|NCT01648101|3849539|FG001|NOT COMPLETED|Titration Phase (4 Weeks)||3
3124480|NCT01648101|3849540|FG002|NOT COMPLETED|Titration Phase (4 Weeks)||6
3124481|NCT01648101|3849538|FG000|STARTED|Maintenance Phase (12 Weeks)||23
3124482|NCT01648101|3849539|FG001|STARTED|Maintenance Phase (12 Weeks)||23
3124483|NCT01648101|3849540|FG002|STARTED|Maintenance Phase (12 Weeks)||18
3124484|NCT01648101|3849538|FG000|COMPLETED|Maintenance Phase (12 Weeks)||20
3124485|NCT01648101|3849539|FG001|COMPLETED|Maintenance Phase (12 Weeks)||20
3124486|NCT01648101|3849540|FG002|COMPLETED|Maintenance Phase (12 Weeks)||12
3124487|NCT01648101|3849538|FG000|NOT COMPLETED|Maintenance Phase (12 Weeks)||3
3124488|NCT01648101|3849539|FG001|NOT COMPLETED|Maintenance Phase (12 Weeks)||3
3124489|NCT01648101|3849540|FG002|NOT COMPLETED|Maintenance Phase (12 Weeks)||6
3124490|NCT01648101|3849538|FG000|STARTED|Transition Phase (4 Weeks)|After completing the MP, only those par. that chose to enter the OLE study started the TnP|17
3124491|NCT01648101|3849539|FG001|STARTED|Transition Phase (4 Weeks)|After completing the MP, only those par. that chose to enter the OLE study started the TnP|18
3124492|NCT01648101|3849540|FG002|STARTED|Transition Phase (4 Weeks)|After completing the MP, only those par. that chose to enter the OLE study started the TnP|9
3124493|NCT01648101|3849538|FG000|COMPLETED|Transition Phase (4 Weeks)||12
3124494|NCT01648101|3849539|FG001|COMPLETED|Transition Phase (4 Weeks)||13
3124495|NCT01648101|3849540|FG002|COMPLETED|Transition Phase (4 Weeks)||5
3124496|NCT01648101|3849538|FG000|NOT COMPLETED|Transition Phase (4 Weeks)||5
3124497|NCT01648101|3849539|FG001|NOT COMPLETED|Transition Phase (4 Weeks)||5
3124498|NCT01648101|3849540|FG002|NOT COMPLETED|Transition Phase (4 Weeks)||4
3124499|NCT01648101|3849538|FG000|STARTED|Taper/Follow-up Phase (4 Weeks)|Includes only those par. who completed the Titration + MN phase, but opted not to enroll in the OLE|1
3124500|NCT01648101|3849539|FG001|STARTED|Taper/Follow-up Phase (4 Weeks)|Includes only those par. who completed the Titration + MN phase, but opted not to enroll in the OLE|2
3124501|NCT01648101|3849540|FG002|STARTED|Taper/Follow-up Phase (4 Weeks)|Includes only those par. who completed the Titration + MN phase, but opted not to enroll in the OLE|3
3124502|NCT01648101|3849538|FG000|COMPLETED|Taper/Follow-up Phase (4 Weeks)||1
3124503|NCT01648101|3849539|FG001|COMPLETED|Taper/Follow-up Phase (4 Weeks)||1
3124504|NCT01648101|3849540|FG002|COMPLETED|Taper/Follow-up Phase (4 Weeks)||3
3124505|NCT01648101|3849538|FG000|NOT COMPLETED|Taper/Follow-up Phase (4 Weeks)||0
3124506|NCT01648101|3849539|FG001|NOT COMPLETED|Taper/Follow-up Phase (4 Weeks)||1
3124507|NCT01648101|3849540|FG002|NOT COMPLETED|Taper/Follow-up Phase (4 Weeks)||0
3124508|NCT01648140|3849556|FG000|STARTED|Overall Study||41
3124509|NCT01648140|3849557|FG001|STARTED|Overall Study||40
3124510|NCT01648140|3849558|FG002|STARTED|Overall Study||17
3124511|NCT01648140|3849559|FG003|STARTED|Overall Study||13
3124512|NCT01648140|3849556|FG000|COMPLETED|Overall Study||29
3124513|NCT01648140|3849557|FG001|COMPLETED|Overall Study||28
3124514|NCT01648140|3849558|FG002|COMPLETED|Overall Study||9
3124515|NCT01648140|3849559|FG003|COMPLETED|Overall Study||11
3124516|NCT01648140|3849556|FG000|NOT COMPLETED|Overall Study||12
3124517|NCT01648140|3849557|FG001|NOT COMPLETED|Overall Study||12
3124518|NCT01648140|3849558|FG002|NOT COMPLETED|Overall Study||8
3124519|NCT01648140|3849559|FG003|NOT COMPLETED|Overall Study||2
3136298|NCT01711879|3861411|FG001|STARTED|Overall Study||4
3136299|NCT01711879|3861410|FG000|COMPLETED|Overall Study||2
3136300|NCT01711879|3861411|FG001|COMPLETED|Overall Study||4
3136301|NCT01711879|3861410|FG000|NOT COMPLETED|Overall Study||1
3136302|NCT01711879|3861411|FG001|NOT COMPLETED|Overall Study||0
3136303|NCT01711918|3861419|FG000|STARTED|Overall Study||9
3136304|NCT01711918|3861419|FG000|COMPLETED|Overall Study||7
3136305|NCT01711918|3861419|FG000|NOT COMPLETED|Overall Study||2
3136306|NCT01711983|3861423|FG000|STARTED|6-Month Clinical Success Evaluation||400
3136307|NCT01711983|3861423|FG000|COMPLETED|6-Month Clinical Success Evaluation||368
3136308|NCT01711983|3861423|FG000|NOT COMPLETED|6-Month Clinical Success Evaluation||32
3136309|NCT01711983|3861423|FG000|STARTED|6-Month Closure Evaluation||368
3136310|NCT01711983|3861423|FG000|COMPLETED|6-Month Closure Evaluation||342
3136311|NCT01711983|3861423|FG000|NOT COMPLETED|6-Month Closure Evaluation||26
3136312|NCT01711983|3861423|FG000|STARTED|36-Month Closure Evaluation||342
3136313|NCT01711983|3861423|FG000|COMPLETED|36-Month Closure Evaluation||278
3136314|NCT01711983|3861423|FG000|NOT COMPLETED|36-Month Closure Evaluation||64
3136315|NCT01712009|3861430|FG000|STARTED|Overall Study||198
3136316|NCT01712009|3861431|FG001|STARTED|Overall Study||200
3136317|NCT01712009|3861432|FG002|STARTED|Overall Study||202
3136318|NCT01712009|3861430|FG000|Received Pegfilgrastim|Overall Study||191
3136319|NCT01712009|3861431|FG001|Received Pegfilgrastim|Overall Study||196
3136320|NCT01712009|3861432|FG002|Received Pegfilgrastim|Overall Study||200
3136321|NCT01712009|3861430|FG000|Received Naproxen / Loratadine|Overall Study||0
3124520|NCT01648166|3849580|FG000|STARTED|Overall Study||153
3124521|NCT01648166|3849581|FG001|STARTED|Overall Study||367
3124522|NCT01648166|3849580|FG000|COMPLETED|Overall Study||100
3124523|NCT01648166|3849581|FG001|COMPLETED|Overall Study||267
3124524|NCT01648166|3849580|FG000|NOT COMPLETED|Overall Study||53
3124525|NCT01648166|3849581|FG001|NOT COMPLETED|Overall Study||100
3124526|NCT01648283|3849587|FG000|STARTED|Overall Study||78
3124527|NCT01648283|3849587|FG000|COMPLETED|Overall Study||64
3124528|NCT01648283|3849587|FG000|NOT COMPLETED|Overall Study||14
3124529|NCT01648322|3849597|FG000|STARTED|Overall Study||35
3124530|NCT01648322|3849598|FG001|STARTED|Overall Study||67
3124531|NCT01648322|3849599|FG002|STARTED|Overall Study||65
3124532|NCT01648322|3849600|FG003|STARTED|Overall Study||65
3124533|NCT01648322|3849597|FG000|COMPLETED|Overall Study||33
3124534|NCT01648322|3849598|FG001|COMPLETED|Overall Study||62
3124535|NCT01648322|3849599|FG002|COMPLETED|Overall Study||60
3124536|NCT01648322|3849600|FG003|COMPLETED|Overall Study||61
3124537|NCT01648322|3849597|FG000|NOT COMPLETED|Overall Study||2
3124538|NCT01648322|3849598|FG001|NOT COMPLETED|Overall Study||5
3124539|NCT01648322|3849599|FG002|NOT COMPLETED|Overall Study||5
3124540|NCT01648322|3849600|FG003|NOT COMPLETED|Overall Study||4
3124541|NCT01648348|3849629|FG000|STARTED|Overall Study||5
3124542|NCT01648348|3849630|FG001|STARTED|Overall Study||3
3124543|NCT01648348|3849631|FG002|STARTED|Overall Study||4
3124544|NCT01648348|3849632|FG003|STARTED|Overall Study||3
3124545|NCT01648348|3849633|FG004|STARTED|Overall Study||52
3124546|NCT01648348|3849634|FG005|STARTED|Overall Study||49
3124547|NCT01648348|3849629|FG000|COMPLETED|Overall Study||3
3124548|NCT01648348|3849630|FG001|COMPLETED|Overall Study||3
3124549|NCT01648348|3849631|FG002|COMPLETED|Overall Study||3
3124550|NCT01648348|3849632|FG003|COMPLETED|Overall Study||3
3124551|NCT01648348|3849633|FG004|COMPLETED|Overall Study||49
3124552|NCT01648348|3849634|FG005|COMPLETED|Overall Study||43
3124553|NCT01648348|3849629|FG000|NOT COMPLETED|Overall Study||2
3124554|NCT01648348|3849630|FG001|NOT COMPLETED|Overall Study||0
3124555|NCT01648348|3849631|FG002|NOT COMPLETED|Overall Study||1
3124556|NCT01648348|3849632|FG003|NOT COMPLETED|Overall Study||0
3124557|NCT01648348|3849633|FG004|NOT COMPLETED|Overall Study||3
3124558|NCT01648348|3849634|FG005|NOT COMPLETED|Overall Study||6
3124559|NCT01648452|3849647|FG000|STARTED|Overall Study||5
3124560|NCT01648452|3849647|FG000|COMPLETED|Overall Study|One participant was explanted due to an adverse event. Remainder kept implant at study completion.|5
3124561|NCT01648452|3849647|FG000|NOT COMPLETED|Overall Study||0
3124562|NCT01648491|3849653|FG000|STARTED|Overall Study||1
3124563|NCT01648491|3849653|FG000|COMPLETED|Overall Study||1
3124564|NCT01648491|3849653|FG000|NOT COMPLETED|Overall Study||0
3124565|NCT01648530|3849658|FG000|STARTED|Overall Study||16789
3124566|NCT01648530|3849658|FG000|COMPLETED|Overall Study||5915
3124567|NCT01648530|3849658|FG000|NOT COMPLETED|Overall Study||10874
3124568|NCT01648582|3849667|FG000|STARTED|Overall Study||258
3124569|NCT01648582|3849668|FG001|STARTED|Overall Study||257
3124570|NCT01648582|3849669|FG002|STARTED|Overall Study||259
3124571|NCT01648582|3849667|FG000|Received at Least One Dose of Study Drug|Overall Study||258
3124572|NCT01648582|3849668|FG001|Received at Least One Dose of Study Drug|Overall Study||257
3124573|NCT01648582|3849669|FG002|Received at Least One Dose of Study Drug|Overall Study||259
3124574|NCT01648582|3849667|FG000|Modified Intent-to-Treat Population|Overall Study||253
3124575|NCT01648582|3849668|FG001|Modified Intent-to-Treat Population|Overall Study||252
3124576|NCT01648582|3849669|FG002|Modified Intent-to-Treat Population|Overall Study||250
3124577|NCT01648582|3849667|FG000|COMPLETED|Overall Study||226
3124578|NCT01648582|3849668|FG001|COMPLETED|Overall Study||219
3124579|NCT01648582|3849669|FG002|COMPLETED|Overall Study||227
3124580|NCT01648582|3849667|FG000|NOT COMPLETED|Overall Study||32
3124581|NCT01648582|3849668|FG001|NOT COMPLETED|Overall Study||38
3124582|NCT01648582|3849669|FG002|NOT COMPLETED|Overall Study||32
3124583|NCT01648699|3849680|FG000|STARTED|Overall Study||20
3124584|NCT01648699|3849680|FG000|COMPLETED|Overall Study||15
3124585|NCT01648699|3849680|FG000|NOT COMPLETED|Overall Study||5
3124586|NCT01648764|3849707|FG000|STARTED|Overall Study||3
3124587|NCT01648764|3849708|FG001|STARTED|Overall Study||3
3124588|NCT01648764|3849709|FG002|STARTED|Overall Study||3
3124589|NCT01648764|3849710|FG003|STARTED|Overall Study||3
3124590|NCT01648764|3849711|FG004|STARTED|Overall Study||3
3124591|NCT01648764|3849712|FG005|STARTED|Overall Study||5
3124592|NCT01648764|3849713|FG006|STARTED|Overall Study||9
3124593|NCT01648764|3849714|FG007|STARTED|Overall Study||3
3124594|NCT01648764|3849715|FG008|STARTED|Overall Study||3
3124595|NCT01648764|3849716|FG009|STARTED|Overall Study||7
3124596|NCT01648764|3849717|FG010|STARTED|Overall Study||3
3124597|NCT01648764|3849718|FG011|STARTED|Overall Study||9
3124598|NCT01648764|3849719|FG012|STARTED|Overall Study||7
3124599|NCT01648764|3849720|FG013|STARTED|Overall Study||12
3124600|NCT01648764|3849707|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
3124601|NCT01648764|3849708|FG001|Received at Least 1 Dose of Study Drug|Overall Study||3
3124602|NCT01648764|3849709|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3
3124603|NCT01648764|3849710|FG003|Received at Least 1 Dose of Study Drug|Overall Study||3
3124604|NCT01648764|3849711|FG004|Received at Least 1 Dose of Study Drug|Overall Study||3
3124605|NCT01648764|3849712|FG005|Received at Least 1 Dose of Study Drug|Overall Study||5
3124606|NCT01648764|3849713|FG006|Received at Least 1 Dose of Study Drug|Overall Study||9
3124607|NCT01648764|3849714|FG007|Received at Least 1 Dose of Study Drug|Overall Study||3
3124608|NCT01648764|3849715|FG008|Received at Least 1 Dose of Study Drug|Overall Study||3
3124609|NCT01648764|3849716|FG009|Received at Least 1 Dose of Study Drug|Overall Study||7
3124610|NCT01648764|3849717|FG010|Received at Least 1 Dose of Study Drug|Overall Study||3
3124611|NCT01648764|3849718|FG011|Received at Least 1 Dose of Study Drug|Overall Study||9
3124612|NCT01648764|3849719|FG012|Received at Least 1 Dose of Study Drug|Overall Study||7
3124613|NCT01648764|3849720|FG013|Received at Least 1 Dose of Study Drug|Overall Study||12
3124614|NCT01648764|3849707|FG000|COMPLETED|Overall Study||3
3124615|NCT01648764|3849708|FG001|COMPLETED|Overall Study||2
3124616|NCT01648764|3849709|FG002|COMPLETED|Overall Study||3
3124617|NCT01648764|3849710|FG003|COMPLETED|Overall Study||3
3124618|NCT01648764|3849711|FG004|COMPLETED|Overall Study||3
3124619|NCT01648764|3849712|FG005|COMPLETED|Overall Study||3
3124620|NCT01648764|3849713|FG006|COMPLETED|Overall Study||4
3124621|NCT01648764|3849714|FG007|COMPLETED|Overall Study||3
3124622|NCT01648764|3849715|FG008|COMPLETED|Overall Study||3
3124623|NCT01648764|3849716|FG009|COMPLETED|Overall Study||4
3124624|NCT01648764|3849717|FG010|COMPLETED|Overall Study||3
3124625|NCT01648764|3849718|FG011|COMPLETED|Overall Study||4
3124626|NCT01648764|3849719|FG012|COMPLETED|Overall Study||3
3124627|NCT01648764|3849720|FG013|COMPLETED|Overall Study||9
3124628|NCT01648764|3849707|FG000|NOT COMPLETED|Overall Study||0
3124629|NCT01648764|3849708|FG001|NOT COMPLETED|Overall Study||1
3124630|NCT01648764|3849709|FG002|NOT COMPLETED|Overall Study||0
3124631|NCT01648764|3849710|FG003|NOT COMPLETED|Overall Study||0
3124632|NCT01648764|3849711|FG004|NOT COMPLETED|Overall Study||0
3124633|NCT01648764|3849712|FG005|NOT COMPLETED|Overall Study||2
3124634|NCT01648764|3849713|FG006|NOT COMPLETED|Overall Study||5
3124635|NCT01648764|3849714|FG007|NOT COMPLETED|Overall Study||0
3124636|NCT01648764|3849715|FG008|NOT COMPLETED|Overall Study||0
3124637|NCT01648764|3849716|FG009|NOT COMPLETED|Overall Study||3
3124638|NCT01648764|3849717|FG010|NOT COMPLETED|Overall Study||0
3124639|NCT01648764|3849718|FG011|NOT COMPLETED|Overall Study||5
3124640|NCT01648764|3849719|FG012|NOT COMPLETED|Overall Study||4
3124641|NCT01648764|3849720|FG013|NOT COMPLETED|Overall Study||3
3124642|NCT01648790|3849754|FG000|STARTED|Treatment 1||4
3124643|NCT01648790|3849755|FG001|STARTED|Treatment 1||4
3124644|NCT01648790|3849756|FG002|STARTED|Treatment 1||4
3124645|NCT01648790|3849757|FG003|STARTED|Treatment 1||4
3124646|NCT01648790|3849758|FG004|STARTED|Treatment 1||4
3124647|NCT01648790|3849754|FG000|Received at Least 1 Dose of Study Drug|Treatment 1||4
3124648|NCT01648790|3849755|FG001|Received at Least 1 Dose of Study Drug|Treatment 1||4
3124649|NCT01648790|3849756|FG002|Received at Least 1 Dose of Study Drug|Treatment 1||4
3124650|NCT01648790|3849757|FG003|Received at Least 1 Dose of Study Drug|Treatment 1||4
3124651|NCT01648790|3849758|FG004|Received at Least 1 Dose of Study Drug|Treatment 1||4
3124652|NCT01648790|3849754|FG000|COMPLETED|Treatment 1||4
3124653|NCT01648790|3849755|FG001|COMPLETED|Treatment 1||4
3124654|NCT01648790|3849756|FG002|COMPLETED|Treatment 1||4
3124655|NCT01648790|3849757|FG003|COMPLETED|Treatment 1||4
3124656|NCT01648790|3849758|FG004|COMPLETED|Treatment 1||4
3124657|NCT01648790|3849754|FG000|NOT COMPLETED|Treatment 1||0
3124658|NCT01648790|3849755|FG001|NOT COMPLETED|Treatment 1||0
3124659|NCT01648790|3849756|FG002|NOT COMPLETED|Treatment 1||0
3124660|NCT01648790|3849757|FG003|NOT COMPLETED|Treatment 1||0
3124661|NCT01648790|3849758|FG004|NOT COMPLETED|Treatment 1||0
3124662|NCT01648790|3849754|FG000|STARTED|Treatment 2||4
3124663|NCT01648790|3849755|FG001|STARTED|Treatment 2||4
3124664|NCT01648790|3849756|FG002|STARTED|Treatment 2||4
3124665|NCT01648790|3849757|FG003|STARTED|Treatment 2||4
3124666|NCT01648790|3849758|FG004|STARTED|Treatment 2||4
3124667|NCT01648790|3849754|FG000|COMPLETED|Treatment 2||4
3124668|NCT01648790|3849755|FG001|COMPLETED|Treatment 2||4
3124669|NCT01648790|3849756|FG002|COMPLETED|Treatment 2||4
3124670|NCT01648790|3849757|FG003|COMPLETED|Treatment 2||4
3124671|NCT01648790|3849758|FG004|COMPLETED|Treatment 2||4
3124672|NCT01648790|3849754|FG000|NOT COMPLETED|Treatment 2||0
3124673|NCT01648790|3849755|FG001|NOT COMPLETED|Treatment 2||0
3124674|NCT01648790|3849756|FG002|NOT COMPLETED|Treatment 2||0
3124675|NCT01648790|3849757|FG003|NOT COMPLETED|Treatment 2||0
3124676|NCT01648790|3849758|FG004|NOT COMPLETED|Treatment 2||0
3124677|NCT01648790|3849754|FG000|STARTED|Treatment 3||4
3124678|NCT01648790|3849755|FG001|STARTED|Treatment 3||4
3124679|NCT01648790|3849756|FG002|STARTED|Treatment 3||4
3124680|NCT01648790|3849757|FG003|STARTED|Treatment 3|Withdrew consent prior to dosing on this treatment day.|4
3124681|NCT01648790|3849758|FG004|STARTED|Treatment 3||4
3124682|NCT01648790|3849754|FG000|COMPLETED|Treatment 3||4
3124683|NCT01648790|3849755|FG001|COMPLETED|Treatment 3||4
3124684|NCT01648790|3849756|FG002|COMPLETED|Treatment 3||4
3124685|NCT01648790|3849757|FG003|COMPLETED|Treatment 3||3
3124686|NCT01648790|3849758|FG004|COMPLETED|Treatment 3||4
3124687|NCT01648790|3849754|FG000|NOT COMPLETED|Treatment 3||0
3124688|NCT01648790|3849755|FG001|NOT COMPLETED|Treatment 3||0
3124689|NCT01648790|3849756|FG002|NOT COMPLETED|Treatment 3||0
3124690|NCT01648790|3849757|FG003|NOT COMPLETED|Treatment 3||1
3124691|NCT01648790|3849758|FG004|NOT COMPLETED|Treatment 3||0
3124692|NCT01648790|3849754|FG000|STARTED|Treatment 4||4
3124693|NCT01648790|3849755|FG001|STARTED|Treatment 4||4
3124694|NCT01648790|3849756|FG002|STARTED|Treatment 4||4
3124695|NCT01648790|3849757|FG003|STARTED|Treatment 4||3
3124696|NCT01648790|3849758|FG004|STARTED|Treatment 4||4
3124697|NCT01648790|3849754|FG000|COMPLETED|Treatment 4||4
3124698|NCT01648790|3849755|FG001|COMPLETED|Treatment 4||4
3124699|NCT01648790|3849756|FG002|COMPLETED|Treatment 4||4
3124700|NCT01648790|3849757|FG003|COMPLETED|Treatment 4||3
3124701|NCT01648790|3849758|FG004|COMPLETED|Treatment 4||4
3124702|NCT01648790|3849754|FG000|NOT COMPLETED|Treatment 4||0
3124703|NCT01648790|3849755|FG001|NOT COMPLETED|Treatment 4||0
3124704|NCT01648790|3849756|FG002|NOT COMPLETED|Treatment 4||0
3124705|NCT01648790|3849757|FG003|NOT COMPLETED|Treatment 4||0
3124706|NCT01648790|3849758|FG004|NOT COMPLETED|Treatment 4||0
3124707|NCT01648790|3849754|FG000|STARTED|Treatment 5||4
3124708|NCT01648790|3849755|FG001|STARTED|Treatment 5||4
3124709|NCT01648790|3849756|FG002|STARTED|Treatment 5||4
3124710|NCT01648790|3849757|FG003|STARTED|Treatment 5||3
3124711|NCT01648790|3849758|FG004|STARTED|Treatment 5||4
3124712|NCT01648790|3849754|FG000|COMPLETED|Treatment 5||4
3124713|NCT01648790|3849755|FG001|COMPLETED|Treatment 5||4
3124714|NCT01648790|3849756|FG002|COMPLETED|Treatment 5||4
3124715|NCT01648790|3849757|FG003|COMPLETED|Treatment 5||3
3124716|NCT01648790|3849758|FG004|COMPLETED|Treatment 5||4
3124717|NCT01648790|3849754|FG000|NOT COMPLETED|Treatment 5||0
3124718|NCT01648790|3849755|FG001|NOT COMPLETED|Treatment 5||0
3124719|NCT01648790|3849756|FG002|NOT COMPLETED|Treatment 5||0
3124720|NCT01648790|3849757|FG003|NOT COMPLETED|Treatment 5||0
3124721|NCT01648790|3849758|FG004|NOT COMPLETED|Treatment 5||0
3124722|NCT01648920|3849770|FG000|STARTED|Overall Study||50
3124723|NCT01648920|3849770|FG000|COMPLETED|Overall Study||50
3124724|NCT01648920|3849770|FG000|NOT COMPLETED|Overall Study||0
3124725|NCT01648959|3849774|FG000|STARTED|Overall Study||5
3124726|NCT01648959|3849774|FG000|COMPLETED|Overall Study||5
3124727|NCT01648959|3849774|FG000|NOT COMPLETED|Overall Study||0
3124728|NCT01649180|3849778|FG000|STARTED|Overall Study||3
3124729|NCT01649180|3849778|FG000|COMPLETED|Overall Study||3
3124730|NCT01649180|3849778|FG000|NOT COMPLETED|Overall Study||0
3124731|NCT01649232|3849784|FG000|STARTED|Overall Study||30
3124732|NCT01649232|3849785|FG001|STARTED|Overall Study||30
3124733|NCT01649232|3849784|FG000|COMPLETED|Overall Study|technical problems or excessive artifacts, two data sets were excluded from further analysis.|28
3124734|NCT01649232|3849785|FG001|COMPLETED|Overall Study||30
3124735|NCT01649232|3849784|FG000|NOT COMPLETED|Overall Study||2
3124736|NCT01649232|3849785|FG001|NOT COMPLETED|Overall Study||0
3124737|NCT01649271|3849799|FG000|STARTED|Overall Study||6
3124738|NCT01649271|3849800|FG001|STARTED|Overall Study||7
3124739|NCT01649271|3849799|FG000|COMPLETED|Overall Study||0
3124740|NCT01649271|3849800|FG001|COMPLETED|Overall Study||0
3124741|NCT01649271|3849799|FG000|NOT COMPLETED|Overall Study||6
3124742|NCT01649271|3849800|FG001|NOT COMPLETED|Overall Study||7
3124743|NCT01649297|3849812|FG000|STARTED|Overall Study|randomised|219
3124744|NCT01649297|3849813|FG001|STARTED|Overall Study|randomised|218
3124745|NCT01649297|3849814|FG002|STARTED|Overall Study|randomised|219
3124746|NCT01649297|3849815|FG003|STARTED|Overall Study|randomised|220
3124747|NCT01649297|3849816|FG004|STARTED|Overall Study|randomised|107
3124748|NCT01649297|3849812|FG000|COMPLETED|Overall Study||205
3124749|NCT01649297|3849813|FG001|COMPLETED|Overall Study||205
3124750|NCT01649297|3849814|FG002|COMPLETED|Overall Study||202
3124751|NCT01649297|3849815|FG003|COMPLETED|Overall Study||201
3124752|NCT01649297|3849816|FG004|COMPLETED|Overall Study||103
3124753|NCT01649297|3849812|FG000|NOT COMPLETED|Overall Study||14
3124754|NCT01649297|3849813|FG001|NOT COMPLETED|Overall Study||13
3124755|NCT01649297|3849814|FG002|NOT COMPLETED|Overall Study||17
3124756|NCT01649297|3849815|FG003|NOT COMPLETED|Overall Study||19
3124757|NCT01649297|3849816|FG004|NOT COMPLETED|Overall Study||4
3124758|NCT01649362|3849830|FG000|STARTED|Overall Study||47
3124759|NCT01649362|3849831|FG001|STARTED|Overall Study||54
3124760|NCT01649362|3849830|FG000|COMPLETED|Overall Study||46
3124761|NCT01649362|3849831|FG001|COMPLETED|Overall Study||40
3124762|NCT01649362|3849830|FG000|NOT COMPLETED|Overall Study||1
3124763|NCT01649362|3849831|FG001|NOT COMPLETED|Overall Study||14
3124764|NCT01649375|3849840|FG000|STARTED|Up to Week 16||73
3124765|NCT01649375|3849841|FG001|STARTED|Up to Week 16||72
3124766|NCT01649375|3849842|FG002|STARTED|Up to Week 16||74
3124767|NCT01649375|3849843|FG003|STARTED|Up to Week 16||0
3124768|NCT01649375|3849844|FG004|STARTED|Up to Week 16||0
3124769|NCT01649375|3849840|FG000|COMPLETED|Up to Week 16||68
3124770|NCT01649375|3849841|FG001|COMPLETED|Up to Week 16||66
3124771|NCT01649375|3849842|FG002|COMPLETED|Up to Week 16||66
3124772|NCT01649375|3849843|FG003|COMPLETED|Up to Week 16||0
3124773|NCT01649375|3849844|FG004|COMPLETED|Up to Week 16||0
3124774|NCT01649375|3849840|FG000|NOT COMPLETED|Up to Week 16||5
3124775|NCT01649375|3849841|FG001|NOT COMPLETED|Up to Week 16||6
3124776|NCT01649375|3849842|FG002|NOT COMPLETED|Up to Week 16||8
3124777|NCT01649375|3849843|FG003|NOT COMPLETED|Up to Week 16||0
3124778|NCT01649375|3849844|FG004|NOT COMPLETED|Up to Week 16||0
3124779|NCT01649375|3849840|FG000|STARTED|Week 16 up to Week 260||68
3124780|NCT01649375|3849841|FG001|STARTED|Week 16 up to Week 260||66
3124781|NCT01649375|3849842|FG002|STARTED|Week 16 up to Week 260||0
3124782|NCT01649375|3849843|FG003|STARTED|Week 16 up to Week 260||32
3124783|NCT01649375|3849844|FG004|STARTED|Week 16 up to Week 260||34
3124784|NCT01649375|3849840|FG000|COMPLETED|Week 16 up to Week 260||48
3124785|NCT01649375|3849841|FG001|COMPLETED|Week 16 up to Week 260||53
3124786|NCT01649375|3849842|FG002|COMPLETED|Week 16 up to Week 260||0
3124787|NCT01649375|3849843|FG003|COMPLETED|Week 16 up to Week 260||20
3124788|NCT01649375|3849844|FG004|COMPLETED|Week 16 up to Week 260||29
3124789|NCT01649375|3849840|FG000|NOT COMPLETED|Week 16 up to Week 260||20
3124790|NCT01649375|3849841|FG001|NOT COMPLETED|Week 16 up to Week 260||13
3124791|NCT01649375|3849842|FG002|NOT COMPLETED|Week 16 up to Week 260||0
3124792|NCT01649375|3849843|FG003|NOT COMPLETED|Week 16 up to Week 260||12
3124793|NCT01649375|3849844|FG004|NOT COMPLETED|Week 16 up to Week 260||5
3124794|NCT01649427|3849854|FG000|STARTED|Overall Study||35
3124795|NCT01649427|3849855|FG001|STARTED|Overall Study||38
3124796|NCT01649427|3849854|FG000|COMPLETED|Overall Study||24
3124797|NCT01649427|3849855|FG001|COMPLETED|Overall Study||26
3124798|NCT01649427|3849854|FG000|NOT COMPLETED|Overall Study||11
3124799|NCT01649427|3849855|FG001|NOT COMPLETED|Overall Study||12
3136322|NCT01712009|3861431|FG001|Received Naproxen / Loratadine|Overall Study||193
3136323|NCT01712009|3861432|FG002|Received Naproxen / Loratadine|Overall Study||198
3136324|NCT01712009|3861430|FG000|COMPLETED|Overall Study||160
3136325|NCT01712009|3861431|FG001|COMPLETED|Overall Study||171
3136326|NCT01712009|3861432|FG002|COMPLETED|Overall Study||181
3136327|NCT01712009|3861430|FG000|NOT COMPLETED|Overall Study||38
3136328|NCT01712009|3861431|FG001|NOT COMPLETED|Overall Study||29
3136329|NCT01712009|3861432|FG002|NOT COMPLETED|Overall Study||21
3136330|NCT01712061|3861442|FG000|STARTED|Overall Study||30
3136331|NCT01712061|3861443|FG001|STARTED|Overall Study||140
3136332|NCT01712061|3861444|FG002|STARTED|Overall Study||56
3136333|NCT01712061|3861442|FG000|COMPLETED|Overall Study||20
3136334|NCT01712061|3861443|FG001|COMPLETED|Overall Study||114
3136335|NCT01712061|3861444|FG002|COMPLETED|Overall Study||45
3136336|NCT01712061|3861442|FG000|NOT COMPLETED|Overall Study||10
3136337|NCT01712061|3861443|FG001|NOT COMPLETED|Overall Study||26
3136338|NCT01712061|3861444|FG002|NOT COMPLETED|Overall Study||11
3136339|NCT01712074|3861456|FG000|STARTED|Placebo Run-in Period||195
3136340|NCT01712074|3861457|FG001|STARTED|Placebo Run-in Period||0
3136341|NCT01712074|3861458|FG002|STARTED|Placebo Run-in Period||0
3136342|NCT01712074|3861456|FG000|COMPLETED|Placebo Run-in Period||185
3136343|NCT01712074|3861457|FG001|COMPLETED|Placebo Run-in Period||0
3136344|NCT01712074|3861458|FG002|COMPLETED|Placebo Run-in Period||0
3136345|NCT01712074|3861456|FG000|NOT COMPLETED|Placebo Run-in Period||10
3136346|NCT01712074|3861457|FG001|NOT COMPLETED|Placebo Run-in Period||0
3136347|NCT01712074|3861458|FG002|NOT COMPLETED|Placebo Run-in Period||0
3136348|NCT01712074|3861456|FG000|STARTED|Double Blind Period||0
3136349|NCT01712074|3861457|FG001|STARTED|Double Blind Period||91
3136350|NCT01712074|3861458|FG002|STARTED|Double Blind Period||94
3136351|NCT01712074|3861456|FG000|COMPLETED|Double Blind Period||0
3136352|NCT01712074|3861457|FG001|COMPLETED|Double Blind Period||77
3136353|NCT01712074|3861458|FG002|COMPLETED|Double Blind Period||86
3136354|NCT01712074|3861456|FG000|NOT COMPLETED|Double Blind Period||0
3136355|NCT01712074|3861457|FG001|NOT COMPLETED|Double Blind Period||14
3136356|NCT01712074|3861458|FG002|NOT COMPLETED|Double Blind Period||8
3136357|NCT01712178|3861475|FG000|STARTED|Overall Study||50
3136358|NCT01712178|3861476|FG001|STARTED|Overall Study||50
3136359|NCT01712178|3861475|FG000|COMPLETED|Overall Study||49
3136360|NCT01712178|3861476|FG001|COMPLETED|Overall Study||47
3136361|NCT01712178|3861475|FG000|NOT COMPLETED|Overall Study||1
3136362|NCT01712178|3861476|FG001|NOT COMPLETED|Overall Study||3
3136363|NCT01712204|3861484|FG000|STARTED|Overall Study||41
3136364|NCT01712204|3861485|FG001|STARTED|Overall Study||41
3136365|NCT01712204|3861484|FG000|COMPLETED|Overall Study||33
3136366|NCT01712204|3861485|FG001|COMPLETED|Overall Study||36
3136367|NCT01712204|3861484|FG000|NOT COMPLETED|Overall Study||8
3136368|NCT01712204|3861485|FG001|NOT COMPLETED|Overall Study||5
3136369|NCT01712230|3861494|FG000|STARTED|Overall Study||11
3136370|NCT01712230|3861495|FG001|STARTED|Overall Study||18
3136371|NCT01712230|3861496|FG002|STARTED|Overall Study||18
3136372|NCT01712230|3861494|FG000|COMPLETED|Overall Study||9
3136373|NCT01712230|3861495|FG001|COMPLETED|Overall Study||14
3136374|NCT01712230|3861496|FG002|COMPLETED|Overall Study||11
3136375|NCT01712230|3861494|FG000|NOT COMPLETED|Overall Study||2
3136376|NCT01712230|3861495|FG001|NOT COMPLETED|Overall Study||4
3136377|NCT01712230|3861496|FG002|NOT COMPLETED|Overall Study||7
3136378|NCT01712256|3861504|FG000|STARTED|Overall Study||33
3136379|NCT01712256|3861504|FG000|COMPLETED|Overall Study||32
3136380|NCT01712256|3861504|FG000|NOT COMPLETED|Overall Study||1
3136381|NCT01712334|3861508|FG000|STARTED|Treatment Period 1||44
3136382|NCT01712334|3861509|FG001|STARTED|Treatment Period 1||43
3136383|NCT01712334|3861508|FG000|Received Treatment|Treatment Period 1||44
3136384|NCT01712334|3861509|FG001|Received Treatment|Treatment Period 1||41
3136385|NCT01712334|3861508|FG000|COMPLETED|Treatment Period 1||44
3136386|NCT01712334|3861509|FG001|COMPLETED|Treatment Period 1||41
3136387|NCT01712334|3861508|FG000|NOT COMPLETED|Treatment Period 1||0
3136388|NCT01712334|3861509|FG001|NOT COMPLETED|Treatment Period 1||2
3136389|NCT01712334|3861508|FG000|STARTED|Treatment Period 2||44
3136390|NCT01712334|3861509|FG001|STARTED|Treatment Period 2||41
3136391|NCT01712334|3861508|FG000|COMPLETED|Treatment Period 2||44
3136392|NCT01712334|3861509|FG001|COMPLETED|Treatment Period 2||41
3136393|NCT01712334|3861508|FG000|NOT COMPLETED|Treatment Period 2||0
3136394|NCT01712334|3861509|FG001|NOT COMPLETED|Treatment Period 2||0
3136395|NCT01712360|3861519|FG000|STARTED|Overall Study||22
3136396|NCT01712360|3861520|FG001|STARTED|Overall Study||22
3136397|NCT01712360|3861521|FG002|STARTED|Overall Study||6
3136398|NCT01712360|3861522|FG003|STARTED|Overall Study||6
3136399|NCT01712360|3861519|FG000|COMPLETED|Overall Study||22
3136400|NCT01712360|3861520|FG001|COMPLETED|Overall Study||21
3136401|NCT01712360|3861521|FG002|COMPLETED|Overall Study||6
3124800|NCT01649557|3849864|FG000|STARTED|Overall Study||179
3124801|NCT01649557|3849865|FG001|STARTED|Overall Study||41
3124802|NCT01649557|3849866|FG002|STARTED|Overall Study||24
3124803|NCT01649557|3849864|FG000|6-week Enrollers|Overall Study||159
3124804|NCT01649557|3849865|FG001|6-week Enrollers|Overall Study||35
3124805|NCT01649557|3849866|FG002|6-week Enrollers|Overall Study||22
3124806|NCT01649557|3849864|FG000|52-week Enrollers|Overall Study||20
3124807|NCT01649557|3849865|FG001|52-week Enrollers|Overall Study||6
3124808|NCT01649557|3849866|FG002|52-week Enrollers|Overall Study||2
3124809|NCT01649557|3849864|FG000|COMPLETED|Overall Study||135
3124810|NCT01649557|3849865|FG001|COMPLETED|Overall Study||27
3124811|NCT01649557|3849866|FG002|COMPLETED|Overall Study||15
3124812|NCT01649557|3849864|FG000|NOT COMPLETED|Overall Study||44
3124813|NCT01649557|3849865|FG001|NOT COMPLETED|Overall Study||14
3124814|NCT01649557|3849866|FG002|NOT COMPLETED|Overall Study||9
3124815|NCT01649596|3849876|FG000|STARTED|Overall Study||46
3124816|NCT01649596|3849877|FG001|STARTED|Overall Study||48
3124817|NCT01649596|3849876|FG000|COMPLETED|Overall Study||46
3124818|NCT01649596|3849877|FG001|COMPLETED|Overall Study||48
3124819|NCT01649596|3849876|FG000|NOT COMPLETED|Overall Study||0
3124820|NCT01649596|3849877|FG001|NOT COMPLETED|Overall Study||0
3124821|NCT01649609|3849885|FG000|STARTED|Overall Study||20
3124822|NCT01649609|3849886|FG001|STARTED|Overall Study||20
3124823|NCT01649609|3849885|FG000|COMPLETED|Overall Study||20
3124824|NCT01649609|3849886|FG001|COMPLETED|Overall Study||20
3124825|NCT01649609|3849885|FG000|NOT COMPLETED|Overall Study||0
3124826|NCT01649609|3849886|FG001|NOT COMPLETED|Overall Study||0
3124827|NCT01649765|3849894|FG000|STARTED|Overall Study||40
3124828|NCT01649765|3849895|FG001|STARTED|Overall Study||53
3124829|NCT01649765|3849894|FG000|COMPLETED|Overall Study||31
3124830|NCT01649765|3849895|FG001|COMPLETED|Overall Study||45
3124831|NCT01649765|3849894|FG000|NOT COMPLETED|Overall Study||9
3124832|NCT01649765|3849895|FG001|NOT COMPLETED|Overall Study||8
3124833|NCT01649791|3849902|FG000|STARTED|Overall Study||8
3124834|NCT01649791|3849902|FG000|COMPLETED|Overall Study||5
3124835|NCT01649791|3849902|FG000|NOT COMPLETED|Overall Study||3
3124836|NCT01649804|3849906|FG000|STARTED|Overall Study||12
3124837|NCT01649804|3849906|FG000|COMPLETED|Overall Study||4
3124838|NCT01649804|3849906|FG000|NOT COMPLETED|Overall Study||8
3124839|NCT01649856|3849912|FG000|STARTED|Overall Study||369
3124840|NCT01649856|3849913|FG001|STARTED|Overall Study||203
3124841|NCT01649856|3849912|FG000|COMPLETED|Overall Study||230
3124842|NCT01649856|3849913|FG001|COMPLETED|Overall Study||125
3124843|NCT01649856|3849912|FG000|NOT COMPLETED|Overall Study||139
3124844|NCT01649856|3849913|FG001|NOT COMPLETED|Overall Study||78
3124845|NCT01649869|3849921|FG000|STARTED|Overall Study||18
3124846|NCT01649869|3849922|FG001|STARTED|Overall Study||17
3124847|NCT01649869|3849921|FG000|COMPLETED|Overall Study||16
3124848|NCT01649869|3849922|FG001|COMPLETED|Overall Study||16
3124849|NCT01649869|3849921|FG000|NOT COMPLETED|Overall Study||2
3124850|NCT01649869|3849922|FG001|NOT COMPLETED|Overall Study||1
3124851|NCT01649947|3849932|FG000|STARTED|Overall Study||12
3124852|NCT01649947|3849933|FG001|STARTED|Overall Study||20
3124853|NCT01649947|3849932|FG000|COMPLETED|Overall Study||0
3124854|NCT01649947|3849933|FG001|COMPLETED|Overall Study||2
3124855|NCT01649947|3849932|FG000|NOT COMPLETED|Overall Study||12
3124856|NCT01649947|3849933|FG001|NOT COMPLETED|Overall Study||18
3124857|NCT01650194|3849940|FG000|STARTED|Overall Study||60
3124858|NCT01650194|3849940|FG000|Treated|Overall Study||60
3124859|NCT01650194|3849940|FG000|COMPLETED|Overall Study||13
3124860|NCT01650194|3849940|FG000|NOT COMPLETED|Overall Study||47
3124861|NCT01650246|3849945|FG000|STARTED|Overall Study||143
3124862|NCT01650246|3849945|FG000|COMPLETED|Overall Study||0
3124863|NCT01650246|3849945|FG000|NOT COMPLETED|Overall Study||143
3124864|NCT01650259|3849951|FG000|STARTED|Overall Study|Started are the registered patients|2513
3124865|NCT01650259|3849952|FG001|STARTED|Overall Study|Started are the registered patients|2363
3124866|NCT01650259|3849951|FG000|COMPLETED|Overall Study||1470
3124867|NCT01650259|3849952|FG001|COMPLETED|Overall Study||2128
3124868|NCT01650259|3849951|FG000|NOT COMPLETED|Overall Study||1043
3124869|NCT01650259|3849952|FG001|NOT COMPLETED|Overall Study||235
3124870|NCT01650285|3849956|FG000|STARTED|Overall Study||5
3124871|NCT01650285|3849956|FG000|COMPLETED|Overall Study||4
3124872|NCT01650285|3849956|FG000|NOT COMPLETED|Overall Study||1
3124873|NCT01650298|3849962|FG000|STARTED|Overall Study||16
3124874|NCT01650298|3849963|FG001|STARTED|Overall Study||48
3296364|NCT02906670|4030254|FG006|STARTED|Cohort 4, Q2W||0
3296365|NCT02906670|4030255|FG007|STARTED|Cohort 4, Q2W||0
3124875|NCT01650298|3849962|FG000|COMPLETED|Overall Study||11
3124876|NCT01650298|3849963|FG001|COMPLETED|Overall Study||42
3124877|NCT01650298|3849962|FG000|NOT COMPLETED|Overall Study||5
3124878|NCT01650298|3849963|FG001|NOT COMPLETED|Overall Study||6
3124879|NCT01650324|3849974|FG000|STARTED|Overall Study||8
3124880|NCT01650324|3849975|FG001|STARTED|Overall Study||6
3124881|NCT01650324|3849976|FG002|STARTED|Overall Study||6
3124882|NCT01650324|3849977|FG003|STARTED|Overall Study||6
3124883|NCT01650324|3849978|FG004|STARTED|Overall Study||6
3124884|NCT01650324|3849974|FG000|COMPLETED|Overall Study||8
3124885|NCT01650324|3849975|FG001|COMPLETED|Overall Study||6
3124886|NCT01650324|3849976|FG002|COMPLETED|Overall Study||6
3124887|NCT01650324|3849977|FG003|COMPLETED|Overall Study||6
3124888|NCT01650324|3849978|FG004|COMPLETED|Overall Study||6
3124889|NCT01650324|3849974|FG000|NOT COMPLETED|Overall Study||0
3296366|NCT02906670|4030256|FG008|STARTED|Cohort 4, Q2W||0
3124890|NCT01650324|3849975|FG001|NOT COMPLETED|Overall Study||0
3124891|NCT01650324|3849976|FG002|NOT COMPLETED|Overall Study||0
3124892|NCT01650324|3849977|FG003|NOT COMPLETED|Overall Study||0
3124893|NCT01650324|3849978|FG004|NOT COMPLETED|Overall Study||0
3124894|NCT01650350|3849995|FG000|STARTED|Overall Study||7
3124895|NCT01650350|3849995|FG000|COMPLETED|Overall Study||7
3124896|NCT01650350|3849995|FG000|NOT COMPLETED|Overall Study||0
3124897|NCT01650402|3850003|FG000|STARTED|Overall Study||99
3124898|NCT01650402|3850004|FG001|STARTED|Overall Study||100
3124899|NCT01650402|3850003|FG000|COMPLETED|Overall Study||79
3124900|NCT01650402|3850004|FG001|COMPLETED|Overall Study||86
3124901|NCT01650402|3850003|FG000|NOT COMPLETED|Overall Study||20
3124902|NCT01650402|3850004|FG001|NOT COMPLETED|Overall Study||14
3124903|NCT01650519|3850012|FG000|STARTED|Overall Study||20
3124904|NCT01650519|3850013|FG001|STARTED|Overall Study||31
3124905|NCT01650519|3850012|FG000|COMPLETED|Overall Study||19
3124906|NCT01650519|3850013|FG001|COMPLETED|Overall Study||31
3124907|NCT01650519|3850012|FG000|NOT COMPLETED|Overall Study||1
3124908|NCT01650519|3850013|FG001|NOT COMPLETED|Overall Study||0
3124909|NCT01650545|3850021|FG000|STARTED|Overall Study||11
3124910|NCT01650545|3850022|FG001|STARTED|Overall Study||10
3124911|NCT01650545|3850021|FG000|COMPLETED|Overall Study||11
3124912|NCT01650545|3850022|FG001|COMPLETED|Overall Study||10
3124913|NCT01650545|3850021|FG000|NOT COMPLETED|Overall Study||0
3124914|NCT01650545|3850022|FG001|NOT COMPLETED|Overall Study||0
3124915|NCT01650558|3850033|FG000|STARTED|Overall Study||500
3124916|NCT01650558|3850034|FG001|STARTED|Overall Study||500
3124917|NCT01650558|3850035|FG002|STARTED|Overall Study||499
3124918|NCT01650558|3850033|FG000|COMPLETED|Overall Study||417
3124919|NCT01650558|3850034|FG001|COMPLETED|Overall Study||408
3124920|NCT01650558|3850035|FG002|COMPLETED|Overall Study||424
3124921|NCT01650558|3850033|FG000|NOT COMPLETED|Overall Study||83
3124922|NCT01650558|3850034|FG001|NOT COMPLETED|Overall Study||92
3124923|NCT01650558|3850035|FG002|NOT COMPLETED|Overall Study||75
3124924|NCT01650584|3850046|FG000|STARTED|Overall Study|Each participant received one of 2 treatments in each eye.|35
3124925|NCT01650584|3850046|FG000|COMPLETED|Overall Study||35
3124926|NCT01650584|3850046|FG000|NOT COMPLETED|Overall Study||0
3124927|NCT01650636|3850053|FG000|STARTED|Intervention Phase||150
3124928|NCT01650636|3850054|FG001|STARTED|Intervention Phase||150
3124929|NCT01650636|3850053|FG000|COMPLETED|Intervention Phase||150
3124930|NCT01650636|3850054|FG001|COMPLETED|Intervention Phase||150
3124931|NCT01650636|3850053|FG000|NOT COMPLETED|Intervention Phase||0
3124932|NCT01650636|3850054|FG001|NOT COMPLETED|Intervention Phase||0
3124933|NCT01650636|3850053|FG000|STARTED|Washout up to 5 Months||150
3124934|NCT01650636|3850054|FG001|STARTED|Washout up to 5 Months||150
3124935|NCT01650636|3850053|FG000|COMPLETED|Washout up to 5 Months||141
3124936|NCT01650636|3850054|FG001|COMPLETED|Washout up to 5 Months||132
3124937|NCT01650636|3850053|FG000|NOT COMPLETED|Washout up to 5 Months||9
3124938|NCT01650636|3850054|FG001|NOT COMPLETED|Washout up to 5 Months||18
3124939|NCT01650636|3850053|FG000|STARTED|5 Month Visit||141
3124940|NCT01650636|3850054|FG001|STARTED|5 Month Visit||132
3124941|NCT01650636|3850053|FG000|COMPLETED|5 Month Visit||141
3124942|NCT01650636|3850054|FG001|COMPLETED|5 Month Visit||132
3124943|NCT01650636|3850053|FG000|NOT COMPLETED|5 Month Visit||0
3124944|NCT01650636|3850054|FG001|NOT COMPLETED|5 Month Visit||0
3124945|NCT01650636|3850053|FG000|STARTED|Washout up to 9 Months||141
3124946|NCT01650636|3850054|FG001|STARTED|Washout up to 9 Months||132
3124947|NCT01650636|3850053|FG000|COMPLETED|Washout up to 9 Months||135
3124948|NCT01650636|3850054|FG001|COMPLETED|Washout up to 9 Months||129
3124949|NCT01650636|3850053|FG000|NOT COMPLETED|Washout up to 9 Months||6
3124950|NCT01650636|3850054|FG001|NOT COMPLETED|Washout up to 9 Months||3
3124951|NCT01650636|3850053|FG000|STARTED|9 Month Visit||135
3124952|NCT01650636|3850054|FG001|STARTED|9 Month Visit||129
3124953|NCT01650636|3850053|FG000|COMPLETED|9 Month Visit||135
3124954|NCT01650636|3850054|FG001|COMPLETED|9 Month Visit||129
3124955|NCT01650636|3850053|FG000|NOT COMPLETED|9 Month Visit||0
3124956|NCT01650636|3850054|FG001|NOT COMPLETED|9 Month Visit||0
3124957|NCT01650779|3850060|FG000|STARTED|Overall Study||15
3124958|NCT01650779|3850060|FG000|COMPLETED|Overall Study||14
3124959|NCT01650779|3850060|FG000|NOT COMPLETED|Overall Study||1
3124960|NCT01650805|3850066|FG000|STARTED|Overall Study|Started means patient has been randomized.|155
3124961|NCT01650805|3850067|FG001|STARTED|Overall Study||152
3124962|NCT01650805|3850066|FG000|COMPLETED|Overall Study|Completed means patient initiated and discontinued study treatment.|154
3124963|NCT01650805|3850067|FG001|COMPLETED|Overall Study||152
3124964|NCT01650805|3850066|FG000|NOT COMPLETED|Overall Study||1
3124965|NCT01650805|3850067|FG001|NOT COMPLETED|Overall Study||0
3124966|NCT01650831|3850073|FG000|STARTED|Overall Study||113
3124967|NCT01650831|3850073|FG000|COMPLETED|Overall Study||112
3124968|NCT01650831|3850073|FG000|NOT COMPLETED|Overall Study||1
3124969|NCT01650844|3850083|FG000|STARTED|Overall Study||200
3124970|NCT01650844|3850084|FG001|STARTED|Overall Study||200
3124971|NCT01650844|3850083|FG000|COMPLETED|Overall Study||199
3124972|NCT01650844|3850084|FG001|COMPLETED|Overall Study||196
3124973|NCT01650844|3850083|FG000|NOT COMPLETED|Overall Study||1
3124974|NCT01650844|3850084|FG001|NOT COMPLETED|Overall Study||4
3124975|NCT01651000|3850092|FG000|STARTED|Overall Study||72
3124976|NCT01651000|3850093|FG001|STARTED|Overall Study||141
3124977|NCT01651000|3850092|FG000|Entered Extension Study|Overall Study||50
3124978|NCT01651000|3850093|FG001|Entered Extension Study|Overall Study||93
3124979|NCT01651000|3850092|FG000|COMPLETED|Overall Study||62
3124980|NCT01651000|3850093|FG001|COMPLETED|Overall Study||113
3124981|NCT01651000|3850092|FG000|NOT COMPLETED|Overall Study||10
3124982|NCT01651000|3850093|FG001|NOT COMPLETED|Overall Study||28
3124983|NCT01651039|3850099|FG000|STARTED|Overall Study||32
3124984|NCT01651039|3850099|FG000|COMPLETED|Overall Study||2
3124985|NCT01651039|3850099|FG000|NOT COMPLETED|Overall Study||30
3124986|NCT01651052|3850103|FG000|STARTED|Overall Study||133
3124987|NCT01651052|3850103|FG000|Study Valve Group|Overall Study||133
3124988|NCT01651052|3850103|FG000|COMPLETED|Overall Study||107
3124989|NCT01651052|3850103|FG000|NOT COMPLETED|Overall Study||26
3124990|NCT01651078|3850107|FG000|STARTED|Overall Study|Two (2) out of 44 patients were enrolled but did not go on to have the NeuroBlate Procedure.|42
3124991|NCT01651078|3850107|FG000|COMPLETED|Overall Study||16
3124992|NCT01651078|3850107|FG000|NOT COMPLETED|Overall Study||26
3124993|NCT01651104|3850111|FG000|STARTED|Overall Study||63
3124994|NCT01651104|3850111|FG000|COMPLETED|Overall Study||63
3124995|NCT01651104|3850111|FG000|NOT COMPLETED|Overall Study||0
3124996|NCT01651117|3850119|FG000|STARTED|Overall Study||156
3124997|NCT01651117|3850120|FG001|STARTED|Overall Study||205
3124998|NCT01651117|3850121|FG002|STARTED|Overall Study||49
3124999|NCT01651117|3850122|FG003|STARTED|Overall Study||70
3125000|NCT01651117|3850119|FG000|COMPLETED|Overall Study||154
3125001|NCT01651117|3850120|FG001|COMPLETED|Overall Study||202
3125002|NCT01651117|3850121|FG002|COMPLETED|Overall Study||47
3125003|NCT01651117|3850122|FG003|COMPLETED|Overall Study||68
3125004|NCT01651117|3850119|FG000|NOT COMPLETED|Overall Study||2
3125005|NCT01651117|3850120|FG001|NOT COMPLETED|Overall Study||3
3125006|NCT01651117|3850121|FG002|NOT COMPLETED|Overall Study||2
3125007|NCT01651117|3850122|FG003|NOT COMPLETED|Overall Study||2
3125008|NCT01651195|3850139|FG000|STARTED|Overall Study||284
3125009|NCT01651195|3850140|FG001|STARTED|Overall Study||284
3125010|NCT01651195|3850141|FG002|STARTED|Overall Study||204
3125011|NCT01651195|3850142|FG003|STARTED|Overall Study||211
3125012|NCT01651195|3850139|FG000|COMPLETED|Overall Study||63
3125013|NCT01651195|3850140|FG001|COMPLETED|Overall Study||73
3125014|NCT01651195|3850141|FG002|COMPLETED|Overall Study||121
3125015|NCT01651195|3850142|FG003|COMPLETED|Overall Study||103
3125016|NCT01651195|3850139|FG000|NOT COMPLETED|Overall Study||221
3125017|NCT01651195|3850140|FG001|NOT COMPLETED|Overall Study||211
3125018|NCT01651195|3850141|FG002|NOT COMPLETED|Overall Study||83
3125019|NCT01651195|3850142|FG003|NOT COMPLETED|Overall Study||108
3125020|NCT01651208|3850158|FG000|STARTED|Overall Study||227
3125021|NCT01651208|3850159|FG001|STARTED|Overall Study||225
3125022|NCT01651208|3850158|FG000|COMPLETED|Overall Study|14 patients had no pharmacy claims data to analyze primary outcome|213
3125023|NCT01651208|3850159|FG001|COMPLETED|Overall Study|16 subjects had no pharmacy claims data to analyze primary outcome|209
3125024|NCT01651208|3850158|FG000|NOT COMPLETED|Overall Study||14
3125025|NCT01651208|3850159|FG001|NOT COMPLETED|Overall Study||16
3125026|NCT01651260|3850166|FG000|STARTED|Overall Study||65
3125027|NCT01651260|3850166|FG000|COMPLETED|Overall Study||62
3125028|NCT01651260|3850166|FG000|NOT COMPLETED|Overall Study||3
3125029|NCT01651351|3850173|FG000|STARTED|Overall Study||15
3125030|NCT01651351|3850174|FG001|STARTED|Overall Study||15
3125031|NCT01651351|3850173|FG000|COMPLETED|Overall Study||15
3125032|NCT01651351|3850174|FG001|COMPLETED|Overall Study||15
3125033|NCT01651351|3850173|FG000|NOT COMPLETED|Overall Study||0
3125034|NCT01651351|3850174|FG001|NOT COMPLETED|Overall Study||0
3125035|NCT01651442|3850183|FG000|STARTED|Phase I Treatment||104
3125036|NCT01651442|3850184|FG001|STARTED|Phase I Treatment||107
3125037|NCT01651442|3850185|FG002|STARTED|Phase I Treatment||0
3125038|NCT01651442|3850186|FG003|STARTED|Phase I Treatment||0
3125039|NCT01651442|3850187|FG004|STARTED|Phase I Treatment||0
3125040|NCT01651442|3850188|FG005|STARTED|Phase I Treatment||0
3125041|NCT01651442|3850183|FG000|COMPLETED|Phase I Treatment||88
3125042|NCT01651442|3850184|FG001|COMPLETED|Phase I Treatment||80
3125043|NCT01651442|3850185|FG002|COMPLETED|Phase I Treatment||0
3125044|NCT01651442|3850186|FG003|COMPLETED|Phase I Treatment||0
3125045|NCT01651442|3850187|FG004|COMPLETED|Phase I Treatment||0
3125046|NCT01651442|3850188|FG005|COMPLETED|Phase I Treatment||0
3125047|NCT01651442|3850183|FG000|NOT COMPLETED|Phase I Treatment||16
3125048|NCT01651442|3850184|FG001|NOT COMPLETED|Phase I Treatment||27
3125049|NCT01651442|3850185|FG002|NOT COMPLETED|Phase I Treatment||0
3125050|NCT01651442|3850186|FG003|NOT COMPLETED|Phase I Treatment||0
3125051|NCT01651442|3850187|FG004|NOT COMPLETED|Phase I Treatment||0
3125052|NCT01651442|3850188|FG005|NOT COMPLETED|Phase I Treatment||0
3125053|NCT01651442|3850183|FG000|STARTED|Phase II Treatment||0
3125054|NCT01651442|3850184|FG001|STARTED|Phase II Treatment||0
3125055|NCT01651442|3850185|FG002|STARTED|Phase II Treatment||27
3125056|NCT01651442|3850186|FG003|STARTED|Phase II Treatment||27
3125057|NCT01651442|3850187|FG004|STARTED|Phase II Treatment||27
3125058|NCT01651442|3850188|FG005|STARTED|Phase II Treatment||27
3125059|NCT01651442|3850183|FG000|COMPLETED|Phase II Treatment||0
3125060|NCT01651442|3850184|FG001|COMPLETED|Phase II Treatment||0
3125061|NCT01651442|3850185|FG002|COMPLETED|Phase II Treatment||25
3125062|NCT01651442|3850186|FG003|COMPLETED|Phase II Treatment||15
3125063|NCT01651442|3850187|FG004|COMPLETED|Phase II Treatment||21
3125064|NCT01651442|3850188|FG005|COMPLETED|Phase II Treatment||17
3125065|NCT01651442|3850183|FG000|NOT COMPLETED|Phase II Treatment||0
3125066|NCT01651442|3850184|FG001|NOT COMPLETED|Phase II Treatment||0
3125067|NCT01651442|3850185|FG002|NOT COMPLETED|Phase II Treatment||2
3125068|NCT01651442|3850186|FG003|NOT COMPLETED|Phase II Treatment||12
3125069|NCT01651442|3850187|FG004|NOT COMPLETED|Phase II Treatment||6
3125070|NCT01651442|3850188|FG005|NOT COMPLETED|Phase II Treatment||10
3125071|NCT01651780|3850202|FG000|STARTED|Overall Study||405
3125072|NCT01651780|3850203|FG001|STARTED|Overall Study||398
3125073|NCT01651780|3850202|FG000|Intent-To-Treat (ITT) Population|Overall Study||404
3125074|NCT01651780|3850203|FG001|Intent-To-Treat (ITT) Population|Overall Study||398
3125075|NCT01651780|3850202|FG000|Received at Least 1 Dose of Study Drug|Overall Study|All but 1 participant in the bivalirudin group (withdrew consent) comprised the ITT population.|393
3125076|NCT01651780|3850203|FG001|Received at Least 1 Dose of Study Drug|Overall Study||394
3125077|NCT01651780|3850202|FG000|BRAVO 2 Feasibility Cohort|Overall Study|1st 2 participants/site made up the bivalirudin feasibility cohort (BRAVO2) and analyzed separately.|65
3125078|NCT01651780|3850203|FG001|BRAVO 2 Feasibility Cohort|Overall Study|1st 2 participants/site made up the bivalirudin feasibility cohort (BRAVO2) and analyzed separately.|0
3125079|NCT01651780|3850202|FG000|COMPLETED|Overall Study||394
3125080|NCT01651780|3850203|FG001|COMPLETED|Overall Study||388
3125081|NCT01651780|3850202|FG000|NOT COMPLETED|Overall Study||11
3125082|NCT01651780|3850203|FG001|NOT COMPLETED|Overall Study||10
3125083|NCT01651793|3850213|FG000|STARTED|Overall Study||6
3125084|NCT01651793|3850214|FG001|STARTED|Overall Study||6
3125085|NCT01651793|3850215|FG002|STARTED|Overall Study||6
3125086|NCT01651793|3850216|FG003|STARTED|Overall Study||6
3125087|NCT01651793|3850213|FG000|COMPLETED|Overall Study||6
3125088|NCT01651793|3850214|FG001|COMPLETED|Overall Study||6
3125089|NCT01651793|3850215|FG002|COMPLETED|Overall Study||6
3125090|NCT01651793|3850216|FG003|COMPLETED|Overall Study||5
3125091|NCT01651793|3850213|FG000|NOT COMPLETED|Overall Study||0
3125092|NCT01651793|3850214|FG001|NOT COMPLETED|Overall Study||0
3125093|NCT01651793|3850215|FG002|NOT COMPLETED|Overall Study||0
3125094|NCT01651793|3850216|FG003|NOT COMPLETED|Overall Study||1
3125095|NCT01651806|3850235|FG000|STARTED|Overall Study||13
3125096|NCT01651806|3850236|FG001|STARTED|Overall Study||12
3125097|NCT01651806|3850237|FG002|STARTED|Overall Study||25
3125098|NCT01651806|3850238|FG003|STARTED|Overall Study||7
3125099|NCT01651806|3850239|FG004|STARTED|Overall Study||8
3125100|NCT01651806|3850235|FG000|COMPLETED|Overall Study||13
3125101|NCT01651806|3850236|FG001|COMPLETED|Overall Study||12
3125102|NCT01651806|3850237|FG002|COMPLETED|Overall Study||25
3125103|NCT01651806|3850238|FG003|COMPLETED|Overall Study||7
3125104|NCT01651806|3850239|FG004|COMPLETED|Overall Study||8
3125105|NCT01651806|3850235|FG000|NOT COMPLETED|Overall Study||0
3125106|NCT01651806|3850236|FG001|NOT COMPLETED|Overall Study||0
3125107|NCT01651806|3850237|FG002|NOT COMPLETED|Overall Study||0
3125108|NCT01651806|3850238|FG003|NOT COMPLETED|Overall Study||0
3125109|NCT01651806|3850239|FG004|NOT COMPLETED|Overall Study||0
3125110|NCT01651936|3850254|FG000|STARTED|Base Study||30
3125111|NCT01651936|3850255|FG001|STARTED|Base Study||26
3125112|NCT01651936|3850256|FG002|STARTED|Base Study||0
3125113|NCT01651936|3850254|FG000|COMPLETED|Base Study||3
3125114|NCT01651936|3850255|FG001|COMPLETED|Base Study||1
3125115|NCT01651936|3850256|FG002|COMPLETED|Base Study||0
3125116|NCT01651936|3850254|FG000|NOT COMPLETED|Base Study||27
3125117|NCT01651936|3850255|FG001|NOT COMPLETED|Base Study||25
3125118|NCT01651936|3850256|FG002|NOT COMPLETED|Base Study||0
3125119|NCT01651936|3850254|FG000|STARTED|Extension Study||0
3125120|NCT01651936|3850255|FG001|STARTED|Extension Study||0
3125121|NCT01651936|3850256|FG002|STARTED|Extension Study|Includes completers and early escapees from the Base Study|14
3125122|NCT01651936|3850254|FG000|COMPLETED|Extension Study||0
3125123|NCT01651936|3850255|FG001|COMPLETED|Extension Study||0
3125124|NCT01651936|3850256|FG002|COMPLETED|Extension Study||0
3125125|NCT01651936|3850254|FG000|NOT COMPLETED|Extension Study||0
3125126|NCT01651936|3850255|FG001|NOT COMPLETED|Extension Study||0
3125127|NCT01651936|3850256|FG002|NOT COMPLETED|Extension Study||14
3125128|NCT01651949|3850266|FG000|STARTED|Overall Study||1106
3125129|NCT01651949|3850267|FG001|STARTED|Overall Study||1101
3125130|NCT01651949|3850268|FG002|STARTED|Overall Study||313
3125131|NCT01651949|3850266|FG000|Vaccination 1|Overall Study||1103
3125132|NCT01651949|3850267|FG001|Vaccination 1|Overall Study||1099
3125133|NCT01651949|3850268|FG002|Vaccination 1|Overall Study||313
3125134|NCT01651949|3850266|FG000|Vaccination 2|Overall Study||1089
3125135|NCT01651949|3850267|FG001|Vaccination 2|Overall Study||1069
3125136|NCT01651949|3850268|FG002|Vaccination 2|Overall Study||298
3125137|NCT01651949|3850266|FG000|Vaccination 3|Overall Study||1067
3125138|NCT01651949|3850267|FG001|Vaccination 3|Overall Study||1037
3125139|NCT01651949|3850268|FG002|Vaccination 3|Overall Study||291
3125140|NCT01651949|3850266|FG000|COMPLETED|Overall Study||1053
3125141|NCT01651949|3850267|FG001|COMPLETED|Overall Study||1015
3125142|NCT01651949|3850268|FG002|COMPLETED|Overall Study||282
3125143|NCT01651949|3850266|FG000|NOT COMPLETED|Overall Study||53
3125144|NCT01651949|3850267|FG001|NOT COMPLETED|Overall Study||86
3125145|NCT01651949|3850268|FG002|NOT COMPLETED|Overall Study||31
3125146|NCT01652001|3850278|FG000|STARTED|Overall Study||100
3125147|NCT01652001|3850279|FG001|STARTED|Overall Study||85
3125148|NCT01652001|3850278|FG000|COMPLETED|Overall Study||91
3125149|NCT01652001|3850279|FG001|COMPLETED|Overall Study||79
3125150|NCT01652001|3850278|FG000|NOT COMPLETED|Overall Study||9
3125151|NCT01652001|3850279|FG001|NOT COMPLETED|Overall Study||6
3125152|NCT01652040|3850287|FG000|STARTED|Overall Study||13
3125153|NCT01652040|3850288|FG001|STARTED|Overall Study||13
3125154|NCT01652040|3850287|FG000|COMPLETED|Overall Study||11
3125155|NCT01652040|3850288|FG001|COMPLETED|Overall Study||11
3296367|NCT02906670|4030257|FG009|STARTED|Cohort 4, Q2W||0
3296368|NCT02906670|4030248|FG000|COMPLETED|Cohort 4, Q2W||0
3296369|NCT02906670|4030249|FG001|COMPLETED|Cohort 4, Q2W||0
3296370|NCT02906670|4030250|FG002|COMPLETED|Cohort 4, Q2W||0
3296371|NCT02906670|4030251|FG003|COMPLETED|Cohort 4, Q2W||0
3296372|NCT02906670|4030252|FG004|COMPLETED|Cohort 4, Q2W||0
3296373|NCT02906670|4030253|FG005|COMPLETED|Cohort 4, Q2W||0
3296374|NCT02906670|4030254|FG006|COMPLETED|Cohort 4, Q2W||0
3296375|NCT02906670|4030255|FG007|COMPLETED|Cohort 4, Q2W||0
3125156|NCT01652040|3850287|FG000|NOT COMPLETED|Overall Study||2
3125157|NCT01652040|3850288|FG001|NOT COMPLETED|Overall Study||2
3125158|NCT01652287|3850297|FG000|STARTED|Overall Study||31
3125159|NCT01652287|3850298|FG001|STARTED|Overall Study||31
3125160|NCT01652287|3850297|FG000|COMPLETED|Overall Study|• Did not receive allocated intervention (withdrew consent) (n=2)|29
3125161|NCT01652287|3850298|FG001|COMPLETED|Overall Study||31
3125162|NCT01652287|3850297|FG000|NOT COMPLETED|Overall Study||2
3125163|NCT01652287|3850298|FG001|NOT COMPLETED|Overall Study||0
3125164|NCT01652469|3850306|FG000|STARTED|Overall Study||38
3125165|NCT01652469|3850307|FG001|STARTED|Overall Study||42
3125166|NCT01652469|3850306|FG000|COMPLETED|Overall Study||37
3125167|NCT01652469|3850307|FG001|COMPLETED|Overall Study||36
3125168|NCT01652469|3850306|FG000|NOT COMPLETED|Overall Study||1
3125169|NCT01652469|3850307|FG001|NOT COMPLETED|Overall Study||6
3125170|NCT01652495|3850315|FG000|STARTED|Overall Study||22
3125171|NCT01652495|3850316|FG001|STARTED|Overall Study||22
3125172|NCT01652495|3850315|FG000|COMPLETED|Overall Study||20
3125173|NCT01652495|3850316|FG001|COMPLETED|Overall Study||20
3125174|NCT01652495|3850315|FG000|NOT COMPLETED|Overall Study||2
3125175|NCT01652495|3850316|FG001|NOT COMPLETED|Overall Study||2
3125176|NCT01652573|3850326|FG000|STARTED|Overall Study||10
3125177|NCT01652573|3850327|FG001|STARTED|Overall Study||11
3125178|NCT01652573|3850326|FG000|COMPLETED|Overall Study||10
3125179|NCT01652573|3850327|FG001|COMPLETED|Overall Study||10
3125180|NCT01652573|3850326|FG000|NOT COMPLETED|Overall Study||0
3125181|NCT01652573|3850327|FG001|NOT COMPLETED|Overall Study||1
3125182|NCT01652664|3850335|FG000|STARTED|Overall Study||77
3125183|NCT01652664|3850336|FG001|STARTED|Overall Study||75
3125184|NCT01652664|3850335|FG000|COMPLETED|Overall Study||71
3125185|NCT01652664|3850336|FG001|COMPLETED|Overall Study||74
3125186|NCT01652664|3850335|FG000|NOT COMPLETED|Overall Study||6
3125187|NCT01652664|3850336|FG001|NOT COMPLETED|Overall Study||1
3125188|NCT01652690|3850345|FG000|STARTED|Overall Study||300
3125189|NCT01652690|3850346|FG001|STARTED|Overall Study||300
3125190|NCT01652690|3850345|FG000|COMPLETED|Overall Study||265
3125191|NCT01652690|3850346|FG001|COMPLETED|Overall Study||279
3125192|NCT01652690|3850345|FG000|NOT COMPLETED|Overall Study||35
3125193|NCT01652690|3850346|FG001|NOT COMPLETED|Overall Study||21
3125194|NCT01652703|3850358|FG000|STARTED|Overall Study||52
3125195|NCT01652703|3850359|FG001|STARTED|Overall Study||51
3125196|NCT01652703|3850360|FG002|STARTED|Overall Study||50
3125197|NCT01652703|3850361|FG003|STARTED|Overall Study||52
3125198|NCT01652703|3850362|FG004|STARTED|Overall Study||52
3125199|NCT01652703|3850363|FG005|STARTED|Overall Study||53
3125200|NCT01652703|3850358|FG000|Received Treatment|Overall Study||52
3125201|NCT01652703|3850359|FG001|Received Treatment|Overall Study||50
3125202|NCT01652703|3850360|FG002|Received Treatment|Overall Study||49
3125203|NCT01652703|3850361|FG003|Received Treatment|Overall Study||52
3125204|NCT01652703|3850362|FG004|Received Treatment|Overall Study||51
3125205|NCT01652703|3850363|FG005|Received Treatment|Overall Study||53
3125206|NCT01652703|3850358|FG000|COMPLETED|Overall Study||52
3125207|NCT01652703|3850359|FG001|COMPLETED|Overall Study||50
3125208|NCT01652703|3850360|FG002|COMPLETED|Overall Study||47
3125209|NCT01652703|3850361|FG003|COMPLETED|Overall Study||50
3125210|NCT01652703|3850362|FG004|COMPLETED|Overall Study||51
3125211|NCT01652703|3850363|FG005|COMPLETED|Overall Study||51
3125212|NCT01652703|3850358|FG000|NOT COMPLETED|Overall Study||0
3125213|NCT01652703|3850359|FG001|NOT COMPLETED|Overall Study||1
3125214|NCT01652703|3850360|FG002|NOT COMPLETED|Overall Study||3
3125215|NCT01652703|3850361|FG003|NOT COMPLETED|Overall Study||2
3125216|NCT01652703|3850362|FG004|NOT COMPLETED|Overall Study||1
3125217|NCT01652703|3850363|FG005|NOT COMPLETED|Overall Study||2
3125218|NCT01652716|3850379|FG000|STARTED|Overall Study||229
3125219|NCT01652716|3850380|FG001|STARTED|Overall Study|Two subjects in the exenatide BID group withdrew from the study before receiving study drug.|148
3125220|NCT01652716|3850379|FG000|Completed 28-week|Overall Study||197
3125221|NCT01652716|3850380|FG001|Completed 28-week|Overall Study||118
3125222|NCT01652716|3850379|FG000|COMPLETED|Overall Study|* completed study|173
3125223|NCT01652716|3850380|FG001|COMPLETED|Overall Study|* completed study|102
3125224|NCT01652716|3850379|FG000|NOT COMPLETED|Overall Study||56
3125225|NCT01652716|3850380|FG001|NOT COMPLETED|Overall Study||46
3125226|NCT01652729|3850389|FG000|STARTED|Overall Study|One subject was enrolled twice at different sites. He was randomized to exenatide at both sites.|182
3125227|NCT01652729|3850390|FG001|STARTED|Overall Study||122
3125228|NCT01652729|3850391|FG002|STARTED|Overall Study||61
3125229|NCT01652729|3850389|FG000|Modified Intent-to-Treat|Overall Study|All randomized subjects who received at least one dose of study drug.|181
3125230|NCT01652729|3850390|FG001|Modified Intent-to-Treat|Overall Study||122
3125231|NCT01652729|3850391|FG002|Modified Intent-to-Treat|Overall Study||61
3296376|NCT02906670|4030256|FG008|COMPLETED|Cohort 4, Q2W||0
3296377|NCT02906670|4030257|FG009|COMPLETED|Cohort 4, Q2W||0
3296378|NCT02906670|4030248|FG000|NOT COMPLETED|Cohort 4, Q2W||0
3125232|NCT01652729|3850389|FG000|Treated|Overall Study|All subjects who received at least one dose of study medication even if not randomized.|181
3125233|NCT01652729|3850390|FG001|Treated|Overall Study||122
3125234|NCT01652729|3850391|FG002|Treated|Overall Study||61
3125235|NCT01652729|3850389|FG000|Evaluable|Overall Study|Subjects who completed study procedures to Week 24 or beyond and had adequate study drug exposure|143
3125236|NCT01652729|3850390|FG001|Evaluable|Overall Study||91
3125237|NCT01652729|3850391|FG002|Evaluable|Overall Study||43
3125238|NCT01652729|3850389|FG000|Meal Test Subjects|Overall Study||60
3125239|NCT01652729|3850390|FG001|Meal Test Subjects|Overall Study||41
3125240|NCT01652729|3850391|FG002|Meal Test Subjects|Overall Study||20
3125241|NCT01652729|3850389|FG000|Meal Test Evaluable|Overall Study|ITT subjects who ate >=75% of meal and did not miss 2-hour postprandial glucose measures at V3 and 8|44
3125242|NCT01652729|3850390|FG001|Meal Test Evaluable|Overall Study||31
3125243|NCT01652729|3850391|FG002|Meal Test Evaluable|Overall Study||15
3125244|NCT01652729|3850389|FG000|COMPLETED|Overall Study|The double-enrolled subject's reasons for withdrawal were LTFU and PV. Only PV is shown below.|155
3125245|NCT01652729|3850390|FG001|COMPLETED|Overall Study||109
3125246|NCT01652729|3850391|FG002|COMPLETED|Overall Study||47
3125247|NCT01652729|3850389|FG000|NOT COMPLETED|Overall Study||27
3125248|NCT01652729|3850390|FG001|NOT COMPLETED|Overall Study||13
3125249|NCT01652729|3850391|FG002|NOT COMPLETED|Overall Study||14
3125250|NCT01652872|3850401|FG000|STARTED|Overall Study||377
3125251|NCT01652872|3850402|FG001|STARTED|Overall Study||379
3125252|NCT01652872|3850401|FG000|Received Investigational Product|Overall Study||377
3125253|NCT01652872|3850402|FG001|Received Investigational Product|Overall Study||377
3125254|NCT01652872|3850401|FG000|COMPLETED|Overall Study||232
3125255|NCT01652872|3850402|FG001|COMPLETED|Overall Study||226
3125256|NCT01652872|3850401|FG000|NOT COMPLETED|Overall Study||145
3125257|NCT01652872|3850402|FG001|NOT COMPLETED|Overall Study||153
3125258|NCT01652885|3850408|FG000|STARTED|Overall Study||23
3125259|NCT01652885|3850408|FG000|COMPLETED|Overall Study||22
3125260|NCT01652885|3850408|FG000|NOT COMPLETED|Overall Study||1
3125261|NCT01652976|3850412|FG000|STARTED|Overall Study||44
3125262|NCT01652976|3850412|FG000|COMPLETED|Overall Study||44
3125263|NCT01652976|3850412|FG000|NOT COMPLETED|Overall Study||0
3125264|NCT01653028|3850421|FG000|STARTED|Overall Study||12
3125265|NCT01653028|3850422|FG001|STARTED|Overall Study||10
3125266|NCT01653028|3850423|FG002|STARTED|Overall Study||11
3125267|NCT01653028|3850424|FG003|STARTED|Overall Study||10
3125268|NCT01653028|3850425|FG004|STARTED|Overall Study||29
3125269|NCT01653028|3850421|FG000|COMPLETED|Overall Study||12
3125270|NCT01653028|3850422|FG001|COMPLETED|Overall Study||10
3125271|NCT01653028|3850423|FG002|COMPLETED|Overall Study||11
3125272|NCT01653028|3850424|FG003|COMPLETED|Overall Study||10
3125273|NCT01653028|3850425|FG004|COMPLETED|Overall Study||29
3125274|NCT01653028|3850421|FG000|NOT COMPLETED|Overall Study||0
3125275|NCT01653028|3850422|FG001|NOT COMPLETED|Overall Study||0
3125276|NCT01653028|3850423|FG002|NOT COMPLETED|Overall Study||0
3125277|NCT01653028|3850424|FG003|NOT COMPLETED|Overall Study||0
3125278|NCT01653028|3850425|FG004|NOT COMPLETED|Overall Study||0
3125279|NCT01653132|3850437|FG000|STARTED|First Intervention||5
3125280|NCT01653132|3850438|FG001|STARTED|First Intervention||5
3125281|NCT01653132|3850437|FG000|COMPLETED|First Intervention|one dropped out: wanted to start anticholinergic drug for tremor that could affect saliva volume|4
3125282|NCT01653132|3850438|FG001|COMPLETED|First Intervention||5
3125283|NCT01653132|3850437|FG000|NOT COMPLETED|First Intervention||1
3125284|NCT01653132|3850438|FG001|NOT COMPLETED|First Intervention||0
3125285|NCT01653132|3850437|FG000|STARTED|Washout 1-2 Months||4
3125286|NCT01653132|3850438|FG001|STARTED|Washout 1-2 Months||5
3125287|NCT01653132|3850437|FG000|COMPLETED|Washout 1-2 Months||4
3125288|NCT01653132|3850438|FG001|COMPLETED|Washout 1-2 Months||5
3125289|NCT01653132|3850437|FG000|NOT COMPLETED|Washout 1-2 Months||0
3125290|NCT01653132|3850438|FG001|NOT COMPLETED|Washout 1-2 Months||0
3125291|NCT01653132|3850437|FG000|STARTED|Second Intervention||4
3125292|NCT01653132|3850438|FG001|STARTED|Second Intervention||5
3125293|NCT01653132|3850437|FG000|COMPLETED|Second Intervention||4
3125294|NCT01653132|3850438|FG001|COMPLETED|Second Intervention||5
3125295|NCT01653132|3850437|FG000|NOT COMPLETED|Second Intervention||0
3125296|NCT01653132|3850438|FG001|NOT COMPLETED|Second Intervention||0
3125297|NCT01653158|3850448|FG000|STARTED|Overall Study||3
3125298|NCT01653158|3850449|FG001|STARTED|Overall Study||3
3125299|NCT01653158|3850450|FG002|STARTED|Overall Study||3
3125300|NCT01653158|3850451|FG003|STARTED|Overall Study||3
3125301|NCT01653158|3850452|FG004|STARTED|Overall Study||3
3125302|NCT01653158|3850453|FG005|STARTED|Overall Study||3
3125303|NCT01653158|3850454|FG006|STARTED|Overall Study||9
3125304|NCT01653158|3850455|FG007|STARTED|Overall Study|Six (6) and 13 participants were enrolled in dose escalation and expansion cohorts, respectively.|19
3125305|NCT01653158|3850448|FG000|COMPLETED|Overall Study||2
3125306|NCT01653158|3850449|FG001|COMPLETED|Overall Study||3
3125307|NCT01653158|3850450|FG002|COMPLETED|Overall Study||3
3125308|NCT01653158|3850451|FG003|COMPLETED|Overall Study||1
3125309|NCT01653158|3850452|FG004|COMPLETED|Overall Study||2
3125310|NCT01653158|3850453|FG005|COMPLETED|Overall Study||2
3125311|NCT01653158|3850454|FG006|COMPLETED|Overall Study||7
3125312|NCT01653158|3850455|FG007|COMPLETED|Overall Study||4
3125313|NCT01653158|3850448|FG000|NOT COMPLETED|Overall Study||1
3125314|NCT01653158|3850449|FG001|NOT COMPLETED|Overall Study||0
3125315|NCT01653158|3850450|FG002|NOT COMPLETED|Overall Study||0
3125316|NCT01653158|3850451|FG003|NOT COMPLETED|Overall Study||2
3125317|NCT01653158|3850452|FG004|NOT COMPLETED|Overall Study||1
3125318|NCT01653158|3850453|FG005|NOT COMPLETED|Overall Study||1
3125319|NCT01653158|3850454|FG006|NOT COMPLETED|Overall Study||2
3125320|NCT01653158|3850455|FG007|NOT COMPLETED|Overall Study||15
3125321|NCT01653210|3850478|FG000|STARTED|Overall Study||15
3125322|NCT01653210|3850478|FG000|COMPLETED|Overall Study||12
3125323|NCT01653210|3850478|FG000|NOT COMPLETED|Overall Study||3
3125324|NCT01653262|3850482|FG000|STARTED|Overall Study||29
3125325|NCT01653262|3850482|FG000|COMPLETED|Overall Study||26
3125326|NCT01653262|3850482|FG000|NOT COMPLETED|Overall Study||3
3125327|NCT01653288|3850488|FG000|STARTED|Overall Study||36
3125328|NCT01653288|3850489|FG001|STARTED|Overall Study||36
3125329|NCT01653288|3850488|FG000|COMPLETED|Overall Study||26
3125330|NCT01653288|3850489|FG001|COMPLETED|Overall Study||35
3125331|NCT01653288|3850488|FG000|NOT COMPLETED|Overall Study||10
3125332|NCT01653288|3850489|FG001|NOT COMPLETED|Overall Study||1
3125333|NCT01653327|3850497|FG000|STARTED|Overall Study||11
3125334|NCT01653327|3850497|FG000|COMPLETED|Overall Study||10
3125335|NCT01653327|3850497|FG000|NOT COMPLETED|Overall Study||1
3125336|NCT01653405|3850505|FG000|STARTED|Overall Study||11794
3125337|NCT01653405|3850506|FG001|STARTED|Overall Study||1248782
3125338|NCT01653405|3850505|FG000|COMPLETED|Overall Study|These patients had enough data to calculate TTR.|8029
3125339|NCT01653405|3850506|FG001|COMPLETED|Overall Study|These patients had enough data to calculate TTR.|179979
3125340|NCT01653405|3850505|FG000|NOT COMPLETED|Overall Study||3765
3125341|NCT01653405|3850506|FG001|NOT COMPLETED|Overall Study||1068803
3125342|NCT01653418|3850512|FG000|STARTED|Overall Study||10
3125343|NCT01653418|3850512|FG000|COMPLETED|Overall Study||10
3125344|NCT01653418|3850512|FG000|NOT COMPLETED|Overall Study||0
3125345|NCT01653509|3850518|FG000|STARTED|Overall Study||12
3125346|NCT01653509|3850519|FG001|STARTED|Overall Study||13
3125347|NCT01653509|3850518|FG000|COMPLETED|Overall Study||12
3125348|NCT01653509|3850519|FG001|COMPLETED|Overall Study||13
3125349|NCT01653509|3850518|FG000|NOT COMPLETED|Overall Study||0
3125350|NCT01653509|3850519|FG001|NOT COMPLETED|Overall Study||0
3125351|NCT01653587|3850529|FG000|STARTED|Overall Study||120
3125352|NCT01653587|3850530|FG001|STARTED|Overall Study||120
3125353|NCT01653587|3850529|FG000|COMPLETED|Overall Study||120
3125354|NCT01653587|3850530|FG001|COMPLETED|Overall Study||120
3125355|NCT01653587|3850529|FG000|NOT COMPLETED|Overall Study||0
3125356|NCT01653587|3850530|FG001|NOT COMPLETED|Overall Study||0
3125357|NCT01653704|3850538|FG000|STARTED|Overall Study||21
3125358|NCT01653704|3850539|FG001|STARTED|Overall Study||21
3125359|NCT01653704|3850538|FG000|COMPLETED|Overall Study||19
3125360|NCT01653704|3850539|FG001|COMPLETED|Overall Study||20
3125361|NCT01653704|3850538|FG000|NOT COMPLETED|Overall Study||2
3125362|NCT01653704|3850539|FG001|NOT COMPLETED|Overall Study||1
3125363|NCT01653743|3850547|FG000|STARTED|Overall Study||54
3125364|NCT01653743|3850548|FG001|STARTED|Overall Study||27
3125365|NCT01653743|3850547|FG000|COMPLETED|Overall Study||50
3125366|NCT01653743|3850548|FG001|COMPLETED|Overall Study||27
3125367|NCT01653743|3850547|FG000|NOT COMPLETED|Overall Study||4
3125368|NCT01653743|3850548|FG001|NOT COMPLETED|Overall Study||0
3125369|NCT01653782|3850557|FG000|STARTED|Overall Study||52
3125370|NCT01653782|3850558|FG001|STARTED|Overall Study||55
3125371|NCT01653782|3850559|FG002|STARTED|Overall Study||52
3125372|NCT01653782|3850557|FG000|COMPLETED|Overall Study||36
3125373|NCT01653782|3850558|FG001|COMPLETED|Overall Study||37
3125374|NCT01653782|3850559|FG002|COMPLETED|Overall Study||46
3125375|NCT01653782|3850557|FG000|NOT COMPLETED|Overall Study||16
3125376|NCT01653782|3850558|FG001|NOT COMPLETED|Overall Study||18
3125377|NCT01653782|3850559|FG002|NOT COMPLETED|Overall Study||6
3125378|NCT01653847|3850569|FG000|STARTED|Overall Study||20
3125379|NCT01653847|3850570|FG001|STARTED|Overall Study||20
3125380|NCT01653847|3850569|FG000|COMPLETED|Overall Study||19
3125381|NCT01653847|3850570|FG001|COMPLETED|Overall Study||20
3125382|NCT01653847|3850569|FG000|NOT COMPLETED|Overall Study||1
3125383|NCT01653847|3850570|FG001|NOT COMPLETED|Overall Study||0
3125384|NCT01653912|3850578|FG000|STARTED|Phase 1-Cohort 1: GSK2110183 50 mg||4
3125385|NCT01653912|3850579|FG001|STARTED|Phase 1-Cohort 1: GSK2110183 50 mg||0
3125386|NCT01653912|3850580|FG002|STARTED|Phase 1-Cohort 1: GSK2110183 50 mg||0
3125387|NCT01653912|3850581|FG003|STARTED|Phase 1-Cohort 1: GSK2110183 50 mg||0
3125388|NCT01653912|3850582|FG004|STARTED|Phase 1-Cohort 1: GSK2110183 50 mg||0
3125389|NCT01653912|3850583|FG005|STARTED|Phase 1-Cohort 1: GSK2110183 50 mg||0
3125390|NCT01653912|3850578|FG000|COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||4
3125391|NCT01653912|3850579|FG001|COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
3125392|NCT01653912|3850580|FG002|COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
3125393|NCT01653912|3850581|FG003|COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
3125394|NCT01653912|3850582|FG004|COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
3125395|NCT01653912|3850583|FG005|COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
3125396|NCT01653912|3850578|FG000|NOT COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
3125397|NCT01653912|3850579|FG001|NOT COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
3125398|NCT01653912|3850580|FG002|NOT COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
3125399|NCT01653912|3850581|FG003|NOT COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
3125400|NCT01653912|3850582|FG004|NOT COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
3125401|NCT01653912|3850583|FG005|NOT COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
3125402|NCT01653912|3850578|FG000|STARTED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
3125403|NCT01653912|3850579|FG001|STARTED|Phase 1-Cohort 1.5: GSK2110183 75 mg||4
3125404|NCT01653912|3850580|FG002|STARTED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
3125405|NCT01653912|3850581|FG003|STARTED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
3125406|NCT01653912|3850582|FG004|STARTED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
3125407|NCT01653912|3850583|FG005|STARTED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
3125408|NCT01653912|3850578|FG000|COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
3125409|NCT01653912|3850579|FG001|COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||3
3125410|NCT01653912|3850580|FG002|COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
3125411|NCT01653912|3850581|FG003|COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
3125412|NCT01653912|3850582|FG004|COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
3125413|NCT01653912|3850583|FG005|COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
3125414|NCT01653912|3850578|FG000|NOT COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
3125415|NCT01653912|3850579|FG001|NOT COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||1
3125416|NCT01653912|3850580|FG002|NOT COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
3125417|NCT01653912|3850581|FG003|NOT COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
3125418|NCT01653912|3850582|FG004|NOT COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
3125419|NCT01653912|3850583|FG005|NOT COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
3125420|NCT01653912|3850578|FG000|STARTED|Phase 1-Cohort 2: GSK2110183 100 mg||0
3125421|NCT01653912|3850579|FG001|STARTED|Phase 1-Cohort 2: GSK2110183 100 mg||0
3125422|NCT01653912|3850580|FG002|STARTED|Phase 1-Cohort 2: GSK2110183 100 mg||6
3125423|NCT01653912|3850581|FG003|STARTED|Phase 1-Cohort 2: GSK2110183 100 mg||0
3125424|NCT01653912|3850582|FG004|STARTED|Phase 1-Cohort 2: GSK2110183 100 mg||0
3125425|NCT01653912|3850583|FG005|STARTED|Phase 1-Cohort 2: GSK2110183 100 mg||0
3125426|NCT01653912|3850578|FG000|COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
3125427|NCT01653912|3850579|FG001|COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
3125428|NCT01653912|3850580|FG002|COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||4
3125429|NCT01653912|3850581|FG003|COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
3125430|NCT01653912|3850582|FG004|COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
3125431|NCT01653912|3850583|FG005|COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
3125432|NCT01653912|3850578|FG000|NOT COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
3125433|NCT01653912|3850579|FG001|NOT COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
3125434|NCT01653912|3850580|FG002|NOT COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||2
3125435|NCT01653912|3850581|FG003|NOT COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
3125436|NCT01653912|3850582|FG004|NOT COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
3125437|NCT01653912|3850583|FG005|NOT COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
3125438|NCT01653912|3850578|FG000|STARTED|Phase 1-Cohort 3: GSK2110183 125 mg||0
3125439|NCT01653912|3850579|FG001|STARTED|Phase 1-Cohort 3: GSK2110183 125 mg||0
3125440|NCT01653912|3850580|FG002|STARTED|Phase 1-Cohort 3: GSK2110183 125 mg||0
3125441|NCT01653912|3850581|FG003|STARTED|Phase 1-Cohort 3: GSK2110183 125 mg||12
3125442|NCT01653912|3850582|FG004|STARTED|Phase 1-Cohort 3: GSK2110183 125 mg||0
3125443|NCT01653912|3850583|FG005|STARTED|Phase 1-Cohort 3: GSK2110183 125 mg||0
3125444|NCT01653912|3850578|FG000|COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
3125445|NCT01653912|3850579|FG001|COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
3125446|NCT01653912|3850580|FG002|COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
3125447|NCT01653912|3850581|FG003|COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||10
3125448|NCT01653912|3850582|FG004|COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
3125449|NCT01653912|3850583|FG005|COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
3125450|NCT01653912|3850578|FG000|NOT COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
3125451|NCT01653912|3850579|FG001|NOT COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
3125452|NCT01653912|3850580|FG002|NOT COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
3125453|NCT01653912|3850581|FG003|NOT COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||2
3125454|NCT01653912|3850582|FG004|NOT COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
3125455|NCT01653912|3850583|FG005|NOT COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
3125456|NCT01653912|3850578|FG000|STARTED|Phase 1-Cohort 4: GSK2110183 150 mg||0
3125457|NCT01653912|3850579|FG001|STARTED|Phase 1-Cohort 4: GSK2110183 150 mg||0
3125458|NCT01653912|3850580|FG002|STARTED|Phase 1-Cohort 4: GSK2110183 150 mg||0
3125459|NCT01653912|3850581|FG003|STARTED|Phase 1-Cohort 4: GSK2110183 150 mg||0
3125460|NCT01653912|3850582|FG004|STARTED|Phase 1-Cohort 4: GSK2110183 150 mg||3
3125461|NCT01653912|3850583|FG005|STARTED|Phase 1-Cohort 4: GSK2110183 150 mg||0
3125462|NCT01653912|3850578|FG000|COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
3125463|NCT01653912|3850579|FG001|COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
3125464|NCT01653912|3850580|FG002|COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
3125465|NCT01653912|3850581|FG003|COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
3125466|NCT01653912|3850582|FG004|COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||3
3125467|NCT01653912|3850583|FG005|COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
3125468|NCT01653912|3850578|FG000|NOT COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
3125469|NCT01653912|3850579|FG001|NOT COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
3125470|NCT01653912|3850580|FG002|NOT COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
3125471|NCT01653912|3850581|FG003|NOT COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
3125472|NCT01653912|3850582|FG004|NOT COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
3125473|NCT01653912|3850583|FG005|NOT COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
3125474|NCT01653912|3850578|FG000|STARTED|Phase 2: GSK2110183 125 mg||0
3125475|NCT01653912|3850579|FG001|STARTED|Phase 2: GSK2110183 125 mg||0
3125476|NCT01653912|3850580|FG002|STARTED|Phase 2: GSK2110183 125 mg||0
3125477|NCT01653912|3850581|FG003|STARTED|Phase 2: GSK2110183 125 mg||0
3125478|NCT01653912|3850582|FG004|STARTED|Phase 2: GSK2110183 125 mg||0
3125479|NCT01653912|3850583|FG005|STARTED|Phase 2: GSK2110183 125 mg|Per SAP, Cohort B (n=2) data was summarized in phase 2 total column as cohort B had <10 subjects.|30
3125480|NCT01653912|3850578|FG000|COMPLETED|Phase 2: GSK2110183 125 mg||0
3125481|NCT01653912|3850579|FG001|COMPLETED|Phase 2: GSK2110183 125 mg||0
3125482|NCT01653912|3850580|FG002|COMPLETED|Phase 2: GSK2110183 125 mg||0
3125483|NCT01653912|3850581|FG003|COMPLETED|Phase 2: GSK2110183 125 mg||0
3125484|NCT01653912|3850582|FG004|COMPLETED|Phase 2: GSK2110183 125 mg||0
3125485|NCT01653912|3850583|FG005|COMPLETED|Phase 2: GSK2110183 125 mg||22
3125486|NCT01653912|3850578|FG000|NOT COMPLETED|Phase 2: GSK2110183 125 mg||0
3125487|NCT01653912|3850579|FG001|NOT COMPLETED|Phase 2: GSK2110183 125 mg||0
3125488|NCT01653912|3850580|FG002|NOT COMPLETED|Phase 2: GSK2110183 125 mg||0
3125489|NCT01653912|3850581|FG003|NOT COMPLETED|Phase 2: GSK2110183 125 mg||0
3125490|NCT01653912|3850582|FG004|NOT COMPLETED|Phase 2: GSK2110183 125 mg||0
3125491|NCT01653912|3850583|FG005|NOT COMPLETED|Phase 2: GSK2110183 125 mg||8
3125492|NCT01653964|3850589|FG000|STARTED|Overall Study||82
3125493|NCT01653964|3850589|FG000|COMPLETED|Overall Study||82
3125494|NCT01653964|3850589|FG000|NOT COMPLETED|Overall Study||0
3125495|NCT01654068|3850593|FG000|STARTED|Overall Study||14
3125496|NCT01654068|3850593|FG000|COMPLETED|Overall Study||14
3125497|NCT01654068|3850593|FG000|NOT COMPLETED|Overall Study||0
3125498|NCT01654107|3850599|FG000|STARTED|Overall Study||28
3125499|NCT01654107|3850600|FG001|STARTED|Overall Study||30
3125500|NCT01654107|3850599|FG000|COMPLETED|Overall Study||25
3125501|NCT01654107|3850600|FG001|COMPLETED|Overall Study||22
3125502|NCT01654107|3850599|FG000|NOT COMPLETED|Overall Study||3
3125503|NCT01654107|3850600|FG001|NOT COMPLETED|Overall Study||8
3125504|NCT01654224|3850608|FG000|STARTED|Overall Study||95
3125505|NCT01654224|3850609|FG001|STARTED|Overall Study||110
3125506|NCT01654224|3850608|FG000|COMPLETED|Overall Study||89
3125507|NCT01654224|3850609|FG001|COMPLETED|Overall Study||98
3125508|NCT01654224|3850608|FG000|NOT COMPLETED|Overall Study||6
3125509|NCT01654224|3850609|FG001|NOT COMPLETED|Overall Study||12
3125510|NCT01654250|3850617|FG000|STARTED|Overall Study||44
3125511|NCT01654250|3850618|FG001|STARTED|Overall Study||42
3125512|NCT01654250|3850617|FG000|COMPLETED|Overall Study||43
3125513|NCT01654250|3850618|FG001|COMPLETED|Overall Study||42
3125514|NCT01654250|3850617|FG000|NOT COMPLETED|Overall Study||1
3125515|NCT01654250|3850618|FG001|NOT COMPLETED|Overall Study||0
3125516|NCT01654263|3850631|FG000|STARTED|Overall Study||164
3125517|NCT01654263|3850632|FG001|STARTED|Overall Study||147
3125518|NCT01654263|3850633|FG002|STARTED|Overall Study||139
3125519|NCT01654263|3850634|FG003|STARTED|Overall Study||145
3125520|NCT01654263|3850635|FG004|STARTED|Overall Study||140
3125521|NCT01654263|3850636|FG005|STARTED|Overall Study||149
3125522|NCT01654263|3850631|FG000|COMPLETED|Overall Study||164
3125523|NCT01654263|3850632|FG001|COMPLETED|Overall Study||147
3125524|NCT01654263|3850633|FG002|COMPLETED|Overall Study||137
3125525|NCT01654263|3850634|FG003|COMPLETED|Overall Study||144
3125526|NCT01654263|3850635|FG004|COMPLETED|Overall Study||139
3125527|NCT01654263|3850636|FG005|COMPLETED|Overall Study||148
3125528|NCT01654263|3850631|FG000|NOT COMPLETED|Overall Study||0
3125529|NCT01654263|3850632|FG001|NOT COMPLETED|Overall Study||0
3125530|NCT01654263|3850633|FG002|NOT COMPLETED|Overall Study||2
3125531|NCT01654263|3850634|FG003|NOT COMPLETED|Overall Study||1
3125532|NCT01654263|3850635|FG004|NOT COMPLETED|Overall Study||1
3125533|NCT01654263|3850636|FG005|NOT COMPLETED|Overall Study||1
3125534|NCT01654276|3850647|FG000|STARTED|Overall Study||24
3125535|NCT01654276|3850647|FG000|Visit 2 (2 Months)|Overall Study||19
3125536|NCT01654276|3850647|FG000|Visit 3 (4 Months)|Overall Study||18
3125537|NCT01654276|3850647|FG000|Visit 4 (6months)|Overall Study||18
3125538|NCT01654276|3850647|FG000|COMPLETED|Overall Study||18
3125539|NCT01654276|3850647|FG000|NOT COMPLETED|Overall Study||6
3125540|NCT01654289|3850654|FG000|STARTED|Overall Study||138
3125541|NCT01654289|3850655|FG001|STARTED|Overall Study||137
3125542|NCT01654289|3850656|FG002|STARTED|Overall Study||138
3125543|NCT01654289|3850654|FG000|COMPLETED|Overall Study||111
3125544|NCT01654289|3850655|FG001|COMPLETED|Overall Study||109
3125545|NCT01654289|3850656|FG002|COMPLETED|Overall Study||133
3125546|NCT01654289|3850654|FG000|NOT COMPLETED|Overall Study||27
3125547|NCT01654289|3850655|FG001|NOT COMPLETED|Overall Study||28
3125548|NCT01654289|3850656|FG002|NOT COMPLETED|Overall Study||5
3136402|NCT01712360|3861522|FG003|COMPLETED|Overall Study||4
3136403|NCT01712360|3861519|FG000|NOT COMPLETED|Overall Study||0
3136404|NCT01712360|3861520|FG001|NOT COMPLETED|Overall Study||1
3136405|NCT01712360|3861521|FG002|NOT COMPLETED|Overall Study||0
3136406|NCT01712360|3861522|FG003|NOT COMPLETED|Overall Study||2
3136407|NCT01712399|3861538|FG000|STARTED|Overall Study||397
3136408|NCT01712399|3861538|FG000|COMPLETED|Overall Study||0
3136409|NCT01712399|3861538|FG000|NOT COMPLETED|Overall Study||397
3136410|NCT01712438|3861542|FG000|STARTED|Overall Study||110
3136411|NCT01712438|3861542|FG000|SAF Population|Overall Study||108
3136412|NCT01712438|3861542|FG000|ITT Population|Overall Study||108
3136413|NCT01712438|3861542|FG000|PP Population|Overall Study||95
3136414|NCT01712438|3861542|FG000|PROPH Population|Overall Study||103
3136415|NCT01712438|3861542|FG000|BLEED Population|Overall Study||94
3136416|NCT01712438|3861542|FG000|SURG Population|Overall Study||24
3136417|NCT01712438|3861542|FG000|COMPLETED|Overall Study||73
3136418|NCT01712438|3861542|FG000|NOT COMPLETED|Overall Study||37
3136419|NCT01712516|3861555|FG000|STARTED|Overall Study||250
3136420|NCT01712516|3861556|FG001|STARTED|Overall Study||251
3125549|NCT01654302|3850666|FG000|STARTED|First Intervention (Day 1)||20
3125550|NCT01654302|3850667|FG001|STARTED|First Intervention (Day 1)||20
3125551|NCT01654302|3850666|FG000|COMPLETED|First Intervention (Day 1)||20
3125552|NCT01654302|3850667|FG001|COMPLETED|First Intervention (Day 1)||20
3125553|NCT01654302|3850666|FG000|NOT COMPLETED|First Intervention (Day 1)||0
3125554|NCT01654302|3850667|FG001|NOT COMPLETED|First Intervention (Day 1)||0
3125555|NCT01654302|3850666|FG000|STARTED|Second Intervention (Day 7)||20
3125556|NCT01654302|3850667|FG001|STARTED|Second Intervention (Day 7)||20
3125557|NCT01654302|3850666|FG000|COMPLETED|Second Intervention (Day 7)||19
3125558|NCT01654302|3850667|FG001|COMPLETED|Second Intervention (Day 7)||19
3125559|NCT01654302|3850666|FG000|NOT COMPLETED|Second Intervention (Day 7)||1
3125560|NCT01654302|3850667|FG001|NOT COMPLETED|Second Intervention (Day 7)||1
3125561|NCT01654380|3850675|FG000|STARTED|Part A, Period 1||4
3125562|NCT01654380|3850676|FG001|STARTED|Part A, Period 1||4
3125563|NCT01654380|3850677|FG002|STARTED|Part A, Period 1||0
3125564|NCT01654380|3850678|FG003|STARTED|Part A, Period 1||0
3125565|NCT01654380|3850675|FG000|Received at Least 1 Dose of Study Drug|Part A, Period 1||4
3125566|NCT01654380|3850676|FG001|Received at Least 1 Dose of Study Drug|Part A, Period 1||4
3125567|NCT01654380|3850677|FG002|Received at Least 1 Dose of Study Drug|Part A, Period 1||0
3125568|NCT01654380|3850678|FG003|Received at Least 1 Dose of Study Drug|Part A, Period 1||0
3125569|NCT01654380|3850675|FG000|COMPLETED|Part A, Period 1||4
3125570|NCT01654380|3850676|FG001|COMPLETED|Part A, Period 1||4
3125571|NCT01654380|3850677|FG002|COMPLETED|Part A, Period 1||0
3125572|NCT01654380|3850678|FG003|COMPLETED|Part A, Period 1||0
3125573|NCT01654380|3850675|FG000|NOT COMPLETED|Part A, Period 1||0
3125574|NCT01654380|3850676|FG001|NOT COMPLETED|Part A, Period 1||0
3125575|NCT01654380|3850677|FG002|NOT COMPLETED|Part A, Period 1||0
3125576|NCT01654380|3850678|FG003|NOT COMPLETED|Part A, Period 1||0
3125577|NCT01654380|3850675|FG000|STARTED|Part A, Washout of at Least 6 Days||4
3125578|NCT01654380|3850676|FG001|STARTED|Part A, Washout of at Least 6 Days||4
3125579|NCT01654380|3850677|FG002|STARTED|Part A, Washout of at Least 6 Days||0
3125580|NCT01654380|3850678|FG003|STARTED|Part A, Washout of at Least 6 Days||0
3125581|NCT01654380|3850675|FG000|COMPLETED|Part A, Washout of at Least 6 Days||4
3125582|NCT01654380|3850676|FG001|COMPLETED|Part A, Washout of at Least 6 Days||4
3125583|NCT01654380|3850677|FG002|COMPLETED|Part A, Washout of at Least 6 Days||0
3125584|NCT01654380|3850678|FG003|COMPLETED|Part A, Washout of at Least 6 Days||0
3125585|NCT01654380|3850675|FG000|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
3125586|NCT01654380|3850676|FG001|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
3125587|NCT01654380|3850677|FG002|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
3125588|NCT01654380|3850678|FG003|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
3125589|NCT01654380|3850675|FG000|STARTED|Part A, Period 2||4
3125590|NCT01654380|3850676|FG001|STARTED|Part A, Period 2||4
3125591|NCT01654380|3850677|FG002|STARTED|Part A, Period 2||0
3125592|NCT01654380|3850678|FG003|STARTED|Part A, Period 2||0
3125593|NCT01654380|3850675|FG000|COMPLETED|Part A, Period 2||4
3125594|NCT01654380|3850676|FG001|COMPLETED|Part A, Period 2||4
3125595|NCT01654380|3850677|FG002|COMPLETED|Part A, Period 2||0
3125596|NCT01654380|3850678|FG003|COMPLETED|Part A, Period 2||0
3125597|NCT01654380|3850675|FG000|NOT COMPLETED|Part A, Period 2||0
3125598|NCT01654380|3850676|FG001|NOT COMPLETED|Part A, Period 2||0
3125599|NCT01654380|3850677|FG002|NOT COMPLETED|Part A, Period 2||0
3125600|NCT01654380|3850678|FG003|NOT COMPLETED|Part A, Period 2||0
3125601|NCT01654380|3850675|FG000|STARTED|Part A, Washout of at Least 6 Days||4
3125602|NCT01654380|3850676|FG001|STARTED|Part A, Washout of at Least 6 Days||4
3125603|NCT01654380|3850677|FG002|STARTED|Part A, Washout of at Least 6 Days||0
3125604|NCT01654380|3850678|FG003|STARTED|Part A, Washout of at Least 6 Days||0
3125605|NCT01654380|3850675|FG000|COMPLETED|Part A, Washout of at Least 6 Days||4
3125606|NCT01654380|3850676|FG001|COMPLETED|Part A, Washout of at Least 6 Days||4
3125607|NCT01654380|3850677|FG002|COMPLETED|Part A, Washout of at Least 6 Days||0
3125608|NCT01654380|3850678|FG003|COMPLETED|Part A, Washout of at Least 6 Days||0
3125609|NCT01654380|3850675|FG000|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
3125610|NCT01654380|3850676|FG001|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
3125611|NCT01654380|3850677|FG002|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
3125612|NCT01654380|3850678|FG003|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
3125613|NCT01654380|3850675|FG000|STARTED|Part A, Period 3||4
3125614|NCT01654380|3850676|FG001|STARTED|Part A, Period 3||4
3125615|NCT01654380|3850677|FG002|STARTED|Part A, Period 3||0
3125616|NCT01654380|3850678|FG003|STARTED|Part A, Period 3||0
3125617|NCT01654380|3850675|FG000|COMPLETED|Part A, Period 3||4
3125618|NCT01654380|3850676|FG001|COMPLETED|Part A, Period 3||4
3125619|NCT01654380|3850677|FG002|COMPLETED|Part A, Period 3||0
3125620|NCT01654380|3850678|FG003|COMPLETED|Part A, Period 3||0
3125621|NCT01654380|3850675|FG000|NOT COMPLETED|Part A, Period 3||0
3125622|NCT01654380|3850676|FG001|NOT COMPLETED|Part A, Period 3||0
3125623|NCT01654380|3850677|FG002|NOT COMPLETED|Part A, Period 3||0
3125624|NCT01654380|3850678|FG003|NOT COMPLETED|Part A, Period 3||0
3125625|NCT01654380|3850675|FG000|STARTED|Part A, Washout of at Least 6 Days||4
3125626|NCT01654380|3850676|FG001|STARTED|Part A, Washout of at Least 6 Days||4
3125627|NCT01654380|3850677|FG002|STARTED|Part A, Washout of at Least 6 Days||0
3125628|NCT01654380|3850678|FG003|STARTED|Part A, Washout of at Least 6 Days||0
3125629|NCT01654380|3850675|FG000|COMPLETED|Part A, Washout of at Least 6 Days||4
3125630|NCT01654380|3850676|FG001|COMPLETED|Part A, Washout of at Least 6 Days||4
3125631|NCT01654380|3850677|FG002|COMPLETED|Part A, Washout of at Least 6 Days||0
3125632|NCT01654380|3850678|FG003|COMPLETED|Part A, Washout of at Least 6 Days||0
3125633|NCT01654380|3850675|FG000|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
3125634|NCT01654380|3850676|FG001|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
3125635|NCT01654380|3850677|FG002|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
3125636|NCT01654380|3850678|FG003|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
3125637|NCT01654380|3850675|FG000|STARTED|Part A, Period 4||4
3125638|NCT01654380|3850676|FG001|STARTED|Part A, Period 4||4
3125639|NCT01654380|3850677|FG002|STARTED|Part A, Period 4||0
3125640|NCT01654380|3850678|FG003|STARTED|Part A, Period 4||0
3125641|NCT01654380|3850675|FG000|COMPLETED|Part A, Period 4||4
3125642|NCT01654380|3850676|FG001|COMPLETED|Part A, Period 4||4
3125643|NCT01654380|3850677|FG002|COMPLETED|Part A, Period 4||0
3125644|NCT01654380|3850678|FG003|COMPLETED|Part A, Period 4||0
3125645|NCT01654380|3850675|FG000|NOT COMPLETED|Part A, Period 4||0
3125646|NCT01654380|3850676|FG001|NOT COMPLETED|Part A, Period 4||0
3125647|NCT01654380|3850677|FG002|NOT COMPLETED|Part A, Period 4||0
3125648|NCT01654380|3850678|FG003|NOT COMPLETED|Part A, Period 4||0
3125649|NCT01654380|3850675|FG000|STARTED|Part B, Period 1|Participants in Part A were not included in Part B.|0
3125650|NCT01654380|3850676|FG001|STARTED|Part B, Period 1|Participants in Part A were not included in Part B.|0
3125651|NCT01654380|3850677|FG002|STARTED|Part B, Period 1|Participants in Part B were not included in Part A.|7
3125652|NCT01654380|3850678|FG003|STARTED|Part B, Period 1|Participants in Part B were not included in Part A.|7
3125653|NCT01654380|3850675|FG000|Received at Least 1 Dose of Study Drug|Part B, Period 1||0
3125654|NCT01654380|3850676|FG001|Received at Least 1 Dose of Study Drug|Part B, Period 1||0
3125655|NCT01654380|3850677|FG002|Received at Least 1 Dose of Study Drug|Part B, Period 1||7
3125656|NCT01654380|3850678|FG003|Received at Least 1 Dose of Study Drug|Part B, Period 1||7
3125657|NCT01654380|3850675|FG000|COMPLETED|Part B, Period 1||0
3125658|NCT01654380|3850676|FG001|COMPLETED|Part B, Period 1||0
3125659|NCT01654380|3850677|FG002|COMPLETED|Part B, Period 1|Participant who did not complete received only 1 dose of LY2605541 74.1 mU/min IV for 8 hours|6
3125660|NCT01654380|3850678|FG003|COMPLETED|Part B, Period 1||7
3125661|NCT01654380|3850675|FG000|NOT COMPLETED|Part B, Period 1||0
3125662|NCT01654380|3850676|FG001|NOT COMPLETED|Part B, Period 1||0
3125663|NCT01654380|3850677|FG002|NOT COMPLETED|Part B, Period 1||1
3125664|NCT01654380|3850678|FG003|NOT COMPLETED|Part B, Period 1||0
3125665|NCT01654380|3850675|FG000|STARTED|Part B, Washout of at Least 6 Days||0
3125666|NCT01654380|3850676|FG001|STARTED|Part B, Washout of at Least 6 Days||0
3125667|NCT01654380|3850677|FG002|STARTED|Part B, Washout of at Least 6 Days||6
3125668|NCT01654380|3850678|FG003|STARTED|Part B, Washout of at Least 6 Days||7
3125669|NCT01654380|3850675|FG000|COMPLETED|Part B, Washout of at Least 6 Days||0
3125670|NCT01654380|3850676|FG001|COMPLETED|Part B, Washout of at Least 6 Days||0
3125671|NCT01654380|3850677|FG002|COMPLETED|Part B, Washout of at Least 6 Days||6
3125672|NCT01654380|3850678|FG003|COMPLETED|Part B, Washout of at Least 6 Days||7
3125673|NCT01654380|3850675|FG000|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
3125674|NCT01654380|3850676|FG001|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
3125675|NCT01654380|3850677|FG002|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
3125676|NCT01654380|3850678|FG003|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
3125677|NCT01654380|3850675|FG000|STARTED|Part B, Period 2||0
3125678|NCT01654380|3850676|FG001|STARTED|Part B, Period 2||0
3125679|NCT01654380|3850677|FG002|STARTED|Part B, Period 2||6
3125680|NCT01654380|3850678|FG003|STARTED|Part B, Period 2||7
3125681|NCT01654380|3850675|FG000|COMPLETED|Part B, Period 2||0
3125682|NCT01654380|3850676|FG001|COMPLETED|Part B, Period 2||0
3125683|NCT01654380|3850677|FG002|COMPLETED|Part B, Period 2||6
3125684|NCT01654380|3850678|FG003|COMPLETED|Part B, Period 2||7
3125685|NCT01654380|3850675|FG000|NOT COMPLETED|Part B, Period 2||0
3125686|NCT01654380|3850676|FG001|NOT COMPLETED|Part B, Period 2||0
3125687|NCT01654380|3850677|FG002|NOT COMPLETED|Part B, Period 2||0
3125688|NCT01654380|3850678|FG003|NOT COMPLETED|Part B, Period 2||0
3125689|NCT01654380|3850675|FG000|STARTED|Part B, Washout of at Least 6 Days||0
3125690|NCT01654380|3850676|FG001|STARTED|Part B, Washout of at Least 6 Days||0
3125691|NCT01654380|3850677|FG002|STARTED|Part B, Washout of at Least 6 Days||6
3125692|NCT01654380|3850678|FG003|STARTED|Part B, Washout of at Least 6 Days||7
3125693|NCT01654380|3850675|FG000|COMPLETED|Part B, Washout of at Least 6 Days||0
3125694|NCT01654380|3850676|FG001|COMPLETED|Part B, Washout of at Least 6 Days||0
3125695|NCT01654380|3850677|FG002|COMPLETED|Part B, Washout of at Least 6 Days||6
3125696|NCT01654380|3850678|FG003|COMPLETED|Part B, Washout of at Least 6 Days||7
3125697|NCT01654380|3850675|FG000|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
3125698|NCT01654380|3850676|FG001|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
3125699|NCT01654380|3850677|FG002|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
3125700|NCT01654380|3850678|FG003|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
3125701|NCT01654380|3850675|FG000|STARTED|Part B, Period 3||0
3125702|NCT01654380|3850676|FG001|STARTED|Part B, Period 3||0
3125703|NCT01654380|3850677|FG002|STARTED|Part B, Period 3||6
3125704|NCT01654380|3850678|FG003|STARTED|Part B, Period 3||7
3125705|NCT01654380|3850675|FG000|COMPLETED|Part B, Period 3||0
3125706|NCT01654380|3850676|FG001|COMPLETED|Part B, Period 3||0
3125707|NCT01654380|3850677|FG002|COMPLETED|Part B, Period 3||6
3125708|NCT01654380|3850678|FG003|COMPLETED|Part B, Period 3||7
3125709|NCT01654380|3850675|FG000|NOT COMPLETED|Part B, Period 3||0
3125710|NCT01654380|3850676|FG001|NOT COMPLETED|Part B, Period 3||0
3125711|NCT01654380|3850677|FG002|NOT COMPLETED|Part B, Period 3||0
3125712|NCT01654380|3850678|FG003|NOT COMPLETED|Part B, Period 3||0
3125713|NCT01654380|3850675|FG000|STARTED|Part B, Washout of at Least 6 Days||0
3125714|NCT01654380|3850676|FG001|STARTED|Part B, Washout of at Least 6 Days||0
3125715|NCT01654380|3850677|FG002|STARTED|Part B, Washout of at Least 6 Days||6
3125716|NCT01654380|3850678|FG003|STARTED|Part B, Washout of at Least 6 Days||7
3125717|NCT01654380|3850675|FG000|COMPLETED|Part B, Washout of at Least 6 Days||0
3125718|NCT01654380|3850676|FG001|COMPLETED|Part B, Washout of at Least 6 Days||0
3125719|NCT01654380|3850677|FG002|COMPLETED|Part B, Washout of at Least 6 Days||6
3125720|NCT01654380|3850678|FG003|COMPLETED|Part B, Washout of at Least 6 Days||7
3125721|NCT01654380|3850675|FG000|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
3125722|NCT01654380|3850676|FG001|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
3125723|NCT01654380|3850677|FG002|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
3125724|NCT01654380|3850678|FG003|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
3125725|NCT01654380|3850675|FG000|STARTED|Part B, Period 4||0
3125726|NCT01654380|3850676|FG001|STARTED|Part B, Period 4||0
3125727|NCT01654380|3850677|FG002|STARTED|Part B, Period 4||6
3125728|NCT01654380|3850678|FG003|STARTED|Part B, Period 4||7
3125729|NCT01654380|3850675|FG000|COMPLETED|Part B, Period 4||0
3125730|NCT01654380|3850676|FG001|COMPLETED|Part B, Period 4||0
3125731|NCT01654380|3850677|FG002|COMPLETED|Part B, Period 4||6
3125732|NCT01654380|3850678|FG003|COMPLETED|Part B, Period 4||7
3125733|NCT01654380|3850675|FG000|NOT COMPLETED|Part B, Period 4||0
3125734|NCT01654380|3850676|FG001|NOT COMPLETED|Part B, Period 4||0
3125735|NCT01654380|3850677|FG002|NOT COMPLETED|Part B, Period 4||0
3125736|NCT01654380|3850678|FG003|NOT COMPLETED|Part B, Period 4||0
3125737|NCT01654445|3850697|FG000|STARTED|Overall Study||25
3125738|NCT01654445|3850698|FG001|STARTED|Overall Study||25
3125739|NCT01654445|3850697|FG000|COMPLETED|Overall Study||25
3125740|NCT01654445|3850698|FG001|COMPLETED|Overall Study||25
3125741|NCT01654445|3850697|FG000|NOT COMPLETED|Overall Study||0
3125742|NCT01654445|3850698|FG001|NOT COMPLETED|Overall Study||0
3125743|NCT01654523|3850704|FG000|STARTED|Overall Study||20
3125744|NCT01654523|3850704|FG000|COMPLETED|Overall Study||19
3125745|NCT01654523|3850704|FG000|NOT COMPLETED|Overall Study||1
3125746|NCT01654536|3850710|FG000|STARTED|Overall Study||368
3125747|NCT01654536|3850711|FG001|STARTED|Overall Study||369
3125748|NCT01654536|3850710|FG000|COMPLETED|Overall Study||324
3125749|NCT01654536|3850711|FG001|COMPLETED|Overall Study||331
3125750|NCT01654536|3850710|FG000|NOT COMPLETED|Overall Study||44
3125751|NCT01654536|3850711|FG001|NOT COMPLETED|Overall Study||38
3125752|NCT01654549|3850720|FG000|STARTED|Overall Study||20
3125753|NCT01654549|3850721|FG001|STARTED|Overall Study||20
3125754|NCT01654549|3850720|FG000|COMPLETED|Overall Study||20
3125755|NCT01654549|3850721|FG001|COMPLETED|Overall Study||19
3125756|NCT01654549|3850720|FG000|NOT COMPLETED|Overall Study||0
3125757|NCT01654549|3850721|FG001|NOT COMPLETED|Overall Study||1
3125758|NCT01654601|3850733|FG000|STARTED|1st Administration||14
3125759|NCT01654601|3850734|FG001|STARTED|1st Administration||14
3125760|NCT01654601|3850733|FG000|COMPLETED|1st Administration||12
3125761|NCT01654601|3850734|FG001|COMPLETED|1st Administration||12
3125762|NCT01654601|3850733|FG000|NOT COMPLETED|1st Administration||2
3125763|NCT01654601|3850734|FG001|NOT COMPLETED|1st Administration||2
3125764|NCT01654601|3850733|FG000|STARTED|2nd Administration||12
3125765|NCT01654601|3850734|FG001|STARTED|2nd Administration||12
3125766|NCT01654601|3850733|FG000|COMPLETED|2nd Administration||11
3125767|NCT01654601|3850734|FG001|COMPLETED|2nd Administration||11
3125768|NCT01654601|3850733|FG000|NOT COMPLETED|2nd Administration||1
3125769|NCT01654601|3850734|FG001|NOT COMPLETED|2nd Administration||1
3125770|NCT01654666|3850743|FG000|STARTED|Overall Study||63
3125771|NCT01654666|3850744|FG001|STARTED|Overall Study||63
3125772|NCT01654666|3850745|FG002|STARTED|Overall Study||63
3125773|NCT01654666|3850743|FG000|Primary Analysis|Overall Study||52
3125774|NCT01654666|3850744|FG001|Primary Analysis|Overall Study||56
3125775|NCT01654666|3850745|FG002|Primary Analysis|Overall Study||54
3125776|NCT01654666|3850743|FG000|COMPLETED|Overall Study||48
3125777|NCT01654666|3850744|FG001|COMPLETED|Overall Study||50
3125778|NCT01654666|3850745|FG002|COMPLETED|Overall Study||49
3125779|NCT01654666|3850743|FG000|NOT COMPLETED|Overall Study||15
3125780|NCT01654666|3850744|FG001|NOT COMPLETED|Overall Study||13
3125781|NCT01654666|3850745|FG002|NOT COMPLETED|Overall Study||14
3125782|NCT01654796|3850756|FG000|STARTED|Overall Study||26
3125783|NCT01654796|3850757|FG001|STARTED|Overall Study||29
3125784|NCT01654796|3850758|FG002|STARTED|Overall Study||29
3125785|NCT01654796|3850756|FG000|COMPLETED|Overall Study||25
3125786|NCT01654796|3850757|FG001|COMPLETED|Overall Study||26
3125787|NCT01654796|3850758|FG002|COMPLETED|Overall Study||28
3125788|NCT01654796|3850756|FG000|NOT COMPLETED|Overall Study||1
3125789|NCT01654796|3850757|FG001|NOT COMPLETED|Overall Study||3
3125790|NCT01654796|3850758|FG002|NOT COMPLETED|Overall Study||1
3125791|NCT01654861|3850767|FG000|STARTED|Overall Study||3
3125792|NCT01654861|3850767|FG000|COMPLETED|Overall Study||3
3125793|NCT01654861|3850767|FG000|NOT COMPLETED|Overall Study||0
3125794|NCT01654887|3850773|FG000|STARTED|Overall Study||103
3125795|NCT01654887|3850774|FG001|STARTED|Overall Study||88
3125796|NCT01654887|3850773|FG000|COMPLETED|Overall Study||103
3125797|NCT01654887|3850774|FG001|COMPLETED|Overall Study||88
3125798|NCT01654887|3850773|FG000|NOT COMPLETED|Overall Study||0
3125799|NCT01654887|3850774|FG001|NOT COMPLETED|Overall Study||0
3125800|NCT01655043|3850781|FG000|STARTED|Overall Study||20
3125801|NCT01655043|3850781|FG000|COMPLETED|Overall Study||20
3125802|NCT01655043|3850781|FG000|NOT COMPLETED|Overall Study||0
3125803|NCT01655069|3850789|FG000|STARTED|Overall Study||61
3125804|NCT01655069|3850790|FG001|STARTED|Overall Study||58
3125805|NCT01655069|3850791|FG002|STARTED|Overall Study||14
3125806|NCT01655069|3850792|FG003|STARTED|Overall Study||15
3125807|NCT01655069|3850789|FG000|Safety Analysis Set (SAF)|Overall Study||61
3125808|NCT01655069|3850790|FG001|Safety Analysis Set (SAF)|Overall Study||57
3125809|NCT01655069|3850791|FG002|Safety Analysis Set (SAF)|Overall Study||14
3125810|NCT01655069|3850792|FG003|Safety Analysis Set (SAF)|Overall Study||15
3125811|NCT01655069|3850789|FG000|Full Analysis Set (FAS)|Overall Study||60
3125812|NCT01655069|3850790|FG001|Full Analysis Set (FAS)|Overall Study||57
3125813|NCT01655069|3850791|FG002|Full Analysis Set (FAS)|Overall Study||14
3125814|NCT01655069|3850792|FG003|Full Analysis Set (FAS)|Overall Study||15
3125815|NCT01655069|3850789|FG000|COMPLETED|Overall Study||53
3125816|NCT01655069|3850790|FG001|COMPLETED|Overall Study||46
3125817|NCT01655069|3850791|FG002|COMPLETED|Overall Study||12
3125818|NCT01655069|3850792|FG003|COMPLETED|Overall Study||11
3125819|NCT01655069|3850789|FG000|NOT COMPLETED|Overall Study||8
3125820|NCT01655069|3850790|FG001|NOT COMPLETED|Overall Study||12
3125821|NCT01655069|3850791|FG002|NOT COMPLETED|Overall Study||2
3125822|NCT01655069|3850792|FG003|NOT COMPLETED|Overall Study||4
3125823|NCT01655329|3850800|FG000|STARTED|Overall Study|The same 10 radiologists are interpreting images in both arms.|10
3125824|NCT01655329|3850800|FG000|COMPLETED|Overall Study||10
3125825|NCT01655329|3850800|FG000|NOT COMPLETED|Overall Study||0
3125826|NCT01655381|3850814|FG000|STARTED|Overall Study||15
3125827|NCT01655381|3850814|FG000|COMPLETED|Overall Study||12
3125828|NCT01655381|3850814|FG000|NOT COMPLETED|Overall Study||3
3125829|NCT01655498|3850819|FG000|STARTED|Overall Study||61
3125830|NCT01655498|3850819|FG000|COMPLETED|Overall Study||56
3125831|NCT01655498|3850819|FG000|NOT COMPLETED|Overall Study||5
3125832|NCT01655563|3850828|FG000|STARTED|Overall Study||18
3125833|NCT01655563|3850829|FG001|STARTED|Overall Study||35
3125834|NCT01655563|3850828|FG000|COMPLETED|Overall Study||18
3125835|NCT01655563|3850829|FG001|COMPLETED|Overall Study||35
3125836|NCT01655563|3850828|FG000|NOT COMPLETED|Overall Study||0
3125837|NCT01655563|3850829|FG001|NOT COMPLETED|Overall Study||0
3125838|NCT01655693|3850838|FG000|STARTED|Overall Study||130
3125839|NCT01655693|3850839|FG001|STARTED|Overall Study||133
3125840|NCT01655693|3850840|FG002|STARTED|Overall Study||134
3125841|NCT01655693|3850838|FG000|COMPLETED|Overall Study||4
3125842|NCT01655693|3850839|FG001|COMPLETED|Overall Study||7
3125843|NCT01655693|3850840|FG002|COMPLETED|Overall Study||4
3125844|NCT01655693|3850838|FG000|NOT COMPLETED|Overall Study||126
3125845|NCT01655693|3850839|FG001|NOT COMPLETED|Overall Study||126
3125846|NCT01655693|3850840|FG002|NOT COMPLETED|Overall Study||130
3125847|NCT01655719|3850858|FG000|STARTED|Overall Study||1
3125848|NCT01655719|3850858|FG000|COMPLETED|Overall Study||1
3125849|NCT01655719|3850858|FG000|NOT COMPLETED|Overall Study||0
3125850|NCT01655823|3850867|FG000|STARTED|Overall Study||25
3125851|NCT01655823|3850868|FG001|STARTED|Overall Study||25
3125852|NCT01655823|3850869|FG002|STARTED|Overall Study||24
3125853|NCT01655823|3850870|FG003|STARTED|Overall Study||25
3125854|NCT01655823|3850871|FG004|STARTED|Overall Study||26
3125855|NCT01655823|3850867|FG000|COMPLETED|Overall Study||25
3125856|NCT01655823|3850868|FG001|COMPLETED|Overall Study||23
3125857|NCT01655823|3850869|FG002|COMPLETED|Overall Study||24
3125858|NCT01655823|3850870|FG003|COMPLETED|Overall Study||24
3125859|NCT01655823|3850871|FG004|COMPLETED|Overall Study||25
3125860|NCT01655823|3850867|FG000|NOT COMPLETED|Overall Study||0
3125861|NCT01655823|3850868|FG001|NOT COMPLETED|Overall Study||2
3125862|NCT01655823|3850869|FG002|NOT COMPLETED|Overall Study||0
3125863|NCT01655823|3850870|FG003|NOT COMPLETED|Overall Study||1
3125864|NCT01655823|3850871|FG004|NOT COMPLETED|Overall Study||1
3125865|NCT01655901|3850883|FG000|STARTED|First Intervention (Hour 1)||5
3125866|NCT01655901|3850884|FG001|STARTED|First Intervention (Hour 1)||5
3125867|NCT01655901|3850885|FG002|STARTED|First Intervention (Hour 1)||5
3125868|NCT01655901|3850886|FG003|STARTED|First Intervention (Hour 1)||5
3125869|NCT01655901|3850887|FG004|STARTED|First Intervention (Hour 1)||5
3125870|NCT01655901|3850888|FG005|STARTED|First Intervention (Hour 1)||5
3125871|NCT01655901|3850883|FG000|COMPLETED|First Intervention (Hour 1)||5
3125872|NCT01655901|3850884|FG001|COMPLETED|First Intervention (Hour 1)||5
3125873|NCT01655901|3850885|FG002|COMPLETED|First Intervention (Hour 1)||5
3125874|NCT01655901|3850886|FG003|COMPLETED|First Intervention (Hour 1)||5
3125875|NCT01655901|3850887|FG004|COMPLETED|First Intervention (Hour 1)||5
3125876|NCT01655901|3850888|FG005|COMPLETED|First Intervention (Hour 1)||5
3125877|NCT01655901|3850883|FG000|NOT COMPLETED|First Intervention (Hour 1)||0
3125878|NCT01655901|3850884|FG001|NOT COMPLETED|First Intervention (Hour 1)||0
3125879|NCT01655901|3850885|FG002|NOT COMPLETED|First Intervention (Hour 1)||0
3125880|NCT01655901|3850886|FG003|NOT COMPLETED|First Intervention (Hour 1)||0
3125881|NCT01655901|3850887|FG004|NOT COMPLETED|First Intervention (Hour 1)||0
3125882|NCT01655901|3850888|FG005|NOT COMPLETED|First Intervention (Hour 1)||0
3125883|NCT01655901|3850883|FG000|STARTED|Washout (1 Week)||5
3125884|NCT01655901|3850884|FG001|STARTED|Washout (1 Week)||5
3125885|NCT01655901|3850885|FG002|STARTED|Washout (1 Week)||5
3125886|NCT01655901|3850886|FG003|STARTED|Washout (1 Week)||5
3125887|NCT01655901|3850887|FG004|STARTED|Washout (1 Week)||5
3125888|NCT01655901|3850888|FG005|STARTED|Washout (1 Week)||5
3125889|NCT01655901|3850883|FG000|COMPLETED|Washout (1 Week)||5
3125890|NCT01655901|3850884|FG001|COMPLETED|Washout (1 Week)||5
3125891|NCT01655901|3850885|FG002|COMPLETED|Washout (1 Week)||5
3125892|NCT01655901|3850886|FG003|COMPLETED|Washout (1 Week)||5
3125893|NCT01655901|3850887|FG004|COMPLETED|Washout (1 Week)||5
3125894|NCT01655901|3850888|FG005|COMPLETED|Washout (1 Week)||5
3125895|NCT01655901|3850883|FG000|NOT COMPLETED|Washout (1 Week)||0
3125896|NCT01655901|3850884|FG001|NOT COMPLETED|Washout (1 Week)||0
3125897|NCT01655901|3850885|FG002|NOT COMPLETED|Washout (1 Week)||0
3125898|NCT01655901|3850886|FG003|NOT COMPLETED|Washout (1 Week)||0
3125899|NCT01655901|3850887|FG004|NOT COMPLETED|Washout (1 Week)||0
3125900|NCT01655901|3850888|FG005|NOT COMPLETED|Washout (1 Week)||0
3125901|NCT01655901|3850883|FG000|STARTED|Second Intervention (Hour 2)||5
3125902|NCT01655901|3850884|FG001|STARTED|Second Intervention (Hour 2)||5
3125903|NCT01655901|3850885|FG002|STARTED|Second Intervention (Hour 2)||5
3125904|NCT01655901|3850886|FG003|STARTED|Second Intervention (Hour 2)||5
3125905|NCT01655901|3850887|FG004|STARTED|Second Intervention (Hour 2)||5
3125906|NCT01655901|3850888|FG005|STARTED|Second Intervention (Hour 2)||5
3125907|NCT01655901|3850883|FG000|COMPLETED|Second Intervention (Hour 2)||5
3125908|NCT01655901|3850884|FG001|COMPLETED|Second Intervention (Hour 2)||5
3125909|NCT01655901|3850885|FG002|COMPLETED|Second Intervention (Hour 2)||5
3125910|NCT01655901|3850886|FG003|COMPLETED|Second Intervention (Hour 2)||5
3125911|NCT01655901|3850887|FG004|COMPLETED|Second Intervention (Hour 2)||5
3125912|NCT01655901|3850888|FG005|COMPLETED|Second Intervention (Hour 2)||5
3125913|NCT01655901|3850883|FG000|NOT COMPLETED|Second Intervention (Hour 2)||0
3125914|NCT01655901|3850884|FG001|NOT COMPLETED|Second Intervention (Hour 2)||0
3125915|NCT01655901|3850885|FG002|NOT COMPLETED|Second Intervention (Hour 2)||0
3125916|NCT01655901|3850886|FG003|NOT COMPLETED|Second Intervention (Hour 2)||0
3125917|NCT01655901|3850887|FG004|NOT COMPLETED|Second Intervention (Hour 2)||0
3125918|NCT01655901|3850888|FG005|NOT COMPLETED|Second Intervention (Hour 2)||0
3125919|NCT01655901|3850883|FG000|STARTED|Washout (1 Week)||5
3125920|NCT01655901|3850884|FG001|STARTED|Washout (1 Week)||5
3125921|NCT01655901|3850885|FG002|STARTED|Washout (1 Week)||5
3125922|NCT01655901|3850886|FG003|STARTED|Washout (1 Week)||5
3125923|NCT01655901|3850887|FG004|STARTED|Washout (1 Week)||5
3125924|NCT01655901|3850888|FG005|STARTED|Washout (1 Week)||5
3125925|NCT01655901|3850883|FG000|COMPLETED|Washout (1 Week)||5
3125926|NCT01655901|3850884|FG001|COMPLETED|Washout (1 Week)||5
3125927|NCT01655901|3850885|FG002|COMPLETED|Washout (1 Week)||5
3125928|NCT01655901|3850886|FG003|COMPLETED|Washout (1 Week)||5
3125929|NCT01655901|3850887|FG004|COMPLETED|Washout (1 Week)||5
3125930|NCT01655901|3850888|FG005|COMPLETED|Washout (1 Week)||5
3125931|NCT01655901|3850883|FG000|NOT COMPLETED|Washout (1 Week)||0
3125932|NCT01655901|3850884|FG001|NOT COMPLETED|Washout (1 Week)||0
3125933|NCT01655901|3850885|FG002|NOT COMPLETED|Washout (1 Week)||0
3125934|NCT01655901|3850886|FG003|NOT COMPLETED|Washout (1 Week)||0
3125935|NCT01655901|3850887|FG004|NOT COMPLETED|Washout (1 Week)||0
3125936|NCT01655901|3850888|FG005|NOT COMPLETED|Washout (1 Week)||0
3125937|NCT01655901|3850883|FG000|STARTED|Third Intervention (Hour 3)||5
3125938|NCT01655901|3850884|FG001|STARTED|Third Intervention (Hour 3)||5
3125939|NCT01655901|3850885|FG002|STARTED|Third Intervention (Hour 3)||5
3125940|NCT01655901|3850886|FG003|STARTED|Third Intervention (Hour 3)||5
3125941|NCT01655901|3850887|FG004|STARTED|Third Intervention (Hour 3)||5
3125942|NCT01655901|3850888|FG005|STARTED|Third Intervention (Hour 3)||5
3125943|NCT01655901|3850883|FG000|COMPLETED|Third Intervention (Hour 3)||4
3125944|NCT01655901|3850884|FG001|COMPLETED|Third Intervention (Hour 3)||4
3125945|NCT01655901|3850885|FG002|COMPLETED|Third Intervention (Hour 3)||4
3125946|NCT01655901|3850886|FG003|COMPLETED|Third Intervention (Hour 3)||5
3125947|NCT01655901|3850887|FG004|COMPLETED|Third Intervention (Hour 3)||4
3125948|NCT01655901|3850888|FG005|COMPLETED|Third Intervention (Hour 3)||5
3125949|NCT01655901|3850883|FG000|NOT COMPLETED|Third Intervention (Hour 3)||1
3125950|NCT01655901|3850884|FG001|NOT COMPLETED|Third Intervention (Hour 3)||1
3125951|NCT01655901|3850885|FG002|NOT COMPLETED|Third Intervention (Hour 3)||1
3125952|NCT01655901|3850886|FG003|NOT COMPLETED|Third Intervention (Hour 3)||0
3125953|NCT01655901|3850887|FG004|NOT COMPLETED|Third Intervention (Hour 3)||1
3125954|NCT01655901|3850888|FG005|NOT COMPLETED|Third Intervention (Hour 3)||0
3125955|NCT01656031|3850897|FG000|STARTED|Overall Study||39
3125956|NCT01656031|3850897|FG000|COMPLETED|Overall Study||39
3125957|NCT01656031|3850897|FG000|NOT COMPLETED|Overall Study||0
3125958|NCT01656161|3850901|FG000|STARTED|Overall Study|Intention to treat analysis set|120
3125959|NCT01656161|3850901|FG000|Received Triptorelin at Day 1|Overall Study|Safety analysis set|120
3125960|NCT01656161|3850901|FG000|Received Triptorelin at Day 169|Overall Study||115
3125961|NCT01656161|3850901|FG000|COMPLETED|Overall Study|Per protocol analysis set|113
3125962|NCT01656161|3850901|FG000|NOT COMPLETED|Overall Study||7
3125963|NCT01656187|3850910|FG000|STARTED|First Intervention (24 Weeks)||20
3125964|NCT01656187|3850911|FG001|STARTED|First Intervention (24 Weeks)||26
3125965|NCT01656187|3850910|FG000|COMPLETED|First Intervention (24 Weeks)||14
3125966|NCT01656187|3850911|FG001|COMPLETED|First Intervention (24 Weeks)||23
3125967|NCT01656187|3850910|FG000|NOT COMPLETED|First Intervention (24 Weeks)||6
3125968|NCT01656187|3850911|FG001|NOT COMPLETED|First Intervention (24 Weeks)||3
3125969|NCT01656187|3850910|FG000|STARTED|Washout (4 Weeks)||14
3125970|NCT01656187|3850911|FG001|STARTED|Washout (4 Weeks)||23
3125971|NCT01656187|3850910|FG000|COMPLETED|Washout (4 Weeks)||14
3125972|NCT01656187|3850911|FG001|COMPLETED|Washout (4 Weeks)||22
3125973|NCT01656187|3850910|FG000|NOT COMPLETED|Washout (4 Weeks)||0
3125974|NCT01656187|3850911|FG001|NOT COMPLETED|Washout (4 Weeks)||1
3125975|NCT01656187|3850910|FG000|STARTED|Second Intervention (24 Weeks)||14
3125976|NCT01656187|3850911|FG001|STARTED|Second Intervention (24 Weeks)||22
3125977|NCT01656187|3850910|FG000|COMPLETED|Second Intervention (24 Weeks)||13
3125978|NCT01656187|3850911|FG001|COMPLETED|Second Intervention (24 Weeks)||19
3125979|NCT01656187|3850910|FG000|NOT COMPLETED|Second Intervention (24 Weeks)||1
3125980|NCT01656187|3850911|FG001|NOT COMPLETED|Second Intervention (24 Weeks)||3
3125981|NCT01656200|3850917|FG000|STARTED|Overall Study||17
3125982|NCT01656200|3850917|FG000|COMPLETED|Overall Study||16
3125983|NCT01656200|3850917|FG000|NOT COMPLETED|Overall Study||1
3125984|NCT01656252|3850921|FG000|STARTED|Phase I||14
3125985|NCT01656252|3850921|FG000|COMPLETED|Phase I||14
3125986|NCT01656252|3850921|FG000|NOT COMPLETED|Phase I||0
3125987|NCT01656252|3850921|FG000|STARTED|Phase II||0
3125988|NCT01656252|3850921|FG000|COMPLETED|Phase II||0
3125989|NCT01656252|3850921|FG000|NOT COMPLETED|Phase II||0
3125990|NCT01656304|3850927|FG000|STARTED|Overall Study||16
3125991|NCT01656304|3850927|FG000|COMPLETED|Overall Study||15
3125992|NCT01656304|3850927|FG000|NOT COMPLETED|Overall Study||1
3125993|NCT01656395|3850937|FG000|STARTED|Overall Study||60
3125994|NCT01656395|3850938|FG001|STARTED|Overall Study||127
3125995|NCT01656395|3850939|FG002|STARTED|Overall Study||142
3125996|NCT01656395|3850940|FG003|STARTED|Overall Study||53
3125997|NCT01656395|3850941|FG004|STARTED|Overall Study||60
3125998|NCT01656395|3850942|FG005|STARTED|Overall Study||134
3125999|NCT01656395|3850943|FG006|STARTED|Overall Study||0
3126000|NCT01656395|3850944|FG007|STARTED|Overall Study||0
3126001|NCT01656395|3850937|FG000|Treated Participants|Overall Study||58
3126002|NCT01656395|3850938|FG001|Treated Participants|Overall Study||126
3126003|NCT01656395|3850939|FG002|Treated Participants|Overall Study||135
3126004|NCT01656395|3850940|FG003|Treated Participants|Overall Study||52
3126005|NCT01656395|3850941|FG004|Treated Participants|Overall Study||60
3126006|NCT01656395|3850942|FG005|Treated Participants|Overall Study||126
3126007|NCT01656395|3850943|FG006|Treated Participants|Overall Study||0
3126008|NCT01656395|3850944|FG007|Treated Participants|Overall Study||0
3126009|NCT01656395|3850937|FG000|COMPLETED|Overall Study||43
3126010|NCT01656395|3850938|FG001|COMPLETED|Overall Study||93
3126011|NCT01656395|3850939|FG002|COMPLETED|Overall Study||106
3126012|NCT01656395|3850940|FG003|COMPLETED|Overall Study||41
3126013|NCT01656395|3850941|FG004|COMPLETED|Overall Study||46
3126014|NCT01656395|3850942|FG005|COMPLETED|Overall Study||94
3126015|NCT01656395|3850943|FG006|COMPLETED|Overall Study||0
3126016|NCT01656395|3850944|FG007|COMPLETED|Overall Study||0
3126017|NCT01656395|3850937|FG000|NOT COMPLETED|Overall Study||17
3126018|NCT01656395|3850938|FG001|NOT COMPLETED|Overall Study||34
3126019|NCT01656395|3850939|FG002|NOT COMPLETED|Overall Study||36
3126020|NCT01656395|3850940|FG003|NOT COMPLETED|Overall Study||12
3126021|NCT01656395|3850941|FG004|NOT COMPLETED|Overall Study||14
3126022|NCT01656395|3850942|FG005|NOT COMPLETED|Overall Study||40
3126023|NCT01656395|3850943|FG006|NOT COMPLETED|Overall Study||0
3126024|NCT01656395|3850944|FG007|NOT COMPLETED|Overall Study||0
3126025|NCT01656408|3850968|FG000|STARTED|Overall Study||8
3126026|NCT01656408|3850969|FG001|STARTED|Overall Study||8
3126027|NCT01656408|3850970|FG002|STARTED|Overall Study||8
3126028|NCT01656408|3850971|FG003|STARTED|Overall Study||7
3126029|NCT01656408|3850972|FG004|STARTED|Overall Study||9
3126030|NCT01656408|3850973|FG005|STARTED|Overall Study||9
3126031|NCT01656408|3850974|FG006|STARTED|Overall Study||10
3126032|NCT01656408|3850975|FG007|STARTED|Overall Study||8
3126033|NCT01656408|3850976|FG008|STARTED|Overall Study||18
3126034|NCT01656408|3850977|FG009|STARTED|Overall Study||18
3126035|NCT01656408|3850968|FG000|COMPLETED|Overall Study||7
3126036|NCT01656408|3850969|FG001|COMPLETED|Overall Study||8
3126037|NCT01656408|3850970|FG002|COMPLETED|Overall Study||6
3126038|NCT01656408|3850971|FG003|COMPLETED|Overall Study||7
3126039|NCT01656408|3850972|FG004|COMPLETED|Overall Study||8
3126040|NCT01656408|3850973|FG005|COMPLETED|Overall Study||7
3126041|NCT01656408|3850974|FG006|COMPLETED|Overall Study||9
3126042|NCT01656408|3850975|FG007|COMPLETED|Overall Study||7
3126043|NCT01656408|3850976|FG008|COMPLETED|Overall Study||16
3126044|NCT01656408|3850977|FG009|COMPLETED|Overall Study||15
3126045|NCT01656408|3850968|FG000|NOT COMPLETED|Overall Study||1
3126046|NCT01656408|3850969|FG001|NOT COMPLETED|Overall Study||0
3126047|NCT01656408|3850970|FG002|NOT COMPLETED|Overall Study||2
3126048|NCT01656408|3850971|FG003|NOT COMPLETED|Overall Study||0
3126049|NCT01656408|3850972|FG004|NOT COMPLETED|Overall Study||1
3126050|NCT01656408|3850973|FG005|NOT COMPLETED|Overall Study||2
3126051|NCT01656408|3850974|FG006|NOT COMPLETED|Overall Study||1
3126052|NCT01656408|3850975|FG007|NOT COMPLETED|Overall Study||1
3126053|NCT01656408|3850976|FG008|NOT COMPLETED|Overall Study||2
3126054|NCT01656408|3850977|FG009|NOT COMPLETED|Overall Study||3
3126055|NCT01656460|3851023|FG000|STARTED|Overall Study||3
3126056|NCT01656460|3851024|FG001|STARTED|Overall Study||3
3126057|NCT01656460|3851025|FG002|STARTED|Overall Study||3
3126058|NCT01656460|3851026|FG003|STARTED|Overall Study||3
3126059|NCT01656460|3851023|FG000|COMPLETED|Overall Study||3
3126060|NCT01656460|3851024|FG001|COMPLETED|Overall Study||3
3126061|NCT01656460|3851025|FG002|COMPLETED|Overall Study||3
3126062|NCT01656460|3851026|FG003|COMPLETED|Overall Study||3
3126063|NCT01656460|3851023|FG000|NOT COMPLETED|Overall Study||0
3126064|NCT01656460|3851024|FG001|NOT COMPLETED|Overall Study||0
3126065|NCT01656460|3851025|FG002|NOT COMPLETED|Overall Study||0
3126066|NCT01656460|3851026|FG003|NOT COMPLETED|Overall Study||0
3126067|NCT01656486|3851036|FG000|STARTED|Overall Study||1
3126068|NCT01656486|3851036|FG000|COMPLETED|Overall Study||1
3126069|NCT01656486|3851036|FG000|NOT COMPLETED|Overall Study||0
3126070|NCT01656629|3851043|FG000|STARTED|Overall Study||21
3126071|NCT01656629|3851044|FG001|STARTED|Overall Study||18
3126072|NCT01656629|3851045|FG002|STARTED|Overall Study||16
3126073|NCT01656629|3851043|FG000|COMPLETED|Overall Study||16
3126074|NCT01656629|3851044|FG001|COMPLETED|Overall Study||16
3126075|NCT01656629|3851045|FG002|COMPLETED|Overall Study||14
3126076|NCT01656629|3851043|FG000|NOT COMPLETED|Overall Study||5
3126077|NCT01656629|3851044|FG001|NOT COMPLETED|Overall Study||2
3126078|NCT01656629|3851045|FG002|NOT COMPLETED|Overall Study||2
3126079|NCT01656733|3851055|FG000|STARTED|Overall Study|4 discontinued after BL visit (lost to follow up)|67
3126080|NCT01656733|3851056|FG001|STARTED|Overall Study|5 discontinued after BL visit ( lost to follow up)|70
3126081|NCT01656733|3851055|FG000|Visit 1 (1 Week After Quit Date)|Overall Study||45
3126082|NCT01656733|3851056|FG001|Visit 1 (1 Week After Quit Date)|Overall Study||42
3126083|NCT01656733|3851055|FG000|Visit 2 (2 Weeks After Quit Date)|Overall Study||32
3126084|NCT01656733|3851056|FG001|Visit 2 (2 Weeks After Quit Date)|Overall Study||44
3126085|NCT01656733|3851055|FG000|Visit 3 (3 Weeks After Quit Date)|Overall Study||33
3126086|NCT01656733|3851056|FG001|Visit 3 (3 Weeks After Quit Date)|Overall Study||34
3126087|NCT01656733|3851055|FG000|Visit 4 (4 Weeks After Quit Date)|Overall Study||32
3126088|NCT01656733|3851056|FG001|Visit 4 (4 Weeks After Quit Date)|Overall Study||30
3126089|NCT01656733|3851055|FG000|Visit 5 (6 Weeks After Quit Date)|Overall Study||37
3126090|NCT01656733|3851056|FG001|Visit 5 (6 Weeks After Quit Date)|Overall Study||36
3126091|NCT01656733|3851055|FG000|Visit 6 ( 32-36 Weeks Gestation)|Overall Study||39
3126092|NCT01656733|3851056|FG001|Visit 6 ( 32-36 Weeks Gestation)|Overall Study||47
3126093|NCT01656733|3851055|FG000|Participants With Perinatal Outcomes|Overall Study||67
3126094|NCT01656733|3851056|FG001|Participants With Perinatal Outcomes|Overall Study||66
3126095|NCT01656733|3851055|FG000|Visit 7 (1 Month Postpartum) Phone Call|Overall Study||47
3126096|NCT01656733|3851056|FG001|Visit 7 (1 Month Postpartum) Phone Call|Overall Study||50
3126097|NCT01656733|3851055|FG000|Visit 8 (6 Months Postpartum)|Overall Study||30
3126098|NCT01656733|3851056|FG001|Visit 8 (6 Months Postpartum)|Overall Study||28
3126099|NCT01656733|3851055|FG000|COMPLETED|Overall Study||67
3126100|NCT01656733|3851056|FG001|COMPLETED|Overall Study||66
3126101|NCT01656733|3851055|FG000|NOT COMPLETED|Overall Study||0
3126102|NCT01656733|3851056|FG001|NOT COMPLETED|Overall Study||4
3126103|NCT01656759|3851064|FG000|STARTED|Overall Study||27
3126104|NCT01656759|3851065|FG001|STARTED|Overall Study||25
3126105|NCT01656759|3851064|FG000|COMPLETED|Overall Study||25
3126106|NCT01656759|3851065|FG001|COMPLETED|Overall Study||22
3126107|NCT01656759|3851064|FG000|NOT COMPLETED|Overall Study||2
3126108|NCT01656759|3851065|FG001|NOT COMPLETED|Overall Study||3
3126109|NCT01656772|3851073|FG000|STARTED|Overall Study||43
3126110|NCT01656772|3851074|FG001|STARTED|Overall Study||77
3126111|NCT01656772|3851073|FG000|COMPLETED|Overall Study||43
3126112|NCT01656772|3851074|FG001|COMPLETED|Overall Study||77
3126113|NCT01656772|3851073|FG000|NOT COMPLETED|Overall Study||0
3126114|NCT01656772|3851074|FG001|NOT COMPLETED|Overall Study||0
3126115|NCT01656850|3851082|FG000|STARTED|First Intervention (3 Months)||20
3126116|NCT01656850|3851083|FG001|STARTED|First Intervention (3 Months)||20
3126117|NCT01656850|3851082|FG000|COMPLETED|First Intervention (3 Months)||17
3126118|NCT01656850|3851083|FG001|COMPLETED|First Intervention (3 Months)||16
3126119|NCT01656850|3851082|FG000|NOT COMPLETED|First Intervention (3 Months)||3
3126120|NCT01656850|3851083|FG001|NOT COMPLETED|First Intervention (3 Months)||4
3126121|NCT01656850|3851082|FG000|STARTED|Washout (2 Weeks)||17
3126122|NCT01656850|3851083|FG001|STARTED|Washout (2 Weeks)||16
3126123|NCT01656850|3851082|FG000|COMPLETED|Washout (2 Weeks)||17
3126124|NCT01656850|3851083|FG001|COMPLETED|Washout (2 Weeks)||16
3126125|NCT01656850|3851082|FG000|NOT COMPLETED|Washout (2 Weeks)||0
3126126|NCT01656850|3851083|FG001|NOT COMPLETED|Washout (2 Weeks)||0
3126127|NCT01656850|3851082|FG000|STARTED|Second Intervention (3 Months)||17
3126128|NCT01656850|3851083|FG001|STARTED|Second Intervention (3 Months)||16
3126129|NCT01656850|3851082|FG000|COMPLETED|Second Intervention (3 Months)||17
3126130|NCT01656850|3851083|FG001|COMPLETED|Second Intervention (3 Months)||16
3126131|NCT01656850|3851082|FG000|NOT COMPLETED|Second Intervention (3 Months)||0
3126132|NCT01656850|3851083|FG001|NOT COMPLETED|Second Intervention (3 Months)||0
3126133|NCT01656889|3851095|FG000|STARTED|Treatment Period, 12 Weeks|Randomized (Met all I/E criteria at completion of run-in)|222
3126134|NCT01656889|3851096|FG001|STARTED|Treatment Period, 12 Weeks|Randomized (Met all I/E criteria at completion of run-in)|225
3126135|NCT01656889|3851095|FG000|COMPLETED|Treatment Period, 12 Weeks|Completed treatment|210
3126136|NCT01656889|3851096|FG001|COMPLETED|Treatment Period, 12 Weeks|Completed treatment|214
3126137|NCT01656889|3851095|FG000|NOT COMPLETED|Treatment Period, 12 Weeks||12
3126138|NCT01656889|3851096|FG001|NOT COMPLETED|Treatment Period, 12 Weeks||11
3126139|NCT01656889|3851095|FG000|STARTED|Post Treatment Follow-Up, 3 Months||210
3126140|NCT01656889|3851096|FG001|STARTED|Post Treatment Follow-Up, 3 Months||213
3126141|NCT01656889|3851095|FG000|COMPLETED|Post Treatment Follow-Up, 3 Months||206
3126142|NCT01656889|3851096|FG001|COMPLETED|Post Treatment Follow-Up, 3 Months||204
3126143|NCT01656889|3851095|FG000|NOT COMPLETED|Post Treatment Follow-Up, 3 Months||4
3126144|NCT01656889|3851096|FG001|NOT COMPLETED|Post Treatment Follow-Up, 3 Months||9
3126145|NCT01656967|3851104|FG000|STARTED|Overall Study||33
3126146|NCT01656967|3851105|FG001|STARTED|Overall Study||33
3126147|NCT01656967|3851104|FG000|SGA Placement|Overall Study||32
3126148|NCT01656967|3851105|FG001|SGA Placement|Overall Study||33
3126149|NCT01656967|3851104|FG000|ETT Insertion|Overall Study||29
3126150|NCT01656967|3851105|FG001|ETT Insertion|Overall Study||31
3126151|NCT01656967|3851104|FG000|COMPLETED|Overall Study||29
3126152|NCT01656967|3851105|FG001|COMPLETED|Overall Study||31
3126153|NCT01656967|3851104|FG000|NOT COMPLETED|Overall Study||4
3126154|NCT01656967|3851105|FG001|NOT COMPLETED|Overall Study||2
3126155|NCT01657019|3851115|FG000|STARTED|Overall Study||604
3126156|NCT01657019|3851115|FG000|COMPLETED|Overall Study||369
3126157|NCT01657019|3851115|FG000|NOT COMPLETED|Overall Study||235
3126158|NCT01657032|3851121|FG000|STARTED|Overall Study||44
3126159|NCT01657032|3851122|FG001|STARTED|Overall Study||44
3126160|NCT01657032|3851121|FG000|COMPLETED|Overall Study||44
3126161|NCT01657032|3851122|FG001|COMPLETED|Overall Study||37
3126162|NCT01657032|3851121|FG000|NOT COMPLETED|Overall Study||0
3126163|NCT01657032|3851122|FG001|NOT COMPLETED|Overall Study||7
3126164|NCT01657162|3851130|FG000|STARTED|Overall Study||558
3126165|NCT01657162|3851131|FG001|STARTED|Overall Study||581
3126166|NCT01657162|3851130|FG000|Study 003 ITT Population|Overall Study|Participants received 80 mcg abaloparatide SC during Study 003.|824
3126167|NCT01657162|3851131|FG001|Study 003 ITT Population|Overall Study|Participants received abaloparatide-matching placebo during Study 003.|821
3126168|NCT01657162|3851130|FG000|Study 003 Modified ITT (mITT) Population|Overall Study|Participants received 80 mcg abaloparatide SC during Study 003.|690
3126169|NCT01657162|3851131|FG001|Study 003 Modified ITT (mITT) Population|Overall Study|Participants received abaloparatide-matching placebo during Study 003.|711
3126170|NCT01657162|3851130|FG000|Completed Study 003|Overall Study|Participants received 80 mcg abaloparatide SC during Study 003.|606
3126171|NCT01657162|3851131|FG001|Completed Study 003|Overall Study|Participants received abaloparatide-matching placebo during Study 003.|637
3126172|NCT01657162|3851130|FG000|Study 005 ITT Population|Overall Study||558
3126173|NCT01657162|3851131|FG001|Study 005 ITT Population|Overall Study||581
3126174|NCT01657162|3851130|FG000|Study 005 Safety Population|Overall Study||553
3126175|NCT01657162|3851131|FG001|Study 005 Safety Population|Overall Study||580
3126176|NCT01657162|3851130|FG000|Study 005 mITT Population|Overall Study||544
3126177|NCT01657162|3851131|FG001|Study 005 mITT Population|Overall Study||568
3126178|NCT01657162|3851130|FG000|COMPLETED|Overall Study||499
3126179|NCT01657162|3851131|FG001|COMPLETED|Overall Study||506
3126180|NCT01657162|3851130|FG000|NOT COMPLETED|Overall Study||59
3126181|NCT01657162|3851131|FG001|NOT COMPLETED|Overall Study||75
3126182|NCT01657253|3851139|FG000|STARTED|Overall Study||93
3126183|NCT01657253|3851140|FG001|STARTED|Overall Study||90
3126184|NCT01657253|3851139|FG000|COMPLETED|Overall Study||76
3126185|NCT01657253|3851140|FG001|COMPLETED|Overall Study||72
3126186|NCT01657253|3851139|FG000|NOT COMPLETED|Overall Study||17
3126187|NCT01657253|3851140|FG001|NOT COMPLETED|Overall Study||18
3126188|NCT01657266|3851148|FG000|STARTED|Overall Study||73
3126189|NCT01657266|3851149|FG001|STARTED|Overall Study||75
3126190|NCT01657266|3851148|FG000|COMPLETED|Overall Study||69
3126191|NCT01657266|3851149|FG001|COMPLETED|Overall Study||70
3126192|NCT01657266|3851148|FG000|NOT COMPLETED|Overall Study||4
3126193|NCT01657266|3851149|FG001|NOT COMPLETED|Overall Study||5
3126194|NCT01657292|3851155|FG000|STARTED|Overall Study||61
3126195|NCT01657292|3851155|FG000|COMPLETED|Overall Study||51
3126196|NCT01657292|3851155|FG000|NOT COMPLETED|Overall Study||10
3126197|NCT01657305|3851162|FG000|STARTED|Overall Study||107
3126198|NCT01657305|3851162|FG000|COMPLETED|Overall Study||82
3126199|NCT01657305|3851162|FG000|NOT COMPLETED|Overall Study||25
3126200|NCT01657344|3851202|FG000|STARTED|Overall Study||421622
3126201|NCT01657344|3851203|FG001|STARTED|Overall Study||409967
3126202|NCT01657344|3851204|FG002|STARTED|Overall Study||196300
3126203|NCT01657344|3851205|FG003|STARTED|Overall Study||376517
3126204|NCT01657344|3851206|FG004|STARTED|Overall Study||157802
3126205|NCT01657344|3851207|FG005|STARTED|Overall Study||316477
3126206|NCT01657344|3851208|FG006|STARTED|Overall Study||140776
3126207|NCT01657344|3851202|FG000|COMPLETED|Overall Study||421622
3126208|NCT01657344|3851203|FG001|COMPLETED|Overall Study||409967
3126209|NCT01657344|3851204|FG002|COMPLETED|Overall Study||196300
3126210|NCT01657344|3851205|FG003|COMPLETED|Overall Study||376517
3126211|NCT01657344|3851206|FG004|COMPLETED|Overall Study||157802
3126212|NCT01657344|3851207|FG005|COMPLETED|Overall Study||316477
3126213|NCT01657344|3851208|FG006|COMPLETED|Overall Study||140776
3126214|NCT01657344|3851202|FG000|NOT COMPLETED|Overall Study||0
3126215|NCT01657344|3851203|FG001|NOT COMPLETED|Overall Study||0
3126216|NCT01657344|3851204|FG002|NOT COMPLETED|Overall Study||0
3126217|NCT01657344|3851205|FG003|NOT COMPLETED|Overall Study||0
3126218|NCT01657344|3851206|FG004|NOT COMPLETED|Overall Study||0
3126219|NCT01657344|3851207|FG005|NOT COMPLETED|Overall Study||0
3126220|NCT01657344|3851208|FG006|NOT COMPLETED|Overall Study||0
3126221|NCT01657370|3851224|FG000|STARTED|Overall Study||33
3126222|NCT01657370|3851225|FG001|STARTED|Overall Study||32
3126223|NCT01657370|3851226|FG002|STARTED|Overall Study||32
3126224|NCT01657370|3851227|FG003|STARTED|Overall Study||33
3126225|NCT01657370|3851228|FG004|STARTED|Overall Study||34
3126226|NCT01657370|3851229|FG005|STARTED|Overall Study||31
3126227|NCT01657370|3851224|FG000|COMPLETED|Overall Study||27
3126228|NCT01657370|3851225|FG001|COMPLETED|Overall Study||28
3126229|NCT01657370|3851226|FG002|COMPLETED|Overall Study||25
3126230|NCT01657370|3851227|FG003|COMPLETED|Overall Study||28
3126231|NCT01657370|3851228|FG004|COMPLETED|Overall Study||27
3126232|NCT01657370|3851229|FG005|COMPLETED|Overall Study||27
3126233|NCT01657370|3851224|FG000|NOT COMPLETED|Overall Study||6
3126234|NCT01657370|3851225|FG001|NOT COMPLETED|Overall Study||4
3126235|NCT01657370|3851226|FG002|NOT COMPLETED|Overall Study||7
3126236|NCT01657370|3851227|FG003|NOT COMPLETED|Overall Study||5
3126237|NCT01657370|3851228|FG004|NOT COMPLETED|Overall Study||7
3126238|NCT01657370|3851229|FG005|NOT COMPLETED|Overall Study||4
3126239|NCT01657461|3851250|FG000|STARTED|Overall Study||98
3126240|NCT01657461|3851251|FG001|STARTED|Overall Study||98
3126241|NCT01657461|3851250|FG000|COMPLETED|Overall Study||88
3126242|NCT01657461|3851251|FG001|COMPLETED|Overall Study||78
3126243|NCT01657461|3851250|FG000|NOT COMPLETED|Overall Study||10
3126244|NCT01657461|3851251|FG001|NOT COMPLETED|Overall Study||20
3126245|NCT01657617|3851257|FG000|STARTED|Overall Study||35
3126246|NCT01657617|3851257|FG000|COMPLETED|Overall Study||35
3126247|NCT01657617|3851257|FG000|NOT COMPLETED|Overall Study||0
3126248|NCT01657760|3851263|FG000|STARTED|Overall Study||5
3126249|NCT01657760|3851264|FG001|STARTED|Overall Study||7
3126250|NCT01657760|3851265|FG002|STARTED|Overall Study||7
3126251|NCT01657760|3851266|FG003|STARTED|Overall Study||7
3126252|NCT01657760|3851263|FG000|COMPLETED|Overall Study||4
3126253|NCT01657760|3851264|FG001|COMPLETED|Overall Study||6
3126254|NCT01657760|3851265|FG002|COMPLETED|Overall Study||6
3126255|NCT01657760|3851266|FG003|COMPLETED|Overall Study||4
3126256|NCT01657760|3851263|FG000|NOT COMPLETED|Overall Study||1
3126257|NCT01657760|3851264|FG001|NOT COMPLETED|Overall Study||1
3126258|NCT01657760|3851265|FG002|NOT COMPLETED|Overall Study||1
3126259|NCT01657760|3851266|FG003|NOT COMPLETED|Overall Study||3
3126260|NCT01657799|3851281|FG000|STARTED|Overall Study||102
3126261|NCT01657799|3851282|FG001|STARTED|Overall Study||103
3126262|NCT01657799|3851283|FG002|STARTED|Overall Study||102
3126263|NCT01657799|3851281|FG000|Received Treatment|Overall Study||101
3126264|NCT01657799|3851282|FG001|Received Treatment|Overall Study||103
3126265|NCT01657799|3851283|FG002|Received Treatment|Overall Study||102
3126266|NCT01657799|3851281|FG000|COMPLETED|Overall Study||0
3126267|NCT01657799|3851282|FG001|COMPLETED|Overall Study||0
3126268|NCT01657799|3851283|FG002|COMPLETED|Overall Study||0
3126269|NCT01657799|3851281|FG000|NOT COMPLETED|Overall Study||102
3126270|NCT01657799|3851282|FG001|NOT COMPLETED|Overall Study||103
3126271|NCT01657799|3851283|FG002|NOT COMPLETED|Overall Study||102
3126272|NCT01657877|3851291|FG000|STARTED|Overall Study||79
3126273|NCT01657877|3851291|FG000|Received 500ppm Fluoride as SMFP+ 0% CSP|Overall Study|Discontinuations: 1 due to other reason in P2 and 1 protocol violation in P4|70
3126274|NCT01657877|3851291|FG000|Received 1500ppm Fluoride as SMFP+5% CSP|Overall Study|Discontinuations:2 withdrawal of consent in period (P) 1; 1 AE in P2;1 protocol violation in P3 & P4|75
3126275|NCT01657877|3851291|FG000|Received 0ppm Fluoride+ 5% CSP|Overall Study|Discontinuations: 1 protocol violation in P1 and P2 each and 1 withdrawal of consent in P1.|71
3126276|NCT01657877|3851291|FG000|Received 0ppm Fluoride+ 0% CSP|Overall Study|Discontinuation: 1 in P4 due to other reasons|69
3126277|NCT01657877|3851291|FG000|Received 1500ppm Fluoride as SMFP+0% CSP|Overall Study|Discontinuations: 1 protocol violation in P1 and 1 withdrawal of consent and AE in P3|71
3126278|NCT01657877|3851291|FG000|COMPLETED|Overall Study||65
3126279|NCT01657877|3851291|FG000|NOT COMPLETED|Overall Study||14
3126280|NCT01657903|3851308|FG000|STARTED|Overall Study||56
3126281|NCT01657903|3851308|FG000|Received Placebo (No NaF/KNO3)Toothpaste|Overall Study|One participant was lost to follow up in study period 1|56
3126282|NCT01657903|3851308|FG000|Received NaF/KNO3 Toothpaste 1|Overall Study|One participant withdrew consent in study period 3|55
3126283|NCT01657903|3851308|FG000|Received NaF/KNO3 Toothpaste 3|Overall Study||54
3126284|NCT01657903|3851308|FG000|Received NaF/KNO3 Toothpaste 2|Overall Study||55
3126285|NCT01657903|3851308|FG000|COMPLETED|Overall Study||54
3126286|NCT01657903|3851308|FG000|NOT COMPLETED|Overall Study||2
3126287|NCT01658020|3851321|FG000|STARTED|Overall Study||175
3126288|NCT01658020|3851322|FG001|STARTED|Overall Study||167
3126289|NCT01658020|3851321|FG000|COMPLETED|Overall Study||167
3126290|NCT01658020|3851322|FG001|COMPLETED|Overall Study||158
3126291|NCT01658020|3851321|FG000|NOT COMPLETED|Overall Study||8
3126292|NCT01658020|3851322|FG001|NOT COMPLETED|Overall Study||9
3126293|NCT01658059|3851329|FG000|STARTED|First Intervention- 2 Days||12
3126294|NCT01658059|3851330|FG001|STARTED|First Intervention- 2 Days||10
3126295|NCT01658059|3851329|FG000|COMPLETED|First Intervention- 2 Days||6
3126296|NCT01658059|3851330|FG001|COMPLETED|First Intervention- 2 Days||5
3126297|NCT01658059|3851329|FG000|NOT COMPLETED|First Intervention- 2 Days||6
3126298|NCT01658059|3851330|FG001|NOT COMPLETED|First Intervention- 2 Days||5
3126299|NCT01658059|3851329|FG000|STARTED|Washout Period- 14 Days||6
3126300|NCT01658059|3851330|FG001|STARTED|Washout Period- 14 Days||5
3126301|NCT01658059|3851329|FG000|COMPLETED|Washout Period- 14 Days||6
3126302|NCT01658059|3851330|FG001|COMPLETED|Washout Period- 14 Days||5
3126303|NCT01658059|3851329|FG000|NOT COMPLETED|Washout Period- 14 Days||0
3126304|NCT01658059|3851330|FG001|NOT COMPLETED|Washout Period- 14 Days||0
3126305|NCT01658059|3851329|FG000|STARTED|Second Intervention- 2 Days||6
3126306|NCT01658059|3851330|FG001|STARTED|Second Intervention- 2 Days||5
3126307|NCT01658059|3851329|FG000|COMPLETED|Second Intervention- 2 Days||6
3126308|NCT01658059|3851330|FG001|COMPLETED|Second Intervention- 2 Days||5
3126309|NCT01658059|3851329|FG000|NOT COMPLETED|Second Intervention- 2 Days||0
3126310|NCT01658059|3851330|FG001|NOT COMPLETED|Second Intervention- 2 Days||0
3126311|NCT01658072|3851338|FG000|STARTED|Overall Study||45
3126312|NCT01658072|3851339|FG001|STARTED|Overall Study||45
3126313|NCT01658072|3851338|FG000|COMPLETED|Overall Study||41
3126314|NCT01658072|3851339|FG001|COMPLETED|Overall Study||43
3126315|NCT01658072|3851338|FG000|NOT COMPLETED|Overall Study||4
3126316|NCT01658072|3851339|FG001|NOT COMPLETED|Overall Study||2
3126317|NCT01658150|3851345|FG000|STARTED|Overall Study||11
3126318|NCT01658150|3851345|FG000|COMPLETED|Overall Study||10
3126319|NCT01658150|3851345|FG000|NOT COMPLETED|Overall Study||1
3126320|NCT01658228|3851352|FG000|STARTED|Overall Study||30
3126321|NCT01658228|3851353|FG001|STARTED|Overall Study||31
3126322|NCT01658228|3851352|FG000|COMPLETED|Overall Study||23
3126323|NCT01658228|3851353|FG001|COMPLETED|Overall Study||23
3126324|NCT01658228|3851352|FG000|NOT COMPLETED|Overall Study||7
3126325|NCT01658228|3851353|FG001|NOT COMPLETED|Overall Study||8
3126326|NCT01658436|3851359|FG000|STARTED|Overall Study||20
3126327|NCT01658436|3851360|FG001|STARTED|Overall Study||11
3126328|NCT01658436|3851359|FG000|COMPLETED|Overall Study||0
3126329|NCT01658436|3851360|FG001|COMPLETED|Overall Study||0
3126330|NCT01658436|3851359|FG000|NOT COMPLETED|Overall Study||20
3126331|NCT01658436|3851360|FG001|NOT COMPLETED|Overall Study||11
3126332|NCT01658514|3851369|FG000|STARTED|Overall Study||14
3126333|NCT01658514|3851370|FG001|STARTED|Overall Study||11
3126334|NCT01658514|3851371|FG002|STARTED|Overall Study||14
3126335|NCT01658514|3851369|FG000|Completed Treatment A|Overall Study||14
3126336|NCT01658514|3851370|FG001|Completed Treatment A|Overall Study||11
3126337|NCT01658514|3851371|FG002|Completed Treatment A|Overall Study||12
3126338|NCT01658514|3851369|FG000|Completed Treatment B|Overall Study||13
3126339|NCT01658514|3851370|FG001|Completed Treatment B|Overall Study||11
3126340|NCT01658514|3851371|FG002|Completed Treatment B|Overall Study||14
3126341|NCT01658514|3851369|FG000|Completed Treatment C|Overall Study||13
3126342|NCT01658514|3851370|FG001|Completed Treatment C|Overall Study||11
3126343|NCT01658514|3851371|FG002|Completed Treatment C|Overall Study||12
3126344|NCT01658514|3851369|FG000|Started - Normal RF Cohort Only|Overall Study||3
3126345|NCT01658514|3851370|FG001|Started - Normal RF Cohort Only|Overall Study||2
3126346|NCT01658514|3851371|FG002|Started - Normal RF Cohort Only|Overall Study||3
3126347|NCT01658514|3851369|FG000|Completed - Normal RF Cohort Only|Overall Study||3
3126348|NCT01658514|3851370|FG001|Completed - Normal RF Cohort Only|Overall Study||2
3126349|NCT01658514|3851371|FG002|Completed - Normal RF Cohort Only|Overall Study||3
3126350|NCT01658514|3851369|FG000|Started - Mild RI Cohort Only|Overall Study||4
3126351|NCT01658514|3851370|FG001|Started - Mild RI Cohort Only|Overall Study||3
3126352|NCT01658514|3851371|FG002|Started - Mild RI Cohort Only|Overall Study||4
3126353|NCT01658514|3851369|FG000|Completed - Mild RI Cohort Only|Overall Study||4
3126354|NCT01658514|3851370|FG001|Completed - Mild RI Cohort Only|Overall Study||3
3126355|NCT01658514|3851371|FG002|Completed - Mild RI Cohort Only|Overall Study||4
3126356|NCT01658514|3851369|FG000|Started - Moderate RI Cohort Only|Overall Study||4
3126357|NCT01658514|3851370|FG001|Started - Moderate RI Cohort Only|Overall Study||4
3126358|NCT01658514|3851371|FG002|Started - Moderate RI Cohort Only|Overall Study||4
3126359|NCT01658514|3851369|FG000|Completed - Moderate RI Cohort Only|Overall Study||3
3126360|NCT01658514|3851370|FG001|Completed - Moderate RI Cohort Only|Overall Study||4
3126361|NCT01658514|3851371|FG002|Completed - Moderate RI Cohort Only|Overall Study||2
3126362|NCT01658514|3851369|FG000|Started - Severe RI Cohort Only|Overall Study||3
3126363|NCT01658514|3851370|FG001|Started - Severe RI Cohort Only|Overall Study||2
3126364|NCT01658514|3851371|FG002|Started - Severe RI Cohort Only|Overall Study||3
3126365|NCT01658514|3851369|FG000|Completed - Severe RI Cohort Only|Overall Study||3
3126366|NCT01658514|3851370|FG001|Completed - Severe RI Cohort Only|Overall Study||2
3126367|NCT01658514|3851371|FG002|Completed - Severe RI Cohort Only|Overall Study||3
3126368|NCT01658514|3851369|FG000|COMPLETED|Overall Study||13
3126369|NCT01658514|3851370|FG001|COMPLETED|Overall Study||11
3126370|NCT01658514|3851371|FG002|COMPLETED|Overall Study||12
3126371|NCT01658514|3851369|FG000|NOT COMPLETED|Overall Study||1
3126372|NCT01658514|3851370|FG001|NOT COMPLETED|Overall Study||0
3126373|NCT01658514|3851371|FG002|NOT COMPLETED|Overall Study||2
3126374|NCT01658579|3851382|FG000|STARTED|Treatment Period A||15
3126375|NCT01658579|3851383|FG001|STARTED|Treatment Period A||15
3126376|NCT01658579|3851384|FG002|STARTED|Treatment Period A||15
3126377|NCT01658579|3851385|FG003|STARTED|Treatment Period A||14
3126378|NCT01658579|3851382|FG000|COMPLETED|Treatment Period A||14
3126379|NCT01658579|3851383|FG001|COMPLETED|Treatment Period A||15
3126380|NCT01658579|3851384|FG002|COMPLETED|Treatment Period A||14
3126381|NCT01658579|3851385|FG003|COMPLETED|Treatment Period A||13
3126382|NCT01658579|3851382|FG000|NOT COMPLETED|Treatment Period A||1
3126383|NCT01658579|3851383|FG001|NOT COMPLETED|Treatment Period A||0
3126384|NCT01658579|3851384|FG002|NOT COMPLETED|Treatment Period A||1
3126385|NCT01658579|3851385|FG003|NOT COMPLETED|Treatment Period A||1
3126386|NCT01658579|3851382|FG000|STARTED|Treatment Period B||14
3126387|NCT01658579|3851383|FG001|STARTED|Treatment Period B||15
3126388|NCT01658579|3851384|FG002|STARTED|Treatment Period B||14
3126389|NCT01658579|3851385|FG003|STARTED|Treatment Period B||13
3126390|NCT01658579|3851382|FG000|COMPLETED|Treatment Period B||14
3126391|NCT01658579|3851383|FG001|COMPLETED|Treatment Period B||15
3126392|NCT01658579|3851384|FG002|COMPLETED|Treatment Period B||14
3126393|NCT01658579|3851385|FG003|COMPLETED|Treatment Period B||12
3126394|NCT01658579|3851382|FG000|NOT COMPLETED|Treatment Period B||0
3126395|NCT01658579|3851383|FG001|NOT COMPLETED|Treatment Period B||0
3126396|NCT01658579|3851384|FG002|NOT COMPLETED|Treatment Period B||0
3126397|NCT01658579|3851385|FG003|NOT COMPLETED|Treatment Period B||1
3126398|NCT01658657|3851393|FG000|STARTED|Overall Study||7
3126399|NCT01658657|3851394|FG001|STARTED|Overall Study||10
3126400|NCT01658657|3851393|FG000|COMPLETED|Overall Study||4
3126401|NCT01658657|3851394|FG001|COMPLETED|Overall Study||7
3126402|NCT01658657|3851393|FG000|NOT COMPLETED|Overall Study||3
3126403|NCT01658657|3851394|FG001|NOT COMPLETED|Overall Study||3
3126404|NCT01658735|3851403|FG000|STARTED|Overall Study||39
3126405|NCT01658735|3851404|FG001|STARTED|Overall Study||36
3126406|NCT01658735|3851405|FG002|STARTED|Overall Study||38
3126407|NCT01658735|3851403|FG000|COMPLETED|Overall Study||34
3126408|NCT01658735|3851404|FG001|COMPLETED|Overall Study||29
3126409|NCT01658735|3851405|FG002|COMPLETED|Overall Study||34
3126410|NCT01658735|3851403|FG000|NOT COMPLETED|Overall Study||5
3126411|NCT01658735|3851404|FG001|NOT COMPLETED|Overall Study||7
3126412|NCT01658735|3851405|FG002|NOT COMPLETED|Overall Study||4
3126413|NCT01658839|3851413|FG000|STARTED|Overall Study||25
3126414|NCT01658839|3851413|FG000|COMPLETED|Overall Study||25
3126415|NCT01658839|3851413|FG000|NOT COMPLETED|Overall Study||0
3126416|NCT01658904|3851420|FG000|STARTED|Overall Study||3
3126417|NCT01658904|3851421|FG001|STARTED|Overall Study||0
3126418|NCT01658904|3851422|FG002|STARTED|Overall Study||0
3126419|NCT01658904|3851420|FG000|COMPLETED|Overall Study||1
3126420|NCT01658904|3851421|FG001|COMPLETED|Overall Study||0
3126421|NCT01658904|3851422|FG002|COMPLETED|Overall Study||0
3126422|NCT01658904|3851420|FG000|NOT COMPLETED|Overall Study||2
3126423|NCT01658904|3851421|FG001|NOT COMPLETED|Overall Study||0
3126424|NCT01658904|3851422|FG002|NOT COMPLETED|Overall Study||0
3126425|NCT01658943|3851435|FG000|STARTED|Overall Study||70
3126426|NCT01658943|3851436|FG001|STARTED|Overall Study||67
3126427|NCT01658943|3851435|FG000|Eligible|Overall Study||63
3126428|NCT01658943|3851436|FG001|Eligible|Overall Study||58
3126429|NCT01658943|3851435|FG000|Eligible and Began Protocol Therapy|Overall Study||62
3126430|NCT01658943|3851436|FG001|Eligible and Began Protocol Therapy|Overall Study||58
3126431|NCT01658943|3851435|FG000|COMPLETED|Overall Study||0
3126432|NCT01658943|3851436|FG001|COMPLETED|Overall Study||0
3126433|NCT01658943|3851435|FG000|NOT COMPLETED|Overall Study||70
3126434|NCT01658943|3851436|FG001|NOT COMPLETED|Overall Study||67
3126435|NCT01658995|3851444|FG000|STARTED|Overall Study||42
3126436|NCT01658995|3851445|FG001|STARTED|Overall Study||40
3126437|NCT01658995|3851444|FG000|COMPLETED|Overall Study||42
3126438|NCT01658995|3851445|FG001|COMPLETED|Overall Study||40
3126439|NCT01658995|3851444|FG000|NOT COMPLETED|Overall Study||0
3126440|NCT01658995|3851445|FG001|NOT COMPLETED|Overall Study||0
3126441|NCT01659021|3851453|FG000|STARTED|Main Study||174
3126442|NCT01659021|3851454|FG001|STARTED|Main Study||87
3126443|NCT01659021|3851453|FG000|Randomized and Treated|Main Study||173
3126444|NCT01659021|3851454|FG001|Randomized and Treated|Main Study||86
3126445|NCT01659021|3851453|FG000|COMPLETED|Main Study||100
3126446|NCT01659021|3851454|FG001|COMPLETED|Main Study||50
3126447|NCT01659021|3851453|FG000|NOT COMPLETED|Main Study||74
3126448|NCT01659021|3851454|FG001|NOT COMPLETED|Main Study||37
3126449|NCT01659021|3851453|FG000|STARTED|Long-Term Follow Up|Participants did not have to complete the main study to enter the Long-Term Follow Up period.|138
3126450|NCT01659021|3851454|FG001|STARTED|Long-Term Follow Up|Participants did not have to complete the main study to enter the Long-Term Follow Up period.|69
3126451|NCT01659021|3851453|FG000|COMPLETED|Long-Term Follow Up||133
3126452|NCT01659021|3851454|FG001|COMPLETED|Long-Term Follow Up||65
3126453|NCT01659021|3851453|FG000|NOT COMPLETED|Long-Term Follow Up||5
3126454|NCT01659021|3851454|FG001|NOT COMPLETED|Long-Term Follow Up||4
3126455|NCT01659125|3851464|FG000|STARTED|Overall Study||26
3126456|NCT01659125|3851464|FG000|Initiated Treatment|Overall Study||24
3126457|NCT01659125|3851464|FG000|Completed the Posttreatment Assessment|Overall Study||17
3126458|NCT01659125|3851464|FG000|Completed 3-month Follow-up|Overall Study||16
3126459|NCT01659125|3851464|FG000|Completed 6-month Follow-up|Overall Study||12
3126460|NCT01659125|3851464|FG000|COMPLETED|Overall Study||12
3126461|NCT01659125|3851464|FG000|NOT COMPLETED|Overall Study||14
3126462|NCT01659255|3851485|FG000|STARTED|Overall Study||3
3126463|NCT01659255|3851486|FG001|STARTED|Overall Study||3
3126464|NCT01659255|3851487|FG002|STARTED|Overall Study||4
3126465|NCT01659255|3851488|FG003|STARTED|Overall Study||3
3126466|NCT01659255|3851489|FG004|STARTED|Overall Study||3
3126467|NCT01659255|3851490|FG005|STARTED|Overall Study||3
3126468|NCT01659255|3851491|FG006|STARTED|Overall Study||3
3126469|NCT01659255|3851492|FG007|STARTED|Overall Study||3
3126470|NCT01659255|3851493|FG008|STARTED|Overall Study||3
3126471|NCT01659255|3851494|FG009|STARTED|Overall Study||3
3126472|NCT01659255|3851495|FG010|STARTED|Overall Study||3
3126473|NCT01659255|3851496|FG011|STARTED|Overall Study||5
3126474|NCT01659255|3851497|FG012|STARTED|Overall Study||8
3126475|NCT01659255|3851498|FG013|STARTED|Overall Study||21
3126476|NCT01659255|3851499|FG014|STARTED|Overall Study||10
3126477|NCT01659255|3851500|FG015|STARTED|Overall Study||9
3126478|NCT01659255|3851501|FG016|STARTED|Overall Study||3
3126479|NCT01659255|3851485|FG000|COMPLETED|Overall Study||1
3126480|NCT01659255|3851486|FG001|COMPLETED|Overall Study||2
3126481|NCT01659255|3851487|FG002|COMPLETED|Overall Study||4
3126482|NCT01659255|3851488|FG003|COMPLETED|Overall Study||3
3126483|NCT01659255|3851489|FG004|COMPLETED|Overall Study||3
3126484|NCT01659255|3851490|FG005|COMPLETED|Overall Study||2
3126485|NCT01659255|3851491|FG006|COMPLETED|Overall Study||1
3126486|NCT01659255|3851492|FG007|COMPLETED|Overall Study||1
3126487|NCT01659255|3851493|FG008|COMPLETED|Overall Study||2
3126488|NCT01659255|3851494|FG009|COMPLETED|Overall Study||0
3126489|NCT01659255|3851495|FG010|COMPLETED|Overall Study||0
3126490|NCT01659255|3851496|FG011|COMPLETED|Overall Study||1
3126491|NCT01659255|3851497|FG012|COMPLETED|Overall Study||0
3126492|NCT01659255|3851498|FG013|COMPLETED|Overall Study||3
3126493|NCT01659255|3851499|FG014|COMPLETED|Overall Study||2
3126494|NCT01659255|3851500|FG015|COMPLETED|Overall Study||4
3126495|NCT01659255|3851501|FG016|COMPLETED|Overall Study||0
3126496|NCT01659255|3851485|FG000|NOT COMPLETED|Overall Study||2
3126497|NCT01659255|3851486|FG001|NOT COMPLETED|Overall Study||1
3126498|NCT01659255|3851487|FG002|NOT COMPLETED|Overall Study||0
3126499|NCT01659255|3851488|FG003|NOT COMPLETED|Overall Study||0
3126500|NCT01659255|3851489|FG004|NOT COMPLETED|Overall Study||0
3126501|NCT01659255|3851490|FG005|NOT COMPLETED|Overall Study||1
3126502|NCT01659255|3851491|FG006|NOT COMPLETED|Overall Study||2
3126503|NCT01659255|3851492|FG007|NOT COMPLETED|Overall Study||2
3126504|NCT01659255|3851493|FG008|NOT COMPLETED|Overall Study||1
3126505|NCT01659255|3851494|FG009|NOT COMPLETED|Overall Study||3
3126506|NCT01659255|3851495|FG010|NOT COMPLETED|Overall Study||3
3126507|NCT01659255|3851496|FG011|NOT COMPLETED|Overall Study||4
3126508|NCT01659255|3851497|FG012|NOT COMPLETED|Overall Study||8
3126509|NCT01659255|3851498|FG013|NOT COMPLETED|Overall Study||18
3126510|NCT01659255|3851499|FG014|NOT COMPLETED|Overall Study||8
3126511|NCT01659255|3851500|FG015|NOT COMPLETED|Overall Study||5
3126512|NCT01659255|3851501|FG016|NOT COMPLETED|Overall Study||3
3126513|NCT01659268|3851541|FG000|STARTED|Overall Study||9
3126514|NCT01659268|3851542|FG001|STARTED|Overall Study||8
3126515|NCT01659268|3851541|FG000|COMPLETED|Overall Study||9
3126516|NCT01659268|3851542|FG001|COMPLETED|Overall Study||8
3126517|NCT01659268|3851541|FG000|NOT COMPLETED|Overall Study||0
3126518|NCT01659268|3851542|FG001|NOT COMPLETED|Overall Study||0
3126519|NCT01659320|3851548|FG000|STARTED|Overall Study||16
3126520|NCT01659320|3851548|FG000|COMPLETED|Overall Study||13
3126521|NCT01659320|3851548|FG000|NOT COMPLETED|Overall Study||3
3126522|NCT01659567|3851552|FG000|STARTED|Overall Study||516
3126523|NCT01659567|3851552|FG000|COMPLETED|Overall Study||393
3126524|NCT01659567|3851552|FG000|NOT COMPLETED|Overall Study||123
3126525|NCT01659736|3851558|FG000|STARTED|Treatment Period||14
3126526|NCT01659736|3851559|FG001|STARTED|Treatment Period||12
3126527|NCT01659736|3851558|FG000|COMPLETED|Treatment Period|n = 10, but data from one completer was excluded from all analyses due to protocol violation.|9
3126528|NCT01659736|3851559|FG001|COMPLETED|Treatment Period||10
3126529|NCT01659736|3851558|FG000|NOT COMPLETED|Treatment Period||5
3126530|NCT01659736|3851559|FG001|NOT COMPLETED|Treatment Period||2
3126531|NCT01659736|3851558|FG000|STARTED|3-month Follow-up||9
3126532|NCT01659736|3851559|FG001|STARTED|3-month Follow-up||10
3126533|NCT01659736|3851558|FG000|COMPLETED|3-month Follow-up||9
3126534|NCT01659736|3851559|FG001|COMPLETED|3-month Follow-up||9
3126535|NCT01659736|3851558|FG000|NOT COMPLETED|3-month Follow-up||0
3126536|NCT01659736|3851559|FG001|NOT COMPLETED|3-month Follow-up||1
3126537|NCT01659853|3851567|FG000|STARTED|Treatment Period 1||35
3126538|NCT01659853|3851568|FG001|STARTED|Treatment Period 1||35
3126539|NCT01659853|3851567|FG000|COMPLETED|Treatment Period 1||35
3126540|NCT01659853|3851568|FG001|COMPLETED|Treatment Period 1||35
3126541|NCT01659853|3851567|FG000|NOT COMPLETED|Treatment Period 1||0
3126542|NCT01659853|3851568|FG001|NOT COMPLETED|Treatment Period 1||0
3126543|NCT01659853|3851567|FG000|STARTED|Washout , 3 to 7 Days||35
3126544|NCT01659853|3851568|FG001|STARTED|Washout , 3 to 7 Days||35
3126545|NCT01659853|3851567|FG000|COMPLETED|Washout , 3 to 7 Days||33
3126546|NCT01659853|3851568|FG001|COMPLETED|Washout , 3 to 7 Days||35
3126547|NCT01659853|3851567|FG000|NOT COMPLETED|Washout , 3 to 7 Days||2
3126548|NCT01659853|3851568|FG001|NOT COMPLETED|Washout , 3 to 7 Days||0
3126549|NCT01659853|3851567|FG000|STARTED|Treatment Period 2||33
3126550|NCT01659853|3851568|FG001|STARTED|Treatment Period 2||35
3126551|NCT01659853|3851567|FG000|COMPLETED|Treatment Period 2||33
3126552|NCT01659853|3851568|FG001|COMPLETED|Treatment Period 2||35
3126553|NCT01659853|3851567|FG000|NOT COMPLETED|Treatment Period 2||0
3126554|NCT01659853|3851568|FG001|NOT COMPLETED|Treatment Period 2||0
3126555|NCT01659866|3851578|FG000|STARTED|Overall Study||430
3126556|NCT01659866|3851579|FG001|STARTED|Overall Study||80
3126557|NCT01659866|3851578|FG000|COMPLETED|Overall Study||430
3126558|NCT01659866|3851579|FG001|COMPLETED|Overall Study||80
3126559|NCT01659866|3851578|FG000|NOT COMPLETED|Overall Study||0
3126560|NCT01659866|3851579|FG001|NOT COMPLETED|Overall Study||0
3126561|NCT01659996|3851588|FG000|STARTED|Overall Study||421
3126562|NCT01659996|3851589|FG001|STARTED|Overall Study||395
3126563|NCT01659996|3851590|FG002|STARTED|Overall Study||472
3126564|NCT01659996|3851588|FG000|COMPLETED|Overall Study||413
3126565|NCT01659996|3851589|FG001|COMPLETED|Overall Study||388
3126566|NCT01659996|3851590|FG002|COMPLETED|Overall Study||461
3126567|NCT01659996|3851588|FG000|NOT COMPLETED|Overall Study||8
3126568|NCT01659996|3851589|FG001|NOT COMPLETED|Overall Study||7
3126569|NCT01659996|3851590|FG002|NOT COMPLETED|Overall Study||11
3126570|NCT01660022|3851606|FG000|STARTED|First Sequence (7 Days)||8
3126571|NCT01660022|3851607|FG001|STARTED|First Sequence (7 Days)||8
3126572|NCT01660022|3851608|FG002|STARTED|First Sequence (7 Days)||8
3126573|NCT01660022|3851609|FG003|STARTED|First Sequence (7 Days)||8
3126574|NCT01660022|3851610|FG004|STARTED|First Sequence (7 Days)||7
3126575|NCT01660022|3851611|FG005|STARTED|First Sequence (7 Days)||20
3126576|NCT01660022|3851606|FG000|COMPLETED|First Sequence (7 Days)||8
3126577|NCT01660022|3851607|FG001|COMPLETED|First Sequence (7 Days)||7
3126578|NCT01660022|3851608|FG002|COMPLETED|First Sequence (7 Days)||8
3126579|NCT01660022|3851609|FG003|COMPLETED|First Sequence (7 Days)||7
3126580|NCT01660022|3851610|FG004|COMPLETED|First Sequence (7 Days)||6
3126581|NCT01660022|3851611|FG005|COMPLETED|First Sequence (7 Days)||16
3126582|NCT01660022|3851606|FG000|NOT COMPLETED|First Sequence (7 Days)||0
3126583|NCT01660022|3851607|FG001|NOT COMPLETED|First Sequence (7 Days)||1
3126584|NCT01660022|3851608|FG002|NOT COMPLETED|First Sequence (7 Days)||0
3126585|NCT01660022|3851609|FG003|NOT COMPLETED|First Sequence (7 Days)||1
3126586|NCT01660022|3851610|FG004|NOT COMPLETED|First Sequence (7 Days)||1
3126587|NCT01660022|3851611|FG005|NOT COMPLETED|First Sequence (7 Days)||4
3126588|NCT01660022|3851606|FG000|STARTED|Second Sequence (42 Days)||8
3126589|NCT01660022|3851607|FG001|STARTED|Second Sequence (42 Days)||7
3126590|NCT01660022|3851608|FG002|STARTED|Second Sequence (42 Days)||8
3126591|NCT01660022|3851609|FG003|STARTED|Second Sequence (42 Days)||7
3126592|NCT01660022|3851610|FG004|STARTED|Second Sequence (42 Days)||6
3126593|NCT01660022|3851611|FG005|STARTED|Second Sequence (42 Days)||16
3126594|NCT01660022|3851606|FG000|COMPLETED|Second Sequence (42 Days)||8
3126595|NCT01660022|3851607|FG001|COMPLETED|Second Sequence (42 Days)||7
3126596|NCT01660022|3851608|FG002|COMPLETED|Second Sequence (42 Days)||8
3126597|NCT01660022|3851609|FG003|COMPLETED|Second Sequence (42 Days)||7
3126598|NCT01660022|3851610|FG004|COMPLETED|Second Sequence (42 Days)||6
3126599|NCT01660022|3851611|FG005|COMPLETED|Second Sequence (42 Days)||16
3126600|NCT01660022|3851606|FG000|NOT COMPLETED|Second Sequence (42 Days)||0
3126601|NCT01660022|3851607|FG001|NOT COMPLETED|Second Sequence (42 Days)||0
3126602|NCT01660022|3851608|FG002|NOT COMPLETED|Second Sequence (42 Days)||0
3126603|NCT01660022|3851609|FG003|NOT COMPLETED|Second Sequence (42 Days)||0
3126604|NCT01660022|3851610|FG004|NOT COMPLETED|Second Sequence (42 Days)||0
3126605|NCT01660022|3851611|FG005|NOT COMPLETED|Second Sequence (42 Days)||0
3126606|NCT01660191|3851640|FG000|STARTED|Enrollment and Washout||45
3126607|NCT01660191|3851641|FG001|STARTED|Enrollment and Washout||45
3126608|NCT01660191|3851642|FG002|STARTED|Enrollment and Washout||44
3126609|NCT01660191|3851640|FG000|COMPLETED|Enrollment and Washout||45
3126610|NCT01660191|3851641|FG001|COMPLETED|Enrollment and Washout||45
3126611|NCT01660191|3851642|FG002|COMPLETED|Enrollment and Washout||44
3126612|NCT01660191|3851640|FG000|NOT COMPLETED|Enrollment and Washout||0
3126613|NCT01660191|3851641|FG001|NOT COMPLETED|Enrollment and Washout||0
3126614|NCT01660191|3851642|FG002|NOT COMPLETED|Enrollment and Washout||0
3126615|NCT01660191|3851640|FG000|STARTED|Randomization||45
3126616|NCT01660191|3851641|FG001|STARTED|Randomization||45
3126617|NCT01660191|3851642|FG002|STARTED|Randomization||44
3126618|NCT01660191|3851640|FG000|COMPLETED|Randomization||45
3126619|NCT01660191|3851641|FG001|COMPLETED|Randomization||45
3126620|NCT01660191|3851642|FG002|COMPLETED|Randomization||44
3126621|NCT01660191|3851640|FG000|NOT COMPLETED|Randomization||0
3126622|NCT01660191|3851641|FG001|NOT COMPLETED|Randomization||0
3126623|NCT01660191|3851642|FG002|NOT COMPLETED|Randomization||0
3126624|NCT01660191|3851640|FG000|STARTED|End of Treatment||45
3126625|NCT01660191|3851641|FG001|STARTED|End of Treatment||45
3126626|NCT01660191|3851642|FG002|STARTED|End of Treatment||44
3126627|NCT01660191|3851640|FG000|COMPLETED|End of Treatment||44
3126628|NCT01660191|3851641|FG001|COMPLETED|End of Treatment||39
3126629|NCT01660191|3851642|FG002|COMPLETED|End of Treatment||43
3126630|NCT01660191|3851640|FG000|NOT COMPLETED|End of Treatment||1
3126631|NCT01660191|3851641|FG001|NOT COMPLETED|End of Treatment||6
3126632|NCT01660191|3851642|FG002|NOT COMPLETED|End of Treatment||1
3126633|NCT01660230|3851662|FG000|STARTED|Overall Study||4
3126634|NCT01660230|3851663|FG001|STARTED|Overall Study||4
3126635|NCT01660230|3851664|FG002|STARTED|Overall Study||4
3126636|NCT01660230|3851665|FG003|STARTED|Overall Study||4
3126637|NCT01660230|3851666|FG004|STARTED|Overall Study||4
3126638|NCT01660230|3851667|FG005|STARTED|Overall Study||2
3126639|NCT01660230|3851668|FG006|STARTED|Overall Study||4
3126640|NCT01660230|3851669|FG007|STARTED|Overall Study||6
3126641|NCT01660230|3851670|FG008|STARTED|Overall Study||6
3126642|NCT01660230|3851671|FG009|STARTED|Overall Study||6
3126643|NCT01660230|3851672|FG010|STARTED|Overall Study||6
3126644|NCT01660230|3851673|FG011|STARTED|Overall Study||14
3126645|NCT01660230|3851662|FG000|COMPLETED|Overall Study||4
3126646|NCT01660230|3851663|FG001|COMPLETED|Overall Study||4
3126647|NCT01660230|3851664|FG002|COMPLETED|Overall Study||4
3126648|NCT01660230|3851665|FG003|COMPLETED|Overall Study||4
3126649|NCT01660230|3851666|FG004|COMPLETED|Overall Study||4
3126650|NCT01660230|3851667|FG005|COMPLETED|Overall Study||2
3126651|NCT01660230|3851668|FG006|COMPLETED|Overall Study||4
3126652|NCT01660230|3851669|FG007|COMPLETED|Overall Study||6
3126653|NCT01660230|3851670|FG008|COMPLETED|Overall Study||6
3126654|NCT01660230|3851671|FG009|COMPLETED|Overall Study||6
3126655|NCT01660230|3851672|FG010|COMPLETED|Overall Study||6
3126656|NCT01660230|3851673|FG011|COMPLETED|Overall Study||14
3126657|NCT01660230|3851662|FG000|NOT COMPLETED|Overall Study||0
3126658|NCT01660230|3851663|FG001|NOT COMPLETED|Overall Study||0
3126659|NCT01660230|3851664|FG002|NOT COMPLETED|Overall Study||0
3126660|NCT01660230|3851665|FG003|NOT COMPLETED|Overall Study||0
3126661|NCT01660230|3851666|FG004|NOT COMPLETED|Overall Study||0
3126662|NCT01660230|3851667|FG005|NOT COMPLETED|Overall Study||0
3126663|NCT01660230|3851668|FG006|NOT COMPLETED|Overall Study||0
3126664|NCT01660230|3851669|FG007|NOT COMPLETED|Overall Study||0
3126665|NCT01660230|3851670|FG008|NOT COMPLETED|Overall Study||0
3126666|NCT01660230|3851671|FG009|NOT COMPLETED|Overall Study||0
3126667|NCT01660230|3851672|FG010|NOT COMPLETED|Overall Study||0
3126668|NCT01660230|3851673|FG011|NOT COMPLETED|Overall Study||0
3126669|NCT01660256|3851703|FG000|STARTED|Overall Study||84
3126670|NCT01660256|3851704|FG001|STARTED|Overall Study||83
3126671|NCT01660256|3851705|FG002|STARTED|Overall Study||42
3126672|NCT01660256|3851703|FG000|COMPLETED|Overall Study||79
3126673|NCT01660256|3851704|FG001|COMPLETED|Overall Study||83
3126674|NCT01660256|3851705|FG002|COMPLETED|Overall Study||38
3126675|NCT01660256|3851703|FG000|NOT COMPLETED|Overall Study||5
3126676|NCT01660256|3851704|FG001|NOT COMPLETED|Overall Study||0
3126677|NCT01660256|3851705|FG002|NOT COMPLETED|Overall Study||4
3126678|NCT01660321|3851713|FG000|STARTED|Overall Study||26
3126679|NCT01660321|3851713|FG000|COMPLETED|Overall Study||26
3126680|NCT01660321|3851713|FG000|NOT COMPLETED|Overall Study||0
3126681|NCT01660334|3851717|FG000|STARTED|Overall Study||13
3126682|NCT01660334|3851717|FG000|COMPLETED|Overall Study||12
3126683|NCT01660334|3851717|FG000|NOT COMPLETED|Overall Study||1
3126684|NCT01660412|3851721|FG000|STARTED|Overall Study||29
3126685|NCT01660412|3851722|FG001|STARTED|Overall Study||31
3126686|NCT01660412|3851721|FG000|Head|Overall Study||1
3126687|NCT01660412|3851722|FG001|Head|Overall Study||4
3126688|NCT01660412|3851721|FG000|Thorax|Overall Study||9
3126689|NCT01660412|3851722|FG001|Thorax|Overall Study||9
3126690|NCT01660412|3851721|FG000|Appendicular Structures|Overall Study||17
3126691|NCT01660412|3851722|FG001|Appendicular Structures|Overall Study||11
3126692|NCT01660412|3851721|FG000|Other|Overall Study||2
3126693|NCT01660412|3851722|FG001|Other|Overall Study||4
3126694|NCT01660412|3851721|FG000|Injection 1|Overall Study||29
3126695|NCT01660412|3851722|FG001|Injection 1|Overall Study||31
3126696|NCT01660412|3851721|FG000|Injection 2|Overall Study||29
3126697|NCT01660412|3851722|FG001|Injection 2|Overall Study||31
3126698|NCT01660412|3851721|FG000|Injection 3|Overall Study||29
3126699|NCT01660412|3851722|FG001|Injection 3|Overall Study||31
3126700|NCT01660412|3851721|FG000|Injection 4|Overall Study||29
3126701|NCT01660412|3851722|FG001|Injection 4|Overall Study||31
3126702|NCT01660412|3851721|FG000|COMPLETED|Overall Study||29
3126703|NCT01660412|3851722|FG001|COMPLETED|Overall Study||28
3126704|NCT01660412|3851721|FG000|NOT COMPLETED|Overall Study||0
3126705|NCT01660412|3851722|FG001|NOT COMPLETED|Overall Study||3
3126706|NCT01660672|3851728|FG000|STARTED|Overall Study||7
3126707|NCT01660672|3851728|FG000|COMPLETED|Overall Study||7
3126708|NCT01660672|3851728|FG000|NOT COMPLETED|Overall Study||0
3126709|NCT01660698|3851735|FG000|STARTED|Overall Study||10
3126710|NCT01660698|3851736|FG001|STARTED|Overall Study||10
3126711|NCT01660698|3851735|FG000|COMPLETED|Overall Study||10
3126712|NCT01660698|3851736|FG001|COMPLETED|Overall Study||10
3126713|NCT01660698|3851735|FG000|NOT COMPLETED|Overall Study||0
3126714|NCT01660698|3851736|FG001|NOT COMPLETED|Overall Study||0
3126715|NCT01660711|3851742|FG000|STARTED|Overall Study||22
3126716|NCT01660711|3851742|FG000|COMPLETED|Overall Study||14
3126717|NCT01660711|3851742|FG000|NOT COMPLETED|Overall Study||8
3126718|NCT01660737|3851746|FG000|STARTED|Overall Study||123
3126719|NCT01660737|3851746|FG000|COMPLETED|Overall Study||123
3126720|NCT01660737|3851746|FG000|NOT COMPLETED|Overall Study||0
3126721|NCT01660763|3851752|FG000|STARTED|Overall Study||315
3126722|NCT01660763|3851753|FG001|STARTED|Overall Study||104
3126723|NCT01660763|3851752|FG000|COMPLETED|Overall Study||215
3126724|NCT01660763|3851753|FG001|COMPLETED|Overall Study||43
3126725|NCT01660763|3851752|FG000|NOT COMPLETED|Overall Study||100
3126726|NCT01660763|3851753|FG001|NOT COMPLETED|Overall Study||61
3126727|NCT01660802|3851761|FG000|STARTED|Overall Study||130
3126728|NCT01660802|3851762|FG001|STARTED|Overall Study||132
3126729|NCT01660802|3851761|FG000|COMPLETED|Overall Study||126
3126730|NCT01660802|3851762|FG001|COMPLETED|Overall Study||121
3126731|NCT01660802|3851761|FG000|NOT COMPLETED|Overall Study||4
3126732|NCT01660802|3851762|FG001|NOT COMPLETED|Overall Study||11
3126733|NCT01660815|3851768|FG000|STARTED|Overall Study||7
3126734|NCT01660815|3851768|FG000|COMPLETED|Overall Study||7
3126735|NCT01660815|3851768|FG000|NOT COMPLETED|Overall Study||0
3126736|NCT01660893|3851776|FG000|STARTED|Overall Study||10
3126737|NCT01660893|3851777|FG001|STARTED|Overall Study||10
3126738|NCT01660893|3851778|FG002|STARTED|Overall Study||6
3126739|NCT01660893|3851776|FG000|COMPLETED|Overall Study||10
3126740|NCT01660893|3851777|FG001|COMPLETED|Overall Study||10
3126741|NCT01660893|3851778|FG002|COMPLETED|Overall Study||6
3126742|NCT01660893|3851776|FG000|NOT COMPLETED|Overall Study||0
3126743|NCT01660893|3851777|FG001|NOT COMPLETED|Overall Study||0
3126744|NCT01660893|3851778|FG002|NOT COMPLETED|Overall Study||0
3126745|NCT01660906|3851786|FG000|STARTED|Overall Study||39
3126746|NCT01660906|3851786|FG000|COMPLETED|Overall Study||36
3126747|NCT01660906|3851786|FG000|NOT COMPLETED|Overall Study||3
3126748|NCT01661062|3851790|FG000|STARTED|Overall Study||23
3126749|NCT01661062|3851790|FG000|COMPLETED|Overall Study||18
3126750|NCT01661062|3851790|FG000|NOT COMPLETED|Overall Study||5
3126751|NCT01661088|3851794|FG000|STARTED|FOLFIRINOX||25
3126752|NCT01661088|3851794|FG000|COMPLETED|FOLFIRINOX||21
3126753|NCT01661088|3851794|FG000|NOT COMPLETED|FOLFIRINOX||4
3126754|NCT01661088|3851794|FG000|STARTED|IMRT With FDR Gemcitabine||21
3126755|NCT01661088|3851794|FG000|COMPLETED|IMRT With FDR Gemcitabine||19
3126756|NCT01661088|3851794|FG000|NOT COMPLETED|IMRT With FDR Gemcitabine||2
3126757|NCT01661114|3851798|FG000|STARTED|Overall Study||39
3126758|NCT01661114|3851798|FG000|COMPLETED|Overall Study||39
3126759|NCT01661114|3851798|FG000|NOT COMPLETED|Overall Study||0
3126760|NCT01661140|3851802|FG000|STARTED|Open-Label Period|All participants entered the study in the initial phase for 24 weeks of open label treatment.|427
3126761|NCT01661140|3851803|FG001|STARTED|Open-Label Period||0
3126762|NCT01661140|3851804|FG002|STARTED|Open-Label Period||0
3126763|NCT01661140|3851802|FG000|COMPLETED|Open-Label Period||351
3126764|NCT01661140|3851803|FG001|COMPLETED|Open-Label Period||0
3126765|NCT01661140|3851804|FG002|COMPLETED|Open-Label Period||0
3126766|NCT01661140|3851802|FG000|NOT COMPLETED|Open-Label Period||76
3126767|NCT01661140|3851803|FG001|NOT COMPLETED|Open-Label Period||0
3126768|NCT01661140|3851804|FG002|NOT COMPLETED|Open-Label Period||0
3126769|NCT01661140|3851802|FG000|STARTED|Double-Blind Period|Those with a good/moderate disease response in the initial phase were randomized to the MTX arms.|0
3126770|NCT01661140|3851803|FG001|STARTED|Double-Blind Period|Only those with a good/moderate disease response in the initial phase were randomized.|136
3126771|NCT01661140|3851804|FG002|STARTED|Double-Blind Period|Only those with a good/moderate disease response in the initial phase were randomized.|136
3126772|NCT01661140|3851802|FG000|COMPLETED|Double-Blind Period||0
3126773|NCT01661140|3851803|FG001|COMPLETED|Double-Blind Period||95
3126774|NCT01661140|3851804|FG002|COMPLETED|Double-Blind Period||86
3126775|NCT01661140|3851802|FG000|NOT COMPLETED|Double-Blind Period||0
3126776|NCT01661140|3851803|FG001|NOT COMPLETED|Double-Blind Period||41
3126777|NCT01661140|3851804|FG002|NOT COMPLETED|Double-Blind Period||50
3126778|NCT01661179|3851812|FG000|STARTED|Overall Study||14
3126779|NCT01661179|3851812|FG000|COMPLETED|Overall Study||8
3126780|NCT01661179|3851812|FG000|NOT COMPLETED|Overall Study||6
3126781|NCT01661205|3851816|FG000|STARTED|Overall Study||26
3126782|NCT01661205|3851816|FG000|COMPLETED|Overall Study||24
3126783|NCT01661205|3851816|FG000|NOT COMPLETED|Overall Study||2
3126784|NCT01661270|3851822|FG000|STARTED|Overall Study||109
3126785|NCT01661270|3851823|FG001|STARTED|Overall Study||223
3126786|NCT01661270|3851822|FG000|Adverse Event|Overall Study|Met end of treatment (EOT) criteria.|26
3126787|NCT01661270|3851823|FG001|Adverse Event|Overall Study|Met EOT criteria|47
3126788|NCT01661270|3851822|FG000|Disease Progression|Overall Study|Met EOT criteria|67
3126789|NCT01661270|3851823|FG001|Disease Progression|Overall Study|Met EOT criteria|118
3126790|NCT01661270|3851822|FG000|Physician Decision|Overall Study|Met EOT criteria|1
3126791|NCT01661270|3851823|FG001|Physician Decision|Overall Study|Met EOT criteria|8
3126792|NCT01661270|3851822|FG000|Participant's Request|Overall Study|Met EOT criteria|15
3126793|NCT01661270|3851823|FG001|Participant's Request|Overall Study|Met EOT criteria|48
3126794|NCT01661270|3851822|FG000|Other Reasons|Overall Study||0
3126795|NCT01661270|3851823|FG001|Other Reasons|Overall Study||2
3126796|NCT01661270|3851822|FG000|COMPLETED|Overall Study|Treatment until disease progression/death, toxicity, consent withdrawal or Investigator's decision.|109
3126797|NCT01661270|3851823|FG001|COMPLETED|Overall Study|Treatment until disease progression/death, toxicity, consent withdrawal or Investigator's decision.|223
3126798|NCT01661270|3851822|FG000|NOT COMPLETED|Overall Study||0
3126799|NCT01661270|3851823|FG001|NOT COMPLETED|Overall Study||0
3136421|NCT01712516|3861557|FG002|STARTED|Overall Study||251
3136422|NCT01712516|3861558|FG003|STARTED|Overall Study||249
3136423|NCT01712516|3861555|FG000|Safety Set|Overall Study||250
3136424|NCT01712516|3861556|FG001|Safety Set|Overall Study||251
3136425|NCT01712516|3861557|FG002|Safety Set|Overall Study||251
3136426|NCT01712516|3861558|FG003|Safety Set|Overall Study||248
3136427|NCT01712516|3861555|FG000|Full Analysis Set|Overall Study||250
3136428|NCT01712516|3861556|FG001|Full Analysis Set|Overall Study||251
3136429|NCT01712516|3861557|FG002|Full Analysis Set|Overall Study||250
3136430|NCT01712516|3861558|FG003|Full Analysis Set|Overall Study||247
3136431|NCT01712516|3861555|FG000|COMPLETED|Overall Study||244
3136432|NCT01712516|3861556|FG001|COMPLETED|Overall Study||241
3136433|NCT01712516|3861557|FG002|COMPLETED|Overall Study||245
3136434|NCT01712516|3861558|FG003|COMPLETED|Overall Study||236
3136435|NCT01712516|3861555|FG000|NOT COMPLETED|Overall Study||6
3136436|NCT01712516|3861556|FG001|NOT COMPLETED|Overall Study||10
3136437|NCT01712516|3861557|FG002|NOT COMPLETED|Overall Study||6
3136438|NCT01712516|3861558|FG003|NOT COMPLETED|Overall Study||13
3136439|NCT01712685|3861568|FG000|STARTED|Overall Study||12
3136440|NCT01712685|3861568|FG000|COMPLETED|Overall Study||11
3136441|NCT01712685|3861568|FG000|NOT COMPLETED|Overall Study||1
3136442|NCT01712711|3861574|FG000|STARTED|Overall Study||20
3136443|NCT01712711|3861575|FG001|STARTED|Overall Study||20
3136444|NCT01712711|3861574|FG000|COMPLETED|Overall Study||20
3136445|NCT01712711|3861575|FG001|COMPLETED|Overall Study||20
3136446|NCT01712711|3861574|FG000|NOT COMPLETED|Overall Study||0
3136447|NCT01712711|3861575|FG001|NOT COMPLETED|Overall Study||0
3136448|NCT01712776|3861583|FG000|STARTED|Overall Study||50
3136449|NCT01712776|3861584|FG001|STARTED|Overall Study||50
3136450|NCT01712776|3861583|FG000|COMPLETED|Overall Study|trial to enroll 50 in each group for total of 100|50
3136451|NCT01712776|3861584|FG001|COMPLETED|Overall Study||50
3136452|NCT01712776|3861583|FG000|NOT COMPLETED|Overall Study||0
3136453|NCT01712776|3861584|FG001|NOT COMPLETED|Overall Study||0
3136454|NCT01712984|3861593|FG000|STARTED|Overall Study||1672
3136455|NCT01712984|3861594|FG001|STARTED|Overall Study||837
3136456|NCT01712984|3861595|FG002|STARTED|Overall Study||846
3136457|NCT01712984|3861593|FG000|COMPLETED|Overall Study||1656
3136458|NCT01712984|3861594|FG001|COMPLETED|Overall Study||821
3136459|NCT01712984|3861595|FG002|COMPLETED|Overall Study||836
3136460|NCT01712984|3861593|FG000|NOT COMPLETED|Overall Study||16
3136461|NCT01712984|3861594|FG001|NOT COMPLETED|Overall Study||16
3136462|NCT01712984|3861595|FG002|NOT COMPLETED|Overall Study||10
3136463|NCT01713036|3861603|FG000|STARTED|Overall Study||6
3136464|NCT01713036|3861603|FG000|COMPLETED|Overall Study||5
3136465|NCT01713036|3861603|FG000|NOT COMPLETED|Overall Study||1
3136466|NCT01713283|3861617|FG000|STARTED|Overall Study||31
3136467|NCT01713283|3861618|FG001|STARTED|Overall Study||29
3126800|NCT01661283|3851830|FG000|STARTED|Overall Study|15 patients enrolled in the first stage; 10 patients enrolled in the second stage|25
3126801|NCT01661283|3851830|FG000|COMPLETED|Overall Study||25
3126802|NCT01661283|3851830|FG000|NOT COMPLETED|Overall Study||0
3126803|NCT01661595|3851838|FG000|STARTED|Phase 1: Week 0-4||5
3126804|NCT01661595|3851839|FG001|STARTED|Phase 1: Week 0-4||4
3126805|NCT01661595|3851840|FG002|STARTED|Phase 1: Week 0-4||5
3126806|NCT01661595|3851841|FG003|STARTED|Phase 1: Week 0-4||4
3126807|NCT01661595|3851838|FG000|COMPLETED|Phase 1: Week 0-4||4
3126808|NCT01661595|3851839|FG001|COMPLETED|Phase 1: Week 0-4||4
3126809|NCT01661595|3851840|FG002|COMPLETED|Phase 1: Week 0-4||5
3126810|NCT01661595|3851841|FG003|COMPLETED|Phase 1: Week 0-4||4
3126811|NCT01661595|3851838|FG000|NOT COMPLETED|Phase 1: Week 0-4||1
3126812|NCT01661595|3851839|FG001|NOT COMPLETED|Phase 1: Week 0-4||0
3126813|NCT01661595|3851840|FG002|NOT COMPLETED|Phase 1: Week 0-4||0
3126814|NCT01661595|3851841|FG003|NOT COMPLETED|Phase 1: Week 0-4||0
3126815|NCT01661595|3851838|FG000|STARTED|Phase 2: Week 5-8.||4
3126816|NCT01661595|3851839|FG001|STARTED|Phase 2: Week 5-8.||4
3126817|NCT01661595|3851840|FG002|STARTED|Phase 2: Week 5-8.||5
3126818|NCT01661595|3851841|FG003|STARTED|Phase 2: Week 5-8.||4
3126819|NCT01661595|3851838|FG000|COMPLETED|Phase 2: Week 5-8.||4
3126820|NCT01661595|3851839|FG001|COMPLETED|Phase 2: Week 5-8.||4
3126821|NCT01661595|3851840|FG002|COMPLETED|Phase 2: Week 5-8.||4
3126822|NCT01661595|3851841|FG003|COMPLETED|Phase 2: Week 5-8.||4
3126823|NCT01661595|3851838|FG000|NOT COMPLETED|Phase 2: Week 5-8.||0
3126824|NCT01661595|3851839|FG001|NOT COMPLETED|Phase 2: Week 5-8.||0
3126825|NCT01661595|3851840|FG002|NOT COMPLETED|Phase 2: Week 5-8.||1
3126826|NCT01661595|3851841|FG003|NOT COMPLETED|Phase 2: Week 5-8.||0
3126827|NCT01661621|3851860|FG000|STARTED|Overall Study||116
3126828|NCT01661621|3851861|FG001|STARTED|Overall Study||279
3126829|NCT01661621|3851860|FG000|COMPLETED|Overall Study||116
3126830|NCT01661621|3851861|FG001|COMPLETED|Overall Study||279
3126831|NCT01661621|3851860|FG000|NOT COMPLETED|Overall Study||0
3126832|NCT01661621|3851861|FG001|NOT COMPLETED|Overall Study||0
3126833|NCT01661686|3851869|FG000|STARTED|Overall Study||49
3126834|NCT01661686|3851870|FG001|STARTED|Overall Study||49
3126835|NCT01661686|3851869|FG000|COMPLETED|Overall Study||47
3126836|NCT01661686|3851870|FG001|COMPLETED|Overall Study||47
3126837|NCT01661686|3851869|FG000|NOT COMPLETED|Overall Study||2
3126838|NCT01661686|3851870|FG001|NOT COMPLETED|Overall Study||2
3126839|NCT01661712|3851878|FG000|STARTED|Overall Study|initial sham stimulation night|18
3126840|NCT01661712|3851879|FG001|STARTED|Overall Study|initial night on transcutaneous electrical stimulation|18
3126841|NCT01661712|3851878|FG000|Washout Period|Overall Study|>Three nights of no stimulation/sham stimulation|18
3126842|NCT01661712|3851879|FG001|Washout Period|Overall Study|>Three nights of no stimulation/sham stimulation|18
3126843|NCT01661712|3851878|FG000|COMPLETED|Overall Study|night on transcutaneous electrical stimulation|18
3126844|NCT01661712|3851879|FG001|COMPLETED|Overall Study|sham stimulation night|18
3126845|NCT01661712|3851878|FG000|NOT COMPLETED|Overall Study||0
3126846|NCT01661712|3851879|FG001|NOT COMPLETED|Overall Study||0
3126847|NCT01661764|3851897|FG000|STARTED|Overall Study||26
3126848|NCT01661764|3851898|FG001|STARTED|Overall Study||25
3126849|NCT01661764|3851899|FG002|STARTED|Overall Study||25
3126850|NCT01661764|3851900|FG003|STARTED|Overall Study||26
3126851|NCT01661764|3851901|FG004|STARTED|Overall Study||19
3126852|NCT01661764|3851902|FG005|STARTED|Overall Study||20
3126853|NCT01661764|3851897|FG000|COMPLETED|Overall Study||24
3126854|NCT01661764|3851898|FG001|COMPLETED|Overall Study||20
3126855|NCT01661764|3851899|FG002|COMPLETED|Overall Study||22
3126856|NCT01661764|3851900|FG003|COMPLETED|Overall Study||24
3126857|NCT01661764|3851901|FG004|COMPLETED|Overall Study||16
3126858|NCT01661764|3851902|FG005|COMPLETED|Overall Study||18
3126859|NCT01661764|3851897|FG000|NOT COMPLETED|Overall Study||2
3126860|NCT01661764|3851898|FG001|NOT COMPLETED|Overall Study||5
3126861|NCT01661764|3851899|FG002|NOT COMPLETED|Overall Study||3
3126862|NCT01661764|3851900|FG003|NOT COMPLETED|Overall Study||2
3126863|NCT01661764|3851901|FG004|NOT COMPLETED|Overall Study||3
3126864|NCT01661764|3851902|FG005|NOT COMPLETED|Overall Study||2
3126865|NCT01661790|3851918|FG000|STARTED|Overall Study||36
3126866|NCT01661790|3851919|FG001|STARTED|Overall Study||36
3126867|NCT01661790|3851918|FG000|COMPLETED|Overall Study||36
3126868|NCT01661790|3851919|FG001|COMPLETED|Overall Study||34
3126869|NCT01661790|3851918|FG000|NOT COMPLETED|Overall Study||0
3126870|NCT01661790|3851919|FG001|NOT COMPLETED|Overall Study||2
3126871|NCT01661881|3851925|FG000|STARTED|Overall Study||23
3126872|NCT01661881|3851925|FG000|COMPLETED|Overall Study||22
3126873|NCT01661881|3851925|FG000|NOT COMPLETED|Overall Study||1
3126874|NCT01661933|3851929|FG000|STARTED|Gluten Micro-challenge|All 12 enrolled completed hookworm inoculation and gluten micro-challenge.|12
3126875|NCT01661933|3851929|FG000|COMPLETED|Gluten Micro-challenge|Two gluten intolerant participants did not proceed to the low-dose challenge.|12
3126876|NCT01661933|3851929|FG000|NOT COMPLETED|Gluten Micro-challenge||0
3126877|NCT01661933|3851929|FG000|STARTED|Low-dose Gluten Challenge|One was symptomatically intolerant to gluten >25 mg. One had active CeD pre- & post-micro-challenge|12
3126878|NCT01661933|3851929|FG000|COMPLETED|Low-dose Gluten Challenge|Two had challenge interrupted for 1-2 weeks. All completed challenge.|10
3126879|NCT01661933|3851929|FG000|NOT COMPLETED|Low-dose Gluten Challenge||2
3126880|NCT01661933|3851929|FG000|STARTED|High-dose Gluten Challenge|2 of 10 available after post-GC-1g did not enroll for reasons unrelated to gluten.|10
3126881|NCT01661933|3851929|FG000|COMPLETED|High-dose Gluten Challenge||8
3126882|NCT01661933|3851929|FG000|NOT COMPLETED|High-dose Gluten Challenge||2
3126883|NCT01661946|3851937|FG000|STARTED|Overall Study||5
3126884|NCT01661946|3851938|FG001|STARTED|Overall Study||5
3126885|NCT01661946|3851937|FG000|COMPLETED|Overall Study||5
3126886|NCT01661946|3851938|FG001|COMPLETED|Overall Study||5
3126887|NCT01661946|3851937|FG000|NOT COMPLETED|Overall Study||0
3126888|NCT01661946|3851938|FG001|NOT COMPLETED|Overall Study||0
3126889|NCT01661972|3851946|FG000|STARTED|Overall Study||13
3126890|NCT01661972|3851947|FG001|STARTED|Overall Study||50
3126891|NCT01661972|3851946|FG000|COMPLETED|Overall Study||11
3126892|NCT01661972|3851947|FG001|COMPLETED|Overall Study||46
3126893|NCT01661972|3851946|FG000|NOT COMPLETED|Overall Study||2
3126894|NCT01661972|3851947|FG001|NOT COMPLETED|Overall Study||4
3126895|NCT01662024|3851955|FG000|STARTED|Overall Study||20
3126896|NCT01662024|3851955|FG000|COMPLETED|Overall Study||15
3126897|NCT01662024|3851955|FG000|NOT COMPLETED|Overall Study||5
3126898|NCT01662063|3851964|FG000|STARTED|Overall Study||44
3126899|NCT01662063|3851965|FG001|STARTED|Overall Study||173
3126900|NCT01662063|3851966|FG002|STARTED|Overall Study||1
3126901|NCT01662063|3851964|FG000|COMPLETED|Overall Study||39
3126902|NCT01662063|3851965|FG001|COMPLETED|Overall Study||144
3126903|NCT01662063|3851966|FG002|COMPLETED|Overall Study||0
3126904|NCT01662063|3851964|FG000|NOT COMPLETED|Overall Study||5
3126905|NCT01662063|3851965|FG001|NOT COMPLETED|Overall Study||29
3126906|NCT01662063|3851966|FG002|NOT COMPLETED|Overall Study||1
3126907|NCT01662115|3851977|FG000|STARTED|Overall Study||2
3126908|NCT01662115|3851978|FG001|STARTED|Overall Study||2
3126909|NCT01662115|3851979|FG002|STARTED|Overall Study||0
3126910|NCT01662115|3851977|FG000|COMPLETED|Overall Study||2
3126911|NCT01662115|3851978|FG001|COMPLETED|Overall Study||2
3126912|NCT01662115|3851979|FG002|COMPLETED|Overall Study||0
3126913|NCT01662115|3851977|FG000|NOT COMPLETED|Overall Study||0
3126914|NCT01662115|3851978|FG001|NOT COMPLETED|Overall Study||0
3126915|NCT01662115|3851979|FG002|NOT COMPLETED|Overall Study||0
3126916|NCT01662297|3851989|FG000|STARTED|Overall Study||0
3126917|NCT01662297|3851990|FG001|STARTED|Overall Study||1
3126918|NCT01662297|3851989|FG000|COMPLETED|Overall Study||0
3126919|NCT01662297|3851990|FG001|COMPLETED|Overall Study||1
3126920|NCT01662297|3851989|FG000|NOT COMPLETED|Overall Study||0
3126921|NCT01662297|3851990|FG001|NOT COMPLETED|Overall Study||0
3126922|NCT01662310|3851996|FG000|STARTED|Run-In or Stabilization Phase||201
3126923|NCT01662310|3851997|FG001|STARTED|Run-In or Stabilization Phase||0
3126924|NCT01662310|3851998|FG002|STARTED|Run-In or Stabilization Phase||0
3126925|NCT01662310|3851999|FG003|STARTED|Run-In or Stabilization Phase||0
3126926|NCT01662310|3852000|FG004|STARTED|Run-In or Stabilization Phase||0
3126927|NCT01662310|3851996|FG000|COMPLETED|Run-In or Stabilization Phase||136
3126928|NCT01662310|3851997|FG001|COMPLETED|Run-In or Stabilization Phase||0
3126929|NCT01662310|3851998|FG002|COMPLETED|Run-In or Stabilization Phase||0
3126930|NCT01662310|3851999|FG003|COMPLETED|Run-In or Stabilization Phase||0
3126931|NCT01662310|3852000|FG004|COMPLETED|Run-In or Stabilization Phase||0
3126932|NCT01662310|3851996|FG000|NOT COMPLETED|Run-In or Stabilization Phase||65
3126933|NCT01662310|3851997|FG001|NOT COMPLETED|Run-In or Stabilization Phase||0
3126934|NCT01662310|3851998|FG002|NOT COMPLETED|Run-In or Stabilization Phase||0
3126935|NCT01662310|3851999|FG003|NOT COMPLETED|Run-In or Stabilization Phase||0
3126936|NCT01662310|3852000|FG004|NOT COMPLETED|Run-In or Stabilization Phase||0
3126937|NCT01662310|3851996|FG000|STARTED|Double-Blind Phase||0
3126938|NCT01662310|3851997|FG001|STARTED|Double-Blind Phase||65
3126939|NCT01662310|3851998|FG002|STARTED|Double-Blind Phase||71
3126940|NCT01662310|3851999|FG003|STARTED|Double-Blind Phase||0
3126941|NCT01662310|3852000|FG004|STARTED|Double-Blind Phase||0
3126942|NCT01662310|3851996|FG000|Treated|Double-Blind Phase||0
3126943|NCT01662310|3851997|FG001|Treated|Double-Blind Phase||64
3126944|NCT01662310|3851998|FG002|Treated|Double-Blind Phase||71
3126945|NCT01662310|3851999|FG003|Treated|Double-Blind Phase||0
3126946|NCT01662310|3852000|FG004|Treated|Double-Blind Phase||0
3126947|NCT01662310|3851996|FG000|COMPLETED|Double-Blind Phase||0
3126948|NCT01662310|3851997|FG001|COMPLETED|Double-Blind Phase||50
3126949|NCT01662310|3851998|FG002|COMPLETED|Double-Blind Phase||66
3126950|NCT01662310|3851999|FG003|COMPLETED|Double-Blind Phase||0
3126951|NCT01662310|3852000|FG004|COMPLETED|Double-Blind Phase||0
3126952|NCT01662310|3851996|FG000|NOT COMPLETED|Double-Blind Phase||0
3126953|NCT01662310|3851997|FG001|NOT COMPLETED|Double-Blind Phase||15
3126954|NCT01662310|3851998|FG002|NOT COMPLETED|Double-Blind Phase||5
3126955|NCT01662310|3851999|FG003|NOT COMPLETED|Double-Blind Phase||0
3126956|NCT01662310|3852000|FG004|NOT COMPLETED|Double-Blind Phase||0
3126957|NCT01662310|3851996|FG000|STARTED|Open-Label Extension Phase||0
3126958|NCT01662310|3851997|FG001|STARTED|Open-Label Extension Phase||0
3126959|NCT01662310|3851998|FG002|STARTED|Open-Label Extension Phase||0
3126960|NCT01662310|3851999|FG003|STARTED|Open-Label Extension Phase||47
3126961|NCT01662310|3852000|FG004|STARTED|Open-Label Extension Phase||59
3126962|NCT01662310|3851996|FG000|COMPLETED|Open-Label Extension Phase||0
3126963|NCT01662310|3851997|FG001|COMPLETED|Open-Label Extension Phase||0
3126964|NCT01662310|3851998|FG002|COMPLETED|Open-Label Extension Phase||0
3126965|NCT01662310|3851999|FG003|COMPLETED|Open-Label Extension Phase||36
3126966|NCT01662310|3852000|FG004|COMPLETED|Open-Label Extension Phase||49
3126967|NCT01662310|3851996|FG000|NOT COMPLETED|Open-Label Extension Phase||0
3126968|NCT01662310|3851997|FG001|NOT COMPLETED|Open-Label Extension Phase||0
3126969|NCT01662310|3851998|FG002|NOT COMPLETED|Open-Label Extension Phase||0
3126970|NCT01662310|3851999|FG003|NOT COMPLETED|Open-Label Extension Phase||11
3126971|NCT01662310|3852000|FG004|NOT COMPLETED|Open-Label Extension Phase||10
3126972|NCT01662336|3852012|FG000|STARTED|Overall Study||173
3126973|NCT01662336|3852012|FG000|Completed Month 6 Visit|Overall Study||142
3126974|NCT01662336|3852012|FG000|Completed Month 12 Visit|Overall Study||109
3126975|NCT01662336|3852012|FG000|COMPLETED|Overall Study||107
3126976|NCT01662336|3852012|FG000|NOT COMPLETED|Overall Study||66
3126977|NCT01662362|3852021|FG000|STARTED|Overall Study||63
3126978|NCT01662362|3852021|FG000|COMPLETED|Overall Study||25
3126979|NCT01662362|3852021|FG000|NOT COMPLETED|Overall Study||38
3126980|NCT01662440|3852030|FG000|STARTED|Overall Study||167
3126981|NCT01662440|3852031|FG001|STARTED|Overall Study||217
3126982|NCT01662440|3852032|FG002|STARTED|Overall Study||221
3126983|NCT01662440|3852033|FG003|STARTED|Overall Study||56
3126984|NCT01662440|3852030|FG000|COMPLETED|Overall Study||158
3126985|NCT01662440|3852031|FG001|COMPLETED|Overall Study||211
3126986|NCT01662440|3852032|FG002|COMPLETED|Overall Study||215
3126987|NCT01662440|3852033|FG003|COMPLETED|Overall Study||52
3126988|NCT01662440|3852030|FG000|NOT COMPLETED|Overall Study||9
3126989|NCT01662440|3852031|FG001|NOT COMPLETED|Overall Study||6
3126990|NCT01662440|3852032|FG002|NOT COMPLETED|Overall Study||6
3126991|NCT01662440|3852033|FG003|NOT COMPLETED|Overall Study||4
3126992|NCT01662492|3852056|FG000|STARTED|Overall Study||45
3126993|NCT01662492|3852057|FG001|STARTED|Overall Study||43
3126994|NCT01662492|3852058|FG002|STARTED|Overall Study||37
3126995|NCT01662492|3852056|FG000|COMPLETED|Overall Study||42
3126996|NCT01662492|3852057|FG001|COMPLETED|Overall Study||42
3126997|NCT01662492|3852058|FG002|COMPLETED|Overall Study||31
3126998|NCT01662492|3852056|FG000|NOT COMPLETED|Overall Study||3
3126999|NCT01662492|3852057|FG001|NOT COMPLETED|Overall Study||1
3127000|NCT01662492|3852058|FG002|NOT COMPLETED|Overall Study||6
3127001|NCT01662505|3852069|FG000|STARTED|Overall Study||7
3127002|NCT01662505|3852070|FG001|STARTED|Overall Study||4
3127003|NCT01662505|3852071|FG002|STARTED|Overall Study||8
3127004|NCT01662505|3852069|FG000|COMPLETED|Overall Study||0
3127005|NCT01662505|3852070|FG001|COMPLETED|Overall Study||0
3127006|NCT01662505|3852071|FG002|COMPLETED|Overall Study||0
3127007|NCT01662505|3852069|FG000|NOT COMPLETED|Overall Study||7
3127008|NCT01662505|3852070|FG001|NOT COMPLETED|Overall Study||4
3127009|NCT01662505|3852071|FG002|NOT COMPLETED|Overall Study||8
3127010|NCT01662531|3852082|FG000|STARTED|Overall Study||27
3127011|NCT01662531|3852082|FG000|COMPLETED|Overall Study||27
3127012|NCT01662531|3852082|FG000|NOT COMPLETED|Overall Study||0
3127013|NCT01662583|3852091|FG000|STARTED|Overall Study||216
3127014|NCT01662583|3852092|FG001|STARTED|Overall Study||225
3127015|NCT01662583|3852093|FG002|STARTED|Overall Study||219
3127016|NCT01662583|3852091|FG000|COMPLETED|Overall Study||216
3127017|NCT01662583|3852092|FG001|COMPLETED|Overall Study||225
3127018|NCT01662583|3852093|FG002|COMPLETED|Overall Study||219
3127019|NCT01662583|3852091|FG000|NOT COMPLETED|Overall Study||0
3127020|NCT01662583|3852092|FG001|NOT COMPLETED|Overall Study||0
3127021|NCT01662583|3852093|FG002|NOT COMPLETED|Overall Study||0
3127022|NCT01662635|3852101|FG000|STARTED|Overall Study||230
3127023|NCT01662635|3852101|FG000|COMPLETED|Overall Study||200
3127024|NCT01662635|3852101|FG000|NOT COMPLETED|Overall Study||30
3127025|NCT01662648|3852109|FG000|STARTED|Overall Study||520
3127026|NCT01662648|3852110|FG001|STARTED|Overall Study||597
3127027|NCT01662648|3852109|FG000|COMPLETED|Overall Study||373
3127028|NCT01662648|3852110|FG001|COMPLETED|Overall Study||419
3127029|NCT01662648|3852109|FG000|NOT COMPLETED|Overall Study||147
3127030|NCT01662648|3852110|FG001|NOT COMPLETED|Overall Study||178
3127031|NCT01662752|3852116|FG000|STARTED|Overall Study||30
3127032|NCT01662752|3852116|FG000|COMPLETED|Overall Study||30
3127033|NCT01662752|3852116|FG000|NOT COMPLETED|Overall Study||0
3127034|NCT01662765|3852122|FG000|STARTED|Overall Study||42
3127035|NCT01662765|3852123|FG001|STARTED|Overall Study||42
3127036|NCT01662765|3852122|FG000|COMPLETED|Overall Study||41
3127037|NCT01662765|3852123|FG001|COMPLETED|Overall Study||40
3127038|NCT01662765|3852122|FG000|NOT COMPLETED|Overall Study||1
3127039|NCT01662765|3852123|FG001|NOT COMPLETED|Overall Study||2
3127040|NCT01662778|3852134|FG000|STARTED|Period 1||6
3127041|NCT01662778|3852135|FG001|STARTED|Period 1||5
3127042|NCT01662778|3852136|FG002|STARTED|Period 1||6
3127043|NCT01662778|3852137|FG003|STARTED|Period 1||4
3127044|NCT01662778|3852134|FG000|COMPLETED|Period 1||6
3127045|NCT01662778|3852135|FG001|COMPLETED|Period 1||5
3127046|NCT01662778|3852136|FG002|COMPLETED|Period 1||6
3127047|NCT01662778|3852137|FG003|COMPLETED|Period 1||4
3127048|NCT01662778|3852134|FG000|NOT COMPLETED|Period 1||0
3127049|NCT01662778|3852135|FG001|NOT COMPLETED|Period 1||0
3127050|NCT01662778|3852136|FG002|NOT COMPLETED|Period 1||0
3127051|NCT01662778|3852137|FG003|NOT COMPLETED|Period 1||0
3127052|NCT01662778|3852134|FG000|STARTED|Period 2||6
3127053|NCT01662778|3852135|FG001|STARTED|Period 2||5
3127054|NCT01662778|3852136|FG002|STARTED|Period 2||6
3127055|NCT01662778|3852137|FG003|STARTED|Period 2||4
3127056|NCT01662778|3852134|FG000|COMPLETED|Period 2||6
3127057|NCT01662778|3852135|FG001|COMPLETED|Period 2||5
3127058|NCT01662778|3852136|FG002|COMPLETED|Period 2||6
3127059|NCT01662778|3852137|FG003|COMPLETED|Period 2||4
3127060|NCT01662778|3852134|FG000|NOT COMPLETED|Period 2||0
3127061|NCT01662778|3852135|FG001|NOT COMPLETED|Period 2||0
3127062|NCT01662778|3852136|FG002|NOT COMPLETED|Period 2||0
3127063|NCT01662778|3852137|FG003|NOT COMPLETED|Period 2||0
3127064|NCT01662778|3852134|FG000|STARTED|Period 3||6
3127065|NCT01662778|3852135|FG001|STARTED|Period 3||5
3127066|NCT01662778|3852136|FG002|STARTED|Period 3||6
3127067|NCT01662778|3852137|FG003|STARTED|Period 3||4
3127068|NCT01662778|3852134|FG000|COMPLETED|Period 3||6
3127069|NCT01662778|3852135|FG001|COMPLETED|Period 3||5
3127070|NCT01662778|3852136|FG002|COMPLETED|Period 3||6
3127071|NCT01662778|3852137|FG003|COMPLETED|Period 3||4
3127072|NCT01662778|3852134|FG000|NOT COMPLETED|Period 3||0
3127073|NCT01662778|3852135|FG001|NOT COMPLETED|Period 3||0
3127074|NCT01662778|3852136|FG002|NOT COMPLETED|Period 3||0
3127075|NCT01662778|3852137|FG003|NOT COMPLETED|Period 3||0
3127076|NCT01662778|3852134|FG000|STARTED|Period 4||6
3127077|NCT01662778|3852135|FG001|STARTED|Period 4||5
3127078|NCT01662778|3852136|FG002|STARTED|Period 4||6
3127079|NCT01662778|3852137|FG003|STARTED|Period 4||4
3127080|NCT01662778|3852134|FG000|COMPLETED|Period 4||6
3127081|NCT01662778|3852135|FG001|COMPLETED|Period 4||5
3127082|NCT01662778|3852136|FG002|COMPLETED|Period 4||6
3127083|NCT01662778|3852137|FG003|COMPLETED|Period 4||4
3127084|NCT01662778|3852134|FG000|NOT COMPLETED|Period 4||0
3127085|NCT01662778|3852135|FG001|NOT COMPLETED|Period 4||0
3127086|NCT01662778|3852136|FG002|NOT COMPLETED|Period 4||0
3127087|NCT01662778|3852137|FG003|NOT COMPLETED|Period 4||0
3127088|NCT01662791|3852153|FG000|STARTED|Part 1 - Observational||8
3127089|NCT01662791|3852154|FG001|STARTED|Part 1 - Observational||41
3127090|NCT01662791|3852153|FG000|COMPLETED|Part 1 - Observational||8
3127091|NCT01662791|3852154|FG001|COMPLETED|Part 1 - Observational||41
3127092|NCT01662791|3852153|FG000|NOT COMPLETED|Part 1 - Observational||0
3127093|NCT01662791|3852154|FG001|NOT COMPLETED|Part 1 - Observational||0
3127094|NCT01662791|3852153|FG000|STARTED|Part 2 - Interventional||8
3127095|NCT01662791|3852154|FG001|STARTED|Part 2 - Interventional|The Control Group did not take part in the second part of the study.|0
3127096|NCT01662791|3852153|FG000|COMPLETED|Part 2 - Interventional||8
3127097|NCT01662791|3852154|FG001|COMPLETED|Part 2 - Interventional||0
3127098|NCT01662791|3852153|FG000|NOT COMPLETED|Part 2 - Interventional||0
3127099|NCT01662791|3852154|FG001|NOT COMPLETED|Part 2 - Interventional||0
3127100|NCT01662856|3852162|FG000|STARTED|Part I + Part II (Overall Study)||168
3127101|NCT01662856|3852163|FG001|STARTED|Part I + Part II (Overall Study)||57
3127102|NCT01662856|3852162|FG000|Completed Study up to Week 6|Part I + Part II (Overall Study)||164
3127103|NCT01662856|3852163|FG001|Completed Study up to Week 6|Part I + Part II (Overall Study)||56
3127104|NCT01662856|3852162|FG000|COMPLETED|Part I + Part II (Overall Study)|Completed Virology follow-up visit at Month 3 or Month 6|152
3127105|NCT01662856|3852163|FG001|COMPLETED|Part I + Part II (Overall Study)|Completed Virology follow-up visit at Month 3 or Month 6|55
3127106|NCT01662856|3852162|FG000|NOT COMPLETED|Part I + Part II (Overall Study)||16
3127107|NCT01662856|3852163|FG001|NOT COMPLETED|Part I + Part II (Overall Study)||2
3127108|NCT01662856|3852162|FG000|STARTED|Primary Part II||109
3127109|NCT01662856|3852163|FG001|STARTED|Primary Part II||57
3127110|NCT01662856|3852162|FG000|Completed Study up to Week 6|Primary Part II||106
3127111|NCT01662856|3852163|FG001|Completed Study up to Week 6|Primary Part II||56
3127112|NCT01662856|3852162|FG000|COMPLETED|Primary Part II|Completed Virology follow-up visit at Month 3 or Month 6|99
3127113|NCT01662856|3852163|FG001|COMPLETED|Primary Part II|Completed Virology follow-up visit at Month 3 or Month 6|55
3127114|NCT01662856|3852162|FG000|NOT COMPLETED|Primary Part II||10
3127115|NCT01662856|3852163|FG001|NOT COMPLETED|Primary Part II||2
3127116|NCT01662882|3852172|FG000|STARTED|Overall Study||15
3127117|NCT01662882|3852173|FG001|STARTED|Overall Study||18
3127118|NCT01662882|3852174|FG002|STARTED|Overall Study||15
3127119|NCT01662882|3852172|FG000|COMPLETED|Overall Study||15
3127120|NCT01662882|3852173|FG001|COMPLETED|Overall Study||18
3127121|NCT01662882|3852174|FG002|COMPLETED|Overall Study||15
3127122|NCT01662882|3852172|FG000|NOT COMPLETED|Overall Study||0
3127123|NCT01662882|3852173|FG001|NOT COMPLETED|Overall Study||0
3127124|NCT01662882|3852174|FG002|NOT COMPLETED|Overall Study||0
3127125|NCT01662895|3852184|FG000|STARTED|Overall Study||21
3127126|NCT01662895|3852185|FG001|STARTED|Overall Study||21
3127127|NCT01662895|3852184|FG000|Initiated Study Drug|Overall Study||21
3127128|NCT01662895|3852185|FG001|Initiated Study Drug|Overall Study||21
3127129|NCT01662895|3852184|FG000|COMPLETED|Overall Study||21
3127130|NCT01662895|3852185|FG001|COMPLETED|Overall Study||20
3127131|NCT01662895|3852184|FG000|NOT COMPLETED|Overall Study||0
3127132|NCT01662895|3852185|FG001|NOT COMPLETED|Overall Study||1
3127133|NCT01662908|3852193|FG000|STARTED|Overall Study||56
3127134|NCT01662908|3852194|FG001|STARTED|Overall Study||28
3127135|NCT01662908|3852193|FG000|COMPLETED|Overall Study||50
3127136|NCT01662908|3852194|FG001|COMPLETED|Overall Study||23
3127137|NCT01662908|3852193|FG000|NOT COMPLETED|Overall Study||6
3127138|NCT01662908|3852194|FG001|NOT COMPLETED|Overall Study||5
3127139|NCT01662960|3852204|FG000|STARTED|End of 4 Week Treatment Period||25
3127140|NCT01662960|3852205|FG001|STARTED|End of 4 Week Treatment Period||23
3127141|NCT01662960|3852206|FG002|STARTED|End of 4 Week Treatment Period||9
3127142|NCT01662960|3852207|FG003|STARTED|End of 4 Week Treatment Period||15
3127143|NCT01662960|3852204|FG000|COMPLETED|End of 4 Week Treatment Period||24
3127144|NCT01662960|3852205|FG001|COMPLETED|End of 4 Week Treatment Period||19
3127145|NCT01662960|3852206|FG002|COMPLETED|End of 4 Week Treatment Period||8
3127146|NCT01662960|3852207|FG003|COMPLETED|End of 4 Week Treatment Period||15
3127147|NCT01662960|3852204|FG000|NOT COMPLETED|End of 4 Week Treatment Period||1
3127148|NCT01662960|3852205|FG001|NOT COMPLETED|End of 4 Week Treatment Period||4
3127149|NCT01662960|3852206|FG002|NOT COMPLETED|End of 4 Week Treatment Period||1
3127150|NCT01662960|3852207|FG003|NOT COMPLETED|End of 4 Week Treatment Period||0
3127151|NCT01662960|3852204|FG000|STARTED|3 Month Follow-up||24
3127152|NCT01662960|3852205|FG001|STARTED|3 Month Follow-up||19
3127153|NCT01662960|3852206|FG002|STARTED|3 Month Follow-up||8
3127154|NCT01662960|3852207|FG003|STARTED|3 Month Follow-up||15
3127155|NCT01662960|3852204|FG000|COMPLETED|3 Month Follow-up||21
3127156|NCT01662960|3852205|FG001|COMPLETED|3 Month Follow-up||16
3127157|NCT01662960|3852206|FG002|COMPLETED|3 Month Follow-up||5
3127158|NCT01662960|3852207|FG003|COMPLETED|3 Month Follow-up||13
3127159|NCT01662960|3852204|FG000|NOT COMPLETED|3 Month Follow-up||3
3127160|NCT01662960|3852205|FG001|NOT COMPLETED|3 Month Follow-up||3
3127161|NCT01662960|3852206|FG002|NOT COMPLETED|3 Month Follow-up||3
3127162|NCT01662960|3852207|FG003|NOT COMPLETED|3 Month Follow-up||2
3127163|NCT01662986|3852219|FG000|STARTED|Overall Study||40
3127164|NCT01662986|3852220|FG001|STARTED|Overall Study||39
3127165|NCT01662986|3852219|FG000|COMPLETED|Overall Study||22
3127166|NCT01662986|3852220|FG001|COMPLETED|Overall Study||26
3127167|NCT01662986|3852219|FG000|NOT COMPLETED|Overall Study||18
3127168|NCT01662986|3852220|FG001|NOT COMPLETED|Overall Study||13
3127169|NCT01662999|3852232|FG000|STARTED|Period 1||7
3127170|NCT01662999|3852233|FG001|STARTED|Period 1||7
3127171|NCT01662999|3852234|FG002|STARTED|Period 1||7
3127172|NCT01662999|3852235|FG003|STARTED|Period 1||7
3127173|NCT01662999|3852236|FG004|STARTED|Period 1||7
3127174|NCT01662999|3852237|FG005|STARTED|Period 1||7
3127175|NCT01662999|3852232|FG000|COMPLETED|Period 1||7
3127176|NCT01662999|3852233|FG001|COMPLETED|Period 1||7
3127177|NCT01662999|3852234|FG002|COMPLETED|Period 1||7
3127178|NCT01662999|3852235|FG003|COMPLETED|Period 1||7
3127179|NCT01662999|3852236|FG004|COMPLETED|Period 1||7
3127180|NCT01662999|3852237|FG005|COMPLETED|Period 1||7
3127181|NCT01662999|3852232|FG000|NOT COMPLETED|Period 1||0
3127182|NCT01662999|3852233|FG001|NOT COMPLETED|Period 1||0
3127183|NCT01662999|3852234|FG002|NOT COMPLETED|Period 1||0
3127184|NCT01662999|3852235|FG003|NOT COMPLETED|Period 1||0
3127185|NCT01662999|3852236|FG004|NOT COMPLETED|Period 1||0
3127186|NCT01662999|3852237|FG005|NOT COMPLETED|Period 1||0
3127187|NCT01662999|3852232|FG000|STARTED|Period 2||7
3127188|NCT01662999|3852233|FG001|STARTED|Period 2||7
3127189|NCT01662999|3852234|FG002|STARTED|Period 2||7
3127190|NCT01662999|3852235|FG003|STARTED|Period 2||7
3127191|NCT01662999|3852236|FG004|STARTED|Period 2||7
3127192|NCT01662999|3852237|FG005|STARTED|Period 2||7
3127193|NCT01662999|3852232|FG000|COMPLETED|Period 2||7
3127194|NCT01662999|3852233|FG001|COMPLETED|Period 2||7
3127195|NCT01662999|3852234|FG002|COMPLETED|Period 2||7
3127196|NCT01662999|3852235|FG003|COMPLETED|Period 2||7
3127197|NCT01662999|3852236|FG004|COMPLETED|Period 2||7
3127198|NCT01662999|3852237|FG005|COMPLETED|Period 2||7
3127199|NCT01662999|3852232|FG000|NOT COMPLETED|Period 2||0
3127200|NCT01662999|3852233|FG001|NOT COMPLETED|Period 2||0
3127201|NCT01662999|3852234|FG002|NOT COMPLETED|Period 2||0
3127202|NCT01662999|3852235|FG003|NOT COMPLETED|Period 2||0
3127203|NCT01662999|3852236|FG004|NOT COMPLETED|Period 2||0
3127204|NCT01662999|3852237|FG005|NOT COMPLETED|Period 2||0
3127205|NCT01662999|3852232|FG000|STARTED|Period 3||7
3127206|NCT01662999|3852233|FG001|STARTED|Period 3||7
3127207|NCT01662999|3852234|FG002|STARTED|Period 3||7
3127208|NCT01662999|3852235|FG003|STARTED|Period 3||7
3127209|NCT01662999|3852236|FG004|STARTED|Period 3||7
3127210|NCT01662999|3852237|FG005|STARTED|Period 3||7
3127211|NCT01662999|3852232|FG000|COMPLETED|Period 3||7
3127212|NCT01662999|3852233|FG001|COMPLETED|Period 3|Participant did not provide 36, 48, or 60 hour samples in this period for Treatment B.|6
3127213|NCT01662999|3852234|FG002|COMPLETED|Period 3||7
3127214|NCT01662999|3852235|FG003|COMPLETED|Period 3||7
3127215|NCT01662999|3852236|FG004|COMPLETED|Period 3||7
3127216|NCT01662999|3852237|FG005|COMPLETED|Period 3||7
3127217|NCT01662999|3852232|FG000|NOT COMPLETED|Period 3||0
3127218|NCT01662999|3852233|FG001|NOT COMPLETED|Period 3||1
3127219|NCT01662999|3852234|FG002|NOT COMPLETED|Period 3||0
3127220|NCT01662999|3852235|FG003|NOT COMPLETED|Period 3||0
3127221|NCT01662999|3852236|FG004|NOT COMPLETED|Period 3||0
3127222|NCT01662999|3852237|FG005|NOT COMPLETED|Period 3||0
3127223|NCT01663012|3852267|FG000|STARTED|Overall Study||20
3127224|NCT01663012|3852267|FG000|COMPLETED|Overall Study||20
3127225|NCT01663012|3852267|FG000|NOT COMPLETED|Overall Study||0
3127226|NCT01663103|3852273|FG000|STARTED|Overall Study||21
3127227|NCT01663103|3852274|FG001|STARTED|Overall Study||21
3127228|NCT01663103|3852273|FG000|COMPLETED|Overall Study||18
3127229|NCT01663103|3852274|FG001|COMPLETED|Overall Study||19
3127230|NCT01663103|3852273|FG000|NOT COMPLETED|Overall Study||3
3127231|NCT01663103|3852274|FG001|NOT COMPLETED|Overall Study||2
3127232|NCT01663233|3852286|FG000|STARTED|Overall Study||130
3127233|NCT01663233|3852287|FG001|STARTED|Overall Study||136
3127234|NCT01663233|3852286|FG000|COMPLETED|Overall Study||126
3127235|NCT01663233|3852287|FG001|COMPLETED|Overall Study||129
3127236|NCT01663233|3852286|FG000|NOT COMPLETED|Overall Study||4
3127237|NCT01663233|3852287|FG001|NOT COMPLETED|Overall Study||7
3127238|NCT01663259|3852293|FG000|STARTED|Overall Study||42
3127239|NCT01663259|3852293|FG000|COMPLETED|Overall Study||42
3127240|NCT01663259|3852293|FG000|NOT COMPLETED|Overall Study||0
3127241|NCT01663272|3852297|FG000|STARTED|Overall Study||5
3127242|NCT01663272|3852298|FG001|STARTED|Overall Study||6
3127243|NCT01663272|3852299|FG002|STARTED|Overall Study||1
3127244|NCT01663272|3852297|FG000|COMPLETED|Overall Study||5
3127245|NCT01663272|3852298|FG001|COMPLETED|Overall Study||6
3127246|NCT01663272|3852299|FG002|COMPLETED|Overall Study||1
3127247|NCT01663272|3852297|FG000|NOT COMPLETED|Overall Study||0
3127248|NCT01663272|3852298|FG001|NOT COMPLETED|Overall Study||0
3127249|NCT01663272|3852299|FG002|NOT COMPLETED|Overall Study||0
3127250|NCT01663363|3852303|FG000|STARTED|Overall Study|334 Eyes were treated among 170 participants|170
3127251|NCT01663363|3852303|FG000|COMPLETED|Overall Study|334 Eyes were treated among 170 participants|170
3127252|NCT01663363|3852303|FG000|NOT COMPLETED|Overall Study||0
3127253|NCT01663402|3852309|FG000|STARTED|Overall Study||9462
3127254|NCT01663402|3852310|FG001|STARTED|Overall Study||9462
3127255|NCT01663402|3852309|FG000|Treated|Overall Study||9443
3127256|NCT01663402|3852310|FG001|Treated|Overall Study||9451
3127257|NCT01663402|3852309|FG000|COMPLETED|Overall Study||7947
3127258|NCT01663402|3852310|FG001|COMPLETED|Overall Study||7378
3127259|NCT01663402|3852309|FG000|NOT COMPLETED|Overall Study||1515
3127260|NCT01663402|3852310|FG001|NOT COMPLETED|Overall Study||2084
3127261|NCT01663506|3852316|FG000|STARTED|Overall Study||23
3127262|NCT01663506|3852316|FG000|COMPLETED|Overall Study||15
3127263|NCT01663506|3852316|FG000|NOT COMPLETED|Overall Study||8
3127264|NCT01663532|3852322|FG000|STARTED|Overall Study||168
3127265|NCT01663532|3852323|FG001|STARTED|Overall Study||172
3127266|NCT01663532|3852322|FG000|COMPLETED|Overall Study||94
3127267|NCT01663532|3852323|FG001|COMPLETED|Overall Study||65
3127268|NCT01663532|3852322|FG000|NOT COMPLETED|Overall Study||74
3127269|NCT01663532|3852323|FG001|NOT COMPLETED|Overall Study||107
3127270|NCT01663623|3852331|FG000|STARTED|Overall Study||52
3127271|NCT01663623|3852332|FG001|STARTED|Overall Study||53
3127272|NCT01663623|3852331|FG000|COMPLETED|Overall Study||40
3127273|NCT01663623|3852332|FG001|COMPLETED|Overall Study||33
3127274|NCT01663623|3852331|FG000|NOT COMPLETED|Overall Study||12
3127275|NCT01663623|3852332|FG001|NOT COMPLETED|Overall Study||20
3127276|NCT01663636|3852340|FG000|STARTED|Infant SMS Reminder Feasibility Study||160
3127277|NCT01663636|3852341|FG001|STARTED|Infant SMS Reminder Feasibility Study||161
3127278|NCT01663636|3852340|FG000|COMPLETED|Infant SMS Reminder Feasibility Study||135
3127279|NCT01663636|3852341|FG001|COMPLETED|Infant SMS Reminder Feasibility Study||130
3127280|NCT01663636|3852340|FG000|NOT COMPLETED|Infant SMS Reminder Feasibility Study||25
3127281|NCT01663636|3852341|FG001|NOT COMPLETED|Infant SMS Reminder Feasibility Study||31
3127282|NCT01663636|3852340|FG000|STARTED|Parent SMS Acceptability Assessment||135
3127283|NCT01663636|3852341|FG001|STARTED|Parent SMS Acceptability Assessment||130
3127284|NCT01663636|3852340|FG000|COMPLETED|Parent SMS Acceptability Assessment||135
3127285|NCT01663636|3852341|FG001|COMPLETED|Parent SMS Acceptability Assessment||130
3127286|NCT01663636|3852340|FG000|NOT COMPLETED|Parent SMS Acceptability Assessment||0
3127287|NCT01663636|3852341|FG001|NOT COMPLETED|Parent SMS Acceptability Assessment||0
3127288|NCT01663714|3852347|FG000|STARTED|Dosimetric and Therapeutic Treatment||30
3127289|NCT01663714|3852347|FG000|COMPLETED|Dosimetric and Therapeutic Treatment||0
3127290|NCT01663714|3852347|FG000|NOT COMPLETED|Dosimetric and Therapeutic Treatment||30
3127291|NCT01663714|3852347|FG000|STARTED|Long-Term Follow-Up|22 of the30 participants withdrawing from Study BEX104514 enrolled in the LTFU study.|22
3127292|NCT01663714|3852347|FG000|COMPLETED|Long-Term Follow-Up||16
3127293|NCT01663714|3852347|FG000|NOT COMPLETED|Long-Term Follow-Up||6
3127294|NCT01663727|3852355|FG000|STARTED|Overall Study||242
3127295|NCT01663727|3852356|FG001|STARTED|Overall Study||239
3127296|NCT01663727|3852355|FG000|COMPLETED|Overall Study||0
3127297|NCT01663727|3852356|FG001|COMPLETED|Overall Study||1
3127298|NCT01663727|3852355|FG000|NOT COMPLETED|Overall Study||242
3127299|NCT01663727|3852356|FG001|NOT COMPLETED|Overall Study||238
3127300|NCT01663740|3852364|FG000|STARTED|Overall Study|Safety Population|38
3127301|NCT01663740|3852365|FG001|STARTED|Overall Study|Safety Population|21
3127302|NCT01663740|3852364|FG000|COMPLETED|Overall Study||22
3127303|NCT01663740|3852365|FG001|COMPLETED|Overall Study||13
3127304|NCT01663740|3852364|FG000|NOT COMPLETED|Overall Study||16
3127305|NCT01663740|3852365|FG001|NOT COMPLETED|Overall Study||8
3127306|NCT01663779|3852373|FG000|STARTED|Overall Study||27
3127307|NCT01663779|3852374|FG001|STARTED|Overall Study||23
3127308|NCT01663779|3852373|FG000|COMPLETED|Overall Study||27
3127309|NCT01663779|3852374|FG001|COMPLETED|Overall Study||23
3127310|NCT01663779|3852373|FG000|NOT COMPLETED|Overall Study||0
3127311|NCT01663779|3852374|FG001|NOT COMPLETED|Overall Study||0
3127312|NCT01663857|3852384|FG000|STARTED|Overall Study||6
3127313|NCT01663857|3852385|FG001|STARTED|Overall Study||2
3127314|NCT01663857|3852386|FG002|STARTED|Overall Study||58
3127315|NCT01663857|3852387|FG003|STARTED|Overall Study||52
3127316|NCT01663857|3852384|FG000|Received at Least One Dose of Study Drug|Overall Study||6
3127317|NCT01663857|3852385|FG001|Received at Least One Dose of Study Drug|Overall Study||2
3127318|NCT01663857|3852386|FG002|Received at Least One Dose of Study Drug|Overall Study||58
3127319|NCT01663857|3852387|FG003|Received at Least One Dose of Study Drug|Overall Study||52
3127320|NCT01663857|3852384|FG000|COMPLETED|Overall Study||6
3127321|NCT01663857|3852385|FG001|COMPLETED|Overall Study||1
3127322|NCT01663857|3852386|FG002|COMPLETED|Overall Study||48
3127323|NCT01663857|3852387|FG003|COMPLETED|Overall Study||48
3127324|NCT01663857|3852384|FG000|NOT COMPLETED|Overall Study||0
3127325|NCT01663857|3852385|FG001|NOT COMPLETED|Overall Study||1
3127326|NCT01663857|3852386|FG002|NOT COMPLETED|Overall Study||10
3127327|NCT01663857|3852387|FG003|NOT COMPLETED|Overall Study||4
3127328|NCT01663896|3852403|FG000|STARTED|Overall Study||418
3127329|NCT01663896|3852403|FG000|COMPLETED|Overall Study||375
3127330|NCT01663896|3852403|FG000|NOT COMPLETED|Overall Study||43
3127331|NCT01663922|3852408|FG000|STARTED|First Intervention (14 Days or 5 Days)||8
3127332|NCT01663922|3852409|FG001|STARTED|First Intervention (14 Days or 5 Days)||9
3127333|NCT01663922|3852408|FG000|COMPLETED|First Intervention (14 Days or 5 Days)||8
3127334|NCT01663922|3852409|FG001|COMPLETED|First Intervention (14 Days or 5 Days)||9
3127335|NCT01663922|3852408|FG000|NOT COMPLETED|First Intervention (14 Days or 5 Days)||0
3127336|NCT01663922|3852409|FG001|NOT COMPLETED|First Intervention (14 Days or 5 Days)||0
3127337|NCT01663922|3852408|FG000|STARTED|Washout (7 Days)||8
3127338|NCT01663922|3852409|FG001|STARTED|Washout (7 Days)||9
3127339|NCT01663922|3852408|FG000|COMPLETED|Washout (7 Days)||8
3127340|NCT01663922|3852409|FG001|COMPLETED|Washout (7 Days)||9
3127341|NCT01663922|3852408|FG000|NOT COMPLETED|Washout (7 Days)||0
3127342|NCT01663922|3852409|FG001|NOT COMPLETED|Washout (7 Days)||0
3127343|NCT01663922|3852408|FG000|STARTED|Second Intervention (14 Days)||8
3127344|NCT01663922|3852409|FG001|STARTED|Second Intervention (14 Days)||9
3127345|NCT01663922|3852408|FG000|COMPLETED|Second Intervention (14 Days)||8
3127346|NCT01663922|3852409|FG001|COMPLETED|Second Intervention (14 Days)||9
3127347|NCT01663922|3852408|FG000|NOT COMPLETED|Second Intervention (14 Days)||0
3127348|NCT01663922|3852409|FG001|NOT COMPLETED|Second Intervention (14 Days)||0
3127349|NCT01663922|3852408|FG000|STARTED|Washout (7 Days)||8
3127350|NCT01663922|3852409|FG001|STARTED|Washout (7 Days)||9
3127351|NCT01663922|3852408|FG000|COMPLETED|Washout (7 Days)||8
3127352|NCT01663922|3852409|FG001|COMPLETED|Washout (7 Days)||9
3127353|NCT01663922|3852408|FG000|NOT COMPLETED|Washout (7 Days)||0
3127354|NCT01663922|3852409|FG001|NOT COMPLETED|Washout (7 Days)||0
3127355|NCT01663922|3852408|FG000|STARTED|Third Intervention (14 Days or 5 Days)||8
3127356|NCT01663922|3852409|FG001|STARTED|Third Intervention (14 Days or 5 Days)||9
3127357|NCT01663922|3852408|FG000|COMPLETED|Third Intervention (14 Days or 5 Days)||8
3127358|NCT01663922|3852409|FG001|COMPLETED|Third Intervention (14 Days or 5 Days)||9
3127359|NCT01663922|3852408|FG000|NOT COMPLETED|Third Intervention (14 Days or 5 Days)||0
3127360|NCT01663922|3852409|FG001|NOT COMPLETED|Third Intervention (14 Days or 5 Days)||0
3127361|NCT01663935|3852414|FG000|STARTED|Overall Study||20
3127362|NCT01663935|3852414|FG000|COMPLETED|Overall Study||20
3127363|NCT01663935|3852414|FG000|NOT COMPLETED|Overall Study||0
3127364|NCT01663987|3852420|FG000|STARTED|Overall Study||39
3127365|NCT01663987|3852421|FG001|STARTED|Overall Study||40
3127366|NCT01663987|3852420|FG000|COMPLETED|Overall Study||26
3127367|NCT01663987|3852421|FG001|COMPLETED|Overall Study||34
3127368|NCT01663987|3852420|FG000|NOT COMPLETED|Overall Study||13
3127369|NCT01663987|3852421|FG001|NOT COMPLETED|Overall Study||6
3127370|NCT01664039|3852429|FG000|STARTED|Overall Study||52
3127371|NCT01664039|3852430|FG001|STARTED|Overall Study||52
3127372|NCT01664039|3852429|FG000|COMPLETED|Overall Study||46
3127373|NCT01664039|3852430|FG001|COMPLETED|Overall Study||43
3127374|NCT01664039|3852429|FG000|NOT COMPLETED|Overall Study||6
3127375|NCT01664039|3852430|FG001|NOT COMPLETED|Overall Study||9
3127376|NCT01664052|3852438|FG000|STARTED|Phase 1|Screening and enrollment|31
3127377|NCT01664052|3852439|FG001|STARTED|Phase 1||0
3127378|NCT01664052|3852438|FG000|Insert Placed in at Least One Tube|Phase 1||25
3127379|NCT01664052|3852439|FG001|Insert Placed in at Least One Tube|Phase 1||0
3127380|NCT01664052|3852438|FG000|HSG 1 Hour Post Placement|Phase 1||24
3127381|NCT01664052|3852439|FG001|HSG 1 Hour Post Placement|Phase 1||0
3127382|NCT01664052|3852438|FG000|Repeat HSG and Hysterectomy at 30 Days|Phase 1||9
3127383|NCT01664052|3852439|FG001|Repeat HSG and Hysterectomy at 30 Days|Phase 1||0
3127384|NCT01664052|3852438|FG000|Repeat HSG and Hysterectomy at 60 Days|Phase 1||8
3127385|NCT01664052|3852439|FG001|Repeat HSG and Hysterectomy at 60 Days|Phase 1||0
3127386|NCT01664052|3852438|FG000|Repeat HSG and Hysterectomy at 90 Days|Phase 1||7
3127387|NCT01664052|3852439|FG001|Repeat HSG and Hysterectomy at 90 Days|Phase 1||0
3127388|NCT01664052|3852438|FG000|COMPLETED|Phase 1||24
3127389|NCT01664052|3852439|FG001|COMPLETED|Phase 1||0
3127390|NCT01664052|3852438|FG000|NOT COMPLETED|Phase 1||7
3127391|NCT01664052|3852439|FG001|NOT COMPLETED|Phase 1||0
3127392|NCT01664052|3852438|FG000|STARTED|Phase 2|Screened and enrolled|0
3127393|NCT01664052|3852439|FG001|STARTED|Phase 2||35
3127394|NCT01664052|3852438|FG000|Insert Placed|Phase 2||0
3127395|NCT01664052|3852439|FG001|Insert Placed|Phase 2||31
3127396|NCT01664052|3852438|FG000|HSG 1 Hour Post Placement|Phase 2||0
3127397|NCT01664052|3852439|FG001|HSG 1 Hour Post Placement|Phase 2||31
3127398|NCT01664052|3852438|FG000|Repeat HSG and Hysterectomy at 30 Days|Phase 2||0
3127399|NCT01664052|3852439|FG001|Repeat HSG and Hysterectomy at 30 Days|Phase 2||10
3127400|NCT01664052|3852438|FG000|Repeat HSG and Hysterectomy at 60 Days|Phase 2||0
3127401|NCT01664052|3852439|FG001|Repeat HSG and Hysterectomy at 60 Days|Phase 2||10
3127402|NCT01664052|3852438|FG000|Repeat HSG and Hysterectomy at 90 Days|Phase 2||0
3127403|NCT01664052|3852439|FG001|Repeat HSG and Hysterectomy at 90 Days|Phase 2||10
3127404|NCT01664052|3852438|FG000|COMPLETED|Phase 2||0
3127405|NCT01664052|3852439|FG001|COMPLETED|Phase 2||31
3127406|NCT01664052|3852438|FG000|NOT COMPLETED|Phase 2||0
3127407|NCT01664052|3852439|FG001|NOT COMPLETED|Phase 2||4
3127408|NCT01664078|3852446|FG000|STARTED|Overall Study||190
3127409|NCT01664078|3852446|FG000|COMPLETED|Overall Study||121
3127410|NCT01664078|3852446|FG000|NOT COMPLETED|Overall Study||69
3127411|NCT01664091|3852496|FG000|STARTED|Overall Study||32
3127412|NCT01664091|3852496|FG000|COMPLETED|Overall Study||26
3127413|NCT01664091|3852496|FG000|NOT COMPLETED|Overall Study||6
3127414|NCT01664104|3852501|FG000|STARTED|Overall Study||136
3127415|NCT01664104|3852501|FG000|COMPLETED|Overall Study||120
3127416|NCT01664104|3852501|FG000|NOT COMPLETED|Overall Study||16
3127417|NCT01664117|3852507|FG000|STARTED|Overall Study||209
3127418|NCT01664117|3852507|FG000|COMPLETED|Overall Study||209
3127419|NCT01664117|3852507|FG000|NOT COMPLETED|Overall Study||0
3127420|NCT01664130|3852514|FG000|STARTED|Overall Study||35
3127421|NCT01664130|3852514|FG000|COMPLETED|Overall Study||33
3127422|NCT01664130|3852514|FG000|NOT COMPLETED|Overall Study||2
3127423|NCT01664247|3852523|FG000|STARTED|Overall Study||174
3127424|NCT01664247|3852524|FG001|STARTED|Overall Study||172
3127425|NCT01664247|3852523|FG000|Exposed|Overall Study|1 subject was randomised in error and withdrew before exposure to the drug|173
3127426|NCT01664247|3852524|FG001|Exposed|Overall Study|Two subjects were randomised in error and withdrew prior to exposure to drug|170
3127427|NCT01664247|3852523|FG000|COMPLETED|Overall Study||160
3127428|NCT01664247|3852524|FG001|COMPLETED|Overall Study||131
3127429|NCT01664247|3852523|FG000|NOT COMPLETED|Overall Study||14
3127430|NCT01664247|3852524|FG001|NOT COMPLETED|Overall Study||41
3127431|NCT01664494|3852530|FG000|STARTED|Overall Study||563
3127432|NCT01664494|3852530|FG000|COMPLETED|Overall Study||370
3127433|NCT01664494|3852530|FG000|NOT COMPLETED|Overall Study||193
3127434|NCT01664533|3852534|FG000|STARTED|Overall Study||57
3127435|NCT01664533|3852534|FG000|COMPLETED|Overall Study||0
3127436|NCT01664533|3852534|FG000|NOT COMPLETED|Overall Study||57
3127437|NCT01664559|3852541|FG000|STARTED|Overall Study||34
3127438|NCT01664559|3852542|FG001|STARTED|Overall Study||33
3127439|NCT01664559|3852541|FG000|COMPLETED|Overall Study||34
3127440|NCT01664559|3852542|FG001|COMPLETED|Overall Study||33
3127441|NCT01664559|3852541|FG000|NOT COMPLETED|Overall Study||0
3127442|NCT01664559|3852542|FG001|NOT COMPLETED|Overall Study||0
3127443|NCT01664624|3852552|FG000|STARTED|Overall Study||10
3127444|NCT01664624|3852553|FG001|STARTED|Overall Study||11
3127445|NCT01664624|3852554|FG002|STARTED|Overall Study||10
3127446|NCT01664624|3852555|FG003|STARTED|Overall Study||9
3127447|NCT01664624|3852552|FG000|COMPLETED|Overall Study||10
3127448|NCT01664624|3852553|FG001|COMPLETED|Overall Study||10
3127449|NCT01664624|3852554|FG002|COMPLETED|Overall Study||10
3127450|NCT01664624|3852555|FG003|COMPLETED|Overall Study||9
3127451|NCT01664624|3852552|FG000|NOT COMPLETED|Overall Study||0
3127452|NCT01664624|3852553|FG001|NOT COMPLETED|Overall Study||1
3127453|NCT01664624|3852554|FG002|NOT COMPLETED|Overall Study||0
3127454|NCT01664624|3852555|FG003|NOT COMPLETED|Overall Study||0
3127455|NCT01664741|3852568|FG000|STARTED|Overall Study||6
3127456|NCT01664741|3852569|FG001|STARTED|Overall Study||6
3127457|NCT01664741|3852570|FG002|STARTED|Overall Study||13
3127458|NCT01664741|3852568|FG000|COMPLETED|Overall Study||6
3127459|NCT01664741|3852569|FG001|COMPLETED|Overall Study||6
3127460|NCT01664741|3852570|FG002|COMPLETED|Overall Study||13
3127461|NCT01664741|3852568|FG000|NOT COMPLETED|Overall Study||0
3127462|NCT01664741|3852569|FG001|NOT COMPLETED|Overall Study||0
3127463|NCT01664741|3852570|FG002|NOT COMPLETED|Overall Study||0
3127464|NCT01664793|3852579|FG000|STARTED|Overall Study||49039
3127465|NCT01664793|3852580|FG001|STARTED|Overall Study||38626
3127466|NCT01664793|3852579|FG000|COMPLETED|Overall Study||49039
3127467|NCT01664793|3852580|FG001|COMPLETED|Overall Study||38626
3127468|NCT01664793|3852579|FG000|NOT COMPLETED|Overall Study||0
3127469|NCT01664793|3852580|FG001|NOT COMPLETED|Overall Study||0
3127470|NCT01664806|3852590|FG000|STARTED|Overall Study||20
3127471|NCT01664806|3852591|FG001|STARTED|Overall Study||20
3127472|NCT01664806|3852590|FG000|COMPLETED|Overall Study||20
3127473|NCT01664806|3852591|FG001|COMPLETED|Overall Study||20
3127474|NCT01664806|3852590|FG000|NOT COMPLETED|Overall Study||0
3127475|NCT01664806|3852591|FG001|NOT COMPLETED|Overall Study||0
3127476|NCT01664858|3852600|FG000|STARTED|Overall Study||481
3127477|NCT01664858|3852601|FG001|STARTED|Overall Study||481
3127478|NCT01664858|3852602|FG002|STARTED|Overall Study||240
3127479|NCT01664858|3852600|FG000|COMPLETED|Overall Study||467
3127480|NCT01664858|3852601|FG001|COMPLETED|Overall Study||468
3127481|NCT01664858|3852602|FG002|COMPLETED|Overall Study||234
3127482|NCT01664858|3852600|FG000|NOT COMPLETED|Overall Study||14
3127483|NCT01664858|3852601|FG001|NOT COMPLETED|Overall Study||13
3127484|NCT01664858|3852602|FG002|NOT COMPLETED|Overall Study||6
3127485|NCT01664897|3852613|FG000|STARTED|Overall Study||29
3127486|NCT01664897|3852613|FG000|COMPLETED|Overall Study||29
3127487|NCT01664897|3852613|FG000|NOT COMPLETED|Overall Study||0
3127488|NCT01664923|3852619|FG000|STARTED|Period1:Double Blind Phase-29 Months||198
3127489|NCT01664923|3852620|FG001|STARTED|Period1:Double Blind Phase-29 Months||198
3127490|NCT01664923|3852619|FG000|Received Study Treatment|Period1:Double Blind Phase-29 Months||197
3127491|NCT01664923|3852620|FG001|Received Study Treatment|Period1:Double Blind Phase-29 Months||198
3127492|NCT01664923|3852619|FG000|COMPLETED|Period1:Double Blind Phase-29 Months||93
3127493|NCT01664923|3852620|FG001|COMPLETED|Period1:Double Blind Phase-29 Months||38
3127494|NCT01664923|3852619|FG000|NOT COMPLETED|Period1:Double Blind Phase-29 Months||105
3127495|NCT01664923|3852620|FG001|NOT COMPLETED|Period1:Double Blind Phase-29 Months||160
3127496|NCT01664923|3852619|FG000|STARTED|Period 2: Open-label Phase-36 Months||93
3127497|NCT01664923|3852620|FG001|STARTED|Period 2: Open-label Phase-36 Months||38
3127498|NCT01664923|3852619|FG000|Treated|Period 2: Open-label Phase-36 Months||93
3127499|NCT01664923|3852620|FG001|Treated|Period 2: Open-label Phase-36 Months||37
3127500|NCT01664923|3852619|FG000|COMPLETED|Period 2: Open-label Phase-36 Months||52
3127501|NCT01664923|3852620|FG001|COMPLETED|Period 2: Open-label Phase-36 Months||15
3127502|NCT01664923|3852619|FG000|NOT COMPLETED|Period 2: Open-label Phase-36 Months||41
3127503|NCT01664923|3852620|FG001|NOT COMPLETED|Period 2: Open-label Phase-36 Months||23
3127504|NCT01664949|3852632|FG000|STARTED|Overall Study||224
3127505|NCT01664949|3852633|FG001|STARTED|Overall Study||236
3127506|NCT01664949|3852632|FG000|COMPLETED|Overall Study||200
3127507|NCT01664949|3852633|FG001|COMPLETED|Overall Study||211
3127508|NCT01664949|3852632|FG000|NOT COMPLETED|Overall Study||24
3127509|NCT01664949|3852633|FG001|NOT COMPLETED|Overall Study||25
3127510|NCT01664975|3852641|FG000|STARTED|Overall Study||57
3127511|NCT01664975|3852642|FG001|STARTED|Overall Study||54
3127512|NCT01664975|3852641|FG000|COMPLETED|Overall Study||52
3127513|NCT01664975|3852642|FG001|COMPLETED|Overall Study||51
3127514|NCT01664975|3852641|FG000|NOT COMPLETED|Overall Study||5
3127515|NCT01664975|3852642|FG001|NOT COMPLETED|Overall Study||3
3127516|NCT01665040|3852648|FG000|STARTED|Overall Study||40
3127517|NCT01665040|3852648|FG000|COMPLETED|Overall Study||36
3127518|NCT01665040|3852648|FG000|NOT COMPLETED|Overall Study||4
3127519|NCT01665053|3852654|FG000|STARTED|Overall Study||838
3127520|NCT01665053|3852655|FG001|STARTED|Overall Study||846
3127521|NCT01665053|3852654|FG000|Completed 12-Month Clinical F/U|Overall Study||797
3127522|NCT01665053|3852655|FG001|Completed 12-Month Clinical F/U|Overall Study||822
3127523|NCT01665053|3852654|FG000|No 12-Month F/U|Overall Study||32
3127524|NCT01665053|3852655|FG001|No 12-Month F/U|Overall Study||15
3127525|NCT01665053|3852654|FG000|Death With No 12-month Clinical FU|Overall Study||9
3127526|NCT01665053|3852655|FG001|Death With No 12-month Clinical FU|Overall Study||9
3127527|NCT01665053|3852654|FG000|COMPLETED|Overall Study||806
3127528|NCT01665053|3852655|FG001|COMPLETED|Overall Study||831
3127529|NCT01665053|3852654|FG000|NOT COMPLETED|Overall Study||32
3127530|NCT01665053|3852655|FG001|NOT COMPLETED|Overall Study||15
3127531|NCT01665092|3852665|FG000|STARTED|Overall Study||75
3127532|NCT01665092|3852666|FG001|STARTED|Overall Study||35
3127533|NCT01665092|3852667|FG002|STARTED|Overall Study||34
3127534|NCT01665092|3852668|FG003|STARTED|Overall Study||106
3127535|NCT01665092|3852665|FG000|COMPLETED|Overall Study||75
3127536|NCT01665092|3852666|FG001|COMPLETED|Overall Study||35
3127537|NCT01665092|3852667|FG002|COMPLETED|Overall Study||32
3127538|NCT01665092|3852668|FG003|COMPLETED|Overall Study||105
3127539|NCT01665092|3852665|FG000|NOT COMPLETED|Overall Study||0
3127540|NCT01665092|3852666|FG001|NOT COMPLETED|Overall Study||0
3127541|NCT01665092|3852667|FG002|NOT COMPLETED|Overall Study||2
3127542|NCT01665092|3852668|FG003|NOT COMPLETED|Overall Study||1
3127543|NCT01665157|3852681|FG000|STARTED|Overall Study||60
3127544|NCT01665157|3852682|FG001|STARTED|Overall Study||60
3127545|NCT01665157|3852683|FG002|STARTED|Overall Study||60
3127546|NCT01665157|3852681|FG000|COMPLETED|Overall Study||60
3127547|NCT01665157|3852682|FG001|COMPLETED|Overall Study||60
3127548|NCT01665157|3852683|FG002|COMPLETED|Overall Study||60
3127549|NCT01665157|3852681|FG000|NOT COMPLETED|Overall Study||0
3127550|NCT01665157|3852682|FG001|NOT COMPLETED|Overall Study||0
3127551|NCT01665157|3852683|FG002|NOT COMPLETED|Overall Study||0
3127552|NCT01665170|3852698|FG000|STARTED|Overall Study|First patient in|30
3127553|NCT01665170|3852699|FG001|STARTED|Overall Study||30
3127554|NCT01665170|3852698|FG000|Bevore TSST|Overall Study||30
3127555|NCT01665170|3852699|FG001|Bevore TSST|Overall Study||30
3127556|NCT01665170|3852698|FG000|During TSST|Overall Study||30
3127557|NCT01665170|3852699|FG001|During TSST|Overall Study||30
3127558|NCT01665170|3852698|FG000|After TSST|Overall Study||30
3127559|NCT01665170|3852699|FG001|After TSST|Overall Study||30
3127560|NCT01665170|3852698|FG000|COMPLETED|Overall Study|Last TSST/ last patient out|30
3127561|NCT01665170|3852699|FG001|COMPLETED|Overall Study||30
3127562|NCT01665170|3852698|FG000|NOT COMPLETED|Overall Study||0
3127563|NCT01665170|3852699|FG001|NOT COMPLETED|Overall Study||0
3127564|NCT01665430|3852707|FG000|STARTED|Overall Study||38
3127565|NCT01665430|3852707|FG000|COMPLETED|Overall Study||29
3127566|NCT01665430|3852707|FG000|NOT COMPLETED|Overall Study||9
3127567|NCT01665508|3852711|FG000|STARTED|Overall Study||12
3127568|NCT01665508|3852711|FG000|COMPLETED|Overall Study||7
3127569|NCT01665508|3852711|FG000|NOT COMPLETED|Overall Study||5
3127570|NCT01665599|3852720|FG000|STARTED|Overall Study||180
3127571|NCT01665599|3852720|FG000|COMPLETED|Overall Study||172
3127572|NCT01665599|3852720|FG000|NOT COMPLETED|Overall Study||8
3127573|NCT01665768|3852724|FG000|STARTED|Overall Study||49
3127574|NCT01665768|3852724|FG000|COMPLETED|Overall Study||26
3127575|NCT01665768|3852724|FG000|NOT COMPLETED|Overall Study||23
3127576|NCT01665807|3852731|FG000|STARTED|Overall Study||411
3127577|NCT01665807|3852732|FG001|STARTED|Overall Study||58
3127578|NCT01665807|3852733|FG002|STARTED|Overall Study||402
3127579|NCT01665807|3852731|FG000|COMPLETED|Overall Study||409
3127580|NCT01665807|3852732|FG001|COMPLETED|Overall Study||58
3127581|NCT01665807|3852733|FG002|COMPLETED|Overall Study||401
3127582|NCT01665807|3852731|FG000|NOT COMPLETED|Overall Study||2
3127583|NCT01665807|3852732|FG001|NOT COMPLETED|Overall Study||0
3127584|NCT01665807|3852733|FG002|NOT COMPLETED|Overall Study||1
3127585|NCT01665872|3852743|FG000|STARTED|Screening||172
3127586|NCT01665872|3852744|FG001|STARTED|Screening||172
3127587|NCT01665872|3852743|FG000|COMPLETED|Screening||172
3127588|NCT01665872|3852744|FG001|COMPLETED|Screening||172
3127589|NCT01665872|3852743|FG000|NOT COMPLETED|Screening||0
3127590|NCT01665872|3852744|FG001|NOT COMPLETED|Screening||0
3127591|NCT01665872|3852743|FG000|STARTED|Treatment||87
3127592|NCT01665872|3852744|FG001|STARTED|Treatment||67
3127593|NCT01665872|3852743|FG000|COMPLETED|Treatment||72
3127594|NCT01665872|3852744|FG001|COMPLETED|Treatment||50
3127595|NCT01665872|3852743|FG000|NOT COMPLETED|Treatment||15
3127596|NCT01665872|3852744|FG001|NOT COMPLETED|Treatment||17
3127597|NCT01665872|3852743|FG000|STARTED|6 Month Follow-up||72
3127598|NCT01665872|3852744|FG001|STARTED|6 Month Follow-up||50
3127599|NCT01665872|3852743|FG000|COMPLETED|6 Month Follow-up||66
3127600|NCT01665872|3852744|FG001|COMPLETED|6 Month Follow-up||49
3127601|NCT01665872|3852743|FG000|NOT COMPLETED|6 Month Follow-up||6
3127602|NCT01665872|3852744|FG001|NOT COMPLETED|6 Month Follow-up||1
3127603|NCT01665872|3852743|FG000|STARTED|12 Month Follow-up||72
3127604|NCT01665872|3852744|FG001|STARTED|12 Month Follow-up||50
3127605|NCT01665872|3852743|FG000|COMPLETED|12 Month Follow-up||58
3127606|NCT01665872|3852744|FG001|COMPLETED|12 Month Follow-up||47
3127607|NCT01665872|3852743|FG000|NOT COMPLETED|12 Month Follow-up||14
3127608|NCT01665872|3852744|FG001|NOT COMPLETED|12 Month Follow-up||3
3127609|NCT01665911|3852750|FG000|STARTED|Overall Study||28
3127610|NCT01665911|3852750|FG000|0 mg Fluoride in 200 ml Milk|Overall Study||22
3127611|NCT01665911|3852750|FG000|1.5 mg Sodium Fluoride in 100 ml Milk|Overall Study||23
3127612|NCT01665911|3852750|FG000|1.5 mg Sodium Fluoride in 200 ml Milk|Overall Study||25
3127613|NCT01665911|3852750|FG000|3.0 mg Sodium Fluoride in 100 ml Milk|Overall Study||22
3127614|NCT01665911|3852750|FG000|3.0 mg Sodium Fluoride in 200 ml Milk|Overall Study||22
3127615|NCT01665911|3852750|FG000|COMPLETED|Overall Study||22
3127616|NCT01665911|3852750|FG000|NOT COMPLETED|Overall Study||6
3127617|NCT01665950|3852758|FG000|STARTED|Overall Study||2
3127618|NCT01665950|3852759|FG001|STARTED|Overall Study||0
3127619|NCT01665950|3852760|FG002|STARTED|Overall Study||2
3127620|NCT01665950|3852758|FG000|COMPLETED|Overall Study||1
3127621|NCT01665950|3852759|FG001|COMPLETED|Overall Study||0
3127622|NCT01665950|3852760|FG002|COMPLETED|Overall Study||1
3127623|NCT01665950|3852758|FG000|NOT COMPLETED|Overall Study||1
3127624|NCT01665950|3852759|FG001|NOT COMPLETED|Overall Study||0
3127625|NCT01665950|3852760|FG002|NOT COMPLETED|Overall Study||1
3127626|NCT01666002|3852770|FG000|STARTED|Overall Study||17
3127627|NCT01666002|3852771|FG001|STARTED|Overall Study||10
3127628|NCT01666002|3852770|FG000|COMPLETED|Overall Study||12
3127629|NCT01666002|3852771|FG001|COMPLETED|Overall Study||10
3127630|NCT01666002|3852770|FG000|NOT COMPLETED|Overall Study||5
3127631|NCT01666002|3852771|FG001|NOT COMPLETED|Overall Study||0
3127632|NCT01666119|3852778|FG000|STARTED|Overall Study||249
3127633|NCT01666119|3852778|FG000|COMPLETED|Overall Study||197
3127634|NCT01666119|3852778|FG000|NOT COMPLETED|Overall Study||52
3127635|NCT01666145|3852782|FG000|STARTED|Overall Study||14
3127636|NCT01666145|3852782|FG000|COMPLETED|Overall Study||14
3127637|NCT01666145|3852782|FG000|NOT COMPLETED|Overall Study||0
3127638|NCT01666197|3852788|FG000|STARTED|Overall Study||50
3127639|NCT01666197|3852789|FG001|STARTED|Overall Study||50
3127640|NCT01666197|3852788|FG000|COMPLETED|Overall Study||50
3127641|NCT01666197|3852789|FG001|COMPLETED|Overall Study||50
3127642|NCT01666197|3852788|FG000|NOT COMPLETED|Overall Study||0
3127643|NCT01666197|3852789|FG001|NOT COMPLETED|Overall Study||0
3127644|NCT01666210|3852797|FG000|STARTED|Overall Study||30
3127645|NCT01666210|3852798|FG001|STARTED|Overall Study||30
3127646|NCT01666210|3852797|FG000|COMPLETED|Overall Study||28
3127647|NCT01666210|3852798|FG001|COMPLETED|Overall Study||29
3127648|NCT01666210|3852797|FG000|NOT COMPLETED|Overall Study||2
3127649|NCT01666210|3852798|FG001|NOT COMPLETED|Overall Study||1
3127650|NCT01666314|3852812|FG000|STARTED|Overall Study||33
3127651|NCT01666314|3852813|FG001|STARTED|Overall Study||32
3127652|NCT01666314|3852814|FG002|STARTED|Overall Study||36
3127653|NCT01666314|3852815|FG003|STARTED|Overall Study||36
3127654|NCT01666314|3852812|FG000|COMPLETED|Overall Study||0
3127655|NCT01666314|3852813|FG001|COMPLETED|Overall Study||0
3127656|NCT01666314|3852814|FG002|COMPLETED|Overall Study||0
3127657|NCT01666314|3852815|FG003|COMPLETED|Overall Study||0
3127658|NCT01666314|3852812|FG000|NOT COMPLETED|Overall Study||33
3127659|NCT01666314|3852813|FG001|NOT COMPLETED|Overall Study||32
3127660|NCT01666314|3852814|FG002|NOT COMPLETED|Overall Study||36
3127661|NCT01666314|3852815|FG003|NOT COMPLETED|Overall Study||36
3127662|NCT01666444|3852838|FG000|STARTED|Overall Study||149
3127663|NCT01666444|3852839|FG001|STARTED|Overall Study||148
3127664|NCT01666444|3852838|FG000|COMPLETED|Overall Study||147
3127665|NCT01666444|3852839|FG001|COMPLETED|Overall Study||147
3127666|NCT01666444|3852838|FG000|NOT COMPLETED|Overall Study||2
3127667|NCT01666444|3852839|FG001|NOT COMPLETED|Overall Study||1
3127668|NCT01666652|3852850|FG000|STARTED|Overall Study||20
3127669|NCT01666652|3852851|FG001|STARTED|Overall Study||20
3127670|NCT01666652|3852852|FG002|STARTED|Overall Study||20
3127671|NCT01666652|3852853|FG003|STARTED|Overall Study||20
3127672|NCT01666652|3852854|FG004|STARTED|Overall Study||20
3127673|NCT01666652|3852850|FG000|COMPLETED|Overall Study||18
3127674|NCT01666652|3852851|FG001|COMPLETED|Overall Study||19
3127675|NCT01666652|3852852|FG002|COMPLETED|Overall Study||19
3127676|NCT01666652|3852853|FG003|COMPLETED|Overall Study||16
3127677|NCT01666652|3852854|FG004|COMPLETED|Overall Study||19
3127678|NCT01666652|3852850|FG000|NOT COMPLETED|Overall Study||2
3127679|NCT01666652|3852851|FG001|NOT COMPLETED|Overall Study||1
3127680|NCT01666652|3852852|FG002|NOT COMPLETED|Overall Study||1
3127681|NCT01666652|3852853|FG003|NOT COMPLETED|Overall Study||4
3127682|NCT01666652|3852854|FG004|NOT COMPLETED|Overall Study||1
3127683|NCT01666730|3852866|FG000|STARTED|Overall Study||50
3127684|NCT01666730|3852866|FG000|COMPLETED|Overall Study||0
3127685|NCT01666730|3852866|FG000|NOT COMPLETED|Overall Study||50
3127686|NCT01666782|3852872|FG000|STARTED|Overall Study||54
3127687|NCT01666782|3852873|FG001|STARTED|Overall Study||51
3127688|NCT01666782|3852872|FG000|COMPLETED|Overall Study||50
3127689|NCT01666782|3852873|FG001|COMPLETED|Overall Study||50
3127690|NCT01666782|3852872|FG000|NOT COMPLETED|Overall Study||4
3127691|NCT01666782|3852873|FG001|NOT COMPLETED|Overall Study||1
3127692|NCT01666912|3852881|FG000|STARTED|Overall Study||48
3127693|NCT01666912|3852882|FG001|STARTED|Overall Study||48
3127694|NCT01666912|3852881|FG000|COMPLETED|Overall Study||27
3127695|NCT01666912|3852882|FG001|COMPLETED|Overall Study||37
3127696|NCT01666912|3852881|FG000|NOT COMPLETED|Overall Study||21
3127697|NCT01666912|3852882|FG001|NOT COMPLETED|Overall Study||11
3136468|NCT01713283|3861617|FG000|COMPLETED|Overall Study||20
3136469|NCT01713283|3861618|FG001|COMPLETED|Overall Study||26
3136470|NCT01713283|3861617|FG000|NOT COMPLETED|Overall Study||11
3136471|NCT01713283|3861618|FG001|NOT COMPLETED|Overall Study||3
3136472|NCT01713348|3861632|FG000|STARTED|Overall Study||29
3136473|NCT01713348|3861633|FG001|STARTED|Overall Study||13
3136474|NCT01713348|3861634|FG002|STARTED|Overall Study||30
3136475|NCT01713348|3861635|FG003|STARTED|Overall Study||15
3136476|NCT01713348|3861632|FG000|COMPLETED|Overall Study||25
3136477|NCT01713348|3861633|FG001|COMPLETED|Overall Study||11
3136478|NCT01713348|3861634|FG002|COMPLETED|Overall Study||28
3136479|NCT01713348|3861635|FG003|COMPLETED|Overall Study||15
3136480|NCT01713348|3861632|FG000|NOT COMPLETED|Overall Study||4
3136481|NCT01713348|3861633|FG001|NOT COMPLETED|Overall Study||2
3136482|NCT01713348|3861634|FG002|NOT COMPLETED|Overall Study||2
3136483|NCT01713348|3861635|FG003|NOT COMPLETED|Overall Study||0
3136484|NCT01713400|3861647|FG000|STARTED|Overall Study||15
3136485|NCT01713400|3861648|FG001|STARTED|Overall Study||15
3136486|NCT01713400|3861647|FG000|COMPLETED|Overall Study||15
3136487|NCT01713400|3861648|FG001|COMPLETED|Overall Study||15
3136488|NCT01713400|3861647|FG000|NOT COMPLETED|Overall Study||0
3136489|NCT01713400|3861648|FG001|NOT COMPLETED|Overall Study||0
3136490|NCT01713530|3861656|FG000|STARTED|Overall Study||138
3136491|NCT01713530|3861657|FG001|STARTED|Overall Study||136
3136492|NCT01713530|3861656|FG000|Exposed|Overall Study|One (1) subject was randomised in error and 1 subject withdrew consent|136
3136493|NCT01713530|3861657|FG001|Exposed|Overall Study|One (1) subject was withdrawn by the investigator|135
3136494|NCT01713530|3861656|FG000|COMPLETED|Overall Study||113
3136495|NCT01713530|3861657|FG001|COMPLETED|Overall Study||117
3136496|NCT01713530|3861656|FG000|NOT COMPLETED|Overall Study||25
3136497|NCT01713530|3861657|FG001|NOT COMPLETED|Overall Study||19
3136498|NCT01713582|3861684|FG000|STARTED|Overall Study|Number treated|3
3136499|NCT01713582|3861685|FG001|STARTED|Overall Study|Number treated|3
3136500|NCT01713582|3861686|FG002|STARTED|Overall Study|Number treated|4
3136501|NCT01713582|3861687|FG003|STARTED|Overall Study|Number treated|3
3136502|NCT01713582|3861688|FG004|STARTED|Overall Study|Number treated|4
3136503|NCT01713582|3861689|FG005|STARTED|Overall Study|Number treated|8
3136504|NCT01713582|3861690|FG006|STARTED|Overall Study|Number treated|7
3136505|NCT01713582|3861691|FG007|STARTED|Overall Study|Number treated|6
3136506|NCT01713582|3861692|FG008|STARTED|Overall Study|Number treated|6
3136507|NCT01713582|3861693|FG009|STARTED|Overall Study|Number treated|18
3136508|NCT01713582|3861694|FG010|STARTED|Overall Study|Number treated|16
3136509|NCT01713582|3861695|FG011|STARTED|Overall Study|Number treated|5
3136510|NCT01713582|3861696|FG012|STARTED|Overall Study|Number treated|3
3136511|NCT01713582|3861697|FG013|STARTED|Overall Study|Number treated|4
3136512|NCT01713582|3861698|FG014|STARTED|Overall Study|Number treated|7
3136513|NCT01713582|3861699|FG015|STARTED|Overall Study|Number treated|6
3136514|NCT01713582|3861700|FG016|STARTED|Overall Study|Number treated|7
3136515|NCT01713582|3861701|FG017|STARTED|Overall Study|Number treated|3
3136516|NCT01713582|3861702|FG018|STARTED|Overall Study|Number treated|5
3136517|NCT01713582|3861703|FG019|STARTED|Overall Study|Number treated|5
3136518|NCT01713582|3861704|FG020|STARTED|Overall Study|Number treated|15
3136519|NCT01713582|3861684|FG000|COMPLETED|Overall Study||0
3136520|NCT01713582|3861685|FG001|COMPLETED|Overall Study||0
3136521|NCT01713582|3861686|FG002|COMPLETED|Overall Study||0
3136522|NCT01713582|3861687|FG003|COMPLETED|Overall Study||0
3136523|NCT01713582|3861688|FG004|COMPLETED|Overall Study||0
3136524|NCT01713582|3861689|FG005|COMPLETED|Overall Study||0
3136525|NCT01713582|3861690|FG006|COMPLETED|Overall Study||0
3136526|NCT01713582|3861691|FG007|COMPLETED|Overall Study||0
3136527|NCT01713582|3861692|FG008|COMPLETED|Overall Study||0
3136528|NCT01713582|3861693|FG009|COMPLETED|Overall Study||0
3136529|NCT01713582|3861694|FG010|COMPLETED|Overall Study||0
3136530|NCT01713582|3861695|FG011|COMPLETED|Overall Study||0
3136531|NCT01713582|3861696|FG012|COMPLETED|Overall Study||0
3136532|NCT01713582|3861697|FG013|COMPLETED|Overall Study||0
3136533|NCT01713582|3861698|FG014|COMPLETED|Overall Study||0
3136534|NCT01713582|3861699|FG015|COMPLETED|Overall Study||0
3136535|NCT01713582|3861700|FG016|COMPLETED|Overall Study||0
3136536|NCT01713582|3861701|FG017|COMPLETED|Overall Study||0
3136537|NCT01713582|3861702|FG018|COMPLETED|Overall Study||0
3136538|NCT01713582|3861703|FG019|COMPLETED|Overall Study||0
3136539|NCT01713582|3861704|FG020|COMPLETED|Overall Study||0
3136540|NCT01713582|3861684|FG000|NOT COMPLETED|Overall Study||3
3136541|NCT01713582|3861685|FG001|NOT COMPLETED|Overall Study||3
3136542|NCT01713582|3861686|FG002|NOT COMPLETED|Overall Study||4
3136543|NCT01713582|3861687|FG003|NOT COMPLETED|Overall Study||3
3136544|NCT01713582|3861688|FG004|NOT COMPLETED|Overall Study||4
3136545|NCT01713582|3861689|FG005|NOT COMPLETED|Overall Study||8
3136546|NCT01713582|3861690|FG006|NOT COMPLETED|Overall Study||7
3127698|NCT01666951|3852890|FG000|STARTED|Overall Study||18
3127699|NCT01666951|3852891|FG001|STARTED|Overall Study||18
3127700|NCT01666951|3852890|FG000|COMPLETED|Overall Study||17
3127701|NCT01666951|3852891|FG001|COMPLETED|Overall Study||17
3127702|NCT01666951|3852890|FG000|NOT COMPLETED|Overall Study||1
3127703|NCT01666951|3852891|FG001|NOT COMPLETED|Overall Study||1
3127704|NCT01667029|3852897|FG000|STARTED|Overall Study||4
3127705|NCT01667029|3852898|FG001|STARTED|Overall Study||4
3127706|NCT01667029|3852897|FG000|COMPLETED|Overall Study||3
3127707|NCT01667029|3852898|FG001|COMPLETED|Overall Study||3
3127708|NCT01667029|3852897|FG000|NOT COMPLETED|Overall Study||1
3127709|NCT01667029|3852898|FG001|NOT COMPLETED|Overall Study||1
3127710|NCT01667107|3852906|FG000|STARTED|Overall Study||8
3127711|NCT01667107|3852907|FG001|STARTED|Overall Study||18
3127712|NCT01667107|3852906|FG000|COMPLETED|Overall Study||4
3127713|NCT01667107|3852907|FG001|COMPLETED|Overall Study||11
3127714|NCT01667107|3852906|FG000|NOT COMPLETED|Overall Study||4
3127715|NCT01667107|3852907|FG001|NOT COMPLETED|Overall Study||7
3127716|NCT01667224|3852915|FG000|STARTED|Overall Study||40
3127717|NCT01667224|3852916|FG001|STARTED|Overall Study||40
3127718|NCT01667224|3852915|FG000|COMPLETED|Overall Study||36
3127719|NCT01667224|3852916|FG001|COMPLETED|Overall Study||38
3127720|NCT01667224|3852915|FG000|NOT COMPLETED|Overall Study||4
3127721|NCT01667224|3852916|FG001|NOT COMPLETED|Overall Study||2
3127722|NCT01667250|3852926|FG000|STARTED|Run-in (no Treatment)||0
3127723|NCT01667250|3852927|FG001|STARTED|Run-in (no Treatment)||0
3127724|NCT01667250|3852928|FG002|STARTED|Run-in (no Treatment)||73
3127725|NCT01667250|3852926|FG000|COMPLETED|Run-in (no Treatment)||0
3127726|NCT01667250|3852927|FG001|COMPLETED|Run-in (no Treatment)||0
3127727|NCT01667250|3852928|FG002|COMPLETED|Run-in (no Treatment)||59
3127728|NCT01667250|3852926|FG000|NOT COMPLETED|Run-in (no Treatment)||0
3127729|NCT01667250|3852927|FG001|NOT COMPLETED|Run-in (no Treatment)||0
3127730|NCT01667250|3852928|FG002|NOT COMPLETED|Run-in (no Treatment)||14
3127731|NCT01667250|3852926|FG000|STARTED|Randomised Period||30
3127732|NCT01667250|3852927|FG001|STARTED|Randomised Period||29
3127733|NCT01667250|3852928|FG002|STARTED|Randomised Period||0
3127734|NCT01667250|3852926|FG000|COMPLETED|Randomised Period||29
3127735|NCT01667250|3852927|FG001|COMPLETED|Randomised Period||28
3127736|NCT01667250|3852928|FG002|COMPLETED|Randomised Period||0
3127737|NCT01667250|3852926|FG000|NOT COMPLETED|Randomised Period||1
3127738|NCT01667250|3852927|FG001|NOT COMPLETED|Randomised Period||1
3127739|NCT01667250|3852928|FG002|NOT COMPLETED|Randomised Period||0
3127740|NCT01667406|3852945|FG000|STARTED|Overall Study||2
3127741|NCT01667406|3852946|FG001|STARTED|Overall Study||3
3127742|NCT01667406|3852947|FG002|STARTED|Overall Study||24
3127743|NCT01667406|3852948|FG003|STARTED|Overall Study||24
3127744|NCT01667406|3852949|FG004|STARTED|Overall Study||5
3127745|NCT01667406|3852950|FG005|STARTED|Overall Study||20
3127746|NCT01667406|3852951|FG006|STARTED|Overall Study||15
3127747|NCT01667406|3852952|FG007|STARTED|Overall Study||20
3127748|NCT01667406|3852953|FG008|STARTED|Overall Study||31
3127749|NCT01667406|3852954|FG009|STARTED|Overall Study||31
3127750|NCT01667406|3852945|FG000|COMPLETED|Overall Study||2
3127751|NCT01667406|3852946|FG001|COMPLETED|Overall Study||3
3127752|NCT01667406|3852947|FG002|COMPLETED|Overall Study||24
3127753|NCT01667406|3852948|FG003|COMPLETED|Overall Study||24
3127754|NCT01667406|3852949|FG004|COMPLETED|Overall Study||5
3127755|NCT01667406|3852950|FG005|COMPLETED|Overall Study||20
3127756|NCT01667406|3852951|FG006|COMPLETED|Overall Study||15
3127757|NCT01667406|3852952|FG007|COMPLETED|Overall Study||20
3127758|NCT01667406|3852953|FG008|COMPLETED|Overall Study||31
3127759|NCT01667406|3852954|FG009|COMPLETED|Overall Study||31
3127760|NCT01667406|3852945|FG000|NOT COMPLETED|Overall Study||0
3127761|NCT01667406|3852946|FG001|NOT COMPLETED|Overall Study||0
3127762|NCT01667406|3852947|FG002|NOT COMPLETED|Overall Study||0
3127763|NCT01667406|3852948|FG003|NOT COMPLETED|Overall Study||0
3127764|NCT01667406|3852949|FG004|NOT COMPLETED|Overall Study||0
3127765|NCT01667406|3852950|FG005|NOT COMPLETED|Overall Study||0
3127766|NCT01667406|3852951|FG006|NOT COMPLETED|Overall Study||0
3127767|NCT01667406|3852952|FG007|NOT COMPLETED|Overall Study||0
3127768|NCT01667406|3852953|FG008|NOT COMPLETED|Overall Study||0
3127769|NCT01667406|3852954|FG009|NOT COMPLETED|Overall Study||0
3127770|NCT01667419|3853010|FG000|STARTED|Overall Study||157
3127771|NCT01667419|3853011|FG001|STARTED|Overall Study||157
3127772|NCT01667419|3853012|FG002|STARTED|Overall Study||93
3127773|NCT01667419|3853013|FG003|STARTED|Overall Study||91
3127774|NCT01667419|3853010|FG000|COMPLETED|Overall Study||114
3127775|NCT01667419|3853011|FG001|COMPLETED|Overall Study||110
3127776|NCT01667419|3853012|FG002|COMPLETED|Overall Study||57
3127777|NCT01667419|3853013|FG003|COMPLETED|Overall Study||52
3127778|NCT01667419|3853010|FG000|NOT COMPLETED|Overall Study||43
3127779|NCT01667419|3853011|FG001|NOT COMPLETED|Overall Study||47
3127780|NCT01667419|3853012|FG002|NOT COMPLETED|Overall Study||36
3127781|NCT01667419|3853013|FG003|NOT COMPLETED|Overall Study||39
3127782|NCT01667432|3853024|FG000|STARTED|Overall Study||141
3127783|NCT01667432|3853024|FG000|COMPLETED|Overall Study||84
3127784|NCT01667432|3853024|FG000|NOT COMPLETED|Overall Study||57
3127785|NCT01667471|3853028|FG000|STARTED|Overall Study||7
3127786|NCT01667471|3853028|FG000|COMPLETED|Overall Study||7
3127787|NCT01667471|3853028|FG000|NOT COMPLETED|Overall Study||0
3127788|NCT01667536|3853033|FG000|STARTED|Overall Study||105
3127789|NCT01667536|3853033|FG000|COMPLETED|Overall Study|105 subjects comprised the safety popn, defined as all subjects who received an MIP-1404 injection.|105
3127790|NCT01667536|3853033|FG000|NOT COMPLETED|Overall Study||0
3127791|NCT01667549|3853045|FG000|STARTED|Overall Study|20 dyads=20 infants, 20 mothers|20
3127792|NCT01667549|3853046|FG001|STARTED|Overall Study|20 dyads=20 infants, 20 mothers|20
3127793|NCT01667549|3853047|FG002|STARTED|Overall Study|21 dyads=21 infants, 21 mothers|21
3127794|NCT01667549|3853048|FG003|STARTED|Overall Study|20 dyads= 20 infants, 20 mothers|20
3127795|NCT01667549|3853049|FG004|STARTED|Overall Study|16 dyads=16 infants, 16 mothers|16
3127796|NCT01667549|3853045|FG000|COMPLETED|Overall Study|17 dyads=17 infants, 17 mothers|17
3127797|NCT01667549|3853046|FG001|COMPLETED|Overall Study|15 dyads=15 infants, 15 mothers|15
3127798|NCT01667549|3853047|FG002|COMPLETED|Overall Study|14 dyads=14 infants, 14 mothers|14
3127799|NCT01667549|3853048|FG003|COMPLETED|Overall Study|14 dyads= 14 infants, 14 mothers|14
3127800|NCT01667549|3853049|FG004|COMPLETED|Overall Study|15 dyads=15 infants, 15 mothers|15
3127801|NCT01667549|3853045|FG000|NOT COMPLETED|Overall Study||3
3127802|NCT01667549|3853046|FG001|NOT COMPLETED|Overall Study||5
3127803|NCT01667549|3853047|FG002|NOT COMPLETED|Overall Study||7
3127804|NCT01667549|3853048|FG003|NOT COMPLETED|Overall Study||6
3127805|NCT01667549|3853049|FG004|NOT COMPLETED|Overall Study||1
3127806|NCT01667562|3853066|FG000|STARTED|Diagnostic Phase||375
3127807|NCT01667562|3853067|FG001|STARTED|Diagnostic Phase||0
3127808|NCT01667562|3853066|FG000|COMPLETED|Diagnostic Phase||345
3127809|NCT01667562|3853067|FG001|COMPLETED|Diagnostic Phase||0
3127810|NCT01667562|3853066|FG000|NOT COMPLETED|Diagnostic Phase||30
3127811|NCT01667562|3853067|FG001|NOT COMPLETED|Diagnostic Phase||0
3127812|NCT01667562|3853066|FG000|STARTED|Erlotinib Phase||0
3127813|NCT01667562|3853067|FG001|STARTED|Erlotinib Phase||30
3127814|NCT01667562|3853066|FG000|COMPLETED|Erlotinib Phase||0
3127815|NCT01667562|3853067|FG001|COMPLETED|Erlotinib Phase||27
3127816|NCT01667562|3853066|FG000|NOT COMPLETED|Erlotinib Phase||0
3127817|NCT01667562|3853067|FG001|NOT COMPLETED|Erlotinib Phase||3
3127818|NCT01667679|3853074|FG000|STARTED|Treatment Period 1 (<=12 Weeks)||138
3127819|NCT01667679|3853075|FG001|STARTED|Treatment Period 1 (<=12 Weeks)||137
3127820|NCT01667679|3853074|FG000|COMPLETED|Treatment Period 1 (<=12 Weeks)||122
3127821|NCT01667679|3853075|FG001|COMPLETED|Treatment Period 1 (<=12 Weeks)||107
3127822|NCT01667679|3853074|FG000|NOT COMPLETED|Treatment Period 1 (<=12 Weeks)||16
3127823|NCT01667679|3853075|FG001|NOT COMPLETED|Treatment Period 1 (<=12 Weeks)||30
3127824|NCT01667679|3853074|FG000|STARTED|Treatment Period 2 (<=12 Weeks)||122
3127825|NCT01667679|3853075|FG001|STARTED|Treatment Period 2 (<=12 Weeks)||107
3127826|NCT01667679|3853074|FG000|COMPLETED|Treatment Period 2 (<=12 Weeks)||100
3127827|NCT01667679|3853075|FG001|COMPLETED|Treatment Period 2 (<=12 Weeks)||85
3127828|NCT01667679|3853074|FG000|NOT COMPLETED|Treatment Period 2 (<=12 Weeks)||22
3127829|NCT01667679|3853075|FG001|NOT COMPLETED|Treatment Period 2 (<=12 Weeks)||22
3127830|NCT01667731|3853088|FG000|STARTED|Overall Study||26
3127831|NCT01667731|3853089|FG001|STARTED|Overall Study||42
3127832|NCT01667731|3853090|FG002|STARTED|Overall Study||24
3127833|NCT01667731|3853091|FG003|STARTED|Overall Study||17
3127834|NCT01667731|3853092|FG004|STARTED|Overall Study||115
3127835|NCT01667731|3853088|FG000|COMPLETED|Overall Study||21
3127836|NCT01667731|3853089|FG001|COMPLETED|Overall Study||26
3127837|NCT01667731|3853090|FG002|COMPLETED|Overall Study||22
3127838|NCT01667731|3853091|FG003|COMPLETED|Overall Study||15
3127839|NCT01667731|3853092|FG004|COMPLETED|Overall Study||87
3127840|NCT01667731|3853088|FG000|NOT COMPLETED|Overall Study||5
3127841|NCT01667731|3853089|FG001|NOT COMPLETED|Overall Study||16
3127842|NCT01667731|3853090|FG002|NOT COMPLETED|Overall Study||2
3127843|NCT01667731|3853091|FG003|NOT COMPLETED|Overall Study||2
3127844|NCT01667731|3853092|FG004|NOT COMPLETED|Overall Study||28
3127845|NCT01667796|3853107|FG000|STARTED|Overall Study||27
3127846|NCT01667796|3853108|FG001|STARTED|Overall Study||30
3127847|NCT01667796|3853107|FG000|COMPLETED|Overall Study||24
3127848|NCT01667796|3853108|FG001|COMPLETED|Overall Study||29
3127849|NCT01667796|3853107|FG000|NOT COMPLETED|Overall Study||3
3127850|NCT01667796|3853108|FG001|NOT COMPLETED|Overall Study||1
3127851|NCT01667848|3853120|FG000|STARTED|Overall Study||67
3127852|NCT01667848|3853121|FG001|STARTED|Overall Study||81
3127853|NCT01667848|3853120|FG000|COMPLETED|Overall Study||67
3127854|NCT01667848|3853121|FG001|COMPLETED|Overall Study||81
3127855|NCT01667848|3853120|FG000|NOT COMPLETED|Overall Study||0
3127856|NCT01667848|3853121|FG001|NOT COMPLETED|Overall Study||0
3127857|NCT01667900|3853132|FG000|STARTED|Part A, Period 1||1
3127858|NCT01667900|3853133|FG001|STARTED|Part A, Period 1||1
3127859|NCT01667900|3853134|FG002|STARTED|Part A, Period 1||1
3127860|NCT01667900|3853135|FG003|STARTED|Part A, Period 1||1
3127861|NCT01667900|3853136|FG004|STARTED|Part A, Period 1||1
3127862|NCT01667900|3853137|FG005|STARTED|Part A, Period 1||1
3127863|NCT01667900|3853138|FG006|STARTED|Part A, Period 1||1
3127864|NCT01667900|3853139|FG007|STARTED|Part A, Period 1||1
3127865|NCT01667900|3853140|FG008|STARTED|Part A, Period 1||1
3127866|NCT01667900|3853141|FG009|STARTED|Part A, Period 1||1
3127867|NCT01667900|3853142|FG010|STARTED|Part A, Period 1||1
3127868|NCT01667900|3853143|FG011|STARTED|Part A, Period 1||1
3127869|NCT01667900|3853144|FG012|STARTED|Part A, Period 1||1
3127870|NCT01667900|3853145|FG013|STARTED|Part A, Period 1||1
3127871|NCT01667900|3853146|FG014|STARTED|Part A, Period 1||1
3127872|NCT01667900|3853147|FG015|STARTED|Part A, Period 1||1
3127873|NCT01667900|3853148|FG016|STARTED|Part A, Period 1|Part B participants did not participate in Part A.|0
3127874|NCT01667900|3853149|FG017|STARTED|Part A, Period 1|Part B participants did not participate in Part A.|0
3127875|NCT01667900|3853150|FG018|STARTED|Part A, Period 1|Part B participants did not participate in Part A.|0
3127876|NCT01667900|3853151|FG019|STARTED|Part A, Period 1|Part B participants did not participate in Part A.|0
3127877|NCT01667900|3853132|FG000|COMPLETED|Part A, Period 1||1
3127878|NCT01667900|3853133|FG001|COMPLETED|Part A, Period 1||1
3127879|NCT01667900|3853134|FG002|COMPLETED|Part A, Period 1||1
3127880|NCT01667900|3853135|FG003|COMPLETED|Part A, Period 1||1
3127881|NCT01667900|3853136|FG004|COMPLETED|Part A, Period 1||1
3127882|NCT01667900|3853137|FG005|COMPLETED|Part A, Period 1||1
3127883|NCT01667900|3853138|FG006|COMPLETED|Part A, Period 1||1
3127884|NCT01667900|3853139|FG007|COMPLETED|Part A, Period 1||1
3127885|NCT01667900|3853140|FG008|COMPLETED|Part A, Period 1||1
3127886|NCT01667900|3853141|FG009|COMPLETED|Part A, Period 1||1
3127887|NCT01667900|3853142|FG010|COMPLETED|Part A, Period 1||1
3127888|NCT01667900|3853143|FG011|COMPLETED|Part A, Period 1||1
3127889|NCT01667900|3853144|FG012|COMPLETED|Part A, Period 1||1
3127890|NCT01667900|3853145|FG013|COMPLETED|Part A, Period 1||1
3127891|NCT01667900|3853146|FG014|COMPLETED|Part A, Period 1||1
3127892|NCT01667900|3853147|FG015|COMPLETED|Part A, Period 1||1
3127893|NCT01667900|3853148|FG016|COMPLETED|Part A, Period 1||0
3127894|NCT01667900|3853149|FG017|COMPLETED|Part A, Period 1||0
3127895|NCT01667900|3853150|FG018|COMPLETED|Part A, Period 1||0
3127896|NCT01667900|3853151|FG019|COMPLETED|Part A, Period 1||0
3127897|NCT01667900|3853132|FG000|NOT COMPLETED|Part A, Period 1||0
3127898|NCT01667900|3853133|FG001|NOT COMPLETED|Part A, Period 1||0
3127899|NCT01667900|3853134|FG002|NOT COMPLETED|Part A, Period 1||0
3127900|NCT01667900|3853135|FG003|NOT COMPLETED|Part A, Period 1||0
3127901|NCT01667900|3853136|FG004|NOT COMPLETED|Part A, Period 1||0
3127902|NCT01667900|3853137|FG005|NOT COMPLETED|Part A, Period 1||0
3127903|NCT01667900|3853138|FG006|NOT COMPLETED|Part A, Period 1||0
3127904|NCT01667900|3853139|FG007|NOT COMPLETED|Part A, Period 1||0
3127905|NCT01667900|3853140|FG008|NOT COMPLETED|Part A, Period 1||0
3127906|NCT01667900|3853141|FG009|NOT COMPLETED|Part A, Period 1||0
3127907|NCT01667900|3853142|FG010|NOT COMPLETED|Part A, Period 1||0
3127908|NCT01667900|3853143|FG011|NOT COMPLETED|Part A, Period 1||0
3127909|NCT01667900|3853144|FG012|NOT COMPLETED|Part A, Period 1||0
3127910|NCT01667900|3853145|FG013|NOT COMPLETED|Part A, Period 1||0
3127911|NCT01667900|3853146|FG014|NOT COMPLETED|Part A, Period 1||0
3127912|NCT01667900|3853147|FG015|NOT COMPLETED|Part A, Period 1||0
3127913|NCT01667900|3853148|FG016|NOT COMPLETED|Part A, Period 1||0
3127914|NCT01667900|3853149|FG017|NOT COMPLETED|Part A, Period 1||0
3127915|NCT01667900|3853150|FG018|NOT COMPLETED|Part A, Period 1||0
3127916|NCT01667900|3853151|FG019|NOT COMPLETED|Part A, Period 1||0
3127917|NCT01667900|3853132|FG000|STARTED|Part A, Washout 1||1
3127918|NCT01667900|3853133|FG001|STARTED|Part A, Washout 1||1
3127919|NCT01667900|3853134|FG002|STARTED|Part A, Washout 1||1
3127920|NCT01667900|3853135|FG003|STARTED|Part A, Washout 1||1
3127921|NCT01667900|3853136|FG004|STARTED|Part A, Washout 1||1
3127922|NCT01667900|3853137|FG005|STARTED|Part A, Washout 1||1
3127923|NCT01667900|3853138|FG006|STARTED|Part A, Washout 1||1
3127924|NCT01667900|3853139|FG007|STARTED|Part A, Washout 1||1
3127925|NCT01667900|3853140|FG008|STARTED|Part A, Washout 1||1
3127926|NCT01667900|3853141|FG009|STARTED|Part A, Washout 1||1
3127927|NCT01667900|3853142|FG010|STARTED|Part A, Washout 1||1
3127928|NCT01667900|3853143|FG011|STARTED|Part A, Washout 1||1
3127929|NCT01667900|3853144|FG012|STARTED|Part A, Washout 1||1
3127930|NCT01667900|3853145|FG013|STARTED|Part A, Washout 1||1
3127931|NCT01667900|3853146|FG014|STARTED|Part A, Washout 1||1
3127932|NCT01667900|3853147|FG015|STARTED|Part A, Washout 1||1
3127933|NCT01667900|3853148|FG016|STARTED|Part A, Washout 1||0
3127934|NCT01667900|3853149|FG017|STARTED|Part A, Washout 1||0
3127935|NCT01667900|3853150|FG018|STARTED|Part A, Washout 1||0
3127936|NCT01667900|3853151|FG019|STARTED|Part A, Washout 1||0
3127937|NCT01667900|3853132|FG000|COMPLETED|Part A, Washout 1||1
3127938|NCT01667900|3853133|FG001|COMPLETED|Part A, Washout 1||1
3127939|NCT01667900|3853134|FG002|COMPLETED|Part A, Washout 1||1
3127940|NCT01667900|3853135|FG003|COMPLETED|Part A, Washout 1||1
3127941|NCT01667900|3853136|FG004|COMPLETED|Part A, Washout 1||1
3127942|NCT01667900|3853137|FG005|COMPLETED|Part A, Washout 1||1
3127943|NCT01667900|3853138|FG006|COMPLETED|Part A, Washout 1||1
3127944|NCT01667900|3853139|FG007|COMPLETED|Part A, Washout 1||1
3127945|NCT01667900|3853140|FG008|COMPLETED|Part A, Washout 1||1
3127946|NCT01667900|3853141|FG009|COMPLETED|Part A, Washout 1||1
3127947|NCT01667900|3853142|FG010|COMPLETED|Part A, Washout 1||1
3127948|NCT01667900|3853143|FG011|COMPLETED|Part A, Washout 1||1
3127949|NCT01667900|3853144|FG012|COMPLETED|Part A, Washout 1||1
3127950|NCT01667900|3853145|FG013|COMPLETED|Part A, Washout 1||1
3127951|NCT01667900|3853146|FG014|COMPLETED|Part A, Washout 1||1
3127952|NCT01667900|3853147|FG015|COMPLETED|Part A, Washout 1||1
3127953|NCT01667900|3853148|FG016|COMPLETED|Part A, Washout 1||0
3127954|NCT01667900|3853149|FG017|COMPLETED|Part A, Washout 1||0
3127955|NCT01667900|3853150|FG018|COMPLETED|Part A, Washout 1||0
3127956|NCT01667900|3853151|FG019|COMPLETED|Part A, Washout 1||0
3127957|NCT01667900|3853132|FG000|NOT COMPLETED|Part A, Washout 1||0
3127958|NCT01667900|3853133|FG001|NOT COMPLETED|Part A, Washout 1||0
3127959|NCT01667900|3853134|FG002|NOT COMPLETED|Part A, Washout 1||0
3127960|NCT01667900|3853135|FG003|NOT COMPLETED|Part A, Washout 1||0
3127961|NCT01667900|3853136|FG004|NOT COMPLETED|Part A, Washout 1||0
3127962|NCT01667900|3853137|FG005|NOT COMPLETED|Part A, Washout 1||0
3127963|NCT01667900|3853138|FG006|NOT COMPLETED|Part A, Washout 1||0
3127964|NCT01667900|3853139|FG007|NOT COMPLETED|Part A, Washout 1||0
3127965|NCT01667900|3853140|FG008|NOT COMPLETED|Part A, Washout 1||0
3127966|NCT01667900|3853141|FG009|NOT COMPLETED|Part A, Washout 1||0
3127967|NCT01667900|3853142|FG010|NOT COMPLETED|Part A, Washout 1||0
3127968|NCT01667900|3853143|FG011|NOT COMPLETED|Part A, Washout 1||0
3127969|NCT01667900|3853144|FG012|NOT COMPLETED|Part A, Washout 1||0
3127970|NCT01667900|3853145|FG013|NOT COMPLETED|Part A, Washout 1||0
3127971|NCT01667900|3853146|FG014|NOT COMPLETED|Part A, Washout 1||0
3127972|NCT01667900|3853147|FG015|NOT COMPLETED|Part A, Washout 1||0
3127973|NCT01667900|3853148|FG016|NOT COMPLETED|Part A, Washout 1||0
3127974|NCT01667900|3853149|FG017|NOT COMPLETED|Part A, Washout 1||0
3127975|NCT01667900|3853150|FG018|NOT COMPLETED|Part A, Washout 1||0
3127976|NCT01667900|3853151|FG019|NOT COMPLETED|Part A, Washout 1||0
3127977|NCT01667900|3853132|FG000|STARTED|Part A, Period 2||1
3127978|NCT01667900|3853133|FG001|STARTED|Part A, Period 2||1
3127979|NCT01667900|3853134|FG002|STARTED|Part A, Period 2||1
3127980|NCT01667900|3853135|FG003|STARTED|Part A, Period 2||1
3127981|NCT01667900|3853136|FG004|STARTED|Part A, Period 2||1
3127982|NCT01667900|3853137|FG005|STARTED|Part A, Period 2||1
3127983|NCT01667900|3853138|FG006|STARTED|Part A, Period 2||1
3127984|NCT01667900|3853139|FG007|STARTED|Part A, Period 2||1
3127985|NCT01667900|3853140|FG008|STARTED|Part A, Period 2||1
3127986|NCT01667900|3853141|FG009|STARTED|Part A, Period 2||1
3127987|NCT01667900|3853142|FG010|STARTED|Part A, Period 2||1
3127988|NCT01667900|3853143|FG011|STARTED|Part A, Period 2||1
3127989|NCT01667900|3853144|FG012|STARTED|Part A, Period 2||1
3127990|NCT01667900|3853145|FG013|STARTED|Part A, Period 2||1
3127991|NCT01667900|3853146|FG014|STARTED|Part A, Period 2||1
3127992|NCT01667900|3853147|FG015|STARTED|Part A, Period 2||1
3127993|NCT01667900|3853148|FG016|STARTED|Part A, Period 2||0
3127994|NCT01667900|3853149|FG017|STARTED|Part A, Period 2||0
3127995|NCT01667900|3853150|FG018|STARTED|Part A, Period 2||0
3127996|NCT01667900|3853151|FG019|STARTED|Part A, Period 2||0
3127997|NCT01667900|3853132|FG000|COMPLETED|Part A, Period 2||1
3127998|NCT01667900|3853133|FG001|COMPLETED|Part A, Period 2||1
3127999|NCT01667900|3853134|FG002|COMPLETED|Part A, Period 2||1
3128000|NCT01667900|3853135|FG003|COMPLETED|Part A, Period 2||1
3128001|NCT01667900|3853136|FG004|COMPLETED|Part A, Period 2||1
3128002|NCT01667900|3853137|FG005|COMPLETED|Part A, Period 2||1
3128003|NCT01667900|3853138|FG006|COMPLETED|Part A, Period 2||1
3128004|NCT01667900|3853139|FG007|COMPLETED|Part A, Period 2||1
3128005|NCT01667900|3853140|FG008|COMPLETED|Part A, Period 2||1
3128006|NCT01667900|3853141|FG009|COMPLETED|Part A, Period 2||1
3128007|NCT01667900|3853142|FG010|COMPLETED|Part A, Period 2||1
3128008|NCT01667900|3853143|FG011|COMPLETED|Part A, Period 2||1
3128009|NCT01667900|3853144|FG012|COMPLETED|Part A, Period 2||1
3128010|NCT01667900|3853145|FG013|COMPLETED|Part A, Period 2||1
3128011|NCT01667900|3853146|FG014|COMPLETED|Part A, Period 2||1
3128012|NCT01667900|3853147|FG015|COMPLETED|Part A, Period 2||1
3128013|NCT01667900|3853148|FG016|COMPLETED|Part A, Period 2||0
3128014|NCT01667900|3853149|FG017|COMPLETED|Part A, Period 2||0
3128015|NCT01667900|3853150|FG018|COMPLETED|Part A, Period 2||0
3128016|NCT01667900|3853151|FG019|COMPLETED|Part A, Period 2||0
3128017|NCT01667900|3853132|FG000|NOT COMPLETED|Part A, Period 2||0
3128018|NCT01667900|3853133|FG001|NOT COMPLETED|Part A, Period 2||0
3128019|NCT01667900|3853134|FG002|NOT COMPLETED|Part A, Period 2||0
3128020|NCT01667900|3853135|FG003|NOT COMPLETED|Part A, Period 2||0
3128021|NCT01667900|3853136|FG004|NOT COMPLETED|Part A, Period 2||0
3128022|NCT01667900|3853137|FG005|NOT COMPLETED|Part A, Period 2||0
3128023|NCT01667900|3853138|FG006|NOT COMPLETED|Part A, Period 2||0
3128024|NCT01667900|3853139|FG007|NOT COMPLETED|Part A, Period 2||0
3128025|NCT01667900|3853140|FG008|NOT COMPLETED|Part A, Period 2||0
3128026|NCT01667900|3853141|FG009|NOT COMPLETED|Part A, Period 2||0
3128027|NCT01667900|3853142|FG010|NOT COMPLETED|Part A, Period 2||0
3128028|NCT01667900|3853143|FG011|NOT COMPLETED|Part A, Period 2||0
3128029|NCT01667900|3853144|FG012|NOT COMPLETED|Part A, Period 2||0
3128030|NCT01667900|3853145|FG013|NOT COMPLETED|Part A, Period 2||0
3128031|NCT01667900|3853146|FG014|NOT COMPLETED|Part A, Period 2||0
3128032|NCT01667900|3853147|FG015|NOT COMPLETED|Part A, Period 2||0
3128033|NCT01667900|3853148|FG016|NOT COMPLETED|Part A, Period 2||0
3128034|NCT01667900|3853149|FG017|NOT COMPLETED|Part A, Period 2||0
3128035|NCT01667900|3853150|FG018|NOT COMPLETED|Part A, Period 2||0
3128036|NCT01667900|3853151|FG019|NOT COMPLETED|Part A, Period 2||0
3128037|NCT01667900|3853132|FG000|STARTED|Part A, Washout 2||1
3128038|NCT01667900|3853133|FG001|STARTED|Part A, Washout 2||1
3128039|NCT01667900|3853134|FG002|STARTED|Part A, Washout 2||1
3128040|NCT01667900|3853135|FG003|STARTED|Part A, Washout 2||1
3128041|NCT01667900|3853136|FG004|STARTED|Part A, Washout 2||1
3128042|NCT01667900|3853137|FG005|STARTED|Part A, Washout 2||1
3296379|NCT02906670|4030249|FG001|NOT COMPLETED|Cohort 4, Q2W||0
3296380|NCT02906670|4030250|FG002|NOT COMPLETED|Cohort 4, Q2W||0
3296381|NCT02906670|4030251|FG003|NOT COMPLETED|Cohort 4, Q2W||0
3296382|NCT02906670|4030252|FG004|NOT COMPLETED|Cohort 4, Q2W||0
3128043|NCT01667900|3853138|FG006|STARTED|Part A, Washout 2||1
3128044|NCT01667900|3853139|FG007|STARTED|Part A, Washout 2||1
3128045|NCT01667900|3853140|FG008|STARTED|Part A, Washout 2||1
3128046|NCT01667900|3853141|FG009|STARTED|Part A, Washout 2||1
3128047|NCT01667900|3853142|FG010|STARTED|Part A, Washout 2||1
3128048|NCT01667900|3853143|FG011|STARTED|Part A, Washout 2||1
3128049|NCT01667900|3853144|FG012|STARTED|Part A, Washout 2||1
3128050|NCT01667900|3853145|FG013|STARTED|Part A, Washout 2||1
3296383|NCT02906670|4030253|FG005|NOT COMPLETED|Cohort 4, Q2W||3
3296384|NCT02906670|4030254|FG006|NOT COMPLETED|Cohort 4, Q2W||0
3128051|NCT01667900|3853146|FG014|STARTED|Part A, Washout 2||1
3128052|NCT01667900|3853147|FG015|STARTED|Part A, Washout 2||1
3128053|NCT01667900|3853148|FG016|STARTED|Part A, Washout 2||0
3128054|NCT01667900|3853149|FG017|STARTED|Part A, Washout 2||0
3128055|NCT01667900|3853150|FG018|STARTED|Part A, Washout 2||0
3128056|NCT01667900|3853151|FG019|STARTED|Part A, Washout 2||0
3128057|NCT01667900|3853132|FG000|COMPLETED|Part A, Washout 2||1
3128058|NCT01667900|3853133|FG001|COMPLETED|Part A, Washout 2||1
3128059|NCT01667900|3853134|FG002|COMPLETED|Part A, Washout 2||1
3128060|NCT01667900|3853135|FG003|COMPLETED|Part A, Washout 2||1
3128061|NCT01667900|3853136|FG004|COMPLETED|Part A, Washout 2||1
3128062|NCT01667900|3853137|FG005|COMPLETED|Part A, Washout 2||1
3128063|NCT01667900|3853138|FG006|COMPLETED|Part A, Washout 2||1
3128064|NCT01667900|3853139|FG007|COMPLETED|Part A, Washout 2||1
3128065|NCT01667900|3853140|FG008|COMPLETED|Part A, Washout 2||1
3128066|NCT01667900|3853141|FG009|COMPLETED|Part A, Washout 2||1
3128067|NCT01667900|3853142|FG010|COMPLETED|Part A, Washout 2||1
3128068|NCT01667900|3853143|FG011|COMPLETED|Part A, Washout 2||1
3128069|NCT01667900|3853144|FG012|COMPLETED|Part A, Washout 2||1
3128070|NCT01667900|3853145|FG013|COMPLETED|Part A, Washout 2||1
3128071|NCT01667900|3853146|FG014|COMPLETED|Part A, Washout 2||1
3128072|NCT01667900|3853147|FG015|COMPLETED|Part A, Washout 2||1
3128073|NCT01667900|3853148|FG016|COMPLETED|Part A, Washout 2||0
3128074|NCT01667900|3853149|FG017|COMPLETED|Part A, Washout 2||0
3128075|NCT01667900|3853150|FG018|COMPLETED|Part A, Washout 2||0
3128076|NCT01667900|3853151|FG019|COMPLETED|Part A, Washout 2||0
3128077|NCT01667900|3853132|FG000|NOT COMPLETED|Part A, Washout 2||0
3128078|NCT01667900|3853133|FG001|NOT COMPLETED|Part A, Washout 2||0
3128079|NCT01667900|3853134|FG002|NOT COMPLETED|Part A, Washout 2||0
3128080|NCT01667900|3853135|FG003|NOT COMPLETED|Part A, Washout 2||0
3128081|NCT01667900|3853136|FG004|NOT COMPLETED|Part A, Washout 2||0
3128082|NCT01667900|3853137|FG005|NOT COMPLETED|Part A, Washout 2||0
3128083|NCT01667900|3853138|FG006|NOT COMPLETED|Part A, Washout 2||0
3128084|NCT01667900|3853139|FG007|NOT COMPLETED|Part A, Washout 2||0
3128085|NCT01667900|3853140|FG008|NOT COMPLETED|Part A, Washout 2||0
3128086|NCT01667900|3853141|FG009|NOT COMPLETED|Part A, Washout 2||0
3128087|NCT01667900|3853142|FG010|NOT COMPLETED|Part A, Washout 2||0
3128088|NCT01667900|3853143|FG011|NOT COMPLETED|Part A, Washout 2||0
3128089|NCT01667900|3853144|FG012|NOT COMPLETED|Part A, Washout 2||0
3128090|NCT01667900|3853145|FG013|NOT COMPLETED|Part A, Washout 2||0
3128091|NCT01667900|3853146|FG014|NOT COMPLETED|Part A, Washout 2||0
3128092|NCT01667900|3853147|FG015|NOT COMPLETED|Part A, Washout 2||0
3128093|NCT01667900|3853148|FG016|NOT COMPLETED|Part A, Washout 2||0
3128094|NCT01667900|3853149|FG017|NOT COMPLETED|Part A, Washout 2||0
3128095|NCT01667900|3853150|FG018|NOT COMPLETED|Part A, Washout 2||0
3128096|NCT01667900|3853151|FG019|NOT COMPLETED|Part A, Washout 2||0
3128097|NCT01667900|3853132|FG000|STARTED|Part A, Period 3||1
3128098|NCT01667900|3853133|FG001|STARTED|Part A, Period 3||1
3128099|NCT01667900|3853134|FG002|STARTED|Part A, Period 3||1
3128100|NCT01667900|3853135|FG003|STARTED|Part A, Period 3||1
3128101|NCT01667900|3853136|FG004|STARTED|Part A, Period 3||1
3128102|NCT01667900|3853137|FG005|STARTED|Part A, Period 3||1
3128103|NCT01667900|3853138|FG006|STARTED|Part A, Period 3||1
3128104|NCT01667900|3853139|FG007|STARTED|Part A, Period 3||1
3128105|NCT01667900|3853140|FG008|STARTED|Part A, Period 3||1
3128106|NCT01667900|3853141|FG009|STARTED|Part A, Period 3||1
3128107|NCT01667900|3853142|FG010|STARTED|Part A, Period 3||1
3128108|NCT01667900|3853143|FG011|STARTED|Part A, Period 3||1
3128109|NCT01667900|3853144|FG012|STARTED|Part A, Period 3||1
3128110|NCT01667900|3853145|FG013|STARTED|Part A, Period 3||1
3128111|NCT01667900|3853146|FG014|STARTED|Part A, Period 3||1
3128112|NCT01667900|3853147|FG015|STARTED|Part A, Period 3||1
3128113|NCT01667900|3853148|FG016|STARTED|Part A, Period 3||0
3128114|NCT01667900|3853149|FG017|STARTED|Part A, Period 3||0
3128115|NCT01667900|3853150|FG018|STARTED|Part A, Period 3||0
3128116|NCT01667900|3853151|FG019|STARTED|Part A, Period 3||0
3128117|NCT01667900|3853132|FG000|COMPLETED|Part A, Period 3||1
3128118|NCT01667900|3853133|FG001|COMPLETED|Part A, Period 3||1
3128119|NCT01667900|3853134|FG002|COMPLETED|Part A, Period 3||1
3128120|NCT01667900|3853135|FG003|COMPLETED|Part A, Period 3||1
3128121|NCT01667900|3853136|FG004|COMPLETED|Part A, Period 3||1
3128122|NCT01667900|3853137|FG005|COMPLETED|Part A, Period 3||1
3128123|NCT01667900|3853138|FG006|COMPLETED|Part A, Period 3||1
3128124|NCT01667900|3853139|FG007|COMPLETED|Part A, Period 3||1
3128125|NCT01667900|3853140|FG008|COMPLETED|Part A, Period 3||1
3128126|NCT01667900|3853141|FG009|COMPLETED|Part A, Period 3||1
3128127|NCT01667900|3853142|FG010|COMPLETED|Part A, Period 3||1
3128128|NCT01667900|3853143|FG011|COMPLETED|Part A, Period 3||1
3128129|NCT01667900|3853144|FG012|COMPLETED|Part A, Period 3||1
3128130|NCT01667900|3853145|FG013|COMPLETED|Part A, Period 3||1
3128131|NCT01667900|3853146|FG014|COMPLETED|Part A, Period 3||1
3128132|NCT01667900|3853147|FG015|COMPLETED|Part A, Period 3||1
3128133|NCT01667900|3853148|FG016|COMPLETED|Part A, Period 3||0
3128134|NCT01667900|3853149|FG017|COMPLETED|Part A, Period 3||0
3128135|NCT01667900|3853150|FG018|COMPLETED|Part A, Period 3||0
3128136|NCT01667900|3853151|FG019|COMPLETED|Part A, Period 3||0
3128137|NCT01667900|3853132|FG000|NOT COMPLETED|Part A, Period 3||0
3128138|NCT01667900|3853133|FG001|NOT COMPLETED|Part A, Period 3||0
3128139|NCT01667900|3853134|FG002|NOT COMPLETED|Part A, Period 3||0
3128140|NCT01667900|3853135|FG003|NOT COMPLETED|Part A, Period 3||0
3128141|NCT01667900|3853136|FG004|NOT COMPLETED|Part A, Period 3||0
3128142|NCT01667900|3853137|FG005|NOT COMPLETED|Part A, Period 3||0
3128143|NCT01667900|3853138|FG006|NOT COMPLETED|Part A, Period 3||0
3128144|NCT01667900|3853139|FG007|NOT COMPLETED|Part A, Period 3||0
3128145|NCT01667900|3853140|FG008|NOT COMPLETED|Part A, Period 3||0
3128146|NCT01667900|3853141|FG009|NOT COMPLETED|Part A, Period 3||0
3128147|NCT01667900|3853142|FG010|NOT COMPLETED|Part A, Period 3||0
3128148|NCT01667900|3853143|FG011|NOT COMPLETED|Part A, Period 3||0
3128149|NCT01667900|3853144|FG012|NOT COMPLETED|Part A, Period 3||0
3128150|NCT01667900|3853145|FG013|NOT COMPLETED|Part A, Period 3||0
3128151|NCT01667900|3853146|FG014|NOT COMPLETED|Part A, Period 3||0
3128152|NCT01667900|3853147|FG015|NOT COMPLETED|Part A, Period 3||0
3128153|NCT01667900|3853148|FG016|NOT COMPLETED|Part A, Period 3||0
3128154|NCT01667900|3853149|FG017|NOT COMPLETED|Part A, Period 3||0
3128155|NCT01667900|3853150|FG018|NOT COMPLETED|Part A, Period 3||0
3128156|NCT01667900|3853151|FG019|NOT COMPLETED|Part A, Period 3||0
3128157|NCT01667900|3853132|FG000|STARTED|Part B|Part A participants did not participate in Part B.|0
3128158|NCT01667900|3853133|FG001|STARTED|Part B|Part A participants did not participate in Part B.|0
3128159|NCT01667900|3853134|FG002|STARTED|Part B|Part A participants did not participate in Part B.|0
3128160|NCT01667900|3853135|FG003|STARTED|Part B|Part A participants did not participate in Part B.|0
3128161|NCT01667900|3853136|FG004|STARTED|Part B|Part A participants did not participate in Part B.|0
3128162|NCT01667900|3853137|FG005|STARTED|Part B|Part A participants did not participate in Part B.|0
3128163|NCT01667900|3853138|FG006|STARTED|Part B|Part A participants did not participate in Part B.|0
3128164|NCT01667900|3853139|FG007|STARTED|Part B|Part A participants did not participate in Part B.|0
3128165|NCT01667900|3853140|FG008|STARTED|Part B|Part A participants did not participate in Part B.|0
3128166|NCT01667900|3853141|FG009|STARTED|Part B|Part A participants did not participate in Part B.|0
3128167|NCT01667900|3853142|FG010|STARTED|Part B|Part A participants did not participate in Part B.|0
3128168|NCT01667900|3853143|FG011|STARTED|Part B|Part A participants did not participate in Part B.|0
3128169|NCT01667900|3853144|FG012|STARTED|Part B|Part A participants did not participate in Part B.|0
3128170|NCT01667900|3853145|FG013|STARTED|Part B|Part A participants did not participate in Part B.|0
3128171|NCT01667900|3853146|FG014|STARTED|Part B|Part A participants did not participate in Part B.|0
3128172|NCT01667900|3853147|FG015|STARTED|Part B|Part A participants did not participate in Part B.|0
3128173|NCT01667900|3853148|FG016|STARTED|Part B||11
3128174|NCT01667900|3853149|FG017|STARTED|Part B||11
3128175|NCT01667900|3853150|FG018|STARTED|Part B||10
3128176|NCT01667900|3853151|FG019|STARTED|Part B||10
3128177|NCT01667900|3853132|FG000|COMPLETED|Part B||0
3128178|NCT01667900|3853133|FG001|COMPLETED|Part B||0
3128179|NCT01667900|3853134|FG002|COMPLETED|Part B||0
3128180|NCT01667900|3853135|FG003|COMPLETED|Part B||0
3128181|NCT01667900|3853136|FG004|COMPLETED|Part B||0
3128182|NCT01667900|3853137|FG005|COMPLETED|Part B||0
3128183|NCT01667900|3853138|FG006|COMPLETED|Part B||0
3128184|NCT01667900|3853139|FG007|COMPLETED|Part B||0
3128185|NCT01667900|3853140|FG008|COMPLETED|Part B||0
3128186|NCT01667900|3853141|FG009|COMPLETED|Part B||0
3128187|NCT01667900|3853142|FG010|COMPLETED|Part B||0
3128188|NCT01667900|3853143|FG011|COMPLETED|Part B||0
3128189|NCT01667900|3853144|FG012|COMPLETED|Part B||0
3128190|NCT01667900|3853145|FG013|COMPLETED|Part B||0
3128191|NCT01667900|3853146|FG014|COMPLETED|Part B||0
3128192|NCT01667900|3853147|FG015|COMPLETED|Part B||0
3128193|NCT01667900|3853148|FG016|COMPLETED|Part B||10
3128194|NCT01667900|3853149|FG017|COMPLETED|Part B||11
3128195|NCT01667900|3853150|FG018|COMPLETED|Part B||10
3128196|NCT01667900|3853151|FG019|COMPLETED|Part B||10
3128197|NCT01667900|3853132|FG000|NOT COMPLETED|Part B||0
3128198|NCT01667900|3853133|FG001|NOT COMPLETED|Part B||0
3128199|NCT01667900|3853134|FG002|NOT COMPLETED|Part B||0
3128200|NCT01667900|3853135|FG003|NOT COMPLETED|Part B||0
3128201|NCT01667900|3853136|FG004|NOT COMPLETED|Part B||0
3128202|NCT01667900|3853137|FG005|NOT COMPLETED|Part B||0
3128203|NCT01667900|3853138|FG006|NOT COMPLETED|Part B||0
3128204|NCT01667900|3853139|FG007|NOT COMPLETED|Part B||0
3128205|NCT01667900|3853140|FG008|NOT COMPLETED|Part B||0
3128206|NCT01667900|3853141|FG009|NOT COMPLETED|Part B||0
3128207|NCT01667900|3853142|FG010|NOT COMPLETED|Part B||0
3128208|NCT01667900|3853143|FG011|NOT COMPLETED|Part B||0
3128209|NCT01667900|3853144|FG012|NOT COMPLETED|Part B||0
3128210|NCT01667900|3853145|FG013|NOT COMPLETED|Part B||0
3128211|NCT01667900|3853146|FG014|NOT COMPLETED|Part B||0
3128212|NCT01667900|3853147|FG015|NOT COMPLETED|Part B||0
3128213|NCT01667900|3853148|FG016|NOT COMPLETED|Part B||1
3128214|NCT01667900|3853149|FG017|NOT COMPLETED|Part B||0
3128215|NCT01667900|3853150|FG018|NOT COMPLETED|Part B||0
3128216|NCT01667900|3853151|FG019|NOT COMPLETED|Part B||0
3128217|NCT01667926|3853173|FG000|STARTED|Overall Study||13
3128218|NCT01667926|3853174|FG001|STARTED|Overall Study||13
3128219|NCT01667926|3853175|FG002|STARTED|Overall Study||11
3128220|NCT01667926|3853173|FG000|COMPLETED|Overall Study||8
3128221|NCT01667926|3853174|FG001|COMPLETED|Overall Study||9
3128222|NCT01667926|3853175|FG002|COMPLETED|Overall Study|Participants in the screen fail group were not randomized in the study.|0
3128223|NCT01667926|3853173|FG000|NOT COMPLETED|Overall Study||5
3128224|NCT01667926|3853174|FG001|NOT COMPLETED|Overall Study||4
3128225|NCT01667926|3853175|FG002|NOT COMPLETED|Overall Study||11
3128226|NCT01667978|3853183|FG000|STARTED|Overall Study||18
3128227|NCT01667978|3853184|FG001|STARTED|Overall Study||17
3128228|NCT01667978|3853183|FG000|COMPLETED|Overall Study||16
3128229|NCT01667978|3853184|FG001|COMPLETED|Overall Study||17
3128230|NCT01667978|3853183|FG000|NOT COMPLETED|Overall Study||2
3128231|NCT01667978|3853184|FG001|NOT COMPLETED|Overall Study||0
3128232|NCT01668004|3853190|FG000|STARTED|Overall Study||101
3128233|NCT01668004|3853190|FG000|Treated|Overall Study||101
3128234|NCT01668004|3853190|FG000|COMPLETED|Overall Study||76
3128235|NCT01668004|3853190|FG000|NOT COMPLETED|Overall Study||25
3128236|NCT01668017|3853201|FG000|STARTED|Overall Study||4
3128237|NCT01668017|3853202|FG001|STARTED|Overall Study||9
3128238|NCT01668017|3853203|FG002|STARTED|Overall Study||6
3128239|NCT01668017|3853204|FG003|STARTED|Overall Study||5
3128240|NCT01668017|3853205|FG004|STARTED|Overall Study||2
3128241|NCT01668017|3853201|FG000|COMPLETED|Overall Study||4
3128242|NCT01668017|3853202|FG001|COMPLETED|Overall Study||9
3128243|NCT01668017|3853203|FG002|COMPLETED|Overall Study||6
3128244|NCT01668017|3853204|FG003|COMPLETED|Overall Study||5
3128245|NCT01668017|3853205|FG004|COMPLETED|Overall Study||2
3128246|NCT01668017|3853201|FG000|NOT COMPLETED|Overall Study||0
3128247|NCT01668017|3853202|FG001|NOT COMPLETED|Overall Study||0
3128248|NCT01668017|3853203|FG002|NOT COMPLETED|Overall Study||0
3128249|NCT01668017|3853204|FG003|NOT COMPLETED|Overall Study||0
3128250|NCT01668017|3853205|FG004|NOT COMPLETED|Overall Study||0
3128251|NCT01668030|3853232|FG000|STARTED|Overall Study||10
3128252|NCT01668030|3853233|FG001|STARTED|Overall Study||10
3128253|NCT01668030|3853232|FG000|COMPLETED|Overall Study||10
3128254|NCT01668030|3853233|FG001|COMPLETED|Overall Study||10
3128255|NCT01668030|3853232|FG000|NOT COMPLETED|Overall Study||0
3128256|NCT01668030|3853233|FG001|NOT COMPLETED|Overall Study||0
3128257|NCT01668173|3853238|FG000|STARTED|Overall Study||7
3128258|NCT01668173|3853238|FG000|COMPLETED|Overall Study||0
3128259|NCT01668173|3853238|FG000|NOT COMPLETED|Overall Study||7
3128260|NCT01668355|3853244|FG000|STARTED|Overall Study||164
3128261|NCT01668355|3853245|FG001|STARTED|Overall Study||167
3128262|NCT01668355|3853244|FG000|COMPLETED|Overall Study||155
3128263|NCT01668355|3853245|FG001|COMPLETED|Overall Study||165
3128264|NCT01668355|3853244|FG000|NOT COMPLETED|Overall Study||9
3128265|NCT01668355|3853245|FG001|NOT COMPLETED|Overall Study||2
3128266|NCT01668537|3853254|FG000|STARTED|Overall Study||327
3128267|NCT01668537|3853255|FG001|STARTED|Overall Study||324
3128268|NCT01668537|3853254|FG000|COMPLETED|Overall Study||305
3128269|NCT01668537|3853255|FG001|COMPLETED|Overall Study||314
3128270|NCT01668537|3853254|FG000|NOT COMPLETED|Overall Study||22
3128271|NCT01668537|3853255|FG001|NOT COMPLETED|Overall Study||10
3128272|NCT01668589|3853265|FG000|STARTED|Overall Study||600
3128273|NCT01668589|3853266|FG001|STARTED|Overall Study||300
3128274|NCT01668589|3853267|FG002|STARTED|Overall Study||300
3128275|NCT01668589|3853268|FG003|STARTED|Overall Study||301
3128276|NCT01668589|3853265|FG000|Received Denosumab|Overall Study||599
3128277|NCT01668589|3853266|FG001|Received Denosumab|Overall Study||300
3128278|NCT01668589|3853267|FG002|Received Denosumab|Overall Study||300
3128279|NCT01668589|3853268|FG003|Received Denosumab|Overall Study||301
3128280|NCT01668589|3853265|FG000|COMPLETED|Overall Study||461
3128281|NCT01668589|3853266|FG001|COMPLETED|Overall Study||242
3128282|NCT01668589|3853267|FG002|COMPLETED|Overall Study||265
3128283|NCT01668589|3853268|FG003|COMPLETED|Overall Study||266
3128284|NCT01668589|3853265|FG000|NOT COMPLETED|Overall Study||139
3128285|NCT01668589|3853266|FG001|NOT COMPLETED|Overall Study||58
3128286|NCT01668589|3853267|FG002|NOT COMPLETED|Overall Study||35
3128287|NCT01668589|3853268|FG003|NOT COMPLETED|Overall Study||35
3128288|NCT01668602|3853280|FG000|STARTED|Overall Study||2
3128289|NCT01668602|3853281|FG001|STARTED|Overall Study||22
3128290|NCT01668602|3853280|FG000|Cohort 2 - Began FastFES Sessions|Overall Study|This milestone does not apply to Cohort 1.|0
3128291|NCT01668602|3853281|FG001|Cohort 2 - Began FastFES Sessions|Overall Study||20
3128292|NCT01668602|3853280|FG000|Cohort 2 - Completed 3 Sessions of FastFES|Overall Study|This milestone does not apply to Cohort 1.|0
3128293|NCT01668602|3853281|FG001|Cohort 2 - Completed 3 Sessions of FastFES|Overall Study||19
3128294|NCT01668602|3853280|FG000|Cohort 2 - Began Fast Walking Sessions|Overall Study|This milestone does not apply to Cohort 1.|0
3128295|NCT01668602|3853281|FG001|Cohort 2 - Began Fast Walking Sessions|Overall Study||20
3128296|NCT01668602|3853280|FG000|Cohort 2 - Completed 3 Sessions of Fast Walking|Overall Study|This milestone does not apply to Cohort 1.|0
3128297|NCT01668602|3853281|FG001|Cohort 2 - Completed 3 Sessions of Fast Walking|Overall Study||18
3128298|NCT01668602|3853280|FG000|COMPLETED|Overall Study||2
3128299|NCT01668602|3853281|FG001|COMPLETED|Overall Study||18
3128300|NCT01668602|3853280|FG000|NOT COMPLETED|Overall Study||0
3128301|NCT01668602|3853281|FG001|NOT COMPLETED|Overall Study||4
3128302|NCT01668628|3853292|FG000|STARTED|Overall Study|5 subjects had been excluded due to protocol violation and then data of the rest were anlayzed.|349
3128303|NCT01668628|3853293|FG001|STARTED|Overall Study||359
3128304|NCT01668628|3853294|FG002|STARTED|Overall Study|2 subjects had been excluded due to protocol violation and then data of the rest were anlayzed.|367
3128305|NCT01668628|3853292|FG000|COMPLETED|Overall Study||347
3128306|NCT01668628|3853293|FG001|COMPLETED|Overall Study||359
3128307|NCT01668628|3853294|FG002|COMPLETED|Overall Study||367
3128308|NCT01668628|3853292|FG000|NOT COMPLETED|Overall Study||2
3128309|NCT01668628|3853293|FG001|NOT COMPLETED|Overall Study||0
3128310|NCT01668628|3853294|FG002|NOT COMPLETED|Overall Study||0
3128311|NCT01668654|3853306|FG000|STARTED|Overall Study||4
3128312|NCT01668654|3853306|FG000|COMPLETED|Overall Study||0
3128313|NCT01668654|3853306|FG000|NOT COMPLETED|Overall Study||4
3128314|NCT01668667|3853314|FG000|STARTED|Overall Study||126
3128315|NCT01668667|3853315|FG001|STARTED|Overall Study||125
3128316|NCT01668667|3853316|FG002|STARTED|Overall Study||125
3128317|NCT01668667|3853317|FG003|STARTED|Overall Study||125
3128318|NCT01668667|3853314|FG000|COMPLETED|Overall Study||95
3128319|NCT01668667|3853315|FG001|COMPLETED|Overall Study||99
3128320|NCT01668667|3853316|FG002|COMPLETED|Overall Study||94
3128321|NCT01668667|3853317|FG003|COMPLETED|Overall Study||102
3128322|NCT01668667|3853314|FG000|NOT COMPLETED|Overall Study||31
3128323|NCT01668667|3853315|FG001|NOT COMPLETED|Overall Study||26
3128324|NCT01668667|3853316|FG002|NOT COMPLETED|Overall Study||31
3128325|NCT01668667|3853317|FG003|NOT COMPLETED|Overall Study||23
3128326|NCT01668719|3853330|FG000|STARTED|Phase I||6
3128327|NCT01668719|3853331|FG001|STARTED|Phase I||0
3128328|NCT01668719|3853332|FG002|STARTED|Phase I||0
3128329|NCT01668719|3853330|FG000|COMPLETED|Phase I||0
3128330|NCT01668719|3853331|FG001|COMPLETED|Phase I||0
3128331|NCT01668719|3853332|FG002|COMPLETED|Phase I||0
3128332|NCT01668719|3853330|FG000|NOT COMPLETED|Phase I||6
3128333|NCT01668719|3853331|FG001|NOT COMPLETED|Phase I||0
3128334|NCT01668719|3853332|FG002|NOT COMPLETED|Phase I||0
3128335|NCT01668719|3853330|FG000|STARTED|Phase II||0
3128336|NCT01668719|3853331|FG001|STARTED|Phase II||52
3128337|NCT01668719|3853332|FG002|STARTED|Phase II||48
3128338|NCT01668719|3853330|FG000|COMPLETED|Phase II||0
3128339|NCT01668719|3853331|FG001|COMPLETED|Phase II||0
3128340|NCT01668719|3853332|FG002|COMPLETED|Phase II||0
3128341|NCT01668719|3853330|FG000|NOT COMPLETED|Phase II||0
3128342|NCT01668719|3853331|FG001|NOT COMPLETED|Phase II||52
3128343|NCT01668719|3853332|FG002|NOT COMPLETED|Phase II||48
3128344|NCT01668784|3853344|FG000|STARTED|Randomized (Pre-treatment)||410
3128345|NCT01668784|3853345|FG001|STARTED|Randomized (Pre-treatment)||411
3128346|NCT01668784|3853344|FG000|COMPLETED|Randomized (Pre-treatment)||406
3128347|NCT01668784|3853345|FG001|COMPLETED|Randomized (Pre-treatment)||397
3128348|NCT01668784|3853344|FG000|NOT COMPLETED|Randomized (Pre-treatment)||4
3128349|NCT01668784|3853345|FG001|NOT COMPLETED|Randomized (Pre-treatment)||14
3128350|NCT01668784|3853344|FG000|STARTED|Treated (Overall)||406
3128351|NCT01668784|3853345|FG001|STARTED|Treated (Overall)||397
3128352|NCT01668784|3853344|FG000|COMPLETED|Treated (Overall)||67
3128353|NCT01668784|3853345|FG001|COMPLETED|Treated (Overall)||28
3128354|NCT01668784|3853344|FG000|NOT COMPLETED|Treated (Overall)||339
3128355|NCT01668784|3853345|FG001|NOT COMPLETED|Treated (Overall)||369
3128356|NCT01668797|3853353|FG000|STARTED|Phase A (Conversion Phase)||406
3128357|NCT01668797|3853354|FG001|STARTED|Phase A (Conversion Phase)||0
3128358|NCT01668797|3853355|FG002|STARTED|Phase A (Conversion Phase)||0
3128359|NCT01668797|3853356|FG003|STARTED|Phase A (Conversion Phase)||0
3128360|NCT01668797|3853353|FG000|COMPLETED|Phase A (Conversion Phase)||346
3128361|NCT01668797|3853354|FG001|COMPLETED|Phase A (Conversion Phase)||0
3128362|NCT01668797|3853355|FG002|COMPLETED|Phase A (Conversion Phase)||0
3128363|NCT01668797|3853356|FG003|COMPLETED|Phase A (Conversion Phase)||0
3128364|NCT01668797|3853353|FG000|NOT COMPLETED|Phase A (Conversion Phase)||60
3128365|NCT01668797|3853354|FG001|NOT COMPLETED|Phase A (Conversion Phase)||0
3128366|NCT01668797|3853355|FG002|NOT COMPLETED|Phase A (Conversion Phase)||0
3128367|NCT01668797|3853356|FG003|NOT COMPLETED|Phase A (Conversion Phase)||0
3128368|NCT01668797|3853353|FG000|STARTED|Phase B (Stabilization Phase)||0
3128369|NCT01668797|3853354|FG001|STARTED|Phase B (Stabilization Phase)|N= 464; 346 rolled over from Phase A and 118 entered directly into Phase B|464
3128370|NCT01668797|3853355|FG002|STARTED|Phase B (Stabilization Phase)||0
3128371|NCT01668797|3853356|FG003|STARTED|Phase B (Stabilization Phase)||0
3128372|NCT01668797|3853353|FG000|COMPLETED|Phase B (Stabilization Phase)||0
3128373|NCT01668797|3853354|FG001|COMPLETED|Phase B (Stabilization Phase)||202
3128374|NCT01668797|3853355|FG002|COMPLETED|Phase B (Stabilization Phase)||0
3128375|NCT01668797|3853356|FG003|COMPLETED|Phase B (Stabilization Phase)||0
3128376|NCT01668797|3853353|FG000|NOT COMPLETED|Phase B (Stabilization Phase)||0
3128377|NCT01668797|3853354|FG001|NOT COMPLETED|Phase B (Stabilization Phase)||262
3128378|NCT01668797|3853355|FG002|NOT COMPLETED|Phase B (Stabilization Phase)||0
3128379|NCT01668797|3853356|FG003|NOT COMPLETED|Phase B (Stabilization Phase)||0
3128380|NCT01668797|3853353|FG000|STARTED|Phase C (Double-Blind Maintenance Phase)||0
3128381|NCT01668797|3853354|FG001|STARTED|Phase C (Double-Blind Maintenance Phase)||0
3128382|NCT01668797|3853355|FG002|STARTED|Phase C (Double-Blind Maintenance Phase)|N= 202 rolled over from Phase B|97
3128383|NCT01668797|3853356|FG003|STARTED|Phase C (Double-Blind Maintenance Phase)||105
3128384|NCT01668797|3853353|FG000|COMPLETED|Phase C (Double-Blind Maintenance Phase)||0
3128385|NCT01668797|3853354|FG001|COMPLETED|Phase C (Double-Blind Maintenance Phase)||0
3128386|NCT01668797|3853355|FG002|COMPLETED|Phase C (Double-Blind Maintenance Phase)||14
3128387|NCT01668797|3853356|FG003|COMPLETED|Phase C (Double-Blind Maintenance Phase)||9
3128388|NCT01668797|3853353|FG000|NOT COMPLETED|Phase C (Double-Blind Maintenance Phase)||0
3128389|NCT01668797|3853354|FG001|NOT COMPLETED|Phase C (Double-Blind Maintenance Phase)||0
3128390|NCT01668797|3853355|FG002|NOT COMPLETED|Phase C (Double-Blind Maintenance Phase)||83
3128391|NCT01668797|3853356|FG003|NOT COMPLETED|Phase C (Double-Blind Maintenance Phase)||96
3128392|NCT01668836|3853367|FG000|STARTED|Overall Study||12
3128393|NCT01668836|3853368|FG001|STARTED|Overall Study||12
3128394|NCT01668836|3853369|FG002|STARTED|Overall Study||12
3128395|NCT01668836|3853370|FG003|STARTED|Overall Study||12
3128396|NCT01668836|3853367|FG000|COMPLETED|Overall Study||12
3128397|NCT01668836|3853368|FG001|COMPLETED|Overall Study||12
3128398|NCT01668836|3853369|FG002|COMPLETED|Overall Study||12
3128399|NCT01668836|3853370|FG003|COMPLETED|Overall Study||12
3128400|NCT01668836|3853367|FG000|NOT COMPLETED|Overall Study||0
3128401|NCT01668836|3853368|FG001|NOT COMPLETED|Overall Study||0
3128402|NCT01668836|3853369|FG002|NOT COMPLETED|Overall Study||0
3128403|NCT01668836|3853370|FG003|NOT COMPLETED|Overall Study||0
3128404|NCT01668966|3853386|FG000|STARTED|Overall Study||23
3128405|NCT01668966|3853386|FG000|Treated|Overall Study||21
3128406|NCT01668966|3853386|FG000|COMPLETED|Overall Study||19
3128407|NCT01668966|3853386|FG000|NOT COMPLETED|Overall Study||4
3128408|NCT01669096|3853390|FG000|STARTED|Overall Study||20
3128409|NCT01669096|3853390|FG000|COMPLETED|Overall Study||20
3128410|NCT01669096|3853390|FG000|NOT COMPLETED|Overall Study||0
3128411|NCT01669122|3853394|FG000|STARTED|Period I|Participants who received Lozenge A=10, Lozenge B=10, Lozenge C=10, Reference Lozenge=10|40
3128412|NCT01669122|3853394|FG000|Safety Population|Period I||39
3128413|NCT01669122|3853394|FG000|COMPLETED|Period I||39
3128414|NCT01669122|3853394|FG000|NOT COMPLETED|Period I||1
3128415|NCT01669122|3853394|FG000|STARTED|Washout Period I||39
3128416|NCT01669122|3853394|FG000|COMPLETED|Washout Period I||39
3128417|NCT01669122|3853394|FG000|NOT COMPLETED|Washout Period I||0
3128418|NCT01669122|3853394|FG000|STARTED|Period II|Participants who received Lozenge A=9, Lozenge B=10, Lozenge C=10, Reference Lozenge=10|39
3128419|NCT01669122|3853394|FG000|COMPLETED|Period II||39
3128420|NCT01669122|3853394|FG000|NOT COMPLETED|Period II||0
3128421|NCT01669122|3853394|FG000|STARTED|Washout Period II||39
3128422|NCT01669122|3853394|FG000|COMPLETED|Washout Period II||37
3128423|NCT01669122|3853394|FG000|NOT COMPLETED|Washout Period II||2
3128424|NCT01669122|3853394|FG000|STARTED|Washout Period III||37
3128425|NCT01669122|3853394|FG000|COMPLETED|Washout Period III||37
3128426|NCT01669122|3853394|FG000|NOT COMPLETED|Washout Period III||0
3128427|NCT01669122|3853394|FG000|STARTED|Period III|Participants who received Lozenge A=10, Lozenge B=8, Lozenge C=10, Reference Lozenge=9|37
3128428|NCT01669122|3853394|FG000|COMPLETED|Period III||37
3128429|NCT01669122|3853394|FG000|NOT COMPLETED|Period III||0
3128430|NCT01669122|3853394|FG000|STARTED|Period IV|Participants who received Lozenge A=9, Lozenge B=10, Lozenge C=9, Reference Lozenge=9|37
3128431|NCT01669122|3853394|FG000|COMPLETED|Period IV||37
3128432|NCT01669122|3853394|FG000|NOT COMPLETED|Period IV||0
3128433|NCT01669174|3853407|FG000|STARTED|Overall Study||33
3128434|NCT01669174|3853408|FG001|STARTED|Overall Study||34
3128435|NCT01669174|3853407|FG000|COMPLETED|Overall Study||27
3128436|NCT01669174|3853408|FG001|COMPLETED|Overall Study||28
3128437|NCT01669174|3853407|FG000|NOT COMPLETED|Overall Study||6
3128438|NCT01669174|3853408|FG001|NOT COMPLETED|Overall Study||6
3128439|NCT01669343|3853414|FG000|STARTED|Part A: All Patients||121
3128440|NCT01669343|3853414|FG000|COMPLETED|Part A: All Patients||112
3128441|NCT01669343|3853414|FG000|NOT COMPLETED|Part A: All Patients||9
3128442|NCT01669343|3853414|FG000|STARTED|Part B: Patients With BMI>=25||48
3128443|NCT01669343|3853414|FG000|COMPLETED|Part B: Patients With BMI>=25||31
3128444|NCT01669343|3853414|FG000|NOT COMPLETED|Part B: Patients With BMI>=25||17
3128445|NCT01669421|3853421|FG000|STARTED|Phase 1: Standard Dose Therapy||10
3128446|NCT01669421|3853421|FG000|COMPLETED|Phase 1: Standard Dose Therapy||8
3128447|NCT01669421|3853421|FG000|NOT COMPLETED|Phase 1: Standard Dose Therapy||2
3128448|NCT01669421|3853421|FG000|STARTED|Phase 2: Double Dose Therapy||8
3128449|NCT01669421|3853421|FG000|COMPLETED|Phase 2: Double Dose Therapy||8
3128450|NCT01669421|3853421|FG000|NOT COMPLETED|Phase 2: Double Dose Therapy||0
3128451|NCT01669421|3853421|FG000|STARTED|Phase 3: Standard Dose Therapy||8
3128452|NCT01669421|3853421|FG000|COMPLETED|Phase 3: Standard Dose Therapy||8
3128453|NCT01669421|3853421|FG000|NOT COMPLETED|Phase 3: Standard Dose Therapy||0
3128454|NCT01669434|3853437|FG000|STARTED|Overall Study||146
3128455|NCT01669434|3853438|FG001|STARTED|Overall Study||145
3128456|NCT01669434|3853437|FG000|COMPLETED|Overall Study||137
3128457|NCT01669434|3853438|FG001|COMPLETED|Overall Study||138
3128458|NCT01669434|3853437|FG000|NOT COMPLETED|Overall Study||9
3128459|NCT01669434|3853438|FG001|NOT COMPLETED|Overall Study||7
3128460|NCT01669538|3853446|FG000|STARTED|Overall Study||40
3128461|NCT01669538|3853447|FG001|STARTED|Overall Study||42
3128462|NCT01669538|3853446|FG000|COMPLETED|Overall Study||28
3128463|NCT01669538|3853447|FG001|COMPLETED|Overall Study||33
3128464|NCT01669538|3853446|FG000|NOT COMPLETED|Overall Study||12
3128465|NCT01669538|3853447|FG001|NOT COMPLETED|Overall Study||9
3128466|NCT01669577|3853453|FG000|STARTED|Overall Study|calculated ISS<16, no informed consent, not enough data(complete case analysis), were excluded|334
3128467|NCT01669577|3853453|FG000|COMPLETED|Overall Study|complete case analysis (data missing completely at random)|200
3128468|NCT01669577|3853453|FG000|NOT COMPLETED|Overall Study||134
3128469|NCT01669603|3853459|FG000|STARTED|Overall Study||95
3128470|NCT01669603|3853460|FG001|STARTED|Overall Study||95
3128471|NCT01669603|3853459|FG000|COMPLETED|Overall Study||58
3128472|NCT01669603|3853460|FG001|COMPLETED|Overall Study||57
3128473|NCT01669603|3853459|FG000|NOT COMPLETED|Overall Study||37
3128474|NCT01669603|3853460|FG001|NOT COMPLETED|Overall Study||38
3128475|NCT01669629|3853466|FG000|STARTED|Period 1||92
3128476|NCT01669629|3853467|FG001|STARTED|Period 1||91
3128477|NCT01669629|3853466|FG000|COMPLETED|Period 1||91
3128478|NCT01669629|3853467|FG001|COMPLETED|Period 1||89
3128479|NCT01669629|3853466|FG000|NOT COMPLETED|Period 1||1
3128480|NCT01669629|3853467|FG001|NOT COMPLETED|Period 1||2
3128481|NCT01669629|3853466|FG000|STARTED|Period 2||91
3128482|NCT01669629|3853467|FG001|STARTED|Period 2||89
3128483|NCT01669629|3853466|FG000|COMPLETED|Period 2||91
3128484|NCT01669629|3853467|FG001|COMPLETED|Period 2||89
3128485|NCT01669629|3853466|FG000|NOT COMPLETED|Period 2||0
3128486|NCT01669629|3853467|FG001|NOT COMPLETED|Period 2||0
3128487|NCT01669642|3853478|FG000|STARTED|Overall Study||20
3128488|NCT01669642|3853479|FG001|STARTED|Overall Study||20
3128489|NCT01669642|3853480|FG002|STARTED|Overall Study||20
3128490|NCT01669642|3853481|FG003|STARTED|Overall Study||21
3128491|NCT01669642|3853482|FG004|STARTED|Overall Study||20
3128492|NCT01669642|3853483|FG005|STARTED|Overall Study||10
3128493|NCT01669642|3853478|FG000|COMPLETED|Overall Study||20
3128494|NCT01669642|3853479|FG001|COMPLETED|Overall Study||20
3128495|NCT01669642|3853480|FG002|COMPLETED|Overall Study||20
3128496|NCT01669642|3853481|FG003|COMPLETED|Overall Study||20
3128497|NCT01669642|3853482|FG004|COMPLETED|Overall Study||20
3128498|NCT01669642|3853483|FG005|COMPLETED|Overall Study||0
3128499|NCT01669642|3853478|FG000|NOT COMPLETED|Overall Study||0
3128500|NCT01669642|3853479|FG001|NOT COMPLETED|Overall Study||0
3128501|NCT01669642|3853480|FG002|NOT COMPLETED|Overall Study||0
3128502|NCT01669642|3853481|FG003|NOT COMPLETED|Overall Study||1
3128503|NCT01669642|3853482|FG004|NOT COMPLETED|Overall Study||0
3128504|NCT01669642|3853483|FG005|NOT COMPLETED|Overall Study||10
3128505|NCT01669720|3853502|FG000|STARTED|Overall Study||7
3128506|NCT01669720|3853503|FG001|STARTED|Overall Study||3
3128507|NCT01669720|3853502|FG000|COMPLETED|Overall Study||7
3128508|NCT01669720|3853503|FG001|COMPLETED|Overall Study||3
3128509|NCT01669720|3853502|FG000|NOT COMPLETED|Overall Study||0
3128510|NCT01669720|3853503|FG001|NOT COMPLETED|Overall Study||0
3128511|NCT01669785|3853512|FG000|STARTED|Overall Study||45
3128512|NCT01669785|3853513|FG001|STARTED|Overall Study||48
3128513|NCT01669785|3853514|FG002|STARTED|Overall Study||46
3128514|NCT01669785|3853512|FG000|COMPLETED|Overall Study||45
3128515|NCT01669785|3853513|FG001|COMPLETED|Overall Study||48
3128516|NCT01669785|3853514|FG002|COMPLETED|Overall Study||46
3128517|NCT01669785|3853512|FG000|NOT COMPLETED|Overall Study||0
3128518|NCT01669785|3853513|FG001|NOT COMPLETED|Overall Study||0
3128519|NCT01669785|3853514|FG002|NOT COMPLETED|Overall Study||0
3128520|NCT01669798|3853523|FG000|STARTED|Overall Study||32
3128521|NCT01669798|3853523|FG000|COMPLETED|Overall Study||27
3128522|NCT01669798|3853523|FG000|NOT COMPLETED|Overall Study||5
3128523|NCT01669811|3853529|FG000|STARTED|Overall Study||145
3128524|NCT01669811|3853530|FG001|STARTED|Overall Study||142
3128525|NCT01669811|3853529|FG000|COMPLETED|Overall Study||142
3128526|NCT01669811|3853530|FG001|COMPLETED|Overall Study||131
3128527|NCT01669811|3853529|FG000|NOT COMPLETED|Overall Study||3
3128528|NCT01669811|3853530|FG001|NOT COMPLETED|Overall Study||11
3128529|NCT01669863|3853536|FG000|STARTED|Overall Study||6
3128530|NCT01669863|3853536|FG000|COMPLETED|Overall Study||6
3128531|NCT01669863|3853536|FG000|NOT COMPLETED|Overall Study||0
3128532|NCT01669902|3853541|FG000|STARTED|Overall Study||107
3128533|NCT01669902|3853541|FG000|COMPLETED|Overall Study||78
3128534|NCT01669902|3853541|FG000|NOT COMPLETED|Overall Study||29
3128535|NCT01669928|3853547|FG000|STARTED|First Intervention||51
3128536|NCT01669928|3853548|FG001|STARTED|First Intervention||52
3128537|NCT01669928|3853547|FG000|COMPLETED|First Intervention||48
3128538|NCT01669928|3853548|FG001|COMPLETED|First Intervention||47
3128539|NCT01669928|3853547|FG000|NOT COMPLETED|First Intervention||3
3128540|NCT01669928|3853548|FG001|NOT COMPLETED|First Intervention||5
3128541|NCT01669928|3853547|FG000|STARTED|Second Intervention||48
3128542|NCT01669928|3853548|FG001|STARTED|Second Intervention||47
3128543|NCT01669928|3853547|FG000|COMPLETED|Second Intervention||48
3128544|NCT01669928|3853548|FG001|COMPLETED|Second Intervention||47
3128545|NCT01669928|3853547|FG000|NOT COMPLETED|Second Intervention||0
3128546|NCT01669928|3853548|FG001|NOT COMPLETED|Second Intervention||0
3128547|NCT01670019|3853558|FG000|STARTED|Overall Study||23
3128548|NCT01670019|3853559|FG001|STARTED|Overall Study||23
3128549|NCT01670019|3853558|FG000|COMPLETED|Overall Study||14
3128550|NCT01670019|3853559|FG001|COMPLETED|Overall Study||23
3128551|NCT01670019|3853558|FG000|NOT COMPLETED|Overall Study||9
3128552|NCT01670019|3853559|FG001|NOT COMPLETED|Overall Study||0
3128553|NCT01670045|3853565|FG000|STARTED|Overall Study||43
3128554|NCT01670045|3853565|FG000|COMPLETED|Overall Study||27
3128555|NCT01670045|3853565|FG000|NOT COMPLETED|Overall Study||16
3128556|NCT01670097|3853571|FG000|STARTED|Overall Study||20
3128557|NCT01670097|3853572|FG001|STARTED|Overall Study||21
3128558|NCT01670097|3853571|FG000|Completed Week 1 Intervention|Overall Study||18
3128559|NCT01670097|3853572|FG001|Completed Week 1 Intervention|Overall Study||17
3128560|NCT01670097|3853571|FG000|Completed Week 2 Intervention|Overall Study||13
3128561|NCT01670097|3853572|FG001|Completed Week 2 Intervention|Overall Study||15
3128562|NCT01670097|3853571|FG000|COMPLETED|Overall Study||18
3128563|NCT01670097|3853572|FG001|COMPLETED|Overall Study||17
3128564|NCT01670097|3853571|FG000|NOT COMPLETED|Overall Study||2
3128565|NCT01670097|3853572|FG001|NOT COMPLETED|Overall Study||4
3128566|NCT01670110|3853580|FG000|STARTED|Overall Study||33
3128567|NCT01670110|3853581|FG001|STARTED|Overall Study||15
3128568|NCT01670110|3853580|FG000|COMPLETED|Overall Study||29
3128569|NCT01670110|3853581|FG001|COMPLETED|Overall Study||12
3128570|NCT01670110|3853580|FG000|NOT COMPLETED|Overall Study||4
3128571|NCT01670110|3853581|FG001|NOT COMPLETED|Overall Study||3
3128572|NCT01670188|3853589|FG000|STARTED|Overall Study||38
3128573|NCT01670188|3853590|FG001|STARTED|Overall Study||40
3128574|NCT01670188|3853589|FG000|COMPLETED|Overall Study||38
3128575|NCT01670188|3853590|FG001|COMPLETED|Overall Study||39
3128576|NCT01670188|3853589|FG000|NOT COMPLETED|Overall Study||0
3128577|NCT01670188|3853590|FG001|NOT COMPLETED|Overall Study||1
3128578|NCT01670201|3853596|FG000|STARTED|Overall Study||8
3128579|NCT01670201|3853596|FG000|COMPLETED|Overall Study||8
3128580|NCT01670201|3853596|FG000|NOT COMPLETED|Overall Study||0
3128581|NCT01670279|3853603|FG000|STARTED|Overall Study||6
3128582|NCT01670279|3853604|FG001|STARTED|Overall Study||7
3128583|NCT01670279|3853605|FG002|STARTED|Overall Study||0
3128584|NCT01670279|3853606|FG003|STARTED|Overall Study||5
3128585|NCT01670279|3853603|FG000|COMPLETED|Overall Study||6
3128586|NCT01670279|3853604|FG001|COMPLETED|Overall Study||5
3128587|NCT01670279|3853605|FG002|COMPLETED|Overall Study||0
3128588|NCT01670279|3853606|FG003|COMPLETED|Overall Study||4
3128589|NCT01670279|3853603|FG000|NOT COMPLETED|Overall Study||0
3128590|NCT01670279|3853604|FG001|NOT COMPLETED|Overall Study||2
3128591|NCT01670279|3853605|FG002|NOT COMPLETED|Overall Study||0
3128592|NCT01670279|3853606|FG003|NOT COMPLETED|Overall Study||1
3128593|NCT01670292|3853614|FG000|STARTED|Overall Study||82
3128594|NCT01670292|3853614|FG000|COMPLETED|Overall Study||68
3128595|NCT01670292|3853614|FG000|NOT COMPLETED|Overall Study||14
3128596|NCT01670487|3853628|FG000|STARTED|Overall Study||150
3128597|NCT01670487|3853629|FG001|STARTED|Overall Study||150
3128598|NCT01670487|3853628|FG000|COMPLETED|Overall Study||150
3128599|NCT01670487|3853629|FG001|COMPLETED|Overall Study||150
3128600|NCT01670487|3853628|FG000|NOT COMPLETED|Overall Study||0
3128601|NCT01670487|3853629|FG001|NOT COMPLETED|Overall Study||0
3128602|NCT01670500|3853637|FG000|STARTED|Overall Study||58
3128603|NCT01670500|3853638|FG001|STARTED|Overall Study||60
3128604|NCT01670500|3853637|FG000|COMPLETED|Overall Study|1 patient withdrew after 3 cycles; 5 patients received additional non-protocol chemo before surgery|57
3128605|NCT01670500|3853638|FG001|COMPLETED|Overall Study|4 pts received <4 cycles of assigned chemo; 2 pts received add'l non-protocol chemo before surgery|60
3128606|NCT01670500|3853637|FG000|NOT COMPLETED|Overall Study||1
3128607|NCT01670500|3853638|FG001|NOT COMPLETED|Overall Study||0
3128608|NCT01670526|3853646|FG000|STARTED|Overall Study||49
3128609|NCT01670526|3853647|FG001|STARTED|Overall Study||45
3296385|NCT02906670|4030255|FG007|NOT COMPLETED|Cohort 4, Q2W||0
3296386|NCT02906670|4030256|FG008|NOT COMPLETED|Cohort 4, Q2W||0
3296387|NCT02906670|4030257|FG009|NOT COMPLETED|Cohort 4, Q2W||0
3296388|NCT02906670|4030248|FG000|STARTED|Cohort 5, Q2W||0
3296389|NCT02906670|4030249|FG001|STARTED|Cohort 5, Q2W||0
3296390|NCT02906670|4030250|FG002|STARTED|Cohort 5, Q2W||0
3296391|NCT02906670|4030251|FG003|STARTED|Cohort 5, Q2W||0
3128610|NCT01670526|3853646|FG000|COMPLETED|Overall Study||37
3128611|NCT01670526|3853647|FG001|COMPLETED|Overall Study||39
3128612|NCT01670526|3853646|FG000|NOT COMPLETED|Overall Study||12
3128613|NCT01670526|3853647|FG001|NOT COMPLETED|Overall Study||6
3128614|NCT01670721|3853653|FG000|STARTED|Overall Study||175
3128615|NCT01670721|3853653|FG000|COMPLETED|Overall Study|81 participants with DP and 41 with adverse events were considered as completed.|122
3128616|NCT01670721|3853653|FG000|NOT COMPLETED|Overall Study||53
3128617|NCT01670760|3853657|FG000|STARTED|Overall Study||20
3128618|NCT01670760|3853657|FG000|COMPLETED|Overall Study||20
3128619|NCT01670760|3853657|FG000|NOT COMPLETED|Overall Study||0
3128620|NCT01670825|3853663|FG000|STARTED|Overall Study||42
3128621|NCT01670825|3853664|FG001|STARTED|Overall Study||39
3128622|NCT01670825|3853663|FG000|COMPLETED|Overall Study||42
3128623|NCT01670825|3853664|FG001|COMPLETED|Overall Study||39
3128624|NCT01670825|3853663|FG000|NOT COMPLETED|Overall Study||0
3128625|NCT01670825|3853664|FG001|NOT COMPLETED|Overall Study||0
3128626|NCT01671007|3853681|FG000|STARTED|Overall Study||2089
3128627|NCT01671007|3853682|FG001|STARTED|Overall Study||2834
3128628|NCT01671007|3853683|FG002|STARTED|Overall Study||2033
3128629|NCT01671007|3853684|FG003|STARTED|Overall Study||2214
3128630|NCT01671007|3853685|FG004|STARTED|Overall Study||180
3128631|NCT01671007|3853686|FG005|STARTED|Overall Study||513
3128632|NCT01671007|3853687|FG006|STARTED|Overall Study||80
3128633|NCT01671007|3853688|FG007|STARTED|Overall Study||526
3128634|NCT01671007|3853689|FG008|STARTED|Overall Study||2
3128635|NCT01671007|3853681|FG000|All Eligible|Overall Study||2066
3128636|NCT01671007|3853682|FG001|All Eligible|Overall Study||2758
3128637|NCT01671007|3853683|FG002|All Eligible|Overall Study||2008
3128638|NCT01671007|3853684|FG003|All Eligible|Overall Study||2197
3128639|NCT01671007|3853685|FG004|All Eligible|Overall Study||180
3128640|NCT01671007|3853686|FG005|All Eligible|Overall Study||507
3128641|NCT01671007|3853687|FG006|All Eligible|Overall Study||79
3128642|NCT01671007|3853688|FG007|All Eligible|Overall Study||507
3128643|NCT01671007|3853689|FG008|All Eligible|Overall Study||2
3128644|NCT01671007|3853681|FG000|COMPLETED|Overall Study||1768
3128645|NCT01671007|3853682|FG001|COMPLETED|Overall Study||2183
3128646|NCT01671007|3853683|FG002|COMPLETED|Overall Study||1667
3128647|NCT01671007|3853684|FG003|COMPLETED|Overall Study||1846
3296392|NCT02906670|4030252|FG004|STARTED|Cohort 5, Q2W||0
3128648|NCT01671007|3853685|FG004|COMPLETED|Overall Study||155
3128649|NCT01671007|3853686|FG005|COMPLETED|Overall Study||401
3128650|NCT01671007|3853687|FG006|COMPLETED|Overall Study||59
3128651|NCT01671007|3853688|FG007|COMPLETED|Overall Study||394
3128652|NCT01671007|3853689|FG008|COMPLETED|Overall Study||2
3128653|NCT01671007|3853681|FG000|NOT COMPLETED|Overall Study||321
3128654|NCT01671007|3853682|FG001|NOT COMPLETED|Overall Study||651
3128655|NCT01671007|3853683|FG002|NOT COMPLETED|Overall Study||366
3128656|NCT01671007|3853684|FG003|NOT COMPLETED|Overall Study||368
3128657|NCT01671007|3853685|FG004|NOT COMPLETED|Overall Study||25
3128658|NCT01671007|3853686|FG005|NOT COMPLETED|Overall Study||112
3296393|NCT02906670|4030253|FG005|STARTED|Cohort 5, Q2W||0
3128659|NCT01671007|3853687|FG006|NOT COMPLETED|Overall Study||21
3128660|NCT01671007|3853688|FG007|NOT COMPLETED|Overall Study||132
3128661|NCT01671007|3853689|FG008|NOT COMPLETED|Overall Study||0
3128662|NCT01671059|3853700|FG000|STARTED|Overall Study||80
3128663|NCT01671059|3853700|FG000|COMPLETED|Overall Study||75
3128664|NCT01671059|3853700|FG000|NOT COMPLETED|Overall Study||5
3128665|NCT01671085|3853707|FG000|STARTED|Overall Study|1 participant who dropped out was replaced.|11
3128666|NCT01671085|3853708|FG001|STARTED|Overall Study||2
3128667|NCT01671085|3853707|FG000|Received at Least 1 Dose of Study Drug|Overall Study||11
3128668|NCT01671085|3853708|FG001|Received at Least 1 Dose of Study Drug|Overall Study||2
3128669|NCT01671085|3853707|FG000|COMPLETED|Overall Study||10
3128670|NCT01671085|3853708|FG001|COMPLETED|Overall Study||2
3128671|NCT01671085|3853707|FG000|NOT COMPLETED|Overall Study||1
3128672|NCT01671085|3853708|FG001|NOT COMPLETED|Overall Study||0
3128673|NCT01671111|3853715|FG000|STARTED|Overall Study||30
3128674|NCT01671111|3853715|FG000|COMPLETED|Overall Study||0
3128675|NCT01671111|3853715|FG000|NOT COMPLETED|Overall Study||30
3128676|NCT01671176|3853719|FG000|STARTED|Overall Study||30
3128677|NCT01671176|3853719|FG000|COMPLETED|Overall Study||30
3128678|NCT01671176|3853719|FG000|NOT COMPLETED|Overall Study||0
3128679|NCT01671280|3853723|FG000|STARTED|Overall Study|The number is enrollment.|403
3128680|NCT01671280|3853723|FG000|COMPLETED|Overall Study||401
3128681|NCT01671280|3853723|FG000|NOT COMPLETED|Overall Study||2
3128682|NCT01671293|3853729|FG000|STARTED|Overall Study||36
3128683|NCT01671293|3853730|FG001|STARTED|Overall Study||34
3128684|NCT01671293|3853729|FG000|COMPLETED|Overall Study||33
3128685|NCT01671293|3853730|FG001|COMPLETED|Overall Study||32
3128686|NCT01671293|3853729|FG000|NOT COMPLETED|Overall Study||3
3128687|NCT01671293|3853730|FG001|NOT COMPLETED|Overall Study||2
3128688|NCT01671319|3853736|FG000|STARTED|Overall Study||42
3128689|NCT01671319|3853736|FG000|COMPLETED|Overall Study||41
3128690|NCT01671319|3853736|FG000|NOT COMPLETED|Overall Study||1
3128691|NCT01671332|3853742|FG000|STARTED|Overall Study||40
3128692|NCT01671332|3853743|FG001|STARTED|Overall Study||40
3128693|NCT01671332|3853742|FG000|Crossed Over to Docetaxel Plus Suramin|Overall Study||0
3128694|NCT01671332|3853743|FG001|Crossed Over to Docetaxel Plus Suramin|Overall Study|Participants with disease progression on Docetaxel Arm were allowed to crossover to Suramin.|13
3128695|NCT01671332|3853742|FG000|COMPLETED|Overall Study||39
3128696|NCT01671332|3853743|FG001|COMPLETED|Overall Study||39
3128697|NCT01671332|3853742|FG000|NOT COMPLETED|Overall Study||1
3128698|NCT01671332|3853743|FG001|NOT COMPLETED|Overall Study||1
3128699|NCT01671345|3853751|FG000|STARTED|Overall Study||77
3128700|NCT01671345|3853752|FG001|STARTED|Overall Study||92
3128701|NCT01671345|3853751|FG000|COMPLETED|Overall Study||64
3128702|NCT01671345|3853752|FG001|COMPLETED|Overall Study||83
3128703|NCT01671345|3853751|FG000|NOT COMPLETED|Overall Study||13
3128704|NCT01671345|3853752|FG001|NOT COMPLETED|Overall Study||9
3128705|NCT01671423|3853763|FG000|STARTED|Overall Study||20
3128706|NCT01671423|3853764|FG001|STARTED|Overall Study||20
3128707|NCT01671423|3853763|FG000|COMPLETED|Overall Study||14
3128708|NCT01671423|3853764|FG001|COMPLETED|Overall Study||9
3128709|NCT01671423|3853763|FG000|NOT COMPLETED|Overall Study||6
3128710|NCT01671423|3853764|FG001|NOT COMPLETED|Overall Study||11
3128711|NCT01671488|3853770|FG000|STARTED|Overall Study||11
3128712|NCT01671488|3853770|FG000|COMPLETED|Overall Study||10
3128713|NCT01671488|3853770|FG000|NOT COMPLETED|Overall Study||1
3128714|NCT01671605|3853776|FG000|STARTED|Overall Study||72
3128715|NCT01671605|3853777|FG001|STARTED|Overall Study||31
3128716|NCT01671605|3853776|FG000|COMPLETED|Overall Study||72
3128717|NCT01671605|3853777|FG001|COMPLETED|Overall Study||31
3128718|NCT01671605|3853776|FG000|NOT COMPLETED|Overall Study||0
3128719|NCT01671605|3853777|FG001|NOT COMPLETED|Overall Study||0
3128720|NCT01671748|3853785|FG000|STARTED|4 Week run-in Phase||47
3128721|NCT01671748|3853786|FG001|STARTED|4 Week run-in Phase||0
3128722|NCT01671748|3853785|FG000|COMPLETED|4 Week run-in Phase||36
3128723|NCT01671748|3853786|FG001|COMPLETED|4 Week run-in Phase||0
3128724|NCT01671748|3853785|FG000|NOT COMPLETED|4 Week run-in Phase||11
3128725|NCT01671748|3853786|FG001|NOT COMPLETED|4 Week run-in Phase||0
3128726|NCT01671748|3853785|FG000|STARTED|12 Week Treatment Phase||19
3128727|NCT01671748|3853786|FG001|STARTED|12 Week Treatment Phase||17
3128728|NCT01671748|3853785|FG000|COMPLETED|12 Week Treatment Phase||19
3128729|NCT01671748|3853786|FG001|COMPLETED|12 Week Treatment Phase||17
3128730|NCT01671748|3853785|FG000|NOT COMPLETED|12 Week Treatment Phase||0
3128731|NCT01671748|3853786|FG001|NOT COMPLETED|12 Week Treatment Phase||0
3128732|NCT01671839|3853792|FG000|STARTED|Overall Study||55
3128733|NCT01671839|3853792|FG000|3-year Follow-up|Overall Study||45
3128734|NCT01671839|3853792|FG000|5-year Follow-up|Overall Study||37
3128735|NCT01671839|3853792|FG000|COMPLETED|Overall Study||37
3128736|NCT01671839|3853792|FG000|NOT COMPLETED|Overall Study||18
3128737|NCT01672242|3853799|FG000|STARTED|Period 1||4
3128738|NCT01672242|3853800|FG001|STARTED|Period 1||2
3128739|NCT01672242|3853799|FG000|COMPLETED|Period 1||4
3128740|NCT01672242|3853800|FG001|COMPLETED|Period 1||2
3128741|NCT01672242|3853799|FG000|NOT COMPLETED|Period 1||0
3128742|NCT01672242|3853800|FG001|NOT COMPLETED|Period 1||0
3128743|NCT01672242|3853799|FG000|STARTED|Period 2||4
3128744|NCT01672242|3853800|FG001|STARTED|Period 2||2
3128745|NCT01672242|3853799|FG000|COMPLETED|Period 2||4
3128746|NCT01672242|3853800|FG001|COMPLETED|Period 2||2
3128747|NCT01672242|3853799|FG000|NOT COMPLETED|Period 2||0
3128748|NCT01672242|3853800|FG001|NOT COMPLETED|Period 2||0
3128749|NCT01672294|3853810|FG000|STARTED|Overall Study||71
3128750|NCT01672294|3853811|FG001|STARTED|Overall Study||71
3128751|NCT01672294|3853812|FG002|STARTED|Overall Study||72
3128752|NCT01672294|3853813|FG003|STARTED|Overall Study||72
3128753|NCT01672294|3853810|FG000|COMPLETED|Overall Study||65
3128754|NCT01672294|3853811|FG001|COMPLETED|Overall Study||50
3128755|NCT01672294|3853812|FG002|COMPLETED|Overall Study||61
3128756|NCT01672294|3853813|FG003|COMPLETED|Overall Study||59
3128757|NCT01672294|3853810|FG000|NOT COMPLETED|Overall Study||6
3128758|NCT01672294|3853811|FG001|NOT COMPLETED|Overall Study||21
3128759|NCT01672294|3853812|FG002|NOT COMPLETED|Overall Study||11
3128760|NCT01672294|3853813|FG003|NOT COMPLETED|Overall Study||13
3296394|NCT02906670|4030254|FG006|STARTED|Cohort 5, Q2W||7
3296395|NCT02906670|4030255|FG007|STARTED|Cohort 5, Q2W||0
3296396|NCT02906670|4030256|FG008|STARTED|Cohort 5, Q2W||0
3128761|NCT01672658|3853825|FG000|STARTED|Overall Study||16
3128762|NCT01672658|3853826|FG001|STARTED|Overall Study||15
3128763|NCT01672658|3853825|FG000|COMPLETED|Overall Study||16
3128764|NCT01672658|3853826|FG001|COMPLETED|Overall Study||14
3128765|NCT01672658|3853825|FG000|NOT COMPLETED|Overall Study||0
3128766|NCT01672658|3853826|FG001|NOT COMPLETED|Overall Study||1
3128767|NCT01672710|3853834|FG000|STARTED|Controlled Comparison 5 Week Follow-up||22
3128768|NCT01672710|3853835|FG001|STARTED|Controlled Comparison 5 Week Follow-up||10
3128769|NCT01672710|3853834|FG000|COMPLETED|Controlled Comparison 5 Week Follow-up|sauna intervention group repeat all assessments 7 days after complete the regimen|22
3128770|NCT01672710|3853835|FG001|COMPLETED|Controlled Comparison 5 Week Follow-up|waitlist group repeat baseline assessments after 4 week time period then begin sauna|10
3128771|NCT01672710|3853834|FG000|NOT COMPLETED|Controlled Comparison 5 Week Follow-up||0
3128772|NCT01672710|3853835|FG001|NOT COMPLETED|Controlled Comparison 5 Week Follow-up||0
3128773|NCT01672710|3853834|FG000|STARTED|Waitlist Assessed After Sauna Regimen|immediate start group no further assessments until 3 month follow up|22
3128774|NCT01672710|3853835|FG001|STARTED|Waitlist Assessed After Sauna Regimen|waitlisted group receive the 4 week intervention and complete 7 day assessments|10
3128775|NCT01672710|3853834|FG000|COMPLETED|Waitlist Assessed After Sauna Regimen|non applicable, cannot compare the immediate start and waitlist in this period|22
3128776|NCT01672710|3853835|FG001|COMPLETED|Waitlist Assessed After Sauna Regimen||9
3128777|NCT01672710|3853834|FG000|NOT COMPLETED|Waitlist Assessed After Sauna Regimen||0
3128778|NCT01672710|3853835|FG001|NOT COMPLETED|Waitlist Assessed After Sauna Regimen||1
3128779|NCT01672710|3853834|FG000|STARTED|3 Month Follow up||22
3128780|NCT01672710|3853835|FG001|STARTED|3 Month Follow up||9
3128781|NCT01672710|3853834|FG000|COMPLETED|3 Month Follow up||16
3128782|NCT01672710|3853835|FG001|COMPLETED|3 Month Follow up||5
3128783|NCT01672710|3853834|FG000|NOT COMPLETED|3 Month Follow up||6
3128784|NCT01672710|3853835|FG001|NOT COMPLETED|3 Month Follow up||4
3128785|NCT01672723|3853841|FG000|STARTED|First Intervention||19
3128786|NCT01672723|3853842|FG001|STARTED|First Intervention||15
3128787|NCT01672723|3853841|FG000|COMPLETED|First Intervention||16
3128788|NCT01672723|3853842|FG001|COMPLETED|First Intervention||15
3128789|NCT01672723|3853841|FG000|NOT COMPLETED|First Intervention||3
3128790|NCT01672723|3853842|FG001|NOT COMPLETED|First Intervention||0
3128791|NCT01672723|3853841|FG000|STARTED|Washout Period of 10 Days||16
3128792|NCT01672723|3853842|FG001|STARTED|Washout Period of 10 Days||15
3128793|NCT01672723|3853841|FG000|COMPLETED|Washout Period of 10 Days||16
3128794|NCT01672723|3853842|FG001|COMPLETED|Washout Period of 10 Days||15
3128795|NCT01672723|3853841|FG000|NOT COMPLETED|Washout Period of 10 Days||0
3128796|NCT01672723|3853842|FG001|NOT COMPLETED|Washout Period of 10 Days||0
3128797|NCT01672723|3853841|FG000|STARTED|Second Intervention||16
3128798|NCT01672723|3853842|FG001|STARTED|Second Intervention||15
3128799|NCT01672723|3853841|FG000|COMPLETED|Second Intervention||16
3128800|NCT01672723|3853842|FG001|COMPLETED|Second Intervention||15
3128801|NCT01672723|3853841|FG000|NOT COMPLETED|Second Intervention||0
3128802|NCT01672723|3853842|FG001|NOT COMPLETED|Second Intervention||0
3128803|NCT01672736|3853848|FG000|STARTED|Overall Study|Phase I study part stopped early due to manufacturer's decision to stop further drug development.|19
3128804|NCT01672736|3853848|FG000|COMPLETED|Overall Study|3 patients taken off study due to non-availability of further study (Linsitinib) drug supply.|16
3128805|NCT01672736|3853848|FG000|NOT COMPLETED|Overall Study||3
3296397|NCT02906670|4030257|FG009|STARTED|Cohort 5, Q2W||0
3296398|NCT02906670|4030248|FG000|COMPLETED|Cohort 5, Q2W||0
3296399|NCT02906670|4030249|FG001|COMPLETED|Cohort 5, Q2W||0
3296400|NCT02906670|4030250|FG002|COMPLETED|Cohort 5, Q2W||0
3296401|NCT02906670|4030251|FG003|COMPLETED|Cohort 5, Q2W||0
3296402|NCT02906670|4030252|FG004|COMPLETED|Cohort 5, Q2W||0
3296403|NCT02906670|4030253|FG005|COMPLETED|Cohort 5, Q2W||0
3296404|NCT02906670|4030254|FG006|COMPLETED|Cohort 5, Q2W||0
3296405|NCT02906670|4030255|FG007|COMPLETED|Cohort 5, Q2W||0
3296406|NCT02906670|4030256|FG008|COMPLETED|Cohort 5, Q2W||0
3296407|NCT02906670|4030257|FG009|COMPLETED|Cohort 5, Q2W||0
3296408|NCT02906670|4030248|FG000|NOT COMPLETED|Cohort 5, Q2W||0
3296409|NCT02906670|4030249|FG001|NOT COMPLETED|Cohort 5, Q2W||0
3296410|NCT02906670|4030250|FG002|NOT COMPLETED|Cohort 5, Q2W||0
3296411|NCT02906670|4030251|FG003|NOT COMPLETED|Cohort 5, Q2W||0
3296412|NCT02906670|4030252|FG004|NOT COMPLETED|Cohort 5, Q2W||0
3296413|NCT02906670|4030253|FG005|NOT COMPLETED|Cohort 5, Q2W||0
3296414|NCT02906670|4030254|FG006|NOT COMPLETED|Cohort 5, Q2W||7
3296415|NCT02906670|4030255|FG007|NOT COMPLETED|Cohort 5, Q2W||0
3296416|NCT02906670|4030256|FG008|NOT COMPLETED|Cohort 5, Q2W||0
3296417|NCT02906670|4030257|FG009|NOT COMPLETED|Cohort 5, Q2W||0
3128806|NCT01672788|3853852|FG000|STARTED|Treatment Period 1 (3 Days)||9
3128807|NCT01672788|3853853|FG001|STARTED|Treatment Period 1 (3 Days)||9
3128808|NCT01672788|3853854|FG002|STARTED|Treatment Period 1 (3 Days)||9
3128809|NCT01672788|3853855|FG003|STARTED|Treatment Period 1 (3 Days)||9
3128810|NCT01672788|3853852|FG000|COMPLETED|Treatment Period 1 (3 Days)||9
3128811|NCT01672788|3853853|FG001|COMPLETED|Treatment Period 1 (3 Days)||9
3128812|NCT01672788|3853854|FG002|COMPLETED|Treatment Period 1 (3 Days)||9
3128813|NCT01672788|3853855|FG003|COMPLETED|Treatment Period 1 (3 Days)||9
3128814|NCT01672788|3853852|FG000|NOT COMPLETED|Treatment Period 1 (3 Days)||0
3128815|NCT01672788|3853853|FG001|NOT COMPLETED|Treatment Period 1 (3 Days)||0
3128816|NCT01672788|3853854|FG002|NOT COMPLETED|Treatment Period 1 (3 Days)||0
3128817|NCT01672788|3853855|FG003|NOT COMPLETED|Treatment Period 1 (3 Days)||0
3128818|NCT01672788|3853852|FG000|STARTED|Washout Period 1 (7 Days)||9
3128819|NCT01672788|3853853|FG001|STARTED|Washout Period 1 (7 Days)||9
3128820|NCT01672788|3853854|FG002|STARTED|Washout Period 1 (7 Days)||9
3128821|NCT01672788|3853855|FG003|STARTED|Washout Period 1 (7 Days)||9
3128822|NCT01672788|3853852|FG000|COMPLETED|Washout Period 1 (7 Days)||9
3128823|NCT01672788|3853853|FG001|COMPLETED|Washout Period 1 (7 Days)||9
3128824|NCT01672788|3853854|FG002|COMPLETED|Washout Period 1 (7 Days)||9
3128825|NCT01672788|3853855|FG003|COMPLETED|Washout Period 1 (7 Days)||9
3128826|NCT01672788|3853852|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0
3128827|NCT01672788|3853853|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0
3128828|NCT01672788|3853854|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||0
3128829|NCT01672788|3853855|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||0
3128830|NCT01672788|3853852|FG000|STARTED|Treatment Period 2 (3 Days)||9
3128831|NCT01672788|3853853|FG001|STARTED|Treatment Period 2 (3 Days)||9
3128832|NCT01672788|3853854|FG002|STARTED|Treatment Period 2 (3 Days)||9
3128833|NCT01672788|3853855|FG003|STARTED|Treatment Period 2 (3 Days)||9
3128834|NCT01672788|3853852|FG000|COMPLETED|Treatment Period 2 (3 Days)||9
3128835|NCT01672788|3853853|FG001|COMPLETED|Treatment Period 2 (3 Days)||9
3128836|NCT01672788|3853854|FG002|COMPLETED|Treatment Period 2 (3 Days)||9
3128837|NCT01672788|3853855|FG003|COMPLETED|Treatment Period 2 (3 Days)||9
3128838|NCT01672788|3853852|FG000|NOT COMPLETED|Treatment Period 2 (3 Days)||0
3128839|NCT01672788|3853853|FG001|NOT COMPLETED|Treatment Period 2 (3 Days)||0
3128840|NCT01672788|3853854|FG002|NOT COMPLETED|Treatment Period 2 (3 Days)||0
3128841|NCT01672788|3853855|FG003|NOT COMPLETED|Treatment Period 2 (3 Days)||0
3128842|NCT01672788|3853852|FG000|STARTED|Washout Period 2 (7 Days)||9
3128843|NCT01672788|3853853|FG001|STARTED|Washout Period 2 (7 Days)||9
3128844|NCT01672788|3853854|FG002|STARTED|Washout Period 2 (7 Days)||9
3128845|NCT01672788|3853855|FG003|STARTED|Washout Period 2 (7 Days)||9
3128846|NCT01672788|3853852|FG000|COMPLETED|Washout Period 2 (7 Days)||9
3128847|NCT01672788|3853853|FG001|COMPLETED|Washout Period 2 (7 Days)||9
3128848|NCT01672788|3853854|FG002|COMPLETED|Washout Period 2 (7 Days)||9
3128849|NCT01672788|3853855|FG003|COMPLETED|Washout Period 2 (7 Days)||8
3128850|NCT01672788|3853852|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||0
3128851|NCT01672788|3853853|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0
3128852|NCT01672788|3853854|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0
3128853|NCT01672788|3853855|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||1
3128854|NCT01672788|3853852|FG000|STARTED|Treatment Period 3 (3 Days)||9
3128855|NCT01672788|3853853|FG001|STARTED|Treatment Period 3 (3 Days)||9
3128856|NCT01672788|3853854|FG002|STARTED|Treatment Period 3 (3 Days)||9
3128857|NCT01672788|3853855|FG003|STARTED|Treatment Period 3 (3 Days)||8
3128858|NCT01672788|3853852|FG000|COMPLETED|Treatment Period 3 (3 Days)||9
3128859|NCT01672788|3853853|FG001|COMPLETED|Treatment Period 3 (3 Days)||9
3128860|NCT01672788|3853854|FG002|COMPLETED|Treatment Period 3 (3 Days)||9
3128861|NCT01672788|3853855|FG003|COMPLETED|Treatment Period 3 (3 Days)||8
3128862|NCT01672788|3853852|FG000|NOT COMPLETED|Treatment Period 3 (3 Days)||0
3128863|NCT01672788|3853853|FG001|NOT COMPLETED|Treatment Period 3 (3 Days)||0
3128864|NCT01672788|3853854|FG002|NOT COMPLETED|Treatment Period 3 (3 Days)||0
3128865|NCT01672788|3853855|FG003|NOT COMPLETED|Treatment Period 3 (3 Days)||0
3128866|NCT01672788|3853852|FG000|STARTED|Washout Period 3 (7 Days)||9
3128867|NCT01672788|3853853|FG001|STARTED|Washout Period 3 (7 Days)||9
3128868|NCT01672788|3853854|FG002|STARTED|Washout Period 3 (7 Days)||9
3128869|NCT01672788|3853855|FG003|STARTED|Washout Period 3 (7 Days)||8
3128870|NCT01672788|3853852|FG000|COMPLETED|Washout Period 3 (7 Days)||9
3128871|NCT01672788|3853853|FG001|COMPLETED|Washout Period 3 (7 Days)||9
3128872|NCT01672788|3853854|FG002|COMPLETED|Washout Period 3 (7 Days)||9
3128873|NCT01672788|3853855|FG003|COMPLETED|Washout Period 3 (7 Days)||8
3128874|NCT01672788|3853852|FG000|NOT COMPLETED|Washout Period 3 (7 Days)||0
3128875|NCT01672788|3853853|FG001|NOT COMPLETED|Washout Period 3 (7 Days)||0
3128876|NCT01672788|3853854|FG002|NOT COMPLETED|Washout Period 3 (7 Days)||0
3128877|NCT01672788|3853855|FG003|NOT COMPLETED|Washout Period 3 (7 Days)||0
3128878|NCT01672788|3853852|FG000|STARTED|Treatment Period 4 (3 Days)||9
3128879|NCT01672788|3853853|FG001|STARTED|Treatment Period 4 (3 Days)||9
3128880|NCT01672788|3853854|FG002|STARTED|Treatment Period 4 (3 Days)||9
3128881|NCT01672788|3853855|FG003|STARTED|Treatment Period 4 (3 Days)||8
3128882|NCT01672788|3853852|FG000|COMPLETED|Treatment Period 4 (3 Days)||9
3128883|NCT01672788|3853853|FG001|COMPLETED|Treatment Period 4 (3 Days)||9
3128884|NCT01672788|3853854|FG002|COMPLETED|Treatment Period 4 (3 Days)||9
3128885|NCT01672788|3853855|FG003|COMPLETED|Treatment Period 4 (3 Days)||8
3128886|NCT01672788|3853852|FG000|NOT COMPLETED|Treatment Period 4 (3 Days)||0
3128887|NCT01672788|3853853|FG001|NOT COMPLETED|Treatment Period 4 (3 Days)||0
3128888|NCT01672788|3853854|FG002|NOT COMPLETED|Treatment Period 4 (3 Days)||0
3128889|NCT01672788|3853855|FG003|NOT COMPLETED|Treatment Period 4 (3 Days)||0
3128890|NCT01672801|3853867|FG000|STARTED|Overall Study||9
3128891|NCT01672801|3853868|FG001|STARTED|Overall Study||9
3128892|NCT01672801|3853867|FG000|COMPLETED|Overall Study||9
3128893|NCT01672801|3853868|FG001|COMPLETED|Overall Study||8
3128894|NCT01672801|3853867|FG000|NOT COMPLETED|Overall Study||0
3128895|NCT01672801|3853868|FG001|NOT COMPLETED|Overall Study||1
3128896|NCT01672827|3853874|FG000|STARTED|Overall Study||276
3128897|NCT01672827|3853874|FG000|COMPLETED|Overall Study||276
3128898|NCT01672827|3853874|FG000|NOT COMPLETED|Overall Study||0
3128899|NCT01672853|3853883|FG000|STARTED|Overall Study||79
3128900|NCT01672853|3853884|FG001|STARTED|Overall Study||77
3128901|NCT01672853|3853885|FG002|STARTED|Overall Study||79
3128902|NCT01672853|3853883|FG000|COMPLETED|Overall Study||69
3128903|NCT01672853|3853884|FG001|COMPLETED|Overall Study||60
3128904|NCT01672853|3853885|FG002|COMPLETED|Overall Study||65
3128905|NCT01672853|3853883|FG000|NOT COMPLETED|Overall Study||10
3128906|NCT01672853|3853884|FG001|NOT COMPLETED|Overall Study||17
3128907|NCT01672853|3853885|FG002|NOT COMPLETED|Overall Study||14
3128908|NCT01672866|3853896|FG000|STARTED|Blinded Phase (up to 240 Weeks)||74
3128909|NCT01672866|3853897|FG001|STARTED|Blinded Phase (up to 240 Weeks)||74
3128910|NCT01672866|3853898|FG002|STARTED|Blinded Phase (up to 240 Weeks)||74
3128911|NCT01672866|3853896|FG000|COMPLETED|Blinded Phase (up to 240 Weeks)||0
3128912|NCT01672866|3853897|FG001|COMPLETED|Blinded Phase (up to 240 Weeks)||0
3128913|NCT01672866|3853898|FG002|COMPLETED|Blinded Phase (up to 240 Weeks)||0
3128914|NCT01672866|3853896|FG000|NOT COMPLETED|Blinded Phase (up to 240 Weeks)||74
3128915|NCT01672866|3853897|FG001|NOT COMPLETED|Blinded Phase (up to 240 Weeks)||74
3128916|NCT01672866|3853898|FG002|NOT COMPLETED|Blinded Phase (up to 240 Weeks)||74
3128917|NCT01672866|3853896|FG000|STARTED|Open-Label Phase (up to 240 Weeks)|Met protocol-specified reason(s) for study discontinuation during Blinded Phase & entered Open-Label|11
3128918|NCT01672866|3853897|FG001|STARTED|Open-Label Phase (up to 240 Weeks)|Met protocol-specified reason(s) for study discontinuation during Blinded Phase & entered Open-Label|15
3128919|NCT01672866|3853898|FG002|STARTED|Open-Label Phase (up to 240 Weeks)|Met protocol-specified reason(s) for study discontinuation during Blinded Phase & entered Open-Label|16
3128920|NCT01672866|3853896|FG000|COMPLETED|Open-Label Phase (up to 240 Weeks)||0
3128921|NCT01672866|3853897|FG001|COMPLETED|Open-Label Phase (up to 240 Weeks)||0
3128922|NCT01672866|3853898|FG002|COMPLETED|Open-Label Phase (up to 240 Weeks)||0
3128923|NCT01672866|3853896|FG000|NOT COMPLETED|Open-Label Phase (up to 240 Weeks)||11
3128924|NCT01672866|3853897|FG001|NOT COMPLETED|Open-Label Phase (up to 240 Weeks)||15
3128925|NCT01672866|3853898|FG002|NOT COMPLETED|Open-Label Phase (up to 240 Weeks)||16
3128926|NCT01672879|3853911|FG000|STARTED|Blinded Phase (Up to 240 Weeks)||87
3128927|NCT01672879|3853912|FG001|STARTED|Blinded Phase (Up to 240 Weeks)||86
3128928|NCT01672879|3853913|FG002|STARTED|Blinded Phase (Up to 240 Weeks)||86
3128929|NCT01672879|3853911|FG000|COMPLETED|Blinded Phase (Up to 240 Weeks)||0
3128930|NCT01672879|3853912|FG001|COMPLETED|Blinded Phase (Up to 240 Weeks)||0
3128931|NCT01672879|3853913|FG002|COMPLETED|Blinded Phase (Up to 240 Weeks)||0
3128932|NCT01672879|3853911|FG000|NOT COMPLETED|Blinded Phase (Up to 240 Weeks)||87
3128933|NCT01672879|3853912|FG001|NOT COMPLETED|Blinded Phase (Up to 240 Weeks)||86
3128934|NCT01672879|3853913|FG002|NOT COMPLETED|Blinded Phase (Up to 240 Weeks)||86
3128935|NCT01672879|3853911|FG000|STARTED|Open-Label Phase (Up to 240 Weeks)|Met protocol-specified reason(s) for study discontinuation during Blinded Phase & entered Open-Label|15
3128936|NCT01672879|3853912|FG001|STARTED|Open-Label Phase (Up to 240 Weeks)|Met protocol-specified reason(s) for study discontinuation during Blinded Phase & entered Open-Label|17
3128937|NCT01672879|3853913|FG002|STARTED|Open-Label Phase (Up to 240 Weeks)|Met protocol-specified reason(s) for study discontinuation during Blinded Phase & entered Open-Label|8
3128938|NCT01672879|3853911|FG000|COMPLETED|Open-Label Phase (Up to 240 Weeks)||0
3128939|NCT01672879|3853912|FG001|COMPLETED|Open-Label Phase (Up to 240 Weeks)||0
3128940|NCT01672879|3853913|FG002|COMPLETED|Open-Label Phase (Up to 240 Weeks)||0
3128941|NCT01672879|3853911|FG000|NOT COMPLETED|Open-Label Phase (Up to 240 Weeks)||15
3128942|NCT01672879|3853912|FG001|NOT COMPLETED|Open-Label Phase (Up to 240 Weeks)||17
3128943|NCT01672879|3853913|FG002|NOT COMPLETED|Open-Label Phase (Up to 240 Weeks)||8
3128944|NCT01672892|3853924|FG000|STARTED|Overall Study||137
3128945|NCT01672892|3853925|FG001|STARTED|Overall Study||152
3128946|NCT01672892|3853924|FG000|Eligible Population|Overall Study||130
3128947|NCT01672892|3853925|FG001|Eligible Population|Overall Study||149
3128948|NCT01672892|3853924|FG000|Adverse Event Population|Overall Study||125
3128949|NCT01672892|3853925|FG001|Adverse Event Population|Overall Study||144
3128950|NCT01672892|3853924|FG000|COMPLETED|Overall Study||130
3128951|NCT01672892|3853925|FG001|COMPLETED|Overall Study||149
3128952|NCT01672892|3853924|FG000|NOT COMPLETED|Overall Study||7
3128953|NCT01672892|3853925|FG001|NOT COMPLETED|Overall Study||3
3128954|NCT01672957|3853934|FG000|STARTED|Overall Study||128
3128955|NCT01672957|3853934|FG000|Intent-to-treat (ITT) Population|Overall Study|All enrolled participants who had no major protocol violation.|123
3128956|NCT01672957|3853934|FG000|COMPLETED|Overall Study||73
3128957|NCT01672957|3853934|FG000|NOT COMPLETED|Overall Study||55
3128958|NCT01672970|3853938|FG000|STARTED|Overall Study||291
3128959|NCT01672970|3853938|FG000|Treated|Overall Study||290
3128960|NCT01672970|3853938|FG000|COMPLETED|Overall Study||244
3128961|NCT01672970|3853938|FG000|NOT COMPLETED|Overall Study||47
3128962|NCT01672983|3853948|FG000|STARTED|Overall Study||18
3128963|NCT01672983|3853949|FG001|STARTED|Overall Study||18
3128964|NCT01672983|3853950|FG002|STARTED|Overall Study||19
3128965|NCT01672983|3853951|FG003|STARTED|Overall Study||18
3128966|NCT01672983|3853952|FG004|STARTED|Overall Study||19
3128967|NCT01672983|3853953|FG005|STARTED|Overall Study||18
3128968|NCT01672983|3853948|FG000|Completed Study Drug|Overall Study||18
3128969|NCT01672983|3853949|FG001|Completed Study Drug|Overall Study||17
3128970|NCT01672983|3853950|FG002|Completed Study Drug|Overall Study||18
3128971|NCT01672983|3853951|FG003|Completed Study Drug|Overall Study||18
3128972|NCT01672983|3853952|FG004|Completed Study Drug|Overall Study||12
3128973|NCT01672983|3853953|FG005|Completed Study Drug|Overall Study||17
3128974|NCT01672983|3853948|FG000|COMPLETED|Overall Study||18
3128975|NCT01672983|3853949|FG001|COMPLETED|Overall Study||18
3128976|NCT01672983|3853950|FG002|COMPLETED|Overall Study||19
3128977|NCT01672983|3853951|FG003|COMPLETED|Overall Study||18
3128978|NCT01672983|3853952|FG004|COMPLETED|Overall Study||19
3128979|NCT01672983|3853953|FG005|COMPLETED|Overall Study||18
3128980|NCT01672983|3853948|FG000|NOT COMPLETED|Overall Study||0
3128981|NCT01672983|3853949|FG001|NOT COMPLETED|Overall Study||0
3128982|NCT01672983|3853950|FG002|NOT COMPLETED|Overall Study||0
3128983|NCT01672983|3853951|FG003|NOT COMPLETED|Overall Study||0
3128984|NCT01672983|3853952|FG004|NOT COMPLETED|Overall Study||0
3128985|NCT01672983|3853953|FG005|NOT COMPLETED|Overall Study||0
3128986|NCT01672996|3853982|FG000|STARTED|Overall Study||30
3128987|NCT01672996|3853983|FG001|STARTED|Overall Study||30
3128988|NCT01672996|3853984|FG002|STARTED|Overall Study||6
3128989|NCT01672996|3853982|FG000|COMPLETED|Overall Study||30
3128990|NCT01672996|3853983|FG001|COMPLETED|Overall Study||30
3128991|NCT01672996|3853984|FG002|COMPLETED|Overall Study||6
3128992|NCT01672996|3853982|FG000|NOT COMPLETED|Overall Study||0
3128993|NCT01672996|3853983|FG001|NOT COMPLETED|Overall Study||0
3128994|NCT01672996|3853984|FG002|NOT COMPLETED|Overall Study||0
3128995|NCT01673009|3854000|FG000|STARTED|Overall Study||36
3128996|NCT01673009|3854000|FG000|COMPLETED|Overall Study||23
3128997|NCT01673009|3854000|FG000|NOT COMPLETED|Overall Study||13
3136547|NCT01713582|3861691|FG007|NOT COMPLETED|Overall Study||6
3136548|NCT01713582|3861692|FG008|NOT COMPLETED|Overall Study||6
3136549|NCT01713582|3861693|FG009|NOT COMPLETED|Overall Study||18
3136550|NCT01713582|3861694|FG010|NOT COMPLETED|Overall Study||16
3136551|NCT01713582|3861695|FG011|NOT COMPLETED|Overall Study||5
3136552|NCT01713582|3861696|FG012|NOT COMPLETED|Overall Study||3
3136553|NCT01713582|3861697|FG013|NOT COMPLETED|Overall Study||4
3136554|NCT01713582|3861698|FG014|NOT COMPLETED|Overall Study||7
3136555|NCT01713582|3861699|FG015|NOT COMPLETED|Overall Study||6
3136556|NCT01713582|3861700|FG016|NOT COMPLETED|Overall Study||7
3136557|NCT01713582|3861701|FG017|NOT COMPLETED|Overall Study||3
3136558|NCT01713582|3861702|FG018|NOT COMPLETED|Overall Study||5
3136559|NCT01713582|3861703|FG019|NOT COMPLETED|Overall Study||5
3136560|NCT01713582|3861704|FG020|NOT COMPLETED|Overall Study||15
3136561|NCT01713608|3861766|FG000|STARTED|Overall Study||8
3136562|NCT01713608|3861767|FG001|STARTED|Overall Study||6
3136563|NCT01713608|3861768|FG002|STARTED|Overall Study||8
3136564|NCT01713608|3861769|FG003|STARTED|Overall Study||12
3136565|NCT01713608|3861766|FG000|COMPLETED|Overall Study||8
3136566|NCT01713608|3861767|FG001|COMPLETED|Overall Study||6
3136567|NCT01713608|3861768|FG002|COMPLETED|Overall Study||8
3136568|NCT01713608|3861769|FG003|COMPLETED|Overall Study||12
3136569|NCT01713608|3861766|FG000|NOT COMPLETED|Overall Study||0
3136570|NCT01713608|3861767|FG001|NOT COMPLETED|Overall Study||0
3136571|NCT01713608|3861768|FG002|NOT COMPLETED|Overall Study||0
3136572|NCT01713608|3861769|FG003|NOT COMPLETED|Overall Study||0
3136573|NCT01713621|3861780|FG000|STARTED|Overall Study||8
3136574|NCT01713621|3861781|FG001|STARTED|Overall Study||17
3136575|NCT01713621|3861780|FG000|COMPLETED|Overall Study||1
3136576|NCT01713621|3861781|FG001|COMPLETED|Overall Study||1
3136577|NCT01713621|3861780|FG000|NOT COMPLETED|Overall Study||7
3136578|NCT01713621|3861781|FG001|NOT COMPLETED|Overall Study||16
3136579|NCT01713660|3861787|FG000|STARTED|Overall Study||37
3136580|NCT01713660|3861787|FG000|COMPLETED|Overall Study||37
3136581|NCT01713660|3861787|FG000|NOT COMPLETED|Overall Study||0
3136582|NCT01713686|3861791|FG000|STARTED|Overall Study|129 enrolled, 125 treated. 2 withdrew consent prior to treatment; 2 excluded after enrollment.|125
3136583|NCT01713686|3861791|FG000|COMPLETED|Overall Study||110
3136584|NCT01713686|3861791|FG000|NOT COMPLETED|Overall Study||15
3136585|NCT01713868|3861799|FG000|STARTED|Overall Study||400
3136586|NCT01713868|3861800|FG001|STARTED|Overall Study||400
3136587|NCT01713868|3861801|FG002|STARTED|Overall Study||400
3136588|NCT01713868|3861802|FG003|STARTED|Overall Study||400
3136589|NCT01713868|3861799|FG000|COMPLETED|Overall Study||303
3136590|NCT01713868|3861800|FG001|COMPLETED|Overall Study||335
3136591|NCT01713868|3861801|FG002|COMPLETED|Overall Study||320
3136592|NCT01713868|3861802|FG003|COMPLETED|Overall Study||305
3136593|NCT01713868|3861799|FG000|NOT COMPLETED|Overall Study||97
3136594|NCT01713868|3861800|FG001|NOT COMPLETED|Overall Study||65
3136595|NCT01713868|3861801|FG002|NOT COMPLETED|Overall Study||80
3136596|NCT01713868|3861802|FG003|NOT COMPLETED|Overall Study||95
3136597|NCT01713933|3861814|FG000|STARTED|Overall Study||37
3136598|NCT01713933|3861814|FG000|COMPLETED|Overall Study||31
3136599|NCT01713933|3861814|FG000|NOT COMPLETED|Overall Study||6
3136600|NCT01713946|3861821|FG000|STARTED|Overall Study||117
3136601|NCT01713946|3861822|FG001|STARTED|Overall Study||130
3136602|NCT01713946|3861823|FG002|STARTED|Overall Study|Of the 119 patients initially randomized to the Placebo arm, 5 patients never switched to everolimus|119
3128998|NCT01673022|3854004|FG000|STARTED|Overall Study||430
3128999|NCT01673022|3854004|FG000|COMPLETED|Overall Study||422
3129000|NCT01673022|3854004|FG000|NOT COMPLETED|Overall Study||8
3129001|NCT01673113|3854010|FG000|STARTED|Overall Study||11
3129002|NCT01673113|3854011|FG001|STARTED|Overall Study||11
3129003|NCT01673113|3854010|FG000|COMPLETED|Overall Study||11
3129004|NCT01673113|3854011|FG001|COMPLETED|Overall Study||11
3129005|NCT01673113|3854010|FG000|NOT COMPLETED|Overall Study||0
3129006|NCT01673113|3854011|FG001|NOT COMPLETED|Overall Study||0
3129007|NCT01673126|3854020|FG000|STARTED|Overall Study|First stimulation (20 minutes) Washout (2 days) Second stimulation (20 minutes)|36
3129008|NCT01673126|3854021|FG001|STARTED|Overall Study|First stimulation (20 minutes) Washout (2days) Second stimulation (20 minutes)|26
3129009|NCT01673126|3854020|FG000|COMPLETED|Overall Study||32
3129010|NCT01673126|3854021|FG001|COMPLETED|Overall Study||23
3129011|NCT01673126|3854020|FG000|NOT COMPLETED|Overall Study||4
3129012|NCT01673126|3854021|FG001|NOT COMPLETED|Overall Study||3
3129013|NCT01673178|3854032|FG000|STARTED|Overall Study||22
3129014|NCT01673178|3854033|FG001|STARTED|Overall Study||21
3129015|NCT01673178|3854034|FG002|STARTED|Overall Study||21
3129016|NCT01673178|3854035|FG003|STARTED|Overall Study||22
3129017|NCT01673178|3854036|FG004|STARTED|Overall Study||21
3129018|NCT01673178|3854032|FG000|COMPLETED|Overall Study||19
3129019|NCT01673178|3854033|FG001|COMPLETED|Overall Study||19
3129020|NCT01673178|3854034|FG002|COMPLETED|Overall Study||18
3129021|NCT01673178|3854035|FG003|COMPLETED|Overall Study||14
3129022|NCT01673178|3854036|FG004|COMPLETED|Overall Study||19
3129023|NCT01673178|3854032|FG000|NOT COMPLETED|Overall Study||3
3129024|NCT01673178|3854033|FG001|NOT COMPLETED|Overall Study||2
3129025|NCT01673178|3854034|FG002|NOT COMPLETED|Overall Study||3
3129026|NCT01673178|3854035|FG003|NOT COMPLETED|Overall Study||8
3129027|NCT01673178|3854036|FG004|NOT COMPLETED|Overall Study||2
3129028|NCT01673191|3854054|FG000|STARTED|Overall Study||26
3129029|NCT01673191|3854055|FG001|STARTED|Overall Study||11
3129030|NCT01673191|3854054|FG000|COMPLETED|Overall Study||26
3129031|NCT01673191|3854055|FG001|COMPLETED|Overall Study||11
3129032|NCT01673191|3854054|FG000|NOT COMPLETED|Overall Study||0
3129033|NCT01673191|3854055|FG001|NOT COMPLETED|Overall Study||0
3129034|NCT01673256|3854061|FG000|STARTED|Overall Study||90
3129035|NCT01673256|3854061|FG000|COMPLETED|Overall Study||90
3296418|NCT02906670|4030248|FG000|STARTED|Cohort 5P, Q2W||0
3296419|NCT02906670|4030249|FG001|STARTED|Cohort 5P, Q2W||0
3296420|NCT02906670|4030250|FG002|STARTED|Cohort 5P, Q2W||0
3296421|NCT02906670|4030251|FG003|STARTED|Cohort 5P, Q2W||0
3296422|NCT02906670|4030252|FG004|STARTED|Cohort 5P, Q2W||0
3296423|NCT02906670|4030253|FG005|STARTED|Cohort 5P, Q2W||0
3129036|NCT01673256|3854061|FG000|NOT COMPLETED|Overall Study||0
3129037|NCT01673282|3854067|FG000|STARTED|Overall Study||153
3129038|NCT01673282|3854068|FG001|STARTED|Overall Study||158
3129039|NCT01673282|3854067|FG000|COMPLETED|Overall Study||120
3129040|NCT01673282|3854068|FG001|COMPLETED|Overall Study||132
3129041|NCT01673282|3854067|FG000|NOT COMPLETED|Overall Study||33
2940896|NCT00639860|3653153|FG000|NOT COMPLETED|Overall Study||0
2940897|NCT00640016|3653161|FG000|STARTED|Overall Study||3
2940898|NCT00640016|3653162|FG001|STARTED|Overall Study||3
2940899|NCT00640016|3653163|FG002|STARTED|Overall Study||4
2940900|NCT00640016|3653164|FG003|STARTED|Overall Study||4
2940901|NCT00640016|3653161|FG000|Treated|Overall Study||3
3129042|NCT01673282|3854068|FG001|NOT COMPLETED|Overall Study||26
3129043|NCT01673347|3854074|FG000|STARTED|Overall Study||24
3129044|NCT01673347|3854074|FG000|COMPLETED|Overall Study||17
3129045|NCT01673347|3854074|FG000|NOT COMPLETED|Overall Study||7
3129046|NCT01673373|3854078|FG000|STARTED|Overall Study||68
3129047|NCT01673373|3854078|FG000|COMPLETED|Overall Study|Completed primary endpoint follow up.|66
3129048|NCT01673373|3854078|FG000|NOT COMPLETED|Overall Study||2
3129049|NCT01673386|3854082|FG000|STARTED|Overall Study||27
3129050|NCT01673386|3854083|FG001|STARTED|Overall Study||31
3129051|NCT01673386|3854082|FG000|COMPLETED|Overall Study|Of 2 subjects, 1 subject discontinued tivozanib early, completed planned treatment with sunitinib.|2
3129052|NCT01673386|3854083|FG001|COMPLETED|Overall Study|Of 4 subjects, 3 subjects discontinued sunitinib early, completed planned treatment with tivozanib.|4
3129053|NCT01673386|3854082|FG000|NOT COMPLETED|Overall Study||25
3129054|NCT01673386|3854083|FG001|NOT COMPLETED|Overall Study||27
3129055|NCT01673490|3854089|FG000|STARTED|Overall Study||59
3129056|NCT01673490|3854089|FG000|COMPLETED|Overall Study||52
3129057|NCT01673490|3854089|FG000|NOT COMPLETED|Overall Study||7
3129058|NCT01673568|3854095|FG000|STARTED|Overall Study||28
3129059|NCT01673568|3854096|FG001|STARTED|Overall Study||28
3129060|NCT01673568|3854095|FG000|COMPLETED|Overall Study||28
3129061|NCT01673568|3854096|FG001|COMPLETED|Overall Study||28
3129062|NCT01673568|3854095|FG000|NOT COMPLETED|Overall Study||0
3129063|NCT01673568|3854096|FG001|NOT COMPLETED|Overall Study||0
3129064|NCT01673594|3854104|FG000|STARTED|Overall Study||18
3129065|NCT01673594|3854105|FG001|STARTED|Overall Study||19
3296424|NCT02906670|4030254|FG006|STARTED|Cohort 5P, Q2W||0
3296425|NCT02906670|4030255|FG007|STARTED|Cohort 5P, Q2W||3
3296426|NCT02906670|4030256|FG008|STARTED|Cohort 5P, Q2W||0
3129066|NCT01673594|3854104|FG000|COMPLETED|Overall Study||12
3129067|NCT01673594|3854105|FG001|COMPLETED|Overall Study||13
3129068|NCT01673594|3854104|FG000|NOT COMPLETED|Overall Study||6
3296427|NCT02906670|4030257|FG009|STARTED|Cohort 5P, Q2W||0
3296428|NCT02906670|4030248|FG000|COMPLETED|Cohort 5P, Q2W||0
3296429|NCT02906670|4030249|FG001|COMPLETED|Cohort 5P, Q2W||0
3129069|NCT01673594|3854105|FG001|NOT COMPLETED|Overall Study||6
3129070|NCT01673646|3854114|FG000|STARTED|Overall Study||11
3129071|NCT01673646|3854115|FG001|STARTED|Overall Study||11
3129072|NCT01673646|3854116|FG002|STARTED|Overall Study||11
3129073|NCT01673646|3854114|FG000|Entered/Treated in Core Phase|Overall Study||11
3129074|NCT01673646|3854115|FG001|Entered/Treated in Core Phase|Overall Study||11
3129075|NCT01673646|3854116|FG002|Entered/Treated in Core Phase|Overall Study||11
3129076|NCT01673646|3854114|FG000|Completed Core Phase|Overall Study||9
3129077|NCT01673646|3854115|FG001|Completed Core Phase|Overall Study||10
3129078|NCT01673646|3854116|FG002|Completed Core Phase|Overall Study||10
3129079|NCT01673646|3854114|FG000|Entered Ext. Phase|Overall Study||7
3129080|NCT01673646|3854115|FG001|Entered Ext. Phase|Overall Study||9
3129081|NCT01673646|3854116|FG002|Entered Ext. Phase|Overall Study||9
3129082|NCT01673646|3854114|FG000|Did Not Enter Ext. Phase|Overall Study||2
3129083|NCT01673646|3854115|FG001|Did Not Enter Ext. Phase|Overall Study||1
3129084|NCT01673646|3854116|FG002|Did Not Enter Ext. Phase|Overall Study||1
3129085|NCT01673646|3854114|FG000|Treated Beyond 24 Months|Overall Study||7
3129086|NCT01673646|3854115|FG001|Treated Beyond 24 Months|Overall Study||8
3129087|NCT01673646|3854116|FG002|Treated Beyond 24 Months|Overall Study||8
3129088|NCT01673646|3854114|FG000|Discontinued Beyond 24 Months|Overall Study||0
3129089|NCT01673646|3854115|FG001|Discontinued Beyond 24 Months|Overall Study||4
3129090|NCT01673646|3854116|FG002|Discontinued Beyond 24 Months|Overall Study||1
3129091|NCT01673646|3854114|FG000|COMPLETED|Overall Study||7
3129092|NCT01673646|3854115|FG001|COMPLETED|Overall Study||4
3129093|NCT01673646|3854116|FG002|COMPLETED|Overall Study||7
3129094|NCT01673646|3854114|FG000|NOT COMPLETED|Overall Study||4
3129095|NCT01673646|3854115|FG001|NOT COMPLETED|Overall Study||7
3129096|NCT01673646|3854116|FG002|NOT COMPLETED|Overall Study||4
3129097|NCT01673698|3854130|FG000|STARTED|Overall Study||187
3129098|NCT01673698|3854131|FG001|STARTED|Overall Study||139
3129099|NCT01673698|3854130|FG000|COMPLETED|Overall Study||136
3129100|NCT01673698|3854131|FG001|COMPLETED|Overall Study||126
3129101|NCT01673698|3854130|FG000|NOT COMPLETED|Overall Study||51
3129102|NCT01673698|3854131|FG001|NOT COMPLETED|Overall Study||13
3129103|NCT01673802|3854138|FG000|STARTED|Gadoxetate Standard Dose 0.025 mmol/kg||8
3129104|NCT01673802|3854138|FG000|COMPLETED|Gadoxetate Standard Dose 0.025 mmol/kg||8
3129105|NCT01673802|3854138|FG000|NOT COMPLETED|Gadoxetate Standard Dose 0.025 mmol/kg||0
3129106|NCT01673802|3854138|FG000|STARTED|Gadoxetate Double Dose 0.050 mmol/kg||10
3129107|NCT01673802|3854138|FG000|COMPLETED|Gadoxetate Double Dose 0.050 mmol/kg||10
3129108|NCT01673802|3854138|FG000|NOT COMPLETED|Gadoxetate Double Dose 0.050 mmol/kg||0
3129109|NCT01673828|3854144|FG000|STARTED|Overall Study||7
3129110|NCT01673828|3854145|FG001|STARTED|Overall Study||6
3129111|NCT01673828|3854144|FG000|COMPLETED|Overall Study||7
3129112|NCT01673828|3854145|FG001|COMPLETED|Overall Study||6
3129113|NCT01673828|3854144|FG000|NOT COMPLETED|Overall Study||0
3129114|NCT01673828|3854145|FG001|NOT COMPLETED|Overall Study||0
3129115|NCT01673854|3854151|FG000|STARTED|Vem 1 Phase (Vemurafenib, 960 mg)||46
3129116|NCT01673854|3854151|FG000|COMPLETED|Vem 1 Phase (Vemurafenib, 960 mg)||46
3129117|NCT01673854|3854151|FG000|NOT COMPLETED|Vem 1 Phase (Vemurafenib, 960 mg)||0
3129118|NCT01673854|3854151|FG000|STARTED|Ipilimumab Phase (Ipilimumab, 10 mg/kg)||46
3129119|NCT01673854|3854151|FG000|COMPLETED|Ipilimumab Phase (Ipilimumab, 10 mg/kg)||19
3129120|NCT01673854|3854151|FG000|NOT COMPLETED|Ipilimumab Phase (Ipilimumab, 10 mg/kg)||27
3129121|NCT01673854|3854151|FG000|STARTED|Vem 2 Phase (Vemurafenib Retreatment)||19
3129122|NCT01673854|3854151|FG000|COMPLETED|Vem 2 Phase (Vemurafenib Retreatment)||0
3129123|NCT01673854|3854151|FG000|NOT COMPLETED|Vem 2 Phase (Vemurafenib Retreatment)||19
3129124|NCT01673867|3854157|FG000|STARTED|Randomization||292
3129125|NCT01673867|3854158|FG001|STARTED|Randomization||290
3129126|NCT01673867|3854157|FG000|COMPLETED|Randomization||287
3129127|NCT01673867|3854158|FG001|COMPLETED|Randomization||268
3129128|NCT01673867|3854157|FG000|NOT COMPLETED|Randomization||5
3129129|NCT01673867|3854158|FG001|NOT COMPLETED|Randomization||22
3129130|NCT01673867|3854157|FG000|STARTED|Treatment||287
3129131|NCT01673867|3854158|FG001|STARTED|Treatment||268
3129132|NCT01673867|3854157|FG000|COMPLETED|Treatment||43
3129133|NCT01673867|3854158|FG001|COMPLETED|Treatment||0
3129134|NCT01673867|3854157|FG000|NOT COMPLETED|Treatment||244
3129135|NCT01673867|3854158|FG001|NOT COMPLETED|Treatment||268
3129136|NCT01673893|3854166|FG000|STARTED|Overall Study||59
3129137|NCT01673893|3854166|FG000|COMPLETED|Overall Study||59
3129138|NCT01673893|3854166|FG000|NOT COMPLETED|Overall Study||0
3129139|NCT01673919|3854172|FG000|STARTED|Overall Study||7
3129140|NCT01673919|3854172|FG000|COMPLETED|Overall Study||7
3129141|NCT01673919|3854172|FG000|NOT COMPLETED|Overall Study||0
3129142|NCT01673984|3854178|FG000|STARTED|Overall Study||14
3129143|NCT01673984|3854179|FG001|STARTED|Overall Study||7
3129144|NCT01673984|3854178|FG000|COMPLETED|Overall Study||4
3129145|NCT01673984|3854179|FG001|COMPLETED|Overall Study||1
3129146|NCT01673984|3854178|FG000|NOT COMPLETED|Overall Study||10
3129147|NCT01673984|3854179|FG001|NOT COMPLETED|Overall Study||6
3129148|NCT01674010|3854185|FG000|STARTED|Open Treatment Phase 1||309
3129149|NCT01674010|3854186|FG001|STARTED|Open Treatment Phase 1||0
3129150|NCT01674010|3854187|FG002|STARTED|Open Treatment Phase 1||0
3129151|NCT01674010|3854185|FG000|COMPLETED|Open Treatment Phase 1||129
3129152|NCT01674010|3854186|FG001|COMPLETED|Open Treatment Phase 1||0
3129153|NCT01674010|3854187|FG002|COMPLETED|Open Treatment Phase 1||0
3129154|NCT01674010|3854185|FG000|NOT COMPLETED|Open Treatment Phase 1||180
3129155|NCT01674010|3854186|FG001|NOT COMPLETED|Open Treatment Phase 1||0
3129156|NCT01674010|3854187|FG002|NOT COMPLETED|Open Treatment Phase 1||0
3129157|NCT01674010|3854185|FG000|STARTED|Randomization Phase 2||0
3129158|NCT01674010|3854186|FG001|STARTED|Randomization Phase 2||65
3129159|NCT01674010|3854187|FG002|STARTED|Randomization Phase 2||64
3129160|NCT01674010|3854185|FG000|COMPLETED|Randomization Phase 2||0
3129161|NCT01674010|3854186|FG001|COMPLETED|Randomization Phase 2||3
3129162|NCT01674010|3854187|FG002|COMPLETED|Randomization Phase 2||3
3129163|NCT01674010|3854185|FG000|NOT COMPLETED|Randomization Phase 2||0
3129164|NCT01674010|3854186|FG001|NOT COMPLETED|Randomization Phase 2||62
3129165|NCT01674010|3854187|FG002|NOT COMPLETED|Randomization Phase 2||61
3129166|NCT01674062|3854197|FG000|STARTED|Overall Study||66
3129167|NCT01674062|3854198|FG001|STARTED|Overall Study||29
3129168|NCT01674062|3854197|FG000|COMPLETED|Overall Study||0
3129169|NCT01674062|3854198|FG001|COMPLETED|Overall Study||0
3129170|NCT01674062|3854197|FG000|NOT COMPLETED|Overall Study||66
3129171|NCT01674062|3854198|FG001|NOT COMPLETED|Overall Study||29
3129172|NCT01674478|3854206|FG000|STARTED|Overall Study||9
3129173|NCT01674478|3854207|FG001|STARTED|Overall Study||9
3129174|NCT01674478|3854206|FG000|COMPLETED|Overall Study||9
3129175|NCT01674478|3854207|FG001|COMPLETED|Overall Study||9
3296430|NCT02906670|4030250|FG002|COMPLETED|Cohort 5P, Q2W||0
3296431|NCT02906670|4030251|FG003|COMPLETED|Cohort 5P, Q2W||0
3296432|NCT02906670|4030252|FG004|COMPLETED|Cohort 5P, Q2W||0
3296433|NCT02906670|4030253|FG005|COMPLETED|Cohort 5P, Q2W||0
3296434|NCT02906670|4030254|FG006|COMPLETED|Cohort 5P, Q2W||0
3296435|NCT02906670|4030255|FG007|COMPLETED|Cohort 5P, Q2W||0
3296436|NCT02906670|4030256|FG008|COMPLETED|Cohort 5P, Q2W||0
3296437|NCT02906670|4030257|FG009|COMPLETED|Cohort 5P, Q2W||0
3296438|NCT02906670|4030248|FG000|NOT COMPLETED|Cohort 5P, Q2W||0
3296439|NCT02906670|4030249|FG001|NOT COMPLETED|Cohort 5P, Q2W||0
3296440|NCT02906670|4030250|FG002|NOT COMPLETED|Cohort 5P, Q2W||0
3296441|NCT02906670|4030251|FG003|NOT COMPLETED|Cohort 5P, Q2W||0
3296442|NCT02906670|4030252|FG004|NOT COMPLETED|Cohort 5P, Q2W||0
3296443|NCT02906670|4030253|FG005|NOT COMPLETED|Cohort 5P, Q2W||0
3296444|NCT02906670|4030254|FG006|NOT COMPLETED|Cohort 5P, Q2W||0
3296445|NCT02906670|4030255|FG007|NOT COMPLETED|Cohort 5P, Q2W||3
3296446|NCT02906670|4030256|FG008|NOT COMPLETED|Cohort 5P, Q2W||0
3296447|NCT02906670|4030257|FG009|NOT COMPLETED|Cohort 5P, Q2W||0
3129176|NCT01674478|3854206|FG000|NOT COMPLETED|Overall Study||0
3129177|NCT01674478|3854207|FG001|NOT COMPLETED|Overall Study||0
3129178|NCT01674569|3854213|FG000|STARTED|Overall Study||3
3129179|NCT01674569|3854214|FG001|STARTED|Overall Study||8
3129180|NCT01674569|3854215|FG002|STARTED|Overall Study||4
3129181|NCT01674569|3854216|FG003|STARTED|Overall Study||10
3129182|NCT01674569|3854217|FG004|STARTED|Overall Study||7
3129183|NCT01674569|3854218|FG005|STARTED|Overall Study||3
3129184|NCT01674569|3854213|FG000|COMPLETED|Overall Study||3
3129185|NCT01674569|3854214|FG001|COMPLETED|Overall Study||5
3129186|NCT01674569|3854215|FG002|COMPLETED|Overall Study||2
3129187|NCT01674569|3854216|FG003|COMPLETED|Overall Study||9
3129188|NCT01674569|3854217|FG004|COMPLETED|Overall Study||5
3129189|NCT01674569|3854218|FG005|COMPLETED|Overall Study||1
3129190|NCT01674569|3854213|FG000|NOT COMPLETED|Overall Study||0
3129191|NCT01674569|3854214|FG001|NOT COMPLETED|Overall Study||3
3129192|NCT01674569|3854215|FG002|NOT COMPLETED|Overall Study||2
3129193|NCT01674569|3854216|FG003|NOT COMPLETED|Overall Study||1
3129194|NCT01674569|3854217|FG004|NOT COMPLETED|Overall Study||2
3129195|NCT01674569|3854218|FG005|NOT COMPLETED|Overall Study||2
3129196|NCT01674621|3854227|FG000|STARTED|Overall Study||50
3129197|NCT01674621|3854228|FG001|STARTED|Overall Study||51
3129198|NCT01674621|3854229|FG002|STARTED|Overall Study||48
3129199|NCT01674621|3854230|FG003|STARTED|Overall Study||51
3129200|NCT01674621|3854231|FG004|STARTED|Overall Study||50
3129201|NCT01674621|3854227|FG000|Modified Intent-to-Treat Population|Overall Study||47
3129202|NCT01674621|3854228|FG001|Modified Intent-to-Treat Population|Overall Study||46
3129203|NCT01674621|3854229|FG002|Modified Intent-to-Treat Population|Overall Study||43
3129204|NCT01674621|3854230|FG003|Modified Intent-to-Treat Population|Overall Study||49
3129205|NCT01674621|3854231|FG004|Modified Intent-to-Treat Population|Overall Study||46
3129206|NCT01674621|3854227|FG000|Safety Population|Overall Study||50
3129207|NCT01674621|3854228|FG001|Safety Population|Overall Study||51
3129208|NCT01674621|3854229|FG002|Safety Population|Overall Study||47
3129209|NCT01674621|3854230|FG003|Safety Population|Overall Study||51
3129210|NCT01674621|3854231|FG004|Safety Population|Overall Study||50
3129211|NCT01674621|3854227|FG000|COMPLETED|Overall Study||45
3129212|NCT01674621|3854228|FG001|COMPLETED|Overall Study||43
3129213|NCT01674621|3854229|FG002|COMPLETED|Overall Study||41
3129214|NCT01674621|3854230|FG003|COMPLETED|Overall Study||45
3129215|NCT01674621|3854231|FG004|COMPLETED|Overall Study||44
3129216|NCT01674621|3854227|FG000|NOT COMPLETED|Overall Study||5
3129217|NCT01674621|3854228|FG001|NOT COMPLETED|Overall Study||8
3129218|NCT01674621|3854229|FG002|NOT COMPLETED|Overall Study||7
3129219|NCT01674621|3854230|FG003|NOT COMPLETED|Overall Study||6
3129220|NCT01674621|3854231|FG004|NOT COMPLETED|Overall Study||6
3129221|NCT01674634|3854244|FG000|STARTED|Overall Study||715
3129222|NCT01674634|3854244|FG000|COMPLETED|Overall Study||709
3129223|NCT01674634|3854244|FG000|NOT COMPLETED|Overall Study||6
3296448|NCT02906670|4030248|FG000|STARTED|Cohort 6P, Q2W||0
3296449|NCT02906670|4030249|FG001|STARTED|Cohort 6P, Q2W||0
3296450|NCT02906670|4030250|FG002|STARTED|Cohort 6P, Q2W||0
3296451|NCT02906670|4030251|FG003|STARTED|Cohort 6P, Q2W||0
3129224|NCT01674647|3854254|FG000|STARTED|Treatment Period||1002
3129225|NCT01674647|3854255|FG001|STARTED|Treatment Period||502
3296452|NCT02906670|4030252|FG004|STARTED|Cohort 6P, Q2W||0
3296453|NCT02906670|4030253|FG005|STARTED|Cohort 6P, Q2W||0
3129226|NCT01674647|3854254|FG000|Subjects Received Treatment|Treatment Period||988
3129227|NCT01674647|3854255|FG001|Subjects Received Treatment|Treatment Period||499
3129228|NCT01674647|3854254|FG000|COMPLETED|Treatment Period||846
3129229|NCT01674647|3854255|FG001|COMPLETED|Treatment Period||400
3129230|NCT01674647|3854254|FG000|NOT COMPLETED|Treatment Period||156
3129231|NCT01674647|3854255|FG001|NOT COMPLETED|Treatment Period||102
3129232|NCT01674647|3854254|FG000|STARTED|30-day Safety Follow-up Period||982
3129233|NCT01674647|3854255|FG001|STARTED|30-day Safety Follow-up Period||487
3129234|NCT01674647|3854254|FG000|COMPLETED|30-day Safety Follow-up Period||924
3129235|NCT01674647|3854255|FG001|COMPLETED|30-day Safety Follow-up Period||446
3129236|NCT01674647|3854254|FG000|NOT COMPLETED|30-day Safety Follow-up Period||58
3129237|NCT01674647|3854255|FG001|NOT COMPLETED|30-day Safety Follow-up Period||41
3129238|NCT01674712|3854266|FG000|STARTED|Overall Study||114
3129239|NCT01674712|3854267|FG001|STARTED|Overall Study||117
3129240|NCT01674712|3854268|FG002|STARTED|Overall Study||115
3129241|NCT01674712|3854269|FG003|STARTED|Overall Study||116
3129242|NCT01674712|3854270|FG004|STARTED|Overall Study||113
3129243|NCT01674712|3854266|FG000|Full Analysis Subject Sample|Overall Study||109
3129244|NCT01674712|3854267|FG001|Full Analysis Subject Sample|Overall Study||114
3129245|NCT01674712|3854268|FG002|Full Analysis Subject Sample|Overall Study||110
3129246|NCT01674712|3854269|FG003|Full Analysis Subject Sample|Overall Study||112
3129247|NCT01674712|3854270|FG004|Full Analysis Subject Sample|Overall Study||111
3129248|NCT01674712|3854266|FG000|Safety Subject Sample|Overall Study||111
3129249|NCT01674712|3854267|FG001|Safety Subject Sample|Overall Study||117
3129250|NCT01674712|3854268|FG002|Safety Subject Sample|Overall Study||113
3129251|NCT01674712|3854269|FG003|Safety Subject Sample|Overall Study||115
3129252|NCT01674712|3854270|FG004|Safety Subject Sample|Overall Study||112
3129253|NCT01674712|3854266|FG000|COMPLETED|Overall Study||104
3129254|NCT01674712|3854267|FG001|COMPLETED|Overall Study||108
3129255|NCT01674712|3854268|FG002|COMPLETED|Overall Study||106
3129256|NCT01674712|3854269|FG003|COMPLETED|Overall Study||108
3129257|NCT01674712|3854270|FG004|COMPLETED|Overall Study||102
3129258|NCT01674712|3854266|FG000|NOT COMPLETED|Overall Study||10
3129259|NCT01674712|3854267|FG001|NOT COMPLETED|Overall Study||9
3129260|NCT01674712|3854268|FG002|NOT COMPLETED|Overall Study||9
3129261|NCT01674712|3854269|FG003|NOT COMPLETED|Overall Study||8
3129262|NCT01674712|3854270|FG004|NOT COMPLETED|Overall Study||11
3129263|NCT01674725|3854284|FG000|STARTED|Overall Study||92
3129264|NCT01674725|3854285|FG001|STARTED|Overall Study||95
3129265|NCT01674725|3854284|FG000|COMPLETED|Overall Study||89
3129266|NCT01674725|3854285|FG001|COMPLETED|Overall Study||94
3129267|NCT01674725|3854284|FG000|NOT COMPLETED|Overall Study||3
3129268|NCT01674725|3854285|FG001|NOT COMPLETED|Overall Study||1
3129269|NCT01675050|3854293|FG000|STARTED|Period One Treatment||2
3129270|NCT01675050|3854294|FG001|STARTED|Period One Treatment||2
3129271|NCT01675050|3854293|FG000|COMPLETED|Period One Treatment||1
3129272|NCT01675050|3854294|FG001|COMPLETED|Period One Treatment||2
3129273|NCT01675050|3854293|FG000|NOT COMPLETED|Period One Treatment||1
3129274|NCT01675050|3854294|FG001|NOT COMPLETED|Period One Treatment||0
3129275|NCT01675050|3854293|FG000|STARTED|Wash Out Period||1
3129276|NCT01675050|3854294|FG001|STARTED|Wash Out Period||2
3129277|NCT01675050|3854293|FG000|COMPLETED|Wash Out Period||1
3129278|NCT01675050|3854294|FG001|COMPLETED|Wash Out Period||2
3129279|NCT01675050|3854293|FG000|NOT COMPLETED|Wash Out Period||0
3129280|NCT01675050|3854294|FG001|NOT COMPLETED|Wash Out Period||0
3129281|NCT01675050|3854293|FG000|STARTED|Second Period Treatment||1
3129282|NCT01675050|3854294|FG001|STARTED|Second Period Treatment||2
3129283|NCT01675050|3854293|FG000|COMPLETED|Second Period Treatment||1
3129284|NCT01675050|3854294|FG001|COMPLETED|Second Period Treatment||2
3129285|NCT01675050|3854293|FG000|NOT COMPLETED|Second Period Treatment||0
3129286|NCT01675050|3854294|FG001|NOT COMPLETED|Second Period Treatment||0
3129287|NCT01675063|3854300|FG000|STARTED|Overall Study||77
3129288|NCT01675063|3854300|FG000|COMPLETED|Overall Study||77
3129289|NCT01675063|3854300|FG000|NOT COMPLETED|Overall Study||0
3129290|NCT01675128|3854307|FG000|STARTED|Overall Study||4
3129291|NCT01675128|3854308|FG001|STARTED|Overall Study||10
3129292|NCT01675128|3854309|FG002|STARTED|Overall Study||10
3129293|NCT01675128|3854307|FG000|COMPLETED|Overall Study||2
3129294|NCT01675128|3854308|FG001|COMPLETED|Overall Study||8
3129295|NCT01675128|3854309|FG002|COMPLETED|Overall Study||9
3129296|NCT01675128|3854307|FG000|NOT COMPLETED|Overall Study||2
3129297|NCT01675128|3854308|FG001|NOT COMPLETED|Overall Study||2
3129298|NCT01675128|3854309|FG002|NOT COMPLETED|Overall Study||1
3129299|NCT01675141|3854324|FG000|STARTED|Overall Study||11
3129300|NCT01675141|3854324|FG000|COMPLETED|Overall Study||0
3129301|NCT01675141|3854324|FG000|NOT COMPLETED|Overall Study||11
3129302|NCT01675154|3854332|FG000|STARTED|First Intervention Period (4 Weeks)||2
3129303|NCT01675154|3854333|FG001|STARTED|First Intervention Period (4 Weeks)||1
3129304|NCT01675154|3854334|FG002|STARTED|First Intervention Period (4 Weeks)||1
3129305|NCT01675154|3854335|FG003|STARTED|First Intervention Period (4 Weeks)||1
3129306|NCT01675154|3854332|FG000|COMPLETED|First Intervention Period (4 Weeks)||2
3129307|NCT01675154|3854333|FG001|COMPLETED|First Intervention Period (4 Weeks)||1
3296454|NCT02906670|4030254|FG006|STARTED|Cohort 6P, Q2W||0
3129308|NCT01675154|3854334|FG002|COMPLETED|First Intervention Period (4 Weeks)||1
3129309|NCT01675154|3854335|FG003|COMPLETED|First Intervention Period (4 Weeks)||1
3129310|NCT01675154|3854332|FG000|NOT COMPLETED|First Intervention Period (4 Weeks)||0
3129311|NCT01675154|3854333|FG001|NOT COMPLETED|First Intervention Period (4 Weeks)||0
3129312|NCT01675154|3854334|FG002|NOT COMPLETED|First Intervention Period (4 Weeks)||0
3129313|NCT01675154|3854335|FG003|NOT COMPLETED|First Intervention Period (4 Weeks)||0
3129314|NCT01675154|3854332|FG000|STARTED|First Washout Period (1 Week)|Subjects were enrolled Regimen 1|2
3129315|NCT01675154|3854333|FG001|STARTED|First Washout Period (1 Week)||1
3129316|NCT01675154|3854334|FG002|STARTED|First Washout Period (1 Week)||1
3129317|NCT01675154|3854335|FG003|STARTED|First Washout Period (1 Week)||1
3129318|NCT01675154|3854332|FG000|COMPLETED|First Washout Period (1 Week)||2
3129319|NCT01675154|3854333|FG001|COMPLETED|First Washout Period (1 Week)||1
3129320|NCT01675154|3854334|FG002|COMPLETED|First Washout Period (1 Week)||1
3129321|NCT01675154|3854335|FG003|COMPLETED|First Washout Period (1 Week)||1
3129322|NCT01675154|3854332|FG000|NOT COMPLETED|First Washout Period (1 Week)||0
3129323|NCT01675154|3854333|FG001|NOT COMPLETED|First Washout Period (1 Week)||0
3129324|NCT01675154|3854334|FG002|NOT COMPLETED|First Washout Period (1 Week)||0
3129325|NCT01675154|3854335|FG003|NOT COMPLETED|First Washout Period (1 Week)||0
3129326|NCT01675154|3854332|FG000|STARTED|Second Intervention Period (4 Weeks)||1
3129327|NCT01675154|3854333|FG001|STARTED|Second Intervention Period (4 Weeks)|Subjects were enrolled in Regimen 2|1
3129328|NCT01675154|3854334|FG002|STARTED|Second Intervention Period (4 Weeks)||1
3129329|NCT01675154|3854335|FG003|STARTED|Second Intervention Period (4 Weeks)||2
3129330|NCT01675154|3854332|FG000|COMPLETED|Second Intervention Period (4 Weeks)||0
3129331|NCT01675154|3854333|FG001|COMPLETED|Second Intervention Period (4 Weeks)||1
3129332|NCT01675154|3854334|FG002|COMPLETED|Second Intervention Period (4 Weeks)||1
3129333|NCT01675154|3854335|FG003|COMPLETED|Second Intervention Period (4 Weeks)||1
3129334|NCT01675154|3854332|FG000|NOT COMPLETED|Second Intervention Period (4 Weeks)||1
3129335|NCT01675154|3854333|FG001|NOT COMPLETED|Second Intervention Period (4 Weeks)||0
3129336|NCT01675154|3854334|FG002|NOT COMPLETED|Second Intervention Period (4 Weeks)||0
3129337|NCT01675154|3854335|FG003|NOT COMPLETED|Second Intervention Period (4 Weeks)||1
3129338|NCT01675154|3854332|FG000|STARTED|Second Washout Period (1 Week)||1
3129339|NCT01675154|3854333|FG001|STARTED|Second Washout Period (1 Week)||1
3129340|NCT01675154|3854334|FG002|STARTED|Second Washout Period (1 Week)||1
3129341|NCT01675154|3854335|FG003|STARTED|Second Washout Period (1 Week)||2
3129342|NCT01675154|3854332|FG000|COMPLETED|Second Washout Period (1 Week)||1
3129343|NCT01675154|3854333|FG001|COMPLETED|Second Washout Period (1 Week)||1
3129344|NCT01675154|3854334|FG002|COMPLETED|Second Washout Period (1 Week)||1
3129345|NCT01675154|3854335|FG003|COMPLETED|Second Washout Period (1 Week)||2
3129346|NCT01675154|3854332|FG000|NOT COMPLETED|Second Washout Period (1 Week)||0
3129347|NCT01675154|3854333|FG001|NOT COMPLETED|Second Washout Period (1 Week)||0
3129348|NCT01675154|3854334|FG002|NOT COMPLETED|Second Washout Period (1 Week)||0
3129349|NCT01675154|3854335|FG003|NOT COMPLETED|Second Washout Period (1 Week)||0
3129350|NCT01675154|3854332|FG000|STARTED|Third Intervention Period (4 Weeks)||1
3129351|NCT01675154|3854333|FG001|STARTED|Third Intervention Period (4 Weeks)||1
3129352|NCT01675154|3854334|FG002|STARTED|Third Intervention Period (4 Weeks)||1
3129353|NCT01675154|3854335|FG003|STARTED|Third Intervention Period (4 Weeks)||0
3129354|NCT01675154|3854332|FG000|COMPLETED|Third Intervention Period (4 Weeks)||1
3129355|NCT01675154|3854333|FG001|COMPLETED|Third Intervention Period (4 Weeks)||0
3129356|NCT01675154|3854334|FG002|COMPLETED|Third Intervention Period (4 Weeks)||1
3129357|NCT01675154|3854335|FG003|COMPLETED|Third Intervention Period (4 Weeks)||0
3129358|NCT01675154|3854332|FG000|NOT COMPLETED|Third Intervention Period (4 Weeks)||0
3129359|NCT01675154|3854333|FG001|NOT COMPLETED|Third Intervention Period (4 Weeks)||1
3129360|NCT01675154|3854334|FG002|NOT COMPLETED|Third Intervention Period (4 Weeks)||0
3129361|NCT01675154|3854335|FG003|NOT COMPLETED|Third Intervention Period (4 Weeks)||0
3129362|NCT01675154|3854332|FG000|STARTED|Third Washout Period (1 Week)||1
3129363|NCT01675154|3854333|FG001|STARTED|Third Washout Period (1 Week)||0
3129364|NCT01675154|3854334|FG002|STARTED|Third Washout Period (1 Week)||1
3129365|NCT01675154|3854335|FG003|STARTED|Third Washout Period (1 Week)||0
3129366|NCT01675154|3854332|FG000|COMPLETED|Third Washout Period (1 Week)||1
3129367|NCT01675154|3854333|FG001|COMPLETED|Third Washout Period (1 Week)||0
3129368|NCT01675154|3854334|FG002|COMPLETED|Third Washout Period (1 Week)||1
3129369|NCT01675154|3854335|FG003|COMPLETED|Third Washout Period (1 Week)||0
3129370|NCT01675154|3854332|FG000|NOT COMPLETED|Third Washout Period (1 Week)||0
3129371|NCT01675154|3854333|FG001|NOT COMPLETED|Third Washout Period (1 Week)||0
3296455|NCT02906670|4030255|FG007|STARTED|Cohort 6P, Q2W||0
3296456|NCT02906670|4030256|FG008|STARTED|Cohort 6P, Q2W||4
3296457|NCT02906670|4030257|FG009|STARTED|Cohort 6P, Q2W||0
3296458|NCT02906670|4030248|FG000|COMPLETED|Cohort 6P, Q2W||0
3296459|NCT02906670|4030249|FG001|COMPLETED|Cohort 6P, Q2W||0
3296460|NCT02906670|4030250|FG002|COMPLETED|Cohort 6P, Q2W||0
3296461|NCT02906670|4030251|FG003|COMPLETED|Cohort 6P, Q2W||0
3296462|NCT02906670|4030252|FG004|COMPLETED|Cohort 6P, Q2W||0
3296463|NCT02906670|4030253|FG005|COMPLETED|Cohort 6P, Q2W||0
3296464|NCT02906670|4030254|FG006|COMPLETED|Cohort 6P, Q2W||0
3296465|NCT02906670|4030255|FG007|COMPLETED|Cohort 6P, Q2W||0
3296466|NCT02906670|4030256|FG008|COMPLETED|Cohort 6P, Q2W||0
3296467|NCT02906670|4030257|FG009|COMPLETED|Cohort 6P, Q2W||0
3296468|NCT02906670|4030248|FG000|NOT COMPLETED|Cohort 6P, Q2W||0
3129372|NCT01675154|3854334|FG002|NOT COMPLETED|Third Washout Period (1 Week)||0
3129373|NCT01675154|3854335|FG003|NOT COMPLETED|Third Washout Period (1 Week)||0
3129374|NCT01675154|3854332|FG000|STARTED|Fourth Intervention Period (4 Weeks)||1
3129375|NCT01675154|3854333|FG001|STARTED|Fourth Intervention Period (4 Weeks)||0
3129376|NCT01675154|3854334|FG002|STARTED|Fourth Intervention Period (4 Weeks)||1
3129377|NCT01675154|3854335|FG003|STARTED|Fourth Intervention Period (4 Weeks)||0
3129378|NCT01675154|3854332|FG000|COMPLETED|Fourth Intervention Period (4 Weeks)||1
3129379|NCT01675154|3854333|FG001|COMPLETED|Fourth Intervention Period (4 Weeks)||0
3129380|NCT01675154|3854334|FG002|COMPLETED|Fourth Intervention Period (4 Weeks)||1
3129381|NCT01675154|3854335|FG003|COMPLETED|Fourth Intervention Period (4 Weeks)||0
3129382|NCT01675154|3854332|FG000|NOT COMPLETED|Fourth Intervention Period (4 Weeks)||0
3129383|NCT01675154|3854333|FG001|NOT COMPLETED|Fourth Intervention Period (4 Weeks)||0
3129384|NCT01675154|3854334|FG002|NOT COMPLETED|Fourth Intervention Period (4 Weeks)||0
3129385|NCT01675154|3854335|FG003|NOT COMPLETED|Fourth Intervention Period (4 Weeks)||0
3129386|NCT01675167|3854359|FG000|STARTED|Open-label Titration Phase||815
3129387|NCT01675167|3854360|FG001|STARTED|Open-label Titration Phase||0
3129388|NCT01675167|3854361|FG002|STARTED|Open-label Titration Phase||0
3129389|NCT01675167|3854359|FG000|COMPLETED|Open-label Titration Phase||511
3129390|NCT01675167|3854360|FG001|COMPLETED|Open-label Titration Phase||0
3129391|NCT01675167|3854361|FG002|COMPLETED|Open-label Titration Phase||0
3129392|NCT01675167|3854359|FG000|NOT COMPLETED|Open-label Titration Phase||304
3129393|NCT01675167|3854360|FG001|NOT COMPLETED|Open-label Titration Phase||0
3129394|NCT01675167|3854361|FG002|NOT COMPLETED|Open-label Titration Phase||0
3129395|NCT01675167|3854359|FG000|STARTED|Double-blind Treatment Phase|All subjects completing OL titration in the previous period were randomized to a DB treatment.|0
3129396|NCT01675167|3854360|FG001|STARTED|Double-blind Treatment Phase|Subjects were randomized to DB treatment after completing OL titration in the previous period.|254
3129397|NCT01675167|3854361|FG002|STARTED|Double-blind Treatment Phase|Subjects were randomized to DB treatment after completing OL titration in the previous period.|257
3129398|NCT01675167|3854359|FG000|COMPLETED|Double-blind Treatment Phase||0
3129399|NCT01675167|3854360|FG001|COMPLETED|Double-blind Treatment Phase||206
3129400|NCT01675167|3854361|FG002|COMPLETED|Double-blind Treatment Phase||147
3129401|NCT01675167|3854359|FG000|NOT COMPLETED|Double-blind Treatment Phase||0
3129402|NCT01675167|3854360|FG001|NOT COMPLETED|Double-blind Treatment Phase||48
3129403|NCT01675167|3854361|FG002|NOT COMPLETED|Double-blind Treatment Phase||110
3129404|NCT01675297|3854371|FG000|STARTED|Overall Study||806
3129405|NCT01675297|3854372|FG001|STARTED|Overall Study||247
3129406|NCT01675297|3854371|FG000|COMPLETED|Overall Study||642
3129407|NCT01675297|3854372|FG001|COMPLETED|Overall Study||199
3129408|NCT01675297|3854371|FG000|NOT COMPLETED|Overall Study||164
3129409|NCT01675297|3854372|FG001|NOT COMPLETED|Overall Study||48
3129410|NCT01675427|3854378|FG000|STARTED|Overall Study||4766
3129411|NCT01675427|3854378|FG000|COMPLETED|Overall Study||4732
3129412|NCT01675427|3854378|FG000|NOT COMPLETED|Overall Study||34
3129413|NCT01675453|3854414|FG000|STARTED|Overall Study||20
3129414|NCT01675453|3854415|FG001|STARTED|Overall Study||20
3129415|NCT01675453|3854414|FG000|COMPLETED|Overall Study||20
3129416|NCT01675453|3854415|FG001|COMPLETED|Overall Study||20
3129417|NCT01675453|3854414|FG000|NOT COMPLETED|Overall Study||0
3129418|NCT01675453|3854415|FG001|NOT COMPLETED|Overall Study||0
3129419|NCT01675492|3854421|FG000|STARTED|Overall Study||84
3129420|NCT01675492|3854421|FG000|COMPLETED|Overall Study||42
3129421|NCT01675492|3854421|FG000|NOT COMPLETED|Overall Study||42
3129422|NCT01675531|3854426|FG000|STARTED|Overall Study||66
3129423|NCT01675531|3854426|FG000|COMPLETED|Overall Study||41
3129424|NCT01675531|3854426|FG000|NOT COMPLETED|Overall Study||25
3129425|NCT01675544|3854431|FG000|STARTED|Overall Study||46
3129426|NCT01675544|3854431|FG000|COMPLETED|Overall Study||44
3129427|NCT01675544|3854431|FG000|NOT COMPLETED|Overall Study||2
3129428|NCT01675596|3854435|FG000|STARTED|Overall Study|One patient did not receive the study device.|199
3129429|NCT01675596|3854435|FG000|COMPLETED|Overall Study||191
3129430|NCT01675596|3854435|FG000|NOT COMPLETED|Overall Study||8
3129431|NCT01675622|3854441|FG000|STARTED|Overall Study||122
3129432|NCT01675622|3854442|FG001|STARTED|Overall Study||120
3129433|NCT01675622|3854441|FG000|COMPLETED|Overall Study||96
3129434|NCT01675622|3854442|FG001|COMPLETED|Overall Study||96
3129435|NCT01675622|3854441|FG000|NOT COMPLETED|Overall Study||26
3129436|NCT01675622|3854442|FG001|NOT COMPLETED|Overall Study||24
3129437|NCT01675635|3854450|FG000|STARTED|Overall Study||117
3129438|NCT01675635|3854451|FG001|STARTED|Overall Study||117
3129439|NCT01675635|3854450|FG000|COMPLETED|Overall Study||117
3129440|NCT01675635|3854451|FG001|COMPLETED|Overall Study||117
3129441|NCT01675635|3854450|FG000|NOT COMPLETED|Overall Study||0
3129442|NCT01675635|3854451|FG001|NOT COMPLETED|Overall Study||0
3129443|NCT01675661|3854464|FG000|STARTED|Overall Study||153
3129444|NCT01675661|3854465|FG001|STARTED|Overall Study||149
3129445|NCT01675661|3854464|FG000|COMPLETED|Overall Study||113
3129446|NCT01675661|3854465|FG001|COMPLETED|Overall Study||103
3129447|NCT01675661|3854464|FG000|NOT COMPLETED|Overall Study||40
3129448|NCT01675661|3854465|FG001|NOT COMPLETED|Overall Study||46
3129449|NCT01675765|3854473|FG000|STARTED|Overall Study||38
3129450|NCT01675765|3854474|FG001|STARTED|Overall Study||22
3129451|NCT01675765|3854473|FG000|COMPLETED|Overall Study||27
3129452|NCT01675765|3854474|FG001|COMPLETED|Overall Study||14
3129453|NCT01675765|3854473|FG000|NOT COMPLETED|Overall Study||11
3129454|NCT01675765|3854474|FG001|NOT COMPLETED|Overall Study||8
3129455|NCT01675778|3854480|FG000|STARTED|Overall Study||174
3129456|NCT01675778|3854480|FG000|COMPLETED|Overall Study||174
3129457|NCT01675778|3854480|FG000|NOT COMPLETED|Overall Study||0
3129458|NCT01675830|3854485|FG000|STARTED|Overall Study||10
3129459|NCT01675830|3854485|FG000|COMPLETED|Overall Study||10
3129460|NCT01675830|3854485|FG000|NOT COMPLETED|Overall Study||0
3129461|NCT01675882|3854493|FG000|STARTED|Overall Study||53
3129462|NCT01675882|3854494|FG001|STARTED|Overall Study||56
3129463|NCT01675882|3854495|FG002|STARTED|Overall Study||56
3129464|NCT01675882|3854496|FG003|STARTED|Overall Study||56
3129465|NCT01675882|3854493|FG000|COMPLETED|Overall Study||51
3129466|NCT01675882|3854494|FG001|COMPLETED|Overall Study||49
3129467|NCT01675882|3854495|FG002|COMPLETED|Overall Study||53
3129468|NCT01675882|3854496|FG003|COMPLETED|Overall Study||54
3129469|NCT01675882|3854493|FG000|NOT COMPLETED|Overall Study||2
3129470|NCT01675882|3854494|FG001|NOT COMPLETED|Overall Study||7
3129471|NCT01675882|3854495|FG002|NOT COMPLETED|Overall Study||3
3129472|NCT01675882|3854496|FG003|NOT COMPLETED|Overall Study||2
3129473|NCT01676012|3854506|FG000|STARTED|Overall Study||32
3129474|NCT01676012|3854506|FG000|COMPLETED|Overall Study||29
3129475|NCT01676012|3854506|FG000|NOT COMPLETED|Overall Study||3
3129476|NCT01676116|3854512|FG000|STARTED|Overall Study||292
3129477|NCT01676116|3854513|FG001|STARTED|Overall Study||146
3129478|NCT01676116|3854512|FG000|COMPLETED|Overall Study||276
3129479|NCT01676116|3854513|FG001|COMPLETED|Overall Study||117
3129480|NCT01676116|3854512|FG000|NOT COMPLETED|Overall Study||16
3129481|NCT01676116|3854513|FG001|NOT COMPLETED|Overall Study||29
3129482|NCT01676220|3854521|FG000|STARTED|Overall Study||439
3129483|NCT01676220|3854522|FG001|STARTED|Overall Study||439
3129484|NCT01676220|3854521|FG000|Treated|Overall Study||435
3129485|NCT01676220|3854522|FG001|Treated|Overall Study||438
3129486|NCT01676220|3854521|FG000|Modified Intent-To-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|432
3129487|NCT01676220|3854522|FG001|Modified Intent-To-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|430
3129488|NCT01676220|3854521|FG000|COMPLETED|Overall Study||337
3129489|NCT01676220|3854522|FG001|COMPLETED|Overall Study||314
3129490|NCT01676220|3854521|FG000|NOT COMPLETED|Overall Study||102
3129491|NCT01676220|3854522|FG001|NOT COMPLETED|Overall Study||125
3129492|NCT01676298|3854538|FG000|STARTED|Overall Study||1
3129493|NCT01676298|3854539|FG001|STARTED|Overall Study||1
3129494|NCT01676298|3854540|FG002|STARTED|Overall Study||1
3129495|NCT01676298|3854541|FG003|STARTED|Overall Study||1
3129496|NCT01676298|3854542|FG004|STARTED|Overall Study||1
3129497|NCT01676298|3854543|FG005|STARTED|Overall Study||1
3129498|NCT01676298|3854544|FG006|STARTED|Overall Study||1
3129499|NCT01676298|3854545|FG007|STARTED|Overall Study||1
3129500|NCT01676298|3854538|FG000|All Genotypes Confirmed With Reference|Overall Study||1
3129501|NCT01676298|3854539|FG001|All Genotypes Confirmed With Reference|Overall Study||1
3129502|NCT01676298|3854540|FG002|All Genotypes Confirmed With Reference|Overall Study||1
3129503|NCT01676298|3854541|FG003|All Genotypes Confirmed With Reference|Overall Study||1
3129504|NCT01676298|3854542|FG004|All Genotypes Confirmed With Reference|Overall Study||1
3129505|NCT01676298|3854543|FG005|All Genotypes Confirmed With Reference|Overall Study||1
3129506|NCT01676298|3854544|FG006|All Genotypes Confirmed With Reference|Overall Study||1
3129507|NCT01676298|3854545|FG007|All Genotypes Confirmed With Reference|Overall Study||1
3129508|NCT01676298|3854538|FG000|Participated in All Tests|Overall Study||1
3129509|NCT01676298|3854539|FG001|Participated in All Tests|Overall Study||1
3129510|NCT01676298|3854540|FG002|Participated in All Tests|Overall Study||1
3129511|NCT01676298|3854541|FG003|Participated in All Tests|Overall Study||1
3129512|NCT01676298|3854542|FG004|Participated in All Tests|Overall Study||1
3129513|NCT01676298|3854543|FG005|Participated in All Tests|Overall Study||1
3129514|NCT01676298|3854544|FG006|Participated in All Tests|Overall Study||1
3129515|NCT01676298|3854545|FG007|Participated in All Tests|Overall Study||1
3129516|NCT01676298|3854538|FG000|COMPLETED|Overall Study||1
3129517|NCT01676298|3854539|FG001|COMPLETED|Overall Study||1
3129518|NCT01676298|3854540|FG002|COMPLETED|Overall Study||1
3129519|NCT01676298|3854541|FG003|COMPLETED|Overall Study||1
3129520|NCT01676298|3854542|FG004|COMPLETED|Overall Study||1
3129521|NCT01676298|3854543|FG005|COMPLETED|Overall Study||1
3129522|NCT01676298|3854544|FG006|COMPLETED|Overall Study||1
3129523|NCT01676298|3854545|FG007|COMPLETED|Overall Study||1
3129524|NCT01676298|3854538|FG000|NOT COMPLETED|Overall Study||0
3129525|NCT01676298|3854539|FG001|NOT COMPLETED|Overall Study||0
3129526|NCT01676298|3854540|FG002|NOT COMPLETED|Overall Study||0
3129527|NCT01676298|3854541|FG003|NOT COMPLETED|Overall Study||0
3129528|NCT01676298|3854542|FG004|NOT COMPLETED|Overall Study||0
3129529|NCT01676298|3854543|FG005|NOT COMPLETED|Overall Study||0
3129530|NCT01676298|3854544|FG006|NOT COMPLETED|Overall Study||0
3129531|NCT01676298|3854545|FG007|NOT COMPLETED|Overall Study||0
3129532|NCT01676311|3854565|FG000|STARTED|Overall Study||7
3129533|NCT01676311|3854566|FG001|STARTED|Overall Study||7
3129534|NCT01676311|3854565|FG000|COMPLETED|Overall Study||7
3129535|NCT01676311|3854566|FG001|COMPLETED|Overall Study||5
3129536|NCT01676311|3854565|FG000|NOT COMPLETED|Overall Study||0
3129537|NCT01676311|3854566|FG001|NOT COMPLETED|Overall Study||2
3129538|NCT01676415|3854574|FG000|STARTED|Overall Study||4
3129539|NCT01676415|3854575|FG001|STARTED|Overall Study||5
3129540|NCT01676415|3854574|FG000|COMPLETED|Overall Study||4
3129541|NCT01676415|3854575|FG001|COMPLETED|Overall Study||5
3129542|NCT01676415|3854574|FG000|NOT COMPLETED|Overall Study||0
3129543|NCT01676415|3854575|FG001|NOT COMPLETED|Overall Study||0
3129544|NCT01676532|3854581|FG000|STARTED|Overall Study||127
3129545|NCT01676532|3854581|FG000|COMPLETED|Overall Study||127
3129546|NCT01676532|3854581|FG000|NOT COMPLETED|Overall Study||0
3129547|NCT01676714|3854590|FG000|STARTED|Overall Study||10
3129548|NCT01676714|3854590|FG000|COMPLETED|Overall Study||10
3129549|NCT01676714|3854590|FG000|NOT COMPLETED|Overall Study||0
3296469|NCT02906670|4030249|FG001|NOT COMPLETED|Cohort 6P, Q2W||0
3296470|NCT02906670|4030250|FG002|NOT COMPLETED|Cohort 6P, Q2W||0
3296471|NCT02906670|4030251|FG003|NOT COMPLETED|Cohort 6P, Q2W||0
3296472|NCT02906670|4030252|FG004|NOT COMPLETED|Cohort 6P, Q2W||0
3296473|NCT02906670|4030253|FG005|NOT COMPLETED|Cohort 6P, Q2W||0
3296474|NCT02906670|4030254|FG006|NOT COMPLETED|Cohort 6P, Q2W||0
3129550|NCT01676727|3854595|FG000|STARTED|Overall Study||100
3129551|NCT01676727|3854595|FG000|Implanted|Overall Study||92
3129552|NCT01676727|3854595|FG000|COMPLETED|Overall Study||68
3129553|NCT01676727|3854595|FG000|NOT COMPLETED|Overall Study||32
3129554|NCT01676831|3854602|FG000|STARTED|Overall Study||8
3129555|NCT01676831|3854603|FG001|STARTED|Overall Study||5
3129556|NCT01676831|3854602|FG000|COMPLETED|Overall Study||8
3129557|NCT01676831|3854603|FG001|COMPLETED|Overall Study||4
3129558|NCT01676831|3854602|FG000|NOT COMPLETED|Overall Study||0
3129559|NCT01676831|3854603|FG001|NOT COMPLETED|Overall Study||1
3129560|NCT01676896|3854612|FG000|STARTED|Overall Study||96
3129561|NCT01676896|3854613|FG001|STARTED|Overall Study||96
3129562|NCT01676896|3854614|FG002|STARTED|Overall Study||100
3129563|NCT01676896|3854612|FG000|COMPLETED|Overall Study||84
3129564|NCT01676896|3854613|FG001|COMPLETED|Overall Study||89
3129565|NCT01676896|3854614|FG002|COMPLETED|Overall Study||81
3129566|NCT01676896|3854612|FG000|NOT COMPLETED|Overall Study||12
3129567|NCT01676896|3854613|FG001|NOT COMPLETED|Overall Study||7
3129568|NCT01676896|3854614|FG002|NOT COMPLETED|Overall Study||19
3129569|NCT01676909|3854624|FG000|STARTED|Overall Study||124
3129570|NCT01676909|3854625|FG001|STARTED|Overall Study||118
3129571|NCT01676909|3854624|FG000|Post-Treatment Assessment|Overall Study|19 not completed (3 withdrawn, 15 timed out, 1 declined)|105
3129572|NCT01676909|3854625|FG001|Post-Treatment Assessment|Overall Study|11 not completed (5 withdrawn, 6 timed out)|107
3129573|NCT01676909|3854624|FG000|COMPLETED|Overall Study|18 not completed (3 withdrawn, 15 timed out)|106
3129574|NCT01676909|3854625|FG001|COMPLETED|Overall Study|14 not completed (5 withdrawn, 9 timed out|104
3129575|NCT01676909|3854624|FG000|NOT COMPLETED|Overall Study||18
3129576|NCT01676909|3854625|FG001|NOT COMPLETED|Overall Study||14
3129577|NCT01677182|3854636|FG000|STARTED|Overall Study||184
3129578|NCT01677182|3854637|FG001|STARTED|Overall Study||169
3129579|NCT01677182|3854638|FG002|STARTED|Overall Study||182
3129580|NCT01677182|3854636|FG000|COMPLETED|Overall Study||150
3129581|NCT01677182|3854637|FG001|COMPLETED|Overall Study||141
3129582|NCT01677182|3854638|FG002|COMPLETED|Overall Study||143
3129583|NCT01677182|3854636|FG000|NOT COMPLETED|Overall Study||34
3129584|NCT01677182|3854637|FG001|NOT COMPLETED|Overall Study||28
3129585|NCT01677182|3854638|FG002|NOT COMPLETED|Overall Study||39
3129586|NCT01677195|3854649|FG000|STARTED|Overall Study||71
3129587|NCT01677195|3854650|FG001|STARTED|Overall Study||83
3129588|NCT01677195|3854651|FG002|STARTED|Overall Study||80
3129589|NCT01677195|3854649|FG000|COMPLETED|Overall Study||42
3129590|NCT01677195|3854650|FG001|COMPLETED|Overall Study||51
3129591|NCT01677195|3854651|FG002|COMPLETED|Overall Study||50
3129592|NCT01677195|3854649|FG000|NOT COMPLETED|Overall Study||29
3129593|NCT01677195|3854650|FG001|NOT COMPLETED|Overall Study||32
3129594|NCT01677195|3854651|FG002|NOT COMPLETED|Overall Study||30
3129595|NCT01677286|3854659|FG000|STARTED|Overall Study||25
3129596|NCT01677286|3854659|FG000|COMPLETED|Overall Study||14
3129597|NCT01677286|3854659|FG000|NOT COMPLETED|Overall Study||11
3129598|NCT01677299|3854669|FG000|STARTED|Overall Study||6
3129599|NCT01677299|3854670|FG001|STARTED|Overall Study||6
3129600|NCT01677299|3854671|FG002|STARTED|Overall Study||6
3129601|NCT01677299|3854672|FG003|STARTED|Overall Study||6
3129602|NCT01677299|3854669|FG000|COMPLETED|Overall Study||6
3129603|NCT01677299|3854670|FG001|COMPLETED|Overall Study||3
3129604|NCT01677299|3854671|FG002|COMPLETED|Overall Study||5
3129605|NCT01677299|3854672|FG003|COMPLETED|Overall Study||5
3129606|NCT01677299|3854669|FG000|NOT COMPLETED|Overall Study||0
3129607|NCT01677299|3854670|FG001|NOT COMPLETED|Overall Study||3
3129608|NCT01677299|3854671|FG002|NOT COMPLETED|Overall Study||1
3296475|NCT02906670|4030255|FG007|NOT COMPLETED|Cohort 6P, Q2W||0
3296476|NCT02906670|4030256|FG008|NOT COMPLETED|Cohort 6P, Q2W||4
3296477|NCT02906670|4030257|FG009|NOT COMPLETED|Cohort 6P, Q2W||0
3296478|NCT02906670|4030248|FG000|STARTED|Cohort 4P, QW||0
3296479|NCT02906670|4030249|FG001|STARTED|Cohort 4P, QW||0
3296480|NCT02906670|4030250|FG002|STARTED|Cohort 4P, QW||0
3129609|NCT01677299|3854672|FG003|NOT COMPLETED|Overall Study||1
3129610|NCT01677312|3854688|FG000|STARTED|Overall Study||36
3129611|NCT01677312|3854689|FG001|STARTED|Overall Study||36
3129612|NCT01677312|3854688|FG000|COMPLETED|Overall Study||36
3129613|NCT01677312|3854689|FG001|COMPLETED|Overall Study||36
3129614|NCT01677312|3854688|FG000|NOT COMPLETED|Overall Study||0
3129615|NCT01677312|3854689|FG001|NOT COMPLETED|Overall Study||0
3129616|NCT01677377|3854698|FG000|STARTED|Overall Study||15
3129617|NCT01677377|3854699|FG001|STARTED|Overall Study||15
3129618|NCT01677377|3854700|FG002|STARTED|Overall Study||15
3129619|NCT01677377|3854698|FG000|COMPLETED|Overall Study||14
3129620|NCT01677377|3854699|FG001|COMPLETED|Overall Study||14
3129621|NCT01677377|3854700|FG002|COMPLETED|Overall Study||9
3129622|NCT01677377|3854698|FG000|NOT COMPLETED|Overall Study||1
3129623|NCT01677377|3854699|FG001|NOT COMPLETED|Overall Study||1
3129624|NCT01677377|3854700|FG002|NOT COMPLETED|Overall Study||6
3129625|NCT01677507|3854708|FG000|STARTED|Initial Assignment||63
3129626|NCT01677507|3854709|FG001|STARTED|Initial Assignment||58
3129627|NCT01677507|3854708|FG000|COMPLETED|Initial Assignment||63
3129628|NCT01677507|3854709|FG001|COMPLETED|Initial Assignment||56
3129629|NCT01677507|3854708|FG000|NOT COMPLETED|Initial Assignment||0
3296481|NCT02906670|4030251|FG003|STARTED|Cohort 4P, QW||3
3296482|NCT02906670|4030252|FG004|STARTED|Cohort 4P, QW||0
3296483|NCT02906670|4030253|FG005|STARTED|Cohort 4P, QW||0
3296484|NCT02906670|4030254|FG006|STARTED|Cohort 4P, QW||0
3296485|NCT02906670|4030255|FG007|STARTED|Cohort 4P, QW||0
3296486|NCT02906670|4030256|FG008|STARTED|Cohort 4P, QW||0
3296487|NCT02906670|4030257|FG009|STARTED|Cohort 4P, QW||0
3296488|NCT02906670|4030248|FG000|COMPLETED|Cohort 4P, QW||0
3129630|NCT01677507|3854709|FG001|NOT COMPLETED|Initial Assignment||2
3129631|NCT01677507|3854708|FG000|STARTED|Second Assigment||63
3129632|NCT01677507|3854709|FG001|STARTED|Second Assigment||56
3129633|NCT01677507|3854708|FG000|COMPLETED|Second Assigment||60
3129634|NCT01677507|3854709|FG001|COMPLETED|Second Assigment||51
3129635|NCT01677507|3854708|FG000|NOT COMPLETED|Second Assigment||3
3129636|NCT01677507|3854709|FG001|NOT COMPLETED|Second Assigment||5
3129637|NCT01677624|3854717|FG000|STARTED|Overall Study||28
3129638|NCT01677624|3854717|FG000|COMPLETED|Overall Study||27
3129639|NCT01677624|3854717|FG000|NOT COMPLETED|Overall Study||1
3129640|NCT01677741|3854729|FG000|STARTED|Overall Study||3
3129641|NCT01677741|3854730|FG001|STARTED|Overall Study||10
3129642|NCT01677741|3854731|FG002|STARTED|Overall Study||8
3129643|NCT01677741|3854732|FG003|STARTED|Overall Study||6
3129644|NCT01677741|3854733|FG004|STARTED|Overall Study||17
3129645|NCT01677741|3854734|FG005|STARTED|Overall Study||28
3129646|NCT01677741|3854735|FG006|STARTED|Overall Study||11
3129647|NCT01677741|3854736|FG007|STARTED|Overall Study||2
3129648|NCT01677741|3854729|FG000|DLT Evaluable Population|Overall Study||3
3129649|NCT01677741|3854730|FG001|DLT Evaluable Population|Overall Study||10
3129650|NCT01677741|3854731|FG002|DLT Evaluable Population|Overall Study||8
3129651|NCT01677741|3854732|FG003|DLT Evaluable Population|Overall Study||6
3129652|NCT01677741|3854733|FG004|DLT Evaluable Population|Overall Study||0
3129653|NCT01677741|3854734|FG005|DLT Evaluable Population|Overall Study||0
3129654|NCT01677741|3854735|FG006|DLT Evaluable Population|Overall Study||0
3129655|NCT01677741|3854736|FG007|DLT Evaluable Population|Overall Study||0
3129656|NCT01677741|3854729|FG000|PK Population|Overall Study||3
3129657|NCT01677741|3854730|FG001|PK Population|Overall Study||10
3129658|NCT01677741|3854731|FG002|PK Population|Overall Study||8
3129659|NCT01677741|3854732|FG003|PK Population|Overall Study||6
3129660|NCT01677741|3854733|FG004|PK Population|Overall Study||17
3129661|NCT01677741|3854734|FG005|PK Population|Overall Study||28
3129662|NCT01677741|3854735|FG006|PK Population|Overall Study||11
3129663|NCT01677741|3854736|FG007|PK Population|Overall Study||2
3129664|NCT01677741|3854729|FG000|COMPLETED|Overall Study||0
3129665|NCT01677741|3854730|FG001|COMPLETED|Overall Study||0
3129666|NCT01677741|3854731|FG002|COMPLETED|Overall Study||0
3129667|NCT01677741|3854732|FG003|COMPLETED|Overall Study||0
3129668|NCT01677741|3854733|FG004|COMPLETED|Overall Study||0
3129669|NCT01677741|3854734|FG005|COMPLETED|Overall Study||0
3129670|NCT01677741|3854735|FG006|COMPLETED|Overall Study||0
3129671|NCT01677741|3854736|FG007|COMPLETED|Overall Study||0
3129672|NCT01677741|3854729|FG000|NOT COMPLETED|Overall Study||3
3129673|NCT01677741|3854730|FG001|NOT COMPLETED|Overall Study||10
3129674|NCT01677741|3854731|FG002|NOT COMPLETED|Overall Study||8
3129675|NCT01677741|3854732|FG003|NOT COMPLETED|Overall Study||6
3129676|NCT01677741|3854733|FG004|NOT COMPLETED|Overall Study||17
3129677|NCT01677741|3854734|FG005|NOT COMPLETED|Overall Study||28
3129678|NCT01677741|3854735|FG006|NOT COMPLETED|Overall Study||11
3129679|NCT01677741|3854736|FG007|NOT COMPLETED|Overall Study||2
3129680|NCT01677767|3854770|FG000|STARTED|Overall Study||124
3129681|NCT01677767|3854770|FG000|COMPLETED|Overall Study||102
3129682|NCT01677767|3854770|FG000|NOT COMPLETED|Overall Study||22
3129683|NCT01677858|3854781|FG000|STARTED|Overall Study||3
3129684|NCT01677858|3854782|FG001|STARTED|Overall Study||3
3129685|NCT01677858|3854783|FG002|STARTED|Overall Study||15
3129686|NCT01677858|3854784|FG003|STARTED|Overall Study||6
3129687|NCT01677858|3854785|FG004|STARTED|Overall Study||89
3296489|NCT02906670|4030249|FG001|COMPLETED|Cohort 4P, QW||0
3296490|NCT02906670|4030250|FG002|COMPLETED|Cohort 4P, QW||0
3296491|NCT02906670|4030251|FG003|COMPLETED|Cohort 4P, QW||0
3383594|NCT01763788|4118662|FG000|STARTED|Overall Study||3
3383595|NCT01763788|4118663|FG001|STARTED|Overall Study||6
2911559|NCT00485264|3621312|FG004|STARTED|Overall Study||15
2911560|NCT00485264|3621313|FG005|STARTED|Overall Study||12
3296492|NCT02906670|4030252|FG004|COMPLETED|Cohort 4P, QW||0
3129688|NCT01677858|3854781|FG000|COMPLETED|Overall Study|Completed indicates participants ongoing in study|0
3129689|NCT01677858|3854782|FG001|COMPLETED|Overall Study|Completed indicates participants ongoing in study|1
3129690|NCT01677858|3854783|FG002|COMPLETED|Overall Study|Completed indicates participants ongoing in study|1
3129691|NCT01677858|3854784|FG003|COMPLETED|Overall Study|Completed indicates participants ongoing in study|0
3383596|NCT01763788|4118664|FG002|STARTED|Overall Study||91
3129692|NCT01677858|3854785|FG004|COMPLETED|Overall Study|Completed indicates participants ongoing in study|4
3129693|NCT01677858|3854781|FG000|NOT COMPLETED|Overall Study||3
3129694|NCT01677858|3854782|FG001|NOT COMPLETED|Overall Study||2
3129695|NCT01677858|3854783|FG002|NOT COMPLETED|Overall Study||14
3129696|NCT01677858|3854784|FG003|NOT COMPLETED|Overall Study||6
3129697|NCT01677858|3854785|FG004|NOT COMPLETED|Overall Study||85
3129698|NCT01677910|3854805|FG000|STARTED|Double-Blind Treatment Period||45
3129699|NCT01677910|3854806|FG001|STARTED|Double-Blind Treatment Period||45
3129700|NCT01677910|3854807|FG002|STARTED|Double-Blind Treatment Period||45
3129701|NCT01677910|3854808|FG003|STARTED|Double-Blind Treatment Period||0
3129702|NCT01677910|3854805|FG000|COMPLETED|Double-Blind Treatment Period||38
3129703|NCT01677910|3854806|FG001|COMPLETED|Double-Blind Treatment Period||42
3129704|NCT01677910|3854807|FG002|COMPLETED|Double-Blind Treatment Period||38
3129705|NCT01677910|3854808|FG003|COMPLETED|Double-Blind Treatment Period||0
3129706|NCT01677910|3854805|FG000|NOT COMPLETED|Double-Blind Treatment Period||7
3129707|NCT01677910|3854806|FG001|NOT COMPLETED|Double-Blind Treatment Period||3
3129708|NCT01677910|3854807|FG002|NOT COMPLETED|Double-Blind Treatment Period||7
3129709|NCT01677910|3854808|FG003|NOT COMPLETED|Double-Blind Treatment Period||0
3129710|NCT01677910|3854805|FG000|STARTED|Open-Label Extension Period (OLE)||0
3129711|NCT01677910|3854806|FG001|STARTED|Open-Label Extension Period (OLE)||0
3129712|NCT01677910|3854807|FG002|STARTED|Open-Label Extension Period (OLE)||0
3129713|NCT01677910|3854808|FG003|STARTED|Open-Label Extension Period (OLE)||115
3129714|NCT01677910|3854805|FG000|COMPLETED|Open-Label Extension Period (OLE)||0
3129715|NCT01677910|3854806|FG001|COMPLETED|Open-Label Extension Period (OLE)||0
3129716|NCT01677910|3854807|FG002|COMPLETED|Open-Label Extension Period (OLE)||0
3129717|NCT01677910|3854808|FG003|COMPLETED|Open-Label Extension Period (OLE)||79
3129718|NCT01677910|3854805|FG000|NOT COMPLETED|Open-Label Extension Period (OLE)||0
3129719|NCT01677910|3854806|FG001|NOT COMPLETED|Open-Label Extension Period (OLE)||0
3129720|NCT01677910|3854807|FG002|NOT COMPLETED|Open-Label Extension Period (OLE)||0
3129721|NCT01677910|3854808|FG003|NOT COMPLETED|Open-Label Extension Period (OLE)||36
3129722|NCT01677936|3854820|FG000|STARTED|Overall Study|31 randomized to raisins; 4 excluded due to lack of post-baseline evaluation; 27 = full dataset|31
3129723|NCT01677936|3854821|FG001|STARTED|Overall Study|20 randomized to snacks; 1 excluded due to lack of post-baseline evaluation; 19 = full dataset|20
3129724|NCT01677936|3854820|FG000|COMPLETED|Overall Study|Full analysis dataset completers|22
3129725|NCT01677936|3854821|FG001|COMPLETED|Overall Study|Full analysis dataset completers|15
3129726|NCT01677936|3854820|FG000|NOT COMPLETED|Overall Study||9
3129727|NCT01677936|3854821|FG001|NOT COMPLETED|Overall Study||5
3129728|NCT01677988|3854827|FG000|STARTED|Overall Study||3
3129729|NCT01677988|3854827|FG000|COMPLETED|Overall Study||1
3129730|NCT01677988|3854827|FG000|NOT COMPLETED|Overall Study||2
3129731|NCT01678131|3854835|FG000|STARTED|Overall Study||10
3129732|NCT01678131|3854836|FG001|STARTED|Overall Study||10
3129733|NCT01678131|3854837|FG002|STARTED|Overall Study||11
3129734|NCT01678131|3854835|FG000|COMPLETED|Overall Study||10
3129735|NCT01678131|3854836|FG001|COMPLETED|Overall Study||9
3129736|NCT01678131|3854837|FG002|COMPLETED|Overall Study||9
3129737|NCT01678131|3854835|FG000|NOT COMPLETED|Overall Study||0
3129738|NCT01678131|3854836|FG001|NOT COMPLETED|Overall Study||1
3129739|NCT01678131|3854837|FG002|NOT COMPLETED|Overall Study||2
3129740|NCT01678144|3854845|FG000|STARTED|Stage 1: MAR Classic||7
3129741|NCT01678144|3854845|FG000|COMPLETED|Stage 1: MAR Classic||6
3129742|NCT01678144|3854845|FG000|NOT COMPLETED|Stage 1: MAR Classic||1
3129743|NCT01678144|3854845|FG000|STARTED|Stage 2: MAR Regular and MAR Expanded||5
3129744|NCT01678144|3854845|FG000|COMPLETED|Stage 2: MAR Regular and MAR Expanded||5
3129745|NCT01678144|3854845|FG000|NOT COMPLETED|Stage 2: MAR Regular and MAR Expanded||0
3129746|NCT01678196|3854851|FG000|STARTED|Overall Study||34
3129747|NCT01678196|3854852|FG001|STARTED|Overall Study||32
3129748|NCT01678196|3854851|FG000|COMPLETED|Overall Study|Primary outcome data was from the electronic medical record and was available for all participants.|34
3129749|NCT01678196|3854852|FG001|COMPLETED|Overall Study|Primary outcome data was from the electronic medical record and was available for all participants.|32
3129750|NCT01678196|3854851|FG000|NOT COMPLETED|Overall Study||0
3129751|NCT01678196|3854852|FG001|NOT COMPLETED|Overall Study||0
3129752|NCT01678209|3854861|FG000|STARTED|Overall Study||47
3129753|NCT01678209|3854862|FG001|STARTED|Overall Study||40
3129754|NCT01678209|3854863|FG002|STARTED|Overall Study||40
3129755|NCT01678209|3854861|FG000|COMPLETED|Overall Study||30
3129756|NCT01678209|3854862|FG001|COMPLETED|Overall Study||22
3129757|NCT01678209|3854863|FG002|COMPLETED|Overall Study||22
3129758|NCT01678209|3854861|FG000|NOT COMPLETED|Overall Study||17
3129759|NCT01678209|3854862|FG001|NOT COMPLETED|Overall Study||18
3129760|NCT01678209|3854863|FG002|NOT COMPLETED|Overall Study||18
3129761|NCT01678313|3854873|FG000|STARTED|Completed the 3-month Therapy||70
3129762|NCT01678313|3854874|FG001|STARTED|Completed the 3-month Therapy||70
3129763|NCT01678313|3854873|FG000|COMPLETED|Completed the 3-month Therapy||64
3129764|NCT01678313|3854874|FG001|COMPLETED|Completed the 3-month Therapy||58
3129765|NCT01678313|3854873|FG000|NOT COMPLETED|Completed the 3-month Therapy||6
3129766|NCT01678313|3854874|FG001|NOT COMPLETED|Completed the 3-month Therapy||12
3129767|NCT01678313|3854873|FG000|STARTED|PSA >4 ng/dL at 3 Months||64
3129768|NCT01678313|3854874|FG001|STARTED|PSA >4 ng/dL at 3 Months||58
3129769|NCT01678313|3854873|FG000|COMPLETED|PSA >4 ng/dL at 3 Months||56
3129770|NCT01678313|3854874|FG001|COMPLETED|PSA >4 ng/dL at 3 Months||49
3129771|NCT01678313|3854873|FG000|NOT COMPLETED|PSA >4 ng/dL at 3 Months||8
3129772|NCT01678313|3854874|FG001|NOT COMPLETED|PSA >4 ng/dL at 3 Months||9
3129773|NCT01678313|3854873|FG000|STARTED|Prostate Biopsy at 3 Months||56
3129774|NCT01678313|3854874|FG001|STARTED|Prostate Biopsy at 3 Months||49
3129775|NCT01678313|3854873|FG000|COMPLETED|Prostate Biopsy at 3 Months||45
3129776|NCT01678313|3854874|FG001|COMPLETED|Prostate Biopsy at 3 Months||37
3129777|NCT01678313|3854873|FG000|NOT COMPLETED|Prostate Biopsy at 3 Months||11
3129778|NCT01678313|3854874|FG001|NOT COMPLETED|Prostate Biopsy at 3 Months||12
3129779|NCT01678443|3854880|FG000|STARTED|Overall Study||2
3129780|NCT01678443|3854880|FG000|COMPLETED|Overall Study||2
3129781|NCT01678443|3854880|FG000|NOT COMPLETED|Overall Study||0
3129782|NCT01678560|3854886|FG000|STARTED|Overall Study||26
3129783|NCT01678560|3854887|FG001|STARTED|Overall Study||26
3129784|NCT01678560|3854886|FG000|COMPLETED|Overall Study||22
3129785|NCT01678560|3854887|FG001|COMPLETED|Overall Study||20
3129786|NCT01678560|3854886|FG000|NOT COMPLETED|Overall Study||4
3129787|NCT01678560|3854887|FG001|NOT COMPLETED|Overall Study||6
3129788|NCT01678794|3854899|FG000|STARTED|Overall Study||16
3129789|NCT01678794|3854900|FG001|STARTED|Overall Study||17
3129790|NCT01678794|3854899|FG000|COMPLETED|Overall Study||16
3129791|NCT01678794|3854900|FG001|COMPLETED|Overall Study||17
3129792|NCT01678794|3854899|FG000|NOT COMPLETED|Overall Study||0
3129793|NCT01678794|3854900|FG001|NOT COMPLETED|Overall Study||0
3129794|NCT01678807|3854909|FG000|STARTED|Overall Study||65
3129795|NCT01678807|3854910|FG001|STARTED|Overall Study||65
3129796|NCT01678807|3854911|FG002|STARTED|Overall Study||65
3129797|NCT01678807|3854909|FG000|COMPLETED|Overall Study||61
3129798|NCT01678807|3854910|FG001|COMPLETED|Overall Study||60
3129799|NCT01678807|3854911|FG002|COMPLETED|Overall Study||65
3129800|NCT01678807|3854909|FG000|NOT COMPLETED|Overall Study||4
3129801|NCT01678807|3854910|FG001|NOT COMPLETED|Overall Study||5
3129802|NCT01678807|3854911|FG002|NOT COMPLETED|Overall Study||0
3129803|NCT01678820|3854922|FG000|STARTED|Overall Study||100
3129804|NCT01678820|3854923|FG001|STARTED|Overall Study||99
3129805|NCT01678820|3854924|FG002|STARTED|Overall Study||100
3129806|NCT01678820|3854922|FG000|Treated With Double-blind Study Drug|Overall Study||100
3129807|NCT01678820|3854923|FG001|Treated With Double-blind Study Drug|Overall Study||97
3129808|NCT01678820|3854924|FG002|Treated With Double-blind Study Drug|Overall Study||98
3129809|NCT01678820|3854922|FG000|COMPLETED|Overall Study||38
3129810|NCT01678820|3854923|FG001|COMPLETED|Overall Study||36
3129811|NCT01678820|3854924|FG002|COMPLETED|Overall Study||43
3129812|NCT01678820|3854922|FG000|NOT COMPLETED|Overall Study||62
3129813|NCT01678820|3854923|FG001|NOT COMPLETED|Overall Study||63
3129814|NCT01678820|3854924|FG002|NOT COMPLETED|Overall Study||57
3129815|NCT01678846|3854935|FG000|STARTED|Overall Study|Whole school implementation. Started and completed shows number of students in the end-line survey.|1921
3129816|NCT01678846|3854936|FG001|STARTED|Overall Study||1899
3129817|NCT01678846|3854935|FG000|COMPLETED|Overall Study||1921
3129818|NCT01678846|3854936|FG001|COMPLETED|Overall Study||1899
3129819|NCT01678846|3854935|FG000|NOT COMPLETED|Overall Study||0
3129820|NCT01678846|3854936|FG001|NOT COMPLETED|Overall Study||0
3129821|NCT01678885|3854944|FG000|STARTED|Phase I; 2 Wks Duration, Both Sub-study||22
3129822|NCT01678885|3854945|FG001|STARTED|Phase I; 2 Wks Duration, Both Sub-study||18
3129823|NCT01678885|3854946|FG002|STARTED|Phase I; 2 Wks Duration, Both Sub-study||23
3129824|NCT01678885|3854947|FG003|STARTED|Phase I; 2 Wks Duration, Both Sub-study||24
3129825|NCT01678885|3854948|FG004|STARTED|Phase I; 2 Wks Duration, Both Sub-study||0
3129826|NCT01678885|3854944|FG000|COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||22
3129827|NCT01678885|3854945|FG001|COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||15
3129828|NCT01678885|3854946|FG002|COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||22
3129829|NCT01678885|3854947|FG003|COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||21
3129830|NCT01678885|3854948|FG004|COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||0
3129831|NCT01678885|3854944|FG000|NOT COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||0
3129832|NCT01678885|3854945|FG001|NOT COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||3
3129833|NCT01678885|3854946|FG002|NOT COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||1
3129834|NCT01678885|3854947|FG003|NOT COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||3
3129835|NCT01678885|3854948|FG004|NOT COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||0
3129836|NCT01678885|3854944|FG000|STARTED|Phase II; 8 Week Low Calorie Diet||0
3129837|NCT01678885|3854945|FG001|STARTED|Phase II; 8 Week Low Calorie Diet||0
3129838|NCT01678885|3854946|FG002|STARTED|Phase II; 8 Week Low Calorie Diet||0
3129839|NCT01678885|3854947|FG003|STARTED|Phase II; 8 Week Low Calorie Diet||0
3129840|NCT01678885|3854948|FG004|STARTED|Phase II; 8 Week Low Calorie Diet||87
3129841|NCT01678885|3854944|FG000|COMPLETED|Phase II; 8 Week Low Calorie Diet||0
3129842|NCT01678885|3854945|FG001|COMPLETED|Phase II; 8 Week Low Calorie Diet||0
3129843|NCT01678885|3854946|FG002|COMPLETED|Phase II; 8 Week Low Calorie Diet||0
3129844|NCT01678885|3854947|FG003|COMPLETED|Phase II; 8 Week Low Calorie Diet||0
3129845|NCT01678885|3854948|FG004|COMPLETED|Phase II; 8 Week Low Calorie Diet||70
3129846|NCT01678885|3854944|FG000|NOT COMPLETED|Phase II; 8 Week Low Calorie Diet||0
3129847|NCT01678885|3854945|FG001|NOT COMPLETED|Phase II; 8 Week Low Calorie Diet||0
3129848|NCT01678885|3854946|FG002|NOT COMPLETED|Phase II; 8 Week Low Calorie Diet||0
3129849|NCT01678885|3854947|FG003|NOT COMPLETED|Phase II; 8 Week Low Calorie Diet||0
3129850|NCT01678885|3854948|FG004|NOT COMPLETED|Phase II; 8 Week Low Calorie Diet||17
3129851|NCT01678898|3854959|FG000|STARTED|PB-102-F01||6
3296493|NCT02906670|4030253|FG005|COMPLETED|Cohort 4P, QW||0
3296494|NCT02906670|4030254|FG006|COMPLETED|Cohort 4P, QW||0
3129852|NCT01678898|3854960|FG001|STARTED|PB-102-F01||8
3129853|NCT01678898|3854961|FG002|STARTED|PB-102-F01||4
3129854|NCT01678898|3854959|FG000|COMPLETED|PB-102-F01||6
3129855|NCT01678898|3854960|FG001|COMPLETED|PB-102-F01||6
3129856|NCT01678898|3854961|FG002|COMPLETED|PB-102-F01||4
3129857|NCT01678898|3854959|FG000|NOT COMPLETED|PB-102-F01||0
3129858|NCT01678898|3854960|FG001|NOT COMPLETED|PB-102-F01||2
3129859|NCT01678898|3854961|FG002|NOT COMPLETED|PB-102-F01||0
3129860|NCT01678898|3854959|FG000|STARTED|PB-102-F02||6
3129861|NCT01678898|3854960|FG001|STARTED|PB-102-F02||6
3129862|NCT01678898|3854961|FG002|STARTED|PB-102-F02||4
3129863|NCT01678898|3854959|FG000|COMPLETED|PB-102-F02||6
3129864|NCT01678898|3854960|FG001|COMPLETED|PB-102-F02||6
3129865|NCT01678898|3854961|FG002|COMPLETED|PB-102-F02||4
3129866|NCT01678898|3854959|FG000|NOT COMPLETED|PB-102-F02||0
3129867|NCT01678898|3854960|FG001|NOT COMPLETED|PB-102-F02||0
3129868|NCT01678898|3854961|FG002|NOT COMPLETED|PB-102-F02||0
3129869|NCT01678911|3854978|FG000|STARTED|First Intervention||4
3129870|NCT01678911|3854979|FG001|STARTED|First Intervention||1
3129871|NCT01678911|3854978|FG000|Cross Over|First Intervention||4
3129872|NCT01678911|3854979|FG001|Cross Over|First Intervention||1
3129873|NCT01678911|3854978|FG000|COMPLETED|First Intervention||4
3129874|NCT01678911|3854979|FG001|COMPLETED|First Intervention||1
3129875|NCT01678911|3854978|FG000|NOT COMPLETED|First Intervention||0
3129876|NCT01678911|3854979|FG001|NOT COMPLETED|First Intervention||0
3129877|NCT01678911|3854978|FG000|STARTED|Second Intervention||4
3129878|NCT01678911|3854979|FG001|STARTED|Second Intervention||1
3129879|NCT01678911|3854978|FG000|COMPLETED|Second Intervention||2
3129880|NCT01678911|3854979|FG001|COMPLETED|Second Intervention||1
3129881|NCT01678911|3854978|FG000|NOT COMPLETED|Second Intervention||2
3129882|NCT01678911|3854979|FG001|NOT COMPLETED|Second Intervention||0
3129883|NCT01678924|3854989|FG000|STARTED|Overall Study||64
3129884|NCT01678924|3854990|FG001|STARTED|Overall Study||63
3129885|NCT01678924|3854991|FG002|STARTED|Overall Study||30
3129886|NCT01678924|3854992|FG003|STARTED|Overall Study||123
3129887|NCT01678924|3854989|FG000|COMPLETED|Overall Study||54
3129888|NCT01678924|3854990|FG001|COMPLETED|Overall Study||51
3129889|NCT01678924|3854991|FG002|COMPLETED|Overall Study||28
3129890|NCT01678924|3854992|FG003|COMPLETED|Overall Study||105
3129891|NCT01678924|3854989|FG000|NOT COMPLETED|Overall Study||10
3129892|NCT01678924|3854990|FG001|NOT COMPLETED|Overall Study||12
3129893|NCT01678924|3854991|FG002|NOT COMPLETED|Overall Study||2
3129894|NCT01678924|3854992|FG003|NOT COMPLETED|Overall Study||18
3129895|NCT01678976|3855005|FG000|STARTED|First Period||6
3129896|NCT01678976|3855006|FG001|STARTED|First Period||7
3129897|NCT01678976|3855005|FG000|COMPLETED|First Period||6
3129898|NCT01678976|3855006|FG001|COMPLETED|First Period||6
3129899|NCT01678976|3855005|FG000|NOT COMPLETED|First Period||0
3129900|NCT01678976|3855006|FG001|NOT COMPLETED|First Period||1
3129901|NCT01678976|3855005|FG000|STARTED|Second Period||6
3129902|NCT01678976|3855006|FG001|STARTED|Second Period||6
3129903|NCT01678976|3855005|FG000|COMPLETED|Second Period||6
3129904|NCT01678976|3855006|FG001|COMPLETED|Second Period||6
3129905|NCT01678976|3855005|FG000|NOT COMPLETED|Second Period||0
3129906|NCT01678976|3855006|FG001|NOT COMPLETED|Second Period||0
3129907|NCT01679002|3855018|FG000|STARTED|Overall Study||4
3129908|NCT01679002|3855019|FG001|STARTED|Overall Study||4
3129909|NCT01679002|3855020|FG002|STARTED|Overall Study||4
3129910|NCT01679002|3855018|FG000|BIA 2-093 900 mg Once-daily Period|Overall Study||4
3129911|NCT01679002|3855019|FG001|BIA 2-093 900 mg Once-daily Period|Overall Study||3
3129912|NCT01679002|3855020|FG002|BIA 2-093 900 mg Once-daily Period|Overall Study||4
3129913|NCT01679002|3855018|FG000|BIA 2-093 450 mg Twice-daily Period|Overall Study||4
3129914|NCT01679002|3855019|FG001|BIA 2-093 450 mg Twice-daily Period|Overall Study||4
3129915|NCT01679002|3855020|FG002|BIA 2-093 450 mg Twice-daily Period|Overall Study||4
3129916|NCT01679002|3855018|FG000|Oxcarbazepine 450 mg Twice-daily Period|Overall Study||3
3129917|NCT01679002|3855019|FG001|Oxcarbazepine 450 mg Twice-daily Period|Overall Study||4
3129918|NCT01679002|3855020|FG002|Oxcarbazepine 450 mg Twice-daily Period|Overall Study||4
3129919|NCT01679002|3855018|FG000|COMPLETED|Overall Study||3
3129920|NCT01679002|3855019|FG001|COMPLETED|Overall Study||3
3129921|NCT01679002|3855020|FG002|COMPLETED|Overall Study||4
3129922|NCT01679002|3855018|FG000|NOT COMPLETED|Overall Study||1
3129923|NCT01679002|3855019|FG001|NOT COMPLETED|Overall Study||1
3129924|NCT01679002|3855020|FG002|NOT COMPLETED|Overall Study||0
3129925|NCT01679028|3855034|FG000|STARTED|Overall Study||2
3129926|NCT01679028|3855035|FG001|STARTED|Overall Study||4
3129927|NCT01679028|3855036|FG002|STARTED|Overall Study||2
3129928|NCT01679028|3855037|FG003|STARTED|Overall Study||4
3129929|NCT01679028|3855038|FG004|STARTED|Overall Study||2
3129930|NCT01679028|3855039|FG005|STARTED|Overall Study||6
3129931|NCT01679028|3855034|FG000|COMPLETED|Overall Study||2
3129932|NCT01679028|3855035|FG001|COMPLETED|Overall Study||4
3129933|NCT01679028|3855036|FG002|COMPLETED|Overall Study||2
3129934|NCT01679028|3855037|FG003|COMPLETED|Overall Study||4
3129935|NCT01679028|3855038|FG004|COMPLETED|Overall Study||2
3129936|NCT01679028|3855039|FG005|COMPLETED|Overall Study||6
3129937|NCT01679028|3855034|FG000|NOT COMPLETED|Overall Study||0
3129938|NCT01679028|3855035|FG001|NOT COMPLETED|Overall Study||0
3129939|NCT01679028|3855036|FG002|NOT COMPLETED|Overall Study||0
3129940|NCT01679028|3855037|FG003|NOT COMPLETED|Overall Study||0
3129941|NCT01679028|3855038|FG004|NOT COMPLETED|Overall Study||0
3129942|NCT01679028|3855039|FG005|NOT COMPLETED|Overall Study||0
3129943|NCT01679197|3855053|FG000|STARTED|Overall Study||23
3129944|NCT01679197|3855053|FG000|COMPLETED|Overall Study||19
3129945|NCT01679197|3855053|FG000|NOT COMPLETED|Overall Study||4
3129946|NCT01679236|3855065|FG000|STARTED|Overall Study||30
3129947|NCT01679236|3855066|FG001|STARTED|Overall Study||25
3129948|NCT01679236|3855065|FG000|COMPLETED|Overall Study||15
3129949|NCT01679236|3855066|FG001|COMPLETED|Overall Study||10
3129950|NCT01679236|3855065|FG000|NOT COMPLETED|Overall Study||15
3129951|NCT01679236|3855066|FG001|NOT COMPLETED|Overall Study||15
3129952|NCT01679301|3855072|FG000|STARTED|Screening Period||11
3129953|NCT01679301|3855073|FG001|STARTED|Screening Period||0
3129954|NCT01679301|3855074|FG002|STARTED|Screening Period||0
3129955|NCT01679301|3855072|FG000|COMPLETED|Screening Period||8
3129956|NCT01679301|3855073|FG001|COMPLETED|Screening Period||0
3129957|NCT01679301|3855074|FG002|COMPLETED|Screening Period||0
3129958|NCT01679301|3855072|FG000|NOT COMPLETED|Screening Period||3
3129959|NCT01679301|3855073|FG001|NOT COMPLETED|Screening Period||0
3129960|NCT01679301|3855074|FG002|NOT COMPLETED|Screening Period||0
3129961|NCT01679301|3855072|FG000|STARTED|Study Period||0
3129962|NCT01679301|3855073|FG001|STARTED|Study Period||4
3129963|NCT01679301|3855074|FG002|STARTED|Study Period||4
3129964|NCT01679301|3855072|FG000|COMPLETED|Study Period||0
3129965|NCT01679301|3855073|FG001|COMPLETED|Study Period||4
3129966|NCT01679301|3855074|FG002|COMPLETED|Study Period||4
3129967|NCT01679301|3855072|FG000|NOT COMPLETED|Study Period||0
3129968|NCT01679301|3855073|FG001|NOT COMPLETED|Study Period||0
3129969|NCT01679301|3855074|FG002|NOT COMPLETED|Study Period||0
3129970|NCT01679314|3855082|FG000|STARTED|Overall Study||26
3129971|NCT01679314|3855083|FG001|STARTED|Overall Study||28
3129972|NCT01679314|3855082|FG000|COMPLETED|Overall Study||24
3129973|NCT01679314|3855083|FG001|COMPLETED|Overall Study||28
3129974|NCT01679314|3855082|FG000|NOT COMPLETED|Overall Study||2
3129975|NCT01679314|3855083|FG001|NOT COMPLETED|Overall Study||0
3129976|NCT01679405|3855095|FG000|STARTED|Overall Study||3
3129977|NCT01679405|3855096|FG001|STARTED|Overall Study||6
3129978|NCT01679405|3855095|FG000|COMPLETED|Overall Study||1
3129979|NCT01679405|3855096|FG001|COMPLETED|Overall Study||1
3129980|NCT01679405|3855095|FG000|NOT COMPLETED|Overall Study||2
3129981|NCT01679405|3855096|FG001|NOT COMPLETED|Overall Study||5
3136603|NCT01713946|3861821|FG000|Completed Core Phase|Overall Study||110
3136604|NCT01713946|3861822|FG001|Completed Core Phase|Overall Study||122
3136605|NCT01713946|3861823|FG002|Completed Core Phase|Overall Study||114
3136606|NCT01713946|3861821|FG000|Continued in Ext. Phase|Overall Study||110
3136607|NCT01713946|3861822|FG001|Continued in Ext. Phase|Overall Study||119
3136608|NCT01713946|3861823|FG002|Continued in Ext. Phase|Overall Study||114
3136609|NCT01713946|3861821|FG000|Completed Ext. Phase|Overall Study||79
3136610|NCT01713946|3861822|FG001|Completed Ext. Phase|Overall Study||92
3136611|NCT01713946|3861823|FG002|Completed Ext. Phase|Overall Study||81
3136612|NCT01713946|3861821|FG000|Continued in Post-Ext. Phase|Overall Study||78
3136613|NCT01713946|3861822|FG001|Continued in Post-Ext. Phase|Overall Study||90
3136614|NCT01713946|3861823|FG002|Continued in Post-Ext. Phase|Overall Study||81
3136615|NCT01713946|3861821|FG000|Completed Post-Ext Phase|Overall Study||74
3136616|NCT01713946|3861822|FG001|Completed Post-Ext Phase|Overall Study||85
3136617|NCT01713946|3861823|FG002|Completed Post-Ext Phase|Overall Study||75
3136618|NCT01713946|3861821|FG000|Did Not Continue in Ext Phase|Overall Study||0
3136619|NCT01713946|3861822|FG001|Did Not Continue in Ext Phase|Overall Study||3
3136620|NCT01713946|3861823|FG002|Did Not Continue in Ext Phase|Overall Study||0
3136621|NCT01713946|3861821|FG000|Did Not Cont. in Post-Ext Phase|Overall Study||1
3136622|NCT01713946|3861822|FG001|Did Not Cont. in Post-Ext Phase|Overall Study||2
3136623|NCT01713946|3861823|FG002|Did Not Cont. in Post-Ext Phase|Overall Study||0
3136624|NCT01713946|3861821|FG000|COMPLETED|Overall Study||74
3136625|NCT01713946|3861822|FG001|COMPLETED|Overall Study||85
3136626|NCT01713946|3861823|FG002|COMPLETED|Overall Study||75
3136627|NCT01713946|3861821|FG000|NOT COMPLETED|Overall Study||43
3136628|NCT01713946|3861822|FG001|NOT COMPLETED|Overall Study||45
3136629|NCT01713946|3861823|FG002|NOT COMPLETED|Overall Study||44
3136630|NCT01713998|3861852|FG000|STARTED|Overall Study||16
3136631|NCT01713998|3861853|FG001|STARTED|Overall Study||15
3136632|NCT01713998|3861854|FG002|STARTED|Overall Study||16
3136633|NCT01713998|3861852|FG000|COMPLETED|Overall Study||13
3136634|NCT01713998|3861853|FG001|COMPLETED|Overall Study||15
3136635|NCT01713998|3861854|FG002|COMPLETED|Overall Study||14
3136636|NCT01713998|3861852|FG000|NOT COMPLETED|Overall Study||3
3136637|NCT01713998|3861853|FG001|NOT COMPLETED|Overall Study||0
3136638|NCT01713998|3861854|FG002|NOT COMPLETED|Overall Study||2
3136639|NCT01714024|3861865|FG000|STARTED|Overall Study||13
3136640|NCT01714024|3861866|FG001|STARTED|Overall Study||18
3136641|NCT01714024|3861867|FG002|STARTED|Overall Study||11
3136642|NCT01714024|3861865|FG000|COMPLETED|Overall Study||12
3136643|NCT01714024|3861866|FG001|COMPLETED|Overall Study||12
3136644|NCT01714024|3861867|FG002|COMPLETED|Overall Study||8
3136645|NCT01714024|3861865|FG000|NOT COMPLETED|Overall Study||1
3136646|NCT01714024|3861866|FG001|NOT COMPLETED|Overall Study||6
3136647|NCT01714024|3861867|FG002|NOT COMPLETED|Overall Study||3
3136648|NCT01714063|3861884|FG000|STARTED|Overall Study||34
3136649|NCT01714063|3861884|FG000|COMPLETED|Overall Study||32
3136650|NCT01714063|3861884|FG000|NOT COMPLETED|Overall Study||2
3136651|NCT01714232|3861892|FG000|STARTED|Overall Study||106
3129982|NCT01679600|3855104|FG000|STARTED|Overall Study||7
3129983|NCT01679600|3855105|FG001|STARTED|Overall Study||7
3129984|NCT01679600|3855104|FG000|COMPLETED|Overall Study||7
3129985|NCT01679600|3855105|FG001|COMPLETED|Overall Study||7
3129986|NCT01679600|3855104|FG000|NOT COMPLETED|Overall Study||0
3129987|NCT01679600|3855105|FG001|NOT COMPLETED|Overall Study||0
3129988|NCT01679613|3855111|FG000|STARTED|Overall Study||4
3129989|NCT01679613|3855112|FG001|STARTED|Overall Study||4
3129990|NCT01679613|3855113|FG002|STARTED|Overall Study||13
3129991|NCT01679613|3855114|FG003|STARTED|Overall Study||13
3129992|NCT01679613|3855111|FG000|Received Nintedanib (Pilot)|Overall Study||4
3129993|NCT01679613|3855112|FG001|Received Nintedanib (Pilot)|Overall Study||3
3129994|NCT01679613|3855113|FG002|Received Nintedanib (Pilot)|Overall Study||0
3129995|NCT01679613|3855114|FG003|Received Nintedanib (Pilot)|Overall Study||0
3129996|NCT01679613|3855111|FG000|Received Nintedanib+Ketoconazole (Pilot)|Overall Study||4
3129997|NCT01679613|3855112|FG001|Received Nintedanib+Ketoconazole (Pilot)|Overall Study|One subject received only ketoconazole not nintedanib|4
3129998|NCT01679613|3855113|FG002|Received Nintedanib+Ketoconazole (Pilot)|Overall Study||0
3129999|NCT01679613|3855114|FG003|Received Nintedanib+Ketoconazole (Pilot)|Overall Study||0
3130000|NCT01679613|3855111|FG000|Received Nintedanib (Main)|Overall Study||0
3130001|NCT01679613|3855112|FG001|Received Nintedanib (Main)|Overall Study||0
3130002|NCT01679613|3855113|FG002|Received Nintedanib (Main)|Overall Study||13
3130003|NCT01679613|3855114|FG003|Received Nintedanib (Main)|Overall Study||11
3130004|NCT01679613|3855111|FG000|Received Nintedanib+Ketoconazole (Main)|Overall Study||0
3130005|NCT01679613|3855112|FG001|Received Nintedanib+Ketoconazole (Main)|Overall Study||0
3130006|NCT01679613|3855113|FG002|Received Nintedanib+Ketoconazole (Main)|Overall Study|Two subjects received only ketoconazole not nintedanib|13
3130007|NCT01679613|3855114|FG003|Received Nintedanib+Ketoconazole (Main)|Overall Study|Two subjects received only ketoconazole not nintedanib|13
3130008|NCT01679613|3855111|FG000|COMPLETED|Overall Study||4
3130009|NCT01679613|3855112|FG001|COMPLETED|Overall Study||3
3130010|NCT01679613|3855113|FG002|COMPLETED|Overall Study||11
3130011|NCT01679613|3855114|FG003|COMPLETED|Overall Study||11
3130012|NCT01679613|3855111|FG000|NOT COMPLETED|Overall Study||0
3130013|NCT01679613|3855112|FG001|NOT COMPLETED|Overall Study||1
3130014|NCT01679613|3855113|FG002|NOT COMPLETED|Overall Study||2
3130015|NCT01679613|3855114|FG003|NOT COMPLETED|Overall Study||2
3130016|NCT01680016|3855123|FG000|STARTED|Overall Study||121
3130017|NCT01680016|3855124|FG001|STARTED|Overall Study||122
3130018|NCT01680016|3855125|FG002|STARTED|Overall Study||201
3130019|NCT01680016|3855126|FG003|STARTED|Overall Study||200
3130020|NCT01680016|3855123|FG000|COMPLETED|Overall Study||115
3130021|NCT01680016|3855124|FG001|COMPLETED|Overall Study||114
3130022|NCT01680016|3855125|FG002|COMPLETED|Overall Study||196
3130023|NCT01680016|3855126|FG003|COMPLETED|Overall Study||195
3130024|NCT01680016|3855123|FG000|NOT COMPLETED|Overall Study||6
3130025|NCT01680016|3855124|FG001|NOT COMPLETED|Overall Study||8
3130026|NCT01680016|3855125|FG002|NOT COMPLETED|Overall Study||5
3130027|NCT01680016|3855126|FG003|NOT COMPLETED|Overall Study||5
3130028|NCT01680159|3855152|FG000|STARTED|Screening Period||46
3130029|NCT01680159|3855152|FG000|COMPLETED|Screening Period||39
3130030|NCT01680159|3855152|FG000|NOT COMPLETED|Screening Period||7
3130031|NCT01680159|3855152|FG000|STARTED|Increased Dose Period||51
3130032|NCT01680159|3855152|FG000|COMPLETED|Increased Dose Period||43
3130033|NCT01680159|3855152|FG000|NOT COMPLETED|Increased Dose Period||8
3130034|NCT01680172|3855174|FG000|STARTED|Overall Study||3
3130035|NCT01680172|3855175|FG001|STARTED|Overall Study||2
3130036|NCT01680172|3855174|FG000|COMPLETED|Overall Study||3
3130037|NCT01680172|3855175|FG001|COMPLETED|Overall Study||2
3130038|NCT01680172|3855174|FG000|NOT COMPLETED|Overall Study||0
3130039|NCT01680172|3855175|FG001|NOT COMPLETED|Overall Study||0
3130040|NCT01680328|3855181|FG000|STARTED|Overall Study||82
3130041|NCT01680328|3855181|FG000|Subjects Missing Injections|Overall Study|One missed the [1600 μL, 450 μL/s; thighs]; one missed the [400 μL, 300 μL/s; abdomen]|2
3130042|NCT01680328|3855181|FG000|COMPLETED|Overall Study||80
3130043|NCT01680328|3855181|FG000|NOT COMPLETED|Overall Study||2
3130044|NCT01680341|3855218|FG000|STARTED|Overall Study||136
3130045|NCT01680341|3855219|FG001|STARTED|Overall Study||136
3130046|NCT01680341|3855218|FG000|Exposed|Overall Study|One (1) subject withdrew consent prior to exposure to trial product.|135
3130047|NCT01680341|3855219|FG001|Exposed|Overall Study|Two (2) subjects withdrew consent prior to exposure to trial product.|134
3130048|NCT01680341|3855218|FG000|COMPLETED|Overall Study||115
3130049|NCT01680341|3855219|FG001|COMPLETED|Overall Study||119
3130050|NCT01680341|3855218|FG000|NOT COMPLETED|Overall Study||21
3130051|NCT01680341|3855219|FG001|NOT COMPLETED|Overall Study||17
3130052|NCT01680458|3855225|FG000|STARTED|Overall Study||30
3130053|NCT01680458|3855225|FG000|COMPLETED|Overall Study||27
3130054|NCT01680458|3855225|FG000|NOT COMPLETED|Overall Study||3
3130055|NCT01680497|3855229|FG000|STARTED|Overall Study||70
3130056|NCT01680497|3855229|FG000|COMPLETED|Overall Study||68
3130057|NCT01680497|3855229|FG000|NOT COMPLETED|Overall Study||2
3130058|NCT01680549|3855235|FG000|STARTED|Overall Study||25
3130059|NCT01680549|3855236|FG001|STARTED|Overall Study||25
3130060|NCT01680549|3855235|FG000|COMPLETED|Overall Study||20
3130061|NCT01680549|3855236|FG001|COMPLETED|Overall Study||17
3130062|NCT01680549|3855235|FG000|NOT COMPLETED|Overall Study||5
3130063|NCT01680549|3855236|FG001|NOT COMPLETED|Overall Study||8
3130064|NCT01680640|3855250|FG000|STARTED|Overall Study||55
3130065|NCT01680640|3855251|FG001|STARTED|Overall Study||49
3130066|NCT01680640|3855250|FG000|COMPLETED|Overall Study||45
3130067|NCT01680640|3855251|FG001|COMPLETED|Overall Study||44
3130068|NCT01680640|3855250|FG000|NOT COMPLETED|Overall Study||10
3130069|NCT01680640|3855251|FG001|NOT COMPLETED|Overall Study||5
3130070|NCT01680653|3855257|FG000|STARTED|Overall Study||57
3130071|NCT01680653|3855257|FG000|COMPLETED|Overall Study||57
3130072|NCT01680653|3855257|FG000|NOT COMPLETED|Overall Study||0
3130073|NCT01680666|3855269|FG000|STARTED|Overall Study||84
3130074|NCT01680666|3855270|FG001|STARTED|Overall Study||66
3130075|NCT01680666|3855269|FG000|COMPLETED|Overall Study||84
3130076|NCT01680666|3855270|FG001|COMPLETED|Overall Study||66
3130077|NCT01680666|3855269|FG000|NOT COMPLETED|Overall Study||0
3130078|NCT01680666|3855270|FG001|NOT COMPLETED|Overall Study||0
3130079|NCT01680783|3855279|FG000|STARTED|Overall Study||39
3130080|NCT01680783|3855280|FG001|STARTED|Overall Study||44
3130081|NCT01680783|3855279|FG000|COMPLETED|Overall Study||39
3130082|NCT01680783|3855280|FG001|COMPLETED|Overall Study||44
3130083|NCT01680783|3855279|FG000|NOT COMPLETED|Overall Study||0
3130084|NCT01680783|3855280|FG001|NOT COMPLETED|Overall Study||0
3130085|NCT01680835|3855286|FG000|STARTED|Overall Study||108
3130086|NCT01680835|3855286|FG000|COMPLETED|Overall Study||83
3130087|NCT01680835|3855286|FG000|NOT COMPLETED|Overall Study||25
3130088|NCT01680848|3855290|FG000|STARTED|Overall Study||282
3130089|NCT01680848|3855290|FG000|COMPLETED|Overall Study||189
3130090|NCT01680848|3855290|FG000|NOT COMPLETED|Overall Study||93
3130091|NCT01680861|3855296|FG000|STARTED|Early Post-transplant Period|One patient didn't produce sufficient urine during first 24hr post-transplant (ineligible).|16
3130092|NCT01680861|3855297|FG001|STARTED|Early Post-transplant Period|One patient developed immediate DGF (delayed graft function) and was therefore ineligible.|16
3130093|NCT01680861|3855296|FG000|COMPLETED|Early Post-transplant Period||15
3130094|NCT01680861|3855297|FG001|COMPLETED|Early Post-transplant Period||15
3130095|NCT01680861|3855296|FG000|NOT COMPLETED|Early Post-transplant Period||1
3130096|NCT01680861|3855297|FG001|NOT COMPLETED|Early Post-transplant Period||1
3130097|NCT01680861|3855296|FG000|STARTED|First 12 Months Post-transplant||15
3130098|NCT01680861|3855297|FG001|STARTED|First 12 Months Post-transplant||15
3130099|NCT01680861|3855296|FG000|COMPLETED|First 12 Months Post-transplant||15
3130100|NCT01680861|3855297|FG001|COMPLETED|First 12 Months Post-transplant||15
3130101|NCT01680861|3855296|FG000|NOT COMPLETED|First 12 Months Post-transplant||0
3130102|NCT01680861|3855297|FG001|NOT COMPLETED|First 12 Months Post-transplant||0
3130103|NCT01680887|3855307|FG000|STARTED|Overall Study||80
3130104|NCT01680887|3855308|FG001|STARTED|Overall Study||76
3130105|NCT01680887|3855307|FG000|COMPLETED|Overall Study||51
3130106|NCT01680887|3855308|FG001|COMPLETED|Overall Study||52
3130107|NCT01680887|3855307|FG000|NOT COMPLETED|Overall Study||29
3130108|NCT01680887|3855308|FG001|NOT COMPLETED|Overall Study||24
3130109|NCT01680900|3855316|FG000|STARTED|Overall Study||24
3130110|NCT01680900|3855317|FG001|STARTED|Overall Study||12
3130111|NCT01680900|3855316|FG000|COMPLETED|Overall Study||20
3130112|NCT01680900|3855317|FG001|COMPLETED|Overall Study||11
3130113|NCT01680900|3855316|FG000|NOT COMPLETED|Overall Study||4
3130114|NCT01680900|3855317|FG001|NOT COMPLETED|Overall Study||1
3130115|NCT01680965|3855327|FG000|STARTED|Overall Study||3
3130116|NCT01680965|3855328|FG001|STARTED|Overall Study||3
3130117|NCT01680965|3855329|FG002|STARTED|Overall Study||6
3130118|NCT01680965|3855330|FG003|STARTED|Overall Study||32
3130119|NCT01680965|3855327|FG000|COMPLETED|Overall Study||3
3130120|NCT01680965|3855328|FG001|COMPLETED|Overall Study||3
3130121|NCT01680965|3855329|FG002|COMPLETED|Overall Study||6
3130122|NCT01680965|3855330|FG003|COMPLETED|Overall Study||26
3130123|NCT01680965|3855327|FG000|NOT COMPLETED|Overall Study||0
3130124|NCT01680965|3855328|FG001|NOT COMPLETED|Overall Study||0
3130125|NCT01680965|3855329|FG002|NOT COMPLETED|Overall Study||0
3130126|NCT01680965|3855330|FG003|NOT COMPLETED|Overall Study||6
3130127|NCT01680991|3855341|FG000|STARTED|Overall Study||12
3130128|NCT01680991|3855342|FG001|STARTED|Overall Study||23
3130129|NCT01680991|3855343|FG002|STARTED|Overall Study||13
3296495|NCT02906670|4030255|FG007|COMPLETED|Cohort 4P, QW||0
3296496|NCT02906670|4030256|FG008|COMPLETED|Cohort 4P, QW||0
3296497|NCT02906670|4030257|FG009|COMPLETED|Cohort 4P, QW||0
3296498|NCT02906670|4030248|FG000|NOT COMPLETED|Cohort 4P, QW||0
3296499|NCT02906670|4030249|FG001|NOT COMPLETED|Cohort 4P, QW||0
3296500|NCT02906670|4030250|FG002|NOT COMPLETED|Cohort 4P, QW||0
3296501|NCT02906670|4030251|FG003|NOT COMPLETED|Cohort 4P, QW||3
3296502|NCT02906670|4030252|FG004|NOT COMPLETED|Cohort 4P, QW||0
3296503|NCT02906670|4030253|FG005|NOT COMPLETED|Cohort 4P, QW||0
3296504|NCT02906670|4030254|FG006|NOT COMPLETED|Cohort 4P, QW||0
3296505|NCT02906670|4030255|FG007|NOT COMPLETED|Cohort 4P, QW||0
3296506|NCT02906670|4030256|FG008|NOT COMPLETED|Cohort 4P, QW||0
3296507|NCT02906670|4030257|FG009|NOT COMPLETED|Cohort 4P, QW||0
3296508|NCT02906670|4030248|FG000|STARTED|Cohort 7P, Q2W||0
3296509|NCT02906670|4030249|FG001|STARTED|Cohort 7P, Q2W||0
3296510|NCT02906670|4030250|FG002|STARTED|Cohort 7P, Q2W||0
3296511|NCT02906670|4030251|FG003|STARTED|Cohort 7P, Q2W||0
3296512|NCT02906670|4030252|FG004|STARTED|Cohort 7P, Q2W||0
3296513|NCT02906670|4030253|FG005|STARTED|Cohort 7P, Q2W||0
3296514|NCT02906670|4030254|FG006|STARTED|Cohort 7P, Q2W||0
3130130|NCT01680991|3855341|FG000|COMPLETED|Overall Study||4
3130131|NCT01680991|3855342|FG001|COMPLETED|Overall Study||4
3130132|NCT01680991|3855343|FG002|COMPLETED|Overall Study||9
3130133|NCT01680991|3855341|FG000|NOT COMPLETED|Overall Study||8
3296515|NCT02906670|4030255|FG007|STARTED|Cohort 7P, Q2W||0
3130134|NCT01680991|3855342|FG001|NOT COMPLETED|Overall Study||19
3130135|NCT01680991|3855343|FG002|NOT COMPLETED|Overall Study||4
3130136|NCT01681004|3855355|FG000|STARTED|Primary Endpoint: 6 Months||102
3130137|NCT01681004|3855356|FG001|STARTED|Primary Endpoint: 6 Months||46
3130138|NCT01681004|3855355|FG000|Crossover to Surgical Treatment|Primary Endpoint: 6 Months||0
3130139|NCT01681004|3855356|FG001|Crossover to Surgical Treatment|Primary Endpoint: 6 Months|Crossover to surgical treatment allowed per study protocol after the 6-month visit was complete.|39
3130140|NCT01681004|3855355|FG000|COMPLETED|Primary Endpoint: 6 Months||101
3130141|NCT01681004|3855356|FG001|COMPLETED|Primary Endpoint: 6 Months||44
3130142|NCT01681004|3855355|FG000|NOT COMPLETED|Primary Endpoint: 6 Months||1
3130143|NCT01681004|3855356|FG001|NOT COMPLETED|Primary Endpoint: 6 Months||2
3130144|NCT01681004|3855355|FG000|STARTED|Study Completion||101
3130145|NCT01681004|3855356|FG001|STARTED|Study Completion||44
3130146|NCT01681004|3855355|FG000|COMPLETED|Study Completion||89
3130147|NCT01681004|3855356|FG001|COMPLETED|Study Completion||36
3130148|NCT01681004|3855355|FG000|NOT COMPLETED|Study Completion||12
3130149|NCT01681004|3855356|FG001|NOT COMPLETED|Study Completion||8
3130150|NCT01681030|3855369|FG000|STARTED|Overall Study||13
3130151|NCT01681030|3855370|FG001|STARTED|Overall Study||18
3130152|NCT01681030|3855371|FG002|STARTED|Overall Study||11
3130153|NCT01681030|3855369|FG000|COMPLETED|Overall Study||13
3130154|NCT01681030|3855370|FG001|COMPLETED|Overall Study||18
3130155|NCT01681030|3855371|FG002|COMPLETED|Overall Study||11
3130156|NCT01681030|3855369|FG000|NOT COMPLETED|Overall Study||0
3130157|NCT01681030|3855370|FG001|NOT COMPLETED|Overall Study||0
3130158|NCT01681030|3855371|FG002|NOT COMPLETED|Overall Study||0
3130159|NCT01681069|3855381|FG000|STARTED|Overall Study||60
3130160|NCT01681069|3855382|FG001|STARTED|Overall Study||60
3130161|NCT01681069|3855381|FG000|Full Analysis Set (FAS)|Overall Study||57
3130162|NCT01681069|3855382|FG001|Full Analysis Set (FAS)|Overall Study||60
3130163|NCT01681069|3855381|FG000|COMPLETED|Overall Study|Valid Case Analysis Set (VAS)|55
3130164|NCT01681069|3855382|FG001|COMPLETED|Overall Study|Valid Case Analysis Set (VAS)|53
3130165|NCT01681069|3855381|FG000|NOT COMPLETED|Overall Study||5
3130166|NCT01681069|3855382|FG001|NOT COMPLETED|Overall Study||7
3130167|NCT01681095|3855390|FG000|STARTED|Overall Study||55
3130168|NCT01681095|3855391|FG001|STARTED|Overall Study||55
3130169|NCT01681095|3855390|FG000|COMPLETED|Overall Study||55
3130170|NCT01681095|3855391|FG001|COMPLETED|Overall Study||55
3130171|NCT01681095|3855390|FG000|NOT COMPLETED|Overall Study||0
3130172|NCT01681095|3855391|FG001|NOT COMPLETED|Overall Study||0
3130173|NCT01681121|3855399|FG000|STARTED|Overall Study||44
3130174|NCT01681121|3855400|FG001|STARTED|Overall Study||49
3130175|NCT01681121|3855399|FG000|COMPLETED|Overall Study||36
3130176|NCT01681121|3855400|FG001|COMPLETED|Overall Study||38
3130177|NCT01681121|3855399|FG000|NOT COMPLETED|Overall Study||8
3130178|NCT01681121|3855400|FG001|NOT COMPLETED|Overall Study||11
3130179|NCT01681186|3855416|FG000|STARTED|First Intervention||4
3130180|NCT01681186|3855417|FG001|STARTED|First Intervention||2
3130181|NCT01681186|3855418|FG002|STARTED|First Intervention||2
3130182|NCT01681186|3855419|FG003|STARTED|First Intervention||3
3130183|NCT01681186|3855420|FG004|STARTED|First Intervention||3
3130184|NCT01681186|3855421|FG005|STARTED|First Intervention||2
3130185|NCT01681186|3855422|FG006|STARTED|First Intervention||7
3130186|NCT01681186|3855423|FG007|STARTED|First Intervention||7
3130187|NCT01681186|3855416|FG000|COMPLETED|First Intervention||4
3130188|NCT01681186|3855417|FG001|COMPLETED|First Intervention||2
3130189|NCT01681186|3855418|FG002|COMPLETED|First Intervention||2
3130190|NCT01681186|3855419|FG003|COMPLETED|First Intervention||3
3130191|NCT01681186|3855420|FG004|COMPLETED|First Intervention||3
3130192|NCT01681186|3855421|FG005|COMPLETED|First Intervention||2
3130193|NCT01681186|3855422|FG006|COMPLETED|First Intervention||7
3130194|NCT01681186|3855423|FG007|COMPLETED|First Intervention||7
3130195|NCT01681186|3855416|FG000|NOT COMPLETED|First Intervention||0
3130196|NCT01681186|3855417|FG001|NOT COMPLETED|First Intervention||0
3130197|NCT01681186|3855418|FG002|NOT COMPLETED|First Intervention||0
3296516|NCT02906670|4030256|FG008|STARTED|Cohort 7P, Q2W||0
3296517|NCT02906670|4030257|FG009|STARTED|Cohort 7P, Q2W||3
3296518|NCT02906670|4030248|FG000|COMPLETED|Cohort 7P, Q2W||0
3296519|NCT02906670|4030249|FG001|COMPLETED|Cohort 7P, Q2W||0
3296520|NCT02906670|4030250|FG002|COMPLETED|Cohort 7P, Q2W||0
3296521|NCT02906670|4030251|FG003|COMPLETED|Cohort 7P, Q2W||0
3296522|NCT02906670|4030252|FG004|COMPLETED|Cohort 7P, Q2W||0
3296523|NCT02906670|4030253|FG005|COMPLETED|Cohort 7P, Q2W||0
3296524|NCT02906670|4030254|FG006|COMPLETED|Cohort 7P, Q2W||0
3296525|NCT02906670|4030255|FG007|COMPLETED|Cohort 7P, Q2W||0
3296526|NCT02906670|4030256|FG008|COMPLETED|Cohort 7P, Q2W||0
3296527|NCT02906670|4030257|FG009|COMPLETED|Cohort 7P, Q2W||0
3296528|NCT02906670|4030248|FG000|NOT COMPLETED|Cohort 7P, Q2W||0
3296529|NCT02906670|4030249|FG001|NOT COMPLETED|Cohort 7P, Q2W||0
3296530|NCT02906670|4030250|FG002|NOT COMPLETED|Cohort 7P, Q2W||0
3296531|NCT02906670|4030251|FG003|NOT COMPLETED|Cohort 7P, Q2W||0
3296532|NCT02906670|4030252|FG004|NOT COMPLETED|Cohort 7P, Q2W||0
3296533|NCT02906670|4030253|FG005|NOT COMPLETED|Cohort 7P, Q2W||0
3296534|NCT02906670|4030254|FG006|NOT COMPLETED|Cohort 7P, Q2W||0
3296535|NCT02906670|4030255|FG007|NOT COMPLETED|Cohort 7P, Q2W||0
3296536|NCT02906670|4030256|FG008|NOT COMPLETED|Cohort 7P, Q2W||0
3296537|NCT02906670|4030257|FG009|NOT COMPLETED|Cohort 7P, Q2W||3
3296538|NCT02906670|4030248|FG000|STARTED|Cohort 5P, QW||0
3296539|NCT02906670|4030249|FG001|STARTED|Cohort 5P, QW||0
3130198|NCT01681186|3855419|FG003|NOT COMPLETED|First Intervention||0
3130199|NCT01681186|3855420|FG004|NOT COMPLETED|First Intervention||0
3130200|NCT01681186|3855421|FG005|NOT COMPLETED|First Intervention||0
3130201|NCT01681186|3855422|FG006|NOT COMPLETED|First Intervention||0
3130202|NCT01681186|3855423|FG007|NOT COMPLETED|First Intervention||0
3130203|NCT01681186|3855416|FG000|STARTED|Washout Period From First Intervention||4
3130204|NCT01681186|3855417|FG001|STARTED|Washout Period From First Intervention||2
3130205|NCT01681186|3855418|FG002|STARTED|Washout Period From First Intervention||2
3130206|NCT01681186|3855419|FG003|STARTED|Washout Period From First Intervention||3
3130207|NCT01681186|3855420|FG004|STARTED|Washout Period From First Intervention||3
3130208|NCT01681186|3855421|FG005|STARTED|Washout Period From First Intervention||2
3130209|NCT01681186|3855422|FG006|STARTED|Washout Period From First Intervention||7
3130210|NCT01681186|3855423|FG007|STARTED|Washout Period From First Intervention||7
3130211|NCT01681186|3855416|FG000|COMPLETED|Washout Period From First Intervention||4
3130212|NCT01681186|3855417|FG001|COMPLETED|Washout Period From First Intervention||2
3130213|NCT01681186|3855418|FG002|COMPLETED|Washout Period From First Intervention||2
3130214|NCT01681186|3855419|FG003|COMPLETED|Washout Period From First Intervention||3
3130215|NCT01681186|3855420|FG004|COMPLETED|Washout Period From First Intervention||3
3130216|NCT01681186|3855421|FG005|COMPLETED|Washout Period From First Intervention||2
3130217|NCT01681186|3855422|FG006|COMPLETED|Washout Period From First Intervention||7
3130218|NCT01681186|3855423|FG007|COMPLETED|Washout Period From First Intervention||7
3130219|NCT01681186|3855416|FG000|NOT COMPLETED|Washout Period From First Intervention||0
3130220|NCT01681186|3855417|FG001|NOT COMPLETED|Washout Period From First Intervention||0
3130221|NCT01681186|3855418|FG002|NOT COMPLETED|Washout Period From First Intervention||0
3130222|NCT01681186|3855419|FG003|NOT COMPLETED|Washout Period From First Intervention||0
3130223|NCT01681186|3855420|FG004|NOT COMPLETED|Washout Period From First Intervention||0
3130224|NCT01681186|3855421|FG005|NOT COMPLETED|Washout Period From First Intervention||0
3130225|NCT01681186|3855422|FG006|NOT COMPLETED|Washout Period From First Intervention||0
3130226|NCT01681186|3855423|FG007|NOT COMPLETED|Washout Period From First Intervention||0
3130227|NCT01681186|3855416|FG000|STARTED|Second Intervention||4
3130228|NCT01681186|3855417|FG001|STARTED|Second Intervention||2
3130229|NCT01681186|3855418|FG002|STARTED|Second Intervention||2
3130230|NCT01681186|3855419|FG003|STARTED|Second Intervention||3
3130231|NCT01681186|3855420|FG004|STARTED|Second Intervention||3
3130232|NCT01681186|3855421|FG005|STARTED|Second Intervention||2
3130233|NCT01681186|3855422|FG006|STARTED|Second Intervention||7
3130234|NCT01681186|3855423|FG007|STARTED|Second Intervention||7
3130235|NCT01681186|3855416|FG000|COMPLETED|Second Intervention||4
3130236|NCT01681186|3855417|FG001|COMPLETED|Second Intervention||2
3130237|NCT01681186|3855418|FG002|COMPLETED|Second Intervention||2
3130238|NCT01681186|3855419|FG003|COMPLETED|Second Intervention||3
3130239|NCT01681186|3855420|FG004|COMPLETED|Second Intervention||3
3130240|NCT01681186|3855421|FG005|COMPLETED|Second Intervention||2
3130241|NCT01681186|3855422|FG006|COMPLETED|Second Intervention||7
3130242|NCT01681186|3855423|FG007|COMPLETED|Second Intervention||7
3130243|NCT01681186|3855416|FG000|NOT COMPLETED|Second Intervention||0
3130244|NCT01681186|3855417|FG001|NOT COMPLETED|Second Intervention||0
3130245|NCT01681186|3855418|FG002|NOT COMPLETED|Second Intervention||0
3130246|NCT01681186|3855419|FG003|NOT COMPLETED|Second Intervention||0
3130247|NCT01681186|3855420|FG004|NOT COMPLETED|Second Intervention||0
3130248|NCT01681186|3855421|FG005|NOT COMPLETED|Second Intervention||0
3130249|NCT01681186|3855422|FG006|NOT COMPLETED|Second Intervention||0
3130250|NCT01681186|3855423|FG007|NOT COMPLETED|Second Intervention||0
3130251|NCT01681186|3855416|FG000|STARTED|Washout Period From Second Intervention|Part A participants received only First Intervention and Second Intervention.|0
3130252|NCT01681186|3855417|FG001|STARTED|Washout Period From Second Intervention|Part A participants received only First Intervention and Second Intervention.|0
3130253|NCT01681186|3855418|FG002|STARTED|Washout Period From Second Intervention|Part A participants received only First Intervention and Second Intervention.|0
3130254|NCT01681186|3855419|FG003|STARTED|Washout Period From Second Intervention|Part A participants received only First Intervention and Second Intervention.|0
3130255|NCT01681186|3855420|FG004|STARTED|Washout Period From Second Intervention|Part A participants received only First Intervention and Second Intervention.|0
3130256|NCT01681186|3855421|FG005|STARTED|Washout Period From Second Intervention|Part A participants received only First Intervention and Second Intervention.|0
3130257|NCT01681186|3855422|FG006|STARTED|Washout Period From Second Intervention||7
3130258|NCT01681186|3855423|FG007|STARTED|Washout Period From Second Intervention||7
3130259|NCT01681186|3855416|FG000|COMPLETED|Washout Period From Second Intervention||0
3130260|NCT01681186|3855417|FG001|COMPLETED|Washout Period From Second Intervention||0
3130261|NCT01681186|3855418|FG002|COMPLETED|Washout Period From Second Intervention||0
3130262|NCT01681186|3855419|FG003|COMPLETED|Washout Period From Second Intervention||0
3130263|NCT01681186|3855420|FG004|COMPLETED|Washout Period From Second Intervention||0
3130264|NCT01681186|3855421|FG005|COMPLETED|Washout Period From Second Intervention||0
3130265|NCT01681186|3855422|FG006|COMPLETED|Washout Period From Second Intervention||6
3130266|NCT01681186|3855423|FG007|COMPLETED|Washout Period From Second Intervention||6
3296540|NCT02906670|4030250|FG002|STARTED|Cohort 5P, QW||0
3296541|NCT02906670|4030251|FG003|STARTED|Cohort 5P, QW||0
3296542|NCT02906670|4030252|FG004|STARTED|Cohort 5P, QW||3
3296543|NCT02906670|4030253|FG005|STARTED|Cohort 5P, QW||0
3296544|NCT02906670|4030254|FG006|STARTED|Cohort 5P, QW||0
3296545|NCT02906670|4030255|FG007|STARTED|Cohort 5P, QW||0
3130267|NCT01681186|3855416|FG000|NOT COMPLETED|Washout Period From Second Intervention||0
3130268|NCT01681186|3855417|FG001|NOT COMPLETED|Washout Period From Second Intervention||0
3130269|NCT01681186|3855418|FG002|NOT COMPLETED|Washout Period From Second Intervention||0
3130270|NCT01681186|3855419|FG003|NOT COMPLETED|Washout Period From Second Intervention||0
3130271|NCT01681186|3855420|FG004|NOT COMPLETED|Washout Period From Second Intervention||0
3130272|NCT01681186|3855421|FG005|NOT COMPLETED|Washout Period From Second Intervention||0
3130273|NCT01681186|3855422|FG006|NOT COMPLETED|Washout Period From Second Intervention||1
3130274|NCT01681186|3855423|FG007|NOT COMPLETED|Washout Period From Second Intervention||1
3130275|NCT01681186|3855416|FG000|STARTED|Third Intervention||0
3130276|NCT01681186|3855417|FG001|STARTED|Third Intervention||0
3130277|NCT01681186|3855418|FG002|STARTED|Third Intervention||0
3130278|NCT01681186|3855419|FG003|STARTED|Third Intervention||0
3130279|NCT01681186|3855420|FG004|STARTED|Third Intervention||0
3130280|NCT01681186|3855421|FG005|STARTED|Third Intervention||0
3130281|NCT01681186|3855422|FG006|STARTED|Third Intervention||6
3130282|NCT01681186|3855423|FG007|STARTED|Third Intervention||6
3130283|NCT01681186|3855416|FG000|COMPLETED|Third Intervention||0
3130284|NCT01681186|3855417|FG001|COMPLETED|Third Intervention||0
3130285|NCT01681186|3855418|FG002|COMPLETED|Third Intervention||0
3130286|NCT01681186|3855419|FG003|COMPLETED|Third Intervention||0
3130287|NCT01681186|3855420|FG004|COMPLETED|Third Intervention||0
3130288|NCT01681186|3855421|FG005|COMPLETED|Third Intervention||0
3130289|NCT01681186|3855422|FG006|COMPLETED|Third Intervention||6
3130290|NCT01681186|3855423|FG007|COMPLETED|Third Intervention||6
3130291|NCT01681186|3855416|FG000|NOT COMPLETED|Third Intervention||0
3130292|NCT01681186|3855417|FG001|NOT COMPLETED|Third Intervention||0
3130293|NCT01681186|3855418|FG002|NOT COMPLETED|Third Intervention||0
3130294|NCT01681186|3855419|FG003|NOT COMPLETED|Third Intervention||0
3130295|NCT01681186|3855420|FG004|NOT COMPLETED|Third Intervention||0
3130296|NCT01681186|3855421|FG005|NOT COMPLETED|Third Intervention||0
3130297|NCT01681186|3855422|FG006|NOT COMPLETED|Third Intervention||0
3130298|NCT01681186|3855423|FG007|NOT COMPLETED|Third Intervention||0
3130299|NCT01681186|3855416|FG000|STARTED|Washout Period From Third Intervention||0
3130300|NCT01681186|3855417|FG001|STARTED|Washout Period From Third Intervention||0
3130301|NCT01681186|3855418|FG002|STARTED|Washout Period From Third Intervention||0
3130302|NCT01681186|3855419|FG003|STARTED|Washout Period From Third Intervention||0
3130303|NCT01681186|3855420|FG004|STARTED|Washout Period From Third Intervention||0
3130304|NCT01681186|3855421|FG005|STARTED|Washout Period From Third Intervention||0
3130305|NCT01681186|3855422|FG006|STARTED|Washout Period From Third Intervention||6
3130306|NCT01681186|3855423|FG007|STARTED|Washout Period From Third Intervention||6
3130307|NCT01681186|3855416|FG000|COMPLETED|Washout Period From Third Intervention||0
3130308|NCT01681186|3855417|FG001|COMPLETED|Washout Period From Third Intervention||0
3130309|NCT01681186|3855418|FG002|COMPLETED|Washout Period From Third Intervention||0
3130310|NCT01681186|3855419|FG003|COMPLETED|Washout Period From Third Intervention||0
3130311|NCT01681186|3855420|FG004|COMPLETED|Washout Period From Third Intervention||0
3130312|NCT01681186|3855421|FG005|COMPLETED|Washout Period From Third Intervention||0
3130313|NCT01681186|3855422|FG006|COMPLETED|Washout Period From Third Intervention||5
3130314|NCT01681186|3855423|FG007|COMPLETED|Washout Period From Third Intervention||6
3130315|NCT01681186|3855416|FG000|NOT COMPLETED|Washout Period From Third Intervention||0
3130316|NCT01681186|3855417|FG001|NOT COMPLETED|Washout Period From Third Intervention||0
3130317|NCT01681186|3855418|FG002|NOT COMPLETED|Washout Period From Third Intervention||0
3130318|NCT01681186|3855419|FG003|NOT COMPLETED|Washout Period From Third Intervention||0
3130319|NCT01681186|3855420|FG004|NOT COMPLETED|Washout Period From Third Intervention||0
3130320|NCT01681186|3855421|FG005|NOT COMPLETED|Washout Period From Third Intervention||0
3130321|NCT01681186|3855422|FG006|NOT COMPLETED|Washout Period From Third Intervention||1
3130322|NCT01681186|3855423|FG007|NOT COMPLETED|Washout Period From Third Intervention||0
3130323|NCT01681186|3855416|FG000|STARTED|Fourth Intervention||0
3130324|NCT01681186|3855417|FG001|STARTED|Fourth Intervention||0
3130325|NCT01681186|3855418|FG002|STARTED|Fourth Intervention||0
3130326|NCT01681186|3855419|FG003|STARTED|Fourth Intervention||0
3130327|NCT01681186|3855420|FG004|STARTED|Fourth Intervention||0
3130328|NCT01681186|3855421|FG005|STARTED|Fourth Intervention||0
3130329|NCT01681186|3855422|FG006|STARTED|Fourth Intervention||5
3130330|NCT01681186|3855423|FG007|STARTED|Fourth Intervention||6
3130331|NCT01681186|3855416|FG000|COMPLETED|Fourth Intervention||0
3130332|NCT01681186|3855417|FG001|COMPLETED|Fourth Intervention||0
3130333|NCT01681186|3855418|FG002|COMPLETED|Fourth Intervention||0
3130334|NCT01681186|3855419|FG003|COMPLETED|Fourth Intervention||0
3130335|NCT01681186|3855420|FG004|COMPLETED|Fourth Intervention||0
3130336|NCT01681186|3855421|FG005|COMPLETED|Fourth Intervention||0
3130337|NCT01681186|3855422|FG006|COMPLETED|Fourth Intervention||5
3130338|NCT01681186|3855423|FG007|COMPLETED|Fourth Intervention||5
3130339|NCT01681186|3855416|FG000|NOT COMPLETED|Fourth Intervention||0
3130340|NCT01681186|3855417|FG001|NOT COMPLETED|Fourth Intervention||0
3130341|NCT01681186|3855418|FG002|NOT COMPLETED|Fourth Intervention||0
3130342|NCT01681186|3855419|FG003|NOT COMPLETED|Fourth Intervention||0
3130343|NCT01681186|3855420|FG004|NOT COMPLETED|Fourth Intervention||0
3130344|NCT01681186|3855421|FG005|NOT COMPLETED|Fourth Intervention||0
3130345|NCT01681186|3855422|FG006|NOT COMPLETED|Fourth Intervention||0
3130346|NCT01681186|3855423|FG007|NOT COMPLETED|Fourth Intervention||1
3130347|NCT01681212|3855453|FG000|STARTED|Overall Study|Enrolled|21
3130348|NCT01681212|3855453|FG000|Received Treatment|Overall Study||15
3130349|NCT01681212|3855453|FG000|COMPLETED|Overall Study|Completed=patients who received treatment; not completed=patients who did not receive treatment|15
3130350|NCT01681212|3855453|FG000|NOT COMPLETED|Overall Study||6
3130351|NCT01681277|3855462|FG000|STARTED|Overall Study||12
3130352|NCT01681277|3855463|FG001|STARTED|Overall Study||9
3130353|NCT01681277|3855464|FG002|STARTED|Overall Study||9
3130354|NCT01681277|3855465|FG003|STARTED|Overall Study||9
3130355|NCT01681277|3855466|FG004|STARTED|Overall Study||9
3130356|NCT01681277|3855462|FG000|COMPLETED|Overall Study||11
3130357|NCT01681277|3855463|FG001|COMPLETED|Overall Study||9
3130358|NCT01681277|3855464|FG002|COMPLETED|Overall Study||9
3130359|NCT01681277|3855465|FG003|COMPLETED|Overall Study||9
3130360|NCT01681277|3855466|FG004|COMPLETED|Overall Study||9
3130361|NCT01681277|3855462|FG000|NOT COMPLETED|Overall Study||1
3130362|NCT01681277|3855463|FG001|NOT COMPLETED|Overall Study||0
3130363|NCT01681277|3855464|FG002|NOT COMPLETED|Overall Study||0
3130364|NCT01681277|3855465|FG003|NOT COMPLETED|Overall Study||0
3130365|NCT01681277|3855466|FG004|NOT COMPLETED|Overall Study||0
3130366|NCT01681368|3855482|FG000|STARTED|Overall Study||11
3130367|NCT01681368|3855482|FG000|COMPLETED|Overall Study||9
3130368|NCT01681368|3855482|FG000|NOT COMPLETED|Overall Study||2
3130369|NCT01681433|3855488|FG000|STARTED|Overall Study||36
3130370|NCT01681433|3855489|FG001|STARTED|Overall Study||36
3130371|NCT01681433|3855488|FG000|COMPLETED|Overall Study||4
3130372|NCT01681433|3855489|FG001|COMPLETED|Overall Study||3
3130373|NCT01681433|3855488|FG000|NOT COMPLETED|Overall Study||32
3130374|NCT01681433|3855489|FG001|NOT COMPLETED|Overall Study||33
3130375|NCT01681472|3855499|FG000|STARTED|Overall Study||8
3130376|NCT01681472|3855500|FG001|STARTED|Overall Study||8
3130377|NCT01681472|3855501|FG002|STARTED|Overall Study||8
3130378|NCT01681472|3855502|FG003|STARTED|Overall Study||8
3130379|NCT01681472|3855499|FG000|COMPLETED|Overall Study||8
3130380|NCT01681472|3855500|FG001|COMPLETED|Overall Study||7
3130381|NCT01681472|3855501|FG002|COMPLETED|Overall Study||8
3130382|NCT01681472|3855502|FG003|COMPLETED|Overall Study||8
3130383|NCT01681472|3855499|FG000|NOT COMPLETED|Overall Study||0
3130384|NCT01681472|3855500|FG001|NOT COMPLETED|Overall Study||1
3130385|NCT01681472|3855501|FG002|NOT COMPLETED|Overall Study||0
3130386|NCT01681472|3855502|FG003|NOT COMPLETED|Overall Study||0
3130387|NCT01681511|3855523|FG000|STARTED|Overall Study|All randomized subjects in the Lubri-Sil arm.|46
3130388|NCT01681511|3855524|FG001|STARTED|Overall Study|All randomized subjects in the TIC arm.|49
3130389|NCT01681511|3855523|FG000|Intent to Treat (ITT) Population|Overall Study|Any subject receiving the Lubri-Sil treatment after randomization.|45
3130390|NCT01681511|3855524|FG001|Intent to Treat (ITT) Population|Overall Study|Any subject receiving the TIC treatment after randomization.|46
3130391|NCT01681511|3855523|FG000|Evaluable Population|Overall Study|Subjects w/ positive urine culture results also removed from the Lubri-Sil arm of this population.|16
3130392|NCT01681511|3855524|FG001|Evaluable Population|Overall Study|Subjects w/ positive urine culture results also removed from the TIC arm of this population.|14
3130393|NCT01681511|3855523|FG000|COMPLETED|Overall Study||28
3130394|NCT01681511|3855524|FG001|COMPLETED|Overall Study||35
3130395|NCT01681511|3855523|FG000|NOT COMPLETED|Overall Study||18
3130396|NCT01681511|3855524|FG001|NOT COMPLETED|Overall Study||14
3130397|NCT01681576|3855532|FG000|STARTED|Period 1||36
3130398|NCT01681576|3855533|FG001|STARTED|Period 1||36
3130399|NCT01681576|3855532|FG000|COMPLETED|Period 1||34
3130400|NCT01681576|3855533|FG001|COMPLETED|Period 1||36
3130401|NCT01681576|3855532|FG000|NOT COMPLETED|Period 1||2
3130402|NCT01681576|3855533|FG001|NOT COMPLETED|Period 1||0
3130403|NCT01681576|3855532|FG000|STARTED|Period 2|Period 2: Valsartan 320mg|34
3130404|NCT01681576|3855533|FG001|STARTED|Period 2|Period 2: LCZ696 400mg|36
3130405|NCT01681576|3855532|FG000|COMPLETED|Period 2||30
3130406|NCT01681576|3855533|FG001|COMPLETED|Period 2||35
3130407|NCT01681576|3855532|FG000|NOT COMPLETED|Period 2||4
3130408|NCT01681576|3855533|FG001|NOT COMPLETED|Period 2||1
3130409|NCT01681628|3855543|FG000|STARTED|Time 1 (Entry) to Time 2 One Week Later.||128
3130410|NCT01681628|3855544|FG001|STARTED|Time 1 (Entry) to Time 2 One Week Later.||128
3130411|NCT01681628|3855543|FG000|COMPLETED|Time 1 (Entry) to Time 2 One Week Later.||114
3130412|NCT01681628|3855544|FG001|COMPLETED|Time 1 (Entry) to Time 2 One Week Later.||122
3130413|NCT01681628|3855543|FG000|NOT COMPLETED|Time 1 (Entry) to Time 2 One Week Later.||14
3130414|NCT01681628|3855544|FG001|NOT COMPLETED|Time 1 (Entry) to Time 2 One Week Later.||6
3130415|NCT01681628|3855543|FG000|STARTED|Time 2 to Time 3 (One Week Later).|Only wait list group studied in this period.|0
3130416|NCT01681628|3855544|FG001|STARTED|Time 2 to Time 3 (One Week Later).||122
3130417|NCT01681628|3855543|FG000|COMPLETED|Time 2 to Time 3 (One Week Later).|Only wait list group studied in this period.|0
3130418|NCT01681628|3855544|FG001|COMPLETED|Time 2 to Time 3 (One Week Later).||107
3130419|NCT01681628|3855543|FG000|NOT COMPLETED|Time 2 to Time 3 (One Week Later).||0
3130420|NCT01681628|3855544|FG001|NOT COMPLETED|Time 2 to Time 3 (One Week Later).||15
3130421|NCT01681628|3855543|FG000|STARTED|19 Months Follow-up||114
3130422|NCT01681628|3855544|FG001|STARTED|19 Months Follow-up||107
3130423|NCT01681628|3855543|FG000|COMPLETED|19 Months Follow-up||52
3130424|NCT01681628|3855544|FG001|COMPLETED|19 Months Follow-up||64
3130425|NCT01681628|3855543|FG000|NOT COMPLETED|19 Months Follow-up||62
3130426|NCT01681628|3855544|FG001|NOT COMPLETED|19 Months Follow-up||43
3130427|NCT01681771|3855555|FG000|STARTED|Overall Study||25
3130428|NCT01681771|3855556|FG001|STARTED|Overall Study||25
3130429|NCT01681771|3855555|FG000|COMPLETED|Overall Study||21
3130430|NCT01681771|3855556|FG001|COMPLETED|Overall Study||23
3130431|NCT01681771|3855555|FG000|NOT COMPLETED|Overall Study||4
3130432|NCT01681771|3855556|FG001|NOT COMPLETED|Overall Study||2
3130433|NCT01681810|3855562|FG000|STARTED|Overall Study||20
3130434|NCT01681810|3855562|FG000|COMPLETED|Overall Study||20
3130435|NCT01681810|3855562|FG000|NOT COMPLETED|Overall Study||0
3130436|NCT01681836|3855566|FG000|STARTED|First Intervention||6
3130437|NCT01681836|3855567|FG001|STARTED|First Intervention||5
3130438|NCT01681836|3855566|FG000|COMPLETED|First Intervention||6
3130439|NCT01681836|3855567|FG001|COMPLETED|First Intervention||5
3130440|NCT01681836|3855566|FG000|NOT COMPLETED|First Intervention||0
3130441|NCT01681836|3855567|FG001|NOT COMPLETED|First Intervention||0
3130442|NCT01681836|3855566|FG000|STARTED|Washout Period of 3-7 Days||6
3130443|NCT01681836|3855567|FG001|STARTED|Washout Period of 3-7 Days||5
3130444|NCT01681836|3855566|FG000|COMPLETED|Washout Period of 3-7 Days||6
3130445|NCT01681836|3855567|FG001|COMPLETED|Washout Period of 3-7 Days||5
3130446|NCT01681836|3855566|FG000|NOT COMPLETED|Washout Period of 3-7 Days||0
3130447|NCT01681836|3855567|FG001|NOT COMPLETED|Washout Period of 3-7 Days||0
3130448|NCT01681836|3855566|FG000|STARTED|Second Intervention||6
3130449|NCT01681836|3855567|FG001|STARTED|Second Intervention||5
3130450|NCT01681836|3855566|FG000|COMPLETED|Second Intervention||6
3130451|NCT01681836|3855567|FG001|COMPLETED|Second Intervention||4
3130452|NCT01681836|3855566|FG000|NOT COMPLETED|Second Intervention||0
3130453|NCT01681836|3855567|FG001|NOT COMPLETED|Second Intervention||1
3130454|NCT01681849|3855576|FG000|STARTED|Overall Study||15
3130455|NCT01681849|3855577|FG001|STARTED|Overall Study||13
3130456|NCT01681849|3855578|FG002|STARTED|Overall Study||56
3130457|NCT01681849|3855576|FG000|COMPLETED|Overall Study||7
3130458|NCT01681849|3855577|FG001|COMPLETED|Overall Study||6
3130459|NCT01681849|3855578|FG002|COMPLETED|Overall Study||17
3130460|NCT01681849|3855576|FG000|NOT COMPLETED|Overall Study||8
3130461|NCT01681849|3855577|FG001|NOT COMPLETED|Overall Study||7
3130462|NCT01681849|3855578|FG002|NOT COMPLETED|Overall Study||39
3130463|NCT01681992|3855588|FG000|STARTED|Overall Study||1493
3130464|NCT01681992|3855589|FG001|STARTED|Overall Study||1497
3130465|NCT01681992|3855590|FG002|STARTED|Overall Study||1526
3130466|NCT01681992|3855588|FG000|COMPLETED|Overall Study||1427
3130467|NCT01681992|3855589|FG001|COMPLETED|Overall Study||1427
3130468|NCT01681992|3855590|FG002|COMPLETED|Overall Study||1443
3130469|NCT01681992|3855588|FG000|NOT COMPLETED|Overall Study||66
3130470|NCT01681992|3855589|FG001|NOT COMPLETED|Overall Study||70
3130471|NCT01681992|3855590|FG002|NOT COMPLETED|Overall Study||83
3130472|NCT01682031|3855600|FG000|STARTED|Overall Study||8
3130473|NCT01682031|3855601|FG001|STARTED|Overall Study||10
3130474|NCT01682031|3855600|FG000|COMPLETED|Overall Study||7
3130475|NCT01682031|3855601|FG001|COMPLETED|Overall Study||5
3130476|NCT01682031|3855600|FG000|NOT COMPLETED|Overall Study||1
3130477|NCT01682031|3855601|FG001|NOT COMPLETED|Overall Study||5
3130478|NCT01682044|3855607|FG000|STARTED|Overall Study||20
3130479|NCT01682044|3855607|FG000|COMPLETED|Overall Study||16
3130480|NCT01682044|3855607|FG000|NOT COMPLETED|Overall Study||4
3130481|NCT01682083|3855613|FG000|STARTED|Overall Study||438
3130482|NCT01682083|3855614|FG001|STARTED|Overall Study||432
3130483|NCT01682083|3855613|FG000|COMPLETED|Overall Study|Ongoing patients at the time of data cut-off. 3 patients were untreated|331
3130484|NCT01682083|3855614|FG001|COMPLETED|Overall Study|Ongoing patients at the time of data cut-off.|277
3130485|NCT01682083|3855613|FG000|NOT COMPLETED|Overall Study||107
3130486|NCT01682083|3855614|FG001|NOT COMPLETED|Overall Study||155
3130487|NCT01682135|3855623|FG000|STARTED|Overall Study||6
3130488|NCT01682135|3855624|FG001|STARTED|Overall Study||10
3130489|NCT01682135|3855625|FG002|STARTED|Overall Study||12
3130490|NCT01682135|3855623|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6
3130491|NCT01682135|3855624|FG001|Received at Least 1 Dose of Study Drug|Overall Study||10
3130492|NCT01682135|3855625|FG002|Received at Least 1 Dose of Study Drug|Overall Study||12
3130493|NCT01682135|3855623|FG000|COMPLETED|Overall Study||6
3130494|NCT01682135|3855624|FG001|COMPLETED|Overall Study||10
3130495|NCT01682135|3855625|FG002|COMPLETED|Overall Study||12
3130496|NCT01682135|3855623|FG000|NOT COMPLETED|Overall Study||0
3130497|NCT01682135|3855624|FG001|NOT COMPLETED|Overall Study||0
3130498|NCT01682135|3855625|FG002|NOT COMPLETED|Overall Study||0
3130499|NCT01682148|3855637|FG000|STARTED|Overall Study||44
3130500|NCT01682148|3855638|FG001|STARTED|Overall Study||44
3130501|NCT01682148|3855637|FG000|COMPLETED|Overall Study||40
3130502|NCT01682148|3855638|FG001|COMPLETED|Overall Study||41
3130503|NCT01682148|3855637|FG000|NOT COMPLETED|Overall Study||4
3130504|NCT01682148|3855638|FG001|NOT COMPLETED|Overall Study||3
3130505|NCT01682213|3855649|FG000|STARTED|Overall Study||23
3130506|NCT01682213|3855649|FG000|COMPLETED|Overall Study||21
3130507|NCT01682213|3855649|FG000|NOT COMPLETED|Overall Study||2
3130508|NCT01682460|3855654|FG000|STARTED|Overall Study||15
3130509|NCT01682460|3855654|FG000|COMPLETED|Overall Study||11
3130510|NCT01682460|3855654|FG000|NOT COMPLETED|Overall Study||4
3130511|NCT01682512|3855661|FG000|STARTED|Overall Study||116
3130512|NCT01682512|3855662|FG001|STARTED|Overall Study||111
3130513|NCT01682512|3855663|FG002|STARTED|Overall Study||66
3130514|NCT01682512|3855661|FG000|Randomized in Part-I|Overall Study||66
3130515|NCT01682512|3855662|FG001|Randomized in Part-I|Overall Study||65
3130516|NCT01682512|3855663|FG002|Randomized in Part-I|Overall Study||66
3130517|NCT01682512|3855661|FG000|Randomized in Part-II|Overall Study||50
3130518|NCT01682512|3855662|FG001|Randomized in Part-II|Overall Study||46
3130519|NCT01682512|3855663|FG002|Randomized in Part-II|Overall Study||0
3130520|NCT01682512|3855661|FG000|COMPLETED|Overall Study||44
3130521|NCT01682512|3855662|FG001|COMPLETED|Overall Study||40
3130522|NCT01682512|3855663|FG002|COMPLETED|Overall Study||48
3130523|NCT01682512|3855661|FG000|NOT COMPLETED|Overall Study||72
3130524|NCT01682512|3855662|FG001|NOT COMPLETED|Overall Study||71
3130525|NCT01682512|3855663|FG002|NOT COMPLETED|Overall Study||18
3130526|NCT01682538|3855671|FG000|STARTED|Overall Study||12
3130527|NCT01682538|3855671|FG000|COMPLETED|Overall Study||12
3130528|NCT01682538|3855671|FG000|NOT COMPLETED|Overall Study||0
3130529|NCT01682603|3855686|FG000|STARTED|Overall Study||37
3130530|NCT01682603|3855686|FG000|COMPLETED|Overall Study||34
3130531|NCT01682603|3855686|FG000|NOT COMPLETED|Overall Study||3
3130532|NCT01682642|3855694|FG000|STARTED|Overall Study||61
3130533|NCT01682642|3855695|FG001|STARTED|Overall Study||59
3130534|NCT01682642|3855694|FG000|COMPLETED|Overall Study||61
3130535|NCT01682642|3855695|FG001|COMPLETED|Overall Study||58
3130536|NCT01682642|3855694|FG000|NOT COMPLETED|Overall Study||0
3130537|NCT01682642|3855695|FG001|NOT COMPLETED|Overall Study||1
3130538|NCT01682681|3855707|FG000|STARTED|Overall Study||1234
3130539|NCT01682681|3855707|FG000|Treated|Overall Study|2 Participants were not compliant with eligibility criteria|1232
3130540|NCT01682681|3855707|FG000|COMPLETED|Overall Study||902
3130541|NCT01682681|3855707|FG000|NOT COMPLETED|Overall Study||332
3130542|NCT01682720|3855715|FG000|STARTED|Overall Study||85
3130543|NCT01682720|3855716|FG001|STARTED|Overall Study||74
3130544|NCT01682720|3855717|FG002|STARTED|Overall Study||12
3130545|NCT01682720|3855718|FG003|STARTED|Overall Study||250
3130546|NCT01682720|3855715|FG000|Included in Full Analysis Set|Overall Study||0
3130547|NCT01682720|3855716|FG001|Included in Full Analysis Set|Overall Study||73
3130548|NCT01682720|3855717|FG002|Included in Full Analysis Set|Overall Study||11
3130549|NCT01682720|3855718|FG003|Included in Full Analysis Set|Overall Study||250
3130550|NCT01682720|3855715|FG000|COMPLETED|Overall Study||0
3130551|NCT01682720|3855716|FG001|COMPLETED|Overall Study||69
3130552|NCT01682720|3855717|FG002|COMPLETED|Overall Study||5
3130553|NCT01682720|3855718|FG003|COMPLETED|Overall Study||211
3130554|NCT01682720|3855715|FG000|NOT COMPLETED|Overall Study||85
3130555|NCT01682720|3855716|FG001|NOT COMPLETED|Overall Study||5
3130556|NCT01682720|3855717|FG002|NOT COMPLETED|Overall Study||7
3130557|NCT01682720|3855718|FG003|NOT COMPLETED|Overall Study||39
3130558|NCT01682759|3855730|FG000|STARTED|Overall Study||376
3130559|NCT01682759|3855731|FG001|STARTED|Overall Study||375
3130560|NCT01682759|3855730|FG000|Treated|Overall Study||375
3130561|NCT01682759|3855731|FG001|Treated|Overall Study||375
3130562|NCT01682759|3855730|FG000|COMPLETED|Overall Study||307
3130563|NCT01682759|3855731|FG001|COMPLETED|Overall Study||305
3130564|NCT01682759|3855730|FG000|NOT COMPLETED|Overall Study||69
3130565|NCT01682759|3855731|FG001|NOT COMPLETED|Overall Study||70
3130566|NCT01682811|3855744|FG000|STARTED|Part 1 Levulan Injection||1
3130567|NCT01682811|3855745|FG001|STARTED|Part 1 Levulan Injection||0
3130568|NCT01682811|3855746|FG002|STARTED|Part 1 Levulan Injection||0
3130569|NCT01682811|3855747|FG003|STARTED|Part 1 Levulan Injection||0
3130570|NCT01682811|3855748|FG004|STARTED|Part 1 Levulan Injection||0
3130571|NCT01682811|3855749|FG005|STARTED|Part 1 Levulan Injection||0
3130572|NCT01682811|3855750|FG006|STARTED|Part 1 Levulan Injection||0
3130573|NCT01682811|3855744|FG000|Control|Part 1 Levulan Injection||1
3130574|NCT01682811|3855745|FG001|Control|Part 1 Levulan Injection||0
3130575|NCT01682811|3855746|FG002|Control|Part 1 Levulan Injection||0
3130576|NCT01682811|3855747|FG003|Control|Part 1 Levulan Injection||0
3130577|NCT01682811|3855748|FG004|Control|Part 1 Levulan Injection||0
3130578|NCT01682811|3855749|FG005|Control|Part 1 Levulan Injection||0
3130579|NCT01682811|3855750|FG006|Control|Part 1 Levulan Injection||0
3130580|NCT01682811|3855744|FG000|Treated 3 Hours|Part 1 Levulan Injection||1
3130581|NCT01682811|3855745|FG001|Treated 3 Hours|Part 1 Levulan Injection||0
3130582|NCT01682811|3855746|FG002|Treated 3 Hours|Part 1 Levulan Injection||0
3130583|NCT01682811|3855747|FG003|Treated 3 Hours|Part 1 Levulan Injection||0
3130584|NCT01682811|3855748|FG004|Treated 3 Hours|Part 1 Levulan Injection||0
3130585|NCT01682811|3855749|FG005|Treated 3 Hours|Part 1 Levulan Injection||0
3130586|NCT01682811|3855750|FG006|Treated 3 Hours|Part 1 Levulan Injection||0
3130587|NCT01682811|3855744|FG000|Treated 24 Hours|Part 1 Levulan Injection||1
3130588|NCT01682811|3855745|FG001|Treated 24 Hours|Part 1 Levulan Injection||0
3130589|NCT01682811|3855746|FG002|Treated 24 Hours|Part 1 Levulan Injection||0
3130590|NCT01682811|3855747|FG003|Treated 24 Hours|Part 1 Levulan Injection||0
3130591|NCT01682811|3855748|FG004|Treated 24 Hours|Part 1 Levulan Injection||0
3130592|NCT01682811|3855749|FG005|Treated 24 Hours|Part 1 Levulan Injection||0
3130593|NCT01682811|3855750|FG006|Treated 24 Hours|Part 1 Levulan Injection||0
3130594|NCT01682811|3855744|FG000|COMPLETED|Part 1 Levulan Injection||1
3130595|NCT01682811|3855745|FG001|COMPLETED|Part 1 Levulan Injection||0
3130596|NCT01682811|3855746|FG002|COMPLETED|Part 1 Levulan Injection||0
3130597|NCT01682811|3855747|FG003|COMPLETED|Part 1 Levulan Injection||0
3130598|NCT01682811|3855748|FG004|COMPLETED|Part 1 Levulan Injection||0
3130599|NCT01682811|3855749|FG005|COMPLETED|Part 1 Levulan Injection||0
3130600|NCT01682811|3855750|FG006|COMPLETED|Part 1 Levulan Injection||0
3130601|NCT01682811|3855744|FG000|NOT COMPLETED|Part 1 Levulan Injection||0
3130602|NCT01682811|3855745|FG001|NOT COMPLETED|Part 1 Levulan Injection||0
3130603|NCT01682811|3855746|FG002|NOT COMPLETED|Part 1 Levulan Injection||0
3130604|NCT01682811|3855747|FG003|NOT COMPLETED|Part 1 Levulan Injection||0
3296546|NCT02906670|4030256|FG008|STARTED|Cohort 5P, QW||0
3296547|NCT02906670|4030257|FG009|STARTED|Cohort 5P, QW||0
3296548|NCT02906670|4030248|FG000|COMPLETED|Cohort 5P, QW||0
3296549|NCT02906670|4030249|FG001|COMPLETED|Cohort 5P, QW||0
3296550|NCT02906670|4030250|FG002|COMPLETED|Cohort 5P, QW||0
3296551|NCT02906670|4030251|FG003|COMPLETED|Cohort 5P, QW||0
3296552|NCT02906670|4030252|FG004|COMPLETED|Cohort 5P, QW||0
3130605|NCT01682811|3855748|FG004|NOT COMPLETED|Part 1 Levulan Injection||0
3130606|NCT01682811|3855749|FG005|NOT COMPLETED|Part 1 Levulan Injection||0
3130607|NCT01682811|3855750|FG006|NOT COMPLETED|Part 1 Levulan Injection||0
3130608|NCT01682811|3855744|FG000|STARTED|Part 1 Levulan Painting||0
3130609|NCT01682811|3855745|FG001|STARTED|Part 1 Levulan Painting||1
3130610|NCT01682811|3855746|FG002|STARTED|Part 1 Levulan Painting||0
3130611|NCT01682811|3855747|FG003|STARTED|Part 1 Levulan Painting||0
3130612|NCT01682811|3855748|FG004|STARTED|Part 1 Levulan Painting||0
3130613|NCT01682811|3855749|FG005|STARTED|Part 1 Levulan Painting||0
3130614|NCT01682811|3855750|FG006|STARTED|Part 1 Levulan Painting||0
3130615|NCT01682811|3855744|FG000|Control|Part 1 Levulan Painting||0
3130616|NCT01682811|3855745|FG001|Control|Part 1 Levulan Painting||1
3130617|NCT01682811|3855746|FG002|Control|Part 1 Levulan Painting||0
3130618|NCT01682811|3855747|FG003|Control|Part 1 Levulan Painting||0
3130619|NCT01682811|3855748|FG004|Control|Part 1 Levulan Painting||0
3130620|NCT01682811|3855749|FG005|Control|Part 1 Levulan Painting||0
3130621|NCT01682811|3855750|FG006|Control|Part 1 Levulan Painting||0
3130622|NCT01682811|3855744|FG000|Treated 3 Hours|Part 1 Levulan Painting||0
3130623|NCT01682811|3855745|FG001|Treated 3 Hours|Part 1 Levulan Painting||1
3130624|NCT01682811|3855746|FG002|Treated 3 Hours|Part 1 Levulan Painting||0
3130625|NCT01682811|3855747|FG003|Treated 3 Hours|Part 1 Levulan Painting||0
3130626|NCT01682811|3855748|FG004|Treated 3 Hours|Part 1 Levulan Painting||0
3130627|NCT01682811|3855749|FG005|Treated 3 Hours|Part 1 Levulan Painting||0
3130628|NCT01682811|3855750|FG006|Treated 3 Hours|Part 1 Levulan Painting||0
3130629|NCT01682811|3855744|FG000|Treated 24 Hours|Part 1 Levulan Painting||0
3130630|NCT01682811|3855745|FG001|Treated 24 Hours|Part 1 Levulan Painting||1
3130631|NCT01682811|3855746|FG002|Treated 24 Hours|Part 1 Levulan Painting||0
3130632|NCT01682811|3855747|FG003|Treated 24 Hours|Part 1 Levulan Painting||0
3130633|NCT01682811|3855748|FG004|Treated 24 Hours|Part 1 Levulan Painting||0
3130634|NCT01682811|3855749|FG005|Treated 24 Hours|Part 1 Levulan Painting||0
3130635|NCT01682811|3855750|FG006|Treated 24 Hours|Part 1 Levulan Painting||0
3130636|NCT01682811|3855744|FG000|COMPLETED|Part 1 Levulan Painting||0
3130637|NCT01682811|3855745|FG001|COMPLETED|Part 1 Levulan Painting||1
3130638|NCT01682811|3855746|FG002|COMPLETED|Part 1 Levulan Painting||0
3130639|NCT01682811|3855747|FG003|COMPLETED|Part 1 Levulan Painting||0
3130640|NCT01682811|3855748|FG004|COMPLETED|Part 1 Levulan Painting||0
3130641|NCT01682811|3855749|FG005|COMPLETED|Part 1 Levulan Painting||0
3130642|NCT01682811|3855750|FG006|COMPLETED|Part 1 Levulan Painting||0
3130643|NCT01682811|3855744|FG000|NOT COMPLETED|Part 1 Levulan Painting||0
3130644|NCT01682811|3855745|FG001|NOT COMPLETED|Part 1 Levulan Painting||0
3130645|NCT01682811|3855746|FG002|NOT COMPLETED|Part 1 Levulan Painting||0
3130646|NCT01682811|3855747|FG003|NOT COMPLETED|Part 1 Levulan Painting||0
3130647|NCT01682811|3855748|FG004|NOT COMPLETED|Part 1 Levulan Painting||0
3130648|NCT01682811|3855749|FG005|NOT COMPLETED|Part 1 Levulan Painting||0
3130649|NCT01682811|3855750|FG006|NOT COMPLETED|Part 1 Levulan Painting||0
3130650|NCT01682811|3855744|FG000|STARTED|Part 1 Levulan Painted Twice||0
3130651|NCT01682811|3855745|FG001|STARTED|Part 1 Levulan Painted Twice||0
3130652|NCT01682811|3855746|FG002|STARTED|Part 1 Levulan Painted Twice||2
3296553|NCT02906670|4030253|FG005|COMPLETED|Cohort 5P, QW||0
3130653|NCT01682811|3855747|FG003|STARTED|Part 1 Levulan Painted Twice||0
3130654|NCT01682811|3855748|FG004|STARTED|Part 1 Levulan Painted Twice||0
3130655|NCT01682811|3855749|FG005|STARTED|Part 1 Levulan Painted Twice||0
3130656|NCT01682811|3855750|FG006|STARTED|Part 1 Levulan Painted Twice||0
3130657|NCT01682811|3855744|FG000|Control|Part 1 Levulan Painted Twice||0
3130658|NCT01682811|3855745|FG001|Control|Part 1 Levulan Painted Twice||0
3130659|NCT01682811|3855746|FG002|Control|Part 1 Levulan Painted Twice||2
3130660|NCT01682811|3855747|FG003|Control|Part 1 Levulan Painted Twice||0
3130661|NCT01682811|3855748|FG004|Control|Part 1 Levulan Painted Twice||0
3130662|NCT01682811|3855749|FG005|Control|Part 1 Levulan Painted Twice||0
3130663|NCT01682811|3855750|FG006|Control|Part 1 Levulan Painted Twice||0
3130664|NCT01682811|3855744|FG000|Treated 24 Hours|Part 1 Levulan Painted Twice||0
3130665|NCT01682811|3855745|FG001|Treated 24 Hours|Part 1 Levulan Painted Twice||0
3130666|NCT01682811|3855746|FG002|Treated 24 Hours|Part 1 Levulan Painted Twice||2
3130667|NCT01682811|3855747|FG003|Treated 24 Hours|Part 1 Levulan Painted Twice||0
3130668|NCT01682811|3855748|FG004|Treated 24 Hours|Part 1 Levulan Painted Twice||0
3130669|NCT01682811|3855749|FG005|Treated 24 Hours|Part 1 Levulan Painted Twice||0
3130670|NCT01682811|3855750|FG006|Treated 24 Hours|Part 1 Levulan Painted Twice||0
3130671|NCT01682811|3855744|FG000|COMPLETED|Part 1 Levulan Painted Twice||0
3130672|NCT01682811|3855745|FG001|COMPLETED|Part 1 Levulan Painted Twice||0
3130673|NCT01682811|3855746|FG002|COMPLETED|Part 1 Levulan Painted Twice||2
3130674|NCT01682811|3855747|FG003|COMPLETED|Part 1 Levulan Painted Twice||0
3130675|NCT01682811|3855748|FG004|COMPLETED|Part 1 Levulan Painted Twice||0
3296554|NCT02906670|4030254|FG006|COMPLETED|Cohort 5P, QW||0
3296555|NCT02906670|4030255|FG007|COMPLETED|Cohort 5P, QW||0
3296556|NCT02906670|4030256|FG008|COMPLETED|Cohort 5P, QW||0
3296557|NCT02906670|4030257|FG009|COMPLETED|Cohort 5P, QW||0
3296558|NCT02906670|4030248|FG000|NOT COMPLETED|Cohort 5P, QW||0
3130676|NCT01682811|3855749|FG005|COMPLETED|Part 1 Levulan Painted Twice||0
3130677|NCT01682811|3855750|FG006|COMPLETED|Part 1 Levulan Painted Twice||0
3130678|NCT01682811|3855744|FG000|NOT COMPLETED|Part 1 Levulan Painted Twice||0
3130679|NCT01682811|3855745|FG001|NOT COMPLETED|Part 1 Levulan Painted Twice||0
3130680|NCT01682811|3855746|FG002|NOT COMPLETED|Part 1 Levulan Painted Twice||0
3130681|NCT01682811|3855747|FG003|NOT COMPLETED|Part 1 Levulan Painted Twice||0
3130682|NCT01682811|3855748|FG004|NOT COMPLETED|Part 1 Levulan Painted Twice||0
3130683|NCT01682811|3855749|FG005|NOT COMPLETED|Part 1 Levulan Painted Twice||0
3130684|NCT01682811|3855750|FG006|NOT COMPLETED|Part 1 Levulan Painted Twice||0
3130685|NCT01682811|3855744|FG000|STARTED|Part 1 Levulan Paint Twice Microneedling||0
3130686|NCT01682811|3855745|FG001|STARTED|Part 1 Levulan Paint Twice Microneedling||0
3130687|NCT01682811|3855746|FG002|STARTED|Part 1 Levulan Paint Twice Microneedling||0
3130688|NCT01682811|3855747|FG003|STARTED|Part 1 Levulan Paint Twice Microneedling||2
3130689|NCT01682811|3855748|FG004|STARTED|Part 1 Levulan Paint Twice Microneedling||0
3130690|NCT01682811|3855749|FG005|STARTED|Part 1 Levulan Paint Twice Microneedling||0
3130691|NCT01682811|3855750|FG006|STARTED|Part 1 Levulan Paint Twice Microneedling||0
3130692|NCT01682811|3855744|FG000|Control|Part 1 Levulan Paint Twice Microneedling||0
3130693|NCT01682811|3855745|FG001|Control|Part 1 Levulan Paint Twice Microneedling||0
3130694|NCT01682811|3855746|FG002|Control|Part 1 Levulan Paint Twice Microneedling||0
3130695|NCT01682811|3855747|FG003|Control|Part 1 Levulan Paint Twice Microneedling||2
3130696|NCT01682811|3855748|FG004|Control|Part 1 Levulan Paint Twice Microneedling||0
3130697|NCT01682811|3855749|FG005|Control|Part 1 Levulan Paint Twice Microneedling||0
3130698|NCT01682811|3855750|FG006|Control|Part 1 Levulan Paint Twice Microneedling||0
3130699|NCT01682811|3855744|FG000|Treated 24 Hours|Part 1 Levulan Paint Twice Microneedling||0
3130700|NCT01682811|3855745|FG001|Treated 24 Hours|Part 1 Levulan Paint Twice Microneedling||0
3130701|NCT01682811|3855746|FG002|Treated 24 Hours|Part 1 Levulan Paint Twice Microneedling||0
3130702|NCT01682811|3855747|FG003|Treated 24 Hours|Part 1 Levulan Paint Twice Microneedling||2
3130703|NCT01682811|3855748|FG004|Treated 24 Hours|Part 1 Levulan Paint Twice Microneedling||0
3130704|NCT01682811|3855749|FG005|Treated 24 Hours|Part 1 Levulan Paint Twice Microneedling||0
3130705|NCT01682811|3855750|FG006|Treated 24 Hours|Part 1 Levulan Paint Twice Microneedling||0
3130706|NCT01682811|3855744|FG000|COMPLETED|Part 1 Levulan Paint Twice Microneedling||0
3130707|NCT01682811|3855745|FG001|COMPLETED|Part 1 Levulan Paint Twice Microneedling||0
3130708|NCT01682811|3855746|FG002|COMPLETED|Part 1 Levulan Paint Twice Microneedling||0
3130709|NCT01682811|3855747|FG003|COMPLETED|Part 1 Levulan Paint Twice Microneedling||2
3130710|NCT01682811|3855748|FG004|COMPLETED|Part 1 Levulan Paint Twice Microneedling||0
3130711|NCT01682811|3855749|FG005|COMPLETED|Part 1 Levulan Paint Twice Microneedling||0
3130712|NCT01682811|3855750|FG006|COMPLETED|Part 1 Levulan Paint Twice Microneedling||0
3130713|NCT01682811|3855744|FG000|NOT COMPLETED|Part 1 Levulan Paint Twice Microneedling||0
3130714|NCT01682811|3855745|FG001|NOT COMPLETED|Part 1 Levulan Paint Twice Microneedling||0
3130715|NCT01682811|3855746|FG002|NOT COMPLETED|Part 1 Levulan Paint Twice Microneedling||0
3130716|NCT01682811|3855747|FG003|NOT COMPLETED|Part 1 Levulan Paint Twice Microneedling||0
3130717|NCT01682811|3855748|FG004|NOT COMPLETED|Part 1 Levulan Paint Twice Microneedling||0
3130718|NCT01682811|3855749|FG005|NOT COMPLETED|Part 1 Levulan Paint Twice Microneedling||0
3130719|NCT01682811|3855750|FG006|NOT COMPLETED|Part 1 Levulan Paint Twice Microneedling||0
3130720|NCT01682811|3855744|FG000|STARTED|Part 2 Dose Level 1||0
3130721|NCT01682811|3855745|FG001|STARTED|Part 2 Dose Level 1||0
3130722|NCT01682811|3855746|FG002|STARTED|Part 2 Dose Level 1||0
3130723|NCT01682811|3855747|FG003|STARTED|Part 2 Dose Level 1||0
3130724|NCT01682811|3855748|FG004|STARTED|Part 2 Dose Level 1||11
3130725|NCT01682811|3855749|FG005|STARTED|Part 2 Dose Level 1||0
3130726|NCT01682811|3855750|FG006|STARTED|Part 2 Dose Level 1||0
3130727|NCT01682811|3855744|FG000|Control|Part 2 Dose Level 1||0
3130728|NCT01682811|3855745|FG001|Control|Part 2 Dose Level 1||0
3130729|NCT01682811|3855746|FG002|Control|Part 2 Dose Level 1||0
3130730|NCT01682811|3855747|FG003|Control|Part 2 Dose Level 1||0
3130731|NCT01682811|3855748|FG004|Control|Part 2 Dose Level 1||10
3130732|NCT01682811|3855749|FG005|Control|Part 2 Dose Level 1||0
3130733|NCT01682811|3855750|FG006|Control|Part 2 Dose Level 1||0
3130734|NCT01682811|3855744|FG000|Treated|Part 2 Dose Level 1||0
3130735|NCT01682811|3855745|FG001|Treated|Part 2 Dose Level 1||0
3130736|NCT01682811|3855746|FG002|Treated|Part 2 Dose Level 1||0
3130737|NCT01682811|3855747|FG003|Treated|Part 2 Dose Level 1||0
3130738|NCT01682811|3855748|FG004|Treated|Part 2 Dose Level 1||10
3130739|NCT01682811|3855749|FG005|Treated|Part 2 Dose Level 1||0
3130740|NCT01682811|3855750|FG006|Treated|Part 2 Dose Level 1||0
3130741|NCT01682811|3855744|FG000|COMPLETED|Part 2 Dose Level 1||0
3130742|NCT01682811|3855745|FG001|COMPLETED|Part 2 Dose Level 1||0
3130743|NCT01682811|3855746|FG002|COMPLETED|Part 2 Dose Level 1||0
3296559|NCT02906670|4030249|FG001|NOT COMPLETED|Cohort 5P, QW||0
3296560|NCT02906670|4030250|FG002|NOT COMPLETED|Cohort 5P, QW||0
3296561|NCT02906670|4030251|FG003|NOT COMPLETED|Cohort 5P, QW||0
3296562|NCT02906670|4030252|FG004|NOT COMPLETED|Cohort 5P, QW||3
3296563|NCT02906670|4030253|FG005|NOT COMPLETED|Cohort 5P, QW||0
3296564|NCT02906670|4030254|FG006|NOT COMPLETED|Cohort 5P, QW||0
3296565|NCT02906670|4030255|FG007|NOT COMPLETED|Cohort 5P, QW||0
3296566|NCT02906670|4030256|FG008|NOT COMPLETED|Cohort 5P, QW||0
3296567|NCT02906670|4030257|FG009|NOT COMPLETED|Cohort 5P, QW||0
3296568|NCT02906696|4030307|FG000|STARTED|Overall Study||8
3296569|NCT02906696|4030307|FG000|COMPLETED|Overall Study||8
3130744|NCT01682811|3855747|FG003|COMPLETED|Part 2 Dose Level 1||0
3130745|NCT01682811|3855748|FG004|COMPLETED|Part 2 Dose Level 1||0
3130746|NCT01682811|3855749|FG005|COMPLETED|Part 2 Dose Level 1||0
3130747|NCT01682811|3855750|FG006|COMPLETED|Part 2 Dose Level 1||0
3130748|NCT01682811|3855744|FG000|NOT COMPLETED|Part 2 Dose Level 1||0
3130749|NCT01682811|3855745|FG001|NOT COMPLETED|Part 2 Dose Level 1||0
3130750|NCT01682811|3855746|FG002|NOT COMPLETED|Part 2 Dose Level 1||0
3130751|NCT01682811|3855747|FG003|NOT COMPLETED|Part 2 Dose Level 1||0
3130752|NCT01682811|3855748|FG004|NOT COMPLETED|Part 2 Dose Level 1||11
3130753|NCT01682811|3855749|FG005|NOT COMPLETED|Part 2 Dose Level 1||0
3130754|NCT01682811|3855750|FG006|NOT COMPLETED|Part 2 Dose Level 1||0
3130755|NCT01682811|3855744|FG000|STARTED|Part 2 Dose Level 2||0
3130756|NCT01682811|3855745|FG001|STARTED|Part 2 Dose Level 2||0
3130757|NCT01682811|3855746|FG002|STARTED|Part 2 Dose Level 2||0
3130758|NCT01682811|3855747|FG003|STARTED|Part 2 Dose Level 2||0
3130759|NCT01682811|3855748|FG004|STARTED|Part 2 Dose Level 2||0
3130760|NCT01682811|3855749|FG005|STARTED|Part 2 Dose Level 2||3
3130761|NCT01682811|3855750|FG006|STARTED|Part 2 Dose Level 2||0
3130762|NCT01682811|3855744|FG000|Control|Part 2 Dose Level 2||0
3130763|NCT01682811|3855745|FG001|Control|Part 2 Dose Level 2||0
3130764|NCT01682811|3855746|FG002|Control|Part 2 Dose Level 2||0
3130765|NCT01682811|3855747|FG003|Control|Part 2 Dose Level 2||0
3130766|NCT01682811|3855748|FG004|Control|Part 2 Dose Level 2||0
3130767|NCT01682811|3855749|FG005|Control|Part 2 Dose Level 2||3
3130768|NCT01682811|3855750|FG006|Control|Part 2 Dose Level 2||0
3130769|NCT01682811|3855744|FG000|Treated|Part 2 Dose Level 2||0
3130770|NCT01682811|3855745|FG001|Treated|Part 2 Dose Level 2||0
3130771|NCT01682811|3855746|FG002|Treated|Part 2 Dose Level 2||0
3130772|NCT01682811|3855747|FG003|Treated|Part 2 Dose Level 2||0
3130773|NCT01682811|3855748|FG004|Treated|Part 2 Dose Level 2||0
3130774|NCT01682811|3855749|FG005|Treated|Part 2 Dose Level 2||3
3130775|NCT01682811|3855750|FG006|Treated|Part 2 Dose Level 2||0
3130776|NCT01682811|3855744|FG000|COMPLETED|Part 2 Dose Level 2||0
3130777|NCT01682811|3855745|FG001|COMPLETED|Part 2 Dose Level 2||0
3130778|NCT01682811|3855746|FG002|COMPLETED|Part 2 Dose Level 2||0
3130779|NCT01682811|3855747|FG003|COMPLETED|Part 2 Dose Level 2||0
3130780|NCT01682811|3855748|FG004|COMPLETED|Part 2 Dose Level 2||0
3130781|NCT01682811|3855749|FG005|COMPLETED|Part 2 Dose Level 2||0
3130782|NCT01682811|3855750|FG006|COMPLETED|Part 2 Dose Level 2||0
3130783|NCT01682811|3855744|FG000|NOT COMPLETED|Part 2 Dose Level 2||0
3130784|NCT01682811|3855745|FG001|NOT COMPLETED|Part 2 Dose Level 2||0
3130785|NCT01682811|3855746|FG002|NOT COMPLETED|Part 2 Dose Level 2||0
3130786|NCT01682811|3855747|FG003|NOT COMPLETED|Part 2 Dose Level 2||0
3130787|NCT01682811|3855748|FG004|NOT COMPLETED|Part 2 Dose Level 2||0
3130788|NCT01682811|3855749|FG005|NOT COMPLETED|Part 2 Dose Level 2||3
3130789|NCT01682811|3855750|FG006|NOT COMPLETED|Part 2 Dose Level 2||0
3130790|NCT01682811|3855744|FG000|STARTED|Part 2 Dose Level 3||0
3130791|NCT01682811|3855745|FG001|STARTED|Part 2 Dose Level 3||0
3130792|NCT01682811|3855746|FG002|STARTED|Part 2 Dose Level 3||0
3130793|NCT01682811|3855747|FG003|STARTED|Part 2 Dose Level 3||0
3130794|NCT01682811|3855748|FG004|STARTED|Part 2 Dose Level 3||0
3130795|NCT01682811|3855749|FG005|STARTED|Part 2 Dose Level 3||0
3130796|NCT01682811|3855750|FG006|STARTED|Part 2 Dose Level 3||0
3130797|NCT01682811|3855744|FG000|Control|Part 2 Dose Level 3||0
3130798|NCT01682811|3855745|FG001|Control|Part 2 Dose Level 3||0
3130799|NCT01682811|3855746|FG002|Control|Part 2 Dose Level 3||0
3130800|NCT01682811|3855747|FG003|Control|Part 2 Dose Level 3||0
3130801|NCT01682811|3855748|FG004|Control|Part 2 Dose Level 3||0
3130802|NCT01682811|3855749|FG005|Control|Part 2 Dose Level 3||0
3130803|NCT01682811|3855750|FG006|Control|Part 2 Dose Level 3||0
3130804|NCT01682811|3855744|FG000|Treated|Part 2 Dose Level 3||0
3130805|NCT01682811|3855745|FG001|Treated|Part 2 Dose Level 3||0
3130806|NCT01682811|3855746|FG002|Treated|Part 2 Dose Level 3||0
3130807|NCT01682811|3855747|FG003|Treated|Part 2 Dose Level 3||0
3130808|NCT01682811|3855748|FG004|Treated|Part 2 Dose Level 3||0
3130809|NCT01682811|3855749|FG005|Treated|Part 2 Dose Level 3||0
3130810|NCT01682811|3855750|FG006|Treated|Part 2 Dose Level 3||0
3130811|NCT01682811|3855744|FG000|COMPLETED|Part 2 Dose Level 3||0
3130812|NCT01682811|3855745|FG001|COMPLETED|Part 2 Dose Level 3||0
3130813|NCT01682811|3855746|FG002|COMPLETED|Part 2 Dose Level 3||0
3130814|NCT01682811|3855747|FG003|COMPLETED|Part 2 Dose Level 3||0
3130815|NCT01682811|3855748|FG004|COMPLETED|Part 2 Dose Level 3||0
3130816|NCT01682811|3855749|FG005|COMPLETED|Part 2 Dose Level 3||0
3130817|NCT01682811|3855750|FG006|COMPLETED|Part 2 Dose Level 3||0
3130818|NCT01682811|3855744|FG000|NOT COMPLETED|Part 2 Dose Level 3||0
3130819|NCT01682811|3855745|FG001|NOT COMPLETED|Part 2 Dose Level 3||0
3130820|NCT01682811|3855746|FG002|NOT COMPLETED|Part 2 Dose Level 3||0
3130821|NCT01682811|3855747|FG003|NOT COMPLETED|Part 2 Dose Level 3||0
3130822|NCT01682811|3855748|FG004|NOT COMPLETED|Part 2 Dose Level 3||0
3130823|NCT01682811|3855749|FG005|NOT COMPLETED|Part 2 Dose Level 3||0
3130824|NCT01682811|3855750|FG006|NOT COMPLETED|Part 2 Dose Level 3||0
3130825|NCT01682837|3855769|FG000|STARTED|Baseline||35
3130826|NCT01682837|3855769|FG000|COMPLETED|Baseline||30
3130827|NCT01682837|3855769|FG000|NOT COMPLETED|Baseline||5
3130828|NCT01682837|3855769|FG000|STARTED|First Intervention (4 Weeks)||30
3130829|NCT01682837|3855769|FG000|Received KMgCit|First Intervention (4 Weeks)||8
3130830|NCT01682837|3855769|FG000|Received KCit|First Intervention (4 Weeks)||8
3130831|NCT01682837|3855769|FG000|Received KCl|First Intervention (4 Weeks)||7
3296570|NCT02906696|4030307|FG000|NOT COMPLETED|Overall Study||0
3296571|NCT02906709|4030313|FG000|STARTED|Phase A (Week 0 to Week 16)||123
3296572|NCT02906709|4030314|FG001|STARTED|Phase A (Week 0 to Week 16)||61
3296573|NCT02906709|4030313|FG000|COMPLETED|Phase A (Week 0 to Week 16)||122
3296574|NCT02906709|4030314|FG001|COMPLETED|Phase A (Week 0 to Week 16)||58
3296575|NCT02906709|4030313|FG000|NOT COMPLETED|Phase A (Week 0 to Week 16)||1
3296576|NCT02906709|4030314|FG001|NOT COMPLETED|Phase A (Week 0 to Week 16)||3
3296577|NCT02906709|4030313|FG000|STARTED|Phase B (Extension, Week 17 to Week 52)||122
3296578|NCT02906709|4030314|FG001|STARTED|Phase B (Extension, Week 17 to Week 52)||58
3296579|NCT02906709|4030313|FG000|COMPLETED|Phase B (Extension, Week 17 to Week 52)||117
3296580|NCT02906709|4030314|FG001|COMPLETED|Phase B (Extension, Week 17 to Week 52)||58
3130832|NCT01682837|3855769|FG000|Received Placebo|First Intervention (4 Weeks)||7
3130833|NCT01682837|3855769|FG000|COMPLETED|First Intervention (4 Weeks)||30
3130834|NCT01682837|3855769|FG000|NOT COMPLETED|First Intervention (4 Weeks)||0
3130835|NCT01682837|3855769|FG000|STARTED|Second Intervention (4 Weeks)||30
3130836|NCT01682837|3855769|FG000|Received KMgCit|Second Intervention (4 Weeks)||7
3130837|NCT01682837|3855769|FG000|Received KCit|Second Intervention (4 Weeks)||6
3130838|NCT01682837|3855769|FG000|Received KCl|Second Intervention (4 Weeks)||8
3130839|NCT01682837|3855769|FG000|Received Placebo|Second Intervention (4 Weeks)||9
3130840|NCT01682837|3855769|FG000|COMPLETED|Second Intervention (4 Weeks)||30
3130841|NCT01682837|3855769|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||0
3130842|NCT01682837|3855769|FG000|STARTED|Third Intervention (4 Weeks)||30
3130843|NCT01682837|3855769|FG000|Received KMgCit|Third Intervention (4 Weeks)||9
3130844|NCT01682837|3855769|FG000|Received KCit|Third Intervention (4 Weeks)||7
3130845|NCT01682837|3855769|FG000|Received KCl|Third Intervention (4 Weeks)||7
3130846|NCT01682837|3855769|FG000|Received Placebo|Third Intervention (4 Weeks)||7
3130847|NCT01682837|3855769|FG000|COMPLETED|Third Intervention (4 Weeks)||30
3130848|NCT01682837|3855769|FG000|NOT COMPLETED|Third Intervention (4 Weeks)||0
3130849|NCT01682837|3855769|FG000|STARTED|Fourth Intervention (4 Weeks)||30
3130850|NCT01682837|3855769|FG000|Received KMgCit|Fourth Intervention (4 Weeks)||6
3130851|NCT01682837|3855769|FG000|Received KCit|Fourth Intervention (4 Weeks)||9
3130852|NCT01682837|3855769|FG000|Received KCl|Fourth Intervention (4 Weeks)||8
3130853|NCT01682837|3855769|FG000|Received Placebo|Fourth Intervention (4 Weeks)||7
3130854|NCT01682837|3855769|FG000|COMPLETED|Fourth Intervention (4 Weeks)||30
3130855|NCT01682837|3855769|FG000|NOT COMPLETED|Fourth Intervention (4 Weeks)||0
3130856|NCT01682863|3855782|FG000|STARTED|Overall Study||204
3130857|NCT01682863|3855783|FG001|STARTED|Overall Study||204
3130858|NCT01682863|3855784|FG002|STARTED|Overall Study||207
3130859|NCT01682863|3855782|FG000|Safety Set|Overall Study||204
3130860|NCT01682863|3855783|FG001|Safety Set|Overall Study||204
3130861|NCT01682863|3855784|FG002|Safety Set|Overall Study||206
3130862|NCT01682863|3855782|FG000|Full Analysis Set (FAS)|Overall Study|included all randomized patients who received at least one dose of study medication|204
3130863|NCT01682863|3855783|FG001|Full Analysis Set (FAS)|Overall Study||204
3130864|NCT01682863|3855784|FG002|Full Analysis Set (FAS)|Overall Study||206
3130865|NCT01682863|3855782|FG000|Randomized Set|Overall Study||204
3130866|NCT01682863|3855783|FG001|Randomized Set|Overall Study||204
3130867|NCT01682863|3855784|FG002|Randomized Set|Overall Study|1 randomized patient was not treated; experienced an AE prior to receiving any study drug|207
3130868|NCT01682863|3855782|FG000|COMPLETED|Overall Study||177
3130869|NCT01682863|3855783|FG001|COMPLETED|Overall Study||187
3130870|NCT01682863|3855784|FG002|COMPLETED|Overall Study||183
3130871|NCT01682863|3855782|FG000|NOT COMPLETED|Overall Study||27
3130872|NCT01682863|3855783|FG001|NOT COMPLETED|Overall Study||17
3130873|NCT01682863|3855784|FG002|NOT COMPLETED|Overall Study||24
3130874|NCT01682876|3855796|FG000|STARTED|Overall Study||176
3130875|NCT01682876|3855797|FG001|STARTED|Overall Study||183
3130876|NCT01682876|3855798|FG002|STARTED|Overall Study||180
3130877|NCT01682876|3855799|FG003|STARTED|Overall Study||176
3130878|NCT01682876|3855796|FG000|COMPLETED|Overall Study||155
3296581|NCT02906709|4030313|FG000|NOT COMPLETED|Phase B (Extension, Week 17 to Week 52)||5
3296582|NCT02906709|4030314|FG001|NOT COMPLETED|Phase B (Extension, Week 17 to Week 52)||0
3296583|NCT02906813|4030329|FG000|STARTED|Intervention Period 1 (3 Days)||3
3296584|NCT02906813|4030330|FG001|STARTED|Intervention Period 1 (3 Days)||3
3296585|NCT02906813|4030331|FG002|STARTED|Intervention Period 1 (3 Days)||3
3296586|NCT02906813|4030329|FG000|COMPLETED|Intervention Period 1 (3 Days)||3
3296587|NCT02906813|4030330|FG001|COMPLETED|Intervention Period 1 (3 Days)||3
3296588|NCT02906813|4030331|FG002|COMPLETED|Intervention Period 1 (3 Days)||3
3296589|NCT02906813|4030329|FG000|NOT COMPLETED|Intervention Period 1 (3 Days)||0
3296590|NCT02906813|4030330|FG001|NOT COMPLETED|Intervention Period 1 (3 Days)||0
3383597|NCT01763788|4118665|FG003|STARTED|Overall Study||92
3383598|NCT01763788|4118662|FG000|Received at Least 1dose of Study Drug|Overall Study||3
3383599|NCT01763788|4118663|FG001|Received at Least 1dose of Study Drug|Overall Study||6
3383600|NCT01763788|4118664|FG002|Received at Least 1dose of Study Drug|Overall Study||90
3383601|NCT01763788|4118665|FG003|Received at Least 1dose of Study Drug|Overall Study||91
3383602|NCT01763788|4118662|FG000|COMPLETED|Overall Study||3
3383603|NCT01763788|4118663|FG001|COMPLETED|Overall Study||6
3383604|NCT01763788|4118664|FG002|COMPLETED|Overall Study||90
3130879|NCT01682876|3855797|FG001|COMPLETED|Overall Study||163
3130880|NCT01682876|3855798|FG002|COMPLETED|Overall Study||169
3130881|NCT01682876|3855799|FG003|COMPLETED|Overall Study||157
3130882|NCT01682876|3855796|FG000|NOT COMPLETED|Overall Study||21
3130883|NCT01682876|3855797|FG001|NOT COMPLETED|Overall Study||20
3130884|NCT01682876|3855798|FG002|NOT COMPLETED|Overall Study||11
3130885|NCT01682876|3855799|FG003|NOT COMPLETED|Overall Study||19
3130886|NCT01682954|3855814|FG000|STARTED|Overall Study||40
3130887|NCT01682954|3855815|FG001|STARTED|Overall Study||38
3130888|NCT01682954|3855814|FG000|COMPLETED|Overall Study||35
3130889|NCT01682954|3855815|FG001|COMPLETED|Overall Study||33
3130890|NCT01682954|3855814|FG000|NOT COMPLETED|Overall Study||5
3130891|NCT01682954|3855815|FG001|NOT COMPLETED|Overall Study||5
3130892|NCT01683019|3855824|FG000|STARTED|Overall Study||18
3130893|NCT01683019|3855825|FG001|STARTED|Overall Study||15
3130894|NCT01683019|3855826|FG002|STARTED|Overall Study||19
3130895|NCT01683019|3855824|FG000|COMPLETED|Overall Study||16
3130896|NCT01683019|3855825|FG001|COMPLETED|Overall Study||14
3130897|NCT01683019|3855826|FG002|COMPLETED|Overall Study||15
3130898|NCT01683019|3855824|FG000|NOT COMPLETED|Overall Study||2
3130899|NCT01683019|3855825|FG001|NOT COMPLETED|Overall Study||1
3130900|NCT01683019|3855826|FG002|NOT COMPLETED|Overall Study||4
3130901|NCT01683058|3855834|FG000|STARTED|Overall Study||74
3130902|NCT01683058|3855834|FG000|COMPLETED|Overall Study||45
3130903|NCT01683058|3855834|FG000|NOT COMPLETED|Overall Study||29
3130904|NCT01683071|3855845|FG000|STARTED|Part 1||25
3130905|NCT01683071|3855846|FG001|STARTED|Part 1||26
3130906|NCT01683071|3855847|FG002|STARTED|Part 1||25
3130907|NCT01683071|3855848|FG003|STARTED|Part 1||25
3130908|NCT01683071|3855849|FG004|STARTED|Part 1||0
3130909|NCT01683071|3855850|FG005|STARTED|Part 1||0
3130910|NCT01683071|3855845|FG000|COMPLETED|Part 1||21
3130911|NCT01683071|3855846|FG001|COMPLETED|Part 1||22
3130912|NCT01683071|3855847|FG002|COMPLETED|Part 1||22
3130913|NCT01683071|3855848|FG003|COMPLETED|Part 1||20
3130914|NCT01683071|3855849|FG004|COMPLETED|Part 1||0
3130915|NCT01683071|3855850|FG005|COMPLETED|Part 1||0
3130916|NCT01683071|3855845|FG000|NOT COMPLETED|Part 1||4
3130917|NCT01683071|3855846|FG001|NOT COMPLETED|Part 1||4
3130918|NCT01683071|3855847|FG002|NOT COMPLETED|Part 1||3
3130919|NCT01683071|3855848|FG003|NOT COMPLETED|Part 1||5
3130920|NCT01683071|3855849|FG004|NOT COMPLETED|Part 1||0
3130921|NCT01683071|3855850|FG005|NOT COMPLETED|Part 1||0
3130922|NCT01683071|3855845|FG000|STARTED|Part 2||0
3130923|NCT01683071|3855846|FG001|STARTED|Part 2||0
3130924|NCT01683071|3855847|FG002|STARTED|Part 2||0
3130925|NCT01683071|3855848|FG003|STARTED|Part 2||0
3130926|NCT01683071|3855849|FG004|STARTED|Part 2||99
3130927|NCT01683071|3855850|FG005|STARTED|Part 2||97
3130928|NCT01683071|3855845|FG000|COMPLETED|Part 2||0
3130929|NCT01683071|3855846|FG001|COMPLETED|Part 2||0
3130930|NCT01683071|3855847|FG002|COMPLETED|Part 2||0
3130931|NCT01683071|3855848|FG003|COMPLETED|Part 2||0
3130932|NCT01683071|3855849|FG004|COMPLETED|Part 2||82
3130933|NCT01683071|3855850|FG005|COMPLETED|Part 2||82
3130934|NCT01683071|3855845|FG000|NOT COMPLETED|Part 2||0
3130935|NCT01683071|3855846|FG001|NOT COMPLETED|Part 2||0
3130936|NCT01683071|3855847|FG002|NOT COMPLETED|Part 2||0
3130937|NCT01683071|3855848|FG003|NOT COMPLETED|Part 2||0
3130938|NCT01683071|3855849|FG004|NOT COMPLETED|Part 2||17
3130939|NCT01683071|3855850|FG005|NOT COMPLETED|Part 2||15
3130940|NCT01683266|3855872|FG000|STARTED|Overall Study||274
3130941|NCT01683266|3855873|FG001|STARTED|Overall Study||275
3130942|NCT01683266|3855872|FG000|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|273
3130943|NCT01683266|3855873|FG001|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|273
3130944|NCT01683266|3855872|FG000|COMPLETED|Overall Study||219
3130945|NCT01683266|3855873|FG001|COMPLETED|Overall Study||225
3130946|NCT01683266|3855872|FG000|NOT COMPLETED|Overall Study||55
3130947|NCT01683266|3855873|FG001|NOT COMPLETED|Overall Study||50
3130948|NCT01683331|3855881|FG000|STARTED|Overall Study||18
3130949|NCT01683331|3855882|FG001|STARTED|Overall Study||18
3130950|NCT01683331|3855881|FG000|Began Dosage|Overall Study||18
3130951|NCT01683331|3855882|FG001|Began Dosage|Overall Study||18
3130952|NCT01683331|3855881|FG000|12 Months|Overall Study||18
3130953|NCT01683331|3855882|FG001|12 Months|Overall Study||18
3130954|NCT01683331|3855881|FG000|24 Months|Overall Study||18
3130955|NCT01683331|3855882|FG001|24 Months|Overall Study||18
3130956|NCT01683331|3855881|FG000|COMPLETED|Overall Study||18
3130957|NCT01683331|3855882|FG001|COMPLETED|Overall Study||18
3130958|NCT01683331|3855881|FG000|NOT COMPLETED|Overall Study||0
3130959|NCT01683331|3855882|FG001|NOT COMPLETED|Overall Study||0
3130960|NCT01683383|3855890|FG000|STARTED|Overall Study||50
3130961|NCT01683383|3855891|FG001|STARTED|Overall Study||51
3130962|NCT01683383|3855890|FG000|Transported and Treated|Overall Study||49
3130963|NCT01683383|3855891|FG001|Transported and Treated|Overall Study||51
3130964|NCT01683383|3855890|FG000|COMPLETED|Overall Study||49
3130965|NCT01683383|3855891|FG001|COMPLETED|Overall Study||51
3130966|NCT01683383|3855890|FG000|NOT COMPLETED|Overall Study||1
3130967|NCT01683383|3855891|FG001|NOT COMPLETED|Overall Study||0
3130968|NCT01683409|3855902|FG000|STARTED|Treatment Period (Weeks 1-24)||27
3130969|NCT01683409|3855903|FG001|STARTED|Treatment Period (Weeks 1-24)||25
3130970|NCT01683409|3855904|FG002|STARTED|Treatment Period (Weeks 1-24)||27
3130971|NCT01683409|3855905|FG003|STARTED|Treatment Period (Weeks 1-24)||26
3130972|NCT01683409|3855906|FG004|STARTED|Treatment Period (Weeks 1-24)||25
3130973|NCT01683409|3855902|FG000|Received at Least One Dose of Study Drug|Treatment Period (Weeks 1-24)||27
3130974|NCT01683409|3855903|FG001|Received at Least One Dose of Study Drug|Treatment Period (Weeks 1-24)||25
3130975|NCT01683409|3855904|FG002|Received at Least One Dose of Study Drug|Treatment Period (Weeks 1-24)||26
3130976|NCT01683409|3855905|FG003|Received at Least One Dose of Study Drug|Treatment Period (Weeks 1-24)||26
3130977|NCT01683409|3855906|FG004|Received at Least One Dose of Study Drug|Treatment Period (Weeks 1-24)||25
3130978|NCT01683409|3855902|FG000|COMPLETED|Treatment Period (Weeks 1-24)||27
3130979|NCT01683409|3855903|FG001|COMPLETED|Treatment Period (Weeks 1-24)||21
3130980|NCT01683409|3855904|FG002|COMPLETED|Treatment Period (Weeks 1-24)||26
3130981|NCT01683409|3855905|FG003|COMPLETED|Treatment Period (Weeks 1-24)||24
3130982|NCT01683409|3855906|FG004|COMPLETED|Treatment Period (Weeks 1-24)||23
3130983|NCT01683409|3855902|FG000|NOT COMPLETED|Treatment Period (Weeks 1-24)||0
3130984|NCT01683409|3855903|FG001|NOT COMPLETED|Treatment Period (Weeks 1-24)||4
3130985|NCT01683409|3855904|FG002|NOT COMPLETED|Treatment Period (Weeks 1-24)||1
3130986|NCT01683409|3855905|FG003|NOT COMPLETED|Treatment Period (Weeks 1-24)||2
3130987|NCT01683409|3855906|FG004|NOT COMPLETED|Treatment Period (Weeks 1-24)||2
3130988|NCT01683409|3855902|FG000|STARTED|Washout Period 1 (Weeks 25-28)||27
3130989|NCT01683409|3855903|FG001|STARTED|Washout Period 1 (Weeks 25-28)||21
3130990|NCT01683409|3855904|FG002|STARTED|Washout Period 1 (Weeks 25-28)||26
3130991|NCT01683409|3855905|FG003|STARTED|Washout Period 1 (Weeks 25-28)||24
3130992|NCT01683409|3855906|FG004|STARTED|Washout Period 1 (Weeks 25-28)||23
3130993|NCT01683409|3855902|FG000|COMPLETED|Washout Period 1 (Weeks 25-28)||24
3130994|NCT01683409|3855903|FG001|COMPLETED|Washout Period 1 (Weeks 25-28)||17
3130995|NCT01683409|3855904|FG002|COMPLETED|Washout Period 1 (Weeks 25-28)||25
3130996|NCT01683409|3855905|FG003|COMPLETED|Washout Period 1 (Weeks 25-28)||22
3130997|NCT01683409|3855906|FG004|COMPLETED|Washout Period 1 (Weeks 25-28)||20
3130998|NCT01683409|3855902|FG000|NOT COMPLETED|Washout Period 1 (Weeks 25-28)||3
3130999|NCT01683409|3855903|FG001|NOT COMPLETED|Washout Period 1 (Weeks 25-28)||4
3131000|NCT01683409|3855904|FG002|NOT COMPLETED|Washout Period 1 (Weeks 25-28)||1
3131001|NCT01683409|3855905|FG003|NOT COMPLETED|Washout Period 1 (Weeks 25-28)||2
3131002|NCT01683409|3855906|FG004|NOT COMPLETED|Washout Period 1 (Weeks 25-28)||3
3131003|NCT01683409|3855902|FG000|STARTED|Washout Period 2 (Weeks 29-32)|Study was completed at Week 28 for 18 participants.|6
3131004|NCT01683409|3855903|FG001|STARTED|Washout Period 2 (Weeks 29-32)|Study was completed at Week 28 for 11 participants.|6
3131005|NCT01683409|3855904|FG002|STARTED|Washout Period 2 (Weeks 29-32)|Study was completed at Week 28 for 17 participants.|8
3131006|NCT01683409|3855905|FG003|STARTED|Washout Period 2 (Weeks 29-32)|Study was completed at Week 28 for 16 participants.|6
3131007|NCT01683409|3855906|FG004|STARTED|Washout Period 2 (Weeks 29-32)|Study was completed at Week 28 for 8 participants.|12
3131008|NCT01683409|3855902|FG000|COMPLETED|Washout Period 2 (Weeks 29-32)||6
3131009|NCT01683409|3855903|FG001|COMPLETED|Washout Period 2 (Weeks 29-32)||6
3131010|NCT01683409|3855904|FG002|COMPLETED|Washout Period 2 (Weeks 29-32)||7
3131011|NCT01683409|3855905|FG003|COMPLETED|Washout Period 2 (Weeks 29-32)||6
3131012|NCT01683409|3855906|FG004|COMPLETED|Washout Period 2 (Weeks 29-32)||9
3131013|NCT01683409|3855902|FG000|NOT COMPLETED|Washout Period 2 (Weeks 29-32)||0
3131014|NCT01683409|3855903|FG001|NOT COMPLETED|Washout Period 2 (Weeks 29-32)||0
3131015|NCT01683409|3855904|FG002|NOT COMPLETED|Washout Period 2 (Weeks 29-32)||1
3131016|NCT01683409|3855905|FG003|NOT COMPLETED|Washout Period 2 (Weeks 29-32)||0
3131017|NCT01683409|3855906|FG004|NOT COMPLETED|Washout Period 2 (Weeks 29-32)||3
3131018|NCT01683422|3855932|FG000|STARTED|Overall Study||9
3131019|NCT01683422|3855932|FG000|COMPLETED|Overall Study||9
3131020|NCT01683422|3855932|FG000|NOT COMPLETED|Overall Study||0
3131021|NCT01683526|3855938|FG000|STARTED|Overall Study||60
3131022|NCT01683526|3855939|FG001|STARTED|Overall Study||57
3131023|NCT01683526|3855938|FG000|COMPLETED|Overall Study||60
3131024|NCT01683526|3855939|FG001|COMPLETED|Overall Study||57
3131025|NCT01683526|3855938|FG000|NOT COMPLETED|Overall Study||0
3131026|NCT01683526|3855939|FG001|NOT COMPLETED|Overall Study||0
3131027|NCT01683565|3855947|FG000|STARTED|Overall Study||15
3131028|NCT01683565|3855948|FG001|STARTED|Overall Study||16
3131029|NCT01683565|3855947|FG000|COMPLETED|Overall Study||12
3131030|NCT01683565|3855948|FG001|COMPLETED|Overall Study||15
3131031|NCT01683565|3855947|FG000|NOT COMPLETED|Overall Study||3
3131032|NCT01683565|3855948|FG001|NOT COMPLETED|Overall Study||1
3131033|NCT01683604|3855956|FG000|STARTED|Overall Study||37
3131034|NCT01683604|3855956|FG000|COMPLETED|Overall Study||32
3131035|NCT01683604|3855956|FG000|NOT COMPLETED|Overall Study||5
3131036|NCT01683630|3855967|FG000|STARTED|Overall Study||1404
3131037|NCT01683630|3855968|FG001|STARTED|Overall Study||445
3131038|NCT01683630|3855967|FG000|COMPLETED|Overall Study||1404
3131039|NCT01683630|3855968|FG001|COMPLETED|Overall Study||445
3131040|NCT01683630|3855967|FG000|NOT COMPLETED|Overall Study||0
3131041|NCT01683630|3855968|FG001|NOT COMPLETED|Overall Study||0
3131042|NCT01683812|3855974|FG000|STARTED|Overall Study||23
3131043|NCT01683812|3855974|FG000|COMPLETED|Overall Study||23
3131044|NCT01683812|3855974|FG000|NOT COMPLETED|Overall Study||0
3131045|NCT01683838|3855980|FG000|STARTED|Overall Study||104
3131046|NCT01683838|3855981|FG001|STARTED|Overall Study||100
3131047|NCT01683838|3855980|FG000|Intent to Treat (ITT) Population|Overall Study||103
3131048|NCT01683838|3855981|FG001|Intent to Treat (ITT) Population|Overall Study||100
3131049|NCT01683838|3855980|FG000|Safety Population|Overall Study||103
3131050|NCT01683838|3855981|FG001|Safety Population|Overall Study||100
3131051|NCT01683838|3855980|FG000|Efficacy Population|Overall Study||89
3131052|NCT01683838|3855981|FG001|Efficacy Population|Overall Study||93
3131053|NCT01683838|3855980|FG000|COMPLETED|Overall Study||78
3131054|NCT01683838|3855981|FG001|COMPLETED|Overall Study||88
3131055|NCT01683838|3855980|FG000|NOT COMPLETED|Overall Study||26
3131056|NCT01683838|3855981|FG001|NOT COMPLETED|Overall Study||12
3131057|NCT01683994|3855992|FG000|STARTED|Overall Study||4
3131058|NCT01683994|3855993|FG001|STARTED|Overall Study||8
3131059|NCT01683994|3855994|FG002|STARTED|Overall Study||7
3131060|NCT01683994|3855995|FG003|STARTED|Overall Study||13
3131061|NCT01683994|3855996|FG004|STARTED|Overall Study||13
3131062|NCT01683994|3855992|FG000|# of Patients Who Received Treatment|Overall Study||4
3131063|NCT01683994|3855993|FG001|# of Patients Who Received Treatment|Overall Study||8
3131064|NCT01683994|3855994|FG002|# of Patients Who Received Treatment|Overall Study||7
3131065|NCT01683994|3855995|FG003|# of Patients Who Received Treatment|Overall Study||12
3131066|NCT01683994|3855996|FG004|# of Patients Who Received Treatment|Overall Study||13
3131067|NCT01683994|3855992|FG000|COMPLETED|Overall Study||3
3131068|NCT01683994|3855993|FG001|COMPLETED|Overall Study||8
3131069|NCT01683994|3855994|FG002|COMPLETED|Overall Study||7
3131070|NCT01683994|3855995|FG003|COMPLETED|Overall Study||10
3131071|NCT01683994|3855996|FG004|COMPLETED|Overall Study||12
3131072|NCT01683994|3855992|FG000|NOT COMPLETED|Overall Study||1
3131073|NCT01683994|3855993|FG001|NOT COMPLETED|Overall Study||0
3131074|NCT01683994|3855994|FG002|NOT COMPLETED|Overall Study||0
3131075|NCT01683994|3855995|FG003|NOT COMPLETED|Overall Study||3
3131076|NCT01683994|3855996|FG004|NOT COMPLETED|Overall Study||1
3131077|NCT01684007|3856016|FG000|STARTED|Overall Study||53
3131078|NCT01684007|3856017|FG001|STARTED|Overall Study||50
3131079|NCT01684007|3856016|FG000|COMPLETED|Overall Study||53
3131080|NCT01684007|3856017|FG001|COMPLETED|Overall Study||50
3131081|NCT01684007|3856016|FG000|NOT COMPLETED|Overall Study||0
3131082|NCT01684007|3856017|FG001|NOT COMPLETED|Overall Study||0
3131083|NCT01684020|3856025|FG000|STARTED|Overall Study||5
3131084|NCT01684020|3856026|FG001|STARTED|Overall Study||5
3131085|NCT01684020|3856025|FG000|COMPLETED|Overall Study||4
3131086|NCT01684020|3856026|FG001|COMPLETED|Overall Study||5
3131087|NCT01684020|3856025|FG000|NOT COMPLETED|Overall Study||1
3131088|NCT01684020|3856026|FG001|NOT COMPLETED|Overall Study||0
3131089|NCT01684033|3856032|FG000|STARTED|Period 1, First 30 Days||99
3131090|NCT01684033|3856033|FG001|STARTED|Period 1, First 30 Days||99
3131091|NCT01684033|3856032|FG000|COMPLETED|Period 1, First 30 Days||95
3131092|NCT01684033|3856033|FG001|COMPLETED|Period 1, First 30 Days||98
3131093|NCT01684033|3856032|FG000|NOT COMPLETED|Period 1, First 30 Days||4
3131094|NCT01684033|3856033|FG001|NOT COMPLETED|Period 1, First 30 Days||1
3131095|NCT01684033|3856032|FG000|STARTED|Period 2, Second 30 Days||95
3131096|NCT01684033|3856033|FG001|STARTED|Period 2, Second 30 Days||98
3131097|NCT01684033|3856032|FG000|COMPLETED|Period 2, Second 30 Days||94
3131098|NCT01684033|3856033|FG001|COMPLETED|Period 2, Second 30 Days||98
3131099|NCT01684033|3856032|FG000|NOT COMPLETED|Period 2, Second 30 Days||1
3131100|NCT01684033|3856033|FG001|NOT COMPLETED|Period 2, Second 30 Days||0
3131101|NCT01684046|3856039|FG000|STARTED|Period 1, First 30 Days||97
3131102|NCT01684046|3856040|FG001|STARTED|Period 1, First 30 Days||95
3131103|NCT01684046|3856039|FG000|COMPLETED|Period 1, First 30 Days||97
3131104|NCT01684046|3856040|FG001|COMPLETED|Period 1, First 30 Days||93
3131105|NCT01684046|3856039|FG000|NOT COMPLETED|Period 1, First 30 Days||0
3131106|NCT01684046|3856040|FG001|NOT COMPLETED|Period 1, First 30 Days||2
3131107|NCT01684046|3856039|FG000|STARTED|Period 2, Second 30 Days||97
3131108|NCT01684046|3856040|FG001|STARTED|Period 2, Second 30 Days||93
3296591|NCT02906813|4030331|FG002|NOT COMPLETED|Intervention Period 1 (3 Days)||0
3296592|NCT02906813|4030329|FG000|STARTED|Washout Period 1 (at Least 3 Days)||3
3296593|NCT02906813|4030330|FG001|STARTED|Washout Period 1 (at Least 3 Days)||3
3296594|NCT02906813|4030331|FG002|STARTED|Washout Period 1 (at Least 3 Days)||3
3296595|NCT02906813|4030329|FG000|COMPLETED|Washout Period 1 (at Least 3 Days)||3
3296596|NCT02906813|4030330|FG001|COMPLETED|Washout Period 1 (at Least 3 Days)||3
3296597|NCT02906813|4030331|FG002|COMPLETED|Washout Period 1 (at Least 3 Days)||3
3296598|NCT02906813|4030329|FG000|NOT COMPLETED|Washout Period 1 (at Least 3 Days)||0
3296599|NCT02906813|4030330|FG001|NOT COMPLETED|Washout Period 1 (at Least 3 Days)||0
3296600|NCT02906813|4030331|FG002|NOT COMPLETED|Washout Period 1 (at Least 3 Days)||0
3296601|NCT02906813|4030329|FG000|STARTED|Intervention Period 2 (3 Days)||3
3296602|NCT02906813|4030330|FG001|STARTED|Intervention Period 2 (3 Days)||3
3296603|NCT02906813|4030331|FG002|STARTED|Intervention Period 2 (3 Days)||3
3296604|NCT02906813|4030329|FG000|COMPLETED|Intervention Period 2 (3 Days)||3
3296605|NCT02906813|4030330|FG001|COMPLETED|Intervention Period 2 (3 Days)||3
3296606|NCT02906813|4030331|FG002|COMPLETED|Intervention Period 2 (3 Days)||3
3296607|NCT02906813|4030329|FG000|NOT COMPLETED|Intervention Period 2 (3 Days)||0
3296608|NCT02906813|4030330|FG001|NOT COMPLETED|Intervention Period 2 (3 Days)||0
3296609|NCT02906813|4030331|FG002|NOT COMPLETED|Intervention Period 2 (3 Days)||0
3296610|NCT02906813|4030329|FG000|STARTED|Washout Period 2 (at Least 3 Days)||3
3296611|NCT02906813|4030330|FG001|STARTED|Washout Period 2 (at Least 3 Days)||3
3296612|NCT02906813|4030331|FG002|STARTED|Washout Period 2 (at Least 3 Days)||3
3296613|NCT02906813|4030329|FG000|COMPLETED|Washout Period 2 (at Least 3 Days)||3
3296614|NCT02906813|4030330|FG001|COMPLETED|Washout Period 2 (at Least 3 Days)||3
3316867|NCT03120520|4050348|FG000|STARTED|Overall Study||31
3131109|NCT01684046|3856039|FG000|COMPLETED|Period 2, Second 30 Days||97
3131110|NCT01684046|3856040|FG001|COMPLETED|Period 2, Second 30 Days||93
3131111|NCT01684046|3856039|FG000|NOT COMPLETED|Period 2, Second 30 Days||0
3131112|NCT01684046|3856040|FG001|NOT COMPLETED|Period 2, Second 30 Days||0
3131113|NCT01684202|3856050|FG000|STARTED|Dose-escalation Period||15
3131114|NCT01684202|3856051|FG001|STARTED|Dose-escalation Period||8
3131115|NCT01684202|3856052|FG002|STARTED|Dose-escalation Period||9
3131116|NCT01684202|3856053|FG003|STARTED|Dose-escalation Period||11
3131117|NCT01684202|3856050|FG000|COMPLETED|Dose-escalation Period||14
3131118|NCT01684202|3856051|FG001|COMPLETED|Dose-escalation Period||7
3131119|NCT01684202|3856052|FG002|COMPLETED|Dose-escalation Period||9
3131120|NCT01684202|3856053|FG003|COMPLETED|Dose-escalation Period||11
3131121|NCT01684202|3856050|FG000|NOT COMPLETED|Dose-escalation Period||1
3131122|NCT01684202|3856051|FG001|NOT COMPLETED|Dose-escalation Period||1
3131123|NCT01684202|3856052|FG002|NOT COMPLETED|Dose-escalation Period||0
3131124|NCT01684202|3856053|FG003|NOT COMPLETED|Dose-escalation Period||0
3131125|NCT01684202|3856050|FG000|STARTED|Maintenance Period||14
3131126|NCT01684202|3856051|FG001|STARTED|Maintenance Period||7
3131127|NCT01684202|3856052|FG002|STARTED|Maintenance Period||9
3131128|NCT01684202|3856053|FG003|STARTED|Maintenance Period||11
3131129|NCT01684202|3856050|FG000|COMPLETED|Maintenance Period||13
3131130|NCT01684202|3856051|FG001|COMPLETED|Maintenance Period||4
3131131|NCT01684202|3856052|FG002|COMPLETED|Maintenance Period||8
3131132|NCT01684202|3856053|FG003|COMPLETED|Maintenance Period||10
3131133|NCT01684202|3856050|FG000|NOT COMPLETED|Maintenance Period||1
3131134|NCT01684202|3856051|FG001|NOT COMPLETED|Maintenance Period||3
3131135|NCT01684202|3856052|FG002|NOT COMPLETED|Maintenance Period||1
3131136|NCT01684202|3856053|FG003|NOT COMPLETED|Maintenance Period||1
3131137|NCT01684215|3856067|FG000|STARTED|Phase 1, Part 1||6
3131138|NCT01684215|3856068|FG001|STARTED|Phase 1, Part 1||6
3131139|NCT01684215|3856069|FG002|STARTED|Phase 1, Part 1||0
3131140|NCT01684215|3856070|FG003|STARTED|Phase 1, Part 1||0
3131141|NCT01684215|3856067|FG000|Treated|Phase 1, Part 1||6
3131142|NCT01684215|3856068|FG001|Treated|Phase 1, Part 1||6
3131143|NCT01684215|3856069|FG002|Treated|Phase 1, Part 1||0
3131144|NCT01684215|3856070|FG003|Treated|Phase 1, Part 1||0
3131145|NCT01684215|3856067|FG000|COMPLETED|Phase 1, Part 1||0
3131146|NCT01684215|3856068|FG001|COMPLETED|Phase 1, Part 1||0
3131147|NCT01684215|3856069|FG002|COMPLETED|Phase 1, Part 1||0
3131148|NCT01684215|3856070|FG003|COMPLETED|Phase 1, Part 1||0
3131149|NCT01684215|3856067|FG000|NOT COMPLETED|Phase 1, Part 1||6
3131150|NCT01684215|3856068|FG001|NOT COMPLETED|Phase 1, Part 1||6
3131151|NCT01684215|3856069|FG002|NOT COMPLETED|Phase 1, Part 1||0
3131152|NCT01684215|3856070|FG003|NOT COMPLETED|Phase 1, Part 1||0
3131153|NCT01684215|3856067|FG000|STARTED|Phase 1, Part 2||0
3131154|NCT01684215|3856068|FG001|STARTED|Phase 1, Part 2||0
3131155|NCT01684215|3856069|FG002|STARTED|Phase 1, Part 2|Eligible participants who consented for Phase 1 Part 2.|6
3131156|NCT01684215|3856070|FG003|STARTED|Phase 1, Part 2||0
3131157|NCT01684215|3856067|FG000|COMPLETED|Phase 1, Part 2||0
3131158|NCT01684215|3856068|FG001|COMPLETED|Phase 1, Part 2||0
3131159|NCT01684215|3856069|FG002|COMPLETED|Phase 1, Part 2||0
3296615|NCT02906813|4030331|FG002|COMPLETED|Washout Period 2 (at Least 3 Days)||3
3296616|NCT02906813|4030329|FG000|NOT COMPLETED|Washout Period 2 (at Least 3 Days)||0
3296617|NCT02906813|4030330|FG001|NOT COMPLETED|Washout Period 2 (at Least 3 Days)||0
3296618|NCT02906813|4030331|FG002|NOT COMPLETED|Washout Period 2 (at Least 3 Days)||0
3296619|NCT02906813|4030329|FG000|STARTED|Intervention Period 3 (3 Days)||3
3296620|NCT02906813|4030330|FG001|STARTED|Intervention Period 3 (3 Days)||3
3296621|NCT02906813|4030331|FG002|STARTED|Intervention Period 3 (3 Days)||3
3296622|NCT02906813|4030329|FG000|COMPLETED|Intervention Period 3 (3 Days)||3
3296623|NCT02906813|4030330|FG001|COMPLETED|Intervention Period 3 (3 Days)||3
3296624|NCT02906813|4030331|FG002|COMPLETED|Intervention Period 3 (3 Days)||3
3296625|NCT02906813|4030329|FG000|NOT COMPLETED|Intervention Period 3 (3 Days)||0
3296626|NCT02906813|4030330|FG001|NOT COMPLETED|Intervention Period 3 (3 Days)||0
3296627|NCT02906813|4030331|FG002|NOT COMPLETED|Intervention Period 3 (3 Days)||0
3296628|NCT02906917|4030341|FG000|STARTED|Initiation Period (Week 0-26)||267
3296629|NCT02906917|4030342|FG001|STARTED|Initiation Period (Week 0-26)||265
3296630|NCT02906917|4030341|FG000|Exposed|Initiation Period (Week 0-26)||265
3296631|NCT02906917|4030342|FG001|Exposed|Initiation Period (Week 0-26)||263
3296632|NCT02906917|4030341|FG000|COMPLETED|Initiation Period (Week 0-26)||261
3296633|NCT02906917|4030342|FG001|COMPLETED|Initiation Period (Week 0-26)||254
3296634|NCT02906917|4030341|FG000|NOT COMPLETED|Initiation Period (Week 0-26)||6
3296635|NCT02906917|4030342|FG001|NOT COMPLETED|Initiation Period (Week 0-26)||11
3296636|NCT02906917|4030341|FG000|STARTED|Intensification Period (Week 26-38)||261
3296637|NCT02906917|4030342|FG001|STARTED|Intensification Period (Week 26-38)||254
3296638|NCT02906917|4030341|FG000|COMPLETED|Intensification Period (Week 26-38)||252
3296639|NCT02906917|4030342|FG001|COMPLETED|Intensification Period (Week 26-38)||247
3296640|NCT02906917|4030341|FG000|NOT COMPLETED|Intensification Period (Week 26-38)||9
3296641|NCT02906917|4030342|FG001|NOT COMPLETED|Intensification Period (Week 26-38)||7
3296642|NCT02906930|4030352|FG000|STARTED|Overall Study||175
3296643|NCT02906930|4030353|FG001|STARTED|Overall Study||175
3296644|NCT02906930|4030354|FG002|STARTED|Overall Study||175
3296645|NCT02906930|4030355|FG003|STARTED|Overall Study||178
3296646|NCT02906930|4030352|FG000|Full Analysis Set (FAS)|Overall Study||175
3296647|NCT02906930|4030353|FG001|Full Analysis Set (FAS)|Overall Study||175
3296648|NCT02906930|4030354|FG002|Full Analysis Set (FAS)|Overall Study||175
3296649|NCT02906930|4030355|FG003|Full Analysis Set (FAS)|Overall Study||178
3296650|NCT02906930|4030352|FG000|Safety Analysis Set (SAS)|Overall Study||175
3296651|NCT02906930|4030353|FG001|Safety Analysis Set (SAS)|Overall Study||175
3296652|NCT02906930|4030354|FG002|Safety Analysis Set (SAS)|Overall Study||175
3131160|NCT01684215|3856070|FG003|COMPLETED|Phase 1, Part 2||0
3131161|NCT01684215|3856067|FG000|NOT COMPLETED|Phase 1, Part 2||0
3131162|NCT01684215|3856068|FG001|NOT COMPLETED|Phase 1, Part 2||0
3131163|NCT01684215|3856069|FG002|NOT COMPLETED|Phase 1, Part 2||6
3131164|NCT01684215|3856070|FG003|NOT COMPLETED|Phase 1, Part 2||0
3131165|NCT01684215|3856067|FG000|STARTED|Phase 2||0
3131166|NCT01684215|3856068|FG001|STARTED|Phase 2||0
3131167|NCT01684215|3856069|FG002|STARTED|Phase 2||0
3131168|NCT01684215|3856070|FG003|STARTED|Phase 2|Eligible participants who consented for Phase 2.|43
3131169|NCT01684215|3856067|FG000|Treated|Phase 2||0
3131170|NCT01684215|3856068|FG001|Treated|Phase 2||0
3131171|NCT01684215|3856069|FG002|Treated|Phase 2||0
3131172|NCT01684215|3856070|FG003|Treated|Phase 2||42
3131173|NCT01684215|3856067|FG000|COMPLETED|Phase 2||0
3131174|NCT01684215|3856068|FG001|COMPLETED|Phase 2||0
3131175|NCT01684215|3856069|FG002|COMPLETED|Phase 2||0
3131176|NCT01684215|3856070|FG003|COMPLETED|Phase 2||0
3131177|NCT01684215|3856067|FG000|NOT COMPLETED|Phase 2||0
3131178|NCT01684215|3856068|FG001|NOT COMPLETED|Phase 2||0
3131179|NCT01684215|3856069|FG002|NOT COMPLETED|Phase 2||0
3131180|NCT01684215|3856070|FG003|NOT COMPLETED|Phase 2||43
3131181|NCT01684410|3856086|FG000|STARTED|Overall Study||10
3131182|NCT01684410|3856087|FG001|STARTED|Overall Study||10
3131183|NCT01684410|3856088|FG002|STARTED|Overall Study||10
3131184|NCT01684410|3856086|FG000|COMPLETED|Overall Study||10
3131185|NCT01684410|3856087|FG001|COMPLETED|Overall Study||10
3131186|NCT01684410|3856088|FG002|COMPLETED|Overall Study||10
3131187|NCT01684410|3856086|FG000|NOT COMPLETED|Overall Study||0
3131188|NCT01684410|3856087|FG001|NOT COMPLETED|Overall Study||0
3131189|NCT01684410|3856088|FG002|NOT COMPLETED|Overall Study||0
3131190|NCT01684423|3856101|FG000|STARTED|Overall Study||11
3131191|NCT01684423|3856102|FG001|STARTED|Overall Study||13
3131192|NCT01684423|3856103|FG002|STARTED|Overall Study||13
3131193|NCT01684423|3856104|FG003|STARTED|Overall Study||19
3131194|NCT01684423|3856105|FG004|STARTED|Overall Study||7
3131195|NCT01684423|3856101|FG000|COMPLETED|Overall Study||11
3131196|NCT01684423|3856102|FG001|COMPLETED|Overall Study||13
3131197|NCT01684423|3856103|FG002|COMPLETED|Overall Study||12
3131198|NCT01684423|3856104|FG003|COMPLETED|Overall Study||19
3131199|NCT01684423|3856105|FG004|COMPLETED|Overall Study||7
3131200|NCT01684423|3856101|FG000|NOT COMPLETED|Overall Study||0
3131201|NCT01684423|3856102|FG001|NOT COMPLETED|Overall Study||0
3131202|NCT01684423|3856103|FG002|NOT COMPLETED|Overall Study||1
3131203|NCT01684423|3856104|FG003|NOT COMPLETED|Overall Study||0
3131204|NCT01684423|3856105|FG004|NOT COMPLETED|Overall Study||0
3131205|NCT01684436|3856119|FG000|STARTED|Overall Study||30
3131206|NCT01684436|3856119|FG000|COMPLETED|Overall Study||29
3131207|NCT01684436|3856119|FG000|NOT COMPLETED|Overall Study||1
3131208|NCT01684566|3856125|FG000|STARTED|Overall Study||60
3131209|NCT01684566|3856126|FG001|STARTED|Overall Study||56
3131210|NCT01684566|3856125|FG000|Treated (ITT)|Overall Study||57
3131211|NCT01684566|3856126|FG001|Treated (ITT)|Overall Study||52
3131212|NCT01684566|3856125|FG000|COMPLETED|Overall Study||44
3131213|NCT01684566|3856126|FG001|COMPLETED|Overall Study||49
3131214|NCT01684566|3856125|FG000|NOT COMPLETED|Overall Study||16
3131215|NCT01684566|3856126|FG001|NOT COMPLETED|Overall Study||7
3131216|NCT01684592|3856134|FG000|STARTED|Overall Study||64
3131217|NCT01684592|3856135|FG001|STARTED|Overall Study||64
3131218|NCT01684592|3856134|FG000|COMPLETED|Overall Study||38
3131219|NCT01684592|3856135|FG001|COMPLETED|Overall Study||40
3131220|NCT01684592|3856134|FG000|NOT COMPLETED|Overall Study||26
3131221|NCT01684592|3856135|FG001|NOT COMPLETED|Overall Study||24
3131222|NCT01684722|3856145|FG000|STARTED|Overall Study||333
3131223|NCT01684722|3856146|FG001|STARTED|Overall Study||289
3131224|NCT01684722|3856147|FG002|STARTED|Overall Study||320
3131225|NCT01684722|3856148|FG003|STARTED|Overall Study||370
3131226|NCT01684722|3856145|FG000|COMPLETED|Overall Study||236
3131227|NCT01684722|3856146|FG001|COMPLETED|Overall Study||212
3131228|NCT01684722|3856147|FG002|COMPLETED|Overall Study||226
3131229|NCT01684722|3856148|FG003|COMPLETED|Overall Study||260
3131230|NCT01684722|3856145|FG000|NOT COMPLETED|Overall Study||97
3131231|NCT01684722|3856146|FG001|NOT COMPLETED|Overall Study||77
3131232|NCT01684722|3856147|FG002|NOT COMPLETED|Overall Study||94
3131233|NCT01684722|3856148|FG003|NOT COMPLETED|Overall Study||110
3131234|NCT01684748|3856172|FG000|STARTED|First Intervention - 8 Weeks||10
3296653|NCT02906930|4030355|FG003|Safety Analysis Set (SAS)|Overall Study||178
3296654|NCT02906930|4030352|FG000|COMPLETED|Overall Study||169
3296655|NCT02906930|4030353|FG001|COMPLETED|Overall Study||161
3131235|NCT01684748|3856173|FG001|STARTED|First Intervention - 8 Weeks||10
3131236|NCT01684748|3856172|FG000|COMPLETED|First Intervention - 8 Weeks||8
3131237|NCT01684748|3856173|FG001|COMPLETED|First Intervention - 8 Weeks||8
3131238|NCT01684748|3856172|FG000|NOT COMPLETED|First Intervention - 8 Weeks||2
3131239|NCT01684748|3856173|FG001|NOT COMPLETED|First Intervention - 8 Weeks||2
3131240|NCT01684748|3856172|FG000|STARTED|Second Intervention - 8 Weeks||8
3131241|NCT01684748|3856173|FG001|STARTED|Second Intervention - 8 Weeks||8
3131242|NCT01684748|3856172|FG000|COMPLETED|Second Intervention - 8 Weeks||8
3131243|NCT01684748|3856173|FG001|COMPLETED|Second Intervention - 8 Weeks||8
3296656|NCT02906930|4030354|FG002|COMPLETED|Overall Study||163
3131244|NCT01684748|3856172|FG000|NOT COMPLETED|Second Intervention - 8 Weeks||0
3131245|NCT01684748|3856173|FG001|NOT COMPLETED|Second Intervention - 8 Weeks||0
3131246|NCT01684826|3856179|FG000|STARTED|Overall Study||49
3131247|NCT01684826|3856179|FG000|Collected Dose and Image Information|Overall Study||39
3296657|NCT02906930|4030355|FG003|COMPLETED|Overall Study||170
3131248|NCT01684826|3856179|FG000|COMPLETED|Overall Study||39
3131249|NCT01684826|3856179|FG000|NOT COMPLETED|Overall Study||10
3131250|NCT01684839|3856183|FG000|STARTED|Overall Study||9
3131251|NCT01684839|3856183|FG000|COMPLETED|Overall Study||9
3131252|NCT01684839|3856183|FG000|NOT COMPLETED|Overall Study||0
3131253|NCT01684878|3856191|FG000|STARTED|Part 1: Safety Run in Phase||22
3131254|NCT01684878|3856192|FG001|STARTED|Part 1: Safety Run in Phase||28
3131255|NCT01684878|3856193|FG002|STARTED|Part 1: Safety Run in Phase||0
3131256|NCT01684878|3856194|FG003|STARTED|Part 1: Safety Run in Phase||0
3131257|NCT01684878|3856191|FG000|COMPLETED|Part 1: Safety Run in Phase||6
3131258|NCT01684878|3856192|FG001|COMPLETED|Part 1: Safety Run in Phase||5
3131259|NCT01684878|3856193|FG002|COMPLETED|Part 1: Safety Run in Phase||0
3131260|NCT01684878|3856194|FG003|COMPLETED|Part 1: Safety Run in Phase||0
3131261|NCT01684878|3856191|FG000|NOT COMPLETED|Part 1: Safety Run in Phase||16
3131262|NCT01684878|3856192|FG001|NOT COMPLETED|Part 1: Safety Run in Phase||23
3131263|NCT01684878|3856193|FG002|NOT COMPLETED|Part 1: Safety Run in Phase||0
3131264|NCT01684878|3856194|FG003|NOT COMPLETED|Part 1: Safety Run in Phase||0
3131265|NCT01684878|3856191|FG000|STARTED|Part 2: Randomized Phase||0
3131266|NCT01684878|3856192|FG001|STARTED|Part 2: Randomized Phase||0
3131267|NCT01684878|3856193|FG002|STARTED|Part 2: Randomized Phase||78
3131268|NCT01684878|3856194|FG003|STARTED|Part 2: Randomized Phase||78
3131269|NCT01684878|3856191|FG000|Participants Randomized But Not Treated|Part 2: Randomized Phase||0
3131270|NCT01684878|3856192|FG001|Participants Randomized But Not Treated|Part 2: Randomized Phase||0
3131271|NCT01684878|3856193|FG002|Participants Randomized But Not Treated|Part 2: Randomized Phase||1
3131272|NCT01684878|3856194|FG003|Participants Randomized But Not Treated|Part 2: Randomized Phase||2
3131273|NCT01684878|3856191|FG000|Participants Mis-randomized|Part 2: Randomized Phase||0
3131274|NCT01684878|3856192|FG001|Participants Mis-randomized|Part 2: Randomized Phase||0
3131275|NCT01684878|3856193|FG002|Participants Mis-randomized|Part 2: Randomized Phase||2
3131276|NCT01684878|3856194|FG003|Participants Mis-randomized|Part 2: Randomized Phase||0
3131277|NCT01684878|3856191|FG000|COMPLETED|Part 2: Randomized Phase||0
3131278|NCT01684878|3856192|FG001|COMPLETED|Part 2: Randomized Phase||0
3131279|NCT01684878|3856193|FG002|COMPLETED|Part 2: Randomized Phase||0
3131280|NCT01684878|3856194|FG003|COMPLETED|Part 2: Randomized Phase||0
3131281|NCT01684878|3856191|FG000|NOT COMPLETED|Part 2: Randomized Phase||0
3131282|NCT01684878|3856192|FG001|NOT COMPLETED|Part 2: Randomized Phase||0
3131283|NCT01684878|3856193|FG002|NOT COMPLETED|Part 2: Randomized Phase||78
3131284|NCT01684878|3856194|FG003|NOT COMPLETED|Part 2: Randomized Phase||78
3131285|NCT01684917|3856208|FG000|STARTED|Overall Study||11
3131286|NCT01684917|3856209|FG001|STARTED|Overall Study||7
3131287|NCT01684917|3856210|FG002|STARTED|Overall Study||13
3131288|NCT01684917|3856211|FG003|STARTED|Overall Study||5
3131289|NCT01684917|3856208|FG000|COMPLETED|Overall Study||11
3131290|NCT01684917|3856209|FG001|COMPLETED|Overall Study||7
3131291|NCT01684917|3856210|FG002|COMPLETED|Overall Study||13
3131292|NCT01684917|3856211|FG003|COMPLETED|Overall Study||5
3131293|NCT01684917|3856208|FG000|NOT COMPLETED|Overall Study||0
3131294|NCT01684917|3856209|FG001|NOT COMPLETED|Overall Study||0
3131295|NCT01684917|3856210|FG002|NOT COMPLETED|Overall Study||0
3131296|NCT01684917|3856211|FG003|NOT COMPLETED|Overall Study||0
3131297|NCT01684930|3856223|FG000|STARTED|Overall Study||12
3131298|NCT01684930|3856224|FG001|STARTED|Overall Study||14
3296658|NCT02906930|4030352|FG000|NOT COMPLETED|Overall Study||6
3296659|NCT02906930|4030353|FG001|NOT COMPLETED|Overall Study||14
3296660|NCT02906930|4030354|FG002|NOT COMPLETED|Overall Study||12
3296661|NCT02906930|4030355|FG003|NOT COMPLETED|Overall Study||8
3296662|NCT02907073|4030368|FG000|STARTED|Overall Study||8
3296663|NCT02907073|4030369|FG001|STARTED|Overall Study||0
3296664|NCT02907073|4030370|FG002|STARTED|Overall Study||0
3296665|NCT02907073|4030368|FG000|COMPLETED|Overall Study||8
3296666|NCT02907073|4030369|FG001|COMPLETED|Overall Study||0
3296667|NCT02907073|4030370|FG002|COMPLETED|Overall Study||0
3296668|NCT02907073|4030368|FG000|NOT COMPLETED|Overall Study||0
3296669|NCT02907073|4030369|FG001|NOT COMPLETED|Overall Study||0
3296670|NCT02907073|4030370|FG002|NOT COMPLETED|Overall Study||0
3296671|NCT02907177|4030380|FG000|STARTED|Overall Study||68
3296672|NCT02907177|4030381|FG001|STARTED|Overall Study||68
3296673|NCT02907177|4030380|FG000|Treated|Overall Study||67
3296674|NCT02907177|4030381|FG001|Treated|Overall Study||68
3296675|NCT02907177|4030380|FG000|Randomized Analysis Set|Overall Study||68
3296676|NCT02907177|4030381|FG001|Randomized Analysis Set|Overall Study||68
3296677|NCT02907177|4030380|FG000|COMPLETED|Overall Study||0
3296678|NCT02907177|4030381|FG001|COMPLETED|Overall Study||0
3296679|NCT02907177|4030380|FG000|NOT COMPLETED|Overall Study||68
3296680|NCT02907177|4030381|FG001|NOT COMPLETED|Overall Study||68
3296681|NCT02907216|4030389|FG000|STARTED|Overall Study||147
3296682|NCT02907216|4030390|FG001|STARTED|Overall Study||145
3296683|NCT02907216|4030389|FG000|COMPLETED|Overall Study||146
3296684|NCT02907216|4030390|FG001|COMPLETED|Overall Study||144
3296685|NCT02907216|4030389|FG000|NOT COMPLETED|Overall Study||1
3296686|NCT02907216|4030390|FG001|NOT COMPLETED|Overall Study||1
3296687|NCT02907268|4030398|FG000|STARTED|Overall Study||5
3296688|NCT02907268|4030399|FG001|STARTED|Overall Study||5
3296689|NCT02907268|4030398|FG000|COMPLETED|Overall Study||5
3296690|NCT02907268|4030399|FG001|COMPLETED|Overall Study||5
3296691|NCT02907268|4030398|FG000|NOT COMPLETED|Overall Study||0
3296692|NCT02907268|4030399|FG001|NOT COMPLETED|Overall Study||0
3131299|NCT01684930|3856223|FG000|COMPLETED|Overall Study||9
3131300|NCT01684930|3856224|FG001|COMPLETED|Overall Study||13
3131301|NCT01684930|3856223|FG000|NOT COMPLETED|Overall Study||3
3131302|NCT01684930|3856224|FG001|NOT COMPLETED|Overall Study||1
3131303|NCT01684943|3856233|FG000|STARTED|Overall Study||29
3131304|NCT01684943|3856234|FG001|STARTED|Overall Study||3
3131305|NCT01684943|3856235|FG002|STARTED|Overall Study||1
3131306|NCT01684943|3856233|FG000|COMPLETED|Overall Study||20
3131307|NCT01684943|3856234|FG001|COMPLETED|Overall Study||2
3131308|NCT01684943|3856235|FG002|COMPLETED|Overall Study||0
3131309|NCT01684943|3856233|FG000|NOT COMPLETED|Overall Study||9
3131310|NCT01684943|3856234|FG001|NOT COMPLETED|Overall Study||1
3131311|NCT01684943|3856235|FG002|NOT COMPLETED|Overall Study||1
3131312|NCT01685021|3856248|FG000|STARTED|Overall Study||22
3131313|NCT01685021|3856248|FG000|COMPLETED|Overall Study|Last patient last visit date. Study was Terminated prematurely.|6
3131314|NCT01685021|3856248|FG000|NOT COMPLETED|Overall Study||16
3131315|NCT01685047|3856252|FG000|STARTED|Overall Study|481 subjects signed the consent. 1 subject was withdrawn prior to the baseline visit.|481
3131316|NCT01685047|3856252|FG000|COMPLETED|Overall Study||396
3131317|NCT01685047|3856252|FG000|NOT COMPLETED|Overall Study||85
3131318|NCT01685060|3856256|FG000|STARTED|Overall Study||140
3131319|NCT01685060|3856256|FG000|Entered Post-treatment Efficacy f/u|Overall Study||7
3131320|NCT01685060|3856256|FG000|Entered Survival Follow up|Overall Study||98
3131321|NCT01685060|3856256|FG000|Discontinued From Study|Overall Study||35
3131322|NCT01685060|3856256|FG000|COMPLETED|Overall Study||0
3131323|NCT01685060|3856256|FG000|NOT COMPLETED|Overall Study||140
3131324|NCT01685073|3856262|FG000|STARTED|Overall Study|Randomized|62
3131325|NCT01685073|3856263|FG001|STARTED|Overall Study|Randomized|65
3131326|NCT01685073|3856262|FG000|COMPLETED|Overall Study|Retained in treatment through 12 weeks|32
3131327|NCT01685073|3856263|FG001|COMPLETED|Overall Study|Retained in treatment through 12 weeks|33
3131328|NCT01685073|3856262|FG000|NOT COMPLETED|Overall Study||30
3131329|NCT01685073|3856263|FG001|NOT COMPLETED|Overall Study||32
3131330|NCT01685138|3856269|FG000|STARTED|Overall Study||124
3131331|NCT01685138|3856269|FG000|Discontinued From Treatment Phase|Overall Study||124
3131332|NCT01685138|3856269|FG000|Entered Post-treatment Efficacy f/up|Overall Study||10
3131333|NCT01685138|3856269|FG000|Entered Survival Follow-up|Overall Study||63
3131334|NCT01685138|3856269|FG000|Discontinued From Study|Overall Study||51
3131335|NCT01685138|3856269|FG000|COMPLETED|Overall Study||32
3131336|NCT01685138|3856269|FG000|NOT COMPLETED|Overall Study||92
3131337|NCT01685203|3856280|FG000|STARTED|Overall Study||44
3131338|NCT01685203|3856281|FG001|STARTED|Overall Study||42
3131339|NCT01685203|3856282|FG002|STARTED|Overall Study||40
3131340|NCT01685203|3856283|FG003|STARTED|Overall Study||42
3131341|NCT01685203|3856284|FG004|STARTED|Overall Study||49
3131342|NCT01685203|3856285|FG005|STARTED|Overall Study||47
3131343|NCT01685203|3856286|FG006|STARTED|Overall Study||52
3131344|NCT01685203|3856280|FG000|Completed Study Drug|Overall Study||42
3131345|NCT01685203|3856281|FG001|Completed Study Drug|Overall Study||40
3131346|NCT01685203|3856282|FG002|Completed Study Drug|Overall Study||39
3131347|NCT01685203|3856283|FG003|Completed Study Drug|Overall Study||42
3131348|NCT01685203|3856284|FG004|Completed Study Drug|Overall Study||49
3131349|NCT01685203|3856285|FG005|Completed Study Drug|Overall Study||43
3131350|NCT01685203|3856286|FG006|Completed Study Drug|Overall Study||52
3131351|NCT01685203|3856280|FG000|COMPLETED|Overall Study||40
3131352|NCT01685203|3856281|FG001|COMPLETED|Overall Study||39
3131353|NCT01685203|3856282|FG002|COMPLETED|Overall Study||40
3131354|NCT01685203|3856283|FG003|COMPLETED|Overall Study||41
3296693|NCT02907463|4030404|FG000|STARTED|Overall Study||280
3296694|NCT02907463|4030404|FG000|Enrolled Cohort|Overall Study||280
3296695|NCT02907463|4030404|FG000|Per Protocol Cohort|Overall Study||276
3296696|NCT02907463|4030404|FG000|COMPLETED|Overall Study||243
3296697|NCT02907463|4030404|FG000|NOT COMPLETED|Overall Study||37
3296698|NCT02907489|4030418|FG000|STARTED|Overall Study||42
3296699|NCT02907489|4030419|FG001|STARTED|Overall Study||42
3296700|NCT02907489|4030418|FG000|COMPLETED|Overall Study||40
3296701|NCT02907489|4030419|FG001|COMPLETED|Overall Study||41
3296702|NCT02907489|4030418|FG000|NOT COMPLETED|Overall Study||2
3383605|NCT01763788|4118665|FG003|COMPLETED|Overall Study||92
3383606|NCT01763788|4118662|FG000|NOT COMPLETED|Overall Study||0
3383607|NCT01763788|4118663|FG001|NOT COMPLETED|Overall Study||0
3383608|NCT01763788|4118664|FG002|NOT COMPLETED|Overall Study||1
3383609|NCT01763788|4118665|FG003|NOT COMPLETED|Overall Study||0
3385816|NCT03135262|4121197|FG003|COMPLETED|Overall Study|The study was terminated after escalation phase. The planned expansion phase did not take place due to the early termination.|0
3385817|NCT03135262|4121198|FG004|COMPLETED|Overall Study|The study was terminated after escalation phase. The planned expansion phase did not take place due to the early termination.|0
3385818|NCT03135262|4121194|FG000|NOT COMPLETED|Overall Study||9
3385819|NCT03135262|4121195|FG001|NOT COMPLETED|Overall Study||6
3131355|NCT01685203|3856284|FG004|COMPLETED|Overall Study||49
3296703|NCT02907489|4030419|FG001|NOT COMPLETED|Overall Study||1
3131356|NCT01685203|3856285|FG005|COMPLETED|Overall Study||44
3131357|NCT01685203|3856286|FG006|COMPLETED|Overall Study||52
3296704|NCT02907619|4030428|FG000|STARTED|Overall Study||19
3296705|NCT02907619|4030429|FG001|STARTED|Overall Study||20
3296706|NCT02907619|4030430|FG002|STARTED|Overall Study||20
3296707|NCT02907619|4030428|FG000|Received Treatment|Overall Study||19
3296708|NCT02907619|4030429|FG001|Received Treatment|Overall Study||20
3296709|NCT02907619|4030430|FG002|Received Treatment|Overall Study||20
3131358|NCT01685203|3856280|FG000|NOT COMPLETED|Overall Study||4
3131359|NCT01685203|3856281|FG001|NOT COMPLETED|Overall Study||3
3131360|NCT01685203|3856282|FG002|NOT COMPLETED|Overall Study||0
3131361|NCT01685203|3856283|FG003|NOT COMPLETED|Overall Study||1
3131362|NCT01685203|3856284|FG004|NOT COMPLETED|Overall Study||0
3131363|NCT01685203|3856285|FG005|NOT COMPLETED|Overall Study||3
3131364|NCT01685203|3856286|FG006|NOT COMPLETED|Overall Study||0
3131365|NCT01685216|3856302|FG000|STARTED|Overall Study||7
3131366|NCT01685216|3856302|FG000|COMPLETED|Overall Study||6
3131367|NCT01685216|3856302|FG000|NOT COMPLETED|Overall Study||1
3136652|NCT01714232|3861892|FG000|COMPLETED|Overall Study||106
3136653|NCT01714232|3861892|FG000|NOT COMPLETED|Overall Study||0
3136654|NCT01714310|3861899|FG000|STARTED|Open Lisdexamfetamine Titration||0
3136655|NCT01714310|3861900|FG001|STARTED|Open Lisdexamfetamine Titration||0
3136656|NCT01714310|3861901|FG002|STARTED|Open Lisdexamfetamine Titration||34
3136657|NCT01714310|3861899|FG000|COMPLETED|Open Lisdexamfetamine Titration||0
3136658|NCT01714310|3861900|FG001|COMPLETED|Open Lisdexamfetamine Titration||0
3136659|NCT01714310|3861901|FG002|COMPLETED|Open Lisdexamfetamine Titration||30
3136660|NCT01714310|3861899|FG000|NOT COMPLETED|Open Lisdexamfetamine Titration||0
3136661|NCT01714310|3861900|FG001|NOT COMPLETED|Open Lisdexamfetamine Titration||0
3136662|NCT01714310|3861901|FG002|NOT COMPLETED|Open Lisdexamfetamine Titration||4
3136663|NCT01714310|3861899|FG000|STARTED|Double Blind Adjunctive Treatment|Adjunctive fluoxetine treatment was initiated at beginning of Period 2, at study week 4.|12
3136664|NCT01714310|3861900|FG001|STARTED|Double Blind Adjunctive Treatment|Adjunctive placebo was initiated at beginning of Period 2, at study week 4.|14
3136665|NCT01714310|3861901|FG002|STARTED|Double Blind Adjunctive Treatment|No one remained on lisdexamfetamine alone in Period 2.|0
3136666|NCT01714310|3861899|FG000|COMPLETED|Double Blind Adjunctive Treatment||10
3136667|NCT01714310|3861900|FG001|COMPLETED|Double Blind Adjunctive Treatment||11
3136668|NCT01714310|3861901|FG002|COMPLETED|Double Blind Adjunctive Treatment||0
3136669|NCT01714310|3861899|FG000|NOT COMPLETED|Double Blind Adjunctive Treatment||2
3136670|NCT01714310|3861900|FG001|NOT COMPLETED|Double Blind Adjunctive Treatment||3
3136671|NCT01714310|3861901|FG002|NOT COMPLETED|Double Blind Adjunctive Treatment||0
3136672|NCT01714323|3861921|FG000|STARTED|Overall Study||677
3136673|NCT01714323|3861922|FG001|STARTED|Overall Study||680
3136674|NCT01714323|3861921|FG000|COMPLETED|Overall Study||513
3136675|NCT01714323|3861922|FG001|COMPLETED|Overall Study||508
3136676|NCT01714323|3861921|FG000|NOT COMPLETED|Overall Study||164
3136677|NCT01714323|3861922|FG001|NOT COMPLETED|Overall Study||172
3136678|NCT01714336|3861930|FG000|STARTED|Overall Study||69
3136679|NCT01714336|3861931|FG001|STARTED|Overall Study||69
3136680|NCT01714336|3861930|FG000|COMPLETED|Overall Study||69
3136681|NCT01714336|3861931|FG001|COMPLETED|Overall Study||69
3136682|NCT01714336|3861930|FG000|NOT COMPLETED|Overall Study||0
3136683|NCT01714336|3861931|FG001|NOT COMPLETED|Overall Study||0
3136684|NCT01714492|3861937|FG000|STARTED|Overall Study||8
3136685|NCT01714492|3861937|FG000|COMPLETED|Overall Study||8
3136686|NCT01714492|3861937|FG000|NOT COMPLETED|Overall Study||0
3136687|NCT01714505|3861942|FG000|STARTED|Admission 1 (40 Hours)||10
3136688|NCT01714505|3861943|FG001|STARTED|Admission 1 (40 Hours)||10
3136689|NCT01714505|3861942|FG000|COMPLETED|Admission 1 (40 Hours)||9
3136690|NCT01714505|3861943|FG001|COMPLETED|Admission 1 (40 Hours)||9
3136691|NCT01714505|3861942|FG000|NOT COMPLETED|Admission 1 (40 Hours)||1
3136692|NCT01714505|3861943|FG001|NOT COMPLETED|Admission 1 (40 Hours)||1
3136693|NCT01714505|3861942|FG000|STARTED|Admission 2 (40 Hours)||9
3136694|NCT01714505|3861943|FG001|STARTED|Admission 2 (40 Hours)||9
3136695|NCT01714505|3861942|FG000|COMPLETED|Admission 2 (40 Hours)||9
3136696|NCT01714505|3861943|FG001|COMPLETED|Admission 2 (40 Hours)||9
3136697|NCT01714505|3861942|FG000|NOT COMPLETED|Admission 2 (40 Hours)||0
3136698|NCT01714505|3861943|FG001|NOT COMPLETED|Admission 2 (40 Hours)||0
3136699|NCT01714544|3861949|FG000|STARTED|Overall Study||60
3136700|NCT01714544|3861949|FG000|COMPLETED|Overall Study||57
3136701|NCT01714544|3861949|FG000|NOT COMPLETED|Overall Study||3
3136702|NCT01714609|3861955|FG000|STARTED|Overall Study||5
3136703|NCT01714609|3861956|FG001|STARTED|Overall Study||5
3136704|NCT01714609|3861955|FG000|COMPLETED|Overall Study||4
3136705|NCT01714609|3861956|FG001|COMPLETED|Overall Study||5
3136706|NCT01714609|3861955|FG000|NOT COMPLETED|Overall Study||1
3136707|NCT01714609|3861956|FG001|NOT COMPLETED|Overall Study||0
3136708|NCT01714635|3861965|FG000|STARTED|Overall Study||147
3136709|NCT01714635|3861966|FG001|STARTED|Overall Study||150
3136710|NCT01714635|3861967|FG002|STARTED|Overall Study||148
3136711|NCT01714635|3861965|FG000|COMPLETED|Overall Study||145
3136712|NCT01714635|3861966|FG001|COMPLETED|Overall Study||150
3136713|NCT01714635|3861967|FG002|COMPLETED|Overall Study||146
3136714|NCT01714635|3861965|FG000|NOT COMPLETED|Overall Study||2
3136715|NCT01714635|3861966|FG001|NOT COMPLETED|Overall Study||0
3136716|NCT01714635|3861967|FG002|NOT COMPLETED|Overall Study||2
3136717|NCT01714687|3861977|FG000|STARTED|Overall Study||29
3136718|NCT01714687|3861978|FG001|STARTED|Overall Study||30
3136719|NCT01714687|3861977|FG000|COMPLETED|Overall Study||26
3136720|NCT01714687|3861978|FG001|COMPLETED|Overall Study||26
3136721|NCT01714687|3861977|FG000|NOT COMPLETED|Overall Study||3
3136722|NCT01714687|3861978|FG001|NOT COMPLETED|Overall Study||4
3136723|NCT01714726|3861988|FG000|STARTED|Double-Blinded Induction Period||60
3136724|NCT01714726|3861989|FG001|STARTED|Double-Blinded Induction Period||59
3136725|NCT01714726|3861990|FG002|STARTED|Double-Blinded Induction Period||0
3136726|NCT01714726|3861991|FG003|STARTED|Double-Blinded Induction Period||0
3131368|NCT01685229|3856308|FG000|STARTED|Overall Study||146
3131369|NCT01685229|3856309|FG001|STARTED|Overall Study||52
3131370|NCT01685229|3856308|FG000|COMPLETED|Overall Study||120
3131371|NCT01685229|3856309|FG001|COMPLETED|Overall Study||36
3131372|NCT01685229|3856308|FG000|NOT COMPLETED|Overall Study||26
3131373|NCT01685229|3856309|FG001|NOT COMPLETED|Overall Study||16
3131374|NCT01685242|3856320|FG000|STARTED|Overall Study||50
3131375|NCT01685242|3856321|FG001|STARTED|Overall Study||50
3131376|NCT01685242|3856320|FG000|COMPLETED|Overall Study||49
3131377|NCT01685242|3856321|FG001|COMPLETED|Overall Study||47
3131378|NCT01685242|3856320|FG000|NOT COMPLETED|Overall Study||1
3131379|NCT01685242|3856321|FG001|NOT COMPLETED|Overall Study||3
3131380|NCT01685320|3856329|FG000|STARTED|Overall Study||15
3131381|NCT01685320|3856330|FG001|STARTED|Overall Study||15
3131382|NCT01685320|3856329|FG000|COMPLETED|Overall Study||15
3131383|NCT01685320|3856330|FG001|COMPLETED|Overall Study||15
3131384|NCT01685320|3856329|FG000|NOT COMPLETED|Overall Study||0
3131385|NCT01685320|3856330|FG001|NOT COMPLETED|Overall Study||0
3131386|NCT01685372|3856338|FG000|STARTED|Timepoint 1 (T1): Vaccine,1st Blood Draw||7
3131387|NCT01685372|3856339|FG001|STARTED|Timepoint 1 (T1): Vaccine,1st Blood Draw||9
3131388|NCT01685372|3856338|FG000|COMPLETED|Timepoint 1 (T1): Vaccine,1st Blood Draw||7
3131389|NCT01685372|3856339|FG001|COMPLETED|Timepoint 1 (T1): Vaccine,1st Blood Draw||9
3131390|NCT01685372|3856338|FG000|NOT COMPLETED|Timepoint 1 (T1): Vaccine,1st Blood Draw||0
3131391|NCT01685372|3856339|FG001|NOT COMPLETED|Timepoint 1 (T1): Vaccine,1st Blood Draw||0
3131392|NCT01685372|3856338|FG000|STARTED|Timepoint 2 (T2): 2nd Blood Draw||7
3131393|NCT01685372|3856339|FG001|STARTED|Timepoint 2 (T2): 2nd Blood Draw||9
3131394|NCT01685372|3856338|FG000|COMPLETED|Timepoint 2 (T2): 2nd Blood Draw||7
3131395|NCT01685372|3856339|FG001|COMPLETED|Timepoint 2 (T2): 2nd Blood Draw||9
3131396|NCT01685372|3856338|FG000|NOT COMPLETED|Timepoint 2 (T2): 2nd Blood Draw||0
3131397|NCT01685372|3856339|FG001|NOT COMPLETED|Timepoint 2 (T2): 2nd Blood Draw||0
3131398|NCT01685372|3856338|FG000|STARTED|Timepoint 3 (T3): 3rd Blood Draw||7
3131399|NCT01685372|3856339|FG001|STARTED|Timepoint 3 (T3): 3rd Blood Draw||9
3131400|NCT01685372|3856338|FG000|COMPLETED|Timepoint 3 (T3): 3rd Blood Draw||4
3131401|NCT01685372|3856339|FG001|COMPLETED|Timepoint 3 (T3): 3rd Blood Draw||5
3131402|NCT01685372|3856338|FG000|NOT COMPLETED|Timepoint 3 (T3): 3rd Blood Draw||3
3131403|NCT01685372|3856339|FG001|NOT COMPLETED|Timepoint 3 (T3): 3rd Blood Draw||4
3131404|NCT01685411|3856345|FG000|STARTED|Overall Study||5
3131405|NCT01685411|3856345|FG000|COMPLETED|Overall Study||5
3131406|NCT01685411|3856345|FG000|NOT COMPLETED|Overall Study||0
3131407|NCT01685437|3856349|FG000|STARTED|Overall Study||189
3131408|NCT01685437|3856349|FG000|COMPLETED|Overall Study||158
3131409|NCT01685437|3856349|FG000|NOT COMPLETED|Overall Study||31
3131410|NCT01685463|3856355|FG000|STARTED|Overall Study||10
3131411|NCT01685463|3856356|FG001|STARTED|Overall Study||8
3131412|NCT01685463|3856355|FG000|COMPLETED|Overall Study||10
3131413|NCT01685463|3856356|FG001|COMPLETED|Overall Study||8
3131414|NCT01685463|3856355|FG000|NOT COMPLETED|Overall Study||0
3131415|NCT01685463|3856356|FG001|NOT COMPLETED|Overall Study||0
3131416|NCT01685567|3856362|FG000|STARTED|Overall Study||219
3131417|NCT01685567|3856362|FG000|COMPLETED|Overall Study||219
3131418|NCT01685567|3856362|FG000|NOT COMPLETED|Overall Study||0
3131419|NCT01685606|3856366|FG000|STARTED|Overall Study||6
3131420|NCT01685606|3856366|FG000|COMPLETED|Overall Study||5
3131421|NCT01685606|3856366|FG000|NOT COMPLETED|Overall Study||1
3131422|NCT01685684|3856372|FG000|STARTED|Titration Phase||740
3131423|NCT01685684|3856373|FG001|STARTED|Titration Phase||0
3131424|NCT01685684|3856374|FG002|STARTED|Titration Phase||0
3131425|NCT01685684|3856372|FG000|COMPLETED|Titration Phase||389
3131426|NCT01685684|3856373|FG001|COMPLETED|Titration Phase||0
3131427|NCT01685684|3856374|FG002|COMPLETED|Titration Phase||0
3163290|NCT01885182|3890814|FG000|Safety Population|Overall Study||114
3163291|NCT01885182|3890815|FG001|Safety Population|Overall Study||111
3296710|NCT02907619|4030428|FG000|COMPLETED|Overall Study||0
3296711|NCT02907619|4030429|FG001|COMPLETED|Overall Study||0
3296712|NCT02907619|4030430|FG002|COMPLETED|Overall Study||0
3296713|NCT02907619|4030428|FG000|NOT COMPLETED|Overall Study||19
3296714|NCT02907619|4030429|FG001|NOT COMPLETED|Overall Study||20
3296715|NCT02907619|4030430|FG002|NOT COMPLETED|Overall Study||20
3296716|NCT02907814|4030442|FG000|STARTED|Overall Study||6
3296717|NCT02907814|4030443|FG001|STARTED|Overall Study||0
3296718|NCT02907814|4030442|FG000|COMPLETED|Overall Study||0
3296719|NCT02907814|4030443|FG001|COMPLETED|Overall Study||0
3296720|NCT02907814|4030442|FG000|NOT COMPLETED|Overall Study||6
3296721|NCT02907814|4030443|FG001|NOT COMPLETED|Overall Study||0
3296722|NCT02907892|4030451|FG000|STARTED|Overall Study||277
3296723|NCT02907892|4030452|FG001|STARTED|Overall Study||276
3163292|NCT01885182|3890814|FG000|FAP Population|Overall Study||107
3163293|NCT01885182|3890815|FG001|FAP Population|Overall Study||106
3163294|NCT01885182|3890814|FG000|COMPLETED|Overall Study||83
3163295|NCT01885182|3890815|FG001|COMPLETED|Overall Study||93
3296724|NCT02907892|4030451|FG000|COMPLETED|Overall Study||250
3296725|NCT02907892|4030452|FG001|COMPLETED|Overall Study||236
3296726|NCT02907892|4030451|FG000|NOT COMPLETED|Overall Study||27
3296727|NCT02907892|4030452|FG001|NOT COMPLETED|Overall Study||40
3296728|NCT02907918|4030458|FG000|STARTED|Overall Study||26
3296729|NCT02907918|4030458|FG000|COMPLETED|Overall Study||26
3296730|NCT02907918|4030458|FG000|NOT COMPLETED|Overall Study||0
3296731|NCT02908100|4030468|FG000|STARTED|Overall Study||86
3131428|NCT01685684|3856372|FG000|NOT COMPLETED|Titration Phase||351
3131429|NCT01685684|3856373|FG001|NOT COMPLETED|Titration Phase||0
3131430|NCT01685684|3856374|FG002|NOT COMPLETED|Titration Phase||0
3131431|NCT01685684|3856372|FG000|STARTED|Double-blind Maintenance Phase||0
3131432|NCT01685684|3856373|FG001|STARTED|Double-blind Maintenance Phase||193
3131433|NCT01685684|3856374|FG002|STARTED|Double-blind Maintenance Phase||196
3131434|NCT01685684|3856372|FG000|COMPLETED|Double-blind Maintenance Phase||0
3131435|NCT01685684|3856373|FG001|COMPLETED|Double-blind Maintenance Phase||122
3131436|NCT01685684|3856374|FG002|COMPLETED|Double-blind Maintenance Phase||100
3131437|NCT01685684|3856372|FG000|NOT COMPLETED|Double-blind Maintenance Phase||0
3131438|NCT01685684|3856373|FG001|NOT COMPLETED|Double-blind Maintenance Phase||71
3131439|NCT01685684|3856374|FG002|NOT COMPLETED|Double-blind Maintenance Phase||96
3131440|NCT01685697|3856384|FG000|STARTED|Overall Study||31
3131441|NCT01685697|3856385|FG001|STARTED|Overall Study||31
3131442|NCT01685697|3856384|FG000|COMPLETED|Overall Study||28
3131443|NCT01685697|3856385|FG001|COMPLETED|Overall Study||28
3131444|NCT01685697|3856384|FG000|NOT COMPLETED|Overall Study||3
3131445|NCT01685697|3856385|FG001|NOT COMPLETED|Overall Study||3
3131446|NCT01685801|3856395|FG000|STARTED|Cycle 1 Period 1 (2 Weeks)||5
3131447|NCT01685801|3856396|FG001|STARTED|Cycle 1 Period 1 (2 Weeks)||6
3131448|NCT01685801|3856397|FG002|STARTED|Cycle 1 Period 1 (2 Weeks)||7
3131449|NCT01685801|3856398|FG003|STARTED|Cycle 1 Period 1 (2 Weeks)||6
3131450|NCT01685801|3856395|FG000|COMPLETED|Cycle 1 Period 1 (2 Weeks)||5
3131451|NCT01685801|3856396|FG001|COMPLETED|Cycle 1 Period 1 (2 Weeks)||6
3131452|NCT01685801|3856397|FG002|COMPLETED|Cycle 1 Period 1 (2 Weeks)||7
3131453|NCT01685801|3856398|FG003|COMPLETED|Cycle 1 Period 1 (2 Weeks)||6
3131454|NCT01685801|3856395|FG000|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||0
3131455|NCT01685801|3856396|FG001|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||0
3131456|NCT01685801|3856397|FG002|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||0
3131457|NCT01685801|3856398|FG003|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||0
3131458|NCT01685801|3856395|FG000|STARTED|Cycle 1 Period 2 (2 Weeks)||5
3131459|NCT01685801|3856396|FG001|STARTED|Cycle 1 Period 2 (2 Weeks)||6
3131460|NCT01685801|3856397|FG002|STARTED|Cycle 1 Period 2 (2 Weeks)||7
3131461|NCT01685801|3856398|FG003|STARTED|Cycle 1 Period 2 (2 Weeks)||6
3296732|NCT02908100|4030469|FG001|STARTED|Overall Study||87
3296733|NCT02908100|4030470|FG002|STARTED|Overall Study||87
3296734|NCT02908100|4030468|FG000|COMPLETED|Overall Study||63
3296735|NCT02908100|4030469|FG001|COMPLETED|Overall Study||66
3296736|NCT02908100|4030470|FG002|COMPLETED|Overall Study||66
3296737|NCT02908100|4030468|FG000|NOT COMPLETED|Overall Study||23
3296738|NCT02908100|4030469|FG001|NOT COMPLETED|Overall Study||21
3296739|NCT02908100|4030470|FG002|NOT COMPLETED|Overall Study||21
3296740|NCT02908178|4030484|FG000|STARTED|Overall Study|The sample prior to Mahalanobis matching.|2409
3296741|NCT02908178|4030485|FG001|STARTED|Overall Study|The sample prior to Mahalanobis matching.|13106
3296742|NCT02908178|4030486|FG002|STARTED|Overall Study|The sample prior to Mahalanobis matching.|1992
3296743|NCT02908178|4030487|FG003|STARTED|Overall Study|The sample prior to Mahalanobis matching.|10784
3296744|NCT02908178|4030484|FG000|COMPLETED|Overall Study|The sample after Mahalanobis matching; that is, the number in the main analyses.|2409
3296745|NCT02908178|4030485|FG001|COMPLETED|Overall Study|The sample after Mahalanobis matching; that is, the number in the main analyses.|4718
3296746|NCT02908178|4030486|FG002|COMPLETED|Overall Study|The sample after Mahalanobis matching; that is, the number in the main analyses.|1992
3296747|NCT02908178|4030487|FG003|COMPLETED|Overall Study|The sample after Mahalanobis matching; that is, the number in the main analyses.|3965
3296748|NCT02908178|4030484|FG000|NOT COMPLETED|Overall Study||0
3296749|NCT02908178|4030485|FG001|NOT COMPLETED|Overall Study||8388
3296750|NCT02908178|4030486|FG002|NOT COMPLETED|Overall Study||0
3296751|NCT02908178|4030487|FG003|NOT COMPLETED|Overall Study||6819
3296752|NCT02908269|4030499|FG000|STARTED|Overall Study||60
3296753|NCT02908269|4030500|FG001|STARTED|Overall Study||60
3296754|NCT02908269|4030501|FG002|STARTED|Overall Study||60
3296755|NCT02908269|4030499|FG000|COMPLETED|Overall Study||60
3296756|NCT02908269|4030500|FG001|COMPLETED|Overall Study||60
3296757|NCT02908269|4030501|FG002|COMPLETED|Overall Study||60
3296758|NCT02908269|4030499|FG000|NOT COMPLETED|Overall Study||0
3296759|NCT02908269|4030500|FG001|NOT COMPLETED|Overall Study||0
3296760|NCT02908269|4030501|FG002|NOT COMPLETED|Overall Study||0
3296761|NCT02908347|4030512|FG000|STARTED|Overall Study||23
3296762|NCT02908347|4030513|FG001|STARTED|Overall Study||23
3296763|NCT02908347|4030512|FG000|COMPLETED|Overall Study||22
3296764|NCT02908347|4030513|FG001|COMPLETED|Overall Study||22
3296765|NCT02908347|4030512|FG000|NOT COMPLETED|Overall Study||1
3296766|NCT02908347|4030513|FG001|NOT COMPLETED|Overall Study||1
3296767|NCT02908464|4030535|FG000|STARTED|Overall Study||22
3296768|NCT02908464|4030536|FG001|STARTED|Overall Study||23
3296769|NCT02908464|4030535|FG000|COMPLETED|Overall Study||20
3296770|NCT02908464|4030536|FG001|COMPLETED|Overall Study||20
3296771|NCT02908464|4030535|FG000|NOT COMPLETED|Overall Study||2
3296772|NCT02908464|4030536|FG001|NOT COMPLETED|Overall Study||3
3296773|NCT02908490|4030545|FG000|STARTED|Overall Study||12
3296774|NCT02908490|4030546|FG001|STARTED|Overall Study||13
3296775|NCT02908490|4030545|FG000|COMPLETED|Overall Study||10
3296776|NCT02908490|4030546|FG001|COMPLETED|Overall Study||11
3296777|NCT02908490|4030545|FG000|NOT COMPLETED|Overall Study||2
3296778|NCT02908490|4030546|FG001|NOT COMPLETED|Overall Study||2
3296779|NCT02908529|4030552|FG000|STARTED|Overall Study||10
3296780|NCT02908529|4030553|FG001|STARTED|Overall Study||12
3296781|NCT02908529|4030552|FG000|COMPLETED|Overall Study||10
3296782|NCT02908529|4030553|FG001|COMPLETED|Overall Study||10
3131462|NCT01685801|3856395|FG000|COMPLETED|Cycle 1 Period 2 (2 Weeks)||5
3131463|NCT01685801|3856396|FG001|COMPLETED|Cycle 1 Period 2 (2 Weeks)||6
3131464|NCT01685801|3856397|FG002|COMPLETED|Cycle 1 Period 2 (2 Weeks)||7
3131465|NCT01685801|3856398|FG003|COMPLETED|Cycle 1 Period 2 (2 Weeks)||5
3131466|NCT01685801|3856395|FG000|NOT COMPLETED|Cycle 1 Period 2 (2 Weeks)||0
3131467|NCT01685801|3856396|FG001|NOT COMPLETED|Cycle 1 Period 2 (2 Weeks)||0
3131468|NCT01685801|3856397|FG002|NOT COMPLETED|Cycle 1 Period 2 (2 Weeks)||0
3131469|NCT01685801|3856398|FG003|NOT COMPLETED|Cycle 1 Period 2 (2 Weeks)||1
3131470|NCT01685801|3856395|FG000|STARTED|Washout Period 1 (4 Weeks)||5
3131471|NCT01685801|3856396|FG001|STARTED|Washout Period 1 (4 Weeks)||6
3131472|NCT01685801|3856397|FG002|STARTED|Washout Period 1 (4 Weeks)||7
3131473|NCT01685801|3856398|FG003|STARTED|Washout Period 1 (4 Weeks)||5
3131474|NCT01685801|3856395|FG000|COMPLETED|Washout Period 1 (4 Weeks)||5
3131475|NCT01685801|3856396|FG001|COMPLETED|Washout Period 1 (4 Weeks)||6
3131476|NCT01685801|3856397|FG002|COMPLETED|Washout Period 1 (4 Weeks)||7
3131477|NCT01685801|3856398|FG003|COMPLETED|Washout Period 1 (4 Weeks)||5
3131478|NCT01685801|3856395|FG000|NOT COMPLETED|Washout Period 1 (4 Weeks)||0
3131479|NCT01685801|3856396|FG001|NOT COMPLETED|Washout Period 1 (4 Weeks)||0
3131480|NCT01685801|3856397|FG002|NOT COMPLETED|Washout Period 1 (4 Weeks)||0
3131481|NCT01685801|3856398|FG003|NOT COMPLETED|Washout Period 1 (4 Weeks)||0
3131482|NCT01685801|3856395|FG000|STARTED|Cycle 2 Period 1 (2 Weeks)||5
3131483|NCT01685801|3856396|FG001|STARTED|Cycle 2 Period 1 (2 Weeks)||6
3131484|NCT01685801|3856397|FG002|STARTED|Cycle 2 Period 1 (2 Weeks)||7
3131485|NCT01685801|3856398|FG003|STARTED|Cycle 2 Period 1 (2 Weeks)||5
3131486|NCT01685801|3856395|FG000|COMPLETED|Cycle 2 Period 1 (2 Weeks)||5
3131487|NCT01685801|3856396|FG001|COMPLETED|Cycle 2 Period 1 (2 Weeks)||6
3131488|NCT01685801|3856397|FG002|COMPLETED|Cycle 2 Period 1 (2 Weeks)||7
3131489|NCT01685801|3856398|FG003|COMPLETED|Cycle 2 Period 1 (2 Weeks)||5
3131490|NCT01685801|3856395|FG000|NOT COMPLETED|Cycle 2 Period 1 (2 Weeks)||0
3131491|NCT01685801|3856396|FG001|NOT COMPLETED|Cycle 2 Period 1 (2 Weeks)||0
3131492|NCT01685801|3856397|FG002|NOT COMPLETED|Cycle 2 Period 1 (2 Weeks)||0
3131493|NCT01685801|3856398|FG003|NOT COMPLETED|Cycle 2 Period 1 (2 Weeks)||0
3131494|NCT01685801|3856395|FG000|STARTED|Cycle 2 Period 2 (2 Weeks)||5
3131495|NCT01685801|3856396|FG001|STARTED|Cycle 2 Period 2 (2 Weeks)||6
3131496|NCT01685801|3856397|FG002|STARTED|Cycle 2 Period 2 (2 Weeks)||7
3131497|NCT01685801|3856398|FG003|STARTED|Cycle 2 Period 2 (2 Weeks)||5
3131498|NCT01685801|3856395|FG000|COMPLETED|Cycle 2 Period 2 (2 Weeks)||5
3131499|NCT01685801|3856396|FG001|COMPLETED|Cycle 2 Period 2 (2 Weeks)||5
3131500|NCT01685801|3856397|FG002|COMPLETED|Cycle 2 Period 2 (2 Weeks)||7
3131501|NCT01685801|3856398|FG003|COMPLETED|Cycle 2 Period 2 (2 Weeks)||4
3131502|NCT01685801|3856395|FG000|NOT COMPLETED|Cycle 2 Period 2 (2 Weeks)||0
3131503|NCT01685801|3856396|FG001|NOT COMPLETED|Cycle 2 Period 2 (2 Weeks)||1
3131504|NCT01685801|3856397|FG002|NOT COMPLETED|Cycle 2 Period 2 (2 Weeks)||0
3131505|NCT01685801|3856398|FG003|NOT COMPLETED|Cycle 2 Period 2 (2 Weeks)||1
3131506|NCT01685801|3856395|FG000|STARTED|Washout Period 2 (4 Weeks)||5
3131507|NCT01685801|3856396|FG001|STARTED|Washout Period 2 (4 Weeks)||5
3131508|NCT01685801|3856397|FG002|STARTED|Washout Period 2 (4 Weeks)||7
3131509|NCT01685801|3856398|FG003|STARTED|Washout Period 2 (4 Weeks)||4
3131510|NCT01685801|3856395|FG000|COMPLETED|Washout Period 2 (4 Weeks)||5
3131511|NCT01685801|3856396|FG001|COMPLETED|Washout Period 2 (4 Weeks)||5
3131512|NCT01685801|3856397|FG002|COMPLETED|Washout Period 2 (4 Weeks)||7
3131513|NCT01685801|3856398|FG003|COMPLETED|Washout Period 2 (4 Weeks)||4
3131514|NCT01685801|3856395|FG000|NOT COMPLETED|Washout Period 2 (4 Weeks)||0
3131515|NCT01685801|3856396|FG001|NOT COMPLETED|Washout Period 2 (4 Weeks)||0
3131516|NCT01685801|3856397|FG002|NOT COMPLETED|Washout Period 2 (4 Weeks)||0
3131517|NCT01685801|3856398|FG003|NOT COMPLETED|Washout Period 2 (4 Weeks)||0
3131518|NCT01685801|3856395|FG000|STARTED|Open-label Period (8 Weeks)||5
3131519|NCT01685801|3856396|FG001|STARTED|Open-label Period (8 Weeks)||5
3131520|NCT01685801|3856397|FG002|STARTED|Open-label Period (8 Weeks)||7
3131521|NCT01685801|3856398|FG003|STARTED|Open-label Period (8 Weeks)||4
3131522|NCT01685801|3856395|FG000|COMPLETED|Open-label Period (8 Weeks)||5
3131523|NCT01685801|3856396|FG001|COMPLETED|Open-label Period (8 Weeks)||5
3131524|NCT01685801|3856397|FG002|COMPLETED|Open-label Period (8 Weeks)||7
3131525|NCT01685801|3856398|FG003|COMPLETED|Open-label Period (8 Weeks)||4
3131526|NCT01685801|3856395|FG000|NOT COMPLETED|Open-label Period (8 Weeks)||0
3131527|NCT01685801|3856396|FG001|NOT COMPLETED|Open-label Period (8 Weeks)||0
3131528|NCT01685801|3856397|FG002|NOT COMPLETED|Open-label Period (8 Weeks)||0
3131529|NCT01685801|3856398|FG003|NOT COMPLETED|Open-label Period (8 Weeks)||0
3131530|NCT01685840|3856417|FG000|STARTED|Overall Study||448
3131531|NCT01685840|3856418|FG001|STARTED|Overall Study||446
3131532|NCT01685840|3856417|FG000|COMPLETED|Overall Study||119
3131533|NCT01685840|3856418|FG001|COMPLETED|Overall Study||114
3131534|NCT01685840|3856417|FG000|NOT COMPLETED|Overall Study||329
3131535|NCT01685840|3856418|FG001|NOT COMPLETED|Overall Study||332
3131536|NCT01685983|3856426|FG000|STARTED|Overall Study||82
3131537|NCT01685983|3856426|FG000|COMPLETED|Overall Study||0
3131538|NCT01685983|3856426|FG000|NOT COMPLETED|Overall Study||82
3131539|NCT01685996|3856432|FG000|STARTED|Overall Study||34
3131540|NCT01685996|3856433|FG001|STARTED|Overall Study||40
3131541|NCT01685996|3856432|FG000|COMPLETED|Overall Study||18
3131542|NCT01685996|3856433|FG001|COMPLETED|Overall Study||27
3131543|NCT01685996|3856432|FG000|NOT COMPLETED|Overall Study||16
3131544|NCT01685996|3856433|FG001|NOT COMPLETED|Overall Study||13
3131545|NCT01686152|3856442|FG000|STARTED|Overall Study||252
3131546|NCT01686152|3856443|FG001|STARTED|Overall Study||253
3131547|NCT01686152|3856444|FG002|STARTED|Overall Study||84
3131548|NCT01686152|3856442|FG000|COMPLETED|Overall Study||211
3131549|NCT01686152|3856443|FG001|COMPLETED|Overall Study||218
3131550|NCT01686152|3856444|FG002|COMPLETED|Overall Study||75
3131551|NCT01686152|3856442|FG000|NOT COMPLETED|Overall Study||41
3131552|NCT01686152|3856443|FG001|NOT COMPLETED|Overall Study||35
3131553|NCT01686152|3856444|FG002|NOT COMPLETED|Overall Study||9
3131554|NCT01686165|3856452|FG000|STARTED|Overall Study||5
3131555|NCT01686165|3856452|FG000|COMPLETED|Overall Study||5
3131556|NCT01686165|3856452|FG000|NOT COMPLETED|Overall Study||0
3131557|NCT01686373|3856458|FG000|STARTED|Overall Study||34
3131558|NCT01686373|3856459|FG001|STARTED|Overall Study||40
3131559|NCT01686373|3856458|FG000|Received 15 Treatment Sessions|Overall Study||33
3131560|NCT01686373|3856459|FG001|Received 15 Treatment Sessions|Overall Study||39
3131561|NCT01686373|3856458|FG000|COMPLETED|Overall Study||31
3131562|NCT01686373|3856459|FG001|COMPLETED|Overall Study||38
3131563|NCT01686373|3856458|FG000|NOT COMPLETED|Overall Study||3
3131564|NCT01686373|3856459|FG001|NOT COMPLETED|Overall Study||2
3131565|NCT01686438|3856468|FG000|STARTED|Overall Study||15
3131566|NCT01686438|3856469|FG001|STARTED|Overall Study||35
3131567|NCT01686438|3856470|FG002|STARTED|Overall Study||37
3131568|NCT01686438|3856468|FG000|2-Week Follow Up|Overall Study||12
3131569|NCT01686438|3856469|FG001|2-Week Follow Up|Overall Study||31
3131570|NCT01686438|3856470|FG002|2-Week Follow Up|Overall Study||27
3131571|NCT01686438|3856468|FG000|3-Month Follow Up|Overall Study||7
3131572|NCT01686438|3856469|FG001|3-Month Follow Up|Overall Study||21
3131573|NCT01686438|3856470|FG002|3-Month Follow Up|Overall Study||17
3131574|NCT01686438|3856468|FG000|6-Month Follow Up|Overall Study||7
3131575|NCT01686438|3856469|FG001|6-Month Follow Up|Overall Study||26
3131576|NCT01686438|3856470|FG002|6-Month Follow Up|Overall Study||24
3131577|NCT01686438|3856468|FG000|COMPLETED|Overall Study||7
3131578|NCT01686438|3856469|FG001|COMPLETED|Overall Study||26
3131579|NCT01686438|3856470|FG002|COMPLETED|Overall Study||24
3131580|NCT01686438|3856468|FG000|NOT COMPLETED|Overall Study||8
3131581|NCT01686438|3856469|FG001|NOT COMPLETED|Overall Study||9
3131582|NCT01686438|3856470|FG002|NOT COMPLETED|Overall Study||13
3131583|NCT01686451|3856482|FG000|STARTED|Overall Study||33
3131584|NCT01686451|3856483|FG001|STARTED|Overall Study||27
3131585|NCT01686451|3856482|FG000|COMPLETED|Overall Study||33
3131586|NCT01686451|3856483|FG001|COMPLETED|Overall Study||27
3131587|NCT01686451|3856482|FG000|NOT COMPLETED|Overall Study||0
3131588|NCT01686451|3856483|FG001|NOT COMPLETED|Overall Study||0
3131589|NCT01686503|3856495|FG000|STARTED|Overall Study||66
3131590|NCT01686503|3856496|FG001|STARTED|Overall Study||66
3131591|NCT01686503|3856497|FG002|STARTED|Overall Study||66
3131592|NCT01686503|3856498|FG003|STARTED|Overall Study||33
3131593|NCT01686503|3856495|FG000|COMPLETED|Overall Study||65
3131594|NCT01686503|3856496|FG001|COMPLETED|Overall Study||63
3131595|NCT01686503|3856497|FG002|COMPLETED|Overall Study||64
3131596|NCT01686503|3856498|FG003|COMPLETED|Overall Study||32
3131597|NCT01686503|3856495|FG000|NOT COMPLETED|Overall Study||1
3131598|NCT01686503|3856496|FG001|NOT COMPLETED|Overall Study||3
3131599|NCT01686503|3856497|FG002|NOT COMPLETED|Overall Study||2
3131600|NCT01686503|3856498|FG003|NOT COMPLETED|Overall Study||1
3131601|NCT01686568|3856510|FG000|STARTED|Main Study||16
3131602|NCT01686568|3856511|FG001|STARTED|Main Study||15
3131603|NCT01686568|3856510|FG000|COMPLETED|Main Study||14
3131604|NCT01686568|3856511|FG001|COMPLETED|Main Study||11
3131605|NCT01686568|3856510|FG000|NOT COMPLETED|Main Study||2
3131606|NCT01686568|3856511|FG001|NOT COMPLETED|Main Study||4
3131607|NCT01686568|3856510|FG000|STARTED|Sub-Study||14
3131608|NCT01686568|3856511|FG001|STARTED|Sub-Study||11
3296783|NCT02908529|4030552|FG000|NOT COMPLETED|Overall Study||0
3296784|NCT02908529|4030553|FG001|NOT COMPLETED|Overall Study||2
3296785|NCT02908620|4030565|FG000|STARTED|Overall Study||10
3296786|NCT02908620|4030566|FG001|STARTED|Overall Study||10
3296787|NCT02908620|4030567|FG002|STARTED|Overall Study||10
3296788|NCT02908620|4030568|FG003|STARTED|Overall Study||10
3296789|NCT02908620|4030565|FG000|COMPLETED|Overall Study||10
3296790|NCT02908620|4030566|FG001|COMPLETED|Overall Study||10
3296791|NCT02908620|4030567|FG002|COMPLETED|Overall Study||10
3296792|NCT02908620|4030568|FG003|COMPLETED|Overall Study||10
3296793|NCT02908620|4030565|FG000|NOT COMPLETED|Overall Study||0
3296794|NCT02908620|4030566|FG001|NOT COMPLETED|Overall Study||0
3296795|NCT02908620|4030567|FG002|NOT COMPLETED|Overall Study||0
3296796|NCT02908620|4030568|FG003|NOT COMPLETED|Overall Study||0
3296797|NCT02908841|4030584|FG000|STARTED|Overall Study||10
3296798|NCT02908841|4030585|FG001|STARTED|Overall Study||12
3296799|NCT02908841|4030584|FG000|COMPLETED|Overall Study||6
3296800|NCT02908841|4030585|FG001|COMPLETED|Overall Study||12
3296801|NCT02908841|4030584|FG000|NOT COMPLETED|Overall Study||4
3296802|NCT02908841|4030585|FG001|NOT COMPLETED|Overall Study||0
3296803|NCT02908880|4030591|FG000|STARTED|Overall Study|Subjects within the Primary Analysis Cohort that received the MANTA Device|263
3316868|NCT03120520|4050349|FG001|STARTED|Overall Study||31
3131609|NCT01686568|3856510|FG000|COMPLETED|Sub-Study||12
3131610|NCT01686568|3856511|FG001|COMPLETED|Sub-Study||9
3131611|NCT01686568|3856510|FG000|NOT COMPLETED|Sub-Study||2
3131612|NCT01686568|3856511|FG001|NOT COMPLETED|Sub-Study||2
3131613|NCT01686581|3856517|FG000|STARTED|Overall Study||641
3131614|NCT01686581|3856517|FG000|Safety Analysis Set; Received Study Drug|Overall Study||633
3131615|NCT01686581|3856517|FG000|Completed 24 Months|Overall Study||128
3131616|NCT01686581|3856517|FG000|COMPLETED|Overall Study||464
3131617|NCT01686581|3856517|FG000|NOT COMPLETED|Overall Study||177
3131618|NCT01686633|3856524|FG000|STARTED|Overall Study||347
3131619|NCT01686633|3856525|FG001|STARTED|Overall Study||346
3131620|NCT01686633|3856526|FG002|STARTED|Overall Study||346
3131621|NCT01686633|3856524|FG000|COMPLETED|Overall Study||296
3131622|NCT01686633|3856525|FG001|COMPLETED|Overall Study||314
3131623|NCT01686633|3856526|FG002|COMPLETED|Overall Study||321
3131624|NCT01686633|3856524|FG000|NOT COMPLETED|Overall Study||51
3131625|NCT01686633|3856525|FG001|NOT COMPLETED|Overall Study||32
3131626|NCT01686633|3856526|FG002|NOT COMPLETED|Overall Study||25
3131627|NCT01686646|3856538|FG000|STARTED|Overall Study||45
3131628|NCT01686646|3856539|FG001|STARTED|Overall Study||45
3131629|NCT01686646|3856540|FG002|STARTED|Overall Study||75
3131630|NCT01686646|3856541|FG003|STARTED|Overall Study||75
3131631|NCT01686646|3856538|FG000|Intent to Treat Population|Overall Study||45
3131632|NCT01686646|3856539|FG001|Intent to Treat Population|Overall Study||45
3131633|NCT01686646|3856540|FG002|Intent to Treat Population|Overall Study||75
3131634|NCT01686646|3856541|FG003|Intent to Treat Population|Overall Study||75
3131635|NCT01686646|3856538|FG000|Safety Population|Overall Study|One subject randomized to Paracetamol+Caffeine (500/65) group but received 1000/130 combination.|46
3131636|NCT01686646|3856539|FG001|Safety Population|Overall Study||45
3131637|NCT01686646|3856540|FG002|Safety Population|Overall Study||74
3131638|NCT01686646|3856541|FG003|Safety Population|Overall Study||75
3131639|NCT01686646|3856538|FG000|COMPLETED|Overall Study||45
3131640|NCT01686646|3856539|FG001|COMPLETED|Overall Study||45
3131641|NCT01686646|3856540|FG002|COMPLETED|Overall Study||75
3131642|NCT01686646|3856541|FG003|COMPLETED|Overall Study||75
3131643|NCT01686646|3856538|FG000|NOT COMPLETED|Overall Study||0
3131644|NCT01686646|3856539|FG001|NOT COMPLETED|Overall Study||0
3131645|NCT01686646|3856540|FG002|NOT COMPLETED|Overall Study||0
3131646|NCT01686646|3856541|FG003|NOT COMPLETED|Overall Study||0
3131647|NCT01686750|3856553|FG000|STARTED|Overall Study||11001
3131648|NCT01686750|3856554|FG001|STARTED|Overall Study||10725
3131649|NCT01686750|3856553|FG000|COMPLETED|Overall Study||11001
3131650|NCT01686750|3856554|FG001|COMPLETED|Overall Study||10725
3131651|NCT01686750|3856553|FG000|NOT COMPLETED|Overall Study||0
3131652|NCT01686750|3856554|FG001|NOT COMPLETED|Overall Study||0
3131653|NCT01686828|3856566|FG000|STARTED|Overall Study||13
3131654|NCT01686828|3856567|FG001|STARTED|Overall Study||14
3131655|NCT01686828|3856568|FG002|STARTED|Overall Study||13
3131656|NCT01686828|3856569|FG003|STARTED|Overall Study||13
3131657|NCT01686828|3856566|FG000|COMPLETED|Overall Study||12
3131658|NCT01686828|3856567|FG001|COMPLETED|Overall Study||13
3131659|NCT01686828|3856568|FG002|COMPLETED|Overall Study||12
3131660|NCT01686828|3856569|FG003|COMPLETED|Overall Study||13
3131661|NCT01686828|3856566|FG000|NOT COMPLETED|Overall Study||1
3131662|NCT01686828|3856567|FG001|NOT COMPLETED|Overall Study||1
3131663|NCT01686828|3856568|FG002|NOT COMPLETED|Overall Study||1
3131664|NCT01686828|3856569|FG003|NOT COMPLETED|Overall Study||0
3131665|NCT01686932|3856585|FG000|STARTED|Period 1||25
3131666|NCT01686932|3856586|FG001|STARTED|Period 1||26
3131667|NCT01686932|3856585|FG000|COMPLETED|Period 1||24
3131668|NCT01686932|3856586|FG001|COMPLETED|Period 1||25
3131669|NCT01686932|3856585|FG000|NOT COMPLETED|Period 1||1
3131670|NCT01686932|3856586|FG001|NOT COMPLETED|Period 1||1
3131671|NCT01686932|3856585|FG000|STARTED|Period 2||24
3131672|NCT01686932|3856586|FG001|STARTED|Period 2||25
3131673|NCT01686932|3856585|FG000|COMPLETED|Period 2||24
3131674|NCT01686932|3856586|FG001|COMPLETED|Period 2||25
3131675|NCT01686932|3856585|FG000|NOT COMPLETED|Period 2||0
3131676|NCT01686932|3856586|FG001|NOT COMPLETED|Period 2||0
3131677|NCT01686958|3856592|FG000|STARTED|Overall Study||30
3131678|NCT01686958|3856592|FG000|COMPLETED|Overall Study|No. of patients who completed ALL assessments at 12 months post treatment; 1 pt only had PSA test.|29
3163296|NCT01885182|3890814|FG000|NOT COMPLETED|Overall Study||34
3163297|NCT01885182|3890815|FG001|NOT COMPLETED|Overall Study||22
3163298|NCT01885195|3890823|FG000|STARTED|Overall Study||110
3296804|NCT02908880|4030591|FG000|COMPLETED|Overall Study|Subjects within the Primary Analysis Cohort that completed all follow-up time points.|236
3296805|NCT02908880|4030591|FG000|NOT COMPLETED|Overall Study||27
3296806|NCT02909101|4030597|FG000|STARTED|Overall Study||29
3296807|NCT02909101|4030598|FG001|STARTED|Overall Study||29
3296808|NCT02909101|4030597|FG000|COMPLETED|Overall Study||28
3296809|NCT02909101|4030598|FG001|COMPLETED|Overall Study||28
3296810|NCT02909101|4030597|FG000|NOT COMPLETED|Overall Study||1
3296811|NCT02909101|4030598|FG001|NOT COMPLETED|Overall Study||1
3296812|NCT02909140|4030607|FG000|STARTED|Overall Study||0
3296813|NCT02909140|4030608|FG001|STARTED|Overall Study||2
3296814|NCT02909140|4030609|FG002|STARTED|Overall Study||0
3296815|NCT02909140|4030607|FG000|COMPLETED|Overall Study||0
3296816|NCT02909140|4030608|FG001|COMPLETED|Overall Study||2
3296817|NCT02909140|4030609|FG002|COMPLETED|Overall Study||0
3296818|NCT02909140|4030607|FG000|NOT COMPLETED|Overall Study||0
3296819|NCT02909140|4030608|FG001|NOT COMPLETED|Overall Study||0
3296820|NCT02909140|4030609|FG002|NOT COMPLETED|Overall Study||0
3296821|NCT02909153|4030622|FG000|STARTED|Overall Study||6
3296822|NCT02909153|4030623|FG001|STARTED|Overall Study||6
3296823|NCT02909153|4030624|FG002|STARTED|Overall Study||6
3296824|NCT02909153|4030625|FG003|STARTED|Overall Study||6
3131679|NCT01686958|3856592|FG000|NOT COMPLETED|Overall Study||1
3131680|NCT01687036|3856597|FG000|STARTED|Overall Study||10
3131681|NCT01687036|3856597|FG000|COMPLETED|Overall Study||10
3131682|NCT01687036|3856597|FG000|NOT COMPLETED|Overall Study||0
3131683|NCT01687088|3856603|FG000|STARTED|Overall Study||50
3131684|NCT01687088|3856604|FG001|STARTED|Overall Study||50
3131685|NCT01687088|3856603|FG000|COMPLETED|Overall Study||50
3131686|NCT01687088|3856604|FG001|COMPLETED|Overall Study||50
3131687|NCT01687088|3856603|FG000|NOT COMPLETED|Overall Study||0
3131688|NCT01687088|3856604|FG001|NOT COMPLETED|Overall Study||0
3131689|NCT01687101|3856610|FG000|STARTED|Overall Study||32
3131690|NCT01687101|3856610|FG000|COMPLETED|Overall Study||25
3131691|NCT01687101|3856610|FG000|NOT COMPLETED|Overall Study||7
3131692|NCT01687114|3856614|FG000|STARTED|Overall Study||5
3131693|NCT01687114|3856614|FG000|COMPLETED|Overall Study||5
3131694|NCT01687114|3856614|FG000|NOT COMPLETED|Overall Study||0
3131695|NCT01687166|3856622|FG000|STARTED|Overall Study||167
3131696|NCT01687166|3856623|FG001|STARTED|Overall Study||172
3131697|NCT01687166|3856624|FG002|STARTED|Overall Study||56
3131698|NCT01687166|3856625|FG003|STARTED|Overall Study||3
3131699|NCT01687166|3856622|FG000|COMPLETED|Overall Study||139
3131700|NCT01687166|3856623|FG001|COMPLETED|Overall Study||145
3131701|NCT01687166|3856624|FG002|COMPLETED|Overall Study||42
3131702|NCT01687166|3856625|FG003|COMPLETED|Overall Study||1
3131703|NCT01687166|3856622|FG000|NOT COMPLETED|Overall Study||28
3131704|NCT01687166|3856623|FG001|NOT COMPLETED|Overall Study||27
3131705|NCT01687166|3856624|FG002|NOT COMPLETED|Overall Study||14
3296825|NCT02909153|4030626|FG004|STARTED|Overall Study||6
3296826|NCT02909153|4030622|FG000|Triferic in Dianeal PD Solution|Overall Study||6
3296827|NCT02909153|4030623|FG001|Triferic in Dianeal PD Solution|Overall Study||6
3296828|NCT02909153|4030624|FG002|Triferic in Dianeal PD Solution|Overall Study||6
3296829|NCT02909153|4030625|FG003|Triferic in Dianeal PD Solution|Overall Study||0
3296830|NCT02909153|4030626|FG004|Triferic in Dianeal PD Solution|Overall Study||0
3296831|NCT02909153|4030622|FG000|Triferic 6.6mg Fe Via 4hr IV Infusions|Overall Study||6
3296832|NCT02909153|4030623|FG001|Triferic 6.6mg Fe Via 4hr IV Infusions|Overall Study||5
3296833|NCT02909153|4030624|FG002|Triferic 6.6mg Fe Via 4hr IV Infusions|Overall Study||6
3296834|NCT02909153|4030625|FG003|Triferic 6.6mg Fe Via 4hr IV Infusions|Overall Study||6
3296835|NCT02909153|4030626|FG004|Triferic 6.6mg Fe Via 4hr IV Infusions|Overall Study||6
3296836|NCT02909153|4030622|FG000|Triferic in Extraneal PD Solution|Overall Study||0
3296837|NCT02909153|4030623|FG001|Triferic in Extraneal PD Solution|Overall Study||0
3296838|NCT02909153|4030624|FG002|Triferic in Extraneal PD Solution|Overall Study||0
3296839|NCT02909153|4030625|FG003|Triferic in Extraneal PD Solution|Overall Study||6
3296840|NCT02909153|4030626|FG004|Triferic in Extraneal PD Solution|Overall Study||6
3296841|NCT02909153|4030622|FG000|COMPLETED|Overall Study||6
3296842|NCT02909153|4030623|FG001|COMPLETED|Overall Study||5
3296843|NCT02909153|4030624|FG002|COMPLETED|Overall Study||6
3296844|NCT02909153|4030625|FG003|COMPLETED|Overall Study||6
3296845|NCT02909153|4030626|FG004|COMPLETED|Overall Study||6
3296846|NCT02909153|4030622|FG000|NOT COMPLETED|Overall Study||0
3296847|NCT02909153|4030623|FG001|NOT COMPLETED|Overall Study||1
3296848|NCT02909153|4030624|FG002|NOT COMPLETED|Overall Study||0
3296849|NCT02909153|4030625|FG003|NOT COMPLETED|Overall Study||0
3296850|NCT02909153|4030626|FG004|NOT COMPLETED|Overall Study||0
3296851|NCT02909439|4030640|FG000|STARTED|Overall Study||31
3296852|NCT02909439|4030641|FG001|STARTED|Overall Study||31
3296853|NCT02909439|4030640|FG000|COMPLETED|Overall Study||31
3296854|NCT02909439|4030641|FG001|COMPLETED|Overall Study||31
3296855|NCT02909439|4030640|FG000|NOT COMPLETED|Overall Study||0
3296856|NCT02909439|4030641|FG001|NOT COMPLETED|Overall Study||0
3296857|NCT02909504|4030647|FG000|STARTED|Overall Study||24
3296858|NCT02909504|4030647|FG000|COMPLETED|Overall Study||12
3296859|NCT02909504|4030647|FG000|NOT COMPLETED|Overall Study||12
3296860|NCT02909764|4030654|FG000|STARTED|Overall Study||19
3296861|NCT02909764|4030655|FG001|STARTED|Overall Study||20
3296862|NCT02909764|4030654|FG000|COMPLETED|Overall Study||19
3296863|NCT02909764|4030655|FG001|COMPLETED|Overall Study||20
3296864|NCT02909764|4030654|FG000|NOT COMPLETED|Overall Study||0
3296865|NCT02909764|4030655|FG001|NOT COMPLETED|Overall Study||0
3296866|NCT02909907|4030666|FG000|STARTED|Overall Study||10
3296867|NCT02909907|4030667|FG001|STARTED|Overall Study||10
3296868|NCT02909907|4030666|FG000|COMPLETED|Overall Study||10
3296869|NCT02909907|4030667|FG001|COMPLETED|Overall Study||9
3296870|NCT02909907|4030666|FG000|NOT COMPLETED|Overall Study||0
3296871|NCT02909907|4030667|FG001|NOT COMPLETED|Overall Study||1
3296872|NCT02909959|4030675|FG000|STARTED|Overall Study||24
3296873|NCT02909959|4030676|FG001|STARTED|Overall Study||24
3296874|NCT02909959|4030675|FG000|COMPLETED|Overall Study||24
3296875|NCT02909959|4030676|FG001|COMPLETED|Overall Study||24
3296876|NCT02909959|4030675|FG000|NOT COMPLETED|Overall Study||0
3296877|NCT02909959|4030676|FG001|NOT COMPLETED|Overall Study||0
3296878|NCT02910011|4030682|FG000|STARTED|Overall Study||15
3296879|NCT02910011|4030682|FG000|COMPLETED|Overall Study||13
3131706|NCT01687166|3856625|FG003|NOT COMPLETED|Overall Study||2
3131707|NCT01687179|3856633|FG000|STARTED|Overall Study||3
3131708|NCT01687179|3856634|FG001|STARTED|Overall Study||10
3131709|NCT01687179|3856633|FG000|COMPLETED|Overall Study||2
3131710|NCT01687179|3856634|FG001|COMPLETED|Overall Study||6
3131711|NCT01687179|3856633|FG000|NOT COMPLETED|Overall Study||1
3131712|NCT01687179|3856634|FG001|NOT COMPLETED|Overall Study||4
3131713|NCT01687218|3856646|FG000|STARTED|Overall Study||33
3131714|NCT01687218|3856647|FG001|STARTED|Overall Study||32
3131715|NCT01687218|3856648|FG002|STARTED|Overall Study||31
3131716|NCT01687218|3856649|FG003|STARTED|Overall Study||34
3131717|NCT01687218|3856650|FG004|STARTED|Overall Study||33
3131718|NCT01687218|3856651|FG005|STARTED|Overall Study||32
3131719|NCT01687218|3856646|FG000|COMPLETED|Overall Study||30
3131720|NCT01687218|3856647|FG001|COMPLETED|Overall Study||29
3131721|NCT01687218|3856648|FG002|COMPLETED|Overall Study||30
3131722|NCT01687218|3856649|FG003|COMPLETED|Overall Study||32
3131723|NCT01687218|3856650|FG004|COMPLETED|Overall Study||32
3131724|NCT01687218|3856651|FG005|COMPLETED|Overall Study||32
3131725|NCT01687218|3856646|FG000|NOT COMPLETED|Overall Study||3
3131726|NCT01687218|3856647|FG001|NOT COMPLETED|Overall Study||3
3131727|NCT01687218|3856648|FG002|NOT COMPLETED|Overall Study||1
3131728|NCT01687218|3856649|FG003|NOT COMPLETED|Overall Study||2
3131729|NCT01687218|3856650|FG004|NOT COMPLETED|Overall Study||1
3131730|NCT01687218|3856651|FG005|NOT COMPLETED|Overall Study||0
3131731|NCT01687244|3856661|FG000|STARTED|Overall Study||21
3131732|NCT01687244|3856662|FG001|STARTED|Overall Study||19
3131733|NCT01687244|3856661|FG000|COMPLETED|Overall Study||21
3131734|NCT01687244|3856662|FG001|COMPLETED|Overall Study||19
3131735|NCT01687244|3856661|FG000|NOT COMPLETED|Overall Study||0
3131736|NCT01687244|3856662|FG001|NOT COMPLETED|Overall Study||0
3131737|NCT01687257|3856678|FG000|STARTED|Overall Study||25
3131738|NCT01687257|3856679|FG001|STARTED|Overall Study||4
3131739|NCT01687257|3856680|FG002|STARTED|Overall Study||21
3131740|NCT01687257|3856678|FG000|COMPLETED|Overall Study||17
3131741|NCT01687257|3856679|FG001|COMPLETED|Overall Study||0
3131742|NCT01687257|3856680|FG002|COMPLETED|Overall Study||15
3131743|NCT01687257|3856678|FG000|NOT COMPLETED|Overall Study||8
3131744|NCT01687257|3856679|FG001|NOT COMPLETED|Overall Study||4
3131745|NCT01687257|3856680|FG002|NOT COMPLETED|Overall Study||6
3131746|NCT01687270|3856694|FG000|STARTED|Overall Study||40
3131747|NCT01687270|3856694|FG000|COMPLETED|Overall Study||28
3131748|NCT01687270|3856694|FG000|NOT COMPLETED|Overall Study||12
3131749|NCT01687283|3856700|FG000|STARTED|Overall Study||158
3131750|NCT01687283|3856701|FG001|STARTED|Overall Study||157
3131751|NCT01687283|3856700|FG000|COMPLETED|Overall Study||123
3131752|NCT01687283|3856701|FG001|COMPLETED|Overall Study||130
3131753|NCT01687283|3856700|FG000|NOT COMPLETED|Overall Study||35
3131754|NCT01687283|3856701|FG001|NOT COMPLETED|Overall Study||27
3131755|NCT01687296|3856709|FG000|STARTED|Overall Study||123
3131756|NCT01687296|3856710|FG001|STARTED|Overall Study||128
3296880|NCT02910011|4030682|FG000|NOT COMPLETED|Overall Study||2
3296881|NCT02910037|4030688|FG000|STARTED|Overall Study||214
3296882|NCT02910037|4030688|FG000|COMPLETED|Overall Study||204
3296883|NCT02910037|4030688|FG000|NOT COMPLETED|Overall Study||10
3296884|NCT02910063|4030708|FG000|STARTED|Phase 2||41
3296885|NCT02910063|4030709|FG001|STARTED|Phase 2|Participants in this Phase 3 arm were not included in the Phase 2 period.|0
3131757|NCT01687296|3856709|FG000|COMPLETED|Overall Study||116
3131758|NCT01687296|3856710|FG001|COMPLETED|Overall Study||123
3131759|NCT01687296|3856709|FG000|NOT COMPLETED|Overall Study||7
3131760|NCT01687296|3856710|FG001|NOT COMPLETED|Overall Study||5
3131761|NCT01687387|3856719|FG000|STARTED|Overall Study||51
3131762|NCT01687387|3856720|FG001|STARTED|Overall Study||50
3131763|NCT01687387|3856721|FG002|STARTED|Overall Study||51
3131764|NCT01687387|3856719|FG000|COMPLETED|Overall Study||10
3131765|NCT01687387|3856720|FG001|COMPLETED|Overall Study||12
3131766|NCT01687387|3856721|FG002|COMPLETED|Overall Study||13
3131767|NCT01687387|3856719|FG000|NOT COMPLETED|Overall Study||41
3131768|NCT01687387|3856720|FG001|NOT COMPLETED|Overall Study||38
3131769|NCT01687387|3856721|FG002|NOT COMPLETED|Overall Study||38
3131770|NCT01687400|3856729|FG000|STARTED|Overall Study||114
3131771|NCT01687400|3856729|FG000|COMPLETED|Overall Study||114
3131772|NCT01687400|3856729|FG000|NOT COMPLETED|Overall Study||0
3131773|NCT01687413|3856740|FG000|STARTED|Overall Study||27
3131774|NCT01687413|3856741|FG001|STARTED|Overall Study||15
3296886|NCT02910063|4030710|FG002|STARTED|Phase 2|Participants in this Phase 3 arm were not included in the Phase 2 period.|0
3296887|NCT02910063|4030708|FG000|Started Cycle 1|Phase 2||41
3296888|NCT02910063|4030709|FG001|Started Cycle 1|Phase 2||0
3296889|NCT02910063|4030710|FG002|Started Cycle 1|Phase 2||0
3131775|NCT01687413|3856740|FG000|COMPLETED|Overall Study||26
3296890|NCT02910063|4030708|FG000|Started Optional Cycle 2|Phase 2||4
3296891|NCT02910063|4030709|FG001|Started Optional Cycle 2|Phase 2||0
3296892|NCT02910063|4030710|FG002|Started Optional Cycle 2|Phase 2||0
3296893|NCT02910063|4030708|FG000|COMPLETED|Phase 2||13
3296894|NCT02910063|4030709|FG001|COMPLETED|Phase 2||0
3296895|NCT02910063|4030710|FG002|COMPLETED|Phase 2||0
3296896|NCT02910063|4030708|FG000|NOT COMPLETED|Phase 2||28
3296897|NCT02910063|4030709|FG001|NOT COMPLETED|Phase 2||0
3296898|NCT02910063|4030710|FG002|NOT COMPLETED|Phase 2||0
3296899|NCT02910063|4030708|FG000|STARTED|Phase 3|Participants in this Phase 2 arm were not included in the Phase 3 period.|0
3296900|NCT02910063|4030709|FG001|STARTED|Phase 3||0
3296901|NCT02910063|4030710|FG002|STARTED|Phase 3||0
3296902|NCT02910063|4030708|FG000|COMPLETED|Phase 3||0
3296903|NCT02910063|4030709|FG001|COMPLETED|Phase 3||0
3296904|NCT02910063|4030710|FG002|COMPLETED|Phase 3||0
3296905|NCT02910063|4030708|FG000|NOT COMPLETED|Phase 3||0
3296906|NCT02910063|4030709|FG001|NOT COMPLETED|Phase 3||0
3131776|NCT01687413|3856741|FG001|COMPLETED|Overall Study||11
3131777|NCT01687413|3856740|FG000|NOT COMPLETED|Overall Study||1
3131778|NCT01687413|3856741|FG001|NOT COMPLETED|Overall Study||4
3131779|NCT01687478|3856767|FG000|STARTED|Overall Study||88
3131780|NCT01687478|3856768|FG001|STARTED|Overall Study||88
3131781|NCT01687478|3856767|FG000|Safety Analysis Set|Overall Study||88
3131782|NCT01687478|3856768|FG001|Safety Analysis Set|Overall Study||87
3131783|NCT01687478|3856767|FG000|COMPLETED|Overall Study||56
3131784|NCT01687478|3856768|FG001|COMPLETED|Overall Study||49
3131785|NCT01687478|3856767|FG000|NOT COMPLETED|Overall Study||32
3131786|NCT01687478|3856768|FG001|NOT COMPLETED|Overall Study||39
3131787|NCT01687595|3856776|FG000|STARTED|Overall Study||70
3131788|NCT01687595|3856777|FG001|STARTED|Overall Study||10
3131789|NCT01687595|3856776|FG000|Received at Least 1 Dose of Study Drug|Overall Study||70
3131790|NCT01687595|3856777|FG001|Received at Least 1 Dose of Study Drug|Overall Study||10
3131791|NCT01687595|3856776|FG000|COMPLETED|Overall Study||0
3131792|NCT01687595|3856777|FG001|COMPLETED|Overall Study||0
3131793|NCT01687595|3856776|FG000|NOT COMPLETED|Overall Study||70
3131794|NCT01687595|3856777|FG001|NOT COMPLETED|Overall Study||10
3131795|NCT01687673|3856783|FG000|STARTED|Overall Study||29
3131796|NCT01687673|3856783|FG000|COMPLETED|Overall Study||28
3131797|NCT01687673|3856783|FG000|NOT COMPLETED|Overall Study||1
3131798|NCT01687712|3856789|FG000|STARTED|Cycle 1||549
3131799|NCT01687712|3856790|FG001|STARTED|Cycle 1||551
3131800|NCT01687712|3856789|FG000|Received hCG|Cycle 1||516
3131801|NCT01687712|3856790|FG001|Received hCG|Cycle 1||520
3131802|NCT01687712|3856789|FG000|Oocyte/Ovum Pick Up|Cycle 1||513
3131803|NCT01687712|3856790|FG001|Oocyte/Ovum Pick Up|Cycle 1||517
3131804|NCT01687712|3856789|FG000|Fertilization Performed|Cycle 1||508
3131805|NCT01687712|3856790|FG001|Fertilization Performed|Cycle 1||512
3131806|NCT01687712|3856789|FG000|Embryo Transfer|Cycle 1||466
3131807|NCT01687712|3856790|FG001|Embryo Transfer|Cycle 1||483
3131808|NCT01687712|3856789|FG000|Biochemical Pregnancy|Cycle 1||163
3131809|NCT01687712|3856790|FG001|Biochemical Pregnancy|Cycle 1||203
3131810|NCT01687712|3856789|FG000|Clinical Pregnancy|Cycle 1||114
3131811|NCT01687712|3856790|FG001|Clinical Pregnancy|Cycle 1||138
3296907|NCT02910063|4030710|FG002|NOT COMPLETED|Phase 3||0
3296908|NCT02910089|4030721|FG000|STARTED|Overall Study|Patients allocated to intervention|700
3296909|NCT02910089|4030722|FG001|STARTED|Overall Study|Patients allocated to control|700
3296910|NCT02910089|4030721|FG000|COMPLETED|Overall Study|22 patients ineligible (3.1%)|678
3296911|NCT02910089|4030722|FG001|COMPLETED|Overall Study|16 Patients ineligible (2.3%)|684
3296912|NCT02910089|4030721|FG000|NOT COMPLETED|Overall Study||22
3296913|NCT02910089|4030722|FG001|NOT COMPLETED|Overall Study||16
3296914|NCT02910102|4030730|FG000|STARTED|Overall Study||21
3296915|NCT02910102|4030731|FG001|STARTED|Overall Study||17
3296916|NCT02910102|4030730|FG000|Safety Population|Overall Study||21
3296917|NCT02910102|4030731|FG001|Safety Population|Overall Study||17
3296918|NCT02910102|4030730|FG000|Intent to Treat (ITT) Population|Overall Study||21
3296919|NCT02910102|4030731|FG001|Intent to Treat (ITT) Population|Overall Study||17
3296920|NCT02910102|4030730|FG000|Per-Protocol Population|Overall Study||20
3296921|NCT02910102|4030731|FG001|Per-Protocol Population|Overall Study||17
3296922|NCT02910102|4030730|FG000|COMPLETED|Overall Study||21
3296923|NCT02910102|4030731|FG001|COMPLETED|Overall Study||17
3296924|NCT02910102|4030730|FG000|NOT COMPLETED|Overall Study||0
3296925|NCT02910102|4030731|FG001|NOT COMPLETED|Overall Study||0
3296926|NCT02910167|4030742|FG000|STARTED|Overall Study||360
3296927|NCT02910167|4030742|FG000|COMPLETED|Overall Study||341
3296928|NCT02910167|4030742|FG000|NOT COMPLETED|Overall Study||19
3296929|NCT02910362|4030748|FG000|STARTED|Overall Study||8
3296930|NCT02910362|4030749|FG001|STARTED|Overall Study||7
3296931|NCT02910362|4030748|FG000|COMPLETED|Overall Study||8
3296932|NCT02910362|4030749|FG001|COMPLETED|Overall Study||7
3296933|NCT02910362|4030748|FG000|NOT COMPLETED|Overall Study||0
3296934|NCT02910362|4030749|FG001|NOT COMPLETED|Overall Study||0
3296935|NCT02910466|4030755|FG000|STARTED|Overall Study||39
3296936|NCT02910466|4030755|FG000|Safety Set|Overall Study||39
3296937|NCT02910466|4030755|FG000|Treated|Overall Study||36
3296938|NCT02910466|4030755|FG000|COMPLETED|Overall Study||0
3296939|NCT02910466|4030755|FG000|NOT COMPLETED|Overall Study||39
3296940|NCT02910674|4030759|FG000|STARTED|Overall Study||102
3383610|NCT01774370|4118675|FG000|STARTED|Overall Study||3182
3383611|NCT01774370|4118675|FG000|COMPLETED|Overall Study||3053
3296941|NCT02910674|4030759|FG000|COMPLETED|Overall Study||102
3296942|NCT02910674|4030759|FG000|NOT COMPLETED|Overall Study||0
3296943|NCT02910713|4030764|FG000|STARTED|Overall Study||185
3296944|NCT02910713|4030764|FG000|Safety Population: Entered CAE|Overall Study||171
3296945|NCT02910713|4030764|FG000|COMPLETED|Overall Study|Completed=Completed both Intranasal and Extranasal applications.|143
3296946|NCT02910713|4030764|FG000|NOT COMPLETED|Overall Study||42
3296947|NCT02910739|4030771|FG000|STARTED|Overall Study||8
3296948|NCT02910739|4030772|FG001|STARTED|Overall Study||8
3296949|NCT02910739|4030773|FG002|STARTED|Overall Study|Participants were not enrolled in Part II as the PK criterion from the Part I IA was not met.|0
3296950|NCT02910739|4030774|FG003|STARTED|Overall Study|Participants were not enrolled in Part II as the PK criterion from the Part I IA was not met.|0
3296951|NCT02910739|4030771|FG000|COMPLETED|Overall Study||7
3296952|NCT02910739|4030772|FG001|COMPLETED|Overall Study||8
3383612|NCT01774370|4118675|FG000|NOT COMPLETED|Overall Study||129
3383613|NCT01777295|4118681|FG000|STARTED|Overall Study||40
3131812|NCT01687712|3856789|FG000|COMPLETED|Cycle 1||101
3131813|NCT01687712|3856790|FG001|COMPLETED|Cycle 1||122
3131814|NCT01687712|3856789|FG000|NOT COMPLETED|Cycle 1||448
3131815|NCT01687712|3856790|FG001|NOT COMPLETED|Cycle 1||429
3131816|NCT01687712|3856789|FG000|STARTED|Cycle 2||109
3131817|NCT01687712|3856790|FG001|STARTED|Cycle 2||120
3131818|NCT01687712|3856789|FG000|Received hCG|Cycle 2||107
3131819|NCT01687712|3856790|FG001|Received hCG|Cycle 2||119
3131820|NCT01687712|3856789|FG000|Oocyte/Ovum Pick Up|Cycle 2||107
3131821|NCT01687712|3856790|FG001|Oocyte/Ovum Pick Up|Cycle 2||119
3131822|NCT01687712|3856789|FG000|Fertilization Performed|Cycle 2||106
3131823|NCT01687712|3856790|FG001|Fertilization Performed|Cycle 2||119
3131824|NCT01687712|3856789|FG000|Embryo Transfer|Cycle 2||101
3131825|NCT01687712|3856790|FG001|Embryo Transfer|Cycle 2||117
3131826|NCT01687712|3856789|FG000|Biochemical Pregnancy|Cycle 2||35
3131827|NCT01687712|3856790|FG001|Biochemical Pregnancy|Cycle 2||43
3131828|NCT01687712|3856789|FG000|Clinical Pregnancy|Cycle 2||17
3131829|NCT01687712|3856790|FG001|Clinical Pregnancy|Cycle 2||26
3131830|NCT01687712|3856789|FG000|COMPLETED|Cycle 2||16
3131831|NCT01687712|3856790|FG001|COMPLETED|Cycle 2||25
3131832|NCT01687712|3856789|FG000|NOT COMPLETED|Cycle 2||93
3131833|NCT01687712|3856790|FG001|NOT COMPLETED|Cycle 2||95
3131834|NCT01687712|3856789|FG000|STARTED|Cycle 3||28
3131835|NCT01687712|3856790|FG001|STARTED|Cycle 3||24
3131836|NCT01687712|3856789|FG000|Received hCG|Cycle 3||27
3131837|NCT01687712|3856790|FG001|Received hCG|Cycle 3||24
3131838|NCT01687712|3856789|FG000|Ooctye/Ovum Pick-Up|Cycle 3||27
3131839|NCT01687712|3856790|FG001|Ooctye/Ovum Pick-Up|Cycle 3||24
3131840|NCT01687712|3856789|FG000|Fertilization Performed|Cycle 3||27
3131841|NCT01687712|3856790|FG001|Fertilization Performed|Cycle 3||24
3131842|NCT01687712|3856789|FG000|Embryo Transfer|Cycle 3||26
3131843|NCT01687712|3856790|FG001|Embryo Transfer|Cycle 3||24
3131844|NCT01687712|3856789|FG000|Biochemically Pregnant|Cycle 3||7
3131845|NCT01687712|3856790|FG001|Biochemically Pregnant|Cycle 3||2
3131846|NCT01687712|3856789|FG000|Clinical Pregnancy|Cycle 3||5
3131847|NCT01687712|3856790|FG001|Clinical Pregnancy|Cycle 3||0
3296953|NCT02910739|4030773|FG002|COMPLETED|Overall Study|Participants were not enrolled in Part II as the PK criterion from the Part I IA was not met.|0
3296954|NCT02910739|4030774|FG003|COMPLETED|Overall Study|Participants were not enrolled in Part II as the PK criterion from the Part I IA was not met.|0
3296955|NCT02910739|4030771|FG000|NOT COMPLETED|Overall Study||1
3296956|NCT02910739|4030772|FG001|NOT COMPLETED|Overall Study||0
3296957|NCT02910739|4030773|FG002|NOT COMPLETED|Overall Study||0
3296958|NCT02910739|4030774|FG003|NOT COMPLETED|Overall Study||0
3296959|NCT02911025|4030780|FG000|STARTED|Overall Study||13
3296960|NCT02911025|4030780|FG000|COMPLETED|Overall Study||10
3296961|NCT02911025|4030780|FG000|NOT COMPLETED|Overall Study||3
3296962|NCT02911116|4030786|FG000|STARTED|Overall Study||5
3296963|NCT02911116|4030787|FG001|STARTED|Overall Study||3
3296964|NCT02911116|4030786|FG000|COMPLETED|Overall Study||4
3296965|NCT02911116|4030787|FG001|COMPLETED|Overall Study||2
3296966|NCT02911116|4030786|FG000|NOT COMPLETED|Overall Study||1
3296967|NCT02911116|4030787|FG001|NOT COMPLETED|Overall Study||1
3296968|NCT02911285|4030795|FG000|STARTED|Overall Study||49
3296969|NCT02911285|4030796|FG001|STARTED|Overall Study||41
3296970|NCT02911285|4030795|FG000|COMPLETED|Overall Study||40
3296971|NCT02911285|4030796|FG001|COMPLETED|Overall Study||36
3296972|NCT02911285|4030795|FG000|NOT COMPLETED|Overall Study||9
3296973|NCT02911285|4030796|FG001|NOT COMPLETED|Overall Study||5
3296974|NCT02911324|4030808|FG000|STARTED|Overall Study||9
3296975|NCT02911324|4030809|FG001|STARTED|Overall Study||7
3296976|NCT02911324|4030808|FG000|COMPLETED|Overall Study||6
3296977|NCT02911324|4030809|FG001|COMPLETED|Overall Study||6
3296978|NCT02911324|4030808|FG000|NOT COMPLETED|Overall Study||3
3296979|NCT02911324|4030809|FG001|NOT COMPLETED|Overall Study||1
3296980|NCT02911519|4030818|FG000|STARTED|Overall Study||90
3296981|NCT02911519|4030819|FG001|STARTED|Overall Study||86
3296982|NCT02911519|4030818|FG000|COMPLETED|Overall Study||88
3296983|NCT02911519|4030819|FG001|COMPLETED|Overall Study||82
3296984|NCT02911519|4030818|FG000|NOT COMPLETED|Overall Study||2
3296985|NCT02911519|4030819|FG001|NOT COMPLETED|Overall Study||4
3296986|NCT02911688|4030827|FG000|STARTED|First Intervention||9
3296987|NCT02911688|4030828|FG001|STARTED|First Intervention||9
3383614|NCT01777295|4118682|FG001|STARTED|Overall Study||41
3131848|NCT01687712|3856789|FG000|COMPLETED|Cycle 3||4
3131849|NCT01687712|3856790|FG001|COMPLETED|Cycle 3||0
3296988|NCT02911688|4030827|FG000|Received Intervention|First Intervention||9
3296989|NCT02911688|4030828|FG001|Received Intervention|First Intervention||9
3296990|NCT02911688|4030827|FG000|COMPLETED|First Intervention||9
3296991|NCT02911688|4030828|FG001|COMPLETED|First Intervention||9
3296992|NCT02911688|4030827|FG000|NOT COMPLETED|First Intervention||0
3296993|NCT02911688|4030828|FG001|NOT COMPLETED|First Intervention||0
3296994|NCT02911688|4030827|FG000|STARTED|Washout||9
3296995|NCT02911688|4030828|FG001|STARTED|Washout||9
3296996|NCT02911688|4030827|FG000|COMPLETED|Washout||8
3296997|NCT02911688|4030828|FG001|COMPLETED|Washout||7
3296998|NCT02911688|4030827|FG000|NOT COMPLETED|Washout||1
3296999|NCT02911688|4030828|FG001|NOT COMPLETED|Washout||2
3297000|NCT02911688|4030827|FG000|STARTED|Second Intervention||8
3297001|NCT02911688|4030828|FG001|STARTED|Second Intervention||7
3297002|NCT02911688|4030827|FG000|COMPLETED|Second Intervention||8
3297003|NCT02911688|4030828|FG001|COMPLETED|Second Intervention||7
3297004|NCT02911688|4030827|FG000|NOT COMPLETED|Second Intervention||0
3297005|NCT02911688|4030828|FG001|NOT COMPLETED|Second Intervention||0
3297006|NCT02911753|4030839|FG000|STARTED|Overall Study||21
3297007|NCT02911753|4030840|FG001|STARTED|Overall Study||19
3297008|NCT02911753|4030841|FG002|STARTED|Overall Study||10
3297009|NCT02911753|4030839|FG000|COMPLETED|Overall Study||18
3297010|NCT02911753|4030840|FG001|COMPLETED|Overall Study||16
3297011|NCT02911753|4030841|FG002|COMPLETED|Overall Study||10
3131850|NCT01687712|3856789|FG000|NOT COMPLETED|Cycle 3||24
3131851|NCT01687712|3856790|FG001|NOT COMPLETED|Cycle 3||24
3297012|NCT02911753|4030839|FG000|NOT COMPLETED|Overall Study||3
3297013|NCT02911753|4030840|FG001|NOT COMPLETED|Overall Study||3
3297014|NCT02911753|4030841|FG002|NOT COMPLETED|Overall Study||0
3131852|NCT01687790|3856800|FG000|STARTED|Overall Study||60
3131853|NCT01687790|3856800|FG000|COMPLETED|Overall Study||60
3131854|NCT01687790|3856800|FG000|NOT COMPLETED|Overall Study||0
3131855|NCT01687972|3856807|FG000|STARTED|Overall Study||44
3131856|NCT01687972|3856808|FG001|STARTED|Overall Study||44
3131857|NCT01687972|3856807|FG000|COMPLETED|Overall Study||44
3131858|NCT01687972|3856808|FG001|COMPLETED|Overall Study||44
3131859|NCT01687972|3856807|FG000|NOT COMPLETED|Overall Study||0
3131860|NCT01687972|3856808|FG001|NOT COMPLETED|Overall Study||0
3131861|NCT01687998|3856816|FG000|STARTED|Overall Study||6038
3131862|NCT01687998|3856817|FG001|STARTED|Overall Study||6054
3131863|NCT01687998|3856816|FG000|Received at Least One Dose of Study Drug|Overall Study||6036
3131864|NCT01687998|3856817|FG001|Received at Least One Dose of Study Drug|Overall Study||6052
3131865|NCT01687998|3856816|FG000|COMPLETED|Overall Study||5926
3131866|NCT01687998|3856817|FG001|COMPLETED|Overall Study||5934
3131867|NCT01687998|3856816|FG000|NOT COMPLETED|Overall Study||112
3131868|NCT01687998|3856817|FG001|NOT COMPLETED|Overall Study||120
3131869|NCT01688037|3856826|FG000|STARTED|Double-Blind Period (Week 0 to 6)||54
3131870|NCT01688037|3856827|FG001|STARTED|Double-Blind Period (Week 0 to 6)||28
3131871|NCT01688037|3856828|FG002|STARTED|Double-Blind Period (Week 0 to 6)||27
3131872|NCT01688037|3856826|FG000|COMPLETED|Double-Blind Period (Week 0 to 6)||47
3297015|NCT02911818|4030870|FG000|STARTED|52 Week Study||50
3297016|NCT02911818|4030871|FG001|STARTED|52 Week Study||50
3297017|NCT02911818|4030872|FG002|STARTED|52 Week Study||50
3297018|NCT02911818|4030873|FG003|STARTED|52 Week Study||0
3297019|NCT02911818|4030874|FG004|STARTED|52 Week Study||0
3297020|NCT02911818|4030870|FG000|COMPLETED|52 Week Study||46
3297021|NCT02911818|4030871|FG001|COMPLETED|52 Week Study||45
3297022|NCT02911818|4030872|FG002|COMPLETED|52 Week Study||46
3297023|NCT02911818|4030873|FG003|COMPLETED|52 Week Study||0
3297024|NCT02911818|4030874|FG004|COMPLETED|52 Week Study||0
3297025|NCT02911818|4030870|FG000|NOT COMPLETED|52 Week Study||4
3297026|NCT02911818|4030871|FG001|NOT COMPLETED|52 Week Study||5
3297027|NCT02911818|4030872|FG002|NOT COMPLETED|52 Week Study||4
3297028|NCT02911818|4030873|FG003|NOT COMPLETED|52 Week Study||0
3297029|NCT02911818|4030874|FG004|NOT COMPLETED|52 Week Study||0
3297030|NCT02911818|4030870|FG000|STARTED|12 Week Extension Study||0
3297031|NCT02911818|4030871|FG001|STARTED|12 Week Extension Study||0
3297032|NCT02911818|4030872|FG002|STARTED|12 Week Extension Study||0
3297033|NCT02911818|4030873|FG003|STARTED|12 Week Extension Study||22
3297034|NCT02911818|4030874|FG004|STARTED|12 Week Extension Study||23
3297035|NCT02911818|4030870|FG000|COMPLETED|12 Week Extension Study||0
3297036|NCT02911818|4030871|FG001|COMPLETED|12 Week Extension Study||0
3297037|NCT02911818|4030872|FG002|COMPLETED|12 Week Extension Study||0
3297038|NCT02911818|4030873|FG003|COMPLETED|12 Week Extension Study||22
3297039|NCT02911818|4030874|FG004|COMPLETED|12 Week Extension Study||22
3297040|NCT02911818|4030870|FG000|NOT COMPLETED|12 Week Extension Study||0
3297041|NCT02911818|4030871|FG001|NOT COMPLETED|12 Week Extension Study||0
3297042|NCT02911818|4030872|FG002|NOT COMPLETED|12 Week Extension Study||0
3297043|NCT02911818|4030873|FG003|NOT COMPLETED|12 Week Extension Study||0
3297044|NCT02911818|4030874|FG004|NOT COMPLETED|12 Week Extension Study||1
3297045|NCT02911844|4030888|FG000|STARTED|Overall Study||5
3297046|NCT02911844|4030888|FG000|COMPLETED|Overall Study||5
3297047|NCT02911844|4030888|FG000|NOT COMPLETED|Overall Study||0
3297048|NCT02911857|4030895|FG000|STARTED|Overall Study||2
3297049|NCT02911857|4030896|FG001|STARTED|Overall Study||1
3297050|NCT02911857|4030897|FG002|STARTED|Overall Study||1
3297051|NCT02911857|4030895|FG000|COMPLETED|Overall Study||2
3297052|NCT02911857|4030896|FG001|COMPLETED|Overall Study||1
3297053|NCT02911857|4030897|FG002|COMPLETED|Overall Study||1
3297054|NCT02911857|4030895|FG000|NOT COMPLETED|Overall Study||0
3297055|NCT02911857|4030896|FG001|NOT COMPLETED|Overall Study||0
3297056|NCT02911857|4030897|FG002|NOT COMPLETED|Overall Study||0
3297057|NCT02911909|4030907|FG000|STARTED|Overall Study||4
3297058|NCT02911909|4030908|FG001|STARTED|Overall Study||3
3297059|NCT02911909|4030907|FG000|COMPLETED|Overall Study||2
3297060|NCT02911909|4030908|FG001|COMPLETED|Overall Study|No Data was obtained in the study group.|0
3297061|NCT02911909|4030907|FG000|NOT COMPLETED|Overall Study||2
3297062|NCT02911909|4030908|FG001|NOT COMPLETED|Overall Study||3
3297063|NCT02911922|4030916|FG000|STARTED|Overall Study||1
3297064|NCT02911922|4030917|FG001|STARTED|Overall Study||0
3297065|NCT02911922|4030916|FG000|COMPLETED|Overall Study||1
3297066|NCT02911922|4030917|FG001|COMPLETED|Overall Study||0
3297067|NCT02911922|4030916|FG000|NOT COMPLETED|Overall Study||0
3297068|NCT02911922|4030917|FG001|NOT COMPLETED|Overall Study||0
3297069|NCT02911948|4030927|FG000|STARTED|Overall Study||105
3297070|NCT02911948|4030928|FG001|STARTED|Overall Study||105
3297071|NCT02911948|4030927|FG000|COMPLETED|Overall Study||105
3297072|NCT02911948|4030928|FG001|COMPLETED|Overall Study||98
3297073|NCT02911948|4030927|FG000|NOT COMPLETED|Overall Study||0
3297074|NCT02911948|4030928|FG001|NOT COMPLETED|Overall Study||7
3297075|NCT02912195|4030936|FG000|STARTED|Overall Study||16
3297076|NCT02912195|4030937|FG001|STARTED|Overall Study||16
3297077|NCT02912195|4030936|FG000|COMPLETED|Overall Study||16
3297078|NCT02912195|4030937|FG001|COMPLETED|Overall Study||16
3297079|NCT02912195|4030936|FG000|NOT COMPLETED|Overall Study||0
3297080|NCT02912195|4030937|FG001|NOT COMPLETED|Overall Study||0
3297081|NCT02912364|4030943|FG000|STARTED|Treatment 1||23
3297082|NCT02912364|4030944|FG001|STARTED|Treatment 1||23
3297083|NCT02912364|4030943|FG000|Received Intervention|Treatment 1||18
3297084|NCT02912364|4030944|FG001|Received Intervention|Treatment 1||18
3297085|NCT02912364|4030943|FG000|COMPLETED|Treatment 1||13
3297086|NCT02912364|4030944|FG001|COMPLETED|Treatment 1||11
3297087|NCT02912364|4030943|FG000|NOT COMPLETED|Treatment 1||10
3297088|NCT02912364|4030944|FG001|NOT COMPLETED|Treatment 1||12
3297089|NCT02912364|4030943|FG000|STARTED|Washout Period||13
3297090|NCT02912364|4030944|FG001|STARTED|Washout Period||11
3297091|NCT02912364|4030943|FG000|COMPLETED|Washout Period||13
3297092|NCT02912364|4030944|FG001|COMPLETED|Washout Period||11
3297093|NCT02912364|4030943|FG000|NOT COMPLETED|Washout Period||0
3131873|NCT01688037|3856827|FG001|COMPLETED|Double-Blind Period (Week 0 to 6)||25
3131874|NCT01688037|3856828|FG002|COMPLETED|Double-Blind Period (Week 0 to 6)||21
3131875|NCT01688037|3856826|FG000|NOT COMPLETED|Double-Blind Period (Week 0 to 6)||7
3131876|NCT01688037|3856827|FG001|NOT COMPLETED|Double-Blind Period (Week 0 to 6)||3
3131877|NCT01688037|3856828|FG002|NOT COMPLETED|Double-Blind Period (Week 0 to 6)||6
3131878|NCT01688037|3856826|FG000|STARTED|Open-Label Period (Week 6 to 12)||47
3131879|NCT01688037|3856827|FG001|STARTED|Open-Label Period (Week 6 to 12)||25
3131880|NCT01688037|3856828|FG002|STARTED|Open-Label Period (Week 6 to 12)||21
3131881|NCT01688037|3856826|FG000|COMPLETED|Open-Label Period (Week 6 to 12)||42
3131882|NCT01688037|3856827|FG001|COMPLETED|Open-Label Period (Week 6 to 12)||22
3131883|NCT01688037|3856828|FG002|COMPLETED|Open-Label Period (Week 6 to 12)||17
3131884|NCT01688037|3856826|FG000|NOT COMPLETED|Open-Label Period (Week 6 to 12)||5
3131885|NCT01688037|3856827|FG001|NOT COMPLETED|Open-Label Period (Week 6 to 12)||3
3131886|NCT01688037|3856828|FG002|NOT COMPLETED|Open-Label Period (Week 6 to 12)||4
3131887|NCT01688037|3856826|FG000|STARTED|Follow-up Period (Week 12 to 16)||42
3131888|NCT01688037|3856827|FG001|STARTED|Follow-up Period (Week 12 to 16)||22
3131889|NCT01688037|3856828|FG002|STARTED|Follow-up Period (Week 12 to 16)||17
3131890|NCT01688037|3856826|FG000|COMPLETED|Follow-up Period (Week 12 to 16)||42
3131891|NCT01688037|3856827|FG001|COMPLETED|Follow-up Period (Week 12 to 16)||21
3131892|NCT01688037|3856828|FG002|COMPLETED|Follow-up Period (Week 12 to 16)||17
3131893|NCT01688037|3856826|FG000|NOT COMPLETED|Follow-up Period (Week 12 to 16)||0
3131894|NCT01688037|3856827|FG001|NOT COMPLETED|Follow-up Period (Week 12 to 16)||1
3131895|NCT01688037|3856828|FG002|NOT COMPLETED|Follow-up Period (Week 12 to 16)||0
3131896|NCT01688050|3856840|FG000|STARTED|Overall Study||50
3131897|NCT01688050|3856840|FG000|5-Year|Overall Study|Patients eligible for Follow-up at 5 year|22
3131898|NCT01688050|3856840|FG000|COMPLETED|Overall Study||19
3131899|NCT01688050|3856840|FG000|NOT COMPLETED|Overall Study||31
3131900|NCT01688102|3856846|FG000|STARTED|Overall Study||60
3131901|NCT01688102|3856847|FG001|STARTED|Overall Study||58
3131902|NCT01688102|3856846|FG000|COMPLETED|Overall Study||44
3131903|NCT01688102|3856847|FG001|COMPLETED|Overall Study||40
3131904|NCT01688102|3856846|FG000|NOT COMPLETED|Overall Study||16
3131905|NCT01688102|3856847|FG001|NOT COMPLETED|Overall Study||18
3131906|NCT01688141|3856855|FG000|STARTED|Overall Study||11706
3131907|NCT01688141|3856856|FG001|STARTED|Overall Study||11651
3131908|NCT01688141|3856855|FG000|COMPLETED|Overall Study||11706
3131909|NCT01688141|3856856|FG001|COMPLETED|Overall Study||11651
3131910|NCT01688141|3856855|FG000|NOT COMPLETED|Overall Study||0
3131911|NCT01688141|3856856|FG001|NOT COMPLETED|Overall Study||0
3131912|NCT01688310|3856864|FG000|STARTED|Overall Study||100
3131913|NCT01688310|3856865|FG001|STARTED|Overall Study||100
3131914|NCT01688310|3856864|FG000|COMPLETED|Overall Study||100
3131915|NCT01688310|3856865|FG001|COMPLETED|Overall Study||100
3131916|NCT01688310|3856864|FG000|NOT COMPLETED|Overall Study||0
3131917|NCT01688310|3856865|FG001|NOT COMPLETED|Overall Study||0
3131918|NCT01688336|3856873|FG000|STARTED|Overall Study||9
3131919|NCT01688336|3856873|FG000|COMPLETED|Overall Study||9
3131920|NCT01688336|3856873|FG000|NOT COMPLETED|Overall Study||0
3297094|NCT02912364|4030944|FG001|NOT COMPLETED|Washout Period||0
3297095|NCT02912364|4030943|FG000|STARTED|Treatment 2||13
3297096|NCT02912364|4030944|FG001|STARTED|Treatment 2||11
3297097|NCT02912364|4030943|FG000|Received Intervention|Treatment 2||12
3297098|NCT02912364|4030944|FG001|Received Intervention|Treatment 2||11
3297099|NCT02912364|4030943|FG000|COMPLETED|Treatment 2||12
3297100|NCT02912364|4030944|FG001|COMPLETED|Treatment 2||11
3297101|NCT02912364|4030943|FG000|NOT COMPLETED|Treatment 2||1
3297102|NCT02912364|4030944|FG001|NOT COMPLETED|Treatment 2||0
3297103|NCT02912455|4030955|FG000|STARTED|Overall Study||11
3297104|NCT02912455|4030956|FG001|STARTED|Overall Study||5
3297105|NCT02912455|4030955|FG000|COMPLETED|Overall Study||9
3297106|NCT02912455|4030956|FG001|COMPLETED|Overall Study||2
3297107|NCT02912455|4030955|FG000|NOT COMPLETED|Overall Study||2
3297108|NCT02912455|4030956|FG001|NOT COMPLETED|Overall Study||3
3297109|NCT02912468|4030964|FG000|STARTED|Overall Study||133
3131921|NCT01688466|3856880|FG000|STARTED|Overall Study||17
3131922|NCT01688466|3856881|FG001|STARTED|Overall Study||17
3131923|NCT01688466|3856880|FG000|COMPLETED|Overall Study||15
3131924|NCT01688466|3856881|FG001|COMPLETED|Overall Study||10
3131925|NCT01688466|3856880|FG000|NOT COMPLETED|Overall Study||2
3131926|NCT01688466|3856881|FG001|NOT COMPLETED|Overall Study||7
3297110|NCT02912468|4030965|FG001|STARTED|Overall Study||143
3297111|NCT02912468|4030964|FG000|Treated|Overall Study||133
3297112|NCT02912468|4030965|FG001|Treated|Overall Study||142
3131927|NCT01688596|3856889|FG000|STARTED|Overall Study||67
3131928|NCT01688596|3856890|FG001|STARTED|Overall Study||68
3131929|NCT01688596|3856889|FG000|COMPLETED|Overall Study||59
3131930|NCT01688596|3856890|FG001|COMPLETED|Overall Study||59
3131931|NCT01688596|3856889|FG000|NOT COMPLETED|Overall Study||8
3131932|NCT01688596|3856890|FG001|NOT COMPLETED|Overall Study||9
3131933|NCT01688609|3856896|FG000|STARTED|Overall Study||18
3131934|NCT01688609|3856896|FG000|COMPLETED|Overall Study||18
3131935|NCT01688609|3856896|FG000|NOT COMPLETED|Overall Study||0
3131936|NCT01688635|3856900|FG000|STARTED|Period 1||45
3131937|NCT01688635|3856901|FG001|STARTED|Period 1||46
3131938|NCT01688635|3856900|FG000|Received at Least 1 Dose of Study Drug|Period 1||45
3131939|NCT01688635|3856901|FG001|Received at Least 1 Dose of Study Drug|Period 1||46
3131940|NCT01688635|3856900|FG000|COMPLETED|Period 1||45
3131941|NCT01688635|3856901|FG001|COMPLETED|Period 1||46
3131942|NCT01688635|3856900|FG000|NOT COMPLETED|Period 1||0
3131943|NCT01688635|3856901|FG001|NOT COMPLETED|Period 1||0
3131944|NCT01688635|3856900|FG000|STARTED|Washout 1||45
3131945|NCT01688635|3856901|FG001|STARTED|Washout 1||46
3131946|NCT01688635|3856900|FG000|COMPLETED|Washout 1||44
3131947|NCT01688635|3856901|FG001|COMPLETED|Washout 1||44
3131948|NCT01688635|3856900|FG000|NOT COMPLETED|Washout 1||1
3131949|NCT01688635|3856901|FG001|NOT COMPLETED|Washout 1||2
3131950|NCT01688635|3856900|FG000|STARTED|Period 2||44
3131951|NCT01688635|3856901|FG001|STARTED|Period 2||44
3131952|NCT01688635|3856900|FG000|COMPLETED|Period 2||44
3131953|NCT01688635|3856901|FG001|COMPLETED|Period 2||44
3131954|NCT01688635|3856900|FG000|NOT COMPLETED|Period 2||0
3131955|NCT01688635|3856901|FG001|NOT COMPLETED|Period 2||0
3131956|NCT01688635|3856900|FG000|STARTED|Washout 2||44
3131957|NCT01688635|3856901|FG001|STARTED|Washout 2||44
3131958|NCT01688635|3856900|FG000|COMPLETED|Washout 2||41
3131959|NCT01688635|3856901|FG001|COMPLETED|Washout 2||42
3131960|NCT01688635|3856900|FG000|NOT COMPLETED|Washout 2||3
3131961|NCT01688635|3856901|FG001|NOT COMPLETED|Washout 2||2
3131962|NCT01688635|3856900|FG000|STARTED|Period 3||41
3131963|NCT01688635|3856901|FG001|STARTED|Period 3||42
3131964|NCT01688635|3856900|FG000|COMPLETED|Period 3||41
3131965|NCT01688635|3856901|FG001|COMPLETED|Period 3||42
3131966|NCT01688635|3856900|FG000|NOT COMPLETED|Period 3||0
3131967|NCT01688635|3856901|FG001|NOT COMPLETED|Period 3||0
3131968|NCT01688635|3856900|FG000|STARTED|Washout 3||41
3131969|NCT01688635|3856901|FG001|STARTED|Washout 3||42
3131970|NCT01688635|3856900|FG000|COMPLETED|Washout 3||40
3131971|NCT01688635|3856901|FG001|COMPLETED|Washout 3||42
3131972|NCT01688635|3856900|FG000|NOT COMPLETED|Washout 3||1
3131973|NCT01688635|3856901|FG001|NOT COMPLETED|Washout 3||0
3297113|NCT02912468|4030964|FG000|Safety Population|Overall Study||132
3297114|NCT02912468|4030965|FG001|Safety Population|Overall Study||143
3297115|NCT02912468|4030964|FG000|COMPLETED|Overall Study||124
3297116|NCT02912468|4030965|FG001|COMPLETED|Overall Study||138
3297117|NCT02912468|4030964|FG000|NOT COMPLETED|Overall Study||9
3297118|NCT02912468|4030965|FG001|NOT COMPLETED|Overall Study||5
3316869|NCT03120520|4050350|FG002|STARTED|Overall Study||30
3316870|NCT03120520|4050351|FG003|STARTED|Overall Study||32
3316871|NCT03120520|4050348|FG000|COMPLETED|Overall Study||27
3316872|NCT03120520|4050349|FG001|COMPLETED|Overall Study||27
3316873|NCT03120520|4050350|FG002|COMPLETED|Overall Study||26
3316874|NCT03120520|4050351|FG003|COMPLETED|Overall Study||29
3316875|NCT03120520|4050348|FG000|NOT COMPLETED|Overall Study||4
3316876|NCT03120520|4050349|FG001|NOT COMPLETED|Overall Study||4
3316877|NCT03120520|4050350|FG002|NOT COMPLETED|Overall Study||4
3316878|NCT03120520|4050351|FG003|NOT COMPLETED|Overall Study||3
3316879|NCT03120832|4050364|FG000|STARTED|Overall Study||3
3316880|NCT03120832|4050365|FG001|STARTED|Overall Study||3
3316881|NCT03120832|4050366|FG002|STARTED|Overall Study||6
3316882|NCT03120832|4050364|FG000|COMPLETED|Overall Study||3
3316883|NCT03120832|4050365|FG001|COMPLETED|Overall Study||3
3316884|NCT03120832|4050366|FG002|COMPLETED|Overall Study||6
3316885|NCT03120832|4050364|FG000|NOT COMPLETED|Overall Study||0
3316886|NCT03120832|4050365|FG001|NOT COMPLETED|Overall Study||0
3316887|NCT03120832|4050366|FG002|NOT COMPLETED|Overall Study||0
3316888|NCT03121144|4050374|FG000|STARTED|Overall Study||34
3316889|NCT03121144|4050374|FG000|COMPLETED|Overall Study||34
3316890|NCT03121144|4050374|FG000|NOT COMPLETED|Overall Study||0
3316891|NCT03121365|4050380|FG000|STARTED|Baseline||55
3316892|NCT03121365|4050381|FG001|STARTED|Baseline||49
3316893|NCT03121365|4050380|FG000|COMPLETED|Baseline||54
3316894|NCT03121365|4050381|FG001|COMPLETED|Baseline||48
3316895|NCT03121365|4050380|FG000|NOT COMPLETED|Baseline||1
3316896|NCT03121365|4050381|FG001|NOT COMPLETED|Baseline||1
3316897|NCT03121365|4050380|FG000|STARTED|1 Months||54
3316898|NCT03121365|4050381|FG001|STARTED|1 Months||48
3316899|NCT03121365|4050380|FG000|COMPLETED|1 Months||52
3316900|NCT03121365|4050381|FG001|COMPLETED|1 Months||45
3316901|NCT03121365|4050380|FG000|NOT COMPLETED|1 Months||2
3316902|NCT03121365|4050381|FG001|NOT COMPLETED|1 Months||3
3316903|NCT03121365|4050380|FG000|STARTED|4 Months||54
3131974|NCT01688635|3856900|FG000|STARTED|Period 4||40
3131975|NCT01688635|3856901|FG001|STARTED|Period 4||42
3131976|NCT01688635|3856900|FG000|COMPLETED|Period 4||40
3131977|NCT01688635|3856901|FG001|COMPLETED|Period 4||42
3131978|NCT01688635|3856900|FG000|NOT COMPLETED|Period 4||0
3131979|NCT01688635|3856901|FG001|NOT COMPLETED|Period 4||0
3131980|NCT01688726|3856910|FG000|STARTED|Overall Study||46
3316904|NCT03121365|4050381|FG001|STARTED|4 Months||45
3316905|NCT03121365|4050380|FG000|COMPLETED|4 Months||51
3131981|NCT01688726|3856911|FG001|STARTED|Overall Study||45
3131982|NCT01688726|3856910|FG000|COMPLETED|Overall Study||45
3131983|NCT01688726|3856911|FG001|COMPLETED|Overall Study||44
3131984|NCT01688726|3856910|FG000|NOT COMPLETED|Overall Study||1
3131985|NCT01688726|3856911|FG001|NOT COMPLETED|Overall Study||1
3131986|NCT01688739|3856931|FG000|STARTED|Overall Study||13
3131987|NCT01688739|3856932|FG001|STARTED|Overall Study||3
3131988|NCT01688739|3856933|FG002|STARTED|Overall Study||3
3131989|NCT01688739|3856934|FG003|STARTED|Overall Study||6
3131990|NCT01688739|3856935|FG004|STARTED|Overall Study||6
3131991|NCT01688739|3856936|FG005|STARTED|Overall Study||6
3131992|NCT01688739|3856937|FG006|STARTED|Overall Study||6
3131993|NCT01688739|3856938|FG007|STARTED|Overall Study||6
3131994|NCT01688739|3856939|FG008|STARTED|Overall Study||6
3131995|NCT01688739|3856940|FG009|STARTED|Overall Study||6
3131996|NCT01688739|3856931|FG000|Received Study Drug|Overall Study||12
3131997|NCT01688739|3856932|FG001|Received Study Drug|Overall Study||3
3131998|NCT01688739|3856933|FG002|Received Study Drug|Overall Study||3
3131999|NCT01688739|3856934|FG003|Received Study Drug|Overall Study||6
3132000|NCT01688739|3856935|FG004|Received Study Drug|Overall Study||6
3132001|NCT01688739|3856936|FG005|Received Study Drug|Overall Study||6
3132002|NCT01688739|3856937|FG006|Received Study Drug|Overall Study||6
3132003|NCT01688739|3856938|FG007|Received Study Drug|Overall Study||6
3132004|NCT01688739|3856939|FG008|Received Study Drug|Overall Study||6
3132005|NCT01688739|3856940|FG009|Received Study Drug|Overall Study||6
3132006|NCT01688739|3856931|FG000|COMPLETED|Overall Study||12
3132007|NCT01688739|3856932|FG001|COMPLETED|Overall Study||3
3132008|NCT01688739|3856933|FG002|COMPLETED|Overall Study||3
3132009|NCT01688739|3856934|FG003|COMPLETED|Overall Study||6
3132010|NCT01688739|3856935|FG004|COMPLETED|Overall Study||6
3132011|NCT01688739|3856936|FG005|COMPLETED|Overall Study||6
3132012|NCT01688739|3856937|FG006|COMPLETED|Overall Study||6
3132013|NCT01688739|3856938|FG007|COMPLETED|Overall Study||6
3132014|NCT01688739|3856939|FG008|COMPLETED|Overall Study||6
3132015|NCT01688739|3856940|FG009|COMPLETED|Overall Study||6
3132016|NCT01688739|3856931|FG000|NOT COMPLETED|Overall Study||1
3132017|NCT01688739|3856932|FG001|NOT COMPLETED|Overall Study||0
3132018|NCT01688739|3856933|FG002|NOT COMPLETED|Overall Study||0
3132019|NCT01688739|3856934|FG003|NOT COMPLETED|Overall Study||0
3132020|NCT01688739|3856935|FG004|NOT COMPLETED|Overall Study||0
3132021|NCT01688739|3856936|FG005|NOT COMPLETED|Overall Study||0
3132022|NCT01688739|3856937|FG006|NOT COMPLETED|Overall Study||0
3132023|NCT01688739|3856938|FG007|NOT COMPLETED|Overall Study||0
3132024|NCT01688739|3856939|FG008|NOT COMPLETED|Overall Study||0
3132025|NCT01688739|3856940|FG009|NOT COMPLETED|Overall Study||0
3132026|NCT01688830|3856991|FG000|STARTED|Overall Study||21
3132027|NCT01688830|3856992|FG001|STARTED|Overall Study||6
3132028|NCT01688830|3856993|FG002|STARTED|Overall Study||6
3132029|NCT01688830|3856994|FG003|STARTED|Overall Study||6
3132030|NCT01688830|3856995|FG004|STARTED|Overall Study||5
3132031|NCT01688830|3856996|FG005|STARTED|Overall Study||6
3132032|NCT01688830|3856997|FG006|STARTED|Overall Study||12
3132033|NCT01688830|3856998|FG007|STARTED|Overall Study||6
3132034|NCT01688830|3856999|FG008|STARTED|Overall Study||6
3132035|NCT01688830|3857000|FG009|STARTED|Overall Study||6
3132036|NCT01688830|3857001|FG010|STARTED|Overall Study||6
3132037|NCT01688830|3857002|FG011|STARTED|Overall Study||6
3132038|NCT01688830|3857003|FG012|STARTED|Overall Study||6
3132039|NCT01688830|3857004|FG013|STARTED|Overall Study||6
3132040|NCT01688830|3857005|FG014|STARTED|Overall Study||6
3132041|NCT01688830|3857006|FG015|STARTED|Overall Study||9
3132042|NCT01688830|3857007|FG016|STARTED|Overall Study||9
3132043|NCT01688830|3857008|FG017|STARTED|Overall Study||9
3132044|NCT01688830|3857009|FG018|STARTED|Overall Study||8
3132045|NCT01688830|3857010|FG019|STARTED|Overall Study||3
3132046|NCT01688830|3857011|FG020|STARTED|Overall Study||9
3132047|NCT01688830|3856991|FG000|COMPLETED|Overall Study||21
3132048|NCT01688830|3856992|FG001|COMPLETED|Overall Study||6
3132049|NCT01688830|3856993|FG002|COMPLETED|Overall Study||6
3132050|NCT01688830|3856994|FG003|COMPLETED|Overall Study||6
3132051|NCT01688830|3856995|FG004|COMPLETED|Overall Study||5
3132052|NCT01688830|3856996|FG005|COMPLETED|Overall Study||6
3132053|NCT01688830|3856997|FG006|COMPLETED|Overall Study||12
3132054|NCT01688830|3856998|FG007|COMPLETED|Overall Study||6
3132055|NCT01688830|3856999|FG008|COMPLETED|Overall Study||6
3132056|NCT01688830|3857000|FG009|COMPLETED|Overall Study||6
3132057|NCT01688830|3857001|FG010|COMPLETED|Overall Study||5
3132058|NCT01688830|3857002|FG011|COMPLETED|Overall Study||6
3132059|NCT01688830|3857003|FG012|COMPLETED|Overall Study||6
3132060|NCT01688830|3857004|FG013|COMPLETED|Overall Study||6
3132061|NCT01688830|3857005|FG014|COMPLETED|Overall Study||6
3132062|NCT01688830|3857006|FG015|COMPLETED|Overall Study||9
3132063|NCT01688830|3857007|FG016|COMPLETED|Overall Study||9
3132064|NCT01688830|3857008|FG017|COMPLETED|Overall Study||9
3132065|NCT01688830|3857009|FG018|COMPLETED|Overall Study||8
3132066|NCT01688830|3857010|FG019|COMPLETED|Overall Study||3
3132067|NCT01688830|3857011|FG020|COMPLETED|Overall Study||9
3132068|NCT01688830|3856991|FG000|NOT COMPLETED|Overall Study||0
3132069|NCT01688830|3856992|FG001|NOT COMPLETED|Overall Study||0
3132070|NCT01688830|3856993|FG002|NOT COMPLETED|Overall Study||0
3132071|NCT01688830|3856994|FG003|NOT COMPLETED|Overall Study||0
3132072|NCT01688830|3856995|FG004|NOT COMPLETED|Overall Study||0
3132073|NCT01688830|3856996|FG005|NOT COMPLETED|Overall Study||0
3132074|NCT01688830|3856997|FG006|NOT COMPLETED|Overall Study||0
3132075|NCT01688830|3856998|FG007|NOT COMPLETED|Overall Study||0
3132076|NCT01688830|3856999|FG008|NOT COMPLETED|Overall Study||0
3132077|NCT01688830|3857000|FG009|NOT COMPLETED|Overall Study||0
3132078|NCT01688830|3857001|FG010|NOT COMPLETED|Overall Study||1
3132079|NCT01688830|3857002|FG011|NOT COMPLETED|Overall Study||0
3132080|NCT01688830|3857003|FG012|NOT COMPLETED|Overall Study||0
3132081|NCT01688830|3857004|FG013|NOT COMPLETED|Overall Study||0
3132082|NCT01688830|3857005|FG014|NOT COMPLETED|Overall Study||0
3132083|NCT01688830|3857006|FG015|NOT COMPLETED|Overall Study||0
3132084|NCT01688830|3857007|FG016|NOT COMPLETED|Overall Study||0
3132085|NCT01688830|3857008|FG017|NOT COMPLETED|Overall Study||0
3132086|NCT01688830|3857009|FG018|NOT COMPLETED|Overall Study||0
3132087|NCT01688830|3857010|FG019|NOT COMPLETED|Overall Study||0
3132088|NCT01688830|3857011|FG020|NOT COMPLETED|Overall Study||0
3132089|NCT01688843|3857095|FG000|STARTED|Overall Study||1060
3132090|NCT01688843|3857095|FG000|COMPLETED|Overall Study||1060
3297119|NCT02912650|4030976|FG000|STARTED|Overall Study||56
3297120|NCT02912650|4030977|FG001|STARTED|Overall Study||172
3297121|NCT02912650|4030978|FG002|STARTED|Overall Study||175
3132091|NCT01688843|3857095|FG000|NOT COMPLETED|Overall Study||0
3132092|NCT01688856|3857104|FG000|STARTED|Overall Study||28
3132093|NCT01688856|3857105|FG001|STARTED|Overall Study||28
3297122|NCT02912650|4030979|FG003|STARTED|Overall Study||165
3297123|NCT02912650|4030976|FG000|COMPLETED|Overall Study||55
3297124|NCT02912650|4030977|FG001|COMPLETED|Overall Study||172
3297125|NCT02912650|4030978|FG002|COMPLETED|Overall Study||173
3297126|NCT02912650|4030979|FG003|COMPLETED|Overall Study||160
3297127|NCT02912650|4030976|FG000|NOT COMPLETED|Overall Study||1
3297128|NCT02912650|4030977|FG001|NOT COMPLETED|Overall Study||0
3297129|NCT02912650|4030978|FG002|NOT COMPLETED|Overall Study||2
3297130|NCT02912650|4030979|FG003|NOT COMPLETED|Overall Study||5
3297131|NCT02913105|4030992|FG000|STARTED|Overall Study||37
3297132|NCT02913105|4030993|FG001|STARTED|Overall Study||44
3297133|NCT02913105|4030994|FG002|STARTED|Overall Study||40
3297134|NCT02913105|4030992|FG000|COMPLETED|Overall Study||22
3297135|NCT02913105|4030993|FG001|COMPLETED|Overall Study||39
3297136|NCT02913105|4030994|FG002|COMPLETED|Overall Study||33
3297137|NCT02913105|4030992|FG000|NOT COMPLETED|Overall Study||15
3297138|NCT02913105|4030993|FG001|NOT COMPLETED|Overall Study||5
3297139|NCT02913105|4030994|FG002|NOT COMPLETED|Overall Study||7
3297140|NCT02913222|4031005|FG000|STARTED|Overall Study||23
3297141|NCT02913222|4031006|FG001|STARTED|Overall Study||23
3297142|NCT02913222|4031005|FG000|COMPLETED|Overall Study||22
3297143|NCT02913222|4031006|FG001|COMPLETED|Overall Study||21
3297144|NCT02913222|4031005|FG000|NOT COMPLETED|Overall Study||1
3297145|NCT02913222|4031006|FG001|NOT COMPLETED|Overall Study||2
3297146|NCT02913326|4031014|FG000|STARTED|Overall Study||60
3297147|NCT02913326|4031015|FG001|STARTED|Overall Study||60
3297148|NCT02913326|4031014|FG000|COMPLETED|Overall Study||59
3297149|NCT02913326|4031015|FG001|COMPLETED|Overall Study||58
3297150|NCT02913326|4031014|FG000|NOT COMPLETED|Overall Study||1
3297151|NCT02913326|4031015|FG001|NOT COMPLETED|Overall Study||2
3297152|NCT02913521|4031024|FG000|STARTED|Overall Study||316
3297153|NCT02913521|4031025|FG001|STARTED|Overall Study||312
3297154|NCT02913521|4031026|FG002|STARTED|Overall Study||306
3297155|NCT02913521|4031024|FG000|COMPLETED|Overall Study||263
3297156|NCT02913521|4031025|FG001|COMPLETED|Overall Study||262
3297157|NCT02913521|4031026|FG002|COMPLETED|Overall Study||261
3297158|NCT02913521|4031024|FG000|NOT COMPLETED|Overall Study||53
3297159|NCT02913521|4031025|FG001|NOT COMPLETED|Overall Study||50
3297160|NCT02913521|4031026|FG002|NOT COMPLETED|Overall Study||45
3297161|NCT02913924|4031036|FG000|STARTED|Overall Study||34
3297162|NCT02913924|4031037|FG001|STARTED|Overall Study||34
3297163|NCT02913924|4031036|FG000|COMPLETED|Overall Study||21
3297164|NCT02913924|4031037|FG001|COMPLETED|Overall Study||21
3297165|NCT02913924|4031036|FG000|NOT COMPLETED|Overall Study||13
3297166|NCT02913924|4031037|FG001|NOT COMPLETED|Overall Study||13
3297167|NCT02914119|4031043|FG000|STARTED|Overall Study||30430
3297168|NCT02914119|4031043|FG000|COMPLETED|Overall Study||30430
3297169|NCT02914119|4031043|FG000|NOT COMPLETED|Overall Study||0
3297170|NCT02914132|4031047|FG000|STARTED|Overall Study||15
3297171|NCT02914132|4031047|FG000|COMPLETED|Overall Study||15
3297172|NCT02914132|4031047|FG000|NOT COMPLETED|Overall Study||0
3297173|NCT02914184|4031055|FG000|STARTED|Overall Study||400
3297174|NCT02914184|4031056|FG001|STARTED|Overall Study||396
3297175|NCT02914184|4031057|FG002|STARTED|Overall Study||402
3297176|NCT02914184|4031058|FG003|STARTED|Overall Study||402
3297177|NCT02914184|4031055|FG000|COMPLETED|Overall Study||386
3297178|NCT02914184|4031056|FG001|COMPLETED|Overall Study||383
3297179|NCT02914184|4031057|FG002|COMPLETED|Overall Study||385
3297180|NCT02914184|4031058|FG003|COMPLETED|Overall Study||391
3297181|NCT02914184|4031055|FG000|NOT COMPLETED|Overall Study||14
3297182|NCT02914184|4031056|FG001|NOT COMPLETED|Overall Study||13
3297183|NCT02914184|4031057|FG002|NOT COMPLETED|Overall Study||17
3297184|NCT02914184|4031058|FG003|NOT COMPLETED|Overall Study||11
3297185|NCT02914210|4031072|FG000|STARTED|Overall Study||153
3132094|NCT01688856|3857106|FG002|STARTED|Overall Study||11
3297186|NCT02914210|4031073|FG001|STARTED|Overall Study||153
3297187|NCT02914210|4031072|FG000|COMPLETED|Overall Study||143
3297188|NCT02914210|4031073|FG001|COMPLETED|Overall Study||144
3297189|NCT02914210|4031072|FG000|NOT COMPLETED|Overall Study||10
3297190|NCT02914210|4031073|FG001|NOT COMPLETED|Overall Study||9
3297191|NCT02914236|4031079|FG000|STARTED|Overall Study||50
3132095|NCT01688856|3857104|FG000|COMPLETED|Overall Study||21
3297192|NCT02914236|4031079|FG000|4-week Follow-up Visit|Overall Study||50
3297193|NCT02914236|4031079|FG000|12-week Follow-up Visit|Overall Study||50
3297194|NCT02914236|4031079|FG000|26-week Follow-up Visit|Overall Study||49
3297195|NCT02914236|4031079|FG000|COMPLETED|Overall Study||49
3297196|NCT02914236|4031079|FG000|NOT COMPLETED|Overall Study||1
3297197|NCT02914275|4031085|FG000|STARTED|Overall Study||1687
3297198|NCT02914275|4031086|FG001|STARTED|Overall Study||563
3297199|NCT02914275|4031085|FG000|Included in Clinical Database / FAS|Overall Study||1684
3297200|NCT02914275|4031086|FG001|Included in Clinical Database / FAS|Overall Study||563
3297201|NCT02914275|4031085|FG000|COMPLETED|Overall Study||1566
3297202|NCT02914275|4031086|FG001|COMPLETED|Overall Study||521
3297203|NCT02914275|4031085|FG000|NOT COMPLETED|Overall Study||121
3297204|NCT02914275|4031086|FG001|NOT COMPLETED|Overall Study||42
3297205|NCT02914457|4031096|FG000|STARTED|Overall Study||31
3297206|NCT02914457|4031096|FG000|COMPLETED|Overall Study|Subjects who completed electrophysiological study with analyzable data|25
3297207|NCT02914457|4031096|FG000|NOT COMPLETED|Overall Study||6
3297208|NCT02914509|4031102|FG000|STARTED|Overall Study||348
3297209|NCT02914509|4031103|FG001|STARTED|Overall Study||217
3297210|NCT02914509|4031102|FG000|COMPLETED|Overall Study||343
3132096|NCT01688856|3857105|FG001|COMPLETED|Overall Study||24
3132097|NCT01688856|3857106|FG002|COMPLETED|Overall Study||8
3132098|NCT01688856|3857104|FG000|NOT COMPLETED|Overall Study||7
3297211|NCT02914509|4031103|FG001|COMPLETED|Overall Study||211
3297212|NCT02914509|4031102|FG000|NOT COMPLETED|Overall Study||5
3297213|NCT02914509|4031103|FG001|NOT COMPLETED|Overall Study||6
3297214|NCT02914522|4031117|FG000|STARTED|Induction Study: Up to Week 11||245
3297215|NCT02914522|4031118|FG001|STARTED|Induction Study: Up to Week 11||278
3297216|NCT02914522|4031119|FG002|STARTED|Induction Study: Up to Week 11||137
3297217|NCT02914522|4031120|FG003|STARTED|Induction Study: Up to Week 11||262
3297218|NCT02914522|4031121|FG004|STARTED|Induction Study: Up to Week 11||286
3297219|NCT02914522|4031122|FG005|STARTED|Induction Study: Up to Week 11||143
3297220|NCT02914522|4031123|FG006|STARTED|Induction Study: Up to Week 11||0
3297221|NCT02914522|4031124|FG007|STARTED|Induction Study: Up to Week 11||0
3297222|NCT02914522|4031125|FG008|STARTED|Induction Study: Up to Week 11||0
3297223|NCT02914522|4031126|FG009|STARTED|Induction Study: Up to Week 11||0
3297224|NCT02914522|4031127|FG010|STARTED|Induction Study: Up to Week 11||0
3297225|NCT02914522|4031117|FG000|COMPLETED|Induction Study: Up to Week 11||235
3297226|NCT02914522|4031118|FG001|COMPLETED|Induction Study: Up to Week 11||256
3297227|NCT02914522|4031119|FG002|COMPLETED|Induction Study: Up to Week 11||127
3297228|NCT02914522|4031120|FG003|COMPLETED|Induction Study: Up to Week 11||234
3297229|NCT02914522|4031121|FG004|COMPLETED|Induction Study: Up to Week 11||262
3297230|NCT02914522|4031122|FG005|COMPLETED|Induction Study: Up to Week 11||127
3297231|NCT02914522|4031123|FG006|COMPLETED|Induction Study: Up to Week 11||0
3297232|NCT02914522|4031124|FG007|COMPLETED|Induction Study: Up to Week 11||0
3297233|NCT02914522|4031125|FG008|COMPLETED|Induction Study: Up to Week 11||0
3297234|NCT02914522|4031126|FG009|COMPLETED|Induction Study: Up to Week 11||0
3297235|NCT02914522|4031127|FG010|COMPLETED|Induction Study: Up to Week 11||0
3297236|NCT02914522|4031117|FG000|NOT COMPLETED|Induction Study: Up to Week 11||10
3297237|NCT02914522|4031118|FG001|NOT COMPLETED|Induction Study: Up to Week 11||22
3297238|NCT02914522|4031119|FG002|NOT COMPLETED|Induction Study: Up to Week 11||10
3297239|NCT02914522|4031120|FG003|NOT COMPLETED|Induction Study: Up to Week 11||28
3297240|NCT02914522|4031121|FG004|NOT COMPLETED|Induction Study: Up to Week 11||24
3297241|NCT02914522|4031122|FG005|NOT COMPLETED|Induction Study: Up to Week 11||16
3297242|NCT02914522|4031123|FG006|NOT COMPLETED|Induction Study: Up to Week 11||0
3297243|NCT02914522|4031124|FG007|NOT COMPLETED|Induction Study: Up to Week 11||0
3297244|NCT02914522|4031125|FG008|NOT COMPLETED|Induction Study: Up to Week 11||0
3297245|NCT02914522|4031126|FG009|NOT COMPLETED|Induction Study: Up to Week 11||0
3297246|NCT02914522|4031127|FG010|NOT COMPLETED|Induction Study: Up to Week 11||0
3297247|NCT02914522|4031117|FG000|STARTED|Maintenance Study: Week 11 to Week 58|Participants achieved either EBS remission/MCS response at Week 10 continued into Maintenance Study.|0
3297248|NCT02914522|4031118|FG001|STARTED|Maintenance Study: Week 11 to Week 58|Participants achieved either EBS remission/MCS response at Week 10 continued into Maintenance Study.|0
3297249|NCT02914522|4031119|FG002|STARTED|Maintenance Study: Week 11 to Week 58|Participants achieved either EBS remission/MCS response at Week 10 continued into Maintenance Study.|0
3297250|NCT02914522|4031120|FG003|STARTED|Maintenance Study: Week 11 to Week 58||0
3297251|NCT02914522|4031121|FG004|STARTED|Maintenance Study: Week 11 to Week 58||0
3297252|NCT02914522|4031122|FG005|STARTED|Maintenance Study: Week 11 to Week 58|Participants achieved either EBS remission/MCS response at Week 10 continued into Maintenance Study.|0
3297253|NCT02914522|4031123|FG006|STARTED|Maintenance Study: Week 11 to Week 58|Participants achieved either EBS remission/MCS response at Week 10 continued into Maintenance Study.|202
3297254|NCT02914522|4031124|FG007|STARTED|Maintenance Study: Week 11 to Week 58|Participants achieved either EBS remission/MCS response at Week 10 continued into Maintenance Study.|99
3297255|NCT02914522|4031125|FG008|STARTED|Maintenance Study: Week 11 to Week 58|Participants achieved either EBS remission/MCS response at Week 10 continued into Maintenance Study.|179
3297256|NCT02914522|4031126|FG009|STARTED|Maintenance Study: Week 11 to Week 58|Participants achieved either EBS remission/MCS response at Week 10 continued into Maintenance Study.|91
3297257|NCT02914522|4031127|FG010|STARTED|Maintenance Study: Week 11 to Week 58||93
3297258|NCT02914522|4031117|FG000|COMPLETED|Maintenance Study: Week 11 to Week 58||0
3297259|NCT02914522|4031118|FG001|COMPLETED|Maintenance Study: Week 11 to Week 58||0
3132099|NCT01688856|3857105|FG001|NOT COMPLETED|Overall Study||4
3132100|NCT01688856|3857106|FG002|NOT COMPLETED|Overall Study||3
3132101|NCT01688882|3857116|FG000|STARTED|Overall Study||13
3132102|NCT01688882|3857117|FG001|STARTED|Overall Study|4 patients who completed 12 weeks of placebo changed to open-label QGE031 treatment.|7
3132103|NCT01688882|3857116|FG000|Safety Follow-up|Overall Study||11
3132104|NCT01688882|3857117|FG001|Safety Follow-up|Overall Study||5
3132105|NCT01688882|3857116|FG000|COMPLETED|Overall Study||10
3132106|NCT01688882|3857117|FG001|COMPLETED|Overall Study|The one patient that discontinued was already switched to open-label QGE031 treatment.|6
3132107|NCT01688882|3857116|FG000|NOT COMPLETED|Overall Study||3
3132108|NCT01688882|3857117|FG001|NOT COMPLETED|Overall Study||1
3132109|NCT01688895|3857127|FG000|STARTED|Overall Study||150
3132110|NCT01688895|3857127|FG000|COMPLETED|Overall Study||150
3132111|NCT01688895|3857127|FG000|NOT COMPLETED|Overall Study||0
3132112|NCT01688921|3857133|FG000|STARTED|Overall Study||627
3132113|NCT01688921|3857134|FG001|STARTED|Overall Study||623
3132114|NCT01688921|3857133|FG000|COMPLETED|Overall Study||611
3132115|NCT01688921|3857134|FG001|COMPLETED|Overall Study||608
3132116|NCT01688921|3857133|FG000|NOT COMPLETED|Overall Study||16
3132117|NCT01688921|3857134|FG001|NOT COMPLETED|Overall Study||15
3132118|NCT01688973|3857143|FG000|STARTED|Overall Study||27
3132119|NCT01688973|3857144|FG001|STARTED|Overall Study||28
3132120|NCT01688973|3857143|FG000|Eligible/Evaluable Patients|Overall Study||25
3132121|NCT01688973|3857144|FG001|Eligible/Evaluable Patients|Overall Study||25
3132122|NCT01688973|3857143|FG000|COMPLETED|Overall Study||25
3132123|NCT01688973|3857144|FG001|COMPLETED|Overall Study||25
3132124|NCT01688973|3857143|FG000|NOT COMPLETED|Overall Study||2
3132125|NCT01688973|3857144|FG001|NOT COMPLETED|Overall Study||3
3132126|NCT01688999|3857154|FG000|STARTED|Overall Study||50
3132127|NCT01688999|3857155|FG001|STARTED|Overall Study||6
3132128|NCT01688999|3857156|FG002|STARTED|Overall Study||13
3132129|NCT01688999|3857154|FG000|COMPLETED|Overall Study||42
3132130|NCT01688999|3857155|FG001|COMPLETED|Overall Study||5
3132131|NCT01688999|3857156|FG002|COMPLETED|Overall Study||10
3132132|NCT01688999|3857154|FG000|NOT COMPLETED|Overall Study||8
3132133|NCT01688999|3857155|FG001|NOT COMPLETED|Overall Study||1
3132134|NCT01688999|3857156|FG002|NOT COMPLETED|Overall Study||3
3132135|NCT01689155|3857163|FG000|STARTED|Overall Study||116
3132136|NCT01689155|3857163|FG000|COMPLETED|Overall Study||116
3132137|NCT01689155|3857163|FG000|NOT COMPLETED|Overall Study||0
3132138|NCT01689207|3857179|FG000|STARTED|Overall Study|Subjects randomised|4
3132139|NCT01689207|3857180|FG001|STARTED|Overall Study|Subjects randomised|8
3132140|NCT01689207|3857181|FG002|STARTED|Overall Study|Subjects randomised|16
3132141|NCT01689207|3857182|FG003|STARTED|Overall Study|Subjects randomised|8
3132142|NCT01689207|3857183|FG004|STARTED|Overall Study|Subjects randomised|4
3132143|NCT01689207|3857184|FG005|STARTED|Overall Study|Subjects randomised|8
3132144|NCT01689207|3857185|FG006|STARTED|Overall Study|Subjects randomised|10
3132145|NCT01689207|3857186|FG007|STARTED|Overall Study|Subjects randomised|10
3132146|NCT01689207|3857187|FG008|STARTED|Overall Study|Subjects randomised|6
3132147|NCT01689207|3857188|FG009|STARTED|Overall Study|Subjects randomised|10
3132148|NCT01689207|3857189|FG010|STARTED|Overall Study|Subjects randomised|8
3132149|NCT01689207|3857179|FG000|COMPLETED|Overall Study|Subjects completed study|4
3132150|NCT01689207|3857180|FG001|COMPLETED|Overall Study|Subjects completed study|7
3297260|NCT02914522|4031119|FG002|COMPLETED|Maintenance Study: Week 11 to Week 58||0
3297261|NCT02914522|4031120|FG003|COMPLETED|Maintenance Study: Week 11 to Week 58||0
3297262|NCT02914522|4031121|FG004|COMPLETED|Maintenance Study: Week 11 to Week 58||0
3297263|NCT02914522|4031122|FG005|COMPLETED|Maintenance Study: Week 11 to Week 58||0
3297264|NCT02914522|4031123|FG006|COMPLETED|Maintenance Study: Week 11 to Week 58||150
3297265|NCT02914522|4031124|FG007|COMPLETED|Maintenance Study: Week 11 to Week 58||41
3297266|NCT02914522|4031125|FG008|COMPLETED|Maintenance Study: Week 11 to Week 58||104
3297267|NCT02914522|4031126|FG009|COMPLETED|Maintenance Study: Week 11 to Week 58||42
3297268|NCT02914522|4031127|FG010|COMPLETED|Maintenance Study: Week 11 to Week 58||64
3297269|NCT02914522|4031117|FG000|NOT COMPLETED|Maintenance Study: Week 11 to Week 58||0
3297270|NCT02914522|4031118|FG001|NOT COMPLETED|Maintenance Study: Week 11 to Week 58||0
3297271|NCT02914522|4031119|FG002|NOT COMPLETED|Maintenance Study: Week 11 to Week 58||0
3297272|NCT02914522|4031120|FG003|NOT COMPLETED|Maintenance Study: Week 11 to Week 58||0
3297273|NCT02914522|4031121|FG004|NOT COMPLETED|Maintenance Study: Week 11 to Week 58||0
3297274|NCT02914522|4031122|FG005|NOT COMPLETED|Maintenance Study: Week 11 to Week 58||0
3297275|NCT02914522|4031123|FG006|NOT COMPLETED|Maintenance Study: Week 11 to Week 58||52
3297276|NCT02914522|4031124|FG007|NOT COMPLETED|Maintenance Study: Week 11 to Week 58||58
3297277|NCT02914522|4031125|FG008|NOT COMPLETED|Maintenance Study: Week 11 to Week 58||75
3297278|NCT02914522|4031126|FG009|NOT COMPLETED|Maintenance Study: Week 11 to Week 58||49
3297279|NCT02914522|4031127|FG010|NOT COMPLETED|Maintenance Study: Week 11 to Week 58||29
3297280|NCT02914548|4031157|FG000|STARTED|Overall Study||67
3297281|NCT02914548|4031158|FG001|STARTED|Overall Study||67
3297282|NCT02914548|4031159|FG002|STARTED|Overall Study||66
3297283|NCT02914548|4031157|FG000|COMPLETED|Overall Study||46
3297284|NCT02914548|4031158|FG001|COMPLETED|Overall Study||53
3297285|NCT02914548|4031159|FG002|COMPLETED|Overall Study||46
3297286|NCT02914548|4031157|FG000|NOT COMPLETED|Overall Study||21
3297287|NCT02914548|4031158|FG001|NOT COMPLETED|Overall Study||14
3297288|NCT02914548|4031159|FG002|NOT COMPLETED|Overall Study||20
3297289|NCT02914795|4031169|FG000|STARTED|Overall Study||77
3297290|NCT02914795|4031170|FG001|STARTED|Overall Study||22
3132151|NCT01689207|3857181|FG002|COMPLETED|Overall Study|Subjects completed study|16
3132152|NCT01689207|3857182|FG003|COMPLETED|Overall Study|Subjects completed study|8
3132153|NCT01689207|3857183|FG004|COMPLETED|Overall Study|Subjects completed study|2
3132154|NCT01689207|3857184|FG005|COMPLETED|Overall Study|Subjects completed study|7
3132155|NCT01689207|3857185|FG006|COMPLETED|Overall Study|Subjects completed study|10
3132156|NCT01689207|3857186|FG007|COMPLETED|Overall Study|Subjects completed study|10
3132157|NCT01689207|3857187|FG008|COMPLETED|Overall Study|Subjects completed study|5
3132158|NCT01689207|3857188|FG009|COMPLETED|Overall Study|Subjects completed study|10
3132159|NCT01689207|3857189|FG010|COMPLETED|Overall Study|Subjects completed study|8
3132160|NCT01689207|3857179|FG000|NOT COMPLETED|Overall Study||0
3132161|NCT01689207|3857180|FG001|NOT COMPLETED|Overall Study||1
3132162|NCT01689207|3857181|FG002|NOT COMPLETED|Overall Study||0
3132163|NCT01689207|3857182|FG003|NOT COMPLETED|Overall Study||0
3132164|NCT01689207|3857183|FG004|NOT COMPLETED|Overall Study||2
3132165|NCT01689207|3857184|FG005|NOT COMPLETED|Overall Study||1
3132166|NCT01689207|3857185|FG006|NOT COMPLETED|Overall Study||0
3132167|NCT01689207|3857186|FG007|NOT COMPLETED|Overall Study||0
3132168|NCT01689207|3857187|FG008|NOT COMPLETED|Overall Study||1
3132169|NCT01689207|3857188|FG009|NOT COMPLETED|Overall Study||0
3132170|NCT01689207|3857189|FG010|NOT COMPLETED|Overall Study||0
3132171|NCT01689324|3857219|FG000|STARTED|Overall Study||43
3132172|NCT01689324|3857219|FG000|COMPLETED|Overall Study||43
3132173|NCT01689324|3857219|FG000|NOT COMPLETED|Overall Study||0
3132174|NCT01689337|3857223|FG000|STARTED|Overall Study||1
3132175|NCT01689337|3857223|FG000|COMPLETED|Overall Study||0
3132176|NCT01689337|3857223|FG000|NOT COMPLETED|Overall Study||1
3132177|NCT01689350|3857231|FG000|STARTED|Overall Study||47
3132178|NCT01689350|3857232|FG001|STARTED|Overall Study||45
3132179|NCT01689350|3857231|FG000|COMPLETED|Overall Study||47
3132180|NCT01689350|3857232|FG001|COMPLETED|Overall Study||45
3132181|NCT01689350|3857231|FG000|NOT COMPLETED|Overall Study||0
3132182|NCT01689350|3857232|FG001|NOT COMPLETED|Overall Study||0
3132183|NCT01689363|3857238|FG000|STARTED|Overall Study||32
3132184|NCT01689363|3857239|FG001|STARTED|Overall Study||32
3132185|NCT01689363|3857240|FG002|STARTED|Overall Study||32
3132186|NCT01689363|3857241|FG003|STARTED|Overall Study||31
3132187|NCT01689363|3857242|FG004|STARTED|Overall Study||31
3132188|NCT01689363|3857243|FG005|STARTED|Overall Study||31
3132189|NCT01689363|3857244|FG006|STARTED|Overall Study||32
3132190|NCT01689363|3857245|FG007|STARTED|Overall Study||32
3132191|NCT01689363|3857238|FG000|COMPLETED|Overall Study||32
3163299|NCT01885195|3890823|FG000|COMPLETED|Overall Study||0
3163300|NCT01885195|3890823|FG000|NOT COMPLETED|Overall Study||110
3297291|NCT02914795|4031169|FG000|COMPLETED|Overall Study||77
3297292|NCT02914795|4031170|FG001|COMPLETED|Overall Study||22
3297293|NCT02914795|4031169|FG000|NOT COMPLETED|Overall Study||0
3297294|NCT02914795|4031170|FG001|NOT COMPLETED|Overall Study||0
3297295|NCT02914834|4031180|FG000|STARTED|Overall Study||12
3297296|NCT02914834|4031181|FG001|STARTED|Overall Study||15
3297297|NCT02914834|4031180|FG000|COMPLETED|Overall Study||11
3297298|NCT02914834|4031181|FG001|COMPLETED|Overall Study||13
3297299|NCT02914834|4031180|FG000|NOT COMPLETED|Overall Study||1
3297300|NCT02914834|4031181|FG001|NOT COMPLETED|Overall Study||2
3297301|NCT02915016|4031195|FG000|STARTED|Overall Study||30
3297302|NCT02915016|4031196|FG001|STARTED|Overall Study||50
3297303|NCT02915016|4031197|FG002|STARTED|Overall Study||50
3297304|NCT02915016|4031198|FG003|STARTED|Overall Study||30
3297305|NCT02915016|4031199|FG004|STARTED|Overall Study||50
3297306|NCT02915016|4031200|FG005|STARTED|Overall Study||50
3297307|NCT02915016|4031201|FG006|STARTED|Overall Study||50
3297308|NCT02915016|4031202|FG007|STARTED|Overall Study||24
3297309|NCT02915016|4031195|FG000|Month 6.5 Immunogenicity Timepoint|Overall Study||23
3297310|NCT02915016|4031196|FG001|Month 6.5 Immunogenicity Timepoint|Overall Study||49
3297311|NCT02915016|4031197|FG002|Month 6.5 Immunogenicity Timepoint|Overall Study||46
3297312|NCT02915016|4031198|FG003|Month 6.5 Immunogenicity Timepoint|Overall Study||26
3297313|NCT02915016|4031199|FG004|Month 6.5 Immunogenicity Timepoint|Overall Study||43
3297314|NCT02915016|4031200|FG005|Month 6.5 Immunogenicity Timepoint|Overall Study||42
3297315|NCT02915016|4031201|FG006|Month 6.5 Immunogenicity Timepoint|Overall Study||42
3297316|NCT02915016|4031202|FG007|Month 6.5 Immunogenicity Timepoint|Overall Study||21
3297317|NCT02915016|4031195|FG000|COMPLETED|Overall Study||23
3297318|NCT02915016|4031196|FG001|COMPLETED|Overall Study||47
3297319|NCT02915016|4031197|FG002|COMPLETED|Overall Study||42
3297320|NCT02915016|4031198|FG003|COMPLETED|Overall Study||26
3297321|NCT02915016|4031199|FG004|COMPLETED|Overall Study||43
3297322|NCT02915016|4031200|FG005|COMPLETED|Overall Study||44
3297323|NCT02915016|4031201|FG006|COMPLETED|Overall Study||38
3297324|NCT02915016|4031202|FG007|COMPLETED|Overall Study||20
3163301|NCT01885208|3890829|FG000|STARTED|Overall Study||406
3297325|NCT02915016|4031195|FG000|NOT COMPLETED|Overall Study||7
3297326|NCT02915016|4031196|FG001|NOT COMPLETED|Overall Study||3
3297327|NCT02915016|4031197|FG002|NOT COMPLETED|Overall Study||8
3297328|NCT02915016|4031198|FG003|NOT COMPLETED|Overall Study||4
3297329|NCT02915016|4031199|FG004|NOT COMPLETED|Overall Study||7
3297330|NCT02915016|4031200|FG005|NOT COMPLETED|Overall Study||6
3132192|NCT01689363|3857239|FG001|COMPLETED|Overall Study||31
3132193|NCT01689363|3857240|FG002|COMPLETED|Overall Study||32
3132194|NCT01689363|3857241|FG003|COMPLETED|Overall Study||31
3132195|NCT01689363|3857242|FG004|COMPLETED|Overall Study||31
3132196|NCT01689363|3857243|FG005|COMPLETED|Overall Study||31
3132197|NCT01689363|3857244|FG006|COMPLETED|Overall Study||32
3132198|NCT01689363|3857245|FG007|COMPLETED|Overall Study||32
3132199|NCT01689363|3857238|FG000|NOT COMPLETED|Overall Study||0
3132200|NCT01689363|3857239|FG001|NOT COMPLETED|Overall Study||1
3132201|NCT01689363|3857240|FG002|NOT COMPLETED|Overall Study||0
3132202|NCT01689363|3857241|FG003|NOT COMPLETED|Overall Study||0
3132203|NCT01689363|3857242|FG004|NOT COMPLETED|Overall Study||0
3132204|NCT01689363|3857243|FG005|NOT COMPLETED|Overall Study||0
3132205|NCT01689363|3857244|FG006|NOT COMPLETED|Overall Study||0
3297331|NCT02915016|4031201|FG006|NOT COMPLETED|Overall Study||12
3297332|NCT02915016|4031202|FG007|NOT COMPLETED|Overall Study||4
3297333|NCT02915029|4031222|FG000|STARTED|Overall Study||63
3297334|NCT02915029|4031223|FG001|STARTED|Overall Study||62
3297335|NCT02915029|4031222|FG000|COMPLETED|Overall Study||50
3297336|NCT02915029|4031223|FG001|COMPLETED|Overall Study||48
3297337|NCT02915029|4031222|FG000|NOT COMPLETED|Overall Study||13
3297338|NCT02915029|4031223|FG001|NOT COMPLETED|Overall Study||14
3297339|NCT02915159|4031231|FG000|STARTED|Overall Study||92
3297340|NCT02915159|4031232|FG001|STARTED|Overall Study||95
3297341|NCT02915159|4031231|FG000|COMPLETED|Overall Study||81
3297342|NCT02915159|4031232|FG001|COMPLETED|Overall Study||87
3297343|NCT02915159|4031231|FG000|NOT COMPLETED|Overall Study||11
3297344|NCT02915159|4031232|FG001|NOT COMPLETED|Overall Study||8
3297345|NCT02915302|4031244|FG000|STARTED|Overall Study||955
3297346|NCT02915302|4031245|FG001|STARTED|Overall Study||995
3297347|NCT02915302|4031244|FG000|Vaccinated (Safety Analysis Set)|Overall Study||949
3297348|NCT02915302|4031245|FG001|Vaccinated (Safety Analysis Set)|Overall Study||992
3297349|NCT02915302|4031244|FG000|COMPLETED|Overall Study||890
3297350|NCT02915302|4031245|FG001|COMPLETED|Overall Study||917
3297351|NCT02915302|4031244|FG000|NOT COMPLETED|Overall Study||65
3297352|NCT02915302|4031245|FG001|NOT COMPLETED|Overall Study||78
3297353|NCT02915705|4031253|FG000|STARTED|Treatment Period||32
3297354|NCT02915705|4031254|FG001|STARTED|Treatment Period||29
3297355|NCT02915705|4031253|FG000|Completed Week 40|Treatment Period||32
3297356|NCT02915705|4031254|FG001|Completed Week 40|Treatment Period||29
3297357|NCT02915705|4031253|FG000|Completed Week 64|Treatment Period||32
3297358|NCT02915705|4031254|FG001|Completed Week 64|Treatment Period||29
3297359|NCT02915705|4031253|FG000|COMPLETED|Treatment Period||32
3297360|NCT02915705|4031254|FG001|COMPLETED|Treatment Period||29
3297361|NCT02915705|4031253|FG000|NOT COMPLETED|Treatment Period||0
3297362|NCT02915705|4031254|FG001|NOT COMPLETED|Treatment Period||0
3297363|NCT02915705|4031253|FG000|STARTED|Long Term Extension Period|6 participants did not enter the extension period|26
3297364|NCT02915705|4031254|FG001|STARTED|Long Term Extension Period|4 participants did not enter the extension period|25
3297365|NCT02915705|4031253|FG000|COMPLETED|Long Term Extension Period||26
3297366|NCT02915705|4031254|FG001|COMPLETED|Long Term Extension Period||25
3297367|NCT02915705|4031253|FG000|NOT COMPLETED|Long Term Extension Period||0
3297368|NCT02915705|4031254|FG001|NOT COMPLETED|Long Term Extension Period||0
3297369|NCT02915744|4031265|FG000|STARTED|Overall Study||92
3297370|NCT02915744|4031266|FG001|STARTED|Overall Study||86
3297371|NCT02915744|4031265|FG000|COMPLETED|Overall Study||13
3297372|NCT02915744|4031266|FG001|COMPLETED|Overall Study||9
3297373|NCT02915744|4031265|FG000|NOT COMPLETED|Overall Study||79
3297374|NCT02915744|4031266|FG001|NOT COMPLETED|Overall Study||77
3297375|NCT02915835|4031276|FG000|STARTED|Overall Study||9
3297376|NCT02915835|4031277|FG001|STARTED|Overall Study||8
3297377|NCT02915835|4031276|FG000|COMPLETED|Overall Study||8
3297378|NCT02915835|4031277|FG001|COMPLETED|Overall Study||7
3297379|NCT02915835|4031276|FG000|NOT COMPLETED|Overall Study||1
3297380|NCT02915835|4031277|FG001|NOT COMPLETED|Overall Study||1
3297381|NCT02915874|4031285|FG000|STARTED|Overall Study||44
3297382|NCT02915874|4031286|FG001|STARTED|Overall Study||28
3297383|NCT02915874|4031285|FG000|Week 6 Follow Up|Overall Study||41
3297384|NCT02915874|4031286|FG001|Week 6 Follow Up|Overall Study||26
3297385|NCT02915874|4031285|FG000|COMPLETED|Overall Study||38
3297386|NCT02915874|4031286|FG001|COMPLETED|Overall Study||22
3297387|NCT02915874|4031285|FG000|NOT COMPLETED|Overall Study||6
3297388|NCT02915874|4031286|FG001|NOT COMPLETED|Overall Study||6
3297389|NCT02915978|4031295|FG000|STARTED|Overall Study||15
3297390|NCT02915978|4031296|FG001|STARTED|Overall Study||15
3297391|NCT02915978|4031297|FG002|STARTED|Overall Study||15
3297392|NCT02915978|4031295|FG000|COMPLETED|Overall Study||13
3297393|NCT02915978|4031296|FG001|COMPLETED|Overall Study||14
3297394|NCT02915978|4031297|FG002|COMPLETED|Overall Study||15
3297395|NCT02915978|4031295|FG000|NOT COMPLETED|Overall Study||2
3297396|NCT02915978|4031296|FG001|NOT COMPLETED|Overall Study||1
3297397|NCT02915978|4031297|FG002|NOT COMPLETED|Overall Study||0
3297398|NCT02916056|4031305|FG000|STARTED|Overall Study||297
3297399|NCT02916056|4031305|FG000|COMPLETED|Overall Study||0
3132206|NCT01689363|3857245|FG007|NOT COMPLETED|Overall Study||0
3132207|NCT01689441|3857258|FG000|STARTED|Overall Study||36
3132208|NCT01689441|3857259|FG001|STARTED|Overall Study||31
3297400|NCT02916056|4031305|FG000|NOT COMPLETED|Overall Study||297
3297401|NCT02916407|4031311|FG000|STARTED|Overall Study||28
3297402|NCT02916407|4031312|FG001|STARTED|Overall Study||28
3297403|NCT02916407|4031311|FG000|COMPLETED|Overall Study||28
3297404|NCT02916407|4031312|FG001|COMPLETED|Overall Study||28
3297405|NCT02916407|4031311|FG000|NOT COMPLETED|Overall Study||0
3297406|NCT02916407|4031312|FG001|NOT COMPLETED|Overall Study||0
3297407|NCT02916433|4031320|FG000|STARTED|Overall Study||3
3297408|NCT02916433|4031321|FG001|STARTED|Overall Study||2
3132209|NCT01689441|3857258|FG000|COMPLETED|Overall Study||36
3132210|NCT01689441|3857259|FG001|COMPLETED|Overall Study||31
3132211|NCT01689441|3857258|FG000|NOT COMPLETED|Overall Study||0
3132212|NCT01689441|3857259|FG001|NOT COMPLETED|Overall Study||0
3297409|NCT02916433|4031320|FG000|COMPLETED|Overall Study||1
3297410|NCT02916433|4031321|FG001|COMPLETED|Overall Study||2
3297411|NCT02916433|4031320|FG000|NOT COMPLETED|Overall Study||2
3297412|NCT02916433|4031321|FG001|NOT COMPLETED|Overall Study||0
3297413|NCT02916498|4031332|FG000|STARTED|First Intervention, 21 Days||2
3297414|NCT02916498|4031333|FG001|STARTED|First Intervention, 21 Days||4
3297415|NCT02916498|4031332|FG000|COMPLETED|First Intervention, 21 Days||2
3297416|NCT02916498|4031333|FG001|COMPLETED|First Intervention, 21 Days||4
3297417|NCT02916498|4031332|FG000|NOT COMPLETED|First Intervention, 21 Days||0
3297418|NCT02916498|4031333|FG001|NOT COMPLETED|First Intervention, 21 Days||0
3297419|NCT02916498|4031332|FG000|STARTED|Second Intervention, 21 Days||2
3297420|NCT02916498|4031333|FG001|STARTED|Second Intervention, 21 Days||4
3297421|NCT02916498|4031332|FG000|COMPLETED|Second Intervention, 21 Days||2
3297422|NCT02916498|4031333|FG001|COMPLETED|Second Intervention, 21 Days||4
3297423|NCT02916498|4031332|FG000|NOT COMPLETED|Second Intervention, 21 Days||0
3297424|NCT02916498|4031333|FG001|NOT COMPLETED|Second Intervention, 21 Days||0
3297425|NCT02916563|4031339|FG000|STARTED|Overall Study||50
3297426|NCT02916563|4031339|FG000|COMPLETED|Overall Study||50
3297427|NCT02916563|4031339|FG000|NOT COMPLETED|Overall Study||0
3297428|NCT02916693|4031343|FG000|STARTED|Overall Study||20
3297429|NCT02916693|4031343|FG000|COMPLETED|Overall Study||13
3297430|NCT02916693|4031343|FG000|NOT COMPLETED|Overall Study||7
3297431|NCT02916745|4031351|FG000|STARTED|Overall Study||5
3297432|NCT02916745|4031351|FG000|COMPLETED|Overall Study||5
3297433|NCT02916745|4031351|FG000|NOT COMPLETED|Overall Study||0
3297434|NCT02916927|4031357|FG000|STARTED|Overall Study||31
3297435|NCT02916927|4031358|FG001|STARTED|Overall Study||31
3297436|NCT02916927|4031357|FG000|Received Study Drug|Overall Study||31
3297437|NCT02916927|4031358|FG001|Received Study Drug|Overall Study||29
3297438|NCT02916927|4031357|FG000|COMPLETED|Overall Study||30
3297439|NCT02916927|4031358|FG001|COMPLETED|Overall Study|1 participant was in radiology for the 45 and 60 minute time points.|28
3297440|NCT02916927|4031357|FG000|NOT COMPLETED|Overall Study||1
3297441|NCT02916927|4031358|FG001|NOT COMPLETED|Overall Study||3
3297442|NCT02917031|4031367|FG000|STARTED|Overall Study||112
3297443|NCT02917031|4031368|FG001|STARTED|Overall Study||115
3297444|NCT02917031|4031369|FG002|STARTED|Overall Study||120
3297445|NCT02917031|4031367|FG000|COMPLETED|Overall Study||94
3297446|NCT02917031|4031368|FG001|COMPLETED|Overall Study||102
3297447|NCT02917031|4031369|FG002|COMPLETED|Overall Study||105
3297448|NCT02917031|4031367|FG000|NOT COMPLETED|Overall Study||18
3297449|NCT02917031|4031368|FG001|NOT COMPLETED|Overall Study||13
3297450|NCT02917031|4031369|FG002|NOT COMPLETED|Overall Study||15
3297451|NCT02917122|4031380|FG000|STARTED|Overall Study||8
3297452|NCT02917122|4031381|FG001|STARTED|Overall Study||7
3297453|NCT02917122|4031380|FG000|COMPLETED|Overall Study||8
3132213|NCT01689519|3857267|FG000|STARTED|Intent to Treat||247
3132214|NCT01689519|3857268|FG001|STARTED|Intent to Treat||248
3297454|NCT02917122|4031381|FG001|COMPLETED|Overall Study||7
3297455|NCT02917122|4031380|FG000|NOT COMPLETED|Overall Study||0
3297456|NCT02917122|4031381|FG001|NOT COMPLETED|Overall Study||0
3297457|NCT02917265|4031389|FG000|STARTED|Overall Study||5
3297458|NCT02917265|4031390|FG001|STARTED|Overall Study||2
3297459|NCT02917265|4031389|FG000|COMPLETED|Overall Study||3
3297460|NCT02917265|4031390|FG001|COMPLETED|Overall Study||2
3297461|NCT02917265|4031389|FG000|NOT COMPLETED|Overall Study||2
3297462|NCT02917265|4031390|FG001|NOT COMPLETED|Overall Study||0
3297463|NCT02917278|4031400|FG000|STARTED|Overall Study||10
3297464|NCT02917278|4031401|FG001|STARTED|Overall Study||9
3297465|NCT02917278|4031400|FG000|COMPLETED|Overall Study||9
3297466|NCT02917278|4031401|FG001|COMPLETED|Overall Study||9
3297467|NCT02917278|4031400|FG000|NOT COMPLETED|Overall Study||1
3297468|NCT02917278|4031401|FG001|NOT COMPLETED|Overall Study||0
3297469|NCT02917447|4031409|FG000|STARTED|Overall Study||51
3297470|NCT02917447|4031410|FG001|STARTED|Overall Study||51
3297471|NCT02917447|4031409|FG000|COMPLETED|Overall Study||44
3297472|NCT02917447|4031410|FG001|COMPLETED|Overall Study||48
3297473|NCT02917447|4031409|FG000|NOT COMPLETED|Overall Study||7
3297474|NCT02917447|4031410|FG001|NOT COMPLETED|Overall Study||3
3297475|NCT02917603|4031418|FG000|STARTED|Overall Study||20
3297476|NCT02917603|4031419|FG001|STARTED|Overall Study||20
3297477|NCT02917603|4031418|FG000|COMPLETED|Overall Study||19
3297478|NCT02917603|4031419|FG001|COMPLETED|Overall Study||16
3297479|NCT02917603|4031418|FG000|NOT COMPLETED|Overall Study||1
3297480|NCT02917603|4031419|FG001|NOT COMPLETED|Overall Study||4
3297481|NCT02917642|4031428|FG000|STARTED|Overall Study||25
3297482|NCT02917642|4031429|FG001|STARTED|Overall Study||25
3297483|NCT02917642|4031428|FG000|COMPLETED|Overall Study||25
3297484|NCT02917642|4031429|FG001|COMPLETED|Overall Study||25
3297485|NCT02917642|4031428|FG000|NOT COMPLETED|Overall Study||0
3297486|NCT02917642|4031429|FG001|NOT COMPLETED|Overall Study||0
3297487|NCT02917941|4031435|FG000|STARTED|Treatment Period||34
3383615|NCT01777295|4118681|FG000|COMPLETED|Overall Study||36
3297488|NCT02917941|4031435|FG000|COMPLETED|Treatment Period||10
3297489|NCT02917941|4031435|FG000|NOT COMPLETED|Treatment Period||24
3297490|NCT02917941|4031435|FG000|STARTED|Survival Follow-up Period||31
3297491|NCT02917941|4031435|FG000|COMPLETED|Survival Follow-up Period||26
3132215|NCT01689519|3857267|FG000|COMPLETED|Intent to Treat||0
3297492|NCT02917941|4031435|FG000|NOT COMPLETED|Survival Follow-up Period||5
3297493|NCT02918071|4031439|FG000|STARTED|Overall Study||121
3297494|NCT02918071|4031439|FG000|COMPLETED|Overall Study||118
3297495|NCT02918071|4031439|FG000|NOT COMPLETED|Overall Study||3
3297496|NCT02918097|4031443|FG000|STARTED|Overall Study||78
3297497|NCT02918097|4031443|FG000|COMPLETED|Overall Study|Primary and secondary outcomes are assessed just at the end of the protocol, not at each step|58
3297498|NCT02918097|4031443|FG000|NOT COMPLETED|Overall Study||20
3297499|NCT02918266|4031458|FG000|STARTED|Part 1||6
3297500|NCT02918266|4031459|FG001|STARTED|Part 1||0
3297501|NCT02918266|4031460|FG002|STARTED|Part 1||0
3297502|NCT02918266|4031461|FG003|STARTED|Part 1||0
3297503|NCT02918266|4031462|FG004|STARTED|Part 1||0
3297504|NCT02918266|4031463|FG005|STARTED|Part 1||0
3297505|NCT02918266|4031464|FG006|STARTED|Part 1||0
3297506|NCT02918266|4031465|FG007|STARTED|Part 1||0
3297507|NCT02918266|4031466|FG008|STARTED|Part 1||0
3297508|NCT02918266|4031467|FG009|STARTED|Part 1||0
3297509|NCT02918266|4031468|FG010|STARTED|Part 1||0
3297510|NCT02918266|4031458|FG000|COMPLETED|Part 1||6
3297511|NCT02918266|4031459|FG001|COMPLETED|Part 1||0
3297512|NCT02918266|4031460|FG002|COMPLETED|Part 1||0
3297513|NCT02918266|4031461|FG003|COMPLETED|Part 1||0
3297514|NCT02918266|4031462|FG004|COMPLETED|Part 1||0
3297515|NCT02918266|4031463|FG005|COMPLETED|Part 1||0
3297516|NCT02918266|4031464|FG006|COMPLETED|Part 1||0
3297517|NCT02918266|4031465|FG007|COMPLETED|Part 1||0
3297518|NCT02918266|4031466|FG008|COMPLETED|Part 1||0
3297519|NCT02918266|4031467|FG009|COMPLETED|Part 1||0
3297520|NCT02918266|4031468|FG010|COMPLETED|Part 1||0
3297521|NCT02918266|4031458|FG000|NOT COMPLETED|Part 1||0
3297522|NCT02918266|4031459|FG001|NOT COMPLETED|Part 1||0
3297523|NCT02918266|4031460|FG002|NOT COMPLETED|Part 1||0
3297524|NCT02918266|4031461|FG003|NOT COMPLETED|Part 1||0
3297525|NCT02918266|4031462|FG004|NOT COMPLETED|Part 1||0
3297526|NCT02918266|4031463|FG005|NOT COMPLETED|Part 1||0
3297527|NCT02918266|4031464|FG006|NOT COMPLETED|Part 1||0
3297528|NCT02918266|4031465|FG007|NOT COMPLETED|Part 1||0
3297529|NCT02918266|4031466|FG008|NOT COMPLETED|Part 1||0
3297530|NCT02918266|4031467|FG009|NOT COMPLETED|Part 1||0
3297531|NCT02918266|4031468|FG010|NOT COMPLETED|Part 1||0
3297532|NCT02918266|4031458|FG000|STARTED|Part 2: Intervention Period 1 (2 Days)||0
3297533|NCT02918266|4031459|FG001|STARTED|Part 2: Intervention Period 1 (2 Days)||1
3383616|NCT01777295|4118682|FG001|COMPLETED|Overall Study||38
3383617|NCT01777295|4118681|FG000|NOT COMPLETED|Overall Study||4
3383618|NCT01777295|4118682|FG001|NOT COMPLETED|Overall Study||3
3385820|NCT03135262|4121196|FG002|NOT COMPLETED|Overall Study||7
3385821|NCT03135262|4121197|FG003|NOT COMPLETED|Overall Study||6
3385822|NCT03135262|4121198|FG004|NOT COMPLETED|Overall Study||1
3385823|NCT03104075|4121230|FG000|STARTED|Overall Study||20
3385824|NCT03104075|4121231|FG001|STARTED|Overall Study||20
3385825|NCT03104075|4121230|FG000|COMPLETED|Overall Study||19
3385826|NCT03104075|4121231|FG001|COMPLETED|Overall Study||20
3385827|NCT03104075|4121230|FG000|NOT COMPLETED|Overall Study||1
3385828|NCT03104075|4121231|FG001|NOT COMPLETED|Overall Study||0
3385829|NCT03038087|4121238|FG000|STARTED|Overall Study||10
3385830|NCT03038087|4121238|FG000|COMPLETED|Overall Study||9
3385831|NCT03038087|4121238|FG000|NOT COMPLETED|Overall Study||1
3386732|NCT02225366|4122058|FG000|NOT COMPLETED|Overall Study||1
3386733|NCT02225366|4122059|FG001|NOT COMPLETED|Overall Study||0
3386734|NCT02021773|4122068|FG000|STARTED|Overall Study||89
3386735|NCT02021773|4122069|FG001|STARTED|Overall Study||88
3386736|NCT02021773|4122070|FG002|STARTED|Overall Study||87
3132216|NCT01689519|3857268|FG001|COMPLETED|Intent to Treat||0
3297534|NCT02918266|4031460|FG002|STARTED|Part 2: Intervention Period 1 (2 Days)||1
3297535|NCT02918266|4031461|FG003|STARTED|Part 2: Intervention Period 1 (2 Days)||1
3297536|NCT02918266|4031462|FG004|STARTED|Part 2: Intervention Period 1 (2 Days)||1
3297537|NCT02918266|4031463|FG005|STARTED|Part 2: Intervention Period 1 (2 Days)||1
3297538|NCT02918266|4031464|FG006|STARTED|Part 2: Intervention Period 1 (2 Days)||2
3297539|NCT02918266|4031465|FG007|STARTED|Part 2: Intervention Period 1 (2 Days)||1
3297540|NCT02918266|4031466|FG008|STARTED|Part 2: Intervention Period 1 (2 Days)||2
3297541|NCT02918266|4031467|FG009|STARTED|Part 2: Intervention Period 1 (2 Days)||1
3297542|NCT02918266|4031468|FG010|STARTED|Part 2: Intervention Period 1 (2 Days)||1
3297543|NCT02918266|4031458|FG000|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
3297544|NCT02918266|4031459|FG001|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
3297545|NCT02918266|4031460|FG002|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
3297546|NCT02918266|4031461|FG003|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
3297547|NCT02918266|4031462|FG004|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
3297548|NCT02918266|4031463|FG005|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
3297549|NCT02918266|4031464|FG006|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
3297550|NCT02918266|4031465|FG007|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
3297551|NCT02918266|4031466|FG008|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
3132217|NCT01689519|3857267|FG000|NOT COMPLETED|Intent to Treat||247
3297552|NCT02918266|4031467|FG009|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
3297553|NCT02918266|4031468|FG010|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
3297554|NCT02918266|4031458|FG000|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
3297555|NCT02918266|4031459|FG001|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1
3386737|NCT02021773|4122068|FG000|Safety Analysis Set|Overall Study||89
3386738|NCT02021773|4122069|FG001|Safety Analysis Set|Overall Study||88
3132218|NCT01689519|3857268|FG001|NOT COMPLETED|Intent to Treat||248
3132219|NCT01689519|3857267|FG000|STARTED|Safety Population||248
3132220|NCT01689519|3857268|FG001|STARTED|Safety Population||245
3132221|NCT01689519|3857267|FG000|COMPLETED|Safety Population||0
3132222|NCT01689519|3857268|FG001|COMPLETED|Safety Population||0
3132223|NCT01689519|3857267|FG000|NOT COMPLETED|Safety Population||248
3132224|NCT01689519|3857268|FG001|NOT COMPLETED|Safety Population||245
3132225|NCT01689532|3857276|FG000|STARTED|Overall Study||61
3297556|NCT02918266|4031460|FG002|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1
3297557|NCT02918266|4031461|FG003|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1
3297558|NCT02918266|4031462|FG004|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1
3297559|NCT02918266|4031463|FG005|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1
3297560|NCT02918266|4031464|FG006|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||2
3297561|NCT02918266|4031465|FG007|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1
3297562|NCT02918266|4031466|FG008|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||2
3297563|NCT02918266|4031467|FG009|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1
3297564|NCT02918266|4031468|FG010|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1
3297565|NCT02918266|4031458|FG000|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
3297566|NCT02918266|4031459|FG001|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
3297567|NCT02918266|4031460|FG002|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
3297568|NCT02918266|4031461|FG003|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
3297569|NCT02918266|4031462|FG004|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
3297570|NCT02918266|4031463|FG005|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
3297571|NCT02918266|4031464|FG006|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
3297572|NCT02918266|4031465|FG007|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
3297573|NCT02918266|4031466|FG008|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
3297574|NCT02918266|4031467|FG009|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
3297575|NCT02918266|4031468|FG010|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
3297576|NCT02918266|4031458|FG000|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
3297577|NCT02918266|4031459|FG001|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
3297578|NCT02918266|4031460|FG002|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
3297579|NCT02918266|4031461|FG003|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
3297580|NCT02918266|4031462|FG004|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
3297581|NCT02918266|4031463|FG005|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
3297582|NCT02918266|4031464|FG006|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
3297583|NCT02918266|4031465|FG007|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
3297584|NCT02918266|4031466|FG008|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
3297585|NCT02918266|4031467|FG009|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
3297586|NCT02918266|4031468|FG010|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
3297587|NCT02918266|4031458|FG000|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
3297588|NCT02918266|4031459|FG001|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
3297589|NCT02918266|4031460|FG002|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
3297590|NCT02918266|4031461|FG003|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
3297591|NCT02918266|4031462|FG004|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
3297592|NCT02918266|4031463|FG005|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
3297593|NCT02918266|4031464|FG006|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
3297594|NCT02918266|4031465|FG007|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
3297595|NCT02918266|4031466|FG008|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
3297596|NCT02918266|4031467|FG009|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
3297597|NCT02918266|4031468|FG010|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
3297598|NCT02918266|4031458|FG000|STARTED|Part 2: Intervention Period 2 (2 Days)||0
3297599|NCT02918266|4031459|FG001|STARTED|Part 2: Intervention Period 2 (2 Days)||0
3297600|NCT02918266|4031460|FG002|STARTED|Part 2: Intervention Period 2 (2 Days)||0
3297601|NCT02918266|4031461|FG003|STARTED|Part 2: Intervention Period 2 (2 Days)||0
3297602|NCT02918266|4031462|FG004|STARTED|Part 2: Intervention Period 2 (2 Days)||0
3297603|NCT02918266|4031463|FG005|STARTED|Part 2: Intervention Period 2 (2 Days)||0
3297604|NCT02918266|4031464|FG006|STARTED|Part 2: Intervention Period 2 (2 Days)||0
3297605|NCT02918266|4031465|FG007|STARTED|Part 2: Intervention Period 2 (2 Days)||0
3297606|NCT02918266|4031466|FG008|STARTED|Part 2: Intervention Period 2 (2 Days)||0
3297607|NCT02918266|4031467|FG009|STARTED|Part 2: Intervention Period 2 (2 Days)||0
3297608|NCT02918266|4031468|FG010|STARTED|Part 2: Intervention Period 2 (2 Days)||0
3297609|NCT02918266|4031458|FG000|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
3297610|NCT02918266|4031459|FG001|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
3297611|NCT02918266|4031460|FG002|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
3297612|NCT02918266|4031461|FG003|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
3297613|NCT02918266|4031462|FG004|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
3297614|NCT02918266|4031463|FG005|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
3297615|NCT02918266|4031464|FG006|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
3297616|NCT02918266|4031465|FG007|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
3297617|NCT02918266|4031466|FG008|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
3297618|NCT02918266|4031467|FG009|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
3297619|NCT02918266|4031468|FG010|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
3132226|NCT01689532|3857277|FG001|STARTED|Overall Study||61
3132227|NCT01689532|3857276|FG000|COMPLETED|Overall Study||47
3132228|NCT01689532|3857277|FG001|COMPLETED|Overall Study||52
3132229|NCT01689532|3857276|FG000|NOT COMPLETED|Overall Study||14
3132230|NCT01689532|3857277|FG001|NOT COMPLETED|Overall Study||9
3132231|NCT01689649|3857283|FG000|STARTED|Overall Study||139
3132232|NCT01689649|3857283|FG000|COMPLETED|Overall Study||117
3132233|NCT01689649|3857283|FG000|NOT COMPLETED|Overall Study||22
3132234|NCT01689701|3857289|FG000|STARTED|Overall Study||27
3132235|NCT01689701|3857290|FG001|STARTED|Overall Study||27
3132236|NCT01689701|3857289|FG000|COMPLETED|Overall Study||22
3132237|NCT01689701|3857290|FG001|COMPLETED|Overall Study||21
3132238|NCT01689701|3857289|FG000|NOT COMPLETED|Overall Study||5
3132239|NCT01689701|3857290|FG001|NOT COMPLETED|Overall Study||6
3132240|NCT01689779|3857298|FG000|STARTED|Overall Study||28
3132241|NCT01689779|3857299|FG001|STARTED|Overall Study||32
3132242|NCT01689779|3857298|FG000|COMPLETED|Overall Study||28
3132243|NCT01689779|3857299|FG001|COMPLETED|Overall Study||32
3132244|NCT01689779|3857298|FG000|NOT COMPLETED|Overall Study||0
3132245|NCT01689779|3857299|FG001|NOT COMPLETED|Overall Study||0
3132246|NCT01689857|3857307|FG000|STARTED|Overall Study||20
3132247|NCT01689857|3857308|FG001|STARTED|Overall Study||20
3132248|NCT01689857|3857307|FG000|COMPLETED|Overall Study||15
3132249|NCT01689857|3857308|FG001|COMPLETED|Overall Study||18
3132250|NCT01689857|3857307|FG000|NOT COMPLETED|Overall Study||5
3132251|NCT01689857|3857308|FG001|NOT COMPLETED|Overall Study||2
3132252|NCT01690000|3857316|FG000|STARTED|Overall Study||40
3132253|NCT01690000|3857317|FG001|STARTED|Overall Study||41
3132254|NCT01690000|3857316|FG000|COMPLETED|Overall Study||37
3132255|NCT01690000|3857317|FG001|COMPLETED|Overall Study||35
3132256|NCT01690000|3857316|FG000|NOT COMPLETED|Overall Study||3
3132257|NCT01690000|3857317|FG001|NOT COMPLETED|Overall Study||6
3132258|NCT01690052|3857323|FG000|STARTED|FIRST INTERVENTION: 4 WEEKS||7
3132259|NCT01690052|3857324|FG001|STARTED|FIRST INTERVENTION: 4 WEEKS||8
3132260|NCT01690052|3857323|FG000|COMPLETED|FIRST INTERVENTION: 4 WEEKS||6
3132261|NCT01690052|3857324|FG001|COMPLETED|FIRST INTERVENTION: 4 WEEKS||6
3132262|NCT01690052|3857323|FG000|NOT COMPLETED|FIRST INTERVENTION: 4 WEEKS||1
3132263|NCT01690052|3857324|FG001|NOT COMPLETED|FIRST INTERVENTION: 4 WEEKS||2
3132264|NCT01690052|3857323|FG000|STARTED|Washout Period of 1 Week||6
3132265|NCT01690052|3857324|FG001|STARTED|Washout Period of 1 Week||6
3132266|NCT01690052|3857323|FG000|COMPLETED|Washout Period of 1 Week||6
3132267|NCT01690052|3857324|FG001|COMPLETED|Washout Period of 1 Week||6
3132268|NCT01690052|3857323|FG000|NOT COMPLETED|Washout Period of 1 Week||0
3132269|NCT01690052|3857324|FG001|NOT COMPLETED|Washout Period of 1 Week||0
3132270|NCT01690052|3857323|FG000|STARTED|SECOND INTERVENTION: 4 WEEKS||6
3132271|NCT01690052|3857324|FG001|STARTED|SECOND INTERVENTION: 4 WEEKS||6
3132272|NCT01690052|3857323|FG000|COMPLETED|SECOND INTERVENTION: 4 WEEKS||6
3132273|NCT01690052|3857324|FG001|COMPLETED|SECOND INTERVENTION: 4 WEEKS||6
3132274|NCT01690052|3857323|FG000|NOT COMPLETED|SECOND INTERVENTION: 4 WEEKS||0
3132275|NCT01690052|3857324|FG001|NOT COMPLETED|SECOND INTERVENTION: 4 WEEKS||0
3132276|NCT01690117|3857332|FG000|STARTED|Overall Study||47
3132277|NCT01690117|3857333|FG001|STARTED|Overall Study||45
3132278|NCT01690117|3857332|FG000|Post-Measurement|Overall Study||41
3132279|NCT01690117|3857333|FG001|Post-Measurement|Overall Study||40
3132280|NCT01690117|3857332|FG000|COMPLETED|Overall Study||31
3132281|NCT01690117|3857333|FG001|COMPLETED|Overall Study||31
3132282|NCT01690117|3857332|FG000|NOT COMPLETED|Overall Study||16
3132283|NCT01690117|3857333|FG001|NOT COMPLETED|Overall Study||14
3132284|NCT01690130|3857343|FG000|STARTED|Overall Study||10
3132285|NCT01690130|3857344|FG001|STARTED|Overall Study||9
3132286|NCT01690130|3857343|FG000|COMPLETED|Overall Study||9
3132287|NCT01690130|3857344|FG001|COMPLETED|Overall Study||9
3132288|NCT01690130|3857343|FG000|NOT COMPLETED|Overall Study||1
3132289|NCT01690130|3857344|FG001|NOT COMPLETED|Overall Study||0
3132290|NCT01690143|3857350|FG000|STARTED|Overall Study||45
3132291|NCT01690143|3857350|FG000|COMPLETED|Overall Study||44
3132292|NCT01690143|3857350|FG000|NOT COMPLETED|Overall Study||1
3132293|NCT01690273|3857358|FG000|STARTED|Overall Study||18
3132294|NCT01690273|3857359|FG001|STARTED|Overall Study||17
3132295|NCT01690273|3857360|FG002|STARTED|Overall Study||20
3132296|NCT01690273|3857358|FG000|COMPLETED|Overall Study||18
3132297|NCT01690273|3857359|FG001|COMPLETED|Overall Study||17
3132298|NCT01690273|3857360|FG002|COMPLETED|Overall Study||20
3132299|NCT01690273|3857358|FG000|NOT COMPLETED|Overall Study||0
3132300|NCT01690273|3857359|FG001|NOT COMPLETED|Overall Study||0
3132301|NCT01690273|3857360|FG002|NOT COMPLETED|Overall Study||0
3132302|NCT01690299|3857375|FG000|STARTED|Placebo-controlled Phase (Weeks 0-16)||84
3132303|NCT01690299|3857376|FG001|STARTED|Placebo-controlled Phase (Weeks 0-16)||83
3132304|NCT01690299|3857377|FG002|STARTED|Placebo-controlled Phase (Weeks 0-16)||83
3132305|NCT01690299|3857378|FG003|STARTED|Placebo-controlled Phase (Weeks 0-16)||0
3132306|NCT01690299|3857379|FG004|STARTED|Placebo-controlled Phase (Weeks 0-16)||0
3132307|NCT01690299|3857380|FG005|STARTED|Placebo-controlled Phase (Weeks 0-16)||0
3132308|NCT01690299|3857375|FG000|Safety Population|Placebo-controlled Phase (Weeks 0-16)|Safety population includes all participants who received at least one dose of study drug.|84
3132309|NCT01690299|3857376|FG001|Safety Population|Placebo-controlled Phase (Weeks 0-16)|Safety population includes all participants who received at least one dose of study drug.|83
3132310|NCT01690299|3857377|FG002|Safety Population|Placebo-controlled Phase (Weeks 0-16)|Safety population includes all participants who received at least one dose of study drug.|83
3132311|NCT01690299|3857378|FG003|Safety Population|Placebo-controlled Phase (Weeks 0-16)||0
3132312|NCT01690299|3857379|FG004|Safety Population|Placebo-controlled Phase (Weeks 0-16)||0
3132313|NCT01690299|3857380|FG005|Safety Population|Placebo-controlled Phase (Weeks 0-16)||0
3132314|NCT01690299|3857375|FG000|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||75
3132315|NCT01690299|3857376|FG001|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||77
3132316|NCT01690299|3857377|FG002|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||81
3132317|NCT01690299|3857378|FG003|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0
3132318|NCT01690299|3857379|FG004|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0
3132319|NCT01690299|3857380|FG005|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0
3132320|NCT01690299|3857375|FG000|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||9
3132321|NCT01690299|3857376|FG001|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||6
3132322|NCT01690299|3857377|FG002|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||2
3132323|NCT01690299|3857378|FG003|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0
3132324|NCT01690299|3857379|FG004|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0
3132325|NCT01690299|3857380|FG005|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0
3132326|NCT01690299|3857375|FG000|STARTED|Apremilast Extension Phase (Weeks16-104)||0
3132327|NCT01690299|3857376|FG001|STARTED|Apremilast Extension Phase (Weeks16-104)||0
3132328|NCT01690299|3857377|FG002|STARTED|Apremilast Extension Phase (Weeks16-104)||0
3132329|NCT01690299|3857378|FG003|STARTED|Apremilast Extension Phase (Weeks16-104)|There are fewer participants in this period because some stopped the study at or prior to Week 16.|73
3136727|NCT01714726|3861988|FG000|COMPLETED|Double-Blinded Induction Period||52
3297620|NCT02918266|4031458|FG000|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
3297621|NCT02918266|4031459|FG001|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
3297622|NCT02918266|4031460|FG002|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
3297623|NCT02918266|4031461|FG003|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
3297624|NCT02918266|4031462|FG004|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
3297625|NCT02918266|4031463|FG005|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
3297626|NCT02918266|4031464|FG006|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
3297627|NCT02918266|4031465|FG007|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
3297628|NCT02918266|4031466|FG008|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
3297629|NCT02918266|4031467|FG009|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
3297630|NCT02918266|4031468|FG010|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
3316906|NCT03121365|4050381|FG001|COMPLETED|4 Months||44
3383619|NCT01787552|4118702|FG000|STARTED|Overall Study||8
3383620|NCT01787552|4118703|FG001|STARTED|Overall Study||10
3383621|NCT01787552|4118704|FG002|STARTED|Overall Study||5
3383622|NCT01787552|4118705|FG003|STARTED|Overall Study||27
3383623|NCT01787552|4118702|FG000|COMPLETED|Overall Study||0
3383624|NCT01787552|4118703|FG001|COMPLETED|Overall Study||1
3383625|NCT01787552|4118704|FG002|COMPLETED|Overall Study||0
3383626|NCT01787552|4118705|FG003|COMPLETED|Overall Study||0
3383627|NCT01787552|4118702|FG000|NOT COMPLETED|Overall Study||8
3383628|NCT01787552|4118703|FG001|NOT COMPLETED|Overall Study||9
3383629|NCT01787552|4118704|FG002|NOT COMPLETED|Overall Study||5
3383630|NCT01787552|4118705|FG003|NOT COMPLETED|Overall Study||27
3383631|NCT01807117|4118720|FG000|STARTED|Overall Study||15
3383632|NCT01807117|4118720|FG000|COMPLETED|Overall Study||12
3383633|NCT01807117|4118720|FG000|NOT COMPLETED|Overall Study||3
3383640|NCT01814826|4118748|FG000|STARTED|Overall Study|6 participants were enrolled into the dose escalation phase and 26 in the MTD expansion phase.|32
3383641|NCT01814826|4118749|FG001|STARTED|Overall Study|29 participants were enrolled into the MTD expansion phase.|29
3383642|NCT01814826|4118750|FG002|STARTED|Overall Study|3 participants were enrolled into the dose escalation phase.|3
3383643|NCT01814826|4118748|FG000|COMPLETED|Overall Study||0
3383644|NCT01814826|4118749|FG001|COMPLETED|Overall Study||0
3383645|NCT01814826|4118750|FG002|COMPLETED|Overall Study||0
3383646|NCT01814826|4118748|FG000|NOT COMPLETED|Overall Study||32
3383647|NCT01814826|4118749|FG001|NOT COMPLETED|Overall Study||29
3383648|NCT01814826|4118750|FG002|NOT COMPLETED|Overall Study||3
3383649|NCT01829711|4118759|FG000|STARTED|Overall Study||80
3383650|NCT01829711|4118759|FG000|COMPLETED|Overall Study||37
3383651|NCT01829711|4118759|FG000|NOT COMPLETED|Overall Study||43
3383652|NCT01846273|4118766|FG000|STARTED|Overall Study||168
3383653|NCT01846273|4118767|FG001|STARTED|Overall Study||113
3383654|NCT01846273|4118768|FG002|STARTED|Overall Study||41
3383655|NCT01846273|4118766|FG000|Safety Analysis Set|Overall Study||172
3383656|NCT01846273|4118767|FG001|Safety Analysis Set|Overall Study||135
3383657|NCT01846273|4118768|FG002|Safety Analysis Set|Overall Study||14
3383658|NCT01846273|4118766|FG000|COMPLETED|Overall Study||146
3383659|NCT01846273|4118767|FG001|COMPLETED|Overall Study||87
3383660|NCT01846273|4118768|FG002|COMPLETED|Overall Study||41
3383661|NCT01846273|4118766|FG000|NOT COMPLETED|Overall Study||22
3383662|NCT01846273|4118767|FG001|NOT COMPLETED|Overall Study||26
2911561|NCT00485264|3621308|FG000|Completed Week 24|Overall Study||67
2911562|NCT00485264|3621309|FG001|Completed Week 24|Overall Study||16
2911563|NCT00485264|3621310|FG002|Completed Week 24|Overall Study||18
2911564|NCT00485264|3621311|FG003|Completed Week 24|Overall Study||21
2911565|NCT00485264|3621312|FG004|Completed Week 24|Overall Study||14
2911566|NCT00485264|3621313|FG005|Completed Week 24|Overall Study||11
2911567|NCT00485264|3621308|FG000|COMPLETED|Overall Study||35
2911568|NCT00485264|3621309|FG001|COMPLETED|Overall Study||9
2911569|NCT00485264|3621310|FG002|COMPLETED|Overall Study||12
2911570|NCT00485264|3621311|FG003|COMPLETED|Overall Study||17
2911571|NCT00485264|3621312|FG004|COMPLETED|Overall Study||9
3383663|NCT01846273|4118768|FG002|NOT COMPLETED|Overall Study||0
3383664|NCT01875185|4118778|FG000|STARTED|Overall Study||52
3383665|NCT01875185|4118779|FG001|STARTED|Overall Study||48
3132330|NCT01690299|3857379|FG004|STARTED|Apremilast Extension Phase (Weeks16-104)|There are fewer participants in this period because some stopped the study at or prior to Week 16.|74
3132331|NCT01690299|3857380|FG005|STARTED|Apremilast Extension Phase (Weeks16-104)|There are fewer participants in this period because some stopped the study at or prior to Week 16.|80
3132332|NCT01690299|3857375|FG000|Safety Population|Apremilast Extension Phase (Weeks16-104)||0
3132333|NCT01690299|3857376|FG001|Safety Population|Apremilast Extension Phase (Weeks16-104)||0
3132334|NCT01690299|3857377|FG002|Safety Population|Apremilast Extension Phase (Weeks16-104)||0
3132335|NCT01690299|3857378|FG003|Safety Population|Apremilast Extension Phase (Weeks16-104)|Safety population includes all participants who received at least one dose of study drug.|73
3132336|NCT01690299|3857379|FG004|Safety Population|Apremilast Extension Phase (Weeks16-104)|Safety population includes all participants who received at least one dose of study drug.|74
3132337|NCT01690299|3857380|FG005|Safety Population|Apremilast Extension Phase (Weeks16-104)|Safety population includes all participants who received at least one dose of study drug.|79
3297631|NCT02918266|4031458|FG000|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
3297632|NCT02918266|4031459|FG001|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
3297633|NCT02918266|4031460|FG002|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
3297634|NCT02918266|4031461|FG003|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
3297635|NCT02918266|4031462|FG004|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
3297636|NCT02918266|4031463|FG005|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
3297637|NCT02918266|4031464|FG006|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
3297638|NCT02918266|4031465|FG007|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
3297639|NCT02918266|4031466|FG008|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
3297640|NCT02918266|4031467|FG009|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
3297641|NCT02918266|4031468|FG010|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
3297642|NCT02918266|4031458|FG000|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
3297643|NCT02918266|4031459|FG001|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
3297644|NCT02918266|4031460|FG002|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
3297645|NCT02918266|4031461|FG003|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
3297646|NCT02918266|4031462|FG004|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
3297647|NCT02918266|4031463|FG005|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
3297648|NCT02918266|4031464|FG006|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
3297649|NCT02918266|4031465|FG007|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
3297650|NCT02918266|4031466|FG008|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
3297651|NCT02918266|4031467|FG009|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
3297652|NCT02918266|4031468|FG010|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
3297653|NCT02918266|4031458|FG000|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
3297654|NCT02918266|4031459|FG001|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
3297655|NCT02918266|4031460|FG002|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
3297656|NCT02918266|4031461|FG003|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
3297657|NCT02918266|4031462|FG004|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
3297658|NCT02918266|4031463|FG005|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
3297659|NCT02918266|4031464|FG006|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
3297660|NCT02918266|4031465|FG007|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
3297661|NCT02918266|4031466|FG008|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
3297662|NCT02918266|4031467|FG009|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
3297663|NCT02918266|4031468|FG010|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
3297664|NCT02918266|4031458|FG000|STARTED|Part 2: Intervention Period 3 (2 Days)||0
3297665|NCT02918266|4031459|FG001|STARTED|Part 2: Intervention Period 3 (2 Days)||0
3297666|NCT02918266|4031460|FG002|STARTED|Part 2: Intervention Period 3 (2 Days)||0
3297667|NCT02918266|4031461|FG003|STARTED|Part 2: Intervention Period 3 (2 Days)||0
3297668|NCT02918266|4031462|FG004|STARTED|Part 2: Intervention Period 3 (2 Days)||0
3297669|NCT02918266|4031463|FG005|STARTED|Part 2: Intervention Period 3 (2 Days)||0
3297670|NCT02918266|4031464|FG006|STARTED|Part 2: Intervention Period 3 (2 Days)||0
3297671|NCT02918266|4031465|FG007|STARTED|Part 2: Intervention Period 3 (2 Days)||0
3297672|NCT02918266|4031466|FG008|STARTED|Part 2: Intervention Period 3 (2 Days)||0
3297673|NCT02918266|4031467|FG009|STARTED|Part 2: Intervention Period 3 (2 Days)||0
3297674|NCT02918266|4031468|FG010|STARTED|Part 2: Intervention Period 3 (2 Days)||0
3297675|NCT02918266|4031458|FG000|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
3297676|NCT02918266|4031459|FG001|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
3297677|NCT02918266|4031460|FG002|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
3297678|NCT02918266|4031461|FG003|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
3297679|NCT02918266|4031462|FG004|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
3297680|NCT02918266|4031463|FG005|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
3297681|NCT02918266|4031464|FG006|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
3297682|NCT02918266|4031465|FG007|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
3297683|NCT02918266|4031466|FG008|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
3297684|NCT02918266|4031467|FG009|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
3297685|NCT02918266|4031468|FG010|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
3297686|NCT02918266|4031458|FG000|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
3297687|NCT02918266|4031459|FG001|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
3297688|NCT02918266|4031460|FG002|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
3297689|NCT02918266|4031461|FG003|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
3297690|NCT02918266|4031462|FG004|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
3297691|NCT02918266|4031463|FG005|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
3132338|NCT01690299|3857375|FG000|COMPLETED|Apremilast Extension Phase (Weeks16-104)||0
3132339|NCT01690299|3857376|FG001|COMPLETED|Apremilast Extension Phase (Weeks16-104)||0
3132340|NCT01690299|3857377|FG002|COMPLETED|Apremilast Extension Phase (Weeks16-104)||0
3132341|NCT01690299|3857378|FG003|COMPLETED|Apremilast Extension Phase (Weeks16-104)||47
3132342|NCT01690299|3857379|FG004|COMPLETED|Apremilast Extension Phase (Weeks16-104)||41
3132343|NCT01690299|3857380|FG005|COMPLETED|Apremilast Extension Phase (Weeks16-104)||50
3132344|NCT01690299|3857375|FG000|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||0
3297692|NCT02918266|4031464|FG006|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
3297693|NCT02918266|4031465|FG007|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
3297694|NCT02918266|4031466|FG008|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
3297695|NCT02918266|4031467|FG009|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
3297696|NCT02918266|4031468|FG010|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
3297697|NCT02918266|4031458|FG000|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
3297698|NCT02918266|4031459|FG001|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
3297699|NCT02918266|4031460|FG002|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
3297700|NCT02918266|4031461|FG003|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
3297701|NCT02918266|4031462|FG004|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
3297702|NCT02918266|4031463|FG005|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
3297703|NCT02918266|4031464|FG006|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
3297704|NCT02918266|4031465|FG007|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
3297705|NCT02918266|4031466|FG008|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
3297706|NCT02918266|4031467|FG009|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
3297707|NCT02918266|4031468|FG010|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
3297708|NCT02918266|4031458|FG000|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
3297709|NCT02918266|4031459|FG001|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
3297710|NCT02918266|4031460|FG002|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
3297711|NCT02918266|4031461|FG003|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
3297712|NCT02918266|4031462|FG004|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
3297713|NCT02918266|4031463|FG005|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
3297714|NCT02918266|4031464|FG006|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
3297715|NCT02918266|4031465|FG007|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
3297716|NCT02918266|4031466|FG008|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
3297717|NCT02918266|4031467|FG009|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
3297718|NCT02918266|4031468|FG010|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
3297719|NCT02918266|4031458|FG000|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
3297720|NCT02918266|4031459|FG001|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
3297721|NCT02918266|4031460|FG002|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
3297722|NCT02918266|4031461|FG003|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
3297723|NCT02918266|4031462|FG004|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
3297724|NCT02918266|4031463|FG005|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
3297725|NCT02918266|4031464|FG006|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
3297726|NCT02918266|4031465|FG007|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
3297727|NCT02918266|4031466|FG008|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
3297728|NCT02918266|4031467|FG009|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
3297729|NCT02918266|4031468|FG010|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
3297730|NCT02918266|4031458|FG000|STARTED|Part 2: Intervention Period 4 (2 Days)||0
3297731|NCT02918266|4031459|FG001|STARTED|Part 2: Intervention Period 4 (2 Days)||0
3297732|NCT02918266|4031460|FG002|STARTED|Part 2: Intervention Period 4 (2 Days)||0
3297733|NCT02918266|4031461|FG003|STARTED|Part 2: Intervention Period 4 (2 Days)||0
3297734|NCT02918266|4031462|FG004|STARTED|Part 2: Intervention Period 4 (2 Days)||0
3297735|NCT02918266|4031463|FG005|STARTED|Part 2: Intervention Period 4 (2 Days)||0
3297736|NCT02918266|4031464|FG006|STARTED|Part 2: Intervention Period 4 (2 Days)||0
3297737|NCT02918266|4031465|FG007|STARTED|Part 2: Intervention Period 4 (2 Days)||0
3297738|NCT02918266|4031466|FG008|STARTED|Part 2: Intervention Period 4 (2 Days)||0
3297739|NCT02918266|4031467|FG009|STARTED|Part 2: Intervention Period 4 (2 Days)||0
3297740|NCT02918266|4031468|FG010|STARTED|Part 2: Intervention Period 4 (2 Days)||0
3297741|NCT02918266|4031458|FG000|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
3297742|NCT02918266|4031459|FG001|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
3297743|NCT02918266|4031460|FG002|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
3297744|NCT02918266|4031461|FG003|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
3297745|NCT02918266|4031462|FG004|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
3297746|NCT02918266|4031463|FG005|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
3297747|NCT02918266|4031464|FG006|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
3297748|NCT02918266|4031465|FG007|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
3297749|NCT02918266|4031466|FG008|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
3297750|NCT02918266|4031467|FG009|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
3297751|NCT02918266|4031468|FG010|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
3297752|NCT02918266|4031458|FG000|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
3297753|NCT02918266|4031459|FG001|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
3297754|NCT02918266|4031460|FG002|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
3297755|NCT02918266|4031461|FG003|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
3297756|NCT02918266|4031462|FG004|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
3297757|NCT02918266|4031463|FG005|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
3297758|NCT02918266|4031464|FG006|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
3297759|NCT02918266|4031465|FG007|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
3297760|NCT02918266|4031466|FG008|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
3297761|NCT02918266|4031467|FG009|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
3297762|NCT02918266|4031468|FG010|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
3297763|NCT02918266|4031458|FG000|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
3297764|NCT02918266|4031459|FG001|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
3297765|NCT02918266|4031460|FG002|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
3297766|NCT02918266|4031461|FG003|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
3297767|NCT02918266|4031462|FG004|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
3297768|NCT02918266|4031463|FG005|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
3297769|NCT02918266|4031464|FG006|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
3297770|NCT02918266|4031465|FG007|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
3297771|NCT02918266|4031466|FG008|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
3297772|NCT02918266|4031467|FG009|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
3297773|NCT02918266|4031468|FG010|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
3297774|NCT02918266|4031458|FG000|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
3297775|NCT02918266|4031459|FG001|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
3297776|NCT02918266|4031460|FG002|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
3297777|NCT02918266|4031461|FG003|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
3297778|NCT02918266|4031462|FG004|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
3297779|NCT02918266|4031463|FG005|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
3297780|NCT02918266|4031464|FG006|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
3297781|NCT02918266|4031465|FG007|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
3297782|NCT02918266|4031466|FG008|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
3297783|NCT02918266|4031467|FG009|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
3297784|NCT02918266|4031468|FG010|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
3297785|NCT02918266|4031458|FG000|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
3297786|NCT02918266|4031459|FG001|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
3297787|NCT02918266|4031460|FG002|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
3383634|NCT01808261|4118728|FG000|STARTED|Overall Study||68
3297788|NCT02918266|4031461|FG003|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
3297789|NCT02918266|4031462|FG004|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
3297790|NCT02918266|4031463|FG005|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
3297791|NCT02918266|4031464|FG006|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
3297792|NCT02918266|4031465|FG007|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
3297793|NCT02918266|4031466|FG008|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
3297794|NCT02918266|4031467|FG009|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
3297795|NCT02918266|4031468|FG010|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
3297796|NCT02918266|4031458|FG000|STARTED|Part 2: Intervention Period 5 (2 Days)||0
3297797|NCT02918266|4031459|FG001|STARTED|Part 2: Intervention Period 5 (2 Days)||0
3297798|NCT02918266|4031460|FG002|STARTED|Part 2: Intervention Period 5 (2 Days)||0
3297799|NCT02918266|4031461|FG003|STARTED|Part 2: Intervention Period 5 (2 Days)||0
3297800|NCT02918266|4031462|FG004|STARTED|Part 2: Intervention Period 5 (2 Days)||0
3297801|NCT02918266|4031463|FG005|STARTED|Part 2: Intervention Period 5 (2 Days)||0
3297802|NCT02918266|4031464|FG006|STARTED|Part 2: Intervention Period 5 (2 Days)||0
3297803|NCT02918266|4031465|FG007|STARTED|Part 2: Intervention Period 5 (2 Days)||0
3297804|NCT02918266|4031466|FG008|STARTED|Part 2: Intervention Period 5 (2 Days)||0
3297805|NCT02918266|4031467|FG009|STARTED|Part 2: Intervention Period 5 (2 Days)||0
3297806|NCT02918266|4031468|FG010|STARTED|Part 2: Intervention Period 5 (2 Days)||0
3297807|NCT02918266|4031458|FG000|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
3297808|NCT02918266|4031459|FG001|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
3297809|NCT02918266|4031460|FG002|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
3297810|NCT02918266|4031461|FG003|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
3297811|NCT02918266|4031462|FG004|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
3297812|NCT02918266|4031463|FG005|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
3297813|NCT02918266|4031464|FG006|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
3297814|NCT02918266|4031465|FG007|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
3297815|NCT02918266|4031466|FG008|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
3297816|NCT02918266|4031467|FG009|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
3297817|NCT02918266|4031468|FG010|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
3297818|NCT02918266|4031458|FG000|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
3297819|NCT02918266|4031459|FG001|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
3297820|NCT02918266|4031460|FG002|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
3297821|NCT02918266|4031461|FG003|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
3297822|NCT02918266|4031462|FG004|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
3297823|NCT02918266|4031463|FG005|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
3297824|NCT02918266|4031464|FG006|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
3297825|NCT02918266|4031465|FG007|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
3297826|NCT02918266|4031466|FG008|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
3383635|NCT01808261|4118729|FG001|STARTED|Overall Study||65
3383636|NCT01808261|4118728|FG000|COMPLETED|Overall Study||32
3383637|NCT01808261|4118729|FG001|COMPLETED|Overall Study||32
3383638|NCT01808261|4118728|FG000|NOT COMPLETED|Overall Study||36
3383639|NCT01808261|4118729|FG001|NOT COMPLETED|Overall Study||33
3297827|NCT02918266|4031467|FG009|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
3297828|NCT02918266|4031468|FG010|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
3297829|NCT02918279|4031490|FG000|STARTED|Overall Study||125
3297830|NCT02918279|4031491|FG001|STARTED|Overall Study||126
3297831|NCT02918279|4031490|FG000|Full Analysis Set|Overall Study||125
3297832|NCT02918279|4031491|FG001|Full Analysis Set|Overall Study||126
3297833|NCT02918279|4031490|FG000|Safety Analysis Set|Overall Study||125
3297834|NCT02918279|4031491|FG001|Safety Analysis Set|Overall Study||126
3297835|NCT02918279|4031490|FG000|COMPLETED|Overall Study||112
3297836|NCT02918279|4031491|FG001|COMPLETED|Overall Study||103
3297837|NCT02918279|4031490|FG000|NOT COMPLETED|Overall Study||13
3297838|NCT02918279|4031491|FG001|NOT COMPLETED|Overall Study||23
3297839|NCT02918318|4031501|FG000|STARTED|Double-blind Induction Phase: 4 Weeks||41
3297840|NCT02918318|4031502|FG001|STARTED|Double-blind Induction Phase: 4 Weeks||40
3297841|NCT02918318|4031503|FG002|STARTED|Double-blind Induction Phase: 4 Weeks||41
3297842|NCT02918318|4031504|FG003|STARTED|Double-blind Induction Phase: 4 Weeks||80
3297843|NCT02918318|4031505|FG004|STARTED|Double-blind Induction Phase: 4 Weeks||0
3297844|NCT02918318|4031501|FG000|Responders|Double-blind Induction Phase: 4 Weeks||13
3297845|NCT02918318|4031502|FG001|Responders|Double-blind Induction Phase: 4 Weeks||11
3297846|NCT02918318|4031503|FG002|Responders|Double-blind Induction Phase: 4 Weeks||17
3297847|NCT02918318|4031504|FG003|Responders|Double-blind Induction Phase: 4 Weeks||27
3297848|NCT02918318|4031505|FG004|Responders|Double-blind Induction Phase: 4 Weeks||0
3297849|NCT02918318|4031501|FG000|COMPLETED|Double-blind Induction Phase: 4 Weeks||39
3297850|NCT02918318|4031502|FG001|COMPLETED|Double-blind Induction Phase: 4 Weeks||33
3297851|NCT02918318|4031503|FG002|COMPLETED|Double-blind Induction Phase: 4 Weeks||39
3297852|NCT02918318|4031504|FG003|COMPLETED|Double-blind Induction Phase: 4 Weeks||72
3297853|NCT02918318|4031505|FG004|COMPLETED|Double-blind Induction Phase: 4 Weeks||0
3297854|NCT02918318|4031501|FG000|NOT COMPLETED|Double-blind Induction Phase: 4 Weeks||2
3297855|NCT02918318|4031502|FG001|NOT COMPLETED|Double-blind Induction Phase: 4 Weeks||7
3297856|NCT02918318|4031503|FG002|NOT COMPLETED|Double-blind Induction Phase: 4 Weeks||2
3297857|NCT02918318|4031504|FG003|NOT COMPLETED|Double-blind Induction Phase: 4 Weeks||8
3297858|NCT02918318|4031505|FG004|NOT COMPLETED|Double-blind Induction Phase: 4 Weeks||0
3297859|NCT02918318|4031501|FG000|STARTED|Double-blind Follow-up Phase: 4 Weeks||27
3297860|NCT02918318|4031502|FG001|STARTED|Double-blind Follow-up Phase: 4 Weeks||28
3297861|NCT02918318|4031503|FG002|STARTED|Double-blind Follow-up Phase: 4 Weeks||24
3297862|NCT02918318|4031504|FG003|STARTED|Double-blind Follow-up Phase: 4 Weeks||53
3297863|NCT02918318|4031505|FG004|STARTED|Double-blind Follow-up Phase: 4 Weeks||0
3297864|NCT02918318|4031501|FG000|COMPLETED|Double-blind Follow-up Phase: 4 Weeks||26
3297865|NCT02918318|4031502|FG001|COMPLETED|Double-blind Follow-up Phase: 4 Weeks||28
3297866|NCT02918318|4031503|FG002|COMPLETED|Double-blind Follow-up Phase: 4 Weeks||23
3297867|NCT02918318|4031504|FG003|COMPLETED|Double-blind Follow-up Phase: 4 Weeks||50
3297868|NCT02918318|4031505|FG004|COMPLETED|Double-blind Follow-up Phase: 4 Weeks||0
3297869|NCT02918318|4031501|FG000|NOT COMPLETED|Double-blind Follow-up Phase: 4 Weeks||1
3297870|NCT02918318|4031502|FG001|NOT COMPLETED|Double-blind Follow-up Phase: 4 Weeks||0
3297871|NCT02918318|4031503|FG002|NOT COMPLETED|Double-blind Follow-up Phase: 4 Weeks||1
3297872|NCT02918318|4031504|FG003|NOT COMPLETED|Double-blind Follow-up Phase: 4 Weeks||3
3297873|NCT02918318|4031505|FG004|NOT COMPLETED|Double-blind Follow-up Phase: 4 Weeks||0
3297874|NCT02918318|4031501|FG000|STARTED|Posttreatment Phase: Up to 24 Weeks||13
3297875|NCT02918318|4031502|FG001|STARTED|Posttreatment Phase: Up to 24 Weeks||11
3297876|NCT02918318|4031503|FG002|STARTED|Posttreatment Phase: Up to 24 Weeks||17
3297877|NCT02918318|4031504|FG003|STARTED|Posttreatment Phase: Up to 24 Weeks||27
3297878|NCT02918318|4031505|FG004|STARTED|Posttreatment Phase: Up to 24 Weeks||0
3297879|NCT02918318|4031501|FG000|COMPLETED|Posttreatment Phase: Up to 24 Weeks||12
3297880|NCT02918318|4031502|FG001|COMPLETED|Posttreatment Phase: Up to 24 Weeks||8
3297881|NCT02918318|4031503|FG002|COMPLETED|Posttreatment Phase: Up to 24 Weeks||16
3297882|NCT02918318|4031504|FG003|COMPLETED|Posttreatment Phase: Up to 24 Weeks||25
3297883|NCT02918318|4031505|FG004|COMPLETED|Posttreatment Phase: Up to 24 Weeks||0
3297884|NCT02918318|4031501|FG000|NOT COMPLETED|Posttreatment Phase: Up to 24 Weeks||1
3297885|NCT02918318|4031502|FG001|NOT COMPLETED|Posttreatment Phase: Up to 24 Weeks||3
3297886|NCT02918318|4031503|FG002|NOT COMPLETED|Posttreatment Phase: Up to 24 Weeks||1
3297887|NCT02918318|4031504|FG003|NOT COMPLETED|Posttreatment Phase: Up to 24 Weeks||2
3297888|NCT02918318|4031505|FG004|NOT COMPLETED|Posttreatment Phase: Up to 24 Weeks||0
3297889|NCT02918318|4031501|FG000|STARTED|Open Label Treatment Phase: 4 Weeks||0
3297890|NCT02918318|4031502|FG001|STARTED|Open Label Treatment Phase: 4 Weeks||0
3297891|NCT02918318|4031503|FG002|STARTED|Open Label Treatment Phase: 4 Weeks||0
3297892|NCT02918318|4031504|FG003|STARTED|Open Label Treatment Phase: 4 Weeks||0
3297893|NCT02918318|4031505|FG004|STARTED|Open Label Treatment Phase: 4 Weeks||48
3297894|NCT02918318|4031501|FG000|COMPLETED|Open Label Treatment Phase: 4 Weeks||0
3297895|NCT02918318|4031502|FG001|COMPLETED|Open Label Treatment Phase: 4 Weeks||0
3132345|NCT01690299|3857376|FG001|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||0
3132346|NCT01690299|3857377|FG002|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||0
3132347|NCT01690299|3857378|FG003|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||26
3132348|NCT01690299|3857379|FG004|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||33
3132349|NCT01690299|3857380|FG005|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||30
3132350|NCT01690520|3857403|FG000|STARTED|Overall Study||78
3132351|NCT01690520|3857404|FG001|STARTED|Overall Study||82
3297896|NCT02918318|4031503|FG002|COMPLETED|Open Label Treatment Phase: 4 Weeks||0
3297897|NCT02918318|4031504|FG003|COMPLETED|Open Label Treatment Phase: 4 Weeks||0
3297898|NCT02918318|4031505|FG004|COMPLETED|Open Label Treatment Phase: 4 Weeks||47
3297899|NCT02918318|4031501|FG000|NOT COMPLETED|Open Label Treatment Phase: 4 Weeks||0
3297900|NCT02918318|4031502|FG001|NOT COMPLETED|Open Label Treatment Phase: 4 Weeks||0
3297901|NCT02918318|4031503|FG002|NOT COMPLETED|Open Label Treatment Phase: 4 Weeks||0
3297902|NCT02918318|4031504|FG003|NOT COMPLETED|Open Label Treatment Phase: 4 Weeks||0
3297903|NCT02918318|4031505|FG004|NOT COMPLETED|Open Label Treatment Phase: 4 Weeks||1
3297904|NCT02918318|4031501|FG000|STARTED|Open Label Follow-up Phase: 4 Weeks||0
3297905|NCT02918318|4031502|FG001|STARTED|Open Label Follow-up Phase: 4 Weeks||0
3297906|NCT02918318|4031503|FG002|STARTED|Open Label Follow-up Phase: 4 Weeks||0
3297907|NCT02918318|4031504|FG003|STARTED|Open Label Follow-up Phase: 4 Weeks||0
3297908|NCT02918318|4031505|FG004|STARTED|Open Label Follow-up Phase: 4 Weeks||48
3297909|NCT02918318|4031501|FG000|COMPLETED|Open Label Follow-up Phase: 4 Weeks||0
3297910|NCT02918318|4031502|FG001|COMPLETED|Open Label Follow-up Phase: 4 Weeks||0
3297911|NCT02918318|4031503|FG002|COMPLETED|Open Label Follow-up Phase: 4 Weeks||0
3297912|NCT02918318|4031504|FG003|COMPLETED|Open Label Follow-up Phase: 4 Weeks||0
3297913|NCT02918318|4031505|FG004|COMPLETED|Open Label Follow-up Phase: 4 Weeks||47
3297914|NCT02918318|4031501|FG000|NOT COMPLETED|Open Label Follow-up Phase: 4 Weeks||0
3297915|NCT02918318|4031502|FG001|NOT COMPLETED|Open Label Follow-up Phase: 4 Weeks||0
2940902|NCT00640016|3653162|FG001|Treated|Overall Study||2
2940903|NCT00640016|3653163|FG002|Treated|Overall Study||4
3297916|NCT02918318|4031503|FG002|NOT COMPLETED|Open Label Follow-up Phase: 4 Weeks||0
3297917|NCT02918318|4031504|FG003|NOT COMPLETED|Open Label Follow-up Phase: 4 Weeks||0
3297918|NCT02918318|4031505|FG004|NOT COMPLETED|Open Label Follow-up Phase: 4 Weeks||1
3297919|NCT02918357|4031526|FG000|STARTED|Overall Study||385
3297920|NCT02918357|4031526|FG000|Investigational Drug Administration|Overall Study||385
3297921|NCT02918357|4031526|FG000|PET/CT Scan|Overall Study||385
3297922|NCT02918357|4031526|FG000|COMPLETED|Overall Study||385
3297923|NCT02918357|4031526|FG000|NOT COMPLETED|Overall Study||0
3297924|NCT02918396|4031551|FG000|STARTED|Overall Study||2
3297925|NCT02918396|4031552|FG001|STARTED|Overall Study||1
3297926|NCT02918396|4031553|FG002|STARTED|Overall Study||2
3297927|NCT02918396|4031551|FG000|COMPLETED|Overall Study||2
3297928|NCT02918396|4031552|FG001|COMPLETED|Overall Study||1
3297929|NCT02918396|4031553|FG002|COMPLETED|Overall Study||2
3297930|NCT02918396|4031551|FG000|NOT COMPLETED|Overall Study||0
3297931|NCT02918396|4031552|FG001|NOT COMPLETED|Overall Study||0
3297932|NCT02918396|4031553|FG002|NOT COMPLETED|Overall Study||0
3297933|NCT02918552|4031563|FG000|STARTED|Overall Study||7
3297934|NCT02918552|4031564|FG001|STARTED|Overall Study||8
3297935|NCT02918552|4031563|FG000|COMPLETED|Overall Study||6
3297936|NCT02918552|4031564|FG001|COMPLETED|Overall Study||6
3297937|NCT02918552|4031563|FG000|NOT COMPLETED|Overall Study||1
3297938|NCT02918552|4031564|FG001|NOT COMPLETED|Overall Study||2
3297939|NCT02918617|4031579|FG000|STARTED|Overall Study||21
3297940|NCT02918617|4031580|FG001|STARTED|Overall Study||20
3297941|NCT02918617|4031581|FG002|STARTED|Overall Study||22
3297942|NCT02918617|4031582|FG003|STARTED|Overall Study||22
3297943|NCT02918617|4031583|FG004|STARTED|Overall Study||24
3297944|NCT02918617|4031584|FG005|STARTED|Overall Study||20
3297945|NCT02918617|4031585|FG006|STARTED|Overall Study||22
3297946|NCT02918617|4031586|FG007|STARTED|Overall Study||26
3297947|NCT02918617|4031587|FG008|STARTED|Overall Study||26
3297948|NCT02918617|4031579|FG000|COMPLETED|Overall Study||20
3297949|NCT02918617|4031580|FG001|COMPLETED|Overall Study||20
3297950|NCT02918617|4031581|FG002|COMPLETED|Overall Study||19
3297951|NCT02918617|4031582|FG003|COMPLETED|Overall Study||22
3297952|NCT02918617|4031583|FG004|COMPLETED|Overall Study||24
3297953|NCT02918617|4031584|FG005|COMPLETED|Overall Study||20
3297954|NCT02918617|4031585|FG006|COMPLETED|Overall Study||22
3297955|NCT02918617|4031586|FG007|COMPLETED|Overall Study||25
3297956|NCT02918617|4031587|FG008|COMPLETED|Overall Study||26
3297957|NCT02918617|4031579|FG000|NOT COMPLETED|Overall Study||1
3297958|NCT02918617|4031580|FG001|NOT COMPLETED|Overall Study||0
3297959|NCT02918617|4031581|FG002|NOT COMPLETED|Overall Study||3
3297960|NCT02918617|4031582|FG003|NOT COMPLETED|Overall Study||0
3297961|NCT02918617|4031583|FG004|NOT COMPLETED|Overall Study||0
3297962|NCT02918617|4031584|FG005|NOT COMPLETED|Overall Study||0
3297963|NCT02918617|4031585|FG006|NOT COMPLETED|Overall Study||0
3297964|NCT02918617|4031586|FG007|NOT COMPLETED|Overall Study||1
3297965|NCT02918617|4031587|FG008|NOT COMPLETED|Overall Study||0
3297966|NCT02918630|4031609|FG000|STARTED|Overall Study||4
3297967|NCT02918630|4031610|FG001|STARTED|Overall Study||3
3297968|NCT02918630|4031609|FG000|COMPLETED|Overall Study||4
3297969|NCT02918630|4031610|FG001|COMPLETED|Overall Study||3
3297970|NCT02918630|4031609|FG000|NOT COMPLETED|Overall Study||0
3297971|NCT02918630|4031610|FG001|NOT COMPLETED|Overall Study||0
3297972|NCT02918656|4031619|FG000|STARTED|Overall Study||54
3297973|NCT02918656|4031620|FG001|STARTED|Overall Study||60
3297974|NCT02918656|4031621|FG002|STARTED|Overall Study||57
3297975|NCT02918656|4031619|FG000|COMPLETED|Overall Study||54
3297976|NCT02918656|4031620|FG001|COMPLETED|Overall Study||60
3297977|NCT02918656|4031621|FG002|COMPLETED|Overall Study||57
3297978|NCT02918656|4031619|FG000|NOT COMPLETED|Overall Study||0
3297979|NCT02918656|4031620|FG001|NOT COMPLETED|Overall Study||0
3297980|NCT02918656|4031621|FG002|NOT COMPLETED|Overall Study||0
3297981|NCT02918669|4031629|FG000|STARTED|Overall Study||12
3297982|NCT02918669|4031629|FG000|COMPLETED|Overall Study||8
3297983|NCT02918669|4031629|FG000|NOT COMPLETED|Overall Study||4
3297984|NCT02918721|4031633|FG000|STARTED|Overall Study||70
3297985|NCT02918721|4031633|FG000|COMPLETED|Overall Study||70
3297986|NCT02918721|4031633|FG000|NOT COMPLETED|Overall Study||0
3297987|NCT02918773|4031640|FG000|STARTED|Overall Study||11
3297988|NCT02918773|4031641|FG001|STARTED|Overall Study||11
3297989|NCT02918773|4031640|FG000|COMPLETED|Overall Study||11
3297990|NCT02918773|4031641|FG001|COMPLETED|Overall Study||11
3297991|NCT02918773|4031640|FG000|NOT COMPLETED|Overall Study||0
3297992|NCT02918773|4031641|FG001|NOT COMPLETED|Overall Study||0
3297993|NCT02918851|4031651|FG000|STARTED|Overall Study||14
3297994|NCT02918851|4031652|FG001|STARTED|Overall Study||14
3297995|NCT02918851|4031653|FG002|STARTED|Overall Study||14
3297996|NCT02918851|4031651|FG000|COMPLETED|Overall Study||10
3297997|NCT02918851|4031652|FG001|COMPLETED|Overall Study||10
3297998|NCT02918851|4031653|FG002|COMPLETED|Overall Study||10
3297999|NCT02918851|4031651|FG000|NOT COMPLETED|Overall Study||4
3298000|NCT02918851|4031652|FG001|NOT COMPLETED|Overall Study||4
3298001|NCT02918851|4031653|FG002|NOT COMPLETED|Overall Study||4
3298002|NCT02918877|4031663|FG000|STARTED|Overall Study||24
3298003|NCT02918877|4031664|FG001|STARTED|Overall Study||25
3298004|NCT02918877|4031663|FG000|COMPLETED|Overall Study||18
3298005|NCT02918877|4031664|FG001|COMPLETED|Overall Study||22
3298006|NCT02918877|4031663|FG000|NOT COMPLETED|Overall Study||6
3298007|NCT02918877|4031664|FG001|NOT COMPLETED|Overall Study||3
3298008|NCT02918968|4031672|FG000|STARTED|1st Line AAT||102
3298009|NCT02918968|4031673|FG001|STARTED|1st Line AAT||104
3298010|NCT02918968|4031672|FG000|Maintained 1st Line AAT Without Progression|1st Line AAT||25
3298011|NCT02918968|4031673|FG001|Maintained 1st Line AAT Without Progression|1st Line AAT||8
3298012|NCT02918968|4031672|FG000|COMPLETED|1st Line AAT||73
3298013|NCT02918968|4031673|FG001|COMPLETED|1st Line AAT||93
3298014|NCT02918968|4031672|FG000|NOT COMPLETED|1st Line AAT||29
3298015|NCT02918968|4031673|FG001|NOT COMPLETED|1st Line AAT||11
3298016|NCT02918968|4031672|FG000|STARTED|2nd Line AAT|Participants who maintained 1st line AAT without progression did not enter 2nd line AAT|48
3298017|NCT02918968|4031673|FG001|STARTED|2nd Line AAT|Participants who maintained 1st line AAT without progression did not enter 2nd line AAT|85
3298018|NCT02918968|4031672|FG000|COMPLETED|2nd Line AAT||23
3298019|NCT02918968|4031673|FG001|COMPLETED|2nd Line AAT||73
3298020|NCT02918968|4031672|FG000|NOT COMPLETED|2nd Line AAT||25
3298021|NCT02918968|4031673|FG001|NOT COMPLETED|2nd Line AAT||12
3298022|NCT02919007|4031681|FG000|STARTED|Overall Study||25
3298023|NCT02919007|4031681|FG000|COMPLETED|Overall Study||25
3298024|NCT02919007|4031681|FG000|NOT COMPLETED|Overall Study||0
3298025|NCT02919111|4031685|FG000|STARTED|Overall Study||299
3298026|NCT02919111|4031685|FG000|COMPLETED|Overall Study||299
3298027|NCT02919111|4031685|FG000|NOT COMPLETED|Overall Study||0
3298028|NCT02919267|4031693|FG000|STARTED|Overall Study||10
3298029|NCT02919267|4031694|FG001|STARTED|Overall Study||12
3298030|NCT02919267|4031695|FG002|STARTED|Overall Study||13
3298031|NCT02919267|4031696|FG003|STARTED|Overall Study||14
3298032|NCT02919267|4031693|FG000|COMPLETED|Overall Study||10
3298033|NCT02919267|4031694|FG001|COMPLETED|Overall Study||9
3298034|NCT02919267|4031695|FG002|COMPLETED|Overall Study||10
3298035|NCT02919267|4031696|FG003|COMPLETED|Overall Study||10
3298036|NCT02919267|4031693|FG000|NOT COMPLETED|Overall Study||0
3298037|NCT02919267|4031694|FG001|NOT COMPLETED|Overall Study||3
3298038|NCT02919267|4031695|FG002|NOT COMPLETED|Overall Study||3
3298039|NCT02919267|4031696|FG003|NOT COMPLETED|Overall Study||4
3298040|NCT02919423|4031708|FG000|STARTED|Overall Study||6
3298041|NCT02919423|4031709|FG001|STARTED|Overall Study||25
3298042|NCT02919423|4031708|FG000|COMPLETED|Overall Study||4
3298043|NCT02919423|4031709|FG001|COMPLETED|Overall Study||16
3298044|NCT02919423|4031708|FG000|NOT COMPLETED|Overall Study||2
3298045|NCT02919423|4031709|FG001|NOT COMPLETED|Overall Study||9
3298046|NCT02919475|4031720|FG000|STARTED|Overall Study||52
3298047|NCT02919475|4031721|FG001|STARTED|Overall Study||52
3298048|NCT02919475|4031722|FG002|STARTED|Overall Study||52
3298049|NCT02919475|4031723|FG003|STARTED|Overall Study||51
3298050|NCT02919475|4031724|FG004|STARTED|Overall Study||52
3298051|NCT02919475|4031720|FG000|Started Dosing|Overall Study||51
3298052|NCT02919475|4031721|FG001|Started Dosing|Overall Study||52
3298053|NCT02919475|4031722|FG002|Started Dosing|Overall Study||52
3298054|NCT02919475|4031723|FG003|Started Dosing|Overall Study||51
3298055|NCT02919475|4031724|FG004|Started Dosing|Overall Study||52
3298056|NCT02919475|4031720|FG000|COMPLETED|Overall Study||46
3298057|NCT02919475|4031721|FG001|COMPLETED|Overall Study||44
3298058|NCT02919475|4031722|FG002|COMPLETED|Overall Study||47
3298059|NCT02919475|4031723|FG003|COMPLETED|Overall Study||38
3298060|NCT02919475|4031724|FG004|COMPLETED|Overall Study||48
3298061|NCT02919475|4031720|FG000|NOT COMPLETED|Overall Study||6
3298062|NCT02919475|4031721|FG001|NOT COMPLETED|Overall Study||8
3298063|NCT02919475|4031722|FG002|NOT COMPLETED|Overall Study||5
3298064|NCT02919475|4031723|FG003|NOT COMPLETED|Overall Study||13
3298065|NCT02919475|4031724|FG004|NOT COMPLETED|Overall Study||4
3298066|NCT02919657|4031736|FG000|STARTED|Overall Study|10 Participants|10
3298067|NCT02919657|4031737|FG001|STARTED|Overall Study|10 Participants|10
3298068|NCT02919657|4031736|FG000|COMPLETED|Overall Study|completed with the same initial 10 participants|10
3298069|NCT02919657|4031737|FG001|COMPLETED|Overall Study|completed with the same initial 10 participants|10
3298070|NCT02919657|4031736|FG000|NOT COMPLETED|Overall Study||0
3298071|NCT02919657|4031737|FG001|NOT COMPLETED|Overall Study||0
3298072|NCT02919696|4031745|FG000|STARTED|Overall Study||12
3298073|NCT02919696|4031746|FG001|STARTED|Overall Study||14
3298074|NCT02919696|4031745|FG000|Received at Least One Dose of Study Drug|Overall Study||12
3298075|NCT02919696|4031746|FG001|Received at Least One Dose of Study Drug|Overall Study||13
3298076|NCT02919696|4031745|FG000|PK 100 mg Abemaciclib Dose|Overall Study||5
3298077|NCT02919696|4031746|FG001|PK 100 mg Abemaciclib Dose|Overall Study||0
3298078|NCT02919696|4031745|FG000|PK 150 mg Abemaciclib Dose|Overall Study||0
3298079|NCT02919696|4031746|FG001|PK 150 mg Abemaciclib Dose|Overall Study||2
3298080|NCT02919696|4031745|FG000|Death On Treatment|Overall Study||1
3298081|NCT02919696|4031746|FG001|Death On Treatment|Overall Study||0
3298082|NCT02919696|4031745|FG000|Progressive Disease|Overall Study||7
3298083|NCT02919696|4031746|FG001|Progressive Disease|Overall Study||9
3298084|NCT02919696|4031745|FG000|COMPLETED|Overall Study||8
3298085|NCT02919696|4031746|FG001|COMPLETED|Overall Study||9
3298086|NCT02919696|4031745|FG000|NOT COMPLETED|Overall Study||4
3298087|NCT02919696|4031746|FG001|NOT COMPLETED|Overall Study||5
3298088|NCT02919761|4031758|FG000|STARTED|Part 1: Open Label||259
3298089|NCT02919761|4031759|FG001|STARTED|Part 1: Open Label|Part 2 Blinded groups were not evaluated as such during Part 1|0
3298090|NCT02919761|4031760|FG002|STARTED|Part 1: Open Label||0
3298091|NCT02919761|4031758|FG000|mITT Population|Part 1: Open Label||259
3298092|NCT02919761|4031759|FG001|mITT Population|Part 1: Open Label||0
3298093|NCT02919761|4031760|FG002|mITT Population|Part 1: Open Label||0
3298094|NCT02919761|4031758|FG000|Safety Population|Part 1: Open Label||259
3298095|NCT02919761|4031759|FG001|Safety Population|Part 1: Open Label||0
3298096|NCT02919761|4031760|FG002|Safety Population|Part 1: Open Label||0
3298097|NCT02919761|4031758|FG000|Per Protocol Population|Part 1: Open Label||236
3298098|NCT02919761|4031759|FG001|Per Protocol Population|Part 1: Open Label||0
3298099|NCT02919761|4031760|FG002|Per Protocol Population|Part 1: Open Label||0
3298100|NCT02919761|4031758|FG000|COMPLETED|Part 1: Open Label||235
3298101|NCT02919761|4031759|FG001|COMPLETED|Part 1: Open Label||0
3298102|NCT02919761|4031760|FG002|COMPLETED|Part 1: Open Label||0
3298103|NCT02919761|4031758|FG000|NOT COMPLETED|Part 1: Open Label||24
3298104|NCT02919761|4031759|FG001|NOT COMPLETED|Part 1: Open Label||0
3298105|NCT02919761|4031760|FG002|NOT COMPLETED|Part 1: Open Label||0
3298106|NCT02919761|4031758|FG000|STARTED|Part 2: Double-blind|154 of the original Part 1 participants continued to Part 2, randomized to Acthar or placebo|0
3298107|NCT02919761|4031759|FG001|STARTED|Part 2: Double-blind|77 participants who completed Part 1 were to receive Acthar for an additional 12 weeks in Part 2|77
3298108|NCT02919761|4031760|FG002|STARTED|Part 2: Double-blind|77 participants who completed Part 1 were to receive placebo for an additional 12 weeks in Part 2|77
3298109|NCT02919761|4031758|FG000|Safety Population|Part 2: Double-blind||0
3298110|NCT02919761|4031759|FG001|Safety Population|Part 2: Double-blind||77
3298111|NCT02919761|4031760|FG002|Safety Population|Part 2: Double-blind||77
3298112|NCT02919761|4031758|FG000|mITT Population|Part 2: Double-blind||0
3298113|NCT02919761|4031759|FG001|mITT Population|Part 2: Double-blind||77
3298114|NCT02919761|4031760|FG002|mITT Population|Part 2: Double-blind||76
3298115|NCT02919761|4031758|FG000|Per Protocol Population|Part 2: Double-blind||0
3298116|NCT02919761|4031759|FG001|Per Protocol Population|Part 2: Double-blind||76
3298117|NCT02919761|4031760|FG002|Per Protocol Population|Part 2: Double-blind||73
3298118|NCT02919761|4031758|FG000|COMPLETED|Part 2: Double-blind||0
3298119|NCT02919761|4031759|FG001|COMPLETED|Part 2: Double-blind||71
3298120|NCT02919761|4031760|FG002|COMPLETED|Part 2: Double-blind||56
3298121|NCT02919761|4031758|FG000|NOT COMPLETED|Part 2: Double-blind||0
3298122|NCT02919761|4031759|FG001|NOT COMPLETED|Part 2: Double-blind||6
3298123|NCT02919761|4031760|FG002|NOT COMPLETED|Part 2: Double-blind||21
3298124|NCT02919813|4031773|FG000|STARTED|Overall Study||14
3298125|NCT02919813|4031774|FG001|STARTED|Overall Study||17
3298126|NCT02919813|4031773|FG000|COMPLETED|Overall Study||14
3298127|NCT02919813|4031774|FG001|COMPLETED|Overall Study||17
3298128|NCT02919813|4031773|FG000|NOT COMPLETED|Overall Study||0
3298129|NCT02919813|4031774|FG001|NOT COMPLETED|Overall Study||0
3298130|NCT02919826|4031782|FG000|STARTED|Overall Study||10
3298131|NCT02919826|4031783|FG001|STARTED|Overall Study||10
3298132|NCT02919826|4031782|FG000|COMPLETED|Overall Study||10
3298133|NCT02919826|4031783|FG001|COMPLETED|Overall Study||8
3298134|NCT02919826|4031782|FG000|NOT COMPLETED|Overall Study||0
3298135|NCT02919826|4031783|FG001|NOT COMPLETED|Overall Study||2
3298136|NCT02919995|4031797|FG000|STARTED|Overall Study||1
3298137|NCT02919995|4031798|FG001|STARTED|Overall Study||2
3298138|NCT02919995|4031799|FG002|STARTED|Overall Study||2
3298139|NCT02919995|4031800|FG003|STARTED|Overall Study||2
3298140|NCT02919995|4031801|FG004|STARTED|Overall Study||1
3298141|NCT02919995|4031802|FG005|STARTED|Overall Study||2
3298142|NCT02919995|4031797|FG000|COMPLETED|Overall Study||1
3298143|NCT02919995|4031798|FG001|COMPLETED|Overall Study||2
3298144|NCT02919995|4031799|FG002|COMPLETED|Overall Study||2
3298145|NCT02919995|4031800|FG003|COMPLETED|Overall Study||2
3298146|NCT02919995|4031801|FG004|COMPLETED|Overall Study||1
3298147|NCT02919995|4031802|FG005|COMPLETED|Overall Study||1
3298148|NCT02919995|4031797|FG000|NOT COMPLETED|Overall Study||0
3298149|NCT02919995|4031798|FG001|NOT COMPLETED|Overall Study||0
3298150|NCT02919995|4031799|FG002|NOT COMPLETED|Overall Study||0
3298151|NCT02919995|4031800|FG003|NOT COMPLETED|Overall Study||0
3298152|NCT02919995|4031801|FG004|NOT COMPLETED|Overall Study||0
3298153|NCT02919995|4031802|FG005|NOT COMPLETED|Overall Study||1
3298154|NCT02920476|4031810|FG000|STARTED|Overall Study||4
3298155|NCT02920476|4031810|FG000|COMPLETED|Overall Study||3
3298156|NCT02920476|4031810|FG000|NOT COMPLETED|Overall Study||1
3298157|NCT02920528|4031817|FG000|STARTED|Overall Study||35
3298158|NCT02920528|4031818|FG001|STARTED|Overall Study||36
3298159|NCT02920528|4031819|FG002|STARTED|Overall Study||35
3298160|NCT02920528|4031817|FG000|COMPLETED|Overall Study||32
3298161|NCT02920528|4031818|FG001|COMPLETED|Overall Study||35
3298162|NCT02920528|4031819|FG002|COMPLETED|Overall Study||30
3298163|NCT02920528|4031817|FG000|NOT COMPLETED|Overall Study||3
3298164|NCT02920528|4031818|FG001|NOT COMPLETED|Overall Study||1
3298165|NCT02920528|4031819|FG002|NOT COMPLETED|Overall Study||5
3298166|NCT02920749|4031831|FG000|STARTED|Overall Study||30
3298167|NCT02920749|4031832|FG001|STARTED|Overall Study||30
3298168|NCT02920749|4031833|FG002|STARTED|Overall Study||30
3298169|NCT02920749|4031834|FG003|STARTED|Overall Study||30
3298170|NCT02920749|4031831|FG000|COMPLETED|Overall Study||30
3298171|NCT02920749|4031832|FG001|COMPLETED|Overall Study||30
3298172|NCT02920749|4031833|FG002|COMPLETED|Overall Study||30
3298173|NCT02920749|4031834|FG003|COMPLETED|Overall Study||30
3298174|NCT02920749|4031831|FG000|NOT COMPLETED|Overall Study||0
3298175|NCT02920749|4031832|FG001|NOT COMPLETED|Overall Study||0
3298176|NCT02920749|4031833|FG002|NOT COMPLETED|Overall Study||0
3298177|NCT02920749|4031834|FG003|NOT COMPLETED|Overall Study||0
3298178|NCT02920918|4031850|FG000|STARTED|Overall Study||17
3298179|NCT02920918|4031851|FG001|STARTED|Overall Study||19
3298180|NCT02920918|4031850|FG000|COMPLETED|Overall Study||17
3298181|NCT02920918|4031851|FG001|COMPLETED|Overall Study||19
3298182|NCT02920918|4031850|FG000|NOT COMPLETED|Overall Study||0
3298183|NCT02920918|4031851|FG001|NOT COMPLETED|Overall Study||0
3298184|NCT02920957|4031857|FG000|STARTED|First Intervention : 1 Month||46
3298185|NCT02920957|4031858|FG001|STARTED|First Intervention : 1 Month||41
3298186|NCT02920957|4031857|FG000|COMPLETED|First Intervention : 1 Month||42
3298187|NCT02920957|4031858|FG001|COMPLETED|First Intervention : 1 Month||41
3298188|NCT02920957|4031857|FG000|NOT COMPLETED|First Intervention : 1 Month||4
3298189|NCT02920957|4031858|FG001|NOT COMPLETED|First Intervention : 1 Month||0
3298190|NCT02920957|4031857|FG000|STARTED|Second Intervention: 1 Month||42
3298191|NCT02920957|4031858|FG001|STARTED|Second Intervention: 1 Month||41
3298192|NCT02920957|4031857|FG000|COMPLETED|Second Intervention: 1 Month||42
3298193|NCT02920957|4031858|FG001|COMPLETED|Second Intervention: 1 Month||40
3298194|NCT02920957|4031857|FG000|NOT COMPLETED|Second Intervention: 1 Month||0
3298195|NCT02920957|4031858|FG001|NOT COMPLETED|Second Intervention: 1 Month||1
3298196|NCT02920970|4031875|FG000|STARTED|First Intervention||38
3298197|NCT02920970|4031876|FG001|STARTED|First Intervention||32
3298198|NCT02920970|4031875|FG000|COMPLETED|First Intervention||38
3298199|NCT02920970|4031876|FG001|COMPLETED|First Intervention||30
3298200|NCT02920970|4031875|FG000|NOT COMPLETED|First Intervention||0
3298201|NCT02920970|4031876|FG001|NOT COMPLETED|First Intervention||2
3298202|NCT02920970|4031875|FG000|STARTED|Second Intervention||38
3298203|NCT02920970|4031876|FG001|STARTED|Second Intervention||30
3298204|NCT02920970|4031875|FG000|COMPLETED|Second Intervention||37
3298205|NCT02920970|4031876|FG001|COMPLETED|Second Intervention||30
3298206|NCT02920970|4031875|FG000|NOT COMPLETED|Second Intervention||1
3298207|NCT02920970|4031876|FG001|NOT COMPLETED|Second Intervention||0
3298208|NCT02920983|4031884|FG000|STARTED|Dispense 1||8
3298209|NCT02920983|4031885|FG001|STARTED|Dispense 1||10
3298210|NCT02920983|4031886|FG002|STARTED|Dispense 1||7
3298211|NCT02920983|4031887|FG003|STARTED|Dispense 1||6
3298212|NCT02920983|4031888|FG004|STARTED|Dispense 1||13
3298213|NCT02920983|4031889|FG005|STARTED|Dispense 1||7
3298214|NCT02920983|4031884|FG000|COMPLETED|Dispense 1||8
3298215|NCT02920983|4031885|FG001|COMPLETED|Dispense 1||10
3298216|NCT02920983|4031886|FG002|COMPLETED|Dispense 1||7
3298217|NCT02920983|4031887|FG003|COMPLETED|Dispense 1||6
3298218|NCT02920983|4031888|FG004|COMPLETED|Dispense 1||12
3298219|NCT02920983|4031889|FG005|COMPLETED|Dispense 1||7
3298220|NCT02920983|4031884|FG000|NOT COMPLETED|Dispense 1||0
3298221|NCT02920983|4031885|FG001|NOT COMPLETED|Dispense 1||0
3298222|NCT02920983|4031886|FG002|NOT COMPLETED|Dispense 1||0
3298223|NCT02920983|4031887|FG003|NOT COMPLETED|Dispense 1||0
3298224|NCT02920983|4031888|FG004|NOT COMPLETED|Dispense 1||1
3298225|NCT02920983|4031889|FG005|NOT COMPLETED|Dispense 1||0
3298226|NCT02920983|4031884|FG000|STARTED|Dispense 2||8
3298227|NCT02920983|4031885|FG001|STARTED|Dispense 2||10
3298228|NCT02920983|4031886|FG002|STARTED|Dispense 2||7
3298229|NCT02920983|4031887|FG003|STARTED|Dispense 2||6
3298230|NCT02920983|4031888|FG004|STARTED|Dispense 2||13
3298231|NCT02920983|4031889|FG005|STARTED|Dispense 2||7
3298232|NCT02920983|4031884|FG000|COMPLETED|Dispense 2||7
3298233|NCT02920983|4031885|FG001|COMPLETED|Dispense 2||10
3298234|NCT02920983|4031886|FG002|COMPLETED|Dispense 2||7
3298235|NCT02920983|4031887|FG003|COMPLETED|Dispense 2||6
3298236|NCT02920983|4031888|FG004|COMPLETED|Dispense 2||12
3298237|NCT02920983|4031889|FG005|COMPLETED|Dispense 2||7
3298238|NCT02920983|4031884|FG000|NOT COMPLETED|Dispense 2||1
3298239|NCT02920983|4031885|FG001|NOT COMPLETED|Dispense 2||0
3298240|NCT02920983|4031886|FG002|NOT COMPLETED|Dispense 2||0
3298241|NCT02920983|4031887|FG003|NOT COMPLETED|Dispense 2||0
3298242|NCT02920983|4031888|FG004|NOT COMPLETED|Dispense 2||1
3298243|NCT02920983|4031889|FG005|NOT COMPLETED|Dispense 2||0
3298244|NCT02920983|4031884|FG000|STARTED|Dispense 3||8
3298245|NCT02920983|4031885|FG001|STARTED|Dispense 3||10
3298246|NCT02920983|4031886|FG002|STARTED|Dispense 3||7
3298247|NCT02920983|4031887|FG003|STARTED|Dispense 3||6
3298248|NCT02920983|4031888|FG004|STARTED|Dispense 3||13
3298249|NCT02920983|4031889|FG005|STARTED|Dispense 3||7
3298250|NCT02920983|4031884|FG000|COMPLETED|Dispense 3||7
3298251|NCT02920983|4031885|FG001|COMPLETED|Dispense 3||9
3298252|NCT02920983|4031886|FG002|COMPLETED|Dispense 3||7
3298253|NCT02920983|4031887|FG003|COMPLETED|Dispense 3||6
3298254|NCT02920983|4031888|FG004|COMPLETED|Dispense 3||12
3298255|NCT02920983|4031889|FG005|COMPLETED|Dispense 3||7
3298256|NCT02920983|4031884|FG000|NOT COMPLETED|Dispense 3||1
3298257|NCT02920983|4031885|FG001|NOT COMPLETED|Dispense 3||1
3298258|NCT02920983|4031886|FG002|NOT COMPLETED|Dispense 3||0
3298259|NCT02920983|4031887|FG003|NOT COMPLETED|Dispense 3||0
3298260|NCT02920983|4031888|FG004|NOT COMPLETED|Dispense 3||1
3383666|NCT01875185|4118778|FG000|COMPLETED|Overall Study||0
3383667|NCT01875185|4118779|FG001|COMPLETED|Overall Study||0
3383668|NCT01875185|4118778|FG000|NOT COMPLETED|Overall Study||52
3298261|NCT02920983|4031889|FG005|NOT COMPLETED|Dispense 3||0
3298262|NCT02921061|4031897|FG000|STARTED|Overall Study||28
3298263|NCT02921061|4031897|FG000|COMPLETED|Overall Study||28
3298264|NCT02921061|4031897|FG000|NOT COMPLETED|Overall Study||0
3298265|NCT02921087|4031903|FG000|STARTED|Overall Study||12
3298266|NCT02921087|4031904|FG001|STARTED|Overall Study||11
3298267|NCT02921087|4031903|FG000|COMPLETED|Overall Study||12
3298268|NCT02921087|4031904|FG001|COMPLETED|Overall Study|One subject dropped out prior to 1 week of lens wear while wearing the control lens (lens 1).|10
3298269|NCT02921087|4031903|FG000|NOT COMPLETED|Overall Study||0
3298270|NCT02921087|4031904|FG001|NOT COMPLETED|Overall Study||1
3298271|NCT02921295|4031920|FG000|STARTED|Sidekicks||1
3298272|NCT02921295|4031920|FG000|COMPLETED|Sidekicks||1
3298273|NCT02921295|4031920|FG000|NOT COMPLETED|Sidekicks||0
3298274|NCT02921295|4031920|FG000|STARTED|Conventional Prostheses||1
3298275|NCT02921295|4031920|FG000|COMPLETED|Conventional Prostheses||1
3383669|NCT01875185|4118779|FG001|NOT COMPLETED|Overall Study||48
3298276|NCT02921295|4031920|FG000|NOT COMPLETED|Conventional Prostheses||0
3298277|NCT02921386|4031929|FG000|STARTED|Sequence A: Fasting||18
3298278|NCT02921386|4031929|FG000|COMPLETED|Sequence A: Fasting||18
3298279|NCT02921386|4031929|FG000|NOT COMPLETED|Sequence A: Fasting||0
3298280|NCT02921386|4031929|FG000|STARTED|Sequence B: 15 g Fat Breakfast||18
3298281|NCT02921386|4031929|FG000|COMPLETED|Sequence B: 15 g Fat Breakfast||18
3298282|NCT02921386|4031929|FG000|NOT COMPLETED|Sequence B: 15 g Fat Breakfast||0
3298283|NCT02921386|4031929|FG000|STARTED|Sequence C: 30 g Fat Breakfast||18
3298284|NCT02921386|4031929|FG000|COMPLETED|Sequence C: 30 g Fat Breakfast||18
3298285|NCT02921386|4031929|FG000|NOT COMPLETED|Sequence C: 30 g Fat Breakfast||0
3298286|NCT02921386|4031929|FG000|STARTED|Sequence D: 45 g Fat Breakfast||18
3298287|NCT02921386|4031929|FG000|COMPLETED|Sequence D: 45 g Fat Breakfast||18
3298288|NCT02921386|4031929|FG000|NOT COMPLETED|Sequence D: 45 g Fat Breakfast||0
3298289|NCT02921386|4031929|FG000|STARTED|Sequence E: FDA High Fat Breakfast||18
3298290|NCT02921386|4031929|FG000|COMPLETED|Sequence E: FDA High Fat Breakfast||18
3298291|NCT02921386|4031929|FG000|NOT COMPLETED|Sequence E: FDA High Fat Breakfast||0
3298292|NCT02921412|4031937|FG000|STARTED|Overall Study||36
3298293|NCT02921412|4031937|FG000|COMPLETED|Overall Study||36
3298294|NCT02921412|4031937|FG000|NOT COMPLETED|Overall Study||0
3298295|NCT02921425|4031948|FG000|STARTED|Overall Study||47
3298296|NCT02921425|4031948|FG000|Second Visit|Overall Study|Participants had to wear an accelerometer and make entries into their PHR over the previous 7 days.|47
3298297|NCT02921425|4031948|FG000|COMPLETED|Overall Study||38
3298298|NCT02921425|4031948|FG000|NOT COMPLETED|Overall Study||9
3298299|NCT02921490|4031952|FG000|STARTED|Overall Study||10
3298300|NCT02921490|4031952|FG000|COMPLETED|Overall Study||10
3298301|NCT02921490|4031952|FG000|NOT COMPLETED|Overall Study||0
3298302|NCT02921737|4031956|FG000|STARTED|Overall Study||7
3298303|NCT02921737|4031956|FG000|COMPLETED|Overall Study||7
3298304|NCT02921737|4031956|FG000|NOT COMPLETED|Overall Study||0
3298305|NCT02921750|4031962|FG000|STARTED|Overall Study||124
3298306|NCT02921750|4031963|FG001|STARTED|Overall Study||124
3298307|NCT02921750|4031962|FG000|Intention to Treat (ITT)|Overall Study||122
3298308|NCT02921750|4031963|FG001|Intention to Treat (ITT)|Overall Study||123
3298309|NCT02921750|4031962|FG000|Per Protocol (PP)|Overall Study||100
3298310|NCT02921750|4031963|FG001|Per Protocol (PP)|Overall Study||107
3298311|NCT02921750|4031962|FG000|Completed 6 Weeks Follow-up (PP)|Overall Study||97
3298312|NCT02921750|4031963|FG001|Completed 6 Weeks Follow-up (PP)|Overall Study||104
3385832|NCT02880540|4121246|FG000|STARTED|Overall Study||13
3385833|NCT02880540|4121247|FG001|STARTED|Overall Study||13
2911572|NCT00485264|3621313|FG005|COMPLETED|Overall Study||5
2911573|NCT00485264|3621308|FG000|NOT COMPLETED|Overall Study||36
3298313|NCT02921750|4031962|FG000|Subgroup Followed for 24 Weeks (ITT)|Overall Study||35
3298314|NCT02921750|4031963|FG001|Subgroup Followed for 24 Weeks (ITT)|Overall Study||40
3298315|NCT02921750|4031962|FG000|Subgroup Followed for 24 Weeks (PP)|Overall Study||19
3298316|NCT02921750|4031963|FG001|Subgroup Followed for 24 Weeks (PP)|Overall Study||36
3298317|NCT02921750|4031962|FG000|COMPLETED|Overall Study||115
3298318|NCT02921750|4031963|FG001|COMPLETED|Overall Study||113
3298319|NCT02921750|4031962|FG000|NOT COMPLETED|Overall Study||9
3298320|NCT02921750|4031963|FG001|NOT COMPLETED|Overall Study||11
3298321|NCT02921841|4031974|FG000|STARTED|Overall Study||68
3298322|NCT02921841|4031975|FG001|STARTED|Overall Study||57
3298323|NCT02921841|4031974|FG000|COMPLETED|Overall Study||52
3298324|NCT02921841|4031975|FG001|COMPLETED|Overall Study||44
3298325|NCT02921841|4031974|FG000|NOT COMPLETED|Overall Study||16
3298326|NCT02921841|4031975|FG001|NOT COMPLETED|Overall Study||13
3298327|NCT02922153|4031983|FG000|STARTED|Overall Study||65
3298328|NCT02922153|4031984|FG001|STARTED|Overall Study||19
3298329|NCT02922153|4031983|FG000|COMPLETED|Overall Study||55
3298330|NCT02922153|4031984|FG001|COMPLETED|Overall Study||17
3298331|NCT02922153|4031983|FG000|NOT COMPLETED|Overall Study||10
3298332|NCT02922153|4031984|FG001|NOT COMPLETED|Overall Study||2
3298333|NCT02922582|4031994|FG000|STARTED|Overall Study||4
3298334|NCT02922582|4031995|FG001|STARTED|Overall Study||4
3298335|NCT02922582|4031996|FG002|STARTED|Overall Study||4
3298336|NCT02922582|4031997|FG003|STARTED|Overall Study||4
3298337|NCT02922582|4031994|FG000|COMPLETED|Overall Study||4
3298338|NCT02922582|4031995|FG001|COMPLETED|Overall Study||3
3298339|NCT02922582|4031996|FG002|COMPLETED|Overall Study||4
3298340|NCT02922582|4031997|FG003|COMPLETED|Overall Study||4
3298341|NCT02922582|4031994|FG000|NOT COMPLETED|Overall Study||0
3298342|NCT02922582|4031995|FG001|NOT COMPLETED|Overall Study||1
3298343|NCT02922582|4031996|FG002|NOT COMPLETED|Overall Study||0
3298344|NCT02922582|4031997|FG003|NOT COMPLETED|Overall Study||0
3298345|NCT02922634|4032007|FG000|STARTED|Overall Study||229
3298346|NCT02922634|4032007|FG000|COMPLETED|Overall Study||219
3298347|NCT02922634|4032007|FG000|NOT COMPLETED|Overall Study||10
3298348|NCT02922738|4032020|FG000|STARTED|Overall Study|158 patients and 17 providers|175
3298349|NCT02922738|4032021|FG001|STARTED|Overall Study|275 patients and 15 providers|290
3298350|NCT02922738|4032020|FG000|COMPLETED|Overall Study||175
3298351|NCT02922738|4032021|FG001|COMPLETED|Overall Study||290
3298352|NCT02922738|4032020|FG000|NOT COMPLETED|Overall Study||0
3298353|NCT02922738|4032021|FG001|NOT COMPLETED|Overall Study||0
3298354|NCT02922868|4032031|FG000|STARTED|Overall Study||30
3298355|NCT02922868|4032032|FG001|STARTED|Overall Study||30
3298356|NCT02922868|4032031|FG000|COMPLETED|Overall Study||30
3298357|NCT02922868|4032032|FG001|COMPLETED|Overall Study||30
3298358|NCT02922868|4032031|FG000|NOT COMPLETED|Overall Study||0
3298359|NCT02922868|4032032|FG001|NOT COMPLETED|Overall Study||0
3298360|NCT02922959|4032040|FG000|STARTED|Overall Study||40
3298361|NCT02922959|4032041|FG001|STARTED|Overall Study||40
3298362|NCT02922959|4032040|FG000|3 Weeks|Overall Study|n=38 (95.0%)|38
3298363|NCT02922959|4032041|FG001|3 Weeks|Overall Study|n=36 (90.0%)|36
3298364|NCT02922959|4032040|FG000|3 Months|Overall Study|n=35 (87.5%)|35
3298365|NCT02922959|4032041|FG001|3 Months|Overall Study|n=31 (77.5%)|31
3298366|NCT02922959|4032040|FG000|6 Months|Overall Study|n=28 (70.0%)|28
3298367|NCT02922959|4032041|FG001|6 Months|Overall Study|n=30 (75.0%)|30
3298368|NCT02922959|4032040|FG000|12 Months|Overall Study|n=21 (52.5%)|21
3298369|NCT02922959|4032041|FG001|12 Months|Overall Study|n=23 (57.5%)|23
3298370|NCT02922959|4032040|FG000|COMPLETED|Overall Study||21
3298371|NCT02922959|4032041|FG001|COMPLETED|Overall Study||23
3298372|NCT02922959|4032040|FG000|NOT COMPLETED|Overall Study||19
3298373|NCT02922959|4032041|FG001|NOT COMPLETED|Overall Study||17
3298374|NCT02923115|4032053|FG000|STARTED|Overall Study||12
3298375|NCT02923115|4032054|FG001|STARTED|Overall Study||16
3298376|NCT02923115|4032055|FG002|STARTED|Overall Study||23
3298377|NCT02923115|4032056|FG003|STARTED|Overall Study||23
3298378|NCT02923115|4032057|FG004|STARTED|Overall Study||22
3298379|NCT02923115|4032058|FG005|STARTED|Overall Study||38
3298380|NCT02923115|4032053|FG000|Treated|Overall Study||12
3298381|NCT02923115|4032054|FG001|Treated|Overall Study||16
3298382|NCT02923115|4032055|FG002|Treated|Overall Study||20
3298383|NCT02923115|4032056|FG003|Treated|Overall Study||22
3298384|NCT02923115|4032057|FG004|Treated|Overall Study||17
3298385|NCT02923115|4032058|FG005|Treated|Overall Study||38
3298386|NCT02923115|4032053|FG000|COMPLETED|Overall Study||12
3298387|NCT02923115|4032054|FG001|COMPLETED|Overall Study||15
3298388|NCT02923115|4032055|FG002|COMPLETED|Overall Study||20
3298389|NCT02923115|4032056|FG003|COMPLETED|Overall Study||21
3298390|NCT02923115|4032057|FG004|COMPLETED|Overall Study||17
3298391|NCT02923115|4032058|FG005|COMPLETED|Overall Study||38
3298392|NCT02923115|4032053|FG000|NOT COMPLETED|Overall Study||0
3298393|NCT02923115|4032054|FG001|NOT COMPLETED|Overall Study||1
3298394|NCT02923115|4032055|FG002|NOT COMPLETED|Overall Study||3
3298395|NCT02923115|4032056|FG003|NOT COMPLETED|Overall Study||2
3298396|NCT02923115|4032057|FG004|NOT COMPLETED|Overall Study||5
3298397|NCT02923115|4032058|FG005|NOT COMPLETED|Overall Study||0
3298398|NCT02923167|4032072|FG000|STARTED|Overall Study||6
3298399|NCT02923167|4032072|FG000|COMPLETED|Overall Study||4
3298400|NCT02923167|4032072|FG000|NOT COMPLETED|Overall Study||2
3298401|NCT02923180|4032077|FG000|STARTED|Overall Study||32
3298402|NCT02923180|4032077|FG000|COMPLETED|Overall Study||6
3298403|NCT02923180|4032077|FG000|NOT COMPLETED|Overall Study||26
3298404|NCT02923245|4032083|FG000|STARTED|Overall Study||60
3298405|NCT02923245|4032084|FG001|STARTED|Overall Study||60
3298406|NCT02923245|4032083|FG000|COMPLETED|Overall Study||58
3298407|NCT02923245|4032084|FG001|COMPLETED|Overall Study||59
3298408|NCT02923245|4032083|FG000|NOT COMPLETED|Overall Study||2
3298409|NCT02923245|4032084|FG001|NOT COMPLETED|Overall Study||1
3298410|NCT02923271|4032093|FG000|STARTED|Overall Study||18
3298411|NCT02923271|4032094|FG001|STARTED|Overall Study||16
3298412|NCT02923271|4032093|FG000|COMPLETED|Overall Study||10
3298413|NCT02923271|4032094|FG001|COMPLETED|Overall Study||14
3298414|NCT02923271|4032093|FG000|NOT COMPLETED|Overall Study||8
3298415|NCT02923271|4032094|FG001|NOT COMPLETED|Overall Study||2
3298416|NCT02923349|4032107|FG000|STARTED|Overall Study||4
3298417|NCT02923349|4032108|FG001|STARTED|Overall Study||4
3298418|NCT02923349|4032109|FG002|STARTED|Overall Study||22
3298419|NCT02923349|4032110|FG003|STARTED|Overall Study||18
3298420|NCT02923349|4032111|FG004|STARTED|Overall Study||23
3298421|NCT02923349|4032112|FG005|STARTED|Overall Study||12
3298422|NCT02923349|4032113|FG006|STARTED|Overall Study||4
3298423|NCT02923349|4032107|FG000|COMPLETED|Overall Study||0
3298424|NCT02923349|4032108|FG001|COMPLETED|Overall Study||0
3298425|NCT02923349|4032109|FG002|COMPLETED|Overall Study||5
3298426|NCT02923349|4032110|FG003|COMPLETED|Overall Study||2
3298427|NCT02923349|4032111|FG004|COMPLETED|Overall Study||4
3298428|NCT02923349|4032112|FG005|COMPLETED|Overall Study||5
3298429|NCT02923349|4032113|FG006|COMPLETED|Overall Study||1
3298430|NCT02923349|4032107|FG000|NOT COMPLETED|Overall Study||4
3298431|NCT02923349|4032108|FG001|NOT COMPLETED|Overall Study||4
3298432|NCT02923349|4032109|FG002|NOT COMPLETED|Overall Study||17
3298433|NCT02923349|4032110|FG003|NOT COMPLETED|Overall Study||16
3298434|NCT02923349|4032111|FG004|NOT COMPLETED|Overall Study||19
3298435|NCT02923349|4032112|FG005|NOT COMPLETED|Overall Study||7
3298436|NCT02923349|4032113|FG006|NOT COMPLETED|Overall Study||3
3316907|NCT03121365|4050380|FG000|NOT COMPLETED|4 Months||3
3316908|NCT03121365|4050381|FG001|NOT COMPLETED|4 Months||1
3316909|NCT03121365|4050380|FG000|STARTED|7 Months||54
3316910|NCT03121365|4050381|FG001|STARTED|7 Months||45
3316911|NCT03121365|4050380|FG000|COMPLETED|7 Months||44
3316912|NCT03121365|4050381|FG001|COMPLETED|7 Months||37
3316913|NCT03121365|4050380|FG000|NOT COMPLETED|7 Months||10
3316914|NCT03121365|4050381|FG001|NOT COMPLETED|7 Months||8
3316915|NCT03121612|4050391|FG000|STARTED|Overall Study||26
3316916|NCT03121612|4050392|FG001|STARTED|Overall Study||25
3316917|NCT03121612|4050391|FG000|COMPLETED|Overall Study||26
3316918|NCT03121612|4050392|FG001|COMPLETED|Overall Study||25
3316919|NCT03121612|4050391|FG000|NOT COMPLETED|Overall Study||0
3316920|NCT03121612|4050392|FG001|NOT COMPLETED|Overall Study||0
3316921|NCT03121820|4050402|FG000|STARTED|First Period||9
3316922|NCT03121820|4050403|FG001|STARTED|First Period||9
3316923|NCT03121820|4050402|FG000|COMPLETED|First Period||9
3316924|NCT03121820|4050403|FG001|COMPLETED|First Period||9
3316925|NCT03121820|4050402|FG000|NOT COMPLETED|First Period||0
3316926|NCT03121820|4050403|FG001|NOT COMPLETED|First Period||0
3316927|NCT03121820|4050402|FG000|STARTED|Second Period (After Washout)||9
3316928|NCT03121820|4050403|FG001|STARTED|Second Period (After Washout)||9
3316929|NCT03121820|4050402|FG000|COMPLETED|Second Period (After Washout)||9
3316930|NCT03121820|4050403|FG001|COMPLETED|Second Period (After Washout)||9
3316931|NCT03121820|4050402|FG000|NOT COMPLETED|Second Period (After Washout)||0
3316932|NCT03121820|4050403|FG001|NOT COMPLETED|Second Period (After Washout)||0
3316933|NCT03121950|4050411|FG000|STARTED|Overall Study||17
3316934|NCT03121950|4050412|FG001|STARTED|Overall Study||3
3316935|NCT03121950|4050411|FG000|COMPLETED|Overall Study||6
3316936|NCT03121950|4050412|FG001|COMPLETED|Overall Study||1
3316937|NCT03121950|4050411|FG000|NOT COMPLETED|Overall Study||11
3316938|NCT03121950|4050412|FG001|NOT COMPLETED|Overall Study||2
3316939|NCT03122145|4050422|FG000|STARTED|Overall Study|34 participants completed the first sub study under this IRB|37
3316940|NCT03122145|4050423|FG001|STARTED|Overall Study||12
3316941|NCT03122145|4050422|FG000|COMPLETED|Overall Study||34
3316942|NCT03122145|4050423|FG001|COMPLETED|Overall Study||12
3316943|NCT03122145|4050422|FG000|NOT COMPLETED|Overall Study||3
3316944|NCT03122145|4050423|FG001|NOT COMPLETED|Overall Study||0
3316945|NCT03122171|4050429|FG000|STARTED|Overall Study||6
3316946|NCT03122171|4050429|FG000|COMPLETED|Overall Study||5
3316947|NCT03122171|4050429|FG000|NOT COMPLETED|Overall Study||1
3316948|NCT03122184|4050435|FG000|STARTED|Overall Study||24
3316949|NCT03122184|4050436|FG001|STARTED|Overall Study||23
3316950|NCT03122184|4050435|FG000|COMPLETED|Overall Study||16
3316951|NCT03122184|4050436|FG001|COMPLETED|Overall Study||17
3316952|NCT03122184|4050435|FG000|NOT COMPLETED|Overall Study||8
3316953|NCT03122184|4050436|FG001|NOT COMPLETED|Overall Study||6
3316954|NCT03122223|4050446|FG000|STARTED|Overall Study||50
3316955|NCT03122223|4050447|FG001|STARTED|Overall Study||50
3316956|NCT03122223|4050448|FG002|STARTED|Overall Study||50
3316957|NCT03122223|4050449|FG003|STARTED|Overall Study||10
3316958|NCT03122223|4050446|FG000|Month 6.5 Immunogenicity Cohort|Overall Study||49
3316959|NCT03122223|4050447|FG001|Month 6.5 Immunogenicity Cohort|Overall Study||48
3316960|NCT03122223|4050448|FG002|Month 6.5 Immunogenicity Cohort|Overall Study||47
3316961|NCT03122223|4050449|FG003|Month 6.5 Immunogenicity Cohort|Overall Study||8
3316962|NCT03122223|4050446|FG000|Month 12 Immunogenicity Cohort|Overall Study||47
3316963|NCT03122223|4050447|FG001|Month 12 Immunogenicity Cohort|Overall Study||45
3316964|NCT03122223|4050448|FG002|Month 12 Immunogenicity Cohort|Overall Study||46
3316965|NCT03122223|4050449|FG003|Month 12 Immunogenicity Cohort|Overall Study||10
3316966|NCT03122223|4050446|FG000|COMPLETED|Overall Study||47
3316967|NCT03122223|4050447|FG001|COMPLETED|Overall Study||45
3316968|NCT03122223|4050448|FG002|COMPLETED|Overall Study||46
3316969|NCT03122223|4050449|FG003|COMPLETED|Overall Study||10
3316970|NCT03122223|4050446|FG000|NOT COMPLETED|Overall Study||3
3316971|NCT03122223|4050447|FG001|NOT COMPLETED|Overall Study||5
3316972|NCT03122223|4050448|FG002|NOT COMPLETED|Overall Study||4
3316973|NCT03122223|4050449|FG003|NOT COMPLETED|Overall Study||0
3316974|NCT03122457|4050459|FG000|STARTED|Overall Study||22
3316975|NCT03122457|4050459|FG000|COMPLETED|Overall Study||16
3316976|NCT03122457|4050459|FG000|NOT COMPLETED|Overall Study||6
3298437|NCT02923427|4032131|FG000|STARTED|Overall Study||55
3298438|NCT02923427|4032132|FG001|STARTED|Overall Study||57
3298439|NCT02923427|4032131|FG000|COMPLETED|Overall Study|"The reasons:~n= 2 Convert to Laparotomy n=1 Desaturation n=1 LMA-S can not be placed"|51
3298440|NCT02923427|4032132|FG001|COMPLETED|Overall Study|"The reasons:~n = 2 Convert to Laparotomy"|55
3298441|NCT02923427|4032131|FG000|NOT COMPLETED|Overall Study||4
3298442|NCT02923427|4032132|FG001|NOT COMPLETED|Overall Study||2
3298443|NCT02923895|4032140|FG000|STARTED|Overall Study||97
3298444|NCT02923895|4032141|FG001|STARTED|Overall Study||95
3298445|NCT02923895|4032140|FG000|COMPLETED|Overall Study||97
3298446|NCT02923895|4032141|FG001|COMPLETED|Overall Study||95
3298447|NCT02923895|4032140|FG000|NOT COMPLETED|Overall Study||0
3298448|NCT02923895|4032141|FG001|NOT COMPLETED|Overall Study||0
3298449|NCT02923921|4032149|FG000|STARTED|Overall Study||283
3298450|NCT02923921|4032150|FG001|STARTED|Overall Study||284
3298451|NCT02923921|4032149|FG000|Received at Least 1 Dose of Study Drug|Overall Study||278
3298452|NCT02923921|4032150|FG001|Received at Least 1 Dose of Study Drug|Overall Study||251
3298453|NCT02923921|4032149|FG000|Safety Population|Overall Study||278
3298454|NCT02923921|4032150|FG001|Safety Population|Overall Study||251
3298455|NCT02923921|4032149|FG000|COMPLETED|Overall Study||230
3298456|NCT02923921|4032150|FG001|COMPLETED|Overall Study||227
3298457|NCT02923921|4032149|FG000|NOT COMPLETED|Overall Study||53
3298458|NCT02923921|4032150|FG001|NOT COMPLETED|Overall Study||57
3298459|NCT02924051|4032158|FG000|STARTED|Overall Study||82
3298460|NCT02924051|4032159|FG001|STARTED|Overall Study||106
3298461|NCT02924051|4032158|FG000|COMPLETED|Overall Study||81
3298462|NCT02924051|4032159|FG001|COMPLETED|Overall Study||97
3298463|NCT02924051|4032158|FG000|NOT COMPLETED|Overall Study||1
3298464|NCT02924051|4032159|FG001|NOT COMPLETED|Overall Study||9
3298465|NCT02924129|4032169|FG000|STARTED|Overall Study||67
3298466|NCT02924129|4032170|FG001|STARTED|Overall Study||67
3298467|NCT02924129|4032169|FG000|COMPLETED|Overall Study||62
3298468|NCT02924129|4032170|FG001|COMPLETED|Overall Study||63
3298469|NCT02924129|4032169|FG000|NOT COMPLETED|Overall Study||5
3298470|NCT02924129|4032170|FG001|NOT COMPLETED|Overall Study||4
3298471|NCT02924350|4032178|FG000|STARTED|Overall Study||102
3298472|NCT02924350|4032179|FG001|STARTED|Overall Study||102
3298473|NCT02924350|4032178|FG000|COMPLETED|Overall Study||102
3298474|NCT02924350|4032179|FG001|COMPLETED|Overall Study||100
3298475|NCT02924350|4032178|FG000|NOT COMPLETED|Overall Study||0
3298476|NCT02924350|4032179|FG001|NOT COMPLETED|Overall Study||2
3298477|NCT02924428|4032187|FG000|STARTED|Overall Study||20
3298478|NCT02924428|4032188|FG001|STARTED|Overall Study||19
3298479|NCT02924428|4032187|FG000|COMPLETED|Overall Study||16
3298480|NCT02924428|4032188|FG001|COMPLETED|Overall Study||14
3298481|NCT02924428|4032187|FG000|NOT COMPLETED|Overall Study||4
3298482|NCT02924428|4032188|FG001|NOT COMPLETED|Overall Study||5
3298483|NCT02924688|4032200|FG000|STARTED|Overall Study||407
3298484|NCT02924688|4032201|FG001|STARTED|Overall Study||405
3298485|NCT02924688|4032202|FG002|STARTED|Overall Study||406
3298486|NCT02924688|4032203|FG003|STARTED|Overall Study||406
3298487|NCT02924688|4032204|FG004|STARTED|Overall Study||404
3298488|NCT02924688|4032205|FG005|STARTED|Overall Study||408
3298489|NCT02924688|4032200|FG000|COMPLETED|Overall Study||374
3298490|NCT02924688|4032201|FG001|COMPLETED|Overall Study||374
3298491|NCT02924688|4032202|FG002|COMPLETED|Overall Study||383
3298492|NCT02924688|4032203|FG003|COMPLETED|Overall Study||378
3298493|NCT02924688|4032204|FG004|COMPLETED|Overall Study||381
3298494|NCT02924688|4032205|FG005|COMPLETED|Overall Study||384
3298495|NCT02924688|4032200|FG000|NOT COMPLETED|Overall Study||33
3298496|NCT02924688|4032201|FG001|NOT COMPLETED|Overall Study||31
3298497|NCT02924688|4032202|FG002|NOT COMPLETED|Overall Study||23
3298498|NCT02924688|4032203|FG003|NOT COMPLETED|Overall Study||28
3298499|NCT02924688|4032204|FG004|NOT COMPLETED|Overall Study||23
3298500|NCT02924688|4032205|FG005|NOT COMPLETED|Overall Study||24
3298501|NCT02924883|4032224|FG000|STARTED|Overall Study||133
3298502|NCT02924883|4032225|FG001|STARTED|Overall Study||69
3298503|NCT02924883|4032224|FG000|COMPLETED|Overall Study||0
3298504|NCT02924883|4032225|FG001|COMPLETED|Overall Study||0
3298505|NCT02924883|4032224|FG000|NOT COMPLETED|Overall Study||133
3298506|NCT02924883|4032225|FG001|NOT COMPLETED|Overall Study||69
3298507|NCT02925078|4032235|FG000|STARTED|Overall Study||14
3298508|NCT02925078|4032236|FG001|STARTED|Overall Study||16
3298509|NCT02925078|4032235|FG000|COMPLETED|Overall Study||13
3298510|NCT02925078|4032236|FG001|COMPLETED|Overall Study||13
3298511|NCT02925078|4032235|FG000|NOT COMPLETED|Overall Study||1
3298512|NCT02925078|4032236|FG001|NOT COMPLETED|Overall Study||3
3298513|NCT02925117|4032246|FG000|STARTED|Period 1 (Weeks 0 - 16)||41
3298514|NCT02925117|4032247|FG001|STARTED|Period 1 (Weeks 0 - 16)||42
3298515|NCT02925117|4032248|FG002|STARTED|Period 1 (Weeks 0 - 16)||42
3298516|NCT02925117|4032249|FG003|STARTED|Period 1 (Weeks 0 - 16)||42
3298517|NCT02925117|4032250|FG004|STARTED|Period 1 (Weeks 0 - 16)||0
3298518|NCT02925117|4032251|FG005|STARTED|Period 1 (Weeks 0 - 16)||0
3298519|NCT02925117|4032252|FG006|STARTED|Period 1 (Weeks 0 - 16)||0
3298520|NCT02925117|4032253|FG007|STARTED|Period 1 (Weeks 0 - 16)||0
3298521|NCT02925117|4032254|FG008|STARTED|Period 1 (Weeks 0 - 16)||0
3298522|NCT02925117|4032255|FG009|STARTED|Period 1 (Weeks 0 - 16)||0
3298523|NCT02925117|4032256|FG010|STARTED|Period 1 (Weeks 0 - 16)||0
3298524|NCT02925117|4032257|FG011|STARTED|Period 1 (Weeks 0 - 16)||0
3298525|NCT02925117|4032246|FG000|Received Treatment|Period 1 (Weeks 0 - 16)||40
3298526|NCT02925117|4032247|FG001|Received Treatment|Period 1 (Weeks 0 - 16)||42
3132352|NCT01690520|3857403|FG000|Modified Intent to Treat (mITT)|Overall Study||78
3132353|NCT01690520|3857404|FG001|Modified Intent to Treat (mITT)|Overall Study||80
3132354|NCT01690520|3857403|FG000|COMPLETED|Overall Study||27
3298527|NCT02925117|4032248|FG002|Received Treatment|Period 1 (Weeks 0 - 16)||42
3298528|NCT02925117|4032249|FG003|Received Treatment|Period 1 (Weeks 0 - 16)||42
3298529|NCT02925117|4032250|FG004|Received Treatment|Period 1 (Weeks 0 - 16)||0
3298530|NCT02925117|4032251|FG005|Received Treatment|Period 1 (Weeks 0 - 16)||0
3298531|NCT02925117|4032252|FG006|Received Treatment|Period 1 (Weeks 0 - 16)||0
3298532|NCT02925117|4032253|FG007|Received Treatment|Period 1 (Weeks 0 - 16)||0
3298533|NCT02925117|4032254|FG008|Received Treatment|Period 1 (Weeks 0 - 16)||0
3298534|NCT02925117|4032255|FG009|Received Treatment|Period 1 (Weeks 0 - 16)||0
3298535|NCT02925117|4032256|FG010|Received Treatment|Period 1 (Weeks 0 - 16)||0
3298536|NCT02925117|4032257|FG011|Received Treatment|Period 1 (Weeks 0 - 16)||0
3298537|NCT02925117|4032246|FG000|COMPLETED|Period 1 (Weeks 0 - 16)||23
3298538|NCT02925117|4032247|FG001|COMPLETED|Period 1 (Weeks 0 - 16)||31
3298539|NCT02925117|4032248|FG002|COMPLETED|Period 1 (Weeks 0 - 16)||37
3298540|NCT02925117|4032249|FG003|COMPLETED|Period 1 (Weeks 0 - 16)||39
3298541|NCT02925117|4032250|FG004|COMPLETED|Period 1 (Weeks 0 - 16)||0
3298542|NCT02925117|4032251|FG005|COMPLETED|Period 1 (Weeks 0 - 16)||0
3298543|NCT02925117|4032252|FG006|COMPLETED|Period 1 (Weeks 0 - 16)||0
3298544|NCT02925117|4032253|FG007|COMPLETED|Period 1 (Weeks 0 - 16)||0
3298545|NCT02925117|4032254|FG008|COMPLETED|Period 1 (Weeks 0 - 16)||0
3298546|NCT02925117|4032255|FG009|COMPLETED|Period 1 (Weeks 0 - 16)||0
3298547|NCT02925117|4032256|FG010|COMPLETED|Period 1 (Weeks 0 - 16)||0
3298548|NCT02925117|4032257|FG011|COMPLETED|Period 1 (Weeks 0 - 16)||0
3298549|NCT02925117|4032246|FG000|NOT COMPLETED|Period 1 (Weeks 0 - 16)||18
3298550|NCT02925117|4032247|FG001|NOT COMPLETED|Period 1 (Weeks 0 - 16)||11
3298551|NCT02925117|4032248|FG002|NOT COMPLETED|Period 1 (Weeks 0 - 16)||5
3298552|NCT02925117|4032249|FG003|NOT COMPLETED|Period 1 (Weeks 0 - 16)||3
3298553|NCT02925117|4032250|FG004|NOT COMPLETED|Period 1 (Weeks 0 - 16)||0
3298554|NCT02925117|4032251|FG005|NOT COMPLETED|Period 1 (Weeks 0 - 16)||0
3298555|NCT02925117|4032252|FG006|NOT COMPLETED|Period 1 (Weeks 0 - 16)||0
3298556|NCT02925117|4032253|FG007|NOT COMPLETED|Period 1 (Weeks 0 - 16)||0
3298557|NCT02925117|4032254|FG008|NOT COMPLETED|Period 1 (Weeks 0 - 16)||0
3298558|NCT02925117|4032255|FG009|NOT COMPLETED|Period 1 (Weeks 0 - 16)||0
3298559|NCT02925117|4032256|FG010|NOT COMPLETED|Period 1 (Weeks 0 - 16)||0
3298560|NCT02925117|4032257|FG011|NOT COMPLETED|Period 1 (Weeks 0 - 16)||0
3298561|NCT02925117|4032246|FG000|STARTED|Period 2 (Weeks 16 - 88)||0
3298562|NCT02925117|4032247|FG001|STARTED|Period 2 (Weeks 16 - 88)||0
3298563|NCT02925117|4032248|FG002|STARTED|Period 2 (Weeks 16 - 88)||0
3298564|NCT02925117|4032249|FG003|STARTED|Period 2 (Weeks 16 - 88)||0
3298565|NCT02925117|4032250|FG004|STARTED|Period 2 (Weeks 16 - 88)||10
3298566|NCT02925117|4032251|FG005|STARTED|Period 2 (Weeks 16 - 88)||10
3298567|NCT02925117|4032252|FG006|STARTED|Period 2 (Weeks 16 - 88)||15
3298568|NCT02925117|4032253|FG007|STARTED|Period 2 (Weeks 16 - 88)||16
3298569|NCT02925117|4032254|FG008|STARTED|Period 2 (Weeks 16 - 88)||19
3298570|NCT02925117|4032255|FG009|STARTED|Period 2 (Weeks 16 - 88)||18
3298571|NCT02925117|4032256|FG010|STARTED|Period 2 (Weeks 16 - 88)||19
3298572|NCT02925117|4032257|FG011|STARTED|Period 2 (Weeks 16 - 88)||19
3298573|NCT02925117|4032246|FG000|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||0
3298574|NCT02925117|4032247|FG001|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||0
3298575|NCT02925117|4032248|FG002|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||0
3298576|NCT02925117|4032249|FG003|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||0
3298577|NCT02925117|4032250|FG004|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||8
3298578|NCT02925117|4032251|FG005|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||1
3298579|NCT02925117|4032252|FG006|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||13
3298580|NCT02925117|4032253|FG007|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||12
3298581|NCT02925117|4032254|FG008|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||17
3298582|NCT02925117|4032255|FG009|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||12
3298583|NCT02925117|4032256|FG010|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||14
3298584|NCT02925117|4032257|FG011|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||4
3298585|NCT02925117|4032246|FG000|COMPLETED|Period 2 (Weeks 16 - 88)||0
3298586|NCT02925117|4032247|FG001|COMPLETED|Period 2 (Weeks 16 - 88)||0
3298587|NCT02925117|4032248|FG002|COMPLETED|Period 2 (Weeks 16 - 88)||0
3298588|NCT02925117|4032249|FG003|COMPLETED|Period 2 (Weeks 16 - 88)||0
3298589|NCT02925117|4032250|FG004|COMPLETED|Period 2 (Weeks 16 - 88)||8
3298590|NCT02925117|4032251|FG005|COMPLETED|Period 2 (Weeks 16 - 88)||5
3298591|NCT02925117|4032252|FG006|COMPLETED|Period 2 (Weeks 16 - 88)||9
3298592|NCT02925117|4032253|FG007|COMPLETED|Period 2 (Weeks 16 - 88)||11
3298593|NCT02925117|4032254|FG008|COMPLETED|Period 2 (Weeks 16 - 88)||13
3298594|NCT02925117|4032255|FG009|COMPLETED|Period 2 (Weeks 16 - 88)||12
3298595|NCT02925117|4032256|FG010|COMPLETED|Period 2 (Weeks 16 - 88)||11
3298596|NCT02925117|4032257|FG011|COMPLETED|Period 2 (Weeks 16 - 88)||14
3298597|NCT02925117|4032246|FG000|NOT COMPLETED|Period 2 (Weeks 16 - 88)||0
3298598|NCT02925117|4032247|FG001|NOT COMPLETED|Period 2 (Weeks 16 - 88)||0
3298599|NCT02925117|4032248|FG002|NOT COMPLETED|Period 2 (Weeks 16 - 88)||0
3298600|NCT02925117|4032249|FG003|NOT COMPLETED|Period 2 (Weeks 16 - 88)||0
3298601|NCT02925117|4032250|FG004|NOT COMPLETED|Period 2 (Weeks 16 - 88)||2
3298602|NCT02925117|4032251|FG005|NOT COMPLETED|Period 2 (Weeks 16 - 88)||5
3132355|NCT01690520|3857404|FG001|COMPLETED|Overall Study||35
3298603|NCT02925117|4032252|FG006|NOT COMPLETED|Period 2 (Weeks 16 - 88)||6
3298604|NCT02925117|4032253|FG007|NOT COMPLETED|Period 2 (Weeks 16 - 88)||5
3298605|NCT02925117|4032254|FG008|NOT COMPLETED|Period 2 (Weeks 16 - 88)||6
3298606|NCT02925117|4032255|FG009|NOT COMPLETED|Period 2 (Weeks 16 - 88)||6
3298607|NCT02925117|4032256|FG010|NOT COMPLETED|Period 2 (Weeks 16 - 88)||8
3298608|NCT02925117|4032257|FG011|NOT COMPLETED|Period 2 (Weeks 16 - 88)||5
3298609|NCT02925143|4032279|FG000|STARTED|Overall Study||6525
3298610|NCT02925143|4032279|FG000|Participants Receiving Depolarizing Neuromuscular Blocking Agent (NMBA) (Succinylcholine)|Overall Study||3099
3298611|NCT02925143|4032279|FG000|Participants Receiving Non-depolarizing Neuromuscular Blocking Agent (NMBA)|Overall Study||3426
3298612|NCT02925143|4032279|FG000|COMPLETED|Overall Study||6525
3298613|NCT02925143|4032279|FG000|NOT COMPLETED|Overall Study||0
3298614|NCT02925312|4032285|FG000|STARTED|Overall Study||125
3298615|NCT02925312|4032286|FG001|STARTED|Overall Study||294
3298616|NCT02925312|4032285|FG000|COMPLETED|Overall Study||98
3298617|NCT02925312|4032286|FG001|COMPLETED|Overall Study||294
3298618|NCT02925312|4032285|FG000|NOT COMPLETED|Overall Study||27
3298619|NCT02925312|4032286|FG001|NOT COMPLETED|Overall Study||0
3298620|NCT02925403|4032294|FG000|STARTED|Overall Study||8
3298621|NCT02925403|4032295|FG001|STARTED|Overall Study||5
3298622|NCT02925403|4032294|FG000|COMPLETED|Overall Study||8
3298623|NCT02925403|4032295|FG001|COMPLETED|Overall Study||4
3298624|NCT02925403|4032294|FG000|NOT COMPLETED|Overall Study||0
3298625|NCT02925403|4032295|FG001|NOT COMPLETED|Overall Study||1
3298626|NCT02925455|4032303|FG000|STARTED|Overall Study||9
3298627|NCT02925455|4032304|FG001|STARTED|Overall Study||6
3298628|NCT02925455|4032303|FG000|COMPLETED|Overall Study||7
3298629|NCT02925455|4032304|FG001|COMPLETED|Overall Study||6
3298630|NCT02925455|4032303|FG000|NOT COMPLETED|Overall Study||2
3298631|NCT02925455|4032304|FG001|NOT COMPLETED|Overall Study||0
3298632|NCT02925494|4032314|FG000|STARTED|Treatment Period||59
3298633|NCT02925494|4032315|FG001|STARTED|Treatment Period||58
3298634|NCT02925494|4032316|FG002|STARTED|Treatment Period||98
3298635|NCT02925494|4032317|FG003|STARTED|Treatment Period||218
3298636|NCT02925494|4032314|FG000|COMPLETED|Treatment Period||50
3298637|NCT02925494|4032315|FG001|COMPLETED|Treatment Period||43
3298638|NCT02925494|4032316|FG002|COMPLETED|Treatment Period||79
3298639|NCT02925494|4032317|FG003|COMPLETED|Treatment Period||182
3298640|NCT02925494|4032314|FG000|NOT COMPLETED|Treatment Period||9
3298641|NCT02925494|4032315|FG001|NOT COMPLETED|Treatment Period||15
3298642|NCT02925494|4032316|FG002|NOT COMPLETED|Treatment Period||19
3298643|NCT02925494|4032317|FG003|NOT COMPLETED|Treatment Period||36
3298644|NCT02925494|4032314|FG000|STARTED|Post-Treatment Follow-Up Period||54
3298645|NCT02925494|4032315|FG001|STARTED|Post-Treatment Follow-Up Period||47
3383670|NCT01887743|4118792|FG000|STARTED|Overall Study||20
3383671|NCT01887743|4118793|FG001|STARTED|Overall Study||19
3383672|NCT01887743|4118794|FG002|STARTED|Overall Study||32
3383673|NCT01887743|4118792|FG000|COMPLETED|Overall Study||19
3383674|NCT01887743|4118793|FG001|COMPLETED|Overall Study||17
3383675|NCT01887743|4118794|FG002|COMPLETED|Overall Study||29
3383676|NCT01887743|4118792|FG000|NOT COMPLETED|Overall Study||1
3383677|NCT01887743|4118793|FG001|NOT COMPLETED|Overall Study||2
3383678|NCT01887743|4118794|FG002|NOT COMPLETED|Overall Study||3
3383679|NCT01891643|4118805|FG000|STARTED|Overall Study||13
3383680|NCT01891643|4118806|FG001|STARTED|Overall Study||10
3383681|NCT01891643|4118805|FG000|COMPLETED|Overall Study||3
3383682|NCT01891643|4118806|FG001|COMPLETED|Overall Study||0
3383683|NCT01891643|4118805|FG000|NOT COMPLETED|Overall Study||10
3383684|NCT01891643|4118806|FG001|NOT COMPLETED|Overall Study||10
3383685|NCT01900691|4118812|FG000|STARTED|Overall Study||130
3383686|NCT01900691|4118812|FG000|COMPLETED|Overall Study||111
3383687|NCT01900691|4118812|FG000|NOT COMPLETED|Overall Study||19
3383688|NCT01901432|4118822|FG000|STARTED|Overall Study||3
3383689|NCT01901432|4118823|FG001|STARTED|Overall Study||3
3383690|NCT01901432|4118824|FG002|STARTED|Overall Study||3
3383691|NCT01901432|4118825|FG003|STARTED|Overall Study||3
3383692|NCT01901432|4118826|FG004|STARTED|Overall Study||36
3383693|NCT01901432|4118822|FG000|Received Study Drug|Overall Study||3
3383694|NCT01901432|4118823|FG001|Received Study Drug|Overall Study||3
3383695|NCT01901432|4118824|FG002|Received Study Drug|Overall Study||3
3383696|NCT01901432|4118825|FG003|Received Study Drug|Overall Study||3
3383697|NCT01901432|4118826|FG004|Received Study Drug|Overall Study||35
3383698|NCT01901432|4118822|FG000|COMPLETED|Overall Study||3
3383699|NCT01901432|4118823|FG001|COMPLETED|Overall Study||2
3383700|NCT01901432|4118824|FG002|COMPLETED|Overall Study||1
3132356|NCT01690520|3857403|FG000|NOT COMPLETED|Overall Study||51
3132357|NCT01690520|3857404|FG001|NOT COMPLETED|Overall Study||47
3132358|NCT01690546|3857410|FG000|STARTED|Overall Study||35
3383701|NCT01901432|4118825|FG003|COMPLETED|Overall Study||3
3383702|NCT01901432|4118826|FG004|COMPLETED|Overall Study||27
3383703|NCT01901432|4118822|FG000|NOT COMPLETED|Overall Study||0
3383704|NCT01901432|4118823|FG001|NOT COMPLETED|Overall Study||1
3383705|NCT01901432|4118824|FG002|NOT COMPLETED|Overall Study||2
3383706|NCT01901432|4118825|FG003|NOT COMPLETED|Overall Study||0
3383707|NCT01901432|4118826|FG004|NOT COMPLETED|Overall Study||9
3383708|NCT01904279|4118847|FG000|STARTED|Overall Study||27
3383709|NCT01904279|4118848|FG001|STARTED|Overall Study||25
3383710|NCT01904279|4118847|FG000|COMPLETED|Overall Study||24
3383711|NCT01904279|4118848|FG001|COMPLETED|Overall Study||22
3383712|NCT01904279|4118847|FG000|NOT COMPLETED|Overall Study||3
3132359|NCT01690546|3857410|FG000|Extended Release Injectable NTX|Overall Study||27
3132360|NCT01690546|3857410|FG000|COMPLETED|Overall Study||26
3383713|NCT01904279|4118848|FG001|NOT COMPLETED|Overall Study||3
3385834|NCT02880540|4121246|FG000|COMPLETED|Overall Study||13
3385835|NCT02880540|4121247|FG001|COMPLETED|Overall Study||13
3385836|NCT02880540|4121246|FG000|NOT COMPLETED|Overall Study||0
3385837|NCT02880540|4121247|FG001|NOT COMPLETED|Overall Study||0
3385838|NCT02740972|4121255|FG000|STARTED|4-week Double-blinded Placebo-controlled||5
2940904|NCT00640016|3653164|FG003|Treated|Overall Study||4
2940905|NCT00640016|3653161|FG000|COMPLETED|Overall Study||1
2940906|NCT00640016|3653162|FG001|COMPLETED|Overall Study||1
2940907|NCT00640016|3653163|FG002|COMPLETED|Overall Study||1
2940908|NCT00640016|3653164|FG003|COMPLETED|Overall Study||1
2940909|NCT00640016|3653161|FG000|NOT COMPLETED|Overall Study||2
2940910|NCT00640016|3653162|FG001|NOT COMPLETED|Overall Study||2
2940911|NCT00640016|3653163|FG002|NOT COMPLETED|Overall Study||3
2940912|NCT00640016|3653164|FG003|NOT COMPLETED|Overall Study||3
2940913|NCT00640042|3653181|FG000|STARTED|Enrollment|Number of patients with evidence of prescription card receipt|1570
2940914|NCT00640042|3653181|FG000|COMPLETED|Enrollment|Number of patients with evidence of study drug receipt|1487
2940915|NCT00640042|3653181|FG000|NOT COMPLETED|Enrollment||83
2940916|NCT00640042|3653181|FG000|STARTED|Treatment||1487
2940917|NCT00640042|3653181|FG000|COMPLETED|Treatment||561
2940918|NCT00640042|3653181|FG000|NOT COMPLETED|Treatment||926
2940919|NCT00640133|3653187|FG000|STARTED|Randomization Phase (Baseline-Month 3)||15
2940920|NCT00640133|3653188|FG001|STARTED|Randomization Phase (Baseline-Month 3)||12
2940921|NCT00640133|3653187|FG000|COMPLETED|Randomization Phase (Baseline-Month 3)||15
2940922|NCT00640133|3653188|FG001|COMPLETED|Randomization Phase (Baseline-Month 3)||12
2940923|NCT00640133|3653187|FG000|NOT COMPLETED|Randomization Phase (Baseline-Month 3)||0
2940924|NCT00640133|3653188|FG001|NOT COMPLETED|Randomization Phase (Baseline-Month 3)||0
2940925|NCT00640133|3653187|FG000|STARTED|Open Label Phase (Month 4-12)||27
2940926|NCT00640133|3653188|FG001|STARTED|Open Label Phase (Month 4-12)||0
2940927|NCT00640133|3653187|FG000|COMPLETED|Open Label Phase (Month 4-12)||24
2940928|NCT00640133|3653188|FG001|COMPLETED|Open Label Phase (Month 4-12)||0
2940929|NCT00640133|3653187|FG000|NOT COMPLETED|Open Label Phase (Month 4-12)||3
2940930|NCT00640133|3653188|FG001|NOT COMPLETED|Open Label Phase (Month 4-12)||0
2940931|NCT00640146|3653198|FG000|STARTED|Overall Study||19
2940932|NCT00640146|3653199|FG001|STARTED|Overall Study||18
2940933|NCT00640146|3653198|FG000|Received at Least 1 Dose of Study Drug|Overall Study||18
2940934|NCT00640146|3653199|FG001|Received at Least 1 Dose of Study Drug|Overall Study||15
2940935|NCT00640146|3653198|FG000|COMPLETED|Overall Study||15
2940936|NCT00640146|3653199|FG001|COMPLETED|Overall Study||12
2940937|NCT00640146|3653198|FG000|NOT COMPLETED|Overall Study||4
2940938|NCT00640146|3653199|FG001|NOT COMPLETED|Overall Study||6
2940939|NCT00640224|3653209|FG000|STARTED|Overall Study||23
2940940|NCT00640224|3653210|FG001|STARTED|Overall Study||23
2940941|NCT00640224|3653211|FG002|STARTED|Overall Study||0
2940942|NCT00640224|3653212|FG003|STARTED|Overall Study||0
2940943|NCT00640224|3653209|FG000|COMPLETED|Overall Study||17
2940944|NCT00640224|3653210|FG001|COMPLETED|Overall Study||20
2940945|NCT00640224|3653211|FG002|COMPLETED|Overall Study||0
2940946|NCT00640224|3653212|FG003|COMPLETED|Overall Study||0
2940947|NCT00640224|3653209|FG000|NOT COMPLETED|Overall Study||6
2940948|NCT00640224|3653210|FG001|NOT COMPLETED|Overall Study||3
2940949|NCT00640224|3653211|FG002|NOT COMPLETED|Overall Study||0
2940950|NCT00640224|3653212|FG003|NOT COMPLETED|Overall Study||0
2940951|NCT00640250|3653222|FG000|STARTED|Overall Study||48
2940952|NCT00640250|3653222|FG000|COMPLETED|Overall Study||48
2940953|NCT00640250|3653222|FG000|NOT COMPLETED|Overall Study||0
2940954|NCT00640289|3653325|FG000|STARTED|Overall Study||72
2940955|NCT00640289|3653325|FG000|COMPLETED|Overall Study||59
2940956|NCT00640289|3653325|FG000|NOT COMPLETED|Overall Study||13
2940957|NCT00640315|3653331|FG000|STARTED|Overall Study||10
2940958|NCT00640315|3653332|FG001|STARTED|Overall Study||13
2940959|NCT00640315|3653331|FG000|Participants Received Treatment|Overall Study||10
2940960|NCT00640315|3653332|FG001|Participants Received Treatment|Overall Study||13
2940961|NCT00640315|3653331|FG000|COMPLETED|Overall Study||10
2940962|NCT00640315|3653332|FG001|COMPLETED|Overall Study||12
2940963|NCT00640315|3653331|FG000|NOT COMPLETED|Overall Study||0
2940964|NCT00640315|3653332|FG001|NOT COMPLETED|Overall Study||1
2940965|NCT00640328|3653344|FG000|STARTED|First Treatment Period (Weeks 0-24)||8
2940966|NCT00640328|3653345|FG001|STARTED|First Treatment Period (Weeks 0-24)||11
2940967|NCT00640328|3653346|FG002|STARTED|First Treatment Period (Weeks 0-24)||7
2940968|NCT00640328|3653347|FG003|STARTED|First Treatment Period (Weeks 0-24)||4
2940969|NCT00640328|3653348|FG004|STARTED|First Treatment Period (Weeks 0-24)||4
2940970|NCT00640328|3653349|FG005|STARTED|First Treatment Period (Weeks 0-24)||4
2940971|NCT00640328|3653344|FG000|COMPLETED|First Treatment Period (Weeks 0-24)||8
2940972|NCT00640328|3653345|FG001|COMPLETED|First Treatment Period (Weeks 0-24)||10
2940973|NCT00640328|3653346|FG002|COMPLETED|First Treatment Period (Weeks 0-24)||7
2940974|NCT00640328|3653347|FG003|COMPLETED|First Treatment Period (Weeks 0-24)||4
3132361|NCT01690546|3857410|FG000|NOT COMPLETED|Overall Study||9
3132362|NCT01690663|3857418|FG000|STARTED|Overall Study||23
3132363|NCT01690663|3857419|FG001|STARTED|Overall Study||20
3132364|NCT01690663|3857420|FG002|STARTED|Overall Study||22
3132365|NCT01690663|3857421|FG003|STARTED|Overall Study||24
2940975|NCT00640328|3653348|FG004|COMPLETED|First Treatment Period (Weeks 0-24)||4
3132366|NCT01690663|3857418|FG000|COMPLETED|Overall Study||20
2940976|NCT00640328|3653349|FG005|COMPLETED|First Treatment Period (Weeks 0-24)||4
2940977|NCT00640328|3653344|FG000|NOT COMPLETED|First Treatment Period (Weeks 0-24)||0
2940978|NCT00640328|3653345|FG001|NOT COMPLETED|First Treatment Period (Weeks 0-24)||1
2940979|NCT00640328|3653346|FG002|NOT COMPLETED|First Treatment Period (Weeks 0-24)||0
2940980|NCT00640328|3653347|FG003|NOT COMPLETED|First Treatment Period (Weeks 0-24)||0
2940981|NCT00640328|3653348|FG004|NOT COMPLETED|First Treatment Period (Weeks 0-24)||0
2940982|NCT00640328|3653349|FG005|NOT COMPLETED|First Treatment Period (Weeks 0-24)||0
2940983|NCT00640328|3653344|FG000|STARTED|Second Treatment Period (Weeks 24-48)||8
2940984|NCT00640328|3653345|FG001|STARTED|Second Treatment Period (Weeks 24-48)||10
2940985|NCT00640328|3653346|FG002|STARTED|Second Treatment Period (Weeks 24-48)||7
2940986|NCT00640328|3653347|FG003|STARTED|Second Treatment Period (Weeks 24-48)||4
2940987|NCT00640328|3653348|FG004|STARTED|Second Treatment Period (Weeks 24-48)||4
2940988|NCT00640328|3653349|FG005|STARTED|Second Treatment Period (Weeks 24-48)||4
2940989|NCT00640328|3653344|FG000|COMPLETED|Second Treatment Period (Weeks 24-48)||8
2940990|NCT00640328|3653345|FG001|COMPLETED|Second Treatment Period (Weeks 24-48)||10
2940991|NCT00640328|3653346|FG002|COMPLETED|Second Treatment Period (Weeks 24-48)||7
2940992|NCT00640328|3653347|FG003|COMPLETED|Second Treatment Period (Weeks 24-48)||4
2940993|NCT00640328|3653348|FG004|COMPLETED|Second Treatment Period (Weeks 24-48)||3
2940994|NCT00640328|3653349|FG005|COMPLETED|Second Treatment Period (Weeks 24-48)||4
2940995|NCT00640328|3653344|FG000|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||0
2940996|NCT00640328|3653345|FG001|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||0
2940997|NCT00640328|3653346|FG002|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||0
2940998|NCT00640328|3653347|FG003|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||0
2940999|NCT00640328|3653348|FG004|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||1
2941000|NCT00640328|3653349|FG005|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||0
2941001|NCT00640328|3653344|FG000|STARTED|IFUP (Week 48 to Individual Termination)||8
2941002|NCT00640328|3653345|FG001|STARTED|IFUP (Week 48 to Individual Termination)||11
2941003|NCT00640328|3653346|FG002|STARTED|IFUP (Week 48 to Individual Termination)||7
2941004|NCT00640328|3653347|FG003|STARTED|IFUP (Week 48 to Individual Termination)||4
2941005|NCT00640328|3653348|FG004|STARTED|IFUP (Week 48 to Individual Termination)||4
2941006|NCT00640328|3653349|FG005|STARTED|IFUP (Week 48 to Individual Termination)||4
2941007|NCT00640328|3653344|FG000|COMPLETED|IFUP (Week 48 to Individual Termination)||8
2941008|NCT00640328|3653345|FG001|COMPLETED|IFUP (Week 48 to Individual Termination)||10
2941009|NCT00640328|3653346|FG002|COMPLETED|IFUP (Week 48 to Individual Termination)||6
2941010|NCT00640328|3653347|FG003|COMPLETED|IFUP (Week 48 to Individual Termination)||3
2941011|NCT00640328|3653348|FG004|COMPLETED|IFUP (Week 48 to Individual Termination)||4
2941012|NCT00640328|3653349|FG005|COMPLETED|IFUP (Week 48 to Individual Termination)||4
2941013|NCT00640328|3653344|FG000|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||0
2941014|NCT00640328|3653345|FG001|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||1
2941015|NCT00640328|3653346|FG002|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||1
2941016|NCT00640328|3653347|FG003|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||1
2941017|NCT00640328|3653348|FG004|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||0
2941018|NCT00640328|3653349|FG005|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||0
2941019|NCT00640341|3653373|FG000|STARTED|Overall Study|All Starting participants were dispensed lenses|170
2941020|NCT00640341|3653374|FG001|STARTED|Overall Study||170
2941021|NCT00640341|3653375|FG002|STARTED|Overall Study||170
2941022|NCT00640341|3653373|FG000|Eligible Participants at Baseline|Overall Study||165
2941023|NCT00640341|3653374|FG001|Eligible Participants at Baseline|Overall Study||167
2941024|NCT00640341|3653375|FG002|Eligible Participants at Baseline|Overall Study||168
2941025|NCT00640341|3653373|FG000|COMPLETED|Overall Study||149
2941026|NCT00640341|3653374|FG001|COMPLETED|Overall Study||165
2941027|NCT00640341|3653375|FG002|COMPLETED|Overall Study||163
2941028|NCT00640341|3653373|FG000|NOT COMPLETED|Overall Study||21
2941029|NCT00640341|3653374|FG001|NOT COMPLETED|Overall Study||5
2941030|NCT00640341|3653375|FG002|NOT COMPLETED|Overall Study||7
2941031|NCT00640393|3653383|FG000|STARTED|Part 1||99
2941032|NCT00640393|3653384|FG001|STARTED|Part 1||0
2941033|NCT00640393|3653385|FG002|STARTED|Part 1||0
2941034|NCT00640393|3653383|FG000|COMPLETED|Part 1||94
2941035|NCT00640393|3653384|FG001|COMPLETED|Part 1||0
2941036|NCT00640393|3653385|FG002|COMPLETED|Part 1||0
2941037|NCT00640393|3653383|FG000|NOT COMPLETED|Part 1||5
2941038|NCT00640393|3653384|FG001|NOT COMPLETED|Part 1||0
2941039|NCT00640393|3653385|FG002|NOT COMPLETED|Part 1||0
2941040|NCT00640393|3653383|FG000|STARTED|Randomization||94
2941041|NCT00640393|3653384|FG001|STARTED|Randomization||0
2941042|NCT00640393|3653385|FG002|STARTED|Randomization||0
2941043|NCT00640393|3653383|FG000|COMPLETED|Randomization||75
2941044|NCT00640393|3653384|FG001|COMPLETED|Randomization||0
2941045|NCT00640393|3653385|FG002|COMPLETED|Randomization||0
2941046|NCT00640393|3653383|FG000|NOT COMPLETED|Randomization||19
2941047|NCT00640393|3653384|FG001|NOT COMPLETED|Randomization||0
2941048|NCT00640393|3653385|FG002|NOT COMPLETED|Randomization||0
2941049|NCT00640393|3653383|FG000|STARTED|Part 2||0
2941050|NCT00640393|3653384|FG001|STARTED|Part 2||37
2941051|NCT00640393|3653385|FG002|STARTED|Part 2||38
2941052|NCT00640393|3653383|FG000|COMPLETED|Part 2||0
2941053|NCT00640393|3653384|FG001|COMPLETED|Part 2|Per Protocol analysis is of 7 participants that were compliant to protocol|27
2941054|NCT00640393|3653385|FG002|COMPLETED|Part 2|Per protocol analysis of 27 to 29 participants that were compliant depending on evaluation or visit|35
2941055|NCT00640393|3653383|FG000|NOT COMPLETED|Part 2||0
2941056|NCT00640393|3653384|FG001|NOT COMPLETED|Part 2||10
2941057|NCT00640393|3653385|FG002|NOT COMPLETED|Part 2||3
2941058|NCT00640510|3653395|FG000|STARTED|Overall Study||17
2941059|NCT00640510|3653396|FG001|STARTED|Overall Study|One patient randomized to placebo discontinued prior to receiving study drug.|17
2941060|NCT00640510|3653395|FG000|COMPLETED|Overall Study||16
2941061|NCT00640510|3653396|FG001|COMPLETED|Overall Study||15
2941062|NCT00640510|3653395|FG000|NOT COMPLETED|Overall Study||1
2941063|NCT00640510|3653396|FG001|NOT COMPLETED|Overall Study||2
2941064|NCT00640562|3653404|FG000|STARTED|Overall Study||109
2941065|NCT00640562|3653405|FG001|STARTED|Overall Study||107
2941066|NCT00640562|3653404|FG000|COMPLETED|Overall Study||91
2941067|NCT00640562|3653405|FG001|COMPLETED|Overall Study||81
2941068|NCT00640562|3653404|FG000|NOT COMPLETED|Overall Study||18
2941069|NCT00640562|3653405|FG001|NOT COMPLETED|Overall Study||26
2941070|NCT00640601|3653411|FG000|STARTED|Overall Study|331 patients enrolled and 295 patients started investigational product (IP)|295
2941071|NCT00640601|3653411|FG000|COMPLETED|Overall Study||183
2941072|NCT00640601|3653411|FG000|NOT COMPLETED|Overall Study||112
2941073|NCT00640614|3653417|FG000|STARTED|Overall Study||125
2941074|NCT00640614|3653418|FG001|STARTED|Overall Study||110
2941075|NCT00640614|3653417|FG000|COMPLETED|Overall Study||124
2941076|NCT00640614|3653418|FG001|COMPLETED|Overall Study||110
2941077|NCT00640614|3653417|FG000|NOT COMPLETED|Overall Study||1
2941078|NCT00640614|3653418|FG001|NOT COMPLETED|Overall Study||0
2941079|NCT00640653|3653452|FG000|STARTED|Overall Study||131
2941080|NCT00640653|3653453|FG001|STARTED|Overall Study||134
2941081|NCT00640653|3653454|FG002|STARTED|Overall Study||129
2941082|NCT00640653|3653455|FG003|STARTED|Overall Study||134
2941083|NCT00640653|3653456|FG004|STARTED|Overall Study||134
2941084|NCT00640653|3653452|FG000|Followed-up at 3 mo|Overall Study||126
2941085|NCT00640653|3653453|FG001|Followed-up at 3 mo|Overall Study||127
2941086|NCT00640653|3653454|FG002|Followed-up at 3 mo|Overall Study||125
2941087|NCT00640653|3653455|FG003|Followed-up at 3 mo|Overall Study||129
2941088|NCT00640653|3653456|FG004|Followed-up at 3 mo|Overall Study||126
2941089|NCT00640653|3653452|FG000|Followed-up at 6 mo|Overall Study||127
2941090|NCT00640653|3653453|FG001|Followed-up at 6 mo|Overall Study||130
3132367|NCT01690663|3857419|FG001|COMPLETED|Overall Study||17
3132368|NCT01690663|3857420|FG002|COMPLETED|Overall Study||19
3132369|NCT01690663|3857421|FG003|COMPLETED|Overall Study||20
2941091|NCT00640653|3653454|FG002|Followed-up at 6 mo|Overall Study||124
2941092|NCT00640653|3653455|FG003|Followed-up at 6 mo|Overall Study||130
2941093|NCT00640653|3653456|FG004|Followed-up at 6 mo|Overall Study||125
2941094|NCT00640653|3653452|FG000|Followed-up at 12 mo|Overall Study||124
2941095|NCT00640653|3653453|FG001|Followed-up at 12 mo|Overall Study||121
2941096|NCT00640653|3653454|FG002|Followed-up at 12 mo|Overall Study||115
2941097|NCT00640653|3653455|FG003|Followed-up at 12 mo|Overall Study||122
2941098|NCT00640653|3653456|FG004|Followed-up at 12 mo|Overall Study||116
2941099|NCT00640653|3653452|FG000|Followed-up at 18 mo|Overall Study||118
2941100|NCT00640653|3653453|FG001|Followed-up at 18 mo|Overall Study||112
2941101|NCT00640653|3653454|FG002|Followed-up at 18 mo|Overall Study||113
2941102|NCT00640653|3653455|FG003|Followed-up at 18 mo|Overall Study||117
2941103|NCT00640653|3653456|FG004|Followed-up at 18 mo|Overall Study||117
2941104|NCT00640653|3653452|FG000|Followed-up at 24 mo|Overall Study||114
2941105|NCT00640653|3653453|FG001|Followed-up at 24 mo|Overall Study||116
2941106|NCT00640653|3653454|FG002|Followed-up at 24 mo|Overall Study||105
2941107|NCT00640653|3653455|FG003|Followed-up at 24 mo|Overall Study||112
2941108|NCT00640653|3653456|FG004|Followed-up at 24 mo|Overall Study||112
2941109|NCT00640653|3653452|FG000|COMPLETED|Overall Study||128
2941110|NCT00640653|3653453|FG001|COMPLETED|Overall Study||131
2941111|NCT00640653|3653454|FG002|COMPLETED|Overall Study||129
2941112|NCT00640653|3653455|FG003|COMPLETED|Overall Study||132
2941113|NCT00640653|3653456|FG004|COMPLETED|Overall Study||129
2941114|NCT00640653|3653452|FG000|NOT COMPLETED|Overall Study||3
2941115|NCT00640653|3653453|FG001|NOT COMPLETED|Overall Study||3
2941116|NCT00640653|3653454|FG002|NOT COMPLETED|Overall Study||0
2941117|NCT00640653|3653455|FG003|NOT COMPLETED|Overall Study||2
2941118|NCT00640653|3653456|FG004|NOT COMPLETED|Overall Study||5
2941119|NCT00640822|3653471|FG000|STARTED|Overall Study||322
2941120|NCT00640822|3653472|FG001|STARTED|Overall Study||317
2941121|NCT00640822|3653473|FG002|STARTED|Overall Study||102
2941122|NCT00640822|3653471|FG000|COMPLETED|Overall Study||279
2941123|NCT00640822|3653472|FG001|COMPLETED|Overall Study||258
2941124|NCT00640822|3653473|FG002|COMPLETED|Overall Study||77
2941125|NCT00640822|3653471|FG000|NOT COMPLETED|Overall Study||43
2941126|NCT00640822|3653472|FG001|NOT COMPLETED|Overall Study||59
2941127|NCT00640822|3653473|FG002|NOT COMPLETED|Overall Study||25
2941128|NCT00640835|3653483|FG000|STARTED|Overall Study||194
2941129|NCT00640835|3653484|FG001|STARTED|Overall Study||188
3132370|NCT01690663|3857418|FG000|NOT COMPLETED|Overall Study||3
3132371|NCT01690663|3857419|FG001|NOT COMPLETED|Overall Study||3
3132372|NCT01690663|3857420|FG002|NOT COMPLETED|Overall Study||3
3132373|NCT01690663|3857421|FG003|NOT COMPLETED|Overall Study||4
3132374|NCT01690923|3857431|FG000|STARTED|Overall Study||10
2941130|NCT00640835|3653483|FG000|COMPLETED|Overall Study||118
2941131|NCT00640835|3653484|FG001|COMPLETED|Overall Study||131
2941132|NCT00640835|3653483|FG000|NOT COMPLETED|Overall Study||76
2941133|NCT00640835|3653484|FG001|NOT COMPLETED|Overall Study||57
2941134|NCT00640926|3653493|FG000|STARTED|Overall Study||53
3132375|NCT01690923|3857432|FG001|STARTED|Overall Study|1 participant was withdrawn and excluded due to poor fit with the pillows mask|11
3132376|NCT01690923|3857431|FG000|COMPLETED|Overall Study||10
3132377|NCT01690923|3857432|FG001|COMPLETED|Overall Study||10
3132378|NCT01690923|3857431|FG000|NOT COMPLETED|Overall Study||0
3132379|NCT01690923|3857432|FG001|NOT COMPLETED|Overall Study||1
3132380|NCT01690988|3857439|FG000|STARTED|Overall Study||227
3132381|NCT01690988|3857440|FG001|STARTED|Overall Study||222
2941135|NCT00640926|3653494|FG001|STARTED|Overall Study||52
2941136|NCT00640926|3653495|FG002|STARTED|Overall Study||53
2941137|NCT00640926|3653493|FG000|COMPLETED|Overall Study||45
2941138|NCT00640926|3653494|FG001|COMPLETED|Overall Study||46
2941139|NCT00640926|3653495|FG002|COMPLETED|Overall Study||45
2941140|NCT00640926|3653493|FG000|NOT COMPLETED|Overall Study||8
2941141|NCT00640926|3653494|FG001|NOT COMPLETED|Overall Study||6
2941142|NCT00640926|3653495|FG002|NOT COMPLETED|Overall Study||8
2941143|NCT00640978|3653503|FG000|STARTED|Overall Study||15
2941144|NCT00640978|3653503|FG000|COMPLETED|Overall Study||15
2941145|NCT00640978|3653503|FG000|NOT COMPLETED|Overall Study||0
2941146|NCT00641043|3653509|FG000|STARTED|Overall Study|number who started treatment|130
2941147|NCT00641043|3653510|FG001|STARTED|Overall Study|number who started treatment|259
2941148|NCT00641043|3653509|FG000|COMPLETED|Overall Study|number who completed treatment|111
2941149|NCT00641043|3653510|FG001|COMPLETED|Overall Study|number who completed treatment|244
2941150|NCT00641043|3653509|FG000|NOT COMPLETED|Overall Study||19
2941151|NCT00641043|3653510|FG001|NOT COMPLETED|Overall Study||15
2941152|NCT00641056|3653518|FG000|STARTED|Overall Study||233
2941153|NCT00641056|3653519|FG001|STARTED|Overall Study||234
2941154|NCT00641056|3653518|FG000|Intent to Treat (ITT)|Overall Study||233
2941155|NCT00641056|3653519|FG001|Intent to Treat (ITT)|Overall Study||223
2941156|NCT00641056|3653518|FG000|COMPLETED|Overall Study||204
2941157|NCT00641056|3653519|FG001|COMPLETED|Overall Study||209
2941158|NCT00641056|3653518|FG000|NOT COMPLETED|Overall Study||29
2941159|NCT00641056|3653519|FG001|NOT COMPLETED|Overall Study||25
2941160|NCT00641147|3653531|FG000|STARTED|Completed 4 Months.||21
2941161|NCT00641147|3653532|FG001|STARTED|Completed 4 Months.||23
2941162|NCT00641147|3653531|FG000|COMPLETED|Completed 4 Months.||19
2941163|NCT00641147|3653532|FG001|COMPLETED|Completed 4 Months.||23
2941164|NCT00641147|3653531|FG000|NOT COMPLETED|Completed 4 Months.||2
2941165|NCT00641147|3653532|FG001|NOT COMPLETED|Completed 4 Months.||0
2941166|NCT00641147|3653531|FG000|STARTED|Completed 8 Months.||19
2941167|NCT00641147|3653532|FG001|STARTED|Completed 8 Months.||23
2941168|NCT00641147|3653531|FG000|COMPLETED|Completed 8 Months.||16
2941169|NCT00641147|3653532|FG001|COMPLETED|Completed 8 Months.||21
2941170|NCT00641147|3653531|FG000|NOT COMPLETED|Completed 8 Months.||3
2941171|NCT00641147|3653532|FG001|NOT COMPLETED|Completed 8 Months.||2
2941172|NCT00641147|3653531|FG000|STARTED|Completed 12 Months.||16
2941173|NCT00641147|3653532|FG001|STARTED|Completed 12 Months.||21
2941174|NCT00641147|3653531|FG000|COMPLETED|Completed 12 Months.||15
2941175|NCT00641147|3653532|FG001|COMPLETED|Completed 12 Months.||19
2941176|NCT00641147|3653531|FG000|NOT COMPLETED|Completed 12 Months.||1
2941177|NCT00641147|3653532|FG001|NOT COMPLETED|Completed 12 Months.||2
2941178|NCT00641147|3653531|FG000|STARTED|Completed 16 Months.||15
2941179|NCT00641147|3653532|FG001|STARTED|Completed 16 Months.||19
2941180|NCT00641147|3653531|FG000|COMPLETED|Completed 16 Months.||13
2941181|NCT00641147|3653532|FG001|COMPLETED|Completed 16 Months.||19
2941182|NCT00641147|3653531|FG000|NOT COMPLETED|Completed 16 Months.||2
2941183|NCT00641147|3653532|FG001|NOT COMPLETED|Completed 16 Months.||0
2941184|NCT00641563|3653542|FG000|STARTED|Infusion 1||5
2941185|NCT00641563|3653543|FG001|STARTED|Infusion 1||5
2941186|NCT00641563|3653542|FG000|COMPLETED|Infusion 1||5
2941187|NCT00641563|3653543|FG001|COMPLETED|Infusion 1||5
2941188|NCT00641563|3653542|FG000|NOT COMPLETED|Infusion 1||0
2941189|NCT00641563|3653543|FG001|NOT COMPLETED|Infusion 1||0
2941190|NCT00641563|3653542|FG000|STARTED|Infusion 2||5
2941191|NCT00641563|3653543|FG001|STARTED|Infusion 2||5
2941192|NCT00641563|3653542|FG000|COMPLETED|Infusion 2||5
2941193|NCT00641563|3653543|FG001|COMPLETED|Infusion 2||5
2941194|NCT00641563|3653542|FG000|NOT COMPLETED|Infusion 2||0
2941195|NCT00641563|3653543|FG001|NOT COMPLETED|Infusion 2||0
2941196|NCT00641641|3653549|FG000|STARTED|Overall Study||16
2941197|NCT00641641|3653549|FG000|COMPLETED|Overall Study||16
2941198|NCT00641641|3653549|FG000|NOT COMPLETED|Overall Study||0
2941199|NCT00641667|3653553|FG000|STARTED|Overall Study||66
2941200|NCT00641667|3653553|FG000|COMPLETED|Overall Study||60
2941201|NCT00641667|3653553|FG000|NOT COMPLETED|Overall Study||6
2941202|NCT00641706|3653559|FG000|STARTED|Overall Study||37
2941203|NCT00641706|3653560|FG001|STARTED|Overall Study||7
2941204|NCT00641706|3653559|FG000|COMPLETED|Overall Study||28
2941205|NCT00641706|3653560|FG001|COMPLETED|Overall Study||4
2941206|NCT00641706|3653559|FG000|NOT COMPLETED|Overall Study||9
2941207|NCT00641706|3653560|FG001|NOT COMPLETED|Overall Study||3
2941208|NCT00641719|3653568|FG000|STARTED|Overall Study||129
2941209|NCT00641719|3653569|FG001|STARTED|Overall Study||129
2941210|NCT00641719|3653568|FG000|COMPLETED|Overall Study||99
2941211|NCT00641719|3653569|FG001|COMPLETED|Overall Study|1 participant discontinued during taper phase, not during treatment phase.|92
2941212|NCT00641719|3653568|FG000|NOT COMPLETED|Overall Study||30
2941213|NCT00641719|3653569|FG001|NOT COMPLETED|Overall Study||37
2941214|NCT00641745|3653577|FG000|STARTED|Overall Study||427
2941215|NCT00641745|3653578|FG001|STARTED|Overall Study||202
2941216|NCT00641745|3653577|FG000|COMPLETED|Overall Study||147
2941217|NCT00641745|3653578|FG001|COMPLETED|Overall Study||89
2941218|NCT00641745|3653577|FG000|NOT COMPLETED|Overall Study||280
2941219|NCT00641745|3653578|FG001|NOT COMPLETED|Overall Study||113
2941220|NCT00641797|3653586|FG000|STARTED|Overall Study||11
2941221|NCT00641797|3653587|FG001|STARTED|Overall Study||15
2941222|NCT00641797|3653586|FG000|COMPLETED|Overall Study||11
2941223|NCT00641797|3653587|FG001|COMPLETED|Overall Study||15
2941224|NCT00641797|3653586|FG000|NOT COMPLETED|Overall Study||0
2941225|NCT00641797|3653587|FG001|NOT COMPLETED|Overall Study||0
2941226|NCT00641862|3653595|FG000|STARTED|Overall Study||183
2941227|NCT00641862|3653596|FG001|STARTED|Overall Study||183
2941228|NCT00641862|3653595|FG000|COMPLETED|Overall Study||139
2941229|NCT00641862|3653596|FG001|COMPLETED|Overall Study||145
2941230|NCT00641862|3653595|FG000|NOT COMPLETED|Overall Study||44
2941231|NCT00641862|3653596|FG001|NOT COMPLETED|Overall Study||38
2941232|NCT00642018|3653604|FG000|STARTED|Overall Study||52
2941233|NCT00642018|3653605|FG001|STARTED|Overall Study||102
2941234|NCT00642018|3653604|FG000|Received at Least One Dose of Study Drug|Overall Study||51
2941235|NCT00642018|3653605|FG001|Received at Least One Dose of Study Drug|Overall Study||98
2941236|NCT00642018|3653604|FG000|COMPLETED|Overall Study|Participants who completed 10 cycles of treatment.|24
2941237|NCT00642018|3653605|FG001|COMPLETED|Overall Study|Participants who completed 10 cycles of treatment.|23
2941238|NCT00642018|3653604|FG000|NOT COMPLETED|Overall Study||28
2941239|NCT00642018|3653605|FG001|NOT COMPLETED|Overall Study||79
2941240|NCT00642174|3653614|FG000|STARTED|Period 1 - Initial Drug||18
2941241|NCT00642174|3653615|FG001|STARTED|Period 1 - Initial Drug||17
2941242|NCT00642174|3653614|FG000|COMPLETED|Period 1 - Initial Drug||18
2941243|NCT00642174|3653615|FG001|COMPLETED|Period 1 - Initial Drug||16
2941244|NCT00642174|3653614|FG000|NOT COMPLETED|Period 1 - Initial Drug||0
2941245|NCT00642174|3653615|FG001|NOT COMPLETED|Period 1 - Initial Drug||1
2941246|NCT00642174|3653614|FG000|STARTED|Period 2 - Crossover Drug||18
2941247|NCT00642174|3653615|FG001|STARTED|Period 2 - Crossover Drug||16
2941248|NCT00642174|3653614|FG000|COMPLETED|Period 2 - Crossover Drug||18
2941249|NCT00642174|3653615|FG001|COMPLETED|Period 2 - Crossover Drug||16
2941250|NCT00642174|3653614|FG000|NOT COMPLETED|Period 2 - Crossover Drug||0
2941251|NCT00642174|3653615|FG001|NOT COMPLETED|Period 2 - Crossover Drug||0
2941252|NCT00642278|3653628|FG000|STARTED|Overall Study||65
2941253|NCT00642278|3653629|FG001|STARTED|Overall Study||64
2941254|NCT00642278|3653630|FG002|STARTED|Overall Study||64
2941255|NCT00642278|3653631|FG003|STARTED|Overall Study||65
2941256|NCT00642278|3653632|FG004|STARTED|Overall Study||64
2941257|NCT00642278|3653633|FG005|STARTED|Overall Study||64
2941258|NCT00642278|3653634|FG006|STARTED|Overall Study||65
2941259|NCT00642278|3653628|FG000|COMPLETED|Overall Study||55
2941260|NCT00642278|3653629|FG001|COMPLETED|Overall Study||59
2941261|NCT00642278|3653630|FG002|COMPLETED|Overall Study||59
2941262|NCT00642278|3653631|FG003|COMPLETED|Overall Study||56
2941263|NCT00642278|3653632|FG004|COMPLETED|Overall Study||56
2941264|NCT00642278|3653633|FG005|COMPLETED|Overall Study||57
2941265|NCT00642278|3653634|FG006|COMPLETED|Overall Study||60
2941266|NCT00642278|3653628|FG000|NOT COMPLETED|Overall Study||10
2941267|NCT00642278|3653629|FG001|NOT COMPLETED|Overall Study||5
2941268|NCT00642278|3653630|FG002|NOT COMPLETED|Overall Study||5
2941269|NCT00642278|3653631|FG003|NOT COMPLETED|Overall Study||9
2941270|NCT00642278|3653632|FG004|NOT COMPLETED|Overall Study||8
2941271|NCT00642278|3653633|FG005|NOT COMPLETED|Overall Study||7
2941272|NCT00642278|3653634|FG006|NOT COMPLETED|Overall Study||5
2941273|NCT00642304|3653650|FG000|STARTED|Overall Study||20
2941274|NCT00642304|3653650|FG000|COMPLETED|Overall Study||14
2941275|NCT00642304|3653650|FG000|NOT COMPLETED|Overall Study||6
2941276|NCT00642356|3653656|FG000|STARTED|Overall Study||7
2941277|NCT00642356|3653657|FG001|STARTED|Overall Study||7
2941278|NCT00642356|3653656|FG000|COMPLETED|Overall Study||5
2941279|NCT00642356|3653657|FG001|COMPLETED|Overall Study||4
2941280|NCT00642356|3653656|FG000|NOT COMPLETED|Overall Study||2
2941281|NCT00642356|3653657|FG001|NOT COMPLETED|Overall Study||3
2941282|NCT00642369|3653665|FG000|STARTED|Overall Study||30
2941283|NCT00642369|3653666|FG001|STARTED|Overall Study||30
2941284|NCT00642369|3653665|FG000|COMPLETED|Overall Study||25
2941285|NCT00642369|3653666|FG001|COMPLETED|Overall Study||24
2941286|NCT00642369|3653665|FG000|NOT COMPLETED|Overall Study||5
2941287|NCT00642369|3653666|FG001|NOT COMPLETED|Overall Study||6
2941288|NCT00642460|3653676|FG000|STARTED|Part I: 12 Week Double-Blind||37
2941289|NCT00642460|3653677|FG001|STARTED|Part I: 12 Week Double-Blind||38
2941290|NCT00642460|3653678|FG002|STARTED|Part I: 12 Week Double-Blind||37
2941291|NCT00642460|3653679|FG003|STARTED|Part I: 12 Week Double-Blind||0
2941292|NCT00642460|3653680|FG004|STARTED|Part I: 12 Week Double-Blind||0
2941293|NCT00642460|3653681|FG005|STARTED|Part I: 12 Week Double-Blind||0
2941294|NCT00642460|3653676|FG000|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||37
2941295|NCT00642460|3653677|FG001|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||38
2941296|NCT00642460|3653678|FG002|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||37
2941297|NCT00642460|3653679|FG003|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||0
3163302|NCT01885208|3890830|FG001|STARTED|Overall Study||407
3163303|NCT01885208|3890829|FG000|Exposed|Overall Study||404
3163304|NCT01885208|3890830|FG001|Exposed|Overall Study||405
2941298|NCT00642460|3653680|FG004|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||0
2941299|NCT00642460|3653681|FG005|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||0
2941300|NCT00642460|3653676|FG000|COMPLETED|Part I: 12 Week Double-Blind||36
2941301|NCT00642460|3653677|FG001|COMPLETED|Part I: 12 Week Double-Blind||37
2941302|NCT00642460|3653678|FG002|COMPLETED|Part I: 12 Week Double-Blind||36
2941303|NCT00642460|3653679|FG003|COMPLETED|Part I: 12 Week Double-Blind||0
2941304|NCT00642460|3653680|FG004|COMPLETED|Part I: 12 Week Double-Blind||0
2941305|NCT00642460|3653681|FG005|COMPLETED|Part I: 12 Week Double-Blind||0
2941306|NCT00642460|3653676|FG000|NOT COMPLETED|Part I: 12 Week Double-Blind||1
2941307|NCT00642460|3653677|FG001|NOT COMPLETED|Part I: 12 Week Double-Blind||1
2941308|NCT00642460|3653678|FG002|NOT COMPLETED|Part I: 12 Week Double-Blind||1
2941309|NCT00642460|3653679|FG003|NOT COMPLETED|Part I: 12 Week Double-Blind||0
2941310|NCT00642460|3653680|FG004|NOT COMPLETED|Part I: 12 Week Double-Blind||0
2941311|NCT00642460|3653681|FG005|NOT COMPLETED|Part I: 12 Week Double-Blind||0
2941312|NCT00642460|3653676|FG000|STARTED|Part II: Open-Label Up to Week 92|Includes Participants who received Open-Label in Part II or Open-Label escape therapy in Part I.|52
2941313|NCT00642460|3653677|FG001|STARTED|Part II: Open-Label Up to Week 92||40
2941314|NCT00642460|3653678|FG002|STARTED|Part II: Open-Label Up to Week 92|Placebo group received open-label Tocilizumab 8 mg/kg or 12 mg/kg based on body weight in Part II.|0
2941315|NCT00642460|3653679|FG003|STARTED|Part II: Open-Label Up to Week 92|19 Participants switched from 12 mg/kg to 8 mg/kg and 1 Participant switched from 8mg/kg to 12 mg/kg|20
2941316|NCT00642460|3653680|FG004|STARTED|Part II: Open-Label Up to Week 92||0
2941317|NCT00642460|3653681|FG005|STARTED|Part II: Open-Label Up to Week 92||0
3163305|NCT01885208|3890829|FG000|Premature Discontinuation of Treatment|Overall Study|Subjects who prematurely discontinued treatment were allowed to continue participation in the trial.|82
3163306|NCT01885208|3890830|FG001|Premature Discontinuation of Treatment|Overall Study|Subjects who prematurely discontinued treatment were allowed to continue participation in the trial.|85
3163307|NCT01885208|3890829|FG000|COMPLETED|Overall Study||374
3163308|NCT01885208|3890830|FG001|COMPLETED|Overall Study||369
3163309|NCT01885208|3890829|FG000|NOT COMPLETED|Overall Study||32
3163310|NCT01885208|3890830|FG001|NOT COMPLETED|Overall Study||38
3163311|NCT01885559|3890838|FG000|STARTED|Overall Study||242
3163312|NCT01885559|3890839|FG001|STARTED|Overall Study||244
3163313|NCT01885559|3890838|FG000|COMPLETED|Overall Study||218
3163314|NCT01885559|3890839|FG001|COMPLETED|Overall Study||208
3163315|NCT01885559|3890838|FG000|NOT COMPLETED|Overall Study||24
3163316|NCT01885559|3890839|FG001|NOT COMPLETED|Overall Study||36
3163317|NCT01885871|3890845|FG000|STARTED|Overall Study||20
3163318|NCT01885871|3890845|FG000|COMPLETED|Overall Study||20
3163319|NCT01885871|3890845|FG000|NOT COMPLETED|Overall Study||0
2941318|NCT00642460|3653676|FG000|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||52
2941319|NCT00642460|3653677|FG001|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||40
2941320|NCT00642460|3653678|FG002|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||0
2941321|NCT00642460|3653679|FG003|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||20
2941322|NCT00642460|3653680|FG004|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||0
2941323|NCT00642460|3653681|FG005|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||0
2941324|NCT00642460|3653676|FG000|COMPLETED|Part II: Open-Label Up to Week 92||43
2941325|NCT00642460|3653677|FG001|COMPLETED|Part II: Open-Label Up to Week 92||32
2941326|NCT00642460|3653678|FG002|COMPLETED|Part II: Open-Label Up to Week 92||0
2941327|NCT00642460|3653679|FG003|COMPLETED|Part II: Open-Label Up to Week 92||17
2941328|NCT00642460|3653680|FG004|COMPLETED|Part II: Open-Label Up to Week 92||0
2941329|NCT00642460|3653681|FG005|COMPLETED|Part II: Open-Label Up to Week 92||0
2941330|NCT00642460|3653676|FG000|NOT COMPLETED|Part II: Open-Label Up to Week 92||9
2941331|NCT00642460|3653677|FG001|NOT COMPLETED|Part II: Open-Label Up to Week 92||8
2941332|NCT00642460|3653678|FG002|NOT COMPLETED|Part II: Open-Label Up to Week 92||0
2941333|NCT00642460|3653679|FG003|NOT COMPLETED|Part II: Open-Label Up to Week 92||3
2941334|NCT00642460|3653680|FG004|NOT COMPLETED|Part II: Open-Label Up to Week 92||0
2941335|NCT00642460|3653681|FG005|NOT COMPLETED|Part II: Open-Label Up to Week 92||0
2941336|NCT00642460|3653676|FG000|STARTED|Part III: Open-Label Up to Week 260||0
2941337|NCT00642460|3653677|FG001|STARTED|Part III: Open-Label Up to Week 260||0
2941338|NCT00642460|3653678|FG002|STARTED|Part III: Open-Label Up to Week 260||0
2941339|NCT00642460|3653679|FG003|STARTED|Part III: Open-Label Up to Week 260||0
2941340|NCT00642460|3653680|FG004|STARTED|Part III: Open-Label Up to Week 260||53
2941341|NCT00642460|3653681|FG005|STARTED|Part III: Open-Label Up to Week 260||59
2941342|NCT00642460|3653676|FG000|COMPLETED|Part III: Open-Label Up to Week 260||0
2941343|NCT00642460|3653677|FG001|COMPLETED|Part III: Open-Label Up to Week 260||0
2941344|NCT00642460|3653678|FG002|COMPLETED|Part III: Open-Label Up to Week 260||0
2941345|NCT00642460|3653679|FG003|COMPLETED|Part III: Open-Label Up to Week 260||0
2941346|NCT00642460|3653680|FG004|COMPLETED|Part III: Open-Label Up to Week 260||28
2941347|NCT00642460|3653681|FG005|COMPLETED|Part III: Open-Label Up to Week 260||38
2941348|NCT00642460|3653676|FG000|NOT COMPLETED|Part III: Open-Label Up to Week 260||0
2941349|NCT00642460|3653677|FG001|NOT COMPLETED|Part III: Open-Label Up to Week 260||0
2941350|NCT00642460|3653678|FG002|NOT COMPLETED|Part III: Open-Label Up to Week 260||0
2941351|NCT00642460|3653679|FG003|NOT COMPLETED|Part III: Open-Label Up to Week 260||0
2941352|NCT00642460|3653680|FG004|NOT COMPLETED|Part III: Open-Label Up to Week 260||25
2941353|NCT00642460|3653681|FG005|NOT COMPLETED|Part III: Open-Label Up to Week 260||21
2941354|NCT00642473|3653693|FG000|STARTED|Overall Study||18
3163320|NCT01885897|3890855|FG000|STARTED|Overall Study||6
3163321|NCT01885897|3890856|FG001|STARTED|Overall Study||3
3163322|NCT01885897|3890857|FG002|STARTED|Overall Study||4
3163323|NCT01885897|3890858|FG003|STARTED|Overall Study||3
2941355|NCT00642473|3653694|FG001|STARTED|Overall Study||16
2941356|NCT00642473|3653693|FG000|COMPLETED|Overall Study||14
2941357|NCT00642473|3653694|FG001|COMPLETED|Overall Study||5
2941358|NCT00642473|3653693|FG000|NOT COMPLETED|Overall Study||4
2941359|NCT00642473|3653694|FG001|NOT COMPLETED|Overall Study||11
2941360|NCT00642616|3653707|FG000|STARTED|Overall Study||9
2941361|NCT00642616|3653708|FG001|STARTED|Overall Study||8
2941362|NCT00642616|3653709|FG002|STARTED|Overall Study||9
2941363|NCT00642616|3653710|FG003|STARTED|Overall Study||8
2941364|NCT00642616|3653707|FG000|COMPLETED|Overall Study||0
2941365|NCT00642616|3653708|FG001|COMPLETED|Overall Study||1
2941366|NCT00642616|3653709|FG002|COMPLETED|Overall Study||0
2941367|NCT00642616|3653710|FG003|COMPLETED|Overall Study||1
2941368|NCT00642616|3653707|FG000|NOT COMPLETED|Overall Study||9
2941369|NCT00642616|3653708|FG001|NOT COMPLETED|Overall Study||7
2941370|NCT00642616|3653709|FG002|NOT COMPLETED|Overall Study||9
2941371|NCT00642616|3653710|FG003|NOT COMPLETED|Overall Study||7
2941372|NCT00642642|3653722|FG000|STARTED|Biopsy & Product Manufacture||122
2941373|NCT00642642|3653722|FG000|COMPLETED|Biopsy & Product Manufacture|Patients biopsied and for whom study product could be produced are considered completed|109
2941374|NCT00642642|3653722|FG000|NOT COMPLETED|Biopsy & Product Manufacture||13
2941375|NCT00642642|3653722|FG000|STARTED|Treatment & Follow Up||109
2941376|NCT00642642|3653722|FG000|COMPLETED|Treatment & Follow Up||92
2941377|NCT00642642|3653722|FG000|NOT COMPLETED|Treatment & Follow Up||17
2941378|NCT00642668|3653732|FG000|STARTED|Overall Study||35
2941379|NCT00642668|3653732|FG000|COMPLETED|Overall Study||21
2941380|NCT00642668|3653732|FG000|NOT COMPLETED|Overall Study||14
2941381|NCT00642694|3653738|FG000|STARTED|Overall Study||14
2941382|NCT00642694|3653739|FG001|STARTED|Overall Study||15
2941383|NCT00642694|3653738|FG000|COMPLETED|Overall Study||8
2941384|NCT00642694|3653739|FG001|COMPLETED|Overall Study||11
2941385|NCT00642694|3653738|FG000|NOT COMPLETED|Overall Study||6
2941386|NCT00642694|3653739|FG001|NOT COMPLETED|Overall Study||4
2941387|NCT00642707|3653749|FG000|STARTED|Overall Study||11
2941388|NCT00642707|3653750|FG001|STARTED|Overall Study||11
2941389|NCT00642707|3653751|FG002|STARTED|Overall Study||12
2941390|NCT00642707|3653752|FG003|STARTED|Overall Study||10
2941391|NCT00642707|3653749|FG000|COMPLETED|Overall Study||10
2941392|NCT00642707|3653750|FG001|COMPLETED|Overall Study||11
2941393|NCT00642707|3653751|FG002|COMPLETED|Overall Study||12
2941394|NCT00642707|3653752|FG003|COMPLETED|Overall Study||8
2941395|NCT00642707|3653749|FG000|NOT COMPLETED|Overall Study||1
2941396|NCT00642707|3653750|FG001|NOT COMPLETED|Overall Study||0
2941397|NCT00642707|3653751|FG002|NOT COMPLETED|Overall Study||0
2941398|NCT00642707|3653752|FG003|NOT COMPLETED|Overall Study||2
2941399|NCT00642746|3653764|FG000|STARTED|Overall Study||10
2941400|NCT00642746|3653765|FG001|STARTED|Overall Study||1
3132382|NCT01690988|3857441|FG002|STARTED|Overall Study||223
3132383|NCT01690988|3857439|FG000|COMPLETED|Overall Study||221
3132384|NCT01690988|3857440|FG001|COMPLETED|Overall Study||217
3132385|NCT01690988|3857441|FG002|COMPLETED|Overall Study||216
3132386|NCT01690988|3857439|FG000|NOT COMPLETED|Overall Study||6
2941401|NCT00642746|3653764|FG000|COMPLETED|Overall Study||9
2941402|NCT00642746|3653765|FG001|COMPLETED|Overall Study||1
2941403|NCT00642746|3653764|FG000|NOT COMPLETED|Overall Study||1
2941404|NCT00642746|3653765|FG001|NOT COMPLETED|Overall Study||0
2941405|NCT00642759|3653771|FG000|STARTED|Overall Study||36
2941406|NCT00642759|3653771|FG000|COMPLETED|Overall Study||35
2941407|NCT00642759|3653771|FG000|NOT COMPLETED|Overall Study||1
2941408|NCT00642772|3653776|FG000|STARTED|Overall Study||24
2941409|NCT00642772|3653776|FG000|COMPLETED|Overall Study||14
2941410|NCT00642772|3653776|FG000|NOT COMPLETED|Overall Study||10
2941411|NCT00642811|3653786|FG000|STARTED|Overall Study||20
2941412|NCT00642811|3653787|FG001|STARTED|Overall Study||21
2941413|NCT00642811|3653788|FG002|STARTED|Overall Study||13
2941414|NCT00642811|3653789|FG003|STARTED|Overall Study||16
2941415|NCT00642811|3653790|FG004|STARTED|Overall Study||14
2941416|NCT00642811|3653791|FG005|STARTED|Overall Study||14
2941417|NCT00642811|3653786|FG000|COMPLETED|Overall Study||17
2941418|NCT00642811|3653787|FG001|COMPLETED|Overall Study||17
2941419|NCT00642811|3653788|FG002|COMPLETED|Overall Study||13
2941420|NCT00642811|3653789|FG003|COMPLETED|Overall Study||15
2941421|NCT00642811|3653790|FG004|COMPLETED|Overall Study||13
2941422|NCT00642811|3653791|FG005|COMPLETED|Overall Study||13
2941423|NCT00642811|3653786|FG000|NOT COMPLETED|Overall Study||3
2941424|NCT00642811|3653787|FG001|NOT COMPLETED|Overall Study||4
2941425|NCT00642811|3653788|FG002|NOT COMPLETED|Overall Study||0
2941426|NCT00642811|3653789|FG003|NOT COMPLETED|Overall Study||1
2941427|NCT00642811|3653790|FG004|NOT COMPLETED|Overall Study||1
2941428|NCT00642811|3653791|FG005|NOT COMPLETED|Overall Study||1
2941429|NCT00642850|3653805|FG000|STARTED|Overall Study||188
2941430|NCT00642850|3653805|FG000|COMPLETED|Overall Study||155
2941431|NCT00642850|3653805|FG000|NOT COMPLETED|Overall Study||33
2941432|NCT00642902|3653813|FG000|STARTED|Overall Study||63
2941433|NCT00642902|3653814|FG001|STARTED|Overall Study||63
2941434|NCT00642902|3653815|FG002|STARTED|Overall Study||64
2941435|NCT00642902|3653816|FG003|STARTED|Overall Study||65
2941436|NCT00642902|3653813|FG000|Treated|Overall Study||63
2941437|NCT00642902|3653814|FG001|Treated|Overall Study||63
2941438|NCT00642902|3653815|FG002|Treated|Overall Study||63
2941439|NCT00642902|3653816|FG003|Treated|Overall Study||65
2941440|NCT00642902|3653813|FG000|COMPLETED|Overall Study||23
2941441|NCT00642902|3653814|FG001|COMPLETED|Overall Study||21
2941442|NCT00642902|3653815|FG002|COMPLETED|Overall Study||21
2941443|NCT00642902|3653816|FG003|COMPLETED|Overall Study||25
2941444|NCT00642902|3653813|FG000|NOT COMPLETED|Overall Study||40
2941445|NCT00642902|3653814|FG001|NOT COMPLETED|Overall Study||42
2941446|NCT00642902|3653815|FG002|NOT COMPLETED|Overall Study||43
2941447|NCT00642902|3653816|FG003|NOT COMPLETED|Overall Study||40
2941448|NCT00642941|3653838|FG000|STARTED|Overall Study||70
2941449|NCT00642941|3653839|FG001|STARTED|Overall Study||54
2941450|NCT00642941|3653840|FG002|STARTED|Overall Study||7
2941451|NCT00642941|3653841|FG003|STARTED|Overall Study||40
2941452|NCT00642941|3653842|FG004|STARTED|Overall Study||25
2941453|NCT00642941|3653843|FG005|STARTED|Overall Study||41
2941454|NCT00642941|3653844|FG006|STARTED|Overall Study||23
2941455|NCT00642941|3653845|FG007|STARTED|Overall Study||14
2941456|NCT00642941|3653846|FG008|STARTED|Overall Study||11
2941457|NCT00642941|3653847|FG009|STARTED|Overall Study||9
2941458|NCT00642941|3653848|FG010|STARTED|Overall Study||12
2941459|NCT00642941|3653849|FG011|STARTED|Overall Study||11
2941460|NCT00642941|3653838|FG000|COMPLETED|Overall Study||0
2941461|NCT00642941|3653839|FG001|COMPLETED|Overall Study||0
2941462|NCT00642941|3653840|FG002|COMPLETED|Overall Study||0
2941463|NCT00642941|3653841|FG003|COMPLETED|Overall Study||0
2941464|NCT00642941|3653842|FG004|COMPLETED|Overall Study||0
2941465|NCT00642941|3653843|FG005|COMPLETED|Overall Study||0
2941466|NCT00642941|3653844|FG006|COMPLETED|Overall Study||0
2941467|NCT00642941|3653845|FG007|COMPLETED|Overall Study||0
2941468|NCT00642941|3653846|FG008|COMPLETED|Overall Study||0
2941469|NCT00642941|3653847|FG009|COMPLETED|Overall Study||0
2941470|NCT00642941|3653848|FG010|COMPLETED|Overall Study||0
2941471|NCT00642941|3653849|FG011|COMPLETED|Overall Study||0
2941472|NCT00642941|3653838|FG000|NOT COMPLETED|Overall Study||70
2941473|NCT00642941|3653839|FG001|NOT COMPLETED|Overall Study||54
2941474|NCT00642941|3653840|FG002|NOT COMPLETED|Overall Study||7
2941475|NCT00642941|3653841|FG003|NOT COMPLETED|Overall Study||40
2941476|NCT00642941|3653842|FG004|NOT COMPLETED|Overall Study||25
2941477|NCT00642941|3653843|FG005|NOT COMPLETED|Overall Study||41
2941478|NCT00642941|3653844|FG006|NOT COMPLETED|Overall Study||23
2941479|NCT00642941|3653845|FG007|NOT COMPLETED|Overall Study||14
2941480|NCT00642941|3653846|FG008|NOT COMPLETED|Overall Study||11
2941481|NCT00642941|3653847|FG009|NOT COMPLETED|Overall Study||9
2941482|NCT00642941|3653848|FG010|NOT COMPLETED|Overall Study||12
2941483|NCT00642941|3653849|FG011|NOT COMPLETED|Overall Study||11
2941484|NCT00642954|3653901|FG000|STARTED|Overall Study||4
2941485|NCT00642954|3653902|FG001|STARTED|Overall Study||4
2941486|NCT00642954|3653903|FG002|STARTED|Overall Study||3
2941487|NCT00642954|3653904|FG003|STARTED|Overall Study||3
2941488|NCT00642954|3653905|FG004|STARTED|Overall Study||17
2941489|NCT00642954|3653901|FG000|COMPLETED|Overall Study||0
2941490|NCT00642954|3653902|FG001|COMPLETED|Overall Study||0
2941491|NCT00642954|3653903|FG002|COMPLETED|Overall Study||0
2941492|NCT00642954|3653904|FG003|COMPLETED|Overall Study||0
2941493|NCT00642954|3653905|FG004|COMPLETED|Overall Study||1
2941494|NCT00642954|3653901|FG000|NOT COMPLETED|Overall Study||4
2941495|NCT00642954|3653902|FG001|NOT COMPLETED|Overall Study||4
2941496|NCT00642954|3653903|FG002|NOT COMPLETED|Overall Study||3
2941497|NCT00642954|3653904|FG003|NOT COMPLETED|Overall Study||3
2941498|NCT00642954|3653905|FG004|NOT COMPLETED|Overall Study||16
2941499|NCT00642993|3653919|FG000|STARTED|Overall Study||267
2941500|NCT00642993|3653920|FG001|STARTED|Overall Study||134
2941501|NCT00642993|3653919|FG000|COMPLETED|Overall Study||161
2941502|NCT00642993|3653920|FG001|COMPLETED|Overall Study||118
2941503|NCT00642993|3653919|FG000|NOT COMPLETED|Overall Study||106
2941504|NCT00642993|3653920|FG001|NOT COMPLETED|Overall Study||16
2941505|NCT00643006|3653928|FG000|STARTED|Overall Study||34
2941506|NCT00643006|3653929|FG001|STARTED|Overall Study||33
2941507|NCT00643006|3653928|FG000|COMPLETED|Overall Study||29
2941508|NCT00643006|3653929|FG001|COMPLETED|Overall Study||29
2941509|NCT00643006|3653928|FG000|NOT COMPLETED|Overall Study||5
2941510|NCT00643006|3653929|FG001|NOT COMPLETED|Overall Study||4
2941511|NCT00643097|3653940|FG000|STARTED|Overall Study||18
2941512|NCT00643097|3653941|FG001|STARTED|Overall Study||12
2941513|NCT00643097|3653942|FG002|STARTED|Overall Study||10
2941514|NCT00643097|3653940|FG000|COMPLETED|Overall Study||18
2941515|NCT00643097|3653941|FG001|COMPLETED|Overall Study||12
2941516|NCT00643097|3653942|FG002|COMPLETED|Overall Study||10
2941517|NCT00643097|3653940|FG000|NOT COMPLETED|Overall Study||0
2941518|NCT00643097|3653941|FG001|NOT COMPLETED|Overall Study||0
2941519|NCT00643097|3653942|FG002|NOT COMPLETED|Overall Study||0
2941520|NCT00643123|3653952|FG000|STARTED|Overall Study||15
2941521|NCT00643123|3653953|FG001|STARTED|Overall Study||12
2941522|NCT00643123|3653952|FG000|COMPLETED|Overall Study||10
2941523|NCT00643123|3653953|FG001|COMPLETED|Overall Study||11
2941524|NCT00643123|3653952|FG000|NOT COMPLETED|Overall Study||5
2941525|NCT00643123|3653953|FG001|NOT COMPLETED|Overall Study||1
2941526|NCT00643162|3653961|FG000|STARTED|Overall Study||7
2941527|NCT00643162|3653962|FG001|STARTED|Overall Study||5
2941528|NCT00643162|3653961|FG000|COMPLETED|Overall Study||6
2941529|NCT00643162|3653962|FG001|COMPLETED|Overall Study||4
2941530|NCT00643162|3653961|FG000|NOT COMPLETED|Overall Study||1
2941531|NCT00643162|3653962|FG001|NOT COMPLETED|Overall Study||1
2941532|NCT00643201|3653970|FG000|STARTED|Randomized, Completed 6 Months of Study|15 participants were randomized to treatment but not treated.|2691
2941533|NCT00643201|3653971|FG001|STARTED|Randomized, Completed 6 Months of Study|15 participants were randomized to treatment but not treated.|2704
2941534|NCT00643201|3653970|FG000|COMPLETED|Randomized, Completed 6 Months of Study||2314
2941535|NCT00643201|3653971|FG001|COMPLETED|Randomized, Completed 6 Months of Study||2291
2941536|NCT00643201|3653970|FG000|NOT COMPLETED|Randomized, Completed 6 Months of Study||377
2941537|NCT00643201|3653971|FG001|NOT COMPLETED|Randomized, Completed 6 Months of Study||413
2941538|NCT00643201|3653970|FG000|STARTED|Completed Study Follow Up||2617
3163324|NCT01885897|3890859|FG004|STARTED|Overall Study||8
3163325|NCT01885897|3890860|FG005|STARTED|Overall Study||9
3163326|NCT01885897|3890855|FG000|COMPLETED|Overall Study||6
3163327|NCT01885897|3890856|FG001|COMPLETED|Overall Study||3
3163328|NCT01885897|3890857|FG002|COMPLETED|Overall Study||4
2941539|NCT00643201|3653971|FG001|STARTED|Completed Study Follow Up||2639
2941540|NCT00643201|3653970|FG000|COMPLETED|Completed Study Follow Up|Of 70 who did not complete follow up: 7 completed treatment; 63 discontinued treatment|2547
2941541|NCT00643201|3653971|FG001|COMPLETED|Completed Study Follow Up|Of 79 who did not complete follow up: 3 completed treatment, 76 discontinued treatment|2560
2941542|NCT00643201|3653970|FG000|NOT COMPLETED|Completed Study Follow Up||70
2941543|NCT00643201|3653971|FG001|NOT COMPLETED|Completed Study Follow Up||79
2941544|NCT00643279|3653981|FG000|STARTED|Overall Study||134
2941545|NCT00643279|3653982|FG001|STARTED|Overall Study||140
2941546|NCT00643279|3653981|FG000|COMPLETED|Overall Study||118
2941547|NCT00643279|3653982|FG001|COMPLETED|Overall Study||127
2941548|NCT00643279|3653981|FG000|NOT COMPLETED|Overall Study||16
2941549|NCT00643279|3653982|FG001|NOT COMPLETED|Overall Study||13
2941550|NCT00643448|3653993|FG000|STARTED|Overall Study||21
2941551|NCT00643448|3653994|FG001|STARTED|Overall Study||22
2941552|NCT00643448|3653995|FG002|STARTED|Overall Study||22
2941553|NCT00643448|3653993|FG000|COMPLETED|Overall Study||17
2941554|NCT00643448|3653994|FG001|COMPLETED|Overall Study||17
2941555|NCT00643448|3653995|FG002|COMPLETED|Overall Study||16
2941556|NCT00643448|3653993|FG000|NOT COMPLETED|Overall Study||4
2941557|NCT00643448|3653994|FG001|NOT COMPLETED|Overall Study||5
2941558|NCT00643448|3653995|FG002|NOT COMPLETED|Overall Study||6
2941559|NCT00643487|3654005|FG000|STARTED|Overall Study||8
2941560|NCT00643487|3654005|FG000|COMPLETED|Overall Study||5
2941561|NCT00643487|3654005|FG000|NOT COMPLETED|Overall Study||3
2941562|NCT00643565|3654011|FG000|STARTED|Overall Study||80
2941563|NCT00643565|3654012|FG001|STARTED|Overall Study||74
2941564|NCT00643565|3654011|FG000|COMPLETED|Overall Study||7
2941565|NCT00643565|3654012|FG001|COMPLETED|Overall Study||7
2941566|NCT00643565|3654011|FG000|NOT COMPLETED|Overall Study||73
2941567|NCT00643565|3654012|FG001|NOT COMPLETED|Overall Study||67
2941568|NCT00643578|3654019|FG000|STARTED|Overall Study||6
2941569|NCT00643578|3654020|FG001|STARTED|Overall Study||6
2941570|NCT00643578|3654019|FG000|COMPLETED|Overall Study||4
2941571|NCT00643578|3654020|FG001|COMPLETED|Overall Study||6
2941572|NCT00643578|3654019|FG000|NOT COMPLETED|Overall Study||2
2941573|NCT00643578|3654020|FG001|NOT COMPLETED|Overall Study||0
2941574|NCT00643604|3654028|FG000|STARTED|Overall Study||7
2941575|NCT00643604|3654028|FG000|COMPLETED|Overall Study||6
2941576|NCT00643604|3654028|FG000|NOT COMPLETED|Overall Study||1
2941577|NCT00643682|3654034|FG000|STARTED|Overall Study||999
2941578|NCT00643682|3654035|FG001|STARTED|Overall Study||1001
2941579|NCT00643682|3654034|FG000|COMPLETED|Overall Study||477
2941580|NCT00643682|3654035|FG001|COMPLETED|Overall Study||492
2941581|NCT00643682|3654034|FG000|NOT COMPLETED|Overall Study||522
2941582|NCT00643682|3654035|FG001|NOT COMPLETED|Overall Study||509
2941583|NCT00643760|3654046|FG000|STARTED|Overall Study||120
2941584|NCT00643760|3654047|FG001|STARTED|Overall Study||62
2941585|NCT00643760|3654048|FG002|STARTED|Overall Study||56
2941586|NCT00643760|3654049|FG003|STARTED|Overall Study||117
2941587|NCT00643760|3654050|FG004|STARTED|Overall Study||66
2941588|NCT00643760|3654046|FG000|Safety Population/Treated With Drug|Overall Study||120
2941589|NCT00643760|3654047|FG001|Safety Population/Treated With Drug|Overall Study||62
2941590|NCT00643760|3654048|FG002|Safety Population/Treated With Drug|Overall Study||56
2941591|NCT00643760|3654049|FG003|Safety Population/Treated With Drug|Overall Study||116
2941592|NCT00643760|3654050|FG004|Safety Population/Treated With Drug|Overall Study||66
2941593|NCT00643760|3654046|FG000|ITT Population|Overall Study||120
2941594|NCT00643760|3654047|FG001|ITT Population|Overall Study||62
2941595|NCT00643760|3654048|FG002|ITT Population|Overall Study||56
2941596|NCT00643760|3654049|FG003|ITT Population|Overall Study||116
2941597|NCT00643760|3654050|FG004|ITT Population|Overall Study||66
2941598|NCT00643760|3654046|FG000|COMPLETED|Overall Study||90
2941599|NCT00643760|3654047|FG001|COMPLETED|Overall Study||47
2941600|NCT00643760|3654048|FG002|COMPLETED|Overall Study||37
2941601|NCT00643760|3654049|FG003|COMPLETED|Overall Study||79
2941602|NCT00643760|3654050|FG004|COMPLETED|Overall Study||47
2941603|NCT00643760|3654046|FG000|NOT COMPLETED|Overall Study||30
2941604|NCT00643760|3654047|FG001|NOT COMPLETED|Overall Study||15
2941605|NCT00643760|3654048|FG002|NOT COMPLETED|Overall Study||19
2941606|NCT00643760|3654049|FG003|NOT COMPLETED|Overall Study||38
2941607|NCT00643760|3654050|FG004|NOT COMPLETED|Overall Study||19
2941608|NCT00643851|3654065|FG000|STARTED|Overall Study||194
2941609|NCT00643851|3654066|FG001|STARTED|Overall Study||203
2941610|NCT00643851|3654067|FG002|STARTED|Overall Study||201
2941611|NCT00643851|3654065|FG000|COMPLETED|Overall Study||177
2941612|NCT00643851|3654066|FG001|COMPLETED|Overall Study||170
2941613|NCT00643851|3654067|FG002|COMPLETED|Overall Study||171
2941614|NCT00643851|3654065|FG000|NOT COMPLETED|Overall Study||17
2941615|NCT00643851|3654066|FG001|NOT COMPLETED|Overall Study||33
2941616|NCT00643851|3654067|FG002|NOT COMPLETED|Overall Study||30
2941617|NCT00643864|3654075|FG000|STARTED|Pre-test Assessment||3
2941618|NCT00643864|3654075|FG000|COMPLETED|Pre-test Assessment||3
3163329|NCT01885897|3890858|FG003|COMPLETED|Overall Study||3
3163330|NCT01885897|3890859|FG004|COMPLETED|Overall Study||8
3163331|NCT01885897|3890860|FG005|COMPLETED|Overall Study||9
3163332|NCT01885897|3890855|FG000|NOT COMPLETED|Overall Study||0
3163333|NCT01885897|3890856|FG001|NOT COMPLETED|Overall Study||0
3163334|NCT01885897|3890857|FG002|NOT COMPLETED|Overall Study||0
3163335|NCT01885897|3890858|FG003|NOT COMPLETED|Overall Study||0
3163336|NCT01885897|3890859|FG004|NOT COMPLETED|Overall Study||0
3163337|NCT01885897|3890860|FG005|NOT COMPLETED|Overall Study||0
3163338|NCT01885910|3890874|FG000|STARTED|Overall Study||32
2941619|NCT00643864|3654075|FG000|NOT COMPLETED|Pre-test Assessment||0
2941620|NCT00643864|3654075|FG000|STARTED|Post-test Assessment||3
2941621|NCT00643864|3654075|FG000|COMPLETED|Post-test Assessment||3
2941622|NCT00643864|3654075|FG000|NOT COMPLETED|Post-test Assessment||0
2941623|NCT00643916|3654086|FG000|STARTED|Overall Study||55
2941624|NCT00643916|3654087|FG001|STARTED|Overall Study||67
2941625|NCT00643916|3654088|FG002|STARTED|Overall Study||68
2941626|NCT00643916|3654089|FG003|STARTED|Overall Study||62
2941627|NCT00643916|3654090|FG004|STARTED|Overall Study||59
2941628|NCT00643916|3654091|FG005|STARTED|Overall Study||67
2941629|NCT00643916|3654086|FG000|COMPLETED|Overall Study||51
2941630|NCT00643916|3654087|FG001|COMPLETED|Overall Study||61
2941631|NCT00643916|3654088|FG002|COMPLETED|Overall Study||62
2941632|NCT00643916|3654089|FG003|COMPLETED|Overall Study||60
2941633|NCT00643916|3654090|FG004|COMPLETED|Overall Study||57
2941634|NCT00643916|3654091|FG005|COMPLETED|Overall Study||66
2941635|NCT00643916|3654086|FG000|NOT COMPLETED|Overall Study||4
2941636|NCT00643916|3654087|FG001|NOT COMPLETED|Overall Study||6
2941637|NCT00643916|3654088|FG002|NOT COMPLETED|Overall Study||6
2941638|NCT00643916|3654089|FG003|NOT COMPLETED|Overall Study||2
2941639|NCT00643916|3654090|FG004|NOT COMPLETED|Overall Study||2
2941640|NCT00643916|3654091|FG005|NOT COMPLETED|Overall Study||1
3034532|NCT01133392|3753605|FG001|STARTED|Interval Between Dosing (4-7 Days)||17
3034533|NCT01133392|3753604|FG000|COMPLETED|Interval Between Dosing (4-7 Days)||20
3034534|NCT01133392|3753605|FG001|COMPLETED|Interval Between Dosing (4-7 Days)||17
3034535|NCT01133392|3753604|FG000|NOT COMPLETED|Interval Between Dosing (4-7 Days)||0
3034536|NCT01133392|3753605|FG001|NOT COMPLETED|Interval Between Dosing (4-7 Days)||0
3034537|NCT01133392|3753604|FG000|STARTED|Third Intervention (1 Day)||20
3034538|NCT01133392|3753605|FG001|STARTED|Third Intervention (1 Day)||17
3034539|NCT01133392|3753604|FG000|COMPLETED|Third Intervention (1 Day)||20
3034540|NCT01133392|3753605|FG001|COMPLETED|Third Intervention (1 Day)||17
3034541|NCT01133392|3753604|FG000|NOT COMPLETED|Third Intervention (1 Day)||0
3034542|NCT01133392|3753605|FG001|NOT COMPLETED|Third Intervention (1 Day)||0
3034543|NCT01133392|3753604|FG000|STARTED|Interval Between Dosing (4-7 Days)||20
3034544|NCT01133392|3753605|FG001|STARTED|Interval Between Dosing (4-7 Days)||17
3034545|NCT01133392|3753604|FG000|COMPLETED|Interval Between Dosing (4-7 Days)||20
3034546|NCT01133392|3753605|FG001|COMPLETED|Interval Between Dosing (4-7 Days)||16
3034547|NCT01133392|3753604|FG000|NOT COMPLETED|Interval Between Dosing (4-7 Days)||0
3034548|NCT01133392|3753605|FG001|NOT COMPLETED|Interval Between Dosing (4-7 Days)||1
3034549|NCT01133392|3753604|FG000|STARTED|Fourth Intervention (1 Day)||20
3034550|NCT01133392|3753605|FG001|STARTED|Fourth Intervention (1 Day)||16
3034551|NCT01133392|3753604|FG000|COMPLETED|Fourth Intervention (1 Day)||20
3034552|NCT01133392|3753605|FG001|COMPLETED|Fourth Intervention (1 Day)||16
3034553|NCT01133392|3753604|FG000|NOT COMPLETED|Fourth Intervention (1 Day)||0
3034554|NCT01133392|3753605|FG001|NOT COMPLETED|Fourth Intervention (1 Day)||0
3034555|NCT01133405|3753621|FG000|STARTED|Period 1||3
3034556|NCT01133405|3753622|FG001|STARTED|Period 1||6
3034557|NCT01133405|3753623|FG002|STARTED|Period 1||5
3034558|NCT01133405|3753624|FG003|STARTED|Period 1||5
3034559|NCT01133405|3753625|FG004|STARTED|Period 1||3
3034560|NCT01133405|3753626|FG005|STARTED|Period 1||5
3034561|NCT01133405|3753627|FG006|STARTED|Period 1||5
3034562|NCT01133405|3753628|FG007|STARTED|Period 1||2
3034563|NCT01133405|3753629|FG008|STARTED|Period 1||4
3034564|NCT01133405|3753630|FG009|STARTED|Period 1||2
3034565|NCT01133405|3753621|FG000|Safety Analysis Population|Period 1|One discontinued from study after randomization but before any study procedures.|2
3034566|NCT01133405|3753622|FG001|Safety Analysis Population|Period 1||6
3034567|NCT01133405|3753623|FG002|Safety Analysis Population|Period 1||5
3034568|NCT01133405|3753624|FG003|Safety Analysis Population|Period 1||5
3034569|NCT01133405|3753625|FG004|Safety Analysis Population|Period 1||3
3034570|NCT01133405|3753626|FG005|Safety Analysis Population|Period 1||5
3034571|NCT01133405|3753627|FG006|Safety Analysis Population|Period 1||5
3034572|NCT01133405|3753628|FG007|Safety Analysis Population|Period 1||2
3034573|NCT01133405|3753629|FG008|Safety Analysis Population|Period 1||4
3034574|NCT01133405|3753630|FG009|Safety Analysis Population|Period 1||2
3034575|NCT01133405|3753621|FG000|Received at Least 1 Dose of Drug|Period 1||2
3034576|NCT01133405|3753622|FG001|Received at Least 1 Dose of Drug|Period 1||4
3034577|NCT01133405|3753623|FG002|Received at Least 1 Dose of Drug|Period 1||4
3163339|NCT01885910|3890874|FG000|COMPLETED|Overall Study||24
3163340|NCT01885910|3890874|FG000|NOT COMPLETED|Overall Study||8
3163341|NCT01885936|3890882|FG000|STARTED|Overall Study||8
3034578|NCT01133405|3753624|FG003|Received at Least 1 Dose of Drug|Period 1||3
3034579|NCT01133405|3753625|FG004|Received at Least 1 Dose of Drug|Period 1||3
3163342|NCT01885936|3890883|FG001|STARTED|Overall Study||5
2941641|NCT00644059|3654108|FG000|STARTED|Overall Study||2019
2941642|NCT00644059|3654109|FG001|STARTED|Overall Study||1849
2941643|NCT00644059|3654110|FG002|STARTED|Overall Study||1034
2941644|NCT00644059|3654108|FG000|COMPLETED|Overall Study||1895
2941645|NCT00644059|3654109|FG001|COMPLETED|Overall Study||1726
2941646|NCT00644059|3654110|FG002|COMPLETED|Overall Study||969
2941647|NCT00644059|3654108|FG000|NOT COMPLETED|Overall Study||124
2941648|NCT00644059|3654109|FG001|NOT COMPLETED|Overall Study||123
2941649|NCT00644059|3654110|FG002|NOT COMPLETED|Overall Study||65
2941650|NCT00644189|3654159|FG000|STARTED|Phase I||3
2941651|NCT00644189|3654160|FG001|STARTED|Phase I||3
2941652|NCT00644189|3654161|FG002|STARTED|Phase I||6
2941653|NCT00644189|3654162|FG003|STARTED|Phase I||18
2941654|NCT00644189|3654159|FG000|COMPLETED|Phase I||3
2941655|NCT00644189|3654160|FG001|COMPLETED|Phase I||3
2941656|NCT00644189|3654161|FG002|COMPLETED|Phase I||6
2941657|NCT00644189|3654162|FG003|COMPLETED|Phase I||18
2941658|NCT00644189|3654159|FG000|NOT COMPLETED|Phase I||0
2941659|NCT00644189|3654160|FG001|NOT COMPLETED|Phase I||0
2941660|NCT00644189|3654161|FG002|NOT COMPLETED|Phase I||0
2941661|NCT00644189|3654162|FG003|NOT COMPLETED|Phase I||0
2941662|NCT00644189|3654159|FG000|STARTED|Phase II|All phase I participants were included in the 3mg Phase II dose group|0
2941663|NCT00644189|3654160|FG001|STARTED|Phase II|All phase I participants were included in the 3mg Phase II dose group|0
2941664|NCT00644189|3654161|FG002|STARTED|Phase II|All phase I participants were included in the 3mg Phase II dose group|0
2941665|NCT00644189|3654162|FG003|STARTED|Phase II|Additional participants were added to the phase I sample at the phase II 3mg dose level|50
2941666|NCT00644189|3654159|FG000|Completed All 6 Cycles of Treatment|Phase II||0
2941667|NCT00644189|3654160|FG001|Completed All 6 Cycles of Treatment|Phase II||0
2941668|NCT00644189|3654161|FG002|Completed All 6 Cycles of Treatment|Phase II||0
2941669|NCT00644189|3654162|FG003|Completed All 6 Cycles of Treatment|Phase II||19
2941670|NCT00644189|3654159|FG000|COMPLETED|Phase II||0
2941671|NCT00644189|3654160|FG001|COMPLETED|Phase II||0
2941672|NCT00644189|3654161|FG002|COMPLETED|Phase II||0
2941673|NCT00644189|3654162|FG003|COMPLETED|Phase II||50
2941674|NCT00644189|3654159|FG000|NOT COMPLETED|Phase II||0
2941675|NCT00644189|3654160|FG001|NOT COMPLETED|Phase II||0
2941676|NCT00644189|3654161|FG002|NOT COMPLETED|Phase II||0
2941677|NCT00644189|3654162|FG003|NOT COMPLETED|Phase II||0
2941678|NCT00644228|3654170|FG000|STARTED|Randomization & Eligibility||261
2941679|NCT00644228|3654171|FG001|STARTED|Randomization & Eligibility||264
2941680|NCT00644228|3654170|FG000|Eligible and Analyzable|Randomization & Eligibility||229
2941681|NCT00644228|3654171|FG001|Eligible and Analyzable|Randomization & Eligibility||242
2941682|NCT00644228|3654170|FG000|COMPLETED|Randomization & Eligibility||229
2941683|NCT00644228|3654171|FG001|COMPLETED|Randomization & Eligibility||242
2941684|NCT00644228|3654170|FG000|NOT COMPLETED|Randomization & Eligibility||32
2941685|NCT00644228|3654171|FG001|NOT COMPLETED|Randomization & Eligibility||22
2941686|NCT00644228|3654170|FG000|STARTED|Induction Therapy||229
2941687|NCT00644228|3654171|FG001|STARTED|Induction Therapy||242
2941688|NCT00644228|3654170|FG000|COMPLETED|Induction Therapy||146
2941689|NCT00644228|3654171|FG001|COMPLETED|Induction Therapy||137
2941690|NCT00644228|3654170|FG000|NOT COMPLETED|Induction Therapy||83
2941691|NCT00644228|3654171|FG001|NOT COMPLETED|Induction Therapy||105
2941692|NCT00644228|3654170|FG000|STARTED|Maintenance|3 patients who completed induction did not continue on to maintenance due to refusal (1), other (2).|143
2941693|NCT00644228|3654171|FG001|STARTED|Maintenance|2 patients who completed induction did not continue on to maintenance due to other (2).|135
2941694|NCT00644228|3654170|FG000|COMPLETED|Maintenance||0
2941695|NCT00644228|3654171|FG001|COMPLETED|Maintenance||0
2941696|NCT00644228|3654170|FG000|NOT COMPLETED|Maintenance||143
2941697|NCT00644228|3654171|FG001|NOT COMPLETED|Maintenance||135
2941698|NCT00644280|3654179|FG000|STARTED|Overall Study||6
2941699|NCT00644280|3654180|FG001|STARTED|Overall Study||5
2941700|NCT00644280|3654179|FG000|COMPLETED|Overall Study||6
2941701|NCT00644280|3654180|FG001|COMPLETED|Overall Study||5
2941702|NCT00644280|3654179|FG000|NOT COMPLETED|Overall Study||0
2941703|NCT00644280|3654180|FG001|NOT COMPLETED|Overall Study||0
2941704|NCT00644332|3654186|FG000|STARTED|Overall Study|172 patients were enrolled; one withdrew consent prior to starting treatment|171
2941705|NCT00644332|3654186|FG000|COMPLETED|Overall Study||150
2941706|NCT00644332|3654186|FG000|NOT COMPLETED|Overall Study||21
2941707|NCT00644358|3654190|FG000|STARTED|Overall Study||616
2941708|NCT00644358|3654190|FG000|COMPLETED|Overall Study||254
2941709|NCT00644358|3654190|FG000|NOT COMPLETED|Overall Study||362
2941710|NCT00644423|3654196|FG000|STARTED|Overall Study||6
2941711|NCT00644423|3654197|FG001|STARTED|Overall Study||5
2941712|NCT00644423|3654196|FG000|COMPLETED|Overall Study||5
2941713|NCT00644423|3654197|FG001|COMPLETED|Overall Study||4
2941714|NCT00644423|3654196|FG000|NOT COMPLETED|Overall Study||1
2941715|NCT00644423|3654197|FG001|NOT COMPLETED|Overall Study||1
2941716|NCT00644592|3654205|FG000|STARTED|Overall Study||5
2941717|NCT00644592|3654206|FG001|STARTED|Overall Study||6
2941718|NCT00644592|3654205|FG000|COMPLETED|Overall Study||5
2941719|NCT00644592|3654206|FG001|COMPLETED|Overall Study||6
2941720|NCT00644592|3654205|FG000|NOT COMPLETED|Overall Study||0
2941721|NCT00644592|3654206|FG001|NOT COMPLETED|Overall Study||0
2941722|NCT00644657|3654212|FG000|STARTED|Overall Study||27
2941723|NCT00644657|3654212|FG000|COMPLETED|Overall Study||27
2941724|NCT00644657|3654212|FG000|NOT COMPLETED|Overall Study||0
2941725|NCT00644787|3654216|FG000|STARTED|Period 1: Titration Phase||156
2941726|NCT00644787|3654217|FG001|STARTED|Period 1: Titration Phase||0
2941727|NCT00644787|3654218|FG002|STARTED|Period 1: Titration Phase||0
2941728|NCT00644787|3654216|FG000|COMPLETED|Period 1: Titration Phase||129
2941729|NCT00644787|3654217|FG001|COMPLETED|Period 1: Titration Phase||0
2941730|NCT00644787|3654218|FG002|COMPLETED|Period 1: Titration Phase||0
2941731|NCT00644787|3654216|FG000|NOT COMPLETED|Period 1: Titration Phase||27
2941732|NCT00644787|3654217|FG001|NOT COMPLETED|Period 1: Titration Phase||0
2941733|NCT00644787|3654218|FG002|NOT COMPLETED|Period 1: Titration Phase||0
2941734|NCT00644787|3654216|FG000|STARTED|Period 2: Double Blind Phase||0
2941735|NCT00644787|3654217|FG001|STARTED|Period 2: Double Blind Phase||58
2941736|NCT00644787|3654218|FG002|STARTED|Period 2: Double Blind Phase||62
2941737|NCT00644787|3654216|FG000|COMPLETED|Period 2: Double Blind Phase||0
2941738|NCT00644787|3654217|FG001|COMPLETED|Period 2: Double Blind Phase||49
2941739|NCT00644787|3654218|FG002|COMPLETED|Period 2: Double Blind Phase||55
2941740|NCT00644787|3654216|FG000|NOT COMPLETED|Period 2: Double Blind Phase||0
2941741|NCT00644787|3654217|FG001|NOT COMPLETED|Period 2: Double Blind Phase||9
2941742|NCT00644787|3654218|FG002|NOT COMPLETED|Period 2: Double Blind Phase||7
3163343|NCT01885936|3890882|FG000|COMPLETED|Overall Study||7
3163344|NCT01885936|3890883|FG001|COMPLETED|Overall Study||5
3163345|NCT01885936|3890882|FG000|NOT COMPLETED|Overall Study||1
3163346|NCT01885936|3890883|FG001|NOT COMPLETED|Overall Study||0
2941743|NCT00644878|3654226|FG000|STARTED|Overall Study||18
2941744|NCT00644878|3654226|FG000|COMPLETED|Overall Study||0
2941745|NCT00644878|3654226|FG000|NOT COMPLETED|Overall Study||18
2941746|NCT00644917|3654230|FG000|STARTED|Overall Study||38
2941747|NCT00644917|3654230|FG000|COMPLETED|Overall Study||36
2941748|NCT00644917|3654230|FG000|NOT COMPLETED|Overall Study||2
2941749|NCT00644969|3654240|FG000|STARTED|Treatment Phase||85
2941750|NCT00644969|3654241|FG001|STARTED|Treatment Phase||43
2941751|NCT00644969|3654240|FG000|COMPLETED|Treatment Phase||71
2941752|NCT00644969|3654241|FG001|COMPLETED|Treatment Phase||40
2941753|NCT00644969|3654240|FG000|NOT COMPLETED|Treatment Phase||14
2941754|NCT00644969|3654241|FG001|NOT COMPLETED|Treatment Phase||3
2941755|NCT00644969|3654240|FG000|STARTED|Post Treatment Phase||71
2941756|NCT00644969|3654241|FG001|STARTED|Post Treatment Phase||40
2941757|NCT00644969|3654240|FG000|COMPLETED|Post Treatment Phase||61
2941758|NCT00644969|3654241|FG001|COMPLETED|Post Treatment Phase||37
2941759|NCT00644969|3654240|FG000|NOT COMPLETED|Post Treatment Phase||10
2941760|NCT00644969|3654241|FG001|NOT COMPLETED|Post Treatment Phase||3
2941761|NCT00644995|3654249|FG000|STARTED|Overall Study||25
2941762|NCT00644995|3654250|FG001|STARTED|Overall Study||27
2941763|NCT00644995|3654249|FG000|Completed 4 Month Assessment|Overall Study||23
2941764|NCT00644995|3654250|FG001|Completed 4 Month Assessment|Overall Study||24
2941765|NCT00644995|3654249|FG000|COMPLETED|Overall Study|Completed 6 month assessment|23
2941766|NCT00644995|3654250|FG001|COMPLETED|Overall Study||23
2941767|NCT00644995|3654249|FG000|NOT COMPLETED|Overall Study||2
2941768|NCT00644995|3654250|FG001|NOT COMPLETED|Overall Study||4
2941769|NCT00645047|3654260|FG000|STARTED|Overall Study||103
2941770|NCT00645047|3654261|FG001|STARTED|Overall Study||104
2941771|NCT00645047|3654260|FG000|Post|Overall Study||74
2941772|NCT00645047|3654261|FG001|Post|Overall Study||80
2941773|NCT00645047|3654260|FG000|COMPLETED|Overall Study|6 month follow up|60
2941774|NCT00645047|3654261|FG001|COMPLETED|Overall Study||65
2941775|NCT00645047|3654260|FG000|NOT COMPLETED|Overall Study||43
2941776|NCT00645047|3654261|FG001|NOT COMPLETED|Overall Study||39
2941777|NCT00645099|3654269|FG000|STARTED|Overall Study||239
2941778|NCT00645099|3654270|FG001|STARTED|Overall Study||220
2941779|NCT00645099|3654269|FG000|COMPLETED|Overall Study||168
2941780|NCT00645099|3654270|FG001|COMPLETED|Overall Study||178
2941781|NCT00645099|3654269|FG000|NOT COMPLETED|Overall Study||71
2941782|NCT00645099|3654270|FG001|NOT COMPLETED|Overall Study||42
2941783|NCT00645164|3654276|FG000|STARTED|Overall Study||59
2941784|NCT00645164|3654276|FG000|COMPLETED|Overall Study||52
2941785|NCT00645164|3654276|FG000|NOT COMPLETED|Overall Study||7
2941786|NCT00645333|3654280|FG000|STARTED|Overall Study||30
2941787|NCT00645333|3654280|FG000|COMPLETED|Overall Study||30
2941788|NCT00645333|3654280|FG000|NOT COMPLETED|Overall Study||0
2941789|NCT00645411|3654288|FG000|STARTED|Overall Study||656
2941790|NCT00645411|3654289|FG001|STARTED|Overall Study||318
2941791|NCT00645411|3654290|FG002|STARTED|Overall Study||1608
2941792|NCT00645411|3654291|FG003|STARTED|Overall Study||1022
2941793|NCT00645411|3654288|FG000|COMPLETED|Overall Study||643
2941794|NCT00645411|3654289|FG001|COMPLETED|Overall Study||312
2941795|NCT00645411|3654290|FG002|COMPLETED|Overall Study||1457
2941796|NCT00645411|3654291|FG003|COMPLETED|Overall Study||919
2941797|NCT00645411|3654288|FG000|NOT COMPLETED|Overall Study||13
2941798|NCT00645411|3654289|FG001|NOT COMPLETED|Overall Study||6
2941799|NCT00645411|3654290|FG002|NOT COMPLETED|Overall Study||151
2941800|NCT00645411|3654291|FG003|NOT COMPLETED|Overall Study||103
2941801|NCT00645450|3654310|FG000|STARTED|Overall Study||5
2941802|NCT00645450|3654311|FG001|STARTED|Overall Study||4
2941803|NCT00645450|3654310|FG000|COMPLETED|Overall Study||5
2941804|NCT00645450|3654311|FG001|COMPLETED|Overall Study||4
2941805|NCT00645450|3654310|FG000|NOT COMPLETED|Overall Study||0
2941806|NCT00645450|3654311|FG001|NOT COMPLETED|Overall Study||0
2941807|NCT00645528|3654317|FG000|STARTED|Overall Study||39
2941808|NCT00645528|3654317|FG000|COMPLETED|Overall Study||32
2941809|NCT00645528|3654317|FG000|NOT COMPLETED|Overall Study||7
2941810|NCT00645593|3654323|FG000|STARTED|Overall Study||29
3163347|NCT01886105|3890889|FG000|STARTED|Overall Study||4
2941811|NCT00645593|3654324|FG001|STARTED|Overall Study||60
2941812|NCT00645593|3654323|FG000|COMPLETED|Overall Study||28
2941813|NCT00645593|3654324|FG001|COMPLETED|Overall Study||60
2941814|NCT00645593|3654323|FG000|NOT COMPLETED|Overall Study||1
2941815|NCT00645593|3654324|FG001|NOT COMPLETED|Overall Study||0
2941816|NCT00645671|3654332|FG000|STARTED|Overall Study||201
2941817|NCT00645671|3654333|FG001|STARTED|Overall Study||199
2941818|NCT00645671|3654332|FG000|COMPLETED|Overall Study||200
2941819|NCT00645671|3654333|FG001|COMPLETED|Overall Study||193
2941820|NCT00645671|3654332|FG000|NOT COMPLETED|Overall Study||1
2941821|NCT00645671|3654333|FG001|NOT COMPLETED|Overall Study||6
2941822|NCT00645710|3654342|FG000|STARTED|Overall Study||3
2941823|NCT00645710|3654343|FG001|STARTED|Overall Study||3
2941824|NCT00645710|3654344|FG002|STARTED|Overall Study||10
2941825|NCT00645710|3654342|FG000|COMPLETED|Overall Study||3
2941826|NCT00645710|3654343|FG001|COMPLETED|Overall Study||3
2941827|NCT00645710|3654344|FG002|COMPLETED|Overall Study||10
2941828|NCT00645710|3654342|FG000|NOT COMPLETED|Overall Study||0
2941829|NCT00645710|3654343|FG001|NOT COMPLETED|Overall Study||0
2941830|NCT00645710|3654344|FG002|NOT COMPLETED|Overall Study||0
2941831|NCT00645762|3654353|FG000|STARTED|Overall Study||71
2941832|NCT00645762|3654353|FG000|COMPLETED|Overall Study||67
2941833|NCT00645762|3654353|FG000|NOT COMPLETED|Overall Study||4
2941834|NCT00645788|3654363|FG000|STARTED|Overall Study||94
2941835|NCT00645788|3654364|FG001|STARTED|Overall Study||94
2941836|NCT00645788|3654365|FG002|STARTED|Overall Study||65
2941837|NCT00645788|3654366|FG003|STARTED|Overall Study||35
2941838|NCT00645788|3654363|FG000|Participants Receive Treatment|Overall Study||93
2941839|NCT00645788|3654364|FG001|Participants Receive Treatment|Overall Study||93
2941840|NCT00645788|3654365|FG002|Participants Receive Treatment|Overall Study||65
2941841|NCT00645788|3654366|FG003|Participants Receive Treatment|Overall Study||35
2941842|NCT00645788|3654363|FG000|COMPLETED|Overall Study||74
2941843|NCT00645788|3654364|FG001|COMPLETED|Overall Study||67
2941844|NCT00645788|3654365|FG002|COMPLETED|Overall Study||47
2941845|NCT00645788|3654366|FG003|COMPLETED|Overall Study||21
2941846|NCT00645788|3654363|FG000|NOT COMPLETED|Overall Study||20
2941847|NCT00645788|3654364|FG001|NOT COMPLETED|Overall Study||27
2941848|NCT00645788|3654365|FG002|NOT COMPLETED|Overall Study||18
2941849|NCT00645788|3654366|FG003|NOT COMPLETED|Overall Study||14
2941850|NCT00645827|3654378|FG000|STARTED|Overall Study||14
2941851|NCT00645827|3654379|FG001|STARTED|Overall Study||17
2941852|NCT00645827|3654378|FG000|COMPLETED|Overall Study||14
2941853|NCT00645827|3654379|FG001|COMPLETED|Overall Study||17
2941854|NCT00645827|3654378|FG000|NOT COMPLETED|Overall Study||0
2941855|NCT00645827|3654379|FG001|NOT COMPLETED|Overall Study||0
2941856|NCT00645840|3654385|FG000|STARTED|Overall Study||15
2941857|NCT00645840|3654385|FG000|COMPLETED|Overall Study||12
2941858|NCT00645840|3654385|FG000|NOT COMPLETED|Overall Study||3
2941859|NCT00645853|3654391|FG000|STARTED|Overall Study||288
2941860|NCT00645853|3654392|FG001|STARTED|Overall Study||235
2941861|NCT00645853|3654391|FG000|No of Patients After Dose Switch|Overall Study|All patients in the AZD0837 arm switched from their initial doses, to a general dose of 300 mg od|209
2941862|NCT00645853|3654392|FG001|No of Patients After Dose Switch|Overall Study|No changes for VKA patients|188
2941863|NCT00645853|3654391|FG000|Discontinued Patient No Due to Closure|Overall Study|No of patients discontinued due the study termination caused tablet formulation stability problems|196
2941864|NCT00645853|3654392|FG001|Discontinued Patient No Due to Closure|Overall Study|No of patients discontinued due the study termination caused tablet formulation stability problems|178
2941865|NCT00645853|3654391|FG000|AZ Study Closure in Hungary|Overall Study||60
2941866|NCT00645853|3654392|FG001|AZ Study Closure in Hungary|Overall Study||40
2941867|NCT00645853|3654391|FG000|COMPLETED|Overall Study||196
2941868|NCT00645853|3654392|FG001|COMPLETED|Overall Study||178
2941869|NCT00645853|3654391|FG000|NOT COMPLETED|Overall Study||92
2941870|NCT00645853|3654392|FG001|NOT COMPLETED|Overall Study||57
2941871|NCT00645944|3654400|FG000|STARTED|Randomized||20
2941872|NCT00645944|3654401|FG001|STARTED|Randomized||19
2941873|NCT00645944|3654400|FG000|COMPLETED|Randomized||19
2941874|NCT00645944|3654401|FG001|COMPLETED|Randomized||17
2941875|NCT00645944|3654400|FG000|NOT COMPLETED|Randomized||1
2941876|NCT00645944|3654401|FG001|NOT COMPLETED|Randomized||2
2941877|NCT00645944|3654400|FG000|STARTED|Received Medication||19
2941878|NCT00645944|3654401|FG001|STARTED|Received Medication||17
2941879|NCT00645944|3654400|FG000|COMPLETED|Received Medication||13
2941880|NCT00645944|3654401|FG001|COMPLETED|Received Medication||14
3132387|NCT01690988|3857440|FG001|NOT COMPLETED|Overall Study||5
3132388|NCT01690988|3857441|FG002|NOT COMPLETED|Overall Study||7
3132389|NCT01691014|3857456|FG000|STARTED|Overall Study||8
3132390|NCT01691014|3857457|FG001|STARTED|Overall Study||26
3132391|NCT01691014|3857458|FG002|STARTED|Overall Study||36
3298646|NCT02925494|4032316|FG002|STARTED|Post-Treatment Follow-Up Period||88
3298647|NCT02925494|4032317|FG003|STARTED|Post-Treatment Follow-Up Period||184
3298648|NCT02925494|4032314|FG000|COMPLETED|Post-Treatment Follow-Up Period||40
3298649|NCT02925494|4032315|FG001|COMPLETED|Post-Treatment Follow-Up Period||37
3298650|NCT02925494|4032316|FG002|COMPLETED|Post-Treatment Follow-Up Period||64
2941881|NCT00645944|3654400|FG000|NOT COMPLETED|Received Medication||6
2941882|NCT00645944|3654401|FG001|NOT COMPLETED|Received Medication||3
2941883|NCT00645970|3654409|FG000|STARTED|Overall Study||141
2941884|NCT00645970|3654410|FG001|STARTED|Overall Study||218
2941885|NCT00645970|3654409|FG000|6 Months|Overall Study||58
2941886|NCT00645970|3654410|FG001|6 Months|Overall Study||97
2941887|NCT00645970|3654409|FG000|1 Year|Overall Study||37
2941888|NCT00645970|3654410|FG001|1 Year|Overall Study||42
2941889|NCT00645970|3654409|FG000|COMPLETED|Overall Study||32
2941890|NCT00645970|3654410|FG001|COMPLETED|Overall Study||32
2941891|NCT00645970|3654409|FG000|NOT COMPLETED|Overall Study||109
2941892|NCT00645970|3654410|FG001|NOT COMPLETED|Overall Study||186
2941893|NCT00646048|3654416|FG000|STARTED|Overall Study||43
2941894|NCT00646048|3654416|FG000|COMPLETED|Overall Study||27
2941895|NCT00646048|3654416|FG000|NOT COMPLETED|Overall Study||16
2941896|NCT00646113|3654420|FG000|STARTED|Overall Study|3 of the 72 enrolled participants were excluded before surgery.|69
2941897|NCT00646113|3654420|FG000|COMPLETED|Overall Study||61
2941898|NCT00646113|3654420|FG000|NOT COMPLETED|Overall Study||8
2941899|NCT00646399|3654426|FG000|STARTED|Overall Study||792
2941900|NCT00646399|3654427|FG001|STARTED|Overall Study||787
2941901|NCT00646399|3654426|FG000|COMPLETED|Overall Study||709
2941902|NCT00646399|3654427|FG001|COMPLETED|Overall Study||713
2941903|NCT00646399|3654426|FG000|NOT COMPLETED|Overall Study||83
2941904|NCT00646399|3654427|FG001|NOT COMPLETED|Overall Study||74
2941905|NCT00646451|3654433|FG000|STARTED|Overall Study||10
2941906|NCT00646451|3654434|FG001|STARTED|Overall Study||10
2941907|NCT00646451|3654433|FG000|COMPLETED|Overall Study||6
2941908|NCT00646451|3654434|FG001|COMPLETED|Overall Study||10
2941909|NCT00646451|3654433|FG000|NOT COMPLETED|Overall Study||4
2941910|NCT00646451|3654434|FG001|NOT COMPLETED|Overall Study||0
2941911|NCT00646581|3654444|FG000|STARTED|Overall Study||15
2941912|NCT00646581|3654445|FG001|STARTED|Overall Study||15
2941913|NCT00646581|3654444|FG000|COMPLETED|Overall Study||15
2941914|NCT00646581|3654445|FG001|COMPLETED|Overall Study||15
2941915|NCT00646581|3654444|FG000|NOT COMPLETED|Overall Study||0
2941916|NCT00646581|3654445|FG001|NOT COMPLETED|Overall Study||0
2941917|NCT00646646|3654455|FG000|STARTED|Overall Study||15
2941918|NCT00646646|3654456|FG001|STARTED|Overall Study||15
2941919|NCT00646646|3654457|FG002|STARTED|Overall Study||15
2941920|NCT00646646|3654458|FG003|STARTED|Overall Study||20
2941921|NCT00646646|3654455|FG000|COMPLETED|Overall Study||15
2941922|NCT00646646|3654456|FG001|COMPLETED|Overall Study||15
2941923|NCT00646646|3654457|FG002|COMPLETED|Overall Study||15
2941924|NCT00646646|3654458|FG003|COMPLETED|Overall Study||20
2941925|NCT00646646|3654455|FG000|NOT COMPLETED|Overall Study||0
2941926|NCT00646646|3654456|FG001|NOT COMPLETED|Overall Study||0
2941927|NCT00646646|3654457|FG002|NOT COMPLETED|Overall Study||0
2941928|NCT00646646|3654458|FG003|NOT COMPLETED|Overall Study||0
2941929|NCT00646763|3654470|FG000|STARTED|Overall Study||18
2941930|NCT00646763|3654471|FG001|STARTED|Overall Study||17
2941931|NCT00646763|3654470|FG000|COMPLETED|Overall Study||18
2941932|NCT00646763|3654471|FG001|COMPLETED|Overall Study||17
2941933|NCT00646763|3654470|FG000|NOT COMPLETED|Overall Study||0
2941934|NCT00646763|3654471|FG001|NOT COMPLETED|Overall Study||0
2941935|NCT00646776|3654479|FG000|STARTED|Overall Study|Treated on Day 1|15
2941936|NCT00646776|3654480|FG001|STARTED|Overall Study|Treated on Day 1|18
2941937|NCT00646776|3654479|FG000|COMPLETED|Overall Study||14
2941938|NCT00646776|3654480|FG001|COMPLETED|Overall Study||5
2941939|NCT00646776|3654479|FG000|NOT COMPLETED|Overall Study||1
2941940|NCT00646776|3654480|FG001|NOT COMPLETED|Overall Study||13
2941941|NCT00646906|3654493|FG000|STARTED|Crossover Period 1||9
2941942|NCT00646906|3654494|FG001|STARTED|Crossover Period 1||9
2941943|NCT00646906|3654495|FG002|STARTED|Crossover Period 1||10
2941944|NCT00646906|3654496|FG003|STARTED|Crossover Period 1||9
2941945|NCT00646906|3654497|FG004|STARTED|Crossover Period 1||8
2941946|NCT00646906|3654498|FG005|STARTED|Crossover Period 1||5
2941947|NCT00646906|3654499|FG006|STARTED|Crossover Period 1||5
2941948|NCT00646906|3654493|FG000|COMPLETED|Crossover Period 1||8
2941949|NCT00646906|3654494|FG001|COMPLETED|Crossover Period 1||9
2941950|NCT00646906|3654495|FG002|COMPLETED|Crossover Period 1||10
2941951|NCT00646906|3654496|FG003|COMPLETED|Crossover Period 1||9
2941952|NCT00646906|3654497|FG004|COMPLETED|Crossover Period 1|Phase 1b had only one treatment period and no crossover. Phase 1b ended here.|8
2941953|NCT00646906|3654498|FG005|COMPLETED|Crossover Period 1||4
2941954|NCT00646906|3654499|FG006|COMPLETED|Crossover Period 1||5
2941955|NCT00646906|3654493|FG000|NOT COMPLETED|Crossover Period 1||1
2941956|NCT00646906|3654494|FG001|NOT COMPLETED|Crossover Period 1||0
2941957|NCT00646906|3654495|FG002|NOT COMPLETED|Crossover Period 1||0
2941958|NCT00646906|3654496|FG003|NOT COMPLETED|Crossover Period 1||0
2941959|NCT00646906|3654497|FG004|NOT COMPLETED|Crossover Period 1||0
2941960|NCT00646906|3654498|FG005|NOT COMPLETED|Crossover Period 1||1
2941961|NCT00646906|3654499|FG006|NOT COMPLETED|Crossover Period 1||0
2941962|NCT00646906|3654493|FG000|STARTED|Washout (>/= 14 Days)||8
2941963|NCT00646906|3654494|FG001|STARTED|Washout (>/= 14 Days)||9
2941964|NCT00646906|3654495|FG002|STARTED|Washout (>/= 14 Days)||10
2941965|NCT00646906|3654496|FG003|STARTED|Washout (>/= 14 Days)||9
2941966|NCT00646906|3654497|FG004|STARTED|Washout (>/= 14 Days)|Phase 1b had only one treatment period and no crossover.|0
2941967|NCT00646906|3654498|FG005|STARTED|Washout (>/= 14 Days)||4
2941968|NCT00646906|3654499|FG006|STARTED|Washout (>/= 14 Days)||5
2941969|NCT00646906|3654493|FG000|COMPLETED|Washout (>/= 14 Days)||8
2941970|NCT00646906|3654494|FG001|COMPLETED|Washout (>/= 14 Days)||9
2941971|NCT00646906|3654495|FG002|COMPLETED|Washout (>/= 14 Days)||10
2941972|NCT00646906|3654496|FG003|COMPLETED|Washout (>/= 14 Days)||9
2941973|NCT00646906|3654497|FG004|COMPLETED|Washout (>/= 14 Days)|Phase 1b had only one treatment period and no crossover.|0
2941974|NCT00646906|3654498|FG005|COMPLETED|Washout (>/= 14 Days)||4
2941975|NCT00646906|3654499|FG006|COMPLETED|Washout (>/= 14 Days)||5
2941976|NCT00646906|3654493|FG000|NOT COMPLETED|Washout (>/= 14 Days)||0
2941977|NCT00646906|3654494|FG001|NOT COMPLETED|Washout (>/= 14 Days)||0
2941978|NCT00646906|3654495|FG002|NOT COMPLETED|Washout (>/= 14 Days)||0
2941979|NCT00646906|3654496|FG003|NOT COMPLETED|Washout (>/= 14 Days)||0
2941980|NCT00646906|3654497|FG004|NOT COMPLETED|Washout (>/= 14 Days)||0
2941981|NCT00646906|3654498|FG005|NOT COMPLETED|Washout (>/= 14 Days)||0
2941982|NCT00646906|3654499|FG006|NOT COMPLETED|Washout (>/= 14 Days)||0
2941983|NCT00646906|3654493|FG000|STARTED|Crossover Period 2||8
2941984|NCT00646906|3654494|FG001|STARTED|Crossover Period 2||9
2941985|NCT00646906|3654495|FG002|STARTED|Crossover Period 2||10
2941986|NCT00646906|3654496|FG003|STARTED|Crossover Period 2||9
2941987|NCT00646906|3654497|FG004|STARTED|Crossover Period 2|Phase 1b had only one treatment period and no crossover.|0
2941988|NCT00646906|3654498|FG005|STARTED|Crossover Period 2||4
2941989|NCT00646906|3654499|FG006|STARTED|Crossover Period 2||5
2941990|NCT00646906|3654493|FG000|COMPLETED|Crossover Period 2||8
2941991|NCT00646906|3654494|FG001|COMPLETED|Crossover Period 2||8
2941992|NCT00646906|3654495|FG002|COMPLETED|Crossover Period 2||8
2941993|NCT00646906|3654496|FG003|COMPLETED|Crossover Period 2||8
2941994|NCT00646906|3654497|FG004|COMPLETED|Crossover Period 2|Phase 1b had only one treatment period and no crossover.|0
2941995|NCT00646906|3654498|FG005|COMPLETED|Crossover Period 2||4
2941996|NCT00646906|3654499|FG006|COMPLETED|Crossover Period 2||4
2941997|NCT00646906|3654493|FG000|NOT COMPLETED|Crossover Period 2||0
2941998|NCT00646906|3654494|FG001|NOT COMPLETED|Crossover Period 2||1
2941999|NCT00646906|3654495|FG002|NOT COMPLETED|Crossover Period 2||2
2942000|NCT00646906|3654496|FG003|NOT COMPLETED|Crossover Period 2||1
2942001|NCT00646906|3654497|FG004|NOT COMPLETED|Crossover Period 2||0
2942002|NCT00646906|3654498|FG005|NOT COMPLETED|Crossover Period 2||0
2942003|NCT00646906|3654499|FG006|NOT COMPLETED|Crossover Period 2||1
2942004|NCT00646958|3654515|FG000|STARTED|Overall Study|Number (No.) Participants Randomized|51
2942005|NCT00646958|3654516|FG001|STARTED|Overall Study|No. Participants Randomized|50
2942006|NCT00646958|3654517|FG002|STARTED|Overall Study|No. Participants Randomized|49
2942007|NCT00646958|3654515|FG000|COMPLETED|Overall Study||40
2942008|NCT00646958|3654516|FG001|COMPLETED|Overall Study||41
2942009|NCT00646958|3654517|FG002|COMPLETED|Overall Study||40
2942010|NCT00646958|3654515|FG000|NOT COMPLETED|Overall Study||11
2942011|NCT00646958|3654516|FG001|NOT COMPLETED|Overall Study||9
2942012|NCT00646958|3654517|FG002|NOT COMPLETED|Overall Study||9
2942013|NCT00647270|3654528|FG000|STARTED|Period 1, Placebo-control (12 Weeks)|Placebo subjects in Period 1 received adalimumab 40 mg every other week in Period 2.|56
2942014|NCT00647270|3654529|FG001|STARTED|Period 1, Placebo-control (12 Weeks)||159
2942015|NCT00647270|3654530|FG002|STARTED|Period 1, Placebo-control (12 Weeks)||205
2942016|NCT00647270|3654528|FG000|COMPLETED|Period 1, Placebo-control (12 Weeks)||48
2942017|NCT00647270|3654529|FG001|COMPLETED|Period 1, Placebo-control (12 Weeks)||146
2942018|NCT00647270|3654530|FG002|COMPLETED|Period 1, Placebo-control (12 Weeks)||182
2942019|NCT00647270|3654528|FG000|NOT COMPLETED|Period 1, Placebo-control (12 Weeks)||8
2942020|NCT00647270|3654529|FG001|NOT COMPLETED|Period 1, Placebo-control (12 Weeks)||13
2942021|NCT00647270|3654530|FG002|NOT COMPLETED|Period 1, Placebo-control (12 Weeks)||23
2942022|NCT00647270|3654528|FG000|STARTED|Period 2, Placebo Switched to Adalimumab|Placebo subjects in Period 1 received adalimumab 40 mg eow in Period 2|48
2942023|NCT00647270|3654529|FG001|STARTED|Period 2, Placebo Switched to Adalimumab||146
2942024|NCT00647270|3654530|FG002|STARTED|Period 2, Placebo Switched to Adalimumab||182
2942025|NCT00647270|3654528|FG000|COMPLETED|Period 2, Placebo Switched to Adalimumab||45
2942026|NCT00647270|3654529|FG001|COMPLETED|Period 2, Placebo Switched to Adalimumab||137
2942027|NCT00647270|3654530|FG002|COMPLETED|Period 2, Placebo Switched to Adalimumab||175
2942028|NCT00647270|3654528|FG000|NOT COMPLETED|Period 2, Placebo Switched to Adalimumab||3
2942029|NCT00647270|3654529|FG001|NOT COMPLETED|Period 2, Placebo Switched to Adalimumab||9
2942030|NCT00647270|3654530|FG002|NOT COMPLETED|Period 2, Placebo Switched to Adalimumab||7
2942031|NCT00647296|3654545|FG000|STARTED|Part 1: 12-week Double-Blind Treatment||27
2942032|NCT00647296|3654546|FG001|STARTED|Part 1: 12-week Double-Blind Treatment||23
2942033|NCT00647296|3654547|FG002|STARTED|Part 1: 12-week Double-Blind Treatment||26
2942034|NCT00647296|3654548|FG003|STARTED|Part 1: 12-week Double-Blind Treatment||26
2942035|NCT00647296|3654545|FG000|COMPLETED|Part 1: 12-week Double-Blind Treatment||26
2942036|NCT00647296|3654546|FG001|COMPLETED|Part 1: 12-week Double-Blind Treatment||22
2942037|NCT00647296|3654547|FG002|COMPLETED|Part 1: 12-week Double-Blind Treatment||26
2942038|NCT00647296|3654548|FG003|COMPLETED|Part 1: 12-week Double-Blind Treatment||24
2942039|NCT00647296|3654545|FG000|NOT COMPLETED|Part 1: 12-week Double-Blind Treatment||1
2942040|NCT00647296|3654546|FG001|NOT COMPLETED|Part 1: 12-week Double-Blind Treatment||1
2942041|NCT00647296|3654547|FG002|NOT COMPLETED|Part 1: 12-week Double-Blind Treatment||0
2942042|NCT00647296|3654548|FG003|NOT COMPLETED|Part 1: 12-week Double-Blind Treatment||2
2942043|NCT00647296|3654545|FG000|STARTED|Part 2: 4-week Placebo Washout||97
2942044|NCT00647296|3654546|FG001|STARTED|Part 2: 4-week Placebo Washout||0
2942045|NCT00647296|3654547|FG002|STARTED|Part 2: 4-week Placebo Washout||0
2942046|NCT00647296|3654548|FG003|STARTED|Part 2: 4-week Placebo Washout||0
2942047|NCT00647296|3654545|FG000|COMPLETED|Part 2: 4-week Placebo Washout||92
2942048|NCT00647296|3654546|FG001|COMPLETED|Part 2: 4-week Placebo Washout||0
2942049|NCT00647296|3654547|FG002|COMPLETED|Part 2: 4-week Placebo Washout||0
2942050|NCT00647296|3654548|FG003|COMPLETED|Part 2: 4-week Placebo Washout||0
2942051|NCT00647296|3654545|FG000|NOT COMPLETED|Part 2: 4-week Placebo Washout||5
2942052|NCT00647296|3654546|FG001|NOT COMPLETED|Part 2: 4-week Placebo Washout||0
2942053|NCT00647296|3654547|FG002|NOT COMPLETED|Part 2: 4-week Placebo Washout||0
2942054|NCT00647296|3654548|FG003|NOT COMPLETED|Part 2: 4-week Placebo Washout||0
2942055|NCT00647296|3654545|FG000|STARTED|Part 2: 76-week Double-Blind Treatment||0
2942056|NCT00647296|3654546|FG001|STARTED|Part 2: 76-week Double-Blind Treatment||48
2942057|NCT00647296|3654547|FG002|STARTED|Part 2: 76-week Double-Blind Treatment||0
2942058|NCT00647296|3654548|FG003|STARTED|Part 2: 76-week Double-Blind Treatment||44
2942059|NCT00647296|3654545|FG000|COMPLETED|Part 2: 76-week Double-Blind Treatment||0
2942060|NCT00647296|3654546|FG001|COMPLETED|Part 2: 76-week Double-Blind Treatment||33
2942061|NCT00647296|3654547|FG002|COMPLETED|Part 2: 76-week Double-Blind Treatment||0
2942062|NCT00647296|3654548|FG003|COMPLETED|Part 2: 76-week Double-Blind Treatment||30
2942063|NCT00647296|3654545|FG000|NOT COMPLETED|Part 2: 76-week Double-Blind Treatment||0
2942064|NCT00647296|3654546|FG001|NOT COMPLETED|Part 2: 76-week Double-Blind Treatment||15
2942065|NCT00647296|3654547|FG002|NOT COMPLETED|Part 2: 76-week Double-Blind Treatment||0
2942066|NCT00647296|3654548|FG003|NOT COMPLETED|Part 2: 76-week Double-Blind Treatment||14
2942067|NCT00647348|3654572|FG000|STARTED|Overall Study||70
2942068|NCT00647348|3654573|FG001|STARTED|Overall Study||70
2942069|NCT00647348|3654572|FG000|COMPLETED|Overall Study||67
2942070|NCT00647348|3654573|FG001|COMPLETED|Overall Study||64
2942071|NCT00647348|3654572|FG000|NOT COMPLETED|Overall Study||3
2942072|NCT00647348|3654573|FG001|NOT COMPLETED|Overall Study||6
2942073|NCT00647400|3654581|FG000|STARTED|Overall Study||89
2942074|NCT00647400|3654582|FG001|STARTED|Overall Study||58
2942075|NCT00647400|3654581|FG000|COMPLETED|Overall Study||67
2942076|NCT00647400|3654582|FG001|COMPLETED|Overall Study||45
2942077|NCT00647400|3654581|FG000|NOT COMPLETED|Overall Study||22
2942078|NCT00647400|3654582|FG001|NOT COMPLETED|Overall Study||13
2942079|NCT00647556|3654590|FG000|STARTED|Overall Study||15
2942080|NCT00647556|3654591|FG001|STARTED|Overall Study||15
2942081|NCT00647556|3654590|FG000|COMPLETED|Overall Study||12
2942082|NCT00647556|3654591|FG001|COMPLETED|Overall Study||13
2942083|NCT00647556|3654590|FG000|NOT COMPLETED|Overall Study||3
2942084|NCT00647556|3654591|FG001|NOT COMPLETED|Overall Study||2
2942085|NCT00647699|3654599|FG000|STARTED|Overall Study||73
2942086|NCT00647699|3654600|FG001|STARTED|Overall Study||74
2942087|NCT00647699|3654599|FG000|COMPLETED|Overall Study||65
2942088|NCT00647699|3654600|FG001|COMPLETED|Overall Study||62
2942089|NCT00647699|3654599|FG000|NOT COMPLETED|Overall Study||8
2942090|NCT00647699|3654600|FG001|NOT COMPLETED|Overall Study||12
2942091|NCT00647998|3654608|FG000|STARTED|Overall Study||9
2942092|NCT00647998|3654609|FG001|STARTED|Overall Study||9
2942093|NCT00647998|3654608|FG000|COMPLETED|Overall Study||9
2942094|NCT00647998|3654609|FG001|COMPLETED|Overall Study||9
2942095|NCT00647998|3654608|FG000|NOT COMPLETED|Overall Study||0
2942096|NCT00647998|3654609|FG001|NOT COMPLETED|Overall Study||0
2942097|NCT00648037|3654617|FG000|STARTED|Overall Study||26
2942098|NCT00648037|3654617|FG000|COMPLETED|Overall Study||10
2942099|NCT00648037|3654617|FG000|NOT COMPLETED|Overall Study||16
2942100|NCT00648115|3654624|FG000|STARTED|Overall Study||42
2942101|NCT00648115|3654625|FG001|STARTED|Overall Study||42
2942102|NCT00648115|3654626|FG002|STARTED|Overall Study||27
2942103|NCT00648115|3654624|FG000|COMPLETED|Overall Study||42
2942104|NCT00648115|3654625|FG001|COMPLETED|Overall Study||42
2942105|NCT00648115|3654626|FG002|COMPLETED|Overall Study||27
2942106|NCT00648115|3654624|FG000|NOT COMPLETED|Overall Study||0
2942107|NCT00648115|3654625|FG001|NOT COMPLETED|Overall Study||0
2942108|NCT00648115|3654626|FG002|NOT COMPLETED|Overall Study||0
2942109|NCT00648167|3654634|FG000|STARTED|Overall Study||55
2942110|NCT00648167|3654634|FG000|Start Dose 4.5 g/Day|Overall Study||34
2942111|NCT00648167|3654634|FG000|Start Dose 6 g/Day|Overall Study||21
2942112|NCT00648167|3654634|FG000|COMPLETED|Overall Study||48
2942113|NCT00648167|3654634|FG000|NOT COMPLETED|Overall Study||7
2942114|NCT00648375|3654640|FG000|STARTED|Overall Study||1
2942115|NCT00648375|3654641|FG001|STARTED|Overall Study||2
2942116|NCT00648375|3654640|FG000|COMPLETED|Overall Study||1
2942117|NCT00648375|3654641|FG001|COMPLETED|Overall Study||2
2942118|NCT00648375|3654640|FG000|NOT COMPLETED|Overall Study||0
2942119|NCT00648375|3654641|FG001|NOT COMPLETED|Overall Study||0
2942120|NCT00648648|3654675|FG000|STARTED|Overall Study||3
2942121|NCT00648648|3654676|FG001|STARTED|Overall Study||3
2942122|NCT00648648|3654677|FG002|STARTED|Overall Study||3
2942123|NCT00648648|3654678|FG003|STARTED|Overall Study|Does not include two Part 1 participants who were randomized to this arm.|4
2942124|NCT00648648|3654679|FG004|STARTED|Overall Study||9
2942125|NCT00648648|3654680|FG005|STARTED|Overall Study|Does not include two Part 1 participants who were randomized to this arm.|1
2942126|NCT00648648|3654681|FG006|STARTED|Overall Study|Does not include one Part 1 participant who was randomized to this arm.|10
2942127|NCT00648648|3654682|FG007|STARTED|Overall Study|Does not include two Part 1 participants who were randomized to this arm.|1
2942128|NCT00648648|3654683|FG008|STARTED|Overall Study|Does not include one Part 1 participant who was randomized to this arm.|3
2942129|NCT00648648|3654684|FG009|STARTED|Overall Study||10
2942130|NCT00648648|3654685|FG010|STARTED|Overall Study||6
2942131|NCT00648648|3654686|FG011|STARTED|Overall Study||13
2942132|NCT00648648|3654687|FG012|STARTED|Overall Study||6
2942133|NCT00648648|3654688|FG013|STARTED|Overall Study||5
2942134|NCT00648648|3654689|FG014|STARTED|Overall Study||4
2942135|NCT00648648|3654690|FG015|STARTED|Overall Study||11
2942136|NCT00648648|3654691|FG016|STARTED|Overall Study||16
2942137|NCT00648648|3654692|FG017|STARTED|Overall Study||6
2942138|NCT00648648|3654693|FG018|STARTED|Overall Study||5
2942139|NCT00648648|3654694|FG019|STARTED|Overall Study||7
2942140|NCT00648648|3654695|FG020|STARTED|Overall Study||6
2942141|NCT00648648|3654696|FG021|STARTED|Overall Study||10
2942142|NCT00648648|3654697|FG022|STARTED|Overall Study||14
2942143|NCT00648648|3654698|FG023|STARTED|Overall Study||4
2942144|NCT00648648|3654699|FG024|STARTED|Overall Study||4
2942145|NCT00648648|3654700|FG025|STARTED|Overall Study||4
2942146|NCT00648648|3654701|FG026|STARTED|Overall Study||26
2942147|NCT00648648|3654702|FG027|STARTED|Overall Study||12
2942148|NCT00648648|3654675|FG000|Treated|Overall Study||3
2942149|NCT00648648|3654676|FG001|Treated|Overall Study||3
2942150|NCT00648648|3654677|FG002|Treated|Overall Study||3
2942151|NCT00648648|3654678|FG003|Treated|Overall Study|Does not include two Part 1 participants who were treated in this arm.|4
2942152|NCT00648648|3654679|FG004|Treated|Overall Study||8
2942153|NCT00648648|3654680|FG005|Treated|Overall Study|Does not include two Part 1 participants who were treated in this arm.|1
2942154|NCT00648648|3654681|FG006|Treated|Overall Study|Does not include one treated participant who was excluded from analysis.|9
2942155|NCT00648648|3654682|FG007|Treated|Overall Study|Does not include two Part 1 participants who were treated in this arm.|1
2942156|NCT00648648|3654683|FG008|Treated|Overall Study|Does not include one Part 1 participant who was treated in this arm.|3
2942157|NCT00648648|3654684|FG009|Treated|Overall Study|Does not include one treated participant who was excluded from analysis.|9
2942158|NCT00648648|3654685|FG010|Treated|Overall Study||6
3163348|NCT01886105|3890889|FG000|COMPLETED|Overall Study||1
3163349|NCT01886105|3890889|FG000|NOT COMPLETED|Overall Study||3
3163350|NCT01886235|3890894|FG000|STARTED|Overall Study||10
2942159|NCT00648648|3654686|FG011|Treated|Overall Study||13
2942160|NCT00648648|3654687|FG012|Treated|Overall Study||6
2942161|NCT00648648|3654688|FG013|Treated|Overall Study||5
2942162|NCT00648648|3654689|FG014|Treated|Overall Study||4
2942163|NCT00648648|3654690|FG015|Treated|Overall Study||11
2942164|NCT00648648|3654691|FG016|Treated|Overall Study||16
2942165|NCT00648648|3654692|FG017|Treated|Overall Study||6
2942166|NCT00648648|3654693|FG018|Treated|Overall Study||4
2942167|NCT00648648|3654694|FG019|Treated|Overall Study||7
2942168|NCT00648648|3654695|FG020|Treated|Overall Study||6
2942169|NCT00648648|3654696|FG021|Treated|Overall Study||10
2942170|NCT00648648|3654697|FG022|Treated|Overall Study||14
2942171|NCT00648648|3654698|FG023|Treated|Overall Study||4
2942172|NCT00648648|3654699|FG024|Treated|Overall Study||4
2942173|NCT00648648|3654700|FG025|Treated|Overall Study||4
2942174|NCT00648648|3654701|FG026|Treated|Overall Study||26
2942175|NCT00648648|3654702|FG027|Treated|Overall Study||12
2942176|NCT00648648|3654675|FG000|COMPLETED|Overall Study||3
2942177|NCT00648648|3654676|FG001|COMPLETED|Overall Study||3
2942178|NCT00648648|3654677|FG002|COMPLETED|Overall Study||3
2942179|NCT00648648|3654678|FG003|COMPLETED|Overall Study||0
2942180|NCT00648648|3654679|FG004|COMPLETED|Overall Study||0
2942181|NCT00648648|3654680|FG005|COMPLETED|Overall Study||0
2942182|NCT00648648|3654681|FG006|COMPLETED|Overall Study||0
2942183|NCT00648648|3654682|FG007|COMPLETED|Overall Study||0
2942184|NCT00648648|3654683|FG008|COMPLETED|Overall Study||0
2942185|NCT00648648|3654684|FG009|COMPLETED|Overall Study||0
2942186|NCT00648648|3654685|FG010|COMPLETED|Overall Study||0
2942187|NCT00648648|3654686|FG011|COMPLETED|Overall Study||0
2942188|NCT00648648|3654687|FG012|COMPLETED|Overall Study||0
2942189|NCT00648648|3654688|FG013|COMPLETED|Overall Study||0
2942190|NCT00648648|3654689|FG014|COMPLETED|Overall Study||0
2942191|NCT00648648|3654690|FG015|COMPLETED|Overall Study||0
2942192|NCT00648648|3654691|FG016|COMPLETED|Overall Study||2
2942193|NCT00648648|3654692|FG017|COMPLETED|Overall Study||0
2942194|NCT00648648|3654693|FG018|COMPLETED|Overall Study||0
2942195|NCT00648648|3654694|FG019|COMPLETED|Overall Study||0
2942196|NCT00648648|3654695|FG020|COMPLETED|Overall Study||0
2942197|NCT00648648|3654696|FG021|COMPLETED|Overall Study||0
2942198|NCT00648648|3654697|FG022|COMPLETED|Overall Study||0
2942199|NCT00648648|3654698|FG023|COMPLETED|Overall Study||0
2942200|NCT00648648|3654699|FG024|COMPLETED|Overall Study||0
2942201|NCT00648648|3654700|FG025|COMPLETED|Overall Study||0
2942202|NCT00648648|3654701|FG026|COMPLETED|Overall Study||0
2942203|NCT00648648|3654702|FG027|COMPLETED|Overall Study||0
2942204|NCT00648648|3654675|FG000|NOT COMPLETED|Overall Study||0
2942205|NCT00648648|3654676|FG001|NOT COMPLETED|Overall Study||0
2942206|NCT00648648|3654677|FG002|NOT COMPLETED|Overall Study||0
2942207|NCT00648648|3654678|FG003|NOT COMPLETED|Overall Study||4
2942208|NCT00648648|3654679|FG004|NOT COMPLETED|Overall Study||9
2942209|NCT00648648|3654680|FG005|NOT COMPLETED|Overall Study||1
2942210|NCT00648648|3654681|FG006|NOT COMPLETED|Overall Study||10
2942211|NCT00648648|3654682|FG007|NOT COMPLETED|Overall Study||1
2942212|NCT00648648|3654683|FG008|NOT COMPLETED|Overall Study||3
2942213|NCT00648648|3654684|FG009|NOT COMPLETED|Overall Study||10
2942214|NCT00648648|3654685|FG010|NOT COMPLETED|Overall Study||6
2942215|NCT00648648|3654686|FG011|NOT COMPLETED|Overall Study||13
2942216|NCT00648648|3654687|FG012|NOT COMPLETED|Overall Study||6
2942217|NCT00648648|3654688|FG013|NOT COMPLETED|Overall Study||5
2942218|NCT00648648|3654689|FG014|NOT COMPLETED|Overall Study||4
2942219|NCT00648648|3654690|FG015|NOT COMPLETED|Overall Study||11
2942220|NCT00648648|3654691|FG016|NOT COMPLETED|Overall Study||14
2942221|NCT00648648|3654692|FG017|NOT COMPLETED|Overall Study||6
2942222|NCT00648648|3654693|FG018|NOT COMPLETED|Overall Study||5
3163351|NCT01886235|3890894|FG000|COMPLETED|Overall Study||10
3132392|NCT01691014|3857459|FG003|STARTED|Overall Study||9
3132393|NCT01691014|3857456|FG000|COMPLETED|Overall Study||5
3132394|NCT01691014|3857457|FG001|COMPLETED|Overall Study||11
2942223|NCT00648648|3654694|FG019|NOT COMPLETED|Overall Study||7
2942224|NCT00648648|3654695|FG020|NOT COMPLETED|Overall Study||6
2942225|NCT00648648|3654696|FG021|NOT COMPLETED|Overall Study||10
2942226|NCT00648648|3654697|FG022|NOT COMPLETED|Overall Study||14
2942227|NCT00648648|3654698|FG023|NOT COMPLETED|Overall Study||4
2942228|NCT00648648|3654699|FG024|NOT COMPLETED|Overall Study||4
2942229|NCT00648648|3654700|FG025|NOT COMPLETED|Overall Study||4
2942230|NCT00648648|3654701|FG026|NOT COMPLETED|Overall Study||26
2942231|NCT00648648|3654702|FG027|NOT COMPLETED|Overall Study||12
2942232|NCT00648739|3654760|FG000|STARTED|Overall Study||4
2942233|NCT00648739|3654761|FG001|STARTED|Overall Study||5
2942234|NCT00648739|3654762|FG002|STARTED|Overall Study||3
2942235|NCT00648739|3654763|FG003|STARTED|Overall Study||3
2942236|NCT00648739|3654764|FG004|STARTED|Overall Study||3
2942237|NCT00648739|3654765|FG005|STARTED|Overall Study||7
2942238|NCT00648739|3654766|FG006|STARTED|Overall Study||1
2942239|NCT00648739|3654760|FG000|Received at Least 1 Dose of Study Drug|Overall Study||4
2942240|NCT00648739|3654761|FG001|Received at Least 1 Dose of Study Drug|Overall Study||5
2942241|NCT00648739|3654762|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3
2942242|NCT00648739|3654763|FG003|Received at Least 1 Dose of Study Drug|Overall Study||3
2942243|NCT00648739|3654764|FG004|Received at Least 1 Dose of Study Drug|Overall Study||3
2942244|NCT00648739|3654765|FG005|Received at Least 1 Dose of Study Drug|Overall Study||7
2942245|NCT00648739|3654766|FG006|Received at Least 1 Dose of Study Drug|Overall Study||1
3298651|NCT02925494|4032317|FG003|COMPLETED|Post-Treatment Follow-Up Period||134
3298652|NCT02925494|4032314|FG000|NOT COMPLETED|Post-Treatment Follow-Up Period||14
2942246|NCT00648739|3654760|FG000|COMPLETED|Overall Study||2
2942247|NCT00648739|3654761|FG001|COMPLETED|Overall Study||3
2942248|NCT00648739|3654762|FG002|COMPLETED|Overall Study||0
2942249|NCT00648739|3654763|FG003|COMPLETED|Overall Study||1
2942250|NCT00648739|3654764|FG004|COMPLETED|Overall Study||1
2942251|NCT00648739|3654765|FG005|COMPLETED|Overall Study||2
2942252|NCT00648739|3654766|FG006|COMPLETED|Overall Study||0
2942253|NCT00648739|3654760|FG000|NOT COMPLETED|Overall Study||2
2942254|NCT00648739|3654761|FG001|NOT COMPLETED|Overall Study||2
2942255|NCT00648739|3654762|FG002|NOT COMPLETED|Overall Study||3
2942256|NCT00648739|3654763|FG003|NOT COMPLETED|Overall Study||2
2942257|NCT00648739|3654764|FG004|NOT COMPLETED|Overall Study||2
2942258|NCT00648739|3654765|FG005|NOT COMPLETED|Overall Study||5
2942259|NCT00648739|3654766|FG006|NOT COMPLETED|Overall Study||1
2942260|NCT00648908|3654787|FG000|STARTED|Overall Study||269
2942261|NCT00648908|3654787|FG000|COMPLETED|Overall Study||154
2942262|NCT00648908|3654787|FG000|NOT COMPLETED|Overall Study||115
2942263|NCT00649220|3654792|FG000|STARTED|Overall Study||19
2942264|NCT00649220|3654792|FG000|COMPLETED|Overall Study||16
2942265|NCT00649220|3654792|FG000|NOT COMPLETED|Overall Study||3
2942266|NCT00649389|3654800|FG000|STARTED|Overall Study||628
2942267|NCT00649389|3654801|FG001|STARTED|Overall Study||637
2942268|NCT00649389|3654802|FG002|STARTED|Overall Study||600
2942269|NCT00649389|3654803|FG003|STARTED|Overall Study||627
2942270|NCT00649389|3654800|FG000|COMPLETED|Overall Study||557
2942271|NCT00649389|3654801|FG001|COMPLETED|Overall Study||531
2942272|NCT00649389|3654802|FG002|COMPLETED|Overall Study||512
2942273|NCT00649389|3654803|FG003|COMPLETED|Overall Study||516
2942274|NCT00649389|3654800|FG000|NOT COMPLETED|Overall Study||71
2942275|NCT00649389|3654801|FG001|NOT COMPLETED|Overall Study||106
2942276|NCT00649389|3654802|FG002|NOT COMPLETED|Overall Study||88
2942277|NCT00649389|3654803|FG003|NOT COMPLETED|Overall Study||111
2942278|NCT00649428|3654815|FG000|STARTED|Overall Study||100
2942279|NCT00649428|3654816|FG001|STARTED|Overall Study||103
2942280|NCT00649428|3654815|FG000|COMPLETED|Overall Study||80
2942281|NCT00649428|3654816|FG001|COMPLETED|Overall Study||88
2942282|NCT00649428|3654815|FG000|NOT COMPLETED|Overall Study||20
2942283|NCT00649428|3654816|FG001|NOT COMPLETED|Overall Study||15
2942284|NCT00649792|3654823|FG000|STARTED|Overall Study||214
2942285|NCT00649792|3654823|FG000|COMPLETED|Overall Study||146
2942286|NCT00649792|3654823|FG000|NOT COMPLETED|Overall Study||68
2942287|NCT00649961|3654827|FG000|STARTED|Overall Study||18
3132395|NCT01691014|3857458|FG002|COMPLETED|Overall Study||25
3298653|NCT02925494|4032315|FG001|NOT COMPLETED|Post-Treatment Follow-Up Period||10
2942288|NCT00649961|3654827|FG000|COMPLETED|Overall Study||18
2942289|NCT00649961|3654827|FG000|NOT COMPLETED|Overall Study||0
2942290|NCT00650078|3654833|FG000|STARTED|Overall Study||231
2942291|NCT00650078|3654834|FG001|STARTED|Overall Study||119
2942292|NCT00650078|3654833|FG000|COMPLETED|Overall Study||217
2942293|NCT00650078|3654834|FG001|COMPLETED|Overall Study||106
2942294|NCT00650078|3654833|FG000|NOT COMPLETED|Overall Study||14
2942295|NCT00650078|3654834|FG001|NOT COMPLETED|Overall Study||13
2942296|NCT00650091|3654842|FG000|STARTED|Initial Study Design - Interim Analysis||81
2942297|NCT00650091|3654843|FG001|STARTED|Initial Study Design - Interim Analysis||78
2942298|NCT00650091|3654844|FG002|STARTED|Initial Study Design - Interim Analysis||77
2942299|NCT00650091|3654842|FG000|COMPLETED|Initial Study Design - Interim Analysis||81
2942300|NCT00650091|3654843|FG001|COMPLETED|Initial Study Design - Interim Analysis||78
2942301|NCT00650091|3654844|FG002|COMPLETED|Initial Study Design - Interim Analysis||77
2942302|NCT00650091|3654842|FG000|NOT COMPLETED|Initial Study Design - Interim Analysis||0
2942303|NCT00650091|3654843|FG001|NOT COMPLETED|Initial Study Design - Interim Analysis||0
2942304|NCT00650091|3654844|FG002|NOT COMPLETED|Initial Study Design - Interim Analysis||0
2942305|NCT00650091|3654842|FG000|STARTED|Amended Study Design||133
2942306|NCT00650091|3654843|FG001|STARTED|Amended Study Design||131
2942307|NCT00650091|3654844|FG002|STARTED|Amended Study Design|Study Drug was discontinued for all subjects due to safety concerns.|0
2942308|NCT00650091|3654842|FG000|COMPLETED|Amended Study Design||110
2942309|NCT00650091|3654843|FG001|COMPLETED|Amended Study Design||111
2942310|NCT00650091|3654844|FG002|COMPLETED|Amended Study Design||0
2942311|NCT00650091|3654842|FG000|NOT COMPLETED|Amended Study Design||23
2942312|NCT00650091|3654843|FG001|NOT COMPLETED|Amended Study Design||20
2942313|NCT00650091|3654844|FG002|NOT COMPLETED|Amended Study Design||0
2942314|NCT00650104|3654852|FG000|STARTED|Overall Study||83
2942315|NCT00650104|3654852|FG000|COMPLETED|Overall Study||42
2942316|NCT00650104|3654852|FG000|NOT COMPLETED|Overall Study||41
2942317|NCT00650260|3654858|FG000|STARTED|Overall Study||21
2942318|NCT00650260|3654859|FG001|STARTED|Overall Study||21
2942319|NCT00650260|3654858|FG000|COMPLETED|Overall Study||21
2942320|NCT00650260|3654859|FG001|COMPLETED|Overall Study||21
2942321|NCT00650260|3654858|FG000|NOT COMPLETED|Overall Study||0
2942322|NCT00650260|3654859|FG001|NOT COMPLETED|Overall Study||0
2942323|NCT00650546|3654865|FG000|STARTED|Overall Study||8
2942324|NCT00650546|3654865|FG000|COMPLETED|Overall Study||8
2942325|NCT00650546|3654865|FG000|NOT COMPLETED|Overall Study||0
2942326|NCT00650585|3654872|FG000|STARTED|Overall Study||4348
2942327|NCT00650585|3654873|FG001|STARTED|Overall Study||3990
2942328|NCT00650585|3654872|FG000|COMPLETED|Overall Study|Completed posttest--a self-report survey administered 30 approximately 30 days after treatment|2551
2942329|NCT00650585|3654873|FG001|COMPLETED|Overall Study|Completed posttest--a self-report survey administered 30 approximately 30 days after treatment|2513
2942330|NCT00650585|3654872|FG000|NOT COMPLETED|Overall Study||1797
2942331|NCT00650585|3654873|FG001|NOT COMPLETED|Overall Study||1477
2942332|NCT00650767|3654883|FG000|STARTED|Overall Study||51
2942333|NCT00650767|3654884|FG001|STARTED|Overall Study||50
2942334|NCT00650767|3654885|FG002|STARTED|Overall Study||50
2942335|NCT00650767|3654886|FG003|STARTED|Overall Study||50
2942336|NCT00650767|3654883|FG000|COMPLETED|Overall Study||46
2942337|NCT00650767|3654884|FG001|COMPLETED|Overall Study||41
2942338|NCT00650767|3654885|FG002|COMPLETED|Overall Study||36
2942339|NCT00650767|3654886|FG003|COMPLETED|Overall Study||39
2942340|NCT00650767|3654883|FG000|NOT COMPLETED|Overall Study||5
2942341|NCT00650767|3654884|FG001|NOT COMPLETED|Overall Study||9
2942342|NCT00650767|3654885|FG002|NOT COMPLETED|Overall Study||14
2942343|NCT00650767|3654886|FG003|NOT COMPLETED|Overall Study||11
2942344|NCT00650806|3654900|FG000|STARTED|Overall Study||89
2942345|NCT00650806|3654901|FG001|STARTED|Overall Study||98
2942346|NCT00650806|3654902|FG002|STARTED|Overall Study||93
2942347|NCT00650806|3654903|FG003|STARTED|Overall Study||96
2942348|NCT00650806|3654900|FG000|COMPLETED|Overall Study||71
2942349|NCT00650806|3654901|FG001|COMPLETED|Overall Study||77
2942350|NCT00650806|3654902|FG002|COMPLETED|Overall Study||64
2942351|NCT00650806|3654903|FG003|COMPLETED|Overall Study||70
2942352|NCT00650806|3654900|FG000|NOT COMPLETED|Overall Study||18
2942353|NCT00650806|3654901|FG001|NOT COMPLETED|Overall Study||21
2942354|NCT00650806|3654902|FG002|NOT COMPLETED|Overall Study||29
2942355|NCT00650806|3654903|FG003|NOT COMPLETED|Overall Study||26
2942356|NCT00650845|3654917|FG000|STARTED|Overall Study||75
2942357|NCT00650845|3654918|FG001|STARTED|Overall Study||57
2942358|NCT00650845|3654917|FG000|COMPLETED|Overall Study||70
3132396|NCT01691014|3857459|FG003|COMPLETED|Overall Study||4
3132397|NCT01691014|3857456|FG000|NOT COMPLETED|Overall Study||3
3132398|NCT01691014|3857457|FG001|NOT COMPLETED|Overall Study||15
3132399|NCT01691014|3857458|FG002|NOT COMPLETED|Overall Study||11
3132400|NCT01691014|3857459|FG003|NOT COMPLETED|Overall Study||5
3298654|NCT02925494|4032316|FG002|NOT COMPLETED|Post-Treatment Follow-Up Period||24
2942359|NCT00650845|3654918|FG001|COMPLETED|Overall Study||44
2942360|NCT00650845|3654917|FG000|NOT COMPLETED|Overall Study||5
2942361|NCT00650845|3654918|FG001|NOT COMPLETED|Overall Study||13
2942362|NCT00650858|3654928|FG000|STARTED|Overall Study||8
2942363|NCT00650858|3654929|FG001|STARTED|Overall Study||8
2942364|NCT00650858|3654930|FG002|STARTED|Overall Study||36
2942365|NCT00650858|3654928|FG000|COMPLETED|Overall Study||8
2942366|NCT00650858|3654929|FG001|COMPLETED|Overall Study||8
2942367|NCT00650858|3654930|FG002|COMPLETED|Overall Study||36
3298655|NCT02925494|4032317|FG003|NOT COMPLETED|Post-Treatment Follow-Up Period||50
3298656|NCT02925611|4032330|FG000|STARTED|Overall Study||30
3298657|NCT02925611|4032331|FG001|STARTED|Overall Study||30
3298658|NCT02925611|4032330|FG000|COMPLETED|Overall Study||30
3298659|NCT02925611|4032331|FG001|COMPLETED|Overall Study||30
3298660|NCT02925611|4032330|FG000|NOT COMPLETED|Overall Study||0
3298661|NCT02925611|4032331|FG001|NOT COMPLETED|Overall Study||0
3298662|NCT02925741|4032339|FG000|STARTED|Overall Study||1637
3298663|NCT02925741|4032340|FG001|STARTED|Overall Study||1706
3298664|NCT02925741|4032339|FG000|COMPLETED|Overall Study||1626
3298665|NCT02925741|4032340|FG001|COMPLETED|Overall Study||1706
3298666|NCT02925741|4032339|FG000|NOT COMPLETED|Overall Study||11
2942368|NCT00650858|3654928|FG000|NOT COMPLETED|Overall Study||0
2942369|NCT00650858|3654929|FG001|NOT COMPLETED|Overall Study||0
2942370|NCT00650858|3654930|FG002|NOT COMPLETED|Overall Study||0
2942371|NCT00650936|3654938|FG000|STARTED|Overall Study||1000
2942372|NCT00650936|3654938|FG000|COMPLETED|Overall Study||930
2942373|NCT00650936|3654938|FG000|NOT COMPLETED|Overall Study||70
2942374|NCT00651040|3654944|FG000|STARTED|Overall Study||16
2942375|NCT00651040|3654945|FG001|STARTED|Overall Study||15
2942376|NCT00651040|3654944|FG000|COMPLETED|Overall Study||13
2942377|NCT00651040|3654945|FG001|COMPLETED|Overall Study||14
2942378|NCT00651040|3654944|FG000|NOT COMPLETED|Overall Study||3
2942379|NCT00651040|3654945|FG001|NOT COMPLETED|Overall Study||1
2942380|NCT00651118|3654955|FG000|STARTED|Overall Study||207
2942381|NCT00651118|3654956|FG001|STARTED|Overall Study||207
2942382|NCT00651118|3654957|FG002|STARTED|Overall Study||208
2942383|NCT00651118|3654958|FG003|STARTED|Overall Study||210
2942384|NCT00651118|3654955|FG000|COMPLETED|Overall Study||198
2942385|NCT00651118|3654956|FG001|COMPLETED|Overall Study||200
2942386|NCT00651118|3654957|FG002|COMPLETED|Overall Study||197
2942387|NCT00651118|3654958|FG003|COMPLETED|Overall Study||203
2942388|NCT00651118|3654955|FG000|NOT COMPLETED|Overall Study||9
2942389|NCT00651118|3654956|FG001|NOT COMPLETED|Overall Study||7
2942390|NCT00651118|3654957|FG002|NOT COMPLETED|Overall Study||11
2942391|NCT00651118|3654958|FG003|NOT COMPLETED|Overall Study||7
2942392|NCT00651157|3654971|FG000|STARTED|Overall Study||23
2942393|NCT00651157|3654971|FG000|COMPLETED|Overall Study||21
2942394|NCT00651157|3654971|FG000|NOT COMPLETED|Overall Study||2
2942395|NCT00651183|3654977|FG000|STARTED|Overall Study|"For one patient the information was not given, therefore, the patient was listed missing"|189
2942396|NCT00651183|3654978|FG001|STARTED|Overall Study||97
2942397|NCT00651183|3654977|FG000|COMPLETED|Overall Study|Case Report Form (CRF) listed reasons for early termination, of which one was|169
2942398|NCT00651183|3654978|FG001|COMPLETED|Overall Study|"other reasons. No explanation was required to be given by the physicians"|87
2942399|NCT00651183|3654977|FG000|NOT COMPLETED|Overall Study||20
2942400|NCT00651183|3654978|FG001|NOT COMPLETED|Overall Study||10
2942401|NCT00651261|3654986|FG000|STARTED|Overall Study||360
2942402|NCT00651261|3654987|FG001|STARTED|Overall Study||357
2942403|NCT00651261|3654986|FG000|COMPLETED|Overall Study||69
2942404|NCT00651261|3654987|FG001|COMPLETED|Overall Study||51
2942405|NCT00651261|3654986|FG000|NOT COMPLETED|Overall Study||291
2942406|NCT00651261|3654987|FG001|NOT COMPLETED|Overall Study||306
2942407|NCT00651313|3654995|FG000|STARTED|Overall Study||41
2942408|NCT00651313|3654996|FG001|STARTED|Overall Study||43
2942409|NCT00651313|3654995|FG000|COMPLETED|Overall Study||35
2942410|NCT00651313|3654996|FG001|COMPLETED|Overall Study||37
2942411|NCT00651313|3654995|FG000|NOT COMPLETED|Overall Study||6
2942412|NCT00651313|3654996|FG001|NOT COMPLETED|Overall Study||6
2942413|NCT00651482|3655002|FG000|STARTED|Overall Study||10
2942414|NCT00651482|3655002|FG000|COMPLETED|Overall Study||10
2942415|NCT00651482|3655002|FG000|NOT COMPLETED|Overall Study||0
2942416|NCT00651573|3655009|FG000|STARTED|Overall Study||365
2942417|NCT00651573|3655010|FG001|STARTED|Overall Study||357
2942418|NCT00651573|3655009|FG000|COMPLETED|Overall Study||363
2942419|NCT00651573|3655010|FG001|COMPLETED|Overall Study||354
2942420|NCT00651573|3655009|FG000|NOT COMPLETED|Overall Study||2
2942421|NCT00651573|3655010|FG001|NOT COMPLETED|Overall Study||3
2942422|NCT00651625|3655018|FG000|STARTED|Overall Study||219
2942423|NCT00651625|3655019|FG001|STARTED|Overall Study||218
2942424|NCT00651625|3655018|FG000|COMPLETED|Overall Study||219
2942425|NCT00651625|3655019|FG001|COMPLETED|Overall Study||218
2942426|NCT00651625|3655018|FG000|NOT COMPLETED|Overall Study||0
2942427|NCT00651625|3655019|FG001|NOT COMPLETED|Overall Study||0
2942428|NCT00651664|3655035|FG000|STARTED|Overall Study||3
2942429|NCT00651664|3655036|FG001|STARTED|Overall Study||3
2942430|NCT00651664|3655037|FG002|STARTED|Overall Study||3
2942431|NCT00651664|3655038|FG003|STARTED|Overall Study||14
2942432|NCT00651664|3655039|FG004|STARTED|Overall Study||6
2942433|NCT00651664|3655040|FG005|STARTED|Overall Study||3
2942434|NCT00651664|3655041|FG006|STARTED|Overall Study||6
2942435|NCT00651664|3655042|FG007|STARTED|Overall Study||7
2942436|NCT00651664|3655043|FG008|STARTED|Overall Study||7
2942437|NCT00651664|3655044|FG009|STARTED|Overall Study||7
2942438|NCT00651664|3655035|FG000|COMPLETED|Overall Study||0
2942439|NCT00651664|3655036|FG001|COMPLETED|Overall Study||0
2942440|NCT00651664|3655037|FG002|COMPLETED|Overall Study||0
2942441|NCT00651664|3655038|FG003|COMPLETED|Overall Study||0
2942442|NCT00651664|3655039|FG004|COMPLETED|Overall Study||0
2942443|NCT00651664|3655040|FG005|COMPLETED|Overall Study||0
3132401|NCT01691027|3857469|FG000|STARTED|Scotoma Awareness|Four subjects started scotoma awareness training module|4
3132402|NCT01691027|3857469|FG000|COMPLETED|Scotoma Awareness|Four subjects were able to complete scotoma awareness training module|4
3132403|NCT01691027|3857469|FG000|NOT COMPLETED|Scotoma Awareness||0
3132404|NCT01691027|3857469|FG000|STARTED|Line and Circle Tracing Training|Four subjects started line and circle tracing training module|4
3136728|NCT01714726|3861989|FG001|COMPLETED|Double-Blinded Induction Period||52
2942444|NCT00651664|3655041|FG006|COMPLETED|Overall Study||0
2942445|NCT00651664|3655042|FG007|COMPLETED|Overall Study||0
2942446|NCT00651664|3655043|FG008|COMPLETED|Overall Study||0
2942447|NCT00651664|3655044|FG009|COMPLETED|Overall Study||0
2942448|NCT00651664|3655035|FG000|NOT COMPLETED|Overall Study||3
2942449|NCT00651664|3655036|FG001|NOT COMPLETED|Overall Study||3
2942450|NCT00651664|3655037|FG002|NOT COMPLETED|Overall Study||3
2942451|NCT00651664|3655038|FG003|NOT COMPLETED|Overall Study||14
2942452|NCT00651664|3655039|FG004|NOT COMPLETED|Overall Study||6
2942453|NCT00651664|3655040|FG005|NOT COMPLETED|Overall Study||3
2942454|NCT00651664|3655041|FG006|NOT COMPLETED|Overall Study||6
2942455|NCT00651664|3655042|FG007|NOT COMPLETED|Overall Study||7
2942456|NCT00651664|3655043|FG008|NOT COMPLETED|Overall Study||7
2942457|NCT00651664|3655044|FG009|NOT COMPLETED|Overall Study||7
2942458|NCT00651755|3655070|FG000|STARTED|Cycle 1 (First 21 Days)||11
2942459|NCT00651755|3655071|FG001|STARTED|Cycle 1 (First 21 Days)||9
2942460|NCT00651755|3655070|FG000|COMPLETED|Cycle 1 (First 21 Days)||10
2942461|NCT00651755|3655071|FG001|COMPLETED|Cycle 1 (First 21 Days)||9
2942462|NCT00651755|3655070|FG000|NOT COMPLETED|Cycle 1 (First 21 Days)||1
2942463|NCT00651755|3655071|FG001|NOT COMPLETED|Cycle 1 (First 21 Days)||0
2942464|NCT00651755|3655070|FG000|STARTED|Cycle 2 (Second 21 Days)||10
2942465|NCT00651755|3655071|FG001|STARTED|Cycle 2 (Second 21 Days)||9
2942466|NCT00651755|3655070|FG000|COMPLETED|Cycle 2 (Second 21 Days)||10
2942467|NCT00651755|3655071|FG001|COMPLETED|Cycle 2 (Second 21 Days)||8
2942468|NCT00651755|3655070|FG000|NOT COMPLETED|Cycle 2 (Second 21 Days)||0
2942469|NCT00651755|3655071|FG001|NOT COMPLETED|Cycle 2 (Second 21 Days)||1
2942470|NCT00651794|3655081|FG000|STARTED|Overall Study||36
2942471|NCT00651794|3655082|FG001|STARTED|Overall Study||31
3163352|NCT01886235|3890894|FG000|NOT COMPLETED|Overall Study||0
3171758|NCT01936948|3898955|FG002|Crossover|Overall Study||22
3171759|NCT01936948|3898956|FG003|Crossover|Overall Study||25
3171760|NCT01936948|3898953|FG000|COMPLETED|Overall Study||227
3171761|NCT01936948|3898954|FG001|COMPLETED|Overall Study||228
3171762|NCT01936948|3898955|FG002|COMPLETED|Overall Study||234
2942472|NCT00651794|3655083|FG002|STARTED|Overall Study||31
2942473|NCT00651794|3655081|FG000|COMPLETED|Overall Study||15
2942474|NCT00651794|3655082|FG001|COMPLETED|Overall Study||9
3132405|NCT01691027|3857469|FG000|COMPLETED|Line and Circle Tracing Training|Four subjects were able to complete line and circle tracing training module.|4
3132406|NCT01691027|3857469|FG000|NOT COMPLETED|Line and Circle Tracing Training||0
3132407|NCT01691027|3857469|FG000|STARTED|Video Games Training|Four subjects started video game training module|4
3132408|NCT01691027|3857469|FG000|COMPLETED|Video Games Training|Four subjects were able to complete video games training module|4
3132409|NCT01691027|3857469|FG000|NOT COMPLETED|Video Games Training||0
3132410|NCT01691092|3857474|FG000|STARTED|Overall Study||79
2942475|NCT00651794|3655083|FG002|COMPLETED|Overall Study||10
2942476|NCT00651794|3655081|FG000|NOT COMPLETED|Overall Study||21
2942477|NCT00651794|3655082|FG001|NOT COMPLETED|Overall Study||22
2942478|NCT00651794|3655083|FG002|NOT COMPLETED|Overall Study||21
2942479|NCT00651820|3655091|FG000|STARTED|Overall Study||28
2942480|NCT00651820|3655091|FG000|COMPLETED|Overall Study||26
2942481|NCT00651820|3655091|FG000|NOT COMPLETED|Overall Study||2
2942482|NCT00651924|3655099|FG000|STARTED|Overall Study||18
2942483|NCT00651924|3655100|FG001|STARTED|Overall Study||9
2942484|NCT00651924|3655099|FG000|COMPLETED|Overall Study||18
2942485|NCT00651924|3655100|FG001|COMPLETED|Overall Study||2
2942486|NCT00651924|3655099|FG000|NOT COMPLETED|Overall Study||0
2942487|NCT00651924|3655100|FG001|NOT COMPLETED|Overall Study||7
2942488|NCT00651937|3655108|FG000|STARTED|Overall Study||39
2942489|NCT00651937|3655109|FG001|STARTED|Overall Study||41
2942490|NCT00651937|3655108|FG000|COMPLETED|Overall Study||35
2942491|NCT00651937|3655109|FG001|COMPLETED|Overall Study||40
2942492|NCT00651937|3655108|FG000|NOT COMPLETED|Overall Study||4
2942493|NCT00651937|3655109|FG001|NOT COMPLETED|Overall Study||1
2942494|NCT00652028|3655119|FG000|STARTED|Overall Study||16
2942495|NCT00652028|3655120|FG001|STARTED|Overall Study||14
2942496|NCT00652028|3655121|FG002|STARTED|Overall Study||15
2942497|NCT00652028|3655122|FG003|STARTED|Overall Study||14
2942498|NCT00652028|3655119|FG000|COMPLETED|Overall Study||15
2942499|NCT00652028|3655120|FG001|COMPLETED|Overall Study||13
2942500|NCT00652028|3655121|FG002|COMPLETED|Overall Study||14
2942501|NCT00652028|3655122|FG003|COMPLETED|Overall Study||14
2942502|NCT00652028|3655119|FG000|NOT COMPLETED|Overall Study||1
2942503|NCT00652028|3655120|FG001|NOT COMPLETED|Overall Study||1
2942504|NCT00652028|3655121|FG002|NOT COMPLETED|Overall Study||1
2942505|NCT00652028|3655122|FG003|NOT COMPLETED|Overall Study||0
2942506|NCT00652080|3655132|FG000|STARTED|Overall Study||35
2942507|NCT00652080|3655132|FG000|COMPLETED|Overall Study||31
2942508|NCT00652080|3655132|FG000|NOT COMPLETED|Overall Study||4
2942509|NCT00652093|3655144|FG000|STARTED|Overall Study||4
2942510|NCT00652093|3655145|FG001|STARTED|Overall Study||4
2942511|NCT00652093|3655146|FG002|STARTED|Overall Study||4
2942512|NCT00652093|3655147|FG003|STARTED|Overall Study||4
2942513|NCT00652093|3655148|FG004|STARTED|Overall Study||4
2942514|NCT00652093|3655149|FG005|STARTED|Overall Study||4
2942515|NCT00652093|3655144|FG000|COMPLETED|Overall Study||4
2942516|NCT00652093|3655145|FG001|COMPLETED|Overall Study||4
2942517|NCT00652093|3655146|FG002|COMPLETED|Overall Study||3
2942518|NCT00652093|3655147|FG003|COMPLETED|Overall Study||4
2942519|NCT00652093|3655148|FG004|COMPLETED|Overall Study||2
2942520|NCT00652093|3655149|FG005|COMPLETED|Overall Study||4
3132411|NCT01691092|3857474|FG000|COMPLETED|Overall Study||38
3132412|NCT01691092|3857474|FG000|NOT COMPLETED|Overall Study||41
3132413|NCT01691105|3857480|FG000|STARTED|Baseline||477
3132414|NCT01691105|3857481|FG001|STARTED|Baseline||567
3132415|NCT01691105|3857480|FG000|COMPLETED|Baseline||477
3132416|NCT01691105|3857481|FG001|COMPLETED|Baseline||567
3132417|NCT01691105|3857480|FG000|NOT COMPLETED|Baseline||0
3132418|NCT01691105|3857481|FG001|NOT COMPLETED|Baseline||0
2942521|NCT00652093|3655144|FG000|NOT COMPLETED|Overall Study||0
2942522|NCT00652093|3655145|FG001|NOT COMPLETED|Overall Study||0
2942523|NCT00652093|3655146|FG002|NOT COMPLETED|Overall Study||1
2942524|NCT00652093|3655147|FG003|NOT COMPLETED|Overall Study||0
2942525|NCT00652093|3655148|FG004|NOT COMPLETED|Overall Study||2
2942526|NCT00652093|3655149|FG005|NOT COMPLETED|Overall Study||0
2942527|NCT00652145|3655165|FG000|STARTED|Overall Study||26
2942528|NCT00652145|3655166|FG001|STARTED|Overall Study||26
2942529|NCT00652145|3655165|FG000|COMPLETED|Overall Study||26
2942530|NCT00652145|3655166|FG001|COMPLETED|Overall Study||26
2942531|NCT00652145|3655165|FG000|NOT COMPLETED|Overall Study||0
2942532|NCT00652145|3655166|FG001|NOT COMPLETED|Overall Study||0
2942533|NCT00652314|3655176|FG000|STARTED|Overall Study||62
2942534|NCT00652314|3655177|FG001|STARTED|Overall Study||35
2942535|NCT00652314|3655176|FG000|COMPLETED|Overall Study||53
2942536|NCT00652314|3655177|FG001|COMPLETED|Overall Study||26
2942537|NCT00652314|3655176|FG000|NOT COMPLETED|Overall Study||9
3298667|NCT02925741|4032340|FG001|NOT COMPLETED|Overall Study||0
2942538|NCT00652314|3655177|FG001|NOT COMPLETED|Overall Study||9
2942539|NCT00652340|3655185|FG000|STARTED|Overall Study||78
2942540|NCT00652340|3655186|FG001|STARTED|Overall Study||42
2942541|NCT00652340|3655185|FG000|COMPLETED|Overall Study|4 patients remained on study at database lock.|74
2942542|NCT00652340|3655186|FG001|COMPLETED|Overall Study|3 patients remained on study at database lock.|39
2942543|NCT00652340|3655185|FG000|NOT COMPLETED|Overall Study||4
2942544|NCT00652340|3655186|FG001|NOT COMPLETED|Overall Study||3
2942545|NCT00652366|3655197|FG000|STARTED|Overall Study||106
2942546|NCT00652366|3655198|FG001|STARTED|Overall Study||75
2942547|NCT00652366|3655199|FG002|STARTED|Overall Study||71
2942548|NCT00652366|3655200|FG003|STARTED|Overall Study||179
2942549|NCT00652366|3655201|FG004|STARTED|Overall Study||36
2942550|NCT00652366|3655197|FG000|COMPLETED|Overall Study||0
2942551|NCT00652366|3655198|FG001|COMPLETED|Overall Study||0
2942552|NCT00652366|3655199|FG002|COMPLETED|Overall Study||0
2942553|NCT00652366|3655200|FG003|COMPLETED|Overall Study||0
2942554|NCT00652366|3655201|FG004|COMPLETED|Overall Study||0
2942555|NCT00652366|3655197|FG000|NOT COMPLETED|Overall Study||106
2942556|NCT00652366|3655198|FG001|NOT COMPLETED|Overall Study||75
2942557|NCT00652366|3655199|FG002|NOT COMPLETED|Overall Study||71
2942558|NCT00652366|3655200|FG003|NOT COMPLETED|Overall Study||179
2942559|NCT00652366|3655201|FG004|NOT COMPLETED|Overall Study||36
2942560|NCT00652626|3655222|FG000|STARTED|Initial Treatment Phase||5
2942561|NCT00652626|3655223|FG001|STARTED|Initial Treatment Phase||5
2942562|NCT00652626|3655224|FG002|STARTED|Initial Treatment Phase||7
2942563|NCT00652626|3655225|FG003|STARTED|Initial Treatment Phase||6
2942564|NCT00652626|3655226|FG004|STARTED|Initial Treatment Phase||8
2942565|NCT00652626|3655227|FG005|STARTED|Initial Treatment Phase||0
2942566|NCT00652626|3655228|FG006|STARTED|Initial Treatment Phase||0
2942567|NCT00652626|3655222|FG000|Received Study Drug|Initial Treatment Phase||5
2942568|NCT00652626|3655223|FG001|Received Study Drug|Initial Treatment Phase||5
2942569|NCT00652626|3655224|FG002|Received Study Drug|Initial Treatment Phase||6
2942570|NCT00652626|3655225|FG003|Received Study Drug|Initial Treatment Phase||5
2942571|NCT00652626|3655226|FG004|Received Study Drug|Initial Treatment Phase||6
2942572|NCT00652626|3655227|FG005|Received Study Drug|Initial Treatment Phase||0
2942573|NCT00652626|3655228|FG006|Received Study Drug|Initial Treatment Phase||0
2942574|NCT00652626|3655222|FG000|COMPLETED|Initial Treatment Phase||5
2942575|NCT00652626|3655223|FG001|COMPLETED|Initial Treatment Phase||5
2942576|NCT00652626|3655224|FG002|COMPLETED|Initial Treatment Phase||6
2942577|NCT00652626|3655225|FG003|COMPLETED|Initial Treatment Phase||5
2942578|NCT00652626|3655226|FG004|COMPLETED|Initial Treatment Phase||5
2942579|NCT00652626|3655227|FG005|COMPLETED|Initial Treatment Phase||0
2942580|NCT00652626|3655228|FG006|COMPLETED|Initial Treatment Phase||0
2942581|NCT00652626|3655222|FG000|NOT COMPLETED|Initial Treatment Phase||0
2942582|NCT00652626|3655223|FG001|NOT COMPLETED|Initial Treatment Phase||0
2942583|NCT00652626|3655224|FG002|NOT COMPLETED|Initial Treatment Phase||1
2942584|NCT00652626|3655225|FG003|NOT COMPLETED|Initial Treatment Phase||1
2942585|NCT00652626|3655226|FG004|NOT COMPLETED|Initial Treatment Phase||3
2942586|NCT00652626|3655227|FG005|NOT COMPLETED|Initial Treatment Phase||0
2942587|NCT00652626|3655228|FG006|NOT COMPLETED|Initial Treatment Phase||0
2942588|NCT00652626|3655222|FG000|STARTED|Extension Phase||0
2942589|NCT00652626|3655223|FG001|STARTED|Extension Phase||0
2942590|NCT00652626|3655224|FG002|STARTED|Extension Phase||0
2942591|NCT00652626|3655225|FG003|STARTED|Extension Phase||0
2942592|NCT00652626|3655226|FG004|STARTED|Extension Phase||0
2942593|NCT00652626|3655227|FG005|STARTED|Extension Phase||14
2942594|NCT00652626|3655228|FG006|STARTED|Extension Phase||4
2942595|NCT00652626|3655222|FG000|COMPLETED|Extension Phase||0
2942596|NCT00652626|3655223|FG001|COMPLETED|Extension Phase||0
2942597|NCT00652626|3655224|FG002|COMPLETED|Extension Phase||0
2942598|NCT00652626|3655225|FG003|COMPLETED|Extension Phase||0
2942599|NCT00652626|3655226|FG004|COMPLETED|Extension Phase||0
2942600|NCT00652626|3655227|FG005|COMPLETED|Extension Phase|A participant was considered completed if they had completed 6 cycles of therapy.|2
2942601|NCT00652626|3655228|FG006|COMPLETED|Extension Phase|A participant was considered completed if they had completed 6 cycles of therapy.|1
2942602|NCT00652626|3655222|FG000|NOT COMPLETED|Extension Phase||0
2942603|NCT00652626|3655223|FG001|NOT COMPLETED|Extension Phase||0
2942604|NCT00652626|3655224|FG002|NOT COMPLETED|Extension Phase||0
2942605|NCT00652626|3655225|FG003|NOT COMPLETED|Extension Phase||0
2942606|NCT00652626|3655226|FG004|NOT COMPLETED|Extension Phase||0
3298668|NCT02925858|4032351|FG000|STARTED|Overall Study||42
2942607|NCT00652626|3655227|FG005|NOT COMPLETED|Extension Phase||12
2942608|NCT00652626|3655228|FG006|NOT COMPLETED|Extension Phase||3
2942609|NCT00652743|3655249|FG000|STARTED|Months 12-18||219
2942610|NCT00652743|3655250|FG001|STARTED|Months 12-18||188
2942611|NCT00652743|3655251|FG002|STARTED|Months 12-18||437
2942612|NCT00652743|3655249|FG000|COMPLETED|Months 12-18||218
2942613|NCT00652743|3655250|FG001|COMPLETED|Months 12-18||186
2942614|NCT00652743|3655251|FG002|COMPLETED|Months 12-18||430
2942615|NCT00652743|3655249|FG000|NOT COMPLETED|Months 12-18||1
2942616|NCT00652743|3655250|FG001|NOT COMPLETED|Months 12-18||2
2942617|NCT00652743|3655251|FG002|NOT COMPLETED|Months 12-18||7
2942618|NCT00652743|3655249|FG000|STARTED|Months 24-30||212
2942619|NCT00652743|3655250|FG001|STARTED|Months 24-30||186
2942620|NCT00652743|3655251|FG002|STARTED|Months 24-30||433
2942621|NCT00652743|3655249|FG000|COMPLETED|Months 24-30||207
2942622|NCT00652743|3655250|FG001|COMPLETED|Months 24-30||185
2942623|NCT00652743|3655251|FG002|COMPLETED|Months 24-30||422
2942624|NCT00652743|3655249|FG000|NOT COMPLETED|Months 24-30||5
2942625|NCT00652743|3655250|FG001|NOT COMPLETED|Months 24-30||1
2942626|NCT00652743|3655251|FG002|NOT COMPLETED|Months 24-30||11
2942627|NCT00652743|3655249|FG000|STARTED|Months 36-42||216
2942628|NCT00652743|3655250|FG001|STARTED|Months 36-42||185
2942629|NCT00652743|3655251|FG002|STARTED|Months 36-42||390
2942630|NCT00652743|3655249|FG000|COMPLETED|Months 36-42||210
2942631|NCT00652743|3655250|FG001|COMPLETED|Months 36-42||180
2942632|NCT00652743|3655251|FG002|COMPLETED|Months 36-42||381
2942633|NCT00652743|3655249|FG000|NOT COMPLETED|Months 36-42||6
2942634|NCT00652743|3655250|FG001|NOT COMPLETED|Months 36-42||5
2942635|NCT00652743|3655251|FG002|NOT COMPLETED|Months 36-42||9
2942636|NCT00652743|3655249|FG000|STARTED|Months 42-48||196
2942637|NCT00652743|3655250|FG001|STARTED|Months 42-48||170
2942638|NCT00652743|3655251|FG002|STARTED|Months 42-48||367
2942639|NCT00652743|3655249|FG000|COMPLETED|Months 42-48||196
2942640|NCT00652743|3655250|FG001|COMPLETED|Months 42-48||170
2942641|NCT00652743|3655251|FG002|COMPLETED|Months 42-48||367
2942642|NCT00652743|3655249|FG000|NOT COMPLETED|Months 42-48||0
2942643|NCT00652743|3655250|FG001|NOT COMPLETED|Months 42-48||0
2942644|NCT00652743|3655251|FG002|NOT COMPLETED|Months 42-48||0
2942645|NCT00652834|3655262|FG000|STARTED|Overall Study||23
2942646|NCT00652834|3655262|FG000|COMPLETED|Overall Study|3 subjects withdrew after completing baseline questionnaire. 2 did not complete 30-day visit.|18
2942647|NCT00652834|3655262|FG000|NOT COMPLETED|Overall Study||5
2942648|NCT00652899|3655266|FG000|STARTED|Overall Study||14
2942649|NCT00652899|3655266|FG000|COMPLETED|Overall Study||12
2942650|NCT00652899|3655266|FG000|NOT COMPLETED|Overall Study||2
2942651|NCT00652938|3655277|FG000|STARTED|Overall Study||247
2942652|NCT00652938|3655278|FG001|STARTED|Overall Study||247
2942653|NCT00652938|3655279|FG002|STARTED|Overall Study||247
2942654|NCT00652938|3655277|FG000|COMPLETED|Overall Study||246
2942655|NCT00652938|3655278|FG001|COMPLETED|Overall Study||240
2942656|NCT00652938|3655279|FG002|COMPLETED|Overall Study||242
2942657|NCT00652938|3655277|FG000|NOT COMPLETED|Overall Study||1
2942658|NCT00652938|3655278|FG001|NOT COMPLETED|Overall Study||7
2942659|NCT00652938|3655279|FG002|NOT COMPLETED|Overall Study||5
2942660|NCT00652951|3655290|FG000|STARTED|Primary Phase||260
2942661|NCT00652951|3655291|FG001|STARTED|Primary Phase||260
2942662|NCT00652951|3655292|FG002|STARTED|Primary Phase||260
2942663|NCT00652951|3655290|FG000|COMPLETED|Primary Phase||260
2942664|NCT00652951|3655291|FG001|COMPLETED|Primary Phase||260
2942665|NCT00652951|3655292|FG002|COMPLETED|Primary Phase||260
2942666|NCT00652951|3655290|FG000|NOT COMPLETED|Primary Phase||0
2942667|NCT00652951|3655291|FG001|NOT COMPLETED|Primary Phase||0
2942668|NCT00652951|3655292|FG002|NOT COMPLETED|Primary Phase||0
2942669|NCT00652951|3655290|FG000|STARTED|Booster Phase||257
2942670|NCT00652951|3655291|FG001|STARTED|Booster Phase||259
2942671|NCT00652951|3655292|FG002|STARTED|Booster Phase||258
2942672|NCT00652951|3655290|FG000|COMPLETED|Booster Phase||256
2942673|NCT00652951|3655291|FG001|COMPLETED|Booster Phase||258
2942674|NCT00652951|3655292|FG002|COMPLETED|Booster Phase||258
2942675|NCT00652951|3655290|FG000|NOT COMPLETED|Booster Phase||1
2942676|NCT00652951|3655291|FG001|NOT COMPLETED|Booster Phase||1
2942677|NCT00652951|3655292|FG002|NOT COMPLETED|Booster Phase||0
2942678|NCT00653068|3655304|FG000|STARTED|Overall Study||70
2942679|NCT00653068|3655304|FG000|COMPLETED|Overall Study||20
2942680|NCT00653068|3655304|FG000|NOT COMPLETED|Overall Study||50
3034580|NCT01133405|3753626|FG005|Received at Least 1 Dose of Drug|Period 1||4
3034581|NCT01133405|3753627|FG006|Received at Least 1 Dose of Drug|Period 1||4
3034582|NCT01133405|3753628|FG007|Received at Least 1 Dose of Drug|Period 1||2
3034583|NCT01133405|3753629|FG008|Received at Least 1 Dose of Drug|Period 1||4
3034584|NCT01133405|3753630|FG009|Received at Least 1 Dose of Drug|Period 1||2
3034585|NCT01133405|3753621|FG000|COMPLETED|Period 1||2
3034586|NCT01133405|3753622|FG001|COMPLETED|Period 1||3
3034587|NCT01133405|3753623|FG002|COMPLETED|Period 1||4
3034588|NCT01133405|3753624|FG003|COMPLETED|Period 1||1
3034589|NCT01133405|3753625|FG004|COMPLETED|Period 1||3
3034590|NCT01133405|3753626|FG005|COMPLETED|Period 1||3
3034591|NCT01133405|3753627|FG006|COMPLETED|Period 1||4
3034592|NCT01133405|3753628|FG007|COMPLETED|Period 1||2
3034593|NCT01133405|3753629|FG008|COMPLETED|Period 1||4
3034594|NCT01133405|3753630|FG009|COMPLETED|Period 1||2
3034595|NCT01133405|3753621|FG000|NOT COMPLETED|Period 1||1
3034596|NCT01133405|3753622|FG001|NOT COMPLETED|Period 1||3
3034597|NCT01133405|3753623|FG002|NOT COMPLETED|Period 1||1
3034598|NCT01133405|3753624|FG003|NOT COMPLETED|Period 1||4
3034599|NCT01133405|3753625|FG004|NOT COMPLETED|Period 1||0
3034600|NCT01133405|3753626|FG005|NOT COMPLETED|Period 1||2
3034601|NCT01133405|3753627|FG006|NOT COMPLETED|Period 1||1
3034602|NCT01133405|3753628|FG007|NOT COMPLETED|Period 1||0
3034603|NCT01133405|3753629|FG008|NOT COMPLETED|Period 1||0
2942681|NCT00653133|3655313|FG000|STARTED|Overall Study||1324
2942682|NCT00653133|3655314|FG001|STARTED|Overall Study||497
2942683|NCT00653133|3655313|FG000|COMPLETED|Overall Study||1324
2942684|NCT00653133|3655314|FG001|COMPLETED|Overall Study||497
2942685|NCT00653133|3655313|FG000|NOT COMPLETED|Overall Study||0
2942686|NCT00653133|3655314|FG001|NOT COMPLETED|Overall Study||0
2942687|NCT00653159|3655322|FG000|STARTED|Overall Study||11
2942688|NCT00653159|3655323|FG001|STARTED|Overall Study||12
2942689|NCT00653159|3655322|FG000|COMPLETED|Overall Study||6
2942690|NCT00653159|3655323|FG001|COMPLETED|Overall Study||9
2942691|NCT00653159|3655322|FG000|NOT COMPLETED|Overall Study||5
2942692|NCT00653159|3655323|FG001|NOT COMPLETED|Overall Study||3
2942693|NCT00653224|3655331|FG000|STARTED|Overall Study||293
2942694|NCT00653224|3655332|FG001|STARTED|Overall Study||287
2942695|NCT00653224|3655331|FG000|COMPLETED|Overall Study||286
2942696|NCT00653224|3655332|FG001|COMPLETED|Overall Study||280
2942697|NCT00653224|3655331|FG000|NOT COMPLETED|Overall Study||7
2942698|NCT00653224|3655332|FG001|NOT COMPLETED|Overall Study||7
2942699|NCT00653263|3655338|FG000|STARTED|Overall Study|1 dropped out of treatment and the other had untreated hypertension|8
2942700|NCT00653263|3655338|FG000|COMPLETED|Overall Study||6
2942701|NCT00653263|3655338|FG000|NOT COMPLETED|Overall Study||2
2942702|NCT00653328|3655342|FG000|STARTED|Overall Study||15
2942703|NCT00653328|3655342|FG000|COMPLETED|Overall Study||0
2942704|NCT00653328|3655342|FG000|NOT COMPLETED|Overall Study||15
2942705|NCT00653432|3655348|FG000|STARTED|Overall Study||184
2942706|NCT00653432|3655349|FG001|STARTED|Overall Study||185
2942707|NCT00653432|3655348|FG000|Intend-to-treat ITT|Overall Study|3 of 184 excluded from ITT group for not having at least 1 post-injection visit. ITT=181 subjects|181
2942708|NCT00653432|3655349|FG001|Intend-to-treat ITT|Overall Study|1 of 185 excluded from ITT group for not having at least 1 post-injection visit. ITT=184 subjects|184
2942709|NCT00653432|3655348|FG000|COMPLETED|Overall Study||162
2942710|NCT00653432|3655349|FG001|COMPLETED|Overall Study||169
2942711|NCT00653432|3655348|FG000|NOT COMPLETED|Overall Study||22
2942712|NCT00653432|3655349|FG001|NOT COMPLETED|Overall Study||16
2942713|NCT00653861|3655355|FG000|STARTED|Overall Study||72
2942714|NCT00653861|3655355|FG000|COMPLETED|Overall Study||72
2942715|NCT00653861|3655355|FG000|NOT COMPLETED|Overall Study||0
2942716|NCT00653939|3655366|FG000|STARTED|Overall Study|2 patients randomized did not receive treatment due to brain metastasis or consent withdrawal.|31
2942717|NCT00653939|3655367|FG001|STARTED|Overall Study|1 patient randomized did not receive treatment due to acute renal failure.|32
2942718|NCT00653939|3655366|FG000|COMPLETED|Overall Study||19
2942719|NCT00653939|3655367|FG001|COMPLETED|Overall Study||17
2942720|NCT00653939|3655366|FG000|NOT COMPLETED|Overall Study||12
2942721|NCT00653939|3655367|FG001|NOT COMPLETED|Overall Study||15
2942722|NCT00653991|3655377|FG000|STARTED|3 Month Follow-up||444
2942723|NCT00653991|3655378|FG001|STARTED|3 Month Follow-up||491
2942724|NCT00653991|3655377|FG000|COMPLETED|3 Month Follow-up||294
2942725|NCT00653991|3655378|FG001|COMPLETED|3 Month Follow-up||334
2942726|NCT00653991|3655377|FG000|NOT COMPLETED|3 Month Follow-up||150
2942727|NCT00653991|3655378|FG001|NOT COMPLETED|3 Month Follow-up||157
2942728|NCT00653991|3655377|FG000|STARTED|6 Month Follow-up|Completion of 3 month follow-up was not required for 6-month eligibility.|444
2942729|NCT00653991|3655378|FG001|STARTED|6 Month Follow-up|Completion of 3 month follow-up was not required for 6-month eligibility.|491
2942730|NCT00653991|3655377|FG000|COMPLETED|6 Month Follow-up||311
2942731|NCT00653991|3655378|FG001|COMPLETED|6 Month Follow-up||350
2942732|NCT00653991|3655377|FG000|NOT COMPLETED|6 Month Follow-up||133
2942733|NCT00653991|3655378|FG001|NOT COMPLETED|6 Month Follow-up||141
2942734|NCT00654004|3655388|FG000|STARTED|Overall Study||14
2942735|NCT00654004|3655389|FG001|STARTED|Overall Study||12
3163353|NCT01886287|3890898|FG000|STARTED|Overall Study||2
3163354|NCT01886287|3890898|FG000|COMPLETED|Overall Study||0
3163355|NCT01886287|3890898|FG000|NOT COMPLETED|Overall Study||2
3163356|NCT01886300|3890902|FG000|STARTED|Overall Study||16
3163357|NCT01886300|3890902|FG000|COMPLETED|Overall Study||0
2942736|NCT00654004|3655388|FG000|COMPLETED|Overall Study||13
2942737|NCT00654004|3655389|FG001|COMPLETED|Overall Study||12
2942738|NCT00654004|3655388|FG000|NOT COMPLETED|Overall Study||1
2942739|NCT00654004|3655389|FG001|NOT COMPLETED|Overall Study||0
2942740|NCT00654030|3655395|FG000|STARTED|Overall Study||12
2942741|NCT00654030|3655395|FG000|COMPLETED|Overall Study||11
2942742|NCT00654030|3655395|FG000|NOT COMPLETED|Overall Study||1
2942743|NCT00654069|3655402|FG000|STARTED|Overall Study||136
2942744|NCT00654069|3655403|FG001|STARTED|Overall Study||135
2942745|NCT00654069|3655404|FG002|STARTED|Overall Study||134
2942746|NCT00654069|3655402|FG000|COMPLETED|Overall Study||119
2942747|NCT00654069|3655403|FG001|COMPLETED|Overall Study||124
2942748|NCT00654069|3655404|FG002|COMPLETED|Overall Study||116
3163358|NCT01886300|3890902|FG000|NOT COMPLETED|Overall Study||16
2942749|NCT00654069|3655402|FG000|NOT COMPLETED|Overall Study||17
2942750|NCT00654069|3655403|FG001|NOT COMPLETED|Overall Study||11
2942751|NCT00654069|3655404|FG002|NOT COMPLETED|Overall Study||18
2942752|NCT00654147|3655414|FG000|STARTED|Overall Study||21
2942753|NCT00654147|3655415|FG001|STARTED|Overall Study||23
2942754|NCT00654147|3655414|FG000|COMPLETED|Overall Study||19
2942755|NCT00654147|3655415|FG001|COMPLETED|Overall Study||19
2942756|NCT00654147|3655414|FG000|NOT COMPLETED|Overall Study||2
2942757|NCT00654147|3655415|FG001|NOT COMPLETED|Overall Study||4
2942758|NCT00654186|3655421|FG000|STARTED|Overall Study||32
2942759|NCT00654186|3655421|FG000|COMPLETED|Overall Study||27
2942760|NCT00654186|3655421|FG000|NOT COMPLETED|Overall Study||5
2942761|NCT00654238|3655425|FG000|STARTED|Overall Study||59
2942762|NCT00654238|3655425|FG000|COMPLETED|Overall Study||55
2942763|NCT00654238|3655425|FG000|NOT COMPLETED|Overall Study||4
2942764|NCT00654329|3655434|FG000|STARTED|Overall Study||23
2942765|NCT00654329|3655435|FG001|STARTED|Overall Study||28
2942766|NCT00654329|3655436|FG002|STARTED|Overall Study||23
2942767|NCT00654329|3655437|FG003|STARTED|Overall Study||27
2942768|NCT00654329|3655434|FG000|COMPLETED|Overall Study||23
2942769|NCT00654329|3655435|FG001|COMPLETED|Overall Study||28
2942770|NCT00654329|3655436|FG002|COMPLETED|Overall Study||23
2942771|NCT00654329|3655437|FG003|COMPLETED|Overall Study||27
2942772|NCT00654329|3655434|FG000|NOT COMPLETED|Overall Study||0
2942773|NCT00654329|3655435|FG001|NOT COMPLETED|Overall Study||0
2942774|NCT00654329|3655436|FG002|NOT COMPLETED|Overall Study||0
2942775|NCT00654329|3655437|FG003|NOT COMPLETED|Overall Study||0
2942776|NCT00654355|3655449|FG000|STARTED|Overall Study||15
2942777|NCT00654355|3655450|FG001|STARTED|Overall Study||15
2942778|NCT00654355|3655449|FG000|COMPLETED|Overall Study||13
2942779|NCT00654355|3655450|FG001|COMPLETED|Overall Study||13
2942780|NCT00654355|3655449|FG000|NOT COMPLETED|Overall Study||2
2942781|NCT00654355|3655450|FG001|NOT COMPLETED|Overall Study||2
2942782|NCT00654368|3655459|FG000|STARTED|Overall Study||53
2942783|NCT00654368|3655460|FG001|STARTED|Overall Study||98
2942784|NCT00654368|3655461|FG002|STARTED|Overall Study||107
2942785|NCT00654368|3655459|FG000|COMPLETED|Overall Study||0
2942786|NCT00654368|3655460|FG001|COMPLETED|Overall Study||50
2942787|NCT00654368|3655461|FG002|COMPLETED|Overall Study||75
2942788|NCT00654368|3655459|FG000|NOT COMPLETED|Overall Study||53
2942789|NCT00654368|3655460|FG001|NOT COMPLETED|Overall Study||48
2942790|NCT00654368|3655461|FG002|NOT COMPLETED|Overall Study||32
2942791|NCT00654381|3655472|FG000|STARTED|1st Stage||39
2942792|NCT00654381|3655473|FG001|STARTED|1st Stage||41
2942793|NCT00654381|3655474|FG002|STARTED|1st Stage||159
2942794|NCT00654381|3655475|FG003|STARTED|1st Stage||160
2942795|NCT00654381|3655476|FG004|STARTED|1st Stage||81
2942796|NCT00654381|3655477|FG005|STARTED|1st Stage||81
2942797|NCT00654381|3655472|FG000|COMPLETED|1st Stage||36
2942798|NCT00654381|3655473|FG001|COMPLETED|1st Stage||38
2942799|NCT00654381|3655474|FG002|COMPLETED|1st Stage||156
2942800|NCT00654381|3655475|FG003|COMPLETED|1st Stage||155
2942801|NCT00654381|3655476|FG004|COMPLETED|1st Stage||79
2942802|NCT00654381|3655477|FG005|COMPLETED|1st Stage||79
2942803|NCT00654381|3655472|FG000|NOT COMPLETED|1st Stage||3
2942804|NCT00654381|3655473|FG001|NOT COMPLETED|1st Stage||3
2942805|NCT00654381|3655474|FG002|NOT COMPLETED|1st Stage||3
2942806|NCT00654381|3655475|FG003|NOT COMPLETED|1st Stage||5
2942807|NCT00654381|3655476|FG004|NOT COMPLETED|1st Stage||2
2942808|NCT00654381|3655477|FG005|NOT COMPLETED|1st Stage||2
2942809|NCT00654381|3655472|FG000|STARTED|2nd Stage||36
2942810|NCT00654381|3655473|FG001|STARTED|2nd Stage||38
2942811|NCT00654381|3655474|FG002|STARTED|2nd Stage||156
2942812|NCT00654381|3655475|FG003|STARTED|2nd Stage||155
2942813|NCT00654381|3655476|FG004|STARTED|2nd Stage||79
2942814|NCT00654381|3655477|FG005|STARTED|2nd Stage||79
2942815|NCT00654381|3655472|FG000|COMPLETED|2nd Stage||34
2942816|NCT00654381|3655473|FG001|COMPLETED|2nd Stage||38
2942817|NCT00654381|3655474|FG002|COMPLETED|2nd Stage||153
3163359|NCT01886313|3890908|FG000|STARTED|Overall Study||6
3163360|NCT01886313|3890909|FG001|STARTED|Overall Study||5
3163361|NCT01886313|3890908|FG000|COMPLETED|Overall Study||5
3163362|NCT01886313|3890909|FG001|COMPLETED|Overall Study||4
3163363|NCT01886313|3890908|FG000|NOT COMPLETED|Overall Study||1
3163364|NCT01886313|3890909|FG001|NOT COMPLETED|Overall Study||1
3163365|NCT01886378|3890915|FG000|STARTED|Overall Study||29
3163366|NCT01886378|3890915|FG000|Completed 24 Weeks of UX007 Treatment|Overall Study||25
3163367|NCT01886378|3890915|FG000|COMPLETED|Overall Study||24
3163368|NCT01886378|3890915|FG000|NOT COMPLETED|Overall Study||5
3163369|NCT01886690|3890921|FG000|STARTED|Overall Study||75
3298669|NCT02925858|4032352|FG001|STARTED|Overall Study||38
3298670|NCT02925858|4032351|FG000|COMPLETED|Overall Study||42
3298671|NCT02925858|4032352|FG001|COMPLETED|Overall Study||38
2942818|NCT00654381|3655475|FG003|COMPLETED|2nd Stage||151
3298672|NCT02925858|4032351|FG000|NOT COMPLETED|Overall Study||0
3298673|NCT02925858|4032352|FG001|NOT COMPLETED|Overall Study||0
2942819|NCT00654381|3655476|FG004|COMPLETED|2nd Stage||71
2942820|NCT00654381|3655477|FG005|COMPLETED|2nd Stage||76
2942821|NCT00654381|3655472|FG000|NOT COMPLETED|2nd Stage||2
2942822|NCT00654381|3655473|FG001|NOT COMPLETED|2nd Stage||0
2942823|NCT00654381|3655474|FG002|NOT COMPLETED|2nd Stage||3
2942824|NCT00654381|3655475|FG003|NOT COMPLETED|2nd Stage||4
2942825|NCT00654381|3655476|FG004|NOT COMPLETED|2nd Stage||8
2942826|NCT00654381|3655477|FG005|NOT COMPLETED|2nd Stage||3
2942827|NCT00654381|3655472|FG000|STARTED|Extension Stage||34
2942828|NCT00654381|3655473|FG001|STARTED|Extension Stage||38
2942829|NCT00654381|3655474|FG002|STARTED|Extension Stage||153
2942830|NCT00654381|3655475|FG003|STARTED|Extension Stage||151
2942831|NCT00654381|3655476|FG004|STARTED|Extension Stage||71
2942832|NCT00654381|3655477|FG005|STARTED|Extension Stage||76
2942833|NCT00654381|3655472|FG000|COMPLETED|Extension Stage||33
2942834|NCT00654381|3655473|FG001|COMPLETED|Extension Stage||36
2942835|NCT00654381|3655474|FG002|COMPLETED|Extension Stage||142
2942836|NCT00654381|3655475|FG003|COMPLETED|Extension Stage||142
2942837|NCT00654381|3655476|FG004|COMPLETED|Extension Stage||68
3163370|NCT01886690|3890922|FG001|STARTED|Overall Study||73
3163371|NCT01886690|3890921|FG000|COMPLETED|Overall Study||75
3163372|NCT01886690|3890922|FG001|COMPLETED|Overall Study||71
2942838|NCT00654381|3655477|FG005|COMPLETED|Extension Stage||73
2942839|NCT00654381|3655472|FG000|NOT COMPLETED|Extension Stage||1
2942840|NCT00654381|3655473|FG001|NOT COMPLETED|Extension Stage||2
2942841|NCT00654381|3655474|FG002|NOT COMPLETED|Extension Stage||11
2942842|NCT00654381|3655475|FG003|NOT COMPLETED|Extension Stage||9
2942843|NCT00654381|3655476|FG004|NOT COMPLETED|Extension Stage||3
2942844|NCT00654381|3655477|FG005|NOT COMPLETED|Extension Stage||3
2942845|NCT00654420|3655498|FG000|STARTED|Phase I (Dose Escalation)||4
2942846|NCT00654420|3655499|FG001|STARTED|Phase I (Dose Escalation)||16
2942847|NCT00654420|3655500|FG002|STARTED|Phase I (Dose Escalation)||0
2942848|NCT00654420|3655501|FG003|STARTED|Phase I (Dose Escalation)||0
2942849|NCT00654420|3655498|FG000|COMPLETED|Phase I (Dose Escalation)||0
2942850|NCT00654420|3655499|FG001|COMPLETED|Phase I (Dose Escalation)||0
2942851|NCT00654420|3655500|FG002|COMPLETED|Phase I (Dose Escalation)||0
2942852|NCT00654420|3655501|FG003|COMPLETED|Phase I (Dose Escalation)||0
2942853|NCT00654420|3655498|FG000|NOT COMPLETED|Phase I (Dose Escalation)||4
2942854|NCT00654420|3655499|FG001|NOT COMPLETED|Phase I (Dose Escalation)||16
2942855|NCT00654420|3655500|FG002|NOT COMPLETED|Phase I (Dose Escalation)||0
2942856|NCT00654420|3655501|FG003|NOT COMPLETED|Phase I (Dose Escalation)||0
2942857|NCT00654420|3655498|FG000|STARTED|Phase II||0
2942858|NCT00654420|3655499|FG001|STARTED|Phase II||0
2942859|NCT00654420|3655500|FG002|STARTED|Phase II|New participants were enrolled in the Phase II part of the study that did not participate in Phase 1|37
2942860|NCT00654420|3655501|FG003|STARTED|Phase II|New participants were enrolled in the Phase II part of the study that did not participate in Phase 1|38
2942861|NCT00654420|3655498|FG000|COMPLETED|Phase II||0
2942862|NCT00654420|3655499|FG001|COMPLETED|Phase II||0
2942863|NCT00654420|3655500|FG002|COMPLETED|Phase II||0
2942864|NCT00654420|3655501|FG003|COMPLETED|Phase II||0
2942865|NCT00654420|3655498|FG000|NOT COMPLETED|Phase II||0
2942866|NCT00654420|3655499|FG001|NOT COMPLETED|Phase II||0
2942867|NCT00654420|3655500|FG002|NOT COMPLETED|Phase II||37
2942868|NCT00654420|3655501|FG003|NOT COMPLETED|Phase II||38
2942869|NCT00654498|3655513|FG000|STARTED|Overall Study||203
2942870|NCT00654498|3655514|FG001|STARTED|Overall Study||103
2942871|NCT00654498|3655513|FG000|COMPLETED|Overall Study||189
2942872|NCT00654498|3655514|FG001|COMPLETED|Overall Study||91
2942873|NCT00654498|3655513|FG000|NOT COMPLETED|Overall Study||14
2942874|NCT00654498|3655514|FG001|NOT COMPLETED|Overall Study||12
2942875|NCT00654511|3655524|FG000|STARTED|Overall Study||26
2942876|NCT00654511|3655525|FG001|STARTED|Overall Study||25
2942877|NCT00654511|3655526|FG002|STARTED|Overall Study||25
2942878|NCT00654511|3655527|FG003|STARTED|Overall Study||25
2942879|NCT00654511|3655524|FG000|COMPLETED|Overall Study||26
2942880|NCT00654511|3655525|FG001|COMPLETED|Overall Study||25
2942881|NCT00654511|3655526|FG002|COMPLETED|Overall Study||25
2942882|NCT00654511|3655527|FG003|COMPLETED|Overall Study||25
2942883|NCT00654511|3655524|FG000|NOT COMPLETED|Overall Study||0
2942884|NCT00654511|3655525|FG001|NOT COMPLETED|Overall Study||0
2942885|NCT00654511|3655526|FG002|NOT COMPLETED|Overall Study||0
2942886|NCT00654511|3655527|FG003|NOT COMPLETED|Overall Study||0
2942887|NCT00654615|3655543|FG000|STARTED|Overall Study||30
2942888|NCT00654615|3655544|FG001|STARTED|Overall Study||30
2942889|NCT00654615|3655543|FG000|COMPLETED|Overall Study||22
2942890|NCT00654615|3655544|FG001|COMPLETED|Overall Study||23
2942891|NCT00654615|3655543|FG000|NOT COMPLETED|Overall Study||8
2942892|NCT00654615|3655544|FG001|NOT COMPLETED|Overall Study||7
2942893|NCT00654641|3655552|FG000|STARTED|Overall Study||28
2942894|NCT00654641|3655553|FG001|STARTED|Overall Study||26
2942895|NCT00654641|3655552|FG000|COMPLETED|Overall Study||26
2942896|NCT00654641|3655553|FG001|COMPLETED|Overall Study||23
2942897|NCT00654641|3655552|FG000|NOT COMPLETED|Overall Study||2
2942898|NCT00654641|3655553|FG001|NOT COMPLETED|Overall Study||3
2942899|NCT00654654|3655559|FG000|STARTED|Overall Study||50
2942900|NCT00654654|3655559|FG000|COMPLETED|Overall Study||43
2942901|NCT00654654|3655559|FG000|NOT COMPLETED|Overall Study||7
2942902|NCT00654732|3655565|FG000|STARTED|Overall Study||26
2942903|NCT00654732|3655566|FG001|STARTED|Overall Study||32
2942904|NCT00654732|3655565|FG000|COMPLETED|Overall Study||22
2942905|NCT00654732|3655566|FG001|COMPLETED|Overall Study||26
2942906|NCT00654732|3655565|FG000|NOT COMPLETED|Overall Study||4
2942907|NCT00654732|3655566|FG001|NOT COMPLETED|Overall Study||6
2942908|NCT00654745|3655572|FG000|STARTED|Overall Study|This is single group study in which subjects were titrated to the next of 7 arms if BP goal not met.|207
2942909|NCT00654745|3655572|FG000|COMPLETED|Overall Study||164
2942910|NCT00654745|3655572|FG000|NOT COMPLETED|Overall Study||43
2942911|NCT00654784|3655584|FG000|STARTED|Overall Study||13
2942912|NCT00654784|3655585|FG001|STARTED|Overall Study||8
2942913|NCT00654784|3655584|FG000|COMPLETED|Overall Study||13
2942914|NCT00654784|3655585|FG001|COMPLETED|Overall Study||8
2942915|NCT00654784|3655584|FG000|NOT COMPLETED|Overall Study||0
2942916|NCT00654784|3655585|FG001|NOT COMPLETED|Overall Study||0
2942917|NCT00654836|3655591|FG000|STARTED|Overall Study||32
2942918|NCT00654836|3655591|FG000|COMPLETED|Overall Study||32
2942919|NCT00654836|3655591|FG000|NOT COMPLETED|Overall Study||0
2942920|NCT00654875|3655597|FG000|STARTED|Overall Study||164
2942921|NCT00654875|3655598|FG001|STARTED|Overall Study||164
2942922|NCT00654875|3655597|FG000|COMPLETED|Overall Study||147
2942923|NCT00654875|3655598|FG001|COMPLETED|Overall Study||147
2942924|NCT00654875|3655597|FG000|NOT COMPLETED|Overall Study||17
2942925|NCT00654875|3655598|FG001|NOT COMPLETED|Overall Study||17
2942926|NCT00654901|3655608|FG000|STARTED|Overall Study||254
2942927|NCT00654901|3655609|FG001|STARTED|Overall Study||262
2942928|NCT00654901|3655610|FG002|STARTED|Overall Study||252
2942929|NCT00654901|3655611|FG003|STARTED|Overall Study||113
2942930|NCT00654901|3655608|FG000|COMPLETED|Overall Study||250
2942931|NCT00654901|3655609|FG001|COMPLETED|Overall Study||262
2942932|NCT00654901|3655610|FG002|COMPLETED|Overall Study||250
2942933|NCT00654901|3655611|FG003|COMPLETED|Overall Study||113
2942934|NCT00654901|3655608|FG000|NOT COMPLETED|Overall Study||4
2942935|NCT00654901|3655609|FG001|NOT COMPLETED|Overall Study||0
2942936|NCT00654901|3655610|FG002|NOT COMPLETED|Overall Study||2
2942937|NCT00654901|3655611|FG003|NOT COMPLETED|Overall Study||0
2942938|NCT00654927|3655621|FG000|STARTED|Overall Study||177
2942939|NCT00654927|3655621|FG000|COMPLETED|Overall Study||70
2942940|NCT00654927|3655621|FG000|NOT COMPLETED|Overall Study||107
2942941|NCT00654940|3655627|FG000|STARTED|Period 1|Assigned to study treatment.|13
2942942|NCT00654940|3655628|FG001|STARTED|Period 1|Assigned to study treatment.|12
2942943|NCT00654940|3655627|FG000|Received Study Treatment|Period 1||12
2942944|NCT00654940|3655628|FG001|Received Study Treatment|Period 1||12
2942945|NCT00654940|3655627|FG000|COMPLETED|Period 1||12
2942946|NCT00654940|3655628|FG001|COMPLETED|Period 1||11
2942947|NCT00654940|3655627|FG000|NOT COMPLETED|Period 1||1
2942948|NCT00654940|3655628|FG001|NOT COMPLETED|Period 1||1
2942949|NCT00654940|3655627|FG000|STARTED|Washout Period of 2 Weeks||12
2942950|NCT00654940|3655628|FG001|STARTED|Washout Period of 2 Weeks||11
2942951|NCT00654940|3655627|FG000|COMPLETED|Washout Period of 2 Weeks||12
2942952|NCT00654940|3655628|FG001|COMPLETED|Washout Period of 2 Weeks||11
2942953|NCT00654940|3655627|FG000|NOT COMPLETED|Washout Period of 2 Weeks||0
2942954|NCT00654940|3655628|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0
2942955|NCT00654940|3655627|FG000|STARTED|Period 2||12
2942956|NCT00654940|3655628|FG001|STARTED|Period 2||11
2942957|NCT00654940|3655627|FG000|COMPLETED|Period 2||12
2942958|NCT00654940|3655628|FG001|COMPLETED|Period 2||11
2942959|NCT00654940|3655627|FG000|NOT COMPLETED|Period 2||0
2942960|NCT00654940|3655628|FG001|NOT COMPLETED|Period 2||0
2942961|NCT00654953|3655643|FG000|STARTED|Overall Study||36
2942962|NCT00654953|3655644|FG001|STARTED|Overall Study||36
2942963|NCT00654953|3655645|FG002|STARTED|Overall Study||30
2942964|NCT00654953|3655643|FG000|COMPLETED|Overall Study||6
2942965|NCT00654953|3655644|FG001|COMPLETED|Overall Study||8
2942966|NCT00654953|3655645|FG002|COMPLETED|Overall Study||8
2942967|NCT00654953|3655643|FG000|NOT COMPLETED|Overall Study||30
2942968|NCT00654953|3655644|FG001|NOT COMPLETED|Overall Study||28
2942969|NCT00654953|3655645|FG002|NOT COMPLETED|Overall Study||22
2942970|NCT00655083|3655655|FG000|STARTED|Overall Study||12
2942971|NCT00655083|3655656|FG001|STARTED|Overall Study||8
2942972|NCT00655083|3655655|FG000|COMPLETED|Overall Study||12
2942973|NCT00655083|3655656|FG001|COMPLETED|Overall Study||8
2942974|NCT00655083|3655655|FG000|NOT COMPLETED|Overall Study||0
2942975|NCT00655083|3655656|FG001|NOT COMPLETED|Overall Study||0
2942976|NCT00655356|3655664|FG000|STARTED|Overall Study||110
2942977|NCT00655356|3655665|FG001|STARTED|Overall Study||108
2942978|NCT00655356|3655664|FG000|COMPLETED|Overall Study||93
2942979|NCT00655356|3655665|FG001|COMPLETED|Overall Study||98
2942980|NCT00655356|3655664|FG000|NOT COMPLETED|Overall Study||17
2942981|NCT00655356|3655665|FG001|NOT COMPLETED|Overall Study||10
2942982|NCT00655473|3655673|FG000|STARTED|Overall Study||64
2942983|NCT00655473|3655674|FG001|STARTED|Overall Study||66
2942984|NCT00655473|3655673|FG000|COMPLETED|Overall Study||53
2942985|NCT00655473|3655674|FG001|COMPLETED|Overall Study||51
2942986|NCT00655473|3655673|FG000|NOT COMPLETED|Overall Study||11
2942987|NCT00655473|3655674|FG001|NOT COMPLETED|Overall Study||15
2942988|NCT00655486|3655680|FG000|STARTED|Overall Study||97
2942989|NCT00655486|3655680|FG000|COMPLETED|Overall Study||69
2942990|NCT00655486|3655680|FG000|NOT COMPLETED|Overall Study||28
2942991|NCT00655499|3655684|FG000|STARTED|Overall Study||69
2942992|NCT00655499|3655684|FG000|COMPLETED|Overall Study||65
2942993|NCT00655499|3655684|FG000|NOT COMPLETED|Overall Study||4
2942994|NCT00655538|3655691|FG000|STARTED|Overall Study||238
2942995|NCT00655538|3655692|FG001|STARTED|Overall Study||238
2942996|NCT00655538|3655691|FG000|COMPLETED|Overall Study||214
2942997|NCT00655538|3655692|FG001|COMPLETED|Overall Study||211
2942998|NCT00655538|3655691|FG000|NOT COMPLETED|Overall Study||24
2942999|NCT00655538|3655692|FG001|NOT COMPLETED|Overall Study||27
2943000|NCT00655551|3655701|FG000|STARTED|All Periods Combined||25
2943001|NCT00655551|3655702|FG001|STARTED|All Periods Combined||50
2943002|NCT00655551|3655703|FG002|STARTED|All Periods Combined||25
2943003|NCT00655551|3655701|FG000|COMPLETED|All Periods Combined||25
2943004|NCT00655551|3655702|FG001|COMPLETED|All Periods Combined||47
2943005|NCT00655551|3655703|FG002|COMPLETED|All Periods Combined||21
2943006|NCT00655551|3655701|FG000|NOT COMPLETED|All Periods Combined||0
2943007|NCT00655551|3655702|FG001|NOT COMPLETED|All Periods Combined||3
2943008|NCT00655551|3655703|FG002|NOT COMPLETED|All Periods Combined||4
2943009|NCT00655551|3655701|FG000|STARTED|Period 1 (up to 7 Days)||25
2943010|NCT00655551|3655702|FG001|STARTED|Period 1 (up to 7 Days)||0
2943011|NCT00655551|3655703|FG002|STARTED|Period 1 (up to 7 Days)||0
2943012|NCT00655551|3655701|FG000|COMPLETED|Period 1 (up to 7 Days)||25
2943013|NCT00655551|3655702|FG001|COMPLETED|Period 1 (up to 7 Days)||0
2943014|NCT00655551|3655703|FG002|COMPLETED|Period 1 (up to 7 Days)||0
2943015|NCT00655551|3655701|FG000|NOT COMPLETED|Period 1 (up to 7 Days)||0
2943016|NCT00655551|3655702|FG001|NOT COMPLETED|Period 1 (up to 7 Days)||0
2943017|NCT00655551|3655703|FG002|NOT COMPLETED|Period 1 (up to 7 Days)||0
2943018|NCT00655551|3655701|FG000|STARTED|Period 2 (up to 7 Days)||0
2943019|NCT00655551|3655702|FG001|STARTED|Period 2 (up to 7 Days)||25
2943020|NCT00655551|3655703|FG002|STARTED|Period 2 (up to 7 Days)||0
2943021|NCT00655551|3655701|FG000|COMPLETED|Period 2 (up to 7 Days)||0
2943022|NCT00655551|3655702|FG001|COMPLETED|Period 2 (up to 7 Days)||24
2943023|NCT00655551|3655703|FG002|COMPLETED|Period 2 (up to 7 Days)||0
2943024|NCT00655551|3655701|FG000|NOT COMPLETED|Period 2 (up to 7 Days)||0
2943025|NCT00655551|3655702|FG001|NOT COMPLETED|Period 2 (up to 7 Days)||1
2943026|NCT00655551|3655703|FG002|NOT COMPLETED|Period 2 (up to 7 Days)||0
2943027|NCT00655551|3655701|FG000|STARTED|Period 3 (up to 7 Days)||0
2943028|NCT00655551|3655702|FG001|STARTED|Period 3 (up to 7 Days)||0
2943029|NCT00655551|3655703|FG002|STARTED|Period 3 (up to 7 Days)||25
2943030|NCT00655551|3655701|FG000|COMPLETED|Period 3 (up to 7 Days)||0
2943031|NCT00655551|3655702|FG001|COMPLETED|Period 3 (up to 7 Days)||0
2943032|NCT00655551|3655703|FG002|COMPLETED|Period 3 (up to 7 Days)||21
2943033|NCT00655551|3655701|FG000|NOT COMPLETED|Period 3 (up to 7 Days)||0
2943034|NCT00655551|3655702|FG001|NOT COMPLETED|Period 3 (up to 7 Days)||0
2943035|NCT00655551|3655703|FG002|NOT COMPLETED|Period 3 (up to 7 Days)||4
2943036|NCT00655551|3655701|FG000|STARTED|Period 4 (up to 7 Days)||0
2943037|NCT00655551|3655702|FG001|STARTED|Period 4 (up to 7 Days)||25
2943038|NCT00655551|3655703|FG002|STARTED|Period 4 (up to 7 Days)||0
2943039|NCT00655551|3655701|FG000|COMPLETED|Period 4 (up to 7 Days)||0
2943040|NCT00655551|3655702|FG001|COMPLETED|Period 4 (up to 7 Days)||23
2943041|NCT00655551|3655703|FG002|COMPLETED|Period 4 (up to 7 Days)||0
2943042|NCT00655551|3655701|FG000|NOT COMPLETED|Period 4 (up to 7 Days)||0
2943043|NCT00655551|3655702|FG001|NOT COMPLETED|Period 4 (up to 7 Days)||2
2943044|NCT00655551|3655703|FG002|NOT COMPLETED|Period 4 (up to 7 Days)||0
2943045|NCT00655564|3655711|FG000|STARTED|Overall Study||15
2943046|NCT00655564|3655711|FG000|COMPLETED|Overall Study||12
2943047|NCT00655564|3655711|FG000|NOT COMPLETED|Overall Study||3
2943048|NCT00655629|3655718|FG000|STARTED|Overall Study||172
2943049|NCT00655629|3655719|FG001|STARTED|Overall Study||167
2943050|NCT00655629|3655718|FG000|Participants Received Treatment|Overall Study|1 patient could not verify drug ingestion. (safety population)|171
2943051|NCT00655629|3655719|FG001|Participants Received Treatment|Overall Study|1 patient could not verify drug ingestion.(safety population)|166
2943052|NCT00655629|3655718|FG000|COMPLETED|Overall Study||151
2943053|NCT00655629|3655719|FG001|COMPLETED|Overall Study||144
2943054|NCT00655629|3655718|FG000|NOT COMPLETED|Overall Study||21
2943055|NCT00655629|3655719|FG001|NOT COMPLETED|Overall Study||23
2943056|NCT00655642|3655729|FG000|STARTED|Overall Study||42
2943057|NCT00655642|3655730|FG001|STARTED|Overall Study||43
2943058|NCT00655642|3655731|FG002|STARTED|Overall Study||45
2943059|NCT00655642|3655732|FG003|STARTED|Overall Study||41
2943060|NCT00655642|3655729|FG000|COMPLETED|Overall Study|1 patient withdrawn by treating physician after consent|41
2943061|NCT00655642|3655730|FG001|COMPLETED|Overall Study|1 patient given drug orally rather than intravenous(iv);1 patient refused iv; 1 pt lost to follow-up|40
2943062|NCT00655642|3655731|FG002|COMPLETED|Overall Study|1 patient left the ED prior to receiving drug; 1 patient's nausea resolved prior to receiving drug|43
2943063|NCT00655642|3655732|FG003|COMPLETED|Overall Study|1 patient's initial Visual analog scale (VAS)<40; 1 patient was withdrawn by treating physician|39
2943064|NCT00655642|3655729|FG000|NOT COMPLETED|Overall Study||1
2943065|NCT00655642|3655730|FG001|NOT COMPLETED|Overall Study||3
2943066|NCT00655642|3655731|FG002|NOT COMPLETED|Overall Study||2
2943067|NCT00655642|3655732|FG003|NOT COMPLETED|Overall Study||2
2943068|NCT00655668|3655742|FG000|STARTED|Overall Study|Planned enrollment: 80 participants|54
2943069|NCT00655668|3655742|FG000|COMPLETED|Overall Study|Participants dosed up to 24 months, disease progression or unacceptable adverse events developed.|0
2943070|NCT00655668|3655742|FG000|NOT COMPLETED|Overall Study||54
2943071|NCT00655707|3655746|FG000|STARTED|Overall Study||5
2943072|NCT00655707|3655746|FG000|COMPLETED|Overall Study||5
2943073|NCT00655707|3655746|FG000|NOT COMPLETED|Overall Study||0
2943074|NCT00655733|3655753|FG000|STARTED|Overall Study||51
2943075|NCT00655733|3655754|FG001|STARTED|Overall Study||50
2943076|NCT00655733|3655753|FG000|COMPLETED|Overall Study||44
2943077|NCT00655733|3655754|FG001|COMPLETED|Overall Study||42
2943078|NCT00655733|3655753|FG000|NOT COMPLETED|Overall Study||7
2943079|NCT00655733|3655754|FG001|NOT COMPLETED|Overall Study||8
2943080|NCT00655746|3655762|FG000|STARTED|Overall Study||14
2943081|NCT00655746|3655762|FG000|COMPLETED|Overall Study||13
2943082|NCT00655746|3655762|FG000|NOT COMPLETED|Overall Study||1
2943083|NCT00655811|3655770|FG000|STARTED|Overall Study||40
2943084|NCT00655811|3655770|FG000|COMPLETED|Overall Study||40
2943085|NCT00655811|3655770|FG000|NOT COMPLETED|Overall Study||0
2943086|NCT00655850|3655780|FG000|STARTED|Overall Study||39
2943087|NCT00655850|3655780|FG000|COMPLETED|Overall Study||36
2943088|NCT00655850|3655780|FG000|NOT COMPLETED|Overall Study||3
2943089|NCT00655863|3655789|FG000|STARTED|Overall Study||24
2943090|NCT00655863|3655790|FG001|STARTED|Overall Study||25
2943091|NCT00655863|3655791|FG002|STARTED|Overall Study||22
2943092|NCT00655863|3655789|FG000|COMPLETED|Overall Study||24
2943093|NCT00655863|3655790|FG001|COMPLETED|Overall Study||25
2943094|NCT00655863|3655791|FG002|COMPLETED|Overall Study||21
2943095|NCT00655863|3655789|FG000|NOT COMPLETED|Overall Study||0
2943096|NCT00655863|3655790|FG001|NOT COMPLETED|Overall Study||0
2943097|NCT00655863|3655791|FG002|NOT COMPLETED|Overall Study||1
2943098|NCT00655876|3655801|FG000|STARTED|Overall Study||168
2943099|NCT00655876|3655802|FG001|STARTED|Overall Study||176
3034604|NCT01133405|3753630|FG009|NOT COMPLETED|Period 1||0
2943100|NCT00655876|3655801|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|159
2943101|NCT00655876|3655802|FG001|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|169
2943102|NCT00655876|3655801|FG000|NOT COMPLETED|Overall Study||9
3298674|NCT02925923|4032360|FG000|STARTED|Overall Study||50
3298675|NCT02925923|4032361|FG001|STARTED|Overall Study||50
3298676|NCT02925923|4032360|FG000|COMPLETED|Overall Study||50
3298677|NCT02925923|4032361|FG001|COMPLETED|Overall Study||48
3298678|NCT02925923|4032360|FG000|NOT COMPLETED|Overall Study||0
3298679|NCT02925923|4032361|FG001|NOT COMPLETED|Overall Study||2
3298680|NCT02926027|4032369|FG000|STARTED|Overall Study||40
3298681|NCT02926027|4032370|FG001|STARTED|Overall Study||40
3298682|NCT02926027|4032369|FG000|COMPLETED|Overall Study||31
3298683|NCT02926027|4032370|FG001|COMPLETED|Overall Study||37
3298684|NCT02926027|4032369|FG000|NOT COMPLETED|Overall Study||9
3298685|NCT02926027|4032370|FG001|NOT COMPLETED|Overall Study||3
3298686|NCT02926209|4032376|FG000|STARTED|Study Cohort|Training cohort patients Aer-O-Scope as first followed by a conventional colonoscopy|42
3298687|NCT02926209|4032377|FG001|STARTED|Study Cohort||37
3298688|NCT02926209|4032376|FG000|COMPLETED|Study Cohort||41
3298689|NCT02926209|4032377|FG001|COMPLETED|Study Cohort||37
3298690|NCT02926209|4032376|FG000|NOT COMPLETED|Study Cohort||1
3298691|NCT02926209|4032377|FG001|NOT COMPLETED|Study Cohort||0
3298692|NCT02926209|4032376|FG000|STARTED|Training Cohort - First Patients||20
3298693|NCT02926209|4032377|FG001|STARTED|Training Cohort - First Patients||0
3298694|NCT02926209|4032376|FG000|COMPLETED|Training Cohort - First Patients||20
3132419|NCT01691105|3857480|FG000|STARTED|1 Month Follow-up||477
3132420|NCT01691105|3857481|FG001|STARTED|1 Month Follow-up||567
3132421|NCT01691105|3857480|FG000|COMPLETED|1 Month Follow-up||434
3132422|NCT01691105|3857481|FG001|COMPLETED|1 Month Follow-up||526
3298695|NCT02926209|4032377|FG001|COMPLETED|Training Cohort - First Patients||0
3298696|NCT02926209|4032376|FG000|NOT COMPLETED|Training Cohort - First Patients||0
3298697|NCT02926209|4032377|FG001|NOT COMPLETED|Training Cohort - First Patients||0
3298698|NCT02926573|4032386|FG000|STARTED|Overall Study||55
3298699|NCT02926573|4032387|FG001|STARTED|Overall Study||55
3298700|NCT02926573|4032386|FG000|COMPLETED|Overall Study||44
3298701|NCT02926573|4032387|FG001|COMPLETED|Overall Study||46
3298702|NCT02926573|4032386|FG000|NOT COMPLETED|Overall Study||11
3298703|NCT02926573|4032387|FG001|NOT COMPLETED|Overall Study||9
3298704|NCT02926677|4032396|FG000|STARTED|Overall Study||25
3298705|NCT02926677|4032397|FG001|STARTED|Overall Study||22
3298706|NCT02926677|4032398|FG002|STARTED|Overall Study||26
3298707|NCT02926677|4032396|FG000|COMPLETED|Overall Study||8
3298708|NCT02926677|4032397|FG001|COMPLETED|Overall Study||8
3298709|NCT02926677|4032398|FG002|COMPLETED|Overall Study||6
3298710|NCT02926677|4032396|FG000|NOT COMPLETED|Overall Study||17
3298711|NCT02926677|4032397|FG001|NOT COMPLETED|Overall Study||14
2943103|NCT00655876|3655802|FG001|NOT COMPLETED|Overall Study||7
2943104|NCT00655889|3655808|FG000|STARTED|Overall Study||13
2943105|NCT00655889|3655808|FG000|COMPLETED|Overall Study||11
2943106|NCT00655889|3655808|FG000|NOT COMPLETED|Overall Study||2
2943107|NCT00655928|3655814|FG000|STARTED|Overall Study||26
2943108|NCT00655928|3655815|FG001|STARTED|Overall Study||26
2943109|NCT00655928|3655814|FG000|COMPLETED|Overall Study||23
2943110|NCT00655928|3655815|FG001|COMPLETED|Overall Study||24
2943111|NCT00655928|3655814|FG000|NOT COMPLETED|Overall Study||3
2943112|NCT00655928|3655815|FG001|NOT COMPLETED|Overall Study||2
2943113|NCT00655980|3655824|FG000|STARTED|Overall Study||276
2943114|NCT00655980|3655825|FG001|STARTED|Overall Study||281
2943115|NCT00655980|3655826|FG002|STARTED|Overall Study||130
2943116|NCT00655980|3655824|FG000|COMPLETED|Overall Study||250
2943117|NCT00655980|3655825|FG001|COMPLETED|Overall Study||250
2943118|NCT00655980|3655826|FG002|COMPLETED|Overall Study||125
2943119|NCT00655980|3655824|FG000|NOT COMPLETED|Overall Study||26
2943120|NCT00655980|3655825|FG001|NOT COMPLETED|Overall Study||31
2943121|NCT00655980|3655826|FG002|NOT COMPLETED|Overall Study||5
2943122|NCT00656019|3655841|FG000|STARTED|Overall Study||29
2943123|NCT00656019|3655842|FG001|STARTED|Overall Study||19
2943124|NCT00656019|3655843|FG002|STARTED|Overall Study||11
2943125|NCT00656019|3655844|FG003|STARTED|Overall Study||4
2943126|NCT00656019|3655841|FG000|COMPLETED|Overall Study||15
2943127|NCT00656019|3655842|FG001|COMPLETED|Overall Study||18
2943128|NCT00656019|3655843|FG002|COMPLETED|Overall Study||11
2943129|NCT00656019|3655844|FG003|COMPLETED|Overall Study||4
2943130|NCT00656019|3655841|FG000|NOT COMPLETED|Overall Study||14
2943131|NCT00656019|3655842|FG001|NOT COMPLETED|Overall Study||1
2943132|NCT00656019|3655843|FG002|NOT COMPLETED|Overall Study||0
2943133|NCT00656019|3655844|FG003|NOT COMPLETED|Overall Study||0
2943134|NCT00656058|3655854|FG000|STARTED|Overall Study||25
2943135|NCT00656058|3655854|FG000|COMPLETED|Overall Study||19
2943136|NCT00656058|3655854|FG000|NOT COMPLETED|Overall Study||6
2943137|NCT00656084|3655858|FG000|STARTED|Overall Study||16
3298712|NCT02926677|4032398|FG002|NOT COMPLETED|Overall Study||20
3298713|NCT02926937|4032410|FG000|STARTED|Overall Study||150
3298714|NCT02926937|4032411|FG001|STARTED|Overall Study||142
3298715|NCT02926937|4032412|FG002|STARTED|Overall Study||107
3298716|NCT02926937|4032410|FG000|COMPLETED|Overall Study||131
2943138|NCT00656084|3655858|FG000|COMPLETED|Overall Study||9
2943139|NCT00656084|3655858|FG000|NOT COMPLETED|Overall Study||7
3132423|NCT01691105|3857480|FG000|NOT COMPLETED|1 Month Follow-up||43
3298717|NCT02926937|4032411|FG001|COMPLETED|Overall Study||127
2943140|NCT00656136|3655864|FG000|STARTED|Overall Study|Randomised patients.|195
2943141|NCT00656136|3655865|FG001|STARTED|Overall Study|Randomised patients.|390
2943142|NCT00656136|3655864|FG000|COMPLETED|Overall Study||0
2943143|NCT00656136|3655865|FG001|COMPLETED|Overall Study||0
2943144|NCT00656136|3655864|FG000|NOT COMPLETED|Overall Study||195
2943145|NCT00656136|3655865|FG001|NOT COMPLETED|Overall Study||390
3132424|NCT01691105|3857481|FG001|NOT COMPLETED|1 Month Follow-up||41
3132425|NCT01691105|3857480|FG000|STARTED|6 Month Follow-up||477
3132426|NCT01691105|3857481|FG001|STARTED|6 Month Follow-up||567
3132427|NCT01691105|3857480|FG000|COMPLETED|6 Month Follow-up||425
2943146|NCT00656175|3655873|FG000|STARTED|Overall Study||18
2943147|NCT00656175|3655874|FG001|STARTED|Overall Study||21
2943148|NCT00656175|3655873|FG000|COMPLETED|Overall Study||17
2943149|NCT00656175|3655874|FG001|COMPLETED|Overall Study||20
2943150|NCT00656175|3655873|FG000|NOT COMPLETED|Overall Study||1
2943151|NCT00656175|3655874|FG001|NOT COMPLETED|Overall Study||1
2943152|NCT00656201|3655882|FG000|STARTED|Overall Study||235
2943153|NCT00656201|3655883|FG001|STARTED|Overall Study||233
2943154|NCT00656201|3655882|FG000|COMPLETED|Overall Study||206
2943155|NCT00656201|3655883|FG001|COMPLETED|Overall Study||201
2943156|NCT00656201|3655882|FG000|NOT COMPLETED|Overall Study||29
2943157|NCT00656201|3655883|FG001|NOT COMPLETED|Overall Study||32
2943158|NCT00656292|3655891|FG000|STARTED|Overall Study||32
2943159|NCT00656292|3655892|FG001|STARTED|Overall Study||29
2943160|NCT00656292|3655891|FG000|COMPLETED|Overall Study||29
2943161|NCT00656292|3655892|FG001|COMPLETED|Overall Study||24
2943162|NCT00656292|3655891|FG000|NOT COMPLETED|Overall Study||3
2943163|NCT00656292|3655892|FG001|NOT COMPLETED|Overall Study||5
2943164|NCT00656305|3655900|FG000|STARTED|Overall Study||87
2943165|NCT00656305|3655901|FG001|STARTED|Overall Study||28
2943166|NCT00656305|3655900|FG000|COMPLETED|Overall Study||65
2943167|NCT00656305|3655901|FG001|COMPLETED|Overall Study||21
2943168|NCT00656305|3655900|FG000|NOT COMPLETED|Overall Study||22
2943169|NCT00656305|3655901|FG001|NOT COMPLETED|Overall Study||7
2943170|NCT00656370|3655907|FG000|STARTED|Overall Study|25 subjects were assessed for eligibility and signed an Informed Consent Form.|25
2943171|NCT00656370|3655907|FG000|COMPLETED|Overall Study|15 subjects were randomized and completed stage 1 (received both NS and LR).|15
2943172|NCT00656370|3655907|FG000|NOT COMPLETED|Overall Study||10
2943173|NCT00656448|3655915|FG000|STARTED|Overall Study||25
2943174|NCT00656448|3655916|FG001|STARTED|Overall Study||25
2943175|NCT00656448|3655915|FG000|COMPLETED|Overall Study||25
2943176|NCT00656448|3655916|FG001|COMPLETED|Overall Study||25
2943177|NCT00656448|3655915|FG000|NOT COMPLETED|Overall Study||0
2943178|NCT00656448|3655916|FG001|NOT COMPLETED|Overall Study||0
2943179|NCT00656474|3655923|FG000|STARTED|Overall Study||12
2943180|NCT00656474|3655923|FG000|COMPLETED|Overall Study||11
2943181|NCT00656474|3655923|FG000|NOT COMPLETED|Overall Study||1
2943182|NCT00656487|3655931|FG000|STARTED|Overall Study||23
2943183|NCT00656487|3655932|FG001|STARTED|Overall Study||23
2943184|NCT00656487|3655933|FG002|STARTED|Overall Study||20
2943185|NCT00656487|3655931|FG000|COMPLETED|Overall Study||21
2943186|NCT00656487|3655932|FG001|COMPLETED|Overall Study||19
2943187|NCT00656487|3655933|FG002|COMPLETED|Overall Study||20
2943188|NCT00656487|3655931|FG000|NOT COMPLETED|Overall Study||2
2943189|NCT00656487|3655932|FG001|NOT COMPLETED|Overall Study||4
2943190|NCT00656487|3655933|FG002|NOT COMPLETED|Overall Study||0
2943191|NCT00656513|3655944|FG000|STARTED|Overall Study||48
2943192|NCT00656513|3655945|FG001|STARTED|Overall Study||73
2943193|NCT00656513|3655946|FG002|STARTED|Overall Study||75
2943194|NCT00656513|3655944|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|44
2943195|NCT00656513|3655945|FG001|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|43
2943196|NCT00656513|3655946|FG002|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|53
2943197|NCT00656513|3655944|FG000|NOT COMPLETED|Overall Study||4
2943198|NCT00656513|3655945|FG001|NOT COMPLETED|Overall Study||30
2943199|NCT00656513|3655946|FG002|NOT COMPLETED|Overall Study||22
2943200|NCT00656617|3655954|FG000|STARTED|Overall Study||106
2943201|NCT00656617|3655954|FG000|Run-in Induction Phase|Overall Study|Initial run-in: Vorinostat induction dose 500 mg orally three times daily for 3 days.|3
2943202|NCT00656617|3655954|FG000|Induction Phase|Overall Study|Induction phase following determination of safe combination Vorinostat with Idarubicin.|103
2943203|NCT00656617|3655954|FG000|COMPLETED|Overall Study||99
2943204|NCT00656617|3655954|FG000|NOT COMPLETED|Overall Study||7
2943205|NCT00656630|3655962|FG000|STARTED|Overall Study||22
2943206|NCT00656630|3655963|FG001|STARTED|Overall Study||27
2943207|NCT00656630|3655964|FG002|STARTED|Overall Study||19
2943208|NCT00656630|3655962|FG000|COMPLETED|Overall Study||20
2943209|NCT00656630|3655963|FG001|COMPLETED|Overall Study||25
2943210|NCT00656630|3655964|FG002|COMPLETED|Overall Study||17
2943211|NCT00656630|3655962|FG000|NOT COMPLETED|Overall Study||2
2943212|NCT00656630|3655963|FG001|NOT COMPLETED|Overall Study||2
2943213|NCT00656630|3655964|FG002|NOT COMPLETED|Overall Study||2
2943214|NCT00656656|3655972|FG000|STARTED|Overall Study||23
2943215|NCT00656656|3655972|FG000|COMPLETED|Overall Study||23
2943216|NCT00656656|3655972|FG000|NOT COMPLETED|Overall Study||0
2943217|NCT00656669|3655976|FG000|STARTED|Single Agent Sunitinib (Cycle 1)||23
3132428|NCT01691105|3857481|FG001|COMPLETED|6 Month Follow-up||496
3132429|NCT01691105|3857480|FG000|NOT COMPLETED|6 Month Follow-up||52
3132430|NCT01691105|3857481|FG001|NOT COMPLETED|6 Month Follow-up||71
2943218|NCT00656669|3655976|FG000|COMPLETED|Single Agent Sunitinib (Cycle 1)||23
2943219|NCT00656669|3655976|FG000|NOT COMPLETED|Single Agent Sunitinib (Cycle 1)||0
2943220|NCT00656669|3655976|FG000|STARTED|Paclitaxel/Sunitinib (Cycles 2-5)||23
2943221|NCT00656669|3655976|FG000|COMPLETED|Paclitaxel/Sunitinib (Cycles 2-5)||17
2943222|NCT00656669|3655976|FG000|NOT COMPLETED|Paclitaxel/Sunitinib (Cycles 2-5)||6
2943223|NCT00656669|3655976|FG000|STARTED|AC (Cycles 6-9)||17
2943224|NCT00656669|3655976|FG000|COMPLETED|AC (Cycles 6-9)||15
2943225|NCT00656669|3655976|FG000|NOT COMPLETED|AC (Cycles 6-9)||2
2943226|NCT00656799|3655985|FG000|STARTED|Overall Study||6
3298718|NCT02926937|4032412|FG002|COMPLETED|Overall Study||96
3298719|NCT02926937|4032410|FG000|NOT COMPLETED|Overall Study||19
3298720|NCT02926937|4032411|FG001|NOT COMPLETED|Overall Study||15
3298721|NCT02926937|4032412|FG002|NOT COMPLETED|Overall Study||11
3298722|NCT02926950|4032423|FG000|STARTED|Overall Study||259
2943227|NCT00656799|3655985|FG000|COMPLETED|Overall Study||4
2943228|NCT00656799|3655985|FG000|NOT COMPLETED|Overall Study||2
2943229|NCT00656851|3655991|FG000|STARTED|Overall Study||12
2943230|NCT00656851|3655992|FG001|STARTED|Overall Study||12
2943231|NCT00656851|3655991|FG000|COMPLETED|Overall Study||12
2943232|NCT00656851|3655992|FG001|COMPLETED|Overall Study||8
2943233|NCT00656851|3655991|FG000|NOT COMPLETED|Overall Study||0
2943234|NCT00656851|3655992|FG001|NOT COMPLETED|Overall Study||4
2943235|NCT00656968|3656000|FG000|STARTED|Overall Study||115
2943236|NCT00656968|3656001|FG001|STARTED|Overall Study||117
2943237|NCT00656968|3656000|FG000|COMPLETED|Overall Study||115
2943238|NCT00656968|3656001|FG001|COMPLETED|Overall Study||117
2943239|NCT00656968|3656000|FG000|NOT COMPLETED|Overall Study||0
2943240|NCT00656968|3656001|FG001|NOT COMPLETED|Overall Study||0
2943241|NCT00657020|3656007|FG000|STARTED|PERIOD 1||11
2943242|NCT00657020|3656008|FG001|STARTED|PERIOD 1||12
2943243|NCT00657020|3656007|FG000|COMPLETED|PERIOD 1||11
2943244|NCT00657020|3656008|FG001|COMPLETED|PERIOD 1||11
2943245|NCT00657020|3656007|FG000|NOT COMPLETED|PERIOD 1||0
2943246|NCT00657020|3656008|FG001|NOT COMPLETED|PERIOD 1||1
2943247|NCT00657020|3656007|FG000|STARTED|PERIOD 2||11
2943248|NCT00657020|3656008|FG001|STARTED|PERIOD 2||11
2943249|NCT00657020|3656007|FG000|COMPLETED|PERIOD 2||11
2943250|NCT00657020|3656008|FG001|COMPLETED|PERIOD 2||11
2943251|NCT00657020|3656007|FG000|NOT COMPLETED|PERIOD 2||0
2943252|NCT00657020|3656008|FG001|NOT COMPLETED|PERIOD 2||0
2943253|NCT00657046|3656023|FG000|STARTED|Overall Study||30
2943254|NCT00657046|3656024|FG001|STARTED|Overall Study||32
2943255|NCT00657046|3656025|FG002|STARTED|Overall Study||23
2943256|NCT00657046|3656023|FG000|Had at Least 1 Post Baseline Visit|Overall Study||30
2943257|NCT00657046|3656024|FG001|Had at Least 1 Post Baseline Visit|Overall Study||31
2943258|NCT00657046|3656025|FG002|Had at Least 1 Post Baseline Visit|Overall Study||23
2943259|NCT00657046|3656023|FG000|Had Visits up to Visit 18|Overall Study||28
2943260|NCT00657046|3656024|FG001|Had Visits up to Visit 18|Overall Study||30
2943261|NCT00657046|3656025|FG002|Had Visits up to Visit 18|Overall Study||23
2943262|NCT00657046|3656023|FG000|COMPLETED|Overall Study||26
2943263|NCT00657046|3656024|FG001|COMPLETED|Overall Study||29
2943264|NCT00657046|3656025|FG002|COMPLETED|Overall Study||21
2943265|NCT00657046|3656023|FG000|NOT COMPLETED|Overall Study||4
2943266|NCT00657046|3656024|FG001|NOT COMPLETED|Overall Study||3
2943267|NCT00657046|3656025|FG002|NOT COMPLETED|Overall Study||2
2943268|NCT00657150|3656035|FG000|STARTED|Overall Study||1010
2943269|NCT00657150|3656036|FG001|STARTED|Overall Study||1003
2943270|NCT00657150|3656035|FG000|COMPLETED|Overall Study||895
2943271|NCT00657150|3656036|FG001|COMPLETED|Overall Study||910
2943272|NCT00657150|3656035|FG000|NOT COMPLETED|Overall Study||115
2943273|NCT00657150|3656036|FG001|NOT COMPLETED|Overall Study||93
2943274|NCT00657150|3656035|FG000|STARTED|Treatment||1010
2943275|NCT00657150|3656036|FG001|STARTED|Treatment||1003
2943276|NCT00657150|3656035|FG000|COMPLETED|Treatment||903
2943277|NCT00657150|3656036|FG001|COMPLETED|Treatment||906
2943278|NCT00657150|3656035|FG000|NOT COMPLETED|Treatment||107
2943279|NCT00657150|3656036|FG001|NOT COMPLETED|Treatment||97
2943280|NCT00657267|3656042|FG000|STARTED|Overall Study||58
2943281|NCT00657267|3656042|FG000|COMPLETED|Overall Study||4
2943282|NCT00657267|3656042|FG000|NOT COMPLETED|Overall Study||54
2943283|NCT00657280|3656048|FG000|STARTED|Overall Study||16
2943284|NCT00657280|3656048|FG000|COMPLETED|Overall Study||16
2943285|NCT00657280|3656048|FG000|NOT COMPLETED|Overall Study||0
2943286|NCT00657358|3656052|FG000|STARTED|Overall Study||22
2943287|NCT00657358|3656052|FG000|COMPLETED|Overall Study||16
2943288|NCT00657358|3656052|FG000|NOT COMPLETED|Overall Study||6
2943289|NCT00657371|3656057|FG000|STARTED|Overall Study||288
2943290|NCT00657371|3656057|FG000|COMPLETED|Overall Study||249
2943291|NCT00657371|3656057|FG000|NOT COMPLETED|Overall Study||39
2943292|NCT00657540|3656063|FG000|STARTED|Overall Study||29
2943293|NCT00657540|3656064|FG001|STARTED|Overall Study||31
2943294|NCT00657540|3656063|FG000|COMPLETED|Overall Study|All subjects had a known treatment failure disposition at time of loss to follow-up.|28
2943295|NCT00657540|3656064|FG001|COMPLETED|Overall Study|All subjects had a known treatment failure disposition at time of loss to follow-up.|27
2943296|NCT00657540|3656063|FG000|NOT COMPLETED|Overall Study||1
2943297|NCT00657540|3656064|FG001|NOT COMPLETED|Overall Study||4
2943298|NCT00657605|3656070|FG000|STARTED|Overall Study||3
2943299|NCT00657605|3656070|FG000|COMPLETED|Overall Study||3
2943300|NCT00657605|3656070|FG000|NOT COMPLETED|Overall Study||0
2943301|NCT00657618|3656074|FG000|STARTED|Overall Study||77
2943302|NCT00657618|3656074|FG000|COMPLETED|Overall Study||34
2943303|NCT00657618|3656074|FG000|NOT COMPLETED|Overall Study||43
2943304|NCT00657657|3656078|FG000|STARTED|Overall Study||29
2943305|NCT00657657|3656078|FG000|COMPLETED|Overall Study||29
2943306|NCT00657657|3656078|FG000|NOT COMPLETED|Overall Study||0
2943307|NCT00657709|3656087|FG000|STARTED|Overall Study||833
2943308|NCT00657709|3656088|FG001|STARTED|Overall Study||828
2943309|NCT00657709|3656089|FG002|STARTED|Overall Study||820
2943310|NCT00657709|3656090|FG003|STARTED|Overall Study||659
2943311|NCT00657709|3656091|FG004|STARTED|Overall Study||490
2943312|NCT00657709|3656087|FG000|COMPLETED|Overall Study||810
2943313|NCT00657709|3656088|FG001|COMPLETED|Overall Study||795
2943314|NCT00657709|3656089|FG002|COMPLETED|Overall Study||792
2943315|NCT00657709|3656090|FG003|COMPLETED|Overall Study||645
2943316|NCT00657709|3656091|FG004|COMPLETED|Overall Study||457
2943317|NCT00657709|3656087|FG000|NOT COMPLETED|Overall Study||23
2943318|NCT00657709|3656088|FG001|NOT COMPLETED|Overall Study||33
2943319|NCT00657709|3656089|FG002|NOT COMPLETED|Overall Study||28
2943320|NCT00657709|3656090|FG003|NOT COMPLETED|Overall Study||14
2943321|NCT00657709|3656091|FG004|NOT COMPLETED|Overall Study||33
2943322|NCT00657917|3656113|FG000|STARTED|Overall Study||1
2943323|NCT00657917|3656113|FG000|COMPLETED|Overall Study||1
2943324|NCT00657917|3656113|FG000|NOT COMPLETED|Overall Study||0
2943325|NCT00658021|3656120|FG000|STARTED|28-Week Treatment Period||42
2943326|NCT00658021|3656121|FG001|STARTED|28-Week Treatment Period||38
2943327|NCT00658021|3656122|FG002|STARTED|28-Week Treatment Period||42
2943328|NCT00658021|3656120|FG000|Received Treatment|28-Week Treatment Period||40
2943329|NCT00658021|3656121|FG001|Received Treatment|28-Week Treatment Period||38
2943330|NCT00658021|3656122|FG002|Received Treatment|28-Week Treatment Period||42
2943331|NCT00658021|3656120|FG000|COMPLETED|28-Week Treatment Period||31
2943332|NCT00658021|3656121|FG001|COMPLETED|28-Week Treatment Period||25
2943333|NCT00658021|3656122|FG002|COMPLETED|28-Week Treatment Period||25
2943334|NCT00658021|3656120|FG000|NOT COMPLETED|28-Week Treatment Period||11
2943335|NCT00658021|3656121|FG001|NOT COMPLETED|28-Week Treatment Period||13
2943336|NCT00658021|3656122|FG002|NOT COMPLETED|28-Week Treatment Period||17
2943337|NCT00658021|3656120|FG000|STARTED|Long-term Safety Follow-up Period|Entered safety follow-up period.|7
2943338|NCT00658021|3656121|FG001|STARTED|Long-term Safety Follow-up Period|Entered safety follow-up period.|5
2943339|NCT00658021|3656122|FG002|STARTED|Long-term Safety Follow-up Period|Entered safety follow-up period.|7
2943340|NCT00658021|3656120|FG000|COMPLETED|Long-term Safety Follow-up Period||7
2943341|NCT00658021|3656121|FG001|COMPLETED|Long-term Safety Follow-up Period||2
2943342|NCT00658021|3656122|FG002|COMPLETED|Long-term Safety Follow-up Period||7
2943343|NCT00658021|3656120|FG000|NOT COMPLETED|Long-term Safety Follow-up Period||0
2943344|NCT00658021|3656121|FG001|NOT COMPLETED|Long-term Safety Follow-up Period||3
2943345|NCT00658021|3656122|FG002|NOT COMPLETED|Long-term Safety Follow-up Period||0
2943346|NCT00658112|3656132|FG000|STARTED|Overall Study||20
2943347|NCT00658112|3656132|FG000|COMPLETED|Overall Study||11
2943348|NCT00658112|3656132|FG000|NOT COMPLETED|Overall Study||9
2943349|NCT00658138|3656136|FG000|STARTED|Overall Study||61
2943350|NCT00658138|3656136|FG000|COMPLETED|Overall Study||40
2943351|NCT00658138|3656136|FG000|NOT COMPLETED|Overall Study||21
2943352|NCT00658320|3656143|FG000|STARTED|Core Study: 12 Months||61
2943353|NCT00658320|3656144|FG001|STARTED|Core Study: 12 Months||61
2943354|NCT00658320|3656143|FG000|COMPLETED|Core Study: 12 Months||56
2943355|NCT00658320|3656144|FG001|COMPLETED|Core Study: 12 Months||58
2943356|NCT00658320|3656143|FG000|NOT COMPLETED|Core Study: 12 Months||5
2943357|NCT00658320|3656144|FG001|NOT COMPLETED|Core Study: 12 Months||3
2943358|NCT00658320|3656143|FG000|STARTED|Extension Study: Month 12 to Month 24||53
2943359|NCT00658320|3656144|FG001|STARTED|Extension Study: Month 12 to Month 24||57
2943360|NCT00658320|3656143|FG000|Extension ITT: Received Study Drug|Extension Study: Month 12 to Month 24||50
2943361|NCT00658320|3656144|FG001|Extension ITT: Received Study Drug|Extension Study: Month 12 to Month 24||50
2943362|NCT00658320|3656143|FG000|COMPLETED|Extension Study: Month 12 to Month 24||47
2943363|NCT00658320|3656144|FG001|COMPLETED|Extension Study: Month 12 to Month 24||50
2943364|NCT00658320|3656143|FG000|NOT COMPLETED|Extension Study: Month 12 to Month 24||6
2943365|NCT00658320|3656144|FG001|NOT COMPLETED|Extension Study: Month 12 to Month 24||7
2943366|NCT00658320|3656143|FG000|STARTED|Extension Study: After Month 24||44
2943367|NCT00658320|3656144|FG001|STARTED|Extension Study: After Month 24||0
2943368|NCT00658320|3656143|FG000|COMPLETED|Extension Study: After Month 24||42
2943369|NCT00658320|3656144|FG001|COMPLETED|Extension Study: After Month 24||0
2943370|NCT00658320|3656143|FG000|NOT COMPLETED|Extension Study: After Month 24||2
2943371|NCT00658320|3656144|FG001|NOT COMPLETED|Extension Study: After Month 24||0
2943372|NCT00658333|3656154|FG000|STARTED|Overall Study||15
2943373|NCT00658333|3656155|FG001|STARTED|Overall Study||15
2943374|NCT00658333|3656154|FG000|COMPLETED|Overall Study||13
2943375|NCT00658333|3656155|FG001|COMPLETED|Overall Study||14
2943376|NCT00658333|3656154|FG000|NOT COMPLETED|Overall Study||2
2943377|NCT00658333|3656155|FG001|NOT COMPLETED|Overall Study||1
2943378|NCT00658359|3656164|FG000|STARTED|Overall Study||64
2943379|NCT00658359|3656165|FG001|STARTED|Overall Study||60
2943380|NCT00658359|3656166|FG002|STARTED|Overall Study||54
2943381|NCT00658359|3656164|FG000|COMPLETED|Overall Study||36
2943382|NCT00658359|3656165|FG001|COMPLETED|Overall Study||15
2943383|NCT00658359|3656166|FG002|COMPLETED|Overall Study||8
2943384|NCT00658359|3656164|FG000|NOT COMPLETED|Overall Study||28
2943385|NCT00658359|3656165|FG001|NOT COMPLETED|Overall Study||45
2943386|NCT00658359|3656166|FG002|NOT COMPLETED|Overall Study||46
2943387|NCT00658385|3656176|FG000|STARTED|Overall Study||5
2943388|NCT00658385|3656176|FG000|COMPLETED|Overall Study||5
2943389|NCT00658385|3656176|FG000|NOT COMPLETED|Overall Study||0
2943390|NCT00658411|3656180|FG000|STARTED|Overall Study||5
2943391|NCT00658411|3656180|FG000|COMPLETED|Overall Study||5
2943392|NCT00658411|3656180|FG000|NOT COMPLETED|Overall Study||0
2943393|NCT00658515|3656190|FG000|STARTED|Overall Study||7938
2943394|NCT00658515|3656191|FG001|STARTED|Overall Study||7933
2943395|NCT00658515|3656190|FG000|COMPLETED|Overall Study||7626
2943396|NCT00658515|3656191|FG001|COMPLETED|Overall Study||7668
2943397|NCT00658515|3656190|FG000|NOT COMPLETED|Overall Study||312
2943398|NCT00658515|3656191|FG001|NOT COMPLETED|Overall Study||265
2943399|NCT00658528|3656199|FG000|STARTED|Overall Study|Treated|531
2943400|NCT00658528|3656200|FG001|STARTED|Overall Study|Treated|524
2943401|NCT00658528|3656199|FG000|COMPLETED|Overall Study||491
2943402|NCT00658528|3656200|FG001|COMPLETED|Overall Study||479
2943403|NCT00658528|3656199|FG000|NOT COMPLETED|Overall Study||40
2943404|NCT00658528|3656200|FG001|NOT COMPLETED|Overall Study||45
2943405|NCT00658541|3656206|FG000|STARTED|First Intervention||19
2943406|NCT00658541|3656207|FG001|STARTED|First Intervention||19
2943407|NCT00658541|3656206|FG000|COMPLETED|First Intervention||19
2943408|NCT00658541|3656207|FG001|COMPLETED|First Intervention||19
2943409|NCT00658541|3656206|FG000|NOT COMPLETED|First Intervention||0
2943410|NCT00658541|3656207|FG001|NOT COMPLETED|First Intervention||0
2943411|NCT00658541|3656206|FG000|STARTED|Washout Period of 7 Days||19
2943412|NCT00658541|3656207|FG001|STARTED|Washout Period of 7 Days||19
2943413|NCT00658541|3656206|FG000|COMPLETED|Washout Period of 7 Days||18
2943414|NCT00658541|3656207|FG001|COMPLETED|Washout Period of 7 Days||17
2943415|NCT00658541|3656206|FG000|NOT COMPLETED|Washout Period of 7 Days||1
2943416|NCT00658541|3656207|FG001|NOT COMPLETED|Washout Period of 7 Days||2
2943417|NCT00658541|3656206|FG000|STARTED|Second Intervention||18
2943418|NCT00658541|3656207|FG001|STARTED|Second Intervention||17
2943419|NCT00658541|3656206|FG000|COMPLETED|Second Intervention||18
2943420|NCT00658541|3656207|FG001|COMPLETED|Second Intervention||17
2943421|NCT00658541|3656206|FG000|NOT COMPLETED|Second Intervention||0
2943422|NCT00658541|3656207|FG001|NOT COMPLETED|Second Intervention||0
2943423|NCT00658567|3656216|FG000|STARTED|Overall Study||40
2943424|NCT00658567|3656217|FG001|STARTED|Overall Study||42
2943425|NCT00658567|3656218|FG002|STARTED|Overall Study||41
2943426|NCT00658567|3656216|FG000|COMPLETED|Overall Study||32
2943427|NCT00658567|3656217|FG001|COMPLETED|Overall Study||38
2943428|NCT00658567|3656218|FG002|COMPLETED|Overall Study||35
2943429|NCT00658567|3656216|FG000|NOT COMPLETED|Overall Study||8
2943430|NCT00658567|3656217|FG001|NOT COMPLETED|Overall Study||4
2943431|NCT00658567|3656218|FG002|NOT COMPLETED|Overall Study||6
3034605|NCT01133405|3753621|FG000|STARTED|Period 2||2
3034606|NCT01133405|3753622|FG001|STARTED|Period 2|One participant started and received 15 mg LY2886721 only in period 2.|4
3034607|NCT01133405|3753623|FG002|STARTED|Period 2||4
3034608|NCT01133405|3753624|FG003|STARTED|Period 2|Two participants started and received 25 mg LY2886721 only in period 2.|3
3034609|NCT01133405|3753625|FG004|STARTED|Period 2||3
3034610|NCT01133405|3753626|FG005|STARTED|Period 2|One participant started and received 25 mg LY2886721 only in period 2.|4
3034611|NCT01133405|3753627|FG006|STARTED|Period 2|Cohort C was planned only for single period.|0
3034612|NCT01133405|3753628|FG007|STARTED|Period 2|Cohort C was planned only for single period.|0
3034613|NCT01133405|3753629|FG008|STARTED|Period 2|Cohort D was planned only for single period.|0
3034614|NCT01133405|3753630|FG009|STARTED|Period 2|Cohort D was planned only for single period.|0
3034615|NCT01133405|3753621|FG000|Received at Least 1 Dose of Study Drug|Period 2||2
3034616|NCT01133405|3753622|FG001|Received at Least 1 Dose of Study Drug|Period 2||4
3034617|NCT01133405|3753623|FG002|Received at Least 1 Dose of Study Drug|Period 2||4
3034618|NCT01133405|3753624|FG003|Received at Least 1 Dose of Study Drug|Period 2||3
3034619|NCT01133405|3753625|FG004|Received at Least 1 Dose of Study Drug|Period 2||3
3034620|NCT01133405|3753626|FG005|Received at Least 1 Dose of Study Drug|Period 2||4
3034621|NCT01133405|3753627|FG006|Received at Least 1 Dose of Study Drug|Period 2||0
3034622|NCT01133405|3753628|FG007|Received at Least 1 Dose of Study Drug|Period 2||0
3034623|NCT01133405|3753629|FG008|Received at Least 1 Dose of Study Drug|Period 2||0
3034624|NCT01133405|3753630|FG009|Received at Least 1 Dose of Study Drug|Period 2||0
3034625|NCT01133405|3753621|FG000|COMPLETED|Period 2||2
3034626|NCT01133405|3753622|FG001|COMPLETED|Period 2||3
3034627|NCT01133405|3753623|FG002|COMPLETED|Period 2||3
3034628|NCT01133405|3753624|FG003|COMPLETED|Period 2||2
3034629|NCT01133405|3753625|FG004|COMPLETED|Period 2||3
3034630|NCT01133405|3753626|FG005|COMPLETED|Period 2||2
3034631|NCT01133405|3753627|FG006|COMPLETED|Period 2||0
3163373|NCT01886690|3890921|FG000|NOT COMPLETED|Overall Study||0
3163374|NCT01886690|3890922|FG001|NOT COMPLETED|Overall Study||2
3163375|NCT01886716|3890932|FG000|STARTED|Week 1||24
3163376|NCT01886716|3890933|FG001|STARTED|Week 1||20
3163377|NCT01886716|3890934|FG002|STARTED|Week 1||22
3163378|NCT01886716|3890935|FG003|STARTED|Week 1||20
3163379|NCT01886716|3890932|FG000|COMPLETED|Week 1||24
3163380|NCT01886716|3890933|FG001|COMPLETED|Week 1||20
3163381|NCT01886716|3890934|FG002|COMPLETED|Week 1||20
3163382|NCT01886716|3890935|FG003|COMPLETED|Week 1||18
3163383|NCT01886716|3890932|FG000|NOT COMPLETED|Week 1||0
3163384|NCT01886716|3890933|FG001|NOT COMPLETED|Week 1||0
3034632|NCT01133405|3753628|FG007|COMPLETED|Period 2||0
3034633|NCT01133405|3753629|FG008|COMPLETED|Period 2||0
3163385|NCT01886716|3890934|FG002|NOT COMPLETED|Week 1||2
2943432|NCT00658606|3656228|FG000|STARTED|Overall Study||49
2943433|NCT00658606|3656229|FG001|STARTED|Overall Study||49
2943434|NCT00658606|3656228|FG000|Completed Treatment|Overall Study||42
2943435|NCT00658606|3656229|FG001|Completed Treatment|Overall Study||44
2943436|NCT00658606|3656228|FG000|COMPLETED|Overall Study|Represents patients who completed follow-up|33
2943437|NCT00658606|3656229|FG001|COMPLETED|Overall Study|Represents patients who completed follow-up|26
2943438|NCT00658606|3656228|FG000|NOT COMPLETED|Overall Study||16
2943439|NCT00658606|3656229|FG001|NOT COMPLETED|Overall Study||23
2943440|NCT00658619|3656240|FG000|STARTED|Overall Study||3
2943441|NCT00658619|3656241|FG001|STARTED|Overall Study||3
2943442|NCT00658619|3656242|FG002|STARTED|Overall Study||41
2943443|NCT00658619|3656243|FG003|STARTED|Overall Study||49
2943444|NCT00658619|3656244|FG004|STARTED|Overall Study||23
2943445|NCT00658619|3656240|FG000|COMPLETED|Overall Study||3
2943446|NCT00658619|3656241|FG001|COMPLETED|Overall Study||2
2943447|NCT00658619|3656242|FG002|COMPLETED|Overall Study||31
2943448|NCT00658619|3656243|FG003|COMPLETED|Overall Study||37
2943449|NCT00658619|3656244|FG004|COMPLETED|Overall Study||21
2943450|NCT00658619|3656240|FG000|NOT COMPLETED|Overall Study||0
2943451|NCT00658619|3656241|FG001|NOT COMPLETED|Overall Study||1
2943452|NCT00658619|3656242|FG002|NOT COMPLETED|Overall Study||10
2943453|NCT00658619|3656243|FG003|NOT COMPLETED|Overall Study||12
2943454|NCT00658619|3656244|FG004|NOT COMPLETED|Overall Study||2
2943455|NCT00658632|3656255|FG000|STARTED|Overall Study|Treated|682
2943456|NCT00658632|3656256|FG001|STARTED|Overall Study|Treated|698
2943457|NCT00658632|3656255|FG000|COMPLETED|Overall Study||618
2943458|NCT00658632|3656256|FG001|COMPLETED|Overall Study||633
2943459|NCT00658632|3656255|FG000|NOT COMPLETED|Overall Study||64
2943460|NCT00658632|3656256|FG001|NOT COMPLETED|Overall Study||65
2943461|NCT00658658|3656267|FG000|STARTED|Overall Study||6
2943462|NCT00658658|3656268|FG001|STARTED|Overall Study||7
2943463|NCT00658658|3656269|FG002|STARTED|Overall Study||4
2943464|NCT00658658|3656270|FG003|STARTED|Overall Study||6
2943465|NCT00658658|3656271|FG004|STARTED|Overall Study||8
2943466|NCT00658658|3656267|FG000|COMPLETED|Overall Study||1
2943467|NCT00658658|3656268|FG001|COMPLETED|Overall Study||5
2943468|NCT00658658|3656269|FG002|COMPLETED|Overall Study||4
2943469|NCT00658658|3656270|FG003|COMPLETED|Overall Study||4
2943470|NCT00658658|3656271|FG004|COMPLETED|Overall Study||3
2943471|NCT00658658|3656267|FG000|NOT COMPLETED|Overall Study||5
2943472|NCT00658658|3656268|FG001|NOT COMPLETED|Overall Study||2
2943473|NCT00658658|3656269|FG002|NOT COMPLETED|Overall Study||0
2943474|NCT00658658|3656270|FG003|NOT COMPLETED|Overall Study||2
2943475|NCT00658658|3656271|FG004|NOT COMPLETED|Overall Study||5
2943476|NCT00658684|3656286|FG000|STARTED|Overall Study||152
2943477|NCT00658684|3656287|FG001|STARTED|Overall Study||99
2943478|NCT00658684|3656288|FG002|STARTED|Overall Study||25
2943479|NCT00658684|3656289|FG003|STARTED|Overall Study||28
2943480|NCT00658684|3656286|FG000|COMPLETED|Overall Study||133
2943481|NCT00658684|3656287|FG001|COMPLETED|Overall Study||84
2943482|NCT00658684|3656288|FG002|COMPLETED|Overall Study||22
2943483|NCT00658684|3656289|FG003|COMPLETED|Overall Study||27
2943484|NCT00658684|3656286|FG000|NOT COMPLETED|Overall Study||19
2943485|NCT00658684|3656287|FG001|NOT COMPLETED|Overall Study||15
2943486|NCT00658684|3656288|FG002|NOT COMPLETED|Overall Study||3
2943487|NCT00658684|3656289|FG003|NOT COMPLETED|Overall Study||1
2943488|NCT00658697|3656299|FG000|STARTED|Overall Study||41
2943489|NCT00658697|3656299|FG000|COMPLETED|Overall Study||41
2943490|NCT00658697|3656299|FG000|NOT COMPLETED|Overall Study||0
2943491|NCT00658723|3656307|FG000|STARTED|Overall Study||60
2943492|NCT00658723|3656308|FG001|STARTED|Overall Study||30
2943493|NCT00658723|3656309|FG002|STARTED|Overall Study||51
2943494|NCT00658723|3656307|FG000|COMPLETED|Overall Study||56
2943495|NCT00658723|3656308|FG001|COMPLETED|Overall Study||26
2943496|NCT00658723|3656309|FG002|COMPLETED|Overall Study||44
2943497|NCT00658723|3656307|FG000|NOT COMPLETED|Overall Study||4
3163386|NCT01886716|3890935|FG003|NOT COMPLETED|Week 1||2
3163387|NCT01886716|3890932|FG000|STARTED|Week 2||24
3163388|NCT01886716|3890933|FG001|STARTED|Week 2||20
2943498|NCT00658723|3656308|FG001|NOT COMPLETED|Overall Study||4
2943499|NCT00658723|3656309|FG002|NOT COMPLETED|Overall Study||7
2943500|NCT00658736|3656322|FG000|STARTED|Overall Study||19
2943501|NCT00658736|3656323|FG001|STARTED|Overall Study||21
2943502|NCT00658736|3656322|FG000|COMPLETED|Overall Study||13
2943503|NCT00658736|3656323|FG001|COMPLETED|Overall Study||19
2943504|NCT00658736|3656322|FG000|NOT COMPLETED|Overall Study||6
2943505|NCT00658736|3656323|FG001|NOT COMPLETED|Overall Study||2
2943506|NCT00658775|3656331|FG000|STARTED|Overall Study|Treated|537
2943507|NCT00658775|3656332|FG001|STARTED|Overall Study|Treated|528
2943508|NCT00658775|3656331|FG000|COMPLETED|Overall Study||495
2943509|NCT00658775|3656332|FG001|COMPLETED|Overall Study||485
2943510|NCT00658775|3656331|FG000|NOT COMPLETED|Overall Study||42
2943511|NCT00658775|3656332|FG001|NOT COMPLETED|Overall Study||43
2943512|NCT00658788|3656338|FG000|STARTED|Overall Study||305
2943513|NCT00658788|3656338|FG000|COMPLETED|Overall Study||231
2943514|NCT00658788|3656338|FG000|NOT COMPLETED|Overall Study||74
2943515|NCT00658814|3656353|FG000|STARTED|Remission Induction Chemotherapy||83
2943516|NCT00658814|3656354|FG001|STARTED|Remission Induction Chemotherapy||59
2943517|NCT00658814|3656353|FG000|Eligible|Remission Induction Chemotherapy||82
2943518|NCT00658814|3656354|FG001|Eligible|Remission Induction Chemotherapy||57
2943519|NCT00658814|3656353|FG000|Eligible and Began Protocol Therapy|Remission Induction Chemotherapy||79
2943520|NCT00658814|3656354|FG001|Eligible and Began Protocol Therapy|Remission Induction Chemotherapy||54
2943521|NCT00658814|3656353|FG000|COMPLETED|Remission Induction Chemotherapy||75
2943522|NCT00658814|3656354|FG001|COMPLETED|Remission Induction Chemotherapy||41
2943523|NCT00658814|3656353|FG000|NOT COMPLETED|Remission Induction Chemotherapy||8
2943524|NCT00658814|3656354|FG001|NOT COMPLETED|Remission Induction Chemotherapy||18
2943525|NCT00658814|3656353|FG000|STARTED|Consolidation Therapy||24
2943526|NCT00658814|3656354|FG001|STARTED|Consolidation Therapy||13
2943527|NCT00658814|3656353|FG000|Eligible|Consolidation Therapy||22
2943528|NCT00658814|3656354|FG001|Eligible|Consolidation Therapy||11
2943529|NCT00658814|3656353|FG000|COMPLETED|Consolidation Therapy||22
2943530|NCT00658814|3656354|FG001|COMPLETED|Consolidation Therapy||10
2943531|NCT00658814|3656353|FG000|NOT COMPLETED|Consolidation Therapy||2
2943532|NCT00658814|3656354|FG001|NOT COMPLETED|Consolidation Therapy||3
2943533|NCT00658814|3656353|FG000|STARTED|Maintenance Therapy||20
2943534|NCT00658814|3656354|FG001|STARTED|Maintenance Therapy||8
2943535|NCT00658814|3656353|FG000|Eligible|Maintenance Therapy||19
2943536|NCT00658814|3656354|FG001|Eligible|Maintenance Therapy||8
2943537|NCT00658814|3656353|FG000|COMPLETED|Maintenance Therapy||17
2943538|NCT00658814|3656354|FG001|COMPLETED|Maintenance Therapy||7
2943539|NCT00658814|3656353|FG000|NOT COMPLETED|Maintenance Therapy||3
2943540|NCT00658814|3656354|FG001|NOT COMPLETED|Maintenance Therapy||1
2943541|NCT00658879|3656364|FG000|STARTED|Overall Study||251
2943542|NCT00658879|3656364|FG000|COMPLETED|Overall Study||250
2943543|NCT00658879|3656364|FG000|NOT COMPLETED|Overall Study||1
2943544|NCT00658996|3656368|FG000|STARTED|First Intervention||109
2943545|NCT00658996|3656369|FG001|STARTED|First Intervention||107
2943546|NCT00658996|3656368|FG000|COMPLETED|First Intervention||108
2943547|NCT00658996|3656369|FG001|COMPLETED|First Intervention||106
2943548|NCT00658996|3656368|FG000|NOT COMPLETED|First Intervention||1
2943549|NCT00658996|3656369|FG001|NOT COMPLETED|First Intervention||1
2943550|NCT00658996|3656368|FG000|STARTED|Crossover Period||108
2943551|NCT00658996|3656369|FG001|STARTED|Crossover Period||106
2943552|NCT00658996|3656368|FG000|COMPLETED|Crossover Period||106
2943553|NCT00658996|3656369|FG001|COMPLETED|Crossover Period||105
2943554|NCT00658996|3656368|FG000|NOT COMPLETED|Crossover Period||2
2943555|NCT00658996|3656369|FG001|NOT COMPLETED|Crossover Period||1
2943556|NCT00658996|3656368|FG000|STARTED|Second Intervention||106
2943557|NCT00658996|3656369|FG001|STARTED|Second Intervention||105
2943558|NCT00658996|3656368|FG000|COMPLETED|Second Intervention||105
2943559|NCT00658996|3656369|FG001|COMPLETED|Second Intervention||104
2943560|NCT00658996|3656368|FG000|NOT COMPLETED|Second Intervention||1
2943561|NCT00658996|3656369|FG001|NOT COMPLETED|Second Intervention||1
2943562|NCT00659165|3656377|FG000|STARTED|Overall Study||5
2943563|NCT00659165|3656378|FG001|STARTED|Overall Study||5
2943564|NCT00659165|3656377|FG000|COMPLETED|Overall Study||5
2943565|NCT00659165|3656378|FG001|COMPLETED|Overall Study||5
2943566|NCT00659165|3656377|FG000|NOT COMPLETED|Overall Study||0
2943567|NCT00659165|3656378|FG001|NOT COMPLETED|Overall Study||0
2943568|NCT00659230|3656386|FG000|STARTED|Overall Study|2 did not return post-randomization, 5 lost source documents, thus 7 excluded from results analysis|51
2943569|NCT00659230|3656387|FG001|STARTED|Overall Study|3 did not return post-randomization, 4 lost source documents, thus 7 excluded from results analysis|49
2943570|NCT00659230|3656386|FG000|COMPLETED|Overall Study||42
2943571|NCT00659230|3656387|FG001|COMPLETED|Overall Study||37
2943572|NCT00659230|3656386|FG000|NOT COMPLETED|Overall Study||9
2943573|NCT00659230|3656387|FG001|NOT COMPLETED|Overall Study||12
2943574|NCT00659269|3656395|FG000|STARTED|Overall Study||157
2943575|NCT00659269|3656396|FG001|STARTED|Overall Study||162
2943576|NCT00659269|3656395|FG000|Group 1 (Heavy Metals)|Overall Study||52
2943577|NCT00659269|3656396|FG001|Group 1 (Heavy Metals)|Overall Study||52
2943578|NCT00659269|3656395|FG000|Group 2 (Vinca Alkaloids)|Overall Study||12
2943579|NCT00659269|3656396|FG001|Group 2 (Vinca Alkaloids)|Overall Study||12
2943580|NCT00659269|3656395|FG000|Group 3 (Taxanes)|Overall Study||92
2943581|NCT00659269|3656396|FG001|Group 3 (Taxanes)|Overall Study||97
2943582|NCT00659269|3656395|FG000|COMPLETED|Overall Study||156
2943583|NCT00659269|3656396|FG001|COMPLETED|Overall Study||161
2943584|NCT00659269|3656395|FG000|NOT COMPLETED|Overall Study||1
2943585|NCT00659269|3656396|FG001|NOT COMPLETED|Overall Study||1
2943586|NCT00659295|3656413|FG000|STARTED|Overall Study||13529
2943587|NCT00659295|3656414|FG001|STARTED|Overall Study||37641
2943588|NCT00659295|3656413|FG000|COMPLETED|Overall Study||10821
2943589|NCT00659295|3656414|FG001|COMPLETED|Overall Study||32038
2943590|NCT00659295|3656413|FG000|NOT COMPLETED|Overall Study||2708
2943591|NCT00659295|3656414|FG001|NOT COMPLETED|Overall Study||5603
2943592|NCT00659334|3656427|FG000|STARTED|Overall Study||46
2943593|NCT00659334|3656428|FG001|STARTED|Overall Study||41
2943594|NCT00659334|3656429|FG002|STARTED|Overall Study||5
2943595|NCT00659334|3656430|FG003|STARTED|Overall Study||2
2943596|NCT00659334|3656431|FG004|STARTED|Overall Study||1
2943597|NCT00659334|3656432|FG005|STARTED|Overall Study||0
2943598|NCT00659334|3656433|FG006|STARTED|Overall Study||21
2943599|NCT00659334|3656427|FG000|COMPLETED|Overall Study|8 Screen failures|38
2943600|NCT00659334|3656428|FG001|COMPLETED|Overall Study|5 Screen failures|36
3298723|NCT02926950|4032424|FG001|STARTED|Overall Study||259
3298724|NCT02926950|4032423|FG000|COMPLETED|Overall Study||210
3298725|NCT02926950|4032424|FG001|COMPLETED|Overall Study||211
3298726|NCT02926950|4032423|FG000|NOT COMPLETED|Overall Study||49
3298727|NCT02926950|4032424|FG001|NOT COMPLETED|Overall Study||48
3298728|NCT02927080|4032441|FG000|STARTED|Overall Study||6
2943601|NCT00659334|3656429|FG002|COMPLETED|Overall Study||5
2943602|NCT00659334|3656430|FG003|COMPLETED|Overall Study||2
2943603|NCT00659334|3656431|FG004|COMPLETED|Overall Study||1
2943604|NCT00659334|3656432|FG005|COMPLETED|Overall Study||0
2943605|NCT00659334|3656433|FG006|COMPLETED|Overall Study|1 screen failure|20
2943606|NCT00659334|3656427|FG000|NOT COMPLETED|Overall Study||8
2943607|NCT00659334|3656428|FG001|NOT COMPLETED|Overall Study||5
2943608|NCT00659334|3656429|FG002|NOT COMPLETED|Overall Study||0
2943609|NCT00659334|3656430|FG003|NOT COMPLETED|Overall Study||0
2943610|NCT00659334|3656431|FG004|NOT COMPLETED|Overall Study||0
2943611|NCT00659334|3656432|FG005|NOT COMPLETED|Overall Study||0
2943612|NCT00659334|3656433|FG006|NOT COMPLETED|Overall Study||1
2943613|NCT00659360|3656449|FG000|STARTED|Overall Study||17
2943614|NCT00659360|3656449|FG000|COMPLETED|Overall Study||17
2943615|NCT00659360|3656449|FG000|NOT COMPLETED|Overall Study||0
2943616|NCT00659373|3656457|FG000|STARTED|Overall Study||25
2943617|NCT00659373|3656458|FG001|STARTED|Overall Study||61
2943618|NCT00659373|3656457|FG000|COMPLETED|Overall Study||20
2943619|NCT00659373|3656458|FG001|COMPLETED|Overall Study||54
2943620|NCT00659373|3656457|FG000|NOT COMPLETED|Overall Study||5
2943621|NCT00659373|3656458|FG001|NOT COMPLETED|Overall Study||7
2943622|NCT00659425|3656474|FG000|STARTED|Overall Study||1
2943623|NCT00659425|3656475|FG001|STARTED|Overall Study||1
2943624|NCT00659425|3656476|FG002|STARTED|Overall Study||1
2943625|NCT00659425|3656477|FG003|STARTED|Overall Study||4
2943626|NCT00659425|3656478|FG004|STARTED|Overall Study||4
2943627|NCT00659425|3656479|FG005|STARTED|Overall Study||5
2943628|NCT00659425|3656480|FG006|STARTED|Overall Study||8
2943629|NCT00659425|3656481|FG007|STARTED|Overall Study||11
2943630|NCT00659425|3656482|FG008|STARTED|Overall Study||6
2943631|NCT00659425|3656483|FG009|STARTED|Overall Study||14
2943632|NCT00659425|3656474|FG000|COMPLETED|Overall Study||0
2943633|NCT00659425|3656475|FG001|COMPLETED|Overall Study||0
2943634|NCT00659425|3656476|FG002|COMPLETED|Overall Study||0
2943635|NCT00659425|3656477|FG003|COMPLETED|Overall Study||0
2943636|NCT00659425|3656478|FG004|COMPLETED|Overall Study||0
2943637|NCT00659425|3656479|FG005|COMPLETED|Overall Study||1
2943638|NCT00659425|3656480|FG006|COMPLETED|Overall Study||0
2943639|NCT00659425|3656481|FG007|COMPLETED|Overall Study||0
2943640|NCT00659425|3656482|FG008|COMPLETED|Overall Study||0
2943641|NCT00659425|3656483|FG009|COMPLETED|Overall Study||1
2943642|NCT00659425|3656474|FG000|NOT COMPLETED|Overall Study||1
2943643|NCT00659425|3656475|FG001|NOT COMPLETED|Overall Study||1
2943644|NCT00659425|3656476|FG002|NOT COMPLETED|Overall Study||1
2943645|NCT00659425|3656477|FG003|NOT COMPLETED|Overall Study||4
2943646|NCT00659425|3656478|FG004|NOT COMPLETED|Overall Study||4
2943647|NCT00659425|3656479|FG005|NOT COMPLETED|Overall Study||4
2943648|NCT00659425|3656480|FG006|NOT COMPLETED|Overall Study||8
2943649|NCT00659425|3656481|FG007|NOT COMPLETED|Overall Study||11
2943650|NCT00659425|3656482|FG008|NOT COMPLETED|Overall Study||6
2943651|NCT00659425|3656483|FG009|NOT COMPLETED|Overall Study||13
2943652|NCT00659438|3656520|FG000|STARTED|Overall Study||47
2943653|NCT00659438|3656521|FG001|STARTED|Overall Study||48
2943654|NCT00659438|3656520|FG000|Assessable Set : Primary Analysis|Overall Study||44
2943655|NCT00659438|3656521|FG001|Assessable Set : Primary Analysis|Overall Study||45
2943656|NCT00659438|3656520|FG000|Secondary Analysis Set|Overall Study||47
2943657|NCT00659438|3656521|FG001|Secondary Analysis Set|Overall Study||48
2943658|NCT00659438|3656520|FG000|Safety Analysis Set|Overall Study|One patient randomized to placebo was accounted in vandetanib group as he mistakenly received drug|48
2943659|NCT00659438|3656521|FG001|Safety Analysis Set|Overall Study||47
2943660|NCT00659438|3656520|FG000|COMPLETED|Overall Study||33
2943661|NCT00659438|3656521|FG001|COMPLETED|Overall Study||40
2943662|NCT00659438|3656520|FG000|NOT COMPLETED|Overall Study||14
2943663|NCT00659438|3656521|FG001|NOT COMPLETED|Overall Study||8
2943664|NCT00659490|3656530|FG000|STARTED|Overall Study||61
3298729|NCT02927080|4032442|FG001|STARTED|Overall Study||6
3298730|NCT02927080|4032443|FG002|STARTED|Overall Study||6
3298731|NCT02927080|4032444|FG003|STARTED|Overall Study||6
3298732|NCT02927080|4032445|FG004|STARTED|Overall Study||7
3298733|NCT02927080|4032446|FG005|STARTED|Overall Study||6
3298734|NCT02927080|4032447|FG006|STARTED|Overall Study||15
3298735|NCT02927080|4032448|FG007|STARTED|Overall Study||14
3298736|NCT02927080|4032449|FG008|STARTED|Overall Study||15
3298737|NCT02927080|4032450|FG009|STARTED|Overall Study||14
3298738|NCT02927080|4032441|FG000|Open-Label Extension From Part 2 Double Blind-Placebo Controlled|Overall Study||0
3298739|NCT02927080|4032442|FG001|Open-Label Extension From Part 2 Double Blind-Placebo Controlled|Overall Study||0
3298740|NCT02927080|4032443|FG002|Open-Label Extension From Part 2 Double Blind-Placebo Controlled|Overall Study||0
2943665|NCT00659490|3656531|FG001|STARTED|Overall Study||59
2943666|NCT00659490|3656532|FG002|STARTED|Overall Study||31
2943667|NCT00659490|3656530|FG000|COMPLETED|Overall Study||59
2943668|NCT00659490|3656531|FG001|COMPLETED|Overall Study||59
2943669|NCT00659490|3656532|FG002|COMPLETED|Overall Study||30
2943670|NCT00659490|3656530|FG000|NOT COMPLETED|Overall Study||2
2943671|NCT00659490|3656531|FG001|NOT COMPLETED|Overall Study||0
2943672|NCT00659490|3656532|FG002|NOT COMPLETED|Overall Study||1
2943673|NCT00659529|3656540|FG000|STARTED|Overall Study|There were 9 screen failures (subjects who did not meet inclusion/exclusion criteria)|36
2943674|NCT00659529|3656540|FG000|Received at Least One Dose of Study Drug|Overall Study|Received at least one dose of study drug|27
3034634|NCT01133405|3753630|FG009|COMPLETED|Period 2||0
2943675|NCT00659529|3656540|FG000|COMPLETED|Overall Study|4 patients withdrew as a result of side effects. 3 subjects were withdrawn by the investigator.|20
2943676|NCT00659529|3656540|FG000|NOT COMPLETED|Overall Study||16
2943677|NCT00659581|3656544|FG000|STARTED|Overall Study||20994
2943678|NCT00659581|3656544|FG000|COMPLETED|Overall Study||12412
2943679|NCT00659581|3656544|FG000|NOT COMPLETED|Overall Study||8582
2943680|NCT00659607|3656548|FG000|STARTED|Overall Study||3932
2943681|NCT00659607|3656548|FG000|COMPLETED|Overall Study||3616
2943682|NCT00659607|3656548|FG000|NOT COMPLETED|Overall Study||316
2943683|NCT00659633|3656554|FG000|STARTED|Overall Study||10
2943684|NCT00659633|3656554|FG000|COMPLETED|Overall Study||10
2943685|NCT00659633|3656554|FG000|NOT COMPLETED|Overall Study||0
2943686|NCT00659724|3656558|FG000|STARTED|Weeks 1-2: Assessment of 180NR or 200NR||33
2943687|NCT00659724|3656558|FG000|COMPLETED|Weeks 1-2: Assessment of 180NR or 200NR||33
2943688|NCT00659724|3656558|FG000|NOT COMPLETED|Weeks 1-2: Assessment of 180NR or 200NR||0
2943689|NCT00659724|3656558|FG000|STARTED|Weeks 3-4: Assessment of HD-C4 Big||33
2943690|NCT00659724|3656558|FG000|COMPLETED|Weeks 3-4: Assessment of HD-C4 Big||33
2943691|NCT00659724|3656558|FG000|NOT COMPLETED|Weeks 3-4: Assessment of HD-C4 Big||0
2943692|NCT00659737|3656566|FG000|STARTED|Overall Study||57
2943693|NCT00659737|3656567|FG001|STARTED|Overall Study||58
2943694|NCT00659737|3656566|FG000|COMPLETED|Overall Study||57
2943695|NCT00659737|3656567|FG001|COMPLETED|Overall Study||58
2943696|NCT00659737|3656566|FG000|NOT COMPLETED|Overall Study||0
2943697|NCT00659737|3656567|FG001|NOT COMPLETED|Overall Study||0
2943698|NCT00659789|3656575|FG000|STARTED|Overall Study||93
2943699|NCT00659789|3656576|FG001|STARTED|Overall Study||43
2943700|NCT00659789|3656575|FG000|COMPLETED|Overall Study||86
2943701|NCT00659789|3656576|FG001|COMPLETED|Overall Study||36
2943702|NCT00659789|3656575|FG000|NOT COMPLETED|Overall Study||7
2943703|NCT00659789|3656576|FG001|NOT COMPLETED|Overall Study||7
2943704|NCT00659802|3656585|FG000|STARTED|Overall Study||74
2943705|NCT00659802|3656586|FG001|STARTED|Overall Study|One patient was incorrectly randomized and was excluded from the efficacy analyses.|75
2943706|NCT00659802|3656587|FG002|STARTED|Overall Study||75
2943707|NCT00659802|3656585|FG000|COMPLETED|Overall Study||59
2943708|NCT00659802|3656586|FG001|COMPLETED|Overall Study||57
2943709|NCT00659802|3656587|FG002|COMPLETED|Overall Study||64
2943710|NCT00659802|3656585|FG000|NOT COMPLETED|Overall Study||15
2943711|NCT00659802|3656586|FG001|NOT COMPLETED|Overall Study||18
2943712|NCT00659802|3656587|FG002|NOT COMPLETED|Overall Study||11
2943713|NCT00659815|3656597|FG000|STARTED|Overall Study||157
2943714|NCT00659815|3656598|FG001|STARTED|Overall Study||151
2943715|NCT00659815|3656597|FG000|COMPLETED|Overall Study||153
2943716|NCT00659815|3656598|FG001|COMPLETED|Overall Study||147
2943717|NCT00659815|3656597|FG000|NOT COMPLETED|Overall Study||4
2943718|NCT00659815|3656598|FG001|NOT COMPLETED|Overall Study||4
2943719|NCT00659828|3656604|FG000|STARTED|Overall Study||1
2943720|NCT00659828|3656604|FG000|COMPLETED|Overall Study||1
2943721|NCT00659828|3656604|FG000|NOT COMPLETED|Overall Study||0
2943722|NCT00659880|3656608|FG000|STARTED|Overall Study||9
2943723|NCT00659880|3656608|FG000|6 Weeks|Overall Study||9
2943724|NCT00659880|3656608|FG000|6 Months|Overall Study||9
2943725|NCT00659880|3656608|FG000|12 Months|Overall Study||7
2943726|NCT00659880|3656608|FG000|24 Months|Overall Study||6
2943727|NCT00659880|3656608|FG000|COMPLETED|Overall Study|60 months|4
2943728|NCT00659880|3656608|FG000|NOT COMPLETED|Overall Study||5
2943729|NCT00659945|3656615|FG000|STARTED|Overall Study||75
2943730|NCT00659945|3656616|FG001|STARTED|Overall Study||75
2943731|NCT00659945|3656615|FG000|COMPLETED|Overall Study||75
2943732|NCT00659945|3656616|FG001|COMPLETED|Overall Study||75
2943733|NCT00659945|3656615|FG000|NOT COMPLETED|Overall Study||0
2943734|NCT00659945|3656616|FG001|NOT COMPLETED|Overall Study||0
2943735|NCT00659984|3656622|FG000|STARTED|Overall Study||15
2943736|NCT00659984|3656622|FG000|COMPLETED|Overall Study||14
2943737|NCT00659984|3656622|FG000|NOT COMPLETED|Overall Study||1
2943738|NCT00660010|3656632|FG000|STARTED|Overall Study||55
2943739|NCT00660010|3656632|FG000|COMPLETED|Overall Study||46
2943740|NCT00660010|3656632|FG000|NOT COMPLETED|Overall Study||9
2943741|NCT00660023|3656636|FG000|STARTED|Overall Study||124
2943742|NCT00660023|3656636|FG000|Treated|Overall Study||114
2943743|NCT00660023|3656636|FG000|COMPLETED|Overall Study||95
2943744|NCT00660023|3656636|FG000|NOT COMPLETED|Overall Study||29
2943745|NCT00660049|3656640|FG000|STARTED|Overall Study||12
2943746|NCT00660049|3656640|FG000|COMPLETED|Overall Study||6
2943747|NCT00660049|3656640|FG000|NOT COMPLETED|Overall Study||6
2943748|NCT00660075|3656646|FG000|STARTED|First Intervention (Week 1 to Week 6)||18
2943749|NCT00660075|3656647|FG001|STARTED|First Intervention (Week 1 to Week 6)||18
2943750|NCT00660075|3656646|FG000|COMPLETED|First Intervention (Week 1 to Week 6)||18
2943751|NCT00660075|3656647|FG001|COMPLETED|First Intervention (Week 1 to Week 6)||18
2943752|NCT00660075|3656646|FG000|NOT COMPLETED|First Intervention (Week 1 to Week 6)||0
2943753|NCT00660075|3656647|FG001|NOT COMPLETED|First Intervention (Week 1 to Week 6)||0
2943754|NCT00660075|3656646|FG000|STARTED|Washout Period (Week 7 to Week 10)||18
2943755|NCT00660075|3656647|FG001|STARTED|Washout Period (Week 7 to Week 10)||18
2943756|NCT00660075|3656646|FG000|COMPLETED|Washout Period (Week 7 to Week 10)||18
2943757|NCT00660075|3656647|FG001|COMPLETED|Washout Period (Week 7 to Week 10)||18
2943758|NCT00660075|3656646|FG000|NOT COMPLETED|Washout Period (Week 7 to Week 10)||0
2943759|NCT00660075|3656647|FG001|NOT COMPLETED|Washout Period (Week 7 to Week 10)||0
2943760|NCT00660075|3656646|FG000|STARTED|Second Intervention (Week 11 to Week 16||18
2943761|NCT00660075|3656647|FG001|STARTED|Second Intervention (Week 11 to Week 16||18
2943762|NCT00660075|3656646|FG000|COMPLETED|Second Intervention (Week 11 to Week 16||18
2943763|NCT00660075|3656647|FG001|COMPLETED|Second Intervention (Week 11 to Week 16||18
2943764|NCT00660075|3656646|FG000|NOT COMPLETED|Second Intervention (Week 11 to Week 16||0
2943765|NCT00660075|3656647|FG001|NOT COMPLETED|Second Intervention (Week 11 to Week 16||0
2943766|NCT00660179|3656656|FG000|STARTED|Overall Study||250
2943767|NCT00660179|3656657|FG001|STARTED|Overall Study||250
2943768|NCT00660179|3656658|FG002|STARTED|Overall Study||242
2943769|NCT00660179|3656656|FG000|COMPLETED|Overall Study||194
2943770|NCT00660179|3656657|FG001|COMPLETED|Overall Study||192
2943771|NCT00660179|3656658|FG002|COMPLETED|Overall Study||201
2943772|NCT00660179|3656656|FG000|NOT COMPLETED|Overall Study||56
2943773|NCT00660179|3656657|FG001|NOT COMPLETED|Overall Study||58
2943774|NCT00660179|3656658|FG002|NOT COMPLETED|Overall Study||41
2943775|NCT00660192|3656668|FG000|STARTED|Overall Study||12
2943776|NCT00660192|3656669|FG001|STARTED|Overall Study||13
2943777|NCT00660192|3656668|FG000|COMPLETED|Overall Study||10
2943778|NCT00660192|3656669|FG001|COMPLETED|Overall Study||10
2943779|NCT00660192|3656668|FG000|NOT COMPLETED|Overall Study||2
2943780|NCT00660192|3656669|FG001|NOT COMPLETED|Overall Study||3
2943781|NCT00660309|3656677|FG000|STARTED|Overall Study|Represents participants who received one dose of Captopril.|23
2943782|NCT00660309|3656678|FG001|STARTED|Overall Study|Represents participants who received one dose of Captopril.|22
2943783|NCT00660309|3656677|FG000|Treated With Aliskiren or Irbesartan|Overall Study||22
2943784|NCT00660309|3656678|FG001|Treated With Aliskiren or Irbesartan|Overall Study||21
2943785|NCT00660309|3656677|FG000|Pharmacodynamic Analysis Set|Overall Study||22
2943786|NCT00660309|3656678|FG001|Pharmacodynamic Analysis Set|Overall Study||20
2943787|NCT00660309|3656677|FG000|COMPLETED|Overall Study||21
2943788|NCT00660309|3656678|FG001|COMPLETED|Overall Study||19
2943789|NCT00660309|3656677|FG000|NOT COMPLETED|Overall Study||2
2943790|NCT00660309|3656678|FG001|NOT COMPLETED|Overall Study||3
2943791|NCT00660387|3656687|FG000|STARTED|Overall Study||37
2943792|NCT00660387|3656688|FG001|STARTED|Overall Study||34
2943793|NCT00660387|3656687|FG000|COMPLETED|Overall Study||35
2943794|NCT00660387|3656688|FG001|COMPLETED|Overall Study||31
2943795|NCT00660387|3656687|FG000|NOT COMPLETED|Overall Study||2
2943796|NCT00660387|3656688|FG001|NOT COMPLETED|Overall Study||3
2943797|NCT00660400|3656694|FG000|STARTED|Overall Study||25
2943798|NCT00660400|3656694|FG000|COMPLETED|Overall Study||21
2943799|NCT00660400|3656694|FG000|NOT COMPLETED|Overall Study||4
2943800|NCT00660504|3656700|FG000|STARTED|Overall Study||149
2943801|NCT00660504|3656701|FG001|STARTED|Overall Study||151
2943802|NCT00660504|3656700|FG000|COMPLETED|Overall Study||149
2943803|NCT00660504|3656701|FG001|COMPLETED|Overall Study||150
2943804|NCT00660504|3656700|FG000|NOT COMPLETED|Overall Study||0
2943805|NCT00660504|3656701|FG001|NOT COMPLETED|Overall Study||1
2943806|NCT00660517|3656711|FG000|STARTED|Overall Study||153
2943807|NCT00660517|3656712|FG001|STARTED|Overall Study||152
2943808|NCT00660517|3656713|FG002|STARTED|Overall Study||151
2943809|NCT00660517|3656714|FG003|STARTED|Overall Study||151
2943810|NCT00660517|3656711|FG000|COMPLETED|Overall Study||145
2943811|NCT00660517|3656712|FG001|COMPLETED|Overall Study||144
2943812|NCT00660517|3656713|FG002|COMPLETED|Overall Study||144
2943813|NCT00660517|3656714|FG003|COMPLETED|Overall Study||144
2943814|NCT00660517|3656711|FG000|NOT COMPLETED|Overall Study||8
2943815|NCT00660517|3656712|FG001|NOT COMPLETED|Overall Study||8
2943816|NCT00660517|3656713|FG002|NOT COMPLETED|Overall Study||7
2943817|NCT00660517|3656714|FG003|NOT COMPLETED|Overall Study||7
2943818|NCT00660530|3656725|FG000|STARTED|Overall Study||11
2943819|NCT00660530|3656725|FG000|COMPLETED|Overall Study||11
2943820|NCT00660530|3656725|FG000|NOT COMPLETED|Overall Study||0
2943821|NCT00660543|3656731|FG000|STARTED|Overall Study||14
2943822|NCT00660543|3656731|FG000|COMPLETED|Overall Study||14
2943823|NCT00660543|3656731|FG000|NOT COMPLETED|Overall Study||0
2943824|NCT00660660|3656742|FG000|STARTED|Overall Study|Randomized|143
2943825|NCT00660660|3656743|FG001|STARTED|Overall Study|Randomized|133
2943826|NCT00660660|3656742|FG000|Met Criteria for MITT Population|Overall Study||137
2943827|NCT00660660|3656743|FG001|Met Criteria for MITT Population|Overall Study||125
2943828|NCT00660660|3656742|FG000|COMPLETED|Overall Study|Number of completed patients is based on randomized population (143) minus withdrawals (5).|138
2943829|NCT00660660|3656743|FG001|COMPLETED|Overall Study|Number of completed patients is based on randomized population (133) minus withdrawals (9).|124
2943830|NCT00660660|3656742|FG000|NOT COMPLETED|Overall Study||5
2943831|NCT00660660|3656743|FG001|NOT COMPLETED|Overall Study||9
2943832|NCT00660699|3656749|FG000|STARTED|Overall Study||50
2943833|NCT00660699|3656749|FG000|COMPLETED|Overall Study||48
2943834|NCT00660699|3656749|FG000|NOT COMPLETED|Overall Study||2
2943835|NCT00660790|3656753|FG000|STARTED|Baseline to 3 Months||97
2943836|NCT00660790|3656753|FG000|COMPLETED|Baseline to 3 Months||94
2943837|NCT00660790|3656753|FG000|NOT COMPLETED|Baseline to 3 Months||3
2943838|NCT00660790|3656753|FG000|STARTED|3 Months to 2 Years||94
2943839|NCT00660790|3656753|FG000|COMPLETED|3 Months to 2 Years||77
2943840|NCT00660790|3656753|FG000|NOT COMPLETED|3 Months to 2 Years||17
2943841|NCT00660816|3656759|FG000|STARTED|Overall Study||24
2943842|NCT00660816|3656760|FG001|STARTED|Overall Study||22
2943843|NCT00660816|3656759|FG000|COMPLETED|Overall Study||4
2943844|NCT00660816|3656760|FG001|COMPLETED|Overall Study||3
2943845|NCT00660816|3656759|FG000|NOT COMPLETED|Overall Study||20
3132431|NCT01691105|3857480|FG000|STARTED|12 Month Follow-up||477
2943846|NCT00660816|3656760|FG001|NOT COMPLETED|Overall Study||19
2943847|NCT00660829|3656768|FG000|STARTED|Overall Study|2 subjects were randomized in error|268
2943848|NCT00660829|3656769|FG001|STARTED|Overall Study|2 subjects were randomized in error|268
2943849|NCT00660829|3656768|FG000|COMPLETED|Overall Study||250
2943850|NCT00660829|3656769|FG001|COMPLETED|Overall Study||249
2943851|NCT00660829|3656768|FG000|NOT COMPLETED|Overall Study||18
2943852|NCT00660829|3656769|FG001|NOT COMPLETED|Overall Study||19
2943853|NCT00660907|3656777|FG000|STARTED|Overall Study|Of the 406 randomized participants only 400 were included in the full analysis set.|406
3163389|NCT01886716|3890934|FG002|STARTED|Week 2||20
3163390|NCT01886716|3890935|FG003|STARTED|Week 2||18
3163391|NCT01886716|3890932|FG000|COMPLETED|Week 2||21
3163392|NCT01886716|3890933|FG001|COMPLETED|Week 2||18
3163393|NCT01886716|3890934|FG002|COMPLETED|Week 2||19
3163394|NCT01886716|3890935|FG003|COMPLETED|Week 2||15
3163395|NCT01886716|3890932|FG000|NOT COMPLETED|Week 2||3
3163396|NCT01886716|3890933|FG001|NOT COMPLETED|Week 2||2
2943854|NCT00660907|3656778|FG001|STARTED|Overall Study|Of the 408 randomized participants only 401 were included in the full analysis set.|408
2943855|NCT00660907|3656777|FG000|COMPLETED|Overall Study||322
2943856|NCT00660907|3656778|FG001|COMPLETED|Overall Study||314
2943857|NCT00660907|3656777|FG000|NOT COMPLETED|Overall Study||84
2943858|NCT00660907|3656778|FG001|NOT COMPLETED|Overall Study||94
2943859|NCT00660985|3656786|FG000|STARTED|Overall Study||26
2943860|NCT00660985|3656787|FG001|STARTED|Overall Study||25
2943861|NCT00660985|3656786|FG000|COMPLETED|Overall Study||25
2943862|NCT00660985|3656787|FG001|COMPLETED|Overall Study||25
2943863|NCT00660985|3656786|FG000|NOT COMPLETED|Overall Study||1
2943864|NCT00660985|3656787|FG001|NOT COMPLETED|Overall Study||0
2943865|NCT00661037|3656795|FG000|STARTED|Overall Study||836
2943866|NCT00661037|3656796|FG001|STARTED|Overall Study||1284
2943867|NCT00661037|3656795|FG000|Witdrawn|Overall Study||47
2943868|NCT00661037|3656796|FG001|Witdrawn|Overall Study||68
2943869|NCT00661037|3656795|FG000|Deaths|Overall Study||108
2943870|NCT00661037|3656796|FG001|Deaths|Overall Study||188
2943871|NCT00661037|3656795|FG000|COMPLETED|Overall Study||682
2943872|NCT00661037|3656796|FG001|COMPLETED|Overall Study||1027
2943873|NCT00661037|3656795|FG000|NOT COMPLETED|Overall Study||154
2943874|NCT00661037|3656796|FG001|NOT COMPLETED|Overall Study||257
2943875|NCT00661089|3656806|FG000|STARTED|Overall Study||10
2943876|NCT00661089|3656807|FG001|STARTED|Overall Study||11
2943877|NCT00661089|3656806|FG000|COMPLETED|Overall Study||10
2943878|NCT00661089|3656807|FG001|COMPLETED|Overall Study||9
2943879|NCT00661089|3656806|FG000|NOT COMPLETED|Overall Study||0
2943880|NCT00661089|3656807|FG001|NOT COMPLETED|Overall Study||2
2943881|NCT00661141|3656817|FG000|STARTED|Overall Study||8
2943882|NCT00661141|3656818|FG001|STARTED|Overall Study||8
2943883|NCT00661141|3656819|FG002|STARTED|Overall Study||4
2943884|NCT00661141|3656820|FG003|STARTED|Overall Study||4
2943885|NCT00661141|3656821|FG004|STARTED|Overall Study||4
2943886|NCT00661141|3656822|FG005|STARTED|Overall Study||4
2943887|NCT00661141|3656817|FG000|Administered 30 Minutes Prior to Ethanol|Overall Study||6
2943888|NCT00661141|3656818|FG001|Administered 30 Minutes Prior to Ethanol|Overall Study||6
2943889|NCT00661141|3656819|FG002|Administered 30 Minutes Prior to Ethanol|Overall Study||2
2943890|NCT00661141|3656820|FG003|Administered 30 Minutes Prior to Ethanol|Overall Study||2
2943891|NCT00661141|3656821|FG004|Administered 30 Minutes Prior to Ethanol|Overall Study||4
2943892|NCT00661141|3656822|FG005|Administered 30 Minutes Prior to Ethanol|Overall Study||4
2943893|NCT00661141|3656817|FG000|Administered 30 Minutes After Ethanol|Overall Study||2
2943894|NCT00661141|3656818|FG001|Administered 30 Minutes After Ethanol|Overall Study||2
2943895|NCT00661141|3656819|FG002|Administered 30 Minutes After Ethanol|Overall Study||2
2943896|NCT00661141|3656820|FG003|Administered 30 Minutes After Ethanol|Overall Study||2
2943897|NCT00661141|3656821|FG004|Administered 30 Minutes After Ethanol|Overall Study||0
2943898|NCT00661141|3656822|FG005|Administered 30 Minutes After Ethanol|Overall Study||0
2943899|NCT00661141|3656817|FG000|COMPLETED|Overall Study||8
2943900|NCT00661141|3656818|FG001|COMPLETED|Overall Study||8
2943901|NCT00661141|3656819|FG002|COMPLETED|Overall Study||4
2943902|NCT00661141|3656820|FG003|COMPLETED|Overall Study||4
2943903|NCT00661141|3656821|FG004|COMPLETED|Overall Study||4
2943904|NCT00661141|3656822|FG005|COMPLETED|Overall Study||4
2943905|NCT00661141|3656817|FG000|NOT COMPLETED|Overall Study||0
2943906|NCT00661141|3656818|FG001|NOT COMPLETED|Overall Study||0
2943907|NCT00661141|3656819|FG002|NOT COMPLETED|Overall Study||0
2943908|NCT00661141|3656820|FG003|NOT COMPLETED|Overall Study||0
2943909|NCT00661141|3656821|FG004|NOT COMPLETED|Overall Study||0
2943910|NCT00661141|3656822|FG005|NOT COMPLETED|Overall Study||0
2943911|NCT00661193|3656843|FG000|STARTED|Overall Study||33
2943912|NCT00661193|3656844|FG001|STARTED|Overall Study||26
2943913|NCT00661193|3656843|FG000|COMPLETED|Overall Study||0
2943914|NCT00661193|3656844|FG001|COMPLETED|Overall Study||0
2943915|NCT00661193|3656843|FG000|NOT COMPLETED|Overall Study||33
2943916|NCT00661193|3656844|FG001|NOT COMPLETED|Overall Study||26
2943917|NCT00661258|3656852|FG000|STARTED|Overall Study||34
2943918|NCT00661258|3656853|FG001|STARTED|Overall Study||34
2943919|NCT00661258|3656852|FG000|COMPLETED|Overall Study||31
2943920|NCT00661258|3656853|FG001|COMPLETED|Overall Study||33
2943921|NCT00661258|3656852|FG000|NOT COMPLETED|Overall Study||3
2943922|NCT00661258|3656853|FG001|NOT COMPLETED|Overall Study||1
2943923|NCT00661271|3656861|FG000|STARTED|Overall Study||48
3163397|NCT01886716|3890934|FG002|NOT COMPLETED|Week 2||1
3163398|NCT01886716|3890935|FG003|NOT COMPLETED|Week 2||3
2943924|NCT00661271|3656862|FG001|STARTED|Overall Study||45
2943925|NCT00661271|3656861|FG000|COMPLETED|Overall Study||20
2943926|NCT00661271|3656862|FG001|COMPLETED|Overall Study||20
2943927|NCT00661271|3656861|FG000|NOT COMPLETED|Overall Study||28
2943928|NCT00661271|3656862|FG001|NOT COMPLETED|Overall Study||25
2943929|NCT00661362|3656870|FG000|STARTED|Overall Study|Randomized and treated|283
2943930|NCT00661362|3656871|FG001|STARTED|Overall Study|Randomized and treated|287
2943931|NCT00661362|3656870|FG000|COMPLETED|Overall Study|Completed 24 Weeks of treatment|254
2943932|NCT00661362|3656871|FG001|COMPLETED|Overall Study|Completed 24 Weeks of treatment|247
2943933|NCT00661362|3656870|FG000|NOT COMPLETED|Overall Study||29
2943934|NCT00661362|3656871|FG001|NOT COMPLETED|Overall Study||40
2943935|NCT00661388|3656877|FG000|STARTED|Overall Study||75
2943936|NCT00661388|3656877|FG000|COMPLETED|Overall Study||51
2943937|NCT00661388|3656877|FG000|NOT COMPLETED|Overall Study||24
2943938|NCT00661427|3656883|FG000|STARTED|Overall Study||35
2943939|NCT00661427|3656884|FG001|STARTED|Overall Study||26
2943940|NCT00661427|3656883|FG000|COMPLETED|Overall Study||30
2943941|NCT00661427|3656884|FG001|COMPLETED|Overall Study||19
2943942|NCT00661427|3656883|FG000|NOT COMPLETED|Overall Study||5
2943943|NCT00661427|3656884|FG001|NOT COMPLETED|Overall Study||7
2943944|NCT00661453|3656890|FG000|STARTED|Overall Study||38
2943945|NCT00661453|3656890|FG000|COMPLETED|Overall Study||25
2943946|NCT00661453|3656890|FG000|NOT COMPLETED|Overall Study||13
2943947|NCT00661479|3656898|FG000|STARTED|Overall Study||12
2943948|NCT00661479|3656899|FG001|STARTED|Overall Study||3
2943949|NCT00661479|3656900|FG002|STARTED|Overall Study||3
2943950|NCT00661479|3656901|FG003|STARTED|Overall Study||3
2943951|NCT00661479|3656898|FG000|COMPLETED|Overall Study||12
2943952|NCT00661479|3656899|FG001|COMPLETED|Overall Study||3
2943953|NCT00661479|3656900|FG002|COMPLETED|Overall Study||3
2943954|NCT00661479|3656901|FG003|COMPLETED|Overall Study||3
2943955|NCT00661479|3656898|FG000|NOT COMPLETED|Overall Study||0
2943956|NCT00661479|3656899|FG001|NOT COMPLETED|Overall Study||0
2943957|NCT00661479|3656900|FG002|NOT COMPLETED|Overall Study||0
2943958|NCT00661479|3656901|FG003|NOT COMPLETED|Overall Study||0
2943959|NCT00661492|3656912|FG000|STARTED|Overall Study||75
2943960|NCT00661492|3656913|FG001|STARTED|Overall Study||40
2943961|NCT00661492|3656912|FG000|COMPLETED|Overall Study||7
2943962|NCT00661492|3656913|FG001|COMPLETED|Overall Study||11
2943963|NCT00661492|3656912|FG000|NOT COMPLETED|Overall Study||68
2943964|NCT00661492|3656913|FG001|NOT COMPLETED|Overall Study||29
2943965|NCT00661505|3656919|FG000|STARTED|Overall Study||132
2943966|NCT00661505|3656919|FG000|COMPLETED|Overall Study||102
2943967|NCT00661505|3656919|FG000|NOT COMPLETED|Overall Study||30
2943968|NCT00661531|3656924|FG000|STARTED|Overall Study||11
2943969|NCT00661531|3656924|FG000|COMPLETED|Overall Study||8
2943970|NCT00661531|3656924|FG000|NOT COMPLETED|Overall Study||3
2943971|NCT00661544|3656928|FG000|STARTED|Overall Study||48
2943972|NCT00661544|3656928|FG000|COMPLETED|Overall Study||48
2943973|NCT00661544|3656928|FG000|NOT COMPLETED|Overall Study||0
2943974|NCT00661557|3656934|FG000|STARTED|Overall Study||192
2943975|NCT00661557|3656935|FG001|STARTED|Overall Study||79
2943976|NCT00661557|3656934|FG000|COMPLETED|Overall Study||183
2943977|NCT00661557|3656935|FG001|COMPLETED|Overall Study||79
2943978|NCT00661557|3656934|FG000|NOT COMPLETED|Overall Study||9
2943979|NCT00661557|3656935|FG001|NOT COMPLETED|Overall Study||0
2943980|NCT00661570|3656941|FG000|STARTED|Overall Study||26
2943981|NCT00661570|3656941|FG000|COMPLETED|Overall Study||26
2943982|NCT00661570|3656941|FG000|NOT COMPLETED|Overall Study||0
2943983|NCT00661583|3656948|FG000|STARTED|Overall Study||10
2943984|NCT00661583|3656949|FG001|STARTED|Overall Study||10
2943985|NCT00661583|3656950|FG002|STARTED|Overall Study||10
2943986|NCT00661583|3656948|FG000|COMPLETED|Overall Study||10
2943987|NCT00661583|3656949|FG001|COMPLETED|Overall Study||10
2943988|NCT00661583|3656950|FG002|COMPLETED|Overall Study||10
2943989|NCT00661583|3656948|FG000|NOT COMPLETED|Overall Study||0
2943990|NCT00661583|3656949|FG001|NOT COMPLETED|Overall Study||0
2943991|NCT00661583|3656950|FG002|NOT COMPLETED|Overall Study||0
2943992|NCT00661609|3656958|FG000|STARTED|Overall Study|All dosed patients|41
2943993|NCT00661609|3656958|FG000|COMPLETED|Overall Study|Treatment is not for a fixed period and continues until a discontinuation criterion is met.|0
2943994|NCT00661609|3656958|FG000|NOT COMPLETED|Overall Study||41
2943995|NCT00661622|3656964|FG000|STARTED|Overall Study||26
2943996|NCT00661622|3656965|FG001|STARTED|Overall Study||27
2943997|NCT00661622|3656964|FG000|COMPLETED|Overall Study||25
2943998|NCT00661622|3656965|FG001|COMPLETED|Overall Study||27
2943999|NCT00661622|3656964|FG000|NOT COMPLETED|Overall Study||1
2944000|NCT00661622|3656965|FG001|NOT COMPLETED|Overall Study||0
2944001|NCT00661661|3656974|FG000|STARTED|Overall Study||382
3132432|NCT01691105|3857481|FG001|STARTED|12 Month Follow-up||567
3132433|NCT01691105|3857480|FG000|COMPLETED|12 Month Follow-up||405
3132434|NCT01691105|3857481|FG001|COMPLETED|12 Month Follow-up||466
3132435|NCT01691105|3857480|FG000|NOT COMPLETED|12 Month Follow-up||72
2944002|NCT00661661|3656975|FG001|STARTED|Overall Study||105
2944003|NCT00661661|3656974|FG000|COMPLETED|Overall Study||242
2944004|NCT00661661|3656975|FG001|COMPLETED|Overall Study||66
2944005|NCT00661661|3656974|FG000|NOT COMPLETED|Overall Study||140
2944006|NCT00661661|3656975|FG001|NOT COMPLETED|Overall Study||39
2944007|NCT00661674|3656983|FG000|STARTED|Overall Study|Participants 1 & 10 were assigned to sequence 1|2
3132436|NCT01691105|3857481|FG001|NOT COMPLETED|12 Month Follow-up||101
3132437|NCT01691105|3857480|FG000|STARTED|12 Month Biochemical Verification||477
2944008|NCT00661674|3656984|FG001|STARTED|Overall Study|Participants 2 & 3 were assigned to sequence 2|2
2944009|NCT00661674|3656985|FG002|STARTED|Overall Study|Participants 4 & 7 were assigned to sequence 3|2
2944010|NCT00661674|3656986|FG003|STARTED|Overall Study|Participant 5 was assigned to sequence 4|1
2944011|NCT00661674|3656987|FG004|STARTED|Overall Study|Participants 6 & 8 were assigned to sequence 5|2
2944012|NCT00661674|3656988|FG005|STARTED|Overall Study|Participant 9 was assigned to sequence 6|1
2944013|NCT00661674|3656983|FG000|COMPLETED|Overall Study|Participants 1 & 10 completed sequence 1|2
2944014|NCT00661674|3656984|FG001|COMPLETED|Overall Study|Participants 2 & 3 completed sequence 2|2
2944015|NCT00661674|3656985|FG002|COMPLETED|Overall Study|Participants 4 & 7 completed sequence 3|2
2944016|NCT00661674|3656986|FG003|COMPLETED|Overall Study|Participant 5 completed sequence 4|1
2944017|NCT00661674|3656987|FG004|COMPLETED|Overall Study|Participants 6 & 8 completed sequence 5|2
2944018|NCT00661674|3656988|FG005|COMPLETED|Overall Study|Participant 9 completed sequence 6|1
2944019|NCT00661674|3656983|FG000|NOT COMPLETED|Overall Study||0
2944020|NCT00661674|3656984|FG001|NOT COMPLETED|Overall Study||0
2944021|NCT00661674|3656985|FG002|NOT COMPLETED|Overall Study||0
2944022|NCT00661674|3656986|FG003|NOT COMPLETED|Overall Study||0
2944023|NCT00661674|3656987|FG004|NOT COMPLETED|Overall Study||0
2944024|NCT00661674|3656988|FG005|NOT COMPLETED|Overall Study||0
2944025|NCT00661687|3656996|FG000|STARTED|Overall Study|Contralateral study design, numbers indicate number of subjects.|204
2944026|NCT00661687|3656996|FG000|COMPLETED|Overall Study|Number indicates number of subjects successfully completing study.|189
2944027|NCT00661687|3656996|FG000|NOT COMPLETED|Overall Study||15
2944028|NCT00661713|3657010|FG000|STARTED|Overall Study||128
2944029|NCT00661713|3657011|FG001|STARTED|Overall Study||247
2944030|NCT00661713|3657012|FG002|STARTED|Overall Study||128
2944031|NCT00661713|3657013|FG003|STARTED|Overall Study||247
2944032|NCT00661713|3657014|FG004|STARTED|Overall Study||127
2944033|NCT00661713|3657015|FG005|STARTED|Overall Study||253
2944034|NCT00661713|3657016|FG006|STARTED|Overall Study||373
2944035|NCT00661713|3657017|FG007|STARTED|Overall Study||128
2944036|NCT00661713|3657010|FG000|COMPLETED|Overall Study||112
2944037|NCT00661713|3657011|FG001|COMPLETED|Overall Study||208
2944038|NCT00661713|3657012|FG002|COMPLETED|Overall Study||111
2944039|NCT00661713|3657013|FG003|COMPLETED|Overall Study||219
2944040|NCT00661713|3657014|FG004|COMPLETED|Overall Study||107
2944041|NCT00661713|3657015|FG005|COMPLETED|Overall Study||216
2944042|NCT00661713|3657016|FG006|COMPLETED|Overall Study||309
2944043|NCT00661713|3657017|FG007|COMPLETED|Overall Study||117
2944044|NCT00661713|3657010|FG000|NOT COMPLETED|Overall Study||16
2944045|NCT00661713|3657011|FG001|NOT COMPLETED|Overall Study||39
2944046|NCT00661713|3657012|FG002|NOT COMPLETED|Overall Study||17
2944047|NCT00661713|3657013|FG003|NOT COMPLETED|Overall Study||28
2944048|NCT00661713|3657014|FG004|NOT COMPLETED|Overall Study||20
2944049|NCT00661713|3657015|FG005|NOT COMPLETED|Overall Study||37
2944050|NCT00661713|3657016|FG006|NOT COMPLETED|Overall Study||64
2944051|NCT00661713|3657017|FG007|NOT COMPLETED|Overall Study||11
2944052|NCT00661726|3657037|FG000|STARTED|Overall Study||6
2944053|NCT00661726|3657037|FG000|COMPLETED|Overall Study||5
2944054|NCT00661726|3657037|FG000|NOT COMPLETED|Overall Study||1
2944055|NCT00661778|3657041|FG000|STARTED|Overall Study||50
2944056|NCT00661778|3657041|FG000|COMPLETED|Overall Study||0
2944057|NCT00661778|3657041|FG000|NOT COMPLETED|Overall Study||50
2944058|NCT00661830|3657047|FG000|STARTED|Overall Study||49
2944059|NCT00661830|3657048|FG001|STARTED|Overall Study||48
2944060|NCT00661830|3657047|FG000|COMPLETED|Overall Study||9
2944061|NCT00661830|3657048|FG001|COMPLETED|Overall Study||6
2944062|NCT00661830|3657047|FG000|NOT COMPLETED|Overall Study||40
2944063|NCT00661830|3657048|FG001|NOT COMPLETED|Overall Study||42
2944064|NCT00661895|3657056|FG000|STARTED|Overall Study||49
2944065|NCT00661895|3657057|FG001|STARTED|Overall Study||50
2944066|NCT00661895|3657056|FG000|COMPLETED|Overall Study||49
2944067|NCT00661895|3657057|FG001|COMPLETED|Overall Study||50
2944068|NCT00661895|3657056|FG000|NOT COMPLETED|Overall Study||0
2944069|NCT00661895|3657057|FG001|NOT COMPLETED|Overall Study||0
2944070|NCT00661960|3657066|FG000|STARTED|Overall Study||5
2944071|NCT00661960|3657067|FG001|STARTED|Overall Study||10
2944072|NCT00661960|3657068|FG002|STARTED|Overall Study||10
2944073|NCT00661960|3657066|FG000|COMPLETED|Overall Study||5
2944074|NCT00661960|3657067|FG001|COMPLETED|Overall Study||7
2944075|NCT00661960|3657068|FG002|COMPLETED|Overall Study||9
2944076|NCT00661960|3657066|FG000|NOT COMPLETED|Overall Study||0
2944077|NCT00661960|3657067|FG001|NOT COMPLETED|Overall Study||3
2944078|NCT00661960|3657068|FG002|NOT COMPLETED|Overall Study||1
2944079|NCT00661999|3657079|FG000|STARTED|Overall Study||164
2944080|NCT00661999|3657080|FG001|STARTED|Overall Study||163
2944081|NCT00661999|3657081|FG002|STARTED|Overall Study||163
2944082|NCT00661999|3657079|FG000|COMPLETED|Overall Study||105
2944083|NCT00661999|3657080|FG001|COMPLETED|Overall Study||113
2944084|NCT00661999|3657081|FG002|COMPLETED|Overall Study||106
2944085|NCT00661999|3657079|FG000|NOT COMPLETED|Overall Study||59
2944086|NCT00661999|3657080|FG001|NOT COMPLETED|Overall Study||50
2944087|NCT00661999|3657081|FG002|NOT COMPLETED|Overall Study||57
2944088|NCT00662012|3657089|FG000|STARTED|Overall Study||414
2944089|NCT00662012|3657089|FG000|COMPLETED|Overall Study||327
2944090|NCT00662012|3657089|FG000|NOT COMPLETED|Overall Study||87
2944091|NCT00662025|3657093|FG000|STARTED|Overall Study|All 63 participants were included in Full Analysis Set population.|63
2944092|NCT00662025|3657093|FG000|COMPLETED|Overall Study||0
2944093|NCT00662025|3657093|FG000|NOT COMPLETED|Overall Study||63
2944094|NCT00662038|3657097|FG000|STARTED|Overall Study||1058
2944095|NCT00662038|3657097|FG000|COMPLETED|Overall Study||427
2944096|NCT00662038|3657097|FG000|NOT COMPLETED|Overall Study||631
2944097|NCT00662129|3657101|FG000|STARTED|Overall Study||50
2944098|NCT00662129|3657101|FG000|COMPLETED|Overall Study||47
2944099|NCT00662129|3657101|FG000|NOT COMPLETED|Overall Study||3
2944100|NCT00662155|3657109|FG000|STARTED|Overall Study||16
2944101|NCT00662155|3657110|FG001|STARTED|Overall Study||20
2944102|NCT00662155|3657111|FG002|STARTED|Overall Study||20
2944103|NCT00662155|3657112|FG003|STARTED|Overall Study||18
2944104|NCT00662155|3657109|FG000|COMPLETED|Overall Study||13
2944105|NCT00662155|3657110|FG001|COMPLETED|Overall Study||15
2944106|NCT00662155|3657111|FG002|COMPLETED|Overall Study||13
2944107|NCT00662155|3657112|FG003|COMPLETED|Overall Study||14
2944108|NCT00662155|3657109|FG000|NOT COMPLETED|Overall Study||3
2944109|NCT00662155|3657110|FG001|NOT COMPLETED|Overall Study||5
2944110|NCT00662155|3657111|FG002|NOT COMPLETED|Overall Study||7
2944111|NCT00662155|3657112|FG003|NOT COMPLETED|Overall Study||4
2944112|NCT00662207|3657122|FG000|STARTED|Overall Study||3
2944113|NCT00662207|3657122|FG000|COMPLETED|Overall Study||3
2944114|NCT00662207|3657122|FG000|NOT COMPLETED|Overall Study||0
2944115|NCT00662259|3657128|FG000|STARTED|Overall Study||21
2944116|NCT00662259|3657129|FG001|STARTED|Overall Study||11
2944117|NCT00662259|3657128|FG000|COMPLETED|Overall Study||19
2944118|NCT00662259|3657129|FG001|COMPLETED|Overall Study||11
2944119|NCT00662259|3657128|FG000|NOT COMPLETED|Overall Study||2
2944120|NCT00662259|3657129|FG001|NOT COMPLETED|Overall Study||0
3132438|NCT01691105|3857481|FG001|STARTED|12 Month Biochemical Verification||567
3132439|NCT01691105|3857480|FG000|COMPLETED|12 Month Biochemical Verification||53
3132440|NCT01691105|3857481|FG001|COMPLETED|12 Month Biochemical Verification||65
3132441|NCT01691105|3857480|FG000|NOT COMPLETED|12 Month Biochemical Verification||424
3132442|NCT01691105|3857481|FG001|NOT COMPLETED|12 Month Biochemical Verification||502
3136729|NCT01714726|3861990|FG002|COMPLETED|Double-Blinded Induction Period||0
3136730|NCT01714726|3861991|FG003|COMPLETED|Double-Blinded Induction Period||0
3136731|NCT01714726|3861988|FG000|NOT COMPLETED|Double-Blinded Induction Period||8
3136732|NCT01714726|3861989|FG001|NOT COMPLETED|Double-Blinded Induction Period||7
2944121|NCT00662298|3657135|FG000|STARTED|Overall Study||5
2944122|NCT00662298|3657135|FG000|COMPLETED|Overall Study||5
2944123|NCT00662298|3657135|FG000|NOT COMPLETED|Overall Study||0
2944124|NCT00662311|3657142|FG000|STARTED|Overall Study||5
2944125|NCT00662311|3657143|FG001|STARTED|Overall Study||0
2944126|NCT00662311|3657144|FG002|STARTED|Overall Study||0
3136733|NCT01714726|3861990|FG002|NOT COMPLETED|Double-Blinded Induction Period||0
2944127|NCT00662311|3657142|FG000|COMPLETED|Overall Study||4
2944128|NCT00662311|3657143|FG001|COMPLETED|Overall Study||0
2944129|NCT00662311|3657144|FG002|COMPLETED|Overall Study||0
2944130|NCT00662311|3657142|FG000|NOT COMPLETED|Overall Study||1
2944131|NCT00662311|3657143|FG001|NOT COMPLETED|Overall Study||0
2944132|NCT00662311|3657144|FG002|NOT COMPLETED|Overall Study||0
2944133|NCT00662363|3657154|FG000|STARTED|Overall Study||32
2944134|NCT00662363|3657155|FG001|STARTED|Overall Study||32
2944135|NCT00662363|3657154|FG000|COMPLETED|Overall Study|1 subject withdrew before taking any study medication|21
2944136|NCT00662363|3657155|FG001|COMPLETED|Overall Study|one subject died before receiving any study med 2 subjects withdrew before taking any study med|22
2944137|NCT00662363|3657154|FG000|NOT COMPLETED|Overall Study||11
2944138|NCT00662363|3657155|FG001|NOT COMPLETED|Overall Study||10
2944139|NCT00662532|3657165|FG000|STARTED|Overall Study||22
2944140|NCT00662532|3657166|FG001|STARTED|Overall Study||22
2944141|NCT00662532|3657165|FG000|COMPLETED|Overall Study||22
2944142|NCT00662532|3657166|FG001|COMPLETED|Overall Study||20
2944143|NCT00662532|3657165|FG000|NOT COMPLETED|Overall Study||0
2944144|NCT00662532|3657166|FG001|NOT COMPLETED|Overall Study||2
2944145|NCT00662545|3657174|FG000|STARTED|Overall Study||5
2944146|NCT00662545|3657175|FG001|STARTED|Overall Study||5
2944147|NCT00662545|3657174|FG000|COMPLETED|Overall Study||5
2944148|NCT00662545|3657175|FG001|COMPLETED|Overall Study||5
2944149|NCT00662545|3657174|FG000|NOT COMPLETED|Overall Study||0
2944150|NCT00662545|3657175|FG001|NOT COMPLETED|Overall Study||0
2944151|NCT00662558|3657183|FG000|STARTED|Overall Study||398
2944152|NCT00662558|3657184|FG001|STARTED|Overall Study||404
2944153|NCT00662558|3657183|FG000|Received Treatment|Overall Study||396
2944154|NCT00662558|3657184|FG001|Received Treatment|Overall Study||396
2944155|NCT00662558|3657183|FG000|COMPLETED|Overall Study||342
2944156|NCT00662558|3657184|FG001|COMPLETED|Overall Study||294
2944157|NCT00662558|3657183|FG000|NOT COMPLETED|Overall Study||56
2944158|NCT00662558|3657184|FG001|NOT COMPLETED|Overall Study||110
2944159|NCT00662649|3657194|FG000|STARTED|Core Study (24 Months)||429
2944160|NCT00662649|3657195|FG001|STARTED|Core Study (24 Months)||425
2944161|NCT00662649|3657196|FG002|STARTED|Core Study (24 Months)||418
2944162|NCT00662649|3657197|FG003|STARTED|Core Study (24 Months)|This reporting group is used only in extension study.|0
2944163|NCT00662649|3657198|FG004|STARTED|Core Study (24 Months)|This reporting group is used only in extension study.|0
2944164|NCT00662649|3657194|FG000|Intent to Treat (ITT)|Core Study (24 Months)||429
2944165|NCT00662649|3657195|FG001|Intent to Treat (ITT)|Core Study (24 Months)||425
2944166|NCT00662649|3657196|FG002|Intent to Treat (ITT)|Core Study (24 Months)||418
2944167|NCT00662649|3657197|FG003|Intent to Treat (ITT)|Core Study (24 Months)||0
2944168|NCT00662649|3657198|FG004|Intent to Treat (ITT)|Core Study (24 Months)||0
3136734|NCT01714726|3861991|FG003|NOT COMPLETED|Double-Blinded Induction Period||0
2944169|NCT00662649|3657194|FG000|COMPLETED|Core Study (24 Months)||332
2944170|NCT00662649|3657195|FG001|COMPLETED|Core Study (24 Months)||369
2944171|NCT00662649|3657196|FG002|COMPLETED|Core Study (24 Months)||332
3132443|NCT01691248|3857489|FG000|STARTED|Overall Study|Randomized|305
3132444|NCT01691248|3857490|FG001|STARTED|Overall Study|Randomized|306
3132445|NCT01691248|3857489|FG000|Treated|Overall Study|Received at least 1 dose of study drug|301
3132446|NCT01691248|3857490|FG001|Treated|Overall Study|Received at least 1 dose of study drug|299
3136735|NCT01714726|3861988|FG000|STARTED|Open-Label Period||0
2944172|NCT00662649|3657197|FG003|COMPLETED|Core Study (24 Months)||0
2944173|NCT00662649|3657198|FG004|COMPLETED|Core Study (24 Months)||0
2944174|NCT00662649|3657194|FG000|NOT COMPLETED|Core Study (24 Months)||97
2944175|NCT00662649|3657195|FG001|NOT COMPLETED|Core Study (24 Months)||56
2944176|NCT00662649|3657196|FG002|NOT COMPLETED|Core Study (24 Months)||86
2944177|NCT00662649|3657197|FG003|NOT COMPLETED|Core Study (24 Months)||0
2944178|NCT00662649|3657198|FG004|NOT COMPLETED|Core Study (24 Months)||0
2944179|NCT00662649|3657194|FG000|STARTED|Extension Study (Month 24 to 60)||289
2944180|NCT00662649|3657195|FG001|STARTED|Extension Study (Month 24 to 60)||331
2944181|NCT00662649|3657196|FG002|STARTED|Extension Study (Month 24 to 60)|This reporting group is used only for core study|0
2944182|NCT00662649|3657197|FG003|STARTED|Extension Study (Month 24 to 60)||145
2944183|NCT00662649|3657198|FG004|STARTED|Extension Study (Month 24 to 60)||155
2944184|NCT00662649|3657194|FG000|Extension Intent to Treat Population|Extension Study (Month 24 to 60)||287
2944185|NCT00662649|3657195|FG001|Extension Intent to Treat Population|Extension Study (Month 24 to 60)||330
2944186|NCT00662649|3657196|FG002|Extension Intent to Treat Population|Extension Study (Month 24 to 60)||0
2944187|NCT00662649|3657197|FG003|Extension Intent to Treat Population|Extension Study (Month 24 to 60)||145
2944188|NCT00662649|3657198|FG004|Extension Intent to Treat Population|Extension Study (Month 24 to 60)||154
2944189|NCT00662649|3657194|FG000|From Beginning of Core at Month 24|Extension Study (Month 24 to 60)||289
2944190|NCT00662649|3657195|FG001|From Beginning of Core at Month 24|Extension Study (Month 24 to 60)||331
2944191|NCT00662649|3657196|FG002|From Beginning of Core at Month 24|Extension Study (Month 24 to 60)||0
2944192|NCT00662649|3657197|FG003|From Beginning of Core at Month 24|Extension Study (Month 24 to 60)||145
2944193|NCT00662649|3657198|FG004|From Beginning of Core at Month 24|Extension Study (Month 24 to 60)||155
2944194|NCT00662649|3657194|FG000|From Beginning of Core at Month 30|Extension Study (Month 24 to 60)||276
2944195|NCT00662649|3657195|FG001|From Beginning of Core at Month 30|Extension Study (Month 24 to 60)||324
2944196|NCT00662649|3657196|FG002|From Beginning of Core at Month 30|Extension Study (Month 24 to 60)||0
2944197|NCT00662649|3657197|FG003|From Beginning of Core at Month 30|Extension Study (Month 24 to 60)||136
2944198|NCT00662649|3657198|FG004|From Beginning of Core at Month 30|Extension Study (Month 24 to 60)||152
2944199|NCT00662649|3657194|FG000|From Beginning of Core at Month 36|Extension Study (Month 24 to 60)||270
2944200|NCT00662649|3657195|FG001|From Beginning of Core at Month 36|Extension Study (Month 24 to 60)||311
2944201|NCT00662649|3657196|FG002|From Beginning of Core at Month 36|Extension Study (Month 24 to 60)||0
2944202|NCT00662649|3657197|FG003|From Beginning of Core at Month 36|Extension Study (Month 24 to 60)||130
2944203|NCT00662649|3657198|FG004|From Beginning of Core at Month 36|Extension Study (Month 24 to 60)||145
2944204|NCT00662649|3657194|FG000|From Beginning of Core at Month 42|Extension Study (Month 24 to 60)||254
2944205|NCT00662649|3657195|FG001|From Beginning of Core at Month 42|Extension Study (Month 24 to 60)||301
2944206|NCT00662649|3657196|FG002|From Beginning of Core at Month 42|Extension Study (Month 24 to 60)||0
2944207|NCT00662649|3657197|FG003|From Beginning of Core at Month 42|Extension Study (Month 24 to 60)||120
2944208|NCT00662649|3657198|FG004|From Beginning of Core at Month 42|Extension Study (Month 24 to 60)||136
2944209|NCT00662649|3657194|FG000|From Beginning of Core at Month 48|Extension Study (Month 24 to 60)||125
2944210|NCT00662649|3657195|FG001|From Beginning of Core at Month 48|Extension Study (Month 24 to 60)||152
2944211|NCT00662649|3657196|FG002|From Beginning of Core at Month 48|Extension Study (Month 24 to 60)||0
2944212|NCT00662649|3657197|FG003|From Beginning of Core at Month 48|Extension Study (Month 24 to 60)||58
2944213|NCT00662649|3657198|FG004|From Beginning of Core at Month 48|Extension Study (Month 24 to 60)||67
2944214|NCT00662649|3657194|FG000|From Beginning of Core at Month 54|Extension Study (Month 24 to 60)||31
2944215|NCT00662649|3657195|FG001|From Beginning of Core at Month 54|Extension Study (Month 24 to 60)||32
2944216|NCT00662649|3657196|FG002|From Beginning of Core at Month 54|Extension Study (Month 24 to 60)||0
2944217|NCT00662649|3657197|FG003|From Beginning of Core at Month 54|Extension Study (Month 24 to 60)||11
2944218|NCT00662649|3657198|FG004|From Beginning of Core at Month 54|Extension Study (Month 24 to 60)||13
2944219|NCT00662649|3657194|FG000|COMPLETED|Extension Study (Month 24 to 60)|"completed refers to patients that completed extension study in different time points."|245
2944220|NCT00662649|3657195|FG001|COMPLETED|Extension Study (Month 24 to 60)||290
2944221|NCT00662649|3657196|FG002|COMPLETED|Extension Study (Month 24 to 60)||0
2944222|NCT00662649|3657197|FG003|COMPLETED|Extension Study (Month 24 to 60)||112
2944223|NCT00662649|3657198|FG004|COMPLETED|Extension Study (Month 24 to 60)||126
2944224|NCT00662649|3657194|FG000|NOT COMPLETED|Extension Study (Month 24 to 60)||44
2944225|NCT00662649|3657195|FG001|NOT COMPLETED|Extension Study (Month 24 to 60)||41
2944226|NCT00662649|3657196|FG002|NOT COMPLETED|Extension Study (Month 24 to 60)||0
2944227|NCT00662649|3657197|FG003|NOT COMPLETED|Extension Study (Month 24 to 60)||33
2944228|NCT00662649|3657198|FG004|NOT COMPLETED|Extension Study (Month 24 to 60)||29
3034635|NCT01133405|3753621|FG000|NOT COMPLETED|Period 2||0
3034636|NCT01133405|3753622|FG001|NOT COMPLETED|Period 2||1
2944229|NCT00662675|3657214|FG000|STARTED|Overall Study||20
2944230|NCT00662675|3657215|FG001|STARTED|Overall Study||20
2944231|NCT00662675|3657214|FG000|COMPLETED|Overall Study||20
2944232|NCT00662675|3657215|FG001|COMPLETED|Overall Study||20
2944233|NCT00662675|3657214|FG000|NOT COMPLETED|Overall Study||0
2944234|NCT00662675|3657215|FG001|NOT COMPLETED|Overall Study||0
2944235|NCT00662818|3657223|FG000|STARTED|Period 1 (6 Weeks)||84
2944236|NCT00662818|3657224|FG001|STARTED|Period 1 (6 Weeks)||81
2944237|NCT00662818|3657223|FG000|Treated|Period 1 (6 Weeks)||56
2944238|NCT00662818|3657224|FG001|Treated|Period 1 (6 Weeks)||58
2944239|NCT00662818|3657223|FG000|COMPLETED|Period 1 (6 Weeks)||56
2944240|NCT00662818|3657224|FG001|COMPLETED|Period 1 (6 Weeks)||58
2944241|NCT00662818|3657223|FG000|NOT COMPLETED|Period 1 (6 Weeks)||28
2944242|NCT00662818|3657224|FG001|NOT COMPLETED|Period 1 (6 Weeks)||23
2944243|NCT00662818|3657223|FG000|STARTED|Wash-Out (14 Days)||56
2944244|NCT00662818|3657224|FG001|STARTED|Wash-Out (14 Days)||58
2944245|NCT00662818|3657223|FG000|COMPLETED|Wash-Out (14 Days)||51
2944246|NCT00662818|3657224|FG001|COMPLETED|Wash-Out (14 Days)||53
2944247|NCT00662818|3657223|FG000|NOT COMPLETED|Wash-Out (14 Days)||5
2944248|NCT00662818|3657224|FG001|NOT COMPLETED|Wash-Out (14 Days)||5
2944249|NCT00662818|3657223|FG000|STARTED|Period 2 (6 Weeks)||51
2944250|NCT00662818|3657224|FG001|STARTED|Period 2 (6 Weeks)||53
2944251|NCT00662818|3657223|FG000|COMPLETED|Period 2 (6 Weeks)||38
2944252|NCT00662818|3657224|FG001|COMPLETED|Period 2 (6 Weeks)||41
2944253|NCT00662818|3657223|FG000|NOT COMPLETED|Period 2 (6 Weeks)||13
2944254|NCT00662818|3657224|FG001|NOT COMPLETED|Period 2 (6 Weeks)||12
2944255|NCT00662831|3657234|FG000|STARTED|Overall Study||184
2944256|NCT00662831|3657235|FG001|STARTED|Overall Study||92
2944257|NCT00662831|3657234|FG000|COMPLETED|Overall Study||78
2944258|NCT00662831|3657235|FG001|COMPLETED|Overall Study||33
2944259|NCT00662831|3657234|FG000|NOT COMPLETED|Overall Study||106
2944260|NCT00662831|3657235|FG001|NOT COMPLETED|Overall Study||59
2944261|NCT00662857|3657241|FG000|STARTED|TI Dosing Period 1 (1 Day)||13
2944262|NCT00662857|3657242|FG001|STARTED|TI Dosing Period 1 (1 Day)||16
2944263|NCT00662857|3657241|FG000|COMPLETED|TI Dosing Period 1 (1 Day)||13
2944264|NCT00662857|3657242|FG001|COMPLETED|TI Dosing Period 1 (1 Day)||16
2944265|NCT00662857|3657241|FG000|NOT COMPLETED|TI Dosing Period 1 (1 Day)||0
2944266|NCT00662857|3657242|FG001|NOT COMPLETED|TI Dosing Period 1 (1 Day)||0
2944267|NCT00662857|3657241|FG000|STARTED|Washout 1 (3 - 14 Days)||13
2944268|NCT00662857|3657242|FG001|STARTED|Washout 1 (3 - 14 Days)||16
2944269|NCT00662857|3657241|FG000|COMPLETED|Washout 1 (3 - 14 Days)||13
2944270|NCT00662857|3657242|FG001|COMPLETED|Washout 1 (3 - 14 Days)||14
2944271|NCT00662857|3657241|FG000|NOT COMPLETED|Washout 1 (3 - 14 Days)||0
2944272|NCT00662857|3657242|FG001|NOT COMPLETED|Washout 1 (3 - 14 Days)||2
2944273|NCT00662857|3657241|FG000|STARTED|TI Dosing Period 2 (1 Day)||13
2944274|NCT00662857|3657242|FG001|STARTED|TI Dosing Period 2 (1 Day)||14
2944275|NCT00662857|3657241|FG000|COMPLETED|TI Dosing Period 2 (1 Day)||13
2944276|NCT00662857|3657242|FG001|COMPLETED|TI Dosing Period 2 (1 Day)||14
2944277|NCT00662857|3657241|FG000|NOT COMPLETED|TI Dosing Period 2 (1 Day)||0
2944278|NCT00662857|3657242|FG001|NOT COMPLETED|TI Dosing Period 2 (1 Day)||0
2944279|NCT00662857|3657241|FG000|STARTED|Washout 2 (3 - 14 Days)||13
2944280|NCT00662857|3657242|FG001|STARTED|Washout 2 (3 - 14 Days)||14
2944281|NCT00662857|3657241|FG000|COMPLETED|Washout 2 (3 - 14 Days)||12
2944282|NCT00662857|3657242|FG001|COMPLETED|Washout 2 (3 - 14 Days)||14
2944283|NCT00662857|3657241|FG000|NOT COMPLETED|Washout 2 (3 - 14 Days)||1
2944284|NCT00662857|3657242|FG001|NOT COMPLETED|Washout 2 (3 - 14 Days)||0
2944285|NCT00662857|3657241|FG000|STARTED|Lispro Dosing Period (1 Day)||12
2944286|NCT00662857|3657242|FG001|STARTED|Lispro Dosing Period (1 Day)||14
2944287|NCT00662857|3657241|FG000|COMPLETED|Lispro Dosing Period (1 Day)||12
2944288|NCT00662857|3657242|FG001|COMPLETED|Lispro Dosing Period (1 Day)||14
2944289|NCT00662857|3657241|FG000|NOT COMPLETED|Lispro Dosing Period (1 Day)||0
2944290|NCT00662857|3657242|FG001|NOT COMPLETED|Lispro Dosing Period (1 Day)||0
2944291|NCT00662909|3657254|FG000|STARTED|Overall Study||454
2944292|NCT00662909|3657255|FG001|STARTED|Overall Study||442
2944293|NCT00662909|3657256|FG002|STARTED|Overall Study||433
2944294|NCT00662909|3657254|FG000|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|453
2944295|NCT00662909|3657255|FG001|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|442
2944296|NCT00662909|3657256|FG002|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|433
2944297|NCT00662909|3657254|FG000|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|433
2944298|NCT00662909|3657255|FG001|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|425
2944299|NCT00662909|3657256|FG002|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|412
2944300|NCT00662909|3657254|FG000|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|325
2944301|NCT00662909|3657255|FG001|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|312
2944302|NCT00662909|3657256|FG002|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|296
2944303|NCT00662909|3657254|FG000|COMPLETED|Overall Study||385
2944304|NCT00662909|3657255|FG001|COMPLETED|Overall Study||383
2944305|NCT00662909|3657256|FG002|COMPLETED|Overall Study||380
2944306|NCT00662909|3657254|FG000|NOT COMPLETED|Overall Study||69
2944307|NCT00662909|3657255|FG001|NOT COMPLETED|Overall Study||59
2944308|NCT00662909|3657256|FG002|NOT COMPLETED|Overall Study||53
2944309|NCT00663026|3657267|FG000|STARTED|Overall Study||19
2944310|NCT00663026|3657268|FG001|STARTED|Overall Study||29
2944311|NCT00663026|3657269|FG002|STARTED|Overall Study||31
2944312|NCT00663026|3657267|FG000|COMPLETED|Overall Study||17
2944313|NCT00663026|3657268|FG001|COMPLETED|Overall Study||23
2944314|NCT00663026|3657269|FG002|COMPLETED|Overall Study||27
2944315|NCT00663026|3657267|FG000|NOT COMPLETED|Overall Study||2
2944316|NCT00663026|3657268|FG001|NOT COMPLETED|Overall Study||6
2944317|NCT00663026|3657269|FG002|NOT COMPLETED|Overall Study||4
2944318|NCT00663039|3657279|FG000|STARTED|Overall Study||14
2944319|NCT00663039|3657280|FG001|STARTED|Overall Study||13
2944320|NCT00663039|3657279|FG000|COMPLETED|Overall Study||10
2944321|NCT00663039|3657280|FG001|COMPLETED|Overall Study||9
2944322|NCT00663039|3657279|FG000|NOT COMPLETED|Overall Study||4
2944323|NCT00663039|3657280|FG001|NOT COMPLETED|Overall Study||4
2944324|NCT00663117|3657288|FG000|STARTED|Overall Study||20
2944325|NCT00663117|3657289|FG001|STARTED|Overall Study||20
2944326|NCT00663117|3657288|FG000|COMPLETED|Overall Study|One patient in placebo flared and was unblinded and crossed over to active drug|19
2944327|NCT00663117|3657289|FG001|COMPLETED|Overall Study||20
2944328|NCT00663117|3657288|FG000|NOT COMPLETED|Overall Study||1
2944329|NCT00663117|3657289|FG001|NOT COMPLETED|Overall Study||0
2944330|NCT00663169|3657303|FG000|STARTED|Overall Study||3
2944331|NCT00663169|3657304|FG001|STARTED|Overall Study||3
2944332|NCT00663169|3657303|FG000|COMPLETED|Overall Study||3
2944333|NCT00663169|3657304|FG001|COMPLETED|Overall Study||3
2944334|NCT00663169|3657303|FG000|NOT COMPLETED|Overall Study||0
2944335|NCT00663169|3657304|FG001|NOT COMPLETED|Overall Study||0
2944336|NCT00663208|3657317|FG000|STARTED|Treatment Period||4
2944337|NCT00663208|3657318|FG001|STARTED|Treatment Period||4
2944338|NCT00663208|3657319|FG002|STARTED|Treatment Period||4
2944339|NCT00663208|3657320|FG003|STARTED|Treatment Period||4
2944340|NCT00663208|3657321|FG004|STARTED|Treatment Period||4
3298741|NCT02927080|4032444|FG003|Open-Label Extension From Part 2 Double Blind-Placebo Controlled|Overall Study||0
3298742|NCT02927080|4032445|FG004|Open-Label Extension From Part 2 Double Blind-Placebo Controlled|Overall Study||0
3298743|NCT02927080|4032446|FG005|Open-Label Extension From Part 2 Double Blind-Placebo Controlled|Overall Study||0
2944341|NCT00663208|3657322|FG005|STARTED|Treatment Period||4
2944342|NCT00663208|3657323|FG006|STARTED|Treatment Period||6
2944343|NCT00663208|3657317|FG000|COMPLETED|Treatment Period||4
2944344|NCT00663208|3657318|FG001|COMPLETED|Treatment Period||3
2944345|NCT00663208|3657319|FG002|COMPLETED|Treatment Period||4
2944346|NCT00663208|3657320|FG003|COMPLETED|Treatment Period||4
2944347|NCT00663208|3657321|FG004|COMPLETED|Treatment Period||4
2944348|NCT00663208|3657322|FG005|COMPLETED|Treatment Period||4
2944349|NCT00663208|3657323|FG006|COMPLETED|Treatment Period||6
2944350|NCT00663208|3657317|FG000|NOT COMPLETED|Treatment Period||0
2944351|NCT00663208|3657318|FG001|NOT COMPLETED|Treatment Period||1
2944352|NCT00663208|3657319|FG002|NOT COMPLETED|Treatment Period||0
2944353|NCT00663208|3657320|FG003|NOT COMPLETED|Treatment Period||0
2944354|NCT00663208|3657321|FG004|NOT COMPLETED|Treatment Period||0
2944355|NCT00663208|3657322|FG005|NOT COMPLETED|Treatment Period||0
2944356|NCT00663208|3657323|FG006|NOT COMPLETED|Treatment Period||0
2944357|NCT00663208|3657317|FG000|STARTED|Follow-up Period||4
2944358|NCT00663208|3657318|FG001|STARTED|Follow-up Period||3
2944359|NCT00663208|3657319|FG002|STARTED|Follow-up Period||4
2944360|NCT00663208|3657320|FG003|STARTED|Follow-up Period||4
2944361|NCT00663208|3657321|FG004|STARTED|Follow-up Period||4
2944362|NCT00663208|3657322|FG005|STARTED|Follow-up Period||4
2944363|NCT00663208|3657323|FG006|STARTED|Follow-up Period||6
2944364|NCT00663208|3657317|FG000|COMPLETED|Follow-up Period||1
2944365|NCT00663208|3657318|FG001|COMPLETED|Follow-up Period||3
2944366|NCT00663208|3657319|FG002|COMPLETED|Follow-up Period||1
2944367|NCT00663208|3657320|FG003|COMPLETED|Follow-up Period||2
2944368|NCT00663208|3657321|FG004|COMPLETED|Follow-up Period||4
2944369|NCT00663208|3657322|FG005|COMPLETED|Follow-up Period||4
2944370|NCT00663208|3657323|FG006|COMPLETED|Follow-up Period||5
2944371|NCT00663208|3657317|FG000|NOT COMPLETED|Follow-up Period||3
2944372|NCT00663208|3657318|FG001|NOT COMPLETED|Follow-up Period||0
2944373|NCT00663208|3657319|FG002|NOT COMPLETED|Follow-up Period||3
2944374|NCT00663208|3657320|FG003|NOT COMPLETED|Follow-up Period||2
2944375|NCT00663208|3657321|FG004|NOT COMPLETED|Follow-up Period||0
2944376|NCT00663208|3657322|FG005|NOT COMPLETED|Follow-up Period||0
2944377|NCT00663208|3657323|FG006|NOT COMPLETED|Follow-up Period||1
2944378|NCT00663234|3657341|FG000|STARTED|Overall Study||28
2944379|NCT00663234|3657341|FG000|Dose Increased to 20 mg at Week 8|Overall Study||10
2944380|NCT00663234|3657341|FG000|COMPLETED|Overall Study||27
2944381|NCT00663234|3657341|FG000|NOT COMPLETED|Overall Study||1
2944382|NCT00663260|3657352|FG000|STARTED|Overall Study||84
2944383|NCT00663260|3657353|FG001|STARTED|Overall Study||83
2944384|NCT00663260|3657354|FG002|STARTED|Overall Study||85
2944385|NCT00663260|3657352|FG000|COMPLETED|Overall Study||63
2944386|NCT00663260|3657353|FG001|COMPLETED|Overall Study||72
2944387|NCT00663260|3657354|FG002|COMPLETED|Overall Study||69
2944388|NCT00663260|3657352|FG000|NOT COMPLETED|Overall Study||21
2944389|NCT00663260|3657353|FG001|NOT COMPLETED|Overall Study||11
2944390|NCT00663260|3657354|FG002|NOT COMPLETED|Overall Study||16
2944391|NCT00663403|3657362|FG000|STARTED|Overall Study||8
2944392|NCT00663403|3657362|FG000|COMPLETED|Overall Study||8
2944393|NCT00663403|3657362|FG000|NOT COMPLETED|Overall Study||0
2944394|NCT00663702|3657368|FG000|STARTED|Overall Study||52
2944395|NCT00663702|3657369|FG001|STARTED|Overall Study||71
2944396|NCT00663702|3657368|FG000|COMPLETED|Overall Study||34
2944397|NCT00663702|3657369|FG001|COMPLETED|Overall Study||61
2944398|NCT00663702|3657368|FG000|NOT COMPLETED|Overall Study||18
2944399|NCT00663702|3657369|FG001|NOT COMPLETED|Overall Study||10
2944400|NCT00663793|3657377|FG000|STARTED|Overall Study||8
2944401|NCT00663793|3657378|FG001|STARTED|Overall Study||8
2944402|NCT00663793|3657377|FG000|COMPLETED|Overall Study||8
2944403|NCT00663793|3657378|FG001|COMPLETED|Overall Study||8
2944404|NCT00663793|3657377|FG000|NOT COMPLETED|Overall Study||0
2944405|NCT00663793|3657378|FG001|NOT COMPLETED|Overall Study||0
2944406|NCT00663819|3657386|FG000|STARTED|Overall Study||123
2944407|NCT00663819|3657387|FG001|STARTED|Overall Study||135
2944408|NCT00663819|3657386|FG000|COMPLETED|Overall Study||123
2944409|NCT00663819|3657387|FG001|COMPLETED|Overall Study||135
2944410|NCT00663819|3657386|FG000|NOT COMPLETED|Overall Study||0
2944411|NCT00663819|3657387|FG001|NOT COMPLETED|Overall Study||0
2944412|NCT00663858|3657398|FG000|STARTED|Overall Study||212
2944413|NCT00663858|3657399|FG001|STARTED|Overall Study||106
2944414|NCT00663858|3657400|FG002|STARTED|Overall Study||102
2944415|NCT00663858|3657398|FG000|COMPLETED|Overall Study||178
2944416|NCT00663858|3657399|FG001|COMPLETED|Overall Study||96
2944417|NCT00663858|3657400|FG002|COMPLETED|Overall Study||82
2944418|NCT00663858|3657398|FG000|NOT COMPLETED|Overall Study||34
2944419|NCT00663858|3657399|FG001|NOT COMPLETED|Overall Study||10
2944420|NCT00663858|3657400|FG002|NOT COMPLETED|Overall Study||20
2944421|NCT00663871|3657410|FG000|STARTED|Overall Study||134
2944422|NCT00663871|3657411|FG001|STARTED|Overall Study||138
2944423|NCT00663871|3657410|FG000|COMPLETED|Overall Study||124
2944424|NCT00663871|3657411|FG001|COMPLETED|Overall Study||131
2944425|NCT00663871|3657410|FG000|NOT COMPLETED|Overall Study||10
2944426|NCT00663871|3657411|FG001|NOT COMPLETED|Overall Study||7
2944427|NCT00663923|3657419|FG000|STARTED|Overall Study||50
2944428|NCT00663923|3657419|FG000|COMPLETED|Overall Study||48
2944429|NCT00663923|3657419|FG000|NOT COMPLETED|Overall Study||2
2944430|NCT00663962|3657427|FG000|STARTED|Overall Study||7
2944431|NCT00663962|3657428|FG001|STARTED|Overall Study||8
2944432|NCT00663962|3657427|FG000|COMPLETED|Overall Study|1 patient excluded for somnolence and unblinded--in 300mg group|6
2944433|NCT00663962|3657428|FG001|COMPLETED|Overall Study||8
2944434|NCT00663962|3657427|FG000|NOT COMPLETED|Overall Study||1
2944435|NCT00663962|3657428|FG001|NOT COMPLETED|Overall Study||0
2944436|NCT00664105|3657434|FG000|STARTED|Overall Study||63
2944437|NCT00664105|3657434|FG000|COMPLETED|Overall Study||39
2944438|NCT00664105|3657434|FG000|NOT COMPLETED|Overall Study||24
2944439|NCT00664209|3657439|FG000|STARTED|Motor Fluctuations Screen||13
2944440|NCT00664209|3657439|FG000|COMPLETED|Motor Fluctuations Screen||6
2944441|NCT00664209|3657439|FG000|NOT COMPLETED|Motor Fluctuations Screen||7
2944442|NCT00664209|3657439|FG000|STARTED|Study Treatment Period||6
2944443|NCT00664209|3657439|FG000|COMPLETED|Study Treatment Period||0
2944444|NCT00664209|3657439|FG000|NOT COMPLETED|Study Treatment Period||6
2944445|NCT00664326|3657444|FG000|STARTED|Overall Study||49
2944446|NCT00664326|3657444|FG000|COMPLETED|Overall Study|transitioned to rollover study|1
2944447|NCT00664326|3657444|FG000|NOT COMPLETED|Overall Study||48
2944448|NCT00664430|3657448|FG000|STARTED|Overall Study||13
2944449|NCT00664430|3657448|FG000|COMPLETED|Overall Study|Study terminated early due to low enrollment rate.|0
2944450|NCT00664430|3657448|FG000|NOT COMPLETED|Overall Study||13
2944451|NCT00664521|3657454|FG000|STARTED|Overall Study||18
2944452|NCT00664521|3657455|FG001|STARTED|Overall Study||9
2944453|NCT00664521|3657454|FG000|COMPLETED|Overall Study||12
2944454|NCT00664521|3657455|FG001|COMPLETED|Overall Study||8
2944455|NCT00664521|3657454|FG000|NOT COMPLETED|Overall Study||6
2944456|NCT00664521|3657455|FG001|NOT COMPLETED|Overall Study||1
2944457|NCT00664534|3657463|FG000|STARTED|Overall Study||173
2944458|NCT00664534|3657464|FG001|STARTED|Overall Study||171
2944459|NCT00664534|3657463|FG000|COMPLETED|Overall Study||132
2944460|NCT00664534|3657464|FG001|COMPLETED|Overall Study||138
2944461|NCT00664534|3657463|FG000|NOT COMPLETED|Overall Study||41
2944462|NCT00664534|3657464|FG001|NOT COMPLETED|Overall Study||33
2944463|NCT00664560|3657473|FG000|STARTED|Overall Study|Safety Population|247
2944464|NCT00664560|3657474|FG001|STARTED|Overall Study|Safety Population|243
2944465|NCT00664560|3657475|FG002|STARTED|Overall Study|Safety Population|124
2944466|NCT00664560|3657473|FG000|COMPLETED|Overall Study||208
2944467|NCT00664560|3657474|FG001|COMPLETED|Overall Study||208
2944468|NCT00664560|3657475|FG002|COMPLETED|Overall Study||105
2944469|NCT00664560|3657473|FG000|NOT COMPLETED|Overall Study||39
2944470|NCT00664560|3657474|FG001|NOT COMPLETED|Overall Study||35
2944471|NCT00664560|3657475|FG002|NOT COMPLETED|Overall Study||19
2944472|NCT00664742|3657483|FG000|STARTED|Overall Study||607
2944473|NCT00664742|3657483|FG000|COMPLETED|Overall Study||481
2944474|NCT00664742|3657483|FG000|NOT COMPLETED|Overall Study||126
2944475|NCT00664755|3657489|FG000|STARTED|Overall Study||67
2944476|NCT00664755|3657490|FG001|STARTED|Overall Study||73
2944477|NCT00664755|3657489|FG000|COMPLETED|Overall Study||67
2944478|NCT00664755|3657490|FG001|COMPLETED|Overall Study||73
2944479|NCT00664755|3657489|FG000|NOT COMPLETED|Overall Study||0
2944480|NCT00664755|3657490|FG001|NOT COMPLETED|Overall Study||0
2944481|NCT00664859|3657499|FG000|STARTED|Overall Study||51
2944482|NCT00664859|3657500|FG001|STARTED|Overall Study||45
2944483|NCT00664859|3657501|FG002|STARTED|Overall Study||44
2944484|NCT00664859|3657499|FG000|COMPLETED|Overall Study||34
2944485|NCT00664859|3657500|FG001|COMPLETED|Overall Study||35
2944486|NCT00664859|3657501|FG002|COMPLETED|Overall Study||23
2944487|NCT00664859|3657499|FG000|NOT COMPLETED|Overall Study||17
2944488|NCT00664859|3657500|FG001|NOT COMPLETED|Overall Study||10
2944489|NCT00664859|3657501|FG002|NOT COMPLETED|Overall Study||21
2944490|NCT00665002|3657509|FG000|STARTED|Overall Study||16
2944491|NCT00665002|3657509|FG000|COMPLETED|Overall Study||4
2944492|NCT00665002|3657509|FG000|NOT COMPLETED|Overall Study||12
2944493|NCT00665132|3657513|FG000|STARTED|Overall Study||10
2944494|NCT00665132|3657513|FG000|COMPLETED|Overall Study||10
2944495|NCT00665132|3657513|FG000|NOT COMPLETED|Overall Study||0
2944496|NCT00665353|3657517|FG000|STARTED|Study Step 1||19
2944497|NCT00665353|3657517|FG000|COMPLETED|Study Step 1||16
2944498|NCT00665353|3657517|FG000|NOT COMPLETED|Study Step 1||3
2944499|NCT00665353|3657517|FG000|STARTED|Study Step 2||16
2944500|NCT00665353|3657517|FG000|COMPLETED|Study Step 2||2
2944501|NCT00665353|3657517|FG000|NOT COMPLETED|Study Step 2||14
2944502|NCT00665366|3657523|FG000|STARTED|Overall Study|Participants randomized|189
2944503|NCT00665366|3657524|FG001|STARTED|Overall Study|Participants randomized|181
2944504|NCT00665366|3657523|FG000|COMPLETED|Overall Study||131
2944505|NCT00665366|3657524|FG001|COMPLETED|Overall Study||122
2944506|NCT00665366|3657523|FG000|NOT COMPLETED|Overall Study||58
2944507|NCT00665366|3657524|FG001|NOT COMPLETED|Overall Study||59
2944508|NCT00665392|3657530|FG000|STARTED|Overall Study||42
2944509|NCT00665392|3657530|FG000|COMPLETED|Overall Study||41
2944510|NCT00665392|3657530|FG000|NOT COMPLETED|Overall Study||1
2944511|NCT00665431|3657538|FG000|STARTED|Overall Study|Safety population|243
2944512|NCT00665431|3657539|FG001|STARTED|Overall Study|Safety population|245
2944513|NCT00665431|3657540|FG002|STARTED|Overall Study|Safety population|122
2944514|NCT00665431|3657538|FG000|COMPLETED|Overall Study||203
2944515|NCT00665431|3657539|FG001|COMPLETED|Overall Study||188
2944516|NCT00665431|3657540|FG002|COMPLETED|Overall Study||98
2944517|NCT00665431|3657538|FG000|NOT COMPLETED|Overall Study||40
2944518|NCT00665431|3657539|FG001|NOT COMPLETED|Overall Study||57
2944519|NCT00665431|3657540|FG002|NOT COMPLETED|Overall Study||24
2944520|NCT00665457|3657548|FG000|STARTED|Overall Study||3
2944521|NCT00665457|3657548|FG000|COMPLETED|Overall Study||3
2944522|NCT00665457|3657548|FG000|NOT COMPLETED|Overall Study||0
2944523|NCT00665470|3657554|FG000|STARTED|Overall Study||10
2944524|NCT00665470|3657555|FG001|STARTED|Overall Study||0
2944525|NCT00665470|3657554|FG000|COMPLETED|Overall Study||10
2944526|NCT00665470|3657555|FG001|COMPLETED|Overall Study||0
2944527|NCT00665470|3657554|FG000|NOT COMPLETED|Overall Study||0
2944528|NCT00665470|3657555|FG001|NOT COMPLETED|Overall Study||0
2944529|NCT00665561|3657563|FG000|STARTED|Overall Study||1316
2944530|NCT00665561|3657564|FG001|STARTED|Overall Study||1130
2944531|NCT00665561|3657563|FG000|COMPLETED|Overall Study||814
2944532|NCT00665561|3657564|FG001|COMPLETED|Overall Study||596
2944533|NCT00665561|3657563|FG000|NOT COMPLETED|Overall Study||502
2944534|NCT00665561|3657564|FG001|NOT COMPLETED|Overall Study||534
2944535|NCT00665626|3657572|FG000|STARTED|Overall Study|Participants randomized|73
2944536|NCT00665626|3657573|FG001|STARTED|Overall Study|Participants randomized|146
2944537|NCT00665626|3657572|FG000|COMPLETED|Overall Study|Participants completed the study|63
2944538|NCT00665626|3657573|FG001|COMPLETED|Overall Study|Participants completed the study|124
2944539|NCT00665626|3657572|FG000|NOT COMPLETED|Overall Study||10
2944540|NCT00665626|3657573|FG001|NOT COMPLETED|Overall Study||22
2944541|NCT00665652|3657579|FG000|STARTED|Overall Study||8
2944542|NCT00665652|3657579|FG000|COMPLETED|Overall Study||2
2944543|NCT00665652|3657579|FG000|NOT COMPLETED|Overall Study||6
2944544|NCT00665704|3657583|FG000|STARTED|Overall Study||9
2944545|NCT00665704|3657583|FG000|COMPLETED|Overall Study||9
2944546|NCT00665704|3657583|FG000|NOT COMPLETED|Overall Study||0
2944547|NCT00665847|3657587|FG000|STARTED|Overall Study||101
2944548|NCT00665847|3657587|FG000|COMPLETED|Overall Study||76
2944549|NCT00665847|3657587|FG000|NOT COMPLETED|Overall Study||25
2944550|NCT00665925|3657595|FG000|STARTED|Overall Study|Participants randomized|77
2944551|NCT00665925|3657596|FG001|STARTED|Overall Study|Participants randomized|76
2944552|NCT00665925|3657597|FG002|STARTED|Overall Study|Participants randomized|152
2944553|NCT00665925|3657598|FG003|STARTED|Overall Study|Participants randomized|152
2944554|NCT00665925|3657595|FG000|COMPLETED|Overall Study|Participants completed the study|62
2944555|NCT00665925|3657596|FG001|COMPLETED|Overall Study|Participants completed the study|59
2944556|NCT00665925|3657597|FG002|COMPLETED|Overall Study|Participants completed the study|126
2944557|NCT00665925|3657598|FG003|COMPLETED|Overall Study|Participants completed the study|131
2944558|NCT00665925|3657595|FG000|NOT COMPLETED|Overall Study||15
2944559|NCT00665925|3657596|FG001|NOT COMPLETED|Overall Study||17
2944560|NCT00665925|3657597|FG002|NOT COMPLETED|Overall Study||26
2944561|NCT00665925|3657598|FG003|NOT COMPLETED|Overall Study||21
2944562|NCT00666029|3657611|FG000|STARTED|Overall Study||20
2944563|NCT00666029|3657612|FG001|STARTED|Overall Study||20
2944564|NCT00666029|3657611|FG000|COMPLETED|Overall Study||19
2944565|NCT00666029|3657612|FG001|COMPLETED|Overall Study||20
2944566|NCT00666029|3657611|FG000|NOT COMPLETED|Overall Study||1
2944567|NCT00666029|3657612|FG001|NOT COMPLETED|Overall Study||0
2944568|NCT00666198|3657619|FG000|STARTED|Overall Study||3337
2944569|NCT00666198|3657619|FG000|COMPLETED|Overall Study||3304
2944570|NCT00666198|3657619|FG000|NOT COMPLETED|Overall Study||33
2944571|NCT00666211|3657625|FG000|STARTED|Overall Study||42
2944572|NCT00666211|3657626|FG001|STARTED|Overall Study||56
2944573|NCT00666211|3657625|FG000|COMPLETED|Overall Study||22
2944574|NCT00666211|3657626|FG001|COMPLETED|Overall Study||18
2944575|NCT00666211|3657625|FG000|NOT COMPLETED|Overall Study||20
2944576|NCT00666211|3657626|FG001|NOT COMPLETED|Overall Study||38
3298744|NCT02927080|4032447|FG006|Open-Label Extension From Part 2 Double Blind-Placebo Controlled|Overall Study||14
3298745|NCT02927080|4032448|FG007|Open-Label Extension From Part 2 Double Blind-Placebo Controlled|Overall Study||13
3298746|NCT02927080|4032449|FG008|Open-Label Extension From Part 2 Double Blind-Placebo Controlled|Overall Study||14
3298747|NCT02927080|4032450|FG009|Open-Label Extension From Part 2 Double Blind-Placebo Controlled|Overall Study||12
3298748|NCT02927080|4032441|FG000|COMPLETED|Overall Study||6
3298749|NCT02927080|4032442|FG001|COMPLETED|Overall Study||5
3298750|NCT02927080|4032443|FG002|COMPLETED|Overall Study||6
3298751|NCT02927080|4032444|FG003|COMPLETED|Overall Study||6
3298752|NCT02927080|4032445|FG004|COMPLETED|Overall Study||6
3298753|NCT02927080|4032446|FG005|COMPLETED|Overall Study||6
2944577|NCT00666224|3657634|FG000|STARTED|Double-Blind||243
2944578|NCT00666224|3657635|FG001|STARTED|Double-Blind||238
2944579|NCT00666224|3657634|FG000|COMPLETED|Double-Blind|78 completed 3 years treatment, 66 converted to CDMS, 54 switched to OL as per DMC|198
2944580|NCT00666224|3657635|FG001|COMPLETED|Double-Blind|55 completed 3 years treatment, 109 converted to CDMS, 47 switched to OL as per DMC|211
2944581|NCT00666224|3657634|FG000|NOT COMPLETED|Double-Blind||45
2944582|NCT00666224|3657635|FG001|NOT COMPLETED|Double-Blind||27
2944583|NCT00666224|3657634|FG000|STARTED|Open-Label|454 participants took at least one dose of GA including 45 who didn't continue into the OL.|198
2944584|NCT00666224|3657635|FG001|STARTED|Open-Label||211
2944585|NCT00666224|3657634|FG000|COMPLETED|Open-Label||163
2944586|NCT00666224|3657635|FG001|COMPLETED|Open-Label||126
2944587|NCT00666224|3657634|FG000|NOT COMPLETED|Open-Label||35
2944588|NCT00666224|3657635|FG001|NOT COMPLETED|Open-Label||85
2944589|NCT00666263|3657642|FG000|STARTED|Study Part 1 (Stabilization Phase 1)||22
2944590|NCT00666263|3657643|FG001|STARTED|Study Part 1 (Stabilization Phase 1)||22
2944591|NCT00666263|3657642|FG000|COMPLETED|Study Part 1 (Stabilization Phase 1)||22
2944592|NCT00666263|3657643|FG001|COMPLETED|Study Part 1 (Stabilization Phase 1)||21
2944593|NCT00666263|3657642|FG000|NOT COMPLETED|Study Part 1 (Stabilization Phase 1)||0
2944594|NCT00666263|3657643|FG001|NOT COMPLETED|Study Part 1 (Stabilization Phase 1)||1
2944595|NCT00666263|3657642|FG000|STARTED|Study Part 2 (Cross-over Period 1)||22
2944596|NCT00666263|3657643|FG001|STARTED|Study Part 2 (Cross-over Period 1)||21
2944597|NCT00666263|3657642|FG000|COMPLETED|Study Part 2 (Cross-over Period 1)||22
2944598|NCT00666263|3657643|FG001|COMPLETED|Study Part 2 (Cross-over Period 1)||21
2944599|NCT00666263|3657642|FG000|NOT COMPLETED|Study Part 2 (Cross-over Period 1)||0
2944600|NCT00666263|3657643|FG001|NOT COMPLETED|Study Part 2 (Cross-over Period 1)||0
2944601|NCT00666263|3657642|FG000|STARTED|Study Part 3 (Stabilization Phase 2)||22
2944602|NCT00666263|3657643|FG001|STARTED|Study Part 3 (Stabilization Phase 2)||21
2944603|NCT00666263|3657642|FG000|COMPLETED|Study Part 3 (Stabilization Phase 2)||22
2944604|NCT00666263|3657643|FG001|COMPLETED|Study Part 3 (Stabilization Phase 2)||21
2944605|NCT00666263|3657642|FG000|NOT COMPLETED|Study Part 3 (Stabilization Phase 2)||0
2944606|NCT00666263|3657643|FG001|NOT COMPLETED|Study Part 3 (Stabilization Phase 2)||0
2944607|NCT00666263|3657642|FG000|STARTED|Study Part 4 (Cross-over Period 2)||22
2944608|NCT00666263|3657643|FG001|STARTED|Study Part 4 (Cross-over Period 2)||21
2944609|NCT00666263|3657642|FG000|COMPLETED|Study Part 4 (Cross-over Period 2)||21
2944610|NCT00666263|3657643|FG001|COMPLETED|Study Part 4 (Cross-over Period 2)||21
2944611|NCT00666263|3657642|FG000|NOT COMPLETED|Study Part 4 (Cross-over Period 2)||1
2944612|NCT00666263|3657643|FG001|NOT COMPLETED|Study Part 4 (Cross-over Period 2)||0
2944613|NCT00666263|3657642|FG000|STARTED|Study Part 5 (Stabilization Phase 3)||21
2944614|NCT00666263|3657643|FG001|STARTED|Study Part 5 (Stabilization Phase 3)||21
2944615|NCT00666263|3657642|FG000|COMPLETED|Study Part 5 (Stabilization Phase 3)||21
2944616|NCT00666263|3657643|FG001|COMPLETED|Study Part 5 (Stabilization Phase 3)||20
2944617|NCT00666263|3657642|FG000|NOT COMPLETED|Study Part 5 (Stabilization Phase 3)||0
2944618|NCT00666263|3657643|FG001|NOT COMPLETED|Study Part 5 (Stabilization Phase 3)||1
2944619|NCT00666263|3657642|FG000|STARTED|End of Study Visit|End of Study Visit done on all 22 randomized regardless of participation in Study Parts|22
2944620|NCT00666263|3657643|FG001|STARTED|End of Study Visit|End of Study Visit done on all 22 randomized regardless of participation in Study Parts|22
2944621|NCT00666263|3657642|FG000|COMPLETED|End of Study Visit||22
2944622|NCT00666263|3657643|FG001|COMPLETED|End of Study Visit||22
2944623|NCT00666263|3657642|FG000|NOT COMPLETED|End of Study Visit||0
2944624|NCT00666263|3657643|FG001|NOT COMPLETED|End of Study Visit||0
2944625|NCT00666276|3657688|FG000|STARTED|Overall Study||1004
2944626|NCT00666276|3657688|FG000|COMPLETED|Overall Study||970
2944627|NCT00666276|3657688|FG000|NOT COMPLETED|Overall Study||34
2944628|NCT00666328|3657711|FG000|STARTED|Overall Study|Safety population: participants dosed with study drug (primary population for Safety analyses)|35
2944629|NCT00666328|3657711|FG000|Modified Intent To Treat (mITT)|Overall Study|mITT population: participants dosed and in whom all inclusion and no exclusion criteria were met|33
2944630|NCT00666328|3657711|FG000|COMPLETED|Overall Study|30/35 completed the study within the Safety population; 28/33 completed within the mITT population.|30
2944631|NCT00666328|3657711|FG000|NOT COMPLETED|Overall Study||5
2944632|NCT00666406|3657717|FG000|STARTED|First PK Infusion||6
2944633|NCT00666406|3657718|FG001|STARTED|First PK Infusion||3
2944634|NCT00666406|3657717|FG000|COMPLETED|First PK Infusion||6
2944635|NCT00666406|3657718|FG001|COMPLETED|First PK Infusion||3
2944636|NCT00666406|3657717|FG000|NOT COMPLETED|First PK Infusion||0
2944637|NCT00666406|3657718|FG001|NOT COMPLETED|First PK Infusion||0
2944638|NCT00666406|3657717|FG000|STARTED|Second PK Infusion||6
2944639|NCT00666406|3657718|FG001|STARTED|Second PK Infusion||3
2944640|NCT00666406|3657717|FG000|COMPLETED|Second PK Infusion||6
2944641|NCT00666406|3657718|FG001|COMPLETED|Second PK Infusion||3
2944642|NCT00666406|3657717|FG000|NOT COMPLETED|Second PK Infusion||0
2944643|NCT00666406|3657718|FG001|NOT COMPLETED|Second PK Infusion||0
2944644|NCT00666458|3657725|FG000|STARTED|Overall Study|Randomized and treated|403
2944645|NCT00666458|3657726|FG001|STARTED|Overall Study|Randomized and treated|398
2944646|NCT00666458|3657725|FG000|COMPLETED|Overall Study|Completed 18 weeks of treatment|365
2944647|NCT00666458|3657726|FG001|COMPLETED|Overall Study|Completed 18 weeks of treatment|374
2944648|NCT00666458|3657725|FG000|NOT COMPLETED|Overall Study||38
2944649|NCT00666458|3657726|FG001|NOT COMPLETED|Overall Study||24
2944650|NCT00666536|3657734|FG000|STARTED|Overall Study||369
2944651|NCT00666536|3657735|FG001|STARTED|Overall Study||359
2944652|NCT00666536|3657734|FG000|COMPLETED|Overall Study||336
2944653|NCT00666536|3657735|FG001|COMPLETED|Overall Study||322
2944654|NCT00666536|3657734|FG000|NOT COMPLETED|Overall Study||33
2944655|NCT00666536|3657735|FG001|NOT COMPLETED|Overall Study||37
2944656|NCT00666562|3657744|FG000|STARTED|Overall Study||11
2944657|NCT00666562|3657745|FG001|STARTED|Overall Study||10
2944658|NCT00666562|3657746|FG002|STARTED|Overall Study||10
2944659|NCT00666562|3657744|FG000|COMPLETED|Overall Study||11
2944660|NCT00666562|3657745|FG001|COMPLETED|Overall Study||8
2944661|NCT00666562|3657746|FG002|COMPLETED|Overall Study||10
2944662|NCT00666562|3657744|FG000|NOT COMPLETED|Overall Study||0
2944663|NCT00666562|3657745|FG001|NOT COMPLETED|Overall Study||2
2944664|NCT00666562|3657746|FG002|NOT COMPLETED|Overall Study||0
2944665|NCT00666588|3657765|FG000|STARTED|Overall Study||18
2944666|NCT00666588|3657766|FG001|STARTED|Overall Study||6
2944667|NCT00666588|3657767|FG002|STARTED|Overall Study||6
2944668|NCT00666588|3657768|FG003|STARTED|Overall Study||22
2944669|NCT00666588|3657765|FG000|COMPLETED|Overall Study||14
2944670|NCT00666588|3657766|FG001|COMPLETED|Overall Study||6
2944671|NCT00666588|3657767|FG002|COMPLETED|Overall Study||6
2944672|NCT00666588|3657768|FG003|COMPLETED|Overall Study||20
2944673|NCT00666588|3657765|FG000|NOT COMPLETED|Overall Study||4
2944674|NCT00666588|3657766|FG001|NOT COMPLETED|Overall Study||0
2944675|NCT00666588|3657767|FG002|NOT COMPLETED|Overall Study||0
2944676|NCT00666588|3657768|FG003|NOT COMPLETED|Overall Study||2
2944677|NCT00666666|3657778|FG000|STARTED|Overall Study||55
2944678|NCT00666666|3657778|FG000|COMPLETED|Overall Study||55
2944679|NCT00666666|3657778|FG000|NOT COMPLETED|Overall Study||0
2944680|NCT00666679|3657784|FG000|STARTED|First Intervention||66
2944681|NCT00666679|3657785|FG001|STARTED|First Intervention||68
2944682|NCT00666679|3657784|FG000|COMPLETED|First Intervention||62
2944683|NCT00666679|3657785|FG001|COMPLETED|First Intervention||67
2944684|NCT00666679|3657784|FG000|NOT COMPLETED|First Intervention||4
2944685|NCT00666679|3657785|FG001|NOT COMPLETED|First Intervention||1
2944686|NCT00666679|3657784|FG000|STARTED|Washout Period of 1 Week||62
2944687|NCT00666679|3657785|FG001|STARTED|Washout Period of 1 Week||67
2944688|NCT00666679|3657784|FG000|COMPLETED|Washout Period of 1 Week||62
2944689|NCT00666679|3657785|FG001|COMPLETED|Washout Period of 1 Week||65
2944690|NCT00666679|3657784|FG000|NOT COMPLETED|Washout Period of 1 Week||0
2944691|NCT00666679|3657785|FG001|NOT COMPLETED|Washout Period of 1 Week||2
2944692|NCT00666679|3657784|FG000|STARTED|Second Intervention||62
2944693|NCT00666679|3657785|FG001|STARTED|Second Intervention||65
2944694|NCT00666679|3657784|FG000|COMPLETED|Second Intervention||61
2944695|NCT00666679|3657785|FG001|COMPLETED|Second Intervention||64
2944696|NCT00666679|3657784|FG000|NOT COMPLETED|Second Intervention||1
2944697|NCT00666679|3657785|FG001|NOT COMPLETED|Second Intervention||1
2944698|NCT00666705|3657791|FG000|STARTED|Overall Study||18
2944699|NCT00666705|3657791|FG000|Raltegravir Alone (Days 1 - 3)|Overall Study|400 mg Raltegravir every 12 hours (AM dose on Day 3)|18
2944700|NCT00666705|3657791|FG000|Washout (Days 4 - 5)|Overall Study||18
3298754|NCT02927080|4032447|FG006|COMPLETED|Overall Study||7
3298755|NCT02927080|4032448|FG007|COMPLETED|Overall Study||5
3298756|NCT02927080|4032449|FG008|COMPLETED|Overall Study||12
3298757|NCT02927080|4032450|FG009|COMPLETED|Overall Study||7
2944701|NCT00666705|3657791|FG000|Maraviroc Alone (Days 6 - 11)|Overall Study|300 mg Maraviroc every 12 hours|18
2944702|NCT00666705|3657791|FG000|Raltegravir + Maraviroc (Days 12 - 14)|Overall Study|400 mg Raltegravir every 12 hours plus 300 mg Maraviroc every 12 hours (AM doses only on Day 14)|17
3132447|NCT01691248|3857489|FG000|Safety Analysis Set|Overall Study|A participant randomized to Fidaxomicin, received placebo instead.|300
3132448|NCT01691248|3857490|FG001|Safety Analysis Set|Overall Study|A participant randomized to Fidaxomicin, received placebo instead.|300
3132449|NCT01691248|3857489|FG000|COMPLETED|Overall Study||194
3132450|NCT01691248|3857490|FG001|COMPLETED|Overall Study||192
3132451|NCT01691248|3857489|FG000|NOT COMPLETED|Overall Study||111
3132452|NCT01691248|3857490|FG001|NOT COMPLETED|Overall Study||114
3132453|NCT01691313|3857500|FG000|STARTED|Overall Study||22
3298758|NCT02927080|4032441|FG000|NOT COMPLETED|Overall Study||0
2944703|NCT00666705|3657791|FG000|COMPLETED|Overall Study||17
2944704|NCT00666705|3657791|FG000|NOT COMPLETED|Overall Study||1
2944705|NCT00666718|3657802|FG000|STARTED|Overall Study||187
2944706|NCT00666718|3657803|FG001|STARTED|Overall Study||187
2944707|NCT00666718|3657802|FG000|COMPLETED|Overall Study||175
2944708|NCT00666718|3657803|FG001|COMPLETED|Overall Study||169
2944709|NCT00666718|3657802|FG000|NOT COMPLETED|Overall Study||12
2944710|NCT00666718|3657803|FG001|NOT COMPLETED|Overall Study||18
2944711|NCT00666757|3657811|FG000|STARTED|Overall Study||372
2944712|NCT00666757|3657812|FG001|STARTED|Overall Study||378
2944713|NCT00666757|3657811|FG000|COMPLETED|Overall Study||272
2944714|NCT00666757|3657812|FG001|COMPLETED|Overall Study||281
2944715|NCT00666757|3657811|FG000|NOT COMPLETED|Overall Study||100
2944716|NCT00666757|3657812|FG001|NOT COMPLETED|Overall Study||97
2944717|NCT00666835|3657823|FG000|STARTED|Overall Study||314
2944718|NCT00666835|3657824|FG001|STARTED|Overall Study||164
2944719|NCT00666835|3657823|FG000|COMPLETED|Overall Study||261
2944720|NCT00666835|3657824|FG001|COMPLETED|Overall Study||142
2944721|NCT00666835|3657823|FG000|NOT COMPLETED|Overall Study||53
2944722|NCT00666835|3657824|FG001|NOT COMPLETED|Overall Study||22
2944723|NCT00666848|3657834|FG000|STARTED|Overall Study|15 didn't meet inclusion criteria. 3 withdrew before randomized. 1 withdrawn before randomized.|8
2944724|NCT00666848|3657835|FG001|STARTED|Overall Study|15 didn't meet inclusion criteria. 3 withdrew before randomized. 1 withdrawn before randomized.|9
2944725|NCT00666848|3657836|FG002|STARTED|Overall Study|15 didn't meet inclusion criteria. 3 withdrew before randomized. 1 withdrawn before randomized.|7
2944726|NCT00666848|3657834|FG000|COMPLETED|Overall Study|finished Aim 2|8
2944727|NCT00666848|3657835|FG001|COMPLETED|Overall Study|finished Aim 1|9
2944728|NCT00666848|3657836|FG002|COMPLETED|Overall Study|finished Aim 3|7
2944729|NCT00666848|3657834|FG000|NOT COMPLETED|Overall Study||0
2944730|NCT00666848|3657835|FG001|NOT COMPLETED|Overall Study||0
2944731|NCT00666848|3657836|FG002|NOT COMPLETED|Overall Study||0
2944732|NCT00666926|3657844|FG000|STARTED|Overall Study||2
2944733|NCT00666926|3657845|FG001|STARTED|Overall Study||4
2944734|NCT00666926|3657846|FG002|STARTED|Overall Study||3
2944735|NCT00666926|3657847|FG003|STARTED|Overall Study||4
2944736|NCT00666926|3657848|FG004|STARTED|Overall Study||3
2944737|NCT00666926|3657849|FG005|STARTED|Overall Study||4
2944738|NCT00666926|3657850|FG006|STARTED|Overall Study||4
2944739|NCT00666926|3657851|FG007|STARTED|Overall Study||1
2944740|NCT00666926|3657852|FG008|STARTED|Overall Study||3
2944741|NCT00666926|3657853|FG009|STARTED|Overall Study||10
2944742|NCT00666926|3657854|FG010|STARTED|Overall Study||6
2944743|NCT00666926|3657855|FG011|STARTED|Overall Study||33
2944744|NCT00666926|3657856|FG012|STARTED|Overall Study||3
2944745|NCT00666926|3657857|FG013|STARTED|Overall Study||4
2944746|NCT00666926|3657858|FG014|STARTED|Overall Study||7
2944747|NCT00666926|3657859|FG015|STARTED|Overall Study||8
2944748|NCT00666926|3657844|FG000|COMPLETED|Overall Study||0
2944749|NCT00666926|3657845|FG001|COMPLETED|Overall Study||0
2944750|NCT00666926|3657846|FG002|COMPLETED|Overall Study||0
2944751|NCT00666926|3657847|FG003|COMPLETED|Overall Study||0
2944752|NCT00666926|3657848|FG004|COMPLETED|Overall Study||0
2944753|NCT00666926|3657849|FG005|COMPLETED|Overall Study||0
2944754|NCT00666926|3657850|FG006|COMPLETED|Overall Study||0
2944755|NCT00666926|3657851|FG007|COMPLETED|Overall Study||0
2944756|NCT00666926|3657852|FG008|COMPLETED|Overall Study||0
2944757|NCT00666926|3657853|FG009|COMPLETED|Overall Study||0
2944758|NCT00666926|3657854|FG010|COMPLETED|Overall Study||0
2944759|NCT00666926|3657855|FG011|COMPLETED|Overall Study||0
2944760|NCT00666926|3657856|FG012|COMPLETED|Overall Study||0
2944761|NCT00666926|3657857|FG013|COMPLETED|Overall Study||0
2944762|NCT00666926|3657858|FG014|COMPLETED|Overall Study||0
2944763|NCT00666926|3657859|FG015|COMPLETED|Overall Study||0
2944764|NCT00666926|3657844|FG000|NOT COMPLETED|Overall Study||2
2944765|NCT00666926|3657845|FG001|NOT COMPLETED|Overall Study||4
2944766|NCT00666926|3657846|FG002|NOT COMPLETED|Overall Study||3
2944767|NCT00666926|3657847|FG003|NOT COMPLETED|Overall Study||4
2944768|NCT00666926|3657848|FG004|NOT COMPLETED|Overall Study||3
2944769|NCT00666926|3657849|FG005|NOT COMPLETED|Overall Study||4
2944770|NCT00666926|3657850|FG006|NOT COMPLETED|Overall Study||4
2944771|NCT00666926|3657851|FG007|NOT COMPLETED|Overall Study||1
2944772|NCT00666926|3657852|FG008|NOT COMPLETED|Overall Study||3
2944773|NCT00666926|3657853|FG009|NOT COMPLETED|Overall Study||10
2944774|NCT00666926|3657854|FG010|NOT COMPLETED|Overall Study||6
2944775|NCT00666926|3657855|FG011|NOT COMPLETED|Overall Study||33
2944776|NCT00666926|3657856|FG012|NOT COMPLETED|Overall Study||3
2944777|NCT00666926|3657857|FG013|NOT COMPLETED|Overall Study||4
2944778|NCT00666926|3657858|FG014|NOT COMPLETED|Overall Study||7
2944779|NCT00666926|3657859|FG015|NOT COMPLETED|Overall Study||8
2944780|NCT00666965|3657914|FG000|STARTED|Overall Study||58
2944781|NCT00666965|3657915|FG001|STARTED|Overall Study||57
2944782|NCT00666965|3657916|FG002|STARTED|Overall Study||58
2944783|NCT00666965|3657917|FG003|STARTED|Overall Study||57
2944784|NCT00666965|3657914|FG000|COMPLETED|Overall Study||55
2944785|NCT00666965|3657915|FG001|COMPLETED|Overall Study||53
2944786|NCT00666965|3657916|FG002|COMPLETED|Overall Study||56
2944787|NCT00666965|3657917|FG003|COMPLETED|Overall Study||42
2944788|NCT00666965|3657914|FG000|NOT COMPLETED|Overall Study||3
2944789|NCT00666965|3657915|FG001|NOT COMPLETED|Overall Study||4
2944790|NCT00666965|3657916|FG002|NOT COMPLETED|Overall Study||2
2944791|NCT00666965|3657917|FG003|NOT COMPLETED|Overall Study||15
2944792|NCT00666978|3657929|FG000|STARTED|Overall Study||270
2944793|NCT00666978|3657930|FG001|STARTED|Overall Study||270
2944794|NCT00666978|3657929|FG000|COMPLETED|Overall Study||192
2944795|NCT00666978|3657930|FG001|COMPLETED|Overall Study||187
2944796|NCT00666978|3657929|FG000|NOT COMPLETED|Overall Study||78
2944797|NCT00666978|3657930|FG001|NOT COMPLETED|Overall Study||83
2944798|NCT00667004|3657940|FG000|STARTED|Overall Study||95
2944799|NCT00667004|3657941|FG001|STARTED|Overall Study||88
2944800|NCT00667004|3657940|FG000|COMPLETED|Overall Study||93
2944801|NCT00667004|3657941|FG001|COMPLETED|Overall Study||85
2944802|NCT00667004|3657940|FG000|NOT COMPLETED|Overall Study||2
2944803|NCT00667004|3657941|FG001|NOT COMPLETED|Overall Study||3
2944804|NCT00667095|3657949|FG000|STARTED|Overall Study||11
2944805|NCT00667095|3657950|FG001|STARTED|Overall Study||10
2944806|NCT00667095|3657949|FG000|COMPLETED|Overall Study||11
2944807|NCT00667095|3657950|FG001|COMPLETED|Overall Study||9
2944808|NCT00667095|3657949|FG000|NOT COMPLETED|Overall Study||0
2944809|NCT00667095|3657950|FG001|NOT COMPLETED|Overall Study||1
2944810|NCT00667186|3657958|FG000|STARTED|Overall Study||4692
2944811|NCT00667186|3657959|FG001|STARTED|Overall Study||4880
2944812|NCT00667186|3657958|FG000|COMPLETED|Overall Study||4692
2944813|NCT00667186|3657959|FG001|COMPLETED|Overall Study||4880
2944814|NCT00667186|3657958|FG000|NOT COMPLETED|Overall Study||0
2944815|NCT00667186|3657959|FG001|NOT COMPLETED|Overall Study||0
2944816|NCT00667225|3657967|FG000|STARTED|Overall Study||16
2944817|NCT00667225|3657968|FG001|STARTED|Overall Study||13
2944818|NCT00667225|3657967|FG000|COMPLETED|Overall Study||15
2944819|NCT00667225|3657968|FG001|COMPLETED|Overall Study||12
2944820|NCT00667225|3657967|FG000|NOT COMPLETED|Overall Study||1
2944821|NCT00667225|3657968|FG001|NOT COMPLETED|Overall Study||1
2944822|NCT00667251|3657976|FG000|STARTED|Overall Study||326
2944823|NCT00667251|3657977|FG001|STARTED|Overall Study||326
2944824|NCT00667251|3657976|FG000|Combination Rx|Overall Study||322
2944825|NCT00667251|3657977|FG001|Combination Rx|Overall Study||325
2944826|NCT00667251|3657976|FG000|Monotherapy|Overall Study||225
2944827|NCT00667251|3657977|FG001|Monotherapy|Overall Study||232
2944828|NCT00667251|3657976|FG000|Not Started|Overall Study||4
2944829|NCT00667251|3657977|FG001|Not Started|Overall Study||1
2944830|NCT00667251|3657976|FG000|COMPLETED|Overall Study||256
2944831|NCT00667251|3657977|FG001|COMPLETED|Overall Study||231
2944832|NCT00667251|3657976|FG000|NOT COMPLETED|Overall Study||70
2944833|NCT00667251|3657977|FG001|NOT COMPLETED|Overall Study||95
2944834|NCT00667277|3657983|FG000|STARTED|Overall Study||13
2944835|NCT00667277|3657983|FG000|COMPLETED|Overall Study||11
2944836|NCT00667277|3657983|FG000|NOT COMPLETED|Overall Study||2
2944837|NCT00667342|3657990|FG000|STARTED|Overall Study||31
2944838|NCT00667342|3657991|FG001|STARTED|Overall Study||0
2944839|NCT00667342|3657992|FG002|STARTED|Overall Study||12
2944840|NCT00667342|3657990|FG000|COMPLETED|Overall Study||17
2944841|NCT00667342|3657991|FG001|COMPLETED|Overall Study||0
2944842|NCT00667342|3657992|FG002|COMPLETED|Overall Study||3
2944843|NCT00667342|3657990|FG000|NOT COMPLETED|Overall Study||14
2944844|NCT00667342|3657991|FG001|NOT COMPLETED|Overall Study||0
2944845|NCT00667342|3657992|FG002|NOT COMPLETED|Overall Study||9
2944846|NCT00667355|3658006|FG000|STARTED|Overall Study||41
2944847|NCT00667355|3658006|FG000|COMPLETED|Overall Study||30
2944848|NCT00667355|3658006|FG000|NOT COMPLETED|Overall Study||11
2944849|NCT00667368|3658012|FG000|STARTED|Overall Study||682
2944850|NCT00667368|3658013|FG001|STARTED|Overall Study||683
2944851|NCT00667368|3658012|FG000|COMPLETED|Overall Study||482
2944852|NCT00667368|3658013|FG001|COMPLETED|Overall Study||511
2944853|NCT00667368|3658012|FG000|NOT COMPLETED|Overall Study||200
2944854|NCT00667368|3658013|FG001|NOT COMPLETED|Overall Study||172
2944855|NCT00667381|3658021|FG000|STARTED|Overall Study||501
2944856|NCT00667381|3658022|FG001|STARTED|Overall Study||503
2944857|NCT00667381|3658021|FG000|COMPLETED|Overall Study||501
2944858|NCT00667381|3658022|FG001|COMPLETED|Overall Study||503
2944859|NCT00667381|3658021|FG000|NOT COMPLETED|Overall Study||0
2944860|NCT00667381|3658022|FG001|NOT COMPLETED|Overall Study||0
2944861|NCT00667394|3658030|FG000|STARTED|Overall Study||41
2944862|NCT00667394|3658031|FG001|STARTED|Overall Study||1
2944863|NCT00667394|3658030|FG000|COMPLETED|Overall Study||37
2944864|NCT00667394|3658031|FG001|COMPLETED|Overall Study||1
2944865|NCT00667394|3658030|FG000|NOT COMPLETED|Overall Study||4
2944866|NCT00667394|3658031|FG001|NOT COMPLETED|Overall Study||0
2944867|NCT00667420|3658037|FG000|STARTED|Overall Study||17
2944868|NCT00667420|3658037|FG000|Completion of Pre-operative EOX-P|Overall Study||15
2944869|NCT00667420|3658037|FG000|Completion of Surgery/Re-staging|Overall Study||11
2944870|NCT00667420|3658037|FG000|COMPLETED|Overall Study||7
2944871|NCT00667420|3658037|FG000|NOT COMPLETED|Overall Study||10
2944872|NCT00667446|3658044|FG000|STARTED|Treatment Period (36 Months)||34
2944873|NCT00667446|3658045|FG001|STARTED|Treatment Period (36 Months)||38
2944874|NCT00667446|3658044|FG000|COMPLETED|Treatment Period (36 Months)||11
2944875|NCT00667446|3658045|FG001|COMPLETED|Treatment Period (36 Months)||13
2944876|NCT00667446|3658044|FG000|NOT COMPLETED|Treatment Period (36 Months)||23
2944877|NCT00667446|3658045|FG001|NOT COMPLETED|Treatment Period (36 Months)||25
2944878|NCT00667446|3658044|FG000|STARTED|Safety Follow-up Period (12 Weeks)||28
2944879|NCT00667446|3658045|FG001|STARTED|Safety Follow-up Period (12 Weeks)||26
2944880|NCT00667446|3658044|FG000|COMPLETED|Safety Follow-up Period (12 Weeks)||28
2944881|NCT00667446|3658045|FG001|COMPLETED|Safety Follow-up Period (12 Weeks)||25
2944882|NCT00667446|3658044|FG000|NOT COMPLETED|Safety Follow-up Period (12 Weeks)||0
2944883|NCT00667446|3658045|FG001|NOT COMPLETED|Safety Follow-up Period (12 Weeks)||1
2944884|NCT00667459|3658053|FG000|STARTED|Overall Study||280
2944885|NCT00667459|3658054|FG001|STARTED|Overall Study||265
2944886|NCT00667459|3658053|FG000|COMPLETED|Overall Study||272
2944887|NCT00667459|3658054|FG001|COMPLETED|Overall Study||220
2944888|NCT00667459|3658053|FG000|NOT COMPLETED|Overall Study||8
2944889|NCT00667459|3658054|FG001|NOT COMPLETED|Overall Study||45
2944890|NCT00667511|3658060|FG000|STARTED|Intervention 1: Home DHD||58
2944891|NCT00667511|3658060|FG000|COMPLETED|Intervention 1: Home DHD||51
2944892|NCT00667511|3658060|FG000|NOT COMPLETED|Intervention 1: Home DHD||7
2944893|NCT00667511|3658060|FG000|STARTED|Training/Transition Period||51
2944894|NCT00667511|3658060|FG000|COMPLETED|Training/Transition Period||43
2944895|NCT00667511|3658060|FG000|NOT COMPLETED|Training/Transition Period||8
2944896|NCT00667511|3658060|FG000|STARTED|Intervention 2: Home NHD||43
2944897|NCT00667511|3658060|FG000|COMPLETED|Intervention 2: Home NHD||39
2944898|NCT00667511|3658060|FG000|NOT COMPLETED|Intervention 2: Home NHD||4
2944899|NCT00667563|3658066|FG000|STARTED|Overall Study||150
2944900|NCT00667563|3658066|FG000|COMPLETED|Overall Study||126
2944901|NCT00667563|3658066|FG000|NOT COMPLETED|Overall Study||24
2944902|NCT00667576|3658075|FG000|STARTED|Overall Study||30
2944903|NCT00667576|3658076|FG001|STARTED|Overall Study||31
2944904|NCT00667576|3658077|FG002|STARTED|Overall Study||31
2944905|NCT00667576|3658078|FG003|STARTED|Overall Study||31
2944906|NCT00667576|3658079|FG004|STARTED|Overall Study||30
2944907|NCT00667576|3658075|FG000|COMPLETED|Overall Study||28
2944908|NCT00667576|3658076|FG001|COMPLETED|Overall Study||30
2944909|NCT00667576|3658077|FG002|COMPLETED|Overall Study||29
2944910|NCT00667576|3658078|FG003|COMPLETED|Overall Study||27
2944911|NCT00667576|3658079|FG004|COMPLETED|Overall Study||29
2944912|NCT00667576|3658075|FG000|NOT COMPLETED|Overall Study||2
2944913|NCT00667576|3658076|FG001|NOT COMPLETED|Overall Study||1
2944914|NCT00667576|3658077|FG002|NOT COMPLETED|Overall Study||2
2944915|NCT00667576|3658078|FG003|NOT COMPLETED|Overall Study||4
2944916|NCT00667576|3658079|FG004|NOT COMPLETED|Overall Study||1
2944917|NCT00667589|3658095|FG000|STARTED|Overall Study||1
2944918|NCT00667589|3658096|FG001|STARTED|Overall Study||0
2944919|NCT00667589|3658097|FG002|STARTED|Overall Study||3
2944920|NCT00667589|3658098|FG003|STARTED|Overall Study||2
2944921|NCT00667589|3658095|FG000|COMPLETED|Overall Study||0
2944922|NCT00667589|3658096|FG001|COMPLETED|Overall Study||0
2944923|NCT00667589|3658097|FG002|COMPLETED|Overall Study||0
2944924|NCT00667589|3658098|FG003|COMPLETED|Overall Study||1
2944925|NCT00667589|3658095|FG000|NOT COMPLETED|Overall Study||1
2944926|NCT00667589|3658096|FG001|NOT COMPLETED|Overall Study||0
2944927|NCT00667589|3658097|FG002|NOT COMPLETED|Overall Study||3
2944928|NCT00667589|3658098|FG003|NOT COMPLETED|Overall Study||1
2944929|NCT00667602|3658111|FG000|STARTED|Overall Study||219
2944930|NCT00667602|3658112|FG001|STARTED|Overall Study||228
2944931|NCT00667602|3658113|FG002|STARTED|Overall Study||215
2944932|NCT00667602|3658111|FG000|COMPLETED|Overall Study||211
2944933|NCT00667602|3658112|FG001|COMPLETED|Overall Study||213
2944934|NCT00667602|3658113|FG002|COMPLETED|Overall Study||197
2944935|NCT00667602|3658111|FG000|NOT COMPLETED|Overall Study||8
2944936|NCT00667602|3658112|FG001|NOT COMPLETED|Overall Study||15
2944937|NCT00667602|3658113|FG002|NOT COMPLETED|Overall Study||18
2944938|NCT00667615|3658126|FG000|STARTED|Overall Study||30
2944939|NCT00667615|3658126|FG000|COMPLETED|Overall Study||30
2944940|NCT00667615|3658126|FG000|NOT COMPLETED|Overall Study||0
2944941|NCT00667693|3658132|FG000|STARTED|Overall Study||49
2944942|NCT00667693|3658133|FG001|STARTED|Overall Study||52
2944943|NCT00667693|3658132|FG000|COMPLETED|Overall Study||49
2944944|NCT00667693|3658133|FG001|COMPLETED|Overall Study||50
2944945|NCT00667693|3658132|FG000|NOT COMPLETED|Overall Study||0
2944946|NCT00667693|3658133|FG001|NOT COMPLETED|Overall Study||2
2944947|NCT00667719|3658139|FG000|STARTED|Overall Study||564
2944948|NCT00667719|3658139|FG000|COMPLETED|Overall Study||493
2944949|NCT00667719|3658139|FG000|NOT COMPLETED|Overall Study||71
2944950|NCT00667732|3658150|FG000|STARTED|Run -In (8 Weeks)||41
2944951|NCT00667732|3658151|FG001|STARTED|Run -In (8 Weeks)||0
2944952|NCT00667732|3658152|FG002|STARTED|Run -In (8 Weeks)||0
2944953|NCT00667732|3658150|FG000|Participants Enrolled in Substudy|Run -In (8 Weeks)||20
2944954|NCT00667732|3658151|FG001|Participants Enrolled in Substudy|Run -In (8 Weeks)||0
2944955|NCT00667732|3658152|FG002|Participants Enrolled in Substudy|Run -In (8 Weeks)||0
2944956|NCT00667732|3658150|FG000|COMPLETED|Run -In (8 Weeks)||34
2944957|NCT00667732|3658151|FG001|COMPLETED|Run -In (8 Weeks)||0
2944958|NCT00667732|3658152|FG002|COMPLETED|Run -In (8 Weeks)||0
2944959|NCT00667732|3658150|FG000|NOT COMPLETED|Run -In (8 Weeks)||7
2944960|NCT00667732|3658151|FG001|NOT COMPLETED|Run -In (8 Weeks)||0
2944961|NCT00667732|3658152|FG002|NOT COMPLETED|Run -In (8 Weeks)||0
2944962|NCT00667732|3658150|FG000|STARTED|Randomization (24 Weeks)||0
2944963|NCT00667732|3658151|FG001|STARTED|Randomization (24 Weeks)||17
2944964|NCT00667732|3658152|FG002|STARTED|Randomization (24 Weeks)||17
2944965|NCT00667732|3658150|FG000|Participants Enrolled in Substudy|Randomization (24 Weeks)||0
2944966|NCT00667732|3658151|FG001|Participants Enrolled in Substudy|Randomization (24 Weeks)||11
2944967|NCT00667732|3658152|FG002|Participants Enrolled in Substudy|Randomization (24 Weeks)||9
2944968|NCT00667732|3658150|FG000|COMPLETED|Randomization (24 Weeks)||0
2944969|NCT00667732|3658151|FG001|COMPLETED|Randomization (24 Weeks)||16
2944970|NCT00667732|3658152|FG002|COMPLETED|Randomization (24 Weeks)||17
2944971|NCT00667732|3658150|FG000|NOT COMPLETED|Randomization (24 Weeks)||0
2944972|NCT00667732|3658151|FG001|NOT COMPLETED|Randomization (24 Weeks)||1
2944973|NCT00667732|3658152|FG002|NOT COMPLETED|Randomization (24 Weeks)||0
2944974|NCT00667732|3658150|FG000|STARTED|Extension (26 Weeks)||0
2944975|NCT00667732|3658151|FG001|STARTED|Extension (26 Weeks)||14
3132454|NCT01691313|3857501|FG001|STARTED|Overall Study||32
3132455|NCT01691313|3857502|FG002|STARTED|Overall Study||25
3132456|NCT01691313|3857503|FG003|STARTED|Overall Study||25
3132457|NCT01691313|3857500|FG000|COMPLETED|Overall Study||22
2944976|NCT00667732|3658152|FG002|STARTED|Extension (26 Weeks)||17
2944977|NCT00667732|3658150|FG000|COMPLETED|Extension (26 Weeks)||0
2944978|NCT00667732|3658151|FG001|COMPLETED|Extension (26 Weeks)||14
2944979|NCT00667732|3658152|FG002|COMPLETED|Extension (26 Weeks)||17
2944980|NCT00667732|3658150|FG000|NOT COMPLETED|Extension (26 Weeks)||0
2944981|NCT00667732|3658151|FG001|NOT COMPLETED|Extension (26 Weeks)||0
2944982|NCT00667732|3658152|FG002|NOT COMPLETED|Extension (26 Weeks)||0
2944983|NCT00667745|3658164|FG000|STARTED|Overall Study||141
2944984|NCT00667745|3658165|FG001|STARTED|Overall Study||142
2944985|NCT00667745|3658164|FG000|COMPLETED|Overall Study||116
2944986|NCT00667745|3658165|FG001|COMPLETED|Overall Study||121
2944987|NCT00667745|3658164|FG000|NOT COMPLETED|Overall Study||25
2944988|NCT00667745|3658165|FG001|NOT COMPLETED|Overall Study||21
2944989|NCT00667810|3658176|FG000|STARTED|Overall Study||269
2944990|NCT00667810|3658177|FG001|STARTED|Overall Study||264
2944991|NCT00667810|3658178|FG002|STARTED|Overall Study||346
2944992|NCT00667810|3658179|FG003|STARTED|Overall Study||11
2944993|NCT00667810|3658176|FG000|Treated|Overall Study||267
2944994|NCT00667810|3658177|FG001|Treated|Overall Study||263
2944995|NCT00667810|3658178|FG002|Treated|Overall Study||344
2944996|NCT00667810|3658179|FG003|Treated|Overall Study||11
2944997|NCT00667810|3658176|FG000|COMPLETED|Overall Study||102
2944998|NCT00667810|3658177|FG001|COMPLETED|Overall Study||94
2944999|NCT00667810|3658178|FG002|COMPLETED|Overall Study||124
2945000|NCT00667810|3658179|FG003|COMPLETED|Overall Study||9
2945001|NCT00667810|3658176|FG000|NOT COMPLETED|Overall Study||167
2945002|NCT00667810|3658177|FG001|NOT COMPLETED|Overall Study||170
2945003|NCT00667810|3658178|FG002|NOT COMPLETED|Overall Study||222
2945004|NCT00667810|3658179|FG003|NOT COMPLETED|Overall Study||2
2945005|NCT00667849|3658196|FG000|STARTED|Overall Study||250
2945006|NCT00667849|3658197|FG001|STARTED|Overall Study||251
2945007|NCT00667849|3658196|FG000|COMPLETED|Overall Study||142
2945008|NCT00667849|3658197|FG001|COMPLETED|Overall Study||130
2945009|NCT00667849|3658196|FG000|NOT COMPLETED|Overall Study||108
2945010|NCT00667849|3658197|FG001|NOT COMPLETED|Overall Study||121
2945011|NCT00667862|3658206|FG000|STARTED|Overall Study||35
2945012|NCT00667862|3658206|FG000|COMPLETED|Overall Study||0
2945013|NCT00667862|3658206|FG000|NOT COMPLETED|Overall Study||35
2945014|NCT00667875|3658213|FG000|STARTED|Overall Study|3 subjects had no data after randomization and were excluded from analysis|23
2945015|NCT00667875|3658214|FG001|STARTED|Overall Study||21
2945016|NCT00667875|3658215|FG002|STARTED|Overall Study|2 subjects had no data following randomization and were excluded from the analysis.|21
2945017|NCT00667875|3658213|FG000|Subjects Included in Analysisd|Overall Study||20
2945018|NCT00667875|3658214|FG001|Subjects Included in Analysisd|Overall Study||21
2945019|NCT00667875|3658215|FG002|Subjects Included in Analysisd|Overall Study||19
2945020|NCT00667875|3658213|FG000|COMPLETED|Overall Study|Subjects who dropped out during treatment are considered completed if they provide end of study data|13
2945021|NCT00667875|3658214|FG001|COMPLETED|Overall Study||10
2945022|NCT00667875|3658215|FG002|COMPLETED|Overall Study||8
2945023|NCT00667875|3658213|FG000|NOT COMPLETED|Overall Study||10
2945024|NCT00667875|3658214|FG001|NOT COMPLETED|Overall Study||11
2945025|NCT00667875|3658215|FG002|NOT COMPLETED|Overall Study||13
2945026|NCT00667888|3658231|FG000|STARTED|Overall Study||111
2945027|NCT00667888|3658232|FG001|STARTED|Overall Study||111
2945028|NCT00667888|3658231|FG000|COMPLETED|Overall Study||101
2945029|NCT00667888|3658232|FG001|COMPLETED|Overall Study||102
2945030|NCT00667888|3658231|FG000|NOT COMPLETED|Overall Study||10
2945031|NCT00667888|3658232|FG001|NOT COMPLETED|Overall Study||9
2945032|NCT00667992|3658240|FG000|STARTED|First Intervention 100 Mcg Twice Daily||49
2945033|NCT00667992|3658241|FG001|STARTED|First Intervention 100 Mcg Twice Daily||50
2945034|NCT00667992|3658240|FG000|COMPLETED|First Intervention 100 Mcg Twice Daily||44
2945035|NCT00667992|3658241|FG001|COMPLETED|First Intervention 100 Mcg Twice Daily||45
2945036|NCT00667992|3658240|FG000|NOT COMPLETED|First Intervention 100 Mcg Twice Daily||5
2945037|NCT00667992|3658241|FG001|NOT COMPLETED|First Intervention 100 Mcg Twice Daily||5
2945038|NCT00667992|3658240|FG000|STARTED|Second Intervention 400 Mcg Twice Daily||44
2945039|NCT00667992|3658241|FG001|STARTED|Second Intervention 400 Mcg Twice Daily||45
2945040|NCT00667992|3658240|FG000|COMPLETED|Second Intervention 400 Mcg Twice Daily||41
2945041|NCT00667992|3658241|FG001|COMPLETED|Second Intervention 400 Mcg Twice Daily||41
2945042|NCT00667992|3658240|FG000|NOT COMPLETED|Second Intervention 400 Mcg Twice Daily||3
2945043|NCT00667992|3658241|FG001|NOT COMPLETED|Second Intervention 400 Mcg Twice Daily||4
2945044|NCT00667992|3658240|FG000|STARTED|Wash-out||41
2945045|NCT00667992|3658241|FG001|STARTED|Wash-out||41
2945046|NCT00667992|3658240|FG000|COMPLETED|Wash-out||34
2945047|NCT00667992|3658241|FG001|COMPLETED|Wash-out||36
2945048|NCT00667992|3658240|FG000|NOT COMPLETED|Wash-out||7
2945049|NCT00667992|3658241|FG001|NOT COMPLETED|Wash-out||5
2945050|NCT00667992|3658240|FG000|STARTED|Third Intervention 100 Mcg Twice Daily||34
2945051|NCT00667992|3658241|FG001|STARTED|Third Intervention 100 Mcg Twice Daily||36
2945052|NCT00667992|3658240|FG000|COMPLETED|Third Intervention 100 Mcg Twice Daily||33
2945053|NCT00667992|3658241|FG001|COMPLETED|Third Intervention 100 Mcg Twice Daily||35
2945054|NCT00667992|3658240|FG000|NOT COMPLETED|Third Intervention 100 Mcg Twice Daily||1
3132458|NCT01691313|3857501|FG001|COMPLETED|Overall Study||32
3132459|NCT01691313|3857502|FG002|COMPLETED|Overall Study||25
2945055|NCT00667992|3658241|FG001|NOT COMPLETED|Third Intervention 100 Mcg Twice Daily||1
2945056|NCT00667992|3658240|FG000|STARTED|Forth Intervention 400 Mcg Twice Daily||33
2945057|NCT00667992|3658241|FG001|STARTED|Forth Intervention 400 Mcg Twice Daily||35
2945058|NCT00667992|3658240|FG000|COMPLETED|Forth Intervention 400 Mcg Twice Daily||33
2945059|NCT00667992|3658241|FG001|COMPLETED|Forth Intervention 400 Mcg Twice Daily||35
2945060|NCT00667992|3658240|FG000|NOT COMPLETED|Forth Intervention 400 Mcg Twice Daily||0
2945061|NCT00667992|3658241|FG001|NOT COMPLETED|Forth Intervention 400 Mcg Twice Daily||0
2945062|NCT00668148|3658257|FG000|STARTED|Overall Study||113
2945063|NCT00668148|3658257|FG000|Received at Least 1 Dose of Study Drug|Overall Study||111
2945064|NCT00668148|3658257|FG000|COMPLETED|Overall Study||103
2945065|NCT00668148|3658257|FG000|NOT COMPLETED|Overall Study||10
2945066|NCT00668200|3658272|FG000|STARTED|Overall Study||80
2945067|NCT00668200|3658272|FG000|Safety Population|Overall Study|1 patient was not included in the ITT patient was enrolled in error|81
2945068|NCT00668200|3658272|FG000|Intent to Treat (ITT)|Overall Study||80
2945069|NCT00668200|3658272|FG000|COMPLETED|Overall Study||77
2945070|NCT00668200|3658272|FG000|NOT COMPLETED|Overall Study||3
2945071|NCT00668317|3658276|FG000|STARTED|Overall Study||5
2945072|NCT00668317|3658276|FG000|COMPLETED|Overall Study||3
2945073|NCT00668317|3658276|FG000|NOT COMPLETED|Overall Study||2
2945074|NCT00668382|3658280|FG000|STARTED|Overall Study|beginning of trial|11
2945075|NCT00668382|3658280|FG000|COMPLETED|Overall Study||11
2945076|NCT00668382|3658280|FG000|NOT COMPLETED|Overall Study||0
3034637|NCT01133405|3753623|FG002|NOT COMPLETED|Period 2||1
3034638|NCT01133405|3753624|FG003|NOT COMPLETED|Period 2||1
3034639|NCT01133405|3753625|FG004|NOT COMPLETED|Period 2||0
3034640|NCT01133405|3753626|FG005|NOT COMPLETED|Period 2||2
3034641|NCT01133405|3753627|FG006|NOT COMPLETED|Period 2||0
3034642|NCT01133405|3753628|FG007|NOT COMPLETED|Period 2||0
3034643|NCT01133405|3753629|FG008|NOT COMPLETED|Period 2||0
3034644|NCT01133405|3753630|FG009|NOT COMPLETED|Period 2||0
3034645|NCT01133405|3753621|FG000|STARTED|Period 3||2
3034646|NCT01133405|3753622|FG001|STARTED|Period 3|One participant started and received placebo only in period 3.|4
3034647|NCT01133405|3753623|FG002|STARTED|Period 3|One participant started and received 35 mg LY2886721 only in period 3.|4
3034648|NCT01133405|3753624|FG003|STARTED|Period 3||2
3034649|NCT01133405|3753625|FG004|STARTED|Period 3||3
3034650|NCT01133405|3753626|FG005|STARTED|Period 3||2
3034651|NCT01133405|3753627|FG006|STARTED|Period 3||0
3034652|NCT01133405|3753628|FG007|STARTED|Period 3||0
3034653|NCT01133405|3753629|FG008|STARTED|Period 3||0
3034654|NCT01133405|3753630|FG009|STARTED|Period 3||0
3034655|NCT01133405|3753621|FG000|Received at Least 1 Dose of Study Drug|Period 3||2
3034656|NCT01133405|3753622|FG001|Received at Least 1 Dose of Study Drug|Period 3||4
3034657|NCT01133405|3753623|FG002|Received at Least 1 Dose of Study Drug|Period 3||4
3034658|NCT01133405|3753624|FG003|Received at Least 1 Dose of Study Drug|Period 3||2
3034659|NCT01133405|3753625|FG004|Received at Least 1 Dose of Study Drug|Period 3||3
3034660|NCT01133405|3753626|FG005|Received at Least 1 Dose of Study Drug|Period 3||2
3034661|NCT01133405|3753627|FG006|Received at Least 1 Dose of Study Drug|Period 3||0
3034662|NCT01133405|3753628|FG007|Received at Least 1 Dose of Study Drug|Period 3||0
3034663|NCT01133405|3753629|FG008|Received at Least 1 Dose of Study Drug|Period 3||0
3034664|NCT01133405|3753630|FG009|Received at Least 1 Dose of Study Drug|Period 3||0
3034665|NCT01133405|3753621|FG000|COMPLETED|Period 3||2
3034666|NCT01133405|3753622|FG001|COMPLETED|Period 3||4
3034667|NCT01133405|3753623|FG002|COMPLETED|Period 3||4
3034668|NCT01133405|3753624|FG003|COMPLETED|Period 3||2
3034669|NCT01133405|3753625|FG004|COMPLETED|Period 3||3
3034670|NCT01133405|3753626|FG005|COMPLETED|Period 3||2
3034671|NCT01133405|3753627|FG006|COMPLETED|Period 3||0
3034672|NCT01133405|3753628|FG007|COMPLETED|Period 3||0
3034673|NCT01133405|3753629|FG008|COMPLETED|Period 3||0
3034674|NCT01133405|3753630|FG009|COMPLETED|Period 3||0
3034675|NCT01133405|3753621|FG000|NOT COMPLETED|Period 3||0
3034676|NCT01133405|3753622|FG001|NOT COMPLETED|Period 3||0
3034677|NCT01133405|3753623|FG002|NOT COMPLETED|Period 3||0
3034678|NCT01133405|3753624|FG003|NOT COMPLETED|Period 3||0
3034679|NCT01133405|3753625|FG004|NOT COMPLETED|Period 3||0
3034680|NCT01133405|3753626|FG005|NOT COMPLETED|Period 3||0
3034681|NCT01133405|3753627|FG006|NOT COMPLETED|Period 3||0
3034682|NCT01133405|3753628|FG007|NOT COMPLETED|Period 3||0
3034683|NCT01133405|3753629|FG008|NOT COMPLETED|Period 3||0
3034684|NCT01133405|3753630|FG009|NOT COMPLETED|Period 3||0
3034685|NCT01133418|3753662|FG000|STARTED|Overall Study||34
3034686|NCT01133418|3753663|FG001|STARTED|Overall Study||38
3298759|NCT02927080|4032442|FG001|NOT COMPLETED|Overall Study||1
3298760|NCT02927080|4032443|FG002|NOT COMPLETED|Overall Study||0
3034687|NCT01133418|3753662|FG000|COMPLETED|Overall Study||29
3034688|NCT01133418|3753663|FG001|COMPLETED|Overall Study||32
3034689|NCT01133418|3753662|FG000|NOT COMPLETED|Overall Study||5
3034690|NCT01133418|3753663|FG001|NOT COMPLETED|Overall Study||6
3034691|NCT01133522|3753679|FG000|STARTED|Overall Study||10
3034692|NCT01133522|3753680|FG001|STARTED|Overall Study||7
3034693|NCT01133522|3753681|FG002|STARTED|Overall Study||6
3034694|NCT01133522|3753682|FG003|STARTED|Overall Study||7
3034695|NCT01133522|3753683|FG004|STARTED|Overall Study||7
3034696|NCT01133522|3753684|FG005|STARTED|Overall Study||6
3034697|NCT01133522|3753685|FG006|STARTED|Overall Study||2
3034698|NCT01133522|3753686|FG007|STARTED|Overall Study||9
3034699|NCT01133522|3753687|FG008|STARTED|Overall Study||2
3034700|NCT01133522|3753688|FG009|STARTED|Overall Study||4
2945077|NCT00668395|3658287|FG000|STARTED|Overall Study||45
2945078|NCT00668395|3658288|FG001|STARTED|Overall Study||22
2945079|NCT00668395|3658289|FG002|STARTED|Overall Study||6
2945080|NCT00668395|3658287|FG000|COMPLETED|Overall Study||39
2945081|NCT00668395|3658288|FG001|COMPLETED|Overall Study||16
2945082|NCT00668395|3658289|FG002|COMPLETED|Overall Study||5
2945083|NCT00668395|3658287|FG000|NOT COMPLETED|Overall Study||6
2945084|NCT00668395|3658288|FG001|NOT COMPLETED|Overall Study||6
2945085|NCT00668395|3658289|FG002|NOT COMPLETED|Overall Study||1
2945086|NCT00668434|3658299|FG000|STARTED|Primary Outcome Time Point (3 Weeks)|Baseline|181
2945087|NCT00668434|3658300|FG001|STARTED|Primary Outcome Time Point (3 Weeks)|Baseline|88
2945088|NCT00668434|3658299|FG000|COMPLETED|Primary Outcome Time Point (3 Weeks)||179
2945089|NCT00668434|3658300|FG001|COMPLETED|Primary Outcome Time Point (3 Weeks)||88
2945090|NCT00668434|3658299|FG000|NOT COMPLETED|Primary Outcome Time Point (3 Weeks)||2
2945091|NCT00668434|3658300|FG001|NOT COMPLETED|Primary Outcome Time Point (3 Weeks)||0
2945092|NCT00668434|3658299|FG000|STARTED|Secondary Outcome Time Point (52 Weeks)|Baseline|179
2945093|NCT00668434|3658300|FG001|STARTED|Secondary Outcome Time Point (52 Weeks)|Baseline|88
2945094|NCT00668434|3658299|FG000|COMPLETED|Secondary Outcome Time Point (52 Weeks)||157
2945095|NCT00668434|3658300|FG001|COMPLETED|Secondary Outcome Time Point (52 Weeks)||77
2945096|NCT00668434|3658299|FG000|NOT COMPLETED|Secondary Outcome Time Point (52 Weeks)||22
2945097|NCT00668434|3658300|FG001|NOT COMPLETED|Secondary Outcome Time Point (52 Weeks)||11
2945098|NCT00668525|3658309|FG000|STARTED|Overall Study|The number of patients started are based on the Randomized Population.|325
2945099|NCT00668525|3658310|FG001|STARTED|Overall Study|The number of patients started are based on the Randomized Population.|332
2945100|NCT00668525|3658311|FG002|STARTED|Overall Study|The number of patients started are based on the Randomized Population.|220
2945101|NCT00668525|3658309|FG000|COMPLETED|Overall Study|The number of patients completed are based on the Randomized Population.|248
2945102|NCT00668525|3658310|FG001|COMPLETED|Overall Study|The number of patients completed are based on the Randomized Population.|239
2945103|NCT00668525|3658311|FG002|COMPLETED|Overall Study|The number of patients completed are based on the Randomized Population.|167
2945104|NCT00668525|3658309|FG000|NOT COMPLETED|Overall Study||77
2945105|NCT00668525|3658310|FG001|NOT COMPLETED|Overall Study||93
2945106|NCT00668525|3658311|FG002|NOT COMPLETED|Overall Study||53
2945107|NCT00668564|3658319|FG000|STARTED|Overall Study||18
2945108|NCT00668564|3658319|FG000|COMPLETED|Overall Study||18
2945109|NCT00668564|3658319|FG000|NOT COMPLETED|Overall Study||0
2945110|NCT00668707|3658325|FG000|STARTED|Overall Study||356
2945111|NCT00668707|3658326|FG001|STARTED|Overall Study||353
2945112|NCT00668707|3658325|FG000|COMPLETED|Overall Study||157
2945113|NCT00668707|3658326|FG001|COMPLETED|Overall Study||173
2945114|NCT00668707|3658325|FG000|NOT COMPLETED|Overall Study||199
2945115|NCT00668707|3658326|FG001|NOT COMPLETED|Overall Study||180
2945116|NCT00668733|3658339|FG000|STARTED|Overall Study||89
2945117|NCT00668733|3658340|FG001|STARTED|Overall Study||90
2945118|NCT00668733|3658339|FG000|COMPLETED|Overall Study||87
2945119|NCT00668733|3658340|FG001|COMPLETED|Overall Study||83
2945120|NCT00668733|3658339|FG000|NOT COMPLETED|Overall Study||2
2945121|NCT00668733|3658340|FG001|NOT COMPLETED|Overall Study||7
2945122|NCT00668746|3658348|FG000|STARTED|Overall Study||23
2945123|NCT00668746|3658349|FG001|STARTED|Overall Study||12
2945124|NCT00668746|3658348|FG000|COMPLETED|Overall Study||21
2945125|NCT00668746|3658349|FG001|COMPLETED|Overall Study||11
2945126|NCT00668746|3658348|FG000|NOT COMPLETED|Overall Study||2
2945127|NCT00668746|3658349|FG001|NOT COMPLETED|Overall Study||1
2945128|NCT00668811|3658365|FG000|STARTED|Overall Study||23
2945129|NCT00668811|3658365|FG000|COMPLETED|Overall Study||23
2945130|NCT00668811|3658365|FG000|NOT COMPLETED|Overall Study||0
2945131|NCT00668863|3658369|FG000|STARTED|Overall Study||71
3298761|NCT02927080|4032444|FG003|NOT COMPLETED|Overall Study||0
3298762|NCT02927080|4032445|FG004|NOT COMPLETED|Overall Study||1
3298763|NCT02927080|4032446|FG005|NOT COMPLETED|Overall Study||0
3298764|NCT02927080|4032447|FG006|NOT COMPLETED|Overall Study||8
2945132|NCT00668863|3658369|FG000|COMPLETED|Overall Study||0
2945133|NCT00668863|3658369|FG000|NOT COMPLETED|Overall Study||71
2945134|NCT00668902|3658376|FG000|STARTED|Overall Study||10
2945135|NCT00668902|3658377|FG001|STARTED|Overall Study||10
2945136|NCT00668902|3658378|FG002|STARTED|Overall Study||5
2945137|NCT00668902|3658376|FG000|COMPLETED|Overall Study||10
2945138|NCT00668902|3658377|FG001|COMPLETED|Overall Study||10
2945139|NCT00668902|3658378|FG002|COMPLETED|Overall Study||5
2945140|NCT00668902|3658376|FG000|NOT COMPLETED|Overall Study||0
2945141|NCT00668902|3658377|FG001|NOT COMPLETED|Overall Study||0
2945142|NCT00668902|3658378|FG002|NOT COMPLETED|Overall Study||0
2945143|NCT00669019|3658386|FG000|STARTED|Overall Study||23
2945144|NCT00669019|3658386|FG000|COMPLETED|Overall Study||23
2945145|NCT00669019|3658386|FG000|NOT COMPLETED|Overall Study||0
2945146|NCT00669032|3658392|FG000|STARTED|Overall Study||153
2945147|NCT00669032|3658393|FG001|STARTED|Overall Study||153
3298765|NCT02927080|4032448|FG007|NOT COMPLETED|Overall Study||9
3298766|NCT02927080|4032449|FG008|NOT COMPLETED|Overall Study||3
2945148|NCT00669032|3658392|FG000|COMPLETED|Overall Study||109
2945149|NCT00669032|3658393|FG001|COMPLETED|Overall Study||94
2945150|NCT00669032|3658392|FG000|NOT COMPLETED|Overall Study||44
2945151|NCT00669032|3658393|FG001|NOT COMPLETED|Overall Study||59
2945152|NCT00669071|3658399|FG000|STARTED|Overall Study||56
2945153|NCT00669071|3658399|FG000|COMPLETED|Overall Study||52
2945154|NCT00669071|3658399|FG000|NOT COMPLETED|Overall Study||4
2945155|NCT00669110|3658407|FG000|STARTED|Overall Study||20
2945156|NCT00669110|3658408|FG001|STARTED|Overall Study||20
2945157|NCT00669110|3658407|FG000|COMPLETED|Overall Study||12
2945158|NCT00669110|3658408|FG001|COMPLETED|Overall Study||7
2945159|NCT00669110|3658407|FG000|NOT COMPLETED|Overall Study||8
2945160|NCT00669110|3658408|FG001|NOT COMPLETED|Overall Study||13
2945161|NCT00669162|3658414|FG000|STARTED|Overall Study||27
2945162|NCT00669162|3658414|FG000|COMPLETED|Overall Study||26
2945163|NCT00669162|3658414|FG000|NOT COMPLETED|Overall Study||1
2945164|NCT00669214|3658420|FG000|STARTED|Double-Blind Treatment Period (Week 12)||27
2945165|NCT00669214|3658421|FG001|STARTED|Double-Blind Treatment Period (Week 12)||62
2945166|NCT00669214|3658420|FG000|COMPLETED|Double-Blind Treatment Period (Week 12)||22
2945167|NCT00669214|3658421|FG001|COMPLETED|Double-Blind Treatment Period (Week 12)||55
2945168|NCT00669214|3658420|FG000|NOT COMPLETED|Double-Blind Treatment Period (Week 12)||5
2945169|NCT00669214|3658421|FG001|NOT COMPLETED|Double-Blind Treatment Period (Week 12)||7
2945170|NCT00669214|3658420|FG000|STARTED|Open-Label Treatment Period (Week 24)||22
2945171|NCT00669214|3658421|FG001|STARTED|Open-Label Treatment Period (Week 24)||55
2945172|NCT00669214|3658420|FG000|COMPLETED|Open-Label Treatment Period (Week 24)||18
2945173|NCT00669214|3658421|FG001|COMPLETED|Open-Label Treatment Period (Week 24)||46
2945174|NCT00669214|3658420|FG000|NOT COMPLETED|Open-Label Treatment Period (Week 24)||4
2945175|NCT00669214|3658421|FG001|NOT COMPLETED|Open-Label Treatment Period (Week 24)||9
2945176|NCT00669240|3658431|FG000|STARTED|Overall Study||567
2945177|NCT00669240|3658431|FG000|Assigned to Treatment|Overall Study||566
2945178|NCT00669240|3658431|FG000|Received Treatment|Overall Study||551
2945179|NCT00669240|3658431|FG000|COMPLETED|Overall Study||402
2945180|NCT00669240|3658431|FG000|NOT COMPLETED|Overall Study||165
2945181|NCT00669279|3658437|FG000|STARTED|Overall Study||22
2945182|NCT00669279|3658438|FG001|STARTED|Overall Study||19
2945183|NCT00669279|3658437|FG000|COMPLETED|Overall Study||22
2945184|NCT00669279|3658438|FG001|COMPLETED|Overall Study||19
2945185|NCT00669279|3658437|FG000|NOT COMPLETED|Overall Study||0
2945186|NCT00669279|3658438|FG001|NOT COMPLETED|Overall Study||0
2945187|NCT00669318|3658444|FG000|STARTED|Overall Study||41
2945188|NCT00669318|3658444|FG000|COMPLETED|Overall Study||39
2945189|NCT00669318|3658444|FG000|NOT COMPLETED|Overall Study||2
2945190|NCT00669331|3658450|FG000|STARTED|Randomisation to First Dose||244
2945191|NCT00669331|3658451|FG001|STARTED|Randomisation to First Dose||241
2945192|NCT00669331|3658450|FG000|COMPLETED|Randomisation to First Dose||233
2945193|NCT00669331|3658451|FG001|COMPLETED|Randomisation to First Dose||228
2945194|NCT00669331|3658450|FG000|NOT COMPLETED|Randomisation to First Dose||11
2945195|NCT00669331|3658451|FG001|NOT COMPLETED|Randomisation to First Dose||13
2945196|NCT00669331|3658450|FG000|STARTED|Blinded Treatment Period||233
2945197|NCT00669331|3658451|FG001|STARTED|Blinded Treatment Period||228
2945198|NCT00669331|3658450|FG000|COMPLETED|Blinded Treatment Period||191
2945199|NCT00669331|3658451|FG001|COMPLETED|Blinded Treatment Period||189
2945200|NCT00669331|3658450|FG000|NOT COMPLETED|Blinded Treatment Period||42
2945201|NCT00669331|3658451|FG001|NOT COMPLETED|Blinded Treatment Period||39
2945202|NCT00669383|3658461|FG000|STARTED|Overall Study||44
2945203|NCT00669383|3658462|FG001|STARTED|Overall Study||41
2945204|NCT00669383|3658461|FG000|COMPLETED|Overall Study||44
2945205|NCT00669383|3658462|FG001|COMPLETED|Overall Study||41
2945206|NCT00669383|3658461|FG000|NOT COMPLETED|Overall Study||0
2945207|NCT00669383|3658462|FG001|NOT COMPLETED|Overall Study||0
2945208|NCT00669396|3658470|FG000|STARTED|Overall Study||23
2945209|NCT00669396|3658471|FG001|STARTED|Overall Study||34
2945210|NCT00669396|3658470|FG000|COMPLETED|Overall Study||13
2945211|NCT00669396|3658471|FG001|COMPLETED|Overall Study||22
2945212|NCT00669396|3658470|FG000|NOT COMPLETED|Overall Study||10
2945213|NCT00669396|3658471|FG001|NOT COMPLETED|Overall Study||12
2945214|NCT00669409|3658483|FG000|STARTED|Part 1||6
2945215|NCT00669409|3658484|FG001|STARTED|Part 1||6
2945216|NCT00669409|3658485|FG002|STARTED|Part 1||6
2945217|NCT00669409|3658486|FG003|STARTED|Part 1||6
2945218|NCT00669409|3658487|FG004|STARTED|Part 1||6
2945219|NCT00669409|3658488|FG005|STARTED|Part 1||12
2945220|NCT00669409|3658489|FG006|STARTED|Part 1||0
2945221|NCT00669409|3658490|FG007|STARTED|Part 1||0
2945222|NCT00669409|3658491|FG008|STARTED|Part 1||0
2945223|NCT00669409|3658492|FG009|STARTED|Part 1||0
2945224|NCT00669409|3658493|FG010|STARTED|Part 1||0
2945225|NCT00669409|3658483|FG000|COMPLETED|Part 1||6
2945226|NCT00669409|3658484|FG001|COMPLETED|Part 1||6
2945227|NCT00669409|3658485|FG002|COMPLETED|Part 1||6
2945228|NCT00669409|3658486|FG003|COMPLETED|Part 1||6
2945229|NCT00669409|3658487|FG004|COMPLETED|Part 1||6
2945230|NCT00669409|3658488|FG005|COMPLETED|Part 1||12
2945231|NCT00669409|3658489|FG006|COMPLETED|Part 1||0
2945232|NCT00669409|3658490|FG007|COMPLETED|Part 1||0
2945233|NCT00669409|3658491|FG008|COMPLETED|Part 1||0
2945234|NCT00669409|3658492|FG009|COMPLETED|Part 1||0
2945235|NCT00669409|3658493|FG010|COMPLETED|Part 1||0
2945236|NCT00669409|3658483|FG000|NOT COMPLETED|Part 1||0
2945237|NCT00669409|3658484|FG001|NOT COMPLETED|Part 1||0
2945238|NCT00669409|3658485|FG002|NOT COMPLETED|Part 1||0
2945239|NCT00669409|3658486|FG003|NOT COMPLETED|Part 1||0
2945240|NCT00669409|3658487|FG004|NOT COMPLETED|Part 1||0
2945241|NCT00669409|3658488|FG005|NOT COMPLETED|Part 1||0
2945242|NCT00669409|3658489|FG006|NOT COMPLETED|Part 1||0
2945243|NCT00669409|3658490|FG007|NOT COMPLETED|Part 1||0
2945244|NCT00669409|3658491|FG008|NOT COMPLETED|Part 1||0
2945245|NCT00669409|3658492|FG009|NOT COMPLETED|Part 1||0
2945246|NCT00669409|3658493|FG010|NOT COMPLETED|Part 1||0
2945247|NCT00669409|3658483|FG000|STARTED|Part 2||0
2945248|NCT00669409|3658484|FG001|STARTED|Part 2||0
2945249|NCT00669409|3658485|FG002|STARTED|Part 2||0
2945250|NCT00669409|3658486|FG003|STARTED|Part 2||0
2945251|NCT00669409|3658487|FG004|STARTED|Part 2||0
2945252|NCT00669409|3658488|FG005|STARTED|Part 2||0
2945253|NCT00669409|3658489|FG006|STARTED|Part 2||9
2945254|NCT00669409|3658490|FG007|STARTED|Part 2||9
2945255|NCT00669409|3658491|FG008|STARTED|Part 2||9
2945256|NCT00669409|3658492|FG009|STARTED|Part 2||10
2945257|NCT00669409|3658493|FG010|STARTED|Part 2||4
2945258|NCT00669409|3658483|FG000|COMPLETED|Part 2||0
2945259|NCT00669409|3658484|FG001|COMPLETED|Part 2||0
2945260|NCT00669409|3658485|FG002|COMPLETED|Part 2||0
2945261|NCT00669409|3658486|FG003|COMPLETED|Part 2||0
2945262|NCT00669409|3658487|FG004|COMPLETED|Part 2||0
2945263|NCT00669409|3658488|FG005|COMPLETED|Part 2||0
2945264|NCT00669409|3658489|FG006|COMPLETED|Part 2||9
2945265|NCT00669409|3658490|FG007|COMPLETED|Part 2||9
2945266|NCT00669409|3658491|FG008|COMPLETED|Part 2||9
2945267|NCT00669409|3658492|FG009|COMPLETED|Part 2||9
2945268|NCT00669409|3658493|FG010|COMPLETED|Part 2||4
2945269|NCT00669409|3658483|FG000|NOT COMPLETED|Part 2||0
2945270|NCT00669409|3658484|FG001|NOT COMPLETED|Part 2||0
2945271|NCT00669409|3658485|FG002|NOT COMPLETED|Part 2||0
2945272|NCT00669409|3658486|FG003|NOT COMPLETED|Part 2||0
2945273|NCT00669409|3658487|FG004|NOT COMPLETED|Part 2||0
2945274|NCT00669409|3658488|FG005|NOT COMPLETED|Part 2||0
2945275|NCT00669409|3658489|FG006|NOT COMPLETED|Part 2||0
2945276|NCT00669409|3658490|FG007|NOT COMPLETED|Part 2||0
2945277|NCT00669409|3658491|FG008|NOT COMPLETED|Part 2||0
2945278|NCT00669409|3658492|FG009|NOT COMPLETED|Part 2||1
2945279|NCT00669409|3658493|FG010|NOT COMPLETED|Part 2||0
2945280|NCT00669539|3658522|FG000|STARTED|Overall Study||94
2945281|NCT00669539|3658523|FG001|STARTED|Overall Study||52
2945282|NCT00669539|3658522|FG000|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|86
2945283|NCT00669539|3658523|FG001|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|43
2945284|NCT00669539|3658522|FG000|NOT COMPLETED|Overall Study||8
2945285|NCT00669539|3658523|FG001|NOT COMPLETED|Overall Study||9
2945286|NCT00669552|3658529|FG000|STARTED|Overall Study||11
2945287|NCT00669552|3658529|FG000|COMPLETED|Overall Study||11
2945288|NCT00669552|3658529|FG000|NOT COMPLETED|Overall Study||0
2945289|NCT00669578|3658535|FG000|STARTED|Overall Study||12
2945290|NCT00669578|3658536|FG001|STARTED|Overall Study||65
2945291|NCT00669578|3658535|FG000|COMPLETED|Overall Study||12
2945292|NCT00669578|3658536|FG001|COMPLETED|Overall Study||65
2945293|NCT00669578|3658535|FG000|NOT COMPLETED|Overall Study||0
2945294|NCT00669578|3658536|FG001|NOT COMPLETED|Overall Study||0
2945295|NCT00669617|3658543|FG000|STARTED|Period 1||18
2945296|NCT00669617|3658544|FG001|STARTED|Period 1||17
2945297|NCT00669617|3658545|FG002|STARTED|Period 1||18
2945298|NCT00669617|3658546|FG003|STARTED|Period 1||18
2945299|NCT00669617|3658547|FG004|STARTED|Period 1||18
2945300|NCT00669617|3658543|FG000|COMPLETED|Period 1||18
2945301|NCT00669617|3658544|FG001|COMPLETED|Period 1||17
2945302|NCT00669617|3658545|FG002|COMPLETED|Period 1||17
2945303|NCT00669617|3658546|FG003|COMPLETED|Period 1||18
2945304|NCT00669617|3658547|FG004|COMPLETED|Period 1||17
2945305|NCT00669617|3658543|FG000|NOT COMPLETED|Period 1||0
2945306|NCT00669617|3658544|FG001|NOT COMPLETED|Period 1||0
2945307|NCT00669617|3658545|FG002|NOT COMPLETED|Period 1||1
2945308|NCT00669617|3658546|FG003|NOT COMPLETED|Period 1||0
2945309|NCT00669617|3658547|FG004|NOT COMPLETED|Period 1||1
2945310|NCT00669617|3658543|FG000|STARTED|Period 2||18
2945311|NCT00669617|3658544|FG001|STARTED|Period 2||17
2945312|NCT00669617|3658545|FG002|STARTED|Period 2||17
2945313|NCT00669617|3658546|FG003|STARTED|Period 2||18
2945314|NCT00669617|3658547|FG004|STARTED|Period 2||17
2945315|NCT00669617|3658543|FG000|COMPLETED|Period 2||18
2945316|NCT00669617|3658544|FG001|COMPLETED|Period 2||17
2945317|NCT00669617|3658545|FG002|COMPLETED|Period 2||17
2945318|NCT00669617|3658546|FG003|COMPLETED|Period 2||18
2945319|NCT00669617|3658547|FG004|COMPLETED|Period 2||17
2945320|NCT00669617|3658543|FG000|NOT COMPLETED|Period 2||0
2945321|NCT00669617|3658544|FG001|NOT COMPLETED|Period 2||0
2945322|NCT00669617|3658545|FG002|NOT COMPLETED|Period 2||0
2945323|NCT00669617|3658546|FG003|NOT COMPLETED|Period 2||0
2945324|NCT00669617|3658547|FG004|NOT COMPLETED|Period 2||0
2945325|NCT00669617|3658543|FG000|STARTED|Period 3||18
2945326|NCT00669617|3658544|FG001|STARTED|Period 3||17
2945327|NCT00669617|3658545|FG002|STARTED|Period 3||17
2945328|NCT00669617|3658546|FG003|STARTED|Period 3||18
2945329|NCT00669617|3658547|FG004|STARTED|Period 3||17
2945330|NCT00669617|3658543|FG000|COMPLETED|Period 3||17
2945331|NCT00669617|3658544|FG001|COMPLETED|Period 3||17
2945332|NCT00669617|3658545|FG002|COMPLETED|Period 3||17
2945333|NCT00669617|3658546|FG003|COMPLETED|Period 3||18
2945334|NCT00669617|3658547|FG004|COMPLETED|Period 3||17
2945335|NCT00669617|3658543|FG000|NOT COMPLETED|Period 3||1
2945336|NCT00669617|3658544|FG001|NOT COMPLETED|Period 3||0
2945337|NCT00669617|3658545|FG002|NOT COMPLETED|Period 3||0
2945338|NCT00669617|3658546|FG003|NOT COMPLETED|Period 3||0
2945339|NCT00669617|3658547|FG004|NOT COMPLETED|Period 3||0
2945340|NCT00669617|3658543|FG000|STARTED|Period 4||17
2945341|NCT00669617|3658544|FG001|STARTED|Period 4||17
2945342|NCT00669617|3658545|FG002|STARTED|Period 4||17
2945343|NCT00669617|3658546|FG003|STARTED|Period 4||18
2945344|NCT00669617|3658547|FG004|STARTED|Period 4||17
2945345|NCT00669617|3658543|FG000|COMPLETED|Period 4||17
2945346|NCT00669617|3658544|FG001|COMPLETED|Period 4||17
2945347|NCT00669617|3658545|FG002|COMPLETED|Period 4||17
2945348|NCT00669617|3658546|FG003|COMPLETED|Period 4||18
2945349|NCT00669617|3658547|FG004|COMPLETED|Period 4||17
2945350|NCT00669617|3658543|FG000|NOT COMPLETED|Period 4||0
2945351|NCT00669617|3658544|FG001|NOT COMPLETED|Period 4||0
2945352|NCT00669617|3658545|FG002|NOT COMPLETED|Period 4||0
2945353|NCT00669617|3658546|FG003|NOT COMPLETED|Period 4||0
2945354|NCT00669617|3658547|FG004|NOT COMPLETED|Period 4||0
2945355|NCT00669617|3658543|FG000|STARTED|Period 5||17
2945356|NCT00669617|3658544|FG001|STARTED|Period 5||17
2945357|NCT00669617|3658545|FG002|STARTED|Period 5||17
2945358|NCT00669617|3658546|FG003|STARTED|Period 5||18
2945359|NCT00669617|3658547|FG004|STARTED|Period 5||17
2945360|NCT00669617|3658543|FG000|COMPLETED|Period 5||17
2945361|NCT00669617|3658544|FG001|COMPLETED|Period 5||17
2945362|NCT00669617|3658545|FG002|COMPLETED|Period 5||17
2945363|NCT00669617|3658546|FG003|COMPLETED|Period 5||18
2945364|NCT00669617|3658547|FG004|COMPLETED|Period 5||17
2945365|NCT00669617|3658543|FG000|NOT COMPLETED|Period 5||0
2945366|NCT00669617|3658544|FG001|NOT COMPLETED|Period 5||0
2945367|NCT00669617|3658545|FG002|NOT COMPLETED|Period 5||0
2945368|NCT00669617|3658546|FG003|NOT COMPLETED|Period 5||0
2945369|NCT00669617|3658547|FG004|NOT COMPLETED|Period 5||0
2945370|NCT00669669|3658559|FG000|STARTED|Overall Study||12
2945371|NCT00669669|3658559|FG000|COMPLETED|Overall Study||11
2945372|NCT00669669|3658559|FG000|NOT COMPLETED|Overall Study||1
2945373|NCT00669682|3658563|FG000|STARTED|Overall Study||9
2945374|NCT00669682|3658563|FG000|COMPLETED|Overall Study||9
2945375|NCT00669682|3658563|FG000|NOT COMPLETED|Overall Study||0
2945376|NCT00669864|3658568|FG000|STARTED|Overall Study||293
2945377|NCT00669864|3658568|FG000|COMPLETED|Overall Study||284
2945378|NCT00669864|3658568|FG000|NOT COMPLETED|Overall Study||9
2945379|NCT00669877|3658572|FG000|STARTED|Overall Study||56
2945380|NCT00669877|3658572|FG000|COMPLETED|Overall Study||52
2945381|NCT00669877|3658572|FG000|NOT COMPLETED|Overall Study||4
2945382|NCT00669903|3658580|FG000|STARTED|Overall Study||23
2945383|NCT00669903|3658581|FG001|STARTED|Overall Study||37
2945384|NCT00669903|3658582|FG002|STARTED|Overall Study||18
2945385|NCT00669903|3658583|FG003|STARTED|Overall Study||22
2945386|NCT00669903|3658580|FG000|Completed Treatment Period|Overall Study||23
2945387|NCT00669903|3658581|FG001|Completed Treatment Period|Overall Study||33
2945388|NCT00669903|3658582|FG002|Completed Treatment Period|Overall Study||13
2945389|NCT00669903|3658583|FG003|Completed Treatment Period|Overall Study||19
2945390|NCT00669903|3658580|FG000|COMPLETED|Overall Study||22
2945391|NCT00669903|3658581|FG001|COMPLETED|Overall Study||32
2945392|NCT00669903|3658582|FG002|COMPLETED|Overall Study||13
2945393|NCT00669903|3658583|FG003|COMPLETED|Overall Study||18
2945394|NCT00669903|3658580|FG000|NOT COMPLETED|Overall Study||1
2945395|NCT00669903|3658581|FG001|NOT COMPLETED|Overall Study||5
2945396|NCT00669903|3658582|FG002|NOT COMPLETED|Overall Study||5
2945397|NCT00669903|3658583|FG003|NOT COMPLETED|Overall Study||4
2945398|NCT00669916|3658595|FG000|STARTED|Overall Study||18
2945399|NCT00669916|3658596|FG001|STARTED|Overall Study||18
2945400|NCT00669916|3658595|FG000|COMPLETED|Overall Study||18
2945401|NCT00669916|3658596|FG001|COMPLETED|Overall Study||18
2945402|NCT00669916|3658595|FG000|NOT COMPLETED|Overall Study||0
2945403|NCT00669916|3658596|FG001|NOT COMPLETED|Overall Study||0
2945404|NCT00669942|3658614|FG000|STARTED|Part 1||6
2945405|NCT00669942|3658615|FG001|STARTED|Part 1||6
2945406|NCT00669942|3658616|FG002|STARTED|Part 1||6
2945407|NCT00669942|3658617|FG003|STARTED|Part 1||6
2945408|NCT00669942|3658618|FG004|STARTED|Part 1||8
2945409|NCT00669942|3658619|FG005|STARTED|Part 1||0
2945410|NCT00669942|3658620|FG006|STARTED|Part 1||0
2945411|NCT00669942|3658621|FG007|STARTED|Part 1||0
2945412|NCT00669942|3658622|FG008|STARTED|Part 1||0
2945413|NCT00669942|3658623|FG009|STARTED|Part 1||0
2945414|NCT00669942|3658624|FG010|STARTED|Part 1||0
2945415|NCT00669942|3658625|FG011|STARTED|Part 1||0
2945416|NCT00669942|3658614|FG000|COMPLETED|Part 1||6
2945417|NCT00669942|3658615|FG001|COMPLETED|Part 1||6
2945418|NCT00669942|3658616|FG002|COMPLETED|Part 1||6
2945419|NCT00669942|3658617|FG003|COMPLETED|Part 1||6
2945420|NCT00669942|3658618|FG004|COMPLETED|Part 1||8
2945421|NCT00669942|3658619|FG005|COMPLETED|Part 1||0
2945422|NCT00669942|3658620|FG006|COMPLETED|Part 1||0
2945423|NCT00669942|3658621|FG007|COMPLETED|Part 1||0
2945424|NCT00669942|3658622|FG008|COMPLETED|Part 1||0
2945425|NCT00669942|3658623|FG009|COMPLETED|Part 1||0
2945426|NCT00669942|3658624|FG010|COMPLETED|Part 1||0
2945427|NCT00669942|3658625|FG011|COMPLETED|Part 1||0
2945428|NCT00669942|3658614|FG000|NOT COMPLETED|Part 1||0
2945429|NCT00669942|3658615|FG001|NOT COMPLETED|Part 1||0
2945430|NCT00669942|3658616|FG002|NOT COMPLETED|Part 1||0
2945431|NCT00669942|3658617|FG003|NOT COMPLETED|Part 1||0
2945432|NCT00669942|3658618|FG004|NOT COMPLETED|Part 1||0
2945433|NCT00669942|3658619|FG005|NOT COMPLETED|Part 1||0
2945434|NCT00669942|3658620|FG006|NOT COMPLETED|Part 1||0
2945435|NCT00669942|3658621|FG007|NOT COMPLETED|Part 1||0
2945436|NCT00669942|3658622|FG008|NOT COMPLETED|Part 1||0
2945437|NCT00669942|3658623|FG009|NOT COMPLETED|Part 1||0
2945438|NCT00669942|3658624|FG010|NOT COMPLETED|Part 1||0
2945439|NCT00669942|3658625|FG011|NOT COMPLETED|Part 1||0
2945440|NCT00669942|3658614|FG000|STARTED|Parts 2 and 3||0
2945441|NCT00669942|3658615|FG001|STARTED|Parts 2 and 3||0
2945442|NCT00669942|3658616|FG002|STARTED|Parts 2 and 3||0
2945443|NCT00669942|3658617|FG003|STARTED|Parts 2 and 3||0
2945444|NCT00669942|3658618|FG004|STARTED|Parts 2 and 3||0
2945445|NCT00669942|3658619|FG005|STARTED|Parts 2 and 3||6
2945446|NCT00669942|3658620|FG006|STARTED|Parts 2 and 3||6
2945447|NCT00669942|3658621|FG007|STARTED|Parts 2 and 3||26
2945448|NCT00669942|3658622|FG008|STARTED|Parts 2 and 3||26
2945449|NCT00669942|3658623|FG009|STARTED|Parts 2 and 3||0
2945450|NCT00669942|3658624|FG010|STARTED|Parts 2 and 3||0
2945451|NCT00669942|3658625|FG011|STARTED|Parts 2 and 3||0
2945452|NCT00669942|3658614|FG000|COMPLETED|Parts 2 and 3||0
2945453|NCT00669942|3658615|FG001|COMPLETED|Parts 2 and 3||0
2945454|NCT00669942|3658616|FG002|COMPLETED|Parts 2 and 3||0
2945455|NCT00669942|3658617|FG003|COMPLETED|Parts 2 and 3||0
2945456|NCT00669942|3658618|FG004|COMPLETED|Parts 2 and 3||0
2945457|NCT00669942|3658619|FG005|COMPLETED|Parts 2 and 3||4
2945458|NCT00669942|3658620|FG006|COMPLETED|Parts 2 and 3||6
2945459|NCT00669942|3658621|FG007|COMPLETED|Parts 2 and 3||24
2945460|NCT00669942|3658622|FG008|COMPLETED|Parts 2 and 3||23
2945461|NCT00669942|3658623|FG009|COMPLETED|Parts 2 and 3||0
2945462|NCT00669942|3658624|FG010|COMPLETED|Parts 2 and 3||0
2945463|NCT00669942|3658625|FG011|COMPLETED|Parts 2 and 3||0
2945464|NCT00669942|3658614|FG000|NOT COMPLETED|Parts 2 and 3||0
2945465|NCT00669942|3658615|FG001|NOT COMPLETED|Parts 2 and 3||0
2945466|NCT00669942|3658616|FG002|NOT COMPLETED|Parts 2 and 3||0
2945467|NCT00669942|3658617|FG003|NOT COMPLETED|Parts 2 and 3||0
2945468|NCT00669942|3658618|FG004|NOT COMPLETED|Parts 2 and 3||0
2945469|NCT00669942|3658619|FG005|NOT COMPLETED|Parts 2 and 3||2
2945470|NCT00669942|3658620|FG006|NOT COMPLETED|Parts 2 and 3||0
2945471|NCT00669942|3658621|FG007|NOT COMPLETED|Parts 2 and 3||2
2945472|NCT00669942|3658622|FG008|NOT COMPLETED|Parts 2 and 3||3
2945473|NCT00669942|3658623|FG009|NOT COMPLETED|Parts 2 and 3||0
2945474|NCT00669942|3658624|FG010|NOT COMPLETED|Parts 2 and 3||0
2945475|NCT00669942|3658625|FG011|NOT COMPLETED|Parts 2 and 3||0
2945476|NCT00669942|3658614|FG000|STARTED|Healthy Volunteers||0
2945477|NCT00669942|3658615|FG001|STARTED|Healthy Volunteers||0
2945478|NCT00669942|3658616|FG002|STARTED|Healthy Volunteers||0
2945479|NCT00669942|3658617|FG003|STARTED|Healthy Volunteers||0
2945480|NCT00669942|3658618|FG004|STARTED|Healthy Volunteers||0
2945481|NCT00669942|3658619|FG005|STARTED|Healthy Volunteers||0
2945482|NCT00669942|3658620|FG006|STARTED|Healthy Volunteers||0
2945483|NCT00669942|3658621|FG007|STARTED|Healthy Volunteers||0
2945484|NCT00669942|3658622|FG008|STARTED|Healthy Volunteers||0
2945485|NCT00669942|3658623|FG009|STARTED|Healthy Volunteers||3
2945486|NCT00669942|3658624|FG010|STARTED|Healthy Volunteers||3
2945487|NCT00669942|3658625|FG011|STARTED|Healthy Volunteers||2
2945488|NCT00669942|3658614|FG000|COMPLETED|Healthy Volunteers||0
2945489|NCT00669942|3658615|FG001|COMPLETED|Healthy Volunteers||0
2945490|NCT00669942|3658616|FG002|COMPLETED|Healthy Volunteers||0
2945491|NCT00669942|3658617|FG003|COMPLETED|Healthy Volunteers||0
2945492|NCT00669942|3658618|FG004|COMPLETED|Healthy Volunteers||0
2945493|NCT00669942|3658619|FG005|COMPLETED|Healthy Volunteers||0
2945494|NCT00669942|3658620|FG006|COMPLETED|Healthy Volunteers||0
2945495|NCT00669942|3658621|FG007|COMPLETED|Healthy Volunteers||0
2945496|NCT00669942|3658622|FG008|COMPLETED|Healthy Volunteers||0
2945497|NCT00669942|3658623|FG009|COMPLETED|Healthy Volunteers||3
2945498|NCT00669942|3658624|FG010|COMPLETED|Healthy Volunteers||2
2945499|NCT00669942|3658625|FG011|COMPLETED|Healthy Volunteers||2
2945500|NCT00669942|3658614|FG000|NOT COMPLETED|Healthy Volunteers||0
2945501|NCT00669942|3658615|FG001|NOT COMPLETED|Healthy Volunteers||0
2945502|NCT00669942|3658616|FG002|NOT COMPLETED|Healthy Volunteers||0
2945503|NCT00669942|3658617|FG003|NOT COMPLETED|Healthy Volunteers||0
2945504|NCT00669942|3658618|FG004|NOT COMPLETED|Healthy Volunteers||0
2945505|NCT00669942|3658619|FG005|NOT COMPLETED|Healthy Volunteers||0
2945506|NCT00669942|3658620|FG006|NOT COMPLETED|Healthy Volunteers||0
2945507|NCT00669942|3658621|FG007|NOT COMPLETED|Healthy Volunteers||0
2945508|NCT00669942|3658622|FG008|NOT COMPLETED|Healthy Volunteers||0
2945509|NCT00669942|3658623|FG009|NOT COMPLETED|Healthy Volunteers||0
2945510|NCT00669942|3658624|FG010|NOT COMPLETED|Healthy Volunteers||1
2945511|NCT00669942|3658625|FG011|NOT COMPLETED|Healthy Volunteers||0
2945512|NCT00669955|3658650|FG000|STARTED|Overall Study|216 patients received study drug. 2 patients were dispensed study drug but did not take it|218
2945513|NCT00669955|3658651|FG001|STARTED|Overall Study||222
2945514|NCT00669955|3658650|FG000|COMPLETED|Overall Study||204
2945515|NCT00669955|3658651|FG001|COMPLETED|Overall Study||195
2945516|NCT00669955|3658650|FG000|NOT COMPLETED|Overall Study||14
2945517|NCT00669955|3658651|FG001|NOT COMPLETED|Overall Study||27
2945518|NCT00670007|3658657|FG000|STARTED|Overall Study||140
2945519|NCT00670007|3658657|FG000|COMPLETED|Overall Study||131
2945520|NCT00670007|3658657|FG000|NOT COMPLETED|Overall Study||9
2945521|NCT00670046|3658664|FG000|STARTED|Overall Study||7
2945522|NCT00670046|3658665|FG001|STARTED|Overall Study||8
2945523|NCT00670046|3658664|FG000|COMPLETED|Overall Study||6
2945524|NCT00670046|3658665|FG001|COMPLETED|Overall Study||6
2945525|NCT00670046|3658664|FG000|NOT COMPLETED|Overall Study||1
2945526|NCT00670046|3658665|FG001|NOT COMPLETED|Overall Study||2
2945527|NCT00670111|3658674|FG000|STARTED|Enrollment to One Month||5
2945528|NCT00670111|3658675|FG001|STARTED|Enrollment to One Month||8
2945529|NCT00670111|3658676|FG002|STARTED|Enrollment to One Month||19
2945530|NCT00670111|3658674|FG000|COMPLETED|Enrollment to One Month||4
2945531|NCT00670111|3658675|FG001|COMPLETED|Enrollment to One Month||8
2945532|NCT00670111|3658676|FG002|COMPLETED|Enrollment to One Month||0
2945533|NCT00670111|3658674|FG000|NOT COMPLETED|Enrollment to One Month||1
2945534|NCT00670111|3658675|FG001|NOT COMPLETED|Enrollment to One Month||0
2945535|NCT00670111|3658676|FG002|NOT COMPLETED|Enrollment to One Month||19
2945536|NCT00670111|3658674|FG000|STARTED|One Month Period A||4
2945537|NCT00670111|3658675|FG001|STARTED|One Month Period A||8
2945538|NCT00670111|3658676|FG002|STARTED|One Month Period A||0
2945539|NCT00670111|3658674|FG000|COMPLETED|One Month Period A||4
2945540|NCT00670111|3658675|FG001|COMPLETED|One Month Period A||8
2945541|NCT00670111|3658676|FG002|COMPLETED|One Month Period A||0
2945542|NCT00670111|3658674|FG000|NOT COMPLETED|One Month Period A||0
2945543|NCT00670111|3658675|FG001|NOT COMPLETED|One Month Period A||0
2945544|NCT00670111|3658676|FG002|NOT COMPLETED|One Month Period A||0
2945545|NCT00670111|3658674|FG000|STARTED|One Month Period B||4
2945546|NCT00670111|3658675|FG001|STARTED|One Month Period B||8
2945547|NCT00670111|3658676|FG002|STARTED|One Month Period B||0
2945548|NCT00670111|3658674|FG000|COMPLETED|One Month Period B|4 patients in this group completed the 1 month visit; 0 had data eligible for endpoint analysis.|4
2945549|NCT00670111|3658675|FG001|COMPLETED|One Month Period B|8 patients in this group completed the 1 month visit; 6 had data eligible for endpoint analysis.|8
2945550|NCT00670111|3658676|FG002|COMPLETED|One Month Period B||0
2945551|NCT00670111|3658674|FG000|NOT COMPLETED|One Month Period B||0
2945552|NCT00670111|3658675|FG001|NOT COMPLETED|One Month Period B||0
2945553|NCT00670111|3658676|FG002|NOT COMPLETED|One Month Period B||0
2945554|NCT00670111|3658674|FG000|STARTED|One Month to Six Months||4
2945555|NCT00670111|3658675|FG001|STARTED|One Month to Six Months||8
2945556|NCT00670111|3658676|FG002|STARTED|One Month to Six Months||0
2945557|NCT00670111|3658674|FG000|COMPLETED|One Month to Six Months|4 patients in this group completed the 1 month visit; 0 had data eligible for endpoint analysis.|4
2945558|NCT00670111|3658675|FG001|COMPLETED|One Month to Six Months|8 patients in this group completed the 1 month visit; 4 had data eligible for endpoint analysis.|8
2945559|NCT00670111|3658676|FG002|COMPLETED|One Month to Six Months||0
2945560|NCT00670111|3658674|FG000|NOT COMPLETED|One Month to Six Months||0
2945561|NCT00670111|3658675|FG001|NOT COMPLETED|One Month to Six Months||0
2945562|NCT00670111|3658676|FG002|NOT COMPLETED|One Month to Six Months||0
2945563|NCT00670111|3658674|FG000|STARTED|Six Months to Twelve Months||4
2945564|NCT00670111|3658675|FG001|STARTED|Six Months to Twelve Months||8
2945565|NCT00670111|3658676|FG002|STARTED|Six Months to Twelve Months||0
2945566|NCT00670111|3658674|FG000|COMPLETED|Six Months to Twelve Months||4
2945567|NCT00670111|3658675|FG001|COMPLETED|Six Months to Twelve Months||8
2945568|NCT00670111|3658676|FG002|COMPLETED|Six Months to Twelve Months||0
2945569|NCT00670111|3658674|FG000|NOT COMPLETED|Six Months to Twelve Months||0
2945570|NCT00670111|3658675|FG001|NOT COMPLETED|Six Months to Twelve Months||0
2945571|NCT00670111|3658676|FG002|NOT COMPLETED|Six Months to Twelve Months||0
2945572|NCT00670202|3658686|FG000|STARTED|Overall Study|Investigators blinded to study drug assignment due to early termination of study|2
2945573|NCT00670202|3658687|FG001|STARTED|Overall Study||0
2945574|NCT00670202|3658686|FG000|COMPLETED|Overall Study|Investigators blinded to study drug assignment due to early termination of study|2
2945575|NCT00670202|3658687|FG001|COMPLETED|Overall Study||0
2945576|NCT00670202|3658686|FG000|NOT COMPLETED|Overall Study||0
2945577|NCT00670202|3658687|FG001|NOT COMPLETED|Overall Study||0
2945578|NCT00670228|3658695|FG000|STARTED|Overall Study||18
2945579|NCT00670228|3658696|FG001|STARTED|Overall Study||15
2945580|NCT00670228|3658695|FG000|COMPLETED|Overall Study||13
2945581|NCT00670228|3658696|FG001|COMPLETED|Overall Study||12
2945582|NCT00670228|3658695|FG000|NOT COMPLETED|Overall Study||5
2945583|NCT00670228|3658696|FG001|NOT COMPLETED|Overall Study||3
2945584|NCT00670241|3658705|FG000|STARTED|Overall Study||183
2945585|NCT00670241|3658706|FG001|STARTED|Overall Study||184
2945586|NCT00670241|3658707|FG002|STARTED|Overall Study||91
2945587|NCT00670241|3658705|FG000|COMPLETED|Overall Study||171
2945588|NCT00670241|3658706|FG001|COMPLETED|Overall Study||163
2945589|NCT00670241|3658707|FG002|COMPLETED|Overall Study||64
2945590|NCT00670241|3658705|FG000|NOT COMPLETED|Overall Study||12
2945591|NCT00670241|3658706|FG001|NOT COMPLETED|Overall Study||21
2945592|NCT00670241|3658707|FG002|NOT COMPLETED|Overall Study||27
2945593|NCT00670267|3658715|FG000|STARTED|Overall Study||10
2945594|NCT00670267|3658715|FG000|COMPLETED|Overall Study||9
2945595|NCT00670267|3658715|FG000|NOT COMPLETED|Overall Study||1
2945596|NCT00670306|3658721|FG000|STARTED|Overall Study||528
2945597|NCT00670306|3658721|FG000|COMPLETED|Overall Study||473
2945598|NCT00670306|3658721|FG000|NOT COMPLETED|Overall Study||55
2945599|NCT00670449|3658729|FG000|STARTED|Overall Study||47
2945600|NCT00670449|3658730|FG001|STARTED|Overall Study||46
2945601|NCT00670449|3658731|FG002|STARTED|Overall Study||27
2945602|NCT00670449|3658732|FG003|STARTED|Overall Study||23
2945603|NCT00670449|3658729|FG000|Switched to 0.5mg (Open Label)|Overall Study||45
2945604|NCT00670449|3658730|FG001|Switched to 0.5mg (Open Label)|Overall Study|Following protocol amendment, study became open-label with all patients receiving FTY720 0.5 mg/day|41
2945605|NCT00670449|3658731|FG002|Switched to 0.5mg (Open Label)|Overall Study||23
2945606|NCT00670449|3658732|FG003|Switched to 0.5mg (Open Label)|Overall Study|Following protocol amendment, study became open-label with all patients receiving FTY720 0.5 mg/day|17
2945607|NCT00670449|3658729|FG000|COMPLETED|Overall Study||38
2945608|NCT00670449|3658730|FG001|COMPLETED|Overall Study||36
2945609|NCT00670449|3658731|FG002|COMPLETED|Overall Study||18
2945610|NCT00670449|3658732|FG003|COMPLETED|Overall Study||15
2945611|NCT00670449|3658729|FG000|NOT COMPLETED|Overall Study||9
2945612|NCT00670449|3658730|FG001|NOT COMPLETED|Overall Study||10
2945613|NCT00670449|3658731|FG002|NOT COMPLETED|Overall Study||9
3298767|NCT02927080|4032450|FG009|NOT COMPLETED|Overall Study||7
3298768|NCT02927171|4032497|FG000|STARTED|Overall Study||53
3298769|NCT02927171|4032498|FG001|STARTED|Overall Study||51
3298770|NCT02927171|4032497|FG000|COMPLETED|Overall Study||53
3298771|NCT02927171|4032498|FG001|COMPLETED|Overall Study||50
3298772|NCT02927171|4032497|FG000|NOT COMPLETED|Overall Study||0
3298773|NCT02927171|4032498|FG001|NOT COMPLETED|Overall Study||1
3298774|NCT02927223|4032504|FG000|STARTED|Overall Study||6
3298775|NCT02927223|4032504|FG000|COMPLETED|Overall Study||6
2945614|NCT00670449|3658732|FG003|NOT COMPLETED|Overall Study||8
2945615|NCT00670462|3658743|FG000|STARTED|Overall Study||106
2945616|NCT00670462|3658744|FG001|STARTED|Overall Study||107
2945617|NCT00670462|3658743|FG000|COMPLETED|Overall Study||76
2945618|NCT00670462|3658744|FG001|COMPLETED|Overall Study||76
2945619|NCT00670462|3658743|FG000|NOT COMPLETED|Overall Study||30
2945620|NCT00670462|3658744|FG001|NOT COMPLETED|Overall Study||31
2945621|NCT00670488|3658762|FG000|STARTED|Overall Study||3
2945622|NCT00670488|3658763|FG001|STARTED|Overall Study||58
3298776|NCT02927223|4032504|FG000|NOT COMPLETED|Overall Study||0
3298777|NCT02927301|4032510|FG000|STARTED|Overall Study||181
3298778|NCT02927301|4032510|FG000|COMPLETED|Overall Study||171
3298779|NCT02927301|4032510|FG000|NOT COMPLETED|Overall Study||10
3298780|NCT02927327|4032516|FG000|STARTED|Overall Study||30
3298781|NCT02927327|4032517|FG001|STARTED|Overall Study||31
2945623|NCT00670488|3658764|FG002|STARTED|Overall Study||3
2945624|NCT00670488|3658765|FG003|STARTED|Overall Study||7
2945625|NCT00670488|3658766|FG004|STARTED|Overall Study||3
2945626|NCT00670488|3658767|FG005|STARTED|Overall Study||5
2945627|NCT00670488|3658768|FG006|STARTED|Overall Study||17
2945628|NCT00670488|3658769|FG007|STARTED|Overall Study||3
2945629|NCT00670488|3658770|FG008|STARTED|Overall Study||3
2945630|NCT00670488|3658771|FG009|STARTED|Overall Study||2
2945631|NCT00670488|3658762|FG000|COMPLETED|Overall Study||0
2945632|NCT00670488|3658763|FG001|COMPLETED|Overall Study||0
2945633|NCT00670488|3658764|FG002|COMPLETED|Overall Study||0
2945634|NCT00670488|3658765|FG003|COMPLETED|Overall Study||0
2945635|NCT00670488|3658766|FG004|COMPLETED|Overall Study||0
2945636|NCT00670488|3658767|FG005|COMPLETED|Overall Study||0
2945637|NCT00670488|3658768|FG006|COMPLETED|Overall Study||0
2945638|NCT00670488|3658769|FG007|COMPLETED|Overall Study||0
2945639|NCT00670488|3658770|FG008|COMPLETED|Overall Study||0
2945640|NCT00670488|3658771|FG009|COMPLETED|Overall Study||0
2945641|NCT00670488|3658762|FG000|NOT COMPLETED|Overall Study||3
2945642|NCT00670488|3658763|FG001|NOT COMPLETED|Overall Study||58
2945643|NCT00670488|3658764|FG002|NOT COMPLETED|Overall Study||3
2945644|NCT00670488|3658765|FG003|NOT COMPLETED|Overall Study||7
2945645|NCT00670488|3658766|FG004|NOT COMPLETED|Overall Study||3
2945646|NCT00670488|3658767|FG005|NOT COMPLETED|Overall Study||5
2945647|NCT00670488|3658768|FG006|NOT COMPLETED|Overall Study||17
2945648|NCT00670488|3658769|FG007|NOT COMPLETED|Overall Study||3
2945649|NCT00670488|3658770|FG008|NOT COMPLETED|Overall Study||3
2945650|NCT00670488|3658771|FG009|NOT COMPLETED|Overall Study||2
2945651|NCT00670540|3658793|FG000|STARTED|Overall Study||8256
2945652|NCT00670540|3658793|FG000|COMPLETED|Overall Study|total recruited for the follow up|4931
2945653|NCT00670540|3658793|FG000|NOT COMPLETED|Overall Study||3325
2945654|NCT00670709|3658799|FG000|STARTED|Overall Study||27
2945655|NCT00670709|3658800|FG001|STARTED|Overall Study||15
2945656|NCT00670709|3658799|FG000|COMPLETED|Overall Study||27
2945657|NCT00670709|3658800|FG001|COMPLETED|Overall Study||15
2945658|NCT00670709|3658799|FG000|NOT COMPLETED|Overall Study||0
2945659|NCT00670709|3658800|FG001|NOT COMPLETED|Overall Study||0
2945660|NCT00670748|3658810|FG000|STARTED|Overall Study||17
2945661|NCT00670748|3658811|FG001|STARTED|Overall Study||16
2945662|NCT00670748|3658812|FG002|STARTED|Overall Study||7
2945663|NCT00670748|3658813|FG003|STARTED|Overall Study||5
2945664|NCT00670748|3658810|FG000|COMPLETED|Overall Study||14
2945665|NCT00670748|3658811|FG001|COMPLETED|Overall Study||14
2945666|NCT00670748|3658812|FG002|COMPLETED|Overall Study||5
2945667|NCT00670748|3658813|FG003|COMPLETED|Overall Study||4
2945668|NCT00670748|3658810|FG000|NOT COMPLETED|Overall Study||3
2945669|NCT00670748|3658811|FG001|NOT COMPLETED|Overall Study||2
2945670|NCT00670748|3658812|FG002|NOT COMPLETED|Overall Study||2
2945671|NCT00670748|3658813|FG003|NOT COMPLETED|Overall Study||1
2945672|NCT00670774|3658823|FG000|STARTED|Overall Study||26
2945673|NCT00670774|3658823|FG000|COMPLETED|Overall Study||26
3298782|NCT02927327|4032516|FG000|COMPLETED|Overall Study||30
3298783|NCT02927327|4032517|FG001|COMPLETED|Overall Study||31
2945674|NCT00670774|3658823|FG000|NOT COMPLETED|Overall Study||0
2945675|NCT00670800|3658829|FG000|STARTED|Overall Study||7
2945676|NCT00670800|3658830|FG001|STARTED|Overall Study||7
2945677|NCT00670800|3658829|FG000|COMPLETED|Overall Study||7
2945678|NCT00670800|3658830|FG001|COMPLETED|Overall Study|Two controls were found to have insulin resistance and were excluded from analysis.|5
2945679|NCT00670800|3658829|FG000|NOT COMPLETED|Overall Study||0
2945680|NCT00670800|3658830|FG001|NOT COMPLETED|Overall Study||2
2945681|NCT00670930|3658840|FG000|STARTED|Overall Study|"Started indicates Randomized and Safety populaiton"|23
2945682|NCT00670930|3658841|FG001|STARTED|Overall Study||13
2945683|NCT00670930|3658840|FG000|Intent to Treat (ITT) Population|Overall Study||23
2945684|NCT00670930|3658841|FG001|Intent to Treat (ITT) Population|Overall Study||12
3298784|NCT02927327|4032516|FG000|NOT COMPLETED|Overall Study||0
2945685|NCT00670930|3658840|FG000|COMPLETED|Overall Study||22
2945686|NCT00670930|3658841|FG001|COMPLETED|Overall Study||12
2945687|NCT00670930|3658840|FG000|NOT COMPLETED|Overall Study||1
2945688|NCT00670930|3658841|FG001|NOT COMPLETED|Overall Study||1
2945689|NCT00670956|3658847|FG000|STARTED|Overall Study||1
2945690|NCT00670956|3658847|FG000|COMPLETED|Overall Study||1
2945691|NCT00670956|3658847|FG000|NOT COMPLETED|Overall Study||0
2945692|NCT00670982|3658853|FG000|STARTED|Overall Study||22
2945693|NCT00670982|3658854|FG001|STARTED|Overall Study||7
2945694|NCT00670982|3658853|FG000|COMPLETED|Overall Study||22
2945695|NCT00670982|3658854|FG001|COMPLETED|Overall Study||7
2945696|NCT00670982|3658853|FG000|NOT COMPLETED|Overall Study||0
2945697|NCT00670982|3658854|FG001|NOT COMPLETED|Overall Study||0
2945698|NCT00671034|3658862|FG000|STARTED|Overall Study||69
2945699|NCT00671034|3658863|FG001|STARTED|Overall Study||42
2945700|NCT00671034|3658864|FG002|STARTED|Overall Study||55
2945701|NCT00671034|3658862|FG000|COMPLETED|Overall Study||30
2945702|NCT00671034|3658863|FG001|COMPLETED|Overall Study||22
2945703|NCT00671034|3658864|FG002|COMPLETED|Overall Study||31
2945704|NCT00671034|3658862|FG000|NOT COMPLETED|Overall Study||39
2945705|NCT00671034|3658863|FG001|NOT COMPLETED|Overall Study||20
2945706|NCT00671034|3658864|FG002|NOT COMPLETED|Overall Study||24
2945707|NCT00671060|3658875|FG000|STARTED|Overall Study||77
2945708|NCT00671060|3658876|FG001|STARTED|Overall Study||76
2945709|NCT00671060|3658875|FG000|COMPLETED|Overall Study|1 woman completed study but was excluded from analysis because gestational age <14 weeks.|76
2945710|NCT00671060|3658876|FG001|COMPLETED|Overall Study|1 woman was withdrawn from the study due to preeclampsia.|75
2945711|NCT00671060|3658875|FG000|NOT COMPLETED|Overall Study||1
2945712|NCT00671060|3658876|FG001|NOT COMPLETED|Overall Study||1
2945713|NCT00671177|3658884|FG000|STARTED|Overall Study||114
2945714|NCT00671177|3658885|FG001|STARTED|Overall Study||115
2945715|NCT00671177|3658884|FG000|COMPLETED|Overall Study||112
2945716|NCT00671177|3658885|FG001|COMPLETED|Overall Study||114
2945717|NCT00671177|3658884|FG000|NOT COMPLETED|Overall Study||2
2945718|NCT00671177|3658885|FG001|NOT COMPLETED|Overall Study||1
2945719|NCT00671437|3658891|FG000|STARTED|Overall Study||42
2945720|NCT00671437|3658891|FG000|COMPLETED|Overall Study||27
2945721|NCT00671437|3658891|FG000|NOT COMPLETED|Overall Study||15
2945722|NCT00671502|3658906|FG000|STARTED|Overall Study||281
2945723|NCT00671502|3658907|FG001|STARTED|Overall Study||280
2945724|NCT00671502|3658908|FG002|STARTED|Overall Study||279
2945725|NCT00671502|3658906|FG000|COMPLETED|Overall Study||242
2945726|NCT00671502|3658907|FG001|COMPLETED|Overall Study||241
2945727|NCT00671502|3658908|FG002|COMPLETED|Overall Study||252
2945728|NCT00671502|3658906|FG000|NOT COMPLETED|Overall Study||39
2945729|NCT00671502|3658907|FG001|NOT COMPLETED|Overall Study||39
2945730|NCT00671502|3658908|FG002|NOT COMPLETED|Overall Study||27
2945731|NCT00671515|3658916|FG000|STARTED|Phase 1||23
2945732|NCT00671515|3658916|FG000|COMPLETED|Phase 1||20
2945733|NCT00671515|3658916|FG000|NOT COMPLETED|Phase 1||3
2945734|NCT00671515|3658916|FG000|STARTED|Phase 2||13
2945735|NCT00671515|3658916|FG000|COMPLETED|Phase 2||9
2945736|NCT00671515|3658916|FG000|NOT COMPLETED|Phase 2||4
2945737|NCT00671554|3658920|FG000|STARTED|Overall Study||3
2945738|NCT00671554|3658920|FG000|COMPLETED|Overall Study||0
2945739|NCT00671554|3658920|FG000|NOT COMPLETED|Overall Study||3
2945740|NCT00671658|3658925|FG000|STARTED|Overall Study||220
2945741|NCT00671658|3658925|FG000|COMPLETED|Overall Study||215
2945742|NCT00671658|3658925|FG000|NOT COMPLETED|Overall Study||5
2945743|NCT00671671|3658931|FG000|STARTED|Overall Study||10
2945744|NCT00671671|3658932|FG001|STARTED|Overall Study||10
2945745|NCT00671671|3658931|FG000|COMPLETED|Overall Study||10
2945746|NCT00671671|3658932|FG001|COMPLETED|Overall Study||10
2945747|NCT00671671|3658931|FG000|NOT COMPLETED|Overall Study||0
2945748|NCT00671671|3658932|FG001|NOT COMPLETED|Overall Study||0
2945749|NCT00671723|3658942|FG000|STARTED|Overall Study||11
2945750|NCT00671723|3658943|FG001|STARTED|Overall Study||11
2945751|NCT00671723|3658944|FG002|STARTED|Overall Study||11
2945752|NCT00671723|3658942|FG000|COMPLETED|Overall Study||11
2945753|NCT00671723|3658943|FG001|COMPLETED|Overall Study||11
2945754|NCT00671723|3658944|FG002|COMPLETED|Overall Study||11
2945755|NCT00671723|3658942|FG000|NOT COMPLETED|Overall Study||0
2945756|NCT00671723|3658943|FG001|NOT COMPLETED|Overall Study||0
2945757|NCT00671723|3658944|FG002|NOT COMPLETED|Overall Study||0
2945758|NCT00671749|3658952|FG000|STARTED|Overall Study||100
2945759|NCT00671749|3658952|FG000|COMPLETED|Overall Study||92
2945760|NCT00671749|3658952|FG000|NOT COMPLETED|Overall Study||8
2945761|NCT00671788|3658956|FG000|STARTED|Overall Study||35
2945762|NCT00671788|3658956|FG000|COMPLETED|Overall Study|Patients treated until disease progression; completed defined as off treatment due to progression.|21
2945763|NCT00671788|3658956|FG000|NOT COMPLETED|Overall Study||14
2945764|NCT00671853|3658962|FG000|STARTED|Overall Study||46
2945765|NCT00671853|3658963|FG001|STARTED|Overall Study||45
2945766|NCT00671853|3658962|FG000|COMPLETED|Overall Study||26
2945767|NCT00671853|3658963|FG001|COMPLETED|Overall Study||18
2945768|NCT00671853|3658962|FG000|NOT COMPLETED|Overall Study||20
2945769|NCT00671853|3658963|FG001|NOT COMPLETED|Overall Study||27
2945770|NCT00671879|3658974|FG000|STARTED|Overall Study||281
2945771|NCT00671879|3658975|FG001|STARTED|Overall Study||279
2945772|NCT00671879|3658976|FG002|STARTED|Overall Study||280
2945773|NCT00671879|3658974|FG000|COMPLETED|Overall Study||281
2945774|NCT00671879|3658975|FG001|COMPLETED|Overall Study||275
2945775|NCT00671879|3658976|FG002|COMPLETED|Overall Study||274
2945776|NCT00671879|3658974|FG000|NOT COMPLETED|Overall Study||0
2945777|NCT00671879|3658975|FG001|NOT COMPLETED|Overall Study||4
2945778|NCT00671879|3658976|FG002|NOT COMPLETED|Overall Study||6
2945779|NCT00671918|3658985|FG000|STARTED|Overall Study||186
2945780|NCT00671918|3658985|FG000|COMPLETED|Overall Study||169
2945781|NCT00671918|3658985|FG000|NOT COMPLETED|Overall Study||17
2945782|NCT00671931|3658995|FG000|STARTED|Overall Study||9
2945783|NCT00671931|3658996|FG001|STARTED|Overall Study||8
2945784|NCT00671931|3658997|FG002|STARTED|Overall Study||9
2945785|NCT00671931|3658998|FG003|STARTED|Overall Study||10
2945786|NCT00671931|3658999|FG004|STARTED|Overall Study||8
2945787|NCT00671931|3658995|FG000|COMPLETED|Overall Study|Nueromonitoring equipment falure|8
2945788|NCT00671931|3658996|FG001|COMPLETED|Overall Study|All completed|8
2945789|NCT00671931|3658997|FG002|COMPLETED|Overall Study|all completed|9
2945790|NCT00671931|3658998|FG003|COMPLETED|Overall Study|Prepositioning - Neuromonitoring required|8
2945791|NCT00671931|3658999|FG004|COMPLETED|Overall Study|Low heart rate requiring treatment|7
2945792|NCT00671931|3658995|FG000|NOT COMPLETED|Overall Study||1
2945793|NCT00671931|3658996|FG001|NOT COMPLETED|Overall Study||0
2945794|NCT00671931|3658997|FG002|NOT COMPLETED|Overall Study||0
2945795|NCT00671931|3658998|FG003|NOT COMPLETED|Overall Study||2
2945796|NCT00671931|3658999|FG004|NOT COMPLETED|Overall Study||1
2945797|NCT00671970|3659013|FG000|STARTED|Overall Study||32
2945798|NCT00671970|3659014|FG001|STARTED|Overall Study||25
2945799|NCT00671970|3659013|FG000|COMPLETED|Overall Study||32
2945800|NCT00671970|3659014|FG001|COMPLETED|Overall Study||25
2945801|NCT00671970|3659013|FG000|NOT COMPLETED|Overall Study||0
2945802|NCT00671970|3659014|FG001|NOT COMPLETED|Overall Study||0
2945803|NCT00672100|3659035|FG000|STARTED|Overall Study||12
2945804|NCT00672100|3659036|FG001|STARTED|Overall Study||12
2945805|NCT00672100|3659037|FG002|STARTED|Overall Study||12
2945806|NCT00672100|3659035|FG000|PACU (Within 8 Hours)|Overall Study||12
2945807|NCT00672100|3659036|FG001|PACU (Within 8 Hours)|Overall Study||12
2945808|NCT00672100|3659037|FG002|PACU (Within 8 Hours)|Overall Study||12
2945809|NCT00672100|3659035|FG000|COMPLETED|Overall Study||12
2945810|NCT00672100|3659036|FG001|COMPLETED|Overall Study||12
2945811|NCT00672100|3659037|FG002|COMPLETED|Overall Study||12
2945812|NCT00672100|3659035|FG000|NOT COMPLETED|Overall Study||0
2945813|NCT00672100|3659036|FG001|NOT COMPLETED|Overall Study||0
2945814|NCT00672100|3659037|FG002|NOT COMPLETED|Overall Study||0
2945815|NCT00672139|3659051|FG000|STARTED|Overall Study|Three of 60 enrolled subjects did not receive study drug.|57
2945816|NCT00672139|3659052|FG001|STARTED|Overall Study|Four of 96 enrolled subjects did not receive study drug.|92
2945817|NCT00672139|3659051|FG000|COMPLETED|Overall Study||27
2945818|NCT00672139|3659052|FG001|COMPLETED|Overall Study||47
2945819|NCT00672139|3659051|FG000|NOT COMPLETED|Overall Study||30
2945820|NCT00672139|3659052|FG001|NOT COMPLETED|Overall Study||45
2945821|NCT00672204|3659058|FG000|STARTED|Overall Study||23
2945822|NCT00672204|3659058|FG000|COMPLETED|Overall Study||3
2945823|NCT00672204|3659058|FG000|NOT COMPLETED|Overall Study||20
2945824|NCT00672243|3659062|FG000|STARTED|Overall Study||32
2945825|NCT00672243|3659062|FG000|COMPLETED|Overall Study||32
2945826|NCT00672243|3659062|FG000|NOT COMPLETED|Overall Study||0
2945827|NCT00672256|3659067|FG000|STARTED|Overall Study|January 2007|62
2945828|NCT00672256|3659067|FG000|COMPLETED|Overall Study||18
2945829|NCT00672256|3659067|FG000|NOT COMPLETED|Overall Study||44
2945830|NCT00672438|3659073|FG000|STARTED|Infusion 1||119
2945831|NCT00672438|3659074|FG001|STARTED|Infusion 1||118
2945832|NCT00672438|3659073|FG000|COMPLETED|Infusion 1||119
2945833|NCT00672438|3659074|FG001|COMPLETED|Infusion 1||118
2945834|NCT00672438|3659073|FG000|NOT COMPLETED|Infusion 1||0
2945835|NCT00672438|3659074|FG001|NOT COMPLETED|Infusion 1||0
2945836|NCT00672438|3659073|FG000|STARTED|Washout||119
2945837|NCT00672438|3659074|FG001|STARTED|Washout||118
2945838|NCT00672438|3659073|FG000|COMPLETED|Washout||119
2945839|NCT00672438|3659074|FG001|COMPLETED|Washout||118
2945840|NCT00672438|3659073|FG000|NOT COMPLETED|Washout||0
2945841|NCT00672438|3659074|FG001|NOT COMPLETED|Washout||0
2945842|NCT00672438|3659073|FG000|STARTED|Infusion 2||119
2945843|NCT00672438|3659074|FG001|STARTED|Infusion 2||118
2945844|NCT00672438|3659073|FG000|COMPLETED|Infusion 2||119
2945845|NCT00672438|3659074|FG001|COMPLETED|Infusion 2||118
2945846|NCT00672438|3659073|FG000|NOT COMPLETED|Infusion 2||0
2945847|NCT00672438|3659074|FG001|NOT COMPLETED|Infusion 2||0
2945848|NCT00672451|3659082|FG000|STARTED|Overall Study||1
2945849|NCT00672451|3659083|FG001|STARTED|Overall Study||2
2945850|NCT00672451|3659082|FG000|COMPLETED|Overall Study||1
2945851|NCT00672451|3659083|FG001|COMPLETED|Overall Study||2
2945852|NCT00672451|3659082|FG000|NOT COMPLETED|Overall Study||0
2945853|NCT00672451|3659083|FG001|NOT COMPLETED|Overall Study||0
2945854|NCT00672477|3659091|FG000|STARTED|Overall Study|120 subjects were randomized to this group, but only 116 subjects received study drug.|116
2945855|NCT00672477|3659092|FG001|STARTED|Overall Study|117 subjects were randomized to this group, but only 114 subjects received study drug.|114
2945856|NCT00672477|3659091|FG000|COMPLETED|Overall Study|One subject had missing data as reason for study termination - not counted as early termination.|89
2945857|NCT00672477|3659092|FG001|COMPLETED|Overall Study||88
2945858|NCT00672477|3659091|FG000|NOT COMPLETED|Overall Study||27
2945859|NCT00672477|3659092|FG001|NOT COMPLETED|Overall Study||26
2945860|NCT00672490|3659100|FG000|STARTED|Overall Study||187
2945861|NCT00672490|3659101|FG001|STARTED|Overall Study||189
2945862|NCT00672490|3659100|FG000|COMPLETED|Overall Study||163
2945863|NCT00672490|3659101|FG001|COMPLETED|Overall Study||157
2945864|NCT00672490|3659100|FG000|NOT COMPLETED|Overall Study||24
2945865|NCT00672490|3659101|FG001|NOT COMPLETED|Overall Study||32
2945866|NCT00672555|3659107|FG000|STARTED|Overall Study||70
2945867|NCT00672555|3659107|FG000|COMPLETED|Overall Study|All patients were seen at 3 weeks in the outpatient clinic.|64
2945868|NCT00672555|3659107|FG000|NOT COMPLETED|Overall Study||6
2945869|NCT00672594|3659111|FG000|STARTED|Overall Study||30
2945870|NCT00672594|3659111|FG000|COMPLETED|Overall Study||27
2945871|NCT00672594|3659111|FG000|NOT COMPLETED|Overall Study||3
2945872|NCT00672620|3659119|FG000|STARTED|Overall Study||153
2945873|NCT00672620|3659120|FG001|STARTED|Overall Study||153
2945874|NCT00672620|3659121|FG002|STARTED|Overall Study||153
2945875|NCT00672620|3659122|FG003|STARTED|Overall Study||152
2945876|NCT00672620|3659119|FG000|Treated|Overall Study||151
2945877|NCT00672620|3659120|FG001|Treated|Overall Study||149
2945878|NCT00672620|3659121|FG002|Treated|Overall Study||153
2945879|NCT00672620|3659122|FG003|Treated|Overall Study||150
2945880|NCT00672620|3659119|FG000|COMPLETED|Overall Study||120
2945881|NCT00672620|3659120|FG001|COMPLETED|Overall Study||99
2945882|NCT00672620|3659121|FG002|COMPLETED|Overall Study||122
2945883|NCT00672620|3659122|FG003|COMPLETED|Overall Study||110
2945884|NCT00672620|3659119|FG000|NOT COMPLETED|Overall Study||33
2945885|NCT00672620|3659120|FG001|NOT COMPLETED|Overall Study||54
2945886|NCT00672620|3659121|FG002|NOT COMPLETED|Overall Study||31
2945887|NCT00672620|3659122|FG003|NOT COMPLETED|Overall Study||42
2945888|NCT00672633|3659134|FG000|STARTED|Overall Study||12
2945889|NCT00672633|3659135|FG001|STARTED|Overall Study||13
2945890|NCT00672633|3659134|FG000|COMPLETED|Overall Study||12
2945891|NCT00672633|3659135|FG001|COMPLETED|Overall Study||12
2945892|NCT00672633|3659134|FG000|NOT COMPLETED|Overall Study||0
2945893|NCT00672633|3659135|FG001|NOT COMPLETED|Overall Study||1
2945894|NCT00672646|3659144|FG000|STARTED|Overall Study||40
2945895|NCT00672646|3659145|FG001|STARTED|Overall Study||23
2945896|NCT00672646|3659146|FG002|STARTED|Overall Study||40
2945897|NCT00672646|3659144|FG000|COMPLETED|Overall Study||40
2945898|NCT00672646|3659145|FG001|COMPLETED|Overall Study||22
2945899|NCT00672646|3659146|FG002|COMPLETED|Overall Study||37
2945900|NCT00672646|3659144|FG000|NOT COMPLETED|Overall Study||0
2945901|NCT00672646|3659145|FG001|NOT COMPLETED|Overall Study||1
2945902|NCT00672646|3659146|FG002|NOT COMPLETED|Overall Study||3
2945903|NCT00672737|3659154|FG000|STARTED|Overall Study||56
2945904|NCT00672737|3659154|FG000|COMPLETED|Overall Study||48
2945905|NCT00672737|3659154|FG000|NOT COMPLETED|Overall Study||8
2945906|NCT00672841|3659161|FG000|STARTED|Overall Study||17
2945907|NCT00672841|3659162|FG001|STARTED|Overall Study||47
2945908|NCT00672841|3659161|FG000|COMPLETED|Overall Study||16
2945909|NCT00672841|3659162|FG001|COMPLETED|Overall Study||32
2945910|NCT00672841|3659161|FG000|NOT COMPLETED|Overall Study||1
2945911|NCT00672841|3659162|FG001|NOT COMPLETED|Overall Study||15
2945912|NCT00672854|3659173|FG000|STARTED|Overall Study||49
2945913|NCT00672854|3659174|FG001|STARTED|Overall Study||51
2945914|NCT00672854|3659173|FG000|COMPLETED|Overall Study||49
2945915|NCT00672854|3659174|FG001|COMPLETED|Overall Study||51
2945916|NCT00672854|3659173|FG000|NOT COMPLETED|Overall Study||0
2945917|NCT00672854|3659174|FG001|NOT COMPLETED|Overall Study||0
2945918|NCT00672932|3659184|FG000|STARTED|Overall Study||9
2945919|NCT00672932|3659185|FG001|STARTED|Overall Study||9
2945920|NCT00672932|3659184|FG000|Completed Initial 12-week Assignment|Overall Study||9
2945921|NCT00672932|3659185|FG001|Completed Initial 12-week Assignment|Overall Study||9
2945922|NCT00672932|3659184|FG000|Provided Analyzable Blood and CSF Sample|Overall Study|one subject was censored when pharmacological study showed no drug in plasma or CSF|8
2945923|NCT00672932|3659185|FG001|Provided Analyzable Blood and CSF Sample|Overall Study||9
2945924|NCT00672932|3659184|FG000|Rolled Over to Raltegravir|Overall Study||0
2945925|NCT00672932|3659185|FG001|Rolled Over to Raltegravir|Overall Study|6 subjects randomized to no drug later rolled over to receive raltegravir|6
2945926|NCT00672932|3659184|FG000|COMPLETED|Overall Study||9
2945927|NCT00672932|3659185|FG001|COMPLETED|Overall Study||9
2945928|NCT00672932|3659184|FG000|NOT COMPLETED|Overall Study||0
2945929|NCT00672932|3659185|FG001|NOT COMPLETED|Overall Study||0
2945930|NCT00672958|3659193|FG000|STARTED|Overall Study||300
2945931|NCT00672958|3659194|FG001|STARTED|Overall Study||300
2945932|NCT00672958|3659193|FG000|Safety Set|Overall Study|All randomized patients who received at least 1 dose of double-blind study drug.|298
2945933|NCT00672958|3659194|FG001|Safety Set|Overall Study|All randomized patients who received at least 1 dose of double-blind study drug.|299
2945934|NCT00672958|3659193|FG000|Full Analysis Set|Overall Study|All safety set patients who had at least 1 valid postbaseline primary efficacy assessment.|286
2945935|NCT00672958|3659194|FG001|Full Analysis Set|Overall Study|All safety set patients who had at least 1 valid postbaseline primary efficacy assessment.|292
2945936|NCT00672958|3659193|FG000|COMPLETED|Overall Study||236
2945937|NCT00672958|3659194|FG001|COMPLETED|Overall Study||244
2945938|NCT00672958|3659193|FG000|NOT COMPLETED|Overall Study||64
2945939|NCT00672958|3659194|FG001|NOT COMPLETED|Overall Study||56
2945940|NCT00672984|3659203|FG000|STARTED|First Intervention||31
2945941|NCT00672984|3659204|FG001|STARTED|First Intervention||25
2945942|NCT00672984|3659205|FG002|STARTED|First Intervention||27
2945943|NCT00672984|3659203|FG000|COMPLETED|First Intervention||22
2945944|NCT00672984|3659204|FG001|COMPLETED|First Intervention||23
2945945|NCT00672984|3659205|FG002|COMPLETED|First Intervention||25
2945946|NCT00672984|3659203|FG000|NOT COMPLETED|First Intervention||9
2945947|NCT00672984|3659204|FG001|NOT COMPLETED|First Intervention||2
2945948|NCT00672984|3659205|FG002|NOT COMPLETED|First Intervention||2
2945949|NCT00672984|3659203|FG000|STARTED|Second Intervention||22
2945950|NCT00672984|3659204|FG001|STARTED|Second Intervention||23
2945951|NCT00672984|3659205|FG002|STARTED|Second Intervention||25
2945952|NCT00672984|3659203|FG000|COMPLETED|Second Intervention||22
2945953|NCT00672984|3659204|FG001|COMPLETED|Second Intervention||17
2945954|NCT00672984|3659205|FG002|COMPLETED|Second Intervention||24
2945955|NCT00672984|3659203|FG000|NOT COMPLETED|Second Intervention||0
2945956|NCT00672984|3659204|FG001|NOT COMPLETED|Second Intervention||6
2945957|NCT00672984|3659205|FG002|NOT COMPLETED|Second Intervention||1
2945958|NCT00672984|3659203|FG000|STARTED|Third Intervention||22
2945959|NCT00672984|3659204|FG001|STARTED|Third Intervention||17
2945960|NCT00672984|3659205|FG002|STARTED|Third Intervention||24
2945961|NCT00672984|3659203|FG000|COMPLETED|Third Intervention||21
2945962|NCT00672984|3659204|FG001|COMPLETED|Third Intervention||17
2945963|NCT00672984|3659205|FG002|COMPLETED|Third Intervention||23
2945964|NCT00672984|3659203|FG000|NOT COMPLETED|Third Intervention||1
2945965|NCT00672984|3659204|FG001|NOT COMPLETED|Third Intervention||0
2945966|NCT00672984|3659205|FG002|NOT COMPLETED|Third Intervention||1
2945967|NCT00673049|3659217|FG000|STARTED|Before Progression on Erlotinib||292
2945968|NCT00673049|3659218|FG001|STARTED|Before Progression on Erlotinib||290
2945969|NCT00673049|3659219|FG002|STARTED|Before Progression on Erlotinib||1
2945970|NCT00673049|3659220|FG003|STARTED|Before Progression on Erlotinib|Participants treated with erlo alone who subsequently received figi upon disease progression.|0
2945971|NCT00673049|3659217|FG000|Treated|Before Progression on Erlotinib||289
2945972|NCT00673049|3659218|FG001|Treated|Before Progression on Erlotinib||289
2945973|NCT00673049|3659219|FG002|Treated|Before Progression on Erlotinib||1
2945974|NCT00673049|3659220|FG003|Treated|Before Progression on Erlotinib||0
2945975|NCT00673049|3659217|FG000|COMPLETED|Before Progression on Erlotinib||0
2945976|NCT00673049|3659218|FG001|COMPLETED|Before Progression on Erlotinib||0
2945977|NCT00673049|3659219|FG002|COMPLETED|Before Progression on Erlotinib||0
2945978|NCT00673049|3659220|FG003|COMPLETED|Before Progression on Erlotinib||0
2945979|NCT00673049|3659217|FG000|NOT COMPLETED|Before Progression on Erlotinib||292
2945980|NCT00673049|3659218|FG001|NOT COMPLETED|Before Progression on Erlotinib||290
2945981|NCT00673049|3659219|FG002|NOT COMPLETED|Before Progression on Erlotinib||1
2945982|NCT00673049|3659220|FG003|NOT COMPLETED|Before Progression on Erlotinib||0
2945983|NCT00673049|3659217|FG000|STARTED|After Progression on Erlotinib||0
2945984|NCT00673049|3659218|FG001|STARTED|After Progression on Erlotinib||0
2945985|NCT00673049|3659219|FG002|STARTED|After Progression on Erlotinib||0
2945986|NCT00673049|3659220|FG003|STARTED|After Progression on Erlotinib||83
2945987|NCT00673049|3659217|FG000|COMPLETED|After Progression on Erlotinib||0
2945988|NCT00673049|3659218|FG001|COMPLETED|After Progression on Erlotinib||0
2945989|NCT00673049|3659219|FG002|COMPLETED|After Progression on Erlotinib||0
2945990|NCT00673049|3659220|FG003|COMPLETED|After Progression on Erlotinib||0
2945991|NCT00673049|3659217|FG000|NOT COMPLETED|After Progression on Erlotinib||0
2945992|NCT00673049|3659218|FG001|NOT COMPLETED|After Progression on Erlotinib||0
2945993|NCT00673049|3659219|FG002|NOT COMPLETED|After Progression on Erlotinib||0
2945994|NCT00673049|3659220|FG003|NOT COMPLETED|After Progression on Erlotinib||83
2945995|NCT00673075|3659230|FG000|STARTED|Overall Study||21
2945996|NCT00673075|3659231|FG001|STARTED|Overall Study||18
2945997|NCT00673075|3659230|FG000|COMPLETED|Overall Study||12
2945998|NCT00673075|3659231|FG001|COMPLETED|Overall Study||11
2945999|NCT00673075|3659230|FG000|NOT COMPLETED|Overall Study||9
2946000|NCT00673075|3659231|FG001|NOT COMPLETED|Overall Study||7
2946001|NCT00673114|3659239|FG000|STARTED|Overall Study||3
2946002|NCT00673114|3659239|FG000|COMPLETED|Overall Study||3
2946003|NCT00673114|3659239|FG000|NOT COMPLETED|Overall Study||0
2946004|NCT00673127|3659243|FG000|STARTED|Overall Study||57
2946005|NCT00673127|3659243|FG000|COMPLETED|Overall Study||57
2946006|NCT00673127|3659243|FG000|NOT COMPLETED|Overall Study||0
2946007|NCT00673153|3659248|FG000|STARTED|Overall Study||31
2946008|NCT00673153|3659248|FG000|COMPLETED|Overall Study||30
2946009|NCT00673153|3659248|FG000|NOT COMPLETED|Overall Study||1
2946010|NCT00673231|3659256|FG000|STARTED|Overall Study|Of the 197 randomized participants only 193 were included in the full analysis set|197
2946011|NCT00673231|3659257|FG001|STARTED|Overall Study|All 202 were included in the full analysis set|202
2946012|NCT00673231|3659258|FG002|STARTED|Overall Study|Of the 212 randomized participants only 211 were included in the full analysis set|212
2946013|NCT00673231|3659259|FG003|STARTED|Overall Study|Of the 196 randomized participants only 194 were included in the full analysis set|196
2946014|NCT00673231|3659256|FG000|COMPLETED|Overall Study||168
2946015|NCT00673231|3659257|FG001|COMPLETED|Overall Study||180
2946016|NCT00673231|3659258|FG002|COMPLETED|Overall Study||186
2946017|NCT00673231|3659259|FG003|COMPLETED|Overall Study||178
2946018|NCT00673231|3659256|FG000|NOT COMPLETED|Overall Study||29
2946019|NCT00673231|3659257|FG001|NOT COMPLETED|Overall Study||22
2946020|NCT00673231|3659258|FG002|NOT COMPLETED|Overall Study||26
2946021|NCT00673231|3659259|FG003|NOT COMPLETED|Overall Study||18
2946022|NCT00673244|3659271|FG000|STARTED|Overall Study||52
2946023|NCT00673244|3659272|FG001|STARTED|Overall Study||25
2946024|NCT00673244|3659271|FG000|COMPLETED|Overall Study||52
2946025|NCT00673244|3659272|FG001|COMPLETED|Overall Study||25
2946026|NCT00673244|3659271|FG000|NOT COMPLETED|Overall Study||0
2946027|NCT00673244|3659272|FG001|NOT COMPLETED|Overall Study||0
2946028|NCT00673257|3659278|FG000|STARTED|Overall Study||107
2946029|NCT00673257|3659278|FG000|COMPLETED|Overall Study||102
2946030|NCT00673257|3659278|FG000|NOT COMPLETED|Overall Study||5
2946031|NCT00673387|3659290|FG000|STARTED|Overall Study||75
2946032|NCT00673387|3659291|FG001|STARTED|Overall Study||77
2946033|NCT00673387|3659292|FG002|STARTED|Overall Study||72
2946034|NCT00673387|3659293|FG003|STARTED|Overall Study||75
2946035|NCT00673387|3659294|FG004|STARTED|Overall Study||78
2946036|NCT00673387|3659295|FG005|STARTED|Overall Study||78
2946037|NCT00673387|3659296|FG006|STARTED|Overall Study||78
2946038|NCT00673387|3659297|FG007|STARTED|Overall Study||75
2946039|NCT00673387|3659290|FG000|COMPLETED|Overall Study||46
2946040|NCT00673387|3659291|FG001|COMPLETED|Overall Study||54
2946041|NCT00673387|3659292|FG002|COMPLETED|Overall Study||41
2946042|NCT00673387|3659293|FG003|COMPLETED|Overall Study||49
2946043|NCT00673387|3659294|FG004|COMPLETED|Overall Study||48
2946044|NCT00673387|3659295|FG005|COMPLETED|Overall Study||44
2946045|NCT00673387|3659296|FG006|COMPLETED|Overall Study||48
2946046|NCT00673387|3659297|FG007|COMPLETED|Overall Study||40
2946047|NCT00673387|3659290|FG000|NOT COMPLETED|Overall Study||29
2946048|NCT00673387|3659291|FG001|NOT COMPLETED|Overall Study||23
2946049|NCT00673387|3659292|FG002|NOT COMPLETED|Overall Study||31
2946050|NCT00673387|3659293|FG003|NOT COMPLETED|Overall Study||26
2946051|NCT00673387|3659294|FG004|NOT COMPLETED|Overall Study||30
2946052|NCT00673387|3659295|FG005|NOT COMPLETED|Overall Study||34
2946053|NCT00673387|3659296|FG006|NOT COMPLETED|Overall Study||30
2946054|NCT00673387|3659297|FG007|NOT COMPLETED|Overall Study||35
3034701|NCT01133522|3753679|FG000|Received Treatment|Overall Study||10
3034702|NCT01133522|3753680|FG001|Received Treatment|Overall Study||6
3034703|NCT01133522|3753681|FG002|Received Treatment|Overall Study||6
3034704|NCT01133522|3753682|FG003|Received Treatment|Overall Study||6
3034705|NCT01133522|3753683|FG004|Received Treatment|Overall Study||6
3034706|NCT01133522|3753684|FG005|Received Treatment|Overall Study||6
3034707|NCT01133522|3753685|FG006|Received Treatment|Overall Study||2
3034708|NCT01133522|3753686|FG007|Received Treatment|Overall Study||9
3034709|NCT01133522|3753687|FG008|Received Treatment|Overall Study||2
3034710|NCT01133522|3753688|FG009|Received Treatment|Overall Study||4
3034711|NCT01133522|3753679|FG000|COMPLETED|Overall Study||10
3034712|NCT01133522|3753680|FG001|COMPLETED|Overall Study||6
3034713|NCT01133522|3753681|FG002|COMPLETED|Overall Study||6
3034714|NCT01133522|3753682|FG003|COMPLETED|Overall Study||6
3034715|NCT01133522|3753683|FG004|COMPLETED|Overall Study||6
3034716|NCT01133522|3753684|FG005|COMPLETED|Overall Study||6
3034717|NCT01133522|3753685|FG006|COMPLETED|Overall Study||2
3034718|NCT01133522|3753686|FG007|COMPLETED|Overall Study||9
3034719|NCT01133522|3753687|FG008|COMPLETED|Overall Study||2
3034720|NCT01133522|3753688|FG009|COMPLETED|Overall Study||4
3034721|NCT01133522|3753679|FG000|NOT COMPLETED|Overall Study||0
3034722|NCT01133522|3753680|FG001|NOT COMPLETED|Overall Study||1
3034723|NCT01133522|3753681|FG002|NOT COMPLETED|Overall Study||0
3034724|NCT01133522|3753682|FG003|NOT COMPLETED|Overall Study||1
3034725|NCT01133522|3753683|FG004|NOT COMPLETED|Overall Study||1
3034726|NCT01133522|3753684|FG005|NOT COMPLETED|Overall Study||0
3298785|NCT02927327|4032517|FG001|NOT COMPLETED|Overall Study||0
3298786|NCT02927366|4032525|FG000|STARTED|Overall Study||6
3298787|NCT02927366|4032526|FG001|STARTED|Overall Study||2
3298788|NCT02927366|4032525|FG000|Pharmacodynamic (PD) Analysis Set|Overall Study||6
3298789|NCT02927366|4032526|FG001|Pharmacodynamic (PD) Analysis Set|Overall Study||2
3298790|NCT02927366|4032525|FG000|Pharmacokinetic (PK) Analysis Set|Overall Study||4
3298791|NCT02927366|4032526|FG001|Pharmacokinetic (PK) Analysis Set|Overall Study||0
3298792|NCT02927366|4032525|FG000|COMPLETED|Overall Study||4
3298793|NCT02927366|4032526|FG001|COMPLETED|Overall Study||2
3034727|NCT01133522|3753685|FG006|NOT COMPLETED|Overall Study||0
3034728|NCT01133522|3753686|FG007|NOT COMPLETED|Overall Study||0
3034729|NCT01133522|3753687|FG008|NOT COMPLETED|Overall Study||0
3034730|NCT01133522|3753688|FG009|NOT COMPLETED|Overall Study||0
3034731|NCT01133626|3753720|FG000|STARTED|Overall Study||50
3034732|NCT01133626|3753721|FG001|STARTED|Overall Study||46
3034733|NCT01133626|3753722|FG002|STARTED|Overall Study||11
3034734|NCT01133626|3753720|FG000|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|50
3034735|NCT01133626|3753721|FG001|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|46
3034736|NCT01133626|3753722|FG002|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|11
3034737|NCT01133626|3753720|FG000|Per Protocol Population|Overall Study|Received >=1 dose of study drug and >=1 post-baseline assessment prior to major protocol deviation.|48
3034738|NCT01133626|3753721|FG001|Per Protocol Population|Overall Study|Received >=1 dose of study drug and >=1 post-baseline assessment prior to major protocol deviation.|41
3034739|NCT01133626|3753722|FG002|Per Protocol Population|Overall Study|Received >=1 dose of study drug and >=1 post-baseline assessment prior to major protocol deviation.|9
3034740|NCT01133626|3753720|FG000|COMPLETED|Overall Study||49
3034741|NCT01133626|3753721|FG001|COMPLETED|Overall Study||41
3034742|NCT01133626|3753722|FG002|COMPLETED|Overall Study||9
3034743|NCT01133626|3753720|FG000|NOT COMPLETED|Overall Study||1
3034744|NCT01133626|3753721|FG001|NOT COMPLETED|Overall Study||5
3034745|NCT01133626|3753722|FG002|NOT COMPLETED|Overall Study||2
3034746|NCT01133665|3753730|FG000|STARTED|Overall Study||42
3034747|NCT01133665|3753730|FG000|COMPLETED|Overall Study||40
3034748|NCT01133665|3753730|FG000|NOT COMPLETED|Overall Study||2
3034749|NCT01133678|3753736|FG000|STARTED|Overall Study||25
3298794|NCT02927366|4032525|FG000|NOT COMPLETED|Overall Study||2
3298795|NCT02927366|4032526|FG001|NOT COMPLETED|Overall Study||0
3298796|NCT02927431|4032535|FG000|STARTED|Overall Study||2
2946055|NCT00673400|3659325|FG000|STARTED|Overall Study||52
2946056|NCT00673400|3659325|FG000|COMPLETED|Overall Study||52
2946057|NCT00673400|3659325|FG000|NOT COMPLETED|Overall Study||0
2946058|NCT00673439|3659335|FG000|STARTED|Overall Study||3
2946059|NCT00673439|3659335|FG000|COMPLETED|Overall Study||3
2946060|NCT00673439|3659335|FG000|NOT COMPLETED|Overall Study||0
2946061|NCT00673452|3659342|FG000|STARTED|Acute Double-Blind Phase||263
2946062|NCT00673452|3659343|FG001|STARTED|Acute Double-Blind Phase||267
2946063|NCT00673452|3659342|FG000|COMPLETED|Acute Double-Blind Phase||176
2946064|NCT00673452|3659343|FG001|COMPLETED|Acute Double-Blind Phase||187
2946065|NCT00673452|3659342|FG000|NOT COMPLETED|Acute Double-Blind Phase||87
2946066|NCT00673452|3659343|FG001|NOT COMPLETED|Acute Double-Blind Phase||80
2946067|NCT00673452|3659342|FG000|STARTED|Continuation Double-Blind Phase||176
2946068|NCT00673452|3659343|FG001|STARTED|Continuation Double-Blind Phase|Patients on placebo in acute phase received 60 mg duloxetine during the continuation phase.|187
2946069|NCT00673452|3659342|FG000|COMPLETED|Continuation Double-Blind Phase||151
2946070|NCT00673452|3659343|FG001|COMPLETED|Continuation Double-Blind Phase||153
2946071|NCT00673452|3659342|FG000|NOT COMPLETED|Continuation Double-Blind Phase||25
2946072|NCT00673452|3659343|FG001|NOT COMPLETED|Continuation Double-Blind Phase||34
2946073|NCT00673465|3659349|FG000|STARTED|Part 1/Period 1 (United States)||3
2946074|NCT00673465|3659350|FG001|STARTED|Part 1/Period 1 (United States)||3
2946075|NCT00673465|3659351|FG002|STARTED|Part 1/Period 1 (United States)||3
2946076|NCT00673465|3659352|FG003|STARTED|Part 1/Period 1 (United States)||3
2946077|NCT00673465|3659353|FG004|STARTED|Part 1/Period 1 (United States)||3
2946078|NCT00673465|3659354|FG005|STARTED|Part 1/Period 1 (United States)||2
2946079|NCT00673465|3659355|FG006|STARTED|Part 1/Period 1 (United States)||0
2946080|NCT00673465|3659356|FG007|STARTED|Part 1/Period 1 (United States)||0
2946081|NCT00673465|3659357|FG008|STARTED|Part 1/Period 1 (United States)||0
2946082|NCT00673465|3659358|FG009|STARTED|Part 1/Period 1 (United States)||0
2946083|NCT00673465|3659359|FG010|STARTED|Part 1/Period 1 (United States)||0
2946084|NCT00673465|3659360|FG011|STARTED|Part 1/Period 1 (United States)||0
2946085|NCT00673465|3659349|FG000|COMPLETED|Part 1/Period 1 (United States)||3
2946086|NCT00673465|3659350|FG001|COMPLETED|Part 1/Period 1 (United States)||3
2946087|NCT00673465|3659351|FG002|COMPLETED|Part 1/Period 1 (United States)||3
2946088|NCT00673465|3659352|FG003|COMPLETED|Part 1/Period 1 (United States)||3
2946089|NCT00673465|3659353|FG004|COMPLETED|Part 1/Period 1 (United States)||2
2946090|NCT00673465|3659354|FG005|COMPLETED|Part 1/Period 1 (United States)||1
2946091|NCT00673465|3659355|FG006|COMPLETED|Part 1/Period 1 (United States)||0
2946092|NCT00673465|3659356|FG007|COMPLETED|Part 1/Period 1 (United States)||0
2946093|NCT00673465|3659357|FG008|COMPLETED|Part 1/Period 1 (United States)||0
2946094|NCT00673465|3659358|FG009|COMPLETED|Part 1/Period 1 (United States)||0
2946095|NCT00673465|3659359|FG010|COMPLETED|Part 1/Period 1 (United States)||0
2946096|NCT00673465|3659360|FG011|COMPLETED|Part 1/Period 1 (United States)||0
2946097|NCT00673465|3659349|FG000|NOT COMPLETED|Part 1/Period 1 (United States)||0
2946098|NCT00673465|3659350|FG001|NOT COMPLETED|Part 1/Period 1 (United States)||0
2946099|NCT00673465|3659351|FG002|NOT COMPLETED|Part 1/Period 1 (United States)||0
2946100|NCT00673465|3659352|FG003|NOT COMPLETED|Part 1/Period 1 (United States)||0
2946101|NCT00673465|3659353|FG004|NOT COMPLETED|Part 1/Period 1 (United States)||1
2946102|NCT00673465|3659354|FG005|NOT COMPLETED|Part 1/Period 1 (United States)||1
2946103|NCT00673465|3659355|FG006|NOT COMPLETED|Part 1/Period 1 (United States)||0
2946104|NCT00673465|3659356|FG007|NOT COMPLETED|Part 1/Period 1 (United States)||0
2946105|NCT00673465|3659357|FG008|NOT COMPLETED|Part 1/Period 1 (United States)||0
2946106|NCT00673465|3659358|FG009|NOT COMPLETED|Part 1/Period 1 (United States)||0
2946107|NCT00673465|3659359|FG010|NOT COMPLETED|Part 1/Period 1 (United States)||0
2946108|NCT00673465|3659360|FG011|NOT COMPLETED|Part 1/Period 1 (United States)||0
2946109|NCT00673465|3659349|FG000|STARTED|Part 1/Period 2 (United States)||3
2946110|NCT00673465|3659350|FG001|STARTED|Part 1/Period 2 (United States)||3
2946111|NCT00673465|3659351|FG002|STARTED|Part 1/Period 2 (United States)||3
2946112|NCT00673465|3659352|FG003|STARTED|Part 1/Period 2 (United States)||3
2946113|NCT00673465|3659353|FG004|STARTED|Part 1/Period 2 (United States)||2
2946114|NCT00673465|3659354|FG005|STARTED|Part 1/Period 2 (United States)||1
2946115|NCT00673465|3659355|FG006|STARTED|Part 1/Period 2 (United States)||0
2946116|NCT00673465|3659356|FG007|STARTED|Part 1/Period 2 (United States)||0
2946117|NCT00673465|3659357|FG008|STARTED|Part 1/Period 2 (United States)||0
2946118|NCT00673465|3659358|FG009|STARTED|Part 1/Period 2 (United States)||0
2946119|NCT00673465|3659359|FG010|STARTED|Part 1/Period 2 (United States)||0
2946120|NCT00673465|3659360|FG011|STARTED|Part 1/Period 2 (United States)||0
2946121|NCT00673465|3659349|FG000|COMPLETED|Part 1/Period 2 (United States)||3
2946122|NCT00673465|3659350|FG001|COMPLETED|Part 1/Period 2 (United States)||3
2946123|NCT00673465|3659351|FG002|COMPLETED|Part 1/Period 2 (United States)||3
2946124|NCT00673465|3659352|FG003|COMPLETED|Part 1/Period 2 (United States)||3
2946125|NCT00673465|3659353|FG004|COMPLETED|Part 1/Period 2 (United States)||1
2946126|NCT00673465|3659354|FG005|COMPLETED|Part 1/Period 2 (United States)||1
2946127|NCT00673465|3659355|FG006|COMPLETED|Part 1/Period 2 (United States)||0
2946128|NCT00673465|3659356|FG007|COMPLETED|Part 1/Period 2 (United States)||0
2946129|NCT00673465|3659357|FG008|COMPLETED|Part 1/Period 2 (United States)||0
2946130|NCT00673465|3659358|FG009|COMPLETED|Part 1/Period 2 (United States)||0
2946131|NCT00673465|3659359|FG010|COMPLETED|Part 1/Period 2 (United States)||0
2946132|NCT00673465|3659360|FG011|COMPLETED|Part 1/Period 2 (United States)||0
2946133|NCT00673465|3659349|FG000|NOT COMPLETED|Part 1/Period 2 (United States)||0
2946134|NCT00673465|3659350|FG001|NOT COMPLETED|Part 1/Period 2 (United States)||0
2946135|NCT00673465|3659351|FG002|NOT COMPLETED|Part 1/Period 2 (United States)||0
2946136|NCT00673465|3659352|FG003|NOT COMPLETED|Part 1/Period 2 (United States)||0
2946137|NCT00673465|3659353|FG004|NOT COMPLETED|Part 1/Period 2 (United States)||1
2946138|NCT00673465|3659354|FG005|NOT COMPLETED|Part 1/Period 2 (United States)||0
2946139|NCT00673465|3659355|FG006|NOT COMPLETED|Part 1/Period 2 (United States)||0
2946140|NCT00673465|3659356|FG007|NOT COMPLETED|Part 1/Period 2 (United States)||0
2946141|NCT00673465|3659357|FG008|NOT COMPLETED|Part 1/Period 2 (United States)||0
2946142|NCT00673465|3659358|FG009|NOT COMPLETED|Part 1/Period 2 (United States)||0
3298797|NCT02927431|4032536|FG001|STARTED|Overall Study||4
3298798|NCT02927431|4032537|FG002|STARTED|Overall Study||4
3298799|NCT02927431|4032535|FG000|COMPLETED|Overall Study||2
3298800|NCT02927431|4032536|FG001|COMPLETED|Overall Study||4
2946143|NCT00673465|3659359|FG010|NOT COMPLETED|Part 1/Period 2 (United States)||0
2946144|NCT00673465|3659360|FG011|NOT COMPLETED|Part 1/Period 2 (United States)||0
2946145|NCT00673465|3659349|FG000|STARTED|Part 1/Period 3 (United States)||3
2946146|NCT00673465|3659350|FG001|STARTED|Part 1/Period 3 (United States)||3
2946147|NCT00673465|3659351|FG002|STARTED|Part 1/Period 3 (United States)||3
2946148|NCT00673465|3659352|FG003|STARTED|Part 1/Period 3 (United States)||3
2946149|NCT00673465|3659353|FG004|STARTED|Part 1/Period 3 (United States)||1
2946150|NCT00673465|3659354|FG005|STARTED|Part 1/Period 3 (United States)||1
2946151|NCT00673465|3659355|FG006|STARTED|Part 1/Period 3 (United States)||0
2946152|NCT00673465|3659356|FG007|STARTED|Part 1/Period 3 (United States)||0
2946153|NCT00673465|3659357|FG008|STARTED|Part 1/Period 3 (United States)||0
2946154|NCT00673465|3659358|FG009|STARTED|Part 1/Period 3 (United States)||0
2946155|NCT00673465|3659359|FG010|STARTED|Part 1/Period 3 (United States)||0
2946156|NCT00673465|3659360|FG011|STARTED|Part 1/Period 3 (United States)||0
2946157|NCT00673465|3659349|FG000|COMPLETED|Part 1/Period 3 (United States)||3
2946158|NCT00673465|3659350|FG001|COMPLETED|Part 1/Period 3 (United States)||3
2946159|NCT00673465|3659351|FG002|COMPLETED|Part 1/Period 3 (United States)||3
2946160|NCT00673465|3659352|FG003|COMPLETED|Part 1/Period 3 (United States)||3
2946161|NCT00673465|3659353|FG004|COMPLETED|Part 1/Period 3 (United States)||1
2946162|NCT00673465|3659354|FG005|COMPLETED|Part 1/Period 3 (United States)||1
2946163|NCT00673465|3659355|FG006|COMPLETED|Part 1/Period 3 (United States)||0
2946164|NCT00673465|3659356|FG007|COMPLETED|Part 1/Period 3 (United States)||0
2946165|NCT00673465|3659357|FG008|COMPLETED|Part 1/Period 3 (United States)||0
2946166|NCT00673465|3659358|FG009|COMPLETED|Part 1/Period 3 (United States)||0
2946167|NCT00673465|3659359|FG010|COMPLETED|Part 1/Period 3 (United States)||0
2946168|NCT00673465|3659360|FG011|COMPLETED|Part 1/Period 3 (United States)||0
2946169|NCT00673465|3659349|FG000|NOT COMPLETED|Part 1/Period 3 (United States)||0
2946170|NCT00673465|3659350|FG001|NOT COMPLETED|Part 1/Period 3 (United States)||0
2946171|NCT00673465|3659351|FG002|NOT COMPLETED|Part 1/Period 3 (United States)||0
2946172|NCT00673465|3659352|FG003|NOT COMPLETED|Part 1/Period 3 (United States)||0
2946173|NCT00673465|3659353|FG004|NOT COMPLETED|Part 1/Period 3 (United States)||0
2946174|NCT00673465|3659354|FG005|NOT COMPLETED|Part 1/Period 3 (United States)||0
2946175|NCT00673465|3659355|FG006|NOT COMPLETED|Part 1/Period 3 (United States)||0
2946176|NCT00673465|3659356|FG007|NOT COMPLETED|Part 1/Period 3 (United States)||0
2946177|NCT00673465|3659357|FG008|NOT COMPLETED|Part 1/Period 3 (United States)||0
2946178|NCT00673465|3659358|FG009|NOT COMPLETED|Part 1/Period 3 (United States)||0
2946179|NCT00673465|3659359|FG010|NOT COMPLETED|Part 1/Period 3 (United States)||0
2946180|NCT00673465|3659360|FG011|NOT COMPLETED|Part 1/Period 3 (United States)||0
2946181|NCT00673465|3659349|FG000|STARTED|Part 2 (India)||0
2946182|NCT00673465|3659350|FG001|STARTED|Part 2 (India)||0
2946183|NCT00673465|3659351|FG002|STARTED|Part 2 (India)||0
2946184|NCT00673465|3659352|FG003|STARTED|Part 2 (India)||0
2946185|NCT00673465|3659353|FG004|STARTED|Part 2 (India)||0
2946186|NCT00673465|3659354|FG005|STARTED|Part 2 (India)||0
2946187|NCT00673465|3659355|FG006|STARTED|Part 2 (India)||0
2946188|NCT00673465|3659356|FG007|STARTED|Part 2 (India)||0
2946189|NCT00673465|3659357|FG008|STARTED|Part 2 (India)||0
2946190|NCT00673465|3659358|FG009|STARTED|Part 2 (India)||0
2946191|NCT00673465|3659359|FG010|STARTED|Part 2 (India)||0
2946192|NCT00673465|3659360|FG011|STARTED|Part 2 (India)||0
2946193|NCT00673465|3659349|FG000|COMPLETED|Part 2 (India)||0
2946194|NCT00673465|3659350|FG001|COMPLETED|Part 2 (India)||0
2946195|NCT00673465|3659351|FG002|COMPLETED|Part 2 (India)||0
2946196|NCT00673465|3659352|FG003|COMPLETED|Part 2 (India)||0
2946197|NCT00673465|3659353|FG004|COMPLETED|Part 2 (India)||0
2946198|NCT00673465|3659354|FG005|COMPLETED|Part 2 (India)||0
2946199|NCT00673465|3659355|FG006|COMPLETED|Part 2 (India)||0
2946200|NCT00673465|3659356|FG007|COMPLETED|Part 2 (India)||0
2946201|NCT00673465|3659357|FG008|COMPLETED|Part 2 (India)||0
2946202|NCT00673465|3659358|FG009|COMPLETED|Part 2 (India)||0
2946203|NCT00673465|3659359|FG010|COMPLETED|Part 2 (India)||0
2946204|NCT00673465|3659360|FG011|COMPLETED|Part 2 (India)||0
2946205|NCT00673465|3659349|FG000|NOT COMPLETED|Part 2 (India)||0
2946206|NCT00673465|3659350|FG001|NOT COMPLETED|Part 2 (India)||0
2946207|NCT00673465|3659351|FG002|NOT COMPLETED|Part 2 (India)||0
2946208|NCT00673465|3659352|FG003|NOT COMPLETED|Part 2 (India)||0
2946209|NCT00673465|3659353|FG004|NOT COMPLETED|Part 2 (India)||0
2946210|NCT00673465|3659354|FG005|NOT COMPLETED|Part 2 (India)||0
2946211|NCT00673465|3659355|FG006|NOT COMPLETED|Part 2 (India)||0
2946212|NCT00673465|3659356|FG007|NOT COMPLETED|Part 2 (India)||0
3298801|NCT02927431|4032537|FG002|COMPLETED|Overall Study||3
3298802|NCT02927431|4032535|FG000|NOT COMPLETED|Overall Study||0
3298803|NCT02927431|4032536|FG001|NOT COMPLETED|Overall Study||0
3298804|NCT02927431|4032537|FG002|NOT COMPLETED|Overall Study||1
3298805|NCT02927457|4032549|FG000|STARTED|Overall Study||0
3298806|NCT02927457|4032550|FG001|STARTED|Overall Study||11
3298807|NCT02927457|4032549|FG000|COMPLETED|Overall Study||0
3298808|NCT02927457|4032550|FG001|COMPLETED|Overall Study||11
3298809|NCT02927457|4032549|FG000|NOT COMPLETED|Overall Study||0
3298810|NCT02927457|4032550|FG001|NOT COMPLETED|Overall Study||0
3298811|NCT02927639|4032562|FG000|STARTED|Overall Study||83
3298812|NCT02927639|4032563|FG001|STARTED|Overall Study|1 subj was inadvertently enrolled in another interventional study just before enrolling so removed.|82
3298813|NCT02927639|4032562|FG000|COMPLETED|Overall Study||10
3298814|NCT02927639|4032563|FG001|COMPLETED|Overall Study||13
3298815|NCT02927639|4032562|FG000|NOT COMPLETED|Overall Study||73
2946213|NCT00673465|3659357|FG008|NOT COMPLETED|Part 2 (India)||0
2946214|NCT00673465|3659358|FG009|NOT COMPLETED|Part 2 (India)||0
2946215|NCT00673465|3659359|FG010|NOT COMPLETED|Part 2 (India)||0
2946216|NCT00673465|3659360|FG011|NOT COMPLETED|Part 2 (India)||0
2946217|NCT00673660|3659368|FG000|STARTED|Overall Study||375
2946218|NCT00673660|3659368|FG000|COMPLETED|Overall Study||268
2946219|NCT00673660|3659368|FG000|NOT COMPLETED|Overall Study||107
2946220|NCT00673673|3659377|FG000|STARTED|Overall Study||39
2946221|NCT00673673|3659377|FG000|COMPLETED|Overall Study||3
2946222|NCT00673673|3659377|FG000|NOT COMPLETED|Overall Study||36
2946223|NCT00673712|3659383|FG000|STARTED|Overall Study||321
2946224|NCT00673712|3659384|FG001|STARTED|Overall Study||326
2946225|NCT00673712|3659383|FG000|COMPLETED|Overall Study||321
2946226|NCT00673712|3659384|FG001|COMPLETED|Overall Study||326
2946227|NCT00673712|3659383|FG000|NOT COMPLETED|Overall Study||0
2946228|NCT00673712|3659384|FG001|NOT COMPLETED|Overall Study||0
2946229|NCT00673738|3659390|FG000|STARTED|Overall Study||27
2946230|NCT00673738|3659390|FG000|COMPLETED|Overall Study||27
2946231|NCT00673738|3659390|FG000|NOT COMPLETED|Overall Study||0
2946232|NCT00673764|3659394|FG000|STARTED|Overall Study||24
2946233|NCT00673764|3659395|FG001|STARTED|Overall Study||24
2946234|NCT00673764|3659394|FG000|COMPLETED|Overall Study||24
2946235|NCT00673764|3659395|FG001|COMPLETED|Overall Study||24
2946236|NCT00673764|3659394|FG000|NOT COMPLETED|Overall Study||0
2946237|NCT00673764|3659395|FG001|NOT COMPLETED|Overall Study||0
2946238|NCT00673790|3659404|FG000|STARTED|Overall Study||223
2946239|NCT00673790|3659405|FG001|STARTED|Overall Study||212
2946240|NCT00673790|3659406|FG002|STARTED|Overall Study||102
2946241|NCT00673790|3659404|FG000|COMPLETED|Overall Study||178
2946242|NCT00673790|3659405|FG001|COMPLETED|Overall Study||174
2946243|NCT00673790|3659406|FG002|COMPLETED|Overall Study||90
2946244|NCT00673790|3659404|FG000|NOT COMPLETED|Overall Study||45
2946245|NCT00673790|3659405|FG001|NOT COMPLETED|Overall Study||38
2946246|NCT00673790|3659406|FG002|NOT COMPLETED|Overall Study||12
2946247|NCT00673816|3659415|FG000|STARTED|Overall Study||2
2946248|NCT00673816|3659415|FG000|COMPLETED|Overall Study||0
2946249|NCT00673816|3659415|FG000|NOT COMPLETED|Overall Study||2
2946250|NCT00673855|3659420|FG000|STARTED|First Intervention||10
2946251|NCT00673855|3659421|FG001|STARTED|First Intervention||10
2946252|NCT00673855|3659420|FG000|COMPLETED|First Intervention||10
2946253|NCT00673855|3659421|FG001|COMPLETED|First Intervention||10
2946254|NCT00673855|3659420|FG000|NOT COMPLETED|First Intervention||0
2946255|NCT00673855|3659421|FG001|NOT COMPLETED|First Intervention||0
2946256|NCT00673855|3659420|FG000|STARTED|Second Intervention||10
2946257|NCT00673855|3659421|FG001|STARTED|Second Intervention||10
2946258|NCT00673855|3659420|FG000|COMPLETED|Second Intervention||10
2946259|NCT00673855|3659421|FG001|COMPLETED|Second Intervention||10
2946260|NCT00673855|3659420|FG000|NOT COMPLETED|Second Intervention||0
2946261|NCT00673855|3659421|FG001|NOT COMPLETED|Second Intervention||0
2946262|NCT00673881|3659427|FG000|STARTED|Overall Study||25
2946263|NCT00673881|3659427|FG000|COMPLETED|Overall Study||24
2946264|NCT00673881|3659427|FG000|NOT COMPLETED|Overall Study||1
2946265|NCT00673894|3659433|FG000|STARTED|First Intervention 4 Weeks||8
2946266|NCT00673894|3659434|FG001|STARTED|First Intervention 4 Weeks||7
2946267|NCT00673894|3659433|FG000|COMPLETED|First Intervention 4 Weeks||6
2946268|NCT00673894|3659434|FG001|COMPLETED|First Intervention 4 Weeks||7
2946269|NCT00673894|3659433|FG000|NOT COMPLETED|First Intervention 4 Weeks||2
2946270|NCT00673894|3659434|FG001|NOT COMPLETED|First Intervention 4 Weeks||0
2946271|NCT00673894|3659433|FG000|STARTED|Washout 4-6 Weeks||6
2946272|NCT00673894|3659434|FG001|STARTED|Washout 4-6 Weeks||7
2946273|NCT00673894|3659433|FG000|COMPLETED|Washout 4-6 Weeks||6
2946274|NCT00673894|3659434|FG001|COMPLETED|Washout 4-6 Weeks||7
2946275|NCT00673894|3659433|FG000|NOT COMPLETED|Washout 4-6 Weeks||0
2946276|NCT00673894|3659434|FG001|NOT COMPLETED|Washout 4-6 Weeks||0
2946277|NCT00673894|3659433|FG000|STARTED|Second Intervention 4 Weeks||6
2946278|NCT00673894|3659434|FG001|STARTED|Second Intervention 4 Weeks||7
2946279|NCT00673894|3659433|FG000|COMPLETED|Second Intervention 4 Weeks||6
2946280|NCT00673894|3659434|FG001|COMPLETED|Second Intervention 4 Weeks||7
2946281|NCT00673894|3659433|FG000|NOT COMPLETED|Second Intervention 4 Weeks||0
2946282|NCT00673894|3659434|FG001|NOT COMPLETED|Second Intervention 4 Weeks||0
2946283|NCT00673920|3659448|FG000|STARTED|Baseline up to Week 48||64
2946284|NCT00673920|3659449|FG001|STARTED|Baseline up to Week 48||117
2946285|NCT00673920|3659450|FG002|STARTED|Baseline up to Week 48||133
2946286|NCT00673920|3659451|FG003|STARTED|Baseline up to Week 48||0
2946287|NCT00673920|3659452|FG004|STARTED|Baseline up to Week 48||0
3298816|NCT02927639|4032563|FG001|NOT COMPLETED|Overall Study||69
3298817|NCT02927795|4032569|FG000|STARTED|Overall Study||257
3298818|NCT02927795|4032569|FG000|Treated|Overall Study||253
3298819|NCT02927795|4032569|FG000|COMPLETED|Overall Study||234
3298820|NCT02927795|4032569|FG000|NOT COMPLETED|Overall Study||23
2946288|NCT00673920|3659453|FG005|STARTED|Baseline up to Week 48||0
2946289|NCT00673920|3659454|FG006|STARTED|Baseline up to Week 48||0
2946290|NCT00673920|3659455|FG007|STARTED|Baseline up to Week 48||0
2946291|NCT00673920|3659448|FG000|COMPLETED|Baseline up to Week 48||60
2946292|NCT00673920|3659449|FG001|COMPLETED|Baseline up to Week 48||114
2946293|NCT00673920|3659450|FG002|COMPLETED|Baseline up to Week 48||126
2946294|NCT00673920|3659451|FG003|COMPLETED|Baseline up to Week 48||0
2946295|NCT00673920|3659452|FG004|COMPLETED|Baseline up to Week 48||0
2946296|NCT00673920|3659453|FG005|COMPLETED|Baseline up to Week 48||0
2946297|NCT00673920|3659454|FG006|COMPLETED|Baseline up to Week 48||0
2946298|NCT00673920|3659455|FG007|COMPLETED|Baseline up to Week 48||0
2946299|NCT00673920|3659448|FG000|NOT COMPLETED|Baseline up to Week 48||4
2946300|NCT00673920|3659449|FG001|NOT COMPLETED|Baseline up to Week 48||3
2946301|NCT00673920|3659450|FG002|NOT COMPLETED|Baseline up to Week 48||7
2946302|NCT00673920|3659451|FG003|NOT COMPLETED|Baseline up to Week 48||0
2946303|NCT00673920|3659452|FG004|NOT COMPLETED|Baseline up to Week 48||0
2946304|NCT00673920|3659453|FG005|NOT COMPLETED|Baseline up to Week 48||0
2946305|NCT00673920|3659454|FG006|NOT COMPLETED|Baseline up to Week 48||0
2946306|NCT00673920|3659455|FG007|NOT COMPLETED|Baseline up to Week 48||0
2946307|NCT00673920|3659448|FG000|STARTED|Week 24 to Week 48||0
2946308|NCT00673920|3659449|FG001|STARTED|Week 24 to Week 48||0
2946309|NCT00673920|3659450|FG002|STARTED|Week 24 to Week 48||0
2946310|NCT00673920|3659451|FG003|STARTED|Week 24 to Week 48||61
2946311|NCT00673920|3659452|FG004|STARTED|Week 24 to Week 48||61
2946312|NCT00673920|3659453|FG005|STARTED|Week 24 to Week 48||109
2946313|NCT00673920|3659454|FG006|STARTED|Week 24 to Week 48||29
2946314|NCT00673920|3659455|FG007|STARTED|Week 24 to Week 48||28
2946315|NCT00673920|3659448|FG000|COMPLETED|Week 24 to Week 48||0
2946316|NCT00673920|3659449|FG001|COMPLETED|Week 24 to Week 48||0
2946317|NCT00673920|3659450|FG002|COMPLETED|Week 24 to Week 48||0
2946318|NCT00673920|3659451|FG003|COMPLETED|Week 24 to Week 48||60
2946319|NCT00673920|3659452|FG004|COMPLETED|Week 24 to Week 48||61
2946320|NCT00673920|3659453|FG005|COMPLETED|Week 24 to Week 48||106
2946321|NCT00673920|3659454|FG006|COMPLETED|Week 24 to Week 48||28
2946322|NCT00673920|3659455|FG007|COMPLETED|Week 24 to Week 48||28
2946323|NCT00673920|3659448|FG000|NOT COMPLETED|Week 24 to Week 48||0
2946324|NCT00673920|3659449|FG001|NOT COMPLETED|Week 24 to Week 48||0
2946325|NCT00673920|3659450|FG002|NOT COMPLETED|Week 24 to Week 48||0
2946326|NCT00673920|3659451|FG003|NOT COMPLETED|Week 24 to Week 48||1
2946327|NCT00673920|3659452|FG004|NOT COMPLETED|Week 24 to Week 48||0
2946328|NCT00673920|3659453|FG005|NOT COMPLETED|Week 24 to Week 48||3
2946329|NCT00673920|3659454|FG006|NOT COMPLETED|Week 24 to Week 48||1
2946330|NCT00673920|3659455|FG007|NOT COMPLETED|Week 24 to Week 48||0
2946331|NCT00673933|3659477|FG000|STARTED|Overall Study||20
2946332|NCT00673933|3659477|FG000|COMPLETED|Overall Study||17
2946333|NCT00673933|3659477|FG000|NOT COMPLETED|Overall Study||3
2946334|NCT00673959|3659483|FG000|STARTED|Overall Study||10
2946335|NCT00673959|3659484|FG001|STARTED|Overall Study||10
2946336|NCT00673959|3659483|FG000|COMPLETED|Overall Study||10
2946337|NCT00673959|3659484|FG001|COMPLETED|Overall Study||10
2946338|NCT00673959|3659483|FG000|NOT COMPLETED|Overall Study||0
2946339|NCT00673959|3659484|FG001|NOT COMPLETED|Overall Study||0
2946340|NCT00674115|3659490|FG000|STARTED|First Intervention||14
2946341|NCT00674115|3659491|FG001|STARTED|First Intervention||16
2946342|NCT00674115|3659492|FG002|STARTED|First Intervention||14
2946343|NCT00674115|3659493|FG003|STARTED|First Intervention||16
2946344|NCT00674115|3659490|FG000|COMPLETED|First Intervention||14
2946345|NCT00674115|3659491|FG001|COMPLETED|First Intervention||16
2946346|NCT00674115|3659492|FG002|COMPLETED|First Intervention||14
2946347|NCT00674115|3659493|FG003|COMPLETED|First Intervention||16
2946348|NCT00674115|3659490|FG000|NOT COMPLETED|First Intervention||0
2946349|NCT00674115|3659491|FG001|NOT COMPLETED|First Intervention||0
2946350|NCT00674115|3659492|FG002|NOT COMPLETED|First Intervention||0
2946351|NCT00674115|3659493|FG003|NOT COMPLETED|First Intervention||0
2946352|NCT00674115|3659490|FG000|STARTED|Washout Period of 2 Weeks||14
2946353|NCT00674115|3659491|FG001|STARTED|Washout Period of 2 Weeks||16
2946354|NCT00674115|3659492|FG002|STARTED|Washout Period of 2 Weeks||14
2946355|NCT00674115|3659493|FG003|STARTED|Washout Period of 2 Weeks||16
2946356|NCT00674115|3659490|FG000|COMPLETED|Washout Period of 2 Weeks||14
2946357|NCT00674115|3659491|FG001|COMPLETED|Washout Period of 2 Weeks||16
2946358|NCT00674115|3659492|FG002|COMPLETED|Washout Period of 2 Weeks||14
2946359|NCT00674115|3659493|FG003|COMPLETED|Washout Period of 2 Weeks||16
2946360|NCT00674115|3659490|FG000|NOT COMPLETED|Washout Period of 2 Weeks||0
2946361|NCT00674115|3659491|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0
2946362|NCT00674115|3659492|FG002|NOT COMPLETED|Washout Period of 2 Weeks||0
2946363|NCT00674115|3659493|FG003|NOT COMPLETED|Washout Period of 2 Weeks||0
2946364|NCT00674115|3659490|FG000|STARTED|Second Intervention||14
2946365|NCT00674115|3659491|FG001|STARTED|Second Intervention||16
2946366|NCT00674115|3659492|FG002|STARTED|Second Intervention||14
2946367|NCT00674115|3659493|FG003|STARTED|Second Intervention||16
2946368|NCT00674115|3659490|FG000|COMPLETED|Second Intervention||14
2946369|NCT00674115|3659491|FG001|COMPLETED|Second Intervention||16
2946370|NCT00674115|3659492|FG002|COMPLETED|Second Intervention||14
2946371|NCT00674115|3659493|FG003|COMPLETED|Second Intervention||16
2946372|NCT00674115|3659490|FG000|NOT COMPLETED|Second Intervention||0
2946373|NCT00674115|3659491|FG001|NOT COMPLETED|Second Intervention||0
2946374|NCT00674115|3659492|FG002|NOT COMPLETED|Second Intervention||0
2946375|NCT00674115|3659493|FG003|NOT COMPLETED|Second Intervention||0
2946376|NCT00674115|3659490|FG000|STARTED|Washout Period of 2 Weeks||14
2946377|NCT00674115|3659491|FG001|STARTED|Washout Period of 2 Weeks||16
2946378|NCT00674115|3659492|FG002|STARTED|Washout Period of 2 Weeks||0
2946379|NCT00674115|3659493|FG003|STARTED|Washout Period of 2 Weeks||0
2946380|NCT00674115|3659490|FG000|COMPLETED|Washout Period of 2 Weeks||14
2946381|NCT00674115|3659491|FG001|COMPLETED|Washout Period of 2 Weeks||16
2946382|NCT00674115|3659492|FG002|COMPLETED|Washout Period of 2 Weeks||0
2946383|NCT00674115|3659493|FG003|COMPLETED|Washout Period of 2 Weeks||0
2946384|NCT00674115|3659490|FG000|NOT COMPLETED|Washout Period of 2 Weeks||0
2946385|NCT00674115|3659491|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0
2946386|NCT00674115|3659492|FG002|NOT COMPLETED|Washout Period of 2 Weeks||0
2946387|NCT00674115|3659493|FG003|NOT COMPLETED|Washout Period of 2 Weeks||0
2946388|NCT00674115|3659490|FG000|STARTED|Third Intervention||14
2946389|NCT00674115|3659491|FG001|STARTED|Third Intervention||16
2946390|NCT00674115|3659492|FG002|STARTED|Third Intervention||0
2946391|NCT00674115|3659493|FG003|STARTED|Third Intervention||0
2946392|NCT00674115|3659490|FG000|COMPLETED|Third Intervention||14
2946393|NCT00674115|3659491|FG001|COMPLETED|Third Intervention||16
2946394|NCT00674115|3659492|FG002|COMPLETED|Third Intervention||0
2946395|NCT00674115|3659493|FG003|COMPLETED|Third Intervention||0
2946396|NCT00674115|3659490|FG000|NOT COMPLETED|Third Intervention||0
2946397|NCT00674115|3659491|FG001|NOT COMPLETED|Third Intervention||0
2946398|NCT00674115|3659492|FG002|NOT COMPLETED|Third Intervention||0
2946399|NCT00674115|3659493|FG003|NOT COMPLETED|Third Intervention||0
2946400|NCT00674128|3659504|FG000|STARTED|Overall Study||50
2946401|NCT00674128|3659505|FG001|STARTED|Overall Study||44
2946402|NCT00674128|3659504|FG000|COMPLETED|Overall Study||25
2946403|NCT00674128|3659505|FG001|COMPLETED|Overall Study||21
2946404|NCT00674128|3659504|FG000|NOT COMPLETED|Overall Study||25
2946405|NCT00674128|3659505|FG001|NOT COMPLETED|Overall Study||23
2946406|NCT00674154|3659513|FG000|STARTED|Overall Study||23
2946407|NCT00674154|3659514|FG001|STARTED|Overall Study||23
2946408|NCT00674154|3659513|FG000|COMPLETED|Overall Study||20
2946409|NCT00674154|3659514|FG001|COMPLETED|Overall Study||20
2946410|NCT00674154|3659513|FG000|NOT COMPLETED|Overall Study||3
2946411|NCT00674154|3659514|FG001|NOT COMPLETED|Overall Study||3
2946412|NCT00674206|3659520|FG000|STARTED|Overall Study||6
2946413|NCT00674206|3659520|FG000|COMPLETED|Overall Study||6
2946414|NCT00674206|3659520|FG000|NOT COMPLETED|Overall Study||0
2946415|NCT00674219|3659526|FG000|STARTED|Overall Study||10
2946416|NCT00674219|3659527|FG001|STARTED|Overall Study||7
2946417|NCT00674219|3659526|FG000|COMPLETED|Overall Study||10
2946418|NCT00674219|3659527|FG001|COMPLETED|Overall Study||7
2946419|NCT00674219|3659526|FG000|NOT COMPLETED|Overall Study||0
2946420|NCT00674219|3659527|FG001|NOT COMPLETED|Overall Study||0
2946421|NCT00674297|3659533|FG000|STARTED|Overall Study||18
2946422|NCT00674297|3659534|FG001|STARTED|Overall Study||7
2946423|NCT00674297|3659535|FG002|STARTED|Overall Study||9
2946424|NCT00674297|3659536|FG003|STARTED|Overall Study||7
2946425|NCT00674297|3659533|FG000|COMPLETED|Overall Study||8
2946426|NCT00674297|3659534|FG001|COMPLETED|Overall Study||7
2946427|NCT00674297|3659535|FG002|COMPLETED|Overall Study||5
2946428|NCT00674297|3659536|FG003|COMPLETED|Overall Study||4
2946429|NCT00674297|3659533|FG000|NOT COMPLETED|Overall Study||10
2946430|NCT00674297|3659534|FG001|NOT COMPLETED|Overall Study||0
2946431|NCT00674297|3659535|FG002|NOT COMPLETED|Overall Study||4
2946432|NCT00674297|3659536|FG003|NOT COMPLETED|Overall Study||3
2946433|NCT00674323|3659546|FG000|STARTED|Overall Study||19
2946434|NCT00674323|3659547|FG001|STARTED|Overall Study||21
2946435|NCT00674323|3659548|FG002|STARTED|Overall Study||21
2946436|NCT00674323|3659546|FG000|COMPLETED|Overall Study||18
2946437|NCT00674323|3659547|FG001|COMPLETED|Overall Study||20
2946438|NCT00674323|3659548|FG002|COMPLETED|Overall Study||21
2946439|NCT00674323|3659546|FG000|NOT COMPLETED|Overall Study||1
3132460|NCT01691313|3857503|FG003|COMPLETED|Overall Study||25
3132461|NCT01691313|3857500|FG000|NOT COMPLETED|Overall Study||0
3132462|NCT01691313|3857501|FG001|NOT COMPLETED|Overall Study||0
3132463|NCT01691313|3857502|FG002|NOT COMPLETED|Overall Study||0
2946440|NCT00674323|3659547|FG001|NOT COMPLETED|Overall Study||1
2946441|NCT00674323|3659548|FG002|NOT COMPLETED|Overall Study||0
2946442|NCT00674362|3659558|FG000|STARTED|Double Blind||96
2946443|NCT00674362|3659559|FG001|STARTED|Double Blind||98
2946444|NCT00674362|3659558|FG000|COMPLETED|Double Blind||84
2946445|NCT00674362|3659559|FG001|COMPLETED|Double Blind||80
2946446|NCT00674362|3659558|FG000|NOT COMPLETED|Double Blind||12
2946447|NCT00674362|3659559|FG001|NOT COMPLETED|Double Blind||18
2946448|NCT00674362|3659558|FG000|STARTED|Open Label||20
2946449|NCT00674362|3659559|FG001|STARTED|Open Label||7
2946450|NCT00674362|3659558|FG000|COMPLETED|Open Label||18
2946451|NCT00674362|3659559|FG001|COMPLETED|Open Label||7
2946452|NCT00674362|3659558|FG000|NOT COMPLETED|Open Label||2
2946453|NCT00674362|3659559|FG001|NOT COMPLETED|Open Label||0
2946454|NCT00674466|3659569|FG000|STARTED|Overall Study||30
2946455|NCT00674466|3659570|FG001|STARTED|Overall Study||30
3132464|NCT01691313|3857503|FG003|NOT COMPLETED|Overall Study||0
2946456|NCT00674466|3659571|FG002|STARTED|Overall Study||30
2946457|NCT00674466|3659569|FG000|COMPLETED|Overall Study||23
2946458|NCT00674466|3659570|FG001|COMPLETED|Overall Study||22
2946459|NCT00674466|3659571|FG002|COMPLETED|Overall Study||21
2946460|NCT00674466|3659569|FG000|NOT COMPLETED|Overall Study||7
2946461|NCT00674466|3659570|FG001|NOT COMPLETED|Overall Study||8
2946462|NCT00674466|3659571|FG002|NOT COMPLETED|Overall Study||9
2946463|NCT00674479|3659579|FG000|STARTED|Overall Study||51
2946464|NCT00674479|3659579|FG000|COMPLETED|Overall Study||51
2946465|NCT00674479|3659579|FG000|NOT COMPLETED|Overall Study||0
2946466|NCT00674492|3659583|FG000|STARTED|Overall Study||21
2946467|NCT00674492|3659583|FG000|COMPLETED|Overall Study||21
2946468|NCT00674492|3659583|FG000|NOT COMPLETED|Overall Study||0
2946469|NCT00674570|3659590|FG000|STARTED|Overall Study||37
2946470|NCT00674570|3659591|FG001|STARTED|Overall Study||34
2946471|NCT00674570|3659592|FG002|STARTED|Overall Study||35
2946472|NCT00674570|3659590|FG000|COMPLETED|Overall Study||37
2946473|NCT00674570|3659591|FG001|COMPLETED|Overall Study||32
3298821|NCT02927834|4032576|FG000|STARTED|Overall Study||8
3298822|NCT02927834|4032577|FG001|STARTED|Overall Study||8
3298823|NCT02927834|4032578|FG002|STARTED|Overall Study||8
2946474|NCT00674570|3659592|FG002|COMPLETED|Overall Study||35
2946475|NCT00674570|3659590|FG000|NOT COMPLETED|Overall Study||0
2946476|NCT00674570|3659591|FG001|NOT COMPLETED|Overall Study||2
2946477|NCT00674570|3659592|FG002|NOT COMPLETED|Overall Study||0
2946478|NCT00674583|3659602|FG000|STARTED|Overall Study||311
2946479|NCT00674583|3659603|FG001|STARTED|Overall Study||103
2946480|NCT00674583|3659602|FG000|COMPLETED|Overall Study||311
2946481|NCT00674583|3659603|FG001|COMPLETED|Overall Study||103
2946482|NCT00674583|3659602|FG000|NOT COMPLETED|Overall Study||0
2946483|NCT00674583|3659603|FG001|NOT COMPLETED|Overall Study||0
2946484|NCT00674609|3659616|FG000|STARTED|Overall Study||60
2946485|NCT00674609|3659617|FG001|STARTED|Overall Study||58
2946486|NCT00674609|3659618|FG002|STARTED|Overall Study||59
2946487|NCT00674609|3659616|FG000|COMPLETED|Overall Study||48
2946488|NCT00674609|3659617|FG001|COMPLETED|Overall Study||45
2946489|NCT00674609|3659618|FG002|COMPLETED|Overall Study||51
2946490|NCT00674609|3659616|FG000|NOT COMPLETED|Overall Study||12
2946491|NCT00674609|3659617|FG001|NOT COMPLETED|Overall Study||13
2946492|NCT00674609|3659618|FG002|NOT COMPLETED|Overall Study||8
2946493|NCT00674622|3659629|FG000|STARTED|Overall Study||22
2946494|NCT00674622|3659630|FG001|STARTED|Overall Study||22
2946495|NCT00674622|3659631|FG002|STARTED|Overall Study||22
2946496|NCT00674622|3659629|FG000|COMPLETED|Overall Study||21
2946497|NCT00674622|3659630|FG001|COMPLETED|Overall Study||18
2946498|NCT00674622|3659631|FG002|COMPLETED|Overall Study||22
2946499|NCT00674622|3659629|FG000|NOT COMPLETED|Overall Study||1
2946500|NCT00674622|3659630|FG001|NOT COMPLETED|Overall Study||4
2946501|NCT00674622|3659631|FG002|NOT COMPLETED|Overall Study||0
2946502|NCT00674661|3659641|FG000|STARTED|Overall Study||67
2946503|NCT00674661|3659642|FG001|STARTED|Overall Study||63
3298824|NCT02927834|4032576|FG000|COMPLETED|Overall Study||7
3298825|NCT02927834|4032577|FG001|COMPLETED|Overall Study||6
3298826|NCT02927834|4032578|FG002|COMPLETED|Overall Study||6
3298827|NCT02927834|4032576|FG000|NOT COMPLETED|Overall Study||1
3298828|NCT02927834|4032577|FG001|NOT COMPLETED|Overall Study||2
2946504|NCT00674661|3659641|FG000|COMPLETED|Overall Study||56
2946505|NCT00674661|3659642|FG001|COMPLETED|Overall Study||48
2946506|NCT00674661|3659641|FG000|NOT COMPLETED|Overall Study||11
2946507|NCT00674661|3659642|FG001|NOT COMPLETED|Overall Study||15
2946508|NCT00674700|3659651|FG000|STARTED|Year 1||170
2946509|NCT00674700|3659652|FG001|STARTED|Year 1||169
2946510|NCT00674700|3659653|FG002|STARTED|Year 1||170
2946511|NCT00674700|3659651|FG000|COMPLETED|Year 1||139
2946512|NCT00674700|3659652|FG001|COMPLETED|Year 1||135
2946513|NCT00674700|3659653|FG002|COMPLETED|Year 1||153
2946514|NCT00674700|3659651|FG000|NOT COMPLETED|Year 1||31
2946515|NCT00674700|3659652|FG001|NOT COMPLETED|Year 1||34
2946516|NCT00674700|3659653|FG002|NOT COMPLETED|Year 1||17
2946517|NCT00674700|3659651|FG000|STARTED|Year 2 Follow-up Without Treatment||139
2946518|NCT00674700|3659652|FG001|STARTED|Year 2 Follow-up Without Treatment||135
2946519|NCT00674700|3659653|FG002|STARTED|Year 2 Follow-up Without Treatment||153
2946520|NCT00674700|3659651|FG000|COMPLETED|Year 2 Follow-up Without Treatment||133
2946521|NCT00674700|3659652|FG001|COMPLETED|Year 2 Follow-up Without Treatment||123
2946522|NCT00674700|3659653|FG002|COMPLETED|Year 2 Follow-up Without Treatment||141
2946523|NCT00674700|3659651|FG000|NOT COMPLETED|Year 2 Follow-up Without Treatment||6
2946524|NCT00674700|3659652|FG001|NOT COMPLETED|Year 2 Follow-up Without Treatment||12
2946525|NCT00674700|3659653|FG002|NOT COMPLETED|Year 2 Follow-up Without Treatment||12
2946526|NCT00674739|3659664|FG000|STARTED|Overall Study||178
2946527|NCT00674739|3659665|FG001|STARTED|Overall Study||195
2946528|NCT00674739|3659666|FG002|STARTED|Overall Study||97
2946529|NCT00674739|3659664|FG000|COMPLETED|Overall Study||121
2946530|NCT00674739|3659665|FG001|COMPLETED|Overall Study||136
2946531|NCT00674739|3659666|FG002|COMPLETED|Overall Study||65
2946532|NCT00674739|3659664|FG000|NOT COMPLETED|Overall Study||57
2946533|NCT00674739|3659665|FG001|NOT COMPLETED|Overall Study||59
2946534|NCT00674739|3659666|FG002|NOT COMPLETED|Overall Study||32
2946535|NCT00674765|3659676|FG000|STARTED|Overall Study||81
2946536|NCT00674765|3659677|FG001|STARTED|Overall Study||75
2946537|NCT00674765|3659676|FG000|COMPLETED|Overall Study||45
2946538|NCT00674765|3659677|FG001|COMPLETED|Overall Study||46
2946539|NCT00674765|3659676|FG000|NOT COMPLETED|Overall Study||36
2946540|NCT00674765|3659677|FG001|NOT COMPLETED|Overall Study||29
2946541|NCT00674817|3659683|FG000|STARTED|Period 1||44
2946542|NCT00674817|3659683|FG000|COMPLETED|Period 1||41
2946543|NCT00674817|3659683|FG000|NOT COMPLETED|Period 1||3
2946544|NCT00674817|3659683|FG000|STARTED|Period 2||41
2946545|NCT00674817|3659683|FG000|COMPLETED|Period 2||41
2946546|NCT00674817|3659683|FG000|NOT COMPLETED|Period 2||0
2946547|NCT00674817|3659683|FG000|STARTED|Period 3||41
2946548|NCT00674817|3659683|FG000|COMPLETED|Period 3||39
2946549|NCT00674817|3659683|FG000|NOT COMPLETED|Period 3||2
2946550|NCT00674817|3659683|FG000|STARTED|Period 4||39
2946551|NCT00674817|3659683|FG000|COMPLETED|Period 4||38
2946552|NCT00674817|3659683|FG000|NOT COMPLETED|Period 4||1
2946553|NCT00674817|3659683|FG000|STARTED|Period 5||38
2946554|NCT00674817|3659683|FG000|COMPLETED|Period 5||38
2946555|NCT00674817|3659683|FG000|NOT COMPLETED|Period 5||0
2946556|NCT00674817|3659683|FG000|STARTED|Period 6||38
2946557|NCT00674817|3659683|FG000|COMPLETED|Period 6||38
2946558|NCT00674817|3659683|FG000|NOT COMPLETED|Period 6||0
2946559|NCT00674973|3659699|FG000|STARTED|Overall Study||103
2946560|NCT00674973|3659700|FG001|STARTED|Overall Study||104
2946561|NCT00674973|3659699|FG000|Switch to Open-Label Erlotinib|Overall Study|Participants with PD were given opportunity to switch.|57
2946562|NCT00674973|3659700|FG001|Switch to Open-Label Erlotinib|Overall Study||0
2946563|NCT00674973|3659699|FG000|COMPLETED|Overall Study|Completed double-blind treatment.|3
2946564|NCT00674973|3659700|FG001|COMPLETED|Overall Study|Completed double-blind treatment.|2
2946565|NCT00674973|3659699|FG000|NOT COMPLETED|Overall Study||100
2946566|NCT00674973|3659700|FG001|NOT COMPLETED|Overall Study||102
2946567|NCT00674986|3659708|FG000|STARTED|Overall Study||230
2946568|NCT00674986|3659709|FG001|STARTED|Overall Study||269
2946569|NCT00674986|3659708|FG000|Intent to Treat Population|Overall Study||227
2946570|NCT00674986|3659709|FG001|Intent to Treat Population|Overall Study||256
2946571|NCT00674986|3659708|FG000|COMPLETED|Overall Study||187
2946572|NCT00674986|3659709|FG001|COMPLETED|Overall Study||188
2946573|NCT00674986|3659708|FG000|NOT COMPLETED|Overall Study||43
2946574|NCT00674986|3659709|FG001|NOT COMPLETED|Overall Study||81
2946575|NCT00675025|3659718|FG000|STARTED|Overall Study||54
2946576|NCT00675025|3659719|FG001|STARTED|Overall Study||63
2946577|NCT00675025|3659718|FG000|COMPLETED|Overall Study||0
2946578|NCT00675025|3659719|FG001|COMPLETED|Overall Study||0
2946579|NCT00675025|3659718|FG000|NOT COMPLETED|Overall Study||54
2946580|NCT00675025|3659719|FG001|NOT COMPLETED|Overall Study||63
2946581|NCT00675103|3659725|FG000|STARTED|Overall Study||7
2946582|NCT00675103|3659725|FG000|COMPLETED|Overall Study||4
2946583|NCT00675103|3659725|FG000|NOT COMPLETED|Overall Study||3
2946584|NCT00675259|3659729|FG000|STARTED|Overall Study||33
2946585|NCT00675259|3659729|FG000|COMPLETED|Overall Study||19
2946586|NCT00675259|3659729|FG000|NOT COMPLETED|Overall Study||14
2946587|NCT00675415|3659739|FG000|STARTED|Overall Study||132
2946588|NCT00675415|3659740|FG001|STARTED|Overall Study||131
2946589|NCT00675415|3659739|FG000|COMPLETED|Overall Study||124
2946590|NCT00675415|3659740|FG001|COMPLETED|Overall Study||123
2946591|NCT00675415|3659739|FG000|NOT COMPLETED|Overall Study||8
2946592|NCT00675415|3659740|FG001|NOT COMPLETED|Overall Study||8
2946593|NCT00675428|3659748|FG000|STARTED|Overall Study||3
2946594|NCT00675428|3659749|FG001|STARTED|Overall Study||3
2946595|NCT00675428|3659748|FG000|COMPLETED|Overall Study||0
2946596|NCT00675428|3659749|FG001|COMPLETED|Overall Study||0
2946597|NCT00675428|3659748|FG000|NOT COMPLETED|Overall Study||3
2946598|NCT00675428|3659749|FG001|NOT COMPLETED|Overall Study||3
2946599|NCT00675441|3659755|FG000|STARTED|Overall Study||5
2946600|NCT00675441|3659755|FG000|COMPLETED|Overall Study||2
2946601|NCT00675441|3659755|FG000|NOT COMPLETED|Overall Study||3
2946602|NCT00675506|3659761|FG000|STARTED|Overall Study||31
2946603|NCT00675506|3659762|FG001|STARTED|Overall Study||29
2946604|NCT00675506|3659761|FG000|Received Intervention|Overall Study|Two subjects did not start treatment: 1) disclosed cancer history, 2) declined participation.|29
2946605|NCT00675506|3659762|FG001|Received Intervention|Overall Study||29
2946606|NCT00675506|3659761|FG000|COMPLETED|Overall Study||19
2946607|NCT00675506|3659762|FG001|COMPLETED|Overall Study||17
2946608|NCT00675506|3659761|FG000|NOT COMPLETED|Overall Study||12
2946609|NCT00675506|3659762|FG001|NOT COMPLETED|Overall Study||12
2946610|NCT00675558|3659772|FG000|STARTED|Surgery||10
2946611|NCT00675558|3659773|FG001|STARTED|Surgery||10
2946612|NCT00675558|3659774|FG002|STARTED|Surgery||30
2946613|NCT00675558|3659772|FG000|COMPLETED|Surgery||10
2946614|NCT00675558|3659773|FG001|COMPLETED|Surgery||10
2946615|NCT00675558|3659774|FG002|COMPLETED|Surgery||30
2946616|NCT00675558|3659772|FG000|NOT COMPLETED|Surgery||0
2946617|NCT00675558|3659773|FG001|NOT COMPLETED|Surgery||0
2946618|NCT00675558|3659774|FG002|NOT COMPLETED|Surgery||0
2946619|NCT00675558|3659772|FG000|STARTED|Second Operation|No medical reason, and no study-related reason for non-obese pts to have a second procedure.|0
2946620|NCT00675558|3659773|FG001|STARTED|Second Operation|No medical reason, and none for the goals of the study, for MO pts to have a second procedure .|0
2946621|NCT00675558|3659774|FG002|STARTED|Second Operation|As predicted, only 10 SMO patients medically required a second operation, and thus met study goals.|10
2946622|NCT00675558|3659772|FG000|COMPLETED|Second Operation||0
2946623|NCT00675558|3659773|FG001|COMPLETED|Second Operation||0
2946624|NCT00675558|3659774|FG002|COMPLETED|Second Operation||10
2946625|NCT00675558|3659772|FG000|NOT COMPLETED|Second Operation||0
2946626|NCT00675558|3659773|FG001|NOT COMPLETED|Second Operation||0
2946627|NCT00675558|3659774|FG002|NOT COMPLETED|Second Operation||0
2946628|NCT00675584|3659784|FG000|STARTED|Overall Study||139
2946629|NCT00675584|3659785|FG001|STARTED|Overall Study||139
2946630|NCT00675584|3659784|FG000|COMPLETED|Overall Study||100
2946631|NCT00675584|3659785|FG001|COMPLETED|Overall Study||113
2946632|NCT00675584|3659784|FG000|NOT COMPLETED|Overall Study||39
2946633|NCT00675584|3659785|FG001|NOT COMPLETED|Overall Study||26
2946634|NCT00675597|3659791|FG000|STARTED|Overall Study||26
2946635|NCT00675597|3659791|FG000|COMPLETED|Overall Study||23
2946636|NCT00675597|3659791|FG000|NOT COMPLETED|Overall Study||3
2946637|NCT00675766|3659799|FG000|STARTED|Overall Study||106
2946638|NCT00675766|3659800|FG001|STARTED|Overall Study||30
2946639|NCT00675766|3659801|FG002|STARTED|Overall Study||50
2946640|NCT00675766|3659802|FG003|STARTED|Overall Study||37
2946641|NCT00675766|3659799|FG000|Year 2|Overall Study||105
2946642|NCT00675766|3659800|FG001|Year 2|Overall Study||28
2946643|NCT00675766|3659801|FG002|Year 2|Overall Study||34
2946644|NCT00675766|3659802|FG003|Year 2|Overall Study||20
2946645|NCT00675766|3659799|FG000|Year 3|Overall Study||100
2946646|NCT00675766|3659800|FG001|Year 3|Overall Study||25
2946647|NCT00675766|3659801|FG002|Year 3|Overall Study||29
2946648|NCT00675766|3659802|FG003|Year 3|Overall Study||11
2946649|NCT00675766|3659799|FG000|COMPLETED|Overall Study||100
2946650|NCT00675766|3659800|FG001|COMPLETED|Overall Study||25
2946651|NCT00675766|3659801|FG002|COMPLETED|Overall Study||29
2946652|NCT00675766|3659802|FG003|COMPLETED|Overall Study||11
2946653|NCT00675766|3659799|FG000|NOT COMPLETED|Overall Study||6
2946654|NCT00675766|3659800|FG001|NOT COMPLETED|Overall Study||5
2946655|NCT00675766|3659801|FG002|NOT COMPLETED|Overall Study||21
2946656|NCT00675766|3659802|FG003|NOT COMPLETED|Overall Study||26
2946657|NCT00675792|3659814|FG000|STARTED|Overall Study||51
2946658|NCT00675792|3659815|FG001|STARTED|Overall Study||49
2946659|NCT00675792|3659814|FG000|COMPLETED|Overall Study||51
2946660|NCT00675792|3659815|FG001|COMPLETED|Overall Study||49
2946661|NCT00675792|3659814|FG000|NOT COMPLETED|Overall Study||0
2946662|NCT00675792|3659815|FG001|NOT COMPLETED|Overall Study||0
2946663|NCT00675909|3659824|FG000|STARTED|Overall Study||60
2946664|NCT00675909|3659825|FG001|STARTED|Overall Study||60
2946665|NCT00675909|3659826|FG002|STARTED|Overall Study||60
2946666|NCT00675909|3659824|FG000|COMPLETED|Overall Study||60
2946667|NCT00675909|3659825|FG001|COMPLETED|Overall Study||60
2946668|NCT00675909|3659826|FG002|COMPLETED|Overall Study||60
2946669|NCT00675909|3659824|FG000|NOT COMPLETED|Overall Study||0
2946670|NCT00675909|3659825|FG001|NOT COMPLETED|Overall Study||0
2946671|NCT00675909|3659826|FG002|NOT COMPLETED|Overall Study||0
2946672|NCT00675922|3659834|FG000|STARTED|Overall Study||98
2946673|NCT00675922|3659834|FG000|COMPLETED|Overall Study||98
2946674|NCT00675922|3659834|FG000|NOT COMPLETED|Overall Study||0
2946675|NCT00675948|3659841|FG000|STARTED|Overall Study||39
2946676|NCT00675948|3659842|FG001|STARTED|Overall Study||4
2946677|NCT00675948|3659841|FG000|COMPLETED|Overall Study||0
2946678|NCT00675948|3659842|FG001|COMPLETED|Overall Study||1
2946679|NCT00675948|3659841|FG000|NOT COMPLETED|Overall Study||39
2946680|NCT00675948|3659842|FG001|NOT COMPLETED|Overall Study||3
2946681|NCT00675987|3659851|FG000|STARTED|Overall Study||26
2946682|NCT00675987|3659852|FG001|STARTED|Overall Study||27
2946683|NCT00675987|3659851|FG000|COMPLETED|Overall Study||26
2946684|NCT00675987|3659852|FG001|COMPLETED|Overall Study||27
2946685|NCT00675987|3659851|FG000|NOT COMPLETED|Overall Study||0
2946686|NCT00675987|3659852|FG001|NOT COMPLETED|Overall Study||0
2946687|NCT00676013|3659860|FG000|STARTED|Overall Study||158
2946688|NCT00676013|3659860|FG000|COMPLETED|Overall Study||157
2946689|NCT00676013|3659860|FG000|NOT COMPLETED|Overall Study||1
2946690|NCT00676052|3659873|FG000|STARTED|Overall Study||96
2946691|NCT00676052|3659874|FG001|STARTED|Overall Study||95
2946692|NCT00676052|3659875|FG002|STARTED|Overall Study||96
2946693|NCT00676052|3659876|FG003|STARTED|Overall Study||97
2946694|NCT00676052|3659877|FG004|STARTED|Overall Study||95
2946695|NCT00676052|3659878|FG005|STARTED|Overall Study||97
2946696|NCT00676052|3659873|FG000|COMPLETED|Overall Study||87
2946697|NCT00676052|3659874|FG001|COMPLETED|Overall Study||88
2946698|NCT00676052|3659875|FG002|COMPLETED|Overall Study||90
2946699|NCT00676052|3659876|FG003|COMPLETED|Overall Study||92
2946700|NCT00676052|3659877|FG004|COMPLETED|Overall Study||89
2946701|NCT00676052|3659878|FG005|COMPLETED|Overall Study||91
2946702|NCT00676052|3659873|FG000|NOT COMPLETED|Overall Study||9
2946703|NCT00676052|3659874|FG001|NOT COMPLETED|Overall Study||7
2946704|NCT00676052|3659875|FG002|NOT COMPLETED|Overall Study||6
2946705|NCT00676052|3659876|FG003|NOT COMPLETED|Overall Study||5
2946706|NCT00676052|3659877|FG004|NOT COMPLETED|Overall Study||6
2946707|NCT00676052|3659878|FG005|NOT COMPLETED|Overall Study||6
2946708|NCT00676065|3659895|FG000|STARTED|Overall Study||16534
2946709|NCT00676065|3659896|FG001|STARTED|Overall Study||15428
2946710|NCT00676065|3659897|FG002|STARTED|Overall Study||26341
2946711|NCT00676065|3659895|FG000|COMPLETED|Overall Study||16534
2946712|NCT00676065|3659896|FG001|COMPLETED|Overall Study||15428
2946713|NCT00676065|3659897|FG002|COMPLETED|Overall Study||26341
2946714|NCT00676065|3659895|FG000|NOT COMPLETED|Overall Study||0
2946715|NCT00676065|3659896|FG001|NOT COMPLETED|Overall Study||0
2946716|NCT00676065|3659897|FG002|NOT COMPLETED|Overall Study||0
2946717|NCT00676091|3659907|FG000|STARTED|Infant Series||177
2946718|NCT00676091|3659908|FG001|STARTED|Infant Series||177
2946719|NCT00676091|3659907|FG000|Vaccinated Dose 1|Infant Series||163
2946720|NCT00676091|3659908|FG001|Vaccinated Dose 1|Infant Series||162
2946721|NCT00676091|3659907|FG000|Vaccinated Dose 2|Infant Series||159
2946722|NCT00676091|3659908|FG001|Vaccinated Dose 2|Infant Series||162
2946723|NCT00676091|3659907|FG000|Vaccinated Dose 3|Infant Series||158
2946724|NCT00676091|3659908|FG001|Vaccinated Dose 3|Infant Series||161
2946725|NCT00676091|3659907|FG000|COMPLETED|Infant Series||157
2946726|NCT00676091|3659908|FG001|COMPLETED|Infant Series||159
2946727|NCT00676091|3659907|FG000|NOT COMPLETED|Infant Series||20
2946728|NCT00676091|3659908|FG001|NOT COMPLETED|Infant Series||18
2946729|NCT00676091|3659907|FG000|STARTED|After Infant Series||157
2946730|NCT00676091|3659908|FG001|STARTED|After Infant Series||159
2946731|NCT00676091|3659907|FG000|COMPLETED|After Infant Series||156
2946732|NCT00676091|3659908|FG001|COMPLETED|After Infant Series||156
2946733|NCT00676091|3659907|FG000|NOT COMPLETED|After Infant Series||1
2946734|NCT00676091|3659908|FG001|NOT COMPLETED|After Infant Series||3
2946735|NCT00676091|3659907|FG000|STARTED|Toddler Dose||156
2946736|NCT00676091|3659908|FG001|STARTED|Toddler Dose||156
2946737|NCT00676091|3659907|FG000|COMPLETED|Toddler Dose||153
2946738|NCT00676091|3659908|FG001|COMPLETED|Toddler Dose||156
2946739|NCT00676091|3659907|FG000|NOT COMPLETED|Toddler Dose||3
2946740|NCT00676091|3659908|FG001|NOT COMPLETED|Toddler Dose||0
2946741|NCT00676130|3659920|FG000|STARTED|Overall Study||76
2946742|NCT00676130|3659921|FG001|STARTED|Overall Study||77
2946743|NCT00676130|3659920|FG000|COMPLETED|Overall Study||73
2946744|NCT00676130|3659921|FG001|COMPLETED|Overall Study||73
2946745|NCT00676130|3659920|FG000|NOT COMPLETED|Overall Study||3
2946746|NCT00676130|3659921|FG001|NOT COMPLETED|Overall Study||4
2946747|NCT00676143|3659929|FG000|STARTED|Overall Study||441
2946748|NCT00676143|3659930|FG001|STARTED|Overall Study||658
2946749|NCT00676143|3659929|FG000|Treated|Overall Study||439
2946750|NCT00676143|3659930|FG001|Treated|Overall Study||654
2946751|NCT00676143|3659929|FG000|COMPLETED|Overall Study||285
2946752|NCT00676143|3659930|FG001|COMPLETED|Overall Study||398
2946753|NCT00676143|3659929|FG000|NOT COMPLETED|Overall Study||156
2946754|NCT00676143|3659930|FG001|NOT COMPLETED|Overall Study||260
2946755|NCT00676182|3659939|FG000|STARTED|Overall Study||75
2946756|NCT00676182|3659939|FG000|COMPLETED|Overall Study||75
2946757|NCT00676182|3659939|FG000|NOT COMPLETED|Overall Study||0
2946758|NCT00676195|3659949|FG000|STARTED|Overall Study||24
2946759|NCT00676195|3659949|FG000|COMPLETED|Overall Study||21
2946760|NCT00676195|3659949|FG000|NOT COMPLETED|Overall Study||3
2946761|NCT00676208|3659956|FG000|STARTED|Overall Study||14
2946762|NCT00676208|3659957|FG001|STARTED|Overall Study||19
2946763|NCT00676208|3659956|FG000|COMPLETED|Overall Study||12
2946764|NCT00676208|3659957|FG001|COMPLETED|Overall Study||13
2946765|NCT00676208|3659956|FG000|NOT COMPLETED|Overall Study||2
2946766|NCT00676208|3659957|FG001|NOT COMPLETED|Overall Study||6
2946767|NCT00676338|3659969|FG000|STARTED|Overall Study||248
2946768|NCT00676338|3659970|FG001|STARTED|Overall Study||246
2946769|NCT00676338|3659971|FG002|STARTED|Overall Study||163
2946770|NCT00676338|3659972|FG003|STARTED|Overall Study||163
2946771|NCT00676338|3659969|FG000|COMPLETED|Overall Study||210
2946772|NCT00676338|3659970|FG001|COMPLETED|Overall Study||213
2946773|NCT00676338|3659971|FG002|COMPLETED|Overall Study||133
2946774|NCT00676338|3659972|FG003|COMPLETED|Overall Study||140
2946775|NCT00676338|3659969|FG000|NOT COMPLETED|Overall Study||38
2946776|NCT00676338|3659970|FG001|NOT COMPLETED|Overall Study||33
2946777|NCT00676338|3659971|FG002|NOT COMPLETED|Overall Study||30
2946778|NCT00676338|3659972|FG003|NOT COMPLETED|Overall Study||23
2946779|NCT00676364|3659984|FG000|STARTED|Overall Study||57
2946780|NCT00676364|3659985|FG001|STARTED|Overall Study||57
2946781|NCT00676364|3659984|FG000|COMPLETED|Overall Study||57
2946782|NCT00676364|3659985|FG001|COMPLETED|Overall Study||57
2946783|NCT00676364|3659984|FG000|NOT COMPLETED|Overall Study||0
2946784|NCT00676364|3659985|FG001|NOT COMPLETED|Overall Study||0
2946785|NCT00676403|3659999|FG000|STARTED|Overall Study||23
2946786|NCT00676403|3660000|FG001|STARTED|Overall Study||22
2946787|NCT00676403|3660001|FG002|STARTED|Overall Study||23
2946788|NCT00676403|3660002|FG003|STARTED|Overall Study||22
2946789|NCT00676403|3660003|FG004|STARTED|Overall Study||24
2946790|NCT00676403|3660004|FG005|STARTED|Overall Study||23
2946791|NCT00676403|3659999|FG000|COMPLETED|Overall Study||21
2946792|NCT00676403|3660000|FG001|COMPLETED|Overall Study||20
2946793|NCT00676403|3660001|FG002|COMPLETED|Overall Study||22
2946794|NCT00676403|3660002|FG003|COMPLETED|Overall Study||17
2946795|NCT00676403|3660003|FG004|COMPLETED|Overall Study||23
2946796|NCT00676403|3660004|FG005|COMPLETED|Overall Study||18
2946797|NCT00676403|3659999|FG000|NOT COMPLETED|Overall Study||2
2946798|NCT00676403|3660000|FG001|NOT COMPLETED|Overall Study||2
2946799|NCT00676403|3660001|FG002|NOT COMPLETED|Overall Study||1
2946800|NCT00676403|3660002|FG003|NOT COMPLETED|Overall Study||5
2946801|NCT00676403|3660003|FG004|NOT COMPLETED|Overall Study||1
2946802|NCT00676403|3660004|FG005|NOT COMPLETED|Overall Study||5
2946803|NCT00676520|3660024|FG000|STARTED|Overall Study||8040
2946804|NCT00676520|3660024|FG000|COMPLETED|Overall Study||7309
2946805|NCT00676520|3660024|FG000|NOT COMPLETED|Overall Study||731
2946806|NCT00676572|3660035|FG000|STARTED|Overall Study||6
2946807|NCT00676572|3660036|FG001|STARTED|Overall Study||6
2946808|NCT00676572|3660035|FG000|COMPLETED|Overall Study||6
2946809|NCT00676572|3660036|FG001|COMPLETED|Overall Study||6
2946810|NCT00676572|3660035|FG000|NOT COMPLETED|Overall Study||0
2946811|NCT00676572|3660036|FG001|NOT COMPLETED|Overall Study||0
2946812|NCT00676585|3660044|FG000|STARTED|Overall Study||25
2946813|NCT00676585|3660045|FG001|STARTED|Overall Study||25
2946814|NCT00676585|3660044|FG000|COMPLETED|Overall Study||25
2946815|NCT00676585|3660045|FG001|COMPLETED|Overall Study||25
2946816|NCT00676585|3660044|FG000|NOT COMPLETED|Overall Study||0
2946817|NCT00676585|3660045|FG001|NOT COMPLETED|Overall Study||0
2946818|NCT00676650|3660053|FG000|STARTED|Overall Study||584
2946819|NCT00676650|3660054|FG001|STARTED|Overall Study||289
2946820|NCT00676650|3660053|FG000|Treated|Overall Study||581
2946821|NCT00676650|3660054|FG001|Treated|Overall Study||285
2946822|NCT00676650|3660053|FG000|COMPLETED|Overall Study||0
2946823|NCT00676650|3660054|FG001|COMPLETED|Overall Study||0
2946824|NCT00676650|3660053|FG000|NOT COMPLETED|Overall Study||584
2946825|NCT00676650|3660054|FG001|NOT COMPLETED|Overall Study||289
2946826|NCT00676663|3660062|FG000|STARTED|Overall Study||66
2946827|NCT00676663|3660063|FG001|STARTED|Overall Study||64
2946828|NCT00676663|3660062|FG000|COMPLETED|Overall Study||21
2946829|NCT00676663|3660063|FG001|COMPLETED|Overall Study||26
2946830|NCT00676663|3660062|FG000|NOT COMPLETED|Overall Study||45
2946831|NCT00676663|3660063|FG001|NOT COMPLETED|Overall Study||38
2946832|NCT00676676|3660071|FG000|STARTED|Overall Study||9
2946833|NCT00676676|3660071|FG000|COMPLETED|Overall Study||9
2946834|NCT00676676|3660071|FG000|NOT COMPLETED|Overall Study||0
2946835|NCT00676689|3660075|FG000|STARTED|Overall Study||81
2946836|NCT00676689|3660075|FG000|Procedure|Overall Study|Two enrolled patients did not meet eligibility criteria and did not undergo the study procedure.|79
2946837|NCT00676689|3660075|FG000|30 Day Follow-up|Overall Study||78
2946838|NCT00676689|3660075|FG000|1 Year Follow-up|Overall Study||64
2946839|NCT00676689|3660075|FG000|COMPLETED|Overall Study||20
2946840|NCT00676689|3660075|FG000|NOT COMPLETED|Overall Study||61
2946841|NCT00676780|3660079|FG000|STARTED|Overall Study||33
2946842|NCT00676780|3660079|FG000|COMPLETED|Overall Study||26
2946843|NCT00676780|3660079|FG000|NOT COMPLETED|Overall Study||7
2946844|NCT00676793|3660085|FG000|STARTED|Overall Study||32
2946845|NCT00676793|3660085|FG000|COMPLETED|Overall Study||19
2946846|NCT00676793|3660085|FG000|NOT COMPLETED|Overall Study||13
2946847|NCT00676806|3660092|FG000|STARTED|Overall Study||3
2946848|NCT00676806|3660093|FG001|STARTED|Overall Study||3
2946849|NCT00676806|3660092|FG000|COMPLETED|Overall Study||3
2946850|NCT00676806|3660093|FG001|COMPLETED|Overall Study||3
2946851|NCT00676806|3660092|FG000|NOT COMPLETED|Overall Study||0
2946852|NCT00676806|3660093|FG001|NOT COMPLETED|Overall Study||0
2946853|NCT00676897|3660105|FG000|STARTED|Overall Study||8
2946854|NCT00676897|3660106|FG001|STARTED|Overall Study||10
2946855|NCT00676897|3660105|FG000|COMPLETED|Overall Study||8
2946856|NCT00676897|3660106|FG001|COMPLETED|Overall Study||10
2946857|NCT00676897|3660105|FG000|NOT COMPLETED|Overall Study||0
2946858|NCT00676897|3660106|FG001|NOT COMPLETED|Overall Study||0
2946859|NCT00677014|3660115|FG000|STARTED|Overall Study||325
2946860|NCT00677014|3660116|FG001|STARTED|Overall Study||323
2946861|NCT00677014|3660117|FG002|STARTED|Overall Study||332
2946862|NCT00677014|3660115|FG000|COMPLETED|Overall Study||281
2946863|NCT00677014|3660116|FG001|COMPLETED|Overall Study||282
2946864|NCT00677014|3660117|FG002|COMPLETED|Overall Study||283
2946865|NCT00677014|3660115|FG000|NOT COMPLETED|Overall Study||44
2946866|NCT00677014|3660116|FG001|NOT COMPLETED|Overall Study||41
2946867|NCT00677014|3660117|FG002|NOT COMPLETED|Overall Study||49
2946868|NCT00677040|3660125|FG000|STARTED|Overall Study||20
2946869|NCT00677040|3660125|FG000|COMPLETED|Overall Study||20
2946870|NCT00677040|3660125|FG000|NOT COMPLETED|Overall Study||0
2946871|NCT00677092|3660130|FG000|STARTED|Overall Study||12
2946872|NCT00677092|3660130|FG000|Received Study Treatment|Overall Study||11
2946873|NCT00677092|3660130|FG000|COMPLETED|Overall Study||6
2946874|NCT00677092|3660130|FG000|NOT COMPLETED|Overall Study||6
2946875|NCT00677235|3660137|FG000|STARTED|Overall Study||138
2946876|NCT00677235|3660138|FG001|STARTED|Overall Study||132
2946877|NCT00677235|3660137|FG000|COMPLETED|Overall Study||97
2946878|NCT00677235|3660138|FG001|COMPLETED|Overall Study||94
2946879|NCT00677235|3660137|FG000|NOT COMPLETED|Overall Study||41
2946880|NCT00677235|3660138|FG001|NOT COMPLETED|Overall Study||38
2946881|NCT00677352|3660146|FG000|STARTED|Treatment Phase|All 157 subjects were treated with Sertraline.|157
2946882|NCT00677352|3660147|FG001|STARTED|Treatment Phase|2 subjects were not teated, therefore 162 subjects were treated with paroxetine.|164
2946883|NCT00677352|3660146|FG000|COMPLETED|Treatment Phase||132
2946884|NCT00677352|3660147|FG001|COMPLETED|Treatment Phase||122
2946885|NCT00677352|3660146|FG000|NOT COMPLETED|Treatment Phase||25
2946886|NCT00677352|3660147|FG001|NOT COMPLETED|Treatment Phase||42
2946887|NCT00677352|3660146|FG000|STARTED|Tapering Phase||132
2946888|NCT00677352|3660147|FG001|STARTED|Tapering Phase||122
2946889|NCT00677352|3660146|FG000|COMPLETED|Tapering Phase||126
2946890|NCT00677352|3660147|FG001|COMPLETED|Tapering Phase||112
2946891|NCT00677352|3660146|FG000|NOT COMPLETED|Tapering Phase||6
2946892|NCT00677352|3660147|FG001|NOT COMPLETED|Tapering Phase||10
2946893|NCT00677365|3660157|FG000|STARTED|Overall Study||37
2946894|NCT00677365|3660158|FG001|STARTED|Overall Study||38
2946895|NCT00677365|3660159|FG002|STARTED|Overall Study||37
2946896|NCT00677365|3660160|FG003|STARTED|Overall Study||39
2946897|NCT00677365|3660157|FG000|COMPLETED|Overall Study||35
2946898|NCT00677365|3660158|FG001|COMPLETED|Overall Study||37
2946899|NCT00677365|3660159|FG002|COMPLETED|Overall Study||35
2946900|NCT00677365|3660160|FG003|COMPLETED|Overall Study||36
2946901|NCT00677365|3660157|FG000|NOT COMPLETED|Overall Study||2
2946902|NCT00677365|3660158|FG001|NOT COMPLETED|Overall Study||1
2946903|NCT00677365|3660159|FG002|NOT COMPLETED|Overall Study||2
2946904|NCT00677365|3660160|FG003|NOT COMPLETED|Overall Study||3
2946905|NCT00677534|3660170|FG000|STARTED|Washout (Weeks 1-4)||10
2946906|NCT00677534|3660170|FG000|COMPLETED|Washout (Weeks 1-4)||7
2946907|NCT00677534|3660170|FG000|NOT COMPLETED|Washout (Weeks 1-4)||3
2946908|NCT00677534|3660170|FG000|STARTED|Cholecalciferol (Weeks 5-12)||7
2946909|NCT00677534|3660170|FG000|COMPLETED|Cholecalciferol (Weeks 5-12)||7
2946910|NCT00677534|3660170|FG000|NOT COMPLETED|Cholecalciferol (Weeks 5-12)||0
2946911|NCT00677534|3660170|FG000|STARTED|After Paricalcitol Restart (Weeks 13-14)||7
2946912|NCT00677534|3660170|FG000|COMPLETED|After Paricalcitol Restart (Weeks 13-14)||7
2946913|NCT00677534|3660170|FG000|NOT COMPLETED|After Paricalcitol Restart (Weeks 13-14)||0
2946914|NCT00677690|3660176|FG000|STARTED|Overall Study||42
2946915|NCT00677690|3660177|FG001|STARTED|Overall Study||41
2946916|NCT00677690|3660176|FG000|COMPLETED|Overall Study||42
2946917|NCT00677690|3660177|FG001|COMPLETED|Overall Study||41
2946918|NCT00677690|3660176|FG000|NOT COMPLETED|Overall Study||0
2946919|NCT00677690|3660177|FG001|NOT COMPLETED|Overall Study||0
2946920|NCT00677807|3660186|FG000|STARTED|Overall Study||144
2946921|NCT00677807|3660187|FG001|STARTED|Overall Study||146
2946922|NCT00677807|3660188|FG002|STARTED|Overall Study||125
2946923|NCT00677807|3660186|FG000|Safety/ITT: Received Study Drug|Overall Study||144
2946924|NCT00677807|3660187|FG001|Safety/ITT: Received Study Drug|Overall Study||146
2946925|NCT00677807|3660188|FG002|Safety/ITT: Received Study Drug|Overall Study|One patient did not take study medication.|124
2946926|NCT00677807|3660186|FG000|COMPLETED|Overall Study||126
2946927|NCT00677807|3660187|FG001|COMPLETED|Overall Study||135
2946928|NCT00677807|3660188|FG002|COMPLETED|Overall Study||105
2946929|NCT00677807|3660186|FG000|NOT COMPLETED|Overall Study||18
2946930|NCT00677807|3660187|FG001|NOT COMPLETED|Overall Study||11
2946931|NCT00677807|3660188|FG002|NOT COMPLETED|Overall Study||20
2946932|NCT00677820|3660198|FG000|STARTED|Overall Study||240
2946933|NCT00677820|3660199|FG001|STARTED|Overall Study||60
2946934|NCT00677820|3660198|FG000|COMPLETED|Overall Study||239
2946935|NCT00677820|3660199|FG001|COMPLETED|Overall Study||60
2946936|NCT00677820|3660198|FG000|NOT COMPLETED|Overall Study||1
2946937|NCT00677820|3660199|FG001|NOT COMPLETED|Overall Study||0
2946938|NCT00677833|3660209|FG000|STARTED|Overall Study||55
2946939|NCT00677833|3660210|FG001|STARTED|Overall Study||51
2946940|NCT00677833|3660211|FG002|STARTED|Overall Study||124
2946941|NCT00677833|3660212|FG003|STARTED|Overall Study||131
2946942|NCT00677833|3660209|FG000|COMPLETED|Overall Study||51
2946943|NCT00677833|3660210|FG001|COMPLETED|Overall Study||51
2946944|NCT00677833|3660211|FG002|COMPLETED|Overall Study||122
2946945|NCT00677833|3660212|FG003|COMPLETED|Overall Study||128
2946946|NCT00677833|3660209|FG000|NOT COMPLETED|Overall Study||4
2946947|NCT00677833|3660210|FG001|NOT COMPLETED|Overall Study||0
2946948|NCT00677833|3660211|FG002|NOT COMPLETED|Overall Study||2
2946949|NCT00677833|3660212|FG003|NOT COMPLETED|Overall Study||3
2946950|NCT00677898|3660222|FG000|STARTED|Overall Study||119
2946951|NCT00677898|3660223|FG001|STARTED|Overall Study||120
2946952|NCT00677898|3660222|FG000|COMPLETED|Overall Study||99
2946953|NCT00677898|3660223|FG001|COMPLETED|Overall Study||102
2946954|NCT00677898|3660222|FG000|NOT COMPLETED|Overall Study||20
2946955|NCT00677898|3660223|FG001|NOT COMPLETED|Overall Study||18
2946956|NCT00677924|3660231|FG000|STARTED|Overall Study||3
2946957|NCT00677924|3660232|FG001|STARTED|Overall Study||6
2946958|NCT00677924|3660231|FG000|COMPLETED|Overall Study||3
2946959|NCT00677924|3660232|FG001|COMPLETED|Overall Study||6
2946960|NCT00677924|3660231|FG000|NOT COMPLETED|Overall Study||0
2946961|NCT00677924|3660232|FG001|NOT COMPLETED|Overall Study||0
2946962|NCT00678015|3660238|FG000|STARTED|Overall Study||12
2946963|NCT00678015|3660238|FG000|COMPLETED|Overall Study||12
2946964|NCT00678015|3660238|FG000|NOT COMPLETED|Overall Study||0
2946965|NCT00678080|3660244|FG000|STARTED|Overall Study||11
2946966|NCT00678080|3660245|FG001|STARTED|Overall Study||14
2946967|NCT00678080|3660244|FG000|COMPLETED|Overall Study||8
2946968|NCT00678080|3660245|FG001|COMPLETED|Overall Study||13
2946969|NCT00678080|3660244|FG000|NOT COMPLETED|Overall Study||3
2946970|NCT00678080|3660245|FG001|NOT COMPLETED|Overall Study||1
2946971|NCT00678210|3660255|FG000|STARTED|Overall Study||49
2946972|NCT00678210|3660256|FG001|STARTED|Overall Study||49
2946973|NCT00678210|3660257|FG002|STARTED|Overall Study||49
2946974|NCT00678210|3660258|FG003|STARTED|Overall Study||50
2946975|NCT00678210|3660255|FG000|COMPLETED|Overall Study||38
2946976|NCT00678210|3660256|FG001|COMPLETED|Overall Study||38
2946977|NCT00678210|3660257|FG002|COMPLETED|Overall Study||43
2946978|NCT00678210|3660258|FG003|COMPLETED|Overall Study||30
2946979|NCT00678210|3660255|FG000|NOT COMPLETED|Overall Study||11
2946980|NCT00678210|3660256|FG001|NOT COMPLETED|Overall Study||11
2946981|NCT00678210|3660257|FG002|NOT COMPLETED|Overall Study||6
2946982|NCT00678210|3660258|FG003|NOT COMPLETED|Overall Study||20
2946983|NCT00678249|3660271|FG000|STARTED|Overall Study||97
2946984|NCT00678249|3660272|FG001|STARTED|Overall Study||93
2946985|NCT00678249|3660273|FG002|STARTED|Overall Study||37
2946986|NCT00678249|3660271|FG000|COMPLETED|Overall Study||97
2946987|NCT00678249|3660272|FG001|COMPLETED|Overall Study||93
2946988|NCT00678249|3660273|FG002|COMPLETED|Overall Study||37
2946989|NCT00678249|3660271|FG000|NOT COMPLETED|Overall Study||0
2946990|NCT00678249|3660272|FG001|NOT COMPLETED|Overall Study||0
2946991|NCT00678249|3660273|FG002|NOT COMPLETED|Overall Study||0
2946992|NCT00678301|3660283|FG000|STARTED|Overall Study||239
2946993|NCT00678301|3660284|FG001|STARTED|Overall Study||118
2946994|NCT00678301|3660283|FG000|COMPLETED|Overall Study||231
2946995|NCT00678301|3660284|FG001|COMPLETED|Overall Study||116
2946996|NCT00678301|3660283|FG000|NOT COMPLETED|Overall Study||8
2946997|NCT00678301|3660284|FG001|NOT COMPLETED|Overall Study||2
2946998|NCT00678379|3660293|FG000|STARTED|Overall Study||40
2946999|NCT00678379|3660294|FG001|STARTED|Overall Study||40
2947000|NCT00678379|3660295|FG002|STARTED|Overall Study||40
2947001|NCT00678379|3660293|FG000|COMPLETED|Overall Study||34
2947002|NCT00678379|3660294|FG001|COMPLETED|Overall Study||37
2947003|NCT00678379|3660295|FG002|COMPLETED|Overall Study||36
2947004|NCT00678379|3660293|FG000|NOT COMPLETED|Overall Study||6
2947005|NCT00678379|3660294|FG001|NOT COMPLETED|Overall Study||3
2947006|NCT00678379|3660295|FG002|NOT COMPLETED|Overall Study||4
2947007|NCT00678392|3660305|FG000|STARTED|Overall Study||361
2947008|NCT00678392|3660306|FG001|STARTED|Overall Study||362
2947009|NCT00678392|3660305|FG000|Treated|Overall Study||359
2947010|NCT00678392|3660306|FG001|Treated|Overall Study||355
2947011|NCT00678392|3660305|FG000|COMPLETED|Overall Study||0
2947012|NCT00678392|3660306|FG001|COMPLETED|Overall Study||0
2947013|NCT00678392|3660305|FG000|NOT COMPLETED|Overall Study||361
2947014|NCT00678392|3660306|FG001|NOT COMPLETED|Overall Study||362
2947015|NCT00678418|3660314|FG000|STARTED|Part A (Double Blind)||126
2947016|NCT00678418|3660315|FG001|STARTED|Part A (Double Blind)||124
2947017|NCT00678418|3660314|FG000|COMPLETED|Part A (Double Blind)||67
2947018|NCT00678418|3660315|FG001|COMPLETED|Part A (Double Blind)||47
2947019|NCT00678418|3660314|FG000|NOT COMPLETED|Part A (Double Blind)||59
2947020|NCT00678418|3660315|FG001|NOT COMPLETED|Part A (Double Blind)||77
2947021|NCT00678418|3660314|FG000|STARTED|Part B (Open Label)|All participants who received placebo in Part A were switched to open-label VIVITROL in Part B.|114
2947022|NCT00678418|3660315|FG001|STARTED|Part B (Open Label)||0
2947023|NCT00678418|3660314|FG000|COMPLETED|Part B (Open Label)||71
2947024|NCT00678418|3660315|FG001|COMPLETED|Part B (Open Label)||0
2947025|NCT00678418|3660314|FG000|NOT COMPLETED|Part B (Open Label)||43
2947026|NCT00678418|3660315|FG001|NOT COMPLETED|Part B (Open Label)||0
2947027|NCT00678444|3660323|FG000|STARTED|Overall Study||100
2947028|NCT00678444|3660324|FG001|STARTED|Overall Study||99
2947029|NCT00678444|3660323|FG000|COMPLETED|Overall Study||100
2947030|NCT00678444|3660324|FG001|COMPLETED|Overall Study||99
2947031|NCT00678444|3660323|FG000|NOT COMPLETED|Overall Study||0
2947032|NCT00678444|3660324|FG001|NOT COMPLETED|Overall Study||0
3034750|NCT01133678|3753737|FG001|STARTED|Overall Study||25
3034751|NCT01133678|3753736|FG000|COMPLETED|Overall Study||24
3034752|NCT01133678|3753737|FG001|COMPLETED|Overall Study||24
3034753|NCT01133678|3753736|FG000|NOT COMPLETED|Overall Study||1
3034754|NCT01133678|3753737|FG001|NOT COMPLETED|Overall Study||1
3034755|NCT01133704|3753745|FG000|STARTED|Overall Study||65
3034756|NCT01133704|3753746|FG001|STARTED|Overall Study||33
3034757|NCT01133704|3753745|FG000|COMPLETED|Overall Study|(including 3 year follow-up)|16
3034758|NCT01133704|3753746|FG001|COMPLETED|Overall Study|(including 3 year follow-up)|7
3034759|NCT01133704|3753745|FG000|NOT COMPLETED|Overall Study||49
3034760|NCT01133704|3753746|FG001|NOT COMPLETED|Overall Study||26
3034761|NCT01133756|3753755|FG000|STARTED|Overall Study||2
3034762|NCT01133756|3753756|FG001|STARTED|Overall Study||3
3034763|NCT01133756|3753757|FG002|STARTED|Overall Study||2
3034764|NCT01133756|3753755|FG000|Completed 6 Cycles|Overall Study|One participant completed 6 cycles and remained in the study until 18 Sep 2012.|1
3034765|NCT01133756|3753756|FG001|Completed 6 Cycles|Overall Study||0
3034766|NCT01133756|3753757|FG002|Completed 6 Cycles|Overall Study||0
3034767|NCT01133756|3753755|FG000|COMPLETED|Overall Study||0
3034768|NCT01133756|3753756|FG001|COMPLETED|Overall Study||0
3034769|NCT01133756|3753757|FG002|COMPLETED|Overall Study||0
3034770|NCT01133756|3753755|FG000|NOT COMPLETED|Overall Study||2
3034771|NCT01133756|3753756|FG001|NOT COMPLETED|Overall Study||3
3034772|NCT01133756|3753757|FG002|NOT COMPLETED|Overall Study||2
3034773|NCT01133821|3753767|FG000|STARTED|Overall Study||45
3034774|NCT01133821|3753768|FG001|STARTED|Overall Study||47
3034775|NCT01133821|3753767|FG000|COMPLETED|Overall Study||27
3034776|NCT01133821|3753768|FG001|COMPLETED|Overall Study||28
3034777|NCT01133821|3753767|FG000|NOT COMPLETED|Overall Study||18
3034778|NCT01133821|3753768|FG001|NOT COMPLETED|Overall Study||19
3034779|NCT01133847|3753777|FG000|STARTED|Active Treatment Phase (Weeks 1-16)||78
3034780|NCT01133847|3753778|FG001|STARTED|Active Treatment Phase (Weeks 1-16)||74
3034781|NCT01133847|3753779|FG002|STARTED|Active Treatment Phase (Weeks 1-16)||70
3034782|NCT01133847|3753777|FG000|COMPLETED|Active Treatment Phase (Weeks 1-16)||73
3034783|NCT01133847|3753778|FG001|COMPLETED|Active Treatment Phase (Weeks 1-16)||73
3034784|NCT01133847|3753779|FG002|COMPLETED|Active Treatment Phase (Weeks 1-16)||67
3034785|NCT01133847|3753777|FG000|NOT COMPLETED|Active Treatment Phase (Weeks 1-16)||5
3034786|NCT01133847|3753778|FG001|NOT COMPLETED|Active Treatment Phase (Weeks 1-16)||1
3034787|NCT01133847|3753779|FG002|NOT COMPLETED|Active Treatment Phase (Weeks 1-16)||3
3034788|NCT01133847|3753777|FG000|STARTED|Follow-Up Phase||73
3034789|NCT01133847|3753778|FG001|STARTED|Follow-Up Phase||73
3034790|NCT01133847|3753779|FG002|STARTED|Follow-Up Phase||67
3034791|NCT01133847|3753777|FG000|COMPLETED|Follow-Up Phase||72
3034792|NCT01133847|3753778|FG001|COMPLETED|Follow-Up Phase||70
3034793|NCT01133847|3753779|FG002|COMPLETED|Follow-Up Phase||60
3034794|NCT01133847|3753777|FG000|NOT COMPLETED|Follow-Up Phase||1
3034795|NCT01133847|3753778|FG001|NOT COMPLETED|Follow-Up Phase||3
3034796|NCT01133847|3753779|FG002|NOT COMPLETED|Follow-Up Phase||7
3034797|NCT01133860|3753788|FG000|STARTED|Overall Study||12
3034798|NCT01133860|3753788|FG000|COMPLETED|Overall Study||12
3034799|NCT01133860|3753788|FG000|NOT COMPLETED|Overall Study||0
2947033|NCT00678470|3660330|FG000|STARTED|Overall Study||18
2947034|NCT00678470|3660330|FG000|COMPLETED|Overall Study||14
2947035|NCT00678470|3660330|FG000|NOT COMPLETED|Overall Study||4
2947036|NCT00678496|3660336|FG000|STARTED|Overall Study||12
2947037|NCT00678496|3660337|FG001|STARTED|Overall Study||12
2947038|NCT00678496|3660336|FG000|Completed 8 Weeks Follow-up|Overall Study||9
2947039|NCT00678496|3660337|FG001|Completed 8 Weeks Follow-up|Overall Study||12
2947040|NCT00678496|3660336|FG000|COMPLETED|Overall Study||10
2947041|NCT00678496|3660337|FG001|COMPLETED|Overall Study||8
2947042|NCT00678496|3660336|FG000|NOT COMPLETED|Overall Study||2
2947043|NCT00678496|3660337|FG001|NOT COMPLETED|Overall Study||4
2947044|NCT00678535|3660347|FG000|STARTED|Overall Study|ITT population|455
2947045|NCT00678535|3660348|FG001|STARTED|Overall Study|ITT population|449
2947046|NCT00678535|3660347|FG000|COMPLETED|Overall Study|subjects who died before or at 31 March 2012|362
2947047|NCT00678535|3660348|FG001|COMPLETED|Overall Study|subjects who died before or at 31 March 2012|351
2947048|NCT00678535|3660347|FG000|NOT COMPLETED|Overall Study||93
2947049|NCT00678535|3660348|FG001|NOT COMPLETED|Overall Study||98
2947050|NCT00678561|3660362|FG000|STARTED|Overall Study||6
2947051|NCT00678561|3660363|FG001|STARTED|Overall Study||6
2947052|NCT00678561|3660364|FG002|STARTED|Overall Study||8
2947053|NCT00678561|3660365|FG003|STARTED|Overall Study||4
2947054|NCT00678561|3660366|FG004|STARTED|Overall Study||17
2947055|NCT00678561|3660367|FG005|STARTED|Overall Study||17
2947056|NCT00678561|3660368|FG006|STARTED|Overall Study||15
2947057|NCT00678561|3660369|FG007|STARTED|Overall Study||8
2947058|NCT00678561|3660362|FG000|COMPLETED|Overall Study||6
2947059|NCT00678561|3660363|FG001|COMPLETED|Overall Study||5
2947060|NCT00678561|3660364|FG002|COMPLETED|Overall Study||7
2947061|NCT00678561|3660365|FG003|COMPLETED|Overall Study||4
2947062|NCT00678561|3660366|FG004|COMPLETED|Overall Study||15
2947063|NCT00678561|3660367|FG005|COMPLETED|Overall Study||16
2947064|NCT00678561|3660368|FG006|COMPLETED|Overall Study||15
2947065|NCT00678561|3660369|FG007|COMPLETED|Overall Study||7
2947066|NCT00678561|3660362|FG000|NOT COMPLETED|Overall Study||0
2947067|NCT00678561|3660363|FG001|NOT COMPLETED|Overall Study||1
2947068|NCT00678561|3660364|FG002|NOT COMPLETED|Overall Study||1
2947069|NCT00678561|3660365|FG003|NOT COMPLETED|Overall Study||0
2947070|NCT00678561|3660366|FG004|NOT COMPLETED|Overall Study||2
2947071|NCT00678561|3660367|FG005|NOT COMPLETED|Overall Study||1
2947072|NCT00678561|3660368|FG006|NOT COMPLETED|Overall Study||0
2947073|NCT00678561|3660369|FG007|NOT COMPLETED|Overall Study||1
2947074|NCT00678587|3660396|FG000|STARTED|Overall Study||147
2947075|NCT00678587|3660397|FG001|STARTED|Overall Study||145
2947076|NCT00678587|3660396|FG000|COMPLETED|Overall Study||127
2947077|NCT00678587|3660397|FG001|COMPLETED|Overall Study||127
2947078|NCT00678587|3660396|FG000|NOT COMPLETED|Overall Study||20
2947079|NCT00678587|3660397|FG001|NOT COMPLETED|Overall Study||18
2947080|NCT00678639|3660406|FG000|STARTED|Overall Study||53
2947081|NCT00678639|3660407|FG001|STARTED|Overall Study||57
2947082|NCT00678639|3660406|FG000|Hospital Discharge|Overall Study||53
2947083|NCT00678639|3660407|FG001|Hospital Discharge|Overall Study||57
2947084|NCT00678639|3660406|FG000|COMPLETED|Overall Study||51
2947085|NCT00678639|3660407|FG001|COMPLETED|Overall Study||57
2947086|NCT00678639|3660406|FG000|NOT COMPLETED|Overall Study||2
2947087|NCT00678639|3660407|FG001|NOT COMPLETED|Overall Study||0
2947088|NCT00678652|3660418|FG000|STARTED|Overall Study||9
2947089|NCT00678652|3660419|FG001|STARTED|Overall Study||9
2947090|NCT00678652|3660420|FG002|STARTED|Overall Study||9
2947091|NCT00678652|3660421|FG003|STARTED|Overall Study||9
2947092|NCT00678652|3660418|FG000|COMPLETED|Overall Study||6
2947093|NCT00678652|3660419|FG001|COMPLETED|Overall Study||9
2947094|NCT00678652|3660420|FG002|COMPLETED|Overall Study||8
2947095|NCT00678652|3660421|FG003|COMPLETED|Overall Study||9
2947096|NCT00678652|3660418|FG000|NOT COMPLETED|Overall Study||3
2947097|NCT00678652|3660419|FG001|NOT COMPLETED|Overall Study||0
2947098|NCT00678652|3660420|FG002|NOT COMPLETED|Overall Study||1
2947099|NCT00678652|3660421|FG003|NOT COMPLETED|Overall Study||0
2947100|NCT00678691|3660433|FG000|STARTED|Overall Study||27
2947101|NCT00678691|3660434|FG001|STARTED|Overall Study||28
2947102|NCT00678691|3660433|FG000|COMPLETED|Overall Study||21
2947103|NCT00678691|3660434|FG001|COMPLETED|Overall Study||24
2947104|NCT00678691|3660433|FG000|NOT COMPLETED|Overall Study||6
2947105|NCT00678691|3660434|FG001|NOT COMPLETED|Overall Study||4
2947106|NCT00678795|3660442|FG000|STARTED|Overall Study||67
2947107|NCT00678795|3660443|FG001|STARTED|Overall Study||68
2947108|NCT00678795|3660442|FG000|COMPLETED|Overall Study||56
2947109|NCT00678795|3660443|FG001|COMPLETED|Overall Study||62
2947110|NCT00678795|3660442|FG000|NOT COMPLETED|Overall Study||11
2947111|NCT00678795|3660443|FG001|NOT COMPLETED|Overall Study||6
2947112|NCT00678834|3660452|FG000|STARTED|Overall Study||40
2947113|NCT00678834|3660453|FG001|STARTED|Overall Study||15
2947114|NCT00678834|3660454|FG002|STARTED|Overall Study||25
2947115|NCT00678834|3660452|FG000|COMPLETED|Overall Study||24
2947116|NCT00678834|3660453|FG001|COMPLETED|Overall Study||15
2947117|NCT00678834|3660454|FG002|COMPLETED|Overall Study||16
2947118|NCT00678834|3660452|FG000|NOT COMPLETED|Overall Study||16
2947119|NCT00678834|3660453|FG001|NOT COMPLETED|Overall Study||0
2947120|NCT00678834|3660454|FG002|NOT COMPLETED|Overall Study||9
2947121|NCT00678886|3660474|FG000|STARTED|Overall Study||10
2947122|NCT00678886|3660475|FG001|STARTED|Overall Study||19
2947123|NCT00678886|3660476|FG002|STARTED|Overall Study||81
2947124|NCT00678886|3660477|FG003|STARTED|Overall Study||162
2947125|NCT00678886|3660474|FG000|COMPLETED|Overall Study||10
2947126|NCT00678886|3660475|FG001|COMPLETED|Overall Study||19
2947127|NCT00678886|3660476|FG002|COMPLETED|Overall Study||72
2947128|NCT00678886|3660477|FG003|COMPLETED|Overall Study||153
2947129|NCT00678886|3660474|FG000|NOT COMPLETED|Overall Study||0
2947130|NCT00678886|3660475|FG001|NOT COMPLETED|Overall Study||0
2947131|NCT00678886|3660476|FG002|NOT COMPLETED|Overall Study||9
2947132|NCT00678886|3660477|FG003|NOT COMPLETED|Overall Study||9
2947133|NCT00678899|3660486|FG000|STARTED|Overall Study||50
2947134|NCT00678899|3660486|FG000|COMPLETED|Overall Study||49
2947135|NCT00678899|3660486|FG000|NOT COMPLETED|Overall Study||1
2947136|NCT00679029|3660491|FG000|STARTED|Overall Study||15
2947137|NCT00679029|3660491|FG000|COMPLETED|Overall Study||10
2947138|NCT00679029|3660491|FG000|NOT COMPLETED|Overall Study||5
2947139|NCT00679042|3660495|FG000|STARTED|Transplant + 1 Year Follow Up||21
2947140|NCT00679042|3660495|FG000|COMPLETED|Transplant + 1 Year Follow Up||19
2947141|NCT00679042|3660495|FG000|NOT COMPLETED|Transplant + 1 Year Follow Up||2
2947142|NCT00679042|3660495|FG000|STARTED|5-Year Follow Up||19
2947143|NCT00679042|3660495|FG000|COMPLETED|5-Year Follow Up||5
2947144|NCT00679042|3660495|FG000|NOT COMPLETED|5-Year Follow Up||14
2947145|NCT00679042|3660495|FG000|STARTED|10-Year Follow Up||5
2947146|NCT00679042|3660495|FG000|COMPLETED|10-Year Follow Up||0
2947147|NCT00679042|3660495|FG000|NOT COMPLETED|10-Year Follow Up||5
2947148|NCT00679055|3660501|FG000|STARTED|Overall Study||8
2947149|NCT00679055|3660502|FG001|STARTED|Overall Study||6
2947150|NCT00679055|3660501|FG000|COMPLETED|Overall Study||6
2947151|NCT00679055|3660502|FG001|COMPLETED|Overall Study||1
2947152|NCT00679055|3660501|FG000|NOT COMPLETED|Overall Study||2
2947153|NCT00679055|3660502|FG001|NOT COMPLETED|Overall Study||5
2947154|NCT00679081|3660508|FG000|STARTED|Overall Study|Study design was within-subject control.|15
2947155|NCT00679081|3660508|FG000|COMPLETED|Overall Study||14
2947156|NCT00679081|3660508|FG000|NOT COMPLETED|Overall Study||1
2947157|NCT00679172|3660521|FG000|STARTED|Overall Study||37
2947158|NCT00679172|3660522|FG001|STARTED|Overall Study||38
2947159|NCT00679172|3660523|FG002|STARTED|Overall Study||36
2947160|NCT00679172|3660524|FG003|STARTED|Overall Study||39
2947161|NCT00679172|3660525|FG004|STARTED|Overall Study||37
2947162|NCT00679172|3660521|FG000|COMPLETED|Overall Study||36
2947163|NCT00679172|3660522|FG001|COMPLETED|Overall Study||37
2947164|NCT00679172|3660523|FG002|COMPLETED|Overall Study||35
2947165|NCT00679172|3660524|FG003|COMPLETED|Overall Study||38
2947166|NCT00679172|3660525|FG004|COMPLETED|Overall Study||37
2947167|NCT00679172|3660521|FG000|NOT COMPLETED|Overall Study||1
2947168|NCT00679172|3660522|FG001|NOT COMPLETED|Overall Study||1
2947169|NCT00679172|3660523|FG002|NOT COMPLETED|Overall Study||1
2947170|NCT00679172|3660524|FG003|NOT COMPLETED|Overall Study||1
2947171|NCT00679172|3660525|FG004|NOT COMPLETED|Overall Study||0
2947172|NCT00679211|3660540|FG000|STARTED|Overall Study||110
2947173|NCT00679211|3660540|FG000|COMPLETED|Overall Study||0
2947174|NCT00679211|3660540|FG000|NOT COMPLETED|Overall Study||110
2947175|NCT00679263|3660549|FG000|STARTED|Visit 3/Dose 2||10
2947176|NCT00679263|3660550|FG001|STARTED|Visit 3/Dose 2||11
2947177|NCT00679263|3660551|FG002|STARTED|Visit 3/Dose 2||11
2947178|NCT00679263|3660549|FG000|COMPLETED|Visit 3/Dose 2||9
2947179|NCT00679263|3660550|FG001|COMPLETED|Visit 3/Dose 2||6
2947180|NCT00679263|3660551|FG002|COMPLETED|Visit 3/Dose 2||11
2947181|NCT00679263|3660549|FG000|NOT COMPLETED|Visit 3/Dose 2||1
2947182|NCT00679263|3660550|FG001|NOT COMPLETED|Visit 3/Dose 2||5
2947183|NCT00679263|3660551|FG002|NOT COMPLETED|Visit 3/Dose 2||0
2947184|NCT00679263|3660549|FG000|STARTED|Visit 2/Dose 1||11
2947185|NCT00679263|3660550|FG001|STARTED|Visit 2/Dose 1||6
2947186|NCT00679263|3660551|FG002|STARTED|Visit 2/Dose 1||11
2947187|NCT00679263|3660549|FG000|COMPLETED|Visit 2/Dose 1||9
2947188|NCT00679263|3660550|FG001|COMPLETED|Visit 2/Dose 1||5
2947189|NCT00679263|3660551|FG002|COMPLETED|Visit 2/Dose 1||11
2947190|NCT00679263|3660549|FG000|NOT COMPLETED|Visit 2/Dose 1||2
2947191|NCT00679263|3660550|FG001|NOT COMPLETED|Visit 2/Dose 1||1
2947192|NCT00679263|3660551|FG002|NOT COMPLETED|Visit 2/Dose 1||0
2947193|NCT00679289|3660562|FG000|STARTED|Overall Study||6
2947194|NCT00679289|3660563|FG001|STARTED|Overall Study||6
2947195|NCT00679289|3660564|FG002|STARTED|Overall Study||24
2947196|NCT00679289|3660562|FG000|COMPLETED|Overall Study||1
2947197|NCT00679289|3660563|FG001|COMPLETED|Overall Study||0
2947198|NCT00679289|3660564|FG002|COMPLETED|Overall Study||1
2947199|NCT00679289|3660562|FG000|NOT COMPLETED|Overall Study||5
2947200|NCT00679289|3660563|FG001|NOT COMPLETED|Overall Study||6
2947201|NCT00679289|3660564|FG002|NOT COMPLETED|Overall Study||23
2947202|NCT00679302|3660576|FG000|STARTED|Overall Study||84
2947203|NCT00679302|3660577|FG001|STARTED|Overall Study||77
2947204|NCT00679302|3660576|FG000|COMPLETED|Overall Study||76
2947205|NCT00679302|3660577|FG001|COMPLETED|Overall Study||73
2947206|NCT00679302|3660576|FG000|NOT COMPLETED|Overall Study||8
2947207|NCT00679302|3660577|FG001|NOT COMPLETED|Overall Study||4
2947208|NCT00679341|3660585|FG000|STARTED|Overall Study||67
2947209|NCT00679341|3660586|FG001|STARTED|Overall Study||70
2947210|NCT00679341|3660585|FG000|COMPLETED|Overall Study||14
2947211|NCT00679341|3660586|FG001|COMPLETED|Overall Study||19
2947212|NCT00679341|3660585|FG000|NOT COMPLETED|Overall Study||53
2947213|NCT00679341|3660586|FG001|NOT COMPLETED|Overall Study||51
2947214|NCT00679354|3660593|FG000|STARTED|Overall Study||30
2947215|NCT00679354|3660593|FG000|COMPLETED|Overall Study||0
2947216|NCT00679354|3660593|FG000|NOT COMPLETED|Overall Study||30
2947217|NCT00679367|3660598|FG000|STARTED|Overall Study||16
2947218|NCT00679367|3660598|FG000|COMPLETED|Overall Study||4
2947219|NCT00679367|3660598|FG000|NOT COMPLETED|Overall Study||12
2947220|NCT00679380|3660607|FG000|STARTED|Overall Study||109
2947221|NCT00679380|3660608|FG001|STARTED|Overall Study||109
2947222|NCT00679380|3660609|FG002|STARTED|Overall Study||103
2947223|NCT00679380|3660610|FG003|STARTED|Overall Study||89
2947224|NCT00679380|3660607|FG000|COMPLETED|Overall Study||67
2947225|NCT00679380|3660608|FG001|COMPLETED|Overall Study||76
2947226|NCT00679380|3660609|FG002|COMPLETED|Overall Study||68
2947227|NCT00679380|3660610|FG003|COMPLETED|Overall Study||61
2947228|NCT00679380|3660607|FG000|NOT COMPLETED|Overall Study||42
3163399|NCT01886716|3890932|FG000|STARTED|Week 3||21
3163400|NCT01886716|3890933|FG001|STARTED|Week 3||18
3163401|NCT01886716|3890934|FG002|STARTED|Week 3||19
3163402|NCT01886716|3890935|FG003|STARTED|Week 3||15
3163403|NCT01886716|3890932|FG000|COMPLETED|Week 3||20
3163404|NCT01886716|3890933|FG001|COMPLETED|Week 3||17
2947229|NCT00679380|3660608|FG001|NOT COMPLETED|Overall Study||33
2947230|NCT00679380|3660609|FG002|NOT COMPLETED|Overall Study||35
2947231|NCT00679380|3660610|FG003|NOT COMPLETED|Overall Study||28
2947232|NCT00679432|3660624|FG000|STARTED|Overall Study||126
2947233|NCT00679432|3660625|FG001|STARTED|Overall Study||127
2947234|NCT00679432|3660626|FG002|STARTED|Overall Study||129
2947235|NCT00679432|3660627|FG003|STARTED|Overall Study||127
2947236|NCT00679432|3660624|FG000|COMPLETED|Overall Study||89
2947237|NCT00679432|3660625|FG001|COMPLETED|Overall Study||89
2947238|NCT00679432|3660626|FG002|COMPLETED|Overall Study||76
2947239|NCT00679432|3660627|FG003|COMPLETED|Overall Study||95
2947240|NCT00679432|3660624|FG000|NOT COMPLETED|Overall Study||37
2947241|NCT00679432|3660625|FG001|NOT COMPLETED|Overall Study||38
2947242|NCT00679432|3660626|FG002|NOT COMPLETED|Overall Study||53
2947243|NCT00679432|3660627|FG003|NOT COMPLETED|Overall Study||32
2947244|NCT00679549|3660639|FG000|STARTED|Overall Study||75
2947245|NCT00679549|3660640|FG001|STARTED|Overall Study||75
2947246|NCT00679549|3660639|FG000|COMPLETED|Overall Study||69
2947247|NCT00679549|3660640|FG001|COMPLETED|Overall Study|4 dropouts in the control arm; 5 missing echocardiograms in the control arm|66
2947248|NCT00679549|3660639|FG000|NOT COMPLETED|Overall Study||6
2947249|NCT00679549|3660640|FG001|NOT COMPLETED|Overall Study||9
2947250|NCT00679627|3660648|FG000|STARTED|Overall Study||1021
2947251|NCT00679627|3660649|FG001|STARTED|Overall Study||1024
2947252|NCT00679627|3660648|FG000|COMPLETED|Overall Study||322
2947253|NCT00679627|3660649|FG001|COMPLETED|Overall Study||339
2947254|NCT00679627|3660648|FG000|NOT COMPLETED|Overall Study||699
2947255|NCT00679627|3660649|FG001|NOT COMPLETED|Overall Study||685
2947256|NCT00679783|3660662|FG000|STARTED|Overall Study|Gave Informed consent and passed screening|4
2947257|NCT00679783|3660663|FG001|STARTED|Overall Study|Gave Informed consent and passed screening|13
2947258|NCT00679783|3660664|FG002|STARTED|Overall Study|Gave Informed consent and passed screening|3
2947259|NCT00679783|3660665|FG003|STARTED|Overall Study|Gave Informed consent and passed screening|45
2947260|NCT00679783|3660666|FG004|STARTED|Overall Study|Gave Informed consent and passed screening|5
2947261|NCT00679783|3660667|FG005|STARTED|Overall Study|Gave Informed consent and passed screening|5
2947262|NCT00679783|3660668|FG006|STARTED|Overall Study|Gave Informed consent and passed screening|16
2947263|NCT00679783|3660662|FG000|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|2
2947264|NCT00679783|3660663|FG001|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|10
2947265|NCT00679783|3660664|FG002|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|2
2947266|NCT00679783|3660665|FG003|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|25
2947267|NCT00679783|3660666|FG004|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|4
2947268|NCT00679783|3660667|FG005|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|5
2947269|NCT00679783|3660668|FG006|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|15
2947270|NCT00679783|3660662|FG000|NOT COMPLETED|Overall Study||2
2947271|NCT00679783|3660663|FG001|NOT COMPLETED|Overall Study||3
2947272|NCT00679783|3660664|FG002|NOT COMPLETED|Overall Study||1
2947273|NCT00679783|3660665|FG003|NOT COMPLETED|Overall Study||20
2947274|NCT00679783|3660666|FG004|NOT COMPLETED|Overall Study||1
2947275|NCT00679783|3660667|FG005|NOT COMPLETED|Overall Study||0
2947276|NCT00679783|3660668|FG006|NOT COMPLETED|Overall Study||1
2947277|NCT00679913|3660686|FG000|STARTED|Overall Study||101
2947278|NCT00679913|3660687|FG001|STARTED|Overall Study||99
2947279|NCT00679913|3660686|FG000|COMPLETED|Overall Study||83
2947280|NCT00679913|3660687|FG001|COMPLETED|Overall Study||86
2947281|NCT00679913|3660686|FG000|NOT COMPLETED|Overall Study||18
2947282|NCT00679913|3660687|FG001|NOT COMPLETED|Overall Study||13
2947283|NCT00679939|3660696|FG000|STARTED|52-Week Double-Blind (DB) Period||114
2947284|NCT00679939|3660697|FG001|STARTED|52-Week Double-Blind (DB) Period||112
2947285|NCT00679939|3660696|FG000|COMPLETED|52-Week Double-Blind (DB) Period||77
2947286|NCT00679939|3660697|FG001|COMPLETED|52-Week Double-Blind (DB) Period||85
2947287|NCT00679939|3660696|FG000|NOT COMPLETED|52-Week Double-Blind (DB) Period||37
2947288|NCT00679939|3660697|FG001|NOT COMPLETED|52-Week Double-Blind (DB) Period||27
2947289|NCT00679939|3660696|FG000|STARTED|24-Week Open-Label (OL) Period|One participant who completed the DB Period did not receive the OL dose of MET.|76
3034800|NCT01133977|3753798|FG000|STARTED|Overall Study|Treated|3
3163405|NCT01886716|3890934|FG002|COMPLETED|Week 3||19
3163406|NCT01886716|3890935|FG003|COMPLETED|Week 3||14
2947290|NCT00679939|3660697|FG001|STARTED|24-Week Open-Label (OL) Period|One participant who completed the DB Period did not receive the OL dose of MET.|84
2947291|NCT00679939|3660696|FG000|COMPLETED|24-Week Open-Label (OL) Period||69
2947292|NCT00679939|3660697|FG001|COMPLETED|24-Week Open-Label (OL) Period||80
2947293|NCT00679939|3660696|FG000|NOT COMPLETED|24-Week Open-Label (OL) Period||7
2947294|NCT00679939|3660697|FG001|NOT COMPLETED|24-Week Open-Label (OL) Period||4
2947295|NCT00679952|3660709|FG000|STARTED|Overall Study||86
2947296|NCT00679952|3660710|FG001|STARTED|Overall Study||82
2947297|NCT00679952|3660709|FG000|COMPLETED|Overall Study||86
2947298|NCT00679952|3660710|FG001|COMPLETED|Overall Study||82
2947299|NCT00679952|3660709|FG000|NOT COMPLETED|Overall Study||0
2947300|NCT00679952|3660710|FG001|NOT COMPLETED|Overall Study||0
2947301|NCT00680017|3660718|FG000|STARTED|Overall Study||140
2947302|NCT00680017|3660719|FG001|STARTED|Overall Study||140
2947303|NCT00680017|3660718|FG000|COMPLETED|Overall Study||123
2947304|NCT00680017|3660719|FG001|COMPLETED|Overall Study||128
2947305|NCT00680017|3660718|FG000|NOT COMPLETED|Overall Study||17
2947306|NCT00680017|3660719|FG001|NOT COMPLETED|Overall Study||12
2947307|NCT00680043|3660728|FG000|STARTED|Overall Study||39
2947308|NCT00680043|3660729|FG001|STARTED|Overall Study||37
2947309|NCT00680043|3660730|FG002|STARTED|Overall Study||38
2947310|NCT00680043|3660728|FG000|COMPLETED|Overall Study||37
2947311|NCT00680043|3660729|FG001|COMPLETED|Overall Study||36
3298829|NCT02927834|4032578|FG002|NOT COMPLETED|Overall Study||2
3298830|NCT02927873|4032592|FG000|STARTED|Overall Study||11
3298831|NCT02927873|4032593|FG001|STARTED|Overall Study||14
3298832|NCT02927873|4032594|FG002|STARTED|Overall Study||18
3298833|NCT02927873|4032595|FG003|STARTED|Overall Study||11
3298834|NCT02927873|4032596|FG004|STARTED|Overall Study||11
3298835|NCT02927873|4032597|FG005|STARTED|Overall Study||17
3298836|NCT02927873|4032592|FG000|COMPLETED|Overall Study||9
2947312|NCT00680043|3660730|FG002|COMPLETED|Overall Study||34
2947313|NCT00680043|3660728|FG000|NOT COMPLETED|Overall Study||2
2947314|NCT00680043|3660729|FG001|NOT COMPLETED|Overall Study||1
2947315|NCT00680043|3660730|FG002|NOT COMPLETED|Overall Study||4
2947316|NCT00680056|3660740|FG000|STARTED|First Intervention||16
2947317|NCT00680056|3660741|FG001|STARTED|First Intervention||17
2947318|NCT00680056|3660740|FG000|COMPLETED|First Intervention||15
2947319|NCT00680056|3660741|FG001|COMPLETED|First Intervention||15
2947320|NCT00680056|3660740|FG000|NOT COMPLETED|First Intervention||1
2947321|NCT00680056|3660741|FG001|NOT COMPLETED|First Intervention||2
2947322|NCT00680056|3660740|FG000|STARTED|Washout Period of One Week||15
2947323|NCT00680056|3660741|FG001|STARTED|Washout Period of One Week||15
2947324|NCT00680056|3660740|FG000|COMPLETED|Washout Period of One Week||15
2947325|NCT00680056|3660741|FG001|COMPLETED|Washout Period of One Week||15
2947326|NCT00680056|3660740|FG000|NOT COMPLETED|Washout Period of One Week||0
2947327|NCT00680056|3660741|FG001|NOT COMPLETED|Washout Period of One Week||0
2947328|NCT00680056|3660740|FG000|STARTED|Second Intervention||15
2947329|NCT00680056|3660741|FG001|STARTED|Second Intervention||15
2947330|NCT00680056|3660740|FG000|COMPLETED|Second Intervention||12
2947331|NCT00680056|3660741|FG001|COMPLETED|Second Intervention||14
2947332|NCT00680056|3660740|FG000|NOT COMPLETED|Second Intervention||3
2947333|NCT00680056|3660741|FG001|NOT COMPLETED|Second Intervention||1
2947334|NCT00680121|3660750|FG000|STARTED|Overall Study||60
2947335|NCT00680121|3660751|FG001|STARTED|Overall Study||60
2947336|NCT00680121|3660750|FG000|COMPLETED|Overall Study||33
2947337|NCT00680121|3660751|FG001|COMPLETED|Overall Study||37
2947338|NCT00680121|3660750|FG000|NOT COMPLETED|Overall Study||27
2947339|NCT00680121|3660751|FG001|NOT COMPLETED|Overall Study||23
2947340|NCT00680186|3660759|FG000|STARTED|Overall Study|Started treatment.|1280
2947341|NCT00680186|3660760|FG001|STARTED|Overall Study|Started treatment.|1288
2947342|NCT00680186|3660759|FG000|COMPLETED|Overall Study|Completed planned observation time.|1155
2947343|NCT00680186|3660760|FG001|COMPLETED|Overall Study|Completed planned observation time.|1172
2947344|NCT00680186|3660759|FG000|NOT COMPLETED|Overall Study||125
2947345|NCT00680186|3660760|FG001|NOT COMPLETED|Overall Study||116
2947346|NCT00680225|3660766|FG000|STARTED|Overall Study||10
2947347|NCT00680225|3660766|FG000|COMPLETED|Overall Study||8
2947348|NCT00680225|3660766|FG000|NOT COMPLETED|Overall Study||2
2947349|NCT00680368|3660770|FG000|STARTED|Overall Study||112
2947350|NCT00680368|3660770|FG000|COMPLETED|Overall Study|15 residents excluded because their attending physician was not participating in the study|97
2947351|NCT00680368|3660770|FG000|NOT COMPLETED|Overall Study||15
2947352|NCT00680407|3660779|FG000|STARTED|Overall Study||26
2947353|NCT00680407|3660780|FG001|STARTED|Overall Study||27
2947354|NCT00680407|3660781|FG002|STARTED|Overall Study||25
2947355|NCT00680407|3660779|FG000|COMPLETED|Overall Study||18
2947356|NCT00680407|3660780|FG001|COMPLETED|Overall Study||22
2947357|NCT00680407|3660781|FG002|COMPLETED|Overall Study||22
2947358|NCT00680407|3660779|FG000|NOT COMPLETED|Overall Study||8
2947359|NCT00680407|3660780|FG001|NOT COMPLETED|Overall Study||5
2947360|NCT00680407|3660781|FG002|NOT COMPLETED|Overall Study||3
2947361|NCT00680459|3660791|FG000|STARTED|Overall Study||7
2947362|NCT00680459|3660792|FG001|STARTED|Overall Study||6
2947363|NCT00680459|3660791|FG000|COMPLETED|Overall Study||7
2947364|NCT00680459|3660792|FG001|COMPLETED|Overall Study||6
2947365|NCT00680459|3660791|FG000|NOT COMPLETED|Overall Study||0
2947366|NCT00680459|3660792|FG001|NOT COMPLETED|Overall Study||0
2947367|NCT00680524|3660798|FG000|STARTED|Overall Study||20
2947368|NCT00680524|3660798|FG000|COMPLETED|Overall Study||17
2947369|NCT00680524|3660798|FG000|NOT COMPLETED|Overall Study||3
2947370|NCT00680628|3660804|FG000|STARTED|Overall Study||43
2947371|NCT00680628|3660805|FG001|STARTED|Overall Study||40
2947372|NCT00680628|3660804|FG000|COMPLETED|Overall Study||43
2947373|NCT00680628|3660805|FG001|COMPLETED|Overall Study||40
2947374|NCT00680628|3660804|FG000|NOT COMPLETED|Overall Study||0
2947375|NCT00680628|3660805|FG001|NOT COMPLETED|Overall Study||0
2947376|NCT00680706|3660813|FG000|STARTED|Overall Study||70
2947377|NCT00680706|3660814|FG001|STARTED|Overall Study||60
2947378|NCT00680706|3660813|FG000|COMPLETED|Overall Study||63
2947379|NCT00680706|3660814|FG001|COMPLETED|Overall Study||55
2947380|NCT00680706|3660813|FG000|NOT COMPLETED|Overall Study||7
2947381|NCT00680706|3660814|FG001|NOT COMPLETED|Overall Study||5
2947382|NCT00680745|3660824|FG000|STARTED|Overall Study|Safety Analysis Set|154
2947383|NCT00680745|3660825|FG001|STARTED|Overall Study|Safety Analysis Set|145
2947384|NCT00680745|3660826|FG002|STARTED|Overall Study|Safety Analysis Set|151
2947385|NCT00680745|3660827|FG003|STARTED|Overall Study|Safety Analysis Set|146
2947386|NCT00680745|3660824|FG000|COMPLETED|Overall Study||140
2947387|NCT00680745|3660825|FG001|COMPLETED|Overall Study||132
2947388|NCT00680745|3660826|FG002|COMPLETED|Overall Study||141
2947389|NCT00680745|3660827|FG003|COMPLETED|Overall Study||133
2947390|NCT00680745|3660824|FG000|NOT COMPLETED|Overall Study||14
2947391|NCT00680745|3660825|FG001|NOT COMPLETED|Overall Study||13
2947392|NCT00680745|3660826|FG002|NOT COMPLETED|Overall Study||10
2947393|NCT00680745|3660827|FG003|NOT COMPLETED|Overall Study||13
2947394|NCT00680771|3660840|FG000|STARTED|Overall Study||15
2947395|NCT00680771|3660841|FG001|STARTED|Overall Study||13
2947396|NCT00680771|3660840|FG000|COMPLETED|Overall Study||9
2947397|NCT00680771|3660841|FG001|COMPLETED|Overall Study||11
2947398|NCT00680771|3660840|FG000|NOT COMPLETED|Overall Study||6
2947399|NCT00680771|3660841|FG001|NOT COMPLETED|Overall Study||2
2947400|NCT00680797|3660851|FG000|STARTED|Overall Study||9
2947401|NCT00680797|3660852|FG001|STARTED|Overall Study||8
2947402|NCT00680797|3660853|FG002|STARTED|Overall Study||8
2947403|NCT00680797|3660854|FG003|STARTED|Overall Study||8
2947404|NCT00680797|3660851|FG000|COMPLETED|Overall Study||9
2947405|NCT00680797|3660852|FG001|COMPLETED|Overall Study||8
2947406|NCT00680797|3660853|FG002|COMPLETED|Overall Study||8
2947407|NCT00680797|3660854|FG003|COMPLETED|Overall Study||8
2947408|NCT00680797|3660851|FG000|NOT COMPLETED|Overall Study||0
2947409|NCT00680797|3660852|FG001|NOT COMPLETED|Overall Study||0
2947410|NCT00680797|3660853|FG002|NOT COMPLETED|Overall Study||0
2947411|NCT00680797|3660854|FG003|NOT COMPLETED|Overall Study||0
2947412|NCT00680823|3660867|FG000|STARTED|Overall Study||50
2947413|NCT00680823|3660868|FG001|STARTED|Overall Study||50
2947414|NCT00680823|3660869|FG002|STARTED|Overall Study||50
2947415|NCT00680823|3660867|FG000|COMPLETED|Overall Study||50
2947416|NCT00680823|3660868|FG001|COMPLETED|Overall Study||50
2947417|NCT00680823|3660869|FG002|COMPLETED|Overall Study||50
2947418|NCT00680823|3660867|FG000|NOT COMPLETED|Overall Study||0
2947419|NCT00680823|3660868|FG001|NOT COMPLETED|Overall Study||0
2947420|NCT00680823|3660869|FG002|NOT COMPLETED|Overall Study||0
2947421|NCT00680836|3660879|FG000|STARTED|Overall Study||27
2947422|NCT00680836|3660880|FG001|STARTED|Overall Study||27
2947423|NCT00680836|3660879|FG000|COMPLETED|Overall Study||19
2947424|NCT00680836|3660880|FG001|COMPLETED|Overall Study||25
2947425|NCT00680836|3660879|FG000|NOT COMPLETED|Overall Study||8
2947426|NCT00680836|3660880|FG001|NOT COMPLETED|Overall Study||2
2947427|NCT00680862|3660887|FG000|STARTED|Overall Study||25
2947428|NCT00680862|3660887|FG000|COMPLETED|Overall Study||25
2947429|NCT00680862|3660887|FG000|NOT COMPLETED|Overall Study||0
2947430|NCT00680901|3660893|FG000|STARTED|Overall Study||272
2947431|NCT00680901|3660894|FG001|STARTED|Overall Study||273
2947432|NCT00680901|3660893|FG000|Ongoing: On Study Treatment|Overall Study||16
2947433|NCT00680901|3660894|FG001|Ongoing: On Study Treatment|Overall Study||13
2947434|NCT00680901|3660893|FG000|Ongoing: In Follow Up|Overall Study||45
2947435|NCT00680901|3660894|FG001|Ongoing: In Follow Up|Overall Study||41
2947436|NCT00680901|3660893|FG000|COMPLETED|Overall Study||199
2947437|NCT00680901|3660894|FG001|COMPLETED|Overall Study||197
2947438|NCT00680901|3660893|FG000|NOT COMPLETED|Overall Study||73
2947439|NCT00680901|3660894|FG001|NOT COMPLETED|Overall Study||76
2947440|NCT00680914|3660902|FG000|STARTED|Overall Study||374
2947441|NCT00680914|3660903|FG001|STARTED|Overall Study||129
2947442|NCT00680914|3660902|FG000|COMPLETED|Overall Study||364
2947443|NCT00680914|3660903|FG001|COMPLETED|Overall Study||125
2947444|NCT00680914|3660902|FG000|NOT COMPLETED|Overall Study||10
2947445|NCT00680914|3660903|FG001|NOT COMPLETED|Overall Study||4
2947446|NCT00680953|3660912|FG000|STARTED|Overall Study||500
2947447|NCT00680953|3660913|FG001|STARTED|Overall Study||511
2947448|NCT00680953|3660914|FG002|STARTED|Overall Study||251
2947449|NCT00680953|3660912|FG000|COMPLETED|Overall Study||414
2947450|NCT00680953|3660913|FG001|COMPLETED|Overall Study||416
2947451|NCT00680953|3660914|FG002|COMPLETED|Overall Study||204
2947452|NCT00680953|3660912|FG000|NOT COMPLETED|Overall Study||86
2947453|NCT00680953|3660913|FG001|NOT COMPLETED|Overall Study||95
2947454|NCT00680953|3660914|FG002|NOT COMPLETED|Overall Study||47
2947455|NCT00680992|3660925|FG000|STARTED|Overall Study||268
2947456|NCT00680992|3660926|FG001|STARTED|Overall Study||252
2947457|NCT00680992|3660927|FG002|STARTED|Overall Study||12
2947458|NCT00680992|3660925|FG000|Safety Analysis Set|Overall Study||265
2947459|NCT00680992|3660926|FG001|Safety Analysis Set|Overall Study||249
2947460|NCT00680992|3660927|FG002|Safety Analysis Set|Overall Study||12
2947461|NCT00680992|3660925|FG000|Efficacy Analysis Set|Overall Study||260
2947462|NCT00680992|3660926|FG001|Efficacy Analysis Set|Overall Study||242
2947463|NCT00680992|3660927|FG002|Efficacy Analysis Set|Overall Study||11
2947464|NCT00680992|3660925|FG000|COMPLETED|Overall Study||0
2947465|NCT00680992|3660926|FG001|COMPLETED|Overall Study||0
2947466|NCT00680992|3660927|FG002|COMPLETED|Overall Study||0
2947467|NCT00680992|3660925|FG000|NOT COMPLETED|Overall Study||268
2947468|NCT00680992|3660926|FG001|NOT COMPLETED|Overall Study||252
2947469|NCT00680992|3660927|FG002|NOT COMPLETED|Overall Study||12
2947470|NCT00681031|3660936|FG000|STARTED|Overall Study||96
2947471|NCT00681031|3660936|FG000|COMPLETED|Overall Study||96
2947472|NCT00681031|3660936|FG000|NOT COMPLETED|Overall Study||0
2947473|NCT00681083|3660940|FG000|STARTED|Night 1|26 participants were initially consented (this is the total for the study).|13
2947474|NCT00681083|3660941|FG001|STARTED|Night 1|26 participants were initially consented (this is the total for the study).|13
2947475|NCT00681083|3660940|FG000|COMPLETED|Night 1|20 in total completed study. 10 randomized to arm 1 and arm 2 then crossed over to other arm.|10
2947476|NCT00681083|3660941|FG001|COMPLETED|Night 1|20 in total completed study. 10 randomized to arm 1 and arm 2 then crossed over to other arm.|10
2947477|NCT00681083|3660940|FG000|NOT COMPLETED|Night 1||3
2947478|NCT00681083|3660941|FG001|NOT COMPLETED|Night 1||3
2947479|NCT00681083|3660940|FG000|STARTED|Night 2 (Crossover of Night 1)||10
2947480|NCT00681083|3660941|FG001|STARTED|Night 2 (Crossover of Night 1)||10
2947481|NCT00681083|3660940|FG000|COMPLETED|Night 2 (Crossover of Night 1)||10
2947482|NCT00681083|3660941|FG001|COMPLETED|Night 2 (Crossover of Night 1)||10
2947483|NCT00681083|3660940|FG000|NOT COMPLETED|Night 2 (Crossover of Night 1)||0
2947484|NCT00681083|3660941|FG001|NOT COMPLETED|Night 2 (Crossover of Night 1)||0
2947485|NCT00681109|3660950|FG000|STARTED|Overall Study||30
2947486|NCT00681109|3660951|FG001|STARTED|Overall Study||30
2947487|NCT00681109|3660952|FG002|STARTED|Overall Study||15
2947488|NCT00681109|3660950|FG000|COMPLETED|Overall Study||28
2947489|NCT00681109|3660951|FG001|COMPLETED|Overall Study||24
2947490|NCT00681109|3660952|FG002|COMPLETED|Overall Study||15
2947491|NCT00681109|3660950|FG000|NOT COMPLETED|Overall Study||2
2947492|NCT00681109|3660951|FG001|NOT COMPLETED|Overall Study||6
2947493|NCT00681109|3660952|FG002|NOT COMPLETED|Overall Study||0
2947494|NCT00681187|3660965|FG000|STARTED|Overall Study||11
2947495|NCT00681187|3660966|FG001|STARTED|Overall Study||15
2947496|NCT00681187|3660965|FG000|COMPLETED|Overall Study||10
2947497|NCT00681187|3660966|FG001|COMPLETED|Overall Study||13
2947498|NCT00681187|3660965|FG000|NOT COMPLETED|Overall Study||1
2947499|NCT00681187|3660966|FG001|NOT COMPLETED|Overall Study||2
2947500|NCT00681265|3660985|FG000|STARTED|Overall Study||16
2947501|NCT00681265|3660985|FG000|COMPLETED|Overall Study||16
2947502|NCT00681265|3660985|FG000|NOT COMPLETED|Overall Study||0
2947503|NCT00681291|3660993|FG000|STARTED|Overall Study||88
2947504|NCT00681291|3660994|FG001|STARTED|Overall Study||84
2947505|NCT00681291|3660993|FG000|COMPLETED|Overall Study||75
2947506|NCT00681291|3660994|FG001|COMPLETED|Overall Study||57
2947507|NCT00681291|3660993|FG000|NOT COMPLETED|Overall Study||13
2947508|NCT00681291|3660994|FG001|NOT COMPLETED|Overall Study||27
2947509|NCT00681473|3661000|FG000|STARTED|Overall Study|20 patients with WHO Grade 2 Glioma were enrolled.|20
2947510|NCT00681473|3661000|FG000|COMPLETED|Overall Study|All 20 patients completed RT and tolerated treatment well.|20
2947511|NCT00681473|3661000|FG000|NOT COMPLETED|Overall Study||0
2947512|NCT00681538|3661006|FG000|STARTED|Phase A- 4 Weeks Single Blind||572
2947513|NCT00681538|3661007|FG001|STARTED|Phase A- 4 Weeks Single Blind||0
2947514|NCT00681538|3661006|FG000|COMPLETED|Phase A- 4 Weeks Single Blind||538
2947515|NCT00681538|3661007|FG001|COMPLETED|Phase A- 4 Weeks Single Blind||0
2947516|NCT00681538|3661006|FG000|NOT COMPLETED|Phase A- 4 Weeks Single Blind||34
2947517|NCT00681538|3661007|FG001|NOT COMPLETED|Phase A- 4 Weeks Single Blind||0
2947518|NCT00681538|3661006|FG000|STARTED|Phase B- Responders;12 Week Double-blind||124
2947519|NCT00681538|3661007|FG001|STARTED|Phase B- Responders;12 Week Double-blind||117
2947520|NCT00681538|3661006|FG000|COMPLETED|Phase B- Responders;12 Week Double-blind||109
2947521|NCT00681538|3661007|FG001|COMPLETED|Phase B- Responders;12 Week Double-blind||115
2947522|NCT00681538|3661006|FG000|NOT COMPLETED|Phase B- Responders;12 Week Double-blind||15
2947523|NCT00681538|3661007|FG001|NOT COMPLETED|Phase B- Responders;12 Week Double-blind||2
2947524|NCT00681564|3661015|FG000|STARTED|Overall Study||47
2947525|NCT00681564|3661016|FG001|STARTED|Overall Study||55
2947526|NCT00681564|3661015|FG000|COMPLETED|Overall Study||41
2947527|NCT00681564|3661016|FG001|COMPLETED|Overall Study||47
2947528|NCT00681564|3661015|FG000|NOT COMPLETED|Overall Study||6
2947529|NCT00681564|3661016|FG001|NOT COMPLETED|Overall Study||8
2947530|NCT00681590|3661024|FG000|STARTED|Overall Study||34
2947531|NCT00681590|3661025|FG001|STARTED|Overall Study||71
2947532|NCT00681590|3661024|FG000|COMPLETED|Overall Study||32
2947533|NCT00681590|3661025|FG001|COMPLETED|Overall Study||59
2947534|NCT00681590|3661024|FG000|NOT COMPLETED|Overall Study||2
2947535|NCT00681590|3661025|FG001|NOT COMPLETED|Overall Study||12
2947536|NCT00681668|3661031|FG000|STARTED|Overall Study||5
2947537|NCT00681668|3661031|FG000|COMPLETED|Overall Study||3
2947538|NCT00681668|3661031|FG000|NOT COMPLETED|Overall Study||2
2947539|NCT00681811|3661037|FG000|STARTED|Overall Study||6
2947540|NCT00681811|3661038|FG001|STARTED|Overall Study||5
2947541|NCT00681811|3661037|FG000|COMPLETED|Overall Study||3
2947542|NCT00681811|3661038|FG001|COMPLETED|Overall Study||1
2947543|NCT00681811|3661037|FG000|NOT COMPLETED|Overall Study||3
2947544|NCT00681811|3661038|FG001|NOT COMPLETED|Overall Study||4
2947545|NCT00681824|3661058|FG000|STARTED|Overall Study||28
2947546|NCT00681824|3661059|FG001|STARTED|Overall Study||13
2947547|NCT00681824|3661060|FG002|STARTED|Overall Study||34
2947548|NCT00681824|3661058|FG000|COMPLETED|Overall Study||27
2947549|NCT00681824|3661059|FG001|COMPLETED|Overall Study||12
2947550|NCT00681824|3661060|FG002|COMPLETED|Overall Study||33
2947551|NCT00681824|3661058|FG000|NOT COMPLETED|Overall Study||1
3132465|NCT01691326|3857515|FG000|STARTED|Overall Study||30
3132466|NCT01691326|3857516|FG001|STARTED|Overall Study||30
3132467|NCT01691326|3857515|FG000|COMPLETED|Overall Study||30
3132468|NCT01691326|3857516|FG001|COMPLETED|Overall Study||30
3132469|NCT01691326|3857515|FG000|NOT COMPLETED|Overall Study||0
3132470|NCT01691326|3857516|FG001|NOT COMPLETED|Overall Study||0
3132471|NCT01691339|3857528|FG000|STARTED|Overall Study||50
3132472|NCT01691339|3857529|FG001|STARTED|Overall Study||50
3132473|NCT01691339|3857530|FG002|STARTED|Overall Study||51
3132474|NCT01691339|3857531|FG003|STARTED|Overall Study||49
3132475|NCT01691339|3857528|FG000|COMPLETED|Overall Study||50
3132476|NCT01691339|3857529|FG001|COMPLETED|Overall Study||50
2947552|NCT00681824|3661059|FG001|NOT COMPLETED|Overall Study||1
2947553|NCT00681824|3661060|FG002|NOT COMPLETED|Overall Study||1
2947554|NCT00681863|3661068|FG000|STARTED|Overall Study||45
2947555|NCT00681863|3661068|FG000|COMPLETED|Overall Study||22
2947556|NCT00681863|3661068|FG000|NOT COMPLETED|Overall Study||23
2947557|NCT00681889|3661072|FG000|STARTED|Overall Study||9
2947558|NCT00681889|3661072|FG000|COMPLETED|Overall Study||9
2947559|NCT00681889|3661072|FG000|NOT COMPLETED|Overall Study||0
2947560|NCT00682357|3661079|FG000|STARTED|Overall Study||10
2947561|NCT00682357|3661080|FG001|STARTED|Overall Study||10
2947562|NCT00682357|3661081|FG002|STARTED|Overall Study||5
2947563|NCT00682357|3661079|FG000|COMPLETED|Overall Study||10
2947564|NCT00682357|3661080|FG001|COMPLETED|Overall Study||10
2947565|NCT00682357|3661081|FG002|COMPLETED|Overall Study||5
2947566|NCT00682357|3661079|FG000|NOT COMPLETED|Overall Study||0
2947567|NCT00682357|3661080|FG001|NOT COMPLETED|Overall Study||0
2947568|NCT00682357|3661081|FG002|NOT COMPLETED|Overall Study||0
2947569|NCT00682435|3661089|FG000|STARTED|Overall Study||230
2947570|NCT00682435|3661089|FG000|Ensured Enrolled Only Once|Overall Study||228
2947571|NCT00682435|3661089|FG000|Sufficient Data to Carry Out Analysis|Overall Study||223
2947572|NCT00682435|3661089|FG000|COMPLETED|Overall Study||223
2947573|NCT00682435|3661089|FG000|NOT COMPLETED|Overall Study||7
2947574|NCT00682448|3661095|FG000|STARTED|Overall Study||12
2947575|NCT00682448|3661096|FG001|STARTED|Overall Study||13
2947576|NCT00682448|3661095|FG000|COMPLETED|Overall Study||7
2947577|NCT00682448|3661096|FG001|COMPLETED|Overall Study||7
2947578|NCT00682448|3661095|FG000|NOT COMPLETED|Overall Study||5
2947579|NCT00682448|3661096|FG001|NOT COMPLETED|Overall Study||6
2947580|NCT00682461|3661104|FG000|STARTED|Overall Study||100
2947581|NCT00682461|3661105|FG001|STARTED|Overall Study||100
2947582|NCT00682461|3661104|FG000|COMPLETED|Overall Study||75
2947583|NCT00682461|3661105|FG001|COMPLETED|Overall Study||69
2947584|NCT00682461|3661104|FG000|NOT COMPLETED|Overall Study||25
2947585|NCT00682461|3661105|FG001|NOT COMPLETED|Overall Study||31
2947586|NCT00682539|3661115|FG000|STARTED|Bevacizumab vs Triamcinolone||18
2947587|NCT00682539|3661116|FG001|STARTED|Bevacizumab vs Triamcinolone||16
2947588|NCT00682539|3661117|FG002|STARTED|Bevacizumab vs Triamcinolone||0
2947589|NCT00682539|3661115|FG000|COMPLETED|Bevacizumab vs Triamcinolone||15
2947590|NCT00682539|3661116|FG001|COMPLETED|Bevacizumab vs Triamcinolone||15
2947591|NCT00682539|3661117|FG002|COMPLETED|Bevacizumab vs Triamcinolone||0
2947592|NCT00682539|3661115|FG000|NOT COMPLETED|Bevacizumab vs Triamcinolone||3
2947593|NCT00682539|3661116|FG001|NOT COMPLETED|Bevacizumab vs Triamcinolone||1
2947594|NCT00682539|3661117|FG002|NOT COMPLETED|Bevacizumab vs Triamcinolone||0
2947595|NCT00682539|3661115|FG000|STARTED|Ranibizumab vs Triamcinolone|Two independent periods.|0
2947596|NCT00682539|3661116|FG001|STARTED|Ranibizumab vs Triamcinolone|None of the patients of the 1st period was included in the second period.|18
2947597|NCT00682539|3661117|FG002|STARTED|Ranibizumab vs Triamcinolone|Both periods recruited independently following the same criteria.|18
2947598|NCT00682539|3661115|FG000|COMPLETED|Ranibizumab vs Triamcinolone||0
2947599|NCT00682539|3661116|FG001|COMPLETED|Ranibizumab vs Triamcinolone||15
2947600|NCT00682539|3661117|FG002|COMPLETED|Ranibizumab vs Triamcinolone||10
2947601|NCT00682539|3661115|FG000|NOT COMPLETED|Ranibizumab vs Triamcinolone||0
2947602|NCT00682539|3661116|FG001|NOT COMPLETED|Ranibizumab vs Triamcinolone||3
2947603|NCT00682539|3661117|FG002|NOT COMPLETED|Ranibizumab vs Triamcinolone||8
2947604|NCT00682565|3661128|FG000|STARTED|Overall Study||31
2947605|NCT00682565|3661129|FG001|STARTED|Overall Study||35
2947606|NCT00682565|3661130|FG002|STARTED|Overall Study||29
2947607|NCT00682565|3661128|FG000|COMPLETED|Overall Study||30
2947608|NCT00682565|3661129|FG001|COMPLETED|Overall Study||32
2947609|NCT00682565|3661130|FG002|COMPLETED|Overall Study||29
2947610|NCT00682565|3661128|FG000|NOT COMPLETED|Overall Study||1
2947611|NCT00682565|3661129|FG001|NOT COMPLETED|Overall Study||3
2947612|NCT00682565|3661130|FG002|NOT COMPLETED|Overall Study||0
2947613|NCT00682617|3661141|FG000|STARTED|Overall Study||13
2947614|NCT00682617|3661142|FG001|STARTED|Overall Study||28
2947615|NCT00682617|3661141|FG000|COMPLETED|Overall Study||10
2947616|NCT00682617|3661142|FG001|COMPLETED|Overall Study||21
2947617|NCT00682617|3661141|FG000|NOT COMPLETED|Overall Study||3
2947618|NCT00682617|3661142|FG001|NOT COMPLETED|Overall Study||7
2947619|NCT00682643|3661150|FG000|STARTED|Overall Study||182
2947620|NCT00682643|3661151|FG001|STARTED|Overall Study||368
3132477|NCT01691339|3857530|FG002|COMPLETED|Overall Study||51
2947621|NCT00682643|3661150|FG000|COMPLETED|Overall Study||104
2947622|NCT00682643|3661151|FG001|COMPLETED|Overall Study||199
2947623|NCT00682643|3661150|FG000|NOT COMPLETED|Overall Study||78
2947624|NCT00682643|3661151|FG001|NOT COMPLETED|Overall Study||169
2947625|NCT00682734|3661161|FG000|STARTED|Emergency Department Portion||113
2947626|NCT00682734|3661162|FG001|STARTED|Emergency Department Portion||118
2947627|NCT00682734|3661163|FG002|STARTED|Emergency Department Portion||118
2947628|NCT00682734|3661161|FG000|COMPLETED|Emergency Department Portion||113
2947629|NCT00682734|3661162|FG001|COMPLETED|Emergency Department Portion||117
2947630|NCT00682734|3661163|FG002|COMPLETED|Emergency Department Portion||117
2947631|NCT00682734|3661161|FG000|NOT COMPLETED|Emergency Department Portion||0
2947632|NCT00682734|3661162|FG001|NOT COMPLETED|Emergency Department Portion||1
2947633|NCT00682734|3661163|FG002|NOT COMPLETED|Emergency Department Portion||1
2947634|NCT00682734|3661161|FG000|STARTED|48 Hour Follow-up||113
2947635|NCT00682734|3661162|FG001|STARTED|48 Hour Follow-up||117
2947636|NCT00682734|3661163|FG002|STARTED|48 Hour Follow-up||117
2947637|NCT00682734|3661161|FG000|COMPLETED|48 Hour Follow-up||107
2947638|NCT00682734|3661162|FG001|COMPLETED|48 Hour Follow-up||111
2947639|NCT00682734|3661163|FG002|COMPLETED|48 Hour Follow-up||106
2947640|NCT00682734|3661161|FG000|NOT COMPLETED|48 Hour Follow-up||6
2947641|NCT00682734|3661162|FG001|NOT COMPLETED|48 Hour Follow-up||6
2947642|NCT00682734|3661163|FG002|NOT COMPLETED|48 Hour Follow-up||11
2947643|NCT00682786|3661173|FG000|STARTED|Overall Study||98
2947644|NCT00682786|3661174|FG001|STARTED|Overall Study||37
2947645|NCT00682786|3661173|FG000|COMPLETED|Overall Study||96
2947646|NCT00682786|3661174|FG001|COMPLETED|Overall Study||34
2947647|NCT00682786|3661173|FG000|NOT COMPLETED|Overall Study||2
2947648|NCT00682786|3661174|FG001|NOT COMPLETED|Overall Study||3
2947649|NCT00682838|3661190|FG000|STARTED|Overall Study||65
2947650|NCT00682838|3661191|FG001|STARTED|Overall Study||67
2947651|NCT00682838|3661192|FG002|STARTED|Overall Study||75
2947652|NCT00682838|3661193|FG003|STARTED|Overall Study||73
2947653|NCT00682838|3661190|FG000|COMPLETED|Overall Study||65
2947654|NCT00682838|3661191|FG001|COMPLETED|Overall Study||67
2947655|NCT00682838|3661192|FG002|COMPLETED|Overall Study||75
2947656|NCT00682838|3661193|FG003|COMPLETED|Overall Study||73
2947657|NCT00682838|3661190|FG000|NOT COMPLETED|Overall Study||0
2947658|NCT00682838|3661191|FG001|NOT COMPLETED|Overall Study||0
2947659|NCT00682838|3661192|FG002|NOT COMPLETED|Overall Study||0
2947660|NCT00682838|3661193|FG003|NOT COMPLETED|Overall Study||0
2947661|NCT00682851|3661205|FG000|STARTED|Overall Study||251
2947662|NCT00682851|3661206|FG001|STARTED|Overall Study||268
2947663|NCT00682851|3661205|FG000|COMPLETED|Overall Study||251
2947664|NCT00682851|3661206|FG001|COMPLETED|Overall Study||268
2947665|NCT00682851|3661205|FG000|NOT COMPLETED|Overall Study||0
2947666|NCT00682851|3661206|FG001|NOT COMPLETED|Overall Study||0
2947667|NCT00682890|3661214|FG000|STARTED|Overall Study||12
2947668|NCT00682890|3661215|FG001|STARTED|Overall Study||11
2947669|NCT00682890|3661214|FG000|COMPLETED|Overall Study||10
2947670|NCT00682890|3661215|FG001|COMPLETED|Overall Study||9
2947671|NCT00682890|3661214|FG000|NOT COMPLETED|Overall Study||2
2947672|NCT00682890|3661215|FG001|NOT COMPLETED|Overall Study||2
2947673|NCT00682929|3661224|FG000|STARTED|Overall Study||13
2947674|NCT00682929|3661225|FG001|STARTED|Overall Study||14
2947675|NCT00682929|3661226|FG002|STARTED|Overall Study||14
2947676|NCT00682929|3661224|FG000|COMPLETED|Overall Study||7
2947677|NCT00682929|3661225|FG001|COMPLETED|Overall Study||9
2947678|NCT00682929|3661226|FG002|COMPLETED|Overall Study||12
2947679|NCT00682929|3661224|FG000|NOT COMPLETED|Overall Study||6
2947680|NCT00682929|3661225|FG001|NOT COMPLETED|Overall Study||5
2947681|NCT00682929|3661226|FG002|NOT COMPLETED|Overall Study||2
2947682|NCT00683020|3661236|FG000|STARTED|Overall Study||182
2947683|NCT00683020|3661237|FG001|STARTED|Overall Study||180
2947684|NCT00683020|3661236|FG000|COMPLETED|Overall Study||127
2947685|NCT00683020|3661237|FG001|COMPLETED|Overall Study||125
2947686|NCT00683020|3661236|FG000|NOT COMPLETED|Overall Study||55
2947687|NCT00683020|3661237|FG001|NOT COMPLETED|Overall Study||55
2947688|NCT00683046|3661243|FG000|STARTED|Overall Study||204
2947689|NCT00683046|3661243|FG000|COMPLETED|Overall Study||204
2947690|NCT00683046|3661243|FG000|NOT COMPLETED|Overall Study||0
2947691|NCT00683085|3661247|FG000|STARTED|Overall Study||2
2947692|NCT00683085|3661247|FG000|COMPLETED|Overall Study||2
2947693|NCT00683085|3661247|FG000|NOT COMPLETED|Overall Study||0
2947694|NCT00683163|3661253|FG000|STARTED|Overall Study||22
2947695|NCT00683163|3661254|FG001|STARTED|Overall Study||22
2947696|NCT00683163|3661253|FG000|COMPLETED|Overall Study||22
2947697|NCT00683163|3661254|FG001|COMPLETED|Overall Study||22
2947698|NCT00683163|3661253|FG000|NOT COMPLETED|Overall Study||0
2947699|NCT00683163|3661254|FG001|NOT COMPLETED|Overall Study||0
2947700|NCT00683293|3661262|FG000|STARTED|Overall Study||50
2947701|NCT00683293|3661263|FG001|STARTED|Overall Study||50
2947702|NCT00683293|3661262|FG000|COMPLETED|Overall Study||48
2947703|NCT00683293|3661263|FG001|COMPLETED|Overall Study||47
2947704|NCT00683293|3661262|FG000|NOT COMPLETED|Overall Study||2
3298837|NCT02927873|4032593|FG001|COMPLETED|Overall Study||11
3298838|NCT02927873|4032594|FG002|COMPLETED|Overall Study||18
3298839|NCT02927873|4032595|FG003|COMPLETED|Overall Study||11
3298840|NCT02927873|4032596|FG004|COMPLETED|Overall Study||11
3298841|NCT02927873|4032597|FG005|COMPLETED|Overall Study||16
2947705|NCT00683293|3661263|FG001|NOT COMPLETED|Overall Study||3
2947706|NCT00683332|3661269|FG000|STARTED|Overall Study||621
2947707|NCT00683332|3661269|FG000|COMPLETED|Overall Study||621
2947708|NCT00683332|3661269|FG000|NOT COMPLETED|Overall Study||0
2947709|NCT00683384|3661273|FG000|STARTED|Overall Study||93
2947710|NCT00683384|3661273|FG000|COMPLETED|Overall Study||91
2947711|NCT00683384|3661273|FG000|NOT COMPLETED|Overall Study||2
2947712|NCT00683410|3661277|FG000|STARTED|Overall Study||3366
2947713|NCT00683410|3661277|FG000|Vaccinated Dose 1|Overall Study||3240
2947714|NCT00683410|3661277|FG000|Vaccinated Dose 2|Overall Study||1623
2947715|NCT00683410|3661277|FG000|Vaccinated Dose 3|Overall Study||817
2947716|NCT00683410|3661277|FG000|Vaccinated Dose 4|Overall Study||175
2947717|NCT00683410|3661277|FG000|COMPLETED|Overall Study||3366
2947718|NCT00683410|3661277|FG000|NOT COMPLETED|Overall Study||0
2947719|NCT00683449|3661286|FG000|STARTED|Overall Study||5
2947720|NCT00683449|3661287|FG001|STARTED|Overall Study||13
2947721|NCT00683449|3661288|FG002|STARTED|Overall Study||3
2947722|NCT00683449|3661289|FG003|STARTED|Overall Study||6
2947723|NCT00683449|3661290|FG004|STARTED|Overall Study||2
2947724|NCT00683449|3661286|FG000|COMPLETED|Overall Study||5
2947725|NCT00683449|3661287|FG001|COMPLETED|Overall Study||12
2947726|NCT00683449|3661288|FG002|COMPLETED|Overall Study||3
2947727|NCT00683449|3661289|FG003|COMPLETED|Overall Study||6
2947728|NCT00683449|3661290|FG004|COMPLETED|Overall Study||2
2947729|NCT00683449|3661286|FG000|NOT COMPLETED|Overall Study||0
2947730|NCT00683449|3661287|FG001|NOT COMPLETED|Overall Study||1
2947731|NCT00683449|3661288|FG002|NOT COMPLETED|Overall Study||0
2947732|NCT00683449|3661289|FG003|NOT COMPLETED|Overall Study||0
2947733|NCT00683449|3661290|FG004|NOT COMPLETED|Overall Study||0
2947734|NCT00683475|3661309|FG000|STARTED|Overall Study||69
2947735|NCT00683475|3661310|FG001|STARTED|Overall Study||69
2947736|NCT00683475|3661309|FG000|Received Any Quantity of Study Drug|Overall Study||66
2947737|NCT00683475|3661310|FG001|Received Any Quantity of Study Drug|Overall Study||66
2947738|NCT00683475|3661309|FG000|COMPLETED|Overall Study||65
2947739|NCT00683475|3661310|FG001|COMPLETED|Overall Study||66
2947740|NCT00683475|3661309|FG000|NOT COMPLETED|Overall Study||4
2947741|NCT00683475|3661310|FG001|NOT COMPLETED|Overall Study||3
2947742|NCT00683592|3661319|FG000|STARTED|Overall Study||240
2947743|NCT00683592|3661320|FG001|STARTED|Overall Study||241
2947744|NCT00683592|3661319|FG000|Intent to Treat Population|Overall Study||231
2947745|NCT00683592|3661320|FG001|Intent to Treat Population|Overall Study||232
2947746|NCT00683592|3661319|FG000|Safety Population|Overall Study||235
2947747|NCT00683592|3661320|FG001|Safety Population|Overall Study||233
2947748|NCT00683592|3661319|FG000|COMPLETED|Overall Study||193
2947749|NCT00683592|3661320|FG001|COMPLETED|Overall Study||195
2947750|NCT00683592|3661319|FG000|NOT COMPLETED|Overall Study||47
2947751|NCT00683592|3661320|FG001|NOT COMPLETED|Overall Study||46
2947752|NCT00683618|3661329|FG000|STARTED|Randomised Treatment Period||145
2947753|NCT00683618|3661330|FG001|STARTED|Randomised Treatment Period||145
2947754|NCT00683618|3661331|FG002|STARTED|Randomised Treatment Period||146
2947755|NCT00683618|3661329|FG000|COMPLETED|Randomised Treatment Period||139
2947756|NCT00683618|3661330|FG001|COMPLETED|Randomised Treatment Period||143
2947757|NCT00683618|3661331|FG002|COMPLETED|Randomised Treatment Period||140
2947758|NCT00683618|3661329|FG000|NOT COMPLETED|Randomised Treatment Period||6
2947759|NCT00683618|3661330|FG001|NOT COMPLETED|Randomised Treatment Period||2
2947760|NCT00683618|3661331|FG002|NOT COMPLETED|Randomised Treatment Period||6
2947761|NCT00683618|3661329|FG000|STARTED|Extension Treatment Period||36
2947762|NCT00683618|3661330|FG001|STARTED|Extension Treatment Period||23
2947763|NCT00683618|3661331|FG002|STARTED|Extension Treatment Period||0
2947764|NCT00683618|3661329|FG000|COMPLETED|Extension Treatment Period||33
2947765|NCT00683618|3661330|FG001|COMPLETED|Extension Treatment Period||23
2947766|NCT00683618|3661331|FG002|COMPLETED|Extension Treatment Period||0
2947767|NCT00683618|3661329|FG000|NOT COMPLETED|Extension Treatment Period||3
2947768|NCT00683618|3661330|FG001|NOT COMPLETED|Extension Treatment Period||0
2947769|NCT00683618|3661331|FG002|NOT COMPLETED|Extension Treatment Period||0
2947770|NCT00683644|3661343|FG000|STARTED|Overall Study||58
2947771|NCT00683644|3661344|FG001|STARTED|Overall Study||58
2947772|NCT00683644|3661343|FG000|COMPLETED|Overall Study||45
2947773|NCT00683644|3661344|FG001|COMPLETED|Overall Study||44
2947774|NCT00683644|3661343|FG000|NOT COMPLETED|Overall Study||13
2947775|NCT00683644|3661344|FG001|NOT COMPLETED|Overall Study||14
2947776|NCT00683657|3661356|FG000|STARTED|Overall Study||46
2947777|NCT00683657|3661357|FG001|STARTED|Overall Study||47
2947778|NCT00683657|3661356|FG000|Randomized Subjects Data Set|Overall Study|Randomized subjects who took at least 1 dose of double-blind study medication.|46
2947779|NCT00683657|3661357|FG001|Randomized Subjects Data Set|Overall Study|Randomized subjects who took at least 1 dose of double-blind study medication.|47
2947780|NCT00683657|3661356|FG000|COMPLETED|Overall Study||45
2947781|NCT00683657|3661357|FG001|COMPLETED|Overall Study||46
2947782|NCT00683657|3661356|FG000|NOT COMPLETED|Overall Study||1
2947783|NCT00683657|3661357|FG001|NOT COMPLETED|Overall Study||1
2947784|NCT00683696|3661365|FG000|STARTED|Overall Study||404
2947785|NCT00683696|3661366|FG001|STARTED|Overall Study||405
2947786|NCT00683696|3661365|FG000|COMPLETED|Overall Study||0
2947787|NCT00683696|3661366|FG001|COMPLETED|Overall Study||0
2947788|NCT00683696|3661365|FG000|NOT COMPLETED|Overall Study||404
2947789|NCT00683696|3661366|FG001|NOT COMPLETED|Overall Study||405
2947790|NCT00683774|3661375|FG000|STARTED|Overall Study||11
2947791|NCT00683774|3661376|FG001|STARTED|Overall Study||10
2947792|NCT00683774|3661375|FG000|COMPLETED|Overall Study||8
2947793|NCT00683774|3661376|FG001|COMPLETED|Overall Study||9
2947794|NCT00683774|3661375|FG000|NOT COMPLETED|Overall Study||3
3298842|NCT02927873|4032592|FG000|NOT COMPLETED|Overall Study||2
3298843|NCT02927873|4032593|FG001|NOT COMPLETED|Overall Study||3
3298844|NCT02927873|4032594|FG002|NOT COMPLETED|Overall Study||0
3298845|NCT02927873|4032595|FG003|NOT COMPLETED|Overall Study||0
3298846|NCT02927873|4032596|FG004|NOT COMPLETED|Overall Study||0
3298847|NCT02927873|4032597|FG005|NOT COMPLETED|Overall Study||1
3298848|NCT02927925|4032611|FG000|STARTED|Overall Study||32
3298849|NCT02927925|4032611|FG000|COMPLETED|Overall Study||0
3298850|NCT02927925|4032611|FG000|NOT COMPLETED|Overall Study||32
3298851|NCT02927938|4032619|FG000|STARTED|Overall Study||1
3298852|NCT02927938|4032620|FG001|STARTED|Overall Study||6
3298853|NCT02927938|4032621|FG002|STARTED|Overall Study||4
3298854|NCT02927938|4032622|FG003|STARTED|Overall Study||7
3298855|NCT02927938|4032619|FG000|COMPLETED|Overall Study||0
3298856|NCT02927938|4032620|FG001|COMPLETED|Overall Study||0
3298857|NCT02927938|4032621|FG002|COMPLETED|Overall Study||0
3298858|NCT02927938|4032622|FG003|COMPLETED|Overall Study||0
3298859|NCT02927938|4032619|FG000|NOT COMPLETED|Overall Study||1
3298860|NCT02927938|4032620|FG001|NOT COMPLETED|Overall Study||6
3298861|NCT02927938|4032621|FG002|NOT COMPLETED|Overall Study||4
3298862|NCT02927938|4032622|FG003|NOT COMPLETED|Overall Study||7
3298863|NCT02928029|4032632|FG000|STARTED|Overall Study||3
3298864|NCT02928029|4032633|FG001|STARTED|Overall Study||4
3298865|NCT02928029|4032632|FG000|COMPLETED|Overall Study||0
3298866|NCT02928029|4032633|FG001|COMPLETED|Overall Study||0
3298867|NCT02928029|4032632|FG000|NOT COMPLETED|Overall Study||3
3298868|NCT02928029|4032633|FG001|NOT COMPLETED|Overall Study||4
3298869|NCT02928055|4032642|FG000|STARTED|Overall Study||8
3298870|NCT02928055|4032643|FG001|STARTED|Overall Study||8
3298871|NCT02928055|4032644|FG002|STARTED|Overall Study||7
3298872|NCT02928055|4032642|FG000|End of Treatment|Overall Study||8
3298873|NCT02928055|4032643|FG001|End of Treatment|Overall Study||8
3298874|NCT02928055|4032644|FG002|End of Treatment|Overall Study||6
3298875|NCT02928055|4032642|FG000|1 Month Follow up|Overall Study||7
3298876|NCT02928055|4032643|FG001|1 Month Follow up|Overall Study||7
3298877|NCT02928055|4032644|FG002|1 Month Follow up|Overall Study||6
3298878|NCT02928055|4032642|FG000|2 Month Follow up|Overall Study||6
3298879|NCT02928055|4032643|FG001|2 Month Follow up|Overall Study||7
3298880|NCT02928055|4032644|FG002|2 Month Follow up|Overall Study||5
3298881|NCT02928055|4032642|FG000|3 Month Follow up|Overall Study||5
3298882|NCT02928055|4032643|FG001|3 Month Follow up|Overall Study||6
3298883|NCT02928055|4032644|FG002|3 Month Follow up|Overall Study||5
3298884|NCT02928055|4032642|FG000|COMPLETED|Overall Study||5
3298885|NCT02928055|4032643|FG001|COMPLETED|Overall Study||6
3298886|NCT02928055|4032644|FG002|COMPLETED|Overall Study||5
3298887|NCT02928055|4032642|FG000|NOT COMPLETED|Overall Study||3
3298888|NCT02928055|4032643|FG001|NOT COMPLETED|Overall Study||2
3298889|NCT02928055|4032644|FG002|NOT COMPLETED|Overall Study||2
3298890|NCT02928380|4032652|FG000|STARTED|Period 1||13
3298891|NCT02928380|4032653|FG001|STARTED|Period 1||14
3298892|NCT02928380|4032654|FG002|STARTED|Period 1||14
3298893|NCT02928380|4032655|FG003|STARTED|Period 1||14
3298894|NCT02928380|4032656|FG004|STARTED|Period 1||14
3298895|NCT02928380|4032657|FG005|STARTED|Period 1||14
3298896|NCT02928380|4032652|FG000|COMPLETED|Period 1||13
3298897|NCT02928380|4032653|FG001|COMPLETED|Period 1||14
3298898|NCT02928380|4032654|FG002|COMPLETED|Period 1||14
3298899|NCT02928380|4032655|FG003|COMPLETED|Period 1||14
3298900|NCT02928380|4032656|FG004|COMPLETED|Period 1||14
3298901|NCT02928380|4032657|FG005|COMPLETED|Period 1||14
3298902|NCT02928380|4032652|FG000|NOT COMPLETED|Period 1||0
3298903|NCT02928380|4032653|FG001|NOT COMPLETED|Period 1||0
3298904|NCT02928380|4032654|FG002|NOT COMPLETED|Period 1||0
3298905|NCT02928380|4032655|FG003|NOT COMPLETED|Period 1||0
3298906|NCT02928380|4032656|FG004|NOT COMPLETED|Period 1||0
3298907|NCT02928380|4032657|FG005|NOT COMPLETED|Period 1||0
3298908|NCT02928380|4032652|FG000|STARTED|Wash Out Period 1||13
3298909|NCT02928380|4032653|FG001|STARTED|Wash Out Period 1||14
3298910|NCT02928380|4032654|FG002|STARTED|Wash Out Period 1||14
3298911|NCT02928380|4032655|FG003|STARTED|Wash Out Period 1||14
3298912|NCT02928380|4032656|FG004|STARTED|Wash Out Period 1||14
3298913|NCT02928380|4032657|FG005|STARTED|Wash Out Period 1||14
3298914|NCT02928380|4032652|FG000|COMPLETED|Wash Out Period 1||13
3298915|NCT02928380|4032653|FG001|COMPLETED|Wash Out Period 1||14
3298916|NCT02928380|4032654|FG002|COMPLETED|Wash Out Period 1||14
3298917|NCT02928380|4032655|FG003|COMPLETED|Wash Out Period 1||14
3298918|NCT02928380|4032656|FG004|COMPLETED|Wash Out Period 1||14
3298919|NCT02928380|4032657|FG005|COMPLETED|Wash Out Period 1||14
3298920|NCT02928380|4032652|FG000|NOT COMPLETED|Wash Out Period 1||0
3298921|NCT02928380|4032653|FG001|NOT COMPLETED|Wash Out Period 1||0
3298922|NCT02928380|4032654|FG002|NOT COMPLETED|Wash Out Period 1||0
3298923|NCT02928380|4032655|FG003|NOT COMPLETED|Wash Out Period 1||0
3298924|NCT02928380|4032656|FG004|NOT COMPLETED|Wash Out Period 1||0
3298925|NCT02928380|4032657|FG005|NOT COMPLETED|Wash Out Period 1||0
3298926|NCT02928380|4032652|FG000|STARTED|Period 2||13
3298927|NCT02928380|4032653|FG001|STARTED|Period 2||14
3298928|NCT02928380|4032654|FG002|STARTED|Period 2||14
3298929|NCT02928380|4032655|FG003|STARTED|Period 2||14
3298930|NCT02928380|4032656|FG004|STARTED|Period 2||14
3298931|NCT02928380|4032657|FG005|STARTED|Period 2||14
3298932|NCT02928380|4032652|FG000|COMPLETED|Period 2||13
3298933|NCT02928380|4032653|FG001|COMPLETED|Period 2||14
3298934|NCT02928380|4032654|FG002|COMPLETED|Period 2||14
3298935|NCT02928380|4032655|FG003|COMPLETED|Period 2||14
3298936|NCT02928380|4032656|FG004|COMPLETED|Period 2||14
3298937|NCT02928380|4032657|FG005|COMPLETED|Period 2||14
3298938|NCT02928380|4032652|FG000|NOT COMPLETED|Period 2||0
3298939|NCT02928380|4032653|FG001|NOT COMPLETED|Period 2||0
2947795|NCT00683774|3661376|FG001|NOT COMPLETED|Overall Study||1
2947796|NCT00683800|3661384|FG000|STARTED|Overall Study||1101
2947797|NCT00683800|3661385|FG001|STARTED|Overall Study||1085
2947798|NCT00683800|3661384|FG000|Treated|Overall Study||1066
2947799|NCT00683800|3661385|FG001|Treated|Overall Study||1052
2947800|NCT00683800|3661384|FG000|COMPLETED|Overall Study||669
2947801|NCT00683800|3661385|FG001|COMPLETED|Overall Study||719
2947802|NCT00683800|3661384|FG000|NOT COMPLETED|Overall Study||432
2947803|NCT00683800|3661385|FG001|NOT COMPLETED|Overall Study||366
3034801|NCT01133977|3753799|FG001|STARTED|Overall Study|Treated|7
3034802|NCT01133977|3753800|FG002|STARTED|Overall Study|Treated|6
3034803|NCT01133977|3753801|FG003|STARTED|Overall Study|Treated|42
3034804|NCT01133977|3753802|FG004|STARTED|Overall Study|Treated|39
3034805|NCT01133977|3753798|FG000|COMPLETED|Overall Study||0
3034806|NCT01133977|3753799|FG001|COMPLETED|Overall Study||0
3034807|NCT01133977|3753800|FG002|COMPLETED|Overall Study||0
3034808|NCT01133977|3753801|FG003|COMPLETED|Overall Study||3
3034809|NCT01133977|3753802|FG004|COMPLETED|Overall Study||1
3034810|NCT01133977|3753798|FG000|NOT COMPLETED|Overall Study||3
3034811|NCT01133977|3753799|FG001|NOT COMPLETED|Overall Study||7
3034812|NCT01133977|3753800|FG002|NOT COMPLETED|Overall Study||6
3034813|NCT01133977|3753801|FG003|NOT COMPLETED|Overall Study||39
3034814|NCT01133977|3753802|FG004|NOT COMPLETED|Overall Study||38
3034815|NCT01134016|3753817|FG000|STARTED|Overall Study||13
3034816|NCT01134016|3753817|FG000|COMPLETED|Overall Study||10
3034817|NCT01134016|3753817|FG000|NOT COMPLETED|Overall Study||3
3034818|NCT01134042|3753853|FG000|STARTED|Overall Study||194
3034819|NCT01134042|3753854|FG001|STARTED|Overall Study||197
3034820|NCT01134042|3753855|FG002|STARTED|Overall Study||195
3034821|NCT01134042|3753853|FG000|COMPLETED|Overall Study||146
3034822|NCT01134042|3753854|FG001|COMPLETED|Overall Study||169
3034823|NCT01134042|3753855|FG002|COMPLETED|Overall Study||161
3034824|NCT01134042|3753853|FG000|NOT COMPLETED|Overall Study||48
3034825|NCT01134042|3753854|FG001|NOT COMPLETED|Overall Study||28
3034826|NCT01134042|3753855|FG002|NOT COMPLETED|Overall Study||34
3034827|NCT01134055|3753871|FG000|STARTED|Overall Study||73
3034828|NCT01134055|3753872|FG001|STARTED|Overall Study||72
3034829|NCT01134055|3753873|FG002|STARTED|Overall Study||74
3034830|NCT01134055|3753874|FG003|STARTED|Overall Study||73
3034831|NCT01134055|3753875|FG004|STARTED|Overall Study||73
3034832|NCT01134055|3753876|FG005|STARTED|Overall Study||72
3034833|NCT01134055|3753877|FG006|STARTED|Overall Study||73
3034834|NCT01134055|3753871|FG000|COMPLETED|Overall Study||65
3034835|NCT01134055|3753872|FG001|COMPLETED|Overall Study||66
3034836|NCT01134055|3753873|FG002|COMPLETED|Overall Study||71
3034837|NCT01134055|3753874|FG003|COMPLETED|Overall Study||67
3034838|NCT01134055|3753875|FG004|COMPLETED|Overall Study||67
3034839|NCT01134055|3753876|FG005|COMPLETED|Overall Study||65
3034840|NCT01134055|3753877|FG006|COMPLETED|Overall Study||62
3034841|NCT01134055|3753871|FG000|NOT COMPLETED|Overall Study||8
3034842|NCT01134055|3753872|FG001|NOT COMPLETED|Overall Study||6
3034843|NCT01134055|3753873|FG002|NOT COMPLETED|Overall Study||3
3034844|NCT01134055|3753874|FG003|NOT COMPLETED|Overall Study||6
3034845|NCT01134055|3753875|FG004|NOT COMPLETED|Overall Study||6
3034846|NCT01134055|3753876|FG005|NOT COMPLETED|Overall Study||7
3034847|NCT01134055|3753877|FG006|NOT COMPLETED|Overall Study||11
3034848|NCT01134081|3753899|FG000|STARTED|Overall Study||44
3034849|NCT01134081|3753899|FG000|COMPLETED|Overall Study||44
3034850|NCT01134081|3753899|FG000|NOT COMPLETED|Overall Study||0
3034851|NCT01134107|3753909|FG000|STARTED|Period 1-First Treatment Intervention||67
3034852|NCT01134107|3753910|FG001|STARTED|Period 1-First Treatment Intervention||66
3034853|NCT01134107|3753909|FG000|Received at Least One Dose of Study Drug|Period 1-First Treatment Intervention||66
3034854|NCT01134107|3753910|FG001|Received at Least One Dose of Study Drug|Period 1-First Treatment Intervention||66
3034855|NCT01134107|3753909|FG000|COMPLETED|Period 1-First Treatment Intervention||61
3034856|NCT01134107|3753910|FG001|COMPLETED|Period 1-First Treatment Intervention||61
3034857|NCT01134107|3753909|FG000|NOT COMPLETED|Period 1-First Treatment Intervention||6
3034858|NCT01134107|3753910|FG001|NOT COMPLETED|Period 1-First Treatment Intervention||5
3034859|NCT01134107|3753909|FG000|STARTED|Period 2-Second Treatment Intervention||61
3034860|NCT01134107|3753910|FG001|STARTED|Period 2-Second Treatment Intervention||61
3034861|NCT01134107|3753909|FG000|COMPLETED|Period 2-Second Treatment Intervention||57
3034862|NCT01134107|3753910|FG001|COMPLETED|Period 2-Second Treatment Intervention||61
3034863|NCT01134107|3753909|FG000|NOT COMPLETED|Period 2-Second Treatment Intervention||4
3034864|NCT01134107|3753910|FG001|NOT COMPLETED|Period 2-Second Treatment Intervention||0
3034865|NCT01134198|3753918|FG000|STARTED|Phase 1||16
3034866|NCT01134198|3753919|FG001|STARTED|Phase 1||13
3034867|NCT01134198|3753918|FG000|COMPLETED|Phase 1||9
3034868|NCT01134198|3753919|FG001|COMPLETED|Phase 1||11
3034869|NCT01134198|3753918|FG000|NOT COMPLETED|Phase 1||7
3034870|NCT01134198|3753919|FG001|NOT COMPLETED|Phase 1||2
3034871|NCT01134198|3753918|FG000|STARTED|Phase 2||9
3034872|NCT01134198|3753919|FG001|STARTED|Phase 2||11
3034873|NCT01134198|3753918|FG000|COMPLETED|Phase 2||9
3034874|NCT01134198|3753919|FG001|COMPLETED|Phase 2||7
3034875|NCT01134198|3753918|FG000|NOT COMPLETED|Phase 2||0
3034876|NCT01134198|3753919|FG001|NOT COMPLETED|Phase 2||4
3038346|NCT01153815|3757771|FG000|COMPLETED|Overall Study||74
2947804|NCT00683826|3661394|FG000|STARTED|Overall Study||8
2947805|NCT00683826|3661394|FG000|0g Leucine|Overall Study||8
2947806|NCT00683826|3661394|FG000|8g Leucine|Overall Study||8
2947807|NCT00683826|3661394|FG000|4g Leucine|Overall Study||7
2947808|NCT00683826|3661394|FG000|COMPLETED|Overall Study||7
2947809|NCT00683826|3661394|FG000|NOT COMPLETED|Overall Study||1
2947810|NCT00683852|3661404|FG000|STARTED|30-Day Phase 1 Period||56
2947811|NCT00683852|3661405|FG001|STARTED|30-Day Phase 1 Period||84
2947812|NCT00683852|3661406|FG002|STARTED|30-Day Phase 1 Period||85
2947813|NCT00683852|3661404|FG000|COMPLETED|30-Day Phase 1 Period||54
2947814|NCT00683852|3661405|FG001|COMPLETED|30-Day Phase 1 Period||83
2947815|NCT00683852|3661406|FG002|COMPLETED|30-Day Phase 1 Period||84
2947816|NCT00683852|3661404|FG000|NOT COMPLETED|30-Day Phase 1 Period||2
2947817|NCT00683852|3661405|FG001|NOT COMPLETED|30-Day Phase 1 Period||1
2947818|NCT00683852|3661406|FG002|NOT COMPLETED|30-Day Phase 1 Period||1
2947819|NCT00683852|3661404|FG000|STARTED|30-Day Phase 2 Period||54
2947820|NCT00683852|3661405|FG001|STARTED|30-Day Phase 2 Period||83
2947821|NCT00683852|3661406|FG002|STARTED|30-Day Phase 2 Period||84
2947822|NCT00683852|3661404|FG000|COMPLETED|30-Day Phase 2 Period||48
2947823|NCT00683852|3661405|FG001|COMPLETED|30-Day Phase 2 Period||78
2947824|NCT00683852|3661406|FG002|COMPLETED|30-Day Phase 2 Period||75
2947825|NCT00683852|3661404|FG000|NOT COMPLETED|30-Day Phase 2 Period||6
2947826|NCT00683852|3661405|FG001|NOT COMPLETED|30-Day Phase 2 Period||5
2947827|NCT00683852|3661406|FG002|NOT COMPLETED|30-Day Phase 2 Period||9
2947828|NCT00683878|3661424|FG000|STARTED|Overall Study||139
2947829|NCT00683878|3661425|FG001|STARTED|Overall Study||141
2947830|NCT00683878|3661426|FG002|STARTED|Overall Study||140
2947831|NCT00683878|3661424|FG000|COMPLETED|Overall Study||116
2947832|NCT00683878|3661425|FG001|COMPLETED|Overall Study||125
2947833|NCT00683878|3661426|FG002|COMPLETED|Overall Study||126
2947834|NCT00683878|3661424|FG000|NOT COMPLETED|Overall Study||23
2947835|NCT00683878|3661425|FG001|NOT COMPLETED|Overall Study||16
2947836|NCT00683878|3661426|FG002|NOT COMPLETED|Overall Study||14
2947837|NCT00683904|3661436|FG000|STARTED|Dose Level 1||6
2947838|NCT00683904|3661437|FG001|STARTED|Dose Level 1||0
2947839|NCT00683904|3661436|FG000|COMPLETED|Dose Level 1||3
2947840|NCT00683904|3661437|FG001|COMPLETED|Dose Level 1||0
2947841|NCT00683904|3661436|FG000|NOT COMPLETED|Dose Level 1||3
2947842|NCT00683904|3661437|FG001|NOT COMPLETED|Dose Level 1||0
2947843|NCT00683904|3661436|FG000|STARTED|Dose Level 2||0
2947844|NCT00683904|3661437|FG001|STARTED|Dose Level 2||6
2947845|NCT00683904|3661436|FG000|COMPLETED|Dose Level 2||0
2947846|NCT00683904|3661437|FG001|COMPLETED|Dose Level 2||4
3298940|NCT02928380|4032654|FG002|NOT COMPLETED|Period 2||0
3298941|NCT02928380|4032655|FG003|NOT COMPLETED|Period 2||0
3298942|NCT02928380|4032656|FG004|NOT COMPLETED|Period 2||0
3298943|NCT02928380|4032657|FG005|NOT COMPLETED|Period 2||0
3298944|NCT02928380|4032652|FG000|STARTED|Wash Out Period 2||13
3298945|NCT02928380|4032653|FG001|STARTED|Wash Out Period 2||14
3298946|NCT02928380|4032654|FG002|STARTED|Wash Out Period 2||14
3298947|NCT02928380|4032655|FG003|STARTED|Wash Out Period 2||14
3298948|NCT02928380|4032656|FG004|STARTED|Wash Out Period 2||14
3298949|NCT02928380|4032657|FG005|STARTED|Wash Out Period 2||14
3298950|NCT02928380|4032652|FG000|COMPLETED|Wash Out Period 2||13
3298951|NCT02928380|4032653|FG001|COMPLETED|Wash Out Period 2||14
3298952|NCT02928380|4032654|FG002|COMPLETED|Wash Out Period 2||14
3298953|NCT02928380|4032655|FG003|COMPLETED|Wash Out Period 2||14
3298954|NCT02928380|4032656|FG004|COMPLETED|Wash Out Period 2||14
3298955|NCT02928380|4032657|FG005|COMPLETED|Wash Out Period 2||14
3298956|NCT02928380|4032652|FG000|NOT COMPLETED|Wash Out Period 2||0
3298957|NCT02928380|4032653|FG001|NOT COMPLETED|Wash Out Period 2||0
3298958|NCT02928380|4032654|FG002|NOT COMPLETED|Wash Out Period 2||0
3298959|NCT02928380|4032655|FG003|NOT COMPLETED|Wash Out Period 2||0
3298960|NCT02928380|4032656|FG004|NOT COMPLETED|Wash Out Period 2||0
3298961|NCT02928380|4032657|FG005|NOT COMPLETED|Wash Out Period 2||0
3298962|NCT02928380|4032652|FG000|STARTED|Period 3||13
3298963|NCT02928380|4032653|FG001|STARTED|Period 3||14
3298964|NCT02928380|4032654|FG002|STARTED|Period 3||14
3298965|NCT02928380|4032655|FG003|STARTED|Period 3||14
3298966|NCT02928380|4032656|FG004|STARTED|Period 3||14
3298967|NCT02928380|4032657|FG005|STARTED|Period 3||14
3298968|NCT02928380|4032652|FG000|COMPLETED|Period 3||13
3298969|NCT02928380|4032653|FG001|COMPLETED|Period 3||14
3298970|NCT02928380|4032654|FG002|COMPLETED|Period 3||14
3298971|NCT02928380|4032655|FG003|COMPLETED|Period 3||14
3298972|NCT02928380|4032656|FG004|COMPLETED|Period 3||14
3298973|NCT02928380|4032657|FG005|COMPLETED|Period 3||14
3298974|NCT02928380|4032652|FG000|NOT COMPLETED|Period 3||0
3298975|NCT02928380|4032653|FG001|NOT COMPLETED|Period 3||0
3298976|NCT02928380|4032654|FG002|NOT COMPLETED|Period 3||0
2947847|NCT00683904|3661436|FG000|NOT COMPLETED|Dose Level 2||0
3298977|NCT02928380|4032655|FG003|NOT COMPLETED|Period 3||0
3298978|NCT02928380|4032656|FG004|NOT COMPLETED|Period 3||0
3298979|NCT02928380|4032657|FG005|NOT COMPLETED|Period 3||0
3298980|NCT02928536|4032668|FG000|STARTED|Overall Study||11902
3298981|NCT02928536|4032668|FG000|COMPLETED|Overall Study||11902
3298982|NCT02928536|4032668|FG000|NOT COMPLETED|Overall Study||0
3298983|NCT02928770|4032672|FG000|STARTED|Overall Study||32
3298984|NCT02928770|4032672|FG000|COMPLETED|Overall Study||30
3298985|NCT02928770|4032672|FG000|NOT COMPLETED|Overall Study||2
3298986|NCT02928848|4032678|FG000|STARTED|Arm 1||9
3298987|NCT02928848|4032679|FG001|STARTED|Arm 1||7
3298988|NCT02928848|4032678|FG000|COMPLETED|Arm 1||9
2947848|NCT00683904|3661437|FG001|NOT COMPLETED|Dose Level 2||2
2947849|NCT00683930|3661452|FG000|STARTED|Overall Study|One subject not included: no study drug dispensed.|36
2947850|NCT00683930|3661453|FG001|STARTED|Overall Study|One subject not included: no study drug dispensed.|21
2947851|NCT00683930|3661454|FG002|STARTED|Overall Study||37
2947852|NCT00683930|3661452|FG000|COMPLETED|Overall Study||29
2947853|NCT00683930|3661453|FG001|COMPLETED|Overall Study||18
2947854|NCT00683930|3661454|FG002|COMPLETED|Overall Study||28
2947855|NCT00683930|3661452|FG000|NOT COMPLETED|Overall Study||7
2947856|NCT00683930|3661453|FG001|NOT COMPLETED|Overall Study||3
2947857|NCT00683930|3661454|FG002|NOT COMPLETED|Overall Study||9
2947858|NCT00684021|3661467|FG000|STARTED|Overall Study||43
2947859|NCT00684021|3661468|FG001|STARTED|Overall Study||24
2947860|NCT00684021|3661469|FG002|STARTED|Overall Study||36
2947861|NCT00684021|3661470|FG003|STARTED|Overall Study||17
2947862|NCT00684021|3661467|FG000|COMPLETED|Overall Study||41
2947863|NCT00684021|3661468|FG001|COMPLETED|Overall Study||22
2947864|NCT00684021|3661469|FG002|COMPLETED|Overall Study||34
2947865|NCT00684021|3661470|FG003|COMPLETED|Overall Study||15
2947866|NCT00684021|3661467|FG000|NOT COMPLETED|Overall Study||2
2947867|NCT00684021|3661468|FG001|NOT COMPLETED|Overall Study||2
2947868|NCT00684021|3661469|FG002|NOT COMPLETED|Overall Study||2
2947869|NCT00684021|3661470|FG003|NOT COMPLETED|Overall Study||2
2947870|NCT00684047|3661483|FG000|STARTED|Overall Study||72
2947871|NCT00684047|3661484|FG001|STARTED|Overall Study||110
2947872|NCT00684047|3661485|FG002|STARTED|Overall Study||57
2947873|NCT00684047|3661483|FG000|COMPLETED|Overall Study||59
2947874|NCT00684047|3661484|FG001|COMPLETED|Overall Study||94
2947875|NCT00684047|3661485|FG002|COMPLETED|Overall Study||52
2947876|NCT00684047|3661483|FG000|NOT COMPLETED|Overall Study||13
2947877|NCT00684047|3661484|FG001|NOT COMPLETED|Overall Study||16
2947878|NCT00684047|3661485|FG002|NOT COMPLETED|Overall Study||5
2947879|NCT00684060|3661495|FG000|STARTED|Overall Study||58
2947880|NCT00684060|3661496|FG001|STARTED|Overall Study||29
2947881|NCT00684060|3661495|FG000|COMPLETED|Overall Study||55
2947882|NCT00684060|3661496|FG001|COMPLETED|Overall Study||26
2947883|NCT00684060|3661495|FG000|NOT COMPLETED|Overall Study||3
2947884|NCT00684060|3661496|FG001|NOT COMPLETED|Overall Study||3
2947885|NCT00684073|3661502|FG000|STARTED|Selection||60
2947886|NCT00684073|3661502|FG000|COMPLETED|Selection|number of subjects who had a Day 1 visit|53
2947887|NCT00684073|3661502|FG000|NOT COMPLETED|Selection||7
2947888|NCT00684073|3661502|FG000|STARTED|Treatment (Days 1 Through 5)|number of subjects who had a Day 1 visit|53
2947889|NCT00684073|3661502|FG000|COMPLETED|Treatment (Days 1 Through 5)|number of subjects who had a Day 5 visit (and therefore completed study)|52
2947890|NCT00684073|3661502|FG000|NOT COMPLETED|Treatment (Days 1 Through 5)||1
2947891|NCT00684138|3661512|FG000|STARTED|Overall Study||141
2947892|NCT00684138|3661513|FG001|STARTED|Overall Study||139
2947893|NCT00684138|3661512|FG000|COMPLETED|Overall Study||138
2947894|NCT00684138|3661513|FG001|COMPLETED|Overall Study||131
2947895|NCT00684138|3661512|FG000|NOT COMPLETED|Overall Study||3
2947896|NCT00684138|3661513|FG001|NOT COMPLETED|Overall Study||8
2947897|NCT00684177|3661523|FG000|STARTED|Overall Study||343
2947898|NCT00684177|3661524|FG001|STARTED|Overall Study||164
2947899|NCT00684177|3661523|FG000|COMPLETED|Overall Study||322
2947900|NCT00684177|3661524|FG001|COMPLETED|Overall Study||141
2947901|NCT00684177|3661523|FG000|NOT COMPLETED|Overall Study||21
2947902|NCT00684177|3661524|FG001|NOT COMPLETED|Overall Study||23
2947903|NCT00684203|3661536|FG000|STARTED|Overall Study||40
2947904|NCT00684203|3661537|FG001|STARTED|Overall Study||31
2947905|NCT00684203|3661538|FG002|STARTED|Overall Study||21
2947906|NCT00684203|3661539|FG003|STARTED|Overall Study||6
2947907|NCT00684203|3661540|FG004|STARTED|Overall Study||17
2947908|NCT00684203|3661541|FG005|STARTED|Overall Study||2
2947909|NCT00684203|3661536|FG000|COMPLETED|Overall Study||31
2947910|NCT00684203|3661537|FG001|COMPLETED|Overall Study||23
2947911|NCT00684203|3661538|FG002|COMPLETED|Overall Study||12
2947912|NCT00684203|3661539|FG003|COMPLETED|Overall Study||6
2947913|NCT00684203|3661540|FG004|COMPLETED|Overall Study||17
2947914|NCT00684203|3661541|FG005|COMPLETED|Overall Study||2
2947915|NCT00684203|3661536|FG000|NOT COMPLETED|Overall Study||9
2947916|NCT00684203|3661537|FG001|NOT COMPLETED|Overall Study||8
2947917|NCT00684203|3661538|FG002|NOT COMPLETED|Overall Study||9
2947918|NCT00684203|3661539|FG003|NOT COMPLETED|Overall Study||0
3298989|NCT02928848|4032679|FG001|COMPLETED|Arm 1||6
3298990|NCT02928848|4032678|FG000|NOT COMPLETED|Arm 1||0
3298991|NCT02928848|4032679|FG001|NOT COMPLETED|Arm 1||1
3298992|NCT02928848|4032678|FG000|STARTED|Arm 2||9
3298993|NCT02928848|4032679|FG001|STARTED|Arm 2||6
3298994|NCT02928848|4032678|FG000|COMPLETED|Arm 2||8
3298995|NCT02928848|4032679|FG001|COMPLETED|Arm 2||6
3298996|NCT02928848|4032678|FG000|NOT COMPLETED|Arm 2||1
3298997|NCT02928848|4032679|FG001|NOT COMPLETED|Arm 2||0
3298998|NCT02928952|4032689|FG000|STARTED|Overall Study||65
3298999|NCT02928952|4032690|FG001|STARTED|Overall Study||67
3299000|NCT02928952|4032689|FG000|COMPLETED|Overall Study||55
3299001|NCT02928952|4032690|FG001|COMPLETED|Overall Study||60
3299002|NCT02928952|4032689|FG000|NOT COMPLETED|Overall Study||10
3299003|NCT02928952|4032690|FG001|NOT COMPLETED|Overall Study||7
3299004|NCT02929329|4032698|FG000|STARTED|Overall Study||4112
3299005|NCT02929329|4032699|FG001|STARTED|Overall Study||4120
3299006|NCT02929329|4032698|FG000|Received Treatment|Overall Study||4101
3299007|NCT02929329|4032699|FG001|Received Treatment|Overall Study||4110
3316977|NCT03122535|4050463|FG000|STARTED|Overall Study||115
2947919|NCT00684203|3661540|FG004|NOT COMPLETED|Overall Study||0
2947920|NCT00684203|3661541|FG005|NOT COMPLETED|Overall Study||0
2947921|NCT00684242|3661562|FG000|STARTED|Overall Study||3
2947922|NCT00684242|3661562|FG000|COMPLETED|Overall Study||3
2947923|NCT00684242|3661562|FG000|NOT COMPLETED|Overall Study||0
2947924|NCT00684307|3661571|FG000|STARTED|Overall Study|Patients who received treatment|164
2947925|NCT00684307|3661572|FG001|STARTED|Overall Study||151
2947926|NCT00684307|3661573|FG002|STARTED|Overall Study||156
2947927|NCT00684307|3661574|FG003|STARTED|Overall Study||160
2947928|NCT00684307|3661575|FG004|STARTED|Overall Study||318
2947929|NCT00684307|3661571|FG000|On Treatment Period Started|Overall Study||164
2947930|NCT00684307|3661572|FG001|On Treatment Period Started|Overall Study||151
2947931|NCT00684307|3661573|FG002|On Treatment Period Started|Overall Study||156
2947932|NCT00684307|3661574|FG003|On Treatment Period Started|Overall Study||160
2947933|NCT00684307|3661575|FG004|On Treatment Period Started|Overall Study||318
2947934|NCT00684307|3661571|FG000|On Treatment Period Completed|Overall Study|Patients who completed treatment|140
2947935|NCT00684307|3661572|FG001|On Treatment Period Completed|Overall Study||129
2947936|NCT00684307|3661573|FG002|On Treatment Period Completed|Overall Study||128
2947937|NCT00684307|3661574|FG003|On Treatment Period Completed|Overall Study||128
2947938|NCT00684307|3661575|FG004|On Treatment Period Completed|Overall Study||293
2947939|NCT00684307|3661571|FG000|COMPLETED|Overall Study||140
2947940|NCT00684307|3661572|FG001|COMPLETED|Overall Study||129
2947941|NCT00684307|3661573|FG002|COMPLETED|Overall Study||128
2947942|NCT00684307|3661574|FG003|COMPLETED|Overall Study||128
2947943|NCT00684307|3661575|FG004|COMPLETED|Overall Study||293
2947944|NCT00684307|3661571|FG000|NOT COMPLETED|Overall Study||24
2947945|NCT00684307|3661572|FG001|NOT COMPLETED|Overall Study||22
2947946|NCT00684307|3661573|FG002|NOT COMPLETED|Overall Study||28
2947947|NCT00684307|3661574|FG003|NOT COMPLETED|Overall Study||32
2947948|NCT00684307|3661575|FG004|NOT COMPLETED|Overall Study||25
2947949|NCT00684320|3661589|FG000|STARTED|Overall Study||26
2947950|NCT00684320|3661590|FG001|STARTED|Overall Study||22
2947951|NCT00684320|3661589|FG000|COMPLETED|Overall Study||22
2947952|NCT00684320|3661590|FG001|COMPLETED|Overall Study||22
2947953|NCT00684320|3661589|FG000|NOT COMPLETED|Overall Study||4
2947954|NCT00684320|3661590|FG001|NOT COMPLETED|Overall Study||0
2947955|NCT00684411|3661596|FG000|STARTED|Overall Study||12
2947956|NCT00684411|3661596|FG000|Disease Evaluable|Overall Study||11
2947957|NCT00684411|3661596|FG000|COMPLETED|Overall Study||0
2947958|NCT00684411|3661596|FG000|NOT COMPLETED|Overall Study||12
2947959|NCT00684424|3661600|FG000|STARTED|Overall Study||199
2947960|NCT00684424|3661600|FG000|COMPLETED|Overall Study||194
2947961|NCT00684424|3661600|FG000|NOT COMPLETED|Overall Study||5
2947962|NCT00684515|3661608|FG000|STARTED|Overall Study||33
2947963|NCT00684515|3661609|FG001|STARTED|Overall Study||29
2947964|NCT00684515|3661610|FG002|STARTED|Overall Study||28
2947965|NCT00684515|3661608|FG000|COMPLETED|Overall Study||29
2947966|NCT00684515|3661609|FG001|COMPLETED|Overall Study||26
2947967|NCT00684515|3661610|FG002|COMPLETED|Overall Study||27
2947968|NCT00684515|3661608|FG000|NOT COMPLETED|Overall Study||4
2947969|NCT00684515|3661609|FG001|NOT COMPLETED|Overall Study||3
2947970|NCT00684515|3661610|FG002|NOT COMPLETED|Overall Study||1
2947971|NCT00684541|3661620|FG000|STARTED|Overall Study||23
2947972|NCT00684541|3661621|FG001|STARTED|Overall Study||26
2947973|NCT00684541|3661620|FG000|COMPLETED|Overall Study||20
2947974|NCT00684541|3661621|FG001|COMPLETED|Overall Study||23
2947975|NCT00684541|3661620|FG000|NOT COMPLETED|Overall Study||3
2947976|NCT00684541|3661621|FG001|NOT COMPLETED|Overall Study||3
2947977|NCT00684554|3661630|FG000|STARTED|Overall Study||10
2947978|NCT00684554|3661631|FG001|STARTED|Overall Study||10
2947979|NCT00684554|3661630|FG000|COMPLETED|Overall Study||10
2947980|NCT00684554|3661631|FG001|COMPLETED|Overall Study||10
2947981|NCT00684554|3661630|FG000|NOT COMPLETED|Overall Study||0
2947982|NCT00684554|3661631|FG001|NOT COMPLETED|Overall Study||0
2947983|NCT00684567|3661637|FG000|STARTED|Concomitant Radiotherapy Period||30
2947984|NCT00684567|3661637|FG000|COMPLETED|Concomitant Radiotherapy Period||28
2947985|NCT00684567|3661637|FG000|NOT COMPLETED|Concomitant Radiotherapy Period||2
2947986|NCT00684567|3661637|FG000|STARTED|Monotherapy Period|5 subjects completed radiotherapy combined therapy phase but did not proceed to monotherapy phase.|23
2947987|NCT00684567|3661637|FG000|COMPLETED|Monotherapy Period||9
2947988|NCT00684567|3661637|FG000|NOT COMPLETED|Monotherapy Period||14
2947989|NCT00684593|3661643|FG000|STARTED|Overall Study||21
2947990|NCT00684593|3661644|FG001|STARTED|Overall Study||10
2947991|NCT00684593|3661643|FG000|COMPLETED|Overall Study||21
2947992|NCT00684593|3661644|FG001|COMPLETED|Overall Study||8
2947993|NCT00684593|3661643|FG000|NOT COMPLETED|Overall Study||0
2947994|NCT00684593|3661644|FG001|NOT COMPLETED|Overall Study||2
2947995|NCT00684645|3661650|FG000|STARTED|Overall Study||186
2947996|NCT00684645|3661650|FG000|COMPLETED|Overall Study||72
2947997|NCT00684645|3661650|FG000|NOT COMPLETED|Overall Study||114
2947998|NCT00684671|3661657|FG000|STARTED|Overall Study||172
2947999|NCT00684671|3661658|FG001|STARTED|Overall Study||170
2948000|NCT00684671|3661659|FG002|STARTED|Overall Study||164
2948001|NCT00684671|3661657|FG000|COMPLETED|Overall Study||169
2948002|NCT00684671|3661658|FG001|COMPLETED|Overall Study||170
2948003|NCT00684671|3661659|FG002|COMPLETED|Overall Study||164
2948004|NCT00684671|3661657|FG000|NOT COMPLETED|Overall Study||3
2948005|NCT00684671|3661658|FG001|NOT COMPLETED|Overall Study||0
2948006|NCT00684671|3661659|FG002|NOT COMPLETED|Overall Study||0
2948007|NCT00684723|3661667|FG000|STARTED|First Intervention||27
2948008|NCT00684723|3661668|FG001|STARTED|First Intervention||27
2948009|NCT00684723|3661667|FG000|COMPLETED|First Intervention||27
2948010|NCT00684723|3661668|FG001|COMPLETED|First Intervention||27
2948011|NCT00684723|3661667|FG000|NOT COMPLETED|First Intervention||0
2948012|NCT00684723|3661668|FG001|NOT COMPLETED|First Intervention||0
2948013|NCT00684723|3661667|FG000|STARTED|Washout Period of 7 Days||27
2948014|NCT00684723|3661668|FG001|STARTED|Washout Period of 7 Days||27
2948015|NCT00684723|3661667|FG000|COMPLETED|Washout Period of 7 Days||27
2948016|NCT00684723|3661668|FG001|COMPLETED|Washout Period of 7 Days||27
2948017|NCT00684723|3661667|FG000|NOT COMPLETED|Washout Period of 7 Days||0
2948018|NCT00684723|3661668|FG001|NOT COMPLETED|Washout Period of 7 Days||0
2948019|NCT00684723|3661667|FG000|STARTED|Second Intervention||27
2948020|NCT00684723|3661668|FG001|STARTED|Second Intervention||27
2948021|NCT00684723|3661667|FG000|COMPLETED|Second Intervention||27
2948022|NCT00684723|3661668|FG001|COMPLETED|Second Intervention||27
2948023|NCT00684723|3661667|FG000|NOT COMPLETED|Second Intervention||0
2948024|NCT00684723|3661668|FG001|NOT COMPLETED|Second Intervention||0
2948025|NCT00684749|3661674|FG000|STARTED|Overall Study||142
2948026|NCT00684749|3661674|FG000|COMPLETED|Overall Study||142
2948027|NCT00684749|3661674|FG000|NOT COMPLETED|Overall Study||0
2948028|NCT00684762|3661678|FG000|STARTED|First Intervention||16
2948029|NCT00684762|3661679|FG001|STARTED|First Intervention||16
2948030|NCT00684762|3661678|FG000|COMPLETED|First Intervention||16
2948031|NCT00684762|3661679|FG001|COMPLETED|First Intervention||16
2948032|NCT00684762|3661678|FG000|NOT COMPLETED|First Intervention||0
2948033|NCT00684762|3661679|FG001|NOT COMPLETED|First Intervention||0
2948034|NCT00684762|3661678|FG000|STARTED|Washout Period of 7 Days||16
2948035|NCT00684762|3661679|FG001|STARTED|Washout Period of 7 Days||16
2948036|NCT00684762|3661678|FG000|COMPLETED|Washout Period of 7 Days||14
2948037|NCT00684762|3661679|FG001|COMPLETED|Washout Period of 7 Days||14
2948038|NCT00684762|3661678|FG000|NOT COMPLETED|Washout Period of 7 Days||2
2948039|NCT00684762|3661679|FG001|NOT COMPLETED|Washout Period of 7 Days||2
2948040|NCT00684762|3661678|FG000|STARTED|Second Intervention||14
2948041|NCT00684762|3661679|FG001|STARTED|Second Intervention||14
2948042|NCT00684762|3661678|FG000|COMPLETED|Second Intervention||14
2948043|NCT00684762|3661679|FG001|COMPLETED|Second Intervention||14
2948044|NCT00684762|3661678|FG000|NOT COMPLETED|Second Intervention||0
2948045|NCT00684762|3661679|FG001|NOT COMPLETED|Second Intervention||0
2948046|NCT00684775|3661687|FG000|STARTED|Overall Study||19
2948047|NCT00684775|3661688|FG001|STARTED|Overall Study||19
2948048|NCT00684775|3661687|FG000|COMPLETED|Overall Study||19
2948049|NCT00684775|3661688|FG001|COMPLETED|Overall Study||19
2948050|NCT00684775|3661687|FG000|NOT COMPLETED|Overall Study||0
2948051|NCT00684775|3661688|FG001|NOT COMPLETED|Overall Study||0
2948052|NCT00684788|3661704|FG000|STARTED|Overall Study||17
2948053|NCT00684788|3661705|FG001|STARTED|Overall Study||18
2948054|NCT00684788|3661704|FG000|COMPLETED|Overall Study||17
2948055|NCT00684788|3661705|FG001|COMPLETED|Overall Study||18
2948056|NCT00684788|3661704|FG000|NOT COMPLETED|Overall Study||0
2948057|NCT00684788|3661705|FG001|NOT COMPLETED|Overall Study||0
2948058|NCT00684814|3661717|FG000|STARTED|First Intervention||19
2948059|NCT00684814|3661718|FG001|STARTED|First Intervention||19
2948060|NCT00684814|3661717|FG000|COMPLETED|First Intervention||19
2948061|NCT00684814|3661718|FG001|COMPLETED|First Intervention||19
2948062|NCT00684814|3661717|FG000|NOT COMPLETED|First Intervention||0
2948063|NCT00684814|3661718|FG001|NOT COMPLETED|First Intervention||0
2948064|NCT00684814|3661717|FG000|STARTED|Washout Period of 7 Days||19
2948065|NCT00684814|3661718|FG001|STARTED|Washout Period of 7 Days||19
2948066|NCT00684814|3661717|FG000|COMPLETED|Washout Period of 7 Days||17
2948067|NCT00684814|3661718|FG001|COMPLETED|Washout Period of 7 Days||15
2948068|NCT00684814|3661717|FG000|NOT COMPLETED|Washout Period of 7 Days||2
2948069|NCT00684814|3661718|FG001|NOT COMPLETED|Washout Period of 7 Days||4
2948070|NCT00684814|3661717|FG000|STARTED|Second Intervention||17
2948071|NCT00684814|3661718|FG001|STARTED|Second Intervention||15
2948072|NCT00684814|3661717|FG000|COMPLETED|Second Intervention||16
2948073|NCT00684814|3661718|FG001|COMPLETED|Second Intervention||15
2948074|NCT00684814|3661717|FG000|NOT COMPLETED|Second Intervention||1
2948075|NCT00684814|3661718|FG001|NOT COMPLETED|Second Intervention||0
2948076|NCT00684983|3661726|FG000|STARTED|Overall Study||19
2948077|NCT00684983|3661727|FG001|STARTED|Overall Study||45
2948078|NCT00684983|3661726|FG000|COMPLETED|Overall Study||19
2948079|NCT00684983|3661727|FG001|COMPLETED|Overall Study|One major violation patient in Arm B is included in the primary analysis per protocol.|45
2948080|NCT00684983|3661726|FG000|NOT COMPLETED|Overall Study||0
2948081|NCT00684983|3661727|FG001|NOT COMPLETED|Overall Study||0
2948082|NCT00684996|3661735|FG000|STARTED|Overall Study||5
2948083|NCT00684996|3661735|FG000|Eligible|Overall Study||5
2948084|NCT00684996|3661735|FG000|COMPLETED|Overall Study||0
2948085|NCT00684996|3661735|FG000|NOT COMPLETED|Overall Study||5
2948086|NCT00685035|3661742|FG000|STARTED|Period 1: First Intervention: 30 Minutes||9
2948087|NCT00685035|3661743|FG001|STARTED|Period 1: First Intervention: 30 Minutes||8
2948088|NCT00685035|3661742|FG000|COMPLETED|Period 1: First Intervention: 30 Minutes||8
2948089|NCT00685035|3661743|FG001|COMPLETED|Period 1: First Intervention: 30 Minutes||8
2948090|NCT00685035|3661742|FG000|NOT COMPLETED|Period 1: First Intervention: 30 Minutes||1
2948091|NCT00685035|3661743|FG001|NOT COMPLETED|Period 1: First Intervention: 30 Minutes||0
2948092|NCT00685035|3661742|FG000|STARTED|Period 2: 2-day Washout||8
2948093|NCT00685035|3661743|FG001|STARTED|Period 2: 2-day Washout||8
2948094|NCT00685035|3661742|FG000|COMPLETED|Period 2: 2-day Washout||8
2948095|NCT00685035|3661743|FG001|COMPLETED|Period 2: 2-day Washout||8
2948096|NCT00685035|3661742|FG000|NOT COMPLETED|Period 2: 2-day Washout||0
2948097|NCT00685035|3661743|FG001|NOT COMPLETED|Period 2: 2-day Washout||0
2948098|NCT00685035|3661742|FG000|STARTED|Period 3: 2nd Intervention||8
2948099|NCT00685035|3661743|FG001|STARTED|Period 3: 2nd Intervention||8
2948100|NCT00685035|3661742|FG000|COMPLETED|Period 3: 2nd Intervention||8
2948101|NCT00685035|3661743|FG001|COMPLETED|Period 3: 2nd Intervention||8
2948102|NCT00685035|3661742|FG000|NOT COMPLETED|Period 3: 2nd Intervention||0
2948103|NCT00685035|3661743|FG001|NOT COMPLETED|Period 3: 2nd Intervention||0
2948104|NCT00685139|3661767|FG000|STARTED|First Intervention||17
2948105|NCT00685139|3661768|FG001|STARTED|First Intervention||17
2948106|NCT00685139|3661767|FG000|COMPLETED|First Intervention||17
2948107|NCT00685139|3661768|FG001|COMPLETED|First Intervention||17
2948108|NCT00685139|3661767|FG000|NOT COMPLETED|First Intervention||0
2948109|NCT00685139|3661768|FG001|NOT COMPLETED|First Intervention||0
2948110|NCT00685139|3661767|FG000|STARTED|Washout Period of 28 Days||17
2948111|NCT00685139|3661768|FG001|STARTED|Washout Period of 28 Days||17
2948112|NCT00685139|3661767|FG000|COMPLETED|Washout Period of 28 Days||17
2948113|NCT00685139|3661768|FG001|COMPLETED|Washout Period of 28 Days||17
2948114|NCT00685139|3661767|FG000|NOT COMPLETED|Washout Period of 28 Days||0
2948115|NCT00685139|3661768|FG001|NOT COMPLETED|Washout Period of 28 Days||0
2948116|NCT00685139|3661767|FG000|STARTED|Second Intervention||17
2948117|NCT00685139|3661768|FG001|STARTED|Second Intervention||17
2948118|NCT00685139|3661767|FG000|COMPLETED|Second Intervention||17
2948119|NCT00685139|3661768|FG001|COMPLETED|Second Intervention||17
2948120|NCT00685139|3661767|FG000|NOT COMPLETED|Second Intervention||0
2948121|NCT00685139|3661768|FG001|NOT COMPLETED|Second Intervention||0
2948122|NCT00685165|3661774|FG000|STARTED|First Intervention||11
2948123|NCT00685165|3661775|FG001|STARTED|First Intervention||11
2948124|NCT00685165|3661774|FG000|COMPLETED|First Intervention||11
2948125|NCT00685165|3661775|FG001|COMPLETED|First Intervention||11
2948126|NCT00685165|3661774|FG000|NOT COMPLETED|First Intervention||0
2948127|NCT00685165|3661775|FG001|NOT COMPLETED|First Intervention||0
2948128|NCT00685165|3661774|FG000|STARTED|Washout Period of 14 Days||11
2948129|NCT00685165|3661775|FG001|STARTED|Washout Period of 14 Days||11
2948130|NCT00685165|3661774|FG000|COMPLETED|Washout Period of 14 Days|adverse event- possible upper respiratory infection|10
2948131|NCT00685165|3661775|FG001|COMPLETED|Washout Period of 14 Days||11
2948132|NCT00685165|3661774|FG000|NOT COMPLETED|Washout Period of 14 Days||1
2948133|NCT00685165|3661775|FG001|NOT COMPLETED|Washout Period of 14 Days||0
2948134|NCT00685165|3661774|FG000|STARTED|Second Intervention||10
2948135|NCT00685165|3661775|FG001|STARTED|Second Intervention||11
2948136|NCT00685165|3661774|FG000|COMPLETED|Second Intervention||10
2948137|NCT00685165|3661775|FG001|COMPLETED|Second Intervention||11
2948138|NCT00685165|3661774|FG000|NOT COMPLETED|Second Intervention||0
2948139|NCT00685165|3661775|FG001|NOT COMPLETED|Second Intervention||0
2948140|NCT00685178|3661785|FG000|STARTED|Overall Study||40
2948141|NCT00685178|3661786|FG001|STARTED|Overall Study||45
2948142|NCT00685178|3661787|FG002|STARTED|Overall Study||39
2948143|NCT00685178|3661788|FG003|STARTED|Overall Study||47
2948144|NCT00685178|3661785|FG000|COMPLETED|Overall Study||27
2948145|NCT00685178|3661786|FG001|COMPLETED|Overall Study||26
2948146|NCT00685178|3661787|FG002|COMPLETED|Overall Study||27
2948147|NCT00685178|3661788|FG003|COMPLETED|Overall Study||33
2948148|NCT00685178|3661785|FG000|NOT COMPLETED|Overall Study||13
2948149|NCT00685178|3661786|FG001|NOT COMPLETED|Overall Study||19
2948150|NCT00685178|3661787|FG002|NOT COMPLETED|Overall Study||12
2948151|NCT00685178|3661788|FG003|NOT COMPLETED|Overall Study||14
2948152|NCT00685295|3661800|FG000|STARTED|Overall Study||30
2948153|NCT00685295|3661801|FG001|STARTED|Overall Study||30
2948154|NCT00685295|3661800|FG000|COMPLETED|Overall Study||30
2948155|NCT00685295|3661801|FG001|COMPLETED|Overall Study||30
2948156|NCT00685295|3661800|FG000|NOT COMPLETED|Overall Study||0
2948157|NCT00685295|3661801|FG001|NOT COMPLETED|Overall Study||0
2948158|NCT00685334|3661811|FG000|STARTED|Overall Study||12
2948159|NCT00685334|3661812|FG001|STARTED|Overall Study||10
2948160|NCT00685334|3661811|FG000|COMPLETED|Overall Study||2
2948161|NCT00685334|3661812|FG001|COMPLETED|Overall Study||3
2948162|NCT00685334|3661811|FG000|NOT COMPLETED|Overall Study||10
2948163|NCT00685334|3661812|FG001|NOT COMPLETED|Overall Study||7
2948164|NCT00685373|3661818|FG000|STARTED|Overall Study||166
2948165|NCT00685373|3661818|FG000|COMPLETED|Overall Study||151
2948166|NCT00685373|3661818|FG000|NOT COMPLETED|Overall Study||15
2948167|NCT00685399|3661829|FG000|STARTED|Treatment Period 1||16
2948168|NCT00685399|3661830|FG001|STARTED|Treatment Period 1||0
2948169|NCT00685399|3661831|FG002|STARTED|Treatment Period 1||0
2948170|NCT00685399|3661832|FG003|STARTED|Treatment Period 1||0
2948171|NCT00685399|3661833|FG004|STARTED|Treatment Period 1||0
2948172|NCT00685399|3661834|FG005|STARTED|Treatment Period 1||0
2948173|NCT00685399|3661835|FG006|STARTED|Treatment Period 1||0
2948174|NCT00685399|3661836|FG007|STARTED|Treatment Period 1||0
2948175|NCT00685399|3661829|FG000|COMPLETED|Treatment Period 1||10
2948176|NCT00685399|3661830|FG001|COMPLETED|Treatment Period 1||0
2948177|NCT00685399|3661831|FG002|COMPLETED|Treatment Period 1||0
2948178|NCT00685399|3661832|FG003|COMPLETED|Treatment Period 1||0
2948179|NCT00685399|3661833|FG004|COMPLETED|Treatment Period 1||0
2948180|NCT00685399|3661834|FG005|COMPLETED|Treatment Period 1||0
2948181|NCT00685399|3661835|FG006|COMPLETED|Treatment Period 1||0
2948182|NCT00685399|3661836|FG007|COMPLETED|Treatment Period 1||0
2948183|NCT00685399|3661829|FG000|NOT COMPLETED|Treatment Period 1||6
2948184|NCT00685399|3661830|FG001|NOT COMPLETED|Treatment Period 1||0
2948185|NCT00685399|3661831|FG002|NOT COMPLETED|Treatment Period 1||0
2948186|NCT00685399|3661832|FG003|NOT COMPLETED|Treatment Period 1||0
2948187|NCT00685399|3661833|FG004|NOT COMPLETED|Treatment Period 1||0
2948188|NCT00685399|3661834|FG005|NOT COMPLETED|Treatment Period 1||0
2948189|NCT00685399|3661835|FG006|NOT COMPLETED|Treatment Period 1||0
2948190|NCT00685399|3661836|FG007|NOT COMPLETED|Treatment Period 1||0
2948191|NCT00685399|3661829|FG000|STARTED|Treatment Period 2||0
2948192|NCT00685399|3661830|FG001|STARTED|Treatment Period 2||14
2948193|NCT00685399|3661831|FG002|STARTED|Treatment Period 2||5
2948194|NCT00685399|3661832|FG003|STARTED|Treatment Period 2|in extension period only|0
2948195|NCT00685399|3661833|FG004|STARTED|Treatment Period 2||4
2948196|NCT00685399|3661834|FG005|STARTED|Treatment Period 2||12
2948197|NCT00685399|3661835|FG006|STARTED|Treatment Period 2||13
2948198|NCT00685399|3661836|FG007|STARTED|Treatment Period 2||12
2948199|NCT00685399|3661829|FG000|COMPLETED|Treatment Period 2||0
2948200|NCT00685399|3661830|FG001|COMPLETED|Treatment Period 2||2
2948201|NCT00685399|3661831|FG002|COMPLETED|Treatment Period 2||2
2948202|NCT00685399|3661832|FG003|COMPLETED|Treatment Period 2|in extension period only|0
2948203|NCT00685399|3661833|FG004|COMPLETED|Treatment Period 2||4
2948204|NCT00685399|3661834|FG005|COMPLETED|Treatment Period 2||10
2948205|NCT00685399|3661835|FG006|COMPLETED|Treatment Period 2||13
2948206|NCT00685399|3661836|FG007|COMPLETED|Treatment Period 2||10
2948207|NCT00685399|3661829|FG000|NOT COMPLETED|Treatment Period 2||0
2948208|NCT00685399|3661830|FG001|NOT COMPLETED|Treatment Period 2||12
2948209|NCT00685399|3661831|FG002|NOT COMPLETED|Treatment Period 2||3
2948210|NCT00685399|3661832|FG003|NOT COMPLETED|Treatment Period 2||0
2948211|NCT00685399|3661833|FG004|NOT COMPLETED|Treatment Period 2||0
2948212|NCT00685399|3661834|FG005|NOT COMPLETED|Treatment Period 2||2
2948213|NCT00685399|3661835|FG006|NOT COMPLETED|Treatment Period 2||0
2948214|NCT00685399|3661836|FG007|NOT COMPLETED|Treatment Period 2||2
2948215|NCT00685399|3661829|FG000|STARTED|Extension||0
2948216|NCT00685399|3661830|FG001|STARTED|Extension||0
2948217|NCT00685399|3661831|FG002|STARTED|Extension||0
2948218|NCT00685399|3661832|FG003|STARTED|Extension||28
2948219|NCT00685399|3661833|FG004|STARTED|Extension||0
2948220|NCT00685399|3661834|FG005|STARTED|Extension||0
2948221|NCT00685399|3661835|FG006|STARTED|Extension||0
2948222|NCT00685399|3661836|FG007|STARTED|Extension||0
2948223|NCT00685399|3661829|FG000|COMPLETED|Extension||0
2948224|NCT00685399|3661830|FG001|COMPLETED|Extension||0
2948225|NCT00685399|3661831|FG002|COMPLETED|Extension||0
2948226|NCT00685399|3661832|FG003|COMPLETED|Extension||21
2948227|NCT00685399|3661833|FG004|COMPLETED|Extension||0
2948228|NCT00685399|3661834|FG005|COMPLETED|Extension||0
2948229|NCT00685399|3661835|FG006|COMPLETED|Extension||0
2948230|NCT00685399|3661836|FG007|COMPLETED|Extension||0
2948231|NCT00685399|3661829|FG000|NOT COMPLETED|Extension||0
2948232|NCT00685399|3661830|FG001|NOT COMPLETED|Extension||0
2948233|NCT00685399|3661831|FG002|NOT COMPLETED|Extension||0
2948234|NCT00685399|3661832|FG003|NOT COMPLETED|Extension||7
2948235|NCT00685399|3661833|FG004|NOT COMPLETED|Extension||0
2948236|NCT00685399|3661834|FG005|NOT COMPLETED|Extension||0
2948237|NCT00685399|3661835|FG006|NOT COMPLETED|Extension||0
2948238|NCT00685399|3661836|FG007|NOT COMPLETED|Extension||0
2948239|NCT00685477|3661863|FG000|STARTED|Overall Study||10
2948240|NCT00685477|3661864|FG001|STARTED|Overall Study||10
2948241|NCT00685477|3661865|FG002|STARTED|Overall Study||10
2948242|NCT00685477|3661866|FG003|STARTED|Overall Study||10
2948243|NCT00685477|3661867|FG004|STARTED|Overall Study||10
2948244|NCT00685477|3661868|FG005|STARTED|Overall Study||10
2948245|NCT00685477|3661863|FG000|COMPLETED|Overall Study||10
2948246|NCT00685477|3661864|FG001|COMPLETED|Overall Study||10
2948247|NCT00685477|3661865|FG002|COMPLETED|Overall Study||10
2948248|NCT00685477|3661866|FG003|COMPLETED|Overall Study||10
2948249|NCT00685477|3661867|FG004|COMPLETED|Overall Study||10
2948250|NCT00685477|3661868|FG005|COMPLETED|Overall Study||10
2948251|NCT00685477|3661863|FG000|NOT COMPLETED|Overall Study||0
2948252|NCT00685477|3661864|FG001|NOT COMPLETED|Overall Study||0
2948253|NCT00685477|3661865|FG002|NOT COMPLETED|Overall Study||0
2948254|NCT00685477|3661866|FG003|NOT COMPLETED|Overall Study||0
2948255|NCT00685477|3661867|FG004|NOT COMPLETED|Overall Study||0
2948256|NCT00685477|3661868|FG005|NOT COMPLETED|Overall Study||0
2948257|NCT00685516|3661880|FG000|STARTED|Overall Study||42
2948258|NCT00685516|3661881|FG001|STARTED|Overall Study||38
2948259|NCT00685516|3661882|FG002|STARTED|Overall Study||33
2948260|NCT00685516|3661880|FG000|COMPLETED|Overall Study||34
2948261|NCT00685516|3661881|FG001|COMPLETED|Overall Study||33
2948262|NCT00685516|3661882|FG002|COMPLETED|Overall Study||26
2948263|NCT00685516|3661880|FG000|NOT COMPLETED|Overall Study||8
2948264|NCT00685516|3661881|FG001|NOT COMPLETED|Overall Study||5
2948265|NCT00685516|3661882|FG002|NOT COMPLETED|Overall Study||7
2948266|NCT00685659|3661896|FG000|STARTED|Overall Study||108
2948267|NCT00685659|3661897|FG001|STARTED|Overall Study||106
2948268|NCT00685659|3661898|FG002|STARTED|Overall Study||107
2948269|NCT00685659|3661896|FG000|COMPLETED|Overall Study||77
2948270|NCT00685659|3661897|FG001|COMPLETED|Overall Study||81
2948271|NCT00685659|3661898|FG002|COMPLETED|Overall Study||92
2948272|NCT00685659|3661896|FG000|NOT COMPLETED|Overall Study||31
2948273|NCT00685659|3661897|FG001|NOT COMPLETED|Overall Study||25
2948274|NCT00685659|3661898|FG002|NOT COMPLETED|Overall Study||15
2948275|NCT00685685|3661906|FG000|STARTED|First Intervention||27
2948276|NCT00685685|3661907|FG001|STARTED|First Intervention||27
2948277|NCT00685685|3661906|FG000|COMPLETED|First Intervention||27
2948278|NCT00685685|3661907|FG001|COMPLETED|First Intervention||27
2948279|NCT00685685|3661906|FG000|NOT COMPLETED|First Intervention||0
2948280|NCT00685685|3661907|FG001|NOT COMPLETED|First Intervention||0
2948281|NCT00685685|3661906|FG000|STARTED|Washout Period of 7 Days||27
2948282|NCT00685685|3661907|FG001|STARTED|Washout Period of 7 Days||27
2948283|NCT00685685|3661906|FG000|COMPLETED|Washout Period of 7 Days||25
2948284|NCT00685685|3661907|FG001|COMPLETED|Washout Period of 7 Days||26
2948285|NCT00685685|3661906|FG000|NOT COMPLETED|Washout Period of 7 Days||2
2948286|NCT00685685|3661907|FG001|NOT COMPLETED|Washout Period of 7 Days||1
2948287|NCT00685685|3661906|FG000|STARTED|Second Intervention||25
2948288|NCT00685685|3661907|FG001|STARTED|Second Intervention||26
2948289|NCT00685685|3661906|FG000|COMPLETED|Second Intervention||25
2948290|NCT00685685|3661907|FG001|COMPLETED|Second Intervention||26
2948291|NCT00685685|3661906|FG000|NOT COMPLETED|Second Intervention||0
2948292|NCT00685685|3661907|FG001|NOT COMPLETED|Second Intervention||0
2948293|NCT00685698|3661913|FG000|STARTED|Overall Study||38
2948294|NCT00685698|3661913|FG000|COMPLETED|Overall Study||25
2948295|NCT00685698|3661913|FG000|NOT COMPLETED|Overall Study||13
2948296|NCT00685750|3661936|FG000|STARTED|Overall Study||17
2948297|NCT00685750|3661937|FG001|STARTED|Overall Study||3
2948298|NCT00685750|3661938|FG002|STARTED|Overall Study||21
2948299|NCT00685750|3661939|FG003|STARTED|Overall Study||2
2948300|NCT00685750|3661940|FG004|STARTED|Overall Study||15
2948301|NCT00685750|3661941|FG005|STARTED|Overall Study||20
2948302|NCT00685750|3661942|FG006|STARTED|Overall Study||10
2948303|NCT00685750|3661936|FG000|COMPLETED|Overall Study||17
2948304|NCT00685750|3661937|FG001|COMPLETED|Overall Study||3
2948305|NCT00685750|3661938|FG002|COMPLETED|Overall Study||19
2948306|NCT00685750|3661939|FG003|COMPLETED|Overall Study||2
2948307|NCT00685750|3661940|FG004|COMPLETED|Overall Study||15
2948308|NCT00685750|3661941|FG005|COMPLETED|Overall Study||20
2948309|NCT00685750|3661942|FG006|COMPLETED|Overall Study||9
2948310|NCT00685750|3661936|FG000|NOT COMPLETED|Overall Study||0
2948311|NCT00685750|3661937|FG001|NOT COMPLETED|Overall Study||0
2948312|NCT00685750|3661938|FG002|NOT COMPLETED|Overall Study||2
2948313|NCT00685750|3661939|FG003|NOT COMPLETED|Overall Study||0
2948314|NCT00685750|3661940|FG004|NOT COMPLETED|Overall Study||0
2948315|NCT00685750|3661941|FG005|NOT COMPLETED|Overall Study||0
2948316|NCT00685750|3661942|FG006|NOT COMPLETED|Overall Study||1
2948317|NCT00685763|3661962|FG000|STARTED|Overall Study||13
2948318|NCT00685763|3661962|FG000|COMPLETED|Overall Study||11
2948319|NCT00685763|3661962|FG000|NOT COMPLETED|Overall Study||2
2948320|NCT00685802|3661966|FG000|STARTED|First Intervention||16
2948321|NCT00685802|3661967|FG001|STARTED|First Intervention||16
2948322|NCT00685802|3661966|FG000|COMPLETED|First Intervention||16
2948323|NCT00685802|3661967|FG001|COMPLETED|First Intervention||16
2948324|NCT00685802|3661966|FG000|NOT COMPLETED|First Intervention||0
2948325|NCT00685802|3661967|FG001|NOT COMPLETED|First Intervention||0
2948326|NCT00685802|3661966|FG000|STARTED|Washout Period of 7 Days||16
2948327|NCT00685802|3661967|FG001|STARTED|Washout Period of 7 Days||16
2948328|NCT00685802|3661966|FG000|COMPLETED|Washout Period of 7 Days||14
2948329|NCT00685802|3661967|FG001|COMPLETED|Washout Period of 7 Days||15
2948330|NCT00685802|3661966|FG000|NOT COMPLETED|Washout Period of 7 Days||2
2948331|NCT00685802|3661967|FG001|NOT COMPLETED|Washout Period of 7 Days||1
2948332|NCT00685802|3661966|FG000|STARTED|Second Intervention||14
2948333|NCT00685802|3661967|FG001|STARTED|Second Intervention||15
2948334|NCT00685802|3661966|FG000|COMPLETED|Second Intervention||14
2948335|NCT00685802|3661967|FG001|COMPLETED|Second Intervention||15
2948336|NCT00685802|3661966|FG000|NOT COMPLETED|Second Intervention||0
2948337|NCT00685802|3661967|FG001|NOT COMPLETED|Second Intervention||0
2948338|NCT00685932|3661975|FG000|STARTED|Overall Study||76
2948339|NCT00685932|3661976|FG001|STARTED|Overall Study||78
2948340|NCT00685932|3661975|FG000|COMPLETED|Overall Study||55
2948341|NCT00685932|3661976|FG001|COMPLETED|Overall Study||58
2948342|NCT00685932|3661975|FG000|NOT COMPLETED|Overall Study||21
2948343|NCT00685932|3661976|FG001|NOT COMPLETED|Overall Study||20
2948344|NCT00685945|3661982|FG000|STARTED|Control (Bradykinin Infusion)|A total of 24 subjects received an infusion of bradykinin|24
2948345|NCT00685945|3661982|FG000|COMPLETED|Control (Bradykinin Infusion)||24
2948346|NCT00685945|3661982|FG000|NOT COMPLETED|Control (Bradykinin Infusion)||0
2948347|NCT00685945|3661982|FG000|STARTED|L-NMMA + Bradykinin||24
2948348|NCT00685945|3661982|FG000|COMPLETED|L-NMMA + Bradykinin||23
2948349|NCT00685945|3661982|FG000|NOT COMPLETED|L-NMMA + Bradykinin||1
2948350|NCT00685945|3661982|FG000|STARTED|Isosorbide + L-NMMA + Bradykinin||11
2948351|NCT00685945|3661982|FG000|COMPLETED|Isosorbide + L-NMMA + Bradykinin||11
2948352|NCT00685945|3661982|FG000|NOT COMPLETED|Isosorbide + L-NMMA + Bradykinin||0
2948353|NCT00685945|3661982|FG000|STARTED|Sildenafil + L-NMMA + Bradykinin||12
2948354|NCT00685945|3661982|FG000|COMPLETED|Sildenafil + L-NMMA + Bradykinin||12
2948355|NCT00685945|3661982|FG000|NOT COMPLETED|Sildenafil + L-NMMA + Bradykinin||0
2948356|NCT00686075|3662002|FG000|STARTED|Overall Study||79
2948357|NCT00686075|3662003|FG001|STARTED|Overall Study||81
2948358|NCT00686075|3662004|FG002|STARTED|Overall Study||80
2948359|NCT00686075|3662005|FG003|STARTED|Overall Study||80
2948360|NCT00686075|3662006|FG004|STARTED|Overall Study||40
2948361|NCT00686075|3662007|FG005|STARTED|Overall Study||40
2948362|NCT00686075|3662008|FG006|STARTED|Overall Study||82
2948363|NCT00686075|3662009|FG007|STARTED|Overall Study||78
2948364|NCT00686075|3662010|FG008|STARTED|Overall Study||81
2948365|NCT00686075|3662011|FG009|STARTED|Overall Study||79
2948366|NCT00686075|3662002|FG000|Treated|Overall Study||78
2948367|NCT00686075|3662003|FG001|Treated|Overall Study||79
2948368|NCT00686075|3662004|FG002|Treated|Overall Study||80
2948369|NCT00686075|3662005|FG003|Treated|Overall Study||80
2948370|NCT00686075|3662006|FG004|Treated|Overall Study||40
2948371|NCT00686075|3662007|FG005|Treated|Overall Study||40
2948372|NCT00686075|3662008|FG006|Treated|Overall Study||82
2948373|NCT00686075|3662009|FG007|Treated|Overall Study||77
2948374|NCT00686075|3662010|FG008|Treated|Overall Study||80
2948375|NCT00686075|3662011|FG009|Treated|Overall Study||78
2948376|NCT00686075|3662002|FG000|COMPLETED|Overall Study||71
2948377|NCT00686075|3662003|FG001|COMPLETED|Overall Study||71
2948378|NCT00686075|3662004|FG002|COMPLETED|Overall Study||74
2948379|NCT00686075|3662005|FG003|COMPLETED|Overall Study||71
2948380|NCT00686075|3662006|FG004|COMPLETED|Overall Study||36
3163407|NCT01886716|3890932|FG000|NOT COMPLETED|Week 3||1
3163408|NCT01886716|3890933|FG001|NOT COMPLETED|Week 3||1
3163409|NCT01886716|3890934|FG002|NOT COMPLETED|Week 3||0
3163410|NCT01886716|3890935|FG003|NOT COMPLETED|Week 3||1
3163411|NCT01886716|3890932|FG000|STARTED|Week 4||20
3163412|NCT01886716|3890933|FG001|STARTED|Week 4||17
3163413|NCT01886716|3890934|FG002|STARTED|Week 4||19
3163414|NCT01886716|3890935|FG003|STARTED|Week 4||14
3163415|NCT01886716|3890932|FG000|COMPLETED|Week 4||20
3163416|NCT01886716|3890933|FG001|COMPLETED|Week 4||17
2948381|NCT00686075|3662007|FG005|COMPLETED|Overall Study||37
2948382|NCT00686075|3662008|FG006|COMPLETED|Overall Study||82
2948383|NCT00686075|3662009|FG007|COMPLETED|Overall Study||76
2948384|NCT00686075|3662010|FG008|COMPLETED|Overall Study||75
2948385|NCT00686075|3662011|FG009|COMPLETED|Overall Study||69
2948386|NCT00686075|3662002|FG000|NOT COMPLETED|Overall Study||8
2948387|NCT00686075|3662003|FG001|NOT COMPLETED|Overall Study||10
2948388|NCT00686075|3662004|FG002|NOT COMPLETED|Overall Study||6
2948389|NCT00686075|3662005|FG003|NOT COMPLETED|Overall Study||9
2948390|NCT00686075|3662006|FG004|NOT COMPLETED|Overall Study||4
2948391|NCT00686075|3662007|FG005|NOT COMPLETED|Overall Study||3
2948392|NCT00686075|3662008|FG006|NOT COMPLETED|Overall Study||0
2948393|NCT00686075|3662009|FG007|NOT COMPLETED|Overall Study||2
2948394|NCT00686075|3662010|FG008|NOT COMPLETED|Overall Study||6
2948395|NCT00686075|3662011|FG009|NOT COMPLETED|Overall Study||10
2948396|NCT00686127|3662035|FG000|STARTED|Overall Study||14
2948397|NCT00686127|3662036|FG001|STARTED|Overall Study||7
2948398|NCT00686127|3662035|FG000|COMPLETED|Overall Study|Patients withdrew from the study because they did not like wearing the patch.|0
2948399|NCT00686127|3662036|FG001|COMPLETED|Overall Study||1
2948400|NCT00686127|3662035|FG000|NOT COMPLETED|Overall Study||14
2948401|NCT00686127|3662036|FG001|NOT COMPLETED|Overall Study||6
2948402|NCT00686166|3662042|FG000|STARTED|Overall Study||83
2948403|NCT00686166|3662042|FG000|Eligible|Overall Study||78
2948404|NCT00686166|3662042|FG000|Eligible and Began Protocol Therapy|Overall Study||74
2948405|NCT00686166|3662042|FG000|COMPLETED|Overall Study||63
2948406|NCT00686166|3662042|FG000|NOT COMPLETED|Overall Study||20
2948407|NCT00686205|3662053|FG000|STARTED|Overall Study||21606
2948408|NCT00686205|3662054|FG001|STARTED|Overall Study||2505
2948409|NCT00686205|3662053|FG000|COMPLETED|Overall Study||15599
2948410|NCT00686205|3662054|FG001|COMPLETED|Overall Study||1524
3163417|NCT01886716|3890934|FG002|COMPLETED|Week 4||19
3163418|NCT01886716|3890935|FG003|COMPLETED|Week 4||14
3163419|NCT01886716|3890932|FG000|NOT COMPLETED|Week 4||0
3299008|NCT02929329|4032698|FG000|COMPLETED|Overall Study|7 participants in this group who discontinued the study had unknown vital status at the end of study|3008
3316978|NCT03122535|4050464|FG001|STARTED|Overall Study||115
3316979|NCT03122535|4050463|FG000|3 Months|Overall Study||92
2948411|NCT00686205|3662053|FG000|NOT COMPLETED|Overall Study||6007
2948412|NCT00686205|3662054|FG001|NOT COMPLETED|Overall Study||981
2948413|NCT00686231|3662060|FG000|STARTED|Dose Test - Visit 1||12
2948414|NCT00686231|3662061|FG001|STARTED|Dose Test - Visit 1||7
2948415|NCT00686231|3662062|FG002|STARTED|Dose Test - Visit 1||0
2948416|NCT00686231|3662063|FG003|STARTED|Dose Test - Visit 1||0
2948417|NCT00686231|3662060|FG000|COMPLETED|Dose Test - Visit 1||12
2948418|NCT00686231|3662061|FG001|COMPLETED|Dose Test - Visit 1||7
2948419|NCT00686231|3662062|FG002|COMPLETED|Dose Test - Visit 1||0
2948420|NCT00686231|3662063|FG003|COMPLETED|Dose Test - Visit 1||0
2948421|NCT00686231|3662060|FG000|NOT COMPLETED|Dose Test - Visit 1||0
2948422|NCT00686231|3662061|FG001|NOT COMPLETED|Dose Test - Visit 1||0
2948423|NCT00686231|3662062|FG002|NOT COMPLETED|Dose Test - Visit 1||0
2948424|NCT00686231|3662063|FG003|NOT COMPLETED|Dose Test - Visit 1||0
2948425|NCT00686231|3662060|FG000|STARTED|Combination Test - Visit 2||0
2948426|NCT00686231|3662061|FG001|STARTED|Combination Test - Visit 2||0
2948427|NCT00686231|3662062|FG002|STARTED|Combination Test - Visit 2||10
2948428|NCT00686231|3662063|FG003|STARTED|Combination Test - Visit 2||9
2948429|NCT00686231|3662060|FG000|COMPLETED|Combination Test - Visit 2||0
2948430|NCT00686231|3662061|FG001|COMPLETED|Combination Test - Visit 2||0
2948431|NCT00686231|3662062|FG002|COMPLETED|Combination Test - Visit 2||10
3163420|NCT01886716|3890933|FG001|NOT COMPLETED|Week 4||0
3163421|NCT01886716|3890934|FG002|NOT COMPLETED|Week 4||0
3163422|NCT01886716|3890935|FG003|NOT COMPLETED|Week 4||0
3163423|NCT01886716|3890932|FG000|STARTED|1-Week Post Follow-Up||20
3163424|NCT01886716|3890933|FG001|STARTED|1-Week Post Follow-Up||17
2948432|NCT00686231|3662063|FG003|COMPLETED|Combination Test - Visit 2||9
2948433|NCT00686231|3662060|FG000|NOT COMPLETED|Combination Test - Visit 2||0
2948434|NCT00686231|3662061|FG001|NOT COMPLETED|Combination Test - Visit 2||0
2948435|NCT00686231|3662062|FG002|NOT COMPLETED|Combination Test - Visit 2||0
2948436|NCT00686231|3662063|FG003|NOT COMPLETED|Combination Test - Visit 2||0
2948437|NCT00686257|3662075|FG000|STARTED|Overall Study||29
2948438|NCT00686257|3662076|FG001|STARTED|Overall Study||31
2948439|NCT00686257|3662075|FG000|COMPLETED|Overall Study||29
2948440|NCT00686257|3662076|FG001|COMPLETED|Overall Study||31
3163425|NCT01886716|3890934|FG002|STARTED|1-Week Post Follow-Up||19
3163426|NCT01886716|3890935|FG003|STARTED|1-Week Post Follow-Up||14
3163427|NCT01886716|3890932|FG000|COMPLETED|1-Week Post Follow-Up||20
3163428|NCT01886716|3890933|FG001|COMPLETED|1-Week Post Follow-Up||17
3163429|NCT01886716|3890934|FG002|COMPLETED|1-Week Post Follow-Up||19
3163430|NCT01886716|3890935|FG003|COMPLETED|1-Week Post Follow-Up||14
3163431|NCT01886716|3890932|FG000|NOT COMPLETED|1-Week Post Follow-Up||0
2948441|NCT00686257|3662075|FG000|NOT COMPLETED|Overall Study||0
2948442|NCT00686257|3662076|FG001|NOT COMPLETED|Overall Study||0
2948443|NCT00686335|3662084|FG000|STARTED|Run-in Period||12
2948444|NCT00686335|3662084|FG000|COMPLETED|Run-in Period||7
2948445|NCT00686335|3662084|FG000|NOT COMPLETED|Run-in Period||5
2948446|NCT00686335|3662084|FG000|STARTED|Treatment Period||7
2948447|NCT00686335|3662084|FG000|COMPLETED|Treatment Period||7
2948448|NCT00686335|3662084|FG000|NOT COMPLETED|Treatment Period||0
2948449|NCT00686517|3662093|FG000|STARTED|Treatment||44
2948450|NCT00686517|3662094|FG001|STARTED|Treatment||43
2948451|NCT00686517|3662095|FG002|STARTED|Treatment||43
2948452|NCT00686517|3662093|FG000|Completed Final Treatment Visit|Treatment|Included 6 that discontinued the treatment before completion,but performed the Final Treatment Visit|44
2948453|NCT00686517|3662094|FG001|Completed Final Treatment Visit|Treatment|Included 3 that discontinued the treatment before completion,but performed the Final Treatment Visit|43
2948454|NCT00686517|3662095|FG002|Completed Final Treatment Visit|Treatment|Included 1 that discontinued the treatment before completion,but performed the Final Treatment Visit|43
2948455|NCT00686517|3662093|FG000|COMPLETED|Treatment||38
2948456|NCT00686517|3662094|FG001|COMPLETED|Treatment||40
2948457|NCT00686517|3662095|FG002|COMPLETED|Treatment||42
2948458|NCT00686517|3662093|FG000|NOT COMPLETED|Treatment||6
2948459|NCT00686517|3662094|FG001|NOT COMPLETED|Treatment||3
2948460|NCT00686517|3662095|FG002|NOT COMPLETED|Treatment||1
2948461|NCT00686517|3662093|FG000|STARTED|Follow-up||37
2948462|NCT00686517|3662094|FG001|STARTED|Follow-up||38
2948463|NCT00686517|3662095|FG002|STARTED|Follow-up||39
2948464|NCT00686517|3662093|FG000|COMPLETED|Follow-up||29
2948465|NCT00686517|3662094|FG001|COMPLETED|Follow-up||28
2948466|NCT00686517|3662095|FG002|COMPLETED|Follow-up||29
2948467|NCT00686517|3662093|FG000|NOT COMPLETED|Follow-up||8
2948468|NCT00686517|3662094|FG001|NOT COMPLETED|Follow-up||10
2948469|NCT00686517|3662095|FG002|NOT COMPLETED|Follow-up||10
2948470|NCT00686543|3662107|FG000|STARTED|Overall Study||14
2948471|NCT00686543|3662108|FG001|STARTED|Overall Study||21
2948472|NCT00686543|3662109|FG002|STARTED|Overall Study||20
2948473|NCT00686543|3662110|FG003|STARTED|Overall Study||20
2948474|NCT00686543|3662107|FG000|COMPLETED|Overall Study||0
2948475|NCT00686543|3662108|FG001|COMPLETED|Overall Study||20
2948476|NCT00686543|3662109|FG002|COMPLETED|Overall Study||15
2948477|NCT00686543|3662110|FG003|COMPLETED|Overall Study||17
2948478|NCT00686543|3662107|FG000|NOT COMPLETED|Overall Study||14
2948479|NCT00686543|3662108|FG001|NOT COMPLETED|Overall Study||1
2948480|NCT00686543|3662109|FG002|NOT COMPLETED|Overall Study||5
2948481|NCT00686543|3662110|FG003|NOT COMPLETED|Overall Study||3
2948482|NCT00686582|3662123|FG000|STARTED|Overall Study||92
2948483|NCT00686582|3662124|FG001|STARTED|Overall Study||91
2948484|NCT00686582|3662125|FG002|STARTED|Overall Study||121
2948485|NCT00686582|3662123|FG000|Booster Vaccination|Overall Study||75
2948486|NCT00686582|3662124|FG001|Booster Vaccination|Overall Study||77
2948487|NCT00686582|3662125|FG002|Booster Vaccination|Overall Study||0
2948488|NCT00686582|3662123|FG000|COMPLETED|Overall Study||74
2948489|NCT00686582|3662124|FG001|COMPLETED|Overall Study||77
2948490|NCT00686582|3662125|FG002|COMPLETED|Overall Study||121
2948491|NCT00686582|3662123|FG000|NOT COMPLETED|Overall Study||18
2948492|NCT00686582|3662124|FG001|NOT COMPLETED|Overall Study||14
2948493|NCT00686582|3662125|FG002|NOT COMPLETED|Overall Study||0
2948494|NCT00686595|3662131|FG000|STARTED|Overall Study||38
2948495|NCT00686595|3662131|FG000|COMPLETED|Overall Study||31
2948496|NCT00686595|3662131|FG000|NOT COMPLETED|Overall Study||7
2948497|NCT00686634|3662135|FG000|STARTED|Overall Study||108
2948498|NCT00686634|3662135|FG000|COMPLETED|Overall Study||102
2948499|NCT00686634|3662135|FG000|NOT COMPLETED|Overall Study||6
2948500|NCT00686647|3662140|FG000|STARTED|Overall Study||93
2948501|NCT00686647|3662140|FG000|COMPLETED|Overall Study||91
2948502|NCT00686647|3662140|FG000|NOT COMPLETED|Overall Study||2
2948503|NCT00686686|3662145|FG000|STARTED|Overall Study||23
2948504|NCT00686686|3662145|FG000|COMPLETED|Overall Study||17
2948505|NCT00686686|3662145|FG000|NOT COMPLETED|Overall Study||6
2948506|NCT00686699|3662151|FG000|STARTED|Treatment Period 1||4
2948507|NCT00686699|3662152|FG001|STARTED|Treatment Period 1||7
2948508|NCT00686699|3662151|FG000|COMPLETED|Treatment Period 1||4
2948509|NCT00686699|3662152|FG001|COMPLETED|Treatment Period 1||5
2948510|NCT00686699|3662151|FG000|NOT COMPLETED|Treatment Period 1||0
2948511|NCT00686699|3662152|FG001|NOT COMPLETED|Treatment Period 1||2
3163432|NCT01886716|3890933|FG001|NOT COMPLETED|1-Week Post Follow-Up||0
2948512|NCT00686699|3662151|FG000|STARTED|Treatment Period 2||4
2948513|NCT00686699|3662152|FG001|STARTED|Treatment Period 2||5
2948514|NCT00686699|3662151|FG000|COMPLETED|Treatment Period 2||4
2948515|NCT00686699|3662152|FG001|COMPLETED|Treatment Period 2||5
2948516|NCT00686699|3662151|FG000|NOT COMPLETED|Treatment Period 2||0
2948517|NCT00686699|3662152|FG001|NOT COMPLETED|Treatment Period 2||0
2948518|NCT00686712|3662161|FG000|STARTED|Overall Study||30
2948519|NCT00686712|3662162|FG001|STARTED|Overall Study||25
2948520|NCT00686712|3662163|FG002|STARTED|Overall Study||30
2948521|NCT00686712|3662161|FG000|COMPLETED|Overall Study||20
2948522|NCT00686712|3662162|FG001|COMPLETED|Overall Study||14
2948523|NCT00686712|3662163|FG002|COMPLETED|Overall Study||17
2948524|NCT00686712|3662161|FG000|NOT COMPLETED|Overall Study||10
2948525|NCT00686712|3662162|FG001|NOT COMPLETED|Overall Study||11
2948526|NCT00686712|3662163|FG002|NOT COMPLETED|Overall Study||13
2948527|NCT00686725|3662176|FG000|STARTED|Overall Study||47
2948528|NCT00686725|3662177|FG001|STARTED|Overall Study||52
2948529|NCT00686725|3662176|FG000|COMPLETED|Overall Study|Completers were defined as those who completed the established treatment.|1
2948530|NCT00686725|3662177|FG001|COMPLETED|Overall Study|Completers were defined as those who completed the established treatment.|10
2948531|NCT00686725|3662176|FG000|NOT COMPLETED|Overall Study||46
2948532|NCT00686725|3662177|FG001|NOT COMPLETED|Overall Study||42
2948533|NCT00686777|3662183|FG000|STARTED|Overall Study||75
2948534|NCT00686777|3662183|FG000|Completed 24 Weeks of Treatment|Overall Study||69
2948535|NCT00686777|3662183|FG000|Completed 48 Weeks of Treatment|Overall Study||65
2948536|NCT00686777|3662183|FG000|Included in Follow-up (All Treated)|Overall Study||75
2948537|NCT00686777|3662183|FG000|Completed 24 Weeks of Follow-up|Overall Study||70
2948538|NCT00686777|3662183|FG000|COMPLETED|Overall Study|Of 10 noncompleters, 6 had AEs including 4 meeting protocol prespecified AE discontinuance criteria.|65
2948539|NCT00686777|3662183|FG000|NOT COMPLETED|Overall Study||10
2948540|NCT00686790|3662187|FG000|STARTED|Overall Study||48
2948541|NCT00686790|3662187|FG000|COMPLETED|Overall Study||32
2948542|NCT00686790|3662187|FG000|NOT COMPLETED|Overall Study||16
2948543|NCT00686803|3662194|FG000|STARTED|Overall Study||6
2948544|NCT00686803|3662195|FG001|STARTED|Overall Study||12
2948545|NCT00686803|3662196|FG002|STARTED|Overall Study||3
2948546|NCT00686803|3662194|FG000|COMPLETED|Overall Study||6
2948547|NCT00686803|3662195|FG001|COMPLETED|Overall Study||12
2948548|NCT00686803|3662196|FG002|COMPLETED|Overall Study||3
2948549|NCT00686803|3662194|FG000|NOT COMPLETED|Overall Study||0
2948550|NCT00686803|3662195|FG001|NOT COMPLETED|Overall Study||0
2948551|NCT00686803|3662196|FG002|NOT COMPLETED|Overall Study||0
2948552|NCT00686829|3662204|FG000|STARTED|Overall Study||79
2948553|NCT00686829|3662204|FG000|COMPLETED|Overall Study||0
2948554|NCT00686829|3662204|FG000|NOT COMPLETED|Overall Study||79
2948555|NCT00686842|3662208|FG000|STARTED|Overall Study||17
2948556|NCT00686842|3662208|FG000|COMPLETED|Overall Study||17
2948557|NCT00686842|3662208|FG000|NOT COMPLETED|Overall Study||0
2948558|NCT00686855|3662214|FG000|STARTED|Overall Study||28
2948559|NCT00686855|3662215|FG001|STARTED|Overall Study||18
2948560|NCT00686855|3662214|FG000|COMPLETED|Overall Study||27
2948561|NCT00686855|3662215|FG001|COMPLETED|Overall Study||17
2948562|NCT00686855|3662214|FG000|NOT COMPLETED|Overall Study||1
2948563|NCT00686855|3662215|FG001|NOT COMPLETED|Overall Study||1
2948564|NCT00686881|3662223|FG000|STARTED|Overall Study|After randomization, 2 participants withdrew consent and did not receive study drug.|127
2948565|NCT00686881|3662224|FG001|STARTED|Overall Study|After randomization, 6 participants withdrew consent and did not receive study drug.|134
2948566|NCT00686881|3662223|FG000|COMPLETED|Overall Study||45
2948567|NCT00686881|3662224|FG001|COMPLETED|Overall Study||53
2948568|NCT00686881|3662223|FG000|NOT COMPLETED|Overall Study||82
2948569|NCT00686881|3662224|FG001|NOT COMPLETED|Overall Study||81
2948570|NCT00686894|3662232|FG000|STARTED|Overall Study||7
2948571|NCT00686894|3662232|FG000|COMPLETED|Overall Study||1
2948572|NCT00686894|3662232|FG000|NOT COMPLETED|Overall Study||6
2948573|NCT00686920|3662238|FG000|STARTED|Overall Study||252
2948574|NCT00686920|3662239|FG001|STARTED|Overall Study||70
2948575|NCT00686920|3662238|FG000|Received At Least 1 Dose Of Study Drug|Overall Study||252
2948576|NCT00686920|3662239|FG001|Received At Least 1 Dose Of Study Drug|Overall Study||70
2948577|NCT00686920|3662238|FG000|COMPLETED|Overall Study||120
2948578|NCT00686920|3662239|FG001|COMPLETED|Overall Study||34
2948579|NCT00686920|3662238|FG000|NOT COMPLETED|Overall Study||132
2948580|NCT00686920|3662239|FG001|NOT COMPLETED|Overall Study||36
2948581|NCT00686959|3662247|FG000|STARTED|Overall Study||301
2948582|NCT00686959|3662248|FG001|STARTED|Overall Study||297
2948583|NCT00686959|3662247|FG000|Received at Least One Dose of Study Drug|Overall Study||283
2948584|NCT00686959|3662248|FG001|Received at Least One Dose of Study Drug|Overall Study||272
2948585|NCT00686959|3662247|FG000|Entered Consolidation Phase|Overall Study||229
2948586|NCT00686959|3662248|FG001|Entered Consolidation Phase|Overall Study||202
2948587|NCT00686959|3662247|FG000|COMPLETED|Overall Study|Study completion includes death due to any cause|177
2948588|NCT00686959|3662248|FG001|COMPLETED|Overall Study|Study completion includes death due to any cause.|180
2948589|NCT00686959|3662247|FG000|NOT COMPLETED|Overall Study||124
2948590|NCT00686959|3662248|FG001|NOT COMPLETED|Overall Study||117
2948591|NCT00686998|3662257|FG000|STARTED|Overall Study|Randomized & received study medication|43
2948592|NCT00686998|3662258|FG001|STARTED|Overall Study|Randomized & received study medication|41
2948593|NCT00686998|3662259|FG002|STARTED|Overall Study|Randomized & received study medication|22
2948594|NCT00686998|3662257|FG000|Randomized|Overall Study||43
2948595|NCT00686998|3662258|FG001|Randomized|Overall Study||41
2948596|NCT00686998|3662259|FG002|Randomized|Overall Study||22
2948597|NCT00686998|3662257|FG000|Received Treatment|Overall Study||43
2948598|NCT00686998|3662258|FG001|Received Treatment|Overall Study||41
2948599|NCT00686998|3662259|FG002|Received Treatment|Overall Study||22
2948600|NCT00686998|3662257|FG000|Eligible for Efficacy Analysis|Overall Study||42
2948601|NCT00686998|3662258|FG001|Eligible for Efficacy Analysis|Overall Study||39
2948602|NCT00686998|3662259|FG002|Eligible for Efficacy Analysis|Overall Study||21
2948603|NCT00686998|3662257|FG000|Completed Scheduled Treatment|Overall Study||30
2948604|NCT00686998|3662258|FG001|Completed Scheduled Treatment|Overall Study||33
2948605|NCT00686998|3662259|FG002|Completed Scheduled Treatment|Overall Study||18
2948606|NCT00686998|3662257|FG000|COMPLETED|Overall Study||30
2948607|NCT00686998|3662258|FG001|COMPLETED|Overall Study||33
2948608|NCT00686998|3662259|FG002|COMPLETED|Overall Study||18
2948609|NCT00686998|3662257|FG000|NOT COMPLETED|Overall Study||13
2948610|NCT00686998|3662258|FG001|NOT COMPLETED|Overall Study||8
2948611|NCT00686998|3662259|FG002|NOT COMPLETED|Overall Study||4
2948612|NCT00687076|3662269|FG000|STARTED|Overall Study||51
2948613|NCT00687076|3662270|FG001|STARTED|Overall Study||51
2948614|NCT00687076|3662269|FG000|COMPLETED|Overall Study||19
2948615|NCT00687076|3662270|FG001|COMPLETED|Overall Study||21
2948616|NCT00687076|3662269|FG000|NOT COMPLETED|Overall Study||32
2948617|NCT00687076|3662270|FG001|NOT COMPLETED|Overall Study||30
2948618|NCT00687102|3662278|FG000|STARTED|Overall Study||733
2948619|NCT00687102|3662279|FG001|STARTED|Overall Study||765
2948620|NCT00687102|3662278|FG000|COMPLETED|Overall Study||733
2948621|NCT00687102|3662279|FG001|COMPLETED|Overall Study||765
2948622|NCT00687102|3662278|FG000|NOT COMPLETED|Overall Study||0
2948623|NCT00687102|3662279|FG001|NOT COMPLETED|Overall Study||0
2948624|NCT00687167|3662285|FG000|STARTED|First Intervention||17
2948625|NCT00687167|3662286|FG001|STARTED|First Intervention||17
2948626|NCT00687167|3662285|FG000|COMPLETED|First Intervention||17
2948627|NCT00687167|3662286|FG001|COMPLETED|First Intervention||17
2948628|NCT00687167|3662285|FG000|NOT COMPLETED|First Intervention||0
2948629|NCT00687167|3662286|FG001|NOT COMPLETED|First Intervention||0
2948630|NCT00687167|3662285|FG000|STARTED|Washout Period of 28 Days||17
2948631|NCT00687167|3662286|FG001|STARTED|Washout Period of 28 Days||17
2948632|NCT00687167|3662285|FG000|COMPLETED|Washout Period of 28 Days||17
2948633|NCT00687167|3662286|FG001|COMPLETED|Washout Period of 28 Days||17
2948634|NCT00687167|3662285|FG000|NOT COMPLETED|Washout Period of 28 Days||0
2948635|NCT00687167|3662286|FG001|NOT COMPLETED|Washout Period of 28 Days||0
2948636|NCT00687167|3662285|FG000|STARTED|Second Intervention||17
2948637|NCT00687167|3662286|FG001|STARTED|Second Intervention||17
2948638|NCT00687167|3662285|FG000|COMPLETED|Second Intervention||17
2948639|NCT00687167|3662286|FG001|COMPLETED|Second Intervention||17
2948640|NCT00687167|3662285|FG000|NOT COMPLETED|Second Intervention||0
2948641|NCT00687167|3662286|FG001|NOT COMPLETED|Second Intervention||0
2948642|NCT00687193|3662298|FG000|STARTED|Overall Study||53
2948643|NCT00687193|3662299|FG001|STARTED|Overall Study||53
2948644|NCT00687193|3662300|FG002|STARTED|Overall Study||52
2948645|NCT00687193|3662301|FG003|STARTED|Overall Study||53
2948646|NCT00687193|3662302|FG004|STARTED|Overall Study||54
2948647|NCT00687193|3662303|FG005|STARTED|Overall Study|One participant withdrew after randomization but prior to treatment.|52
2948648|NCT00687193|3662298|FG000|COMPLETED|Overall Study||51
2948649|NCT00687193|3662299|FG001|COMPLETED|Overall Study||49
2948650|NCT00687193|3662300|FG002|COMPLETED|Overall Study||50
2948651|NCT00687193|3662301|FG003|COMPLETED|Overall Study||49
2948652|NCT00687193|3662302|FG004|COMPLETED|Overall Study||52
2948653|NCT00687193|3662303|FG005|COMPLETED|Overall Study||48
2948654|NCT00687193|3662298|FG000|NOT COMPLETED|Overall Study||2
2948655|NCT00687193|3662299|FG001|NOT COMPLETED|Overall Study||4
2948656|NCT00687193|3662300|FG002|NOT COMPLETED|Overall Study||2
3299009|NCT02929329|4032699|FG001|COMPLETED|Overall Study|9 participants in this group who discontinued the study had unknown vital status at the end of study|3028
3299010|NCT02929329|4032698|FG000|NOT COMPLETED|Overall Study||1104
3299011|NCT02929329|4032699|FG001|NOT COMPLETED|Overall Study||1092
3299012|NCT02929407|4032709|FG000|STARTED|Overall Study||4
3299013|NCT02929407|4032709|FG000|COMPLETED|Overall Study||3
3299014|NCT02929407|4032709|FG000|NOT COMPLETED|Overall Study||1
3299015|NCT02929498|4032716|FG000|STARTED|Part 1: Dose Confirmation (Upto 2 Years)||5
3299016|NCT02929498|4032717|FG001|STARTED|Part 1: Dose Confirmation (Upto 2 Years)||0
3299017|NCT02929498|4032718|FG002|STARTED|Part 1: Dose Confirmation (Upto 2 Years)||0
3299018|NCT02929498|4032716|FG000|COMPLETED|Part 1: Dose Confirmation (Upto 2 Years)||0
3299019|NCT02929498|4032717|FG001|COMPLETED|Part 1: Dose Confirmation (Upto 2 Years)||0
3299020|NCT02929498|4032718|FG002|COMPLETED|Part 1: Dose Confirmation (Upto 2 Years)||0
3299021|NCT02929498|4032716|FG000|NOT COMPLETED|Part 1: Dose Confirmation (Upto 2 Years)||5
3299022|NCT02929498|4032717|FG001|NOT COMPLETED|Part 1: Dose Confirmation (Upto 2 Years)||0
3299023|NCT02929498|4032718|FG002|NOT COMPLETED|Part 1: Dose Confirmation (Upto 2 Years)||0
3299024|NCT02929498|4032716|FG000|STARTED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
3299025|NCT02929498|4032717|FG001|STARTED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
3299026|NCT02929498|4032718|FG002|STARTED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
3299027|NCT02929498|4032716|FG000|COMPLETED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
3299028|NCT02929498|4032717|FG001|COMPLETED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
3299029|NCT02929498|4032718|FG002|COMPLETED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
2948657|NCT00687193|3662301|FG003|NOT COMPLETED|Overall Study||4
2948658|NCT00687193|3662302|FG004|NOT COMPLETED|Overall Study||2
2948659|NCT00687193|3662303|FG005|NOT COMPLETED|Overall Study||4
2948660|NCT00687219|3662320|FG000|STARTED|Overall Study||102
2948661|NCT00687219|3662320|FG000|COMPLETED|Overall Study||51
2948662|NCT00687219|3662320|FG000|NOT COMPLETED|Overall Study||51
2948663|NCT00687271|3662328|FG000|STARTED|Overall Study||94
2948664|NCT00687271|3662329|FG001|STARTED|Overall Study||96
2948665|NCT00687271|3662330|FG002|STARTED|Overall Study||96
2948666|NCT00687271|3662331|FG003|STARTED|Overall Study||48
2948667|NCT00687271|3662328|FG000|Treated|Overall Study||94
2948668|NCT00687271|3662329|FG001|Treated|Overall Study||95
2948669|NCT00687271|3662330|FG002|Treated|Overall Study||96
2948670|NCT00687271|3662331|FG003|Treated|Overall Study||48
2948671|NCT00687271|3662328|FG000|COMPLETED|Overall Study||91
2948672|NCT00687271|3662329|FG001|COMPLETED|Overall Study||90
2948673|NCT00687271|3662330|FG002|COMPLETED|Overall Study||91
2948674|NCT00687271|3662331|FG003|COMPLETED|Overall Study||48
2948675|NCT00687271|3662328|FG000|NOT COMPLETED|Overall Study||3
2948676|NCT00687271|3662329|FG001|NOT COMPLETED|Overall Study||6
2948677|NCT00687271|3662330|FG002|NOT COMPLETED|Overall Study||5
2948678|NCT00687271|3662331|FG003|NOT COMPLETED|Overall Study||0
2948679|NCT00687297|3662343|FG000|STARTED|Randomization||80
2948680|NCT00687297|3662344|FG001|STARTED|Randomization||82
2948681|NCT00687297|3662343|FG000|COMPLETED|Randomization||77
2948682|NCT00687297|3662344|FG001|COMPLETED|Randomization||81
2948683|NCT00687297|3662343|FG000|NOT COMPLETED|Randomization||3
2948684|NCT00687297|3662344|FG001|NOT COMPLETED|Randomization||1
2948685|NCT00687297|3662343|FG000|STARTED|Induction||77
2948686|NCT00687297|3662344|FG001|STARTED|Induction||81
2948687|NCT00687297|3662343|FG000|COMPLETED|Induction||32
2948688|NCT00687297|3662344|FG001|COMPLETED|Induction||26
2948689|NCT00687297|3662343|FG000|NOT COMPLETED|Induction||45
2948690|NCT00687297|3662344|FG001|NOT COMPLETED|Induction||55
2948691|NCT00687297|3662343|FG000|STARTED|Maintenance||32
2948692|NCT00687297|3662344|FG001|STARTED|Maintenance||26
2948693|NCT00687297|3662343|FG000|COMPLETED|Maintenance||29
2948694|NCT00687297|3662344|FG001|COMPLETED|Maintenance||25
2948695|NCT00687297|3662343|FG000|NOT COMPLETED|Maintenance||3
2948696|NCT00687297|3662344|FG001|NOT COMPLETED|Maintenance||1
2948697|NCT00687323|3662352|FG000|STARTED|Overall Study|Number of screened participants|195
2948698|NCT00687323|3662352|FG000|Received Treatment|Overall Study||47
2948699|NCT00687323|3662352|FG000|COMPLETED|Overall Study|Number of participants alive at one year|15
2948700|NCT00687323|3662352|FG000|NOT COMPLETED|Overall Study||180
2948701|NCT00687362|3662356|FG000|STARTED|Overall Study||22
2948702|NCT00687362|3662356|FG000|COMPLETED|Overall Study|Completed protocol at Week 24|19
2948703|NCT00687362|3662356|FG000|NOT COMPLETED|Overall Study||3
2948704|NCT00687401|3662360|FG000|STARTED|Overall Study|215 participants enrolled in the study, of which 56 failed screening and did not receive study drug.|159
2948705|NCT00687401|3662360|FG000|COMPLETED|Overall Study||129
2948706|NCT00687401|3662360|FG000|NOT COMPLETED|Overall Study||30
2948707|NCT00687440|3662365|FG000|STARTED|Overall Study|Number of screened participants|27
2948708|NCT00687440|3662365|FG000|COMPLETED|Overall Study||15
2948709|NCT00687440|3662365|FG000|NOT COMPLETED|Overall Study||12
2948710|NCT00687453|3662371|FG000|STARTED|Overall Study||11
2948711|NCT00687453|3662372|FG001|STARTED|Overall Study||13
2948712|NCT00687453|3662371|FG000|COMPLETED|Overall Study||8
2948713|NCT00687453|3662372|FG001|COMPLETED|Overall Study||7
2948714|NCT00687453|3662371|FG000|NOT COMPLETED|Overall Study||3
2948715|NCT00687453|3662372|FG001|NOT COMPLETED|Overall Study||6
2948716|NCT00687544|3662378|FG000|STARTED|Overall Study||11
2948717|NCT00687544|3662378|FG000|COMPLETED|Overall Study||0
2948718|NCT00687544|3662378|FG000|NOT COMPLETED|Overall Study||11
2948719|NCT00687609|3662382|FG000|STARTED|Overall Study||7
2948720|NCT00687609|3662382|FG000|COMPLETED|Overall Study||4
2948721|NCT00687609|3662382|FG000|NOT COMPLETED|Overall Study||3
2948722|NCT00687674|3662386|FG000|STARTED|Overall Study||13
2948723|NCT00687674|3662386|FG000|COMPLETED|Overall Study||11
2948724|NCT00687674|3662386|FG000|NOT COMPLETED|Overall Study||2
2948725|NCT00687713|3662392|FG000|STARTED|Overall Study||100
2948726|NCT00687713|3662393|FG001|STARTED|Overall Study||104
2948727|NCT00687713|3662392|FG000|COMPLETED|Overall Study||68
2948728|NCT00687713|3662393|FG001|COMPLETED|Overall Study||64
2948729|NCT00687713|3662392|FG000|NOT COMPLETED|Overall Study||32
2948730|NCT00687713|3662393|FG001|NOT COMPLETED|Overall Study||40
2948731|NCT00687739|3662405|FG000|STARTED|Overall Study||25
2948732|NCT00687739|3662406|FG001|STARTED|Overall Study||15
2948733|NCT00687739|3662407|FG002|STARTED|Overall Study||25
2948734|NCT00687739|3662408|FG003|STARTED|Overall Study||14
2948735|NCT00687739|3662405|FG000|COMPLETED|Overall Study||23
2948736|NCT00687739|3662406|FG001|COMPLETED|Overall Study||12
2948737|NCT00687739|3662407|FG002|COMPLETED|Overall Study||23
2948738|NCT00687739|3662408|FG003|COMPLETED|Overall Study||12
2948739|NCT00687739|3662405|FG000|NOT COMPLETED|Overall Study||2
2948740|NCT00687739|3662406|FG001|NOT COMPLETED|Overall Study||3
2948741|NCT00687739|3662407|FG002|NOT COMPLETED|Overall Study||2
2948742|NCT00687739|3662408|FG003|NOT COMPLETED|Overall Study||2
2948743|NCT00687804|3662423|FG000|STARTED|Core Study||116
2948744|NCT00687804|3662424|FG001|STARTED|Core Study||118
2948745|NCT00687804|3662425|FG002|STARTED|Core Study||111
2948746|NCT00687804|3662423|FG000|COMPLETED|Core Study||102
2948747|NCT00687804|3662424|FG001|COMPLETED|Core Study||103
2948748|NCT00687804|3662425|FG002|COMPLETED|Core Study||98
2948749|NCT00687804|3662423|FG000|NOT COMPLETED|Core Study||14
2948750|NCT00687804|3662424|FG001|NOT COMPLETED|Core Study||15
2948751|NCT00687804|3662425|FG002|NOT COMPLETED|Core Study||13
2948752|NCT00687804|3662423|FG000|STARTED|Open-Label Extension Study||83
2948753|NCT00687804|3662424|FG001|STARTED|Open-Label Extension Study||83
2948754|NCT00687804|3662425|FG002|STARTED|Open-Label Extension Study||74
2948755|NCT00687804|3662423|FG000|Did Not Receive Ranibizumab in Extension|Open-Label Extension Study||16
2948756|NCT00687804|3662424|FG001|Did Not Receive Ranibizumab in Extension|Open-Label Extension Study||21
2948757|NCT00687804|3662425|FG002|Did Not Receive Ranibizumab in Extension|Open-Label Extension Study||15
2948758|NCT00687804|3662423|FG000|COMPLETED|Open-Label Extension Study||73
2948759|NCT00687804|3662424|FG001|COMPLETED|Open-Label Extension Study||72
2948760|NCT00687804|3662425|FG002|COMPLETED|Open-Label Extension Study||63
2948761|NCT00687804|3662423|FG000|NOT COMPLETED|Open-Label Extension Study||10
2948762|NCT00687804|3662424|FG001|NOT COMPLETED|Open-Label Extension Study||11
2948763|NCT00687804|3662425|FG002|NOT COMPLETED|Open-Label Extension Study||11
2948764|NCT00687830|3662441|FG000|STARTED|Overall Study||68
2948765|NCT00687830|3662442|FG001|STARTED|Overall Study||68
2948766|NCT00687830|3662441|FG000|COMPLETED|Overall Study||68
2948767|NCT00687830|3662442|FG001|COMPLETED|Overall Study||68
2948768|NCT00687830|3662441|FG000|NOT COMPLETED|Overall Study||0
2948769|NCT00687830|3662442|FG001|NOT COMPLETED|Overall Study||0
2948770|NCT00687856|3662448|FG000|STARTED|Overall Study||211
2948771|NCT00687856|3662448|FG000|COMPLETED|Overall Study||211
2948772|NCT00687856|3662448|FG000|NOT COMPLETED|Overall Study||0
2948773|NCT00687908|3662454|FG000|STARTED|Overall Study||123
2948774|NCT00687908|3662455|FG001|STARTED|Overall Study||120
2948775|NCT00687908|3662454|FG000|COMPLETED|Overall Study||105
2948776|NCT00687908|3662455|FG001|COMPLETED|Overall Study||78
2948777|NCT00687908|3662454|FG000|NOT COMPLETED|Overall Study||18
2948778|NCT00687908|3662455|FG001|NOT COMPLETED|Overall Study||42
2948779|NCT00687973|3662463|FG000|STARTED|Overall Study||193
2948780|NCT00687973|3662464|FG001|STARTED|Overall Study||200
2948781|NCT00687973|3662463|FG000|COMPLETED|Overall Study||169
2948782|NCT00687973|3662464|FG001|COMPLETED|Overall Study||162
2948783|NCT00687973|3662463|FG000|NOT COMPLETED|Overall Study||24
2948784|NCT00687973|3662464|FG001|NOT COMPLETED|Overall Study||38
3299030|NCT02929498|4032716|FG000|NOT COMPLETED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
3299031|NCT02929498|4032717|FG001|NOT COMPLETED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
3299032|NCT02929498|4032718|FG002|NOT COMPLETED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
3299033|NCT02929667|4032726|FG000|STARTED|Overall Study||11
3299034|NCT02929667|4032727|FG001|STARTED|Overall Study||11
3299035|NCT02929667|4032726|FG000|COMPLETED|Overall Study||11
3299036|NCT02929667|4032727|FG001|COMPLETED|Overall Study||11
3299037|NCT02929667|4032726|FG000|NOT COMPLETED|Overall Study||0
3299038|NCT02929667|4032727|FG001|NOT COMPLETED|Overall Study||0
3299039|NCT02929823|4032738|FG000|STARTED|Overall Study||42
3299040|NCT02929823|4032739|FG001|STARTED|Overall Study||46
3299041|NCT02929823|4032740|FG002|STARTED|Overall Study||42
3299042|NCT02929823|4032738|FG000|COMPLETED|Overall Study||39
3299043|NCT02929823|4032739|FG001|COMPLETED|Overall Study||40
3299044|NCT02929823|4032740|FG002|COMPLETED|Overall Study||38
3299045|NCT02929823|4032738|FG000|NOT COMPLETED|Overall Study||3
3299046|NCT02929823|4032739|FG001|NOT COMPLETED|Overall Study||6
3299047|NCT02929823|4032740|FG002|NOT COMPLETED|Overall Study||4
3034877|NCT01134263|3753930|FG000|STARTED|Overall Study||164
3034878|NCT01134263|3753931|FG001|STARTED|Overall Study||163
3034879|NCT01134263|3753932|FG002|STARTED|Overall Study||163
3034880|NCT01134263|3753933|FG003|STARTED|Overall Study||168
3034881|NCT01134263|3753934|FG004|STARTED|Overall Study||57
3034882|NCT01134263|3753930|FG000|Received Vaccination 1|Overall Study||163
3034883|NCT01134263|3753931|FG001|Received Vaccination 1|Overall Study||162
3034884|NCT01134263|3753932|FG002|Received Vaccination 1|Overall Study||163
3034885|NCT01134263|3753933|FG003|Received Vaccination 1|Overall Study||167
3034886|NCT01134263|3753934|FG004|Received Vaccination 1|Overall Study||57
3034887|NCT01134263|3753930|FG000|Received Vaccination 2|Overall Study||151
3034888|NCT01134263|3753931|FG001|Received Vaccination 2|Overall Study||152
3034889|NCT01134263|3753932|FG002|Received Vaccination 2|Overall Study||139
3034890|NCT01134263|3753933|FG003|Received Vaccination 2|Overall Study||154
3034891|NCT01134263|3753934|FG004|Received Vaccination 2|Overall Study||53
3299048|NCT02929979|4032750|FG000|STARTED|Overall Study||52
3299049|NCT02929979|4032751|FG001|STARTED|Overall Study||38
3299050|NCT02929979|4032750|FG000|COMPLETED|Overall Study||25
3299051|NCT02929979|4032751|FG001|COMPLETED|Overall Study||28
3299052|NCT02929979|4032750|FG000|NOT COMPLETED|Overall Study||27
3299053|NCT02929979|4032751|FG001|NOT COMPLETED|Overall Study||10
3299054|NCT02930005|4032760|FG000|STARTED|Overall Study||2
3299055|NCT02930005|4032761|FG001|STARTED|Overall Study||6
3299056|NCT02930005|4032760|FG000|Completed 2 Weeks|Overall Study||2
3299057|NCT02930005|4032761|FG001|Completed 2 Weeks|Overall Study||2
3299058|NCT02930005|4032760|FG000|COMPLETED|Overall Study||1
3299059|NCT02930005|4032761|FG001|COMPLETED|Overall Study||1
3034892|NCT01134263|3753930|FG000|Received Vaccination 3|Overall Study||140
3034893|NCT01134263|3753931|FG001|Received Vaccination 3|Overall Study||145
3034894|NCT01134263|3753932|FG002|Received Vaccination 3|Overall Study||134
3299060|NCT02930005|4032760|FG000|NOT COMPLETED|Overall Study||1
3299061|NCT02930005|4032761|FG001|NOT COMPLETED|Overall Study||5
3299062|NCT02930018|4032769|FG000|STARTED|Overall Study||556
3299063|NCT02930018|4032770|FG001|STARTED|Overall Study||549
2948785|NCT00688064|3662473|FG000|STARTED|Overall Study||232
2948786|NCT00688064|3662474|FG001|STARTED|Overall Study||227
2948787|NCT00688064|3662473|FG000|COMPLETED|Overall Study||211
2948788|NCT00688064|3662474|FG001|COMPLETED|Overall Study||201
2948789|NCT00688064|3662473|FG000|NOT COMPLETED|Overall Study||21
2948790|NCT00688064|3662474|FG001|NOT COMPLETED|Overall Study||26
2948791|NCT00688103|3662482|FG000|STARTED|Overall Study||74
2948792|NCT00688103|3662483|FG001|STARTED|Overall Study||77
2948793|NCT00688103|3662482|FG000|Actually Treated|Overall Study||71
2948794|NCT00688103|3662483|FG001|Actually Treated|Overall Study||76
2948795|NCT00688103|3662482|FG000|COMPLETED|Overall Study||44
2948796|NCT00688103|3662483|FG001|COMPLETED|Overall Study||64
2948797|NCT00688103|3662482|FG000|NOT COMPLETED|Overall Study||30
2948798|NCT00688103|3662483|FG001|NOT COMPLETED|Overall Study||13
2948799|NCT00688155|3662495|FG000|STARTED|Overall Study||18
2948800|NCT00688155|3662496|FG001|STARTED|Overall Study||18
2948801|NCT00688155|3662497|FG002|STARTED|Overall Study||19
2948802|NCT00688155|3662498|FG003|STARTED|Overall Study||18
2948803|NCT00688155|3662495|FG000|COMPLETED|Overall Study||16
2948804|NCT00688155|3662496|FG001|COMPLETED|Overall Study||16
2948805|NCT00688155|3662497|FG002|COMPLETED|Overall Study||18
2948806|NCT00688155|3662498|FG003|COMPLETED|Overall Study||17
2948807|NCT00688155|3662495|FG000|NOT COMPLETED|Overall Study||2
2948808|NCT00688155|3662496|FG001|NOT COMPLETED|Overall Study||2
2948809|NCT00688155|3662497|FG002|NOT COMPLETED|Overall Study||1
2948810|NCT00688155|3662498|FG003|NOT COMPLETED|Overall Study||1
2948811|NCT00688181|3662508|FG000|STARTED|Overall Study||36
2948812|NCT00688181|3662508|FG000|COMPLETED|Overall Study||13
2948813|NCT00688181|3662508|FG000|NOT COMPLETED|Overall Study||23
2948814|NCT00688259|3662516|FG000|STARTED|Overall Study||44
2948815|NCT00688259|3662517|FG001|STARTED|Overall Study||44
2948816|NCT00688259|3662516|FG000|End to Active Treatment,|Overall Study||37
2948817|NCT00688259|3662517|FG001|End to Active Treatment,|Overall Study||37
2948818|NCT00688259|3662516|FG000|COMPLETED|Overall Study||37
2948819|NCT00688259|3662517|FG001|COMPLETED|Overall Study||36
2948820|NCT00688259|3662516|FG000|NOT COMPLETED|Overall Study||7
2948821|NCT00688259|3662517|FG001|NOT COMPLETED|Overall Study||8
2948822|NCT00688324|3662523|FG000|STARTED|Overall Study||36
2948823|NCT00688324|3662523|FG000|COMPLETED|Overall Study||28
2948824|NCT00688324|3662523|FG000|NOT COMPLETED|Overall Study||8
2948825|NCT00688467|3662530|FG000|STARTED|Treatment Period 1||9
2948826|NCT00688467|3662531|FG001|STARTED|Treatment Period 1||10
2948827|NCT00688467|3662530|FG000|COMPLETED|Treatment Period 1||7
2948828|NCT00688467|3662531|FG001|COMPLETED|Treatment Period 1||8
2948829|NCT00688467|3662530|FG000|NOT COMPLETED|Treatment Period 1||2
2948830|NCT00688467|3662531|FG001|NOT COMPLETED|Treatment Period 1||2
2948831|NCT00688467|3662530|FG000|STARTED|Treatment Period 2||7
2948832|NCT00688467|3662531|FG001|STARTED|Treatment Period 2||8
2948833|NCT00688467|3662530|FG000|COMPLETED|Treatment Period 2||7
2948834|NCT00688467|3662531|FG001|COMPLETED|Treatment Period 2||6
2948835|NCT00688467|3662530|FG000|NOT COMPLETED|Treatment Period 2||0
2948836|NCT00688467|3662531|FG001|NOT COMPLETED|Treatment Period 2||2
2948837|NCT00688519|3662539|FG000|STARTED|Overall Study||223
2948838|NCT00688519|3662540|FG001|STARTED|Overall Study||113
2948839|NCT00688519|3662539|FG000|COMPLETED|Overall Study||204
2948840|NCT00688519|3662540|FG001|COMPLETED|Overall Study||98
2948841|NCT00688519|3662539|FG000|NOT COMPLETED|Overall Study||19
2948842|NCT00688519|3662540|FG001|NOT COMPLETED|Overall Study||15
2948843|NCT00688545|3662548|FG000|STARTED|Overall Study||55
2948844|NCT00688545|3662549|FG001|STARTED|Overall Study||219
2948845|NCT00688545|3662548|FG000|Switched Treatment at Least Once|Overall Study||6
2948846|NCT00688545|3662549|FG001|Switched Treatment at Least Once|Overall Study||13
2948847|NCT00688545|3662548|FG000|COMPLETED|Overall Study||50
2948848|NCT00688545|3662549|FG001|COMPLETED|Overall Study||204
2948849|NCT00688545|3662548|FG000|NOT COMPLETED|Overall Study||5
2948850|NCT00688545|3662549|FG001|NOT COMPLETED|Overall Study||15
2948851|NCT00688597|3662560|FG000|STARTED|Overall Study||3
2948852|NCT00688597|3662561|FG001|STARTED|Overall Study||0
2948853|NCT00688597|3662562|FG002|STARTED|Overall Study||0
2948854|NCT00688597|3662560|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
2948855|NCT00688597|3662561|FG001|Received at Least 1 Dose of Study Drug|Overall Study||0
2948856|NCT00688597|3662562|FG002|Received at Least 1 Dose of Study Drug|Overall Study||0
2948857|NCT00688597|3662560|FG000|COMPLETED|Overall Study||0
2948858|NCT00688597|3662561|FG001|COMPLETED|Overall Study||0
2948859|NCT00688597|3662562|FG002|COMPLETED|Overall Study||0
2948860|NCT00688597|3662560|FG000|NOT COMPLETED|Overall Study||3
2948861|NCT00688597|3662561|FG001|NOT COMPLETED|Overall Study||0
2948862|NCT00688597|3662562|FG002|NOT COMPLETED|Overall Study||0
2948863|NCT00688623|3662570|FG000|STARTED|Overall Study|Intent to treat (ITT)|73
2948864|NCT00688623|3662570|FG000|Safety Analysis Set|Overall Study|received at least one dose of study drug and had at least one post-baseline safety assessment|73
2948865|NCT00688623|3662570|FG000|Per Protocol (PP)|Overall Study|no major protocol deviation and 50% of planned dose of 8 weeks or d/c due to disease progression|60
2948866|NCT00688623|3662570|FG000|COMPLETED|Overall Study||18
2948867|NCT00688623|3662570|FG000|NOT COMPLETED|Overall Study||55
3299064|NCT02930018|4032769|FG000|COMPLETED|Overall Study||550
3299065|NCT02930018|4032770|FG001|COMPLETED|Overall Study||546
3299066|NCT02930018|4032769|FG000|NOT COMPLETED|Overall Study||6
3299067|NCT02930018|4032770|FG001|NOT COMPLETED|Overall Study||3
3299068|NCT02930174|4032778|FG000|STARTED|Overall Study||12
2948868|NCT00688636|3662576|FG000|STARTED|Overall Study||11
2948869|NCT00688636|3662577|FG001|STARTED|Overall Study||13
2948870|NCT00688636|3662576|FG000|COMPLETED|Overall Study||9
2948871|NCT00688636|3662577|FG001|COMPLETED|Overall Study||12
2948872|NCT00688636|3662576|FG000|NOT COMPLETED|Overall Study||2
2948873|NCT00688636|3662577|FG001|NOT COMPLETED|Overall Study||1
2948874|NCT00688662|3662585|FG000|STARTED|Overall Study||141
2948875|NCT00688662|3662586|FG001|STARTED|Overall Study||73
2948876|NCT00688662|3662585|FG000|COMPLETED|Overall Study||118
2948877|NCT00688662|3662586|FG001|COMPLETED|Overall Study||55
2948878|NCT00688662|3662585|FG000|NOT COMPLETED|Overall Study||23
2948879|NCT00688662|3662586|FG001|NOT COMPLETED|Overall Study||18
2948880|NCT00688688|3662596|FG000|STARTED|Overall Study||815
2948881|NCT00688688|3662597|FG001|STARTED|Overall Study||824
2948882|NCT00688688|3662598|FG002|STARTED|Overall Study||813
2948883|NCT00688688|3662596|FG000|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|812
2948884|NCT00688688|3662597|FG001|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|820
2948885|NCT00688688|3662598|FG002|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|812
2948886|NCT00688688|3662596|FG000|Full Analysis Set (FAS)|Overall Study|All treated patients with a baseline and at least 1 post-baseline micturition measurement.|789
2948887|NCT00688688|3662597|FG001|Full Analysis Set (FAS)|Overall Study|All treated patients with a baseline and at least 1 post-baseline micturition measurement.|802
2948888|NCT00688688|3662598|FG002|Full Analysis Set (FAS)|Overall Study|All treated patients with a baseline and at least 1 post-baseline micturition measurement.|791
2948889|NCT00688688|3662596|FG000|Full Analysis Set Incontinence (FAS-I)|Overall Study|All FAS patients who had at least 1 incontinence episode at Baseline.|479
2948890|NCT00688688|3662597|FG001|Full Analysis Set Incontinence (FAS-I)|Overall Study|All FAS patients who had at least 1 incontinence episode at Baseline.|483
2948891|NCT00688688|3662598|FG002|Full Analysis Set Incontinence (FAS-I)|Overall Study|All FAS patients who had at least 1 incontinence episode at Baseline.|488
2948892|NCT00688688|3662596|FG000|COMPLETED|Overall Study||629
2948893|NCT00688688|3662597|FG001|COMPLETED|Overall Study||645
2948894|NCT00688688|3662598|FG002|COMPLETED|Overall Study||621
2948895|NCT00688688|3662596|FG000|NOT COMPLETED|Overall Study||186
2948896|NCT00688688|3662597|FG001|NOT COMPLETED|Overall Study||179
2948897|NCT00688688|3662598|FG002|NOT COMPLETED|Overall Study||192
2948898|NCT00688701|3662609|FG000|STARTED|Overall Study|Randomized|61
2948899|NCT00688701|3662610|FG001|STARTED|Overall Study||61
2948900|NCT00688701|3662611|FG002|STARTED|Overall Study||120
2948901|NCT00688701|3662612|FG003|STARTED|Overall Study||119
2948902|NCT00688701|3662609|FG000|Treated/Safety Population|Overall Study|All patients who received at least 1 dose, regardless of amount of treatment administered.|61
2948903|NCT00688701|3662610|FG001|Treated/Safety Population|Overall Study||61
2948904|NCT00688701|3662611|FG002|Treated/Safety Population|Overall Study||120
2948905|NCT00688701|3662612|FG003|Treated/Safety Population|Overall Study||119
2948906|NCT00688701|3662609|FG000|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|61
2948907|NCT00688701|3662610|FG001|Modified Intent-to-Treat(mITT)Population|Overall Study||60
2948908|NCT00688701|3662611|FG002|Modified Intent-to-Treat(mITT)Population|Overall Study||120
2948909|NCT00688701|3662612|FG003|Modified Intent-to-Treat(mITT)Population|Overall Study||118
2948910|NCT00688701|3662609|FG000|Subgroup for Standardized Meal Test|Overall Study|Patients at selected sites where standardized meal test was performed.|27
2948911|NCT00688701|3662610|FG001|Subgroup for Standardized Meal Test|Overall Study||35
2948912|NCT00688701|3662611|FG002|Subgroup for Standardized Meal Test|Overall Study||60
2948913|NCT00688701|3662612|FG003|Subgroup for Standardized Meal Test|Overall Study||65
2948914|NCT00688701|3662609|FG000|COMPLETED|Overall Study||57
2948915|NCT00688701|3662610|FG001|COMPLETED|Overall Study||56
2948916|NCT00688701|3662611|FG002|COMPLETED|Overall Study||110
2948917|NCT00688701|3662612|FG003|COMPLETED|Overall Study||108
2948918|NCT00688701|3662609|FG000|NOT COMPLETED|Overall Study||4
2948919|NCT00688701|3662610|FG001|NOT COMPLETED|Overall Study||5
2948920|NCT00688701|3662611|FG002|NOT COMPLETED|Overall Study||10
2948921|NCT00688701|3662612|FG003|NOT COMPLETED|Overall Study||11
2948922|NCT00688740|3662625|FG000|STARTED|Overall Study||745
2948923|NCT00688740|3662626|FG001|STARTED|Overall Study||746
2948924|NCT00688740|3662625|FG000|COMPLETED|Overall Study||679
2948925|NCT00688740|3662626|FG001|COMPLETED|Overall Study||711
2948926|NCT00688740|3662625|FG000|NOT COMPLETED|Overall Study||66
2948927|NCT00688740|3662626|FG001|NOT COMPLETED|Overall Study||35
2948928|NCT00688753|3662632|FG000|STARTED|Overall Study||92
2948929|NCT00688753|3662632|FG000|COMPLETED|Overall Study||0
2948930|NCT00688753|3662632|FG000|NOT COMPLETED|Overall Study||92
2948931|NCT00688844|3662636|FG000|STARTED|Overall Study||58
3299069|NCT02930174|4032779|FG001|STARTED|Overall Study||8
3299070|NCT02930174|4032778|FG000|COMPLETED|Overall Study||12
3299071|NCT02930174|4032779|FG001|COMPLETED|Overall Study||8
3299072|NCT02930174|4032778|FG000|NOT COMPLETED|Overall Study||0
3299073|NCT02930174|4032779|FG001|NOT COMPLETED|Overall Study||0
3299074|NCT02930226|4032793|FG000|STARTED|Overall Study||4
3299075|NCT02930226|4032794|FG001|STARTED|Overall Study||4
3299076|NCT02930226|4032795|FG002|STARTED|Overall Study||4
3299077|NCT02930226|4032796|FG003|STARTED|Overall Study||4
3299078|NCT02930226|4032797|FG004|STARTED|Overall Study||4
3299079|NCT02930226|4032798|FG005|STARTED|Overall Study||4
3299080|NCT02930226|4032793|FG000|COMPLETED|Overall Study||4
3299081|NCT02930226|4032794|FG001|COMPLETED|Overall Study||4
2948932|NCT00688844|3662636|FG000|COMPLETED|Overall Study||48
2948933|NCT00688844|3662636|FG000|NOT COMPLETED|Overall Study||10
2948934|NCT00688870|3662642|FG000|STARTED|Infant Series||84
2948935|NCT00688870|3662643|FG001|STARTED|Infant Series||84
2948936|NCT00688870|3662642|FG000|Vaccinated Dose 1|Infant Series||83
2948937|NCT00688870|3662643|FG001|Vaccinated Dose 1|Infant Series||84
2948938|NCT00688870|3662642|FG000|Vaccinated Dose 2|Infant Series||80
2948939|NCT00688870|3662643|FG001|Vaccinated Dose 2|Infant Series||84
2948940|NCT00688870|3662642|FG000|Vaccinated Dose 3|Infant Series||80
2948941|NCT00688870|3662643|FG001|Vaccinated Dose 3|Infant Series||84
2948942|NCT00688870|3662642|FG000|COMPLETED|Infant Series||80
2948943|NCT00688870|3662643|FG001|COMPLETED|Infant Series||84
2948944|NCT00688870|3662642|FG000|NOT COMPLETED|Infant Series||4
2948945|NCT00688870|3662643|FG001|NOT COMPLETED|Infant Series||0
2948946|NCT00688870|3662642|FG000|STARTED|After Infant Series||80
2948947|NCT00688870|3662643|FG001|STARTED|After Infant Series||84
2948948|NCT00688870|3662642|FG000|COMPLETED|After Infant Series||80
2948949|NCT00688870|3662643|FG001|COMPLETED|After Infant Series||84
2948950|NCT00688870|3662642|FG000|NOT COMPLETED|After Infant Series||0
2948951|NCT00688870|3662643|FG001|NOT COMPLETED|After Infant Series||0
2948952|NCT00688870|3662642|FG000|STARTED|Toddler Dose||80
2948953|NCT00688870|3662643|FG001|STARTED|Toddler Dose||84
2948954|NCT00688870|3662642|FG000|COMPLETED|Toddler Dose||80
2948955|NCT00688870|3662643|FG001|COMPLETED|Toddler Dose||84
2948956|NCT00688870|3662642|FG000|NOT COMPLETED|Toddler Dose||0
2948957|NCT00688870|3662643|FG001|NOT COMPLETED|Toddler Dose||0
2948958|NCT00688909|3662653|FG000|STARTED|Overall Study||261
2948959|NCT00688909|3662653|FG000|COMPLETED|Overall Study||228
2948960|NCT00688909|3662653|FG000|NOT COMPLETED|Overall Study||33
2948961|NCT00689026|3662660|FG000|STARTED|Overall Study||30
2948962|NCT00689026|3662661|FG001|STARTED|Overall Study||30
2948963|NCT00689026|3662660|FG000|COMPLETED|Overall Study||17
2948964|NCT00689026|3662661|FG001|COMPLETED|Overall Study||24
2948965|NCT00689026|3662660|FG000|NOT COMPLETED|Overall Study||13
2948966|NCT00689026|3662661|FG001|NOT COMPLETED|Overall Study||6
2948967|NCT00689078|3662671|FG000|STARTED|Overall Study||9
2948968|NCT00689078|3662672|FG001|STARTED|Overall Study||9
2948969|NCT00689078|3662673|FG002|STARTED|Overall Study||9
2948970|NCT00689078|3662674|FG003|STARTED|Overall Study||9
2948971|NCT00689078|3662671|FG000|Intent to Treat|Overall Study||9
2948972|NCT00689078|3662672|FG001|Intent to Treat|Overall Study||7
2948973|NCT00689078|3662673|FG002|Intent to Treat|Overall Study||8
2948974|NCT00689078|3662674|FG003|Intent to Treat|Overall Study||8
2948975|NCT00689078|3662671|FG000|COMPLETED|Overall Study||9
2948976|NCT00689078|3662672|FG001|COMPLETED|Overall Study||7
2948977|NCT00689078|3662673|FG002|COMPLETED|Overall Study||8
2948978|NCT00689078|3662674|FG003|COMPLETED|Overall Study||8
2948979|NCT00689078|3662671|FG000|NOT COMPLETED|Overall Study||0
2948980|NCT00689078|3662672|FG001|NOT COMPLETED|Overall Study||2
2948981|NCT00689078|3662673|FG002|NOT COMPLETED|Overall Study||1
2948982|NCT00689078|3662674|FG003|NOT COMPLETED|Overall Study||1
2948983|NCT00689091|3662686|FG000|STARTED|Overall Study||10831
2948984|NCT00689091|3662687|FG001|STARTED|Overall Study||10770
2948985|NCT00689091|3662686|FG000|COMPLETED|Overall Study||9460
2948986|NCT00689091|3662687|FG001|COMPLETED|Overall Study||9376
2948987|NCT00689091|3662686|FG000|NOT COMPLETED|Overall Study||1371
2948988|NCT00689091|3662687|FG001|NOT COMPLETED|Overall Study||1394
2948989|NCT00689104|3662701|FG000|STARTED|Overall Study||497
2948990|NCT00689104|3662702|FG001|STARTED|Overall Study||497
2948991|NCT00689104|3662703|FG002|STARTED|Overall Study||498
2948992|NCT00689104|3662704|FG003|STARTED|Overall Study||495
2948993|NCT00689104|3662701|FG000|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|494
2948994|NCT00689104|3662702|FG001|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|493
2948995|NCT00689104|3662703|FG002|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|496
2948996|NCT00689104|3662704|FG003|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|495
2948997|NCT00689104|3662701|FG000|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|480
2948998|NCT00689104|3662702|FG001|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|473
2948999|NCT00689104|3662703|FG002|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|478
2949000|NCT00689104|3662704|FG003|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|475
2949001|NCT00689104|3662701|FG000|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|291
2949002|NCT00689104|3662702|FG001|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|293
2949003|NCT00689104|3662703|FG002|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|281
2949004|NCT00689104|3662704|FG003|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|300
2949005|NCT00689104|3662701|FG000|COMPLETED|Overall Study||453
2949006|NCT00689104|3662702|FG001|COMPLETED|Overall Study||440
2949007|NCT00689104|3662703|FG002|COMPLETED|Overall Study||453
2949008|NCT00689104|3662704|FG003|COMPLETED|Overall Study||445
2949009|NCT00689104|3662701|FG000|NOT COMPLETED|Overall Study||44
2949010|NCT00689104|3662702|FG001|NOT COMPLETED|Overall Study||57
2949011|NCT00689104|3662703|FG002|NOT COMPLETED|Overall Study||45
2949012|NCT00689104|3662704|FG003|NOT COMPLETED|Overall Study||50
2949013|NCT00689117|3662718|FG000|STARTED|Overall Study||476
2949014|NCT00689117|3662719|FG001|STARTED|Overall Study||467
2949015|NCT00689117|3662720|FG002|STARTED|Overall Study||464
2949016|NCT00689117|3662721|FG003|STARTED|Overall Study||242
3132478|NCT01691339|3857531|FG003|COMPLETED|Overall Study||49
3299082|NCT02930226|4032795|FG002|COMPLETED|Overall Study||4
3299083|NCT02930226|4032796|FG003|COMPLETED|Overall Study||4
2949017|NCT00689117|3662718|FG000|COMPLETED|Overall Study||414
2949018|NCT00689117|3662719|FG001|COMPLETED|Overall Study||416
2949019|NCT00689117|3662720|FG002|COMPLETED|Overall Study||405
2949020|NCT00689117|3662721|FG003|COMPLETED|Overall Study||211
2949021|NCT00689117|3662718|FG000|NOT COMPLETED|Overall Study||62
2949022|NCT00689117|3662719|FG001|NOT COMPLETED|Overall Study||51
2949023|NCT00689117|3662720|FG002|NOT COMPLETED|Overall Study||59
2949024|NCT00689117|3662721|FG003|NOT COMPLETED|Overall Study||31
2949025|NCT00689221|3662733|FG000|STARTED|Overall Study||272
2949026|NCT00689221|3662734|FG001|STARTED|Overall Study||273
2949027|NCT00689221|3662733|FG000|COMPLETED|Overall Study||233
2949028|NCT00689221|3662734|FG001|COMPLETED|Overall Study||237
2949029|NCT00689221|3662733|FG000|NOT COMPLETED|Overall Study||39
2949030|NCT00689221|3662734|FG001|NOT COMPLETED|Overall Study||36
2949031|NCT00689260|3662742|FG000|STARTED|Overall Study||21
2949032|NCT00689260|3662743|FG001|STARTED|Overall Study||21
2949033|NCT00689260|3662742|FG000|COMPLETED|Overall Study||19
2949034|NCT00689260|3662743|FG001|COMPLETED|Overall Study||21
2949035|NCT00689260|3662742|FG000|NOT COMPLETED|Overall Study||2
2949036|NCT00689260|3662743|FG001|NOT COMPLETED|Overall Study||0
2949037|NCT00689273|3662754|FG000|STARTED|Overall Study||79
2949038|NCT00689273|3662755|FG001|STARTED|Overall Study||78
2949039|NCT00689273|3662754|FG000|Treated|Overall Study||78
2949040|NCT00689273|3662755|FG001|Treated|Overall Study||78
2949041|NCT00689273|3662754|FG000|COMPLETED|Overall Study||66
2949042|NCT00689273|3662755|FG001|COMPLETED|Overall Study||73
2949043|NCT00689273|3662754|FG000|NOT COMPLETED|Overall Study||13
2949044|NCT00689273|3662755|FG001|NOT COMPLETED|Overall Study||5
2949045|NCT00689299|3662764|FG000|STARTED|Overall Study||58
2949046|NCT00689299|3662765|FG001|STARTED|Overall Study||57
2949047|NCT00689299|3662766|FG002|STARTED|Overall Study||54
2949048|NCT00689299|3662764|FG000|COMPLETED|Overall Study||51
2949049|NCT00689299|3662765|FG001|COMPLETED|Overall Study||54
2949050|NCT00689299|3662766|FG002|COMPLETED|Overall Study||49
2949051|NCT00689299|3662764|FG000|NOT COMPLETED|Overall Study||7
2949052|NCT00689299|3662765|FG001|NOT COMPLETED|Overall Study||3
2949053|NCT00689299|3662766|FG002|NOT COMPLETED|Overall Study||5
2949054|NCT00689338|3662774|FG000|STARTED|Overall Study||216
2949055|NCT00689338|3662774|FG000|COMPLETED|Overall Study||73
2949056|NCT00689338|3662774|FG000|NOT COMPLETED|Overall Study||143
2949057|NCT00689351|3662780|FG000|STARTED|Infant Series of Dosing||91
2949058|NCT00689351|3662781|FG001|STARTED|Infant Series of Dosing||89
2949059|NCT00689351|3662780|FG000|Vaccinated Dose 1|Infant Series of Dosing||88
2949060|NCT00689351|3662781|FG001|Vaccinated Dose 1|Infant Series of Dosing||89
2949061|NCT00689351|3662780|FG000|Vaccinated Dose 2|Infant Series of Dosing||86
2949062|NCT00689351|3662781|FG001|Vaccinated Dose 2|Infant Series of Dosing||88
2949063|NCT00689351|3662780|FG000|Vaccinated Dose 3|Infant Series of Dosing||85
2949064|NCT00689351|3662781|FG001|Vaccinated Dose 3|Infant Series of Dosing||88
2949065|NCT00689351|3662780|FG000|COMPLETED|Infant Series of Dosing||85
2949066|NCT00689351|3662781|FG001|COMPLETED|Infant Series of Dosing||88
3299084|NCT02930226|4032797|FG004|COMPLETED|Overall Study||3
3299085|NCT02930226|4032798|FG005|COMPLETED|Overall Study||4
3299086|NCT02930226|4032793|FG000|NOT COMPLETED|Overall Study||0
3299087|NCT02930226|4032794|FG001|NOT COMPLETED|Overall Study||0
3299088|NCT02930226|4032795|FG002|NOT COMPLETED|Overall Study||0
3299089|NCT02930226|4032796|FG003|NOT COMPLETED|Overall Study||0
3299090|NCT02930226|4032797|FG004|NOT COMPLETED|Overall Study||1
3299091|NCT02930226|4032798|FG005|NOT COMPLETED|Overall Study||0
3299092|NCT02930343|4032816|FG000|STARTED|Overall Study||68
3299093|NCT02930343|4032817|FG001|STARTED|Overall Study||68
3299094|NCT02930343|4032816|FG000|COMPLETED|Overall Study||59
3299095|NCT02930343|4032817|FG001|COMPLETED|Overall Study||61
3299096|NCT02930343|4032816|FG000|NOT COMPLETED|Overall Study||9
3299097|NCT02930343|4032817|FG001|NOT COMPLETED|Overall Study||7
3299098|NCT02930590|4032823|FG000|STARTED|First Intervention (2 Hours)||3
3299099|NCT02930590|4032824|FG001|STARTED|First Intervention (2 Hours)||3
3299100|NCT02930590|4032825|FG002|STARTED|First Intervention (2 Hours)||3
3299101|NCT02930590|4032826|FG003|STARTED|First Intervention (2 Hours)||2
3299102|NCT02930590|4032827|FG004|STARTED|First Intervention (2 Hours)||2
3299103|NCT02930590|4032828|FG005|STARTED|First Intervention (2 Hours)||2
3299104|NCT02930590|4032823|FG000|COMPLETED|First Intervention (2 Hours)||3
3299105|NCT02930590|4032824|FG001|COMPLETED|First Intervention (2 Hours)||3
3299106|NCT02930590|4032825|FG002|COMPLETED|First Intervention (2 Hours)||3
3299107|NCT02930590|4032826|FG003|COMPLETED|First Intervention (2 Hours)||2
3299108|NCT02930590|4032827|FG004|COMPLETED|First Intervention (2 Hours)||2
3299109|NCT02930590|4032828|FG005|COMPLETED|First Intervention (2 Hours)||2
3299110|NCT02930590|4032823|FG000|NOT COMPLETED|First Intervention (2 Hours)||0
3299111|NCT02930590|4032824|FG001|NOT COMPLETED|First Intervention (2 Hours)||0
3299112|NCT02930590|4032825|FG002|NOT COMPLETED|First Intervention (2 Hours)||0
2949067|NCT00689351|3662780|FG000|NOT COMPLETED|Infant Series of Dosing||6
2949068|NCT00689351|3662781|FG001|NOT COMPLETED|Infant Series of Dosing||1
2949069|NCT00689351|3662780|FG000|STARTED|After Infant Series||85
2949070|NCT00689351|3662781|FG001|STARTED|After Infant Series||88
2949071|NCT00689351|3662780|FG000|COMPLETED|After Infant Series||84
2949072|NCT00689351|3662781|FG001|COMPLETED|After Infant Series||88
2949073|NCT00689351|3662780|FG000|NOT COMPLETED|After Infant Series||1
2949074|NCT00689351|3662781|FG001|NOT COMPLETED|After Infant Series||0
2949075|NCT00689351|3662780|FG000|STARTED|Toddler Dose||84
2949076|NCT00689351|3662781|FG001|STARTED|Toddler Dose||88
2949077|NCT00689351|3662780|FG000|COMPLETED|Toddler Dose||84
2949078|NCT00689351|3662781|FG001|COMPLETED|Toddler Dose||88
2949079|NCT00689351|3662780|FG000|NOT COMPLETED|Toddler Dose||0
2949080|NCT00689351|3662781|FG001|NOT COMPLETED|Toddler Dose||0
2949081|NCT00689390|3662793|FG000|STARTED|Overall Study||1907
2949082|NCT00689390|3662794|FG001|STARTED|Overall Study||47
2949083|NCT00689390|3662793|FG000|COMPLETED|Overall Study||1481
2949084|NCT00689390|3662794|FG001|COMPLETED|Overall Study||37
2949085|NCT00689390|3662793|FG000|NOT COMPLETED|Overall Study||426
2949086|NCT00689390|3662794|FG001|NOT COMPLETED|Overall Study||10
2949087|NCT00689481|3662807|FG000|STARTED|Overall Study||214
2949088|NCT00689481|3662808|FG001|STARTED|Overall Study||109
2949089|NCT00689481|3662807|FG000|COMPLETED|Overall Study||190
2949090|NCT00689481|3662808|FG001|COMPLETED|Overall Study||95
2949091|NCT00689481|3662807|FG000|NOT COMPLETED|Overall Study||24
2949092|NCT00689481|3662808|FG001|NOT COMPLETED|Overall Study||14
2949093|NCT00689572|3662816|FG000|STARTED|Overall Study||53
2949094|NCT00689572|3662817|FG001|STARTED|Overall Study||55
2949095|NCT00689572|3662816|FG000|COMPLETED|Overall Study||39
2949096|NCT00689572|3662817|FG001|COMPLETED|Overall Study||34
2949097|NCT00689572|3662816|FG000|NOT COMPLETED|Overall Study||14
2949098|NCT00689572|3662817|FG001|NOT COMPLETED|Overall Study||21
2949099|NCT00689611|3662825|FG000|STARTED|Overall Study||200
2949100|NCT00689611|3662826|FG001|STARTED|Overall Study||192
2949101|NCT00689611|3662825|FG000|COMPLETED|Overall Study||159
2949102|NCT00689611|3662826|FG001|COMPLETED|Overall Study||146
2949103|NCT00689611|3662825|FG000|NOT COMPLETED|Overall Study||41
2949104|NCT00689611|3662826|FG001|NOT COMPLETED|Overall Study||46
2949105|NCT00689728|3662835|FG000|STARTED|Double-Blind Treatment||35
2949106|NCT00689728|3662836|FG001|STARTED|Double-Blind Treatment||30
2949107|NCT00689728|3662837|FG002|STARTED|Double-Blind Treatment||35
2949108|NCT00689728|3662835|FG000|COMPLETED|Double-Blind Treatment||31
2949109|NCT00689728|3662836|FG001|COMPLETED|Double-Blind Treatment||26
2949110|NCT00689728|3662837|FG002|COMPLETED|Double-Blind Treatment||30
2949111|NCT00689728|3662835|FG000|NOT COMPLETED|Double-Blind Treatment||4
2949112|NCT00689728|3662836|FG001|NOT COMPLETED|Double-Blind Treatment||4
2949113|NCT00689728|3662837|FG002|NOT COMPLETED|Double-Blind Treatment||5
2949114|NCT00689728|3662835|FG000|STARTED|Rescue||31
2949115|NCT00689728|3662836|FG001|STARTED|Rescue||26
2949116|NCT00689728|3662837|FG002|STARTED|Rescue||30
2949117|NCT00689728|3662835|FG000|COMPLETED|Rescue||30
2949118|NCT00689728|3662836|FG001|COMPLETED|Rescue||24
2949119|NCT00689728|3662837|FG002|COMPLETED|Rescue||29
2949120|NCT00689728|3662835|FG000|NOT COMPLETED|Rescue||1
2949121|NCT00689728|3662836|FG001|NOT COMPLETED|Rescue||2
2949122|NCT00689728|3662837|FG002|NOT COMPLETED|Rescue||1
2949123|NCT00689728|3662835|FG000|STARTED|Optional Follow-Up|21 participants who completed the rescue period did not enter the optional follow-up period.|9
2949124|NCT00689728|3662836|FG001|STARTED|Optional Follow-Up|13 participants who completed the rescue period did not enter the optional follow-up period.|11
2949125|NCT00689728|3662837|FG002|STARTED|Optional Follow-Up|19 participants who completed the rescue period did not enter the optional follow-up period.|10
2949126|NCT00689728|3662835|FG000|COMPLETED|Optional Follow-Up||6
2949127|NCT00689728|3662836|FG001|COMPLETED|Optional Follow-Up||5
2949128|NCT00689728|3662837|FG002|COMPLETED|Optional Follow-Up||4
2949129|NCT00689728|3662835|FG000|NOT COMPLETED|Optional Follow-Up||3
2949130|NCT00689728|3662836|FG001|NOT COMPLETED|Optional Follow-Up||6
2949131|NCT00689728|3662837|FG002|NOT COMPLETED|Optional Follow-Up||6
2949132|NCT00689793|3662868|FG000|STARTED|Overall Study||78
2949133|NCT00689793|3662869|FG001|STARTED|Overall Study||76
2949134|NCT00689793|3662868|FG000|COMPLETED|Overall Study||74
2949135|NCT00689793|3662869|FG001|COMPLETED|Overall Study||71
2949136|NCT00689793|3662868|FG000|NOT COMPLETED|Overall Study||4
2949137|NCT00689793|3662869|FG001|NOT COMPLETED|Overall Study||5
2949138|NCT00689819|3662879|FG000|STARTED|Overall Study||65
2949139|NCT00689819|3662880|FG001|STARTED|Overall Study||58
2949140|NCT00689819|3662879|FG000|COMPLETED|Overall Study||45
2949141|NCT00689819|3662880|FG001|COMPLETED|Overall Study||43
2949142|NCT00689819|3662879|FG000|NOT COMPLETED|Overall Study||20
2949143|NCT00689819|3662880|FG001|NOT COMPLETED|Overall Study||15
2949144|NCT00689871|3662890|FG000|STARTED|Overall Study|908 Implants|455
2949145|NCT00689871|3662891|FG001|STARTED|Overall Study|127 Implants|98
2949146|NCT00689871|3662892|FG002|STARTED|Overall Study|288 Implants|147
2949147|NCT00689871|3662893|FG003|STARTED|Overall Study|25 Implants|15
2949148|NCT00689871|3662890|FG000|COMPLETED|Overall Study|35 Patients discontinued|280
2949149|NCT00689871|3662891|FG001|COMPLETED|Overall Study|35 Patients discontinued|46
2949150|NCT00689871|3662892|FG002|COMPLETED|Overall Study|28 Patients discontinued|74
2949151|NCT00689871|3662893|FG003|COMPLETED|Overall Study|4 Patients discontinued|8
2949152|NCT00689871|3662890|FG000|NOT COMPLETED|Overall Study||175
2949153|NCT00689871|3662891|FG001|NOT COMPLETED|Overall Study||52
2949154|NCT00689871|3662892|FG002|NOT COMPLETED|Overall Study||73
2949155|NCT00689871|3662893|FG003|NOT COMPLETED|Overall Study||7
2949156|NCT00689936|3662906|FG000|STARTED|Active Treatment Phase||535
2949157|NCT00689936|3662907|FG001|STARTED|Active Treatment Phase||541
2949158|NCT00689936|3662908|FG002|STARTED|Active Treatment Phase||547
2949159|NCT00689936|3662906|FG000|Safety Population|Active Treatment Phase|Safety population = all randomized participants who received at least 1 dose of study treatment.|532
2949160|NCT00689936|3662907|FG001|Safety Population|Active Treatment Phase|Safety population = all randomized participants who received at least 1 dose of study treatment.|540
2949161|NCT00689936|3662908|FG002|Safety Population|Active Treatment Phase|Safety population = all randomized participants who received at least 1 dose of study treatment.|541
3132479|NCT01691339|3857528|FG000|NOT COMPLETED|Overall Study||0
3132480|NCT01691339|3857529|FG001|NOT COMPLETED|Overall Study||0
3132481|NCT01691339|3857530|FG002|NOT COMPLETED|Overall Study||0
3132482|NCT01691339|3857531|FG003|NOT COMPLETED|Overall Study||0
3299113|NCT02930590|4032826|FG003|NOT COMPLETED|First Intervention (2 Hours)||0
3299114|NCT02930590|4032827|FG004|NOT COMPLETED|First Intervention (2 Hours)||0
2949162|NCT00689936|3662906|FG000|Untreated|Active Treatment Phase|Participants randomized, but did not receive any study drug treatment.|3
2949163|NCT00689936|3662907|FG001|Untreated|Active Treatment Phase|Participants randomized, but did not receive any study drug treatment.|1
2949164|NCT00689936|3662908|FG002|Untreated|Active Treatment Phase|Participants randomized, but did not receive any study drug treatment.|6
2949165|NCT00689936|3662906|FG000|COMPLETED|Active Treatment Phase||0
2949166|NCT00689936|3662907|FG001|COMPLETED|Active Treatment Phase||0
2949167|NCT00689936|3662908|FG002|COMPLETED|Active Treatment Phase||0
2949168|NCT00689936|3662906|FG000|NOT COMPLETED|Active Treatment Phase||535
2949169|NCT00689936|3662907|FG001|NOT COMPLETED|Active Treatment Phase||541
2949170|NCT00689936|3662908|FG002|NOT COMPLETED|Active Treatment Phase||547
2949171|NCT00689936|3662906|FG000|STARTED|Progression Free Survival-PFS-Follow-Up|Includes participants who discontinued treatment for reasons other than progressive disease.|87
2949172|NCT00689936|3662907|FG001|STARTED|Progression Free Survival-PFS-Follow-Up|Includes participants who completed 18 cycles (Rd18) and did not experience progressive disease.|300
2949173|NCT00689936|3662908|FG002|STARTED|Progression Free Survival-PFS-Follow-Up|Includes participants who completed 12 cycles MPT and did not experience progressive disease.|273
2949174|NCT00689936|3662906|FG000|COMPLETED|Progression Free Survival-PFS-Follow-Up||87
2949175|NCT00689936|3662907|FG001|COMPLETED|Progression Free Survival-PFS-Follow-Up||300
2949176|NCT00689936|3662908|FG002|COMPLETED|Progression Free Survival-PFS-Follow-Up||273
2949177|NCT00689936|3662906|FG000|NOT COMPLETED|Progression Free Survival-PFS-Follow-Up||0
2949178|NCT00689936|3662907|FG001|NOT COMPLETED|Progression Free Survival-PFS-Follow-Up||0
2949179|NCT00689936|3662908|FG002|NOT COMPLETED|Progression Free Survival-PFS-Follow-Up||0
2949180|NCT00689936|3662906|FG000|STARTED|Long-Term Follow Up Phase|Includes participants from both the active treatment phase and from the PFS follow-up phase.|382
2949181|NCT00689936|3662907|FG001|STARTED|Long-Term Follow Up Phase|Includes participants from both the active treatment phase and from the PFS follow-up phase.|463
2949182|NCT00689936|3662908|FG002|STARTED|Long-Term Follow Up Phase|Includes participants from both the active treatment phase and from the PFS follow-up phase.|459
2949183|NCT00689936|3662906|FG000|COMPLETED|Long-Term Follow Up Phase||255
2949184|NCT00689936|3662907|FG001|COMPLETED|Long-Term Follow Up Phase||275
3132483|NCT01691378|3857543|FG000|STARTED|Overall Study||22
3299115|NCT02930590|4032828|FG005|NOT COMPLETED|First Intervention (2 Hours)||0
3299116|NCT02930590|4032823|FG000|STARTED|Second Intervention (2 Hours)||3
3299117|NCT02930590|4032824|FG001|STARTED|Second Intervention (2 Hours)||3
3299118|NCT02930590|4032825|FG002|STARTED|Second Intervention (2 Hours)||3
3299119|NCT02930590|4032826|FG003|STARTED|Second Intervention (2 Hours)||2
3299120|NCT02930590|4032827|FG004|STARTED|Second Intervention (2 Hours)||2
3299121|NCT02930590|4032828|FG005|STARTED|Second Intervention (2 Hours)||2
3299122|NCT02930590|4032823|FG000|COMPLETED|Second Intervention (2 Hours)||3
3299123|NCT02930590|4032824|FG001|COMPLETED|Second Intervention (2 Hours)||3
3299124|NCT02930590|4032825|FG002|COMPLETED|Second Intervention (2 Hours)||3
3299125|NCT02930590|4032826|FG003|COMPLETED|Second Intervention (2 Hours)||2
3299126|NCT02930590|4032827|FG004|COMPLETED|Second Intervention (2 Hours)||2
3299127|NCT02930590|4032828|FG005|COMPLETED|Second Intervention (2 Hours)||2
3299128|NCT02930590|4032823|FG000|NOT COMPLETED|Second Intervention (2 Hours)||0
3299129|NCT02930590|4032824|FG001|NOT COMPLETED|Second Intervention (2 Hours)||0
3299130|NCT02930590|4032825|FG002|NOT COMPLETED|Second Intervention (2 Hours)||0
3299131|NCT02930590|4032826|FG003|NOT COMPLETED|Second Intervention (2 Hours)||0
3299132|NCT02930590|4032827|FG004|NOT COMPLETED|Second Intervention (2 Hours)||0
3299133|NCT02930590|4032828|FG005|NOT COMPLETED|Second Intervention (2 Hours)||0
3299134|NCT02930590|4032823|FG000|STARTED|Third Intervention (2 Hours)||3
3299135|NCT02930590|4032824|FG001|STARTED|Third Intervention (2 Hours)||3
3299136|NCT02930590|4032825|FG002|STARTED|Third Intervention (2 Hours)||3
3299137|NCT02930590|4032826|FG003|STARTED|Third Intervention (2 Hours)||2
3299138|NCT02930590|4032827|FG004|STARTED|Third Intervention (2 Hours)||2
3299139|NCT02930590|4032828|FG005|STARTED|Third Intervention (2 Hours)||2
3299140|NCT02930590|4032823|FG000|COMPLETED|Third Intervention (2 Hours)||3
3299141|NCT02930590|4032824|FG001|COMPLETED|Third Intervention (2 Hours)||3
3299142|NCT02930590|4032825|FG002|COMPLETED|Third Intervention (2 Hours)||3
3299143|NCT02930590|4032826|FG003|COMPLETED|Third Intervention (2 Hours)||2
3299144|NCT02930590|4032827|FG004|COMPLETED|Third Intervention (2 Hours)||2
3299145|NCT02930590|4032828|FG005|COMPLETED|Third Intervention (2 Hours)||2
3299146|NCT02930590|4032823|FG000|NOT COMPLETED|Third Intervention (2 Hours)||0
2949185|NCT00689936|3662908|FG002|COMPLETED|Long-Term Follow Up Phase||315
2949186|NCT00689936|3662906|FG000|NOT COMPLETED|Long-Term Follow Up Phase||127
2949187|NCT00689936|3662907|FG001|NOT COMPLETED|Long-Term Follow Up Phase||188
2949188|NCT00689936|3662908|FG002|NOT COMPLETED|Long-Term Follow Up Phase||144
2949189|NCT00690040|3662918|FG000|STARTED|Overall Study||145
2949190|NCT00690040|3662919|FG001|STARTED|Overall Study||148
2949191|NCT00690040|3662918|FG000|COMPLETED|Overall Study||145
2949192|NCT00690040|3662919|FG001|COMPLETED|Overall Study||148
2949193|NCT00690040|3662918|FG000|NOT COMPLETED|Overall Study||0
2949194|NCT00690040|3662919|FG001|NOT COMPLETED|Overall Study||0
2949195|NCT00690235|3662927|FG000|STARTED|Overall Study||17
2949196|NCT00690235|3662928|FG001|STARTED|Overall Study||16
3132484|NCT01691378|3857544|FG001|STARTED|Overall Study||22
3132485|NCT01691378|3857543|FG000|COMPLETED|Overall Study||15
3132486|NCT01691378|3857544|FG001|COMPLETED|Overall Study||20
3132487|NCT01691378|3857543|FG000|NOT COMPLETED|Overall Study||7
3132488|NCT01691378|3857544|FG001|NOT COMPLETED|Overall Study||2
3132489|NCT01691430|3857552|FG000|STARTED|Overall Study||92
2949197|NCT00690235|3662927|FG000|COMPLETED|Overall Study||12
2949198|NCT00690235|3662928|FG001|COMPLETED|Overall Study||12
2949199|NCT00690235|3662927|FG000|NOT COMPLETED|Overall Study||5
2949200|NCT00690235|3662928|FG001|NOT COMPLETED|Overall Study||4
2949201|NCT00690274|3662936|FG000|STARTED|Overall Study||29
2949202|NCT00690274|3662937|FG001|STARTED|Overall Study||23
2949203|NCT00690274|3662936|FG000|COMPLETED|Overall Study||23
2949204|NCT00690274|3662937|FG001|COMPLETED|Overall Study||15
2949205|NCT00690274|3662936|FG000|NOT COMPLETED|Overall Study||6
2949206|NCT00690274|3662937|FG001|NOT COMPLETED|Overall Study||8
2949207|NCT00690339|3662947|FG000|STARTED|Overall Study||492
2949208|NCT00690339|3662948|FG001|STARTED|Overall Study||225
3299147|NCT02930590|4032824|FG001|NOT COMPLETED|Third Intervention (2 Hours)||0
3299148|NCT02930590|4032825|FG002|NOT COMPLETED|Third Intervention (2 Hours)||0
3299149|NCT02930590|4032826|FG003|NOT COMPLETED|Third Intervention (2 Hours)||0
3299150|NCT02930590|4032827|FG004|NOT COMPLETED|Third Intervention (2 Hours)||0
3299151|NCT02930590|4032828|FG005|NOT COMPLETED|Third Intervention (2 Hours)||0
3299152|NCT02930824|4032842|FG000|STARTED|Overall Study||62
3299153|NCT02930824|4032843|FG001|STARTED|Overall Study||63
3299154|NCT02930824|4032844|FG002|STARTED|Overall Study||30
3299155|NCT02930824|4032845|FG003|STARTED|Overall Study||30
3299156|NCT02930824|4032842|FG000|COMPLETED|Overall Study||56
3299157|NCT02930824|4032843|FG001|COMPLETED|Overall Study||57
3299158|NCT02930824|4032844|FG002|COMPLETED|Overall Study||20
3299159|NCT02930824|4032845|FG003|COMPLETED|Overall Study||23
3299160|NCT02930824|4032842|FG000|NOT COMPLETED|Overall Study||6
3299161|NCT02930824|4032843|FG001|NOT COMPLETED|Overall Study||6
3299162|NCT02930824|4032844|FG002|NOT COMPLETED|Overall Study||10
3299163|NCT02930824|4032845|FG003|NOT COMPLETED|Overall Study||7
2949209|NCT00690339|3662949|FG002|STARTED|Overall Study||156
2949210|NCT00690339|3662950|FG003|STARTED|Overall Study||68
2949211|NCT00690339|3662947|FG000|COMPLETED|Overall Study||375
2949212|NCT00690339|3662948|FG001|COMPLETED|Overall Study||144
2949213|NCT00690339|3662949|FG002|COMPLETED|Overall Study||99
2949214|NCT00690339|3662950|FG003|COMPLETED|Overall Study||43
2949215|NCT00690339|3662947|FG000|NOT COMPLETED|Overall Study||117
2949216|NCT00690339|3662948|FG001|NOT COMPLETED|Overall Study||81
2949217|NCT00690339|3662949|FG002|NOT COMPLETED|Overall Study||57
2949218|NCT00690339|3662950|FG003|NOT COMPLETED|Overall Study||25
2949219|NCT00690378|3662962|FG000|STARTED|Overall Study|Randomized|69
2949220|NCT00690378|3662963|FG001|STARTED|Overall Study|Randomized|68
2949221|NCT00690378|3662962|FG000|Treated|Overall Study||68
2949222|NCT00690378|3662963|FG001|Treated|Overall Study||67
2949223|NCT00690378|3662962|FG000|COMPLETED|Overall Study|Up to Late follow up (LFU) visit|49
2949224|NCT00690378|3662963|FG001|COMPLETED|Overall Study|Up to LFU visit|54
2949225|NCT00690378|3662962|FG000|NOT COMPLETED|Overall Study||20
2949226|NCT00690378|3662963|FG001|NOT COMPLETED|Overall Study||14
2949227|NCT00690430|3662971|FG000|STARTED|Core Phase|"Started indicates Full Analysis Set (FAS) and Safety Set."|53
2949228|NCT00690430|3662972|FG001|STARTED|Core Phase||57
2949229|NCT00690430|3662973|FG002|STARTED|Core Phase|This arm belongs to Extension Phase.|0
2949230|NCT00690430|3662971|FG000|COMPLETED|Core Phase||35
3132490|NCT01691430|3857553|FG001|STARTED|Overall Study||93
2949231|NCT00690430|3662972|FG001|COMPLETED|Core Phase||34
2949232|NCT00690430|3662973|FG002|COMPLETED|Core Phase||0
2949233|NCT00690430|3662971|FG000|NOT COMPLETED|Core Phase||18
2949234|NCT00690430|3662972|FG001|NOT COMPLETED|Core Phase||23
2949235|NCT00690430|3662973|FG002|NOT COMPLETED|Core Phase||0
2949236|NCT00690430|3662971|FG000|STARTED|Extension Phase|Only those patients (except from UK) who received clinical benefit could extend therapy in extension|20
2949237|NCT00690430|3662972|FG001|STARTED|Extension Phase|Only those patients (except from UK) who received clinical benefit could extend therapy in extension|6
2949238|NCT00690430|3662973|FG002|STARTED|Extension Phase|Only those patients (except from UK) who received clinical benefit could extend therapy in extension|15
2949239|NCT00690430|3662971|FG000|COMPLETED|Extension Phase||2
2949240|NCT00690430|3662972|FG001|COMPLETED|Extension Phase||1
2949241|NCT00690430|3662973|FG002|COMPLETED|Extension Phase||2
2949242|NCT00690430|3662971|FG000|NOT COMPLETED|Extension Phase||18
2949243|NCT00690430|3662972|FG001|NOT COMPLETED|Extension Phase||5
3132491|NCT01691430|3857552|FG000|Received Medication|Overall Study||92
3132492|NCT01691430|3857553|FG001|Received Medication|Overall Study||93
3299164|NCT02930837|4032861|FG000|STARTED|Overall Study|Started are treated patients|120
2949244|NCT00690430|3662973|FG002|NOT COMPLETED|Extension Phase||13
2949245|NCT00690443|3662984|FG000|STARTED|Overall Study||23
2949246|NCT00690443|3662985|FG001|STARTED|Overall Study||21
2949247|NCT00690443|3662984|FG000|COMPLETED|Overall Study||22
2949248|NCT00690443|3662985|FG001|COMPLETED|Overall Study||19
2949249|NCT00690443|3662984|FG000|NOT COMPLETED|Overall Study||1
2949250|NCT00690443|3662985|FG001|NOT COMPLETED|Overall Study||2
2949251|NCT00690482|3662993|FG000|STARTED|Overall Study||61
2949252|NCT00690482|3662994|FG001|STARTED|Overall Study||57
2949253|NCT00690482|3662993|FG000|COMPLETED|Overall Study||57
2949254|NCT00690482|3662994|FG001|COMPLETED|Overall Study||54
2949255|NCT00690482|3662993|FG000|NOT COMPLETED|Overall Study||4
2949256|NCT00690482|3662994|FG001|NOT COMPLETED|Overall Study||3
2949257|NCT00690495|3663002|FG000|STARTED|Overall Study||50
2949258|NCT00690495|3663003|FG001|STARTED|Overall Study||50
2949259|NCT00690495|3663002|FG000|Primary Endpoint|Overall Study||50
2949260|NCT00690495|3663003|FG001|Primary Endpoint|Overall Study||50
2949261|NCT00690495|3663002|FG000|COMPLETED|Overall Study||50
2949262|NCT00690495|3663003|FG001|COMPLETED|Overall Study||50
2949263|NCT00690495|3663002|FG000|NOT COMPLETED|Overall Study||0
2949264|NCT00690495|3663003|FG001|NOT COMPLETED|Overall Study||0
2949265|NCT00690573|3663009|FG000|STARTED|Overall Study||25
2949266|NCT00690573|3663009|FG000|COMPLETED|Overall Study||16
2949267|NCT00690573|3663009|FG000|NOT COMPLETED|Overall Study||9
2949268|NCT00690612|3663013|FG000|STARTED|Overall Study||35
2949269|NCT00690612|3663013|FG000|COMPLETED|Overall Study||32
2949270|NCT00690612|3663013|FG000|NOT COMPLETED|Overall Study||3
2949271|NCT00690755|3663024|FG000|STARTED|Overall Study||30
2949272|NCT00690755|3663025|FG001|STARTED|Overall Study||0
2949273|NCT00690755|3663026|FG002|STARTED|Overall Study||97
2949274|NCT00690755|3663027|FG003|STARTED|Overall Study||20
2949275|NCT00690755|3663028|FG004|STARTED|Overall Study||0
2949276|NCT00690755|3663029|FG005|STARTED|Overall Study||10
2949277|NCT00690755|3663030|FG006|STARTED|Overall Study||0
2949278|NCT00690755|3663024|FG000|COMPLETED|Overall Study|Patient recruitment ended on 12/31/2010|28
2949279|NCT00690755|3663025|FG001|COMPLETED|Overall Study||0
2949280|NCT00690755|3663026|FG002|COMPLETED|Overall Study||51
2949281|NCT00690755|3663027|FG003|COMPLETED|Overall Study||15
2949282|NCT00690755|3663028|FG004|COMPLETED|Overall Study||0
2949283|NCT00690755|3663029|FG005|COMPLETED|Overall Study||6
2949284|NCT00690755|3663030|FG006|COMPLETED|Overall Study||0
2949285|NCT00690755|3663024|FG000|NOT COMPLETED|Overall Study||2
2949286|NCT00690755|3663025|FG001|NOT COMPLETED|Overall Study||0
2949287|NCT00690755|3663026|FG002|NOT COMPLETED|Overall Study||46
2949288|NCT00690755|3663027|FG003|NOT COMPLETED|Overall Study||5
2949289|NCT00690755|3663028|FG004|NOT COMPLETED|Overall Study||0
2949290|NCT00690755|3663029|FG005|NOT COMPLETED|Overall Study||4
2949291|NCT00690755|3663030|FG006|NOT COMPLETED|Overall Study||0
2949292|NCT00690794|3663048|FG000|STARTED|Overall Study||363
2949293|NCT00690794|3663049|FG001|STARTED|Overall Study||363
2949294|NCT00690794|3663048|FG000|COMPLETED|Overall Study||342
2949295|NCT00690794|3663049|FG001|COMPLETED|Overall Study||328
2949296|NCT00690794|3663048|FG000|NOT COMPLETED|Overall Study||21
2949297|NCT00690794|3663049|FG001|NOT COMPLETED|Overall Study||35
2949298|NCT00690820|3663057|FG000|STARTED|Period 1||8
2949299|NCT00690820|3663058|FG001|STARTED|Period 1||9
2949300|NCT00690820|3663057|FG000|COMPLETED|Period 1||8
2949301|NCT00690820|3663058|FG001|COMPLETED|Period 1||8
2949302|NCT00690820|3663057|FG000|NOT COMPLETED|Period 1||0
2949303|NCT00690820|3663058|FG001|NOT COMPLETED|Period 1||1
2949304|NCT00690820|3663057|FG000|STARTED|Period 2||8
2949305|NCT00690820|3663058|FG001|STARTED|Period 2||8
2949306|NCT00690820|3663057|FG000|COMPLETED|Period 2||8
2949307|NCT00690820|3663058|FG001|COMPLETED|Period 2||8
2949308|NCT00690820|3663057|FG000|NOT COMPLETED|Period 2||0
2949309|NCT00690820|3663058|FG001|NOT COMPLETED|Period 2||0
2949310|NCT00690833|3663064|FG000|STARTED|Overall Study||41
2949311|NCT00690833|3663064|FG000|COMPLETED|Overall Study||39
2949312|NCT00690833|3663064|FG000|NOT COMPLETED|Overall Study||2
2949313|NCT00690898|3663068|FG000|STARTED|SCREENING|Total of patients screened for the study.|108
2949314|NCT00690898|3663068|FG000|COMPLETED|SCREENING|Number of patients included in the study.|90
2949315|NCT00690898|3663068|FG000|NOT COMPLETED|SCREENING||18
2949316|NCT00690898|3663068|FG000|STARTED|TREATMENT|Total number of patients treated.|90
2949317|NCT00690898|3663068|FG000|COMPLETED|TREATMENT||64
2949318|NCT00690898|3663068|FG000|NOT COMPLETED|TREATMENT||26
2949319|NCT00690924|3663072|FG000|STARTED|Overall Study||16
2949320|NCT00690924|3663072|FG000|COMPLETED|Overall Study||16
2949321|NCT00690924|3663072|FG000|NOT COMPLETED|Overall Study||0
2949322|NCT00691002|3663080|FG000|STARTED|8-week, Double-blind, 4-arm||353
2949323|NCT00691002|3663081|FG001|STARTED|8-week, Double-blind, 4-arm||342
2949324|NCT00691002|3663082|FG002|STARTED|8-week, Double-blind, 4-arm||363
2949325|NCT00691002|3663083|FG003|STARTED|8-week, Double-blind, 4-arm||181
2949326|NCT00691002|3663084|FG004|STARTED|8-week, Double-blind, 4-arm||0
2949327|NCT00691002|3663080|FG000|COMPLETED|8-week, Double-blind, 4-arm||325
2949328|NCT00691002|3663081|FG001|COMPLETED|8-week, Double-blind, 4-arm||308
2949329|NCT00691002|3663082|FG002|COMPLETED|8-week, Double-blind, 4-arm||340
2949330|NCT00691002|3663083|FG003|COMPLETED|8-week, Double-blind, 4-arm||169
2949331|NCT00691002|3663084|FG004|COMPLETED|8-week, Double-blind, 4-arm||0
2949332|NCT00691002|3663080|FG000|NOT COMPLETED|8-week, Double-blind, 4-arm||28
2949333|NCT00691002|3663081|FG001|NOT COMPLETED|8-week, Double-blind, 4-arm||34
2949334|NCT00691002|3663082|FG002|NOT COMPLETED|8-week, Double-blind, 4-arm||23
2949335|NCT00691002|3663083|FG003|NOT COMPLETED|8-week, Double-blind, 4-arm||12
2949336|NCT00691002|3663084|FG004|NOT COMPLETED|8-week, Double-blind, 4-arm||0
2949337|NCT00691002|3663080|FG000|STARTED|52-week, Open-label, Single Arm||454
2949338|NCT00691002|3663081|FG001|STARTED|52-week, Open-label, Single Arm||0
2949339|NCT00691002|3663082|FG002|STARTED|52-week, Open-label, Single Arm||0
2949340|NCT00691002|3663083|FG003|STARTED|52-week, Open-label, Single Arm||0
2949341|NCT00691002|3663084|FG004|STARTED|52-week, Open-label, Single Arm||0
2949342|NCT00691002|3663080|FG000|COMPLETED|52-week, Open-label, Single Arm||403
2949343|NCT00691002|3663081|FG001|COMPLETED|52-week, Open-label, Single Arm||0
2949344|NCT00691002|3663082|FG002|COMPLETED|52-week, Open-label, Single Arm||0
2949345|NCT00691002|3663083|FG003|COMPLETED|52-week, Open-label, Single Arm||0
2949346|NCT00691002|3663084|FG004|COMPLETED|52-week, Open-label, Single Arm||0
2949347|NCT00691002|3663080|FG000|NOT COMPLETED|52-week, Open-label, Single Arm||51
2949348|NCT00691002|3663081|FG001|NOT COMPLETED|52-week, Open-label, Single Arm||0
2949349|NCT00691002|3663082|FG002|NOT COMPLETED|52-week, Open-label, Single Arm||0
2949350|NCT00691002|3663083|FG003|NOT COMPLETED|52-week, Open-label, Single Arm||0
2949351|NCT00691002|3663084|FG004|NOT COMPLETED|52-week, Open-label, Single Arm||0
2949352|NCT00691015|3663095|FG000|STARTED|Overall Study||48
2949353|NCT00691015|3663095|FG000|COMPLETED|Overall Study||47
2949354|NCT00691015|3663095|FG000|NOT COMPLETED|Overall Study||1
2949355|NCT00691028|3663102|FG000|STARTED|Open-label Period||0
2949356|NCT00691028|3663103|FG001|STARTED|Open-label Period||0
2949357|NCT00691028|3663104|FG002|STARTED|Open-label Period||0
2949358|NCT00691028|3663105|FG003|STARTED|Open-label Period||327
2949359|NCT00691028|3663102|FG000|COMPLETED|Open-label Period||0
2949360|NCT00691028|3663103|FG001|COMPLETED|Open-label Period||0
2949361|NCT00691028|3663104|FG002|COMPLETED|Open-label Period||0
2949362|NCT00691028|3663105|FG003|COMPLETED|Open-label Period||307
2949363|NCT00691028|3663102|FG000|NOT COMPLETED|Open-label Period||0
2949364|NCT00691028|3663103|FG001|NOT COMPLETED|Open-label Period||0
2949365|NCT00691028|3663104|FG002|NOT COMPLETED|Open-label Period||0
2949366|NCT00691028|3663105|FG003|NOT COMPLETED|Open-label Period||20
2949367|NCT00691028|3663102|FG000|STARTED|Double-blind Period||99
2949368|NCT00691028|3663103|FG001|STARTED|Double-blind Period||104
2949369|NCT00691028|3663104|FG002|STARTED|Double-blind Period||104
2949370|NCT00691028|3663105|FG003|STARTED|Double-blind Period||0
2949371|NCT00691028|3663102|FG000|COMPLETED|Double-blind Period||86
2949372|NCT00691028|3663103|FG001|COMPLETED|Double-blind Period||91
2949373|NCT00691028|3663104|FG002|COMPLETED|Double-blind Period||95
2949374|NCT00691028|3663105|FG003|COMPLETED|Double-blind Period||0
2949375|NCT00691028|3663102|FG000|NOT COMPLETED|Double-blind Period||13
2949376|NCT00691028|3663103|FG001|NOT COMPLETED|Double-blind Period||13
2949377|NCT00691028|3663104|FG002|NOT COMPLETED|Double-blind Period||9
2949378|NCT00691028|3663105|FG003|NOT COMPLETED|Double-blind Period||0
2949379|NCT00691054|3663117|FG000|STARTED|Overall Study||20
2949380|NCT00691054|3663117|FG000|COMPLETED|Overall Study||19
2949381|NCT00691054|3663117|FG000|NOT COMPLETED|Overall Study||1
2949382|NCT00691093|3663123|FG000|STARTED|Overall Study||823
2949383|NCT00691093|3663123|FG000|COMPLETED|Overall Study||816
2949384|NCT00691093|3663123|FG000|NOT COMPLETED|Overall Study||7
2949385|NCT00691132|3663134|FG000|STARTED|Overall Study||53
2949386|NCT00691132|3663135|FG001|STARTED|Overall Study|107 total randomized. Approximately 1/2 per arm.|54
2949387|NCT00691132|3663134|FG000|COMPLETED|Overall Study||41
2949388|NCT00691132|3663135|FG001|COMPLETED|Overall Study|45 completed, but 4 excluded b/c urinary measures indicated they did not smoke study cigarettes.|41
2949389|NCT00691132|3663134|FG000|NOT COMPLETED|Overall Study||12
2949390|NCT00691132|3663135|FG001|NOT COMPLETED|Overall Study||13
2949391|NCT00691197|3663153|FG000|STARTED|Overall Study||166
2949392|NCT00691197|3663154|FG001|STARTED|Overall Study||80
2949393|NCT00691197|3663153|FG000|COMPLETED|Overall Study||155
2949394|NCT00691197|3663154|FG001|COMPLETED|Overall Study||75
2949395|NCT00691197|3663153|FG000|NOT COMPLETED|Overall Study||11
3299165|NCT02930837|4032861|FG000|COMPLETED|Overall Study|Completed the trial|108
3299166|NCT02930837|4032861|FG000|NOT COMPLETED|Overall Study||12
3299167|NCT02930941|4032867|FG000|STARTED|Overall Study||17
3299168|NCT02930941|4032868|FG001|STARTED|Overall Study||18
3299169|NCT02930941|4032867|FG000|COMPLETED|Overall Study||16
3299170|NCT02930941|4032868|FG001|COMPLETED|Overall Study||16
3299171|NCT02930941|4032867|FG000|NOT COMPLETED|Overall Study||1
3299172|NCT02930941|4032868|FG001|NOT COMPLETED|Overall Study||2
3299173|NCT02930980|4032878|FG000|STARTED|Overall Study||43
3299174|NCT02930980|4032878|FG000|COMPLETED|Overall Study||43
3299175|NCT02930980|4032878|FG000|NOT COMPLETED|Overall Study||0
3299176|NCT02931045|4032884|FG000|STARTED|Overall Study||30
3299177|NCT02931045|4032885|FG001|STARTED|Overall Study||30
3299178|NCT02931045|4032884|FG000|COMPLETED|Overall Study||27
2949396|NCT00691197|3663154|FG001|NOT COMPLETED|Overall Study||5
2949397|NCT00691210|3663168|FG000|STARTED|Overall Study||3
2949398|NCT00691210|3663169|FG001|STARTED|Overall Study||5
2949399|NCT00691210|3663170|FG002|STARTED|Overall Study||3
2949400|NCT00691210|3663171|FG003|STARTED|Overall Study||9
2949401|NCT00691210|3663172|FG004|STARTED|Overall Study||5
2949402|NCT00691210|3663173|FG005|STARTED|Overall Study||7
3299179|NCT02931045|4032885|FG001|COMPLETED|Overall Study||28
3299180|NCT02931045|4032884|FG000|NOT COMPLETED|Overall Study||3
2949403|NCT00691210|3663174|FG006|STARTED|Overall Study||6
2949404|NCT00691210|3663175|FG007|STARTED|Overall Study||0
2949405|NCT00691210|3663168|FG000|COMPLETED|Overall Study||3
3299181|NCT02931045|4032885|FG001|NOT COMPLETED|Overall Study||2
2949406|NCT00691210|3663169|FG001|COMPLETED|Overall Study||5
2949407|NCT00691210|3663170|FG002|COMPLETED|Overall Study||3
2949408|NCT00691210|3663171|FG003|COMPLETED|Overall Study||6
2949409|NCT00691210|3663172|FG004|COMPLETED|Overall Study||5
2949410|NCT00691210|3663173|FG005|COMPLETED|Overall Study||6
2949411|NCT00691210|3663174|FG006|COMPLETED|Overall Study||6
2949412|NCT00691210|3663175|FG007|COMPLETED|Overall Study||0
2949413|NCT00691210|3663168|FG000|NOT COMPLETED|Overall Study||0
2949414|NCT00691210|3663169|FG001|NOT COMPLETED|Overall Study||0
2949415|NCT00691210|3663170|FG002|NOT COMPLETED|Overall Study||0
2949416|NCT00691210|3663171|FG003|NOT COMPLETED|Overall Study||3
2949417|NCT00691210|3663172|FG004|NOT COMPLETED|Overall Study||0
2949418|NCT00691210|3663173|FG005|NOT COMPLETED|Overall Study||1
2949419|NCT00691210|3663174|FG006|NOT COMPLETED|Overall Study||0
2949420|NCT00691210|3663175|FG007|NOT COMPLETED|Overall Study||0
2949421|NCT00691301|3663193|FG000|STARTED|Overall Study||55
2949422|NCT00691301|3663193|FG000|COMPLETED|Overall Study||1
2949423|NCT00691301|3663193|FG000|NOT COMPLETED|Overall Study||54
2949424|NCT00691327|3663205|FG000|STARTED|Overall Study||45055
2949425|NCT00691327|3663206|FG001|STARTED|Overall Study||39274
2949426|NCT00691327|3663205|FG000|COMPLETED|Overall Study||42214
2949427|NCT00691327|3663206|FG001|COMPLETED|Overall Study||36766
2949428|NCT00691327|3663205|FG000|NOT COMPLETED|Overall Study||2841
2949429|NCT00691327|3663206|FG001|NOT COMPLETED|Overall Study||2508
2949430|NCT00691483|3663214|FG000|STARTED|Overall Study||493
2949431|NCT00691483|3663215|FG001|STARTED|Overall Study||166
2949432|NCT00691483|3663214|FG000|Received Treatment|Overall Study||486
2949433|NCT00691483|3663215|FG001|Received Treatment|Overall Study||165
2949434|NCT00691483|3663214|FG000|COMPLETED|Overall Study|Completed refers to completion of the study.|425
3299182|NCT02931253|4032893|FG000|STARTED|Overall Study||2
3299183|NCT02931253|4032894|FG001|STARTED|Overall Study||4
3299184|NCT02931253|4032893|FG000|COMPLETED|Overall Study||2
3299185|NCT02931253|4032894|FG001|COMPLETED|Overall Study||4
3299186|NCT02931253|4032893|FG000|NOT COMPLETED|Overall Study||0
3299187|NCT02931253|4032894|FG001|NOT COMPLETED|Overall Study||0
3299188|NCT02931396|4032902|FG000|STARTED|Overall Study||10
3299189|NCT02931396|4032903|FG001|STARTED|Overall Study||10
3299190|NCT02931396|4032902|FG000|COMPLETED|Overall Study||5
3299191|NCT02931396|4032903|FG001|COMPLETED|Overall Study||10
3299192|NCT02931396|4032902|FG000|NOT COMPLETED|Overall Study||5
3299193|NCT02931396|4032903|FG001|NOT COMPLETED|Overall Study||0
3299194|NCT02931539|4032911|FG000|STARTED|Period 1: Treatment Phase||117
3299195|NCT02931539|4032912|FG001|STARTED|Period 1: Treatment Phase||235
3299196|NCT02931539|4032913|FG002|STARTED|Period 1: Treatment Phase||0
3299197|NCT02931539|4032911|FG000|Treated Participants|Period 1: Treatment Phase||116
3299198|NCT02931539|4032912|FG001|Treated Participants|Period 1: Treatment Phase||234
3299199|NCT02931539|4032913|FG002|Treated Participants|Period 1: Treatment Phase||0
3299200|NCT02931539|4032911|FG000|IAT (Ganciclovir/ Valganciclovir)|Period 1: Treatment Phase||56
3299201|NCT02931539|4032912|FG001|IAT (Ganciclovir/ Valganciclovir)|Period 1: Treatment Phase||0
3299202|NCT02931539|4032913|FG002|IAT (Ganciclovir/ Valganciclovir)|Period 1: Treatment Phase||0
3299203|NCT02931539|4032911|FG000|IAT (Foscarnet)|Period 1: Treatment Phase||47
3299204|NCT02931539|4032912|FG001|IAT (Foscarnet)|Period 1: Treatment Phase||0
3299205|NCT02931539|4032913|FG002|IAT (Foscarnet)|Period 1: Treatment Phase||0
3299206|NCT02931539|4032911|FG000|IAT (Cidofovir)|Period 1: Treatment Phase||6
3299207|NCT02931539|4032912|FG001|IAT (Cidofovir)|Period 1: Treatment Phase||0
3299208|NCT02931539|4032913|FG002|IAT (Cidofovir)|Period 1: Treatment Phase||0
3299209|NCT02931539|4032911|FG000|IAT (Foscarnet + Valganciclovir/Ganciclovir)|Period 1: Treatment Phase||7
3299210|NCT02931539|4032912|FG001|IAT (Foscarnet + Valganciclovir/Ganciclovir)|Period 1: Treatment Phase||0
3299211|NCT02931539|4032913|FG002|IAT (Foscarnet + Valganciclovir/Ganciclovir)|Period 1: Treatment Phase||0
3299212|NCT02931539|4032911|FG000|COMPLETED|Period 1: Treatment Phase||58
3299213|NCT02931539|4032912|FG001|COMPLETED|Period 1: Treatment Phase||199
3299214|NCT02931539|4032913|FG002|COMPLETED|Period 1: Treatment Phase||0
3299215|NCT02931539|4032911|FG000|NOT COMPLETED|Period 1: Treatment Phase||59
3299216|NCT02931539|4032912|FG001|NOT COMPLETED|Period 1: Treatment Phase||36
3299217|NCT02931539|4032913|FG002|NOT COMPLETED|Period 1: Treatment Phase||0
3299218|NCT02931539|4032911|FG000|STARTED|Period 2: Maribavir Rescue Therapy||0
3299219|NCT02931539|4032912|FG001|STARTED|Period 2: Maribavir Rescue Therapy||0
3299220|NCT02931539|4032913|FG002|STARTED|Period 2: Maribavir Rescue Therapy||22
3299221|NCT02931539|4032911|FG000|COMPLETED|Period 2: Maribavir Rescue Therapy||0
3299222|NCT02931539|4032912|FG001|COMPLETED|Period 2: Maribavir Rescue Therapy||0
3299223|NCT02931539|4032913|FG002|COMPLETED|Period 2: Maribavir Rescue Therapy||20
3299224|NCT02931539|4032911|FG000|NOT COMPLETED|Period 2: Maribavir Rescue Therapy||0
3299225|NCT02931539|4032912|FG001|NOT COMPLETED|Period 2: Maribavir Rescue Therapy||0
3299226|NCT02931539|4032913|FG002|NOT COMPLETED|Period 2: Maribavir Rescue Therapy||2
3299227|NCT02931565|4032928|FG000|STARTED|Overall Study||2
3299228|NCT02931565|4032929|FG001|STARTED|Overall Study||7
2949435|NCT00691483|3663215|FG001|COMPLETED|Overall Study||141
2949436|NCT00691483|3663214|FG000|NOT COMPLETED|Overall Study||68
2949437|NCT00691483|3663215|FG001|NOT COMPLETED|Overall Study||25
2949438|NCT00691600|3663223|FG000|STARTED|Overall Study||12
2949439|NCT00691600|3663224|FG001|STARTED|Overall Study||11
2949440|NCT00691600|3663223|FG000|COMPLETED|Overall Study||12
2949441|NCT00691600|3663224|FG001|COMPLETED|Overall Study||11
2949442|NCT00691600|3663223|FG000|NOT COMPLETED|Overall Study||0
2949443|NCT00691600|3663224|FG001|NOT COMPLETED|Overall Study||0
2949444|NCT00691665|3663232|FG000|STARTED|Overall Study||65
2949445|NCT00691665|3663233|FG001|STARTED|Overall Study||65
2949446|NCT00691665|3663232|FG000|COMPLETED|Overall Study||65
2949447|NCT00691665|3663233|FG001|COMPLETED|Overall Study||65
2949448|NCT00691665|3663232|FG000|NOT COMPLETED|Overall Study||0
2949449|NCT00691665|3663233|FG001|NOT COMPLETED|Overall Study||0
2949450|NCT00691704|3663239|FG000|STARTED|Induction Therapy||18
2949451|NCT00691704|3663239|FG000|COMPLETED|Induction Therapy||16
2949452|NCT00691704|3663239|FG000|NOT COMPLETED|Induction Therapy||2
2949453|NCT00691704|3663239|FG000|STARTED|Two Years of Maintenance Therapy||16
2949454|NCT00691704|3663239|FG000|COMPLETED|Two Years of Maintenance Therapy||3
2949455|NCT00691704|3663239|FG000|NOT COMPLETED|Two Years of Maintenance Therapy||13
2949456|NCT00691808|3663246|FG000|STARTED|Overall Study||35
2949457|NCT00691808|3663247|FG001|STARTED|Overall Study||36
2949458|NCT00691808|3663248|FG002|STARTED|Overall Study||32
2949459|NCT00691808|3663246|FG000|COMPLETED|Overall Study||35
2949460|NCT00691808|3663247|FG001|COMPLETED|Overall Study||35
2949461|NCT00691808|3663248|FG002|COMPLETED|Overall Study||32
2949462|NCT00691808|3663246|FG000|NOT COMPLETED|Overall Study||0
2949463|NCT00691808|3663247|FG001|NOT COMPLETED|Overall Study||1
2949464|NCT00691808|3663248|FG002|NOT COMPLETED|Overall Study||0
2949465|NCT00691938|3663263|FG000|STARTED|Overall Study||5
2949466|NCT00691938|3663264|FG001|STARTED|Overall Study||3
2949467|NCT00691938|3663265|FG002|STARTED|Overall Study||6
2949468|NCT00691938|3663266|FG003|STARTED|Overall Study||8
2949469|NCT00691938|3663267|FG004|STARTED|Overall Study||10
2949470|NCT00691938|3663268|FG005|STARTED|Overall Study||6
2949471|NCT00691938|3663269|FG006|STARTED|Overall Study||14
2949472|NCT00691938|3663263|FG000|COMPLETED|Overall Study||4
2949473|NCT00691938|3663264|FG001|COMPLETED|Overall Study||3
2949474|NCT00691938|3663265|FG002|COMPLETED|Overall Study||6
2949475|NCT00691938|3663266|FG003|COMPLETED|Overall Study||8
2949476|NCT00691938|3663267|FG004|COMPLETED|Overall Study||10
2949477|NCT00691938|3663268|FG005|COMPLETED|Overall Study||6
2949478|NCT00691938|3663269|FG006|COMPLETED|Overall Study||14
2949479|NCT00691938|3663263|FG000|NOT COMPLETED|Overall Study||1
2949480|NCT00691938|3663264|FG001|NOT COMPLETED|Overall Study||0
2949481|NCT00691938|3663265|FG002|NOT COMPLETED|Overall Study||0
2949482|NCT00691938|3663266|FG003|NOT COMPLETED|Overall Study||0
2949483|NCT00691938|3663267|FG004|NOT COMPLETED|Overall Study||0
2949484|NCT00691938|3663268|FG005|NOT COMPLETED|Overall Study||0
2949485|NCT00691938|3663269|FG006|NOT COMPLETED|Overall Study||0
2949486|NCT00692185|3663282|FG000|STARTED|Overall Study||11
2949487|NCT00692185|3663283|FG001|STARTED|Overall Study||12
2949488|NCT00692185|3663282|FG000|COMPLETED|Overall Study||8
2949489|NCT00692185|3663283|FG001|COMPLETED|Overall Study||9
2949490|NCT00692185|3663282|FG000|NOT COMPLETED|Overall Study||3
2949491|NCT00692185|3663283|FG001|NOT COMPLETED|Overall Study||3
2949492|NCT00692198|3663293|FG000|STARTED|Overall Study||368
2949493|NCT00692198|3663294|FG001|STARTED|Overall Study||370
2949494|NCT00692198|3663293|FG000|COMPLETED|Overall Study||368
2949495|NCT00692198|3663294|FG001|COMPLETED|Overall Study||370
2949496|NCT00692198|3663293|FG000|NOT COMPLETED|Overall Study||0
2949497|NCT00692198|3663294|FG001|NOT COMPLETED|Overall Study||0
2949498|NCT00692211|3663303|FG000|STARTED|Overall Study||202
2949499|NCT00692211|3663304|FG001|STARTED|Overall Study||202
2949500|NCT00692211|3663303|FG000|COMPLETED|Overall Study||202
2949501|NCT00692211|3663304|FG001|COMPLETED|Overall Study||202
2949502|NCT00692211|3663303|FG000|NOT COMPLETED|Overall Study||0
2949503|NCT00692211|3663304|FG001|NOT COMPLETED|Overall Study||0
2949504|NCT00692237|3663312|FG000|STARTED|Overall Study||30
2949505|NCT00692237|3663313|FG001|STARTED|Overall Study||29
2949506|NCT00692237|3663312|FG000|COMPLETED|Overall Study||29
2949507|NCT00692237|3663313|FG001|COMPLETED|Overall Study||25
2949508|NCT00692237|3663312|FG000|NOT COMPLETED|Overall Study||1
2949509|NCT00692237|3663313|FG001|NOT COMPLETED|Overall Study||4
2949510|NCT00692276|3663321|FG000|STARTED|Randomized Population||190
2949511|NCT00692276|3663322|FG001|STARTED|Randomized Population||201
2949512|NCT00692276|3663321|FG000|COMPLETED|Randomized Population||190
2949513|NCT00692276|3663322|FG001|COMPLETED|Randomized Population||201
2949514|NCT00692276|3663321|FG000|NOT COMPLETED|Randomized Population||0
2949515|NCT00692276|3663322|FG001|NOT COMPLETED|Randomized Population||0
2949516|NCT00692276|3663321|FG000|STARTED|Completed 24 Months||190
2949517|NCT00692276|3663322|FG001|STARTED|Completed 24 Months||201
2949518|NCT00692276|3663321|FG000|COMPLETED|Completed 24 Months||183
2949519|NCT00692276|3663322|FG001|COMPLETED|Completed 24 Months||187
2949520|NCT00692276|3663321|FG000|NOT COMPLETED|Completed 24 Months||7
2949521|NCT00692276|3663322|FG001|NOT COMPLETED|Completed 24 Months||14
2949522|NCT00692341|3663331|FG000|STARTED|Overall Study||8
2949523|NCT00692341|3663332|FG001|STARTED|Overall Study||8
2949524|NCT00692341|3663333|FG002|STARTED|Overall Study||8
2949525|NCT00692341|3663331|FG000|COMPLETED|Overall Study||8
2949526|NCT00692341|3663332|FG001|COMPLETED|Overall Study||8
2949527|NCT00692341|3663333|FG002|COMPLETED|Overall Study||8
2949528|NCT00692341|3663331|FG000|NOT COMPLETED|Overall Study||0
2949529|NCT00692341|3663332|FG001|NOT COMPLETED|Overall Study||0
2949530|NCT00692341|3663333|FG002|NOT COMPLETED|Overall Study||0
2949531|NCT00692406|3663341|FG000|STARTED|Overall Study|Initially this group was assigned to quit smoking before the second scan.|80
2949532|NCT00692406|3663341|FG000|COMPLETED|Overall Study|This group quit smoking before their second scan.|23
2949533|NCT00692406|3663341|FG000|NOT COMPLETED|Overall Study||57
2949534|NCT00692419|3663347|FG000|STARTED|Overall Study||100
2949535|NCT00692419|3663348|FG001|STARTED|Overall Study||120
2949536|NCT00692419|3663347|FG000|COMPLETED|Overall Study||84
2949537|NCT00692419|3663348|FG001|COMPLETED|Overall Study||102
2949538|NCT00692419|3663347|FG000|NOT COMPLETED|Overall Study||16
2949539|NCT00692419|3663348|FG001|NOT COMPLETED|Overall Study||18
2949540|NCT00692692|3663358|FG000|STARTED|Overall Study||20
2949541|NCT00692692|3663359|FG001|STARTED|Overall Study||16
2949542|NCT00692692|3663358|FG000|COMPLETED|Overall Study||20
2949543|NCT00692692|3663359|FG001|COMPLETED|Overall Study||16
2949544|NCT00692692|3663358|FG000|NOT COMPLETED|Overall Study||0
2949545|NCT00692692|3663359|FG001|NOT COMPLETED|Overall Study||0
2949546|NCT00692770|3663367|FG000|STARTED|Overall Study||556
2949547|NCT00692770|3663368|FG001|STARTED|Overall Study||558
2949548|NCT00692770|3663367|FG000|Participants Received Treatment|Overall Study||553
2949549|NCT00692770|3663368|FG001|Participants Received Treatment|Overall Study||554
2949550|NCT00692770|3663367|FG000|COMPLETED|Overall Study||0
2949551|NCT00692770|3663368|FG001|COMPLETED|Overall Study||0
2949552|NCT00692770|3663367|FG000|NOT COMPLETED|Overall Study||556
2949553|NCT00692770|3663368|FG001|NOT COMPLETED|Overall Study||558
2949554|NCT00692978|3663382|FG000|STARTED|FP From Active 250 ug MDI Inhaler||15
2949555|NCT00692978|3663383|FG001|STARTED|FP From Active 250 ug MDI Inhaler||15
2949556|NCT00692978|3663382|FG000|COMPLETED|FP From Active 250 ug MDI Inhaler||15
2949557|NCT00692978|3663383|FG001|COMPLETED|FP From Active 250 ug MDI Inhaler||15
2949558|NCT00692978|3663382|FG000|NOT COMPLETED|FP From Active 250 ug MDI Inhaler||0
2949559|NCT00692978|3663383|FG001|NOT COMPLETED|FP From Active 250 ug MDI Inhaler||0
2949560|NCT00692978|3663382|FG000|STARTED|FP1.5 Microns Size With MDI Inhaler||15
2949561|NCT00692978|3663383|FG001|STARTED|FP1.5 Microns Size With MDI Inhaler||15
2949562|NCT00692978|3663382|FG000|COMPLETED|FP1.5 Microns Size With MDI Inhaler||15
2949563|NCT00692978|3663383|FG001|COMPLETED|FP1.5 Microns Size With MDI Inhaler||15
2949564|NCT00692978|3663382|FG000|NOT COMPLETED|FP1.5 Microns Size With MDI Inhaler||0
2949565|NCT00692978|3663383|FG001|NOT COMPLETED|FP1.5 Microns Size With MDI Inhaler||0
2949566|NCT00692978|3663382|FG000|STARTED|FP 3 Microns Size With MDI Inhaler||15
2949567|NCT00692978|3663383|FG001|STARTED|FP 3 Microns Size With MDI Inhaler||15
2949568|NCT00692978|3663382|FG000|COMPLETED|FP 3 Microns Size With MDI Inhaler||15
2949569|NCT00692978|3663383|FG001|COMPLETED|FP 3 Microns Size With MDI Inhaler||15
2949570|NCT00692978|3663382|FG000|NOT COMPLETED|FP 3 Microns Size With MDI Inhaler||0
2949571|NCT00692978|3663383|FG001|NOT COMPLETED|FP 3 Microns Size With MDI Inhaler||0
2949572|NCT00692978|3663382|FG000|STARTED|FP 6 Microns Size With MDI Inhaler||15
2949573|NCT00692978|3663383|FG001|STARTED|FP 6 Microns Size With MDI Inhaler||15
2949574|NCT00692978|3663382|FG000|COMPLETED|FP 6 Microns Size With MDI Inhaler||15
2949575|NCT00692978|3663383|FG001|COMPLETED|FP 6 Microns Size With MDI Inhaler||15
2949576|NCT00692978|3663382|FG000|NOT COMPLETED|FP 6 Microns Size With MDI Inhaler||0
2949577|NCT00692978|3663383|FG001|NOT COMPLETED|FP 6 Microns Size With MDI Inhaler||0
2949578|NCT00693160|3663403|FG000|STARTED|Overall Study||14
2949579|NCT00693160|3663404|FG001|STARTED|Overall Study||16
2949580|NCT00693160|3663403|FG000|COMPLETED|Overall Study||14
2949581|NCT00693160|3663404|FG001|COMPLETED|Overall Study||16
2949582|NCT00693160|3663403|FG000|NOT COMPLETED|Overall Study||0
2949583|NCT00693160|3663404|FG001|NOT COMPLETED|Overall Study||0
2949584|NCT00693225|3663412|FG000|STARTED|Overall Study||43
2949585|NCT00693225|3663413|FG001|STARTED|Overall Study||48
2949586|NCT00693225|3663412|FG000|COMPLETED|Overall Study||41
2949587|NCT00693225|3663413|FG001|COMPLETED|Overall Study||43
2949588|NCT00693225|3663412|FG000|NOT COMPLETED|Overall Study||2
2949589|NCT00693225|3663413|FG001|NOT COMPLETED|Overall Study||5
2949590|NCT00693303|3663419|FG000|STARTED|Overall Study||21
2949591|NCT00693303|3663419|FG000|COMPLETED|Overall Study||21
2949592|NCT00693303|3663419|FG000|NOT COMPLETED|Overall Study||0
2949593|NCT00693420|3663425|FG000|STARTED|Overall Study||137
2949594|NCT00693420|3663426|FG001|STARTED|Overall Study||141
2949595|NCT00693420|3663425|FG000|COMPLETED|Overall Study||131
2949596|NCT00693420|3663426|FG001|COMPLETED|Overall Study||126
2949597|NCT00693420|3663425|FG000|NOT COMPLETED|Overall Study||6
2949598|NCT00693420|3663426|FG001|NOT COMPLETED|Overall Study||15
2949599|NCT00693472|3663436|FG000|STARTED|Part 1||19
2949600|NCT00693472|3663437|FG001|STARTED|Part 1||13
2949601|NCT00693472|3663438|FG002|STARTED|Part 1||0
2949602|NCT00693472|3663439|FG003|STARTED|Part 1||0
2949603|NCT00693472|3663436|FG000|COMPLETED|Part 1||13
2949604|NCT00693472|3663437|FG001|COMPLETED|Part 1||9
2949605|NCT00693472|3663438|FG002|COMPLETED|Part 1||0
2949606|NCT00693472|3663439|FG003|COMPLETED|Part 1||0
2949607|NCT00693472|3663436|FG000|NOT COMPLETED|Part 1||6
2949608|NCT00693472|3663437|FG001|NOT COMPLETED|Part 1||4
2949609|NCT00693472|3663438|FG002|NOT COMPLETED|Part 1||0
2949610|NCT00693472|3663439|FG003|NOT COMPLETED|Part 1||0
2949611|NCT00693472|3663436|FG000|STARTED|Part 2||0
2949612|NCT00693472|3663437|FG001|STARTED|Part 2||0
2949613|NCT00693472|3663438|FG002|STARTED|Part 2||8
2949614|NCT00693472|3663439|FG003|STARTED|Part 2||6
2949615|NCT00693472|3663436|FG000|COMPLETED|Part 2||0
2949616|NCT00693472|3663437|FG001|COMPLETED|Part 2||0
2949617|NCT00693472|3663438|FG002|COMPLETED|Part 2||6
2949618|NCT00693472|3663439|FG003|COMPLETED|Part 2||4
2949619|NCT00693472|3663436|FG000|NOT COMPLETED|Part 2||0
2949620|NCT00693472|3663437|FG001|NOT COMPLETED|Part 2||0
2949621|NCT00693472|3663438|FG002|NOT COMPLETED|Part 2||2
2949622|NCT00693472|3663439|FG003|NOT COMPLETED|Part 2||2
2949623|NCT00693485|3663452|FG000|STARTED|Overall Study||25
2949624|NCT00693485|3663453|FG001|STARTED|Overall Study||21
2949625|NCT00693485|3663454|FG002|STARTED|Overall Study||24
2949626|NCT00693485|3663452|FG000|COMPLETED|Overall Study||25
2949627|NCT00693485|3663453|FG001|COMPLETED|Overall Study||19
2949628|NCT00693485|3663454|FG002|COMPLETED|Overall Study||24
2949629|NCT00693485|3663452|FG000|NOT COMPLETED|Overall Study||0
2949630|NCT00693485|3663453|FG001|NOT COMPLETED|Overall Study||2
2949631|NCT00693485|3663454|FG002|NOT COMPLETED|Overall Study||0
2949632|NCT00693498|3663464|FG000|STARTED|Overall Study||81
2949633|NCT00693498|3663465|FG001|STARTED|Overall Study||81
2949634|NCT00693498|3663464|FG000|COMPLETED|Overall Study||81
2949635|NCT00693498|3663465|FG001|COMPLETED|Overall Study||81
2949636|NCT00693498|3663464|FG000|NOT COMPLETED|Overall Study||0
2949637|NCT00693498|3663465|FG001|NOT COMPLETED|Overall Study||0
2949638|NCT00693654|3663473|FG000|STARTED|Overall Study||14
2949639|NCT00693654|3663474|FG001|STARTED|Overall Study||14
2949640|NCT00693654|3663473|FG000|COMPLETED|Overall Study||14
2949641|NCT00693654|3663474|FG001|COMPLETED|Overall Study||14
2949642|NCT00693654|3663473|FG000|NOT COMPLETED|Overall Study||0
2949643|NCT00693654|3663474|FG001|NOT COMPLETED|Overall Study||0
2949644|NCT00693693|3663484|FG000|STARTED|Overall Study||7
2949645|NCT00693693|3663485|FG001|STARTED|Overall Study||9
2949646|NCT00693693|3663486|FG002|STARTED|Overall Study||9
2949647|NCT00693693|3663484|FG000|COMPLETED|Overall Study||6
2949648|NCT00693693|3663485|FG001|COMPLETED|Overall Study||8
2949649|NCT00693693|3663486|FG002|COMPLETED|Overall Study||7
2949650|NCT00693693|3663484|FG000|NOT COMPLETED|Overall Study||1
2949651|NCT00693693|3663485|FG001|NOT COMPLETED|Overall Study||1
2949652|NCT00693693|3663486|FG002|NOT COMPLETED|Overall Study||2
2949653|NCT00693706|3663496|FG000|STARTED|Overall Study||101
2949654|NCT00693706|3663497|FG001|STARTED|Overall Study||99
2949655|NCT00693706|3663496|FG000|COMPLETED|Overall Study||101
2949656|NCT00693706|3663497|FG001|COMPLETED|Overall Study||98
2949657|NCT00693706|3663496|FG000|NOT COMPLETED|Overall Study||0
2949658|NCT00693706|3663497|FG001|NOT COMPLETED|Overall Study||1
2949659|NCT00693719|3663503|FG000|STARTED|Overall Study||31
2949660|NCT00693719|3663503|FG000|COMPLETED|Overall Study||31
2949661|NCT00693719|3663503|FG000|NOT COMPLETED|Overall Study||0
2949662|NCT00693784|3663507|FG000|STARTED|Overall Study||15
2949663|NCT00693784|3663507|FG000|26-Week Primary Endpoint|Overall Study||15
2949664|NCT00693784|3663507|FG000|52-week Extended Follow-up|Overall Study||13
2949665|NCT00693784|3663507|FG000|104-week Extended Follow-up|Overall Study||11
2949666|NCT00693784|3663507|FG000|COMPLETED|Overall Study||11
2949667|NCT00693784|3663507|FG000|NOT COMPLETED|Overall Study||4
2949668|NCT00693992|3663513|FG000|STARTED|Overall Study||106
2949669|NCT00693992|3663514|FG001|STARTED|Overall Study||104
2949670|NCT00693992|3663513|FG000|COMPLETED|Overall Study||106
2949671|NCT00693992|3663514|FG001|COMPLETED|Overall Study||104
2949672|NCT00693992|3663513|FG000|NOT COMPLETED|Overall Study||0
2949673|NCT00693992|3663514|FG001|NOT COMPLETED|Overall Study||0
2949674|NCT00694018|3663522|FG000|STARTED|Overall Study||118
2949675|NCT00694018|3663523|FG001|STARTED|Overall Study||111
2949676|NCT00694018|3663522|FG000|6 Months|Overall Study||106
2949677|NCT00694018|3663523|FG001|6 Months|Overall Study||101
2949678|NCT00694018|3663522|FG000|COMPLETED|Overall Study||105
2949679|NCT00694018|3663523|FG001|COMPLETED|Overall Study||102
2949680|NCT00694018|3663522|FG000|NOT COMPLETED|Overall Study||13
2949681|NCT00694018|3663523|FG001|NOT COMPLETED|Overall Study||9
2949682|NCT00694070|3663529|FG000|STARTED|Overall Study||51
2949683|NCT00694070|3663529|FG000|COMPLETED|Overall Study||51
2949684|NCT00694070|3663529|FG000|NOT COMPLETED|Overall Study||0
2949685|NCT00694096|3663533|FG000|STARTED|Overall Study||25
2949686|NCT00694096|3663533|FG000|COMPLETED|Overall Study||20
2949687|NCT00694096|3663533|FG000|NOT COMPLETED|Overall Study||5
3034895|NCT01134263|3753933|FG003|Received Vaccination 3|Overall Study||151
3034896|NCT01134263|3753934|FG004|Received Vaccination 3|Overall Study||49
3034897|NCT01134263|3753930|FG000|Safety Population|Overall Study||163
3034898|NCT01134263|3753931|FG001|Safety Population|Overall Study||161
3034899|NCT01134263|3753932|FG002|Safety Population|Overall Study|1 participant randomized to the Phase III Lot 2 group, received Phase III Lot 3 vaccination.|164
3034900|NCT01134263|3753933|FG003|Safety Population|Overall Study||167
3034901|NCT01134263|3753934|FG004|Safety Population|Overall Study||57
3034902|NCT01134263|3753930|FG000|COMPLETED|Overall Study||140
3034903|NCT01134263|3753931|FG001|COMPLETED|Overall Study||143
3034904|NCT01134263|3753932|FG002|COMPLETED|Overall Study||134
3034905|NCT01134263|3753933|FG003|COMPLETED|Overall Study||149
3034906|NCT01134263|3753934|FG004|COMPLETED|Overall Study||48
3034907|NCT01134263|3753930|FG000|NOT COMPLETED|Overall Study||24
3034908|NCT01134263|3753931|FG001|NOT COMPLETED|Overall Study||20
3034909|NCT01134263|3753932|FG002|NOT COMPLETED|Overall Study||29
3034910|NCT01134263|3753933|FG003|NOT COMPLETED|Overall Study||19
3034911|NCT01134263|3753934|FG004|NOT COMPLETED|Overall Study||9
3034912|NCT01134276|3753954|FG000|STARTED|Overall Study||104
3034913|NCT01134276|3753955|FG001|STARTED|Overall Study||107
3034914|NCT01134276|3753954|FG000|COMPLETED|Overall Study||104
3034915|NCT01134276|3753955|FG001|COMPLETED|Overall Study||107
3034916|NCT01134276|3753954|FG000|NOT COMPLETED|Overall Study||0
3034917|NCT01134276|3753955|FG001|NOT COMPLETED|Overall Study||0
3034918|NCT01134315|3753966|FG000|STARTED|Overall Study||21
3034919|NCT01134315|3753967|FG001|STARTED|Overall Study||40
3034920|NCT01134315|3753966|FG000|COMPLETED|Overall Study|Completed study drug treatment during the observational study (ie, prior to study termination).|12
3038347|NCT01153815|3757772|FG001|COMPLETED|Overall Study||82
2949688|NCT00694109|3663537|FG000|STARTED|Overall Study|This does not include 2 patients from phase 2 trial with very different treatment experience.|142
2949689|NCT00694109|3663537|FG000|Treated|Overall Study||141
2949690|NCT00694109|3663537|FG000|Consented 2 Years Additional Treatment|Overall Study||42
2949691|NCT00694109|3663537|FG000|Completed Consented Length of Treatment|Overall Study||60
2949692|NCT00694109|3663537|FG000|COMPLETED|Overall Study||25
2949693|NCT00694109|3663537|FG000|NOT COMPLETED|Overall Study||117
2949694|NCT00694122|3663542|FG000|STARTED|First Intervention (3-4 Weeks)|Started Lantus then on NPH.|20
2949695|NCT00694122|3663543|FG001|STARTED|First Intervention (3-4 Weeks)|Started on NPH then on Lantus.|7
2949696|NCT00694122|3663542|FG000|COMPLETED|First Intervention (3-4 Weeks)||10
2949697|NCT00694122|3663543|FG001|COMPLETED|First Intervention (3-4 Weeks)||5
2949698|NCT00694122|3663542|FG000|NOT COMPLETED|First Intervention (3-4 Weeks)||10
2949699|NCT00694122|3663543|FG001|NOT COMPLETED|First Intervention (3-4 Weeks)||2
2949700|NCT00694122|3663542|FG000|STARTED|Washout (1 Day)||10
2949701|NCT00694122|3663543|FG001|STARTED|Washout (1 Day)||5
2949702|NCT00694122|3663542|FG000|COMPLETED|Washout (1 Day)||10
2949703|NCT00694122|3663543|FG001|COMPLETED|Washout (1 Day)||5
2949704|NCT00694122|3663542|FG000|NOT COMPLETED|Washout (1 Day)||0
2949705|NCT00694122|3663543|FG001|NOT COMPLETED|Washout (1 Day)||0
2949706|NCT00694122|3663542|FG000|STARTED|Second Intervention (3-4 Weeks)||10
2949707|NCT00694122|3663543|FG001|STARTED|Second Intervention (3-4 Weeks)||5
2949708|NCT00694122|3663542|FG000|COMPLETED|Second Intervention (3-4 Weeks)||10
2949709|NCT00694122|3663543|FG001|COMPLETED|Second Intervention (3-4 Weeks)||5
2949710|NCT00694122|3663542|FG000|NOT COMPLETED|Second Intervention (3-4 Weeks)||0
2949711|NCT00694122|3663543|FG001|NOT COMPLETED|Second Intervention (3-4 Weeks)||0
2949712|NCT00694161|3663554|FG000|STARTED|Part 1 (up to Week 6)||35
2949713|NCT00694161|3663554|FG000|COMPLETED|Part 1 (up to Week 6)||35
2949714|NCT00694161|3663554|FG000|NOT COMPLETED|Part 1 (up to Week 6)||0
2949715|NCT00694161|3663554|FG000|STARTED|Part 2 (After Week 6 up to Month 12)||35
2949716|NCT00694161|3663554|FG000|COMPLETED|Part 2 (After Week 6 up to Month 12)||32
2949717|NCT00694161|3663554|FG000|NOT COMPLETED|Part 2 (After Week 6 up to Month 12)||3
2949718|NCT00694304|3663558|FG000|STARTED|Overall Study||535
2949719|NCT00694304|3663558|FG000|COMPLETED|Overall Study||328
2949720|NCT00694304|3663558|FG000|NOT COMPLETED|Overall Study||207
2949721|NCT00694356|3663565|FG000|STARTED|Overall Study||3
2949722|NCT00694356|3663566|FG001|STARTED|Overall Study||6
2949723|NCT00694356|3663567|FG002|STARTED|Overall Study||6
2949724|NCT00694356|3663565|FG000|COMPLETED|Overall Study||0
2949725|NCT00694356|3663566|FG001|COMPLETED|Overall Study||0
2949726|NCT00694356|3663567|FG002|COMPLETED|Overall Study||0
2949727|NCT00694356|3663565|FG000|NOT COMPLETED|Overall Study||3
2949728|NCT00694356|3663566|FG001|NOT COMPLETED|Overall Study||6
2949729|NCT00694356|3663567|FG002|NOT COMPLETED|Overall Study||6
2949730|NCT00694473|3663575|FG000|STARTED|Overall Study|Aug 2008|76
2949731|NCT00694473|3663575|FG000|COMPLETED|Overall Study|Dec 2010|69
2949732|NCT00694473|3663575|FG000|NOT COMPLETED|Overall Study||7
2949733|NCT00694551|3663582|FG000|STARTED|Overall Study||10
2949734|NCT00694551|3663583|FG001|STARTED|Overall Study||10
2949735|NCT00694551|3663584|FG002|STARTED|Overall Study||9
2949736|NCT00694551|3663582|FG000|COMPLETED|Overall Study||9
2949737|NCT00694551|3663583|FG001|COMPLETED|Overall Study||10
2949738|NCT00694551|3663584|FG002|COMPLETED|Overall Study||8
2949739|NCT00694551|3663582|FG000|NOT COMPLETED|Overall Study||1
2949740|NCT00694551|3663583|FG001|NOT COMPLETED|Overall Study||0
2949741|NCT00694551|3663584|FG002|NOT COMPLETED|Overall Study||1
2949742|NCT00694564|3663593|FG000|STARTED|Overall Study||8
2949743|NCT00694564|3663593|FG000|COMPLETED|Overall Study||6
2949744|NCT00694564|3663593|FG000|NOT COMPLETED|Overall Study||2
2949745|NCT00694603|3663597|FG000|STARTED|Overall Study||18
2949746|NCT00694603|3663597|FG000|COMPLETED|Overall Study||18
2949747|NCT00694603|3663597|FG000|NOT COMPLETED|Overall Study||0
2949748|NCT00694707|3663606|FG000|STARTED|Overall Study||151
2949749|NCT00694707|3663607|FG001|STARTED|Overall Study||145
2949750|NCT00694707|3663608|FG002|STARTED|Overall Study||147
2949751|NCT00694707|3663609|FG003|STARTED|Overall Study||148
2949752|NCT00694707|3663610|FG004|STARTED|Overall Study||141
2949753|NCT00694707|3663606|FG000|COMPLETED|Overall Study||79
2949754|NCT00694707|3663607|FG001|COMPLETED|Overall Study||90
2949755|NCT00694707|3663608|FG002|COMPLETED|Overall Study||96
2949756|NCT00694707|3663609|FG003|COMPLETED|Overall Study||98
2949757|NCT00694707|3663610|FG004|COMPLETED|Overall Study||101
2949758|NCT00694707|3663606|FG000|NOT COMPLETED|Overall Study||72
2949759|NCT00694707|3663607|FG001|NOT COMPLETED|Overall Study||55
2949760|NCT00694707|3663608|FG002|NOT COMPLETED|Overall Study||51
2949761|NCT00694707|3663609|FG003|NOT COMPLETED|Overall Study||50
2949762|NCT00694707|3663610|FG004|NOT COMPLETED|Overall Study||40
2949763|NCT00695019|3663625|FG000|STARTED|Overall Study||59
2949764|NCT00695019|3663626|FG001|STARTED|Overall Study||53
2949765|NCT00695019|3663627|FG002|STARTED|Overall Study||57
2949766|NCT00695019|3663625|FG000|COMPLETED|Overall Study||46
3132493|NCT01691430|3857552|FG000|COMPLETED|Overall Study||70
3132494|NCT01691430|3857553|FG001|COMPLETED|Overall Study||73
3132495|NCT01691430|3857552|FG000|NOT COMPLETED|Overall Study||22
3132496|NCT01691430|3857553|FG001|NOT COMPLETED|Overall Study||20
3132497|NCT01691482|3857559|FG000|STARTED|Treatment Period 1||28
3132498|NCT01691482|3857560|FG001|STARTED|Treatment Period 1||28
3132499|NCT01691482|3857559|FG000|COMPLETED|Treatment Period 1||28
3132500|NCT01691482|3857560|FG001|COMPLETED|Treatment Period 1||28
2949767|NCT00695019|3663626|FG001|COMPLETED|Overall Study||39
2949768|NCT00695019|3663627|FG002|COMPLETED|Overall Study||47
2949769|NCT00695019|3663625|FG000|NOT COMPLETED|Overall Study||13
2949770|NCT00695019|3663626|FG001|NOT COMPLETED|Overall Study||14
2949771|NCT00695019|3663627|FG002|NOT COMPLETED|Overall Study||10
2949772|NCT00695097|3663637|FG000|STARTED|Overall Study||10
2949773|NCT00695097|3663638|FG001|STARTED|Overall Study||5
2949774|NCT00695097|3663637|FG000|COMPLETED|Overall Study||9
2949775|NCT00695097|3663638|FG001|COMPLETED|Overall Study||5
2949776|NCT00695097|3663637|FG000|NOT COMPLETED|Overall Study||1
2949777|NCT00695097|3663638|FG001|NOT COMPLETED|Overall Study||0
2949778|NCT00695110|3663644|FG000|STARTED|Treatment Period 1||29
2949779|NCT00695110|3663644|FG000|COMPLETED|Treatment Period 1||26
2949780|NCT00695110|3663644|FG000|NOT COMPLETED|Treatment Period 1||3
2949781|NCT00695110|3663644|FG000|STARTED|Treatment Period 2||26
2949782|NCT00695110|3663644|FG000|COMPLETED|Treatment Period 2||26
2949783|NCT00695110|3663644|FG000|NOT COMPLETED|Treatment Period 2||0
2949784|NCT00695110|3663644|FG000|STARTED|Treatment Period 3||26
2949785|NCT00695110|3663644|FG000|COMPLETED|Treatment Period 3||25
2949786|NCT00695110|3663644|FG000|NOT COMPLETED|Treatment Period 3||1
2949787|NCT00695110|3663644|FG000|STARTED|Treatment Period 4||25
2949788|NCT00695110|3663644|FG000|COMPLETED|Treatment Period 4||24
2949789|NCT00695110|3663644|FG000|NOT COMPLETED|Treatment Period 4||1
2949790|NCT00695136|3663651|FG000|STARTED|Overall Study|7|7
2949791|NCT00695136|3663651|FG000|COMPLETED|Overall Study||5
2949792|NCT00695136|3663651|FG000|NOT COMPLETED|Overall Study||2
2949793|NCT00695188|3663657|FG000|STARTED|Overall Study||10
2949794|NCT00695188|3663658|FG001|STARTED|Overall Study||9
2949795|NCT00695188|3663657|FG000|COMPLETED|Overall Study||10
2949796|NCT00695188|3663658|FG001|COMPLETED|Overall Study||9
2949797|NCT00695188|3663657|FG000|NOT COMPLETED|Overall Study||0
2949798|NCT00695188|3663658|FG001|NOT COMPLETED|Overall Study||0
2949799|NCT00695253|3663664|FG000|STARTED|Overall Study|75 patients were screened and a total of 49 were enrolled in the study.|49
2949800|NCT00695253|3663664|FG000|COMPLETED|Overall Study|Eighteen (18) completed the study up to the 5 year followup.|18
2949801|NCT00695253|3663664|FG000|NOT COMPLETED|Overall Study||31
2949802|NCT00695292|3663669|FG000|STARTED|Overall Study||37
2949803|NCT00695292|3663669|FG000|COMPLETED|Overall Study||37
2949804|NCT00695292|3663669|FG000|NOT COMPLETED|Overall Study||0
2949805|NCT00695318|3663675|FG000|STARTED|Overall Study||10
2949806|NCT00695318|3663676|FG001|STARTED|Overall Study||7
2949807|NCT00695318|3663675|FG000|COMPLETED|Overall Study||5
2949808|NCT00695318|3663676|FG001|COMPLETED|Overall Study||6
2949809|NCT00695318|3663675|FG000|NOT COMPLETED|Overall Study||5
2949810|NCT00695318|3663676|FG001|NOT COMPLETED|Overall Study||1
2949811|NCT00695396|3663690|FG000|STARTED|Overall Study||8
2949812|NCT00695396|3663691|FG001|STARTED|Overall Study||8
2949813|NCT00695396|3663692|FG002|STARTED|Overall Study||9
3299229|NCT02931565|4032928|FG000|COMPLETED|Overall Study||2
3299230|NCT02931565|4032929|FG001|COMPLETED|Overall Study||7
3299231|NCT02931565|4032928|FG000|NOT COMPLETED|Overall Study||0
3299232|NCT02931565|4032929|FG001|NOT COMPLETED|Overall Study||0
3299233|NCT02931838|4032942|FG000|STARTED|Overall Study||45
3299234|NCT02931838|4032943|FG001|STARTED|Overall Study||44
3299235|NCT02931838|4032944|FG002|STARTED|Overall Study||44
3299236|NCT02931838|4032945|FG003|STARTED|Overall Study||45
3299237|NCT02931838|4032946|FG004|STARTED|Overall Study||45
3299238|NCT02931838|4032947|FG005|STARTED|Overall Study||44
3299239|NCT02931838|4032942|FG000|COMPLETED|Overall Study||31
3299240|NCT02931838|4032943|FG001|COMPLETED|Overall Study||34
3299241|NCT02931838|4032944|FG002|COMPLETED|Overall Study||36
3299242|NCT02931838|4032945|FG003|COMPLETED|Overall Study||42
3299243|NCT02931838|4032946|FG004|COMPLETED|Overall Study||39
3299244|NCT02931838|4032947|FG005|COMPLETED|Overall Study||42
3299245|NCT02931838|4032942|FG000|NOT COMPLETED|Overall Study||14
3299246|NCT02931838|4032943|FG001|NOT COMPLETED|Overall Study||10
3299247|NCT02931838|4032944|FG002|NOT COMPLETED|Overall Study||8
3299248|NCT02931838|4032945|FG003|NOT COMPLETED|Overall Study||3
3299249|NCT02931838|4032946|FG004|NOT COMPLETED|Overall Study||6
3299250|NCT02931838|4032947|FG005|NOT COMPLETED|Overall Study||2
3299251|NCT02932228|4032968|FG000|STARTED|Overall Study||150
3299252|NCT02932228|4032969|FG001|STARTED|Overall Study||433
3299253|NCT02932228|4032968|FG000|COMPLETED|Overall Study||140
3299254|NCT02932228|4032969|FG001|COMPLETED|Overall Study||405
3299255|NCT02932228|4032968|FG000|NOT COMPLETED|Overall Study||10
3299256|NCT02932228|4032969|FG001|NOT COMPLETED|Overall Study||28
3299257|NCT02932267|4032977|FG000|STARTED|Overall Study||50
3299258|NCT02932267|4032977|FG000|COMPLETED|Overall Study||42
3299259|NCT02932267|4032977|FG000|NOT COMPLETED|Overall Study||8
3299260|NCT02932306|4032983|FG000|STARTED|Overall Study||406
3299261|NCT02932306|4032984|FG001|STARTED|Overall Study||414
3299262|NCT02932306|4032983|FG000|Intent-to-treat (ITT) Population|Overall Study||406
3299263|NCT02932306|4032984|FG001|Intent-to-treat (ITT) Population|Overall Study||414
3299264|NCT02932306|4032983|FG000|Safety Population|Overall Study||378
3299265|NCT02932306|4032984|FG001|Safety Population|Overall Study||385
3299266|NCT02932306|4032983|FG000|COMPLETED|Overall Study||338
2949814|NCT00695396|3663690|FG000|COMPLETED|Overall Study||1
2949815|NCT00695396|3663691|FG001|COMPLETED|Overall Study||0
3299267|NCT02932306|4032984|FG001|COMPLETED|Overall Study||337
3299268|NCT02932306|4032983|FG000|NOT COMPLETED|Overall Study||68
3299269|NCT02932306|4032984|FG001|NOT COMPLETED|Overall Study||77
3299270|NCT02932332|4032994|FG000|STARTED|Overall Study||5
2949816|NCT00695396|3663692|FG002|COMPLETED|Overall Study||1
2949817|NCT00695396|3663690|FG000|NOT COMPLETED|Overall Study||7
2949818|NCT00695396|3663691|FG001|NOT COMPLETED|Overall Study||8
2949819|NCT00695396|3663692|FG002|NOT COMPLETED|Overall Study||8
2949820|NCT00695409|3663700|FG000|STARTED|Overall Study||122
2949821|NCT00695409|3663700|FG000|COMPLETED|Overall Study||122
2949822|NCT00695409|3663700|FG000|NOT COMPLETED|Overall Study||0
2949823|NCT00695435|3663705|FG000|STARTED|Overall Study||7
2949824|NCT00695435|3663706|FG001|STARTED|Overall Study||7
2949825|NCT00695435|3663707|FG002|STARTED|Overall Study||7
2949826|NCT00695435|3663705|FG000|COMPLETED|Overall Study||7
2949827|NCT00695435|3663706|FG001|COMPLETED|Overall Study||7
2949828|NCT00695435|3663707|FG002|COMPLETED|Overall Study||7
2949829|NCT00695435|3663705|FG000|NOT COMPLETED|Overall Study||0
2949830|NCT00695435|3663706|FG001|NOT COMPLETED|Overall Study||0
2949831|NCT00695435|3663707|FG002|NOT COMPLETED|Overall Study||0
2949832|NCT00695500|3663717|FG000|STARTED|Overall Study||24
2949833|NCT00695500|3663718|FG001|STARTED|Overall Study||22
2949834|NCT00695500|3663717|FG000|COMPLETED|Overall Study||21
2949835|NCT00695500|3663718|FG001|COMPLETED|Overall Study||17
2949836|NCT00695500|3663717|FG000|NOT COMPLETED|Overall Study||3
2949837|NCT00695500|3663718|FG001|NOT COMPLETED|Overall Study||5
3299271|NCT02932332|4032995|FG001|STARTED|Overall Study||4
3299272|NCT02932332|4032996|FG002|STARTED|Overall Study||5
3299273|NCT02932332|4032997|FG003|STARTED|Overall Study||5
3299274|NCT02932332|4032994|FG000|Intervention 1|Overall Study||4
3299275|NCT02932332|4032995|FG001|Intervention 1|Overall Study||4
3299276|NCT02932332|4032996|FG002|Intervention 1|Overall Study||5
3299277|NCT02932332|4032997|FG003|Intervention 1|Overall Study||4
3299278|NCT02932332|4032994|FG000|Intervention 2|Overall Study||4
3299279|NCT02932332|4032995|FG001|Intervention 2|Overall Study||3
3299280|NCT02932332|4032996|FG002|Intervention 2|Overall Study||4
3299281|NCT02932332|4032997|FG003|Intervention 2|Overall Study||4
3299282|NCT02932332|4032994|FG000|Intervention 3|Overall Study||3
3299283|NCT02932332|4032995|FG001|Intervention 3|Overall Study||2
3299284|NCT02932332|4032996|FG002|Intervention 3|Overall Study||4
3299285|NCT02932332|4032997|FG003|Intervention 3|Overall Study||3
3299286|NCT02932332|4032994|FG000|Intervention 4|Overall Study||3
3299287|NCT02932332|4032995|FG001|Intervention 4|Overall Study||1
3299288|NCT02932332|4032996|FG002|Intervention 4|Overall Study||4
3299289|NCT02932332|4032997|FG003|Intervention 4|Overall Study||3
3299290|NCT02932332|4032994|FG000|COMPLETED|Overall Study||3
3299291|NCT02932332|4032995|FG001|COMPLETED|Overall Study||1
3299292|NCT02932332|4032996|FG002|COMPLETED|Overall Study||4
3299293|NCT02932332|4032997|FG003|COMPLETED|Overall Study||3
3299294|NCT02932332|4032994|FG000|NOT COMPLETED|Overall Study||2
3299295|NCT02932332|4032995|FG001|NOT COMPLETED|Overall Study||3
3299296|NCT02932332|4032996|FG002|NOT COMPLETED|Overall Study||1
3299297|NCT02932332|4032997|FG003|NOT COMPLETED|Overall Study||2
3299298|NCT02932462|4033009|FG000|STARTED|Overall Study||184
3299299|NCT02932462|4033010|FG001|STARTED|Overall Study||189
3299300|NCT02932462|4033009|FG000|COMPLETED|Overall Study||177
3299301|NCT02932462|4033010|FG001|COMPLETED|Overall Study||176
3299302|NCT02932462|4033009|FG000|NOT COMPLETED|Overall Study||7
3299303|NCT02932462|4033010|FG001|NOT COMPLETED|Overall Study||13
3299304|NCT02932787|4033018|FG000|STARTED|Overall Study||22
3299305|NCT02932787|4033019|FG001|STARTED|Overall Study||9
3299306|NCT02932787|4033018|FG000|COMPLETED|Overall Study||22
3299307|NCT02932787|4033019|FG001|COMPLETED|Overall Study||9
3299308|NCT02932787|4033018|FG000|NOT COMPLETED|Overall Study||0
3299309|NCT02932787|4033019|FG001|NOT COMPLETED|Overall Study||0
3299310|NCT02932878|4033030|FG000|STARTED|Overall Study||15
3299311|NCT02932878|4033031|FG001|STARTED|Overall Study||1
3299312|NCT02932878|4033030|FG000|COMPLETED|Overall Study||13
3299313|NCT02932878|4033031|FG001|COMPLETED|Overall Study||0
3299314|NCT02932878|4033030|FG000|NOT COMPLETED|Overall Study||2
3299315|NCT02932878|4033031|FG001|NOT COMPLETED|Overall Study||1
3299316|NCT02932891|4033037|FG000|STARTED|Overall Study||28
3299317|NCT02932891|4033037|FG000|COMPLETED|Overall Study||24
3299318|NCT02932891|4033037|FG000|NOT COMPLETED|Overall Study||4
3299319|NCT02932904|4033045|FG000|STARTED|Overall Study||92
3299320|NCT02932904|4033046|FG001|STARTED|Overall Study||85
3299321|NCT02932904|4033047|FG002|STARTED|Overall Study||91
3299322|NCT02932904|4033048|FG003|STARTED|Overall Study||93
3299323|NCT02932904|4033045|FG000|Treated|Overall Study||91
3299324|NCT02932904|4033046|FG001|Treated|Overall Study||84
3299325|NCT02932904|4033047|FG002|Treated|Overall Study||91
3299326|NCT02932904|4033048|FG003|Treated|Overall Study||91
3299327|NCT02932904|4033045|FG000|COMPLETED|Overall Study||76
3299328|NCT02932904|4033046|FG001|COMPLETED|Overall Study||67
3299329|NCT02932904|4033047|FG002|COMPLETED|Overall Study||68
3299330|NCT02932904|4033048|FG003|COMPLETED|Overall Study||79
2949838|NCT00695565|3663726|FG000|STARTED|Overall Study||90
2949839|NCT00695565|3663727|FG001|STARTED|Overall Study||90
2949840|NCT00695565|3663726|FG000|COMPLETED|Overall Study||77
3299331|NCT02932904|4033045|FG000|NOT COMPLETED|Overall Study||16
3299332|NCT02932904|4033046|FG001|NOT COMPLETED|Overall Study||18
3299333|NCT02932904|4033047|FG002|NOT COMPLETED|Overall Study||23
3299334|NCT02932904|4033048|FG003|NOT COMPLETED|Overall Study||14
3299335|NCT02932943|4033063|FG000|STARTED|Overall Study||227
2949841|NCT00695565|3663727|FG001|COMPLETED|Overall Study||81
2949842|NCT00695565|3663726|FG000|NOT COMPLETED|Overall Study||13
2949843|NCT00695565|3663727|FG001|NOT COMPLETED|Overall Study||9
2949844|NCT00695578|3663735|FG000|STARTED|Overall Study||10
2949845|NCT00695578|3663736|FG001|STARTED|Overall Study||10
2949846|NCT00695578|3663735|FG000|COMPLETED|Overall Study||10
2949847|NCT00695578|3663736|FG001|COMPLETED|Overall Study||10
2949848|NCT00695578|3663735|FG000|NOT COMPLETED|Overall Study||0
2949849|NCT00695578|3663736|FG001|NOT COMPLETED|Overall Study||0
2949850|NCT00695669|3663746|FG000|STARTED|Overall Study||78
2949851|NCT00695669|3663747|FG001|STARTED|Overall Study||78
2949852|NCT00695669|3663748|FG002|STARTED|Overall Study||78
2949853|NCT00695669|3663749|FG003|STARTED|Overall Study||78
2949854|NCT00695669|3663746|FG000|COMPLETED|Overall Study||74
2949855|NCT00695669|3663747|FG001|COMPLETED|Overall Study||74
2949856|NCT00695669|3663748|FG002|COMPLETED|Overall Study||75
2949857|NCT00695669|3663749|FG003|COMPLETED|Overall Study||74
2949858|NCT00695669|3663746|FG000|NOT COMPLETED|Overall Study||4
2949859|NCT00695669|3663747|FG001|NOT COMPLETED|Overall Study||4
2949860|NCT00695669|3663748|FG002|NOT COMPLETED|Overall Study||3
2949861|NCT00695669|3663749|FG003|NOT COMPLETED|Overall Study||4
3299336|NCT02932943|4033064|FG001|STARTED|Overall Study||231
3299337|NCT02932943|4033063|FG000|COMPLETED|Overall Study||222
3299338|NCT02932943|4033064|FG001|COMPLETED|Overall Study||224
3299339|NCT02932943|4033063|FG000|NOT COMPLETED|Overall Study||5
3299340|NCT02932943|4033064|FG001|NOT COMPLETED|Overall Study||7
3299341|NCT02933034|4033070|FG000|STARTED|Overall Study||33
3299342|NCT02933034|4033070|FG000|Received Both MEMRI and DEMRI Scans|Overall Study||24
3299343|NCT02933034|4033070|FG000|COMPLETED|Overall Study||24
3299344|NCT02933034|4033070|FG000|NOT COMPLETED|Overall Study||9
3299345|NCT02933060|4033076|FG000|STARTED|Overall Study||25
3299346|NCT02933060|4033077|FG001|STARTED|Overall Study||25
3299347|NCT02933060|4033076|FG000|COMPLETED|Overall Study||25
3299348|NCT02933060|4033077|FG001|COMPLETED|Overall Study||24
3299349|NCT02933060|4033076|FG000|NOT COMPLETED|Overall Study||0
3299350|NCT02933060|4033077|FG001|NOT COMPLETED|Overall Study||1
3299351|NCT02933320|4033087|FG000|STARTED|Overall Study||13
3299352|NCT02933320|4033088|FG001|STARTED|Overall Study||1
3299353|NCT02933320|4033089|FG002|STARTED|Overall Study|Trial terminated early|0
3299354|NCT02933320|4033090|FG003|STARTED|Overall Study|Trial terminated early|0
3299355|NCT02933320|4033087|FG000|COMPLETED|Overall Study||13
3299356|NCT02933320|4033088|FG001|COMPLETED|Overall Study||1
3299357|NCT02933320|4033089|FG002|COMPLETED|Overall Study||0
3299358|NCT02933320|4033090|FG003|COMPLETED|Overall Study||0
3299359|NCT02933320|4033087|FG000|NOT COMPLETED|Overall Study||0
3299360|NCT02933320|4033088|FG001|NOT COMPLETED|Overall Study||0
3299361|NCT02933320|4033089|FG002|NOT COMPLETED|Overall Study||0
3299362|NCT02933320|4033090|FG003|NOT COMPLETED|Overall Study||0
3299363|NCT02933372|4033102|FG000|STARTED|Overall Study||15
3299364|NCT02933372|4033103|FG001|STARTED|Overall Study||10
3299365|NCT02933372|4033102|FG000|COMPLETED|Overall Study||15
3299366|NCT02933372|4033103|FG001|COMPLETED|Overall Study||10
3299367|NCT02933372|4033102|FG000|NOT COMPLETED|Overall Study||0
3299368|NCT02933372|4033103|FG001|NOT COMPLETED|Overall Study||0
3299369|NCT02933450|4033111|FG000|STARTED|Overall Study||20
3299370|NCT02933450|4033112|FG001|STARTED|Overall Study||23
3299371|NCT02933450|4033111|FG000|COMPLETED|Overall Study||15
3299372|NCT02933450|4033112|FG001|COMPLETED|Overall Study||15
3299373|NCT02933450|4033111|FG000|NOT COMPLETED|Overall Study||5
3299374|NCT02933450|4033112|FG001|NOT COMPLETED|Overall Study||8
3299375|NCT02933476|4033118|FG000|STARTED|Overall Study||5
3299376|NCT02933476|4033118|FG000|COMPLETED|Overall Study||5
3299377|NCT02933476|4033118|FG000|NOT COMPLETED|Overall Study||0
3299378|NCT02933489|4033124|FG000|STARTED|Overall Study||757
3299379|NCT02933489|4033125|FG001|STARTED|Overall Study||759
3299380|NCT02933489|4033124|FG000|DBTperformed|Overall Study||726
3299381|NCT02933489|4033125|FG001|DBTperformed|Overall Study||737
3299382|NCT02933489|4033124|FG000|AB MR Performed|Overall Study||713
3299383|NCT02933489|4033125|FG001|AB MR Performed|Overall Study||733
3299384|NCT02933489|4033124|FG000|COMPLETED|Overall Study||713
3299385|NCT02933489|4033125|FG001|COMPLETED|Overall Study||731
3299386|NCT02933489|4033124|FG000|NOT COMPLETED|Overall Study||44
3299387|NCT02933489|4033125|FG001|NOT COMPLETED|Overall Study||28
3299388|NCT02933502|4033136|FG000|STARTED|Overall Study||3
3299389|NCT02933502|4033136|FG000|COMPLETED|Overall Study||3
3299390|NCT02933502|4033136|FG000|NOT COMPLETED|Overall Study||0
3299391|NCT02933528|4033140|FG000|STARTED|Overall Study||24
3299392|NCT02933528|4033140|FG000|COMPLETED|Overall Study||22
3299393|NCT02933528|4033140|FG000|NOT COMPLETED|Overall Study||2
3299394|NCT02933866|4033146|FG000|STARTED|Overall Study||186
3299395|NCT02933866|4033147|FG001|STARTED|Overall Study||185
2949862|NCT00695786|3663766|FG000|STARTED|Overall Study||2
2949863|NCT00695786|3663767|FG001|STARTED|Overall Study||79
2949864|NCT00695786|3663768|FG002|STARTED|Overall Study||31
2949865|NCT00695786|3663769|FG003|STARTED|Overall Study||44
2949866|NCT00695786|3663766|FG000|COMPLETED|Overall Study||1
3299396|NCT02933866|4033146|FG000|COMPLETED|Overall Study||174
3299397|NCT02933866|4033147|FG001|COMPLETED|Overall Study||176
3299398|NCT02933866|4033146|FG000|NOT COMPLETED|Overall Study||12
2949867|NCT00695786|3663767|FG001|COMPLETED|Overall Study||67
3299399|NCT02933866|4033147|FG001|NOT COMPLETED|Overall Study||9
3299400|NCT02933879|4033156|FG000|STARTED|Overall Study||64
3299401|NCT02933879|4033157|FG001|STARTED|Overall Study||62
3299402|NCT02933879|4033158|FG002|STARTED|Overall Study||58
3299403|NCT02933879|4033156|FG000|COMPLETED|Overall Study||48
3299404|NCT02933879|4033157|FG001|COMPLETED|Overall Study||48
2949868|NCT00695786|3663768|FG002|COMPLETED|Overall Study||23
2949869|NCT00695786|3663769|FG003|COMPLETED|Overall Study||36
2949870|NCT00695786|3663766|FG000|NOT COMPLETED|Overall Study||1
2949871|NCT00695786|3663767|FG001|NOT COMPLETED|Overall Study||12
2949872|NCT00695786|3663768|FG002|NOT COMPLETED|Overall Study||8
2949873|NCT00695786|3663769|FG003|NOT COMPLETED|Overall Study||8
2949874|NCT00695864|3663779|FG000|STARTED|Placebo||14
2949875|NCT00695864|3663779|FG000|COMPLETED|Placebo||9
2949876|NCT00695864|3663779|FG000|NOT COMPLETED|Placebo||5
2949877|NCT00695864|3663779|FG000|STARTED|Ondansetron||14
2949878|NCT00695864|3663779|FG000|COMPLETED|Ondansetron||9
2949879|NCT00695864|3663779|FG000|NOT COMPLETED|Ondansetron||5
2949880|NCT00695903|3663787|FG000|STARTED|Had End of Therapy (EOT) Assessment||19
2949881|NCT00695903|3663788|FG001|STARTED|Had End of Therapy (EOT) Assessment||19
2949882|NCT00695903|3663787|FG000|Met Continuation Criteria|Had End of Therapy (EOT) Assessment||9
2949883|NCT00695903|3663788|FG001|Met Continuation Criteria|Had End of Therapy (EOT) Assessment||6
2949884|NCT00695903|3663787|FG000|COMPLETED|Had End of Therapy (EOT) Assessment||7
2949885|NCT00695903|3663788|FG001|COMPLETED|Had End of Therapy (EOT) Assessment||4
2949886|NCT00695903|3663787|FG000|NOT COMPLETED|Had End of Therapy (EOT) Assessment||12
2949887|NCT00695903|3663788|FG001|NOT COMPLETED|Had End of Therapy (EOT) Assessment||15
2949888|NCT00695903|3663787|FG000|STARTED|Had Test of Cure (TOC) Assessment||7
2949889|NCT00695903|3663788|FG001|STARTED|Had Test of Cure (TOC) Assessment||4
2949890|NCT00695903|3663787|FG000|COMPLETED|Had Test of Cure (TOC) Assessment||5
2949891|NCT00695903|3663788|FG001|COMPLETED|Had Test of Cure (TOC) Assessment||3
2949892|NCT00695903|3663787|FG000|NOT COMPLETED|Had Test of Cure (TOC) Assessment||2
2949893|NCT00695903|3663788|FG001|NOT COMPLETED|Had Test of Cure (TOC) Assessment||1
2949894|NCT00695955|3663794|FG000|STARTED|Cohort 1||362
2949895|NCT00695955|3663794|FG000|COMPLETED|Cohort 1||260
2949896|NCT00695955|3663794|FG000|NOT COMPLETED|Cohort 1||102
2949897|NCT00695955|3663794|FG000|STARTED|Cohort 2||307
2949898|NCT00695955|3663794|FG000|COMPLETED|Cohort 2||203
2949899|NCT00695955|3663794|FG000|NOT COMPLETED|Cohort 2||104
2949900|NCT00696020|3663804|FG000|STARTED|Overall Study||90
2949901|NCT00696020|3663805|FG001|STARTED|Overall Study||89
2949902|NCT00696020|3663806|FG002|STARTED|Overall Study||93
2949903|NCT00696020|3663807|FG003|STARTED|Overall Study||88
2949904|NCT00696020|3663804|FG000|COMPLETED|Overall Study||86
2949905|NCT00696020|3663805|FG001|COMPLETED|Overall Study||87
2949906|NCT00696020|3663806|FG002|COMPLETED|Overall Study||90
2949907|NCT00696020|3663807|FG003|COMPLETED|Overall Study||84
2949908|NCT00696020|3663804|FG000|NOT COMPLETED|Overall Study||4
2949909|NCT00696020|3663805|FG001|NOT COMPLETED|Overall Study||2
2949910|NCT00696020|3663806|FG002|NOT COMPLETED|Overall Study||3
2949911|NCT00696020|3663807|FG003|NOT COMPLETED|Overall Study||4
2949912|NCT00696072|3663821|FG000|STARTED|Overall Study||57
2949913|NCT00696072|3663822|FG001|STARTED|Overall Study||63
2949914|NCT00696072|3663821|FG000|COMPLETED|Overall Study||0
2949915|NCT00696072|3663822|FG001|COMPLETED|Overall Study||0
2949916|NCT00696072|3663821|FG000|NOT COMPLETED|Overall Study||57
2949917|NCT00696072|3663822|FG001|NOT COMPLETED|Overall Study||63
2949918|NCT00696137|3663829|FG000|STARTED|Overall Study||5
2949919|NCT00696137|3663829|FG000|COMPLETED|Overall Study||3
2949920|NCT00696137|3663829|FG000|NOT COMPLETED|Overall Study||2
2949921|NCT00696241|3663838|FG000|STARTED|Overall Study||283
2949922|NCT00696241|3663839|FG001|STARTED|Overall Study||283
2949923|NCT00696241|3663840|FG002|STARTED|Overall Study||285
2949924|NCT00696241|3663841|FG003|STARTED|Overall Study||282
2949925|NCT00696241|3663842|FG004|STARTED|Overall Study||142
2949926|NCT00696241|3663838|FG000|COMPLETED|Overall Study||259
2949927|NCT00696241|3663839|FG001|COMPLETED|Overall Study||261
3299405|NCT02933879|4033158|FG002|COMPLETED|Overall Study||41
3299406|NCT02933879|4033156|FG000|NOT COMPLETED|Overall Study||16
3299407|NCT02933879|4033157|FG001|NOT COMPLETED|Overall Study||14
3299408|NCT02933879|4033158|FG002|NOT COMPLETED|Overall Study||17
3299409|NCT02934178|4033170|FG000|STARTED|Received Vaccination 1||12
3299410|NCT02934178|4033171|FG001|STARTED|Received Vaccination 1||4
3299411|NCT02934178|4033170|FG000|COMPLETED|Received Vaccination 1||12
3299412|NCT02934178|4033171|FG001|COMPLETED|Received Vaccination 1||4
3299413|NCT02934178|4033170|FG000|NOT COMPLETED|Received Vaccination 1||0
3299414|NCT02934178|4033171|FG001|NOT COMPLETED|Received Vaccination 1||0
3299415|NCT02934178|4033170|FG000|STARTED|Received Vaccination 2||12
3299416|NCT02934178|4033171|FG001|STARTED|Received Vaccination 2||4
3299417|NCT02934178|4033170|FG000|COMPLETED|Received Vaccination 2||12
3299418|NCT02934178|4033171|FG001|COMPLETED|Received Vaccination 2||3
3299419|NCT02934178|4033170|FG000|NOT COMPLETED|Received Vaccination 2||0
3299420|NCT02934178|4033171|FG001|NOT COMPLETED|Received Vaccination 2||1
3299421|NCT02934178|4033170|FG000|STARTED|Received Vaccination 3||12
3299422|NCT02934178|4033171|FG001|STARTED|Received Vaccination 3||3
3299423|NCT02934178|4033170|FG000|COMPLETED|Received Vaccination 3||11
3299424|NCT02934178|4033171|FG001|COMPLETED|Received Vaccination 3||3
3299425|NCT02934178|4033170|FG000|NOT COMPLETED|Received Vaccination 3||1
2949928|NCT00696241|3663840|FG002|COMPLETED|Overall Study||261
2949929|NCT00696241|3663841|FG003|COMPLETED|Overall Study||268
3299426|NCT02934178|4033171|FG001|NOT COMPLETED|Received Vaccination 3||0
3299427|NCT02934191|4033180|FG000|STARTED|Overall Study||87
3299428|NCT02934191|4033181|FG001|STARTED|Overall Study||85
3299429|NCT02934191|4033180|FG000|COMPLETED|Overall Study||87
3299430|NCT02934191|4033181|FG001|COMPLETED|Overall Study||85
3299431|NCT02934191|4033180|FG000|NOT COMPLETED|Overall Study||0
2949930|NCT00696241|3663842|FG004|COMPLETED|Overall Study||130
2949931|NCT00696241|3663838|FG000|NOT COMPLETED|Overall Study||24
2949932|NCT00696241|3663839|FG001|NOT COMPLETED|Overall Study||22
2949933|NCT00696241|3663840|FG002|NOT COMPLETED|Overall Study||24
2949934|NCT00696241|3663841|FG003|NOT COMPLETED|Overall Study||14
2949935|NCT00696241|3663842|FG004|NOT COMPLETED|Overall Study||12
2949936|NCT00696293|3663854|FG000|STARTED|Overall Study||30
2949937|NCT00696293|3663854|FG000|COMPLETED|Overall Study||28
2949938|NCT00696293|3663854|FG000|NOT COMPLETED|Overall Study||2
2949939|NCT00696384|3663859|FG000|STARTED|Open Label Phase||418
2949940|NCT00696384|3663860|FG001|STARTED|Open Label Phase||0
2949941|NCT00696384|3663861|FG002|STARTED|Open Label Phase||0
2949942|NCT00696384|3663859|FG000|COMPLETED|Open Label Phase||299
2949943|NCT00696384|3663860|FG001|COMPLETED|Open Label Phase||0
2949944|NCT00696384|3663861|FG002|COMPLETED|Open Label Phase||0
2949945|NCT00696384|3663859|FG000|NOT COMPLETED|Open Label Phase||119
2949946|NCT00696384|3663860|FG001|NOT COMPLETED|Open Label Phase||0
2949947|NCT00696384|3663861|FG002|NOT COMPLETED|Open Label Phase||0
2949948|NCT00696384|3663859|FG000|STARTED|Double Blind Phase||0
2949949|NCT00696384|3663860|FG001|STARTED|Double Blind Phase||148
2949950|NCT00696384|3663861|FG002|STARTED|Double Blind Phase||151
2949951|NCT00696384|3663859|FG000|COMPLETED|Double Blind Phase||0
2949952|NCT00696384|3663860|FG001|COMPLETED|Double Blind Phase||137
2949953|NCT00696384|3663861|FG002|COMPLETED|Double Blind Phase||145
2949954|NCT00696384|3663859|FG000|NOT COMPLETED|Double Blind Phase||0
2949955|NCT00696384|3663860|FG001|NOT COMPLETED|Double Blind Phase||11
2949956|NCT00696384|3663861|FG002|NOT COMPLETED|Double Blind Phase||6
2949957|NCT00696410|3663872|FG000|STARTED|Overall Study||38
2949958|NCT00696410|3663873|FG001|STARTED|Overall Study||10
3299432|NCT02934191|4033181|FG001|NOT COMPLETED|Overall Study||0
3299433|NCT02934347|4033189|FG000|STARTED|Overall Study||374
3299434|NCT02934347|4033190|FG001|STARTED|Overall Study||407
3299435|NCT02934347|4033189|FG000|COMPLETED|Overall Study||374
3299436|NCT02934347|4033190|FG001|COMPLETED|Overall Study||407
3299437|NCT02934347|4033189|FG000|NOT COMPLETED|Overall Study||0
3299438|NCT02934347|4033190|FG001|NOT COMPLETED|Overall Study||0
3299439|NCT02934555|4033198|FG000|STARTED|Overall Study||23
3299440|NCT02934555|4033199|FG001|STARTED|Overall Study||25
3299441|NCT02934555|4033198|FG000|COMPLETED|Overall Study||21
3299442|NCT02934555|4033199|FG001|COMPLETED|Overall Study||22
3299443|NCT02934555|4033198|FG000|NOT COMPLETED|Overall Study||2
3299444|NCT02934555|4033199|FG001|NOT COMPLETED|Overall Study||3
3299445|NCT02934698|4033205|FG000|STARTED|Overall Study||2
3299446|NCT02934698|4033205|FG000|COMPLETED|Overall Study||2
3299447|NCT02934698|4033205|FG000|NOT COMPLETED|Overall Study||0
3299448|NCT02935036|4033211|FG000|STARTED|Overall Study||147
3299449|NCT02935036|4033212|FG001|STARTED|Overall Study||147
3299450|NCT02935036|4033211|FG000|COMPLETED|Overall Study||137
3299451|NCT02935036|4033212|FG001|COMPLETED|Overall Study||136
3299452|NCT02935036|4033211|FG000|NOT COMPLETED|Overall Study||10
3299453|NCT02935036|4033212|FG001|NOT COMPLETED|Overall Study||11
3299454|NCT02935062|4033221|FG000|STARTED|Overall Study||8
3299455|NCT02935062|4033222|FG001|STARTED|Overall Study||8
3299456|NCT02935062|4033223|FG002|STARTED|Overall Study||8
3299457|NCT02935062|4033221|FG000|COMPLETED|Overall Study||8
3299458|NCT02935062|4033222|FG001|COMPLETED|Overall Study||8
3299459|NCT02935062|4033223|FG002|COMPLETED|Overall Study||8
3299460|NCT02935062|4033221|FG000|NOT COMPLETED|Overall Study||0
3299461|NCT02935062|4033222|FG001|NOT COMPLETED|Overall Study||0
3299462|NCT02935062|4033223|FG002|NOT COMPLETED|Overall Study||0
3299463|NCT02935088|4033231|FG000|STARTED|Overall Study||2217
3299464|NCT02935088|4033231|FG000|COMPLETED|Overall Study||2115
3299465|NCT02935088|4033231|FG000|NOT COMPLETED|Overall Study||102
3299466|NCT02935179|4033244|FG000|STARTED|Overall Study||30
3299467|NCT02935179|4033245|FG001|STARTED|Overall Study||30
3299468|NCT02935179|4033244|FG000|COMPLETED|Overall Study||29
3299469|NCT02935179|4033245|FG001|COMPLETED|Overall Study||29
3299470|NCT02935179|4033244|FG000|NOT COMPLETED|Overall Study||1
3299471|NCT02935179|4033245|FG001|NOT COMPLETED|Overall Study||1
3299472|NCT02935192|4033253|FG000|STARTED|Overall Study|312 subjects were included in the Full Protocol Analysis because 8 withdrew without getting product.|320
3299473|NCT02935192|4033254|FG001|STARTED|Overall Study|156 subjects were included in the Full Protocol Analysis because 4 withdrew without getting product.|160
3299474|NCT02935192|4033253|FG000|Received Vaccine/Placebo|Overall Study||312
3299475|NCT02935192|4033254|FG001|Received Vaccine/Placebo|Overall Study||156
3299476|NCT02935192|4033253|FG000|COMPLETED|Overall Study||312
3299477|NCT02935192|4033254|FG001|COMPLETED|Overall Study||156
3299478|NCT02935192|4033253|FG000|NOT COMPLETED|Overall Study||8
3299479|NCT02935192|4033254|FG001|NOT COMPLETED|Overall Study||4
3316980|NCT03122535|4050464|FG001|3 Months|Overall Study||92
3316981|NCT03122535|4050463|FG000|12 Months|Overall Study||42
3316982|NCT03122535|4050464|FG001|12 Months|Overall Study||42
3316983|NCT03122535|4050463|FG000|COMPLETED|Overall Study||42
3316984|NCT03122535|4050464|FG001|COMPLETED|Overall Study||42
3316985|NCT03122535|4050463|FG000|NOT COMPLETED|Overall Study||73
3316986|NCT03122535|4050464|FG001|NOT COMPLETED|Overall Study||73
3316987|NCT03122548|4050470|FG000|STARTED|Overall Study||5
3316988|NCT03122548|4050470|FG000|COMPLETED|Overall Study||0
2949959|NCT00696410|3663872|FG000|COMPLETED|Overall Study||25
2949960|NCT00696410|3663873|FG001|COMPLETED|Overall Study||10
3316989|NCT03122548|4050470|FG000|NOT COMPLETED|Overall Study||5
3316990|NCT03122587|4050477|FG000|STARTED|Overall Study||13
2949961|NCT00696410|3663872|FG000|NOT COMPLETED|Overall Study||13
2949962|NCT00696410|3663873|FG001|NOT COMPLETED|Overall Study||0
2949963|NCT00696423|3663886|FG000|STARTED|Overall Study||244
2949964|NCT00696423|3663887|FG001|STARTED|Overall Study||223
2949965|NCT00696423|3663886|FG000|COMPLETED|Overall Study||244
2949966|NCT00696423|3663887|FG001|COMPLETED|Overall Study||218
2949967|NCT00696423|3663886|FG000|NOT COMPLETED|Overall Study||0
2949968|NCT00696423|3663887|FG001|NOT COMPLETED|Overall Study||5
2949969|NCT00696436|3663898|FG000|STARTED|Overall Study|Randomized participants only.|280
2949970|NCT00696436|3663899|FG001|STARTED|Overall Study|Randomized participants only. One participant treated but not randomized and is not included.|285
2949971|NCT00696436|3663900|FG002|STARTED|Overall Study|Randomized participants only.|282
2949972|NCT00696436|3663901|FG003|STARTED|Overall Study|Randomized participants only.|290
2949973|NCT00696436|3663902|FG004|STARTED|Overall Study|Randomized participants only.|154
2949974|NCT00696436|3663898|FG000|COMPLETED|Overall Study||257
2949975|NCT00696436|3663899|FG001|COMPLETED|Overall Study||255
2949976|NCT00696436|3663900|FG002|COMPLETED|Overall Study||254
2949977|NCT00696436|3663901|FG003|COMPLETED|Overall Study||268
2949978|NCT00696436|3663902|FG004|COMPLETED|Overall Study||141
2949979|NCT00696436|3663898|FG000|NOT COMPLETED|Overall Study||23
2949980|NCT00696436|3663899|FG001|NOT COMPLETED|Overall Study||30
2949981|NCT00696436|3663900|FG002|NOT COMPLETED|Overall Study||28
2949982|NCT00696436|3663901|FG003|NOT COMPLETED|Overall Study||22
2949983|NCT00696436|3663902|FG004|NOT COMPLETED|Overall Study||13
2949984|NCT00696449|3663918|FG000|STARTED|Overall Study||15
2949985|NCT00696449|3663919|FG001|STARTED|Overall Study||15
2949986|NCT00696449|3663920|FG002|STARTED|Overall Study||15
2949987|NCT00696449|3663921|FG003|STARTED|Overall Study||16
2949988|NCT00696449|3663918|FG000|COMPLETED|Overall Study||12
2949989|NCT00696449|3663919|FG001|COMPLETED|Overall Study||9
2949990|NCT00696449|3663920|FG002|COMPLETED|Overall Study||14
2949991|NCT00696449|3663921|FG003|COMPLETED|Overall Study||13
2949992|NCT00696449|3663918|FG000|NOT COMPLETED|Overall Study||3
2949993|NCT00696449|3663919|FG001|NOT COMPLETED|Overall Study||6
2949994|NCT00696449|3663920|FG002|NOT COMPLETED|Overall Study||1
2949995|NCT00696449|3663921|FG003|NOT COMPLETED|Overall Study||3
2949996|NCT00696488|3663931|FG000|STARTED|Overall Study||20
2949997|NCT00696488|3663931|FG000|COMPLETED|Overall Study||20
3299480|NCT02935452|4033262|FG000|STARTED|Overall Study||30
3299481|NCT02935452|4033263|FG001|STARTED|Overall Study||30
3299482|NCT02935452|4033262|FG000|COMPLETED|Overall Study||27
3299483|NCT02935452|4033263|FG001|COMPLETED|Overall Study||29
3299484|NCT02935452|4033262|FG000|NOT COMPLETED|Overall Study||3
3299485|NCT02935452|4033263|FG001|NOT COMPLETED|Overall Study||1
3299486|NCT02935543|4033269|FG000|STARTED|Overall Study||1
3299487|NCT02935543|4033269|FG000|COMPLETED|Overall Study||1
3299488|NCT02935543|4033269|FG000|NOT COMPLETED|Overall Study||0
3299489|NCT02935673|4033276|FG000|STARTED|Overall Study||16
3299490|NCT02935673|4033277|FG001|STARTED|Overall Study||27
3299491|NCT02935673|4033278|FG002|STARTED|Overall Study||6
3299492|NCT02935673|4033276|FG000|COMPLETED|Overall Study||15
3299493|NCT02935673|4033277|FG001|COMPLETED|Overall Study||24
3299494|NCT02935673|4033278|FG002|COMPLETED|Overall Study||6
3299495|NCT02935673|4033276|FG000|NOT COMPLETED|Overall Study||1
3299496|NCT02935673|4033277|FG001|NOT COMPLETED|Overall Study||3
3299497|NCT02935673|4033278|FG002|NOT COMPLETED|Overall Study||0
3299498|NCT02935699|4033290|FG000|STARTED|Overall Study||127
3299499|NCT02935699|4033291|FG001|STARTED|Overall Study||135
3299500|NCT02935699|4033290|FG000|COMPLETED|Overall Study||127
3299501|NCT02935699|4033291|FG001|COMPLETED|Overall Study||135
3299502|NCT02935699|4033290|FG000|NOT COMPLETED|Overall Study||0
3299503|NCT02935699|4033291|FG001|NOT COMPLETED|Overall Study||0
3299504|NCT02935738|4033301|FG000|STARTED|Overall Study||67
3299505|NCT02935738|4033302|FG001|STARTED|Overall Study||74
3299506|NCT02935738|4033303|FG002|STARTED|Overall Study||47
3299507|NCT02935738|4033304|FG003|STARTED|Overall Study||53
3299508|NCT02935738|4033301|FG000|COMPLETED|Overall Study||50
3299509|NCT02935738|4033302|FG001|COMPLETED|Overall Study||53
3299510|NCT02935738|4033303|FG002|COMPLETED|Overall Study||46
3299511|NCT02935738|4033304|FG003|COMPLETED|Overall Study||48
3299512|NCT02935738|4033301|FG000|NOT COMPLETED|Overall Study||17
3299513|NCT02935738|4033302|FG001|NOT COMPLETED|Overall Study||21
3299514|NCT02935738|4033303|FG002|NOT COMPLETED|Overall Study||1
3299515|NCT02935738|4033304|FG003|NOT COMPLETED|Overall Study||5
3299516|NCT02935842|4033318|FG000|STARTED|Testing and Therapy Period 1||8
3299517|NCT02935842|4033319|FG001|STARTED|Testing and Therapy Period 1||6
3299518|NCT02935842|4033320|FG002|STARTED|Testing and Therapy Period 1||6
3299519|NCT02935842|4033321|FG003|STARTED|Testing and Therapy Period 1|Due to limited staff capacity, HC have only been included in the final tranche.|0
3299520|NCT02935842|4033318|FG000|COMPLETED|Testing and Therapy Period 1||8
3299521|NCT02935842|4033319|FG001|COMPLETED|Testing and Therapy Period 1||6
3299522|NCT02935842|4033320|FG002|COMPLETED|Testing and Therapy Period 1||6
3299523|NCT02935842|4033321|FG003|COMPLETED|Testing and Therapy Period 1||0
3299524|NCT02935842|4033318|FG000|NOT COMPLETED|Testing and Therapy Period 1||0
2949998|NCT00696488|3663931|FG000|NOT COMPLETED|Overall Study||0
2949999|NCT00696618|3663938|FG000|STARTED|Overall Study||3
2950000|NCT00696618|3663939|FG001|STARTED|Overall Study||3
3299525|NCT02935842|4033319|FG001|NOT COMPLETED|Testing and Therapy Period 1||0
3299526|NCT02935842|4033320|FG002|NOT COMPLETED|Testing and Therapy Period 1||0
3299527|NCT02935842|4033321|FG003|NOT COMPLETED|Testing and Therapy Period 1||0
2950001|NCT00696618|3663940|FG002|STARTED|Overall Study||3
2950002|NCT00696618|3663938|FG000|COMPLETED|Overall Study||3
2950003|NCT00696618|3663939|FG001|COMPLETED|Overall Study||3
2950004|NCT00696618|3663940|FG002|COMPLETED|Overall Study||3
2950005|NCT00696618|3663938|FG000|NOT COMPLETED|Overall Study||0
2950006|NCT00696618|3663939|FG001|NOT COMPLETED|Overall Study||0
2950007|NCT00696618|3663940|FG002|NOT COMPLETED|Overall Study||0
2950008|NCT00696657|3663957|FG000|STARTED|Overall Study||46
2950009|NCT00696657|3663958|FG001|STARTED|Overall Study||47
2950010|NCT00696657|3663959|FG002|STARTED|Overall Study||44
2950011|NCT00696657|3663960|FG003|STARTED|Overall Study||49
2950012|NCT00696657|3663961|FG004|STARTED|Overall Study||44
2950013|NCT00696657|3663962|FG005|STARTED|Overall Study||45
2950014|NCT00696657|3663963|FG006|STARTED|Overall Study||45
2950015|NCT00696657|3663964|FG007|STARTED|Overall Study||45
2950016|NCT00696657|3663965|FG008|STARTED|Overall Study||50
2950017|NCT00696657|3663957|FG000|EXPOSED|Overall Study||46
2950018|NCT00696657|3663958|FG001|EXPOSED|Overall Study||47
2950019|NCT00696657|3663959|FG002|EXPOSED|Overall Study||43
2950020|NCT00696657|3663960|FG003|EXPOSED|Overall Study||48
2950021|NCT00696657|3663961|FG004|EXPOSED|Overall Study||44
2950022|NCT00696657|3663962|FG005|EXPOSED|Overall Study||43
2950023|NCT00696657|3663963|FG006|EXPOSED|Overall Study||45
2950024|NCT00696657|3663964|FG007|EXPOSED|Overall Study||45
2950025|NCT00696657|3663965|FG008|EXPOSED|Overall Study||50
2950026|NCT00696657|3663957|FG000|COMPLETED|Overall Study||45
2950027|NCT00696657|3663958|FG001|COMPLETED|Overall Study||42
2950028|NCT00696657|3663959|FG002|COMPLETED|Overall Study||36
2950029|NCT00696657|3663960|FG003|COMPLETED|Overall Study||38
2950030|NCT00696657|3663961|FG004|COMPLETED|Overall Study||34
2950031|NCT00696657|3663962|FG005|COMPLETED|Overall Study||33
2950032|NCT00696657|3663963|FG006|COMPLETED|Overall Study||30
2950033|NCT00696657|3663964|FG007|COMPLETED|Overall Study||42
2950034|NCT00696657|3663965|FG008|COMPLETED|Overall Study||41
2950035|NCT00696657|3663957|FG000|NOT COMPLETED|Overall Study||1
2950036|NCT00696657|3663958|FG001|NOT COMPLETED|Overall Study||5
2950037|NCT00696657|3663959|FG002|NOT COMPLETED|Overall Study||8
2950038|NCT00696657|3663960|FG003|NOT COMPLETED|Overall Study||11
2950039|NCT00696657|3663961|FG004|NOT COMPLETED|Overall Study||10
2950040|NCT00696657|3663962|FG005|NOT COMPLETED|Overall Study||12
2950041|NCT00696657|3663963|FG006|NOT COMPLETED|Overall Study||15
2950042|NCT00696657|3663964|FG007|NOT COMPLETED|Overall Study||3
2950043|NCT00696657|3663965|FG008|NOT COMPLETED|Overall Study||9
2950044|NCT00696696|3663985|FG000|STARTED|Overall Study||44
2950045|NCT00696696|3663985|FG000|COMPLETED|Overall Study|number of patients off treatment due to progression of disease only|26
2950046|NCT00696696|3663985|FG000|NOT COMPLETED|Overall Study||18
2950047|NCT00696709|3663994|FG000|STARTED|Overall Study||65
2950048|NCT00696709|3663995|FG001|STARTED|Overall Study||63
3299528|NCT02935842|4033318|FG000|STARTED|Testing and Therapy Period 2||8
3299529|NCT02935842|4033319|FG001|STARTED|Testing and Therapy Period 2||6
3299530|NCT02935842|4033320|FG002|STARTED|Testing and Therapy Period 2||6
3299531|NCT02935842|4033321|FG003|STARTED|Testing and Therapy Period 2|Due to limited staff capacity, HC have only been included in the final tranche.|0
3299532|NCT02935842|4033318|FG000|COMPLETED|Testing and Therapy Period 2||6
3299533|NCT02935842|4033319|FG001|COMPLETED|Testing and Therapy Period 2||6
3299534|NCT02935842|4033320|FG002|COMPLETED|Testing and Therapy Period 2||6
3299535|NCT02935842|4033321|FG003|COMPLETED|Testing and Therapy Period 2||0
3299536|NCT02935842|4033318|FG000|NOT COMPLETED|Testing and Therapy Period 2||2
3299537|NCT02935842|4033319|FG001|NOT COMPLETED|Testing and Therapy Period 2||0
3299538|NCT02935842|4033320|FG002|NOT COMPLETED|Testing and Therapy Period 2||0
3299539|NCT02935842|4033321|FG003|NOT COMPLETED|Testing and Therapy Period 2||0
3299540|NCT02935842|4033318|FG000|STARTED|Testing and Therapy Period 3||6
3299541|NCT02935842|4033319|FG001|STARTED|Testing and Therapy Period 3||6
3299542|NCT02935842|4033320|FG002|STARTED|Testing and Therapy Period 3||6
3299543|NCT02935842|4033321|FG003|STARTED|Testing and Therapy Period 3|HC received no interventions. They have only been tested at BL, 4 Weeks and 6 Months.|18
3299544|NCT02935842|4033318|FG000|COMPLETED|Testing and Therapy Period 3||3
3299545|NCT02935842|4033319|FG001|COMPLETED|Testing and Therapy Period 3||2
3299546|NCT02935842|4033320|FG002|COMPLETED|Testing and Therapy Period 3||1
3299547|NCT02935842|4033321|FG003|COMPLETED|Testing and Therapy Period 3||17
3299548|NCT02935842|4033318|FG000|NOT COMPLETED|Testing and Therapy Period 3||3
3299549|NCT02935842|4033319|FG001|NOT COMPLETED|Testing and Therapy Period 3||4
3299550|NCT02935842|4033320|FG002|NOT COMPLETED|Testing and Therapy Period 3||5
3299551|NCT02935842|4033321|FG003|NOT COMPLETED|Testing and Therapy Period 3||1
3299552|NCT02935894|4033338|FG000|STARTED|Overall Study||14
3299553|NCT02935894|4033338|FG000|COMPLETED|Overall Study||13
3299554|NCT02935894|4033338|FG000|NOT COMPLETED|Overall Study||1
3299555|NCT02936037|4033344|FG000|STARTED|Double-Blind Treatment Period||316
3299556|NCT02936037|4033345|FG001|STARTED|Double-Blind Treatment Period||326
3299557|NCT02936037|4033344|FG000|COMPLETED|Double-Blind Treatment Period||267
3299558|NCT02936037|4033345|FG001|COMPLETED|Double-Blind Treatment Period||261
3299559|NCT02936037|4033344|FG000|NOT COMPLETED|Double-Blind Treatment Period||49
3299560|NCT02936037|4033345|FG001|NOT COMPLETED|Double-Blind Treatment Period||65
3299561|NCT02936037|4033344|FG000|STARTED|Open Label Extension||0
3299562|NCT02936037|4033345|FG001|STARTED|Open Label Extension||528
2950049|NCT00696709|3663996|FG002|STARTED|Overall Study||33
2950050|NCT00696709|3663997|FG003|STARTED|Overall Study||64
2950051|NCT00696709|3663998|FG004|STARTED|Overall Study||65
2950052|NCT00696709|3663994|FG000|Vaccination 1 (Day 1)|Overall Study||65
2950053|NCT00696709|3663995|FG001|Vaccination 1 (Day 1)|Overall Study||63
2950054|NCT00696709|3663996|FG002|Vaccination 1 (Day 1)|Overall Study||32
2950055|NCT00696709|3663997|FG003|Vaccination 1 (Day 1)|Overall Study||64
2950056|NCT00696709|3663998|FG004|Vaccination 1 (Day 1)|Overall Study||65
2950057|NCT00696709|3663994|FG000|Vaccination 2 (~Day 30)|Overall Study||64
2950058|NCT00696709|3663995|FG001|Vaccination 2 (~Day 30)|Overall Study||60
2950059|NCT00696709|3663996|FG002|Vaccination 2 (~Day 30)|Overall Study||32
2950060|NCT00696709|3663997|FG003|Vaccination 2 (~Day 30)|Overall Study||61
2950061|NCT00696709|3663998|FG004|Vaccination 2 (~Day 30)|Overall Study||64
2950062|NCT00696709|3663994|FG000|Vaccination 3 (~Day 60)|Overall Study||64
2950063|NCT00696709|3663995|FG001|Vaccination 3 (~Day 60)|Overall Study||60
2950064|NCT00696709|3663996|FG002|Vaccination 3 (~Day 60)|Overall Study||32
2950065|NCT00696709|3663997|FG003|Vaccination 3 (~Day 60)|Overall Study||59
2950066|NCT00696709|3663998|FG004|Vaccination 3 (~Day 60)|Overall Study||63
2950067|NCT00696709|3663994|FG000|Vaccination 4 (~Day 90)|Overall Study||62
2950068|NCT00696709|3663995|FG001|Vaccination 4 (~Day 90)|Overall Study||60
2950069|NCT00696709|3663996|FG002|Vaccination 4 (~Day 90)|Overall Study||32
2950070|NCT00696709|3663997|FG003|Vaccination 4 (~Day 90)|Overall Study||59
2950071|NCT00696709|3663998|FG004|Vaccination 4 (~Day 90)|Overall Study||63
2950072|NCT00696709|3663994|FG000|COMPLETED|Overall Study||62
2950073|NCT00696709|3663995|FG001|COMPLETED|Overall Study||60
2950074|NCT00696709|3663996|FG002|COMPLETED|Overall Study||32
2950075|NCT00696709|3663997|FG003|COMPLETED|Overall Study||59
2950076|NCT00696709|3663998|FG004|COMPLETED|Overall Study||62
2950077|NCT00696709|3663994|FG000|NOT COMPLETED|Overall Study||3
2950078|NCT00696709|3663995|FG001|NOT COMPLETED|Overall Study||3
2950079|NCT00696709|3663996|FG002|NOT COMPLETED|Overall Study||1
2950080|NCT00696709|3663997|FG003|NOT COMPLETED|Overall Study||5
2950081|NCT00696709|3663998|FG004|NOT COMPLETED|Overall Study||3
2950082|NCT00696761|3664018|FG000|STARTED|Overall Study||61
2950083|NCT00696761|3664019|FG001|STARTED|Overall Study||76
2950084|NCT00696761|3664020|FG002|STARTED|Overall Study||41
2950085|NCT00696761|3664021|FG003|STARTED|Overall Study||54
2950086|NCT00696761|3664018|FG000|COMPLETED|Overall Study||41
2950087|NCT00696761|3664019|FG001|COMPLETED|Overall Study||50
2950088|NCT00696761|3664020|FG002|COMPLETED|Overall Study||30
2950089|NCT00696761|3664021|FG003|COMPLETED|Overall Study||44
2950090|NCT00696761|3664018|FG000|NOT COMPLETED|Overall Study||20
2950091|NCT00696761|3664019|FG001|NOT COMPLETED|Overall Study||26
2950092|NCT00696761|3664020|FG002|NOT COMPLETED|Overall Study||11
2950093|NCT00696761|3664021|FG003|NOT COMPLETED|Overall Study||10
2950094|NCT00696774|3664042|FG000|STARTED|Period II||115
2950095|NCT00696774|3664043|FG001|STARTED|Period II||91
2950096|NCT00696774|3664044|FG002|STARTED|Period II|1 participant did not receive study drug and was not included in the safety analyses.|36
2950097|NCT00696774|3664042|FG000|COMPLETED|Period II||115
2950098|NCT00696774|3664043|FG001|COMPLETED|Period II||91
2950099|NCT00696774|3664044|FG002|COMPLETED|Period II||0
2950100|NCT00696774|3664042|FG000|NOT COMPLETED|Period II||0
2950101|NCT00696774|3664043|FG001|NOT COMPLETED|Period II||0
2950102|NCT00696774|3664044|FG002|NOT COMPLETED|Period II||36
2950103|NCT00696774|3664042|FG000|STARTED|Period III|115 reported at Week 4; 113 started Period 3 (1 lost to follow-up and 1 protocol violation).|113
2950104|NCT00696774|3664043|FG001|STARTED|Period III|91 reported at Week 4; 88 start Period 3 (1 adverse event, 1 protocol violation, 1 lack of efficacy)|88
2950105|NCT00696774|3664044|FG002|STARTED|Period III||0
2950106|NCT00696774|3664042|FG000|COMPLETED|Period III||106
2950107|NCT00696774|3664043|FG001|COMPLETED|Period III|82 participants were reported at Week 8; 81 completed Week 8 as 1 participant decided to withdraw.|81
2950108|NCT00696774|3664044|FG002|COMPLETED|Period III||0
2950109|NCT00696774|3664042|FG000|NOT COMPLETED|Period III||7
2950110|NCT00696774|3664043|FG001|NOT COMPLETED|Period III||7
2950111|NCT00696774|3664044|FG002|NOT COMPLETED|Period III||0
2950112|NCT00696787|3664055|FG000|STARTED|Overall Study||40
2950113|NCT00696787|3664056|FG001|STARTED|Overall Study||42
2950114|NCT00696787|3664057|FG002|STARTED|Overall Study||43
2950115|NCT00696787|3664055|FG000|COMPLETED|Overall Study||25
2950116|NCT00696787|3664056|FG001|COMPLETED|Overall Study||22
2950117|NCT00696787|3664057|FG002|COMPLETED|Overall Study||17
2950118|NCT00696787|3664055|FG000|NOT COMPLETED|Overall Study||15
2950119|NCT00696787|3664056|FG001|NOT COMPLETED|Overall Study||20
2950120|NCT00696787|3664057|FG002|NOT COMPLETED|Overall Study||26
2950121|NCT00697073|3664065|FG000|STARTED|Overall Study||68
2950122|NCT00697073|3664065|FG000|COMPLETED|Overall Study||59
2950123|NCT00697073|3664065|FG000|NOT COMPLETED|Overall Study||9
2950124|NCT00697112|3664069|FG000|STARTED|Overall Study||53
2950125|NCT00697112|3664069|FG000|Met the Inclusion Criteria|Overall Study||52
2950126|NCT00697112|3664069|FG000|COMPLETED|Overall Study||43
2950127|NCT00697112|3664069|FG000|NOT COMPLETED|Overall Study||10
2950128|NCT00697190|3664073|FG000|STARTED|First Intervention||19
2950129|NCT00697190|3664074|FG001|STARTED|First Intervention||20
2950130|NCT00697190|3664073|FG000|COMPLETED|First Intervention||19
2950131|NCT00697190|3664074|FG001|COMPLETED|First Intervention||20
2950132|NCT00697190|3664073|FG000|NOT COMPLETED|First Intervention||0
2950133|NCT00697190|3664074|FG001|NOT COMPLETED|First Intervention||0
2950134|NCT00697190|3664073|FG000|STARTED|Second Intervention|one subject moved away between the first period and second period.|18
2950135|NCT00697190|3664074|FG001|STARTED|Second Intervention||20
2950136|NCT00697190|3664073|FG000|COMPLETED|Second Intervention||18
2950137|NCT00697190|3664074|FG001|COMPLETED|Second Intervention||20
2950138|NCT00697190|3664073|FG000|NOT COMPLETED|Second Intervention||0
2950139|NCT00697190|3664074|FG001|NOT COMPLETED|Second Intervention||0
2950140|NCT00697203|3664088|FG000|STARTED|Overall Study||76
2950141|NCT00697203|3664089|FG001|STARTED|Overall Study||68
2950142|NCT00697203|3664090|FG002|STARTED|Overall Study||74
2950143|NCT00697203|3664091|FG003|STARTED|Overall Study||74
2950144|NCT00697203|3664088|FG000|COMPLETED|Overall Study||67
2950145|NCT00697203|3664089|FG001|COMPLETED|Overall Study||62
2950146|NCT00697203|3664090|FG002|COMPLETED|Overall Study||66
2950147|NCT00697203|3664091|FG003|COMPLETED|Overall Study||67
2950148|NCT00697203|3664088|FG000|NOT COMPLETED|Overall Study||9
2950149|NCT00697203|3664089|FG001|NOT COMPLETED|Overall Study||6
2950150|NCT00697203|3664090|FG002|NOT COMPLETED|Overall Study||8
2950151|NCT00697203|3664091|FG003|NOT COMPLETED|Overall Study||7
2950152|NCT00697346|3664104|FG000|STARTED|Overall Study||28
2950153|NCT00697346|3664105|FG001|STARTED|Overall Study||28
2950154|NCT00697346|3664106|FG002|STARTED|Overall Study||2
2950155|NCT00697346|3664104|FG000|COMPLETED|Overall Study|Completed = participants who completed study treatment.|0
2950156|NCT00697346|3664105|FG001|COMPLETED|Overall Study|2 participants were ongoing as of primary completion date 27 Dec 2011 and have now completed.|2
2950157|NCT00697346|3664106|FG002|COMPLETED|Overall Study|1 participant was ongoing as of primary completion date 27 Dec 2011 and has now completed.|1
2950158|NCT00697346|3664104|FG000|NOT COMPLETED|Overall Study||28
2950159|NCT00697346|3664105|FG001|NOT COMPLETED|Overall Study||26
2950160|NCT00697346|3664106|FG002|NOT COMPLETED|Overall Study||1
2950161|NCT00697463|3664133|FG000|STARTED|Overall Study||22
2950162|NCT00697463|3664133|FG000|COMPLETED|Overall Study||21
2950163|NCT00697463|3664133|FG000|NOT COMPLETED|Overall Study||1
2950164|NCT00697515|3664137|FG000|STARTED|Dose Optimization Period||142
2950165|NCT00697515|3664138|FG001|STARTED|Dose Optimization Period||0
2950166|NCT00697515|3664137|FG000|COMPLETED|Dose Optimization Period||127
2950167|NCT00697515|3664138|FG001|COMPLETED|Dose Optimization Period||0
2950168|NCT00697515|3664137|FG000|NOT COMPLETED|Dose Optimization Period||15
2950169|NCT00697515|3664138|FG001|NOT COMPLETED|Dose Optimization Period||0
2950170|NCT00697515|3664137|FG000|STARTED|First Intervention (Crossover Period)||63
2950171|NCT00697515|3664138|FG001|STARTED|First Intervention (Crossover Period)||64
2950172|NCT00697515|3664137|FG000|COMPLETED|First Intervention (Crossover Period)||53
2950173|NCT00697515|3664138|FG001|COMPLETED|First Intervention (Crossover Period)||52
2950174|NCT00697515|3664137|FG000|NOT COMPLETED|First Intervention (Crossover Period)||10
2950175|NCT00697515|3664138|FG001|NOT COMPLETED|First Intervention (Crossover Period)||12
2950176|NCT00697515|3664137|FG000|STARTED|Second Intervention (Crossover Period)||53
2950177|NCT00697515|3664138|FG001|STARTED|Second Intervention (Crossover Period)||52
2950178|NCT00697515|3664137|FG000|COMPLETED|Second Intervention (Crossover Period)||52
2950179|NCT00697515|3664138|FG001|COMPLETED|Second Intervention (Crossover Period)||51
2950180|NCT00697515|3664137|FG000|NOT COMPLETED|Second Intervention (Crossover Period)||1
2950181|NCT00697515|3664138|FG001|NOT COMPLETED|Second Intervention (Crossover Period)||1
2950182|NCT00697541|3664146|FG000|STARTED|Overall Study||10
2950183|NCT00697541|3664147|FG001|STARTED|Overall Study||10
2950184|NCT00697541|3664146|FG000|COMPLETED|Overall Study||8
2950185|NCT00697541|3664147|FG001|COMPLETED|Overall Study||9
2950186|NCT00697541|3664146|FG000|NOT COMPLETED|Overall Study||2
2950187|NCT00697541|3664147|FG001|NOT COMPLETED|Overall Study||1
2950188|NCT00697593|3664154|FG000|STARTED|Overall Study||70
2950189|NCT00697593|3664154|FG000|COMPLETED|Overall Study||51
2950190|NCT00697593|3664154|FG000|NOT COMPLETED|Overall Study||19
2950191|NCT00697619|3664160|FG000|STARTED|Overall Study||30
2950192|NCT00697619|3664161|FG001|STARTED|Overall Study||30
2950193|NCT00697619|3664160|FG000|COMPLETED|Overall Study||24
2950194|NCT00697619|3664161|FG001|COMPLETED|Overall Study||22
2950195|NCT00697619|3664160|FG000|NOT COMPLETED|Overall Study||6
2950196|NCT00697619|3664161|FG001|NOT COMPLETED|Overall Study||8
2950197|NCT00697697|3664169|FG000|STARTED|Overall Study||94
2950198|NCT00697697|3664170|FG001|STARTED|Overall Study||98
2950199|NCT00697697|3664169|FG000|COMPLETED|Overall Study||45
2950200|NCT00697697|3664170|FG001|COMPLETED|Overall Study||44
2950201|NCT00697697|3664169|FG000|NOT COMPLETED|Overall Study||49
2950202|NCT00697697|3664170|FG001|NOT COMPLETED|Overall Study||54
2950203|NCT00697788|3664176|FG000|STARTED|Dexmedetomidine Bolus 1 mcg/kg||8
2950204|NCT00697788|3664177|FG001|STARTED|Dexmedetomidine Bolus 1 mcg/kg|One participant did not begin infusion due to hypotension (mean pressure <50)|0
2950205|NCT00697788|3664178|FG002|STARTED|Dexmedetomidine Bolus 1 mcg/kg|2 participants did not begin the ascending (1.0 mcg/kg/hr) due to MAP<50|0
2950206|NCT00697788|3664179|FG003|STARTED|Dexmedetomidine Bolus 1 mcg/kg||0
2950207|NCT00697788|3664180|FG004|STARTED|Dexmedetomidine Bolus 1 mcg/kg||0
2950208|NCT00697788|3664181|FG005|STARTED|Dexmedetomidine Bolus 1 mcg/kg||0
2950209|NCT00697788|3664182|FG006|STARTED|Dexmedetomidine Bolus 1 mcg/kg||0
2950210|NCT00697788|3664183|FG007|STARTED|Dexmedetomidine Bolus 1 mcg/kg||0
2950211|NCT00697788|3664176|FG000|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||8
3299563|NCT02936037|4033344|FG000|COMPLETED|Open Label Extension||0
3299564|NCT02936037|4033345|FG001|COMPLETED|Open Label Extension||518
3299565|NCT02936037|4033344|FG000|NOT COMPLETED|Open Label Extension||0
3299566|NCT02936037|4033345|FG001|NOT COMPLETED|Open Label Extension||10
3299567|NCT02936076|4033353|FG000|STARTED|Overall Study||25
3299568|NCT02936076|4033354|FG001|STARTED|Overall Study||24
3299569|NCT02936076|4033353|FG000|COMPLETED|Overall Study||19
2950212|NCT00697788|3664177|FG001|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
2950213|NCT00697788|3664178|FG002|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
2950214|NCT00697788|3664179|FG003|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
2950215|NCT00697788|3664180|FG004|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
2950216|NCT00697788|3664181|FG005|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
2950217|NCT00697788|3664182|FG006|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
2950218|NCT00697788|3664183|FG007|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
2950219|NCT00697788|3664176|FG000|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
2950220|NCT00697788|3664177|FG001|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
2950221|NCT00697788|3664178|FG002|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
2950222|NCT00697788|3664179|FG003|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
2950223|NCT00697788|3664180|FG004|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
2950224|NCT00697788|3664181|FG005|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
2950225|NCT00697788|3664182|FG006|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
2950226|NCT00697788|3664183|FG007|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
2950227|NCT00697788|3664176|FG000|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
2950228|NCT00697788|3664177|FG001|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion|1 participant did not begin infusion due to hypotension (MAP<50)|7
2950229|NCT00697788|3664178|FG002|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
2950230|NCT00697788|3664179|FG003|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
2950231|NCT00697788|3664180|FG004|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
2950232|NCT00697788|3664181|FG005|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
2950233|NCT00697788|3664182|FG006|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
2950234|NCT00697788|3664183|FG007|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
2950235|NCT00697788|3664176|FG000|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
2950236|NCT00697788|3664177|FG001|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||5
2950237|NCT00697788|3664178|FG002|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
2950238|NCT00697788|3664179|FG003|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
2950239|NCT00697788|3664180|FG004|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
2950240|NCT00697788|3664181|FG005|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
2950241|NCT00697788|3664182|FG006|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
2950242|NCT00697788|3664183|FG007|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
2950243|NCT00697788|3664176|FG000|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
2950244|NCT00697788|3664177|FG001|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||2
2950245|NCT00697788|3664178|FG002|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
2950246|NCT00697788|3664179|FG003|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
2950247|NCT00697788|3664180|FG004|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
2950248|NCT00697788|3664181|FG005|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
2950249|NCT00697788|3664182|FG006|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
2950250|NCT00697788|3664183|FG007|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
2950251|NCT00697788|3664176|FG000|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
2950252|NCT00697788|3664177|FG001|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
3038348|NCT01153815|3757771|FG000|NOT COMPLETED|Overall Study||9
3299570|NCT02936076|4033354|FG001|COMPLETED|Overall Study||20
3299571|NCT02936076|4033353|FG000|NOT COMPLETED|Overall Study||6
3299572|NCT02936076|4033354|FG001|NOT COMPLETED|Overall Study||4
3299573|NCT02936479|4033360|FG000|STARTED|Overall Study||1
3299574|NCT02936479|4033360|FG000|COMPLETED|Overall Study||1
3299575|NCT02936479|4033360|FG000|NOT COMPLETED|Overall Study||0
3299576|NCT02936635|4033366|FG000|STARTED|Overall Study||115
3299577|NCT02936635|4033367|FG001|STARTED|Overall Study||165
3299578|NCT02936635|4033366|FG000|COMPLETED|Overall Study||0
3299579|NCT02936635|4033367|FG001|COMPLETED|Overall Study||0
3299580|NCT02936635|4033366|FG000|NOT COMPLETED|Overall Study||115
3299581|NCT02936635|4033367|FG001|NOT COMPLETED|Overall Study||165
3299582|NCT02936648|4033373|FG000|STARTED|Overall Study||2209
3299583|NCT02936648|4033373|FG000|COMPLETED|Overall Study||2209
3299584|NCT02936648|4033373|FG000|NOT COMPLETED|Overall Study||0
3299585|NCT02936869|4033379|FG000|STARTED|Overall Study||104
3299586|NCT02936869|4033380|FG001|STARTED|Overall Study||103
3299587|NCT02936869|4033379|FG000|COMPLETED|Overall Study||102
3299588|NCT02936869|4033380|FG001|COMPLETED|Overall Study||98
3299589|NCT02936869|4033379|FG000|NOT COMPLETED|Overall Study||2
3299590|NCT02936869|4033380|FG001|NOT COMPLETED|Overall Study||5
3299591|NCT02937116|4033399|FG000|STARTED|Overall Study||3
3299592|NCT02937116|4033400|FG001|STARTED|Overall Study||3
3299593|NCT02937116|4033401|FG002|STARTED|Overall Study||3
3299594|NCT02937116|4033402|FG003|STARTED|Overall Study||3
3299595|NCT02937116|4033403|FG004|STARTED|Overall Study||22
3299596|NCT02937116|4033404|FG005|STARTED|Overall Study||87
3299597|NCT02937116|4033405|FG006|STARTED|Overall Study||37
3299598|NCT02937116|4033406|FG007|STARTED|Overall Study||21
3299599|NCT02937116|4033407|FG008|STARTED|Overall Study||20
3299600|NCT02937116|4033408|FG009|STARTED|Overall Study||20
3299601|NCT02937116|4033409|FG010|STARTED|Overall Study||7
3299602|NCT02937116|4033410|FG011|STARTED|Overall Study||7
3299603|NCT02937116|4033399|FG000|COMPLETED|Overall Study||0
3299604|NCT02937116|4033400|FG001|COMPLETED|Overall Study||0
3299605|NCT02937116|4033401|FG002|COMPLETED|Overall Study||0
3299606|NCT02937116|4033402|FG003|COMPLETED|Overall Study||0
3299607|NCT02937116|4033403|FG004|COMPLETED|Overall Study||0
3299608|NCT02937116|4033404|FG005|COMPLETED|Overall Study||0
3299609|NCT02937116|4033405|FG006|COMPLETED|Overall Study||0
3299610|NCT02937116|4033406|FG007|COMPLETED|Overall Study||0
2950253|NCT00697788|3664178|FG002|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion|2 participants did not begin this infusion due to hypotension (MAP<50)|3
2950254|NCT00697788|3664179|FG003|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
2950255|NCT00697788|3664180|FG004|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
2950256|NCT00697788|3664181|FG005|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
2950257|NCT00697788|3664182|FG006|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
2950258|NCT00697788|3664183|FG007|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
2950259|NCT00697788|3664176|FG000|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
2950260|NCT00697788|3664177|FG001|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
2950261|NCT00697788|3664178|FG002|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||3
2950262|NCT00697788|3664179|FG003|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
2950263|NCT00697788|3664180|FG004|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
2950264|NCT00697788|3664181|FG005|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
2950265|NCT00697788|3664182|FG006|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
2950266|NCT00697788|3664183|FG007|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
2950267|NCT00697788|3664176|FG000|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
2950268|NCT00697788|3664177|FG001|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
2950269|NCT00697788|3664178|FG002|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
2950270|NCT00697788|3664179|FG003|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
2950271|NCT00697788|3664180|FG004|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
2950272|NCT00697788|3664181|FG005|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
2950273|NCT00697788|3664182|FG006|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
2950274|NCT00697788|3664183|FG007|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
2950275|NCT00697788|3664176|FG000|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
2950276|NCT00697788|3664177|FG001|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
2950277|NCT00697788|3664178|FG002|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
2950278|NCT00697788|3664179|FG003|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||3
2950279|NCT00697788|3664180|FG004|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
2950280|NCT00697788|3664181|FG005|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
2950281|NCT00697788|3664182|FG006|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
2950282|NCT00697788|3664183|FG007|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
2950283|NCT00697788|3664176|FG000|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
2950284|NCT00697788|3664177|FG001|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
2950285|NCT00697788|3664178|FG002|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
2950286|NCT00697788|3664179|FG003|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||3
2950287|NCT00697788|3664180|FG004|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
2950288|NCT00697788|3664181|FG005|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
2950289|NCT00697788|3664182|FG006|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
2950290|NCT00697788|3664183|FG007|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
2950291|NCT00697788|3664176|FG000|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
2950292|NCT00697788|3664177|FG001|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
2950293|NCT00697788|3664178|FG002|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
2950294|NCT00697788|3664179|FG003|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
2950295|NCT00697788|3664180|FG004|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
2950296|NCT00697788|3664181|FG005|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
2950297|NCT00697788|3664182|FG006|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
2950298|NCT00697788|3664183|FG007|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
2950299|NCT00697788|3664176|FG000|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
2950300|NCT00697788|3664177|FG001|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
2950301|NCT00697788|3664178|FG002|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
2950302|NCT00697788|3664179|FG003|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
2950303|NCT00697788|3664180|FG004|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||3
2950304|NCT00697788|3664181|FG005|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
2950305|NCT00697788|3664182|FG006|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
2950306|NCT00697788|3664183|FG007|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
2950307|NCT00697788|3664176|FG000|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
2950308|NCT00697788|3664177|FG001|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
2950309|NCT00697788|3664178|FG002|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
2950310|NCT00697788|3664179|FG003|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
2950311|NCT00697788|3664180|FG004|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||2
2950312|NCT00697788|3664181|FG005|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
2950313|NCT00697788|3664182|FG006|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
2950314|NCT00697788|3664183|FG007|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
2950315|NCT00697788|3664176|FG000|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
2950316|NCT00697788|3664177|FG001|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
2950317|NCT00697788|3664178|FG002|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
2950318|NCT00697788|3664179|FG003|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
2950319|NCT00697788|3664180|FG004|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||1
2950320|NCT00697788|3664181|FG005|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
2950321|NCT00697788|3664182|FG006|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
2950322|NCT00697788|3664183|FG007|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
2950323|NCT00697788|3664176|FG000|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
2950324|NCT00697788|3664177|FG001|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
2950325|NCT00697788|3664178|FG002|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
2950326|NCT00697788|3664179|FG003|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
2950327|NCT00697788|3664180|FG004|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
2950328|NCT00697788|3664181|FG005|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||2
2950329|NCT00697788|3664182|FG006|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
2950330|NCT00697788|3664183|FG007|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
2950331|NCT00697788|3664176|FG000|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
2950332|NCT00697788|3664177|FG001|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
2950333|NCT00697788|3664178|FG002|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
2950334|NCT00697788|3664179|FG003|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
2950335|NCT00697788|3664180|FG004|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
2950336|NCT00697788|3664181|FG005|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||2
2950337|NCT00697788|3664182|FG006|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
2950338|NCT00697788|3664183|FG007|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
2950339|NCT00697788|3664176|FG000|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
2950340|NCT00697788|3664177|FG001|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
2950341|NCT00697788|3664178|FG002|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
2950342|NCT00697788|3664179|FG003|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
2950343|NCT00697788|3664180|FG004|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
2950344|NCT00697788|3664181|FG005|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
2950345|NCT00697788|3664182|FG006|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
2950346|NCT00697788|3664183|FG007|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
2950347|NCT00697788|3664176|FG000|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
2950348|NCT00697788|3664177|FG001|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
2950349|NCT00697788|3664178|FG002|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
2950350|NCT00697788|3664179|FG003|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
2950351|NCT00697788|3664180|FG004|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
2950352|NCT00697788|3664181|FG005|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
2950353|NCT00697788|3664182|FG006|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||2
2950354|NCT00697788|3664183|FG007|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
2950355|NCT00697788|3664176|FG000|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
2950356|NCT00697788|3664177|FG001|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
2950357|NCT00697788|3664178|FG002|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
2950358|NCT00697788|3664179|FG003|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
2950359|NCT00697788|3664180|FG004|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
2950360|NCT00697788|3664181|FG005|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
2950361|NCT00697788|3664182|FG006|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||2
2950362|NCT00697788|3664183|FG007|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
2950363|NCT00697788|3664176|FG000|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
2950364|NCT00697788|3664177|FG001|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
2950365|NCT00697788|3664178|FG002|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
2950366|NCT00697788|3664179|FG003|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
2950367|NCT00697788|3664180|FG004|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
2950368|NCT00697788|3664181|FG005|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
2950369|NCT00697788|3664182|FG006|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
2950370|NCT00697788|3664183|FG007|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
2950371|NCT00697788|3664176|FG000|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
2950372|NCT00697788|3664177|FG001|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
2950373|NCT00697788|3664178|FG002|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
2950374|NCT00697788|3664179|FG003|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
2950375|NCT00697788|3664180|FG004|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
3299611|NCT02937116|4033407|FG008|COMPLETED|Overall Study||0
3299612|NCT02937116|4033408|FG009|COMPLETED|Overall Study||0
3299613|NCT02937116|4033409|FG010|COMPLETED|Overall Study||0
3299614|NCT02937116|4033410|FG011|COMPLETED|Overall Study||0
3299615|NCT02937116|4033399|FG000|NOT COMPLETED|Overall Study||3
3299616|NCT02937116|4033400|FG001|NOT COMPLETED|Overall Study||3
3299617|NCT02937116|4033401|FG002|NOT COMPLETED|Overall Study||3
3299618|NCT02937116|4033402|FG003|NOT COMPLETED|Overall Study||3
3299619|NCT02937116|4033403|FG004|NOT COMPLETED|Overall Study||22
3299620|NCT02937116|4033404|FG005|NOT COMPLETED|Overall Study||87
3299621|NCT02937116|4033405|FG006|NOT COMPLETED|Overall Study||37
3299622|NCT02937116|4033406|FG007|NOT COMPLETED|Overall Study||21
3299623|NCT02937116|4033407|FG008|NOT COMPLETED|Overall Study||20
3299624|NCT02937116|4033408|FG009|NOT COMPLETED|Overall Study||20
3299625|NCT02937116|4033409|FG010|NOT COMPLETED|Overall Study||7
3299626|NCT02937116|4033410|FG011|NOT COMPLETED|Overall Study||7
3299627|NCT02937168|4033436|FG000|STARTED|PET/CT Screening Period (21 Days)||5
3299628|NCT02937168|4033437|FG001|STARTED|PET/CT Screening Period (21 Days)||0
3299629|NCT02937168|4033438|FG002|STARTED|PET/CT Screening Period (21 Days)||0
3299630|NCT02937168|4033436|FG000|COMPLETED|PET/CT Screening Period (21 Days)||5
3299631|NCT02937168|4033437|FG001|COMPLETED|PET/CT Screening Period (21 Days)||0
3299632|NCT02937168|4033438|FG002|COMPLETED|PET/CT Screening Period (21 Days)||0
3299633|NCT02937168|4033436|FG000|NOT COMPLETED|PET/CT Screening Period (21 Days)||0
3299634|NCT02937168|4033437|FG001|NOT COMPLETED|PET/CT Screening Period (21 Days)||0
3299635|NCT02937168|4033438|FG002|NOT COMPLETED|PET/CT Screening Period (21 Days)||0
2950376|NCT00697788|3664181|FG005|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
2950377|NCT00697788|3664182|FG006|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
2950378|NCT00697788|3664183|FG007|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||2
2950379|NCT00697788|3664176|FG000|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
2950380|NCT00697788|3664177|FG001|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
2950381|NCT00697788|3664178|FG002|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
2950382|NCT00697788|3664179|FG003|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
3299636|NCT02937168|4033436|FG000|STARTED|Double-Blind Treatment Period (6 Weeks)||0
3299637|NCT02937168|4033437|FG001|STARTED|Double-Blind Treatment Period (6 Weeks)||0
3299638|NCT02937168|4033438|FG002|STARTED|Double-Blind Treatment Period (6 Weeks)||0
3299639|NCT02937168|4033436|FG000|COMPLETED|Double-Blind Treatment Period (6 Weeks)||0
3299640|NCT02937168|4033437|FG001|COMPLETED|Double-Blind Treatment Period (6 Weeks)||0
3299641|NCT02937168|4033438|FG002|COMPLETED|Double-Blind Treatment Period (6 Weeks)||0
3299642|NCT02937168|4033436|FG000|NOT COMPLETED|Double-Blind Treatment Period (6 Weeks)||0
3299643|NCT02937168|4033437|FG001|NOT COMPLETED|Double-Blind Treatment Period (6 Weeks)||0
3299644|NCT02937168|4033438|FG002|NOT COMPLETED|Double-Blind Treatment Period (6 Weeks)||0
3299645|NCT02937194|4033446|FG000|STARTED|1-year Followup||294
3299646|NCT02937194|4033447|FG001|STARTED|1-year Followup||286
3299647|NCT02937194|4033446|FG000|COMPLETED|1-year Followup||223
3299648|NCT02937194|4033447|FG001|COMPLETED|1-year Followup||218
3299649|NCT02937194|4033446|FG000|NOT COMPLETED|1-year Followup||71
3299650|NCT02937194|4033447|FG001|NOT COMPLETED|1-year Followup||68
3299651|NCT02937194|4033446|FG000|STARTED|2-years Followup|The researchers contacted all the participants recruited/enrolled at baseline at each follow-up regardless if they had participated in the previous follow-up or not. So the number started equals 294 for each follow-up.|294
3299652|NCT02937194|4033447|FG001|STARTED|2-years Followup|The researchers contacted all the participants recruited/enrolled at baseline at each follow-up regardless if they had participated in the previous follow-up or not. So the number started equals 286 for each follow-up.|286
3299653|NCT02937194|4033446|FG000|COMPLETED|2-years Followup||216
3299654|NCT02937194|4033447|FG001|COMPLETED|2-years Followup||208
3299655|NCT02937194|4033446|FG000|NOT COMPLETED|2-years Followup||78
3299656|NCT02937194|4033447|FG001|NOT COMPLETED|2-years Followup||78
3299657|NCT02937194|4033446|FG000|STARTED|3-years Followup|The researchers contacted all the participants recruited/enrolled at baseline at each follow-up regardless if they had participated in the previous follow-up or not. So the number started equals 294 for each follow-up.|294
3299658|NCT02937194|4033447|FG001|STARTED|3-years Followup|The researchers contacted all the participants recruited/enrolled at baseline at each follow-up regardless if they had participated in the previous follow-up or not. So the number started equals 286 for each follow-up.|286
3299659|NCT02937194|4033446|FG000|COMPLETED|3-years Followup||228
3299660|NCT02937194|4033447|FG001|COMPLETED|3-years Followup||208
3299661|NCT02937194|4033446|FG000|NOT COMPLETED|3-years Followup||66
3299662|NCT02937194|4033447|FG001|NOT COMPLETED|3-years Followup||78
3299663|NCT02937350|4033456|FG000|STARTED|Overall Study||43
3299664|NCT02937350|4033457|FG001|STARTED|Overall Study||25
3299665|NCT02937350|4033458|FG002|STARTED|Overall Study||20
3299666|NCT02937350|4033456|FG000|COMPLETED|Overall Study||43
3299667|NCT02937350|4033457|FG001|COMPLETED|Overall Study||24
3299668|NCT02937350|4033458|FG002|COMPLETED|Overall Study||20
3299669|NCT02937350|4033456|FG000|NOT COMPLETED|Overall Study||0
3299670|NCT02937350|4033457|FG001|NOT COMPLETED|Overall Study||1
3299671|NCT02937350|4033458|FG002|NOT COMPLETED|Overall Study||0
3299672|NCT02937454|4033466|FG000|STARTED|Overall Study||567
3299673|NCT02937454|4033467|FG001|STARTED|Overall Study||565
3299674|NCT02937454|4033466|FG000|Started Treatment|Overall Study||559
3299675|NCT02937454|4033467|FG001|Started Treatment|Overall Study||551
3299676|NCT02937454|4033466|FG000|COMPLETED|Overall Study||427
3299677|NCT02937454|4033467|FG001|COMPLETED|Overall Study||437
3299678|NCT02937454|4033466|FG000|NOT COMPLETED|Overall Study||140
3299679|NCT02937454|4033467|FG001|NOT COMPLETED|Overall Study||128
3299680|NCT02937506|4033476|FG000|STARTED|Overall Study||300
3299681|NCT02937506|4033477|FG001|STARTED|Overall Study||300
3299682|NCT02937506|4033476|FG000|COMPLETED|Overall Study||300
3299683|NCT02937506|4033477|FG001|COMPLETED|Overall Study||300
3299684|NCT02937506|4033476|FG000|NOT COMPLETED|Overall Study||0
3299685|NCT02937506|4033477|FG001|NOT COMPLETED|Overall Study||0
3299686|NCT02937545|4033485|FG000|STARTED|Overall Study||69
3299687|NCT02937545|4033486|FG001|STARTED|Overall Study||85
3299688|NCT02937545|4033487|FG002|STARTED|Overall Study||15
3299689|NCT02937545|4033488|FG003|STARTED|Overall Study||21
3299690|NCT02937545|4033485|FG000|COMPLETED|Overall Study||67
3299691|NCT02937545|4033486|FG001|COMPLETED|Overall Study||83
3299692|NCT02937545|4033487|FG002|COMPLETED|Overall Study||9
3299693|NCT02937545|4033488|FG003|COMPLETED|Overall Study||14
3299694|NCT02937545|4033485|FG000|NOT COMPLETED|Overall Study||2
3299695|NCT02937545|4033486|FG001|NOT COMPLETED|Overall Study||2
3299696|NCT02937545|4033487|FG002|NOT COMPLETED|Overall Study||6
3299697|NCT02937545|4033488|FG003|NOT COMPLETED|Overall Study||7
3299698|NCT02937558|4033501|FG000|STARTED|Double-blind Phase||3
3299699|NCT02937558|4033502|FG001|STARTED|Double-blind Phase||2
3299700|NCT02937558|4033501|FG000|COMPLETED|Double-blind Phase||3
3299701|NCT02937558|4033502|FG001|COMPLETED|Double-blind Phase||2
3299702|NCT02937558|4033501|FG000|NOT COMPLETED|Double-blind Phase||0
3299703|NCT02937558|4033502|FG001|NOT COMPLETED|Double-blind Phase||0
3299704|NCT02937558|4033501|FG000|STARTED|Open-label Phase||5
3299705|NCT02937558|4033502|FG001|STARTED|Open-label Phase||0
3299706|NCT02937558|4033501|FG000|COMPLETED|Open-label Phase||5
2950383|NCT00697788|3664180|FG004|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
3299707|NCT02937558|4033502|FG001|COMPLETED|Open-label Phase||0
3299708|NCT02937558|4033501|FG000|NOT COMPLETED|Open-label Phase||0
3299709|NCT02937558|4033502|FG001|NOT COMPLETED|Open-label Phase||0
3299710|NCT02937584|4033509|FG000|STARTED|Period 1||11
3299711|NCT02937584|4033510|FG001|STARTED|Period 1||12
3299712|NCT02937584|4033509|FG000|COMPLETED|Period 1||10
3299713|NCT02937584|4033510|FG001|COMPLETED|Period 1||10
3299714|NCT02937584|4033509|FG000|NOT COMPLETED|Period 1||1
3299715|NCT02937584|4033510|FG001|NOT COMPLETED|Period 1||2
3299716|NCT02937584|4033509|FG000|STARTED|Washout||10
3299717|NCT02937584|4033510|FG001|STARTED|Washout||10
3299718|NCT02937584|4033509|FG000|COMPLETED|Washout||10
3299719|NCT02937584|4033510|FG001|COMPLETED|Washout||9
3299720|NCT02937584|4033509|FG000|NOT COMPLETED|Washout||0
3299721|NCT02937584|4033510|FG001|NOT COMPLETED|Washout||1
3299722|NCT02937584|4033509|FG000|STARTED|Period 2||10
3299723|NCT02937584|4033510|FG001|STARTED|Period 2||9
3299724|NCT02937584|4033509|FG000|COMPLETED|Period 2||10
3299725|NCT02937584|4033510|FG001|COMPLETED|Period 2||9
3299726|NCT02937584|4033509|FG000|NOT COMPLETED|Period 2||0
3299727|NCT02937584|4033510|FG001|NOT COMPLETED|Period 2||0
3299728|NCT02937623|4033518|FG000|STARTED|Overall Study||60
3299729|NCT02937623|4033519|FG001|STARTED|Overall Study||60
3299730|NCT02937623|4033518|FG000|COMPLETED|Overall Study||60
3299731|NCT02937623|4033519|FG001|COMPLETED|Overall Study||60
3299732|NCT02937623|4033518|FG000|NOT COMPLETED|Overall Study||0
3299733|NCT02937623|4033519|FG001|NOT COMPLETED|Overall Study||0
3299734|NCT02937636|4033527|FG000|STARTED|Overall Study||63
3299735|NCT02937636|4033528|FG001|STARTED|Overall Study||65
3299736|NCT02937636|4033527|FG000|COMPLETED|Overall Study||60
3299737|NCT02937636|4033528|FG001|COMPLETED|Overall Study||63
3299738|NCT02937636|4033527|FG000|NOT COMPLETED|Overall Study||3
3299739|NCT02937636|4033528|FG001|NOT COMPLETED|Overall Study||2
3299740|NCT02937701|4033537|FG000|STARTED|Day 1 to Week 22||279
3299741|NCT02937701|4033538|FG001|STARTED|Day 1 to Week 22||279
3299742|NCT02937701|4033539|FG002|STARTED|Day 1 to Week 22||0
3299743|NCT02937701|4033540|FG003|STARTED|Day 1 to Week 22||0
3299744|NCT02937701|4033541|FG004|STARTED|Day 1 to Week 22||0
3299745|NCT02937701|4033537|FG000|Received Treatment|Day 1 to Week 22||278
3299746|NCT02937701|4033538|FG001|Received Treatment|Day 1 to Week 22||278
3299747|NCT02937701|4033539|FG002|Received Treatment|Day 1 to Week 22||0
3299748|NCT02937701|4033540|FG003|Received Treatment|Day 1 to Week 22||0
3299749|NCT02937701|4033541|FG004|Received Treatment|Day 1 to Week 22||0
3299750|NCT02937701|4033537|FG000|COMPLETED|Day 1 to Week 22||244
3299751|NCT02937701|4033538|FG001|COMPLETED|Day 1 to Week 22||240
3299752|NCT02937701|4033539|FG002|COMPLETED|Day 1 to Week 22||0
3299753|NCT02937701|4033540|FG003|COMPLETED|Day 1 to Week 22||0
3299754|NCT02937701|4033541|FG004|COMPLETED|Day 1 to Week 22||0
3299755|NCT02937701|4033537|FG000|NOT COMPLETED|Day 1 to Week 22||35
3299756|NCT02937701|4033538|FG001|NOT COMPLETED|Day 1 to Week 22||39
3299757|NCT02937701|4033539|FG002|NOT COMPLETED|Day 1 to Week 22||0
3299758|NCT02937701|4033540|FG003|NOT COMPLETED|Day 1 to Week 22||0
3299759|NCT02937701|4033541|FG004|NOT COMPLETED|Day 1 to Week 22||0
3299760|NCT02937701|4033537|FG000|STARTED|Week 22 to Week 50||0
3299761|NCT02937701|4033538|FG001|STARTED|Week 22 to Week 50||0
3299762|NCT02937701|4033539|FG002|STARTED|Week 22 to Week 50||244
3299763|NCT02937701|4033540|FG003|STARTED|Week 22 to Week 50||121
3299764|NCT02937701|4033541|FG004|STARTED|Week 22 to Week 50||119
3299765|NCT02937701|4033537|FG000|COMPLETED|Week 22 to Week 50||0
3299766|NCT02937701|4033538|FG001|COMPLETED|Week 22 to Week 50||0
3299767|NCT02937701|4033539|FG002|COMPLETED|Week 22 to Week 50||212
3299768|NCT02937701|4033540|FG003|COMPLETED|Week 22 to Week 50||113
3299769|NCT02937701|4033541|FG004|COMPLETED|Week 22 to Week 50||110
3299770|NCT02937701|4033537|FG000|NOT COMPLETED|Week 22 to Week 50||0
3299771|NCT02937701|4033538|FG001|NOT COMPLETED|Week 22 to Week 50||0
3299772|NCT02937701|4033539|FG002|NOT COMPLETED|Week 22 to Week 50||32
3299773|NCT02937701|4033540|FG003|NOT COMPLETED|Week 22 to Week 50||8
3299774|NCT02937701|4033541|FG004|NOT COMPLETED|Week 22 to Week 50||9
3299775|NCT02937740|4033555|FG000|STARTED|BID for 90 Days, 22 mg/Day||24
3299776|NCT02937740|4033556|FG001|STARTED|BID for 90 Days, 22 mg/Day||93
3299777|NCT02937740|4033555|FG000|COMPLETED|BID for 90 Days, 22 mg/Day||19
3299778|NCT02937740|4033556|FG001|COMPLETED|BID for 90 Days, 22 mg/Day||62
3299779|NCT02937740|4033555|FG000|NOT COMPLETED|BID for 90 Days, 22 mg/Day||5
3299780|NCT02937740|4033556|FG001|NOT COMPLETED|BID for 90 Days, 22 mg/Day||31
3299781|NCT02937740|4033555|FG000|STARTED|Uptitrated to TID on Day 90 for 30 Days||13
3299782|NCT02937740|4033556|FG001|STARTED|Uptitrated to TID on Day 90 for 30 Days||17
3299783|NCT02937740|4033555|FG000|COMPLETED|Uptitrated to TID on Day 90 for 30 Days||12
3299784|NCT02937740|4033556|FG001|COMPLETED|Uptitrated to TID on Day 90 for 30 Days||15
3299785|NCT02937740|4033555|FG000|NOT COMPLETED|Uptitrated to TID on Day 90 for 30 Days||1
3299786|NCT02937740|4033556|FG001|NOT COMPLETED|Uptitrated to TID on Day 90 for 30 Days||2
3299787|NCT02937766|4033570|FG000|STARTED|Overall Study||30
3299788|NCT02937766|4033571|FG001|STARTED|Overall Study||30
3299789|NCT02937766|4033570|FG000|COMPLETED|Overall Study||23
3299790|NCT02937766|4033571|FG001|COMPLETED|Overall Study||30
3299791|NCT02937766|4033570|FG000|NOT COMPLETED|Overall Study||7
3299792|NCT02937766|4033571|FG001|NOT COMPLETED|Overall Study||0
3299793|NCT02937870|4033577|FG000|STARTED|Overall Study||23
3299794|NCT02937870|4033577|FG000|Received Test Adhesive 1|Overall Study||21
3299795|NCT02937870|4033577|FG000|Received Test Adhesive 2|Overall Study||22
2950384|NCT00697788|3664181|FG005|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
2950385|NCT00697788|3664182|FG006|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
2950386|NCT00697788|3664183|FG007|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||2
2950387|NCT00697788|3664176|FG000|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
3299796|NCT02937870|4033577|FG000|Received Positive Control Adhesive|Overall Study||21
3299797|NCT02937870|4033577|FG000|Received no Adhesive|Overall Study||20
3299798|NCT02937870|4033577|FG000|COMPLETED|Overall Study||20
3299799|NCT02937870|4033577|FG000|NOT COMPLETED|Overall Study||3
3299800|NCT02938052|4033591|FG000|STARTED|Overall Study||10
3299801|NCT02938052|4033591|FG000|COMPLETED|Overall Study||10
3299802|NCT02938052|4033591|FG000|NOT COMPLETED|Overall Study||0
3299803|NCT02938169|4033600|FG000|STARTED|Overall Study||15
3299804|NCT02938169|4033601|FG001|STARTED|Overall Study||15
3299805|NCT02938169|4033602|FG002|STARTED|Overall Study||15
3299806|NCT02938169|4033603|FG003|STARTED|Overall Study||15
3299807|NCT02938169|4033600|FG000|COMPLETED|Overall Study||13
3299808|NCT02938169|4033601|FG001|COMPLETED|Overall Study||13
3299809|NCT02938169|4033602|FG002|COMPLETED|Overall Study||10
3299810|NCT02938169|4033603|FG003|COMPLETED|Overall Study||12
3299811|NCT02938169|4033600|FG000|NOT COMPLETED|Overall Study||2
3299812|NCT02938169|4033601|FG001|NOT COMPLETED|Overall Study||2
3299813|NCT02938169|4033602|FG002|NOT COMPLETED|Overall Study||5
3299814|NCT02938169|4033603|FG003|NOT COMPLETED|Overall Study||3
3299815|NCT02938494|4033624|FG000|STARTED|Overall Study||69
3299816|NCT02938494|4033625|FG001|STARTED|Overall Study||72
3299817|NCT02938494|4033626|FG002|STARTED|Overall Study||34
3299818|NCT02938494|4033627|FG003|STARTED|Overall Study||35
3299819|NCT02938494|4033624|FG000|COMPLETED|Overall Study||65
3299820|NCT02938494|4033625|FG001|COMPLETED|Overall Study||63
3299821|NCT02938494|4033626|FG002|COMPLETED|Overall Study||30
3299822|NCT02938494|4033627|FG003|COMPLETED|Overall Study||31
3299823|NCT02938494|4033624|FG000|NOT COMPLETED|Overall Study||4
3299824|NCT02938494|4033625|FG001|NOT COMPLETED|Overall Study||9
3299825|NCT02938494|4033626|FG002|NOT COMPLETED|Overall Study||4
3299826|NCT02938494|4033627|FG003|NOT COMPLETED|Overall Study||4
3299827|NCT02938520|4033638|FG000|STARTED|Overall Study||283
3299828|NCT02938520|4033639|FG001|STARTED|Overall Study||283
3299829|NCT02938520|4033638|FG000|COMPLETED|Overall Study||0
3299830|NCT02938520|4033639|FG001|COMPLETED|Overall Study||0
3299831|NCT02938520|4033638|FG000|NOT COMPLETED|Overall Study||283
3299832|NCT02938520|4033639|FG001|NOT COMPLETED|Overall Study||283
3299833|NCT02938585|4033652|FG000|STARTED|Overall Study||9
3299834|NCT02938585|4033653|FG001|STARTED|Overall Study||33
3299835|NCT02938585|4033654|FG002|STARTED|Overall Study||11
3299836|NCT02938585|4033655|FG003|STARTED|Overall Study||15
3299837|NCT02938585|4033652|FG000|Exposed to Prophylaxis Regimen|Overall Study||9
3299838|NCT02938585|4033653|FG001|Exposed to Prophylaxis Regimen|Overall Study||31
3299839|NCT02938585|4033654|FG002|Exposed to Prophylaxis Regimen|Overall Study||11
3299840|NCT02938585|4033655|FG003|Exposed to Prophylaxis Regimen|Overall Study||12
3299841|NCT02938585|4033652|FG000|Exposed to On-demand Regimen|Overall Study||1
3299842|NCT02938585|4033653|FG001|Exposed to On-demand Regimen|Overall Study||7
3299843|NCT02938585|4033654|FG002|Exposed to On-demand Regimen|Overall Study||1
3299844|NCT02938585|4033655|FG003|Exposed to On-demand Regimen|Overall Study||8
3299845|NCT02938585|4033652|FG000|COMPLETED|Overall Study||9
3299846|NCT02938585|4033653|FG001|COMPLETED|Overall Study||32
3299847|NCT02938585|4033654|FG002|COMPLETED|Overall Study||11
3299848|NCT02938585|4033655|FG003|COMPLETED|Overall Study||10
3299849|NCT02938585|4033652|FG000|NOT COMPLETED|Overall Study||0
3299850|NCT02938585|4033653|FG001|NOT COMPLETED|Overall Study||1
3299851|NCT02938585|4033654|FG002|NOT COMPLETED|Overall Study||0
3299852|NCT02938585|4033655|FG003|NOT COMPLETED|Overall Study||5
3299853|NCT02938949|4033681|FG000|STARTED|Overall Study||10
3299854|NCT02938949|4033682|FG001|STARTED|Overall Study||10
3299855|NCT02938949|4033681|FG000|COMPLETED|Overall Study||10
3299856|NCT02938949|4033682|FG001|COMPLETED|Overall Study||10
3299857|NCT02938949|4033681|FG000|NOT COMPLETED|Overall Study||0
3299858|NCT02938949|4033682|FG001|NOT COMPLETED|Overall Study||0
3299859|NCT02939014|4033690|FG000|STARTED|Overall Study||30
3299860|NCT02939014|4033691|FG001|STARTED|Overall Study||9
3299861|NCT02939014|4033690|FG000|COMPLETED|Overall Study||25
3299862|NCT02939014|4033691|FG001|COMPLETED|Overall Study||6
3299863|NCT02939014|4033690|FG000|NOT COMPLETED|Overall Study||5
3299864|NCT02939014|4033691|FG001|NOT COMPLETED|Overall Study||3
3299865|NCT02939079|4033700|FG000|STARTED|Overall Study||25
3299866|NCT02939079|4033701|FG001|STARTED|Overall Study||25
3299867|NCT02939079|4033700|FG000|COMPLETED|Overall Study||21
3299868|NCT02939079|4033701|FG001|COMPLETED|Overall Study||20
3299869|NCT02939079|4033700|FG000|NOT COMPLETED|Overall Study||4
3299870|NCT02939079|4033701|FG001|NOT COMPLETED|Overall Study||5
3299871|NCT02939105|4033707|FG000|STARTED|Overall Study||15
3299872|NCT02939105|4033707|FG000|COMPLETED|Overall Study||15
3299873|NCT02939105|4033707|FG000|NOT COMPLETED|Overall Study||0
3299874|NCT02939131|4033714|FG000|STARTED|Overall Study|One additional site in the COMB-R group withdrew prior to the start of participant enrollment.|81
3299875|NCT02939131|4033715|FG001|STARTED|Overall Study||75
3299876|NCT02939131|4033714|FG000|Week 24 Visit|Overall Study|These are the numbers still on study at week 24|74
3299877|NCT02939131|4033715|FG001|Week 24 Visit|Overall Study||72
3299878|NCT02939131|4033714|FG000|COMPLETED|Overall Study||70
3299879|NCT02939131|4033715|FG001|COMPLETED|Overall Study||66
3132501|NCT01691482|3857559|FG000|NOT COMPLETED|Treatment Period 1||0
3299880|NCT02939131|4033714|FG000|NOT COMPLETED|Overall Study||11
3299881|NCT02939131|4033715|FG001|NOT COMPLETED|Overall Study||9
3299882|NCT02939170|4033724|FG000|STARTED|Overall Study||40
3299883|NCT02939170|4033725|FG001|STARTED|Overall Study||40
3299884|NCT02939170|4033724|FG000|COMPLETED|Overall Study||40
3299885|NCT02939170|4033725|FG001|COMPLETED|Overall Study||40
3299886|NCT02939170|4033724|FG000|NOT COMPLETED|Overall Study||0
3299887|NCT02939170|4033725|FG001|NOT COMPLETED|Overall Study||0
3299888|NCT02939326|4033740|FG000|STARTED|Overall Study||7
3299889|NCT02939326|4033741|FG001|STARTED|Overall Study||5
3299890|NCT02939326|4033742|FG002|STARTED|Overall Study||5
3299891|NCT02939326|4033743|FG003|STARTED|Overall Study||5
3299892|NCT02939326|4033744|FG004|STARTED|Overall Study||5
3299893|NCT02939326|4033745|FG005|STARTED|Overall Study||5
3299894|NCT02939326|4033746|FG006|STARTED|Overall Study||5
3299895|NCT02939326|4033747|FG007|STARTED|Overall Study||5
3299896|NCT02939326|4033740|FG000|COMPLETED|Overall Study||7
3299897|NCT02939326|4033741|FG001|COMPLETED|Overall Study||5
3299898|NCT02939326|4033742|FG002|COMPLETED|Overall Study||5
3299899|NCT02939326|4033743|FG003|COMPLETED|Overall Study||5
3299900|NCT02939326|4033744|FG004|COMPLETED|Overall Study||5
3299901|NCT02939326|4033745|FG005|COMPLETED|Overall Study||5
3299902|NCT02939326|4033746|FG006|COMPLETED|Overall Study||5
3299903|NCT02939326|4033747|FG007|COMPLETED|Overall Study||5
3299904|NCT02939326|4033740|FG000|NOT COMPLETED|Overall Study||0
3299905|NCT02939326|4033741|FG001|NOT COMPLETED|Overall Study||0
3299906|NCT02939326|4033742|FG002|NOT COMPLETED|Overall Study||0
3299907|NCT02939326|4033743|FG003|NOT COMPLETED|Overall Study||0
3299908|NCT02939326|4033744|FG004|NOT COMPLETED|Overall Study||0
3299909|NCT02939326|4033745|FG005|NOT COMPLETED|Overall Study||0
3299910|NCT02939326|4033746|FG006|NOT COMPLETED|Overall Study||0
3299911|NCT02939326|4033747|FG007|NOT COMPLETED|Overall Study||0
3299912|NCT02939560|4033765|FG000|STARTED|Overall Study||13
3299913|NCT02939560|4033765|FG000|COMPLETED|Overall Study||10
3299914|NCT02939560|4033765|FG000|NOT COMPLETED|Overall Study||3
3299915|NCT02939599|4033771|FG000|STARTED|Overall Study||3
3299916|NCT02939599|4033772|FG001|STARTED|Overall Study||2
3299917|NCT02939599|4033771|FG000|COMPLETED|Overall Study||0
3299918|NCT02939599|4033772|FG001|COMPLETED|Overall Study||0
3299919|NCT02939599|4033771|FG000|NOT COMPLETED|Overall Study||3
3299920|NCT02939599|4033772|FG001|NOT COMPLETED|Overall Study||2
3299921|NCT02939651|4033779|FG000|STARTED|Overall Study||21
3299922|NCT02939651|4033779|FG000|COMPLETED|Overall Study||21
3299923|NCT02939651|4033779|FG000|NOT COMPLETED|Overall Study||0
3299924|NCT02939716|4033783|FG000|STARTED|Overall Study||3
3299925|NCT02939716|4033784|FG001|STARTED|Overall Study||3
3299926|NCT02939716|4033785|FG002|STARTED|Overall Study||3
3299927|NCT02939716|4033786|FG003|STARTED|Overall Study||3
3299928|NCT02939716|4033787|FG004|STARTED|Overall Study||3
3299929|NCT02939716|4033788|FG005|STARTED|Overall Study||3
3299930|NCT02939716|4033783|FG000|COMPLETED|Overall Study||3
3299931|NCT02939716|4033784|FG001|COMPLETED|Overall Study||3
3299932|NCT02939716|4033785|FG002|COMPLETED|Overall Study||3
3299933|NCT02939716|4033786|FG003|COMPLETED|Overall Study||2
3299934|NCT02939716|4033787|FG004|COMPLETED|Overall Study||2
3299935|NCT02939716|4033788|FG005|COMPLETED|Overall Study||2
3299936|NCT02939716|4033783|FG000|NOT COMPLETED|Overall Study||0
3299937|NCT02939716|4033784|FG001|NOT COMPLETED|Overall Study||0
3299938|NCT02939716|4033785|FG002|NOT COMPLETED|Overall Study||0
3299939|NCT02939716|4033786|FG003|NOT COMPLETED|Overall Study||1
3299940|NCT02939716|4033787|FG004|NOT COMPLETED|Overall Study||1
3299941|NCT02939716|4033788|FG005|NOT COMPLETED|Overall Study||1
3299942|NCT02939781|4033805|FG000|STARTED|Overall Study||12
3299943|NCT02939781|4033805|FG000|COMPLETED|Overall Study||3
3299944|NCT02939781|4033805|FG000|NOT COMPLETED|Overall Study||9
3299945|NCT02939937|4033812|FG000|STARTED|Overall Study|5 patients had drug reaction and 1 patient excluded from study,|21
3299946|NCT02939937|4033813|FG001|STARTED|Overall Study|3 patients excluded from study|50
3299947|NCT02939937|4033812|FG000|COMPLETED|Overall Study||15
3299948|NCT02939937|4033813|FG001|COMPLETED|Overall Study||47
3299949|NCT02939937|4033812|FG000|NOT COMPLETED|Overall Study||6
3299950|NCT02939937|4033813|FG001|NOT COMPLETED|Overall Study||3
3299951|NCT02939950|4033821|FG000|STARTED|Overall Study||406
3299952|NCT02939950|4033822|FG001|STARTED|Overall Study||410
3132502|NCT01691482|3857560|FG001|NOT COMPLETED|Treatment Period 1||0
3299953|NCT02939950|4033821|FG000|Dispensed the Assigned Lenses|Overall Study||405
3299954|NCT02939950|4033822|FG001|Dispensed the Assigned Lenses|Overall Study||410
3299955|NCT02939950|4033821|FG000|Eligible at Baseline|Overall Study||403
3299956|NCT02939950|4033822|FG001|Eligible at Baseline|Overall Study||402
3299957|NCT02939950|4033821|FG000|COMPLETED|Overall Study||340
3299958|NCT02939950|4033822|FG001|COMPLETED|Overall Study||329
3299959|NCT02939950|4033821|FG000|NOT COMPLETED|Overall Study||66
3299960|NCT02939950|4033822|FG001|NOT COMPLETED|Overall Study||81
3299961|NCT02940249|4033828|FG000|STARTED|Overall Study||34
3299962|NCT02940249|4033828|FG000|COMPLETED|Overall Study||30
3299963|NCT02940249|4033828|FG000|NOT COMPLETED|Overall Study||4
3299964|NCT02940327|4033838|FG000|STARTED|Overall Study||24
3299965|NCT02940327|4033838|FG000|COMPLETED|Overall Study||24
3299966|NCT02940327|4033838|FG000|NOT COMPLETED|Overall Study||0
3299967|NCT02940392|4033843|FG000|STARTED|Overall Study||15
3299968|NCT02940392|4033843|FG000|COMPLETED|Overall Study||7
3299969|NCT02940392|4033843|FG000|NOT COMPLETED|Overall Study||8
2950388|NCT00697788|3664177|FG001|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
2950389|NCT00697788|3664178|FG002|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
2950390|NCT00697788|3664179|FG003|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
2950391|NCT00697788|3664180|FG004|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
2950392|NCT00697788|3664181|FG005|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
2950393|NCT00697788|3664182|FG006|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
2950394|NCT00697788|3664183|FG007|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
2950395|NCT00697801|3664213|FG000|STARTED|Overall Study||69
2950396|NCT00697801|3664214|FG001|STARTED|Overall Study||70
2950397|NCT00697801|3664215|FG002|STARTED|Overall Study||69
2950398|NCT00697801|3664213|FG000|COMPLETED|Overall Study||57
2950399|NCT00697801|3664214|FG001|COMPLETED|Overall Study||58
2950400|NCT00697801|3664215|FG002|COMPLETED|Overall Study||45
2950401|NCT00697801|3664213|FG000|NOT COMPLETED|Overall Study||12
2950402|NCT00697801|3664214|FG001|NOT COMPLETED|Overall Study||12
2950403|NCT00697801|3664215|FG002|NOT COMPLETED|Overall Study||24
2950404|NCT00697827|3664225|FG000|STARTED|Overall Study||28
2950405|NCT00697827|3664226|FG001|STARTED|Overall Study||16
2950406|NCT00697827|3664225|FG000|COMPLETED|Overall Study||26
2950407|NCT00697827|3664226|FG001|COMPLETED|Overall Study||15
2950408|NCT00697827|3664225|FG000|NOT COMPLETED|Overall Study||2
2950409|NCT00697827|3664226|FG001|NOT COMPLETED|Overall Study||1
2950410|NCT00698035|3664234|FG000|STARTED|Overall Study||39
2950411|NCT00698035|3664235|FG001|STARTED|Overall Study||36
2950412|NCT00698035|3664234|FG000|COMPLETED|Overall Study||35
2950413|NCT00698035|3664235|FG001|COMPLETED|Overall Study||34
2950414|NCT00698035|3664234|FG000|NOT COMPLETED|Overall Study||4
2950415|NCT00698035|3664235|FG001|NOT COMPLETED|Overall Study||2
2950416|NCT00698139|3664247|FG000|STARTED|Overall Study||1
2950417|NCT00698139|3664248|FG001|STARTED|Overall Study||1
2950418|NCT00698139|3664249|FG002|STARTED|Overall Study||1
2950419|NCT00698139|3664247|FG000|2nd Visit|Overall Study||1
2950420|NCT00698139|3664248|FG001|2nd Visit|Overall Study||1
2950421|NCT00698139|3664249|FG002|2nd Visit|Overall Study|1 subject in the Intervention Group did not have a 2nd visit (per design).|0
2950422|NCT00698139|3664247|FG000|COMPLETED|Overall Study||1
2950423|NCT00698139|3664248|FG001|COMPLETED|Overall Study||1
2950424|NCT00698139|3664249|FG002|COMPLETED|Overall Study||1
2950425|NCT00698139|3664247|FG000|NOT COMPLETED|Overall Study||0
2950426|NCT00698139|3664248|FG001|NOT COMPLETED|Overall Study||0
2950427|NCT00698139|3664249|FG002|NOT COMPLETED|Overall Study||0
2950428|NCT00698204|3664259|FG000|STARTED|Overall Study||20
2950429|NCT00698204|3664260|FG001|STARTED|Overall Study||20
2950430|NCT00698204|3664259|FG000|COMPLETED|Overall Study||19
2950431|NCT00698204|3664260|FG001|COMPLETED|Overall Study||20
2950432|NCT00698204|3664259|FG000|NOT COMPLETED|Overall Study||1
2950433|NCT00698204|3664260|FG001|NOT COMPLETED|Overall Study||0
2950434|NCT00698451|3664268|FG000|STARTED|Overall Study||54
2950435|NCT00698451|3664268|FG000|COMPLETED|Overall Study||15
2950436|NCT00698451|3664268|FG000|NOT COMPLETED|Overall Study||39
2950437|NCT00698516|3664272|FG000|STARTED|Overall Study||50
2950438|NCT00698516|3664272|FG000|COMPLETED|Overall Study||45
2950439|NCT00698516|3664272|FG000|NOT COMPLETED|Overall Study||5
2950440|NCT00698581|3664282|FG000|STARTED|Overall Study||68
2950441|NCT00698581|3664283|FG001|STARTED|Overall Study||20
2950442|NCT00698581|3664282|FG000|COMPLETED|Overall Study||23
2950443|NCT00698581|3664283|FG001|COMPLETED|Overall Study||8
2950444|NCT00698581|3664282|FG000|NOT COMPLETED|Overall Study||45
2950445|NCT00698581|3664283|FG001|NOT COMPLETED|Overall Study||12
2950446|NCT00698646|3664293|FG000|STARTED|Overall Study||128
2950447|NCT00698646|3664294|FG001|STARTED|Overall Study||128
2950448|NCT00698646|3664295|FG002|STARTED|Overall Study||128
2950449|NCT00698646|3664293|FG000|COMPLETED|Overall Study||92
2950450|NCT00698646|3664294|FG001|COMPLETED|Overall Study||97
2950451|NCT00698646|3664295|FG002|COMPLETED|Overall Study||99
2950452|NCT00698646|3664293|FG000|NOT COMPLETED|Overall Study||36
2950453|NCT00698646|3664294|FG001|NOT COMPLETED|Overall Study||31
2950454|NCT00698646|3664295|FG002|NOT COMPLETED|Overall Study||29
2950455|NCT00698685|3664303|FG000|STARTED|Overall Study||14
2950456|NCT00698685|3664303|FG000|COMPLETED|Overall Study||12
2950457|NCT00698685|3664303|FG000|NOT COMPLETED|Overall Study||2
2950458|NCT00698841|3664307|FG000|STARTED|Overall Study||51
2950459|NCT00698841|3664307|FG000|COMPLETED|Overall Study||33
2950460|NCT00698841|3664307|FG000|NOT COMPLETED|Overall Study||18
2950461|NCT00698867|3664311|FG000|STARTED|Overall Study||118
2950462|NCT00698867|3664311|FG000|Subjects With 1 Year Data|Overall Study||68
2950463|NCT00698867|3664311|FG000|Subjects With 2 Year Data|Overall Study||55
2950464|NCT00698867|3664311|FG000|Subjects With 3 Year Data|Overall Study||35
2950465|NCT00698867|3664311|FG000|Subjects With 4 Year Data|Overall Study||34
2950466|NCT00698867|3664311|FG000|COMPLETED|Overall Study||27
2950467|NCT00698867|3664311|FG000|NOT COMPLETED|Overall Study||91
2950468|NCT00698932|3664317|FG000|STARTED|Overall Study|Randomized and treated|284
2950469|NCT00698932|3664318|FG001|STARTED|Overall Study|Randomized and treated|284
2950470|NCT00698932|3664317|FG000|COMPLETED|Overall Study|Completed 24 Weeks of treatment|262
2950471|NCT00698932|3664318|FG001|COMPLETED|Overall Study|Completed 24 Weeks of treatment|248
2950472|NCT00698932|3664317|FG000|NOT COMPLETED|Overall Study||22
2950473|NCT00698932|3664318|FG001|NOT COMPLETED|Overall Study||36
2950474|NCT00698997|3664326|FG000|STARTED|Overall Study|1 enrollment|55
2950475|NCT00698997|3664327|FG001|STARTED|Overall Study|1 enrollment|63
2950476|NCT00698997|3664326|FG000|COMPLETED|Overall Study|45 - final participant assessment completed|45
2950477|NCT00698997|3664327|FG001|COMPLETED|Overall Study|36 - final assessment completed|36
2950478|NCT00698997|3664326|FG000|NOT COMPLETED|Overall Study||10
2950479|NCT00698997|3664327|FG001|NOT COMPLETED|Overall Study||27
2950480|NCT00699010|3664336|FG000|STARTED|Overall Study||15
2950481|NCT00699010|3664337|FG001|STARTED|Overall Study||15
2950482|NCT00699010|3664336|FG000|COMPLETED|Overall Study||15
3299970|NCT02940522|4033849|FG000|STARTED|Overall Study||59
3299971|NCT02940522|4033850|FG001|STARTED|Overall Study||61
3299972|NCT02940522|4033849|FG000|COMPLETED|Overall Study||57
3299973|NCT02940522|4033850|FG001|COMPLETED|Overall Study||59
3299974|NCT02940522|4033849|FG000|NOT COMPLETED|Overall Study||2
3299975|NCT02940522|4033850|FG001|NOT COMPLETED|Overall Study||2
3299976|NCT02940574|4033858|FG000|STARTED|From Study Start to 1-month Follow-up||22
3299977|NCT02940574|4033859|FG001|STARTED|From Study Start to 1-month Follow-up||18
3299978|NCT02940574|4033858|FG000|COMPLETED|From Study Start to 1-month Follow-up|Discontinued intervention (N=1): self-termination unrelated to treatment|21
3299979|NCT02940574|4033859|FG001|COMPLETED|From Study Start to 1-month Follow-up|All participants completed, but data from 1 participant was not included in analyses.|18
3299980|NCT02940574|4033858|FG000|NOT COMPLETED|From Study Start to 1-month Follow-up||1
3299981|NCT02940574|4033859|FG001|NOT COMPLETED|From Study Start to 1-month Follow-up||0
3299982|NCT02940574|4033858|FG000|STARTED|1-year Follow-up||21
3299983|NCT02940574|4033859|FG001|STARTED|1-year Follow-up||18
3299984|NCT02940574|4033858|FG000|COMPLETED|1-year Follow-up||18
3299985|NCT02940574|4033859|FG001|COMPLETED|1-year Follow-up||14
3299986|NCT02940574|4033858|FG000|NOT COMPLETED|1-year Follow-up||3
3299987|NCT02940574|4033859|FG001|NOT COMPLETED|1-year Follow-up||4
3299988|NCT02940626|4033871|FG000|STARTED|Overall Study||77
3299989|NCT02940626|4033872|FG001|STARTED|Overall Study||78
3299990|NCT02940626|4033871|FG000|Randomized Into Primary Prevention Study|Overall Study||77
3299991|NCT02940626|4033872|FG001|Randomized Into Primary Prevention Study|Overall Study||77
3299992|NCT02940626|4033871|FG000|Randomized Into Treatment Sub-study|Overall Study||0
3299993|NCT02940626|4033872|FG001|Randomized Into Treatment Sub-study|Overall Study||1
3299994|NCT02940626|4033871|FG000|Received Study Treatment|Overall Study||77
3299995|NCT02940626|4033872|FG001|Received Study Treatment|Overall Study||77
3299996|NCT02940626|4033871|FG000|Completed Through Study Day 22|Overall Study||42
3299997|NCT02940626|4033872|FG001|Completed Through Study Day 22|Overall Study||49
3299998|NCT02940626|4033871|FG000|COMPLETED|Overall Study||30
3299999|NCT02940626|4033872|FG001|COMPLETED|Overall Study||43
3300000|NCT02940626|4033871|FG000|NOT COMPLETED|Overall Study||47
3300001|NCT02940626|4033872|FG001|NOT COMPLETED|Overall Study||35
3300002|NCT02940691|4033880|FG000|STARTED|Overall Study||32
3300003|NCT02940691|4033880|FG000|COMPLETED|Overall Study||26
3300004|NCT02940691|4033880|FG000|NOT COMPLETED|Overall Study||6
3300005|NCT02940730|4033887|FG000|STARTED|Intervention 1||10
3300006|NCT02940730|4033888|FG001|STARTED|Intervention 1||0
3300007|NCT02940730|4033887|FG000|Received Intervention|Intervention 1||10
3300008|NCT02940730|4033888|FG001|Received Intervention|Intervention 1||0
3300009|NCT02940730|4033887|FG000|COMPLETED|Intervention 1||10
3300010|NCT02940730|4033888|FG001|COMPLETED|Intervention 1||0
3300011|NCT02940730|4033887|FG000|NOT COMPLETED|Intervention 1||0
3300012|NCT02940730|4033888|FG001|NOT COMPLETED|Intervention 1||0
3300013|NCT02940730|4033887|FG000|STARTED|Intervention 2||10
3300014|NCT02940730|4033888|FG001|STARTED|Intervention 2||0
3300015|NCT02940730|4033887|FG000|Received Intervention|Intervention 2||3
3300016|NCT02940730|4033888|FG001|Received Intervention|Intervention 2||0
3300017|NCT02940730|4033887|FG000|COMPLETED|Intervention 2||3
3300018|NCT02940730|4033888|FG001|COMPLETED|Intervention 2||0
3300019|NCT02940730|4033887|FG000|NOT COMPLETED|Intervention 2||7
3300020|NCT02940730|4033888|FG001|NOT COMPLETED|Intervention 2||0
3300021|NCT02940860|4033896|FG000|STARTED|Overall Study||1027
3300022|NCT02940860|4033897|FG001|STARTED|Overall Study||511
3300023|NCT02940860|4033896|FG000|COMPLETED|Overall Study||971
3300024|NCT02940860|4033897|FG001|COMPLETED|Overall Study||476
3300025|NCT02940860|4033896|FG000|NOT COMPLETED|Overall Study||56
3300026|NCT02940860|4033897|FG001|NOT COMPLETED|Overall Study||35
3300027|NCT02940886|4033907|FG000|STARTED|Overall Study|Intention-to-treat analysis set included 1009 subjects, safety analysis set included 989 subjects.|1009
3300028|NCT02940886|4033908|FG001|STARTED|Overall Study|Intention-to-treat analysis set included 503 subjects, safety analysis set included 494 subjects.|503
3300029|NCT02940886|4033907|FG000|Safety Analysis Set|Overall Study||989
3300030|NCT02940886|4033908|FG001|Safety Analysis Set|Overall Study||494
3300031|NCT02940886|4033907|FG000|COMPLETED|Overall Study||907
3300032|NCT02940886|4033908|FG001|COMPLETED|Overall Study||449
3300033|NCT02940886|4033907|FG000|NOT COMPLETED|Overall Study||102
3300034|NCT02940886|4033908|FG001|NOT COMPLETED|Overall Study||54
3300035|NCT02941523|4033918|FG000|STARTED|Monotherapy|8 received NOX66 400 mg monotherapy and combination therapy with carboplatin.|8
2950483|NCT00699010|3664337|FG001|COMPLETED|Overall Study||15
3300036|NCT02941523|4033919|FG001|STARTED|Monotherapy||8
3300037|NCT02941523|4033918|FG000|COMPLETED|Monotherapy||8
3300038|NCT02941523|4033919|FG001|COMPLETED|Monotherapy||7
3300039|NCT02941523|4033918|FG000|NOT COMPLETED|Monotherapy||0
3300040|NCT02941523|4033919|FG001|NOT COMPLETED|Monotherapy||1
3300041|NCT02941523|4033918|FG000|STARTED|Carboplatin Combination Therapy|All continued to combination therapy|8
3300042|NCT02941523|4033919|FG001|STARTED|Carboplatin Combination Therapy|7 continued to combination therapy; 3 started combination therapy only|10
3300043|NCT02941523|4033918|FG000|COMPLETED|Carboplatin Combination Therapy||3
2950484|NCT00699010|3664336|FG000|NOT COMPLETED|Overall Study||0
2950485|NCT00699010|3664337|FG001|NOT COMPLETED|Overall Study||0
3300044|NCT02941523|4033919|FG001|COMPLETED|Carboplatin Combination Therapy||6
3300045|NCT02941523|4033918|FG000|NOT COMPLETED|Carboplatin Combination Therapy||5
3300046|NCT02941523|4033919|FG001|NOT COMPLETED|Carboplatin Combination Therapy||4
3300047|NCT02941614|4033935|FG000|STARTED|Overall Study||744
3300048|NCT02941614|4033936|FG001|STARTED|Overall Study||692
3300049|NCT02941614|4033935|FG000|COMPLETED|Overall Study||603
3300050|NCT02941614|4033936|FG001|COMPLETED|Overall Study||446
3300051|NCT02941614|4033935|FG000|NOT COMPLETED|Overall Study||141
3300052|NCT02941614|4033936|FG001|NOT COMPLETED|Overall Study||246
3300053|NCT02941627|4033944|FG000|STARTED|Overall Study|Among 53 patients enrolled: 1 passed away after the informed consent completion, 1 was not implanted for surgical failure, and 1 for cholesteatoma discovered during surgical procedure. This last patient was included in safety analysis as defined in the protocol. Therefore, among 53 patients enrolled 51 were evaluated for safety outcomes, and 50 were successfully implanted and complete the study.|53
3300054|NCT02941627|4033944|FG000|Clinical Safety on Overall Participants|Overall Study||51
3300055|NCT02941627|4033944|FG000|Clinical Efficiency on English Speaking Participants|Overall Study|Among the 50 patients successfully implanted 33 English speaking participant complete speech performance measure.|33
3300056|NCT02941627|4033944|FG000|COMPLETED|Overall Study||50
3300057|NCT02941627|4033944|FG000|NOT COMPLETED|Overall Study||3
3300058|NCT02941640|4033958|FG000|STARTED|Overall Study||30
3300059|NCT02941640|4033959|FG001|STARTED|Overall Study||30
3300060|NCT02941640|4033960|FG002|STARTED|Overall Study||30
3300061|NCT02941640|4033961|FG003|STARTED|Overall Study||30
3300062|NCT02941640|4033958|FG000|COMPLETED|Overall Study||30
3300063|NCT02941640|4033959|FG001|COMPLETED|Overall Study||30
3300064|NCT02941640|4033960|FG002|COMPLETED|Overall Study||30
3300065|NCT02941640|4033961|FG003|COMPLETED|Overall Study||30
3300066|NCT02941640|4033958|FG000|NOT COMPLETED|Overall Study||0
3300067|NCT02941640|4033959|FG001|NOT COMPLETED|Overall Study||0
3300068|NCT02941640|4033960|FG002|NOT COMPLETED|Overall Study||0
3300069|NCT02941640|4033961|FG003|NOT COMPLETED|Overall Study||0
3300070|NCT02941692|4033973|FG000|STARTED|Overall Study||32
3300071|NCT02941692|4033974|FG001|STARTED|Overall Study||34
3300072|NCT02941692|4033973|FG000|COMPLETED|Overall Study||32
3300073|NCT02941692|4033974|FG001|COMPLETED|Overall Study||34
3300074|NCT02941692|4033973|FG000|NOT COMPLETED|Overall Study||0
3300075|NCT02941692|4033974|FG001|NOT COMPLETED|Overall Study||0
3300076|NCT02942160|4033980|FG000|STARTED|Overall Study|Observation Phase prior to open-label treatment phase|259
3300077|NCT02942160|4033980|FG000|EN3835-202 Participants|Overall Study|Observation Phase Completed|222
3300078|NCT02942160|4033980|FG000|EN3835 Treated Subjects in EN3835-202|Overall Study|EN3835 Treated Participants in EN3835-202 Started|200
3300079|NCT02942160|4033980|FG000|COMPLETED|Overall Study|EN3835 Treated Participants in EN3835-202 Completed|156
3300080|NCT02942160|4033980|FG000|NOT COMPLETED|Overall Study||103
3300081|NCT02942264|4033997|FG000|STARTED|Phase 1 MTD Finding Stage||6
3300082|NCT02942264|4033998|FG001|STARTED|Phase 1 MTD Finding Stage||13
3300083|NCT02942264|4033999|FG002|STARTED|Phase 1 MTD Finding Stage||3
3300084|NCT02942264|4034000|FG003|STARTED|Phase 1 MTD Finding Stage||6
3300085|NCT02942264|4034001|FG004|STARTED|Phase 1 MTD Finding Stage||3
3300086|NCT02942264|4034002|FG005|STARTED|Phase 1 MTD Finding Stage||2
3300087|NCT02942264|4034003|FG006|STARTED|Phase 1 MTD Finding Stage||7
3300088|NCT02942264|4034004|FG007|STARTED|Phase 1 MTD Finding Stage||0
3300089|NCT02942264|4034005|FG008|STARTED|Phase 1 MTD Finding Stage||0
3300090|NCT02942264|4033997|FG000|COMPLETED|Phase 1 MTD Finding Stage||6
3300091|NCT02942264|4033998|FG001|COMPLETED|Phase 1 MTD Finding Stage||12
3300092|NCT02942264|4033999|FG002|COMPLETED|Phase 1 MTD Finding Stage||3
3300093|NCT02942264|4034000|FG003|COMPLETED|Phase 1 MTD Finding Stage||6
3300094|NCT02942264|4034001|FG004|COMPLETED|Phase 1 MTD Finding Stage||3
3300095|NCT02942264|4034002|FG005|COMPLETED|Phase 1 MTD Finding Stage||2
3300096|NCT02942264|4034003|FG006|COMPLETED|Phase 1 MTD Finding Stage||6
3300097|NCT02942264|4034004|FG007|COMPLETED|Phase 1 MTD Finding Stage||0
3300098|NCT02942264|4034005|FG008|COMPLETED|Phase 1 MTD Finding Stage||0
3300099|NCT02942264|4033997|FG000|NOT COMPLETED|Phase 1 MTD Finding Stage||0
3300100|NCT02942264|4033998|FG001|NOT COMPLETED|Phase 1 MTD Finding Stage||1
3300101|NCT02942264|4033999|FG002|NOT COMPLETED|Phase 1 MTD Finding Stage||0
3300102|NCT02942264|4034000|FG003|NOT COMPLETED|Phase 1 MTD Finding Stage||0
3300103|NCT02942264|4034001|FG004|NOT COMPLETED|Phase 1 MTD Finding Stage||0
3300104|NCT02942264|4034002|FG005|NOT COMPLETED|Phase 1 MTD Finding Stage||0
3300105|NCT02942264|4034003|FG006|NOT COMPLETED|Phase 1 MTD Finding Stage||1
3300106|NCT02942264|4034004|FG007|NOT COMPLETED|Phase 1 MTD Finding Stage||0
3300107|NCT02942264|4034005|FG008|NOT COMPLETED|Phase 1 MTD Finding Stage||0
3300108|NCT02942264|4033997|FG000|STARTED|Phase 1 Cohort Expansion Stage||0
3300109|NCT02942264|4033998|FG001|STARTED|Phase 1 Cohort Expansion Stage||0
3300110|NCT02942264|4033999|FG002|STARTED|Phase 1 Cohort Expansion Stage||0
3300111|NCT02942264|4034000|FG003|STARTED|Phase 1 Cohort Expansion Stage||0
3300112|NCT02942264|4034001|FG004|STARTED|Phase 1 Cohort Expansion Stage||0
3300113|NCT02942264|4034002|FG005|STARTED|Phase 1 Cohort Expansion Stage||0
3300114|NCT02942264|4034003|FG006|STARTED|Phase 1 Cohort Expansion Stage||0
3300115|NCT02942264|4034004|FG007|STARTED|Phase 1 Cohort Expansion Stage||6
3300116|NCT02942264|4034005|FG008|STARTED|Phase 1 Cohort Expansion Stage||7
3300117|NCT02942264|4033997|FG000|COMPLETED|Phase 1 Cohort Expansion Stage||0
3300118|NCT02942264|4033998|FG001|COMPLETED|Phase 1 Cohort Expansion Stage||0
3300119|NCT02942264|4033999|FG002|COMPLETED|Phase 1 Cohort Expansion Stage||0
2950486|NCT00699140|3664343|FG000|STARTED|Overall Study||18
2950487|NCT00699140|3664343|FG000|COMPLETED|Overall Study||18
2950488|NCT00699140|3664343|FG000|NOT COMPLETED|Overall Study||0
3300120|NCT02942264|4034000|FG003|COMPLETED|Phase 1 Cohort Expansion Stage||0
3300121|NCT02942264|4034001|FG004|COMPLETED|Phase 1 Cohort Expansion Stage||0
3300122|NCT02942264|4034002|FG005|COMPLETED|Phase 1 Cohort Expansion Stage||0
3300123|NCT02942264|4034003|FG006|COMPLETED|Phase 1 Cohort Expansion Stage||0
3300124|NCT02942264|4034004|FG007|COMPLETED|Phase 1 Cohort Expansion Stage||6
3300125|NCT02942264|4034005|FG008|COMPLETED|Phase 1 Cohort Expansion Stage||6
3300126|NCT02942264|4033997|FG000|NOT COMPLETED|Phase 1 Cohort Expansion Stage||0
3300127|NCT02942264|4033998|FG001|NOT COMPLETED|Phase 1 Cohort Expansion Stage||0
3300128|NCT02942264|4033999|FG002|NOT COMPLETED|Phase 1 Cohort Expansion Stage||0
3300129|NCT02942264|4034000|FG003|NOT COMPLETED|Phase 1 Cohort Expansion Stage||0
3300130|NCT02942264|4034001|FG004|NOT COMPLETED|Phase 1 Cohort Expansion Stage||0
3300131|NCT02942264|4034002|FG005|NOT COMPLETED|Phase 1 Cohort Expansion Stage||0
3300132|NCT02942264|4034003|FG006|NOT COMPLETED|Phase 1 Cohort Expansion Stage||0
3300133|NCT02942264|4034004|FG007|NOT COMPLETED|Phase 1 Cohort Expansion Stage||0
3300134|NCT02942264|4034005|FG008|NOT COMPLETED|Phase 1 Cohort Expansion Stage||1
3300135|NCT02942407|4034032|FG000|STARTED|Overall Study||82
3300136|NCT02942407|4034033|FG001|STARTED|Overall Study||72
3300137|NCT02942407|4034032|FG000|COMPLETED|Overall Study||56
3300138|NCT02942407|4034033|FG001|COMPLETED|Overall Study||48
3300139|NCT02942407|4034032|FG000|NOT COMPLETED|Overall Study||26
3300140|NCT02942407|4034033|FG001|NOT COMPLETED|Overall Study||24
3300141|NCT02942485|4034049|FG000|STARTED|Overall Study||7
3300142|NCT02942485|4034050|FG001|STARTED|Overall Study||1
3300143|NCT02942485|4034049|FG000|COMPLETED|Overall Study||6
3300144|NCT02942485|4034050|FG001|COMPLETED|Overall Study||1
3300145|NCT02942485|4034049|FG000|NOT COMPLETED|Overall Study||1
3300146|NCT02942485|4034050|FG001|NOT COMPLETED|Overall Study||0
3300147|NCT02942576|4034058|FG000|STARTED|Overall Study||405
3300148|NCT02942576|4034059|FG001|STARTED|Overall Study||197
3300149|NCT02942576|4034058|FG000|COMPLETED|Overall Study||359
3300150|NCT02942576|4034059|FG001|COMPLETED|Overall Study||174
3300151|NCT02942576|4034058|FG000|NOT COMPLETED|Overall Study||46
3300152|NCT02942576|4034059|FG001|NOT COMPLETED|Overall Study||23
3300153|NCT02942654|4034065|FG000|STARTED|Period 1||16
3300154|NCT02942654|4034066|FG001|STARTED|Period 1||16
3300155|NCT02942654|4034065|FG000|Received at Least 1 Dose of Study Drug|Period 1||16
3300156|NCT02942654|4034066|FG001|Received at Least 1 Dose of Study Drug|Period 1||16
3300157|NCT02942654|4034065|FG000|COMPLETED|Period 1||16
3300158|NCT02942654|4034066|FG001|COMPLETED|Period 1||16
3300159|NCT02942654|4034065|FG000|NOT COMPLETED|Period 1||0
3300160|NCT02942654|4034066|FG001|NOT COMPLETED|Period 1||0
3300161|NCT02942654|4034065|FG000|STARTED|Washout||16
3300162|NCT02942654|4034066|FG001|STARTED|Washout||16
3300163|NCT02942654|4034065|FG000|COMPLETED|Washout||16
3300164|NCT02942654|4034066|FG001|COMPLETED|Washout||16
3300165|NCT02942654|4034065|FG000|NOT COMPLETED|Washout||0
3300166|NCT02942654|4034066|FG001|NOT COMPLETED|Washout||0
3300167|NCT02942654|4034065|FG000|STARTED|Period 2||16
3300168|NCT02942654|4034066|FG001|STARTED|Period 2||16
3300169|NCT02942654|4034065|FG000|COMPLETED|Period 2||16
3300170|NCT02942654|4034066|FG001|COMPLETED|Period 2||16
3300171|NCT02942654|4034065|FG000|NOT COMPLETED|Period 2||0
3300172|NCT02942654|4034066|FG001|NOT COMPLETED|Period 2||0
3300173|NCT02942771|4034077|FG000|STARTED|Overall Study||9
3300174|NCT02942771|4034078|FG001|STARTED|Overall Study||6
3300175|NCT02942771|4034079|FG002|STARTED|Overall Study||6
3300176|NCT02942771|4034080|FG003|STARTED|Overall Study||6
3300177|NCT02942771|4034081|FG004|STARTED|Overall Study||8
3300178|NCT02942771|4034077|FG000|COMPLETED|Overall Study||6
3300179|NCT02942771|4034078|FG001|COMPLETED|Overall Study||6
3300180|NCT02942771|4034079|FG002|COMPLETED|Overall Study||6
3300181|NCT02942771|4034080|FG003|COMPLETED|Overall Study||6
3300182|NCT02942771|4034081|FG004|COMPLETED|Overall Study||4
3300183|NCT02942771|4034077|FG000|NOT COMPLETED|Overall Study||3
3300184|NCT02942771|4034078|FG001|NOT COMPLETED|Overall Study||0
3300185|NCT02942771|4034079|FG002|NOT COMPLETED|Overall Study||0
3300186|NCT02942771|4034080|FG003|NOT COMPLETED|Overall Study||0
3300187|NCT02942771|4034081|FG004|NOT COMPLETED|Overall Study||4
3300188|NCT02942979|4034095|FG000|STARTED|Step 0||108
3300189|NCT02942979|4034096|FG001|STARTED|Step 0||0
3300190|NCT02942979|4034095|FG000|COMPLETED|Step 0||108
3300191|NCT02942979|4034096|FG001|COMPLETED|Step 0|This is a stepped wedge design - all participants received both MISSION Implementation as Usual and Facilitation|0
3300192|NCT02942979|4034095|FG000|NOT COMPLETED|Step 0||0
3300193|NCT02942979|4034096|FG001|NOT COMPLETED|Step 0||0
3300194|NCT02942979|4034095|FG000|STARTED|Step 1||15
3300195|NCT02942979|4034096|FG001|STARTED|Step 1||93
3300196|NCT02942979|4034095|FG000|COMPLETED|Step 1||15
3300197|NCT02942979|4034096|FG001|COMPLETED|Step 1||93
3300198|NCT02942979|4034095|FG000|NOT COMPLETED|Step 1||0
3300199|NCT02942979|4034096|FG001|NOT COMPLETED|Step 1||0
3300200|NCT02942979|4034095|FG000|STARTED|Step 2||0
3300201|NCT02942979|4034096|FG001|STARTED|Step 2||108
3300202|NCT02942979|4034095|FG000|COMPLETED|Step 2||0
3300203|NCT02942979|4034096|FG001|COMPLETED|Step 2||108
3300204|NCT02942979|4034095|FG000|NOT COMPLETED|Step 2||0
3300205|NCT02942979|4034096|FG001|NOT COMPLETED|Step 2||0
3300206|NCT02943070|4034102|FG000|STARTED|Overall Study||50
3300207|NCT02943070|4034102|FG000|COMPLETED|Overall Study||7
3300208|NCT02943070|4034102|FG000|NOT COMPLETED|Overall Study||43
3300209|NCT02943096|4034115|FG000|STARTED|Overall Study||3
3300210|NCT02943096|4034116|FG001|STARTED|Overall Study||3
3300211|NCT02943096|4034115|FG000|COMPLETED|Overall Study||3
3300212|NCT02943096|4034116|FG001|COMPLETED|Overall Study||2
3300213|NCT02943096|4034115|FG000|NOT COMPLETED|Overall Study||0
3300214|NCT02943096|4034116|FG001|NOT COMPLETED|Overall Study||1
3300215|NCT02943213|4034122|FG000|STARTED|Treatment Period 1||20
3300216|NCT02943213|4034122|FG000|COMPLETED|Treatment Period 1||20
3300217|NCT02943213|4034122|FG000|NOT COMPLETED|Treatment Period 1||0
3300218|NCT02943213|4034122|FG000|STARTED|Treatment Period 2||20
3300219|NCT02943213|4034122|FG000|COMPLETED|Treatment Period 2||20
3300220|NCT02943213|4034122|FG000|NOT COMPLETED|Treatment Period 2||0
3300221|NCT02943226|4034130|FG000|STARTED|Overall Study||31
3300222|NCT02943226|4034131|FG001|STARTED|Overall Study||30
3300223|NCT02943226|4034130|FG000|COMPLETED|Overall Study||31
3300224|NCT02943226|4034131|FG001|COMPLETED|Overall Study||30
3300225|NCT02943226|4034130|FG000|NOT COMPLETED|Overall Study||0
3300226|NCT02943226|4034131|FG001|NOT COMPLETED|Overall Study||0
3300227|NCT02943447|4034140|FG000|STARTED|Blinded Study Phase||28
3300228|NCT02943447|4034141|FG001|STARTED|Blinded Study Phase||30
3300229|NCT02943447|4034142|FG002|STARTED|Blinded Study Phase||13
3300230|NCT02943447|4034140|FG000|COMPLETED|Blinded Study Phase||23
3300231|NCT02943447|4034141|FG001|COMPLETED|Blinded Study Phase||28
3300232|NCT02943447|4034142|FG002|COMPLETED|Blinded Study Phase||12
3300233|NCT02943447|4034140|FG000|NOT COMPLETED|Blinded Study Phase||5
3300234|NCT02943447|4034141|FG001|NOT COMPLETED|Blinded Study Phase||2
3300235|NCT02943447|4034142|FG002|NOT COMPLETED|Blinded Study Phase||1
3300236|NCT02943447|4034140|FG000|STARTED|Open-Label Extension Phase||23
3300237|NCT02943447|4034141|FG001|STARTED|Open-Label Extension Phase||28
3300238|NCT02943447|4034142|FG002|STARTED|Open-Label Extension Phase||12
3300239|NCT02943447|4034140|FG000|COMPLETED|Open-Label Extension Phase||5
3300240|NCT02943447|4034141|FG001|COMPLETED|Open-Label Extension Phase||3
3300241|NCT02943447|4034142|FG002|COMPLETED|Open-Label Extension Phase||2
3300242|NCT02943447|4034140|FG000|NOT COMPLETED|Open-Label Extension Phase||18
3300243|NCT02943447|4034141|FG001|NOT COMPLETED|Open-Label Extension Phase||25
3300244|NCT02943447|4034142|FG002|NOT COMPLETED|Open-Label Extension Phase||10
3300245|NCT02943460|4034162|FG000|STARTED|Blinded Study Phase||22
3300246|NCT02943460|4034163|FG001|STARTED|Blinded Study Phase||20
3300247|NCT02943460|4034164|FG002|STARTED|Blinded Study Phase||10
3300248|NCT02943460|4034162|FG000|COMPLETED|Blinded Study Phase||19
3300249|NCT02943460|4034163|FG001|COMPLETED|Blinded Study Phase||19
3300250|NCT02943460|4034164|FG002|COMPLETED|Blinded Study Phase||10
3300251|NCT02943460|4034162|FG000|NOT COMPLETED|Blinded Study Phase||3
3300252|NCT02943460|4034163|FG001|NOT COMPLETED|Blinded Study Phase||1
3300253|NCT02943460|4034164|FG002|NOT COMPLETED|Blinded Study Phase||0
3300254|NCT02943460|4034162|FG000|STARTED|Open Label Extension (OLE) Phase||19
3300255|NCT02943460|4034163|FG001|STARTED|Open Label Extension (OLE) Phase|1 participant completed the Blinded Study Phase, but did not continue in the OLE Phase.|18
3300256|NCT02943460|4034164|FG002|STARTED|Open Label Extension (OLE) Phase||10
3300257|NCT02943460|4034162|FG000|COMPLETED|Open Label Extension (OLE) Phase||14
3300258|NCT02943460|4034163|FG001|COMPLETED|Open Label Extension (OLE) Phase||11
3300259|NCT02943460|4034164|FG002|COMPLETED|Open Label Extension (OLE) Phase||8
3300260|NCT02943460|4034162|FG000|NOT COMPLETED|Open Label Extension (OLE) Phase||5
3300261|NCT02943460|4034163|FG001|NOT COMPLETED|Open Label Extension (OLE) Phase||7
3300262|NCT02943460|4034164|FG002|NOT COMPLETED|Open Label Extension (OLE) Phase||2
3300263|NCT02943473|4034173|FG000|STARTED|Overall Study||9
3300264|NCT02943473|4034173|FG000|COMPLETED|Overall Study||3
3300265|NCT02943473|4034173|FG000|NOT COMPLETED|Overall Study||6
3300266|NCT02943499|4034179|FG000|STARTED|Overall Study||41
3300267|NCT02943499|4034180|FG001|STARTED|Overall Study||39
3300268|NCT02943499|4034179|FG000|COMPLETED|Overall Study||34
3300269|NCT02943499|4034180|FG001|COMPLETED|Overall Study||34
3300270|NCT02943499|4034179|FG000|NOT COMPLETED|Overall Study||7
3300271|NCT02943499|4034180|FG001|NOT COMPLETED|Overall Study||5
3300272|NCT02943564|4034189|FG000|STARTED|Overall Study||217
3300273|NCT02943564|4034190|FG001|STARTED|Overall Study||211
3300274|NCT02943564|4034191|FG002|STARTED|Overall Study||210
3300275|NCT02943564|4034189|FG000|Responder|Overall Study||83
3300276|NCT02943564|4034190|FG001|Responder|Overall Study||77
3300277|NCT02943564|4034191|FG002|Responder|Overall Study||77
3300278|NCT02943564|4034189|FG000|Non-Responder|Overall Study||134
3300279|NCT02943564|4034190|FG001|Non-Responder|Overall Study||134
3300280|NCT02943564|4034191|FG002|Non-Responder|Overall Study||133
3300281|NCT02943564|4034189|FG000|COMPLETED|Overall Study||207
3300282|NCT02943564|4034190|FG001|COMPLETED|Overall Study||198
3300283|NCT02943564|4034191|FG002|COMPLETED|Overall Study||201
3300284|NCT02943564|4034189|FG000|NOT COMPLETED|Overall Study||10
3300285|NCT02943564|4034190|FG001|NOT COMPLETED|Overall Study||13
3300286|NCT02943564|4034191|FG002|NOT COMPLETED|Overall Study||9
3300287|NCT02943577|4034201|FG000|STARTED|Overall Study||209
3300288|NCT02943577|4034202|FG001|STARTED|Overall Study||206
3300289|NCT02943577|4034201|FG000|COMPLETED|Overall Study||204
3300290|NCT02943577|4034202|FG001|COMPLETED|Overall Study||201
3300291|NCT02943577|4034201|FG000|NOT COMPLETED|Overall Study||5
3300292|NCT02943577|4034202|FG001|NOT COMPLETED|Overall Study||5
3300293|NCT02943668|4034208|FG000|STARTED|Overall Study||2
3300294|NCT02943668|4034208|FG000|COMPLETED|Overall Study||1
3300295|NCT02943668|4034208|FG000|NOT COMPLETED|Overall Study||1
3300296|NCT02943941|4034215|FG000|STARTED|Overall Study||16
2950489|NCT00699153|3664353|FG000|STARTED|Overall Study|Intent to treat population|203
2950490|NCT00699153|3664354|FG001|STARTED|Overall Study|Intent to treat population|202
2950491|NCT00699153|3664353|FG000|COMPLETED|Overall Study||200
2950492|NCT00699153|3664354|FG001|COMPLETED|Overall Study||200
2950493|NCT00699153|3664353|FG000|NOT COMPLETED|Overall Study||3
2950494|NCT00699153|3664354|FG001|NOT COMPLETED|Overall Study||2
2950495|NCT00699192|3664363|FG000|STARTED|Overall Study||275
2950496|NCT00699192|3664364|FG001|STARTED|Overall Study||272
2950497|NCT00699192|3664365|FG002|STARTED|Overall Study||272
2950498|NCT00699192|3664363|FG000|COMPLETED|Overall Study||259
2950499|NCT00699192|3664364|FG001|COMPLETED|Overall Study||260
2950500|NCT00699192|3664365|FG002|COMPLETED|Overall Study||261
2950501|NCT00699192|3664363|FG000|NOT COMPLETED|Overall Study||16
2950502|NCT00699192|3664364|FG001|NOT COMPLETED|Overall Study||12
2950503|NCT00699192|3664365|FG002|NOT COMPLETED|Overall Study||11
2950504|NCT00699218|3664373|FG000|STARTED|Overall Study||15
2950505|NCT00699218|3664373|FG000|COMPLETED|Overall Study||15
2950506|NCT00699218|3664373|FG000|NOT COMPLETED|Overall Study||0
2950507|NCT00699283|3664379|FG000|STARTED|Overall Study||47
2950508|NCT00699283|3664380|FG001|STARTED|Overall Study||15
2950509|NCT00699283|3664379|FG000|COMPLETED|Overall Study||14
2950510|NCT00699283|3664380|FG001|COMPLETED|Overall Study||7
2950511|NCT00699283|3664379|FG000|NOT COMPLETED|Overall Study||33
2950512|NCT00699283|3664380|FG001|NOT COMPLETED|Overall Study||8
2950513|NCT00699335|3664385|FG000|STARTED|Overall Study||5308
2950514|NCT00699335|3664385|FG000|COMPLETED|Overall Study||5080
2950515|NCT00699335|3664385|FG000|NOT COMPLETED|Overall Study||228
2950516|NCT00699348|3664392|FG000|STARTED|Overall Study||351
2950517|NCT00699348|3664392|FG000|COMPLETED|Overall Study||261
2950518|NCT00699348|3664392|FG000|NOT COMPLETED|Overall Study||90
2950519|NCT00699374|3664398|FG000|STARTED|Overall Study||530
2950520|NCT00699374|3664399|FG001|STARTED|Overall Study||544
2950521|NCT00699374|3664398|FG000|Treated|Overall Study||526
2950522|NCT00699374|3664399|FG001|Treated|Overall Study||542
2950523|NCT00699374|3664398|FG000|COMPLETED|Overall Study||0
2950524|NCT00699374|3664399|FG001|COMPLETED|Overall Study||0
2950525|NCT00699374|3664398|FG000|NOT COMPLETED|Overall Study||530
2950526|NCT00699374|3664399|FG001|NOT COMPLETED|Overall Study||544
2950527|NCT00699400|3664408|FG000|STARTED|Overall Study||42
2950528|NCT00699400|3664409|FG001|STARTED|Overall Study||3
2950529|NCT00699400|3664410|FG002|STARTED|Overall Study||138
2950530|NCT00699400|3664411|FG003|STARTED|Overall Study||6
2950531|NCT00699400|3664412|FG004|STARTED|Overall Study||4
2950532|NCT00699400|3664413|FG005|STARTED|Overall Study||11
2950533|NCT00699400|3664408|FG000|COMPLETED|Overall Study||42
2950534|NCT00699400|3664409|FG001|COMPLETED|Overall Study||3
2950535|NCT00699400|3664410|FG002|COMPLETED|Overall Study||138
2950536|NCT00699400|3664411|FG003|COMPLETED|Overall Study||6
2950537|NCT00699400|3664412|FG004|COMPLETED|Overall Study||4
2950538|NCT00699400|3664413|FG005|COMPLETED|Overall Study||0
2950539|NCT00699400|3664408|FG000|NOT COMPLETED|Overall Study||0
2950540|NCT00699400|3664409|FG001|NOT COMPLETED|Overall Study||0
2950541|NCT00699400|3664410|FG002|NOT COMPLETED|Overall Study||0
2950542|NCT00699400|3664411|FG003|NOT COMPLETED|Overall Study||0
2950543|NCT00699400|3664412|FG004|NOT COMPLETED|Overall Study||0
2950544|NCT00699400|3664413|FG005|NOT COMPLETED|Overall Study||11
2950545|NCT00699491|3664427|FG000|STARTED|Overall Study||3
2950546|NCT00699491|3664428|FG001|STARTED|Overall Study||2
2950547|NCT00699491|3664429|FG002|STARTED|Overall Study||7
2950548|NCT00699491|3664430|FG003|STARTED|Overall Study||6
2950549|NCT00699491|3664431|FG004|STARTED|Overall Study||8
2950550|NCT00699491|3664432|FG005|STARTED|Overall Study||22
2950551|NCT00699491|3664427|FG000|COMPLETED|Overall Study||3
2950552|NCT00699491|3664428|FG001|COMPLETED|Overall Study||2
2950553|NCT00699491|3664429|FG002|COMPLETED|Overall Study||7
2950554|NCT00699491|3664430|FG003|COMPLETED|Overall Study||6
2950555|NCT00699491|3664431|FG004|COMPLETED|Overall Study||8
2950556|NCT00699491|3664432|FG005|COMPLETED|Overall Study||22
2950557|NCT00699491|3664427|FG000|NOT COMPLETED|Overall Study||0
2950558|NCT00699491|3664428|FG001|NOT COMPLETED|Overall Study||0
2950559|NCT00699491|3664429|FG002|NOT COMPLETED|Overall Study||0
2950560|NCT00699491|3664430|FG003|NOT COMPLETED|Overall Study||0
2950561|NCT00699491|3664431|FG004|NOT COMPLETED|Overall Study||0
2950562|NCT00699491|3664432|FG005|NOT COMPLETED|Overall Study||0
2950563|NCT00699556|3664446|FG000|STARTED|First Intervention (1 Day)||11
2950564|NCT00699556|3664447|FG001|STARTED|First Intervention (1 Day)||11
2950565|NCT00699556|3664446|FG000|COMPLETED|First Intervention (1 Day)||11
2950566|NCT00699556|3664447|FG001|COMPLETED|First Intervention (1 Day)||11
2950567|NCT00699556|3664446|FG000|NOT COMPLETED|First Intervention (1 Day)||0
2950568|NCT00699556|3664447|FG001|NOT COMPLETED|First Intervention (1 Day)||0
2950569|NCT00699556|3664446|FG000|STARTED|Second Intervention (1 Day)||11
2950570|NCT00699556|3664447|FG001|STARTED|Second Intervention (1 Day)||11
2950571|NCT00699556|3664446|FG000|COMPLETED|Second Intervention (1 Day)||11
2950572|NCT00699556|3664447|FG001|COMPLETED|Second Intervention (1 Day)||11
2950573|NCT00699556|3664446|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
2950574|NCT00699556|3664447|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
2950575|NCT00699582|3664457|FG000|STARTED|Overall Study||138
2950576|NCT00699582|3664458|FG001|STARTED|Overall Study||130
2950577|NCT00699582|3664459|FG002|STARTED|Overall Study||121
2950578|NCT00699582|3664457|FG000|COMPLETED|Overall Study||120
2950579|NCT00699582|3664458|FG001|COMPLETED|Overall Study||108
2950580|NCT00699582|3664459|FG002|COMPLETED|Overall Study||93
2950581|NCT00699582|3664457|FG000|NOT COMPLETED|Overall Study||18
2950582|NCT00699582|3664458|FG001|NOT COMPLETED|Overall Study||22
2950583|NCT00699582|3664459|FG002|NOT COMPLETED|Overall Study||28
2950584|NCT00699608|3664467|FG000|STARTED|First Intervention||16
3132503|NCT01691482|3857559|FG000|STARTED|Treatment Period 2||28
3132504|NCT01691482|3857560|FG001|STARTED|Treatment Period 2||28
2950585|NCT00699608|3664468|FG001|STARTED|First Intervention||15
2950586|NCT00699608|3664469|FG002|STARTED|First Intervention||15
2950587|NCT00699608|3664470|FG003|STARTED|First Intervention||15
2950588|NCT00699608|3664471|FG004|STARTED|First Intervention||15
2950589|NCT00699608|3664472|FG005|STARTED|First Intervention||15
2950590|NCT00699608|3664467|FG000|COMPLETED|First Intervention||16
2950591|NCT00699608|3664468|FG001|COMPLETED|First Intervention||15
2950592|NCT00699608|3664469|FG002|COMPLETED|First Intervention||14
2950593|NCT00699608|3664470|FG003|COMPLETED|First Intervention||15
2950594|NCT00699608|3664471|FG004|COMPLETED|First Intervention||14
2950595|NCT00699608|3664472|FG005|COMPLETED|First Intervention||15
2950596|NCT00699608|3664467|FG000|NOT COMPLETED|First Intervention||0
2950597|NCT00699608|3664468|FG001|NOT COMPLETED|First Intervention||0
2950598|NCT00699608|3664469|FG002|NOT COMPLETED|First Intervention||1
2950599|NCT00699608|3664470|FG003|NOT COMPLETED|First Intervention||0
2950600|NCT00699608|3664471|FG004|NOT COMPLETED|First Intervention||1
2950601|NCT00699608|3664472|FG005|NOT COMPLETED|First Intervention||0
2950602|NCT00699608|3664467|FG000|STARTED|First 4-14 Day Washout Period||16
2950603|NCT00699608|3664468|FG001|STARTED|First 4-14 Day Washout Period||15
2950604|NCT00699608|3664469|FG002|STARTED|First 4-14 Day Washout Period||14
2950605|NCT00699608|3664470|FG003|STARTED|First 4-14 Day Washout Period||15
2950606|NCT00699608|3664471|FG004|STARTED|First 4-14 Day Washout Period||14
2950607|NCT00699608|3664472|FG005|STARTED|First 4-14 Day Washout Period||15
2950608|NCT00699608|3664467|FG000|COMPLETED|First 4-14 Day Washout Period||16
2950609|NCT00699608|3664468|FG001|COMPLETED|First 4-14 Day Washout Period||15
2950610|NCT00699608|3664469|FG002|COMPLETED|First 4-14 Day Washout Period||14
2950611|NCT00699608|3664470|FG003|COMPLETED|First 4-14 Day Washout Period||15
2950612|NCT00699608|3664471|FG004|COMPLETED|First 4-14 Day Washout Period||14
2950613|NCT00699608|3664472|FG005|COMPLETED|First 4-14 Day Washout Period||15
2950614|NCT00699608|3664467|FG000|NOT COMPLETED|First 4-14 Day Washout Period||0
2950615|NCT00699608|3664468|FG001|NOT COMPLETED|First 4-14 Day Washout Period||0
2950616|NCT00699608|3664469|FG002|NOT COMPLETED|First 4-14 Day Washout Period||0
2950617|NCT00699608|3664470|FG003|NOT COMPLETED|First 4-14 Day Washout Period||0
2950618|NCT00699608|3664471|FG004|NOT COMPLETED|First 4-14 Day Washout Period||0
2950619|NCT00699608|3664472|FG005|NOT COMPLETED|First 4-14 Day Washout Period||0
2950620|NCT00699608|3664467|FG000|STARTED|Second Intervention||16
2950621|NCT00699608|3664468|FG001|STARTED|Second Intervention||15
2950622|NCT00699608|3664469|FG002|STARTED|Second Intervention||14
2950623|NCT00699608|3664470|FG003|STARTED|Second Intervention||15
2950624|NCT00699608|3664471|FG004|STARTED|Second Intervention||14
2950625|NCT00699608|3664472|FG005|STARTED|Second Intervention||15
2950626|NCT00699608|3664467|FG000|COMPLETED|Second Intervention||16
2950627|NCT00699608|3664468|FG001|COMPLETED|Second Intervention||15
2950628|NCT00699608|3664469|FG002|COMPLETED|Second Intervention||13
2950629|NCT00699608|3664470|FG003|COMPLETED|Second Intervention||14
2950630|NCT00699608|3664471|FG004|COMPLETED|Second Intervention||14
2950631|NCT00699608|3664472|FG005|COMPLETED|Second Intervention||15
2950632|NCT00699608|3664467|FG000|NOT COMPLETED|Second Intervention||0
2950633|NCT00699608|3664468|FG001|NOT COMPLETED|Second Intervention||0
2950634|NCT00699608|3664469|FG002|NOT COMPLETED|Second Intervention||1
2950635|NCT00699608|3664470|FG003|NOT COMPLETED|Second Intervention||1
2950636|NCT00699608|3664471|FG004|NOT COMPLETED|Second Intervention||0
2950637|NCT00699608|3664472|FG005|NOT COMPLETED|Second Intervention||0
2950638|NCT00699608|3664467|FG000|STARTED|Second 4-14 Day Washout Period||16
2950639|NCT00699608|3664468|FG001|STARTED|Second 4-14 Day Washout Period||15
2950640|NCT00699608|3664469|FG002|STARTED|Second 4-14 Day Washout Period||13
2950641|NCT00699608|3664470|FG003|STARTED|Second 4-14 Day Washout Period||14
2950642|NCT00699608|3664471|FG004|STARTED|Second 4-14 Day Washout Period||14
2950643|NCT00699608|3664472|FG005|STARTED|Second 4-14 Day Washout Period||15
2950644|NCT00699608|3664467|FG000|COMPLETED|Second 4-14 Day Washout Period||16
2950645|NCT00699608|3664468|FG001|COMPLETED|Second 4-14 Day Washout Period||15
2950646|NCT00699608|3664469|FG002|COMPLETED|Second 4-14 Day Washout Period||13
2950647|NCT00699608|3664470|FG003|COMPLETED|Second 4-14 Day Washout Period||14
2950648|NCT00699608|3664471|FG004|COMPLETED|Second 4-14 Day Washout Period||14
2950649|NCT00699608|3664472|FG005|COMPLETED|Second 4-14 Day Washout Period||15
2950650|NCT00699608|3664467|FG000|NOT COMPLETED|Second 4-14 Day Washout Period||0
2950651|NCT00699608|3664468|FG001|NOT COMPLETED|Second 4-14 Day Washout Period||0
2950652|NCT00699608|3664469|FG002|NOT COMPLETED|Second 4-14 Day Washout Period||0
2950653|NCT00699608|3664470|FG003|NOT COMPLETED|Second 4-14 Day Washout Period||0
2950654|NCT00699608|3664471|FG004|NOT COMPLETED|Second 4-14 Day Washout Period||0
2950655|NCT00699608|3664472|FG005|NOT COMPLETED|Second 4-14 Day Washout Period||0
2950656|NCT00699608|3664467|FG000|STARTED|Third Intervention||16
2950657|NCT00699608|3664468|FG001|STARTED|Third Intervention||15
2950658|NCT00699608|3664469|FG002|STARTED|Third Intervention||13
2950659|NCT00699608|3664470|FG003|STARTED|Third Intervention||14
2950660|NCT00699608|3664471|FG004|STARTED|Third Intervention||14
2950661|NCT00699608|3664472|FG005|STARTED|Third Intervention||15
2950662|NCT00699608|3664467|FG000|COMPLETED|Third Intervention||16
2950663|NCT00699608|3664468|FG001|COMPLETED|Third Intervention||15
2950664|NCT00699608|3664469|FG002|COMPLETED|Third Intervention||13
2950665|NCT00699608|3664470|FG003|COMPLETED|Third Intervention||14
2950666|NCT00699608|3664471|FG004|COMPLETED|Third Intervention||14
2950667|NCT00699608|3664472|FG005|COMPLETED|Third Intervention||15
2950668|NCT00699608|3664467|FG000|NOT COMPLETED|Third Intervention||0
2950669|NCT00699608|3664468|FG001|NOT COMPLETED|Third Intervention||0
2950670|NCT00699608|3664469|FG002|NOT COMPLETED|Third Intervention||0
2950671|NCT00699608|3664470|FG003|NOT COMPLETED|Third Intervention||0
2950672|NCT00699608|3664471|FG004|NOT COMPLETED|Third Intervention||0
2950673|NCT00699608|3664472|FG005|NOT COMPLETED|Third Intervention||0
2950674|NCT00699660|3664482|FG000|STARTED|Overall Study||190
2950675|NCT00699660|3664483|FG001|STARTED|Overall Study||216
2950676|NCT00699660|3664482|FG000|COMPLETED|Overall Study||176
2950677|NCT00699660|3664483|FG001|COMPLETED|Overall Study||208
2950678|NCT00699660|3664482|FG000|NOT COMPLETED|Overall Study||14
2950679|NCT00699660|3664483|FG001|NOT COMPLETED|Overall Study||8
2950680|NCT00699699|3664489|FG000|STARTED|Overall Study||1280
2950681|NCT00699699|3664489|FG000|COMPLETED|Overall Study||1223
2950682|NCT00699699|3664489|FG000|NOT COMPLETED|Overall Study||57
2950683|NCT00699751|3664495|FG000|STARTED|Period 1: Without/Before Drug Switch||614
2950684|NCT00699751|3664496|FG001|STARTED|Period 1: Without/Before Drug Switch||307
2950685|NCT00699751|3664495|FG000|Participants Received Treatment|Period 1: Without/Before Drug Switch||600
2950686|NCT00699751|3664496|FG001|Participants Received Treatment|Period 1: Without/Before Drug Switch||301
2950687|NCT00699751|3664495|FG000|Entered 3-Year Follow-up Period|Period 1: Without/Before Drug Switch|Participants were not required to complete all 6 injections to enter to 3-year follow-up period.|407
2950688|NCT00699751|3664496|FG001|Entered 3-Year Follow-up Period|Period 1: Without/Before Drug Switch|Participants were not required to complete all 6 injections to enter to 3-year follow-up period.|168
2950689|NCT00699751|3664495|FG000|Completed 3-Year Follow-up Period|Period 1: Without/Before Drug Switch||49
2950690|NCT00699751|3664496|FG001|Completed 3-Year Follow-up Period|Period 1: Without/Before Drug Switch||12
3163433|NCT01886716|3890934|FG002|NOT COMPLETED|1-Week Post Follow-Up||0
3163434|NCT01886716|3890935|FG003|NOT COMPLETED|1-Week Post Follow-Up||0
3163435|NCT01886716|3890932|FG000|STARTED|1-Month Post Follow-Up||20
3163436|NCT01886716|3890933|FG001|STARTED|1-Month Post Follow-Up||17
3163437|NCT01886716|3890934|FG002|STARTED|1-Month Post Follow-Up||19
3163438|NCT01886716|3890935|FG003|STARTED|1-Month Post Follow-Up||14
3163439|NCT01886716|3890932|FG000|COMPLETED|1-Month Post Follow-Up||20
2950691|NCT00699751|3664495|FG000|COMPLETED|Period 1: Without/Before Drug Switch|Completed all 6 injections|389
2950692|NCT00699751|3664496|FG001|COMPLETED|Period 1: Without/Before Drug Switch|Completed all 6 injections|145
2950693|NCT00699751|3664495|FG000|NOT COMPLETED|Period 1: Without/Before Drug Switch||225
2950694|NCT00699751|3664496|FG001|NOT COMPLETED|Period 1: Without/Before Drug Switch||162
2950695|NCT00699751|3664495|FG000|STARTED|Period 2:Switched From Placebo to Xofigo||0
2950696|NCT00699751|3664496|FG001|STARTED|Period 2:Switched From Placebo to Xofigo|Participants in the placebo group switched to Xofigo treatment|26
2950697|NCT00699751|3664495|FG000|Participants Received Treatment|Period 2:Switched From Placebo to Xofigo||0
2950698|NCT00699751|3664496|FG001|Participants Received Treatment|Period 2:Switched From Placebo to Xofigo||24
2950699|NCT00699751|3664495|FG000|Entered 3-Year Follow-up Period|Period 2:Switched From Placebo to Xofigo||0
2950700|NCT00699751|3664496|FG001|Entered 3-Year Follow-up Period|Period 2:Switched From Placebo to Xofigo||15
2950701|NCT00699751|3664495|FG000|Completed 3-Year Follow-up Period|Period 2:Switched From Placebo to Xofigo||0
2950702|NCT00699751|3664496|FG001|Completed 3-Year Follow-up Period|Period 2:Switched From Placebo to Xofigo||0
2950703|NCT00699751|3664495|FG000|COMPLETED|Period 2:Switched From Placebo to Xofigo||0
2950704|NCT00699751|3664496|FG001|COMPLETED|Period 2:Switched From Placebo to Xofigo|Completed all 6 injections|17
2950705|NCT00699751|3664495|FG000|NOT COMPLETED|Period 2:Switched From Placebo to Xofigo||0
2950706|NCT00699751|3664496|FG001|NOT COMPLETED|Period 2:Switched From Placebo to Xofigo||9
2950707|NCT00699803|3664505|FG000|STARTED|Overall Study||32
2950708|NCT00699803|3664506|FG001|STARTED|Overall Study||32
2950709|NCT00699803|3664505|FG000|COMPLETED|Overall Study||30
2950710|NCT00699803|3664506|FG001|COMPLETED|Overall Study||26
2950711|NCT00699803|3664505|FG000|NOT COMPLETED|Overall Study||2
2950712|NCT00699803|3664506|FG001|NOT COMPLETED|Overall Study||6
2950713|NCT00699816|3664514|FG000|STARTED|Overall Study||115
2950714|NCT00699816|3664515|FG001|STARTED|Overall Study||115
2950715|NCT00699816|3664514|FG000|COMPLETED|Overall Study||114
2950716|NCT00699816|3664515|FG001|COMPLETED|Overall Study||112
2950717|NCT00699816|3664514|FG000|NOT COMPLETED|Overall Study||1
2950718|NCT00699816|3664515|FG001|NOT COMPLETED|Overall Study||3
2950719|NCT00699907|3664524|FG000|STARTED|Overall Study||14
2950720|NCT00699907|3664525|FG001|STARTED|Overall Study||57
2950721|NCT00699907|3664526|FG002|STARTED|Overall Study||56
2950722|NCT00699907|3664524|FG000|COMPLETED|Overall Study||12
2950723|NCT00699907|3664525|FG001|COMPLETED|Overall Study||47
2950724|NCT00699907|3664526|FG002|COMPLETED|Overall Study||48
2950725|NCT00699907|3664524|FG000|NOT COMPLETED|Overall Study||2
2950726|NCT00699907|3664525|FG001|NOT COMPLETED|Overall Study||10
2950727|NCT00699907|3664526|FG002|NOT COMPLETED|Overall Study||8
2950728|NCT00699972|3664537|FG000|STARTED|Overall Study||122
2950729|NCT00699972|3664538|FG001|STARTED|Overall Study||133
2950730|NCT00699972|3664539|FG002|STARTED|Overall Study||135
2950731|NCT00699972|3664537|FG000|COMPLETED|Overall Study||106
3163440|NCT01886716|3890933|FG001|COMPLETED|1-Month Post Follow-Up||17
2950732|NCT00699972|3664538|FG001|COMPLETED|Overall Study||114
2950733|NCT00699972|3664539|FG002|COMPLETED|Overall Study||100
2950734|NCT00699972|3664537|FG000|NOT COMPLETED|Overall Study||16
2950735|NCT00699972|3664538|FG001|NOT COMPLETED|Overall Study||19
2950736|NCT00699972|3664539|FG002|NOT COMPLETED|Overall Study||35
2950737|NCT00699998|3664551|FG000|STARTED|Overall Study||3620
2950738|NCT00699998|3664552|FG001|STARTED|Overall Study||1043
2950739|NCT00699998|3664553|FG002|STARTED|Overall Study||3623
2950740|NCT00699998|3664554|FG003|STARTED|Overall Study||1040
2950741|NCT00699998|3664551|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3590
2950742|NCT00699998|3664552|FG001|Received at Least 1 Dose of Study Drug|Overall Study||1033
2950743|NCT00699998|3664553|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3590
2950744|NCT00699998|3664554|FG003|Received at Least 1 Dose of Study Drug|Overall Study||1027
2950745|NCT00699998|3664551|FG000|COMPLETED|Overall Study||3421
2950746|NCT00699998|3664552|FG001|COMPLETED|Overall Study||957
2950747|NCT00699998|3664553|FG002|COMPLETED|Overall Study||3417
2950748|NCT00699998|3664554|FG003|COMPLETED|Overall Study||958
2950749|NCT00699998|3664551|FG000|NOT COMPLETED|Overall Study||199
2950750|NCT00699998|3664552|FG001|NOT COMPLETED|Overall Study||86
2950751|NCT00699998|3664553|FG002|NOT COMPLETED|Overall Study||206
2950752|NCT00699998|3664554|FG003|NOT COMPLETED|Overall Study||82
2950753|NCT00700011|3664571|FG000|STARTED|Overall Study||8
2950754|NCT00700011|3664572|FG001|STARTED|Overall Study||2
2950755|NCT00700011|3664571|FG000|COMPLETED|Overall Study||8
2950756|NCT00700011|3664572|FG001|COMPLETED|Overall Study||1
2950757|NCT00700011|3664571|FG000|NOT COMPLETED|Overall Study||0
2950758|NCT00700011|3664572|FG001|NOT COMPLETED|Overall Study||1
2950759|NCT00700063|3664586|FG000|STARTED|Overall Study||33
2950760|NCT00700063|3664587|FG001|STARTED|Overall Study||34
2950761|NCT00700063|3664588|FG002|STARTED|Overall Study||33
2950762|NCT00700063|3664589|FG003|STARTED|Overall Study||33
2950763|NCT00700063|3664590|FG004|STARTED|Overall Study||33
2950764|NCT00700063|3664591|FG005|STARTED|Overall Study||34
2950765|NCT00700063|3664592|FG006|STARTED|Overall Study||32
2950766|NCT00700063|3664593|FG007|STARTED|Overall Study||33
2950767|NCT00700063|3664586|FG000|COMPLETED|Overall Study||32
2950768|NCT00700063|3664587|FG001|COMPLETED|Overall Study||34
2950769|NCT00700063|3664588|FG002|COMPLETED|Overall Study||33
2950770|NCT00700063|3664589|FG003|COMPLETED|Overall Study||31
2950771|NCT00700063|3664590|FG004|COMPLETED|Overall Study||31
2950772|NCT00700063|3664591|FG005|COMPLETED|Overall Study||34
2950773|NCT00700063|3664592|FG006|COMPLETED|Overall Study||32
2950774|NCT00700063|3664593|FG007|COMPLETED|Overall Study||33
2950775|NCT00700063|3664586|FG000|NOT COMPLETED|Overall Study||1
2950776|NCT00700063|3664587|FG001|NOT COMPLETED|Overall Study||0
2950777|NCT00700063|3664588|FG002|NOT COMPLETED|Overall Study||0
2950778|NCT00700063|3664589|FG003|NOT COMPLETED|Overall Study||2
2950779|NCT00700063|3664590|FG004|NOT COMPLETED|Overall Study||2
2950780|NCT00700063|3664591|FG005|NOT COMPLETED|Overall Study||0
2950781|NCT00700063|3664592|FG006|NOT COMPLETED|Overall Study||0
2950782|NCT00700063|3664593|FG007|NOT COMPLETED|Overall Study||0
2950783|NCT00700102|3664613|FG000|STARTED|Overall Study||411
2950784|NCT00700102|3664614|FG001|STARTED|Overall Study||409
2950785|NCT00700102|3664613|FG000|Intention to Treat|Overall Study||410
2950786|NCT00700102|3664614|FG001|Intention to Treat|Overall Study||409
2950787|NCT00700102|3664613|FG000|Received at Least One Dose|Overall Study||407
2950788|NCT00700102|3664614|FG001|Received at Least One Dose|Overall Study||403
2950789|NCT00700102|3664613|FG000|COMPLETED|Overall Study||9
2950790|NCT00700102|3664614|FG001|COMPLETED|Overall Study||14
2950791|NCT00700102|3664613|FG000|NOT COMPLETED|Overall Study||402
2950792|NCT00700102|3664614|FG001|NOT COMPLETED|Overall Study||395
2950793|NCT00700115|3664622|FG000|STARTED|Overall Study||40
2950794|NCT00700115|3664623|FG001|STARTED|Overall Study||20
2950795|NCT00700115|3664622|FG000|COMPLETED|Overall Study||39
2950796|NCT00700115|3664623|FG001|COMPLETED|Overall Study||19
2950797|NCT00700115|3664622|FG000|NOT COMPLETED|Overall Study||1
2950798|NCT00700115|3664623|FG001|NOT COMPLETED|Overall Study||1
2950799|NCT00700141|3664629|FG000|STARTED|Overall Study||482
2950800|NCT00700141|3664629|FG000|COMPLETED|Overall Study||482
2950801|NCT00700141|3664629|FG000|NOT COMPLETED|Overall Study||0
3034921|NCT01134315|3753967|FG001|COMPLETED|Overall Study|Completed study drug treatment during the observational study (ie, prior to study termination).|21
3034922|NCT01134315|3753966|FG000|NOT COMPLETED|Overall Study||9
3034923|NCT01134315|3753967|FG001|NOT COMPLETED|Overall Study||19
3034924|NCT01134328|3753977|FG000|STARTED|Overall Study||21
3034925|NCT01134328|3753978|FG001|STARTED|Overall Study||21
3034926|NCT01134328|3753979|FG002|STARTED|Overall Study||20
3034927|NCT01134328|3753980|FG003|STARTED|Overall Study||21
3034928|NCT01134328|3753977|FG000|COMPLETED|Overall Study||19
3034929|NCT01134328|3753978|FG001|COMPLETED|Overall Study||18
3034930|NCT01134328|3753979|FG002|COMPLETED|Overall Study||17
3034931|NCT01134328|3753980|FG003|COMPLETED|Overall Study||17
3034932|NCT01134328|3753977|FG000|NOT COMPLETED|Overall Study||2
3034933|NCT01134328|3753978|FG001|NOT COMPLETED|Overall Study||3
3034934|NCT01134328|3753979|FG002|NOT COMPLETED|Overall Study||3
3034935|NCT01134328|3753980|FG003|NOT COMPLETED|Overall Study||4
3034936|NCT01134393|3753990|FG000|STARTED|Overall Study|Entered and treated.|501
3034937|NCT01134393|3753990|FG000|COMPLETED|Overall Study|Completed trial medication.|449
3034938|NCT01134393|3753990|FG000|NOT COMPLETED|Overall Study||52
3034939|NCT01134510|3753997|FG000|STARTED|Overall Study|Transplant Day; Infusion #1 C1 esterase inhibitor vs Placebo|10
2950802|NCT00700180|3664635|FG000|STARTED|Overall Study||154
2950803|NCT00700180|3664636|FG001|STARTED|Overall Study||149
2950804|NCT00700180|3664635|FG000|COMPLETED|Overall Study|Clinical cutoff date: July 11, 2011|0
2950805|NCT00700180|3664636|FG001|COMPLETED|Overall Study|Clinical cutoff date: July 11, 2011|0
2950806|NCT00700180|3664635|FG000|NOT COMPLETED|Overall Study||154
2950807|NCT00700180|3664636|FG001|NOT COMPLETED|Overall Study||149
2950808|NCT00700271|3664644|FG000|STARTED|Overall Study||278
2950809|NCT00700271|3664645|FG001|STARTED|Overall Study||268
2950810|NCT00700271|3664644|FG000|COMPLETED|Overall Study||264
2950811|NCT00700271|3664645|FG001|COMPLETED|Overall Study||256
2950812|NCT00700271|3664644|FG000|NOT COMPLETED|Overall Study||14
2950813|NCT00700271|3664645|FG001|NOT COMPLETED|Overall Study||12
2950814|NCT00700310|3664655|FG000|STARTED|Overall Study||187
2950815|NCT00700310|3664656|FG001|STARTED|Overall Study||180
2950816|NCT00700310|3664657|FG002|STARTED|Overall Study||174
2950817|NCT00700310|3664658|FG003|STARTED|Overall Study||171
2950818|NCT00700310|3664655|FG000|COMPLETED|Overall Study||166
2950819|NCT00700310|3664656|FG001|COMPLETED|Overall Study||154
2950820|NCT00700310|3664657|FG002|COMPLETED|Overall Study||158
2950821|NCT00700310|3664658|FG003|COMPLETED|Overall Study||145
2950822|NCT00700310|3664655|FG000|NOT COMPLETED|Overall Study||21
2950823|NCT00700310|3664656|FG001|NOT COMPLETED|Overall Study||26
2950824|NCT00700310|3664657|FG002|NOT COMPLETED|Overall Study||16
2950825|NCT00700310|3664658|FG003|NOT COMPLETED|Overall Study||26
2950826|NCT00700336|3664671|FG000|STARTED|Overall Study||40
2950827|NCT00700336|3664672|FG001|STARTED|Overall Study||23
2950828|NCT00700336|3664673|FG002|STARTED|Overall Study||6
2950829|NCT00700336|3664671|FG000|COMPLETED|Overall Study||40
2950830|NCT00700336|3664672|FG001|COMPLETED|Overall Study||23
2950831|NCT00700336|3664673|FG002|COMPLETED|Overall Study||6
2950832|NCT00700336|3664671|FG000|NOT COMPLETED|Overall Study||0
2950833|NCT00700336|3664672|FG001|NOT COMPLETED|Overall Study||0
2950834|NCT00700336|3664673|FG002|NOT COMPLETED|Overall Study||0
2950835|NCT00700375|3664682|FG000|STARTED|Overall Study||30
2950836|NCT00700375|3664683|FG001|STARTED|Overall Study||29
2950837|NCT00700375|3664682|FG000|2 Days After Creatinine Mesurement|Overall Study||30
2950838|NCT00700375|3664683|FG001|2 Days After Creatinine Mesurement|Overall Study||29
2950839|NCT00700375|3664682|FG000|COMPLETED|Overall Study||30
2950840|NCT00700375|3664683|FG001|COMPLETED|Overall Study||29
2950841|NCT00700375|3664682|FG000|NOT COMPLETED|Overall Study||0
2950842|NCT00700375|3664683|FG001|NOT COMPLETED|Overall Study||0
2950843|NCT00700401|3664689|FG000|STARTED|Overall Study||262
2950844|NCT00700401|3664689|FG000|COMPLETED|Overall Study||168
2950845|NCT00700401|3664689|FG000|NOT COMPLETED|Overall Study||94
2950846|NCT00700427|3664693|FG000|STARTED|Study Period 2 (Open-Label Acute Trx)||2017
2950847|NCT00700427|3664694|FG001|STARTED|Study Period 2 (Open-Label Acute Trx)||0
2950848|NCT00700427|3664695|FG002|STARTED|Study Period 2 (Open-Label Acute Trx)||0
2950849|NCT00700427|3664696|FG003|STARTED|Study Period 2 (Open-Label Acute Trx)||0
2950850|NCT00700427|3664697|FG004|STARTED|Study Period 2 (Open-Label Acute Trx)||0
2950851|NCT00700427|3664693|FG000|Received at Least One Dose of Study Drug|Study Period 2 (Open-Label Acute Trx)||2011
2950852|NCT00700427|3664694|FG001|Received at Least One Dose of Study Drug|Study Period 2 (Open-Label Acute Trx)||0
2950853|NCT00700427|3664695|FG002|Received at Least One Dose of Study Drug|Study Period 2 (Open-Label Acute Trx)||0
2950854|NCT00700427|3664696|FG003|Received at Least One Dose of Study Drug|Study Period 2 (Open-Label Acute Trx)||0
2950855|NCT00700427|3664697|FG004|Received at Least One Dose of Study Drug|Study Period 2 (Open-Label Acute Trx)||0
2950856|NCT00700427|3664693|FG000|COMPLETED|Study Period 2 (Open-Label Acute Trx)|One participant was mistakenly recorded as completed. The reason for discontinuation is unknown.|1006
2950857|NCT00700427|3664694|FG001|COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
2950858|NCT00700427|3664695|FG002|COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
2950859|NCT00700427|3664696|FG003|COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
2950860|NCT00700427|3664697|FG004|COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
2950861|NCT00700427|3664693|FG000|NOT COMPLETED|Study Period 2 (Open-Label Acute Trx)||1011
2950862|NCT00700427|3664694|FG001|NOT COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
2950863|NCT00700427|3664695|FG002|NOT COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
2950864|NCT00700427|3664696|FG003|NOT COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
2950865|NCT00700427|3664697|FG004|NOT COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
2950866|NCT00700427|3664693|FG000|STARTED|Study Period 3A (Blinded Maintenance)||0
2950867|NCT00700427|3664694|FG001|STARTED|Study Period 3A (Blinded Maintenance)||1005
2950868|NCT00700427|3664695|FG002|STARTED|Study Period 3A (Blinded Maintenance)||0
2950869|NCT00700427|3664696|FG003|STARTED|Study Period 3A (Blinded Maintenance)||0
2950870|NCT00700427|3664697|FG004|STARTED|Study Period 3A (Blinded Maintenance)||0
2950871|NCT00700427|3664693|FG000|COMPLETED|Study Period 3A (Blinded Maintenance)||0
2950872|NCT00700427|3664694|FG001|COMPLETED|Study Period 3A (Blinded Maintenance)||524
2950873|NCT00700427|3664695|FG002|COMPLETED|Study Period 3A (Blinded Maintenance)||0
2950874|NCT00700427|3664696|FG003|COMPLETED|Study Period 3A (Blinded Maintenance)||0
2950875|NCT00700427|3664697|FG004|COMPLETED|Study Period 3A (Blinded Maintenance)||0
2950876|NCT00700427|3664693|FG000|NOT COMPLETED|Study Period 3A (Blinded Maintenance)||0
2950877|NCT00700427|3664694|FG001|NOT COMPLETED|Study Period 3A (Blinded Maintenance)||481
2950878|NCT00700427|3664695|FG002|NOT COMPLETED|Study Period 3A (Blinded Maintenance)||0
2950879|NCT00700427|3664696|FG003|NOT COMPLETED|Study Period 3A (Blinded Maintenance)||0
2950880|NCT00700427|3664697|FG004|NOT COMPLETED|Study Period 3A (Blinded Maintenance)||0
2950881|NCT00700427|3664693|FG000|STARTED|Study Period 3B (Randomized Withdrawal)||0
2950882|NCT00700427|3664694|FG001|STARTED|Study Period 3B (Randomized Withdrawal)||0
2950883|NCT00700427|3664695|FG002|STARTED|Study Period 3B (Randomized Withdrawal)||266
2950884|NCT00700427|3664696|FG003|STARTED|Study Period 3B (Randomized Withdrawal)||258
2950885|NCT00700427|3664697|FG004|STARTED|Study Period 3B (Randomized Withdrawal)||0
2950886|NCT00700427|3664693|FG000|COMPLETED|Study Period 3B (Randomized Withdrawal)||0
2950887|NCT00700427|3664694|FG001|COMPLETED|Study Period 3B (Randomized Withdrawal)||0
2950888|NCT00700427|3664695|FG002|COMPLETED|Study Period 3B (Randomized Withdrawal)||184
2950889|NCT00700427|3664696|FG003|COMPLETED|Study Period 3B (Randomized Withdrawal)||165
2950890|NCT00700427|3664697|FG004|COMPLETED|Study Period 3B (Randomized Withdrawal)||0
2950891|NCT00700427|3664693|FG000|NOT COMPLETED|Study Period 3B (Randomized Withdrawal)||0
2950892|NCT00700427|3664694|FG001|NOT COMPLETED|Study Period 3B (Randomized Withdrawal)||0
2950893|NCT00700427|3664695|FG002|NOT COMPLETED|Study Period 3B (Randomized Withdrawal)||82
2950894|NCT00700427|3664696|FG003|NOT COMPLETED|Study Period 3B (Randomized Withdrawal)||93
2950895|NCT00700427|3664697|FG004|NOT COMPLETED|Study Period 3B (Randomized Withdrawal)||0
2950896|NCT00700427|3664693|FG000|STARTED|Study Period 4 (Open-Label Extension)||0
2950897|NCT00700427|3664694|FG001|STARTED|Study Period 4 (Open-Label Extension)||0
2950898|NCT00700427|3664695|FG002|STARTED|Study Period 4 (Open-Label Extension)||0
2950899|NCT00700427|3664696|FG003|STARTED|Study Period 4 (Open-Label Extension)||0
2950900|NCT00700427|3664697|FG004|STARTED|Study Period 4 (Open-Label Extension)||180
2950901|NCT00700427|3664693|FG000|COMPLETED|Study Period 4 (Open-Label Extension)||0
2950902|NCT00700427|3664694|FG001|COMPLETED|Study Period 4 (Open-Label Extension)||0
2950903|NCT00700427|3664695|FG002|COMPLETED|Study Period 4 (Open-Label Extension)||0
2950904|NCT00700427|3664696|FG003|COMPLETED|Study Period 4 (Open-Label Extension)||0
2950905|NCT00700427|3664697|FG004|COMPLETED|Study Period 4 (Open-Label Extension)||96
2950906|NCT00700427|3664693|FG000|NOT COMPLETED|Study Period 4 (Open-Label Extension)||0
2950907|NCT00700427|3664694|FG001|NOT COMPLETED|Study Period 4 (Open-Label Extension)||0
2950908|NCT00700427|3664695|FG002|NOT COMPLETED|Study Period 4 (Open-Label Extension)||0
2950909|NCT00700427|3664696|FG003|NOT COMPLETED|Study Period 4 (Open-Label Extension)||0
2950910|NCT00700427|3664697|FG004|NOT COMPLETED|Study Period 4 (Open-Label Extension)||84
2950911|NCT00700440|3664705|FG000|STARTED|Overall Study||100
2950912|NCT00700440|3664705|FG000|COMPLETED|Overall Study||100
2950913|NCT00700440|3664705|FG000|NOT COMPLETED|Overall Study||0
2950914|NCT00700570|3664711|FG000|STARTED|Overall Study||19
2950915|NCT00700570|3664712|FG001|STARTED|Overall Study||26
2950916|NCT00700570|3664711|FG000|COMPLETED|Overall Study||8
2950917|NCT00700570|3664712|FG001|COMPLETED|Overall Study||0
2950918|NCT00700570|3664711|FG000|NOT COMPLETED|Overall Study||11
2950919|NCT00700570|3664712|FG001|NOT COMPLETED|Overall Study||26
2950920|NCT00700622|3664720|FG000|STARTED|Overall Study||65
2950921|NCT00700622|3664721|FG001|STARTED|Overall Study||65
2950922|NCT00700622|3664720|FG000|COMPLETED|Overall Study||52
2950923|NCT00700622|3664721|FG001|COMPLETED|Overall Study||60
2950924|NCT00700622|3664720|FG000|NOT COMPLETED|Overall Study||13
2950925|NCT00700622|3664721|FG001|NOT COMPLETED|Overall Study||5
2950926|NCT00700635|3664730|FG000|STARTED|Overall Study||111
2950927|NCT00700635|3664731|FG001|STARTED|Overall Study||111
2950928|NCT00700635|3664732|FG002|STARTED|Overall Study||111
2950929|NCT00700635|3664730|FG000|COMPLETED|Overall Study||100
2950930|NCT00700635|3664731|FG001|COMPLETED|Overall Study||103
2950931|NCT00700635|3664732|FG002|COMPLETED|Overall Study||110
2950932|NCT00700635|3664730|FG000|NOT COMPLETED|Overall Study||11
2950933|NCT00700635|3664731|FG001|NOT COMPLETED|Overall Study||8
2950934|NCT00700635|3664732|FG002|NOT COMPLETED|Overall Study||1
2950935|NCT00700713|3664743|FG000|STARTED|Overall Study||48
2950936|NCT00700713|3664744|FG001|STARTED|Overall Study||66
2950937|NCT00700713|3664745|FG002|STARTED|Overall Study||67
2950938|NCT00700713|3664743|FG000|COMPLETED|Overall Study||47
2950939|NCT00700713|3664744|FG001|COMPLETED|Overall Study||66
2950940|NCT00700713|3664745|FG002|COMPLETED|Overall Study||65
2950941|NCT00700713|3664743|FG000|NOT COMPLETED|Overall Study||1
2950942|NCT00700713|3664744|FG001|NOT COMPLETED|Overall Study||0
2950943|NCT00700713|3664745|FG002|NOT COMPLETED|Overall Study||2
2950944|NCT00700739|3664755|FG000|STARTED|Overall Study||22
2950945|NCT00700739|3664756|FG001|STARTED|Overall Study||16
2950946|NCT00700739|3664755|FG000|COMPLETED|Overall Study||18
2950947|NCT00700739|3664756|FG001|COMPLETED|Overall Study||12
2950948|NCT00700739|3664755|FG000|NOT COMPLETED|Overall Study||4
2950949|NCT00700739|3664756|FG001|NOT COMPLETED|Overall Study||4
2950950|NCT00700752|3664763|FG000|STARTED|First Intervention||20
2950951|NCT00700752|3664764|FG001|STARTED|First Intervention||20
2950952|NCT00700752|3664763|FG000|COMPLETED|First Intervention||20
2950953|NCT00700752|3664764|FG001|COMPLETED|First Intervention||18
2950954|NCT00700752|3664763|FG000|NOT COMPLETED|First Intervention||0
2950955|NCT00700752|3664764|FG001|NOT COMPLETED|First Intervention||2
2950956|NCT00700752|3664763|FG000|STARTED|Second Intervention||20
2950957|NCT00700752|3664764|FG001|STARTED|Second Intervention||18
2950958|NCT00700752|3664763|FG000|COMPLETED|Second Intervention||20
2950959|NCT00700752|3664764|FG001|COMPLETED|Second Intervention||18
2950960|NCT00700752|3664763|FG000|NOT COMPLETED|Second Intervention||0
2950961|NCT00700752|3664764|FG001|NOT COMPLETED|Second Intervention||0
2950962|NCT00700804|3664772|FG000|STARTED|Overall Study||17
2950963|NCT00700804|3664773|FG001|STARTED|Overall Study||17
2950964|NCT00700804|3664772|FG000|COMPLETED|Overall Study||14
2950965|NCT00700804|3664773|FG001|COMPLETED|Overall Study||13
2950966|NCT00700804|3664772|FG000|NOT COMPLETED|Overall Study||3
2950967|NCT00700804|3664773|FG001|NOT COMPLETED|Overall Study||4
2950968|NCT00700817|3664784|FG000|STARTED|Week 0-26 (Main Period)|Randomised|225
2950969|NCT00700817|3664785|FG001|STARTED|Week 0-26 (Main Period)|Randomised|221
2950970|NCT00700817|3664786|FG002|STARTED|Week 0-26 (Main Period)|Randomised|219
2950971|NCT00700817|3664787|FG003|STARTED|Week 0-26 (Main Period)||0
2950972|NCT00700817|3664788|FG004|STARTED|Week 0-26 (Main Period)||0
2950973|NCT00700817|3664784|FG000|Exposed|Week 0-26 (Main Period)|4 subjects withdrew before exposure to trial drug and were not included in Full Analysis Set (FAS)|221
2950974|NCT00700817|3664785|FG001|Exposed|Week 0-26 (Main Period)|3 subjects withdrew before exposure to trial drug and were not included in Full Analysis Set (FAS)|218
2950975|NCT00700817|3664786|FG002|Exposed|Week 0-26 (Main Period)||219
2950976|NCT00700817|3664787|FG003|Exposed|Week 0-26 (Main Period)||0
2950977|NCT00700817|3664788|FG004|Exposed|Week 0-26 (Main Period)||0
2950978|NCT00700817|3664784|FG000|COMPLETED|Week 0-26 (Main Period)||169
2950979|NCT00700817|3664785|FG001|COMPLETED|Week 0-26 (Main Period)||191
2950980|NCT00700817|3664786|FG002|COMPLETED|Week 0-26 (Main Period)||194
2950981|NCT00700817|3664787|FG003|COMPLETED|Week 0-26 (Main Period)||0
2950982|NCT00700817|3664788|FG004|COMPLETED|Week 0-26 (Main Period)||0
2950983|NCT00700817|3664784|FG000|NOT COMPLETED|Week 0-26 (Main Period)||56
2950984|NCT00700817|3664785|FG001|NOT COMPLETED|Week 0-26 (Main Period)||30
2950985|NCT00700817|3664786|FG002|NOT COMPLETED|Week 0-26 (Main Period)||25
2950986|NCT00700817|3664787|FG003|NOT COMPLETED|Week 0-26 (Main Period)||0
2950987|NCT00700817|3664788|FG004|NOT COMPLETED|Week 0-26 (Main Period)||0
2950988|NCT00700817|3664784|FG000|STARTED|Week 26-52 (Extension Period 1)|Subjects withdrew before entry to extension period 1|155
2950989|NCT00700817|3664785|FG001|STARTED|Week 26-52 (Extension Period 1)|Subjects withdrew before entry to extension period 1|176
2950990|NCT00700817|3664786|FG002|STARTED|Week 26-52 (Extension Period 1)|Subjects withdrew before entry to extension period 1|166
2950991|NCT00700817|3664787|FG003|STARTED|Week 26-52 (Extension Period 1)||0
2950992|NCT00700817|3664788|FG004|STARTED|Week 26-52 (Extension Period 1)||0
2950993|NCT00700817|3664784|FG000|COMPLETED|Week 26-52 (Extension Period 1)||135
2950994|NCT00700817|3664785|FG001|COMPLETED|Week 26-52 (Extension Period 1)||150
2950995|NCT00700817|3664786|FG002|COMPLETED|Week 26-52 (Extension Period 1)||151
2950996|NCT00700817|3664787|FG003|COMPLETED|Week 26-52 (Extension Period 1)||0
2950997|NCT00700817|3664788|FG004|COMPLETED|Week 26-52 (Extension Period 1)||0
2950998|NCT00700817|3664784|FG000|NOT COMPLETED|Week 26-52 (Extension Period 1)||20
2950999|NCT00700817|3664785|FG001|NOT COMPLETED|Week 26-52 (Extension Period 1)||26
2951000|NCT00700817|3664786|FG002|NOT COMPLETED|Week 26-52 (Extension Period 1)||15
2951001|NCT00700817|3664787|FG003|NOT COMPLETED|Week 26-52 (Extension Period 1)||0
2951002|NCT00700817|3664788|FG004|NOT COMPLETED|Week 26-52 (Extension Period 1)||0
2951003|NCT00700817|3664784|FG000|STARTED|Week 52-78 (Extension Period 2)|Subject withdrew before entry to extension period 2|134
2951004|NCT00700817|3664785|FG001|STARTED|Week 52-78 (Extension Period 2)||150
2951005|NCT00700817|3664786|FG002|STARTED|Week 52-78 (Extension Period 2)|Re-randomised to lira 1.2 or 1.8 mg|0
2951006|NCT00700817|3664787|FG003|STARTED|Week 52-78 (Extension Period 2)|Re-randomised from sita treatment group. Some subjects withdrew before entry to extension period 2.|67
2951007|NCT00700817|3664788|FG004|STARTED|Week 52-78 (Extension Period 2)|Re-randomised from sita treatment group. Some subjects withdrew before entry to extension period 2.|68
2951008|NCT00700817|3664784|FG000|COMPLETED|Week 52-78 (Extension Period 2)||124
2951009|NCT00700817|3664785|FG001|COMPLETED|Week 52-78 (Extension Period 2)||135
2951010|NCT00700817|3664786|FG002|COMPLETED|Week 52-78 (Extension Period 2)||0
2951011|NCT00700817|3664787|FG003|COMPLETED|Week 52-78 (Extension Period 2)||59
2951012|NCT00700817|3664788|FG004|COMPLETED|Week 52-78 (Extension Period 2)||63
2951013|NCT00700817|3664784|FG000|NOT COMPLETED|Week 52-78 (Extension Period 2)||10
2951014|NCT00700817|3664785|FG001|NOT COMPLETED|Week 52-78 (Extension Period 2)||15
2951015|NCT00700817|3664786|FG002|NOT COMPLETED|Week 52-78 (Extension Period 2)||0
2951016|NCT00700817|3664787|FG003|NOT COMPLETED|Week 52-78 (Extension Period 2)||8
2951017|NCT00700817|3664788|FG004|NOT COMPLETED|Week 52-78 (Extension Period 2)||5
2951018|NCT00700882|3664798|FG000|STARTED|Overall Study||81
2951019|NCT00700882|3664798|FG000|Received Protocol Therapy|Overall Study||75
2951020|NCT00700882|3664798|FG000|Eligible and Treated Patients|Overall Study||73
2951021|NCT00700882|3664798|FG000|Eligible, Treated and KIT+ Patients|Overall Study||22
2951022|NCT00700882|3664798|FG000|COMPLETED|Overall Study||22
2951023|NCT00700882|3664798|FG000|NOT COMPLETED|Overall Study||59
2951024|NCT00700973|3664804|FG000|STARTED|Overall Study||71
2951025|NCT00700973|3664805|FG001|STARTED|Overall Study||70
2951026|NCT00700973|3664804|FG000|COMPLETED|Overall Study||63
2951027|NCT00700973|3664805|FG001|COMPLETED|Overall Study||63
2951028|NCT00700973|3664804|FG000|NOT COMPLETED|Overall Study||8
2951029|NCT00700973|3664805|FG001|NOT COMPLETED|Overall Study||7
2951030|NCT00700999|3664813|FG000|STARTED|Overall Study||36
2951031|NCT00700999|3664814|FG001|STARTED|Overall Study||29
2951032|NCT00700999|3664813|FG000|First MRI Scan|Overall Study||29
2951033|NCT00700999|3664814|FG001|First MRI Scan|Overall Study||22
2951034|NCT00700999|3664813|FG000|Second MRI Scan|Overall Study||19
2951035|NCT00700999|3664814|FG001|Second MRI Scan|Overall Study||18
2951036|NCT00700999|3664813|FG000|COMPLETED|Overall Study||21
2951037|NCT00700999|3664814|FG001|COMPLETED|Overall Study||20
2951038|NCT00700999|3664813|FG000|NOT COMPLETED|Overall Study||15
2951039|NCT00700999|3664814|FG001|NOT COMPLETED|Overall Study||9
2951040|NCT00701038|3664822|FG000|STARTED|Overall Study||27
2951041|NCT00701038|3664823|FG001|STARTED|Overall Study||27
2951042|NCT00701038|3664822|FG000|COMPLETED|Overall Study||23
2951043|NCT00701038|3664823|FG001|COMPLETED|Overall Study||23
2951044|NCT00701038|3664822|FG000|NOT COMPLETED|Overall Study||4
2951045|NCT00701038|3664823|FG001|NOT COMPLETED|Overall Study||4
2951046|NCT00701051|3664831|FG000|STARTED|Screening|Arm assignment not known until baseline testing; both arms included in this number|90
2951047|NCT00701051|3664832|FG001|STARTED|Screening||0
2951048|NCT00701051|3664833|FG002|STARTED|Screening||0
2951049|NCT00701051|3664831|FG000|COMPLETED|Screening|Arm assignment not known until baseline testing; both arms included in this number|31
2951050|NCT00701051|3664832|FG001|COMPLETED|Screening||0
2951051|NCT00701051|3664833|FG002|COMPLETED|Screening||0
2951052|NCT00701051|3664831|FG000|NOT COMPLETED|Screening||59
2951053|NCT00701051|3664832|FG001|NOT COMPLETED|Screening||0
2951054|NCT00701051|3664833|FG002|NOT COMPLETED|Screening||0
2951055|NCT00701051|3664831|FG000|STARTED|Exercise Intervention|Participants assigned to Normal or Impaired glucose tolerance arm after screening.|0
2951056|NCT00701051|3664832|FG001|STARTED|Exercise Intervention|Participants assigned to group after Period 1: Screening|19
2951057|NCT00701051|3664833|FG002|STARTED|Exercise Intervention|Participants assigned to group after Period 1: Screening|12
2951058|NCT00701051|3664831|FG000|COMPLETED|Exercise Intervention||0
2951059|NCT00701051|3664832|FG001|COMPLETED|Exercise Intervention||14
2951060|NCT00701051|3664833|FG002|COMPLETED|Exercise Intervention||9
2951061|NCT00701051|3664831|FG000|NOT COMPLETED|Exercise Intervention||0
2951062|NCT00701051|3664832|FG001|NOT COMPLETED|Exercise Intervention||5
2951063|NCT00701051|3664833|FG002|NOT COMPLETED|Exercise Intervention||3
2951064|NCT00701051|3664831|FG000|STARTED|Detraining Intervention (Optional)||0
2951065|NCT00701051|3664832|FG001|STARTED|Detraining Intervention (Optional)|Participation in this period was optional.|6
2951066|NCT00701051|3664833|FG002|STARTED|Detraining Intervention (Optional)|Participation in this period was optional.|6
2951067|NCT00701051|3664831|FG000|COMPLETED|Detraining Intervention (Optional)||0
2951068|NCT00701051|3664832|FG001|COMPLETED|Detraining Intervention (Optional)||6
2951069|NCT00701051|3664833|FG002|COMPLETED|Detraining Intervention (Optional)||6
2951070|NCT00701051|3664831|FG000|NOT COMPLETED|Detraining Intervention (Optional)||0
2951071|NCT00701051|3664832|FG001|NOT COMPLETED|Detraining Intervention (Optional)||0
2951072|NCT00701051|3664833|FG002|NOT COMPLETED|Detraining Intervention (Optional)||0
2951073|NCT00701064|3664841|FG000|STARTED|Overall Study||35
2951074|NCT00701064|3664842|FG001|STARTED|Overall Study||36
2951075|NCT00701064|3664841|FG000|COMPLETED|Overall Study||31
2951076|NCT00701064|3664842|FG001|COMPLETED|Overall Study||32
2951077|NCT00701064|3664841|FG000|NOT COMPLETED|Overall Study||4
2951078|NCT00701064|3664842|FG001|NOT COMPLETED|Overall Study||4
2951079|NCT00701090|3664850|FG000|STARTED|Overall Study||516
2951080|NCT00701090|3664851|FG001|STARTED|Overall Study||519
2951081|NCT00701090|3664850|FG000|COMPLETED|Overall Study||468
2951082|NCT00701090|3664851|FG001|COMPLETED|Overall Study||468
2951083|NCT00701090|3664850|FG000|NOT COMPLETED|Overall Study||48
2951084|NCT00701090|3664851|FG001|NOT COMPLETED|Overall Study||51
2951085|NCT00701103|3664868|FG000|STARTED|Overall Study||5
2951086|NCT00701103|3664869|FG001|STARTED|Overall Study||3
2951087|NCT00701103|3664870|FG002|STARTED|Overall Study||8
2951088|NCT00701103|3664871|FG003|STARTED|Overall Study||6
2951089|NCT00701103|3664872|FG004|STARTED|Overall Study||6
2951090|NCT00701103|3664873|FG005|STARTED|Overall Study||6
2951091|NCT00701103|3664874|FG006|STARTED|Overall Study||8
2951092|NCT00701103|3664875|FG007|STARTED|Overall Study||7
2951093|NCT00701103|3664876|FG008|STARTED|Overall Study||9
2951094|NCT00701103|3664877|FG009|STARTED|Overall Study||11
2951095|NCT00701103|3664878|FG010|STARTED|Overall Study||11
2951096|NCT00701103|3664868|FG000|COMPLETED|Overall Study||0
2951097|NCT00701103|3664869|FG001|COMPLETED|Overall Study||0
2951098|NCT00701103|3664870|FG002|COMPLETED|Overall Study||0
2951099|NCT00701103|3664871|FG003|COMPLETED|Overall Study||0
2951100|NCT00701103|3664872|FG004|COMPLETED|Overall Study||0
2951101|NCT00701103|3664873|FG005|COMPLETED|Overall Study||0
2951102|NCT00701103|3664874|FG006|COMPLETED|Overall Study||0
2951103|NCT00701103|3664875|FG007|COMPLETED|Overall Study||0
2951104|NCT00701103|3664876|FG008|COMPLETED|Overall Study||0
2951105|NCT00701103|3664877|FG009|COMPLETED|Overall Study||0
2951106|NCT00701103|3664878|FG010|COMPLETED|Overall Study||0
2951107|NCT00701103|3664868|FG000|NOT COMPLETED|Overall Study||5
2951108|NCT00701103|3664869|FG001|NOT COMPLETED|Overall Study||3
2951109|NCT00701103|3664870|FG002|NOT COMPLETED|Overall Study||8
2951110|NCT00701103|3664871|FG003|NOT COMPLETED|Overall Study||6
2951111|NCT00701103|3664872|FG004|NOT COMPLETED|Overall Study||6
2951112|NCT00701103|3664873|FG005|NOT COMPLETED|Overall Study||6
2951113|NCT00701103|3664874|FG006|NOT COMPLETED|Overall Study||8
2951114|NCT00701103|3664875|FG007|NOT COMPLETED|Overall Study||7
2951115|NCT00701103|3664876|FG008|NOT COMPLETED|Overall Study||9
2951116|NCT00701103|3664877|FG009|NOT COMPLETED|Overall Study||11
2951117|NCT00701103|3664878|FG010|NOT COMPLETED|Overall Study||11
2951118|NCT00701129|3664906|FG000|STARTED|Overall Study||4
2951119|NCT00701129|3664906|FG000|Full Analysis Set (FAS)|Overall Study|All enrolled patients who signed informed consent, received at least 1 dose of alglucosidase alfa.|4
2951120|NCT00701129|3664906|FG000|COMPLETED|Overall Study||2
2951121|NCT00701129|3664906|FG000|NOT COMPLETED|Overall Study||2
2951122|NCT00701311|3664910|FG000|STARTED|Overall Study||17
2951123|NCT00701311|3664910|FG000|COMPLETED|Overall Study|Eight subjects did not complete full period of treatment but their data was included in analysis.|9
2951124|NCT00701311|3664910|FG000|NOT COMPLETED|Overall Study||8
2951125|NCT00701363|3664918|FG000|STARTED|Screening (Pre-assignment) Phase||128
2951126|NCT00701363|3664919|FG001|STARTED|Screening (Pre-assignment) Phase||0
2951127|NCT00701363|3664920|FG002|STARTED|Screening (Pre-assignment) Phase||0
2951128|NCT00701363|3664921|FG003|STARTED|Screening (Pre-assignment) Phase||0
2951129|NCT00701363|3664918|FG000|COMPLETED|Screening (Pre-assignment) Phase||124
2951130|NCT00701363|3664919|FG001|COMPLETED|Screening (Pre-assignment) Phase||0
2951131|NCT00701363|3664920|FG002|COMPLETED|Screening (Pre-assignment) Phase||0
2951132|NCT00701363|3664921|FG003|COMPLETED|Screening (Pre-assignment) Phase||0
2951133|NCT00701363|3664918|FG000|NOT COMPLETED|Screening (Pre-assignment) Phase||4
2951134|NCT00701363|3664919|FG001|NOT COMPLETED|Screening (Pre-assignment) Phase||0
2951135|NCT00701363|3664920|FG002|NOT COMPLETED|Screening (Pre-assignment) Phase||0
2951136|NCT00701363|3664921|FG003|NOT COMPLETED|Screening (Pre-assignment) Phase||0
2951137|NCT00701363|3664918|FG000|STARTED|Treatment Phase 1||124
2951138|NCT00701363|3664919|FG001|STARTED|Treatment Phase 1||0
2951139|NCT00701363|3664920|FG002|STARTED|Treatment Phase 1||0
2951140|NCT00701363|3664921|FG003|STARTED|Treatment Phase 1||0
2951141|NCT00701363|3664918|FG000|COMPLETED|Treatment Phase 1||109
2951142|NCT00701363|3664919|FG001|COMPLETED|Treatment Phase 1||0
2951143|NCT00701363|3664920|FG002|COMPLETED|Treatment Phase 1||0
2951144|NCT00701363|3664921|FG003|COMPLETED|Treatment Phase 1||0
2951145|NCT00701363|3664918|FG000|NOT COMPLETED|Treatment Phase 1||15
2951146|NCT00701363|3664919|FG001|NOT COMPLETED|Treatment Phase 1||0
2951147|NCT00701363|3664920|FG002|NOT COMPLETED|Treatment Phase 1||0
2951148|NCT00701363|3664921|FG003|NOT COMPLETED|Treatment Phase 1||0
2951149|NCT00701363|3664918|FG000|STARTED|Treatment Phase 2||0
2951150|NCT00701363|3664919|FG001|STARTED|Treatment Phase 2||13
2951151|NCT00701363|3664920|FG002|STARTED|Treatment Phase 2||70
2951152|NCT00701363|3664921|FG003|STARTED|Treatment Phase 2||26
2951153|NCT00701363|3664918|FG000|COMPLETED|Treatment Phase 2||0
2951154|NCT00701363|3664919|FG001|COMPLETED|Treatment Phase 2||13
2951155|NCT00701363|3664920|FG002|COMPLETED|Treatment Phase 2||68
2951156|NCT00701363|3664921|FG003|COMPLETED|Treatment Phase 2||26
2951157|NCT00701363|3664918|FG000|NOT COMPLETED|Treatment Phase 2||0
2951158|NCT00701363|3664919|FG001|NOT COMPLETED|Treatment Phase 2||0
2951159|NCT00701363|3664920|FG002|NOT COMPLETED|Treatment Phase 2||2
2951160|NCT00701363|3664921|FG003|NOT COMPLETED|Treatment Phase 2||0
2951161|NCT00701376|3664941|FG000|STARTED|Overall Study||106
2951162|NCT00701376|3664941|FG000|COMPLETED|Overall Study||105
2951163|NCT00701376|3664941|FG000|NOT COMPLETED|Overall Study||1
2951164|NCT00701389|3664946|FG000|STARTED|Period 1||6
2951165|NCT00701389|3664947|FG001|STARTED|Period 1||6
2951166|NCT00701389|3664948|FG002|STARTED|Period 1||6
3300297|NCT02943941|4034215|FG000|COMPLETED|Overall Study||16
3300298|NCT02943941|4034215|FG000|NOT COMPLETED|Overall Study||0
3300299|NCT02944383|4034223|FG000|STARTED|Overall Study||30
3300300|NCT02944383|4034224|FG001|STARTED|Overall Study||30
3300301|NCT02944383|4034225|FG002|STARTED|Overall Study||31
3300302|NCT02944383|4034223|FG000|COMPLETED|Overall Study||29
2951167|NCT00701389|3664949|FG003|STARTED|Period 1||6
2951168|NCT00701389|3664946|FG000|COMPLETED|Period 1||6
2951169|NCT00701389|3664947|FG001|COMPLETED|Period 1||6
2951170|NCT00701389|3664948|FG002|COMPLETED|Period 1||6
2951171|NCT00701389|3664949|FG003|COMPLETED|Period 1||6
2951172|NCT00701389|3664946|FG000|NOT COMPLETED|Period 1||0
2951173|NCT00701389|3664947|FG001|NOT COMPLETED|Period 1||0
2951174|NCT00701389|3664948|FG002|NOT COMPLETED|Period 1||0
2951175|NCT00701389|3664949|FG003|NOT COMPLETED|Period 1||0
2951176|NCT00701389|3664946|FG000|STARTED|Period 2||6
2951177|NCT00701389|3664947|FG001|STARTED|Period 2||6
2951178|NCT00701389|3664948|FG002|STARTED|Period 2||6
2951179|NCT00701389|3664949|FG003|STARTED|Period 2||6
2951180|NCT00701389|3664946|FG000|COMPLETED|Period 2||6
2951181|NCT00701389|3664947|FG001|COMPLETED|Period 2||6
2951182|NCT00701389|3664948|FG002|COMPLETED|Period 2||6
2951183|NCT00701389|3664949|FG003|COMPLETED|Period 2||6
2951184|NCT00701389|3664946|FG000|NOT COMPLETED|Period 2||0
2951185|NCT00701389|3664947|FG001|NOT COMPLETED|Period 2||0
2951186|NCT00701389|3664948|FG002|NOT COMPLETED|Period 2||0
2951187|NCT00701389|3664949|FG003|NOT COMPLETED|Period 2||0
2951188|NCT00701389|3664946|FG000|STARTED|Period 3||6
2951189|NCT00701389|3664947|FG001|STARTED|Period 3||6
2951190|NCT00701389|3664948|FG002|STARTED|Period 3||6
2951191|NCT00701389|3664949|FG003|STARTED|Period 3||6
2951192|NCT00701389|3664946|FG000|COMPLETED|Period 3||6
2951193|NCT00701389|3664947|FG001|COMPLETED|Period 3||6
2951194|NCT00701389|3664948|FG002|COMPLETED|Period 3||6
2951195|NCT00701389|3664949|FG003|COMPLETED|Period 3||6
2951196|NCT00701389|3664946|FG000|NOT COMPLETED|Period 3||0
2951197|NCT00701389|3664947|FG001|NOT COMPLETED|Period 3||0
2951198|NCT00701389|3664948|FG002|NOT COMPLETED|Period 3||0
2951199|NCT00701389|3664949|FG003|NOT COMPLETED|Period 3||0
2951200|NCT00701389|3664946|FG000|STARTED|Period 4||6
2951201|NCT00701389|3664947|FG001|STARTED|Period 4||6
2951202|NCT00701389|3664948|FG002|STARTED|Period 4||6
2951203|NCT00701389|3664949|FG003|STARTED|Period 4||6
2951204|NCT00701389|3664946|FG000|COMPLETED|Period 4||6
2951205|NCT00701389|3664947|FG001|COMPLETED|Period 4||6
2951206|NCT00701389|3664948|FG002|COMPLETED|Period 4||6
2951207|NCT00701389|3664949|FG003|COMPLETED|Period 4||6
2951208|NCT00701389|3664946|FG000|NOT COMPLETED|Period 4||0
2951209|NCT00701389|3664947|FG001|NOT COMPLETED|Period 4||0
2951210|NCT00701389|3664948|FG002|NOT COMPLETED|Period 4||0
2951211|NCT00701389|3664949|FG003|NOT COMPLETED|Period 4||0
2951212|NCT00701415|3664965|FG000|STARTED|Overall Study||16
2951213|NCT00701415|3664966|FG001|STARTED|Overall Study||15
2951214|NCT00701415|3664965|FG000|COMPLETED|Overall Study||15
2951215|NCT00701415|3664966|FG001|COMPLETED|Overall Study||14
2951216|NCT00701415|3664965|FG000|NOT COMPLETED|Overall Study||1
2951217|NCT00701415|3664966|FG001|NOT COMPLETED|Overall Study||1
2951218|NCT00701441|3664974|FG000|STARTED|Overall Study||9
2951219|NCT00701441|3664975|FG001|STARTED|Overall Study||16
2951220|NCT00701441|3664974|FG000|COMPLETED|Overall Study||9
2951221|NCT00701441|3664975|FG001|COMPLETED|Overall Study||12
2951222|NCT00701441|3664974|FG000|NOT COMPLETED|Overall Study||0
2951223|NCT00701441|3664975|FG001|NOT COMPLETED|Overall Study||4
2951224|NCT00701558|3664985|FG000|STARTED|Overall Study||19
2951225|NCT00701558|3664985|FG000|COMPLETED|Overall Study||4
2951226|NCT00701558|3664985|FG000|NOT COMPLETED|Overall Study||15
2951227|NCT00701636|3664991|FG000|STARTED|Overall Study||15
2951228|NCT00701636|3664992|FG001|STARTED|Overall Study||15
2951229|NCT00701636|3664991|FG000|COMPLETED|Overall Study||15
2951230|NCT00701636|3664992|FG001|COMPLETED|Overall Study||15
2951231|NCT00701636|3664991|FG000|NOT COMPLETED|Overall Study||0
2951232|NCT00701636|3664992|FG001|NOT COMPLETED|Overall Study||0
2951233|NCT00701662|3664997|FG000|STARTED|Overall Study||8
2951234|NCT00701662|3664997|FG000|COMPLETED|Overall Study||7
2951235|NCT00701662|3664997|FG000|NOT COMPLETED|Overall Study||1
2951236|NCT00701675|3665004|FG000|STARTED|Overall Study||14
2951237|NCT00701675|3665005|FG001|STARTED|Overall Study||14
2951238|NCT00701675|3665006|FG002|STARTED|Overall Study||14
2951239|NCT00701675|3665004|FG000|COMPLETED|Overall Study||10
2951240|NCT00701675|3665005|FG001|COMPLETED|Overall Study||6
2951241|NCT00701675|3665006|FG002|COMPLETED|Overall Study||7
2951242|NCT00701675|3665004|FG000|NOT COMPLETED|Overall Study||4
2951243|NCT00701675|3665005|FG001|NOT COMPLETED|Overall Study||8
2951244|NCT00701675|3665006|FG002|NOT COMPLETED|Overall Study||7
2951245|NCT00701701|3665016|FG000|STARTED|Overall Study||1
2951246|NCT00701701|3665017|FG001|STARTED|Overall Study||3
2951247|NCT00701701|3665016|FG000|COMPLETED|Overall Study||1
2951248|NCT00701701|3665017|FG001|COMPLETED|Overall Study||1
2951249|NCT00701701|3665016|FG000|NOT COMPLETED|Overall Study||0
2951250|NCT00701701|3665017|FG001|NOT COMPLETED|Overall Study||2
2951251|NCT00701714|3665026|FG000|STARTED|Treatment Period (up to 1 Year)||174
2951252|NCT00701714|3665027|FG001|STARTED|Treatment Period (up to 1 Year)||163
2951253|NCT00701714|3665026|FG000|COMPLETED|Treatment Period (up to 1 Year)||37
2951254|NCT00701714|3665027|FG001|COMPLETED|Treatment Period (up to 1 Year)||29
2951255|NCT00701714|3665026|FG000|NOT COMPLETED|Treatment Period (up to 1 Year)||137
2951256|NCT00701714|3665027|FG001|NOT COMPLETED|Treatment Period (up to 1 Year)||134
2951257|NCT00701714|3665026|FG000|STARTED|Safety Follow-up Period (6 Months)|Study terminated prematurely, all available randomized patients followed-up 6 months for safety|151
2951258|NCT00701714|3665027|FG001|STARTED|Safety Follow-up Period (6 Months)|Study terminated prematurely, all available randomized patients followed-up 6 months for safety|119
2951259|NCT00701714|3665026|FG000|COMPLETED|Safety Follow-up Period (6 Months)||144
2951260|NCT00701714|3665027|FG001|COMPLETED|Safety Follow-up Period (6 Months)||112
2951261|NCT00701714|3665026|FG000|NOT COMPLETED|Safety Follow-up Period (6 Months)||7
2951262|NCT00701714|3665027|FG001|NOT COMPLETED|Safety Follow-up Period (6 Months)||7
2951263|NCT00701727|3665037|FG000|STARTED|First Treatment Period||16
2951264|NCT00701727|3665038|FG001|STARTED|First Treatment Period||15
2951265|NCT00701727|3665037|FG000|COMPLETED|First Treatment Period||15
2951266|NCT00701727|3665038|FG001|COMPLETED|First Treatment Period||13
2951267|NCT00701727|3665037|FG000|NOT COMPLETED|First Treatment Period||1
2951268|NCT00701727|3665038|FG001|NOT COMPLETED|First Treatment Period||2
2951269|NCT00701727|3665037|FG000|STARTED|Second Treatment Period||15
2951270|NCT00701727|3665038|FG001|STARTED|Second Treatment Period||13
2951271|NCT00701727|3665037|FG000|COMPLETED|Second Treatment Period||13
2951272|NCT00701727|3665038|FG001|COMPLETED|Second Treatment Period||13
2951273|NCT00701727|3665037|FG000|NOT COMPLETED|Second Treatment Period||2
2951274|NCT00701727|3665038|FG001|NOT COMPLETED|Second Treatment Period||0
2951275|NCT00701779|3665044|FG000|STARTED|Overall Study||63
2951276|NCT00701779|3665044|FG000|3 Month|Overall Study||60
2951277|NCT00701779|3665044|FG000|6 Month|Overall Study||58
2951278|NCT00701779|3665044|FG000|9 Month|Overall Study||56
2951279|NCT00701779|3665044|FG000|12 Month|Overall Study||54
2951280|NCT00701779|3665044|FG000|COMPLETED|Overall Study||54
2951281|NCT00701779|3665044|FG000|NOT COMPLETED|Overall Study||9
2951282|NCT00701805|3665052|FG000|STARTED|Overall Study||26
2951283|NCT00701805|3665053|FG001|STARTED|Overall Study||29
2951284|NCT00701805|3665054|FG002|STARTED|Overall Study||23
2951285|NCT00701805|3665055|FG003|STARTED|Overall Study||26
2951286|NCT00701805|3665052|FG000|COMPLETED|Overall Study||23
2951287|NCT00701805|3665053|FG001|COMPLETED|Overall Study||25
2951288|NCT00701805|3665054|FG002|COMPLETED|Overall Study||16
2951289|NCT00701805|3665055|FG003|COMPLETED|Overall Study||22
2951290|NCT00701805|3665052|FG000|NOT COMPLETED|Overall Study||3
2951291|NCT00701805|3665053|FG001|NOT COMPLETED|Overall Study||4
2951292|NCT00701805|3665054|FG002|NOT COMPLETED|Overall Study||7
2951293|NCT00701805|3665055|FG003|NOT COMPLETED|Overall Study||4
2951294|NCT00701896|3665067|FG000|STARTED|Overall Study|Includes those eligible but declined to participate|143
2951295|NCT00701896|3665068|FG001|STARTED|Overall Study|Includes those eligible but declined to participate|151
2951296|NCT00701896|3665067|FG000|COMPLETED|Overall Study||110
2951297|NCT00701896|3665068|FG001|COMPLETED|Overall Study||118
2951298|NCT00701896|3665067|FG000|NOT COMPLETED|Overall Study||33
2951299|NCT00701896|3665068|FG001|NOT COMPLETED|Overall Study||33
2951300|NCT00701935|3665076|FG000|STARTED|Overall Study||43
2951301|NCT00701935|3665077|FG001|STARTED|Overall Study||37
2951302|NCT00701935|3665076|FG000|COMPLETED|Overall Study||27
2951303|NCT00701935|3665077|FG001|COMPLETED|Overall Study||26
2951304|NCT00701935|3665076|FG000|NOT COMPLETED|Overall Study||16
2951305|NCT00701935|3665077|FG001|NOT COMPLETED|Overall Study||11
2951306|NCT00702052|3665083|FG000|STARTED|Overall Study||58
2951307|NCT00702052|3665083|FG000|COMPLETED|Overall Study||0
2951308|NCT00702052|3665083|FG000|NOT COMPLETED|Overall Study||58
2951309|NCT00702143|3665090|FG000|STARTED|Overall Study||45
2951310|NCT00702143|3665091|FG001|STARTED|Overall Study||60
2951311|NCT00702143|3665092|FG002|STARTED|Overall Study||79
2951312|NCT00702143|3665090|FG000|COMPLETED|Overall Study||45
2951313|NCT00702143|3665091|FG001|COMPLETED|Overall Study||60
2951314|NCT00702143|3665092|FG002|COMPLETED|Overall Study||78
2951315|NCT00702143|3665090|FG000|NOT COMPLETED|Overall Study||0
2951316|NCT00702143|3665091|FG001|NOT COMPLETED|Overall Study||0
2951317|NCT00702143|3665092|FG002|NOT COMPLETED|Overall Study||1
2951318|NCT00702208|3665098|FG000|STARTED|Overall Study||198
2951319|NCT00702208|3665098|FG000|COMPLETED|Overall Study||167
2951320|NCT00702208|3665098|FG000|NOT COMPLETED|Overall Study||31
2951321|NCT00702221|3665105|FG000|STARTED|Overall Study||10
2951322|NCT00702221|3665106|FG001|STARTED|Overall Study||10
2951323|NCT00702221|3665105|FG000|COMPLETED|Overall Study||6
2951324|NCT00702221|3665106|FG001|COMPLETED|Overall Study||7
2951325|NCT00702221|3665105|FG000|NOT COMPLETED|Overall Study||4
2951326|NCT00702221|3665106|FG001|NOT COMPLETED|Overall Study||3
2951327|NCT00702299|3665112|FG000|STARTED|Overall Study||15
2951328|NCT00702299|3665112|FG000|COMPLETED|Overall Study||15
2951329|NCT00702299|3665112|FG000|NOT COMPLETED|Overall Study||0
2951330|NCT00702325|3665121|FG000|STARTED|Overall Study|Randomized|156
2951331|NCT00702325|3665122|FG001|STARTED|Overall Study|Randomized|155
2951332|NCT00702325|3665121|FG000|COMPLETED|Overall Study|Completed participants based on randomized population (156) minus discontinued participants (38).|118
2951333|NCT00702325|3665122|FG001|COMPLETED|Overall Study|Completed participants based on randomized population (155) minus discontinued participants (53).|102
2951334|NCT00702325|3665121|FG000|NOT COMPLETED|Overall Study||38
2951335|NCT00702325|3665122|FG001|NOT COMPLETED|Overall Study||53
2951336|NCT00702364|3665130|FG000|STARTED|Overall Study||26
2951337|NCT00702364|3665131|FG001|STARTED|Overall Study||29
2951338|NCT00702364|3665130|FG000|COMPLETED|Overall Study||24
2951339|NCT00702364|3665131|FG001|COMPLETED|Overall Study||25
2951340|NCT00702364|3665130|FG000|NOT COMPLETED|Overall Study||2
2951341|NCT00702364|3665131|FG001|NOT COMPLETED|Overall Study||4
2951342|NCT00702377|3665139|FG000|STARTED|Overall Study||53
2951343|NCT00702377|3665140|FG001|STARTED|Overall Study||56
2951344|NCT00702377|3665139|FG000|COMPLETED|Overall Study||52
2951345|NCT00702377|3665140|FG001|COMPLETED|Overall Study||53
2951346|NCT00702377|3665139|FG000|NOT COMPLETED|Overall Study||1
2951347|NCT00702377|3665140|FG001|NOT COMPLETED|Overall Study||3
2951348|NCT00702403|3665146|FG000|STARTED|From Consent to Engraftment|"57 agreed to participate and completed informed consent (= the 1st intention to treat population)"|57
2951349|NCT00702403|3665146|FG000|Ineligible for Study Drug|From Consent to Engraftment||17
2951350|NCT00702403|3665146|FG000|COMPLETED|From Consent to Engraftment|40 of 57 originally consented subjects remained eligible at engraftment (= the 2nd ITT population)|40
2951351|NCT00702403|3665146|FG000|NOT COMPLETED|From Consent to Engraftment||17
2951352|NCT00702403|3665146|FG000|STARTED|From Engraftment to Study Completion||40
2951353|NCT00702403|3665146|FG000|Patient Drop-outs|From Engraftment to Study Completion||27
2951354|NCT00702403|3665146|FG000|COMPLETED|From Engraftment to Study Completion||13
2951355|NCT00702403|3665146|FG000|NOT COMPLETED|From Engraftment to Study Completion||27
3132505|NCT01691482|3857559|FG000|COMPLETED|Treatment Period 2||27
3132506|NCT01691482|3857560|FG001|COMPLETED|Treatment Period 2||26
3132507|NCT01691482|3857559|FG000|NOT COMPLETED|Treatment Period 2||1
3132508|NCT01691482|3857560|FG001|NOT COMPLETED|Treatment Period 2||2
2951356|NCT00702468|3665155|FG000|STARTED|Overall Study||18
2951357|NCT00702468|3665156|FG001|STARTED|Overall Study||18
2951358|NCT00702468|3665155|FG000|COMPLETED|Overall Study||15
2951359|NCT00702468|3665156|FG001|COMPLETED|Overall Study||2
2951360|NCT00702468|3665155|FG000|NOT COMPLETED|Overall Study||3
2951361|NCT00702468|3665156|FG001|NOT COMPLETED|Overall Study||16
2951362|NCT00702507|3665162|FG000|STARTED|Initial Treatment Phase||200
2951363|NCT00702507|3665162|FG000|COMPLETED|Initial Treatment Phase||159
2951364|NCT00702507|3665162|FG000|NOT COMPLETED|Initial Treatment Phase||41
2951365|NCT00702507|3665162|FG000|STARTED|Follow-up Phase||159
2951366|NCT00702507|3665162|FG000|COMPLETED|Follow-up Phase||132
2951367|NCT00702507|3665162|FG000|NOT COMPLETED|Follow-up Phase||27
2951368|NCT00702650|3665167|FG000|STARTED|Overall Study||155
2951369|NCT00702650|3665167|FG000|COMPLETED|Overall Study||135
2951370|NCT00702650|3665167|FG000|NOT COMPLETED|Overall Study||20
2951371|NCT00702689|3665171|FG000|STARTED|Overall Study||20
2951372|NCT00702689|3665171|FG000|COMPLETED|Overall Study||14
3132509|NCT01691508|3857569|FG000|STARTED|Overall Study||66
3132510|NCT01691508|3857570|FG001|STARTED|Overall Study||69
2951373|NCT00702689|3665171|FG000|NOT COMPLETED|Overall Study||6
2951374|NCT00702715|3665177|FG000|STARTED|Overall Study||35
2951375|NCT00702715|3665178|FG001|STARTED|Overall Study|One subject was enrolled but did not start study|33
2951376|NCT00702715|3665177|FG000|COMPLETED|Overall Study||34
2951377|NCT00702715|3665178|FG001|COMPLETED|Overall Study||33
3132511|NCT01691508|3857569|FG000|COMPLETED|Overall Study||62
2951378|NCT00702715|3665177|FG000|NOT COMPLETED|Overall Study||1
2951379|NCT00702715|3665178|FG001|NOT COMPLETED|Overall Study||0
2951380|NCT00702754|3665184|FG000|STARTED|MYOBLOC Treatment Session 1 (Time 0)||502
2951381|NCT00702754|3665184|FG000|COMPLETED|MYOBLOC Treatment Session 1 (Time 0)|Approximately 70% of subjects completed at least 2 years of treatment.|495
2951382|NCT00702754|3665184|FG000|NOT COMPLETED|MYOBLOC Treatment Session 1 (Time 0)||7
2951383|NCT00702754|3665184|FG000|STARTED|MYOBLOC Treatment Session 2 (App 12 Wks)||495
2951384|NCT00702754|3665184|FG000|COMPLETED|MYOBLOC Treatment Session 2 (App 12 Wks)||475
2951385|NCT00702754|3665184|FG000|NOT COMPLETED|MYOBLOC Treatment Session 2 (App 12 Wks)||20
2951386|NCT00702754|3665184|FG000|STARTED|MYOBLOC Treatment Session 3 (App 24 Wks)||475
2951387|NCT00702754|3665184|FG000|COMPLETED|MYOBLOC Treatment Session 3 (App 24 Wks)||450
2951388|NCT00702754|3665184|FG000|NOT COMPLETED|MYOBLOC Treatment Session 3 (App 24 Wks)||25
2951389|NCT00702754|3665184|FG000|STARTED|MYOBLOC Treatment Session 4 (App 36 Wks)||450
2951390|NCT00702754|3665184|FG000|COMPLETED|MYOBLOC Treatment Session 4 (App 36 Wks)||428
2951391|NCT00702754|3665184|FG000|NOT COMPLETED|MYOBLOC Treatment Session 4 (App 36 Wks)||22
2951392|NCT00702754|3665184|FG000|STARTED|MYOBLOC Treatment Session 5 (App 48 Wks)||428
2951393|NCT00702754|3665184|FG000|COMPLETED|MYOBLOC Treatment Session 5 (App 48 Wks)||396
2951394|NCT00702754|3665184|FG000|NOT COMPLETED|MYOBLOC Treatment Session 5 (App 48 Wks)||32
2951395|NCT00702754|3665184|FG000|STARTED|MYOBLOC Treatment Session 6 (App 60 Wks)||396
2951396|NCT00702754|3665184|FG000|COMPLETED|MYOBLOC Treatment Session 6 (App 60 Wks)||377
2951397|NCT00702754|3665184|FG000|NOT COMPLETED|MYOBLOC Treatment Session 6 (App 60 Wks)||19
2951398|NCT00702754|3665184|FG000|STARTED|MYOBLOC Treatment Session 7 (App 72 Wks)||377
2951399|NCT00702754|3665184|FG000|COMPLETED|MYOBLOC Treatment Session 7 (App 72 Wks)||353
2951400|NCT00702754|3665184|FG000|NOT COMPLETED|MYOBLOC Treatment Session 7 (App 72 Wks)||24
2951401|NCT00702754|3665184|FG000|STARTED|MYOBLOC Treatment Session 8 (App 84 Wks)||353
2951402|NCT00702754|3665184|FG000|COMPLETED|MYOBLOC Treatment Session 8 (App 84 Wks)||329
2951403|NCT00702754|3665184|FG000|NOT COMPLETED|MYOBLOC Treatment Session 8 (App 84 Wks)||24
2951404|NCT00702780|3665190|FG000|STARTED|Overall Study||37
2951405|NCT00702780|3665191|FG001|STARTED|Overall Study||37
2951406|NCT00702780|3665190|FG000|COMPLETED|Overall Study||28
2951407|NCT00702780|3665191|FG001|COMPLETED|Overall Study||29
2951408|NCT00702780|3665190|FG000|NOT COMPLETED|Overall Study||9
2951409|NCT00702780|3665191|FG001|NOT COMPLETED|Overall Study||8
2951410|NCT00702884|3665197|FG000|STARTED|Overall Study||25
2951411|NCT00702884|3665197|FG000|COMPLETED|Overall Study||25
2951412|NCT00702884|3665197|FG000|NOT COMPLETED|Overall Study||0
2951413|NCT00702923|3665204|FG000|STARTED|Overall Study||12
2951414|NCT00702923|3665204|FG000|COMPLETED|Overall Study||11
2951415|NCT00702923|3665204|FG000|NOT COMPLETED|Overall Study||1
2951416|NCT00702949|3665212|FG000|STARTED|Overall Study||63
2951417|NCT00702949|3665213|FG001|STARTED|Overall Study||66
2951418|NCT00702949|3665214|FG002|STARTED|Overall Study||62
2951419|NCT00702949|3665212|FG000|Evaluable for Primary Endpoint|Overall Study||56
2951420|NCT00702949|3665213|FG001|Evaluable for Primary Endpoint|Overall Study||56
2951421|NCT00702949|3665214|FG002|Evaluable for Primary Endpoint|Overall Study||51
2951422|NCT00702949|3665212|FG000|COMPLETED|Overall Study||58
2951423|NCT00702949|3665213|FG001|COMPLETED|Overall Study||57
2951424|NCT00702949|3665214|FG002|COMPLETED|Overall Study||54
2951425|NCT00702949|3665212|FG000|NOT COMPLETED|Overall Study||5
2951426|NCT00702949|3665213|FG001|NOT COMPLETED|Overall Study||9
2951427|NCT00702949|3665214|FG002|NOT COMPLETED|Overall Study||8
2951428|NCT00703053|3665233|FG000|STARTED|Overall Study||27
2951429|NCT00703053|3665234|FG001|STARTED|Overall Study||26
2951430|NCT00703053|3665235|FG002|STARTED|Overall Study||51
2951431|NCT00703053|3665236|FG003|STARTED|Overall Study||49
2951432|NCT00703053|3665237|FG004|STARTED|Overall Study||51
2951433|NCT00703053|3665238|FG005|STARTED|Overall Study||49
2951434|NCT00703053|3665239|FG006|STARTED|Overall Study||52
2951435|NCT00703053|3665240|FG007|STARTED|Overall Study||97
2951436|NCT00703053|3665241|FG008|STARTED|Overall Study||103
2951437|NCT00703053|3665233|FG000|COMPLETED|Overall Study||26
2951438|NCT00703053|3665234|FG001|COMPLETED|Overall Study||24
2951439|NCT00703053|3665235|FG002|COMPLETED|Overall Study||48
2951440|NCT00703053|3665236|FG003|COMPLETED|Overall Study||46
2951441|NCT00703053|3665237|FG004|COMPLETED|Overall Study||50
2951442|NCT00703053|3665238|FG005|COMPLETED|Overall Study||43
2951443|NCT00703053|3665239|FG006|COMPLETED|Overall Study||45
2951444|NCT00703053|3665240|FG007|COMPLETED|Overall Study||91
3163441|NCT01886716|3890934|FG002|COMPLETED|1-Month Post Follow-Up||19
3163442|NCT01886716|3890935|FG003|COMPLETED|1-Month Post Follow-Up||14
3163443|NCT01886716|3890932|FG000|NOT COMPLETED|1-Month Post Follow-Up||0
2951445|NCT00703053|3665241|FG008|COMPLETED|Overall Study||102
2951446|NCT00703053|3665233|FG000|NOT COMPLETED|Overall Study||1
2951447|NCT00703053|3665234|FG001|NOT COMPLETED|Overall Study||2
2951448|NCT00703053|3665235|FG002|NOT COMPLETED|Overall Study||3
2951449|NCT00703053|3665236|FG003|NOT COMPLETED|Overall Study||3
2951450|NCT00703053|3665237|FG004|NOT COMPLETED|Overall Study||1
2951451|NCT00703053|3665238|FG005|NOT COMPLETED|Overall Study||6
2951452|NCT00703053|3665239|FG006|NOT COMPLETED|Overall Study||7
2951453|NCT00703053|3665240|FG007|NOT COMPLETED|Overall Study||6
2951454|NCT00703053|3665241|FG008|NOT COMPLETED|Overall Study||1
2951455|NCT00703118|3665266|FG000|STARTED|Overall Study||266
2951456|NCT00703118|3665267|FG001|STARTED|Overall Study||264
2951457|NCT00703118|3665268|FG002|STARTED|Overall Study||132
2951458|NCT00703118|3665266|FG000|COMPLETED|Overall Study||245
2951459|NCT00703118|3665267|FG001|COMPLETED|Overall Study||248
2951460|NCT00703118|3665268|FG002|COMPLETED|Overall Study||110
2951461|NCT00703118|3665266|FG000|NOT COMPLETED|Overall Study||21
2951462|NCT00703118|3665267|FG001|NOT COMPLETED|Overall Study||16
2951463|NCT00703118|3665268|FG002|NOT COMPLETED|Overall Study||22
2951464|NCT00703157|3665281|FG000|STARTED|Overall Study||26
2951465|NCT00703157|3665282|FG001|STARTED|Overall Study||26
2951466|NCT00703157|3665281|FG000|6 Months FU|Overall Study||25
2951467|NCT00703157|3665282|FG001|6 Months FU|Overall Study||25
2951468|NCT00703157|3665281|FG000|24 Months FU|Overall Study||22
2951469|NCT00703157|3665282|FG001|24 Months FU|Overall Study||24
2951470|NCT00703157|3665281|FG000|COMPLETED|Overall Study||22
2951471|NCT00703157|3665282|FG001|COMPLETED|Overall Study||24
2951472|NCT00703157|3665281|FG000|NOT COMPLETED|Overall Study||4
2951473|NCT00703157|3665282|FG001|NOT COMPLETED|Overall Study||2
2951474|NCT00703261|3665292|FG000|STARTED|Overall Study||42
2951475|NCT00703261|3665293|FG001|STARTED|Overall Study||41
2951476|NCT00703261|3665292|FG000|COMPLETED|Overall Study||36
2951477|NCT00703261|3665293|FG001|COMPLETED|Overall Study||35
2951478|NCT00703261|3665292|FG000|NOT COMPLETED|Overall Study||6
2951479|NCT00703261|3665293|FG001|NOT COMPLETED|Overall Study||6
2951480|NCT00703391|3665302|FG000|STARTED|Overall Study||12
2951481|NCT00703391|3665303|FG001|STARTED|Overall Study||6
2951482|NCT00703391|3665302|FG000|COMPLETED|Overall Study||12
2951483|NCT00703391|3665303|FG001|COMPLETED|Overall Study||6
2951484|NCT00703391|3665302|FG000|NOT COMPLETED|Overall Study||0
2951485|NCT00703391|3665303|FG001|NOT COMPLETED|Overall Study||0
2951486|NCT00703508|3665309|FG000|STARTED|Overall Study||26
2951487|NCT00703508|3665309|FG000|COMPLETED|Overall Study||26
2951488|NCT00703508|3665309|FG000|NOT COMPLETED|Overall Study||0
2951489|NCT00703664|3665318|FG000|STARTED|Overall Study||22
2951490|NCT00703664|3665319|FG001|STARTED|Overall Study||4
2951491|NCT00703664|3665320|FG002|STARTED|Overall Study||39
2951492|NCT00703664|3665318|FG000|COMPLETED|Overall Study||22
2951493|NCT00703664|3665319|FG001|COMPLETED|Overall Study||4
2951494|NCT00703664|3665320|FG002|COMPLETED|Overall Study||39
2951495|NCT00703664|3665318|FG000|NOT COMPLETED|Overall Study||0
2951496|NCT00703664|3665319|FG001|NOT COMPLETED|Overall Study||0
2951497|NCT00703664|3665320|FG002|NOT COMPLETED|Overall Study||0
2951498|NCT00703677|3665328|FG000|STARTED|Overall Study||17
2951499|NCT00703677|3665328|FG000|COMPLETED|Overall Study||14
2951500|NCT00703677|3665328|FG000|NOT COMPLETED|Overall Study||3
2951501|NCT00703729|3665334|FG000|STARTED|Overall Study||25
2951502|NCT00703729|3665335|FG001|STARTED|Overall Study||24
2951503|NCT00703729|3665334|FG000|COMPLETED|Overall Study||25
2951504|NCT00703729|3665335|FG001|COMPLETED|Overall Study||21
2951505|NCT00703729|3665334|FG000|NOT COMPLETED|Overall Study||0
2951506|NCT00703729|3665335|FG001|NOT COMPLETED|Overall Study||3
2951507|NCT00703781|3665343|FG000|STARTED|Overall Study||63
2951508|NCT00703781|3665344|FG001|STARTED|Overall Study||63
2951509|NCT00703781|3665343|FG000|COMPLETED|Overall Study||61
2951510|NCT00703781|3665344|FG001|COMPLETED|Overall Study||61
2951511|NCT00703781|3665343|FG000|NOT COMPLETED|Overall Study||2
2951512|NCT00703781|3665344|FG001|NOT COMPLETED|Overall Study||2
2951513|NCT00703820|3665352|FG000|STARTED|Overall Study||133
2951514|NCT00703820|3665353|FG001|STARTED|Overall Study||129
2951515|NCT00703820|3665352|FG000|COMPLETED|Overall Study||98
2951516|NCT00703820|3665353|FG001|COMPLETED|Overall Study||95
2951517|NCT00703820|3665352|FG000|NOT COMPLETED|Overall Study||35
2951518|NCT00703820|3665353|FG001|NOT COMPLETED|Overall Study||34
2951519|NCT00703846|3665361|FG000|STARTED|Overall Study||500
2951520|NCT00703846|3665361|FG000|COMPLETED|Overall Study||363
2951521|NCT00703846|3665361|FG000|NOT COMPLETED|Overall Study||137
2951522|NCT00703911|3665365|FG000|STARTED|Overall Study||102
2951523|NCT00703911|3665365|FG000|COMPLETED|Overall Study||92
2951524|NCT00703911|3665365|FG000|NOT COMPLETED|Overall Study||10
2951525|NCT00703924|3665371|FG000|STARTED|Overall Study||50
2951526|NCT00703924|3665372|FG001|STARTED|Overall Study||42
2951527|NCT00703924|3665371|FG000|COMPLETED|Overall Study||49
2951528|NCT00703924|3665372|FG001|COMPLETED|Overall Study||41
2951529|NCT00703924|3665371|FG000|NOT COMPLETED|Overall Study||1
2951530|NCT00703924|3665372|FG001|NOT COMPLETED|Overall Study||1
2951531|NCT00703937|3665384|FG000|STARTED|Overall Study||343
2951532|NCT00703937|3665385|FG001|STARTED|Overall Study||360
2951533|NCT00703937|3665384|FG000|COMPLETED|Overall Study||278
2951534|NCT00703937|3665385|FG001|COMPLETED|Overall Study||267
2951535|NCT00703937|3665384|FG000|NOT COMPLETED|Overall Study||65
2951536|NCT00703937|3665385|FG001|NOT COMPLETED|Overall Study||93
2951537|NCT00703963|3665393|FG000|STARTED|Overall Study||100
2951538|NCT00703963|3665394|FG001|STARTED|Overall Study||100
2951539|NCT00703963|3665393|FG000|COMPLETED|Overall Study||93
2951540|NCT00703963|3665394|FG001|COMPLETED|Overall Study||86
2951541|NCT00703963|3665393|FG000|NOT COMPLETED|Overall Study||7
2951542|NCT00703963|3665394|FG001|NOT COMPLETED|Overall Study||14
2951543|NCT00703976|3665402|FG000|STARTED|Overall Study||37
2951544|NCT00703976|3665403|FG001|STARTED|Overall Study||41
2951545|NCT00703976|3665402|FG000|COMPLETED|Overall Study||37
2951546|NCT00703976|3665403|FG001|COMPLETED|Overall Study||41
2951547|NCT00703976|3665402|FG000|NOT COMPLETED|Overall Study||0
2951548|NCT00703976|3665403|FG001|NOT COMPLETED|Overall Study||0
2951549|NCT00704028|3665413|FG000|STARTED|Overall Study||82
2951550|NCT00704028|3665414|FG001|STARTED|Overall Study|A subject randomized to iron dextran never received study drug and was d/c due to subject request.|78
2951551|NCT00704028|3665413|FG000|COMPLETED|Overall Study||70
2951552|NCT00704028|3665414|FG001|COMPLETED|Overall Study||57
2951553|NCT00704028|3665413|FG000|NOT COMPLETED|Overall Study||12
2951554|NCT00704028|3665414|FG001|NOT COMPLETED|Overall Study||21
2951555|NCT00704132|3665422|FG000|STARTED|Overall Study||26
2951556|NCT00704132|3665423|FG001|STARTED|Overall Study||24
2951557|NCT00704132|3665422|FG000|COMPLETED|Overall Study||25
2951558|NCT00704132|3665423|FG001|COMPLETED|Overall Study||22
2951559|NCT00704132|3665422|FG000|NOT COMPLETED|Overall Study||1
2951560|NCT00704132|3665423|FG001|NOT COMPLETED|Overall Study||2
2951561|NCT00704171|3665431|FG000|STARTED|Overall Study||62
2951562|NCT00704171|3665432|FG001|STARTED|Overall Study||59
2951563|NCT00704171|3665431|FG000|COMPLETED|Overall Study|One subject withdrew consent prior to study completion. No reason given.|61
2951564|NCT00704171|3665432|FG001|COMPLETED|Overall Study|All control subjects completed the study.|59
2951565|NCT00704171|3665431|FG000|NOT COMPLETED|Overall Study||1
2951566|NCT00704171|3665432|FG001|NOT COMPLETED|Overall Study||0
2951567|NCT00704184|3665443|FG000|STARTED|Double-Blind Treatment||20
2951568|NCT00704184|3665444|FG001|STARTED|Double-Blind Treatment||18
2951569|NCT00704184|3665445|FG002|STARTED|Double-Blind Treatment||20
2951570|NCT00704184|3665446|FG003|STARTED|Double-Blind Treatment||18
2951571|NCT00704184|3665447|FG004|STARTED|Double-Blind Treatment||19
2951572|NCT00704184|3665443|FG000|Treated|Double-Blind Treatment|One participant was randomized to placebo but withdrew prior to receiving study medication.|19
2951573|NCT00704184|3665444|FG001|Treated|Double-Blind Treatment||18
2951574|NCT00704184|3665445|FG002|Treated|Double-Blind Treatment||20
2951575|NCT00704184|3665446|FG003|Treated|Double-Blind Treatment||18
2951576|NCT00704184|3665447|FG004|Treated|Double-Blind Treatment||19
2951577|NCT00704184|3665443|FG000|COMPLETED|Double-Blind Treatment||19
2951578|NCT00704184|3665444|FG001|COMPLETED|Double-Blind Treatment||18
2951579|NCT00704184|3665445|FG002|COMPLETED|Double-Blind Treatment||20
2951580|NCT00704184|3665446|FG003|COMPLETED|Double-Blind Treatment||18
2951581|NCT00704184|3665447|FG004|COMPLETED|Double-Blind Treatment||19
2951582|NCT00704184|3665443|FG000|NOT COMPLETED|Double-Blind Treatment||1
2951583|NCT00704184|3665444|FG001|NOT COMPLETED|Double-Blind Treatment||0
2951584|NCT00704184|3665445|FG002|NOT COMPLETED|Double-Blind Treatment||0
2951585|NCT00704184|3665446|FG003|NOT COMPLETED|Double-Blind Treatment||0
2951586|NCT00704184|3665447|FG004|NOT COMPLETED|Double-Blind Treatment||0
2951587|NCT00704184|3665443|FG000|STARTED|Open-Label Treatment||19
2951588|NCT00704184|3665444|FG001|STARTED|Open-Label Treatment||18
2951589|NCT00704184|3665445|FG002|STARTED|Open-Label Treatment||20
2951590|NCT00704184|3665446|FG003|STARTED|Open-Label Treatment||18
2951591|NCT00704184|3665447|FG004|STARTED|Open-Label Treatment||19
2951592|NCT00704184|3665443|FG000|COMPLETED|Open-Label Treatment||18
2951593|NCT00704184|3665444|FG001|COMPLETED|Open-Label Treatment||16
2951594|NCT00704184|3665445|FG002|COMPLETED|Open-Label Treatment||16
2951595|NCT00704184|3665446|FG003|COMPLETED|Open-Label Treatment||13
2951596|NCT00704184|3665447|FG004|COMPLETED|Open-Label Treatment||16
2951597|NCT00704184|3665443|FG000|NOT COMPLETED|Open-Label Treatment||1
2951598|NCT00704184|3665444|FG001|NOT COMPLETED|Open-Label Treatment||2
2951599|NCT00704184|3665445|FG002|NOT COMPLETED|Open-Label Treatment||4
2951600|NCT00704184|3665446|FG003|NOT COMPLETED|Open-Label Treatment||5
2951601|NCT00704184|3665447|FG004|NOT COMPLETED|Open-Label Treatment||3
2951602|NCT00704262|3665459|FG000|STARTED|Overall Study||33
2951603|NCT00704262|3665459|FG000|COMPLETED|Overall Study||31
2951604|NCT00704262|3665459|FG000|NOT COMPLETED|Overall Study||2
2951605|NCT00704340|3665465|FG000|STARTED|Overall Study||120
2951606|NCT00704340|3665466|FG001|STARTED|Overall Study||117
2951607|NCT00704340|3665465|FG000|COMPLETED|Overall Study||118
2951608|NCT00704340|3665466|FG001|COMPLETED|Overall Study||115
2951609|NCT00704340|3665465|FG000|NOT COMPLETED|Overall Study||2
2951610|NCT00704340|3665466|FG001|NOT COMPLETED|Overall Study||2
2951611|NCT00704353|3665474|FG000|STARTED|Overall Study||366
2951612|NCT00704353|3665475|FG001|STARTED|Overall Study||369
2951613|NCT00704353|3665474|FG000|COMPLETED|Overall Study||268
2951614|NCT00704353|3665475|FG001|COMPLETED|Overall Study||255
2951615|NCT00704353|3665474|FG000|NOT COMPLETED|Overall Study||98
2951616|NCT00704353|3665475|FG001|NOT COMPLETED|Overall Study||114
2951617|NCT00704379|3665483|FG000|STARTED|Overall Study||46
2951618|NCT00704379|3665484|FG001|STARTED|Overall Study||48
2951619|NCT00704379|3665483|FG000|COMPLETED|Overall Study||39
2951620|NCT00704379|3665484|FG001|COMPLETED|Overall Study||41
2951621|NCT00704379|3665483|FG000|NOT COMPLETED|Overall Study||7
2951622|NCT00704379|3665484|FG001|NOT COMPLETED|Overall Study||7
2951623|NCT00704405|3665497|FG000|STARTED|Overall Study (NC Population)||42
2951624|NCT00704405|3665498|FG001|STARTED|Overall Study (NC Population)||44
2951625|NCT00704405|3665499|FG002|STARTED|Overall Study (NC Population)||41
2951626|NCT00704405|3665500|FG003|STARTED|Overall Study (NC Population)||42
2951627|NCT00704405|3665501|FG004|STARTED|Overall Study (NC Population)||42
2951628|NCT00704405|3665497|FG000|COMPLETED|Overall Study (NC Population)||37
2951629|NCT00704405|3665498|FG001|COMPLETED|Overall Study (NC Population)||40
3163444|NCT01886716|3890933|FG001|NOT COMPLETED|1-Month Post Follow-Up||0
3163445|NCT01886716|3890934|FG002|NOT COMPLETED|1-Month Post Follow-Up||0
2951630|NCT00704405|3665499|FG002|COMPLETED|Overall Study (NC Population)||38
2951631|NCT00704405|3665500|FG003|COMPLETED|Overall Study (NC Population)||38
2951632|NCT00704405|3665501|FG004|COMPLETED|Overall Study (NC Population)||37
2951633|NCT00704405|3665497|FG000|NOT COMPLETED|Overall Study (NC Population)||5
2951634|NCT00704405|3665498|FG001|NOT COMPLETED|Overall Study (NC Population)||4
3132512|NCT01691508|3857570|FG001|COMPLETED|Overall Study||66
3132513|NCT01691508|3857569|FG000|NOT COMPLETED|Overall Study||4
3132514|NCT01691508|3857570|FG001|NOT COMPLETED|Overall Study||3
3132515|NCT01691521|3857579|FG000|STARTED|Overall Study||191
3132516|NCT01691521|3857580|FG001|STARTED|Overall Study||191
3132517|NCT01691521|3857581|FG002|STARTED|Overall Study||194
2951635|NCT00704405|3665499|FG002|NOT COMPLETED|Overall Study (NC Population)||3
2951636|NCT00704405|3665500|FG003|NOT COMPLETED|Overall Study (NC Population)||4
2951637|NCT00704405|3665501|FG004|NOT COMPLETED|Overall Study (NC Population)||5
2951638|NCT00704405|3665497|FG000|STARTED|Overall Study (C Population)||16
2951639|NCT00704405|3665498|FG001|STARTED|Overall Study (C Population)||14
2951640|NCT00704405|3665499|FG002|STARTED|Overall Study (C Population)||15
2951641|NCT00704405|3665500|FG003|STARTED|Overall Study (C Population)||15
2951642|NCT00704405|3665501|FG004|STARTED|Overall Study (C Population)||14
2951643|NCT00704405|3665497|FG000|COMPLETED|Overall Study (C Population)||15
2951644|NCT00704405|3665498|FG001|COMPLETED|Overall Study (C Population)||11
2951645|NCT00704405|3665499|FG002|COMPLETED|Overall Study (C Population)||14
2951646|NCT00704405|3665500|FG003|COMPLETED|Overall Study (C Population)||14
2951647|NCT00704405|3665501|FG004|COMPLETED|Overall Study (C Population)||14
2951648|NCT00704405|3665497|FG000|NOT COMPLETED|Overall Study (C Population)||1
2951649|NCT00704405|3665498|FG001|NOT COMPLETED|Overall Study (C Population)||3
2951650|NCT00704405|3665499|FG002|NOT COMPLETED|Overall Study (C Population)||1
2951651|NCT00704405|3665500|FG003|NOT COMPLETED|Overall Study (C Population)||1
2951652|NCT00704405|3665501|FG004|NOT COMPLETED|Overall Study (C Population)||0
2951653|NCT00704418|3665521|FG000|STARTED|Overall Study||78
2951654|NCT00704418|3665522|FG001|STARTED|Overall Study||78
2951655|NCT00704418|3665521|FG000|COMPLETED|Overall Study||73
2951656|NCT00704418|3665522|FG001|COMPLETED|Overall Study||72
2951657|NCT00704418|3665521|FG000|NOT COMPLETED|Overall Study||5
2951658|NCT00704418|3665522|FG001|NOT COMPLETED|Overall Study||6
2951659|NCT00704522|3665530|FG000|STARTED|Overall Study||481
2951660|NCT00704522|3665531|FG001|STARTED|Overall Study||120
2951661|NCT00704522|3665530|FG000|COMPLETED|Overall Study||298
2951662|NCT00704522|3665531|FG001|COMPLETED|Overall Study||75
2951663|NCT00704522|3665530|FG000|NOT COMPLETED|Overall Study||183
2951664|NCT00704522|3665531|FG001|NOT COMPLETED|Overall Study||45
2951665|NCT00704717|3665536|FG000|STARTED|Overall Study||185
2951666|NCT00704717|3665536|FG000|COMPLETED|Overall Study||185
2951667|NCT00704717|3665536|FG000|NOT COMPLETED|Overall Study||0
2951668|NCT00704730|3665542|FG000|STARTED|Overall Study|Randomized|219
2951669|NCT00704730|3665543|FG001|STARTED|Overall Study|Randomized|111
2951670|NCT00704730|3665542|FG000|COMPLETED|Overall Study|Continuing treatment at data cutoff for primary analysis, but subsequently discontinued study|98
2951671|NCT00704730|3665543|FG001|COMPLETED|Overall Study|Continuing study treatment at the time of data cut-off.|15
2951672|NCT00704730|3665542|FG000|NOT COMPLETED|Overall Study||121
2951673|NCT00704730|3665543|FG001|NOT COMPLETED|Overall Study||96
2951674|NCT00704808|3665550|FG000|STARTED|Overall Study||180
2951675|NCT00704808|3665550|FG000|COMPLETED|Overall Study||49
2951676|NCT00704808|3665550|FG000|NOT COMPLETED|Overall Study||131
2951677|NCT00704847|3665556|FG000|STARTED|Overall Study||521
2951678|NCT00704847|3665557|FG001|STARTED|Overall Study||509
2951679|NCT00704847|3665556|FG000|COMPLETED|Overall Study||300
2951680|NCT00704847|3665557|FG001|COMPLETED|Overall Study||339
2951681|NCT00704847|3665556|FG000|NOT COMPLETED|Overall Study||221
2951682|NCT00704847|3665557|FG001|NOT COMPLETED|Overall Study||170
2951683|NCT00704912|3665566|FG000|STARTED|Overall Study||50
2951684|NCT00704912|3665567|FG001|STARTED|Overall Study||49
2951685|NCT00704912|3665568|FG002|STARTED|Overall Study||50
2951686|NCT00704912|3665566|FG000|COMPLETED|Overall Study||44
2951687|NCT00704912|3665567|FG001|COMPLETED|Overall Study||45
2951688|NCT00704912|3665568|FG002|COMPLETED|Overall Study||43
2951689|NCT00704912|3665566|FG000|NOT COMPLETED|Overall Study||6
2951690|NCT00704912|3665567|FG001|NOT COMPLETED|Overall Study||4
2951691|NCT00704912|3665568|FG002|NOT COMPLETED|Overall Study||7
2951692|NCT00704938|3665578|FG000|STARTED|Overall Study||2
2951693|NCT00704938|3665579|FG001|STARTED|Overall Study||1
2951694|NCT00704938|3665578|FG000|COMPLETED|Overall Study||2
2951695|NCT00704938|3665579|FG001|COMPLETED|Overall Study||1
2951696|NCT00704938|3665578|FG000|NOT COMPLETED|Overall Study||0
2951697|NCT00704938|3665579|FG001|NOT COMPLETED|Overall Study||0
2951698|NCT00704964|3665585|FG000|STARTED|Overall Study|Number of participants who took at least one dose of study medication.|746
2951699|NCT00704964|3665585|FG000|COMPLETED|Overall Study|Number of participants who completed therapy as scheduled.|418
2951700|NCT00704964|3665585|FG000|NOT COMPLETED|Overall Study||328
2951701|NCT00705003|3665592|FG000|STARTED|Enrolled||71
2951702|NCT00705003|3665593|FG001|STARTED|Enrolled||37
2951703|NCT00705003|3665594|FG002|STARTED|Enrolled||34
2951704|NCT00705003|3665592|FG000|COMPLETED|Enrolled||67
2951705|NCT00705003|3665593|FG001|COMPLETED|Enrolled||34
2951706|NCT00705003|3665594|FG002|COMPLETED|Enrolled||33
2951707|NCT00705003|3665592|FG000|NOT COMPLETED|Enrolled||4
2951708|NCT00705003|3665593|FG001|NOT COMPLETED|Enrolled||3
2951709|NCT00705003|3665594|FG002|NOT COMPLETED|Enrolled||1
2951710|NCT00705003|3665592|FG000|STARTED|Treated||67
2951711|NCT00705003|3665593|FG001|STARTED|Treated||34
3132518|NCT01691521|3857579|FG000|COMPLETED|Overall Study||179
3132519|NCT01691521|3857580|FG001|COMPLETED|Overall Study||175
3132520|NCT01691521|3857581|FG002|COMPLETED|Overall Study||185
3132521|NCT01691521|3857579|FG000|NOT COMPLETED|Overall Study||12
2951712|NCT00705003|3665594|FG002|STARTED|Treated||33
2951713|NCT00705003|3665592|FG000|COMPLETED|Treated||54
2951714|NCT00705003|3665593|FG001|COMPLETED|Treated||28
2951715|NCT00705003|3665594|FG002|COMPLETED|Treated||30
2951716|NCT00705003|3665592|FG000|NOT COMPLETED|Treated||13
2951717|NCT00705003|3665593|FG001|NOT COMPLETED|Treated||6
2951718|NCT00705003|3665594|FG002|NOT COMPLETED|Treated||3
2951719|NCT00705016|3665606|FG000|STARTED|Overall Study||62
2951720|NCT00705016|3665607|FG001|STARTED|Overall Study||60
2951721|NCT00705016|3665608|FG002|STARTED|Overall Study||62
2951722|NCT00705016|3665606|FG000|COMPLETED|Overall Study||2
2951723|NCT00705016|3665607|FG001|COMPLETED|Overall Study||2
2951724|NCT00705016|3665608|FG002|COMPLETED|Overall Study||4
2951725|NCT00705016|3665606|FG000|NOT COMPLETED|Overall Study||60
2951726|NCT00705016|3665607|FG001|NOT COMPLETED|Overall Study||58
2951727|NCT00705016|3665608|FG002|NOT COMPLETED|Overall Study||58
2951728|NCT00705107|3665616|FG000|STARTED|Overall Study||267
2951729|NCT00705107|3665616|FG000|COMPLETED|Overall Study||218
2951730|NCT00705107|3665616|FG000|NOT COMPLETED|Overall Study||49
2951731|NCT00705133|3665620|FG000|STARTED|Overall Study||15
2951732|NCT00705133|3665620|FG000|COMPLETED|Overall Study||15
2951733|NCT00705133|3665620|FG000|NOT COMPLETED|Overall Study||0
3034940|NCT01134510|3753998|FG001|STARTED|Overall Study|Transplant Day; Infusion #1 C1 esterase inhibitor vs Placebo|10
3034941|NCT01134510|3753997|FG000|Day 2|Overall Study|Infusion #2 C1 esterase inhibitor vs Placebo|10
3034942|NCT01134510|3753998|FG001|Day 2|Overall Study|Infusion #2 C1 esterase inhibitor vs Placebo|10
3034943|NCT01134510|3753997|FG000|Week 2|Overall Study|Infusion #3 C1 esterase inhibitor vs Placebo|10
3034944|NCT01134510|3753998|FG001|Week 2|Overall Study|Infusion #3 C1 esterase inhibitor vs Placebo|10
3034945|NCT01134510|3753997|FG000|Week 2|Overall Study|Infusion #4 C1 esterase inhibitor vs Placebo|10
3034946|NCT01134510|3753998|FG001|Week 2|Overall Study|Infusion #4 C1 esterase inhibitor vs Placebo|10
3034947|NCT01134510|3753997|FG000|Week 3|Overall Study|Infusion #5 C1 esterase inhibitor vs Placebo|10
3034948|NCT01134510|3753998|FG001|Week 3|Overall Study|Infusion #5 C1 esterase inhibitor vs Placebo|10
3034949|NCT01134510|3753997|FG000|Week 3|Overall Study|Infusion #6 C1 esterase inhibitor vs Placebo|10
3034950|NCT01134510|3753998|FG001|Week 3|Overall Study|Infusion #6 C1 esterase inhibitor vs Placebo|10
3034951|NCT01134510|3753997|FG000|Week 4|Overall Study|Infusion #7 C1 esterase inhibitor vs Placebo|10
3034952|NCT01134510|3753998|FG001|Week 4|Overall Study|Infusion #7 C1 esterase inhibitor vs Placebo|10
3034953|NCT01134510|3753997|FG000|Week 4|Overall Study|Infusion #8 C1 esterase inhibitor vs Placebo|10
3034954|NCT01134510|3753998|FG001|Week 4|Overall Study|Infusion #8 C1 esterase inhibitor vs Placebo|10
3034955|NCT01134510|3753997|FG000|Month 1|Overall Study||10
3034956|NCT01134510|3753998|FG001|Month 1|Overall Study||10
3034957|NCT01134510|3753997|FG000|Month 3|Overall Study||10
3034958|NCT01134510|3753998|FG001|Month 3|Overall Study||9
3034959|NCT01134510|3753997|FG000|COMPLETED|Overall Study||10
3034960|NCT01134510|3753998|FG001|COMPLETED|Overall Study||9
3034961|NCT01134510|3753997|FG000|NOT COMPLETED|Overall Study||0
3034962|NCT01134510|3753998|FG001|NOT COMPLETED|Overall Study||1
3034963|NCT01134549|3754012|FG000|STARTED|Overall Study||8
3034964|NCT01134549|3754013|FG001|STARTED|Overall Study||6
3034965|NCT01134549|3754014|FG002|STARTED|Overall Study||6
3034966|NCT01134549|3754015|FG003|STARTED|Overall Study||6
3034967|NCT01134549|3754016|FG004|STARTED|Overall Study||6
3034968|NCT01134549|3754012|FG000|COMPLETED|Overall Study||8
3034969|NCT01134549|3754013|FG001|COMPLETED|Overall Study||6
3034970|NCT01134549|3754014|FG002|COMPLETED|Overall Study||6
3034971|NCT01134549|3754015|FG003|COMPLETED|Overall Study||6
3034972|NCT01134549|3754016|FG004|COMPLETED|Overall Study||6
3034973|NCT01134549|3754012|FG000|NOT COMPLETED|Overall Study||0
3034974|NCT01134549|3754013|FG001|NOT COMPLETED|Overall Study||0
3034975|NCT01134549|3754014|FG002|NOT COMPLETED|Overall Study||0
3034976|NCT01134549|3754015|FG003|NOT COMPLETED|Overall Study||0
3034977|NCT01134549|3754016|FG004|NOT COMPLETED|Overall Study||0
3034978|NCT01134562|3754038|FG000|STARTED|Overall Study||4
3034979|NCT01134562|3754039|FG001|STARTED|Overall Study||4
3034980|NCT01134562|3754040|FG002|STARTED|Overall Study||4
3034981|NCT01134562|3754041|FG003|STARTED|Overall Study||8
3034982|NCT01134562|3754042|FG004|STARTED|Overall Study||8
3034983|NCT01134562|3754038|FG000|COMPLETED|Overall Study||4
3034984|NCT01134562|3754039|FG001|COMPLETED|Overall Study||3
3034985|NCT01134562|3754040|FG002|COMPLETED|Overall Study||4
3034986|NCT01134562|3754041|FG003|COMPLETED|Overall Study||8
3034987|NCT01134562|3754042|FG004|COMPLETED|Overall Study||8
3034988|NCT01134562|3754038|FG000|NOT COMPLETED|Overall Study||0
3034989|NCT01134562|3754039|FG001|NOT COMPLETED|Overall Study||1
3034990|NCT01134562|3754040|FG002|NOT COMPLETED|Overall Study||0
3034991|NCT01134562|3754041|FG003|NOT COMPLETED|Overall Study||0
3034992|NCT01134562|3754042|FG004|NOT COMPLETED|Overall Study||0
3034993|NCT01134575|3754065|FG000|STARTED|Overall Study||3
3034994|NCT01134575|3754066|FG001|STARTED|Overall Study||45
3034995|NCT01134575|3754067|FG002|STARTED|Overall Study||42
3034996|NCT01134575|3754065|FG000|COMPLETED|Overall Study||3
3034997|NCT01134575|3754066|FG001|COMPLETED|Overall Study||45
3034998|NCT01134575|3754067|FG002|COMPLETED|Overall Study||42
3034999|NCT01134575|3754065|FG000|NOT COMPLETED|Overall Study||0
3035000|NCT01134575|3754066|FG001|NOT COMPLETED|Overall Study||0
3035001|NCT01134575|3754067|FG002|NOT COMPLETED|Overall Study||0
3035002|NCT01134614|3754077|FG000|STARTED|Overall Study||123
3035003|NCT01134614|3754078|FG001|STARTED|Overall Study||122
3035004|NCT01134614|3754077|FG000|Treated|Overall Study||119
3035005|NCT01134614|3754078|FG001|Treated|Overall Study||121
2951734|NCT00705146|3665626|FG000|STARTED|Overall Study||32
2951735|NCT00705146|3665627|FG001|STARTED|Overall Study||24
2951736|NCT00705146|3665626|FG000|COMPLETED|Overall Study||31
2951737|NCT00705146|3665627|FG001|COMPLETED|Overall Study||23
2951738|NCT00705146|3665626|FG000|NOT COMPLETED|Overall Study||1
2951739|NCT00705146|3665627|FG001|NOT COMPLETED|Overall Study||1
2951740|NCT00705159|3665637|FG000|STARTED|Overall Study||34
2951741|NCT00705159|3665638|FG001|STARTED|Overall Study||35
2951742|NCT00705159|3665639|FG002|STARTED|Overall Study||34
2951743|NCT00705159|3665640|FG003|STARTED|Overall Study||34
2951744|NCT00705159|3665637|FG000|COMPLETED|Overall Study||34
2951745|NCT00705159|3665638|FG001|COMPLETED|Overall Study||33
2951746|NCT00705159|3665639|FG002|COMPLETED|Overall Study||29
2951747|NCT00705159|3665640|FG003|COMPLETED|Overall Study||30
2951748|NCT00705159|3665637|FG000|NOT COMPLETED|Overall Study||0
2951749|NCT00705159|3665638|FG001|NOT COMPLETED|Overall Study||2
2951750|NCT00705159|3665639|FG002|NOT COMPLETED|Overall Study||5
2951751|NCT00705159|3665640|FG003|NOT COMPLETED|Overall Study||4
2951752|NCT00705224|3665650|FG000|STARTED|Overall Study||250
2951753|NCT00705224|3665650|FG000|COMPLETED|Overall Study||239
2951754|NCT00705224|3665650|FG000|NOT COMPLETED|Overall Study||11
2951755|NCT00705250|3665657|FG000|STARTED|Overall Study||36
2951756|NCT00705250|3665657|FG000|COMPLETED|Overall Study||34
2951757|NCT00705250|3665657|FG000|NOT COMPLETED|Overall Study||2
2951758|NCT00705263|3665661|FG000|STARTED|Overall Study|113 patients started the treatment; however, data were available for only 110 patients.|110
2951759|NCT00705263|3665661|FG000|COMPLETED|Overall Study||108
2951760|NCT00705263|3665661|FG000|NOT COMPLETED|Overall Study||2
2951761|NCT00705289|3665665|FG000|STARTED|Overall Study||728
2951762|NCT00705289|3665665|FG000|COMPLETED|Overall Study||597
2951763|NCT00705289|3665665|FG000|NOT COMPLETED|Overall Study||131
2951764|NCT00705341|3665688|FG000|STARTED|Phase 1:Control Challenge||126
2951765|NCT00705341|3665689|FG001|STARTED|Phase 1:Control Challenge||93
2951766|NCT00705341|3665690|FG002|STARTED|Phase 1:Control Challenge||0
2951767|NCT00705341|3665691|FG003|STARTED|Phase 1:Control Challenge||0
2951768|NCT00705341|3665688|FG000|COMPLETED|Phase 1:Control Challenge|If participants in this group met criteria, they were randomized into phase 2|126
2951769|NCT00705341|3665689|FG001|COMPLETED|Phase 1:Control Challenge|Nonasthmatic controls did not advance to phase 2 due to design of study|93
2951770|NCT00705341|3665690|FG002|COMPLETED|Phase 1:Control Challenge||0
2951771|NCT00705341|3665691|FG003|COMPLETED|Phase 1:Control Challenge||0
2951772|NCT00705341|3665688|FG000|NOT COMPLETED|Phase 1:Control Challenge||0
2951773|NCT00705341|3665689|FG001|NOT COMPLETED|Phase 1:Control Challenge||0
2951774|NCT00705341|3665690|FG002|NOT COMPLETED|Phase 1:Control Challenge||0
2951775|NCT00705341|3665691|FG003|NOT COMPLETED|Phase 1:Control Challenge||0
2951776|NCT00705341|3665688|FG000|STARTED|Phase 2: Trial||0
2951777|NCT00705341|3665689|FG001|STARTED|Phase 2: Trial||0
2951778|NCT00705341|3665690|FG002|STARTED|Phase 2: Trial|This group was randomized from asthmatic controls in phase 1 if they met criteria to be in phase 2|30
2951779|NCT00705341|3665691|FG003|STARTED|Phase 2: Trial|This group was randomized from asthmatic controls in phase 1 if they met criteria to be in phase 2|32
2951780|NCT00705341|3665688|FG000|COMPLETED|Phase 2: Trial||0
2951781|NCT00705341|3665689|FG001|COMPLETED|Phase 2: Trial||0
2951782|NCT00705341|3665690|FG002|COMPLETED|Phase 2: Trial||23
2951783|NCT00705341|3665691|FG003|COMPLETED|Phase 2: Trial||28
2951784|NCT00705341|3665688|FG000|NOT COMPLETED|Phase 2: Trial||0
2951785|NCT00705341|3665689|FG001|NOT COMPLETED|Phase 2: Trial||0
2951786|NCT00705341|3665690|FG002|NOT COMPLETED|Phase 2: Trial||7
2951787|NCT00705341|3665691|FG003|NOT COMPLETED|Phase 2: Trial||4
2951788|NCT00705367|3665701|FG000|STARTED|Short-term Period||6
2951789|NCT00705367|3665702|FG001|STARTED|Short-term Period||3
2951790|NCT00705367|3665701|FG000|COMPLETED|Short-term Period||6
2951791|NCT00705367|3665702|FG001|COMPLETED|Short-term Period||3
2951792|NCT00705367|3665701|FG000|NOT COMPLETED|Short-term Period||0
2951793|NCT00705367|3665702|FG001|NOT COMPLETED|Short-term Period||0
2951794|NCT00705367|3665701|FG000|STARTED|Long-term Extension Period||9
2951795|NCT00705367|3665702|FG001|STARTED|Long-term Extension Period||0
2951796|NCT00705367|3665701|FG000|COMPLETED|Long-term Extension Period||0
2951797|NCT00705367|3665702|FG001|COMPLETED|Long-term Extension Period||0
2951798|NCT00705367|3665701|FG000|NOT COMPLETED|Long-term Extension Period||9
3300303|NCT02944383|4034224|FG001|COMPLETED|Overall Study||30
3300304|NCT02944383|4034225|FG002|COMPLETED|Overall Study||30
3300305|NCT02944383|4034223|FG000|NOT COMPLETED|Overall Study||1
3300306|NCT02944383|4034224|FG001|NOT COMPLETED|Overall Study||0
3300307|NCT02944383|4034225|FG002|NOT COMPLETED|Overall Study||1
3300308|NCT02944448|4034237|FG000|STARTED|Overall Study||316
3300309|NCT02944448|4034238|FG001|STARTED|Overall Study||160
3300310|NCT02944448|4034237|FG000|COMPLETED|Overall Study||227
2951799|NCT00705367|3665702|FG001|NOT COMPLETED|Long-term Extension Period||0
2951800|NCT00705406|3665712|FG000|STARTED|Overall Study||203
2951801|NCT00705406|3665713|FG001|STARTED|Overall Study||202
2951802|NCT00705406|3665712|FG000|COMPLETED|Overall Study||199
2951803|NCT00705406|3665713|FG001|COMPLETED|Overall Study||197
2951804|NCT00705406|3665712|FG000|NOT COMPLETED|Overall Study||4
2951805|NCT00705406|3665713|FG001|NOT COMPLETED|Overall Study||5
2951806|NCT00705432|3665726|FG000|STARTED|Treatment Period||311
2951807|NCT00705432|3665727|FG001|STARTED|Treatment Period||316
2951808|NCT00705432|3665728|FG002|STARTED|Treatment Period||311
2951809|NCT00705432|3665729|FG003|STARTED|Treatment Period||52
2951810|NCT00705432|3665730|FG004|STARTED|Treatment Period||52
3300311|NCT02944448|4034238|FG001|COMPLETED|Overall Study||136
2951811|NCT00705432|3665731|FG005|STARTED|Treatment Period||55
2951812|NCT00705432|3665726|FG000|STARTED BOCEPREVIR/PLACEBO|Treatment Period||297
2951813|NCT00705432|3665727|FG001|STARTED BOCEPREVIR/PLACEBO|Treatment Period||303
2951814|NCT00705432|3665728|FG002|STARTED BOCEPREVIR/PLACEBO|Treatment Period||299
2951815|NCT00705432|3665729|FG003|STARTED BOCEPREVIR/PLACEBO|Treatment Period||47
2951816|NCT00705432|3665730|FG004|STARTED BOCEPREVIR/PLACEBO|Treatment Period||47
2951817|NCT00705432|3665731|FG005|STARTED BOCEPREVIR/PLACEBO|Treatment Period||55
2951818|NCT00705432|3665726|FG000|COMPLETED|Treatment Period||148
2951819|NCT00705432|3665727|FG001|COMPLETED|Treatment Period||205
2951820|NCT00705432|3665728|FG002|COMPLETED|Treatment Period||190
2951821|NCT00705432|3665729|FG003|COMPLETED|Treatment Period||11
2951822|NCT00705432|3665730|FG004|COMPLETED|Treatment Period||24
2951823|NCT00705432|3665731|FG005|COMPLETED|Treatment Period||25
2951824|NCT00705432|3665726|FG000|NOT COMPLETED|Treatment Period||163
2951825|NCT00705432|3665727|FG001|NOT COMPLETED|Treatment Period||111
2951826|NCT00705432|3665728|FG002|NOT COMPLETED|Treatment Period||121
2951827|NCT00705432|3665729|FG003|NOT COMPLETED|Treatment Period||41
2951828|NCT00705432|3665730|FG004|NOT COMPLETED|Treatment Period||28
2951829|NCT00705432|3665731|FG005|NOT COMPLETED|Treatment Period||30
2951830|NCT00705432|3665726|FG000|STARTED|Follow-up Period (Upto Week 72)||278
2951831|NCT00705432|3665727|FG001|STARTED|Follow-up Period (Upto Week 72)||295
2951832|NCT00705432|3665728|FG002|STARTED|Follow-up Period (Upto Week 72)||291
2951833|NCT00705432|3665729|FG003|STARTED|Follow-up Period (Upto Week 72)||42
2951834|NCT00705432|3665730|FG004|STARTED|Follow-up Period (Upto Week 72)||44
2951835|NCT00705432|3665731|FG005|STARTED|Follow-up Period (Upto Week 72)||53
2951836|NCT00705432|3665726|FG000|COMPLETED|Follow-up Period (Upto Week 72)||207
2951837|NCT00705432|3665727|FG001|COMPLETED|Follow-up Period (Upto Week 72)||252
2951838|NCT00705432|3665728|FG002|COMPLETED|Follow-up Period (Upto Week 72)||266
2951839|NCT00705432|3665729|FG003|COMPLETED|Follow-up Period (Upto Week 72)||28
2951840|NCT00705432|3665730|FG004|COMPLETED|Follow-up Period (Upto Week 72)||38
2951841|NCT00705432|3665731|FG005|COMPLETED|Follow-up Period (Upto Week 72)||46
2951842|NCT00705432|3665726|FG000|NOT COMPLETED|Follow-up Period (Upto Week 72)||71
2951843|NCT00705432|3665727|FG001|NOT COMPLETED|Follow-up Period (Upto Week 72)||43
2951844|NCT00705432|3665728|FG002|NOT COMPLETED|Follow-up Period (Upto Week 72)||25
2951845|NCT00705432|3665729|FG003|NOT COMPLETED|Follow-up Period (Upto Week 72)||14
2951846|NCT00705432|3665730|FG004|NOT COMPLETED|Follow-up Period (Upto Week 72)||6
2951847|NCT00705432|3665731|FG005|NOT COMPLETED|Follow-up Period (Upto Week 72)||7
2951848|NCT00705484|3665744|FG000|STARTED|Overall Study|Number Enrolled|1059
2951849|NCT00705484|3665745|FG001|STARTED|Overall Study|Number Enrolled|1180
2951850|NCT00705484|3665744|FG000|Follow-up Period|Overall Study||1059
2951851|NCT00705484|3665745|FG001|Follow-up Period|Overall Study|Switched From Standard Therapy to Remicade|296
2951852|NCT00705484|3665744|FG000|COMPLETED|Overall Study||677
3300312|NCT02944448|4034237|FG000|NOT COMPLETED|Overall Study||89
3300313|NCT02944448|4034238|FG001|NOT COMPLETED|Overall Study||24
3300314|NCT02944461|4034245|FG000|STARTED|Overall Study||20
3300315|NCT02944461|4034245|FG000|COMPLETED|Overall Study||15
3300316|NCT02944461|4034245|FG000|NOT COMPLETED|Overall Study||5
3300317|NCT02944513|4034251|FG000|STARTED|Overall Study||35
3300318|NCT02944513|4034252|FG001|STARTED|Overall Study||33
2951853|NCT00705484|3665745|FG001|COMPLETED|Overall Study||772
2951854|NCT00705484|3665744|FG000|NOT COMPLETED|Overall Study||382
2951855|NCT00705484|3665745|FG001|NOT COMPLETED|Overall Study||408
2951856|NCT00705523|3665755|FG000|STARTED|Overall Study||19
2951857|NCT00705523|3665756|FG001|STARTED|Overall Study||21
2951858|NCT00705523|3665755|FG000|COMPLETED|Overall Study||17
2951859|NCT00705523|3665756|FG001|COMPLETED|Overall Study||18
2951860|NCT00705523|3665755|FG000|NOT COMPLETED|Overall Study||2
2951861|NCT00705523|3665756|FG001|NOT COMPLETED|Overall Study||3
2951862|NCT00705536|3665764|FG000|STARTED|Start Period 1||6
2951863|NCT00705536|3665765|FG001|STARTED|Start Period 1||6
2951864|NCT00705536|3665766|FG002|STARTED|Start Period 1||7
2951865|NCT00705536|3665767|FG003|STARTED|Start Period 1||7
2951866|NCT00705536|3665764|FG000|Received at Least 1 Dose of Study Drug|Start Period 1||6
2951867|NCT00705536|3665765|FG001|Received at Least 1 Dose of Study Drug|Start Period 1||6
2951868|NCT00705536|3665766|FG002|Received at Least 1 Dose of Study Drug|Start Period 1||7
2951869|NCT00705536|3665767|FG003|Received at Least 1 Dose of Study Drug|Start Period 1||7
2951870|NCT00705536|3665764|FG000|COMPLETED|Start Period 1||6
2951871|NCT00705536|3665765|FG001|COMPLETED|Start Period 1||6
2951872|NCT00705536|3665766|FG002|COMPLETED|Start Period 1||7
2951873|NCT00705536|3665767|FG003|COMPLETED|Start Period 1||6
2951874|NCT00705536|3665764|FG000|NOT COMPLETED|Start Period 1||0
2951875|NCT00705536|3665765|FG001|NOT COMPLETED|Start Period 1||0
2951876|NCT00705536|3665766|FG002|NOT COMPLETED|Start Period 1||0
2951877|NCT00705536|3665767|FG003|NOT COMPLETED|Start Period 1||1
2951878|NCT00705536|3665764|FG000|STARTED|Washout Period of at Least 6 Days||6
2951879|NCT00705536|3665765|FG001|STARTED|Washout Period of at Least 6 Days||6
2951880|NCT00705536|3665766|FG002|STARTED|Washout Period of at Least 6 Days||7
2951881|NCT00705536|3665767|FG003|STARTED|Washout Period of at Least 6 Days||6
2951882|NCT00705536|3665764|FG000|COMPLETED|Washout Period of at Least 6 Days||6
2951883|NCT00705536|3665765|FG001|COMPLETED|Washout Period of at Least 6 Days||6
2951884|NCT00705536|3665766|FG002|COMPLETED|Washout Period of at Least 6 Days||7
2951885|NCT00705536|3665767|FG003|COMPLETED|Washout Period of at Least 6 Days||6
2951886|NCT00705536|3665764|FG000|NOT COMPLETED|Washout Period of at Least 6 Days||0
3300319|NCT02944513|4034251|FG000|COMPLETED|Overall Study||31
2951887|NCT00705536|3665765|FG001|NOT COMPLETED|Washout Period of at Least 6 Days||0
2951888|NCT00705536|3665766|FG002|NOT COMPLETED|Washout Period of at Least 6 Days||0
2951889|NCT00705536|3665767|FG003|NOT COMPLETED|Washout Period of at Least 6 Days||0
2951890|NCT00705536|3665764|FG000|STARTED|Start Period 2||6
2951891|NCT00705536|3665765|FG001|STARTED|Start Period 2||6
2951892|NCT00705536|3665766|FG002|STARTED|Start Period 2||7
2951893|NCT00705536|3665767|FG003|STARTED|Start Period 2||6
2951894|NCT00705536|3665764|FG000|COMPLETED|Start Period 2||6
2951895|NCT00705536|3665765|FG001|COMPLETED|Start Period 2||6
2951896|NCT00705536|3665766|FG002|COMPLETED|Start Period 2||7
2951897|NCT00705536|3665767|FG003|COMPLETED|Start Period 2||6
2951898|NCT00705536|3665764|FG000|NOT COMPLETED|Start Period 2||0
2951899|NCT00705536|3665765|FG001|NOT COMPLETED|Start Period 2||0
2951900|NCT00705536|3665766|FG002|NOT COMPLETED|Start Period 2||0
2951901|NCT00705536|3665767|FG003|NOT COMPLETED|Start Period 2||0
2951902|NCT00705536|3665764|FG000|STARTED|Completed Study||6
2951903|NCT00705536|3665765|FG001|STARTED|Completed Study||6
2951904|NCT00705536|3665766|FG002|STARTED|Completed Study||7
2951905|NCT00705536|3665767|FG003|STARTED|Completed Study||6
2951906|NCT00705536|3665764|FG000|COMPLETED|Completed Study||6
2951907|NCT00705536|3665765|FG001|COMPLETED|Completed Study||6
2951908|NCT00705536|3665766|FG002|COMPLETED|Completed Study||7
2951909|NCT00705536|3665767|FG003|COMPLETED|Completed Study||6
2951910|NCT00705536|3665764|FG000|NOT COMPLETED|Completed Study||0
2951911|NCT00705536|3665765|FG001|NOT COMPLETED|Completed Study||0
2951912|NCT00705536|3665766|FG002|NOT COMPLETED|Completed Study||0
2951913|NCT00705536|3665767|FG003|NOT COMPLETED|Completed Study||0
2951914|NCT00705575|3665788|FG000|STARTED|Overall Study||349
2951915|NCT00705575|3665789|FG001|STARTED|Overall Study||339
2951916|NCT00705575|3665788|FG000|COMPLETED|Overall Study||326
2951917|NCT00705575|3665789|FG001|COMPLETED|Overall Study||293
2951918|NCT00705575|3665788|FG000|NOT COMPLETED|Overall Study||23
2951919|NCT00705575|3665789|FG001|NOT COMPLETED|Overall Study||46
2951920|NCT00705614|3665797|FG000|STARTED|Initial Intervention||1541
2951921|NCT00705614|3665798|FG001|STARTED|Initial Intervention||1121
2951922|NCT00705614|3665797|FG000|COMPLETED|Initial Intervention||1023
2951923|NCT00705614|3665798|FG001|COMPLETED|Initial Intervention||800
2951924|NCT00705614|3665797|FG000|NOT COMPLETED|Initial Intervention||518
2951925|NCT00705614|3665798|FG001|NOT COMPLETED|Initial Intervention||321
2951926|NCT00705614|3665797|FG000|STARTED|Switch to Remicade||0
2951927|NCT00705614|3665798|FG001|STARTED|Switch to Remicade||298
2951928|NCT00705614|3665797|FG000|COMPLETED|Switch to Remicade||0
2951929|NCT00705614|3665798|FG001|COMPLETED|Switch to Remicade||249
2951930|NCT00705614|3665797|FG000|NOT COMPLETED|Switch to Remicade||0
2951931|NCT00705614|3665798|FG001|NOT COMPLETED|Switch to Remicade||49
2951932|NCT00705653|3665806|FG000|STARTED|Overall Study||46
2951933|NCT00705653|3665806|FG000|COMPLETED|Overall Study||46
2951934|NCT00705653|3665806|FG000|NOT COMPLETED|Overall Study||0
2951935|NCT00705666|3665810|FG000|STARTED|Overall Study||789
2951936|NCT00705666|3665810|FG000|COMPLETED|Overall Study||450
2951937|NCT00705666|3665810|FG000|NOT COMPLETED|Overall Study||339
2951938|NCT00705679|3665819|FG000|STARTED|Overall Study||1007
2951939|NCT00705679|3665820|FG001|STARTED|Overall Study||1003
2951940|NCT00705679|3665821|FG002|STARTED|Overall Study||1009
2951941|NCT00705679|3665822|FG003|STARTED|Overall Study||1007
2951942|NCT00705679|3665823|FG004|STARTED|Overall Study||1003
2951943|NCT00705679|3665819|FG000|COMPLETED|Overall Study||942
2951944|NCT00705679|3665820|FG001|COMPLETED|Overall Study||864
2951945|NCT00705679|3665821|FG002|COMPLETED|Overall Study||894
2951946|NCT00705679|3665822|FG003|COMPLETED|Overall Study||927
2951947|NCT00705679|3665823|FG004|COMPLETED|Overall Study||934
2951948|NCT00705679|3665819|FG000|NOT COMPLETED|Overall Study||65
2951949|NCT00705679|3665820|FG001|NOT COMPLETED|Overall Study||139
2951950|NCT00705679|3665821|FG002|NOT COMPLETED|Overall Study||115
2951951|NCT00705679|3665822|FG003|NOT COMPLETED|Overall Study||80
2951952|NCT00705679|3665823|FG004|NOT COMPLETED|Overall Study||69
2951953|NCT00705718|3665842|FG000|STARTED|Overall Study||44
2951954|NCT00705718|3665843|FG001|STARTED|Overall Study||150
2951955|NCT00705718|3665842|FG000|1 Month Follow up|Overall Study|1 Death|43
2951956|NCT00705718|3665843|FG001|1 Month Follow up|Overall Study|1 Subject Missed Visit|149
2951957|NCT00705718|3665842|FG000|6 Month Follow up|Overall Study|3 Deaths|40
2951958|NCT00705718|3665843|FG001|6 Month Follow up|Overall Study|2 Deaths, 5 Subjects Missed Visit|143
2951959|NCT00705718|3665842|FG000|12 Month Follow up|Overall Study|2 Deaths|37
2951960|NCT00705718|3665843|FG001|12 Month Follow up|Overall Study|4 Deaths, 12 Subjects Not due for next visit, 4 Subjects Missed Visit|128
2951961|NCT00705718|3665842|FG000|COMPLETED|Overall Study||37
2951962|NCT00705718|3665843|FG001|COMPLETED|Overall Study||128
2951963|NCT00705718|3665842|FG000|NOT COMPLETED|Overall Study||7
2951964|NCT00705718|3665843|FG001|NOT COMPLETED|Overall Study||22
2951965|NCT00705757|3665852|FG000|STARTED|Overall Study||32
2951966|NCT00705757|3665853|FG001|STARTED|Overall Study||29
2951967|NCT00705757|3665854|FG002|STARTED|Overall Study||28
2951968|NCT00705757|3665852|FG000|COMPLETED|Overall Study||19
2951969|NCT00705757|3665853|FG001|COMPLETED|Overall Study||21
2951970|NCT00705757|3665854|FG002|COMPLETED|Overall Study||17
2951971|NCT00705757|3665852|FG000|NOT COMPLETED|Overall Study||13
2951972|NCT00705757|3665853|FG001|NOT COMPLETED|Overall Study||8
2951973|NCT00705757|3665854|FG002|NOT COMPLETED|Overall Study||11
2951974|NCT00705783|3665864|FG000|STARTED|Conversion Phase||633
2951975|NCT00705783|3665865|FG001|STARTED|Conversion Phase|There were no patients in this reporting group in this phase of the study.|0
2951976|NCT00705783|3665866|FG002|STARTED|Conversion Phase|There were no patients in this reporting group in this phase of the study.|0
2951977|NCT00705783|3665864|FG000|Received Study Medication|Conversion Phase||632
2951978|NCT00705783|3665865|FG001|Received Study Medication|Conversion Phase||0
2951979|NCT00705783|3665866|FG002|Received Study Medication|Conversion Phase||0
2951980|NCT00705783|3665864|FG000|COMPLETED|Conversion Phase||500
2951981|NCT00705783|3665865|FG001|COMPLETED|Conversion Phase||0
2951982|NCT00705783|3665866|FG002|COMPLETED|Conversion Phase||0
2951983|NCT00705783|3665864|FG000|NOT COMPLETED|Conversion Phase||133
2951984|NCT00705783|3665865|FG001|NOT COMPLETED|Conversion Phase||0
2951985|NCT00705783|3665866|FG002|NOT COMPLETED|Conversion Phase||0
2951986|NCT00705783|3665864|FG000|STARTED|Oral Stabilization Phase|210 of the 710 patients who started this phase enrolled in this study directly into this phase.|710
2951987|NCT00705783|3665865|FG001|STARTED|Oral Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
2951988|NCT00705783|3665866|FG002|STARTED|Oral Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
2951989|NCT00705783|3665864|FG000|Received Study Medication|Oral Stabilization Phase||709
2951990|NCT00705783|3665865|FG001|Received Study Medication|Oral Stabilization Phase||0
2951991|NCT00705783|3665866|FG002|Received Study Medication|Oral Stabilization Phase||0
2951992|NCT00705783|3665864|FG000|COMPLETED|Oral Stabilization Phase||576
2951993|NCT00705783|3665865|FG001|COMPLETED|Oral Stabilization Phase||0
2951994|NCT00705783|3665866|FG002|COMPLETED|Oral Stabilization Phase||0
2951995|NCT00705783|3665864|FG000|NOT COMPLETED|Oral Stabilization Phase||134
2951996|NCT00705783|3665865|FG001|NOT COMPLETED|Oral Stabilization Phase||0
2951997|NCT00705783|3665866|FG002|NOT COMPLETED|Oral Stabilization Phase||0
2951998|NCT00705783|3665864|FG000|STARTED|Depot Stabilization Phase||576
2951999|NCT00705783|3665865|FG001|STARTED|Depot Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
2952000|NCT00705783|3665866|FG002|STARTED|Depot Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
2952001|NCT00705783|3665864|FG000|COMPLETED|Depot Stabilization Phase||403
2952002|NCT00705783|3665865|FG001|COMPLETED|Depot Stabilization Phase||0
2952003|NCT00705783|3665866|FG002|COMPLETED|Depot Stabilization Phase||0
2952004|NCT00705783|3665864|FG000|NOT COMPLETED|Depot Stabilization Phase||173
2952005|NCT00705783|3665865|FG001|NOT COMPLETED|Depot Stabilization Phase||0
2952006|NCT00705783|3665866|FG002|NOT COMPLETED|Depot Stabilization Phase||0
2952007|NCT00705783|3665864|FG000|STARTED|Depot Maintenance Phase|Patients were randomized into the aripiprazole and placebo depot groups in this phase of the study.|0
2952008|NCT00705783|3665865|FG001|STARTED|Depot Maintenance Phase||269
2952009|NCT00705783|3665866|FG002|STARTED|Depot Maintenance Phase||134
2952010|NCT00705783|3665864|FG000|COMPLETED|Depot Maintenance Phase||0
2952011|NCT00705783|3665865|FG001|COMPLETED|Depot Maintenance Phase||23
2952012|NCT00705783|3665866|FG002|COMPLETED|Depot Maintenance Phase||3
2952013|NCT00705783|3665864|FG000|NOT COMPLETED|Depot Maintenance Phase||0
2952014|NCT00705783|3665865|FG001|NOT COMPLETED|Depot Maintenance Phase||246
2952015|NCT00705783|3665866|FG002|NOT COMPLETED|Depot Maintenance Phase||131
2952016|NCT00705874|3665882|FG000|STARTED|Overall Study||12
2952017|NCT00705874|3665883|FG001|STARTED|Overall Study||9
2952018|NCT00705874|3665884|FG002|STARTED|Overall Study||34
2952019|NCT00705874|3665885|FG003|STARTED|Overall Study||34
2952020|NCT00705874|3665886|FG004|STARTED|Overall Study||48
2952021|NCT00705874|3665887|FG005|STARTED|Overall Study||32
2952022|NCT00705874|3665888|FG006|STARTED|Overall Study||3
2952023|NCT00705874|3665882|FG000|COMPLETED|Overall Study||10
2952024|NCT00705874|3665883|FG001|COMPLETED|Overall Study||8
2952025|NCT00705874|3665884|FG002|COMPLETED|Overall Study||32
2952026|NCT00705874|3665885|FG003|COMPLETED|Overall Study||33
2952027|NCT00705874|3665886|FG004|COMPLETED|Overall Study||36
2952028|NCT00705874|3665887|FG005|COMPLETED|Overall Study||28
2952029|NCT00705874|3665888|FG006|COMPLETED|Overall Study||3
2952030|NCT00705874|3665882|FG000|NOT COMPLETED|Overall Study||2
2952031|NCT00705874|3665883|FG001|NOT COMPLETED|Overall Study||1
2952032|NCT00705874|3665884|FG002|NOT COMPLETED|Overall Study||2
2952033|NCT00705874|3665885|FG003|NOT COMPLETED|Overall Study||1
2952034|NCT00705874|3665886|FG004|NOT COMPLETED|Overall Study||12
2952035|NCT00705874|3665887|FG005|NOT COMPLETED|Overall Study||4
2952036|NCT00705874|3665888|FG006|NOT COMPLETED|Overall Study||0
2952037|NCT00705939|3665907|FG000|STARTED|Overall Study||12
2952038|NCT00705939|3665908|FG001|STARTED|Overall Study||14
2952039|NCT00705939|3665909|FG002|STARTED|Overall Study|1 subject enrolled but not treated in this protocol.|18
2952040|NCT00705939|3665907|FG000|COMPLETED|Overall Study||12
2952041|NCT00705939|3665908|FG001|COMPLETED|Overall Study||12
2952042|NCT00705939|3665909|FG002|COMPLETED|Overall Study||14
2952043|NCT00705939|3665907|FG000|NOT COMPLETED|Overall Study||0
2952044|NCT00705939|3665908|FG001|NOT COMPLETED|Overall Study||2
2952045|NCT00705939|3665909|FG002|NOT COMPLETED|Overall Study||4
2952046|NCT00706004|3665918|FG000|STARTED|Overall Study||9
2952047|NCT00706004|3665918|FG000|COMPLETED|Overall Study||7
2952048|NCT00706004|3665918|FG000|NOT COMPLETED|Overall Study||2
2952049|NCT00706030|3665927|FG000|STARTED|Overall Study||6
2952050|NCT00706030|3665928|FG001|STARTED|Overall Study||6
2952051|NCT00706030|3665929|FG002|STARTED|Overall Study||64
2952052|NCT00706030|3665930|FG003|STARTED|Overall Study||16
2952053|NCT00706030|3665927|FG000|Treated|Overall Study||6
2952054|NCT00706030|3665928|FG001|Treated|Overall Study||6
2952055|NCT00706030|3665929|FG002|Treated|Overall Study||64
2952056|NCT00706030|3665930|FG003|Treated|Overall Study||15
2952057|NCT00706030|3665927|FG000|COMPLETED|Overall Study||0
2952058|NCT00706030|3665928|FG001|COMPLETED|Overall Study||0
2952059|NCT00706030|3665929|FG002|COMPLETED|Overall Study||4
2952060|NCT00706030|3665930|FG003|COMPLETED|Overall Study||0
2952061|NCT00706030|3665927|FG000|NOT COMPLETED|Overall Study||6
2952062|NCT00706030|3665928|FG001|NOT COMPLETED|Overall Study||6
3300320|NCT02944513|4034252|FG001|COMPLETED|Overall Study||32
3300321|NCT02944513|4034251|FG000|NOT COMPLETED|Overall Study||4
3300322|NCT02944513|4034252|FG001|NOT COMPLETED|Overall Study||1
3300323|NCT02944565|4034258|FG000|STARTED|Overall Study||28
3300324|NCT02944565|4034258|FG000|COMPLETED|Overall Study||28
3300325|NCT02944565|4034258|FG000|NOT COMPLETED|Overall Study||0
3300326|NCT02944656|4034265|FG000|STARTED|Overall Study||57
3300327|NCT02944656|4034266|FG001|STARTED|Overall Study||57
3300328|NCT02944656|4034265|FG000|Completed Procedure Day|Overall Study||54
3300329|NCT02944656|4034266|FG001|Completed Procedure Day|Overall Study||57
3300330|NCT02944656|4034265|FG000|Completed Day 1 Follow up|Overall Study||47
3300331|NCT02944656|4034266|FG001|Completed Day 1 Follow up|Overall Study||47
3300332|NCT02944656|4034265|FG000|COMPLETED|Overall Study||47
3300333|NCT02944656|4034266|FG001|COMPLETED|Overall Study||47
2952063|NCT00706030|3665929|FG002|NOT COMPLETED|Overall Study||60
2952064|NCT00706030|3665930|FG003|NOT COMPLETED|Overall Study||16
2952065|NCT00706095|3665944|FG000|STARTED|Overall Study||6
2952066|NCT00706095|3665945|FG001|STARTED|Overall Study||7
2952067|NCT00706095|3665946|FG002|STARTED|Overall Study||5
2952068|NCT00706095|3665944|FG000|COMPLETED|Overall Study||0
2952069|NCT00706095|3665945|FG001|COMPLETED|Overall Study||0
2952070|NCT00706095|3665946|FG002|COMPLETED|Overall Study||0
2952071|NCT00706095|3665944|FG000|NOT COMPLETED|Overall Study||6
2952072|NCT00706095|3665945|FG001|NOT COMPLETED|Overall Study||7
2952073|NCT00706095|3665946|FG002|NOT COMPLETED|Overall Study||5
2952074|NCT00706121|3665958|FG000|STARTED|Overall Study||2039
2952075|NCT00706121|3665959|FG001|STARTED|Overall Study||2096
2952076|NCT00706121|3665960|FG002|STARTED|Overall Study||2030
2952077|NCT00706121|3665961|FG003|STARTED|Overall Study||1929
2952078|NCT00706121|3665958|FG000|COMPLETED|Overall Study||1643
2952079|NCT00706121|3665959|FG001|COMPLETED|Overall Study||1700
2952080|NCT00706121|3665960|FG002|COMPLETED|Overall Study||1626
2952081|NCT00706121|3665961|FG003|COMPLETED|Overall Study||1577
2952082|NCT00706121|3665958|FG000|NOT COMPLETED|Overall Study||396
2952083|NCT00706121|3665959|FG001|NOT COMPLETED|Overall Study||396
2952084|NCT00706121|3665960|FG002|NOT COMPLETED|Overall Study||404
2952085|NCT00706121|3665961|FG003|NOT COMPLETED|Overall Study||352
2952086|NCT00706134|3665983|FG000|STARTED|Overall Study||189
2952087|NCT00706134|3665984|FG001|STARTED|Overall Study||192
2952088|NCT00706134|3665985|FG002|STARTED|Overall Study||189
2952089|NCT00706134|3665986|FG003|STARTED|Overall Study||186
2952090|NCT00706134|3665983|FG000|Entered Double-blind Period|Overall Study||187
2952091|NCT00706134|3665984|FG001|Entered Double-blind Period|Overall Study||192
2952092|NCT00706134|3665985|FG002|Entered Double-blind Period|Overall Study||189
2952093|NCT00706134|3665986|FG003|Entered Double-blind Period|Overall Study||186
2952094|NCT00706134|3665983|FG000|COMPLETED|Overall Study||169
2952095|NCT00706134|3665984|FG001|COMPLETED|Overall Study||173
2952096|NCT00706134|3665985|FG002|COMPLETED|Overall Study||183
2952097|NCT00706134|3665986|FG003|COMPLETED|Overall Study||175
2952098|NCT00706134|3665983|FG000|NOT COMPLETED|Overall Study||20
2952099|NCT00706134|3665984|FG001|NOT COMPLETED|Overall Study||19
2952100|NCT00706134|3665985|FG002|NOT COMPLETED|Overall Study||6
2952101|NCT00706134|3665986|FG003|NOT COMPLETED|Overall Study||11
2952102|NCT00706238|3665996|FG000|STARTED|Overall Study||5
2952103|NCT00706238|3665996|FG000|COMPLETED|Overall Study||0
2952104|NCT00706238|3665996|FG000|NOT COMPLETED|Overall Study||5
2952105|NCT00706264|3666002|FG000|STARTED|Overall Study||193
2952106|NCT00706264|3666003|FG001|STARTED|Overall Study||192
2952107|NCT00706264|3666002|FG000|COMPLETED|Overall Study||190
2952108|NCT00706264|3666003|FG001|COMPLETED|Overall Study||190
2952109|NCT00706264|3666002|FG000|NOT COMPLETED|Overall Study||3
2952110|NCT00706264|3666003|FG001|NOT COMPLETED|Overall Study||2
2952111|NCT00706342|3666011|FG000|STARTED|Overall Study||18
2952112|NCT00706342|3666011|FG000|COMPLETED|Overall Study||0
2952113|NCT00706342|3666011|FG000|NOT COMPLETED|Overall Study||18
2952114|NCT00706355|3666019|FG000|STARTED|Period 1: PF-04217903 50 mg||3
2952115|NCT00706355|3666020|FG001|STARTED|Period 1: PF-04217903 50 mg||0
2952116|NCT00706355|3666021|FG002|STARTED|Period 1: PF-04217903 50 mg||0
2952117|NCT00706355|3666022|FG003|STARTED|Period 1: PF-04217903 50 mg||0
2952118|NCT00706355|3666019|FG000|COMPLETED|Period 1: PF-04217903 50 mg||0
2952119|NCT00706355|3666020|FG001|COMPLETED|Period 1: PF-04217903 50 mg||0
2952120|NCT00706355|3666021|FG002|COMPLETED|Period 1: PF-04217903 50 mg||0
2952121|NCT00706355|3666022|FG003|COMPLETED|Period 1: PF-04217903 50 mg||0
2952122|NCT00706355|3666019|FG000|NOT COMPLETED|Period 1: PF-04217903 50 mg||3
2952123|NCT00706355|3666020|FG001|NOT COMPLETED|Period 1: PF-04217903 50 mg||0
2952124|NCT00706355|3666021|FG002|NOT COMPLETED|Period 1: PF-04217903 50 mg||0
2952125|NCT00706355|3666022|FG003|NOT COMPLETED|Period 1: PF-04217903 50 mg||0
2952126|NCT00706355|3666019|FG000|STARTED|Period 2: PF-04217903 100 mg||0
2952127|NCT00706355|3666020|FG001|STARTED|Period 2: PF-04217903 100 mg||7
2952128|NCT00706355|3666021|FG002|STARTED|Period 2: PF-04217903 100 mg||0
2952129|NCT00706355|3666022|FG003|STARTED|Period 2: PF-04217903 100 mg||0
2952130|NCT00706355|3666019|FG000|COMPLETED|Period 2: PF-04217903 100 mg||0
2952131|NCT00706355|3666020|FG001|COMPLETED|Period 2: PF-04217903 100 mg||0
3300334|NCT02944656|4034265|FG000|NOT COMPLETED|Overall Study||10
3300335|NCT02944656|4034266|FG001|NOT COMPLETED|Overall Study||10
3300336|NCT02944968|4034272|FG000|STARTED|Overall Study||51
3300337|NCT02944968|4034272|FG000|COMPLETED|Overall Study||48
3300338|NCT02944968|4034272|FG000|NOT COMPLETED|Overall Study||3
3300339|NCT02945046|4034279|FG000|STARTED|Overall Study||59
3300340|NCT02945046|4034280|FG001|STARTED|Overall Study||55
3300341|NCT02945046|4034281|FG002|STARTED|Overall Study||55
3300342|NCT02945046|4034279|FG000|Safety Analysis Set|Overall Study||59
3300343|NCT02945046|4034280|FG001|Safety Analysis Set|Overall Study||55
3300344|NCT02945046|4034281|FG002|Safety Analysis Set|Overall Study||55
3300345|NCT02945046|4034279|FG000|Full Analysis Set|Overall Study||57
3300346|NCT02945046|4034280|FG001|Full Analysis Set|Overall Study||53
3300347|NCT02945046|4034281|FG002|Full Analysis Set|Overall Study||55
3383714|NCT01915498|4118873|FG000|STARTED|Main Analysis (Sept 2013 - Sept 2017)||7
3383715|NCT01915498|4118874|FG001|STARTED|Main Analysis (Sept 2013 - Sept 2017)||7
3383716|NCT01915498|4118875|FG002|STARTED|Main Analysis (Sept 2013 - Sept 2017)||7
2952132|NCT00706355|3666021|FG002|COMPLETED|Period 2: PF-04217903 100 mg||0
2952133|NCT00706355|3666022|FG003|COMPLETED|Period 2: PF-04217903 100 mg||0
2952134|NCT00706355|3666019|FG000|NOT COMPLETED|Period 2: PF-04217903 100 mg||0
2952135|NCT00706355|3666020|FG001|NOT COMPLETED|Period 2: PF-04217903 100 mg||7
2952136|NCT00706355|3666021|FG002|NOT COMPLETED|Period 2: PF-04217903 100 mg||0
2952137|NCT00706355|3666022|FG003|NOT COMPLETED|Period 2: PF-04217903 100 mg||0
2952138|NCT00706355|3666019|FG000|STARTED|Period 3: PF-04217903 200 mg||0
2952139|NCT00706355|3666020|FG001|STARTED|Period 3: PF-04217903 200 mg||0
2952140|NCT00706355|3666021|FG002|STARTED|Period 3: PF-04217903 200 mg||2
2952141|NCT00706355|3666022|FG003|STARTED|Period 3: PF-04217903 200 mg||0
2952142|NCT00706355|3666019|FG000|COMPLETED|Period 3: PF-04217903 200 mg||0
2952143|NCT00706355|3666020|FG001|COMPLETED|Period 3: PF-04217903 200 mg||0
2952144|NCT00706355|3666021|FG002|COMPLETED|Period 3: PF-04217903 200 mg||0
2952145|NCT00706355|3666022|FG003|COMPLETED|Period 3: PF-04217903 200 mg||0
2952146|NCT00706355|3666019|FG000|NOT COMPLETED|Period 3: PF-04217903 200 mg||0
2952147|NCT00706355|3666020|FG001|NOT COMPLETED|Period 3: PF-04217903 200 mg||0
2952148|NCT00706355|3666021|FG002|NOT COMPLETED|Period 3: PF-04217903 200 mg||2
2952149|NCT00706355|3666022|FG003|NOT COMPLETED|Period 3: PF-04217903 200 mg||0
3163446|NCT01886716|3890935|FG003|NOT COMPLETED|1-Month Post Follow-Up||0
3163447|NCT01886781|3890947|FG000|STARTED|Overall Study||54
3163448|NCT01886781|3890948|FG001|STARTED|Overall Study||27
3163449|NCT01886781|3890947|FG000|COMPLETED|Overall Study||40
3163450|NCT01886781|3890948|FG001|COMPLETED|Overall Study||25
3163451|NCT01886781|3890947|FG000|NOT COMPLETED|Overall Study||14
3163452|NCT01886781|3890948|FG001|NOT COMPLETED|Overall Study||2
3163453|NCT01886807|3890957|FG000|STARTED|Overall Study||164
3163454|NCT01886807|3890958|FG001|STARTED|Overall Study||155
3163455|NCT01886807|3890959|FG002|STARTED|Overall Study||163
3163456|NCT01886807|3890957|FG000|COMPLETED|Overall Study||159
2952150|NCT00706355|3666019|FG000|STARTED|Period 4: PF-04217903 150 mg||0
2952151|NCT00706355|3666020|FG001|STARTED|Period 4: PF-04217903 150 mg||0
2952152|NCT00706355|3666021|FG002|STARTED|Period 4: PF-04217903 150 mg||0
2952153|NCT00706355|3666022|FG003|STARTED|Period 4: PF-04217903 150 mg||4
2952154|NCT00706355|3666019|FG000|COMPLETED|Period 4: PF-04217903 150 mg||0
2952155|NCT00706355|3666020|FG001|COMPLETED|Period 4: PF-04217903 150 mg||0
2952156|NCT00706355|3666021|FG002|COMPLETED|Period 4: PF-04217903 150 mg||0
2952157|NCT00706355|3666022|FG003|COMPLETED|Period 4: PF-04217903 150 mg||0
2952158|NCT00706355|3666019|FG000|NOT COMPLETED|Period 4: PF-04217903 150 mg||0
2952159|NCT00706355|3666020|FG001|NOT COMPLETED|Period 4: PF-04217903 150 mg||0
2952160|NCT00706355|3666021|FG002|NOT COMPLETED|Period 4: PF-04217903 150 mg||0
2952161|NCT00706355|3666022|FG003|NOT COMPLETED|Period 4: PF-04217903 150 mg||4
2952162|NCT00706381|3666038|FG000|STARTED|Overall Study||10
2952163|NCT00706381|3666039|FG001|STARTED|Overall Study||6
2952164|NCT00706381|3666040|FG002|STARTED|Overall Study||6
2952165|NCT00706381|3666041|FG003|STARTED|Overall Study||9
2952166|NCT00706381|3666038|FG000|Intervention 1 (1 Day)|Overall Study||10
2952167|NCT00706381|3666039|FG001|Intervention 1 (1 Day)|Overall Study||6
2952168|NCT00706381|3666040|FG002|Intervention 1 (1 Day)|Overall Study||6
2952169|NCT00706381|3666041|FG003|Intervention 1 (1 Day)|Overall Study||9
2952170|NCT00706381|3666038|FG000|Intervention 2 (1 Day)|Overall Study||10
2952171|NCT00706381|3666039|FG001|Intervention 2 (1 Day)|Overall Study||6
2952172|NCT00706381|3666040|FG002|Intervention 2 (1 Day)|Overall Study||6
2952173|NCT00706381|3666041|FG003|Intervention 2 (1 Day)|Overall Study||9
2952174|NCT00706381|3666038|FG000|Intervention 3 (1 Day)|Overall Study||10
2952175|NCT00706381|3666039|FG001|Intervention 3 (1 Day)|Overall Study||6
2952176|NCT00706381|3666040|FG002|Intervention 3 (1 Day)|Overall Study||6
2952177|NCT00706381|3666041|FG003|Intervention 3 (1 Day)|Overall Study||9
2952178|NCT00706381|3666038|FG000|Intervention 4 (1 Day)|Overall Study||10
2952179|NCT00706381|3666039|FG001|Intervention 4 (1 Day)|Overall Study||5
2952180|NCT00706381|3666040|FG002|Intervention 4 (1 Day)|Overall Study||6
2952181|NCT00706381|3666041|FG003|Intervention 4 (1 Day)|Overall Study||9
2952182|NCT00706381|3666038|FG000|Intervention 5 (1 Day)|Overall Study||10
2952183|NCT00706381|3666039|FG001|Intervention 5 (1 Day)|Overall Study||5
2952184|NCT00706381|3666040|FG002|Intervention 5 (1 Day)|Overall Study||5
3163457|NCT01886807|3890958|FG001|COMPLETED|Overall Study||145
3163458|NCT01886807|3890959|FG002|COMPLETED|Overall Study||153
2952185|NCT00706381|3666041|FG003|Intervention 5 (1 Day)|Overall Study||9
2952186|NCT00706381|3666038|FG000|COMPLETED|Overall Study||10
2952187|NCT00706381|3666039|FG001|COMPLETED|Overall Study||5
2952188|NCT00706381|3666040|FG002|COMPLETED|Overall Study||5
2952189|NCT00706381|3666041|FG003|COMPLETED|Overall Study||9
2952190|NCT00706381|3666038|FG000|NOT COMPLETED|Overall Study||0
2952191|NCT00706381|3666039|FG001|NOT COMPLETED|Overall Study||1
2952192|NCT00706381|3666040|FG002|NOT COMPLETED|Overall Study||1
2952193|NCT00706381|3666041|FG003|NOT COMPLETED|Overall Study||0
2952194|NCT00706394|3666054|FG000|STARTED|Overall Study||19
2952195|NCT00706394|3666054|FG000|COMPLETED|Overall Study||8
2952196|NCT00706394|3666054|FG000|NOT COMPLETED|Overall Study||11
2952197|NCT00706407|3666060|FG000|STARTED|Overall Study||42
2952198|NCT00706407|3666060|FG000|COMPLETED|Overall Study||33
2952199|NCT00706407|3666060|FG000|NOT COMPLETED|Overall Study||9
2952200|NCT00706433|3666071|FG000|STARTED|Overall Study||68
2952201|NCT00706433|3666072|FG001|STARTED|Overall Study||65
2952202|NCT00706433|3666073|FG002|STARTED|Overall Study||67
3300348|NCT02945046|4034279|FG000|COMPLETED|Overall Study||46
3300349|NCT02945046|4034280|FG001|COMPLETED|Overall Study||42
3300350|NCT02945046|4034281|FG002|COMPLETED|Overall Study||40
3300351|NCT02945046|4034279|FG000|NOT COMPLETED|Overall Study||13
3300352|NCT02945046|4034280|FG001|NOT COMPLETED|Overall Study||13
3300353|NCT02945046|4034281|FG002|NOT COMPLETED|Overall Study||15
3300354|NCT02945150|4034289|FG000|STARTED|Overall Study||8
2952203|NCT00706433|3666074|FG003|STARTED|Overall Study||66
2952204|NCT00706433|3666071|FG000|COMPLETED|Overall Study||63
2952205|NCT00706433|3666072|FG001|COMPLETED|Overall Study||62
2952206|NCT00706433|3666073|FG002|COMPLETED|Overall Study||57
2952207|NCT00706433|3666074|FG003|COMPLETED|Overall Study||64
2952208|NCT00706433|3666071|FG000|NOT COMPLETED|Overall Study||5
2952209|NCT00706433|3666072|FG001|NOT COMPLETED|Overall Study||3
2952210|NCT00706433|3666073|FG002|NOT COMPLETED|Overall Study||10
2952211|NCT00706433|3666074|FG003|NOT COMPLETED|Overall Study||2
2952212|NCT00706446|3666090|FG000|STARTED|Overall Study||29
2952213|NCT00706446|3666091|FG001|STARTED|Overall Study||57
2952214|NCT00706446|3666092|FG002|STARTED|Overall Study||44
2952215|NCT00706446|3666093|FG003|STARTED|Overall Study||26
2952216|NCT00706446|3666094|FG004|STARTED|Overall Study||54
2952217|NCT00706446|3666095|FG005|STARTED|Overall Study||45
2952218|NCT00706446|3666090|FG000|COMPLETED|Overall Study||3
2952219|NCT00706446|3666091|FG001|COMPLETED|Overall Study||8
2952220|NCT00706446|3666092|FG002|COMPLETED|Overall Study||7
2952221|NCT00706446|3666093|FG003|COMPLETED|Overall Study||4
2952222|NCT00706446|3666094|FG004|COMPLETED|Overall Study||10
2952223|NCT00706446|3666095|FG005|COMPLETED|Overall Study||7
2952224|NCT00706446|3666090|FG000|NOT COMPLETED|Overall Study||26
2952225|NCT00706446|3666091|FG001|NOT COMPLETED|Overall Study||49
2952226|NCT00706446|3666092|FG002|NOT COMPLETED|Overall Study||37
2952227|NCT00706446|3666093|FG003|NOT COMPLETED|Overall Study||22
2952228|NCT00706446|3666094|FG004|NOT COMPLETED|Overall Study||44
2952229|NCT00706446|3666095|FG005|NOT COMPLETED|Overall Study||38
2952230|NCT00706485|3666109|FG000|STARTED|Overall Study||5
2952231|NCT00706485|3666109|FG000|COMPLETED|Overall Study||5
2952232|NCT00706485|3666109|FG000|NOT COMPLETED|Overall Study||0
2952233|NCT00706511|3666117|FG000|STARTED|Overall Study||10
2952234|NCT00706511|3666118|FG001|STARTED|Overall Study||4
2952235|NCT00706511|3666119|FG002|STARTED|Overall Study||3
2952236|NCT00706511|3666120|FG003|STARTED|Overall Study||10
2952237|NCT00706511|3666117|FG000|COMPLETED|Overall Study||9
2952238|NCT00706511|3666118|FG001|COMPLETED|Overall Study||4
2952239|NCT00706511|3666119|FG002|COMPLETED|Overall Study||3
2952240|NCT00706511|3666120|FG003|COMPLETED|Overall Study||10
2952241|NCT00706511|3666117|FG000|NOT COMPLETED|Overall Study||1
2952242|NCT00706511|3666118|FG001|NOT COMPLETED|Overall Study||0
2952243|NCT00706511|3666119|FG002|NOT COMPLETED|Overall Study||0
2952244|NCT00706511|3666120|FG003|NOT COMPLETED|Overall Study||0
2952245|NCT00706550|3666130|FG000|STARTED|Overall Study||43
2952246|NCT00706550|3666131|FG001|STARTED|Overall Study||64
2952247|NCT00706550|3666130|FG000|COMPLETED|Overall Study||36
2952248|NCT00706550|3666131|FG001|COMPLETED|Overall Study||36
2952249|NCT00706550|3666130|FG000|NOT COMPLETED|Overall Study||7
2952250|NCT00706550|3666131|FG001|NOT COMPLETED|Overall Study||28
2952251|NCT00706563|3666140|FG000|STARTED|Overall Study||61
2952252|NCT00706563|3666141|FG001|STARTED|Overall Study||59
2952253|NCT00706563|3666140|FG000|COMPLETED|Overall Study||61
2952254|NCT00706563|3666141|FG001|COMPLETED|Overall Study||59
2952255|NCT00706563|3666140|FG000|NOT COMPLETED|Overall Study||0
2952256|NCT00706563|3666141|FG001|NOT COMPLETED|Overall Study||0
2952257|NCT00706589|3666149|FG000|STARTED|Overall Study||32
2952258|NCT00706589|3666150|FG001|STARTED|Overall Study||29
2952259|NCT00706589|3666149|FG000|COMPLETED|Overall Study||29
2952260|NCT00706589|3666150|FG001|COMPLETED|Overall Study||25
2952261|NCT00706589|3666149|FG000|NOT COMPLETED|Overall Study||3
2952262|NCT00706589|3666150|FG001|NOT COMPLETED|Overall Study||4
2952263|NCT00706628|3666160|FG000|STARTED|Overall Study||47
2952264|NCT00706628|3666161|FG001|STARTED|Overall Study||21
3300355|NCT02945150|4034289|FG000|SVR12|Overall Study||8
3300356|NCT02945150|4034289|FG000|COMPLETED|Overall Study||8
2952265|NCT00706628|3666162|FG002|STARTED|Overall Study||16
2952266|NCT00706628|3666163|FG003|STARTED|Overall Study||3
2952267|NCT00706628|3666160|FG000|COMPLETED|Overall Study||0
2952268|NCT00706628|3666161|FG001|COMPLETED|Overall Study||0
2952269|NCT00706628|3666162|FG002|COMPLETED|Overall Study||0
2952270|NCT00706628|3666163|FG003|COMPLETED|Overall Study||0
2952271|NCT00706628|3666160|FG000|NOT COMPLETED|Overall Study||47
2952272|NCT00706628|3666161|FG001|NOT COMPLETED|Overall Study||21
2952273|NCT00706628|3666162|FG002|NOT COMPLETED|Overall Study||16
2952274|NCT00706628|3666163|FG003|NOT COMPLETED|Overall Study||3
2952275|NCT00706641|3666176|FG000|STARTED|Dasatinib Administration||25
2952276|NCT00706641|3666176|FG000|Toxicity Evaluation|Dasatinib Administration||24
2952277|NCT00706641|3666176|FG000|COMPLETED|Dasatinib Administration||23
2952278|NCT00706641|3666176|FG000|NOT COMPLETED|Dasatinib Administration||2
2952279|NCT00706641|3666176|FG000|STARTED|Radical Cystectomy||23
2952280|NCT00706641|3666176|FG000|COMPLETED|Radical Cystectomy||22
2952281|NCT00706641|3666176|FG000|NOT COMPLETED|Radical Cystectomy||1
2952282|NCT00706654|3666183|FG000|STARTED|Conversion Phase||709
2952283|NCT00706654|3666184|FG001|STARTED|Conversion Phase|There were no patients in this reporting group in this phase of the study.|0
2952284|NCT00706654|3666185|FG002|STARTED|Conversion Phase|There were no patients in this reporting group in this phase of the study.|0
2952285|NCT00706654|3666186|FG003|STARTED|Conversion Phase|There were no patients in this reporting group in this phase of the study.|0
2952286|NCT00706654|3666183|FG000|COMPLETED|Conversion Phase||614
2952287|NCT00706654|3666184|FG001|COMPLETED|Conversion Phase||0
2952288|NCT00706654|3666185|FG002|COMPLETED|Conversion Phase||0
2952289|NCT00706654|3666186|FG003|COMPLETED|Conversion Phase||0
2952290|NCT00706654|3666183|FG000|NOT COMPLETED|Conversion Phase||95
2952291|NCT00706654|3666184|FG001|NOT COMPLETED|Conversion Phase||0
2952292|NCT00706654|3666185|FG002|NOT COMPLETED|Conversion Phase||0
2952293|NCT00706654|3666186|FG003|NOT COMPLETED|Conversion Phase||0
2952294|NCT00706654|3666183|FG000|STARTED|Oral Stabilization Phase|228 of the 842 patients who started this phase enrolled directly into this phase of the study.|842
2952295|NCT00706654|3666184|FG001|STARTED|Oral Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
2952296|NCT00706654|3666185|FG002|STARTED|Oral Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
2952297|NCT00706654|3666186|FG003|STARTED|Oral Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
2952298|NCT00706654|3666183|FG000|COMPLETED|Oral Stabilization Phase||662
2952299|NCT00706654|3666184|FG001|COMPLETED|Oral Stabilization Phase||0
2952300|NCT00706654|3666185|FG002|COMPLETED|Oral Stabilization Phase||0
2952301|NCT00706654|3666186|FG003|COMPLETED|Oral Stabilization Phase||0
2952302|NCT00706654|3666183|FG000|NOT COMPLETED|Oral Stabilization Phase||180
2952303|NCT00706654|3666184|FG001|NOT COMPLETED|Oral Stabilization Phase||0
2952304|NCT00706654|3666185|FG002|NOT COMPLETED|Oral Stabilization Phase||0
2952305|NCT00706654|3666186|FG003|NOT COMPLETED|Oral Stabilization Phase||0
2952306|NCT00706654|3666183|FG000|STARTED|Depot Maintenance Phase|Patients were randomized into the 3 aripiprazole treatment groups in this phase of the study.|0
2952307|NCT00706654|3666184|FG001|STARTED|Depot Maintenance Phase||265
3132522|NCT01691521|3857580|FG001|NOT COMPLETED|Overall Study||16
3132523|NCT01691521|3857581|FG002|NOT COMPLETED|Overall Study||9
2952308|NCT00706654|3666185|FG002|STARTED|Depot Maintenance Phase||266
2952309|NCT00706654|3666186|FG003|STARTED|Depot Maintenance Phase||131
2952310|NCT00706654|3666183|FG000|COMPLETED|Depot Maintenance Phase||0
2952311|NCT00706654|3666184|FG001|COMPLETED|Depot Maintenance Phase||196
2952312|NCT00706654|3666185|FG002|COMPLETED|Depot Maintenance Phase||178
2952313|NCT00706654|3666186|FG003|COMPLETED|Depot Maintenance Phase||61
2952314|NCT00706654|3666183|FG000|NOT COMPLETED|Depot Maintenance Phase||0
2952315|NCT00706654|3666184|FG001|NOT COMPLETED|Depot Maintenance Phase||69
2952316|NCT00706654|3666185|FG002|NOT COMPLETED|Depot Maintenance Phase||88
2952317|NCT00706654|3666186|FG003|NOT COMPLETED|Depot Maintenance Phase||70
2952318|NCT00706706|3666196|FG000|STARTED|Overall Study||105
2952319|NCT00706706|3666196|FG000|COMPLETED|Overall Study||0
2952320|NCT00706706|3666196|FG000|NOT COMPLETED|Overall Study||105
2952321|NCT00706719|3666203|FG000|STARTED|Overall Study||5
2952322|NCT00706719|3666204|FG001|STARTED|Overall Study||7
2952323|NCT00706719|3666205|FG002|STARTED|Overall Study||5
2952324|NCT00706719|3666203|FG000|COMPLETED|Overall Study||5
2952325|NCT00706719|3666204|FG001|COMPLETED|Overall Study||6
2952326|NCT00706719|3666205|FG002|COMPLETED|Overall Study||1
2952327|NCT00706719|3666203|FG000|NOT COMPLETED|Overall Study||0
2952328|NCT00706719|3666204|FG001|NOT COMPLETED|Overall Study||1
2952329|NCT00706719|3666205|FG002|NOT COMPLETED|Overall Study||4
2952330|NCT00706784|3666214|FG000|STARTED|Overall Study||3
2952331|NCT00706784|3666215|FG001|STARTED|Overall Study||3
2952332|NCT00706784|3666214|FG000|COMPLETED|Overall Study||3
2952333|NCT00706784|3666215|FG001|COMPLETED|Overall Study||3
2952334|NCT00706784|3666214|FG000|NOT COMPLETED|Overall Study||0
2952335|NCT00706784|3666215|FG001|NOT COMPLETED|Overall Study||0
2952336|NCT00706810|3666221|FG000|STARTED|Overall Study||8
2952337|NCT00706810|3666221|FG000|COMPLETED|Overall Study||7
2952338|NCT00706810|3666221|FG000|NOT COMPLETED|Overall Study||1
2952339|NCT00706823|3666228|FG000|STARTED|Overall Study||25
2952340|NCT00706823|3666229|FG001|STARTED|Overall Study||25
2952341|NCT00706823|3666228|FG000|COMPLETED|Overall Study||25
2952342|NCT00706823|3666229|FG001|COMPLETED|Overall Study||25
2952343|NCT00706823|3666228|FG000|NOT COMPLETED|Overall Study||0
2952344|NCT00706823|3666229|FG001|NOT COMPLETED|Overall Study||0
2952345|NCT00706836|3666235|FG000|STARTED|Overall Study||16
2952346|NCT00706836|3666235|FG000|COMPLETED|Overall Study||16
3132524|NCT01691534|3857597|FG000|STARTED|Overall Study||15
2952347|NCT00706836|3666235|FG000|NOT COMPLETED|Overall Study||0
2952348|NCT00706849|3666245|FG000|STARTED|Treatment Period||41
2952349|NCT00706849|3666246|FG001|STARTED|Treatment Period||83
2952350|NCT00706849|3666245|FG000|Full Analysis Set|Treatment Period|Treated patients with a valid baseline & post-baseline LDL-C measurement|41
2952351|NCT00706849|3666246|FG001|Full Analysis Set|Treatment Period|Treated patients with a valid baseline & post-baseline LDL-C measurement.|82
2952352|NCT00706849|3666245|FG000|COMPLETED|Treatment Period|38 patients entered the open-label extension study (301012-CS6; NCT00694109).|41
2952353|NCT00706849|3666246|FG001|COMPLETED|Treatment Period|55 patients entered the open-label extension study (301012-CS6; NCT00694109).|73
2952354|NCT00706849|3666245|FG000|NOT COMPLETED|Treatment Period||0
2952355|NCT00706849|3666246|FG001|NOT COMPLETED|Treatment Period||10
2952356|NCT00706849|3666245|FG000|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|3
2952357|NCT00706849|3666246|FG001|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|28
2952358|NCT00706849|3666245|FG000|COMPLETED|Follow-up Period||3
2952359|NCT00706849|3666246|FG001|COMPLETED|Follow-up Period||25
2952360|NCT00706849|3666245|FG000|NOT COMPLETED|Follow-up Period||0
2952361|NCT00706849|3666246|FG001|NOT COMPLETED|Follow-up Period||3
2952362|NCT00706901|3666255|FG000|STARTED|Overall Study||59
2952363|NCT00706901|3666256|FG001|STARTED|Overall Study||62
2952364|NCT00706901|3666257|FG002|STARTED|Overall Study||59
2952365|NCT00706901|3666255|FG000|COMPLETED|Overall Study||51
2952366|NCT00706901|3666256|FG001|COMPLETED|Overall Study||57
2952367|NCT00706901|3666257|FG002|COMPLETED|Overall Study||51
2952368|NCT00706901|3666255|FG000|NOT COMPLETED|Overall Study||8
2952369|NCT00706901|3666256|FG001|NOT COMPLETED|Overall Study||5
2952370|NCT00706901|3666257|FG002|NOT COMPLETED|Overall Study||8
2952371|NCT00706914|3666269|FG000|STARTED|Overall Study||63
2952372|NCT00706914|3666270|FG001|STARTED|Overall Study||62
2952373|NCT00706914|3666271|FG002|STARTED|Overall Study||31
2952374|NCT00706914|3666269|FG000|COMPLETED|Overall Study||57
2952375|NCT00706914|3666270|FG001|COMPLETED|Overall Study||58
2952376|NCT00706914|3666271|FG002|COMPLETED|Overall Study||30
2952377|NCT00706914|3666269|FG000|NOT COMPLETED|Overall Study||6
2952378|NCT00706914|3666270|FG001|NOT COMPLETED|Overall Study||4
2952379|NCT00706914|3666271|FG002|NOT COMPLETED|Overall Study||1
2952380|NCT00706966|3666279|FG000|STARTED|Overall Study||10
2952381|NCT00706966|3666279|FG000|COMPLETED|Overall Study||9
2952382|NCT00706966|3666279|FG000|NOT COMPLETED|Overall Study||1
2952383|NCT00706979|3666313|FG000|STARTED|Overall Study||426
2952384|NCT00706979|3666314|FG001|STARTED|Overall Study||423
2952385|NCT00706979|3666313|FG000|COMPLETED|Overall Study||426
2952386|NCT00706979|3666314|FG001|COMPLETED|Overall Study||423
2952387|NCT00706979|3666313|FG000|NOT COMPLETED|Overall Study||0
2952388|NCT00706979|3666314|FG001|NOT COMPLETED|Overall Study||0
2952389|NCT00706992|3666327|FG000|STARTED|Overall Study||8
2952390|NCT00706992|3666328|FG001|STARTED|Overall Study||8
2952391|NCT00706992|3666329|FG002|STARTED|Overall Study||9
2952392|NCT00706992|3666330|FG003|STARTED|Overall Study||8
2952393|NCT00706992|3666331|FG004|STARTED|Overall Study||6
2952394|NCT00706992|3666332|FG005|STARTED|Overall Study||5
2952395|NCT00706992|3666333|FG006|STARTED|Overall Study||6
2952396|NCT00706992|3666327|FG000|COMPLETED|Overall Study||3
2952397|NCT00706992|3666328|FG001|COMPLETED|Overall Study||3
2952398|NCT00706992|3666329|FG002|COMPLETED|Overall Study||3
2952399|NCT00706992|3666330|FG003|COMPLETED|Overall Study||6
2952400|NCT00706992|3666331|FG004|COMPLETED|Overall Study||2
2952401|NCT00706992|3666332|FG005|COMPLETED|Overall Study||3
2952402|NCT00706992|3666333|FG006|COMPLETED|Overall Study||3
2952403|NCT00706992|3666327|FG000|NOT COMPLETED|Overall Study||5
2952404|NCT00706992|3666328|FG001|NOT COMPLETED|Overall Study||5
2952405|NCT00706992|3666329|FG002|NOT COMPLETED|Overall Study||6
2952406|NCT00706992|3666330|FG003|NOT COMPLETED|Overall Study||2
2952407|NCT00706992|3666331|FG004|NOT COMPLETED|Overall Study||4
2952408|NCT00706992|3666332|FG005|NOT COMPLETED|Overall Study||2
2952409|NCT00706992|3666333|FG006|NOT COMPLETED|Overall Study||3
2952410|NCT00707031|3666352|FG000|STARTED|Overall Study|Randomized|320
2952411|NCT00707031|3666353|FG001|STARTED|Overall Study||319
2952412|NCT00707031|3666352|FG000|Treated/Safety Population|Overall Study|All patients who received at least 1 dose, regardless of amount of treatment administered.|318
2952413|NCT00707031|3666353|FG001|Treated/Safety Population|Overall Study||316
2952414|NCT00707031|3666352|FG000|Modified Intent-to-Treat Population|Overall Study|All patients who received at least 1 dose;had baseline;at least 1 post-baseline efficacy assessment.|315
2952415|NCT00707031|3666353|FG001|Modified Intent-to-Treat Population|Overall Study||315
2952416|NCT00707031|3666352|FG000|COMPLETED|Overall Study||216
2952417|NCT00707031|3666353|FG001|COMPLETED|Overall Study||220
2952418|NCT00707031|3666352|FG000|NOT COMPLETED|Overall Study||104
2952419|NCT00707031|3666353|FG001|NOT COMPLETED|Overall Study||99
2952420|NCT00707057|3666362|FG000|STARTED|Overall Study||169
2952421|NCT00707057|3666363|FG001|STARTED|Overall Study||87
2952422|NCT00707057|3666362|FG000|COMPLETED|Overall Study||161
2952423|NCT00707057|3666363|FG001|COMPLETED|Overall Study||83
2952424|NCT00707057|3666362|FG000|NOT COMPLETED|Overall Study||8
2952425|NCT00707057|3666363|FG001|NOT COMPLETED|Overall Study||4
2952426|NCT00707174|3666371|FG000|STARTED|Overall Study||46
2952427|NCT00707174|3666372|FG001|STARTED|Overall Study||44
2952428|NCT00707174|3666371|FG000|COMPLETED|Overall Study||41
2952429|NCT00707174|3666372|FG001|COMPLETED|Overall Study||37
2952430|NCT00707174|3666371|FG000|NOT COMPLETED|Overall Study||5
2952431|NCT00707174|3666372|FG001|NOT COMPLETED|Overall Study||7
2952432|NCT00707239|3666381|FG000|STARTED|Overall Study||37
2952433|NCT00707239|3666382|FG001|STARTED|Overall Study||36
2952434|NCT00707239|3666383|FG002|STARTED|Overall Study||35
2952435|NCT00707239|3666381|FG000|Treated|Overall Study||36
2952436|NCT00707239|3666382|FG001|Treated|Overall Study||35
2952437|NCT00707239|3666383|FG002|Treated|Overall Study||34
2952438|NCT00707239|3666381|FG000|COMPLETED|Overall Study||18
2952439|NCT00707239|3666382|FG001|COMPLETED|Overall Study||25
2952440|NCT00707239|3666383|FG002|COMPLETED|Overall Study||21
2952441|NCT00707239|3666381|FG000|NOT COMPLETED|Overall Study||19
2952442|NCT00707239|3666382|FG001|NOT COMPLETED|Overall Study||11
2952443|NCT00707239|3666383|FG002|NOT COMPLETED|Overall Study||14
2952444|NCT00707343|3666394|FG000|STARTED|Overall Study||15
2952445|NCT00707343|3666394|FG000|COMPLETED|Overall Study||15
2952446|NCT00707343|3666394|FG000|NOT COMPLETED|Overall Study||0
2952447|NCT00707447|3666400|FG000|STARTED|Overall Study||89
2952448|NCT00707447|3666401|FG001|STARTED|Overall Study||93
2952449|NCT00707447|3666400|FG000|COMPLETED|Overall Study||81
2952450|NCT00707447|3666401|FG001|COMPLETED|Overall Study||85
2952451|NCT00707447|3666400|FG000|NOT COMPLETED|Overall Study||8
2952452|NCT00707447|3666401|FG001|NOT COMPLETED|Overall Study||8
2952453|NCT00707486|3666407|FG000|STARTED|Overall Study||72
2952454|NCT00707486|3666407|FG000|COMPLETED|Overall Study||71
2952455|NCT00707486|3666407|FG000|NOT COMPLETED|Overall Study||1
2952456|NCT00707577|3666415|FG000|STARTED|Overall Study||174
2952457|NCT00707577|3666416|FG001|STARTED|Overall Study||156
2952458|NCT00707577|3666415|FG000|COMPLETED|Overall Study||120
2952459|NCT00707577|3666416|FG001|COMPLETED|Overall Study||118
2952460|NCT00707577|3666415|FG000|NOT COMPLETED|Overall Study||54
2952461|NCT00707577|3666416|FG001|NOT COMPLETED|Overall Study||38
2952462|NCT00707655|3666424|FG000|STARTED|Overall Study||3
2952463|NCT00707655|3666425|FG001|STARTED|Overall Study||5
2952464|NCT00707655|3666424|FG000|COMPLETED|Overall Study||3
2952465|NCT00707655|3666425|FG001|COMPLETED|Overall Study||3
2952466|NCT00707655|3666424|FG000|NOT COMPLETED|Overall Study||0
2952467|NCT00707655|3666425|FG001|NOT COMPLETED|Overall Study||2
2952468|NCT00707746|3666435|FG000|STARTED|Treatment Period||12
2952469|NCT00707746|3666436|FG001|STARTED|Treatment Period||22
2952470|NCT00707746|3666435|FG000|Full Analysis Set (FAS) and Safety Set|Treatment Period|FAS: Treated patients with a valid baseline & post-baseline LDL-C measurement|12
2952471|NCT00707746|3666436|FG001|Full Analysis Set (FAS) and Safety Set|Treatment Period|FAS: Treated patients with a valid baseline & post-baseline LDL-C measurement|21
2952472|NCT00707746|3666435|FG000|COMPLETED|Treatment Period||10
2952473|NCT00707746|3666436|FG001|COMPLETED|Treatment Period||17
2952474|NCT00707746|3666435|FG000|NOT COMPLETED|Treatment Period||2
2952475|NCT00707746|3666436|FG001|NOT COMPLETED|Treatment Period||5
2952476|NCT00707746|3666435|FG000|STARTED|Follow-up Period||12
2952477|NCT00707746|3666436|FG001|STARTED|Follow-up Period||21
2952478|NCT00707746|3666435|FG000|COMPLETED|Follow-up Period||12
2952479|NCT00707746|3666436|FG001|COMPLETED|Follow-up Period||21
2952480|NCT00707746|3666435|FG000|NOT COMPLETED|Follow-up Period||0
2952481|NCT00707746|3666436|FG001|NOT COMPLETED|Follow-up Period||0
2952482|NCT00707759|3666444|FG000|STARTED|Overall Study||14
2952483|NCT00707759|3666445|FG001|STARTED|Overall Study||14
2952484|NCT00707759|3666444|FG000|COMPLETED|Overall Study||12
2952485|NCT00707759|3666445|FG001|COMPLETED|Overall Study||12
2952486|NCT00707759|3666444|FG000|NOT COMPLETED|Overall Study||2
2952487|NCT00707759|3666445|FG001|NOT COMPLETED|Overall Study||2
2952488|NCT00707863|3666453|FG000|STARTED|Overall Study||6
2952489|NCT00707863|3666454|FG001|STARTED|Overall Study||11
2952490|NCT00707863|3666453|FG000|COMPLETED|Overall Study||6
2952491|NCT00707863|3666454|FG001|COMPLETED|Overall Study||8
2952492|NCT00707863|3666453|FG000|NOT COMPLETED|Overall Study||0
2952493|NCT00707863|3666454|FG001|NOT COMPLETED|Overall Study||3
2952494|NCT00707915|3666460|FG000|STARTED|Overall Study||30
2952495|NCT00707915|3666460|FG000|Effects of Discontinuing Benzodiazepine|Overall Study||30
2952496|NCT00707915|3666460|FG000|COMPLETED|Overall Study||30
2952497|NCT00707915|3666460|FG000|NOT COMPLETED|Overall Study||0
2952498|NCT00707954|3666469|FG000|STARTED|Overall Study||12
2952499|NCT00707954|3666470|FG001|STARTED|Overall Study||12
2952500|NCT00707954|3666471|FG002|STARTED|Overall Study||14
2952501|NCT00707954|3666472|FG003|STARTED|Overall Study||13
2952502|NCT00707954|3666473|FG004|STARTED|Overall Study||10
2952503|NCT00707954|3666469|FG000|COMPLETED|Overall Study||12
2952504|NCT00707954|3666470|FG001|COMPLETED|Overall Study||12
2952505|NCT00707954|3666471|FG002|COMPLETED|Overall Study||14
2952506|NCT00707954|3666472|FG003|COMPLETED|Overall Study||13
2952507|NCT00707954|3666473|FG004|COMPLETED|Overall Study||9
2952508|NCT00707954|3666469|FG000|NOT COMPLETED|Overall Study||0
2952509|NCT00707954|3666470|FG001|NOT COMPLETED|Overall Study||0
2952510|NCT00707954|3666471|FG002|NOT COMPLETED|Overall Study||0
2952511|NCT00707954|3666472|FG003|NOT COMPLETED|Overall Study||0
2952512|NCT00707954|3666473|FG004|NOT COMPLETED|Overall Study||1
2952513|NCT00707967|3666488|FG000|STARTED|Overall Study||22
2952514|NCT00707967|3666489|FG001|STARTED|Overall Study||8
2952515|NCT00707967|3666490|FG002|STARTED|Overall Study||7
2952516|NCT00707967|3666488|FG000|COMPLETED|Overall Study||22
2952517|NCT00707967|3666489|FG001|COMPLETED|Overall Study||8
2952518|NCT00707967|3666490|FG002|COMPLETED|Overall Study||7
2952519|NCT00707967|3666488|FG000|NOT COMPLETED|Overall Study||0
2952520|NCT00707967|3666489|FG001|NOT COMPLETED|Overall Study||0
2952521|NCT00707967|3666490|FG002|NOT COMPLETED|Overall Study||0
2952522|NCT00707980|3666498|FG000|STARTED|Overall Study||836
2952523|NCT00707980|3666498|FG000|Received Treatment|Overall Study||834
2952524|NCT00707980|3666498|FG000|COMPLETED|Overall Study||526
2952525|NCT00707980|3666498|FG000|NOT COMPLETED|Overall Study||310
2952526|NCT00707993|3666504|FG000|STARTED|Overall Study||222
2952527|NCT00707993|3666505|FG001|STARTED|Overall Study||219
2952528|NCT00707993|3666504|FG000|COMPLETED|Overall Study||133
2952529|NCT00707993|3666505|FG001|COMPLETED|Overall Study||125
2952530|NCT00707993|3666504|FG000|NOT COMPLETED|Overall Study||89
2952531|NCT00707993|3666505|FG001|NOT COMPLETED|Overall Study||94
2952532|NCT00708019|3666513|FG000|STARTED|Overall Study||92
2952533|NCT00708019|3666514|FG001|STARTED|Overall Study||93
2952534|NCT00708019|3666513|FG000|COMPLETED|Overall Study||77
2952535|NCT00708019|3666514|FG001|COMPLETED|Overall Study||78
2952536|NCT00708019|3666513|FG000|NOT COMPLETED|Overall Study||15
2952537|NCT00708019|3666514|FG001|NOT COMPLETED|Overall Study||15
2952538|NCT00708032|3666522|FG000|STARTED|Overall Study||36
2952539|NCT00708032|3666523|FG001|STARTED|Overall Study||38
2952540|NCT00708032|3666522|FG000|COMPLETED|Overall Study||26
2952541|NCT00708032|3666523|FG001|COMPLETED|Overall Study||22
2952542|NCT00708032|3666522|FG000|NOT COMPLETED|Overall Study||10
2952543|NCT00708032|3666523|FG001|NOT COMPLETED|Overall Study||16
2952544|NCT00708071|3666529|FG000|STARTED|Overall Study|Randomized and treated|45
2952545|NCT00708071|3666529|FG000|COMPLETED|Overall Study||45
2952546|NCT00708071|3666529|FG000|NOT COMPLETED|Overall Study||0
2952547|NCT00708097|3666563|FG000|STARTED|Period 1||11
2952548|NCT00708097|3666564|FG001|STARTED|Period 1||12
2952549|NCT00708097|3666565|FG002|STARTED|Period 1||12
2952550|NCT00708097|3666566|FG003|STARTED|Period 1||11
2952551|NCT00708097|3666567|FG004|STARTED|Period 1||11
2952552|NCT00708097|3666563|FG000|COMPLETED|Period 1||11
2952553|NCT00708097|3666564|FG001|COMPLETED|Period 1||11
2952554|NCT00708097|3666565|FG002|COMPLETED|Period 1||12
2952555|NCT00708097|3666566|FG003|COMPLETED|Period 1||9
2952556|NCT00708097|3666567|FG004|COMPLETED|Period 1||10
2952557|NCT00708097|3666563|FG000|NOT COMPLETED|Period 1||0
2952558|NCT00708097|3666564|FG001|NOT COMPLETED|Period 1||1
2952559|NCT00708097|3666565|FG002|NOT COMPLETED|Period 1||0
2952560|NCT00708097|3666566|FG003|NOT COMPLETED|Period 1||2
2952561|NCT00708097|3666567|FG004|NOT COMPLETED|Period 1||1
2952562|NCT00708097|3666563|FG000|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1.|10
2952563|NCT00708097|3666564|FG001|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1.|12
2952564|NCT00708097|3666565|FG002|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1.|10
2952565|NCT00708097|3666566|FG003|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1.|11
2952566|NCT00708097|3666567|FG004|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1.|10
2952567|NCT00708097|3666563|FG000|COMPLETED|Period 2||10
2952568|NCT00708097|3666564|FG001|COMPLETED|Period 2||11
2952569|NCT00708097|3666565|FG002|COMPLETED|Period 2||9
2952570|NCT00708097|3666566|FG003|COMPLETED|Period 2||10
2952571|NCT00708097|3666567|FG004|COMPLETED|Period 2||10
2952572|NCT00708097|3666563|FG000|NOT COMPLETED|Period 2||0
2952573|NCT00708097|3666564|FG001|NOT COMPLETED|Period 2||1
2952574|NCT00708097|3666565|FG002|NOT COMPLETED|Period 2||1
2952575|NCT00708097|3666566|FG003|NOT COMPLETED|Period 2||1
2952576|NCT00708097|3666567|FG004|NOT COMPLETED|Period 2||0
2952577|NCT00708097|3666563|FG000|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2.|9
2952578|NCT00708097|3666564|FG001|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2.|11
2952579|NCT00708097|3666565|FG002|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2.|10
2952580|NCT00708097|3666566|FG003|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2.|10
2952581|NCT00708097|3666567|FG004|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2.|10
2952582|NCT00708097|3666563|FG000|COMPLETED|Period 3||9
2952583|NCT00708097|3666564|FG001|COMPLETED|Period 3||11
2952584|NCT00708097|3666565|FG002|COMPLETED|Period 3||10
2952585|NCT00708097|3666566|FG003|COMPLETED|Period 3||10
2952586|NCT00708097|3666567|FG004|COMPLETED|Period 3||10
2952587|NCT00708097|3666563|FG000|NOT COMPLETED|Period 3||0
2952588|NCT00708097|3666564|FG001|NOT COMPLETED|Period 3||0
2952589|NCT00708097|3666565|FG002|NOT COMPLETED|Period 3||0
2952590|NCT00708097|3666566|FG003|NOT COMPLETED|Period 3||0
2952591|NCT00708097|3666567|FG004|NOT COMPLETED|Period 3||0
2952592|NCT00708097|3666563|FG000|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3.|12
2952593|NCT00708097|3666564|FG001|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3.|9
2952594|NCT00708097|3666565|FG002|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3.|10
2952595|NCT00708097|3666566|FG003|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3.|11
2952596|NCT00708097|3666567|FG004|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3.|8
2952597|NCT00708097|3666563|FG000|COMPLETED|Period 4||12
2952598|NCT00708097|3666564|FG001|COMPLETED|Period 4||9
2952599|NCT00708097|3666565|FG002|COMPLETED|Period 4||10
2952600|NCT00708097|3666566|FG003|COMPLETED|Period 4||11
2952601|NCT00708097|3666567|FG004|COMPLETED|Period 4||8
2952602|NCT00708097|3666563|FG000|NOT COMPLETED|Period 4||0
2952603|NCT00708097|3666564|FG001|NOT COMPLETED|Period 4||0
2952604|NCT00708097|3666565|FG002|NOT COMPLETED|Period 4||0
2952605|NCT00708097|3666566|FG003|NOT COMPLETED|Period 4||0
2952606|NCT00708097|3666567|FG004|NOT COMPLETED|Period 4||0
2952607|NCT00708097|3666563|FG000|STARTED|Period 5|Due to crossover design, a different set of subjects received this treatment compared to Period 4.|8
2952608|NCT00708097|3666564|FG001|STARTED|Period 5|Due to crossover design, a different set of subjects received this treatment compared to Period 4.|9
2952609|NCT00708097|3666565|FG002|STARTED|Period 5|Due to crossover design, a different set of subjects received this treatment compared to Period 4.|11
2952610|NCT00708097|3666566|FG003|STARTED|Period 5|Due to crossover design, a different set of subjects received this treatment compared to Period 4.|10
2952611|NCT00708097|3666567|FG004|STARTED|Period 5|Due to crossover design, a different set of subjects received this treatment compared to Period 4.|12
3132525|NCT01691534|3857598|FG001|STARTED|Overall Study||15
3132526|NCT01691534|3857599|FG002|STARTED|Overall Study||15
3132527|NCT01691534|3857600|FG003|STARTED|Overall Study||15
3132528|NCT01691534|3857601|FG004|STARTED|Overall Study||15
3132529|NCT01691534|3857602|FG005|STARTED|Overall Study||15
3132530|NCT01691534|3857603|FG006|STARTED|Overall Study||15
3132531|NCT01691534|3857597|FG000|COMPLETED|Overall Study||15
3132532|NCT01691534|3857598|FG001|COMPLETED|Overall Study||14
2952612|NCT00708097|3666563|FG000|COMPLETED|Period 5||8
2952613|NCT00708097|3666564|FG001|COMPLETED|Period 5||9
2952614|NCT00708097|3666565|FG002|COMPLETED|Period 5||11
2952615|NCT00708097|3666566|FG003|COMPLETED|Period 5||10
2952616|NCT00708097|3666567|FG004|COMPLETED|Period 5||12
2952617|NCT00708097|3666563|FG000|NOT COMPLETED|Period 5||0
2952618|NCT00708097|3666564|FG001|NOT COMPLETED|Period 5||0
2952619|NCT00708097|3666565|FG002|NOT COMPLETED|Period 5||0
2952620|NCT00708097|3666566|FG003|NOT COMPLETED|Period 5||0
3132533|NCT01691534|3857599|FG002|COMPLETED|Overall Study||14
3132534|NCT01691534|3857600|FG003|COMPLETED|Overall Study||14
3132535|NCT01691534|3857601|FG004|COMPLETED|Overall Study||15
3132536|NCT01691534|3857602|FG005|COMPLETED|Overall Study||14
3132537|NCT01691534|3857603|FG006|COMPLETED|Overall Study||14
3132538|NCT01691534|3857597|FG000|NOT COMPLETED|Overall Study||0
3132539|NCT01691534|3857598|FG001|NOT COMPLETED|Overall Study||1
3132540|NCT01691534|3857599|FG002|NOT COMPLETED|Overall Study||1
3132541|NCT01691534|3857600|FG003|NOT COMPLETED|Overall Study||1
3132542|NCT01691534|3857601|FG004|NOT COMPLETED|Overall Study||0
3132543|NCT01691534|3857602|FG005|NOT COMPLETED|Overall Study||1
3132544|NCT01691534|3857603|FG006|NOT COMPLETED|Overall Study||1
3132545|NCT01691560|3857624|FG000|STARTED|Overall Study||34
3132546|NCT01691560|3857625|FG001|STARTED|Overall Study||33
3132547|NCT01691560|3857626|FG002|STARTED|Overall Study||34
3132548|NCT01691560|3857627|FG003|STARTED|Overall Study||33
3132549|NCT01691560|3857624|FG000|COMPLETED|Overall Study||34
3132550|NCT01691560|3857625|FG001|COMPLETED|Overall Study||33
3132551|NCT01691560|3857626|FG002|COMPLETED|Overall Study||34
3132552|NCT01691560|3857627|FG003|COMPLETED|Overall Study||33
3132553|NCT01691560|3857624|FG000|NOT COMPLETED|Overall Study||0
3132554|NCT01691560|3857625|FG001|NOT COMPLETED|Overall Study||0
3132555|NCT01691560|3857626|FG002|NOT COMPLETED|Overall Study||0
3132556|NCT01691560|3857627|FG003|NOT COMPLETED|Overall Study||0
3132557|NCT01691612|3857637|FG000|STARTED|Overall Study||14
3132558|NCT01691612|3857637|FG000|First Visit (Allergen Challenge)|Overall Study||8
3132559|NCT01691612|3857637|FG000|Second Visit (Bronchoscopy)|Overall Study||7
3132560|NCT01691612|3857637|FG000|COMPLETED|Overall Study||7
3132561|NCT01691612|3857637|FG000|NOT COMPLETED|Overall Study||7
3132562|NCT01691690|3857643|FG000|STARTED|Overall Study||125
3132563|NCT01691690|3857644|FG001|STARTED|Overall Study||125
3132564|NCT01691690|3857643|FG000|COMPLETED|Overall Study||118
3132565|NCT01691690|3857644|FG001|COMPLETED|Overall Study||121
3132566|NCT01691690|3857643|FG000|NOT COMPLETED|Overall Study||7
3132567|NCT01691690|3857644|FG001|NOT COMPLETED|Overall Study||4
3132568|NCT01691768|3857655|FG000|STARTED|Overall Study||189
3132569|NCT01691768|3857656|FG001|STARTED|Overall Study||183
3132570|NCT01691768|3857655|FG000|COMPLETED|Overall Study||174
3132571|NCT01691768|3857656|FG001|COMPLETED|Overall Study||167
3132572|NCT01691768|3857655|FG000|NOT COMPLETED|Overall Study||15
3132573|NCT01691768|3857656|FG001|NOT COMPLETED|Overall Study||16
3132574|NCT01691781|3857665|FG000|STARTED|Overall Study||19
3132575|NCT01691781|3857666|FG001|STARTED|Overall Study||22
3132576|NCT01691781|3857665|FG000|COMPLETED|Overall Study||12
3132577|NCT01691781|3857666|FG001|COMPLETED|Overall Study||15
3132578|NCT01691781|3857665|FG000|NOT COMPLETED|Overall Study||7
3132579|NCT01691781|3857666|FG001|NOT COMPLETED|Overall Study||7
3132580|NCT01691794|3857675|FG000|STARTED|Overall Study||3
3132581|NCT01691794|3857676|FG001|STARTED|Overall Study||33
3132582|NCT01691794|3857677|FG002|STARTED|Overall Study||23
3132583|NCT01691794|3857675|FG000|COMPLETED|Overall Study|Completed baseline to End of Study|2
3132584|NCT01691794|3857676|FG001|COMPLETED|Overall Study|Completed baseline to End of Study|15
3132585|NCT01691794|3857677|FG002|COMPLETED|Overall Study|Completed baseline to End of Study|13
3132586|NCT01691794|3857675|FG000|NOT COMPLETED|Overall Study||1
3163459|NCT01886807|3890957|FG000|NOT COMPLETED|Overall Study||5
3163460|NCT01886807|3890958|FG001|NOT COMPLETED|Overall Study||10
3163461|NCT01886807|3890959|FG002|NOT COMPLETED|Overall Study||10
3163462|NCT01886833|3890970|FG000|STARTED|Overall Study||420
3163463|NCT01886833|3890970|FG000|COMPLETED|Overall Study||216
3163464|NCT01886833|3890970|FG000|NOT COMPLETED|Overall Study||204
3163465|NCT01886937|3890979|FG000|STARTED|Overall Study||7
3163466|NCT01886937|3890980|FG001|STARTED|Overall Study||6
3163467|NCT01886937|3890979|FG000|COMPLETED|Overall Study||7
3163468|NCT01886937|3890980|FG001|COMPLETED|Overall Study||6
3163469|NCT01886937|3890979|FG000|NOT COMPLETED|Overall Study||0
3163470|NCT01886937|3890980|FG001|NOT COMPLETED|Overall Study||0
3163471|NCT01886963|3890988|FG000|STARTED|Overall Study||57
3163472|NCT01886963|3890989|FG001|STARTED|Overall Study||58
3163473|NCT01886963|3890988|FG000|2 Week Follow Up|Overall Study||55
3163474|NCT01886963|3890989|FG001|2 Week Follow Up|Overall Study||55
3163475|NCT01886963|3890988|FG000|4 Week Follow Up|Overall Study||50
3163476|NCT01886963|3890989|FG001|4 Week Follow Up|Overall Study||51
3163477|NCT01886963|3890988|FG000|12 Week Follow Up|Overall Study||46
3163478|NCT01886963|3890989|FG001|12 Week Follow Up|Overall Study||49
3163479|NCT01886963|3890988|FG000|COMPLETED|Overall Study||46
3163480|NCT01886963|3890989|FG001|COMPLETED|Overall Study||49
3163481|NCT01886963|3890988|FG000|NOT COMPLETED|Overall Study||11
3163482|NCT01886963|3890989|FG001|NOT COMPLETED|Overall Study||9
3163483|NCT01887132|3890995|FG000|STARTED|Overall Study||4
3163484|NCT01887132|3890995|FG000|COMPLETED|Overall Study||4
3163485|NCT01887132|3890995|FG000|NOT COMPLETED|Overall Study||0
3163486|NCT01887171|3891001|FG000|STARTED|Overall Study||43
3163487|NCT01887171|3891002|FG001|STARTED|Overall Study||43
3163488|NCT01887171|3891001|FG000|COMPLETED|Overall Study||43
3163489|NCT01887171|3891002|FG001|COMPLETED|Overall Study||43
3163490|NCT01887171|3891001|FG000|NOT COMPLETED|Overall Study||0
3163491|NCT01887171|3891002|FG001|NOT COMPLETED|Overall Study||0
3163492|NCT01887210|3891010|FG000|STARTED|Overall Study||33
3163493|NCT01887210|3891011|FG001|STARTED|Overall Study||33
3163494|NCT01887210|3891010|FG000|COMPLETED|Overall Study||32
3163495|NCT01887210|3891011|FG001|COMPLETED|Overall Study||29
3163496|NCT01887210|3891010|FG000|NOT COMPLETED|Overall Study||1
3163497|NCT01887210|3891011|FG001|NOT COMPLETED|Overall Study||4
3163498|NCT01887327|3891020|FG000|STARTED|Overall Study||30
3163499|NCT01887327|3891021|FG001|STARTED|Overall Study||31
3163500|NCT01887327|3891022|FG002|STARTED|Overall Study||30
3163501|NCT01887327|3891020|FG000|COMPLETED|Overall Study||29
3163502|NCT01887327|3891021|FG001|COMPLETED|Overall Study||27
3163503|NCT01887327|3891022|FG002|COMPLETED|Overall Study||27
3163504|NCT01887327|3891020|FG000|NOT COMPLETED|Overall Study||1
3163505|NCT01887327|3891021|FG001|NOT COMPLETED|Overall Study||4
3163506|NCT01887327|3891022|FG002|NOT COMPLETED|Overall Study||3
3163507|NCT01887353|3891033|FG000|STARTED|Overall Study||4
2952621|NCT00708097|3666567|FG004|NOT COMPLETED|Period 5||0
2952622|NCT00708110|3666588|FG000|STARTED|Overall Study||7
2952623|NCT00708110|3666589|FG001|STARTED|Overall Study||9
2952624|NCT00708110|3666590|FG002|STARTED|Overall Study||9
2952625|NCT00708110|3666591|FG003|STARTED|Overall Study||10
2952626|NCT00708110|3666588|FG000|COMPLETED|Overall Study||7
2952627|NCT00708110|3666589|FG001|COMPLETED|Overall Study||9
2952628|NCT00708110|3666590|FG002|COMPLETED|Overall Study||9
2952629|NCT00708110|3666591|FG003|COMPLETED|Overall Study||10
2952630|NCT00708110|3666588|FG000|NOT COMPLETED|Overall Study||0
2952631|NCT00708110|3666589|FG001|NOT COMPLETED|Overall Study||0
2952632|NCT00708110|3666590|FG002|NOT COMPLETED|Overall Study||0
2952633|NCT00708110|3666591|FG003|NOT COMPLETED|Overall Study||0
2952634|NCT00708123|3666601|FG000|STARTED|Period 1||12
2952635|NCT00708123|3666602|FG001|STARTED|Period 1||12
2952636|NCT00708123|3666603|FG002|STARTED|Period 1||12
2952637|NCT00708123|3666604|FG003|STARTED|Period 1||12
2952638|NCT00708123|3666605|FG004|STARTED|Period 1||12
2952639|NCT00708123|3666601|FG000|COMPLETED|Period 1||12
2952640|NCT00708123|3666602|FG001|COMPLETED|Period 1||11
2952641|NCT00708123|3666603|FG002|COMPLETED|Period 1||11
2952642|NCT00708123|3666604|FG003|COMPLETED|Period 1||11
2952643|NCT00708123|3666605|FG004|COMPLETED|Period 1||12
2952644|NCT00708123|3666601|FG000|NOT COMPLETED|Period 1||0
2952645|NCT00708123|3666602|FG001|NOT COMPLETED|Period 1||1
2952646|NCT00708123|3666603|FG002|NOT COMPLETED|Period 1||1
2952647|NCT00708123|3666604|FG003|NOT COMPLETED|Period 1||1
2952648|NCT00708123|3666605|FG004|NOT COMPLETED|Period 1||0
2952649|NCT00708123|3666601|FG000|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|11
2952650|NCT00708123|3666602|FG001|STARTED|Period 2|Due to crossover design,different set of participants received this treatment compared to Period 1|12
2952651|NCT00708123|3666603|FG002|STARTED|Period 2|Due to crossover design,different set of participants received this treatment compared to Period 1|12
2952652|NCT00708123|3666604|FG003|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|11
2952653|NCT00708123|3666605|FG004|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|11
2952654|NCT00708123|3666601|FG000|COMPLETED|Period 2||10
2952655|NCT00708123|3666602|FG001|COMPLETED|Period 2||12
2952656|NCT00708123|3666603|FG002|COMPLETED|Period 2||12
3163508|NCT01887353|3891034|FG001|STARTED|Overall Study||4
3163509|NCT01887353|3891033|FG000|COMPLETED|Overall Study|Study was stopped early because of difficulty recruiting.|0
3171763|NCT01936948|3898956|FG003|COMPLETED|Overall Study||230
2952657|NCT00708123|3666604|FG003|COMPLETED|Period 2||10
2952658|NCT00708123|3666605|FG004|COMPLETED|Period 2||11
2952659|NCT00708123|3666601|FG000|NOT COMPLETED|Period 2||1
2952660|NCT00708123|3666602|FG001|NOT COMPLETED|Period 2||0
2952661|NCT00708123|3666603|FG002|NOT COMPLETED|Period 2||0
2952662|NCT00708123|3666604|FG003|NOT COMPLETED|Period 2||1
2952663|NCT00708123|3666605|FG004|NOT COMPLETED|Period 2||0
2952664|NCT00708123|3666601|FG000|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|12
2952665|NCT00708123|3666602|FG001|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|10
2952666|NCT00708123|3666603|FG002|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|11
2952667|NCT00708123|3666604|FG003|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|12
2952668|NCT00708123|3666605|FG004|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|10
2952669|NCT00708123|3666601|FG000|COMPLETED|Period 3||12
2952670|NCT00708123|3666602|FG001|COMPLETED|Period 3||10
2952671|NCT00708123|3666603|FG002|COMPLETED|Period 3||10
2952672|NCT00708123|3666604|FG003|COMPLETED|Period 3||11
2952673|NCT00708123|3666605|FG004|COMPLETED|Period 3||10
2952674|NCT00708123|3666601|FG000|NOT COMPLETED|Period 3||0
2952675|NCT00708123|3666602|FG001|NOT COMPLETED|Period 3||0
2952676|NCT00708123|3666603|FG002|NOT COMPLETED|Period 3||1
2952677|NCT00708123|3666604|FG003|NOT COMPLETED|Period 3||1
2952678|NCT00708123|3666605|FG004|NOT COMPLETED|Period 3||0
2952679|NCT00708123|3666601|FG000|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|10
2952680|NCT00708123|3666602|FG001|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|12
2952681|NCT00708123|3666603|FG002|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|10
2952682|NCT00708123|3666604|FG003|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|10
2952683|NCT00708123|3666605|FG004|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|11
2952684|NCT00708123|3666601|FG000|COMPLETED|Period 4||10
2952685|NCT00708123|3666602|FG001|COMPLETED|Period 4||11
2952686|NCT00708123|3666603|FG002|COMPLETED|Period 4||10
2952687|NCT00708123|3666604|FG003|COMPLETED|Period 4||10
2952688|NCT00708123|3666605|FG004|COMPLETED|Period 4||11
2952689|NCT00708123|3666601|FG000|NOT COMPLETED|Period 4||0
2952690|NCT00708123|3666602|FG001|NOT COMPLETED|Period 4||1
2952691|NCT00708123|3666603|FG002|NOT COMPLETED|Period 4||0
2952692|NCT00708123|3666604|FG003|NOT COMPLETED|Period 4||0
2952693|NCT00708123|3666605|FG004|NOT COMPLETED|Period 4||0
2952694|NCT00708123|3666601|FG000|STARTED|Period 5|Due to crossover design, different set of participants received this treatment compared to Period 4|10
2952695|NCT00708123|3666602|FG001|STARTED|Period 5|Due to crossover design, different set of participants received this treatment compared to Period 4|10
2952696|NCT00708123|3666603|FG002|STARTED|Period 5|Due to crossover design, different set of participants received this treatment compared to Period 4|11
2952697|NCT00708123|3666604|FG003|STARTED|Period 5|Due to crossover design, different set of participants received this treatment compared to Period 4|11
2952698|NCT00708123|3666605|FG004|STARTED|Period 5|Due to crossover design, different set of participants received this treatment compared to Period 4|10
2952699|NCT00708123|3666601|FG000|COMPLETED|Period 5||10
2952700|NCT00708123|3666602|FG001|COMPLETED|Period 5||10
2952701|NCT00708123|3666603|FG002|COMPLETED|Period 5||11
2952702|NCT00708123|3666604|FG003|COMPLETED|Period 5||11
2952703|NCT00708123|3666605|FG004|COMPLETED|Period 5||10
2952704|NCT00708123|3666601|FG000|NOT COMPLETED|Period 5||0
2952705|NCT00708123|3666602|FG001|NOT COMPLETED|Period 5||0
2952706|NCT00708123|3666603|FG002|NOT COMPLETED|Period 5||0
2952707|NCT00708123|3666604|FG003|NOT COMPLETED|Period 5||0
2952708|NCT00708123|3666605|FG004|NOT COMPLETED|Period 5||0
2952709|NCT00708162|3666623|FG000|STARTED|Randomized Phase||361
2952710|NCT00708162|3666624|FG001|STARTED|Randomized Phase||363
2952711|NCT00708162|3666623|FG000|Randomized and Treated|Randomized Phase||354
2952712|NCT00708162|3666624|FG001|Randomized and Treated|Randomized Phase||358
2952713|NCT00708162|3666623|FG000|COMPLETED|Randomized Phase||205
2952714|NCT00708162|3666624|FG001|COMPLETED|Randomized Phase||209
2952715|NCT00708162|3666623|FG000|NOT COMPLETED|Randomized Phase||156
2952716|NCT00708162|3666624|FG001|NOT COMPLETED|Randomized Phase||154
2952717|NCT00708162|3666623|FG000|STARTED|Open-Label Phase|9 participants completing the Randomized Phase did not continue to the Open-Label Phase.|196
2952718|NCT00708162|3666624|FG001|STARTED|Open-Label Phase|58 participants completing the Randomized Phase did not continue to the Open-Label Phase.|151
2952719|NCT00708162|3666623|FG000|COMPLETED|Open-Label Phase||152
2952720|NCT00708162|3666624|FG001|COMPLETED|Open-Label Phase||121
2952721|NCT00708162|3666623|FG000|NOT COMPLETED|Open-Label Phase||44
2952722|NCT00708162|3666624|FG001|NOT COMPLETED|Open-Label Phase||30
2952723|NCT00708175|3666633|FG000|STARTED|Overall Study||78
2952724|NCT00708175|3666634|FG001|STARTED|Overall Study||78
2952725|NCT00708175|3666633|FG000|COMPLETED|Overall Study||60
2952726|NCT00708175|3666634|FG001|COMPLETED|Overall Study||57
2952727|NCT00708175|3666633|FG000|NOT COMPLETED|Overall Study||18
2952728|NCT00708175|3666634|FG001|NOT COMPLETED|Overall Study||21
2952729|NCT00708201|3666642|FG000|STARTED|Overall Study||137
2952730|NCT00708201|3666643|FG001|STARTED|Overall Study||143
2952731|NCT00708201|3666642|FG000|Received at Least 1 Dose of Study Drug|Overall Study||130
2952732|NCT00708201|3666643|FG001|Received at Least 1 Dose of Study Drug|Overall Study||137
2952733|NCT00708201|3666642|FG000|COMPLETED|Overall Study||130
2952734|NCT00708201|3666643|FG001|COMPLETED|Overall Study||137
2952735|NCT00708201|3666642|FG000|NOT COMPLETED|Overall Study||7
2952736|NCT00708201|3666643|FG001|NOT COMPLETED|Overall Study||6
2952737|NCT00708214|3666652|FG000|STARTED|Overall Study||7
2952738|NCT00708214|3666653|FG001|STARTED|Overall Study||13
2952739|NCT00708214|3666654|FG002|STARTED|Overall Study||8
2952740|NCT00708214|3666652|FG000|COMPLETED|Overall Study|On treatment at analysis cut-off date (04 Jan 2010)|0
2952741|NCT00708214|3666653|FG001|COMPLETED|Overall Study|On treatment at analysis cut-off date (04 Jan 2010)|0
2952742|NCT00708214|3666654|FG002|COMPLETED|Overall Study|On treatment at analysis cut-off date (04 Jan 2010)|0
2952743|NCT00708214|3666652|FG000|NOT COMPLETED|Overall Study||7
3132587|NCT01691794|3857676|FG001|NOT COMPLETED|Overall Study||18
3132588|NCT01691794|3857677|FG002|NOT COMPLETED|Overall Study||10
3132589|NCT01691820|3857687|FG000|STARTED|Overall Study||210
3132590|NCT01691820|3857688|FG001|STARTED|Overall Study||152
3132591|NCT01691820|3857687|FG000|COMPLETED|Overall Study||184
2952744|NCT00708214|3666653|FG001|NOT COMPLETED|Overall Study||13
2952745|NCT00708214|3666654|FG002|NOT COMPLETED|Overall Study||8
2952746|NCT00708227|3666671|FG000|STARTED|Overall Study||19
2952747|NCT00708227|3666672|FG001|STARTED|Overall Study||26
2952748|NCT00708227|3666673|FG002|STARTED|Overall Study||18
2952749|NCT00708227|3666674|FG003|STARTED|Overall Study||25
2952750|NCT00708227|3666671|FG000|COMPLETED|Overall Study||18
2952751|NCT00708227|3666672|FG001|COMPLETED|Overall Study||21
2952752|NCT00708227|3666673|FG002|COMPLETED|Overall Study||17
2952753|NCT00708227|3666674|FG003|COMPLETED|Overall Study||22
2952754|NCT00708227|3666671|FG000|NOT COMPLETED|Overall Study||1
2952755|NCT00708227|3666672|FG001|NOT COMPLETED|Overall Study||5
2952756|NCT00708227|3666673|FG002|NOT COMPLETED|Overall Study||1
2952757|NCT00708227|3666674|FG003|NOT COMPLETED|Overall Study||3
2952758|NCT00708305|3666704|FG000|STARTED|Period 1||16
2952759|NCT00708305|3666705|FG001|STARTED|Period 1||16
2952760|NCT00708305|3666706|FG002|STARTED|Period 1||17
2952761|NCT00708305|3666707|FG003|STARTED|Period 1||16
2952762|NCT00708305|3666704|FG000|COMPLETED|Period 1||15
2952763|NCT00708305|3666705|FG001|COMPLETED|Period 1||16
2952764|NCT00708305|3666706|FG002|COMPLETED|Period 1||16
2952765|NCT00708305|3666707|FG003|COMPLETED|Period 1||14
2952766|NCT00708305|3666704|FG000|NOT COMPLETED|Period 1||1
2952767|NCT00708305|3666705|FG001|NOT COMPLETED|Period 1||0
2952768|NCT00708305|3666706|FG002|NOT COMPLETED|Period 1||1
2952769|NCT00708305|3666707|FG003|NOT COMPLETED|Period 1||2
2952770|NCT00708305|3666704|FG000|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|15
2952771|NCT00708305|3666705|FG001|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|15
2952772|NCT00708305|3666706|FG002|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|16
2952773|NCT00708305|3666707|FG003|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|15
2952774|NCT00708305|3666704|FG000|COMPLETED|Period 2||14
2952775|NCT00708305|3666705|FG001|COMPLETED|Period 2||13
2952776|NCT00708305|3666706|FG002|COMPLETED|Period 2||16
2952777|NCT00708305|3666707|FG003|COMPLETED|Period 2||14
2952778|NCT00708305|3666704|FG000|NOT COMPLETED|Period 2||1
2952779|NCT00708305|3666705|FG001|NOT COMPLETED|Period 2||2
2952780|NCT00708305|3666706|FG002|NOT COMPLETED|Period 2||0
2952781|NCT00708305|3666707|FG003|NOT COMPLETED|Period 2||1
2952782|NCT00708305|3666704|FG000|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|15
2952783|NCT00708305|3666705|FG001|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|14
2952784|NCT00708305|3666706|FG002|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|14
2952785|NCT00708305|3666707|FG003|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|14
2952786|NCT00708305|3666704|FG000|COMPLETED|Period 3||14
2952787|NCT00708305|3666705|FG001|COMPLETED|Period 3||12
2952788|NCT00708305|3666706|FG002|COMPLETED|Period 3||14
2952789|NCT00708305|3666707|FG003|COMPLETED|Period 3||14
2952790|NCT00708305|3666704|FG000|NOT COMPLETED|Period 3||1
2952791|NCT00708305|3666705|FG001|NOT COMPLETED|Period 3||2
2952792|NCT00708305|3666706|FG002|NOT COMPLETED|Period 3||0
2952793|NCT00708305|3666707|FG003|NOT COMPLETED|Period 3||0
2952794|NCT00708305|3666704|FG000|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|12
2952795|NCT00708305|3666705|FG001|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|14
2952796|NCT00708305|3666706|FG002|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|14
2952797|NCT00708305|3666707|FG003|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|14
2952798|NCT00708305|3666704|FG000|COMPLETED|Period 4||12
2952799|NCT00708305|3666705|FG001|COMPLETED|Period 4||14
2952800|NCT00708305|3666706|FG002|COMPLETED|Period 4||14
2952801|NCT00708305|3666707|FG003|COMPLETED|Period 4||14
2952802|NCT00708305|3666704|FG000|NOT COMPLETED|Period 4||0
2952803|NCT00708305|3666705|FG001|NOT COMPLETED|Period 4||0
2952804|NCT00708305|3666706|FG002|NOT COMPLETED|Period 4||0
2952805|NCT00708305|3666707|FG003|NOT COMPLETED|Period 4||0
2952806|NCT00708422|3666722|FG000|STARTED|Overall Study||116
2952807|NCT00708422|3666723|FG001|STARTED|Overall Study||115
2952808|NCT00708422|3666722|FG000|COMPLETED|Overall Study||112
2952809|NCT00708422|3666723|FG001|COMPLETED|Overall Study||114
2952810|NCT00708422|3666722|FG000|NOT COMPLETED|Overall Study||4
2952811|NCT00708422|3666723|FG001|NOT COMPLETED|Overall Study||1
2952812|NCT00708435|3666731|FG000|STARTED|Overall Study||107
2952813|NCT00708435|3666732|FG001|STARTED|Overall Study||109
2952814|NCT00708435|3666731|FG000|COMPLETED|Overall Study|These data are 'on-study' results collected up to the subject's Day 45 visit.|82
2952815|NCT00708435|3666732|FG001|COMPLETED|Overall Study|These data are 'on-study' results collected up to the subject's Day 45 visit.|92
2952816|NCT00708435|3666731|FG000|NOT COMPLETED|Overall Study||25
2952817|NCT00708435|3666732|FG001|NOT COMPLETED|Overall Study||17
2952818|NCT00708461|3666742|FG000|STARTED|Overall Study||752
2952819|NCT00708461|3666743|FG001|STARTED|Overall Study||995
2952820|NCT00708461|3666742|FG000|COMPLETED|Overall Study||611
2952821|NCT00708461|3666743|FG001|COMPLETED|Overall Study||795
2952822|NCT00708461|3666742|FG000|NOT COMPLETED|Overall Study||141
2952823|NCT00708461|3666743|FG001|NOT COMPLETED|Overall Study||200
2952824|NCT00708500|3666752|FG000|STARTED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||80
2952825|NCT00708500|3666753|FG001|STARTED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||162
2952826|NCT00708500|3666754|FG002|STARTED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||162
2952827|NCT00708500|3666752|FG000|Treated With PEG2b + RBV|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||80
2952828|NCT00708500|3666753|FG001|Treated With PEG2b + RBV|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||162
2952829|NCT00708500|3666754|FG002|Treated With PEG2b + RBV|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||161
2952830|NCT00708500|3666752|FG000|COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||78
2952831|NCT00708500|3666753|FG001|COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||156
2952832|NCT00708500|3666754|FG002|COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||160
2952833|NCT00708500|3666752|FG000|NOT COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||2
2952834|NCT00708500|3666753|FG001|NOT COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||6
2952835|NCT00708500|3666754|FG002|NOT COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||2
2952836|NCT00708500|3666752|FG000|STARTED|Tx: RECEIVING BOCEPREVIR/PLACEBO||78
2952837|NCT00708500|3666753|FG001|STARTED|Tx: RECEIVING BOCEPREVIR/PLACEBO||156
2952838|NCT00708500|3666754|FG002|STARTED|Tx: RECEIVING BOCEPREVIR/PLACEBO||160
2952839|NCT00708500|3666752|FG000|COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||23
2952840|NCT00708500|3666753|FG001|COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||104
2952841|NCT00708500|3666754|FG002|COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||105
2952842|NCT00708500|3666752|FG000|NOT COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||55
2952843|NCT00708500|3666753|FG001|NOT COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||52
2952844|NCT00708500|3666754|FG002|NOT COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||55
2952845|NCT00708500|3666752|FG000|STARTED|FOLLOWUP||77
2952846|NCT00708500|3666753|FG001|STARTED|FOLLOWUP||151
2952847|NCT00708500|3666754|FG002|STARTED|FOLLOWUP||158
2952848|NCT00708500|3666752|FG000|COMPLETED|FOLLOWUP||37
2952849|NCT00708500|3666753|FG001|COMPLETED|FOLLOWUP||136
2952850|NCT00708500|3666754|FG002|COMPLETED|FOLLOWUP||143
2952851|NCT00708500|3666752|FG000|NOT COMPLETED|FOLLOWUP||40
2952852|NCT00708500|3666753|FG001|NOT COMPLETED|FOLLOWUP||15
2952853|NCT00708500|3666754|FG002|NOT COMPLETED|FOLLOWUP||15
2952854|NCT00708526|3666764|FG000|STARTED|Wake up After Anesthesia||11
2952855|NCT00708526|3666765|FG001|STARTED|Wake up After Anesthesia||11
2952856|NCT00708526|3666764|FG000|COMPLETED|Wake up After Anesthesia||11
2952857|NCT00708526|3666765|FG001|COMPLETED|Wake up After Anesthesia||11
2952858|NCT00708526|3666764|FG000|NOT COMPLETED|Wake up After Anesthesia||0
2952859|NCT00708526|3666765|FG001|NOT COMPLETED|Wake up After Anesthesia||0
2952860|NCT00708526|3666764|FG000|STARTED|Return of Cognitive Function||11
2952861|NCT00708526|3666765|FG001|STARTED|Return of Cognitive Function||11
2952862|NCT00708526|3666764|FG000|COMPLETED|Return of Cognitive Function||11
2952863|NCT00708526|3666765|FG001|COMPLETED|Return of Cognitive Function||11
2952864|NCT00708526|3666764|FG000|NOT COMPLETED|Return of Cognitive Function||0
2952865|NCT00708526|3666765|FG001|NOT COMPLETED|Return of Cognitive Function||0
2952866|NCT00708552|3666775|FG000|STARTED|Overall Study||145
2952867|NCT00708552|3666776|FG001|STARTED|Overall Study||145
2952868|NCT00708552|3666777|FG002|STARTED|Overall Study||133
2952869|NCT00708552|3666778|FG003|STARTED|Overall Study||151
2952870|NCT00708552|3666775|FG000|COMPLETED|Overall Study||118
2952871|NCT00708552|3666776|FG001|COMPLETED|Overall Study||127
2952872|NCT00708552|3666777|FG002|COMPLETED|Overall Study||118
2952873|NCT00708552|3666778|FG003|COMPLETED|Overall Study||130
2952874|NCT00708552|3666775|FG000|NOT COMPLETED|Overall Study||27
2952875|NCT00708552|3666776|FG001|NOT COMPLETED|Overall Study||18
2952876|NCT00708552|3666777|FG002|NOT COMPLETED|Overall Study||15
2952877|NCT00708552|3666778|FG003|NOT COMPLETED|Overall Study||21
2952878|NCT00708643|3666794|FG000|STARTED|Overall Study||40
2952879|NCT00708643|3666795|FG001|STARTED|Overall Study||40
2952880|NCT00708643|3666794|FG000|COMPLETED|Overall Study||40
2952881|NCT00708643|3666795|FG001|COMPLETED|Overall Study||39
2952882|NCT00708643|3666794|FG000|NOT COMPLETED|Overall Study||0
2952883|NCT00708643|3666795|FG001|NOT COMPLETED|Overall Study||1
2952884|NCT00708682|3666801|FG000|STARTED|Infant Series||225
2952885|NCT00708682|3666801|FG000|Vaccinated Dose 1|Infant Series||223
2952886|NCT00708682|3666801|FG000|Vaccinated Dose 2|Infant Series||214
2952887|NCT00708682|3666801|FG000|Vaccinated Dose 3|Infant Series||194
2952888|NCT00708682|3666801|FG000|COMPLETED|Infant Series||192
2952889|NCT00708682|3666801|FG000|NOT COMPLETED|Infant Series||33
2952890|NCT00708682|3666801|FG000|STARTED|After Infant Series||192
2952891|NCT00708682|3666801|FG000|COMPLETED|After Infant Series||191
2952892|NCT00708682|3666801|FG000|NOT COMPLETED|After Infant Series||1
2952893|NCT00708682|3666801|FG000|STARTED|Toddler Dose||191
2952894|NCT00708682|3666801|FG000|COMPLETED|Toddler Dose||183
2952895|NCT00708682|3666801|FG000|NOT COMPLETED|Toddler Dose||8
2952896|NCT00708708|3666807|FG000|STARTED|Overall Study||955
2952897|NCT00708708|3666807|FG000|COMPLETED|Overall Study|Included participants completed total observation period and participants with planned study end.|213
2952898|NCT00708708|3666807|FG000|NOT COMPLETED|Overall Study||742
2952899|NCT00708721|3666814|FG000|STARTED|Overall Study||2
2952900|NCT00708721|3666815|FG001|STARTED|Overall Study||4
2952901|NCT00708721|3666816|FG002|STARTED|Overall Study||3
2952902|NCT00708721|3666817|FG003|STARTED|Overall Study||2
2952903|NCT00708721|3666814|FG000|COMPLETED|Overall Study||2
2952904|NCT00708721|3666815|FG001|COMPLETED|Overall Study||4
2952905|NCT00708721|3666816|FG002|COMPLETED|Overall Study||3
2952906|NCT00708721|3666817|FG003|COMPLETED|Overall Study||2
2952907|NCT00708721|3666814|FG000|NOT COMPLETED|Overall Study||0
2952908|NCT00708721|3666815|FG001|NOT COMPLETED|Overall Study||0
2952909|NCT00708721|3666816|FG002|NOT COMPLETED|Overall Study||0
2952910|NCT00708721|3666817|FG003|NOT COMPLETED|Overall Study||0
2952911|NCT00708851|3666828|FG000|STARTED|Overall Study||12
2952912|NCT00708851|3666828|FG000|COMPLETED|Overall Study||12
2952913|NCT00708851|3666828|FG000|NOT COMPLETED|Overall Study||0
2952914|NCT00708877|3666834|FG000|STARTED|Overall Study||5
2952915|NCT00708877|3666834|FG000|COMPLETED|Overall Study||5
2952916|NCT00708877|3666834|FG000|NOT COMPLETED|Overall Study||0
2952917|NCT00708942|3666843|FG000|STARTED|Overall Study||47
2952918|NCT00708942|3666844|FG001|STARTED|Overall Study||12
2952919|NCT00708942|3666845|FG002|STARTED|Overall Study||11
2952920|NCT00708942|3666846|FG003|STARTED|Overall Study||10
2952921|NCT00708942|3666847|FG004|STARTED|Overall Study||3
2952922|NCT00708942|3666843|FG000|COMPLETED|Overall Study||40
2952923|NCT00708942|3666844|FG001|COMPLETED|Overall Study||11
2952924|NCT00708942|3666845|FG002|COMPLETED|Overall Study||9
2952925|NCT00708942|3666846|FG003|COMPLETED|Overall Study||10
2952926|NCT00708942|3666847|FG004|COMPLETED|Overall Study||2
2952927|NCT00708942|3666843|FG000|NOT COMPLETED|Overall Study||7
2952928|NCT00708942|3666844|FG001|NOT COMPLETED|Overall Study||1
2952929|NCT00708942|3666845|FG002|NOT COMPLETED|Overall Study||2
2952930|NCT00708942|3666846|FG003|NOT COMPLETED|Overall Study||0
2952931|NCT00708942|3666847|FG004|NOT COMPLETED|Overall Study||1
2952932|NCT00709059|3666859|FG000|STARTED|Overall Study||538
2952933|NCT00709059|3666859|FG000|COMPLETED|Overall Study||444
2952934|NCT00709059|3666859|FG000|NOT COMPLETED|Overall Study||94
3035006|NCT01134614|3754077|FG000|Treated and Toxicity Assessed|Overall Study||118
3035007|NCT01134614|3754078|FG001|Treated and Toxicity Assessed|Overall Study||120
3035008|NCT01134614|3754077|FG000|COMPLETED|Overall Study|Treatment continues until disease progression or unacceptable toxicity.|0
3035009|NCT01134614|3754078|FG001|COMPLETED|Overall Study|Treatment continues until disease progression or unacceptable toxicities|0
3035010|NCT01134614|3754077|FG000|NOT COMPLETED|Overall Study||123
3035011|NCT01134614|3754078|FG001|NOT COMPLETED|Overall Study||122
3035012|NCT01134627|3754086|FG000|STARTED|Overall Study|Number of participants treated.|149
3035013|NCT01134627|3754087|FG001|STARTED|Overall Study|Number of participants treated.|155
3035014|NCT01134627|3754086|FG000|COMPLETED|Overall Study||80
3035015|NCT01134627|3754087|FG001|COMPLETED|Overall Study||88
3035016|NCT01134627|3754086|FG000|NOT COMPLETED|Overall Study||69
3035017|NCT01134627|3754087|FG001|NOT COMPLETED|Overall Study||67
3035018|NCT01134705|3754095|FG000|STARTED|Overall Study||236
3035019|NCT01134705|3754096|FG001|STARTED|Overall Study||238
3035020|NCT01134705|3754095|FG000|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment.|232
3035021|NCT01134705|3754096|FG001|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment.|234
3035022|NCT01134705|3754095|FG000|COMPLETED|Overall Study||221
3035023|NCT01134705|3754096|FG001|COMPLETED|Overall Study||216
3035024|NCT01134705|3754095|FG000|NOT COMPLETED|Overall Study||15
3035025|NCT01134705|3754096|FG001|NOT COMPLETED|Overall Study||22
3035026|NCT01134731|3754105|FG000|STARTED|Overall Study||23
3035027|NCT01134731|3754106|FG001|STARTED|Overall Study||21
3035028|NCT01134731|3754107|FG002|STARTED|Overall Study||10
3035029|NCT01134731|3754105|FG000|COMPLETED|Overall Study||10
3035030|NCT01134731|3754106|FG001|COMPLETED|Overall Study||10
3035031|NCT01134731|3754107|FG002|COMPLETED|Overall Study||2
3035032|NCT01134731|3754105|FG000|NOT COMPLETED|Overall Study||13
3035033|NCT01134731|3754106|FG001|NOT COMPLETED|Overall Study||11
3035034|NCT01134731|3754107|FG002|NOT COMPLETED|Overall Study||8
3035035|NCT01134783|3754118|FG000|STARTED|Overall Study||224
3035036|NCT01134783|3754119|FG001|STARTED|Overall Study||217
3035037|NCT01134783|3754118|FG000|COMPLETED|Overall Study||188
3132592|NCT01691820|3857688|FG001|COMPLETED|Overall Study||115
3132593|NCT01691820|3857687|FG000|NOT COMPLETED|Overall Study||26
3132594|NCT01691820|3857688|FG001|NOT COMPLETED|Overall Study||37
3035038|NCT01134783|3754119|FG001|COMPLETED|Overall Study||180
3132595|NCT01691833|3857701|FG000|STARTED|Overall Study||50
3132596|NCT01691833|3857702|FG001|STARTED|Overall Study||50
3132597|NCT01691833|3857703|FG002|STARTED|Overall Study||13
3132598|NCT01691833|3857701|FG000|COMPLETED|Overall Study||49
3132599|NCT01691833|3857702|FG001|COMPLETED|Overall Study||49
3132600|NCT01691833|3857703|FG002|COMPLETED|Overall Study||13
3132601|NCT01691833|3857701|FG000|NOT COMPLETED|Overall Study||1
3132602|NCT01691833|3857702|FG001|NOT COMPLETED|Overall Study||1
3132603|NCT01691833|3857703|FG002|NOT COMPLETED|Overall Study||0
3132604|NCT01691859|3857711|FG000|STARTED|Overall Study||347
2952935|NCT00709098|3666866|FG000|STARTED|Double-blind Period||25
2952936|NCT00709098|3666867|FG001|STARTED|Double-blind Period||24
2952937|NCT00709098|3666868|FG002|STARTED|Double-blind Period||0
2952938|NCT00709098|3666866|FG000|COMPLETED|Double-blind Period||19
2952939|NCT00709098|3666867|FG001|COMPLETED|Double-blind Period||16
2952940|NCT00709098|3666868|FG002|COMPLETED|Double-blind Period||0
2952941|NCT00709098|3666866|FG000|NOT COMPLETED|Double-blind Period||6
2952942|NCT00709098|3666867|FG001|NOT COMPLETED|Double-blind Period||8
2952943|NCT00709098|3666868|FG002|NOT COMPLETED|Double-blind Period||0
2952944|NCT00709098|3666866|FG000|STARTED|Open-label Period||0
2952945|NCT00709098|3666867|FG001|STARTED|Open-label Period||0
2952946|NCT00709098|3666868|FG002|STARTED|Open-label Period|The open-label period was only made available to patients in US centers|32
2952947|NCT00709098|3666866|FG000|COMPLETED|Open-label Period||0
2952948|NCT00709098|3666867|FG001|COMPLETED|Open-label Period||0
2952949|NCT00709098|3666868|FG002|COMPLETED|Open-label Period||18
2952950|NCT00709098|3666866|FG000|NOT COMPLETED|Open-label Period||0
2952951|NCT00709098|3666867|FG001|NOT COMPLETED|Open-label Period||0
2952952|NCT00709098|3666868|FG002|NOT COMPLETED|Open-label Period||14
2952953|NCT00709111|3666877|FG000|STARTED|Overall Study||34
2952954|NCT00709111|3666877|FG000|Week 22/24|Overall Study||33
2952955|NCT00709111|3666877|FG000|COMPLETED|Overall Study||32
2952956|NCT00709111|3666877|FG000|NOT COMPLETED|Overall Study||2
2952957|NCT00709124|3666883|FG000|STARTED|Overall Study||16
2952958|NCT00709124|3666884|FG001|STARTED|Overall Study||18
2952959|NCT00709124|3666883|FG000|COMPLETED|Overall Study||12
2952960|NCT00709124|3666884|FG001|COMPLETED|Overall Study||17
2952961|NCT00709124|3666883|FG000|NOT COMPLETED|Overall Study||4
2952962|NCT00709124|3666884|FG001|NOT COMPLETED|Overall Study||1
2952963|NCT00709202|3666896|FG000|STARTED|Overall Study||19
2952964|NCT00709202|3666897|FG001|STARTED|Overall Study||21
2952965|NCT00709202|3666896|FG000|COMPLETED|Overall Study||13
2952966|NCT00709202|3666897|FG001|COMPLETED|Overall Study||15
2952967|NCT00709202|3666896|FG000|NOT COMPLETED|Overall Study||6
2952968|NCT00709202|3666897|FG001|NOT COMPLETED|Overall Study||6
2952969|NCT00709228|3666904|FG000|STARTED|Overall Study||496
2952970|NCT00709228|3666904|FG000|COMPLETED|Overall Study|Number completed is defined as participants who completed the follow-up period.|164
2952971|NCT00709228|3666904|FG000|NOT COMPLETED|Overall Study||332
2952972|NCT00709306|3666912|FG000|STARTED|Overall Study||48
2952973|NCT00709306|3666913|FG001|STARTED|Overall Study||44
2952974|NCT00709306|3666914|FG002|STARTED|Overall Study||58
2952975|NCT00709306|3666915|FG003|STARTED|Overall Study||47
2952976|NCT00709306|3666912|FG000|COMPLETED|Overall Study||39
2952977|NCT00709306|3666913|FG001|COMPLETED|Overall Study||30
2952978|NCT00709306|3666914|FG002|COMPLETED|Overall Study||48
2952979|NCT00709306|3666915|FG003|COMPLETED|Overall Study||37
2952980|NCT00709306|3666912|FG000|NOT COMPLETED|Overall Study||9
2952981|NCT00709306|3666913|FG001|NOT COMPLETED|Overall Study||14
2952982|NCT00709306|3666914|FG002|NOT COMPLETED|Overall Study||10
2952983|NCT00709306|3666915|FG003|NOT COMPLETED|Overall Study||10
2952984|NCT00709319|3666925|FG000|STARTED|Overall Study||87
2952985|NCT00709319|3666925|FG000|COMPLETED|Overall Study||81
2952986|NCT00709319|3666925|FG000|NOT COMPLETED|Overall Study||6
2952987|NCT00709592|3666931|FG000|STARTED|Overall Study||19
2952988|NCT00709592|3666932|FG001|STARTED|Overall Study||23
2952989|NCT00709592|3666931|FG000|COMPLETED|Overall Study||19
2952990|NCT00709592|3666932|FG001|COMPLETED|Overall Study||22
2952991|NCT00709592|3666931|FG000|NOT COMPLETED|Overall Study||0
2952992|NCT00709592|3666932|FG001|NOT COMPLETED|Overall Study||1
2952993|NCT00709618|3666938|FG000|STARTED|Overall Study||44
2952994|NCT00709618|3666938|FG000|COMPLETED|Overall Study||14
2952995|NCT00709618|3666938|FG000|NOT COMPLETED|Overall Study||30
2952996|NCT00709696|3666944|FG000|STARTED|Overall Study||4
2952997|NCT00709696|3666945|FG001|STARTED|Overall Study||3
2952998|NCT00709696|3666944|FG000|COMPLETED|Overall Study||4
2952999|NCT00709696|3666945|FG001|COMPLETED|Overall Study||3
2953000|NCT00709696|3666944|FG000|NOT COMPLETED|Overall Study||0
2953001|NCT00709696|3666945|FG001|NOT COMPLETED|Overall Study||0
2953002|NCT00709722|3666951|FG000|STARTED|Overall Study||21
2953003|NCT00709722|3666951|FG000|COMPLETED|Overall Study||20
2953004|NCT00709722|3666951|FG000|NOT COMPLETED|Overall Study||1
2953005|NCT00709735|3666957|FG000|STARTED|Overall Study||11
2953006|NCT00709735|3666958|FG001|STARTED|Overall Study||12
2953007|NCT00709735|3666957|FG000|COMPLETED|Overall Study||8
2953008|NCT00709735|3666958|FG001|COMPLETED|Overall Study||10
2953009|NCT00709735|3666957|FG000|NOT COMPLETED|Overall Study||3
2953010|NCT00709735|3666958|FG001|NOT COMPLETED|Overall Study||2
2953011|NCT00709761|3666964|FG000|STARTED|Overall Study||60
2953012|NCT00709761|3666964|FG000|COMPLETED|Overall Study||33
2953013|NCT00709761|3666964|FG000|NOT COMPLETED|Overall Study||27
2953014|NCT00709826|3666970|FG000|STARTED|Overall Study||70
2953015|NCT00709826|3666971|FG001|STARTED|Overall Study||39
2953016|NCT00709826|3666970|FG000|COMPLETED|Overall Study||68
2953017|NCT00709826|3666971|FG001|COMPLETED|Overall Study||38
2953018|NCT00709826|3666970|FG000|NOT COMPLETED|Overall Study||2
2953019|NCT00709826|3666971|FG001|NOT COMPLETED|Overall Study||1
2953020|NCT00709852|3666977|FG000|STARTED|Period 1||228
3132605|NCT01691859|3857711|FG000|COMPLETED|Overall Study||0
2953021|NCT00709852|3666978|FG001|STARTED|Period 1||174
2953022|NCT00709852|3666977|FG000|COMPLETED|Period 1||220
2953023|NCT00709852|3666978|FG001|COMPLETED|Period 1||171
2953024|NCT00709852|3666977|FG000|NOT COMPLETED|Period 1||8
2953025|NCT00709852|3666978|FG001|NOT COMPLETED|Period 1||3
2953026|NCT00709852|3666977|FG000|STARTED|Period 2||220
2953027|NCT00709852|3666978|FG001|STARTED|Period 2||171
2953028|NCT00709852|3666977|FG000|COMPLETED|Period 2||211
2953029|NCT00709852|3666978|FG001|COMPLETED|Period 2||169
2953030|NCT00709852|3666977|FG000|NOT COMPLETED|Period 2||9
2953031|NCT00709852|3666978|FG001|NOT COMPLETED|Period 2||2
2953032|NCT00709878|3666997|FG000|STARTED|Overall Study||8
2953033|NCT00709878|3666998|FG001|STARTED|Overall Study||8
2953034|NCT00709878|3666999|FG002|STARTED|Overall Study||8
2953035|NCT00709878|3667000|FG003|STARTED|Overall Study||8
2953036|NCT00709878|3666997|FG000|COMPLETED|Overall Study||8
2953037|NCT00709878|3666998|FG001|COMPLETED|Overall Study||8
2953038|NCT00709878|3666999|FG002|COMPLETED|Overall Study||8
2953039|NCT00709878|3667000|FG003|COMPLETED|Overall Study||8
2953040|NCT00709878|3666997|FG000|NOT COMPLETED|Overall Study||0
2953041|NCT00709878|3666998|FG001|NOT COMPLETED|Overall Study||0
2953042|NCT00709878|3666999|FG002|NOT COMPLETED|Overall Study||0
2953043|NCT00709878|3667000|FG003|NOT COMPLETED|Overall Study||0
2953044|NCT00709891|3667010|FG000|STARTED|Baseline, Cross-sectional Phase||47208
2953045|NCT00709891|3667010|FG000|COMPLETED|Baseline, Cross-sectional Phase||45758
2953046|NCT00709891|3667010|FG000|NOT COMPLETED|Baseline, Cross-sectional Phase||1450
2953047|NCT00709891|3667010|FG000|STARTED|Longitudinal Follow-up Phase|Only participants who met study criteria in the Baseline phase started the Follow-up phase.|10002
2953048|NCT00709891|3667010|FG000|COMPLETED|Longitudinal Follow-up Phase||5020
2953049|NCT00709891|3667010|FG000|NOT COMPLETED|Longitudinal Follow-up Phase||4982
2953050|NCT00709956|3667016|FG000|STARTED|Overall Study|Day 1 Single-blind placebo run-in|33
2953051|NCT00709956|3667017|FG001|STARTED|Overall Study|Day 1 Single-blind placebo run-in|37
2953052|NCT00709956|3667016|FG000|Double-blind Crossover-period|Overall Study|Days 2 and 3|31
2953053|NCT00709956|3667017|FG001|Double-blind Crossover-period|Overall Study|Days 2 and 3|33
2953054|NCT00709956|3667016|FG000|COMPLETED|Overall Study||30
2953055|NCT00709956|3667017|FG001|COMPLETED|Overall Study||33
2953056|NCT00709956|3667016|FG000|NOT COMPLETED|Overall Study||3
2953057|NCT00709956|3667017|FG001|NOT COMPLETED|Overall Study||4
2953058|NCT00709995|3667027|FG000|STARTED|Overall Study||11
2953059|NCT00709995|3667028|FG001|STARTED|Overall Study||6
2953060|NCT00709995|3667027|FG000|Progressive Disease|Overall Study||6
2953061|NCT00709995|3667028|FG001|Progressive Disease|Overall Study||1
2953062|NCT00709995|3667027|FG000|COMPLETED|Overall Study||6
2953063|NCT00709995|3667028|FG001|COMPLETED|Overall Study||1
2953064|NCT00709995|3667027|FG000|NOT COMPLETED|Overall Study||5
2953065|NCT00709995|3667028|FG001|NOT COMPLETED|Overall Study||5
2953066|NCT00710021|3667040|FG000|STARTED|Overall Study||19
2953067|NCT00710021|3667041|FG001|STARTED|Overall Study||19
2953068|NCT00710021|3667042|FG002|STARTED|Overall Study||19
2953069|NCT00710021|3667040|FG000|Modified Intent-to-Treat (mITT)|Overall Study||19
2953070|NCT00710021|3667041|FG001|Modified Intent-to-Treat (mITT)|Overall Study|2 subjects who did not take study drug were excluded from mITT|17
2953071|NCT00710021|3667042|FG002|Modified Intent-to-Treat (mITT)|Overall Study|1 subject who did not take study drug was excluded from mITT|18
2953072|NCT00710021|3667040|FG000|COMPLETED|Overall Study||18
2953073|NCT00710021|3667041|FG001|COMPLETED|Overall Study||16
2953074|NCT00710021|3667042|FG002|COMPLETED|Overall Study||18
2953075|NCT00710021|3667040|FG000|NOT COMPLETED|Overall Study||1
2953076|NCT00710021|3667041|FG001|NOT COMPLETED|Overall Study||3
2953077|NCT00710021|3667042|FG002|NOT COMPLETED|Overall Study||1
2953078|NCT00710034|3667053|FG000|STARTED|Completed 6 Weeks of Treatment||195
2953079|NCT00710034|3667054|FG001|STARTED|Completed 6 Weeks of Treatment||196
2953080|NCT00710034|3667053|FG000|COMPLETED|Completed 6 Weeks of Treatment|Completed 6 weeks of treatment for primary outcome assessment: N=154|154
2953081|NCT00710034|3667054|FG001|COMPLETED|Completed 6 Weeks of Treatment|Completed 6 weeks of treatment for primary outcome assessment: N=149|149
2953082|NCT00710034|3667053|FG000|NOT COMPLETED|Completed 6 Weeks of Treatment||41
2953083|NCT00710034|3667054|FG001|NOT COMPLETED|Completed 6 Weeks of Treatment||47
2953084|NCT00710034|3667053|FG000|STARTED|Completed 12 Weeks of Treatment||154
2953085|NCT00710034|3667054|FG001|STARTED|Completed 12 Weeks of Treatment||149
2953086|NCT00710034|3667053|FG000|COMPLETED|Completed 12 Weeks of Treatment||141
2953087|NCT00710034|3667054|FG001|COMPLETED|Completed 12 Weeks of Treatment||138
2953088|NCT00710034|3667053|FG000|NOT COMPLETED|Completed 12 Weeks of Treatment||13
2953089|NCT00710034|3667054|FG001|NOT COMPLETED|Completed 12 Weeks of Treatment||11
2953090|NCT00710203|3667060|FG000|STARTED|Overall Study||10
2953091|NCT00710203|3667060|FG000|COMPLETED|Overall Study||10
2953092|NCT00710203|3667060|FG000|NOT COMPLETED|Overall Study||0
2953093|NCT00710385|3667070|FG000|STARTED|Overall Study|19 participants signed consent for the study 2 withdrew before any study procedures were initiated.|17
2953094|NCT00710385|3667070|FG000|COMPLETED|Overall Study||12
2953095|NCT00710385|3667070|FG000|NOT COMPLETED|Overall Study||5
2953096|NCT00710424|3667082|FG000|STARTED|Overall Study||149
2953097|NCT00710424|3667083|FG001|STARTED|Overall Study||148
2953098|NCT00710424|3667082|FG000|COMPLETED|Overall Study||105
2953099|NCT00710424|3667083|FG001|COMPLETED|Overall Study||125
2953100|NCT00710424|3667082|FG000|NOT COMPLETED|Overall Study||44
2953101|NCT00710424|3667083|FG001|NOT COMPLETED|Overall Study||23
2953102|NCT00710554|3667091|FG000|STARTED|Overall Study||128
2953103|NCT00710554|3667092|FG001|STARTED|Overall Study||118
2953104|NCT00710554|3667091|FG000|COMPLETED|Overall Study||79
2953105|NCT00710554|3667092|FG001|COMPLETED|Overall Study||94
2953106|NCT00710554|3667091|FG000|NOT COMPLETED|Overall Study||49
2953107|NCT00710554|3667092|FG001|NOT COMPLETED|Overall Study||24
2953108|NCT00710593|3667100|FG000|STARTED|Overall Study||69
2953109|NCT00710593|3667101|FG001|STARTED|Overall Study||30
2953110|NCT00710593|3667100|FG000|COMPLETED|Overall Study|54 completed study and vaccine. 6 did not receive all vaccine, but completed all study visits.|54
2953111|NCT00710593|3667101|FG001|COMPLETED|Overall Study|25 completed study and vaccine. 2 did not receive all vaccine, but completed all study visits.|25
2953112|NCT00710593|3667100|FG000|NOT COMPLETED|Overall Study||15
2953113|NCT00710593|3667101|FG001|NOT COMPLETED|Overall Study||5
2953114|NCT00710606|3667125|FG000|STARTED|Overall Study||20
2953115|NCT00710606|3667126|FG001|STARTED|Overall Study||20
2953116|NCT00710606|3667125|FG000|COMPLETED|Overall Study||20
2953117|NCT00710606|3667126|FG001|COMPLETED|Overall Study||18
2953118|NCT00710606|3667125|FG000|NOT COMPLETED|Overall Study||0
2953119|NCT00710606|3667126|FG001|NOT COMPLETED|Overall Study||2
2953120|NCT00710684|3667137|FG000|STARTED|Overall Study||225
2953121|NCT00710684|3667138|FG001|STARTED|Overall Study||221
2953122|NCT00710684|3667139|FG002|STARTED|Overall Study||236
2953123|NCT00710684|3667137|FG000|COMPLETED|Overall Study||151
2953124|NCT00710684|3667138|FG001|COMPLETED|Overall Study||147
2953125|NCT00710684|3667139|FG002|COMPLETED|Overall Study||172
3163510|NCT01887353|3891034|FG001|COMPLETED|Overall Study|Study was stopped early because of difficulty recruiting.|1
3163511|NCT01887353|3891033|FG000|NOT COMPLETED|Overall Study||4
3163512|NCT01887353|3891034|FG001|NOT COMPLETED|Overall Study||3
3163513|NCT01887418|3891043|FG000|STARTED|Overall Study||15
3163514|NCT01887418|3891044|FG001|STARTED|Overall Study||14
3163515|NCT01887418|3891045|FG002|STARTED|Overall Study||10
2953126|NCT00710684|3667137|FG000|NOT COMPLETED|Overall Study||74
2953127|NCT00710684|3667138|FG001|NOT COMPLETED|Overall Study||74
2953128|NCT00710684|3667139|FG002|NOT COMPLETED|Overall Study||64
2953129|NCT00710749|3667153|FG000|STARTED|Clinic Baseline Recording||30
2953130|NCT00710749|3667154|FG001|STARTED|Clinic Baseline Recording||30
2953131|NCT00710749|3667153|FG000|COMPLETED|Clinic Baseline Recording||30
2953132|NCT00710749|3667154|FG001|COMPLETED|Clinic Baseline Recording||30
2953133|NCT00710749|3667153|FG000|NOT COMPLETED|Clinic Baseline Recording||0
2953134|NCT00710749|3667154|FG001|NOT COMPLETED|Clinic Baseline Recording||0
2953135|NCT00710749|3667153|FG000|STARTED|First Intervention||30
2953136|NCT00710749|3667154|FG001|STARTED|First Intervention||30
2953137|NCT00710749|3667153|FG000|COMPLETED|First Intervention||29
2953138|NCT00710749|3667154|FG001|COMPLETED|First Intervention||30
2953139|NCT00710749|3667153|FG000|NOT COMPLETED|First Intervention||1
2953140|NCT00710749|3667154|FG001|NOT COMPLETED|First Intervention||0
2953141|NCT00710749|3667153|FG000|STARTED|Second Intervention||29
2953142|NCT00710749|3667154|FG001|STARTED|Second Intervention||30
2953143|NCT00710749|3667153|FG000|COMPLETED|Second Intervention||29
2953144|NCT00710749|3667154|FG001|COMPLETED|Second Intervention||30
2953145|NCT00710749|3667153|FG000|NOT COMPLETED|Second Intervention||0
2953146|NCT00710749|3667154|FG001|NOT COMPLETED|Second Intervention||0
2953147|NCT00710762|3667164|FG000|STARTED|Overall Study||44
2953148|NCT00710762|3667165|FG001|STARTED|Overall Study||40
2953149|NCT00710762|3667164|FG000|COMPLETED|Overall Study||5
2953150|NCT00710762|3667165|FG001|COMPLETED|Overall Study||0
2953151|NCT00710762|3667164|FG000|NOT COMPLETED|Overall Study||39
2953152|NCT00710762|3667165|FG001|NOT COMPLETED|Overall Study||40
2953153|NCT00710814|3667173|FG000|STARTED|Overall Study||15
2953154|NCT00710814|3667174|FG001|STARTED|Overall Study||16
2953155|NCT00710814|3667173|FG000|COMPLETED|Overall Study||14
2953156|NCT00710814|3667174|FG001|COMPLETED|Overall Study||13
2953157|NCT00710814|3667173|FG000|NOT COMPLETED|Overall Study||1
2953158|NCT00710814|3667174|FG001|NOT COMPLETED|Overall Study||3
2953159|NCT00710840|3667182|FG000|STARTED|Overall Study||22
2953160|NCT00710840|3667183|FG001|STARTED|Overall Study||22
2953161|NCT00710840|3667182|FG000|COMPLETED|Overall Study||22
2953162|NCT00710840|3667183|FG001|COMPLETED|Overall Study||19
2953163|NCT00710840|3667182|FG000|NOT COMPLETED|Overall Study||0
2953164|NCT00710840|3667183|FG001|NOT COMPLETED|Overall Study||3
2953165|NCT00710866|3667191|FG000|STARTED|Overall Study||133
2953166|NCT00710866|3667192|FG001|STARTED|Overall Study||134
2953167|NCT00710866|3667191|FG000|COMPLETED|Overall Study||124
2953168|NCT00710866|3667192|FG001|COMPLETED|Overall Study||128
2953169|NCT00710866|3667191|FG000|NOT COMPLETED|Overall Study||9
2953170|NCT00710866|3667192|FG001|NOT COMPLETED|Overall Study||6
2953171|NCT00710879|3667200|FG000|STARTED|Overall Study||60
2953172|NCT00710879|3667201|FG001|STARTED|Overall Study||117
2953173|NCT00710879|3667200|FG000|COMPLETED|Overall Study||58
3163516|NCT01887418|3891043|FG000|COMPLETED|Overall Study||15
3163517|NCT01887418|3891044|FG001|COMPLETED|Overall Study||14
3163518|NCT01887418|3891045|FG002|COMPLETED|Overall Study||9
3163519|NCT01887418|3891043|FG000|NOT COMPLETED|Overall Study||0
3163520|NCT01887418|3891044|FG001|NOT COMPLETED|Overall Study||0
2953174|NCT00710879|3667201|FG001|COMPLETED|Overall Study||113
2953175|NCT00710879|3667200|FG000|NOT COMPLETED|Overall Study||2
2953176|NCT00710879|3667201|FG001|NOT COMPLETED|Overall Study||4
2953177|NCT00710905|3667207|FG000|STARTED|Overall Study||50
2953178|NCT00710905|3667207|FG000|COMPLETED|Overall Study||34
2953179|NCT00710905|3667207|FG000|NOT COMPLETED|Overall Study||16
2953180|NCT00710931|3667211|FG000|STARTED|Overall Study||34
3163521|NCT01887418|3891045|FG002|NOT COMPLETED|Overall Study||1
3132606|NCT01691859|3857711|FG000|NOT COMPLETED|Overall Study||347
3132607|NCT01691885|3857715|FG000|STARTED|Treatment Period 1(7-14 Days)||22
3132608|NCT01691885|3857716|FG001|STARTED|Treatment Period 1(7-14 Days)||23
3163522|NCT01887470|3891057|FG000|STARTED|Overall Study||10
3163523|NCT01887470|3891058|FG001|STARTED|Overall Study||10
3163524|NCT01887470|3891059|FG002|STARTED|Overall Study||10
3163525|NCT01887470|3891060|FG003|STARTED|Overall Study||10
3163526|NCT01887470|3891057|FG000|COMPLETED|Overall Study||10
3163527|NCT01887470|3891058|FG001|COMPLETED|Overall Study||10
3163528|NCT01887470|3891059|FG002|COMPLETED|Overall Study||10
3163529|NCT01887470|3891060|FG003|COMPLETED|Overall Study||10
3163530|NCT01887470|3891057|FG000|NOT COMPLETED|Overall Study||0
3163531|NCT01887470|3891058|FG001|NOT COMPLETED|Overall Study||0
3163532|NCT01887470|3891059|FG002|NOT COMPLETED|Overall Study||0
3163533|NCT01887470|3891060|FG003|NOT COMPLETED|Overall Study||0
3163534|NCT01887587|3891070|FG000|STARTED|Overall Study||5
3163535|NCT01887587|3891070|FG000|COMPLETED|Overall Study||5
3163536|NCT01887587|3891070|FG000|NOT COMPLETED|Overall Study||0
3163537|NCT01887600|3891077|FG000|STARTED|Overall Study||391
3163538|NCT01887600|3891078|FG001|STARTED|Overall Study||203
2953181|NCT00710931|3667211|FG000|COMPLETED|Overall Study||29
2953182|NCT00710931|3667211|FG000|NOT COMPLETED|Overall Study||5
2953183|NCT00710944|3667218|FG000|STARTED|Overall Study||55
2953184|NCT00710944|3667219|FG001|STARTED|Overall Study||58
2953185|NCT00710944|3667220|FG002|STARTED|Overall Study||19
2953186|NCT00710944|3667218|FG000|COMPLETED|Overall Study||45
2953187|NCT00710944|3667219|FG001|COMPLETED|Overall Study||49
2953188|NCT00710944|3667220|FG002|COMPLETED|Overall Study||17
2953189|NCT00710944|3667218|FG000|NOT COMPLETED|Overall Study||10
2953190|NCT00710944|3667219|FG001|NOT COMPLETED|Overall Study||9
2953191|NCT00710944|3667220|FG002|NOT COMPLETED|Overall Study||2
2953192|NCT00710996|3667231|FG000|STARTED|Overall Study||17
2953193|NCT00710996|3667232|FG001|STARTED|Overall Study||20
2953194|NCT00710996|3667233|FG002|STARTED|Overall Study||21
2953195|NCT00710996|3667231|FG000|COMPLETED|Overall Study||16
2953196|NCT00710996|3667232|FG001|COMPLETED|Overall Study||16
2953197|NCT00710996|3667233|FG002|COMPLETED|Overall Study||21
2953198|NCT00710996|3667231|FG000|NOT COMPLETED|Overall Study||1
2953199|NCT00710996|3667232|FG001|NOT COMPLETED|Overall Study||4
2953200|NCT00710996|3667233|FG002|NOT COMPLETED|Overall Study||0
2953201|NCT00711009|3667243|FG000|STARTED|Overall Study||105
2953202|NCT00711009|3667244|FG001|STARTED|Overall Study||101
2953203|NCT00711009|3667243|FG000|COMPLETED|Overall Study||90
2953204|NCT00711009|3667244|FG001|COMPLETED|Overall Study||82
2953205|NCT00711009|3667243|FG000|NOT COMPLETED|Overall Study||15
2953206|NCT00711009|3667244|FG001|NOT COMPLETED|Overall Study||19
2953207|NCT00711022|3667250|FG000|STARTED|Overall Study||51
2953208|NCT00711022|3667250|FG000|COMPLETED|Overall Study||40
2953209|NCT00711022|3667250|FG000|NOT COMPLETED|Overall Study||11
2953210|NCT00711100|3667254|FG000|STARTED|Overall Study||104
2953211|NCT00711100|3667254|FG000|COMPLETED|Overall Study||91
2953212|NCT00711100|3667254|FG000|NOT COMPLETED|Overall Study||13
2953213|NCT00711113|3667270|FG000|STARTED|Overall Study||47
2953214|NCT00711113|3667270|FG000|COMPLETED|Overall Study||36
3132609|NCT01691885|3857715|FG000|COMPLETED|Treatment Period 1(7-14 Days)||21
3132610|NCT01691885|3857716|FG001|COMPLETED|Treatment Period 1(7-14 Days)||22
3132611|NCT01691885|3857715|FG000|NOT COMPLETED|Treatment Period 1(7-14 Days)||1
3132612|NCT01691885|3857716|FG001|NOT COMPLETED|Treatment Period 1(7-14 Days)||1
3132613|NCT01691885|3857715|FG000|STARTED|Washout Period (7-9 Days)||21
3132614|NCT01691885|3857716|FG001|STARTED|Washout Period (7-9 Days)||22
3132615|NCT01691885|3857715|FG000|COMPLETED|Washout Period (7-9 Days)||21
3132616|NCT01691885|3857716|FG001|COMPLETED|Washout Period (7-9 Days)||21
3132617|NCT01691885|3857715|FG000|NOT COMPLETED|Washout Period (7-9 Days)||0
3132618|NCT01691885|3857716|FG001|NOT COMPLETED|Washout Period (7-9 Days)||1
3132619|NCT01691885|3857715|FG000|STARTED|Treatment Period 2 (7-14 Days)||21
3132620|NCT01691885|3857716|FG001|STARTED|Treatment Period 2 (7-14 Days)||21
3132621|NCT01691885|3857715|FG000|COMPLETED|Treatment Period 2 (7-14 Days)||21
3132622|NCT01691885|3857716|FG001|COMPLETED|Treatment Period 2 (7-14 Days)||21
3132623|NCT01691885|3857715|FG000|NOT COMPLETED|Treatment Period 2 (7-14 Days)||0
3132624|NCT01691885|3857716|FG001|NOT COMPLETED|Treatment Period 2 (7-14 Days)||0
3132625|NCT01691898|3857728|FG000|STARTED|Overall Study||63
3132626|NCT01691898|3857729|FG001|STARTED|Overall Study||59
3132627|NCT01691898|3857730|FG002|STARTED|Overall Study||20
3132628|NCT01691898|3857731|FG003|STARTED|Overall Study||9
3132629|NCT01691898|3857732|FG004|STARTED|Overall Study||40
3132630|NCT01691898|3857733|FG005|STARTED|Overall Study||40
3132631|NCT01691898|3857728|FG000|COMPLETED|Overall Study||16
3132632|NCT01691898|3857729|FG001|COMPLETED|Overall Study||15
3132633|NCT01691898|3857730|FG002|COMPLETED|Overall Study||11
3132634|NCT01691898|3857731|FG003|COMPLETED|Overall Study||4
3132635|NCT01691898|3857732|FG004|COMPLETED|Overall Study||26
3132636|NCT01691898|3857733|FG005|COMPLETED|Overall Study||5
3132637|NCT01691898|3857728|FG000|NOT COMPLETED|Overall Study||47
3163539|NCT01887600|3891077|FG000|Treatment Received|Overall Study||391
3163540|NCT01887600|3891078|FG001|Treatment Received|Overall Study||203
3163541|NCT01887600|3891077|FG000|COMPLETED|Overall Study||245
3163542|NCT01887600|3891078|FG001|COMPLETED|Overall Study||89
2953215|NCT00711113|3667270|FG000|NOT COMPLETED|Overall Study||11
2953216|NCT00711191|3667277|FG000|STARTED|Overall Study||3
2953217|NCT00711191|3667278|FG001|STARTED|Overall Study||6
2953218|NCT00711191|3667279|FG002|STARTED|Overall Study||13
2953219|NCT00711191|3667277|FG000|COMPLETED|Overall Study||0
2953220|NCT00711191|3667278|FG001|COMPLETED|Overall Study||1
2953221|NCT00711191|3667279|FG002|COMPLETED|Overall Study||1
2953222|NCT00711191|3667277|FG000|NOT COMPLETED|Overall Study||3
2953223|NCT00711191|3667278|FG001|NOT COMPLETED|Overall Study||5
2953224|NCT00711191|3667279|FG002|NOT COMPLETED|Overall Study||12
2953225|NCT00711243|3667296|FG000|STARTED|Registed and Started Treatment||3
2953226|NCT00711243|3667297|FG001|STARTED|Registed and Started Treatment||3
2953227|NCT00711243|3667298|FG002|STARTED|Registed and Started Treatment||3
2953228|NCT00711243|3667299|FG003|STARTED|Registed and Started Treatment||3
2953229|NCT00711243|3667300|FG004|STARTED|Registed and Started Treatment||3
2953230|NCT00711243|3667301|FG005|STARTED|Registed and Started Treatment||44
2953231|NCT00711243|3667296|FG000|Registered to Study|Registed and Started Treatment||3
2953232|NCT00711243|3667297|FG001|Registered to Study|Registed and Started Treatment||3
2953233|NCT00711243|3667298|FG002|Registered to Study|Registed and Started Treatment||3
2953234|NCT00711243|3667299|FG003|Registered to Study|Registed and Started Treatment||3
2953235|NCT00711243|3667300|FG004|Registered to Study|Registed and Started Treatment||3
2953236|NCT00711243|3667301|FG005|Registered to Study|Registed and Started Treatment||44
2953237|NCT00711243|3667296|FG000|Started Treatment|Registed and Started Treatment||3
2953238|NCT00711243|3667297|FG001|Started Treatment|Registed and Started Treatment||3
2953239|NCT00711243|3667298|FG002|Started Treatment|Registed and Started Treatment||3
2953240|NCT00711243|3667299|FG003|Started Treatment|Registed and Started Treatment||3
2953241|NCT00711243|3667300|FG004|Started Treatment|Registed and Started Treatment||3
2953242|NCT00711243|3667301|FG005|Started Treatment|Registed and Started Treatment||43
2953243|NCT00711243|3667296|FG000|COMPLETED|Registed and Started Treatment||3
2953244|NCT00711243|3667297|FG001|COMPLETED|Registed and Started Treatment||3
2953245|NCT00711243|3667298|FG002|COMPLETED|Registed and Started Treatment||3
2953246|NCT00711243|3667299|FG003|COMPLETED|Registed and Started Treatment||3
2953247|NCT00711243|3667300|FG004|COMPLETED|Registed and Started Treatment||3
2953248|NCT00711243|3667301|FG005|COMPLETED|Registed and Started Treatment||43
2953249|NCT00711243|3667296|FG000|NOT COMPLETED|Registed and Started Treatment||0
2953250|NCT00711243|3667297|FG001|NOT COMPLETED|Registed and Started Treatment||0
2953251|NCT00711243|3667298|FG002|NOT COMPLETED|Registed and Started Treatment||0
2953252|NCT00711243|3667299|FG003|NOT COMPLETED|Registed and Started Treatment||0
2953253|NCT00711243|3667300|FG004|NOT COMPLETED|Registed and Started Treatment||0
2953254|NCT00711243|3667301|FG005|NOT COMPLETED|Registed and Started Treatment||1
2953255|NCT00711243|3667296|FG000|STARTED|Reached First Response/4 Cycles||3
2953256|NCT00711243|3667297|FG001|STARTED|Reached First Response/4 Cycles||3
2953257|NCT00711243|3667298|FG002|STARTED|Reached First Response/4 Cycles||3
2953258|NCT00711243|3667299|FG003|STARTED|Reached First Response/4 Cycles||3
2953259|NCT00711243|3667300|FG004|STARTED|Reached First Response/4 Cycles||3
2953260|NCT00711243|3667301|FG005|STARTED|Reached First Response/4 Cycles||43
2953261|NCT00711243|3667296|FG000|COMPLETED|Reached First Response/4 Cycles||3
2953262|NCT00711243|3667297|FG001|COMPLETED|Reached First Response/4 Cycles||3
2953263|NCT00711243|3667298|FG002|COMPLETED|Reached First Response/4 Cycles||3
2953264|NCT00711243|3667299|FG003|COMPLETED|Reached First Response/4 Cycles||2
2953265|NCT00711243|3667300|FG004|COMPLETED|Reached First Response/4 Cycles||3
2953266|NCT00711243|3667301|FG005|COMPLETED|Reached First Response/4 Cycles||41
2953267|NCT00711243|3667296|FG000|NOT COMPLETED|Reached First Response/4 Cycles||0
2953268|NCT00711243|3667297|FG001|NOT COMPLETED|Reached First Response/4 Cycles||0
2953269|NCT00711243|3667298|FG002|NOT COMPLETED|Reached First Response/4 Cycles||0
2953270|NCT00711243|3667299|FG003|NOT COMPLETED|Reached First Response/4 Cycles||1
2953271|NCT00711243|3667300|FG004|NOT COMPLETED|Reached First Response/4 Cycles||0
2953272|NCT00711243|3667301|FG005|NOT COMPLETED|Reached First Response/4 Cycles||2
2953273|NCT00711243|3667296|FG000|STARTED|Treated Cycle 5 After First Response||3
2953274|NCT00711243|3667297|FG001|STARTED|Treated Cycle 5 After First Response||3
2953275|NCT00711243|3667298|FG002|STARTED|Treated Cycle 5 After First Response||3
2953276|NCT00711243|3667299|FG003|STARTED|Treated Cycle 5 After First Response||2
2953277|NCT00711243|3667300|FG004|STARTED|Treated Cycle 5 After First Response||3
2953278|NCT00711243|3667301|FG005|STARTED|Treated Cycle 5 After First Response||41
2953279|NCT00711243|3667296|FG000|COMPLETED|Treated Cycle 5 After First Response||2
2953280|NCT00711243|3667297|FG001|COMPLETED|Treated Cycle 5 After First Response||1
2953281|NCT00711243|3667298|FG002|COMPLETED|Treated Cycle 5 After First Response||3
2953282|NCT00711243|3667299|FG003|COMPLETED|Treated Cycle 5 After First Response||2
2953283|NCT00711243|3667300|FG004|COMPLETED|Treated Cycle 5 After First Response||2
2953284|NCT00711243|3667301|FG005|COMPLETED|Treated Cycle 5 After First Response||37
2953285|NCT00711243|3667296|FG000|NOT COMPLETED|Treated Cycle 5 After First Response||1
2953286|NCT00711243|3667297|FG001|NOT COMPLETED|Treated Cycle 5 After First Response||2
2953287|NCT00711243|3667298|FG002|NOT COMPLETED|Treated Cycle 5 After First Response||0
2953288|NCT00711243|3667299|FG003|NOT COMPLETED|Treated Cycle 5 After First Response||0
2953289|NCT00711243|3667300|FG004|NOT COMPLETED|Treated Cycle 5 After First Response||1
3132638|NCT01691898|3857729|FG001|NOT COMPLETED|Overall Study||44
3132639|NCT01691898|3857730|FG002|NOT COMPLETED|Overall Study||9
3132640|NCT01691898|3857731|FG003|NOT COMPLETED|Overall Study||5
3132641|NCT01691898|3857732|FG004|NOT COMPLETED|Overall Study||14
3132642|NCT01691898|3857733|FG005|NOT COMPLETED|Overall Study||35
3132643|NCT01691950|3857767|FG000|STARTED|Overall Study||20
2953290|NCT00711243|3667301|FG005|NOT COMPLETED|Treated Cycle 5 After First Response||4
2953291|NCT00711243|3667296|FG000|STARTED|Follow up Every 3 Months Until Death||3
2953292|NCT00711243|3667297|FG001|STARTED|Follow up Every 3 Months Until Death||3
2953293|NCT00711243|3667298|FG002|STARTED|Follow up Every 3 Months Until Death||3
2953294|NCT00711243|3667299|FG003|STARTED|Follow up Every 3 Months Until Death||3
2953295|NCT00711243|3667300|FG004|STARTED|Follow up Every 3 Months Until Death||3
2953296|NCT00711243|3667301|FG005|STARTED|Follow up Every 3 Months Until Death|4 patients died whilst on study and 1 patient did not get treated on study|39
2953297|NCT00711243|3667296|FG000|COMPLETED|Follow up Every 3 Months Until Death||3
2953298|NCT00711243|3667297|FG001|COMPLETED|Follow up Every 3 Months Until Death||3
2953299|NCT00711243|3667298|FG002|COMPLETED|Follow up Every 3 Months Until Death||3
2953300|NCT00711243|3667299|FG003|COMPLETED|Follow up Every 3 Months Until Death||3
2953301|NCT00711243|3667300|FG004|COMPLETED|Follow up Every 3 Months Until Death||3
2953302|NCT00711243|3667301|FG005|COMPLETED|Follow up Every 3 Months Until Death||37
2953303|NCT00711243|3667296|FG000|NOT COMPLETED|Follow up Every 3 Months Until Death||0
2953304|NCT00711243|3667297|FG001|NOT COMPLETED|Follow up Every 3 Months Until Death||0
2953305|NCT00711243|3667298|FG002|NOT COMPLETED|Follow up Every 3 Months Until Death||0
2953306|NCT00711243|3667299|FG003|NOT COMPLETED|Follow up Every 3 Months Until Death||0
2953307|NCT00711243|3667300|FG004|NOT COMPLETED|Follow up Every 3 Months Until Death||0
2953308|NCT00711243|3667301|FG005|NOT COMPLETED|Follow up Every 3 Months Until Death||2
2953309|NCT00711269|3667321|FG000|STARTED|Overall Study||131
2953310|NCT00711269|3667322|FG001|STARTED|Overall Study||131
2953311|NCT00711269|3667323|FG002|STARTED|Overall Study||133
2953312|NCT00711269|3667324|FG003|STARTED|Overall Study||65
2953313|NCT00711269|3667321|FG000|COMPLETED|Overall Study||87
2953314|NCT00711269|3667322|FG001|COMPLETED|Overall Study||83
2953315|NCT00711269|3667323|FG002|COMPLETED|Overall Study||83
2953316|NCT00711269|3667324|FG003|COMPLETED|Overall Study||51
2953317|NCT00711269|3667321|FG000|NOT COMPLETED|Overall Study||44
2953318|NCT00711269|3667322|FG001|NOT COMPLETED|Overall Study||48
2953319|NCT00711269|3667323|FG002|NOT COMPLETED|Overall Study||50
2953320|NCT00711269|3667324|FG003|NOT COMPLETED|Overall Study||14
2953321|NCT00711347|3667337|FG000|STARTED|Overall Study||14
2953322|NCT00711347|3667338|FG001|STARTED|Overall Study||14
2953323|NCT00711347|3667337|FG000|COMPLETED|Overall Study||14
2953324|NCT00711347|3667338|FG001|COMPLETED|Overall Study||14
2953325|NCT00711347|3667337|FG000|NOT COMPLETED|Overall Study||0
2953326|NCT00711347|3667338|FG001|NOT COMPLETED|Overall Study||0
2953327|NCT00711412|3667344|FG000|STARTED|Induction Treatment||44
2953328|NCT00711412|3667344|FG000|Registered to Study|Induction Treatment||44
2953329|NCT00711412|3667344|FG000|Started Induction Treatment|Induction Treatment||43
2953330|NCT00711412|3667344|FG000|COMPLETED|Induction Treatment||40
2953331|NCT00711412|3667344|FG000|NOT COMPLETED|Induction Treatment||4
2953332|NCT00711412|3667344|FG000|STARTED|Evaluated for Combination Treatment||40
2953333|NCT00711412|3667344|FG000|COMPLETED|Evaluated for Combination Treatment||34
2953334|NCT00711412|3667344|FG000|NOT COMPLETED|Evaluated for Combination Treatment||6
2953335|NCT00711412|3667344|FG000|STARTED|Combination Treatment||34
2953336|NCT00711412|3667344|FG000|COMPLETED|Combination Treatment||33
2953337|NCT00711412|3667344|FG000|NOT COMPLETED|Combination Treatment||1
2953338|NCT00711412|3667344|FG000|STARTED|Evaluation for Response and Surgery|1 patient only completed 2 cycles of therapy was evaluated and eligible for surgical resection.|34
2953339|NCT00711412|3667344|FG000|COMPLETED|Evaluation for Response and Surgery||28
2953340|NCT00711412|3667344|FG000|NOT COMPLETED|Evaluation for Response and Surgery||6
2953341|NCT00711412|3667344|FG000|STARTED|Survival Follow up Until Death|All patients that received treatment went into follow up period.|38
2953342|NCT00711412|3667344|FG000|COMPLETED|Survival Follow up Until Death||26
2953343|NCT00711412|3667344|FG000|NOT COMPLETED|Survival Follow up Until Death||12
2953344|NCT00711425|3667349|FG000|STARTED|Overall Study|Implant placement in 45 patients. Implant loading (baseline) in 44 patients.|45
2953345|NCT00711425|3667349|FG000|COMPLETED|Overall Study||41
2953346|NCT00711425|3667349|FG000|NOT COMPLETED|Overall Study||4
2953347|NCT00711464|3667353|FG000|STARTED|Overall Study||29
2953348|NCT00711464|3667353|FG000|COMPLETED|Overall Study||29
2953349|NCT00711464|3667353|FG000|NOT COMPLETED|Overall Study||0
2953350|NCT00711477|3667365|FG000|STARTED|Overall Study||23
2953351|NCT00711477|3667366|FG001|STARTED|Overall Study||23
2953352|NCT00711477|3667365|FG000|COMPLETED|Overall Study||20
2953353|NCT00711477|3667366|FG001|COMPLETED|Overall Study||20
2953354|NCT00711477|3667365|FG000|NOT COMPLETED|Overall Study||3
2953355|NCT00711477|3667366|FG001|NOT COMPLETED|Overall Study||3
2953356|NCT00711490|3667374|FG000|STARTED|Overall Study||5
2953357|NCT00711490|3667374|FG000|COMPLETED|Overall Study||5
2953358|NCT00711490|3667374|FG000|NOT COMPLETED|Overall Study||0
2953359|NCT00711516|3667381|FG000|STARTED|Overall Study||21
2953360|NCT00711516|3667382|FG001|STARTED|Overall Study||19
2953361|NCT00711516|3667381|FG000|COMPLETED|Overall Study||20
2953362|NCT00711516|3667382|FG001|COMPLETED|Overall Study||16
2953363|NCT00711516|3667381|FG000|NOT COMPLETED|Overall Study||1
2953364|NCT00711516|3667382|FG001|NOT COMPLETED|Overall Study||3
2953365|NCT00711529|3667390|FG000|STARTED|Overall Study||13
2953366|NCT00711529|3667391|FG001|STARTED|Overall Study||14
2953367|NCT00711529|3667390|FG000|COMPLETED|Overall Study|2 women lost their hot flash diary, so only 7 patients were evaluable for primary endpoint.|9
2953368|NCT00711529|3667391|FG001|COMPLETED|Overall Study||8
2953369|NCT00711529|3667390|FG000|NOT COMPLETED|Overall Study||4
2953370|NCT00711529|3667391|FG001|NOT COMPLETED|Overall Study||6
2953371|NCT00711594|3667401|FG000|STARTED|Overall Study||3
2953372|NCT00711594|3667402|FG001|STARTED|Overall Study||3
2953373|NCT00711594|3667403|FG002|STARTED|Overall Study||6
2953374|NCT00711594|3667404|FG003|STARTED|Overall Study||62
2953375|NCT00711594|3667401|FG000|COMPLETED|Overall Study||0
2953376|NCT00711594|3667402|FG001|COMPLETED|Overall Study||0
2953377|NCT00711594|3667403|FG002|COMPLETED|Overall Study||0
2953378|NCT00711594|3667404|FG003|COMPLETED|Overall Study||0
2953379|NCT00711594|3667401|FG000|NOT COMPLETED|Overall Study||3
2953380|NCT00711594|3667402|FG001|NOT COMPLETED|Overall Study||3
2953381|NCT00711594|3667403|FG002|NOT COMPLETED|Overall Study||6
2953382|NCT00711594|3667404|FG003|NOT COMPLETED|Overall Study||62
2953383|NCT00711646|3667418|FG000|STARTED|Overall Study||124
2953384|NCT00711646|3667419|FG001|STARTED|Overall Study||65
2953385|NCT00711646|3667418|FG000|COMPLETED|Overall Study||112
2953386|NCT00711646|3667419|FG001|COMPLETED|Overall Study||62
2953387|NCT00711646|3667418|FG000|NOT COMPLETED|Overall Study||12
3132644|NCT01691950|3857768|FG001|STARTED|Overall Study||10
3132645|NCT01691950|3857767|FG000|COMPLETED|Overall Study||10
3132646|NCT01691950|3857768|FG001|COMPLETED|Overall Study||10
3132647|NCT01691950|3857767|FG000|NOT COMPLETED|Overall Study||10
3132648|NCT01691950|3857768|FG001|NOT COMPLETED|Overall Study||0
3132649|NCT01692119|3857776|FG000|STARTED|Overall Study||130
2953388|NCT00711646|3667419|FG001|NOT COMPLETED|Overall Study||3
2953389|NCT00711711|3667427|FG000|STARTED|Overall Study||30
2953390|NCT00711711|3667428|FG001|STARTED|Overall Study||30
2953391|NCT00711711|3667427|FG000|Second Postsurgical Day|Overall Study||30
2953392|NCT00711711|3667428|FG001|Second Postsurgical Day|Overall Study||30
2953393|NCT00711711|3667427|FG000|Seventh Postsurgical Day|Overall Study||29
3300357|NCT02945150|4034289|FG000|NOT COMPLETED|Overall Study||0
3300358|NCT02945254|4034295|FG000|STARTED|Overall Study||10
3300359|NCT02945254|4034296|FG001|STARTED|Overall Study||10
3300360|NCT02945254|4034295|FG000|COMPLETED|Overall Study||8
3300361|NCT02945254|4034296|FG001|COMPLETED|Overall Study||10
3300362|NCT02945254|4034295|FG000|NOT COMPLETED|Overall Study||2
3300363|NCT02945254|4034296|FG001|NOT COMPLETED|Overall Study||0
3300364|NCT02945410|4034308|FG000|STARTED|Intervention 1 (5 Days)||3
3300365|NCT02945410|4034309|FG001|STARTED|Intervention 1 (5 Days)||4
3300366|NCT02945410|4034310|FG002|STARTED|Intervention 1 (5 Days)||2
3300367|NCT02945410|4034311|FG003|STARTED|Intervention 1 (5 Days)||3
3300368|NCT02945410|4034312|FG004|STARTED|Intervention 1 (5 Days)||2
3300369|NCT02945410|4034313|FG005|STARTED|Intervention 1 (5 Days)||1
3300370|NCT02945410|4034308|FG000|COMPLETED|Intervention 1 (5 Days)||2
3300371|NCT02945410|4034309|FG001|COMPLETED|Intervention 1 (5 Days)||1
3300372|NCT02945410|4034310|FG002|COMPLETED|Intervention 1 (5 Days)||2
3300373|NCT02945410|4034311|FG003|COMPLETED|Intervention 1 (5 Days)||3
3300374|NCT02945410|4034312|FG004|COMPLETED|Intervention 1 (5 Days)||2
3300375|NCT02945410|4034313|FG005|COMPLETED|Intervention 1 (5 Days)||0
3300376|NCT02945410|4034308|FG000|NOT COMPLETED|Intervention 1 (5 Days)||1
3300377|NCT02945410|4034309|FG001|NOT COMPLETED|Intervention 1 (5 Days)||3
3300378|NCT02945410|4034310|FG002|NOT COMPLETED|Intervention 1 (5 Days)||0
3300379|NCT02945410|4034311|FG003|NOT COMPLETED|Intervention 1 (5 Days)||0
2953394|NCT00711711|3667428|FG001|Seventh Postsurgical Day|Overall Study||27
2953395|NCT00711711|3667427|FG000|COMPLETED|Overall Study||29
2953396|NCT00711711|3667428|FG001|COMPLETED|Overall Study||24
2953397|NCT00711711|3667427|FG000|NOT COMPLETED|Overall Study||1
2953398|NCT00711711|3667428|FG001|NOT COMPLETED|Overall Study||6
2953399|NCT00711802|3667444|FG000|STARTED|Overall Study||75
2953400|NCT00711802|3667445|FG001|STARTED|Overall Study||38
2953401|NCT00711802|3667446|FG002|STARTED|Overall Study||75
2953402|NCT00711802|3667447|FG003|STARTED|Overall Study||38
2953403|NCT00711802|3667448|FG004|STARTED|Overall Study||83
3132650|NCT01692119|3857777|FG001|STARTED|Overall Study||128
3132651|NCT01692119|3857776|FG000|COMPLETED|Overall Study||110
3132652|NCT01692119|3857777|FG001|COMPLETED|Overall Study||127
3132653|NCT01692119|3857776|FG000|NOT COMPLETED|Overall Study||20
3132654|NCT01692119|3857777|FG001|NOT COMPLETED|Overall Study||1
3132655|NCT01692197|3857783|FG000|STARTED|Overall Study||43
2953404|NCT00711802|3667449|FG005|STARTED|Overall Study||42
2953405|NCT00711802|3667450|FG006|STARTED|Overall Study||30
2953406|NCT00711802|3667451|FG007|STARTED|Overall Study||15
3132656|NCT01692197|3857783|FG000|COMPLETED|Overall Study||40
3300380|NCT02945410|4034312|FG004|NOT COMPLETED|Intervention 1 (5 Days)||0
2953407|NCT00711802|3667444|FG000|Received at Least 1 Dose of Study Drug|Overall Study||73
2953408|NCT00711802|3667445|FG001|Received at Least 1 Dose of Study Drug|Overall Study||37
2953409|NCT00711802|3667446|FG002|Received at Least 1 Dose of Study Drug|Overall Study||73
2953410|NCT00711802|3667447|FG003|Received at Least 1 Dose of Study Drug|Overall Study||38
2953411|NCT00711802|3667448|FG004|Received at Least 1 Dose of Study Drug|Overall Study||81
2953412|NCT00711802|3667449|FG005|Received at Least 1 Dose of Study Drug|Overall Study||42
2953413|NCT00711802|3667450|FG006|Received at Least 1 Dose of Study Drug|Overall Study||30
2953414|NCT00711802|3667451|FG007|Received at Least 1 Dose of Study Drug|Overall Study||15
2953415|NCT00711802|3667444|FG000|COMPLETED|Overall Study||73
2953416|NCT00711802|3667445|FG001|COMPLETED|Overall Study||32
2953417|NCT00711802|3667446|FG002|COMPLETED|Overall Study||69
3300381|NCT02945410|4034313|FG005|NOT COMPLETED|Intervention 1 (5 Days)||1
3300382|NCT02945410|4034308|FG000|STARTED|Washout 1 (14 Days)||2
3300383|NCT02945410|4034309|FG001|STARTED|Washout 1 (14 Days)||1
3300384|NCT02945410|4034310|FG002|STARTED|Washout 1 (14 Days)||2
2953418|NCT00711802|3667447|FG003|COMPLETED|Overall Study||35
2953419|NCT00711802|3667448|FG004|COMPLETED|Overall Study||69
2953420|NCT00711802|3667449|FG005|COMPLETED|Overall Study||34
2953421|NCT00711802|3667450|FG006|COMPLETED|Overall Study||25
2953422|NCT00711802|3667451|FG007|COMPLETED|Overall Study||13
2953423|NCT00711802|3667444|FG000|NOT COMPLETED|Overall Study||2
3132657|NCT01692197|3857783|FG000|NOT COMPLETED|Overall Study||3
3132658|NCT01692275|3857794|FG000|STARTED|Overall Study||375
3132659|NCT01692275|3857795|FG001|STARTED|Overall Study||375
2953424|NCT00711802|3667445|FG001|NOT COMPLETED|Overall Study||6
2953425|NCT00711802|3667446|FG002|NOT COMPLETED|Overall Study||6
2953426|NCT00711802|3667447|FG003|NOT COMPLETED|Overall Study||3
2953427|NCT00711802|3667448|FG004|NOT COMPLETED|Overall Study||14
2953428|NCT00711802|3667449|FG005|NOT COMPLETED|Overall Study||8
2953429|NCT00711802|3667450|FG006|NOT COMPLETED|Overall Study||5
2953430|NCT00711802|3667451|FG007|NOT COMPLETED|Overall Study||2
2953431|NCT00711828|3667472|FG000|STARTED|Overall Study||21
2953432|NCT00711828|3667472|FG000|COMPLETED|Overall Study||21
2953433|NCT00711828|3667472|FG000|NOT COMPLETED|Overall Study||0
2953434|NCT00711867|3667478|FG000|STARTED|Overall Study||30
2953435|NCT00711867|3667479|FG001|STARTED|Overall Study||25
2953436|NCT00711867|3667478|FG000|COMPLETED|Overall Study|2 received additional warming. 3 missing primary measure.|25
2953437|NCT00711867|3667479|FG001|COMPLETED|Overall Study|3 received additional warming. 1 missing primary measure.|21
2953438|NCT00711867|3667478|FG000|NOT COMPLETED|Overall Study||5
2953439|NCT00711867|3667479|FG001|NOT COMPLETED|Overall Study||4
2953440|NCT00711880|3667487|FG000|STARTED|Overall Study||63
2953441|NCT00711880|3667488|FG001|STARTED|Overall Study||62
2953442|NCT00711880|3667487|FG000|COMPLETED|Overall Study||50
2953443|NCT00711880|3667488|FG001|COMPLETED|Overall Study||55
2953444|NCT00711880|3667487|FG000|NOT COMPLETED|Overall Study||13
2953445|NCT00711880|3667488|FG001|NOT COMPLETED|Overall Study||7
2953446|NCT00711958|3667496|FG000|STARTED|Overall Study||74
2953447|NCT00711958|3667497|FG001|STARTED|Overall Study||40
2953448|NCT00711958|3667496|FG000|COMPLETED|Overall Study||41
2953449|NCT00711958|3667497|FG001|COMPLETED|Overall Study||17
2953450|NCT00711958|3667496|FG000|NOT COMPLETED|Overall Study||33
2953451|NCT00711958|3667497|FG001|NOT COMPLETED|Overall Study||23
2953452|NCT00711971|3667506|FG000|STARTED|Overall Study||42
2953453|NCT00711971|3667507|FG001|STARTED|Overall Study||42
2953454|NCT00711971|3667508|FG002|STARTED|Overall Study||42
2953455|NCT00711971|3667506|FG000|COMPLETED|Overall Study||39
2953456|NCT00711971|3667507|FG001|COMPLETED|Overall Study||38
2953457|NCT00711971|3667508|FG002|COMPLETED|Overall Study||41
2953458|NCT00711971|3667506|FG000|NOT COMPLETED|Overall Study||3
2953459|NCT00711971|3667507|FG001|NOT COMPLETED|Overall Study||4
2953460|NCT00711971|3667508|FG002|NOT COMPLETED|Overall Study||1
2953461|NCT00711997|3667522|FG000|STARTED|Overall Study||3
2953462|NCT00711997|3667523|FG001|STARTED|Overall Study||6
2953463|NCT00711997|3667522|FG000|COMPLETED|Overall Study||3
2953464|NCT00711997|3667523|FG001|COMPLETED|Overall Study||6
2953465|NCT00711997|3667522|FG000|NOT COMPLETED|Overall Study||0
2953466|NCT00711997|3667523|FG001|NOT COMPLETED|Overall Study||0
2953467|NCT00712010|3667531|FG000|STARTED|1st Protein Testing (1 Day)|1 subject withdrew his consent form before to starting the 1st intervention|24
2953468|NCT00712010|3667531|FG000|COMPLETED|1st Protein Testing (1 Day)||24
2953469|NCT00712010|3667531|FG000|NOT COMPLETED|1st Protein Testing (1 Day)||0
2953470|NCT00712010|3667531|FG000|STARTED|Washout (7 Days)||24
2953471|NCT00712010|3667531|FG000|COMPLETED|Washout (7 Days)||24
2953472|NCT00712010|3667531|FG000|NOT COMPLETED|Washout (7 Days)||0
2953473|NCT00712010|3667531|FG000|STARTED|2nd Protein Testing (1 Day)||24
2953474|NCT00712010|3667531|FG000|COMPLETED|2nd Protein Testing (1 Day)||24
2953475|NCT00712010|3667531|FG000|NOT COMPLETED|2nd Protein Testing (1 Day)||0
2953476|NCT00712010|3667531|FG000|STARTED|Washout (7 Days)||24
2953477|NCT00712010|3667531|FG000|COMPLETED|Washout (7 Days)||24
2953478|NCT00712010|3667531|FG000|NOT COMPLETED|Washout (7 Days)||0
2953479|NCT00712010|3667531|FG000|STARTED|3rd Protein Testing (1 Day)||24
2953480|NCT00712010|3667531|FG000|COMPLETED|3rd Protein Testing (1 Day)||24
2953481|NCT00712010|3667531|FG000|NOT COMPLETED|3rd Protein Testing (1 Day)||0
2953482|NCT00712010|3667531|FG000|STARTED|Washout (7 Days)||24
2953483|NCT00712010|3667531|FG000|COMPLETED|Washout (7 Days)||24
2953484|NCT00712010|3667531|FG000|NOT COMPLETED|Washout (7 Days)||0
2953485|NCT00712010|3667531|FG000|STARTED|4th Protein Testing (1 Day)||24
2953486|NCT00712010|3667531|FG000|COMPLETED|4th Protein Testing (1 Day)||24
2953487|NCT00712010|3667531|FG000|NOT COMPLETED|4th Protein Testing (1 Day)||0
2953488|NCT00712010|3667531|FG000|STARTED|Washout (7 Days)||24
2953489|NCT00712010|3667531|FG000|COMPLETED|Washout (7 Days)||23
2953490|NCT00712010|3667531|FG000|NOT COMPLETED|Washout (7 Days)||1
2953491|NCT00712010|3667531|FG000|STARTED|5th Protein Testing (1 Day)||23
2953492|NCT00712010|3667531|FG000|COMPLETED|5th Protein Testing (1 Day)||23
2953493|NCT00712010|3667531|FG000|NOT COMPLETED|5th Protein Testing (1 Day)||0
3300385|NCT02945410|4034311|FG003|STARTED|Washout 1 (14 Days)||3
3300386|NCT02945410|4034312|FG004|STARTED|Washout 1 (14 Days)||2
3300387|NCT02945410|4034313|FG005|STARTED|Washout 1 (14 Days)||0
3300388|NCT02945410|4034308|FG000|COMPLETED|Washout 1 (14 Days)||2
2953494|NCT00712010|3667531|FG000|STARTED|Washout (7 Days)||23
2953495|NCT00712010|3667531|FG000|COMPLETED|Washout (7 Days)||23
3300389|NCT02945410|4034309|FG001|COMPLETED|Washout 1 (14 Days)||1
2953496|NCT00712010|3667531|FG000|NOT COMPLETED|Washout (7 Days)||0
2953497|NCT00712010|3667531|FG000|STARTED|6th Protein Testing (1 Day)||23
2953498|NCT00712010|3667531|FG000|COMPLETED|6th Protein Testing (1 Day)||23
2953499|NCT00712010|3667531|FG000|NOT COMPLETED|6th Protein Testing (1 Day)||0
2953500|NCT00712010|3667531|FG000|STARTED|Washout (7 Days)||23
2953501|NCT00712010|3667531|FG000|COMPLETED|Washout (7 Days)||23
2953502|NCT00712010|3667531|FG000|NOT COMPLETED|Washout (7 Days)||0
2953503|NCT00712010|3667531|FG000|STARTED|7th and Last Protein Testing (1 Day)||23
2953504|NCT00712010|3667531|FG000|COMPLETED|7th and Last Protein Testing (1 Day)||23
2953505|NCT00712010|3667531|FG000|NOT COMPLETED|7th and Last Protein Testing (1 Day)||0
2953506|NCT00712075|3667550|FG000|STARTED|Overall Study||22
2953507|NCT00712075|3667551|FG001|STARTED|Overall Study||30
2953508|NCT00712075|3667552|FG002|STARTED|Overall Study||25
2953509|NCT00712075|3667550|FG000|COMPLETED|Overall Study||17
2953510|NCT00712075|3667551|FG001|COMPLETED|Overall Study||26
2953511|NCT00712075|3667552|FG002|COMPLETED|Overall Study||14
2953512|NCT00712075|3667550|FG000|NOT COMPLETED|Overall Study||5
2953513|NCT00712075|3667551|FG001|NOT COMPLETED|Overall Study||4
2953514|NCT00712075|3667552|FG002|NOT COMPLETED|Overall Study||11
2953515|NCT00712166|3667562|FG000|STARTED|Overall Study||81
2953516|NCT00712166|3667563|FG001|STARTED|Overall Study||76
2953517|NCT00712166|3667562|FG000|COMPLETED|Overall Study||81
2953518|NCT00712166|3667563|FG001|COMPLETED|Overall Study||75
2953519|NCT00712166|3667562|FG000|NOT COMPLETED|Overall Study||0
2953520|NCT00712166|3667563|FG001|NOT COMPLETED|Overall Study||1
2953521|NCT00712179|3667571|FG000|STARTED|Overall Study||49
2953522|NCT00712179|3667571|FG000|COMPLETED|Overall Study|Data from 4 subjects was excluded due to noise in recorded EMG signal, so 33 subjects were analysed.|37
2953523|NCT00712179|3667571|FG000|NOT COMPLETED|Overall Study||12
2953524|NCT00712244|3667579|FG000|STARTED|Overall Study||29
2953525|NCT00712244|3667580|FG001|STARTED|Overall Study||29
2953526|NCT00712244|3667581|FG002|STARTED|Overall Study||27
2953527|NCT00712244|3667582|FG003|STARTED|Overall Study||27
2953528|NCT00712244|3667579|FG000|COMPLETED|Overall Study||25
2953529|NCT00712244|3667580|FG001|COMPLETED|Overall Study||28
2953530|NCT00712244|3667581|FG002|COMPLETED|Overall Study||25
2953531|NCT00712244|3667582|FG003|COMPLETED|Overall Study||26
2953532|NCT00712244|3667579|FG000|NOT COMPLETED|Overall Study||4
2953533|NCT00712244|3667580|FG001|NOT COMPLETED|Overall Study||1
2953534|NCT00712244|3667581|FG002|NOT COMPLETED|Overall Study||2
2953535|NCT00712244|3667582|FG003|NOT COMPLETED|Overall Study||1
2953536|NCT00712270|3667595|FG000|STARTED|Overall Study||21
2953537|NCT00712270|3667595|FG000|COMPLETED|Overall Study||7
2953538|NCT00712270|3667595|FG000|NOT COMPLETED|Overall Study||14
2953539|NCT00712296|3667609|FG000|STARTED|Phase I ( 1 Week)||12
2953540|NCT00712296|3667610|FG001|STARTED|Phase I ( 1 Week)||8
2953541|NCT00712296|3667611|FG002|STARTED|Phase I ( 1 Week)||0
2953542|NCT00712296|3667612|FG003|STARTED|Phase I ( 1 Week)||0
2953543|NCT00712296|3667613|FG004|STARTED|Phase I ( 1 Week)||0
2953544|NCT00712296|3667609|FG000|COMPLETED|Phase I ( 1 Week)||12
2953545|NCT00712296|3667610|FG001|COMPLETED|Phase I ( 1 Week)||8
2953546|NCT00712296|3667611|FG002|COMPLETED|Phase I ( 1 Week)||0
2953547|NCT00712296|3667612|FG003|COMPLETED|Phase I ( 1 Week)||0
2953548|NCT00712296|3667613|FG004|COMPLETED|Phase I ( 1 Week)||0
2953549|NCT00712296|3667609|FG000|NOT COMPLETED|Phase I ( 1 Week)||0
2953550|NCT00712296|3667610|FG001|NOT COMPLETED|Phase I ( 1 Week)||0
3300390|NCT02945410|4034310|FG002|COMPLETED|Washout 1 (14 Days)||0
3300391|NCT02945410|4034311|FG003|COMPLETED|Washout 1 (14 Days)||3
3300392|NCT02945410|4034312|FG004|COMPLETED|Washout 1 (14 Days)||1
3300393|NCT02945410|4034313|FG005|COMPLETED|Washout 1 (14 Days)||0
3300394|NCT02945410|4034308|FG000|NOT COMPLETED|Washout 1 (14 Days)||0
2953551|NCT00712296|3667611|FG002|NOT COMPLETED|Phase I ( 1 Week)||0
2953552|NCT00712296|3667612|FG003|NOT COMPLETED|Phase I ( 1 Week)||0
2953553|NCT00712296|3667613|FG004|NOT COMPLETED|Phase I ( 1 Week)||0
2953554|NCT00712296|3667609|FG000|STARTED|Phase II (28 Weeks)||0
2953555|NCT00712296|3667610|FG001|STARTED|Phase II (28 Weeks)||0
2953556|NCT00712296|3667611|FG002|STARTED|Phase II (28 Weeks)||15
2953557|NCT00712296|3667612|FG003|STARTED|Phase II (28 Weeks)||16
2953558|NCT00712296|3667613|FG004|STARTED|Phase II (28 Weeks)||15
2953559|NCT00712296|3667609|FG000|COMPLETED|Phase II (28 Weeks)||0
2953560|NCT00712296|3667610|FG001|COMPLETED|Phase II (28 Weeks)||0
2953561|NCT00712296|3667611|FG002|COMPLETED|Phase II (28 Weeks)|ASHMI/Placebo was discontinued on 9/29/10.20 participants were re-randomized into the Phase II.|2
2953562|NCT00712296|3667612|FG003|COMPLETED|Phase II (28 Weeks)||1
2953563|NCT00712296|3667613|FG004|COMPLETED|Phase II (28 Weeks)||3
2953564|NCT00712296|3667609|FG000|NOT COMPLETED|Phase II (28 Weeks)||0
2953565|NCT00712296|3667610|FG001|NOT COMPLETED|Phase II (28 Weeks)||0
2953566|NCT00712296|3667611|FG002|NOT COMPLETED|Phase II (28 Weeks)||13
2953567|NCT00712296|3667612|FG003|NOT COMPLETED|Phase II (28 Weeks)||15
2953568|NCT00712296|3667613|FG004|NOT COMPLETED|Phase II (28 Weeks)||12
2953569|NCT00712335|3667649|FG000|STARTED|Overall Study||8
2953570|NCT00712335|3667650|FG001|STARTED|Overall Study||32
2953571|NCT00712335|3667651|FG002|STARTED|Overall Study||11
2953572|NCT00712335|3667652|FG003|STARTED|Overall Study||24
2953573|NCT00712335|3667653|FG004|STARTED|Overall Study||30
2953574|NCT00712335|3667649|FG000|COMPLETED|Overall Study||5
2953575|NCT00712335|3667650|FG001|COMPLETED|Overall Study||15
2953576|NCT00712335|3667651|FG002|COMPLETED|Overall Study||6
2953577|NCT00712335|3667652|FG003|COMPLETED|Overall Study||19
2953578|NCT00712335|3667653|FG004|COMPLETED|Overall Study||30
2953579|NCT00712335|3667649|FG000|NOT COMPLETED|Overall Study||3
3300395|NCT02945410|4034309|FG001|NOT COMPLETED|Washout 1 (14 Days)||0
2953580|NCT00712335|3667650|FG001|NOT COMPLETED|Overall Study||17
2953581|NCT00712335|3667651|FG002|NOT COMPLETED|Overall Study||5
2953582|NCT00712335|3667652|FG003|NOT COMPLETED|Overall Study||5
2953583|NCT00712335|3667653|FG004|NOT COMPLETED|Overall Study||0
2953584|NCT00712348|3667665|FG000|STARTED|Overall Study||31
2953585|NCT00712348|3667665|FG000|COMPLETED|Overall Study||30
2953586|NCT00712348|3667665|FG000|NOT COMPLETED|Overall Study||1
2953587|NCT00712530|3667672|FG000|STARTED|Overall Study||3
2953588|NCT00712530|3667673|FG001|STARTED|Overall Study||3
2953589|NCT00712530|3667674|FG002|STARTED|Overall Study|Screened 4 patients, but one failed to meet entry criteria due to a history of bleeding and diabetes|3
2953590|NCT00712530|3667672|FG000|COMPLETED|Overall Study||3
2953591|NCT00712530|3667673|FG001|COMPLETED|Overall Study||3
2953592|NCT00712530|3667674|FG002|COMPLETED|Overall Study||3
3132660|NCT01692275|3857794|FG000|COMPLETED|Overall Study||309
3132661|NCT01692275|3857795|FG001|COMPLETED|Overall Study||316
3132662|NCT01692275|3857794|FG000|NOT COMPLETED|Overall Study||66
2953593|NCT00712530|3667672|FG000|NOT COMPLETED|Overall Study||0
2953594|NCT00712530|3667673|FG001|NOT COMPLETED|Overall Study||0
2953595|NCT00712530|3667674|FG002|NOT COMPLETED|Overall Study||0
2953596|NCT00712543|3667684|FG000|STARTED|Day 1-7||23
2953597|NCT00712543|3667685|FG001|STARTED|Day 1-7||27
2953598|NCT00712543|3667684|FG000|COMPLETED|Day 1-7||23
2953599|NCT00712543|3667685|FG001|COMPLETED|Day 1-7||27
2953600|NCT00712543|3667684|FG000|NOT COMPLETED|Day 1-7||0
2953601|NCT00712543|3667685|FG001|NOT COMPLETED|Day 1-7||0
2953602|NCT00712543|3667684|FG000|STARTED|Day 8-14||23
2953603|NCT00712543|3667685|FG001|STARTED|Day 8-14||27
2953604|NCT00712543|3667684|FG000|COMPLETED|Day 8-14||23
2953605|NCT00712543|3667685|FG001|COMPLETED|Day 8-14||25
2953606|NCT00712543|3667684|FG000|NOT COMPLETED|Day 8-14||0
2953607|NCT00712543|3667685|FG001|NOT COMPLETED|Day 8-14||2
2953608|NCT00712673|3667694|FG000|STARTED|Overall Study|Randomized.|85
2953609|NCT00712673|3667695|FG001|STARTED|Overall Study||85
2953610|NCT00712673|3667696|FG002|STARTED|Overall Study||255
2953611|NCT00712673|3667697|FG003|STARTED|Overall Study||255
2953612|NCT00712673|3667694|FG000|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|85
2953613|NCT00712673|3667695|FG001|Safety Population|Overall Study||85
2953614|NCT00712673|3667696|FG002|Safety Population|Overall Study||255
2953615|NCT00712673|3667697|FG003|Safety Population|Overall Study||255
2953616|NCT00712673|3667694|FG000|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|85
2953617|NCT00712673|3667695|FG001|Modified Intent-to-Treat(mITT)Population|Overall Study||85
2953618|NCT00712673|3667696|FG002|Modified Intent-to-Treat(mITT)Population|Overall Study||255
2953619|NCT00712673|3667697|FG003|Modified Intent-to-Treat(mITT)Population|Overall Study||255
2953620|NCT00712673|3667694|FG000|Subgroup for Standardized Meal Test|Overall Study|Patients from morning injection arms where standardized meal test was performed.|85
2953621|NCT00712673|3667695|FG001|Subgroup for Standardized Meal Test|Overall Study||0
2953622|NCT00712673|3667696|FG002|Subgroup for Standardized Meal Test|Overall Study||255
2953623|NCT00712673|3667697|FG003|Subgroup for Standardized Meal Test|Overall Study||0
2953624|NCT00712673|3667694|FG000|COMPLETED|Overall Study||64
2953625|NCT00712673|3667695|FG001|COMPLETED|Overall Study||64
2953626|NCT00712673|3667696|FG002|COMPLETED|Overall Study||198
2953627|NCT00712673|3667697|FG003|COMPLETED|Overall Study||185
2953628|NCT00712673|3667694|FG000|NOT COMPLETED|Overall Study||21
2953629|NCT00712673|3667695|FG001|NOT COMPLETED|Overall Study||21
2953630|NCT00712673|3667696|FG002|NOT COMPLETED|Overall Study||57
2953631|NCT00712673|3667697|FG003|NOT COMPLETED|Overall Study||70
2953632|NCT00712712|3667716|FG000|STARTED|Overall Study||78
2953633|NCT00712712|3667716|FG000|COMPLETED|Overall Study||55
2953634|NCT00712712|3667716|FG000|NOT COMPLETED|Overall Study||23
2953635|NCT00712725|3667728|FG000|STARTED|Overall Study||169
2953636|NCT00712725|3667729|FG001|STARTED|Overall Study||39
2953637|NCT00712725|3667730|FG002|STARTED|Overall Study||57
2953638|NCT00712725|3667731|FG003|STARTED|Overall Study||84
2953639|NCT00712725|3667732|FG004|STARTED|Overall Study||86
2953640|NCT00712725|3667733|FG005|STARTED|Overall Study||84
2953641|NCT00712725|3667734|FG006|STARTED|Overall Study||83
2953642|NCT00712725|3667735|FG007|STARTED|Overall Study||74
2953643|NCT00712725|3667728|FG000|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|140
2953644|NCT00712725|3667729|FG001|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|33
2953645|NCT00712725|3667730|FG002|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|47
2953646|NCT00712725|3667731|FG003|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|67
2953647|NCT00712725|3667732|FG004|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|67
2953648|NCT00712725|3667733|FG005|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|68
3035039|NCT01134783|3754118|FG000|NOT COMPLETED|Overall Study||36
3035040|NCT01134783|3754119|FG001|NOT COMPLETED|Overall Study||37
3035041|NCT01134887|3754133|FG000|STARTED|Overall Study||9
3035042|NCT01134887|3754134|FG001|STARTED|Overall Study||11
3035043|NCT01134887|3754135|FG002|STARTED|Overall Study||5
3035044|NCT01134887|3754136|FG003|STARTED|Overall Study||5
3035045|NCT01134887|3754133|FG000|COMPLETED|Overall Study||9
3035046|NCT01134887|3754134|FG001|COMPLETED|Overall Study|Four patients in the Veteran-Control arm did not have two clinic visits videotaped and left study.|7
2953649|NCT00712725|3667734|FG006|COMPLETED|Overall Study|One patient received study drug. The remaining patients discontinued prior to receiving study drug.|61
2953650|NCT00712725|3667735|FG007|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|63
2953651|NCT00712725|3667728|FG000|NOT COMPLETED|Overall Study||29
2953652|NCT00712725|3667729|FG001|NOT COMPLETED|Overall Study||6
2953653|NCT00712725|3667730|FG002|NOT COMPLETED|Overall Study||10
2953654|NCT00712725|3667731|FG003|NOT COMPLETED|Overall Study||17
2953655|NCT00712725|3667732|FG004|NOT COMPLETED|Overall Study||19
2953656|NCT00712725|3667733|FG005|NOT COMPLETED|Overall Study||16
2953657|NCT00712725|3667734|FG006|NOT COMPLETED|Overall Study||22
2953658|NCT00712725|3667735|FG007|NOT COMPLETED|Overall Study||11
2953659|NCT00712920|3667756|FG000|STARTED|Overall Study||192
2953660|NCT00712920|3667757|FG001|STARTED|Overall Study|3 subjects were randomized in error|197
2953661|NCT00712920|3667758|FG002|STARTED|Overall Study||192
2953662|NCT00712920|3667756|FG000|COMPLETED|Overall Study||175
2953663|NCT00712920|3667757|FG001|COMPLETED|Overall Study||180
2953664|NCT00712920|3667758|FG002|COMPLETED|Overall Study||180
2953665|NCT00712920|3667756|FG000|NOT COMPLETED|Overall Study||17
2953666|NCT00712920|3667757|FG001|NOT COMPLETED|Overall Study||17
2953667|NCT00712920|3667758|FG002|NOT COMPLETED|Overall Study||12
2953668|NCT00712959|3667768|FG000|STARTED|Overall Study||361
2953669|NCT00712959|3667769|FG001|STARTED|Overall Study||407
2953670|NCT00712959|3667768|FG000|COMPLETED|Overall Study||342
2953671|NCT00712959|3667769|FG001|COMPLETED|Overall Study||404
2953672|NCT00712959|3667768|FG000|NOT COMPLETED|Overall Study||19
2953673|NCT00712959|3667769|FG001|NOT COMPLETED|Overall Study||3
2953674|NCT00712985|3667775|FG000|STARTED|Overall Study||18
2953675|NCT00712985|3667775|FG000|COMPLETED|Overall Study||13
2953676|NCT00712985|3667775|FG000|NOT COMPLETED|Overall Study||5
2953677|NCT00713206|3667781|FG000|STARTED|Overall Study||65
2953678|NCT00713206|3667782|FG001|STARTED|Overall Study||57
2953679|NCT00713206|3667781|FG000|COMPLETED|Overall Study||60
2953680|NCT00713206|3667782|FG001|COMPLETED|Overall Study||53
2953681|NCT00713206|3667781|FG000|NOT COMPLETED|Overall Study||5
2953682|NCT00713206|3667782|FG001|NOT COMPLETED|Overall Study||4
2953683|NCT00713219|3667788|FG000|STARTED|Overall Study||14
2953684|NCT00713219|3667788|FG000|COMPLETED|Overall Study||12
2953685|NCT00713219|3667788|FG000|NOT COMPLETED|Overall Study||2
2953686|NCT00713284|3667792|FG000|STARTED|Overall Study|29 participants were screened but only 13 eligible for conversion and continue in the study.|29
2953687|NCT00713284|3667792|FG000|COMPLETED|Overall Study||13
2953688|NCT00713284|3667792|FG000|NOT COMPLETED|Overall Study||16
2953689|NCT00713310|3667798|FG000|STARTED|Overall Study||41
2953690|NCT00713310|3667799|FG001|STARTED|Overall Study||42
2953691|NCT00713310|3667798|FG000|mITT Population|Overall Study||41
2953692|NCT00713310|3667799|FG001|mITT Population|Overall Study|1 subject randomized to high dose not dosed so not included in the mITT population.|41
2953693|NCT00713310|3667798|FG000|COMPLETED|Overall Study||36
2953694|NCT00713310|3667799|FG001|COMPLETED|Overall Study||36
2953695|NCT00713310|3667798|FG000|NOT COMPLETED|Overall Study||5
2953696|NCT00713310|3667799|FG001|NOT COMPLETED|Overall Study||6
2953697|NCT00713323|3667805|FG000|STARTED|Overall Study||380
2953698|NCT00713323|3667805|FG000|COMPLETED|Overall Study||234
2953699|NCT00713323|3667805|FG000|NOT COMPLETED|Overall Study||146
2953700|NCT00713349|3667809|FG000|STARTED|Overall Study||25
2953701|NCT00713349|3667809|FG000|COMPLETED|Overall Study||24
2953702|NCT00713349|3667809|FG000|NOT COMPLETED|Overall Study||1
2953703|NCT00713427|3667815|FG000|STARTED|Overall Study||70
2953704|NCT00713427|3667815|FG000|COMPLETED|Overall Study||66
2953705|NCT00713427|3667815|FG000|NOT COMPLETED|Overall Study||4
2953706|NCT00713479|3667819|FG000|STARTED|First Medication Condition||6
2953707|NCT00713479|3667820|FG001|STARTED|First Medication Condition||6
2953708|NCT00713479|3667819|FG000|COMPLETED|First Medication Condition||2
2953709|NCT00713479|3667820|FG001|COMPLETED|First Medication Condition||6
2953710|NCT00713479|3667819|FG000|NOT COMPLETED|First Medication Condition||4
2953711|NCT00713479|3667820|FG001|NOT COMPLETED|First Medication Condition||0
2953712|NCT00713479|3667819|FG000|STARTED|Washout||2
2953713|NCT00713479|3667820|FG001|STARTED|Washout||6
2953714|NCT00713479|3667819|FG000|COMPLETED|Washout||2
2953715|NCT00713479|3667820|FG001|COMPLETED|Washout||6
2953716|NCT00713479|3667819|FG000|NOT COMPLETED|Washout||0
2953717|NCT00713479|3667820|FG001|NOT COMPLETED|Washout||0
2953718|NCT00713479|3667819|FG000|STARTED|Next Medication Condition||2
2953719|NCT00713479|3667820|FG001|STARTED|Next Medication Condition||6
2953720|NCT00713479|3667819|FG000|COMPLETED|Next Medication Condition||2
2953721|NCT00713479|3667820|FG001|COMPLETED|Next Medication Condition||6
2953722|NCT00713479|3667819|FG000|NOT COMPLETED|Next Medication Condition||0
2953723|NCT00713479|3667820|FG001|NOT COMPLETED|Next Medication Condition||0
2953724|NCT00713544|3667834|FG000|STARTED|Overall Study||52
2953725|NCT00713544|3667835|FG001|STARTED|Overall Study||52
2953726|NCT00713544|3667836|FG002|STARTED|Overall Study|Participants randomised. One of these participants did not subsequently receive treatment.|52
2953727|NCT00713544|3667837|FG003|STARTED|Overall Study||76
2953728|NCT00713544|3667838|FG004|STARTED|Overall Study||65
2953729|NCT00713544|3667839|FG005|STARTED|Overall Study|Participants randomised. One of these participants did not subsequently receive treatment.|76
2953730|NCT00713544|3667834|FG000|COMPLETED|Overall Study||45
2953731|NCT00713544|3667835|FG001|COMPLETED|Overall Study||46
2953732|NCT00713544|3667836|FG002|COMPLETED|Overall Study||41
2953733|NCT00713544|3667837|FG003|COMPLETED|Overall Study||66
2953734|NCT00713544|3667838|FG004|COMPLETED|Overall Study||57
2953735|NCT00713544|3667839|FG005|COMPLETED|Overall Study||67
2953736|NCT00713544|3667834|FG000|NOT COMPLETED|Overall Study||7
2953737|NCT00713544|3667835|FG001|NOT COMPLETED|Overall Study||6
2953738|NCT00713544|3667836|FG002|NOT COMPLETED|Overall Study||11
2953739|NCT00713544|3667837|FG003|NOT COMPLETED|Overall Study||10
2953740|NCT00713544|3667838|FG004|NOT COMPLETED|Overall Study||8
2953741|NCT00713544|3667839|FG005|NOT COMPLETED|Overall Study||9
2953742|NCT00713583|3667855|FG000|STARTED|Overall Study||45
2953743|NCT00713583|3667856|FG001|STARTED|Overall Study||40
2953744|NCT00713583|3667855|FG000|COMPLETED|Overall Study||45
2953745|NCT00713583|3667856|FG001|COMPLETED|Overall Study||40
2953746|NCT00713583|3667855|FG000|NOT COMPLETED|Overall Study||0
2953747|NCT00713583|3667856|FG001|NOT COMPLETED|Overall Study||0
2953748|NCT00713609|3667868|FG000|STARTED|Overall Study||106
2953749|NCT00713609|3667869|FG001|STARTED|Overall Study||105
2953750|NCT00713609|3667870|FG002|STARTED|Overall Study||107
2953751|NCT00713609|3667871|FG003|STARTED|Overall Study||108
2953752|NCT00713609|3667872|FG004|STARTED|Overall Study||106
2953753|NCT00713609|3667873|FG005|STARTED|Overall Study||55
2953754|NCT00713609|3667868|FG000|COMPLETED|Overall Study||85
2953755|NCT00713609|3667869|FG001|COMPLETED|Overall Study||90
2953756|NCT00713609|3667870|FG002|COMPLETED|Overall Study||92
2953757|NCT00713609|3667871|FG003|COMPLETED|Overall Study||99
2953758|NCT00713609|3667872|FG004|COMPLETED|Overall Study||87
2953759|NCT00713609|3667873|FG005|COMPLETED|Overall Study||47
2953760|NCT00713609|3667868|FG000|NOT COMPLETED|Overall Study||21
2953761|NCT00713609|3667869|FG001|NOT COMPLETED|Overall Study||15
2953762|NCT00713609|3667870|FG002|NOT COMPLETED|Overall Study||15
2953763|NCT00713609|3667871|FG003|NOT COMPLETED|Overall Study||9
2953764|NCT00713609|3667872|FG004|NOT COMPLETED|Overall Study||19
2953765|NCT00713609|3667873|FG005|NOT COMPLETED|Overall Study||8
2953766|NCT00713648|3667887|FG000|STARTED|Overall Study||41
2953767|NCT00713648|3667887|FG000|COMPLETED|Overall Study||33
2953768|NCT00713648|3667887|FG000|NOT COMPLETED|Overall Study||8
2953769|NCT00713661|3667895|FG000|STARTED|Overall Study||7
2953770|NCT00713661|3667896|FG001|STARTED|Overall Study||9
2953771|NCT00713661|3667897|FG002|STARTED|Overall Study||4
2953772|NCT00713661|3667898|FG003|STARTED|Overall Study||5
2953773|NCT00713661|3667895|FG000|COMPLETED|Overall Study||7
2953774|NCT00713661|3667896|FG001|COMPLETED|Overall Study||9
2953775|NCT00713661|3667897|FG002|COMPLETED|Overall Study||4
2953776|NCT00713661|3667898|FG003|COMPLETED|Overall Study||5
2953777|NCT00713661|3667895|FG000|NOT COMPLETED|Overall Study||0
2953778|NCT00713661|3667896|FG001|NOT COMPLETED|Overall Study||0
2953779|NCT00713661|3667897|FG002|NOT COMPLETED|Overall Study||0
2953780|NCT00713661|3667898|FG003|NOT COMPLETED|Overall Study||0
2953781|NCT00713700|3667908|FG000|STARTED|Overall Study||192
2953782|NCT00713700|3667908|FG000|COMPLETED|Overall Study||188
2953783|NCT00713700|3667908|FG000|NOT COMPLETED|Overall Study||4
2953784|NCT00713817|3667914|FG000|STARTED|Overall Study||10
2953785|NCT00713817|3667915|FG001|STARTED|Overall Study||9
2953786|NCT00713817|3667914|FG000|COMPLETED|Overall Study||10
2953787|NCT00713817|3667915|FG001|COMPLETED|Overall Study||9
2953788|NCT00713817|3667914|FG000|NOT COMPLETED|Overall Study||0
2953789|NCT00713817|3667915|FG001|NOT COMPLETED|Overall Study||0
2953790|NCT00713830|3667923|FG000|STARTED|Overall Study|Randomized.|286
2953791|NCT00713830|3667924|FG001|STARTED|Overall Study||573
2953792|NCT00713830|3667923|FG000|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|286
2953793|NCT00713830|3667924|FG001|Modified Intent-to-Treat(mITT)Population|Overall Study||570
2953794|NCT00713830|3667923|FG000|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|285
2953795|NCT00713830|3667924|FG001|Safety Population|Overall Study|1 patient randomized to placebo received Lixisenatide (at least one dose)|574
2953796|NCT00713830|3667923|FG000|Subgroup for Standardized Meal Test|Overall Study|Patients at selected sites where standardized meal challenge test was performed.|155
2953797|NCT00713830|3667924|FG001|Subgroup for Standardized Meal Test|Overall Study||313
2953798|NCT00713830|3667923|FG000|COMPLETED|Overall Study||204
2953799|NCT00713830|3667924|FG001|COMPLETED|Overall Study||396
2953800|NCT00713830|3667923|FG000|NOT COMPLETED|Overall Study||82
2953801|NCT00713830|3667924|FG001|NOT COMPLETED|Overall Study||177
2953802|NCT00714051|3667932|FG000|STARTED|Overall Study||27
2953803|NCT00714051|3667933|FG001|STARTED|Overall Study||28
2953804|NCT00714051|3667932|FG000|COMPLETED|Overall Study||26
2953805|NCT00714051|3667933|FG001|COMPLETED|Overall Study||27
2953806|NCT00714051|3667932|FG000|NOT COMPLETED|Overall Study||1
2953807|NCT00714051|3667933|FG001|NOT COMPLETED|Overall Study||1
2953808|NCT00714168|3667941|FG000|STARTED|Overall Study||165
2953809|NCT00714168|3667942|FG001|STARTED|Overall Study||198
2953810|NCT00714168|3667941|FG000|COMPLETED|Overall Study||121
2953811|NCT00714168|3667942|FG001|COMPLETED|Overall Study||139
2953812|NCT00714168|3667941|FG000|NOT COMPLETED|Overall Study||44
2953813|NCT00714168|3667942|FG001|NOT COMPLETED|Overall Study||59
2953814|NCT00714233|3667952|FG000|STARTED|Overall Study||10
2953815|NCT00714233|3667953|FG001|STARTED|Overall Study||11
2953816|NCT00714233|3667954|FG002|STARTED|Overall Study||11
2953817|NCT00714233|3667955|FG003|STARTED|Overall Study||10
2953818|NCT00714233|3667952|FG000|COMPLETED|Overall Study||6
2953819|NCT00714233|3667953|FG001|COMPLETED|Overall Study||10
2953820|NCT00714233|3667954|FG002|COMPLETED|Overall Study||10
2953821|NCT00714233|3667955|FG003|COMPLETED|Overall Study||6
2953822|NCT00714233|3667952|FG000|NOT COMPLETED|Overall Study||4
2953823|NCT00714233|3667953|FG001|NOT COMPLETED|Overall Study||1
2953824|NCT00714233|3667954|FG002|NOT COMPLETED|Overall Study||1
2953825|NCT00714233|3667955|FG003|NOT COMPLETED|Overall Study||4
2953826|NCT00714259|3667970|FG000|STARTED|Overall Study||5
2953827|NCT00714259|3667970|FG000|COMPLETED|Overall Study||3
2953828|NCT00714259|3667970|FG000|NOT COMPLETED|Overall Study||2
3035047|NCT01134887|3754135|FG002|COMPLETED|Overall Study||5
3035048|NCT01134887|3754136|FG003|COMPLETED|Overall Study||5
3035049|NCT01134887|3754133|FG000|NOT COMPLETED|Overall Study||0
3035050|NCT01134887|3754134|FG001|NOT COMPLETED|Overall Study||4
3035051|NCT01134887|3754135|FG002|NOT COMPLETED|Overall Study||0
3035052|NCT01134887|3754136|FG003|NOT COMPLETED|Overall Study||0
3035053|NCT01134900|3754146|FG000|STARTED|Overall Study||200
3035054|NCT01134900|3754147|FG001|STARTED|Overall Study||196
3035055|NCT01134900|3754146|FG000|COMPLETED|Overall Study||200
3035056|NCT01134900|3754147|FG001|COMPLETED|Overall Study||196
3035057|NCT01134900|3754146|FG000|NOT COMPLETED|Overall Study||0
3035058|NCT01134900|3754147|FG001|NOT COMPLETED|Overall Study||0
3035059|NCT01134939|3754161|FG000|STARTED|Overall Study||59
3035060|NCT01134939|3754162|FG001|STARTED|Overall Study||42
3035061|NCT01134939|3754163|FG002|STARTED|Overall Study||51
3035062|NCT01134939|3754164|FG003|STARTED|Overall Study||46
3035063|NCT01134939|3754165|FG004|STARTED|Overall Study||33
3035064|NCT01134939|3754166|FG005|STARTED|Overall Study||14
3035065|NCT01134939|3754167|FG006|STARTED|Overall Study||19
3035066|NCT01134939|3754168|FG007|STARTED|Overall Study||1
3035067|NCT01134939|3754161|FG000|COMPLETED|Overall Study||42
3035068|NCT01134939|3754162|FG001|COMPLETED|Overall Study||24
3035069|NCT01134939|3754163|FG002|COMPLETED|Overall Study||41
3035070|NCT01134939|3754164|FG003|COMPLETED|Overall Study||32
3035071|NCT01134939|3754165|FG004|COMPLETED|Overall Study||23
3035072|NCT01134939|3754166|FG005|COMPLETED|Overall Study||5
3035073|NCT01134939|3754167|FG006|COMPLETED|Overall Study||10
3035074|NCT01134939|3754168|FG007|COMPLETED|Overall Study||1
3035075|NCT01134939|3754161|FG000|NOT COMPLETED|Overall Study||17
3035076|NCT01134939|3754162|FG001|NOT COMPLETED|Overall Study||18
3035077|NCT01134939|3754163|FG002|NOT COMPLETED|Overall Study||10
3035078|NCT01134939|3754164|FG003|NOT COMPLETED|Overall Study||14
3035079|NCT01134939|3754165|FG004|NOT COMPLETED|Overall Study||10
3035080|NCT01134939|3754166|FG005|NOT COMPLETED|Overall Study||9
3035081|NCT01134939|3754167|FG006|NOT COMPLETED|Overall Study||9
3035082|NCT01134939|3754168|FG007|NOT COMPLETED|Overall Study||0
3035083|NCT01134952|3754182|FG000|STARTED|Overall Study||11
3035084|NCT01134952|3754182|FG000|COMPLETED|Overall Study||11
3035085|NCT01134952|3754182|FG000|NOT COMPLETED|Overall Study||0
3035086|NCT01135017|3754192|FG000|STARTED|Overall Study||55
3035087|NCT01135017|3754193|FG001|STARTED|Overall Study||57
3035088|NCT01135017|3754192|FG000|Treated|Overall Study||55
3035089|NCT01135017|3754193|FG001|Treated|Overall Study||57
3035090|NCT01135017|3754192|FG000|Evaluable for Efficacy|Overall Study||55
3035091|NCT01135017|3754193|FG001|Evaluable for Efficacy|Overall Study|Two participants did not have interrogation of the pacemaker after randomization|55
3035092|NCT01135017|3754192|FG000|COMPLETED|Overall Study|The study was terminated after enrolled participants completed the study period as per protocol|49
3035093|NCT01135017|3754193|FG001|COMPLETED|Overall Study|The study was terminated after enrolled participants completed the study period as per protocol|45
3163543|NCT01887600|3891077|FG000|NOT COMPLETED|Overall Study||146
3163544|NCT01887600|3891078|FG001|NOT COMPLETED|Overall Study||114
3163545|NCT01887678|3891087|FG000|STARTED|Overall Study||119
3163546|NCT01887678|3891088|FG001|STARTED|Overall Study||113
3163547|NCT01887678|3891087|FG000|COMPLETED|Overall Study||102
3035094|NCT01135017|3754192|FG000|NOT COMPLETED|Overall Study||6
3035095|NCT01135017|3754193|FG001|NOT COMPLETED|Overall Study||12
3035096|NCT01135069|3754202|FG000|STARTED|Overall Study||205
3035097|NCT01135069|3754203|FG001|STARTED|Overall Study||209
3035098|NCT01135069|3754204|FG002|STARTED|Overall Study||66
3035099|NCT01135069|3754202|FG000|COMPLETED|Overall Study||169
3035100|NCT01135069|3754203|FG001|COMPLETED|Overall Study||177
3035101|NCT01135069|3754204|FG002|COMPLETED|Overall Study||56
3035102|NCT01135069|3754202|FG000|NOT COMPLETED|Overall Study||36
3035103|NCT01135069|3754203|FG001|NOT COMPLETED|Overall Study||32
3035104|NCT01135069|3754204|FG002|NOT COMPLETED|Overall Study||10
3035105|NCT01135095|3754212|FG000|STARTED|Overall Study||101
3035106|NCT01135095|3754212|FG000|COMPLETED|Overall Study||101
3035107|NCT01135095|3754212|FG000|NOT COMPLETED|Overall Study||0
3035108|NCT01135186|3754216|FG000|STARTED|Overall Study||9
3035109|NCT01135186|3754216|FG000|COMPLETED|Overall Study||9
3035110|NCT01135186|3754216|FG000|NOT COMPLETED|Overall Study||0
3035111|NCT01135329|3754222|FG000|STARTED|Overall Study||15
3035112|NCT01135329|3754222|FG000|COMPLETED|Overall Study||15
3035113|NCT01135329|3754222|FG000|NOT COMPLETED|Overall Study||0
3163548|NCT01887678|3891088|FG001|COMPLETED|Overall Study||85
3035114|NCT01135368|3754227|FG000|STARTED|Overall Study||506
3035115|NCT01135368|3754227|FG000|COMPLETED|Overall Study||255
3035116|NCT01135368|3754227|FG000|NOT COMPLETED|Overall Study||251
3035117|NCT01135381|3754269|FG000|STARTED|Overall Study||189
3035118|NCT01135381|3754270|FG001|STARTED|Overall Study||185
3035119|NCT01135381|3754271|FG002|STARTED|Overall Study||69
3035120|NCT01135381|3754272|FG003|STARTED|Overall Study||68
3035121|NCT01135381|3754269|FG000|COMPLETED|Overall Study||168
3035122|NCT01135381|3754270|FG001|COMPLETED|Overall Study||178
3035123|NCT01135381|3754271|FG002|COMPLETED|Overall Study||65
2953829|NCT00714272|3667976|FG000|STARTED|Overall Study||2
2953830|NCT00714272|3667977|FG001|STARTED|Overall Study||2
2953831|NCT00714272|3667976|FG000|COMPLETED|Overall Study||2
2953832|NCT00714272|3667977|FG001|COMPLETED|Overall Study||2
2953833|NCT00714272|3667976|FG000|NOT COMPLETED|Overall Study||0
2953834|NCT00714272|3667977|FG001|NOT COMPLETED|Overall Study||0
2953835|NCT00714285|3667987|FG000|STARTED|Overall Study||105
3163549|NCT01887678|3891087|FG000|NOT COMPLETED|Overall Study||17
3163550|NCT01887678|3891088|FG001|NOT COMPLETED|Overall Study||28
2953836|NCT00714285|3667988|FG001|STARTED|Overall Study||105
2953837|NCT00714285|3667989|FG002|STARTED|Overall Study||105
2953838|NCT00714285|3667990|FG003|STARTED|Overall Study||105
2953839|NCT00714285|3667987|FG000|COMPLETED|Overall Study|Completed upto Day 180|105
2953840|NCT00714285|3667988|FG001|COMPLETED|Overall Study|Completed upto Day 180|102
2953841|NCT00714285|3667989|FG002|COMPLETED|Overall Study|Completed upto Day 180|105
2953842|NCT00714285|3667990|FG003|COMPLETED|Overall Study|Completed upto Day 180|104
2953843|NCT00714285|3667987|FG000|NOT COMPLETED|Overall Study||0
2953844|NCT00714285|3667988|FG001|NOT COMPLETED|Overall Study||3
2953845|NCT00714285|3667989|FG002|NOT COMPLETED|Overall Study||0
2953846|NCT00714285|3667990|FG003|NOT COMPLETED|Overall Study||1
2953847|NCT00714311|3668004|FG000|STARTED|Overall Study||52
2953848|NCT00714311|3668005|FG001|STARTED|Overall Study||52
2953849|NCT00714311|3668004|FG000|COMPLETED|Overall Study||39
2953850|NCT00714311|3668005|FG001|COMPLETED|Overall Study||30
2953851|NCT00714311|3668004|FG000|NOT COMPLETED|Overall Study||13
2953852|NCT00714311|3668005|FG001|NOT COMPLETED|Overall Study||22
2953853|NCT00714389|3668011|FG000|STARTED|Overall Study||12
2953854|NCT00714389|3668011|FG000|COMPLETED|Overall Study||12
2953855|NCT00714389|3668011|FG000|NOT COMPLETED|Overall Study||0
2953856|NCT00714415|3668017|FG000|STARTED|Overall Study||25
2953857|NCT00714415|3668018|FG001|STARTED|Overall Study||55
2953858|NCT00714415|3668017|FG000|COMPLETED|Overall Study||23
2953859|NCT00714415|3668018|FG001|COMPLETED|Overall Study||55
2953860|NCT00714415|3668017|FG000|NOT COMPLETED|Overall Study||2
2953861|NCT00714415|3668018|FG001|NOT COMPLETED|Overall Study||0
2953862|NCT00714493|3668024|FG000|STARTED|Overall Study||203
2953863|NCT00714493|3668024|FG000|COMPLETED|Overall Study||154
2953864|NCT00714493|3668024|FG000|NOT COMPLETED|Overall Study||49
2953865|NCT00714571|3668034|FG000|STARTED|Stage 1||12
2953866|NCT00714571|3668035|FG001|STARTED|Stage 1|11 allocated to intervention, but 1 withdrew before the first intervention session|15
2953867|NCT00714571|3668036|FG002|STARTED|Stage 1||11
2953868|NCT00714571|3668037|FG003|STARTED|Stage 1||14
2953869|NCT00714571|3668038|FG004|STARTED|Stage 1||0
2953870|NCT00714571|3668039|FG005|STARTED|Stage 1||0
2953871|NCT00714571|3668034|FG000|COMPLETED|Stage 1|1 patient excluded who completed training but did not disclose ongoing chemotherapy for cancer|12
2953872|NCT00714571|3668035|FG001|COMPLETED|Stage 1||15
2953873|NCT00714571|3668036|FG002|COMPLETED|Stage 1||10
2953874|NCT00714571|3668037|FG003|COMPLETED|Stage 1||14
2953875|NCT00714571|3668038|FG004|COMPLETED|Stage 1||0
2953876|NCT00714571|3668039|FG005|COMPLETED|Stage 1||0
2953877|NCT00714571|3668034|FG000|NOT COMPLETED|Stage 1||0
2953878|NCT00714571|3668035|FG001|NOT COMPLETED|Stage 1||0
2953879|NCT00714571|3668036|FG002|NOT COMPLETED|Stage 1||1
2953880|NCT00714571|3668037|FG003|NOT COMPLETED|Stage 1||0
2953881|NCT00714571|3668038|FG004|NOT COMPLETED|Stage 1||0
2953882|NCT00714571|3668039|FG005|NOT COMPLETED|Stage 1||0
2953883|NCT00714571|3668034|FG000|STARTED|Stage 2||0
2953884|NCT00714571|3668035|FG001|STARTED|Stage 2||0
2953885|NCT00714571|3668036|FG002|STARTED|Stage 2||0
2953886|NCT00714571|3668037|FG003|STARTED|Stage 2||0
2953887|NCT00714571|3668038|FG004|STARTED|Stage 2||15
2953888|NCT00714571|3668039|FG005|STARTED|Stage 2||15
2953889|NCT00714571|3668034|FG000|COMPLETED|Stage 2||0
2953890|NCT00714571|3668035|FG001|COMPLETED|Stage 2||0
2953891|NCT00714571|3668036|FG002|COMPLETED|Stage 2||0
2953892|NCT00714571|3668037|FG003|COMPLETED|Stage 2||0
2953893|NCT00714571|3668038|FG004|COMPLETED|Stage 2||15
2953894|NCT00714571|3668039|FG005|COMPLETED|Stage 2||15
2953895|NCT00714571|3668034|FG000|NOT COMPLETED|Stage 2||0
2953896|NCT00714571|3668035|FG001|NOT COMPLETED|Stage 2||0
2953897|NCT00714571|3668036|FG002|NOT COMPLETED|Stage 2||0
2953898|NCT00714571|3668037|FG003|NOT COMPLETED|Stage 2||0
2953899|NCT00714571|3668038|FG004|NOT COMPLETED|Stage 2||0
2953900|NCT00714571|3668039|FG005|NOT COMPLETED|Stage 2||0
2953901|NCT00714688|3668056|FG000|STARTED|Overall Study||97
2953902|NCT00714688|3668057|FG001|STARTED|Overall Study||90
2953903|NCT00714688|3668058|FG002|STARTED|Overall Study||92
2953904|NCT00714688|3668056|FG000|COMPLETED|Overall Study||68
2953905|NCT00714688|3668057|FG001|COMPLETED|Overall Study||55
2953906|NCT00714688|3668058|FG002|COMPLETED|Overall Study||55
2953907|NCT00714688|3668056|FG000|NOT COMPLETED|Overall Study||29
2953908|NCT00714688|3668057|FG001|NOT COMPLETED|Overall Study||35
2953909|NCT00714688|3668058|FG002|NOT COMPLETED|Overall Study||37
2953910|NCT00714714|3668066|FG000|STARTED|Overall Study||25
2953911|NCT00714714|3668066|FG000|COMPLETED|Overall Study||24
2953912|NCT00714714|3668066|FG000|NOT COMPLETED|Overall Study||1
2953913|NCT00714753|3668072|FG000|STARTED|Overall Study||5
2953914|NCT00714753|3668072|FG000|HDR Brachytherapy|Overall Study||5
2953915|NCT00714753|3668072|FG000|External Beam Radiotherapy (EBRT)|Overall Study||1
2953916|NCT00714753|3668072|FG000|COMPLETED|Overall Study||5
2953917|NCT00714753|3668072|FG000|NOT COMPLETED|Overall Study||0
2953918|NCT00714792|3668078|FG000|STARTED|Overall Study||10
2953919|NCT00714792|3668079|FG001|STARTED|Overall Study||8
3383717|NCT01915498|4118876|FG003|STARTED|Main Analysis (Sept 2013 - Sept 2017)||8
3383718|NCT01915498|4118877|FG004|STARTED|Main Analysis (Sept 2013 - Sept 2017)||5
3383719|NCT01915498|4118878|FG005|STARTED|Main Analysis (Sept 2013 - Sept 2017)||9
3383720|NCT01915498|4118879|FG006|STARTED|Main Analysis (Sept 2013 - Sept 2017)||7
3386739|NCT02021773|4122070|FG002|Safety Analysis Set|Overall Study||86
2953920|NCT00714792|3668078|FG000|COMPLETED|Overall Study||10
2953921|NCT00714792|3668079|FG001|COMPLETED|Overall Study||8
2953922|NCT00714792|3668078|FG000|NOT COMPLETED|Overall Study||0
2953923|NCT00714792|3668079|FG001|NOT COMPLETED|Overall Study||0
2953924|NCT00714870|3668087|FG000|STARTED|Overall Study||49
2953925|NCT00714870|3668088|FG001|STARTED|Overall Study||27
2953926|NCT00714870|3668087|FG000|COMPLETED|Overall Study||22
2953927|NCT00714870|3668088|FG001|COMPLETED|Overall Study||22
2953928|NCT00714870|3668087|FG000|NOT COMPLETED|Overall Study||27
2953929|NCT00714870|3668088|FG001|NOT COMPLETED|Overall Study||5
2953930|NCT00715026|3668094|FG000|STARTED|Overall Study|30 unilateral subjects and 1 bilateral|31
2953931|NCT00715026|3668094|FG000|Subjects That Received Surgery|Overall Study|24 unilateral subjects and 1 bilateral|25
2953932|NCT00715026|3668094|FG000|COMPLETED|Overall Study|20 unilateral subjects and 1 bilateral|21
2953933|NCT00715026|3668094|FG000|NOT COMPLETED|Overall Study||10
2953934|NCT00715078|3668101|FG000|STARTED|Overall Study||41
2953935|NCT00715078|3668102|FG001|STARTED|Overall Study||40
2953936|NCT00715078|3668103|FG002|STARTED|Overall Study||41
2953937|NCT00715078|3668101|FG000|Received ≥ 1 Study Infusion|Overall Study||40
2953938|NCT00715078|3668102|FG001|Received ≥ 1 Study Infusion|Overall Study||40
2953939|NCT00715078|3668103|FG002|Received ≥ 1 Study Infusion|Overall Study||39
2953940|NCT00715078|3668101|FG000|Received ≥ 1 Leukapheresis|Overall Study||40
2953941|NCT00715078|3668102|FG001|Received ≥ 1 Leukapheresis|Overall Study||40
2953942|NCT00715078|3668103|FG002|Received ≥ 1 Leukapheresis|Overall Study||40
2953943|NCT00715078|3668101|FG000|COMPLETED|Overall Study||11
2953944|NCT00715078|3668102|FG001|COMPLETED|Overall Study||4
2953945|NCT00715078|3668103|FG002|COMPLETED|Overall Study||3
2953946|NCT00715078|3668101|FG000|NOT COMPLETED|Overall Study||30
2953947|NCT00715078|3668102|FG001|NOT COMPLETED|Overall Study||36
2953948|NCT00715078|3668103|FG002|NOT COMPLETED|Overall Study||38
2953949|NCT00715104|3668114|FG000|STARTED|Overall Study||18
2953950|NCT00715104|3668115|FG001|STARTED|Overall Study||16
2953951|NCT00715104|3668116|FG002|STARTED|Overall Study||8
2953952|NCT00715104|3668114|FG000|COMPLETED|Overall Study||18
2953953|NCT00715104|3668115|FG001|COMPLETED|Overall Study||16
2953954|NCT00715104|3668116|FG002|COMPLETED|Overall Study||8
2953955|NCT00715104|3668114|FG000|NOT COMPLETED|Overall Study||0
2953956|NCT00715104|3668115|FG001|NOT COMPLETED|Overall Study||0
2953957|NCT00715104|3668116|FG002|NOT COMPLETED|Overall Study||0
2953958|NCT00715117|3668160|FG000|STARTED|Overall Study||6
2953959|NCT00715117|3668161|FG001|STARTED|Overall Study||6
2953960|NCT00715117|3668160|FG000|Completion fo 8 Week Study|Overall Study||6
2953961|NCT00715117|3668161|FG001|Completion fo 8 Week Study|Overall Study||6
2953962|NCT00715117|3668160|FG000|COMPLETED|Overall Study||6
2953963|NCT00715117|3668161|FG001|COMPLETED|Overall Study|One subject flared and was rescued with steroids|5
2953964|NCT00715117|3668160|FG000|NOT COMPLETED|Overall Study||0
2953965|NCT00715117|3668161|FG001|NOT COMPLETED|Overall Study||1
2953966|NCT00715208|3668174|FG000|STARTED|Overall Study||7
2953967|NCT00715208|3668175|FG001|STARTED|Overall Study||48
2953968|NCT00715208|3668174|FG000|COMPLETED|Overall Study||6
2953969|NCT00715208|3668175|FG001|COMPLETED|Overall Study||39
2953970|NCT00715208|3668174|FG000|NOT COMPLETED|Overall Study||1
2953971|NCT00715208|3668175|FG001|NOT COMPLETED|Overall Study||9
2953972|NCT00715299|3668181|FG000|STARTED|Overall Study|A total of 38 participants were consented to the study, but only 36 made it to day one of testing.|36
2953973|NCT00715299|3668181|FG000|COMPLETED|Overall Study||30
2953974|NCT00715299|3668181|FG000|NOT COMPLETED|Overall Study||6
2953975|NCT00715390|3668185|FG000|STARTED|Overall Study|114,209 Anesthetic records were screened to identify 234 records.|234
2953976|NCT00715390|3668185|FG000|Eligible|Overall Study||234
2953977|NCT00715390|3668185|FG000|COMPLETED|Overall Study|These were broken down to different types of dysrhythymia.|234
2953978|NCT00715390|3668185|FG000|NOT COMPLETED|Overall Study||0
2953979|NCT00715403|3668196|FG000|STARTED|Overall Study||1
2953980|NCT00715403|3668197|FG001|STARTED|Overall Study||1
2953981|NCT00715403|3668198|FG002|STARTED|Overall Study||4
2953982|NCT00715403|3668199|FG003|STARTED|Overall Study||9
2953983|NCT00715403|3668200|FG004|STARTED|Overall Study||6
2953984|NCT00715403|3668201|FG005|STARTED|Overall Study||19
2953985|NCT00715403|3668202|FG006|STARTED|Overall Study||1
2953986|NCT00715403|3668196|FG000|COMPLETED|Overall Study||0
2953987|NCT00715403|3668197|FG001|COMPLETED|Overall Study||0
2953988|NCT00715403|3668198|FG002|COMPLETED|Overall Study||0
2953989|NCT00715403|3668199|FG003|COMPLETED|Overall Study||0
2953990|NCT00715403|3668200|FG004|COMPLETED|Overall Study||0
2953991|NCT00715403|3668201|FG005|COMPLETED|Overall Study||0
2953992|NCT00715403|3668202|FG006|COMPLETED|Overall Study||0
2953993|NCT00715403|3668196|FG000|NOT COMPLETED|Overall Study||1
2953994|NCT00715403|3668197|FG001|NOT COMPLETED|Overall Study||1
2953995|NCT00715403|3668198|FG002|NOT COMPLETED|Overall Study||4
2953996|NCT00715403|3668199|FG003|NOT COMPLETED|Overall Study||9
2953997|NCT00715403|3668200|FG004|NOT COMPLETED|Overall Study||6
2953998|NCT00715403|3668201|FG005|NOT COMPLETED|Overall Study||19
2953999|NCT00715403|3668202|FG006|NOT COMPLETED|Overall Study||1
2954000|NCT00715429|3668220|FG000|STARTED|Overall Study||7
2954001|NCT00715429|3668221|FG001|STARTED|Overall Study||7
2954002|NCT00715429|3668220|FG000|COMPLETED|Overall Study||7
2954003|NCT00715429|3668221|FG001|COMPLETED|Overall Study||6
2954004|NCT00715429|3668220|FG000|NOT COMPLETED|Overall Study||0
2954005|NCT00715429|3668221|FG001|NOT COMPLETED|Overall Study||1
2954006|NCT00715520|3668230|FG000|STARTED|Overall Study||20
2954007|NCT00715520|3668231|FG001|STARTED|Overall Study||10
2954008|NCT00715520|3668232|FG002|STARTED|Overall Study||3
2954009|NCT00715520|3668230|FG000|COMPLETED|Overall Study||10
2954010|NCT00715520|3668231|FG001|COMPLETED|Overall Study||9
2954011|NCT00715520|3668232|FG002|COMPLETED|Overall Study||1
2954012|NCT00715520|3668230|FG000|NOT COMPLETED|Overall Study||10
2954013|NCT00715520|3668231|FG001|NOT COMPLETED|Overall Study||1
2954014|NCT00715520|3668232|FG002|NOT COMPLETED|Overall Study||2
2954015|NCT00715559|3668240|FG000|STARTED|Overall Study||3
2954016|NCT00715559|3668240|FG000|COMPLETED|Overall Study||2
2954017|NCT00715559|3668240|FG000|NOT COMPLETED|Overall Study||1
2954018|NCT00715624|3668246|FG000|STARTED|Overall Study|Randomized|167
2954019|NCT00715624|3668247|FG001|STARTED|Overall Study||329
2954020|NCT00715624|3668246|FG000|Treated/Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|167
2954021|NCT00715624|3668247|FG001|Treated/Safety Population|Overall Study||328
2954022|NCT00715624|3668246|FG000|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|166
2954023|NCT00715624|3668247|FG001|Modified Intent-to-Treat(mITT)Population|Overall Study||327
2954024|NCT00715624|3668246|FG000|COMPLETED|Overall Study||115
2954025|NCT00715624|3668247|FG001|COMPLETED|Overall Study||213
2954026|NCT00715624|3668246|FG000|NOT COMPLETED|Overall Study||52
2954027|NCT00715624|3668247|FG001|NOT COMPLETED|Overall Study||116
2954028|NCT00715650|3668255|FG000|STARTED|Intervention||47
2954029|NCT00715650|3668256|FG001|STARTED|Intervention||45
2954030|NCT00715650|3668255|FG000|Received Any Session|Intervention||39
2954031|NCT00715650|3668256|FG001|Received Any Session|Intervention||38
2954032|NCT00715650|3668255|FG000|Attended ≥ 2 Sessions|Intervention||36
2954033|NCT00715650|3668256|FG001|Attended ≥ 2 Sessions|Intervention||33
2954034|NCT00715650|3668255|FG000|Attended ≥ 3 Sessions|Intervention||23
2954035|NCT00715650|3668256|FG001|Attended ≥ 3 Sessions|Intervention||17
2954036|NCT00715650|3668255|FG000|COMPLETED|Intervention||42
2954037|NCT00715650|3668256|FG001|COMPLETED|Intervention||42
2954038|NCT00715650|3668255|FG000|NOT COMPLETED|Intervention||5
2954039|NCT00715650|3668256|FG001|NOT COMPLETED|Intervention||3
2954040|NCT00715650|3668255|FG000|STARTED|Follow-up||42
2954041|NCT00715650|3668256|FG001|STARTED|Follow-up||42
2954042|NCT00715650|3668255|FG000|Completed Month 1 Follow-up|Follow-up||40
2954043|NCT00715650|3668256|FG001|Completed Month 1 Follow-up|Follow-up||38
2954044|NCT00715650|3668255|FG000|Completed Month 3 Follow-up|Follow-up||35
2954045|NCT00715650|3668256|FG001|Completed Month 3 Follow-up|Follow-up||40
2954046|NCT00715650|3668255|FG000|Completed Month 6 Follow-up|Follow-up||29
2954047|NCT00715650|3668256|FG001|Completed Month 6 Follow-up|Follow-up||37
2954048|NCT00715650|3668255|FG000|COMPLETED|Follow-up||29
2954049|NCT00715650|3668256|FG001|COMPLETED|Follow-up||37
2954050|NCT00715650|3668255|FG000|NOT COMPLETED|Follow-up||13
2954051|NCT00715650|3668256|FG001|NOT COMPLETED|Follow-up||5
2954052|NCT00715676|3668265|FG000|STARTED|Overall Study|1 additional subject was enrolled in the placebo group but discontinued before taking any study drug|49
2954053|NCT00715676|3668266|FG001|STARTED|Overall Study||54
2954054|NCT00715676|3668267|FG002|STARTED|Overall Study||53
2954055|NCT00715676|3668265|FG000|COMPLETED|Overall Study||43
2954056|NCT00715676|3668266|FG001|COMPLETED|Overall Study||43
2954057|NCT00715676|3668267|FG002|COMPLETED|Overall Study||21
2954058|NCT00715676|3668265|FG000|NOT COMPLETED|Overall Study||6
2954059|NCT00715676|3668266|FG001|NOT COMPLETED|Overall Study||11
2954060|NCT00715676|3668267|FG002|NOT COMPLETED|Overall Study||32
2954061|NCT00715728|3668277|FG000|STARTED|Overall Study||14
3132663|NCT01692275|3857795|FG001|NOT COMPLETED|Overall Study||59
3136736|NCT01714726|3861989|FG001|STARTED|Open-Label Period||0
2954062|NCT00715728|3668278|FG001|STARTED|Overall Study||14
2954063|NCT00715728|3668277|FG000|COMPLETED|Overall Study||14
2954064|NCT00715728|3668278|FG001|COMPLETED|Overall Study||14
2954065|NCT00715728|3668277|FG000|NOT COMPLETED|Overall Study||0
2954066|NCT00715728|3668278|FG001|NOT COMPLETED|Overall Study||0
2954067|NCT00715741|3668290|FG000|STARTED|Overall Study||25
2954068|NCT00715741|3668291|FG001|STARTED|Overall Study||25
2954069|NCT00715741|3668292|FG002|STARTED|Overall Study||25
2954070|NCT00715741|3668293|FG003|STARTED|Overall Study||25
2954071|NCT00715741|3668290|FG000|COMPLETED|Overall Study||25
2954072|NCT00715741|3668291|FG001|COMPLETED|Overall Study||25
2954073|NCT00715741|3668292|FG002|COMPLETED|Overall Study||25
2954074|NCT00715741|3668293|FG003|COMPLETED|Overall Study||25
2954075|NCT00715741|3668290|FG000|NOT COMPLETED|Overall Study||0
2954076|NCT00715741|3668291|FG001|NOT COMPLETED|Overall Study||0
2954077|NCT00715741|3668292|FG002|NOT COMPLETED|Overall Study||0
2954078|NCT00715741|3668293|FG003|NOT COMPLETED|Overall Study||0
2954079|NCT00715754|3668303|FG000|STARTED|Overall Study||47
2954080|NCT00715754|3668303|FG000|COMPLETED|Overall Study||47
2954081|NCT00715754|3668303|FG000|NOT COMPLETED|Overall Study||0
2954082|NCT00715793|3668307|FG000|STARTED|Phase 1 RP2D DAC + TMZ||4
2954083|NCT00715793|3668308|FG001|STARTED|Phase 1 RP2D DAC + TMZ||6
2954084|NCT00715793|3668307|FG000|COMPLETED|Phase 1 RP2D DAC + TMZ||3
2954085|NCT00715793|3668308|FG001|COMPLETED|Phase 1 RP2D DAC + TMZ||6
2954086|NCT00715793|3668307|FG000|NOT COMPLETED|Phase 1 RP2D DAC + TMZ||1
2954087|NCT00715793|3668308|FG001|NOT COMPLETED|Phase 1 RP2D DAC + TMZ||0
2954088|NCT00715793|3668307|FG000|STARTED|Phase 2 DAC (0.15 mg/kg) + TMZ||0
2954089|NCT00715793|3668308|FG001|STARTED|Phase 2 DAC (0.15 mg/kg) + TMZ||29
2954090|NCT00715793|3668307|FG000|COMPLETED|Phase 2 DAC (0.15 mg/kg) + TMZ||0
2954091|NCT00715793|3668308|FG001|COMPLETED|Phase 2 DAC (0.15 mg/kg) + TMZ||27
2954092|NCT00715793|3668307|FG000|NOT COMPLETED|Phase 2 DAC (0.15 mg/kg) + TMZ||0
2954093|NCT00715793|3668308|FG001|NOT COMPLETED|Phase 2 DAC (0.15 mg/kg) + TMZ||2
2954094|NCT00715884|3668317|FG000|STARTED|Overall Study||452
2954095|NCT00715884|3668318|FG001|STARTED|Overall Study||226
2954096|NCT00715884|3668317|FG000|COMPLETED|Overall Study||444
2954097|NCT00715884|3668318|FG001|COMPLETED|Overall Study||225
2954098|NCT00715884|3668317|FG000|NOT COMPLETED|Overall Study||8
2954099|NCT00715884|3668318|FG001|NOT COMPLETED|Overall Study||1
2954100|NCT00715910|3668328|FG000|STARTED|Year 1||433
2954101|NCT00715910|3668329|FG001|STARTED|Year 1||147
2954102|NCT00715910|3668330|FG002|STARTED|Year 1||68
2954103|NCT00715910|3668331|FG003|STARTED|Year 1|Group not applicable during Year 1 Persistence phase|0
2954104|NCT00715910|3668332|FG004|STARTED|Year 1|Group not applicable during Year 1 Persistence phase|0
2954105|NCT00715910|3668333|FG005|STARTED|Year 1|Group not applicable during Year 1 Persistence phase|0
2954106|NCT00715910|3668328|FG000|COMPLETED|Year 1||433
2954107|NCT00715910|3668329|FG001|COMPLETED|Year 1||147
2954108|NCT00715910|3668330|FG002|COMPLETED|Year 1||68
2954109|NCT00715910|3668331|FG003|COMPLETED|Year 1|Group not applicable during Year 1 Persistence phase|0
2954110|NCT00715910|3668332|FG004|COMPLETED|Year 1|Group not applicable during Year 1 Persistence phase|0
2954111|NCT00715910|3668333|FG005|COMPLETED|Year 1|Group not applicable during Year 1 Persistence phase|0
2954112|NCT00715910|3668328|FG000|NOT COMPLETED|Year 1||0
2954113|NCT00715910|3668329|FG001|NOT COMPLETED|Year 1||0
2954114|NCT00715910|3668330|FG002|NOT COMPLETED|Year 1||0
2954115|NCT00715910|3668331|FG003|NOT COMPLETED|Year 1||0
2954116|NCT00715910|3668332|FG004|NOT COMPLETED|Year 1||0
2954117|NCT00715910|3668333|FG005|NOT COMPLETED|Year 1||0
2954118|NCT00715910|3668328|FG000|STARTED|Year 3||345
2954119|NCT00715910|3668329|FG001|STARTED|Year 3||86
2954120|NCT00715910|3668330|FG002|STARTED|Year 3||56
2954121|NCT00715910|3668331|FG003|STARTED|Year 3|Group not applicable during Year 3 Persistence phase|0
2954122|NCT00715910|3668332|FG004|STARTED|Year 3|Group not applicable during Year 3 Persistence phase|0
2954123|NCT00715910|3668333|FG005|STARTED|Year 3|Group not applicable during Year 3 Persistence phase|0
2954124|NCT00715910|3668328|FG000|COMPLETED|Year 3||345
2954125|NCT00715910|3668329|FG001|COMPLETED|Year 3||86
2954126|NCT00715910|3668330|FG002|COMPLETED|Year 3||56
2954127|NCT00715910|3668331|FG003|COMPLETED|Year 3|Group not applicable during Year 3 Persistence phase|0
2954128|NCT00715910|3668332|FG004|COMPLETED|Year 3|Group not applicable during Year 3 Persistence phase|0
2954129|NCT00715910|3668333|FG005|COMPLETED|Year 3|Group not applicable during Year 3 Persistence phase|0
2954130|NCT00715910|3668328|FG000|NOT COMPLETED|Year 3||0
2954131|NCT00715910|3668329|FG001|NOT COMPLETED|Year 3||0
2954132|NCT00715910|3668330|FG002|NOT COMPLETED|Year 3||0
2954133|NCT00715910|3668331|FG003|NOT COMPLETED|Year 3||0
2954134|NCT00715910|3668332|FG004|NOT COMPLETED|Year 3||0
2954135|NCT00715910|3668333|FG005|NOT COMPLETED|Year 3||0
2954136|NCT00715910|3668328|FG000|STARTED|Year 5||218
2954137|NCT00715910|3668329|FG001|STARTED|Year 5||56
2954138|NCT00715910|3668330|FG002|STARTED|Year 5||38
2954139|NCT00715910|3668331|FG003|STARTED|Year 5|Group not applicable during Year 5 Persistence phase|0
2954140|NCT00715910|3668332|FG004|STARTED|Year 5|Group not applicable during Year 5 Persistence phase|0
2954141|NCT00715910|3668333|FG005|STARTED|Year 5|Group not applicable during Year 5 Persistence phase|0
2954142|NCT00715910|3668328|FG000|COMPLETED|Year 5||218
2954143|NCT00715910|3668329|FG001|COMPLETED|Year 5||56
2954144|NCT00715910|3668330|FG002|COMPLETED|Year 5||38
2954145|NCT00715910|3668331|FG003|COMPLETED|Year 5|Group not applicable during Year 5 Persistence phase|0
2954146|NCT00715910|3668332|FG004|COMPLETED|Year 5|Group not applicable during Year 5 Persistence phase|0
2954147|NCT00715910|3668333|FG005|COMPLETED|Year 5|Group not applicable during Year 5 Persistence phase|0
2954148|NCT00715910|3668328|FG000|NOT COMPLETED|Year 5||0
2954149|NCT00715910|3668329|FG001|NOT COMPLETED|Year 5||0
2954150|NCT00715910|3668330|FG002|NOT COMPLETED|Year 5||0
2954151|NCT00715910|3668331|FG003|NOT COMPLETED|Year 5||0
2954152|NCT00715910|3668332|FG004|NOT COMPLETED|Year 5||0
2954153|NCT00715910|3668333|FG005|NOT COMPLETED|Year 5||0
2954154|NCT00715910|3668328|FG000|STARTED|Booster and ESFU Phase|Group not applicable during booster phase|0
2954155|NCT00715910|3668329|FG001|STARTED|Booster and ESFU Phase|Group not applicable during booster phase|0
2954156|NCT00715910|3668330|FG002|STARTED|Booster and ESFU Phase|Group not applicable during booster phase|0
2954157|NCT00715910|3668331|FG003|STARTED|Booster and ESFU Phase||183
2954158|NCT00715910|3668332|FG004|STARTED|Booster and ESFU Phase||38
2954159|NCT00715910|3668333|FG005|STARTED|Booster and ESFU Phase||101
2954160|NCT00715910|3668328|FG000|COMPLETED|Booster and ESFU Phase|Group not applicable during booster phase|0
2954161|NCT00715910|3668329|FG001|COMPLETED|Booster and ESFU Phase|Group not applicable during booster phase|0
2954162|NCT00715910|3668330|FG002|COMPLETED|Booster and ESFU Phase|Group not applicable during booster phase|0
2954163|NCT00715910|3668331|FG003|COMPLETED|Booster and ESFU Phase||172
2954164|NCT00715910|3668332|FG004|COMPLETED|Booster and ESFU Phase||36
2954165|NCT00715910|3668333|FG005|COMPLETED|Booster and ESFU Phase||88
2954166|NCT00715910|3668328|FG000|NOT COMPLETED|Booster and ESFU Phase||0
2954167|NCT00715910|3668329|FG001|NOT COMPLETED|Booster and ESFU Phase||0
2954168|NCT00715910|3668330|FG002|NOT COMPLETED|Booster and ESFU Phase||0
2954169|NCT00715910|3668331|FG003|NOT COMPLETED|Booster and ESFU Phase||11
2954170|NCT00715910|3668332|FG004|NOT COMPLETED|Booster and ESFU Phase||2
2954171|NCT00715910|3668333|FG005|NOT COMPLETED|Booster and ESFU Phase||13
2954172|NCT00715949|3668349|FG000|STARTED|Overall Study|4 dropped because could not finish first test|120
2954173|NCT00715949|3668349|FG000|COMPLETED|Overall Study|116 patients completed first test|116
2954174|NCT00715949|3668349|FG000|NOT COMPLETED|Overall Study||4
2954175|NCT00715962|3668355|FG000|STARTED|Overall Study||50
2954176|NCT00715962|3668356|FG001|STARTED|Overall Study||50
2954177|NCT00715962|3668355|FG000|COMPLETED|Overall Study||44
2954178|NCT00715962|3668356|FG001|COMPLETED|Overall Study||48
2954179|NCT00715962|3668355|FG000|NOT COMPLETED|Overall Study||6
2954180|NCT00715962|3668356|FG001|NOT COMPLETED|Overall Study||2
2954181|NCT00716079|3668365|FG000|STARTED|Overall Study||1403
2954182|NCT00716079|3668366|FG001|STARTED|Overall Study||1436
2954183|NCT00716079|3668365|FG000|COMPLETED|Overall Study||1394
2954184|NCT00716079|3668366|FG001|COMPLETED|Overall Study||1421
2954185|NCT00716079|3668365|FG000|NOT COMPLETED|Overall Study||9
2954186|NCT00716079|3668366|FG001|NOT COMPLETED|Overall Study||15
2954187|NCT00716092|3668375|FG000|STARTED|Overall Study||40
2954188|NCT00716092|3668376|FG001|STARTED|Overall Study||40
2954189|NCT00716092|3668377|FG002|STARTED|Overall Study||41
2954190|NCT00716092|3668375|FG000|COMPLETED|Overall Study||38
2954191|NCT00716092|3668376|FG001|COMPLETED|Overall Study||39
2954192|NCT00716092|3668377|FG002|COMPLETED|Overall Study||41
2954193|NCT00716092|3668375|FG000|NOT COMPLETED|Overall Study||2
2954194|NCT00716092|3668376|FG001|NOT COMPLETED|Overall Study||1
2954195|NCT00716092|3668377|FG002|NOT COMPLETED|Overall Study||0
2954196|NCT00716144|3668389|FG000|STARTED|Overall Study||41
2954197|NCT00716144|3668390|FG001|STARTED|Overall Study||45
2954198|NCT00716144|3668391|FG002|STARTED|Overall Study||45
2954199|NCT00716144|3668392|FG003|STARTED|Overall Study||45
2954200|NCT00716144|3668389|FG000|COMPLETED|Overall Study||32
2954201|NCT00716144|3668390|FG001|COMPLETED|Overall Study||38
2954202|NCT00716144|3668391|FG002|COMPLETED|Overall Study||33
2954203|NCT00716144|3668392|FG003|COMPLETED|Overall Study||33
2954204|NCT00716144|3668389|FG000|NOT COMPLETED|Overall Study||9
2954205|NCT00716144|3668390|FG001|NOT COMPLETED|Overall Study||7
2954206|NCT00716144|3668391|FG002|NOT COMPLETED|Overall Study||12
2954207|NCT00716144|3668392|FG003|NOT COMPLETED|Overall Study||12
2954208|NCT00716274|3668405|FG000|STARTED|Study Period II (16-Weeks)||45
2954209|NCT00716274|3668406|FG001|STARTED|Study Period II (16-Weeks)||44
2954210|NCT00716274|3668407|FG002|STARTED|Study Period II (16-Weeks)||0
2954211|NCT00716274|3668408|FG003|STARTED|Study Period II (16-Weeks)||0
2954212|NCT00716274|3668409|FG004|STARTED|Study Period II (16-Weeks)||0
2954213|NCT00716274|3668410|FG005|STARTED|Study Period II (16-Weeks)||21
2954214|NCT00716274|3668405|FG000|COMPLETED|Study Period II (16-Weeks)||36
2954215|NCT00716274|3668406|FG001|COMPLETED|Study Period II (16-Weeks)||35
2954216|NCT00716274|3668407|FG002|COMPLETED|Study Period II (16-Weeks)||0
2954217|NCT00716274|3668408|FG003|COMPLETED|Study Period II (16-Weeks)||0
2954218|NCT00716274|3668409|FG004|COMPLETED|Study Period II (16-Weeks)||0
2954219|NCT00716274|3668410|FG005|COMPLETED|Study Period II (16-Weeks)||19
2954220|NCT00716274|3668405|FG000|NOT COMPLETED|Study Period II (16-Weeks)||9
2954221|NCT00716274|3668406|FG001|NOT COMPLETED|Study Period II (16-Weeks)||9
2954222|NCT00716274|3668407|FG002|NOT COMPLETED|Study Period II (16-Weeks)||0
2954223|NCT00716274|3668408|FG003|NOT COMPLETED|Study Period II (16-Weeks)||0
2954224|NCT00716274|3668409|FG004|NOT COMPLETED|Study Period II (16-Weeks)||0
2954225|NCT00716274|3668410|FG005|NOT COMPLETED|Study Period II (16-Weeks)||2
2954226|NCT00716274|3668405|FG000|STARTED|Study Period III (16-Weeks)|Participants were assessed for maintenance of benefit after discontinuation of atomoxetine.|0
2954227|NCT00716274|3668406|FG001|STARTED|Study Period III (16-Weeks)|Participants were assessed for maintenance of benefit after discontinuation of atomoxetine.|0
2954228|NCT00716274|3668407|FG002|STARTED|Study Period III (16-Weeks)|Participants were assessed for maintenance of benefit after discontinuation of atomoxetine.|18
2954229|NCT00716274|3668408|FG003|STARTED|Study Period III (16-Weeks)|Participants were assessed for maintenance of benefit after discontinuation of atomoxetine.|18
2954230|NCT00716274|3668409|FG004|STARTED|Study Period III (16-Weeks)|Participants were assessed for maintenance of benefit after discontinuation of atomoxetine.|35
2954231|NCT00716274|3668410|FG005|STARTED|Study Period III (16-Weeks)|Participants were assessed for maintenance of benefit after discontinuation of atomoxetine.|19
2954232|NCT00716274|3668405|FG000|COMPLETED|Study Period III (16-Weeks)||0
2954233|NCT00716274|3668406|FG001|COMPLETED|Study Period III (16-Weeks)||0
2954234|NCT00716274|3668407|FG002|COMPLETED|Study Period III (16-Weeks)||16
2954235|NCT00716274|3668408|FG003|COMPLETED|Study Period III (16-Weeks)||17
2954236|NCT00716274|3668409|FG004|COMPLETED|Study Period III (16-Weeks)||32
2954237|NCT00716274|3668410|FG005|COMPLETED|Study Period III (16-Weeks)||19
2954238|NCT00716274|3668405|FG000|NOT COMPLETED|Study Period III (16-Weeks)||0
2954239|NCT00716274|3668406|FG001|NOT COMPLETED|Study Period III (16-Weeks)||0
2954240|NCT00716274|3668407|FG002|NOT COMPLETED|Study Period III (16-Weeks)||2
2954241|NCT00716274|3668408|FG003|NOT COMPLETED|Study Period III (16-Weeks)||1
2954242|NCT00716274|3668409|FG004|NOT COMPLETED|Study Period III (16-Weeks)||3
2954243|NCT00716274|3668410|FG005|NOT COMPLETED|Study Period III (16-Weeks)||0
2954244|NCT00716417|3668437|FG000|STARTED|Overall Study||3
2954245|NCT00716417|3668438|FG001|STARTED|Overall Study||6
2954246|NCT00716417|3668439|FG002|STARTED|Overall Study||5
2954247|NCT00716417|3668440|FG003|STARTED|Overall Study||11
2954248|NCT00716417|3668441|FG004|STARTED|Overall Study||1
2954249|NCT00716417|3668442|FG005|STARTED|Overall Study||3
2954250|NCT00716417|3668443|FG006|STARTED|Overall Study||7
2954251|NCT00716417|3668444|FG007|STARTED|Overall Study||3
2954252|NCT00716417|3668445|FG008|STARTED|Overall Study||5
2954253|NCT00716417|3668446|FG009|STARTED|Overall Study||3
2954254|NCT00716417|3668437|FG000|COMPLETED|Overall Study||0
2954255|NCT00716417|3668438|FG001|COMPLETED|Overall Study||0
2954256|NCT00716417|3668439|FG002|COMPLETED|Overall Study||0
2954257|NCT00716417|3668440|FG003|COMPLETED|Overall Study||0
2954258|NCT00716417|3668441|FG004|COMPLETED|Overall Study||0
2954259|NCT00716417|3668442|FG005|COMPLETED|Overall Study||0
2954260|NCT00716417|3668443|FG006|COMPLETED|Overall Study||0
2954261|NCT00716417|3668444|FG007|COMPLETED|Overall Study||0
2954262|NCT00716417|3668445|FG008|COMPLETED|Overall Study||0
2954263|NCT00716417|3668446|FG009|COMPLETED|Overall Study||0
2954264|NCT00716417|3668437|FG000|NOT COMPLETED|Overall Study||3
2954265|NCT00716417|3668438|FG001|NOT COMPLETED|Overall Study||6
2954266|NCT00716417|3668439|FG002|NOT COMPLETED|Overall Study||5
2954267|NCT00716417|3668440|FG003|NOT COMPLETED|Overall Study||11
2954268|NCT00716417|3668441|FG004|NOT COMPLETED|Overall Study||1
2954269|NCT00716417|3668442|FG005|NOT COMPLETED|Overall Study||3
2954270|NCT00716417|3668443|FG006|NOT COMPLETED|Overall Study||7
2954271|NCT00716417|3668444|FG007|NOT COMPLETED|Overall Study||3
2954272|NCT00716417|3668445|FG008|NOT COMPLETED|Overall Study||5
2954273|NCT00716417|3668446|FG009|NOT COMPLETED|Overall Study||3
2954274|NCT00716443|3668470|FG000|STARTED|Overall Study||51
2954275|NCT00716443|3668470|FG000|COMPLETED|Overall Study||51
2954276|NCT00716443|3668470|FG000|NOT COMPLETED|Overall Study||0
2954277|NCT00716456|3668478|FG000|STARTED|Overall Study||3
2954278|NCT00716456|3668479|FG001|STARTED|Overall Study||5
2954279|NCT00716456|3668480|FG002|STARTED|Overall Study||13
2954280|NCT00716456|3668478|FG000|COMPLETED|Overall Study||3
2954281|NCT00716456|3668479|FG001|COMPLETED|Overall Study||3
2954282|NCT00716456|3668480|FG002|COMPLETED|Overall Study||13
2954283|NCT00716456|3668478|FG000|NOT COMPLETED|Overall Study||0
2954284|NCT00716456|3668479|FG001|NOT COMPLETED|Overall Study||2
2954285|NCT00716456|3668480|FG002|NOT COMPLETED|Overall Study||0
2954286|NCT00716482|3668488|FG000|STARTED|Overall Study||1681
2954287|NCT00716482|3668488|FG000|COMPLETED|Overall Study||1562
2954288|NCT00716482|3668488|FG000|NOT COMPLETED|Overall Study||119
2954289|NCT00716586|3668498|FG000|STARTED|Overall Study||44
2954290|NCT00716586|3668498|FG000|COMPLETED|Overall Study||44
2954291|NCT00716586|3668498|FG000|NOT COMPLETED|Overall Study||0
2954292|NCT00716625|3668503|FG000|STARTED|Overall Study||1674
2954293|NCT00716625|3668503|FG000|COMPLETED|Overall Study||1673
2954294|NCT00716625|3668503|FG000|NOT COMPLETED|Overall Study||1
2954295|NCT00716742|3668524|FG000|STARTED|Baseline||364
2954296|NCT00716742|3668525|FG001|STARTED|Baseline||370
2954297|NCT00716742|3668526|FG002|STARTED|Baseline||365
2954298|NCT00716742|3668524|FG000|COMPLETED|Baseline||347
2954299|NCT00716742|3668525|FG001|COMPLETED|Baseline||356
2954300|NCT00716742|3668526|FG002|COMPLETED|Baseline||352
2954301|NCT00716742|3668524|FG000|NOT COMPLETED|Baseline||17
2954302|NCT00716742|3668525|FG001|NOT COMPLETED|Baseline||14
2954303|NCT00716742|3668526|FG002|NOT COMPLETED|Baseline||13
2954304|NCT00716742|3668524|FG000|STARTED|1 Year Follow-up||347
2954305|NCT00716742|3668525|FG001|STARTED|1 Year Follow-up||356
2954306|NCT00716742|3668526|FG002|STARTED|1 Year Follow-up||352
2954307|NCT00716742|3668524|FG000|COMPLETED|1 Year Follow-up||160
2954308|NCT00716742|3668525|FG001|COMPLETED|1 Year Follow-up||163
2954309|NCT00716742|3668526|FG002|COMPLETED|1 Year Follow-up||152
2954310|NCT00716742|3668524|FG000|NOT COMPLETED|1 Year Follow-up||187
2954311|NCT00716742|3668525|FG001|NOT COMPLETED|1 Year Follow-up||193
2954312|NCT00716742|3668526|FG002|NOT COMPLETED|1 Year Follow-up||200
2954313|NCT00716742|3668524|FG000|STARTED|2 Year Follow-up||160
2954314|NCT00716742|3668525|FG001|STARTED|2 Year Follow-up||163
2954315|NCT00716742|3668526|FG002|STARTED|2 Year Follow-up||152
2954316|NCT00716742|3668524|FG000|COMPLETED|2 Year Follow-up||56
2954317|NCT00716742|3668525|FG001|COMPLETED|2 Year Follow-up||67
2954318|NCT00716742|3668526|FG002|COMPLETED|2 Year Follow-up||50
2954319|NCT00716742|3668524|FG000|NOT COMPLETED|2 Year Follow-up||104
2954320|NCT00716742|3668525|FG001|NOT COMPLETED|2 Year Follow-up||96
2954321|NCT00716742|3668526|FG002|NOT COMPLETED|2 Year Follow-up||102
2954322|NCT00716742|3668524|FG000|STARTED|3 Year Follow-up||56
2954323|NCT00716742|3668525|FG001|STARTED|3 Year Follow-up||67
2954324|NCT00716742|3668526|FG002|STARTED|3 Year Follow-up||50
2954325|NCT00716742|3668524|FG000|COMPLETED|3 Year Follow-up||26
2954326|NCT00716742|3668525|FG001|COMPLETED|3 Year Follow-up||35
2954327|NCT00716742|3668526|FG002|COMPLETED|3 Year Follow-up||29
2954328|NCT00716742|3668524|FG000|NOT COMPLETED|3 Year Follow-up||30
2954329|NCT00716742|3668525|FG001|NOT COMPLETED|3 Year Follow-up||32
2954330|NCT00716742|3668526|FG002|NOT COMPLETED|3 Year Follow-up||21
2954331|NCT00716820|3668534|FG000|STARTED|Overall Study||472
2954332|NCT00716820|3668534|FG000|COMPLETED|Overall Study||472
2954333|NCT00716820|3668534|FG000|NOT COMPLETED|Overall Study||0
2954334|NCT00716859|3668561|FG000|STARTED|Overall Study||70
2954335|NCT00716859|3668562|FG001|STARTED|Overall Study||69
2954336|NCT00716859|3668561|FG000|Received Treatment|Overall Study||69
2954337|NCT00716859|3668562|FG001|Received Treatment|Overall Study||68
2954338|NCT00716859|3668561|FG000|COMPLETED|Overall Study||61
2954339|NCT00716859|3668562|FG001|COMPLETED|Overall Study||64
2954340|NCT00716859|3668561|FG000|NOT COMPLETED|Overall Study||9
2954341|NCT00716859|3668562|FG001|NOT COMPLETED|Overall Study||5
2954342|NCT00716963|3668568|FG000|STARTED|Overall Study||2
2954343|NCT00716963|3668569|FG001|STARTED|Overall Study||1
2954344|NCT00716963|3668570|FG002|STARTED|Overall Study||1
2954345|NCT00716963|3668571|FG003|STARTED|Overall Study||1
2954346|NCT00716963|3668572|FG004|STARTED|Overall Study||1
2954347|NCT00716963|3668573|FG005|STARTED|Overall Study||1
2954348|NCT00716963|3668568|FG000|COMPLETED|Overall Study||1
2954349|NCT00716963|3668569|FG001|COMPLETED|Overall Study||1
2954350|NCT00716963|3668570|FG002|COMPLETED|Overall Study||1
2954351|NCT00716963|3668571|FG003|COMPLETED|Overall Study||1
2954352|NCT00716963|3668572|FG004|COMPLETED|Overall Study||1
2954353|NCT00716963|3668573|FG005|COMPLETED|Overall Study||1
2954354|NCT00716963|3668568|FG000|NOT COMPLETED|Overall Study||1
2954355|NCT00716963|3668569|FG001|NOT COMPLETED|Overall Study||0
2954356|NCT00716963|3668570|FG002|NOT COMPLETED|Overall Study||0
2954357|NCT00716963|3668571|FG003|NOT COMPLETED|Overall Study||0
2954358|NCT00716963|3668572|FG004|NOT COMPLETED|Overall Study||0
2954359|NCT00716963|3668573|FG005|NOT COMPLETED|Overall Study||0
2954360|NCT00716976|3668583|FG000|STARTED|Overall Study||65
2954361|NCT00716976|3668584|FG001|STARTED|Overall Study||66
2954362|NCT00716976|3668583|FG000|COMPLETED|Overall Study||45
2954363|NCT00716976|3668584|FG001|COMPLETED|Overall Study||57
2954364|NCT00716976|3668583|FG000|NOT COMPLETED|Overall Study||20
2954365|NCT00716976|3668584|FG001|NOT COMPLETED|Overall Study||9
2954366|NCT00717041|3668592|FG000|STARTED|Overall Study||1206
2954367|NCT00717041|3668592|FG000|COMPLETED|Overall Study||1206
2954368|NCT00717041|3668592|FG000|NOT COMPLETED|Overall Study||0
2954369|NCT00717054|3668600|FG000|STARTED|Overall Study||58
2954370|NCT00717054|3668601|FG001|STARTED|Overall Study||57
2954371|NCT00717054|3668600|FG000|COMPLETED|Overall Study||58
2954372|NCT00717054|3668601|FG001|COMPLETED|Overall Study||57
2954373|NCT00717054|3668600|FG000|NOT COMPLETED|Overall Study||0
2954374|NCT00717054|3668601|FG001|NOT COMPLETED|Overall Study||0
2954375|NCT00717067|3668613|FG000|STARTED|Part 1a: Normal/Mild/Moderate Group||6
2954376|NCT00717067|3668614|FG001|STARTED|Part 1a: Normal/Mild/Moderate Group||6
2954377|NCT00717067|3668615|FG002|STARTED|Part 1a: Normal/Mild/Moderate Group||6
2954378|NCT00717067|3668616|FG003|STARTED|Part 1a: Normal/Mild/Moderate Group||0
2954379|NCT00717067|3668617|FG004|STARTED|Part 1a: Normal/Mild/Moderate Group||0
2954380|NCT00717067|3668613|FG000|COMPLETED|Part 1a: Normal/Mild/Moderate Group||6
2954381|NCT00717067|3668614|FG001|COMPLETED|Part 1a: Normal/Mild/Moderate Group||6
2954382|NCT00717067|3668615|FG002|COMPLETED|Part 1a: Normal/Mild/Moderate Group||5
2954383|NCT00717067|3668616|FG003|COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
2954384|NCT00717067|3668617|FG004|COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
2954385|NCT00717067|3668613|FG000|NOT COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
2954386|NCT00717067|3668614|FG001|NOT COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
2954387|NCT00717067|3668615|FG002|NOT COMPLETED|Part 1a: Normal/Mild/Moderate Group||1
2954388|NCT00717067|3668616|FG003|NOT COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
2954389|NCT00717067|3668617|FG004|NOT COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
2954390|NCT00717067|3668613|FG000|STARTED|Part 1b: Severe Renal Impairment||0
2954391|NCT00717067|3668614|FG001|STARTED|Part 1b: Severe Renal Impairment||0
2954392|NCT00717067|3668615|FG002|STARTED|Part 1b: Severe Renal Impairment||0
2954393|NCT00717067|3668616|FG003|STARTED|Part 1b: Severe Renal Impairment||6
2954394|NCT00717067|3668617|FG004|STARTED|Part 1b: Severe Renal Impairment||0
2954395|NCT00717067|3668613|FG000|COMPLETED|Part 1b: Severe Renal Impairment||0
2954396|NCT00717067|3668614|FG001|COMPLETED|Part 1b: Severe Renal Impairment||0
2954397|NCT00717067|3668615|FG002|COMPLETED|Part 1b: Severe Renal Impairment||0
2954398|NCT00717067|3668616|FG003|COMPLETED|Part 1b: Severe Renal Impairment||6
2954399|NCT00717067|3668617|FG004|COMPLETED|Part 1b: Severe Renal Impairment||0
2954400|NCT00717067|3668613|FG000|NOT COMPLETED|Part 1b: Severe Renal Impairment||0
2954401|NCT00717067|3668614|FG001|NOT COMPLETED|Part 1b: Severe Renal Impairment||0
2954402|NCT00717067|3668615|FG002|NOT COMPLETED|Part 1b: Severe Renal Impairment||0
2954403|NCT00717067|3668616|FG003|NOT COMPLETED|Part 1b: Severe Renal Impairment||0
2954404|NCT00717067|3668617|FG004|NOT COMPLETED|Part 1b: Severe Renal Impairment||0
2954405|NCT00717067|3668613|FG000|STARTED|Part 2: End Stage Renal Disease||0
2954406|NCT00717067|3668614|FG001|STARTED|Part 2: End Stage Renal Disease||0
2954407|NCT00717067|3668615|FG002|STARTED|Part 2: End Stage Renal Disease||0
2954408|NCT00717067|3668616|FG003|STARTED|Part 2: End Stage Renal Disease||0
2954409|NCT00717067|3668617|FG004|STARTED|Part 2: End Stage Renal Disease||6
2954410|NCT00717067|3668613|FG000|COMPLETED|Part 2: End Stage Renal Disease||0
2954411|NCT00717067|3668614|FG001|COMPLETED|Part 2: End Stage Renal Disease||0
2954412|NCT00717067|3668615|FG002|COMPLETED|Part 2: End Stage Renal Disease||0
2954413|NCT00717067|3668616|FG003|COMPLETED|Part 2: End Stage Renal Disease||0
2954414|NCT00717067|3668617|FG004|COMPLETED|Part 2: End Stage Renal Disease||6
2954415|NCT00717067|3668613|FG000|NOT COMPLETED|Part 2: End Stage Renal Disease||0
2954416|NCT00717067|3668614|FG001|NOT COMPLETED|Part 2: End Stage Renal Disease||0
2954417|NCT00717067|3668615|FG002|NOT COMPLETED|Part 2: End Stage Renal Disease||0
2954418|NCT00717067|3668616|FG003|NOT COMPLETED|Part 2: End Stage Renal Disease||0
2954419|NCT00717067|3668617|FG004|NOT COMPLETED|Part 2: End Stage Renal Disease||0
2954420|NCT00717093|3668641|FG000|STARTED|Overall Study||214
2954421|NCT00717093|3668642|FG001|STARTED|Overall Study||218
2954422|NCT00717093|3668641|FG000|Received Treatment|Overall Study||213
2954423|NCT00717093|3668642|FG001|Received Treatment|Overall Study||218
2954424|NCT00717093|3668641|FG000|COMPLETED|Overall Study||170
2954425|NCT00717093|3668642|FG001|COMPLETED|Overall Study||170
2954426|NCT00717093|3668641|FG000|NOT COMPLETED|Overall Study||44
2954427|NCT00717093|3668642|FG001|NOT COMPLETED|Overall Study||48
2954428|NCT00717197|3668648|FG000|STARTED|Overall Study||30
2954429|NCT00717197|3668648|FG000|COMPLETED|Overall Study||23
2954430|NCT00717197|3668648|FG000|NOT COMPLETED|Overall Study||7
2954431|NCT00717236|3668654|FG000|STARTED|Double-Blind Period||851
2954432|NCT00717236|3668655|FG001|STARTED|Double-Blind Period||212
2954433|NCT00717236|3668654|FG000|COMPLETED|Double-Blind Period||771
2954434|NCT00717236|3668655|FG001|COMPLETED|Double-Blind Period||184
2954435|NCT00717236|3668654|FG000|NOT COMPLETED|Double-Blind Period||80
2954436|NCT00717236|3668655|FG001|NOT COMPLETED|Double-Blind Period||28
2954437|NCT00717236|3668654|FG000|STARTED|Open-Label Period||771
2954438|NCT00717236|3668655|FG001|STARTED|Open-Label Period||184
2954439|NCT00717236|3668654|FG000|COMPLETED|Open-Label Period||646
2954440|NCT00717236|3668655|FG001|COMPLETED|Open-Label Period||163
2954441|NCT00717236|3668654|FG000|NOT COMPLETED|Open-Label Period||125
2954442|NCT00717236|3668655|FG001|NOT COMPLETED|Open-Label Period||21
2954443|NCT00717249|3668665|FG000|STARTED|Overall Study||326
2954444|NCT00717249|3668666|FG001|STARTED|Overall Study||165
2954445|NCT00717249|3668665|FG000|COMPLETED|Overall Study||304
2954446|NCT00717249|3668666|FG001|COMPLETED|Overall Study||150
2954447|NCT00717249|3668665|FG000|NOT COMPLETED|Overall Study||22
2954448|NCT00717249|3668666|FG001|NOT COMPLETED|Overall Study||15
2954449|NCT00717288|3668675|FG000|STARTED|Overall Study||28
2954450|NCT00717288|3668676|FG001|STARTED|Overall Study||29
2954451|NCT00717288|3668677|FG002|STARTED|Overall Study||25
2954452|NCT00717288|3668675|FG000|COMPLETED|Overall Study||28
2954453|NCT00717288|3668676|FG001|COMPLETED|Overall Study||29
2954454|NCT00717288|3668677|FG002|COMPLETED|Overall Study||25
2954455|NCT00717288|3668675|FG000|NOT COMPLETED|Overall Study||0
2954456|NCT00717288|3668676|FG001|NOT COMPLETED|Overall Study||0
2954457|NCT00717288|3668677|FG002|NOT COMPLETED|Overall Study||0
2954458|NCT00717314|3668693|FG000|STARTED|Overall Study||43
2954459|NCT00717314|3668694|FG001|STARTED|Overall Study||44
2954460|NCT00717314|3668693|FG000|COMPLETED|Overall Study||37
2954461|NCT00717314|3668694|FG001|COMPLETED|Overall Study||34
2954462|NCT00717314|3668693|FG000|NOT COMPLETED|Overall Study||6
2954463|NCT00717314|3668694|FG001|NOT COMPLETED|Overall Study||10
2954464|NCT00717366|3668702|FG000|STARTED|Core Study Period (20 Weeks)||16
2954465|NCT00717366|3668703|FG001|STARTED|Core Study Period (20 Weeks)||48
2954466|NCT00717366|3668702|FG000|COMPLETED|Core Study Period (20 Weeks)||12
2954467|NCT00717366|3668703|FG001|COMPLETED|Core Study Period (20 Weeks)||35
2954468|NCT00717366|3668702|FG000|NOT COMPLETED|Core Study Period (20 Weeks)||4
2954469|NCT00717366|3668703|FG001|NOT COMPLETED|Core Study Period (20 Weeks)||13
2954470|NCT00717366|3668702|FG000|STARTED|Extension Period (52 Weeks)||9
2954471|NCT00717366|3668703|FG001|STARTED|Extension Period (52 Weeks)||28
2954472|NCT00717366|3668702|FG000|Received Visit/Week 21 Dose|Extension Period (52 Weeks)||8
2954473|NCT00717366|3668703|FG001|Received Visit/Week 21 Dose|Extension Period (52 Weeks)||28
2954474|NCT00717366|3668702|FG000|COMPLETED|Extension Period (52 Weeks)||5
2954475|NCT00717366|3668703|FG001|COMPLETED|Extension Period (52 Weeks)||12
2954476|NCT00717366|3668702|FG000|NOT COMPLETED|Extension Period (52 Weeks)||4
2954477|NCT00717366|3668703|FG001|NOT COMPLETED|Extension Period (52 Weeks)||16
2954478|NCT00717405|3668709|FG000|STARTED|Overall Study||52
2954479|NCT00717405|3668709|FG000|COMPLETED|Overall Study||52
2954480|NCT00717405|3668709|FG000|NOT COMPLETED|Overall Study||0
2954481|NCT00717418|3668717|FG000|STARTED|Baseline||180
2954482|NCT00717418|3668718|FG001|STARTED|Baseline||74
2954483|NCT00717418|3668719|FG002|STARTED|Baseline||508
2954484|NCT00717418|3668720|FG003|STARTED|Baseline||19
2954485|NCT00717418|3668717|FG000|COMPLETED|Baseline||180
2954486|NCT00717418|3668718|FG001|COMPLETED|Baseline||74
2954487|NCT00717418|3668719|FG002|COMPLETED|Baseline||508
2954488|NCT00717418|3668720|FG003|COMPLETED|Baseline||4
2954489|NCT00717418|3668717|FG000|NOT COMPLETED|Baseline||0
2954490|NCT00717418|3668718|FG001|NOT COMPLETED|Baseline||0
2954491|NCT00717418|3668719|FG002|NOT COMPLETED|Baseline||0
2954492|NCT00717418|3668720|FG003|NOT COMPLETED|Baseline||15
2954493|NCT00717418|3668717|FG000|STARTED|1-Year Follow-Up||180
2954494|NCT00717418|3668718|FG001|STARTED|1-Year Follow-Up||74
2954495|NCT00717418|3668719|FG002|STARTED|1-Year Follow-Up||508
2954496|NCT00717418|3668720|FG003|STARTED|1-Year Follow-Up||4
2954497|NCT00717418|3668717|FG000|COMPLETED|1-Year Follow-Up||33
2954498|NCT00717418|3668718|FG001|COMPLETED|1-Year Follow-Up||23
2954499|NCT00717418|3668719|FG002|COMPLETED|1-Year Follow-Up||74
2954500|NCT00717418|3668720|FG003|COMPLETED|1-Year Follow-Up||0
2954501|NCT00717418|3668717|FG000|NOT COMPLETED|1-Year Follow-Up||147
2954502|NCT00717418|3668718|FG001|NOT COMPLETED|1-Year Follow-Up||51
2954503|NCT00717418|3668719|FG002|NOT COMPLETED|1-Year Follow-Up||434
2954504|NCT00717418|3668720|FG003|NOT COMPLETED|1-Year Follow-Up||4
2954505|NCT00717522|3668724|FG000|STARTED|Overall Study||7
2954506|NCT00717522|3668724|FG000|COMPLETED|Overall Study||0
2954507|NCT00717522|3668724|FG000|NOT COMPLETED|Overall Study||7
2954508|NCT00717574|3668730|FG000|STARTED|Overall Study||16
2954509|NCT00717574|3668731|FG001|STARTED|Overall Study||16
2954510|NCT00717574|3668730|FG000|COMPLETED|Overall Study||14
2954511|NCT00717574|3668731|FG001|COMPLETED|Overall Study||14
2954512|NCT00717574|3668730|FG000|NOT COMPLETED|Overall Study||2
2954513|NCT00717574|3668731|FG001|NOT COMPLETED|Overall Study||2
2954514|NCT00717626|3668737|FG000|STARTED|Overall Study||14
2954515|NCT00717626|3668737|FG000|COMPLETED|Overall Study||14
2954516|NCT00717626|3668737|FG000|NOT COMPLETED|Overall Study||0
2954517|NCT00717756|3668741|FG000|STARTED|Overall Study||41
2954518|NCT00717756|3668741|FG000|COMPLETED|Overall Study||40
2954519|NCT00717756|3668741|FG000|NOT COMPLETED|Overall Study||1
2954520|NCT00717769|3668748|FG000|STARTED|Overall Study||120
2954521|NCT00717769|3668749|FG001|STARTED|Overall Study||120
2954522|NCT00717769|3668750|FG002|STARTED|Overall Study||30
2954523|NCT00717769|3668748|FG000|COMPLETED|Overall Study||104
2954524|NCT00717769|3668749|FG001|COMPLETED|Overall Study||102
2954525|NCT00717769|3668750|FG002|COMPLETED|Overall Study||19
2954526|NCT00717769|3668748|FG000|NOT COMPLETED|Overall Study||16
2954527|NCT00717769|3668749|FG001|NOT COMPLETED|Overall Study||18
2954528|NCT00717769|3668750|FG002|NOT COMPLETED|Overall Study||11
2954529|NCT00717860|3668762|FG000|STARTED|Overall Study||61
2954530|NCT00717860|3668763|FG001|STARTED|Overall Study||60
2954531|NCT00717860|3668762|FG000|COMPLETED|Overall Study||34
2954532|NCT00717860|3668763|FG001|COMPLETED|Overall Study||32
2954533|NCT00717860|3668762|FG000|NOT COMPLETED|Overall Study||27
2954534|NCT00717860|3668763|FG001|NOT COMPLETED|Overall Study||28
2954535|NCT00717873|3668771|FG000|STARTED|Overall Study||46
2954536|NCT00717873|3668772|FG001|STARTED|Overall Study||59
2954537|NCT00717873|3668771|FG000|COMPLETED|Overall Study||46
2954538|NCT00717873|3668772|FG001|COMPLETED|Overall Study||59
2954539|NCT00717873|3668771|FG000|NOT COMPLETED|Overall Study||0
2954540|NCT00717873|3668772|FG001|NOT COMPLETED|Overall Study||0
2954541|NCT00717886|3668778|FG000|STARTED|Overall Study||13
2954542|NCT00717886|3668778|FG000|COMPLETED|Overall Study||9
2954543|NCT00717886|3668778|FG000|NOT COMPLETED|Overall Study||4
2954544|NCT00717912|3668782|FG000|STARTED|Overall Study||1
2954545|NCT00717912|3668783|FG001|STARTED|Overall Study||1
2954546|NCT00717912|3668784|FG002|STARTED|Overall Study||1
2954547|NCT00717912|3668785|FG003|STARTED|Overall Study||1
2954548|NCT00717912|3668786|FG004|STARTED|Overall Study||1
2954549|NCT00717912|3668787|FG005|STARTED|Overall Study||1
2954550|NCT00717912|3668782|FG000|COMPLETED|Overall Study||1
2954551|NCT00717912|3668783|FG001|COMPLETED|Overall Study||1
2954552|NCT00717912|3668784|FG002|COMPLETED|Overall Study||1
2954553|NCT00717912|3668785|FG003|COMPLETED|Overall Study||1
2954554|NCT00717912|3668786|FG004|COMPLETED|Overall Study||1
2954555|NCT00717912|3668787|FG005|COMPLETED|Overall Study||1
2954556|NCT00717912|3668782|FG000|NOT COMPLETED|Overall Study||0
2954557|NCT00717912|3668783|FG001|NOT COMPLETED|Overall Study||0
2954558|NCT00717912|3668784|FG002|NOT COMPLETED|Overall Study||0
2954559|NCT00717912|3668785|FG003|NOT COMPLETED|Overall Study||0
2954560|NCT00717912|3668786|FG004|NOT COMPLETED|Overall Study||0
2954561|NCT00717912|3668787|FG005|NOT COMPLETED|Overall Study||0
2954562|NCT00717977|3668796|FG000|STARTED|Overall Study||74
2954563|NCT00717977|3668796|FG000|COMPLETED|Overall Study||74
2954564|NCT00717977|3668796|FG000|NOT COMPLETED|Overall Study||0
2954565|NCT00718042|3668806|FG000|STARTED|ABBOTT PRISM Chagas Testing||16313
2954566|NCT00718042|3668807|FG001|STARTED|ABBOTT PRISM Chagas Testing||289
2954567|NCT00718042|3668808|FG002|STARTED|ABBOTT PRISM Chagas Testing||525
2954568|NCT00718042|3668809|FG003|STARTED|ABBOTT PRISM Chagas Testing||110
2954569|NCT00718042|3668810|FG004|STARTED|ABBOTT PRISM Chagas Testing||25549
2954570|NCT00718042|3668811|FG005|STARTED|ABBOTT PRISM Chagas Testing|Specimens not screened with PRISM Chagas assay per protocol.|0
2954571|NCT00718042|3668806|FG000|COMPLETED|ABBOTT PRISM Chagas Testing||16249
2954572|NCT00718042|3668807|FG001|COMPLETED|ABBOTT PRISM Chagas Testing||287
2954573|NCT00718042|3668808|FG002|COMPLETED|ABBOTT PRISM Chagas Testing||524
2954574|NCT00718042|3668809|FG003|COMPLETED|ABBOTT PRISM Chagas Testing||110
2954575|NCT00718042|3668810|FG004|COMPLETED|ABBOTT PRISM Chagas Testing||25511
2954576|NCT00718042|3668811|FG005|COMPLETED|ABBOTT PRISM Chagas Testing||0
2954577|NCT00718042|3668806|FG000|NOT COMPLETED|ABBOTT PRISM Chagas Testing||64
2954578|NCT00718042|3668807|FG001|NOT COMPLETED|ABBOTT PRISM Chagas Testing||2
2954579|NCT00718042|3668808|FG002|NOT COMPLETED|ABBOTT PRISM Chagas Testing||1
2954580|NCT00718042|3668809|FG003|NOT COMPLETED|ABBOTT PRISM Chagas Testing||0
2954581|NCT00718042|3668810|FG004|NOT COMPLETED|ABBOTT PRISM Chagas Testing||38
2954582|NCT00718042|3668811|FG005|NOT COMPLETED|ABBOTT PRISM Chagas Testing||0
2954583|NCT00718042|3668806|FG000|STARTED|ESA Chagas Testing|Only specimens repeatedly reactive by screening assay or PRISM grayzone tested with ESA Chagas|36
2954584|NCT00718042|3668807|FG001|STARTED|ESA Chagas Testing||287
2954585|NCT00718042|3668808|FG002|STARTED|ESA Chagas Testing||524
2954586|NCT00718042|3668809|FG003|STARTED|ESA Chagas Testing||110
2954587|NCT00718042|3668810|FG004|STARTED|ESA Chagas Testing|Only specimens repeatedly reactive by screening assay or PRISM grayzone tested with ESA Chagas|43
2954588|NCT00718042|3668811|FG005|STARTED|ESA Chagas Testing|Specimens only tested with ESA Chagas|330
2954589|NCT00718042|3668806|FG000|COMPLETED|ESA Chagas Testing||36
2954590|NCT00718042|3668807|FG001|COMPLETED|ESA Chagas Testing||287
2954591|NCT00718042|3668808|FG002|COMPLETED|ESA Chagas Testing||524
2954592|NCT00718042|3668809|FG003|COMPLETED|ESA Chagas Testing||110
2954593|NCT00718042|3668810|FG004|COMPLETED|ESA Chagas Testing||43
2954594|NCT00718042|3668811|FG005|COMPLETED|ESA Chagas Testing||330
2954595|NCT00718042|3668806|FG000|NOT COMPLETED|ESA Chagas Testing||0
2954596|NCT00718042|3668807|FG001|NOT COMPLETED|ESA Chagas Testing||0
2954597|NCT00718042|3668808|FG002|NOT COMPLETED|ESA Chagas Testing||0
2954598|NCT00718042|3668809|FG003|NOT COMPLETED|ESA Chagas Testing||0
2954599|NCT00718042|3668810|FG004|NOT COMPLETED|ESA Chagas Testing||0
2954600|NCT00718042|3668811|FG005|NOT COMPLETED|ESA Chagas Testing||0
2954601|NCT00718042|3668806|FG000|STARTED|Donor Follow-up||36
2954602|NCT00718042|3668807|FG001|STARTED|Donor Follow-up|Follow-up not performed for this specimen population.|0
2954603|NCT00718042|3668808|FG002|STARTED|Donor Follow-up|Follow-up not performed for this specimen population.|0
2954604|NCT00718042|3668809|FG003|STARTED|Donor Follow-up|Follow-up not performed for this specimen population.|0
2954605|NCT00718042|3668810|FG004|STARTED|Donor Follow-up||43
3300396|NCT02945410|4034310|FG002|NOT COMPLETED|Washout 1 (14 Days)||2
3300397|NCT02945410|4034311|FG003|NOT COMPLETED|Washout 1 (14 Days)||0
3300398|NCT02945410|4034312|FG004|NOT COMPLETED|Washout 1 (14 Days)||1
3300399|NCT02945410|4034313|FG005|NOT COMPLETED|Washout 1 (14 Days)||0
3300400|NCT02945410|4034308|FG000|STARTED|Intervention 2 (5 Days)||2
3300401|NCT02945410|4034309|FG001|STARTED|Intervention 2 (5 Days)||1
3300402|NCT02945410|4034310|FG002|STARTED|Intervention 2 (5 Days)||0
3300403|NCT02945410|4034311|FG003|STARTED|Intervention 2 (5 Days)||3
3300404|NCT02945410|4034312|FG004|STARTED|Intervention 2 (5 Days)||1
3300405|NCT02945410|4034313|FG005|STARTED|Intervention 2 (5 Days)||0
3300406|NCT02945410|4034308|FG000|COMPLETED|Intervention 2 (5 Days)||2
3300407|NCT02945410|4034309|FG001|COMPLETED|Intervention 2 (5 Days)||1
3300408|NCT02945410|4034310|FG002|COMPLETED|Intervention 2 (5 Days)||0
3300409|NCT02945410|4034311|FG003|COMPLETED|Intervention 2 (5 Days)||3
3300410|NCT02945410|4034312|FG004|COMPLETED|Intervention 2 (5 Days)||1
3300411|NCT02945410|4034313|FG005|COMPLETED|Intervention 2 (5 Days)||0
3300412|NCT02945410|4034308|FG000|NOT COMPLETED|Intervention 2 (5 Days)||0
3300413|NCT02945410|4034309|FG001|NOT COMPLETED|Intervention 2 (5 Days)||0
3300414|NCT02945410|4034310|FG002|NOT COMPLETED|Intervention 2 (5 Days)||0
3300415|NCT02945410|4034311|FG003|NOT COMPLETED|Intervention 2 (5 Days)||0
3300416|NCT02945410|4034312|FG004|NOT COMPLETED|Intervention 2 (5 Days)||0
3300417|NCT02945410|4034313|FG005|NOT COMPLETED|Intervention 2 (5 Days)||0
2954606|NCT00718042|3668811|FG005|STARTED|Donor Follow-up|Follow-up not performed for this specimen population.|0
2954607|NCT00718042|3668806|FG000|COMPLETED|Donor Follow-up||23
2954608|NCT00718042|3668807|FG001|COMPLETED|Donor Follow-up||0
2954609|NCT00718042|3668808|FG002|COMPLETED|Donor Follow-up||0
2954610|NCT00718042|3668809|FG003|COMPLETED|Donor Follow-up||0
2954611|NCT00718042|3668810|FG004|COMPLETED|Donor Follow-up||24
2954612|NCT00718042|3668811|FG005|COMPLETED|Donor Follow-up||0
2954613|NCT00718042|3668806|FG000|NOT COMPLETED|Donor Follow-up||13
2954614|NCT00718042|3668807|FG001|NOT COMPLETED|Donor Follow-up||0
2954615|NCT00718042|3668808|FG002|NOT COMPLETED|Donor Follow-up||0
2954616|NCT00718042|3668809|FG003|NOT COMPLETED|Donor Follow-up||0
2954617|NCT00718042|3668810|FG004|NOT COMPLETED|Donor Follow-up||19
2954618|NCT00718042|3668811|FG005|NOT COMPLETED|Donor Follow-up||0
2954619|NCT00718081|3668826|FG000|STARTED|Overall Study||29
2954620|NCT00718081|3668827|FG001|STARTED|Overall Study||29
2954621|NCT00718081|3668828|FG002|STARTED|Overall Study||30
2954622|NCT00718081|3668826|FG000|COMPLETED|Overall Study||22
2954623|NCT00718081|3668827|FG001|COMPLETED|Overall Study||25
2954624|NCT00718081|3668828|FG002|COMPLETED|Overall Study||9
2954625|NCT00718081|3668826|FG000|NOT COMPLETED|Overall Study||7
2954626|NCT00718081|3668827|FG001|NOT COMPLETED|Overall Study||4
2954627|NCT00718081|3668828|FG002|NOT COMPLETED|Overall Study||21
2954628|NCT00718094|3668838|FG000|STARTED|Overall Study||15
2954629|NCT00718094|3668839|FG001|STARTED|Overall Study||5
2954630|NCT00718094|3668838|FG000|COMPLETED|Overall Study||15
2954631|NCT00718094|3668839|FG001|COMPLETED|Overall Study||5
2954632|NCT00718094|3668838|FG000|NOT COMPLETED|Overall Study||0
2954633|NCT00718094|3668839|FG001|NOT COMPLETED|Overall Study||0
2954634|NCT00718120|3668847|FG000|STARTED|Overall Study||55
2954635|NCT00718120|3668848|FG001|STARTED|Overall Study||55
2954636|NCT00718120|3668847|FG000|COMPLETED|Overall Study||55
2954637|NCT00718120|3668848|FG001|COMPLETED|Overall Study||55
2954638|NCT00718120|3668847|FG000|NOT COMPLETED|Overall Study||0
2954639|NCT00718120|3668848|FG001|NOT COMPLETED|Overall Study||0
2954640|NCT00718159|3668861|FG000|STARTED|Overall Study||3
2954641|NCT00718159|3668862|FG001|STARTED|Overall Study||3
2954642|NCT00718159|3668863|FG002|STARTED|Overall Study||3
2954643|NCT00718159|3668864|FG003|STARTED|Overall Study||4
2954644|NCT00718159|3668865|FG004|STARTED|Overall Study||8
2954645|NCT00718159|3668866|FG005|STARTED|Overall Study||1
2954646|NCT00718159|3668867|FG006|STARTED|Overall Study||1
2954647|NCT00718159|3668861|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
2954648|NCT00718159|3668862|FG001|Received at Least 1 Dose of Study Drug|Overall Study||3
2954649|NCT00718159|3668863|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3
2954650|NCT00718159|3668864|FG003|Received at Least 1 Dose of Study Drug|Overall Study||4
2954651|NCT00718159|3668865|FG004|Received at Least 1 Dose of Study Drug|Overall Study||8
2954652|NCT00718159|3668866|FG005|Received at Least 1 Dose of Study Drug|Overall Study||1
2954653|NCT00718159|3668867|FG006|Received at Least 1 Dose of Study Drug|Overall Study||1
2954654|NCT00718159|3668861|FG000|COMPLETED|Overall Study||0
2954655|NCT00718159|3668862|FG001|COMPLETED|Overall Study||0
2954656|NCT00718159|3668863|FG002|COMPLETED|Overall Study||0
2954657|NCT00718159|3668864|FG003|COMPLETED|Overall Study||0
2954658|NCT00718159|3668865|FG004|COMPLETED|Overall Study||0
2954659|NCT00718159|3668866|FG005|COMPLETED|Overall Study||0
2954660|NCT00718159|3668867|FG006|COMPLETED|Overall Study||0
2954661|NCT00718159|3668861|FG000|NOT COMPLETED|Overall Study||3
2954662|NCT00718159|3668862|FG001|NOT COMPLETED|Overall Study||3
2954663|NCT00718159|3668863|FG002|NOT COMPLETED|Overall Study||3
3300418|NCT02945410|4034308|FG000|STARTED|Washout 2 (14 Days)||2
2954664|NCT00718159|3668864|FG003|NOT COMPLETED|Overall Study||4
2954665|NCT00718159|3668865|FG004|NOT COMPLETED|Overall Study||8
2954666|NCT00718159|3668866|FG005|NOT COMPLETED|Overall Study||1
2954667|NCT00718159|3668867|FG006|NOT COMPLETED|Overall Study||1
2954668|NCT00718237|3668885|FG000|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized into the study|381
2954669|NCT00718237|3668886|FG001|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized into the study|381
2954670|NCT00718237|3668885|FG000|Vaccinated at Visit 1|Overall Study||380
2954671|NCT00718237|3668886|FG001|Vaccinated at Visit 1|Overall Study||381
2954672|NCT00718237|3668885|FG000|Vaccinated at Visit 2|Overall Study||373
2954673|NCT00718237|3668886|FG001|Vaccinated at Visit 2|Overall Study||374
2954674|NCT00718237|3668885|FG000|Vaccinated at Visit 3|Overall Study||371
3132664|NCT01692301|3857815|FG000|STARTED|Overall Study|"Started indicates patients in randomized, full analysis and safety set"|229
3132665|NCT01692301|3857816|FG001|STARTED|Overall Study||225
3132666|NCT01692301|3857815|FG000|COMPLETED|Overall Study||184
2954675|NCT00718237|3668886|FG001|Vaccinated at Visit 3|Overall Study||369
2954676|NCT00718237|3668885|FG000|COMPLETED|Overall Study|Subjects who continued follow-up until the last visit, regardless of number of vaccinations received|368
2954677|NCT00718237|3668886|FG001|COMPLETED|Overall Study|Subjects who continued follow-up until the last visit, regardless of number of vaccinations received|366
2954678|NCT00718237|3668885|FG000|NOT COMPLETED|Overall Study||13
2954679|NCT00718237|3668886|FG001|NOT COMPLETED|Overall Study||15
2954680|NCT00718302|3668896|FG000|STARTED|Overall Study||119
2954681|NCT00718302|3668897|FG001|STARTED|Overall Study||114
2954682|NCT00718302|3668896|FG000|COMPLETED|Overall Study||119
2954683|NCT00718302|3668897|FG001|COMPLETED|Overall Study||114
2954684|NCT00718302|3668896|FG000|NOT COMPLETED|Overall Study||0
2954685|NCT00718302|3668897|FG001|NOT COMPLETED|Overall Study||0
2954686|NCT00718315|3668908|FG000|STARTED|Overall Study||67
2954687|NCT00718315|3668909|FG001|STARTED|Overall Study||67
2954688|NCT00718315|3668910|FG002|STARTED|Overall Study||67
2954689|NCT00718315|3668908|FG000|COMPLETED|Overall Study||48
2954690|NCT00718315|3668909|FG001|COMPLETED|Overall Study||45
2954691|NCT00718315|3668910|FG002|COMPLETED|Overall Study||46
2954692|NCT00718315|3668908|FG000|NOT COMPLETED|Overall Study||19
2954693|NCT00718315|3668909|FG001|NOT COMPLETED|Overall Study||22
2954694|NCT00718315|3668910|FG002|NOT COMPLETED|Overall Study||21
2954695|NCT00718328|3668920|FG000|STARTED|Overall Study||1
2954696|NCT00718328|3668921|FG001|STARTED|Overall Study||0
2954697|NCT00718328|3668920|FG000|COMPLETED|Overall Study|Prematurely terminated due to poor enrollment|0
2954698|NCT00718328|3668921|FG001|COMPLETED|Overall Study|Terminated due to poor enrollment|0
2954699|NCT00718328|3668920|FG000|NOT COMPLETED|Overall Study||1
2954700|NCT00718328|3668921|FG001|NOT COMPLETED|Overall Study||0
2954701|NCT00718419|3668929|FG000|STARTED|Overall Study||14
2954702|NCT00718419|3668930|FG001|STARTED|Overall Study||42
2954703|NCT00718419|3668929|FG000|Received at Least One Dose of Study Drug|Overall Study||14
2954704|NCT00718419|3668930|FG001|Received at Least One Dose of Study Drug|Overall Study||42
2954705|NCT00718419|3668929|FG000|COMPLETED|Overall Study|Participants who completed 8 cycles of treatment.|1
2954706|NCT00718419|3668930|FG001|COMPLETED|Overall Study|Participants who completed 8 cycles of treatment.|3
2954707|NCT00718419|3668929|FG000|NOT COMPLETED|Overall Study||13
2954708|NCT00718419|3668930|FG001|NOT COMPLETED|Overall Study||39
2954709|NCT00718510|3668938|FG000|STARTED|First Intervention (3 Weeks)||7
2954710|NCT00718510|3668939|FG001|STARTED|First Intervention (3 Weeks)||8
2954711|NCT00718510|3668938|FG000|Received Intervention|First Intervention (3 Weeks)||7
2954712|NCT00718510|3668939|FG001|Received Intervention|First Intervention (3 Weeks)||7
2954713|NCT00718510|3668938|FG000|COMPLETED|First Intervention (3 Weeks)||7
2954714|NCT00718510|3668939|FG001|COMPLETED|First Intervention (3 Weeks)||7
2954715|NCT00718510|3668938|FG000|NOT COMPLETED|First Intervention (3 Weeks)||0
2954716|NCT00718510|3668939|FG001|NOT COMPLETED|First Intervention (3 Weeks)||1
2954717|NCT00718510|3668938|FG000|STARTED|Washout (5 Days)||7
2954718|NCT00718510|3668939|FG001|STARTED|Washout (5 Days)||7
2954719|NCT00718510|3668938|FG000|COMPLETED|Washout (5 Days)||7
2954720|NCT00718510|3668939|FG001|COMPLETED|Washout (5 Days)||7
2954721|NCT00718510|3668938|FG000|NOT COMPLETED|Washout (5 Days)||0
2954722|NCT00718510|3668939|FG001|NOT COMPLETED|Washout (5 Days)||0
2954723|NCT00718510|3668938|FG000|STARTED|Second Intervention (3 Weeks)||7
2954724|NCT00718510|3668939|FG001|STARTED|Second Intervention (3 Weeks)||7
2954725|NCT00718510|3668938|FG000|COMPLETED|Second Intervention (3 Weeks)||6
2954726|NCT00718510|3668939|FG001|COMPLETED|Second Intervention (3 Weeks)||7
2954727|NCT00718510|3668938|FG000|NOT COMPLETED|Second Intervention (3 Weeks)||1
2954728|NCT00718510|3668939|FG001|NOT COMPLETED|Second Intervention (3 Weeks)||0
2954729|NCT00718523|3668947|FG000|STARTED|Overall Study||84
2954730|NCT00718523|3668948|FG001|STARTED|Overall Study||86
3132667|NCT01692301|3857816|FG001|COMPLETED|Overall Study||183
3132668|NCT01692301|3857815|FG000|NOT COMPLETED|Overall Study||45
3132669|NCT01692301|3857816|FG001|NOT COMPLETED|Overall Study||42
3132670|NCT01692340|3857825|FG000|STARTED|Overall Study||8
3132671|NCT01692340|3857826|FG001|STARTED|Overall Study||4
3132672|NCT01692340|3857827|FG002|STARTED|Overall Study||0
3132673|NCT01692340|3857825|FG000|COMPLETED|Overall Study||8
3132674|NCT01692340|3857826|FG001|COMPLETED|Overall Study||4
3132675|NCT01692340|3857827|FG002|COMPLETED|Overall Study||0
3132676|NCT01692340|3857825|FG000|NOT COMPLETED|Overall Study||0
3132677|NCT01692340|3857826|FG001|NOT COMPLETED|Overall Study||0
2954731|NCT00718523|3668947|FG000|COMPLETED|Overall Study||66
2954732|NCT00718523|3668948|FG001|COMPLETED|Overall Study||62
2954733|NCT00718523|3668947|FG000|NOT COMPLETED|Overall Study||18
2954734|NCT00718523|3668948|FG001|NOT COMPLETED|Overall Study||24
2954735|NCT00718549|3668954|FG000|STARTED|Induction Phase||128
2954736|NCT00718549|3668955|FG001|STARTED|Induction Phase||0
2954737|NCT00718549|3668956|FG002|STARTED|Induction Phase||0
2954738|NCT00718549|3668954|FG000|COMPLETED|Induction Phase||66
2954739|NCT00718549|3668955|FG001|COMPLETED|Induction Phase||0
2954740|NCT00718549|3668956|FG002|COMPLETED|Induction Phase||0
2954741|NCT00718549|3668954|FG000|NOT COMPLETED|Induction Phase||62
3132678|NCT01692340|3857827|FG002|NOT COMPLETED|Overall Study||0
3132679|NCT01692496|3857836|FG000|STARTED|Overall Study||52
3132680|NCT01692496|3857836|FG000|3 Weeks Pazopanib (Per Protocol PP)|Overall Study||50
3132681|NCT01692496|3857836|FG000|COMPLETED|Overall Study||52
3132682|NCT01692496|3857836|FG000|NOT COMPLETED|Overall Study||0
3132683|NCT01692626|3857840|FG000|STARTED|Overall Study||6
2954742|NCT00718549|3668955|FG001|NOT COMPLETED|Induction Phase||0
2954743|NCT00718549|3668956|FG002|NOT COMPLETED|Induction Phase||0
2954744|NCT00718549|3668954|FG000|STARTED|Maintenance/ Observation Phase||0
2954745|NCT00718549|3668955|FG001|STARTED|Maintenance/ Observation Phase||33
2954746|NCT00718549|3668956|FG002|STARTED|Maintenance/ Observation Phase||33
2954747|NCT00718549|3668954|FG000|COMPLETED|Maintenance/ Observation Phase||0
2954748|NCT00718549|3668955|FG001|COMPLETED|Maintenance/ Observation Phase||5
2954749|NCT00718549|3668956|FG002|COMPLETED|Maintenance/ Observation Phase||3
2954750|NCT00718549|3668954|FG000|NOT COMPLETED|Maintenance/ Observation Phase||0
2954751|NCT00718549|3668955|FG001|NOT COMPLETED|Maintenance/ Observation Phase||28
2954752|NCT00718549|3668956|FG002|NOT COMPLETED|Maintenance/ Observation Phase||30
2954753|NCT00718666|3668972|FG000|STARTED|Persistence Phase Year 1||118
2954754|NCT00718666|3668973|FG001|STARTED|Persistence Phase Year 1||130
2954755|NCT00718666|3668974|FG002|STARTED|Persistence Phase Year 1||0
2954756|NCT00718666|3668972|FG000|COMPLETED|Persistence Phase Year 1||118
2954757|NCT00718666|3668973|FG001|COMPLETED|Persistence Phase Year 1||130
2954758|NCT00718666|3668974|FG002|COMPLETED|Persistence Phase Year 1|Subjects enrolled to receive Nimenrix vaccine as primary vaccination only at Booster Phase-Year 5.|0
2954759|NCT00718666|3668972|FG000|NOT COMPLETED|Persistence Phase Year 1||0
2954760|NCT00718666|3668973|FG001|NOT COMPLETED|Persistence Phase Year 1||0
2954761|NCT00718666|3668974|FG002|NOT COMPLETED|Persistence Phase Year 1||0
2954762|NCT00718666|3668972|FG000|STARTED|Persistence Phase Year 3||98
2954763|NCT00718666|3668973|FG001|STARTED|Persistence Phase Year 3||104
2954764|NCT00718666|3668974|FG002|STARTED|Persistence Phase Year 3||0
2954765|NCT00718666|3668972|FG000|COMPLETED|Persistence Phase Year 3||98
2954766|NCT00718666|3668973|FG001|COMPLETED|Persistence Phase Year 3||104
2954767|NCT00718666|3668974|FG002|COMPLETED|Persistence Phase Year 3|Subjects enrolled to receive Nimenrix vaccine as primary vaccination only at Booster Phase-Year 5.|0
2954768|NCT00718666|3668972|FG000|NOT COMPLETED|Persistence Phase Year 3||0
2954769|NCT00718666|3668973|FG001|NOT COMPLETED|Persistence Phase Year 3||0
2954770|NCT00718666|3668974|FG002|NOT COMPLETED|Persistence Phase Year 3||0
2954771|NCT00718666|3668972|FG000|STARTED|Persistence Phase Year 5||70
2954772|NCT00718666|3668973|FG001|STARTED|Persistence Phase Year 5||82
2954773|NCT00718666|3668974|FG002|STARTED|Persistence Phase Year 5||0
2954774|NCT00718666|3668972|FG000|COMPLETED|Persistence Phase Year 5||70
2954775|NCT00718666|3668973|FG001|COMPLETED|Persistence Phase Year 5||82
2954776|NCT00718666|3668974|FG002|COMPLETED|Persistence Phase Year 5|Subjects enrolled to receive Nimenrix vaccine as primary vaccination only at Booster Phase-Year 5.|0
2954777|NCT00718666|3668972|FG000|NOT COMPLETED|Persistence Phase Year 5||0
2954778|NCT00718666|3668973|FG001|NOT COMPLETED|Persistence Phase Year 5||0
2954779|NCT00718666|3668974|FG002|NOT COMPLETED|Persistence Phase Year 5||0
2954780|NCT00718666|3668972|FG000|STARTED|Booster Phase Year 5||38
2954781|NCT00718666|3668973|FG001|STARTED|Booster Phase Year 5||46
2954782|NCT00718666|3668974|FG002|STARTED|Booster Phase Year 5||100
2954783|NCT00718666|3668972|FG000|COMPLETED|Booster Phase Year 5||36
2954784|NCT00718666|3668973|FG001|COMPLETED|Booster Phase Year 5||46
2954785|NCT00718666|3668974|FG002|COMPLETED|Booster Phase Year 5||94
3132684|NCT01692626|3857841|FG001|STARTED|Overall Study||7
3132685|NCT01692626|3857840|FG000|COMPLETED|Overall Study||2
2954786|NCT00718666|3668972|FG000|NOT COMPLETED|Booster Phase Year 5||2
2954787|NCT00718666|3668973|FG001|NOT COMPLETED|Booster Phase Year 5||0
2954788|NCT00718666|3668974|FG002|NOT COMPLETED|Booster Phase Year 5||6
2954789|NCT00718718|3668999|FG000|STARTED|Prior to Week 12||19
2954790|NCT00718718|3669000|FG001|STARTED|Prior to Week 12||0
2954791|NCT00718718|3669001|FG002|STARTED|Prior to Week 12||17
2954792|NCT00718718|3669002|FG003|STARTED|Prior to Week 12||0
2954793|NCT00718718|3669003|FG004|STARTED|Prior to Week 12||30
2954794|NCT00718718|3669004|FG005|STARTED|Prior to Week 12||0
2954795|NCT00718718|3669005|FG006|STARTED|Prior to Week 12||30
2954796|NCT00718718|3669006|FG007|STARTED|Prior to Week 12||30
2954797|NCT00718718|3669007|FG008|STARTED|Prior to Week 12||30
2954798|NCT00718718|3669008|FG009|STARTED|Prior to Week 12||31
2954799|NCT00718718|3668999|FG000|COMPLETED|Prior to Week 12||18
2954800|NCT00718718|3669000|FG001|COMPLETED|Prior to Week 12||0
2954801|NCT00718718|3669001|FG002|COMPLETED|Prior to Week 12||16
2954802|NCT00718718|3669002|FG003|COMPLETED|Prior to Week 12||0
3132686|NCT01692626|3857841|FG001|COMPLETED|Overall Study||1
2954803|NCT00718718|3669003|FG004|COMPLETED|Prior to Week 12||27
2954804|NCT00718718|3669004|FG005|COMPLETED|Prior to Week 12||0
2954805|NCT00718718|3669005|FG006|COMPLETED|Prior to Week 12||29
2954806|NCT00718718|3669006|FG007|COMPLETED|Prior to Week 12||28
2954807|NCT00718718|3669007|FG008|COMPLETED|Prior to Week 12||28
2954808|NCT00718718|3669008|FG009|COMPLETED|Prior to Week 12||31
2954809|NCT00718718|3668999|FG000|NOT COMPLETED|Prior to Week 12||1
2954810|NCT00718718|3669000|FG001|NOT COMPLETED|Prior to Week 12||0
2954811|NCT00718718|3669001|FG002|NOT COMPLETED|Prior to Week 12||1
2954812|NCT00718718|3669002|FG003|NOT COMPLETED|Prior to Week 12||0
2954813|NCT00718718|3669003|FG004|NOT COMPLETED|Prior to Week 12||3
2954814|NCT00718718|3669004|FG005|NOT COMPLETED|Prior to Week 12||0
2954815|NCT00718718|3669005|FG006|NOT COMPLETED|Prior to Week 12||1
2954816|NCT00718718|3669006|FG007|NOT COMPLETED|Prior to Week 12||2
2954817|NCT00718718|3669007|FG008|NOT COMPLETED|Prior to Week 12||2
2954818|NCT00718718|3669008|FG009|NOT COMPLETED|Prior to Week 12||0
2954819|NCT00718718|3668999|FG000|STARTED|Week 12 to End of Study||0
2954820|NCT00718718|3669000|FG001|STARTED|Week 12 to End of Study||18
2954821|NCT00718718|3669001|FG002|STARTED|Week 12 to End of Study||0
2954822|NCT00718718|3669002|FG003|STARTED|Week 12 to End of Study||16
2954823|NCT00718718|3669003|FG004|STARTED|Week 12 to End of Study||0
2954824|NCT00718718|3669004|FG005|STARTED|Week 12 to End of Study||27
2954825|NCT00718718|3669005|FG006|STARTED|Week 12 to End of Study||29
2954826|NCT00718718|3669006|FG007|STARTED|Week 12 to End of Study||28
2954827|NCT00718718|3669007|FG008|STARTED|Week 12 to End of Study||28
2954828|NCT00718718|3669008|FG009|STARTED|Week 12 to End of Study||31
2954829|NCT00718718|3668999|FG000|Treated|Week 12 to End of Study||0
2954830|NCT00718718|3669000|FG001|Treated|Week 12 to End of Study||18
2954831|NCT00718718|3669001|FG002|Treated|Week 12 to End of Study||0
2954832|NCT00718718|3669002|FG003|Treated|Week 12 to End of Study||16
2954833|NCT00718718|3669003|FG004|Treated|Week 12 to End of Study||0
2954834|NCT00718718|3669004|FG005|Treated|Week 12 to End of Study||26
2954835|NCT00718718|3669005|FG006|Treated|Week 12 to End of Study||29
2954836|NCT00718718|3669006|FG007|Treated|Week 12 to End of Study||28
2954837|NCT00718718|3669007|FG008|Treated|Week 12 to End of Study||28
2954838|NCT00718718|3669008|FG009|Treated|Week 12 to End of Study||31
2954839|NCT00718718|3668999|FG000|COMPLETED|Week 12 to End of Study||0
2954840|NCT00718718|3669000|FG001|COMPLETED|Week 12 to End of Study||17
2954841|NCT00718718|3669001|FG002|COMPLETED|Week 12 to End of Study||0
2954842|NCT00718718|3669002|FG003|COMPLETED|Week 12 to End of Study||15
2954843|NCT00718718|3669003|FG004|COMPLETED|Week 12 to End of Study||0
2954844|NCT00718718|3669004|FG005|COMPLETED|Week 12 to End of Study||24
2954845|NCT00718718|3669005|FG006|COMPLETED|Week 12 to End of Study||27
2954846|NCT00718718|3669006|FG007|COMPLETED|Week 12 to End of Study||27
2954847|NCT00718718|3669007|FG008|COMPLETED|Week 12 to End of Study||27
2954848|NCT00718718|3669008|FG009|COMPLETED|Week 12 to End of Study||31
2954849|NCT00718718|3668999|FG000|NOT COMPLETED|Week 12 to End of Study||0
2954850|NCT00718718|3669000|FG001|NOT COMPLETED|Week 12 to End of Study||1
2954851|NCT00718718|3669001|FG002|NOT COMPLETED|Week 12 to End of Study||0
2954852|NCT00718718|3669002|FG003|NOT COMPLETED|Week 12 to End of Study||1
2954853|NCT00718718|3669003|FG004|NOT COMPLETED|Week 12 to End of Study||0
2954854|NCT00718718|3669004|FG005|NOT COMPLETED|Week 12 to End of Study||3
2954855|NCT00718718|3669005|FG006|NOT COMPLETED|Week 12 to End of Study||2
2954856|NCT00718718|3669006|FG007|NOT COMPLETED|Week 12 to End of Study||1
2954857|NCT00718718|3669007|FG008|NOT COMPLETED|Week 12 to End of Study||1
2954858|NCT00718718|3669008|FG009|NOT COMPLETED|Week 12 to End of Study||0
2954859|NCT00718770|3669034|FG000|STARTED|Overall Study||10
2954860|NCT00718770|3669034|FG000|COMPLETED|Overall Study||2
2954861|NCT00718770|3669034|FG000|NOT COMPLETED|Overall Study||8
2954862|NCT00718809|3669040|FG000|STARTED|Overall Study||12
2954863|NCT00718809|3669041|FG001|STARTED|Overall Study||9
2954864|NCT00718809|3669040|FG000|COMPLETED|Overall Study||0
2954865|NCT00718809|3669041|FG001|COMPLETED|Overall Study||0
2954866|NCT00718809|3669040|FG000|NOT COMPLETED|Overall Study||12
2954867|NCT00718809|3669041|FG001|NOT COMPLETED|Overall Study||9
2954868|NCT00718861|3669049|FG000|STARTED|Overall Study|"Started indicates Randomized and Intent-to Treat (ITT) population"|95
2954869|NCT00718861|3669050|FG001|STARTED|Overall Study||95
2954870|NCT00718861|3669049|FG000|Safety Set|Overall Study|3 patients randomized but never received study drug|92
2954871|NCT00718861|3669050|FG001|Safety Set|Overall Study||95
2954872|NCT00718861|3669049|FG000|Modified Intent to Treat|Overall Study|ITT patients with DXA total hip measure at extension 2 baseline and year 9|67
2954873|NCT00718861|3669050|FG001|Modified Intent to Treat|Overall Study|ITT patients with DXA total hip measure at extension 2 baseline and year 9|69
2954874|NCT00718861|3669049|FG000|COMPLETED|Overall Study||74
2954875|NCT00718861|3669050|FG001|COMPLETED|Overall Study||77
2954876|NCT00718861|3669049|FG000|NOT COMPLETED|Overall Study||21
2954877|NCT00718861|3669050|FG001|NOT COMPLETED|Overall Study||18
2954878|NCT00718887|3669058|FG000|STARTED|Overall Study|Participants who received treatment.|89
2954879|NCT00718887|3669059|FG001|STARTED|Overall Study|Participants who received treatment.|77
2954880|NCT00718887|3669058|FG000|COMPLETED|Overall Study|Continued in study after 48 weeks|84
2954881|NCT00718887|3669059|FG001|COMPLETED|Overall Study||68
2954882|NCT00718887|3669058|FG000|NOT COMPLETED|Overall Study||5
2954883|NCT00718887|3669059|FG001|NOT COMPLETED|Overall Study||9
2954884|NCT00719043|3669078|FG000|STARTED|Overall Study||120
2954885|NCT00719043|3669079|FG001|STARTED|Overall Study||121
2954886|NCT00719043|3669080|FG002|STARTED|Overall Study||119
2954887|NCT00719043|3669081|FG003|STARTED|Overall Study||119
2954888|NCT00719043|3669082|FG004|STARTED|Overall Study||122
2954889|NCT00719043|3669083|FG005|STARTED|Overall Study||120
2954890|NCT00719043|3669084|FG006|STARTED|Overall Study||120
2954891|NCT00719043|3669078|FG000|COMPLETED|Overall Study|Up to Day 909|88
2954892|NCT00719043|3669079|FG001|COMPLETED|Overall Study|Up to Day 909|96
2954893|NCT00719043|3669080|FG002|COMPLETED|Overall Study|Up to Day 909|99
2954894|NCT00719043|3669081|FG003|COMPLETED|Overall Study|Up to Day 909|96
2954895|NCT00719043|3669082|FG004|COMPLETED|Overall Study|Up to Day 909|95
2954896|NCT00719043|3669083|FG005|COMPLETED|Overall Study|Up to Day 909|86
2954897|NCT00719043|3669084|FG006|COMPLETED|Overall Study|Up to Day 909|92
2954898|NCT00719043|3669078|FG000|NOT COMPLETED|Overall Study||32
2954899|NCT00719043|3669079|FG001|NOT COMPLETED|Overall Study||25
2954900|NCT00719043|3669080|FG002|NOT COMPLETED|Overall Study||20
2954901|NCT00719043|3669081|FG003|NOT COMPLETED|Overall Study||23
2954902|NCT00719043|3669082|FG004|NOT COMPLETED|Overall Study||27
2954903|NCT00719043|3669083|FG005|NOT COMPLETED|Overall Study||34
2954904|NCT00719043|3669084|FG006|NOT COMPLETED|Overall Study||28
2954905|NCT00719134|3669112|FG000|STARTED|Overall Study||76
2954906|NCT00719134|3669112|FG000|COMPLETED|Overall Study||66
2954907|NCT00719134|3669112|FG000|NOT COMPLETED|Overall Study||10
2954908|NCT00719160|3669117|FG000|STARTED|Overall Study||6
2954909|NCT00719160|3669118|FG001|STARTED|Overall Study||6
2954910|NCT00719160|3669117|FG000|COMPLETED|Overall Study||6
2954911|NCT00719160|3669118|FG001|COMPLETED|Overall Study||6
2954912|NCT00719160|3669117|FG000|NOT COMPLETED|Overall Study||0
2954913|NCT00719160|3669118|FG001|NOT COMPLETED|Overall Study||0
2954914|NCT00719186|3669127|FG000|STARTED|Overall Study||376
2954915|NCT00719186|3669128|FG001|STARTED|Overall Study||374
2954916|NCT00719186|3669127|FG000|COMPLETED|Overall Study||376
2954917|NCT00719186|3669128|FG001|COMPLETED|Overall Study||374
2954918|NCT00719186|3669127|FG000|NOT COMPLETED|Overall Study||0
2954919|NCT00719186|3669128|FG001|NOT COMPLETED|Overall Study||0
2954920|NCT00719212|3669134|FG000|STARTED|Overall Study||61
2954921|NCT00719212|3669134|FG000|COMPLETED|Overall Study||17
2954922|NCT00719212|3669134|FG000|NOT COMPLETED|Overall Study||44
2954923|NCT00719264|3669140|FG000|STARTED|Overall Study||182
2954924|NCT00719264|3669141|FG001|STARTED|Overall Study||183
2954925|NCT00719264|3669140|FG000|Full Analysis Set|Overall Study||182
2954926|NCT00719264|3669141|FG001|Full Analysis Set|Overall Study||183
2954927|NCT00719264|3669140|FG000|Safety Set|Overall Study||180
2954928|NCT00719264|3669141|FG001|Safety Set|Overall Study||181
2954929|NCT00719264|3669140|FG000|COMPLETED|Overall Study||0
2954930|NCT00719264|3669141|FG001|COMPLETED|Overall Study||0
2954931|NCT00719264|3669140|FG000|NOT COMPLETED|Overall Study||182
2954932|NCT00719264|3669141|FG001|NOT COMPLETED|Overall Study||183
2954933|NCT00719329|3669150|FG000|STARTED|Overall Study||705
2954934|NCT00719329|3669151|FG001|STARTED|Overall Study||571
2954935|NCT00719329|3669152|FG002|STARTED|Overall Study||647
2954936|NCT00719329|3669150|FG000|Day 1 Swab|Overall Study||705
2954937|NCT00719329|3669151|FG001|Day 1 Swab|Overall Study||569
2954938|NCT00719329|3669152|FG002|Day 1 Swab|Overall Study||646
2954939|NCT00719329|3669150|FG000|Day 3 Swab|Overall Study||614
2954940|NCT00719329|3669151|FG001|Day 3 Swab|Overall Study||501
2954941|NCT00719329|3669152|FG002|Day 3 Swab|Overall Study||578
2954942|NCT00719329|3669150|FG000|Day 7 Swab|Overall Study||593
2954943|NCT00719329|3669151|FG001|Day 7 Swab|Overall Study||467
2954944|NCT00719329|3669152|FG002|Day 7 Swab|Overall Study||561
2954945|NCT00719329|3669150|FG000|COMPLETED|Overall Study||705
2954946|NCT00719329|3669151|FG001|COMPLETED|Overall Study||569
2954947|NCT00719329|3669152|FG002|COMPLETED|Overall Study||646
2954948|NCT00719329|3669150|FG000|NOT COMPLETED|Overall Study||0
2954949|NCT00719329|3669151|FG001|NOT COMPLETED|Overall Study||2
2954950|NCT00719329|3669152|FG002|NOT COMPLETED|Overall Study||1
2954951|NCT00719355|3669165|FG000|STARTED|Overall Study||51
2954952|NCT00719355|3669166|FG001|STARTED|Overall Study||52
2954953|NCT00719355|3669165|FG000|Completed 6 Weeks|Overall Study||49
2954954|NCT00719355|3669166|FG001|Completed 6 Weeks|Overall Study||48
2954955|NCT00719355|3669165|FG000|Completed 12 Weeks|Overall Study||43
2954956|NCT00719355|3669166|FG001|Completed 12 Weeks|Overall Study||46
2954957|NCT00719355|3669165|FG000|Completed 24 Weeks|Overall Study||34
2954958|NCT00719355|3669166|FG001|Completed 24 Weeks|Overall Study||43
2954959|NCT00719355|3669165|FG000|Completed 32 Weeks|Overall Study||33
2954960|NCT00719355|3669166|FG001|Completed 32 Weeks|Overall Study||39
2954961|NCT00719355|3669165|FG000|COMPLETED|Overall Study||33
2954962|NCT00719355|3669166|FG001|COMPLETED|Overall Study||39
2954963|NCT00719355|3669165|FG000|NOT COMPLETED|Overall Study||18
2954964|NCT00719355|3669166|FG001|NOT COMPLETED|Overall Study||13
2954965|NCT00719472|3669172|FG000|STARTED|Enrolled in Study||451
2954966|NCT00719472|3669172|FG000|COMPLETED|Enrolled in Study||425
2954967|NCT00719472|3669172|FG000|NOT COMPLETED|Enrolled in Study||26
2954968|NCT00719472|3669172|FG000|STARTED|Received Cycle 1 Treatment||425
2954969|NCT00719472|3669172|FG000|COMPLETED|Received Cycle 1 Treatment||372
2954970|NCT00719472|3669172|FG000|NOT COMPLETED|Received Cycle 1 Treatment||53
2954971|NCT00719472|3669172|FG000|STARTED|Received Cycle 2 Treatment||372
2954972|NCT00719472|3669172|FG000|COMPLETED|Received Cycle 2 Treatment||304
2954973|NCT00719472|3669172|FG000|NOT COMPLETED|Received Cycle 2 Treatment||68
2954974|NCT00719537|3669178|FG000|STARTED|Overall Study||2
2954975|NCT00719537|3669179|FG001|STARTED|Overall Study||1
2954976|NCT00719537|3669178|FG000|COMPLETED|Overall Study||1
2954977|NCT00719537|3669179|FG001|COMPLETED|Overall Study||0
2954978|NCT00719537|3669178|FG000|NOT COMPLETED|Overall Study||1
2954979|NCT00719537|3669179|FG001|NOT COMPLETED|Overall Study||1
3035124|NCT01135381|3754272|FG003|COMPLETED|Overall Study||67
3035125|NCT01135381|3754269|FG000|NOT COMPLETED|Overall Study||21
2954980|NCT00719563|3669187|FG000|STARTED|Overall Study||171
2954981|NCT00719563|3669188|FG001|STARTED|Overall Study||170
2954982|NCT00719563|3669187|FG000|COMPLETED|Overall Study||133
2954983|NCT00719563|3669188|FG001|COMPLETED|Overall Study||128
2954984|NCT00719563|3669187|FG000|NOT COMPLETED|Overall Study||38
2954985|NCT00719563|3669188|FG001|NOT COMPLETED|Overall Study||42
2954986|NCT00719576|3669197|FG000|STARTED|Overall Study||72
2954987|NCT00719576|3669198|FG001|STARTED|Overall Study||72
2954988|NCT00719576|3669197|FG000|COMPLETED|Overall Study||70
2954989|NCT00719576|3669198|FG001|COMPLETED|Overall Study||67
2954990|NCT00719576|3669197|FG000|NOT COMPLETED|Overall Study||2
2954991|NCT00719576|3669198|FG001|NOT COMPLETED|Overall Study||5
2954992|NCT00719615|3669209|FG000|STARTED|Overall Study||42
2954993|NCT00719615|3669210|FG001|STARTED|Overall Study||45
2954994|NCT00719615|3669211|FG002|STARTED|Overall Study||24
2954995|NCT00719615|3669209|FG000|COMPLETED|Overall Study||42
2954996|NCT00719615|3669210|FG001|COMPLETED|Overall Study||45
2954997|NCT00719615|3669211|FG002|COMPLETED|Overall Study||24
2954998|NCT00719615|3669209|FG000|NOT COMPLETED|Overall Study||0
2954999|NCT00719615|3669210|FG001|NOT COMPLETED|Overall Study||0
2955000|NCT00719615|3669211|FG002|NOT COMPLETED|Overall Study||0
2955001|NCT00719680|3669219|FG000|STARTED|Overall Study||21
2955002|NCT00719680|3669219|FG000|COMPLETED|Overall Study||16
2955003|NCT00719680|3669219|FG000|NOT COMPLETED|Overall Study||5
2955004|NCT00719706|3669225|FG000|STARTED|Overall Study||20
2955005|NCT00719706|3669226|FG001|STARTED|Overall Study||20
2955006|NCT00719706|3669225|FG000|COMPLETED|Overall Study||11
2955007|NCT00719706|3669226|FG001|COMPLETED|Overall Study||14
2955008|NCT00719706|3669225|FG000|NOT COMPLETED|Overall Study||9
2955009|NCT00719706|3669226|FG001|NOT COMPLETED|Overall Study||6
2955010|NCT00719732|3669232|FG000|STARTED|Overall Study||218
2955011|NCT00719732|3669232|FG000|COMPLETED|Overall Study||196
2955012|NCT00719732|3669232|FG000|NOT COMPLETED|Overall Study||22
2955013|NCT00719810|3669239|FG000|STARTED|Overall Study||49
2955014|NCT00719810|3669240|FG001|STARTED|Overall Study||51
2955015|NCT00719810|3669241|FG002|STARTED|Overall Study||50
2955016|NCT00719810|3669239|FG000|COMPLETED|Overall Study||46
2955017|NCT00719810|3669240|FG001|COMPLETED|Overall Study||47
2955018|NCT00719810|3669241|FG002|COMPLETED|Overall Study||42
2955019|NCT00719810|3669239|FG000|NOT COMPLETED|Overall Study||3
2955020|NCT00719810|3669240|FG001|NOT COMPLETED|Overall Study||4
2955021|NCT00719810|3669241|FG002|NOT COMPLETED|Overall Study||8
2955022|NCT00719849|3669251|FG000|STARTED|Overall Study||4
2955023|NCT00719849|3669252|FG001|STARTED|Overall Study||9
2955024|NCT00719849|3669251|FG000|COMPLETED|Overall Study||4
2955025|NCT00719849|3669252|FG001|COMPLETED|Overall Study||8
2955026|NCT00719849|3669251|FG000|NOT COMPLETED|Overall Study||0
2955027|NCT00719849|3669252|FG001|NOT COMPLETED|Overall Study||1
2955028|NCT00719862|3669260|FG000|STARTED|Overall Study||242
2955029|NCT00719862|3669261|FG001|STARTED|Overall Study|1 subject was randomized in error|239
2955030|NCT00719862|3669260|FG000|COMPLETED|Overall Study||234
2955031|NCT00719862|3669261|FG001|COMPLETED|Overall Study||233
2955032|NCT00719862|3669260|FG000|NOT COMPLETED|Overall Study||8
2955033|NCT00719862|3669261|FG001|NOT COMPLETED|Overall Study||6
2955034|NCT00719901|3669267|FG000|STARTED|Overall Study||11
2955035|NCT00719901|3669267|FG000|COMPLETED|Overall Study||0
2955036|NCT00719901|3669267|FG000|NOT COMPLETED|Overall Study||11
2955037|NCT00719953|3669271|FG000|STARTED|Overall Study||30
2955038|NCT00719953|3669271|FG000|COMPLETED|Overall Study||26
2955039|NCT00719953|3669271|FG000|NOT COMPLETED|Overall Study||4
2955040|NCT00720057|3669277|FG000|STARTED|Overall Study||153
2955041|NCT00720057|3669278|FG001|STARTED|Overall Study||159
2955042|NCT00720057|3669277|FG000|COMPLETED|Overall Study||152
2955043|NCT00720057|3669278|FG001|COMPLETED|Overall Study||156
2955044|NCT00720057|3669277|FG000|NOT COMPLETED|Overall Study||1
2955045|NCT00720057|3669278|FG001|NOT COMPLETED|Overall Study||3
2955046|NCT00720096|3669286|FG000|STARTED|Overall Study||2
2955047|NCT00720096|3669287|FG001|STARTED|Overall Study||2
2955048|NCT00720096|3669286|FG000|COMPLETED|Overall Study||2
2955049|NCT00720096|3669287|FG001|COMPLETED|Overall Study||0
2955050|NCT00720096|3669286|FG000|NOT COMPLETED|Overall Study||0
2955051|NCT00720096|3669287|FG001|NOT COMPLETED|Overall Study||2
2955052|NCT00720109|3669293|FG000|STARTED|Induction Period||63
2955053|NCT00720109|3669294|FG001|STARTED|Induction Period||0
2955054|NCT00720109|3669295|FG002|STARTED|Induction Period||0
2955055|NCT00720109|3669293|FG000|COMPLETED|Induction Period||57
2955056|NCT00720109|3669294|FG001|COMPLETED|Induction Period||0
2955057|NCT00720109|3669295|FG002|COMPLETED|Induction Period||0
2955058|NCT00720109|3669293|FG000|NOT COMPLETED|Induction Period||6
2955059|NCT00720109|3669294|FG001|NOT COMPLETED|Induction Period||0
2955060|NCT00720109|3669295|FG002|NOT COMPLETED|Induction Period||0
2955061|NCT00720109|3669293|FG000|STARTED|Risk Stratification Period||0
2955062|NCT00720109|3669294|FG001|STARTED|Risk Stratification Period||48
2955063|NCT00720109|3669295|FG002|STARTED|Risk Stratification Period||9
2955064|NCT00720109|3669293|FG000|COMPLETED|Risk Stratification Period||0
2955065|NCT00720109|3669294|FG001|COMPLETED|Risk Stratification Period||33
2955066|NCT00720109|3669295|FG002|COMPLETED|Risk Stratification Period||1
2955067|NCT00720109|3669293|FG000|NOT COMPLETED|Risk Stratification Period||0
2955068|NCT00720109|3669294|FG001|NOT COMPLETED|Risk Stratification Period||15
2955069|NCT00720109|3669295|FG002|NOT COMPLETED|Risk Stratification Period||8
2955070|NCT00720122|3669304|FG000|STARTED|Overall Study||28
2955071|NCT00720122|3669304|FG000|COMPLETED|Overall Study||19
2955072|NCT00720122|3669304|FG000|NOT COMPLETED|Overall Study||9
2955073|NCT00720213|3669308|FG000|STARTED|Screening Phase With Diagnostic PSG||44
2955074|NCT00720213|3669309|FG001|STARTED|Screening Phase With Diagnostic PSG||0
2955075|NCT00720213|3669310|FG002|STARTED|Screening Phase With Diagnostic PSG||0
2955076|NCT00720213|3669308|FG000|COMPLETED|Screening Phase With Diagnostic PSG||37
2955077|NCT00720213|3669309|FG001|COMPLETED|Screening Phase With Diagnostic PSG||0
2955078|NCT00720213|3669310|FG002|COMPLETED|Screening Phase With Diagnostic PSG||0
2955079|NCT00720213|3669308|FG000|NOT COMPLETED|Screening Phase With Diagnostic PSG||7
2955080|NCT00720213|3669309|FG001|NOT COMPLETED|Screening Phase With Diagnostic PSG||0
2955081|NCT00720213|3669310|FG002|NOT COMPLETED|Screening Phase With Diagnostic PSG||0
2955082|NCT00720213|3669308|FG000|STARTED|Treatment Period||0
2955083|NCT00720213|3669309|FG001|STARTED|Treatment Period||20
2955084|NCT00720213|3669310|FG002|STARTED|Treatment Period||17
2955085|NCT00720213|3669308|FG000|COMPLETED|Treatment Period||0
2955086|NCT00720213|3669309|FG001|COMPLETED|Treatment Period||20
3163551|NCT01887717|3891096|FG000|STARTED|Overall Study||17
3163552|NCT01887717|3891097|FG001|STARTED|Overall Study||19
2955087|NCT00720213|3669310|FG002|COMPLETED|Treatment Period||17
2955088|NCT00720213|3669308|FG000|NOT COMPLETED|Treatment Period||0
2955089|NCT00720213|3669309|FG001|NOT COMPLETED|Treatment Period||0
2955090|NCT00720213|3669310|FG002|NOT COMPLETED|Treatment Period||0
2955091|NCT00720226|3669320|FG000|STARTED|Overall Study||54
2955092|NCT00720226|3669321|FG001|STARTED|Overall Study||52
2955093|NCT00720226|3669320|FG000|COMPLETED|Overall Study|Participants not completing did not have 12 month CT scan|47
2955094|NCT00720226|3669321|FG001|COMPLETED|Overall Study|Participants not completing did not have 12 month CT scan|48
2955095|NCT00720226|3669320|FG000|NOT COMPLETED|Overall Study||7
2955096|NCT00720226|3669321|FG001|NOT COMPLETED|Overall Study||4
2955097|NCT00720278|3669330|FG000|STARTED|Overall Study|1 subject was randomized in error|178
2955098|NCT00720278|3669331|FG001|STARTED|Overall Study|1 subject was randomized in error|170
2955099|NCT00720278|3669332|FG002|STARTED|Overall Study|1 subject was randomized in error|178
2955100|NCT00720278|3669330|FG000|COMPLETED|Overall Study||171
2955101|NCT00720278|3669331|FG001|COMPLETED|Overall Study||166
2955102|NCT00720278|3669332|FG002|COMPLETED|Overall Study||172
2955103|NCT00720278|3669330|FG000|NOT COMPLETED|Overall Study||7
2955104|NCT00720278|3669331|FG001|NOT COMPLETED|Overall Study||4
2955105|NCT00720278|3669332|FG002|NOT COMPLETED|Overall Study||6
2955106|NCT00720330|3669343|FG000|STARTED|Overall Study||5
2955107|NCT00720330|3669344|FG001|STARTED|Overall Study||4
2955108|NCT00720330|3669345|FG002|STARTED|Overall Study||3
2955109|NCT00720330|3669343|FG000|COMPLETED|Overall Study||5
2955110|NCT00720330|3669344|FG001|COMPLETED|Overall Study||4
2955111|NCT00720330|3669345|FG002|COMPLETED|Overall Study||3
2955112|NCT00720330|3669343|FG000|NOT COMPLETED|Overall Study||0
2955113|NCT00720330|3669344|FG001|NOT COMPLETED|Overall Study||0
2955114|NCT00720330|3669345|FG002|NOT COMPLETED|Overall Study||0
2955115|NCT00720356|3669353|FG000|STARTED|Registration to Study||115
2955116|NCT00720356|3669353|FG000|Completed Registration Step 1|Registration to Study||115
2955117|NCT00720356|3669353|FG000|Completed Registration Step 2|Registration to Study||48
2955118|NCT00720356|3669353|FG000|COMPLETED|Registration to Study||48
2955119|NCT00720356|3669353|FG000|NOT COMPLETED|Registration to Study||67
2955120|NCT00720356|3669353|FG000|STARTED|Reached 1st Response/2 Cycles||48
2955121|NCT00720356|3669353|FG000|COMPLETED|Reached 1st Response/2 Cycles||46
2955122|NCT00720356|3669353|FG000|NOT COMPLETED|Reached 1st Response/2 Cycles||2
2955123|NCT00720356|3669353|FG000|STARTED|Went on to be Treated Cycle 3||46
2955124|NCT00720356|3669353|FG000|COMPLETED|Went on to be Treated Cycle 3||44
2955125|NCT00720356|3669353|FG000|NOT COMPLETED|Went on to be Treated Cycle 3||2
2955126|NCT00720356|3669353|FG000|STARTED|Follow up Until Death|All patients that are treated on study go into the follow up period|48
2955127|NCT00720356|3669353|FG000|COMPLETED|Follow up Until Death||43
2955128|NCT00720356|3669353|FG000|NOT COMPLETED|Follow up Until Death||5
2955129|NCT00720369|3669359|FG000|STARTED|Overall Study||11
2955130|NCT00720369|3669360|FG001|STARTED|Overall Study||8
2955131|NCT00720369|3669359|FG000|COMPLETED|Overall Study|one subject discontinued due to an adverse event.|10
2955132|NCT00720369|3669360|FG001|COMPLETED|Overall Study||8
2955133|NCT00720369|3669359|FG000|NOT COMPLETED|Overall Study||1
2955134|NCT00720369|3669360|FG001|NOT COMPLETED|Overall Study||0
2955135|NCT00720382|3669370|FG000|STARTED|Overall Study||466
2955136|NCT00720382|3669371|FG001|STARTED|Overall Study||237
2955137|NCT00720382|3669370|FG000|COMPLETED|Overall Study||290
2955138|NCT00720382|3669371|FG001|COMPLETED|Overall Study||178
2955139|NCT00720382|3669370|FG000|NOT COMPLETED|Overall Study||176
2955140|NCT00720382|3669371|FG001|NOT COMPLETED|Overall Study||59
2955141|NCT00720434|3669381|FG000|STARTED|Double-Blind Period (Week 1-4)||10
2955142|NCT00720434|3669382|FG001|STARTED|Double-Blind Period (Week 1-4)||9
2955143|NCT00720434|3669383|FG002|STARTED|Double-Blind Period (Week 1-4)||8
2955144|NCT00720434|3669384|FG003|STARTED|Double-Blind Period (Week 1-4)||8
2955145|NCT00720434|3669381|FG000|COMPLETED|Double-Blind Period (Week 1-4)||10
2955146|NCT00720434|3669382|FG001|COMPLETED|Double-Blind Period (Week 1-4)||8
2955147|NCT00720434|3669383|FG002|COMPLETED|Double-Blind Period (Week 1-4)||8
2955148|NCT00720434|3669384|FG003|COMPLETED|Double-Blind Period (Week 1-4)||8
2955149|NCT00720434|3669381|FG000|NOT COMPLETED|Double-Blind Period (Week 1-4)||0
2955150|NCT00720434|3669382|FG001|NOT COMPLETED|Double-Blind Period (Week 1-4)||1
2955151|NCT00720434|3669383|FG002|NOT COMPLETED|Double-Blind Period (Week 1-4)||0
2955152|NCT00720434|3669384|FG003|NOT COMPLETED|Double-Blind Period (Week 1-4)||0
2955153|NCT00720434|3669381|FG000|STARTED|Open-Label Period (Week 5-72)||10
2955154|NCT00720434|3669382|FG001|STARTED|Open-Label Period (Week 5-72)||8
2955155|NCT00720434|3669383|FG002|STARTED|Open-Label Period (Week 5-72)||8
2955156|NCT00720434|3669384|FG003|STARTED|Open-Label Period (Week 5-72)||8
2955157|NCT00720434|3669381|FG000|COMPLETED|Open-Label Period (Week 5-72)||4
2955158|NCT00720434|3669382|FG001|COMPLETED|Open-Label Period (Week 5-72)||5
2955159|NCT00720434|3669383|FG002|COMPLETED|Open-Label Period (Week 5-72)||4
2955160|NCT00720434|3669384|FG003|COMPLETED|Open-Label Period (Week 5-72)||4
2955161|NCT00720434|3669381|FG000|NOT COMPLETED|Open-Label Period (Week 5-72)||6
2955162|NCT00720434|3669382|FG001|NOT COMPLETED|Open-Label Period (Week 5-72)||3
2955163|NCT00720434|3669383|FG002|NOT COMPLETED|Open-Label Period (Week 5-72)||4
2955164|NCT00720434|3669384|FG003|NOT COMPLETED|Open-Label Period (Week 5-72)||4
2955165|NCT00720473|3669396|FG000|STARTED|Overall Study||45
2955166|NCT00720473|3669397|FG001|STARTED|Overall Study||24
2955167|NCT00720473|3669396|FG000|COMPLETED|Overall Study||15
2955168|NCT00720473|3669397|FG001|COMPLETED|Overall Study||16
2955169|NCT00720473|3669396|FG000|NOT COMPLETED|Overall Study||30
2955170|NCT00720473|3669397|FG001|NOT COMPLETED|Overall Study||8
2955171|NCT00720499|3669404|FG000|STARTED|Treatment Period 1 (4 Weeks)||69
2955172|NCT00720499|3669405|FG001|STARTED|Treatment Period 1 (4 Weeks)||72
2955173|NCT00720499|3669404|FG000|COMPLETED|Treatment Period 1 (4 Weeks)||66
2955174|NCT00720499|3669405|FG001|COMPLETED|Treatment Period 1 (4 Weeks)||70
2955175|NCT00720499|3669404|FG000|NOT COMPLETED|Treatment Period 1 (4 Weeks)||3
2955176|NCT00720499|3669405|FG001|NOT COMPLETED|Treatment Period 1 (4 Weeks)||2
2955177|NCT00720499|3669404|FG000|STARTED|Washout Period (2 Weeks)||66
2955178|NCT00720499|3669405|FG001|STARTED|Washout Period (2 Weeks)||70
2955179|NCT00720499|3669404|FG000|COMPLETED|Washout Period (2 Weeks)||66
2955180|NCT00720499|3669405|FG001|COMPLETED|Washout Period (2 Weeks)||70
2955181|NCT00720499|3669404|FG000|NOT COMPLETED|Washout Period (2 Weeks)||0
2955182|NCT00720499|3669405|FG001|NOT COMPLETED|Washout Period (2 Weeks)||0
2955183|NCT00720499|3669404|FG000|STARTED|Treatment Period 2 (4 Weeks)||66
2955184|NCT00720499|3669405|FG001|STARTED|Treatment Period 2 (4 Weeks)||70
2955185|NCT00720499|3669404|FG000|COMPLETED|Treatment Period 2 (4 Weeks)||64
2955186|NCT00720499|3669405|FG001|COMPLETED|Treatment Period 2 (4 Weeks)||67
2955187|NCT00720499|3669404|FG000|NOT COMPLETED|Treatment Period 2 (4 Weeks)||2
2955188|NCT00720499|3669405|FG001|NOT COMPLETED|Treatment Period 2 (4 Weeks)||3
2955189|NCT00720629|3669412|FG000|STARTED|Overall Study||8
2955190|NCT00720629|3669412|FG000|COMPLETED|Overall Study||8
2955191|NCT00720629|3669412|FG000|NOT COMPLETED|Overall Study||0
2955192|NCT00720759|3669422|FG000|STARTED|Overall Study||6
2955193|NCT00720759|3669423|FG001|STARTED|Overall Study||6
2955194|NCT00720759|3669424|FG002|STARTED|Overall Study||6
2955195|NCT00720759|3669425|FG003|STARTED|Overall Study||6
2955196|NCT00720759|3669422|FG000|COMPLETED|Overall Study||6
2955197|NCT00720759|3669423|FG001|COMPLETED|Overall Study||5
2955198|NCT00720759|3669424|FG002|COMPLETED|Overall Study||5
2955199|NCT00720759|3669425|FG003|COMPLETED|Overall Study||6
2955200|NCT00720759|3669422|FG000|NOT COMPLETED|Overall Study||0
2955201|NCT00720759|3669423|FG001|NOT COMPLETED|Overall Study||1
2955202|NCT00720759|3669424|FG002|NOT COMPLETED|Overall Study||1
2955203|NCT00720759|3669425|FG003|NOT COMPLETED|Overall Study||0
2955204|NCT00720798|3669435|FG000|STARTED|Overall Study||2067
2955205|NCT00720798|3669435|FG000|COMPLETED|Overall Study||1311
2955206|NCT00720798|3669435|FG000|NOT COMPLETED|Overall Study||756
2955207|NCT00720876|3669439|FG000|STARTED|Overall Study||30
2955208|NCT00720876|3669439|FG000|COMPLETED|Overall Study||28
2955209|NCT00720876|3669439|FG000|NOT COMPLETED|Overall Study||2
2955210|NCT00720941|3669445|FG000|STARTED|Overall Study||557
2955211|NCT00720941|3669446|FG001|STARTED|Overall Study||553
2955212|NCT00720941|3669445|FG000|Ongoing|Overall Study||34
2955213|NCT00720941|3669446|FG001|Ongoing|Overall Study||23
2955214|NCT00720941|3669445|FG000|COMPLETED|Overall Study||144
2955215|NCT00720941|3669446|FG001|COMPLETED|Overall Study||138
2955216|NCT00720941|3669445|FG000|NOT COMPLETED|Overall Study||413
2955217|NCT00720941|3669446|FG001|NOT COMPLETED|Overall Study||415
2955218|NCT00721110|3669456|FG000|STARTED|Overall Study||16
2955219|NCT00721110|3669457|FG001|STARTED|Overall Study||16
2955220|NCT00721110|3669458|FG002|STARTED|Overall Study||16
2955221|NCT00721110|3669459|FG003|STARTED|Overall Study||16
2955222|NCT00721110|3669456|FG000|COMPLETED|Overall Study||15
2955223|NCT00721110|3669457|FG001|COMPLETED|Overall Study||16
2955224|NCT00721110|3669458|FG002|COMPLETED|Overall Study||15
2955225|NCT00721110|3669459|FG003|COMPLETED|Overall Study||16
2955226|NCT00721110|3669456|FG000|NOT COMPLETED|Overall Study||1
2955227|NCT00721110|3669457|FG001|NOT COMPLETED|Overall Study||0
2955228|NCT00721110|3669458|FG002|NOT COMPLETED|Overall Study||1
2955229|NCT00721110|3669459|FG003|NOT COMPLETED|Overall Study||0
2955230|NCT00721123|3669469|FG000|STARTED|Overall Study||538
3132687|NCT01692626|3857840|FG000|NOT COMPLETED|Overall Study||4
3132688|NCT01692626|3857841|FG001|NOT COMPLETED|Overall Study||6
3132689|NCT01692730|3857848|FG000|STARTED|Overall Study||723
3132690|NCT01692730|3857849|FG001|STARTED|Overall Study||729
3132691|NCT01692730|3857848|FG000|COMPLETED|Overall Study||498
3132692|NCT01692730|3857849|FG001|COMPLETED|Overall Study||502
2955231|NCT00721123|3669469|FG000|COMPLETED|Overall Study||355
2955232|NCT00721123|3669469|FG000|NOT COMPLETED|Overall Study||183
2955233|NCT00721136|3669493|FG000|STARTED|Overall Study||42
2955234|NCT00721136|3669494|FG001|STARTED|Overall Study||42
2955235|NCT00721136|3669495|FG002|STARTED|Overall Study||8
2955236|NCT00721136|3669496|FG003|STARTED|Overall Study||8
2955237|NCT00721136|3669493|FG000|COMPLETED|Overall Study||42
2955238|NCT00721136|3669494|FG001|COMPLETED|Overall Study||42
2955239|NCT00721136|3669495|FG002|COMPLETED|Overall Study||8
2955240|NCT00721136|3669496|FG003|COMPLETED|Overall Study||8
2955241|NCT00721136|3669493|FG000|NOT COMPLETED|Overall Study||0
2955242|NCT00721136|3669494|FG001|NOT COMPLETED|Overall Study||0
2955243|NCT00721136|3669495|FG002|NOT COMPLETED|Overall Study||0
2955244|NCT00721136|3669496|FG003|NOT COMPLETED|Overall Study||0
2955245|NCT00721149|3669510|FG000|STARTED|Overall Study|Enrollment was stopped after 10 subjects entered the trial.|10
2955246|NCT00721149|3669510|FG000|COMPLETED|Overall Study||9
2955247|NCT00721149|3669510|FG000|NOT COMPLETED|Overall Study||1
2955248|NCT00721162|3669514|FG000|STARTED|Overall Study||60
2955249|NCT00721162|3669514|FG000|Received Any Amount of Study Drug|Overall Study||60
2955250|NCT00721162|3669514|FG000|COMPLETED|Overall Study||60
2955251|NCT00721162|3669514|FG000|NOT COMPLETED|Overall Study||0
2955252|NCT00721175|3669520|FG000|STARTED|Overall Study||54
2955253|NCT00721175|3669521|FG001|STARTED|Overall Study||54
2955254|NCT00721175|3669520|FG000|COMPLETED|Overall Study||54
2955255|NCT00721175|3669521|FG001|COMPLETED|Overall Study||54
2955256|NCT00721175|3669520|FG000|NOT COMPLETED|Overall Study||0
2955257|NCT00721175|3669521|FG001|NOT COMPLETED|Overall Study||0
2955258|NCT00721188|3669527|FG000|STARTED|Overall Study||11
2955259|NCT00721188|3669527|FG000|COMPLETED|Overall Study||11
2955260|NCT00721188|3669527|FG000|NOT COMPLETED|Overall Study||0
2955261|NCT00721214|3669531|FG000|STARTED|Overall Study||16
2955262|NCT00721214|3669531|FG000|COMPLETED|Overall Study||12
2955263|NCT00721214|3669531|FG000|NOT COMPLETED|Overall Study||4
2955264|NCT00721227|3669537|FG000|STARTED|Overall Study||9
2955265|NCT00721227|3669538|FG001|STARTED|Overall Study||6
2955266|NCT00721227|3669537|FG000|COMPLETED|Overall Study|3 subjects lost to follow up; 1 subject did not complete due to noncompliance of scheduled visits.|5
2955267|NCT00721227|3669538|FG001|COMPLETED|Overall Study||6
2955268|NCT00721227|3669537|FG000|NOT COMPLETED|Overall Study||4
2955269|NCT00721227|3669538|FG001|NOT COMPLETED|Overall Study||0
2955270|NCT00721253|3669546|FG000|STARTED|Overall Study||20
2955271|NCT00721253|3669547|FG001|STARTED|Overall Study||22
2955272|NCT00721253|3669548|FG002|STARTED|Overall Study|There were no subjects that were implanted with the Tecnis lens.|0
2955273|NCT00721253|3669546|FG000|COMPLETED|Overall Study||20
2955274|NCT00721253|3669547|FG001|COMPLETED|Overall Study||22
2955275|NCT00721253|3669548|FG002|COMPLETED|Overall Study||0
2955276|NCT00721253|3669546|FG000|NOT COMPLETED|Overall Study||0
2955277|NCT00721253|3669547|FG001|NOT COMPLETED|Overall Study||0
2955278|NCT00721253|3669548|FG002|NOT COMPLETED|Overall Study||0
2955279|NCT00721279|3669556|FG000|STARTED|Overall Study||452
2955280|NCT00721279|3669557|FG001|STARTED|Overall Study||97
2955281|NCT00721279|3669556|FG000|COMPLETED|Overall Study||416
2955282|NCT00721279|3669557|FG001|COMPLETED|Overall Study||73
2955283|NCT00721279|3669556|FG000|NOT COMPLETED|Overall Study||36
2955284|NCT00721279|3669557|FG001|NOT COMPLETED|Overall Study||24
2955285|NCT00721357|3669566|FG000|STARTED|Overall Study||15
2955286|NCT00721357|3669567|FG001|STARTED|Overall Study||15
2955287|NCT00721357|3669566|FG000|COMPLETED|Overall Study||15
2955288|NCT00721357|3669567|FG001|COMPLETED|Overall Study||15
2955289|NCT00721357|3669566|FG000|NOT COMPLETED|Overall Study||0
2955290|NCT00721357|3669567|FG001|NOT COMPLETED|Overall Study||0
2955291|NCT00721396|3669579|FG000|STARTED|Overall Study||627
2955292|NCT00721396|3669580|FG001|STARTED|Overall Study||628
2955293|NCT00721396|3669581|FG002|STARTED|Overall Study||318
2955294|NCT00721396|3669582|FG003|STARTED|Overall Study||312
2955295|NCT00721396|3669579|FG000|COMPLETED|Overall Study||597
2955296|NCT00721396|3669580|FG001|COMPLETED|Overall Study||592
2955297|NCT00721396|3669581|FG002|COMPLETED|Overall Study||308
2955298|NCT00721396|3669582|FG003|COMPLETED|Overall Study||302
2955299|NCT00721396|3669579|FG000|NOT COMPLETED|Overall Study||30
2955300|NCT00721396|3669580|FG001|NOT COMPLETED|Overall Study||36
2955301|NCT00721396|3669581|FG002|NOT COMPLETED|Overall Study||10
2955302|NCT00721396|3669582|FG003|NOT COMPLETED|Overall Study||10
2955303|NCT00721409|3669600|FG000|STARTED|Overall Study||12
2955304|NCT00721409|3669601|FG001|STARTED|Overall Study||84
2955305|NCT00721409|3669602|FG002|STARTED|Overall Study||81
2955306|NCT00721409|3669600|FG000|Treated|Overall Study||12
2955307|NCT00721409|3669601|FG001|Treated|Overall Study||83
2955308|NCT00721409|3669602|FG002|Treated|Overall Study||77
2955309|NCT00721409|3669600|FG000|COMPLETED|Overall Study||0
2955310|NCT00721409|3669601|FG001|COMPLETED|Overall Study||2
2955311|NCT00721409|3669602|FG002|COMPLETED|Overall Study||2
2955312|NCT00721409|3669600|FG000|NOT COMPLETED|Overall Study||12
2955313|NCT00721409|3669601|FG001|NOT COMPLETED|Overall Study||82
2955314|NCT00721409|3669602|FG002|NOT COMPLETED|Overall Study||79
2955315|NCT00721500|3669626|FG000|STARTED|Period One||6
2955316|NCT00721500|3669627|FG001|STARTED|Period One||7
2955317|NCT00721500|3669628|FG002|STARTED|Period One||6
2955318|NCT00721500|3669629|FG003|STARTED|Period One||6
2955319|NCT00721500|3669626|FG000|COMPLETED|Period One||6
2955320|NCT00721500|3669627|FG001|COMPLETED|Period One||7
2955321|NCT00721500|3669628|FG002|COMPLETED|Period One||6
2955322|NCT00721500|3669629|FG003|COMPLETED|Period One||6
2955323|NCT00721500|3669626|FG000|NOT COMPLETED|Period One||0
2955324|NCT00721500|3669627|FG001|NOT COMPLETED|Period One||0
2955325|NCT00721500|3669628|FG002|NOT COMPLETED|Period One||0
2955326|NCT00721500|3669629|FG003|NOT COMPLETED|Period One||0
2955327|NCT00721500|3669626|FG000|STARTED|Period Two||6
2955328|NCT00721500|3669627|FG001|STARTED|Period Two||7
2955329|NCT00721500|3669628|FG002|STARTED|Period Two||6
2955330|NCT00721500|3669629|FG003|STARTED|Period Two||6
2955331|NCT00721500|3669626|FG000|COMPLETED|Period Two||6
2955332|NCT00721500|3669627|FG001|COMPLETED|Period Two||7
2955333|NCT00721500|3669628|FG002|COMPLETED|Period Two||6
2955334|NCT00721500|3669629|FG003|COMPLETED|Period Two||6
2955335|NCT00721500|3669626|FG000|NOT COMPLETED|Period Two||0
2955336|NCT00721500|3669627|FG001|NOT COMPLETED|Period Two||0
2955337|NCT00721500|3669628|FG002|NOT COMPLETED|Period Two||0
2955338|NCT00721500|3669629|FG003|NOT COMPLETED|Period Two||0
2955339|NCT00721500|3669626|FG000|STARTED|Period Three||6
2955340|NCT00721500|3669627|FG001|STARTED|Period Three||7
2955341|NCT00721500|3669628|FG002|STARTED|Period Three||6
2955342|NCT00721500|3669629|FG003|STARTED|Period Three||6
2955343|NCT00721500|3669626|FG000|COMPLETED|Period Three||6
2955344|NCT00721500|3669627|FG001|COMPLETED|Period Three||7
2955345|NCT00721500|3669628|FG002|COMPLETED|Period Three||6
2955346|NCT00721500|3669629|FG003|COMPLETED|Period Three||6
2955347|NCT00721500|3669626|FG000|NOT COMPLETED|Period Three||0
2955348|NCT00721500|3669627|FG001|NOT COMPLETED|Period Three||0
2955349|NCT00721500|3669628|FG002|NOT COMPLETED|Period Three||0
2955350|NCT00721500|3669629|FG003|NOT COMPLETED|Period Three||0
2955351|NCT00721513|3669641|FG000|STARTED|Overall Study||20
2955352|NCT00721513|3669641|FG000|COMPLETED|Overall Study||20
2955353|NCT00721513|3669641|FG000|NOT COMPLETED|Overall Study||0
2955354|NCT00721539|3669645|FG000|STARTED|Overall Study||9
2955355|NCT00721539|3669645|FG000|COMPLETED|Overall Study||9
2955356|NCT00721539|3669645|FG000|NOT COMPLETED|Overall Study||0
2955357|NCT00721578|3669649|FG000|STARTED|Overall Study||12
2955358|NCT00721578|3669650|FG001|STARTED|Overall Study||11
2955359|NCT00721578|3669649|FG000|COMPLETED|Overall Study||10
2955360|NCT00721578|3669650|FG001|COMPLETED|Overall Study||9
2955361|NCT00721578|3669649|FG000|NOT COMPLETED|Overall Study||2
2955362|NCT00721578|3669650|FG001|NOT COMPLETED|Overall Study||2
2955363|NCT00721617|3669656|FG000|STARTED|0 Hour (Baseline) of Saline Infusion||12
2955364|NCT00721617|3669656|FG000|COMPLETED|0 Hour (Baseline) of Saline Infusion||12
2955365|NCT00721617|3669656|FG000|NOT COMPLETED|0 Hour (Baseline) of Saline Infusion||0
2955366|NCT00721617|3669656|FG000|STARTED|4 Hours Into Saline Infusion||12
2955367|NCT00721617|3669656|FG000|COMPLETED|4 Hours Into Saline Infusion||12
2955368|NCT00721617|3669656|FG000|NOT COMPLETED|4 Hours Into Saline Infusion||0
2955369|NCT00721617|3669656|FG000|STARTED|8 Hours Into Saline Infusion||12
2955370|NCT00721617|3669656|FG000|COMPLETED|8 Hours Into Saline Infusion||12
2955371|NCT00721617|3669656|FG000|NOT COMPLETED|8 Hours Into Saline Infusion||0
2955372|NCT00721617|3669656|FG000|STARTED|0 Hour (Baseline) of Intralipid Infusion||12
2955373|NCT00721617|3669656|FG000|COMPLETED|0 Hour (Baseline) of Intralipid Infusion||12
2955374|NCT00721617|3669656|FG000|NOT COMPLETED|0 Hour (Baseline) of Intralipid Infusion||0
2955375|NCT00721617|3669656|FG000|STARTED|4 Hours Into Intralipid Infusion||12
2955376|NCT00721617|3669656|FG000|COMPLETED|4 Hours Into Intralipid Infusion||12
2955377|NCT00721617|3669656|FG000|NOT COMPLETED|4 Hours Into Intralipid Infusion||0
2955378|NCT00721617|3669656|FG000|STARTED|8 Hours Into Intralipid Infusion||12
2955379|NCT00721617|3669656|FG000|COMPLETED|8 Hours Into Intralipid Infusion||12
2955380|NCT00721617|3669656|FG000|NOT COMPLETED|8 Hours Into Intralipid Infusion||0
2955381|NCT00721617|3669656|FG000|STARTED|0 Hour (Baseline) of Dextrose Infusion||12
2955382|NCT00721617|3669656|FG000|COMPLETED|0 Hour (Baseline) of Dextrose Infusion||12
2955383|NCT00721617|3669656|FG000|NOT COMPLETED|0 Hour (Baseline) of Dextrose Infusion||0
2955384|NCT00721617|3669656|FG000|STARTED|4 Hours Into Dextrose Infusion||12
2955385|NCT00721617|3669656|FG000|COMPLETED|4 Hours Into Dextrose Infusion||12
2955386|NCT00721617|3669656|FG000|NOT COMPLETED|4 Hours Into Dextrose Infusion||0
2955387|NCT00721617|3669656|FG000|STARTED|8 Hours Into Dextrose Infusion||12
2955388|NCT00721617|3669656|FG000|COMPLETED|8 Hours Into Dextrose Infusion||12
2955389|NCT00721617|3669656|FG000|NOT COMPLETED|8 Hours Into Dextrose Infusion||0
2955390|NCT00721617|3669656|FG000|STARTED|0 Hour (Baseline) of Intralipid/Dextrose||12
2955391|NCT00721617|3669656|FG000|COMPLETED|0 Hour (Baseline) of Intralipid/Dextrose||12
2955392|NCT00721617|3669656|FG000|NOT COMPLETED|0 Hour (Baseline) of Intralipid/Dextrose||0
2955393|NCT00721617|3669656|FG000|STARTED|4 Hours Into Intralipid/Dextrose||12
2955394|NCT00721617|3669656|FG000|COMPLETED|4 Hours Into Intralipid/Dextrose||12
2955395|NCT00721617|3669656|FG000|NOT COMPLETED|4 Hours Into Intralipid/Dextrose||0
2955396|NCT00721617|3669656|FG000|STARTED|8 Hours Into Intralipid/Dextrose||12
2955397|NCT00721617|3669656|FG000|COMPLETED|8 Hours Into Intralipid/Dextrose||12
2955398|NCT00721617|3669656|FG000|NOT COMPLETED|8 Hours Into Intralipid/Dextrose||0
2955399|NCT00721630|3669661|FG000|STARTED|Overall Study||24
2955400|NCT00721630|3669661|FG000|COMPLETED|Overall Study||23
2955401|NCT00721630|3669661|FG000|NOT COMPLETED|Overall Study||1
2955402|NCT00721734|3669670|FG000|STARTED|Overall Study||12
2955403|NCT00721734|3669671|FG001|STARTED|Overall Study||12
2955404|NCT00721734|3669672|FG002|STARTED|Overall Study||10
2955405|NCT00721734|3669673|FG003|STARTED|Overall Study||8
2955406|NCT00721734|3669674|FG004|STARTED|Overall Study||8
2955407|NCT00721734|3669670|FG000|COMPLETED|Overall Study|Completed 12 cycles of carfilzomib treatment|4
2955408|NCT00721734|3669671|FG001|COMPLETED|Overall Study|Completed 12 cycles of carfilzomib treatment|0
2955409|NCT00721734|3669672|FG002|COMPLETED|Overall Study|Completed 12 cycles of carfilzomib treatment|2
2955410|NCT00721734|3669673|FG003|COMPLETED|Overall Study|Completed 12 cycles of carfilzomib treatment|2
2955411|NCT00721734|3669674|FG004|COMPLETED|Overall Study|Completed 12 cycles of carfilzomib treatment|2
2955412|NCT00721734|3669670|FG000|NOT COMPLETED|Overall Study||8
2955413|NCT00721734|3669671|FG001|NOT COMPLETED|Overall Study||12
2955414|NCT00721734|3669672|FG002|NOT COMPLETED|Overall Study||8
2955415|NCT00721734|3669673|FG003|NOT COMPLETED|Overall Study||6
2955416|NCT00721734|3669674|FG004|NOT COMPLETED|Overall Study||6
2955417|NCT00721799|3669686|FG000|STARTED|Overall Study||33
2955418|NCT00721799|3669686|FG000|Recieved FLT PET Scan 1|Overall Study||26
2955419|NCT00721799|3669686|FG000|Received FLT PET Scan #2|Overall Study||25
2955420|NCT00721799|3669686|FG000|COMPLETED|Overall Study||25
2955421|NCT00721799|3669686|FG000|NOT COMPLETED|Overall Study||8
2955422|NCT00721955|3669693|FG000|STARTED|Overall Study||105
2955423|NCT00721955|3669694|FG001|STARTED|Overall Study||104
2955424|NCT00721955|3669695|FG002|STARTED|Overall Study||105
2955425|NCT00721955|3669693|FG000|COMPLETED|Overall Study||105
2955426|NCT00721955|3669694|FG001|COMPLETED|Overall Study||104
2955427|NCT00721955|3669695|FG002|COMPLETED|Overall Study||103
2955428|NCT00721955|3669693|FG000|NOT COMPLETED|Overall Study||0
2955429|NCT00721955|3669694|FG001|NOT COMPLETED|Overall Study||0
2955430|NCT00721955|3669695|FG002|NOT COMPLETED|Overall Study||2
2955431|NCT00721968|3669705|FG000|STARTED|Overall Study||27
2955432|NCT00721968|3669706|FG001|STARTED|Overall Study||17
2955433|NCT00721968|3669705|FG000|COMPLETED|Overall Study||25
2955434|NCT00721968|3669706|FG001|COMPLETED|Overall Study||17
2955435|NCT00721968|3669705|FG000|NOT COMPLETED|Overall Study||2
2955436|NCT00721968|3669706|FG001|NOT COMPLETED|Overall Study||0
2955437|NCT00722007|3669712|FG000|STARTED|Overall Study||147
2955438|NCT00722007|3669712|FG000|COMPLETED|Overall Study||117
2955439|NCT00722007|3669712|FG000|NOT COMPLETED|Overall Study||30
2955440|NCT00722020|3669719|FG000|STARTED|Overall Study||19
2955441|NCT00722020|3669720|FG001|STARTED|Overall Study||24
2955442|NCT00722020|3669719|FG000|COMPLETED|Overall Study||19
2955443|NCT00722020|3669720|FG001|COMPLETED|Overall Study||24
2955444|NCT00722020|3669719|FG000|NOT COMPLETED|Overall Study||0
2955445|NCT00722020|3669720|FG001|NOT COMPLETED|Overall Study||0
2955446|NCT00722072|3669728|FG000|STARTED|Overall Study||12
2955447|NCT00722072|3669728|FG000|COMPLETED|Overall Study||9
2955448|NCT00722072|3669728|FG000|NOT COMPLETED|Overall Study||3
2955449|NCT00722111|3669734|FG000|STARTED|Overall Study||11
2955450|NCT00722111|3669735|FG001|STARTED|Overall Study||72
2955451|NCT00722111|3669734|FG000|COMPLETED|Overall Study||11
2955452|NCT00722111|3669735|FG001|COMPLETED|Overall Study||72
2955453|NCT00722111|3669734|FG000|NOT COMPLETED|Overall Study||0
2955454|NCT00722111|3669735|FG001|NOT COMPLETED|Overall Study||0
2955455|NCT00722124|3669744|FG000|STARTED|Overall Study||40
2955456|NCT00722124|3669745|FG001|STARTED|Overall Study||40
2955457|NCT00722124|3669746|FG002|STARTED|Overall Study||40
3132693|NCT01692730|3857848|FG000|NOT COMPLETED|Overall Study||225
3132694|NCT01692730|3857849|FG001|NOT COMPLETED|Overall Study||227
3132695|NCT01692743|3857858|FG000|STARTED|Overall Study||117
3132696|NCT01692743|3857859|FG001|STARTED|Overall Study||116
3132697|NCT01692743|3857860|FG002|STARTED|Overall Study||115
3132698|NCT01692743|3857858|FG000|COMPLETED|Overall Study||90
2955458|NCT00722124|3669744|FG000|COMPLETED|Overall Study||23
2955459|NCT00722124|3669745|FG001|COMPLETED|Overall Study||26
2955460|NCT00722124|3669746|FG002|COMPLETED|Overall Study||20
2955461|NCT00722124|3669744|FG000|NOT COMPLETED|Overall Study||17
2955462|NCT00722124|3669745|FG001|NOT COMPLETED|Overall Study||14
2955463|NCT00722124|3669746|FG002|NOT COMPLETED|Overall Study||20
2955464|NCT00722137|3669756|FG000|STARTED|Overall Study||244
2955465|NCT00722137|3669757|FG001|STARTED|Overall Study||243
2955466|NCT00722137|3669756|FG000|COMPLETED|Overall Study||199
2955467|NCT00722137|3669757|FG001|COMPLETED|Overall Study||195
2955468|NCT00722137|3669756|FG000|NOT COMPLETED|Overall Study||45
2955469|NCT00722137|3669757|FG001|NOT COMPLETED|Overall Study||48
2955470|NCT00722371|3669770|FG000|STARTED|Overall Study||231
2955471|NCT00722371|3669771|FG001|STARTED|Overall Study||230
2955472|NCT00722371|3669772|FG002|STARTED|Overall Study||233
2955473|NCT00722371|3669773|FG003|STARTED|Overall Study||230
2955474|NCT00722371|3669774|FG004|STARTED|Overall Study||230
2955475|NCT00722371|3669775|FG005|STARTED|Overall Study||231
2955476|NCT00722371|3669776|FG006|STARTED|Overall Study||230
2955477|NCT00722371|3669770|FG000|COMPLETED|Overall Study||175
2955478|NCT00722371|3669771|FG001|COMPLETED|Overall Study||158
2955479|NCT00722371|3669772|FG002|COMPLETED|Overall Study||168
2955480|NCT00722371|3669773|FG003|COMPLETED|Overall Study||167
2955481|NCT00722371|3669774|FG004|COMPLETED|Overall Study||182
2955482|NCT00722371|3669775|FG005|COMPLETED|Overall Study||178
2955483|NCT00722371|3669776|FG006|COMPLETED|Overall Study||179
2955484|NCT00722371|3669770|FG000|NOT COMPLETED|Overall Study||56
2955485|NCT00722371|3669771|FG001|NOT COMPLETED|Overall Study||72
2955486|NCT00722371|3669772|FG002|NOT COMPLETED|Overall Study||65
2955487|NCT00722371|3669773|FG003|NOT COMPLETED|Overall Study||63
2955488|NCT00722371|3669774|FG004|NOT COMPLETED|Overall Study||48
2955489|NCT00722371|3669775|FG005|NOT COMPLETED|Overall Study||53
2955490|NCT00722371|3669776|FG006|NOT COMPLETED|Overall Study||51
2955491|NCT00722423|3669794|FG000|STARTED|Overall Study||182
2955492|NCT00722423|3669795|FG001|STARTED|Overall Study||182
2955493|NCT00722423|3669794|FG000|COMPLETED|Overall Study||182
2955494|NCT00722423|3669795|FG001|COMPLETED|Overall Study||181
2955495|NCT00722423|3669794|FG000|NOT COMPLETED|Overall Study||0
2955496|NCT00722423|3669795|FG001|NOT COMPLETED|Overall Study||1
2955497|NCT00722436|3669805|FG000|STARTED|Overall Study||9
2955498|NCT00722436|3669806|FG001|STARTED|Overall Study||11
2955499|NCT00722436|3669805|FG000|COMPLETED|Overall Study||9
2955500|NCT00722436|3669806|FG001|COMPLETED|Overall Study||11
2955501|NCT00722436|3669805|FG000|NOT COMPLETED|Overall Study||0
2955502|NCT00722436|3669806|FG001|NOT COMPLETED|Overall Study||0
2955503|NCT00722553|3669812|FG000|STARTED|Overall Study||30
2955504|NCT00722553|3669812|FG000|COMPLETED|Overall Study||30
2955505|NCT00722553|3669812|FG000|NOT COMPLETED|Overall Study||0
2955506|NCT00722566|3669820|FG000|STARTED|Overall Study|One patient randomized and not dosed|148
2955507|NCT00722566|3669821|FG001|STARTED|Overall Study||74
2955508|NCT00722566|3669820|FG000|COMPLETED|Overall Study|Completed 8 cycles|81
2955509|NCT00722566|3669821|FG001|COMPLETED|Overall Study|Completed 8 cycles|39
2955510|NCT00722566|3669820|FG000|NOT COMPLETED|Overall Study||67
2955511|NCT00722566|3669821|FG001|NOT COMPLETED|Overall Study||35
2955512|NCT00722722|3669832|FG000|STARTED|Overall Study||3
2955513|NCT00722722|3669833|FG001|STARTED|Overall Study||5
2955514|NCT00722722|3669834|FG002|STARTED|Overall Study||10
2955515|NCT00722722|3669832|FG000|COMPLETED|Overall Study||3
2955516|NCT00722722|3669833|FG001|COMPLETED|Overall Study||5
2955517|NCT00722722|3669834|FG002|COMPLETED|Overall Study||10
2955518|NCT00722722|3669832|FG000|NOT COMPLETED|Overall Study||0
2955519|NCT00722722|3669833|FG001|NOT COMPLETED|Overall Study||0
2955520|NCT00722722|3669834|FG002|NOT COMPLETED|Overall Study||0
2955521|NCT00722761|3669844|FG000|STARTED|Overall Study||16
2955522|NCT00722761|3669845|FG001|STARTED|Overall Study||14
2955523|NCT00722761|3669844|FG000|COMPLETED AT LEAST 1 FOLLOW-UP VISIT|Overall Study||15
2955524|NCT00722761|3669845|FG001|COMPLETED AT LEAST 1 FOLLOW-UP VISIT|Overall Study||10
2955525|NCT00722761|3669844|FG000|COMPLETED|Overall Study||10
2955526|NCT00722761|3669845|FG001|COMPLETED|Overall Study||8
2955527|NCT00722761|3669844|FG000|NOT COMPLETED|Overall Study||6
2955528|NCT00722761|3669845|FG001|NOT COMPLETED|Overall Study||6
2955529|NCT00722800|3669853|FG000|STARTED|Overall Study||2
2955530|NCT00722800|3669854|FG001|STARTED|Overall Study||2
2955531|NCT00722800|3669853|FG000|COMPLETED|Overall Study||0
2955532|NCT00722800|3669854|FG001|COMPLETED|Overall Study||2
2955533|NCT00722800|3669853|FG000|NOT COMPLETED|Overall Study||2
2955534|NCT00722800|3669854|FG001|NOT COMPLETED|Overall Study||0
2955535|NCT00722865|3669860|FG000|STARTED|Overall Study||25
2955536|NCT00722865|3669860|FG000|COMPLETED|Overall Study||23
2955537|NCT00722865|3669860|FG000|NOT COMPLETED|Overall Study||2
2955538|NCT00723008|3669866|FG000|STARTED|Enrollment||11
2955539|NCT00723008|3669867|FG001|STARTED|Enrollment||9
2955540|NCT00723008|3669866|FG000|COMPLETED|Enrollment||10
2955541|NCT00723008|3669867|FG001|COMPLETED|Enrollment||9
2955542|NCT00723008|3669866|FG000|NOT COMPLETED|Enrollment||1
2955543|NCT00723008|3669867|FG001|NOT COMPLETED|Enrollment||0
2955544|NCT00723008|3669866|FG000|STARTED|4-Week Double Blinded||10
2955545|NCT00723008|3669867|FG001|STARTED|4-Week Double Blinded||9
2955546|NCT00723008|3669866|FG000|COMPLETED|4-Week Double Blinded||5
2955547|NCT00723008|3669867|FG001|COMPLETED|4-Week Double Blinded||4
2955548|NCT00723008|3669866|FG000|NOT COMPLETED|4-Week Double Blinded||5
2955549|NCT00723008|3669867|FG001|NOT COMPLETED|4-Week Double Blinded||5
2955550|NCT00723008|3669866|FG000|STARTED|4-Week Unblinded Treatment||5
2955551|NCT00723008|3669867|FG001|STARTED|4-Week Unblinded Treatment||4
2955552|NCT00723008|3669866|FG000|COMPLETED|4-Week Unblinded Treatment||4
2955553|NCT00723008|3669867|FG001|COMPLETED|4-Week Unblinded Treatment||3
2955554|NCT00723008|3669866|FG000|NOT COMPLETED|4-Week Unblinded Treatment||1
2955555|NCT00723008|3669867|FG001|NOT COMPLETED|4-Week Unblinded Treatment||1
2955556|NCT00723021|3669881|FG000|STARTED|Intervention Period 1||3
2955557|NCT00723021|3669882|FG001|STARTED|Intervention Period 1||3
2955558|NCT00723021|3669883|FG002|STARTED|Intervention Period 1||3
2955559|NCT00723021|3669884|FG003|STARTED|Intervention Period 1||3
2955560|NCT00723021|3669885|FG004|STARTED|Intervention Period 1||3
2955561|NCT00723021|3669881|FG000|COMPLETED|Intervention Period 1||3
2955562|NCT00723021|3669882|FG001|COMPLETED|Intervention Period 1||3
2955563|NCT00723021|3669883|FG002|COMPLETED|Intervention Period 1||3
2955564|NCT00723021|3669884|FG003|COMPLETED|Intervention Period 1||3
2955565|NCT00723021|3669885|FG004|COMPLETED|Intervention Period 1||3
2955566|NCT00723021|3669881|FG000|NOT COMPLETED|Intervention Period 1||0
2955567|NCT00723021|3669882|FG001|NOT COMPLETED|Intervention Period 1||0
2955568|NCT00723021|3669883|FG002|NOT COMPLETED|Intervention Period 1||0
2955569|NCT00723021|3669884|FG003|NOT COMPLETED|Intervention Period 1||0
2955570|NCT00723021|3669885|FG004|NOT COMPLETED|Intervention Period 1||0
2955571|NCT00723021|3669881|FG000|STARTED|Intervention Period 2||3
2955572|NCT00723021|3669882|FG001|STARTED|Intervention Period 2||3
2955573|NCT00723021|3669883|FG002|STARTED|Intervention Period 2||3
2955574|NCT00723021|3669884|FG003|STARTED|Intervention Period 2||3
2955575|NCT00723021|3669885|FG004|STARTED|Intervention Period 2||3
2955576|NCT00723021|3669881|FG000|COMPLETED|Intervention Period 2||3
2955577|NCT00723021|3669882|FG001|COMPLETED|Intervention Period 2||3
2955578|NCT00723021|3669883|FG002|COMPLETED|Intervention Period 2||3
2955579|NCT00723021|3669884|FG003|COMPLETED|Intervention Period 2||3
2955580|NCT00723021|3669885|FG004|COMPLETED|Intervention Period 2||3
2955581|NCT00723021|3669881|FG000|NOT COMPLETED|Intervention Period 2||0
2955582|NCT00723021|3669882|FG001|NOT COMPLETED|Intervention Period 2||0
2955583|NCT00723021|3669883|FG002|NOT COMPLETED|Intervention Period 2||0
2955584|NCT00723021|3669884|FG003|NOT COMPLETED|Intervention Period 2||0
2955585|NCT00723021|3669885|FG004|NOT COMPLETED|Intervention Period 2||0
2955586|NCT00723021|3669881|FG000|STARTED|Intervention Period 3||3
2955587|NCT00723021|3669882|FG001|STARTED|Intervention Period 3||3
2955588|NCT00723021|3669883|FG002|STARTED|Intervention Period 3||3
2955589|NCT00723021|3669884|FG003|STARTED|Intervention Period 3||3
2955590|NCT00723021|3669885|FG004|STARTED|Intervention Period 3||3
2955591|NCT00723021|3669881|FG000|COMPLETED|Intervention Period 3||3
2955592|NCT00723021|3669882|FG001|COMPLETED|Intervention Period 3||3
2955593|NCT00723021|3669883|FG002|COMPLETED|Intervention Period 3||3
2955594|NCT00723021|3669884|FG003|COMPLETED|Intervention Period 3||3
2955595|NCT00723021|3669885|FG004|COMPLETED|Intervention Period 3||3
2955596|NCT00723021|3669881|FG000|NOT COMPLETED|Intervention Period 3||0
2955597|NCT00723021|3669882|FG001|NOT COMPLETED|Intervention Period 3||0
2955598|NCT00723021|3669883|FG002|NOT COMPLETED|Intervention Period 3||0
2955599|NCT00723021|3669884|FG003|NOT COMPLETED|Intervention Period 3||0
2955600|NCT00723021|3669885|FG004|NOT COMPLETED|Intervention Period 3||0
2955601|NCT00723021|3669881|FG000|STARTED|Intervention Period 4||3
2955602|NCT00723021|3669882|FG001|STARTED|Intervention Period 4||3
2955603|NCT00723021|3669883|FG002|STARTED|Intervention Period 4||3
2955604|NCT00723021|3669884|FG003|STARTED|Intervention Period 4||3
2955605|NCT00723021|3669885|FG004|STARTED|Intervention Period 4||3
2955606|NCT00723021|3669881|FG000|COMPLETED|Intervention Period 4||3
2955607|NCT00723021|3669882|FG001|COMPLETED|Intervention Period 4||3
2955608|NCT00723021|3669883|FG002|COMPLETED|Intervention Period 4||3
2955609|NCT00723021|3669884|FG003|COMPLETED|Intervention Period 4||3
2955610|NCT00723021|3669885|FG004|COMPLETED|Intervention Period 4||2
2955611|NCT00723021|3669881|FG000|NOT COMPLETED|Intervention Period 4||0
2955612|NCT00723021|3669882|FG001|NOT COMPLETED|Intervention Period 4||0
2955613|NCT00723021|3669883|FG002|NOT COMPLETED|Intervention Period 4||0
2955614|NCT00723021|3669884|FG003|NOT COMPLETED|Intervention Period 4||0
2955615|NCT00723021|3669885|FG004|NOT COMPLETED|Intervention Period 4||1
2955616|NCT00723021|3669881|FG000|STARTED|Intervention Period 5||3
2955617|NCT00723021|3669882|FG001|STARTED|Intervention Period 5||3
2955618|NCT00723021|3669883|FG002|STARTED|Intervention Period 5||3
2955619|NCT00723021|3669884|FG003|STARTED|Intervention Period 5||3
2955620|NCT00723021|3669885|FG004|STARTED|Intervention Period 5||2
2955621|NCT00723021|3669881|FG000|COMPLETED|Intervention Period 5||3
2955622|NCT00723021|3669882|FG001|COMPLETED|Intervention Period 5||3
2955623|NCT00723021|3669883|FG002|COMPLETED|Intervention Period 5||3
2955624|NCT00723021|3669884|FG003|COMPLETED|Intervention Period 5||3
2955625|NCT00723021|3669885|FG004|COMPLETED|Intervention Period 5||2
2955626|NCT00723021|3669881|FG000|NOT COMPLETED|Intervention Period 5||0
2955627|NCT00723021|3669882|FG001|NOT COMPLETED|Intervention Period 5||0
2955628|NCT00723021|3669883|FG002|NOT COMPLETED|Intervention Period 5||0
2955629|NCT00723021|3669884|FG003|NOT COMPLETED|Intervention Period 5||0
2955630|NCT00723021|3669885|FG004|NOT COMPLETED|Intervention Period 5||0
2955631|NCT00723073|3669906|FG000|STARTED|Overall Study||149
2955632|NCT00723073|3669907|FG001|STARTED|Overall Study||174
2955633|NCT00723073|3669906|FG000|COMPLETED|Overall Study||149
2955634|NCT00723073|3669907|FG001|COMPLETED|Overall Study||174
2955635|NCT00723073|3669906|FG000|NOT COMPLETED|Overall Study||0
2955636|NCT00723073|3669907|FG001|NOT COMPLETED|Overall Study||0
2955637|NCT00723099|3669913|FG000|STARTED|Overall Study||73
2955638|NCT00723099|3669913|FG000|COMPLETED|Overall Study||72
2955639|NCT00723099|3669913|FG000|NOT COMPLETED|Overall Study||1
2955640|NCT00723125|3669920|FG000|STARTED|Overall Study|33 pts Neo-adjuvant, 28 evaluable,DDAC: Of 28 pts,27 treated DDAC Avastin:Of 27,15 Avastin post-op|33
2955641|NCT00723125|3669921|FG001|STARTED|Overall Study|27 evaluable Neo-adjuvant Of 27 patients neo-adjuvant, 24 DDAC Of 24 DDAC, 21 Avastin post-op|27
2955642|NCT00723125|3669920|FG000|COMPLETED|Overall Study||15
2955643|NCT00723125|3669921|FG001|COMPLETED|Overall Study||21
2955644|NCT00723125|3669920|FG000|NOT COMPLETED|Overall Study||18
2955645|NCT00723125|3669921|FG001|NOT COMPLETED|Overall Study||6
2955646|NCT00723177|3669936|FG000|STARTED|Overall Study||15
2955647|NCT00723177|3669937|FG001|STARTED|Overall Study||14
2955648|NCT00723177|3669938|FG002|STARTED|Overall Study||15
2955649|NCT00723177|3669936|FG000|COMPLETED|Overall Study||10
2955650|NCT00723177|3669937|FG001|COMPLETED|Overall Study||10
2955651|NCT00723177|3669938|FG002|COMPLETED|Overall Study||10
2955652|NCT00723177|3669936|FG000|NOT COMPLETED|Overall Study||5
2955653|NCT00723177|3669937|FG001|NOT COMPLETED|Overall Study||4
2955654|NCT00723177|3669938|FG002|NOT COMPLETED|Overall Study||5
3300419|NCT02945410|4034309|FG001|STARTED|Washout 2 (14 Days)||1
3300420|NCT02945410|4034310|FG002|STARTED|Washout 2 (14 Days)||0
3300421|NCT02945410|4034311|FG003|STARTED|Washout 2 (14 Days)||3
2955655|NCT00723190|3669946|FG000|STARTED|Overall Study|Study CLON-301 (168 participants) and Study CLON-302 (135 participants)|303
2955656|NCT00723190|3669946|FG000|SAFETY POPULATION|Overall Study||301
2955657|NCT00723190|3669946|FG000|COMPLETED|Overall Study|53 participants completed 6-month protocol and 108 participants completed 12-month protocol|161
2955658|NCT00723190|3669946|FG000|NOT COMPLETED|Overall Study||142
2955659|NCT00723203|3669950|FG000|STARTED|Overall Study||16
2955660|NCT00723203|3669950|FG000|COMPLETED|Overall Study||13
2955661|NCT00723203|3669950|FG000|NOT COMPLETED|Overall Study||3
2955662|NCT00723229|3669956|FG000|STARTED|First Intervention||25
2955663|NCT00723229|3669957|FG001|STARTED|First Intervention||23
2955664|NCT00723229|3669956|FG000|COMPLETED|First Intervention||18
2955665|NCT00723229|3669957|FG001|COMPLETED|First Intervention||20
2955666|NCT00723229|3669956|FG000|NOT COMPLETED|First Intervention||7
2955667|NCT00723229|3669957|FG001|NOT COMPLETED|First Intervention||3
2955668|NCT00723229|3669956|FG000|STARTED|Second Intervention||18
2955669|NCT00723229|3669957|FG001|STARTED|Second Intervention||20
2955670|NCT00723229|3669956|FG000|COMPLETED|Second Intervention||18
2955671|NCT00723229|3669957|FG001|COMPLETED|Second Intervention||20
2955672|NCT00723229|3669956|FG000|NOT COMPLETED|Second Intervention||0
2955673|NCT00723229|3669957|FG001|NOT COMPLETED|Second Intervention||0
2955674|NCT00723255|3669963|FG000|STARTED|Overall Study||53
2955675|NCT00723255|3669963|FG000|COMPLETED|Overall Study|Eligible and treated patients|49
2955676|NCT00723255|3669963|FG000|NOT COMPLETED|Overall Study||4
2955677|NCT00723294|3669979|FG000|STARTED|Overall Study||99
2955678|NCT00723294|3669979|FG000|COMPLETED|Overall Study||86
2955679|NCT00723294|3669979|FG000|NOT COMPLETED|Overall Study||13
2955680|NCT00723398|3669988|FG000|STARTED|Overall Study||53
2955681|NCT00723398|3669989|FG001|STARTED|Overall Study||53
2955682|NCT00723398|3669990|FG002|STARTED|Overall Study||53
2955683|NCT00723398|3669991|FG003|STARTED|Overall Study||54
2955684|NCT00723398|3669992|FG004|STARTED|Overall Study||53
2955685|NCT00723398|3669988|FG000|COMPLETED|Overall Study||47
2955686|NCT00723398|3669989|FG001|COMPLETED|Overall Study||38
2955687|NCT00723398|3669990|FG002|COMPLETED|Overall Study||36
2955688|NCT00723398|3669991|FG003|COMPLETED|Overall Study||49
2955689|NCT00723398|3669992|FG004|COMPLETED|Overall Study||44
2955690|NCT00723398|3669988|FG000|NOT COMPLETED|Overall Study||6
2955691|NCT00723398|3669989|FG001|NOT COMPLETED|Overall Study||15
2955692|NCT00723398|3669990|FG002|NOT COMPLETED|Overall Study||17
2955693|NCT00723398|3669991|FG003|NOT COMPLETED|Overall Study||5
2955694|NCT00723398|3669992|FG004|NOT COMPLETED|Overall Study||9
2955695|NCT00723450|3670006|FG000|STARTED|Open-Label Phase||298
2955696|NCT00723450|3670007|FG001|STARTED|Open-Label Phase||0
2955697|NCT00723450|3670008|FG002|STARTED|Open-Label Phase||0
2955698|NCT00723450|3670006|FG000|COMPLETED|Open-Label Phase||173
2955699|NCT00723450|3670007|FG001|COMPLETED|Open-Label Phase||0
2955700|NCT00723450|3670008|FG002|COMPLETED|Open-Label Phase||0
2955701|NCT00723450|3670006|FG000|NOT COMPLETED|Open-Label Phase||125
2955702|NCT00723450|3670007|FG001|NOT COMPLETED|Open-Label Phase||0
2955703|NCT00723450|3670008|FG002|NOT COMPLETED|Open-Label Phase||0
2955704|NCT00723450|3670006|FG000|STARTED|Randomized Phase||0
2955705|NCT00723450|3670007|FG001|STARTED|Randomized Phase||86
2955706|NCT00723450|3670008|FG002|STARTED|Randomized Phase||87
2955707|NCT00723450|3670006|FG000|COMPLETED|Randomized Phase||0
2955708|NCT00723450|3670007|FG001|COMPLETED|Randomized Phase||21
2955709|NCT00723450|3670008|FG002|COMPLETED|Randomized Phase||20
2955710|NCT00723450|3670006|FG000|NOT COMPLETED|Randomized Phase||0
2955711|NCT00723450|3670007|FG001|NOT COMPLETED|Randomized Phase||65
2955712|NCT00723450|3670008|FG002|NOT COMPLETED|Randomized Phase||67
2955713|NCT00723489|3670021|FG000|STARTED|Overall Study||21
2955714|NCT00723489|3670022|FG001|STARTED|Overall Study||19
2955715|NCT00723489|3670023|FG002|STARTED|Overall Study||19
2955716|NCT00723489|3670024|FG003|STARTED|Overall Study||23
2955717|NCT00723489|3670021|FG000|COMPLETED|Overall Study|Includes seroconverters and non-seroconverters|20
2955718|NCT00723489|3670022|FG001|COMPLETED|Overall Study|Includes seroconverters and non-seroconverters|15
2955719|NCT00723489|3670023|FG002|COMPLETED|Overall Study|Includes seroconverters and non-seroconverters|19
2955720|NCT00723489|3670024|FG003|COMPLETED|Overall Study|Includes seroconverters and non-seroconverters|20
2955721|NCT00723489|3670021|FG000|NOT COMPLETED|Overall Study||1
2955722|NCT00723489|3670022|FG001|NOT COMPLETED|Overall Study||4
2955723|NCT00723489|3670023|FG002|NOT COMPLETED|Overall Study||0
2955724|NCT00723489|3670024|FG003|NOT COMPLETED|Overall Study||3
2955725|NCT00723528|3670037|FG000|STARTED|Period 1: Controlled Period (CP)||32
2955726|NCT00723528|3670038|FG001|STARTED|Period 1: Controlled Period (CP)||64
2955727|NCT00723528|3670039|FG002|STARTED|Period 1: Controlled Period (CP)||62
2955728|NCT00723528|3670040|FG003|STARTED|Period 1: Controlled Period (CP)||0
2955729|NCT00723528|3670041|FG004|STARTED|Period 1: Controlled Period (CP)||0
2955730|NCT00723528|3670042|FG005|STARTED|Period 1: Controlled Period (CP)||0
2955731|NCT00723528|3670043|FG006|STARTED|Period 1: Controlled Period (CP)||0
2955732|NCT00723528|3670037|FG000|COMPLETED|Period 1: Controlled Period (CP)||28
2955733|NCT00723528|3670038|FG001|COMPLETED|Period 1: Controlled Period (CP)||64
2955734|NCT00723528|3670039|FG002|COMPLETED|Period 1: Controlled Period (CP)||58
2955735|NCT00723528|3670040|FG003|COMPLETED|Period 1: Controlled Period (CP)||0
2955736|NCT00723528|3670041|FG004|COMPLETED|Period 1: Controlled Period (CP)||0
2955737|NCT00723528|3670042|FG005|COMPLETED|Period 1: Controlled Period (CP)||0
2955738|NCT00723528|3670043|FG006|COMPLETED|Period 1: Controlled Period (CP)||0
2955739|NCT00723528|3670037|FG000|NOT COMPLETED|Period 1: Controlled Period (CP)||4
2955740|NCT00723528|3670038|FG001|NOT COMPLETED|Period 1: Controlled Period (CP)||0
2955741|NCT00723528|3670039|FG002|NOT COMPLETED|Period 1: Controlled Period (CP)||4
2955742|NCT00723528|3670040|FG003|NOT COMPLETED|Period 1: Controlled Period (CP)||0
2955743|NCT00723528|3670041|FG004|NOT COMPLETED|Period 1: Controlled Period (CP)||0
2955744|NCT00723528|3670042|FG005|NOT COMPLETED|Period 1: Controlled Period (CP)||0
2955745|NCT00723528|3670043|FG006|NOT COMPLETED|Period 1: Controlled Period (CP)||0
2955746|NCT00723528|3670037|FG000|STARTED|Period 2: After Controlled Period||0
2955747|NCT00723528|3670038|FG001|STARTED|Period 2: After Controlled Period||0
2955748|NCT00723528|3670039|FG002|STARTED|Period 2: After Controlled Period||0
2955749|NCT00723528|3670040|FG003|STARTED|Period 2: After Controlled Period||15
2955750|NCT00723528|3670041|FG004|STARTED|Period 2: After Controlled Period||13
2955751|NCT00723528|3670042|FG005|STARTED|Period 2: After Controlled Period||64
2955752|NCT00723528|3670043|FG006|STARTED|Period 2: After Controlled Period||58
2955753|NCT00723528|3670037|FG000|COMPLETED|Period 2: After Controlled Period||0
2955754|NCT00723528|3670038|FG001|COMPLETED|Period 2: After Controlled Period||0
2955755|NCT00723528|3670039|FG002|COMPLETED|Period 2: After Controlled Period||0
2955756|NCT00723528|3670040|FG003|COMPLETED|Period 2: After Controlled Period||14
2955757|NCT00723528|3670041|FG004|COMPLETED|Period 2: After Controlled Period||11
2955758|NCT00723528|3670042|FG005|COMPLETED|Period 2: After Controlled Period||58
2955759|NCT00723528|3670043|FG006|COMPLETED|Period 2: After Controlled Period||54
2955760|NCT00723528|3670037|FG000|NOT COMPLETED|Period 2: After Controlled Period||0
2955761|NCT00723528|3670038|FG001|NOT COMPLETED|Period 2: After Controlled Period||0
2955762|NCT00723528|3670039|FG002|NOT COMPLETED|Period 2: After Controlled Period||0
2955763|NCT00723528|3670040|FG003|NOT COMPLETED|Period 2: After Controlled Period||1
2955764|NCT00723528|3670041|FG004|NOT COMPLETED|Period 2: After Controlled Period||2
2955765|NCT00723528|3670042|FG005|NOT COMPLETED|Period 2: After Controlled Period||6
2955766|NCT00723528|3670043|FG006|NOT COMPLETED|Period 2: After Controlled Period||4
2955767|NCT00723554|3670059|FG000|STARTED|Overall Study||63
2955768|NCT00723554|3670059|FG000|COMPLETED|Overall Study||34
2955769|NCT00723554|3670059|FG000|NOT COMPLETED|Overall Study||29
2955770|NCT00723580|3670065|FG000|STARTED|Overall Study|Study was extended with continued repeated measurements.|1
2955771|NCT00723580|3670065|FG000|Baseline Measurements|Overall Study|Actigraphic, Psychometric and Observational Baseline Data Collected.|1
2955772|NCT00723580|3670065|FG000|COMPLETED|Overall Study|Completion of repeated Measurements|1
2955773|NCT00723580|3670065|FG000|NOT COMPLETED|Overall Study||0
2955774|NCT00723606|3670071|FG000|STARTED|Overall Study||189
2955775|NCT00723606|3670072|FG001|STARTED|Overall Study||187
2955776|NCT00723606|3670071|FG000|COMPLETED|Overall Study||185
2955777|NCT00723606|3670072|FG001|COMPLETED|Overall Study||180
2955778|NCT00723606|3670071|FG000|NOT COMPLETED|Overall Study||4
2955779|NCT00723606|3670072|FG001|NOT COMPLETED|Overall Study||7
2955780|NCT00723632|3670078|FG000|STARTED|Overall Study||901
2955781|NCT00723632|3670078|FG000|COMPLETED|Overall Study|Completed initial exam form and >= 1 follow up visit form; end of treatment and SVR status recorded|698
2955782|NCT00723632|3670078|FG000|NOT COMPLETED|Overall Study||203
2955783|NCT00723645|3670082|FG000|STARTED|Visit 1 (≤4 Weeks Post-treatment)||258
2955784|NCT00723645|3670082|FG000|COMPLETED|Visit 1 (≤4 Weeks Post-treatment)||258
2955785|NCT00723645|3670082|FG000|NOT COMPLETED|Visit 1 (≤4 Weeks Post-treatment)||0
2955786|NCT00723645|3670082|FG000|STARTED|Visit 2 (Week 24 Post-treatment)|10 discontinued before Visit 2; 7 lost to follow-up and 3 were HCV RNA+ before Wk 24|248
2955787|NCT00723645|3670082|FG000|COMPLETED|Visit 2 (Week 24 Post-treatment)||248
2955788|NCT00723645|3670082|FG000|NOT COMPLETED|Visit 2 (Week 24 Post-treatment)||0
2955789|NCT00723645|3670082|FG000|STARTED|Visit 3 (Week 72 Post-treatment)|61 discontinued before V3; 26 lost to followup, 34 HCV RNA+ at Wk 24,1 death,1 HCV RNA not available|187
2955790|NCT00723645|3670082|FG000|COMPLETED|Visit 3 (Week 72 Post-treatment)||187
2955791|NCT00723645|3670082|FG000|NOT COMPLETED|Visit 3 (Week 72 Post-treatment)||0
2955792|NCT00723697|3670086|FG000|STARTED|Overall Study||1307
2955793|NCT00723697|3670086|FG000|COMPLETED|Overall Study||1289
2955794|NCT00723697|3670086|FG000|NOT COMPLETED|Overall Study||18
2955795|NCT00723710|3670093|FG000|STARTED|Overall Study||294
2955796|NCT00723710|3670093|FG000|COMPLETED|Overall Study||120
2955797|NCT00723710|3670093|FG000|NOT COMPLETED|Overall Study||174
2955798|NCT00723749|3670097|FG000|STARTED|Overall Study|384 patients were enrolled, 36 non-eligible datasets were excluded from analysis|345
2955799|NCT00723749|3670097|FG000|COMPLETED|Overall Study||182
2955800|NCT00723749|3670097|FG000|NOT COMPLETED|Overall Study||163
2955801|NCT00723788|3670101|FG000|STARTED|Overall Study||21
2955802|NCT00723788|3670101|FG000|COMPLETED|Overall Study||21
2955803|NCT00723788|3670101|FG000|NOT COMPLETED|Overall Study||0
2955804|NCT00723801|3670109|FG000|STARTED|Overall Study||20
2955805|NCT00723801|3670110|FG001|STARTED|Overall Study||20
2955806|NCT00723801|3670109|FG000|COMPLETED|Overall Study||17
2955807|NCT00723801|3670110|FG001|COMPLETED|Overall Study||17
2955808|NCT00723801|3670109|FG000|NOT COMPLETED|Overall Study||3
2955809|NCT00723801|3670110|FG001|NOT COMPLETED|Overall Study||3
2955810|NCT00723827|3670116|FG000|STARTED|Overall Study||682
2955811|NCT00723827|3670116|FG000|COMPLETED|Overall Study||682
2955812|NCT00723827|3670116|FG000|NOT COMPLETED|Overall Study||0
2955813|NCT00723840|3670120|FG000|STARTED|Overall Study||245
3132699|NCT01692743|3857859|FG001|COMPLETED|Overall Study||81
3132700|NCT01692743|3857860|FG002|COMPLETED|Overall Study||88
3132701|NCT01692743|3857858|FG000|NOT COMPLETED|Overall Study||27
2955814|NCT00723840|3670120|FG000|COMPLETED|Overall Study||163
2955815|NCT00723840|3670120|FG000|NOT COMPLETED|Overall Study||82
2955816|NCT00723892|3670133|FG000|STARTED|Overall Study||313
2955817|NCT00723892|3670134|FG001|STARTED|Overall Study||255
2955818|NCT00723892|3670133|FG000|COMPLETED|Overall Study||206
2955819|NCT00723892|3670134|FG001|COMPLETED|Overall Study||168
2955820|NCT00723892|3670133|FG000|NOT COMPLETED|Overall Study||107
2955821|NCT00723892|3670134|FG001|NOT COMPLETED|Overall Study||87
2955822|NCT00723931|3670140|FG000|STARTED|Overall Study||1267
2955823|NCT00723931|3670140|FG000|COMPLETED|Overall Study||1267
2955824|NCT00723931|3670140|FG000|NOT COMPLETED|Overall Study||0
2955825|NCT00723944|3670146|FG000|STARTED|Implant Placement Surgery|number of individual implant units is 148|52
2955826|NCT00723944|3670147|FG001|STARTED|Implant Placement Surgery|number of individual implant units is 138|50
2955827|NCT00723944|3670146|FG000|COMPLETED|Implant Placement Surgery|number of individual implant units completing is 148|52
2955828|NCT00723944|3670147|FG001|COMPLETED|Implant Placement Surgery|number of individual implant units completing is 138|50
2955829|NCT00723944|3670146|FG000|NOT COMPLETED|Implant Placement Surgery||0
2955830|NCT00723944|3670147|FG001|NOT COMPLETED|Implant Placement Surgery||0
2955831|NCT00723944|3670146|FG000|STARTED|Permanent Prosthesis Placement|number of individual implant units is 148|52
2955832|NCT00723944|3670147|FG001|STARTED|Permanent Prosthesis Placement|number of individual implant units is 138|50
2955833|NCT00723944|3670146|FG000|COMPLETED|Permanent Prosthesis Placement|number of individual implant units completing is 134|49
2955834|NCT00723944|3670147|FG001|COMPLETED|Permanent Prosthesis Placement|number of individual implant units completing is 112|41
2955835|NCT00723944|3670146|FG000|NOT COMPLETED|Permanent Prosthesis Placement||3
2955836|NCT00723944|3670147|FG001|NOT COMPLETED|Permanent Prosthesis Placement||9
2955837|NCT00723944|3670146|FG000|STARTED|One Year Post Placement Follow-up|number of individual implant units is 134|49
2955838|NCT00723944|3670147|FG001|STARTED|One Year Post Placement Follow-up|number of individual implant units is 112|41
2955839|NCT00723944|3670146|FG000|COMPLETED|One Year Post Placement Follow-up|number of individual implant units completing is 130|48
2955840|NCT00723944|3670147|FG001|COMPLETED|One Year Post Placement Follow-up|number of individual implant units completing is 108|37
2955841|NCT00723944|3670146|FG000|NOT COMPLETED|One Year Post Placement Follow-up||1
2955842|NCT00723944|3670147|FG001|NOT COMPLETED|One Year Post Placement Follow-up||4
2955843|NCT00723944|3670146|FG000|STARTED|Two Year Post Placement Follow-up|number of individual implant units is 130|48
2955844|NCT00723944|3670147|FG001|STARTED|Two Year Post Placement Follow-up|number of individual implant units is 108|37
2955845|NCT00723944|3670146|FG000|COMPLETED|Two Year Post Placement Follow-up|number of individual implant units completing is 130|48
2955846|NCT00723944|3670147|FG001|COMPLETED|Two Year Post Placement Follow-up|number of individual implant units completing is 108|37
2955847|NCT00723944|3670146|FG000|NOT COMPLETED|Two Year Post Placement Follow-up||0
2955848|NCT00723944|3670147|FG001|NOT COMPLETED|Two Year Post Placement Follow-up||0
2955849|NCT00723957|3670155|FG000|STARTED|Overall Study|Randomized|98
2955850|NCT00723957|3670156|FG001|STARTED|Overall Study|Randomized|99
2955851|NCT00723957|3670155|FG000|COMPLETED|Overall Study|Completed 6 cycles of study drug (maximum per protocol)|47
2955852|NCT00723957|3670156|FG001|COMPLETED|Overall Study|Completed 6 cycles of study drug (maximum per protocol)|46
2955853|NCT00723957|3670155|FG000|NOT COMPLETED|Overall Study||51
2955854|NCT00723957|3670156|FG001|NOT COMPLETED|Overall Study||53
3035126|NCT01135381|3754270|FG001|NOT COMPLETED|Overall Study||7
3035127|NCT01135381|3754271|FG002|NOT COMPLETED|Overall Study||4
3035128|NCT01135381|3754272|FG003|NOT COMPLETED|Overall Study||1
3035129|NCT01135394|3754282|FG000|STARTED|Screening||114
3035130|NCT01135394|3754282|FG000|COMPLETED|Screening||81
3035131|NCT01135394|3754282|FG000|NOT COMPLETED|Screening||33
3035132|NCT01135394|3754282|FG000|STARTED|Baseline Assessment||81
3035133|NCT01135394|3754282|FG000|COMPLETED|Baseline Assessment||66
3035134|NCT01135394|3754282|FG000|NOT COMPLETED|Baseline Assessment||15
3035135|NCT01135394|3754282|FG000|STARTED|Study Treatment||66
3035136|NCT01135394|3754282|FG000|COMPLETED|Study Treatment||62
3035137|NCT01135394|3754282|FG000|NOT COMPLETED|Study Treatment||4
3035138|NCT01135420|3754288|FG000|STARTED|Overall Study||199
3035139|NCT01135420|3754289|FG001|STARTED|Overall Study||207
3035140|NCT01135420|3754288|FG000|COMPLETED|Overall Study||155
3035141|NCT01135420|3754289|FG001|COMPLETED|Overall Study||175
3035142|NCT01135420|3754288|FG000|NOT COMPLETED|Overall Study||44
3035143|NCT01135420|3754289|FG001|NOT COMPLETED|Overall Study||32
3035144|NCT01135498|3754295|FG000|STARTED|Overall Study||90
3035145|NCT01135498|3754295|FG000|COMPLETED|Overall Study||0
3035146|NCT01135498|3754295|FG000|NOT COMPLETED|Overall Study||90
3035147|NCT01135511|3754309|FG000|STARTED|Overall Study||41
3035148|NCT01135511|3754310|FG001|STARTED|Overall Study||42
3035149|NCT01135511|3754311|FG002|STARTED|Overall Study||41
3035150|NCT01135511|3754312|FG003|STARTED|Overall Study||40
3035151|NCT01135511|3754313|FG004|STARTED|Overall Study||39
3035152|NCT01135511|3754314|FG005|STARTED|Overall Study||21
3035153|NCT01135511|3754315|FG006|STARTED|Overall Study||19
3035154|NCT01135511|3754316|FG007|STARTED|Overall Study||21
3035155|NCT01135511|3754317|FG008|STARTED|Overall Study||21
3035156|NCT01135511|3754309|FG000|COMPLETED|Overall Study||41
3035157|NCT01135511|3754310|FG001|COMPLETED|Overall Study||39
3035158|NCT01135511|3754311|FG002|COMPLETED|Overall Study||33
3035159|NCT01135511|3754312|FG003|COMPLETED|Overall Study||37
3035160|NCT01135511|3754313|FG004|COMPLETED|Overall Study||38
3035161|NCT01135511|3754314|FG005|COMPLETED|Overall Study||20
3035162|NCT01135511|3754315|FG006|COMPLETED|Overall Study||18
3035163|NCT01135511|3754316|FG007|COMPLETED|Overall Study||20
3035164|NCT01135511|3754317|FG008|COMPLETED|Overall Study||20
3035165|NCT01135511|3754309|FG000|NOT COMPLETED|Overall Study||0
3035166|NCT01135511|3754310|FG001|NOT COMPLETED|Overall Study||3
3035167|NCT01135511|3754311|FG002|NOT COMPLETED|Overall Study||8
3035168|NCT01135511|3754312|FG003|NOT COMPLETED|Overall Study||3
3035169|NCT01135511|3754313|FG004|NOT COMPLETED|Overall Study||1
3035170|NCT01135511|3754314|FG005|NOT COMPLETED|Overall Study||1
3035171|NCT01135511|3754315|FG006|NOT COMPLETED|Overall Study||1
3035172|NCT01135511|3754316|FG007|NOT COMPLETED|Overall Study||1
3035173|NCT01135511|3754317|FG008|NOT COMPLETED|Overall Study||1
2955855|NCT00724009|3670162|FG000|STARTED|Overall Study||29
2955856|NCT00724009|3670162|FG000|COMPLETED|Overall Study|One patient underwent conditioning but died 1 day before stem cell infusion due to sepsis.|29
2955857|NCT00724009|3670162|FG000|NOT COMPLETED|Overall Study||0
2955858|NCT00724061|3670166|FG000|STARTED|Dose Escalation Phase||7
2955859|NCT00724061|3670166|FG000|COMPLETED|Dose Escalation Phase||2
2955860|NCT00724061|3670166|FG000|NOT COMPLETED|Dose Escalation Phase||5
2955861|NCT00724061|3670166|FG000|STARTED|Maintenance Therapy||2
2955862|NCT00724061|3670166|FG000|COMPLETED|Maintenance Therapy||2
2955863|NCT00724061|3670166|FG000|NOT COMPLETED|Maintenance Therapy||0
2955864|NCT00724126|3670172|FG000|STARTED|Overall Study||321
2955865|NCT00724126|3670173|FG001|STARTED|Overall Study||316
2955866|NCT00724126|3670172|FG000|COMPLETED|Overall Study||302
2955867|NCT00724126|3670173|FG001|COMPLETED|Overall Study||301
2955868|NCT00724126|3670172|FG000|NOT COMPLETED|Overall Study||19
2955869|NCT00724126|3670173|FG001|NOT COMPLETED|Overall Study||15
2955870|NCT00724152|3670184|FG000|STARTED|Two-arm Study Period||14
2955871|NCT00724152|3670185|FG001|STARTED|Two-arm Study Period||11
2955872|NCT00724152|3670186|FG002|STARTED|Two-arm Study Period|Standard Care arm was added later (Period 2)|0
2955873|NCT00724152|3670184|FG000|COMPLETED|Two-arm Study Period||11
2955874|NCT00724152|3670185|FG001|COMPLETED|Two-arm Study Period||9
2955875|NCT00724152|3670186|FG002|COMPLETED|Two-arm Study Period||0
2955876|NCT00724152|3670184|FG000|NOT COMPLETED|Two-arm Study Period||3
2955877|NCT00724152|3670185|FG001|NOT COMPLETED|Two-arm Study Period||2
2955878|NCT00724152|3670186|FG002|NOT COMPLETED|Two-arm Study Period||0
2955879|NCT00724152|3670184|FG000|STARTED|Three-arm Study Period (+Standard Care)||4
2955880|NCT00724152|3670185|FG001|STARTED|Three-arm Study Period (+Standard Care)||2
2955881|NCT00724152|3670186|FG002|STARTED|Three-arm Study Period (+Standard Care)|3-group randomization began|2
2955882|NCT00724152|3670184|FG000|COMPLETED|Three-arm Study Period (+Standard Care)||3
2955883|NCT00724152|3670185|FG001|COMPLETED|Three-arm Study Period (+Standard Care)||0
2955884|NCT00724152|3670186|FG002|COMPLETED|Three-arm Study Period (+Standard Care)||1
2955885|NCT00724152|3670184|FG000|NOT COMPLETED|Three-arm Study Period (+Standard Care)||1
2955886|NCT00724152|3670185|FG001|NOT COMPLETED|Three-arm Study Period (+Standard Care)||2
2955887|NCT00724152|3670186|FG002|NOT COMPLETED|Three-arm Study Period (+Standard Care)||1
2955888|NCT00724243|3670196|FG000|STARTED|Overall Study||33
2955889|NCT00724243|3670196|FG000|COMPLETED|Overall Study||18
2955890|NCT00724243|3670196|FG000|NOT COMPLETED|Overall Study||15
2955891|NCT00724308|3670202|FG000|STARTED|Overall Study||270
2955892|NCT00724308|3670203|FG001|STARTED|Overall Study||307
2955893|NCT00724308|3670202|FG000|COMPLETED|Overall Study||190
2955894|NCT00724308|3670203|FG001|COMPLETED|Overall Study||210
2955895|NCT00724308|3670202|FG000|NOT COMPLETED|Overall Study||80
2955896|NCT00724308|3670203|FG001|NOT COMPLETED|Overall Study||97
2955897|NCT00724347|3670209|FG000|STARTED|Overall Study|Training was the final step in the program, once the outcome tests had been developed.|18
2955898|NCT00724347|3670209|FG000|Baseline Testing|Overall Study||18
2955899|NCT00724347|3670209|FG000|COMPLETED|Overall Study||16
2955900|NCT00724347|3670209|FG000|NOT COMPLETED|Overall Study||2
2955901|NCT00724373|3670213|FG000|STARTED|Overall Study||442
2955902|NCT00724373|3670213|FG000|COMPLETED|Overall Study||271
2955903|NCT00724373|3670213|FG000|NOT COMPLETED|Overall Study||171
2955904|NCT00724451|3670217|FG000|STARTED|Overall Study||1128
2955905|NCT00724451|3670217|FG000|Received Antiviral Treatment|Overall Study||500
2955906|NCT00724451|3670217|FG000|COMPLETED|Overall Study|Completed defined as participants who completed anti-viral treatment.|326
2955907|NCT00724451|3670217|FG000|NOT COMPLETED|Overall Study||802
2955908|NCT00724464|3670221|FG000|STARTED|Overall Study||332
2955909|NCT00724464|3670221|FG000|COMPLETED|Overall Study||309
2955910|NCT00724464|3670221|FG000|NOT COMPLETED|Overall Study||23
2955911|NCT00724503|3670228|FG000|STARTED|Overall Study||267
2955912|NCT00724503|3670229|FG001|STARTED|Overall Study||263
2955913|NCT00724503|3670228|FG000|COMPLETED|Overall Study||57
2955914|NCT00724503|3670229|FG001|COMPLETED|Overall Study||43
2955915|NCT00724503|3670228|FG000|NOT COMPLETED|Overall Study||210
2955916|NCT00724503|3670229|FG001|NOT COMPLETED|Overall Study||220
2955917|NCT00724568|3670237|FG000|STARTED|Overall Study||42
2955918|NCT00724568|3670238|FG001|STARTED|Overall Study||32
2955919|NCT00724568|3670237|FG000|COMPLETED|Overall Study||42
2955920|NCT00724568|3670238|FG001|COMPLETED|Overall Study||32
2955921|NCT00724568|3670237|FG000|NOT COMPLETED|Overall Study||0
2955922|NCT00724568|3670238|FG001|NOT COMPLETED|Overall Study||0
2955923|NCT00724594|3670246|FG000|STARTED|Overall Study||12
2955924|NCT00724594|3670247|FG001|STARTED|Overall Study||12
2955925|NCT00724594|3670248|FG002|STARTED|Overall Study||11
2955926|NCT00724594|3670249|FG003|STARTED|Overall Study||11
2955927|NCT00724594|3670246|FG000|COMPLETED|Overall Study||12
2955928|NCT00724594|3670247|FG001|COMPLETED|Overall Study||12
2955929|NCT00724594|3670248|FG002|COMPLETED|Overall Study||11
2955930|NCT00724594|3670249|FG003|COMPLETED|Overall Study||10
2955931|NCT00724594|3670246|FG000|NOT COMPLETED|Overall Study||0
2955932|NCT00724594|3670247|FG001|NOT COMPLETED|Overall Study||0
2955933|NCT00724594|3670248|FG002|NOT COMPLETED|Overall Study||0
2955934|NCT00724594|3670249|FG003|NOT COMPLETED|Overall Study||1
2955935|NCT00724711|3670276|FG000|STARTED|Overall Study||155
2955936|NCT00724711|3670277|FG001|STARTED|Overall Study||156
2955937|NCT00724711|3670276|FG000|COMPLETED|Overall Study||138
2955938|NCT00724711|3670277|FG001|COMPLETED|Overall Study||139
2955939|NCT00724711|3670276|FG000|NOT COMPLETED|Overall Study||17
2955940|NCT00724711|3670277|FG001|NOT COMPLETED|Overall Study||17
2955941|NCT00724750|3670285|FG000|STARTED|Overall Study||45
2955942|NCT00724750|3670286|FG001|STARTED|Overall Study||42
2955943|NCT00724750|3670285|FG000|COMPLETED|Overall Study||45
2955944|NCT00724750|3670286|FG001|COMPLETED|Overall Study||42
2955945|NCT00724750|3670285|FG000|NOT COMPLETED|Overall Study||0
2955946|NCT00724750|3670286|FG001|NOT COMPLETED|Overall Study||0
2955947|NCT00724815|3670294|FG000|STARTED|Overall Study|subjects randomized|265
2955948|NCT00724815|3670295|FG001|STARTED|Overall Study|subjects randomized|265
2955949|NCT00724815|3670294|FG000|COMPLETED|Overall Study||222
2955950|NCT00724815|3670295|FG001|COMPLETED|Overall Study||226
2955951|NCT00724815|3670294|FG000|NOT COMPLETED|Overall Study||43
2955952|NCT00724815|3670295|FG001|NOT COMPLETED|Overall Study||39
2955953|NCT00724854|3670303|FG000|STARTED|Overall Study|Number enrolled was 1146. 64 participants were screen failures.|1010
2955954|NCT00724854|3670304|FG001|STARTED|Overall Study|Number enrolled was 1146. 64 participants were screen failures.|72
2955955|NCT00724854|3670303|FG000|COMPLETED|Overall Study||607
2955956|NCT00724854|3670304|FG001|COMPLETED|Overall Study||41
2955957|NCT00724854|3670303|FG000|NOT COMPLETED|Overall Study||403
2955958|NCT00724854|3670304|FG001|NOT COMPLETED|Overall Study||31
2955959|NCT00724867|3670311|FG000|STARTED|Overall Study||268
2955960|NCT00724867|3670311|FG000|COMPLETED|Overall Study||140
2955961|NCT00724867|3670311|FG000|NOT COMPLETED|Overall Study||128
2955962|NCT00724893|3670320|FG000|STARTED|Overall Study||1302
2955963|NCT00724893|3670321|FG001|STARTED|Overall Study||1128
2955964|NCT00724893|3670320|FG000|COMPLETED|Overall Study||938
2955965|NCT00724893|3670321|FG001|COMPLETED|Overall Study||670
2955966|NCT00724893|3670320|FG000|NOT COMPLETED|Overall Study||364
2955967|NCT00724893|3670321|FG001|NOT COMPLETED|Overall Study||458
2955968|NCT00724932|3670344|FG000|STARTED|Overall Study||70
2955969|NCT00724932|3670345|FG001|STARTED|Overall Study||70
2955970|NCT00724932|3670344|FG000|COMPLETED|Overall Study||65
2955971|NCT00724932|3670345|FG001|COMPLETED|Overall Study||67
2955972|NCT00724932|3670344|FG000|NOT COMPLETED|Overall Study||5
2955973|NCT00724932|3670345|FG001|NOT COMPLETED|Overall Study||3
2955974|NCT00724945|3670353|FG000|STARTED|Period 1||58
2955975|NCT00724945|3670354|FG001|STARTED|Period 1||55
2955976|NCT00724945|3670353|FG000|COMPLETED|Period 1||55
2955977|NCT00724945|3670354|FG001|COMPLETED|Period 1||54
2955978|NCT00724945|3670353|FG000|NOT COMPLETED|Period 1||3
2955979|NCT00724945|3670354|FG001|NOT COMPLETED|Period 1||1
2955980|NCT00724945|3670353|FG000|STARTED|Period 2||55
2955981|NCT00724945|3670354|FG001|STARTED|Period 2||54
2955982|NCT00724945|3670353|FG000|COMPLETED|Period 2||51
2955983|NCT00724945|3670354|FG001|COMPLETED|Period 2||54
2955984|NCT00724945|3670353|FG000|NOT COMPLETED|Period 2||4
2955985|NCT00724945|3670354|FG001|NOT COMPLETED|Period 2||0
2955986|NCT00724958|3670360|FG000|STARTED|Overall Study||348
2955987|NCT00724958|3670360|FG000|COMPLETED|Overall Study||166
2955988|NCT00724958|3670360|FG000|NOT COMPLETED|Overall Study||182
2955989|NCT00724971|3670364|FG000|STARTED|Overall Study||10
2955990|NCT00724971|3670364|FG000|COMPLETED|Overall Study||4
2955991|NCT00724971|3670364|FG000|NOT COMPLETED|Overall Study||6
2955992|NCT00724984|3670374|FG000|STARTED|Overall Study||5
2955993|NCT00724984|3670375|FG001|STARTED|Overall Study||8
2955994|NCT00724984|3670376|FG002|STARTED|Overall Study||3
2955995|NCT00724984|3670377|FG003|STARTED|Overall Study||9
2955996|NCT00724984|3670378|FG004|STARTED|Overall Study||16
2955997|NCT00724984|3670379|FG005|STARTED|Overall Study||14
2955998|NCT00724984|3670374|FG000|COMPLETED|Overall Study||4
2955999|NCT00724984|3670375|FG001|COMPLETED|Overall Study||7
2956000|NCT00724984|3670376|FG002|COMPLETED|Overall Study||3
2956001|NCT00724984|3670377|FG003|COMPLETED|Overall Study||7
2956002|NCT00724984|3670378|FG004|COMPLETED|Overall Study||12
2956003|NCT00724984|3670379|FG005|COMPLETED|Overall Study||9
2956004|NCT00724984|3670374|FG000|NOT COMPLETED|Overall Study||1
2956005|NCT00724984|3670375|FG001|NOT COMPLETED|Overall Study||1
2956006|NCT00724984|3670376|FG002|NOT COMPLETED|Overall Study||0
2956007|NCT00724984|3670377|FG003|NOT COMPLETED|Overall Study||2
2956008|NCT00724984|3670378|FG004|NOT COMPLETED|Overall Study||4
2956009|NCT00724984|3670379|FG005|NOT COMPLETED|Overall Study||5
2956010|NCT00725010|3670393|FG000|STARTED|Overall Study|Only in 50 of 64 participants the documentation of therapy and follow-up was received and evaluated.|50
2956011|NCT00725010|3670393|FG000|COMPLETED|Overall Study||25
2956012|NCT00725010|3670393|FG000|NOT COMPLETED|Overall Study||25
2956013|NCT00725049|3670401|FG000|STARTED|Overall Study||17
2956014|NCT00725049|3670402|FG001|STARTED|Overall Study||20
2956015|NCT00725049|3670401|FG000|COMPLETED|Overall Study||17
2956016|NCT00725049|3670402|FG001|COMPLETED|Overall Study||20
2956017|NCT00725049|3670401|FG000|NOT COMPLETED|Overall Study||0
2956018|NCT00725049|3670402|FG001|NOT COMPLETED|Overall Study||0
2956019|NCT00725075|3670411|FG000|STARTED|Overall Study||72
2956020|NCT00725075|3670412|FG001|STARTED|Overall Study||73
2956021|NCT00725075|3670413|FG002|STARTED|Overall Study||70
2956022|NCT00725075|3670411|FG000|Treated|Overall Study||71
2956023|NCT00725075|3670412|FG001|Treated|Overall Study||73
2956024|NCT00725075|3670413|FG002|Treated|Overall Study||70
2956025|NCT00725075|3670411|FG000|COMPLETED|Overall Study||61
2956026|NCT00725075|3670412|FG001|COMPLETED|Overall Study||65
2956027|NCT00725075|3670413|FG002|COMPLETED|Overall Study||61
2956028|NCT00725075|3670411|FG000|NOT COMPLETED|Overall Study||11
2956029|NCT00725075|3670412|FG001|NOT COMPLETED|Overall Study||8
2956030|NCT00725075|3670413|FG002|NOT COMPLETED|Overall Study||9
2956031|NCT00725101|3670421|FG000|STARTED|Overall Study||1700
2956032|NCT00725101|3670421|FG000|COMPLETED|Overall Study||1205
2956033|NCT00725101|3670421|FG000|NOT COMPLETED|Overall Study||495
2956034|NCT00725153|3670425|FG000|STARTED|Period One, 10 Hours of Wear||27
2956035|NCT00725153|3670426|FG001|STARTED|Period One, 10 Hours of Wear||28
2956036|NCT00725153|3670425|FG000|COMPLETED|Period One, 10 Hours of Wear||27
2956037|NCT00725153|3670426|FG001|COMPLETED|Period One, 10 Hours of Wear||28
2956038|NCT00725153|3670425|FG000|NOT COMPLETED|Period One, 10 Hours of Wear||0
2956039|NCT00725153|3670426|FG001|NOT COMPLETED|Period One, 10 Hours of Wear||0
2956040|NCT00725153|3670425|FG000|STARTED|Period Two, 10 Hours of Wear||27
2956041|NCT00725153|3670426|FG001|STARTED|Period Two, 10 Hours of Wear||28
2956042|NCT00725153|3670425|FG000|COMPLETED|Period Two, 10 Hours of Wear||27
2956043|NCT00725153|3670426|FG001|COMPLETED|Period Two, 10 Hours of Wear||28
2956044|NCT00725153|3670425|FG000|NOT COMPLETED|Period Two, 10 Hours of Wear||0
2956045|NCT00725153|3670426|FG001|NOT COMPLETED|Period Two, 10 Hours of Wear||0
2956046|NCT00725205|3670432|FG000|STARTED|Overall Study||294
2956047|NCT00725205|3670432|FG000|COMPLETED|Overall Study||207
2956048|NCT00725205|3670432|FG000|NOT COMPLETED|Overall Study||87
2956049|NCT00725270|3670438|FG000|STARTED|Overall Study||5
2956050|NCT00725270|3670439|FG001|STARTED|Overall Study||7
2956051|NCT00725270|3670438|FG000|COMPLETED|Overall Study||5
2956052|NCT00725270|3670439|FG001|COMPLETED|Overall Study||7
2956053|NCT00725270|3670438|FG000|NOT COMPLETED|Overall Study||0
2956054|NCT00725270|3670439|FG001|NOT COMPLETED|Overall Study||0
2956055|NCT00725283|3670445|FG000|STARTED|Overall Study||34
2956056|NCT00725283|3670445|FG000|COMPLETED|Overall Study||10
2956057|NCT00725283|3670445|FG000|NOT COMPLETED|Overall Study||24
2956058|NCT00725296|3670449|FG000|STARTED|Overall Study|163 of the 178 enrolled participants received at least one dose of Infliximab.|163
2956059|NCT00725296|3670449|FG000|COMPLETED|Overall Study|Completed was defined as the number of participants who received 9 consecutive infusions.|101
2956060|NCT00725296|3670449|FG000|NOT COMPLETED|Overall Study||62
2956061|NCT00725322|3670456|FG000|STARTED|First Injection Visit||15
2956062|NCT00725322|3670457|FG001|STARTED|First Injection Visit||15
2956063|NCT00725322|3670456|FG000|COMPLETED|First Injection Visit||15
2956064|NCT00725322|3670457|FG001|COMPLETED|First Injection Visit||15
2956065|NCT00725322|3670456|FG000|NOT COMPLETED|First Injection Visit||0
2956066|NCT00725322|3670457|FG001|NOT COMPLETED|First Injection Visit||0
2956067|NCT00725322|3670456|FG000|STARTED|Washout (28 Days)||15
2956068|NCT00725322|3670457|FG001|STARTED|Washout (28 Days)||15
2956069|NCT00725322|3670456|FG000|COMPLETED|Washout (28 Days)||13
2956070|NCT00725322|3670457|FG001|COMPLETED|Washout (28 Days)||14
2956071|NCT00725322|3670456|FG000|NOT COMPLETED|Washout (28 Days)||2
2956072|NCT00725322|3670457|FG001|NOT COMPLETED|Washout (28 Days)||1
2956073|NCT00725322|3670456|FG000|STARTED|Second Injection Visit||13
2956074|NCT00725322|3670457|FG001|STARTED|Second Injection Visit||14
2956075|NCT00725322|3670456|FG000|COMPLETED|Second Injection Visit||13
2956076|NCT00725322|3670457|FG001|COMPLETED|Second Injection Visit||14
2956077|NCT00725322|3670456|FG000|NOT COMPLETED|Second Injection Visit||0
2956078|NCT00725322|3670457|FG001|NOT COMPLETED|Second Injection Visit||0
2956079|NCT00725361|3670463|FG000|STARTED|Overall Study||20
2956080|NCT00725361|3670463|FG000|COMPLETED|Overall Study||16
2956081|NCT00725361|3670463|FG000|NOT COMPLETED|Overall Study||4
2956082|NCT00725452|3670467|FG000|STARTED|Overall Study||26
2956083|NCT00725452|3670467|FG000|COMPLETED|Overall Study|Completed was defined as the number of participants who received 9 consecutive Infliximab infusions.|15
2956084|NCT00725452|3670467|FG000|NOT COMPLETED|Overall Study||11
2956085|NCT00725504|3670471|FG000|STARTED|Overall Study||71
2956086|NCT00725504|3670471|FG000|COMPLETED|Overall Study||71
2956087|NCT00725504|3670471|FG000|NOT COMPLETED|Overall Study||0
2956088|NCT00725530|3670478|FG000|STARTED|First Intervention, 7 Days (+0/-1)||27
2956089|NCT00725530|3670479|FG001|STARTED|First Intervention, 7 Days (+0/-1)||27
2956090|NCT00725530|3670478|FG000|COMPLETED|First Intervention, 7 Days (+0/-1)||27
2956091|NCT00725530|3670479|FG001|COMPLETED|First Intervention, 7 Days (+0/-1)||27
2956092|NCT00725530|3670478|FG000|NOT COMPLETED|First Intervention, 7 Days (+0/-1)||0
2956093|NCT00725530|3670479|FG001|NOT COMPLETED|First Intervention, 7 Days (+0/-1)||0
2956094|NCT00725530|3670478|FG000|STARTED|Second Intervention, 7 Days (+0/-1)||27
2956095|NCT00725530|3670479|FG001|STARTED|Second Intervention, 7 Days (+0/-1)||27
2956096|NCT00725530|3670478|FG000|COMPLETED|Second Intervention, 7 Days (+0/-1)||27
2956097|NCT00725530|3670479|FG001|COMPLETED|Second Intervention, 7 Days (+0/-1)||27
2956098|NCT00725530|3670478|FG000|NOT COMPLETED|Second Intervention, 7 Days (+0/-1)||0
2956099|NCT00725530|3670479|FG001|NOT COMPLETED|Second Intervention, 7 Days (+0/-1)||0
2956100|NCT00725543|3670485|FG000|STARTED|Overall Study||358
2956101|NCT00725543|3670485|FG000|COMPLETED|Overall Study|Completed was defined as the number of participants who received 9 consecutive Remicade infusions.|205
2956102|NCT00725543|3670485|FG000|NOT COMPLETED|Overall Study||153
2956103|NCT00725608|3670489|FG000|STARTED|Overall Study|339 patients enrolled, 32 non-eligible datasets excluded from final general and safety analysis|307
2956104|NCT00725608|3670489|FG000|COMPLETED|Overall Study|1 patient terminated treatment at day 368 and was counted as dropout|140
2956105|NCT00725608|3670489|FG000|NOT COMPLETED|Overall Study||167
2956106|NCT00725621|3670493|FG000|STARTED|Overall Study|Started was defined as the number of participants who received at least one infusion of Remicade.|516
3035174|NCT01135524|3754337|FG000|STARTED|Overall Study||196
3132702|NCT01692743|3857859|FG001|NOT COMPLETED|Overall Study||35
3132703|NCT01692743|3857860|FG002|NOT COMPLETED|Overall Study||27
2956107|NCT00725621|3670493|FG000|COMPLETED|Overall Study|Completed was defined as the number of participants who received 9 consecutive Remicade infusions.|245
2956108|NCT00725621|3670493|FG000|NOT COMPLETED|Overall Study||271
2956109|NCT00725712|3670503|FG000|STARTED|Overall Study||48
2956110|NCT00725712|3670504|FG001|STARTED|Overall Study||26
2956111|NCT00725712|3670503|FG000|COMPLETED|Overall Study||0
2956112|NCT00725712|3670504|FG001|COMPLETED|Overall Study||0
2956113|NCT00725712|3670503|FG000|NOT COMPLETED|Overall Study||48
2956114|NCT00725712|3670504|FG001|NOT COMPLETED|Overall Study||26
2956115|NCT00725725|3670517|FG000|STARTED|Overall Study||14
2956116|NCT00725725|3670518|FG001|STARTED|Overall Study||15
2956117|NCT00725725|3670519|FG002|STARTED|Overall Study||17
2956118|NCT00725725|3670517|FG000|Treated|Overall Study||11
2956119|NCT00725725|3670518|FG001|Treated|Overall Study||15
2956120|NCT00725725|3670519|FG002|Treated|Overall Study||14
3163553|NCT01887717|3891096|FG000|Received at Least 1 Dose of Study Drug|Overall Study||15
3163554|NCT01887717|3891097|FG001|Received at Least 1 Dose of Study Drug|Overall Study||16
3163555|NCT01887717|3891096|FG000|COMPLETED|Overall Study||11
3163556|NCT01887717|3891097|FG001|COMPLETED|Overall Study||8
3163557|NCT01887717|3891096|FG000|NOT COMPLETED|Overall Study||6
3163558|NCT01887717|3891097|FG001|NOT COMPLETED|Overall Study||11
3163559|NCT01887912|3891105|FG000|STARTED|Overall Study||6201
3163560|NCT01887912|3891106|FG001|STARTED|Overall Study||3101
3163561|NCT01887912|3891105|FG000|Safety Population|Overall Study||6113
3163562|NCT01887912|3891106|FG001|Safety Population|Overall Study||3057
3163563|NCT01887912|3891105|FG000|COMPLETED|Overall Study||4809
3163564|NCT01887912|3891106|FG001|COMPLETED|Overall Study||2370
3163565|NCT01887912|3891105|FG000|NOT COMPLETED|Overall Study||1392
3163566|NCT01887912|3891106|FG001|NOT COMPLETED|Overall Study||731
3163567|NCT01887990|3891116|FG000|STARTED|Overall Study||7
3163568|NCT01887990|3891117|FG001|STARTED|Overall Study||7
3163569|NCT01887990|3891118|FG002|STARTED|Overall Study||2
3163570|NCT01887990|3891119|FG003|STARTED|Overall Study||2
2956121|NCT00725725|3670517|FG000|COMPLETED|Overall Study||10
2956122|NCT00725725|3670518|FG001|COMPLETED|Overall Study||11
2956123|NCT00725725|3670519|FG002|COMPLETED|Overall Study||12
2956124|NCT00725725|3670517|FG000|NOT COMPLETED|Overall Study||4
2956125|NCT00725725|3670518|FG001|NOT COMPLETED|Overall Study||4
2956126|NCT00725725|3670519|FG002|NOT COMPLETED|Overall Study||5
2956127|NCT00725751|3670529|FG000|STARTED|Overall Study||90
2956128|NCT00725751|3670530|FG001|STARTED|Overall Study||258
2956129|NCT00725751|3670529|FG000|COMPLETED|Overall Study||56
2956130|NCT00725751|3670530|FG001|COMPLETED|Overall Study||150
2956131|NCT00725751|3670529|FG000|NOT COMPLETED|Overall Study||34
2956132|NCT00725751|3670530|FG001|NOT COMPLETED|Overall Study||108
2956133|NCT00725764|3670537|FG000|STARTED|Overall Study||14
2956134|NCT00725764|3670537|FG000|COMPLETED|Overall Study||0
2956135|NCT00725764|3670537|FG000|NOT COMPLETED|Overall Study||14
2956136|NCT00725842|3670542|FG000|STARTED|Overall Study||97
2956137|NCT00725842|3670542|FG000|Participants Eligible for Analysis|Overall Study||90
2956138|NCT00725842|3670542|FG000|COMPLETED|Overall Study||57
2956139|NCT00725842|3670542|FG000|NOT COMPLETED|Overall Study||40
2956140|NCT00725920|3670548|FG000|STARTED|Overall Study||17
2956141|NCT00725920|3670549|FG001|STARTED|Overall Study||18
2956142|NCT00725920|3670548|FG000|COMPLETED|Overall Study||14
2956143|NCT00725920|3670549|FG001|COMPLETED|Overall Study||12
2956144|NCT00725920|3670548|FG000|NOT COMPLETED|Overall Study||3
2956145|NCT00725920|3670549|FG001|NOT COMPLETED|Overall Study||6
2956146|NCT00725959|3670557|FG000|STARTED|Overall Study||942
2956147|NCT00725959|3670558|FG001|STARTED|Overall Study||636
2956148|NCT00725959|3670557|FG000|COMPLETED|Overall Study||653
2956149|NCT00725959|3670558|FG001|COMPLETED|Overall Study||439
2956150|NCT00725959|3670557|FG000|NOT COMPLETED|Overall Study||289
2956151|NCT00725959|3670558|FG001|NOT COMPLETED|Overall Study||197
2956152|NCT00726063|3670566|FG000|STARTED|Overall Study|Number of implants= 239|122
2956153|NCT00726063|3670567|FG001|STARTED|Overall Study|Number of implants= 246|119
2956154|NCT00726063|3670566|FG000|COMPLETED|Overall Study|Number of implants =230|113
2956155|NCT00726063|3670567|FG001|COMPLETED|Overall Study|Number of implants = 239|112
2956156|NCT00726063|3670566|FG000|NOT COMPLETED|Overall Study||9
2956157|NCT00726063|3670567|FG001|NOT COMPLETED|Overall Study||7
2956158|NCT00726232|3670579|FG000|STARTED|Initial Phase (Dose-finding)|The starting dose selected for the PV expansion cohort was 10 mg bid hence the sample size is larger|19
2956159|NCT00726232|3670580|FG001|STARTED|Initial Phase (Dose-finding)||8
2956160|NCT00726232|3670581|FG002|STARTED|Initial Phase (Dose-finding)||7
2956161|NCT00726232|3670582|FG003|STARTED|Initial Phase (Dose-finding)||8
2956162|NCT00726232|3670583|FG004|STARTED|Initial Phase (Dose-finding)|The starting dose selected for the ET expansion cohort was 25 mg bid hence the sample size is larger|22
2956163|NCT00726232|3670584|FG005|STARTED|Initial Phase (Dose-finding)||9
2956164|NCT00726232|3670585|FG006|STARTED|Initial Phase (Dose-finding)||0
2956165|NCT00726232|3670586|FG007|STARTED|Initial Phase (Dose-finding)||0
2956166|NCT00726232|3670579|FG000|Safety Evaluable Participants|Initial Phase (Dose-finding)||19
2956167|NCT00726232|3670580|FG001|Safety Evaluable Participants|Initial Phase (Dose-finding)||8
2956168|NCT00726232|3670581|FG002|Safety Evaluable Participants|Initial Phase (Dose-finding)||7
3035175|NCT01135524|3754337|FG000|COMPLETED|Overall Study||0
3163571|NCT01887990|3891116|FG000|COMPLETED|Overall Study||7
3163572|NCT01887990|3891117|FG001|COMPLETED|Overall Study||7
3163573|NCT01887990|3891118|FG002|COMPLETED|Overall Study||2
3163574|NCT01887990|3891119|FG003|COMPLETED|Overall Study||2
2956169|NCT00726232|3670582|FG003|Safety Evaluable Participants|Initial Phase (Dose-finding)||8
2956170|NCT00726232|3670583|FG004|Safety Evaluable Participants|Initial Phase (Dose-finding)||22
2956171|NCT00726232|3670584|FG005|Safety Evaluable Participants|Initial Phase (Dose-finding)||9
2956172|NCT00726232|3670585|FG006|Safety Evaluable Participants|Initial Phase (Dose-finding)||0
2956173|NCT00726232|3670586|FG007|Safety Evaluable Participants|Initial Phase (Dose-finding)||0
2956174|NCT00726232|3670579|FG000|ITT Participants|Initial Phase (Dose-finding)||19
2956175|NCT00726232|3670580|FG001|ITT Participants|Initial Phase (Dose-finding)||8
2956176|NCT00726232|3670581|FG002|ITT Participants|Initial Phase (Dose-finding)||7
2956177|NCT00726232|3670582|FG003|ITT Participants|Initial Phase (Dose-finding)||8
2956178|NCT00726232|3670583|FG004|ITT Participants|Initial Phase (Dose-finding)||22
2956179|NCT00726232|3670584|FG005|ITT Participants|Initial Phase (Dose-finding)||9
2956180|NCT00726232|3670585|FG006|ITT Participants|Initial Phase (Dose-finding)||0
2956181|NCT00726232|3670586|FG007|ITT Participants|Initial Phase (Dose-finding)||0
2956182|NCT00726232|3670579|FG000|COMPLETED|Initial Phase (Dose-finding)||6
2956183|NCT00726232|3670580|FG001|COMPLETED|Initial Phase (Dose-finding)||2
2956184|NCT00726232|3670581|FG002|COMPLETED|Initial Phase (Dose-finding)||2
2956185|NCT00726232|3670582|FG003|COMPLETED|Initial Phase (Dose-finding)||0
2956186|NCT00726232|3670583|FG004|COMPLETED|Initial Phase (Dose-finding)||1
2956187|NCT00726232|3670584|FG005|COMPLETED|Initial Phase (Dose-finding)||0
2956188|NCT00726232|3670585|FG006|COMPLETED|Initial Phase (Dose-finding)||0
2956189|NCT00726232|3670586|FG007|COMPLETED|Initial Phase (Dose-finding)||0
2956190|NCT00726232|3670579|FG000|NOT COMPLETED|Initial Phase (Dose-finding)||13
2956191|NCT00726232|3670580|FG001|NOT COMPLETED|Initial Phase (Dose-finding)||6
2956192|NCT00726232|3670581|FG002|NOT COMPLETED|Initial Phase (Dose-finding)||5
2956193|NCT00726232|3670582|FG003|NOT COMPLETED|Initial Phase (Dose-finding)||8
2956194|NCT00726232|3670583|FG004|NOT COMPLETED|Initial Phase (Dose-finding)||21
2956195|NCT00726232|3670584|FG005|NOT COMPLETED|Initial Phase (Dose-finding)||9
2956196|NCT00726232|3670585|FG006|NOT COMPLETED|Initial Phase (Dose-finding)||0
2956197|NCT00726232|3670586|FG007|NOT COMPLETED|Initial Phase (Dose-finding)||0
2956198|NCT00726232|3670579|FG000|STARTED|Expansion Phase||0
2956199|NCT00726232|3670580|FG001|STARTED|Expansion Phase||0
2956200|NCT00726232|3670581|FG002|STARTED|Expansion Phase||0
2956201|NCT00726232|3670582|FG003|STARTED|Expansion Phase||0
2956202|NCT00726232|3670583|FG004|STARTED|Expansion Phase||0
2956203|NCT00726232|3670584|FG005|STARTED|Expansion Phase||0
2956204|NCT00726232|3670585|FG006|STARTED|Expansion Phase||34
2956205|NCT00726232|3670586|FG007|STARTED|Expansion Phase||39
2956206|NCT00726232|3670579|FG000|Safety Evaluable Participants|Expansion Phase||0
2956207|NCT00726232|3670580|FG001|Safety Evaluable Participants|Expansion Phase||0
2956208|NCT00726232|3670581|FG002|Safety Evaluable Participants|Expansion Phase||0
2956209|NCT00726232|3670582|FG003|Safety Evaluable Participants|Expansion Phase||0
2956210|NCT00726232|3670583|FG004|Safety Evaluable Participants|Expansion Phase||0
2956211|NCT00726232|3670584|FG005|Safety Evaluable Participants|Expansion Phase||0
2956212|NCT00726232|3670585|FG006|Safety Evaluable Participants|Expansion Phase||34
2956213|NCT00726232|3670586|FG007|Safety Evaluable Participants|Expansion Phase||39
2956214|NCT00726232|3670579|FG000|ITT Participants|Expansion Phase||0
2956215|NCT00726232|3670580|FG001|ITT Participants|Expansion Phase||0
2956216|NCT00726232|3670581|FG002|ITT Participants|Expansion Phase||0
2956217|NCT00726232|3670582|FG003|ITT Participants|Expansion Phase||0
2956218|NCT00726232|3670583|FG004|ITT Participants|Expansion Phase||0
2956219|NCT00726232|3670584|FG005|ITT Participants|Expansion Phase||0
2956220|NCT00726232|3670585|FG006|ITT Participants|Expansion Phase||34
2956221|NCT00726232|3670586|FG007|ITT Participants|Expansion Phase||39
2956222|NCT00726232|3670579|FG000|COMPLETED|Expansion Phase||0
2956223|NCT00726232|3670580|FG001|COMPLETED|Expansion Phase||0
2956224|NCT00726232|3670581|FG002|COMPLETED|Expansion Phase||0
2956225|NCT00726232|3670582|FG003|COMPLETED|Expansion Phase||0
2956226|NCT00726232|3670583|FG004|COMPLETED|Expansion Phase||0
3163575|NCT01887990|3891116|FG000|NOT COMPLETED|Overall Study||0
3163576|NCT01887990|3891117|FG001|NOT COMPLETED|Overall Study||0
2956227|NCT00726232|3670584|FG005|COMPLETED|Expansion Phase||0
2956228|NCT00726232|3670585|FG006|COMPLETED|Expansion Phase||10
2956229|NCT00726232|3670586|FG007|COMPLETED|Expansion Phase||1
2956230|NCT00726232|3670579|FG000|NOT COMPLETED|Expansion Phase||0
2956231|NCT00726232|3670580|FG001|NOT COMPLETED|Expansion Phase||0
2956232|NCT00726232|3670581|FG002|NOT COMPLETED|Expansion Phase||0
2956233|NCT00726232|3670582|FG003|NOT COMPLETED|Expansion Phase||0
2956234|NCT00726232|3670583|FG004|NOT COMPLETED|Expansion Phase||0
2956235|NCT00726232|3670584|FG005|NOT COMPLETED|Expansion Phase||0
2956236|NCT00726232|3670585|FG006|NOT COMPLETED|Expansion Phase||24
2956237|NCT00726232|3670586|FG007|NOT COMPLETED|Expansion Phase||38
2956238|NCT00726323|3670607|FG000|STARTED|Overall Study||37
2956239|NCT00726323|3670608|FG001|STARTED|Overall Study||37
2956240|NCT00726323|3670607|FG000|COMPLETED|Overall Study||0
2956241|NCT00726323|3670608|FG001|COMPLETED|Overall Study||6
2956242|NCT00726323|3670607|FG000|NOT COMPLETED|Overall Study||37
2956243|NCT00726323|3670608|FG001|NOT COMPLETED|Overall Study||31
2956244|NCT00726375|3670614|FG000|STARTED|Overall Study||34
2956245|NCT00726375|3670614|FG000|COMPLETED|Overall Study||34
2956246|NCT00726375|3670614|FG000|NOT COMPLETED|Overall Study||0
2956247|NCT00726388|3670618|FG000|STARTED|Overall Study||1050
2956248|NCT00726388|3670618|FG000|Treated|Overall Study||971
3163577|NCT01887990|3891118|FG002|NOT COMPLETED|Overall Study||0
2956249|NCT00726388|3670618|FG000|COMPLETED|Overall Study||943
2956250|NCT00726388|3670618|FG000|NOT COMPLETED|Overall Study||107
2956251|NCT00726414|3670622|FG000|STARTED|First Intervention||11
2956252|NCT00726414|3670623|FG001|STARTED|First Intervention||11
2956253|NCT00726414|3670622|FG000|COMPLETED|First Intervention||11
2956254|NCT00726414|3670623|FG001|COMPLETED|First Intervention||11
2956255|NCT00726414|3670622|FG000|NOT COMPLETED|First Intervention||0
2956256|NCT00726414|3670623|FG001|NOT COMPLETED|First Intervention||0
2956257|NCT00726414|3670622|FG000|STARTED|Washout Period of 7 Days||11
2956258|NCT00726414|3670623|FG001|STARTED|Washout Period of 7 Days||11
2956259|NCT00726414|3670622|FG000|COMPLETED|Washout Period of 7 Days||11
2956260|NCT00726414|3670623|FG001|COMPLETED|Washout Period of 7 Days||11
2956261|NCT00726414|3670622|FG000|NOT COMPLETED|Washout Period of 7 Days||0
2956262|NCT00726414|3670623|FG001|NOT COMPLETED|Washout Period of 7 Days||0
2956263|NCT00726414|3670622|FG000|STARTED|Second Intervention||11
2956264|NCT00726414|3670623|FG001|STARTED|Second Intervention||11
2956265|NCT00726414|3670622|FG000|COMPLETED|Second Intervention||11
2956266|NCT00726414|3670623|FG001|COMPLETED|Second Intervention||11
2956267|NCT00726414|3670622|FG000|NOT COMPLETED|Second Intervention||0
2956268|NCT00726414|3670623|FG001|NOT COMPLETED|Second Intervention||0
2956269|NCT00726453|3670631|FG000|STARTED|Primary Enrollment Group||1402
2956270|NCT00726453|3670632|FG001|STARTED|Primary Enrollment Group||0
2956271|NCT00726453|3670631|FG000|COMPLETED|Primary Enrollment Group||1371
2956272|NCT00726453|3670632|FG001|COMPLETED|Primary Enrollment Group||0
2956273|NCT00726453|3670631|FG000|NOT COMPLETED|Primary Enrollment Group||31
2956274|NCT00726453|3670632|FG001|NOT COMPLETED|Primary Enrollment Group||0
2956275|NCT00726453|3670631|FG000|STARTED|38 mm Length Group||0
2956276|NCT00726453|3670632|FG001|STARTED|38 mm Length Group||114
2956277|NCT00726453|3670631|FG000|COMPLETED|38 mm Length Group||0
2956278|NCT00726453|3670632|FG001|COMPLETED|38 mm Length Group|This sub-study completed the primary endpoint in March 2012 results not yet available.|111
2956279|NCT00726453|3670631|FG000|NOT COMPLETED|38 mm Length Group||0
2956280|NCT00726453|3670632|FG001|NOT COMPLETED|38 mm Length Group||3
2956281|NCT00726557|3670637|FG000|STARTED|Overall Study||246
2956282|NCT00726557|3670637|FG000|COMPLETED|Overall Study|Completed is defined as those who finished the follow-up period.|118
2956283|NCT00726557|3670637|FG000|NOT COMPLETED|Overall Study||128
2956284|NCT00726609|3670642|FG000|STARTED|Overall Study||214
2956285|NCT00726609|3670642|FG000|COMPLETED|Overall Study|For 26 participants in the Missing category, it is unknown if they completed the study.|116
2956286|NCT00726609|3670642|FG000|NOT COMPLETED|Overall Study||98
2956287|NCT00726622|3670648|FG000|STARTED|Overall Study||243
2956288|NCT00726622|3670649|FG001|STARTED|Overall Study||243
2956289|NCT00726622|3670648|FG000|COMPLETED|Overall Study||225
2956290|NCT00726622|3670649|FG001|COMPLETED|Overall Study||240
2956291|NCT00726622|3670648|FG000|NOT COMPLETED|Overall Study||18
3300422|NCT02945410|4034312|FG004|STARTED|Washout 2 (14 Days)||1
3300423|NCT02945410|4034313|FG005|STARTED|Washout 2 (14 Days)||0
2956292|NCT00726622|3670649|FG001|NOT COMPLETED|Overall Study||3
2956293|NCT00726661|3670657|FG000|STARTED|Overall Study||832
2956294|NCT00726661|3670658|FG001|STARTED|Overall Study||435
2956295|NCT00726661|3670657|FG000|COMPLETED|Overall Study||18
2956296|NCT00726661|3670658|FG001|COMPLETED|Overall Study||17
2956297|NCT00726661|3670657|FG000|NOT COMPLETED|Overall Study||814
2956298|NCT00726661|3670658|FG001|NOT COMPLETED|Overall Study||418
2956299|NCT00726713|3670667|FG000|STARTED|Overall Study||106
2956300|NCT00726713|3670668|FG001|STARTED|Overall Study||108
2956301|NCT00726713|3670667|FG000|COMPLETED|Overall Study||99
2956302|NCT00726713|3670668|FG001|COMPLETED|Overall Study||101
2956303|NCT00726713|3670667|FG000|NOT COMPLETED|Overall Study||7
2956304|NCT00726713|3670668|FG001|NOT COMPLETED|Overall Study||7
2956305|NCT00726739|3670677|FG000|STARTED|Overall Study||11
2956306|NCT00726739|3670678|FG001|STARTED|Overall Study||10
2956307|NCT00726739|3670677|FG000|COMPLETED|Overall Study|1 patient failed during screening due to brain metastasis.|10
2956308|NCT00726739|3670678|FG001|COMPLETED|Overall Study||10
2956309|NCT00726739|3670677|FG000|NOT COMPLETED|Overall Study||1
2956310|NCT00726739|3670678|FG001|NOT COMPLETED|Overall Study||0
2956311|NCT00726752|3670685|FG000|STARTED|Overall Study||6
2956312|NCT00726752|3670685|FG000|COMPLETED|Overall Study||0
2956313|NCT00726752|3670685|FG000|NOT COMPLETED|Overall Study||6
3300424|NCT02945410|4034308|FG000|COMPLETED|Washout 2 (14 Days)||2
2956314|NCT00726882|3670689|FG000|STARTED|Overall Study||35
2956315|NCT00726882|3670689|FG000|Received ABT-333 in Study M10-380|Overall Study|Participants who received ABT-333 (and not placebo) in previous study (NCT00851890/M10-380).|22
2956316|NCT00726882|3670689|FG000|Received ABT-333 in Study M10-351|Overall Study|Participants who received ABT-333 (and not placebo) in previous study (NCT00696904/M10-351).|6
2956317|NCT00726882|3670689|FG000|COMPLETED|Overall Study||13
2956318|NCT00726882|3670689|FG000|NOT COMPLETED|Overall Study||22
2956319|NCT00726895|3670695|FG000|STARTED|First Intervention||12
2956320|NCT00726895|3670696|FG001|STARTED|First Intervention||12
2956321|NCT00726895|3670695|FG000|COMPLETED|First Intervention||12
2956322|NCT00726895|3670696|FG001|COMPLETED|First Intervention||12
2956323|NCT00726895|3670695|FG000|NOT COMPLETED|First Intervention||0
2956324|NCT00726895|3670696|FG001|NOT COMPLETED|First Intervention||0
2956325|NCT00726895|3670695|FG000|STARTED|Washout Period of 7 Days||12
2956326|NCT00726895|3670696|FG001|STARTED|Washout Period of 7 Days||12
2956327|NCT00726895|3670695|FG000|COMPLETED|Washout Period of 7 Days||12
2956328|NCT00726895|3670696|FG001|COMPLETED|Washout Period of 7 Days||11
3300425|NCT02945410|4034309|FG001|COMPLETED|Washout 2 (14 Days)||1
3300426|NCT02945410|4034310|FG002|COMPLETED|Washout 2 (14 Days)||0
3300427|NCT02945410|4034311|FG003|COMPLETED|Washout 2 (14 Days)||3
2956329|NCT00726895|3670695|FG000|NOT COMPLETED|Washout Period of 7 Days||0
2956330|NCT00726895|3670696|FG001|NOT COMPLETED|Washout Period of 7 Days||1
2956331|NCT00726895|3670695|FG000|STARTED|Second Intervention||12
2956332|NCT00726895|3670696|FG001|STARTED|Second Intervention||11
2956333|NCT00726895|3670695|FG000|COMPLETED|Second Intervention||12
2956334|NCT00726895|3670696|FG001|COMPLETED|Second Intervention||11
2956335|NCT00726895|3670695|FG000|NOT COMPLETED|Second Intervention||0
3132704|NCT01692756|3857872|FG000|STARTED|Overall Study||12
3132705|NCT01692756|3857873|FG001|STARTED|Overall Study||12
3132706|NCT01692756|3857874|FG002|STARTED|Overall Study||13
3132707|NCT01692756|3857875|FG003|STARTED|Overall Study||12
3132708|NCT01692756|3857872|FG000|COMPLETED|Overall Study||11
2956336|NCT00726895|3670696|FG001|NOT COMPLETED|Second Intervention||0
2956337|NCT00726986|3670703|FG000|STARTED|Induction Phase||18
2956338|NCT00726986|3670703|FG000|Maintance|Induction Phase||3
2956339|NCT00726986|3670703|FG000|COMPLETED|Induction Phase||3
2956340|NCT00726986|3670703|FG000|NOT COMPLETED|Induction Phase||15
2956341|NCT00726986|3670703|FG000|STARTED|Maintenance Phase||3
2956342|NCT00726986|3670703|FG000|COMPLETED|Maintenance Phase||0
2956343|NCT00726986|3670703|FG000|NOT COMPLETED|Maintenance Phase||3
2956344|NCT00726999|3670709|FG000|STARTED|Overall Study||32
2956345|NCT00726999|3670710|FG001|STARTED|Overall Study||31
2956346|NCT00726999|3670709|FG000|COMPLETED|Overall Study||29
2956347|NCT00726999|3670710|FG001|COMPLETED|Overall Study||30
2956348|NCT00726999|3670709|FG000|NOT COMPLETED|Overall Study||3
2956349|NCT00726999|3670710|FG001|NOT COMPLETED|Overall Study||1
2956350|NCT00727025|3670718|FG000|STARTED|Overall Study||74
2956351|NCT00727025|3670718|FG000|COMPLETED|Overall Study||51
2956352|NCT00727025|3670718|FG000|NOT COMPLETED|Overall Study||23
2956353|NCT00727064|3670728|FG000|STARTED|Overall Study||7
2956354|NCT00727064|3670729|FG001|STARTED|Overall Study||7
2956355|NCT00727064|3670728|FG000|COMPLETED|Overall Study||7
2956356|NCT00727064|3670729|FG001|COMPLETED|Overall Study||7
2956357|NCT00727064|3670728|FG000|NOT COMPLETED|Overall Study||0
2956358|NCT00727064|3670729|FG001|NOT COMPLETED|Overall Study||0
2956359|NCT00727090|3670737|FG000|STARTED|Overall Study||3
2956360|NCT00727090|3670738|FG001|STARTED|Overall Study||3
2956361|NCT00727090|3670737|FG000|COMPLETED|Overall Study||3
2956362|NCT00727090|3670738|FG001|COMPLETED|Overall Study||3
2956363|NCT00727090|3670737|FG000|NOT COMPLETED|Overall Study||0
2956364|NCT00727090|3670738|FG001|NOT COMPLETED|Overall Study||0
2956365|NCT00727194|3670744|FG000|STARTED|Screening Period||7
2956366|NCT00727194|3670745|FG001|STARTED|Screening Period||7
2956367|NCT00727194|3670746|FG002|STARTED|Screening Period||16
2956368|NCT00727194|3670744|FG000|COMPLETED|Screening Period||7
2956369|NCT00727194|3670745|FG001|COMPLETED|Screening Period||7
2956370|NCT00727194|3670746|FG002|COMPLETED|Screening Period||0
2956371|NCT00727194|3670744|FG000|NOT COMPLETED|Screening Period||0
2956372|NCT00727194|3670745|FG001|NOT COMPLETED|Screening Period||0
2956373|NCT00727194|3670746|FG002|NOT COMPLETED|Screening Period||16
2956374|NCT00727194|3670744|FG000|STARTED|Treatment Period 1||7
2956375|NCT00727194|3670745|FG001|STARTED|Treatment Period 1||7
2956376|NCT00727194|3670746|FG002|STARTED|Treatment Period 1||0
2956377|NCT00727194|3670744|FG000|COMPLETED|Treatment Period 1||7
2956378|NCT00727194|3670745|FG001|COMPLETED|Treatment Period 1||7
2956379|NCT00727194|3670746|FG002|COMPLETED|Treatment Period 1||0
2956380|NCT00727194|3670744|FG000|NOT COMPLETED|Treatment Period 1||0
2956381|NCT00727194|3670745|FG001|NOT COMPLETED|Treatment Period 1||0
2956382|NCT00727194|3670746|FG002|NOT COMPLETED|Treatment Period 1||0
2956383|NCT00727194|3670744|FG000|STARTED|Washout Period||7
2956384|NCT00727194|3670745|FG001|STARTED|Washout Period||7
2956385|NCT00727194|3670746|FG002|STARTED|Washout Period||0
2956386|NCT00727194|3670744|FG000|COMPLETED|Washout Period||7
2956387|NCT00727194|3670745|FG001|COMPLETED|Washout Period||7
2956388|NCT00727194|3670746|FG002|COMPLETED|Washout Period||0
2956389|NCT00727194|3670744|FG000|NOT COMPLETED|Washout Period||0
2956390|NCT00727194|3670745|FG001|NOT COMPLETED|Washout Period||0
2956391|NCT00727194|3670746|FG002|NOT COMPLETED|Washout Period||0
2956392|NCT00727194|3670744|FG000|STARTED|Treatment Period 2|Sponsor terminated study early; 2 patients (total) exited study without starting Treatment Period 2.|6
2956393|NCT00727194|3670745|FG001|STARTED|Treatment Period 2|Sponsor terminated study early; 2 patients (total) exited study without starting Treatment Period 2.|6
2956394|NCT00727194|3670746|FG002|STARTED|Treatment Period 2||0
2956395|NCT00727194|3670744|FG000|COMPLETED|Treatment Period 2||6
2956396|NCT00727194|3670745|FG001|COMPLETED|Treatment Period 2||5
2956397|NCT00727194|3670746|FG002|COMPLETED|Treatment Period 2||0
2956398|NCT00727194|3670744|FG000|NOT COMPLETED|Treatment Period 2||0
2956399|NCT00727194|3670745|FG001|NOT COMPLETED|Treatment Period 2||1
2956400|NCT00727194|3670746|FG002|NOT COMPLETED|Treatment Period 2||0
2956401|NCT00727220|3670762|FG000|STARTED|Overall Study||21
2956402|NCT00727220|3670763|FG001|STARTED|Overall Study||21
2956403|NCT00727220|3670762|FG000|COMPLETED|Overall Study||20
2956404|NCT00727220|3670763|FG001|COMPLETED|Overall Study||17
2956405|NCT00727220|3670762|FG000|NOT COMPLETED|Overall Study||1
2956406|NCT00727220|3670763|FG001|NOT COMPLETED|Overall Study||4
2956407|NCT00727246|3670773|FG000|STARTED|Overall Study||3
3132709|NCT01692756|3857873|FG001|COMPLETED|Overall Study||11
3300428|NCT02945410|4034312|FG004|COMPLETED|Washout 2 (14 Days)||1
2956408|NCT00727246|3670774|FG001|STARTED|Overall Study||3
3132710|NCT01692756|3857874|FG002|COMPLETED|Overall Study||11
3132711|NCT01692756|3857875|FG003|COMPLETED|Overall Study||12
2956409|NCT00727246|3670775|FG002|STARTED|Overall Study||8
2956410|NCT00727246|3670776|FG003|STARTED|Overall Study||5
2956411|NCT00727246|3670773|FG000|COMPLETED|Overall Study||3
2956412|NCT00727246|3670774|FG001|COMPLETED|Overall Study||2
2956413|NCT00727246|3670775|FG002|COMPLETED|Overall Study||7
2956414|NCT00727246|3670776|FG003|COMPLETED|Overall Study||3
2956415|NCT00727246|3670773|FG000|NOT COMPLETED|Overall Study||0
2956416|NCT00727246|3670774|FG001|NOT COMPLETED|Overall Study||1
2956417|NCT00727246|3670775|FG002|NOT COMPLETED|Overall Study||1
2956418|NCT00727246|3670776|FG003|NOT COMPLETED|Overall Study||2
2956419|NCT00727259|3670786|FG000|STARTED|Overall Study||1995
2956420|NCT00727259|3670786|FG000|COMPLETED|Overall Study||940
2956421|NCT00727259|3670786|FG000|NOT COMPLETED|Overall Study||1055
2956422|NCT00727272|3670791|FG000|STARTED|Period I||9
2956423|NCT00727272|3670792|FG001|STARTED|Period I||9
2956424|NCT00727272|3670793|FG002|STARTED|Period I||9
2956425|NCT00727272|3670791|FG000|COMPLETED|Period I||9
2956426|NCT00727272|3670792|FG001|COMPLETED|Period I||9
2956427|NCT00727272|3670793|FG002|COMPLETED|Period I||9
2956428|NCT00727272|3670791|FG000|NOT COMPLETED|Period I||0
2956429|NCT00727272|3670792|FG001|NOT COMPLETED|Period I||0
2956430|NCT00727272|3670793|FG002|NOT COMPLETED|Period I||0
2956431|NCT00727272|3670791|FG000|STARTED|Washout Period A||9
2956432|NCT00727272|3670792|FG001|STARTED|Washout Period A||9
2956433|NCT00727272|3670793|FG002|STARTED|Washout Period A||9
2956434|NCT00727272|3670791|FG000|COMPLETED|Washout Period A||9
2956435|NCT00727272|3670792|FG001|COMPLETED|Washout Period A||9
2956436|NCT00727272|3670793|FG002|COMPLETED|Washout Period A|positive pregnancy test - recorded as an adverse event|8
2956437|NCT00727272|3670791|FG000|NOT COMPLETED|Washout Period A||0
2956438|NCT00727272|3670792|FG001|NOT COMPLETED|Washout Period A||0
2956439|NCT00727272|3670793|FG002|NOT COMPLETED|Washout Period A||1
2956440|NCT00727272|3670791|FG000|STARTED|Period II||9
2956441|NCT00727272|3670792|FG001|STARTED|Period II||9
2956442|NCT00727272|3670793|FG002|STARTED|Period II||8
2956443|NCT00727272|3670791|FG000|COMPLETED|Period II||9
2956444|NCT00727272|3670792|FG001|COMPLETED|Period II||9
2956445|NCT00727272|3670793|FG002|COMPLETED|Period II||8
2956446|NCT00727272|3670791|FG000|NOT COMPLETED|Period II||0
2956447|NCT00727272|3670792|FG001|NOT COMPLETED|Period II||0
2956448|NCT00727272|3670793|FG002|NOT COMPLETED|Period II||0
2956449|NCT00727272|3670791|FG000|STARTED|Washout Period B||9
2956450|NCT00727272|3670792|FG001|STARTED|Washout Period B||9
2956451|NCT00727272|3670793|FG002|STARTED|Washout Period B||8
2956452|NCT00727272|3670791|FG000|COMPLETED|Washout Period B||9
2956453|NCT00727272|3670792|FG001|COMPLETED|Washout Period B||9
2956454|NCT00727272|3670793|FG002|COMPLETED|Washout Period B|personal reasons|7
2956455|NCT00727272|3670791|FG000|NOT COMPLETED|Washout Period B||0
2956456|NCT00727272|3670792|FG001|NOT COMPLETED|Washout Period B||0
2956457|NCT00727272|3670793|FG002|NOT COMPLETED|Washout Period B||1
2956458|NCT00727272|3670791|FG000|STARTED|Period III||9
2956459|NCT00727272|3670792|FG001|STARTED|Period III||9
2956460|NCT00727272|3670793|FG002|STARTED|Period III||7
2956461|NCT00727272|3670791|FG000|COMPLETED|Period III||9
2956462|NCT00727272|3670792|FG001|COMPLETED|Period III||9
2956463|NCT00727272|3670793|FG002|COMPLETED|Period III||7
2956464|NCT00727272|3670791|FG000|NOT COMPLETED|Period III||0
2956465|NCT00727272|3670792|FG001|NOT COMPLETED|Period III||0
2956466|NCT00727272|3670793|FG002|NOT COMPLETED|Period III||0
2956467|NCT00727298|3670803|FG000|STARTED|Overall Study||4485
2956468|NCT00727298|3670803|FG000|COMPLETED|Overall Study||3228
2956469|NCT00727298|3670803|FG000|NOT COMPLETED|Overall Study||1257
2956470|NCT00727311|3670807|FG000|STARTED|Overall Study||2302
2956471|NCT00727311|3670807|FG000|COMPLETED|Overall Study||1195
2956472|NCT00727311|3670807|FG000|NOT COMPLETED|Overall Study||1107
2956473|NCT00727337|3670815|FG000|STARTED|Overall Study||68
2956474|NCT00727337|3670816|FG001|STARTED|Overall Study||65
2956475|NCT00727337|3670817|FG002|STARTED|Overall Study||73
2956476|NCT00727337|3670818|FG003|STARTED|Overall Study||73
2956477|NCT00727337|3670815|FG000|COMPLETED|Overall Study||61
2956478|NCT00727337|3670816|FG001|COMPLETED|Overall Study||55
2956479|NCT00727337|3670817|FG002|COMPLETED|Overall Study||63
2956480|NCT00727337|3670818|FG003|COMPLETED|Overall Study||64
2956481|NCT00727337|3670815|FG000|NOT COMPLETED|Overall Study||7
2956482|NCT00727337|3670816|FG001|NOT COMPLETED|Overall Study||10
2956483|NCT00727337|3670817|FG002|NOT COMPLETED|Overall Study||10
2956484|NCT00727337|3670818|FG003|NOT COMPLETED|Overall Study||9
2956485|NCT00727402|3670833|FG000|STARTED|Overall Study||205
2956486|NCT00727402|3670833|FG000|COMPLETED|Overall Study||89
2956487|NCT00727402|3670833|FG000|NOT COMPLETED|Overall Study||116
2956488|NCT00727415|3670837|FG000|STARTED|Phase I||9
2956489|NCT00727415|3670837|FG000|COMPLETED|Phase I||7
2956490|NCT00727415|3670837|FG000|NOT COMPLETED|Phase I||2
2956491|NCT00727415|3670837|FG000|STARTED|Phase II||33
2956492|NCT00727415|3670837|FG000|COMPLETED|Phase II||33
2956493|NCT00727415|3670837|FG000|NOT COMPLETED|Phase II||0
3132712|NCT01692756|3857872|FG000|NOT COMPLETED|Overall Study||1
2956494|NCT00727441|3670844|FG000|STARTED|Overall Study||29
2956495|NCT00727441|3670845|FG001|STARTED|Overall Study||28
2956496|NCT00727441|3670846|FG002|STARTED|Overall Study||30
2956497|NCT00727441|3670844|FG000|COMPLETED|Overall Study||11
2956498|NCT00727441|3670845|FG001|COMPLETED|Overall Study||6
2956499|NCT00727441|3670846|FG002|COMPLETED|Overall Study||5
2956500|NCT00727441|3670844|FG000|NOT COMPLETED|Overall Study||18
2956501|NCT00727441|3670845|FG001|NOT COMPLETED|Overall Study||22
2956502|NCT00727441|3670846|FG002|NOT COMPLETED|Overall Study||25
2956503|NCT00727506|3670863|FG000|STARTED|Overall Study|Entered|6
2956504|NCT00727506|3670864|FG001|STARTED|Overall Study|Entered|8
2956505|NCT00727506|3670865|FG002|STARTED|Overall Study|Entered|18
2956506|NCT00727506|3670866|FG003|STARTED|Overall Study|Randomized|39
2956507|NCT00727506|3670867|FG004|STARTED|Overall Study|Randomized|41
2956508|NCT00727506|3670868|FG005|STARTED|Overall Study|Randomized|39
2956509|NCT00727506|3670863|FG000|COMPLETED|Overall Study||0
2956510|NCT00727506|3670864|FG001|COMPLETED|Overall Study||0
2956511|NCT00727506|3670865|FG002|COMPLETED|Overall Study||0
2956512|NCT00727506|3670866|FG003|COMPLETED|Overall Study||0
2956513|NCT00727506|3670867|FG004|COMPLETED|Overall Study||0
2956514|NCT00727506|3670868|FG005|COMPLETED|Overall Study||0
2956515|NCT00727506|3670863|FG000|NOT COMPLETED|Overall Study||6
2956516|NCT00727506|3670864|FG001|NOT COMPLETED|Overall Study||8
2956517|NCT00727506|3670865|FG002|NOT COMPLETED|Overall Study||18
2956518|NCT00727506|3670866|FG003|NOT COMPLETED|Overall Study||39
2956519|NCT00727506|3670867|FG004|NOT COMPLETED|Overall Study||41
2956520|NCT00727506|3670868|FG005|NOT COMPLETED|Overall Study||39
2956521|NCT00727532|3670888|FG000|STARTED|Overall Study||9
2956522|NCT00727532|3670888|FG000|COMPLETED|Overall Study||7
2956523|NCT00727532|3670888|FG000|NOT COMPLETED|Overall Study||2
2956524|NCT00727558|3670894|FG000|STARTED|Overall Study||127
2956525|NCT00727558|3670895|FG001|STARTED|Overall Study||121
2956526|NCT00727558|3670894|FG000|COMPLETED|Overall Study||125
2956527|NCT00727558|3670895|FG001|COMPLETED|Overall Study||118
2956528|NCT00727558|3670894|FG000|NOT COMPLETED|Overall Study||2
2956529|NCT00727558|3670895|FG001|NOT COMPLETED|Overall Study||3
2956530|NCT00727571|3670905|FG000|STARTED|Overall Study||232
2956531|NCT00727571|3670906|FG001|STARTED|Overall Study||228
2956532|NCT00727571|3670907|FG002|STARTED|Overall Study||165
2956533|NCT00727571|3670908|FG003|STARTED|Overall Study||169
2956534|NCT00727571|3670905|FG000|COMPLETED|Overall Study||231
2956535|NCT00727571|3670906|FG001|COMPLETED|Overall Study||173
2956536|NCT00727571|3670907|FG002|COMPLETED|Overall Study||135
2956537|NCT00727571|3670908|FG003|COMPLETED|Overall Study||163
2956538|NCT00727571|3670905|FG000|NOT COMPLETED|Overall Study||1
2956539|NCT00727571|3670906|FG001|NOT COMPLETED|Overall Study||55
2956540|NCT00727571|3670907|FG002|NOT COMPLETED|Overall Study||30
2956541|NCT00727571|3670908|FG003|NOT COMPLETED|Overall Study||6
2956542|NCT00727597|3670920|FG000|STARTED|Overall Study||51
2956543|NCT00727597|3670921|FG001|STARTED|Overall Study||50
2956544|NCT00727597|3670920|FG000|COMPLETED|Overall Study||51
2956545|NCT00727597|3670921|FG001|COMPLETED|Overall Study||50
2956546|NCT00727597|3670920|FG000|NOT COMPLETED|Overall Study||0
2956547|NCT00727597|3670921|FG001|NOT COMPLETED|Overall Study||0
2956548|NCT00727636|3670929|FG000|STARTED|Overall Study||37
2956549|NCT00727636|3670930|FG001|STARTED|Overall Study||15
2956550|NCT00727636|3670929|FG000|COMPLETED|Overall Study||33
2956551|NCT00727636|3670930|FG001|COMPLETED|Overall Study||15
2956552|NCT00727636|3670929|FG000|NOT COMPLETED|Overall Study||4
2956553|NCT00727636|3670930|FG001|NOT COMPLETED|Overall Study||0
2956554|NCT00727649|3670938|FG000|STARTED|First Intervention (4-weeks)||37
2956555|NCT00727649|3670939|FG001|STARTED|First Intervention (4-weeks)||43
2956556|NCT00727649|3670938|FG000|COMPLETED|First Intervention (4-weeks)||34
2956557|NCT00727649|3670939|FG001|COMPLETED|First Intervention (4-weeks)||40
2956558|NCT00727649|3670938|FG000|NOT COMPLETED|First Intervention (4-weeks)||3
2956559|NCT00727649|3670939|FG001|NOT COMPLETED|First Intervention (4-weeks)||3
2956560|NCT00727649|3670938|FG000|STARTED|Wash-out (2-weeks)||34
2956561|NCT00727649|3670939|FG001|STARTED|Wash-out (2-weeks)||40
2956562|NCT00727649|3670938|FG000|COMPLETED|Wash-out (2-weeks)||30
2956563|NCT00727649|3670939|FG001|COMPLETED|Wash-out (2-weeks)||37
2956564|NCT00727649|3670938|FG000|NOT COMPLETED|Wash-out (2-weeks)||4
2956565|NCT00727649|3670939|FG001|NOT COMPLETED|Wash-out (2-weeks)||3
2956566|NCT00727649|3670938|FG000|STARTED|Second Intervention (4-weeks)||30
2956567|NCT00727649|3670939|FG001|STARTED|Second Intervention (4-weeks)||37
2956568|NCT00727649|3670938|FG000|COMPLETED|Second Intervention (4-weeks)||29
2956569|NCT00727649|3670939|FG001|COMPLETED|Second Intervention (4-weeks)||34
2956570|NCT00727649|3670938|FG000|NOT COMPLETED|Second Intervention (4-weeks)||1
2956571|NCT00727649|3670939|FG001|NOT COMPLETED|Second Intervention (4-weeks)||3
2956572|NCT00727714|3670947|FG000|STARTED|Overall Study||95
2956573|NCT00727714|3670947|FG000|COMPLETED|Overall Study||93
2956574|NCT00727714|3670947|FG000|NOT COMPLETED|Overall Study||2
2956575|NCT00727740|3670953|FG000|STARTED|Overall Study||56
2956576|NCT00727740|3670954|FG001|STARTED|Overall Study||61
2956577|NCT00727740|3670953|FG000|COMPLETED|Overall Study||56
2956578|NCT00727740|3670954|FG001|COMPLETED|Overall Study||61
2956579|NCT00727740|3670953|FG000|NOT COMPLETED|Overall Study||0
2956580|NCT00727740|3670954|FG001|NOT COMPLETED|Overall Study||0
2956581|NCT00727844|3670962|FG000|STARTED|Initial Randomization|2 patients withdrawn before receiving any linezolid owing to baseline neuropathy|21
2956582|NCT00727844|3670963|FG001|STARTED|Initial Randomization||20
2956583|NCT00727844|3670964|FG002|STARTED|Initial Randomization||0
2956584|NCT00727844|3670965|FG003|STARTED|Initial Randomization||0
2956585|NCT00727844|3670962|FG000|Included in MITT Analysis|Initial Randomization||19
2956586|NCT00727844|3670963|FG001|Included in MITT Analysis|Initial Randomization||20
2956587|NCT00727844|3670964|FG002|Included in MITT Analysis|Initial Randomization||0
2956588|NCT00727844|3670965|FG003|Included in MITT Analysis|Initial Randomization||0
2956589|NCT00727844|3670962|FG000|COMPLETED|Initial Randomization||19
2956590|NCT00727844|3670963|FG001|COMPLETED|Initial Randomization||20
2956591|NCT00727844|3670964|FG002|COMPLETED|Initial Randomization||0
2956592|NCT00727844|3670965|FG003|COMPLETED|Initial Randomization||0
2956593|NCT00727844|3670962|FG000|NOT COMPLETED|Initial Randomization||2
2956594|NCT00727844|3670963|FG001|NOT COMPLETED|Initial Randomization||0
2956595|NCT00727844|3670964|FG002|NOT COMPLETED|Initial Randomization||0
2956596|NCT00727844|3670965|FG003|NOT COMPLETED|Initial Randomization||0
2956597|NCT00727844|3670962|FG000|STARTED|Second Randomization||0
2956598|NCT00727844|3670963|FG001|STARTED|Second Randomization||0
2956599|NCT00727844|3670964|FG002|STARTED|Second Randomization|6 patients excluded before 2nd randomization: 2 had withdrawn and 4 already dose reduced due to AE|17
2956600|NCT00727844|3670965|FG003|STARTED|Second Randomization|6 patients excluded before 2nd randomization: 2 had withdrawn and 4 already dose reduced due to AE|16
2956601|NCT00727844|3670962|FG000|COMPLETED|Second Randomization||0
2956602|NCT00727844|3670963|FG001|COMPLETED|Second Randomization||0
2956603|NCT00727844|3670964|FG002|COMPLETED|Second Randomization||17
2956604|NCT00727844|3670965|FG003|COMPLETED|Second Randomization||16
2956605|NCT00727844|3670962|FG000|NOT COMPLETED|Second Randomization||0
2956606|NCT00727844|3670963|FG001|NOT COMPLETED|Second Randomization||0
2956607|NCT00727844|3670964|FG002|NOT COMPLETED|Second Randomization||0
2956608|NCT00727844|3670965|FG003|NOT COMPLETED|Second Randomization||0
2956609|NCT00727857|3670973|FG000|STARTED|Overall Study||201
2956610|NCT00727857|3670974|FG001|STARTED|Overall Study||189
2956611|NCT00727857|3670975|FG002|STARTED|Overall Study||210
2956612|NCT00727857|3670973|FG000|COMPLETED|Overall Study||157
2956613|NCT00727857|3670974|FG001|COMPLETED|Overall Study||125
2956614|NCT00727857|3670975|FG002|COMPLETED|Overall Study||142
2956615|NCT00727857|3670973|FG000|NOT COMPLETED|Overall Study||44
2956616|NCT00727857|3670974|FG001|NOT COMPLETED|Overall Study||64
2956617|NCT00727857|3670975|FG002|NOT COMPLETED|Overall Study||68
2956618|NCT00727909|3670984|FG000|STARTED|Overall Study||65
2956619|NCT00727909|3670985|FG001|STARTED|Overall Study||72
2956620|NCT00727909|3670986|FG002|STARTED|Overall Study||67
2956621|NCT00727909|3670987|FG003|STARTED|Overall Study||75
2956622|NCT00727909|3670984|FG000|COMPLETED|Overall Study||60
2956623|NCT00727909|3670985|FG001|COMPLETED|Overall Study||61
2956624|NCT00727909|3670986|FG002|COMPLETED|Overall Study||58
2956625|NCT00727909|3670987|FG003|COMPLETED|Overall Study||70
2956626|NCT00727909|3670984|FG000|NOT COMPLETED|Overall Study||5
2956627|NCT00727909|3670985|FG001|NOT COMPLETED|Overall Study||11
2956628|NCT00727909|3670986|FG002|NOT COMPLETED|Overall Study||9
2956629|NCT00727909|3670987|FG003|NOT COMPLETED|Overall Study||5
2956630|NCT00727961|3670991|FG000|STARTED|Overall Study||58
2956631|NCT00727961|3670991|FG000|COMPLETED|Overall Study||21
2956632|NCT00727961|3670991|FG000|NOT COMPLETED|Overall Study||37
2956633|NCT00728130|3670995|FG000|STARTED|Overall Study||22
2956634|NCT00728130|3670995|FG000|COMPLETED|Overall Study||19
2956635|NCT00728130|3670995|FG000|NOT COMPLETED|Overall Study||3
2956636|NCT00728182|3671001|FG000|STARTED|Overall Study||92
2956637|NCT00728182|3671002|FG001|STARTED|Overall Study||93
2956638|NCT00728182|3671001|FG000|COMPLETED|Overall Study||89
2956639|NCT00728182|3671002|FG001|COMPLETED|Overall Study||90
2956640|NCT00728182|3671001|FG000|NOT COMPLETED|Overall Study||3
2956641|NCT00728182|3671002|FG001|NOT COMPLETED|Overall Study||3
2956642|NCT00728260|3671010|FG000|STARTED|Overall Study||1421
2956643|NCT00728260|3671010|FG000|COMPLETED|Overall Study||1421
2956644|NCT00728260|3671010|FG000|NOT COMPLETED|Overall Study||0
2956645|NCT00728468|3671014|FG000|STARTED|Overall Study||16
2956646|NCT00728468|3671014|FG000|Treated|Overall Study||15
2956647|NCT00728468|3671014|FG000|COMPLETED|Overall Study||0
2956648|NCT00728468|3671014|FG000|NOT COMPLETED|Overall Study||16
3035176|NCT01135524|3754337|FG000|NOT COMPLETED|Overall Study||196
3035177|NCT01135537|3754341|FG000|STARTED|Overall Study||30
3035178|NCT01135537|3754341|FG000|COMPLETED|Overall Study||17
3035179|NCT01135537|3754341|FG000|NOT COMPLETED|Overall Study||13
3035180|NCT01135914|3754348|FG000|STARTED|Overall Study||78
3035181|NCT01135914|3754349|FG001|STARTED|Overall Study||80
3035182|NCT01135914|3754350|FG002|STARTED|Overall Study||81
3035183|NCT01135914|3754348|FG000|Intent to Treat (ITT) Population|Overall Study||73
3035184|NCT01135914|3754349|FG001|Intent to Treat (ITT) Population|Overall Study||75
3035185|NCT01135914|3754350|FG002|Intent to Treat (ITT) Population|Overall Study||72
3035186|NCT01135914|3754348|FG000|Safety Population|Overall Study||73
3035187|NCT01135914|3754349|FG001|Safety Population|Overall Study||75
3035188|NCT01135914|3754350|FG002|Safety Population|Overall Study||74
3035189|NCT01135914|3754348|FG000|COMPLETED|Overall Study||74
3035190|NCT01135914|3754349|FG001|COMPLETED|Overall Study||75
3035191|NCT01135914|3754350|FG002|COMPLETED|Overall Study||59
3035192|NCT01135914|3754348|FG000|NOT COMPLETED|Overall Study||4
3035193|NCT01135914|3754349|FG001|NOT COMPLETED|Overall Study||5
3035194|NCT01135914|3754350|FG002|NOT COMPLETED|Overall Study||22
3035195|NCT01135992|3754358|FG000|STARTED|Overall Study||143
3035196|NCT01135992|3754358|FG000|Exposed|Overall Study|One subject was withdrawn before being exposed.|142
3035197|NCT01135992|3754358|FG000|Full Analysis Set|Overall Study||129
3035198|NCT01135992|3754358|FG000|COMPLETED|Overall Study||122
3035199|NCT01135992|3754358|FG000|NOT COMPLETED|Overall Study||21
3035200|NCT01136174|3754366|FG000|STARTED|Overall Study||12
2956649|NCT00728481|3671020|FG000|STARTED|Overall Study||19
2956650|NCT00728481|3671021|FG001|STARTED|Overall Study||32
2956651|NCT00728481|3671020|FG000|COMPLETED|Overall Study||18
2956652|NCT00728481|3671021|FG001|COMPLETED|Overall Study||28
2956653|NCT00728481|3671020|FG000|NOT COMPLETED|Overall Study||1
2956654|NCT00728481|3671021|FG001|NOT COMPLETED|Overall Study||4
2956655|NCT00728494|3671029|FG000|STARTED|Overall Study||60
2956656|NCT00728494|3671030|FG001|STARTED|Overall Study||39
2956657|NCT00728494|3671029|FG000|COMPLETED|Overall Study||51
2956658|NCT00728494|3671030|FG001|COMPLETED|Overall Study||32
2956659|NCT00728494|3671029|FG000|NOT COMPLETED|Overall Study||9
2956660|NCT00728494|3671030|FG001|NOT COMPLETED|Overall Study||7
2956661|NCT00728507|3671038|FG000|STARTED|Overall Study||62
2956662|NCT00728507|3671039|FG001|STARTED|Overall Study||59
2956663|NCT00728507|3671038|FG000|COMPLETED|Overall Study||60
2956664|NCT00728507|3671039|FG001|COMPLETED|Overall Study||51
2956665|NCT00728507|3671038|FG000|NOT COMPLETED|Overall Study||2
2956666|NCT00728507|3671039|FG001|NOT COMPLETED|Overall Study||8
3035201|NCT01136174|3754367|FG001|STARTED|Overall Study||6
3035202|NCT01136174|3754368|FG002|STARTED|Overall Study||8
3035203|NCT01136174|3754369|FG003|STARTED|Overall Study||24
3035204|NCT01136174|3754366|FG000|COMPLETED|Overall Study||12
3035205|NCT01136174|3754367|FG001|COMPLETED|Overall Study||6
3035206|NCT01136174|3754368|FG002|COMPLETED|Overall Study||8
3035207|NCT01136174|3754369|FG003|COMPLETED|Overall Study||20
3035208|NCT01136174|3754366|FG000|NOT COMPLETED|Overall Study||0
3035209|NCT01136174|3754367|FG001|NOT COMPLETED|Overall Study||0
3035210|NCT01136174|3754368|FG002|NOT COMPLETED|Overall Study||0
3035211|NCT01136174|3754369|FG003|NOT COMPLETED|Overall Study||4
3035212|NCT01136226|3754388|FG000|STARTED|Overall Study||42
3035213|NCT01136226|3754388|FG000|COMPLETED|Overall Study||29
3035214|NCT01136226|3754388|FG000|NOT COMPLETED|Overall Study||13
3035215|NCT01136291|3754395|FG000|STARTED|Overall Study||40
3035216|NCT01136291|3754396|FG001|STARTED|Overall Study||42
3035217|NCT01136291|3754395|FG000|Follow|Overall Study||40
3035218|NCT01136291|3754396|FG001|Follow|Overall Study||42
3035219|NCT01136291|3754395|FG000|COMPLETED|Overall Study||39
3035220|NCT01136291|3754396|FG001|COMPLETED|Overall Study||41
3035221|NCT01136291|3754395|FG000|NOT COMPLETED|Overall Study||1
3035222|NCT01136291|3754396|FG001|NOT COMPLETED|Overall Study||1
3035223|NCT01136356|3754402|FG000|STARTED|First Intervention||6
3035224|NCT01136356|3754403|FG001|STARTED|First Intervention||6
3035225|NCT01136356|3754402|FG000|COMPLETED|First Intervention||6
3035226|NCT01136356|3754403|FG001|COMPLETED|First Intervention||6
3035227|NCT01136356|3754402|FG000|NOT COMPLETED|First Intervention||0
3035228|NCT01136356|3754403|FG001|NOT COMPLETED|First Intervention||0
3035229|NCT01136356|3754402|FG000|STARTED|First 18-day Withdrawal||6
3035230|NCT01136356|3754403|FG001|STARTED|First 18-day Withdrawal||6
3035231|NCT01136356|3754402|FG000|COMPLETED|First 18-day Withdrawal||2
3035232|NCT01136356|3754403|FG001|COMPLETED|First 18-day Withdrawal||6
3035233|NCT01136356|3754402|FG000|NOT COMPLETED|First 18-day Withdrawal||4
3035234|NCT01136356|3754403|FG001|NOT COMPLETED|First 18-day Withdrawal||0
3035235|NCT01136356|3754402|FG000|STARTED|Second Intervention||2
3035236|NCT01136356|3754403|FG001|STARTED|Second Intervention||6
3035237|NCT01136356|3754402|FG000|COMPLETED|Second Intervention||2
3035238|NCT01136356|3754403|FG001|COMPLETED|Second Intervention||6
3035239|NCT01136356|3754402|FG000|NOT COMPLETED|Second Intervention||0
3035240|NCT01136356|3754403|FG001|NOT COMPLETED|Second Intervention||0
3035241|NCT01136356|3754402|FG000|STARTED|Second 18-day Withdrawal||2
3035242|NCT01136356|3754403|FG001|STARTED|Second 18-day Withdrawal||6
3035243|NCT01136356|3754402|FG000|COMPLETED|Second 18-day Withdrawal||2
3035244|NCT01136356|3754403|FG001|COMPLETED|Second 18-day Withdrawal||5
3035245|NCT01136356|3754402|FG000|NOT COMPLETED|Second 18-day Withdrawal||0
3035246|NCT01136356|3754403|FG001|NOT COMPLETED|Second 18-day Withdrawal||1
3035247|NCT01136382|3754410|FG000|STARTED|Overall Study||152
3035248|NCT01136382|3754411|FG001|STARTED|Overall Study||152
3035249|NCT01136382|3754410|FG000|COMPLETED|Overall Study||92
3035250|NCT01136382|3754411|FG001|COMPLETED|Overall Study||121
3035251|NCT01136382|3754410|FG000|NOT COMPLETED|Overall Study||60
3035252|NCT01136382|3754411|FG001|NOT COMPLETED|Overall Study||31
3035253|NCT01136408|3754420|FG000|STARTED|Overall Study||46
3035254|NCT01136408|3754421|FG001|STARTED|Overall Study||58
3035255|NCT01136408|3754422|FG002|STARTED|Overall Study||62
3035256|NCT01136408|3754420|FG000|COMPLETED|Overall Study||41
3035257|NCT01136408|3754421|FG001|COMPLETED|Overall Study||49
3035258|NCT01136408|3754422|FG002|COMPLETED|Overall Study||57
3035259|NCT01136408|3754420|FG000|NOT COMPLETED|Overall Study||5
3035260|NCT01136408|3754421|FG001|NOT COMPLETED|Overall Study||9
3035261|NCT01136408|3754422|FG002|NOT COMPLETED|Overall Study||5
3035262|NCT01136486|3754434|FG000|STARTED|Overall Study||56
3035263|NCT01136486|3754434|FG000|COMPLETED|Overall Study||56
3035264|NCT01136486|3754434|FG000|NOT COMPLETED|Overall Study||0
3035265|NCT01136655|3754438|FG000|STARTED|BUD 160/FM 2.25 (1 Dose)||54
3035266|NCT01136655|3754438|FG000|COMPLETED|BUD 160/FM 2.25 (1 Dose)||54
3035267|NCT01136655|3754438|FG000|NOT COMPLETED|BUD 160/FM 2.25 (1 Dose)||0
3035268|NCT01136655|3754438|FG000|STARTED|Washout After BUD 160/FM 2.25 (7 Days)||54
3035269|NCT01136655|3754438|FG000|COMPLETED|Washout After BUD 160/FM 2.25 (7 Days)||53
3035270|NCT01136655|3754438|FG000|NOT COMPLETED|Washout After BUD 160/FM 2.25 (7 Days)||1
3035271|NCT01136655|3754438|FG000|STARTED|BUD 160/FM 4.5 (1 Dose)||53
3035272|NCT01136655|3754438|FG000|COMPLETED|BUD 160/FM 4.5 (1 Dose)||53
2956667|NCT00728689|3671047|FG000|STARTED|First Intervention (Days 1 - 3)||6
2956668|NCT00728689|3671048|FG001|STARTED|First Intervention (Days 1 - 3)||6
2956669|NCT00728689|3671047|FG000|COMPLETED|First Intervention (Days 1 - 3)||6
2956670|NCT00728689|3671048|FG001|COMPLETED|First Intervention (Days 1 - 3)||6
2956671|NCT00728689|3671047|FG000|NOT COMPLETED|First Intervention (Days 1 - 3)||0
2956672|NCT00728689|3671048|FG001|NOT COMPLETED|First Intervention (Days 1 - 3)||0
2956673|NCT00728689|3671047|FG000|STARTED|Washout Period (Days 4 - 10)||6
2956674|NCT00728689|3671048|FG001|STARTED|Washout Period (Days 4 - 10)||6
2956675|NCT00728689|3671047|FG000|COMPLETED|Washout Period (Days 4 - 10)|Death in family during the Washout period. Completed First Intervention period with ST-246 Form I.|5
2956676|NCT00728689|3671048|FG001|COMPLETED|Washout Period (Days 4 - 10)||6
2956677|NCT00728689|3671047|FG000|NOT COMPLETED|Washout Period (Days 4 - 10)||1
2956678|NCT00728689|3671048|FG001|NOT COMPLETED|Washout Period (Days 4 - 10)||0
2956679|NCT00728689|3671047|FG000|STARTED|Second Intervention (Days 11 - 13)||5
2956680|NCT00728689|3671048|FG001|STARTED|Second Intervention (Days 11 - 13)||6
2956681|NCT00728689|3671047|FG000|COMPLETED|Second Intervention (Days 11 - 13)||5
2956682|NCT00728689|3671048|FG001|COMPLETED|Second Intervention (Days 11 - 13)||6
2956683|NCT00728689|3671047|FG000|NOT COMPLETED|Second Intervention (Days 11 - 13)||0
2956684|NCT00728689|3671048|FG001|NOT COMPLETED|Second Intervention (Days 11 - 13)||0
2956685|NCT00728728|3671058|FG000|STARTED|Overall Study||42
2956686|NCT00728728|3671059|FG001|STARTED|Overall Study||46
2956687|NCT00728728|3671058|FG000|COMPLETED|Overall Study||38
2956688|NCT00728728|3671059|FG001|COMPLETED|Overall Study||34
2956689|NCT00728728|3671058|FG000|NOT COMPLETED|Overall Study||4
2956690|NCT00728728|3671059|FG001|NOT COMPLETED|Overall Study||12
2956691|NCT00728754|3671068|FG000|STARTED|Implant Placement Surgery|Individual test implant units is 75|29
2956692|NCT00728754|3671069|FG001|STARTED|Implant Placement Surgery|Individual control implant units is 78|32
2956693|NCT00728754|3671068|FG000|COMPLETED|Implant Placement Surgery|Individual test implant units completed = 75|29
2956694|NCT00728754|3671069|FG001|COMPLETED|Implant Placement Surgery|Individual control implant units completed = 78|32
2956695|NCT00728754|3671068|FG000|NOT COMPLETED|Implant Placement Surgery||0
2956696|NCT00728754|3671069|FG001|NOT COMPLETED|Implant Placement Surgery||0
2956697|NCT00728754|3671068|FG000|STARTED|Permanent Prosthesis Placement|Individual test implant units is 75|29
3163578|NCT01887990|3891119|FG003|NOT COMPLETED|Overall Study||0
3163579|NCT01888003|3891134|FG000|STARTED|Overall Study||5
3163580|NCT01888003|3891135|FG001|STARTED|Overall Study||6
3163581|NCT01888003|3891136|FG002|STARTED|Overall Study||40
3163582|NCT01888003|3891134|FG000|COMPLETED|Overall Study||0
3163583|NCT01888003|3891135|FG001|COMPLETED|Overall Study||0
2956698|NCT00728754|3671069|FG001|STARTED|Permanent Prosthesis Placement|Individual control implant units is 78|32
2956699|NCT00728754|3671068|FG000|COMPLETED|Permanent Prosthesis Placement|Individual test implant units completed = 66|25
2956700|NCT00728754|3671069|FG001|COMPLETED|Permanent Prosthesis Placement|Individual control implant units completed = 68|28
2956701|NCT00728754|3671068|FG000|NOT COMPLETED|Permanent Prosthesis Placement||4
2956702|NCT00728754|3671069|FG001|NOT COMPLETED|Permanent Prosthesis Placement||4
2956703|NCT00728754|3671068|FG000|STARTED|One Year Post Placement Follow-up|individual test implant units is 66|25
2956704|NCT00728754|3671069|FG001|STARTED|One Year Post Placement Follow-up|individual control implant units is 68|28
2956705|NCT00728754|3671068|FG000|COMPLETED|One Year Post Placement Follow-up|individual test implant units completing is 65|24
2956706|NCT00728754|3671069|FG001|COMPLETED|One Year Post Placement Follow-up|individual control implant units completed= 68|28
2956707|NCT00728754|3671068|FG000|NOT COMPLETED|One Year Post Placement Follow-up||1
2956708|NCT00728754|3671069|FG001|NOT COMPLETED|One Year Post Placement Follow-up||0
2956709|NCT00728754|3671068|FG000|STARTED|Two Year Post Placement Follow-up|individual test implant units is 65|24
2956710|NCT00728754|3671069|FG001|STARTED|Two Year Post Placement Follow-up|individual control implant units is 68|28
2956711|NCT00728754|3671068|FG000|COMPLETED|Two Year Post Placement Follow-up|individual test implant units completed= 65|24
2956712|NCT00728754|3671069|FG001|COMPLETED|Two Year Post Placement Follow-up|individual test implant units completed= 68|28
2956713|NCT00728754|3671068|FG000|NOT COMPLETED|Two Year Post Placement Follow-up||0
2956714|NCT00728754|3671069|FG001|NOT COMPLETED|Two Year Post Placement Follow-up||0
2956715|NCT00728819|3671077|FG000|STARTED|Overall Study||171
2956716|NCT00728819|3671078|FG001|STARTED|Overall Study||168
3300429|NCT02945410|4034313|FG005|COMPLETED|Washout 2 (14 Days)||0
3300430|NCT02945410|4034308|FG000|NOT COMPLETED|Washout 2 (14 Days)||0
3300431|NCT02945410|4034309|FG001|NOT COMPLETED|Washout 2 (14 Days)||0
3300432|NCT02945410|4034310|FG002|NOT COMPLETED|Washout 2 (14 Days)||0
2956717|NCT00728819|3671077|FG000|COMPLETED|Overall Study||135
2956718|NCT00728819|3671078|FG001|COMPLETED|Overall Study||139
2956719|NCT00728819|3671077|FG000|NOT COMPLETED|Overall Study||36
2956720|NCT00728819|3671078|FG001|NOT COMPLETED|Overall Study||29
2956721|NCT00728884|3671084|FG000|STARTED|Implant Placement Surgery||162
2956722|NCT00728884|3671084|FG000|COMPLETED|Implant Placement Surgery||162
2956723|NCT00728884|3671084|FG000|NOT COMPLETED|Implant Placement Surgery||0
2956724|NCT00728884|3671084|FG000|STARTED|Permanent Prosthesis Placement||162
2956725|NCT00728884|3671084|FG000|COMPLETED|Permanent Prosthesis Placement||149
2956726|NCT00728884|3671084|FG000|NOT COMPLETED|Permanent Prosthesis Placement||13
2956727|NCT00728884|3671084|FG000|STARTED|One Year Post Placement Follow-up||149
2956728|NCT00728884|3671084|FG000|COMPLETED|One Year Post Placement Follow-up||145
3163584|NCT01888003|3891136|FG002|COMPLETED|Overall Study||0
3163585|NCT01888003|3891134|FG000|NOT COMPLETED|Overall Study||5
2956729|NCT00728884|3671084|FG000|NOT COMPLETED|One Year Post Placement Follow-up||4
2956730|NCT00728884|3671084|FG000|STARTED|Two Year Post Placement Follow-up||145
2956731|NCT00728884|3671084|FG000|COMPLETED|Two Year Post Placement Follow-up||145
2956732|NCT00728884|3671084|FG000|NOT COMPLETED|Two Year Post Placement Follow-up||0
2956733|NCT00728910|3671088|FG000|STARTED|Atorvastatin||25
2956734|NCT00728910|3671088|FG000|COMPLETED|Atorvastatin||22
2956735|NCT00728910|3671088|FG000|NOT COMPLETED|Atorvastatin||3
2956736|NCT00728910|3671088|FG000|STARTED|Atorvastatin+ABT335||22
2956737|NCT00728910|3671088|FG000|COMPLETED|Atorvastatin+ABT335||22
2956738|NCT00728910|3671088|FG000|NOT COMPLETED|Atorvastatin+ABT335||0
2956739|NCT00728910|3671088|FG000|STARTED|Atorvastatin+ABT335+ER Niacin||22
2956740|NCT00728910|3671088|FG000|COMPLETED|Atorvastatin+ABT335+ER Niacin||22
2956741|NCT00728910|3671088|FG000|NOT COMPLETED|Atorvastatin+ABT335+ER Niacin||0
2956742|NCT00728923|3671097|FG000|STARTED|Overall Study||9
2956743|NCT00728923|3671097|FG000|COMPLETED|Overall Study||9
2956744|NCT00728923|3671097|FG000|NOT COMPLETED|Overall Study||0
2956745|NCT00728936|3671108|FG000|STARTED|Overall Study||10
2956746|NCT00728936|3671109|FG001|STARTED|Overall Study||8
2956747|NCT00728936|3671110|FG002|STARTED|Overall Study||9
2956748|NCT00728936|3671111|FG003|STARTED|Overall Study||8
2956749|NCT00728936|3671112|FG004|STARTED|Overall Study||8
2956750|NCT00728936|3671113|FG005|STARTED|Overall Study||8
2956751|NCT00728936|3671114|FG006|STARTED|Overall Study||7
2956752|NCT00728936|3671108|FG000|COMPLETED|Overall Study||10
2956753|NCT00728936|3671109|FG001|COMPLETED|Overall Study||8
2956754|NCT00728936|3671110|FG002|COMPLETED|Overall Study||9
2956755|NCT00728936|3671111|FG003|COMPLETED|Overall Study||8
2956756|NCT00728936|3671112|FG004|COMPLETED|Overall Study||8
2956757|NCT00728936|3671113|FG005|COMPLETED|Overall Study||7
2956758|NCT00728936|3671114|FG006|COMPLETED|Overall Study||7
2956759|NCT00728936|3671108|FG000|NOT COMPLETED|Overall Study||0
2956760|NCT00728936|3671109|FG001|NOT COMPLETED|Overall Study||0
2956761|NCT00728936|3671110|FG002|NOT COMPLETED|Overall Study||0
2956762|NCT00728936|3671111|FG003|NOT COMPLETED|Overall Study||0
2956763|NCT00728936|3671112|FG004|NOT COMPLETED|Overall Study||0
2956764|NCT00728936|3671113|FG005|NOT COMPLETED|Overall Study||1
2956765|NCT00728936|3671114|FG006|NOT COMPLETED|Overall Study||0
2956766|NCT00728949|3671132|FG000|STARTED|Overall Study||62
2956767|NCT00728949|3671133|FG001|STARTED|Overall Study||31
2956768|NCT00728949|3671132|FG000|COMPLETED|Overall Study||51
2956769|NCT00728949|3671133|FG001|COMPLETED|Overall Study||27
2956770|NCT00728949|3671132|FG000|NOT COMPLETED|Overall Study||11
3163586|NCT01888003|3891135|FG001|NOT COMPLETED|Overall Study||6
3163587|NCT01888003|3891136|FG002|NOT COMPLETED|Overall Study||40
3163588|NCT01888367|3891147|FG000|STARTED|Overall Study||296
3163589|NCT01888367|3891148|FG001|STARTED|Overall Study||71
3163590|NCT01888367|3891149|FG002|STARTED|Overall Study||78
3163591|NCT01888367|3891147|FG000|COMPLETED|Overall Study||288
3163592|NCT01888367|3891148|FG001|COMPLETED|Overall Study||66
3163593|NCT01888367|3891149|FG002|COMPLETED|Overall Study||73
3163594|NCT01888367|3891147|FG000|NOT COMPLETED|Overall Study||8
3163595|NCT01888367|3891148|FG001|NOT COMPLETED|Overall Study||5
2956771|NCT00728949|3671133|FG001|NOT COMPLETED|Overall Study||4
2956772|NCT00728962|3671139|FG000|STARTED|Implant Placement Surgery||75
2956773|NCT00728962|3671139|FG000|COMPLETED|Implant Placement Surgery||65
2956774|NCT00728962|3671139|FG000|NOT COMPLETED|Implant Placement Surgery||10
2956775|NCT00728962|3671139|FG000|STARTED|Permanent Prosthesis Placement||65
2956776|NCT00728962|3671139|FG000|COMPLETED|Permanent Prosthesis Placement||62
2956777|NCT00728962|3671139|FG000|NOT COMPLETED|Permanent Prosthesis Placement||3
2956778|NCT00728962|3671139|FG000|STARTED|One Year Post Placement Follow-up||62
2956779|NCT00728962|3671139|FG000|COMPLETED|One Year Post Placement Follow-up||62
2956780|NCT00728962|3671139|FG000|NOT COMPLETED|One Year Post Placement Follow-up||0
2956781|NCT00728962|3671139|FG000|STARTED|Two Year Post Placement Follow-up||62
2956782|NCT00728962|3671139|FG000|COMPLETED|Two Year Post Placement Follow-up||59
2956783|NCT00728962|3671139|FG000|NOT COMPLETED|Two Year Post Placement Follow-up||3
2956784|NCT00728988|3671145|FG000|STARTED|Overall Study||247
2956785|NCT00728988|3671146|FG001|STARTED|Overall Study||252
2956786|NCT00728988|3671145|FG000|Treated|Overall Study||245
2956787|NCT00728988|3671146|FG001|Treated|Overall Study||250
2956788|NCT00728988|3671145|FG000|Full Analysis Set|Overall Study||163
2956789|NCT00728988|3671146|FG001|Full Analysis Set|Overall Study||172
2956790|NCT00728988|3671145|FG000|COMPLETED|Overall Study||154
2956791|NCT00728988|3671146|FG001|COMPLETED|Overall Study||164
2956792|NCT00728988|3671145|FG000|NOT COMPLETED|Overall Study||93
2956793|NCT00728988|3671146|FG001|NOT COMPLETED|Overall Study||88
2956794|NCT00729053|3671157|FG000|STARTED|Overall Study||23
2956795|NCT00729053|3671158|FG001|STARTED|Overall Study||23
2956796|NCT00729053|3671159|FG002|STARTED|Overall Study||23
2956797|NCT00729053|3671160|FG003|STARTED|Overall Study||23
2956798|NCT00729053|3671157|FG000|COMPLETED|Overall Study||23
2956799|NCT00729053|3671158|FG001|COMPLETED|Overall Study||23
3163596|NCT01888367|3891149|FG002|NOT COMPLETED|Overall Study||5
2956800|NCT00729053|3671159|FG002|COMPLETED|Overall Study||23
2956801|NCT00729053|3671160|FG003|COMPLETED|Overall Study||23
2956802|NCT00729053|3671157|FG000|NOT COMPLETED|Overall Study||0
2956803|NCT00729053|3671158|FG001|NOT COMPLETED|Overall Study||0
2956804|NCT00729053|3671159|FG002|NOT COMPLETED|Overall Study||0
2956805|NCT00729053|3671160|FG003|NOT COMPLETED|Overall Study||0
2956806|NCT00729157|3671170|FG000|STARTED|Overall Study||41
2956807|NCT00729157|3671170|FG000|COMPLETED|Overall Study||40
2956808|NCT00729157|3671170|FG000|NOT COMPLETED|Overall Study||1
2956809|NCT00729183|3671176|FG000|STARTED|Overall Study||109
2956810|NCT00729183|3671177|FG001|STARTED|Overall Study||105
2956811|NCT00729183|3671176|FG000|COMPLETED|Overall Study|Completed 24 month visit|84
2956812|NCT00729183|3671177|FG001|COMPLETED|Overall Study|Completed 24 month visit|90
2956813|NCT00729183|3671176|FG000|NOT COMPLETED|Overall Study||25
2956814|NCT00729183|3671177|FG001|NOT COMPLETED|Overall Study||15
2956815|NCT00729248|3671183|FG000|STARTED|Overall Study||12
2956816|NCT00729248|3671183|FG000|COMPLETED|Overall Study||10
2956817|NCT00729248|3671183|FG000|NOT COMPLETED|Overall Study||2
2956818|NCT00729326|3671190|FG000|STARTED|Overall Study||41
2956819|NCT00729326|3671191|FG001|STARTED|Overall Study||42
2956820|NCT00729326|3671190|FG000|COMPLETED|Overall Study||31
2956821|NCT00729326|3671191|FG001|COMPLETED|Overall Study||33
2956822|NCT00729326|3671190|FG000|NOT COMPLETED|Overall Study||10
2956823|NCT00729326|3671191|FG001|NOT COMPLETED|Overall Study||9
2956824|NCT00729378|3671199|FG000|STARTED|Baseline||430
2956825|NCT00729378|3671200|FG001|STARTED|Baseline||309
2956826|NCT00729378|3671199|FG000|COMPLETED|Baseline||292
2956827|NCT00729378|3671200|FG001|COMPLETED|Baseline||217
2956828|NCT00729378|3671199|FG000|NOT COMPLETED|Baseline||138
2956829|NCT00729378|3671200|FG001|NOT COMPLETED|Baseline||92
2956830|NCT00729378|3671199|FG000|STARTED|12-months||292
2956831|NCT00729378|3671200|FG001|STARTED|12-months||217
2956832|NCT00729378|3671199|FG000|COMPLETED|12-months||192
2956833|NCT00729378|3671200|FG001|COMPLETED|12-months||152
2956834|NCT00729378|3671199|FG000|NOT COMPLETED|12-months||100
2956835|NCT00729378|3671200|FG001|NOT COMPLETED|12-months||65
2956836|NCT00729378|3671199|FG000|STARTED|24-months||192
2956837|NCT00729378|3671200|FG001|STARTED|24-months||152
2956838|NCT00729378|3671199|FG000|COMPLETED|24-months||120
2956839|NCT00729378|3671200|FG001|COMPLETED|24-months||101
2956840|NCT00729378|3671199|FG000|NOT COMPLETED|24-months||72
2956841|NCT00729378|3671200|FG001|NOT COMPLETED|24-months||51
2956842|NCT00729378|3671199|FG000|STARTED|36-months||120
2956843|NCT00729378|3671200|FG001|STARTED|36-months||101
2956844|NCT00729378|3671199|FG000|COMPLETED|36-months||105
2956845|NCT00729378|3671200|FG001|COMPLETED|36-months||95
2956846|NCT00729378|3671199|FG000|NOT COMPLETED|36-months||15
2956847|NCT00729378|3671200|FG001|NOT COMPLETED|36-months||6
2956848|NCT00729430|3671211|FG000|STARTED|Overall Study||180
2956849|NCT00729430|3671212|FG001|STARTED|Overall Study||178
2956850|NCT00729430|3671211|FG000|COMPLETED|Overall Study||133
2956851|NCT00729430|3671212|FG001|COMPLETED|Overall Study||128
2956852|NCT00729430|3671211|FG000|NOT COMPLETED|Overall Study||47
2956853|NCT00729430|3671212|FG001|NOT COMPLETED|Overall Study||50
2956854|NCT00729469|3671221|FG000|STARTED|Overall Study||456
2956855|NCT00729469|3671222|FG001|STARTED|Overall Study||463
2956856|NCT00729469|3671221|FG000|COMPLETED|Overall Study||403
2956857|NCT00729469|3671222|FG001|COMPLETED|Overall Study||416
2956858|NCT00729469|3671221|FG000|NOT COMPLETED|Overall Study||53
2956859|NCT00729469|3671222|FG001|NOT COMPLETED|Overall Study||47
2956860|NCT00729482|3671228|FG000|STARTED|Overall Study||54
2956861|NCT00729482|3671228|FG000|COMPLETED|Overall Study||54
2956862|NCT00729482|3671228|FG000|NOT COMPLETED|Overall Study||0
2956863|NCT00729521|3671235|FG000|STARTED|Overall Study|10 communities in Control with average annual population of 12,494 residents over 65 years old.|12494
2956864|NCT00729521|3671236|FG001|STARTED|Overall Study|Five communities with average annual population of 14,842 residents over 65 years old.|14842
2956865|NCT00729521|3671237|FG002|STARTED|Overall Study|5 communities in Facilitative System with average annual pop. of 7,701 residents over 65 years.|7701
2956866|NCT00729521|3671235|FG000|COMPLETED|Overall Study|Average annual population over 65 years old.|12494
2956867|NCT00729521|3671236|FG001|COMPLETED|Overall Study|Average annual population over 65 years old.|14842
2956868|NCT00729521|3671237|FG002|COMPLETED|Overall Study|Average annual population over 65 years old.|7701
2956869|NCT00729521|3671235|FG000|NOT COMPLETED|Overall Study||0
2956870|NCT00729521|3671236|FG001|NOT COMPLETED|Overall Study||0
2956871|NCT00729521|3671237|FG002|NOT COMPLETED|Overall Study||0
2956872|NCT00729586|3671247|FG000|STARTED|Overall Study||51
2956873|NCT00729586|3671248|FG001|STARTED|Overall Study||22
2956874|NCT00729586|3671247|FG000|COMPLETED|Overall Study|Eligible and treated patients|50
2956875|NCT00729586|3671248|FG001|COMPLETED|Overall Study|Eligible and treated patients|21
2956876|NCT00729586|3671247|FG000|NOT COMPLETED|Overall Study||1
2956877|NCT00729586|3671248|FG001|NOT COMPLETED|Overall Study||1
2956878|NCT00729612|3671255|FG000|STARTED|Overall Study||63
2956879|NCT00729612|3671255|FG000|Died Before Cycle 1|Overall Study||1
2956880|NCT00729612|3671255|FG000|Received Cycle 1|Overall Study||62
2956881|NCT00729612|3671255|FG000|Did Not Receive Cycle 2|Overall Study||7
2956882|NCT00729612|3671255|FG000|Received Cycle 2|Overall Study||54
2956883|NCT00729612|3671255|FG000|Died After Cycle 2 Before Response Eval|Overall Study||1
2956884|NCT00729612|3671255|FG000|COMPLETED|Overall Study||53
2956885|NCT00729612|3671255|FG000|NOT COMPLETED|Overall Study||10
2956886|NCT00729677|3671259|FG000|STARTED|Overall Study||64
2956887|NCT00729677|3671259|FG000|COMPLETED|Overall Study||64
2956888|NCT00729677|3671259|FG000|NOT COMPLETED|Overall Study||0
2956889|NCT00729690|3671273|FG000|STARTED|Overall Study||16
2956890|NCT00729690|3671274|FG001|STARTED|Overall Study||16
2956891|NCT00729690|3671275|FG002|STARTED|Overall Study||16
2956892|NCT00729690|3671273|FG000|COMPLETED|Overall Study||16
2956893|NCT00729690|3671274|FG001|COMPLETED|Overall Study||14
2956894|NCT00729690|3671275|FG002|COMPLETED|Overall Study||14
2956895|NCT00729690|3671273|FG000|NOT COMPLETED|Overall Study||0
2956896|NCT00729690|3671274|FG001|NOT COMPLETED|Overall Study||2
2956897|NCT00729690|3671275|FG002|NOT COMPLETED|Overall Study||2
2956898|NCT00729781|3671283|FG000|STARTED|Original Study||45
2956899|NCT00729781|3671283|FG000|COMPLETED|Original Study||45
2956900|NCT00729781|3671283|FG000|NOT COMPLETED|Original Study||0
2956901|NCT00729781|3671283|FG000|STARTED|Long-term Follow-up Study|Enrollment in the long-term follow-up required contact and a new Informed Consent.|42
2956902|NCT00729781|3671283|FG000|COMPLETED|Long-term Follow-up Study|All subjects completed the original study, but 3 did not consent to enroll in the follow-up study.|42
2956903|NCT00729781|3671283|FG000|NOT COMPLETED|Long-term Follow-up Study||0
2956904|NCT00729807|3671287|FG000|STARTED|Overall Study||6
2956905|NCT00729807|3671287|FG000|COMPLETED|Overall Study||6
2956906|NCT00729807|3671287|FG000|NOT COMPLETED|Overall Study||0
2956907|NCT00729833|3671291|FG000|STARTED|Overall Study||20
2956908|NCT00729833|3671292|FG001|STARTED|Overall Study||7
2956909|NCT00729833|3671293|FG002|STARTED|Overall Study||12
2956910|NCT00729833|3671294|FG003|STARTED|Overall Study||6
2956911|NCT00729833|3671291|FG000|COMPLETED|Overall Study||0
2956912|NCT00729833|3671292|FG001|COMPLETED|Overall Study||0
2956913|NCT00729833|3671293|FG002|COMPLETED|Overall Study||0
2956914|NCT00729833|3671294|FG003|COMPLETED|Overall Study||0
2956915|NCT00729833|3671291|FG000|NOT COMPLETED|Overall Study||20
2956916|NCT00729833|3671292|FG001|NOT COMPLETED|Overall Study||7
2956917|NCT00729833|3671293|FG002|NOT COMPLETED|Overall Study||12
2956918|NCT00729833|3671294|FG003|NOT COMPLETED|Overall Study||6
2956919|NCT00729846|3671307|FG000|STARTED|Overall Study||11
2956920|NCT00729846|3671308|FG001|STARTED|Overall Study||11
2956921|NCT00729846|3671307|FG000|COMPLETED|Overall Study||11
2956922|NCT00729846|3671308|FG001|COMPLETED|Overall Study||11
2956923|NCT00729846|3671307|FG000|NOT COMPLETED|Overall Study||0
2956924|NCT00729846|3671308|FG001|NOT COMPLETED|Overall Study||0
2956925|NCT00729859|3671317|FG000|STARTED|Overall Study||8
2956926|NCT00729859|3671318|FG001|STARTED|Overall Study||8
2956927|NCT00729859|3671319|FG002|STARTED|Overall Study||8
2956928|NCT00729859|3671317|FG000|COMPLETED|Overall Study||8
2956929|NCT00729859|3671318|FG001|COMPLETED|Overall Study||6
2956930|NCT00729859|3671319|FG002|COMPLETED|Overall Study||8
2956931|NCT00729859|3671317|FG000|NOT COMPLETED|Overall Study||0
2956932|NCT00729859|3671318|FG001|NOT COMPLETED|Overall Study||2
2956933|NCT00729859|3671319|FG002|NOT COMPLETED|Overall Study||0
2956934|NCT00729924|3671335|FG000|STARTED|Overall Study||40
2956935|NCT00729924|3671335|FG000|COMPLETED|Overall Study||40
2956936|NCT00729924|3671335|FG000|NOT COMPLETED|Overall Study||0
2956937|NCT00729937|3671348|FG000|STARTED|Overall Study||629
2956938|NCT00729937|3671349|FG001|STARTED|Overall Study||636
2956939|NCT00729937|3671350|FG002|STARTED|Overall Study||251
2956940|NCT00729937|3671351|FG003|STARTED|Overall Study||249
2956941|NCT00729937|3671352|FG004|STARTED|Overall Study||249
2956942|NCT00729937|3671353|FG005|STARTED|Overall Study||251
2956943|NCT00729937|3671348|FG000|COMPLETED|Overall Study||555
2956944|NCT00729937|3671349|FG001|COMPLETED|Overall Study||548
2956945|NCT00729937|3671350|FG002|COMPLETED|Overall Study||222
2956946|NCT00729937|3671351|FG003|COMPLETED|Overall Study||215
2956947|NCT00729937|3671352|FG004|COMPLETED|Overall Study||221
2956948|NCT00729937|3671353|FG005|COMPLETED|Overall Study||214
2956949|NCT00729937|3671348|FG000|NOT COMPLETED|Overall Study||74
2956950|NCT00729937|3671349|FG001|NOT COMPLETED|Overall Study||88
2956951|NCT00729937|3671350|FG002|NOT COMPLETED|Overall Study||29
2956952|NCT00729937|3671351|FG003|NOT COMPLETED|Overall Study||34
2956953|NCT00729937|3671352|FG004|NOT COMPLETED|Overall Study||28
2956954|NCT00729937|3671353|FG005|NOT COMPLETED|Overall Study||37
2956955|NCT00730015|3671370|FG000|STARTED|Overall Study||217
2956956|NCT00730015|3671371|FG001|STARTED|Overall Study||217
2956957|NCT00730015|3671372|FG002|STARTED|Overall Study||209
2956958|NCT00730015|3671370|FG000|COMPLETED|Overall Study||186
2956959|NCT00730015|3671371|FG001|COMPLETED|Overall Study||177
2956960|NCT00730015|3671372|FG002|COMPLETED|Overall Study||177
2956961|NCT00730015|3671370|FG000|NOT COMPLETED|Overall Study||31
2956962|NCT00730015|3671371|FG001|NOT COMPLETED|Overall Study||40
2956963|NCT00730015|3671372|FG002|NOT COMPLETED|Overall Study||32
2956964|NCT00730028|3671390|FG000|STARTED|Overall Study||264
2956965|NCT00730028|3671391|FG001|STARTED|Overall Study||260
2956966|NCT00730028|3671392|FG002|STARTED|Overall Study||266
2956967|NCT00730028|3671393|FG003|STARTED|Overall Study||263
2956968|NCT00730028|3671394|FG004|STARTED|Overall Study||257
2956969|NCT00730028|3671390|FG000|COMPLETED|Overall Study||204
2956970|NCT00730028|3671391|FG001|COMPLETED|Overall Study||194
2956971|NCT00730028|3671392|FG002|COMPLETED|Overall Study||221
2956972|NCT00730028|3671393|FG003|COMPLETED|Overall Study||207
2956973|NCT00730028|3671394|FG004|COMPLETED|Overall Study||175
2956974|NCT00730028|3671390|FG000|NOT COMPLETED|Overall Study||60
2956975|NCT00730028|3671391|FG001|NOT COMPLETED|Overall Study||66
2956976|NCT00730028|3671392|FG002|NOT COMPLETED|Overall Study||45
2956977|NCT00730028|3671393|FG003|NOT COMPLETED|Overall Study||56
2956978|NCT00730028|3671394|FG004|NOT COMPLETED|Overall Study||82
2956979|NCT00730041|3671408|FG000|STARTED|Overall Study|4/26 (15.4%) female, 22/26 (84.6%) male|26
2956980|NCT00730041|3671409|FG001|STARTED|Overall Study|4/25 (16.0%) female, 21/25 (84.0%) male|25
2956981|NCT00730041|3671408|FG000|COMPLETED|Overall Study||26
2956982|NCT00730041|3671409|FG001|COMPLETED|Overall Study|One subject did not return for the final PSG or final visit, and one missed only the final visit.|23
2956983|NCT00730041|3671408|FG000|NOT COMPLETED|Overall Study||0
2956984|NCT00730041|3671409|FG001|NOT COMPLETED|Overall Study||2
2956985|NCT00730158|3671417|FG000|STARTED|Overall Study||17
2956986|NCT00730158|3671418|FG001|STARTED|Overall Study||16
2956987|NCT00730158|3671417|FG000|COMPLETED|Overall Study||16
2956988|NCT00730158|3671418|FG001|COMPLETED|Overall Study||15
2956989|NCT00730158|3671417|FG000|NOT COMPLETED|Overall Study||1
2956990|NCT00730158|3671418|FG001|NOT COMPLETED|Overall Study||1
2956991|NCT00730171|3671428|FG000|STARTED|Overall Study||1725
2956992|NCT00730171|3671428|FG000|CC Safety Population|Overall Study||607
2956993|NCT00730171|3671428|FG000|IBS-C Safety Population|Overall Study||1119
2956994|NCT00730171|3671428|FG000|COMPLETED|Overall Study||954
2956995|NCT00730171|3671428|FG000|NOT COMPLETED|Overall Study||771
2956996|NCT00730236|3671436|FG000|STARTED|Overall Study||29
2956997|NCT00730236|3671436|FG000|COMPLETED|Overall Study||23
2956998|NCT00730236|3671436|FG000|NOT COMPLETED|Overall Study||6
2956999|NCT00730275|3671444|FG000|STARTED|Overall Study||9
2957000|NCT00730275|3671445|FG001|STARTED|Overall Study||9
2957001|NCT00730275|3671446|FG002|STARTED|Overall Study||8
2957002|NCT00730275|3671447|FG003|STARTED|Overall Study||9
2957003|NCT00730275|3671444|FG000|COMPLETED|Overall Study||9
2957004|NCT00730275|3671445|FG001|COMPLETED|Overall Study||9
2957005|NCT00730275|3671446|FG002|COMPLETED|Overall Study||8
2957006|NCT00730275|3671447|FG003|COMPLETED|Overall Study||8
2957007|NCT00730275|3671444|FG000|NOT COMPLETED|Overall Study||0
2957008|NCT00730275|3671445|FG001|NOT COMPLETED|Overall Study||0
2957009|NCT00730275|3671446|FG002|NOT COMPLETED|Overall Study||0
2957010|NCT00730275|3671447|FG003|NOT COMPLETED|Overall Study||1
2957011|NCT00730327|3671460|FG000|STARTED|Overall Study|Started is defined as subjects that began treatment.|125
2957012|NCT00730327|3671461|FG001|STARTED|Overall Study||130
2957013|NCT00730327|3671460|FG000|Completed Week 26|Overall Study|Week 26 was halfway through the study, at which point the BIB group had their balloon removed.|125
2957014|NCT00730327|3671461|FG001|Completed Week 26|Overall Study||99
2957015|NCT00730327|3671460|FG000|COMPLETED|Overall Study|Completed defined as subjects who completed the Week 52 follow-up visit.|98
2957016|NCT00730327|3671461|FG001|COMPLETED|Overall Study||93
2957017|NCT00730327|3671460|FG000|NOT COMPLETED|Overall Study||27
2957018|NCT00730327|3671461|FG001|NOT COMPLETED|Overall Study||37
2957019|NCT00730353|3671467|FG000|STARTED|Overall Study||28
2957020|NCT00730353|3671467|FG000|COMPLETED|Overall Study||28
2957021|NCT00730353|3671467|FG000|NOT COMPLETED|Overall Study||0
2957022|NCT00730405|3671476|FG000|STARTED|Overall Study-Treatment Phase||116
2957023|NCT00730405|3671477|FG001|STARTED|Overall Study-Treatment Phase||117
2957024|NCT00730405|3671478|FG002|STARTED|Overall Study-Treatment Phase||117
2957025|NCT00730405|3671479|FG003|STARTED|Overall Study-Treatment Phase||117
2957026|NCT00730405|3671480|FG004|STARTED|Overall Study-Treatment Phase||115
2957027|NCT00730405|3671476|FG000|COMPLETED|Overall Study-Treatment Phase||97
2957028|NCT00730405|3671477|FG001|COMPLETED|Overall Study-Treatment Phase||96
2957029|NCT00730405|3671478|FG002|COMPLETED|Overall Study-Treatment Phase||96
2957030|NCT00730405|3671479|FG003|COMPLETED|Overall Study-Treatment Phase||98
2957031|NCT00730405|3671480|FG004|COMPLETED|Overall Study-Treatment Phase||95
2957032|NCT00730405|3671476|FG000|NOT COMPLETED|Overall Study-Treatment Phase||19
2957033|NCT00730405|3671477|FG001|NOT COMPLETED|Overall Study-Treatment Phase||21
2957034|NCT00730405|3671478|FG002|NOT COMPLETED|Overall Study-Treatment Phase||21
2957035|NCT00730405|3671479|FG003|NOT COMPLETED|Overall Study-Treatment Phase||19
2957036|NCT00730405|3671480|FG004|NOT COMPLETED|Overall Study-Treatment Phase||20
2957037|NCT00730405|3671476|FG000|STARTED|Overall Study-follow-up Phase||116
2957038|NCT00730405|3671477|FG001|STARTED|Overall Study-follow-up Phase||117
2957039|NCT00730405|3671478|FG002|STARTED|Overall Study-follow-up Phase||117
2957040|NCT00730405|3671479|FG003|STARTED|Overall Study-follow-up Phase||117
2957041|NCT00730405|3671480|FG004|STARTED|Overall Study-follow-up Phase||115
2957042|NCT00730405|3671476|FG000|COMPLETED|Overall Study-follow-up Phase||95
2957043|NCT00730405|3671477|FG001|COMPLETED|Overall Study-follow-up Phase||96
2957044|NCT00730405|3671478|FG002|COMPLETED|Overall Study-follow-up Phase||94
2957045|NCT00730405|3671479|FG003|COMPLETED|Overall Study-follow-up Phase||100
2957046|NCT00730405|3671480|FG004|COMPLETED|Overall Study-follow-up Phase||93
2957047|NCT00730405|3671476|FG000|NOT COMPLETED|Overall Study-follow-up Phase||21
2957048|NCT00730405|3671477|FG001|NOT COMPLETED|Overall Study-follow-up Phase||21
2957049|NCT00730405|3671478|FG002|NOT COMPLETED|Overall Study-follow-up Phase||23
2957050|NCT00730405|3671479|FG003|NOT COMPLETED|Overall Study-follow-up Phase||17
2957051|NCT00730405|3671480|FG004|NOT COMPLETED|Overall Study-follow-up Phase||22
2957052|NCT00730483|3671494|FG000|STARTED|Overall Study||13
2957053|NCT00730483|3671494|FG000|1 Month After First DEB-TACE|Overall Study||13
2957054|NCT00730483|3671494|FG000|6 Months After First DEB-TACE|Overall Study||10
2957055|NCT00730483|3671494|FG000|COMPLETED|Overall Study||6
2957056|NCT00730483|3671494|FG000|NOT COMPLETED|Overall Study||7
2957057|NCT00730522|3671501|FG000|STARTED|Overall Study||28
2957058|NCT00730522|3671502|FG001|STARTED|Overall Study||27
2957059|NCT00730522|3671501|FG000|COMPLETED|Overall Study||28
2957060|NCT00730522|3671502|FG001|COMPLETED|Overall Study||27
2957061|NCT00730522|3671501|FG000|NOT COMPLETED|Overall Study||0
2957062|NCT00730522|3671502|FG001|NOT COMPLETED|Overall Study||0
2957063|NCT00730691|3671515|FG000|STARTED|Overall Study||157
2957064|NCT00730691|3671516|FG001|STARTED|Overall Study||156
2957065|NCT00730691|3671517|FG002|STARTED|Overall Study|One participant was randomized by error. Reason not completed is reported as Other.|156
2957066|NCT00730691|3671518|FG003|STARTED|Overall Study||156
2957067|NCT00730691|3671519|FG004|STARTED|Overall Study||156
2957068|NCT00730691|3671515|FG000|COMPLETED|Overall Study||121
2957069|NCT00730691|3671516|FG001|COMPLETED|Overall Study||120
2957070|NCT00730691|3671517|FG002|COMPLETED|Overall Study||117
2957071|NCT00730691|3671518|FG003|COMPLETED|Overall Study||111
2957072|NCT00730691|3671519|FG004|COMPLETED|Overall Study||106
2957073|NCT00730691|3671515|FG000|NOT COMPLETED|Overall Study||36
2957074|NCT00730691|3671516|FG001|NOT COMPLETED|Overall Study||36
2957075|NCT00730691|3671517|FG002|NOT COMPLETED|Overall Study||39
2957076|NCT00730691|3671518|FG003|NOT COMPLETED|Overall Study||45
2957077|NCT00730691|3671519|FG004|NOT COMPLETED|Overall Study||50
2957078|NCT00730730|3671531|FG000|STARTED|Overall Study||50
2957079|NCT00730730|3671531|FG000|COMPLETED|Overall Study||50
2957080|NCT00730730|3671531|FG000|NOT COMPLETED|Overall Study||0
2957081|NCT00730756|3671537|FG000|STARTED|Overall Study||49
2957082|NCT00730756|3671538|FG001|STARTED|Overall Study||53
2957083|NCT00730756|3671537|FG000|COMPLETED|Overall Study||45
2957084|NCT00730756|3671538|FG001|COMPLETED|Overall Study||48
2957085|NCT00730756|3671537|FG000|NOT COMPLETED|Overall Study||4
2957086|NCT00730756|3671538|FG001|NOT COMPLETED|Overall Study||5
2957087|NCT00730847|3671544|FG000|STARTED|Overall Study||596
2957088|NCT00730847|3671544|FG000|COMPLETED|Overall Study||465
2957089|NCT00730847|3671544|FG000|NOT COMPLETED|Overall Study||131
2957090|NCT00730912|3671551|FG000|STARTED|Overall Study||53
2957091|NCT00730912|3671552|FG001|STARTED|Overall Study||104
2957092|NCT00730912|3671553|FG002|STARTED|Overall Study||104
2957093|NCT00730912|3671551|FG000|COMPLETED|Overall Study||53
2957094|NCT00730912|3671552|FG001|COMPLETED|Overall Study||104
2957095|NCT00730912|3671553|FG002|COMPLETED|Overall Study||103
2957096|NCT00730912|3671551|FG000|NOT COMPLETED|Overall Study||0
2957097|NCT00730912|3671552|FG001|NOT COMPLETED|Overall Study||0
2957098|NCT00730912|3671553|FG002|NOT COMPLETED|Overall Study||1
2957099|NCT00730925|3671561|FG000|STARTED|Overall Study||41
2957100|NCT00730925|3671561|FG000|COMPLETED|Overall Study|On treatment at analysis cut-off date|0
2957101|NCT00730925|3671561|FG000|NOT COMPLETED|Overall Study||41
2957102|NCT00730964|3671565|FG000|STARTED|Overall Study||1039
2957103|NCT00730964|3671565|FG000|COMPLETED|Overall Study||1039
2957104|NCT00730964|3671565|FG000|NOT COMPLETED|Overall Study||0
2957105|NCT00731042|3671572|FG000|STARTED|First Intervention||16
2957106|NCT00731042|3671573|FG001|STARTED|First Intervention||17
2957107|NCT00731042|3671572|FG000|COMPLETED|First Intervention||16
2957108|NCT00731042|3671573|FG001|COMPLETED|First Intervention||17
2957109|NCT00731042|3671572|FG000|NOT COMPLETED|First Intervention||0
2957110|NCT00731042|3671573|FG001|NOT COMPLETED|First Intervention||0
2957111|NCT00731042|3671572|FG000|STARTED|Wash-out||16
2957112|NCT00731042|3671573|FG001|STARTED|Wash-out||17
2957113|NCT00731042|3671572|FG000|COMPLETED|Wash-out||16
2957114|NCT00731042|3671573|FG001|COMPLETED|Wash-out||17
2957115|NCT00731042|3671572|FG000|NOT COMPLETED|Wash-out||0
2957116|NCT00731042|3671573|FG001|NOT COMPLETED|Wash-out||0
2957117|NCT00731042|3671572|FG000|STARTED|Second Intervention||16
2957118|NCT00731042|3671573|FG001|STARTED|Second Intervention||17
2957119|NCT00731042|3671572|FG000|COMPLETED|Second Intervention||16
2957120|NCT00731042|3671573|FG001|COMPLETED|Second Intervention|2 subjects did not met inclusion criteria for Period 2 Visual scoring skin condition|15
2957121|NCT00731042|3671572|FG000|NOT COMPLETED|Second Intervention||0
2957122|NCT00731042|3671573|FG001|NOT COMPLETED|Second Intervention||2
2957123|NCT00731055|3671579|FG000|STARTED|Overall Study|This is a within-subjects study design.|16
2957124|NCT00731055|3671579|FG000|Received Placebo|Overall Study||16
2957125|NCT00731055|3671579|FG000|Received Varenicline 0.5 mg|Overall Study||16
2957126|NCT00731055|3671579|FG000|Received Varenicline 1.0 mg|Overall Study||16
2957127|NCT00731055|3671579|FG000|Received Varenicline 2.0 mg|Overall Study||16
2957128|NCT00731055|3671579|FG000|COMPLETED|Overall Study||16
2957129|NCT00731055|3671579|FG000|NOT COMPLETED|Overall Study||0
2957130|NCT00731094|3671588|FG000|STARTED|Overall Study||116
2957131|NCT00731094|3671589|FG001|STARTED|Overall Study||116
2957132|NCT00731094|3671588|FG000|Month 6|Overall Study||101
2957133|NCT00731094|3671589|FG001|Month 6|Overall Study||107
2957134|NCT00731094|3671588|FG000|COMPLETED|Overall Study||98
2957135|NCT00731094|3671589|FG001|COMPLETED|Overall Study||105
2957136|NCT00731094|3671588|FG000|NOT COMPLETED|Overall Study||18
2957137|NCT00731094|3671589|FG001|NOT COMPLETED|Overall Study||11
2957138|NCT00731120|3671598|FG000|STARTED|Overall Study||153
2957139|NCT00731120|3671599|FG001|STARTED|Overall Study||152
2957140|NCT00731120|3671600|FG002|STARTED|Overall Study||152
2957141|NCT00731120|3671598|FG000|Treated|Overall Study||153
2957142|NCT00731120|3671599|FG001|Treated|Overall Study||151
2957143|NCT00731120|3671600|FG002|Treated|Overall Study||152
2957144|NCT00731120|3671598|FG000|COMPLETED|Overall Study||111
2957145|NCT00731120|3671599|FG001|COMPLETED|Overall Study||109
2957146|NCT00731120|3671600|FG002|COMPLETED|Overall Study||116
2957147|NCT00731120|3671598|FG000|NOT COMPLETED|Overall Study||42
2957148|NCT00731120|3671599|FG001|NOT COMPLETED|Overall Study||43
2957149|NCT00731120|3671600|FG002|NOT COMPLETED|Overall Study||36
2957150|NCT00731133|3671608|FG000|STARTED|Overall Study||15
2957151|NCT00731133|3671608|FG000|COMPLETED|Overall Study||5
2957152|NCT00731133|3671608|FG000|NOT COMPLETED|Overall Study||10
2957153|NCT00731198|3671614|FG000|STARTED|Overall Study||325
2957154|NCT00731198|3671615|FG001|STARTED|Overall Study||325
2957155|NCT00731198|3671614|FG000|COMPLETED|Overall Study||319
2957156|NCT00731198|3671615|FG001|COMPLETED|Overall Study||319
2957157|NCT00731198|3671614|FG000|NOT COMPLETED|Overall Study||6
2957158|NCT00731198|3671615|FG001|NOT COMPLETED|Overall Study||6
2957159|NCT00731211|3671621|FG000|STARTED|Overall Study|2 patients ineligible (papillary histologic type-1 pt. Previous treatment with everolimus alone-1 pt|55
2957160|NCT00731211|3671621|FG000|COMPLETED|Overall Study||55
2957161|NCT00731211|3671621|FG000|NOT COMPLETED|Overall Study||0
2957162|NCT00731341|3671625|FG000|STARTED|Overall Study||3
2957163|NCT00731341|3671625|FG000|COMPLETED|Overall Study||3
2957164|NCT00731341|3671625|FG000|NOT COMPLETED|Overall Study||0
2957165|NCT00731484|3671629|FG000|STARTED|Overall Study||233
2957166|NCT00731484|3671629|FG000|COMPLETED|Overall Study||233
2957167|NCT00731484|3671629|FG000|NOT COMPLETED|Overall Study||0
2957168|NCT00731549|3671633|FG000|STARTED|Overall Study||1081
2957169|NCT00731549|3671633|FG000|COMPLETED|Overall Study||858
2957170|NCT00731549|3671633|FG000|NOT COMPLETED|Overall Study||223
2957171|NCT00731588|3671639|FG000|STARTED|Overall Study||9
2957172|NCT00731588|3671640|FG001|STARTED|Overall Study||95
2957173|NCT00731588|3671639|FG000|COMPLETED|Overall Study||9
2957174|NCT00731588|3671640|FG001|COMPLETED|Overall Study||53
2957175|NCT00731588|3671639|FG000|NOT COMPLETED|Overall Study||0
2957176|NCT00731588|3671640|FG001|NOT COMPLETED|Overall Study||42
2957177|NCT00731614|3671649|FG000|STARTED|Overall Study||23
2957178|NCT00731614|3671650|FG001|STARTED|Overall Study||31
2957179|NCT00731614|3671649|FG000|End of Treatment|Overall Study||16
2957180|NCT00731614|3671650|FG001|End of Treatment|Overall Study||24
2957181|NCT00731614|3671649|FG000|12 Weeks Posttreatment|Overall Study||18
2957182|NCT00731614|3671650|FG001|12 Weeks Posttreatment|Overall Study||23
2957183|NCT00731614|3671649|FG000|COMPLETED|Overall Study||16
2957184|NCT00731614|3671650|FG001|COMPLETED|Overall Study||18
2957185|NCT00731614|3671649|FG000|NOT COMPLETED|Overall Study||7
2957186|NCT00731614|3671650|FG001|NOT COMPLETED|Overall Study||13
2957187|NCT00731640|3671658|FG000|STARTED|Overall Study||20
2957188|NCT00731640|3671659|FG001|STARTED|Overall Study||32
2957189|NCT00731640|3671658|FG000|COMPLETED|Overall Study||20
2957190|NCT00731640|3671659|FG001|COMPLETED|Overall Study||32
2957191|NCT00731640|3671658|FG000|NOT COMPLETED|Overall Study||0
2957192|NCT00731640|3671659|FG001|NOT COMPLETED|Overall Study||0
2957193|NCT00731653|3671665|FG000|STARTED|Overall Study||81
2957194|NCT00731653|3671665|FG000|COMPLETED|Overall Study||72
2957195|NCT00731653|3671665|FG000|NOT COMPLETED|Overall Study||9
2957196|NCT00731666|3671669|FG000|STARTED|Overall Study||40
2957197|NCT00731666|3671669|FG000|COMPLETED|Overall Study||28
2957198|NCT00731666|3671669|FG000|NOT COMPLETED|Overall Study||12
2957199|NCT00731679|3671675|FG000|STARTED|Overall Study||314
2957200|NCT00731679|3671676|FG001|STARTED|Overall Study||309
2957201|NCT00731679|3671675|FG000|COMPLETED|Overall Study||292
2957202|NCT00731679|3671676|FG001|COMPLETED|Overall Study||283
2957203|NCT00731679|3671675|FG000|NOT COMPLETED|Overall Study||22
2957204|NCT00731679|3671676|FG001|NOT COMPLETED|Overall Study||26
2957205|NCT00731692|3671685|FG000|STARTED|Core Study (36 Months)||147
2957206|NCT00731692|3671686|FG001|STARTED|Core Study (36 Months)||336
2957207|NCT00731692|3671687|FG002|STARTED|Core Study (36 Months)||487
2957208|NCT00731692|3671685|FG000|Safety Set (SAF)|Core Study (36 Months)||0
2957209|NCT00731692|3671686|FG001|Safety Set (SAF)|Core Study (36 Months)||336
2957210|NCT00731692|3671687|FG002|Safety Set (SAF)|Core Study (36 Months)||487
2957211|NCT00731692|3671685|FG000|Full Analysis Set (FAS)|Core Study (36 Months)||0
2957212|NCT00731692|3671686|FG001|Full Analysis Set (FAS)|Core Study (36 Months)||336
2957213|NCT00731692|3671687|FG002|Full Analysis Set (FAS)|Core Study (36 Months)||487
2957214|NCT00731692|3671685|FG000|Pharmacokinetic Analysis Set|Core Study (36 Months)||102
2957215|NCT00731692|3671686|FG001|Pharmacokinetic Analysis Set|Core Study (36 Months)||249
2957216|NCT00731692|3671687|FG002|Pharmacokinetic Analysis Set|Core Study (36 Months)||0
2957217|NCT00731692|3671685|FG000|Post Protocol Amendment 5 Switch|Core Study (36 Months)||0
2957218|NCT00731692|3671686|FG001|Post Protocol Amendment 5 Switch|Core Study (36 Months)|post protocol amendment 121 patients switch to 0.5 mg dose from 125mg dose|121
2957219|NCT00731692|3671687|FG002|Post Protocol Amendment 5 Switch|Core Study (36 Months)||0
2957220|NCT00731692|3671685|FG000|COMPLETED|Core Study (36 Months)||79
2957221|NCT00731692|3671686|FG001|COMPLETED|Core Study (36 Months)||220
2957222|NCT00731692|3671687|FG002|COMPLETED|Core Study (36 Months)||317
2957223|NCT00731692|3671685|FG000|NOT COMPLETED|Core Study (36 Months)||68
2957224|NCT00731692|3671686|FG001|NOT COMPLETED|Core Study (36 Months)||116
2957225|NCT00731692|3671687|FG002|NOT COMPLETED|Core Study (36 Months)||170
2957226|NCT00731692|3671685|FG000|STARTED|Extension Phase||74
2957227|NCT00731692|3671686|FG001|STARTED|Extension Phase||196
2957228|NCT00731692|3671687|FG002|STARTED|Extension Phase||301
2957229|NCT00731692|3671685|FG000|COMPLETED|Extension Phase||0
2957230|NCT00731692|3671686|FG001|COMPLETED|Extension Phase||0
2957231|NCT00731692|3671687|FG002|COMPLETED|Extension Phase||0
2957232|NCT00731692|3671685|FG000|NOT COMPLETED|Extension Phase||74
2957233|NCT00731692|3671686|FG001|NOT COMPLETED|Extension Phase||196
2957234|NCT00731692|3671687|FG002|NOT COMPLETED|Extension Phase||301
2957235|NCT00731783|3671705|FG000|STARTED|One Month Follow-Up Visit||92
2957236|NCT00731783|3671706|FG001|STARTED|One Month Follow-Up Visit||91
2957237|NCT00731783|3671705|FG000|COMPLETED|One Month Follow-Up Visit||78
2957238|NCT00731783|3671706|FG001|COMPLETED|One Month Follow-Up Visit||69
2957239|NCT00731783|3671705|FG000|NOT COMPLETED|One Month Follow-Up Visit||14
2957240|NCT00731783|3671706|FG001|NOT COMPLETED|One Month Follow-Up Visit||22
2957241|NCT00731783|3671705|FG000|STARTED|Three Month Follow-Up Visit||79
2957242|NCT00731783|3671706|FG001|STARTED|Three Month Follow-Up Visit||73
2957243|NCT00731783|3671705|FG000|COMPLETED|Three Month Follow-Up Visit||72
2957244|NCT00731783|3671706|FG001|COMPLETED|Three Month Follow-Up Visit||57
2957245|NCT00731783|3671705|FG000|NOT COMPLETED|Three Month Follow-Up Visit||7
2957246|NCT00731783|3671706|FG001|NOT COMPLETED|Three Month Follow-Up Visit||16
2957247|NCT00731783|3671705|FG000|STARTED|Six Month Follow-Up Visit||77
2957248|NCT00731783|3671706|FG001|STARTED|Six Month Follow-Up Visit||67
2957249|NCT00731783|3671705|FG000|COMPLETED|Six Month Follow-Up Visit||71
2957250|NCT00731783|3671706|FG001|COMPLETED|Six Month Follow-Up Visit||64
2957251|NCT00731783|3671705|FG000|NOT COMPLETED|Six Month Follow-Up Visit||6
2957252|NCT00731783|3671706|FG001|NOT COMPLETED|Six Month Follow-Up Visit||3
2957253|NCT00731783|3671705|FG000|STARTED|12 Month Follow-Up Visit||74
2957254|NCT00731783|3671706|FG001|STARTED|12 Month Follow-Up Visit||65
2957255|NCT00731783|3671705|FG000|COMPLETED|12 Month Follow-Up Visit||68
3300433|NCT02945410|4034311|FG003|NOT COMPLETED|Washout 2 (14 Days)||0
3300434|NCT02945410|4034312|FG004|NOT COMPLETED|Washout 2 (14 Days)||0
3300435|NCT02945410|4034313|FG005|NOT COMPLETED|Washout 2 (14 Days)||0
3300436|NCT02945410|4034308|FG000|STARTED|Intervention 3 (5 Days)||2
3300437|NCT02945410|4034309|FG001|STARTED|Intervention 3 (5 Days)||1
2957256|NCT00731783|3671706|FG001|COMPLETED|12 Month Follow-Up Visit||58
2957257|NCT00731783|3671705|FG000|NOT COMPLETED|12 Month Follow-Up Visit||6
2957258|NCT00731783|3671706|FG001|NOT COMPLETED|12 Month Follow-Up Visit||7
2957259|NCT00731822|3671714|FG000|STARTED|Overall Study||20
2957260|NCT00731822|3671715|FG001|STARTED|Overall Study||40
2957261|NCT00731822|3671714|FG000|COMPLETED|Overall Study||16
2957262|NCT00731822|3671715|FG001|COMPLETED|Overall Study||39
2957263|NCT00731822|3671714|FG000|NOT COMPLETED|Overall Study||4
2957264|NCT00731822|3671715|FG001|NOT COMPLETED|Overall Study||1
2957265|NCT00731874|3671723|FG000|STARTED|Overall Study||10
2957266|NCT00731874|3671724|FG001|STARTED|Overall Study||13
2957267|NCT00731874|3671723|FG000|COMPLETED|Overall Study||10
2957268|NCT00731874|3671724|FG001|COMPLETED|Overall Study||13
2957269|NCT00731874|3671723|FG000|NOT COMPLETED|Overall Study||0
2957270|NCT00731874|3671724|FG001|NOT COMPLETED|Overall Study||0
3132713|NCT01692756|3857873|FG001|NOT COMPLETED|Overall Study||1
3132714|NCT01692756|3857874|FG002|NOT COMPLETED|Overall Study||2
3132715|NCT01692756|3857875|FG003|NOT COMPLETED|Overall Study||0
2957271|NCT00731939|3671730|FG000|STARTED|Overall Study||124
2957272|NCT00731939|3671730|FG000|COMPLETED|Overall Study||90
2957273|NCT00731939|3671730|FG000|NOT COMPLETED|Overall Study||34
2957274|NCT00732030|3671734|FG000|STARTED|Overall Study||26
2957275|NCT00732030|3671734|FG000|COMPLETED|Overall Study||24
2957276|NCT00732030|3671734|FG000|NOT COMPLETED|Overall Study||2
2957277|NCT00732069|3671738|FG000|STARTED|First Study Drug||3
2957278|NCT00732069|3671739|FG001|STARTED|First Study Drug||3
2957279|NCT00732069|3671740|FG002|STARTED|First Study Drug||3
2957280|NCT00732069|3671741|FG003|STARTED|First Study Drug||2
2957281|NCT00732069|3671742|FG004|STARTED|First Study Drug||3
2957282|NCT00732069|3671743|FG005|STARTED|First Study Drug||2
2957283|NCT00732069|3671738|FG000|COMPLETED|First Study Drug||3
2957284|NCT00732069|3671739|FG001|COMPLETED|First Study Drug||3
2957285|NCT00732069|3671740|FG002|COMPLETED|First Study Drug||3
2957286|NCT00732069|3671741|FG003|COMPLETED|First Study Drug||2
2957287|NCT00732069|3671742|FG004|COMPLETED|First Study Drug||3
2957288|NCT00732069|3671743|FG005|COMPLETED|First Study Drug||2
2957289|NCT00732069|3671738|FG000|NOT COMPLETED|First Study Drug||0
2957290|NCT00732069|3671739|FG001|NOT COMPLETED|First Study Drug||0
2957291|NCT00732069|3671740|FG002|NOT COMPLETED|First Study Drug||0
2957292|NCT00732069|3671741|FG003|NOT COMPLETED|First Study Drug||0
2957293|NCT00732069|3671742|FG004|NOT COMPLETED|First Study Drug||0
2957294|NCT00732069|3671743|FG005|NOT COMPLETED|First Study Drug||0
2957295|NCT00732069|3671738|FG000|STARTED|Washout After First Study Drug||3
2957296|NCT00732069|3671739|FG001|STARTED|Washout After First Study Drug||3
2957297|NCT00732069|3671740|FG002|STARTED|Washout After First Study Drug||3
2957298|NCT00732069|3671741|FG003|STARTED|Washout After First Study Drug||2
2957299|NCT00732069|3671742|FG004|STARTED|Washout After First Study Drug||3
2957300|NCT00732069|3671743|FG005|STARTED|Washout After First Study Drug||2
2957301|NCT00732069|3671738|FG000|COMPLETED|Washout After First Study Drug||2
2957302|NCT00732069|3671739|FG001|COMPLETED|Washout After First Study Drug||3
2957303|NCT00732069|3671740|FG002|COMPLETED|Washout After First Study Drug||3
2957304|NCT00732069|3671741|FG003|COMPLETED|Washout After First Study Drug||2
2957305|NCT00732069|3671742|FG004|COMPLETED|Washout After First Study Drug||3
2957306|NCT00732069|3671743|FG005|COMPLETED|Washout After First Study Drug||2
2957307|NCT00732069|3671738|FG000|NOT COMPLETED|Washout After First Study Drug||1
3132716|NCT01692782|3857888|FG000|STARTED|Overall Study||116
3132717|NCT01692782|3857889|FG001|STARTED|Overall Study||115
3132718|NCT01692782|3857890|FG002|STARTED|Overall Study||110
3132719|NCT01692782|3857888|FG000|COMPLETED|Overall Study||96
3132720|NCT01692782|3857889|FG001|COMPLETED|Overall Study||59
3132721|NCT01692782|3857890|FG002|COMPLETED|Overall Study||100
3132722|NCT01692782|3857888|FG000|NOT COMPLETED|Overall Study||20
3132723|NCT01692782|3857889|FG001|NOT COMPLETED|Overall Study||56
3132724|NCT01692782|3857890|FG002|NOT COMPLETED|Overall Study||10
3132725|NCT01692938|3857900|FG000|STARTED|Overall Study||16
3132726|NCT01692938|3857901|FG001|STARTED|Overall Study||16
3132727|NCT01692938|3857900|FG000|COMPLETED|Overall Study||12
3132728|NCT01692938|3857901|FG001|COMPLETED|Overall Study||12
3300438|NCT02945410|4034310|FG002|STARTED|Intervention 3 (5 Days)||0
3300439|NCT02945410|4034311|FG003|STARTED|Intervention 3 (5 Days)||3
3300440|NCT02945410|4034312|FG004|STARTED|Intervention 3 (5 Days)||1
2957308|NCT00732069|3671739|FG001|NOT COMPLETED|Washout After First Study Drug||0
2957309|NCT00732069|3671740|FG002|NOT COMPLETED|Washout After First Study Drug||0
2957310|NCT00732069|3671741|FG003|NOT COMPLETED|Washout After First Study Drug||0
2957311|NCT00732069|3671742|FG004|NOT COMPLETED|Washout After First Study Drug||0
2957312|NCT00732069|3671743|FG005|NOT COMPLETED|Washout After First Study Drug||0
2957313|NCT00732069|3671738|FG000|STARTED|Second Study Drug||2
2957314|NCT00732069|3671739|FG001|STARTED|Second Study Drug||3
2957315|NCT00732069|3671740|FG002|STARTED|Second Study Drug||3
2957316|NCT00732069|3671741|FG003|STARTED|Second Study Drug||2
2957317|NCT00732069|3671742|FG004|STARTED|Second Study Drug||3
2957318|NCT00732069|3671743|FG005|STARTED|Second Study Drug||2
2957319|NCT00732069|3671738|FG000|COMPLETED|Second Study Drug||2
2957320|NCT00732069|3671739|FG001|COMPLETED|Second Study Drug||3
2957321|NCT00732069|3671740|FG002|COMPLETED|Second Study Drug||3
2957322|NCT00732069|3671741|FG003|COMPLETED|Second Study Drug||2
2957323|NCT00732069|3671742|FG004|COMPLETED|Second Study Drug||3
2957324|NCT00732069|3671743|FG005|COMPLETED|Second Study Drug||2
2957325|NCT00732069|3671738|FG000|NOT COMPLETED|Second Study Drug||0
2957326|NCT00732069|3671739|FG001|NOT COMPLETED|Second Study Drug||0
3163597|NCT01888432|3891159|FG000|STARTED|12-month Analysis (FAS)||142
3163598|NCT01888432|3891160|FG001|STARTED|12-month Analysis (FAS)||142
3163599|NCT01888432|3891159|FG000|COMPLETED|12-month Analysis (FAS)||131
3163600|NCT01888432|3891160|FG001|COMPLETED|12-month Analysis (FAS)||133
3163601|NCT01888432|3891159|FG000|NOT COMPLETED|12-month Analysis (FAS)||11
3163602|NCT01888432|3891160|FG001|NOT COMPLETED|12-month Analysis (FAS)||9
3163603|NCT01888432|3891159|FG000|STARTED|24-month Analysis (FAS)||142
3163604|NCT01888432|3891160|FG001|STARTED|24-month Analysis (FAS)||142
2957327|NCT00732069|3671740|FG002|NOT COMPLETED|Second Study Drug||0
2957328|NCT00732069|3671741|FG003|NOT COMPLETED|Second Study Drug||0
2957329|NCT00732069|3671742|FG004|NOT COMPLETED|Second Study Drug||0
2957330|NCT00732069|3671743|FG005|NOT COMPLETED|Second Study Drug||0
2957331|NCT00732069|3671738|FG000|STARTED|Washout After Second Study Drug||2
2957332|NCT00732069|3671739|FG001|STARTED|Washout After Second Study Drug||3
2957333|NCT00732069|3671740|FG002|STARTED|Washout After Second Study Drug||3
2957334|NCT00732069|3671741|FG003|STARTED|Washout After Second Study Drug||2
2957335|NCT00732069|3671742|FG004|STARTED|Washout After Second Study Drug||3
2957336|NCT00732069|3671743|FG005|STARTED|Washout After Second Study Drug||2
2957337|NCT00732069|3671738|FG000|COMPLETED|Washout After Second Study Drug||2
2957338|NCT00732069|3671739|FG001|COMPLETED|Washout After Second Study Drug||3
2957339|NCT00732069|3671740|FG002|COMPLETED|Washout After Second Study Drug||3
2957340|NCT00732069|3671741|FG003|COMPLETED|Washout After Second Study Drug||2
2957341|NCT00732069|3671742|FG004|COMPLETED|Washout After Second Study Drug||3
2957342|NCT00732069|3671743|FG005|COMPLETED|Washout After Second Study Drug||2
2957343|NCT00732069|3671738|FG000|NOT COMPLETED|Washout After Second Study Drug||0
2957344|NCT00732069|3671739|FG001|NOT COMPLETED|Washout After Second Study Drug||0
2957345|NCT00732069|3671740|FG002|NOT COMPLETED|Washout After Second Study Drug||0
2957346|NCT00732069|3671741|FG003|NOT COMPLETED|Washout After Second Study Drug||0
2957347|NCT00732069|3671742|FG004|NOT COMPLETED|Washout After Second Study Drug||0
2957348|NCT00732069|3671743|FG005|NOT COMPLETED|Washout After Second Study Drug||0
2957349|NCT00732069|3671738|FG000|STARTED|Third Study Drug||2
2957350|NCT00732069|3671739|FG001|STARTED|Third Study Drug||3
2957351|NCT00732069|3671740|FG002|STARTED|Third Study Drug||3
2957352|NCT00732069|3671741|FG003|STARTED|Third Study Drug||2
2957353|NCT00732069|3671742|FG004|STARTED|Third Study Drug||3
2957354|NCT00732069|3671743|FG005|STARTED|Third Study Drug||2
2957355|NCT00732069|3671738|FG000|COMPLETED|Third Study Drug||2
2957356|NCT00732069|3671739|FG001|COMPLETED|Third Study Drug||3
2957357|NCT00732069|3671740|FG002|COMPLETED|Third Study Drug||3
2957358|NCT00732069|3671741|FG003|COMPLETED|Third Study Drug||2
2957359|NCT00732069|3671742|FG004|COMPLETED|Third Study Drug||3
2957360|NCT00732069|3671743|FG005|COMPLETED|Third Study Drug||2
2957361|NCT00732069|3671738|FG000|NOT COMPLETED|Third Study Drug||0
2957362|NCT00732069|3671739|FG001|NOT COMPLETED|Third Study Drug||0
2957363|NCT00732069|3671740|FG002|NOT COMPLETED|Third Study Drug||0
2957364|NCT00732069|3671741|FG003|NOT COMPLETED|Third Study Drug||0
2957365|NCT00732069|3671742|FG004|NOT COMPLETED|Third Study Drug||0
2957366|NCT00732069|3671743|FG005|NOT COMPLETED|Third Study Drug||0
2957367|NCT00732160|3671755|FG000|STARTED|Overall Study||7
2957368|NCT00732160|3671756|FG001|STARTED|Overall Study||5
2957369|NCT00732160|3671757|FG002|STARTED|Overall Study||6
2957370|NCT00732160|3671758|FG003|STARTED|Overall Study||5
2957371|NCT00732160|3671755|FG000|HS Vehicle|Overall Study||7
2957372|NCT00732160|3671756|FG001|HS Vehicle|Overall Study||5
2957373|NCT00732160|3671757|FG002|HS Vehicle|Overall Study||3
2957374|NCT00732160|3671758|FG003|HS Vehicle|Overall Study||3
2957375|NCT00732160|3671755|FG000|HS Aldosterone|Overall Study||7
2957376|NCT00732160|3671756|FG001|HS Aldosterone|Overall Study||5
2957377|NCT00732160|3671757|FG002|HS Aldosterone|Overall Study||3
2957378|NCT00732160|3671758|FG003|HS Aldosterone|Overall Study||3
2957379|NCT00732160|3671755|FG000|LS Vehicle|Overall Study||2
2957380|NCT00732160|3671756|FG001|LS Vehicle|Overall Study||1
2957381|NCT00732160|3671757|FG002|LS Vehicle|Overall Study||6
2957382|NCT00732160|3671758|FG003|LS Vehicle|Overall Study||5
2957383|NCT00732160|3671755|FG000|LS Aldosterone|Overall Study||2
2957384|NCT00732160|3671756|FG001|LS Aldosterone|Overall Study||1
2957385|NCT00732160|3671757|FG002|LS Aldosterone|Overall Study||6
2957386|NCT00732160|3671758|FG003|LS Aldosterone|Overall Study||5
2957387|NCT00732160|3671755|FG000|COMPLETED|Overall Study||2
2957388|NCT00732160|3671756|FG001|COMPLETED|Overall Study||1
2957389|NCT00732160|3671757|FG002|COMPLETED|Overall Study||3
2957390|NCT00732160|3671758|FG003|COMPLETED|Overall Study||3
2957391|NCT00732160|3671755|FG000|NOT COMPLETED|Overall Study||5
2957392|NCT00732160|3671756|FG001|NOT COMPLETED|Overall Study||4
2957393|NCT00732160|3671757|FG002|NOT COMPLETED|Overall Study||3
2957394|NCT00732160|3671758|FG003|NOT COMPLETED|Overall Study||2
2957395|NCT00732199|3671770|FG000|STARTED|Overall Study||50
2957396|NCT00732199|3671771|FG001|STARTED|Overall Study||42
2957397|NCT00732199|3671770|FG000|COMPLETED|Overall Study||16
2957398|NCT00732199|3671771|FG001|COMPLETED|Overall Study||16
2957399|NCT00732199|3671770|FG000|NOT COMPLETED|Overall Study||34
2957400|NCT00732199|3671771|FG001|NOT COMPLETED|Overall Study||26
2957401|NCT00732212|3671784|FG000|STARTED|Overall Study||112
2957402|NCT00732212|3671785|FG001|STARTED|Overall Study||123
2957403|NCT00732212|3671784|FG000|Temporarily Suspended|Overall Study|Study was suspended for a 9 month period by the VA DMC because of slow enrollment, then restarted.|50
2957404|NCT00732212|3671785|FG001|Temporarily Suspended|Overall Study||50
2957405|NCT00732212|3671784|FG000|COMPLETED|Overall Study||112
2957406|NCT00732212|3671785|FG001|COMPLETED|Overall Study||123
2957407|NCT00732212|3671784|FG000|NOT COMPLETED|Overall Study||0
2957408|NCT00732212|3671785|FG001|NOT COMPLETED|Overall Study||0
2957409|NCT00732225|3671820|FG000|STARTED|Overall Study|76 eyes of 71 patients|71
2957410|NCT00732225|3671821|FG001|STARTED|Overall Study|41 eyes of 40 patients|40
2957411|NCT00732225|3671822|FG002|STARTED|Overall Study|26 eyes of 26 patients|26
2957412|NCT00732225|3671823|FG003|STARTED|Overall Study|33 eyes of 33 patients|33
2957413|NCT00732225|3671824|FG004|STARTED|Overall Study|55 eyes of 54 patients|54
2957414|NCT00732225|3671820|FG000|COMPLETED|Overall Study|64 eyes of 60 patients|60
2957415|NCT00732225|3671821|FG001|COMPLETED|Overall Study|33 eyes of 32 patients|32
2957416|NCT00732225|3671822|FG002|COMPLETED|Overall Study|23 eyes of 23 patients|23
2957417|NCT00732225|3671823|FG003|COMPLETED|Overall Study|29 eyes of 29 patients|29
2957418|NCT00732225|3671824|FG004|COMPLETED|Overall Study|48 eyes of 48 patients|48
2957419|NCT00732225|3671820|FG000|NOT COMPLETED|Overall Study||11
2957420|NCT00732225|3671821|FG001|NOT COMPLETED|Overall Study||8
2957421|NCT00732225|3671822|FG002|NOT COMPLETED|Overall Study||3
2957422|NCT00732225|3671823|FG003|NOT COMPLETED|Overall Study||4
2957423|NCT00732225|3671824|FG004|NOT COMPLETED|Overall Study||6
2957424|NCT00732238|3671838|FG000|STARTED|Overall Study||33
2957425|NCT00732238|3671839|FG001|STARTED|Overall Study||28
2957426|NCT00732238|3671838|FG000|COMPLETED|Overall Study||28
2957427|NCT00732238|3671839|FG001|COMPLETED|Overall Study||27
2957428|NCT00732238|3671838|FG000|NOT COMPLETED|Overall Study||5
2957429|NCT00732238|3671839|FG001|NOT COMPLETED|Overall Study||1
2957430|NCT00732251|3671847|FG000|STARTED|Overall Study||8
2957431|NCT00732251|3671847|FG000|COMPLETED|Overall Study||1
2957432|NCT00732251|3671847|FG000|NOT COMPLETED|Overall Study||7
2957433|NCT00732303|3671851|FG000|STARTED|Overall Study||8
2957434|NCT00732303|3671851|FG000|COMPLETED|Overall Study||6
2957435|NCT00732303|3671851|FG000|NOT COMPLETED|Overall Study||2
2957436|NCT00732472|3671859|FG000|STARTED|Overall Study||9
2957437|NCT00732472|3671860|FG001|STARTED|Overall Study|One par. (counted as 2 on outputs) was randomized/dosed with UMEC 250 µg on 2 separate occasions.|10
2957438|NCT00732472|3671861|FG002|STARTED|Overall Study||10
2957439|NCT00732472|3671862|FG003|STARTED|Overall Study||9
2957440|NCT00732472|3671859|FG000|COMPLETED|Overall Study||9
2957441|NCT00732472|3671860|FG001|COMPLETED|Overall Study||7
2957442|NCT00732472|3671861|FG002|COMPLETED|Overall Study||9
2957443|NCT00732472|3671862|FG003|COMPLETED|Overall Study||6
2957444|NCT00732472|3671859|FG000|NOT COMPLETED|Overall Study||0
2957445|NCT00732472|3671860|FG001|NOT COMPLETED|Overall Study||3
2957446|NCT00732472|3671861|FG002|NOT COMPLETED|Overall Study||1
2957447|NCT00732472|3671862|FG003|NOT COMPLETED|Overall Study||3
2957448|NCT00732498|3671873|FG000|STARTED|Overall Study||28
2957449|NCT00732498|3671873|FG000|COMPLETED|Overall Study||22
2957450|NCT00732498|3671873|FG000|NOT COMPLETED|Overall Study||6
2957451|NCT00732615|3671879|FG000|STARTED|Overall Study||40
2957452|NCT00732615|3671880|FG001|STARTED|Overall Study||84
2957453|NCT00732615|3671879|FG000|COMPLETED|Overall Study||33
2957454|NCT00732615|3671880|FG001|COMPLETED|Overall Study||79
2957455|NCT00732615|3671879|FG000|NOT COMPLETED|Overall Study||7
2957456|NCT00732615|3671880|FG001|NOT COMPLETED|Overall Study||5
2957457|NCT00732641|3671889|FG000|STARTED|Overall Study||123
2957458|NCT00732641|3671890|FG001|STARTED|Overall Study||121
2957459|NCT00732641|3671889|FG000|COMPLETED|Overall Study||17
2957460|NCT00732641|3671890|FG001|COMPLETED|Overall Study||9
2957461|NCT00732641|3671889|FG000|NOT COMPLETED|Overall Study||106
2957462|NCT00732641|3671890|FG001|NOT COMPLETED|Overall Study||112
3132729|NCT01692938|3857900|FG000|NOT COMPLETED|Overall Study||4
3132730|NCT01692938|3857901|FG001|NOT COMPLETED|Overall Study||4
2957463|NCT00732654|3671899|FG000|STARTED|Overall Study||10
2957464|NCT00732654|3671900|FG001|STARTED|Overall Study||10
2957465|NCT00732654|3671901|FG002|STARTED|Overall Study||10
2957466|NCT00732654|3671899|FG000|COMPLETED|Overall Study||10
2957467|NCT00732654|3671900|FG001|COMPLETED|Overall Study||9
2957468|NCT00732654|3671901|FG002|COMPLETED|Overall Study||10
2957469|NCT00732654|3671899|FG000|NOT COMPLETED|Overall Study||0
2957470|NCT00732654|3671900|FG001|NOT COMPLETED|Overall Study||1
2957471|NCT00732654|3671901|FG002|NOT COMPLETED|Overall Study||0
3132731|NCT01692951|3857911|FG000|STARTED|Overall Study||37
2957472|NCT00732758|3671911|FG000|STARTED|Overall Study||78
2957473|NCT00732758|3671912|FG001|STARTED|Overall Study||79
2957474|NCT00732758|3671911|FG000|COMPLETED|Overall Study||70
2957475|NCT00732758|3671912|FG001|COMPLETED|Overall Study||63
2957476|NCT00732758|3671911|FG000|NOT COMPLETED|Overall Study||8
2957477|NCT00732758|3671912|FG001|NOT COMPLETED|Overall Study||16
2957478|NCT00732875|3671918|FG000|STARTED|Overall Study||92
2957479|NCT00732875|3671918|FG000|COMPLETED|Overall Study|These participants continued treatment until trial was completed by Sponsor.|57
2957480|NCT00732875|3671918|FG000|NOT COMPLETED|Overall Study||35
2957481|NCT00732901|3671924|FG000|STARTED|Overall Study||11
2957482|NCT00732901|3671925|FG001|STARTED|Overall Study||12
2957483|NCT00732901|3671924|FG000|COMPLETED|Overall Study||11
2957484|NCT00732901|3671925|FG001|COMPLETED|Overall Study||12
2957485|NCT00732901|3671924|FG000|NOT COMPLETED|Overall Study||0
2957486|NCT00732901|3671925|FG001|NOT COMPLETED|Overall Study||0
2957487|NCT00732940|3671933|FG000|STARTED|Overall Study||28
2957488|NCT00732940|3671934|FG001|STARTED|Overall Study||28
2957489|NCT00732940|3671933|FG000|COMPLETED|Overall Study||26
2957490|NCT00732940|3671934|FG001|COMPLETED|Overall Study||25
2957491|NCT00732940|3671933|FG000|NOT COMPLETED|Overall Study||2
2957492|NCT00732940|3671934|FG001|NOT COMPLETED|Overall Study||3
2957493|NCT00732992|3671942|FG000|STARTED|Overall Study||6
2957494|NCT00732992|3671943|FG001|STARTED|Overall Study||6
2957495|NCT00732992|3671942|FG000|COMPLETED|Overall Study||0
2957496|NCT00732992|3671943|FG001|COMPLETED|Overall Study||0
2957497|NCT00732992|3671942|FG000|NOT COMPLETED|Overall Study||6
2957498|NCT00732992|3671943|FG001|NOT COMPLETED|Overall Study||6
2957499|NCT00733096|3671953|FG000|STARTED|Overall Study||28
2957500|NCT00733096|3671954|FG001|STARTED|Overall Study||26
2957501|NCT00733096|3671955|FG002|STARTED|Overall Study||30
2957502|NCT00733096|3671953|FG000|COMPLETED|Overall Study||28
2957503|NCT00733096|3671954|FG001|COMPLETED|Overall Study||26
2957504|NCT00733096|3671955|FG002|COMPLETED|Overall Study||30
2957505|NCT00733096|3671953|FG000|NOT COMPLETED|Overall Study||0
2957506|NCT00733096|3671954|FG001|NOT COMPLETED|Overall Study||0
2957507|NCT00733096|3671955|FG002|NOT COMPLETED|Overall Study||0
2957508|NCT00733135|3671963|FG000|STARTED|Overall Study||133
2957509|NCT00733135|3671963|FG000|COMPLETED|Overall Study||131
2957510|NCT00733135|3671963|FG000|NOT COMPLETED|Overall Study||2
2957511|NCT00733226|3671971|FG000|STARTED|Overall Study||40
2957512|NCT00733226|3671972|FG001|STARTED|Overall Study||40
2957513|NCT00733226|3671971|FG000|COMPLETED|Overall Study||35
2957514|NCT00733226|3671972|FG001|COMPLETED|Overall Study||40
2957515|NCT00733226|3671971|FG000|NOT COMPLETED|Overall Study||5
2957516|NCT00733226|3671972|FG001|NOT COMPLETED|Overall Study||0
2957517|NCT00733278|3671978|FG000|STARTED|Overall Study||7
2957518|NCT00733278|3671978|FG000|COMPLETED|Overall Study||7
2957519|NCT00733278|3671978|FG000|NOT COMPLETED|Overall Study||0
2957520|NCT00733291|3671985|FG000|STARTED|First Intervention, 2 Hrs (+/- 30 Min)||13
2957521|NCT00733291|3671986|FG001|STARTED|First Intervention, 2 Hrs (+/- 30 Min)||17
2957522|NCT00733291|3671987|FG002|STARTED|First Intervention, 2 Hrs (+/- 30 Min)||17
2957523|NCT00733291|3671988|FG003|STARTED|First Intervention, 2 Hrs (+/- 30 Min)||17
2957524|NCT00733291|3671985|FG000|COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||13
2957525|NCT00733291|3671986|FG001|COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||17
2957526|NCT00733291|3671987|FG002|COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||17
2957527|NCT00733291|3671988|FG003|COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||17
2957528|NCT00733291|3671985|FG000|NOT COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||0
2957529|NCT00733291|3671986|FG001|NOT COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||0
2957530|NCT00733291|3671987|FG002|NOT COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||0
2957531|NCT00733291|3671988|FG003|NOT COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||0
2957532|NCT00733291|3671985|FG000|STARTED|Washout Period, 3 Days (+/-1 Day)||13
2957533|NCT00733291|3671986|FG001|STARTED|Washout Period, 3 Days (+/-1 Day)||17
2957534|NCT00733291|3671987|FG002|STARTED|Washout Period, 3 Days (+/-1 Day)||17
2957535|NCT00733291|3671988|FG003|STARTED|Washout Period, 3 Days (+/-1 Day)||17
2957536|NCT00733291|3671985|FG000|COMPLETED|Washout Period, 3 Days (+/-1 Day)||12
2957537|NCT00733291|3671986|FG001|COMPLETED|Washout Period, 3 Days (+/-1 Day)||17
2957538|NCT00733291|3671987|FG002|COMPLETED|Washout Period, 3 Days (+/-1 Day)||17
2957539|NCT00733291|3671988|FG003|COMPLETED|Washout Period, 3 Days (+/-1 Day)||17
2957540|NCT00733291|3671985|FG000|NOT COMPLETED|Washout Period, 3 Days (+/-1 Day)||1
2957541|NCT00733291|3671986|FG001|NOT COMPLETED|Washout Period, 3 Days (+/-1 Day)||0
2957542|NCT00733291|3671987|FG002|NOT COMPLETED|Washout Period, 3 Days (+/-1 Day)||0
2957543|NCT00733291|3671988|FG003|NOT COMPLETED|Washout Period, 3 Days (+/-1 Day)||0
2957544|NCT00733291|3671985|FG000|STARTED|Second Intervention, 2 Hrs (+/- 30 Min)||12
2957545|NCT00733291|3671986|FG001|STARTED|Second Intervention, 2 Hrs (+/- 30 Min)||17
2957546|NCT00733291|3671987|FG002|STARTED|Second Intervention, 2 Hrs (+/- 30 Min)||17
2957547|NCT00733291|3671988|FG003|STARTED|Second Intervention, 2 Hrs (+/- 30 Min)||17
2957548|NCT00733291|3671985|FG000|COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||12
2957549|NCT00733291|3671986|FG001|COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||17
2957550|NCT00733291|3671987|FG002|COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||17
2957551|NCT00733291|3671988|FG003|COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||17
2957552|NCT00733291|3671985|FG000|NOT COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||0
2957553|NCT00733291|3671986|FG001|NOT COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||0
2957554|NCT00733291|3671987|FG002|NOT COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||0
2957555|NCT00733291|3671988|FG003|NOT COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||0
2957556|NCT00733304|3672002|FG000|STARTED|Overall Study||19
2957557|NCT00733304|3672003|FG001|STARTED|Overall Study||15
2957558|NCT00733304|3672004|FG002|STARTED|Overall Study||8
2957559|NCT00733304|3672002|FG000|COMPLETED|Overall Study||12
2957560|NCT00733304|3672003|FG001|COMPLETED|Overall Study||12
2957561|NCT00733304|3672004|FG002|COMPLETED|Overall Study||3
2957562|NCT00733304|3672002|FG000|NOT COMPLETED|Overall Study||7
2957563|NCT00733304|3672003|FG001|NOT COMPLETED|Overall Study||3
2957564|NCT00733304|3672004|FG002|NOT COMPLETED|Overall Study||5
2957565|NCT00733330|3672014|FG000|STARTED|Overall Study||32
2957566|NCT00733330|3672015|FG001|STARTED|Overall Study||52
2957567|NCT00733330|3672014|FG000|COMPLETED|Overall Study||30
2957568|NCT00733330|3672015|FG001|COMPLETED|Overall Study||48
2957569|NCT00733330|3672014|FG000|NOT COMPLETED|Overall Study||2
2957570|NCT00733330|3672015|FG001|NOT COMPLETED|Overall Study||4
2957571|NCT00733343|3672025|FG000|STARTED|Overall Study||666
2957572|NCT00733343|3672026|FG001|STARTED|Overall Study||659
2957573|NCT00733343|3672025|FG000|COMPLETED|Overall Study||583
2957574|NCT00733343|3672026|FG001|COMPLETED|Overall Study||578
2957575|NCT00733343|3672025|FG000|NOT COMPLETED|Overall Study||83
2957576|NCT00733343|3672026|FG001|NOT COMPLETED|Overall Study||81
2957577|NCT00733356|3672033|FG000|STARTED|Vyvanse Dose Titration||28
2957578|NCT00733356|3672033|FG000|COMPLETED|Vyvanse Dose Titration||26
2957579|NCT00733356|3672033|FG000|NOT COMPLETED|Vyvanse Dose Titration||2
2957580|NCT00733356|3672033|FG000|STARTED|Modified Lab School, Reading Evaluation||26
2957581|NCT00733356|3672033|FG000|COMPLETED|Modified Lab School, Reading Evaluation||26
2957582|NCT00733356|3672033|FG000|NOT COMPLETED|Modified Lab School, Reading Evaluation||0
3035273|NCT01136655|3754438|FG000|NOT COMPLETED|BUD 160/FM 4.5 (1 Dose)||0
3035274|NCT01136655|3754438|FG000|STARTED|Washout After BUD 160/FM 4.5 (7 Days)||53
3035275|NCT01136655|3754438|FG000|COMPLETED|Washout After BUD 160/FM 4.5 (7 Days)||52
3035276|NCT01136655|3754438|FG000|NOT COMPLETED|Washout After BUD 160/FM 4.5 (7 Days)||1
3035277|NCT01136655|3754438|FG000|STARTED|BUD 160/FM 9.0 (1 Dose)||53
3035278|NCT01136655|3754438|FG000|COMPLETED|BUD 160/FM 9.0 (1 Dose)||53
3035279|NCT01136655|3754438|FG000|NOT COMPLETED|BUD 160/FM 9.0 (1 Dose)||0
3035280|NCT01136655|3754438|FG000|STARTED|Washout After BUD 160/FM 9.0 (7 Days)||53
3035281|NCT01136655|3754438|FG000|COMPLETED|Washout After BUD 160/FM 9.0 (7 Days)||51
3035282|NCT01136655|3754438|FG000|NOT COMPLETED|Washout After BUD 160/FM 9.0 (7 Days)||2
3035283|NCT01136655|3754438|FG000|STARTED|BUD 160 (1 Dose)||51
3035284|NCT01136655|3754438|FG000|COMPLETED|BUD 160 (1 Dose)||51
3035285|NCT01136655|3754438|FG000|NOT COMPLETED|BUD 160 (1 Dose)||0
3035286|NCT01136655|3754438|FG000|STARTED|Washout After BUD 160 (7 Days)||51
3035287|NCT01136655|3754438|FG000|COMPLETED|Washout After BUD 160 (7 Days)||51
3035288|NCT01136655|3754438|FG000|NOT COMPLETED|Washout After BUD 160 (7 Days)||0
3035289|NCT01136655|3754438|FG000|STARTED|BUD 160/ Foradil 12.0 (1 Dose)||50
3035290|NCT01136655|3754438|FG000|COMPLETED|BUD 160/ Foradil 12.0 (1 Dose)||50
3035291|NCT01136655|3754438|FG000|NOT COMPLETED|BUD 160/ Foradil 12.0 (1 Dose)||0
3035292|NCT01136655|3754438|FG000|STARTED|Washout After BUD 160/ Foradil (7 Days)||50
3035293|NCT01136655|3754438|FG000|COMPLETED|Washout After BUD 160/ Foradil (7 Days)||50
3035294|NCT01136655|3754438|FG000|NOT COMPLETED|Washout After BUD 160/ Foradil (7 Days)||0
3035295|NCT01136733|3754458|FG000|STARTED|Phase 1b|Participants in Phase 1b did not advance to Phase 2.|7
3035296|NCT01136733|3754459|FG001|STARTED|Phase 1b|Participants in Phase 1b did not advance to Phase 2.|11
3035297|NCT01136733|3754460|FG002|STARTED|Phase 1b|Participants in Phase 1b did not advance to Phase 2.|2
3035298|NCT01136733|3754461|FG003|STARTED|Phase 1b|Participants in Phase 1b did not advance to Phase 2.|0
3035299|NCT01136733|3754462|FG004|STARTED|Phase 1b||0
3035300|NCT01136733|3754463|FG005|STARTED|Phase 1b||0
3035301|NCT01136733|3754464|FG006|STARTED|Phase 1b||0
3035302|NCT01136733|3754458|FG000|COMPLETED|Phase 1b||6
3035303|NCT01136733|3754459|FG001|COMPLETED|Phase 1b||6
3035304|NCT01136733|3754460|FG002|COMPLETED|Phase 1b||0
3035305|NCT01136733|3754461|FG003|COMPLETED|Phase 1b||0
3035306|NCT01136733|3754462|FG004|COMPLETED|Phase 1b||0
3035307|NCT01136733|3754463|FG005|COMPLETED|Phase 1b||0
3035308|NCT01136733|3754464|FG006|COMPLETED|Phase 1b||0
3035309|NCT01136733|3754458|FG000|NOT COMPLETED|Phase 1b||1
3035310|NCT01136733|3754459|FG001|NOT COMPLETED|Phase 1b||5
3035311|NCT01136733|3754460|FG002|NOT COMPLETED|Phase 1b||2
3035312|NCT01136733|3754461|FG003|NOT COMPLETED|Phase 1b||0
3035313|NCT01136733|3754462|FG004|NOT COMPLETED|Phase 1b||0
3035314|NCT01136733|3754463|FG005|NOT COMPLETED|Phase 1b||0
3035315|NCT01136733|3754464|FG006|NOT COMPLETED|Phase 1b||0
3035316|NCT01136733|3754458|FG000|STARTED|Phase 2||0
3035317|NCT01136733|3754459|FG001|STARTED|Phase 2||0
3035318|NCT01136733|3754460|FG002|STARTED|Phase 2||0
3035319|NCT01136733|3754461|FG003|STARTED|Phase 2||0
3035320|NCT01136733|3754462|FG004|STARTED|Phase 2|Participants in Phase 2 did not participate in Phase 1b.|51
3035321|NCT01136733|3754463|FG005|STARTED|Phase 2|Participants in Phase 2 did not participate in Phase 1b.|52
3035322|NCT01136733|3754464|FG006|STARTED|Phase 2|Participants in Phase 2 did not participate in Phase 1b.|50
3035323|NCT01136733|3754458|FG000|COMPLETED|Phase 2||0
3035324|NCT01136733|3754459|FG001|COMPLETED|Phase 2||0
3035325|NCT01136733|3754460|FG002|COMPLETED|Phase 2||0
3035326|NCT01136733|3754461|FG003|COMPLETED|Phase 2||0
3035327|NCT01136733|3754462|FG004|COMPLETED|Phase 2||0
3035328|NCT01136733|3754463|FG005|COMPLETED|Phase 2||0
3035329|NCT01136733|3754464|FG006|COMPLETED|Phase 2||0
3035330|NCT01136733|3754458|FG000|NOT COMPLETED|Phase 2||0
3035331|NCT01136733|3754459|FG001|NOT COMPLETED|Phase 2||0
2957583|NCT00733369|3672039|FG000|STARTED|Overall Study||50
2957584|NCT00733369|3672040|FG001|STARTED|Overall Study||56
2957585|NCT00733369|3672039|FG000|COMPLETED|Overall Study||40
2957586|NCT00733369|3672040|FG001|COMPLETED|Overall Study||47
2957587|NCT00733369|3672039|FG000|NOT COMPLETED|Overall Study||10
2957588|NCT00733369|3672040|FG001|NOT COMPLETED|Overall Study||9
2957589|NCT00733408|3672046|FG000|STARTED|Overall Study||59
2957590|NCT00733408|3672046|FG000|COMPLETED|Overall Study||55
2957591|NCT00733408|3672046|FG000|NOT COMPLETED|Overall Study||4
2957592|NCT00733421|3672052|FG000|STARTED|Overall Study|November 2008|50
2957593|NCT00733421|3672053|FG001|STARTED|Overall Study|November 2008|50
2957594|NCT00733421|3672052|FG000|COMPLETED|Overall Study|All but one randomsied patient|49
2957595|NCT00733421|3672053|FG001|COMPLETED|Overall Study|All but one randomised patient|49
2957596|NCT00733421|3672052|FG000|NOT COMPLETED|Overall Study||1
2957597|NCT00733421|3672053|FG001|NOT COMPLETED|Overall Study||1
2957598|NCT00733499|3672061|FG000|STARTED|Pre-operative||102
2957599|NCT00733499|3672062|FG001|STARTED|Pre-operative|A death occurred prior to surgery which left a total of 102 participants|103
3132732|NCT01692951|3857912|FG001|STARTED|Overall Study||111
3132733|NCT01692951|3857913|FG002|STARTED|Overall Study||18
3132734|NCT01692951|3857914|FG003|STARTED|Overall Study||54
3132735|NCT01692951|3857911|FG000|COMPLETED|Overall Study||37
3132736|NCT01692951|3857912|FG001|COMPLETED|Overall Study||111
3132737|NCT01692951|3857913|FG002|COMPLETED|Overall Study||18
2957600|NCT00733499|3672061|FG000|COMPLETED|Pre-operative||102
2957601|NCT00733499|3672062|FG001|COMPLETED|Pre-operative||102
2957602|NCT00733499|3672061|FG000|NOT COMPLETED|Pre-operative||0
2957603|NCT00733499|3672062|FG001|NOT COMPLETED|Pre-operative||1
2957604|NCT00733499|3672061|FG000|STARTED|3 Months Follow-up||102
2957605|NCT00733499|3672062|FG001|STARTED|3 Months Follow-up||102
2957606|NCT00733499|3672061|FG000|COMPLETED|3 Months Follow-up||101
2957607|NCT00733499|3672062|FG001|COMPLETED|3 Months Follow-up||100
2957608|NCT00733499|3672061|FG000|NOT COMPLETED|3 Months Follow-up||1
2957609|NCT00733499|3672062|FG001|NOT COMPLETED|3 Months Follow-up||2
2957610|NCT00733499|3672061|FG000|STARTED|6 Months Follow-up||101
2957611|NCT00733499|3672062|FG001|STARTED|6 Months Follow-up||100
2957612|NCT00733499|3672061|FG000|COMPLETED|6 Months Follow-up||101
2957613|NCT00733499|3672062|FG001|COMPLETED|6 Months Follow-up||97
2957614|NCT00733499|3672061|FG000|NOT COMPLETED|6 Months Follow-up||0
2957615|NCT00733499|3672062|FG001|NOT COMPLETED|6 Months Follow-up||3
2957616|NCT00733499|3672061|FG000|STARTED|12 Months Follow-up||101
2957617|NCT00733499|3672062|FG001|STARTED|12 Months Follow-up||97
2957618|NCT00733499|3672061|FG000|COMPLETED|12 Months Follow-up||99
2957619|NCT00733499|3672062|FG001|COMPLETED|12 Months Follow-up||96
2957620|NCT00733499|3672061|FG000|NOT COMPLETED|12 Months Follow-up||2
2957621|NCT00733499|3672062|FG001|NOT COMPLETED|12 Months Follow-up||1
2957622|NCT00733499|3672061|FG000|STARTED|24 Months Follow-up||99
2957623|NCT00733499|3672062|FG001|STARTED|24 Months Follow-up||96
2957624|NCT00733499|3672061|FG000|COMPLETED|24 Months Follow-up||99
2957625|NCT00733499|3672062|FG001|COMPLETED|24 Months Follow-up||95
2957626|NCT00733499|3672061|FG000|NOT COMPLETED|24 Months Follow-up||0
2957627|NCT00733499|3672062|FG001|NOT COMPLETED|24 Months Follow-up||1
2957628|NCT00733499|3672061|FG000|STARTED|5 Year Followup||91
2957629|NCT00733499|3672062|FG001|STARTED|5 Year Followup||78
2957630|NCT00733499|3672061|FG000|COMPLETED|5 Year Followup||70
2957631|NCT00733499|3672062|FG001|COMPLETED|5 Year Followup||53
2957632|NCT00733499|3672061|FG000|NOT COMPLETED|5 Year Followup||21
2957633|NCT00733499|3672062|FG001|NOT COMPLETED|5 Year Followup||25
2957634|NCT00733499|3672061|FG000|STARTED|10 Year Followup||46
2957635|NCT00733499|3672062|FG001|STARTED|10 Year Followup||32
2957636|NCT00733499|3672061|FG000|COMPLETED|10 Year Followup||26
2957637|NCT00733499|3672062|FG001|COMPLETED|10 Year Followup||13
2957638|NCT00733499|3672061|FG000|NOT COMPLETED|10 Year Followup||20
2957639|NCT00733499|3672062|FG001|NOT COMPLETED|10 Year Followup||19
2957640|NCT00733512|3672068|FG000|STARTED|Overall Study||146
2957641|NCT00733512|3672068|FG000|COMPLETED|Overall Study||146
2957642|NCT00733512|3672068|FG000|NOT COMPLETED|Overall Study||0
2957643|NCT00733746|3672072|FG000|STARTED|Overall Study||119
2957644|NCT00733746|3672072|FG000|COMPLETED|Overall Study||114
2957645|NCT00733746|3672072|FG000|NOT COMPLETED|Overall Study||5
2957646|NCT00733824|3672081|FG000|STARTED|Phase I||10
2957647|NCT00733824|3672082|FG001|STARTED|Phase I||3
2957648|NCT00733824|3672083|FG002|STARTED|Phase I||6
2957649|NCT00733824|3672084|FG003|STARTED|Phase I||6
2957650|NCT00733824|3672085|FG004|STARTED|Phase I||0
2957651|NCT00733824|3672081|FG000|COMPLETED|Phase I||9
2957652|NCT00733824|3672082|FG001|COMPLETED|Phase I||3
2957653|NCT00733824|3672083|FG002|COMPLETED|Phase I||6
2957654|NCT00733824|3672084|FG003|COMPLETED|Phase I||6
2957655|NCT00733824|3672085|FG004|COMPLETED|Phase I||0
2957656|NCT00733824|3672081|FG000|NOT COMPLETED|Phase I||1
2957657|NCT00733824|3672082|FG001|NOT COMPLETED|Phase I||0
2957658|NCT00733824|3672083|FG002|NOT COMPLETED|Phase I||0
2957659|NCT00733824|3672084|FG003|NOT COMPLETED|Phase I||0
2957660|NCT00733824|3672085|FG004|NOT COMPLETED|Phase I||0
2957661|NCT00733824|3672081|FG000|STARTED|Phase II||0
2957662|NCT00733824|3672082|FG001|STARTED|Phase II||0
2957663|NCT00733824|3672083|FG002|STARTED|Phase II||0
2957664|NCT00733824|3672084|FG003|STARTED|Phase II||0
2957665|NCT00733824|3672085|FG004|STARTED|Phase II||36
2957666|NCT00733824|3672081|FG000|COMPLETED|Phase II||0
2957667|NCT00733824|3672082|FG001|COMPLETED|Phase II||0
2957668|NCT00733824|3672083|FG002|COMPLETED|Phase II||0
2957669|NCT00733824|3672084|FG003|COMPLETED|Phase II||0
2957670|NCT00733824|3672085|FG004|COMPLETED|Phase II||36
2957671|NCT00733824|3672081|FG000|NOT COMPLETED|Phase II||0
2957672|NCT00733824|3672082|FG001|NOT COMPLETED|Phase II||0
2957673|NCT00733824|3672083|FG002|NOT COMPLETED|Phase II||0
2957674|NCT00733824|3672084|FG003|NOT COMPLETED|Phase II||0
2957675|NCT00733824|3672085|FG004|NOT COMPLETED|Phase II||0
2957676|NCT00733902|3672103|FG000|STARTED|Overall Study||174
2957677|NCT00733902|3672104|FG001|STARTED|Overall Study||174
2957678|NCT00733902|3672105|FG002|STARTED|Overall Study||174
2957679|NCT00733902|3672106|FG003|STARTED|Overall Study||175
2957680|NCT00733902|3672103|FG000|Treated|Overall Study||172
2957681|NCT00733902|3672104|FG001|Treated|Overall Study||172
2957682|NCT00733902|3672105|FG002|Treated|Overall Study||172
2957683|NCT00733902|3672106|FG003|Treated|Overall Study||174
2957684|NCT00733902|3672103|FG000|COMPLETED|Overall Study||10
2957685|NCT00733902|3672104|FG001|COMPLETED|Overall Study||12
2957686|NCT00733902|3672105|FG002|COMPLETED|Overall Study||13
2957687|NCT00733902|3672106|FG003|COMPLETED|Overall Study||11
3300441|NCT02945410|4034313|FG005|STARTED|Intervention 3 (5 Days)||0
3300442|NCT02945410|4034308|FG000|COMPLETED|Intervention 3 (5 Days)||2
2957688|NCT00733902|3672103|FG000|NOT COMPLETED|Overall Study||164
2957689|NCT00733902|3672104|FG001|NOT COMPLETED|Overall Study||162
2957690|NCT00733902|3672105|FG002|NOT COMPLETED|Overall Study||161
2957691|NCT00733902|3672106|FG003|NOT COMPLETED|Overall Study||164
2957692|NCT00733954|3672118|FG000|STARTED|Overall Study||124
2957693|NCT00733954|3672119|FG001|STARTED|Overall Study||125
2957694|NCT00733954|3672118|FG000|COMPLETED|Overall Study||116
2957695|NCT00733954|3672119|FG001|COMPLETED|Overall Study||123
2957696|NCT00733954|3672118|FG000|NOT COMPLETED|Overall Study||8
2957697|NCT00733954|3672119|FG001|NOT COMPLETED|Overall Study||2
2957698|NCT00733980|3672127|FG000|STARTED|Overall Study||74
2957699|NCT00733980|3672128|FG001|STARTED|Overall Study||76
2957700|NCT00733980|3672127|FG000|COMPLETED|Overall Study||52
2957701|NCT00733980|3672128|FG001|COMPLETED|Overall Study||55
2957702|NCT00733980|3672127|FG000|NOT COMPLETED|Overall Study||22
2957703|NCT00733980|3672128|FG001|NOT COMPLETED|Overall Study||21
2957704|NCT00733993|3672137|FG000|STARTED|Overall Study||13
2957705|NCT00733993|3672138|FG001|STARTED|Overall Study||10
2957706|NCT00733993|3672137|FG000|COMPLETED|Overall Study||13
2957707|NCT00733993|3672138|FG001|COMPLETED|Overall Study||10
2957708|NCT00733993|3672137|FG000|NOT COMPLETED|Overall Study||0
2957709|NCT00733993|3672138|FG001|NOT COMPLETED|Overall Study||0
2957710|NCT00734032|3672153|FG000|STARTED|Overall Study||25
2957711|NCT00734032|3672154|FG001|STARTED|Overall Study||28
2957712|NCT00734032|3672155|FG002|STARTED|Overall Study||28
2957713|NCT00734032|3672156|FG003|STARTED|Overall Study||26
2957714|NCT00734032|3672153|FG000|COMPLETED|Overall Study||25
2957715|NCT00734032|3672154|FG001|COMPLETED|Overall Study||27
2957716|NCT00734032|3672155|FG002|COMPLETED|Overall Study||28
2957717|NCT00734032|3672156|FG003|COMPLETED|Overall Study||26
2957718|NCT00734032|3672153|FG000|NOT COMPLETED|Overall Study||0
2957719|NCT00734032|3672154|FG001|NOT COMPLETED|Overall Study||1
2957720|NCT00734032|3672155|FG002|NOT COMPLETED|Overall Study||0
2957721|NCT00734032|3672156|FG003|NOT COMPLETED|Overall Study||0
2957722|NCT00734071|3672168|FG000|STARTED|Overall Study||152
2957723|NCT00734071|3672169|FG001|STARTED|Overall Study||152
2957724|NCT00734071|3672168|FG000|Treated|Overall Study||151
2957725|NCT00734071|3672169|FG001|Treated|Overall Study||148
2957726|NCT00734071|3672168|FG000|COMPLETED|Overall Study||114
2957727|NCT00734071|3672169|FG001|COMPLETED|Overall Study||125
2957728|NCT00734071|3672168|FG000|NOT COMPLETED|Overall Study||38
2957729|NCT00734071|3672169|FG001|NOT COMPLETED|Overall Study||27
2957730|NCT00734097|3672175|FG000|STARTED|Screening||337
2957731|NCT00734097|3672175|FG000|COMPLETED|Screening|20 participants were screening failure.|317
2957732|NCT00734097|3672175|FG000|NOT COMPLETED|Screening||20
2957733|NCT00734097|3672175|FG000|STARTED|Open Label|Full analysis performed in 311|317
2957734|NCT00734097|3672175|FG000|Safety Analysis|Open Label||317
2957735|NCT00734097|3672175|FG000|Full Analysis|Open Label||311
2957736|NCT00734097|3672175|FG000|Per Protocol|Open Label||301
2957737|NCT00734097|3672175|FG000|COMPLETED|Open Label|16 patients discontinued after randomization|301
2957738|NCT00734097|3672175|FG000|NOT COMPLETED|Open Label||16
2957739|NCT00734149|3672179|FG000|STARTED|Overall Study||45
2957740|NCT00734149|3672179|FG000|COMPLETED|Overall Study||44
2957741|NCT00734149|3672179|FG000|NOT COMPLETED|Overall Study||1
2957742|NCT00734162|3672189|FG000|STARTED|Randomized Phase (Through Week 72)||10
2957743|NCT00734162|3672190|FG001|STARTED|Randomized Phase (Through Week 72)||42
2957744|NCT00734162|3672191|FG002|STARTED|Randomized Phase (Through Week 72)||13
2957745|NCT00734162|3672192|FG003|STARTED|Randomized Phase (Through Week 72)||41
2957746|NCT00734162|3672189|FG000|COMPLETED|Randomized Phase (Through Week 72)||10
3300443|NCT02945410|4034309|FG001|COMPLETED|Intervention 3 (5 Days)||1
2957747|NCT00734162|3672190|FG001|COMPLETED|Randomized Phase (Through Week 72)||41
2957748|NCT00734162|3672191|FG002|COMPLETED|Randomized Phase (Through Week 72)||13
2957749|NCT00734162|3672192|FG003|COMPLETED|Randomized Phase (Through Week 72)||37
2957750|NCT00734162|3672189|FG000|NOT COMPLETED|Randomized Phase (Through Week 72)||0
2957751|NCT00734162|3672190|FG001|NOT COMPLETED|Randomized Phase (Through Week 72)||1
2957752|NCT00734162|3672191|FG002|NOT COMPLETED|Randomized Phase (Through Week 72)||0
2957753|NCT00734162|3672192|FG003|NOT COMPLETED|Randomized Phase (Through Week 72)||4
2957754|NCT00734162|3672189|FG000|STARTED|Open-Label Phase||10
3300444|NCT02945410|4034310|FG002|COMPLETED|Intervention 3 (5 Days)||0
2957755|NCT00734162|3672190|FG001|STARTED|Open-Label Phase||41
2957756|NCT00734162|3672191|FG002|STARTED|Open-Label Phase||13
2957757|NCT00734162|3672192|FG003|STARTED|Open-Label Phase|2 participants switched to open-label treatment before completing double-blind period (elevated ALT)|39
2957758|NCT00734162|3672189|FG000|COMPLETED|Open-Label Phase||7
2957759|NCT00734162|3672190|FG001|COMPLETED|Open-Label Phase||39
2957760|NCT00734162|3672191|FG002|COMPLETED|Open-Label Phase||12
2957761|NCT00734162|3672192|FG003|COMPLETED|Open-Label Phase||36
2957762|NCT00734162|3672189|FG000|NOT COMPLETED|Open-Label Phase||3
2957763|NCT00734162|3672190|FG001|NOT COMPLETED|Open-Label Phase||2
2957764|NCT00734162|3672191|FG002|NOT COMPLETED|Open-Label Phase||1
2957765|NCT00734162|3672192|FG003|NOT COMPLETED|Open-Label Phase||3
2957766|NCT00734214|3672208|FG000|STARTED|Overall Study||128
2957767|NCT00734214|3672209|FG001|STARTED|Overall Study||130
2957768|NCT00734214|3672208|FG000|COMPLETED|Overall Study||124
2957769|NCT00734214|3672209|FG001|COMPLETED|Overall Study||126
2957770|NCT00734214|3672208|FG000|NOT COMPLETED|Overall Study||4
2957771|NCT00734214|3672209|FG001|NOT COMPLETED|Overall Study||4
2957772|NCT00734305|3672217|FG000|STARTED|Overall Study||7
2957773|NCT00734305|3672218|FG001|STARTED|Overall Study||3
2957774|NCT00734305|3672219|FG002|STARTED|Overall Study||4
2957775|NCT00734305|3672220|FG003|STARTED|Overall Study||3
2957776|NCT00734305|3672221|FG004|STARTED|Overall Study||5
2957777|NCT00734305|3672222|FG005|STARTED|Overall Study||4
2957778|NCT00734305|3672223|FG006|STARTED|Overall Study||18
2957779|NCT00734305|3672217|FG000|COMPLETED|Overall Study|1 patient was enrolled but did not meet eligibility criteria at C1W1, and thus was never dosed|6
2957780|NCT00734305|3672218|FG001|COMPLETED|Overall Study||3
2957781|NCT00734305|3672219|FG002|COMPLETED|Overall Study||4
2957782|NCT00734305|3672220|FG003|COMPLETED|Overall Study||3
2957783|NCT00734305|3672221|FG004|COMPLETED|Overall Study||5
2957784|NCT00734305|3672222|FG005|COMPLETED|Overall Study||4
2957785|NCT00734305|3672223|FG006|COMPLETED|Overall Study||18
2957786|NCT00734305|3672217|FG000|NOT COMPLETED|Overall Study||1
2957787|NCT00734305|3672218|FG001|NOT COMPLETED|Overall Study||0
2957788|NCT00734305|3672219|FG002|NOT COMPLETED|Overall Study||0
2957789|NCT00734305|3672220|FG003|NOT COMPLETED|Overall Study||0
2957790|NCT00734305|3672221|FG004|NOT COMPLETED|Overall Study||0
2957791|NCT00734305|3672222|FG005|NOT COMPLETED|Overall Study||0
2957792|NCT00734305|3672223|FG006|NOT COMPLETED|Overall Study||0
2957793|NCT00734344|3672243|FG000|STARTED|Overall Study||9
2957794|NCT00734344|3672244|FG001|STARTED|Overall Study||9
2957795|NCT00734344|3672243|FG000|COMPLETED|Overall Study||9
2957796|NCT00734344|3672244|FG001|COMPLETED|Overall Study||9
2957797|NCT00734344|3672243|FG000|NOT COMPLETED|Overall Study||0
2957798|NCT00734344|3672244|FG001|NOT COMPLETED|Overall Study||0
2957799|NCT00734409|3672254|FG000|STARTED|Overall Study||155
2957800|NCT00734409|3672255|FG001|STARTED|Overall Study||145
2957801|NCT00734409|3672254|FG000|COMPLETED|Overall Study||155
2957802|NCT00734409|3672255|FG001|COMPLETED|Overall Study||145
2957803|NCT00734409|3672254|FG000|NOT COMPLETED|Overall Study||0
2957804|NCT00734409|3672255|FG001|NOT COMPLETED|Overall Study||0
2957805|NCT00734474|3672270|FG000|STARTED|Overall Study||15
2957806|NCT00734474|3672271|FG001|STARTED|Overall Study||30
2957807|NCT00734474|3672272|FG002|STARTED|Overall Study||304
2957808|NCT00734474|3672273|FG003|STARTED|Overall Study||10
2957809|NCT00734474|3672274|FG004|STARTED|Overall Study||302
2957810|NCT00734474|3672275|FG005|STARTED|Overall Study||25
2957811|NCT00734474|3672276|FG006|STARTED|Overall Study||24
2957812|NCT00734474|3672277|FG007|STARTED|Overall Study||315
3163605|NCT01888432|3891159|FG000|COMPLETED|24-month Analysis (FAS)||125
3163606|NCT01888432|3891160|FG001|COMPLETED|24-month Analysis (FAS)||125
3163607|NCT01888432|3891159|FG000|NOT COMPLETED|24-month Analysis (FAS)||17
3163608|NCT01888432|3891160|FG001|NOT COMPLETED|24-month Analysis (FAS)||17
3163609|NCT01888432|3891159|FG000|STARTED|36-month Analysis (Extension)||13
3163610|NCT01888432|3891160|FG001|STARTED|36-month Analysis (Extension)||5
3163611|NCT01888432|3891159|FG000|COMPLETED|36-month Analysis (Extension)||12
2957813|NCT00734474|3672278|FG008|STARTED|Overall Study||177
2957814|NCT00734474|3672270|FG000|Received at Least 1 Dose of Study Drug|Overall Study||15
2957815|NCT00734474|3672271|FG001|Received at Least 1 Dose of Study Drug|Overall Study||30
2957816|NCT00734474|3672272|FG002|Received at Least 1 Dose of Study Drug|Overall Study||304
2957817|NCT00734474|3672273|FG003|Received at Least 1 Dose of Study Drug|Overall Study||10
2957818|NCT00734474|3672274|FG004|Received at Least 1 Dose of Study Drug|Overall Study||302
2957819|NCT00734474|3672275|FG005|Received at Least 1 Dose of Study Drug|Overall Study||25
2957820|NCT00734474|3672276|FG006|Received at Least 1 Dose of Study Drug|Overall Study||24
2957821|NCT00734474|3672277|FG007|Received at Least 1 Dose of Study Drug|Overall Study||315
2957822|NCT00734474|3672278|FG008|Received at Least 1 Dose of Study Drug|Overall Study||177
2957823|NCT00734474|3672270|FG000|Entered Study Before Dose Decision Point|Overall Study||15
2957824|NCT00734474|3672271|FG001|Entered Study Before Dose Decision Point|Overall Study||30
2957825|NCT00734474|3672272|FG002|Entered Study Before Dose Decision Point|Overall Study||25
2957826|NCT00734474|3672273|FG003|Entered Study Before Dose Decision Point|Overall Study||10
2957827|NCT00734474|3672274|FG004|Entered Study Before Dose Decision Point|Overall Study||21
2957828|NCT00734474|3672275|FG005|Entered Study Before Dose Decision Point|Overall Study||25
2957829|NCT00734474|3672276|FG006|Entered Study Before Dose Decision Point|Overall Study||24
2957830|NCT00734474|3672277|FG007|Entered Study Before Dose Decision Point|Overall Study||42
3163612|NCT01888432|3891160|FG001|COMPLETED|36-month Analysis (Extension)||5
2957831|NCT00734474|3672278|FG008|Entered Study Before Dose Decision Point|Overall Study||38
2957832|NCT00734474|3672270|FG000|Completed Up to Dose Decision Point|Overall Study|These participants discontinued the study after the dose decision point.|8
2957833|NCT00734474|3672271|FG001|Completed Up to Dose Decision Point|Overall Study|These participants discontinued the study after the dose decision point.|25
2957834|NCT00734474|3672272|FG002|Completed Up to Dose Decision Point|Overall Study|These participants continued the study after the dose decision point (selected arm).|24
2957835|NCT00734474|3672273|FG003|Completed Up to Dose Decision Point|Overall Study|These participants discontinued the study after the dose decision point.|8
2957836|NCT00734474|3672274|FG004|Completed Up to Dose Decision Point|Overall Study|These participants continued the study after the dose decision point (selected arm).|21
2957837|NCT00734474|3672275|FG005|Completed Up to Dose Decision Point|Overall Study|These participants discontinued the study after the dose decision point.|21
2957838|NCT00734474|3672276|FG006|Completed Up to Dose Decision Point|Overall Study|These participants discontinued the study after the dose decision point.|23
2957839|NCT00734474|3672277|FG007|Completed Up to Dose Decision Point|Overall Study|These participants continued the study after the dose decision point (comparator arm).|42
2957840|NCT00734474|3672278|FG008|Completed Up to Dose Decision Point|Overall Study|These participants continued the study after the dose decision point (comparator arm).|34
2957841|NCT00734474|3672270|FG000|Entered Study After Dose Decision Point|Overall Study||0
2957842|NCT00734474|3672271|FG001|Entered Study After Dose Decision Point|Overall Study||0
2957843|NCT00734474|3672272|FG002|Entered Study After Dose Decision Point|Overall Study||279
2957844|NCT00734474|3672273|FG003|Entered Study After Dose Decision Point|Overall Study||0
2957845|NCT00734474|3672274|FG004|Entered Study After Dose Decision Point|Overall Study||281
2957846|NCT00734474|3672275|FG005|Entered Study After Dose Decision Point|Overall Study||0
2957847|NCT00734474|3672276|FG006|Entered Study After Dose Decision Point|Overall Study||0
2957848|NCT00734474|3672277|FG007|Entered Study After Dose Decision Point|Overall Study||273
2957849|NCT00734474|3672278|FG008|Entered Study After Dose Decision Point|Overall Study||139
2957850|NCT00734474|3672270|FG000|Completed 26-Week Visit|Overall Study||0
2957851|NCT00734474|3672271|FG001|Completed 26-Week Visit|Overall Study||0
2957852|NCT00734474|3672272|FG002|Completed 26-Week Visit|Overall Study||258
2957853|NCT00734474|3672273|FG003|Completed 26-Week Visit|Overall Study||2
2957854|NCT00734474|3672274|FG004|Completed 26-Week Visit|Overall Study||268
2957855|NCT00734474|3672275|FG005|Completed 26-Week Visit|Overall Study||2
2957856|NCT00734474|3672276|FG006|Completed 26-Week Visit|Overall Study||2
2957857|NCT00734474|3672277|FG007|Completed 26-Week Visit|Overall Study||270
2957858|NCT00734474|3672278|FG008|Completed 26-Week Visit|Overall Study||124
2957859|NCT00734474|3672270|FG000|Completed 52-Week Visit|Overall Study||0
2957860|NCT00734474|3672271|FG001|Completed 52-Week Visit|Overall Study||0
2957861|NCT00734474|3672272|FG002|Completed 52-Week Visit|Overall Study||238
2957862|NCT00734474|3672273|FG003|Completed 52-Week Visit|Overall Study||0
2957863|NCT00734474|3672274|FG004|Completed 52-Week Visit|Overall Study||243
2957864|NCT00734474|3672275|FG005|Completed 52-Week Visit|Overall Study||0
2957865|NCT00734474|3672276|FG006|Completed 52-Week Visit|Overall Study||0
2957866|NCT00734474|3672277|FG007|Completed 52-Week Visit|Overall Study||238
2957867|NCT00734474|3672278|FG008|Completed 52-Week Visit|Overall Study||112
2957868|NCT00734474|3672270|FG000|COMPLETED|Overall Study||0
2957869|NCT00734474|3672271|FG001|COMPLETED|Overall Study||0
2957870|NCT00734474|3672272|FG002|COMPLETED|Overall Study||192
2957871|NCT00734474|3672273|FG003|COMPLETED|Overall Study||0
2957872|NCT00734474|3672274|FG004|COMPLETED|Overall Study||184
2957873|NCT00734474|3672275|FG005|COMPLETED|Overall Study||0
2957874|NCT00734474|3672276|FG006|COMPLETED|Overall Study||0
2957875|NCT00734474|3672277|FG007|COMPLETED|Overall Study||186
2957876|NCT00734474|3672278|FG008|COMPLETED|Overall Study||95
2957877|NCT00734474|3672270|FG000|NOT COMPLETED|Overall Study||15
2957878|NCT00734474|3672271|FG001|NOT COMPLETED|Overall Study||30
2957879|NCT00734474|3672272|FG002|NOT COMPLETED|Overall Study||112
2957880|NCT00734474|3672273|FG003|NOT COMPLETED|Overall Study||10
2957881|NCT00734474|3672274|FG004|NOT COMPLETED|Overall Study||118
2957882|NCT00734474|3672275|FG005|NOT COMPLETED|Overall Study||25
2957883|NCT00734474|3672276|FG006|NOT COMPLETED|Overall Study||24
2957884|NCT00734474|3672277|FG007|NOT COMPLETED|Overall Study||129
2957885|NCT00734474|3672278|FG008|NOT COMPLETED|Overall Study||82
2957886|NCT00734500|3672304|FG000|STARTED|Overall Study||15
2957887|NCT00734500|3672304|FG000|COMPLETED|Overall Study||14
2957888|NCT00734500|3672304|FG000|NOT COMPLETED|Overall Study||1
2957889|NCT00734539|3672310|FG000|STARTED|Main Study||189
2957890|NCT00734539|3672311|FG001|STARTED|Main Study||173
2957891|NCT00734539|3672310|FG000|COMPLETED|Main Study|Number of subjects who participated through hospital discharge or study end|152
2957892|NCT00734539|3672311|FG001|COMPLETED|Main Study|Number of subjects who participated through hospital discharge or study end|138
2957893|NCT00734539|3672310|FG000|NOT COMPLETED|Main Study||37
2957894|NCT00734539|3672311|FG001|NOT COMPLETED|Main Study||35
2957895|NCT00734539|3672310|FG000|STARTED|Long Term Follow up||152
2957896|NCT00734539|3672311|FG001|STARTED|Long Term Follow up||138
2957897|NCT00734539|3672310|FG000|COMPLETED|Long Term Follow up|Number of participants who completed the 18-22 months follow-up|118
2957898|NCT00734539|3672311|FG001|COMPLETED|Long Term Follow up|Number of participants who completed the 18-22 months follow-up|107
2957899|NCT00734539|3672310|FG000|NOT COMPLETED|Long Term Follow up||34
2957900|NCT00734539|3672311|FG001|NOT COMPLETED|Long Term Follow up||31
2957901|NCT00734578|3672323|FG000|STARTED|Overall Study||154
2957902|NCT00734578|3672324|FG001|STARTED|Overall Study||153
2957903|NCT00734578|3672325|FG002|STARTED|Overall Study||154
2957904|NCT00734578|3672323|FG000|COMPLETED|Overall Study||121
2957905|NCT00734578|3672324|FG001|COMPLETED|Overall Study||128
2957906|NCT00734578|3672325|FG002|COMPLETED|Overall Study||129
2957907|NCT00734578|3672323|FG000|NOT COMPLETED|Overall Study||33
2957908|NCT00734578|3672324|FG001|NOT COMPLETED|Overall Study||25
2957909|NCT00734578|3672325|FG002|NOT COMPLETED|Overall Study||25
2957910|NCT00734591|3672335|FG000|STARTED|Retrospective Period||3875
2957911|NCT00734591|3672336|FG001|STARTED|Retrospective Period||3564
2957912|NCT00734591|3672335|FG000|COMPLETED|Retrospective Period||3875
2957913|NCT00734591|3672336|FG001|COMPLETED|Retrospective Period||3564
2957914|NCT00734591|3672335|FG000|NOT COMPLETED|Retrospective Period||0
2957915|NCT00734591|3672336|FG001|NOT COMPLETED|Retrospective Period||0
2957916|NCT00734591|3672335|FG000|STARTED|Screening for Prospective Period||3875
2957917|NCT00734591|3672336|FG001|STARTED|Screening for Prospective Period||3564
2957918|NCT00734591|3672335|FG000|COMPLETED|Screening for Prospective Period||1358
2957919|NCT00734591|3672336|FG001|COMPLETED|Screening for Prospective Period||1273
2957920|NCT00734591|3672335|FG000|NOT COMPLETED|Screening for Prospective Period||2517
2957921|NCT00734591|3672336|FG001|NOT COMPLETED|Screening for Prospective Period||2291
2957922|NCT00734591|3672335|FG000|STARTED|Prospective Period||1358
2957923|NCT00734591|3672336|FG001|STARTED|Prospective Period||1273
2957924|NCT00734591|3672335|FG000|COMPLETED|Prospective Period||1307
2957925|NCT00734591|3672336|FG001|COMPLETED|Prospective Period||1229
2957926|NCT00734591|3672335|FG000|NOT COMPLETED|Prospective Period||51
2957927|NCT00734591|3672336|FG001|NOT COMPLETED|Prospective Period||44
2957928|NCT00734604|3672348|FG000|STARTED|Overall Study||62
2957929|NCT00734604|3672349|FG001|STARTED|Overall Study||63
2957930|NCT00734604|3672350|FG002|STARTED|Overall Study||63
2957931|NCT00734604|3672351|FG003|STARTED|Overall Study||63
2957932|NCT00734604|3672352|FG004|STARTED|Overall Study||63
2957933|NCT00734604|3672353|FG005|STARTED|Overall Study||64
2957934|NCT00734604|3672348|FG000|COMPLETED|Overall Study||59
2957935|NCT00734604|3672349|FG001|COMPLETED|Overall Study||51
2957936|NCT00734604|3672350|FG002|COMPLETED|Overall Study||57
2957937|NCT00734604|3672351|FG003|COMPLETED|Overall Study||54
2957938|NCT00734604|3672352|FG004|COMPLETED|Overall Study||55
2957939|NCT00734604|3672353|FG005|COMPLETED|Overall Study||58
2957940|NCT00734604|3672348|FG000|NOT COMPLETED|Overall Study||3
2957941|NCT00734604|3672349|FG001|NOT COMPLETED|Overall Study||12
2957942|NCT00734604|3672350|FG002|NOT COMPLETED|Overall Study||6
2957943|NCT00734604|3672351|FG003|NOT COMPLETED|Overall Study||9
2957944|NCT00734604|3672352|FG004|NOT COMPLETED|Overall Study||8
2957945|NCT00734604|3672353|FG005|NOT COMPLETED|Overall Study||6
2957946|NCT00734617|3672366|FG000|STARTED|Overall Study||249
2957947|NCT00734617|3672367|FG001|STARTED|Overall Study||230
2957948|NCT00734617|3672366|FG000|COMPLETED|Overall Study||142
2957949|NCT00734617|3672367|FG001|COMPLETED|Overall Study||128
2957950|NCT00734617|3672366|FG000|NOT COMPLETED|Overall Study||107
2957951|NCT00734617|3672367|FG001|NOT COMPLETED|Overall Study||102
2957952|NCT00734630|3672375|FG000|STARTED|Overall Study||258
2957953|NCT00734630|3672376|FG001|STARTED|Overall Study||233
2957954|NCT00734630|3672375|FG000|COMPLETED|Overall Study||229
2957955|NCT00734630|3672376|FG001|COMPLETED|Overall Study||200
2957956|NCT00734630|3672375|FG000|NOT COMPLETED|Overall Study||29
2957957|NCT00734630|3672376|FG001|NOT COMPLETED|Overall Study||33
2957958|NCT00734656|3672382|FG000|STARTED|Lab Session 1||24
2957959|NCT00734656|3672383|FG001|STARTED|Lab Session 1||23
2957960|NCT00734656|3672384|FG002|STARTED|Lab Session 1||26
2957961|NCT00734656|3672385|FG003|STARTED|Lab Session 1||21
2957962|NCT00734656|3672382|FG000|COMPLETED|Lab Session 1||22
2957963|NCT00734656|3672383|FG001|COMPLETED|Lab Session 1||23
2957964|NCT00734656|3672384|FG002|COMPLETED|Lab Session 1||26
2957965|NCT00734656|3672385|FG003|COMPLETED|Lab Session 1||21
2957966|NCT00734656|3672382|FG000|NOT COMPLETED|Lab Session 1||2
2957967|NCT00734656|3672383|FG001|NOT COMPLETED|Lab Session 1||0
2957968|NCT00734656|3672384|FG002|NOT COMPLETED|Lab Session 1||0
2957969|NCT00734656|3672385|FG003|NOT COMPLETED|Lab Session 1||0
2957970|NCT00734656|3672382|FG000|STARTED|Washout 1||22
2957971|NCT00734656|3672383|FG001|STARTED|Washout 1||23
2957972|NCT00734656|3672384|FG002|STARTED|Washout 1||26
2957973|NCT00734656|3672385|FG003|STARTED|Washout 1||21
2957974|NCT00734656|3672382|FG000|COMPLETED|Washout 1||21
2957975|NCT00734656|3672383|FG001|COMPLETED|Washout 1||18
2957976|NCT00734656|3672384|FG002|COMPLETED|Washout 1||24
2957977|NCT00734656|3672385|FG003|COMPLETED|Washout 1||18
2957978|NCT00734656|3672382|FG000|NOT COMPLETED|Washout 1||1
2957979|NCT00734656|3672383|FG001|NOT COMPLETED|Washout 1||5
2957980|NCT00734656|3672384|FG002|NOT COMPLETED|Washout 1||2
2957981|NCT00734656|3672385|FG003|NOT COMPLETED|Washout 1||3
2957982|NCT00734656|3672382|FG000|STARTED|Lab Session 2|subjects cross-over to different treatment condition with each lab session in factorial design,|19
2957983|NCT00734656|3672383|FG001|STARTED|Lab Session 2|subjects cross-over to different treatment condition with each lab session in factorial design,|21
2957984|NCT00734656|3672384|FG002|STARTED|Lab Session 2|subjects cross-over to different treatment condition with each lab session in factorial design,|21
2957985|NCT00734656|3672385|FG003|STARTED|Lab Session 2|subjects cross-over to different treatment condition with each lab session in factorial design,|20
2957986|NCT00734656|3672382|FG000|COMPLETED|Lab Session 2||18
2957987|NCT00734656|3672383|FG001|COMPLETED|Lab Session 2||21
2957988|NCT00734656|3672384|FG002|COMPLETED|Lab Session 2||21
2957989|NCT00734656|3672385|FG003|COMPLETED|Lab Session 2||19
2957990|NCT00734656|3672382|FG000|NOT COMPLETED|Lab Session 2||1
2957991|NCT00734656|3672383|FG001|NOT COMPLETED|Lab Session 2||0
2957992|NCT00734656|3672384|FG002|NOT COMPLETED|Lab Session 2||0
2957993|NCT00734656|3672385|FG003|NOT COMPLETED|Lab Session 2||1
2957994|NCT00734656|3672382|FG000|STARTED|Washout 2||18
2957995|NCT00734656|3672383|FG001|STARTED|Washout 2||21
2957996|NCT00734656|3672384|FG002|STARTED|Washout 2||21
2957997|NCT00734656|3672385|FG003|STARTED|Washout 2||19
2957998|NCT00734656|3672382|FG000|COMPLETED|Washout 2||17
2957999|NCT00734656|3672383|FG001|COMPLETED|Washout 2||20
2958000|NCT00734656|3672384|FG002|COMPLETED|Washout 2||20
2958001|NCT00734656|3672385|FG003|COMPLETED|Washout 2||19
2958002|NCT00734656|3672382|FG000|NOT COMPLETED|Washout 2||1
2958003|NCT00734656|3672383|FG001|NOT COMPLETED|Washout 2||1
2958004|NCT00734656|3672384|FG002|NOT COMPLETED|Washout 2||1
2958005|NCT00734656|3672385|FG003|NOT COMPLETED|Washout 2||0
2958006|NCT00734656|3672382|FG000|STARTED|Lab Session 3|subjects cross-over to different treatment condition with each lab session in factorial design,|18
2958007|NCT00734656|3672383|FG001|STARTED|Lab Session 3|subjects cross-over to different treatment condition with each lab session in factorial design,|19
2958008|NCT00734656|3672384|FG002|STARTED|Lab Session 3|subjects cross-over to different treatment condition with each lab session in factorial design,|20
2958009|NCT00734656|3672385|FG003|STARTED|Lab Session 3|subjects cross-over to different treatment condition with each lab session in factorial design,|19
2958010|NCT00734656|3672382|FG000|COMPLETED|Lab Session 3||18
2958011|NCT00734656|3672383|FG001|COMPLETED|Lab Session 3||19
2958012|NCT00734656|3672384|FG002|COMPLETED|Lab Session 3||20
2958013|NCT00734656|3672385|FG003|COMPLETED|Lab Session 3||19
2958014|NCT00734656|3672382|FG000|NOT COMPLETED|Lab Session 3||0
2958015|NCT00734656|3672383|FG001|NOT COMPLETED|Lab Session 3||0
2958016|NCT00734656|3672384|FG002|NOT COMPLETED|Lab Session 3||0
2958017|NCT00734656|3672385|FG003|NOT COMPLETED|Lab Session 3||0
2958018|NCT00734656|3672382|FG000|STARTED|Washout 3||18
3163613|NCT01888432|3891159|FG000|NOT COMPLETED|36-month Analysis (Extension)||1
3163614|NCT01888432|3891160|FG001|NOT COMPLETED|36-month Analysis (Extension)||0
3163615|NCT01888484|3891168|FG000|STARTED|Overall Study||12
3163616|NCT01888484|3891169|FG001|STARTED|Overall Study||14
3163617|NCT01888484|3891170|FG002|STARTED|Overall Study||12
3163618|NCT01888484|3891171|FG003|STARTED|Overall Study||37
3163619|NCT01888484|3891168|FG000|COMPLETED|Overall Study||12
3163620|NCT01888484|3891169|FG001|COMPLETED|Overall Study||14
3163621|NCT01888484|3891170|FG002|COMPLETED|Overall Study||8
3163622|NCT01888484|3891171|FG003|COMPLETED|Overall Study||34
3163623|NCT01888484|3891168|FG000|NOT COMPLETED|Overall Study||0
3163624|NCT01888484|3891169|FG001|NOT COMPLETED|Overall Study||0
3163625|NCT01888484|3891170|FG002|NOT COMPLETED|Overall Study||4
3163626|NCT01888484|3891171|FG003|NOT COMPLETED|Overall Study||3
3163627|NCT01888497|3891176|FG000|STARTED|First Intervention Period||13
3163628|NCT01888497|3891177|FG001|STARTED|First Intervention Period||14
3163629|NCT01888497|3891178|FG002|STARTED|First Intervention Period||15
3163630|NCT01888497|3891179|FG003|STARTED|First Intervention Period||17
3163631|NCT01888497|3891176|FG000|COMPLETED|First Intervention Period||13
3163632|NCT01888497|3891177|FG001|COMPLETED|First Intervention Period||14
3163633|NCT01888497|3891178|FG002|COMPLETED|First Intervention Period||15
3163634|NCT01888497|3891179|FG003|COMPLETED|First Intervention Period||17
3163635|NCT01888497|3891176|FG000|NOT COMPLETED|First Intervention Period||0
3163636|NCT01888497|3891177|FG001|NOT COMPLETED|First Intervention Period||0
3163637|NCT01888497|3891178|FG002|NOT COMPLETED|First Intervention Period||0
3163638|NCT01888497|3891179|FG003|NOT COMPLETED|First Intervention Period||0
3163639|NCT01888497|3891176|FG000|STARTED|Washout Period 1||13
3163640|NCT01888497|3891177|FG001|STARTED|Washout Period 1||14
3163641|NCT01888497|3891178|FG002|STARTED|Washout Period 1||15
3163642|NCT01888497|3891179|FG003|STARTED|Washout Period 1||17
3163643|NCT01888497|3891176|FG000|COMPLETED|Washout Period 1||13
3163644|NCT01888497|3891177|FG001|COMPLETED|Washout Period 1||14
3163645|NCT01888497|3891178|FG002|COMPLETED|Washout Period 1||14
2958019|NCT00734656|3672383|FG001|STARTED|Washout 3||19
2958020|NCT00734656|3672384|FG002|STARTED|Washout 3||20
2958021|NCT00734656|3672385|FG003|STARTED|Washout 3||19
2958022|NCT00734656|3672382|FG000|COMPLETED|Washout 3||17
2958023|NCT00734656|3672383|FG001|COMPLETED|Washout 3||19
2958024|NCT00734656|3672384|FG002|COMPLETED|Washout 3||20
2958025|NCT00734656|3672385|FG003|COMPLETED|Washout 3||18
2958026|NCT00734656|3672382|FG000|NOT COMPLETED|Washout 3||1
2958027|NCT00734656|3672383|FG001|NOT COMPLETED|Washout 3||0
2958028|NCT00734656|3672384|FG002|NOT COMPLETED|Washout 3||0
2958029|NCT00734656|3672385|FG003|NOT COMPLETED|Washout 3||1
2958030|NCT00734656|3672382|FG000|STARTED|Lab Session 4|subjects cross-over to different treatment condition with each lab session in factorial design,|20
2958031|NCT00734656|3672383|FG001|STARTED|Lab Session 4|subjects cross-over to different treatment condition with each lab session in factorial design,|18
2958032|NCT00734656|3672384|FG002|STARTED|Lab Session 4|subjects cross-over to different treatment condition with each lab session in factorial design,|16
2958033|NCT00734656|3672385|FG003|STARTED|Lab Session 4|subjects cross-over to different treatment condition with each lab session in factorial design,|20
2958034|NCT00734656|3672382|FG000|COMPLETED|Lab Session 4||20
2958035|NCT00734656|3672383|FG001|COMPLETED|Lab Session 4||18
2958036|NCT00734656|3672384|FG002|COMPLETED|Lab Session 4||16
2958037|NCT00734656|3672385|FG003|COMPLETED|Lab Session 4||19
2958038|NCT00734656|3672382|FG000|NOT COMPLETED|Lab Session 4||0
2958039|NCT00734656|3672383|FG001|NOT COMPLETED|Lab Session 4||0
2958040|NCT00734656|3672384|FG002|NOT COMPLETED|Lab Session 4||0
2958041|NCT00734656|3672385|FG003|NOT COMPLETED|Lab Session 4||1
2958042|NCT00734734|3672395|FG000|STARTED|Overall Study||64
2958043|NCT00734734|3672395|FG000|COMPLETED|Overall Study||64
2958044|NCT00734734|3672395|FG000|NOT COMPLETED|Overall Study||0
2958045|NCT00734747|3672400|FG000|STARTED|SRS Procedure||72
2958046|NCT00734747|3672400|FG000|COMPLETED|SRS Procedure||69
2958047|NCT00734747|3672400|FG000|NOT COMPLETED|SRS Procedure||3
2958048|NCT00734747|3672400|FG000|STARTED|6 Month Follow-up||69
2958049|NCT00734747|3672400|FG000|COMPLETED|6 Month Follow-up||66
2958050|NCT00734747|3672400|FG000|NOT COMPLETED|6 Month Follow-up||3
2958051|NCT00734799|3672406|FG000|STARTED|Overall Study||9
2958052|NCT00734799|3672407|FG001|STARTED|Overall Study||13
2958053|NCT00734799|3672406|FG000|COMPLETED|Overall Study||9
2958054|NCT00734799|3672407|FG001|COMPLETED|Overall Study||9
2958055|NCT00734799|3672406|FG000|NOT COMPLETED|Overall Study||0
2958056|NCT00734799|3672407|FG001|NOT COMPLETED|Overall Study||4
2958057|NCT00734851|3672413|FG000|STARTED|Overall Study||34
2958058|NCT00734851|3672413|FG000|COMPLETED|Overall Study||13
2958059|NCT00734851|3672413|FG000|NOT COMPLETED|Overall Study||21
2958060|NCT00734903|3672419|FG000|STARTED|Overall Study||33
2958061|NCT00734903|3672420|FG001|STARTED|Overall Study||33
2958062|NCT00734903|3672419|FG000|Completed End of Treatment Assessment|Overall Study||21
2958063|NCT00734903|3672420|FG001|Completed End of Treatment Assessment|Overall Study||23
2958064|NCT00734903|3672419|FG000|Completed 3-month Followup|Overall Study||14
2958065|NCT00734903|3672420|FG001|Completed 3-month Followup|Overall Study||15
3163646|NCT01888497|3891179|FG003|COMPLETED|Washout Period 1||16
3163647|NCT01888497|3891176|FG000|NOT COMPLETED|Washout Period 1||0
3163648|NCT01888497|3891177|FG001|NOT COMPLETED|Washout Period 1||0
3163649|NCT01888497|3891178|FG002|NOT COMPLETED|Washout Period 1||1
3163650|NCT01888497|3891179|FG003|NOT COMPLETED|Washout Period 1||1
3163651|NCT01888497|3891176|FG000|STARTED|Second Intervention Period||13
2958066|NCT00734903|3672419|FG000|COMPLETED|Overall Study||30
2958067|NCT00734903|3672420|FG001|COMPLETED|Overall Study||32
2958068|NCT00734903|3672419|FG000|NOT COMPLETED|Overall Study||3
2958069|NCT00734903|3672420|FG001|NOT COMPLETED|Overall Study||1
2958070|NCT00734929|3672428|FG000|STARTED|Overall Study||57
2958071|NCT00734929|3672429|FG001|STARTED|Overall Study||58
2958072|NCT00734929|3672428|FG000|COMPLETED|Overall Study||51
2958073|NCT00734929|3672429|FG001|COMPLETED|Overall Study||53
2958074|NCT00734929|3672428|FG000|NOT COMPLETED|Overall Study||6
2958075|NCT00734929|3672429|FG001|NOT COMPLETED|Overall Study||5
2958076|NCT00734968|3672439|FG000|STARTED|Overall Study||77
2958077|NCT00734968|3672440|FG001|STARTED|Overall Study||76
2958078|NCT00734968|3672439|FG000|COMPLETED|Overall Study||76
2958079|NCT00734968|3672440|FG001|COMPLETED|Overall Study||75
2958080|NCT00734968|3672439|FG000|NOT COMPLETED|Overall Study||1
2958081|NCT00734968|3672440|FG001|NOT COMPLETED|Overall Study||1
2958082|NCT00734994|3672446|FG000|STARTED|Overall Study||15
2958083|NCT00734994|3672446|FG000|COMPLETED|Overall Study||14
2958084|NCT00734994|3672446|FG000|NOT COMPLETED|Overall Study||1
2958085|NCT00735007|3672451|FG000|STARTED|Overall Study||106
2958086|NCT00735007|3672451|FG000|COMPLETED|Overall Study||101
2958087|NCT00735007|3672451|FG000|NOT COMPLETED|Overall Study||5
2958088|NCT00735072|3672457|FG000|STARTED|Overall Study||23
2958089|NCT00735072|3672458|FG001|STARTED|Overall Study||22
2958090|NCT00735072|3672457|FG000|COMPLETED|Overall Study||22
2958091|NCT00735072|3672458|FG001|COMPLETED|Overall Study||21
2958092|NCT00735072|3672457|FG000|NOT COMPLETED|Overall Study||1
2958093|NCT00735072|3672458|FG001|NOT COMPLETED|Overall Study||1
2958094|NCT00735306|3672466|FG000|STARTED|Overall Study||12
2958095|NCT00735306|3672466|FG000|COMPLETED|Overall Study||12
2958096|NCT00735306|3672466|FG000|NOT COMPLETED|Overall Study||0
2958097|NCT00735371|3672475|FG000|STARTED|Overall Study||78
2958098|NCT00735371|3672476|FG001|STARTED|Overall Study||79
2958099|NCT00735371|3672477|FG002|STARTED|Overall Study||78
2958100|NCT00735371|3672478|FG003|STARTED|Overall Study||79
2958101|NCT00735371|3672475|FG000|COMPLETED|Overall Study||63
2958102|NCT00735371|3672476|FG001|COMPLETED|Overall Study||66
2958103|NCT00735371|3672477|FG002|COMPLETED|Overall Study||67
2958104|NCT00735371|3672478|FG003|COMPLETED|Overall Study||69
2958105|NCT00735371|3672475|FG000|NOT COMPLETED|Overall Study||15
2958106|NCT00735371|3672476|FG001|NOT COMPLETED|Overall Study||13
2958107|NCT00735371|3672477|FG002|NOT COMPLETED|Overall Study||11
2958108|NCT00735371|3672478|FG003|NOT COMPLETED|Overall Study||10
2958109|NCT00735397|3672488|FG000|STARTED|Overall Study||1218
2958110|NCT00735397|3672488|FG000|COMPLETED|Overall Study||35
2958111|NCT00735397|3672488|FG000|NOT COMPLETED|Overall Study||1183
2958112|NCT00735436|3672495|FG000|STARTED|Overall Study||18
2958113|NCT00735436|3672495|FG000|COMPLETED|Overall Study||18
2958114|NCT00735436|3672495|FG000|NOT COMPLETED|Overall Study||0
2958115|NCT00735449|3672502|FG000|STARTED|Overall Study||102
2958116|NCT00735449|3672503|FG001|STARTED|Overall Study||102
2958117|NCT00735449|3672502|FG000|COMPLETED|Overall Study||95
2958118|NCT00735449|3672503|FG001|COMPLETED|Overall Study||96
2958119|NCT00735449|3672502|FG000|NOT COMPLETED|Overall Study||7
2958120|NCT00735449|3672503|FG001|NOT COMPLETED|Overall Study||6
2958121|NCT00735462|3672512|FG000|STARTED|Overall Study||202
2958122|NCT00735462|3672513|FG001|STARTED|Overall Study||204
2958123|NCT00735462|3672514|FG002|STARTED|Overall Study||105
2958124|NCT00735462|3672512|FG000|COMPLETED|Overall Study||139
2958125|NCT00735462|3672513|FG001|COMPLETED|Overall Study||149
2958126|NCT00735462|3672514|FG002|COMPLETED|Overall Study||77
2958127|NCT00735462|3672512|FG000|NOT COMPLETED|Overall Study||63
2958128|NCT00735462|3672513|FG001|NOT COMPLETED|Overall Study||55
2958129|NCT00735462|3672514|FG002|NOT COMPLETED|Overall Study||28
2958130|NCT00735475|3672524|FG000|STARTED|Overall Study||631
2958131|NCT00735475|3672525|FG001|STARTED|Overall Study||637
2958132|NCT00735475|3672524|FG000|COMPLETED|Overall Study||623
2958133|NCT00735475|3672525|FG001|COMPLETED|Overall Study||626
2958134|NCT00735475|3672524|FG000|NOT COMPLETED|Overall Study||8
2958135|NCT00735475|3672525|FG001|NOT COMPLETED|Overall Study||11
2958136|NCT00735618|3672531|FG000|STARTED|Overall Study||19
2958137|NCT00735618|3672531|FG000|COMPLETED|Overall Study||19
2958138|NCT00735618|3672531|FG000|NOT COMPLETED|Overall Study||0
2958139|NCT00735644|3672540|FG000|STARTED|Overall Study||303
2958140|NCT00735644|3672541|FG001|STARTED|Overall Study||300
2958141|NCT00735644|3672542|FG002|STARTED|Overall Study||296
2958142|NCT00735644|3672543|FG003|STARTED|Overall Study||199
2958143|NCT00735644|3672544|FG004|STARTED|Overall Study||102
2958144|NCT00735644|3672540|FG000|COMPLETED|Overall Study||303
2958145|NCT00735644|3672541|FG001|COMPLETED|Overall Study||298
2958146|NCT00735644|3672542|FG002|COMPLETED|Overall Study||295
2958147|NCT00735644|3672543|FG003|COMPLETED|Overall Study||198
2958148|NCT00735644|3672544|FG004|COMPLETED|Overall Study||102
2958149|NCT00735644|3672540|FG000|NOT COMPLETED|Overall Study||0
2958150|NCT00735644|3672541|FG001|NOT COMPLETED|Overall Study||2
2958151|NCT00735644|3672542|FG002|NOT COMPLETED|Overall Study||1
2958152|NCT00735644|3672543|FG003|NOT COMPLETED|Overall Study||1
2958153|NCT00735644|3672544|FG004|NOT COMPLETED|Overall Study||0
2958154|NCT00735670|3672565|FG000|STARTED|Overall Study||10
2958155|NCT00735670|3672566|FG001|STARTED|Overall Study||11
2958156|NCT00735670|3672565|FG000|COMPLETED|Overall Study||6
2958157|NCT00735670|3672566|FG001|COMPLETED|Overall Study||6
2958158|NCT00735670|3672565|FG000|NOT COMPLETED|Overall Study||4
2958159|NCT00735670|3672566|FG001|NOT COMPLETED|Overall Study||5
2958160|NCT00735696|3672572|FG000|STARTED|Overall Study||41
2958161|NCT00735696|3672572|FG000|Received Any Quantity of Study Drug|Overall Study||40
2958162|NCT00735696|3672572|FG000|COMPLETED|Overall Study||39
2958163|NCT00735696|3672572|FG000|NOT COMPLETED|Overall Study||2
2958164|NCT00735709|3672580|FG000|STARTED|Overall Study||140
2958165|NCT00735709|3672581|FG001|STARTED|Overall Study||140
2958166|NCT00735709|3672582|FG002|STARTED|Overall Study||140
2958167|NCT00735709|3672583|FG003|STARTED|Overall Study||140
2958168|NCT00735709|3672580|FG000|Treated|Overall Study||140
2958169|NCT00735709|3672581|FG001|Treated|Overall Study||140
2958170|NCT00735709|3672582|FG002|Treated|Overall Study||140
2958171|NCT00735709|3672583|FG003|Treated|Overall Study||139
2958172|NCT00735709|3672580|FG000|COMPLETED|Overall Study||127
2958173|NCT00735709|3672581|FG001|COMPLETED|Overall Study||127
2958174|NCT00735709|3672582|FG002|COMPLETED|Overall Study||129
2958175|NCT00735709|3672583|FG003|COMPLETED|Overall Study||122
2958176|NCT00735709|3672580|FG000|NOT COMPLETED|Overall Study||13
2958177|NCT00735709|3672581|FG001|NOT COMPLETED|Overall Study||13
2958178|NCT00735709|3672582|FG002|NOT COMPLETED|Overall Study||11
2958179|NCT00735709|3672583|FG003|NOT COMPLETED|Overall Study||18
2958180|NCT00735787|3672595|FG000|STARTED|Period 1||23
2958181|NCT00735787|3672596|FG001|STARTED|Period 1||49
2958182|NCT00735787|3672595|FG000|COMPLETED|Period 1|Per visit window, 18 completed; 17 completed per subject case report form.|17
2958183|NCT00735787|3672596|FG001|COMPLETED|Period 1||41
2958184|NCT00735787|3672595|FG000|NOT COMPLETED|Period 1||6
2958185|NCT00735787|3672596|FG001|NOT COMPLETED|Period 1||8
2958186|NCT00735787|3672595|FG000|STARTED|Period 2||18
2958187|NCT00735787|3672596|FG001|STARTED|Period 2||41
2958188|NCT00735787|3672595|FG000|COMPLETED|Period 2||13
2958189|NCT00735787|3672596|FG001|COMPLETED|Period 2||40
2958190|NCT00735787|3672595|FG000|NOT COMPLETED|Period 2||5
2958191|NCT00735787|3672596|FG001|NOT COMPLETED|Period 2||1
2958192|NCT00735826|3672602|FG000|STARTED|Overall Study||10
2958193|NCT00735826|3672602|FG000|COMPLETED|Overall Study||10
2958194|NCT00735826|3672602|FG000|NOT COMPLETED|Overall Study||0
2958195|NCT00735839|3672610|FG000|STARTED|Overall Study||30
2958196|NCT00735839|3672611|FG001|STARTED|Overall Study||10
2958197|NCT00735839|3672610|FG000|COMPLETED|Overall Study||30
2958198|NCT00735839|3672611|FG001|COMPLETED|Overall Study||10
2958199|NCT00735839|3672610|FG000|NOT COMPLETED|Overall Study||0
2958200|NCT00735839|3672611|FG001|NOT COMPLETED|Overall Study||0
2958201|NCT00735878|3672620|FG000|STARTED|Phase I- Dose Determination|13 subjects enrolled. One subject withdrew consent prior to receiving therapy & was replaced.|1
2958202|NCT00735878|3672621|FG001|STARTED|Phase I- Dose Determination||7
3132738|NCT01692951|3857914|FG003|COMPLETED|Overall Study||54
2958203|NCT00735878|3672622|FG002|STARTED|Phase I- Dose Determination||5
2958204|NCT00735878|3672620|FG000|COMPLETED|Phase I- Dose Determination|12 subjects received at least one cycle of treatment and were evaluable per the protocol.|1
2958205|NCT00735878|3672621|FG001|COMPLETED|Phase I- Dose Determination||7
2958206|NCT00735878|3672622|FG002|COMPLETED|Phase I- Dose Determination||4
2958207|NCT00735878|3672620|FG000|NOT COMPLETED|Phase I- Dose Determination||0
2958208|NCT00735878|3672621|FG001|NOT COMPLETED|Phase I- Dose Determination||0
3132739|NCT01692951|3857911|FG000|NOT COMPLETED|Overall Study||0
3132740|NCT01692951|3857912|FG001|NOT COMPLETED|Overall Study||0
3132741|NCT01692951|3857913|FG002|NOT COMPLETED|Overall Study||0
3132742|NCT01692951|3857914|FG003|NOT COMPLETED|Overall Study||0
3132743|NCT01692964|3857924|FG000|STARTED|Overall Study||237
3132744|NCT01692964|3857924|FG000|COMPLETED|Overall Study||237
2958209|NCT00735878|3672622|FG002|NOT COMPLETED|Phase I- Dose Determination||1
2958210|NCT00735878|3672620|FG000|STARTED|Phase II- Determined Dose||0
2958211|NCT00735878|3672621|FG001|STARTED|Phase II- Determined Dose||7
2958212|NCT00735878|3672622|FG002|STARTED|Phase II- Determined Dose||0
2958213|NCT00735878|3672620|FG000|COMPLETED|Phase II- Determined Dose|Seven subjects completed therapy within the Phase II portion of the trial.|0
2958214|NCT00735878|3672621|FG001|COMPLETED|Phase II- Determined Dose||7
2958215|NCT00735878|3672622|FG002|COMPLETED|Phase II- Determined Dose||0
2958216|NCT00735878|3672620|FG000|NOT COMPLETED|Phase II- Determined Dose||0
2958217|NCT00735878|3672621|FG001|NOT COMPLETED|Phase II- Determined Dose||0
2958218|NCT00735878|3672622|FG002|NOT COMPLETED|Phase II- Determined Dose||0
2958219|NCT00735904|3672633|FG000|STARTED|Overall Study||38
2958220|NCT00735904|3672633|FG000|COMPLETED|Overall Study||0
2958221|NCT00735904|3672633|FG000|NOT COMPLETED|Overall Study||38
2958222|NCT00735917|3672637|FG000|STARTED|Overall Study||19
2958223|NCT00735917|3672637|FG000|COMPLETED|Overall Study||19
2958224|NCT00735917|3672637|FG000|NOT COMPLETED|Overall Study||0
2958225|NCT00735943|3672641|FG000|STARTED|Overall Study||22
2958226|NCT00735943|3672641|FG000|COMPLETED|Overall Study||20
2958227|NCT00735943|3672641|FG000|NOT COMPLETED|Overall Study||2
2958228|NCT00735969|3672645|FG000|STARTED|Overall Study||21
2958229|NCT00735969|3672645|FG000|COMPLETED|Overall Study||21
2958230|NCT00735969|3672645|FG000|NOT COMPLETED|Overall Study||0
2958231|NCT00736034|3672649|FG000|STARTED|Overall Study||18
2958232|NCT00736034|3672649|FG000|COMPLETED|Overall Study||16
2958233|NCT00736034|3672649|FG000|NOT COMPLETED|Overall Study||2
2958234|NCT00736073|3672655|FG000|STARTED|Overall Study||34
2958235|NCT00736073|3672656|FG001|STARTED|Overall Study||39
2958236|NCT00736073|3672655|FG000|COMPLETED|Overall Study||34
2958237|NCT00736073|3672656|FG001|COMPLETED|Overall Study||39
3132745|NCT01692964|3857924|FG000|NOT COMPLETED|Overall Study||0
3132746|NCT01693029|3857931|FG000|STARTED|Overall Study||217
3300445|NCT02945410|4034311|FG003|COMPLETED|Intervention 3 (5 Days)||3
2958238|NCT00736073|3672655|FG000|NOT COMPLETED|Overall Study||0
2958239|NCT00736073|3672656|FG001|NOT COMPLETED|Overall Study||0
2958240|NCT00736099|3672665|FG000|STARTED|Overall Study|Number who started treatment.|1532
2958241|NCT00736099|3672666|FG001|STARTED|Overall Study|Number who started treatment.|589
2958242|NCT00736099|3672665|FG000|COMPLETED|Overall Study|Number who completed treatment.|1349
2958243|NCT00736099|3672666|FG001|COMPLETED|Overall Study|Number who completed treatment.|531
2958244|NCT00736099|3672665|FG000|NOT COMPLETED|Overall Study||183
2958245|NCT00736099|3672666|FG001|NOT COMPLETED|Overall Study||58
2958246|NCT00736125|3672674|FG000|STARTED|Overall Study||10
2958247|NCT00736125|3672675|FG001|STARTED|Overall Study||10
2958248|NCT00736125|3672674|FG000|COMPLETED|Overall Study||9
2958249|NCT00736125|3672675|FG001|COMPLETED|Overall Study||8
2958250|NCT00736125|3672674|FG000|NOT COMPLETED|Overall Study||1
2958251|NCT00736125|3672675|FG001|NOT COMPLETED|Overall Study||2
2958252|NCT00736190|3672681|FG000|STARTED|Overall Study||90
2958253|NCT00736190|3672681|FG000|COMPLETED|Overall Study||87
2958254|NCT00736190|3672681|FG000|NOT COMPLETED|Overall Study||3
2958255|NCT00736229|3672688|FG000|STARTED|Overall Study|Actively Enrolled|40
2958256|NCT00736229|3672689|FG001|STARTED|Overall Study|Historic control|71
2958257|NCT00736229|3672690|FG002|STARTED|Overall Study|Historic Control|84
2958258|NCT00736229|3672688|FG000|COMPLETED|Overall Study|All patients received bolus and fixed infusion of study drug, thus completed the study|40
2958259|NCT00736229|3672689|FG001|COMPLETED|Overall Study||71
2958260|NCT00736229|3672690|FG002|COMPLETED|Overall Study||84
2958261|NCT00736229|3672688|FG000|NOT COMPLETED|Overall Study||0
2958262|NCT00736229|3672689|FG001|NOT COMPLETED|Overall Study||0
2958263|NCT00736229|3672690|FG002|NOT COMPLETED|Overall Study||0
2958264|NCT00736242|3672699|FG000|STARTED|Overall Study||232
2958265|NCT00736242|3672699|FG000|Participants in Safety Analysis Set|Overall Study||229
2958266|NCT00736242|3672699|FG000|COMPLETED|Overall Study||107
2958267|NCT00736242|3672699|FG000|NOT COMPLETED|Overall Study||125
2958268|NCT00736255|3672705|FG000|STARTED|Overall Study||17
2958269|NCT00736255|3672706|FG001|STARTED|Overall Study||15
2958270|NCT00736255|3672705|FG000|COMPLETED|Overall Study||14
2958271|NCT00736255|3672706|FG001|COMPLETED|Overall Study||14
2958272|NCT00736255|3672705|FG000|NOT COMPLETED|Overall Study||3
2958273|NCT00736255|3672706|FG001|NOT COMPLETED|Overall Study||1
2958274|NCT00736333|3672712|FG000|STARTED|Overall Study||167
2958275|NCT00736333|3672712|FG000|COMPLETED|Overall Study||56
2958276|NCT00736333|3672712|FG000|NOT COMPLETED|Overall Study||111
2958277|NCT00736450|3672716|FG000|STARTED|Overall Study||37
2958278|NCT00736450|3672716|FG000|COMPLETED|Overall Study||12
2958279|NCT00736450|3672716|FG000|NOT COMPLETED|Overall Study||25
2958280|NCT00736476|3672722|FG000|STARTED|Overall Study||36
2958281|NCT00736476|3672723|FG001|STARTED|Overall Study||27
2958282|NCT00736476|3672722|FG000|COMPLETED|Overall Study||35
2958283|NCT00736476|3672723|FG001|COMPLETED|Overall Study||27
2958284|NCT00736476|3672722|FG000|NOT COMPLETED|Overall Study||1
2958285|NCT00736476|3672723|FG001|NOT COMPLETED|Overall Study||0
2958286|NCT00736489|3672735|FG000|STARTED|Period 1|Cross-over study|6
3132747|NCT01693029|3857932|FG001|STARTED|Overall Study||218
3300446|NCT02945410|4034312|FG004|COMPLETED|Intervention 3 (5 Days)||1
3300447|NCT02945410|4034313|FG005|COMPLETED|Intervention 3 (5 Days)||0
3300448|NCT02945410|4034308|FG000|NOT COMPLETED|Intervention 3 (5 Days)||0
3300449|NCT02945410|4034309|FG001|NOT COMPLETED|Intervention 3 (5 Days)||0
3300450|NCT02945410|4034310|FG002|NOT COMPLETED|Intervention 3 (5 Days)||0
3300451|NCT02945410|4034311|FG003|NOT COMPLETED|Intervention 3 (5 Days)||0
2958287|NCT00736489|3672736|FG001|STARTED|Period 1||5
2958288|NCT00736489|3672737|FG002|STARTED|Period 1||6
2958289|NCT00736489|3672738|FG003|STARTED|Period 1||7
2958290|NCT00736489|3672739|FG004|STARTED|Period 1||7
2958291|NCT00736489|3672740|FG005|STARTED|Period 1||6
2958292|NCT00736489|3672735|FG000|COMPLETED|Period 1||5
2958293|NCT00736489|3672736|FG001|COMPLETED|Period 1||5
2958294|NCT00736489|3672737|FG002|COMPLETED|Period 1||6
2958295|NCT00736489|3672738|FG003|COMPLETED|Period 1||7
2958296|NCT00736489|3672739|FG004|COMPLETED|Period 1||7
2958297|NCT00736489|3672740|FG005|COMPLETED|Period 1||5
2958298|NCT00736489|3672735|FG000|NOT COMPLETED|Period 1||1
2958299|NCT00736489|3672736|FG001|NOT COMPLETED|Period 1||0
2958300|NCT00736489|3672737|FG002|NOT COMPLETED|Period 1||0
2958301|NCT00736489|3672738|FG003|NOT COMPLETED|Period 1||0
2958302|NCT00736489|3672739|FG004|NOT COMPLETED|Period 1||0
2958303|NCT00736489|3672740|FG005|NOT COMPLETED|Period 1||1
2958304|NCT00736489|3672735|FG000|STARTED|Period 2||5
2958305|NCT00736489|3672736|FG001|STARTED|Period 2||5
2958306|NCT00736489|3672737|FG002|STARTED|Period 2||6
2958307|NCT00736489|3672738|FG003|STARTED|Period 2||7
2958308|NCT00736489|3672739|FG004|STARTED|Period 2||7
2958309|NCT00736489|3672740|FG005|STARTED|Period 2||5
2958310|NCT00736489|3672735|FG000|COMPLETED|Period 2||5
2958311|NCT00736489|3672736|FG001|COMPLETED|Period 2||5
2958312|NCT00736489|3672737|FG002|COMPLETED|Period 2||6
2958313|NCT00736489|3672738|FG003|COMPLETED|Period 2||7
2958314|NCT00736489|3672739|FG004|COMPLETED|Period 2||7
2958315|NCT00736489|3672740|FG005|COMPLETED|Period 2||5
2958316|NCT00736489|3672735|FG000|NOT COMPLETED|Period 2||0
2958317|NCT00736489|3672736|FG001|NOT COMPLETED|Period 2||0
2958318|NCT00736489|3672737|FG002|NOT COMPLETED|Period 2||0
2958319|NCT00736489|3672738|FG003|NOT COMPLETED|Period 2||0
2958320|NCT00736489|3672739|FG004|NOT COMPLETED|Period 2||0
2958321|NCT00736489|3672740|FG005|NOT COMPLETED|Period 2||0
2958322|NCT00736489|3672735|FG000|STARTED|Period 3||5
2958323|NCT00736489|3672736|FG001|STARTED|Period 3||5
2958324|NCT00736489|3672737|FG002|STARTED|Period 3||6
2958325|NCT00736489|3672738|FG003|STARTED|Period 3||7
2958326|NCT00736489|3672739|FG004|STARTED|Period 3||7
2958327|NCT00736489|3672740|FG005|STARTED|Period 3||5
2958328|NCT00736489|3672735|FG000|COMPLETED|Period 3||5
2958329|NCT00736489|3672736|FG001|COMPLETED|Period 3||5
2958330|NCT00736489|3672737|FG002|COMPLETED|Period 3||6
2958331|NCT00736489|3672738|FG003|COMPLETED|Period 3||7
2958332|NCT00736489|3672739|FG004|COMPLETED|Period 3||7
2958333|NCT00736489|3672740|FG005|COMPLETED|Period 3||5
3132748|NCT01693029|3857931|FG000|COMPLETED|Overall Study||173
3132749|NCT01693029|3857932|FG001|COMPLETED|Overall Study||161
3132750|NCT01693029|3857931|FG000|NOT COMPLETED|Overall Study||44
2958334|NCT00736489|3672735|FG000|NOT COMPLETED|Period 3||0
2958335|NCT00736489|3672736|FG001|NOT COMPLETED|Period 3||0
2958336|NCT00736489|3672737|FG002|NOT COMPLETED|Period 3||0
2958337|NCT00736489|3672738|FG003|NOT COMPLETED|Period 3||0
2958338|NCT00736489|3672739|FG004|NOT COMPLETED|Period 3||0
2958339|NCT00736489|3672740|FG005|NOT COMPLETED|Period 3||0
2958340|NCT00736489|3672735|FG000|STARTED|Period 4||5
2958341|NCT00736489|3672736|FG001|STARTED|Period 4||5
2958342|NCT00736489|3672737|FG002|STARTED|Period 4||6
2958343|NCT00736489|3672738|FG003|STARTED|Period 4||7
2958344|NCT00736489|3672739|FG004|STARTED|Period 4||7
2958345|NCT00736489|3672740|FG005|STARTED|Period 4||5
2958346|NCT00736489|3672735|FG000|COMPLETED|Period 4||5
2958347|NCT00736489|3672736|FG001|COMPLETED|Period 4||5
2958348|NCT00736489|3672737|FG002|COMPLETED|Period 4||6
2958349|NCT00736489|3672738|FG003|COMPLETED|Period 4||7
2958350|NCT00736489|3672739|FG004|COMPLETED|Period 4||7
2958351|NCT00736489|3672740|FG005|COMPLETED|Period 4||5
2958352|NCT00736489|3672735|FG000|NOT COMPLETED|Period 4||0
2958353|NCT00736489|3672736|FG001|NOT COMPLETED|Period 4||0
2958354|NCT00736489|3672737|FG002|NOT COMPLETED|Period 4||0
2958355|NCT00736489|3672738|FG003|NOT COMPLETED|Period 4||0
2958356|NCT00736489|3672739|FG004|NOT COMPLETED|Period 4||0
2958357|NCT00736489|3672740|FG005|NOT COMPLETED|Period 4||0
2958358|NCT00736489|3672735|FG000|STARTED|Period 5||5
2958359|NCT00736489|3672736|FG001|STARTED|Period 5||5
2958360|NCT00736489|3672737|FG002|STARTED|Period 5||6
2958361|NCT00736489|3672738|FG003|STARTED|Period 5||7
2958362|NCT00736489|3672739|FG004|STARTED|Period 5||7
2958363|NCT00736489|3672740|FG005|STARTED|Period 5||5
2958364|NCT00736489|3672735|FG000|COMPLETED|Period 5||5
2958365|NCT00736489|3672736|FG001|COMPLETED|Period 5||5
2958366|NCT00736489|3672737|FG002|COMPLETED|Period 5||6
2958367|NCT00736489|3672738|FG003|COMPLETED|Period 5||7
2958368|NCT00736489|3672739|FG004|COMPLETED|Period 5||7
2958369|NCT00736489|3672740|FG005|COMPLETED|Period 5||5
2958370|NCT00736489|3672735|FG000|NOT COMPLETED|Period 5||0
2958371|NCT00736489|3672736|FG001|NOT COMPLETED|Period 5||0
2958372|NCT00736489|3672737|FG002|NOT COMPLETED|Period 5||0
2958373|NCT00736489|3672738|FG003|NOT COMPLETED|Period 5||0
2958374|NCT00736489|3672739|FG004|NOT COMPLETED|Period 5||0
2958375|NCT00736489|3672740|FG005|NOT COMPLETED|Period 5||0
2958376|NCT00736489|3672735|FG000|STARTED|Period 6||5
2958377|NCT00736489|3672736|FG001|STARTED|Period 6||5
2958378|NCT00736489|3672737|FG002|STARTED|Period 6||6
2958379|NCT00736489|3672738|FG003|STARTED|Period 6||7
2958380|NCT00736489|3672739|FG004|STARTED|Period 6||7
2958381|NCT00736489|3672740|FG005|STARTED|Period 6||5
2958382|NCT00736489|3672735|FG000|COMPLETED|Period 6||5
2958383|NCT00736489|3672736|FG001|COMPLETED|Period 6||5
2958384|NCT00736489|3672737|FG002|COMPLETED|Period 6||6
2958385|NCT00736489|3672738|FG003|COMPLETED|Period 6||7
2958386|NCT00736489|3672739|FG004|COMPLETED|Period 6||7
2958387|NCT00736489|3672740|FG005|COMPLETED|Period 6||5
2958388|NCT00736489|3672735|FG000|NOT COMPLETED|Period 6||0
2958389|NCT00736489|3672736|FG001|NOT COMPLETED|Period 6||0
2958390|NCT00736489|3672737|FG002|NOT COMPLETED|Period 6||0
2958391|NCT00736489|3672738|FG003|NOT COMPLETED|Period 6||0
2958392|NCT00736489|3672739|FG004|NOT COMPLETED|Period 6||0
2958393|NCT00736489|3672740|FG005|NOT COMPLETED|Period 6||0
2958394|NCT00736502|3672754|FG000|STARTED|Overall Study|Entered and treated.|278
2958395|NCT00736502|3672754|FG000|COMPLETED|Overall Study||213
2958396|NCT00736502|3672754|FG000|NOT COMPLETED|Overall Study||65
2958397|NCT00736580|3672760|FG000|STARTED|Overall Study||117
2958398|NCT00736580|3672761|FG001|STARTED|Overall Study||123
2958399|NCT00736580|3672760|FG000|COMPLETED|Overall Study||117
2958400|NCT00736580|3672761|FG001|COMPLETED|Overall Study||123
2958401|NCT00736580|3672760|FG000|NOT COMPLETED|Overall Study||0
2958402|NCT00736580|3672761|FG001|NOT COMPLETED|Overall Study||0
2958403|NCT00736632|3672770|FG000|STARTED|Overall Study||44
2958404|NCT00736632|3672771|FG001|STARTED|Overall Study||50
2958405|NCT00736632|3672772|FG002|STARTED|Overall Study||31
2958406|NCT00736632|3672770|FG000|COMPLETED|Overall Study||44
2958407|NCT00736632|3672771|FG001|COMPLETED|Overall Study||50
2958408|NCT00736632|3672772|FG002|COMPLETED|Overall Study||31
2958409|NCT00736632|3672770|FG000|NOT COMPLETED|Overall Study||0
2958410|NCT00736632|3672771|FG001|NOT COMPLETED|Overall Study||0
2958411|NCT00736632|3672772|FG002|NOT COMPLETED|Overall Study||0
2958412|NCT00736645|3672782|FG000|STARTED|Overall Study||13
2958413|NCT00736645|3672783|FG001|STARTED|Overall Study||15
2958414|NCT00736645|3672784|FG002|STARTED|Overall Study||14
2958415|NCT00736645|3672785|FG003|STARTED|Overall Study||13
2958416|NCT00736645|3672782|FG000|COMPLETED|Overall Study||13
2958417|NCT00736645|3672783|FG001|COMPLETED|Overall Study||13
2958418|NCT00736645|3672784|FG002|COMPLETED|Overall Study||14
2958419|NCT00736645|3672785|FG003|COMPLETED|Overall Study||13
2958420|NCT00736645|3672782|FG000|NOT COMPLETED|Overall Study||0
2958421|NCT00736645|3672783|FG001|NOT COMPLETED|Overall Study||2
2958422|NCT00736645|3672784|FG002|NOT COMPLETED|Overall Study||0
2958423|NCT00736645|3672785|FG003|NOT COMPLETED|Overall Study||0
2958424|NCT00736723|3672797|FG000|STARTED|Overall Study||30
2958425|NCT00736723|3672798|FG001|STARTED|Overall Study||21
2958426|NCT00736723|3672797|FG000|COMPLETED|Overall Study||26
2958427|NCT00736723|3672798|FG001|COMPLETED|Overall Study||18
2958428|NCT00736723|3672797|FG000|NOT COMPLETED|Overall Study||4
2958429|NCT00736723|3672798|FG001|NOT COMPLETED|Overall Study||3
2958430|NCT00736840|3672804|FG000|STARTED|Overall Study||414
2958431|NCT00736840|3672804|FG000|COMPLETED|Overall Study|9 subjects-no biopsy results, 2-no breath test, 2 no biopsy results and no complete breath test|401
2958432|NCT00736840|3672804|FG000|NOT COMPLETED|Overall Study||13
2958433|NCT00736853|3672808|FG000|STARTED|Open-Label Period||319
2958434|NCT00736853|3672809|FG001|STARTED|Open-Label Period||0
2958435|NCT00736853|3672810|FG002|STARTED|Open-Label Period||0
2958436|NCT00736853|3672808|FG000|Treated|Open-Label Period||277
2958437|NCT00736853|3672809|FG001|Treated|Open-Label Period||0
2958438|NCT00736853|3672810|FG002|Treated|Open-Label Period||0
2958439|NCT00736853|3672808|FG000|COMPLETED|Open-Label Period||187
2958440|NCT00736853|3672809|FG001|COMPLETED|Open-Label Period||0
2958441|NCT00736853|3672810|FG002|COMPLETED|Open-Label Period||0
2958442|NCT00736853|3672808|FG000|NOT COMPLETED|Open-Label Period||132
2958443|NCT00736853|3672809|FG001|NOT COMPLETED|Open-Label Period||0
2958444|NCT00736853|3672810|FG002|NOT COMPLETED|Open-Label Period||0
2958445|NCT00736853|3672808|FG000|STARTED|Double-Blind Period||0
2958446|NCT00736853|3672809|FG001|STARTED|Double-Blind Period||94
2958447|NCT00736853|3672810|FG002|STARTED|Double-Blind Period||93
2958448|NCT00736853|3672808|FG000|COMPLETED|Double-Blind Period||0
2958449|NCT00736853|3672809|FG001|COMPLETED|Double-Blind Period||70
2958450|NCT00736853|3672810|FG002|COMPLETED|Double-Blind Period||45
2958451|NCT00736853|3672808|FG000|NOT COMPLETED|Double-Blind Period||0
2958452|NCT00736853|3672809|FG001|NOT COMPLETED|Double-Blind Period||24
2958453|NCT00736853|3672810|FG002|NOT COMPLETED|Double-Blind Period||48
2958454|NCT00736879|3672823|FG000|STARTED|Double Blind Treatment Period||68
2958455|NCT00736879|3672824|FG001|STARTED|Double Blind Treatment Period||72
2958456|NCT00736879|3672825|FG002|STARTED|Double Blind Treatment Period||74
2958457|NCT00736879|3672826|FG003|STARTED|Double Blind Treatment Period||68
2958458|NCT00736879|3672823|FG000|COMPLETED|Double Blind Treatment Period||65
2958459|NCT00736879|3672824|FG001|COMPLETED|Double Blind Treatment Period||68
2958460|NCT00736879|3672825|FG002|COMPLETED|Double Blind Treatment Period||67
2958461|NCT00736879|3672826|FG003|COMPLETED|Double Blind Treatment Period||63
2958462|NCT00736879|3672823|FG000|NOT COMPLETED|Double Blind Treatment Period||3
2958463|NCT00736879|3672824|FG001|NOT COMPLETED|Double Blind Treatment Period||4
2958464|NCT00736879|3672825|FG002|NOT COMPLETED|Double Blind Treatment Period||7
2958465|NCT00736879|3672826|FG003|NOT COMPLETED|Double Blind Treatment Period||5
2958466|NCT00736879|3672823|FG000|STARTED|Follow up Period - No Drug Treatment|Those not completing 24 weeks of treatment can still remain in the trial for 4 weeks of follow up.|66
2958467|NCT00736879|3672824|FG001|STARTED|Follow up Period - No Drug Treatment|Those not completing 24 weeks of treatment can still remain in the trial for 4 weeks of follow up.|70
2958468|NCT00736879|3672825|FG002|STARTED|Follow up Period - No Drug Treatment|Those not completing 24 weeks of treatment can still remain in the trial for 4 weeks of follow up.|66
3132751|NCT01693029|3857932|FG001|NOT COMPLETED|Overall Study||57
3132752|NCT01693068|3857940|FG000|STARTED|Randomization Period||64
2958469|NCT00736879|3672826|FG003|STARTED|Follow up Period - No Drug Treatment|Those not completing 24 weeks of treatment can still remain in the trial for 4 weeks of follow up.|62
2958470|NCT00736879|3672823|FG000|COMPLETED|Follow up Period - No Drug Treatment||65
2958471|NCT00736879|3672824|FG001|COMPLETED|Follow up Period - No Drug Treatment||67
2958472|NCT00736879|3672825|FG002|COMPLETED|Follow up Period - No Drug Treatment||66
2958473|NCT00736879|3672826|FG003|COMPLETED|Follow up Period - No Drug Treatment||62
2958474|NCT00736879|3672823|FG000|NOT COMPLETED|Follow up Period - No Drug Treatment||1
2958475|NCT00736879|3672824|FG001|NOT COMPLETED|Follow up Period - No Drug Treatment||3
2958476|NCT00736879|3672825|FG002|NOT COMPLETED|Follow up Period - No Drug Treatment||0
2958477|NCT00736879|3672826|FG003|NOT COMPLETED|Follow up Period - No Drug Treatment||0
2958478|NCT00736944|3672839|FG000|STARTED|Induction||30
2958479|NCT00736944|3672839|FG000|COMPLETED|Induction||29
2958480|NCT00736944|3672839|FG000|NOT COMPLETED|Induction||1
2958481|NCT00736944|3672839|FG000|STARTED|Definitive Treatment||29
2958482|NCT00736944|3672839|FG000|COMPLETED|Definitive Treatment||28
2958483|NCT00736944|3672839|FG000|NOT COMPLETED|Definitive Treatment||1
2958484|NCT00736957|3672846|FG000|STARTED|Overall Study||219
2958485|NCT00736957|3672846|FG000|Treated|Overall Study||190
2958486|NCT00736957|3672846|FG000|COMPLETED|Overall Study||97
2958487|NCT00736957|3672846|FG000|NOT COMPLETED|Overall Study||122
2958488|NCT00736996|3672853|FG000|STARTED|Overall Study||25
2958489|NCT00736996|3672854|FG001|STARTED|Overall Study||26
2958490|NCT00736996|3672855|FG002|STARTED|Overall Study||27
2958491|NCT00736996|3672853|FG000|COMPLETED|Overall Study||24
2958492|NCT00736996|3672854|FG001|COMPLETED|Overall Study||17
2958493|NCT00736996|3672855|FG002|COMPLETED|Overall Study||25
2958494|NCT00736996|3672853|FG000|NOT COMPLETED|Overall Study||1
2958495|NCT00736996|3672854|FG001|NOT COMPLETED|Overall Study||9
2958496|NCT00736996|3672855|FG002|NOT COMPLETED|Overall Study||2
2958497|NCT00737048|3672866|FG000|STARTED|Overall Study||132
2958498|NCT00737048|3672867|FG001|STARTED|Overall Study||66
2958499|NCT00737048|3672868|FG002|STARTED|Overall Study||130
2958500|NCT00737048|3672866|FG000|COMPLETED|Overall Study||129
2958501|NCT00737048|3672867|FG001|COMPLETED|Overall Study||60
2958502|NCT00737048|3672868|FG002|COMPLETED|Overall Study||126
2958503|NCT00737048|3672866|FG000|NOT COMPLETED|Overall Study||3
2958504|NCT00737048|3672867|FG001|NOT COMPLETED|Overall Study||6
2958505|NCT00737048|3672868|FG002|NOT COMPLETED|Overall Study||4
2958506|NCT00737061|3672876|FG000|STARTED|Waiting Period||645
2958507|NCT00737061|3672876|FG000|COMPLETED|Waiting Period||570
2958508|NCT00737061|3672876|FG000|NOT COMPLETED|Waiting Period||75
2958509|NCT00737061|3672876|FG000|STARTED|1 Year Wearing Period||570
2958510|NCT00737061|3672876|FG000|COMPLETED|1 Year Wearing Period||553
2958511|NCT00737061|3672876|FG000|NOT COMPLETED|1 Year Wearing Period||17
2958512|NCT00737100|3672883|FG000|STARTED|Overall Study||168
2958513|NCT00737100|3672884|FG001|STARTED|Overall Study||166
2958514|NCT00737100|3672885|FG002|STARTED|Overall Study||176
2958515|NCT00737100|3672883|FG000|COMPLETED|Overall Study||161
2958516|NCT00737100|3672884|FG001|COMPLETED|Overall Study||159
2958517|NCT00737100|3672885|FG002|COMPLETED|Overall Study||169
2958518|NCT00737100|3672883|FG000|NOT COMPLETED|Overall Study||7
2958519|NCT00737100|3672884|FG001|NOT COMPLETED|Overall Study||7
2958520|NCT00737100|3672885|FG002|NOT COMPLETED|Overall Study||7
2958521|NCT00737178|3672897|FG000|STARTED|Overall Study||71
2958522|NCT00737178|3672898|FG001|STARTED|Overall Study||85
2958523|NCT00737178|3672897|FG000|COMPLETED|Overall Study||66
2958524|NCT00737178|3672898|FG001|COMPLETED|Overall Study||76
2958525|NCT00737178|3672897|FG000|NOT COMPLETED|Overall Study||5
2958526|NCT00737178|3672898|FG001|NOT COMPLETED|Overall Study||9
2958527|NCT00737204|3672906|FG000|STARTED|Overall Study||36
2958528|NCT00737204|3672907|FG001|STARTED|Overall Study||34
2958529|NCT00737204|3672906|FG000|COMPLETED|Overall Study||36
2958530|NCT00737204|3672907|FG001|COMPLETED|Overall Study||28
2958531|NCT00737204|3672906|FG000|NOT COMPLETED|Overall Study||0
2958532|NCT00737204|3672907|FG001|NOT COMPLETED|Overall Study||6
2958533|NCT00737243|3672913|FG000|STARTED|Overall Study||289
2958534|NCT00737243|3672913|FG000|Successful Assay Performed|Overall Study||252
2958535|NCT00737243|3672913|FG000|Insufficient Tissue for Assay, Withdrawn|Overall Study||37
2958536|NCT00737243|3672913|FG000|Treated|Overall Study||223
2958537|NCT00737243|3672913|FG000|Not Treated|Overall Study|16 pts no longer met eligibility criteria; 13 came off study due to physician or pt preference.|29
2958538|NCT00737243|3672913|FG000|Site Specific Therapy More Responsive|Overall Study||115
2958539|NCT00737243|3672913|FG000|Site Specific Therapy Less Responsive|Overall Study||79
2958540|NCT00737243|3672913|FG000|Empiric CUP Therapy|Overall Study||29
2958541|NCT00737243|3672913|FG000|COMPLETED|Overall Study||194
2958542|NCT00737243|3672913|FG000|NOT COMPLETED|Overall Study||95
2958543|NCT00737360|3672919|FG000|STARTED|Overall Study||27
2958544|NCT00737360|3672919|FG000|COMPLETED|Overall Study||27
2958545|NCT00737360|3672919|FG000|NOT COMPLETED|Overall Study||0
2958546|NCT00737438|3672923|FG000|STARTED|Overall Study||23
2958547|NCT00737438|3672923|FG000|COMPLETED|Overall Study||20
2958548|NCT00737438|3672923|FG000|NOT COMPLETED|Overall Study||3
2958549|NCT00737464|3672927|FG000|STARTED|Overall Study||132
2958550|NCT00737464|3672927|FG000|COMPLETED|Overall Study||114
2958551|NCT00737464|3672927|FG000|NOT COMPLETED|Overall Study||18
2958552|NCT00737477|3672931|FG000|STARTED|Overall Study||96
2958553|NCT00737477|3672931|FG000|COMPLETED|Overall Study||62
2958554|NCT00737477|3672931|FG000|NOT COMPLETED|Overall Study||34
2958555|NCT00737529|3672935|FG000|STARTED|Overall Study||134
2958556|NCT00737529|3672935|FG000|COMPLETED|Overall Study|Completed equals participants ongoing on treatment at the time of the data cut-off of 30 March 2017|1
2958557|NCT00737529|3672935|FG000|NOT COMPLETED|Overall Study||133
2958558|NCT00737568|3672941|FG000|STARTED|Treatment Period Through Week 240||141
2958559|NCT00737568|3672942|FG001|STARTED|Treatment Period Through Week 240||139
2958560|NCT00737568|3672941|FG000|COMPLETED|Treatment Period Through Week 240||121
2958561|NCT00737568|3672942|FG001|COMPLETED|Treatment Period Through Week 240||118
2958562|NCT00737568|3672941|FG000|NOT COMPLETED|Treatment Period Through Week 240||20
2958563|NCT00737568|3672942|FG001|NOT COMPLETED|Treatment Period Through Week 240||21
2958564|NCT00737568|3672941|FG000|STARTED|Treatment-Free Follow-up (TFFU) Period|1 participant not completing the 240 week treatment period enrolled in the TFFU period.|38
2958565|NCT00737568|3672942|FG001|STARTED|Treatment-Free Follow-up (TFFU) Period|4 participants not completing the 240 week treatment period enrolled in the TFFU period.|37
2958566|NCT00737568|3672941|FG000|COMPLETED|Treatment-Free Follow-up (TFFU) Period||12
2958567|NCT00737568|3672942|FG001|COMPLETED|Treatment-Free Follow-up (TFFU) Period||19
2958568|NCT00737568|3672941|FG000|NOT COMPLETED|Treatment-Free Follow-up (TFFU) Period||26
2958569|NCT00737568|3672942|FG001|NOT COMPLETED|Treatment-Free Follow-up (TFFU) Period||18
2958570|NCT00737633|3672950|FG000|STARTED|Overall Study||44
2958571|NCT00737633|3672951|FG001|STARTED|Overall Study||57
2958572|NCT00737633|3672950|FG000|COMPLETED|Overall Study||0
2958573|NCT00737633|3672951|FG001|COMPLETED|Overall Study||0
2958574|NCT00737633|3672950|FG000|NOT COMPLETED|Overall Study||44
2958575|NCT00737633|3672951|FG001|NOT COMPLETED|Overall Study||57
2958576|NCT00737672|3672959|FG000|STARTED|Overall Study||145
2958577|NCT00737672|3672960|FG001|STARTED|Overall Study||148
2958578|NCT00737672|3672959|FG000|Exclusions Due to Protocol Deviations|Overall Study||14
2958579|NCT00737672|3672960|FG001|Exclusions Due to Protocol Deviations|Overall Study||10
2958580|NCT00737672|3672959|FG000|Per Protocol Population|Overall Study||131
2958581|NCT00737672|3672960|FG001|Per Protocol Population|Overall Study||138
2958582|NCT00737672|3672959|FG000|COMPLETED|Overall Study||65
2958583|NCT00737672|3672960|FG001|COMPLETED|Overall Study||65
2958584|NCT00737672|3672959|FG000|NOT COMPLETED|Overall Study||80
2958585|NCT00737672|3672960|FG001|NOT COMPLETED|Overall Study||83
2958586|NCT00737698|3672969|FG000|STARTED|Overall Study||23
2958587|NCT00737698|3672970|FG001|STARTED|Overall Study||42
2958588|NCT00737698|3672971|FG002|STARTED|Overall Study||21
2958589|NCT00737698|3672969|FG000|COMPLETED|Overall Study||17
2958590|NCT00737698|3672970|FG001|COMPLETED|Overall Study||37
2958591|NCT00737698|3672971|FG002|COMPLETED|Overall Study||17
2958592|NCT00737698|3672969|FG000|NOT COMPLETED|Overall Study||6
2958593|NCT00737698|3672970|FG001|NOT COMPLETED|Overall Study||5
2958594|NCT00737698|3672971|FG002|NOT COMPLETED|Overall Study||4
2958595|NCT00737711|3672979|FG000|STARTED|Overall Study||189
2958596|NCT00737711|3672979|FG000|COMPLETED|Overall Study||158
2958597|NCT00737711|3672979|FG000|NOT COMPLETED|Overall Study||31
2958598|NCT00737737|3672985|FG000|STARTED|Overall Study||2
2958599|NCT00737737|3672986|FG001|STARTED|Overall Study||2
2958600|NCT00737737|3672985|FG000|COMPLETED|Overall Study||2
2958601|NCT00737737|3672986|FG001|COMPLETED|Overall Study||2
2958602|NCT00737737|3672985|FG000|NOT COMPLETED|Overall Study||0
2958603|NCT00737737|3672986|FG001|NOT COMPLETED|Overall Study||0
2958604|NCT00737893|3672994|FG000|STARTED|Overall Study||29
2958605|NCT00737893|3672995|FG001|STARTED|Overall Study||27
2958606|NCT00737893|3672994|FG000|COMPLETED|Overall Study||29
2958607|NCT00737893|3672995|FG001|COMPLETED|Overall Study||27
2958608|NCT00737893|3672994|FG000|NOT COMPLETED|Overall Study||0
2958609|NCT00737893|3672995|FG001|NOT COMPLETED|Overall Study||0
3035332|NCT01136733|3754460|FG002|NOT COMPLETED|Phase 2||0
3035333|NCT01136733|3754461|FG003|NOT COMPLETED|Phase 2||0
3035334|NCT01136733|3754462|FG004|NOT COMPLETED|Phase 2||51
3035335|NCT01136733|3754463|FG005|NOT COMPLETED|Phase 2||52
3035336|NCT01136733|3754464|FG006|NOT COMPLETED|Phase 2||50
3035337|NCT01136746|3754496|FG000|STARTED|Overall Study||9
3035338|NCT01136746|3754497|FG001|STARTED|Overall Study||7
3035339|NCT01136746|3754496|FG000|COMPLETED|Overall Study||6
3035340|NCT01136746|3754497|FG001|COMPLETED|Overall Study||4
3035341|NCT01136746|3754496|FG000|NOT COMPLETED|Overall Study||3
3035342|NCT01136746|3754497|FG001|NOT COMPLETED|Overall Study||3
3035343|NCT01136772|3754505|FG000|STARTED|Overall Study||157
3035344|NCT01136772|3754506|FG001|STARTED|Overall Study||154
3035345|NCT01136772|3754505|FG000|Safety Population|Overall Study|Includes all randomized participants who received at least one dose of the injectable medication|147
3035346|NCT01136772|3754506|FG001|Safety Population|Overall Study|Includes all randomized participants who received at least one dose of the injectable medication|147
3035347|NCT01136772|3754505|FG000|COMPLETED|Overall Study||41
3035348|NCT01136772|3754506|FG001|COMPLETED|Overall Study||44
3035349|NCT01136772|3754505|FG000|NOT COMPLETED|Overall Study||116
3035350|NCT01136772|3754506|FG001|NOT COMPLETED|Overall Study||110
3035351|NCT01136785|3754514|FG000|STARTED|Overall Study||15
3035352|NCT01136785|3754515|FG001|STARTED|Overall Study||7
3035353|NCT01136785|3754514|FG000|COMPLETED|Overall Study||13
3035354|NCT01136785|3754515|FG001|COMPLETED|Overall Study||6
3035355|NCT01136785|3754514|FG000|NOT COMPLETED|Overall Study||2
3035356|NCT01136785|3754515|FG001|NOT COMPLETED|Overall Study||1
3035357|NCT01136798|3754527|FG000|STARTED|Overall Study||10
3035358|NCT01136798|3754528|FG001|STARTED|Overall Study||8
3035359|NCT01136798|3754527|FG000|COMPLETED|Overall Study||10
2958610|NCT00738023|3673003|FG000|STARTED|Intralipid Infusion||19
2958611|NCT00738023|3673004|FG001|STARTED|Intralipid Infusion||13
2958612|NCT00738023|3673003|FG000|COMPLETED|Intralipid Infusion||19
2958613|NCT00738023|3673004|FG001|COMPLETED|Intralipid Infusion||13
2958614|NCT00738023|3673003|FG000|NOT COMPLETED|Intralipid Infusion||0
2958615|NCT00738023|3673004|FG001|NOT COMPLETED|Intralipid Infusion||0
2958616|NCT00738023|3673003|FG000|STARTED|Saline Infusion||19
2958617|NCT00738023|3673004|FG001|STARTED|Saline Infusion||0
2958618|NCT00738023|3673003|FG000|COMPLETED|Saline Infusion||19
2958619|NCT00738023|3673004|FG001|COMPLETED|Saline Infusion||0
2958620|NCT00738023|3673003|FG000|NOT COMPLETED|Saline Infusion||0
2958621|NCT00738023|3673004|FG001|NOT COMPLETED|Saline Infusion||0
2958622|NCT00738023|3673003|FG000|STARTED|Intralipid Infusion (Post 6 Wks of Drug)||19
2958623|NCT00738023|3673004|FG001|STARTED|Intralipid Infusion (Post 6 Wks of Drug)||0
2958624|NCT00738023|3673003|FG000|COMPLETED|Intralipid Infusion (Post 6 Wks of Drug)||19
2958625|NCT00738023|3673004|FG001|COMPLETED|Intralipid Infusion (Post 6 Wks of Drug)||0
2958626|NCT00738023|3673003|FG000|NOT COMPLETED|Intralipid Infusion (Post 6 Wks of Drug)||0
2958627|NCT00738023|3673004|FG001|NOT COMPLETED|Intralipid Infusion (Post 6 Wks of Drug)||0
2958628|NCT00738049|3673013|FG000|STARTED|1st Intervention(14 Days)||13
2958629|NCT00738049|3673014|FG001|STARTED|1st Intervention(14 Days)||7
2958630|NCT00738049|3673013|FG000|COMPLETED|1st Intervention(14 Days)||13
3300452|NCT02945410|4034312|FG004|NOT COMPLETED|Intervention 3 (5 Days)||0
3300453|NCT02945410|4034313|FG005|NOT COMPLETED|Intervention 3 (5 Days)||0
3300454|NCT02945553|4034323|FG000|STARTED|Overall Study||14
2958631|NCT00738049|3673014|FG001|COMPLETED|1st Intervention(14 Days)||7
2958632|NCT00738049|3673013|FG000|NOT COMPLETED|1st Intervention(14 Days)||0
2958633|NCT00738049|3673014|FG001|NOT COMPLETED|1st Intervention(14 Days)||0
2958634|NCT00738049|3673013|FG000|STARTED|2nd Intervention(14 Days)||13
2958635|NCT00738049|3673014|FG001|STARTED|2nd Intervention(14 Days)||7
2958636|NCT00738049|3673013|FG000|COMPLETED|2nd Intervention(14 Days)||13
2958637|NCT00738049|3673014|FG001|COMPLETED|2nd Intervention(14 Days)||7
2958638|NCT00738049|3673013|FG000|NOT COMPLETED|2nd Intervention(14 Days)||0
2958639|NCT00738049|3673014|FG001|NOT COMPLETED|2nd Intervention(14 Days)||0
2958640|NCT00738049|3673013|FG000|STARTED|Washout||13
2958641|NCT00738049|3673014|FG001|STARTED|Washout||7
2958642|NCT00738049|3673013|FG000|COMPLETED|Washout||13
2958643|NCT00738049|3673014|FG001|COMPLETED|Washout||7
2958644|NCT00738049|3673013|FG000|NOT COMPLETED|Washout||0
2958645|NCT00738049|3673014|FG001|NOT COMPLETED|Washout||0
2958646|NCT00738062|3673029|FG000|STARTED|Open Label Treatment||103
2958647|NCT00738062|3673030|FG001|STARTED|Open Label Treatment||0
2958648|NCT00738062|3673031|FG002|STARTED|Open Label Treatment||0
2958649|NCT00738062|3673029|FG000|COMPLETED|Open Label Treatment||75
2958650|NCT00738062|3673030|FG001|COMPLETED|Open Label Treatment||0
2958651|NCT00738062|3673031|FG002|COMPLETED|Open Label Treatment||0
2958652|NCT00738062|3673029|FG000|NOT COMPLETED|Open Label Treatment||28
2958653|NCT00738062|3673030|FG001|NOT COMPLETED|Open Label Treatment||0
2958654|NCT00738062|3673031|FG002|NOT COMPLETED|Open Label Treatment||0
2958655|NCT00738062|3673029|FG000|STARTED|2 Week Randomized Withdrawal|Patients completing the open label titration phase were randomized to either Droxidopa or Placebo|0
2958656|NCT00738062|3673030|FG001|STARTED|2 Week Randomized Withdrawal||38
2958657|NCT00738062|3673031|FG002|STARTED|2 Week Randomized Withdrawal||37
2958658|NCT00738062|3673029|FG000|COMPLETED|2 Week Randomized Withdrawal||0
2958659|NCT00738062|3673030|FG001|COMPLETED|2 Week Randomized Withdrawal||38
2958660|NCT00738062|3673031|FG002|COMPLETED|2 Week Randomized Withdrawal||37
2958661|NCT00738062|3673029|FG000|NOT COMPLETED|2 Week Randomized Withdrawal||0
2958662|NCT00738062|3673030|FG001|NOT COMPLETED|2 Week Randomized Withdrawal||0
2958663|NCT00738062|3673031|FG002|NOT COMPLETED|2 Week Randomized Withdrawal||0
2958664|NCT00738062|3673029|FG000|STARTED|Open-Label Extension|One patient completed double blind randomization but did not enter the open label extension|74
2958665|NCT00738062|3673030|FG001|STARTED|Open-Label Extension||0
3163652|NCT01888497|3891177|FG001|STARTED|Second Intervention Period||14
3163653|NCT01888497|3891178|FG002|STARTED|Second Intervention Period||14
3300455|NCT02945553|4034324|FG001|STARTED|Overall Study||11
3300456|NCT02945553|4034323|FG000|COMPLETED|Overall Study|Included in analysis for primary aim.|11
3300457|NCT02945553|4034324|FG001|COMPLETED|Overall Study|Included in analysis for primary aim.|9
3300458|NCT02945553|4034323|FG000|NOT COMPLETED|Overall Study||3
3300459|NCT02945553|4034324|FG001|NOT COMPLETED|Overall Study||2
3300460|NCT02945657|4034334|FG000|STARTED|Overall Study||32
3300461|NCT02945657|4034334|FG000|COMPLETED|Overall Study||28
3300462|NCT02945657|4034334|FG000|NOT COMPLETED|Overall Study||4
3300463|NCT02946021|4034341|FG000|STARTED|Overall Study||6
3300464|NCT02946021|4034342|FG001|STARTED|Overall Study||5
3300465|NCT02946021|4034341|FG000|COMPLETED|Overall Study||6
3300466|NCT02946021|4034342|FG001|COMPLETED|Overall Study||5
3300467|NCT02946021|4034341|FG000|NOT COMPLETED|Overall Study||0
3300468|NCT02946021|4034342|FG001|NOT COMPLETED|Overall Study||0
3300469|NCT02946034|4034348|FG000|STARTED|Overall Study||10
3300470|NCT02946034|4034348|FG000|COMPLETED|Overall Study||10
3300471|NCT02946034|4034348|FG000|NOT COMPLETED|Overall Study||0
3300472|NCT02946073|4034358|FG000|STARTED|Titration Phase||811
3300473|NCT02946073|4034359|FG001|STARTED|Titration Phase||0
3300474|NCT02946073|4034360|FG002|STARTED|Titration Phase||98
3300475|NCT02946073|4034361|FG003|STARTED|Titration Phase||0
3300476|NCT02946073|4034358|FG000|COMPLETED|Titration Phase||222
3300477|NCT02946073|4034359|FG001|COMPLETED|Titration Phase||0
2958666|NCT00738062|3673031|FG002|STARTED|Open-Label Extension||0
2958667|NCT00738062|3673029|FG000|COMPLETED|Open-Label Extension||57
2958668|NCT00738062|3673030|FG001|COMPLETED|Open-Label Extension||0
2958669|NCT00738062|3673031|FG002|COMPLETED|Open-Label Extension||0
2958670|NCT00738062|3673029|FG000|NOT COMPLETED|Open-Label Extension||17
2958671|NCT00738062|3673030|FG001|NOT COMPLETED|Open-Label Extension||0
2958672|NCT00738062|3673031|FG002|NOT COMPLETED|Open-Label Extension||0
2958673|NCT00738101|3673040|FG000|STARTED|Overall Study||293
2958674|NCT00738101|3673040|FG000|COMPLETED|Overall Study|7 exclusions. 5 primary liver or unrelated disease, 1 died before Omegaven, 1 repeat enrollment|286
2958675|NCT00738101|3673040|FG000|NOT COMPLETED|Overall Study||7
2958676|NCT00738283|3673044|FG000|STARTED|Overall Study||17
2958677|NCT00738283|3673044|FG000|COMPLETED|Overall Study||13
2958678|NCT00738283|3673044|FG000|NOT COMPLETED|Overall Study||4
2958679|NCT00738361|3673048|FG000|STARTED|Overall Study||4
2958680|NCT00738361|3673048|FG000|COMPLETED|Overall Study||4
2958681|NCT00738361|3673048|FG000|NOT COMPLETED|Overall Study||0
2958682|NCT00738374|3673056|FG000|STARTED|Induction Treatment Phase||97
2958683|NCT00738374|3673057|FG001|STARTED|Induction Treatment Phase||0
2958684|NCT00738374|3673058|FG002|STARTED|Induction Treatment Phase|Participants were randomized at the end of the Induction Treatment Phase.|0
2958685|NCT00738374|3673059|FG003|STARTED|Induction Treatment Phase|Participants were randomized at the end of the Induction Treatment Phase.|0
2958686|NCT00738374|3673056|FG000|COMPLETED|Induction Treatment Phase||73
2958687|NCT00738374|3673057|FG001|COMPLETED|Induction Treatment Phase||0
2958688|NCT00738374|3673058|FG002|COMPLETED|Induction Treatment Phase||0
2958689|NCT00738374|3673059|FG003|COMPLETED|Induction Treatment Phase||0
2958690|NCT00738374|3673056|FG000|NOT COMPLETED|Induction Treatment Phase||24
2958691|NCT00738374|3673057|FG001|NOT COMPLETED|Induction Treatment Phase||0
2958692|NCT00738374|3673058|FG002|NOT COMPLETED|Induction Treatment Phase||0
2958693|NCT00738374|3673059|FG003|NOT COMPLETED|Induction Treatment Phase||0
2958694|NCT00738374|3673056|FG000|STARTED|Maintenance Treatment/Observation Phase|Participants were randomized to either maintenance therapy or observation at the end of induction.|0
2958695|NCT00738374|3673057|FG001|STARTED|Maintenance Treatment/Observation Phase||7
2958696|NCT00738374|3673058|FG002|STARTED|Maintenance Treatment/Observation Phase||34
2958697|NCT00738374|3673059|FG003|STARTED|Maintenance Treatment/Observation Phase||32
2958698|NCT00738374|3673056|FG000|COMPLETED|Maintenance Treatment/Observation Phase||0
2958699|NCT00738374|3673057|FG001|COMPLETED|Maintenance Treatment/Observation Phase||0
2958700|NCT00738374|3673058|FG002|COMPLETED|Maintenance Treatment/Observation Phase||27
2958701|NCT00738374|3673059|FG003|COMPLETED|Maintenance Treatment/Observation Phase||20
2958702|NCT00738374|3673056|FG000|NOT COMPLETED|Maintenance Treatment/Observation Phase||0
2958703|NCT00738374|3673057|FG001|NOT COMPLETED|Maintenance Treatment/Observation Phase||7
2958704|NCT00738374|3673058|FG002|NOT COMPLETED|Maintenance Treatment/Observation Phase||7
2958705|NCT00738374|3673059|FG003|NOT COMPLETED|Maintenance Treatment/Observation Phase||12
2958706|NCT00738400|3673070|FG000|STARTED|Overall Study||76
2958707|NCT00738400|3673071|FG001|STARTED|Overall Study||74
2958708|NCT00738400|3673070|FG000|Received Treatment, Safety Population|Overall Study|One invalid participant (no evidence that this randomized participant took study medication).|75
2958709|NCT00738400|3673071|FG001|Received Treatment, Safety Population|Overall Study|Two invalid participants (no evidence that these randomized participants took study medication).|72
2958710|NCT00738400|3673070|FG000|ITT (Intent To Treatment) Population|Overall Study||75
2958711|NCT00738400|3673071|FG001|ITT (Intent To Treatment) Population|Overall Study|No post-baseline efficacy measurement in 2 participants|70
2958712|NCT00738400|3673070|FG000|COMPLETED|Overall Study||72
2958713|NCT00738400|3673071|FG001|COMPLETED|Overall Study||67
2958714|NCT00738400|3673070|FG000|NOT COMPLETED|Overall Study||4
2958715|NCT00738400|3673071|FG001|NOT COMPLETED|Overall Study||7
2958716|NCT00738426|3673079|FG000|STARTED|Overall Study||37
2958717|NCT00738426|3673080|FG001|STARTED|Overall Study||35
2958718|NCT00738426|3673079|FG000|COMPLETED|Overall Study||35
2958719|NCT00738426|3673080|FG001|COMPLETED|Overall Study||32
2958720|NCT00738426|3673079|FG000|NOT COMPLETED|Overall Study||2
2958721|NCT00738426|3673080|FG001|NOT COMPLETED|Overall Study||3
2958722|NCT00738530|3673088|FG000|STARTED|Overall Study||327
2958723|NCT00738530|3673089|FG001|STARTED|Overall Study||322
2958724|NCT00738530|3673088|FG000|Treated|Overall Study||325
2958725|NCT00738530|3673089|FG001|Treated|Overall Study||316
2958726|NCT00738530|3673088|FG000|COMPLETED|Overall Study||93
2958727|NCT00738530|3673089|FG001|COMPLETED|Overall Study||84
2958728|NCT00738530|3673088|FG000|NOT COMPLETED|Overall Study||234
2958729|NCT00738530|3673089|FG001|NOT COMPLETED|Overall Study||238
2958730|NCT00738543|3673095|FG000|STARTED|Povidone Iodine||48
2958731|NCT00738543|3673095|FG000|COMPLETED|Povidone Iodine||48
2958732|NCT00738543|3673095|FG000|NOT COMPLETED|Povidone Iodine||0
2958733|NCT00738543|3673095|FG000|STARTED|Sodium Hypochlorite||48
2958734|NCT00738543|3673095|FG000|COMPLETED|Sodium Hypochlorite||48
2958735|NCT00738543|3673095|FG000|NOT COMPLETED|Sodium Hypochlorite||0
2958736|NCT00738543|3673095|FG000|STARTED|Control||48
2958737|NCT00738543|3673095|FG000|COMPLETED|Control||48
2958738|NCT00738543|3673095|FG000|NOT COMPLETED|Control||0
3163654|NCT01888497|3891179|FG003|STARTED|Second Intervention Period||16
3163655|NCT01888497|3891176|FG000|COMPLETED|Second Intervention Period||13
3163656|NCT01888497|3891177|FG001|COMPLETED|Second Intervention Period||14
3163657|NCT01888497|3891178|FG002|COMPLETED|Second Intervention Period||14
2958739|NCT00738673|3673101|FG000|STARTED|Overall Study||25
2958740|NCT00738673|3673102|FG001|STARTED|Overall Study||12
2958741|NCT00738673|3673101|FG000|Intent to Treat Population|Overall Study||24
2958742|NCT00738673|3673102|FG001|Intent to Treat Population|Overall Study||12
2958743|NCT00738673|3673101|FG000|COMPLETED|Overall Study||1
2958744|NCT00738673|3673102|FG001|COMPLETED|Overall Study||1
2958745|NCT00738673|3673101|FG000|NOT COMPLETED|Overall Study||24
2958746|NCT00738673|3673102|FG001|NOT COMPLETED|Overall Study||11
2958747|NCT00738699|3673110|FG000|STARTED|Overall Study||275
2958748|NCT00738699|3673111|FG001|STARTED|Overall Study||140
2958749|NCT00738699|3673110|FG000|Participants Not Treated|Overall Study||2
2958750|NCT00738699|3673111|FG001|Participants Not Treated|Overall Study||1
2958751|NCT00738699|3673110|FG000|Participants Treated|Overall Study||273
2958752|NCT00738699|3673111|FG001|Participants Treated|Overall Study||139
2958753|NCT00738699|3673110|FG000|COMPLETED|Overall Study||0
2958754|NCT00738699|3673111|FG001|COMPLETED|Overall Study||0
2958755|NCT00738699|3673110|FG000|NOT COMPLETED|Overall Study||275
2958756|NCT00738699|3673111|FG001|NOT COMPLETED|Overall Study||140
2958757|NCT00738881|3673119|FG000|STARTED|Overall Study||11
2958758|NCT00738881|3673120|FG001|STARTED|Overall Study||12
2958759|NCT00738881|3673119|FG000|COMPLETED|Overall Study||11
2958760|NCT00738881|3673120|FG001|COMPLETED|Overall Study||10
2958761|NCT00738881|3673119|FG000|NOT COMPLETED|Overall Study||0
2958762|NCT00738881|3673120|FG001|NOT COMPLETED|Overall Study||2
2958763|NCT00738894|3673128|FG000|STARTED|Overall Study||441
2958764|NCT00738894|3673129|FG001|STARTED|Overall Study||223
2958765|NCT00738894|3673128|FG000|COMPLETED|Overall Study||402
2958766|NCT00738894|3673129|FG001|COMPLETED|Overall Study||190
2958767|NCT00738894|3673128|FG000|NOT COMPLETED|Overall Study||39
2958768|NCT00738894|3673129|FG001|NOT COMPLETED|Overall Study||33
2958769|NCT00739102|3673135|FG000|STARTED|Overall Study||250
2958770|NCT00739102|3673135|FG000|COMPLETED|Overall Study|Completed 12-Month Follow-up|235
2958771|NCT00739102|3673135|FG000|NOT COMPLETED|Overall Study||15
2958772|NCT00739297|3673139|FG000|STARTED|First Intervention (Visit 3 to Visit 4)||17
2958773|NCT00739297|3673140|FG001|STARTED|First Intervention (Visit 3 to Visit 4)||11
2958774|NCT00739297|3673141|FG002|STARTED|First Intervention (Visit 3 to Visit 4)||6
2958775|NCT00739297|3673142|FG003|STARTED|First Intervention (Visit 3 to Visit 4)||19
2958776|NCT00739297|3673143|FG004|STARTED|First Intervention (Visit 3 to Visit 4)||6
2958777|NCT00739297|3673144|FG005|STARTED|First Intervention (Visit 3 to Visit 4)||9
2958778|NCT00739297|3673145|FG006|STARTED|First Intervention (Visit 3 to Visit 4)||68
2958779|NCT00739297|3673139|FG000|COMPLETED|First Intervention (Visit 3 to Visit 4)||17
2958780|NCT00739297|3673140|FG001|COMPLETED|First Intervention (Visit 3 to Visit 4)||11
2958781|NCT00739297|3673141|FG002|COMPLETED|First Intervention (Visit 3 to Visit 4)||6
2958782|NCT00739297|3673142|FG003|COMPLETED|First Intervention (Visit 3 to Visit 4)||19
2958783|NCT00739297|3673143|FG004|COMPLETED|First Intervention (Visit 3 to Visit 4)||6
2958784|NCT00739297|3673144|FG005|COMPLETED|First Intervention (Visit 3 to Visit 4)||9
2958785|NCT00739297|3673145|FG006|COMPLETED|First Intervention (Visit 3 to Visit 4)||68
2958786|NCT00739297|3673139|FG000|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
2958787|NCT00739297|3673140|FG001|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
2958788|NCT00739297|3673141|FG002|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
2958789|NCT00739297|3673142|FG003|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
2958790|NCT00739297|3673143|FG004|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
2958791|NCT00739297|3673144|FG005|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
2958792|NCT00739297|3673145|FG006|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
2958793|NCT00739297|3673139|FG000|STARTED|First Washout Period of 4-7 Days||17
2958794|NCT00739297|3673140|FG001|STARTED|First Washout Period of 4-7 Days||11
2958795|NCT00739297|3673141|FG002|STARTED|First Washout Period of 4-7 Days||6
2958796|NCT00739297|3673142|FG003|STARTED|First Washout Period of 4-7 Days||19
2958797|NCT00739297|3673143|FG004|STARTED|First Washout Period of 4-7 Days||6
2958798|NCT00739297|3673144|FG005|STARTED|First Washout Period of 4-7 Days||9
2958799|NCT00739297|3673145|FG006|STARTED|First Washout Period of 4-7 Days||68
3163658|NCT01888497|3891179|FG003|COMPLETED|Second Intervention Period||16
3163659|NCT01888497|3891176|FG000|NOT COMPLETED|Second Intervention Period||0
3163660|NCT01888497|3891177|FG001|NOT COMPLETED|Second Intervention Period||0
3163661|NCT01888497|3891178|FG002|NOT COMPLETED|Second Intervention Period||0
3163662|NCT01888497|3891179|FG003|NOT COMPLETED|Second Intervention Period||0
3163663|NCT01888497|3891176|FG000|STARTED|Washout Period 2||13
3163664|NCT01888497|3891177|FG001|STARTED|Washout Period 2||14
3163665|NCT01888497|3891178|FG002|STARTED|Washout Period 2||14
3163666|NCT01888497|3891179|FG003|STARTED|Washout Period 2||16
3163667|NCT01888497|3891176|FG000|COMPLETED|Washout Period 2||13
3163668|NCT01888497|3891177|FG001|COMPLETED|Washout Period 2||14
3163669|NCT01888497|3891178|FG002|COMPLETED|Washout Period 2||14
3163670|NCT01888497|3891179|FG003|COMPLETED|Washout Period 2||14
3163671|NCT01888497|3891176|FG000|NOT COMPLETED|Washout Period 2||0
3163672|NCT01888497|3891177|FG001|NOT COMPLETED|Washout Period 2||0
3163673|NCT01888497|3891178|FG002|NOT COMPLETED|Washout Period 2||0
3163674|NCT01888497|3891179|FG003|NOT COMPLETED|Washout Period 2||2
3163675|NCT01888497|3891176|FG000|STARTED|Third Intervention Period||13
3163676|NCT01888497|3891177|FG001|STARTED|Third Intervention Period||14
3163677|NCT01888497|3891178|FG002|STARTED|Third Intervention Period||14
2958800|NCT00739297|3673139|FG000|COMPLETED|First Washout Period of 4-7 Days||17
2958801|NCT00739297|3673140|FG001|COMPLETED|First Washout Period of 4-7 Days||11
2958802|NCT00739297|3673141|FG002|COMPLETED|First Washout Period of 4-7 Days||6
3163678|NCT01888497|3891179|FG003|STARTED|Third Intervention Period||14
2958803|NCT00739297|3673142|FG003|COMPLETED|First Washout Period of 4-7 Days||17
2958804|NCT00739297|3673143|FG004|COMPLETED|First Washout Period of 4-7 Days||6
2958805|NCT00739297|3673144|FG005|COMPLETED|First Washout Period of 4-7 Days||9
2958806|NCT00739297|3673145|FG006|COMPLETED|First Washout Period of 4-7 Days||66
2958807|NCT00739297|3673139|FG000|NOT COMPLETED|First Washout Period of 4-7 Days||0
2958808|NCT00739297|3673140|FG001|NOT COMPLETED|First Washout Period of 4-7 Days||0
2958809|NCT00739297|3673141|FG002|NOT COMPLETED|First Washout Period of 4-7 Days||0
2958810|NCT00739297|3673142|FG003|NOT COMPLETED|First Washout Period of 4-7 Days||2
2958811|NCT00739297|3673143|FG004|NOT COMPLETED|First Washout Period of 4-7 Days||0
2958812|NCT00739297|3673144|FG005|NOT COMPLETED|First Washout Period of 4-7 Days||0
2958813|NCT00739297|3673145|FG006|NOT COMPLETED|First Washout Period of 4-7 Days||2
2958814|NCT00739297|3673139|FG000|STARTED|Second Intervention (Visit 5 to Visit 6)||18
2958815|NCT00739297|3673140|FG001|STARTED|Second Intervention (Visit 5 to Visit 6)||8
2958816|NCT00739297|3673141|FG002|STARTED|Second Intervention (Visit 5 to Visit 6)||10
2958817|NCT00739297|3673142|FG003|STARTED|Second Intervention (Visit 5 to Visit 6)||14
2958818|NCT00739297|3673143|FG004|STARTED|Second Intervention (Visit 5 to Visit 6)||6
2958819|NCT00739297|3673144|FG005|STARTED|Second Intervention (Visit 5 to Visit 6)||10
2958820|NCT00739297|3673145|FG006|STARTED|Second Intervention (Visit 5 to Visit 6)||66
2958821|NCT00739297|3673139|FG000|COMPLETED|Second Intervention (Visit 5 to Visit 6)||18
2958822|NCT00739297|3673140|FG001|COMPLETED|Second Intervention (Visit 5 to Visit 6)||8
2958823|NCT00739297|3673141|FG002|COMPLETED|Second Intervention (Visit 5 to Visit 6)||10
2958824|NCT00739297|3673142|FG003|COMPLETED|Second Intervention (Visit 5 to Visit 6)||14
2958825|NCT00739297|3673143|FG004|COMPLETED|Second Intervention (Visit 5 to Visit 6)||6
2958826|NCT00739297|3673144|FG005|COMPLETED|Second Intervention (Visit 5 to Visit 6)||10
2958827|NCT00739297|3673145|FG006|COMPLETED|Second Intervention (Visit 5 to Visit 6)||66
2958828|NCT00739297|3673139|FG000|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
2958829|NCT00739297|3673140|FG001|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
2958830|NCT00739297|3673141|FG002|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
2958831|NCT00739297|3673142|FG003|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
2958832|NCT00739297|3673143|FG004|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
2958833|NCT00739297|3673144|FG005|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
2958834|NCT00739297|3673145|FG006|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
2958835|NCT00739297|3673139|FG000|STARTED|Second Washout Period of 4-7 Days||18
2958836|NCT00739297|3673140|FG001|STARTED|Second Washout Period of 4-7 Days||8
2958837|NCT00739297|3673141|FG002|STARTED|Second Washout Period of 4-7 Days||10
2958838|NCT00739297|3673142|FG003|STARTED|Second Washout Period of 4-7 Days||14
2958839|NCT00739297|3673143|FG004|STARTED|Second Washout Period of 4-7 Days||6
2958840|NCT00739297|3673144|FG005|STARTED|Second Washout Period of 4-7 Days||10
2958841|NCT00739297|3673145|FG006|STARTED|Second Washout Period of 4-7 Days||66
2958842|NCT00739297|3673139|FG000|COMPLETED|Second Washout Period of 4-7 Days||18
2958843|NCT00739297|3673140|FG001|COMPLETED|Second Washout Period of 4-7 Days||8
2958844|NCT00739297|3673141|FG002|COMPLETED|Second Washout Period of 4-7 Days||10
2958845|NCT00739297|3673142|FG003|COMPLETED|Second Washout Period of 4-7 Days||14
2958846|NCT00739297|3673143|FG004|COMPLETED|Second Washout Period of 4-7 Days||6
2958847|NCT00739297|3673144|FG005|COMPLETED|Second Washout Period of 4-7 Days||10
2958848|NCT00739297|3673145|FG006|COMPLETED|Second Washout Period of 4-7 Days||66
2958849|NCT00739297|3673139|FG000|NOT COMPLETED|Second Washout Period of 4-7 Days||0
2958850|NCT00739297|3673140|FG001|NOT COMPLETED|Second Washout Period of 4-7 Days||0
2958851|NCT00739297|3673141|FG002|NOT COMPLETED|Second Washout Period of 4-7 Days||0
2958852|NCT00739297|3673142|FG003|NOT COMPLETED|Second Washout Period of 4-7 Days||0
2958853|NCT00739297|3673143|FG004|NOT COMPLETED|Second Washout Period of 4-7 Days||0
2958854|NCT00739297|3673144|FG005|NOT COMPLETED|Second Washout Period of 4-7 Days||0
2958855|NCT00739297|3673145|FG006|NOT COMPLETED|Second Washout Period of 4-7 Days||0
2958856|NCT00739297|3673139|FG000|STARTED|Third Intervention (Visit 7 to Visit 8)||16
2958857|NCT00739297|3673140|FG001|STARTED|Third Intervention (Visit 7 to Visit 8)||12
2958858|NCT00739297|3673141|FG002|STARTED|Third Intervention (Visit 7 to Visit 8)||6
2958859|NCT00739297|3673142|FG003|STARTED|Third Intervention (Visit 7 to Visit 8)||18
2958860|NCT00739297|3673143|FG004|STARTED|Third Intervention (Visit 7 to Visit 8)||6
2958861|NCT00739297|3673144|FG005|STARTED|Third Intervention (Visit 7 to Visit 8)||8
2958862|NCT00739297|3673145|FG006|STARTED|Third Intervention (Visit 7 to Visit 8)||66
2958863|NCT00739297|3673139|FG000|COMPLETED|Third Intervention (Visit 7 to Visit 8)||16
2958864|NCT00739297|3673140|FG001|COMPLETED|Third Intervention (Visit 7 to Visit 8)||12
2958865|NCT00739297|3673141|FG002|COMPLETED|Third Intervention (Visit 7 to Visit 8)||6
2958866|NCT00739297|3673142|FG003|COMPLETED|Third Intervention (Visit 7 to Visit 8)||18
2958867|NCT00739297|3673143|FG004|COMPLETED|Third Intervention (Visit 7 to Visit 8)||6
2958868|NCT00739297|3673144|FG005|COMPLETED|Third Intervention (Visit 7 to Visit 8)||8
2958869|NCT00739297|3673145|FG006|COMPLETED|Third Intervention (Visit 7 to Visit 8)||66
2958870|NCT00739297|3673139|FG000|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
2958871|NCT00739297|3673140|FG001|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
2958872|NCT00739297|3673141|FG002|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
2958873|NCT00739297|3673142|FG003|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
2958874|NCT00739297|3673143|FG004|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
2958875|NCT00739297|3673144|FG005|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
2958876|NCT00739297|3673145|FG006|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
2958877|NCT00739297|3673139|FG000|STARTED|Third Washout Period of 4-7 Days||16
2958878|NCT00739297|3673140|FG001|STARTED|Third Washout Period of 4-7 Days||12
2958879|NCT00739297|3673141|FG002|STARTED|Third Washout Period of 4-7 Days||6
2958880|NCT00739297|3673142|FG003|STARTED|Third Washout Period of 4-7 Days||18
2958881|NCT00739297|3673143|FG004|STARTED|Third Washout Period of 4-7 Days||6
2958882|NCT00739297|3673144|FG005|STARTED|Third Washout Period of 4-7 Days||8
2958883|NCT00739297|3673145|FG006|STARTED|Third Washout Period of 4-7 Days||66
2958884|NCT00739297|3673139|FG000|COMPLETED|Third Washout Period of 4-7 Days||16
2958885|NCT00739297|3673140|FG001|COMPLETED|Third Washout Period of 4-7 Days||12
2958886|NCT00739297|3673141|FG002|COMPLETED|Third Washout Period of 4-7 Days||6
2958887|NCT00739297|3673142|FG003|COMPLETED|Third Washout Period of 4-7 Days||18
2958888|NCT00739297|3673143|FG004|COMPLETED|Third Washout Period of 4-7 Days||6
2958889|NCT00739297|3673144|FG005|COMPLETED|Third Washout Period of 4-7 Days||8
2958890|NCT00739297|3673145|FG006|COMPLETED|Third Washout Period of 4-7 Days||66
2958891|NCT00739297|3673139|FG000|NOT COMPLETED|Third Washout Period of 4-7 Days||0
2958892|NCT00739297|3673140|FG001|NOT COMPLETED|Third Washout Period of 4-7 Days||0
2958893|NCT00739297|3673141|FG002|NOT COMPLETED|Third Washout Period of 4-7 Days||0
2958894|NCT00739297|3673142|FG003|NOT COMPLETED|Third Washout Period of 4-7 Days||0
2958895|NCT00739297|3673143|FG004|NOT COMPLETED|Third Washout Period of 4-7 Days||0
2958896|NCT00739297|3673144|FG005|NOT COMPLETED|Third Washout Period of 4-7 Days||0
2958897|NCT00739297|3673145|FG006|NOT COMPLETED|Third Washout Period of 4-7 Days||0
2958898|NCT00739297|3673139|FG000|STARTED|Fourth Intervention(Visit 9 to Visit 10)||16
2958899|NCT00739297|3673140|FG001|STARTED|Fourth Intervention(Visit 9 to Visit 10)||11
2958900|NCT00739297|3673141|FG002|STARTED|Fourth Intervention(Visit 9 to Visit 10)||8
2958901|NCT00739297|3673142|FG003|STARTED|Fourth Intervention(Visit 9 to Visit 10)||15
2958902|NCT00739297|3673143|FG004|STARTED|Fourth Intervention(Visit 9 to Visit 10)||7
2958903|NCT00739297|3673144|FG005|STARTED|Fourth Intervention(Visit 9 to Visit 10)||9
2958904|NCT00739297|3673145|FG006|STARTED|Fourth Intervention(Visit 9 to Visit 10)||66
2958905|NCT00739297|3673139|FG000|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||16
2958906|NCT00739297|3673140|FG001|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||11
2958907|NCT00739297|3673141|FG002|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||8
2958908|NCT00739297|3673142|FG003|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||15
2958909|NCT00739297|3673143|FG004|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||7
2958910|NCT00739297|3673144|FG005|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||8
2958911|NCT00739297|3673145|FG006|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||65
2958912|NCT00739297|3673139|FG000|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||0
2958913|NCT00739297|3673140|FG001|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||0
2958914|NCT00739297|3673141|FG002|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||0
2958915|NCT00739297|3673142|FG003|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||0
2958916|NCT00739297|3673143|FG004|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||0
2958917|NCT00739297|3673144|FG005|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||1
2958918|NCT00739297|3673145|FG006|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||1
2958919|NCT00739310|3673161|FG000|STARTED|Overall Study||29
2958920|NCT00739310|3673161|FG000|COMPLETED|Overall Study||22
2958921|NCT00739310|3673161|FG000|NOT COMPLETED|Overall Study||7
2958922|NCT00739336|3673168|FG000|STARTED|Overall Study||21
2958923|NCT00739336|3673169|FG001|STARTED|Overall Study||24
2958924|NCT00739336|3673168|FG000|COMPLETED|Overall Study||17
2958925|NCT00739336|3673169|FG001|COMPLETED|Overall Study||24
2958926|NCT00739336|3673168|FG000|NOT COMPLETED|Overall Study||4
2958927|NCT00739336|3673169|FG001|NOT COMPLETED|Overall Study||0
2958928|NCT00739583|3673177|FG000|STARTED|Overall Study||10
2958929|NCT00739583|3673178|FG001|STARTED|Overall Study||10
2958930|NCT00739583|3673177|FG000|COMPLETED|Overall Study||10
2958931|NCT00739583|3673178|FG001|COMPLETED|Overall Study||10
2958932|NCT00739583|3673177|FG000|NOT COMPLETED|Overall Study||0
2958933|NCT00739583|3673178|FG001|NOT COMPLETED|Overall Study||0
2958934|NCT00739596|3673186|FG000|STARTED|Overall Study||166
2958935|NCT00739596|3673187|FG001|STARTED|Overall Study||166
2958936|NCT00739596|3673186|FG000|COMPLETED|Overall Study||141
2958937|NCT00739596|3673187|FG001|COMPLETED|Overall Study||149
2958938|NCT00739596|3673186|FG000|NOT COMPLETED|Overall Study||25
2958939|NCT00739596|3673187|FG001|NOT COMPLETED|Overall Study||17
2958940|NCT00739648|3673195|FG000|STARTED|Overall Study||108
2958941|NCT00739648|3673196|FG001|STARTED|Overall Study||214
2958942|NCT00739648|3673195|FG000|COMPLETED|Overall Study||82
2958943|NCT00739648|3673196|FG001|COMPLETED|Overall Study||161
3383721|NCT01915498|4118880|FG007|STARTED|Main Analysis (Sept 2013 - Sept 2017)||22
3383722|NCT01915498|4118881|FG008|STARTED|Main Analysis (Sept 2013 - Sept 2017)||6
3383723|NCT01915498|4118882|FG009|STARTED|Main Analysis (Sept 2013 - Sept 2017)||14
3383724|NCT01915498|4118883|FG010|STARTED|Main Analysis (Sept 2013 - Sept 2017)||9
3383725|NCT01915498|4118884|FG011|STARTED|Main Analysis (Sept 2013 - Sept 2017)||5
3383726|NCT01915498|4118885|FG012|STARTED|Main Analysis (Sept 2013 - Sept 2017)||7
3383727|NCT01915498|4118886|FG013|STARTED|Main Analysis (Sept 2013 - Sept 2017)||49
3383728|NCT01915498|4118887|FG014|STARTED|Main Analysis (Sept 2013 - Sept 2017)||25
3383729|NCT01915498|4118888|FG015|STARTED|Main Analysis (Sept 2013 - Sept 2017)||25
3383730|NCT01915498|4118889|FG016|STARTED|Main Analysis (Sept 2013 - Sept 2017)||27
3383731|NCT01915498|4118890|FG017|STARTED|Main Analysis (Sept 2013 - Sept 2017)||106
2958944|NCT00739648|3673195|FG000|NOT COMPLETED|Overall Study||26
2958945|NCT00739648|3673196|FG001|NOT COMPLETED|Overall Study||53
2958946|NCT00739661|3673208|FG000|STARTED|Overall Study||52
2958947|NCT00739661|3673209|FG001|STARTED|Overall Study||52
2958948|NCT00739661|3673208|FG000|COMPLETED|Overall Study||6
2958949|NCT00739661|3673209|FG001|COMPLETED|Overall Study||10
2958950|NCT00739661|3673208|FG000|NOT COMPLETED|Overall Study||46
2958951|NCT00739661|3673209|FG001|NOT COMPLETED|Overall Study||42
2958952|NCT00739752|3673221|FG000|STARTED|Overall Study||299
2958953|NCT00739752|3673222|FG001|STARTED|Overall Study||284
2958954|NCT00739752|3673223|FG002|STARTED|Overall Study||292
2958955|NCT00739752|3673224|FG003|STARTED|Overall Study||288
2958956|NCT00739752|3673225|FG004|STARTED|Overall Study||291
2958957|NCT00739752|3673226|FG005|STARTED|Overall Study||293
2958958|NCT00739752|3673221|FG000|COMPLETED|Overall Study||299
2958959|NCT00739752|3673222|FG001|COMPLETED|Overall Study||284
2958960|NCT00739752|3673223|FG002|COMPLETED|Overall Study||292
2958961|NCT00739752|3673224|FG003|COMPLETED|Overall Study||288
2958962|NCT00739752|3673225|FG004|COMPLETED|Overall Study||291
2958963|NCT00739752|3673226|FG005|COMPLETED|Overall Study||293
2958964|NCT00739752|3673221|FG000|NOT COMPLETED|Overall Study||0
2958965|NCT00739752|3673222|FG001|NOT COMPLETED|Overall Study||0
2958966|NCT00739752|3673223|FG002|NOT COMPLETED|Overall Study||0
2958967|NCT00739752|3673224|FG003|NOT COMPLETED|Overall Study||0
2958968|NCT00739752|3673225|FG004|NOT COMPLETED|Overall Study||0
2958969|NCT00739752|3673226|FG005|NOT COMPLETED|Overall Study||0
2958970|NCT00739765|3673243|FG000|STARTED|Overall Study||40
2958971|NCT00739765|3673244|FG001|STARTED|Overall Study||38
2958972|NCT00739765|3673245|FG002|STARTED|Overall Study||32
2958973|NCT00739765|3673243|FG000|COMPLETED|Overall Study||34
2958974|NCT00739765|3673244|FG001|COMPLETED|Overall Study||27
2958975|NCT00739765|3673245|FG002|COMPLETED|Overall Study||21
2958976|NCT00739765|3673243|FG000|NOT COMPLETED|Overall Study||6
2958977|NCT00739765|3673244|FG001|NOT COMPLETED|Overall Study||11
2958978|NCT00739765|3673245|FG002|NOT COMPLETED|Overall Study||11
2958979|NCT00739908|3673255|FG000|STARTED|Overall Study||142
2958980|NCT00739908|3673256|FG001|STARTED|Overall Study||143
2958981|NCT00739908|3673255|FG000|COMPLETED|Overall Study||117
2958982|NCT00739908|3673256|FG001|COMPLETED|Overall Study||118
2958983|NCT00739908|3673255|FG000|NOT COMPLETED|Overall Study||25
2958984|NCT00739908|3673256|FG001|NOT COMPLETED|Overall Study||25
2958985|NCT00739934|3673264|FG000|STARTED|Voriconazole IV||40
2958986|NCT00739934|3673264|FG000|COMPLETED|Voriconazole IV||34
2958987|NCT00739934|3673264|FG000|NOT COMPLETED|Voriconazole IV||6
2958988|NCT00739934|3673264|FG000|STARTED|Voriconazole Oral||34
2958989|NCT00739934|3673264|FG000|COMPLETED|Voriconazole Oral||31
2958990|NCT00739934|3673264|FG000|NOT COMPLETED|Voriconazole Oral||3
2958991|NCT00739960|3673273|FG000|STARTED|Overall Study||1
2958992|NCT00739960|3673273|FG000|COMPLETED|Overall Study||1
2958993|NCT00739960|3673273|FG000|NOT COMPLETED|Overall Study||0
2958994|NCT00739973|3673286|FG000|STARTED|Single-blind Period (2 to 4 Weeks)|In this period, participants were enrolled to only Placebo arm.|2694
2958995|NCT00739973|3673287|FG001|STARTED|Single-blind Period (2 to 4 Weeks)||0
2958996|NCT00739973|3673288|FG002|STARTED|Single-blind Period (2 to 4 Weeks)||0
2958997|NCT00739973|3673289|FG003|STARTED|Single-blind Period (2 to 4 Weeks)||0
2958998|NCT00739973|3673290|FG004|STARTED|Single-blind Period (2 to 4 Weeks)||0
2958999|NCT00739973|3673291|FG005|STARTED|Single-blind Period (2 to 4 Weeks)||0
2959000|NCT00739973|3673292|FG006|STARTED|Single-blind Period (2 to 4 Weeks)||0
2959001|NCT00739973|3673293|FG007|STARTED|Single-blind Period (2 to 4 Weeks)||0
2959002|NCT00739973|3673294|FG008|STARTED|Single-blind Period (2 to 4 Weeks)||0
2959003|NCT00739973|3673286|FG000|COMPLETED|Single-blind Period (2 to 4 Weeks)||1685
2959004|NCT00739973|3673287|FG001|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
2959005|NCT00739973|3673288|FG002|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
2959006|NCT00739973|3673289|FG003|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
2959007|NCT00739973|3673290|FG004|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
2959008|NCT00739973|3673291|FG005|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
2959009|NCT00739973|3673292|FG006|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
2959010|NCT00739973|3673293|FG007|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
2959011|NCT00739973|3673294|FG008|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
2959012|NCT00739973|3673286|FG000|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||1009
2959013|NCT00739973|3673287|FG001|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
2959014|NCT00739973|3673288|FG002|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
2959015|NCT00739973|3673289|FG003|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
2959016|NCT00739973|3673290|FG004|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
2959017|NCT00739973|3673291|FG005|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
2959018|NCT00739973|3673292|FG006|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
2959019|NCT00739973|3673293|FG007|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
2959020|NCT00739973|3673294|FG008|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
2959021|NCT00739973|3673286|FG000|STARTED|Double-blind:Randomized Period (8 Weeks)||198
2959022|NCT00739973|3673287|FG001|STARTED|Double-blind:Randomized Period (8 Weeks)|One pt. was mis-randomized, so discontinued from single-blind and was untreated in the double-blind.|195
2959023|NCT00739973|3673288|FG002|STARTED|Double-blind:Randomized Period (8 Weeks)||203
2959024|NCT00739973|3673289|FG003|STARTED|Double-blind:Randomized Period (8 Weeks)||185
2959025|NCT00739973|3673290|FG004|STARTED|Double-blind:Randomized Period (8 Weeks)||181
2959026|NCT00739973|3673291|FG005|STARTED|Double-blind:Randomized Period (8 Weeks)||181
2959027|NCT00739973|3673292|FG006|STARTED|Double-blind:Randomized Period (8 Weeks)|2 pts. were mis-randomized, so discontinued from single-blind and were untreated in double-blind.|183
2959028|NCT00739973|3673293|FG007|STARTED|Double-blind:Randomized Period (8 Weeks)||178
2959029|NCT00739973|3673294|FG008|STARTED|Double-blind:Randomized Period (8 Weeks)||184
2959030|NCT00739973|3673286|FG000|COMPLETED|Double-blind:Randomized Period (8 Weeks)||168
2959031|NCT00739973|3673287|FG001|COMPLETED|Double-blind:Randomized Period (8 Weeks)||175
2959032|NCT00739973|3673288|FG002|COMPLETED|Double-blind:Randomized Period (8 Weeks)||184
2959033|NCT00739973|3673289|FG003|COMPLETED|Double-blind:Randomized Period (8 Weeks)||173
2959034|NCT00739973|3673290|FG004|COMPLETED|Double-blind:Randomized Period (8 Weeks)||162
2959035|NCT00739973|3673291|FG005|COMPLETED|Double-blind:Randomized Period (8 Weeks)||169
2959036|NCT00739973|3673292|FG006|COMPLETED|Double-blind:Randomized Period (8 Weeks)||170
2959037|NCT00739973|3673293|FG007|COMPLETED|Double-blind:Randomized Period (8 Weeks)||168
2959038|NCT00739973|3673294|FG008|COMPLETED|Double-blind:Randomized Period (8 Weeks)||170
2959039|NCT00739973|3673286|FG000|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||30
2959040|NCT00739973|3673287|FG001|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||20
2959041|NCT00739973|3673288|FG002|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||19
2959042|NCT00739973|3673289|FG003|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||12
2959043|NCT00739973|3673290|FG004|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||19
2959044|NCT00739973|3673291|FG005|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||12
2959045|NCT00739973|3673292|FG006|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||13
2959046|NCT00739973|3673293|FG007|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||10
2959047|NCT00739973|3673294|FG008|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||14
2959048|NCT00739999|3673324|FG000|STARTED|Overall Study||15
2959049|NCT00739999|3673325|FG001|STARTED|Overall Study||24
2959050|NCT00739999|3673324|FG000|COMPLETED|Overall Study||15
2959051|NCT00739999|3673325|FG001|COMPLETED|Overall Study||24
2959052|NCT00739999|3673324|FG000|NOT COMPLETED|Overall Study||0
2959053|NCT00739999|3673325|FG001|NOT COMPLETED|Overall Study||0
2959054|NCT00740051|3673338|FG000|STARTED|Overall Study||76
2959055|NCT00740051|3673339|FG001|STARTED|Overall Study||151
2959056|NCT00740051|3673338|FG000|COMPLETED|Overall Study||58
2959057|NCT00740051|3673339|FG001|COMPLETED|Overall Study||119
2959058|NCT00740051|3673338|FG000|NOT COMPLETED|Overall Study||18
2959059|NCT00740051|3673339|FG001|NOT COMPLETED|Overall Study||32
2959060|NCT00740129|3673346|FG000|STARTED|Overall Study||6
3300478|NCT02946073|4034360|FG002|COMPLETED|Titration Phase||75
3300479|NCT02946073|4034361|FG003|COMPLETED|Titration Phase||0
3300480|NCT02946073|4034358|FG000|NOT COMPLETED|Titration Phase||589
3300481|NCT02946073|4034359|FG001|NOT COMPLETED|Titration Phase||0
3300482|NCT02946073|4034360|FG002|NOT COMPLETED|Titration Phase||23
3300483|NCT02946073|4034361|FG003|NOT COMPLETED|Titration Phase||0
3300484|NCT02946073|4034358|FG000|STARTED|Double Blind Phase||112
3300485|NCT02946073|4034359|FG001|STARTED|Double Blind Phase||110
3300486|NCT02946073|4034360|FG002|STARTED|Double Blind Phase||0
3300487|NCT02946073|4034361|FG003|STARTED|Double Blind Phase||0
2959061|NCT00740129|3673346|FG000|COMPLETED|Overall Study||6
2959062|NCT00740129|3673346|FG000|NOT COMPLETED|Overall Study||0
2959063|NCT00740207|3673353|FG000|STARTED|Overall Study||17
2959064|NCT00740207|3673354|FG001|STARTED|Overall Study||16
2959065|NCT00740207|3673353|FG000|COMPLETED|Overall Study||17
2959066|NCT00740207|3673354|FG001|COMPLETED|Overall Study||16
2959067|NCT00740207|3673353|FG000|NOT COMPLETED|Overall Study||0
2959068|NCT00740207|3673354|FG001|NOT COMPLETED|Overall Study||0
2959069|NCT00740220|3673364|FG000|STARTED|Overall Study||97
2959070|NCT00740220|3673364|FG000|COMPLETED|Overall Study||88
2959071|NCT00740220|3673364|FG000|NOT COMPLETED|Overall Study||9
2959072|NCT00740376|3673370|FG000|STARTED|Overall Study||22
2959073|NCT00740376|3673371|FG001|STARTED|Overall Study||15
2959074|NCT00740376|3673370|FG000|COMPLETED|Overall Study||19
2959075|NCT00740376|3673371|FG001|COMPLETED|Overall Study||12
2959076|NCT00740376|3673370|FG000|NOT COMPLETED|Overall Study||3
2959077|NCT00740376|3673371|FG001|NOT COMPLETED|Overall Study||3
2959078|NCT00740584|3673377|FG000|STARTED|Overall Study||12
2959079|NCT00740584|3673377|FG000|COMPLETED|Overall Study||11
2959080|NCT00740584|3673377|FG000|NOT COMPLETED|Overall Study||1
2959081|NCT00740636|3673384|FG000|STARTED|Overall Study||25
2959082|NCT00740636|3673385|FG001|STARTED|Overall Study||67
2959083|NCT00740636|3673384|FG000|COMPLETED|Overall Study||23
2959084|NCT00740636|3673385|FG001|COMPLETED|Overall Study||63
2959085|NCT00740636|3673384|FG000|NOT COMPLETED|Overall Study||2
2959086|NCT00740636|3673385|FG001|NOT COMPLETED|Overall Study||4
2959087|NCT00740714|3673394|FG000|STARTED|Overall Study|Randomized throughout the recruitment period|196
2959088|NCT00740714|3673395|FG001|STARTED|Overall Study|Randomized throughout the recruitment period|201
2959089|NCT00740714|3673396|FG002|STARTED|Overall Study|Randomized throughout the recruitment period|203
2959090|NCT00740714|3673394|FG000|Reaching Endpoint Before May 6, 2011|Overall Study||86
2959091|NCT00740714|3673395|FG001|Reaching Endpoint Before May 6, 2011|Overall Study||87
2959092|NCT00740714|3673396|FG002|Reaching Endpoint Before May 6, 2011|Overall Study||94
2959093|NCT00740714|3673394|FG000|Active Patients at Study Termination|Overall Study||24
2959094|NCT00740714|3673395|FG001|Active Patients at Study Termination|Overall Study||12
2959095|NCT00740714|3673396|FG002|Active Patients at Study Termination|Overall Study||33
3300488|NCT02946073|4034358|FG000|COMPLETED|Double Blind Phase||88
3300489|NCT02946073|4034359|FG001|COMPLETED|Double Blind Phase||70
2959096|NCT00740714|3673394|FG000|COMPLETED|Overall Study||179
2959097|NCT00740714|3673395|FG001|COMPLETED|Overall Study||182
2959098|NCT00740714|3673396|FG002|COMPLETED|Overall Study||174
2959099|NCT00740714|3673394|FG000|NOT COMPLETED|Overall Study||17
2959100|NCT00740714|3673395|FG001|NOT COMPLETED|Overall Study||19
2959101|NCT00740714|3673396|FG002|NOT COMPLETED|Overall Study||29
2959102|NCT00740779|3673407|FG000|STARTED|Overall Study||52
2959103|NCT00740779|3673408|FG001|STARTED|Overall Study||45
2959104|NCT00740779|3673409|FG002|STARTED|Overall Study||54
2959105|NCT00740779|3673407|FG000|COMPLETED|Overall Study||43
2959106|NCT00740779|3673408|FG001|COMPLETED|Overall Study||31
2959107|NCT00740779|3673409|FG002|COMPLETED|Overall Study||41
2959108|NCT00740779|3673407|FG000|NOT COMPLETED|Overall Study||9
2959109|NCT00740779|3673408|FG001|NOT COMPLETED|Overall Study||14
2959110|NCT00740779|3673409|FG002|NOT COMPLETED|Overall Study||13
2959111|NCT00740792|3673421|FG000|STARTED|Overall Study||193
2959112|NCT00740792|3673422|FG001|STARTED|Overall Study||194
2959113|NCT00740792|3673423|FG002|STARTED|Overall Study||189
2959114|NCT00740792|3673424|FG003|STARTED|Overall Study||200
2959115|NCT00740792|3673421|FG000|COMPLETED|Overall Study||183
2959116|NCT00740792|3673422|FG001|COMPLETED|Overall Study||186
2959117|NCT00740792|3673423|FG002|COMPLETED|Overall Study||180
2959118|NCT00740792|3673424|FG003|COMPLETED|Overall Study||190
2959119|NCT00740792|3673421|FG000|NOT COMPLETED|Overall Study||10
2959120|NCT00740792|3673422|FG001|NOT COMPLETED|Overall Study||8
2959121|NCT00740792|3673423|FG002|NOT COMPLETED|Overall Study||9
2959122|NCT00740792|3673424|FG003|NOT COMPLETED|Overall Study||10
2959123|NCT00740831|3673437|FG000|STARTED|Overall Study|Safety population|97
2959124|NCT00740831|3673438|FG001|STARTED|Overall Study|Safety population|103
2959125|NCT00740831|3673439|FG002|STARTED|Overall Study|Safety population|101
2959126|NCT00740831|3673437|FG000|COMPLETED|Overall Study|Patients who completed part A (visit 6)|93
2959127|NCT00740831|3673438|FG001|COMPLETED|Overall Study|Patients who completed part A (visit 6)|100
2959128|NCT00740831|3673439|FG002|COMPLETED|Overall Study|Patients who completed part A (visit 6)|95
2959129|NCT00740831|3673437|FG000|NOT COMPLETED|Overall Study||4
2959130|NCT00740831|3673438|FG001|NOT COMPLETED|Overall Study||3
2959131|NCT00740831|3673439|FG002|NOT COMPLETED|Overall Study||6
2959132|NCT00740857|3673450|FG000|STARTED|Overall Study||33
2959133|NCT00740857|3673451|FG001|STARTED|Overall Study||88
2959134|NCT00740857|3673452|FG002|STARTED|Overall Study||90
2959135|NCT00740857|3673450|FG000|COMPLETED|Overall Study||32
2959136|NCT00740857|3673451|FG001|COMPLETED|Overall Study||88
2959137|NCT00740857|3673452|FG002|COMPLETED|Overall Study||90
2959138|NCT00740857|3673450|FG000|NOT COMPLETED|Overall Study||1
2959139|NCT00740857|3673451|FG001|NOT COMPLETED|Overall Study||0
2959140|NCT00740857|3673452|FG002|NOT COMPLETED|Overall Study||0
2959141|NCT00740870|3673460|FG000|STARTED|Overall Study||171
2959142|NCT00740870|3673460|FG000|COMPLETED|Overall Study||150
2959143|NCT00740870|3673460|FG000|NOT COMPLETED|Overall Study||21
2959144|NCT00741013|3673470|FG000|STARTED|Overall Study||7
2959145|NCT00741013|3673471|FG001|STARTED|Overall Study||8
2959146|NCT00741013|3673472|FG002|STARTED|Overall Study||7
2959147|NCT00741013|3673470|FG000|COMPLETED|Overall Study||6
2959148|NCT00741013|3673471|FG001|COMPLETED|Overall Study||6
2959149|NCT00741013|3673472|FG002|COMPLETED|Overall Study||6
2959150|NCT00741013|3673470|FG000|NOT COMPLETED|Overall Study||1
2959151|NCT00741013|3673471|FG001|NOT COMPLETED|Overall Study||2
2959152|NCT00741013|3673472|FG002|NOT COMPLETED|Overall Study||1
2959153|NCT00741026|3673480|FG000|STARTED|Overall Study||15
2959154|NCT00741026|3673480|FG000|COMPLETED|Overall Study||15
2959155|NCT00741026|3673480|FG000|NOT COMPLETED|Overall Study||0
2959156|NCT00741039|3673488|FG000|STARTED|Overall Study||102
2959157|NCT00741039|3673489|FG001|STARTED|Overall Study||25
2959158|NCT00741039|3673488|FG000|COMPLETED|Overall Study||100
2959159|NCT00741039|3673489|FG001|COMPLETED|Overall Study||25
2959160|NCT00741039|3673488|FG000|NOT COMPLETED|Overall Study||2
2959161|NCT00741039|3673489|FG001|NOT COMPLETED|Overall Study||0
2959162|NCT00741091|3673495|FG000|STARTED|Overall Study||1097
2959163|NCT00741091|3673495|FG000|COMPLETED|Overall Study||1040
2959164|NCT00741091|3673495|FG000|NOT COMPLETED|Overall Study||57
2959165|NCT00741104|3673499|FG000|STARTED|Overall Study||363
2959166|NCT00741104|3673499|FG000|COMPLETED|Overall Study||363
2959167|NCT00741104|3673499|FG000|NOT COMPLETED|Overall Study||0
2959168|NCT00741156|3673503|FG000|STARTED|Overall Study||12
2959169|NCT00741156|3673503|FG000|COMPLETED|Overall Study||12
2959170|NCT00741156|3673503|FG000|NOT COMPLETED|Overall Study||0
2959171|NCT00741260|3673525|FG000|STARTED|Overall Study||6
2959172|NCT00741260|3673526|FG001|STARTED|Overall Study||8
2959173|NCT00741260|3673527|FG002|STARTED|Overall Study||4
2959174|NCT00741260|3673528|FG003|STARTED|Overall Study||6
2959175|NCT00741260|3673529|FG004|STARTED|Overall Study||9
2959176|NCT00741260|3673530|FG005|STARTED|Overall Study||65
2959177|NCT00741260|3673531|FG006|STARTED|Overall Study||7
2959178|NCT00741260|3673525|FG000|COMPLETED|Overall Study||0
2959179|NCT00741260|3673526|FG001|COMPLETED|Overall Study||0
2959180|NCT00741260|3673527|FG002|COMPLETED|Overall Study||0
2959181|NCT00741260|3673528|FG003|COMPLETED|Overall Study||0
2959182|NCT00741260|3673529|FG004|COMPLETED|Overall Study||0
2959183|NCT00741260|3673530|FG005|COMPLETED|Overall Study||20
2959184|NCT00741260|3673531|FG006|COMPLETED|Overall Study||0
2959185|NCT00741260|3673525|FG000|NOT COMPLETED|Overall Study||6
2959186|NCT00741260|3673526|FG001|NOT COMPLETED|Overall Study||8
2959187|NCT00741260|3673527|FG002|NOT COMPLETED|Overall Study||4
2959188|NCT00741260|3673528|FG003|NOT COMPLETED|Overall Study||6
2959189|NCT00741260|3673529|FG004|NOT COMPLETED|Overall Study||9
2959190|NCT00741260|3673530|FG005|NOT COMPLETED|Overall Study||45
2959191|NCT00741260|3673531|FG006|NOT COMPLETED|Overall Study||7
2959192|NCT00741273|3673554|FG000|STARTED|Overall Study||8
2959193|NCT00741273|3673555|FG001|STARTED|Overall Study||8
2959194|NCT00741273|3673554|FG000|COMPLETED|Overall Study||8
2959195|NCT00741273|3673555|FG001|COMPLETED|Overall Study||8
2959196|NCT00741273|3673554|FG000|NOT COMPLETED|Overall Study||0
2959197|NCT00741273|3673555|FG001|NOT COMPLETED|Overall Study||0
2959198|NCT00741286|3673567|FG000|STARTED|Overall Study||103
2959199|NCT00741286|3673568|FG001|STARTED|Overall Study||100
2959200|NCT00741286|3673567|FG000|COMPLETED|Overall Study||83
2959201|NCT00741286|3673568|FG001|COMPLETED|Overall Study||81
2959202|NCT00741286|3673567|FG000|NOT COMPLETED|Overall Study||20
2959203|NCT00741286|3673568|FG001|NOT COMPLETED|Overall Study||19
2959204|NCT00741338|3673576|FG000|STARTED|Overall Study||3
2959205|NCT00741338|3673577|FG001|STARTED|Overall Study||3
2959206|NCT00741338|3673576|FG000|COMPLETED|Overall Study||3
2959207|NCT00741338|3673577|FG001|COMPLETED|Overall Study||2
2959208|NCT00741338|3673576|FG000|NOT COMPLETED|Overall Study||0
2959209|NCT00741338|3673577|FG001|NOT COMPLETED|Overall Study||1
2959210|NCT00741390|3673583|FG000|STARTED|Visit 1||62
2959211|NCT00741390|3673584|FG001|STARTED|Visit 1||63
2959212|NCT00741390|3673585|FG002|STARTED|Visit 1||62
2959213|NCT00741390|3673586|FG003|STARTED|Visit 1||63
2959214|NCT00741390|3673583|FG000|COMPLETED|Visit 1||60
2959215|NCT00741390|3673584|FG001|COMPLETED|Visit 1||63
2959216|NCT00741390|3673585|FG002|COMPLETED|Visit 1||55
2959217|NCT00741390|3673586|FG003|COMPLETED|Visit 1||62
2959218|NCT00741390|3673583|FG000|NOT COMPLETED|Visit 1||2
2959219|NCT00741390|3673584|FG001|NOT COMPLETED|Visit 1||0
2959220|NCT00741390|3673585|FG002|NOT COMPLETED|Visit 1||7
2959221|NCT00741390|3673586|FG003|NOT COMPLETED|Visit 1||1
2959222|NCT00741390|3673583|FG000|STARTED|Visit 2|1 subject lost to follow-up between Visit 1 and Visit 2.|59
2959223|NCT00741390|3673584|FG001|STARTED|Visit 2|2 subjects lost to follow-up between Visit 1 and Visit 2.|61
2959224|NCT00741390|3673585|FG002|STARTED|Visit 2||55
2959225|NCT00741390|3673586|FG003|STARTED|Visit 2|1 subject lost to follow-up between Visit 1 and Visit 2.|61
2959226|NCT00741390|3673583|FG000|COMPLETED|Visit 2||59
2959227|NCT00741390|3673584|FG001|COMPLETED|Visit 2||61
2959228|NCT00741390|3673585|FG002|COMPLETED|Visit 2||54
2959229|NCT00741390|3673586|FG003|COMPLETED|Visit 2||60
2959230|NCT00741390|3673583|FG000|NOT COMPLETED|Visit 2||0
2959231|NCT00741390|3673584|FG001|NOT COMPLETED|Visit 2||0
2959232|NCT00741390|3673585|FG002|NOT COMPLETED|Visit 2||1
2959233|NCT00741390|3673586|FG003|NOT COMPLETED|Visit 2||1
2959234|NCT00741455|3673605|FG000|STARTED|Overall Study||18
2959235|NCT00741455|3673605|FG000|COMPLETED|Overall Study||17
2959236|NCT00741455|3673605|FG000|NOT COMPLETED|Overall Study||1
2959237|NCT00741468|3673609|FG000|STARTED|Overall Study||18
2959238|NCT00741468|3673609|FG000|COMPLETED|Overall Study||18
2959239|NCT00741468|3673609|FG000|NOT COMPLETED|Overall Study||0
2959240|NCT00741598|3673619|FG000|STARTED|Overall Study||33
2959241|NCT00741598|3673620|FG001|STARTED|Overall Study||39
2959242|NCT00741598|3673619|FG000|COMPLETED|Overall Study||24
3300490|NCT02946073|4034360|FG002|COMPLETED|Double Blind Phase||0
3300491|NCT02946073|4034361|FG003|COMPLETED|Double Blind Phase||0
3300492|NCT02946073|4034358|FG000|NOT COMPLETED|Double Blind Phase||24
2959243|NCT00741598|3673620|FG001|COMPLETED|Overall Study||30
2959244|NCT00741598|3673619|FG000|NOT COMPLETED|Overall Study||9
2959245|NCT00741598|3673620|FG001|NOT COMPLETED|Overall Study||9
2959246|NCT00741611|3673630|FG000|STARTED|Overall Study||4
2959247|NCT00741611|3673631|FG001|STARTED|Overall Study||3
2959248|NCT00741611|3673632|FG002|STARTED|Overall Study||29
2959249|NCT00741611|3673630|FG000|COMPLETED|Overall Study||4
2959250|NCT00741611|3673631|FG001|COMPLETED|Overall Study||1
2959251|NCT00741611|3673632|FG002|COMPLETED|Overall Study||26
2959252|NCT00741611|3673630|FG000|NOT COMPLETED|Overall Study||0
2959253|NCT00741611|3673631|FG001|NOT COMPLETED|Overall Study||2
2959254|NCT00741611|3673632|FG002|NOT COMPLETED|Overall Study||3
2959255|NCT00741819|3673641|FG000|STARTED|Overall Study||73
2959256|NCT00741819|3673641|FG000|COMPLETED|Overall Study||65
2959257|NCT00741819|3673641|FG000|NOT COMPLETED|Overall Study||8
2959258|NCT00741858|3673649|FG000|STARTED|Overall Study||16
2959259|NCT00741858|3673650|FG001|STARTED|Overall Study||18
2959260|NCT00741858|3673649|FG000|COMPLETED|Overall Study||16
2959261|NCT00741858|3673650|FG001|COMPLETED|Overall Study||18
2959262|NCT00741858|3673649|FG000|NOT COMPLETED|Overall Study||0
3300493|NCT02946073|4034359|FG001|NOT COMPLETED|Double Blind Phase||40
3300494|NCT02946073|4034360|FG002|NOT COMPLETED|Double Blind Phase||0
3300495|NCT02946073|4034361|FG003|NOT COMPLETED|Double Blind Phase||0
3300496|NCT02946073|4034358|FG000|STARTED|Open Label Phase||0
3300497|NCT02946073|4034359|FG001|STARTED|Open Label Phase||0
2959263|NCT00741858|3673650|FG001|NOT COMPLETED|Overall Study||0
2959264|NCT00741936|3673658|FG000|STARTED|Overall Study||60
2959265|NCT00741936|3673659|FG001|STARTED|Overall Study||60
2959266|NCT00741936|3673658|FG000|COMPLETED|Overall Study||51
2959267|NCT00741936|3673659|FG001|COMPLETED|Overall Study||52
2959268|NCT00741936|3673658|FG000|NOT COMPLETED|Overall Study||9
2959269|NCT00741936|3673659|FG001|NOT COMPLETED|Overall Study||8
2959270|NCT00742001|3673668|FG000|STARTED|Overall Study||4
2959271|NCT00742001|3673669|FG001|STARTED|Overall Study||4
2959272|NCT00742001|3673670|FG002|STARTED|Overall Study||4
2959273|NCT00742001|3673668|FG000|COMPLETED|Overall Study||4
2959274|NCT00742001|3673669|FG001|COMPLETED|Overall Study||4
2959275|NCT00742001|3673670|FG002|COMPLETED|Overall Study||3
2959276|NCT00742001|3673668|FG000|NOT COMPLETED|Overall Study||0
2959277|NCT00742001|3673669|FG001|NOT COMPLETED|Overall Study||0
2959278|NCT00742001|3673670|FG002|NOT COMPLETED|Overall Study||1
2959279|NCT00742027|3673681|FG000|STARTED|Overall Study||129
2959280|NCT00742027|3673681|FG000|COMPLETED|Overall Study||0
2959281|NCT00742027|3673681|FG000|NOT COMPLETED|Overall Study||129
2959282|NCT00742053|3673685|FG000|STARTED|Overall Study||7
2959283|NCT00742053|3673685|FG000|COMPLETED|Overall Study||7
2959284|NCT00742053|3673685|FG000|NOT COMPLETED|Overall Study||0
2959285|NCT00742079|3673691|FG000|STARTED|Overall Study||11
2959286|NCT00742079|3673692|FG001|STARTED|Overall Study||10
2959287|NCT00742079|3673691|FG000|Baseline/Week 1 (Received Dose 1)|Overall Study||11
2959288|NCT00742079|3673692|FG001|Baseline/Week 1 (Received Dose 1)|Overall Study||9
2959289|NCT00742079|3673691|FG000|Week 2 (Received Dose 2)|Overall Study||11
2959290|NCT00742079|3673692|FG001|Week 2 (Received Dose 2)|Overall Study||9
2959291|NCT00742079|3673691|FG000|COMPLETED|Overall Study||11
2959292|NCT00742079|3673692|FG001|COMPLETED|Overall Study||9
2959293|NCT00742079|3673691|FG000|NOT COMPLETED|Overall Study||0
2959294|NCT00742079|3673692|FG001|NOT COMPLETED|Overall Study||1
2959295|NCT00742170|3673700|FG000|STARTED|Overall Study||26
2959296|NCT00742170|3673701|FG001|STARTED|Overall Study||29
2959297|NCT00742170|3673700|FG000|COMPLETED|Overall Study||24
2959298|NCT00742170|3673701|FG001|COMPLETED|Overall Study||24
2959299|NCT00742170|3673700|FG000|NOT COMPLETED|Overall Study||2
2959300|NCT00742170|3673701|FG001|NOT COMPLETED|Overall Study||5
2959301|NCT00742183|3673709|FG000|STARTED|Overall Study|50 subjects randomised, one of them did not receive any treatment.|49
2959302|NCT00742183|3673710|FG001|STARTED|Overall Study||51
2959303|NCT00742183|3673709|FG000|COMPLETED|Overall Study||40
2959304|NCT00742183|3673710|FG001|COMPLETED|Overall Study||39
2959305|NCT00742183|3673709|FG000|NOT COMPLETED|Overall Study||9
3300498|NCT02946073|4034360|FG002|STARTED|Open Label Phase||75
3300499|NCT02946073|4034361|FG003|STARTED|Open Label Phase||57
3300500|NCT02946073|4034358|FG000|COMPLETED|Open Label Phase||0
3300501|NCT02946073|4034359|FG001|COMPLETED|Open Label Phase||0
3300502|NCT02946073|4034360|FG002|COMPLETED|Open Label Phase||54
3300503|NCT02946073|4034361|FG003|COMPLETED|Open Label Phase||44
3300504|NCT02946073|4034358|FG000|NOT COMPLETED|Open Label Phase||0
3300505|NCT02946073|4034359|FG001|NOT COMPLETED|Open Label Phase||0
3300506|NCT02946073|4034360|FG002|NOT COMPLETED|Open Label Phase||21
3300507|NCT02946073|4034361|FG003|NOT COMPLETED|Open Label Phase||13
3300508|NCT02946229|4034380|FG000|STARTED|Overall Study||142
3300509|NCT02946229|4034380|FG000|COMPLETED|Overall Study||142
2959306|NCT00742183|3673710|FG001|NOT COMPLETED|Overall Study||12
2959307|NCT00742209|3673721|FG000|STARTED|Overall Study||129
2959308|NCT00742209|3673722|FG001|STARTED|Overall Study||67
2959309|NCT00742209|3673723|FG002|STARTED|Overall Study||134
2959310|NCT00742209|3673724|FG003|STARTED|Overall Study||134
2959311|NCT00742209|3673725|FG004|STARTED|Overall Study||62
2959312|NCT00742209|3673721|FG000|COMPLETED|Overall Study||95
2959313|NCT00742209|3673722|FG001|COMPLETED|Overall Study||49
2959314|NCT00742209|3673723|FG002|COMPLETED|Overall Study||88
2959315|NCT00742209|3673724|FG003|COMPLETED|Overall Study||97
2959316|NCT00742209|3673725|FG004|COMPLETED|Overall Study||37
2959317|NCT00742209|3673721|FG000|NOT COMPLETED|Overall Study||34
2959318|NCT00742209|3673722|FG001|NOT COMPLETED|Overall Study||18
2959319|NCT00742209|3673723|FG002|NOT COMPLETED|Overall Study||46
2959320|NCT00742209|3673724|FG003|NOT COMPLETED|Overall Study||37
2959321|NCT00742209|3673725|FG004|NOT COMPLETED|Overall Study||25
2959322|NCT00742235|3673740|FG000|STARTED|Overall Study||32
2959323|NCT00742235|3673741|FG001|STARTED|Overall Study||67
2959324|NCT00742235|3673740|FG000|COMPLETED|Overall Study||32
2959325|NCT00742235|3673741|FG001|COMPLETED|Overall Study||36
3300510|NCT02946229|4034380|FG000|NOT COMPLETED|Overall Study||0
3300511|NCT02946385|4034390|FG000|STARTED|Overall Study||126
3300512|NCT02946385|4034391|FG001|STARTED|Overall Study||127
3300513|NCT02946385|4034392|FG002|STARTED|Overall Study||99
3300514|NCT02946385|4034393|FG003|STARTED|Overall Study||74
3300515|NCT02946385|4034394|FG004|STARTED|Overall Study||101
3300516|NCT02946385|4034395|FG005|STARTED|Overall Study||77
3300517|NCT02946385|4034390|FG000|COMPLETED|Overall Study||126
3300518|NCT02946385|4034391|FG001|COMPLETED|Overall Study||127
3300519|NCT02946385|4034392|FG002|COMPLETED|Overall Study||96
3300520|NCT02946385|4034393|FG003|COMPLETED|Overall Study||74
3300521|NCT02946385|4034394|FG004|COMPLETED|Overall Study||99
3300522|NCT02946385|4034395|FG005|COMPLETED|Overall Study||76
3300523|NCT02946385|4034390|FG000|NOT COMPLETED|Overall Study||0
3300524|NCT02946385|4034391|FG001|NOT COMPLETED|Overall Study||0
3300525|NCT02946385|4034392|FG002|NOT COMPLETED|Overall Study||3
3300526|NCT02946385|4034393|FG003|NOT COMPLETED|Overall Study||0
3300527|NCT02946385|4034394|FG004|NOT COMPLETED|Overall Study||2
3300528|NCT02946385|4034395|FG005|NOT COMPLETED|Overall Study||1
3316991|NCT03122587|4050478|FG001|STARTED|Overall Study||12
2959326|NCT00742235|3673740|FG000|NOT COMPLETED|Overall Study||0
3316992|NCT03122587|4050479|FG002|STARTED|Overall Study||13
3316993|NCT03122587|4050477|FG000|COMPLETED|Overall Study||11
3316994|NCT03122587|4050478|FG001|COMPLETED|Overall Study||10
3316995|NCT03122587|4050479|FG002|COMPLETED|Overall Study||12
3316996|NCT03122587|4050477|FG000|NOT COMPLETED|Overall Study||2
3316997|NCT03122587|4050478|FG001|NOT COMPLETED|Overall Study||2
2959327|NCT00742235|3673741|FG001|NOT COMPLETED|Overall Study||31
2959328|NCT00742274|3673749|FG000|STARTED|Overall Study||30
2959329|NCT00742274|3673750|FG001|STARTED|Overall Study||31
2959330|NCT00742274|3673749|FG000|COMPLETED|Overall Study||27
2959331|NCT00742274|3673750|FG001|COMPLETED|Overall Study||28
2959332|NCT00742274|3673749|FG000|NOT COMPLETED|Overall Study||3
2959333|NCT00742274|3673750|FG001|NOT COMPLETED|Overall Study||3
2959334|NCT00742313|3673758|FG000|STARTED|Overall Study||25
2959335|NCT00742313|3673759|FG001|STARTED|Overall Study||19
2959336|NCT00742313|3673758|FG000|COMPLETED|Overall Study||24
2959337|NCT00742313|3673759|FG001|COMPLETED|Overall Study||19
2959338|NCT00742313|3673758|FG000|NOT COMPLETED|Overall Study||1
2959339|NCT00742313|3673759|FG001|NOT COMPLETED|Overall Study||0
2959340|NCT00742326|3673767|FG000|STARTED|Overall Study||6
2959341|NCT00742326|3673768|FG001|STARTED|Overall Study||7
2959342|NCT00742326|3673767|FG000|COMPLETED|Overall Study||6
2959343|NCT00742326|3673768|FG001|COMPLETED|Overall Study||6
2959344|NCT00742326|3673767|FG000|NOT COMPLETED|Overall Study||0
2959345|NCT00742326|3673768|FG001|NOT COMPLETED|Overall Study||1
2959346|NCT00742391|3673776|FG000|STARTED|Overall Study||126
2959347|NCT00742391|3673777|FG001|STARTED|Overall Study||129
2959348|NCT00742391|3673776|FG000|COMPLETED|Overall Study||122
2959349|NCT00742391|3673777|FG001|COMPLETED|Overall Study||128
2959350|NCT00742391|3673776|FG000|NOT COMPLETED|Overall Study||4
2959351|NCT00742391|3673777|FG001|NOT COMPLETED|Overall Study||1
2959352|NCT00742417|3673785|FG000|STARTED|Randomized||21
2959353|NCT00742417|3673786|FG001|STARTED|Randomized||21
2959354|NCT00742417|3673785|FG000|COMPLETED|Randomized||19
2959355|NCT00742417|3673786|FG001|COMPLETED|Randomized||20
2959356|NCT00742417|3673785|FG000|NOT COMPLETED|Randomized||2
2959357|NCT00742417|3673786|FG001|NOT COMPLETED|Randomized||1
2959358|NCT00742417|3673785|FG000|STARTED|Intensive Period||19
2959359|NCT00742417|3673786|FG001|STARTED|Intensive Period||20
2959360|NCT00742417|3673785|FG000|COMPLETED|Intensive Period|16 patients completed all the 6 plasma exchange with Albutein 5% during the Intensive Period|16
2959361|NCT00742417|3673786|FG001|COMPLETED|Intensive Period|19 control patients completed all the 6 plasma exchange during the Intensive Period|19
2959362|NCT00742417|3673785|FG000|NOT COMPLETED|Intensive Period||3
2959363|NCT00742417|3673786|FG001|NOT COMPLETED|Intensive Period||1
2959364|NCT00742417|3673785|FG000|STARTED|Maintenance I||16
2959365|NCT00742417|3673786|FG001|STARTED|Maintenance I||19
2959366|NCT00742417|3673785|FG000|COMPLETED|Maintenance I||16
2959367|NCT00742417|3673786|FG001|COMPLETED|Maintenance I||19
2959368|NCT00742417|3673785|FG000|NOT COMPLETED|Maintenance I||0
2959369|NCT00742417|3673786|FG001|NOT COMPLETED|Maintenance I||0
2959370|NCT00742417|3673785|FG000|STARTED|Maintenance II||16
2959371|NCT00742417|3673786|FG001|STARTED|Maintenance II||19
2959372|NCT00742417|3673785|FG000|COMPLETED|Maintenance II||16
2959373|NCT00742417|3673786|FG001|COMPLETED|Maintenance II||19
2959374|NCT00742417|3673785|FG000|NOT COMPLETED|Maintenance II||0
2959375|NCT00742417|3673786|FG001|NOT COMPLETED|Maintenance II||0
2959376|NCT00742469|3673796|FG000|STARTED|Overall Study||106
2959377|NCT00742469|3673797|FG001|STARTED|Overall Study||104
2959378|NCT00742469|3673796|FG000|COMPLETED|Overall Study||88
2959379|NCT00742469|3673797|FG001|COMPLETED|Overall Study||69
2959380|NCT00742469|3673796|FG000|NOT COMPLETED|Overall Study||18
2959381|NCT00742469|3673797|FG001|NOT COMPLETED|Overall Study||35
2959382|NCT00742508|3673805|FG000|STARTED|8-Week Primary Evaluation Period||22
2959383|NCT00742508|3673806|FG001|STARTED|8-Week Primary Evaluation Period||19
2959384|NCT00742508|3673805|FG000|COMPLETED|8-Week Primary Evaluation Period||11
2959385|NCT00742508|3673806|FG001|COMPLETED|8-Week Primary Evaluation Period||8
2959386|NCT00742508|3673805|FG000|NOT COMPLETED|8-Week Primary Evaluation Period||11
2959387|NCT00742508|3673806|FG001|NOT COMPLETED|8-Week Primary Evaluation Period||11
2959388|NCT00742508|3673805|FG000|STARTED|4-Week Exploratory Evaluation Period||0
2959389|NCT00742508|3673806|FG001|STARTED|4-Week Exploratory Evaluation Period||8
2959390|NCT00742508|3673805|FG000|COMPLETED|4-Week Exploratory Evaluation Period||0
2959391|NCT00742508|3673806|FG001|COMPLETED|4-Week Exploratory Evaluation Period||7
2959392|NCT00742508|3673805|FG000|NOT COMPLETED|4-Week Exploratory Evaluation Period||0
2959393|NCT00742508|3673806|FG001|NOT COMPLETED|4-Week Exploratory Evaluation Period||1
2959394|NCT00742560|3673817|FG000|STARTED|Overall Study||3
2959395|NCT00742560|3673818|FG001|STARTED|Overall Study||3
2959396|NCT00742560|3673819|FG002|STARTED|Overall Study||22
2959397|NCT00742560|3673820|FG003|STARTED|Overall Study||36
2959398|NCT00742560|3673821|FG004|STARTED|Overall Study||37
2959399|NCT00742560|3673817|FG000|COMPLETED|Overall Study||0
2959400|NCT00742560|3673818|FG001|COMPLETED|Overall Study||0
2959401|NCT00742560|3673819|FG002|COMPLETED|Overall Study||0
2959402|NCT00742560|3673820|FG003|COMPLETED|Overall Study||0
2959403|NCT00742560|3673821|FG004|COMPLETED|Overall Study||0
2959404|NCT00742560|3673817|FG000|NOT COMPLETED|Overall Study||3
2959405|NCT00742560|3673818|FG001|NOT COMPLETED|Overall Study||3
2959406|NCT00742560|3673819|FG002|NOT COMPLETED|Overall Study||22
2959407|NCT00742560|3673820|FG003|NOT COMPLETED|Overall Study||36
2959408|NCT00742560|3673821|FG004|NOT COMPLETED|Overall Study||37
2959409|NCT00742573|3673854|FG000|STARTED|Overall Study||83
2959410|NCT00742573|3673855|FG001|STARTED|Overall Study||87
2959411|NCT00742573|3673854|FG000|Week 12|Overall Study||46
2959412|NCT00742573|3673855|FG001|Week 12|Overall Study||51
2959413|NCT00742573|3673854|FG000|Week 24|Overall Study||39
2959414|NCT00742573|3673855|FG001|Week 24|Overall Study||37
2959415|NCT00742573|3673854|FG000|Week 52|Overall Study||26
2959416|NCT00742573|3673855|FG001|Week 52|Overall Study||25
2959417|NCT00742573|3673854|FG000|COMPLETED|Overall Study||26
2959418|NCT00742573|3673855|FG001|COMPLETED|Overall Study||25
2959419|NCT00742573|3673854|FG000|NOT COMPLETED|Overall Study||57
2959420|NCT00742573|3673855|FG001|NOT COMPLETED|Overall Study||62
2959421|NCT00742625|3673861|FG000|STARTED|Remission Induction||95
2959422|NCT00742625|3673861|FG000|COMPLETED|Remission Induction||41
2959423|NCT00742625|3673861|FG000|NOT COMPLETED|Remission Induction||54
2959424|NCT00742625|3673861|FG000|STARTED|Consolidation||41
2959425|NCT00742625|3673861|FG000|COMPLETED|Consolidation||20
2959426|NCT00742625|3673861|FG000|NOT COMPLETED|Consolidation||21
2959427|NCT00742781|3673868|FG000|STARTED|Overall Study||21
2959428|NCT00742781|3673868|FG000|COMPLETED|Overall Study||18
2959429|NCT00742781|3673868|FG000|NOT COMPLETED|Overall Study||3
2959430|NCT00742859|3673877|FG000|STARTED|Overall Study||127
2959431|NCT00742859|3673878|FG001|STARTED|Overall Study||127
3132753|NCT01693068|3857941|FG001|STARTED|Randomization Period||130
3132754|NCT01693068|3857942|FG002|STARTED|Randomization Period||0
3132755|NCT01693068|3857940|FG000|Treated|Randomization Period||61
3132756|NCT01693068|3857941|FG001|Treated|Randomization Period||130
2959432|NCT00742859|3673879|FG002|STARTED|Overall Study||127
2959433|NCT00742859|3673880|FG003|STARTED|Overall Study||127
2959434|NCT00742859|3673877|FG000|COMPLETED|Overall Study||116
2959435|NCT00742859|3673878|FG001|COMPLETED|Overall Study||115
2959436|NCT00742859|3673879|FG002|COMPLETED|Overall Study||116
2959437|NCT00742859|3673880|FG003|COMPLETED|Overall Study||119
2959438|NCT00742859|3673877|FG000|NOT COMPLETED|Overall Study||11
2959439|NCT00742859|3673878|FG001|NOT COMPLETED|Overall Study||12
2959440|NCT00742859|3673879|FG002|NOT COMPLETED|Overall Study||11
2959441|NCT00742859|3673880|FG003|NOT COMPLETED|Overall Study||8
2959442|NCT00742872|3673892|FG000|STARTED|Overall Study||21
2959443|NCT00742872|3673893|FG001|STARTED|Overall Study||20
2959444|NCT00742872|3673892|FG000|COMPLETED|Overall Study||9
2959445|NCT00742872|3673893|FG001|COMPLETED|Overall Study||12
2959446|NCT00742872|3673892|FG000|NOT COMPLETED|Overall Study||12
2959447|NCT00742872|3673893|FG001|NOT COMPLETED|Overall Study||8
2959448|NCT00742885|3673901|FG000|STARTED|Overall Study||50
2959449|NCT00742885|3673902|FG001|STARTED|Overall Study||50
2959450|NCT00742885|3673901|FG000|COMPLETED|Overall Study|to Day 182|49
2959451|NCT00742885|3673902|FG001|COMPLETED|Overall Study|to Day 182|50
2959452|NCT00742885|3673901|FG000|NOT COMPLETED|Overall Study||1
2959453|NCT00742885|3673902|FG001|NOT COMPLETED|Overall Study||0
2959454|NCT00742924|3673915|FG000|STARTED|Overall Study||6
2959455|NCT00742924|3673916|FG001|STARTED|Overall Study||6
2959456|NCT00742924|3673917|FG002|STARTED|Overall Study||6
2959457|NCT00742924|3673918|FG003|STARTED|Overall Study||6
2959458|NCT00742924|3673915|FG000|COMPLETED|Overall Study||1
3300529|NCT02946463|4034417|FG000|STARTED|Primary Evaluation Period||125
3300530|NCT02946463|4034418|FG001|STARTED|Primary Evaluation Period||121
3300531|NCT02946463|4034417|FG000|Received at Least 1 Dose of Study Drug|Primary Evaluation Period||125
2959459|NCT00742924|3673916|FG001|COMPLETED|Overall Study||4
2959460|NCT00742924|3673917|FG002|COMPLETED|Overall Study||2
2959461|NCT00742924|3673918|FG003|COMPLETED|Overall Study||0
2959462|NCT00742924|3673915|FG000|NOT COMPLETED|Overall Study||5
2959463|NCT00742924|3673916|FG001|NOT COMPLETED|Overall Study||2
2959464|NCT00742924|3673917|FG002|NOT COMPLETED|Overall Study||4
2959465|NCT00742924|3673918|FG003|NOT COMPLETED|Overall Study||6
2959466|NCT00742963|3673928|FG000|STARTED|Overall Study||101
2959467|NCT00742963|3673928|FG000|Completed All Treatment Cycles|Overall Study||68
2959468|NCT00742963|3673928|FG000|COMPLETED|Overall Study||68
2959469|NCT00742963|3673928|FG000|NOT COMPLETED|Overall Study||33
2959470|NCT00743093|3673934|FG000|STARTED|Base Study Period||224
2959471|NCT00743093|3673935|FG001|STARTED|Base Study Period||52
2959472|NCT00743093|3673934|FG000|COMPLETED|Base Study Period||205
3300532|NCT02946463|4034418|FG001|Received at Least 1 Dose of Study Drug|Primary Evaluation Period||121
3300533|NCT02946463|4034417|FG000|COMPLETED|Primary Evaluation Period||125
3300534|NCT02946463|4034418|FG001|COMPLETED|Primary Evaluation Period||119
3300535|NCT02946463|4034417|FG000|NOT COMPLETED|Primary Evaluation Period||0
3300536|NCT02946463|4034418|FG001|NOT COMPLETED|Primary Evaluation Period||2
3300537|NCT02946463|4034417|FG000|STARTED|Extension Period||124
3300538|NCT02946463|4034418|FG001|STARTED|Extension Period||119
3300539|NCT02946463|4034417|FG000|Received at Least 1 Dose of Ravulizumab|Extension Period||124
3300540|NCT02946463|4034418|FG001|Received at Least 1 Dose of Ravulizumab|Extension Period||119
3300541|NCT02946463|4034417|FG000|COMPLETED|Extension Period||0
3300542|NCT02946463|4034418|FG001|COMPLETED|Extension Period||0
3300543|NCT02946463|4034417|FG000|NOT COMPLETED|Extension Period||124
3300544|NCT02946463|4034418|FG001|NOT COMPLETED|Extension Period||119
3300545|NCT02946489|4034424|FG000|STARTED|Overall Study||8
3300546|NCT02946489|4034424|FG000|COMPLETED|Overall Study||8
3300547|NCT02946489|4034424|FG000|NOT COMPLETED|Overall Study||0
3300548|NCT02946515|4034430|FG000|STARTED|Overall Study||22
3300549|NCT02946515|4034431|FG001|STARTED|Overall Study||22
2959473|NCT00743093|3673935|FG001|COMPLETED|Base Study Period||47
2959474|NCT00743093|3673934|FG000|NOT COMPLETED|Base Study Period||19
2959475|NCT00743093|3673935|FG001|NOT COMPLETED|Base Study Period||5
2959476|NCT00743093|3673934|FG000|STARTED|Extended Dosing Period|Subjects not meeting stopping criteria after base continued into the extended dosing.|51
3035360|NCT01136798|3754528|FG001|COMPLETED|Overall Study||8
3035361|NCT01136798|3754527|FG000|NOT COMPLETED|Overall Study||0
3300550|NCT02946515|4034430|FG000|COMPLETED|Overall Study||20
2959477|NCT00743093|3673935|FG001|STARTED|Extended Dosing Period|Subjects not meeting stopping criteria after base continued into the extended dosing.|1
2959478|NCT00743093|3673934|FG000|COMPLETED|Extended Dosing Period||48
2959479|NCT00743093|3673935|FG001|COMPLETED|Extended Dosing Period||1
2959480|NCT00743093|3673934|FG000|NOT COMPLETED|Extended Dosing Period||3
2959481|NCT00743093|3673935|FG001|NOT COMPLETED|Extended Dosing Period||0
2959482|NCT00743106|3673943|FG000|STARTED|Overall Study||42
2959483|NCT00743106|3673944|FG001|STARTED|Overall Study||48
2959484|NCT00743106|3673943|FG000|COMPLETED|Overall Study||34
2959485|NCT00743106|3673944|FG001|COMPLETED|Overall Study||43
2959486|NCT00743106|3673943|FG000|NOT COMPLETED|Overall Study||8
2959487|NCT00743106|3673944|FG001|NOT COMPLETED|Overall Study||5
2959488|NCT00743119|3673950|FG000|STARTED|Overall Study||34
2959489|NCT00743119|3673950|FG000|COMPLETED|Overall Study||30
2959490|NCT00743119|3673950|FG000|NOT COMPLETED|Overall Study||4
2959491|NCT00743145|3673962|FG000|STARTED|Overall Study||23
2959492|NCT00743145|3673962|FG000|COMPLETED|Overall Study||19
2959493|NCT00743145|3673962|FG000|NOT COMPLETED|Overall Study||4
2959494|NCT00743249|3673978|FG000|STARTED|Overall Study||30
2959495|NCT00743249|3673979|FG001|STARTED|Overall Study||30
2959496|NCT00743249|3673978|FG000|COMPLETED|Overall Study||28
2959497|NCT00743249|3673979|FG001|COMPLETED|Overall Study||24
2959498|NCT00743249|3673978|FG000|NOT COMPLETED|Overall Study||2
2959499|NCT00743249|3673979|FG001|NOT COMPLETED|Overall Study||6
2959500|NCT00743262|3673985|FG000|STARTED|Overall Study||15
2959501|NCT00743262|3673985|FG000|COMPLETED|Overall Study||15
2959502|NCT00743262|3673985|FG000|NOT COMPLETED|Overall Study||0
2959503|NCT00743275|3673991|FG000|STARTED|Overall Study||59
2959504|NCT00743275|3673992|FG001|STARTED|Overall Study||61
2959505|NCT00743275|3673991|FG000|COMPLETED|Overall Study||59
2959506|NCT00743275|3673992|FG001|COMPLETED|Overall Study||60
2959507|NCT00743275|3673991|FG000|NOT COMPLETED|Overall Study||0
2959508|NCT00743275|3673992|FG001|NOT COMPLETED|Overall Study||1
2959509|NCT00743288|3673998|FG000|STARTED|Overall Study||3
2959510|NCT00743288|3673999|FG001|STARTED|Overall Study||3
2959511|NCT00743288|3674000|FG002|STARTED|Overall Study||6
2959512|NCT00743288|3674001|FG003|STARTED|Overall Study||7
2959513|NCT00743288|3674002|FG004|STARTED|Overall Study||6
2959514|NCT00743288|3674003|FG005|STARTED|Overall Study||6
2959515|NCT00743288|3674004|FG006|STARTED|Overall Study|6 subjects were enrolled in phase 1 and 3 subjects were enrolled as part of the phase 2 expansion.|9
2959516|NCT00743288|3673998|FG000|COMPLETED|Overall Study||0
2959517|NCT00743288|3673999|FG001|COMPLETED|Overall Study||0
2959518|NCT00743288|3674000|FG002|COMPLETED|Overall Study||1
2959519|NCT00743288|3674001|FG003|COMPLETED|Overall Study||0
2959520|NCT00743288|3674002|FG004|COMPLETED|Overall Study||0
2959521|NCT00743288|3674003|FG005|COMPLETED|Overall Study||1
2959522|NCT00743288|3674004|FG006|COMPLETED|Overall Study||0
2959523|NCT00743288|3673998|FG000|NOT COMPLETED|Overall Study||3
2959524|NCT00743288|3673999|FG001|NOT COMPLETED|Overall Study||3
2959525|NCT00743288|3674000|FG002|NOT COMPLETED|Overall Study||5
2959526|NCT00743288|3674001|FG003|NOT COMPLETED|Overall Study||7
2959527|NCT00743288|3674002|FG004|NOT COMPLETED|Overall Study||6
2959528|NCT00743288|3674003|FG005|NOT COMPLETED|Overall Study||5
2959529|NCT00743288|3674004|FG006|NOT COMPLETED|Overall Study||9
2959530|NCT00743340|3674015|FG000|STARTED|Overall Study||50
2959531|NCT00743340|3674015|FG000|COMPLETED|Overall Study||9
2959532|NCT00743340|3674015|FG000|NOT COMPLETED|Overall Study||41
2959533|NCT00743366|3674019|FG000|STARTED|Intervention 1 (8 Days)||10
2959534|NCT00743366|3674020|FG001|STARTED|Intervention 1 (8 Days)||10
2959535|NCT00743366|3674019|FG000|COMPLETED|Intervention 1 (8 Days)|A total of 6 participants withdrew before completion of the final inpatient phase|7
2959536|NCT00743366|3674020|FG001|COMPLETED|Intervention 1 (8 Days)|A total of 6 participants withdrew before completion of the final inpatient phase|7
2959537|NCT00743366|3674019|FG000|NOT COMPLETED|Intervention 1 (8 Days)||3
2959538|NCT00743366|3674020|FG001|NOT COMPLETED|Intervention 1 (8 Days)||3
2959539|NCT00743366|3674019|FG000|STARTED|Intervention 2 (8 Days)||7
2959540|NCT00743366|3674020|FG001|STARTED|Intervention 2 (8 Days)||7
2959541|NCT00743366|3674019|FG000|COMPLETED|Intervention 2 (8 Days)||7
2959542|NCT00743366|3674020|FG001|COMPLETED|Intervention 2 (8 Days)||7
2959543|NCT00743366|3674019|FG000|NOT COMPLETED|Intervention 2 (8 Days)||0
2959544|NCT00743366|3674020|FG001|NOT COMPLETED|Intervention 2 (8 Days)||0
2959545|NCT00743431|3674026|FG000|STARTED|Overall Study||224
2959546|NCT00743431|3674026|FG000|COMPLETED|Overall Study||98
2959547|NCT00743431|3674026|FG000|NOT COMPLETED|Overall Study||126
2959548|NCT00743444|3674030|FG000|STARTED|First Intervention||14
2959549|NCT00743444|3674031|FG001|STARTED|First Intervention||13
2959550|NCT00743444|3674030|FG000|COMPLETED|First Intervention||14
2959551|NCT00743444|3674031|FG001|COMPLETED|First Intervention||12
2959552|NCT00743444|3674030|FG000|NOT COMPLETED|First Intervention||0
2959553|NCT00743444|3674031|FG001|NOT COMPLETED|First Intervention||1
2959554|NCT00743444|3674030|FG000|STARTED|Washout Period||14
2959555|NCT00743444|3674031|FG001|STARTED|Washout Period||12
2959556|NCT00743444|3674030|FG000|COMPLETED|Washout Period||14
3300551|NCT02946515|4034431|FG001|COMPLETED|Overall Study||21
3300552|NCT02946515|4034430|FG000|NOT COMPLETED|Overall Study||2
3300553|NCT02946515|4034431|FG001|NOT COMPLETED|Overall Study||1
3300554|NCT02946580|4034439|FG000|STARTED|Overall Study||28
3300555|NCT02946580|4034440|FG001|STARTED|Overall Study||25
3300556|NCT02946580|4034439|FG000|COMPLETED|Overall Study||27
3300557|NCT02946580|4034440|FG001|COMPLETED|Overall Study||20
2959557|NCT00743444|3674031|FG001|COMPLETED|Washout Period||11
2959558|NCT00743444|3674030|FG000|NOT COMPLETED|Washout Period||0
2959559|NCT00743444|3674031|FG001|NOT COMPLETED|Washout Period||1
2959560|NCT00743444|3674030|FG000|STARTED|Second Intervention||14
2959561|NCT00743444|3674031|FG001|STARTED|Second Intervention||11
2959562|NCT00743444|3674030|FG000|COMPLETED|Second Intervention||14
2959563|NCT00743444|3674031|FG001|COMPLETED|Second Intervention||11
2959564|NCT00743444|3674030|FG000|NOT COMPLETED|Second Intervention||0
2959565|NCT00743444|3674031|FG001|NOT COMPLETED|Second Intervention||0
2959566|NCT00743483|3674037|FG000|STARTED|Baseline Period||15
2959567|NCT00743483|3674037|FG000|COMPLETED|Baseline Period||14
2959568|NCT00743483|3674037|FG000|NOT COMPLETED|Baseline Period||1
2959569|NCT00743483|3674037|FG000|STARTED|Treatment Period||14
2959570|NCT00743483|3674037|FG000|COMPLETED|Treatment Period||13
2959571|NCT00743483|3674037|FG000|NOT COMPLETED|Treatment Period||1
2959572|NCT00743509|3674041|FG000|STARTED|Overall Study||49
2959573|NCT00743509|3674041|FG000|COMPLETED|Overall Study||47
2959574|NCT00743509|3674041|FG000|NOT COMPLETED|Overall Study||2
2959575|NCT00743574|3674045|FG000|STARTED|Overall Study||36
2959576|NCT00743574|3674045|FG000|Dropped Out Before Eligibility Testing|Overall Study||13
2959577|NCT00743574|3674045|FG000|Further Exclusions|Overall Study||8
2959578|NCT00743574|3674045|FG000|Dropped Out After Initiating Trial|Overall Study||3
2959579|NCT00743574|3674045|FG000|COMPLETED|Overall Study||12
2959580|NCT00743574|3674045|FG000|NOT COMPLETED|Overall Study||24
3035362|NCT01136798|3754528|FG001|NOT COMPLETED|Overall Study||0
3035363|NCT01136876|3754536|FG000|STARTED|Overall Study||28
3035364|NCT01136876|3754537|FG001|STARTED|Overall Study||29
3035365|NCT01136876|3754536|FG000|COMPLETED|Overall Study||23
3035366|NCT01136876|3754537|FG001|COMPLETED|Overall Study||18
3035367|NCT01136876|3754536|FG000|NOT COMPLETED|Overall Study||5
3132757|NCT01693068|3857942|FG002|Treated|Randomization Period||0
3132758|NCT01693068|3857940|FG000|COMPLETED|Randomization Period||62
3132759|NCT01693068|3857941|FG001|COMPLETED|Randomization Period||125
3035368|NCT01136876|3754537|FG001|NOT COMPLETED|Overall Study||11
3035369|NCT01136915|3754547|FG000|STARTED|Overall Study||8
3035370|NCT01136915|3754548|FG001|STARTED|Overall Study||7
3035371|NCT01136915|3754547|FG000|COMPLETED|Overall Study||6
3035372|NCT01136915|3754548|FG001|COMPLETED|Overall Study||6
3035373|NCT01136915|3754547|FG000|NOT COMPLETED|Overall Study||2
3035374|NCT01136915|3754548|FG001|NOT COMPLETED|Overall Study||1
3035375|NCT01136954|3754558|FG000|STARTED|Overall Study||72
3035376|NCT01136954|3754559|FG001|STARTED|Overall Study||72
3035377|NCT01136954|3754558|FG000|COMPLETED|Overall Study||48
3035378|NCT01136954|3754559|FG001|COMPLETED|Overall Study||51
3035379|NCT01136954|3754558|FG000|NOT COMPLETED|Overall Study||24
3035380|NCT01136954|3754559|FG001|NOT COMPLETED|Overall Study||21
3035381|NCT01137006|3754573|FG000|STARTED|Overall Study||3
3035382|NCT01137006|3754574|FG001|STARTED|Overall Study||3
3035383|NCT01137006|3754575|FG002|STARTED|Overall Study||8
3035384|NCT01137006|3754576|FG003|STARTED|Overall Study||3
3035385|NCT01137006|3754577|FG004|STARTED|Overall Study||3
3035386|NCT01137006|3754578|FG005|STARTED|Overall Study||4
3035387|NCT01137006|3754579|FG006|STARTED|Overall Study||3
3035388|NCT01137006|3754573|FG000|Completed at Least 1 Treatment Cycle|Overall Study||3
3035389|NCT01137006|3754574|FG001|Completed at Least 1 Treatment Cycle|Overall Study||3
3035390|NCT01137006|3754575|FG002|Completed at Least 1 Treatment Cycle|Overall Study||8
3035391|NCT01137006|3754576|FG003|Completed at Least 1 Treatment Cycle|Overall Study||3
3035392|NCT01137006|3754577|FG004|Completed at Least 1 Treatment Cycle|Overall Study||3
3035393|NCT01137006|3754578|FG005|Completed at Least 1 Treatment Cycle|Overall Study||4
3035394|NCT01137006|3754579|FG006|Completed at Least 1 Treatment Cycle|Overall Study||3
3035395|NCT01137006|3754573|FG000|COMPLETED|Overall Study||3
3035396|NCT01137006|3754574|FG001|COMPLETED|Overall Study||3
3035397|NCT01137006|3754575|FG002|COMPLETED|Overall Study||8
3035398|NCT01137006|3754576|FG003|COMPLETED|Overall Study||3
3035399|NCT01137006|3754577|FG004|COMPLETED|Overall Study||3
3035400|NCT01137006|3754578|FG005|COMPLETED|Overall Study||4
3035401|NCT01137006|3754579|FG006|COMPLETED|Overall Study||3
3035402|NCT01137006|3754573|FG000|NOT COMPLETED|Overall Study||0
3035403|NCT01137006|3754574|FG001|NOT COMPLETED|Overall Study||0
3035404|NCT01137006|3754575|FG002|NOT COMPLETED|Overall Study||0
3035405|NCT01137006|3754576|FG003|NOT COMPLETED|Overall Study||0
3035406|NCT01137006|3754577|FG004|NOT COMPLETED|Overall Study||0
3035407|NCT01137006|3754578|FG005|NOT COMPLETED|Overall Study||0
3035408|NCT01137006|3754579|FG006|NOT COMPLETED|Overall Study||0
3035409|NCT01137032|3754596|FG000|STARTED|Overall Study||19
3035410|NCT01137032|3754596|FG000|COMPLETED|Overall Study||19
3035411|NCT01137032|3754596|FG000|NOT COMPLETED|Overall Study||0
3035412|NCT01137071|3754600|FG000|STARTED|Overall Study|all patients considered eligible were included on the study|29
3035413|NCT01137071|3754600|FG000|COMPLETED|Overall Study|Of the eligible patients|15
3035414|NCT01137071|3754600|FG000|NOT COMPLETED|Overall Study||14
3035415|NCT01137110|3754611|FG000|STARTED|Overall Study||35
3035416|NCT01137110|3754612|FG001|STARTED|Overall Study||49
3035417|NCT01137110|3754611|FG000|COMPLETED|Overall Study||34
3035418|NCT01137110|3754612|FG001|COMPLETED|Overall Study||49
3035419|NCT01137110|3754611|FG000|NOT COMPLETED|Overall Study||1
3035420|NCT01137110|3754612|FG001|NOT COMPLETED|Overall Study||0
3035421|NCT01137292|3754618|FG000|STARTED|Overall Study||177
3035422|NCT01137292|3754618|FG000|COMPLETED|Overall Study||123
3035423|NCT01137292|3754618|FG000|NOT COMPLETED|Overall Study||54
2959581|NCT00743652|3674054|FG000|STARTED|Overall Study||151
2959582|NCT00743652|3674055|FG001|STARTED|Overall Study||51
2959583|NCT00743652|3674056|FG002|STARTED|Overall Study||25
2959584|NCT00743652|3674057|FG003|STARTED|Overall Study||67
2959585|NCT00743652|3674058|FG004|STARTED|Overall Study||79
2959586|NCT00743652|3674054|FG000|Vaccinated Dose 1|Overall Study||151
2959587|NCT00743652|3674055|FG001|Vaccinated Dose 1|Overall Study||51
2959588|NCT00743652|3674056|FG002|Vaccinated Dose 1|Overall Study||25
2959589|NCT00743652|3674057|FG003|Vaccinated Dose 1|Overall Study||66
2959590|NCT00743652|3674058|FG004|Vaccinated Dose 1|Overall Study||79
2959591|NCT00743652|3674054|FG000|Vaccinated Dose 2|Overall Study||112
2959592|NCT00743652|3674055|FG001|Vaccinated Dose 2|Overall Study||41
2959593|NCT00743652|3674056|FG002|Vaccinated Dose 2|Overall Study||0
2959594|NCT00743652|3674057|FG003|Vaccinated Dose 2|Overall Study||49
2959595|NCT00743652|3674058|FG004|Vaccinated Dose 2|Overall Study||0
2959596|NCT00743652|3674054|FG000|Vaccinated Dose 3|Overall Study||74
2959597|NCT00743652|3674055|FG001|Vaccinated Dose 3|Overall Study||0
2959598|NCT00743652|3674056|FG002|Vaccinated Dose 3|Overall Study||0
2959599|NCT00743652|3674057|FG003|Vaccinated Dose 3|Overall Study||0
2959600|NCT00743652|3674058|FG004|Vaccinated Dose 3|Overall Study||0
2959601|NCT00743652|3674054|FG000|Toddler Dose|Overall Study||15
2959602|NCT00743652|3674055|FG001|Toddler Dose|Overall Study||23
2959603|NCT00743652|3674056|FG002|Toddler Dose|Overall Study||16
2959604|NCT00743652|3674057|FG003|Toddler Dose|Overall Study||0
2959605|NCT00743652|3674058|FG004|Toddler Dose|Overall Study||0
2959606|NCT00743652|3674054|FG000|COMPLETED|Overall Study||141
2959607|NCT00743652|3674055|FG001|COMPLETED|Overall Study||48
2959608|NCT00743652|3674056|FG002|COMPLETED|Overall Study||23
2959609|NCT00743652|3674057|FG003|COMPLETED|Overall Study||63
2959610|NCT00743652|3674058|FG004|COMPLETED|Overall Study||79
2959611|NCT00743652|3674054|FG000|NOT COMPLETED|Overall Study||10
2959612|NCT00743652|3674055|FG001|NOT COMPLETED|Overall Study||3
2959613|NCT00743652|3674056|FG002|NOT COMPLETED|Overall Study||2
2959614|NCT00743652|3674057|FG003|NOT COMPLETED|Overall Study||4
2959615|NCT00743652|3674058|FG004|NOT COMPLETED|Overall Study||0
2959616|NCT00743717|3674076|FG000|STARTED|Overall Study||2
2959617|NCT00743717|3674077|FG001|STARTED|Overall Study||2
2959618|NCT00743717|3674076|FG000|COMPLETED|Overall Study||2
2959619|NCT00743717|3674077|FG001|COMPLETED|Overall Study||2
2959620|NCT00743717|3674076|FG000|NOT COMPLETED|Overall Study||0
2959621|NCT00743717|3674077|FG001|NOT COMPLETED|Overall Study||0
2959622|NCT00743730|3674086|FG000|STARTED|Overall Study||27
2959623|NCT00743730|3674087|FG001|STARTED|Overall Study||34
2959624|NCT00743730|3674088|FG002|STARTED|Overall Study||33
2959625|NCT00743730|3674086|FG000|COMPLETED|Overall Study||22
2959626|NCT00743730|3674087|FG001|COMPLETED|Overall Study||30
2959627|NCT00743730|3674088|FG002|COMPLETED|Overall Study||28
2959628|NCT00743730|3674086|FG000|NOT COMPLETED|Overall Study||5
2959629|NCT00743730|3674087|FG001|NOT COMPLETED|Overall Study||4
2959630|NCT00743730|3674088|FG002|NOT COMPLETED|Overall Study||5
2959631|NCT00744042|3674100|FG000|STARTED|Overall Study||11
2959632|NCT00744042|3674100|FG000|COMPLETED|Overall Study||10
2959633|NCT00744042|3674100|FG000|NOT COMPLETED|Overall Study||1
2959634|NCT00744055|3674112|FG000|STARTED|Overall Study||50
2959635|NCT00744055|3674113|FG001|STARTED|Overall Study||46
2959636|NCT00744055|3674112|FG000|COMPLETED|Overall Study||43
2959637|NCT00744055|3674113|FG001|COMPLETED|Overall Study||32
2959638|NCT00744055|3674112|FG000|NOT COMPLETED|Overall Study||7
2959639|NCT00744055|3674113|FG001|NOT COMPLETED|Overall Study||14
2959640|NCT00744211|3674122|FG000|STARTED|Baseline||10
2959641|NCT00744211|3674123|FG001|STARTED|Baseline||9
2959642|NCT00744211|3674124|FG002|STARTED|Baseline||10
2959643|NCT00744211|3674122|FG000|COMPLETED|Baseline||10
2959644|NCT00744211|3674123|FG001|COMPLETED|Baseline||9
2959645|NCT00744211|3674124|FG002|COMPLETED|Baseline||10
2959646|NCT00744211|3674122|FG000|NOT COMPLETED|Baseline||0
2959647|NCT00744211|3674123|FG001|NOT COMPLETED|Baseline||0
2959648|NCT00744211|3674124|FG002|NOT COMPLETED|Baseline||0
2959649|NCT00744211|3674122|FG000|STARTED|0.5 Hours After Cardiopulmonary Bypass||10
2959650|NCT00744211|3674123|FG001|STARTED|0.5 Hours After Cardiopulmonary Bypass||9
2959651|NCT00744211|3674124|FG002|STARTED|0.5 Hours After Cardiopulmonary Bypass||10
2959652|NCT00744211|3674122|FG000|COMPLETED|0.5 Hours After Cardiopulmonary Bypass||10
2959653|NCT00744211|3674123|FG001|COMPLETED|0.5 Hours After Cardiopulmonary Bypass||9
2959654|NCT00744211|3674124|FG002|COMPLETED|0.5 Hours After Cardiopulmonary Bypass||10
2959655|NCT00744211|3674122|FG000|NOT COMPLETED|0.5 Hours After Cardiopulmonary Bypass||0
2959656|NCT00744211|3674123|FG001|NOT COMPLETED|0.5 Hours After Cardiopulmonary Bypass||0
2959657|NCT00744211|3674124|FG002|NOT COMPLETED|0.5 Hours After Cardiopulmonary Bypass||0
2959658|NCT00744211|3674122|FG000|STARTED|6 Hours After Cardiopulmonary Bypass||10
2959659|NCT00744211|3674123|FG001|STARTED|6 Hours After Cardiopulmonary Bypass||9
2959660|NCT00744211|3674124|FG002|STARTED|6 Hours After Cardiopulmonary Bypass||10
2959661|NCT00744211|3674122|FG000|COMPLETED|6 Hours After Cardiopulmonary Bypass||10
2959662|NCT00744211|3674123|FG001|COMPLETED|6 Hours After Cardiopulmonary Bypass||9
2959663|NCT00744211|3674124|FG002|COMPLETED|6 Hours After Cardiopulmonary Bypass||10
2959664|NCT00744211|3674122|FG000|NOT COMPLETED|6 Hours After Cardiopulmonary Bypass||0
2959665|NCT00744211|3674123|FG001|NOT COMPLETED|6 Hours After Cardiopulmonary Bypass||0
2959666|NCT00744211|3674124|FG002|NOT COMPLETED|6 Hours After Cardiopulmonary Bypass||0
2959667|NCT00744211|3674122|FG000|STARTED|12 Hours After Cardiopulmonary Bypass||10
2959668|NCT00744211|3674123|FG001|STARTED|12 Hours After Cardiopulmonary Bypass||9
2959669|NCT00744211|3674124|FG002|STARTED|12 Hours After Cardiopulmonary Bypass||10
2959670|NCT00744211|3674122|FG000|COMPLETED|12 Hours After Cardiopulmonary Bypass||10
2959671|NCT00744211|3674123|FG001|COMPLETED|12 Hours After Cardiopulmonary Bypass||9
2959672|NCT00744211|3674124|FG002|COMPLETED|12 Hours After Cardiopulmonary Bypass||10
3132760|NCT01693068|3857942|FG002|COMPLETED|Randomization Period||0
3132761|NCT01693068|3857940|FG000|NOT COMPLETED|Randomization Period||2
3132762|NCT01693068|3857941|FG001|NOT COMPLETED|Randomization Period||5
2959673|NCT00744211|3674122|FG000|NOT COMPLETED|12 Hours After Cardiopulmonary Bypass||0
2959674|NCT00744211|3674123|FG001|NOT COMPLETED|12 Hours After Cardiopulmonary Bypass||0
3300558|NCT02946580|4034439|FG000|NOT COMPLETED|Overall Study||1
3300559|NCT02946580|4034440|FG001|NOT COMPLETED|Overall Study||5
3300560|NCT02946892|4034446|FG000|STARTED|First Intervention (12 Weeks)||11
3300561|NCT02946892|4034447|FG001|STARTED|First Intervention (12 Weeks)||15
3300562|NCT02946892|4034446|FG000|COMPLETED|First Intervention (12 Weeks)||11
3300563|NCT02946892|4034447|FG001|COMPLETED|First Intervention (12 Weeks)||14
3300564|NCT02946892|4034446|FG000|NOT COMPLETED|First Intervention (12 Weeks)||0
3300565|NCT02946892|4034447|FG001|NOT COMPLETED|First Intervention (12 Weeks)||1
2959675|NCT00744211|3674124|FG002|NOT COMPLETED|12 Hours After Cardiopulmonary Bypass||0
2959676|NCT00744211|3674122|FG000|STARTED|24 Hours After Cardiopulmonary Bypass||10
2959677|NCT00744211|3674123|FG001|STARTED|24 Hours After Cardiopulmonary Bypass||9
3132763|NCT01693068|3857942|FG002|NOT COMPLETED|Randomization Period||0
3132764|NCT01693068|3857940|FG000|STARTED|Cross-over (Dacarbazine To Pimasertib)||0
3300566|NCT02946892|4034446|FG000|STARTED|Washout (6 Weeks)||11
2959678|NCT00744211|3674124|FG002|STARTED|24 Hours After Cardiopulmonary Bypass||10
2959679|NCT00744211|3674122|FG000|COMPLETED|24 Hours After Cardiopulmonary Bypass||10
2959680|NCT00744211|3674123|FG001|COMPLETED|24 Hours After Cardiopulmonary Bypass||9
2959681|NCT00744211|3674124|FG002|COMPLETED|24 Hours After Cardiopulmonary Bypass||10
2959682|NCT00744211|3674122|FG000|NOT COMPLETED|24 Hours After Cardiopulmonary Bypass||0
2959683|NCT00744211|3674123|FG001|NOT COMPLETED|24 Hours After Cardiopulmonary Bypass||0
2959684|NCT00744211|3674124|FG002|NOT COMPLETED|24 Hours After Cardiopulmonary Bypass||0
2959685|NCT00744237|3674138|FG000|STARTED|Overall Study||83
2959686|NCT00744237|3674139|FG001|STARTED|Overall Study||73
2959687|NCT00744237|3674140|FG002|STARTED|Overall Study||74
2959688|NCT00744237|3674138|FG000|COMPLETED|Overall Study||56
2959689|NCT00744237|3674139|FG001|COMPLETED|Overall Study||46
2959690|NCT00744237|3674140|FG002|COMPLETED|Overall Study||59
2959691|NCT00744237|3674138|FG000|NOT COMPLETED|Overall Study||27
2959692|NCT00744237|3674139|FG001|NOT COMPLETED|Overall Study||27
2959693|NCT00744237|3674140|FG002|NOT COMPLETED|Overall Study||15
2959694|NCT00744263|3674150|FG000|STARTED|Overall Study||42240
2959695|NCT00744263|3674151|FG001|STARTED|Overall Study||42256
2959696|NCT00744263|3674150|FG000|COMPLETED|Overall Study||37004
2959697|NCT00744263|3674151|FG001|COMPLETED|Overall Study||36936
2959698|NCT00744263|3674150|FG000|NOT COMPLETED|Overall Study||5236
2959699|NCT00744263|3674151|FG001|NOT COMPLETED|Overall Study||5320
2959700|NCT00744328|3674162|FG000|STARTED|Overall Study||26
2959701|NCT00744328|3674163|FG001|STARTED|Overall Study||30
2959702|NCT00744328|3674164|FG002|STARTED|Overall Study||29
2959703|NCT00744328|3674162|FG000|COMPLETED|Overall Study||19
2959704|NCT00744328|3674163|FG001|COMPLETED|Overall Study||22
2959705|NCT00744328|3674164|FG002|COMPLETED|Overall Study||21
2959706|NCT00744328|3674162|FG000|NOT COMPLETED|Overall Study||7
2959707|NCT00744328|3674163|FG001|NOT COMPLETED|Overall Study||8
2959708|NCT00744328|3674164|FG002|NOT COMPLETED|Overall Study||8
2959709|NCT00744380|3674174|FG000|STARTED|Overall Study||12
2959710|NCT00744380|3674175|FG001|STARTED|Overall Study||11
2959711|NCT00744380|3674174|FG000|COMPLETED|Overall Study||12
3300567|NCT02946892|4034447|FG001|STARTED|Washout (6 Weeks)||14
3300568|NCT02946892|4034446|FG000|COMPLETED|Washout (6 Weeks)||9
3300569|NCT02946892|4034447|FG001|COMPLETED|Washout (6 Weeks)||14
3300570|NCT02946892|4034446|FG000|NOT COMPLETED|Washout (6 Weeks)||2
3300571|NCT02946892|4034447|FG001|NOT COMPLETED|Washout (6 Weeks)||0
3300572|NCT02946892|4034446|FG000|STARTED|Second Intervention||9
3300573|NCT02946892|4034447|FG001|STARTED|Second Intervention||14
3300574|NCT02946892|4034446|FG000|COMPLETED|Second Intervention||9
3300575|NCT02946892|4034447|FG001|COMPLETED|Second Intervention||14
3300576|NCT02946892|4034446|FG000|NOT COMPLETED|Second Intervention||0
3300577|NCT02946892|4034447|FG001|NOT COMPLETED|Second Intervention||0
3300578|NCT02946918|4034455|FG000|STARTED|Overall Study||6
3300579|NCT02946918|4034456|FG001|STARTED|Overall Study||8
3300580|NCT02946918|4034455|FG000|COMPLETED|Overall Study||5
3300581|NCT02946918|4034456|FG001|COMPLETED|Overall Study||5
3300582|NCT02946918|4034455|FG000|NOT COMPLETED|Overall Study||1
3300583|NCT02946918|4034456|FG001|NOT COMPLETED|Overall Study||3
3300584|NCT02947984|4034464|FG000|STARTED|Overall Study||22
3300585|NCT02947984|4034465|FG001|STARTED|Overall Study||22
3300586|NCT02947984|4034464|FG000|COMPLETED|Overall Study||22
2959712|NCT00744380|3674175|FG001|COMPLETED|Overall Study||11
2959713|NCT00744380|3674174|FG000|NOT COMPLETED|Overall Study||0
2959714|NCT00744380|3674175|FG001|NOT COMPLETED|Overall Study||0
2959715|NCT00744471|3674186|FG000|STARTED|Overall Study||156
3300587|NCT02947984|4034465|FG001|COMPLETED|Overall Study||22
3300588|NCT02947984|4034464|FG000|NOT COMPLETED|Overall Study||0
3300589|NCT02947984|4034465|FG001|NOT COMPLETED|Overall Study||0
3300590|NCT02947997|4034471|FG000|STARTED|Overall Study||4
3300591|NCT02947997|4034471|FG000|COMPLETED|Overall Study||4
2959716|NCT00744471|3674187|FG001|STARTED|Overall Study||156
2959717|NCT00744471|3674188|FG002|STARTED|Overall Study||158
2959718|NCT00744471|3674189|FG003|STARTED|Overall Study||157
2959719|NCT00744471|3674186|FG000|Treated|Overall Study||155
2959720|NCT00744471|3674187|FG001|Treated|Overall Study||155
2959721|NCT00744471|3674188|FG002|Treated|Overall Study||154
2959722|NCT00744471|3674189|FG003|Treated|Overall Study||157
2959723|NCT00744471|3674186|FG000|COMPLETED|Overall Study||13
2959724|NCT00744471|3674187|FG001|COMPLETED|Overall Study||11
2959725|NCT00744471|3674188|FG002|COMPLETED|Overall Study||6
2959726|NCT00744471|3674189|FG003|COMPLETED|Overall Study||9
2959727|NCT00744471|3674186|FG000|NOT COMPLETED|Overall Study||143
2959728|NCT00744471|3674187|FG001|NOT COMPLETED|Overall Study||145
2959729|NCT00744471|3674188|FG002|NOT COMPLETED|Overall Study||152
2959730|NCT00744471|3674189|FG003|NOT COMPLETED|Overall Study||148
2959731|NCT00744497|3674201|FG000|STARTED|Overall Study|Randomized|760
2959732|NCT00744497|3674202|FG001|STARTED|Overall Study|Randomized|762
2959733|NCT00744497|3674201|FG000|Received Treatment|Overall Study||757
2959734|NCT00744497|3674202|FG001|Received Treatment|Overall Study||761
2959735|NCT00744497|3674201|FG000|COMPLETED|Overall Study||0
2959736|NCT00744497|3674202|FG001|COMPLETED|Overall Study||0
2959737|NCT00744497|3674201|FG000|NOT COMPLETED|Overall Study||760
2959738|NCT00744497|3674202|FG001|NOT COMPLETED|Overall Study||762
2959739|NCT00744523|3674210|FG000|STARTED|Procedure||37
2959740|NCT00744523|3674211|FG001|STARTED|Procedure||225
2959741|NCT00744523|3674210|FG000|COMPLETED|Procedure||37
2959742|NCT00744523|3674211|FG001|COMPLETED|Procedure||225
2959743|NCT00744523|3674210|FG000|NOT COMPLETED|Procedure||0
2959744|NCT00744523|3674211|FG001|NOT COMPLETED|Procedure||0
2959745|NCT00744523|3674210|FG000|STARTED|30 Days After the Procedure||37
2959746|NCT00744523|3674211|FG001|STARTED|30 Days After the Procedure||225
2959747|NCT00744523|3674210|FG000|COMPLETED|30 Days After the Procedure||37
2959748|NCT00744523|3674211|FG001|COMPLETED|30 Days After the Procedure||220
2959749|NCT00744523|3674210|FG000|NOT COMPLETED|30 Days After the Procedure||0
2959750|NCT00744523|3674211|FG001|NOT COMPLETED|30 Days After the Procedure||5
2959751|NCT00744627|3674221|FG000|STARTED|Overall Study||151
2959752|NCT00744627|3674222|FG001|STARTED|Overall Study||150
2959753|NCT00744627|3674221|FG000|Treated|Overall Study||150
2959754|NCT00744627|3674222|FG001|Treated|Overall Study||150
2959755|NCT00744627|3674221|FG000|COMPLETED|Overall Study||126
2959756|NCT00744627|3674222|FG001|COMPLETED|Overall Study||128
2959757|NCT00744627|3674221|FG000|NOT COMPLETED|Overall Study||25
2959758|NCT00744627|3674222|FG001|NOT COMPLETED|Overall Study||22
2959759|NCT00744653|3674228|FG000|STARTED|Overall Study||17
2959760|NCT00744653|3674228|FG000|COMPLETED|Overall Study||1
2959761|NCT00744653|3674228|FG000|NOT COMPLETED|Overall Study||16
2959762|NCT00744692|3674233|FG000|STARTED|Overall Study||22
2959763|NCT00744692|3674233|FG000|COMPLETED|Overall Study||22
2959764|NCT00744692|3674233|FG000|NOT COMPLETED|Overall Study||0
2959765|NCT00744757|3674237|FG000|STARTED|Overall Study||37
2959766|NCT00744757|3674237|FG000|COMPLETED|Overall Study||16
2959767|NCT00744757|3674237|FG000|NOT COMPLETED|Overall Study||21
2959768|NCT00744796|3674241|FG000|STARTED|Pre-operative||21
2959769|NCT00744796|3674241|FG000|COMPLETED|Pre-operative||21
2959770|NCT00744796|3674241|FG000|NOT COMPLETED|Pre-operative||0
2959771|NCT00744796|3674241|FG000|STARTED|Post-Operative Day 1||21
2959772|NCT00744796|3674241|FG000|COMPLETED|Post-Operative Day 1||21
2959773|NCT00744796|3674241|FG000|NOT COMPLETED|Post-Operative Day 1||0
2959774|NCT00744796|3674241|FG000|STARTED|Post-Operative 3-6 Months||21
2959775|NCT00744796|3674241|FG000|COMPLETED|Post-Operative 3-6 Months||21
2959776|NCT00744796|3674241|FG000|NOT COMPLETED|Post-Operative 3-6 Months||0
2959777|NCT00744796|3674241|FG000|STARTED|Post-Operative 6-9 Months||21
2959778|NCT00744796|3674241|FG000|COMPLETED|Post-Operative 6-9 Months||9
2959779|NCT00744796|3674241|FG000|NOT COMPLETED|Post-Operative 6-9 Months||12
2959780|NCT00744848|3674247|FG000|STARTED|Overall Study||103
2959781|NCT00744848|3674248|FG001|STARTED|Overall Study||101
2959782|NCT00744848|3674247|FG000|COMPLETED|Overall Study||103
2959783|NCT00744848|3674248|FG001|COMPLETED|Overall Study||101
2959784|NCT00744848|3674247|FG000|NOT COMPLETED|Overall Study||0
2959785|NCT00744848|3674248|FG001|NOT COMPLETED|Overall Study||0
2959786|NCT00744861|3674258|FG000|STARTED|Feasibility Stage 1|Stage 1: Study phase to determine the feasibility of the study treatment and assessments|8
3300592|NCT02947997|4034471|FG000|NOT COMPLETED|Overall Study||0
3300593|NCT02948257|4034475|FG000|STARTED|Overall Study||52
3300594|NCT02948257|4034475|FG000|COMPLETED|Overall Study||52
3300595|NCT02948257|4034475|FG000|NOT COMPLETED|Overall Study||0
3300596|NCT02948426|4034483|FG000|STARTED|Overall Study||3
3300597|NCT02948426|4034484|FG001|STARTED|Overall Study||6
3300598|NCT02948426|4034485|FG002|STARTED|Overall Study||3
3300599|NCT02948426|4034486|FG003|STARTED|Overall Study||6
3300600|NCT02948426|4034483|FG000|COMPLETED|Overall Study||3
3300601|NCT02948426|4034484|FG001|COMPLETED|Overall Study||6
3300602|NCT02948426|4034485|FG002|COMPLETED|Overall Study||3
2959787|NCT00744861|3674259|FG001|STARTED|Feasibility Stage 1|Stage 1: Study phase to determine the feasibility of the study treatment and assessments|10
2959788|NCT00744861|3674260|FG002|STARTED|Feasibility Stage 1|No subjects enrolled in Stage 1/Feasibility study|0
2959789|NCT00744861|3674261|FG003|STARTED|Feasibility Stage 1|No subjects enrolled in Stage 1/Feasibility study|0
2959790|NCT00744861|3674258|FG000|COMPLETED|Feasibility Stage 1||7
2959791|NCT00744861|3674259|FG001|COMPLETED|Feasibility Stage 1||8
2959792|NCT00744861|3674260|FG002|COMPLETED|Feasibility Stage 1||0
3300603|NCT02948426|4034486|FG003|COMPLETED|Overall Study||6
2959793|NCT00744861|3674261|FG003|COMPLETED|Feasibility Stage 1||0
2959794|NCT00744861|3674258|FG000|NOT COMPLETED|Feasibility Stage 1||1
2959795|NCT00744861|3674259|FG001|NOT COMPLETED|Feasibility Stage 1||2
2959796|NCT00744861|3674260|FG002|NOT COMPLETED|Feasibility Stage 1||0
2959797|NCT00744861|3674261|FG003|NOT COMPLETED|Feasibility Stage 1||0
2959798|NCT00744861|3674258|FG000|STARTED|Pivotal Stage 2|No subjects enrolled in Stage 2 pivotal study phase|0
2959799|NCT00744861|3674259|FG001|STARTED|Pivotal Stage 2|No subjects enrolled in Stage 2 pivotal study phase|0
2959800|NCT00744861|3674260|FG002|STARTED|Pivotal Stage 2|Stage 2 pivotal study phase assessed safety and effectiveness of LIPUS treatment via Exospine device|154
2959801|NCT00744861|3674261|FG003|STARTED|Pivotal Stage 2|Stage 2 pivotal study phase assessed safety and effectiveness of LIPUS treatment via Exospine device|156
2959802|NCT00744861|3674258|FG000|COMPLETED|Pivotal Stage 2||0
2959803|NCT00744861|3674259|FG001|COMPLETED|Pivotal Stage 2||0
2959804|NCT00744861|3674260|FG002|COMPLETED|Pivotal Stage 2||52
2959805|NCT00744861|3674261|FG003|COMPLETED|Pivotal Stage 2||51
2959806|NCT00744861|3674258|FG000|NOT COMPLETED|Pivotal Stage 2||0
2959807|NCT00744861|3674259|FG001|NOT COMPLETED|Pivotal Stage 2||0
2959808|NCT00744861|3674260|FG002|NOT COMPLETED|Pivotal Stage 2||102
2959809|NCT00744861|3674261|FG003|NOT COMPLETED|Pivotal Stage 2||105
2959810|NCT00744874|3674269|FG000|STARTED|Overall Study||55
2959811|NCT00744874|3674269|FG000|COMPLETED|Overall Study||51
2959812|NCT00744874|3674269|FG000|NOT COMPLETED|Overall Study||4
2959813|NCT00744939|3674284|FG000|STARTED|Overall Study||168
2959814|NCT00744939|3674284|FG000|Treatment Received|Overall Study||141
2959815|NCT00744939|3674284|FG000|COMPLETED|Overall Study||77
2959816|NCT00744939|3674284|FG000|NOT COMPLETED|Overall Study||91
2959817|NCT00744965|3674298|FG000|STARTED|Overall Study||197
2959818|NCT00744965|3674299|FG001|STARTED|Overall Study||198
2959819|NCT00744965|3674298|FG000|COMPLETED|Overall Study||186
2959820|NCT00744965|3674299|FG001|COMPLETED|Overall Study||189
2959821|NCT00744965|3674298|FG000|NOT COMPLETED|Overall Study||11
2959822|NCT00744965|3674299|FG001|NOT COMPLETED|Overall Study||9
2959823|NCT00744978|3674307|FG000|STARTED|Period 1||32
2959824|NCT00744978|3674308|FG001|STARTED|Period 1||34
2959825|NCT00744978|3674307|FG000|Treated|Period 1||31
2959826|NCT00744978|3674308|FG001|Treated|Period 1||33
2959827|NCT00744978|3674307|FG000|COMPLETED|Period 1||26
2959828|NCT00744978|3674308|FG001|COMPLETED|Period 1||29
2959829|NCT00744978|3674307|FG000|NOT COMPLETED|Period 1||6
2959830|NCT00744978|3674308|FG001|NOT COMPLETED|Period 1||5
2959831|NCT00744978|3674307|FG000|STARTED|Placebo Washout||26
2959832|NCT00744978|3674308|FG001|STARTED|Placebo Washout||29
2959833|NCT00744978|3674307|FG000|COMPLETED|Placebo Washout||26
2959834|NCT00744978|3674308|FG001|COMPLETED|Placebo Washout||29
2959835|NCT00744978|3674307|FG000|NOT COMPLETED|Placebo Washout||0
2959836|NCT00744978|3674308|FG001|NOT COMPLETED|Placebo Washout||0
2959837|NCT00744978|3674307|FG000|STARTED|Period 2||26
2959838|NCT00744978|3674308|FG001|STARTED|Period 2||29
2959839|NCT00744978|3674307|FG000|COMPLETED|Period 2||26
2959840|NCT00744978|3674308|FG001|COMPLETED|Period 2||28
2959841|NCT00744978|3674307|FG000|NOT COMPLETED|Period 2||0
2959842|NCT00744978|3674308|FG001|NOT COMPLETED|Period 2||1
3300604|NCT02948426|4034483|FG000|NOT COMPLETED|Overall Study||0
3300605|NCT02948426|4034484|FG001|NOT COMPLETED|Overall Study||0
3300606|NCT02948426|4034485|FG002|NOT COMPLETED|Overall Study||0
3300607|NCT02948426|4034486|FG003|NOT COMPLETED|Overall Study||0
3300608|NCT02948582|4034498|FG000|STARTED|Treatment Period 1||7
3300609|NCT02948582|4034499|FG001|STARTED|Treatment Period 1||7
3300610|NCT02948582|4034500|FG002|STARTED|Treatment Period 1||7
3300611|NCT02948582|4034501|FG003|STARTED|Treatment Period 1||7
3300612|NCT02948582|4034502|FG004|STARTED|Treatment Period 1||7
3300613|NCT02948582|4034503|FG005|STARTED|Treatment Period 1||7
3300614|NCT02948582|4034498|FG000|COMPLETED|Treatment Period 1||7
3300615|NCT02948582|4034499|FG001|COMPLETED|Treatment Period 1||7
3300616|NCT02948582|4034500|FG002|COMPLETED|Treatment Period 1||7
3300617|NCT02948582|4034501|FG003|COMPLETED|Treatment Period 1||7
3300618|NCT02948582|4034502|FG004|COMPLETED|Treatment Period 1||7
3300619|NCT02948582|4034503|FG005|COMPLETED|Treatment Period 1||7
3300620|NCT02948582|4034498|FG000|NOT COMPLETED|Treatment Period 1||0
3300621|NCT02948582|4034499|FG001|NOT COMPLETED|Treatment Period 1||0
3300622|NCT02948582|4034500|FG002|NOT COMPLETED|Treatment Period 1||0
3300623|NCT02948582|4034501|FG003|NOT COMPLETED|Treatment Period 1||0
3300624|NCT02948582|4034502|FG004|NOT COMPLETED|Treatment Period 1||0
3300625|NCT02948582|4034503|FG005|NOT COMPLETED|Treatment Period 1||0
3300626|NCT02948582|4034498|FG000|STARTED|Washout Period 1||7
3300627|NCT02948582|4034499|FG001|STARTED|Washout Period 1||7
3300628|NCT02948582|4034500|FG002|STARTED|Washout Period 1||7
3300629|NCT02948582|4034501|FG003|STARTED|Washout Period 1||7
3300630|NCT02948582|4034502|FG004|STARTED|Washout Period 1||7
3300631|NCT02948582|4034503|FG005|STARTED|Washout Period 1||7
3300632|NCT02948582|4034498|FG000|COMPLETED|Washout Period 1||7
3300633|NCT02948582|4034499|FG001|COMPLETED|Washout Period 1||5
3300634|NCT02948582|4034500|FG002|COMPLETED|Washout Period 1||7
3300635|NCT02948582|4034501|FG003|COMPLETED|Washout Period 1||7
3300636|NCT02948582|4034502|FG004|COMPLETED|Washout Period 1||7
3300637|NCT02948582|4034503|FG005|COMPLETED|Washout Period 1||6
3300638|NCT02948582|4034498|FG000|NOT COMPLETED|Washout Period 1||0
3300639|NCT02948582|4034499|FG001|NOT COMPLETED|Washout Period 1||2
3300640|NCT02948582|4034500|FG002|NOT COMPLETED|Washout Period 1||0
2959843|NCT00744991|3674314|FG000|STARTED|Overall Study||25
3300641|NCT02948582|4034501|FG003|NOT COMPLETED|Washout Period 1||0
3132765|NCT01693068|3857941|FG001|STARTED|Cross-over (Dacarbazine To Pimasertib)||0
3132766|NCT01693068|3857942|FG002|STARTED|Cross-over (Dacarbazine To Pimasertib)||41
3136737|NCT01714726|3861990|FG002|STARTED|Open-Label Period||52
2959844|NCT00744991|3674314|FG000|Received at Least 1 Dose|Overall Study||25
2959845|NCT00744991|3674314|FG000|COMPLETED|Overall Study||0
2959846|NCT00744991|3674314|FG000|NOT COMPLETED|Overall Study||25
2959847|NCT00745095|3674327|FG000|STARTED|Overall Study||15
2959848|NCT00745095|3674328|FG001|STARTED|Overall Study||15
2959849|NCT00745095|3674329|FG002|STARTED|Overall Study||15
2959850|NCT00745095|3674330|FG003|STARTED|Overall Study||15
2959851|NCT00745095|3674331|FG004|STARTED|Overall Study||150
2959852|NCT00745095|3674332|FG005|STARTED|Overall Study||150
2959853|NCT00745095|3674327|FG000|COMPLETED|Overall Study||14
2959854|NCT00745095|3674328|FG001|COMPLETED|Overall Study||13
2959855|NCT00745095|3674329|FG002|COMPLETED|Overall Study||12
2959856|NCT00745095|3674330|FG003|COMPLETED|Overall Study||12
2959857|NCT00745095|3674331|FG004|COMPLETED|Overall Study||28
2959858|NCT00745095|3674332|FG005|COMPLETED|Overall Study||27
2959859|NCT00745095|3674327|FG000|NOT COMPLETED|Overall Study||1
2959860|NCT00745095|3674328|FG001|NOT COMPLETED|Overall Study||2
2959861|NCT00745095|3674329|FG002|NOT COMPLETED|Overall Study||3
2959862|NCT00745095|3674330|FG003|NOT COMPLETED|Overall Study||3
2959863|NCT00745095|3674331|FG004|NOT COMPLETED|Overall Study||122
2959864|NCT00745095|3674332|FG005|NOT COMPLETED|Overall Study||123
2959865|NCT00745121|3674351|FG000|STARTED|Overall Study||20
2959866|NCT00745121|3674352|FG001|STARTED|Overall Study||28
2959867|NCT00745121|3674351|FG000|COMPLETED|Overall Study||11
2959868|NCT00745121|3674352|FG001|COMPLETED|Overall Study||26
2959869|NCT00745121|3674351|FG000|NOT COMPLETED|Overall Study||9
2959870|NCT00745121|3674352|FG001|NOT COMPLETED|Overall Study||2
2959871|NCT00745251|3674360|FG000|STARTED|Overall Study||23
2959872|NCT00745251|3674361|FG001|STARTED|Overall Study||22
2959873|NCT00745251|3674360|FG000|COMPLETED|Overall Study||21
2959874|NCT00745251|3674361|FG001|COMPLETED|Overall Study||19
2959875|NCT00745251|3674360|FG000|NOT COMPLETED|Overall Study||2
2959876|NCT00745251|3674361|FG001|NOT COMPLETED|Overall Study||3
2959877|NCT00745290|3674369|FG000|STARTED|Overall Study||123
2959878|NCT00745290|3674370|FG001|STARTED|Overall Study||122
2959879|NCT00745290|3674369|FG000|COMPLETED|Overall Study||123
2959880|NCT00745290|3674370|FG001|COMPLETED|Overall Study||122
2959881|NCT00745290|3674369|FG000|NOT COMPLETED|Overall Study||0
2959882|NCT00745290|3674370|FG001|NOT COMPLETED|Overall Study||0
2959883|NCT00745368|3674376|FG000|STARTED|Overall Study|Of the 28 subjects who enrolled, 19 participated in a study visit|19
2959884|NCT00745368|3674376|FG000|COMPLETED|Overall Study|3 male subjects were unable to provide a sample and are not included in the results|16
2959885|NCT00745368|3674376|FG000|NOT COMPLETED|Overall Study||3
2959886|NCT00745420|3674380|FG000|STARTED|Overall Study||30
2959887|NCT00745420|3674380|FG000|COMPLETED|Overall Study||29
2959888|NCT00745420|3674380|FG000|NOT COMPLETED|Overall Study||1
2959889|NCT00745498|3674387|FG000|STARTED|Overall Study||41
2959890|NCT00745498|3674388|FG001|STARTED|Overall Study||43
2959891|NCT00745498|3674389|FG002|STARTED|Overall Study||42
2959892|NCT00745498|3674387|FG000|COMPLETED|Overall Study||36
2959893|NCT00745498|3674388|FG001|COMPLETED|Overall Study||37
2959894|NCT00745498|3674389|FG002|COMPLETED|Overall Study||34
2959895|NCT00745498|3674387|FG000|NOT COMPLETED|Overall Study||5
2959896|NCT00745498|3674388|FG001|NOT COMPLETED|Overall Study||6
2959897|NCT00745498|3674389|FG002|NOT COMPLETED|Overall Study||8
2959898|NCT00745615|3674401|FG000|STARTED|Double-Blind Extension (36 Weeks)||80
2959899|NCT00745615|3674402|FG001|STARTED|Double-Blind Extension (36 Weeks)||94
2959900|NCT00745615|3674403|FG002|STARTED|Double-Blind Extension (36 Weeks)||39
2959901|NCT00745615|3674404|FG003|STARTED|Double-Blind Extension (36 Weeks)||44
2959902|NCT00745615|3674405|FG004|STARTED|Double-Blind Extension (36 Weeks)||0
2959903|NCT00745615|3674406|FG005|STARTED|Double-Blind Extension (36 Weeks)||0
2959904|NCT00745615|3674401|FG000|COMPLETED|Double-Blind Extension (36 Weeks)||75
2959905|NCT00745615|3674402|FG001|COMPLETED|Double-Blind Extension (36 Weeks)||87
2959906|NCT00745615|3674403|FG002|COMPLETED|Double-Blind Extension (36 Weeks)||38
2959907|NCT00745615|3674404|FG003|COMPLETED|Double-Blind Extension (36 Weeks)||39
2959908|NCT00745615|3674405|FG004|COMPLETED|Double-Blind Extension (36 Weeks)||0
2959909|NCT00745615|3674406|FG005|COMPLETED|Double-Blind Extension (36 Weeks)||0
2959910|NCT00745615|3674401|FG000|NOT COMPLETED|Double-Blind Extension (36 Weeks)||5
2959911|NCT00745615|3674402|FG001|NOT COMPLETED|Double-Blind Extension (36 Weeks)||7
2959912|NCT00745615|3674403|FG002|NOT COMPLETED|Double-Blind Extension (36 Weeks)||1
2959913|NCT00745615|3674404|FG003|NOT COMPLETED|Double-Blind Extension (36 Weeks)||5
2959914|NCT00745615|3674405|FG004|NOT COMPLETED|Double-Blind Extension (36 Weeks)||0
2959915|NCT00745615|3674406|FG005|NOT COMPLETED|Double-Blind Extension (36 Weeks)||0
2959916|NCT00745615|3674401|FG000|STARTED|Open-Label (up to Approx 10.5 Years)||0
2959917|NCT00745615|3674402|FG001|STARTED|Open-Label (up to Approx 10.5 Years)||0
2959918|NCT00745615|3674403|FG002|STARTED|Open-Label (up to Approx 10.5 Years)||0
2959919|NCT00745615|3674404|FG003|STARTED|Open-Label (up to Approx 10.5 Years)||0
2959920|NCT00745615|3674405|FG004|STARTED|Open-Label (up to Approx 10.5 Years)||96
2959921|NCT00745615|3674406|FG005|STARTED|Open-Label (up to Approx 10.5 Years)||113
2959922|NCT00745615|3674401|FG000|COMPLETED|Open-Label (up to Approx 10.5 Years)||0
2959923|NCT00745615|3674402|FG001|COMPLETED|Open-Label (up to Approx 10.5 Years)||0
2959924|NCT00745615|3674403|FG002|COMPLETED|Open-Label (up to Approx 10.5 Years)||0
2959925|NCT00745615|3674404|FG003|COMPLETED|Open-Label (up to Approx 10.5 Years)||0
2959926|NCT00745615|3674405|FG004|COMPLETED|Open-Label (up to Approx 10.5 Years)||5
3300642|NCT02948582|4034502|FG004|NOT COMPLETED|Washout Period 1||0
3300643|NCT02948582|4034503|FG005|NOT COMPLETED|Washout Period 1||1
3300644|NCT02948582|4034498|FG000|STARTED|Treatment Period 2||7
3300645|NCT02948582|4034499|FG001|STARTED|Treatment Period 2||5
3300646|NCT02948582|4034500|FG002|STARTED|Treatment Period 2||7
3300647|NCT02948582|4034501|FG003|STARTED|Treatment Period 2||7
3300648|NCT02948582|4034502|FG004|STARTED|Treatment Period 2||7
2959927|NCT00745615|3674406|FG005|COMPLETED|Open-Label (up to Approx 10.5 Years)||5
2959928|NCT00745615|3674401|FG000|NOT COMPLETED|Open-Label (up to Approx 10.5 Years)||0
2959929|NCT00745615|3674402|FG001|NOT COMPLETED|Open-Label (up to Approx 10.5 Years)||0
2959930|NCT00745615|3674403|FG002|NOT COMPLETED|Open-Label (up to Approx 10.5 Years)||0
2959931|NCT00745615|3674404|FG003|NOT COMPLETED|Open-Label (up to Approx 10.5 Years)||0
2959932|NCT00745615|3674405|FG004|NOT COMPLETED|Open-Label (up to Approx 10.5 Years)||91
2959933|NCT00745615|3674406|FG005|NOT COMPLETED|Open-Label (up to Approx 10.5 Years)||108
2959934|NCT00745823|3674420|FG000|STARTED|Overall Study||386
2959935|NCT00745823|3674421|FG001|STARTED|Overall Study||389
2959936|NCT00745823|3674420|FG000|TREATED Week 0 - 96|Overall Study||382
2959937|NCT00745823|3674421|FG001|TREATED Week 0 - 96|Overall Study||388
2959938|NCT00745823|3674420|FG000|COMPLETED|Overall Study||1
2959939|NCT00745823|3674421|FG001|COMPLETED|Overall Study||3
2959940|NCT00745823|3674420|FG000|NOT COMPLETED|Overall Study||385
2959941|NCT00745823|3674421|FG001|NOT COMPLETED|Overall Study||386
2959942|NCT00745849|3674429|FG000|STARTED|First Intervention||21
2959943|NCT00745849|3674430|FG001|STARTED|First Intervention||22
2959944|NCT00745849|3674429|FG000|COMPLETED|First Intervention||20
2959945|NCT00745849|3674430|FG001|COMPLETED|First Intervention||20
2959946|NCT00745849|3674429|FG000|NOT COMPLETED|First Intervention||1
2959947|NCT00745849|3674430|FG001|NOT COMPLETED|First Intervention||2
2959948|NCT00745849|3674429|FG000|STARTED|Washout Period||20
2959949|NCT00745849|3674430|FG001|STARTED|Washout Period||20
2959950|NCT00745849|3674429|FG000|COMPLETED|Washout Period||20
2959951|NCT00745849|3674430|FG001|COMPLETED|Washout Period||20
2959952|NCT00745849|3674429|FG000|NOT COMPLETED|Washout Period||0
2959953|NCT00745849|3674430|FG001|NOT COMPLETED|Washout Period||0
2959954|NCT00745849|3674429|FG000|STARTED|Second Intervention||20
2959955|NCT00745849|3674430|FG001|STARTED|Second Intervention||20
2959956|NCT00745849|3674429|FG000|COMPLETED|Second Intervention||18
2959957|NCT00745849|3674430|FG001|COMPLETED|Second Intervention||19
2959958|NCT00745849|3674429|FG000|NOT COMPLETED|Second Intervention||2
2959959|NCT00745849|3674430|FG001|NOT COMPLETED|Second Intervention||1
2959960|NCT00745875|3674438|FG000|STARTED|Overall Study|Started - Number of patients randomised|36
2959961|NCT00745875|3674439|FG001|STARTED|Overall Study|Started - Number of patients randomised|30
2959962|NCT00745875|3674438|FG000|COMPLETED|Overall Study|Completed - Number of patients discontinued study treatment at data cut-off (17th January 2010)|32
2959963|NCT00745875|3674439|FG001|COMPLETED|Overall Study|Completed - Number of patients discontinued study treatment at data cut-off (17th January 2010)|26
2959964|NCT00745875|3674438|FG000|NOT COMPLETED|Overall Study||4
2959965|NCT00745875|3674439|FG001|NOT COMPLETED|Overall Study||4
2959966|NCT00745901|3674447|FG000|STARTED|Overall Study|Number of Patients Randomized|178
2959967|NCT00745901|3674448|FG001|STARTED|Overall Study|Number of Patients Randomized|177
2959968|NCT00745901|3674447|FG000|COMPLETED|Overall Study||154
2959969|NCT00745901|3674448|FG001|COMPLETED|Overall Study||156
2959970|NCT00745901|3674447|FG000|NOT COMPLETED|Overall Study||24
2959971|NCT00745901|3674448|FG001|NOT COMPLETED|Overall Study||21
2959972|NCT00745940|3674456|FG000|STARTED|Overall Study||57
2959973|NCT00745940|3674457|FG001|STARTED|Overall Study||48
2959974|NCT00745940|3674456|FG000|COMPLETED|Overall Study||38
2959975|NCT00745940|3674457|FG001|COMPLETED|Overall Study||38
2959976|NCT00745940|3674456|FG000|NOT COMPLETED|Overall Study||19
2959977|NCT00745940|3674457|FG001|NOT COMPLETED|Overall Study||10
2959978|NCT00746096|3674465|FG000|STARTED|Overall Study||58
2959979|NCT00746096|3674466|FG001|STARTED|Overall Study||57
2959980|NCT00746096|3674465|FG000|COMPLETED|Overall Study||48
2959981|NCT00746096|3674466|FG001|COMPLETED|Overall Study||54
2959982|NCT00746096|3674465|FG000|NOT COMPLETED|Overall Study||10
2959983|NCT00746096|3674466|FG001|NOT COMPLETED|Overall Study||3
2959984|NCT00746122|3674474|FG000|STARTED|Overall Study||297
2959985|NCT00746122|3674475|FG001|STARTED|Overall Study|After 600 recruitment target 13 more patients were randomised before sites could be closed down.|316
2959986|NCT00746122|3674474|FG000|COMPLETED|Overall Study||297
2959987|NCT00746122|3674475|FG001|COMPLETED|Overall Study||316
2959988|NCT00746122|3674474|FG000|NOT COMPLETED|Overall Study||0
2959989|NCT00746122|3674475|FG001|NOT COMPLETED|Overall Study||0
2959990|NCT00746187|3674483|FG000|STARTED|Overall Study||18
2959991|NCT00746187|3674484|FG001|STARTED|Overall Study||18
2959992|NCT00746187|3674483|FG000|COMPLETED|Overall Study||15
2959993|NCT00746187|3674484|FG001|COMPLETED|Overall Study||16
2959994|NCT00746187|3674483|FG000|NOT COMPLETED|Overall Study||3
2959995|NCT00746187|3674484|FG001|NOT COMPLETED|Overall Study||2
2959996|NCT00746252|3674492|FG000|STARTED|Overall Study||1
2959997|NCT00746252|3674493|FG001|STARTED|Overall Study||2
2959998|NCT00746252|3674492|FG000|COMPLETED|Overall Study||0
2959999|NCT00746252|3674493|FG001|COMPLETED|Overall Study||0
2960000|NCT00746252|3674492|FG000|NOT COMPLETED|Overall Study||1
3300649|NCT02948582|4034503|FG005|STARTED|Treatment Period 2||6
3300650|NCT02948582|4034498|FG000|COMPLETED|Treatment Period 2||7
2960001|NCT00746252|3674493|FG001|NOT COMPLETED|Overall Study||2
2960002|NCT00746330|3674503|FG000|STARTED|Period 1||7
2960003|NCT00746330|3674504|FG001|STARTED|Period 1||9
2960004|NCT00746330|3674505|FG002|STARTED|Period 1||9
2960005|NCT00746330|3674506|FG003|STARTED|Period 1||7
2960006|NCT00746330|3674503|FG000|COMPLETED|Period 1||7
2960007|NCT00746330|3674504|FG001|COMPLETED|Period 1||9
2960008|NCT00746330|3674505|FG002|COMPLETED|Period 1||8
2960009|NCT00746330|3674506|FG003|COMPLETED|Period 1||7
2960010|NCT00746330|3674503|FG000|NOT COMPLETED|Period 1||0
2960011|NCT00746330|3674504|FG001|NOT COMPLETED|Period 1||0
2960012|NCT00746330|3674505|FG002|NOT COMPLETED|Period 1||1
2960013|NCT00746330|3674506|FG003|NOT COMPLETED|Period 1||0
2960014|NCT00746330|3674503|FG000|STARTED|Period 2||7
2960015|NCT00746330|3674504|FG001|STARTED|Period 2||9
2960016|NCT00746330|3674505|FG002|STARTED|Period 2||8
2960017|NCT00746330|3674506|FG003|STARTED|Period 2||7
2960018|NCT00746330|3674503|FG000|COMPLETED|Period 2||7
3132767|NCT01693068|3857940|FG000|Treated|Cross-over (Dacarbazine To Pimasertib)||0
3132768|NCT01693068|3857941|FG001|Treated|Cross-over (Dacarbazine To Pimasertib)||0
3132769|NCT01693068|3857942|FG002|Treated|Cross-over (Dacarbazine To Pimasertib)||41
2960019|NCT00746330|3674504|FG001|COMPLETED|Period 2||9
2960020|NCT00746330|3674505|FG002|COMPLETED|Period 2||8
2960021|NCT00746330|3674506|FG003|COMPLETED|Period 2||7
2960022|NCT00746330|3674503|FG000|NOT COMPLETED|Period 2||0
2960023|NCT00746330|3674504|FG001|NOT COMPLETED|Period 2||0
2960024|NCT00746330|3674505|FG002|NOT COMPLETED|Period 2||0
2960025|NCT00746330|3674506|FG003|NOT COMPLETED|Period 2||0
2960026|NCT00746330|3674503|FG000|STARTED|Period 3||7
2960027|NCT00746330|3674504|FG001|STARTED|Period 3||9
2960028|NCT00746330|3674505|FG002|STARTED|Period 3||8
2960029|NCT00746330|3674506|FG003|STARTED|Period 3||7
2960030|NCT00746330|3674503|FG000|COMPLETED|Period 3||7
2960031|NCT00746330|3674504|FG001|COMPLETED|Period 3||9
2960032|NCT00746330|3674505|FG002|COMPLETED|Period 3||8
3132770|NCT01693068|3857940|FG000|COMPLETED|Cross-over (Dacarbazine To Pimasertib)||0
3132771|NCT01693068|3857941|FG001|COMPLETED|Cross-over (Dacarbazine To Pimasertib)||0
3132772|NCT01693068|3857942|FG002|COMPLETED|Cross-over (Dacarbazine To Pimasertib)||40
2960033|NCT00746330|3674506|FG003|COMPLETED|Period 3||7
2960034|NCT00746330|3674503|FG000|NOT COMPLETED|Period 3||0
2960035|NCT00746330|3674504|FG001|NOT COMPLETED|Period 3||0
2960036|NCT00746330|3674505|FG002|NOT COMPLETED|Period 3||0
2960037|NCT00746330|3674506|FG003|NOT COMPLETED|Period 3||0
2960038|NCT00746330|3674503|FG000|STARTED|Period 4||7
2960039|NCT00746330|3674504|FG001|STARTED|Period 4||9
2960040|NCT00746330|3674505|FG002|STARTED|Period 4||8
2960041|NCT00746330|3674506|FG003|STARTED|Period 4||7
2960042|NCT00746330|3674503|FG000|COMPLETED|Period 4||7
2960043|NCT00746330|3674504|FG001|COMPLETED|Period 4||9
2960044|NCT00746330|3674505|FG002|COMPLETED|Period 4||8
2960045|NCT00746330|3674506|FG003|COMPLETED|Period 4||7
2960046|NCT00746330|3674503|FG000|NOT COMPLETED|Period 4||0
2960047|NCT00746330|3674504|FG001|NOT COMPLETED|Period 4||0
2960048|NCT00746330|3674505|FG002|NOT COMPLETED|Period 4||0
2960049|NCT00746330|3674506|FG003|NOT COMPLETED|Period 4||0
2960050|NCT00746356|3674517|FG000|STARTED|Overall Study||81
2960051|NCT00746356|3674518|FG001|STARTED|Overall Study||47
2960052|NCT00746356|3674517|FG000|COMPLETED|Overall Study||70
2960053|NCT00746356|3674518|FG001|COMPLETED|Overall Study||40
2960054|NCT00746356|3674517|FG000|NOT COMPLETED|Overall Study||11
2960055|NCT00746356|3674518|FG001|NOT COMPLETED|Overall Study||7
2960056|NCT00746395|3674528|FG000|STARTED|Overall Study||20
2960057|NCT00746395|3674529|FG001|STARTED|Overall Study||20
2960058|NCT00746395|3674528|FG000|COMPLETED|Overall Study||20
2960059|NCT00746395|3674529|FG001|COMPLETED|Overall Study||20
2960060|NCT00746395|3674528|FG000|NOT COMPLETED|Overall Study||0
2960061|NCT00746395|3674529|FG001|NOT COMPLETED|Overall Study||0
2960062|NCT00746421|3674537|FG000|STARTED|Overall Study||12
2960063|NCT00746421|3674538|FG001|STARTED|Overall Study||11
2960064|NCT00746421|3674537|FG000|COMPLETED|Overall Study||5
2960065|NCT00746421|3674538|FG001|COMPLETED|Overall Study||9
2960066|NCT00746421|3674537|FG000|NOT COMPLETED|Overall Study||7
2960067|NCT00746421|3674538|FG001|NOT COMPLETED|Overall Study||2
2960068|NCT00746512|3674548|FG000|STARTED|Overall Study||8
2960069|NCT00746512|3674549|FG001|STARTED|Overall Study||10
2960070|NCT00746512|3674550|FG002|STARTED|Overall Study||18
3132773|NCT01693068|3857940|FG000|NOT COMPLETED|Cross-over (Dacarbazine To Pimasertib)||0
3132774|NCT01693068|3857941|FG001|NOT COMPLETED|Cross-over (Dacarbazine To Pimasertib)||0
3132775|NCT01693068|3857942|FG002|NOT COMPLETED|Cross-over (Dacarbazine To Pimasertib)||1
3132776|NCT01693120|3857950|FG000|STARTED|Enrollment|70 subjects exited the study after consent, but prior to undergoing a study ablation procedure.|199
3132777|NCT01693120|3857950|FG000|COMPLETED|Enrollment|129 of the 199 enrolled subjects underwent a Phased RF study procedure|129
3132778|NCT01693120|3857950|FG000|NOT COMPLETED|Enrollment||70
3132779|NCT01693120|3857950|FG000|STARTED|Phased RF Study Procedure and Follow-up||129
2960071|NCT00746512|3674551|FG003|STARTED|Overall Study||9
2960072|NCT00746512|3674548|FG000|COMPLETED|Overall Study||8
2960073|NCT00746512|3674549|FG001|COMPLETED|Overall Study||10
2960074|NCT00746512|3674550|FG002|COMPLETED|Overall Study||18
2960075|NCT00746512|3674551|FG003|COMPLETED|Overall Study||9
2960076|NCT00746512|3674548|FG000|NOT COMPLETED|Overall Study||0
2960077|NCT00746512|3674549|FG001|NOT COMPLETED|Overall Study||0
2960078|NCT00746512|3674550|FG002|NOT COMPLETED|Overall Study||0
2960079|NCT00746512|3674551|FG003|NOT COMPLETED|Overall Study||0
2960080|NCT00746551|3674563|FG000|STARTED|At Gestational Age of 36 Weeks||40
2960081|NCT00746551|3674564|FG001|STARTED|At Gestational Age of 36 Weeks||40
2960082|NCT00746551|3674563|FG000|COMPLETED|At Gestational Age of 36 Weeks||38
2960083|NCT00746551|3674564|FG001|COMPLETED|At Gestational Age of 36 Weeks||36
2960084|NCT00746551|3674563|FG000|NOT COMPLETED|At Gestational Age of 36 Weeks||2
2960085|NCT00746551|3674564|FG001|NOT COMPLETED|At Gestational Age of 36 Weeks||4
2960086|NCT00746551|3674563|FG000|STARTED|At Delivery (GA of 39 Weeks)||40
2960087|NCT00746551|3674564|FG001|STARTED|At Delivery (GA of 39 Weeks)||40
2960088|NCT00746551|3674563|FG000|COMPLETED|At Delivery (GA of 39 Weeks)||25
2960089|NCT00746551|3674564|FG001|COMPLETED|At Delivery (GA of 39 Weeks)||25
2960090|NCT00746551|3674563|FG000|NOT COMPLETED|At Delivery (GA of 39 Weeks)||15
2960091|NCT00746551|3674564|FG001|NOT COMPLETED|At Delivery (GA of 39 Weeks)||15
2960092|NCT00746564|3674570|FG000|STARTED|Overall Study||75
2960093|NCT00746564|3674570|FG000|COMPLETED|Overall Study||73
2960094|NCT00746564|3674570|FG000|NOT COMPLETED|Overall Study||2
2960095|NCT00746668|3674576|FG000|STARTED|Overall Study||6
2960096|NCT00746668|3674577|FG001|STARTED|Overall Study||5
2960097|NCT00746668|3674578|FG002|STARTED|Overall Study||5
2960098|NCT00746668|3674579|FG003|STARTED|Overall Study||5
2960099|NCT00746668|3674580|FG004|STARTED|Overall Study||5
2960100|NCT00746668|3674581|FG005|STARTED|Overall Study||5
2960101|NCT00746668|3674582|FG006|STARTED|Overall Study||5
2960102|NCT00746668|3674576|FG000|COMPLETED|Overall Study||6
2960103|NCT00746668|3674577|FG001|COMPLETED|Overall Study||5
2960104|NCT00746668|3674578|FG002|COMPLETED|Overall Study||5
2960105|NCT00746668|3674579|FG003|COMPLETED|Overall Study||5
2960106|NCT00746668|3674580|FG004|COMPLETED|Overall Study||5
2960107|NCT00746668|3674581|FG005|COMPLETED|Overall Study||5
2960108|NCT00746668|3674582|FG006|COMPLETED|Overall Study||5
2960109|NCT00746668|3674576|FG000|NOT COMPLETED|Overall Study||0
2960110|NCT00746668|3674577|FG001|NOT COMPLETED|Overall Study||0
2960111|NCT00746668|3674578|FG002|NOT COMPLETED|Overall Study||0
2960112|NCT00746668|3674579|FG003|NOT COMPLETED|Overall Study||0
2960113|NCT00746668|3674580|FG004|NOT COMPLETED|Overall Study||0
2960114|NCT00746668|3674581|FG005|NOT COMPLETED|Overall Study||0
2960115|NCT00746668|3674582|FG006|NOT COMPLETED|Overall Study||0
2960116|NCT00746694|3674595|FG000|STARTED|Overall Study||154
2960117|NCT00746694|3674595|FG000|COMPLETED|Overall Study||154
2960118|NCT00746694|3674595|FG000|NOT COMPLETED|Overall Study||0
2960119|NCT00746733|3674599|FG000|STARTED|First Intervention||12
2960120|NCT00746733|3674600|FG001|STARTED|First Intervention||12
2960121|NCT00746733|3674599|FG000|COMPLETED|First Intervention||12
2960122|NCT00746733|3674600|FG001|COMPLETED|First Intervention||12
2960123|NCT00746733|3674599|FG000|NOT COMPLETED|First Intervention||0
2960124|NCT00746733|3674600|FG001|NOT COMPLETED|First Intervention||0
2960125|NCT00746733|3674599|FG000|STARTED|Second Intervention||12
2960126|NCT00746733|3674600|FG001|STARTED|Second Intervention||12
2960127|NCT00746733|3674599|FG000|COMPLETED|Second Intervention||11
2960128|NCT00746733|3674600|FG001|COMPLETED|Second Intervention||12
2960129|NCT00746733|3674599|FG000|NOT COMPLETED|Second Intervention||1
2960130|NCT00746733|3674600|FG001|NOT COMPLETED|Second Intervention||0
2960131|NCT00746733|3674599|FG000|STARTED|Third Intervention||11
2960132|NCT00746733|3674600|FG001|STARTED|Third Intervention||12
2960133|NCT00746733|3674599|FG000|COMPLETED|Third Intervention||10
2960134|NCT00746733|3674600|FG001|COMPLETED|Third Intervention||11
2960135|NCT00746733|3674599|FG000|NOT COMPLETED|Third Intervention||1
2960136|NCT00746733|3674600|FG001|NOT COMPLETED|Third Intervention||1
2960137|NCT00746733|3674599|FG000|STARTED|Fourth Intervention||10
2960138|NCT00746733|3674600|FG001|STARTED|Fourth Intervention||11
2960139|NCT00746733|3674599|FG000|COMPLETED|Fourth Intervention||10
2960140|NCT00746733|3674600|FG001|COMPLETED|Fourth Intervention||11
2960141|NCT00746733|3674599|FG000|NOT COMPLETED|Fourth Intervention||0
2960142|NCT00746733|3674600|FG001|NOT COMPLETED|Fourth Intervention||0
2960143|NCT00746785|3674616|FG000|STARTED|Overall Study||43
2960144|NCT00746785|3674617|FG001|STARTED|Overall Study||46
2960145|NCT00746785|3674618|FG002|STARTED|Overall Study||40
2960146|NCT00746785|3674616|FG000|COMPLETED|Overall Study||14
2960147|NCT00746785|3674617|FG001|COMPLETED|Overall Study||21
2960148|NCT00746785|3674618|FG002|COMPLETED|Overall Study||13
2960149|NCT00746785|3674616|FG000|NOT COMPLETED|Overall Study||29
3300651|NCT02948582|4034499|FG001|COMPLETED|Treatment Period 2||5
3300652|NCT02948582|4034500|FG002|COMPLETED|Treatment Period 2||7
3300653|NCT02948582|4034501|FG003|COMPLETED|Treatment Period 2||7
3300654|NCT02948582|4034502|FG004|COMPLETED|Treatment Period 2||7
3300655|NCT02948582|4034503|FG005|COMPLETED|Treatment Period 2||6
3300656|NCT02948582|4034498|FG000|NOT COMPLETED|Treatment Period 2||0
3300657|NCT02948582|4034499|FG001|NOT COMPLETED|Treatment Period 2||0
3300658|NCT02948582|4034500|FG002|NOT COMPLETED|Treatment Period 2||0
3300659|NCT02948582|4034501|FG003|NOT COMPLETED|Treatment Period 2||0
3300660|NCT02948582|4034502|FG004|NOT COMPLETED|Treatment Period 2||0
3300661|NCT02948582|4034503|FG005|NOT COMPLETED|Treatment Period 2||0
3300662|NCT02948582|4034498|FG000|STARTED|Washout Period 2||7
2960150|NCT00746785|3674617|FG001|NOT COMPLETED|Overall Study||25
2960151|NCT00746785|3674618|FG002|NOT COMPLETED|Overall Study||27
2960152|NCT00746798|3674630|FG000|STARTED|Overall Study||122
2960153|NCT00746798|3674631|FG001|STARTED|Overall Study||124
2960154|NCT00746798|3674632|FG002|STARTED|Overall Study||113
2960155|NCT00746798|3674633|FG003|STARTED|Overall Study||120
3300663|NCT02948582|4034499|FG001|STARTED|Washout Period 2||5
2960156|NCT00746798|3674630|FG000|COMPLETED|Overall Study||121
2960157|NCT00746798|3674631|FG001|COMPLETED|Overall Study||122
2960158|NCT00746798|3674632|FG002|COMPLETED|Overall Study||110
2960159|NCT00746798|3674633|FG003|COMPLETED|Overall Study||120
2960160|NCT00746798|3674630|FG000|NOT COMPLETED|Overall Study||1
2960161|NCT00746798|3674631|FG001|NOT COMPLETED|Overall Study||2
2960162|NCT00746798|3674632|FG002|NOT COMPLETED|Overall Study||3
2960163|NCT00746798|3674633|FG003|NOT COMPLETED|Overall Study||0
2960164|NCT00746863|3674645|FG000|STARTED|Overall Study||21
2960165|NCT00746863|3674646|FG001|STARTED|Overall Study||21
2960166|NCT00746863|3674645|FG000|COMPLETED|Overall Study||21
2960167|NCT00746863|3674646|FG001|COMPLETED|Overall Study||21
2960168|NCT00746863|3674645|FG000|NOT COMPLETED|Overall Study||0
2960169|NCT00746863|3674646|FG001|NOT COMPLETED|Overall Study||0
2960170|NCT00746889|3674654|FG000|STARTED|Overall Study||40
2960171|NCT00746889|3674655|FG001|STARTED|Overall Study||39
2960172|NCT00746889|3674654|FG000|COMPLETED|Overall Study||36
2960173|NCT00746889|3674655|FG001|COMPLETED|Overall Study||35
2960174|NCT00746889|3674654|FG000|NOT COMPLETED|Overall Study||4
2960175|NCT00746889|3674655|FG001|NOT COMPLETED|Overall Study||4
2960176|NCT00746941|3674667|FG000|STARTED|Overall Study||7
2960177|NCT00746941|3674668|FG001|STARTED|Overall Study||5
2960178|NCT00746941|3674669|FG002|STARTED|Overall Study||5
2960179|NCT00746941|3674670|FG003|STARTED|Overall Study||20
2960180|NCT00746941|3674667|FG000|COMPLETED|Overall Study||0
2960181|NCT00746941|3674668|FG001|COMPLETED|Overall Study||1
2960182|NCT00746941|3674669|FG002|COMPLETED|Overall Study||3
2960183|NCT00746941|3674670|FG003|COMPLETED|Overall Study||7
2960184|NCT00746941|3674667|FG000|NOT COMPLETED|Overall Study||7
2960185|NCT00746941|3674668|FG001|NOT COMPLETED|Overall Study||4
2960186|NCT00746941|3674669|FG002|NOT COMPLETED|Overall Study||2
2960187|NCT00746941|3674670|FG003|NOT COMPLETED|Overall Study||13
2960188|NCT00746954|3674679|FG000|STARTED|Overall Study||3
2960189|NCT00746954|3674680|FG001|STARTED|Overall Study||3
2960190|NCT00746954|3674681|FG002|STARTED|Overall Study||2
2960191|NCT00746954|3674679|FG000|COMPLETED|Overall Study||3
2960192|NCT00746954|3674680|FG001|COMPLETED|Overall Study||3
2960193|NCT00746954|3674681|FG002|COMPLETED|Overall Study||2
2960194|NCT00746954|3674679|FG000|NOT COMPLETED|Overall Study||0
2960195|NCT00746954|3674680|FG001|NOT COMPLETED|Overall Study||0
2960196|NCT00746954|3674681|FG002|NOT COMPLETED|Overall Study||0
2960197|NCT00747006|3674690|FG000|STARTED|Overall Study||7
2960198|NCT00747006|3674691|FG001|STARTED|Overall Study||8
2960199|NCT00747006|3674692|FG002|STARTED|Overall Study||3
2960200|NCT00747006|3674690|FG000|COMPLETED|Overall Study||4
2960201|NCT00747006|3674691|FG001|COMPLETED|Overall Study||7
2960202|NCT00747006|3674692|FG002|COMPLETED|Overall Study||2
2960203|NCT00747006|3674690|FG000|NOT COMPLETED|Overall Study||3
2960204|NCT00747006|3674691|FG001|NOT COMPLETED|Overall Study||1
2960205|NCT00747006|3674692|FG002|NOT COMPLETED|Overall Study||1
2960206|NCT00747149|3674705|FG000|STARTED|Overall Study||154
2960207|NCT00747149|3674706|FG001|STARTED|Overall Study||444
2960208|NCT00747149|3674705|FG000|COMPLETED|Overall Study||153
2960209|NCT00747149|3674706|FG001|COMPLETED|Overall Study||401
2960210|NCT00747149|3674705|FG000|NOT COMPLETED|Overall Study||1
2960211|NCT00747149|3674706|FG001|NOT COMPLETED|Overall Study||43
2960212|NCT00747214|3674720|FG000|STARTED|Overall Study||27
2960213|NCT00747214|3674721|FG001|STARTED|Overall Study||32
2960214|NCT00747214|3674720|FG000|COMPLETED|Overall Study||19
2960215|NCT00747214|3674721|FG001|COMPLETED|Overall Study||29
2960216|NCT00747214|3674720|FG000|NOT COMPLETED|Overall Study||8
2960217|NCT00747214|3674721|FG001|NOT COMPLETED|Overall Study||3
2960218|NCT00747227|3674729|FG000|STARTED|Overall Study||126
2960219|NCT00747227|3674730|FG001|STARTED|Overall Study||124
2960220|NCT00747227|3674729|FG000|COMPLETED|Overall Study||120
2960221|NCT00747227|3674730|FG001|COMPLETED|Overall Study||120
2960222|NCT00747227|3674729|FG000|NOT COMPLETED|Overall Study||6
2960223|NCT00747227|3674730|FG001|NOT COMPLETED|Overall Study||4
2960224|NCT00747344|3674738|FG000|STARTED|Controlled Period||60
2960225|NCT00747344|3674739|FG001|STARTED|Controlled Period||61
2960226|NCT00747344|3674740|FG002|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
3300664|NCT02948582|4034500|FG002|STARTED|Washout Period 2||7
3300665|NCT02948582|4034501|FG003|STARTED|Washout Period 2||7
3300666|NCT02948582|4034502|FG004|STARTED|Washout Period 2||7
3300667|NCT02948582|4034503|FG005|STARTED|Washout Period 2||6
3300668|NCT02948582|4034498|FG000|COMPLETED|Washout Period 2||7
3300669|NCT02948582|4034499|FG001|COMPLETED|Washout Period 2||4
3300670|NCT02948582|4034500|FG002|COMPLETED|Washout Period 2||7
3300671|NCT02948582|4034501|FG003|COMPLETED|Washout Period 2||6
3300672|NCT02948582|4034502|FG004|COMPLETED|Washout Period 2||7
3300673|NCT02948582|4034503|FG005|COMPLETED|Washout Period 2||6
3300674|NCT02948582|4034498|FG000|NOT COMPLETED|Washout Period 2||0
3300675|NCT02948582|4034499|FG001|NOT COMPLETED|Washout Period 2||1
3300676|NCT02948582|4034500|FG002|NOT COMPLETED|Washout Period 2||0
3300677|NCT02948582|4034501|FG003|NOT COMPLETED|Washout Period 2||1
3300678|NCT02948582|4034502|FG004|NOT COMPLETED|Washout Period 2||0
3300679|NCT02948582|4034503|FG005|NOT COMPLETED|Washout Period 2||0
3300680|NCT02948582|4034498|FG000|STARTED|Treatment Period 3||7
3035424|NCT01137370|3754624|FG000|STARTED|Overall Study||116
3300681|NCT02948582|4034499|FG001|STARTED|Treatment Period 3||4
3300682|NCT02948582|4034500|FG002|STARTED|Treatment Period 3||7
3300683|NCT02948582|4034501|FG003|STARTED|Treatment Period 3||6
2960227|NCT00747344|3674741|FG003|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
2960228|NCT00747344|3674738|FG000|COMPLETED|Controlled Period||55
2960229|NCT00747344|3674739|FG001|COMPLETED|Controlled Period||57
2960230|NCT00747344|3674740|FG002|COMPLETED|Controlled Period||0
2960231|NCT00747344|3674741|FG003|COMPLETED|Controlled Period||0
2960232|NCT00747344|3674738|FG000|NOT COMPLETED|Controlled Period||5
2960233|NCT00747344|3674739|FG001|NOT COMPLETED|Controlled Period||4
2960234|NCT00747344|3674740|FG002|NOT COMPLETED|Controlled Period||0
2960235|NCT00747344|3674741|FG003|NOT COMPLETED|Controlled Period||0
2960236|NCT00747344|3674738|FG000|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
2960237|NCT00747344|3674739|FG001|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
2960238|NCT00747344|3674740|FG002|STARTED|After Controlled Period||55
2960239|NCT00747344|3674741|FG003|STARTED|After Controlled Period|2 participants discontinued in CP, had follow-up, and are among frequent and serious adverse events.|57
2960240|NCT00747344|3674738|FG000|COMPLETED|After Controlled Period||0
2960241|NCT00747344|3674739|FG001|COMPLETED|After Controlled Period||0
2960242|NCT00747344|3674740|FG002|COMPLETED|After Controlled Period||55
2960243|NCT00747344|3674741|FG003|COMPLETED|After Controlled Period||56
2960244|NCT00747344|3674738|FG000|NOT COMPLETED|After Controlled Period||0
2960245|NCT00747344|3674739|FG001|NOT COMPLETED|After Controlled Period||0
2960246|NCT00747344|3674740|FG002|NOT COMPLETED|After Controlled Period||0
2960247|NCT00747344|3674741|FG003|NOT COMPLETED|After Controlled Period||1
2960248|NCT00747435|3674749|FG000|STARTED|Overall Study||73
2960249|NCT00747435|3674749|FG000|COMPLETED|Overall Study||67
2960250|NCT00747435|3674749|FG000|NOT COMPLETED|Overall Study||6
2960251|NCT00747474|3674753|FG000|STARTED|Cohort 1 (1.5 mg/m^2) Period||3
2960252|NCT00747474|3674754|FG001|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
2960253|NCT00747474|3674755|FG002|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
2960254|NCT00747474|3674756|FG003|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
2960255|NCT00747474|3674757|FG004|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
2960256|NCT00747474|3674758|FG005|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
2960257|NCT00747474|3674759|FG006|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
2960258|NCT00747474|3674760|FG007|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
2960259|NCT00747474|3674761|FG008|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
3163679|NCT01888497|3891176|FG000|COMPLETED|Third Intervention Period||13
3163680|NCT01888497|3891177|FG001|COMPLETED|Third Intervention Period||14
3163681|NCT01888497|3891178|FG002|COMPLETED|Third Intervention Period||14
3163682|NCT01888497|3891179|FG003|COMPLETED|Third Intervention Period||14
3163683|NCT01888497|3891176|FG000|NOT COMPLETED|Third Intervention Period||0
3163684|NCT01888497|3891177|FG001|NOT COMPLETED|Third Intervention Period||0
3300684|NCT02948582|4034502|FG004|STARTED|Treatment Period 3||7
3300685|NCT02948582|4034503|FG005|STARTED|Treatment Period 3||6
3300686|NCT02948582|4034498|FG000|COMPLETED|Treatment Period 3||7
3300687|NCT02948582|4034499|FG001|COMPLETED|Treatment Period 3||4
3300688|NCT02948582|4034500|FG002|COMPLETED|Treatment Period 3||7
3300689|NCT02948582|4034501|FG003|COMPLETED|Treatment Period 3||6
3300690|NCT02948582|4034502|FG004|COMPLETED|Treatment Period 3||7
3300691|NCT02948582|4034503|FG005|COMPLETED|Treatment Period 3||6
3300692|NCT02948582|4034498|FG000|NOT COMPLETED|Treatment Period 3||0
3300693|NCT02948582|4034499|FG001|NOT COMPLETED|Treatment Period 3||0
3300694|NCT02948582|4034500|FG002|NOT COMPLETED|Treatment Period 3||0
3300695|NCT02948582|4034501|FG003|NOT COMPLETED|Treatment Period 3||0
3300696|NCT02948582|4034502|FG004|NOT COMPLETED|Treatment Period 3||0
3300697|NCT02948582|4034503|FG005|NOT COMPLETED|Treatment Period 3||0
3300698|NCT02948582|4034498|FG000|STARTED|Washout Period 3||7
3300699|NCT02948582|4034499|FG001|STARTED|Washout Period 3||4
3300700|NCT02948582|4034500|FG002|STARTED|Washout Period 3||7
3300701|NCT02948582|4034501|FG003|STARTED|Washout Period 3||6
3300702|NCT02948582|4034502|FG004|STARTED|Washout Period 3||7
3300703|NCT02948582|4034503|FG005|STARTED|Washout Period 3||6
3300704|NCT02948582|4034498|FG000|COMPLETED|Washout Period 3||7
3300705|NCT02948582|4034499|FG001|COMPLETED|Washout Period 3||4
3300706|NCT02948582|4034500|FG002|COMPLETED|Washout Period 3||7
3300707|NCT02948582|4034501|FG003|COMPLETED|Washout Period 3||6
3300708|NCT02948582|4034502|FG004|COMPLETED|Washout Period 3||7
3300709|NCT02948582|4034503|FG005|COMPLETED|Washout Period 3||6
3300710|NCT02948582|4034498|FG000|NOT COMPLETED|Washout Period 3||0
3300711|NCT02948582|4034499|FG001|NOT COMPLETED|Washout Period 3||0
3300712|NCT02948582|4034500|FG002|NOT COMPLETED|Washout Period 3||0
3300713|NCT02948582|4034501|FG003|NOT COMPLETED|Washout Period 3||0
3300714|NCT02948582|4034502|FG004|NOT COMPLETED|Washout Period 3||0
3300715|NCT02948582|4034503|FG005|NOT COMPLETED|Washout Period 3||0
3300716|NCT02948582|4034498|FG000|STARTED|Treatment Period 4||7
3300717|NCT02948582|4034499|FG001|STARTED|Treatment Period 4||4
3300718|NCT02948582|4034500|FG002|STARTED|Treatment Period 4||7
3300719|NCT02948582|4034501|FG003|STARTED|Treatment Period 4||6
3300720|NCT02948582|4034502|FG004|STARTED|Treatment Period 4||7
3300721|NCT02948582|4034503|FG005|STARTED|Treatment Period 4||6
3300722|NCT02948582|4034498|FG000|COMPLETED|Treatment Period 4||7
3300723|NCT02948582|4034499|FG001|COMPLETED|Treatment Period 4||4
3300724|NCT02948582|4034500|FG002|COMPLETED|Treatment Period 4||7
3300725|NCT02948582|4034501|FG003|COMPLETED|Treatment Period 4||6
3300726|NCT02948582|4034502|FG004|COMPLETED|Treatment Period 4||7
3300727|NCT02948582|4034503|FG005|COMPLETED|Treatment Period 4||6
2960260|NCT00747474|3674762|FG009|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
2960261|NCT00747474|3674763|FG010|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
2960262|NCT00747474|3674764|FG011|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
2960263|NCT00747474|3674753|FG000|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||3
2960264|NCT00747474|3674754|FG001|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
2960265|NCT00747474|3674755|FG002|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
2960266|NCT00747474|3674756|FG003|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
2960267|NCT00747474|3674757|FG004|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
2960268|NCT00747474|3674758|FG005|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
2960269|NCT00747474|3674759|FG006|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
2960270|NCT00747474|3674760|FG007|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
2960271|NCT00747474|3674761|FG008|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
2960272|NCT00747474|3674762|FG009|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
2960273|NCT00747474|3674763|FG010|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
2960274|NCT00747474|3674764|FG011|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
2960275|NCT00747474|3674753|FG000|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
2960276|NCT00747474|3674754|FG001|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
2960277|NCT00747474|3674755|FG002|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
2960278|NCT00747474|3674756|FG003|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
2960279|NCT00747474|3674757|FG004|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
2960280|NCT00747474|3674758|FG005|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
2960281|NCT00747474|3674759|FG006|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
2960282|NCT00747474|3674760|FG007|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
2960283|NCT00747474|3674761|FG008|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
2960284|NCT00747474|3674762|FG009|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
2960285|NCT00747474|3674763|FG010|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
2960286|NCT00747474|3674764|FG011|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
2960287|NCT00747474|3674753|FG000|STARTED|Cohort 2 (3 mg/m^2) Period||0
2960288|NCT00747474|3674754|FG001|STARTED|Cohort 2 (3 mg/m^2) Period||4
2960289|NCT00747474|3674755|FG002|STARTED|Cohort 2 (3 mg/m^2) Period||0
2960290|NCT00747474|3674756|FG003|STARTED|Cohort 2 (3 mg/m^2) Period||0
2960291|NCT00747474|3674757|FG004|STARTED|Cohort 2 (3 mg/m^2) Period||0
2960292|NCT00747474|3674758|FG005|STARTED|Cohort 2 (3 mg/m^2) Period||0
2960293|NCT00747474|3674759|FG006|STARTED|Cohort 2 (3 mg/m^2) Period||0
2960294|NCT00747474|3674760|FG007|STARTED|Cohort 2 (3 mg/m^2) Period||0
2960295|NCT00747474|3674761|FG008|STARTED|Cohort 2 (3 mg/m^2) Period||0
2960296|NCT00747474|3674762|FG009|STARTED|Cohort 2 (3 mg/m^2) Period||0
2960297|NCT00747474|3674763|FG010|STARTED|Cohort 2 (3 mg/m^2) Period||0
2960298|NCT00747474|3674764|FG011|STARTED|Cohort 2 (3 mg/m^2) Period||0
2960299|NCT00747474|3674753|FG000|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
2960300|NCT00747474|3674754|FG001|COMPLETED|Cohort 2 (3 mg/m^2) Period||4
2960301|NCT00747474|3674755|FG002|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
3163685|NCT01888497|3891178|FG002|NOT COMPLETED|Third Intervention Period||0
3163686|NCT01888497|3891179|FG003|NOT COMPLETED|Third Intervention Period||0
3163687|NCT01888497|3891176|FG000|STARTED|Washout Period 3||13
3163688|NCT01888497|3891177|FG001|STARTED|Washout Period 3||14
3163689|NCT01888497|3891178|FG002|STARTED|Washout Period 3||14
3163690|NCT01888497|3891179|FG003|STARTED|Washout Period 3||14
3163691|NCT01888497|3891176|FG000|COMPLETED|Washout Period 3||13
3163692|NCT01888497|3891177|FG001|COMPLETED|Washout Period 3||14
3163693|NCT01888497|3891178|FG002|COMPLETED|Washout Period 3||14
3163694|NCT01888497|3891179|FG003|COMPLETED|Washout Period 3||14
3163695|NCT01888497|3891176|FG000|NOT COMPLETED|Washout Period 3||0
3163696|NCT01888497|3891177|FG001|NOT COMPLETED|Washout Period 3||0
3163697|NCT01888497|3891178|FG002|NOT COMPLETED|Washout Period 3||0
3163698|NCT01888497|3891179|FG003|NOT COMPLETED|Washout Period 3||0
3163699|NCT01888497|3891176|FG000|STARTED|Fourth Intervention Period||13
3163700|NCT01888497|3891177|FG001|STARTED|Fourth Intervention Period||14
3163701|NCT01888497|3891178|FG002|STARTED|Fourth Intervention Period||14
3163702|NCT01888497|3891179|FG003|STARTED|Fourth Intervention Period||14
3163703|NCT01888497|3891176|FG000|COMPLETED|Fourth Intervention Period||13
3163704|NCT01888497|3891177|FG001|COMPLETED|Fourth Intervention Period||14
3163705|NCT01888497|3891178|FG002|COMPLETED|Fourth Intervention Period||14
3163706|NCT01888497|3891179|FG003|COMPLETED|Fourth Intervention Period||14
3163707|NCT01888497|3891176|FG000|NOT COMPLETED|Fourth Intervention Period||0
3163708|NCT01888497|3891177|FG001|NOT COMPLETED|Fourth Intervention Period||0
3163709|NCT01888497|3891178|FG002|NOT COMPLETED|Fourth Intervention Period||0
3163710|NCT01888497|3891179|FG003|NOT COMPLETED|Fourth Intervention Period||0
3163711|NCT01888640|3891192|FG000|STARTED|Overall Study||103
3300728|NCT02948582|4034498|FG000|NOT COMPLETED|Treatment Period 4||0
3300729|NCT02948582|4034499|FG001|NOT COMPLETED|Treatment Period 4||0
3300730|NCT02948582|4034500|FG002|NOT COMPLETED|Treatment Period 4||0
3300731|NCT02948582|4034501|FG003|NOT COMPLETED|Treatment Period 4||0
3300732|NCT02948582|4034502|FG004|NOT COMPLETED|Treatment Period 4||0
3300733|NCT02948582|4034503|FG005|NOT COMPLETED|Treatment Period 4||0
3300734|NCT02948582|4034498|FG000|STARTED|Washout Period 4||7
3300735|NCT02948582|4034499|FG001|STARTED|Washout Period 4||4
2960302|NCT00747474|3674756|FG003|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
2960303|NCT00747474|3674757|FG004|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
2960304|NCT00747474|3674758|FG005|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
2960305|NCT00747474|3674759|FG006|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
2960306|NCT00747474|3674760|FG007|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
3300736|NCT02948582|4034500|FG002|STARTED|Washout Period 4||7
3300737|NCT02948582|4034501|FG003|STARTED|Washout Period 4||6
3300738|NCT02948582|4034502|FG004|STARTED|Washout Period 4||7
3300739|NCT02948582|4034503|FG005|STARTED|Washout Period 4||6
3300740|NCT02948582|4034498|FG000|COMPLETED|Washout Period 4||6
3300741|NCT02948582|4034499|FG001|COMPLETED|Washout Period 4||4
3300742|NCT02948582|4034500|FG002|COMPLETED|Washout Period 4||6
3300743|NCT02948582|4034501|FG003|COMPLETED|Washout Period 4||6
3300744|NCT02948582|4034502|FG004|COMPLETED|Washout Period 4||7
3300745|NCT02948582|4034503|FG005|COMPLETED|Washout Period 4||6
3300746|NCT02948582|4034498|FG000|NOT COMPLETED|Washout Period 4||1
3300747|NCT02948582|4034499|FG001|NOT COMPLETED|Washout Period 4||0
3300748|NCT02948582|4034500|FG002|NOT COMPLETED|Washout Period 4||1
3300749|NCT02948582|4034501|FG003|NOT COMPLETED|Washout Period 4||0
3300750|NCT02948582|4034502|FG004|NOT COMPLETED|Washout Period 4||0
3300751|NCT02948582|4034503|FG005|NOT COMPLETED|Washout Period 4||0
3300752|NCT02948582|4034498|FG000|STARTED|Treatment Period 5||6
3300753|NCT02948582|4034499|FG001|STARTED|Treatment Period 5||4
3300754|NCT02948582|4034500|FG002|STARTED|Treatment Period 5||6
3300755|NCT02948582|4034501|FG003|STARTED|Treatment Period 5||6
3300756|NCT02948582|4034502|FG004|STARTED|Treatment Period 5||7
3300757|NCT02948582|4034503|FG005|STARTED|Treatment Period 5||6
3300758|NCT02948582|4034498|FG000|COMPLETED|Treatment Period 5||6
3300759|NCT02948582|4034499|FG001|COMPLETED|Treatment Period 5||4
3300760|NCT02948582|4034500|FG002|COMPLETED|Treatment Period 5||6
3300761|NCT02948582|4034501|FG003|COMPLETED|Treatment Period 5||6
3300762|NCT02948582|4034502|FG004|COMPLETED|Treatment Period 5||7
3300763|NCT02948582|4034503|FG005|COMPLETED|Treatment Period 5||6
3300764|NCT02948582|4034498|FG000|NOT COMPLETED|Treatment Period 5||0
3300765|NCT02948582|4034499|FG001|NOT COMPLETED|Treatment Period 5||0
3300766|NCT02948582|4034500|FG002|NOT COMPLETED|Treatment Period 5||0
3300767|NCT02948582|4034501|FG003|NOT COMPLETED|Treatment Period 5||0
3300768|NCT02948582|4034502|FG004|NOT COMPLETED|Treatment Period 5||0
3300769|NCT02948582|4034503|FG005|NOT COMPLETED|Treatment Period 5||0
3300770|NCT02948582|4034498|FG000|STARTED|Washout Period 5||6
3300771|NCT02948582|4034499|FG001|STARTED|Washout Period 5||4
3132780|NCT01693120|3857950|FG000|COMPLETED|Phased RF Study Procedure and Follow-up|112 of the 129 subjects with a Phased RF procedure completed the 6-month follow-up visit|112
3132781|NCT01693120|3857950|FG000|NOT COMPLETED|Phased RF Study Procedure and Follow-up||17
3132782|NCT01693185|3857956|FG000|STARTED|Overall Study||27
3132783|NCT01693185|3857957|FG001|STARTED|Overall Study||33
3132784|NCT01693185|3857956|FG000|COMPLETED|Overall Study||27
3132785|NCT01693185|3857957|FG001|COMPLETED|Overall Study||27
3132786|NCT01693185|3857956|FG000|NOT COMPLETED|Overall Study||0
3132787|NCT01693185|3857957|FG001|NOT COMPLETED|Overall Study||6
3132788|NCT01693250|3857965|FG000|STARTED|Overall Study|3 months post baseline assessment|23
3300772|NCT02948582|4034500|FG002|STARTED|Washout Period 5||6
3300773|NCT02948582|4034501|FG003|STARTED|Washout Period 5||6
3300774|NCT02948582|4034502|FG004|STARTED|Washout Period 5||7
3300775|NCT02948582|4034503|FG005|STARTED|Washout Period 5||6
3300776|NCT02948582|4034498|FG000|COMPLETED|Washout Period 5||6
3300777|NCT02948582|4034499|FG001|COMPLETED|Washout Period 5||4
3300778|NCT02948582|4034500|FG002|COMPLETED|Washout Period 5||6
3300779|NCT02948582|4034501|FG003|COMPLETED|Washout Period 5||6
3300780|NCT02948582|4034502|FG004|COMPLETED|Washout Period 5||7
3300781|NCT02948582|4034503|FG005|COMPLETED|Washout Period 5||6
3300782|NCT02948582|4034498|FG000|NOT COMPLETED|Washout Period 5||0
3300783|NCT02948582|4034499|FG001|NOT COMPLETED|Washout Period 5||0
3300784|NCT02948582|4034500|FG002|NOT COMPLETED|Washout Period 5||0
3300785|NCT02948582|4034501|FG003|NOT COMPLETED|Washout Period 5||0
3300786|NCT02948582|4034502|FG004|NOT COMPLETED|Washout Period 5||0
3132789|NCT01693250|3857966|FG001|STARTED|Overall Study|three month post baseline assessment|17
3132790|NCT01693250|3857965|FG000|COMPLETED|Overall Study|21 teens completed 6 months post baseline assessment|21
3132791|NCT01693250|3857966|FG001|COMPLETED|Overall Study|15 teens completed 6 months post baseline assessment|15
3132792|NCT01693250|3857965|FG000|NOT COMPLETED|Overall Study||2
3132793|NCT01693250|3857966|FG001|NOT COMPLETED|Overall Study||2
3132794|NCT01693523|3857977|FG000|STARTED|Overall Study||23
3132795|NCT01693523|3857978|FG001|STARTED|Overall Study||21
3132796|NCT01693523|3857979|FG002|STARTED|Overall Study||35
3132797|NCT01693523|3857977|FG000|COMPLETED|Overall Study||18
3132798|NCT01693523|3857978|FG001|COMPLETED|Overall Study||13
3132799|NCT01693523|3857979|FG002|COMPLETED|Overall Study||27
3132800|NCT01693523|3857977|FG000|NOT COMPLETED|Overall Study||5
3132801|NCT01693523|3857978|FG001|NOT COMPLETED|Overall Study||8
3132802|NCT01693523|3857979|FG002|NOT COMPLETED|Overall Study||8
3132803|NCT01693562|3858009|FG000|STARTED|Escalation Phase||4
3132804|NCT01693562|3858010|FG001|STARTED|Escalation Phase||4
3132805|NCT01693562|3858011|FG002|STARTED|Escalation Phase||3
3132806|NCT01693562|3858012|FG003|STARTED|Escalation Phase||3
3132807|NCT01693562|3858013|FG004|STARTED|Escalation Phase||6
3132808|NCT01693562|3858014|FG005|STARTED|Escalation Phase||7
3132809|NCT01693562|3858015|FG006|STARTED|Escalation Phase||0
3132810|NCT01693562|3858016|FG007|STARTED|Escalation Phase||0
3132811|NCT01693562|3858017|FG008|STARTED|Escalation Phase||0
3132812|NCT01693562|3858018|FG009|STARTED|Escalation Phase||0
3132813|NCT01693562|3858019|FG010|STARTED|Escalation Phase||0
3132814|NCT01693562|3858020|FG011|STARTED|Escalation Phase||0
3163712|NCT01888640|3891193|FG001|STARTED|Overall Study||99
3163713|NCT01888640|3891194|FG002|STARTED|Overall Study||99
3163714|NCT01888640|3891192|FG000|COMPLETED|Overall Study||76
3163715|NCT01888640|3891193|FG001|COMPLETED|Overall Study||68
3163716|NCT01888640|3891194|FG002|COMPLETED|Overall Study||94
3163717|NCT01888640|3891192|FG000|NOT COMPLETED|Overall Study||27
3163718|NCT01888640|3891193|FG001|NOT COMPLETED|Overall Study||31
3163719|NCT01888640|3891194|FG002|NOT COMPLETED|Overall Study||5
3163720|NCT01888874|3891212|FG000|STARTED|Period 1 (Baseline up to Week 12)||86
3163721|NCT01888874|3891213|FG001|STARTED|Period 1 (Baseline up to Week 12)||82
3163722|NCT01888874|3891214|FG002|STARTED|Period 1 (Baseline up to Week 12)||85
3163723|NCT01888874|3891215|FG003|STARTED|Period 1 (Baseline up to Week 12)||86
3163724|NCT01888874|3891216|FG004|STARTED|Period 1 (Baseline up to Week 12)||86
3163725|NCT01888874|3891217|FG005|STARTED|Period 1 (Baseline up to Week 12)||85
3163726|NCT01888874|3891218|FG006|STARTED|Period 1 (Baseline up to Week 12)||84
3163727|NCT01888874|3891212|FG000|COMPLETED|Period 1 (Baseline up to Week 12)||83
3163728|NCT01888874|3891213|FG001|COMPLETED|Period 1 (Baseline up to Week 12)||76
3163729|NCT01888874|3891214|FG002|COMPLETED|Period 1 (Baseline up to Week 12)||78
3163730|NCT01888874|3891215|FG003|COMPLETED|Period 1 (Baseline up to Week 12)||80
3163731|NCT01888874|3891216|FG004|COMPLETED|Period 1 (Baseline up to Week 12)||77
3163732|NCT01888874|3891217|FG005|COMPLETED|Period 1 (Baseline up to Week 12)||80
3163733|NCT01888874|3891218|FG006|COMPLETED|Period 1 (Baseline up to Week 12)||83
3163734|NCT01888874|3891212|FG000|NOT COMPLETED|Period 1 (Baseline up to Week 12)||3
3163735|NCT01888874|3891213|FG001|NOT COMPLETED|Period 1 (Baseline up to Week 12)||6
3163736|NCT01888874|3891214|FG002|NOT COMPLETED|Period 1 (Baseline up to Week 12)||7
3163737|NCT01888874|3891215|FG003|NOT COMPLETED|Period 1 (Baseline up to Week 12)||6
3163738|NCT01888874|3891216|FG004|NOT COMPLETED|Period 1 (Baseline up to Week 12)||9
3163739|NCT01888874|3891217|FG005|NOT COMPLETED|Period 1 (Baseline up to Week 12)||5
3163740|NCT01888874|3891218|FG006|NOT COMPLETED|Period 1 (Baseline up to Week 12)||1
3163741|NCT01888874|3891212|FG000|STARTED|Period 2 (Week 13 to Week 24)|Nonresponders from Placebo group moved to 100 mg QD(15 participants) and 50 mg BID(15 participants).|53
3300787|NCT02948582|4034503|FG005|NOT COMPLETED|Washout Period 5||0
3300788|NCT02948582|4034498|FG000|STARTED|Treatment Period 6||6
3300789|NCT02948582|4034499|FG001|STARTED|Treatment Period 6||4
2960307|NCT00747474|3674761|FG008|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
2960308|NCT00747474|3674762|FG009|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
2960309|NCT00747474|3674763|FG010|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
2960310|NCT00747474|3674764|FG011|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
2960311|NCT00747474|3674753|FG000|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
2960312|NCT00747474|3674754|FG001|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
2960313|NCT00747474|3674755|FG002|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
2960314|NCT00747474|3674756|FG003|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
3300790|NCT02948582|4034500|FG002|STARTED|Treatment Period 6||6
3300791|NCT02948582|4034501|FG003|STARTED|Treatment Period 6||6
3300792|NCT02948582|4034502|FG004|STARTED|Treatment Period 6||7
3300793|NCT02948582|4034503|FG005|STARTED|Treatment Period 6||6
3300794|NCT02948582|4034498|FG000|COMPLETED|Treatment Period 6||6
3300795|NCT02948582|4034499|FG001|COMPLETED|Treatment Period 6||4
3300796|NCT02948582|4034500|FG002|COMPLETED|Treatment Period 6||6
3300797|NCT02948582|4034501|FG003|COMPLETED|Treatment Period 6||6
3300798|NCT02948582|4034502|FG004|COMPLETED|Treatment Period 6||7
3300799|NCT02948582|4034503|FG005|COMPLETED|Treatment Period 6||6
3300800|NCT02948582|4034498|FG000|NOT COMPLETED|Treatment Period 6||0
3300801|NCT02948582|4034499|FG001|NOT COMPLETED|Treatment Period 6||0
3300802|NCT02948582|4034500|FG002|NOT COMPLETED|Treatment Period 6||0
3300803|NCT02948582|4034501|FG003|NOT COMPLETED|Treatment Period 6||0
3300804|NCT02948582|4034502|FG004|NOT COMPLETED|Treatment Period 6||0
3300805|NCT02948582|4034503|FG005|NOT COMPLETED|Treatment Period 6||0
3300806|NCT02948582|4034498|FG000|STARTED|Wshout Period 6||6
3300807|NCT02948582|4034499|FG001|STARTED|Wshout Period 6||4
3300808|NCT02948582|4034500|FG002|STARTED|Wshout Period 6||6
3300809|NCT02948582|4034501|FG003|STARTED|Wshout Period 6||6
3300810|NCT02948582|4034502|FG004|STARTED|Wshout Period 6||7
3300811|NCT02948582|4034503|FG005|STARTED|Wshout Period 6||6
3300812|NCT02948582|4034498|FG000|COMPLETED|Wshout Period 6||6
3300813|NCT02948582|4034499|FG001|COMPLETED|Wshout Period 6||4
3300814|NCT02948582|4034500|FG002|COMPLETED|Wshout Period 6||6
3300815|NCT02948582|4034501|FG003|COMPLETED|Wshout Period 6||6
3300816|NCT02948582|4034502|FG004|COMPLETED|Wshout Period 6||7
3300817|NCT02948582|4034503|FG005|COMPLETED|Wshout Period 6||6
3300818|NCT02948582|4034498|FG000|NOT COMPLETED|Wshout Period 6||0
3300819|NCT02948582|4034499|FG001|NOT COMPLETED|Wshout Period 6||0
3300820|NCT02948582|4034500|FG002|NOT COMPLETED|Wshout Period 6||0
3300821|NCT02948582|4034501|FG003|NOT COMPLETED|Wshout Period 6||0
3300822|NCT02948582|4034502|FG004|NOT COMPLETED|Wshout Period 6||0
3300823|NCT02948582|4034503|FG005|NOT COMPLETED|Wshout Period 6||0
3300824|NCT02948634|4034519|FG000|STARTED|Overall Study||17
3300825|NCT02948634|4034520|FG001|STARTED|Overall Study||11
3300826|NCT02948634|4034519|FG000|COMPLETED|Overall Study||7
3300827|NCT02948634|4034520|FG001|COMPLETED|Overall Study||9
3300828|NCT02948634|4034519|FG000|NOT COMPLETED|Overall Study||10
3300829|NCT02948634|4034520|FG001|NOT COMPLETED|Overall Study||2
3300830|NCT02948777|4034526|FG000|STARTED|Overall Study||14
3300831|NCT02948777|4034526|FG000|COMPLETED|Overall Study||13
3300832|NCT02948777|4034526|FG000|NOT COMPLETED|Overall Study||1
3300833|NCT02948829|4034531|FG000|STARTED|Overall Study||200
2960315|NCT00747474|3674757|FG004|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
2960316|NCT00747474|3674758|FG005|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
2960317|NCT00747474|3674759|FG006|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
2960318|NCT00747474|3674760|FG007|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
2960319|NCT00747474|3674761|FG008|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
2960320|NCT00747474|3674762|FG009|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
2960321|NCT00747474|3674763|FG010|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
2960322|NCT00747474|3674764|FG011|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
2960323|NCT00747474|3674753|FG000|STARTED|Cohort 3 (6 mg/m^2) Period||0
2960324|NCT00747474|3674754|FG001|STARTED|Cohort 3 (6 mg/m^2) Period||0
2960325|NCT00747474|3674755|FG002|STARTED|Cohort 3 (6 mg/m^2) Period||3
2960326|NCT00747474|3674756|FG003|STARTED|Cohort 3 (6 mg/m^2) Period||0
2960327|NCT00747474|3674757|FG004|STARTED|Cohort 3 (6 mg/m^2) Period||0
2960328|NCT00747474|3674758|FG005|STARTED|Cohort 3 (6 mg/m^2) Period||0
2960329|NCT00747474|3674759|FG006|STARTED|Cohort 3 (6 mg/m^2) Period||0
2960330|NCT00747474|3674760|FG007|STARTED|Cohort 3 (6 mg/m^2) Period||0
2960331|NCT00747474|3674761|FG008|STARTED|Cohort 3 (6 mg/m^2) Period||0
2960332|NCT00747474|3674762|FG009|STARTED|Cohort 3 (6 mg/m^2) Period||0
3132815|NCT01693562|3858021|FG012|STARTED|Escalation Phase||0
3132816|NCT01693562|3858022|FG013|STARTED|Escalation Phase||0
3132817|NCT01693562|3858023|FG014|STARTED|Escalation Phase||0
3132818|NCT01693562|3858024|FG015|STARTED|Escalation Phase||0
3132819|NCT01693562|3858025|FG016|STARTED|Escalation Phase||0
3132820|NCT01693562|3858026|FG017|STARTED|Escalation Phase||0
3132821|NCT01693562|3858027|FG018|STARTED|Escalation Phase||0
3132822|NCT01693562|3858028|FG019|STARTED|Escalation Phase||0
3132823|NCT01693562|3858029|FG020|STARTED|Escalation Phase||0
3132824|NCT01693562|3858030|FG021|STARTED|Escalation Phase||0
3132825|NCT01693562|3858031|FG022|STARTED|Escalation Phase||0
3132826|NCT01693562|3858009|FG000|COMPLETED|Escalation Phase||0
3132827|NCT01693562|3858010|FG001|COMPLETED|Escalation Phase||0
3132828|NCT01693562|3858011|FG002|COMPLETED|Escalation Phase||0
3132829|NCT01693562|3858012|FG003|COMPLETED|Escalation Phase||0
3132830|NCT01693562|3858013|FG004|COMPLETED|Escalation Phase||0
3132831|NCT01693562|3858014|FG005|COMPLETED|Escalation Phase||0
3132832|NCT01693562|3858015|FG006|COMPLETED|Escalation Phase||0
3132833|NCT01693562|3858016|FG007|COMPLETED|Escalation Phase||0
3132834|NCT01693562|3858017|FG008|COMPLETED|Escalation Phase||0
3300834|NCT02948829|4034531|FG000|COMPLETED|Overall Study||0
3300835|NCT02948829|4034531|FG000|NOT COMPLETED|Overall Study||200
3300836|NCT02948959|4034552|FG000|STARTED|52 Weeks Treatment Period||135
3300837|NCT02948959|4034553|FG001|STARTED|52 Weeks Treatment Period||273
3300838|NCT02948959|4034552|FG000|Treated|52 Weeks Treatment Period||135
3300839|NCT02948959|4034553|FG001|Treated|52 Weeks Treatment Period||270
3300840|NCT02948959|4034552|FG000|Safety Population|52 Weeks Treatment Period|1 participant randomized to placebo received dupilumab; counted in dupilumab arm for safety analysis.|134
3300841|NCT02948959|4034553|FG001|Safety Population|52 Weeks Treatment Period|1 participant randomized to placebo received dupilumab; counted in dupilumab arm for safety analysis.|271
3300842|NCT02948959|4034552|FG000|Type 2 Inflammatory Asthma Phenotype Population|52 Weeks Treatment Period||114
3300843|NCT02948959|4034553|FG001|Type 2 Inflammatory Asthma Phenotype Population|52 Weeks Treatment Period||236
3300844|NCT02948959|4034552|FG000|Baseline Blood Eosinophils Count >=300 Cells Per Microlitre Population|52 Weeks Treatment Period||84
3300845|NCT02948959|4034553|FG001|Baseline Blood Eosinophils Count >=300 Cells Per Microlitre Population|52 Weeks Treatment Period||175
3300846|NCT02948959|4034552|FG000|COMPLETED|52 Weeks Treatment Period||130
3300847|NCT02948959|4034553|FG001|COMPLETED|52 Weeks Treatment Period||248
3300848|NCT02948959|4034552|FG000|NOT COMPLETED|52 Weeks Treatment Period||5
3300849|NCT02948959|4034553|FG001|NOT COMPLETED|52 Weeks Treatment Period||25
3300850|NCT02948959|4034552|FG000|STARTED|12 Weeks Follow-up Period||9
3300851|NCT02948959|4034553|FG001|STARTED|12 Weeks Follow-up Period||31
3300852|NCT02948959|4034552|FG000|COMPLETED|12 Weeks Follow-up Period||4
3300853|NCT02948959|4034553|FG001|COMPLETED|12 Weeks Follow-up Period||19
3300854|NCT02948959|4034552|FG000|NOT COMPLETED|12 Weeks Follow-up Period||5
3300855|NCT02948959|4034553|FG001|NOT COMPLETED|12 Weeks Follow-up Period||12
3300856|NCT02949011|4034570|FG000|STARTED|Overall Study||730
3300857|NCT02949011|4034571|FG001|STARTED|Overall Study||729
3300858|NCT02949011|4034572|FG002|STARTED|Overall Study||725
3300859|NCT02949011|4034570|FG000|Received Study Drug|Overall Study||728
3300860|NCT02949011|4034571|FG001|Received Study Drug|Overall Study|Includes one participant who received baloxavir marboxil in error|728
3300861|NCT02949011|4034572|FG002|Received Study Drug|Overall Study|Includes one participant who received baloxavir marboxil in error|722
3300862|NCT02949011|4034570|FG000|Intention to Treat Infected Population|Overall Study||388
3300863|NCT02949011|4034571|FG001|Intention to Treat Infected Population|Overall Study||386
3300864|NCT02949011|4034572|FG002|Intention to Treat Infected Population|Overall Study||389
3300865|NCT02949011|4034570|FG000|COMPLETED|Overall Study||697
3300866|NCT02949011|4034571|FG001|COMPLETED|Overall Study||695
3300867|NCT02949011|4034572|FG002|COMPLETED|Overall Study||683
3300868|NCT02949011|4034570|FG000|NOT COMPLETED|Overall Study||33
3300869|NCT02949011|4034571|FG001|NOT COMPLETED|Overall Study||34
3300870|NCT02949011|4034572|FG002|NOT COMPLETED|Overall Study||42
3300871|NCT02949024|4034582|FG000|STARTED|Overall Study||10
3300872|NCT02949024|4034583|FG001|STARTED|Overall Study||10
3300873|NCT02949024|4034582|FG000|COMPLETED|Overall Study||10
3300874|NCT02949024|4034583|FG001|COMPLETED|Overall Study||9
3132835|NCT01693562|3858018|FG009|COMPLETED|Escalation Phase||0
3132836|NCT01693562|3858019|FG010|COMPLETED|Escalation Phase||0
3132837|NCT01693562|3858020|FG011|COMPLETED|Escalation Phase||0
3132838|NCT01693562|3858021|FG012|COMPLETED|Escalation Phase||0
2960333|NCT00747474|3674763|FG010|STARTED|Cohort 3 (6 mg/m^2) Period||0
2960334|NCT00747474|3674764|FG011|STARTED|Cohort 3 (6 mg/m^2) Period||0
2960335|NCT00747474|3674753|FG000|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
2960336|NCT00747474|3674754|FG001|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
2960337|NCT00747474|3674755|FG002|COMPLETED|Cohort 3 (6 mg/m^2) Period||3
2960338|NCT00747474|3674756|FG003|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
2960339|NCT00747474|3674757|FG004|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
2960340|NCT00747474|3674758|FG005|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
2960341|NCT00747474|3674759|FG006|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
2960342|NCT00747474|3674760|FG007|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
2960343|NCT00747474|3674761|FG008|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
2960344|NCT00747474|3674762|FG009|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
2960345|NCT00747474|3674763|FG010|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
2960346|NCT00747474|3674764|FG011|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
2960347|NCT00747474|3674753|FG000|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
2960348|NCT00747474|3674754|FG001|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
2960349|NCT00747474|3674755|FG002|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
2960350|NCT00747474|3674756|FG003|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
2960351|NCT00747474|3674757|FG004|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
2960352|NCT00747474|3674758|FG005|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
2960353|NCT00747474|3674759|FG006|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
2960354|NCT00747474|3674760|FG007|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
2960355|NCT00747474|3674761|FG008|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
2960356|NCT00747474|3674762|FG009|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
2960357|NCT00747474|3674763|FG010|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
2960358|NCT00747474|3674764|FG011|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
2960359|NCT00747474|3674753|FG000|STARTED|Cohort 4 (9 mg/m^2) Period||0
2960360|NCT00747474|3674754|FG001|STARTED|Cohort 4 (9 mg/m^2) Period||0
2960361|NCT00747474|3674755|FG002|STARTED|Cohort 4 (9 mg/m^2) Period||0
2960362|NCT00747474|3674756|FG003|STARTED|Cohort 4 (9 mg/m^2) Period||4
2960363|NCT00747474|3674757|FG004|STARTED|Cohort 4 (9 mg/m^2) Period||0
3300875|NCT02949024|4034582|FG000|NOT COMPLETED|Overall Study||0
3300876|NCT02949024|4034583|FG001|NOT COMPLETED|Overall Study||1
3300877|NCT02949128|4034591|FG000|STARTED|Initial Evaluation Period||58
3300878|NCT02949128|4034591|FG000|Received At Least 1 Dose of Study Drug|Initial Evaluation Period||58
3300879|NCT02949128|4034591|FG000|COMPLETED|Initial Evaluation Period||49
3300880|NCT02949128|4034591|FG000|NOT COMPLETED|Initial Evaluation Period||9
3300881|NCT02949128|4034591|FG000|STARTED|Extension Period||49
3300882|NCT02949128|4034591|FG000|Received At Least 1 Dose of Study Drug|Extension Period||47
3300883|NCT02949128|4034591|FG000|COMPLETED|Extension Period||47
3300884|NCT02949128|4034591|FG000|NOT COMPLETED|Extension Period||2
3300885|NCT02949141|4034595|FG000|STARTED|Overall Study||62
3300886|NCT02949141|4034595|FG000|COMPLETED|Overall Study||62
3300887|NCT02949141|4034595|FG000|NOT COMPLETED|Overall Study||0
3300888|NCT02949219|4034602|FG000|STARTED|Overall Study||41
3300889|NCT02949219|4034602|FG000|COMPLETED|Overall Study||40
3300890|NCT02949219|4034602|FG000|NOT COMPLETED|Overall Study||1
3300891|NCT02949271|4034608|FG000|STARTED|Overall Study||90
3300892|NCT02949271|4034609|FG001|STARTED|Overall Study||89
3300893|NCT02949271|4034608|FG000|COMPLETED|Overall Study||61
3300894|NCT02949271|4034609|FG001|COMPLETED|Overall Study||59
3300895|NCT02949271|4034608|FG000|NOT COMPLETED|Overall Study||29
3300896|NCT02949271|4034609|FG001|NOT COMPLETED|Overall Study||30
3300897|NCT02949362|4034617|FG000|STARTED|Retrospective Period||24
3300898|NCT02949362|4034618|FG001|STARTED|Retrospective Period||5
3300899|NCT02949362|4034619|FG002|STARTED|Retrospective Period||0
3300900|NCT02949362|4034620|FG003|STARTED|Retrospective Period||0
3300901|NCT02949362|4034617|FG000|COMPLETED|Retrospective Period||20
3300902|NCT02949362|4034618|FG001|COMPLETED|Retrospective Period||4
3300903|NCT02949362|4034619|FG002|COMPLETED|Retrospective Period||0
3300904|NCT02949362|4034620|FG003|COMPLETED|Retrospective Period||0
3300905|NCT02949362|4034617|FG000|NOT COMPLETED|Retrospective Period||4
3300906|NCT02949362|4034618|FG001|NOT COMPLETED|Retrospective Period||1
3300907|NCT02949362|4034619|FG002|NOT COMPLETED|Retrospective Period||0
3300908|NCT02949362|4034620|FG003|NOT COMPLETED|Retrospective Period||0
3300909|NCT02949362|4034617|FG000|STARTED|Prospective Period||0
3300910|NCT02949362|4034618|FG001|STARTED|Prospective Period||0
3300911|NCT02949362|4034619|FG002|STARTED|Prospective Period|Participants were enrolled from retrospective period.|5
3300912|NCT02949362|4034620|FG003|STARTED|Prospective Period|Participants were enrolled from retrospective period.|19
3300913|NCT02949362|4034617|FG000|COMPLETED|Prospective Period||0
3300914|NCT02949362|4034618|FG001|COMPLETED|Prospective Period||0
3300915|NCT02949362|4034619|FG002|COMPLETED|Prospective Period||4
3300916|NCT02949362|4034620|FG003|COMPLETED|Prospective Period||15
3300917|NCT02949362|4034617|FG000|NOT COMPLETED|Prospective Period||0
3300918|NCT02949362|4034618|FG001|NOT COMPLETED|Prospective Period||0
3300919|NCT02949362|4034619|FG002|NOT COMPLETED|Prospective Period||1
3300920|NCT02949362|4034620|FG003|NOT COMPLETED|Prospective Period||4
3300921|NCT02949518|4034634|FG000|STARTED|Overall Study||28
3300922|NCT02949518|4034635|FG001|STARTED|Overall Study||28
3300923|NCT02949518|4034634|FG000|COMPLETED|Overall Study||25
3300924|NCT02949518|4034635|FG001|COMPLETED|Overall Study||26
2960364|NCT00747474|3674758|FG005|STARTED|Cohort 4 (9 mg/m^2) Period||0
2960365|NCT00747474|3674759|FG006|STARTED|Cohort 4 (9 mg/m^2) Period||0
2960366|NCT00747474|3674760|FG007|STARTED|Cohort 4 (9 mg/m^2) Period||0
2960367|NCT00747474|3674761|FG008|STARTED|Cohort 4 (9 mg/m^2) Period||0
2960368|NCT00747474|3674762|FG009|STARTED|Cohort 4 (9 mg/m^2) Period||0
2960369|NCT00747474|3674763|FG010|STARTED|Cohort 4 (9 mg/m^2) Period||0
2960370|NCT00747474|3674764|FG011|STARTED|Cohort 4 (9 mg/m^2) Period||0
2960371|NCT00747474|3674753|FG000|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
2960372|NCT00747474|3674754|FG001|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
2960373|NCT00747474|3674755|FG002|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
2960374|NCT00747474|3674756|FG003|COMPLETED|Cohort 4 (9 mg/m^2) Period||4
2960375|NCT00747474|3674757|FG004|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
2960376|NCT00747474|3674758|FG005|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
2960377|NCT00747474|3674759|FG006|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
2960378|NCT00747474|3674760|FG007|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
2960379|NCT00747474|3674761|FG008|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
2960380|NCT00747474|3674762|FG009|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
2960381|NCT00747474|3674763|FG010|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
3300925|NCT02949518|4034634|FG000|NOT COMPLETED|Overall Study||3
3300926|NCT02949518|4034635|FG001|NOT COMPLETED|Overall Study||2
3300927|NCT02949674|4034646|FG000|STARTED|Overall Study||31
3300928|NCT02949674|4034647|FG001|STARTED|Overall Study||31
3300929|NCT02949674|4034648|FG002|STARTED|Overall Study||31
3300930|NCT02949674|4034646|FG000|COMPLETED|Overall Study||31
3300931|NCT02949674|4034647|FG001|COMPLETED|Overall Study||31
3300932|NCT02949674|4034648|FG002|COMPLETED|Overall Study||31
3300933|NCT02949674|4034646|FG000|NOT COMPLETED|Overall Study||0
3300934|NCT02949674|4034647|FG001|NOT COMPLETED|Overall Study||0
3300935|NCT02949674|4034648|FG002|NOT COMPLETED|Overall Study||0
3300936|NCT02949908|4034656|FG000|STARTED|Overall Study||2
3300937|NCT02949908|4034656|FG000|COMPLETED|Overall Study||0
3300938|NCT02949908|4034656|FG000|NOT COMPLETED|Overall Study||2
3300939|NCT02949921|4034662|FG000|STARTED|Overall Study||10
3300940|NCT02949921|4034663|FG001|STARTED|Overall Study||10
3300941|NCT02949921|4034662|FG000|COMPLETED|Overall Study||10
3300942|NCT02949921|4034663|FG001|COMPLETED|Overall Study||10
3300943|NCT02949921|4034662|FG000|NOT COMPLETED|Overall Study||0
3300944|NCT02949921|4034663|FG001|NOT COMPLETED|Overall Study||0
3300945|NCT02949973|4034669|FG000|STARTED|Overall Study||10
3300946|NCT02949973|4034669|FG000|COMPLETED|Overall Study||9
3300947|NCT02949973|4034669|FG000|NOT COMPLETED|Overall Study||1
3300948|NCT02950025|4034675|FG000|STARTED|Overall Study||2
3300949|NCT02950025|4034676|FG001|STARTED|Overall Study||3
3300950|NCT02950025|4034675|FG000|COMPLETED|Overall Study||2
3300951|NCT02950025|4034676|FG001|COMPLETED|Overall Study||3
3300952|NCT02950025|4034675|FG000|NOT COMPLETED|Overall Study||0
3300953|NCT02950025|4034676|FG001|NOT COMPLETED|Overall Study||0
3300954|NCT02950467|4034682|FG000|STARTED|Open-label Treatment||18
3300955|NCT02950467|4034682|FG000|COMPLETED|Open-label Treatment|1 participant completed study period but missed some visits due to an adverse event (AE).|18
3300956|NCT02950467|4034682|FG000|NOT COMPLETED|Open-label Treatment||0
3300957|NCT02950467|4034682|FG000|STARTED|3-month Follow-up||18
3300958|NCT02950467|4034682|FG000|COMPLETED|3-month Follow-up|All participants completed the safety follow-up assessment, but not all completed outcomes measures.|18
3300959|NCT02950467|4034682|FG000|NOT COMPLETED|3-month Follow-up||0
3300960|NCT02950545|4034692|FG000|STARTED|Session 1 (70 Minutes)||9
3300961|NCT02950545|4034693|FG001|STARTED|Session 1 (70 Minutes)||9
3300962|NCT02950545|4034694|FG002|STARTED|Session 1 (70 Minutes)||7
3300963|NCT02950545|4034695|FG003|STARTED|Session 1 (70 Minutes)||8
3300964|NCT02950545|4034696|FG004|STARTED|Session 1 (70 Minutes)||8
3300965|NCT02950545|4034697|FG005|STARTED|Session 1 (70 Minutes)||10
3300966|NCT02950545|4034692|FG000|COMPLETED|Session 1 (70 Minutes)||9
3300967|NCT02950545|4034693|FG001|COMPLETED|Session 1 (70 Minutes)||9
3300968|NCT02950545|4034694|FG002|COMPLETED|Session 1 (70 Minutes)||7
3300969|NCT02950545|4034695|FG003|COMPLETED|Session 1 (70 Minutes)||8
3300970|NCT02950545|4034696|FG004|COMPLETED|Session 1 (70 Minutes)||8
3300971|NCT02950545|4034697|FG005|COMPLETED|Session 1 (70 Minutes)||9
3300972|NCT02950545|4034692|FG000|NOT COMPLETED|Session 1 (70 Minutes)||0
3300973|NCT02950545|4034693|FG001|NOT COMPLETED|Session 1 (70 Minutes)||0
3300974|NCT02950545|4034694|FG002|NOT COMPLETED|Session 1 (70 Minutes)||0
3300975|NCT02950545|4034695|FG003|NOT COMPLETED|Session 1 (70 Minutes)||0
3300976|NCT02950545|4034696|FG004|NOT COMPLETED|Session 1 (70 Minutes)||0
3300977|NCT02950545|4034697|FG005|NOT COMPLETED|Session 1 (70 Minutes)||1
3300978|NCT02950545|4034692|FG000|STARTED|Washout 1 (5 Minutes)||9
3300979|NCT02950545|4034693|FG001|STARTED|Washout 1 (5 Minutes)||9
3300980|NCT02950545|4034694|FG002|STARTED|Washout 1 (5 Minutes)||7
3300981|NCT02950545|4034695|FG003|STARTED|Washout 1 (5 Minutes)||8
3300982|NCT02950545|4034696|FG004|STARTED|Washout 1 (5 Minutes)||8
3300983|NCT02950545|4034697|FG005|STARTED|Washout 1 (5 Minutes)||9
3300984|NCT02950545|4034692|FG000|COMPLETED|Washout 1 (5 Minutes)||8
3300985|NCT02950545|4034693|FG001|COMPLETED|Washout 1 (5 Minutes)||9
3300986|NCT02950545|4034694|FG002|COMPLETED|Washout 1 (5 Minutes)||7
3300987|NCT02950545|4034695|FG003|COMPLETED|Washout 1 (5 Minutes)||7
3300988|NCT02950545|4034696|FG004|COMPLETED|Washout 1 (5 Minutes)||8
3300989|NCT02950545|4034697|FG005|COMPLETED|Washout 1 (5 Minutes)||8
3300990|NCT02950545|4034692|FG000|NOT COMPLETED|Washout 1 (5 Minutes)||1
3300991|NCT02950545|4034693|FG001|NOT COMPLETED|Washout 1 (5 Minutes)||0
2960382|NCT00747474|3674764|FG011|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
2960383|NCT00747474|3674753|FG000|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
2960384|NCT00747474|3674754|FG001|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
2960385|NCT00747474|3674755|FG002|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
2960386|NCT00747474|3674756|FG003|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
2960387|NCT00747474|3674757|FG004|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
2960388|NCT00747474|3674758|FG005|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
2960389|NCT00747474|3674759|FG006|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
3132839|NCT01693562|3858022|FG013|COMPLETED|Escalation Phase||0
3132840|NCT01693562|3858023|FG014|COMPLETED|Escalation Phase||0
3132841|NCT01693562|3858024|FG015|COMPLETED|Escalation Phase||0
3132842|NCT01693562|3858025|FG016|COMPLETED|Escalation Phase||0
3132843|NCT01693562|3858026|FG017|COMPLETED|Escalation Phase||0
3300992|NCT02950545|4034694|FG002|NOT COMPLETED|Washout 1 (5 Minutes)||0
2960390|NCT00747474|3674760|FG007|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
2960391|NCT00747474|3674761|FG008|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
2960392|NCT00747474|3674762|FG009|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
2960393|NCT00747474|3674763|FG010|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
2960394|NCT00747474|3674764|FG011|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
2960395|NCT00747474|3674753|FG000|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
2960396|NCT00747474|3674754|FG001|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
2960397|NCT00747474|3674755|FG002|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
2960398|NCT00747474|3674756|FG003|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
2960399|NCT00747474|3674757|FG004|STARTED|Cohort 5 (13.5 mg/m^2) Period||4
2960400|NCT00747474|3674758|FG005|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
2960401|NCT00747474|3674759|FG006|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
2960402|NCT00747474|3674760|FG007|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
2960403|NCT00747474|3674761|FG008|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
2960404|NCT00747474|3674762|FG009|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
2960405|NCT00747474|3674763|FG010|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
3300993|NCT02950545|4034695|FG003|NOT COMPLETED|Washout 1 (5 Minutes)||1
3300994|NCT02950545|4034696|FG004|NOT COMPLETED|Washout 1 (5 Minutes)||0
3300995|NCT02950545|4034697|FG005|NOT COMPLETED|Washout 1 (5 Minutes)||1
3300996|NCT02950545|4034692|FG000|STARTED|Session 2 (70 Minutes)||8
3300997|NCT02950545|4034693|FG001|STARTED|Session 2 (70 Minutes)||9
3300998|NCT02950545|4034694|FG002|STARTED|Session 2 (70 Minutes)||7
3300999|NCT02950545|4034695|FG003|STARTED|Session 2 (70 Minutes)||7
3301000|NCT02950545|4034696|FG004|STARTED|Session 2 (70 Minutes)||8
3301001|NCT02950545|4034697|FG005|STARTED|Session 2 (70 Minutes)||8
3301002|NCT02950545|4034692|FG000|COMPLETED|Session 2 (70 Minutes)||8
3301003|NCT02950545|4034693|FG001|COMPLETED|Session 2 (70 Minutes)||9
3301004|NCT02950545|4034694|FG002|COMPLETED|Session 2 (70 Minutes)||7
3301005|NCT02950545|4034695|FG003|COMPLETED|Session 2 (70 Minutes)||7
3301006|NCT02950545|4034696|FG004|COMPLETED|Session 2 (70 Minutes)||7
3301007|NCT02950545|4034697|FG005|COMPLETED|Session 2 (70 Minutes)||8
3301008|NCT02950545|4034692|FG000|NOT COMPLETED|Session 2 (70 Minutes)||0
3301009|NCT02950545|4034693|FG001|NOT COMPLETED|Session 2 (70 Minutes)||0
3301010|NCT02950545|4034694|FG002|NOT COMPLETED|Session 2 (70 Minutes)||0
3301011|NCT02950545|4034695|FG003|NOT COMPLETED|Session 2 (70 Minutes)||0
3301012|NCT02950545|4034696|FG004|NOT COMPLETED|Session 2 (70 Minutes)||1
3301013|NCT02950545|4034697|FG005|NOT COMPLETED|Session 2 (70 Minutes)||0
3301014|NCT02950545|4034692|FG000|STARTED|Washout 2 (5 Minutes)||8
3301015|NCT02950545|4034693|FG001|STARTED|Washout 2 (5 Minutes)||9
3301016|NCT02950545|4034694|FG002|STARTED|Washout 2 (5 Minutes)||7
3301017|NCT02950545|4034695|FG003|STARTED|Washout 2 (5 Minutes)||7
3301018|NCT02950545|4034696|FG004|STARTED|Washout 2 (5 Minutes)||7
3301019|NCT02950545|4034697|FG005|STARTED|Washout 2 (5 Minutes)||8
3301020|NCT02950545|4034692|FG000|COMPLETED|Washout 2 (5 Minutes)||7
3301021|NCT02950545|4034693|FG001|COMPLETED|Washout 2 (5 Minutes)||9
3301022|NCT02950545|4034694|FG002|COMPLETED|Washout 2 (5 Minutes)||7
3301023|NCT02950545|4034695|FG003|COMPLETED|Washout 2 (5 Minutes)||7
3301024|NCT02950545|4034696|FG004|COMPLETED|Washout 2 (5 Minutes)||7
3301025|NCT02950545|4034697|FG005|COMPLETED|Washout 2 (5 Minutes)||8
3301026|NCT02950545|4034692|FG000|NOT COMPLETED|Washout 2 (5 Minutes)||1
3301027|NCT02950545|4034693|FG001|NOT COMPLETED|Washout 2 (5 Minutes)||0
3301028|NCT02950545|4034694|FG002|NOT COMPLETED|Washout 2 (5 Minutes)||0
3301029|NCT02950545|4034695|FG003|NOT COMPLETED|Washout 2 (5 Minutes)||0
3301030|NCT02950545|4034696|FG004|NOT COMPLETED|Washout 2 (5 Minutes)||0
3301031|NCT02950545|4034697|FG005|NOT COMPLETED|Washout 2 (5 Minutes)||0
3301032|NCT02950545|4034692|FG000|STARTED|Session 3 (70 Minutes)||7
3301033|NCT02950545|4034693|FG001|STARTED|Session 3 (70 Minutes)||9
3301034|NCT02950545|4034694|FG002|STARTED|Session 3 (70 Minutes)||7
3301035|NCT02950545|4034695|FG003|STARTED|Session 3 (70 Minutes)||7
3301036|NCT02950545|4034696|FG004|STARTED|Session 3 (70 Minutes)||7
3301037|NCT02950545|4034697|FG005|STARTED|Session 3 (70 Minutes)||8
3301038|NCT02950545|4034692|FG000|COMPLETED|Session 3 (70 Minutes)||7
3301039|NCT02950545|4034693|FG001|COMPLETED|Session 3 (70 Minutes)||9
3301040|NCT02950545|4034694|FG002|COMPLETED|Session 3 (70 Minutes)||7
3301041|NCT02950545|4034695|FG003|COMPLETED|Session 3 (70 Minutes)||7
3301042|NCT02950545|4034696|FG004|COMPLETED|Session 3 (70 Minutes)||7
3301043|NCT02950545|4034697|FG005|COMPLETED|Session 3 (70 Minutes)||7
3301044|NCT02950545|4034692|FG000|NOT COMPLETED|Session 3 (70 Minutes)||0
3301045|NCT02950545|4034693|FG001|NOT COMPLETED|Session 3 (70 Minutes)||0
3301046|NCT02950545|4034694|FG002|NOT COMPLETED|Session 3 (70 Minutes)||0
2960406|NCT00747474|3674764|FG011|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
2960407|NCT00747474|3674753|FG000|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
2960408|NCT00747474|3674754|FG001|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
2960409|NCT00747474|3674755|FG002|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
2960410|NCT00747474|3674756|FG003|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
2960411|NCT00747474|3674757|FG004|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||4
2960412|NCT00747474|3674758|FG005|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
2960413|NCT00747474|3674759|FG006|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
2960414|NCT00747474|3674760|FG007|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
2960415|NCT00747474|3674761|FG008|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
2960416|NCT00747474|3674762|FG009|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
2960417|NCT00747474|3674763|FG010|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
2960418|NCT00747474|3674764|FG011|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
2960419|NCT00747474|3674753|FG000|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
2960420|NCT00747474|3674754|FG001|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
2960421|NCT00747474|3674755|FG002|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
2960422|NCT00747474|3674756|FG003|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
2960423|NCT00747474|3674757|FG004|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
3301047|NCT02950545|4034695|FG003|NOT COMPLETED|Session 3 (70 Minutes)||0
3301048|NCT02950545|4034696|FG004|NOT COMPLETED|Session 3 (70 Minutes)||0
3301049|NCT02950545|4034697|FG005|NOT COMPLETED|Session 3 (70 Minutes)||1
3301050|NCT02950558|4034705|FG000|STARTED|Overall Study||8
3301051|NCT02950558|4034706|FG001|STARTED|Overall Study||6
3301052|NCT02950558|4034705|FG000|12 Month Pain Questionnaire|Overall Study||6
3301053|NCT02950558|4034706|FG001|12 Month Pain Questionnaire|Overall Study||6
3301054|NCT02950558|4034705|FG000|COMPLETED|Overall Study||6
3301055|NCT02950558|4034706|FG001|COMPLETED|Overall Study||6
3301056|NCT02950558|4034705|FG000|NOT COMPLETED|Overall Study||2
3301057|NCT02950558|4034706|FG001|NOT COMPLETED|Overall Study||0
3301058|NCT02950753|4034715|FG000|STARTED|Overall Study||15
3301059|NCT02950753|4034716|FG001|STARTED|Overall Study||15
3301060|NCT02950753|4034715|FG000|COMPLETED|Overall Study||15
3301061|NCT02950753|4034716|FG001|COMPLETED|Overall Study||15
3301062|NCT02950753|4034715|FG000|NOT COMPLETED|Overall Study||0
3301063|NCT02950753|4034716|FG001|NOT COMPLETED|Overall Study||0
3301064|NCT02950831|4034722|FG000|STARTED|Overall Study||27
3301065|NCT02950831|4034722|FG000|Complete Trial|Overall Study||26
3301066|NCT02950831|4034722|FG000|Permanent Implant|Overall Study||20
3301067|NCT02950831|4034722|FG000|4 Week Follow up|Overall Study||20
3301068|NCT02950831|4034722|FG000|8 Weeks Follow up|Overall Study||19
3301069|NCT02950831|4034722|FG000|COMPLETED|Overall Study||18
3301070|NCT02950831|4034722|FG000|NOT COMPLETED|Overall Study||9
3301071|NCT02951143|4034732|FG000|STARTED|Overall Study||97
3301072|NCT02951143|4034733|FG001|STARTED|Overall Study||41
3301073|NCT02951143|4034734|FG002|STARTED|Overall Study||47
3301074|NCT02951143|4034735|FG003|STARTED|Overall Study||39
3301075|NCT02951143|4034736|FG004|STARTED|Overall Study||37
3301076|NCT02951143|4034737|FG005|STARTED|Overall Study||44
3301077|NCT02951143|4034732|FG000|COMPLETED|Overall Study||36
3301078|NCT02951143|4034733|FG001|COMPLETED|Overall Study||32
3301079|NCT02951143|4034734|FG002|COMPLETED|Overall Study||29
3301080|NCT02951143|4034735|FG003|COMPLETED|Overall Study||30
3301081|NCT02951143|4034736|FG004|COMPLETED|Overall Study||31
3301082|NCT02951143|4034737|FG005|COMPLETED|Overall Study||29
3301083|NCT02951143|4034732|FG000|NOT COMPLETED|Overall Study||61
3301084|NCT02951143|4034733|FG001|NOT COMPLETED|Overall Study||9
3301085|NCT02951143|4034734|FG002|NOT COMPLETED|Overall Study||18
3301086|NCT02951143|4034735|FG003|NOT COMPLETED|Overall Study||9
3301087|NCT02951143|4034736|FG004|NOT COMPLETED|Overall Study||6
3301088|NCT02951143|4034737|FG005|NOT COMPLETED|Overall Study||15
3301089|NCT02951156|4034754|FG000|STARTED|Overall Study||9
3301090|NCT02951156|4034755|FG001|STARTED|Overall Study||9
3301091|NCT02951156|4034756|FG002|STARTED|Overall Study||11
3301092|NCT02951156|4034754|FG000|COMPLETED|Overall Study||0
3301093|NCT02951156|4034755|FG001|COMPLETED|Overall Study||0
3301094|NCT02951156|4034756|FG002|COMPLETED|Overall Study||1
3301095|NCT02951156|4034754|FG000|NOT COMPLETED|Overall Study||9
3301096|NCT02951156|4034755|FG001|NOT COMPLETED|Overall Study||9
3301097|NCT02951156|4034756|FG002|NOT COMPLETED|Overall Study||10
3301098|NCT02951182|4034771|FG000|STARTED|Overall Study||11
3301099|NCT02951182|4034772|FG001|STARTED|Overall Study||9
3301100|NCT02951182|4034773|FG002|STARTED|Overall Study||9
3301101|NCT02951182|4034774|FG003|STARTED|Overall Study||18
3301102|NCT02951182|4034775|FG004|STARTED|Overall Study||6
3301103|NCT02951182|4034776|FG005|STARTED|Overall Study||20
3301104|NCT02951182|4034771|FG000|COMPLETED|Overall Study||11
3301105|NCT02951182|4034772|FG001|COMPLETED|Overall Study||9
3301106|NCT02951182|4034773|FG002|COMPLETED|Overall Study||9
3301107|NCT02951182|4034774|FG003|COMPLETED|Overall Study||18
3301108|NCT02951182|4034775|FG004|COMPLETED|Overall Study||6
3301109|NCT02951182|4034776|FG005|COMPLETED|Overall Study||20
3301110|NCT02951182|4034771|FG000|NOT COMPLETED|Overall Study||0
3301111|NCT02951182|4034772|FG001|NOT COMPLETED|Overall Study||0
3301112|NCT02951182|4034773|FG002|NOT COMPLETED|Overall Study||0
3301113|NCT02951182|4034774|FG003|NOT COMPLETED|Overall Study||0
3301114|NCT02951182|4034775|FG004|NOT COMPLETED|Overall Study||0
3301115|NCT02951182|4034776|FG005|NOT COMPLETED|Overall Study||0
3301116|NCT02951195|4034804|FG000|STARTED|Overall Study||8
3301117|NCT02951195|4034805|FG001|STARTED|Overall Study||6
2960424|NCT00747474|3674758|FG005|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
2960425|NCT00747474|3674759|FG006|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
2960426|NCT00747474|3674760|FG007|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
2960427|NCT00747474|3674761|FG008|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
2960428|NCT00747474|3674762|FG009|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
2960429|NCT00747474|3674763|FG010|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
2960430|NCT00747474|3674764|FG011|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
2960431|NCT00747474|3674753|FG000|STARTED|Cohort 6 (20 mg/m^2) Period||0
2960432|NCT00747474|3674754|FG001|STARTED|Cohort 6 (20 mg/m^2) Period||0
2960433|NCT00747474|3674755|FG002|STARTED|Cohort 6 (20 mg/m^2) Period||0
2960434|NCT00747474|3674756|FG003|STARTED|Cohort 6 (20 mg/m^2) Period||0
2960435|NCT00747474|3674757|FG004|STARTED|Cohort 6 (20 mg/m^2) Period||0
2960436|NCT00747474|3674758|FG005|STARTED|Cohort 6 (20 mg/m^2) Period||4
2960437|NCT00747474|3674759|FG006|STARTED|Cohort 6 (20 mg/m^2) Period||0
2960438|NCT00747474|3674760|FG007|STARTED|Cohort 6 (20 mg/m^2) Period||0
3301118|NCT02951195|4034806|FG002|STARTED|Overall Study||10
3301119|NCT02951195|4034807|FG003|STARTED|Overall Study||10
3301120|NCT02951195|4034808|FG004|STARTED|Overall Study||4
3301121|NCT02951195|4034809|FG005|STARTED|Overall Study||10
3301122|NCT02951195|4034810|FG006|STARTED|Overall Study||7
3301123|NCT02951195|4034811|FG007|STARTED|Overall Study||21
3301124|NCT02951195|4034804|FG000|COMPLETED|Overall Study||8
3301125|NCT02951195|4034805|FG001|COMPLETED|Overall Study||6
3301126|NCT02951195|4034806|FG002|COMPLETED|Overall Study||10
3301127|NCT02951195|4034807|FG003|COMPLETED|Overall Study||10
3301128|NCT02951195|4034808|FG004|COMPLETED|Overall Study||4
3301129|NCT02951195|4034809|FG005|COMPLETED|Overall Study||10
3301130|NCT02951195|4034810|FG006|COMPLETED|Overall Study||7
3301131|NCT02951195|4034811|FG007|COMPLETED|Overall Study||21
3301132|NCT02951195|4034804|FG000|NOT COMPLETED|Overall Study||0
3301133|NCT02951195|4034805|FG001|NOT COMPLETED|Overall Study||0
3301134|NCT02951195|4034806|FG002|NOT COMPLETED|Overall Study||0
3301135|NCT02951195|4034807|FG003|NOT COMPLETED|Overall Study||0
3301136|NCT02951195|4034808|FG004|NOT COMPLETED|Overall Study||0
3301137|NCT02951195|4034809|FG005|NOT COMPLETED|Overall Study||0
3301138|NCT02951195|4034810|FG006|NOT COMPLETED|Overall Study||0
3301139|NCT02951195|4034811|FG007|NOT COMPLETED|Overall Study||0
3301140|NCT02951273|4034839|FG000|STARTED|Overall Study||30
3301141|NCT02951273|4034839|FG000|COMPLETED|Overall Study||27
3301142|NCT02951273|4034839|FG000|NOT COMPLETED|Overall Study||3
3301143|NCT02951312|4034847|FG000|STARTED|Study Part 1||6
3301144|NCT02951312|4034848|FG001|STARTED|Study Part 1||6
3301145|NCT02951312|4034849|FG002|STARTED|Study Part 1||0
3301146|NCT02951312|4034850|FG003|STARTED|Study Part 1||0
3301147|NCT02951312|4034847|FG000|COMPLETED|Study Part 1||6
3301148|NCT02951312|4034848|FG001|COMPLETED|Study Part 1||6
3301149|NCT02951312|4034849|FG002|COMPLETED|Study Part 1||0
3301150|NCT02951312|4034850|FG003|COMPLETED|Study Part 1||0
3301151|NCT02951312|4034847|FG000|NOT COMPLETED|Study Part 1||0
3301152|NCT02951312|4034848|FG001|NOT COMPLETED|Study Part 1||0
3301153|NCT02951312|4034849|FG002|NOT COMPLETED|Study Part 1||0
3301154|NCT02951312|4034850|FG003|NOT COMPLETED|Study Part 1||0
3301155|NCT02951312|4034847|FG000|STARTED|Study Part 2||0
3301156|NCT02951312|4034848|FG001|STARTED|Study Part 2||0
3301157|NCT02951312|4034849|FG002|STARTED|Study Part 2||6
3301158|NCT02951312|4034850|FG003|STARTED|Study Part 2||6
3301159|NCT02951312|4034847|FG000|COMPLETED|Study Part 2||0
3301160|NCT02951312|4034848|FG001|COMPLETED|Study Part 2||0
3301161|NCT02951312|4034849|FG002|COMPLETED|Study Part 2||6
3301162|NCT02951312|4034850|FG003|COMPLETED|Study Part 2||6
3301163|NCT02951312|4034847|FG000|NOT COMPLETED|Study Part 2||0
3301164|NCT02951312|4034848|FG001|NOT COMPLETED|Study Part 2||0
3301165|NCT02951312|4034849|FG002|NOT COMPLETED|Study Part 2||0
3301166|NCT02951312|4034850|FG003|NOT COMPLETED|Study Part 2||0
3301167|NCT02951351|4034872|FG000|STARTED|Overall Study||19
3301168|NCT02951351|4034873|FG001|STARTED|Overall Study||17
3301169|NCT02951351|4034872|FG000|COMPLETED|Overall Study||19
3301170|NCT02951351|4034873|FG001|COMPLETED|Overall Study||17
3301171|NCT02951351|4034872|FG000|NOT COMPLETED|Overall Study||0
3301172|NCT02951351|4034873|FG001|NOT COMPLETED|Overall Study||0
3301173|NCT02951429|4034881|FG000|STARTED|Overall Study||88
3301174|NCT02951429|4034882|FG001|STARTED|Overall Study||89
3301175|NCT02951429|4034881|FG000|COMPLETED|Overall Study||16
3301176|NCT02951429|4034882|FG001|COMPLETED|Overall Study||6
3301177|NCT02951429|4034881|FG000|NOT COMPLETED|Overall Study||72
3301178|NCT02951429|4034882|FG001|NOT COMPLETED|Overall Study||83
3301179|NCT02951481|4034890|FG000|STARTED|Overall Study||231
3301180|NCT02951481|4034891|FG001|STARTED|Overall Study||172
3301181|NCT02951481|4034890|FG000|COMPLETED|Overall Study||231
3301182|NCT02951481|4034891|FG001|COMPLETED|Overall Study||172
3301183|NCT02951481|4034890|FG000|NOT COMPLETED|Overall Study||0
3301184|NCT02951481|4034891|FG001|NOT COMPLETED|Overall Study||0
3301185|NCT02951533|4034899|FG000|STARTED|Part I (Week 0 Through Week 24)||60
3301186|NCT02951533|4034900|FG001|STARTED|Part I (Week 0 Through Week 24)||59
3301187|NCT02951533|4034901|FG002|STARTED|Part I (Week 0 Through Week 24)||0
3301188|NCT02951533|4034899|FG000|Treated|Part I (Week 0 Through Week 24)||60
3301189|NCT02951533|4034900|FG001|Treated|Part I (Week 0 Through Week 24)||58
3301190|NCT02951533|4034901|FG002|Treated|Part I (Week 0 Through Week 24)||0
3301191|NCT02951533|4034899|FG000|COMPLETED|Part I (Week 0 Through Week 24)||56
3301192|NCT02951533|4034900|FG001|COMPLETED|Part I (Week 0 Through Week 24)||36
2960439|NCT00747474|3674761|FG008|STARTED|Cohort 6 (20 mg/m^2) Period||0
2960440|NCT00747474|3674762|FG009|STARTED|Cohort 6 (20 mg/m^2) Period||0
2960441|NCT00747474|3674763|FG010|STARTED|Cohort 6 (20 mg/m^2) Period||0
2960442|NCT00747474|3674764|FG011|STARTED|Cohort 6 (20 mg/m^2) Period||0
2960443|NCT00747474|3674753|FG000|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
2960444|NCT00747474|3674754|FG001|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
2960445|NCT00747474|3674755|FG002|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
2960446|NCT00747474|3674756|FG003|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
2960447|NCT00747474|3674757|FG004|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
2960448|NCT00747474|3674758|FG005|COMPLETED|Cohort 6 (20 mg/m^2) Period||4
2960449|NCT00747474|3674759|FG006|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
2960450|NCT00747474|3674760|FG007|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
2960451|NCT00747474|3674761|FG008|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
2960452|NCT00747474|3674762|FG009|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
2960453|NCT00747474|3674763|FG010|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
2960454|NCT00747474|3674764|FG011|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
2960455|NCT00747474|3674753|FG000|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
2960456|NCT00747474|3674754|FG001|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
2960457|NCT00747474|3674755|FG002|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
3301193|NCT02951533|4034901|FG002|COMPLETED|Part I (Week 0 Through Week 24)||0
3301194|NCT02951533|4034899|FG000|NOT COMPLETED|Part I (Week 0 Through Week 24)||4
3301195|NCT02951533|4034900|FG001|NOT COMPLETED|Part I (Week 0 Through Week 24)||23
3301196|NCT02951533|4034901|FG002|NOT COMPLETED|Part I (Week 0 Through Week 24)||0
3301197|NCT02951533|4034899|FG000|STARTED|Part IIa (Week 24 Through Week 32)||56
3301198|NCT02951533|4034900|FG001|STARTED|Part IIa (Week 24 Through Week 32)|1 participant did not sign informed consent form (ICF) for Study Part II but completed Study Part I.|35
3301199|NCT02951533|4034901|FG002|STARTED|Part IIa (Week 24 Through Week 32)||0
3301200|NCT02951533|4034899|FG000|PASI 75 Responder at Week 32|Part IIa (Week 24 Through Week 32)||54
3301201|NCT02951533|4034900|FG001|PASI 75 Responder at Week 32|Part IIa (Week 24 Through Week 32)||14
3301202|NCT02951533|4034901|FG002|PASI 75 Responder at Week 32|Part IIa (Week 24 Through Week 32)||0
3301203|NCT02951533|4034899|FG000|PASI 75 Non-responder at Week 32|Part IIa (Week 24 Through Week 32)||1
3301204|NCT02951533|4034900|FG001|PASI 75 Non-responder at Week 32|Part IIa (Week 24 Through Week 32)||20
3301205|NCT02951533|4034901|FG002|PASI 75 Non-responder at Week 32|Part IIa (Week 24 Through Week 32)||0
3301206|NCT02951533|4034899|FG000|COMPLETED|Part IIa (Week 24 Through Week 32)||55
3301207|NCT02951533|4034900|FG001|COMPLETED|Part IIa (Week 24 Through Week 32)||34
3301208|NCT02951533|4034901|FG002|COMPLETED|Part IIa (Week 24 Through Week 32)||0
3301209|NCT02951533|4034899|FG000|NOT COMPLETED|Part IIa (Week 24 Through Week 32)||1
3301210|NCT02951533|4034900|FG001|NOT COMPLETED|Part IIa (Week 24 Through Week 32)||1
3301211|NCT02951533|4034901|FG002|NOT COMPLETED|Part IIa (Week 24 Through Week 32)||0
3301212|NCT02951533|4034899|FG000|STARTED|Part IIb (Week 32 Through Week 56)||55
3301213|NCT02951533|4034900|FG001|STARTED|Part IIb (Week 32 Through Week 56)|Out of 34 participants in the FAE group, 14 PASI 75 responders remained on FAE treatment.|14
3301214|NCT02951533|4034901|FG002|STARTED|Part IIb (Week 32 Through Week 56)|Out of 34 participants in FAE group, 20 PASI 75 non-responders switched to GUS group.|20
3301215|NCT02951533|4034899|FG000|COMPLETED|Part IIb (Week 32 Through Week 56)||54
3301216|NCT02951533|4034900|FG001|COMPLETED|Part IIb (Week 32 Through Week 56)||10
3301217|NCT02951533|4034901|FG002|COMPLETED|Part IIb (Week 32 Through Week 56)||20
3301218|NCT02951533|4034899|FG000|NOT COMPLETED|Part IIb (Week 32 Through Week 56)||1
3301219|NCT02951533|4034900|FG001|NOT COMPLETED|Part IIb (Week 32 Through Week 56)||4
3301220|NCT02951533|4034901|FG002|NOT COMPLETED|Part IIb (Week 32 Through Week 56)||0
3301221|NCT02951533|4034899|FG000|STARTED|Part III (Week 64 Through Week 100)|18 participants were not eligible to enter Part III.|36
3301222|NCT02951533|4034900|FG001|STARTED|Part III (Week 64 Through Week 100)|10 participants in the FAE group were not eligible to enter Part III.|0
3301223|NCT02951533|4034901|FG002|STARTED|Part III (Week 64 Through Week 100)|8 participants were not eligible to enter Part III.|12
3301224|NCT02951533|4034899|FG000|COMPLETED|Part III (Week 64 Through Week 100)||32
3301225|NCT02951533|4034900|FG001|COMPLETED|Part III (Week 64 Through Week 100)||0
3301226|NCT02951533|4034901|FG002|COMPLETED|Part III (Week 64 Through Week 100)||10
3301227|NCT02951533|4034899|FG000|NOT COMPLETED|Part III (Week 64 Through Week 100)||4
3301228|NCT02951533|4034900|FG001|NOT COMPLETED|Part III (Week 64 Through Week 100)||0
3301229|NCT02951533|4034901|FG002|NOT COMPLETED|Part III (Week 64 Through Week 100)||2
3301230|NCT02951702|4034920|FG000|STARTED|Overall Study||34
3301231|NCT02951702|4034921|FG001|STARTED|Overall Study||17
3301232|NCT02951702|4034920|FG000|COMPLETED|Overall Study||34
3301233|NCT02951702|4034921|FG001|COMPLETED|Overall Study||17
3301234|NCT02951702|4034920|FG000|NOT COMPLETED|Overall Study||0
3301235|NCT02951702|4034921|FG001|NOT COMPLETED|Overall Study||0
3301236|NCT02951780|4034936|FG000|STARTED|Period 1||3
3301237|NCT02951780|4034937|FG001|STARTED|Period 1||2
3301238|NCT02951780|4034938|FG002|STARTED|Period 1||3
3301239|NCT02951780|4034939|FG003|STARTED|Period 1||3
3301240|NCT02951780|4034940|FG004|STARTED|Period 1||2
3301241|NCT02951780|4034941|FG005|STARTED|Period 1||3
3301242|NCT02951780|4034942|FG006|STARTED|Period 1||2
3301243|NCT02951780|4034943|FG007|STARTED|Period 1||3
3301244|NCT02951780|4034944|FG008|STARTED|Period 1||2
3301245|NCT02951780|4034936|FG000|COMPLETED|Period 1||3
3301246|NCT02951780|4034937|FG001|COMPLETED|Period 1||2
3301247|NCT02951780|4034938|FG002|COMPLETED|Period 1||3
3301248|NCT02951780|4034939|FG003|COMPLETED|Period 1||2
3301249|NCT02951780|4034940|FG004|COMPLETED|Period 1||2
2960458|NCT00747474|3674756|FG003|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
2960459|NCT00747474|3674757|FG004|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
2960460|NCT00747474|3674758|FG005|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
2960461|NCT00747474|3674759|FG006|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
3132844|NCT01693562|3858027|FG018|COMPLETED|Escalation Phase||0
3132845|NCT01693562|3858028|FG019|COMPLETED|Escalation Phase||0
3132846|NCT01693562|3858029|FG020|COMPLETED|Escalation Phase||0
3132847|NCT01693562|3858030|FG021|COMPLETED|Escalation Phase||0
3132848|NCT01693562|3858031|FG022|COMPLETED|Escalation Phase||0
3132849|NCT01693562|3858009|FG000|NOT COMPLETED|Escalation Phase||4
3132850|NCT01693562|3858010|FG001|NOT COMPLETED|Escalation Phase||4
3132851|NCT01693562|3858011|FG002|NOT COMPLETED|Escalation Phase||3
3132852|NCT01693562|3858012|FG003|NOT COMPLETED|Escalation Phase||3
3132853|NCT01693562|3858013|FG004|NOT COMPLETED|Escalation Phase||6
2960462|NCT00747474|3674760|FG007|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
2960463|NCT00747474|3674761|FG008|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
2960464|NCT00747474|3674762|FG009|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
2960465|NCT00747474|3674763|FG010|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
2960466|NCT00747474|3674764|FG011|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
2960467|NCT00747474|3674753|FG000|STARTED|Cohort 7 (30 mg/m^2) Period||0
2960468|NCT00747474|3674754|FG001|STARTED|Cohort 7 (30 mg/m^2) Period||0
2960469|NCT00747474|3674755|FG002|STARTED|Cohort 7 (30 mg/m^2) Period||0
2960470|NCT00747474|3674756|FG003|STARTED|Cohort 7 (30 mg/m^2) Period||0
2960471|NCT00747474|3674757|FG004|STARTED|Cohort 7 (30 mg/m^2) Period||0
2960472|NCT00747474|3674758|FG005|STARTED|Cohort 7 (30 mg/m^2) Period||0
2960473|NCT00747474|3674759|FG006|STARTED|Cohort 7 (30 mg/m^2) Period||4
2960474|NCT00747474|3674760|FG007|STARTED|Cohort 7 (30 mg/m^2) Period||0
2960475|NCT00747474|3674761|FG008|STARTED|Cohort 7 (30 mg/m^2) Period||0
2960476|NCT00747474|3674762|FG009|STARTED|Cohort 7 (30 mg/m^2) Period||0
2960477|NCT00747474|3674763|FG010|STARTED|Cohort 7 (30 mg/m^2) Period||0
2960478|NCT00747474|3674764|FG011|STARTED|Cohort 7 (30 mg/m^2) Period||0
2960479|NCT00747474|3674753|FG000|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
2960480|NCT00747474|3674754|FG001|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
2960481|NCT00747474|3674755|FG002|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
2960482|NCT00747474|3674756|FG003|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
2960483|NCT00747474|3674757|FG004|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
2960484|NCT00747474|3674758|FG005|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
2960485|NCT00747474|3674759|FG006|COMPLETED|Cohort 7 (30 mg/m^2) Period||4
2960486|NCT00747474|3674760|FG007|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
2960487|NCT00747474|3674761|FG008|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
2960488|NCT00747474|3674762|FG009|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
2960489|NCT00747474|3674763|FG010|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
2960490|NCT00747474|3674764|FG011|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
3132854|NCT01693562|3858014|FG005|NOT COMPLETED|Escalation Phase||7
3301250|NCT02951780|4034941|FG005|COMPLETED|Period 1||3
3301251|NCT02951780|4034942|FG006|COMPLETED|Period 1||2
3301252|NCT02951780|4034943|FG007|COMPLETED|Period 1||2
3301253|NCT02951780|4034944|FG008|COMPLETED|Period 1||2
3301254|NCT02951780|4034936|FG000|NOT COMPLETED|Period 1||0
3301255|NCT02951780|4034937|FG001|NOT COMPLETED|Period 1||0
3301256|NCT02951780|4034938|FG002|NOT COMPLETED|Period 1||0
3301257|NCT02951780|4034939|FG003|NOT COMPLETED|Period 1||1
3301258|NCT02951780|4034940|FG004|NOT COMPLETED|Period 1||0
3301259|NCT02951780|4034941|FG005|NOT COMPLETED|Period 1||0
3301260|NCT02951780|4034942|FG006|NOT COMPLETED|Period 1||0
3301261|NCT02951780|4034943|FG007|NOT COMPLETED|Period 1||1
3301262|NCT02951780|4034944|FG008|NOT COMPLETED|Period 1||0
3301263|NCT02951780|4034936|FG000|STARTED|Period 2||3
3301264|NCT02951780|4034937|FG001|STARTED|Period 2||2
3301265|NCT02951780|4034938|FG002|STARTED|Period 2||3
3301266|NCT02951780|4034939|FG003|STARTED|Period 2||2
3301267|NCT02951780|4034940|FG004|STARTED|Period 2||2
3301268|NCT02951780|4034941|FG005|STARTED|Period 2||3
3301269|NCT02951780|4034942|FG006|STARTED|Period 2||2
3301270|NCT02951780|4034943|FG007|STARTED|Period 2||2
3301271|NCT02951780|4034944|FG008|STARTED|Period 2||2
3301272|NCT02951780|4034936|FG000|COMPLETED|Period 2||3
3301273|NCT02951780|4034937|FG001|COMPLETED|Period 2||2
3301274|NCT02951780|4034938|FG002|COMPLETED|Period 2||3
3301275|NCT02951780|4034939|FG003|COMPLETED|Period 2||2
3301276|NCT02951780|4034940|FG004|COMPLETED|Period 2||2
3301277|NCT02951780|4034941|FG005|COMPLETED|Period 2||3
3301278|NCT02951780|4034942|FG006|COMPLETED|Period 2||2
3301279|NCT02951780|4034943|FG007|COMPLETED|Period 2||1
3301280|NCT02951780|4034944|FG008|COMPLETED|Period 2||2
3301281|NCT02951780|4034936|FG000|NOT COMPLETED|Period 2||0
3301282|NCT02951780|4034937|FG001|NOT COMPLETED|Period 2||0
3301283|NCT02951780|4034938|FG002|NOT COMPLETED|Period 2||0
3301284|NCT02951780|4034939|FG003|NOT COMPLETED|Period 2||0
3301285|NCT02951780|4034940|FG004|NOT COMPLETED|Period 2||0
2960491|NCT00747474|3674753|FG000|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
2960492|NCT00747474|3674754|FG001|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
2960493|NCT00747474|3674755|FG002|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
3301286|NCT02951780|4034941|FG005|NOT COMPLETED|Period 2||0
3301287|NCT02951780|4034942|FG006|NOT COMPLETED|Period 2||0
3301288|NCT02951780|4034943|FG007|NOT COMPLETED|Period 2||1
3301289|NCT02951780|4034944|FG008|NOT COMPLETED|Period 2||0
3301290|NCT02951780|4034936|FG000|STARTED|Period 3||3
3301291|NCT02951780|4034937|FG001|STARTED|Period 3||2
3301292|NCT02951780|4034938|FG002|STARTED|Period 3||3
2960494|NCT00747474|3674756|FG003|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
2960495|NCT00747474|3674757|FG004|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
2960496|NCT00747474|3674758|FG005|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
2960497|NCT00747474|3674759|FG006|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
2960498|NCT00747474|3674760|FG007|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
2960499|NCT00747474|3674761|FG008|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
2960500|NCT00747474|3674762|FG009|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
2960501|NCT00747474|3674763|FG010|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
2960502|NCT00747474|3674764|FG011|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
3163742|NCT01888874|3891213|FG001|STARTED|Period 2 (Week 13 to Week 24)|Nonresponders from 50 mg QD group moved to 100 mg QD group (19 participants).|57
3163743|NCT01888874|3891214|FG002|STARTED|Period 2 (Week 13 to Week 24)|Nonresponders from Placebo(15 participants) and 50 mg QD (19 participants) moved to 100 mg QD group.|112
3163744|NCT01888874|3891215|FG003|STARTED|Period 2 (Week 13 to Week 24)||80
3163745|NCT01888874|3891216|FG004|STARTED|Period 2 (Week 13 to Week 24)|Nonresponders from 25 mg BID group moved to 50 mg BID group (17 participants).|60
3163746|NCT01888874|3891217|FG005|STARTED|Period 2 (Week 13 to Week 24)|Nonresponders from Placebo(15 participants) and 25 mg BID(17 participants) moved to 50 mg BID group.|112
3163747|NCT01888874|3891218|FG006|STARTED|Period 2 (Week 13 to Week 24)||83
3163748|NCT01888874|3891212|FG000|COMPLETED|Period 2 (Week 13 to Week 24)||50
3163749|NCT01888874|3891213|FG001|COMPLETED|Period 2 (Week 13 to Week 24)||55
3163750|NCT01888874|3891214|FG002|COMPLETED|Period 2 (Week 13 to Week 24)||104
3163751|NCT01888874|3891215|FG003|COMPLETED|Period 2 (Week 13 to Week 24)||78
3163752|NCT01888874|3891216|FG004|COMPLETED|Period 2 (Week 13 to Week 24)||57
3163753|NCT01888874|3891217|FG005|COMPLETED|Period 2 (Week 13 to Week 24)||109
3163754|NCT01888874|3891218|FG006|COMPLETED|Period 2 (Week 13 to Week 24)||80
3163755|NCT01888874|3891212|FG000|NOT COMPLETED|Period 2 (Week 13 to Week 24)||3
3163756|NCT01888874|3891213|FG001|NOT COMPLETED|Period 2 (Week 13 to Week 24)||2
3163757|NCT01888874|3891214|FG002|NOT COMPLETED|Period 2 (Week 13 to Week 24)||8
3163758|NCT01888874|3891215|FG003|NOT COMPLETED|Period 2 (Week 13 to Week 24)||2
2960503|NCT00747474|3674753|FG000|STARTED|Cohort 8 (40 mg/m^2) Period||0
2960504|NCT00747474|3674754|FG001|STARTED|Cohort 8 (40 mg/m^2) Period||0
2960505|NCT00747474|3674755|FG002|STARTED|Cohort 8 (40 mg/m^2) Period||0
2960506|NCT00747474|3674756|FG003|STARTED|Cohort 8 (40 mg/m^2) Period||0
2960507|NCT00747474|3674757|FG004|STARTED|Cohort 8 (40 mg/m^2) Period||0
2960508|NCT00747474|3674758|FG005|STARTED|Cohort 8 (40 mg/m^2) Period||0
2960509|NCT00747474|3674759|FG006|STARTED|Cohort 8 (40 mg/m^2) Period||0
2960510|NCT00747474|3674760|FG007|STARTED|Cohort 8 (40 mg/m^2) Period||6
2960511|NCT00747474|3674761|FG008|STARTED|Cohort 8 (40 mg/m^2) Period||0
2960512|NCT00747474|3674762|FG009|STARTED|Cohort 8 (40 mg/m^2) Period||0
2960513|NCT00747474|3674763|FG010|STARTED|Cohort 8 (40 mg/m^2) Period||0
2960514|NCT00747474|3674764|FG011|STARTED|Cohort 8 (40 mg/m^2) Period||0
2960515|NCT00747474|3674753|FG000|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
2960516|NCT00747474|3674754|FG001|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
2960517|NCT00747474|3674755|FG002|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
2960518|NCT00747474|3674756|FG003|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
2960519|NCT00747474|3674757|FG004|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
2960520|NCT00747474|3674758|FG005|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
2960521|NCT00747474|3674759|FG006|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
2960522|NCT00747474|3674760|FG007|COMPLETED|Cohort 8 (40 mg/m^2) Period||5
2960523|NCT00747474|3674761|FG008|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
2960524|NCT00747474|3674762|FG009|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
2960525|NCT00747474|3674763|FG010|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
2960526|NCT00747474|3674764|FG011|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
2960527|NCT00747474|3674753|FG000|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
2960528|NCT00747474|3674754|FG001|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
2960529|NCT00747474|3674755|FG002|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
2960530|NCT00747474|3674756|FG003|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
2960531|NCT00747474|3674757|FG004|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
2960532|NCT00747474|3674758|FG005|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
2960533|NCT00747474|3674759|FG006|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
2960534|NCT00747474|3674760|FG007|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||1
2960535|NCT00747474|3674761|FG008|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
2960536|NCT00747474|3674762|FG009|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
2960537|NCT00747474|3674763|FG010|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
2960538|NCT00747474|3674764|FG011|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
2960539|NCT00747474|3674753|FG000|STARTED|Cohort 9 (35 mg/m^2) Period||0
2960540|NCT00747474|3674754|FG001|STARTED|Cohort 9 (35 mg/m^2) Period||0
2960541|NCT00747474|3674755|FG002|STARTED|Cohort 9 (35 mg/m^2) Period||0
2960542|NCT00747474|3674756|FG003|STARTED|Cohort 9 (35 mg/m^2) Period||0
2960543|NCT00747474|3674757|FG004|STARTED|Cohort 9 (35 mg/m^2) Period||0
2960544|NCT00747474|3674758|FG005|STARTED|Cohort 9 (35 mg/m^2) Period||0
2960545|NCT00747474|3674759|FG006|STARTED|Cohort 9 (35 mg/m^2) Period||0
2960546|NCT00747474|3674760|FG007|STARTED|Cohort 9 (35 mg/m^2) Period||0
2960547|NCT00747474|3674761|FG008|STARTED|Cohort 9 (35 mg/m^2) Period||4
2960548|NCT00747474|3674762|FG009|STARTED|Cohort 9 (35 mg/m^2) Period||0
2960549|NCT00747474|3674763|FG010|STARTED|Cohort 9 (35 mg/m^2) Period||0
2960550|NCT00747474|3674764|FG011|STARTED|Cohort 9 (35 mg/m^2) Period||0
2960551|NCT00747474|3674753|FG000|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
2960552|NCT00747474|3674754|FG001|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
2960553|NCT00747474|3674755|FG002|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
3132855|NCT01693562|3858015|FG006|NOT COMPLETED|Escalation Phase||0
3132856|NCT01693562|3858016|FG007|NOT COMPLETED|Escalation Phase||0
3132857|NCT01693562|3858017|FG008|NOT COMPLETED|Escalation Phase||0
2960554|NCT00747474|3674756|FG003|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
2960555|NCT00747474|3674757|FG004|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
2960556|NCT00747474|3674758|FG005|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
2960557|NCT00747474|3674759|FG006|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
2960558|NCT00747474|3674760|FG007|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
2960559|NCT00747474|3674761|FG008|COMPLETED|Cohort 9 (35 mg/m^2) Period||4
2960560|NCT00747474|3674762|FG009|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
2960561|NCT00747474|3674763|FG010|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
2960562|NCT00747474|3674764|FG011|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
2960563|NCT00747474|3674753|FG000|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
2960564|NCT00747474|3674754|FG001|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
2960565|NCT00747474|3674755|FG002|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
2960566|NCT00747474|3674756|FG003|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
2960567|NCT00747474|3674757|FG004|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
2960568|NCT00747474|3674758|FG005|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
2960569|NCT00747474|3674759|FG006|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
2960570|NCT00747474|3674760|FG007|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
2960571|NCT00747474|3674761|FG008|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
2960572|NCT00747474|3674762|FG009|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
2960573|NCT00747474|3674763|FG010|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
2960574|NCT00747474|3674764|FG011|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
2960575|NCT00747474|3674753|FG000|STARTED|Cohort 10 (40 mg/m^2) Period||0
2960576|NCT00747474|3674754|FG001|STARTED|Cohort 10 (40 mg/m^2) Period||0
2960577|NCT00747474|3674755|FG002|STARTED|Cohort 10 (40 mg/m^2) Period||0
2960578|NCT00747474|3674756|FG003|STARTED|Cohort 10 (40 mg/m^2) Period||0
2960579|NCT00747474|3674757|FG004|STARTED|Cohort 10 (40 mg/m^2) Period||0
2960580|NCT00747474|3674758|FG005|STARTED|Cohort 10 (40 mg/m^2) Period||0
2960581|NCT00747474|3674759|FG006|STARTED|Cohort 10 (40 mg/m^2) Period||0
2960582|NCT00747474|3674760|FG007|STARTED|Cohort 10 (40 mg/m^2) Period||0
2960583|NCT00747474|3674761|FG008|STARTED|Cohort 10 (40 mg/m^2) Period||0
2960584|NCT00747474|3674762|FG009|STARTED|Cohort 10 (40 mg/m^2) Period||7
2960585|NCT00747474|3674763|FG010|STARTED|Cohort 10 (40 mg/m^2) Period||0
2960586|NCT00747474|3674764|FG011|STARTED|Cohort 10 (40 mg/m^2) Period||0
2960587|NCT00747474|3674753|FG000|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
2960588|NCT00747474|3674754|FG001|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
2960589|NCT00747474|3674755|FG002|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
2960590|NCT00747474|3674756|FG003|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
2960591|NCT00747474|3674757|FG004|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
2960592|NCT00747474|3674758|FG005|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
2960593|NCT00747474|3674759|FG006|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
2960594|NCT00747474|3674760|FG007|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
2960595|NCT00747474|3674761|FG008|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
2960596|NCT00747474|3674762|FG009|COMPLETED|Cohort 10 (40 mg/m^2) Period||7
2960597|NCT00747474|3674763|FG010|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
2960598|NCT00747474|3674764|FG011|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
2960599|NCT00747474|3674753|FG000|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
2960600|NCT00747474|3674754|FG001|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
2960601|NCT00747474|3674755|FG002|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
2960602|NCT00747474|3674756|FG003|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
2960603|NCT00747474|3674757|FG004|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
2960604|NCT00747474|3674758|FG005|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
2960605|NCT00747474|3674759|FG006|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
2960606|NCT00747474|3674760|FG007|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
2960607|NCT00747474|3674761|FG008|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
2960608|NCT00747474|3674762|FG009|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
2960609|NCT00747474|3674763|FG010|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
2960610|NCT00747474|3674764|FG011|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
2960611|NCT00747474|3674753|FG000|STARTED|Cohort 11 (50 mg/m^2) Period||0
2960612|NCT00747474|3674754|FG001|STARTED|Cohort 11 (50 mg/m^2) Period||0
2960613|NCT00747474|3674755|FG002|STARTED|Cohort 11 (50 mg/m^2) Period||0
2960614|NCT00747474|3674756|FG003|STARTED|Cohort 11 (50 mg/m^2) Period||0
2960615|NCT00747474|3674757|FG004|STARTED|Cohort 11 (50 mg/m^2) Period||0
2960616|NCT00747474|3674758|FG005|STARTED|Cohort 11 (50 mg/m^2) Period||0
2960617|NCT00747474|3674759|FG006|STARTED|Cohort 11 (50 mg/m^2) Period||0
2960618|NCT00747474|3674760|FG007|STARTED|Cohort 11 (50 mg/m^2) Period||0
2960619|NCT00747474|3674761|FG008|STARTED|Cohort 11 (50 mg/m^2) Period||0
2960620|NCT00747474|3674762|FG009|STARTED|Cohort 11 (50 mg/m^2) Period||0
2960621|NCT00747474|3674763|FG010|STARTED|Cohort 11 (50 mg/m^2) Period||5
2960622|NCT00747474|3674764|FG011|STARTED|Cohort 11 (50 mg/m^2) Period||0
2960623|NCT00747474|3674753|FG000|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
2960624|NCT00747474|3674754|FG001|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
2960625|NCT00747474|3674755|FG002|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
2960626|NCT00747474|3674756|FG003|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
2960627|NCT00747474|3674757|FG004|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
2960628|NCT00747474|3674758|FG005|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
2960629|NCT00747474|3674759|FG006|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
2960630|NCT00747474|3674760|FG007|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
2960631|NCT00747474|3674761|FG008|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
2960632|NCT00747474|3674762|FG009|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
2960633|NCT00747474|3674763|FG010|COMPLETED|Cohort 11 (50 mg/m^2) Period||5
2960634|NCT00747474|3674764|FG011|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
2960635|NCT00747474|3674753|FG000|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
2960636|NCT00747474|3674754|FG001|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
2960637|NCT00747474|3674755|FG002|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
2960638|NCT00747474|3674756|FG003|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
2960639|NCT00747474|3674757|FG004|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
2960640|NCT00747474|3674758|FG005|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
2960641|NCT00747474|3674759|FG006|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
2960642|NCT00747474|3674760|FG007|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
2960643|NCT00747474|3674761|FG008|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
3132858|NCT01693562|3858018|FG009|NOT COMPLETED|Escalation Phase||0
3132859|NCT01693562|3858019|FG010|NOT COMPLETED|Escalation Phase||0
3132860|NCT01693562|3858020|FG011|NOT COMPLETED|Escalation Phase||0
3132861|NCT01693562|3858021|FG012|NOT COMPLETED|Escalation Phase||0
3132862|NCT01693562|3858022|FG013|NOT COMPLETED|Escalation Phase||0
3132863|NCT01693562|3858023|FG014|NOT COMPLETED|Escalation Phase||0
3301293|NCT02951780|4034939|FG003|STARTED|Period 3||2
3301294|NCT02951780|4034940|FG004|STARTED|Period 3||2
3301295|NCT02951780|4034941|FG005|STARTED|Period 3||3
3301296|NCT02951780|4034942|FG006|STARTED|Period 3||2
3301297|NCT02951780|4034943|FG007|STARTED|Period 3||1
3301298|NCT02951780|4034944|FG008|STARTED|Period 3||2
3301299|NCT02951780|4034936|FG000|COMPLETED|Period 3||3
3301300|NCT02951780|4034937|FG001|COMPLETED|Period 3||2
3301301|NCT02951780|4034938|FG002|COMPLETED|Period 3||3
3301302|NCT02951780|4034939|FG003|COMPLETED|Period 3||2
3301303|NCT02951780|4034940|FG004|COMPLETED|Period 3||2
3301304|NCT02951780|4034941|FG005|COMPLETED|Period 3||3
3301305|NCT02951780|4034942|FG006|COMPLETED|Period 3||2
3301306|NCT02951780|4034943|FG007|COMPLETED|Period 3||1
3301307|NCT02951780|4034944|FG008|COMPLETED|Period 3||2
3301308|NCT02951780|4034936|FG000|NOT COMPLETED|Period 3||0
3301309|NCT02951780|4034937|FG001|NOT COMPLETED|Period 3||0
3301310|NCT02951780|4034938|FG002|NOT COMPLETED|Period 3||0
3301311|NCT02951780|4034939|FG003|NOT COMPLETED|Period 3||0
3301312|NCT02951780|4034940|FG004|NOT COMPLETED|Period 3||0
3301313|NCT02951780|4034941|FG005|NOT COMPLETED|Period 3||0
3301314|NCT02951780|4034942|FG006|NOT COMPLETED|Period 3||0
3301315|NCT02951780|4034943|FG007|NOT COMPLETED|Period 3||0
3301316|NCT02951780|4034944|FG008|NOT COMPLETED|Period 3||0
3301317|NCT02951819|4034966|FG000|STARTED|Overall Study||87
3301318|NCT02951819|4034967|FG001|STARTED|Overall Study||14
3301319|NCT02951819|4034966|FG000|Treated|Overall Study||86
3301320|NCT02951819|4034967|FG001|Treated|Overall Study||14
3301321|NCT02951819|4034966|FG000|COMPLETED|Overall Study||59
3301322|NCT02951819|4034967|FG001|COMPLETED|Overall Study||7
3301323|NCT02951819|4034966|FG000|NOT COMPLETED|Overall Study||28
3301324|NCT02951819|4034967|FG001|NOT COMPLETED|Overall Study||7
3301325|NCT02951884|4034976|FG000|STARTED|Overall Study||0
3301326|NCT02951884|4034977|FG001|STARTED|Overall Study||1
3301327|NCT02951884|4034978|FG002|STARTED|Overall Study||1
3301328|NCT02951884|4034976|FG000|COMPLETED|Overall Study||0
3301329|NCT02951884|4034977|FG001|COMPLETED|Overall Study||1
3301330|NCT02951884|4034978|FG002|COMPLETED|Overall Study||1
3301331|NCT02951884|4034976|FG000|NOT COMPLETED|Overall Study||0
3301332|NCT02951884|4034977|FG001|NOT COMPLETED|Overall Study||0
3301333|NCT02951884|4034978|FG002|NOT COMPLETED|Overall Study||0
3301334|NCT02951988|4034989|FG000|STARTED|Open-Label Treatment Period||1304
3301335|NCT02951988|4034990|FG001|STARTED|Open-Label Treatment Period||0
3301336|NCT02951988|4034991|FG002|STARTED|Open-Label Treatment Period||0
3301337|NCT02951988|4034992|FG003|STARTED|Open-Label Treatment Period||0
3301338|NCT02951988|4034989|FG000|COMPLETED|Open-Label Treatment Period||1056
3301339|NCT02951988|4034990|FG001|COMPLETED|Open-Label Treatment Period||0
3301340|NCT02951988|4034991|FG002|COMPLETED|Open-Label Treatment Period||0
3301341|NCT02951988|4034992|FG003|COMPLETED|Open-Label Treatment Period||0
3301342|NCT02951988|4034989|FG000|NOT COMPLETED|Open-Label Treatment Period||248
3301343|NCT02951988|4034990|FG001|NOT COMPLETED|Open-Label Treatment Period||0
3301344|NCT02951988|4034991|FG002|NOT COMPLETED|Open-Label Treatment Period||0
3301345|NCT02951988|4034992|FG003|NOT COMPLETED|Open-Label Treatment Period||0
3301346|NCT02951988|4034989|FG000|STARTED|Double-Blind Treatment Period||0
3301347|NCT02951988|4034990|FG001|STARTED|Double-Blind Treatment Period||202
3301348|NCT02951988|4034991|FG002|STARTED|Double-Blind Treatment Period||202
3301349|NCT02951988|4034992|FG003|STARTED|Double-Blind Treatment Period||200
3301350|NCT02951988|4034989|FG000|COMPLETED|Double-Blind Treatment Period||0
3301351|NCT02951988|4034990|FG001|COMPLETED|Double-Blind Treatment Period||101
3301352|NCT02951988|4034991|FG002|COMPLETED|Double-Blind Treatment Period||101
2960644|NCT00747474|3674762|FG009|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
3132864|NCT01693562|3858024|FG015|NOT COMPLETED|Escalation Phase||0
3132865|NCT01693562|3858025|FG016|NOT COMPLETED|Escalation Phase||0
3301353|NCT02951988|4034992|FG003|COMPLETED|Double-Blind Treatment Period||85
3301354|NCT02951988|4034989|FG000|NOT COMPLETED|Double-Blind Treatment Period||0
3301355|NCT02951988|4034990|FG001|NOT COMPLETED|Double-Blind Treatment Period||101
3301356|NCT02951988|4034991|FG002|NOT COMPLETED|Double-Blind Treatment Period||101
3301357|NCT02951988|4034992|FG003|NOT COMPLETED|Double-Blind Treatment Period||115
2960645|NCT00747474|3674763|FG010|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
2960646|NCT00747474|3674764|FG011|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
2960647|NCT00747474|3674753|FG000|STARTED|Cohort 12 (60 mg/m^2) Period||0
2960648|NCT00747474|3674754|FG001|STARTED|Cohort 12 (60 mg/m^2) Period||0
2960649|NCT00747474|3674755|FG002|STARTED|Cohort 12 (60 mg/m^2) Period||0
2960650|NCT00747474|3674756|FG003|STARTED|Cohort 12 (60 mg/m^2) Period||0
2960651|NCT00747474|3674757|FG004|STARTED|Cohort 12 (60 mg/m^2) Period||0
2960652|NCT00747474|3674758|FG005|STARTED|Cohort 12 (60 mg/m^2) Period||0
2960653|NCT00747474|3674759|FG006|STARTED|Cohort 12 (60 mg/m^2) Period||0
2960654|NCT00747474|3674760|FG007|STARTED|Cohort 12 (60 mg/m^2) Period||0
2960655|NCT00747474|3674761|FG008|STARTED|Cohort 12 (60 mg/m^2) Period||0
2960656|NCT00747474|3674762|FG009|STARTED|Cohort 12 (60 mg/m^2) Period||0
2960657|NCT00747474|3674763|FG010|STARTED|Cohort 12 (60 mg/m^2) Period||0
2960658|NCT00747474|3674764|FG011|STARTED|Cohort 12 (60 mg/m^2) Period||6
2960659|NCT00747474|3674753|FG000|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
2960660|NCT00747474|3674754|FG001|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
2960661|NCT00747474|3674755|FG002|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
2960662|NCT00747474|3674756|FG003|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
2960663|NCT00747474|3674757|FG004|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
2960664|NCT00747474|3674758|FG005|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
2960665|NCT00747474|3674759|FG006|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
2960666|NCT00747474|3674760|FG007|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
2960667|NCT00747474|3674761|FG008|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
2960668|NCT00747474|3674762|FG009|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
2960669|NCT00747474|3674763|FG010|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
3301358|NCT02952001|4035004|FG000|STARTED|Overall Study||28
3301359|NCT02952001|4035005|FG001|STARTED|Overall Study||5
3301360|NCT02952001|4035004|FG000|COMPLETED|Overall Study||14
3301361|NCT02952001|4035005|FG001|COMPLETED|Overall Study||2
3301362|NCT02952001|4035004|FG000|NOT COMPLETED|Overall Study||14
3301363|NCT02952001|4035005|FG001|NOT COMPLETED|Overall Study||3
3301364|NCT02952261|4035014|FG000|STARTED|Overall Study||100
3301365|NCT02952261|4035015|FG001|STARTED|Overall Study||100
3301366|NCT02952261|4035014|FG000|COMPLETED|Overall Study||95
3301367|NCT02952261|4035015|FG001|COMPLETED|Overall Study||95
3301368|NCT02952261|4035014|FG000|NOT COMPLETED|Overall Study||5
3301369|NCT02952261|4035015|FG001|NOT COMPLETED|Overall Study||5
3301370|NCT02952313|4035021|FG000|STARTED|Primary Endpoint||113
3301371|NCT02952313|4035021|FG000|6 Months|Primary Endpoint||106
3301372|NCT02952313|4035021|FG000|COMPLETED|Primary Endpoint||106
3301373|NCT02952313|4035021|FG000|NOT COMPLETED|Primary Endpoint||7
3301374|NCT02952313|4035021|FG000|STARTED|Long-term Follow-up||107
3301375|NCT02952313|4035021|FG000|12-Month|Long-term Follow-up||93
3301376|NCT02952313|4035021|FG000|18-Month|Long-term Follow-up||79
3301377|NCT02952313|4035021|FG000|COMPLETED|Long-term Follow-up||75
3301378|NCT02952313|4035021|FG000|NOT COMPLETED|Long-term Follow-up||32
3301379|NCT02952586|4035028|FG000|STARTED|Lead-In Phase (7 Days)||350
3301380|NCT02952586|4035029|FG001|STARTED|Lead-In Phase (7 Days)||347
3301381|NCT02952586|4035028|FG000|Safety Analysis Set|Lead-In Phase (7 Days)||348
3301382|NCT02952586|4035029|FG001|Safety Analysis Set|Lead-In Phase (7 Days)||344
3301383|NCT02952586|4035028|FG000|COMPLETED|Lead-In Phase (7 Days)||345
3301384|NCT02952586|4035029|FG001|COMPLETED|Lead-In Phase (7 Days)||343
3301385|NCT02952586|4035028|FG000|NOT COMPLETED|Lead-In Phase (7 Days)||5
3301386|NCT02952586|4035029|FG001|NOT COMPLETED|Lead-In Phase (7 Days)||4
3301387|NCT02952586|4035028|FG000|STARTED|CRT for Avelumab or Placebo (63 Days)||345
3301388|NCT02952586|4035029|FG001|STARTED|CRT for Avelumab or Placebo (63 Days)|All participants who did not withdraw from study after Lead-In phase, entered into CRT phase.|340
3301389|NCT02952586|4035028|FG000|COMPLETED|CRT for Avelumab or Placebo (63 Days)||312
3301390|NCT02952586|4035029|FG001|COMPLETED|CRT for Avelumab or Placebo (63 Days)||313
3301391|NCT02952586|4035028|FG000|NOT COMPLETED|CRT for Avelumab or Placebo (63 Days)||33
3301392|NCT02952586|4035029|FG001|NOT COMPLETED|CRT for Avelumab or Placebo (63 Days)||27
3301393|NCT02952586|4035028|FG000|STARTED|CRT for Cisplatin (63 Days)|Avelumab, Cisplatin, and IMRT were treatments in CRT phase.|345
3301394|NCT02952586|4035029|FG001|STARTED|CRT for Cisplatin (63 Days)|Placebo, Cisplatin, and IMRT were treatments in CRT phase.|340
3301395|NCT02952586|4035028|FG000|COMPLETED|CRT for Cisplatin (63 Days)||234
3301396|NCT02952586|4035029|FG001|COMPLETED|CRT for Cisplatin (63 Days)||236
3301397|NCT02952586|4035028|FG000|NOT COMPLETED|CRT for Cisplatin (63 Days)||111
3301398|NCT02952586|4035029|FG001|NOT COMPLETED|CRT for Cisplatin (63 Days)||104
3301399|NCT02952586|4035028|FG000|STARTED|CRT for IMRT (63 Days)|Avelumab, Cisplatin, and IMRT were treatments in CRT phase.|345
3301400|NCT02952586|4035029|FG001|STARTED|CRT for IMRT (63 Days)|Placebo, Cisplatin, and IMRT were treatments in CRT phase.|340
3301401|NCT02952586|4035028|FG000|COMPLETED|CRT for IMRT (63 Days)||322
3301402|NCT02952586|4035029|FG001|COMPLETED|CRT for IMRT (63 Days)||320
3301403|NCT02952586|4035028|FG000|NOT COMPLETED|CRT for IMRT (63 Days)||23
3301404|NCT02952586|4035029|FG001|NOT COMPLETED|CRT for IMRT (63 Days)||20
3301405|NCT02952586|4035028|FG000|STARTED|Maintenance Phase (12 Months)|All participants who did not withdraw from study after CRT phases, entered into maintenance phase.|291
3301406|NCT02952586|4035029|FG001|STARTED|Maintenance Phase (12 Months)|All participants who did not withdraw from study after CRT phases, entered into maintenance phase.|304
3301407|NCT02952586|4035028|FG000|COMPLETED|Maintenance Phase (12 Months)||139
3301408|NCT02952586|4035029|FG001|COMPLETED|Maintenance Phase (12 Months)||177
3301409|NCT02952586|4035028|FG000|NOT COMPLETED|Maintenance Phase (12 Months)||152
2960670|NCT00747474|3674764|FG011|COMPLETED|Cohort 12 (60 mg/m^2) Period||6
2960671|NCT00747474|3674753|FG000|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
2960672|NCT00747474|3674754|FG001|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
2960673|NCT00747474|3674755|FG002|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
2960674|NCT00747474|3674756|FG003|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
2960675|NCT00747474|3674757|FG004|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
2960676|NCT00747474|3674758|FG005|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
2960677|NCT00747474|3674759|FG006|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
2960678|NCT00747474|3674760|FG007|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
2960679|NCT00747474|3674761|FG008|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
2960680|NCT00747474|3674762|FG009|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
2960681|NCT00747474|3674763|FG010|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
2960682|NCT00747474|3674764|FG011|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
2960683|NCT00747552|3674769|FG000|STARTED|Overall Study|This number does not include the 2 who were enrolled but had no data collected on them.|30
2960684|NCT00747552|3674769|FG000|COMPLETED|Overall Study||30
2960685|NCT00747552|3674769|FG000|NOT COMPLETED|Overall Study||0
3035425|NCT01137370|3754625|FG001|STARTED|Overall Study||87
3035426|NCT01137370|3754624|FG000|COMPLETED|Overall Study||116
3163759|NCT01888874|3891216|FG004|NOT COMPLETED|Period 2 (Week 13 to Week 24)||3
3163760|NCT01888874|3891217|FG005|NOT COMPLETED|Period 2 (Week 13 to Week 24)||3
3163761|NCT01888874|3891218|FG006|NOT COMPLETED|Period 2 (Week 13 to Week 24)||3
3301410|NCT02952586|4035029|FG001|NOT COMPLETED|Maintenance Phase (12 Months)||127
3301411|NCT02952586|4035028|FG000|STARTED|Follow-Up Phase (90 Days)|Participants who did not withdraw study after previous phases, entered in short-term follow up phase.|266
3301412|NCT02952586|4035029|FG001|STARTED|Follow-Up Phase (90 Days)|Participants who did not withdraw study after previous phases, entered in short-term follow up phase.|284
3301413|NCT02952586|4035028|FG000|COMPLETED|Follow-Up Phase (90 Days)||208
3301414|NCT02952586|4035029|FG001|COMPLETED|Follow-Up Phase (90 Days)||216
3301415|NCT02952586|4035028|FG000|NOT COMPLETED|Follow-Up Phase (90 Days)||58
3301416|NCT02952586|4035029|FG001|NOT COMPLETED|Follow-Up Phase (90 Days)||68
3301417|NCT02952586|4035028|FG000|STARTED|LT Follow-up (up to 45 Months)|Participants who did not withdraw study after previous phases, entered in long-term follow up phase.|247
3301418|NCT02952586|4035029|FG001|STARTED|LT Follow-up (up to 45 Months)|Participants who did not withdraw study after previous phases, entered in long-term follow up phase.|237
3301419|NCT02952586|4035028|FG000|COMPLETED|LT Follow-up (up to 45 Months)||0
3301420|NCT02952586|4035029|FG001|COMPLETED|LT Follow-up (up to 45 Months)||0
3301421|NCT02952586|4035028|FG000|NOT COMPLETED|LT Follow-up (up to 45 Months)||247
3301422|NCT02952586|4035029|FG001|NOT COMPLETED|LT Follow-up (up to 45 Months)||237
3301423|NCT02952820|4035039|FG000|STARTED|Placebo-Controlled Treatment (6 Months)||325
3301424|NCT02952820|4035040|FG001|STARTED|Placebo-Controlled Treatment (6 Months)||323
3301425|NCT02952820|4035041|FG002|STARTED|Placebo-Controlled Treatment (6 Months)||323
3301426|NCT02952820|4035039|FG000|Treated|Placebo-Controlled Treatment (6 Months)||321
3301427|NCT02952820|4035040|FG001|Treated|Placebo-Controlled Treatment (6 Months)||319
3301428|NCT02952820|4035041|FG002|Treated|Placebo-Controlled Treatment (6 Months)||319
3301429|NCT02952820|4035039|FG000|Safety Analysis Set|Placebo-Controlled Treatment (6 Months)||319
3301430|NCT02952820|4035040|FG001|Safety Analysis Set|Placebo-Controlled Treatment (6 Months)||314
3301431|NCT02952820|4035041|FG002|Safety Analysis Set|Placebo-Controlled Treatment (6 Months)||314
3301432|NCT02952820|4035039|FG000|COMPLETED|Placebo-Controlled Treatment (6 Months)||261
3301433|NCT02952820|4035040|FG001|COMPLETED|Placebo-Controlled Treatment (6 Months)||254
3301434|NCT02952820|4035041|FG002|COMPLETED|Placebo-Controlled Treatment (6 Months)||235
3301435|NCT02952820|4035039|FG000|NOT COMPLETED|Placebo-Controlled Treatment (6 Months)||64
3301436|NCT02952820|4035040|FG001|NOT COMPLETED|Placebo-Controlled Treatment (6 Months)||69
3301437|NCT02952820|4035041|FG002|NOT COMPLETED|Placebo-Controlled Treatment (6 Months)||88
3301438|NCT02952820|4035039|FG000|STARTED|Active Treatment Period (6 Months)|Participants from Placebo were re-randomized to Lemborexant 5 mg and Lemborexant 10 mg.|0
3301439|NCT02952820|4035040|FG001|STARTED|Active Treatment Period (6 Months)||384
3301440|NCT02952820|4035041|FG002|STARTED|Active Treatment Period (6 Months)||352
3301441|NCT02952820|4035039|FG000|COMPLETED|Active Treatment Period (6 Months)||0
3301442|NCT02952820|4035040|FG001|COMPLETED|Active Treatment Period (6 Months)||346
3301443|NCT02952820|4035041|FG002|COMPLETED|Active Treatment Period (6 Months)||321
3301444|NCT02952820|4035039|FG000|NOT COMPLETED|Active Treatment Period (6 Months)||0
3301445|NCT02952820|4035040|FG001|NOT COMPLETED|Active Treatment Period (6 Months)||38
3301446|NCT02952820|4035041|FG002|NOT COMPLETED|Active Treatment Period (6 Months)||31
3301447|NCT02952872|4035068|FG000|STARTED|Overall Study||22
3301448|NCT02952872|4035069|FG001|STARTED|Overall Study||22
3301449|NCT02952872|4035070|FG002|STARTED|Overall Study||22
3301450|NCT02952872|4035071|FG003|STARTED|Overall Study||22
3301451|NCT02952872|4035072|FG004|STARTED|Overall Study||22
3301452|NCT02952872|4035073|FG005|STARTED|Overall Study||21
3301453|NCT02952872|4035074|FG006|STARTED|Overall Study||22
3163762|NCT01888900|3891237|FG000|STARTED|Overall Study||22
3163763|NCT01888900|3891238|FG001|STARTED|Overall Study||13
3163764|NCT01888900|3891237|FG000|COMPLETED|Overall Study||22
3163765|NCT01888900|3891238|FG001|COMPLETED|Overall Study||11
3163766|NCT01888900|3891237|FG000|NOT COMPLETED|Overall Study||0
3163767|NCT01888900|3891238|FG001|NOT COMPLETED|Overall Study||2
3163768|NCT01888952|3891246|FG000|STARTED|Overall Study||10
3163769|NCT01888952|3891246|FG000|COMPLETED|Overall Study||10
3301454|NCT02952872|4035075|FG007|STARTED|Overall Study||21
3132866|NCT01693562|3858026|FG017|NOT COMPLETED|Escalation Phase||0
3132867|NCT01693562|3858027|FG018|NOT COMPLETED|Escalation Phase||0
3132868|NCT01693562|3858028|FG019|NOT COMPLETED|Escalation Phase||0
3132869|NCT01693562|3858029|FG020|NOT COMPLETED|Escalation Phase||0
3132870|NCT01693562|3858030|FG021|NOT COMPLETED|Escalation Phase||0
3132871|NCT01693562|3858031|FG022|NOT COMPLETED|Escalation Phase||0
3132872|NCT01693562|3858009|FG000|STARTED|Exploration Phase||0
3132873|NCT01693562|3858010|FG001|STARTED|Exploration Phase||0
3132874|NCT01693562|3858011|FG002|STARTED|Exploration Phase||0
3163770|NCT01888952|3891246|FG000|NOT COMPLETED|Overall Study||0
3163771|NCT01888965|3891250|FG000|STARTED|Overall Study||9
3163772|NCT01888965|3891250|FG000|COMPLETED|Overall Study||0
2960686|NCT00747565|3674775|FG000|STARTED|Overall Study|125 multifocal subjects in original study plus 222 multifocal subjects in the expansion study.|347
2960687|NCT00747565|3674776|FG001|STARTED|Overall Study||123
2960688|NCT00747565|3674775|FG000|COMPLETED|Overall Study|118 multifocal subjects in the original study plus 215 multifocal subejcts in the expansion study.|333
2960689|NCT00747565|3674776|FG001|COMPLETED|Overall Study||116
2960690|NCT00747565|3674775|FG000|NOT COMPLETED|Overall Study||14
2960691|NCT00747565|3674776|FG001|NOT COMPLETED|Overall Study||7
2960692|NCT00747617|3674784|FG000|STARTED|Overall Study||13
2960693|NCT00747617|3674785|FG001|STARTED|Overall Study||12
2960694|NCT00747617|3674784|FG000|COMPLETED|Overall Study||10
2960695|NCT00747617|3674785|FG001|COMPLETED|Overall Study||11
2960696|NCT00747617|3674784|FG000|NOT COMPLETED|Overall Study||3
2960697|NCT00747617|3674785|FG001|NOT COMPLETED|Overall Study||1
2960698|NCT00747643|3674793|FG000|STARTED|Overall Study||82
2960699|NCT00747643|3674794|FG001|STARTED|Overall Study||81
2960700|NCT00747643|3674793|FG000|COMPLETED|Overall Study||46
2960701|NCT00747643|3674794|FG001|COMPLETED|Overall Study||54
2960702|NCT00747643|3674793|FG000|NOT COMPLETED|Overall Study||36
2960703|NCT00747643|3674794|FG001|NOT COMPLETED|Overall Study||27
2960704|NCT00747747|3674803|FG000|STARTED|Overall Study||14
2960705|NCT00747747|3674804|FG001|STARTED|Overall Study||14
2960706|NCT00747747|3674805|FG002|STARTED|Overall Study||21
2960707|NCT00747747|3674803|FG000|COMPLETED|Overall Study|13 with acute episode + 1 with recurrent episode|14
2960708|NCT00747747|3674804|FG001|COMPLETED|Overall Study|11 with acute episode + 3 with recurrent episode|14
2960709|NCT00747747|3674805|FG002|COMPLETED|Overall Study|17 with acute episode + 4 with recurrent episode|21
2960710|NCT00747747|3674803|FG000|NOT COMPLETED|Overall Study||0
2960711|NCT00747747|3674804|FG001|NOT COMPLETED|Overall Study||0
2960712|NCT00747747|3674805|FG002|NOT COMPLETED|Overall Study||0
2960713|NCT00747812|3674815|FG000|STARTED|Overall Study||5
2960714|NCT00747812|3674816|FG001|STARTED|Overall Study|4 subjects were randomized to the Control Group; 1 was not implanted due to early enrollment closure|3
2960715|NCT00747812|3674815|FG000|COMPLETED|Overall Study||0
2960716|NCT00747812|3674816|FG001|COMPLETED|Overall Study||0
2960717|NCT00747812|3674815|FG000|NOT COMPLETED|Overall Study||5
2960718|NCT00747812|3674816|FG001|NOT COMPLETED|Overall Study||3
2960719|NCT00748033|3674824|FG000|STARTED|Overall Study||12
2960720|NCT00748033|3674825|FG001|STARTED|Overall Study||13
2960721|NCT00748033|3674824|FG000|COMPLETED|Overall Study||12
2960722|NCT00748033|3674825|FG001|COMPLETED|Overall Study|One subject participated only in 2 arms due to an adverse event.|12
2960723|NCT00748033|3674824|FG000|NOT COMPLETED|Overall Study||0
2960724|NCT00748033|3674825|FG001|NOT COMPLETED|Overall Study||1
2960725|NCT00748072|3674841|FG000|STARTED|Overall Study||82
2960726|NCT00748072|3674842|FG001|STARTED|Overall Study||80
2960727|NCT00748072|3674841|FG000|COMPLETED|Overall Study||82
2960728|NCT00748072|3674842|FG001|COMPLETED|Overall Study||80
2960729|NCT00748072|3674841|FG000|NOT COMPLETED|Overall Study||0
2960730|NCT00748072|3674842|FG001|NOT COMPLETED|Overall Study||0
2960731|NCT00748098|3674848|FG000|STARTED|First Treatment Intervention Period||69
2960732|NCT00748098|3674849|FG001|STARTED|First Treatment Intervention Period||67
2960733|NCT00748098|3674848|FG000|COMPLETED|First Treatment Intervention Period||64
2960734|NCT00748098|3674849|FG001|COMPLETED|First Treatment Intervention Period||66
2960735|NCT00748098|3674848|FG000|NOT COMPLETED|First Treatment Intervention Period||5
2960736|NCT00748098|3674849|FG001|NOT COMPLETED|First Treatment Intervention Period||1
2960737|NCT00748098|3674848|FG000|STARTED|First Taper Period||64
3163773|NCT01888965|3891250|FG000|NOT COMPLETED|Overall Study||9
3163774|NCT01889069|3891256|FG000|STARTED|Overall Study||158
3163775|NCT01889069|3891256|FG000|COMPLETED|Overall Study||113
3163776|NCT01889069|3891256|FG000|NOT COMPLETED|Overall Study||45
3163777|NCT01889238|3891266|FG000|STARTED|Overall Study||118
3163778|NCT01889238|3891266|FG000|COMPLETED|Overall Study|DP, AE, death, treatment withdrawal were considered completed (defined in protocol).|109
3163779|NCT01889238|3891266|FG000|NOT COMPLETED|Overall Study||9
3163780|NCT01889251|3891272|FG000|STARTED|Overall Study||115
3163781|NCT01889251|3891273|FG001|STARTED|Overall Study||57
3163782|NCT01889251|3891272|FG000|COMPLETED|Overall Study||114
3163783|NCT01889251|3891273|FG001|COMPLETED|Overall Study||57
3163784|NCT01889251|3891272|FG000|NOT COMPLETED|Overall Study||1
3163785|NCT01889251|3891273|FG001|NOT COMPLETED|Overall Study||0
3163786|NCT01889355|3891279|FG000|STARTED|Overall Study||115
3132875|NCT01693562|3858012|FG003|STARTED|Exploration Phase||0
3163787|NCT01889355|3891279|FG000|COMPLETED|Overall Study||113
3163788|NCT01889355|3891279|FG000|NOT COMPLETED|Overall Study||2
3163789|NCT01889563|3891285|FG000|STARTED|Overall Study||17
3132876|NCT01693562|3858013|FG004|STARTED|Exploration Phase||0
3132877|NCT01693562|3858014|FG005|STARTED|Exploration Phase||0
3132878|NCT01693562|3858015|FG006|STARTED|Exploration Phase||21
2960738|NCT00748098|3674849|FG001|STARTED|First Taper Period||66
2960739|NCT00748098|3674848|FG000|COMPLETED|First Taper Period||61
2960740|NCT00748098|3674849|FG001|COMPLETED|First Taper Period||65
2960741|NCT00748098|3674848|FG000|NOT COMPLETED|First Taper Period||3
3163790|NCT01889563|3891286|FG001|STARTED|Overall Study||15
3163791|NCT01889563|3891285|FG000|COMPLETED|Overall Study||10
3163792|NCT01889563|3891286|FG001|COMPLETED|Overall Study||10
3163793|NCT01889563|3891285|FG000|NOT COMPLETED|Overall Study||7
3163794|NCT01889563|3891286|FG001|NOT COMPLETED|Overall Study||5
3163795|NCT01889602|3891295|FG000|STARTED|First Intervention||20
3301455|NCT02952872|4035076|FG008|STARTED|Overall Study||22
3301456|NCT02952872|4035077|FG009|STARTED|Overall Study||22
3301457|NCT02952872|4035078|FG010|STARTED|Overall Study||23
3301458|NCT02952872|4035079|FG011|STARTED|Overall Study||22
3301459|NCT02952872|4035080|FG012|STARTED|Overall Study||22
3301460|NCT02952872|4035081|FG013|STARTED|Overall Study||22
3301461|NCT02952872|4035082|FG014|STARTED|Overall Study||22
3301462|NCT02952872|4035083|FG015|STARTED|Overall Study||23
3301463|NCT02952872|4035068|FG000|COMPLETED|Overall Study||22
3301464|NCT02952872|4035069|FG001|COMPLETED|Overall Study||22
3301465|NCT02952872|4035070|FG002|COMPLETED|Overall Study||22
3301466|NCT02952872|4035071|FG003|COMPLETED|Overall Study||22
3301467|NCT02952872|4035072|FG004|COMPLETED|Overall Study||22
3301468|NCT02952872|4035073|FG005|COMPLETED|Overall Study||21
3301469|NCT02952872|4035074|FG006|COMPLETED|Overall Study||22
3301470|NCT02952872|4035075|FG007|COMPLETED|Overall Study||21
3301471|NCT02952872|4035076|FG008|COMPLETED|Overall Study||22
3301472|NCT02952872|4035077|FG009|COMPLETED|Overall Study||22
3301473|NCT02952872|4035078|FG010|COMPLETED|Overall Study||23
3301474|NCT02952872|4035079|FG011|COMPLETED|Overall Study||22
3301475|NCT02952872|4035080|FG012|COMPLETED|Overall Study||22
3301476|NCT02952872|4035081|FG013|COMPLETED|Overall Study||22
3301477|NCT02952872|4035082|FG014|COMPLETED|Overall Study||22
3301478|NCT02952872|4035083|FG015|COMPLETED|Overall Study||23
3301479|NCT02952872|4035068|FG000|NOT COMPLETED|Overall Study||0
3301480|NCT02952872|4035069|FG001|NOT COMPLETED|Overall Study||0
3301481|NCT02952872|4035070|FG002|NOT COMPLETED|Overall Study||0
3301482|NCT02952872|4035071|FG003|NOT COMPLETED|Overall Study||0
3301483|NCT02952872|4035072|FG004|NOT COMPLETED|Overall Study||0
3301484|NCT02952872|4035073|FG005|NOT COMPLETED|Overall Study||0
3301485|NCT02952872|4035074|FG006|NOT COMPLETED|Overall Study||0
3301486|NCT02952872|4035075|FG007|NOT COMPLETED|Overall Study||0
3301487|NCT02952872|4035076|FG008|NOT COMPLETED|Overall Study||0
3301488|NCT02952872|4035077|FG009|NOT COMPLETED|Overall Study||0
3301489|NCT02952872|4035078|FG010|NOT COMPLETED|Overall Study||0
3301490|NCT02952872|4035079|FG011|NOT COMPLETED|Overall Study||0
3301491|NCT02952872|4035080|FG012|NOT COMPLETED|Overall Study||0
3301492|NCT02952872|4035081|FG013|NOT COMPLETED|Overall Study||0
3301493|NCT02952872|4035082|FG014|NOT COMPLETED|Overall Study||0
3301494|NCT02952872|4035083|FG015|NOT COMPLETED|Overall Study||0
3301495|NCT02952898|4035120|FG000|STARTED|Overall Study||220
3301496|NCT02952898|4035121|FG001|STARTED|Overall Study||221
3301497|NCT02952898|4035122|FG002|STARTED|Overall Study||224
3301498|NCT02952898|4035120|FG000|COMPLETED|Overall Study||198
3301499|NCT02952898|4035121|FG001|COMPLETED|Overall Study||202
3301500|NCT02952898|4035122|FG002|COMPLETED|Overall Study||209
3301501|NCT02952898|4035120|FG000|NOT COMPLETED|Overall Study||22
3301502|NCT02952898|4035121|FG001|NOT COMPLETED|Overall Study||19
3301503|NCT02952898|4035122|FG002|NOT COMPLETED|Overall Study||15
3301504|NCT02953262|4035134|FG000|STARTED|Overall Study||68
3301505|NCT02953262|4035135|FG001|STARTED|Overall Study||69
3301506|NCT02953262|4035136|FG002|STARTED|Overall Study||68
3301507|NCT02953262|4035137|FG003|STARTED|Overall Study||70
3301508|NCT02953262|4035134|FG000|COMPLETED|Overall Study||65
3301509|NCT02953262|4035135|FG001|COMPLETED|Overall Study||63
3163796|NCT01889602|3891296|FG001|STARTED|First Intervention||20
3163797|NCT01889602|3891297|FG002|STARTED|First Intervention||20
3163798|NCT01889602|3891295|FG000|COMPLETED|First Intervention||19
3163799|NCT01889602|3891296|FG001|COMPLETED|First Intervention||17
3163800|NCT01889602|3891297|FG002|COMPLETED|First Intervention||18
3163801|NCT01889602|3891295|FG000|NOT COMPLETED|First Intervention||1
3301510|NCT02953262|4035136|FG002|COMPLETED|Overall Study||65
3301511|NCT02953262|4035137|FG003|COMPLETED|Overall Study||67
3301512|NCT02953262|4035134|FG000|NOT COMPLETED|Overall Study||3
3301513|NCT02953262|4035135|FG001|NOT COMPLETED|Overall Study||6
3301514|NCT02953262|4035136|FG002|NOT COMPLETED|Overall Study||3
3301515|NCT02953262|4035137|FG003|NOT COMPLETED|Overall Study||3
3301516|NCT02953314|4035153|FG000|STARTED|Overall Study||13
3301517|NCT02953314|4035154|FG001|STARTED|Overall Study||70
3301518|NCT02953314|4035153|FG000|COMPLETED|Overall Study||13
3301519|NCT02953314|4035154|FG001|COMPLETED|Overall Study||67
3301520|NCT02953314|4035153|FG000|NOT COMPLETED|Overall Study||0
3301521|NCT02953314|4035154|FG001|NOT COMPLETED|Overall Study||3
3301522|NCT02953418|4035160|FG000|STARTED|Overall Study||34
3163802|NCT01889602|3891296|FG001|NOT COMPLETED|First Intervention||3
3301523|NCT02953418|4035160|FG000|COMPLETED|Overall Study||34
3301524|NCT02953418|4035160|FG000|NOT COMPLETED|Overall Study||0
3301525|NCT02953548|4035164|FG000|STARTED|Overall Study||5
3301526|NCT02953548|4035165|FG001|STARTED|Overall Study||4
3301527|NCT02953548|4035164|FG000|COMPLETED|Overall Study||5
3301528|NCT02953548|4035165|FG001|COMPLETED|Overall Study||4
3301529|NCT02953548|4035164|FG000|NOT COMPLETED|Overall Study||0
3301530|NCT02953548|4035165|FG001|NOT COMPLETED|Overall Study||0
2960742|NCT00748098|3674849|FG001|NOT COMPLETED|First Taper Period||1
2960743|NCT00748098|3674848|FG000|STARTED|1-Week Washout Period||61
2960744|NCT00748098|3674849|FG001|STARTED|1-Week Washout Period||65
2960745|NCT00748098|3674848|FG000|COMPLETED|1-Week Washout Period||59
2960746|NCT00748098|3674849|FG001|COMPLETED|1-Week Washout Period||64
2960747|NCT00748098|3674848|FG000|NOT COMPLETED|1-Week Washout Period||2
2960748|NCT00748098|3674849|FG001|NOT COMPLETED|1-Week Washout Period||1
2960749|NCT00748098|3674848|FG000|STARTED|Second Treatment Intervention Period||59
2960750|NCT00748098|3674849|FG001|STARTED|Second Treatment Intervention Period||64
2960751|NCT00748098|3674848|FG000|COMPLETED|Second Treatment Intervention Period||53
3301531|NCT02953561|4035172|FG000|STARTED|Overall Study||19
3301532|NCT02953561|4035172|FG000|COMPLETED|Overall Study||19
3301533|NCT02953561|4035172|FG000|NOT COMPLETED|Overall Study||0
3301534|NCT02953639|4035179|FG000|STARTED|Overall Study||81
3301535|NCT02953639|4035180|FG001|STARTED|Overall Study||54
3301536|NCT02953639|4035181|FG002|STARTED|Overall Study||78
3301537|NCT02953639|4035179|FG000|COMPLETED|Overall Study||61
3301538|NCT02953639|4035180|FG001|COMPLETED|Overall Study||40
3301539|NCT02953639|4035181|FG002|COMPLETED|Overall Study||62
3301540|NCT02953639|4035179|FG000|NOT COMPLETED|Overall Study||20
3301541|NCT02953639|4035180|FG001|NOT COMPLETED|Overall Study||14
3301542|NCT02953639|4035181|FG002|NOT COMPLETED|Overall Study||16
3301543|NCT02953678|4035191|FG000|STARTED|Overall Study||71
3301544|NCT02953678|4035191|FG000|COMPLETED|Overall Study||0
3301545|NCT02953678|4035191|FG000|NOT COMPLETED|Overall Study||71
3301546|NCT02953782|4035204|FG000|STARTED|Phase 1b (Maximum Duration: 14.3 Months)||6
3301547|NCT02953782|4035205|FG001|STARTED|Phase 1b (Maximum Duration: 14.3 Months)||3
3301548|NCT02953782|4035206|FG002|STARTED|Phase 1b (Maximum Duration: 14.3 Months)||9
3301549|NCT02953782|4035207|FG003|STARTED|Phase 1b (Maximum Duration: 14.3 Months)||8
3301550|NCT02953782|4035208|FG004|STARTED|Phase 1b (Maximum Duration: 14.3 Months)||6
3301551|NCT02953782|4035209|FG005|STARTED|Phase 1b (Maximum Duration: 14.3 Months)||0
3301552|NCT02953782|4035210|FG006|STARTED|Phase 1b (Maximum Duration: 14.3 Months)||0
3301553|NCT02953782|4035211|FG007|STARTED|Phase 1b (Maximum Duration: 14.3 Months)||0
3301554|NCT02953782|4035204|FG000|COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||0
3301555|NCT02953782|4035205|FG001|COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||0
3301556|NCT02953782|4035206|FG002|COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||0
3301557|NCT02953782|4035207|FG003|COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||0
3301558|NCT02953782|4035208|FG004|COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||0
3301559|NCT02953782|4035209|FG005|COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||0
3301560|NCT02953782|4035210|FG006|COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||0
3301561|NCT02953782|4035211|FG007|COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||0
3301562|NCT02953782|4035204|FG000|NOT COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||6
3301563|NCT02953782|4035205|FG001|NOT COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||3
3301564|NCT02953782|4035206|FG002|NOT COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||9
3301565|NCT02953782|4035207|FG003|NOT COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||8
3301566|NCT02953782|4035208|FG004|NOT COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||6
3301567|NCT02953782|4035209|FG005|NOT COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||0
3301568|NCT02953782|4035210|FG006|NOT COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||0
3301569|NCT02953782|4035211|FG007|NOT COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||0
3301570|NCT02953782|4035204|FG000|STARTED|Phase 2 (Maximum Duration: 11.1 Months)||0
3301571|NCT02953782|4035205|FG001|STARTED|Phase 2 (Maximum Duration: 11.1 Months)||0
3301572|NCT02953782|4035206|FG002|STARTED|Phase 2 (Maximum Duration: 11.1 Months)||0
3301573|NCT02953782|4035207|FG003|STARTED|Phase 2 (Maximum Duration: 11.1 Months)||0
3301574|NCT02953782|4035208|FG004|STARTED|Phase 2 (Maximum Duration: 11.1 Months)||0
3301575|NCT02953782|4035209|FG005|STARTED|Phase 2 (Maximum Duration: 11.1 Months)|11 participants were included in safety run-in to evaluate DLT. 9 out of 11 were evaluable for DLT.|16
3301576|NCT02953782|4035210|FG006|STARTED|Phase 2 (Maximum Duration: 11.1 Months)||15
3301577|NCT02953782|4035211|FG007|STARTED|Phase 2 (Maximum Duration: 11.1 Months)||15
3301578|NCT02953782|4035204|FG000|COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0
3301579|NCT02953782|4035205|FG001|COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0
3301580|NCT02953782|4035206|FG002|COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0
3301581|NCT02953782|4035207|FG003|COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0
3301582|NCT02953782|4035208|FG004|COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0
3301583|NCT02953782|4035209|FG005|COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0
3301584|NCT02953782|4035210|FG006|COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0
3301585|NCT02953782|4035211|FG007|COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0
3301586|NCT02953782|4035204|FG000|NOT COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0
3301587|NCT02953782|4035205|FG001|NOT COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0
3301588|NCT02953782|4035206|FG002|NOT COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0
3301589|NCT02953782|4035207|FG003|NOT COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0
3301590|NCT02953782|4035208|FG004|NOT COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0
3301591|NCT02953782|4035209|FG005|NOT COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||16
3301592|NCT02953782|4035210|FG006|NOT COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||15
3301593|NCT02953782|4035211|FG007|NOT COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||15
3301594|NCT02953821|4035234|FG000|STARTED|Overall Study||86
3301595|NCT02953821|4035235|FG001|STARTED|Overall Study||86
2960752|NCT00748098|3674849|FG001|COMPLETED|Second Treatment Intervention Period||61
2960753|NCT00748098|3674848|FG000|NOT COMPLETED|Second Treatment Intervention Period||6
3035427|NCT01137370|3754625|FG001|COMPLETED|Overall Study||87
3301596|NCT02953821|4035234|FG000|Safety Population|Overall Study||86
3301597|NCT02953821|4035235|FG001|Safety Population|Overall Study||86
3301598|NCT02953821|4035234|FG000|Modified Intent to Treat (mITT) Populati|Overall Study||85
3301599|NCT02953821|4035235|FG001|Modified Intent to Treat (mITT) Populati|Overall Study||84
3301600|NCT02953821|4035234|FG000|Per Protocol (PP) Population|Overall Study||72
3301601|NCT02953821|4035235|FG001|Per Protocol (PP) Population|Overall Study||75
3301602|NCT02953821|4035234|FG000|Completed Week 16 Visit|Overall Study||76
3301603|NCT02953821|4035235|FG001|Completed Week 16 Visit|Overall Study||77
3301604|NCT02953821|4035234|FG000|Completed Study Treatment (Week 24)|Overall Study||73
3301605|NCT02953821|4035235|FG001|Completed Study Treatment (Week 24)|Overall Study||76
3301606|NCT02953821|4035234|FG000|COMPLETED|Overall Study||71
3301607|NCT02953821|4035235|FG001|COMPLETED|Overall Study||73
3301608|NCT02953821|4035234|FG000|NOT COMPLETED|Overall Study||15
3301609|NCT02953821|4035235|FG001|NOT COMPLETED|Overall Study||13
3301610|NCT02953860|4035243|FG000|STARTED|Overall Study||32
3301611|NCT02953860|4035243|FG000|COMPLETED|Overall Study||32
3301612|NCT02953860|4035243|FG000|NOT COMPLETED|Overall Study||0
3301613|NCT02953873|4035247|FG000|STARTED|Overall Study||25
3301614|NCT02953873|4035247|FG000|COMPLETED|Overall Study||25
3301615|NCT02953873|4035247|FG000|NOT COMPLETED|Overall Study||0
3301616|NCT02953886|4035251|FG000|STARTED|Overall Study||20
3301617|NCT02953886|4035251|FG000|COMPLETED|Overall Study||20
3301618|NCT02953886|4035251|FG000|NOT COMPLETED|Overall Study||0
3301619|NCT02953938|4035257|FG000|STARTED|Overall Study||29
3301620|NCT02953938|4035258|FG001|STARTED|Overall Study||30
3301621|NCT02953938|4035257|FG000|COMPLETED|Overall Study||28
3301622|NCT02953938|4035258|FG001|COMPLETED|Overall Study||28
3301623|NCT02953938|4035257|FG000|NOT COMPLETED|Overall Study||1
3301624|NCT02953938|4035258|FG001|NOT COMPLETED|Overall Study||2
3301625|NCT02954172|4035267|FG000|STARTED|Overall Study||226
3301626|NCT02954172|4035268|FG001|STARTED|Overall Study||224
3301627|NCT02954172|4035267|FG000|COMPLETED|Overall Study||220
3301628|NCT02954172|4035268|FG001|COMPLETED|Overall Study||221
3301629|NCT02954172|4035267|FG000|NOT COMPLETED|Overall Study||6
3301630|NCT02954172|4035268|FG001|NOT COMPLETED|Overall Study||3
3301631|NCT02954198|4035277|FG000|STARTED|Overall Study||20
3301632|NCT02954198|4035278|FG001|STARTED|Overall Study||20
3301633|NCT02954198|4035277|FG000|COMPLETED|Overall Study||20
3301634|NCT02954198|4035278|FG001|COMPLETED|Overall Study||20
3301635|NCT02954198|4035277|FG000|NOT COMPLETED|Overall Study||0
3301636|NCT02954198|4035278|FG001|NOT COMPLETED|Overall Study||0
3301637|NCT02954354|4035287|FG000|STARTED|Overall Study||612
3301638|NCT02954354|4035288|FG001|STARTED|Overall Study||310
3301639|NCT02954354|4035289|FG002|STARTED|Overall Study||514
3301640|NCT02954354|4035287|FG000|Received Study Drug|Overall Study||610
3301641|NCT02954354|4035288|FG001|Received Study Drug|Overall Study||309
3301642|NCT02954354|4035289|FG002|Received Study Drug|Overall Study||513
3301643|NCT02954354|4035287|FG000|Intention to Treat Infected Population|Overall Study||456
3301644|NCT02954354|4035288|FG001|Intention to Treat Infected Population|Overall Study||231
3301645|NCT02954354|4035289|FG002|Intention to Treat Infected Population|Overall Study||377
3301646|NCT02954354|4035287|FG000|COMPLETED|Overall Study||578
3301647|NCT02954354|4035288|FG001|COMPLETED|Overall Study||290
3301648|NCT02954354|4035289|FG002|COMPLETED|Overall Study||498
3301649|NCT02954354|4035287|FG000|NOT COMPLETED|Overall Study||34
3301650|NCT02954354|4035288|FG001|NOT COMPLETED|Overall Study||20
3301651|NCT02954354|4035289|FG002|NOT COMPLETED|Overall Study||16
3301652|NCT02954458|4035303|FG000|STARTED|Overall Study||7
3301653|NCT02954458|4035304|FG001|STARTED|Overall Study||3
3301654|NCT02954458|4035305|FG002|STARTED|Overall Study||1
3301655|NCT02954458|4035306|FG003|STARTED|Overall Study||50
3301656|NCT02954458|4035303|FG000|COMPLETED|Overall Study||6
3301657|NCT02954458|4035304|FG001|COMPLETED|Overall Study||3
3301658|NCT02954458|4035305|FG002|COMPLETED|Overall Study||0
3301659|NCT02954458|4035306|FG003|COMPLETED|Overall Study||38
3301660|NCT02954458|4035303|FG000|NOT COMPLETED|Overall Study||1
3301661|NCT02954458|4035304|FG001|NOT COMPLETED|Overall Study||0
3301662|NCT02954458|4035305|FG002|NOT COMPLETED|Overall Study||1
3301663|NCT02954458|4035306|FG003|NOT COMPLETED|Overall Study||12
3301664|NCT02954575|4035320|FG000|STARTED|Overall Study||57
3301665|NCT02954575|4035320|FG000|Received Treatment|Overall Study||55
3301666|NCT02954575|4035320|FG000|SAF Population|Overall Study||55
3301667|NCT02954575|4035320|FG000|FAS Population|Overall Study||55
3301668|NCT02954575|4035320|FG000|PP Population|Overall Study||52
3301669|NCT02954575|4035320|FG000|PK Population|Overall Study||21
3301670|NCT02954575|4035320|FG000|SURG Population|Overall Study||1
3301671|NCT02954575|4035320|FG000|COMPLETED|Overall Study||54
3301672|NCT02954575|4035320|FG000|NOT COMPLETED|Overall Study||3
3301673|NCT02954601|4035332|FG000|STARTED|First Intervention (Five Days)||11
3301674|NCT02954601|4035333|FG001|STARTED|First Intervention (Five Days)||6
3301675|NCT02954601|4035334|FG002|STARTED|First Intervention (Five Days)||8
3301676|NCT02954601|4035335|FG003|STARTED|First Intervention (Five Days)||7
3301677|NCT02954601|4035332|FG000|COMPLETED|First Intervention (Five Days)||11
3301678|NCT02954601|4035333|FG001|COMPLETED|First Intervention (Five Days)||6
3301679|NCT02954601|4035334|FG002|COMPLETED|First Intervention (Five Days)||7
3301680|NCT02954601|4035335|FG003|COMPLETED|First Intervention (Five Days)||7
3301681|NCT02954601|4035332|FG000|NOT COMPLETED|First Intervention (Five Days)||0
2960754|NCT00748098|3674849|FG001|NOT COMPLETED|Second Treatment Intervention Period||3
2960755|NCT00748098|3674848|FG000|STARTED|Second Taper Period||53
2960756|NCT00748098|3674849|FG001|STARTED|Second Taper Period||61
2960757|NCT00748098|3674848|FG000|COMPLETED|Second Taper Period||53
2960758|NCT00748098|3674849|FG001|COMPLETED|Second Taper Period||61
2960759|NCT00748098|3674848|FG000|NOT COMPLETED|Second Taper Period||0
2960760|NCT00748098|3674849|FG001|NOT COMPLETED|Second Taper Period||0
2960761|NCT00748189|3674858|FG000|STARTED|Overall Study||226
2960762|NCT00748189|3674859|FG001|STARTED|Overall Study||221
2960763|NCT00748189|3674858|FG000|COMPLETED|Overall Study||10
2960764|NCT00748189|3674859|FG001|COMPLETED|Overall Study||9
2960765|NCT00748189|3674858|FG000|NOT COMPLETED|Overall Study||216
2960766|NCT00748189|3674859|FG001|NOT COMPLETED|Overall Study||212
2960767|NCT00748215|3674872|FG000|STARTED|Overall Study||50
2960768|NCT00748215|3674873|FG001|STARTED|Overall Study||50
2960769|NCT00748215|3674872|FG000|Open Label CASAD After Initial 6 Weeks Intervention|Overall Study||22
2960770|NCT00748215|3674873|FG001|Open Label CASAD After Initial 6 Weeks Intervention|Overall Study||17
2960771|NCT00748215|3674872|FG000|COMPLETED|Overall Study||41
2960772|NCT00748215|3674873|FG001|COMPLETED|Overall Study||32
2960773|NCT00748215|3674872|FG000|NOT COMPLETED|Overall Study||9
2960774|NCT00748215|3674873|FG001|NOT COMPLETED|Overall Study||18
2960775|NCT00748241|3674879|FG000|STARTED|Overall Study||19
2960776|NCT00748241|3674879|FG000|COMPLETED|Overall Study||11
2960777|NCT00748241|3674879|FG000|NOT COMPLETED|Overall Study||8
2960778|NCT00748410|3674885|FG000|STARTED|Overall Study||1
2960779|NCT00748410|3674886|FG001|STARTED|Overall Study||2
2960780|NCT00748410|3674885|FG000|COMPLETED|Overall Study||1
2960781|NCT00748410|3674886|FG001|COMPLETED|Overall Study||2
2960782|NCT00748410|3674885|FG000|NOT COMPLETED|Overall Study||0
2960783|NCT00748410|3674886|FG001|NOT COMPLETED|Overall Study||0
2960784|NCT00748540|3674892|FG000|STARTED|Overall Study||50
2960785|NCT00748540|3674892|FG000|COMPLETED|Overall Study||49
2960786|NCT00748540|3674892|FG000|NOT COMPLETED|Overall Study||1
2960787|NCT00748553|3674898|FG000|STARTED|Overall Study||16
2960788|NCT00748553|3674899|FG001|STARTED|Overall Study||14
2960789|NCT00748553|3674898|FG000|COMPLETED|Overall Study||13
2960790|NCT00748553|3674899|FG001|COMPLETED|Overall Study||13
2960791|NCT00748553|3674898|FG000|NOT COMPLETED|Overall Study||3
2960792|NCT00748553|3674899|FG001|NOT COMPLETED|Overall Study||1
2960793|NCT00748566|3674904|FG000|STARTED|Overall Study||172
2960794|NCT00748566|3674904|FG000|COMPLETED|Overall Study||60
2960795|NCT00748566|3674904|FG000|NOT COMPLETED|Overall Study||112
2960796|NCT00748657|3674908|FG000|STARTED|Overall Study||36
2960797|NCT00748657|3674908|FG000|COMPLETED|Overall Study||36
2960798|NCT00748657|3674908|FG000|NOT COMPLETED|Overall Study||0
2960799|NCT00748709|3674918|FG000|STARTED|Overall Study|Treated|20
2960800|NCT00748709|3674918|FG000|COMPLETED|Overall Study||0
2960801|NCT00748709|3674918|FG000|NOT COMPLETED|Overall Study||20
2960802|NCT00748826|3674922|FG000|STARTED|Overall Study|Of 576 total enrolled, 68 out of scope participants were not used for analyses|508
2960803|NCT00748826|3674922|FG000|COMPLETED|Overall Study||207
2960804|NCT00748826|3674922|FG000|NOT COMPLETED|Overall Study||301
2960805|NCT00748865|3674926|FG000|STARTED|Overall Study||10
2960806|NCT00748865|3674927|FG001|STARTED|Overall Study||10
2960807|NCT00748865|3674926|FG000|COMPLETED|Overall Study||10
2960808|NCT00748865|3674927|FG001|COMPLETED|Overall Study||10
2960809|NCT00748865|3674926|FG000|NOT COMPLETED|Overall Study||0
2960810|NCT00748865|3674927|FG001|NOT COMPLETED|Overall Study||0
2960811|NCT00748956|3674936|FG000|STARTED|Overall Study||0
2960812|NCT00748956|3674937|FG001|STARTED|Overall Study||5
2960813|NCT00748956|3674938|FG002|STARTED|Overall Study||5
2960814|NCT00748956|3674936|FG000|COMPLETED|Overall Study||0
2960815|NCT00748956|3674937|FG001|COMPLETED|Overall Study||5
2960816|NCT00748956|3674938|FG002|COMPLETED|Overall Study||5
2960817|NCT00748956|3674936|FG000|NOT COMPLETED|Overall Study||0
2960818|NCT00748956|3674937|FG001|NOT COMPLETED|Overall Study||0
2960819|NCT00748956|3674938|FG002|NOT COMPLETED|Overall Study||0
2960820|NCT00748969|3674948|FG000|STARTED|Overall Study|Subject withdrew from study due to worsening sleep apnea|1
2960821|NCT00748969|3674949|FG001|STARTED|Overall Study|Subject withdrew from study due to randomization to no treatment|1
2960822|NCT00748969|3674948|FG000|COMPLETED|Overall Study||0
2960823|NCT00748969|3674949|FG001|COMPLETED|Overall Study||0
2960824|NCT00748969|3674948|FG000|NOT COMPLETED|Overall Study||1
2960825|NCT00748969|3674949|FG001|NOT COMPLETED|Overall Study||1
2960826|NCT00748982|3674957|FG000|STARTED|Overall Study||12
2960827|NCT00748982|3674958|FG001|STARTED|Overall Study||4
2960828|NCT00748982|3674957|FG000|COMPLETED|Overall Study||12
2960829|NCT00748982|3674958|FG001|COMPLETED|Overall Study||4
2960830|NCT00748982|3674957|FG000|NOT COMPLETED|Overall Study||0
2960831|NCT00748982|3674958|FG001|NOT COMPLETED|Overall Study||0
2960832|NCT00749073|3674964|FG000|STARTED|Overall Study||10
2960833|NCT00749073|3674964|FG000|COMPLETED|Overall Study||10
2960834|NCT00749073|3674964|FG000|NOT COMPLETED|Overall Study||0
2960835|NCT00749125|3674971|FG000|STARTED|Overall Study||47
2960836|NCT00749125|3674972|FG001|STARTED|Overall Study||52
2960837|NCT00749125|3674971|FG000|COMPLETED|Overall Study||36
2960838|NCT00749125|3674972|FG001|COMPLETED|Overall Study||34
2960839|NCT00749125|3674971|FG000|NOT COMPLETED|Overall Study||11
2960840|NCT00749125|3674972|FG001|NOT COMPLETED|Overall Study||18
2960841|NCT00749190|3674985|FG000|STARTED|Overall Study||71
2960842|NCT00749190|3674986|FG001|STARTED|Overall Study||71
2960843|NCT00749190|3674987|FG002|STARTED|Overall Study||71
2960844|NCT00749190|3674988|FG003|STARTED|Overall Study||71
2960845|NCT00749190|3674989|FG004|STARTED|Overall Study||70
2960846|NCT00749190|3674990|FG005|STARTED|Overall Study||70
2960847|NCT00749190|3674991|FG006|STARTED|Overall Study||71
2960848|NCT00749190|3674985|FG000|COMPLETED|Overall Study||66
2960849|NCT00749190|3674986|FG001|COMPLETED|Overall Study||66
2960850|NCT00749190|3674987|FG002|COMPLETED|Overall Study||70
2960851|NCT00749190|3674988|FG003|COMPLETED|Overall Study||66
2960852|NCT00749190|3674989|FG004|COMPLETED|Overall Study||70
2960853|NCT00749190|3674990|FG005|COMPLETED|Overall Study||65
2960854|NCT00749190|3674991|FG006|COMPLETED|Overall Study||70
2960855|NCT00749190|3674985|FG000|NOT COMPLETED|Overall Study||5
2960856|NCT00749190|3674986|FG001|NOT COMPLETED|Overall Study||5
2960857|NCT00749190|3674987|FG002|NOT COMPLETED|Overall Study||1
2960858|NCT00749190|3674988|FG003|NOT COMPLETED|Overall Study||5
2960859|NCT00749190|3674989|FG004|NOT COMPLETED|Overall Study||0
2960860|NCT00749190|3674990|FG005|NOT COMPLETED|Overall Study||5
2960861|NCT00749190|3674991|FG006|NOT COMPLETED|Overall Study||1
2960862|NCT00749203|3675014|FG000|STARTED|First Infusion Day 1||22
2960863|NCT00749203|3675015|FG001|STARTED|First Infusion Day 1||19
2960864|NCT00749203|3675014|FG000|COMPLETED|First Infusion Day 1||22
2960865|NCT00749203|3675015|FG001|COMPLETED|First Infusion Day 1||19
2960866|NCT00749203|3675014|FG000|NOT COMPLETED|First Infusion Day 1||0
2960867|NCT00749203|3675015|FG001|NOT COMPLETED|First Infusion Day 1||0
2960868|NCT00749203|3675014|FG000|STARTED|no Infusion at Week 1||22
2960869|NCT00749203|3675015|FG001|STARTED|no Infusion at Week 1||19
2960870|NCT00749203|3675014|FG000|COMPLETED|no Infusion at Week 1||22
2960871|NCT00749203|3675015|FG001|COMPLETED|no Infusion at Week 1||15
2960872|NCT00749203|3675014|FG000|NOT COMPLETED|no Infusion at Week 1||0
2960873|NCT00749203|3675015|FG001|NOT COMPLETED|no Infusion at Week 1||4
2960874|NCT00749203|3675014|FG000|STARTED|Second Infusion at 2 Weeks|N=6 completed the study at 2 wks due to CAPS scores < 50, precluding 2nd infusion.|16
2960875|NCT00749203|3675015|FG001|STARTED|Second Infusion at 2 Weeks||15
2960876|NCT00749203|3675014|FG000|COMPLETED|Second Infusion at 2 Weeks||16
2960877|NCT00749203|3675015|FG001|COMPLETED|Second Infusion at 2 Weeks||13
2960878|NCT00749203|3675014|FG000|NOT COMPLETED|Second Infusion at 2 Weeks||0
2960879|NCT00749203|3675015|FG001|NOT COMPLETED|Second Infusion at 2 Weeks||2
2960880|NCT00749268|3675025|FG000|STARTED|Overall Study||106
3163803|NCT01889602|3891297|FG002|NOT COMPLETED|First Intervention||2
3163804|NCT01889602|3891295|FG000|STARTED|First Washout Period of at Least 2 Weeks||19
3163805|NCT01889602|3891296|FG001|STARTED|First Washout Period of at Least 2 Weeks||17
3171764|NCT01936948|3898953|FG000|NOT COMPLETED|Overall Study||0
2960881|NCT00749268|3675026|FG001|STARTED|Overall Study||110
2960882|NCT00749268|3675025|FG000|COMPLETED|Overall Study||72
2960883|NCT00749268|3675026|FG001|COMPLETED|Overall Study||74
2960884|NCT00749268|3675025|FG000|NOT COMPLETED|Overall Study||34
2960885|NCT00749268|3675026|FG001|NOT COMPLETED|Overall Study||36
2960886|NCT00749398|3675036|FG000|STARTED|Overall Study|Nine participants were excluded because they did not fulfill the inclusion criteria.|124
2960887|NCT00749398|3675036|FG000|COMPLETED|Overall Study||71
2960888|NCT00749398|3675036|FG000|NOT COMPLETED|Overall Study||53
2960889|NCT00749411|3675042|FG000|STARTED|Overall Study||21
2960890|NCT00749411|3675043|FG001|STARTED|Overall Study||40
2960891|NCT00749411|3675042|FG000|COMPLETED|Overall Study||20
2960892|NCT00749411|3675043|FG001|COMPLETED|Overall Study||35
2960893|NCT00749411|3675042|FG000|NOT COMPLETED|Overall Study||1
2960894|NCT00749411|3675043|FG001|NOT COMPLETED|Overall Study||5
2960895|NCT00749463|3675052|FG000|STARTED|Overall Study||86
2960896|NCT00749463|3675053|FG001|STARTED|Overall Study||64
2960897|NCT00749463|3675054|FG002|STARTED|Overall Study||150
2960898|NCT00749463|3675052|FG000|COMPLETED|Overall Study||85
2960899|NCT00749463|3675053|FG001|COMPLETED|Overall Study||60
2960900|NCT00749463|3675054|FG002|COMPLETED|Overall Study||149
2960901|NCT00749463|3675052|FG000|NOT COMPLETED|Overall Study||1
2960902|NCT00749463|3675053|FG001|NOT COMPLETED|Overall Study||4
2960903|NCT00749463|3675054|FG002|NOT COMPLETED|Overall Study||1
2960904|NCT00749515|3675064|FG000|STARTED|Overall Study||10
2960905|NCT00749515|3675065|FG001|STARTED|Overall Study||5
2960906|NCT00749515|3675064|FG000|COMPLETED|Overall Study||10
2960907|NCT00749515|3675065|FG001|COMPLETED|Overall Study||5
2960908|NCT00749515|3675064|FG000|NOT COMPLETED|Overall Study||0
2960909|NCT00749515|3675065|FG001|NOT COMPLETED|Overall Study||0
2960910|NCT00749580|3675073|FG000|STARTED|Overall Study|September 2008|21
2960911|NCT00749580|3675074|FG001|STARTED|Overall Study||25
2960912|NCT00749580|3675073|FG000|COMPLETED|Overall Study|December 2010|17
2960913|NCT00749580|3675074|FG001|COMPLETED|Overall Study||16
2960914|NCT00749580|3675073|FG000|NOT COMPLETED|Overall Study||4
2960915|NCT00749580|3675074|FG001|NOT COMPLETED|Overall Study||9
2960916|NCT00749606|3675082|FG000|STARTED|Year 1||129
2960917|NCT00749606|3675083|FG001|STARTED|Year 1||128
2960918|NCT00749606|3675082|FG000|COMPLETED|Year 1||74
2960919|NCT00749606|3675083|FG001|COMPLETED|Year 1||80
2960920|NCT00749606|3675082|FG000|NOT COMPLETED|Year 1||55
2960921|NCT00749606|3675083|FG001|NOT COMPLETED|Year 1||48
2960922|NCT00749606|3675082|FG000|STARTED|Year 2||74
2960923|NCT00749606|3675083|FG001|STARTED|Year 2||80
2960924|NCT00749606|3675082|FG000|COMPLETED|Year 2||63
2960925|NCT00749606|3675083|FG001|COMPLETED|Year 2||72
2960926|NCT00749606|3675082|FG000|NOT COMPLETED|Year 2||11
2960927|NCT00749606|3675083|FG001|NOT COMPLETED|Year 2||8
2960928|NCT00749606|3675082|FG000|STARTED|Year 3 (Observation)||63
2960929|NCT00749606|3675083|FG001|STARTED|Year 3 (Observation)||72
2960930|NCT00749606|3675082|FG000|COMPLETED|Year 3 (Observation)||63
2960931|NCT00749606|3675083|FG001|COMPLETED|Year 3 (Observation)||69
2960932|NCT00749606|3675082|FG000|NOT COMPLETED|Year 3 (Observation)||0
2960933|NCT00749606|3675083|FG001|NOT COMPLETED|Year 3 (Observation)||3
2960934|NCT00749671|3675093|FG000|STARTED|Overall Study||11
2960935|NCT00749671|3675094|FG001|STARTED|Overall Study||9
2960936|NCT00749671|3675093|FG000|COMPLETED|Overall Study||11
2960937|NCT00749671|3675094|FG001|COMPLETED|Overall Study||9
2960938|NCT00749671|3675093|FG000|NOT COMPLETED|Overall Study||0
2960939|NCT00749671|3675094|FG001|NOT COMPLETED|Overall Study||0
3035428|NCT01137370|3754624|FG000|NOT COMPLETED|Overall Study||0
3035429|NCT01137370|3754625|FG001|NOT COMPLETED|Overall Study||0
3035430|NCT01137396|3754633|FG000|STARTED|Overall Study||30
3035431|NCT01137396|3754634|FG001|STARTED|Overall Study||27
3035432|NCT01137396|3754633|FG000|COMPLETED|Overall Study||22
3035433|NCT01137396|3754634|FG001|COMPLETED|Overall Study||25
3035434|NCT01137396|3754633|FG000|NOT COMPLETED|Overall Study||8
3035435|NCT01137396|3754634|FG001|NOT COMPLETED|Overall Study||2
3035436|NCT01137435|3754640|FG000|STARTED|Overall Study||687
3035437|NCT01137435|3754640|FG000|COMPLETED|Overall Study||659
3035438|NCT01137435|3754640|FG000|NOT COMPLETED|Overall Study||28
3035439|NCT01137474|3754648|FG000|STARTED|Overall Study||311
3035440|NCT01137474|3754649|FG001|STARTED|Overall Study||166
3035441|NCT01137474|3754650|FG002|STARTED|Overall Study||165
3035442|NCT01137474|3754651|FG003|STARTED|Overall Study||302
3035443|NCT01137474|3754648|FG000|Received Treatment|Overall Study||311
3035444|NCT01137474|3754649|FG001|Received Treatment|Overall Study||166
3035445|NCT01137474|3754650|FG002|Received Treatment|Overall Study||165
3035446|NCT01137474|3754651|FG003|Received Treatment|Overall Study||302
3035447|NCT01137474|3754648|FG000|COMPLETED|Overall Study||287
3035448|NCT01137474|3754649|FG001|COMPLETED|Overall Study||154
3035449|NCT01137474|3754650|FG002|COMPLETED|Overall Study||158
3035450|NCT01137474|3754651|FG003|COMPLETED|Overall Study||281
3035451|NCT01137474|3754648|FG000|NOT COMPLETED|Overall Study||24
3035452|NCT01137474|3754649|FG001|NOT COMPLETED|Overall Study||12
3035453|NCT01137474|3754650|FG002|NOT COMPLETED|Overall Study||7
3035454|NCT01137474|3754651|FG003|NOT COMPLETED|Overall Study||21
3035455|NCT01137539|3754661|FG000|STARTED|Overall Study||50
3035456|NCT01137539|3754661|FG000|COMPLETED|Overall Study||50
3035457|NCT01137539|3754661|FG000|NOT COMPLETED|Overall Study||0
3035458|NCT01137578|3754665|FG000|STARTED|Overall Study||77
3035459|NCT01137578|3754666|FG001|STARTED|Overall Study||14
3035460|NCT01137578|3754667|FG002|STARTED|Overall Study||43
3035461|NCT01137578|3754665|FG000|COMPLETED|Overall Study|Completed defined as having completed all 3 study-related imaging procedures.|61
3035462|NCT01137578|3754666|FG001|COMPLETED|Overall Study|Completed defined as having completed all 3 study-related imaging procedures.|12
3035463|NCT01137578|3754667|FG002|COMPLETED|Overall Study|Completed defined as having completed all 3 study-related imaging procedures.|37
3035464|NCT01137578|3754665|FG000|NOT COMPLETED|Overall Study||16
3035465|NCT01137578|3754666|FG001|NOT COMPLETED|Overall Study||2
3035466|NCT01137578|3754667|FG002|NOT COMPLETED|Overall Study||6
3035467|NCT01137604|3754699|FG000|STARTED|Overall Study|39 participants were randomized but 1 participant died prior to receiving treatment.|38
3035468|NCT01137604|3754700|FG001|STARTED|Overall Study||42
3035469|NCT01137604|3754701|FG002|STARTED|Overall Study||39
3035470|NCT01137604|3754702|FG003|STARTED|Overall Study||32
3035471|NCT01137604|3754699|FG000|Disease Progression|Overall Study||34
3035472|NCT01137604|3754700|FG001|Disease Progression|Overall Study||29
3035473|NCT01137604|3754701|FG002|Disease Progression|Overall Study||25
3035474|NCT01137604|3754702|FG003|Disease Progression|Overall Study||21
3035475|NCT01137604|3754699|FG000|Treatment Ongoing at Data Cutoff|Overall Study||2
3035476|NCT01137604|3754700|FG001|Treatment Ongoing at Data Cutoff|Overall Study||3
3035477|NCT01137604|3754701|FG002|Treatment Ongoing at Data Cutoff|Overall Study||1
3035478|NCT01137604|3754702|FG003|Treatment Ongoing at Data Cutoff|Overall Study||0
3035479|NCT01137604|3754699|FG000|COMPLETED|Overall Study|Participants with disease progression and treatment ongoing at data cutoff (19 Mar 2013)|36
3035480|NCT01137604|3754700|FG001|COMPLETED|Overall Study||32
3035481|NCT01137604|3754701|FG002|COMPLETED|Overall Study||26
3035482|NCT01137604|3754702|FG003|COMPLETED|Overall Study||21
3035483|NCT01137604|3754699|FG000|NOT COMPLETED|Overall Study||2
3035484|NCT01137604|3754700|FG001|NOT COMPLETED|Overall Study||10
3035485|NCT01137604|3754701|FG002|NOT COMPLETED|Overall Study||13
3035486|NCT01137604|3754702|FG003|NOT COMPLETED|Overall Study||11
3035487|NCT01137682|3754715|FG000|STARTED|Overall Study||65
3035488|NCT01137682|3754716|FG001|STARTED|Overall Study||65
3035489|NCT01137682|3754717|FG002|STARTED|Overall Study||68
3035490|NCT01137682|3754715|FG000|Not Treated|Overall Study||2
3035491|NCT01137682|3754716|FG001|Not Treated|Overall Study||2
3035492|NCT01137682|3754717|FG002|Not Treated|Overall Study||1
3035493|NCT01137682|3754715|FG000|Treated|Overall Study||63
3035494|NCT01137682|3754716|FG001|Treated|Overall Study||63
3035495|NCT01137682|3754717|FG002|Treated|Overall Study||67
3035496|NCT01137682|3754715|FG000|Completed 24-Week Core Phase|Overall Study||59
3035497|NCT01137682|3754716|FG001|Completed 24-Week Core Phase|Overall Study||57
3035498|NCT01137682|3754717|FG002|Completed 24-Week Core Phase|Overall Study||65
3035499|NCT01137682|3754715|FG000|Not Continuing Into Extension|Overall Study||2
3035500|NCT01137682|3754716|FG001|Not Continuing Into Extension|Overall Study||3
3035501|NCT01137682|3754717|FG002|Not Continuing Into Extension|Overall Study||2
3035502|NCT01137682|3754715|FG000|Continuing Into Extension|Overall Study||57
2960940|NCT00749684|3675102|FG000|STARTED|Overall Study||138
2960941|NCT00749684|3675102|FG000|COMPLETED|Overall Study||56
2960942|NCT00749684|3675102|FG000|NOT COMPLETED|Overall Study||82
2960943|NCT00749749|3675108|FG000|STARTED|Overall Study||14
2960944|NCT00749749|3675109|FG001|STARTED|Overall Study||13
2960945|NCT00749749|3675108|FG000|COMPLETED|Overall Study||14
2960946|NCT00749749|3675109|FG001|COMPLETED|Overall Study||13
2960947|NCT00749749|3675108|FG000|NOT COMPLETED|Overall Study||0
2960948|NCT00749749|3675109|FG001|NOT COMPLETED|Overall Study||0
2960949|NCT00749775|3675115|FG000|STARTED|Overall Study||3317
2960950|NCT00749775|3675115|FG000|COMPLETED|Overall Study||3210
2960951|NCT00749775|3675115|FG000|NOT COMPLETED|Overall Study||107
2960952|NCT00749879|3675129|FG000|STARTED|Overall Study||12
2960953|NCT00749879|3675129|FG000|COMPLETED|Overall Study||12
2960954|NCT00749879|3675129|FG000|NOT COMPLETED|Overall Study||0
2960955|NCT00749892|3675141|FG000|STARTED|Overall Study||34
2960956|NCT00749892|3675141|FG000|COMPLETED|Overall Study||31
2960957|NCT00749892|3675141|FG000|NOT COMPLETED|Overall Study||3
2960958|NCT00749931|3675147|FG000|STARTED|Overall Study||298
2960959|NCT00749931|3675148|FG001|STARTED|Overall Study||298
2960960|NCT00749931|3675149|FG002|STARTED|Overall Study||68
2960961|NCT00749931|3675147|FG000|COMPLETED|Overall Study||298
2960962|NCT00749931|3675148|FG001|COMPLETED|Overall Study||298
2960963|NCT00749931|3675149|FG002|COMPLETED|Overall Study||68
2960964|NCT00749931|3675147|FG000|NOT COMPLETED|Overall Study||0
2960965|NCT00749931|3675148|FG001|NOT COMPLETED|Overall Study||0
2960966|NCT00749931|3675149|FG002|NOT COMPLETED|Overall Study||0
2960967|NCT00749944|3675158|FG000|STARTED|Overall Study||55
2960968|NCT00749944|3675159|FG001|STARTED|Overall Study||55
2960969|NCT00749944|3675158|FG000|COMPLETED|Overall Study||50
2960970|NCT00749944|3675159|FG001|COMPLETED|Overall Study||54
2960971|NCT00749944|3675158|FG000|NOT COMPLETED|Overall Study||5
2960972|NCT00749944|3675159|FG001|NOT COMPLETED|Overall Study||1
2960973|NCT00749957|3675167|FG000|STARTED|Overall Study||6
2960974|NCT00749957|3675168|FG001|STARTED|Overall Study||6
2960975|NCT00749957|3675167|FG000|COMPLETED|Overall Study||6
2960976|NCT00749957|3675168|FG001|COMPLETED|Overall Study||6
2960977|NCT00749957|3675167|FG000|NOT COMPLETED|Overall Study||0
2960978|NCT00749957|3675168|FG001|NOT COMPLETED|Overall Study||0
2960979|NCT00749996|3675178|FG000|STARTED|Overall Study|4 pts were removed due to compliance issue. 2 pts were randomized but not treated (non-eligible)|75
2960980|NCT00749996|3675179|FG001|STARTED|Overall Study|5 pts were removed due to compliance issue. 1 pt was randomized but not treated (Non-eligible)|71
2960981|NCT00749996|3675178|FG000|6 Weeks Follow-up|Overall Study|Withdrawn (n=1). Visit not done (n=2)|72
2960982|NCT00749996|3675179|FG001|6 Weeks Follow-up|Overall Study|Withdrawn (n=2). Visit not done (n=2)|67
2960983|NCT00749996|3675178|FG000|3 Months Follow-up|Overall Study|Visit not done (n=2)|72
2960984|NCT00749996|3675179|FG001|3 Months Follow-up|Overall Study|Visit not done (n=1)|68
3163806|NCT01889602|3891297|FG002|STARTED|First Washout Period of at Least 2 Weeks||18
3163807|NCT01889602|3891295|FG000|COMPLETED|First Washout Period of at Least 2 Weeks||19
3171765|NCT01936948|3898954|FG001|NOT COMPLETED|Overall Study||3
3132879|NCT01693562|3858016|FG007|STARTED|Exploration Phase||0
3132880|NCT01693562|3858017|FG008|STARTED|Exploration Phase||0
3132881|NCT01693562|3858018|FG009|STARTED|Exploration Phase||0
3132882|NCT01693562|3858019|FG010|STARTED|Exploration Phase||0
3132883|NCT01693562|3858020|FG011|STARTED|Exploration Phase||0
3132884|NCT01693562|3858021|FG012|STARTED|Exploration Phase||0
3132885|NCT01693562|3858022|FG013|STARTED|Exploration Phase||0
3132886|NCT01693562|3858023|FG014|STARTED|Exploration Phase||0
3132887|NCT01693562|3858024|FG015|STARTED|Exploration Phase||0
3132888|NCT01693562|3858025|FG016|STARTED|Exploration Phase||0
3132889|NCT01693562|3858026|FG017|STARTED|Exploration Phase||0
3132890|NCT01693562|3858027|FG018|STARTED|Exploration Phase||0
2960985|NCT00749996|3675178|FG000|6 Months Follow-up|Overall Study|Visit not done (n=3)|71
2960986|NCT00749996|3675179|FG001|6 Months Follow-up|Overall Study|Withdrawn (n=3). Visit not done (n=3)|63
2960987|NCT00749996|3675178|FG000|12 Months Follow-up|Overall Study|Withdrawn(n=4). Visit not done (n=2)|68
2960988|NCT00749996|3675179|FG001|12 Months Follow-up|Overall Study|Withdrawn (n=1). Visit not done (n=4). Lost to follow-up (n=1)|60
2960989|NCT00749996|3675178|FG000|24 Months Follow up|Overall Study|Withdrawn (n=5) Accidental death (n=1) Lost to follow up (n=7)|57
2960990|NCT00749996|3675179|FG001|24 Months Follow up|Overall Study|Withdrawn (n=3). Lost to follow-up (n=3)|58
2960991|NCT00749996|3675178|FG000|COMPLETED|Overall Study||57
2960992|NCT00749996|3675179|FG001|COMPLETED|Overall Study||58
2960993|NCT00749996|3675178|FG000|NOT COMPLETED|Overall Study||18
2960994|NCT00749996|3675179|FG001|NOT COMPLETED|Overall Study||13
2960995|NCT00750061|3675187|FG000|STARTED|Overall Study||20
2960996|NCT00750061|3675188|FG001|STARTED|Overall Study||20
2960997|NCT00750061|3675187|FG000|COMPLETED|Overall Study||18
2960998|NCT00750061|3675188|FG001|COMPLETED|Overall Study||18
2960999|NCT00750061|3675187|FG000|NOT COMPLETED|Overall Study||2
2961000|NCT00750061|3675188|FG001|NOT COMPLETED|Overall Study||2
2961001|NCT00750139|3675198|FG000|STARTED|Overall Study||234
2961002|NCT00750139|3675199|FG001|STARTED|Overall Study||118
2961003|NCT00750139|3675200|FG002|STARTED|Overall Study||236
2961004|NCT00750139|3675201|FG003|STARTED|Overall Study||119
3132891|NCT01693562|3858028|FG019|STARTED|Exploration Phase||0
3132892|NCT01693562|3858029|FG020|STARTED|Exploration Phase||0
3132893|NCT01693562|3858030|FG021|STARTED|Exploration Phase||0
3132894|NCT01693562|3858031|FG022|STARTED|Exploration Phase||0
3132895|NCT01693562|3858009|FG000|COMPLETED|Exploration Phase||0
3132896|NCT01693562|3858010|FG001|COMPLETED|Exploration Phase||0
2961005|NCT00750139|3675198|FG000|COMPLETED|Overall Study||145
2961006|NCT00750139|3675199|FG001|COMPLETED|Overall Study||59
2961007|NCT00750139|3675200|FG002|COMPLETED|Overall Study||135
2961008|NCT00750139|3675201|FG003|COMPLETED|Overall Study||73
2961009|NCT00750139|3675198|FG000|NOT COMPLETED|Overall Study||89
2961010|NCT00750139|3675199|FG001|NOT COMPLETED|Overall Study||59
2961011|NCT00750139|3675200|FG002|NOT COMPLETED|Overall Study||101
2961012|NCT00750139|3675201|FG003|NOT COMPLETED|Overall Study||46
2961013|NCT00750152|3675215|FG000|STARTED|Overall Study||166
2961014|NCT00750152|3675216|FG001|STARTED|Overall Study||168
2961015|NCT00750152|3675215|FG000|COMPLETED|Overall Study||144
2961016|NCT00750152|3675216|FG001|COMPLETED|Overall Study||141
2961017|NCT00750152|3675215|FG000|NOT COMPLETED|Overall Study||22
2961018|NCT00750152|3675216|FG001|NOT COMPLETED|Overall Study||27
2961019|NCT00750165|3675222|FG000|STARTED|Overall Study||32
2961020|NCT00750165|3675222|FG000|COMPLETED|Overall Study||21
2961021|NCT00750165|3675222|FG000|NOT COMPLETED|Overall Study||11
2961022|NCT00750191|3675228|FG000|STARTED|Overall Study||27
2961023|NCT00750191|3675229|FG001|STARTED|Overall Study||30
2961024|NCT00750191|3675228|FG000|COMPLETED|Overall Study||22
2961025|NCT00750191|3675229|FG001|COMPLETED|Overall Study||20
2961026|NCT00750191|3675228|FG000|NOT COMPLETED|Overall Study||5
2961027|NCT00750191|3675229|FG001|NOT COMPLETED|Overall Study||10
2961028|NCT00750269|3675240|FG000|STARTED|Overall Study||8
2961029|NCT00750269|3675241|FG001|STARTED|Overall Study||8
2961030|NCT00750269|3675242|FG002|STARTED|Overall Study||18
2961031|NCT00750269|3675243|FG003|STARTED|Overall Study||43
2961032|NCT00750269|3675244|FG004|STARTED|Overall Study||43
2961033|NCT00750269|3675240|FG000|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study|8
2961034|NCT00750269|3675241|FG001|COMPLETED|Overall Study||7
2961035|NCT00750269|3675242|FG002|COMPLETED|Overall Study||14
2961036|NCT00750269|3675243|FG003|COMPLETED|Overall Study||38
2961037|NCT00750269|3675244|FG004|COMPLETED|Overall Study||33
2961038|NCT00750269|3675240|FG000|NOT COMPLETED|Overall Study||0
2961039|NCT00750269|3675241|FG001|NOT COMPLETED|Overall Study||1
2961040|NCT00750269|3675242|FG002|NOT COMPLETED|Overall Study||4
2961041|NCT00750269|3675243|FG003|NOT COMPLETED|Overall Study||5
2961042|NCT00750269|3675244|FG004|NOT COMPLETED|Overall Study||10
2961043|NCT00750282|3675267|FG000|STARTED|Overall Study||69
2961044|NCT00750282|3675268|FG001|STARTED|Overall Study||82
2961045|NCT00750282|3675269|FG002|STARTED|Overall Study||126
2961046|NCT00750282|3675270|FG003|STARTED|Overall Study||148
2961047|NCT00750282|3675267|FG000|COMPLETED|Overall Study||69
2961048|NCT00750282|3675268|FG001|COMPLETED|Overall Study||81
2961049|NCT00750282|3675269|FG002|COMPLETED|Overall Study||125
2961050|NCT00750282|3675270|FG003|COMPLETED|Overall Study||147
2961051|NCT00750282|3675267|FG000|NOT COMPLETED|Overall Study||0
2961052|NCT00750282|3675268|FG001|NOT COMPLETED|Overall Study||1
2961053|NCT00750282|3675269|FG002|NOT COMPLETED|Overall Study||1
2961054|NCT00750282|3675270|FG003|NOT COMPLETED|Overall Study||1
2961055|NCT00750308|3675294|FG000|STARTED|First Treatment|One female withdrew due to muscle pain|2
2961056|NCT00750308|3675295|FG001|STARTED|First Treatment||3
2961057|NCT00750308|3675296|FG002|STARTED|First Treatment||2
2961058|NCT00750308|3675297|FG003|STARTED|First Treatment||2
2961059|NCT00750308|3675298|FG004|STARTED|First Treatment||2
2961060|NCT00750308|3675299|FG005|STARTED|First Treatment||3
2961061|NCT00750308|3675300|FG006|STARTED|First Treatment||2
2961062|NCT00750308|3675301|FG007|STARTED|First Treatment||3
2961063|NCT00750308|3675302|FG008|STARTED|First Treatment||2
2961064|NCT00750308|3675303|FG009|STARTED|First Treatment||2
2961065|NCT00750308|3675304|FG010|STARTED|First Treatment||2
2961066|NCT00750308|3675305|FG011|STARTED|First Treatment||2
2961067|NCT00750308|3675294|FG000|COMPLETED|First Treatment||2
2961068|NCT00750308|3675295|FG001|COMPLETED|First Treatment||2
2961069|NCT00750308|3675296|FG002|COMPLETED|First Treatment||2
2961070|NCT00750308|3675297|FG003|COMPLETED|First Treatment||1
2961071|NCT00750308|3675298|FG004|COMPLETED|First Treatment||2
2961072|NCT00750308|3675299|FG005|COMPLETED|First Treatment||3
2961073|NCT00750308|3675300|FG006|COMPLETED|First Treatment||2
2961074|NCT00750308|3675301|FG007|COMPLETED|First Treatment||2
2961075|NCT00750308|3675302|FG008|COMPLETED|First Treatment||2
2961076|NCT00750308|3675303|FG009|COMPLETED|First Treatment||2
2961077|NCT00750308|3675304|FG010|COMPLETED|First Treatment||1
2961078|NCT00750308|3675305|FG011|COMPLETED|First Treatment||1
2961079|NCT00750308|3675294|FG000|NOT COMPLETED|First Treatment||0
2961080|NCT00750308|3675295|FG001|NOT COMPLETED|First Treatment||1
2961081|NCT00750308|3675296|FG002|NOT COMPLETED|First Treatment||0
2961082|NCT00750308|3675297|FG003|NOT COMPLETED|First Treatment||1
2961083|NCT00750308|3675298|FG004|NOT COMPLETED|First Treatment||0
2961084|NCT00750308|3675299|FG005|NOT COMPLETED|First Treatment||0
2961085|NCT00750308|3675300|FG006|NOT COMPLETED|First Treatment||0
2961086|NCT00750308|3675301|FG007|NOT COMPLETED|First Treatment||1
2961087|NCT00750308|3675302|FG008|NOT COMPLETED|First Treatment||0
2961088|NCT00750308|3675303|FG009|NOT COMPLETED|First Treatment||0
2961089|NCT00750308|3675304|FG010|NOT COMPLETED|First Treatment||1
2961090|NCT00750308|3675305|FG011|NOT COMPLETED|First Treatment||1
2961091|NCT00750308|3675294|FG000|STARTED|Washout||2
2961092|NCT00750308|3675295|FG001|STARTED|Washout||2
2961093|NCT00750308|3675296|FG002|STARTED|Washout||2
2961094|NCT00750308|3675297|FG003|STARTED|Washout||1
2961095|NCT00750308|3675298|FG004|STARTED|Washout||2
2961096|NCT00750308|3675299|FG005|STARTED|Washout||3
2961097|NCT00750308|3675300|FG006|STARTED|Washout||2
2961098|NCT00750308|3675301|FG007|STARTED|Washout||2
2961099|NCT00750308|3675302|FG008|STARTED|Washout||2
2961100|NCT00750308|3675303|FG009|STARTED|Washout||2
2961101|NCT00750308|3675304|FG010|STARTED|Washout||1
2961102|NCT00750308|3675305|FG011|STARTED|Washout||1
2961103|NCT00750308|3675294|FG000|COMPLETED|Washout||2
2961104|NCT00750308|3675295|FG001|COMPLETED|Washout||2
2961105|NCT00750308|3675296|FG002|COMPLETED|Washout||2
2961106|NCT00750308|3675297|FG003|COMPLETED|Washout||1
2961107|NCT00750308|3675298|FG004|COMPLETED|Washout||2
2961108|NCT00750308|3675299|FG005|COMPLETED|Washout||3
2961109|NCT00750308|3675300|FG006|COMPLETED|Washout||2
2961110|NCT00750308|3675301|FG007|COMPLETED|Washout||2
2961111|NCT00750308|3675302|FG008|COMPLETED|Washout||2
2961112|NCT00750308|3675303|FG009|COMPLETED|Washout||2
2961113|NCT00750308|3675304|FG010|COMPLETED|Washout||1
2961114|NCT00750308|3675305|FG011|COMPLETED|Washout||1
2961115|NCT00750308|3675294|FG000|NOT COMPLETED|Washout||0
2961116|NCT00750308|3675295|FG001|NOT COMPLETED|Washout||0
2961117|NCT00750308|3675296|FG002|NOT COMPLETED|Washout||0
2961118|NCT00750308|3675297|FG003|NOT COMPLETED|Washout||0
2961119|NCT00750308|3675298|FG004|NOT COMPLETED|Washout||0
2961120|NCT00750308|3675299|FG005|NOT COMPLETED|Washout||0
2961121|NCT00750308|3675300|FG006|NOT COMPLETED|Washout||0
2961122|NCT00750308|3675301|FG007|NOT COMPLETED|Washout||0
2961123|NCT00750308|3675302|FG008|NOT COMPLETED|Washout||0
2961124|NCT00750308|3675303|FG009|NOT COMPLETED|Washout||0
2961125|NCT00750308|3675304|FG010|NOT COMPLETED|Washout||0
2961126|NCT00750308|3675305|FG011|NOT COMPLETED|Washout||0
2961127|NCT00750308|3675294|FG000|STARTED|Second Treatment||2
2961128|NCT00750308|3675295|FG001|STARTED|Second Treatment||2
2961129|NCT00750308|3675296|FG002|STARTED|Second Treatment||2
2961130|NCT00750308|3675297|FG003|STARTED|Second Treatment||1
2961131|NCT00750308|3675298|FG004|STARTED|Second Treatment||2
2961132|NCT00750308|3675299|FG005|STARTED|Second Treatment||3
2961133|NCT00750308|3675300|FG006|STARTED|Second Treatment||2
2961134|NCT00750308|3675301|FG007|STARTED|Second Treatment||2
2961135|NCT00750308|3675302|FG008|STARTED|Second Treatment||2
2961136|NCT00750308|3675303|FG009|STARTED|Second Treatment||2
2961137|NCT00750308|3675304|FG010|STARTED|Second Treatment||1
2961138|NCT00750308|3675305|FG011|STARTED|Second Treatment||1
2961139|NCT00750308|3675294|FG000|COMPLETED|Second Treatment||2
2961140|NCT00750308|3675295|FG001|COMPLETED|Second Treatment||2
2961141|NCT00750308|3675296|FG002|COMPLETED|Second Treatment||2
2961142|NCT00750308|3675297|FG003|COMPLETED|Second Treatment||1
2961143|NCT00750308|3675298|FG004|COMPLETED|Second Treatment||1
2961144|NCT00750308|3675299|FG005|COMPLETED|Second Treatment||2
2961145|NCT00750308|3675300|FG006|COMPLETED|Second Treatment||2
2961146|NCT00750308|3675301|FG007|COMPLETED|Second Treatment||2
3132897|NCT01693562|3858011|FG002|COMPLETED|Exploration Phase||0
2961147|NCT00750308|3675302|FG008|COMPLETED|Second Treatment||1
2961148|NCT00750308|3675303|FG009|COMPLETED|Second Treatment||2
2961149|NCT00750308|3675304|FG010|COMPLETED|Second Treatment||1
2961150|NCT00750308|3675305|FG011|COMPLETED|Second Treatment||1
2961151|NCT00750308|3675294|FG000|NOT COMPLETED|Second Treatment||0
2961152|NCT00750308|3675295|FG001|NOT COMPLETED|Second Treatment||0
2961153|NCT00750308|3675296|FG002|NOT COMPLETED|Second Treatment||0
2961154|NCT00750308|3675297|FG003|NOT COMPLETED|Second Treatment||0
2961155|NCT00750308|3675298|FG004|NOT COMPLETED|Second Treatment||1
2961156|NCT00750308|3675299|FG005|NOT COMPLETED|Second Treatment||1
2961157|NCT00750308|3675300|FG006|NOT COMPLETED|Second Treatment||0
2961158|NCT00750308|3675301|FG007|NOT COMPLETED|Second Treatment||0
2961159|NCT00750308|3675302|FG008|NOT COMPLETED|Second Treatment||1
2961160|NCT00750308|3675303|FG009|NOT COMPLETED|Second Treatment||0
2961161|NCT00750308|3675304|FG010|NOT COMPLETED|Second Treatment||0
2961162|NCT00750308|3675305|FG011|NOT COMPLETED|Second Treatment||0
2961163|NCT00750308|3675294|FG000|STARTED|Washout||2
2961164|NCT00750308|3675295|FG001|STARTED|Washout||2
2961165|NCT00750308|3675296|FG002|STARTED|Washout||2
2961166|NCT00750308|3675297|FG003|STARTED|Washout||1
2961167|NCT00750308|3675298|FG004|STARTED|Washout||1
2961168|NCT00750308|3675299|FG005|STARTED|Washout||2
2961169|NCT00750308|3675300|FG006|STARTED|Washout||2
2961170|NCT00750308|3675301|FG007|STARTED|Washout||2
2961171|NCT00750308|3675302|FG008|STARTED|Washout||1
2961172|NCT00750308|3675303|FG009|STARTED|Washout||2
2961173|NCT00750308|3675304|FG010|STARTED|Washout||1
2961174|NCT00750308|3675305|FG011|STARTED|Washout||1
2961175|NCT00750308|3675294|FG000|COMPLETED|Washout||2
2961176|NCT00750308|3675295|FG001|COMPLETED|Washout||2
2961177|NCT00750308|3675296|FG002|COMPLETED|Washout||2
2961178|NCT00750308|3675297|FG003|COMPLETED|Washout||1
2961179|NCT00750308|3675298|FG004|COMPLETED|Washout||1
2961180|NCT00750308|3675299|FG005|COMPLETED|Washout||2
2961181|NCT00750308|3675300|FG006|COMPLETED|Washout||2
3132898|NCT01693562|3858012|FG003|COMPLETED|Exploration Phase||0
2961182|NCT00750308|3675301|FG007|COMPLETED|Washout||2
2961183|NCT00750308|3675302|FG008|COMPLETED|Washout||1
2961184|NCT00750308|3675303|FG009|COMPLETED|Washout||2
2961185|NCT00750308|3675304|FG010|COMPLETED|Washout||1
2961186|NCT00750308|3675305|FG011|COMPLETED|Washout||1
2961187|NCT00750308|3675294|FG000|NOT COMPLETED|Washout||0
2961188|NCT00750308|3675295|FG001|NOT COMPLETED|Washout||0
2961189|NCT00750308|3675296|FG002|NOT COMPLETED|Washout||0
2961190|NCT00750308|3675297|FG003|NOT COMPLETED|Washout||0
2961191|NCT00750308|3675298|FG004|NOT COMPLETED|Washout||0
2961192|NCT00750308|3675299|FG005|NOT COMPLETED|Washout||0
2961193|NCT00750308|3675300|FG006|NOT COMPLETED|Washout||0
2961194|NCT00750308|3675301|FG007|NOT COMPLETED|Washout||0
2961195|NCT00750308|3675302|FG008|NOT COMPLETED|Washout||0
2961196|NCT00750308|3675303|FG009|NOT COMPLETED|Washout||0
2961197|NCT00750308|3675304|FG010|NOT COMPLETED|Washout||0
2961198|NCT00750308|3675305|FG011|NOT COMPLETED|Washout||0
2961199|NCT00750308|3675294|FG000|STARTED|Third Treatment||2
2961200|NCT00750308|3675295|FG001|STARTED|Third Treatment||2
2961201|NCT00750308|3675296|FG002|STARTED|Third Treatment||2
2961202|NCT00750308|3675297|FG003|STARTED|Third Treatment||1
2961203|NCT00750308|3675298|FG004|STARTED|Third Treatment||1
2961204|NCT00750308|3675299|FG005|STARTED|Third Treatment||2
2961205|NCT00750308|3675300|FG006|STARTED|Third Treatment||2
2961206|NCT00750308|3675301|FG007|STARTED|Third Treatment||2
2961207|NCT00750308|3675302|FG008|STARTED|Third Treatment||1
2961208|NCT00750308|3675303|FG009|STARTED|Third Treatment||2
2961209|NCT00750308|3675304|FG010|STARTED|Third Treatment||1
2961210|NCT00750308|3675305|FG011|STARTED|Third Treatment||1
2961211|NCT00750308|3675294|FG000|COMPLETED|Third Treatment||2
2961212|NCT00750308|3675295|FG001|COMPLETED|Third Treatment||1
2961213|NCT00750308|3675296|FG002|COMPLETED|Third Treatment||2
2961214|NCT00750308|3675297|FG003|COMPLETED|Third Treatment||1
2961215|NCT00750308|3675298|FG004|COMPLETED|Third Treatment||1
2961216|NCT00750308|3675299|FG005|COMPLETED|Third Treatment||2
2961217|NCT00750308|3675300|FG006|COMPLETED|Third Treatment||2
2961218|NCT00750308|3675301|FG007|COMPLETED|Third Treatment||2
2961219|NCT00750308|3675302|FG008|COMPLETED|Third Treatment||1
2961220|NCT00750308|3675303|FG009|COMPLETED|Third Treatment||2
2961221|NCT00750308|3675304|FG010|COMPLETED|Third Treatment||1
2961222|NCT00750308|3675305|FG011|COMPLETED|Third Treatment||1
2961223|NCT00750308|3675294|FG000|NOT COMPLETED|Third Treatment||0
2961224|NCT00750308|3675295|FG001|NOT COMPLETED|Third Treatment||1
2961225|NCT00750308|3675296|FG002|NOT COMPLETED|Third Treatment||0
2961226|NCT00750308|3675297|FG003|NOT COMPLETED|Third Treatment||0
2961227|NCT00750308|3675298|FG004|NOT COMPLETED|Third Treatment||0
2961228|NCT00750308|3675299|FG005|NOT COMPLETED|Third Treatment||0
2961229|NCT00750308|3675300|FG006|NOT COMPLETED|Third Treatment||0
2961230|NCT00750308|3675301|FG007|NOT COMPLETED|Third Treatment||0
2961231|NCT00750308|3675302|FG008|NOT COMPLETED|Third Treatment||0
2961232|NCT00750308|3675303|FG009|NOT COMPLETED|Third Treatment||0
2961233|NCT00750308|3675304|FG010|NOT COMPLETED|Third Treatment||0
2961234|NCT00750308|3675305|FG011|NOT COMPLETED|Third Treatment||0
2961235|NCT00750308|3675294|FG000|STARTED|Washout||2
2961236|NCT00750308|3675295|FG001|STARTED|Washout||1
2961237|NCT00750308|3675296|FG002|STARTED|Washout||2
2961238|NCT00750308|3675297|FG003|STARTED|Washout||1
2961239|NCT00750308|3675298|FG004|STARTED|Washout||1
2961240|NCT00750308|3675299|FG005|STARTED|Washout||2
2961241|NCT00750308|3675300|FG006|STARTED|Washout||2
3163808|NCT01889602|3891296|FG001|COMPLETED|First Washout Period of at Least 2 Weeks||17
3163809|NCT01889602|3891297|FG002|COMPLETED|First Washout Period of at Least 2 Weeks||18
3163810|NCT01889602|3891295|FG000|NOT COMPLETED|First Washout Period of at Least 2 Weeks||0
3163811|NCT01889602|3891296|FG001|NOT COMPLETED|First Washout Period of at Least 2 Weeks||0
3163812|NCT01889602|3891297|FG002|NOT COMPLETED|First Washout Period of at Least 2 Weeks||0
3163813|NCT01889602|3891295|FG000|STARTED|Second Intervention||19
3163814|NCT01889602|3891296|FG001|STARTED|Second Intervention||17
3163815|NCT01889602|3891297|FG002|STARTED|Second Intervention||18
3163816|NCT01889602|3891295|FG000|COMPLETED|Second Intervention||18
3163817|NCT01889602|3891296|FG001|COMPLETED|Second Intervention||17
3163818|NCT01889602|3891297|FG002|COMPLETED|Second Intervention||16
3163819|NCT01889602|3891295|FG000|NOT COMPLETED|Second Intervention||1
3163820|NCT01889602|3891296|FG001|NOT COMPLETED|Second Intervention||0
3163821|NCT01889602|3891297|FG002|NOT COMPLETED|Second Intervention||2
3163822|NCT01889602|3891295|FG000|STARTED|Second Washout Period of at Least 2 Week||18
3163823|NCT01889602|3891296|FG001|STARTED|Second Washout Period of at Least 2 Week||17
2961242|NCT00750308|3675301|FG007|STARTED|Washout||2
2961243|NCT00750308|3675302|FG008|STARTED|Washout||1
2961244|NCT00750308|3675303|FG009|STARTED|Washout||2
2961245|NCT00750308|3675304|FG010|STARTED|Washout||1
2961246|NCT00750308|3675305|FG011|STARTED|Washout||1
2961247|NCT00750308|3675294|FG000|COMPLETED|Washout||2
2961248|NCT00750308|3675295|FG001|COMPLETED|Washout||1
2961249|NCT00750308|3675296|FG002|COMPLETED|Washout||2
2961250|NCT00750308|3675297|FG003|COMPLETED|Washout||1
2961251|NCT00750308|3675298|FG004|COMPLETED|Washout||1
2961252|NCT00750308|3675299|FG005|COMPLETED|Washout||2
2961253|NCT00750308|3675300|FG006|COMPLETED|Washout||2
2961254|NCT00750308|3675301|FG007|COMPLETED|Washout||2
2961255|NCT00750308|3675302|FG008|COMPLETED|Washout||1
2961256|NCT00750308|3675303|FG009|COMPLETED|Washout||2
2961257|NCT00750308|3675304|FG010|COMPLETED|Washout||1
2961258|NCT00750308|3675305|FG011|COMPLETED|Washout||1
2961259|NCT00750308|3675294|FG000|NOT COMPLETED|Washout||0
2961260|NCT00750308|3675295|FG001|NOT COMPLETED|Washout||0
2961261|NCT00750308|3675296|FG002|NOT COMPLETED|Washout||0
2961262|NCT00750308|3675297|FG003|NOT COMPLETED|Washout||0
2961263|NCT00750308|3675298|FG004|NOT COMPLETED|Washout||0
2961264|NCT00750308|3675299|FG005|NOT COMPLETED|Washout||0
2961265|NCT00750308|3675300|FG006|NOT COMPLETED|Washout||0
2961266|NCT00750308|3675301|FG007|NOT COMPLETED|Washout||0
2961267|NCT00750308|3675302|FG008|NOT COMPLETED|Washout||0
2961268|NCT00750308|3675303|FG009|NOT COMPLETED|Washout||0
2961269|NCT00750308|3675304|FG010|NOT COMPLETED|Washout||0
2961270|NCT00750308|3675305|FG011|NOT COMPLETED|Washout||0
2961271|NCT00750308|3675294|FG000|STARTED|Fourth Treatment||2
2961272|NCT00750308|3675295|FG001|STARTED|Fourth Treatment||1
2961273|NCT00750308|3675296|FG002|STARTED|Fourth Treatment||2
2961274|NCT00750308|3675297|FG003|STARTED|Fourth Treatment||1
2961275|NCT00750308|3675298|FG004|STARTED|Fourth Treatment||1
2961276|NCT00750308|3675299|FG005|STARTED|Fourth Treatment||2
2961277|NCT00750308|3675300|FG006|STARTED|Fourth Treatment||2
2961278|NCT00750308|3675301|FG007|STARTED|Fourth Treatment||2
2961279|NCT00750308|3675302|FG008|STARTED|Fourth Treatment||1
2961280|NCT00750308|3675303|FG009|STARTED|Fourth Treatment||2
2961281|NCT00750308|3675304|FG010|STARTED|Fourth Treatment||1
2961282|NCT00750308|3675305|FG011|STARTED|Fourth Treatment||1
2961283|NCT00750308|3675294|FG000|COMPLETED|Fourth Treatment||2
3132899|NCT01693562|3858013|FG004|COMPLETED|Exploration Phase||0
3132900|NCT01693562|3858014|FG005|COMPLETED|Exploration Phase||0
3132901|NCT01693562|3858015|FG006|COMPLETED|Exploration Phase||0
3132902|NCT01693562|3858016|FG007|COMPLETED|Exploration Phase||0
3132903|NCT01693562|3858017|FG008|COMPLETED|Exploration Phase||0
3132904|NCT01693562|3858018|FG009|COMPLETED|Exploration Phase||0
2961284|NCT00750308|3675295|FG001|COMPLETED|Fourth Treatment||1
2961285|NCT00750308|3675296|FG002|COMPLETED|Fourth Treatment||2
2961286|NCT00750308|3675297|FG003|COMPLETED|Fourth Treatment||1
2961287|NCT00750308|3675298|FG004|COMPLETED|Fourth Treatment||1
2961288|NCT00750308|3675299|FG005|COMPLETED|Fourth Treatment||2
2961289|NCT00750308|3675300|FG006|COMPLETED|Fourth Treatment||2
2961290|NCT00750308|3675301|FG007|COMPLETED|Fourth Treatment||2
2961291|NCT00750308|3675302|FG008|COMPLETED|Fourth Treatment||1
2961292|NCT00750308|3675303|FG009|COMPLETED|Fourth Treatment||2
2961293|NCT00750308|3675304|FG010|COMPLETED|Fourth Treatment||1
2961294|NCT00750308|3675305|FG011|COMPLETED|Fourth Treatment||1
2961295|NCT00750308|3675294|FG000|NOT COMPLETED|Fourth Treatment||0
3132905|NCT01693562|3858019|FG010|COMPLETED|Exploration Phase||0
3132906|NCT01693562|3858020|FG011|COMPLETED|Exploration Phase||0
3132907|NCT01693562|3858021|FG012|COMPLETED|Exploration Phase||0
3132908|NCT01693562|3858022|FG013|COMPLETED|Exploration Phase||0
2961296|NCT00750308|3675295|FG001|NOT COMPLETED|Fourth Treatment||0
2961297|NCT00750308|3675296|FG002|NOT COMPLETED|Fourth Treatment||0
2961298|NCT00750308|3675297|FG003|NOT COMPLETED|Fourth Treatment||0
2961299|NCT00750308|3675298|FG004|NOT COMPLETED|Fourth Treatment||0
2961300|NCT00750308|3675299|FG005|NOT COMPLETED|Fourth Treatment||0
2961301|NCT00750308|3675300|FG006|NOT COMPLETED|Fourth Treatment||0
2961302|NCT00750308|3675301|FG007|NOT COMPLETED|Fourth Treatment||0
2961303|NCT00750308|3675302|FG008|NOT COMPLETED|Fourth Treatment||0
2961304|NCT00750308|3675303|FG009|NOT COMPLETED|Fourth Treatment||0
2961305|NCT00750308|3675304|FG010|NOT COMPLETED|Fourth Treatment||0
2961306|NCT00750308|3675305|FG011|NOT COMPLETED|Fourth Treatment||0
2961307|NCT00750360|3675325|FG000|STARTED|Overall Study|"Seven subjects enrolled in this group were not vaccinated and as such not included as STARTED."|294
2961308|NCT00750360|3675326|FG001|STARTED|Overall Study|"One subject enrolled in this group was not vaccinated and as such not included as STARTED."|1
2961309|NCT00750360|3675327|FG002|STARTED|Overall Study||384
2961310|NCT00750360|3675328|FG003|STARTED|Overall Study||79
2961311|NCT00750360|3675329|FG004|STARTED|Overall Study||46
2961312|NCT00750360|3675330|FG005|STARTED|Overall Study||71
2961313|NCT00750360|3675325|FG000|COMPLETED|Overall Study||294
2961314|NCT00750360|3675326|FG001|COMPLETED|Overall Study||1
2961315|NCT00750360|3675327|FG002|COMPLETED|Overall Study||384
2961316|NCT00750360|3675328|FG003|COMPLETED|Overall Study||79
2961317|NCT00750360|3675329|FG004|COMPLETED|Overall Study||46
2961318|NCT00750360|3675330|FG005|COMPLETED|Overall Study||71
2961319|NCT00750360|3675325|FG000|NOT COMPLETED|Overall Study||0
2961320|NCT00750360|3675326|FG001|NOT COMPLETED|Overall Study||0
2961321|NCT00750360|3675327|FG002|NOT COMPLETED|Overall Study||0
2961322|NCT00750360|3675328|FG003|NOT COMPLETED|Overall Study||0
2961323|NCT00750360|3675329|FG004|NOT COMPLETED|Overall Study||0
2961324|NCT00750360|3675330|FG005|NOT COMPLETED|Overall Study||0
2961325|NCT00750373|3675352|FG000|STARTED|Overall Study||39
2961326|NCT00750373|3675353|FG001|STARTED|Overall Study||37
2961327|NCT00750373|3675352|FG000|COMPLETED|Overall Study||39
2961328|NCT00750373|3675353|FG001|COMPLETED|Overall Study||37
2961329|NCT00750373|3675352|FG000|NOT COMPLETED|Overall Study||0
2961330|NCT00750373|3675353|FG001|NOT COMPLETED|Overall Study||0
2961331|NCT00750438|3675361|FG000|STARTED|Overall Study||31
2961332|NCT00750438|3675362|FG001|STARTED|Overall Study||29
2961333|NCT00750438|3675361|FG000|COMPLETED|Overall Study||24
2961334|NCT00750438|3675362|FG001|COMPLETED|Overall Study||25
2961335|NCT00750438|3675361|FG000|NOT COMPLETED|Overall Study||7
2961336|NCT00750438|3675362|FG001|NOT COMPLETED|Overall Study||4
2961337|NCT00750737|3675370|FG000|STARTED|Overall Study||24
2961338|NCT00750737|3675371|FG001|STARTED|Overall Study||22
2961339|NCT00750737|3675370|FG000|COMPLETED|Overall Study||21
2961340|NCT00750737|3675371|FG001|COMPLETED|Overall Study||19
2961341|NCT00750737|3675370|FG000|NOT COMPLETED|Overall Study||3
2961342|NCT00750737|3675371|FG001|NOT COMPLETED|Overall Study||3
2961343|NCT00750815|3675379|FG000|STARTED|Overall Study||12
2961344|NCT00750815|3675380|FG001|STARTED|Overall Study||46
2961345|NCT00750815|3675379|FG000|COMPLETED|Overall Study||12
2961346|NCT00750815|3675380|FG001|COMPLETED|Overall Study||46
2961347|NCT00750815|3675379|FG000|NOT COMPLETED|Overall Study||0
2961348|NCT00750815|3675380|FG001|NOT COMPLETED|Overall Study||0
2961349|NCT00750867|3675390|FG000|STARTED|Overall Study||9
2961350|NCT00750867|3675390|FG000|COMPLETED|Overall Study||7
2961351|NCT00750867|3675390|FG000|NOT COMPLETED|Overall Study||2
2961352|NCT00750880|3675394|FG000|STARTED|Overall Study||1681
2961353|NCT00750880|3675394|FG000|COMPLETED|Overall Study||1466
2961354|NCT00750880|3675394|FG000|NOT COMPLETED|Overall Study||215
2961355|NCT00750893|3675399|FG000|STARTED|Overall Study||3111
2961356|NCT00750893|3675399|FG000|COMPLETED|Overall Study||2569
3163824|NCT01889602|3891297|FG002|STARTED|Second Washout Period of at Least 2 Week||16
3163825|NCT01889602|3891295|FG000|COMPLETED|Second Washout Period of at Least 2 Week||18
3163826|NCT01889602|3891296|FG001|COMPLETED|Second Washout Period of at Least 2 Week||17
3163827|NCT01889602|3891297|FG002|COMPLETED|Second Washout Period of at Least 2 Week||16
3163828|NCT01889602|3891295|FG000|NOT COMPLETED|Second Washout Period of at Least 2 Week||0
3163829|NCT01889602|3891296|FG001|NOT COMPLETED|Second Washout Period of at Least 2 Week||0
3163830|NCT01889602|3891297|FG002|NOT COMPLETED|Second Washout Period of at Least 2 Week||0
3163831|NCT01889602|3891295|FG000|STARTED|Third Intervention||18
3163832|NCT01889602|3891296|FG001|STARTED|Third Intervention||17
3163833|NCT01889602|3891297|FG002|STARTED|Third Intervention||16
2961357|NCT00750893|3675399|FG000|NOT COMPLETED|Overall Study||542
2961358|NCT00750919|3675403|FG000|STARTED|Overall Study||184
2961359|NCT00750919|3675403|FG000|COMPLETED|Overall Study||126
2961360|NCT00750919|3675403|FG000|NOT COMPLETED|Overall Study||58
2961361|NCT00751023|3675409|FG000|STARTED|Overall Study||20
2961362|NCT00751023|3675410|FG001|STARTED|Overall Study||20
2961363|NCT00751023|3675409|FG000|COMPLETED|Overall Study||9
2961364|NCT00751023|3675410|FG001|COMPLETED|Overall Study||13
2961365|NCT00751023|3675409|FG000|NOT COMPLETED|Overall Study||11
2961366|NCT00751023|3675410|FG001|NOT COMPLETED|Overall Study||7
2961367|NCT00751036|3675418|FG000|STARTED|Overall Study|Started = Treated|48
2961368|NCT00751036|3675419|FG001|STARTED|Overall Study|Started = Treated|46
2961369|NCT00751036|3675418|FG000|COMPLETED|Overall Study|Reason Not Completed = Reason for End of Treatment|0
2961370|NCT00751036|3675419|FG001|COMPLETED|Overall Study|Reason Not Completed = Reason for End of Treatment|0
2961371|NCT00751036|3675418|FG000|NOT COMPLETED|Overall Study||48
2961372|NCT00751036|3675419|FG001|NOT COMPLETED|Overall Study||46
2961373|NCT00751101|3675427|FG000|STARTED|Overall Study||12
2961374|NCT00751101|3675428|FG001|STARTED|Overall Study||12
2961375|NCT00751101|3675427|FG000|Started Capecitabine|Overall Study||11
2961376|NCT00751101|3675428|FG001|Started Capecitabine|Overall Study||11
2961377|NCT00751101|3675427|FG000|COMPLETED|Overall Study||10
2961378|NCT00751101|3675428|FG001|COMPLETED|Overall Study||7
2961379|NCT00751101|3675427|FG000|NOT COMPLETED|Overall Study||2
2961380|NCT00751101|3675428|FG001|NOT COMPLETED|Overall Study||5
2961381|NCT00751114|3675440|FG000|STARTED|Overall Study|randomized|250
2961382|NCT00751114|3675441|FG001|STARTED|Overall Study||265
2961383|NCT00751114|3675440|FG000|TREATED = Safety Population|Overall Study|safety population: randomized patients who received at least one dose of investigational product|237
2961384|NCT00751114|3675441|FG001|TREATED = Safety Population|Overall Study||264
2961385|NCT00751114|3675440|FG000|mITT Population|Overall Study|modified Intent-To-Treat population: treated patients with at least 1 on-treatment efficacy measure|227
2961386|NCT00751114|3675441|FG001|mITT Population|Overall Study||253
2961387|NCT00751114|3675440|FG000|COMPLETED|Overall Study||212
2961388|NCT00751114|3675441|FG001|COMPLETED|Overall Study||233
2961389|NCT00751114|3675440|FG000|NOT COMPLETED|Overall Study||38
2961390|NCT00751114|3675441|FG001|NOT COMPLETED|Overall Study||32
2961391|NCT00751140|3675447|FG000|STARTED|Overall Study||20
2961392|NCT00751140|3675447|FG000|COMPLETED|Overall Study||19
3132909|NCT01693562|3858023|FG014|COMPLETED|Exploration Phase||0
3132910|NCT01693562|3858024|FG015|COMPLETED|Exploration Phase||0
3132911|NCT01693562|3858025|FG016|COMPLETED|Exploration Phase||0
3132912|NCT01693562|3858026|FG017|COMPLETED|Exploration Phase||0
3132913|NCT01693562|3858027|FG018|COMPLETED|Exploration Phase||0
3132914|NCT01693562|3858028|FG019|COMPLETED|Exploration Phase||0
2961393|NCT00751140|3675447|FG000|NOT COMPLETED|Overall Study||1
2961394|NCT00751179|3675457|FG000|STARTED|Overall Study|10 of 76 randomized were not treated with sugammadex; 4 of these 10 received rocuronium only|76
2961395|NCT00751179|3675458|FG001|STARTED|Overall Study|5 of 85 randomized were not treated with succinylcholine|85
2961396|NCT00751179|3675457|FG000|COMPLETED|Overall Study||62
2961397|NCT00751179|3675458|FG001|COMPLETED|Overall Study||70
2961398|NCT00751179|3675457|FG000|NOT COMPLETED|Overall Study||14
2961399|NCT00751179|3675458|FG001|NOT COMPLETED|Overall Study||15
2961400|NCT00751296|3675465|FG000|STARTED|Overall Study|The start date of the study was 25 August 2006.|27
2961401|NCT00751296|3675465|FG000|COMPLETED|Overall Study||25
2961402|NCT00751296|3675465|FG000|NOT COMPLETED|Overall Study||2
2961403|NCT00751348|3675471|FG000|STARTED|Overall Study||313
2961404|NCT00751348|3675472|FG001|STARTED|Overall Study||161
2961405|NCT00751348|3675471|FG000|COMPLETED|Overall Study||307
2961406|NCT00751348|3675472|FG001|COMPLETED|Overall Study||159
2961407|NCT00751348|3675471|FG000|NOT COMPLETED|Overall Study||6
2961408|NCT00751348|3675472|FG001|NOT COMPLETED|Overall Study||2
2961409|NCT00751400|3675478|FG000|STARTED|Overall Study||497
2961410|NCT00751400|3675478|FG000|Subjects Provided Drug|Overall Study||497
3132915|NCT01693562|3858029|FG020|COMPLETED|Exploration Phase||0
3132916|NCT01693562|3858030|FG021|COMPLETED|Exploration Phase||0
3132917|NCT01693562|3858031|FG022|COMPLETED|Exploration Phase||0
3132918|NCT01693562|3858009|FG000|NOT COMPLETED|Exploration Phase||0
3132919|NCT01693562|3858010|FG001|NOT COMPLETED|Exploration Phase||0
3132920|NCT01693562|3858011|FG002|NOT COMPLETED|Exploration Phase||0
3132921|NCT01693562|3858012|FG003|NOT COMPLETED|Exploration Phase||0
2961411|NCT00751400|3675478|FG000|Subjects Consumed Drug|Overall Study||485
2961412|NCT00751400|3675478|FG000|Subjects Provided Detailed Use Data|Overall Study||467
2961413|NCT00751400|3675478|FG000|COMPLETED|Overall Study||487
2961414|NCT00751400|3675478|FG000|NOT COMPLETED|Overall Study||10
2961415|NCT00751530|3675484|FG000|STARTED|Overall Study||332
2961416|NCT00751530|3675485|FG001|STARTED|Overall Study||110
2961417|NCT00751530|3675484|FG000|COMPLETED|Overall Study||332
2961418|NCT00751530|3675485|FG001|COMPLETED|Overall Study||110
2961419|NCT00751530|3675484|FG000|NOT COMPLETED|Overall Study||0
2961420|NCT00751530|3675485|FG001|NOT COMPLETED|Overall Study||0
2961421|NCT00751621|3675491|FG000|STARTED|Overall Study||40
2961422|NCT00751621|3675491|FG000|COMPLETED|Overall Study||36
2961423|NCT00751621|3675491|FG000|NOT COMPLETED|Overall Study||4
2961424|NCT00751634|3675497|FG000|STARTED|Overall Study||20
2961425|NCT00751634|3675497|FG000|COMPLETED|Overall Study||20
2961426|NCT00751634|3675497|FG000|NOT COMPLETED|Overall Study||0
2961427|NCT00751777|3675504|FG000|STARTED|Overall Study||81
2961428|NCT00751777|3675505|FG001|STARTED|Overall Study||39
2961429|NCT00751777|3675504|FG000|COMPLETED|Overall Study|Day 380: study completion for LT group|70
2961430|NCT00751777|3675505|FG001|COMPLETED|Overall Study|Day 194: study completion for placebo group|36
2961431|NCT00751777|3675504|FG000|NOT COMPLETED|Overall Study||11
2961432|NCT00751777|3675505|FG001|NOT COMPLETED|Overall Study||3
2961433|NCT00751790|3675511|FG000|STARTED|Overall Study||120
2961434|NCT00751790|3675511|FG000|COMPLETED|Overall Study||115
2961435|NCT00751790|3675511|FG000|NOT COMPLETED|Overall Study||5
2961436|NCT00751881|3675518|FG000|STARTED|Core Treatment Period|Randomized|389
2961437|NCT00751881|3675519|FG001|STARTED|Core Treatment Period|Randomized|408
2961438|NCT00751881|3675520|FG002|STARTED|Core Treatment Period|Randomized|372
2961439|NCT00751881|3675518|FG000|Treated|Core Treatment Period|1 participant received teriflunomide 7 mg and 2 participants teriflunomide 14 mg (at least 1 dose)|388
2961440|NCT00751881|3675519|FG001|Treated|Core Treatment Period|1 participant received placebo (at least 1 dose)|407
2961441|NCT00751881|3675520|FG002|Treated|Core Treatment Period|1 participant received teriflunomide 7 mg and 1 participant placebo (at least 1 dose)|370
2961442|NCT00751881|3675518|FG000|COMPLETED|Core Treatment Period||263
2961443|NCT00751881|3675519|FG001|COMPLETED|Core Treatment Period||273
2961444|NCT00751881|3675520|FG002|COMPLETED|Core Treatment Period||244
2961445|NCT00751881|3675518|FG000|NOT COMPLETED|Core Treatment Period||126
2961446|NCT00751881|3675519|FG001|NOT COMPLETED|Core Treatment Period||135
2961447|NCT00751881|3675520|FG002|NOT COMPLETED|Core Treatment Period||128
2961448|NCT00751881|3675518|FG000|STARTED|Extension Study Period|10 participants completed core treatment period but did not enter in extension treatment period.|253
2961449|NCT00751881|3675519|FG001|STARTED|Extension Study Period|8 participants completed core treatment period but did not enter in extension treatment period.|265
2961450|NCT00751881|3675520|FG002|STARTED|Extension Study Period|11 participants completed core treatment period but did not enter in extension treatment period.|233
2961451|NCT00751881|3675518|FG000|COMPLETED|Extension Study Period||188
2961452|NCT00751881|3675519|FG001|COMPLETED|Extension Study Period||194
2961453|NCT00751881|3675520|FG002|COMPLETED|Extension Study Period||167
2961454|NCT00751881|3675518|FG000|NOT COMPLETED|Extension Study Period||65
2961455|NCT00751881|3675519|FG001|NOT COMPLETED|Extension Study Period||71
2961456|NCT00751881|3675520|FG002|NOT COMPLETED|Extension Study Period||66
2961457|NCT00751972|3675536|FG000|STARTED|Overall Study||140
2961458|NCT00751972|3675537|FG001|STARTED|Overall Study||499
2961459|NCT00751972|3675536|FG000|COMPLETED|Overall Study||140
2961460|NCT00751972|3675537|FG001|COMPLETED|Overall Study||499
2961461|NCT00751972|3675536|FG000|NOT COMPLETED|Overall Study||0
2961462|NCT00751972|3675537|FG001|NOT COMPLETED|Overall Study||0
2961463|NCT00751998|3675542|FG000|STARTED|Overall Study||297
2961464|NCT00751998|3675542|FG000|COMPLETED|Overall Study||277
2961465|NCT00751998|3675542|FG000|NOT COMPLETED|Overall Study||20
2961466|NCT00752089|3675546|FG000|STARTED|Overall Study||20
2961467|NCT00752089|3675546|FG000|Received NaF/ KNO3/ 2% Isopentane|Overall Study||19
2961468|NCT00752089|3675546|FG000|Received NaF/KNO3/ 0% Isopentane|Overall Study||17
2961469|NCT00752089|3675546|FG000|Received NaF|Overall Study||18
2961470|NCT00752089|3675546|FG000|Received Placebo|Overall Study||18
2961471|NCT00752089|3675546|FG000|COMPLETED|Overall Study||14
2961472|NCT00752089|3675546|FG000|NOT COMPLETED|Overall Study||6
2961473|NCT00752102|3675559|FG000|STARTED|Overall Study||22
2961474|NCT00752102|3675560|FG001|STARTED|Overall Study||22
2961475|NCT00752102|3675559|FG000|COMPLETED|Overall Study||19
2961476|NCT00752102|3675560|FG001|COMPLETED|Overall Study||21
2961477|NCT00752102|3675559|FG000|NOT COMPLETED|Overall Study||3
2961478|NCT00752102|3675560|FG001|NOT COMPLETED|Overall Study||1
2961479|NCT00752128|3675566|FG000|STARTED|Overall Study||2349
2961480|NCT00752128|3675566|FG000|COMPLETED|Overall Study||2345
2961481|NCT00752128|3675566|FG000|NOT COMPLETED|Overall Study||4
2961482|NCT00752206|3675573|FG000|STARTED|Overall Study||19
2961483|NCT00752206|3675574|FG001|STARTED|Overall Study||19
2961484|NCT00752206|3675573|FG000|COMPLETED|Overall Study||10
2961485|NCT00752206|3675574|FG001|COMPLETED|Overall Study||8
2961486|NCT00752206|3675573|FG000|NOT COMPLETED|Overall Study||9
2961487|NCT00752206|3675574|FG001|NOT COMPLETED|Overall Study||11
2961488|NCT00752219|3675582|FG000|STARTED|Overall Study||102
2961489|NCT00752219|3675583|FG001|STARTED|Overall Study||102
2961490|NCT00752219|3675582|FG000|Treated|Overall Study||101
2961491|NCT00752219|3675583|FG001|Treated|Overall Study||102
2961492|NCT00752219|3675582|FG000|COMPLETED|Overall Study||91
2961493|NCT00752219|3675583|FG001|COMPLETED|Overall Study||96
2961494|NCT00752219|3675582|FG000|NOT COMPLETED|Overall Study||11
2961495|NCT00752219|3675583|FG001|NOT COMPLETED|Overall Study||6
2961496|NCT00752232|3675596|FG000|STARTED|Overall Study||6
2961497|NCT00752232|3675597|FG001|STARTED|Overall Study||6
2961498|NCT00752232|3675598|FG002|STARTED|Overall Study||6
2961499|NCT00752232|3675599|FG003|STARTED|Overall Study||6
2961500|NCT00752232|3675600|FG004|STARTED|Overall Study||6
2961501|NCT00752232|3675601|FG005|STARTED|Overall Study||6
2961502|NCT00752232|3675602|FG006|STARTED|Overall Study||4
2961503|NCT00752232|3675596|FG000|COMPLETED|Overall Study||4
2961504|NCT00752232|3675597|FG001|COMPLETED|Overall Study||6
2961505|NCT00752232|3675598|FG002|COMPLETED|Overall Study||5
2961506|NCT00752232|3675599|FG003|COMPLETED|Overall Study||5
2961507|NCT00752232|3675600|FG004|COMPLETED|Overall Study||3
2961508|NCT00752232|3675601|FG005|COMPLETED|Overall Study||5
2961509|NCT00752232|3675602|FG006|COMPLETED|Overall Study||4
2961510|NCT00752232|3675596|FG000|NOT COMPLETED|Overall Study||2
2961511|NCT00752232|3675597|FG001|NOT COMPLETED|Overall Study||0
2961512|NCT00752232|3675598|FG002|NOT COMPLETED|Overall Study||1
2961513|NCT00752232|3675599|FG003|NOT COMPLETED|Overall Study||1
2961514|NCT00752232|3675600|FG004|NOT COMPLETED|Overall Study||3
2961515|NCT00752232|3675601|FG005|NOT COMPLETED|Overall Study||1
2961516|NCT00752232|3675602|FG006|NOT COMPLETED|Overall Study||0
2961517|NCT00752557|3675622|FG000|STARTED|Overall Study||17
2961518|NCT00752557|3675623|FG001|STARTED|Overall Study||16
2961519|NCT00752557|3675624|FG002|STARTED|Overall Study||17
2961520|NCT00752557|3675622|FG000|COMPLETED|Overall Study||12
2961521|NCT00752557|3675623|FG001|COMPLETED|Overall Study||11
2961522|NCT00752557|3675624|FG002|COMPLETED|Overall Study||11
2961523|NCT00752557|3675622|FG000|NOT COMPLETED|Overall Study||5
2961524|NCT00752557|3675623|FG001|NOT COMPLETED|Overall Study||5
2961525|NCT00752557|3675624|FG002|NOT COMPLETED|Overall Study||6
2961526|NCT00752609|3675636|FG000|STARTED|Overall Study||53
2961527|NCT00752609|3675637|FG001|STARTED|Overall Study||49
2961528|NCT00752609|3675636|FG000|Full Analysis Set|Overall Study|One patient withdrew consent before receiving any study medication.|52
2961529|NCT00752609|3675637|FG001|Full Analysis Set|Overall Study||49
2961530|NCT00752609|3675636|FG000|COMPLETED|Overall Study||44
2961531|NCT00752609|3675637|FG001|COMPLETED|Overall Study||47
2961532|NCT00752609|3675636|FG000|NOT COMPLETED|Overall Study||9
2961533|NCT00752609|3675637|FG001|NOT COMPLETED|Overall Study||2
2961534|NCT00752622|3675646|FG000|STARTED|Induction Phase|The ELIG population comprised of 98 participants|100
2961535|NCT00752622|3675646|FG000|COMPLETED|Induction Phase||65
2961536|NCT00752622|3675646|FG000|NOT COMPLETED|Induction Phase||35
2961537|NCT00752622|3675646|FG000|STARTED|Observational Phase||65
2961538|NCT00752622|3675646|FG000|COMPLETED|Observational Phase|14 completed without loss of response 8 had loss of response & randomized into interventional phase|22
2961539|NCT00752622|3675646|FG000|NOT COMPLETED|Observational Phase||43
2961540|NCT00752622|3675646|FG000|STARTED|Interventional Phase|5 participants randomized into increased dose group and 3 randomized into shortened interval group|8
2961541|NCT00752622|3675646|FG000|COMPLETED|Interventional Phase|8 participants received at least 1 infusion of interventional treatment, but none completed trial|0
2961542|NCT00752622|3675646|FG000|NOT COMPLETED|Interventional Phase||8
2961543|NCT00752726|3675653|FG000|STARTED|Overall Study||65
2961544|NCT00752726|3675654|FG001|STARTED|Overall Study||66
2961545|NCT00752726|3675653|FG000|Safety Population|Overall Study|2 participants were never dosed with the study medication.|63
2961546|NCT00752726|3675654|FG001|Safety Population|Overall Study|2 participants were never dosed with the study medication.|64
2961547|NCT00752726|3675653|FG000|Intention to Treat (ITT) Population|Overall Study|ITT population had atleast 1 post treatment efficacy measurement.|62
2961548|NCT00752726|3675654|FG001|Intention to Treat (ITT) Population|Overall Study|ITT population had atleast 1 post treatment efficacy measurement.|61
2961549|NCT00752726|3675653|FG000|COMPLETED|Overall Study||54
2961550|NCT00752726|3675654|FG001|COMPLETED|Overall Study||53
2961551|NCT00752726|3675653|FG000|NOT COMPLETED|Overall Study||11
2961552|NCT00752726|3675654|FG001|NOT COMPLETED|Overall Study||13
2961553|NCT00752791|3675660|FG000|STARTED|Overall Study||59
2961554|NCT00752791|3675660|FG000|COMPLETED|Overall Study||43
2961555|NCT00752791|3675660|FG000|NOT COMPLETED|Overall Study||16
2961556|NCT00752856|3675666|FG000|STARTED|Overall Study||26
2961557|NCT00752856|3675667|FG001|STARTED|Overall Study||25
2961558|NCT00752856|3675666|FG000|COMPLETED|Overall Study||26
2961559|NCT00752856|3675667|FG001|COMPLETED|Overall Study||24
2961560|NCT00752856|3675666|FG000|NOT COMPLETED|Overall Study||0
2961561|NCT00752856|3675667|FG001|NOT COMPLETED|Overall Study||1
2961562|NCT00752895|3675675|FG000|STARTED|Overall Study||147
2961563|NCT00752895|3675676|FG001|STARTED|Overall Study||146
2961564|NCT00752895|3675675|FG000|COMPLETED|Overall Study||139
2961565|NCT00752895|3675676|FG001|COMPLETED|Overall Study||143
2961566|NCT00752895|3675675|FG000|NOT COMPLETED|Overall Study||8
2961567|NCT00752895|3675676|FG001|NOT COMPLETED|Overall Study||3
2961568|NCT00752908|3675684|FG000|STARTED|Overall Study||14
2961569|NCT00752908|3675685|FG001|STARTED|Overall Study||13
2961570|NCT00752908|3675684|FG000|COMPLETED|Overall Study||14
2961571|NCT00752908|3675685|FG001|COMPLETED|Overall Study||13
2961572|NCT00752908|3675684|FG000|NOT COMPLETED|Overall Study||0
2961573|NCT00752908|3675685|FG001|NOT COMPLETED|Overall Study||0
2961574|NCT00752973|3675691|FG000|STARTED|Overall Study||12
2961575|NCT00752973|3675691|FG000|COMPLETED|Overall Study||12
2961576|NCT00752973|3675691|FG000|NOT COMPLETED|Overall Study||0
2961577|NCT00753012|3675699|FG000|STARTED|Overall Study||15
2961578|NCT00753012|3675700|FG001|STARTED|Overall Study||9
2961579|NCT00753012|3675699|FG000|COMPLETED|Overall Study||7
2961580|NCT00753012|3675700|FG001|COMPLETED|Overall Study||8
2961581|NCT00753012|3675699|FG000|NOT COMPLETED|Overall Study||8
2961582|NCT00753012|3675700|FG001|NOT COMPLETED|Overall Study||1
2961583|NCT00753142|3675710|FG000|STARTED|Overall Study||8
2961584|NCT00753142|3675711|FG001|STARTED|Overall Study||7
2961585|NCT00753142|3675712|FG002|STARTED|Overall Study||13
2961586|NCT00753142|3675710|FG000|COMPLETED|Overall Study||8
2961587|NCT00753142|3675711|FG001|COMPLETED|Overall Study||7
2961588|NCT00753142|3675712|FG002|COMPLETED|Overall Study||13
2961589|NCT00753142|3675710|FG000|NOT COMPLETED|Overall Study||0
2961590|NCT00753142|3675711|FG001|NOT COMPLETED|Overall Study||0
2961591|NCT00753142|3675712|FG002|NOT COMPLETED|Overall Study||0
2961592|NCT00753220|3675720|FG000|STARTED|Overall Study||7
2961593|NCT00753220|3675720|FG000|COMPLETED|Overall Study||2
2961594|NCT00753220|3675720|FG000|NOT COMPLETED|Overall Study||5
2961595|NCT00753272|3675726|FG000|STARTED|Overall Study||21893
2961596|NCT00753272|3675727|FG001|STARTED|Overall Study||21802
3163834|NCT01889602|3891295|FG000|COMPLETED|Third Intervention||15
3163835|NCT01889602|3891296|FG001|COMPLETED|Third Intervention||15
3163836|NCT01889602|3891297|FG002|COMPLETED|Third Intervention||16
3163837|NCT01889602|3891295|FG000|NOT COMPLETED|Third Intervention||3
3163838|NCT01889602|3891296|FG001|NOT COMPLETED|Third Intervention||2
3163839|NCT01889602|3891297|FG002|NOT COMPLETED|Third Intervention||0
3163840|NCT01889602|3891295|FG000|STARTED|Third Washout Period of at Least 2 Weeks||15
3163841|NCT01889602|3891296|FG001|STARTED|Third Washout Period of at Least 2 Weeks||15
3163842|NCT01889602|3891297|FG002|STARTED|Third Washout Period of at Least 2 Weeks||16
3163843|NCT01889602|3891295|FG000|COMPLETED|Third Washout Period of at Least 2 Weeks||15
3163844|NCT01889602|3891296|FG001|COMPLETED|Third Washout Period of at Least 2 Weeks||15
3163845|NCT01889602|3891297|FG002|COMPLETED|Third Washout Period of at Least 2 Weeks||16
2961597|NCT00753272|3675726|FG000|COMPLETED|Overall Study||16911
2961598|NCT00753272|3675727|FG001|COMPLETED|Overall Study||16895
2961599|NCT00753272|3675726|FG000|NOT COMPLETED|Overall Study||4982
2961600|NCT00753272|3675727|FG001|NOT COMPLETED|Overall Study||4907
2961601|NCT00753298|3675738|FG000|STARTED|Overall Study||97
2961602|NCT00753298|3675739|FG001|STARTED|Overall Study||98
2961603|NCT00753298|3675738|FG000|COMPLETED|Overall Study||89
2961604|NCT00753298|3675739|FG001|COMPLETED|Overall Study||94
2961605|NCT00753298|3675738|FG000|NOT COMPLETED|Overall Study||8
2961606|NCT00753298|3675739|FG001|NOT COMPLETED|Overall Study||4
2961607|NCT00753337|3675745|FG000|STARTED|Overall Study||123
3163846|NCT01889602|3891295|FG000|NOT COMPLETED|Third Washout Period of at Least 2 Weeks||0
3163847|NCT01889602|3891296|FG001|NOT COMPLETED|Third Washout Period of at Least 2 Weeks||0
3163848|NCT01889602|3891297|FG002|NOT COMPLETED|Third Washout Period of at Least 2 Weeks||0
2961608|NCT00753337|3675745|FG000|COMPLETED|Overall Study||123
2961609|NCT00753337|3675745|FG000|NOT COMPLETED|Overall Study||0
2961610|NCT00753363|3675752|FG000|STARTED|Overall Study||59
2961611|NCT00753363|3675753|FG001|STARTED|Overall Study||60
2961612|NCT00753363|3675752|FG000|COMPLETED|Overall Study||19
2961613|NCT00753363|3675753|FG001|COMPLETED|Overall Study||21
2961614|NCT00753363|3675752|FG000|NOT COMPLETED|Overall Study||40
2961615|NCT00753363|3675753|FG001|NOT COMPLETED|Overall Study||39
2961616|NCT00753415|3675764|FG000|STARTED|Part A||3
2961617|NCT00753415|3675765|FG001|STARTED|Part A||3
2961618|NCT00753415|3675766|FG002|STARTED|Part A||10
2961619|NCT00753415|3675767|FG003|STARTED|Part A||11
2961620|NCT00753415|3675768|FG004|STARTED|Part A||10
2961621|NCT00753415|3675769|FG005|STARTED|Part A||0
2961622|NCT00753415|3675770|FG006|STARTED|Part A||0
2961623|NCT00753415|3675771|FG007|STARTED|Part A||0
2961624|NCT00753415|3675772|FG008|STARTED|Part A||0
2961625|NCT00753415|3675773|FG009|STARTED|Part A||0
2961626|NCT00753415|3675764|FG000|COMPLETED|Part A||2
2961627|NCT00753415|3675765|FG001|COMPLETED|Part A||3
2961628|NCT00753415|3675766|FG002|COMPLETED|Part A||8
2961629|NCT00753415|3675767|FG003|COMPLETED|Part A||9
2961630|NCT00753415|3675768|FG004|COMPLETED|Part A||10
2961631|NCT00753415|3675769|FG005|COMPLETED|Part A||0
2961632|NCT00753415|3675770|FG006|COMPLETED|Part A||0
2961633|NCT00753415|3675771|FG007|COMPLETED|Part A||0
2961634|NCT00753415|3675772|FG008|COMPLETED|Part A||0
2961635|NCT00753415|3675773|FG009|COMPLETED|Part A||0
2961636|NCT00753415|3675764|FG000|NOT COMPLETED|Part A||1
2961637|NCT00753415|3675765|FG001|NOT COMPLETED|Part A||0
2961638|NCT00753415|3675766|FG002|NOT COMPLETED|Part A||2
2961639|NCT00753415|3675767|FG003|NOT COMPLETED|Part A||2
2961640|NCT00753415|3675768|FG004|NOT COMPLETED|Part A||0
2961641|NCT00753415|3675769|FG005|NOT COMPLETED|Part A||0
2961642|NCT00753415|3675770|FG006|NOT COMPLETED|Part A||0
2961643|NCT00753415|3675771|FG007|NOT COMPLETED|Part A||0
2961644|NCT00753415|3675772|FG008|NOT COMPLETED|Part A||0
2961645|NCT00753415|3675773|FG009|NOT COMPLETED|Part A||0
2961646|NCT00753415|3675764|FG000|STARTED|Part B||0
2961647|NCT00753415|3675765|FG001|STARTED|Part B||0
2961648|NCT00753415|3675766|FG002|STARTED|Part B||0
2961649|NCT00753415|3675767|FG003|STARTED|Part B||0
2961650|NCT00753415|3675768|FG004|STARTED|Part B||0
2961651|NCT00753415|3675769|FG005|STARTED|Part B|Of 2 eligible participants who completed Part A, 1 chose to enter Part B|1
2961652|NCT00753415|3675770|FG006|STARTED|Part B|Of 3 eligible participants who completed Part A, 2 chose to enter Part B|2
2961653|NCT00753415|3675771|FG007|STARTED|Part B|Of 8 eligible participants who completed Part A, 7 chose to enter Part B|7
3035503|NCT01137682|3754716|FG001|Continuing Into Extension|Overall Study||54
2961654|NCT00753415|3675772|FG008|STARTED|Part B|9 participants who completed Part A were eligible and enrolled in Part B|9
2961655|NCT00753415|3675773|FG009|STARTED|Part B|Of 10 eligible participants who completed Part A, 9 chose to enter Part B|9
2961656|NCT00753415|3675764|FG000|COMPLETED|Part B||0
2961657|NCT00753415|3675765|FG001|COMPLETED|Part B||0
2961658|NCT00753415|3675766|FG002|COMPLETED|Part B||0
2961659|NCT00753415|3675767|FG003|COMPLETED|Part B||0
2961660|NCT00753415|3675768|FG004|COMPLETED|Part B||0
2961661|NCT00753415|3675769|FG005|COMPLETED|Part B||1
2961662|NCT00753415|3675770|FG006|COMPLETED|Part B||2
2961663|NCT00753415|3675771|FG007|COMPLETED|Part B||6
2961664|NCT00753415|3675772|FG008|COMPLETED|Part B||6
2961665|NCT00753415|3675773|FG009|COMPLETED|Part B||8
2961666|NCT00753415|3675764|FG000|NOT COMPLETED|Part B||0
2961667|NCT00753415|3675765|FG001|NOT COMPLETED|Part B||0
2961668|NCT00753415|3675766|FG002|NOT COMPLETED|Part B||0
2961669|NCT00753415|3675767|FG003|NOT COMPLETED|Part B||0
2961670|NCT00753415|3675768|FG004|NOT COMPLETED|Part B||0
2961671|NCT00753415|3675769|FG005|NOT COMPLETED|Part B||0
2961672|NCT00753415|3675770|FG006|NOT COMPLETED|Part B||0
2961673|NCT00753415|3675771|FG007|NOT COMPLETED|Part B||1
2961674|NCT00753415|3675772|FG008|NOT COMPLETED|Part B||3
2961675|NCT00753415|3675773|FG009|NOT COMPLETED|Part B||1
2961676|NCT00753454|3675797|FG000|STARTED|Overall Study||168
2961677|NCT00753454|3675797|FG000|COMPLETED|Overall Study||154
2961678|NCT00753454|3675797|FG000|NOT COMPLETED|Overall Study||14
2961679|NCT00753506|3675803|FG000|STARTED|Overall Study||33
2961680|NCT00753506|3675804|FG001|STARTED|Overall Study||33
2961681|NCT00753506|3675803|FG000|COMPLETED|Overall Study||26
2961682|NCT00753506|3675804|FG001|COMPLETED|Overall Study||31
2961683|NCT00753506|3675803|FG000|NOT COMPLETED|Overall Study||7
2961684|NCT00753506|3675804|FG001|NOT COMPLETED|Overall Study||2
2961685|NCT00753519|3675812|FG000|STARTED|Overall Study||13
2961686|NCT00753519|3675813|FG001|STARTED|Overall Study||15
3132922|NCT01693562|3858013|FG004|NOT COMPLETED|Exploration Phase||0
3132923|NCT01693562|3858014|FG005|NOT COMPLETED|Exploration Phase||0
3132924|NCT01693562|3858015|FG006|NOT COMPLETED|Exploration Phase||21
3132925|NCT01693562|3858016|FG007|NOT COMPLETED|Exploration Phase||0
3132926|NCT01693562|3858017|FG008|NOT COMPLETED|Exploration Phase||0
3132927|NCT01693562|3858018|FG009|NOT COMPLETED|Exploration Phase||0
3132928|NCT01693562|3858019|FG010|NOT COMPLETED|Exploration Phase||0
3132929|NCT01693562|3858020|FG011|NOT COMPLETED|Exploration Phase||0
3132930|NCT01693562|3858021|FG012|NOT COMPLETED|Exploration Phase||0
3132931|NCT01693562|3858022|FG013|NOT COMPLETED|Exploration Phase||0
3132932|NCT01693562|3858023|FG014|NOT COMPLETED|Exploration Phase||0
3132933|NCT01693562|3858024|FG015|NOT COMPLETED|Exploration Phase||0
3132934|NCT01693562|3858025|FG016|NOT COMPLETED|Exploration Phase||0
3132935|NCT01693562|3858026|FG017|NOT COMPLETED|Exploration Phase||0
3132936|NCT01693562|3858027|FG018|NOT COMPLETED|Exploration Phase||0
3132937|NCT01693562|3858028|FG019|NOT COMPLETED|Exploration Phase||0
3132938|NCT01693562|3858029|FG020|NOT COMPLETED|Exploration Phase||0
3132939|NCT01693562|3858030|FG021|NOT COMPLETED|Exploration Phase||0
3132940|NCT01693562|3858031|FG022|NOT COMPLETED|Exploration Phase||0
3132941|NCT01693562|3858009|FG000|STARTED|Expansion Phase||0
3132942|NCT01693562|3858010|FG001|STARTED|Expansion Phase||0
3132943|NCT01693562|3858011|FG002|STARTED|Expansion Phase||0
3132944|NCT01693562|3858012|FG003|STARTED|Expansion Phase||0
3132945|NCT01693562|3858013|FG004|STARTED|Expansion Phase||0
3132946|NCT01693562|3858014|FG005|STARTED|Expansion Phase||0
3132947|NCT01693562|3858015|FG006|STARTED|Expansion Phase||0
3132948|NCT01693562|3858016|FG007|STARTED|Expansion Phase||62
3132949|NCT01693562|3858017|FG008|STARTED|Expansion Phase||22
3132950|NCT01693562|3858018|FG009|STARTED|Expansion Phase|2 eligible NSCLC participants from dose-escalation were added to the dose expansion summaries.|304
3132951|NCT01693562|3858019|FG010|STARTED|Expansion Phase||40
3132952|NCT01693562|3858020|FG011|STARTED|Expansion Phase||21
3132953|NCT01693562|3858021|FG012|STARTED|Expansion Phase||24
3132954|NCT01693562|3858022|FG013|STARTED|Expansion Phase||51
3132955|NCT01693562|3858023|FG014|STARTED|Expansion Phase||40
3132956|NCT01693562|3858024|FG015|STARTED|Expansion Phase||31
3132957|NCT01693562|3858025|FG016|STARTED|Expansion Phase||201
3132958|NCT01693562|3858026|FG017|STARTED|Expansion Phase||20
3132959|NCT01693562|3858027|FG018|STARTED|Expansion Phase||47
3132960|NCT01693562|3858028|FG019|STARTED|Expansion Phase||20
3132961|NCT01693562|3858029|FG020|STARTED|Expansion Phase||21
3132962|NCT01693562|3858030|FG021|STARTED|Expansion Phase||62
3132963|NCT01693562|3858031|FG022|STARTED|Expansion Phase||10
3132964|NCT01693562|3858009|FG000|COMPLETED|Expansion Phase||0
3132965|NCT01693562|3858010|FG001|COMPLETED|Expansion Phase||0
3132966|NCT01693562|3858011|FG002|COMPLETED|Expansion Phase||0
3132967|NCT01693562|3858012|FG003|COMPLETED|Expansion Phase||0
3132968|NCT01693562|3858013|FG004|COMPLETED|Expansion Phase||0
3132969|NCT01693562|3858014|FG005|COMPLETED|Expansion Phase||0
3132970|NCT01693562|3858015|FG006|COMPLETED|Expansion Phase||0
3132971|NCT01693562|3858016|FG007|COMPLETED|Expansion Phase||0
3132972|NCT01693562|3858017|FG008|COMPLETED|Expansion Phase||0
3132973|NCT01693562|3858018|FG009|COMPLETED|Expansion Phase||4
2961687|NCT00753519|3675812|FG000|COMPLETED|Overall Study||13
2961688|NCT00753519|3675813|FG001|COMPLETED|Overall Study||13
3132974|NCT01693562|3858019|FG010|COMPLETED|Expansion Phase||0
3132975|NCT01693562|3858020|FG011|COMPLETED|Expansion Phase||0
3132976|NCT01693562|3858021|FG012|COMPLETED|Expansion Phase||1
2961689|NCT00753519|3675812|FG000|NOT COMPLETED|Overall Study||0
2961690|NCT00753519|3675813|FG001|NOT COMPLETED|Overall Study||2
2961691|NCT00753545|3675823|FG000|STARTED|Overall Study|Patients randomized|136
2961692|NCT00753545|3675824|FG001|STARTED|Overall Study|Patients randomized|129
2961693|NCT00753545|3675823|FG000|COMPLETED|Overall Study|Patients completing the Study|28
2961694|NCT00753545|3675824|FG001|COMPLETED|Overall Study|Patients completing the Study|11
2961695|NCT00753545|3675823|FG000|NOT COMPLETED|Overall Study||108
2961696|NCT00753545|3675824|FG001|NOT COMPLETED|Overall Study||118
2961697|NCT00753623|3675832|FG000|STARTED|Phase I (14 Days)||11
2961698|NCT00753623|3675833|FG001|STARTED|Phase I (14 Days)||12
2961699|NCT00753623|3675832|FG000|COMPLETED|Phase I (14 Days)||9
2961700|NCT00753623|3675833|FG001|COMPLETED|Phase I (14 Days)||8
2961701|NCT00753623|3675832|FG000|NOT COMPLETED|Phase I (14 Days)||2
2961702|NCT00753623|3675833|FG001|NOT COMPLETED|Phase I (14 Days)||4
2961703|NCT00753623|3675832|FG000|STARTED|Washout (7 Days)||9
2961704|NCT00753623|3675833|FG001|STARTED|Washout (7 Days)||8
2961705|NCT00753623|3675832|FG000|COMPLETED|Washout (7 Days)||8
2961706|NCT00753623|3675833|FG001|COMPLETED|Washout (7 Days)||8
2961707|NCT00753623|3675832|FG000|NOT COMPLETED|Washout (7 Days)||1
2961708|NCT00753623|3675833|FG001|NOT COMPLETED|Washout (7 Days)||0
2961709|NCT00753623|3675832|FG000|STARTED|Phase II (14 Days)||8
2961710|NCT00753623|3675833|FG001|STARTED|Phase II (14 Days)||8
2961711|NCT00753623|3675832|FG000|COMPLETED|Phase II (14 Days)||8
2961712|NCT00753623|3675833|FG001|COMPLETED|Phase II (14 Days)||7
2961713|NCT00753623|3675832|FG000|NOT COMPLETED|Phase II (14 Days)||0
2961714|NCT00753623|3675833|FG001|NOT COMPLETED|Phase II (14 Days)||1
2961715|NCT00753636|3675839|FG000|STARTED|Overall Study||31
2961716|NCT00753636|3675839|FG000|COMPLETED|Overall Study||25
2961717|NCT00753636|3675839|FG000|NOT COMPLETED|Overall Study||6
2961718|NCT00753649|3675845|FG000|STARTED|Overall Study||112
3132977|NCT01693562|3858022|FG013|COMPLETED|Expansion Phase||0
3132978|NCT01693562|3858023|FG014|COMPLETED|Expansion Phase||0
3132979|NCT01693562|3858024|FG015|COMPLETED|Expansion Phase||0
3132980|NCT01693562|3858025|FG016|COMPLETED|Expansion Phase||4
3132981|NCT01693562|3858026|FG017|COMPLETED|Expansion Phase||0
3132982|NCT01693562|3858027|FG018|COMPLETED|Expansion Phase||0
3132983|NCT01693562|3858028|FG019|COMPLETED|Expansion Phase||0
3132984|NCT01693562|3858029|FG020|COMPLETED|Expansion Phase||0
2961719|NCT00753649|3675846|FG001|STARTED|Overall Study||112
2961720|NCT00753649|3675845|FG000|COMPLETED|Overall Study||105
2961721|NCT00753649|3675846|FG001|COMPLETED|Overall Study||112
2961722|NCT00753649|3675845|FG000|NOT COMPLETED|Overall Study||7
2961723|NCT00753649|3675846|FG001|NOT COMPLETED|Overall Study||0
2961724|NCT00753675|3675855|FG000|STARTED|Overall Study||59
2961725|NCT00753675|3675856|FG001|STARTED|Overall Study||59
2961726|NCT00753675|3675857|FG002|STARTED|Overall Study||56
2961727|NCT00753675|3675855|FG000|COMPLETED|Overall Study||0
2961728|NCT00753675|3675856|FG001|COMPLETED|Overall Study||0
2961729|NCT00753675|3675857|FG002|COMPLETED|Overall Study||0
2961730|NCT00753675|3675855|FG000|NOT COMPLETED|Overall Study||59
2961731|NCT00753675|3675856|FG001|NOT COMPLETED|Overall Study||59
2961732|NCT00753675|3675857|FG002|NOT COMPLETED|Overall Study||56
2961733|NCT00753688|3675867|FG000|STARTED|Overall Study||123
2961734|NCT00753688|3675868|FG001|STARTED|Overall Study||246
2961735|NCT00753688|3675867|FG000|Ongoing - in Follow-up|Overall Study||15
2961736|NCT00753688|3675868|FG001|Ongoing - in Follow-up|Overall Study||31
2961737|NCT00753688|3675867|FG000|COMPLETED|Overall Study||0
2961738|NCT00753688|3675868|FG001|COMPLETED|Overall Study||0
2961739|NCT00753688|3675867|FG000|NOT COMPLETED|Overall Study||123
2961740|NCT00753688|3675868|FG001|NOT COMPLETED|Overall Study||246
2961741|NCT00753714|3675876|FG000|STARTED|Overall Study||61
2961742|NCT00753714|3675877|FG001|STARTED|Overall Study||63
2961743|NCT00753714|3675876|FG000|COMPLETED|Overall Study||1
2961744|NCT00753714|3675877|FG001|COMPLETED|Overall Study||1
2961745|NCT00753714|3675876|FG000|NOT COMPLETED|Overall Study||60
2961746|NCT00753714|3675877|FG001|NOT COMPLETED|Overall Study||62
2961747|NCT00753766|3675888|FG000|STARTED|Overall Study||1
2961748|NCT00753766|3675889|FG001|STARTED|Overall Study||0
2961749|NCT00753766|3675888|FG000|COMPLETED|Overall Study||0
2961750|NCT00753766|3675889|FG001|COMPLETED|Overall Study||0
2961751|NCT00753766|3675888|FG000|NOT COMPLETED|Overall Study||1
2961752|NCT00753766|3675889|FG001|NOT COMPLETED|Overall Study||0
2961753|NCT00753896|3675896|FG000|STARTED|Overall Study||134
2961754|NCT00753896|3675896|FG000|COMPLETED|Overall Study||118
2961755|NCT00753896|3675896|FG000|NOT COMPLETED|Overall Study||16
2961756|NCT00753922|3675904|FG000|STARTED|Overall Study||552
2961757|NCT00753922|3675905|FG001|STARTED|Overall Study||251
2961758|NCT00753922|3675906|FG002|STARTED|Overall Study||145
2961759|NCT00753922|3675907|FG003|STARTED|Overall Study||60
2961760|NCT00753922|3675904|FG000|COMPLETED|Overall Study||306
2961761|NCT00753922|3675905|FG001|COMPLETED|Overall Study||157
2961762|NCT00753922|3675906|FG002|COMPLETED|Overall Study||82
2961763|NCT00753922|3675907|FG003|COMPLETED|Overall Study||37
2961764|NCT00753922|3675904|FG000|NOT COMPLETED|Overall Study||246
2961765|NCT00753922|3675905|FG001|NOT COMPLETED|Overall Study||94
2961766|NCT00753922|3675906|FG002|NOT COMPLETED|Overall Study||63
2961767|NCT00753922|3675907|FG003|NOT COMPLETED|Overall Study||23
2961768|NCT00753935|3675919|FG000|STARTED|Overall Study||45
3132985|NCT01693562|3858030|FG021|COMPLETED|Expansion Phase||0
3132986|NCT01693562|3858031|FG022|COMPLETED|Expansion Phase||0
3132987|NCT01693562|3858009|FG000|NOT COMPLETED|Expansion Phase||0
3132988|NCT01693562|3858010|FG001|NOT COMPLETED|Expansion Phase||0
2961769|NCT00753935|3675920|FG001|STARTED|Overall Study||47
2961770|NCT00753935|3675919|FG000|COMPLETED|Overall Study||45
2961771|NCT00753935|3675920|FG001|COMPLETED|Overall Study||47
2961772|NCT00753935|3675919|FG000|NOT COMPLETED|Overall Study||0
2961773|NCT00753935|3675920|FG001|NOT COMPLETED|Overall Study||0
2961774|NCT00753948|3675929|FG000|STARTED|Overall Study||9
2961775|NCT00753948|3675930|FG001|STARTED|Overall Study||7
2961776|NCT00753948|3675931|FG002|STARTED|Overall Study||7
2961777|NCT00753948|3675929|FG000|COMPLETED|Overall Study||9
2961778|NCT00753948|3675930|FG001|COMPLETED|Overall Study||7
2961779|NCT00753948|3675931|FG002|COMPLETED|Overall Study||7
2961780|NCT00753948|3675929|FG000|NOT COMPLETED|Overall Study||0
2961781|NCT00753948|3675930|FG001|NOT COMPLETED|Overall Study||0
2961782|NCT00753948|3675931|FG002|NOT COMPLETED|Overall Study||0
2961783|NCT00754065|3675941|FG000|STARTED|Overall Study||203
2961784|NCT00754065|3675942|FG001|STARTED|Overall Study||206
2961785|NCT00754065|3675941|FG000|Participants Received Treatment|Overall Study||191
2961786|NCT00754065|3675942|FG001|Participants Received Treatment|Overall Study||204
2961787|NCT00754065|3675941|FG000|Cycle 6|Overall Study||141
2961788|NCT00754065|3675942|FG001|Cycle 6|Overall Study||153
2961789|NCT00754065|3675941|FG000|COMPLETED|Overall Study||122
2961790|NCT00754065|3675942|FG001|COMPLETED|Overall Study||126
2961791|NCT00754065|3675941|FG000|NOT COMPLETED|Overall Study||81
2961792|NCT00754065|3675942|FG001|NOT COMPLETED|Overall Study||80
2961793|NCT00754130|3675954|FG000|STARTED|Period 1 (5 Days)||2
2961794|NCT00754130|3675955|FG001|STARTED|Period 1 (5 Days)||2
2961795|NCT00754130|3675956|FG002|STARTED|Period 1 (5 Days)||4
2961796|NCT00754130|3675957|FG003|STARTED|Period 1 (5 Days)||2
2961797|NCT00754130|3675958|FG004|STARTED|Period 1 (5 Days)||2
2961798|NCT00754130|3675959|FG005|STARTED|Period 1 (5 Days)|One participant received MK-0941 10 mg in both Periods 1 and 2.|4
2961799|NCT00754130|3675954|FG000|COMPLETED|Period 1 (5 Days)||2
2961800|NCT00754130|3675955|FG001|COMPLETED|Period 1 (5 Days)||2
2961801|NCT00754130|3675956|FG002|COMPLETED|Period 1 (5 Days)||4
2961802|NCT00754130|3675957|FG003|COMPLETED|Period 1 (5 Days)||2
2961803|NCT00754130|3675958|FG004|COMPLETED|Period 1 (5 Days)||2
2961804|NCT00754130|3675959|FG005|COMPLETED|Period 1 (5 Days)||4
2961805|NCT00754130|3675954|FG000|NOT COMPLETED|Period 1 (5 Days)||0
2961806|NCT00754130|3675955|FG001|NOT COMPLETED|Period 1 (5 Days)||0
2961807|NCT00754130|3675956|FG002|NOT COMPLETED|Period 1 (5 Days)||0
3301682|NCT02954601|4035333|FG001|NOT COMPLETED|First Intervention (Five Days)||0
3301683|NCT02954601|4035334|FG002|NOT COMPLETED|First Intervention (Five Days)||1
3301684|NCT02954601|4035335|FG003|NOT COMPLETED|First Intervention (Five Days)||0
3301685|NCT02954601|4035332|FG000|STARTED|Second Intervention (Five Days)||11
3301686|NCT02954601|4035333|FG001|STARTED|Second Intervention (Five Days)||6
3301687|NCT02954601|4035334|FG002|STARTED|Second Intervention (Five Days)||8
3301688|NCT02954601|4035335|FG003|STARTED|Second Intervention (Five Days)||6
3301689|NCT02954601|4035332|FG000|COMPLETED|Second Intervention (Five Days)||11
3301690|NCT02954601|4035333|FG001|COMPLETED|Second Intervention (Five Days)||6
3301691|NCT02954601|4035334|FG002|COMPLETED|Second Intervention (Five Days)||8
3301692|NCT02954601|4035335|FG003|COMPLETED|Second Intervention (Five Days)||6
3301693|NCT02954601|4035332|FG000|NOT COMPLETED|Second Intervention (Five Days)||0
2961808|NCT00754130|3675957|FG003|NOT COMPLETED|Period 1 (5 Days)||0
2961809|NCT00754130|3675958|FG004|NOT COMPLETED|Period 1 (5 Days)||0
2961810|NCT00754130|3675959|FG005|NOT COMPLETED|Period 1 (5 Days)||0
2961811|NCT00754130|3675954|FG000|STARTED|Washout Period (>=8 Days)||2
2961812|NCT00754130|3675955|FG001|STARTED|Washout Period (>=8 Days)||2
2961813|NCT00754130|3675956|FG002|STARTED|Washout Period (>=8 Days)||4
2961814|NCT00754130|3675957|FG003|STARTED|Washout Period (>=8 Days)||2
2961815|NCT00754130|3675958|FG004|STARTED|Washout Period (>=8 Days)||2
2961816|NCT00754130|3675959|FG005|STARTED|Washout Period (>=8 Days)||4
2961817|NCT00754130|3675954|FG000|COMPLETED|Washout Period (>=8 Days)||2
2961818|NCT00754130|3675955|FG001|COMPLETED|Washout Period (>=8 Days)||2
2961819|NCT00754130|3675956|FG002|COMPLETED|Washout Period (>=8 Days)||4
2961820|NCT00754130|3675957|FG003|COMPLETED|Washout Period (>=8 Days)||2
2961821|NCT00754130|3675958|FG004|COMPLETED|Washout Period (>=8 Days)||2
2961822|NCT00754130|3675959|FG005|COMPLETED|Washout Period (>=8 Days)||4
2961823|NCT00754130|3675954|FG000|NOT COMPLETED|Washout Period (>=8 Days)||0
2961824|NCT00754130|3675955|FG001|NOT COMPLETED|Washout Period (>=8 Days)||0
2961825|NCT00754130|3675956|FG002|NOT COMPLETED|Washout Period (>=8 Days)||0
2961826|NCT00754130|3675957|FG003|NOT COMPLETED|Washout Period (>=8 Days)||0
2961827|NCT00754130|3675958|FG004|NOT COMPLETED|Washout Period (>=8 Days)||0
2961828|NCT00754130|3675959|FG005|NOT COMPLETED|Washout Period (>=8 Days)||0
2961829|NCT00754130|3675954|FG000|STARTED|Period 2 (5 Days)|One participant received MK-0941 15 mg starting with Dose 2 on Day 2.|2
2961830|NCT00754130|3675955|FG001|STARTED|Period 2 (5 Days)||2
2961831|NCT00754130|3675956|FG002|STARTED|Period 2 (5 Days)||4
2961832|NCT00754130|3675957|FG003|STARTED|Period 2 (5 Days)||2
2961833|NCT00754130|3675958|FG004|STARTED|Period 2 (5 Days)||2
2961834|NCT00754130|3675959|FG005|STARTED|Period 2 (5 Days)|One participant received MK-0941 35 mg starting with Dose 3 on Day 3.|4
2961835|NCT00754130|3675954|FG000|COMPLETED|Period 2 (5 Days)||2
2961836|NCT00754130|3675955|FG001|COMPLETED|Period 2 (5 Days)||2
2961837|NCT00754130|3675956|FG002|COMPLETED|Period 2 (5 Days)||4
2961838|NCT00754130|3675957|FG003|COMPLETED|Period 2 (5 Days)||2
2961839|NCT00754130|3675958|FG004|COMPLETED|Period 2 (5 Days)||2
2961840|NCT00754130|3675959|FG005|COMPLETED|Period 2 (5 Days)||4
2961841|NCT00754130|3675954|FG000|NOT COMPLETED|Period 2 (5 Days)||0
2961842|NCT00754130|3675955|FG001|NOT COMPLETED|Period 2 (5 Days)||0
2961843|NCT00754130|3675956|FG002|NOT COMPLETED|Period 2 (5 Days)||0
2961844|NCT00754130|3675957|FG003|NOT COMPLETED|Period 2 (5 Days)||0
2961845|NCT00754130|3675958|FG004|NOT COMPLETED|Period 2 (5 Days)||0
2961846|NCT00754130|3675959|FG005|NOT COMPLETED|Period 2 (5 Days)||0
2961847|NCT00754156|3675977|FG000|STARTED|Overall Study||8
2961848|NCT00754156|3675978|FG001|STARTED|Overall Study||6
2961849|NCT00754156|3675977|FG000|COMPLETED|Overall Study||8
2961850|NCT00754156|3675978|FG001|COMPLETED|Overall Study||6
2961851|NCT00754156|3675977|FG000|NOT COMPLETED|Overall Study||0
2961852|NCT00754156|3675978|FG001|NOT COMPLETED|Overall Study||0
2961853|NCT00754208|3675990|FG000|STARTED|Overall Study||7
2961854|NCT00754208|3675990|FG000|COMPLETED|Overall Study||7
2961855|NCT00754208|3675990|FG000|NOT COMPLETED|Overall Study||0
2961856|NCT00754234|3675995|FG000|STARTED|Overall Study|7 Menus were consumed in randomized order|16
2961857|NCT00754234|3675995|FG000|COMPLETED|Overall Study|2 participants did not receive the Day 1,4,5,6 menu and 1 did not receive the Day 2 menu|13
2961858|NCT00754234|3675995|FG000|NOT COMPLETED|Overall Study||3
2961859|NCT00754247|3676002|FG000|STARTED|Overall Study||10
2961860|NCT00754247|3676003|FG001|STARTED|Overall Study||10
2961861|NCT00754247|3676004|FG002|STARTED|Overall Study||10
2961862|NCT00754247|3676002|FG000|COMPLETED|Overall Study||5
2961863|NCT00754247|3676003|FG001|COMPLETED|Overall Study||5
2961864|NCT00754247|3676004|FG002|COMPLETED|Overall Study||5
2961865|NCT00754247|3676002|FG000|NOT COMPLETED|Overall Study||5
2961866|NCT00754247|3676003|FG001|NOT COMPLETED|Overall Study||5
2961867|NCT00754247|3676004|FG002|NOT COMPLETED|Overall Study||5
2961868|NCT00754325|3676014|FG000|STARTED|Initial Treatment||50
2961869|NCT00754325|3676015|FG001|STARTED|Initial Treatment||49
2961870|NCT00754325|3676014|FG000|COMPLETED|Initial Treatment||0
2961871|NCT00754325|3676015|FG001|COMPLETED|Initial Treatment||0
2961872|NCT00754325|3676014|FG000|NOT COMPLETED|Initial Treatment||50
2961873|NCT00754325|3676015|FG001|NOT COMPLETED|Initial Treatment||49
2961874|NCT00754325|3676014|FG000|STARTED|Progression and Cross-over|Arm 1 participants with dasatinib-related toxicity stop dasatinib, continue fulvestrant (Arm 1b).|0
2961875|NCT00754325|3676015|FG001|STARTED|Progression and Cross-over|Progressive disease participants in Arm 2 could add dasatinib (Arm 2b) at investigator discretion.|21
2961876|NCT00754325|3676014|FG000|COMPLETED|Progression and Cross-over||0
2961877|NCT00754325|3676015|FG001|COMPLETED|Progression and Cross-over||0
2961878|NCT00754325|3676014|FG000|NOT COMPLETED|Progression and Cross-over||0
2961879|NCT00754325|3676015|FG001|NOT COMPLETED|Progression and Cross-over||21
2961880|NCT00754338|3676026|FG000|STARTED|First Intervention for Phase1&Phase2||17
2961881|NCT00754338|3676027|FG001|STARTED|First Intervention for Phase1&Phase2||21
2961882|NCT00754338|3676028|FG002|STARTED|First Intervention for Phase1&Phase2||19
2961883|NCT00754338|3676029|FG003|STARTED|First Intervention for Phase1&Phase2||19
2961884|NCT00754338|3676026|FG000|COMPLETED|First Intervention for Phase1&Phase2||17
2961885|NCT00754338|3676027|FG001|COMPLETED|First Intervention for Phase1&Phase2||18
2961886|NCT00754338|3676028|FG002|COMPLETED|First Intervention for Phase1&Phase2||16
2961887|NCT00754338|3676029|FG003|COMPLETED|First Intervention for Phase1&Phase2||19
2961888|NCT00754338|3676026|FG000|NOT COMPLETED|First Intervention for Phase1&Phase2||0
2961889|NCT00754338|3676027|FG001|NOT COMPLETED|First Intervention for Phase1&Phase2||3
2961890|NCT00754338|3676028|FG002|NOT COMPLETED|First Intervention for Phase1&Phase2||3
2961891|NCT00754338|3676029|FG003|NOT COMPLETED|First Intervention for Phase1&Phase2||0
2961892|NCT00754338|3676026|FG000|STARTED|Second Intervention for Phase1&Phase2||17
2961893|NCT00754338|3676027|FG001|STARTED|Second Intervention for Phase1&Phase2||18
2961894|NCT00754338|3676028|FG002|STARTED|Second Intervention for Phase1&Phase2||16
2961895|NCT00754338|3676029|FG003|STARTED|Second Intervention for Phase1&Phase2||19
2961896|NCT00754338|3676026|FG000|COMPLETED|Second Intervention for Phase1&Phase2||17
2961897|NCT00754338|3676027|FG001|COMPLETED|Second Intervention for Phase1&Phase2||17
3163849|NCT01889667|3891316|FG000|STARTED|Overall Study||10
3163850|NCT01889667|3891317|FG001|STARTED|Overall Study||10
3163851|NCT01889667|3891318|FG002|STARTED|Overall Study||10
3163852|NCT01889667|3891316|FG000|COMPLETED|Overall Study||10
3163853|NCT01889667|3891317|FG001|COMPLETED|Overall Study||10
3163854|NCT01889667|3891318|FG002|COMPLETED|Overall Study||10
2961898|NCT00754338|3676028|FG002|COMPLETED|Second Intervention for Phase1&Phase2||16
2961899|NCT00754338|3676029|FG003|COMPLETED|Second Intervention for Phase1&Phase2||18
2961900|NCT00754338|3676026|FG000|NOT COMPLETED|Second Intervention for Phase1&Phase2||0
2961901|NCT00754338|3676027|FG001|NOT COMPLETED|Second Intervention for Phase1&Phase2||1
2961902|NCT00754338|3676028|FG002|NOT COMPLETED|Second Intervention for Phase1&Phase2||0
2961903|NCT00754338|3676029|FG003|NOT COMPLETED|Second Intervention for Phase1&Phase2||1
2961904|NCT00754377|3676043|FG000|STARTED|Overall Study||50
2961905|NCT00754377|3676044|FG001|STARTED|Overall Study||42
2961906|NCT00754377|3676043|FG000|COMPLETED|Overall Study||50
2961907|NCT00754377|3676044|FG001|COMPLETED|Overall Study||42
2961908|NCT00754377|3676043|FG000|NOT COMPLETED|Overall Study||0
2961909|NCT00754377|3676044|FG001|NOT COMPLETED|Overall Study||0
3301694|NCT02954601|4035333|FG001|NOT COMPLETED|Second Intervention (Five Days)||0
3301695|NCT02954601|4035334|FG002|NOT COMPLETED|Second Intervention (Five Days)||0
3301696|NCT02954601|4035335|FG003|NOT COMPLETED|Second Intervention (Five Days)||0
3301697|NCT02954601|4035332|FG000|STARTED|Third Intervention (Five Days)||9
3301698|NCT02954601|4035333|FG001|STARTED|Third Intervention (Five Days)||8
2961910|NCT00754390|3676052|FG000|STARTED|Ca/Phytate Test Meal 1 (Randomized)||17
2961911|NCT00754390|3676052|FG000|COMPLETED|Ca/Phytate Test Meal 1 (Randomized)||12
2961912|NCT00754390|3676052|FG000|NOT COMPLETED|Ca/Phytate Test Meal 1 (Randomized)||5
2961913|NCT00754390|3676052|FG000|STARTED|Ca/Phytate Test Meal 2 (Randomized)||12
2961914|NCT00754390|3676052|FG000|COMPLETED|Ca/Phytate Test Meal 2 (Randomized)||12
2961915|NCT00754390|3676052|FG000|NOT COMPLETED|Ca/Phytate Test Meal 2 (Randomized)||0
2961916|NCT00754390|3676052|FG000|STARTED|Ca/Phytate Test Meal 3 (Randomized)||12
2961917|NCT00754390|3676052|FG000|COMPLETED|Ca/Phytate Test Meal 3 (Randomized)||11
2961918|NCT00754390|3676052|FG000|NOT COMPLETED|Ca/Phytate Test Meal 3 (Randomized)||1
2961919|NCT00754390|3676052|FG000|STARTED|Ca/Phytate Test Meal 4 (Randomized)||11
2961920|NCT00754390|3676052|FG000|COMPLETED|Ca/Phytate Test Meal 4 (Randomized)||10
2961921|NCT00754390|3676052|FG000|NOT COMPLETED|Ca/Phytate Test Meal 4 (Randomized)||1
2961922|NCT00754442|3676061|FG000|STARTED|Overall Study|controls 11|11
2961923|NCT00754442|3676062|FG001|STARTED|Overall Study|patients 9|9
2961924|NCT00754442|3676061|FG000|COMPLETED|Overall Study||6
2961925|NCT00754442|3676062|FG001|COMPLETED|Overall Study||6
2961926|NCT00754442|3676061|FG000|NOT COMPLETED|Overall Study||5
2961927|NCT00754442|3676062|FG001|NOT COMPLETED|Overall Study||3
2961928|NCT00754468|3676071|FG000|STARTED|Overall Study||4
2961929|NCT00754468|3676072|FG001|STARTED|Overall Study||3
2961930|NCT00754468|3676071|FG000|COMPLETED|Overall Study||4
2961931|NCT00754468|3676072|FG001|COMPLETED|Overall Study||3
2961932|NCT00754468|3676071|FG000|NOT COMPLETED|Overall Study||0
2961933|NCT00754468|3676072|FG001|NOT COMPLETED|Overall Study||0
2961934|NCT00754494|3676083|FG000|STARTED|Overall Study||15
2961935|NCT00754494|3676084|FG001|STARTED|Overall Study||15
2961936|NCT00754494|3676085|FG002|STARTED|Overall Study||15
2961937|NCT00754494|3676083|FG000|COMPLETED|Overall Study||13
2961938|NCT00754494|3676084|FG001|COMPLETED|Overall Study||15
2961939|NCT00754494|3676085|FG002|COMPLETED|Overall Study||14
2961940|NCT00754494|3676083|FG000|NOT COMPLETED|Overall Study||2
2961941|NCT00754494|3676084|FG001|NOT COMPLETED|Overall Study||0
2961942|NCT00754494|3676085|FG002|NOT COMPLETED|Overall Study||1
2961943|NCT00754546|3676093|FG000|STARTED|Overall Study||20
2961944|NCT00754546|3676093|FG000|COMPLETED|Overall Study||20
2961945|NCT00754546|3676093|FG000|NOT COMPLETED|Overall Study||0
2961946|NCT00754559|3676103|FG000|STARTED|Overall Study||286
2961947|NCT00754559|3676103|FG000|COMPLETED|Overall Study||239
2961948|NCT00754559|3676103|FG000|NOT COMPLETED|Overall Study||47
2961949|NCT00754572|3676110|FG000|STARTED|Overall Study||418
2961950|NCT00754572|3676110|FG000|COMPLETED|Overall Study||347
2961951|NCT00754572|3676110|FG000|NOT COMPLETED|Overall Study||71
2961952|NCT00754624|3676114|FG000|STARTED|Overall Study||229
2961953|NCT00754624|3676114|FG000|COMPLETED|Overall Study||160
2961954|NCT00754624|3676114|FG000|NOT COMPLETED|Overall Study||69
2961955|NCT00754650|3676118|FG000|STARTED|Overall Study||2
2961956|NCT00754650|3676118|FG000|COMPLETED|Overall Study||0
3301699|NCT02954601|4035334|FG002|STARTED|Third Intervention (Five Days)||6
3301700|NCT02954601|4035335|FG003|STARTED|Third Intervention (Five Days)||8
3301701|NCT02954601|4035332|FG000|COMPLETED|Third Intervention (Five Days)||9
3301702|NCT02954601|4035333|FG001|COMPLETED|Third Intervention (Five Days)||8
2961957|NCT00754650|3676118|FG000|NOT COMPLETED|Overall Study||2
2961958|NCT00754741|3676125|FG000|STARTED|Overall Study||567
2961959|NCT00754741|3676126|FG001|STARTED|Overall Study||569
2961960|NCT00754741|3676127|FG002|STARTED|Overall Study||556
2961961|NCT00754741|3676125|FG000|COMPLETED|Overall Study||510
2961962|NCT00754741|3676126|FG001|COMPLETED|Overall Study||500
2961963|NCT00754741|3676127|FG002|COMPLETED|Overall Study||502
2961964|NCT00754741|3676125|FG000|NOT COMPLETED|Overall Study||57
2961965|NCT00754741|3676126|FG001|NOT COMPLETED|Overall Study||69
2961966|NCT00754741|3676127|FG002|NOT COMPLETED|Overall Study||54
3035504|NCT01137682|3754717|FG002|Continuing Into Extension|Overall Study||63
3035505|NCT01137682|3754715|FG000|Safety Set - CORE|Overall Study|2 patients never received drug.|63
3035506|NCT01137682|3754716|FG001|Safety Set - CORE|Overall Study|2 patients never received drug. 1 patient had no post baseline safety assement.|62
3035507|NCT01137682|3754717|FG002|Safety Set - CORE|Overall Study|2 patients never received drug.|66
3035508|NCT01137682|3754715|FG000|Safety Set - Extension|Overall Study||57
3035509|NCT01137682|3754716|FG001|Safety Set - Extension|Overall Study||54
3035510|NCT01137682|3754717|FG002|Safety Set - Extension|Overall Study|1 patient did not receive study treatment|62
3035511|NCT01137682|3754715|FG000|COMPLETED|Overall Study||28
3035512|NCT01137682|3754716|FG001|COMPLETED|Overall Study||25
3035513|NCT01137682|3754717|FG002|COMPLETED|Overall Study||34
3035514|NCT01137682|3754715|FG000|NOT COMPLETED|Overall Study||37
3035515|NCT01137682|3754716|FG001|NOT COMPLETED|Overall Study||40
3035516|NCT01137682|3754717|FG002|NOT COMPLETED|Overall Study||34
3035517|NCT01137786|3754731|FG000|STARTED|Overall Study||25
3035518|NCT01137786|3754732|FG001|STARTED|Overall Study||24
3035519|NCT01137786|3754731|FG000|COMPLETED|Overall Study||24
3035520|NCT01137786|3754732|FG001|COMPLETED|Overall Study||21
3035521|NCT01137786|3754731|FG000|NOT COMPLETED|Overall Study||1
3035522|NCT01137786|3754732|FG001|NOT COMPLETED|Overall Study||3
3035523|NCT01137812|3754742|FG000|STARTED|Overall Study||377
3035524|NCT01137812|3754743|FG001|STARTED|Overall Study||378
3035525|NCT01137812|3754742|FG000|COMPLETED|Overall Study||254
3035526|NCT01137812|3754743|FG001|COMPLETED|Overall Study||210
3035527|NCT01137812|3754742|FG000|NOT COMPLETED|Overall Study||123
3035528|NCT01137812|3754743|FG001|NOT COMPLETED|Overall Study||168
3035529|NCT01137890|3754751|FG000|STARTED|Overall Study||14
3035530|NCT01137890|3754752|FG001|STARTED|Overall Study||5
2961967|NCT00754832|3676135|FG000|STARTED|First 6 Weeks Intervention||26
2961968|NCT00754832|3676136|FG001|STARTED|First 6 Weeks Intervention||30
2961969|NCT00754832|3676135|FG000|COMPLETED|First 6 Weeks Intervention||18
2961970|NCT00754832|3676136|FG001|COMPLETED|First 6 Weeks Intervention||28
2961971|NCT00754832|3676135|FG000|NOT COMPLETED|First 6 Weeks Intervention||8
2961972|NCT00754832|3676136|FG001|NOT COMPLETED|First 6 Weeks Intervention||2
2961973|NCT00754832|3676135|FG000|STARTED|2 Weeks Washout||18
2961974|NCT00754832|3676136|FG001|STARTED|2 Weeks Washout||28
2961975|NCT00754832|3676135|FG000|COMPLETED|2 Weeks Washout||17
2961976|NCT00754832|3676136|FG001|COMPLETED|2 Weeks Washout||26
2961977|NCT00754832|3676135|FG000|NOT COMPLETED|2 Weeks Washout||1
2961978|NCT00754832|3676136|FG001|NOT COMPLETED|2 Weeks Washout||2
2961979|NCT00754832|3676135|FG000|STARTED|Second 6 Weeks Intervention||17
2961980|NCT00754832|3676136|FG001|STARTED|Second 6 Weeks Intervention||26
2961981|NCT00754832|3676135|FG000|COMPLETED|Second 6 Weeks Intervention||17
2961982|NCT00754832|3676136|FG001|COMPLETED|Second 6 Weeks Intervention||24
2961983|NCT00754832|3676135|FG000|NOT COMPLETED|Second 6 Weeks Intervention||0
2961984|NCT00754832|3676136|FG001|NOT COMPLETED|Second 6 Weeks Intervention||2
2961985|NCT00754845|3676144|FG000|STARTED|Overall Study||959
2961986|NCT00754845|3676145|FG001|STARTED|Overall Study||959
2961987|NCT00754845|3676144|FG000|COMPLETED|Overall Study||959
2961988|NCT00754845|3676145|FG001|COMPLETED|Overall Study||959
2961989|NCT00754845|3676144|FG000|NOT COMPLETED|Overall Study||0
2961990|NCT00754845|3676145|FG001|NOT COMPLETED|Overall Study||0
2961991|NCT00754923|3676153|FG000|STARTED|Overall Study||11
2961992|NCT00754923|3676153|FG000|COMPLETED|Overall Study||11
2961993|NCT00754923|3676153|FG000|NOT COMPLETED|Overall Study||0
2961994|NCT00754936|3676157|FG000|STARTED|Overall Study||71
2961995|NCT00754936|3676157|FG000|COMPLETED|Overall Study||59
2961996|NCT00754936|3676157|FG000|NOT COMPLETED|Overall Study||12
2961997|NCT00755040|3676163|FG000|STARTED|Overall Study||83
2961998|NCT00755040|3676164|FG001|STARTED|Overall Study||81
2961999|NCT00755040|3676163|FG000|COMPLETED|Overall Study||40
2962000|NCT00755040|3676164|FG001|COMPLETED|Overall Study||47
2962001|NCT00755040|3676163|FG000|NOT COMPLETED|Overall Study||43
2962002|NCT00755040|3676164|FG001|NOT COMPLETED|Overall Study||34
2962003|NCT00755079|3676172|FG000|STARTED|Overall Study||18
2962004|NCT00755079|3676173|FG001|STARTED|Overall Study||22
2962005|NCT00755079|3676172|FG000|COMPLETED|Overall Study||17
2962006|NCT00755079|3676173|FG001|COMPLETED|Overall Study||16
2962007|NCT00755079|3676172|FG000|NOT COMPLETED|Overall Study||1
2962008|NCT00755079|3676173|FG001|NOT COMPLETED|Overall Study||6
2962009|NCT00755105|3676182|FG000|STARTED|Overall Study||38
2962010|NCT00755105|3676183|FG001|STARTED|Overall Study||30
2962011|NCT00755105|3676184|FG002|STARTED|Overall Study||9
2962012|NCT00755105|3676182|FG000|COMPLETED|Overall Study||29
2962013|NCT00755105|3676183|FG001|COMPLETED|Overall Study||19
2962014|NCT00755105|3676184|FG002|COMPLETED|Overall Study||5
2962015|NCT00755105|3676182|FG000|NOT COMPLETED|Overall Study||9
2962016|NCT00755105|3676183|FG001|NOT COMPLETED|Overall Study||11
2962017|NCT00755105|3676184|FG002|NOT COMPLETED|Overall Study||4
2962018|NCT00755131|3676194|FG000|STARTED|Overall Study||37
2962019|NCT00755131|3676195|FG001|STARTED|Overall Study||38
2962020|NCT00755131|3676194|FG000|COMPLETED|Overall Study||37
2962021|NCT00755131|3676195|FG001|COMPLETED|Overall Study||38
2962022|NCT00755131|3676194|FG000|NOT COMPLETED|Overall Study||0
2962023|NCT00755131|3676195|FG001|NOT COMPLETED|Overall Study||0
2962024|NCT00755183|3676203|FG000|STARTED|Overall Study||30
2962025|NCT00755183|3676204|FG001|STARTED|Overall Study||30
2962026|NCT00755183|3676203|FG000|COMPLETED|Overall Study||23
2962027|NCT00755183|3676204|FG001|COMPLETED|Overall Study||24
2962028|NCT00755183|3676203|FG000|NOT COMPLETED|Overall Study||7
2962029|NCT00755183|3676204|FG001|NOT COMPLETED|Overall Study||6
2962030|NCT00755196|3676212|FG000|STARTED|Overall Study||30
2962031|NCT00755196|3676212|FG000|COMPLETED|Overall Study||28
2962032|NCT00755196|3676212|FG000|NOT COMPLETED|Overall Study||2
2962033|NCT00755222|3676219|FG000|STARTED|Overall Study||111
2962034|NCT00755222|3676220|FG001|STARTED|Overall Study||36
2962035|NCT00755222|3676219|FG000|COMPLETED|Overall Study||103
2962036|NCT00755222|3676220|FG001|COMPLETED|Overall Study||34
2962037|NCT00755222|3676219|FG000|NOT COMPLETED|Overall Study||8
2962038|NCT00755222|3676220|FG001|NOT COMPLETED|Overall Study||2
2962039|NCT00755235|3676228|FG000|STARTED|Overall Study||106
2962040|NCT00755235|3676229|FG001|STARTED|Overall Study||102
2962041|NCT00755235|3676228|FG000|COMPLETED|Overall Study||104
2962042|NCT00755235|3676229|FG001|COMPLETED|Overall Study||93
2962043|NCT00755235|3676228|FG000|NOT COMPLETED|Overall Study||2
2962044|NCT00755235|3676229|FG001|NOT COMPLETED|Overall Study||9
2962045|NCT00755274|3676237|FG000|STARTED|Overall Study||24
2962046|NCT00755274|3676238|FG001|STARTED|Overall Study||8
2962047|NCT00755274|3676237|FG000|COMPLETED|Overall Study||24
2962048|NCT00755274|3676238|FG001|COMPLETED|Overall Study||8
2962049|NCT00755274|3676237|FG000|NOT COMPLETED|Overall Study||0
2962050|NCT00755274|3676238|FG001|NOT COMPLETED|Overall Study||0
2962051|NCT00755326|3676246|FG000|STARTED|Overall Study||47
2962052|NCT00755326|3676247|FG001|STARTED|Overall Study||45
2962053|NCT00755326|3676246|FG000|COMPLETED|Overall Study||45
2962054|NCT00755326|3676247|FG001|COMPLETED|Overall Study||42
2962055|NCT00755326|3676246|FG000|NOT COMPLETED|Overall Study||2
2962056|NCT00755326|3676247|FG001|NOT COMPLETED|Overall Study||3
2962057|NCT00755417|3676257|FG000|STARTED|Overall Study|Number of patients that received assigned treatment; ITT and safety populations|174
2962058|NCT00755417|3676258|FG001|STARTED|Overall Study|Number of patients that received assigned treatment; ITT and safety populations|181
2962059|NCT00755417|3676259|FG002|STARTED|Overall Study|Number of patients that received assigned treatment; ITT and safety populations|177
2962060|NCT00755417|3676257|FG000|COMPLETED|Overall Study||112
2962061|NCT00755417|3676258|FG001|COMPLETED|Overall Study||126
2962062|NCT00755417|3676259|FG002|COMPLETED|Overall Study||135
2962063|NCT00755417|3676257|FG000|NOT COMPLETED|Overall Study||62
2962064|NCT00755417|3676258|FG001|NOT COMPLETED|Overall Study||55
2962065|NCT00755417|3676259|FG002|NOT COMPLETED|Overall Study||42
2962066|NCT00755716|3676270|FG000|STARTED|Overall Study||19
2962067|NCT00755716|3676271|FG001|STARTED|Overall Study||19
2962068|NCT00755716|3676272|FG002|STARTED|Overall Study||19
2962069|NCT00755716|3676270|FG000|COMPLETED|Overall Study||11
2962070|NCT00755716|3676271|FG001|COMPLETED|Overall Study||11
2962071|NCT00755716|3676272|FG002|COMPLETED|Overall Study||16
2962072|NCT00755716|3676270|FG000|NOT COMPLETED|Overall Study||8
2962073|NCT00755716|3676271|FG001|NOT COMPLETED|Overall Study||8
2962074|NCT00755716|3676272|FG002|NOT COMPLETED|Overall Study||3
2962075|NCT00755755|3676283|FG000|STARTED|Overall Study|Safety population|95
2962076|NCT00755755|3676284|FG001|STARTED|Overall Study|Safety population|98
2962077|NCT00755755|3676285|FG002|STARTED|Overall Study|Safety population|48
2962078|NCT00755755|3676283|FG000|COMPLETED|Overall Study|Patients who completed the overall study up to the follow-up visit (visit 6)|89
2962079|NCT00755755|3676284|FG001|COMPLETED|Overall Study|Patients who completed the overall study up to the follow-up visit (visit 6)|90
2962080|NCT00755755|3676285|FG002|COMPLETED|Overall Study|Patients who completed the overall study up to the follow-up visit (visit 6)|45
2962081|NCT00755755|3676283|FG000|NOT COMPLETED|Overall Study||6
2962082|NCT00755755|3676284|FG001|NOT COMPLETED|Overall Study||8
2962083|NCT00755755|3676285|FG002|NOT COMPLETED|Overall Study||3
2962084|NCT00755807|3676295|FG000|STARTED|Acute Phase||118
2962085|NCT00755807|3676296|FG001|STARTED|Acute Phase||121
2962086|NCT00755807|3676295|FG000|COMPLETED|Acute Phase||100
2962087|NCT00755807|3676296|FG001|COMPLETED|Acute Phase||109
2962088|NCT00755807|3676295|FG000|NOT COMPLETED|Acute Phase||18
2962089|NCT00755807|3676296|FG001|NOT COMPLETED|Acute Phase||12
2962090|NCT00755807|3676295|FG000|STARTED|Open-label Extension Phase||100
2962091|NCT00755807|3676296|FG001|STARTED|Open-label Extension Phase||109
2962092|NCT00755807|3676295|FG000|COMPLETED|Open-label Extension Phase||82
2962093|NCT00755807|3676296|FG001|COMPLETED|Open-label Extension Phase||93
2962094|NCT00755807|3676295|FG000|NOT COMPLETED|Open-label Extension Phase||18
2962095|NCT00755807|3676296|FG001|NOT COMPLETED|Open-label Extension Phase||16
2962096|NCT00755846|3676312|FG000|STARTED|Overall Study||43
2962097|NCT00755846|3676313|FG001|STARTED|Overall Study||44
2962098|NCT00755846|3676314|FG002|STARTED|Overall Study||44
2962099|NCT00755846|3676315|FG003|STARTED|Overall Study||45
2962100|NCT00755846|3676316|FG004|STARTED|Overall Study||44
3301703|NCT02954601|4035334|FG002|COMPLETED|Third Intervention (Five Days)||6
3301704|NCT02954601|4035335|FG003|COMPLETED|Third Intervention (Five Days)||8
3301705|NCT02954601|4035332|FG000|NOT COMPLETED|Third Intervention (Five Days)||0
3301706|NCT02954601|4035333|FG001|NOT COMPLETED|Third Intervention (Five Days)||0
3301707|NCT02954601|4035334|FG002|NOT COMPLETED|Third Intervention (Five Days)||0
3301708|NCT02954601|4035335|FG003|NOT COMPLETED|Third Intervention (Five Days)||0
3301709|NCT02954653|4035347|FG000|STARTED|Overall Study||4
3301710|NCT02954653|4035348|FG001|STARTED|Overall Study||4
3301711|NCT02954653|4035349|FG002|STARTED|Overall Study|No participants were enrolled in this arm.|0
3301712|NCT02954653|4035350|FG003|STARTED|Overall Study|No participants were enrolled in this arm.|0
3301713|NCT02954653|4035351|FG004|STARTED|Overall Study|No participants were enrolled in this arm.|0
3301714|NCT02954653|4035352|FG005|STARTED|Overall Study|No participants were enrolled in this arm.|0
2962101|NCT00755846|3676317|FG005|STARTED|Overall Study||45
2962102|NCT00755846|3676312|FG000|COMPLETED|Overall Study||18
2962103|NCT00755846|3676313|FG001|COMPLETED|Overall Study||27
2962104|NCT00755846|3676314|FG002|COMPLETED|Overall Study||32
2962105|NCT00755846|3676315|FG003|COMPLETED|Overall Study||32
2962106|NCT00755846|3676316|FG004|COMPLETED|Overall Study||27
2962107|NCT00755846|3676317|FG005|COMPLETED|Overall Study||31
2962108|NCT00755846|3676312|FG000|NOT COMPLETED|Overall Study||25
2962109|NCT00755846|3676313|FG001|NOT COMPLETED|Overall Study||17
2962110|NCT00755846|3676314|FG002|NOT COMPLETED|Overall Study||12
2962111|NCT00755846|3676315|FG003|NOT COMPLETED|Overall Study||13
2962112|NCT00755846|3676316|FG004|NOT COMPLETED|Overall Study||17
2962113|NCT00755846|3676317|FG005|NOT COMPLETED|Overall Study||14
2962114|NCT00755911|3676333|FG000|STARTED|Overall Study||12
2962115|NCT00755911|3676334|FG001|STARTED|Overall Study||12
2962116|NCT00755911|3676333|FG000|COMPLETED|Overall Study||12
2962117|NCT00755911|3676334|FG001|COMPLETED|Overall Study||12
2962118|NCT00755911|3676333|FG000|NOT COMPLETED|Overall Study||0
2962119|NCT00755911|3676334|FG001|NOT COMPLETED|Overall Study||0
2962120|NCT00755937|3676340|FG000|STARTED|Recruitment|Subjects registered in the program|556
2962121|NCT00755937|3676340|FG000|COMPLETED|Recruitment|Subjects who had a baseline visit and at least 1 additional follow-up visit (analyzed population)|392
2962122|NCT00755937|3676340|FG000|NOT COMPLETED|Recruitment||164
2962123|NCT00755937|3676340|FG000|STARTED|Observational Follow-up||392
2962124|NCT00755937|3676340|FG000|COMPLETED|Observational Follow-up|Subjects followed until end of study/subjects for whom end of participation data were collected|244
2962125|NCT00755937|3676340|FG000|NOT COMPLETED|Observational Follow-up||148
2962126|NCT00756002|3676346|FG000|STARTED|Placebo Run-in||488
3316998|NCT03122587|4050479|FG002|NOT COMPLETED|Overall Study||1
2962127|NCT00756002|3676347|FG001|STARTED|Placebo Run-in||0
2962128|NCT00756002|3676346|FG000|COMPLETED|Placebo Run-in||259
2962129|NCT00756002|3676347|FG001|COMPLETED|Placebo Run-in||0
2962130|NCT00756002|3676346|FG000|NOT COMPLETED|Placebo Run-in||229
2962131|NCT00756002|3676347|FG001|NOT COMPLETED|Placebo Run-in||0
2962132|NCT00756002|3676346|FG000|STARTED|Double-Blind Treatment Period||129
2962133|NCT00756002|3676347|FG001|STARTED|Double-Blind Treatment Period||130
2962134|NCT00756002|3676346|FG000|COMPLETED|Double-Blind Treatment Period||114
2962135|NCT00756002|3676347|FG001|COMPLETED|Double-Blind Treatment Period||115
2962136|NCT00756002|3676346|FG000|NOT COMPLETED|Double-Blind Treatment Period||15
2962137|NCT00756002|3676347|FG001|NOT COMPLETED|Double-Blind Treatment Period||15
2962138|NCT00756002|3676346|FG000|STARTED|Placebo Run-out||114
2962139|NCT00756002|3676347|FG001|STARTED|Placebo Run-out||0
2962140|NCT00756002|3676346|FG000|COMPLETED|Placebo Run-out||114
2962141|NCT00756002|3676347|FG001|COMPLETED|Placebo Run-out||0
2962142|NCT00756002|3676346|FG000|NOT COMPLETED|Placebo Run-out||0
2962143|NCT00756002|3676347|FG001|NOT COMPLETED|Placebo Run-out||0
2962144|NCT00756093|3676353|FG000|STARTED|First Intervention||5
2962145|NCT00756093|3676354|FG001|STARTED|First Intervention||5
2962146|NCT00756093|3676355|FG002|STARTED|First Intervention||5
3301715|NCT02954653|4035353|FG006|STARTED|Overall Study|No participants were enrolled in this arm.|0
3301716|NCT02954653|4035354|FG007|STARTED|Overall Study|No participants were enrolled in this arm.|0
3301717|NCT02954653|4035355|FG008|STARTED|Overall Study|No participants were enrolled in this arm.|0
3301718|NCT02954653|4035347|FG000|Received Treatment|Overall Study||3
3301719|NCT02954653|4035348|FG001|Received Treatment|Overall Study||4
3301720|NCT02954653|4035349|FG002|Received Treatment|Overall Study||0
3301721|NCT02954653|4035350|FG003|Received Treatment|Overall Study||0
3301722|NCT02954653|4035351|FG004|Received Treatment|Overall Study||0
3301723|NCT02954653|4035352|FG005|Received Treatment|Overall Study||0
2962147|NCT00756093|3676356|FG003|STARTED|First Intervention||5
2962148|NCT00756093|3676353|FG000|COMPLETED|First Intervention||5
2962149|NCT00756093|3676354|FG001|COMPLETED|First Intervention||5
2962150|NCT00756093|3676355|FG002|COMPLETED|First Intervention||5
2962151|NCT00756093|3676356|FG003|COMPLETED|First Intervention||5
2962152|NCT00756093|3676353|FG000|NOT COMPLETED|First Intervention||0
2962153|NCT00756093|3676354|FG001|NOT COMPLETED|First Intervention||0
2962154|NCT00756093|3676355|FG002|NOT COMPLETED|First Intervention||0
2962155|NCT00756093|3676356|FG003|NOT COMPLETED|First Intervention||0
2962156|NCT00756093|3676353|FG000|STARTED|Second Intervention||5
2962157|NCT00756093|3676354|FG001|STARTED|Second Intervention||5
2962158|NCT00756093|3676355|FG002|STARTED|Second Intervention||5
2962159|NCT00756093|3676356|FG003|STARTED|Second Intervention||5
2962160|NCT00756093|3676353|FG000|COMPLETED|Second Intervention||5
2962161|NCT00756093|3676354|FG001|COMPLETED|Second Intervention||5
2962162|NCT00756093|3676355|FG002|COMPLETED|Second Intervention||5
2962163|NCT00756093|3676356|FG003|COMPLETED|Second Intervention||5
2962164|NCT00756093|3676353|FG000|NOT COMPLETED|Second Intervention||0
2962165|NCT00756093|3676354|FG001|NOT COMPLETED|Second Intervention||0
2962166|NCT00756093|3676355|FG002|NOT COMPLETED|Second Intervention||0
2962167|NCT00756093|3676356|FG003|NOT COMPLETED|Second Intervention||0
2962168|NCT00756093|3676353|FG000|STARTED|Third Intervention||5
2962169|NCT00756093|3676354|FG001|STARTED|Third Intervention||5
2962170|NCT00756093|3676355|FG002|STARTED|Third Intervention||5
2962171|NCT00756093|3676356|FG003|STARTED|Third Intervention||5
2962172|NCT00756093|3676353|FG000|COMPLETED|Third Intervention||5
2962173|NCT00756093|3676354|FG001|COMPLETED|Third Intervention||5
2962174|NCT00756093|3676355|FG002|COMPLETED|Third Intervention||5
2962175|NCT00756093|3676356|FG003|COMPLETED|Third Intervention||5
2962176|NCT00756093|3676353|FG000|NOT COMPLETED|Third Intervention||0
2962177|NCT00756093|3676354|FG001|NOT COMPLETED|Third Intervention||0
2962178|NCT00756093|3676355|FG002|NOT COMPLETED|Third Intervention||0
2962179|NCT00756093|3676356|FG003|NOT COMPLETED|Third Intervention||0
2962180|NCT00756093|3676353|FG000|STARTED|Fourth Intervention||5
2962181|NCT00756093|3676354|FG001|STARTED|Fourth Intervention||5
2962182|NCT00756093|3676355|FG002|STARTED|Fourth Intervention||5
2962183|NCT00756093|3676356|FG003|STARTED|Fourth Intervention||5
2962184|NCT00756093|3676353|FG000|COMPLETED|Fourth Intervention||5
2962185|NCT00756093|3676354|FG001|COMPLETED|Fourth Intervention||5
2962186|NCT00756093|3676355|FG002|COMPLETED|Fourth Intervention||5
2962187|NCT00756093|3676356|FG003|COMPLETED|Fourth Intervention||5
2962188|NCT00756093|3676353|FG000|NOT COMPLETED|Fourth Intervention||0
2962189|NCT00756093|3676354|FG001|NOT COMPLETED|Fourth Intervention||0
2962190|NCT00756093|3676355|FG002|NOT COMPLETED|Fourth Intervention||0
2962191|NCT00756093|3676356|FG003|NOT COMPLETED|Fourth Intervention||0
2962192|NCT00756106|3676366|FG000|STARTED|Overall Study||15
2962193|NCT00756106|3676366|FG000|COMPLETED|Overall Study||3
2962194|NCT00756106|3676366|FG000|NOT COMPLETED|Overall Study||12
2962195|NCT00756236|3676373|FG000|STARTED|Overall Study||20
2962196|NCT00756236|3676374|FG001|STARTED|Overall Study||20
2962197|NCT00756236|3676375|FG002|STARTED|Overall Study||20
2962198|NCT00756236|3676373|FG000|COMPLETED|Overall Study||20
2962199|NCT00756236|3676374|FG001|COMPLETED|Overall Study||20
2962200|NCT00756236|3676375|FG002|COMPLETED|Overall Study||20
2962201|NCT00756236|3676373|FG000|NOT COMPLETED|Overall Study||0
3301724|NCT02954653|4035353|FG006|Received Treatment|Overall Study||0
3301725|NCT02954653|4035354|FG007|Received Treatment|Overall Study||0
3301726|NCT02954653|4035355|FG008|Received Treatment|Overall Study||0
2962202|NCT00756236|3676374|FG001|NOT COMPLETED|Overall Study||0
2962203|NCT00756236|3676375|FG002|NOT COMPLETED|Overall Study||0
2962204|NCT00756275|3676385|FG000|STARTED|Overall Study||60
2962205|NCT00756275|3676386|FG001|STARTED|Overall Study||77
2962206|NCT00756275|3676385|FG000|COMPLETED|Overall Study||31
2962207|NCT00756275|3676386|FG001|COMPLETED|Overall Study||49
2962208|NCT00756275|3676385|FG000|NOT COMPLETED|Overall Study||29
2962209|NCT00756275|3676386|FG001|NOT COMPLETED|Overall Study||28
2962210|NCT00756314|3676394|FG000|STARTED|Overall Study||123
2962211|NCT00756314|3676395|FG001|STARTED|Overall Study||123
2962212|NCT00756314|3676394|FG000|COMPLETED|Overall Study|"2 participants discontinued the intervention and were analyzed by intention to treat analysis."|121
2962213|NCT00756314|3676395|FG001|COMPLETED|Overall Study|"4 participants did not do the follow up, 55 discontinued and were analyzed by intention to treat"|64
2962214|NCT00756314|3676394|FG000|NOT COMPLETED|Overall Study||2
2962215|NCT00756314|3676395|FG001|NOT COMPLETED|Overall Study||59
2962216|NCT00756444|3676403|FG000|STARTED|Overall Study||33
2962217|NCT00756444|3676404|FG001|STARTED|Overall Study||34
2962218|NCT00756444|3676403|FG000|COMPLETED|Overall Study||18
2962219|NCT00756444|3676404|FG001|COMPLETED|Overall Study||13
2962220|NCT00756444|3676403|FG000|NOT COMPLETED|Overall Study||15
2962221|NCT00756444|3676404|FG001|NOT COMPLETED|Overall Study||21
2962222|NCT00756457|3676413|FG000|STARTED|Overall Study||20
2962223|NCT00756457|3676414|FG001|STARTED|Overall Study||19
2962224|NCT00756457|3676413|FG000|COMPLETED|Overall Study|One participant in the Active treatment group decided to have surgery after the 2 week follow-up.|19
2962225|NCT00756457|3676414|FG001|COMPLETED|Overall Study|One participant moved overseas; the other participant resumed cancer treatment|17
2962226|NCT00756457|3676413|FG000|NOT COMPLETED|Overall Study||1
2962227|NCT00756457|3676414|FG001|NOT COMPLETED|Overall Study||2
2962228|NCT00756470|3676436|FG000|STARTED|Overall Study||15
2962229|NCT00756470|3676436|FG000|COMPLETED|Overall Study||10
2962230|NCT00756470|3676436|FG000|NOT COMPLETED|Overall Study||5
2962231|NCT00756496|3676440|FG000|STARTED|Overall Study||442
2962232|NCT00756496|3676440|FG000|COMPLETED|Overall Study||442
2962233|NCT00756496|3676440|FG000|NOT COMPLETED|Overall Study||0
2962234|NCT00756548|3676447|FG000|STARTED|Overall Study||186
2962235|NCT00756548|3676448|FG001|STARTED|Overall Study||185
2962236|NCT00756548|3676447|FG000|COMPLETED|Overall Study||184
2962237|NCT00756548|3676448|FG001|COMPLETED|Overall Study||185
2962238|NCT00756548|3676447|FG000|NOT COMPLETED|Overall Study||2
2962239|NCT00756548|3676448|FG001|NOT COMPLETED|Overall Study||0
2962240|NCT00756561|3676456|FG000|STARTED|Overall Study||10
2962241|NCT00756561|3676456|FG000|COMPLETED|Overall Study||10
2962242|NCT00756561|3676456|FG000|NOT COMPLETED|Overall Study||0
2962243|NCT00756600|3676463|FG000|STARTED|Overall Study||287
2962244|NCT00756600|3676464|FG001|STARTED|Overall Study||356
2962245|NCT00756600|3676463|FG000|COMPLETED|Overall Study||287
2962246|NCT00756600|3676464|FG001|COMPLETED|Overall Study||356
2962247|NCT00756600|3676463|FG000|NOT COMPLETED|Overall Study||0
2962248|NCT00756600|3676464|FG001|NOT COMPLETED|Overall Study||0
2962249|NCT00756613|3676473|FG000|STARTED|Overall Study||512
2962250|NCT00756613|3676474|FG001|STARTED|Overall Study||532
2962251|NCT00756613|3676473|FG000|COMPLETED|Overall Study||426
2962252|NCT00756613|3676474|FG001|COMPLETED|Overall Study||462
2962253|NCT00756613|3676473|FG000|NOT COMPLETED|Overall Study||86
2962254|NCT00756613|3676474|FG001|NOT COMPLETED|Overall Study||70
2962255|NCT00756652|3676483|FG000|STARTED|Original Phase||41452
2962256|NCT00756652|3676484|FG001|STARTED|Original Phase||1039
2962257|NCT00756652|3676483|FG000|COMPLETED|Original Phase|At Year 7|6063
2962258|NCT00756652|3676484|FG001|COMPLETED|Original Phase||118
2962259|NCT00756652|3676483|FG000|NOT COMPLETED|Original Phase||35389
2962260|NCT00756652|3676484|FG001|NOT COMPLETED|Original Phase||921
2962261|NCT00756652|3676483|FG000|STARTED|Re-Op Phase||11101
2962262|NCT00756652|3676484|FG001|STARTED|Re-Op Phase|NA - The Re-Op Phase was limited in scope to data collection for only MemoryGel participants.|0
2962263|NCT00756652|3676483|FG000|COMPLETED|Re-Op Phase||8225
2962264|NCT00756652|3676484|FG001|COMPLETED|Re-Op Phase||0
2962265|NCT00756652|3676483|FG000|NOT COMPLETED|Re-Op Phase||2876
2962266|NCT00756652|3676484|FG001|NOT COMPLETED|Re-Op Phase||0
2962267|NCT00756678|3676488|FG000|STARTED|Overall Study||51
2962268|NCT00756678|3676488|FG000|COMPLETED|Overall Study||50
2962269|NCT00756678|3676488|FG000|NOT COMPLETED|Overall Study||1
2962270|NCT00756717|3676493|FG000|STARTED|Overall Study||22
2962271|NCT00756717|3676493|FG000|COMPLETED|Overall Study||20
2962272|NCT00756717|3676493|FG000|NOT COMPLETED|Overall Study||2
2962273|NCT00756730|3676499|FG000|STARTED|Overall Study||25
2962274|NCT00756730|3676500|FG001|STARTED|Overall Study||24
2962275|NCT00756730|3676499|FG000|COMPLETED|Overall Study||25
2962276|NCT00756730|3676500|FG001|COMPLETED|Overall Study||22
2962277|NCT00756730|3676499|FG000|NOT COMPLETED|Overall Study||0
2962278|NCT00756730|3676500|FG001|NOT COMPLETED|Overall Study||2
3132989|NCT01693562|3858011|FG002|NOT COMPLETED|Expansion Phase||0
3132990|NCT01693562|3858012|FG003|NOT COMPLETED|Expansion Phase||0
3132991|NCT01693562|3858013|FG004|NOT COMPLETED|Expansion Phase||0
2962279|NCT00756886|3676508|FG000|STARTED|Overall Study||41
2962280|NCT00756886|3676509|FG001|STARTED|Overall Study||32
2962281|NCT00756886|3676508|FG000|COMPLETED|Overall Study||30
2962282|NCT00756886|3676509|FG001|COMPLETED|Overall Study||25
2962283|NCT00756886|3676508|FG000|NOT COMPLETED|Overall Study||11
2962284|NCT00756886|3676509|FG001|NOT COMPLETED|Overall Study||7
3132992|NCT01693562|3858014|FG005|NOT COMPLETED|Expansion Phase||0
3132993|NCT01693562|3858015|FG006|NOT COMPLETED|Expansion Phase||0
3163855|NCT01889667|3891316|FG000|NOT COMPLETED|Overall Study||0
3163856|NCT01889667|3891317|FG001|NOT COMPLETED|Overall Study||0
3163857|NCT01889667|3891318|FG002|NOT COMPLETED|Overall Study||0
3163858|NCT01889797|3891330|FG000|STARTED|Overall Study||16
3163859|NCT01889797|3891331|FG001|STARTED|Overall Study||16
3163860|NCT01889797|3891330|FG000|COMPLETED|Overall Study||16
3163861|NCT01889797|3891331|FG001|COMPLETED|Overall Study||16
3163862|NCT01889797|3891330|FG000|NOT COMPLETED|Overall Study||0
3163863|NCT01889797|3891331|FG001|NOT COMPLETED|Overall Study||0
3163864|NCT01889862|3891337|FG000|STARTED|Part 1 (Up to 13 Weeks)||86
3163865|NCT01889862|3891338|FG001|STARTED|Part 1 (Up to 13 Weeks)||0
3163866|NCT01889862|3891339|FG002|STARTED|Part 1 (Up to 13 Weeks)||78
3163867|NCT01889862|3891340|FG003|STARTED|Part 1 (Up to 13 Weeks)||0
3163868|NCT01889862|3891341|FG004|STARTED|Part 1 (Up to 13 Weeks)||0
3163869|NCT01889862|3891337|FG000|COMPLETED|Part 1 (Up to 13 Weeks)|Out of 164, total 12 subjects have not completed Part 1.|74
3163870|NCT01889862|3891338|FG001|COMPLETED|Part 1 (Up to 13 Weeks)||0
3163871|NCT01889862|3891339|FG002|COMPLETED|Part 1 (Up to 13 Weeks)||78
3163872|NCT01889862|3891340|FG003|COMPLETED|Part 1 (Up to 13 Weeks)||0
3163873|NCT01889862|3891341|FG004|COMPLETED|Part 1 (Up to 13 Weeks)||0
3163874|NCT01889862|3891337|FG000|NOT COMPLETED|Part 1 (Up to 13 Weeks)||12
3163875|NCT01889862|3891338|FG001|NOT COMPLETED|Part 1 (Up to 13 Weeks)||0
3163876|NCT01889862|3891339|FG002|NOT COMPLETED|Part 1 (Up to 13 Weeks)||0
3163877|NCT01889862|3891340|FG003|NOT COMPLETED|Part 1 (Up to 13 Weeks)||0
3163878|NCT01889862|3891341|FG004|NOT COMPLETED|Part 1 (Up to 13 Weeks)||0
2962285|NCT00756964|3676517|FG000|STARTED|Overall Study||13
2962286|NCT00756964|3676518|FG001|STARTED|Overall Study||13
2962287|NCT00756964|3676517|FG000|COMPLETED|Overall Study||13
2962288|NCT00756964|3676518|FG001|COMPLETED|Overall Study||13
2962289|NCT00756964|3676517|FG000|NOT COMPLETED|Overall Study||0
2962290|NCT00756964|3676518|FG001|NOT COMPLETED|Overall Study||0
2962291|NCT00756977|3676526|FG000|STARTED|Overall Study||196
2962292|NCT00756977|3676527|FG001|STARTED|Overall Study||198
2962293|NCT00756977|3676526|FG000|COMPLETED|Overall Study||175
2962294|NCT00756977|3676527|FG001|COMPLETED|Overall Study||187
2962295|NCT00756977|3676526|FG000|NOT COMPLETED|Overall Study||21
2962296|NCT00756977|3676527|FG001|NOT COMPLETED|Overall Study||11
2962297|NCT00757003|3676533|FG000|STARTED|Overall Study||100
2962298|NCT00757003|3676533|FG000|COMPLETED|Overall Study||51
2962299|NCT00757003|3676533|FG000|NOT COMPLETED|Overall Study||49
2962300|NCT00757172|3676538|FG000|STARTED|Overall Study||65
2962301|NCT00757172|3676538|FG000|COMPLETED|Overall Study|Participants underwent surgery.|54
2962302|NCT00757172|3676538|FG000|NOT COMPLETED|Overall Study||11
2962303|NCT00757237|3676544|FG000|STARTED|Overall Study||137
2962304|NCT00757237|3676545|FG001|STARTED|Overall Study||136
2962305|NCT00757237|3676544|FG000|Treated|Overall Study||136
2962306|NCT00757237|3676545|FG001|Treated|Overall Study||132
2962307|NCT00757237|3676544|FG000|COMPLETED|Overall Study||124
2962308|NCT00757237|3676545|FG001|COMPLETED|Overall Study||111
2962309|NCT00757237|3676544|FG000|NOT COMPLETED|Overall Study||13
2962310|NCT00757237|3676545|FG001|NOT COMPLETED|Overall Study||25
2962311|NCT00757484|3676551|FG000|STARTED|Overall Study||491
2962312|NCT00757484|3676551|FG000|COMPLETED|Overall Study||491
2962313|NCT00757484|3676551|FG000|NOT COMPLETED|Overall Study||0
2962314|NCT00757588|3676559|FG000|STARTED|Period 1: Short-term (24-week) Phase||304
2962315|NCT00757588|3676560|FG001|STARTED|Period 1: Short-term (24-week) Phase||151
2962316|NCT00757588|3676559|FG000|COMPLETED|Period 1: Short-term (24-week) Phase|Does not include 2 who completed Period 1 but were erroneously reported in the CSR as noncompleters.|268
2962317|NCT00757588|3676560|FG001|COMPLETED|Period 1: Short-term (24-week) Phase||134
2962318|NCT00757588|3676559|FG000|NOT COMPLETED|Period 1: Short-term (24-week) Phase||36
2962319|NCT00757588|3676560|FG001|NOT COMPLETED|Period 1: Short-term (24-week) Phase||17
2962320|NCT00757588|3676559|FG000|STARTED|Period 2: Long-term (52-week) Phase|270 participants completed short-term phase; 2 of these did not enter long-term phase.|268
2962321|NCT00757588|3676560|FG001|STARTED|Period 2: Long-term (52-week) Phase||134
2962322|NCT00757588|3676559|FG000|COMPLETED|Period 2: Long-term (52-week) Phase||246
2962323|NCT00757588|3676560|FG001|COMPLETED|Period 2: Long-term (52-week) Phase||125
2962324|NCT00757588|3676559|FG000|NOT COMPLETED|Period 2: Long-term (52-week) Phase||22
2962325|NCT00757588|3676560|FG001|NOT COMPLETED|Period 2: Long-term (52-week) Phase||9
2962326|NCT00757601|3676566|FG000|STARTED|Period 1||2
2962327|NCT00757601|3676567|FG001|STARTED|Period 1||2
2962328|NCT00757601|3676568|FG002|STARTED|Period 1||2
2962329|NCT00757601|3676569|FG003|STARTED|Period 1||2
2962330|NCT00757601|3676570|FG004|STARTED|Period 1||2
2962331|NCT00757601|3676571|FG005|STARTED|Period 1||2
2962332|NCT00757601|3676572|FG006|STARTED|Period 1||2
2962333|NCT00757601|3676573|FG007|STARTED|Period 1||2
2962334|NCT00757601|3676574|FG008|STARTED|Period 1||2
2962335|NCT00757601|3676575|FG009|STARTED|Period 1||2
2962336|NCT00757601|3676576|FG010|STARTED|Period 1||2
2962337|NCT00757601|3676577|FG011|STARTED|Period 1||3
2962338|NCT00757601|3676566|FG000|COMPLETED|Period 1||2
2962339|NCT00757601|3676567|FG001|COMPLETED|Period 1||2
2962340|NCT00757601|3676568|FG002|COMPLETED|Period 1||2
2962341|NCT00757601|3676569|FG003|COMPLETED|Period 1||2
2962342|NCT00757601|3676570|FG004|COMPLETED|Period 1||2
3163879|NCT01889862|3891337|FG000|STARTED|Part 2 (8 Weeks)|Subjects ≥20% reduction in blood Phe from naïve baseline levels are randomized in Part 2.|34
2962343|NCT00757601|3676571|FG005|COMPLETED|Period 1||2
3163880|NCT01889862|3891338|FG001|STARTED|Part 2 (8 Weeks)|Subjects ≥20% reduction in blood Phe from naïve baseline levels are randomized in Part 2.|15
2962344|NCT00757601|3676572|FG006|COMPLETED|Period 1||2
2962345|NCT00757601|3676573|FG007|COMPLETED|Period 1||2
2962346|NCT00757601|3676574|FG008|COMPLETED|Period 1||2
2962347|NCT00757601|3676575|FG009|COMPLETED|Period 1||2
2962348|NCT00757601|3676576|FG010|COMPLETED|Period 1||2
2962349|NCT00757601|3676577|FG011|COMPLETED|Period 1||3
2962350|NCT00757601|3676566|FG000|NOT COMPLETED|Period 1||0
2962351|NCT00757601|3676567|FG001|NOT COMPLETED|Period 1||0
2962352|NCT00757601|3676568|FG002|NOT COMPLETED|Period 1||0
2962353|NCT00757601|3676569|FG003|NOT COMPLETED|Period 1||0
2962354|NCT00757601|3676570|FG004|NOT COMPLETED|Period 1||0
2962355|NCT00757601|3676571|FG005|NOT COMPLETED|Period 1||0
2962356|NCT00757601|3676572|FG006|NOT COMPLETED|Period 1||0
2962357|NCT00757601|3676573|FG007|NOT COMPLETED|Period 1||0
2962358|NCT00757601|3676574|FG008|NOT COMPLETED|Period 1||0
2962359|NCT00757601|3676575|FG009|NOT COMPLETED|Period 1||0
2962360|NCT00757601|3676576|FG010|NOT COMPLETED|Period 1||0
2962361|NCT00757601|3676577|FG011|NOT COMPLETED|Period 1||0
2962362|NCT00757601|3676566|FG000|STARTED|Period 2||2
2962363|NCT00757601|3676567|FG001|STARTED|Period 2||2
2962364|NCT00757601|3676568|FG002|STARTED|Period 2||2
2962365|NCT00757601|3676569|FG003|STARTED|Period 2||2
2962366|NCT00757601|3676570|FG004|STARTED|Period 2||2
2962367|NCT00757601|3676571|FG005|STARTED|Period 2||2
2962368|NCT00757601|3676572|FG006|STARTED|Period 2||2
2962369|NCT00757601|3676573|FG007|STARTED|Period 2||2
2962370|NCT00757601|3676574|FG008|STARTED|Period 2||2
2962371|NCT00757601|3676575|FG009|STARTED|Period 2||2
2962372|NCT00757601|3676576|FG010|STARTED|Period 2||2
2962373|NCT00757601|3676577|FG011|STARTED|Period 2||3
2962374|NCT00757601|3676566|FG000|COMPLETED|Period 2||2
2962375|NCT00757601|3676567|FG001|COMPLETED|Period 2||2
2962376|NCT00757601|3676568|FG002|COMPLETED|Period 2||2
2962377|NCT00757601|3676569|FG003|COMPLETED|Period 2||2
2962378|NCT00757601|3676570|FG004|COMPLETED|Period 2||2
2962379|NCT00757601|3676571|FG005|COMPLETED|Period 2||2
2962380|NCT00757601|3676572|FG006|COMPLETED|Period 2||2
2962381|NCT00757601|3676573|FG007|COMPLETED|Period 2||2
2962382|NCT00757601|3676574|FG008|COMPLETED|Period 2||2
2962383|NCT00757601|3676575|FG009|COMPLETED|Period 2||2
2962384|NCT00757601|3676576|FG010|COMPLETED|Period 2||2
2962385|NCT00757601|3676577|FG011|COMPLETED|Period 2|One participant discontinued the study after Period 2 and was replaced by another participant.|2
2962386|NCT00757601|3676566|FG000|NOT COMPLETED|Period 2||0
2962387|NCT00757601|3676567|FG001|NOT COMPLETED|Period 2||0
2962388|NCT00757601|3676568|FG002|NOT COMPLETED|Period 2||0
2962389|NCT00757601|3676569|FG003|NOT COMPLETED|Period 2||0
2962390|NCT00757601|3676570|FG004|NOT COMPLETED|Period 2||0
2962391|NCT00757601|3676571|FG005|NOT COMPLETED|Period 2||0
2962392|NCT00757601|3676572|FG006|NOT COMPLETED|Period 2||0
2962393|NCT00757601|3676573|FG007|NOT COMPLETED|Period 2||0
2962394|NCT00757601|3676574|FG008|NOT COMPLETED|Period 2||0
2962395|NCT00757601|3676575|FG009|NOT COMPLETED|Period 2||0
2962396|NCT00757601|3676576|FG010|NOT COMPLETED|Period 2||0
2962397|NCT00757601|3676577|FG011|NOT COMPLETED|Period 2||1
2962398|NCT00757601|3676566|FG000|STARTED|Period 3||2
2962399|NCT00757601|3676567|FG001|STARTED|Period 3||2
2962400|NCT00757601|3676568|FG002|STARTED|Period 3||2
2962401|NCT00757601|3676569|FG003|STARTED|Period 3||2
2962402|NCT00757601|3676570|FG004|STARTED|Period 3||2
2962403|NCT00757601|3676571|FG005|STARTED|Period 3||2
2962404|NCT00757601|3676572|FG006|STARTED|Period 3||2
2962405|NCT00757601|3676573|FG007|STARTED|Period 3||2
2962406|NCT00757601|3676574|FG008|STARTED|Period 3||2
2962407|NCT00757601|3676575|FG009|STARTED|Period 3||2
2962408|NCT00757601|3676576|FG010|STARTED|Period 3||2
2962409|NCT00757601|3676577|FG011|STARTED|Period 3||2
2962410|NCT00757601|3676566|FG000|COMPLETED|Period 3||2
2962411|NCT00757601|3676567|FG001|COMPLETED|Period 3||2
2962412|NCT00757601|3676568|FG002|COMPLETED|Period 3||2
2962413|NCT00757601|3676569|FG003|COMPLETED|Period 3||2
2962414|NCT00757601|3676570|FG004|COMPLETED|Period 3||2
2962415|NCT00757601|3676571|FG005|COMPLETED|Period 3||2
2962416|NCT00757601|3676572|FG006|COMPLETED|Period 3||2
2962417|NCT00757601|3676573|FG007|COMPLETED|Period 3||2
2962418|NCT00757601|3676574|FG008|COMPLETED|Period 3||2
2962419|NCT00757601|3676575|FG009|COMPLETED|Period 3||2
2962420|NCT00757601|3676576|FG010|COMPLETED|Period 3||2
2962421|NCT00757601|3676577|FG011|COMPLETED|Period 3||2
2962422|NCT00757601|3676566|FG000|NOT COMPLETED|Period 3||0
2962423|NCT00757601|3676567|FG001|NOT COMPLETED|Period 3||0
2962424|NCT00757601|3676568|FG002|NOT COMPLETED|Period 3||0
2962425|NCT00757601|3676569|FG003|NOT COMPLETED|Period 3||0
2962426|NCT00757601|3676570|FG004|NOT COMPLETED|Period 3||0
2962427|NCT00757601|3676571|FG005|NOT COMPLETED|Period 3||0
2962428|NCT00757601|3676572|FG006|NOT COMPLETED|Period 3||0
2962429|NCT00757601|3676573|FG007|NOT COMPLETED|Period 3||0
2962430|NCT00757601|3676574|FG008|NOT COMPLETED|Period 3||0
2962431|NCT00757601|3676575|FG009|NOT COMPLETED|Period 3||0
2962432|NCT00757601|3676576|FG010|NOT COMPLETED|Period 3||0
2962433|NCT00757601|3676577|FG011|NOT COMPLETED|Period 3||0
2962434|NCT00757601|3676566|FG000|STARTED|Period 4||2
2962435|NCT00757601|3676567|FG001|STARTED|Period 4||2
2962436|NCT00757601|3676568|FG002|STARTED|Period 4||2
2962437|NCT00757601|3676569|FG003|STARTED|Period 4||2
2962438|NCT00757601|3676570|FG004|STARTED|Period 4||2
2962439|NCT00757601|3676571|FG005|STARTED|Period 4||2
2962440|NCT00757601|3676572|FG006|STARTED|Period 4||2
2962441|NCT00757601|3676573|FG007|STARTED|Period 4||2
2962442|NCT00757601|3676574|FG008|STARTED|Period 4||2
2962443|NCT00757601|3676575|FG009|STARTED|Period 4||2
2962444|NCT00757601|3676576|FG010|STARTED|Period 4||2
2962445|NCT00757601|3676577|FG011|STARTED|Period 4||2
2962446|NCT00757601|3676566|FG000|COMPLETED|Period 4||2
2962447|NCT00757601|3676567|FG001|COMPLETED|Period 4||2
2962448|NCT00757601|3676568|FG002|COMPLETED|Period 4||2
2962449|NCT00757601|3676569|FG003|COMPLETED|Period 4||2
2962450|NCT00757601|3676570|FG004|COMPLETED|Period 4||2
2962451|NCT00757601|3676571|FG005|COMPLETED|Period 4||2
2962452|NCT00757601|3676572|FG006|COMPLETED|Period 4||2
2962453|NCT00757601|3676573|FG007|COMPLETED|Period 4||2
2962454|NCT00757601|3676574|FG008|COMPLETED|Period 4||2
2962455|NCT00757601|3676575|FG009|COMPLETED|Period 4|One participant discontinued after receiving the 230 mg dose of MK1006 and was not replaced|1
2962456|NCT00757601|3676576|FG010|COMPLETED|Period 4||2
2962457|NCT00757601|3676577|FG011|COMPLETED|Period 4|Replacement participant discontinued after receiving placebo to 230mg MK1006 and was not replaced|1
2962458|NCT00757601|3676566|FG000|NOT COMPLETED|Period 4||0
2962459|NCT00757601|3676567|FG001|NOT COMPLETED|Period 4||0
2962460|NCT00757601|3676568|FG002|NOT COMPLETED|Period 4||0
2962461|NCT00757601|3676569|FG003|NOT COMPLETED|Period 4||0
2962462|NCT00757601|3676570|FG004|NOT COMPLETED|Period 4||0
2962463|NCT00757601|3676571|FG005|NOT COMPLETED|Period 4||0
2962464|NCT00757601|3676572|FG006|NOT COMPLETED|Period 4||0
2962465|NCT00757601|3676573|FG007|NOT COMPLETED|Period 4||0
2962466|NCT00757601|3676574|FG008|NOT COMPLETED|Period 4||0
2962467|NCT00757601|3676575|FG009|NOT COMPLETED|Period 4||1
2962468|NCT00757601|3676576|FG010|NOT COMPLETED|Period 4||0
2962469|NCT00757601|3676577|FG011|NOT COMPLETED|Period 4||1
2962470|NCT00757601|3676566|FG000|STARTED|Period 5||2
2962471|NCT00757601|3676567|FG001|STARTED|Period 5||2
2962472|NCT00757601|3676568|FG002|STARTED|Period 5||2
2962473|NCT00757601|3676569|FG003|STARTED|Period 5||2
2962474|NCT00757601|3676570|FG004|STARTED|Period 5||2
2962475|NCT00757601|3676571|FG005|STARTED|Period 5||2
2962476|NCT00757601|3676572|FG006|STARTED|Period 5||2
2962477|NCT00757601|3676573|FG007|STARTED|Period 5||2
2962478|NCT00757601|3676574|FG008|STARTED|Period 5||2
2962479|NCT00757601|3676575|FG009|STARTED|Period 5||1
2962480|NCT00757601|3676576|FG010|STARTED|Period 5||2
2962481|NCT00757601|3676577|FG011|STARTED|Period 5||1
2962482|NCT00757601|3676566|FG000|COMPLETED|Period 5||2
2962483|NCT00757601|3676567|FG001|COMPLETED|Period 5||2
2962484|NCT00757601|3676568|FG002|COMPLETED|Period 5||2
2962485|NCT00757601|3676569|FG003|COMPLETED|Period 5||2
2962486|NCT00757601|3676570|FG004|COMPLETED|Period 5||2
2962487|NCT00757601|3676571|FG005|COMPLETED|Period 5||2
2962488|NCT00757601|3676572|FG006|COMPLETED|Period 5||2
2962489|NCT00757601|3676573|FG007|COMPLETED|Period 5||2
2962490|NCT00757601|3676574|FG008|COMPLETED|Period 5||2
2962491|NCT00757601|3676575|FG009|COMPLETED|Period 5||1
2962492|NCT00757601|3676576|FG010|COMPLETED|Period 5||2
2962493|NCT00757601|3676577|FG011|COMPLETED|Period 5||1
2962494|NCT00757601|3676566|FG000|NOT COMPLETED|Period 5||0
2962495|NCT00757601|3676567|FG001|NOT COMPLETED|Period 5||0
2962496|NCT00757601|3676568|FG002|NOT COMPLETED|Period 5||0
2962497|NCT00757601|3676569|FG003|NOT COMPLETED|Period 5||0
2962498|NCT00757601|3676570|FG004|NOT COMPLETED|Period 5||0
2962499|NCT00757601|3676571|FG005|NOT COMPLETED|Period 5||0
2962500|NCT00757601|3676572|FG006|NOT COMPLETED|Period 5||0
2962501|NCT00757601|3676573|FG007|NOT COMPLETED|Period 5||0
2962502|NCT00757601|3676574|FG008|NOT COMPLETED|Period 5||0
2962503|NCT00757601|3676575|FG009|NOT COMPLETED|Period 5||0
2962504|NCT00757601|3676576|FG010|NOT COMPLETED|Period 5||0
2962505|NCT00757601|3676577|FG011|NOT COMPLETED|Period 5||0
2962506|NCT00757666|3676609|FG000|STARTED|Overall Study||34
2962507|NCT00757666|3676610|FG001|STARTED|Overall Study||34
2962508|NCT00757666|3676609|FG000|COMPLETED|Overall Study|Number of patients with complete CPX test results from 1 month and 2 month visits|12
2962509|NCT00757666|3676610|FG001|COMPLETED|Overall Study|Number of patients with complete CPX test results from 1 month and 2 month visits|11
3163881|NCT01889862|3891339|FG002|STARTED|Part 2 (8 Weeks)|Subjects ≥20% reduction in blood Phe from naïve baseline levels are randomized in Part 2.|32
3163882|NCT01889862|3891340|FG003|STARTED|Part 2 (8 Weeks)|Subjects ≥20% reduction in blood Phe from naïve baseline levels are randomized in Part 2.|14
3163883|NCT01889862|3891341|FG004|STARTED|Part 2 (8 Weeks)||0
3163884|NCT01889862|3891337|FG000|Per Amendment #2 of the Protocol|Part 2 (8 Weeks)||29
3163885|NCT01889862|3891338|FG001|Per Amendment #2 of the Protocol|Part 2 (8 Weeks)||14
3163886|NCT01889862|3891339|FG002|Per Amendment #2 of the Protocol|Part 2 (8 Weeks)||29
2962510|NCT00757666|3676609|FG000|NOT COMPLETED|Overall Study||22
2962511|NCT00757666|3676610|FG001|NOT COMPLETED|Overall Study||23
2962512|NCT00757705|3676620|FG000|STARTED|Overall Study||299
2962513|NCT00757705|3676620|FG000|COMPLETED|Overall Study||178
2962514|NCT00757705|3676620|FG000|NOT COMPLETED|Overall Study||121
2962515|NCT00757783|3676626|FG000|STARTED|Overall Study||34
2962516|NCT00757783|3676627|FG001|STARTED|Overall Study||31
2962517|NCT00757783|3676626|FG000|COMPLETED|Overall Study||29
2962518|NCT00757783|3676627|FG001|COMPLETED|Overall Study||25
2962519|NCT00757783|3676626|FG000|NOT COMPLETED|Overall Study||5
3163887|NCT01889862|3891340|FG003|Per Amendment #2 of the Protocol|Part 2 (8 Weeks)||14
2962520|NCT00757783|3676627|FG001|NOT COMPLETED|Overall Study||6
2962521|NCT00757822|3676635|FG000|STARTED|Overall Study||92
2962522|NCT00757822|3676636|FG001|STARTED|Overall Study||88
2962523|NCT00757822|3676635|FG000|Day of Surgery (DOS) Assessment|Overall Study||92
2962524|NCT00757822|3676636|FG001|Day of Surgery (DOS) Assessment|Overall Study||88
2962525|NCT00757822|3676635|FG000|Withdrawal by Subject-no Intervention|Overall Study||1
2962526|NCT00757822|3676636|FG001|Withdrawal by Subject-no Intervention|Overall Study||3
2962527|NCT00757822|3676635|FG000|DOS Withdrawn by Investigator|Overall Study|No longer met inclusion criteria or developed exclusion criteria on DOS|6
2962528|NCT00757822|3676636|FG001|DOS Withdrawn by Investigator|Overall Study|No longer met inclusion criteria or developed exclusion criteria on DOS|11
2962529|NCT00757822|3676635|FG000|Received Study Intervention|Overall Study||85
2962530|NCT00757822|3676636|FG001|Received Study Intervention|Overall Study||74
2962531|NCT00757822|3676635|FG000|DOS: Post-operative Assessments|Overall Study||85
2962532|NCT00757822|3676636|FG001|DOS: Post-operative Assessments|Overall Study||74
2962533|NCT00757822|3676635|FG000|24-48 hr Telephone Assessment|Overall Study||85
2962534|NCT00757822|3676636|FG001|24-48 hr Telephone Assessment|Overall Study||74
2962535|NCT00757822|3676635|FG000|2-6 wk Post-op Assessment|Overall Study||85
2962536|NCT00757822|3676636|FG001|2-6 wk Post-op Assessment|Overall Study||74
2962537|NCT00757822|3676635|FG000|Data Entry, QC Assessment|Overall Study||85
2962538|NCT00757822|3676636|FG001|Data Entry, QC Assessment|Overall Study||74
2962539|NCT00757822|3676635|FG000|Withdrawn-low-risk for PONV|Overall Study|K score for PONV risk<2|12
2962540|NCT00757822|3676636|FG001|Withdrawn-low-risk for PONV|Overall Study|K score for PONV risk < 2|9
2962541|NCT00757822|3676635|FG000|Withdrawn-protocol Deviation|Overall Study||9
2962542|NCT00757822|3676636|FG001|Withdrawn-protocol Deviation|Overall Study||8
2962543|NCT00757822|3676635|FG000|Data Lock, Unblinding Analysis|Overall Study||64
2962544|NCT00757822|3676636|FG001|Data Lock, Unblinding Analysis|Overall Study||57
2962545|NCT00757822|3676635|FG000|COMPLETED|Overall Study||64
2962546|NCT00757822|3676636|FG001|COMPLETED|Overall Study||57
2962547|NCT00757822|3676635|FG000|NOT COMPLETED|Overall Study||28
2962548|NCT00757822|3676636|FG001|NOT COMPLETED|Overall Study||31
2962549|NCT00757848|3676647|FG000|STARTED|Overall Study||27
2962550|NCT00757848|3676648|FG001|STARTED|Overall Study||29
2962551|NCT00757848|3676647|FG000|COMPLETED|Overall Study||24
2962552|NCT00757848|3676648|FG001|COMPLETED|Overall Study||27
2962553|NCT00757848|3676647|FG000|NOT COMPLETED|Overall Study||3
2962554|NCT00757848|3676648|FG001|NOT COMPLETED|Overall Study||2
2962555|NCT00758043|3676658|FG000|STARTED|Overall Study||162
2962556|NCT00758043|3676659|FG001|STARTED|Overall Study||160
2962557|NCT00758043|3676660|FG002|STARTED|Overall Study||118
2962558|NCT00758043|3676661|FG003|STARTED|Overall Study||100
2962559|NCT00758043|3676658|FG000|COMPLETED|Overall Study||161
2962560|NCT00758043|3676659|FG001|COMPLETED|Overall Study||119
2962561|NCT00758043|3676660|FG002|COMPLETED|Overall Study||79
2962562|NCT00758043|3676661|FG003|COMPLETED|Overall Study||0
2962563|NCT00758043|3676658|FG000|NOT COMPLETED|Overall Study||1
2962564|NCT00758043|3676659|FG001|NOT COMPLETED|Overall Study||41
2962565|NCT00758043|3676660|FG002|NOT COMPLETED|Overall Study||39
2962566|NCT00758043|3676661|FG003|NOT COMPLETED|Overall Study||100
2962567|NCT00758069|3676680|FG000|STARTED|Overall Study|Study enrolled slightly more than the target of N=20|27
2962568|NCT00758069|3676681|FG001|STARTED|Overall Study|Study enrolled slightly more than the target of N=20|25
2962569|NCT00758069|3676682|FG002|STARTED|Overall Study|Study enrolled slightly more than the target of N=20|28
2962570|NCT00758069|3676680|FG000|COMPLETED|Overall Study||26
2962571|NCT00758069|3676681|FG001|COMPLETED|Overall Study||25
2962572|NCT00758069|3676682|FG002|COMPLETED|Overall Study||27
2962573|NCT00758069|3676680|FG000|NOT COMPLETED|Overall Study||1
2962574|NCT00758069|3676681|FG001|NOT COMPLETED|Overall Study||0
2962575|NCT00758069|3676682|FG002|NOT COMPLETED|Overall Study||1
2962576|NCT00758160|3676690|FG000|STARTED|Overall Study||296
2962577|NCT00758160|3676690|FG000|COMPLETED|Overall Study||230
2962578|NCT00758160|3676690|FG000|NOT COMPLETED|Overall Study||66
2962579|NCT00758264|3676701|FG000|STARTED|Active Phase||182
2962580|NCT00758264|3676702|FG001|STARTED|Active Phase||91
2962581|NCT00758264|3676703|FG002|STARTED|Active Phase||90
2962582|NCT00758264|3676701|FG000|COMPLETED|Active Phase||181
2962583|NCT00758264|3676702|FG001|COMPLETED|Active Phase||91
2962584|NCT00758264|3676703|FG002|COMPLETED|Active Phase||85
2962585|NCT00758264|3676701|FG000|NOT COMPLETED|Active Phase||1
2962586|NCT00758264|3676702|FG001|NOT COMPLETED|Active Phase||0
2962587|NCT00758264|3676703|FG002|NOT COMPLETED|Active Phase||5
2962588|NCT00758264|3676701|FG000|STARTED|Extended Safety Follow Up (ESFU) Phase||181
2962589|NCT00758264|3676702|FG001|STARTED|Extended Safety Follow Up (ESFU) Phase||90
2962590|NCT00758264|3676703|FG002|STARTED|Extended Safety Follow Up (ESFU) Phase||89
2962591|NCT00758264|3676701|FG000|COMPLETED|Extended Safety Follow Up (ESFU) Phase||181
2962592|NCT00758264|3676702|FG001|COMPLETED|Extended Safety Follow Up (ESFU) Phase||90
2962593|NCT00758264|3676703|FG002|COMPLETED|Extended Safety Follow Up (ESFU) Phase||89
2962594|NCT00758264|3676701|FG000|NOT COMPLETED|Extended Safety Follow Up (ESFU) Phase||0
2962595|NCT00758264|3676702|FG001|NOT COMPLETED|Extended Safety Follow Up (ESFU) Phase||0
3132994|NCT01693562|3858016|FG007|NOT COMPLETED|Expansion Phase||62
3132995|NCT01693562|3858017|FG008|NOT COMPLETED|Expansion Phase||22
3132996|NCT01693562|3858018|FG009|NOT COMPLETED|Expansion Phase||300
3132997|NCT01693562|3858019|FG010|NOT COMPLETED|Expansion Phase||40
3132998|NCT01693562|3858020|FG011|NOT COMPLETED|Expansion Phase||21
3132999|NCT01693562|3858021|FG012|NOT COMPLETED|Expansion Phase||23
3133000|NCT01693562|3858022|FG013|NOT COMPLETED|Expansion Phase||51
2962596|NCT00758264|3676703|FG002|NOT COMPLETED|Extended Safety Follow Up (ESFU) Phase||0
2962597|NCT00758342|3676713|FG000|STARTED|Overall Study||19
3133001|NCT01693562|3858023|FG014|NOT COMPLETED|Expansion Phase||40
3133002|NCT01693562|3858024|FG015|NOT COMPLETED|Expansion Phase||31
3133003|NCT01693562|3858025|FG016|NOT COMPLETED|Expansion Phase||197
3133004|NCT01693562|3858026|FG017|NOT COMPLETED|Expansion Phase||20
3301727|NCT02954653|4035347|FG000|COMPLETED|Overall Study||0
3301728|NCT02954653|4035348|FG001|COMPLETED|Overall Study||1
3301729|NCT02954653|4035349|FG002|COMPLETED|Overall Study||0
2962598|NCT00758342|3676714|FG001|STARTED|Overall Study||18
2962599|NCT00758342|3676713|FG000|COMPLETED|Overall Study||15
2962600|NCT00758342|3676714|FG001|COMPLETED|Overall Study||17
2962601|NCT00758342|3676713|FG000|NOT COMPLETED|Overall Study||4
2962602|NCT00758342|3676714|FG001|NOT COMPLETED|Overall Study||1
2962603|NCT00758394|3676724|FG000|STARTED|1st Intervention||8
2962604|NCT00758394|3676725|FG001|STARTED|1st Intervention||7
2962605|NCT00758394|3676726|FG002|STARTED|1st Intervention||6
2962606|NCT00758394|3676727|FG003|STARTED|1st Intervention||8
2962607|NCT00758394|3676724|FG000|COMPLETED|1st Intervention||8
2962608|NCT00758394|3676725|FG001|COMPLETED|1st Intervention||7
2962609|NCT00758394|3676726|FG002|COMPLETED|1st Intervention||6
2962610|NCT00758394|3676727|FG003|COMPLETED|1st Intervention||8
2962611|NCT00758394|3676724|FG000|NOT COMPLETED|1st Intervention||0
2962612|NCT00758394|3676725|FG001|NOT COMPLETED|1st Intervention||0
2962613|NCT00758394|3676726|FG002|NOT COMPLETED|1st Intervention||0
2962614|NCT00758394|3676727|FG003|NOT COMPLETED|1st Intervention||0
2962615|NCT00758394|3676724|FG000|STARTED|Washout After 1st Intervention||8
2962616|NCT00758394|3676725|FG001|STARTED|Washout After 1st Intervention||7
2962617|NCT00758394|3676726|FG002|STARTED|Washout After 1st Intervention||6
2962618|NCT00758394|3676727|FG003|STARTED|Washout After 1st Intervention||8
2962619|NCT00758394|3676724|FG000|COMPLETED|Washout After 1st Intervention||8
2962620|NCT00758394|3676725|FG001|COMPLETED|Washout After 1st Intervention||7
2962621|NCT00758394|3676726|FG002|COMPLETED|Washout After 1st Intervention||6
2962622|NCT00758394|3676727|FG003|COMPLETED|Washout After 1st Intervention||8
2962623|NCT00758394|3676724|FG000|NOT COMPLETED|Washout After 1st Intervention||0
2962624|NCT00758394|3676725|FG001|NOT COMPLETED|Washout After 1st Intervention||0
2962625|NCT00758394|3676726|FG002|NOT COMPLETED|Washout After 1st Intervention||0
2962626|NCT00758394|3676727|FG003|NOT COMPLETED|Washout After 1st Intervention||0
2962627|NCT00758394|3676724|FG000|STARTED|2nd Intervention Order||8
2962628|NCT00758394|3676725|FG001|STARTED|2nd Intervention Order||7
2962629|NCT00758394|3676726|FG002|STARTED|2nd Intervention Order||6
2962630|NCT00758394|3676727|FG003|STARTED|2nd Intervention Order||8
2962631|NCT00758394|3676724|FG000|COMPLETED|2nd Intervention Order||8
2962632|NCT00758394|3676725|FG001|COMPLETED|2nd Intervention Order||6
2962633|NCT00758394|3676726|FG002|COMPLETED|2nd Intervention Order||6
2962634|NCT00758394|3676727|FG003|COMPLETED|2nd Intervention Order||8
2962635|NCT00758394|3676724|FG000|NOT COMPLETED|2nd Intervention Order||0
2962636|NCT00758394|3676725|FG001|NOT COMPLETED|2nd Intervention Order||1
2962637|NCT00758394|3676726|FG002|NOT COMPLETED|2nd Intervention Order||0
2962638|NCT00758394|3676727|FG003|NOT COMPLETED|2nd Intervention Order||0
2962639|NCT00758394|3676724|FG000|STARTED|Washout After 2nd Intervention||8
2962640|NCT00758394|3676725|FG001|STARTED|Washout After 2nd Intervention||6
2962641|NCT00758394|3676726|FG002|STARTED|Washout After 2nd Intervention||6
2962642|NCT00758394|3676727|FG003|STARTED|Washout After 2nd Intervention||8
2962643|NCT00758394|3676724|FG000|COMPLETED|Washout After 2nd Intervention||8
2962644|NCT00758394|3676725|FG001|COMPLETED|Washout After 2nd Intervention||6
2962645|NCT00758394|3676726|FG002|COMPLETED|Washout After 2nd Intervention||6
2962646|NCT00758394|3676727|FG003|COMPLETED|Washout After 2nd Intervention||8
2962647|NCT00758394|3676724|FG000|NOT COMPLETED|Washout After 2nd Intervention||0
2962648|NCT00758394|3676725|FG001|NOT COMPLETED|Washout After 2nd Intervention||0
2962649|NCT00758394|3676726|FG002|NOT COMPLETED|Washout After 2nd Intervention||0
2962650|NCT00758394|3676727|FG003|NOT COMPLETED|Washout After 2nd Intervention||0
2962651|NCT00758394|3676724|FG000|STARTED|3rd Intervention||8
2962652|NCT00758394|3676725|FG001|STARTED|3rd Intervention||6
2962653|NCT00758394|3676726|FG002|STARTED|3rd Intervention||6
2962654|NCT00758394|3676727|FG003|STARTED|3rd Intervention||8
3133005|NCT01693562|3858027|FG018|NOT COMPLETED|Expansion Phase||47
3133006|NCT01693562|3858028|FG019|NOT COMPLETED|Expansion Phase||20
3301730|NCT02954653|4035350|FG003|COMPLETED|Overall Study||0
3301731|NCT02954653|4035351|FG004|COMPLETED|Overall Study||0
3301732|NCT02954653|4035352|FG005|COMPLETED|Overall Study||0
3301733|NCT02954653|4035353|FG006|COMPLETED|Overall Study||0
3301734|NCT02954653|4035354|FG007|COMPLETED|Overall Study||0
3301735|NCT02954653|4035355|FG008|COMPLETED|Overall Study||0
3301736|NCT02954653|4035347|FG000|NOT COMPLETED|Overall Study||4
3301737|NCT02954653|4035348|FG001|NOT COMPLETED|Overall Study||3
3301738|NCT02954653|4035349|FG002|NOT COMPLETED|Overall Study||0
3301739|NCT02954653|4035350|FG003|NOT COMPLETED|Overall Study||0
3301740|NCT02954653|4035351|FG004|NOT COMPLETED|Overall Study||0
3301741|NCT02954653|4035352|FG005|NOT COMPLETED|Overall Study||0
3301742|NCT02954653|4035353|FG006|NOT COMPLETED|Overall Study||0
3301743|NCT02954653|4035354|FG007|NOT COMPLETED|Overall Study||0
3301744|NCT02954653|4035355|FG008|NOT COMPLETED|Overall Study||0
3301745|NCT02954848|4035369|FG000|STARTED|Overall Study||245
3301746|NCT02954848|4035370|FG001|STARTED|Overall Study||239
3301747|NCT02954848|4035369|FG000|Treated|Overall Study||245
3301748|NCT02954848|4035370|FG001|Treated|Overall Study||238
3301749|NCT02954848|4035369|FG000|COMPLETED|Overall Study||243
3301750|NCT02954848|4035370|FG001|COMPLETED|Overall Study||234
3301751|NCT02954848|4035369|FG000|NOT COMPLETED|Overall Study||2
3133007|NCT01693562|3858029|FG020|NOT COMPLETED|Expansion Phase||21
3133008|NCT01693562|3858030|FG021|NOT COMPLETED|Expansion Phase||62
3133009|NCT01693562|3858031|FG022|NOT COMPLETED|Expansion Phase||10
3133010|NCT01693614|3858117|FG000|STARTED|Overall Study||26
3133011|NCT01693614|3858118|FG001|STARTED|Overall Study||22
3133012|NCT01693614|3858119|FG002|STARTED|Overall Study||24
2962655|NCT00758394|3676724|FG000|COMPLETED|3rd Intervention||7
2962656|NCT00758394|3676725|FG001|COMPLETED|3rd Intervention||6
2962657|NCT00758394|3676726|FG002|COMPLETED|3rd Intervention||6
2962658|NCT00758394|3676727|FG003|COMPLETED|3rd Intervention||7
2962659|NCT00758394|3676724|FG000|NOT COMPLETED|3rd Intervention||1
2962660|NCT00758394|3676725|FG001|NOT COMPLETED|3rd Intervention||0
2962661|NCT00758394|3676726|FG002|NOT COMPLETED|3rd Intervention||0
2962662|NCT00758394|3676727|FG003|NOT COMPLETED|3rd Intervention||1
2962663|NCT00758394|3676724|FG000|STARTED|Washout After 3rd Intervention||7
2962664|NCT00758394|3676725|FG001|STARTED|Washout After 3rd Intervention||6
2962665|NCT00758394|3676726|FG002|STARTED|Washout After 3rd Intervention||6
2962666|NCT00758394|3676727|FG003|STARTED|Washout After 3rd Intervention||7
2962667|NCT00758394|3676724|FG000|COMPLETED|Washout After 3rd Intervention||7
2962668|NCT00758394|3676725|FG001|COMPLETED|Washout After 3rd Intervention||6
2962669|NCT00758394|3676726|FG002|COMPLETED|Washout After 3rd Intervention||6
2962670|NCT00758394|3676727|FG003|COMPLETED|Washout After 3rd Intervention||7
2962671|NCT00758394|3676724|FG000|NOT COMPLETED|Washout After 3rd Intervention||0
2962672|NCT00758394|3676725|FG001|NOT COMPLETED|Washout After 3rd Intervention||0
2962673|NCT00758394|3676726|FG002|NOT COMPLETED|Washout After 3rd Intervention||0
2962674|NCT00758394|3676727|FG003|NOT COMPLETED|Washout After 3rd Intervention||0
2962675|NCT00758394|3676724|FG000|STARTED|4th Intervention||7
2962676|NCT00758394|3676725|FG001|STARTED|4th Intervention||6
2962677|NCT00758394|3676726|FG002|STARTED|4th Intervention||6
2962678|NCT00758394|3676727|FG003|STARTED|4th Intervention||7
2962679|NCT00758394|3676724|FG000|COMPLETED|4th Intervention||7
2962680|NCT00758394|3676725|FG001|COMPLETED|4th Intervention||6
2962681|NCT00758394|3676726|FG002|COMPLETED|4th Intervention||6
2962682|NCT00758394|3676727|FG003|COMPLETED|4th Intervention||7
2962683|NCT00758394|3676724|FG000|NOT COMPLETED|4th Intervention||0
2962684|NCT00758394|3676725|FG001|NOT COMPLETED|4th Intervention||0
2962685|NCT00758394|3676726|FG002|NOT COMPLETED|4th Intervention||0
2962686|NCT00758394|3676727|FG003|NOT COMPLETED|4th Intervention||0
2962687|NCT00758420|3676739|FG000|STARTED|Overall Study||39
2962688|NCT00758420|3676740|FG001|STARTED|Overall Study||38
2962689|NCT00758420|3676739|FG000|COMPLETED|Overall Study||39
2962690|NCT00758420|3676740|FG001|COMPLETED|Overall Study||38
2962691|NCT00758420|3676739|FG000|NOT COMPLETED|Overall Study||0
2962692|NCT00758420|3676740|FG001|NOT COMPLETED|Overall Study||0
2962693|NCT00758459|3676748|FG000|STARTED|Overall Study||35
2962694|NCT00758459|3676749|FG001|STARTED|Overall Study||39
2962695|NCT00758459|3676748|FG000|COMPLETED|Overall Study||32
2962696|NCT00758459|3676749|FG001|COMPLETED|Overall Study||35
2962697|NCT00758459|3676748|FG000|NOT COMPLETED|Overall Study||3
2962698|NCT00758459|3676749|FG001|NOT COMPLETED|Overall Study||4
2962699|NCT00758485|3676757|FG000|STARTED|Overall Study||70
2962700|NCT00758485|3676758|FG001|STARTED|Overall Study||70
2962701|NCT00758485|3676757|FG000|TREATED|Overall Study||69
2962702|NCT00758485|3676758|FG001|TREATED|Overall Study||68
2962703|NCT00758485|3676757|FG000|COMPLETED|Overall Study||69
2962704|NCT00758485|3676758|FG001|COMPLETED|Overall Study||67
2962705|NCT00758485|3676757|FG000|NOT COMPLETED|Overall Study||1
2962706|NCT00758485|3676758|FG001|NOT COMPLETED|Overall Study||3
2962707|NCT00758498|3676768|FG000|STARTED|Overall Study||142
2962708|NCT00758498|3676769|FG001|STARTED|Overall Study||143
2962709|NCT00758498|3676770|FG002|STARTED|Overall Study||142
2962710|NCT00758498|3676768|FG000|COMPLETED|Overall Study||139
2962711|NCT00758498|3676769|FG001|COMPLETED|Overall Study||141
2962712|NCT00758498|3676770|FG002|COMPLETED|Overall Study||137
2962713|NCT00758498|3676768|FG000|NOT COMPLETED|Overall Study||3
2962714|NCT00758498|3676769|FG001|NOT COMPLETED|Overall Study||2
2962715|NCT00758498|3676770|FG002|NOT COMPLETED|Overall Study||5
2962716|NCT00758524|3676784|FG000|STARTED|Core Period (Week 0 to Week 8)||92
2962717|NCT00758524|3676785|FG001|STARTED|Core Period (Week 0 to Week 8)||88
2962718|NCT00758524|3676786|FG002|STARTED|Core Period (Week 0 to Week 8)||86
2962719|NCT00758524|3676787|FG003|STARTED|Core Period (Week 0 to Week 8)|One participant in this arm group was randomized twice and was excluded from Full Analysis Set.|97
2962720|NCT00758524|3676788|FG004|STARTED|Core Period (Week 0 to Week 8)||84
2962721|NCT00758524|3676789|FG005|STARTED|Core Period (Week 0 to Week 8)||77
2962722|NCT00758524|3676790|FG006|STARTED|Core Period (Week 0 to Week 8)||0
2962723|NCT00758524|3676791|FG007|STARTED|Core Period (Week 0 to Week 8)||0
2962724|NCT00758524|3676792|FG008|STARTED|Core Period (Week 0 to Week 8)||0
2962725|NCT00758524|3676793|FG009|STARTED|Core Period (Week 0 to Week 8)||0
2962726|NCT00758524|3676794|FG010|STARTED|Core Period (Week 0 to Week 8)||0
2962727|NCT00758524|3676795|FG011|STARTED|Core Period (Week 0 to Week 8)||0
2962728|NCT00758524|3676796|FG012|STARTED|Core Period (Week 0 to Week 8)||0
3133013|NCT01693614|3858117|FG000|COMPLETED|Overall Study||0
3133014|NCT01693614|3858118|FG001|COMPLETED|Overall Study||0
3133015|NCT01693614|3858119|FG002|COMPLETED|Overall Study||0
3133016|NCT01693614|3858117|FG000|NOT COMPLETED|Overall Study||26
3133017|NCT01693614|3858118|FG001|NOT COMPLETED|Overall Study||22
3133018|NCT01693614|3858119|FG002|NOT COMPLETED|Overall Study||24
3133019|NCT01693900|3858130|FG000|STARTED|Overall Study||25
2962729|NCT00758524|3676797|FG013|STARTED|Core Period (Week 0 to Week 8)||0
2962730|NCT00758524|3676798|FG014|STARTED|Core Period (Week 0 to Week 8)||0
2962731|NCT00758524|3676799|FG015|STARTED|Core Period (Week 0 to Week 8)||0
2962732|NCT00758524|3676800|FG016|STARTED|Core Period (Week 0 to Week 8)||0
2962733|NCT00758524|3676784|FG000|Treated|Core Period (Week 0 to Week 8)||92
2962734|NCT00758524|3676785|FG001|Treated|Core Period (Week 0 to Week 8)||87
2962735|NCT00758524|3676786|FG002|Treated|Core Period (Week 0 to Week 8)|One participant from LCI699 0.5 mg QD was randomized to LCI699 1.0 mg QD and received LCI699 1.0 mg QD, thus was included in this arm in the Safety Set.|87
2962736|NCT00758524|3676787|FG003|Treated|Core Period (Week 0 to Week 8)||97
2962737|NCT00758524|3676788|FG004|Treated|Core Period (Week 0 to Week 8)||84
2962738|NCT00758524|3676789|FG005|Treated|Core Period (Week 0 to Week 8)||76
2962739|NCT00758524|3676790|FG006|Treated|Core Period (Week 0 to Week 8)||0
2962740|NCT00758524|3676791|FG007|Treated|Core Period (Week 0 to Week 8)||0
2962741|NCT00758524|3676792|FG008|Treated|Core Period (Week 0 to Week 8)||0
2962742|NCT00758524|3676793|FG009|Treated|Core Period (Week 0 to Week 8)||0
2962743|NCT00758524|3676794|FG010|Treated|Core Period (Week 0 to Week 8)||0
2962744|NCT00758524|3676795|FG011|Treated|Core Period (Week 0 to Week 8)||0
2962745|NCT00758524|3676796|FG012|Treated|Core Period (Week 0 to Week 8)||0
2962746|NCT00758524|3676797|FG013|Treated|Core Period (Week 0 to Week 8)||0
2962747|NCT00758524|3676798|FG014|Treated|Core Period (Week 0 to Week 8)||0
2962748|NCT00758524|3676799|FG015|Treated|Core Period (Week 0 to Week 8)||0
2962749|NCT00758524|3676800|FG016|Treated|Core Period (Week 0 to Week 8)||0
2962750|NCT00758524|3676784|FG000|COMPLETED|Core Period (Week 0 to Week 8)||84
2962751|NCT00758524|3676785|FG001|COMPLETED|Core Period (Week 0 to Week 8)||81
2962752|NCT00758524|3676786|FG002|COMPLETED|Core Period (Week 0 to Week 8)||77
2962753|NCT00758524|3676787|FG003|COMPLETED|Core Period (Week 0 to Week 8)||90
2962754|NCT00758524|3676788|FG004|COMPLETED|Core Period (Week 0 to Week 8)||75
2962755|NCT00758524|3676789|FG005|COMPLETED|Core Period (Week 0 to Week 8)||67
2962756|NCT00758524|3676790|FG006|COMPLETED|Core Period (Week 0 to Week 8)||0
2962757|NCT00758524|3676791|FG007|COMPLETED|Core Period (Week 0 to Week 8)||0
2962758|NCT00758524|3676792|FG008|COMPLETED|Core Period (Week 0 to Week 8)||0
2962759|NCT00758524|3676793|FG009|COMPLETED|Core Period (Week 0 to Week 8)||0
2962760|NCT00758524|3676794|FG010|COMPLETED|Core Period (Week 0 to Week 8)||0
2962761|NCT00758524|3676795|FG011|COMPLETED|Core Period (Week 0 to Week 8)||0
2962762|NCT00758524|3676796|FG012|COMPLETED|Core Period (Week 0 to Week 8)||0
2962763|NCT00758524|3676797|FG013|COMPLETED|Core Period (Week 0 to Week 8)||0
2962764|NCT00758524|3676798|FG014|COMPLETED|Core Period (Week 0 to Week 8)||0
2962765|NCT00758524|3676799|FG015|COMPLETED|Core Period (Week 0 to Week 8)||0
2962766|NCT00758524|3676800|FG016|COMPLETED|Core Period (Week 0 to Week 8)||0
2962767|NCT00758524|3676784|FG000|NOT COMPLETED|Core Period (Week 0 to Week 8)||8
2962768|NCT00758524|3676785|FG001|NOT COMPLETED|Core Period (Week 0 to Week 8)||7
2962769|NCT00758524|3676786|FG002|NOT COMPLETED|Core Period (Week 0 to Week 8)||9
2962770|NCT00758524|3676787|FG003|NOT COMPLETED|Core Period (Week 0 to Week 8)||7
2962771|NCT00758524|3676788|FG004|NOT COMPLETED|Core Period (Week 0 to Week 8)||9
2962772|NCT00758524|3676789|FG005|NOT COMPLETED|Core Period (Week 0 to Week 8)||10
2962773|NCT00758524|3676790|FG006|NOT COMPLETED|Core Period (Week 0 to Week 8)||0
2962774|NCT00758524|3676791|FG007|NOT COMPLETED|Core Period (Week 0 to Week 8)||0
2962775|NCT00758524|3676792|FG008|NOT COMPLETED|Core Period (Week 0 to Week 8)||0
2962776|NCT00758524|3676793|FG009|NOT COMPLETED|Core Period (Week 0 to Week 8)||0
2962777|NCT00758524|3676794|FG010|NOT COMPLETED|Core Period (Week 0 to Week 8)||0
2962778|NCT00758524|3676795|FG011|NOT COMPLETED|Core Period (Week 0 to Week 8)||0
2962779|NCT00758524|3676796|FG012|NOT COMPLETED|Core Period (Week 0 to Week 8)||0
2962780|NCT00758524|3676797|FG013|NOT COMPLETED|Core Period (Week 0 to Week 8)||0
2962781|NCT00758524|3676798|FG014|NOT COMPLETED|Core Period (Week 0 to Week 8)||0
2962782|NCT00758524|3676799|FG015|NOT COMPLETED|Core Period (Week 0 to Week 8)||0
2962783|NCT00758524|3676800|FG016|NOT COMPLETED|Core Period (Week 0 to Week 8)||0
2962784|NCT00758524|3676784|FG000|STARTED|Withdrawal Period (Week 8 to Week 9)||0
2962785|NCT00758524|3676785|FG001|STARTED|Withdrawal Period (Week 8 to Week 9)||0
2962786|NCT00758524|3676786|FG002|STARTED|Withdrawal Period (Week 8 to Week 9)||0
2962787|NCT00758524|3676787|FG003|STARTED|Withdrawal Period (Week 8 to Week 9)||0
2962788|NCT00758524|3676788|FG004|STARTED|Withdrawal Period (Week 8 to Week 9)||0
2962789|NCT00758524|3676789|FG005|STARTED|Withdrawal Period (Week 8 to Week 9)||0
2962790|NCT00758524|3676790|FG006|STARTED|Withdrawal Period (Week 8 to Week 9)||46
2962791|NCT00758524|3676791|FG007|STARTED|Withdrawal Period (Week 8 to Week 9)||38
2962792|NCT00758524|3676792|FG008|STARTED|Withdrawal Period (Week 8 to Week 9)||44
2962793|NCT00758524|3676793|FG009|STARTED|Withdrawal Period (Week 8 to Week 9)|One participant randomized to Placebo arm in Withdrawal Period received LCI699 0.5 mg QD and was counted in LCI699 0.5 mg QD arm in the Randomized Withdrawal Safety Set.|37
2962794|NCT00758524|3676794|FG010|STARTED|Withdrawal Period (Week 8 to Week 9)||41
2962795|NCT00758524|3676795|FG011|STARTED|Withdrawal Period (Week 8 to Week 9)|One participant randomized to LCI699 0.5 mg BID in the core period received LCI699 1.0 mg QD and was considered in the LCI699 1.0 mg QD arm in Randomized Withdrawal Safety Set.|37
2962796|NCT00758524|3676796|FG012|STARTED|Withdrawal Period (Week 8 to Week 9)||45
2962797|NCT00758524|3676797|FG013|STARTED|Withdrawal Period (Week 8 to Week 9)||45
2962798|NCT00758524|3676798|FG014|STARTED|Withdrawal Period (Week 8 to Week 9)||39
2962799|NCT00758524|3676799|FG015|STARTED|Withdrawal Period (Week 8 to Week 9)||36
2962800|NCT00758524|3676800|FG016|STARTED|Withdrawal Period (Week 8 to Week 9)||66
2962801|NCT00758524|3676784|FG000|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||0
2962802|NCT00758524|3676785|FG001|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||0
2962803|NCT00758524|3676786|FG002|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||0
2962804|NCT00758524|3676787|FG003|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||0
2962805|NCT00758524|3676788|FG004|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||0
2962806|NCT00758524|3676789|FG005|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||0
2962807|NCT00758524|3676790|FG006|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||45
2962808|NCT00758524|3676791|FG007|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||38
2962809|NCT00758524|3676792|FG008|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||43
2962810|NCT00758524|3676793|FG009|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||37
2962811|NCT00758524|3676794|FG010|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||41
2962812|NCT00758524|3676795|FG011|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||36
2962813|NCT00758524|3676796|FG012|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||45
2962814|NCT00758524|3676797|FG013|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||44
2962815|NCT00758524|3676798|FG014|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||39
2962816|NCT00758524|3676799|FG015|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||36
2962817|NCT00758524|3676800|FG016|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)|One participant randomized to Placebo arm in Withdrawal Period received LCI699 0.5 mg QD and was counted in LCI699 0.5 mg QD arm in the Randomized Withdrawal Safety Set. However, this participant was counted in the Placebo arm (N=67) in the Randomized Withdrawal Set.|67
2962818|NCT00758524|3676784|FG000|COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
2962819|NCT00758524|3676785|FG001|COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
2962820|NCT00758524|3676786|FG002|COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
2962821|NCT00758524|3676787|FG003|COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
2962822|NCT00758524|3676788|FG004|COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
2962823|NCT00758524|3676789|FG005|COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
2962824|NCT00758524|3676790|FG006|COMPLETED|Withdrawal Period (Week 8 to Week 9)||45
2962825|NCT00758524|3676791|FG007|COMPLETED|Withdrawal Period (Week 8 to Week 9)||38
2962826|NCT00758524|3676792|FG008|COMPLETED|Withdrawal Period (Week 8 to Week 9)||42
2962827|NCT00758524|3676793|FG009|COMPLETED|Withdrawal Period (Week 8 to Week 9)||37
2962828|NCT00758524|3676794|FG010|COMPLETED|Withdrawal Period (Week 8 to Week 9)||41
2962829|NCT00758524|3676795|FG011|COMPLETED|Withdrawal Period (Week 8 to Week 9)||37
2962830|NCT00758524|3676796|FG012|COMPLETED|Withdrawal Period (Week 8 to Week 9)||45
2962831|NCT00758524|3676797|FG013|COMPLETED|Withdrawal Period (Week 8 to Week 9)||45
2962832|NCT00758524|3676798|FG014|COMPLETED|Withdrawal Period (Week 8 to Week 9)||39
2962833|NCT00758524|3676799|FG015|COMPLETED|Withdrawal Period (Week 8 to Week 9)||36
2962834|NCT00758524|3676800|FG016|COMPLETED|Withdrawal Period (Week 8 to Week 9)||66
2962835|NCT00758524|3676784|FG000|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
2962836|NCT00758524|3676785|FG001|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
2962837|NCT00758524|3676786|FG002|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
2962838|NCT00758524|3676787|FG003|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
2962839|NCT00758524|3676788|FG004|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
2962840|NCT00758524|3676789|FG005|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
2962841|NCT00758524|3676790|FG006|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||1
2962842|NCT00758524|3676791|FG007|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
2962843|NCT00758524|3676792|FG008|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||2
2962844|NCT00758524|3676793|FG009|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
2962845|NCT00758524|3676794|FG010|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
2962846|NCT00758524|3676795|FG011|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
2962847|NCT00758524|3676796|FG012|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
2962848|NCT00758524|3676797|FG013|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
2962849|NCT00758524|3676798|FG014|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
2962850|NCT00758524|3676799|FG015|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
2962851|NCT00758524|3676800|FG016|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
2962852|NCT00758550|3676840|FG000|STARTED|Overall Study||30
2962853|NCT00758550|3676841|FG001|STARTED|Overall Study||30
2962854|NCT00758550|3676840|FG000|COMPLETED|Overall Study||30
2962855|NCT00758550|3676841|FG001|COMPLETED|Overall Study||30
2962856|NCT00758550|3676840|FG000|NOT COMPLETED|Overall Study||0
2962857|NCT00758550|3676841|FG001|NOT COMPLETED|Overall Study||0
2962858|NCT00758576|3676847|FG000|STARTED|Overall Study||64
2962859|NCT00758576|3676847|FG000|COMPLETED|Overall Study||63
2962860|NCT00758576|3676847|FG000|NOT COMPLETED|Overall Study||1
2962861|NCT00758589|3676855|FG000|STARTED|Overall Study||95
2962862|NCT00758589|3676856|FG001|STARTED|Overall Study||90
2962863|NCT00758589|3676857|FG002|STARTED|Overall Study||92
2962864|NCT00758589|3676858|FG003|STARTED|Overall Study||91
2962865|NCT00758589|3676855|FG000|COMPLETED|Overall Study||92
2962866|NCT00758589|3676856|FG001|COMPLETED|Overall Study||87
2962867|NCT00758589|3676857|FG002|COMPLETED|Overall Study||86
2962868|NCT00758589|3676858|FG003|COMPLETED|Overall Study||85
2962869|NCT00758589|3676855|FG000|NOT COMPLETED|Overall Study||3
2962870|NCT00758589|3676856|FG001|NOT COMPLETED|Overall Study||3
2962871|NCT00758589|3676857|FG002|NOT COMPLETED|Overall Study||6
2962872|NCT00758589|3676858|FG003|NOT COMPLETED|Overall Study||6
2962873|NCT00758602|3676870|FG000|STARTED|Overall Study||104
2962874|NCT00758602|3676871|FG001|STARTED|Overall Study||106
2962875|NCT00758602|3676870|FG000|COMPLETED|Overall Study||85
2962876|NCT00758602|3676871|FG001|COMPLETED|Overall Study||84
2962877|NCT00758602|3676870|FG000|NOT COMPLETED|Overall Study||19
2962878|NCT00758602|3676871|FG001|NOT COMPLETED|Overall Study||22
2962879|NCT00758667|3676880|FG000|STARTED|Overall Study||9
2962880|NCT00758667|3676881|FG001|STARTED|Overall Study||11
2962881|NCT00758667|3676880|FG000|COMPLETED|Overall Study||9
2962882|NCT00758667|3676881|FG001|COMPLETED|Overall Study||11
2962883|NCT00758667|3676880|FG000|NOT COMPLETED|Overall Study||0
2962884|NCT00758667|3676881|FG001|NOT COMPLETED|Overall Study||0
2962885|NCT00758680|3676888|FG000|STARTED|Overall Study||6
2962886|NCT00758680|3676889|FG001|STARTED|Overall Study||6
2962887|NCT00758680|3676890|FG002|STARTED|Overall Study||6
2962888|NCT00758680|3676891|FG003|STARTED|Overall Study||6
2962889|NCT00758680|3676892|FG004|STARTED|Overall Study||6
2962890|NCT00758680|3676893|FG005|STARTED|Overall Study||6
2962891|NCT00758680|3676894|FG006|STARTED|Overall Study||7
2962892|NCT00758680|3676895|FG007|STARTED|Overall Study||20
2962893|NCT00758680|3676896|FG008|STARTED|Overall Study||20
2962894|NCT00758680|3676897|FG009|STARTED|Overall Study||29
2962895|NCT00758680|3676888|FG000|COMPLETED|Overall Study||6
2962896|NCT00758680|3676889|FG001|COMPLETED|Overall Study||6
2962897|NCT00758680|3676890|FG002|COMPLETED|Overall Study||6
2962898|NCT00758680|3676891|FG003|COMPLETED|Overall Study||6
2962899|NCT00758680|3676892|FG004|COMPLETED|Overall Study||6
2962900|NCT00758680|3676893|FG005|COMPLETED|Overall Study||6
2962901|NCT00758680|3676894|FG006|COMPLETED|Overall Study||6
2962902|NCT00758680|3676895|FG007|COMPLETED|Overall Study||19
2962903|NCT00758680|3676896|FG008|COMPLETED|Overall Study||18
2962904|NCT00758680|3676897|FG009|COMPLETED|Overall Study||28
2962905|NCT00758680|3676888|FG000|NOT COMPLETED|Overall Study||0
2962906|NCT00758680|3676889|FG001|NOT COMPLETED|Overall Study||0
2962907|NCT00758680|3676890|FG002|NOT COMPLETED|Overall Study||0
2962908|NCT00758680|3676891|FG003|NOT COMPLETED|Overall Study||0
2962909|NCT00758680|3676892|FG004|NOT COMPLETED|Overall Study||0
2962910|NCT00758680|3676893|FG005|NOT COMPLETED|Overall Study||0
2962911|NCT00758680|3676894|FG006|NOT COMPLETED|Overall Study||1
3301752|NCT02954848|4035370|FG001|NOT COMPLETED|Overall Study||5
3301753|NCT02954887|4035376|FG000|STARTED|Overall Study||9
3301754|NCT02954887|4035376|FG000|COMPLETED|Overall Study||2
3301755|NCT02954887|4035376|FG000|NOT COMPLETED|Overall Study||7
3301756|NCT02955069|4035382|FG000|STARTED|Overall Study||95
3301757|NCT02955069|4035383|FG001|STARTED|Overall Study||21
3301758|NCT02955069|4035382|FG000|Full Analysis Set (FAS)|Overall Study||95
3301759|NCT02955069|4035383|FG001|Full Analysis Set (FAS)|Overall Study||21
3301760|NCT02955069|4035382|FG000|Safety Set|Overall Study||95
3301761|NCT02955069|4035383|FG001|Safety Set|Overall Study||21
3301762|NCT02955069|4035382|FG000|Pharmacokinetic Analysis Set (PAS)|Overall Study||94
3301763|NCT02955069|4035383|FG001|Pharmacokinetic Analysis Set (PAS)|Overall Study||18
2962912|NCT00758680|3676895|FG007|NOT COMPLETED|Overall Study||1
2962913|NCT00758680|3676896|FG008|NOT COMPLETED|Overall Study||2
2962914|NCT00758680|3676897|FG009|NOT COMPLETED|Overall Study||1
2962915|NCT00758706|3676922|FG000|STARTED|Overall Study||26
2962916|NCT00758706|3676923|FG001|STARTED|Overall Study||29
2962917|NCT00758706|3676922|FG000|COMPLETED|Overall Study||22
2962918|NCT00758706|3676923|FG001|COMPLETED|Overall Study||25
2962919|NCT00758706|3676922|FG000|NOT COMPLETED|Overall Study||4
2962920|NCT00758706|3676923|FG001|NOT COMPLETED|Overall Study||4
2962921|NCT00758745|3676931|FG000|STARTED|Overall Study||81
2962922|NCT00758745|3676932|FG001|STARTED|Overall Study||81
2962923|NCT00758745|3676931|FG000|COMPLETED|Overall Study||60
2962924|NCT00758745|3676932|FG001|COMPLETED|Overall Study||60
2962925|NCT00758745|3676931|FG000|NOT COMPLETED|Overall Study||21
2962926|NCT00758745|3676932|FG001|NOT COMPLETED|Overall Study||21
2962927|NCT00758758|3676946|FG000|STARTED|Overall Study||14
2962928|NCT00758758|3676947|FG001|STARTED|Overall Study||74
2962929|NCT00758758|3676948|FG002|STARTED|Overall Study||53
2962930|NCT00758758|3676949|FG003|STARTED|Overall Study||6
2962931|NCT00758758|3676950|FG004|STARTED|Overall Study||3
2962932|NCT00758758|3676951|FG005|STARTED|Overall Study||50
2962933|NCT00758758|3676952|FG006|STARTED|Overall Study||31
2962934|NCT00758758|3676953|FG007|STARTED|Overall Study||0
2962935|NCT00758758|3676946|FG000|COMPLETED|Overall Study||11
2962936|NCT00758758|3676947|FG001|COMPLETED|Overall Study||49
2962937|NCT00758758|3676948|FG002|COMPLETED|Overall Study||35
2962938|NCT00758758|3676949|FG003|COMPLETED|Overall Study||4
2962939|NCT00758758|3676950|FG004|COMPLETED|Overall Study||1
3301764|NCT02955069|4035382|FG000|Immunogenicity (IG) Prevalence Set|Overall Study||94
2962940|NCT00758758|3676951|FG005|COMPLETED|Overall Study||36
2962941|NCT00758758|3676952|FG006|COMPLETED|Overall Study||17
2962942|NCT00758758|3676953|FG007|COMPLETED|Overall Study||0
2962943|NCT00758758|3676946|FG000|NOT COMPLETED|Overall Study||3
2962944|NCT00758758|3676947|FG001|NOT COMPLETED|Overall Study||25
2962945|NCT00758758|3676948|FG002|NOT COMPLETED|Overall Study||18
2962946|NCT00758758|3676949|FG003|NOT COMPLETED|Overall Study||2
2962947|NCT00758758|3676950|FG004|NOT COMPLETED|Overall Study||2
2962948|NCT00758758|3676951|FG005|NOT COMPLETED|Overall Study||14
2962949|NCT00758758|3676952|FG006|NOT COMPLETED|Overall Study||14
2962950|NCT00758758|3676953|FG007|NOT COMPLETED|Overall Study||0
2962951|NCT00758771|3676981|FG000|STARTED|Overall Study||18
2962952|NCT00758771|3676982|FG001|STARTED|Overall Study||20
2962953|NCT00758771|3676981|FG000|COMPLETED|Overall Study||15
2962954|NCT00758771|3676982|FG001|COMPLETED|Overall Study||15
2962955|NCT00758771|3676981|FG000|NOT COMPLETED|Overall Study||3
2962956|NCT00758771|3676982|FG001|NOT COMPLETED|Overall Study||5
2962957|NCT00758784|3676988|FG000|STARTED|Overall Study||38
2962958|NCT00758784|3676988|FG000|COMPLETED|Overall Study||36
2962959|NCT00758784|3676988|FG000|NOT COMPLETED|Overall Study||2
2962960|NCT00758836|3676996|FG000|STARTED|Overall Study||171
2962961|NCT00758836|3676997|FG001|STARTED|Overall Study||171
2962962|NCT00758836|3676998|FG002|STARTED|Overall Study||171
2962963|NCT00758836|3676999|FG003|STARTED|Overall Study||170
2962964|NCT00758836|3676996|FG000|Treated|Overall Study||147
2962965|NCT00758836|3676997|FG001|Treated|Overall Study||145
2962966|NCT00758836|3676998|FG002|Treated|Overall Study||133
2962967|NCT00758836|3676999|FG003|Treated|Overall Study||138
2962968|NCT00758836|3676996|FG000|COMPLETED|Overall Study||147
2962969|NCT00758836|3676997|FG001|COMPLETED|Overall Study||145
2962970|NCT00758836|3676998|FG002|COMPLETED|Overall Study||133
2962971|NCT00758836|3676999|FG003|COMPLETED|Overall Study||138
2962972|NCT00758836|3676996|FG000|NOT COMPLETED|Overall Study||24
2962973|NCT00758836|3676997|FG001|NOT COMPLETED|Overall Study||26
2962974|NCT00758836|3676998|FG002|NOT COMPLETED|Overall Study||38
2962975|NCT00758836|3676999|FG003|NOT COMPLETED|Overall Study||32
2962976|NCT00758862|3677009|FG000|STARTED|Overall Study||20
2962977|NCT00758862|3677009|FG000|COMPLETED|Overall Study||19
2962978|NCT00758862|3677009|FG000|NOT COMPLETED|Overall Study||1
2962979|NCT00759031|3677015|FG000|STARTED|First Intervention (1 Day)||10
2962980|NCT00759031|3677016|FG001|STARTED|First Intervention (1 Day)||9
2962981|NCT00759031|3677015|FG000|COMPLETED|First Intervention (1 Day)||8
2962982|NCT00759031|3677016|FG001|COMPLETED|First Intervention (1 Day)||8
2962983|NCT00759031|3677015|FG000|NOT COMPLETED|First Intervention (1 Day)||2
2962984|NCT00759031|3677016|FG001|NOT COMPLETED|First Intervention (1 Day)||1
2962985|NCT00759031|3677015|FG000|STARTED|Washout After 1st Intervention (1 Week)||8
2962986|NCT00759031|3677016|FG001|STARTED|Washout After 1st Intervention (1 Week)||8
2962987|NCT00759031|3677015|FG000|COMPLETED|Washout After 1st Intervention (1 Week)||8
2962988|NCT00759031|3677016|FG001|COMPLETED|Washout After 1st Intervention (1 Week)||8
2962989|NCT00759031|3677015|FG000|NOT COMPLETED|Washout After 1st Intervention (1 Week)||0
2962990|NCT00759031|3677016|FG001|NOT COMPLETED|Washout After 1st Intervention (1 Week)||0
2962991|NCT00759031|3677015|FG000|STARTED|Second Intervention (1 Day)||8
2962992|NCT00759031|3677016|FG001|STARTED|Second Intervention (1 Day)||8
2962993|NCT00759031|3677015|FG000|COMPLETED|Second Intervention (1 Day)||8
2962994|NCT00759031|3677016|FG001|COMPLETED|Second Intervention (1 Day)||8
2962995|NCT00759031|3677015|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
2962996|NCT00759031|3677016|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
2962997|NCT00759096|3677022|FG000|STARTED|Overall Study||30
2962998|NCT00759096|3677022|FG000|COMPLETED|Overall Study||30
2962999|NCT00759096|3677022|FG000|NOT COMPLETED|Overall Study||0
2963000|NCT00759109|3677028|FG000|STARTED|Overall Study||74
2963001|NCT00759109|3677029|FG001|STARTED|Overall Study||76
2963002|NCT00759109|3677028|FG000|COMPLETED|Overall Study|From both arms combined, 7 discontinued due to death and there were 8 deaths during follow up.|35
2963003|NCT00759109|3677029|FG001|COMPLETED|Overall Study|From both arms combined, 7 discontinued due to death and there were 8 deaths during follow up.|41
2963004|NCT00759109|3677028|FG000|NOT COMPLETED|Overall Study||39
2963005|NCT00759109|3677029|FG001|NOT COMPLETED|Overall Study||35
2963006|NCT00759148|3677037|FG000|STARTED|Overall Study||593
2963007|NCT00759148|3677038|FG001|STARTED|Overall Study||586
2963008|NCT00759148|3677037|FG000|COMPLETED|Overall Study||579
2963009|NCT00759148|3677038|FG001|COMPLETED|Overall Study||554
2963010|NCT00759148|3677037|FG000|NOT COMPLETED|Overall Study||14
2963011|NCT00759148|3677038|FG001|NOT COMPLETED|Overall Study||32
2963012|NCT00759161|3677044|FG000|STARTED|Overall Study||35
3301765|NCT02955069|4035383|FG001|Immunogenicity (IG) Prevalence Set|Overall Study||21
3301766|NCT02955069|4035382|FG000|IG Incidence Set|Overall Study||84
3301767|NCT02955069|4035383|FG001|IG Incidence Set|Overall Study||17
3301768|NCT02955069|4035382|FG000|COMPLETED|Overall Study||0
3301769|NCT02955069|4035383|FG001|COMPLETED|Overall Study||0
3301770|NCT02955069|4035382|FG000|NOT COMPLETED|Overall Study||95
2963013|NCT00759161|3677044|FG000|COMPLETED|Overall Study||35
2963014|NCT00759161|3677044|FG000|NOT COMPLETED|Overall Study||0
2963015|NCT00759174|3677053|FG000|STARTED|Overall Study||76
2963016|NCT00759174|3677054|FG001|STARTED|Overall Study||597
2963017|NCT00759174|3677053|FG000|COMPLETED|Overall Study||76
2963018|NCT00759174|3677054|FG001|COMPLETED|Overall Study||595
2963019|NCT00759174|3677053|FG000|NOT COMPLETED|Overall Study||0
2963020|NCT00759174|3677054|FG001|NOT COMPLETED|Overall Study||2
2963021|NCT00759187|3677064|FG000|STARTED|Overall Study||8
2963022|NCT00759187|3677065|FG001|STARTED|Overall Study||8
2963023|NCT00759187|3677066|FG002|STARTED|Overall Study||9
2963024|NCT00759187|3677064|FG000|COMPLETED|Overall Study||8
2963025|NCT00759187|3677065|FG001|COMPLETED|Overall Study||8
2963026|NCT00759187|3677066|FG002|COMPLETED|Overall Study||9
2963027|NCT00759187|3677064|FG000|NOT COMPLETED|Overall Study||0
2963028|NCT00759187|3677065|FG001|NOT COMPLETED|Overall Study||0
2963029|NCT00759187|3677066|FG002|NOT COMPLETED|Overall Study||0
2963030|NCT00759330|3677078|FG000|STARTED|Overall Study||20
2963031|NCT00759330|3677079|FG001|STARTED|Overall Study||42
2963032|NCT00759330|3677080|FG002|STARTED|Overall Study||22
2963033|NCT00759330|3677081|FG003|STARTED|Overall Study||43
2963034|NCT00759330|3677078|FG000|COMPLETED|Overall Study||19
2963035|NCT00759330|3677079|FG001|COMPLETED|Overall Study||41
2963036|NCT00759330|3677080|FG002|COMPLETED|Overall Study||22
2963037|NCT00759330|3677081|FG003|COMPLETED|Overall Study||41
2963038|NCT00759330|3677078|FG000|NOT COMPLETED|Overall Study||1
2963039|NCT00759330|3677079|FG001|NOT COMPLETED|Overall Study||1
2963040|NCT00759330|3677080|FG002|NOT COMPLETED|Overall Study||0
2963041|NCT00759330|3677081|FG003|NOT COMPLETED|Overall Study||2
2963042|NCT00759356|3677094|FG000|STARTED|Overall Study||18
2963043|NCT00759356|3677095|FG001|STARTED|Overall Study||18
2963044|NCT00759356|3677094|FG000|COMPLETED|Overall Study||17
2963045|NCT00759356|3677095|FG001|COMPLETED|Overall Study||15
2963046|NCT00759356|3677094|FG000|NOT COMPLETED|Overall Study||1
2963047|NCT00759356|3677095|FG001|NOT COMPLETED|Overall Study||3
2963048|NCT00759395|3677103|FG000|STARTED|Overall Study||13
2963049|NCT00759395|3677104|FG001|STARTED|Overall Study||9
2963050|NCT00759395|3677103|FG000|COMPLETED|Overall Study||11
2963051|NCT00759395|3677104|FG001|COMPLETED|Overall Study||7
3133020|NCT01693900|3858131|FG001|STARTED|Overall Study||25
3133021|NCT01693900|3858130|FG000|COMPLETED|Overall Study||25
3133022|NCT01693900|3858131|FG001|COMPLETED|Overall Study||25
3133023|NCT01693900|3858130|FG000|NOT COMPLETED|Overall Study||0
2963052|NCT00759395|3677103|FG000|NOT COMPLETED|Overall Study||2
2963053|NCT00759395|3677104|FG001|NOT COMPLETED|Overall Study||2
2963054|NCT00759408|3677110|FG000|STARTED|Overall Study||38
2963055|NCT00759408|3677110|FG000|COMPLETED|Overall Study||19
2963056|NCT00759408|3677110|FG000|NOT COMPLETED|Overall Study||19
2963057|NCT00759473|3677119|FG000|STARTED|Overall Study||10
2963058|NCT00759473|3677120|FG001|STARTED|Overall Study||10
2963059|NCT00759473|3677121|FG002|STARTED|Overall Study||12
2963060|NCT00759473|3677122|FG003|STARTED|Overall Study||23
2963061|NCT00759473|3677123|FG004|STARTED|Overall Study||24
2963062|NCT00759473|3677119|FG000|COMPLETED|Overall Study||10
2963063|NCT00759473|3677120|FG001|COMPLETED|Overall Study||10
2963064|NCT00759473|3677121|FG002|COMPLETED|Overall Study||12
2963065|NCT00759473|3677122|FG003|COMPLETED|Overall Study||23
2963066|NCT00759473|3677123|FG004|COMPLETED|Overall Study||24
2963067|NCT00759473|3677119|FG000|NOT COMPLETED|Overall Study||0
2963068|NCT00759473|3677120|FG001|NOT COMPLETED|Overall Study||0
2963069|NCT00759473|3677121|FG002|NOT COMPLETED|Overall Study||0
2963070|NCT00759473|3677122|FG003|NOT COMPLETED|Overall Study||0
2963071|NCT00759473|3677123|FG004|NOT COMPLETED|Overall Study||0
2963072|NCT00759525|3677135|FG000|STARTED|First Intervention (14 Days)||7
2963073|NCT00759525|3677136|FG001|STARTED|First Intervention (14 Days)||8
2963074|NCT00759525|3677135|FG000|COMPLETED|First Intervention (14 Days)||7
2963075|NCT00759525|3677136|FG001|COMPLETED|First Intervention (14 Days)||8
2963076|NCT00759525|3677135|FG000|NOT COMPLETED|First Intervention (14 Days)||0
2963077|NCT00759525|3677136|FG001|NOT COMPLETED|First Intervention (14 Days)||0
2963078|NCT00759525|3677135|FG000|STARTED|Washout (14 Days)||7
2963079|NCT00759525|3677136|FG001|STARTED|Washout (14 Days)||8
2963080|NCT00759525|3677135|FG000|COMPLETED|Washout (14 Days)||7
2963081|NCT00759525|3677136|FG001|COMPLETED|Washout (14 Days)||8
2963082|NCT00759525|3677135|FG000|NOT COMPLETED|Washout (14 Days)||0
2963083|NCT00759525|3677136|FG001|NOT COMPLETED|Washout (14 Days)||0
2963084|NCT00759525|3677135|FG000|STARTED|Second Intervention (14 Days)||7
2963085|NCT00759525|3677136|FG001|STARTED|Second Intervention (14 Days)||8
2963086|NCT00759525|3677135|FG000|COMPLETED|Second Intervention (14 Days)||7
2963087|NCT00759525|3677136|FG001|COMPLETED|Second Intervention (14 Days)||8
2963088|NCT00759525|3677135|FG000|NOT COMPLETED|Second Intervention (14 Days)||0
2963089|NCT00759525|3677136|FG001|NOT COMPLETED|Second Intervention (14 Days)||0
2963090|NCT00759564|3677147|FG000|STARTED|First Intervention Period (4 Days)||8
2963091|NCT00759564|3677148|FG001|STARTED|First Intervention Period (4 Days)||8
2963092|NCT00759564|3677149|FG002|STARTED|First Intervention Period (4 Days)||8
2963093|NCT00759564|3677150|FG003|STARTED|First Intervention Period (4 Days)||1
2963094|NCT00759564|3677151|FG004|STARTED|First Intervention Period (4 Days)||4
2963095|NCT00759564|3677147|FG000|COMPLETED|First Intervention Period (4 Days)||8
2963096|NCT00759564|3677148|FG001|COMPLETED|First Intervention Period (4 Days)||8
2963097|NCT00759564|3677149|FG002|COMPLETED|First Intervention Period (4 Days)||8
2963098|NCT00759564|3677150|FG003|COMPLETED|First Intervention Period (4 Days)||1
2963099|NCT00759564|3677151|FG004|COMPLETED|First Intervention Period (4 Days)||4
2963100|NCT00759564|3677147|FG000|NOT COMPLETED|First Intervention Period (4 Days)||0
2963101|NCT00759564|3677148|FG001|NOT COMPLETED|First Intervention Period (4 Days)||0
2963102|NCT00759564|3677149|FG002|NOT COMPLETED|First Intervention Period (4 Days)||0
2963103|NCT00759564|3677150|FG003|NOT COMPLETED|First Intervention Period (4 Days)||0
2963104|NCT00759564|3677151|FG004|NOT COMPLETED|First Intervention Period (4 Days)||0
2963105|NCT00759564|3677147|FG000|STARTED|Washout Period (at Least 14 Days)||8
2963106|NCT00759564|3677148|FG001|STARTED|Washout Period (at Least 14 Days)||8
2963107|NCT00759564|3677149|FG002|STARTED|Washout Period (at Least 14 Days)||8
2963108|NCT00759564|3677150|FG003|STARTED|Washout Period (at Least 14 Days)||1
2963109|NCT00759564|3677151|FG004|STARTED|Washout Period (at Least 14 Days)||4
2963110|NCT00759564|3677147|FG000|COMPLETED|Washout Period (at Least 14 Days)||8
2963111|NCT00759564|3677148|FG001|COMPLETED|Washout Period (at Least 14 Days)||8
2963112|NCT00759564|3677149|FG002|COMPLETED|Washout Period (at Least 14 Days)||8
3133024|NCT01693900|3858131|FG001|NOT COMPLETED|Overall Study||0
3133025|NCT01694108|3858139|FG000|STARTED|Overall Study||2129
3133026|NCT01694108|3858140|FG001|STARTED|Overall Study||2133
2963113|NCT00759564|3677150|FG003|COMPLETED|Washout Period (at Least 14 Days)||1
2963114|NCT00759564|3677151|FG004|COMPLETED|Washout Period (at Least 14 Days)||3
2963115|NCT00759564|3677147|FG000|NOT COMPLETED|Washout Period (at Least 14 Days)||0
2963116|NCT00759564|3677148|FG001|NOT COMPLETED|Washout Period (at Least 14 Days)||0
2963117|NCT00759564|3677149|FG002|NOT COMPLETED|Washout Period (at Least 14 Days)||0
2963118|NCT00759564|3677150|FG003|NOT COMPLETED|Washout Period (at Least 14 Days)||0
2963119|NCT00759564|3677151|FG004|NOT COMPLETED|Washout Period (at Least 14 Days)||1
2963120|NCT00759564|3677147|FG000|STARTED|Second Intervention Period (4 Days)||8
2963121|NCT00759564|3677148|FG001|STARTED|Second Intervention Period (4 Days)||8
2963122|NCT00759564|3677149|FG002|STARTED|Second Intervention Period (4 Days)||8
2963123|NCT00759564|3677150|FG003|STARTED|Second Intervention Period (4 Days)||1
2963124|NCT00759564|3677151|FG004|STARTED|Second Intervention Period (4 Days)||3
2963125|NCT00759564|3677147|FG000|COMPLETED|Second Intervention Period (4 Days)||8
2963126|NCT00759564|3677148|FG001|COMPLETED|Second Intervention Period (4 Days)||8
2963127|NCT00759564|3677149|FG002|COMPLETED|Second Intervention Period (4 Days)||8
2963128|NCT00759564|3677150|FG003|COMPLETED|Second Intervention Period (4 Days)||1
2963129|NCT00759564|3677151|FG004|COMPLETED|Second Intervention Period (4 Days)||3
2963130|NCT00759564|3677147|FG000|NOT COMPLETED|Second Intervention Period (4 Days)||0
2963131|NCT00759564|3677148|FG001|NOT COMPLETED|Second Intervention Period (4 Days)||0
2963132|NCT00759564|3677149|FG002|NOT COMPLETED|Second Intervention Period (4 Days)||0
2963133|NCT00759564|3677150|FG003|NOT COMPLETED|Second Intervention Period (4 Days)||0
2963134|NCT00759564|3677151|FG004|NOT COMPLETED|Second Intervention Period (4 Days)||0
2963135|NCT00759603|3677183|FG000|STARTED|Overall Study||59
2963136|NCT00759603|3677183|FG000|COMPLETED|Overall Study||59
2963137|NCT00759603|3677183|FG000|NOT COMPLETED|Overall Study||0
2963138|NCT00759642|3677187|FG000|STARTED|Overall Study||33
2963139|NCT00759642|3677187|FG000|COMPLETED|Overall Study||33
2963140|NCT00759642|3677187|FG000|NOT COMPLETED|Overall Study||0
2963141|NCT00759655|3677191|FG000|STARTED|Overall Study||1
2963142|NCT00759655|3677191|FG000|COMPLETED|Overall Study||0
3133027|NCT01694108|3858139|FG000|COMPLETED|Overall Study|100% follow-up|2129
3133028|NCT01694108|3858140|FG001|COMPLETED|Overall Study|100% follow-up|2133
3133029|NCT01694108|3858139|FG000|NOT COMPLETED|Overall Study||0
3133030|NCT01694108|3858140|FG001|NOT COMPLETED|Overall Study||0
3133031|NCT01694121|3858155|FG000|STARTED|Overall Study||228
3133032|NCT01694121|3858156|FG001|STARTED|Overall Study||227
3133033|NCT01694121|3858155|FG000|COMPLETED|Overall Study||227
3133034|NCT01694121|3858156|FG001|COMPLETED|Overall Study||227
3301771|NCT02955069|4035383|FG001|NOT COMPLETED|Overall Study||21
3301772|NCT02955147|4035391|FG000|STARTED|Overall Study||13
3301773|NCT02955147|4035391|FG000|COMPLETED|Overall Study||13
3301774|NCT02955147|4035391|FG000|NOT COMPLETED|Overall Study||0
2963143|NCT00759655|3677191|FG000|NOT COMPLETED|Overall Study||1
2963144|NCT00759668|3677197|FG000|STARTED|Overall Study||17
2963145|NCT00759668|3677198|FG001|STARTED|Overall Study||18
2963146|NCT00759668|3677197|FG000|COMPLETED|Overall Study||16
2963147|NCT00759668|3677198|FG001|COMPLETED|Overall Study||15
2963148|NCT00759668|3677197|FG000|NOT COMPLETED|Overall Study||1
2963149|NCT00759668|3677198|FG001|NOT COMPLETED|Overall Study||3
2963150|NCT00759681|3677206|FG000|STARTED|Overall Study||107
2963151|NCT00759681|3677207|FG001|STARTED|Overall Study||110
2963152|NCT00759681|3677206|FG000|COMPLETED|Overall Study||97
2963153|NCT00759681|3677207|FG001|COMPLETED|Overall Study||100
2963154|NCT00759681|3677206|FG000|NOT COMPLETED|Overall Study||10
2963155|NCT00759681|3677207|FG001|NOT COMPLETED|Overall Study||10
2963156|NCT00759707|3677214|FG000|STARTED|Overall Study||19
2963157|NCT00759707|3677214|FG000|COMPLETED|Overall Study||19
2963158|NCT00759707|3677214|FG000|NOT COMPLETED|Overall Study||0
2963159|NCT00759759|3677220|FG000|STARTED|Overall Study||18
3301775|NCT02955186|4035397|FG000|STARTED|Overall Study||33
2963160|NCT00759759|3677221|FG001|STARTED|Overall Study||18
2963161|NCT00759759|3677220|FG000|COMPLETED|Overall Study||14
2963162|NCT00759759|3677221|FG001|COMPLETED|Overall Study||17
2963163|NCT00759759|3677220|FG000|NOT COMPLETED|Overall Study||4
2963164|NCT00759759|3677221|FG001|NOT COMPLETED|Overall Study||1
2963165|NCT00759772|3677229|FG000|STARTED|Overall Study||12
2963166|NCT00759772|3677230|FG001|STARTED|Overall Study||11
2963167|NCT00759772|3677229|FG000|COMPLETED|Overall Study||12
2963168|NCT00759772|3677230|FG001|COMPLETED|Overall Study||11
2963169|NCT00759772|3677229|FG000|NOT COMPLETED|Overall Study||0
2963170|NCT00759772|3677230|FG001|NOT COMPLETED|Overall Study||0
2963171|NCT00759785|3677238|FG000|STARTED|Overall Study||26
2963172|NCT00759785|3677239|FG001|STARTED|Overall Study||22
2963173|NCT00759785|3677238|FG000|Treated|Overall Study||25
2963174|NCT00759785|3677239|FG001|Treated|Overall Study||20
2963175|NCT00759785|3677238|FG000|COMPLETED|Overall Study||14
2963176|NCT00759785|3677239|FG001|COMPLETED|Overall Study||17
2963177|NCT00759785|3677238|FG000|NOT COMPLETED|Overall Study||12
2963178|NCT00759785|3677239|FG001|NOT COMPLETED|Overall Study||5
3035531|NCT01137890|3754751|FG000|COMPLETED|Overall Study||8
3035532|NCT01137890|3754752|FG001|COMPLETED|Overall Study||2
3035533|NCT01137890|3754751|FG000|NOT COMPLETED|Overall Study||6
3035534|NCT01137890|3754752|FG001|NOT COMPLETED|Overall Study||3
3035535|NCT01138007|3754807|FG000|STARTED|Overall Study||187
3035536|NCT01138007|3754808|FG001|STARTED|Overall Study||190
3133035|NCT01694121|3858155|FG000|NOT COMPLETED|Overall Study||1
3133036|NCT01694121|3858156|FG001|NOT COMPLETED|Overall Study||0
2963179|NCT00759798|3677245|FG000|STARTED|Overall Study||289
2963180|NCT00759798|3677245|FG000|COMPLETED|Overall Study||289
2963181|NCT00759798|3677245|FG000|NOT COMPLETED|Overall Study||0
2963182|NCT00759811|3677251|FG000|STARTED|Overall Study||25
2963183|NCT00759811|3677252|FG001|STARTED|Overall Study||25
2963184|NCT00759811|3677251|FG000|COMPLETED|Overall Study||23
2963185|NCT00759811|3677252|FG001|COMPLETED|Overall Study||24
2963186|NCT00759811|3677251|FG000|NOT COMPLETED|Overall Study||2
2963187|NCT00759811|3677252|FG001|NOT COMPLETED|Overall Study||1
2963188|NCT00759863|3677260|FG000|STARTED|Overall Study||144
2963189|NCT00759863|3677261|FG001|STARTED|Overall Study||98
2963190|NCT00759863|3677260|FG000|COMPLETED|Overall Study||124
2963191|NCT00759863|3677261|FG001|COMPLETED|Overall Study||80
2963192|NCT00759863|3677260|FG000|NOT COMPLETED|Overall Study||20
2963193|NCT00759863|3677261|FG001|NOT COMPLETED|Overall Study||18
2963194|NCT00759876|3677267|FG000|STARTED|Overall Study||36
2963195|NCT00759876|3677267|FG000|As-Treated Population|Overall Study||36
2963196|NCT00759876|3677267|FG000|Evaluable Population|Overall Study||35
2963197|NCT00759876|3677267|FG000|Ambulatory Evaluable Population|Overall Study||24
2963198|NCT00759876|3677267|FG000|COMPLETED|Overall Study||0
2963199|NCT00759876|3677267|FG000|NOT COMPLETED|Overall Study||36
2963200|NCT00759902|3677273|FG000|STARTED|Overall Study||18
2963201|NCT00759902|3677274|FG001|STARTED|Overall Study||18
2963202|NCT00759902|3677273|FG000|COMPLETED|Overall Study||18
2963203|NCT00759902|3677274|FG001|COMPLETED|Overall Study||17
2963204|NCT00759902|3677273|FG000|NOT COMPLETED|Overall Study||0
2963205|NCT00759902|3677274|FG001|NOT COMPLETED|Overall Study||1
2963206|NCT00759915|3677282|FG000|STARTED|Overall Study||18
2963207|NCT00759915|3677283|FG001|STARTED|Overall Study||18
2963208|NCT00759915|3677282|FG000|COMPLETED|Overall Study||17
2963209|NCT00759915|3677283|FG001|COMPLETED|Overall Study||17
2963210|NCT00759915|3677282|FG000|NOT COMPLETED|Overall Study||1
2963211|NCT00759915|3677283|FG001|NOT COMPLETED|Overall Study||1
2963212|NCT00759941|3677291|FG000|STARTED|Overall Study||42
2963213|NCT00759941|3677292|FG001|STARTED|Overall Study||44
2963214|NCT00759941|3677291|FG000|COMPLETED|Overall Study||39
2963215|NCT00759941|3677292|FG001|COMPLETED|Overall Study||43
2963216|NCT00759941|3677291|FG000|NOT COMPLETED|Overall Study||3
2963217|NCT00759941|3677292|FG001|NOT COMPLETED|Overall Study||1
2963218|NCT00759954|3677300|FG000|STARTED|Overall Study|All assigned participants entered trial|18
2963219|NCT00759954|3677301|FG001|STARTED|Overall Study|All assigned participants entered trial|18
2963220|NCT00759954|3677300|FG000|COMPLETED|Overall Study|One participant(#225) did not enter Period 2 and one participant (#203)dropped out during Period 2|16
2963221|NCT00759954|3677301|FG001|COMPLETED|Overall Study|Two participants (#202 and #228) did not enter Period 2.|16
2963222|NCT00759954|3677300|FG000|NOT COMPLETED|Overall Study||2
2963223|NCT00759954|3677301|FG001|NOT COMPLETED|Overall Study||2
2963224|NCT00759967|3677307|FG000|STARTED|First Intervention||10
2963225|NCT00759967|3677308|FG001|STARTED|First Intervention||9
2963226|NCT00759967|3677307|FG000|COMPLETED|First Intervention||10
2963227|NCT00759967|3677308|FG001|COMPLETED|First Intervention||9
2963228|NCT00759967|3677307|FG000|NOT COMPLETED|First Intervention||0
2963229|NCT00759967|3677308|FG001|NOT COMPLETED|First Intervention||0
2963230|NCT00759967|3677307|FG000|STARTED|Second Intervention||10
2963231|NCT00759967|3677308|FG001|STARTED|Second Intervention||9
2963232|NCT00759967|3677307|FG000|COMPLETED|Second Intervention||8
2963233|NCT00759967|3677308|FG001|COMPLETED|Second Intervention||9
2963234|NCT00759967|3677307|FG000|NOT COMPLETED|Second Intervention||2
2963235|NCT00759967|3677308|FG001|NOT COMPLETED|Second Intervention||0
2963236|NCT00760006|3677320|FG000|STARTED|Overall Study||86
2963237|NCT00760006|3677321|FG001|STARTED|Overall Study||138
2963238|NCT00760006|3677320|FG000|COMPLETED|Overall Study||86
2963239|NCT00760006|3677321|FG001|COMPLETED|Overall Study||138
2963240|NCT00760006|3677320|FG000|NOT COMPLETED|Overall Study||0
2963241|NCT00760006|3677321|FG001|NOT COMPLETED|Overall Study||0
2963242|NCT00760019|3677329|FG000|STARTED|Overall Study||15
2963243|NCT00760019|3677330|FG001|STARTED|Overall Study||15
2963244|NCT00760019|3677331|FG002|STARTED|Overall Study||14
2963245|NCT00760019|3677332|FG003|STARTED|Overall Study||14
2963246|NCT00760019|3677329|FG000|COMPLETED|Overall Study||15
2963247|NCT00760019|3677330|FG001|COMPLETED|Overall Study||15
2963248|NCT00760019|3677331|FG002|COMPLETED|Overall Study||14
2963249|NCT00760019|3677332|FG003|COMPLETED|Overall Study||14
2963250|NCT00760019|3677329|FG000|NOT COMPLETED|Overall Study||0
2963251|NCT00760019|3677330|FG001|NOT COMPLETED|Overall Study||0
2963252|NCT00760019|3677331|FG002|NOT COMPLETED|Overall Study||0
2963253|NCT00760019|3677332|FG003|NOT COMPLETED|Overall Study||0
2963254|NCT00760084|3677338|FG000|STARTED|Overall Study||10
2963255|NCT00760084|3677338|FG000|COMPLETED|Overall Study||0
2963256|NCT00760084|3677338|FG000|NOT COMPLETED|Overall Study||10
2963257|NCT00760214|3677345|FG000|STARTED|Overall Study||295
2963258|NCT00760214|3677346|FG001|STARTED|Overall Study||294
2963259|NCT00760214|3677347|FG002|STARTED|Overall Study||296
2963260|NCT00760214|3677345|FG000|COMPLETED|Overall Study||265
2963261|NCT00760214|3677346|FG001|COMPLETED|Overall Study||264
2963262|NCT00760214|3677347|FG002|COMPLETED|Overall Study||255
2963263|NCT00760214|3677345|FG000|NOT COMPLETED|Overall Study||30
2963264|NCT00760214|3677346|FG001|NOT COMPLETED|Overall Study||30
2963265|NCT00760214|3677347|FG002|NOT COMPLETED|Overall Study||41
2963266|NCT00760266|3677357|FG000|STARTED|Overall Study||228
2963267|NCT00760266|3677358|FG001|STARTED|Overall Study||223
2963268|NCT00760266|3677357|FG000|COMPLETED|Overall Study||204
2963269|NCT00760266|3677358|FG001|COMPLETED|Overall Study||205
2963270|NCT00760266|3677357|FG000|NOT COMPLETED|Overall Study||24
2963271|NCT00760266|3677358|FG001|NOT COMPLETED|Overall Study||18
2963272|NCT00760383|3677366|FG000|STARTED|Overall Study||21
2963273|NCT00760383|3677367|FG001|STARTED|Overall Study||19
2963274|NCT00760383|3677366|FG000|COMPLETED|Overall Study||16
2963275|NCT00760383|3677367|FG001|COMPLETED|Overall Study||12
2963276|NCT00760383|3677366|FG000|NOT COMPLETED|Overall Study||5
2963277|NCT00760383|3677367|FG001|NOT COMPLETED|Overall Study||7
2963278|NCT00760435|3677375|FG000|STARTED|Overall Study||98
2963279|NCT00760435|3677376|FG001|STARTED|Overall Study||98
2963280|NCT00760435|3677375|FG000|COMPLETED|Overall Study||94
2963281|NCT00760435|3677376|FG001|COMPLETED|Overall Study||93
2963282|NCT00760435|3677375|FG000|NOT COMPLETED|Overall Study||4
2963283|NCT00760435|3677376|FG001|NOT COMPLETED|Overall Study||5
2963284|NCT00760474|3677382|FG000|STARTED|Period 1 (P1)||13
2963285|NCT00760474|3677383|FG001|STARTED|Period 1 (P1)||14
2963286|NCT00760474|3677382|FG000|Treated|Period 1 (P1)|1 participant discontinued in P1; re-entered with new identification number and completed P1, P2.|13
2963287|NCT00760474|3677383|FG001|Treated|Period 1 (P1)|1 participant discontinued in P1; re-entered with new identification number and completed P1, P2.|14
2963288|NCT00760474|3677382|FG000|Overall Number of Unique Participants|Period 1 (P1)||12
2963289|NCT00760474|3677383|FG001|Overall Number of Unique Participants|Period 1 (P1)||13
2963290|NCT00760474|3677382|FG000|COMPLETED|Period 1 (P1)||12
2963291|NCT00760474|3677383|FG001|COMPLETED|Period 1 (P1)||13
2963292|NCT00760474|3677382|FG000|NOT COMPLETED|Period 1 (P1)||1
2963293|NCT00760474|3677383|FG001|NOT COMPLETED|Period 1 (P1)||1
2963294|NCT00760474|3677382|FG000|STARTED|Placebo Washout Period||12
2963295|NCT00760474|3677383|FG001|STARTED|Placebo Washout Period||13
2963296|NCT00760474|3677382|FG000|COMPLETED|Placebo Washout Period||12
2963297|NCT00760474|3677383|FG001|COMPLETED|Placebo Washout Period||12
2963298|NCT00760474|3677382|FG000|NOT COMPLETED|Placebo Washout Period||0
2963299|NCT00760474|3677383|FG001|NOT COMPLETED|Placebo Washout Period||1
2963300|NCT00760474|3677382|FG000|STARTED|Period 2 (P2)||12
2963301|NCT00760474|3677383|FG001|STARTED|Period 2 (P2)||12
2963302|NCT00760474|3677382|FG000|COMPLETED|Period 2 (P2)||11
2963303|NCT00760474|3677383|FG001|COMPLETED|Period 2 (P2)||11
2963304|NCT00760474|3677382|FG000|NOT COMPLETED|Period 2 (P2)||1
2963305|NCT00760474|3677383|FG001|NOT COMPLETED|Period 2 (P2)||1
2963306|NCT00760487|3677390|FG000|STARTED|Overall Study||120
2963307|NCT00760487|3677390|FG000|COMPLETED|Overall Study||117
2963308|NCT00760487|3677390|FG000|NOT COMPLETED|Overall Study||3
2963309|NCT00760513|3677396|FG000|STARTED|Overall Study||51
2963310|NCT00760513|3677397|FG001|STARTED|Overall Study||52
2963311|NCT00760513|3677396|FG000|COMPLETED|Overall Study||46
2963312|NCT00760513|3677397|FG001|COMPLETED|Overall Study||45
2963313|NCT00760513|3677396|FG000|NOT COMPLETED|Overall Study||5
2963314|NCT00760513|3677397|FG001|NOT COMPLETED|Overall Study||7
2963315|NCT00760526|3677407|FG000|STARTED|Overall Study||74
3163888|NCT01889862|3891341|FG004|Per Amendment #2 of the Protocol|Part 2 (8 Weeks)||0
3163889|NCT01889862|3891337|FG000|COMPLETED|Part 2 (8 Weeks)||34
3163890|NCT01889862|3891338|FG001|COMPLETED|Part 2 (8 Weeks)||15
3163891|NCT01889862|3891339|FG002|COMPLETED|Part 2 (8 Weeks)||31
3163892|NCT01889862|3891340|FG003|COMPLETED|Part 2 (8 Weeks)||14
3163893|NCT01889862|3891341|FG004|COMPLETED|Part 2 (8 Weeks)||0
3163894|NCT01889862|3891337|FG000|NOT COMPLETED|Part 2 (8 Weeks)||0
3163895|NCT01889862|3891338|FG001|NOT COMPLETED|Part 2 (8 Weeks)||0
2963316|NCT00760526|3677408|FG001|STARTED|Overall Study||72
2963317|NCT00760526|3677407|FG000|COMPLETED|Overall Study||69
2963318|NCT00760526|3677408|FG001|COMPLETED|Overall Study||68
2963319|NCT00760526|3677407|FG000|NOT COMPLETED|Overall Study||5
2963320|NCT00760526|3677408|FG001|NOT COMPLETED|Overall Study||4
2963321|NCT00760552|3677423|FG000|STARTED|Overall Study||61
2963322|NCT00760552|3677424|FG001|STARTED|Overall Study||62
2963323|NCT00760552|3677423|FG000|COMPLETED|Overall Study||48
2963324|NCT00760552|3677424|FG001|COMPLETED|Overall Study||52
2963325|NCT00760552|3677423|FG000|NOT COMPLETED|Overall Study||13
2963326|NCT00760552|3677424|FG001|NOT COMPLETED|Overall Study||10
2963327|NCT00760578|3677434|FG000|STARTED|Overall Study||22
2963328|NCT00760578|3677435|FG001|STARTED|Overall Study||21
2963329|NCT00760578|3677436|FG002|STARTED|Overall Study||21
2963330|NCT00760578|3677437|FG003|STARTED|Overall Study||22
2963331|NCT00760578|3677434|FG000|Entered Drug Treatment Period|Overall Study||21
2963332|NCT00760578|3677435|FG001|Entered Drug Treatment Period|Overall Study||20
2963333|NCT00760578|3677436|FG002|Entered Drug Treatment Period|Overall Study||19
3163896|NCT01889862|3891339|FG002|NOT COMPLETED|Part 2 (8 Weeks)||1
3163897|NCT01889862|3891340|FG003|NOT COMPLETED|Part 2 (8 Weeks)||0
2963334|NCT00760578|3677437|FG003|Entered Drug Treatment Period|Overall Study||22
2963335|NCT00760578|3677434|FG000|COMPLETED|Overall Study||19
2963336|NCT00760578|3677435|FG001|COMPLETED|Overall Study||19
2963337|NCT00760578|3677436|FG002|COMPLETED|Overall Study||16
2963338|NCT00760578|3677437|FG003|COMPLETED|Overall Study||18
2963339|NCT00760578|3677434|FG000|NOT COMPLETED|Overall Study||3
2963340|NCT00760578|3677435|FG001|NOT COMPLETED|Overall Study||2
2963341|NCT00760578|3677436|FG002|NOT COMPLETED|Overall Study||5
2963342|NCT00760578|3677437|FG003|NOT COMPLETED|Overall Study||4
2963343|NCT00760617|3677455|FG000|STARTED|Overall Study||266
2963344|NCT00760617|3677456|FG001|STARTED|Overall Study||144
2963345|NCT00760617|3677457|FG002|STARTED|Overall Study||116
2963346|NCT00760617|3677455|FG000|COMPLETED|Overall Study||261
2963347|NCT00760617|3677456|FG001|COMPLETED|Overall Study||142
2963348|NCT00760617|3677457|FG002|COMPLETED|Overall Study||111
2963349|NCT00760617|3677455|FG000|NOT COMPLETED|Overall Study||5
2963350|NCT00760617|3677456|FG001|NOT COMPLETED|Overall Study||2
2963351|NCT00760617|3677457|FG002|NOT COMPLETED|Overall Study||5
2963352|NCT00760669|3677465|FG000|STARTED|Overall Study||1061
2963353|NCT00760669|3677465|FG000|COMPLETED|Overall Study||1031
2963354|NCT00760669|3677465|FG000|NOT COMPLETED|Overall Study||30
2963355|NCT00760747|3677471|FG000|STARTED|Study Period II||57
2963356|NCT00760747|3677472|FG001|STARTED|Study Period II||55
2963357|NCT00760747|3677471|FG000|Received at Least One Dose of Study Drug|Study Period II||57
2963358|NCT00760747|3677472|FG001|Received at Least One Dose of Study Drug|Study Period II||54
2963359|NCT00760747|3677471|FG000|COMPLETED|Study Period II||44
2963360|NCT00760747|3677472|FG001|COMPLETED|Study Period II||41
2963361|NCT00760747|3677471|FG000|NOT COMPLETED|Study Period II||13
2963362|NCT00760747|3677472|FG001|NOT COMPLETED|Study Period II||14
2963363|NCT00760747|3677471|FG000|STARTED|Study Period III||44
2963364|NCT00760747|3677472|FG001|STARTED|Study Period III||41
2963365|NCT00760747|3677471|FG000|COMPLETED|Study Period III||41
2963366|NCT00760747|3677472|FG001|COMPLETED|Study Period III||38
2963367|NCT00760747|3677471|FG000|NOT COMPLETED|Study Period III||3
2963368|NCT00760747|3677472|FG001|NOT COMPLETED|Study Period III||3
2963369|NCT00760838|3677480|FG000|STARTED|Overall Study||54
2963370|NCT00760838|3677481|FG001|STARTED|Overall Study||55
2963371|NCT00760838|3677480|FG000|COMPLETED|Overall Study||49
2963372|NCT00760838|3677481|FG001|COMPLETED|Overall Study||53
2963373|NCT00760838|3677480|FG000|NOT COMPLETED|Overall Study||5
2963374|NCT00760838|3677481|FG001|NOT COMPLETED|Overall Study||2
2963375|NCT00760877|3677489|FG000|STARTED|Overall Study||104
2963376|NCT00760877|3677490|FG001|STARTED|Overall Study||103
2963377|NCT00760877|3677489|FG000|Cross-over to Nilotinib|Overall Study|Not applicable: cross-over occurred from imatinib to nilotinib only.|0
2963378|NCT00760877|3677490|FG001|Cross-over to Nilotinib|Overall Study||46
2963379|NCT00760877|3677489|FG000|Safety Set|Overall Study||101
2963380|NCT00760877|3677490|FG001|Safety Set|Overall Study||103
2963381|NCT00760877|3677489|FG000|COMPLETED|Overall Study||59
2963382|NCT00760877|3677490|FG001|COMPLETED|Overall Study||77
2963383|NCT00760877|3677489|FG000|NOT COMPLETED|Overall Study||45
2963384|NCT00760877|3677490|FG001|NOT COMPLETED|Overall Study||26
2963385|NCT00760929|3677501|FG000|STARTED|Overall Study||26
2963386|NCT00760929|3677502|FG001|STARTED|Overall Study||29
2963387|NCT00760929|3677503|FG002|STARTED|Overall Study||59
2963388|NCT00760929|3677504|FG003|STARTED|Overall Study||57
2963389|NCT00760929|3677501|FG000|COMPLETED|Overall Study||0
2963390|NCT00760929|3677502|FG001|COMPLETED|Overall Study||1
2963391|NCT00760929|3677503|FG002|COMPLETED|Overall Study||1
2963392|NCT00760929|3677504|FG003|COMPLETED|Overall Study||2
2963393|NCT00760929|3677501|FG000|NOT COMPLETED|Overall Study||26
2963394|NCT00760929|3677502|FG001|NOT COMPLETED|Overall Study||28
2963395|NCT00760929|3677503|FG002|NOT COMPLETED|Overall Study||58
2963396|NCT00760929|3677504|FG003|NOT COMPLETED|Overall Study||55
2963397|NCT00760994|3677516|FG000|STARTED|Overall Study||29
2963398|NCT00760994|3677517|FG001|STARTED|Overall Study||31
2963399|NCT00760994|3677518|FG002|STARTED|Overall Study||20
2963400|NCT00760994|3677516|FG000|COMPLETED|Overall Study||25
2963401|NCT00760994|3677517|FG001|COMPLETED|Overall Study||27
2963402|NCT00760994|3677518|FG002|COMPLETED|Overall Study||17
2963403|NCT00760994|3677516|FG000|NOT COMPLETED|Overall Study||4
2963404|NCT00760994|3677517|FG001|NOT COMPLETED|Overall Study||4
2963405|NCT00760994|3677518|FG002|NOT COMPLETED|Overall Study||3
3301776|NCT02955186|4035398|FG001|STARTED|Overall Study||17
3301777|NCT02955186|4035397|FG000|COMPLETED|Overall Study||26
3301778|NCT02955186|4035398|FG001|COMPLETED|Overall Study||15
3301779|NCT02955186|4035397|FG000|NOT COMPLETED|Overall Study||7
3301780|NCT02955186|4035398|FG001|NOT COMPLETED|Overall Study||2
2963406|NCT00761007|3677532|FG000|STARTED|Overall Study||142
2963407|NCT00761007|3677533|FG001|STARTED|Overall Study||135
2963408|NCT00761007|3677534|FG002|STARTED|Overall Study||139
2963409|NCT00761007|3677535|FG003|STARTED|Overall Study||138
2963410|NCT00761007|3677532|FG000|Safety (>=1 Dose of Study Medication)|Overall Study||140
2963411|NCT00761007|3677533|FG001|Safety (>=1 Dose of Study Medication)|Overall Study||135
2963412|NCT00761007|3677534|FG002|Safety (>=1 Dose of Study Medication)|Overall Study||139
2963413|NCT00761007|3677535|FG003|Safety (>=1 Dose of Study Medication)|Overall Study||137
2963414|NCT00761007|3677532|FG000|ITT (>= 1 Assessment Post-Randomisation)|Overall Study||140
2963415|NCT00761007|3677533|FG001|ITT (>= 1 Assessment Post-Randomisation)|Overall Study||133
2963416|NCT00761007|3677534|FG002|ITT (>= 1 Assessment Post-Randomisation)|Overall Study||135
2963417|NCT00761007|3677535|FG003|ITT (>= 1 Assessment Post-Randomisation)|Overall Study||136
2963418|NCT00761007|3677532|FG000|COMPLETED|Overall Study||129
2963419|NCT00761007|3677533|FG001|COMPLETED|Overall Study||124
2963420|NCT00761007|3677534|FG002|COMPLETED|Overall Study||121
2963421|NCT00761007|3677535|FG003|COMPLETED|Overall Study||131
2963422|NCT00761007|3677532|FG000|NOT COMPLETED|Overall Study||13
2963423|NCT00761007|3677533|FG001|NOT COMPLETED|Overall Study||11
2963424|NCT00761007|3677534|FG002|NOT COMPLETED|Overall Study||18
2963425|NCT00761007|3677535|FG003|NOT COMPLETED|Overall Study||7
2963426|NCT00761085|3677549|FG000|STARTED|Overall Study||12
2963427|NCT00761085|3677550|FG001|STARTED|Overall Study||12
2963428|NCT00761085|3677551|FG002|STARTED|Overall Study||11
2963429|NCT00761085|3677552|FG003|STARTED|Overall Study||12
3301781|NCT02955212|4035406|FG000|STARTED|Period 1: Double-blind Treatment Period||169
3301782|NCT02955212|4035407|FG001|STARTED|Period 1: Double-blind Treatment Period||169
3301783|NCT02955212|4035406|FG000|COMPLETED|Period 1: Double-blind Treatment Period||153
3301784|NCT02955212|4035407|FG001|COMPLETED|Period 1: Double-blind Treatment Period||157
3301785|NCT02955212|4035406|FG000|NOT COMPLETED|Period 1: Double-blind Treatment Period||16
3301786|NCT02955212|4035407|FG001|NOT COMPLETED|Period 1: Double-blind Treatment Period||12
2963430|NCT00761085|3677549|FG000|COMPLETED|Overall Study||12
2963431|NCT00761085|3677550|FG001|COMPLETED|Overall Study||6
2963432|NCT00761085|3677551|FG002|COMPLETED|Overall Study||11
2963433|NCT00761085|3677552|FG003|COMPLETED|Overall Study||8
2963434|NCT00761085|3677549|FG000|NOT COMPLETED|Overall Study||0
2963435|NCT00761085|3677550|FG001|NOT COMPLETED|Overall Study||6
2963436|NCT00761085|3677551|FG002|NOT COMPLETED|Overall Study||0
2963437|NCT00761085|3677552|FG003|NOT COMPLETED|Overall Study||4
2963438|NCT00761137|3677562|FG000|STARTED|Overall Study||19
2963439|NCT00761137|3677562|FG000|Placebo|Overall Study||19
2963440|NCT00761137|3677562|FG000|0.3 mg Tropicamide|Overall Study||19
2963441|NCT00761137|3677562|FG000|1 mg Tropicamide|Overall Study||19
2963442|NCT00761137|3677562|FG000|3 mg Tropicamide|Overall Study||19
2963443|NCT00761137|3677562|FG000|COMPLETED|Overall Study||19
2963444|NCT00761137|3677562|FG000|NOT COMPLETED|Overall Study||0
2963445|NCT00761150|3677572|FG000|STARTED|Open-label Period||308
2963446|NCT00761150|3677573|FG001|STARTED|Open-label Period||0
2963447|NCT00761150|3677574|FG002|STARTED|Open-label Period||0
2963448|NCT00761150|3677572|FG000|COMPLETED|Open-label Period||238
2963449|NCT00761150|3677573|FG001|COMPLETED|Open-label Period||0
2963450|NCT00761150|3677574|FG002|COMPLETED|Open-label Period||0
2963451|NCT00761150|3677572|FG000|NOT COMPLETED|Open-label Period||70
2963452|NCT00761150|3677573|FG001|NOT COMPLETED|Open-label Period||0
2963453|NCT00761150|3677574|FG002|NOT COMPLETED|Open-label Period||0
2963454|NCT00761150|3677572|FG000|STARTED|Double-blind Period||0
2963455|NCT00761150|3677573|FG001|STARTED|Double-blind Period||120
2963456|NCT00761150|3677574|FG002|STARTED|Double-blind Period||118
2963457|NCT00761150|3677572|FG000|COMPLETED|Double-blind Period||0
2963458|NCT00761150|3677573|FG001|COMPLETED|Double-blind Period||106
2963459|NCT00761150|3677574|FG002|COMPLETED|Double-blind Period||89
2963460|NCT00761150|3677572|FG000|NOT COMPLETED|Double-blind Period||0
2963461|NCT00761150|3677573|FG001|NOT COMPLETED|Double-blind Period||14
2963462|NCT00761150|3677574|FG002|NOT COMPLETED|Double-blind Period||29
2963463|NCT00761189|3677581|FG000|STARTED|Overall Study||491
2963464|NCT00761189|3677581|FG000|COMPLETED|Overall Study||306
2963465|NCT00761189|3677581|FG000|NOT COMPLETED|Overall Study||185
2963466|NCT00761202|3677587|FG000|STARTED|Overall Study||22
2963467|NCT00761202|3677588|FG001|STARTED|Overall Study||28
2963468|NCT00761202|3677587|FG000|COMPLETED|Overall Study||21
2963469|NCT00761202|3677588|FG001|COMPLETED|Overall Study||26
2963470|NCT00761202|3677587|FG000|NOT COMPLETED|Overall Study||1
2963471|NCT00761202|3677588|FG001|NOT COMPLETED|Overall Study||2
2963472|NCT00761215|3677597|FG000|STARTED|Overall Study||64
2963473|NCT00761215|3677598|FG001|STARTED|Overall Study||64
2963474|NCT00761215|3677599|FG002|STARTED|Overall Study||64
2963475|NCT00761215|3677597|FG000|COMPLETED|Overall Study||55
2963476|NCT00761215|3677598|FG001|COMPLETED|Overall Study||60
2963477|NCT00761215|3677599|FG002|COMPLETED|Overall Study||56
2963478|NCT00761215|3677597|FG000|NOT COMPLETED|Overall Study||9
2963479|NCT00761215|3677598|FG001|NOT COMPLETED|Overall Study||4
2963480|NCT00761215|3677599|FG002|NOT COMPLETED|Overall Study||8
3163898|NCT01889862|3891341|FG004|NOT COMPLETED|Part 2 (8 Weeks)||0
3163899|NCT01889862|3891337|FG000|STARTED|Part 3A/B (6 Week)|Subjects switch from placebo to active 20mg/kg.|48
2963481|NCT00761267|3677613|FG000|STARTED|Overall Study||20
2963482|NCT00761267|3677614|FG001|STARTED|Overall Study||20
2963483|NCT00761267|3677615|FG002|STARTED|Overall Study||30
2963484|NCT00761267|3677613|FG000|Treated|Overall Study||19
2963485|NCT00761267|3677614|FG001|Treated|Overall Study||19
2963486|NCT00761267|3677615|FG002|Treated|Overall Study||30
2963487|NCT00761267|3677613|FG000|COMPLETED|Overall Study||18
2963488|NCT00761267|3677614|FG001|COMPLETED|Overall Study||16
2963489|NCT00761267|3677615|FG002|COMPLETED|Overall Study||24
2963490|NCT00761267|3677613|FG000|NOT COMPLETED|Overall Study||2
2963491|NCT00761267|3677614|FG001|NOT COMPLETED|Overall Study||4
2963492|NCT00761267|3677615|FG002|NOT COMPLETED|Overall Study||6
2963493|NCT00761280|3677636|FG000|STARTED|Randomization to First Dose||14
2963494|NCT00761280|3677637|FG001|STARTED|Randomization to First Dose||13
2963495|NCT00761280|3677636|FG000|Catheter Surgery|Randomization to First Dose|Safety population|13
2963496|NCT00761280|3677637|FG001|Catheter Surgery|Randomization to First Dose|Not applicable to control group|0
2963497|NCT00761280|3677636|FG000|First Dose of Study Drug / Chemotherapy|Randomization to First Dose||12
2963498|NCT00761280|3677637|FG001|First Dose of Study Drug / Chemotherapy|Randomization to First Dose|Safety population|11
2963499|NCT00761280|3677636|FG000|COMPLETED|Randomization to First Dose||12
2963500|NCT00761280|3677637|FG001|COMPLETED|Randomization to First Dose||11
2963501|NCT00761280|3677636|FG000|NOT COMPLETED|Randomization to First Dose||2
2963502|NCT00761280|3677637|FG001|NOT COMPLETED|Randomization to First Dose||2
2963503|NCT00761280|3677636|FG000|STARTED|First Dose to End of Study||12
2963504|NCT00761280|3677637|FG001|STARTED|First Dose to End of Study||11
2963505|NCT00761280|3677636|FG000|COMPLETED|First Dose to End of Study|Study was discontinued early due to the inability to recruit a sufficient number of participants.|0
2963506|NCT00761280|3677637|FG001|COMPLETED|First Dose to End of Study|Study was discontinued early due to the inability to recruit a sufficient number of participants.|0
2963507|NCT00761280|3677636|FG000|NOT COMPLETED|First Dose to End of Study||12
2963508|NCT00761280|3677637|FG001|NOT COMPLETED|First Dose to End of Study||11
2963509|NCT00761306|3677643|FG000|STARTED|Overall Study||74
2963510|NCT00761306|3677643|FG000|COMPLETED|Overall Study||54
2963511|NCT00761306|3677643|FG000|NOT COMPLETED|Overall Study||20
2963512|NCT00761319|3677649|FG000|STARTED|Overall Study||353
2963513|NCT00761319|3677650|FG001|STARTED|Overall Study||352
2963514|NCT00761319|3677649|FG000|COMPLETED|Overall Study||305
2963515|NCT00761319|3677650|FG001|COMPLETED|Overall Study||318
2963516|NCT00761319|3677649|FG000|NOT COMPLETED|Overall Study||48
2963517|NCT00761319|3677650|FG001|NOT COMPLETED|Overall Study||34
2963518|NCT00761345|3677656|FG000|STARTED|Overall Study||27
2963519|NCT00761345|3677656|FG000|COMPLETED|Overall Study||24
2963520|NCT00761345|3677656|FG000|NOT COMPLETED|Overall Study||3
2963521|NCT00761462|3677662|FG000|STARTED|Treatment|Patients enrolled in study group|510
2963522|NCT00761462|3677663|FG001|STARTED|Treatment|Patients enrolled in study group|519
2963523|NCT00761462|3677662|FG000|COMPLETED|Treatment|Patients with confirmed intake of study drug|487
2963524|NCT00761462|3677663|FG001|COMPLETED|Treatment|Patients with confirmed intake of study drug|507
2963525|NCT00761462|3677662|FG000|NOT COMPLETED|Treatment||23
2963526|NCT00761462|3677663|FG001|NOT COMPLETED|Treatment||12
2963527|NCT00761462|3677662|FG000|STARTED|2 or 5 Years Long-term Safety Follow-up|Patients with confirmed intake of study drug entering long-term safety evaluation|487
2963528|NCT00761462|3677663|FG001|STARTED|2 or 5 Years Long-term Safety Follow-up|Patients with confirmed intake of study drug entering long-term safety evaluation|507
2963529|NCT00761462|3677662|FG000|4-6 Weeks Post Treatment|2 or 5 Years Long-term Safety Follow-up||487
2963530|NCT00761462|3677663|FG001|4-6 Weeks Post Treatment|2 or 5 Years Long-term Safety Follow-up||507
2963531|NCT00761462|3677662|FG000|1 Year Follow-up|2 or 5 Years Long-term Safety Follow-up||485
2963532|NCT00761462|3677663|FG001|1 Year Follow-up|2 or 5 Years Long-term Safety Follow-up||507
2963533|NCT00761462|3677662|FG000|COMPLETED|2 or 5 Years Long-term Safety Follow-up|Patients under safety evaluation at end of 5 year safety Follow-up.|333
2963534|NCT00761462|3677663|FG001|COMPLETED|2 or 5 Years Long-term Safety Follow-up|Patients under safety evaluation at end of 2 year safety Follow-up.|456
2963535|NCT00761462|3677662|FG000|NOT COMPLETED|2 or 5 Years Long-term Safety Follow-up||154
2963536|NCT00761462|3677663|FG001|NOT COMPLETED|2 or 5 Years Long-term Safety Follow-up||51
2963537|NCT00761514|3677669|FG000|STARTED|Overall Study||14
2963538|NCT00761514|3677669|FG000|COMPLETED|Overall Study||7
2963539|NCT00761514|3677669|FG000|NOT COMPLETED|Overall Study||7
2963540|NCT00761579|3677673|FG000|STARTED|Overall Study||190
2963541|NCT00761579|3677673|FG000|COMPLETED|Overall Study||98
2963542|NCT00761579|3677673|FG000|NOT COMPLETED|Overall Study||92
2963543|NCT00761592|3677681|FG000|STARTED|Overall Study||32
2963544|NCT00761592|3677682|FG001|STARTED|Overall Study||33
2963545|NCT00761592|3677681|FG000|COMPLETED|Overall Study||31
2963546|NCT00761592|3677682|FG001|COMPLETED|Overall Study||32
2963547|NCT00761592|3677681|FG000|NOT COMPLETED|Overall Study||1
2963548|NCT00761592|3677682|FG001|NOT COMPLETED|Overall Study||1
2963549|NCT00761605|3677688|FG000|STARTED|Overall Study||387
2963550|NCT00761605|3677688|FG000|COMPLETED|Overall Study||246
2963551|NCT00761605|3677688|FG000|NOT COMPLETED|Overall Study||141
2963552|NCT00761631|3677700|FG000|STARTED|Overall Study||126
2963553|NCT00761631|3677701|FG001|STARTED|Overall Study||181
2963554|NCT00761631|3677702|FG002|STARTED|Overall Study||176
2963555|NCT00761631|3677703|FG003|STARTED|Overall Study||119
2963556|NCT00761631|3677704|FG004|STARTED|Overall Study||299
2963557|NCT00761631|3677705|FG005|STARTED|Overall Study||299
2963558|NCT00761631|3677700|FG000|Vaccinated Dose 1|Overall Study||124
2963559|NCT00761631|3677701|FG001|Vaccinated Dose 1|Overall Study||179
2963560|NCT00761631|3677702|FG002|Vaccinated Dose 1|Overall Study||175
2963561|NCT00761631|3677703|FG003|Vaccinated Dose 1|Overall Study||118
2963562|NCT00761631|3677704|FG004|Vaccinated Dose 1|Overall Study||294
2963563|NCT00761631|3677705|FG005|Vaccinated Dose 1|Overall Study||298
2963564|NCT00761631|3677700|FG000|Vaccinated Dose 2|Overall Study||112
2963565|NCT00761631|3677701|FG001|Vaccinated Dose 2|Overall Study||0
2963566|NCT00761631|3677702|FG002|Vaccinated Dose 2|Overall Study||165
2963567|NCT00761631|3677703|FG003|Vaccinated Dose 2|Overall Study||0
2963568|NCT00761631|3677704|FG004|Vaccinated Dose 2|Overall Study||0
2963569|NCT00761631|3677705|FG005|Vaccinated Dose 2|Overall Study||0
2963570|NCT00761631|3677700|FG000|COMPLETED|Overall Study||111
2963571|NCT00761631|3677701|FG001|COMPLETED|Overall Study||174
2963572|NCT00761631|3677702|FG002|COMPLETED|Overall Study||160
2963573|NCT00761631|3677703|FG003|COMPLETED|Overall Study||116
2963574|NCT00761631|3677704|FG004|COMPLETED|Overall Study||277
2963575|NCT00761631|3677705|FG005|COMPLETED|Overall Study||294
2963576|NCT00761631|3677700|FG000|NOT COMPLETED|Overall Study||15
2963577|NCT00761631|3677701|FG001|NOT COMPLETED|Overall Study||7
2963578|NCT00761631|3677702|FG002|NOT COMPLETED|Overall Study||16
2963579|NCT00761631|3677703|FG003|NOT COMPLETED|Overall Study||3
2963580|NCT00761631|3677704|FG004|NOT COMPLETED|Overall Study||22
2963581|NCT00761631|3677705|FG005|NOT COMPLETED|Overall Study||5
2963582|NCT00761657|3677737|FG000|STARTED|Part 1 (up to Day 57)||0
2963583|NCT00761657|3677738|FG001|STARTED|Part 1 (up to Day 57)||0
2963584|NCT00761657|3677739|FG002|STARTED|Part 1 (up to Day 57)||12
2963585|NCT00761657|3677740|FG003|STARTED|Part 1 (up to Day 57)||10
2963586|NCT00761657|3677741|FG004|STARTED|Part 1 (up to Day 57)||0
2963587|NCT00761657|3677742|FG005|STARTED|Part 1 (up to Day 57)||0
2963588|NCT00761657|3677743|FG006|STARTED|Part 1 (up to Day 57)||1
2963589|NCT00761657|3677744|FG007|STARTED|Part 1 (up to Day 57)||2
2963590|NCT00761657|3677745|FG008|STARTED|Part 1 (up to Day 57)||10
2963591|NCT00761657|3677737|FG000|Safety Population|Part 1 (up to Day 57)||0
2963592|NCT00761657|3677738|FG001|Safety Population|Part 1 (up to Day 57)||0
2963593|NCT00761657|3677739|FG002|Safety Population|Part 1 (up to Day 57)||12
2963594|NCT00761657|3677740|FG003|Safety Population|Part 1 (up to Day 57)||9
2963595|NCT00761657|3677741|FG004|Safety Population|Part 1 (up to Day 57)||0
2963596|NCT00761657|3677742|FG005|Safety Population|Part 1 (up to Day 57)||0
2963597|NCT00761657|3677743|FG006|Safety Population|Part 1 (up to Day 57)||1
2963598|NCT00761657|3677744|FG007|Safety Population|Part 1 (up to Day 57)||2
2963599|NCT00761657|3677745|FG008|Safety Population|Part 1 (up to Day 57)||10
2963600|NCT00761657|3677737|FG000|Efficacy Evaluable (EE) Population|Part 1 (up to Day 57)||0
2963601|NCT00761657|3677738|FG001|Efficacy Evaluable (EE) Population|Part 1 (up to Day 57)||0
2963602|NCT00761657|3677739|FG002|Efficacy Evaluable (EE) Population|Part 1 (up to Day 57)||5
2963603|NCT00761657|3677740|FG003|Efficacy Evaluable (EE) Population|Part 1 (up to Day 57)||5
2963604|NCT00761657|3677741|FG004|Efficacy Evaluable (EE) Population|Part 1 (up to Day 57)||0
2963605|NCT00761657|3677742|FG005|Efficacy Evaluable (EE) Population|Part 1 (up to Day 57)||0
2963606|NCT00761657|3677743|FG006|Efficacy Evaluable (EE) Population|Part 1 (up to Day 57)||0
2963607|NCT00761657|3677744|FG007|Efficacy Evaluable (EE) Population|Part 1 (up to Day 57)||1
2963608|NCT00761657|3677745|FG008|Efficacy Evaluable (EE) Population|Part 1 (up to Day 57)||6
2963609|NCT00761657|3677737|FG000|Pharmacokinetic (PK) Population|Part 1 (up to Day 57)||0
2963610|NCT00761657|3677738|FG001|Pharmacokinetic (PK) Population|Part 1 (up to Day 57)||0
2963611|NCT00761657|3677739|FG002|Pharmacokinetic (PK) Population|Part 1 (up to Day 57)||5
2963612|NCT00761657|3677740|FG003|Pharmacokinetic (PK) Population|Part 1 (up to Day 57)||3
2963613|NCT00761657|3677741|FG004|Pharmacokinetic (PK) Population|Part 1 (up to Day 57)||0
2963614|NCT00761657|3677742|FG005|Pharmacokinetic (PK) Population|Part 1 (up to Day 57)||0
2963615|NCT00761657|3677743|FG006|Pharmacokinetic (PK) Population|Part 1 (up to Day 57)||1
2963616|NCT00761657|3677744|FG007|Pharmacokinetic (PK) Population|Part 1 (up to Day 57)||2
3301787|NCT02955212|4035406|FG000|STARTED|Period 2: Open-label Extension||153
3301788|NCT02955212|4035407|FG001|STARTED|Period 2: Open-label Extension||157
3301789|NCT02955212|4035406|FG000|COMPLETED|Period 2: Open-label Extension||136
3301790|NCT02955212|4035407|FG001|COMPLETED|Period 2: Open-label Extension||139
3301791|NCT02955212|4035406|FG000|NOT COMPLETED|Period 2: Open-label Extension||17
3301792|NCT02955212|4035407|FG001|NOT COMPLETED|Period 2: Open-label Extension||18
3301793|NCT02955329|4035414|FG000|STARTED|Tobacco Arm||8
3301794|NCT02955329|4035414|FG000|COMPLETED|Tobacco Arm||8
3301795|NCT02955329|4035414|FG000|NOT COMPLETED|Tobacco Arm||0
3301796|NCT02955329|4035414|FG000|STARTED|Cannabis Arm||8
3301797|NCT02955329|4035414|FG000|COMPLETED|Cannabis Arm||8
3301798|NCT02955329|4035414|FG000|NOT COMPLETED|Cannabis Arm||0
3301799|NCT02955329|4035414|FG000|STARTED|Combined Cannabis and Tobacco Arm||8
3301800|NCT02955329|4035414|FG000|COMPLETED|Combined Cannabis and Tobacco Arm||8
3301801|NCT02955329|4035414|FG000|NOT COMPLETED|Combined Cannabis and Tobacco Arm||0
3301802|NCT02955797|4035426|FG000|STARTED|Overall Study||306
3301803|NCT02955797|4035427|FG001|STARTED|Overall Study||306
3301804|NCT02955797|4035428|FG002|STARTED|Overall Study||203
3301805|NCT02955797|4035429|FG003|STARTED|Overall Study||103
2963617|NCT00761657|3677745|FG008|Pharmacokinetic (PK) Population|Part 1 (up to Day 57)||0
2963618|NCT00761657|3677737|FG000|COMPLETED|Part 1 (up to Day 57)||0
2963619|NCT00761657|3677738|FG001|COMPLETED|Part 1 (up to Day 57)||0
2963620|NCT00761657|3677739|FG002|COMPLETED|Part 1 (up to Day 57)||8
2963621|NCT00761657|3677740|FG003|COMPLETED|Part 1 (up to Day 57)||4
2963622|NCT00761657|3677741|FG004|COMPLETED|Part 1 (up to Day 57)||0
2963623|NCT00761657|3677742|FG005|COMPLETED|Part 1 (up to Day 57)||0
2963624|NCT00761657|3677743|FG006|COMPLETED|Part 1 (up to Day 57)||0
2963625|NCT00761657|3677744|FG007|COMPLETED|Part 1 (up to Day 57)||1
2963626|NCT00761657|3677745|FG008|COMPLETED|Part 1 (up to Day 57)||9
2963627|NCT00761657|3677737|FG000|NOT COMPLETED|Part 1 (up to Day 57)||0
2963628|NCT00761657|3677738|FG001|NOT COMPLETED|Part 1 (up to Day 57)||0
2963629|NCT00761657|3677739|FG002|NOT COMPLETED|Part 1 (up to Day 57)||4
2963630|NCT00761657|3677740|FG003|NOT COMPLETED|Part 1 (up to Day 57)||6
2963631|NCT00761657|3677741|FG004|NOT COMPLETED|Part 1 (up to Day 57)||0
2963632|NCT00761657|3677742|FG005|NOT COMPLETED|Part 1 (up to Day 57)||0
2963633|NCT00761657|3677743|FG006|NOT COMPLETED|Part 1 (up to Day 57)||1
2963634|NCT00761657|3677744|FG007|NOT COMPLETED|Part 1 (up to Day 57)||1
2963635|NCT00761657|3677745|FG008|NOT COMPLETED|Part 1 (up to Day 57)||1
2963636|NCT00761657|3677737|FG000|STARTED|Part 2 (up to Day 114)||10
2963637|NCT00761657|3677738|FG001|STARTED|Part 2 (up to Day 114)||13
2963638|NCT00761657|3677739|FG002|STARTED|Part 2 (up to Day 114)||0
2963639|NCT00761657|3677740|FG003|STARTED|Part 2 (up to Day 114)||0
2963640|NCT00761657|3677741|FG004|STARTED|Part 2 (up to Day 114)||10
2963641|NCT00761657|3677742|FG005|STARTED|Part 2 (up to Day 114)||11
2963642|NCT00761657|3677743|FG006|STARTED|Part 2 (up to Day 114)||10
2963643|NCT00761657|3677744|FG007|STARTED|Part 2 (up to Day 114)||10
2963644|NCT00761657|3677745|FG008|STARTED|Part 2 (up to Day 114)||18
2963645|NCT00761657|3677737|FG000|Safety Population|Part 2 (up to Day 114)||10
3301806|NCT02955797|4035426|FG000|Safety Analysis Set (SafAS)|Overall Study||303
3301807|NCT02955797|4035427|FG001|Safety Analysis Set (SafAS)|Overall Study||306
3301808|NCT02955797|4035428|FG002|Safety Analysis Set (SafAS)|Overall Study||203
3301809|NCT02955797|4035429|FG003|Safety Analysis Set (SafAS)|Overall Study||102
3301810|NCT02955797|4035426|FG000|Per Protocol Analysis Set (PPAS)|Overall Study||293
2963646|NCT00761657|3677738|FG001|Safety Population|Part 2 (up to Day 114)||13
2963647|NCT00761657|3677739|FG002|Safety Population|Part 2 (up to Day 114)||0
2963648|NCT00761657|3677740|FG003|Safety Population|Part 2 (up to Day 114)||0
2963649|NCT00761657|3677741|FG004|Safety Population|Part 2 (up to Day 114)||10
2963650|NCT00761657|3677742|FG005|Safety Population|Part 2 (up to Day 114)||11
2963651|NCT00761657|3677743|FG006|Safety Population|Part 2 (up to Day 114)||10
2963652|NCT00761657|3677744|FG007|Safety Population|Part 2 (up to Day 114)||10
2963653|NCT00761657|3677745|FG008|Safety Population|Part 2 (up to Day 114)||18
2963654|NCT00761657|3677737|FG000|EE Population|Part 2 (up to Day 114)||10
2963655|NCT00761657|3677738|FG001|EE Population|Part 2 (up to Day 114)||12
2963656|NCT00761657|3677739|FG002|EE Population|Part 2 (up to Day 114)||0
2963657|NCT00761657|3677740|FG003|EE Population|Part 2 (up to Day 114)||0
2963658|NCT00761657|3677741|FG004|EE Population|Part 2 (up to Day 114)||10
2963659|NCT00761657|3677742|FG005|EE Population|Part 2 (up to Day 114)||11
2963660|NCT00761657|3677743|FG006|EE Population|Part 2 (up to Day 114)||10
2963661|NCT00761657|3677744|FG007|EE Population|Part 2 (up to Day 114)||10
2963662|NCT00761657|3677745|FG008|EE Population|Part 2 (up to Day 114)||11
2963663|NCT00761657|3677737|FG000|PK Population|Part 2 (up to Day 114)||10
2963664|NCT00761657|3677738|FG001|PK Population|Part 2 (up to Day 114)||13
2963665|NCT00761657|3677739|FG002|PK Population|Part 2 (up to Day 114)||0
2963666|NCT00761657|3677740|FG003|PK Population|Part 2 (up to Day 114)||0
2963667|NCT00761657|3677741|FG004|PK Population|Part 2 (up to Day 114)||10
2963668|NCT00761657|3677742|FG005|PK Population|Part 2 (up to Day 114)||11
2963669|NCT00761657|3677743|FG006|PK Population|Part 2 (up to Day 114)||10
2963670|NCT00761657|3677744|FG007|PK Population|Part 2 (up to Day 114)||10
2963671|NCT00761657|3677745|FG008|PK Population|Part 2 (up to Day 114)||0
2963672|NCT00761657|3677737|FG000|COMPLETED|Part 2 (up to Day 114)||10
2963673|NCT00761657|3677738|FG001|COMPLETED|Part 2 (up to Day 114)||13
2963674|NCT00761657|3677739|FG002|COMPLETED|Part 2 (up to Day 114)||0
2963675|NCT00761657|3677740|FG003|COMPLETED|Part 2 (up to Day 114)||0
2963676|NCT00761657|3677741|FG004|COMPLETED|Part 2 (up to Day 114)||10
2963677|NCT00761657|3677742|FG005|COMPLETED|Part 2 (up to Day 114)||11
2963678|NCT00761657|3677743|FG006|COMPLETED|Part 2 (up to Day 114)||10
2963679|NCT00761657|3677744|FG007|COMPLETED|Part 2 (up to Day 114)||10
2963680|NCT00761657|3677745|FG008|COMPLETED|Part 2 (up to Day 114)||17
2963681|NCT00761657|3677737|FG000|NOT COMPLETED|Part 2 (up to Day 114)||0
2963682|NCT00761657|3677738|FG001|NOT COMPLETED|Part 2 (up to Day 114)||0
2963683|NCT00761657|3677739|FG002|NOT COMPLETED|Part 2 (up to Day 114)||0
2963684|NCT00761657|3677740|FG003|NOT COMPLETED|Part 2 (up to Day 114)||0
2963685|NCT00761657|3677741|FG004|NOT COMPLETED|Part 2 (up to Day 114)||0
2963686|NCT00761657|3677742|FG005|NOT COMPLETED|Part 2 (up to Day 114)||0
2963687|NCT00761657|3677743|FG006|NOT COMPLETED|Part 2 (up to Day 114)||0
2963688|NCT00761657|3677744|FG007|NOT COMPLETED|Part 2 (up to Day 114)||0
2963689|NCT00761657|3677745|FG008|NOT COMPLETED|Part 2 (up to Day 114)||1
2963690|NCT00761735|3677775|FG000|STARTED|Overall Study||94
2963691|NCT00761735|3677775|FG000|COMPLETED|Overall Study||80
2963692|NCT00761735|3677775|FG000|NOT COMPLETED|Overall Study||14
2963693|NCT00761748|3677783|FG000|STARTED|First Intervention (21 +/- 3 Days)||20
2963694|NCT00761748|3677784|FG001|STARTED|First Intervention (21 +/- 3 Days)||10
2963695|NCT00761748|3677783|FG000|COMPLETED|First Intervention (21 +/- 3 Days)||17
2963696|NCT00761748|3677784|FG001|COMPLETED|First Intervention (21 +/- 3 Days)||7
2963697|NCT00761748|3677783|FG000|NOT COMPLETED|First Intervention (21 +/- 3 Days)||3
2963698|NCT00761748|3677784|FG001|NOT COMPLETED|First Intervention (21 +/- 3 Days)||3
2963699|NCT00761748|3677783|FG000|STARTED|Second Intervention (21 +/- 3 Days)||17
2963700|NCT00761748|3677784|FG001|STARTED|Second Intervention (21 +/- 3 Days)||7
2963701|NCT00761748|3677783|FG000|COMPLETED|Second Intervention (21 +/- 3 Days)||17
2963702|NCT00761748|3677784|FG001|COMPLETED|Second Intervention (21 +/- 3 Days)||7
2963703|NCT00761748|3677783|FG000|NOT COMPLETED|Second Intervention (21 +/- 3 Days)||0
2963704|NCT00761748|3677784|FG001|NOT COMPLETED|Second Intervention (21 +/- 3 Days)||0
2963705|NCT00761761|3677792|FG000|STARTED|Overall Study||30
2963706|NCT00761761|3677793|FG001|STARTED|Overall Study||30
2963707|NCT00761761|3677792|FG000|COMPLETED|Overall Study||24
2963708|NCT00761761|3677793|FG001|COMPLETED|Overall Study||29
2963709|NCT00761761|3677792|FG000|NOT COMPLETED|Overall Study||6
2963710|NCT00761761|3677793|FG001|NOT COMPLETED|Overall Study||1
2963711|NCT00761774|3677801|FG000|STARTED|Overall Study||108
2963712|NCT00761774|3677801|FG000|COMPLETED|Overall Study||29
2963713|NCT00761774|3677801|FG000|NOT COMPLETED|Overall Study||79
2963714|NCT00761813|3677809|FG000|STARTED|Overall Study||557
2963715|NCT00761813|3677810|FG001|STARTED|Overall Study||551
2963716|NCT00761813|3677809|FG000|COMPLETED|Overall Study||542
2963717|NCT00761813|3677810|FG001|COMPLETED|Overall Study||537
2963718|NCT00761813|3677809|FG000|NOT COMPLETED|Overall Study||15
2963719|NCT00761813|3677810|FG001|NOT COMPLETED|Overall Study||14
2963720|NCT00761865|3677818|FG000|STARTED|Overall Study||16
2963721|NCT00761865|3677819|FG001|STARTED|Overall Study||18
2963722|NCT00761865|3677818|FG000|COMPLETED|Overall Study||8
2963723|NCT00761865|3677819|FG001|COMPLETED|Overall Study||11
2963724|NCT00761865|3677818|FG000|NOT COMPLETED|Overall Study||8
2963725|NCT00761865|3677819|FG001|NOT COMPLETED|Overall Study||7
2963726|NCT00761891|3677825|FG000|STARTED|Overall Study||64
2963727|NCT00761891|3677825|FG000|COMPLETED|Overall Study||54
2963728|NCT00761891|3677825|FG000|NOT COMPLETED|Overall Study||10
2963729|NCT00761930|3677833|FG000|STARTED|Overall Study||34
2963730|NCT00761930|3677834|FG001|STARTED|Overall Study||34
2963731|NCT00761930|3677835|FG002|STARTED|Overall Study||35
2963732|NCT00761930|3677833|FG000|COMPLETED|Overall Study||34
2963733|NCT00761930|3677834|FG001|COMPLETED|Overall Study||34
2963734|NCT00761930|3677835|FG002|COMPLETED|Overall Study||35
2963735|NCT00761930|3677833|FG000|NOT COMPLETED|Overall Study||0
2963736|NCT00761930|3677834|FG001|NOT COMPLETED|Overall Study||0
2963737|NCT00761930|3677835|FG002|NOT COMPLETED|Overall Study||0
2963738|NCT00761956|3677845|FG000|STARTED|Overall Study||87
2963739|NCT00761956|3677846|FG001|STARTED|Overall Study||102
2963740|NCT00761956|3677845|FG000|COMPLETED|Overall Study||52
2963741|NCT00761956|3677846|FG001|COMPLETED|Overall Study||48
2963742|NCT00761956|3677845|FG000|NOT COMPLETED|Overall Study||35
2963743|NCT00761956|3677846|FG001|NOT COMPLETED|Overall Study||54
2963744|NCT00761969|3677854|FG000|STARTED|Overall Study||742
2963745|NCT00761969|3677855|FG001|STARTED|Overall Study||713
2963746|NCT00761969|3677854|FG000|COMPLETED|Overall Study||542
2963747|NCT00761969|3677855|FG001|COMPLETED|Overall Study||573
2963748|NCT00761969|3677854|FG000|NOT COMPLETED|Overall Study||200
2963749|NCT00761969|3677855|FG001|NOT COMPLETED|Overall Study||140
2963750|NCT00762021|3677863|FG000|STARTED|Overall Study||52
2963751|NCT00762021|3677864|FG001|STARTED|Overall Study||52
2963752|NCT00762021|3677863|FG000|COMPLETED|Overall Study||44
2963753|NCT00762021|3677864|FG001|COMPLETED|Overall Study||44
2963754|NCT00762021|3677863|FG000|NOT COMPLETED|Overall Study||8
2963755|NCT00762021|3677864|FG001|NOT COMPLETED|Overall Study||8
2963756|NCT00762034|3677872|FG000|STARTED|Induction Period||472
2963757|NCT00762034|3677873|FG001|STARTED|Induction Period||467
2963758|NCT00762034|3677872|FG000|Received at Least 1 Dose of Study Drug|Induction Period||442
2963759|NCT00762034|3677873|FG001|Received at Least 1 Dose of Study Drug|Induction Period||443
2963760|NCT00762034|3677872|FG000|COMPLETED|Induction Period||294
2963761|NCT00762034|3677873|FG001|COMPLETED|Induction Period||298
2963762|NCT00762034|3677872|FG000|NOT COMPLETED|Induction Period||178
2963763|NCT00762034|3677873|FG001|NOT COMPLETED|Induction Period||169
2963764|NCT00762034|3677872|FG000|STARTED|Maintenance Period||294
2963765|NCT00762034|3677873|FG001|STARTED|Maintenance Period||298
2963766|NCT00762034|3677872|FG000|Received at Least 1 Dose of Study Drug|Maintenance Period||294
2963767|NCT00762034|3677873|FG001|Received at Least 1 Dose of Study Drug|Maintenance Period||298
2963768|NCT00762034|3677872|FG000|COMPLETED|Maintenance Period||0
2963769|NCT00762034|3677873|FG001|COMPLETED|Maintenance Period||0
2963770|NCT00762034|3677872|FG000|NOT COMPLETED|Maintenance Period||294
2963771|NCT00762034|3677873|FG001|NOT COMPLETED|Maintenance Period||298
2963772|NCT00762073|3677891|FG000|STARTED|Overall Study||21
2963773|NCT00762073|3677892|FG001|STARTED|Overall Study||21
2963774|NCT00762073|3677893|FG002|STARTED|Overall Study||20
2963775|NCT00762073|3677894|FG003|STARTED|Overall Study||20
2963776|NCT00762073|3677891|FG000|COMPLETED|Overall Study||17
2963777|NCT00762073|3677892|FG001|COMPLETED|Overall Study||17
2963778|NCT00762073|3677893|FG002|COMPLETED|Overall Study|One participant was enrolled and randomized then withdrew consent and did not receive study drug.|18
2963779|NCT00762073|3677894|FG003|COMPLETED|Overall Study||17
2963780|NCT00762073|3677891|FG000|NOT COMPLETED|Overall Study||4
2963781|NCT00762073|3677892|FG001|NOT COMPLETED|Overall Study||4
2963782|NCT00762073|3677893|FG002|NOT COMPLETED|Overall Study||2
2963783|NCT00762073|3677894|FG003|NOT COMPLETED|Overall Study||3
2963784|NCT00762086|3677913|FG000|STARTED|Overall Study||39
2963785|NCT00762086|3677914|FG001|STARTED|Overall Study||28
2963786|NCT00762086|3677913|FG000|COMPLETED|Overall Study||33
2963787|NCT00762086|3677914|FG001|COMPLETED|Overall Study||24
2963788|NCT00762086|3677913|FG000|NOT COMPLETED|Overall Study||6
2963789|NCT00762086|3677914|FG001|NOT COMPLETED|Overall Study||4
2963790|NCT00762164|3677922|FG000|STARTED|Overall Study||17
2963791|NCT00762164|3677923|FG001|STARTED|Overall Study||17
2963792|NCT00762164|3677922|FG000|COMPLETED|Overall Study||14
2963793|NCT00762164|3677923|FG001|COMPLETED|Overall Study||15
2963794|NCT00762164|3677922|FG000|NOT COMPLETED|Overall Study||3
2963795|NCT00762164|3677923|FG001|NOT COMPLETED|Overall Study||2
2963796|NCT00762177|3677932|FG000|STARTED|1st Treatment Period||8
2963797|NCT00762177|3677933|FG001|STARTED|1st Treatment Period||8
2963798|NCT00762177|3677934|FG002|STARTED|1st Treatment Period||8
2963799|NCT00762177|3677932|FG000|COMPLETED|1st Treatment Period||8
2963800|NCT00762177|3677933|FG001|COMPLETED|1st Treatment Period||8
2963801|NCT00762177|3677934|FG002|COMPLETED|1st Treatment Period||8
2963802|NCT00762177|3677932|FG000|NOT COMPLETED|1st Treatment Period||0
2963803|NCT00762177|3677933|FG001|NOT COMPLETED|1st Treatment Period||0
2963804|NCT00762177|3677934|FG002|NOT COMPLETED|1st Treatment Period||0
2963805|NCT00762177|3677932|FG000|STARTED|Washout After 1st Treatment||8
2963806|NCT00762177|3677933|FG001|STARTED|Washout After 1st Treatment||8
2963807|NCT00762177|3677934|FG002|STARTED|Washout After 1st Treatment||8
2963808|NCT00762177|3677932|FG000|COMPLETED|Washout After 1st Treatment||8
2963809|NCT00762177|3677933|FG001|COMPLETED|Washout After 1st Treatment||8
2963810|NCT00762177|3677934|FG002|COMPLETED|Washout After 1st Treatment||8
2963811|NCT00762177|3677932|FG000|NOT COMPLETED|Washout After 1st Treatment||0
2963812|NCT00762177|3677933|FG001|NOT COMPLETED|Washout After 1st Treatment||0
2963813|NCT00762177|3677934|FG002|NOT COMPLETED|Washout After 1st Treatment||0
2963814|NCT00762177|3677932|FG000|STARTED|2nd Treatment Period||8
2963815|NCT00762177|3677933|FG001|STARTED|2nd Treatment Period||8
2963816|NCT00762177|3677934|FG002|STARTED|2nd Treatment Period||8
2963817|NCT00762177|3677932|FG000|COMPLETED|2nd Treatment Period||8
2963818|NCT00762177|3677933|FG001|COMPLETED|2nd Treatment Period||8
2963819|NCT00762177|3677934|FG002|COMPLETED|2nd Treatment Period||8
2963820|NCT00762177|3677932|FG000|NOT COMPLETED|2nd Treatment Period||0
2963821|NCT00762177|3677933|FG001|NOT COMPLETED|2nd Treatment Period||0
2963822|NCT00762177|3677934|FG002|NOT COMPLETED|2nd Treatment Period||0
2963823|NCT00762177|3677932|FG000|STARTED|Washout After 2nd Treatment||8
2963824|NCT00762177|3677933|FG001|STARTED|Washout After 2nd Treatment||8
2963825|NCT00762177|3677934|FG002|STARTED|Washout After 2nd Treatment||8
2963826|NCT00762177|3677932|FG000|COMPLETED|Washout After 2nd Treatment||8
2963827|NCT00762177|3677933|FG001|COMPLETED|Washout After 2nd Treatment||8
2963828|NCT00762177|3677934|FG002|COMPLETED|Washout After 2nd Treatment||8
2963829|NCT00762177|3677932|FG000|NOT COMPLETED|Washout After 2nd Treatment||0
2963830|NCT00762177|3677933|FG001|NOT COMPLETED|Washout After 2nd Treatment||0
2963831|NCT00762177|3677934|FG002|NOT COMPLETED|Washout After 2nd Treatment||0
2963832|NCT00762177|3677932|FG000|STARTED|3rd Treatment Period||8
2963833|NCT00762177|3677933|FG001|STARTED|3rd Treatment Period||8
2963834|NCT00762177|3677934|FG002|STARTED|3rd Treatment Period||8
2963835|NCT00762177|3677932|FG000|COMPLETED|3rd Treatment Period||8
2963836|NCT00762177|3677933|FG001|COMPLETED|3rd Treatment Period||8
2963837|NCT00762177|3677934|FG002|COMPLETED|3rd Treatment Period||8
2963838|NCT00762177|3677932|FG000|NOT COMPLETED|3rd Treatment Period||0
2963839|NCT00762177|3677933|FG001|NOT COMPLETED|3rd Treatment Period||0
2963840|NCT00762177|3677934|FG002|NOT COMPLETED|3rd Treatment Period||0
2963841|NCT00762216|3677945|FG000|STARTED|Overall Study||71
2963842|NCT00762216|3677945|FG000|COMPLETED|Overall Study||71
2963843|NCT00762216|3677945|FG000|NOT COMPLETED|Overall Study||0
2963844|NCT00762229|3677951|FG000|STARTED|Overall Study||15
2963845|NCT00762229|3677952|FG001|STARTED|Overall Study||24
2963846|NCT00762229|3677951|FG000|COMPLETED|Overall Study||14
2963847|NCT00762229|3677952|FG001|COMPLETED|Overall Study||22
2963848|NCT00762229|3677951|FG000|NOT COMPLETED|Overall Study||1
2963849|NCT00762229|3677952|FG001|NOT COMPLETED|Overall Study||2
2963850|NCT00762268|3677960|FG000|STARTED|Overall Study||12
2963851|NCT00762268|3677961|FG001|STARTED|Overall Study||11
2963852|NCT00762268|3677960|FG000|COMPLETED|Overall Study||9
2963853|NCT00762268|3677961|FG001|COMPLETED|Overall Study||8
2963854|NCT00762268|3677960|FG000|NOT COMPLETED|Overall Study||3
2963855|NCT00762268|3677961|FG001|NOT COMPLETED|Overall Study||3
2963856|NCT00762307|3677971|FG000|STARTED|Overall Study||28
2963857|NCT00762307|3677972|FG001|STARTED|Overall Study||11
2963858|NCT00762307|3677973|FG002|STARTED|Overall Study||11
2963859|NCT00762307|3677974|FG003|STARTED|Overall Study||10
2963860|NCT00762307|3677971|FG000|COMPLETED|Overall Study||26
2963861|NCT00762307|3677972|FG001|COMPLETED|Overall Study||11
2963862|NCT00762307|3677973|FG002|COMPLETED|Overall Study||11
2963863|NCT00762307|3677974|FG003|COMPLETED|Overall Study||9
2963864|NCT00762307|3677971|FG000|NOT COMPLETED|Overall Study||2
2963865|NCT00762307|3677972|FG001|NOT COMPLETED|Overall Study||0
2963866|NCT00762307|3677973|FG002|NOT COMPLETED|Overall Study||0
2963867|NCT00762307|3677974|FG003|NOT COMPLETED|Overall Study||1
2963868|NCT00762320|3677995|FG000|STARTED|Overall Study||8
2963869|NCT00762320|3677995|FG000|COMPLETED|Overall Study||8
2963870|NCT00762320|3677995|FG000|NOT COMPLETED|Overall Study||0
2963871|NCT00762359|3678006|FG000|STARTED|Overall Study||226
2963872|NCT00762359|3678007|FG001|STARTED|Overall Study||235
2963873|NCT00762359|3678006|FG000|COMPLETED|Overall Study||167
2963874|NCT00762359|3678007|FG001|COMPLETED|Overall Study||178
2963875|NCT00762359|3678006|FG000|NOT COMPLETED|Overall Study||59
2963876|NCT00762359|3678007|FG001|NOT COMPLETED|Overall Study||57
2963877|NCT00762372|3678016|FG000|STARTED|Overall Study|N=114 enrolled but 3 participant's discontinued before start of study drug administration.|111
2963878|NCT00762372|3678017|FG001|STARTED|Overall Study|N=57 enrolled but 2 participant's discontinued before start of study drug administration.|55
2963879|NCT00762372|3678018|FG002|STARTED|Overall Study|N=53 enrolled but 3 participant's discontinued before start of study drug administration.|50
2963880|NCT00762372|3678016|FG000|COMPLETED|Overall Study||110
2963881|NCT00762372|3678017|FG001|COMPLETED|Overall Study||55
2963882|NCT00762372|3678018|FG002|COMPLETED|Overall Study||50
2963883|NCT00762372|3678016|FG000|NOT COMPLETED|Overall Study||1
2963884|NCT00762372|3678017|FG001|NOT COMPLETED|Overall Study||0
2963885|NCT00762372|3678018|FG002|NOT COMPLETED|Overall Study||0
2963886|NCT00762385|3678032|FG000|STARTED|First Intervention||51
2963887|NCT00762385|3678033|FG001|STARTED|First Intervention||46
2963888|NCT00762385|3678032|FG000|COMPLETED|First Intervention||49
2963889|NCT00762385|3678033|FG001|COMPLETED|First Intervention||42
2963890|NCT00762385|3678032|FG000|NOT COMPLETED|First Intervention||2
2963891|NCT00762385|3678033|FG001|NOT COMPLETED|First Intervention||4
2963892|NCT00762385|3678032|FG000|STARTED|Second Intervention||49
2963893|NCT00762385|3678033|FG001|STARTED|Second Intervention||42
2963894|NCT00762385|3678032|FG000|COMPLETED|Second Intervention||46
2963895|NCT00762385|3678033|FG001|COMPLETED|Second Intervention||39
2963896|NCT00762385|3678032|FG000|NOT COMPLETED|Second Intervention||3
2963897|NCT00762385|3678033|FG001|NOT COMPLETED|Second Intervention||3
2963898|NCT00762411|3678044|FG000|STARTED|Initial Treatment||556
2963899|NCT00762411|3678045|FG001|STARTED|Initial Treatment||555
2963900|NCT00762411|3678044|FG000|Intent-to-treat (ITT)|Initial Treatment|ITT population included all randomized participants(pts) who received at least 1 dose of study drug.|555
2963901|NCT00762411|3678045|FG001|Intent-to-treat (ITT)|Initial Treatment|ITT population included all randomized participants who received at least 1 dose of study drug.|553
2963902|NCT00762411|3678044|FG000|COMPLETED|Initial Treatment||22
2963903|NCT00762411|3678045|FG001|COMPLETED|Initial Treatment||34
2963904|NCT00762411|3678044|FG000|NOT COMPLETED|Initial Treatment||534
2963905|NCT00762411|3678045|FG001|NOT COMPLETED|Initial Treatment||521
2963906|NCT00762411|3678044|FG000|STARTED|Delayed Start||22
2963907|NCT00762411|3678045|FG001|STARTED|Delayed Start||34
2963908|NCT00762411|3678044|FG000|COMPLETED|Delayed Start||5
2963909|NCT00762411|3678045|FG001|COMPLETED|Delayed Start||8
2963910|NCT00762411|3678044|FG000|NOT COMPLETED|Delayed Start||17
2963911|NCT00762411|3678045|FG001|NOT COMPLETED|Delayed Start||26
2963912|NCT00762411|3678044|FG000|STARTED|Safety Follow Up (SFU)-Optional|SFU was optional; pts entered from initial treatment and delayed start or did not enter SFU.|312
2963913|NCT00762411|3678045|FG001|STARTED|Safety Follow Up (SFU)-Optional|SFU was optional; pts entered from initial treatment and delayed start or did not enter SFU.|430
2963914|NCT00762411|3678044|FG000|COMPLETED|Safety Follow Up (SFU)-Optional||228
2963915|NCT00762411|3678045|FG001|COMPLETED|Safety Follow Up (SFU)-Optional||312
2963916|NCT00762411|3678044|FG000|NOT COMPLETED|Safety Follow Up (SFU)-Optional||84
2963917|NCT00762411|3678045|FG001|NOT COMPLETED|Safety Follow Up (SFU)-Optional||118
2963918|NCT00762424|3678057|FG000|STARTED|Overall Study||28
3301811|NCT02955797|4035427|FG001|Per Protocol Analysis Set (PPAS)|Overall Study||296
3301812|NCT02955797|4035428|FG002|Per Protocol Analysis Set (PPAS)|Overall Study||198
3301813|NCT02955797|4035429|FG003|Per Protocol Analysis Set (PPAS)|Overall Study||99
3301814|NCT02955797|4035426|FG000|COMPLETED|Overall Study||303
3301815|NCT02955797|4035427|FG001|COMPLETED|Overall Study||303
3301816|NCT02955797|4035428|FG002|COMPLETED|Overall Study||203
2963919|NCT00762424|3678058|FG001|STARTED|Overall Study||25
2963920|NCT00762424|3678057|FG000|COMPLETED|Overall Study||28
2963921|NCT00762424|3678058|FG001|COMPLETED|Overall Study||25
2963922|NCT00762424|3678057|FG000|NOT COMPLETED|Overall Study||0
2963923|NCT00762424|3678058|FG001|NOT COMPLETED|Overall Study||0
2963924|NCT00762450|3678067|FG000|STARTED|1st Treatment Period||2
2963925|NCT00762450|3678068|FG001|STARTED|1st Treatment Period||2
2963926|NCT00762450|3678069|FG002|STARTED|1st Treatment Period||2
2963927|NCT00762450|3678067|FG000|COMPLETED|1st Treatment Period||2
2963928|NCT00762450|3678068|FG001|COMPLETED|1st Treatment Period||2
2963929|NCT00762450|3678069|FG002|COMPLETED|1st Treatment Period||2
2963930|NCT00762450|3678067|FG000|NOT COMPLETED|1st Treatment Period||0
2963931|NCT00762450|3678068|FG001|NOT COMPLETED|1st Treatment Period||0
2963932|NCT00762450|3678069|FG002|NOT COMPLETED|1st Treatment Period||0
2963933|NCT00762450|3678067|FG000|STARTED|Washout After 1st Treatment Period||2
3301817|NCT02955797|4035429|FG003|COMPLETED|Overall Study||101
3301818|NCT02955797|4035426|FG000|NOT COMPLETED|Overall Study||3
3301819|NCT02955797|4035427|FG001|NOT COMPLETED|Overall Study||3
2963934|NCT00762450|3678068|FG001|STARTED|Washout After 1st Treatment Period||2
2963935|NCT00762450|3678069|FG002|STARTED|Washout After 1st Treatment Period||2
2963936|NCT00762450|3678067|FG000|COMPLETED|Washout After 1st Treatment Period||2
2963937|NCT00762450|3678068|FG001|COMPLETED|Washout After 1st Treatment Period||2
2963938|NCT00762450|3678069|FG002|COMPLETED|Washout After 1st Treatment Period||2
2963939|NCT00762450|3678067|FG000|NOT COMPLETED|Washout After 1st Treatment Period||0
2963940|NCT00762450|3678068|FG001|NOT COMPLETED|Washout After 1st Treatment Period||0
2963941|NCT00762450|3678069|FG002|NOT COMPLETED|Washout After 1st Treatment Period||0
2963942|NCT00762450|3678067|FG000|STARTED|2nd Treatment Period||2
2963943|NCT00762450|3678068|FG001|STARTED|2nd Treatment Period||2
2963944|NCT00762450|3678069|FG002|STARTED|2nd Treatment Period||2
2963945|NCT00762450|3678067|FG000|COMPLETED|2nd Treatment Period||2
2963946|NCT00762450|3678068|FG001|COMPLETED|2nd Treatment Period||2
2963947|NCT00762450|3678069|FG002|COMPLETED|2nd Treatment Period||2
2963948|NCT00762450|3678067|FG000|NOT COMPLETED|2nd Treatment Period||0
2963949|NCT00762450|3678068|FG001|NOT COMPLETED|2nd Treatment Period||0
2963950|NCT00762450|3678069|FG002|NOT COMPLETED|2nd Treatment Period||0
2963951|NCT00762450|3678067|FG000|STARTED|Washout After 2nd Treatment Period||2
2963952|NCT00762450|3678068|FG001|STARTED|Washout After 2nd Treatment Period||2
2963953|NCT00762450|3678069|FG002|STARTED|Washout After 2nd Treatment Period||2
2963954|NCT00762450|3678067|FG000|COMPLETED|Washout After 2nd Treatment Period||2
2963955|NCT00762450|3678068|FG001|COMPLETED|Washout After 2nd Treatment Period||2
2963956|NCT00762450|3678069|FG002|COMPLETED|Washout After 2nd Treatment Period||2
2963957|NCT00762450|3678067|FG000|NOT COMPLETED|Washout After 2nd Treatment Period||0
2963958|NCT00762450|3678068|FG001|NOT COMPLETED|Washout After 2nd Treatment Period||0
2963959|NCT00762450|3678069|FG002|NOT COMPLETED|Washout After 2nd Treatment Period||0
2963960|NCT00762450|3678067|FG000|STARTED|3rd Treatment Period||2
2963961|NCT00762450|3678068|FG001|STARTED|3rd Treatment Period||2
2963962|NCT00762450|3678069|FG002|STARTED|3rd Treatment Period||2
2963963|NCT00762450|3678067|FG000|COMPLETED|3rd Treatment Period||2
2963964|NCT00762450|3678068|FG001|COMPLETED|3rd Treatment Period||2
2963965|NCT00762450|3678069|FG002|COMPLETED|3rd Treatment Period||2
2963966|NCT00762450|3678067|FG000|NOT COMPLETED|3rd Treatment Period||0
2963967|NCT00762450|3678068|FG001|NOT COMPLETED|3rd Treatment Period||0
2963968|NCT00762450|3678069|FG002|NOT COMPLETED|3rd Treatment Period||0
2963969|NCT00762463|3678079|FG000|STARTED|Double-blind Phase (Baseline to Week 6)||120
2963970|NCT00762463|3678080|FG001|STARTED|Double-blind Phase (Baseline to Week 6)||120
2963971|NCT00762463|3678081|FG002|STARTED|Double-blind Phase (Baseline to Week 6)||0
3301820|NCT02955797|4035428|FG002|NOT COMPLETED|Overall Study||0
3301821|NCT02955797|4035429|FG003|NOT COMPLETED|Overall Study||2
3301822|NCT02956044|4035445|FG000|STARTED|Overall Study||18
2963972|NCT00762463|3678082|FG003|STARTED|Double-blind Phase (Baseline to Week 6)||0
2963973|NCT00762463|3678079|FG000|COMPLETED|Double-blind Phase (Baseline to Week 6)||113
2963974|NCT00762463|3678080|FG001|COMPLETED|Double-blind Phase (Baseline to Week 6)||110
2963975|NCT00762463|3678081|FG002|COMPLETED|Double-blind Phase (Baseline to Week 6)||0
2963976|NCT00762463|3678082|FG003|COMPLETED|Double-blind Phase (Baseline to Week 6)||0
2963977|NCT00762463|3678079|FG000|NOT COMPLETED|Double-blind Phase (Baseline to Week 6)||7
2963978|NCT00762463|3678080|FG001|NOT COMPLETED|Double-blind Phase (Baseline to Week 6)||10
2963979|NCT00762463|3678081|FG002|NOT COMPLETED|Double-blind Phase (Baseline to Week 6)||0
2963980|NCT00762463|3678082|FG003|NOT COMPLETED|Double-blind Phase (Baseline to Week 6)||0
2963981|NCT00762463|3678079|FG000|STARTED|Enrollment in Extension Phase (Week 6)||113
2963982|NCT00762463|3678080|FG001|STARTED|Enrollment in Extension Phase (Week 6)||110
2963983|NCT00762463|3678081|FG002|STARTED|Enrollment in Extension Phase (Week 6)||0
2963984|NCT00762463|3678082|FG003|STARTED|Enrollment in Extension Phase (Week 6)||0
2963985|NCT00762463|3678079|FG000|COMPLETED|Enrollment in Extension Phase (Week 6)||109
2963986|NCT00762463|3678080|FG001|COMPLETED|Enrollment in Extension Phase (Week 6)||109
2963987|NCT00762463|3678081|FG002|COMPLETED|Enrollment in Extension Phase (Week 6)||0
2963988|NCT00762463|3678082|FG003|COMPLETED|Enrollment in Extension Phase (Week 6)||0
2963989|NCT00762463|3678079|FG000|NOT COMPLETED|Enrollment in Extension Phase (Week 6)||4
2963990|NCT00762463|3678080|FG001|NOT COMPLETED|Enrollment in Extension Phase (Week 6)||1
2963991|NCT00762463|3678081|FG002|NOT COMPLETED|Enrollment in Extension Phase (Week 6)||0
2963992|NCT00762463|3678082|FG003|NOT COMPLETED|Enrollment in Extension Phase (Week 6)||0
2963993|NCT00762463|3678079|FG000|STARTED|Extension Phase (Week 6 to Week 12)||55
2963994|NCT00762463|3678080|FG001|STARTED|Extension Phase (Week 6 to Week 12)||55
2963995|NCT00762463|3678081|FG002|STARTED|Extension Phase (Week 6 to Week 12)||54
2963996|NCT00762463|3678082|FG003|STARTED|Extension Phase (Week 6 to Week 12)||54
2963997|NCT00762463|3678079|FG000|COMPLETED|Extension Phase (Week 6 to Week 12)||52
2963998|NCT00762463|3678080|FG001|COMPLETED|Extension Phase (Week 6 to Week 12)||54
2963999|NCT00762463|3678081|FG002|COMPLETED|Extension Phase (Week 6 to Week 12)||50
2964000|NCT00762463|3678082|FG003|COMPLETED|Extension Phase (Week 6 to Week 12)||52
2964001|NCT00762463|3678079|FG000|NOT COMPLETED|Extension Phase (Week 6 to Week 12)||3
2964002|NCT00762463|3678080|FG001|NOT COMPLETED|Extension Phase (Week 6 to Week 12)||1
2964003|NCT00762463|3678081|FG002|NOT COMPLETED|Extension Phase (Week 6 to Week 12)||4
2964004|NCT00762463|3678082|FG003|NOT COMPLETED|Extension Phase (Week 6 to Week 12)||2
2964005|NCT00762476|3678097|FG000|STARTED|Overall Study||206
2964006|NCT00762476|3678098|FG001|STARTED|Overall Study||205
2964007|NCT00762476|3678097|FG000|COMPLETED|Overall Study||183
2964008|NCT00762476|3678098|FG001|COMPLETED|Overall Study||169
2964009|NCT00762476|3678097|FG000|NOT COMPLETED|Overall Study||23
2964010|NCT00762476|3678098|FG001|NOT COMPLETED|Overall Study||36
2964011|NCT00762502|3678108|FG000|STARTED|Baseline to Month 3 (Period 1)||36
2964012|NCT00762502|3678109|FG001|STARTED|Baseline to Month 3 (Period 1)||25
2964013|NCT00762502|3678110|FG002|STARTED|Baseline to Month 3 (Period 1)||51
2964014|NCT00762502|3678108|FG000|COMPLETED|Baseline to Month 3 (Period 1)||26
2964015|NCT00762502|3678109|FG001|COMPLETED|Baseline to Month 3 (Period 1)||19
2964016|NCT00762502|3678110|FG002|COMPLETED|Baseline to Month 3 (Period 1)||32
2964017|NCT00762502|3678108|FG000|NOT COMPLETED|Baseline to Month 3 (Period 1)||10
2964018|NCT00762502|3678109|FG001|NOT COMPLETED|Baseline to Month 3 (Period 1)||6
2964019|NCT00762502|3678110|FG002|NOT COMPLETED|Baseline to Month 3 (Period 1)||19
2964020|NCT00762502|3678108|FG000|STARTED|Month 3 to Month 6 (Period 2)||9
2964021|NCT00762502|3678109|FG001|STARTED|Month 3 to Month 6 (Period 2)||5
2964022|NCT00762502|3678110|FG002|STARTED|Month 3 to Month 6 (Period 2)||23
2964023|NCT00762502|3678108|FG000|COMPLETED|Month 3 to Month 6 (Period 2)||9
2964024|NCT00762502|3678109|FG001|COMPLETED|Month 3 to Month 6 (Period 2)||4
2964025|NCT00762502|3678110|FG002|COMPLETED|Month 3 to Month 6 (Period 2)||23
2964026|NCT00762502|3678108|FG000|NOT COMPLETED|Month 3 to Month 6 (Period 2)||0
2964027|NCT00762502|3678109|FG001|NOT COMPLETED|Month 3 to Month 6 (Period 2)||1
2964028|NCT00762502|3678110|FG002|NOT COMPLETED|Month 3 to Month 6 (Period 2)||0
2964029|NCT00762515|3678118|FG000|STARTED|Overall Study||22
2964030|NCT00762515|3678119|FG001|STARTED|Overall Study||22
2964031|NCT00762515|3678118|FG000|COMPLETED|Overall Study||22
2964032|NCT00762515|3678119|FG001|COMPLETED|Overall Study||22
2964033|NCT00762515|3678118|FG000|NOT COMPLETED|Overall Study||0
2964034|NCT00762515|3678119|FG001|NOT COMPLETED|Overall Study||0
2964035|NCT00762528|3678127|FG000|STARTED|Overall Study||24
2964036|NCT00762528|3678128|FG001|STARTED|Overall Study||25
2964037|NCT00762528|3678127|FG000|COMPLETED|Overall Study||24
2964038|NCT00762528|3678128|FG001|COMPLETED|Overall Study||25
2964039|NCT00762528|3678127|FG000|NOT COMPLETED|Overall Study||0
2964040|NCT00762528|3678128|FG001|NOT COMPLETED|Overall Study||0
2964041|NCT00762606|3678136|FG000|STARTED|Overall Study||55
2964042|NCT00762606|3678137|FG001|STARTED|Overall Study||51
2964043|NCT00762606|3678136|FG000|COMPLETED|Overall Study||37
2964044|NCT00762606|3678137|FG001|COMPLETED|Overall Study||38
2964045|NCT00762606|3678136|FG000|NOT COMPLETED|Overall Study||18
2964046|NCT00762606|3678137|FG001|NOT COMPLETED|Overall Study||13
2964047|NCT00762619|3678145|FG000|STARTED|Overall Study||55
2964048|NCT00762619|3678146|FG001|STARTED|Overall Study||50
2964049|NCT00762619|3678145|FG000|COMPLETED|Overall Study||55
2964050|NCT00762619|3678146|FG001|COMPLETED|Overall Study||50
2964051|NCT00762619|3678145|FG000|NOT COMPLETED|Overall Study||0
2964052|NCT00762619|3678146|FG001|NOT COMPLETED|Overall Study||0
2964053|NCT00762645|3678156|FG000|STARTED|Overall Study||16
2964054|NCT00762645|3678157|FG001|STARTED|Overall Study||14
2964055|NCT00762645|3678156|FG000|COMPLETED|Overall Study||12
2964056|NCT00762645|3678157|FG001|COMPLETED|Overall Study||12
2964057|NCT00762645|3678156|FG000|NOT COMPLETED|Overall Study||4
2964058|NCT00762645|3678157|FG001|NOT COMPLETED|Overall Study||2
2964059|NCT00762710|3678165|FG000|STARTED|Overall Study||48
2964060|NCT00762710|3678166|FG001|STARTED|Overall Study||44
2964061|NCT00762710|3678165|FG000|COMPLETED|Overall Study||27
2964062|NCT00762710|3678166|FG001|COMPLETED|Overall Study||29
2964063|NCT00762710|3678165|FG000|NOT COMPLETED|Overall Study||21
2964064|NCT00762710|3678166|FG001|NOT COMPLETED|Overall Study||15
2964065|NCT00762762|3678174|FG000|STARTED|Overall Study||30
2964066|NCT00762762|3678175|FG001|STARTED|Overall Study||30
2964067|NCT00762762|3678174|FG000|COMPLETED|Overall Study||22
2964068|NCT00762762|3678175|FG001|COMPLETED|Overall Study||20
2964069|NCT00762762|3678174|FG000|NOT COMPLETED|Overall Study||8
2964070|NCT00762762|3678175|FG001|NOT COMPLETED|Overall Study||10
2964071|NCT00762788|3678187|FG000|STARTED|Overall Study||55
2964072|NCT00762788|3678188|FG001|STARTED|Overall Study||58
2964073|NCT00762788|3678189|FG002|STARTED|Overall Study||42
2964074|NCT00762788|3678190|FG003|STARTED|Overall Study||64
2964075|NCT00762788|3678191|FG004|STARTED|Overall Study||43
2964076|NCT00762788|3678192|FG005|STARTED|Overall Study||52
2964077|NCT00762788|3678187|FG000|COMPLETED|Overall Study||29
2964078|NCT00762788|3678188|FG001|COMPLETED|Overall Study||21
2964079|NCT00762788|3678189|FG002|COMPLETED|Overall Study||21
2964080|NCT00762788|3678190|FG003|COMPLETED|Overall Study||38
2964081|NCT00762788|3678191|FG004|COMPLETED|Overall Study||30
2964082|NCT00762788|3678192|FG005|COMPLETED|Overall Study||31
2964083|NCT00762788|3678187|FG000|NOT COMPLETED|Overall Study||26
2964084|NCT00762788|3678188|FG001|NOT COMPLETED|Overall Study||37
2964085|NCT00762788|3678189|FG002|NOT COMPLETED|Overall Study||21
2964086|NCT00762788|3678190|FG003|NOT COMPLETED|Overall Study||26
2964087|NCT00762788|3678191|FG004|NOT COMPLETED|Overall Study||13
2964088|NCT00762788|3678192|FG005|NOT COMPLETED|Overall Study||21
2964089|NCT00762853|3678208|FG000|STARTED|First Treatment Period||10
2964090|NCT00762853|3678209|FG001|STARTED|First Treatment Period||10
2964091|NCT00762853|3678208|FG000|COMPLETED|First Treatment Period||10
2964092|NCT00762853|3678209|FG001|COMPLETED|First Treatment Period||10
2964093|NCT00762853|3678208|FG000|NOT COMPLETED|First Treatment Period||0
2964094|NCT00762853|3678209|FG001|NOT COMPLETED|First Treatment Period||0
2964095|NCT00762853|3678208|FG000|STARTED|1 Week Washout After Treatment 1||10
2964096|NCT00762853|3678209|FG001|STARTED|1 Week Washout After Treatment 1||10
2964097|NCT00762853|3678208|FG000|COMPLETED|1 Week Washout After Treatment 1||10
2964098|NCT00762853|3678209|FG001|COMPLETED|1 Week Washout After Treatment 1||10
2964099|NCT00762853|3678208|FG000|NOT COMPLETED|1 Week Washout After Treatment 1||0
2964100|NCT00762853|3678209|FG001|NOT COMPLETED|1 Week Washout After Treatment 1||0
2964101|NCT00762853|3678208|FG000|STARTED|Second Treatment Period||10
2964102|NCT00762853|3678209|FG001|STARTED|Second Treatment Period||10
2964103|NCT00762853|3678208|FG000|COMPLETED|Second Treatment Period||10
2964104|NCT00762853|3678209|FG001|COMPLETED|Second Treatment Period||10
2964105|NCT00762853|3678208|FG000|NOT COMPLETED|Second Treatment Period||0
2964106|NCT00762853|3678209|FG001|NOT COMPLETED|Second Treatment Period||0
2964107|NCT00762892|3678217|FG000|STARTED|Overall Study||14
2964108|NCT00762892|3678218|FG001|STARTED|Overall Study||14
2964109|NCT00762892|3678217|FG000|COMPLETED|Overall Study||9
2964110|NCT00762892|3678218|FG001|COMPLETED|Overall Study||8
2964111|NCT00762892|3678217|FG000|NOT COMPLETED|Overall Study||5
2964112|NCT00762892|3678218|FG001|NOT COMPLETED|Overall Study||6
2964113|NCT00762931|3678224|FG000|STARTED|Overall Study||25
2964114|NCT00762931|3678224|FG000|COMPLETED|Overall Study||23
2964115|NCT00762931|3678224|FG000|NOT COMPLETED|Overall Study||2
2964116|NCT00762970|3678231|FG000|STARTED|Overall Study||46
2964117|NCT00762970|3678232|FG001|STARTED|Overall Study||44
2964118|NCT00762970|3678233|FG002|STARTED|Overall Study||47
2964119|NCT00762970|3678231|FG000|COMPLETED|Overall Study||34
2964120|NCT00762970|3678232|FG001|COMPLETED|Overall Study||35
2964121|NCT00762970|3678233|FG002|COMPLETED|Overall Study||46
2964122|NCT00762970|3678231|FG000|NOT COMPLETED|Overall Study||12
2964123|NCT00762970|3678232|FG001|NOT COMPLETED|Overall Study||9
2964124|NCT00762970|3678233|FG002|NOT COMPLETED|Overall Study||1
2964125|NCT00762996|3678241|FG000|STARTED|Period One||15
2964126|NCT00762996|3678242|FG001|STARTED|Period One||16
2964127|NCT00762996|3678243|FG002|STARTED|Period One||17
2964128|NCT00762996|3678244|FG003|STARTED|Period One||17
2964129|NCT00762996|3678241|FG000|COMPLETED|Period One||15
2964130|NCT00762996|3678242|FG001|COMPLETED|Period One||16
2964131|NCT00762996|3678243|FG002|COMPLETED|Period One||13
2964132|NCT00762996|3678244|FG003|COMPLETED|Period One||16
2964133|NCT00762996|3678241|FG000|NOT COMPLETED|Period One||0
2964134|NCT00762996|3678242|FG001|NOT COMPLETED|Period One||0
2964135|NCT00762996|3678243|FG002|NOT COMPLETED|Period One||4
2964136|NCT00762996|3678244|FG003|NOT COMPLETED|Period One||1
2964137|NCT00762996|3678241|FG000|STARTED|Period Two||15
2964138|NCT00762996|3678242|FG001|STARTED|Period Two||16
2964139|NCT00762996|3678243|FG002|STARTED|Period Two||13
2964140|NCT00762996|3678244|FG003|STARTED|Period Two||16
2964141|NCT00762996|3678241|FG000|COMPLETED|Period Two||15
2964142|NCT00762996|3678242|FG001|COMPLETED|Period Two||16
2964143|NCT00762996|3678243|FG002|COMPLETED|Period Two||13
2964144|NCT00762996|3678244|FG003|COMPLETED|Period Two||16
2964145|NCT00762996|3678241|FG000|NOT COMPLETED|Period Two||0
2964146|NCT00762996|3678242|FG001|NOT COMPLETED|Period Two||0
2964147|NCT00762996|3678243|FG002|NOT COMPLETED|Period Two||0
2964148|NCT00762996|3678244|FG003|NOT COMPLETED|Period Two||0
2964149|NCT00763035|3678252|FG000|STARTED|First Intervention||10
2964150|NCT00763035|3678253|FG001|STARTED|First Intervention||4
2964151|NCT00763035|3678252|FG000|COMPLETED|First Intervention||9
2964152|NCT00763035|3678253|FG001|COMPLETED|First Intervention||3
2964153|NCT00763035|3678252|FG000|NOT COMPLETED|First Intervention||1
2964154|NCT00763035|3678253|FG001|NOT COMPLETED|First Intervention||1
2964155|NCT00763035|3678252|FG000|STARTED|Second Intervention||9
2964156|NCT00763035|3678253|FG001|STARTED|Second Intervention||3
2964157|NCT00763035|3678252|FG000|COMPLETED|Second Intervention||6
2964158|NCT00763035|3678253|FG001|COMPLETED|Second Intervention||3
2964159|NCT00763035|3678252|FG000|NOT COMPLETED|Second Intervention||3
2964160|NCT00763035|3678253|FG001|NOT COMPLETED|Second Intervention||0
2964161|NCT00763048|3678261|FG000|STARTED|Overall Study||21
2964162|NCT00763048|3678262|FG001|STARTED|Overall Study||18
2964163|NCT00763048|3678261|FG000|COMPLETED|Overall Study||21
2964164|NCT00763048|3678262|FG001|COMPLETED|Overall Study||18
2964165|NCT00763048|3678261|FG000|NOT COMPLETED|Overall Study||0
2964166|NCT00763048|3678262|FG001|NOT COMPLETED|Overall Study||0
2964167|NCT00763061|3678270|FG000|STARTED|Overall Study||54
2964168|NCT00763061|3678271|FG001|STARTED|Overall Study||57
2964169|NCT00763061|3678270|FG000|COMPLETED|Overall Study||49
2964170|NCT00763061|3678271|FG001|COMPLETED|Overall Study||44
2964171|NCT00763061|3678270|FG000|NOT COMPLETED|Overall Study||5
2964172|NCT00763061|3678271|FG001|NOT COMPLETED|Overall Study||13
2964173|NCT00763139|3678277|FG000|STARTED|Overall Study||17
2964174|NCT00763139|3678278|FG001|STARTED|Overall Study||17
2964175|NCT00763139|3678277|FG000|COMPLETED|Overall Study||12
2964176|NCT00763139|3678278|FG001|COMPLETED|Overall Study||14
2964177|NCT00763139|3678277|FG000|NOT COMPLETED|Overall Study||5
2964178|NCT00763139|3678278|FG001|NOT COMPLETED|Overall Study||3
2964179|NCT00763243|3678289|FG000|STARTED|Waiting Period||9
2964180|NCT00763243|3678289|FG000|COMPLETED|Waiting Period||9
2964181|NCT00763243|3678289|FG000|NOT COMPLETED|Waiting Period||0
2964182|NCT00763243|3678289|FG000|STARTED|Training Period||9
2964183|NCT00763243|3678289|FG000|COMPLETED|Training Period||9
2964184|NCT00763243|3678289|FG000|NOT COMPLETED|Training Period||0
2964185|NCT00763243|3678289|FG000|STARTED|1-Month Follow-Up Period||9
2964186|NCT00763243|3678289|FG000|COMPLETED|1-Month Follow-Up Period||9
2964187|NCT00763243|3678289|FG000|NOT COMPLETED|1-Month Follow-Up Period||0
2964188|NCT00763243|3678289|FG000|STARTED|6-Month Follow-Up Period||9
2964189|NCT00763243|3678289|FG000|COMPLETED|6-Month Follow-Up Period||9
2964190|NCT00763243|3678289|FG000|NOT COMPLETED|6-Month Follow-Up Period||0
2964191|NCT00763256|3678303|FG000|STARTED|Overall Study||15
2964192|NCT00763256|3678304|FG001|STARTED|Overall Study||18
2964193|NCT00763256|3678303|FG000|COMPLETED|Overall Study||8
2964194|NCT00763256|3678304|FG001|COMPLETED|Overall Study||8
2964195|NCT00763256|3678303|FG000|NOT COMPLETED|Overall Study||7
2964196|NCT00763256|3678304|FG001|NOT COMPLETED|Overall Study||10
2964197|NCT00763269|3678312|FG000|STARTED|Overall Study||314
2964198|NCT00763269|3678313|FG001|STARTED|Overall Study||312
2964199|NCT00763269|3678312|FG000|COMPLETED|Overall Study||302
2964200|NCT00763269|3678313|FG001|COMPLETED|Overall Study||299
2964201|NCT00763269|3678312|FG000|NOT COMPLETED|Overall Study||12
2964202|NCT00763269|3678313|FG001|NOT COMPLETED|Overall Study||13
2964203|NCT00763282|3678321|FG000|STARTED|Overall Study||72
2964204|NCT00763282|3678322|FG001|STARTED|Overall Study||72
2964205|NCT00763282|3678321|FG000|COMPLETED|Overall Study||40
2964206|NCT00763282|3678322|FG001|COMPLETED|Overall Study||38
2964207|NCT00763282|3678321|FG000|NOT COMPLETED|Overall Study||32
2964208|NCT00763282|3678322|FG001|NOT COMPLETED|Overall Study||34
2964209|NCT00763321|3678333|FG000|STARTED|Open-label Period||285
2964210|NCT00763321|3678334|FG001|STARTED|Open-label Period||0
2964211|NCT00763321|3678335|FG002|STARTED|Open-label Period||0
2964212|NCT00763321|3678333|FG000|COMPLETED|Open-label Period||222
2964213|NCT00763321|3678334|FG001|COMPLETED|Open-label Period||0
2964214|NCT00763321|3678335|FG002|COMPLETED|Open-label Period||0
2964215|NCT00763321|3678333|FG000|NOT COMPLETED|Open-label Period||63
2964216|NCT00763321|3678334|FG001|NOT COMPLETED|Open-label Period||0
2964217|NCT00763321|3678335|FG002|NOT COMPLETED|Open-label Period||0
2964218|NCT00763321|3678333|FG000|STARTED|Double-blind Period||0
2964219|NCT00763321|3678334|FG001|STARTED|Double-blind Period||109
2964220|NCT00763321|3678335|FG002|STARTED|Double-blind Period||113
2964221|NCT00763321|3678333|FG000|COMPLETED|Double-blind Period||0
2964222|NCT00763321|3678334|FG001|COMPLETED|Double-blind Period||88
2964223|NCT00763321|3678335|FG002|COMPLETED|Double-blind Period||84
2964224|NCT00763321|3678333|FG000|NOT COMPLETED|Double-blind Period||0
2964225|NCT00763321|3678334|FG001|NOT COMPLETED|Double-blind Period||21
2964226|NCT00763321|3678335|FG002|NOT COMPLETED|Double-blind Period||29
3035537|NCT01138007|3754809|FG002|STARTED|Overall Study||192
3035538|NCT01138007|3754807|FG000|COMPLETED|Overall Study||165
3035539|NCT01138007|3754808|FG001|COMPLETED|Overall Study||160
3035540|NCT01138007|3754809|FG002|COMPLETED|Overall Study||144
3035541|NCT01138007|3754807|FG000|NOT COMPLETED|Overall Study||22
3035542|NCT01138007|3754808|FG001|NOT COMPLETED|Overall Study||30
3035543|NCT01138007|3754809|FG002|NOT COMPLETED|Overall Study||48
3035544|NCT01138046|3754819|FG000|STARTED|Overall Study||12
3035545|NCT01138046|3754819|FG000|COMPLETED|Overall Study||6
2964227|NCT00763360|3678345|FG000|STARTED|Overall Study||61
2964228|NCT00763360|3678346|FG001|STARTED|Overall Study||60
2964229|NCT00763360|3678347|FG002|STARTED|Overall Study||63
2964230|NCT00763360|3678345|FG000|COMPLETED|Overall Study||61
2964231|NCT00763360|3678346|FG001|COMPLETED|Overall Study||58
2964232|NCT00763360|3678347|FG002|COMPLETED|Overall Study||63
2964233|NCT00763360|3678345|FG000|NOT COMPLETED|Overall Study||0
2964234|NCT00763360|3678346|FG001|NOT COMPLETED|Overall Study||2
2964235|NCT00763360|3678347|FG002|NOT COMPLETED|Overall Study||0
3133037|NCT01694186|3858164|FG000|STARTED|Overall Study|Two investigators each site Investigator 1 unmasked treating and investigator 2 masked follow up.|42
2964236|NCT00763386|3678357|FG000|STARTED|Overall Study||164
2964237|NCT00763386|3678358|FG001|STARTED|Overall Study||167
2964238|NCT00763386|3678357|FG000|COMPLETED|Overall Study||116
2964239|NCT00763386|3678358|FG001|COMPLETED|Overall Study||127
2964240|NCT00763386|3678357|FG000|NOT COMPLETED|Overall Study||48
2964241|NCT00763386|3678358|FG001|NOT COMPLETED|Overall Study||40
2964242|NCT00763412|3678366|FG000|STARTED|Overall Study||8
2964243|NCT00763412|3678367|FG001|STARTED|Overall Study||8
2964244|NCT00763412|3678366|FG000|COMPLETED|Overall Study||4
2964245|NCT00763412|3678367|FG001|COMPLETED|Overall Study||4
2964246|NCT00763412|3678366|FG000|NOT COMPLETED|Overall Study||4
2964247|NCT00763412|3678367|FG001|NOT COMPLETED|Overall Study||4
2964248|NCT00763451|3678377|FG000|STARTED|Overall Study|Randomized.|80
2964249|NCT00763451|3678378|FG001|STARTED|Overall Study||82
2964250|NCT00763451|3678379|FG002|STARTED|Overall Study||161
2964251|NCT00763451|3678380|FG003|STARTED|Overall Study||161
2964252|NCT00763451|3678377|FG000|Treated/Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|79
2964253|NCT00763451|3678378|FG001|Treated/Safety Population|Overall Study||81
2964254|NCT00763451|3678379|FG002|Treated/Safety Population|Overall Study||161
2964255|NCT00763451|3678380|FG003|Treated/Safety Population|Overall Study||161
2964256|NCT00763451|3678377|FG000|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|79
2964257|NCT00763451|3678378|FG001|Modified Intent-to-Treat(mITT)Population|Overall Study||80
2964258|NCT00763451|3678379|FG002|Modified Intent-to-Treat(mITT)Population|Overall Study||160
2964259|NCT00763451|3678380|FG003|Modified Intent-to-Treat(mITT)Population|Overall Study||160
2964260|NCT00763451|3678377|FG000|COMPLETED|Overall Study||67
2964261|NCT00763451|3678378|FG001|COMPLETED|Overall Study||60
2964262|NCT00763451|3678379|FG002|COMPLETED|Overall Study||121
2964263|NCT00763451|3678380|FG003|COMPLETED|Overall Study||131
2964264|NCT00763451|3678377|FG000|NOT COMPLETED|Overall Study||13
2964265|NCT00763451|3678378|FG001|NOT COMPLETED|Overall Study||22
2964266|NCT00763451|3678379|FG002|NOT COMPLETED|Overall Study||40
2964267|NCT00763451|3678380|FG003|NOT COMPLETED|Overall Study||30
2964268|NCT00763490|3678391|FG000|STARTED|Overall Study||20
2964269|NCT00763490|3678391|FG000|COMPLETED|Overall Study||20
2964270|NCT00763490|3678391|FG000|NOT COMPLETED|Overall Study||0
2964271|NCT00763698|3678395|FG000|STARTED|Overall Study||86
2964272|NCT00763698|3678395|FG000|COMPLETED|Overall Study||76
2964273|NCT00763698|3678395|FG000|NOT COMPLETED|Overall Study||10
2964274|NCT00763750|3678400|FG000|STARTED|Overall Study||25
2964275|NCT00763750|3678400|FG000|COMPLETED|Overall Study||25
2964276|NCT00763750|3678400|FG000|NOT COMPLETED|Overall Study||0
2964277|NCT00763815|3678406|FG000|STARTED|Overall Study|Randomized.|161
2964278|NCT00763815|3678407|FG001|STARTED|Overall Study||323
2964279|NCT00763815|3678406|FG000|Treated/Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|161
2964280|NCT00763815|3678407|FG001|Treated/Safety Population|Overall Study||323
2964281|NCT00763815|3678406|FG000|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|159
2964282|NCT00763815|3678407|FG001|Modified Intent-to-Treat(mITT)Population|Overall Study||320
2964283|NCT00763815|3678406|FG000|COMPLETED|Overall Study||109
2964284|NCT00763815|3678407|FG001|COMPLETED|Overall Study||239
2964285|NCT00763815|3678406|FG000|NOT COMPLETED|Overall Study||52
2964286|NCT00763815|3678407|FG001|NOT COMPLETED|Overall Study||84
2964287|NCT00763867|3678415|FG000|STARTED|Overall Study||103
2964288|NCT00763867|3678416|FG001|STARTED|Overall Study||113
2964289|NCT00763867|3678415|FG000|COMPLETED|Overall Study||98
2964290|NCT00763867|3678416|FG001|COMPLETED|Overall Study||101
2964291|NCT00763867|3678415|FG000|NOT COMPLETED|Overall Study||5
2964292|NCT00763867|3678416|FG001|NOT COMPLETED|Overall Study||12
2964293|NCT00763919|3678422|FG000|STARTED|Overall Study||43
2964294|NCT00763919|3678422|FG000|COMPLETED|Overall Study||30
2964295|NCT00763919|3678422|FG000|NOT COMPLETED|Overall Study||13
2964296|NCT00763958|3678428|FG000|STARTED|Overall Study||28
2964297|NCT00763958|3678429|FG001|STARTED|Overall Study||16
2964298|NCT00763958|3678428|FG000|COMPLETED|Overall Study||14
2964299|NCT00763958|3678429|FG001|COMPLETED|Overall Study||5
2964300|NCT00763958|3678428|FG000|NOT COMPLETED|Overall Study||14
2964301|NCT00763958|3678429|FG001|NOT COMPLETED|Overall Study||11
2964302|NCT00763971|3678439|FG000|STARTED|Overall Study||113
2964303|NCT00763971|3678440|FG001|STARTED|Overall Study||112
2964304|NCT00763971|3678441|FG002|STARTED|Overall Study||111
2964305|NCT00763971|3678439|FG000|COMPLETED|Overall Study||80
2964306|NCT00763971|3678440|FG001|COMPLETED|Overall Study||74
2964307|NCT00763971|3678441|FG002|COMPLETED|Overall Study||42
2964308|NCT00763971|3678439|FG000|NOT COMPLETED|Overall Study||33
2964309|NCT00763971|3678440|FG001|NOT COMPLETED|Overall Study||38
2964310|NCT00763971|3678441|FG002|NOT COMPLETED|Overall Study||69
2964311|NCT00764309|3678449|FG000|STARTED|Overall Study|Number of participants treated.|31
2964312|NCT00764309|3678449|FG000|COMPLETED|Overall Study|Completed=off study. Major Reasons for off study: AE-13; withdrawn by sponsor-10; Lack of efficacy-3|31
2964313|NCT00764309|3678449|FG000|NOT COMPLETED|Overall Study||0
2964314|NCT00764322|3678455|FG000|STARTED|Overall Study||500
2964315|NCT00764322|3678455|FG000|COMPLETED|Overall Study||480
2964316|NCT00764322|3678455|FG000|NOT COMPLETED|Overall Study||20
2964317|NCT00764361|3678474|FG000|STARTED|Overall Study||8
2964318|NCT00764361|3678475|FG001|STARTED|Overall Study||7
2964319|NCT00764361|3678474|FG000|COMPLETED|Overall Study||6
2964320|NCT00764361|3678475|FG001|COMPLETED|Overall Study||3
2964321|NCT00764361|3678474|FG000|NOT COMPLETED|Overall Study||2
2964322|NCT00764361|3678475|FG001|NOT COMPLETED|Overall Study||4
2964323|NCT00764465|3678487|FG000|STARTED|Overall Study||9
2964324|NCT00764465|3678488|FG001|STARTED|Overall Study||7
2964325|NCT00764465|3678489|FG002|STARTED|Overall Study||7
2964326|NCT00764465|3678490|FG003|STARTED|Overall Study||7
2964327|NCT00764465|3678491|FG004|STARTED|Overall Study||7
2964328|NCT00764465|3678492|FG005|STARTED|Overall Study||8
2964329|NCT00764465|3678487|FG000|COMPLETED|Overall Study||7
2964330|NCT00764465|3678488|FG001|COMPLETED|Overall Study||6
2964331|NCT00764465|3678489|FG002|COMPLETED|Overall Study||6
2964332|NCT00764465|3678490|FG003|COMPLETED|Overall Study||6
2964333|NCT00764465|3678491|FG004|COMPLETED|Overall Study||6
2964334|NCT00764465|3678492|FG005|COMPLETED|Overall Study||7
2964335|NCT00764465|3678487|FG000|NOT COMPLETED|Overall Study||2
2964336|NCT00764465|3678488|FG001|NOT COMPLETED|Overall Study||1
2964337|NCT00764465|3678489|FG002|NOT COMPLETED|Overall Study||1
2964338|NCT00764465|3678490|FG003|NOT COMPLETED|Overall Study||1
2964339|NCT00764465|3678491|FG004|NOT COMPLETED|Overall Study||1
2964340|NCT00764465|3678492|FG005|NOT COMPLETED|Overall Study||1
2964341|NCT00764491|3678511|FG000|STARTED|Overall Study||123
2964342|NCT00764491|3678512|FG001|STARTED|Overall Study||33
2964343|NCT00764491|3678511|FG000|COMPLETED|Overall Study||88
2964344|NCT00764491|3678512|FG001|COMPLETED|Overall Study||16
2964345|NCT00764491|3678511|FG000|NOT COMPLETED|Overall Study||35
3133038|NCT01694186|3858165|FG001|STARTED|Overall Study|Two investigators each site Investigator 1 unmasked treating and investigator 2 masked follow up.|87
3133039|NCT01694186|3858164|FG000|COMPLETED|Overall Study|Two investigators each site Investigator 1 unmasked treating and investigator 2 masked follow up.|36
3133040|NCT01694186|3858165|FG001|COMPLETED|Overall Study|Two investigators each site Investigator 1 unmasked treating and investigator 2 masked follow up.|80
3133041|NCT01694186|3858164|FG000|NOT COMPLETED|Overall Study||6
3133042|NCT01694186|3858165|FG001|NOT COMPLETED|Overall Study||7
3133043|NCT01694199|3858173|FG000|STARTED|Overall Study||71
3133044|NCT01694199|3858174|FG001|STARTED|Overall Study||68
3133045|NCT01694199|3858173|FG000|COMPLETED|Overall Study||71
3133046|NCT01694199|3858174|FG001|COMPLETED|Overall Study||68
2964346|NCT00764491|3678512|FG001|NOT COMPLETED|Overall Study||17
2964347|NCT00764504|3678521|FG000|STARTED|Overall Study||141
2964348|NCT00764504|3678522|FG001|STARTED|Overall Study||141
2964349|NCT00764504|3678523|FG002|STARTED|Overall Study||234
2964350|NCT00764504|3678521|FG000|COMPLETED|Overall Study||75
2964351|NCT00764504|3678522|FG001|COMPLETED|Overall Study||71
2964352|NCT00764504|3678523|FG002|COMPLETED|Overall Study||131
2964353|NCT00764504|3678521|FG000|NOT COMPLETED|Overall Study||66
2964354|NCT00764504|3678522|FG001|NOT COMPLETED|Overall Study||70
2964355|NCT00764504|3678523|FG002|NOT COMPLETED|Overall Study||103
2964356|NCT00764517|3678533|FG000|STARTED|Overall Study||39
2964357|NCT00764517|3678534|FG001|STARTED|Overall Study||18
2964358|NCT00764517|3678533|FG000|COMPLETED|Overall Study||24
2964359|NCT00764517|3678534|FG001|COMPLETED|Overall Study||4
2964360|NCT00764517|3678533|FG000|NOT COMPLETED|Overall Study||15
2964361|NCT00764517|3678534|FG001|NOT COMPLETED|Overall Study||14
2964362|NCT00764660|3678542|FG000|STARTED|Overall Study||75
2964363|NCT00764660|3678543|FG001|STARTED|Overall Study||66
2964364|NCT00764660|3678542|FG000|COMPLETED|Overall Study||53
2964365|NCT00764660|3678543|FG001|COMPLETED|Overall Study||55
2964366|NCT00764660|3678542|FG000|NOT COMPLETED|Overall Study||22
2964367|NCT00764660|3678543|FG001|NOT COMPLETED|Overall Study||11
2964368|NCT00764673|3678549|FG000|STARTED|Overall Study||71
2964369|NCT00764673|3678549|FG000|COMPLETED|Overall Study||59
2964370|NCT00764673|3678549|FG000|NOT COMPLETED|Overall Study||12
2964371|NCT00764738|3678557|FG000|STARTED|Overall Study||24
2964372|NCT00764738|3678558|FG001|STARTED|Overall Study||28
2964373|NCT00764738|3678559|FG002|STARTED|Overall Study||15
2964374|NCT00764738|3678560|FG003|STARTED|Overall Study||24
2964375|NCT00764738|3678557|FG000|COMPLETED|Overall Study||22
2964376|NCT00764738|3678558|FG001|COMPLETED|Overall Study||25
2964377|NCT00764738|3678559|FG002|COMPLETED|Overall Study||12
2964378|NCT00764738|3678560|FG003|COMPLETED|Overall Study||18
2964379|NCT00764738|3678557|FG000|NOT COMPLETED|Overall Study||2
2964380|NCT00764738|3678558|FG001|NOT COMPLETED|Overall Study||3
2964381|NCT00764738|3678559|FG002|NOT COMPLETED|Overall Study||3
2964382|NCT00764738|3678560|FG003|NOT COMPLETED|Overall Study||6
2964383|NCT00764751|3678572|FG000|STARTED|Overall Study||39
2964384|NCT00764751|3678573|FG001|STARTED|Overall Study||12
2964385|NCT00764751|3678572|FG000|COMPLETED|Overall Study||37
2964386|NCT00764751|3678573|FG001|COMPLETED|Overall Study||11
2964387|NCT00764751|3678572|FG000|NOT COMPLETED|Overall Study||2
2964388|NCT00764751|3678573|FG001|NOT COMPLETED|Overall Study||1
2964389|NCT00764790|3678587|FG000|STARTED|Overall Study||1107
2964390|NCT00764790|3678588|FG001|STARTED|Overall Study||1106
2964391|NCT00764790|3678589|FG002|STARTED|Overall Study||1104
2964392|NCT00764790|3678587|FG000|COMPLETED|Overall Study||1069
2964393|NCT00764790|3678588|FG001|COMPLETED|Overall Study||1065
2964394|NCT00764790|3678589|FG002|COMPLETED|Overall Study||1074
2964395|NCT00764790|3678587|FG000|NOT COMPLETED|Overall Study||38
2964396|NCT00764790|3678588|FG001|NOT COMPLETED|Overall Study||41
2964397|NCT00764790|3678589|FG002|NOT COMPLETED|Overall Study||30
2964398|NCT00764868|3678597|FG000|STARTED|Overall Study||269
2964399|NCT00764868|3678597|FG000|COMPLETED|Overall Study||156
2964400|NCT00764868|3678597|FG000|NOT COMPLETED|Overall Study||113
2964401|NCT00764881|3678603|FG000|STARTED|Overall Study||108
2964402|NCT00764881|3678604|FG001|STARTED|Overall Study||109
2964403|NCT00764881|3678603|FG000|Subjects Received Treatment|Overall Study|Full Analysis Set (FAS)|106
2964404|NCT00764881|3678604|FG001|Subjects Received Treatment|Overall Study|Full Analysis Set (FAS)|107
2964405|NCT00764881|3678603|FG000|COMPLETED|Overall Study||92
2964406|NCT00764881|3678604|FG001|COMPLETED|Overall Study||99
2964407|NCT00764881|3678603|FG000|NOT COMPLETED|Overall Study||16
2964408|NCT00764881|3678604|FG001|NOT COMPLETED|Overall Study||10
2964409|NCT00764946|3678613|FG000|STARTED|Overall Study||98
2964410|NCT00764946|3678614|FG001|STARTED|Overall Study||89
2964411|NCT00764946|3678615|FG002|STARTED|Overall Study||22
2964412|NCT00764946|3678613|FG000|TREATED|Overall Study||97
2964413|NCT00764946|3678614|FG001|TREATED|Overall Study||88
2964414|NCT00764946|3678615|FG002|TREATED|Overall Study||21
2964415|NCT00764946|3678613|FG000|COMPLETED|Overall Study||85
2964416|NCT00764946|3678614|FG001|COMPLETED|Overall Study||72
2964417|NCT00764946|3678615|FG002|COMPLETED|Overall Study||18
2964418|NCT00764946|3678613|FG000|NOT COMPLETED|Overall Study||13
2964419|NCT00764946|3678614|FG001|NOT COMPLETED|Overall Study||17
2964420|NCT00764946|3678615|FG002|NOT COMPLETED|Overall Study||4
2964421|NCT00765037|3678629|FG000|STARTED|Overall Study|Original number of eligible subjects who signed a consent form.|19
2964422|NCT00765037|3678629|FG000|COMPLETED|Overall Study|Subjects who came in for 1 year visit.|13
2964423|NCT00765037|3678629|FG000|NOT COMPLETED|Overall Study||6
2964424|NCT00765063|3678633|FG000|STARTED|Overall Study||62
2964425|NCT00765063|3678633|FG000|COMPLETED|Overall Study||30
2964426|NCT00765063|3678633|FG000|NOT COMPLETED|Overall Study||32
2964427|NCT00765076|3678640|FG000|STARTED|Overall Study||69
2964428|NCT00765076|3678641|FG001|STARTED|Overall Study||73
3133047|NCT01694199|3858173|FG000|NOT COMPLETED|Overall Study||0
3133048|NCT01694199|3858174|FG001|NOT COMPLETED|Overall Study||0
2964429|NCT00765076|3678642|FG002|STARTED|Overall Study||50
2964430|NCT00765076|3678640|FG000|COMPLETED|Overall Study||68
2964431|NCT00765076|3678641|FG001|COMPLETED|Overall Study||73
2964432|NCT00765076|3678642|FG002|COMPLETED|Overall Study||49
2964433|NCT00765076|3678640|FG000|NOT COMPLETED|Overall Study||1
2964434|NCT00765076|3678641|FG001|NOT COMPLETED|Overall Study||0
2964435|NCT00765076|3678642|FG002|NOT COMPLETED|Overall Study||1
2964436|NCT00765102|3678650|FG000|STARTED|Overall Study||32
2964437|NCT00765102|3678650|FG000|COMPLETED|Overall Study|Completed 8 cycles of treatment|1
2964438|NCT00765102|3678650|FG000|NOT COMPLETED|Overall Study||31
2964439|NCT00765128|3678658|FG000|STARTED|Overall Study||8
2964440|NCT00765128|3678659|FG001|STARTED|Overall Study||9
2964441|NCT00765128|3678658|FG000|COMPLETED|Overall Study||8
2964442|NCT00765128|3678659|FG001|COMPLETED|Overall Study||9
2964443|NCT00765128|3678658|FG000|NOT COMPLETED|Overall Study||0
2964444|NCT00765128|3678659|FG001|NOT COMPLETED|Overall Study||0
2964445|NCT00765193|3678665|FG000|STARTED|Problem Area Examination||14381
2964446|NCT00765193|3678665|FG000|COMPLETED|Problem Area Examination||14381
2964447|NCT00765193|3678665|FG000|NOT COMPLETED|Problem Area Examination||0
2964448|NCT00765193|3678665|FG000|STARTED|Full Body Examination||14381
2964449|NCT00765193|3678665|FG000|COMPLETED|Full Body Examination||14381
2964450|NCT00765193|3678665|FG000|NOT COMPLETED|Full Body Examination||0
2964451|NCT00765206|3678670|FG000|STARTED|First Intervention||15
2964452|NCT00765206|3678671|FG001|STARTED|First Intervention||15
2964453|NCT00765206|3678672|FG002|STARTED|First Intervention||15
2964454|NCT00765206|3678673|FG003|STARTED|First Intervention||15
2964455|NCT00765206|3678670|FG000|COMPLETED|First Intervention||15
2964456|NCT00765206|3678671|FG001|COMPLETED|First Intervention||15
2964457|NCT00765206|3678672|FG002|COMPLETED|First Intervention||15
2964458|NCT00765206|3678673|FG003|COMPLETED|First Intervention||15
2964459|NCT00765206|3678670|FG000|NOT COMPLETED|First Intervention||0
2964460|NCT00765206|3678671|FG001|NOT COMPLETED|First Intervention||0
2964461|NCT00765206|3678672|FG002|NOT COMPLETED|First Intervention||0
2964462|NCT00765206|3678673|FG003|NOT COMPLETED|First Intervention||0
2964463|NCT00765206|3678670|FG000|STARTED|Washout Period of 14 Days||15
2964464|NCT00765206|3678671|FG001|STARTED|Washout Period of 14 Days||15
2964465|NCT00765206|3678672|FG002|STARTED|Washout Period of 14 Days||15
2964466|NCT00765206|3678673|FG003|STARTED|Washout Period of 14 Days||15
2964467|NCT00765206|3678670|FG000|COMPLETED|Washout Period of 14 Days||15
2964468|NCT00765206|3678671|FG001|COMPLETED|Washout Period of 14 Days||15
2964469|NCT00765206|3678672|FG002|COMPLETED|Washout Period of 14 Days||15
2964470|NCT00765206|3678673|FG003|COMPLETED|Washout Period of 14 Days||15
2964471|NCT00765206|3678670|FG000|NOT COMPLETED|Washout Period of 14 Days||0
2964472|NCT00765206|3678671|FG001|NOT COMPLETED|Washout Period of 14 Days||0
2964473|NCT00765206|3678672|FG002|NOT COMPLETED|Washout Period of 14 Days||0
2964474|NCT00765206|3678673|FG003|NOT COMPLETED|Washout Period of 14 Days||0
2964475|NCT00765206|3678670|FG000|STARTED|Second Intervention||15
2964476|NCT00765206|3678671|FG001|STARTED|Second Intervention||15
2964477|NCT00765206|3678672|FG002|STARTED|Second Intervention||15
2964478|NCT00765206|3678673|FG003|STARTED|Second Intervention||15
3163900|NCT01889862|3891338|FG001|STARTED|Part 3A/B (6 Week)|Subjects switch from placebo to active 20mg/kg.|0
3163901|NCT01889862|3891339|FG002|STARTED|Part 3A/B (6 Week)|Subjects switch from placebo to active 40mg/kg.|41
3163902|NCT01889862|3891340|FG003|STARTED|Part 3A/B (6 Week)|Subjects switch from placebo to active 40mg/kg.|0
3163903|NCT01889862|3891341|FG004|STARTED|Part 3A/B (6 Week)||0
3163904|NCT01889862|3891337|FG000|Per Amendment #2 of the Protocol|Part 3A/B (6 Week)||34
3163905|NCT01889862|3891338|FG001|Per Amendment #2 of the Protocol|Part 3A/B (6 Week)||0
2964479|NCT00765206|3678670|FG000|COMPLETED|Second Intervention||15
2964480|NCT00765206|3678671|FG001|COMPLETED|Second Intervention||15
2964481|NCT00765206|3678672|FG002|COMPLETED|Second Intervention||15
2964482|NCT00765206|3678673|FG003|COMPLETED|Second Intervention||15
2964483|NCT00765206|3678670|FG000|NOT COMPLETED|Second Intervention||0
2964484|NCT00765206|3678671|FG001|NOT COMPLETED|Second Intervention||0
2964485|NCT00765206|3678672|FG002|NOT COMPLETED|Second Intervention||0
2964486|NCT00765206|3678673|FG003|NOT COMPLETED|Second Intervention||0
2964487|NCT00765232|3678681|FG000|STARTED|Overall Study||57
2964488|NCT00765232|3678682|FG001|STARTED|Overall Study||54
2964489|NCT00765232|3678681|FG000|COMPLETED|Overall Study||57
2964490|NCT00765232|3678682|FG001|COMPLETED|Overall Study||54
2964491|NCT00765232|3678681|FG000|NOT COMPLETED|Overall Study||0
2964492|NCT00765232|3678682|FG001|NOT COMPLETED|Overall Study||0
2964493|NCT00765245|3678690|FG000|STARTED|Overall Study||22
2964494|NCT00765245|3678691|FG001|STARTED|Overall Study||22
2964495|NCT00765245|3678690|FG000|COMPLETED|Overall Study||9
2964496|NCT00765245|3678691|FG001|COMPLETED|Overall Study||20
2964497|NCT00765245|3678690|FG000|NOT COMPLETED|Overall Study||13
2964498|NCT00765245|3678691|FG001|NOT COMPLETED|Overall Study||2
2964499|NCT00765336|3678699|FG000|STARTED|Overall Study||91
2964500|NCT00765336|3678700|FG001|STARTED|Overall Study||89
2964501|NCT00765336|3678699|FG000|COMPLETED|Overall Study||72
2964502|NCT00765336|3678700|FG001|COMPLETED|Overall Study||73
2964503|NCT00765336|3678699|FG000|NOT COMPLETED|Overall Study||19
2964504|NCT00765336|3678700|FG001|NOT COMPLETED|Overall Study||16
2964505|NCT00765362|3678706|FG000|STARTED|Overall Study||419
2964506|NCT00765362|3678706|FG000|COMPLETED|Overall Study||282
2964507|NCT00765362|3678706|FG000|NOT COMPLETED|Overall Study||137
2964508|NCT00765375|3678710|FG000|STARTED|Overall Study||5
2964509|NCT00765375|3678710|FG000|COMPLETED|Overall Study||5
2964510|NCT00765375|3678710|FG000|NOT COMPLETED|Overall Study||0
2964511|NCT00765388|3678716|FG000|STARTED|Period 1|A cross-over study|16
2964512|NCT00765388|3678717|FG001|STARTED|Period 1||11
2964513|NCT00765388|3678716|FG000|COMPLETED|Period 1||15
2964514|NCT00765388|3678717|FG001|COMPLETED|Period 1||6
2964515|NCT00765388|3678716|FG000|NOT COMPLETED|Period 1||1
2964516|NCT00765388|3678717|FG001|NOT COMPLETED|Period 1||5
2964517|NCT00765388|3678716|FG000|STARTED|Period 2||15
2964518|NCT00765388|3678717|FG001|STARTED|Period 2||6
2964519|NCT00765388|3678716|FG000|COMPLETED|Period 2||15
2964520|NCT00765388|3678717|FG001|COMPLETED|Period 2||6
2964521|NCT00765388|3678716|FG000|NOT COMPLETED|Period 2||0
2964522|NCT00765388|3678717|FG001|NOT COMPLETED|Period 2||0
2964523|NCT00765570|3678725|FG000|STARTED|Overall Study||9
2964524|NCT00765570|3678726|FG001|STARTED|Overall Study||3
2964525|NCT00765570|3678725|FG000|COMPLETED|Overall Study||7
2964526|NCT00765570|3678726|FG001|COMPLETED|Overall Study||3
2964527|NCT00765570|3678725|FG000|NOT COMPLETED|Overall Study||2
2964528|NCT00765570|3678726|FG001|NOT COMPLETED|Overall Study||0
2964529|NCT00765648|3678734|FG000|STARTED|Overall Study||110
2964530|NCT00765648|3678735|FG001|STARTED|Overall Study||116
2964531|NCT00765648|3678734|FG000|COMPLETED|Overall Study||109
2964532|NCT00765648|3678735|FG001|COMPLETED|Overall Study||114
2964533|NCT00765648|3678734|FG000|NOT COMPLETED|Overall Study||1
2964534|NCT00765648|3678735|FG001|NOT COMPLETED|Overall Study||2
2964535|NCT00765661|3678743|FG000|STARTED|Overall Study||32
2964536|NCT00765661|3678744|FG001|STARTED|Overall Study||31
2964537|NCT00765661|3678743|FG000|COMPLETED|Overall Study||32
2964538|NCT00765661|3678744|FG001|COMPLETED|Overall Study||31
2964539|NCT00765661|3678743|FG000|NOT COMPLETED|Overall Study||0
2964540|NCT00765661|3678744|FG001|NOT COMPLETED|Overall Study||0
2964541|NCT00765674|3678754|FG000|STARTED|Overall Study||287
2964542|NCT00765674|3678755|FG001|STARTED|Overall Study|1 patient was randomized in error and discontinued without taking any double-blind study medication.|298
2964543|NCT00765674|3678756|FG002|STARTED|Overall Study||296
2964544|NCT00765674|3678757|FG003|STARTED|Overall Study|1 patient was randomized in error and discontinued without taking any double-blind study medication.|310
2964545|NCT00765674|3678754|FG000|COMPLETED|Overall Study||266
2964546|NCT00765674|3678755|FG001|COMPLETED|Overall Study||276
2964547|NCT00765674|3678756|FG002|COMPLETED|Overall Study||279
2964548|NCT00765674|3678757|FG003|COMPLETED|Overall Study||285
2964549|NCT00765674|3678754|FG000|NOT COMPLETED|Overall Study||21
2964550|NCT00765674|3678755|FG001|NOT COMPLETED|Overall Study||22
2964551|NCT00765674|3678756|FG002|NOT COMPLETED|Overall Study||17
2964552|NCT00765674|3678757|FG003|NOT COMPLETED|Overall Study||25
2964553|NCT00765726|3678767|FG000|STARTED|Overall Study||12
2964554|NCT00765726|3678767|FG000|COMPLETED|Overall Study||3
2964555|NCT00765726|3678767|FG000|NOT COMPLETED|Overall Study||9
2964556|NCT00765817|3678773|FG000|STARTED|Overall Study|One subject withdrew prior to receiving study medication, not included in analysis set|138
2964557|NCT00765817|3678774|FG001|STARTED|Overall Study|One subject withdrew prior to receiving study medication, not included in analysis set|123
2964558|NCT00765817|3678773|FG000|COMPLETED|Overall Study||112
2964559|NCT00765817|3678774|FG001|COMPLETED|Overall Study||101
2964560|NCT00765817|3678773|FG000|NOT COMPLETED|Overall Study||26
2964561|NCT00765817|3678774|FG001|NOT COMPLETED|Overall Study||22
2964562|NCT00765843|3678783|FG000|STARTED|Overall Study||26
2964563|NCT00765843|3678784|FG001|STARTED|Overall Study||25
2964564|NCT00765843|3678785|FG002|STARTED|Overall Study||26
2964565|NCT00765843|3678783|FG000|COMPLETED|Overall Study||25
2964566|NCT00765843|3678784|FG001|COMPLETED|Overall Study||21
2964567|NCT00765843|3678785|FG002|COMPLETED|Overall Study||23
2964568|NCT00765843|3678783|FG000|NOT COMPLETED|Overall Study||1
2964569|NCT00765843|3678784|FG001|NOT COMPLETED|Overall Study||4
2964570|NCT00765843|3678785|FG002|NOT COMPLETED|Overall Study||3
2964571|NCT00765856|3678793|FG000|STARTED|Titration Period||27
2964572|NCT00765856|3678793|FG000|COMPLETED|Titration Period||24
2964573|NCT00765856|3678793|FG000|NOT COMPLETED|Titration Period||3
2964574|NCT00765856|3678793|FG000|STARTED|Maintenance Period||24
2964575|NCT00765856|3678793|FG000|COMPLETED|Maintenance Period||18
2964576|NCT00765856|3678793|FG000|NOT COMPLETED|Maintenance Period||6
2964577|NCT00765882|3678803|FG000|STARTED|Overall Study||215
2964578|NCT00765882|3678804|FG001|STARTED|Overall Study||213
2964579|NCT00765882|3678805|FG002|STARTED|Overall Study||205
2964580|NCT00765882|3678803|FG000|COMPLETED|Overall Study||191
2964581|NCT00765882|3678804|FG001|COMPLETED|Overall Study||173
2964582|NCT00765882|3678805|FG002|COMPLETED|Overall Study||169
2964583|NCT00765882|3678803|FG000|NOT COMPLETED|Overall Study||24
2964584|NCT00765882|3678804|FG001|NOT COMPLETED|Overall Study||40
2964585|NCT00765882|3678805|FG002|NOT COMPLETED|Overall Study||36
2964586|NCT00765895|3678815|FG000|STARTED|Overall Study||65
2964587|NCT00765895|3678816|FG001|STARTED|Overall Study||65
2964588|NCT00765895|3678815|FG000|COMPLETED|Overall Study||65
2964589|NCT00765895|3678816|FG001|COMPLETED|Overall Study||65
2964590|NCT00765895|3678815|FG000|NOT COMPLETED|Overall Study||0
2964591|NCT00765895|3678816|FG001|NOT COMPLETED|Overall Study||0
2964592|NCT00765947|3678822|FG000|STARTED|Overall Study||256
2964593|NCT00765947|3678822|FG000|COMPLETED|Overall Study||232
2964594|NCT00765947|3678822|FG000|NOT COMPLETED|Overall Study||24
2964595|NCT00765999|3678828|FG000|STARTED|Overall Study||1554
2964596|NCT00765999|3678828|FG000|COMPLETED|Overall Study||770
2964597|NCT00765999|3678828|FG000|NOT COMPLETED|Overall Study||784
2964598|NCT00766038|3678836|FG000|STARTED|Overall Study||31
2964599|NCT00766038|3678837|FG001|STARTED|Overall Study||32
2964600|NCT00766038|3678836|FG000|COMPLETED|Overall Study||16
2964601|NCT00766038|3678837|FG001|COMPLETED|Overall Study||18
2964602|NCT00766038|3678836|FG000|NOT COMPLETED|Overall Study||15
2964603|NCT00766038|3678837|FG001|NOT COMPLETED|Overall Study||14
2964604|NCT00766051|3678847|FG000|STARTED|Overall Study||12
2964605|NCT00766051|3678848|FG001|STARTED|Overall Study||10
2964606|NCT00766051|3678847|FG000|COMPLETED|Overall Study||10
2964607|NCT00766051|3678848|FG001|COMPLETED|Overall Study||10
2964608|NCT00766051|3678847|FG000|NOT COMPLETED|Overall Study||2
2964609|NCT00766051|3678848|FG001|NOT COMPLETED|Overall Study||0
2964610|NCT00766090|3678858|FG000|STARTED|Treatment Period 1 (28 Days)||25
2964611|NCT00766090|3678859|FG001|STARTED|Treatment Period 1 (28 Days)||27
2964612|NCT00766090|3678860|FG002|STARTED|Treatment Period 1 (28 Days)||23
2964613|NCT00766090|3678861|FG003|STARTED|Treatment Period 1 (28 Days)||26
2964614|NCT00766090|3678862|FG004|STARTED|Treatment Period 1 (28 Days)||23
2964615|NCT00766090|3678863|FG005|STARTED|Treatment Period 1 (28 Days)||23
2964616|NCT00766090|3678864|FG006|STARTED|Treatment Period 1 (28 Days)||6
2964617|NCT00766090|3678865|FG007|STARTED|Treatment Period 1 (28 Days)||8
2964618|NCT00766090|3678866|FG008|STARTED|Treatment Period 1 (28 Days)||7
2964619|NCT00766090|3678867|FG009|STARTED|Treatment Period 1 (28 Days)||8
2964620|NCT00766090|3678868|FG010|STARTED|Treatment Period 1 (28 Days)||7
2964621|NCT00766090|3678869|FG011|STARTED|Treatment Period 1 (28 Days)||7
2964622|NCT00766090|3678858|FG000|COMPLETED|Treatment Period 1 (28 Days)||22
2964623|NCT00766090|3678859|FG001|COMPLETED|Treatment Period 1 (28 Days)||27
2964624|NCT00766090|3678860|FG002|COMPLETED|Treatment Period 1 (28 Days)||23
2964625|NCT00766090|3678861|FG003|COMPLETED|Treatment Period 1 (28 Days)||25
2964626|NCT00766090|3678862|FG004|COMPLETED|Treatment Period 1 (28 Days)||23
2964627|NCT00766090|3678863|FG005|COMPLETED|Treatment Period 1 (28 Days)||23
2964628|NCT00766090|3678864|FG006|COMPLETED|Treatment Period 1 (28 Days)||6
2964629|NCT00766090|3678865|FG007|COMPLETED|Treatment Period 1 (28 Days)||8
2964630|NCT00766090|3678866|FG008|COMPLETED|Treatment Period 1 (28 Days)||6
3133049|NCT01694420|3858180|FG000|STARTED|Overall Study||33
3133050|NCT01694420|3858180|FG000|COMPLETED|Overall Study||30
3133051|NCT01694420|3858180|FG000|NOT COMPLETED|Overall Study||3
3133052|NCT01694433|3858186|FG000|STARTED|Overall Study||33
3133053|NCT01694433|3858187|FG001|STARTED|Overall Study||33
3133054|NCT01694433|3858186|FG000|Baseline Visit|Overall Study||33
3133055|NCT01694433|3858187|FG001|Baseline Visit|Overall Study||32
2964631|NCT00766090|3678867|FG009|COMPLETED|Treatment Period 1 (28 Days)||8
2964632|NCT00766090|3678868|FG010|COMPLETED|Treatment Period 1 (28 Days)||7
2964633|NCT00766090|3678869|FG011|COMPLETED|Treatment Period 1 (28 Days)||7
2964634|NCT00766090|3678858|FG000|NOT COMPLETED|Treatment Period 1 (28 Days)||3
2964635|NCT00766090|3678859|FG001|NOT COMPLETED|Treatment Period 1 (28 Days)||0
2964636|NCT00766090|3678860|FG002|NOT COMPLETED|Treatment Period 1 (28 Days)||0
2964637|NCT00766090|3678861|FG003|NOT COMPLETED|Treatment Period 1 (28 Days)||1
2964638|NCT00766090|3678862|FG004|NOT COMPLETED|Treatment Period 1 (28 Days)||0
2964639|NCT00766090|3678863|FG005|NOT COMPLETED|Treatment Period 1 (28 Days)||0
2964640|NCT00766090|3678864|FG006|NOT COMPLETED|Treatment Period 1 (28 Days)||0
2964641|NCT00766090|3678865|FG007|NOT COMPLETED|Treatment Period 1 (28 Days)||0
2964642|NCT00766090|3678866|FG008|NOT COMPLETED|Treatment Period 1 (28 Days)||1
2964643|NCT00766090|3678867|FG009|NOT COMPLETED|Treatment Period 1 (28 Days)||0
2964644|NCT00766090|3678868|FG010|NOT COMPLETED|Treatment Period 1 (28 Days)||0
2964645|NCT00766090|3678869|FG011|NOT COMPLETED|Treatment Period 1 (28 Days)||0
2964646|NCT00766090|3678858|FG000|STARTED|Washout Period 1 (14 Days)||22
2964647|NCT00766090|3678859|FG001|STARTED|Washout Period 1 (14 Days)||27
2964648|NCT00766090|3678860|FG002|STARTED|Washout Period 1 (14 Days)||23
2964649|NCT00766090|3678861|FG003|STARTED|Washout Period 1 (14 Days)||25
2964650|NCT00766090|3678862|FG004|STARTED|Washout Period 1 (14 Days)||23
2964651|NCT00766090|3678863|FG005|STARTED|Washout Period 1 (14 Days)||23
2964652|NCT00766090|3678864|FG006|STARTED|Washout Period 1 (14 Days)||6
2964653|NCT00766090|3678865|FG007|STARTED|Washout Period 1 (14 Days)||8
2964654|NCT00766090|3678866|FG008|STARTED|Washout Period 1 (14 Days)||6
2964655|NCT00766090|3678867|FG009|STARTED|Washout Period 1 (14 Days)||8
2964656|NCT00766090|3678868|FG010|STARTED|Washout Period 1 (14 Days)||7
3163906|NCT01889862|3891339|FG002|Per Amendment #2 of the Protocol|Part 3A/B (6 Week)||26
3163907|NCT01889862|3891340|FG003|Per Amendment #2 of the Protocol|Part 3A/B (6 Week)||0
3163908|NCT01889862|3891341|FG004|Per Amendment #2 of the Protocol|Part 3A/B (6 Week)||0
3163909|NCT01889862|3891337|FG000|COMPLETED|Part 3A/B (6 Week)||48
3163910|NCT01889862|3891338|FG001|COMPLETED|Part 3A/B (6 Week)||0
3163911|NCT01889862|3891339|FG002|COMPLETED|Part 3A/B (6 Week)||41
3163912|NCT01889862|3891340|FG003|COMPLETED|Part 3A/B (6 Week)||0
3163913|NCT01889862|3891341|FG004|COMPLETED|Part 3A/B (6 Week)||0
3163914|NCT01889862|3891337|FG000|NOT COMPLETED|Part 3A/B (6 Week)||0
2964657|NCT00766090|3678869|FG011|STARTED|Washout Period 1 (14 Days)||7
2964658|NCT00766090|3678858|FG000|COMPLETED|Washout Period 1 (14 Days)||22
2964659|NCT00766090|3678859|FG001|COMPLETED|Washout Period 1 (14 Days)||27
2964660|NCT00766090|3678860|FG002|COMPLETED|Washout Period 1 (14 Days)||22
2964661|NCT00766090|3678861|FG003|COMPLETED|Washout Period 1 (14 Days)||25
2964662|NCT00766090|3678862|FG004|COMPLETED|Washout Period 1 (14 Days)||23
2964663|NCT00766090|3678863|FG005|COMPLETED|Washout Period 1 (14 Days)||23
2964664|NCT00766090|3678864|FG006|COMPLETED|Washout Period 1 (14 Days)||6
2964665|NCT00766090|3678865|FG007|COMPLETED|Washout Period 1 (14 Days)||8
2964666|NCT00766090|3678866|FG008|COMPLETED|Washout Period 1 (14 Days)||6
2964667|NCT00766090|3678867|FG009|COMPLETED|Washout Period 1 (14 Days)||8
2964668|NCT00766090|3678868|FG010|COMPLETED|Washout Period 1 (14 Days)||7
2964669|NCT00766090|3678869|FG011|COMPLETED|Washout Period 1 (14 Days)||7
2964670|NCT00766090|3678858|FG000|NOT COMPLETED|Washout Period 1 (14 Days)||0
2964671|NCT00766090|3678859|FG001|NOT COMPLETED|Washout Period 1 (14 Days)||0
2964672|NCT00766090|3678860|FG002|NOT COMPLETED|Washout Period 1 (14 Days)||1
2964673|NCT00766090|3678861|FG003|NOT COMPLETED|Washout Period 1 (14 Days)||0
2964674|NCT00766090|3678862|FG004|NOT COMPLETED|Washout Period 1 (14 Days)||0
2964675|NCT00766090|3678863|FG005|NOT COMPLETED|Washout Period 1 (14 Days)||0
2964676|NCT00766090|3678864|FG006|NOT COMPLETED|Washout Period 1 (14 Days)||0
2964677|NCT00766090|3678865|FG007|NOT COMPLETED|Washout Period 1 (14 Days)||0
2964678|NCT00766090|3678866|FG008|NOT COMPLETED|Washout Period 1 (14 Days)||0
2964679|NCT00766090|3678867|FG009|NOT COMPLETED|Washout Period 1 (14 Days)||0
2964680|NCT00766090|3678868|FG010|NOT COMPLETED|Washout Period 1 (14 Days)||0
2964681|NCT00766090|3678869|FG011|NOT COMPLETED|Washout Period 1 (14 Days)||0
2964682|NCT00766090|3678858|FG000|STARTED|Treatment Period 2 (28 Days)||22
2964683|NCT00766090|3678859|FG001|STARTED|Treatment Period 2 (28 Days)||27
2964684|NCT00766090|3678860|FG002|STARTED|Treatment Period 2 (28 Days)||22
2964685|NCT00766090|3678861|FG003|STARTED|Treatment Period 2 (28 Days)||25
2964686|NCT00766090|3678862|FG004|STARTED|Treatment Period 2 (28 Days)||23
2964687|NCT00766090|3678863|FG005|STARTED|Treatment Period 2 (28 Days)||23
2964688|NCT00766090|3678864|FG006|STARTED|Treatment Period 2 (28 Days)||6
2964689|NCT00766090|3678865|FG007|STARTED|Treatment Period 2 (28 Days)||8
2964690|NCT00766090|3678866|FG008|STARTED|Treatment Period 2 (28 Days)||6
2964691|NCT00766090|3678867|FG009|STARTED|Treatment Period 2 (28 Days)||8
2964692|NCT00766090|3678868|FG010|STARTED|Treatment Period 2 (28 Days)||7
2964693|NCT00766090|3678869|FG011|STARTED|Treatment Period 2 (28 Days)||7
2964694|NCT00766090|3678858|FG000|COMPLETED|Treatment Period 2 (28 Days)||22
2964695|NCT00766090|3678859|FG001|COMPLETED|Treatment Period 2 (28 Days)||27
2964696|NCT00766090|3678860|FG002|COMPLETED|Treatment Period 2 (28 Days)||21
2964697|NCT00766090|3678861|FG003|COMPLETED|Treatment Period 2 (28 Days)||25
2964698|NCT00766090|3678862|FG004|COMPLETED|Treatment Period 2 (28 Days)||21
2964699|NCT00766090|3678863|FG005|COMPLETED|Treatment Period 2 (28 Days)||23
2964700|NCT00766090|3678864|FG006|COMPLETED|Treatment Period 2 (28 Days)||6
2964701|NCT00766090|3678865|FG007|COMPLETED|Treatment Period 2 (28 Days)||8
2964702|NCT00766090|3678866|FG008|COMPLETED|Treatment Period 2 (28 Days)||6
2964703|NCT00766090|3678867|FG009|COMPLETED|Treatment Period 2 (28 Days)||8
2964704|NCT00766090|3678868|FG010|COMPLETED|Treatment Period 2 (28 Days)||7
2964705|NCT00766090|3678869|FG011|COMPLETED|Treatment Period 2 (28 Days)||7
2964706|NCT00766090|3678858|FG000|NOT COMPLETED|Treatment Period 2 (28 Days)||0
3163915|NCT01889862|3891338|FG001|NOT COMPLETED|Part 3A/B (6 Week)||0
2964707|NCT00766090|3678859|FG001|NOT COMPLETED|Treatment Period 2 (28 Days)||0
2964708|NCT00766090|3678860|FG002|NOT COMPLETED|Treatment Period 2 (28 Days)||1
2964709|NCT00766090|3678861|FG003|NOT COMPLETED|Treatment Period 2 (28 Days)||0
2964710|NCT00766090|3678862|FG004|NOT COMPLETED|Treatment Period 2 (28 Days)||2
2964711|NCT00766090|3678863|FG005|NOT COMPLETED|Treatment Period 2 (28 Days)||0
2964712|NCT00766090|3678864|FG006|NOT COMPLETED|Treatment Period 2 (28 Days)||0
2964713|NCT00766090|3678865|FG007|NOT COMPLETED|Treatment Period 2 (28 Days)||0
2964714|NCT00766090|3678866|FG008|NOT COMPLETED|Treatment Period 2 (28 Days)||0
2964715|NCT00766090|3678867|FG009|NOT COMPLETED|Treatment Period 2 (28 Days)||0
2964716|NCT00766090|3678868|FG010|NOT COMPLETED|Treatment Period 2 (28 Days)||0
2964717|NCT00766090|3678869|FG011|NOT COMPLETED|Treatment Period 2 (28 Days)||0
2964718|NCT00766090|3678858|FG000|STARTED|Washout Period 2 (14 Days)||22
2964719|NCT00766090|3678859|FG001|STARTED|Washout Period 2 (14 Days)||27
2964720|NCT00766090|3678860|FG002|STARTED|Washout Period 2 (14 Days)||21
3133056|NCT01694433|3858186|FG000|COMPLETED|Overall Study||22
3133057|NCT01694433|3858187|FG001|COMPLETED|Overall Study||29
3133058|NCT01694433|3858186|FG000|NOT COMPLETED|Overall Study||11
3133059|NCT01694433|3858187|FG001|NOT COMPLETED|Overall Study||4
3133060|NCT01694485|3858198|FG000|STARTED|Overall Study||117
3133061|NCT01694485|3858199|FG001|STARTED|Overall Study||22
2964721|NCT00766090|3678861|FG003|STARTED|Washout Period 2 (14 Days)||25
2964722|NCT00766090|3678862|FG004|STARTED|Washout Period 2 (14 Days)||21
2964723|NCT00766090|3678863|FG005|STARTED|Washout Period 2 (14 Days)||23
2964724|NCT00766090|3678864|FG006|STARTED|Washout Period 2 (14 Days)||6
2964725|NCT00766090|3678865|FG007|STARTED|Washout Period 2 (14 Days)||8
2964726|NCT00766090|3678866|FG008|STARTED|Washout Period 2 (14 Days)||6
2964727|NCT00766090|3678867|FG009|STARTED|Washout Period 2 (14 Days)||8
2964728|NCT00766090|3678868|FG010|STARTED|Washout Period 2 (14 Days)||7
2964729|NCT00766090|3678869|FG011|STARTED|Washout Period 2 (14 Days)||7
2964730|NCT00766090|3678858|FG000|COMPLETED|Washout Period 2 (14 Days)||22
2964731|NCT00766090|3678859|FG001|COMPLETED|Washout Period 2 (14 Days)||27
2964732|NCT00766090|3678860|FG002|COMPLETED|Washout Period 2 (14 Days)||20
2964733|NCT00766090|3678861|FG003|COMPLETED|Washout Period 2 (14 Days)||25
2964734|NCT00766090|3678862|FG004|COMPLETED|Washout Period 2 (14 Days)||21
2964735|NCT00766090|3678863|FG005|COMPLETED|Washout Period 2 (14 Days)||23
2964736|NCT00766090|3678864|FG006|COMPLETED|Washout Period 2 (14 Days)||6
2964737|NCT00766090|3678865|FG007|COMPLETED|Washout Period 2 (14 Days)||8
2964738|NCT00766090|3678866|FG008|COMPLETED|Washout Period 2 (14 Days)||6
2964739|NCT00766090|3678867|FG009|COMPLETED|Washout Period 2 (14 Days)||8
2964740|NCT00766090|3678868|FG010|COMPLETED|Washout Period 2 (14 Days)||7
2964741|NCT00766090|3678869|FG011|COMPLETED|Washout Period 2 (14 Days)||7
3133062|NCT01694485|3858200|FG002|STARTED|Overall Study||40
3133063|NCT01694485|3858201|FG003|STARTED|Overall Study||100
3133064|NCT01694485|3858202|FG004|STARTED|Overall Study||80
2964742|NCT00766090|3678858|FG000|NOT COMPLETED|Washout Period 2 (14 Days)||0
2964743|NCT00766090|3678859|FG001|NOT COMPLETED|Washout Period 2 (14 Days)||0
2964744|NCT00766090|3678860|FG002|NOT COMPLETED|Washout Period 2 (14 Days)||1
2964745|NCT00766090|3678861|FG003|NOT COMPLETED|Washout Period 2 (14 Days)||0
2964746|NCT00766090|3678862|FG004|NOT COMPLETED|Washout Period 2 (14 Days)||0
2964747|NCT00766090|3678863|FG005|NOT COMPLETED|Washout Period 2 (14 Days)||0
2964748|NCT00766090|3678864|FG006|NOT COMPLETED|Washout Period 2 (14 Days)||0
2964749|NCT00766090|3678865|FG007|NOT COMPLETED|Washout Period 2 (14 Days)||0
2964750|NCT00766090|3678866|FG008|NOT COMPLETED|Washout Period 2 (14 Days)||0
2964751|NCT00766090|3678867|FG009|NOT COMPLETED|Washout Period 2 (14 Days)||0
2964752|NCT00766090|3678868|FG010|NOT COMPLETED|Washout Period 2 (14 Days)||0
2964753|NCT00766090|3678869|FG011|NOT COMPLETED|Washout Period 2 (14 Days)||0
2964754|NCT00766090|3678858|FG000|STARTED|Treatment Period 3 (28 Days)||22
2964755|NCT00766090|3678859|FG001|STARTED|Treatment Period 3 (28 Days)||27
2964756|NCT00766090|3678860|FG002|STARTED|Treatment Period 3 (28 Days)||20
2964757|NCT00766090|3678861|FG003|STARTED|Treatment Period 3 (28 Days)||25
2964758|NCT00766090|3678862|FG004|STARTED|Treatment Period 3 (28 Days)||21
2964759|NCT00766090|3678863|FG005|STARTED|Treatment Period 3 (28 Days)||23
2964760|NCT00766090|3678864|FG006|STARTED|Treatment Period 3 (28 Days)||6
2964761|NCT00766090|3678865|FG007|STARTED|Treatment Period 3 (28 Days)||8
2964762|NCT00766090|3678866|FG008|STARTED|Treatment Period 3 (28 Days)||6
2964763|NCT00766090|3678867|FG009|STARTED|Treatment Period 3 (28 Days)||8
2964764|NCT00766090|3678868|FG010|STARTED|Treatment Period 3 (28 Days)||7
2964765|NCT00766090|3678869|FG011|STARTED|Treatment Period 3 (28 Days)||7
2964766|NCT00766090|3678858|FG000|COMPLETED|Treatment Period 3 (28 Days)||22
2964767|NCT00766090|3678859|FG001|COMPLETED|Treatment Period 3 (28 Days)||26
2964768|NCT00766090|3678860|FG002|COMPLETED|Treatment Period 3 (28 Days)||20
2964769|NCT00766090|3678861|FG003|COMPLETED|Treatment Period 3 (28 Days)||24
2964770|NCT00766090|3678862|FG004|COMPLETED|Treatment Period 3 (28 Days)||20
2964771|NCT00766090|3678863|FG005|COMPLETED|Treatment Period 3 (28 Days)||22
2964772|NCT00766090|3678864|FG006|COMPLETED|Treatment Period 3 (28 Days)||6
2964773|NCT00766090|3678865|FG007|COMPLETED|Treatment Period 3 (28 Days)||8
3133065|NCT01694485|3858198|FG000|Received Treatment|Overall Study||116
3133066|NCT01694485|3858199|FG001|Received Treatment|Overall Study||21
3133067|NCT01694485|3858200|FG002|Received Treatment|Overall Study||40
3133068|NCT01694485|3858201|FG003|Received Treatment|Overall Study||98
3133069|NCT01694485|3858202|FG004|Received Treatment|Overall Study||79
3133070|NCT01694485|3858198|FG000|Completed Week 8 Assessment|Overall Study||106
2964774|NCT00766090|3678866|FG008|COMPLETED|Treatment Period 3 (28 Days)||6
2964775|NCT00766090|3678867|FG009|COMPLETED|Treatment Period 3 (28 Days)||8
2964776|NCT00766090|3678868|FG010|COMPLETED|Treatment Period 3 (28 Days)||7
2964777|NCT00766090|3678869|FG011|COMPLETED|Treatment Period 3 (28 Days)||6
2964778|NCT00766090|3678858|FG000|NOT COMPLETED|Treatment Period 3 (28 Days)||0
2964779|NCT00766090|3678859|FG001|NOT COMPLETED|Treatment Period 3 (28 Days)||1
2964780|NCT00766090|3678860|FG002|NOT COMPLETED|Treatment Period 3 (28 Days)||0
2964781|NCT00766090|3678861|FG003|NOT COMPLETED|Treatment Period 3 (28 Days)||1
2964782|NCT00766090|3678862|FG004|NOT COMPLETED|Treatment Period 3 (28 Days)||1
2964783|NCT00766090|3678863|FG005|NOT COMPLETED|Treatment Period 3 (28 Days)||1
2964784|NCT00766090|3678864|FG006|NOT COMPLETED|Treatment Period 3 (28 Days)||0
2964785|NCT00766090|3678865|FG007|NOT COMPLETED|Treatment Period 3 (28 Days)||0
2964786|NCT00766090|3678866|FG008|NOT COMPLETED|Treatment Period 3 (28 Days)||0
2964787|NCT00766090|3678867|FG009|NOT COMPLETED|Treatment Period 3 (28 Days)||0
2964788|NCT00766090|3678868|FG010|NOT COMPLETED|Treatment Period 3 (28 Days)||0
2964789|NCT00766090|3678869|FG011|NOT COMPLETED|Treatment Period 3 (28 Days)||1
2964790|NCT00766116|3678883|FG000|STARTED|Overall Study||50
2964791|NCT00766116|3678883|FG000|COMPLETED|Overall Study||50
2964792|NCT00766116|3678883|FG000|NOT COMPLETED|Overall Study||0
2964793|NCT00766142|3678890|FG000|STARTED|Overall Study||18
2964794|NCT00766142|3678890|FG000|COMPLETED|Overall Study||14
2964795|NCT00766142|3678890|FG000|NOT COMPLETED|Overall Study||4
2964796|NCT00766363|3678898|FG000|STARTED|Overall Study||12
2964797|NCT00766363|3678899|FG001|STARTED|Overall Study||13
2964798|NCT00766363|3678900|FG002|STARTED|Overall Study|Number randomized.|12
2964799|NCT00766363|3678901|FG003|STARTED|Overall Study|Number randomized.|12
2964800|NCT00766363|3678898|FG000|SAFETY POPULATION|Overall Study||12
2964801|NCT00766363|3678899|FG001|SAFETY POPULATION|Overall Study||13
2964802|NCT00766363|3678900|FG002|SAFETY POPULATION|Overall Study|Decreased by one subject who took placebo instead due to treatment assignment error.|11
2964803|NCT00766363|3678901|FG003|SAFETY POPULATION|Overall Study|Increased by one subject who took placebo due to treatment assignment error.|13
2964804|NCT00766363|3678898|FG000|PK POPULATION|Overall Study||12
2964805|NCT00766363|3678899|FG001|PK POPULATION|Overall Study||13
2964806|NCT00766363|3678900|FG002|PK POPULATION|Overall Study||10
2964807|NCT00766363|3678901|FG003|PK POPULATION|Overall Study||13
2964808|NCT00766363|3678898|FG000|COMPLETED|Overall Study||11
2964809|NCT00766363|3678899|FG001|COMPLETED|Overall Study||12
2964810|NCT00766363|3678900|FG002|COMPLETED|Overall Study||12
2964811|NCT00766363|3678901|FG003|COMPLETED|Overall Study||12
2964812|NCT00766363|3678898|FG000|NOT COMPLETED|Overall Study||1
2964813|NCT00766363|3678899|FG001|NOT COMPLETED|Overall Study||1
2964814|NCT00766363|3678900|FG002|NOT COMPLETED|Overall Study||0
2964815|NCT00766363|3678901|FG003|NOT COMPLETED|Overall Study||0
2964816|NCT00766376|3678912|FG000|STARTED|Overall Study||151
2964817|NCT00766376|3678912|FG000|COMPLETED|Overall Study||124
2964818|NCT00766376|3678912|FG000|NOT COMPLETED|Overall Study||27
2964819|NCT00766415|3678918|FG000|STARTED|Overall Study||25
2964820|NCT00766415|3678919|FG001|STARTED|Overall Study||27
2964821|NCT00766415|3678918|FG000|COMPLETED|Overall Study||25
2964822|NCT00766415|3678919|FG001|COMPLETED|Overall Study||26
2964823|NCT00766415|3678918|FG000|NOT COMPLETED|Overall Study||0
2964824|NCT00766415|3678919|FG001|NOT COMPLETED|Overall Study||1
2964825|NCT00766467|3678927|FG000|STARTED|Overall Study||42
2964826|NCT00766467|3678928|FG001|STARTED|Overall Study||39
2964827|NCT00766467|3678927|FG000|Initiated Treatment|Overall Study||39
2964828|NCT00766467|3678928|FG001|Initiated Treatment|Overall Study||38
2964829|NCT00766467|3678927|FG000|COMPLETED|Overall Study||31
3301823|NCT02956044|4035446|FG001|STARTED|Overall Study||18
3301824|NCT02956044|4035447|FG002|STARTED|Overall Study||18
3301825|NCT02956044|4035445|FG000|COMPLETED|Overall Study||18
3301826|NCT02956044|4035446|FG001|COMPLETED|Overall Study||18
3301827|NCT02956044|4035447|FG002|COMPLETED|Overall Study||18
3301828|NCT02956044|4035445|FG000|NOT COMPLETED|Overall Study||0
3301829|NCT02956044|4035446|FG001|NOT COMPLETED|Overall Study||0
2964830|NCT00766467|3678928|FG001|COMPLETED|Overall Study||31
2964831|NCT00766467|3678927|FG000|NOT COMPLETED|Overall Study||11
2964832|NCT00766467|3678928|FG001|NOT COMPLETED|Overall Study||8
2964833|NCT00766493|3678934|FG000|STARTED|Pre-Discharge||250
2964834|NCT00766493|3678934|FG000|COMPLETED|Pre-Discharge||250
2964835|NCT00766493|3678934|FG000|NOT COMPLETED|Pre-Discharge||0
2964836|NCT00766493|3678934|FG000|STARTED|30 Days Post-Procedure||250
2964837|NCT00766493|3678934|FG000|COMPLETED|30 Days Post-Procedure||238
2964838|NCT00766493|3678934|FG000|NOT COMPLETED|30 Days Post-Procedure||12
2964839|NCT00766506|3678940|FG000|STARTED|Overall Study||58
2964840|NCT00766506|3678941|FG001|STARTED|Overall Study||50
2964841|NCT00766506|3678940|FG000|COMPLETED|Overall Study||53
2964842|NCT00766506|3678941|FG001|COMPLETED|Overall Study||48
2964843|NCT00766506|3678940|FG000|NOT COMPLETED|Overall Study||5
2964844|NCT00766506|3678941|FG001|NOT COMPLETED|Overall Study||2
2964845|NCT00766532|3678947|FG000|STARTED|Overall Study||12
2964846|NCT00766532|3678947|FG000|COMPLETED|Overall Study||10
2964847|NCT00766532|3678947|FG000|NOT COMPLETED|Overall Study||2
2964848|NCT00766597|3678951|FG000|STARTED|Overall Study|Screened participants who were evaluated for co-receptor tropism|9
3301830|NCT02956044|4035447|FG002|NOT COMPLETED|Overall Study||0
3301831|NCT02956057|4035475|FG000|STARTED|Overall Study||174
2964849|NCT00766597|3678951|FG000|With CCR5-tropic Virus|Overall Study|Evaluable participants, received the study drug|4
2964850|NCT00766597|3678951|FG000|Without CCR5-tropic Virus|Overall Study|Not evaluable participants, did not receive the study drug|5
2964851|NCT00766597|3678951|FG000|Completed Week 24|Overall Study|Week 24 is the first primary time point of analysis|1
2964852|NCT00766597|3678951|FG000|Completed Week 48|Overall Study|Week 48 is the second primary time point of analysis|0
2964853|NCT00766597|3678951|FG000|COMPLETED|Overall Study|Treatment duration is 48 weeks plus 5 years of follow-up|0
2964854|NCT00766597|3678951|FG000|NOT COMPLETED|Overall Study||9
2964855|NCT00766649|3678957|FG000|STARTED|Overall Study||11
2964856|NCT00766649|3678957|FG000|COMPLETED|Overall Study||1
2964857|NCT00766649|3678957|FG000|NOT COMPLETED|Overall Study||10
2964858|NCT00766675|3678961|FG000|STARTED|Overall Study||80
2964859|NCT00766675|3678961|FG000|COMPLETED|Overall Study||40
2964860|NCT00766675|3678961|FG000|NOT COMPLETED|Overall Study||40
2964861|NCT00766727|3678965|FG000|STARTED|Overall Study||12
2964862|NCT00766727|3678965|FG000|COMPLETED|Overall Study||9
2964863|NCT00766727|3678965|FG000|NOT COMPLETED|Overall Study||3
2964864|NCT00766753|3678973|FG000|STARTED|Overall Study||11
2964865|NCT00766753|3678974|FG001|STARTED|Overall Study||11
2964866|NCT00766753|3678973|FG000|Received at Least One Vaccine|Overall Study||11
2964867|NCT00766753|3678974|FG001|Received at Least One Vaccine|Overall Study||11
2964868|NCT00766753|3678973|FG000|Completed at Least Four Vaccines|Overall Study||10
2964869|NCT00766753|3678974|FG001|Completed at Least Four Vaccines|Overall Study||9
2964870|NCT00766753|3678973|FG000|COMPLETED|Overall Study||11
2964871|NCT00766753|3678974|FG001|COMPLETED|Overall Study||11
2964872|NCT00766753|3678973|FG000|NOT COMPLETED|Overall Study||0
2964873|NCT00766753|3678974|FG001|NOT COMPLETED|Overall Study||0
2964874|NCT00766831|3678981|FG000|STARTED|Overall Study||190
2964875|NCT00766831|3678981|FG000|COMPLETED|Overall Study||75
2964876|NCT00766831|3678981|FG000|NOT COMPLETED|Overall Study||115
2964877|NCT00767000|3678990|FG000|STARTED|54-week Study||119
2964878|NCT00767000|3678991|FG001|STARTED|54-week Study||117
2964879|NCT00767000|3678992|FG002|STARTED|54-week Study||117
2964880|NCT00767000|3678993|FG003|STARTED|54-week Study|Includes additional participants enrolled to enhance evaluation of the safety profile of MK-0941|229
2964881|NCT00767000|3678994|FG004|STARTED|54-week Study|Includes additional participants enrolled to enhance evaluation of the safety profile of MK-0941|231
2964882|NCT00767000|3678990|FG000|COMPLETED|54-week Study||11
2964883|NCT00767000|3678991|FG001|COMPLETED|54-week Study||4
2964884|NCT00767000|3678992|FG002|COMPLETED|54-week Study||8
2964885|NCT00767000|3678993|FG003|COMPLETED|54-week Study||4
2964886|NCT00767000|3678994|FG004|COMPLETED|54-week Study||7
2964887|NCT00767000|3678990|FG000|NOT COMPLETED|54-week Study||108
2964888|NCT00767000|3678991|FG001|NOT COMPLETED|54-week Study||113
2964889|NCT00767000|3678992|FG002|NOT COMPLETED|54-week Study||109
2964890|NCT00767000|3678993|FG003|NOT COMPLETED|54-week Study||225
2964891|NCT00767000|3678994|FG004|NOT COMPLETED|54-week Study||224
2964892|NCT00767000|3678990|FG000|STARTED|Optional 104-week Extension|The extension study was optional. Not all participants completing the 54-week study continued.|7
2964893|NCT00767000|3678991|FG001|STARTED|Optional 104-week Extension|The extension study was optional. Not all participants completing the 54-week study continued.|3
2964894|NCT00767000|3678992|FG002|STARTED|Optional 104-week Extension|The extension study was optional. Not all participants completing the 54-week study continued.|7
2964895|NCT00767000|3678993|FG003|STARTED|Optional 104-week Extension|The extension study was optional. Not all participants completing the 54-week study continued.|2
2964896|NCT00767000|3678994|FG004|STARTED|Optional 104-week Extension|The extension study was optional. Not all participants completing the 54-week study continued.|4
2964897|NCT00767000|3678990|FG000|COMPLETED|Optional 104-week Extension||0
2964898|NCT00767000|3678991|FG001|COMPLETED|Optional 104-week Extension||0
2964899|NCT00767000|3678992|FG002|COMPLETED|Optional 104-week Extension||0
2964900|NCT00767000|3678993|FG003|COMPLETED|Optional 104-week Extension||0
2964901|NCT00767000|3678994|FG004|COMPLETED|Optional 104-week Extension||0
2964902|NCT00767000|3678990|FG000|NOT COMPLETED|Optional 104-week Extension||7
2964903|NCT00767000|3678991|FG001|NOT COMPLETED|Optional 104-week Extension||3
2964904|NCT00767000|3678992|FG002|NOT COMPLETED|Optional 104-week Extension||7
2964905|NCT00767000|3678993|FG003|NOT COMPLETED|Optional 104-week Extension||2
2964906|NCT00767000|3678994|FG004|NOT COMPLETED|Optional 104-week Extension||4
2964907|NCT00767039|3679008|FG000|STARTED|Overall Study|Two early deaths and 3 late deaths occurred in this group|27
2964908|NCT00767039|3679009|FG001|STARTED|Overall Study||25
2964909|NCT00767039|3679008|FG000|COMPLETED|Overall Study||22
2964910|NCT00767039|3679009|FG001|COMPLETED|Overall Study||23
2964911|NCT00767039|3679008|FG000|NOT COMPLETED|Overall Study||5
2964912|NCT00767039|3679009|FG001|NOT COMPLETED|Overall Study||2
2964913|NCT00767104|3679017|FG000|STARTED|Overall Study||20
2964914|NCT00767104|3679018|FG001|STARTED|Overall Study||20
2964915|NCT00767104|3679017|FG000|COMPLETED|Overall Study||19
2964916|NCT00767104|3679018|FG001|COMPLETED|Overall Study||18
2964917|NCT00767104|3679017|FG000|NOT COMPLETED|Overall Study||1
2964918|NCT00767104|3679018|FG001|NOT COMPLETED|Overall Study||2
2964919|NCT00767325|3679026|FG000|STARTED|Overall Study||104
2964920|NCT00767325|3679026|FG000|COMPLETED|Overall Study||89
2964921|NCT00767325|3679026|FG000|NOT COMPLETED|Overall Study||15
2964922|NCT00767338|3679034|FG000|STARTED|Overall Study||1
2964923|NCT00767338|3679035|FG001|STARTED|Overall Study||2
2964924|NCT00767338|3679036|FG002|STARTED|Overall Study||0
2964925|NCT00767338|3679037|FG003|STARTED|Overall Study||0
2964926|NCT00767338|3679034|FG000|COMPLETED|Overall Study||0
2964927|NCT00767338|3679035|FG001|COMPLETED|Overall Study||0
2964928|NCT00767338|3679036|FG002|COMPLETED|Overall Study||0
2964929|NCT00767338|3679037|FG003|COMPLETED|Overall Study||0
2964930|NCT00767338|3679034|FG000|NOT COMPLETED|Overall Study||1
2964931|NCT00767338|3679035|FG001|NOT COMPLETED|Overall Study||2
2964932|NCT00767338|3679036|FG002|NOT COMPLETED|Overall Study||0
2964933|NCT00767338|3679037|FG003|NOT COMPLETED|Overall Study||0
2964934|NCT00767364|3679049|FG000|STARTED|Overall Study||5
2964935|NCT00767364|3679050|FG001|STARTED|Overall Study||3
2964936|NCT00767364|3679049|FG000|COMPLETED|Overall Study||5
2964937|NCT00767364|3679050|FG001|COMPLETED|Overall Study||3
2964938|NCT00767364|3679049|FG000|NOT COMPLETED|Overall Study||0
2964939|NCT00767364|3679050|FG001|NOT COMPLETED|Overall Study||0
2964940|NCT00767455|3679056|FG000|STARTED|Overall Study||59
2964941|NCT00767455|3679056|FG000|COMPLETED|Overall Study||40
2964942|NCT00767455|3679056|FG000|NOT COMPLETED|Overall Study||19
2964943|NCT00767507|3679066|FG000|STARTED|Overall Study||5
2964944|NCT00767507|3679067|FG001|STARTED|Overall Study||6
2964945|NCT00767507|3679068|FG002|STARTED|Overall Study||106
2964946|NCT00767507|3679069|FG003|STARTED|Overall Study||104
2964947|NCT00767507|3679066|FG000|COMPLETED|Overall Study||5
2964948|NCT00767507|3679067|FG001|COMPLETED|Overall Study||6
2964949|NCT00767507|3679068|FG002|COMPLETED|Overall Study||106
2964950|NCT00767507|3679069|FG003|COMPLETED|Overall Study||101
2964951|NCT00767507|3679066|FG000|NOT COMPLETED|Overall Study||0
2964952|NCT00767507|3679067|FG001|NOT COMPLETED|Overall Study||0
2964953|NCT00767507|3679068|FG002|NOT COMPLETED|Overall Study||0
2964954|NCT00767507|3679069|FG003|NOT COMPLETED|Overall Study||3
2964955|NCT00767520|3679088|FG000|STARTED|Overall Study||79
2964956|NCT00767520|3679089|FG001|STARTED|Overall Study||78
2964957|NCT00767520|3679088|FG000|COMPLETED|Overall Study|Completed=Off-treatment; Major reasons: disease progression-50, study drug toxicity-10,AE-3,Death-2|68
2964958|NCT00767520|3679089|FG001|COMPLETED|Overall Study|Completed=Off-treatment; Major reasons: disease progression-56, study drug toxicity-2,AE-1,Death-1|61
2964959|NCT00767520|3679088|FG000|NOT COMPLETED|Overall Study||11
2964960|NCT00767520|3679089|FG001|NOT COMPLETED|Overall Study||17
2964961|NCT00767572|3679095|FG000|STARTED|First Intervention (12 Weeks)||12
2964962|NCT00767572|3679095|FG000|COMPLETED|First Intervention (12 Weeks)||12
2964963|NCT00767572|3679095|FG000|NOT COMPLETED|First Intervention (12 Weeks)||0
2964964|NCT00767572|3679095|FG000|STARTED|Washout (4 Weeks)||12
2964965|NCT00767572|3679095|FG000|COMPLETED|Washout (4 Weeks)||12
2964966|NCT00767572|3679095|FG000|NOT COMPLETED|Washout (4 Weeks)||0
2964967|NCT00767572|3679095|FG000|STARTED|Second Intervention (12 Weeks)||12
2964968|NCT00767572|3679095|FG000|COMPLETED|Second Intervention (12 Weeks)||12
2964969|NCT00767572|3679095|FG000|NOT COMPLETED|Second Intervention (12 Weeks)||0
2964970|NCT00767624|3679103|FG000|STARTED|Overall Study||75
2964971|NCT00767624|3679104|FG001|STARTED|Overall Study||75
2964972|NCT00767624|3679103|FG000|COMPLETED|Overall Study||51
2964973|NCT00767624|3679104|FG001|COMPLETED|Overall Study||58
2964974|NCT00767624|3679103|FG000|NOT COMPLETED|Overall Study||24
2964975|NCT00767624|3679104|FG001|NOT COMPLETED|Overall Study||17
2964976|NCT00767676|3679110|FG000|STARTED|Overall Study||259
2964977|NCT00767676|3679110|FG000|COMPLETED|Overall Study||205
2964978|NCT00767676|3679110|FG000|NOT COMPLETED|Overall Study||54
2964979|NCT00767767|3679119|FG000|STARTED|Overall Study||21
2964980|NCT00767767|3679120|FG001|STARTED|Overall Study||20
2964981|NCT00767767|3679121|FG002|STARTED|Overall Study||20
2964982|NCT00767767|3679122|FG003|STARTED|Overall Study||3
2964983|NCT00767767|3679123|FG004|STARTED|Overall Study||3
2964984|NCT00767767|3679119|FG000|COMPLETED|Overall Study||21
2964985|NCT00767767|3679120|FG001|COMPLETED|Overall Study||20
2964986|NCT00767767|3679121|FG002|COMPLETED|Overall Study||20
2964987|NCT00767767|3679122|FG003|COMPLETED|Overall Study||3
2964988|NCT00767767|3679123|FG004|COMPLETED|Overall Study||3
2964989|NCT00767767|3679119|FG000|NOT COMPLETED|Overall Study||0
2964990|NCT00767767|3679120|FG001|NOT COMPLETED|Overall Study||0
2964991|NCT00767767|3679121|FG002|NOT COMPLETED|Overall Study||0
2964992|NCT00767767|3679122|FG003|NOT COMPLETED|Overall Study||0
2964993|NCT00767767|3679123|FG004|NOT COMPLETED|Overall Study||0
2964994|NCT00767806|3679137|FG000|STARTED|Overall Study||198
2964995|NCT00767806|3679138|FG001|STARTED|Overall Study||203
2964996|NCT00767806|3679137|FG000|COMPLETED|Overall Study||147
2964997|NCT00767806|3679138|FG001|COMPLETED|Overall Study||156
2964998|NCT00767806|3679137|FG000|NOT COMPLETED|Overall Study||51
2964999|NCT00767806|3679138|FG001|NOT COMPLETED|Overall Study||47
2965000|NCT00767819|3679147|FG000|STARTED|Overall Study||37
2965001|NCT00767819|3679148|FG001|STARTED|Overall Study||24
2965002|NCT00767819|3679149|FG002|STARTED|Overall Study||10
2965003|NCT00767819|3679147|FG000|Intent to Treat (ITT) Analysis Set|Overall Study||37
2965004|NCT00767819|3679148|FG001|Intent to Treat (ITT) Analysis Set|Overall Study||24
2965005|NCT00767819|3679149|FG002|Intent to Treat (ITT) Analysis Set|Overall Study||10
2965006|NCT00767819|3679147|FG000|Safety Analysis Set (SAF)|Overall Study||37
2965007|NCT00767819|3679148|FG001|Safety Analysis Set (SAF)|Overall Study||24
2965008|NCT00767819|3679149|FG002|Safety Analysis Set (SAF)|Overall Study||10
2965009|NCT00767819|3679147|FG000|COMPLETED|Overall Study||12
2965010|NCT00767819|3679148|FG001|COMPLETED|Overall Study||5
2965011|NCT00767819|3679149|FG002|COMPLETED|Overall Study||10
2965012|NCT00767819|3679147|FG000|NOT COMPLETED|Overall Study||25
2965013|NCT00767819|3679148|FG001|NOT COMPLETED|Overall Study||19
2965014|NCT00767819|3679149|FG002|NOT COMPLETED|Overall Study||0
2965015|NCT00768053|3679157|FG000|STARTED|Overall Study||108
2965016|NCT00768053|3679157|FG000|COMPLETED|Overall Study||97
2965017|NCT00768053|3679157|FG000|NOT COMPLETED|Overall Study||11
2965018|NCT00768066|3679164|FG000|STARTED|Overall Study||22
2965019|NCT00768066|3679165|FG001|STARTED|Overall Study||22
2965020|NCT00768066|3679166|FG002|STARTED|Overall Study||21
2965021|NCT00768066|3679164|FG000|COMPLETED|Overall Study||19
2965022|NCT00768066|3679165|FG001|COMPLETED|Overall Study||19
2965023|NCT00768066|3679166|FG002|COMPLETED|Overall Study||21
2965024|NCT00768066|3679164|FG000|NOT COMPLETED|Overall Study||3
2965025|NCT00768066|3679165|FG001|NOT COMPLETED|Overall Study||3
2965026|NCT00768066|3679166|FG002|NOT COMPLETED|Overall Study||0
2965027|NCT00768079|3679177|FG000|STARTED|Overall Study||38
2965028|NCT00768079|3679178|FG001|STARTED|Overall Study||36
2965029|NCT00768079|3679179|FG002|STARTED|Overall Study||36
2965030|NCT00768079|3679177|FG000|COMPLETED|Overall Study||36
2965031|NCT00768079|3679178|FG001|COMPLETED|Overall Study||35
2965032|NCT00768079|3679179|FG002|COMPLETED|Overall Study||32
2965033|NCT00768079|3679177|FG000|NOT COMPLETED|Overall Study||2
2965034|NCT00768079|3679178|FG001|NOT COMPLETED|Overall Study||1
2965035|NCT00768079|3679179|FG002|NOT COMPLETED|Overall Study||4
2965036|NCT00768118|3679189|FG000|STARTED|Overall Study||11
2965037|NCT00768118|3679189|FG000|COMPLETED|Overall Study||11
2965038|NCT00768118|3679189|FG000|NOT COMPLETED|Overall Study||0
2965039|NCT00768144|3679193|FG000|STARTED|Overall Study||36
2965040|NCT00768144|3679193|FG000|COMPLETED|Overall Study||0
2965041|NCT00768144|3679193|FG000|NOT COMPLETED|Overall Study||36
2965042|NCT00768222|3679199|FG000|STARTED|Overall Study||50
2965043|NCT00768222|3679200|FG001|STARTED|Overall Study||51
2965044|NCT00768222|3679199|FG000|COMPLETED|Overall Study||46
2965045|NCT00768222|3679200|FG001|COMPLETED|Overall Study||47
2965046|NCT00768222|3679199|FG000|NOT COMPLETED|Overall Study||4
2965047|NCT00768222|3679200|FG001|NOT COMPLETED|Overall Study||4
2965048|NCT00768261|3679210|FG000|STARTED|Overall Study||14
2965049|NCT00768261|3679211|FG001|STARTED|Overall Study||18
2965050|NCT00768261|3679212|FG002|STARTED|Overall Study||39
2965051|NCT00768261|3679213|FG003|STARTED|Overall Study||56
2965052|NCT00768261|3679210|FG000|COMPLETED|Overall Study||14
2965053|NCT00768261|3679211|FG001|COMPLETED|Overall Study||18
2965054|NCT00768261|3679212|FG002|COMPLETED|Overall Study||14
2965055|NCT00768261|3679213|FG003|COMPLETED|Overall Study||56
2965056|NCT00768261|3679210|FG000|NOT COMPLETED|Overall Study||0
2965057|NCT00768261|3679211|FG001|NOT COMPLETED|Overall Study||0
2965058|NCT00768261|3679212|FG002|NOT COMPLETED|Overall Study||25
2965059|NCT00768261|3679213|FG003|NOT COMPLETED|Overall Study||0
2965060|NCT00768287|3679226|FG000|STARTED|Pharmacokinetic Study||16
2965061|NCT00768287|3679227|FG001|STARTED|Pharmacokinetic Study||16
2965062|NCT00768287|3679228|FG002|STARTED|Pharmacokinetic Study||0
2965063|NCT00768287|3679229|FG003|STARTED|Pharmacokinetic Study||0
2965064|NCT00768287|3679230|FG004|STARTED|Pharmacokinetic Study||0
2965065|NCT00768287|3679231|FG005|STARTED|Pharmacokinetic Study||0
2965066|NCT00768287|3679226|FG000|COMPLETED|Pharmacokinetic Study||16
2965067|NCT00768287|3679227|FG001|COMPLETED|Pharmacokinetic Study||16
2965068|NCT00768287|3679228|FG002|COMPLETED|Pharmacokinetic Study||0
2965069|NCT00768287|3679229|FG003|COMPLETED|Pharmacokinetic Study||0
2965070|NCT00768287|3679230|FG004|COMPLETED|Pharmacokinetic Study||0
2965071|NCT00768287|3679231|FG005|COMPLETED|Pharmacokinetic Study||0
2965072|NCT00768287|3679226|FG000|NOT COMPLETED|Pharmacokinetic Study||0
2965073|NCT00768287|3679227|FG001|NOT COMPLETED|Pharmacokinetic Study||0
2965074|NCT00768287|3679228|FG002|NOT COMPLETED|Pharmacokinetic Study||0
2965075|NCT00768287|3679229|FG003|NOT COMPLETED|Pharmacokinetic Study||0
2965076|NCT00768287|3679230|FG004|NOT COMPLETED|Pharmacokinetic Study||0
2965077|NCT00768287|3679231|FG005|NOT COMPLETED|Pharmacokinetic Study||0
2965078|NCT00768287|3679226|FG000|STARTED|Repeat Pharmacokinetic Study||0
2965079|NCT00768287|3679227|FG001|STARTED|Repeat Pharmacokinetic Study||0
2965080|NCT00768287|3679228|FG002|STARTED|Repeat Pharmacokinetic Study|Eight subjects were part of the IB1001 first group; 6 were from the nonacog alfa first group.|14
2965081|NCT00768287|3679229|FG003|STARTED|Repeat Pharmacokinetic Study||0
2965082|NCT00768287|3679230|FG004|STARTED|Repeat Pharmacokinetic Study||0
2965083|NCT00768287|3679231|FG005|STARTED|Repeat Pharmacokinetic Study||0
2965084|NCT00768287|3679226|FG000|COMPLETED|Repeat Pharmacokinetic Study||0
2965085|NCT00768287|3679227|FG001|COMPLETED|Repeat Pharmacokinetic Study||0
2965086|NCT00768287|3679228|FG002|COMPLETED|Repeat Pharmacokinetic Study||14
2965087|NCT00768287|3679229|FG003|COMPLETED|Repeat Pharmacokinetic Study||0
2965088|NCT00768287|3679230|FG004|COMPLETED|Repeat Pharmacokinetic Study||0
2965089|NCT00768287|3679231|FG005|COMPLETED|Repeat Pharmacokinetic Study||0
2965090|NCT00768287|3679226|FG000|NOT COMPLETED|Repeat Pharmacokinetic Study||0
2965091|NCT00768287|3679227|FG001|NOT COMPLETED|Repeat Pharmacokinetic Study||0
2965092|NCT00768287|3679228|FG002|NOT COMPLETED|Repeat Pharmacokinetic Study||0
2965093|NCT00768287|3679229|FG003|NOT COMPLETED|Repeat Pharmacokinetic Study||0
2965094|NCT00768287|3679230|FG004|NOT COMPLETED|Repeat Pharmacokinetic Study||0
2965095|NCT00768287|3679231|FG005|NOT COMPLETED|Repeat Pharmacokinetic Study||0
2965096|NCT00768287|3679226|FG000|STARTED|Treatment Study||0
2965097|NCT00768287|3679227|FG001|STARTED|Treatment Study||0
2965098|NCT00768287|3679228|FG002|STARTED|Treatment Study||0
2965099|NCT00768287|3679229|FG003|STARTED|Treatment Study|1 subject was not assigned a regimen at the start of the study.|58
2965100|NCT00768287|3679230|FG004|STARTED|Treatment Study|1 subject was not assigned a regimen at the start of the study.|9
2965101|NCT00768287|3679231|FG005|STARTED|Treatment Study||0
2965102|NCT00768287|3679226|FG000|Treated|Treatment Study||0
2965103|NCT00768287|3679227|FG001|Treated|Treatment Study||0
2965104|NCT00768287|3679228|FG002|Treated|Treatment Study||0
2965105|NCT00768287|3679229|FG003|Treated|Treatment Study|Subjects could switch treatment regimens. 3 subjects switched from On Demand to Prophylaxis.|61
2965106|NCT00768287|3679230|FG004|Treated|Treatment Study|Subjects could switch treatment regimens. 3 subjects switched from Prophylaxis to On Demand.|12
2965107|NCT00768287|3679231|FG005|Treated|Treatment Study||0
2965108|NCT00768287|3679226|FG000|COMPLETED|Treatment Study||0
2965109|NCT00768287|3679227|FG001|COMPLETED|Treatment Study||0
2965110|NCT00768287|3679228|FG002|COMPLETED|Treatment Study||0
2965111|NCT00768287|3679229|FG003|COMPLETED|Treatment Study||58
2965112|NCT00768287|3679230|FG004|COMPLETED|Treatment Study||9
2965113|NCT00768287|3679231|FG005|COMPLETED|Treatment Study||0
2965114|NCT00768287|3679226|FG000|NOT COMPLETED|Treatment Study||0
2965115|NCT00768287|3679227|FG001|NOT COMPLETED|Treatment Study||0
2965116|NCT00768287|3679228|FG002|NOT COMPLETED|Treatment Study||0
2965117|NCT00768287|3679229|FG003|NOT COMPLETED|Treatment Study||0
2965118|NCT00768287|3679230|FG004|NOT COMPLETED|Treatment Study||0
2965119|NCT00768287|3679231|FG005|NOT COMPLETED|Treatment Study||0
2965120|NCT00768287|3679226|FG000|STARTED|Surgical Sub-study||0
2965121|NCT00768287|3679227|FG001|STARTED|Surgical Sub-study||0
2965122|NCT00768287|3679228|FG002|STARTED|Surgical Sub-study||0
2965123|NCT00768287|3679229|FG003|STARTED|Surgical Sub-study||0
2965124|NCT00768287|3679230|FG004|STARTED|Surgical Sub-study||0
2965125|NCT00768287|3679231|FG005|STARTED|Surgical Sub-study|1 female subject was excluded from the efficacy analysis. She was included in the safety population.|17
2965126|NCT00768287|3679226|FG000|COMPLETED|Surgical Sub-study||0
2965127|NCT00768287|3679227|FG001|COMPLETED|Surgical Sub-study||0
2965128|NCT00768287|3679228|FG002|COMPLETED|Surgical Sub-study||0
2965129|NCT00768287|3679229|FG003|COMPLETED|Surgical Sub-study||0
2965130|NCT00768287|3679230|FG004|COMPLETED|Surgical Sub-study||0
2965131|NCT00768287|3679231|FG005|COMPLETED|Surgical Sub-study||17
2965132|NCT00768287|3679226|FG000|NOT COMPLETED|Surgical Sub-study||0
2965133|NCT00768287|3679227|FG001|NOT COMPLETED|Surgical Sub-study||0
2965134|NCT00768287|3679228|FG002|NOT COMPLETED|Surgical Sub-study||0
2965135|NCT00768287|3679229|FG003|NOT COMPLETED|Surgical Sub-study||0
2965136|NCT00768287|3679230|FG004|NOT COMPLETED|Surgical Sub-study||0
2965137|NCT00768287|3679231|FG005|NOT COMPLETED|Surgical Sub-study||0
2965138|NCT00768300|3679245|FG000|STARTED|Overall Study||330
2965139|NCT00768300|3679246|FG001|STARTED|Overall Study||164
2965140|NCT00768300|3679245|FG000|Randomized and Treated|Overall Study||329
2965141|NCT00768300|3679246|FG001|Randomized and Treated|Overall Study||163
2965142|NCT00768300|3679245|FG000|COMPLETED|Overall Study||1
2965143|NCT00768300|3679246|FG001|COMPLETED|Overall Study||1
2965144|NCT00768300|3679245|FG000|NOT COMPLETED|Overall Study||329
2965145|NCT00768300|3679246|FG001|NOT COMPLETED|Overall Study||163
2965146|NCT00768430|3679254|FG000|STARTED|24 Hour Endpoint||48
2965147|NCT00768430|3679255|FG001|STARTED|24 Hour Endpoint||25
2965148|NCT00768430|3679254|FG000|COMPLETED|24 Hour Endpoint||47
2965149|NCT00768430|3679255|FG001|COMPLETED|24 Hour Endpoint||25
2965150|NCT00768430|3679254|FG000|NOT COMPLETED|24 Hour Endpoint||1
2965151|NCT00768430|3679255|FG001|NOT COMPLETED|24 Hour Endpoint||0
2965152|NCT00768430|3679254|FG000|STARTED|7 Day Endpoint||47
2965153|NCT00768430|3679255|FG001|STARTED|7 Day Endpoint||25
2965154|NCT00768430|3679254|FG000|COMPLETED|7 Day Endpoint||45
2965155|NCT00768430|3679255|FG001|COMPLETED|7 Day Endpoint||22
2965156|NCT00768430|3679254|FG000|NOT COMPLETED|7 Day Endpoint||2
2965157|NCT00768430|3679255|FG001|NOT COMPLETED|7 Day Endpoint||3
2965158|NCT00768469|3679263|FG000|STARTED|Overall Study||3
2965159|NCT00768469|3679264|FG001|STARTED|Overall Study||7
2965160|NCT00768469|3679263|FG000|COMPLETED|Overall Study||0
2965161|NCT00768469|3679264|FG001|COMPLETED|Overall Study||0
2965162|NCT00768469|3679263|FG000|NOT COMPLETED|Overall Study||3
2965163|NCT00768469|3679264|FG001|NOT COMPLETED|Overall Study||7
2965164|NCT00768521|3679271|FG000|STARTED|Period 1||9
2965165|NCT00768521|3679272|FG001|STARTED|Period 1||11
2965166|NCT00768521|3679271|FG000|COMPLETED|Period 1||9
2965167|NCT00768521|3679272|FG001|COMPLETED|Period 1||11
2965168|NCT00768521|3679271|FG000|NOT COMPLETED|Period 1||0
2965169|NCT00768521|3679272|FG001|NOT COMPLETED|Period 1||0
2965170|NCT00768521|3679271|FG000|STARTED|Period 2||9
2965171|NCT00768521|3679272|FG001|STARTED|Period 2||11
2965172|NCT00768521|3679271|FG000|COMPLETED|Period 2||9
2965173|NCT00768521|3679272|FG001|COMPLETED|Period 2||11
2965174|NCT00768521|3679271|FG000|NOT COMPLETED|Period 2||0
2965175|NCT00768521|3679272|FG001|NOT COMPLETED|Period 2||0
2965176|NCT00768560|3679284|FG000|STARTED|Intervention Set 1|3-period/treatment crossover|5
2965177|NCT00768560|3679285|FG001|STARTED|Intervention Set 1|3-period/treatment crossover|6
2965178|NCT00768560|3679286|FG002|STARTED|Intervention Set 1|3-period/treatment crossover|6
2965179|NCT00768560|3679287|FG003|STARTED|Intervention Set 1|3-period/treatment crossover|6
2965180|NCT00768560|3679288|FG004|STARTED|Intervention Set 1|3-period/treatment crossover|6
2965181|NCT00768560|3679289|FG005|STARTED|Intervention Set 1|3-period/treatment crossover|6
2965182|NCT00768560|3679284|FG000|Subjects Received Treatment|Intervention Set 1|40 mg OD for 2 weeks|5
2965183|NCT00768560|3679285|FG001|Subjects Received Treatment|Intervention Set 1|40 mg OD for 2 weeks|6
2965184|NCT00768560|3679286|FG002|Subjects Received Treatment|Intervention Set 1|40 mg twice daily (BID) for 2 weeks|6
2965185|NCT00768560|3679287|FG003|Subjects Received Treatment|Intervention Set 1|40 mg BID for 2 weeks|6
2965186|NCT00768560|3679288|FG004|Subjects Received Treatment|Intervention Set 1|80 mg OD for 2 weeks|6
2965187|NCT00768560|3679289|FG005|Subjects Received Treatment|Intervention Set 1|80 mg OD for 2 weeks|6
3301832|NCT02956057|4035476|FG001|STARTED|Overall Study||174
3301833|NCT02956057|4035477|FG002|STARTED|Overall Study||174
3301834|NCT02956057|4035478|FG003|STARTED|Overall Study||174
3301835|NCT02956057|4035479|FG004|STARTED|Overall Study||174
3301836|NCT02956057|4035480|FG005|STARTED|Overall Study||174
3301837|NCT02956057|4035475|FG000|COMPLETED|Overall Study||160
3301838|NCT02956057|4035476|FG001|COMPLETED|Overall Study||162
3301839|NCT02956057|4035477|FG002|COMPLETED|Overall Study||166
3301840|NCT02956057|4035478|FG003|COMPLETED|Overall Study||159
3301841|NCT02956057|4035479|FG004|COMPLETED|Overall Study||169
3301842|NCT02956057|4035480|FG005|COMPLETED|Overall Study||157
3301843|NCT02956057|4035475|FG000|NOT COMPLETED|Overall Study||14
3301844|NCT02956057|4035476|FG001|NOT COMPLETED|Overall Study||12
3301845|NCT02956057|4035477|FG002|NOT COMPLETED|Overall Study||8
3301846|NCT02956057|4035478|FG003|NOT COMPLETED|Overall Study||15
3301847|NCT02956057|4035479|FG004|NOT COMPLETED|Overall Study||5
3301848|NCT02956057|4035480|FG005|NOT COMPLETED|Overall Study||17
3301849|NCT02956070|4035496|FG000|STARTED|Overall Study||35
3301850|NCT02956070|4035497|FG001|STARTED|Overall Study||35
3301851|NCT02956070|4035496|FG000|COMPLETED|Overall Study||35
3301852|NCT02956070|4035497|FG001|COMPLETED|Overall Study||35
3301853|NCT02956070|4035496|FG000|NOT COMPLETED|Overall Study||0
3301854|NCT02956070|4035497|FG001|NOT COMPLETED|Overall Study||0
3301855|NCT02956122|4035503|FG000|STARTED|Overall Study||1
3301856|NCT02956122|4035503|FG000|COMPLETED|Overall Study||1
3301857|NCT02956122|4035503|FG000|NOT COMPLETED|Overall Study||0
3301858|NCT02956278|4035517|FG000|STARTED|Overall Study||15
3301859|NCT02956278|4035518|FG001|STARTED|Overall Study||9
3301860|NCT02956278|4035519|FG002|STARTED|Overall Study||3
3301861|NCT02956278|4035517|FG000|COMPLETED|Overall Study||9
3301862|NCT02956278|4035518|FG001|COMPLETED|Overall Study||7
3301863|NCT02956278|4035519|FG002|COMPLETED|Overall Study||3
3301864|NCT02956278|4035517|FG000|NOT COMPLETED|Overall Study||6
3301865|NCT02956278|4035518|FG001|NOT COMPLETED|Overall Study||2
3301866|NCT02956278|4035519|FG002|NOT COMPLETED|Overall Study||0
3301867|NCT02956460|4035529|FG000|STARTED|Lens 1||30
3301868|NCT02956460|4035530|FG001|STARTED|Lens 1||34
3301869|NCT02956460|4035529|FG000|COMPLETED|Lens 1||29
3301870|NCT02956460|4035530|FG001|COMPLETED|Lens 1||34
3301871|NCT02956460|4035529|FG000|NOT COMPLETED|Lens 1||1
3301872|NCT02956460|4035530|FG001|NOT COMPLETED|Lens 1||0
3301873|NCT02956460|4035529|FG000|STARTED|Lens 2||29
3301874|NCT02956460|4035530|FG001|STARTED|Lens 2||34
3301875|NCT02956460|4035529|FG000|COMPLETED|Lens 2||29
3301876|NCT02956460|4035530|FG001|COMPLETED|Lens 2||34
3301877|NCT02956460|4035529|FG000|NOT COMPLETED|Lens 2||0
3301878|NCT02956460|4035530|FG001|NOT COMPLETED|Lens 2||0
3301879|NCT02956486|4035538|FG000|STARTED|Core Phase||1108
3301880|NCT02956486|4035539|FG001|STARTED|Core Phase||1104
3301881|NCT02956486|4035540|FG002|STARTED|Core Phase||0
3301882|NCT02956486|4035538|FG000|Treated|Core Phase||1108
3301883|NCT02956486|4035539|FG001|Treated|Core Phase||1101
3301884|NCT02956486|4035540|FG002|Treated|Core Phase||0
3301885|NCT02956486|4035538|FG000|Safety Analysis Set (SAS)|Core Phase||1105
3301886|NCT02956486|4035539|FG001|Safety Analysis Set (SAS)|Core Phase||1099
3301887|NCT02956486|4035540|FG002|Safety Analysis Set (SAS)|Core Phase||0
3301888|NCT02956486|4035538|FG000|Full Analysis Set (FAS)|Core Phase||1084
3301889|NCT02956486|4035539|FG001|Full Analysis Set (FAS)|Core Phase||1062
3301890|NCT02956486|4035540|FG002|Full Analysis Set (FAS)|Core Phase||0
3301891|NCT02956486|4035538|FG000|COMPLETED|Core Phase||29
3301892|NCT02956486|4035539|FG001|COMPLETED|Core Phase||32
3301893|NCT02956486|4035540|FG002|COMPLETED|Core Phase||0
3301894|NCT02956486|4035538|FG000|NOT COMPLETED|Core Phase||1079
3301895|NCT02956486|4035539|FG001|NOT COMPLETED|Core Phase||1072
3301896|NCT02956486|4035540|FG002|NOT COMPLETED|Core Phase||0
3301897|NCT02956486|4035538|FG000|STARTED|Extension Phase||0
3301898|NCT02956486|4035539|FG001|STARTED|Extension Phase||0
2965188|NCT00768560|3679284|FG000|COMPLETED|Intervention Set 1||5
2965189|NCT00768560|3679285|FG001|COMPLETED|Intervention Set 1||5
2965190|NCT00768560|3679286|FG002|COMPLETED|Intervention Set 1||6
2965191|NCT00768560|3679287|FG003|COMPLETED|Intervention Set 1||6
2965192|NCT00768560|3679288|FG004|COMPLETED|Intervention Set 1||6
2965193|NCT00768560|3679289|FG005|COMPLETED|Intervention Set 1||6
2965194|NCT00768560|3679284|FG000|NOT COMPLETED|Intervention Set 1||0
2965195|NCT00768560|3679285|FG001|NOT COMPLETED|Intervention Set 1||1
2965196|NCT00768560|3679286|FG002|NOT COMPLETED|Intervention Set 1||0
2965197|NCT00768560|3679287|FG003|NOT COMPLETED|Intervention Set 1||0
2965198|NCT00768560|3679288|FG004|NOT COMPLETED|Intervention Set 1||0
3301899|NCT02956486|4035540|FG002|STARTED|Extension Phase|Eligible participants who completed core and consented for extension phase, entered extension phase.|19
3301900|NCT02956486|4035538|FG000|Treated|Extension Phase||0
3301901|NCT02956486|4035539|FG001|Treated|Extension Phase||0
3301902|NCT02956486|4035540|FG002|Treated|Extension Phase||18
3301903|NCT02956486|4035538|FG000|Safety Analysis Set (SAS)|Extension Phase||0
3301904|NCT02956486|4035539|FG001|Safety Analysis Set (SAS)|Extension Phase||0
3301905|NCT02956486|4035540|FG002|Safety Analysis Set (SAS)|Extension Phase||18
3301906|NCT02956486|4035538|FG000|COMPLETED|Extension Phase||0
3301907|NCT02956486|4035539|FG001|COMPLETED|Extension Phase||0
3301908|NCT02956486|4035540|FG002|COMPLETED|Extension Phase||0
3301909|NCT02956486|4035538|FG000|NOT COMPLETED|Extension Phase||0
3301910|NCT02956486|4035539|FG001|NOT COMPLETED|Extension Phase||0
3301911|NCT02956486|4035540|FG002|NOT COMPLETED|Extension Phase||19
3301912|NCT02956616|4035551|FG000|STARTED|Overall Study||58
2965199|NCT00768560|3679289|FG005|NOT COMPLETED|Intervention Set 1||0
2965200|NCT00768560|3679284|FG000|STARTED|Intervention Set 2|40 mg BID for 2 weeks|5
2965201|NCT00768560|3679285|FG001|STARTED|Intervention Set 2|80 mg OD for 2 weeks|5
2965202|NCT00768560|3679286|FG002|STARTED|Intervention Set 2|80 mg OD for 2 weeks|6
2965203|NCT00768560|3679287|FG003|STARTED|Intervention Set 2|40 mg OD for 2 weeks|6
2965204|NCT00768560|3679288|FG004|STARTED|Intervention Set 2|40 mg OD for 2 weeks|6
2965205|NCT00768560|3679289|FG005|STARTED|Intervention Set 2|40 mg BID for 2 weeks|6
2965206|NCT00768560|3679284|FG000|COMPLETED|Intervention Set 2||5
2965207|NCT00768560|3679285|FG001|COMPLETED|Intervention Set 2||5
2965208|NCT00768560|3679286|FG002|COMPLETED|Intervention Set 2||6
2965209|NCT00768560|3679287|FG003|COMPLETED|Intervention Set 2||6
2965210|NCT00768560|3679288|FG004|COMPLETED|Intervention Set 2||6
2965211|NCT00768560|3679289|FG005|COMPLETED|Intervention Set 2||6
2965212|NCT00768560|3679284|FG000|NOT COMPLETED|Intervention Set 2||0
2965213|NCT00768560|3679285|FG001|NOT COMPLETED|Intervention Set 2||0
2965214|NCT00768560|3679286|FG002|NOT COMPLETED|Intervention Set 2||0
2965215|NCT00768560|3679287|FG003|NOT COMPLETED|Intervention Set 2||0
2965216|NCT00768560|3679288|FG004|NOT COMPLETED|Intervention Set 2||0
2965217|NCT00768560|3679289|FG005|NOT COMPLETED|Intervention Set 2||0
2965218|NCT00768560|3679284|FG000|STARTED|Intervention Set 3|80 mg OD for 2 weeks|5
2965219|NCT00768560|3679285|FG001|STARTED|Intervention Set 3|40 mg BID for 2 weeks|5
2965220|NCT00768560|3679286|FG002|STARTED|Intervention Set 3|40 mg OD for 2 weeks|6
2965221|NCT00768560|3679287|FG003|STARTED|Intervention Set 3|80 mg OD for 2 weeks|6
2965222|NCT00768560|3679288|FG004|STARTED|Intervention Set 3|40 mg BID for 2 weeks|6
2965223|NCT00768560|3679289|FG005|STARTED|Intervention Set 3|40 mg OD for 2 weeks|6
2965224|NCT00768560|3679284|FG000|COMPLETED|Intervention Set 3||5
2965225|NCT00768560|3679285|FG001|COMPLETED|Intervention Set 3||5
2965226|NCT00768560|3679286|FG002|COMPLETED|Intervention Set 3||6
2965227|NCT00768560|3679287|FG003|COMPLETED|Intervention Set 3||6
2965228|NCT00768560|3679288|FG004|COMPLETED|Intervention Set 3||6
2965229|NCT00768560|3679289|FG005|COMPLETED|Intervention Set 3||6
2965230|NCT00768560|3679284|FG000|NOT COMPLETED|Intervention Set 3||0
2965231|NCT00768560|3679285|FG001|NOT COMPLETED|Intervention Set 3||0
2965232|NCT00768560|3679286|FG002|NOT COMPLETED|Intervention Set 3||0
2965233|NCT00768560|3679287|FG003|NOT COMPLETED|Intervention Set 3||0
2965234|NCT00768560|3679288|FG004|NOT COMPLETED|Intervention Set 3||0
2965235|NCT00768560|3679289|FG005|NOT COMPLETED|Intervention Set 3||0
2965236|NCT00768599|3679300|FG000|STARTED|Overall Study||45
2965237|NCT00768599|3679301|FG001|STARTED|Overall Study||43
2965238|NCT00768599|3679302|FG002|STARTED|Overall Study||47
2965239|NCT00768599|3679300|FG000|COMPLETED|Overall Study||34
2965240|NCT00768599|3679301|FG001|COMPLETED|Overall Study||27
2965241|NCT00768599|3679302|FG002|COMPLETED|Overall Study||35
2965242|NCT00768599|3679300|FG000|NOT COMPLETED|Overall Study||11
2965243|NCT00768599|3679301|FG001|NOT COMPLETED|Overall Study||16
2965244|NCT00768599|3679302|FG002|NOT COMPLETED|Overall Study||12
2965245|NCT00768651|3679310|FG000|STARTED|Overall Study||8
2965246|NCT00768651|3679310|FG000|COMPLETED|Overall Study||7
2965247|NCT00768651|3679310|FG000|NOT COMPLETED|Overall Study||1
3035546|NCT01138046|3754819|FG000|NOT COMPLETED|Overall Study||6
3035547|NCT01138098|3754825|FG000|STARTED|Overall Study||95
3035548|NCT01138098|3754826|FG001|STARTED|Overall Study||90
3035549|NCT01138098|3754825|FG000|COMPLETED|Overall Study||95
3035550|NCT01138098|3754826|FG001|COMPLETED|Overall Study||90
3035551|NCT01138098|3754825|FG000|NOT COMPLETED|Overall Study||0
3035552|NCT01138098|3754826|FG001|NOT COMPLETED|Overall Study||0
3035553|NCT01138111|3754832|FG000|STARTED|Overall Study||45
3035554|NCT01138111|3754832|FG000|COMPLETED|Overall Study||36
3035555|NCT01138111|3754832|FG000|NOT COMPLETED|Overall Study||9
3035556|NCT01138124|3754865|FG000|STARTED|Overall Study||3149
3035557|NCT01138124|3754866|FG001|STARTED|Overall Study||30026
3035558|NCT01138124|3754867|FG002|STARTED|Overall Study||1981
3035559|NCT01138124|3754868|FG003|STARTED|Overall Study||19046
3035560|NCT01138124|3754865|FG000|COMPLETED|Overall Study||3149
3035561|NCT01138124|3754866|FG001|COMPLETED|Overall Study||30026
3035562|NCT01138124|3754867|FG002|COMPLETED|Overall Study||1981
3035563|NCT01138124|3754868|FG003|COMPLETED|Overall Study||19046
3035564|NCT01138124|3754865|FG000|NOT COMPLETED|Overall Study||0
3035565|NCT01138124|3754866|FG001|NOT COMPLETED|Overall Study||0
3035566|NCT01138124|3754867|FG002|NOT COMPLETED|Overall Study||0
3035567|NCT01138124|3754868|FG003|NOT COMPLETED|Overall Study||0
3035568|NCT01138150|3754878|FG000|STARTED|Overall Study||18
3035569|NCT01138150|3754879|FG001|STARTED|Overall Study||18
3035570|NCT01138150|3754878|FG000|COMPLETED|Overall Study||17
3035571|NCT01138150|3754879|FG001|COMPLETED|Overall Study||17
3035572|NCT01138150|3754878|FG000|NOT COMPLETED|Overall Study||1
3035573|NCT01138150|3754879|FG001|NOT COMPLETED|Overall Study||1
3035574|NCT01138475|3754898|FG000|STARTED|Overall Study||16
3035575|NCT01138475|3754899|FG001|STARTED|Overall Study||16
3035576|NCT01138475|3754900|FG002|STARTED|Overall Study||17
3035577|NCT01138475|3754898|FG000|COMPLETED|Overall Study||16
3035578|NCT01138475|3754899|FG001|COMPLETED|Overall Study||16
3035579|NCT01138475|3754900|FG002|COMPLETED|Overall Study||17
3035580|NCT01138475|3754898|FG000|NOT COMPLETED|Overall Study||0
3035581|NCT01138475|3754899|FG001|NOT COMPLETED|Overall Study||0
3035582|NCT01138475|3754900|FG002|NOT COMPLETED|Overall Study||0
3035583|NCT01138501|3754914|FG000|STARTED|Overall Study|Two subjects withdrew consent after being enrolled but before receiving any trial product.|65
3035584|NCT01138501|3754914|FG000|Exposed|Overall Study||63
2965248|NCT00768664|3679315|FG000|STARTED|Overall Study||69
2965249|NCT00768664|3679315|FG000|COMPLETED|Overall Study||0
2965250|NCT00768664|3679315|FG000|NOT COMPLETED|Overall Study||69
2965251|NCT00768716|3679321|FG000|STARTED|Overall Study||54
2965252|NCT00768716|3679322|FG001|STARTED|Overall Study||41
2965253|NCT00768716|3679321|FG000|COMPLETED|Overall Study||54
2965254|NCT00768716|3679322|FG001|COMPLETED|Overall Study||41
2965255|NCT00768716|3679321|FG000|NOT COMPLETED|Overall Study||0
2965256|NCT00768716|3679322|FG001|NOT COMPLETED|Overall Study||0
2965257|NCT00768755|3679335|FG000|STARTED|Phase 1||10
2965258|NCT00768755|3679336|FG001|STARTED|Phase 1||0
2965259|NCT00768755|3679337|FG002|STARTED|Phase 1||0
2965260|NCT00768755|3679338|FG003|STARTED|Phase 1||0
2965261|NCT00768755|3679335|FG000|COMPLETED|Phase 1||0
2965262|NCT00768755|3679336|FG001|COMPLETED|Phase 1||0
2965263|NCT00768755|3679337|FG002|COMPLETED|Phase 1||0
2965264|NCT00768755|3679338|FG003|COMPLETED|Phase 1||0
2965265|NCT00768755|3679335|FG000|NOT COMPLETED|Phase 1||10
2965266|NCT00768755|3679336|FG001|NOT COMPLETED|Phase 1||0
2965267|NCT00768755|3679337|FG002|NOT COMPLETED|Phase 1||0
2965268|NCT00768755|3679338|FG003|NOT COMPLETED|Phase 1||0
2965269|NCT00768755|3679335|FG000|STARTED|Phase 2||0
2965270|NCT00768755|3679336|FG001|STARTED|Phase 2||55
2965271|NCT00768755|3679337|FG002|STARTED|Phase 2||58
2965272|NCT00768755|3679338|FG003|STARTED|Phase 2||57
2965273|NCT00768755|3679335|FG000|Treated|Phase 2||0
2965274|NCT00768755|3679336|FG001|Treated|Phase 2||55
2965275|NCT00768755|3679337|FG002|Treated|Phase 2||58
2965276|NCT00768755|3679338|FG003|Treated|Phase 2||55
2965277|NCT00768755|3679335|FG000|COMPLETED|Phase 2||0
2965278|NCT00768755|3679336|FG001|COMPLETED|Phase 2||0
2965279|NCT00768755|3679337|FG002|COMPLETED|Phase 2||0
2965280|NCT00768755|3679338|FG003|COMPLETED|Phase 2||0
2965281|NCT00768755|3679335|FG000|NOT COMPLETED|Phase 2||0
2965282|NCT00768755|3679336|FG001|NOT COMPLETED|Phase 2||55
2965283|NCT00768755|3679337|FG002|NOT COMPLETED|Phase 2||58
2965284|NCT00768755|3679338|FG003|NOT COMPLETED|Phase 2||57
2965285|NCT00768898|3679347|FG000|STARTED|Overall Study||30
2965286|NCT00768898|3679347|FG000|COMPLETED|Overall Study||28
2965287|NCT00768898|3679347|FG000|NOT COMPLETED|Overall Study||2
2965288|NCT00768989|3679358|FG000|STARTED|Prior to Week 24||63
2965289|NCT00768989|3679359|FG001|STARTED|Prior to Week 24||30
2965290|NCT00768989|3679358|FG000|COMPLETED|Prior to Week 24||59
2965291|NCT00768989|3679359|FG001|COMPLETED|Prior to Week 24||27
2965292|NCT00768989|3679358|FG000|NOT COMPLETED|Prior to Week 24||4
2965293|NCT00768989|3679359|FG001|NOT COMPLETED|Prior to Week 24||3
2965294|NCT00768989|3679358|FG000|STARTED|Week 24 to Prior to Week 36||59
2965295|NCT00768989|3679359|FG001|STARTED|Week 24 to Prior to Week 36||27
2965296|NCT00768989|3679358|FG000|COMPLETED|Week 24 to Prior to Week 36||51
2965297|NCT00768989|3679359|FG001|COMPLETED|Week 24 to Prior to Week 36||27
2965298|NCT00768989|3679358|FG000|NOT COMPLETED|Week 24 to Prior to Week 36||8
2965299|NCT00768989|3679359|FG001|NOT COMPLETED|Week 24 to Prior to Week 36||0
2965300|NCT00768989|3679358|FG000|STARTED|On or After Week 36||51
2965301|NCT00768989|3679359|FG001|STARTED|On or After Week 36||27
2965302|NCT00768989|3679358|FG000|COMPLETED|On or After Week 36||0
2965303|NCT00768989|3679359|FG001|COMPLETED|On or After Week 36||0
2965304|NCT00768989|3679358|FG000|NOT COMPLETED|On or After Week 36||51
2965305|NCT00768989|3679359|FG001|NOT COMPLETED|On or After Week 36||27
2965306|NCT00769015|3679369|FG000|STARTED|Overall Study||96
2965307|NCT00769015|3679370|FG001|STARTED|Overall Study||92
2965308|NCT00769015|3679369|FG000|COMPLETED|Overall Study||87
2965309|NCT00769015|3679370|FG001|COMPLETED|Overall Study||76
2965310|NCT00769015|3679369|FG000|NOT COMPLETED|Overall Study||9
2965311|NCT00769015|3679370|FG001|NOT COMPLETED|Overall Study||16
2965312|NCT00769067|3679378|FG000|STARTED|Overall Study||94
2965313|NCT00769067|3679379|FG001|STARTED|Overall Study||94
2965314|NCT00769067|3679378|FG000|Treated|Overall Study||94
2965315|NCT00769067|3679379|FG001|Treated|Overall Study|One participant was not treated: refused treatment for reason other than an adverse event (AE).|93
2965316|NCT00769067|3679378|FG000|COMPLETED|Overall Study||0
2965317|NCT00769067|3679379|FG001|COMPLETED|Overall Study||0
2965318|NCT00769067|3679378|FG000|NOT COMPLETED|Overall Study||94
2965319|NCT00769067|3679379|FG001|NOT COMPLETED|Overall Study||94
2965320|NCT00769119|3679388|FG000|STARTED|Overall Study||22
2965321|NCT00769119|3679389|FG001|STARTED|Overall Study||16
2965322|NCT00769119|3679388|FG000|COMPLETED|Overall Study||20
2965323|NCT00769119|3679389|FG001|COMPLETED|Overall Study||13
2965324|NCT00769119|3679388|FG000|NOT COMPLETED|Overall Study||2
2965325|NCT00769119|3679389|FG001|NOT COMPLETED|Overall Study||3
2965326|NCT00769132|3679395|FG000|STARTED|Period 1||7
2965327|NCT00769132|3679396|FG001|STARTED|Period 1||6
2965328|NCT00769132|3679397|FG002|STARTED|Period 1||6
2965329|NCT00769132|3679398|FG003|STARTED|Period 1||7
2965330|NCT00769132|3679395|FG000|COMPLETED|Period 1||6
2965331|NCT00769132|3679396|FG001|COMPLETED|Period 1||6
2965332|NCT00769132|3679397|FG002|COMPLETED|Period 1||6
2965333|NCT00769132|3679398|FG003|COMPLETED|Period 1||6
2965334|NCT00769132|3679395|FG000|NOT COMPLETED|Period 1||1
2965335|NCT00769132|3679396|FG001|NOT COMPLETED|Period 1||0
2965336|NCT00769132|3679397|FG002|NOT COMPLETED|Period 1||0
2965337|NCT00769132|3679398|FG003|NOT COMPLETED|Period 1||1
2965338|NCT00769132|3679395|FG000|STARTED|Period 2||6
2965339|NCT00769132|3679396|FG001|STARTED|Period 2||6
2965340|NCT00769132|3679397|FG002|STARTED|Period 2||6
2965341|NCT00769132|3679398|FG003|STARTED|Period 2||6
2965342|NCT00769132|3679395|FG000|COMPLETED|Period 2||6
2965343|NCT00769132|3679396|FG001|COMPLETED|Period 2||6
2965344|NCT00769132|3679397|FG002|COMPLETED|Period 2||6
2965345|NCT00769132|3679398|FG003|COMPLETED|Period 2||5
2965346|NCT00769132|3679395|FG000|NOT COMPLETED|Period 2||0
2965347|NCT00769132|3679396|FG001|NOT COMPLETED|Period 2||0
2965348|NCT00769132|3679397|FG002|NOT COMPLETED|Period 2||0
2965349|NCT00769132|3679398|FG003|NOT COMPLETED|Period 2||1
2965350|NCT00769132|3679395|FG000|STARTED|Period 3||6
2965351|NCT00769132|3679396|FG001|STARTED|Period 3||6
2965352|NCT00769132|3679397|FG002|STARTED|Period 3||6
2965353|NCT00769132|3679398|FG003|STARTED|Period 3||5
2965354|NCT00769132|3679395|FG000|COMPLETED|Period 3||5
2965355|NCT00769132|3679396|FG001|COMPLETED|Period 3||6
3301913|NCT02956616|4035552|FG001|STARTED|Overall Study||60
3301914|NCT02956616|4035551|FG000|COMPLETED|Overall Study||58
3301915|NCT02956616|4035552|FG001|COMPLETED|Overall Study||60
3301916|NCT02956616|4035551|FG000|NOT COMPLETED|Overall Study||0
3301917|NCT02956616|4035552|FG001|NOT COMPLETED|Overall Study||0
3301918|NCT02956629|4035564|FG000|STARTED|Overall Study||78
3301919|NCT02956629|4035565|FG001|STARTED|Overall Study||47
3301920|NCT02956629|4035566|FG002|STARTED|Overall Study||61
3301921|NCT02956629|4035567|FG003|STARTED|Overall Study||56
3301922|NCT02956629|4035568|FG004|STARTED|Overall Study||18
3301923|NCT02956629|4035569|FG005|STARTED|Overall Study||22
3301924|NCT02956629|4035564|FG000|COMPLETED|Overall Study||73
3301925|NCT02956629|4035565|FG001|COMPLETED|Overall Study||41
3301926|NCT02956629|4035566|FG002|COMPLETED|Overall Study||57
3301927|NCT02956629|4035567|FG003|COMPLETED|Overall Study||55
3301928|NCT02956629|4035568|FG004|COMPLETED|Overall Study||18
3301929|NCT02956629|4035569|FG005|COMPLETED|Overall Study||21
3301930|NCT02956629|4035564|FG000|NOT COMPLETED|Overall Study||5
3301931|NCT02956629|4035565|FG001|NOT COMPLETED|Overall Study||6
3301932|NCT02956629|4035566|FG002|NOT COMPLETED|Overall Study||4
3301933|NCT02956629|4035567|FG003|NOT COMPLETED|Overall Study||1
3301934|NCT02956629|4035568|FG004|NOT COMPLETED|Overall Study||0
3301935|NCT02956629|4035569|FG005|NOT COMPLETED|Overall Study||1
3301936|NCT02956746|4035587|FG000|STARTED|Overall Study||40
3301937|NCT02956746|4035588|FG001|STARTED|Overall Study||40
3301938|NCT02956746|4035589|FG002|STARTED|Overall Study||42
3301939|NCT02956746|4035590|FG003|STARTED|Overall Study||42
3301940|NCT02956746|4035587|FG000|COMPLETED|Overall Study||38
3301941|NCT02956746|4035588|FG001|COMPLETED|Overall Study||37
3301942|NCT02956746|4035589|FG002|COMPLETED|Overall Study||36
3301943|NCT02956746|4035590|FG003|COMPLETED|Overall Study||38
3301944|NCT02956746|4035587|FG000|NOT COMPLETED|Overall Study||2
3301945|NCT02956746|4035588|FG001|NOT COMPLETED|Overall Study||3
3301946|NCT02956746|4035589|FG002|NOT COMPLETED|Overall Study||6
3301947|NCT02956746|4035590|FG003|NOT COMPLETED|Overall Study||4
3301948|NCT02956837|4035605|FG000|STARTED|Overall Study||100
3301949|NCT02956837|4035606|FG001|STARTED|Overall Study||99
3301950|NCT02956837|4035607|FG002|STARTED|Overall Study||99
3301951|NCT02956837|4035608|FG003|STARTED|Overall Study||102
3301952|NCT02956837|4035605|FG000|COMPLETED|Overall Study||100
3301953|NCT02956837|4035606|FG001|COMPLETED|Overall Study||96
3301954|NCT02956837|4035607|FG002|COMPLETED|Overall Study||97
3301955|NCT02956837|4035608|FG003|COMPLETED|Overall Study||99
3301956|NCT02956837|4035605|FG000|NOT COMPLETED|Overall Study||0
3301957|NCT02956837|4035606|FG001|NOT COMPLETED|Overall Study||3
3301958|NCT02956837|4035607|FG002|NOT COMPLETED|Overall Study||2
3301959|NCT02956837|4035608|FG003|NOT COMPLETED|Overall Study||3
3301960|NCT02956967|4035621|FG000|STARTED|Overall Study||171
3301961|NCT02956967|4035621|FG000|COMPLETED|Overall Study||123
3301962|NCT02956967|4035621|FG000|NOT COMPLETED|Overall Study||48
2965356|NCT00769132|3679397|FG002|COMPLETED|Period 3||6
2965357|NCT00769132|3679398|FG003|COMPLETED|Period 3||5
2965358|NCT00769132|3679395|FG000|NOT COMPLETED|Period 3||1
2965359|NCT00769132|3679396|FG001|NOT COMPLETED|Period 3||0
2965360|NCT00769132|3679397|FG002|NOT COMPLETED|Period 3||0
2965361|NCT00769132|3679398|FG003|NOT COMPLETED|Period 3||0
2965362|NCT00769132|3679395|FG000|STARTED|Period 4||5
2965363|NCT00769132|3679396|FG001|STARTED|Period 4||6
2965364|NCT00769132|3679397|FG002|STARTED|Period 4||6
2965365|NCT00769132|3679398|FG003|STARTED|Period 4||5
2965366|NCT00769132|3679395|FG000|COMPLETED|Period 4||5
2965367|NCT00769132|3679396|FG001|COMPLETED|Period 4||5
2965368|NCT00769132|3679397|FG002|COMPLETED|Period 4||6
2965369|NCT00769132|3679398|FG003|COMPLETED|Period 4||5
2965370|NCT00769132|3679395|FG000|NOT COMPLETED|Period 4||0
2965371|NCT00769132|3679396|FG001|NOT COMPLETED|Period 4||1
2965372|NCT00769132|3679397|FG002|NOT COMPLETED|Period 4||0
2965373|NCT00769132|3679398|FG003|NOT COMPLETED|Period 4||0
2965374|NCT00769184|3679408|FG000|STARTED|Corticosteroid + LCD/ +Placebo (2 Weeks)||7
2965375|NCT00769184|3679409|FG001|STARTED|Corticosteroid + LCD/ +Placebo (2 Weeks)||8
2965376|NCT00769184|3679408|FG000|COMPLETED|Corticosteroid + LCD/ +Placebo (2 Weeks)||6
2965377|NCT00769184|3679409|FG001|COMPLETED|Corticosteroid + LCD/ +Placebo (2 Weeks)||7
2965378|NCT00769184|3679408|FG000|NOT COMPLETED|Corticosteroid + LCD/ +Placebo (2 Weeks)||1
2965379|NCT00769184|3679409|FG001|NOT COMPLETED|Corticosteroid + LCD/ +Placebo (2 Weeks)||1
3301963|NCT02957123|4035625|FG000|STARTED|Overall Study||30
3301964|NCT02957123|4035625|FG000|COMPLETED|Overall Study||30
2965380|NCT00769184|3679408|FG000|STARTED|+LCD / +Placebo Only (4 Weeks)||6
3301965|NCT02957123|4035625|FG000|NOT COMPLETED|Overall Study||0
3301966|NCT02957136|4035631|FG000|STARTED|Overall Study||95
3301967|NCT02957136|4035632|FG001|STARTED|Overall Study||99
2965381|NCT00769184|3679409|FG001|STARTED|+LCD / +Placebo Only (4 Weeks)||7
2965382|NCT00769184|3679408|FG000|COMPLETED|+LCD / +Placebo Only (4 Weeks)||6
2965383|NCT00769184|3679409|FG001|COMPLETED|+LCD / +Placebo Only (4 Weeks)||7
2965384|NCT00769184|3679408|FG000|NOT COMPLETED|+LCD / +Placebo Only (4 Weeks)||0
2965385|NCT00769184|3679409|FG001|NOT COMPLETED|+LCD / +Placebo Only (4 Weeks)||0
2965386|NCT00769184|3679408|FG000|STARTED|No Treatment (6 Weeks)||6
2965387|NCT00769184|3679409|FG001|STARTED|No Treatment (6 Weeks)||7
2965388|NCT00769184|3679408|FG000|COMPLETED|No Treatment (6 Weeks)||5
2965389|NCT00769184|3679409|FG001|COMPLETED|No Treatment (6 Weeks)||6
2965390|NCT00769184|3679408|FG000|NOT COMPLETED|No Treatment (6 Weeks)||1
2965391|NCT00769184|3679409|FG001|NOT COMPLETED|No Treatment (6 Weeks)||1
2965392|NCT00769314|3679419|FG000|STARTED|Overall Study|The number of participants started is defined as those that were randomized and received treatment.|378
2965393|NCT00769314|3679420|FG001|STARTED|Overall Study|The number of participants started is defined as those that were randomized and received treatment.|397
2965394|NCT00769314|3679419|FG000|COMPLETED|Overall Study||361
2965395|NCT00769314|3679420|FG001|COMPLETED|Overall Study||384
2965396|NCT00769314|3679419|FG000|NOT COMPLETED|Overall Study||17
2965397|NCT00769314|3679420|FG001|NOT COMPLETED|Overall Study||13
2965398|NCT00769392|3679426|FG000|STARTED|Overall Study||28
2965399|NCT00769392|3679426|FG000|COMPLETED|Overall Study||24
2965400|NCT00769392|3679426|FG000|NOT COMPLETED|Overall Study||4
2965401|NCT00769483|3679436|FG000|STARTED|Overall Study||9
2965402|NCT00769483|3679437|FG001|STARTED|Overall Study||13
2965403|NCT00769483|3679438|FG002|STARTED|Overall Study||15
2965404|NCT00769483|3679439|FG003|STARTED|Overall Study||15
2965405|NCT00769483|3679440|FG004|STARTED|Overall Study||16
2965406|NCT00769483|3679441|FG005|STARTED|Overall Study||9
2965407|NCT00769483|3679436|FG000|COMPLETED|Overall Study||9
2965408|NCT00769483|3679437|FG001|COMPLETED|Overall Study||12
2965409|NCT00769483|3679438|FG002|COMPLETED|Overall Study||15
2965410|NCT00769483|3679439|FG003|COMPLETED|Overall Study||15
2965411|NCT00769483|3679440|FG004|COMPLETED|Overall Study||15
2965412|NCT00769483|3679441|FG005|COMPLETED|Overall Study||9
2965413|NCT00769483|3679436|FG000|NOT COMPLETED|Overall Study||0
2965414|NCT00769483|3679437|FG001|NOT COMPLETED|Overall Study||1
2965415|NCT00769483|3679438|FG002|NOT COMPLETED|Overall Study||0
2965416|NCT00769483|3679439|FG003|NOT COMPLETED|Overall Study||0
2965417|NCT00769483|3679440|FG004|NOT COMPLETED|Overall Study||1
2965418|NCT00769483|3679441|FG005|NOT COMPLETED|Overall Study||0
2965419|NCT00769561|3679459|FG000|STARTED|Overall Study||29
2965420|NCT00769561|3679460|FG001|STARTED|Overall Study||29
3133071|NCT01694485|3858199|FG001|Completed Week 8 Assessment|Overall Study||18
3133072|NCT01694485|3858200|FG002|Completed Week 8 Assessment|Overall Study||38
3133073|NCT01694485|3858201|FG003|Completed Week 8 Assessment|Overall Study||94
3133074|NCT01694485|3858202|FG004|Completed Week 8 Assessment|Overall Study||76
3133075|NCT01694485|3858198|FG000|Entered Open-label Period|Overall Study||100
3133076|NCT01694485|3858199|FG001|Entered Open-label Period|Overall Study||19
3133077|NCT01694485|3858200|FG002|Entered Open-label Period|Overall Study||36
3133078|NCT01694485|3858201|FG003|Entered Open-label Period|Overall Study||88
3133079|NCT01694485|3858202|FG004|Entered Open-label Period|Overall Study||68
3133080|NCT01694485|3858198|FG000|COMPLETED|Overall Study||84
2965421|NCT00769561|3679459|FG000|COMPLETED|Overall Study||26
2965422|NCT00769561|3679460|FG001|COMPLETED|Overall Study||24
2965423|NCT00769561|3679459|FG000|NOT COMPLETED|Overall Study||3
2965424|NCT00769561|3679460|FG001|NOT COMPLETED|Overall Study||5
2965425|NCT00769600|3679468|FG000|STARTED|Overall Study||15
2965426|NCT00769600|3679469|FG001|STARTED|Overall Study||8
2965427|NCT00769600|3679468|FG000|COMPLETED|Overall Study||15
2965428|NCT00769600|3679469|FG001|COMPLETED|Overall Study||8
2965429|NCT00769600|3679468|FG000|NOT COMPLETED|Overall Study||0
2965430|NCT00769600|3679469|FG001|NOT COMPLETED|Overall Study||0
2965431|NCT00769704|3679480|FG000|STARTED|Overall Study||141
2965432|NCT00769704|3679481|FG001|STARTED|Overall Study||296
2965433|NCT00769704|3679480|FG000|Intent-to-treat Population|Overall Study|All participants who were randomized once to study treatment|141
2965434|NCT00769704|3679481|FG001|Intent-to-treat Population|Overall Study|Participants who were randomized once to study treatment; excludes 1 participant randomized 3 times|295
2965435|NCT00769704|3679480|FG000|Received Treatment|Overall Study||127
2965436|NCT00769704|3679481|FG001|Received Treatment|Overall Study||292
2965437|NCT00769704|3679480|FG000|COMPLETED|Overall Study||30
2965438|NCT00769704|3679481|FG001|COMPLETED|Overall Study||97
2965439|NCT00769704|3679480|FG000|NOT COMPLETED|Overall Study||111
2965440|NCT00769704|3679481|FG001|NOT COMPLETED|Overall Study||199
2965441|NCT00769808|3679488|FG000|STARTED|Overall Study||72
2965442|NCT00769808|3679488|FG000|COMPLETED|Overall Study||64
2965443|NCT00769808|3679488|FG000|NOT COMPLETED|Overall Study||8
2965444|NCT00769860|3679494|FG000|STARTED|Overall Study||16
2965445|NCT00769860|3679495|FG001|STARTED|Overall Study||8
2965446|NCT00769860|3679494|FG000|Month 4|Overall Study||16
2965447|NCT00769860|3679495|FG001|Month 4|Overall Study||8
2965448|NCT00769860|3679494|FG000|Month 8|Overall Study||14
2965449|NCT00769860|3679495|FG001|Month 8|Overall Study||8
2965450|NCT00769860|3679494|FG000|COMPLETED|Overall Study||14
2965451|NCT00769860|3679495|FG001|COMPLETED|Overall Study||8
2965452|NCT00769860|3679494|FG000|NOT COMPLETED|Overall Study||2
2965453|NCT00769860|3679495|FG001|NOT COMPLETED|Overall Study||0
2965454|NCT00769886|3679505|FG000|STARTED|Overall Study||36
2965455|NCT00769886|3679506|FG001|STARTED|Overall Study||36
2965456|NCT00769886|3679507|FG002|STARTED|Overall Study||35
2965457|NCT00769886|3679508|FG003|STARTED|Overall Study||37
2965458|NCT00769886|3679505|FG000|COMPLETED|Overall Study||31
2965459|NCT00769886|3679506|FG001|COMPLETED|Overall Study||32
2965460|NCT00769886|3679507|FG002|COMPLETED|Overall Study||34
2965461|NCT00769886|3679508|FG003|COMPLETED|Overall Study||35
2965462|NCT00769886|3679505|FG000|NOT COMPLETED|Overall Study||5
2965463|NCT00769886|3679506|FG001|NOT COMPLETED|Overall Study||4
2965464|NCT00769886|3679507|FG002|NOT COMPLETED|Overall Study||1
2965465|NCT00769886|3679508|FG003|NOT COMPLETED|Overall Study||2
2965466|NCT00770029|3679520|FG000|STARTED|Overall Study||184
2965467|NCT00770029|3679521|FG001|STARTED|Overall Study||92
2965468|NCT00770029|3679520|FG000|COMPLETED|Overall Study||178
2965469|NCT00770029|3679521|FG001|COMPLETED|Overall Study||89
2965470|NCT00770029|3679520|FG000|NOT COMPLETED|Overall Study||6
2965471|NCT00770029|3679521|FG001|NOT COMPLETED|Overall Study||3
2965472|NCT00770120|3679527|FG000|STARTED|Overall Study||61
2965473|NCT00770120|3679527|FG000|Eligible|Overall Study||60
2965474|NCT00770120|3679527|FG000|Not Analyzable|Overall Study||1
2965475|NCT00770120|3679527|FG000|COMPLETED|Overall Study||0
2965476|NCT00770120|3679527|FG000|NOT COMPLETED|Overall Study||61
2965477|NCT00770133|3679536|FG000|STARTED|Overall Study||35
2965478|NCT00770133|3679537|FG001|STARTED|Overall Study||36
2965479|NCT00770133|3679538|FG002|STARTED|Overall Study||35
2965480|NCT00770133|3679539|FG003|STARTED|Overall Study||35
2965481|NCT00770133|3679536|FG000|COMPLETED|Overall Study||32
2965482|NCT00770133|3679537|FG001|COMPLETED|Overall Study||35
2965483|NCT00770133|3679538|FG002|COMPLETED|Overall Study||32
2965484|NCT00770133|3679539|FG003|COMPLETED|Overall Study||32
2965485|NCT00770133|3679536|FG000|NOT COMPLETED|Overall Study||3
2965486|NCT00770133|3679537|FG001|NOT COMPLETED|Overall Study||1
2965487|NCT00770133|3679538|FG002|NOT COMPLETED|Overall Study||3
2965488|NCT00770133|3679539|FG003|NOT COMPLETED|Overall Study||3
2965489|NCT00770146|3679551|FG000|STARTED|Treatment Period||53
2965490|NCT00770146|3679552|FG001|STARTED|Treatment Period||105
2965491|NCT00770146|3679551|FG000|Treated|Treatment Period||52
2965492|NCT00770146|3679552|FG001|Treated|Treatment Period||105
2965493|NCT00770146|3679551|FG000|Full Analysis Set|Treatment Period|Treated patients with a valid baseline & post-baseline LDL-C measurement|50
2965494|NCT00770146|3679552|FG001|Full Analysis Set|Treatment Period|Treated patients with a valid baseline & post-baseline LDL-C measurement|101
2965495|NCT00770146|3679551|FG000|COMPLETED|Treatment Period||44
2965496|NCT00770146|3679552|FG001|COMPLETED|Treatment Period||60
2965497|NCT00770146|3679551|FG000|NOT COMPLETED|Treatment Period||9
2965498|NCT00770146|3679552|FG001|NOT COMPLETED|Treatment Period||45
2965499|NCT00770146|3679551|FG000|STARTED|Follow-up Period||53
2965500|NCT00770146|3679552|FG001|STARTED|Follow-up Period||105
2965501|NCT00770146|3679551|FG000|COMPLETED|Follow-up Period||42
2965502|NCT00770146|3679552|FG001|COMPLETED|Follow-up Period||85
2965503|NCT00770146|3679551|FG000|NOT COMPLETED|Follow-up Period||11
2965504|NCT00770146|3679552|FG001|NOT COMPLETED|Follow-up Period||20
2965505|NCT00770211|3679560|FG000|STARTED|Overall Study||182
2965506|NCT00770211|3679561|FG001|STARTED|Overall Study||89
2965507|NCT00770211|3679560|FG000|COMPLETED|Overall Study||181
2965508|NCT00770211|3679561|FG001|COMPLETED|Overall Study||87
2965509|NCT00770211|3679560|FG000|NOT COMPLETED|Overall Study||1
2965510|NCT00770211|3679561|FG001|NOT COMPLETED|Overall Study||2
2965511|NCT00770224|3679567|FG000|STARTED|Step 1: Induction||87
2965512|NCT00770224|3679568|FG001|STARTED|Step 1: Induction||0
2965513|NCT00770224|3679567|FG000|Eligible and Evaluable|Step 1: Induction||84
2965514|NCT00770224|3679568|FG001|Eligible and Evaluable|Step 1: Induction||0
2965515|NCT00770224|3679567|FG000|COMPLETED|Step 1: Induction||73
2965516|NCT00770224|3679568|FG001|COMPLETED|Step 1: Induction||0
2965517|NCT00770224|3679567|FG000|NOT COMPLETED|Step 1: Induction||14
2965518|NCT00770224|3679568|FG001|NOT COMPLETED|Step 1: Induction||0
3163916|NCT01889862|3891339|FG002|NOT COMPLETED|Part 3A/B (6 Week)||0
3163917|NCT01889862|3891340|FG003|NOT COMPLETED|Part 3A/B (6 Week)||0
3163918|NCT01889862|3891341|FG004|NOT COMPLETED|Part 3A/B (6 Week)||0
3163919|NCT01889862|3891337|FG000|STARTED|Part 4 (Up to 274 Weeks)|51, 57, 5 and 89 subjects from 165-301, 165-302 Part 1, 2 & 3 entered 165-302 Part 4 respectively.|0
3163920|NCT01889862|3891338|FG001|STARTED|Part 4 (Up to 274 Weeks)||0
2965519|NCT00770224|3679567|FG000|STARTED|Step 2: Maintenance||0
2965520|NCT00770224|3679568|FG001|STARTED|Step 2: Maintenance||71
2965521|NCT00770224|3679567|FG000|Eligible and Evaluable|Step 2: Maintenance||0
2965522|NCT00770224|3679568|FG001|Eligible and Evaluable|Step 2: Maintenance||69
2965523|NCT00770224|3679567|FG000|COMPLETED|Step 2: Maintenance||0
2965524|NCT00770224|3679568|FG001|COMPLETED|Step 2: Maintenance||41
2965525|NCT00770224|3679567|FG000|NOT COMPLETED|Step 2: Maintenance||0
2965526|NCT00770224|3679568|FG001|NOT COMPLETED|Step 2: Maintenance||30
2965527|NCT00770289|3679575|FG000|STARTED|Overall Study||851
2965528|NCT00770289|3679575|FG000|COMPLETED|Overall Study||845
2965529|NCT00770289|3679575|FG000|NOT COMPLETED|Overall Study||6
2965530|NCT00770315|3679588|FG000|STARTED|Overall Study||197
2965531|NCT00770315|3679589|FG001|STARTED|Overall Study||195
2965532|NCT00770315|3679590|FG002|STARTED|Overall Study||194
2965533|NCT00770315|3679591|FG003|STARTED|Overall Study||198
2965534|NCT00770315|3679588|FG000|COMPLETED|Overall Study||157
2965535|NCT00770315|3679589|FG001|COMPLETED|Overall Study||152
2965536|NCT00770315|3679590|FG002|COMPLETED|Overall Study||137
2965537|NCT00770315|3679591|FG003|COMPLETED|Overall Study||160
2965538|NCT00770315|3679588|FG000|NOT COMPLETED|Overall Study||40
2965539|NCT00770315|3679589|FG001|NOT COMPLETED|Overall Study||43
2965540|NCT00770315|3679590|FG002|NOT COMPLETED|Overall Study||57
2965541|NCT00770315|3679591|FG003|NOT COMPLETED|Overall Study||38
2965542|NCT00770328|3679603|FG000|STARTED|Overall Study||22
2965543|NCT00770328|3679604|FG001|STARTED|Overall Study||15
2965544|NCT00770328|3679603|FG000|COMPLETED|Overall Study||9
2965545|NCT00770328|3679604|FG001|COMPLETED|Overall Study||11
2965546|NCT00770328|3679603|FG000|NOT COMPLETED|Overall Study||13
2965547|NCT00770328|3679604|FG001|NOT COMPLETED|Overall Study||4
2965548|NCT00770341|3679613|FG000|STARTED|Overall Study|Number randomized|89
2965549|NCT00770341|3679614|FG001|STARTED|Overall Study|Number randomized|22
2965550|NCT00770341|3679615|FG002|STARTED|Overall Study|Number randomized|11
2965551|NCT00770341|3679613|FG000|COMPLETED|Overall Study||77
2965552|NCT00770341|3679614|FG001|COMPLETED|Overall Study||17
2965553|NCT00770341|3679615|FG002|COMPLETED|Overall Study||8
2965554|NCT00770341|3679613|FG000|NOT COMPLETED|Overall Study||12
2965555|NCT00770341|3679614|FG001|NOT COMPLETED|Overall Study||5
2965556|NCT00770341|3679615|FG002|NOT COMPLETED|Overall Study||3
2965557|NCT00770367|3679626|FG000|STARTED|First Intervention||18
2965558|NCT00770367|3679627|FG001|STARTED|First Intervention||18
2965559|NCT00770367|3679626|FG000|COMPLETED|First Intervention||18
2965560|NCT00770367|3679627|FG001|COMPLETED|First Intervention||16
2965561|NCT00770367|3679626|FG000|NOT COMPLETED|First Intervention||0
2965562|NCT00770367|3679627|FG001|NOT COMPLETED|First Intervention||2
2965563|NCT00770367|3679626|FG000|STARTED|Washout Period of 4 Weeks||18
2965564|NCT00770367|3679627|FG001|STARTED|Washout Period of 4 Weeks||16
2965565|NCT00770367|3679626|FG000|COMPLETED|Washout Period of 4 Weeks||18
2965566|NCT00770367|3679627|FG001|COMPLETED|Washout Period of 4 Weeks||15
2965567|NCT00770367|3679626|FG000|NOT COMPLETED|Washout Period of 4 Weeks||0
2965568|NCT00770367|3679627|FG001|NOT COMPLETED|Washout Period of 4 Weeks||1
2965569|NCT00770367|3679626|FG000|STARTED|Second Intervention||18
2965570|NCT00770367|3679627|FG001|STARTED|Second Intervention||15
2965571|NCT00770367|3679626|FG000|COMPLETED|Second Intervention||16
2965572|NCT00770367|3679627|FG001|COMPLETED|Second Intervention||15
2965573|NCT00770367|3679626|FG000|NOT COMPLETED|Second Intervention||2
2965574|NCT00770367|3679627|FG001|NOT COMPLETED|Second Intervention||0
2965575|NCT00770432|3679637|FG000|STARTED|Overall Study||102
2965576|NCT00770432|3679638|FG001|STARTED|Overall Study||101
2965577|NCT00770432|3679637|FG000|COMPLETED|Overall Study||98
2965578|NCT00770432|3679638|FG001|COMPLETED|Overall Study||94
2965579|NCT00770432|3679637|FG000|NOT COMPLETED|Overall Study||4
2965580|NCT00770432|3679638|FG001|NOT COMPLETED|Overall Study||7
2965581|NCT00770484|3679646|FG000|STARTED|Overall Study||8
2965582|NCT00770484|3679647|FG001|STARTED|Overall Study||4
2965583|NCT00770484|3679646|FG000|COMPLETED|Overall Study||7
2965584|NCT00770484|3679647|FG001|COMPLETED|Overall Study||4
2965585|NCT00770484|3679646|FG000|NOT COMPLETED|Overall Study||1
2965586|NCT00770484|3679647|FG001|NOT COMPLETED|Overall Study||0
2965587|NCT00770510|3679653|FG000|STARTED|Overall Study||72
2965588|NCT00770510|3679653|FG000|COMPLETED|Overall Study||67
2965589|NCT00770510|3679653|FG000|NOT COMPLETED|Overall Study||5
2965590|NCT00770562|3679667|FG000|STARTED|Overall Study||53
2965591|NCT00770562|3679668|FG001|STARTED|Overall Study||50
2965592|NCT00770562|3679667|FG000|COMPLETED|Overall Study||52
2965593|NCT00770562|3679668|FG001|COMPLETED|Overall Study||49
2965594|NCT00770562|3679667|FG000|NOT COMPLETED|Overall Study||1
2965595|NCT00770562|3679668|FG001|NOT COMPLETED|Overall Study||1
2965596|NCT00770588|3679677|FG000|STARTED|Overall Study||148
2965597|NCT00770588|3679678|FG001|STARTED|Overall Study||148
2965598|NCT00770588|3679677|FG000|COMPLETED|Overall Study||67
2965599|NCT00770588|3679678|FG001|COMPLETED|Overall Study||53
2965600|NCT00770588|3679677|FG000|NOT COMPLETED|Overall Study||81
2965601|NCT00770588|3679678|FG001|NOT COMPLETED|Overall Study||95
2965602|NCT00770601|3679685|FG000|STARTED|Overall Study||7
2965603|NCT00770601|3679685|FG000|COMPLETED|Overall Study||6
2965604|NCT00770601|3679685|FG000|NOT COMPLETED|Overall Study||1
2965605|NCT00770653|3679691|FG000|STARTED|Overall Study||155
2965606|NCT00770653|3679692|FG001|STARTED|Overall Study||150
2965607|NCT00770653|3679691|FG000|COMPLETED|Overall Study||123
2965608|NCT00770653|3679692|FG001|COMPLETED|Overall Study||121
2965609|NCT00770653|3679691|FG000|NOT COMPLETED|Overall Study||32
2965610|NCT00770653|3679692|FG001|NOT COMPLETED|Overall Study||29
2965611|NCT00770679|3679698|FG000|STARTED|Overall Study||16
2965612|NCT00770679|3679698|FG000|COMPLETED|Overall Study||10
2965613|NCT00770679|3679698|FG000|NOT COMPLETED|Overall Study||6
2965614|NCT00770692|3679706|FG000|STARTED|Overall Study|"1 participant whose compliance was unknown, was regarded as a treatment compliance unknown"|81
2965615|NCT00770692|3679707|FG001|STARTED|Overall Study||83
2965616|NCT00770692|3679708|FG002|STARTED|Overall Study||84
2965617|NCT00770692|3679709|FG003|STARTED|Overall Study||77
2965618|NCT00770692|3679706|FG000|COMPLETED|Overall Study||69
2965619|NCT00770692|3679707|FG001|COMPLETED|Overall Study||74
2965620|NCT00770692|3679708|FG002|COMPLETED|Overall Study||70
2965621|NCT00770692|3679709|FG003|COMPLETED|Overall Study||66
2965622|NCT00770692|3679706|FG000|NOT COMPLETED|Overall Study||12
2965623|NCT00770692|3679707|FG001|NOT COMPLETED|Overall Study||9
2965624|NCT00770692|3679708|FG002|NOT COMPLETED|Overall Study||14
2965625|NCT00770692|3679709|FG003|NOT COMPLETED|Overall Study||11
2965626|NCT00770757|3679719|FG000|STARTED|Overall Study||13
2965627|NCT00770757|3679719|FG000|COMPLETED|Overall Study||13
2965628|NCT00770757|3679719|FG000|NOT COMPLETED|Overall Study||0
2965629|NCT00770770|3679725|FG000|STARTED|Overall Study||14
2965630|NCT00770770|3679726|FG001|STARTED|Overall Study||6
2965631|NCT00770770|3679725|FG000|COMPLETED|Overall Study||4
2965632|NCT00770770|3679726|FG001|COMPLETED|Overall Study||5
2965633|NCT00770770|3679725|FG000|NOT COMPLETED|Overall Study||10
2965634|NCT00770770|3679726|FG001|NOT COMPLETED|Overall Study||1
2965635|NCT00770809|3679735|FG000|STARTED|Overall Study||118
2965636|NCT00770809|3679736|FG001|STARTED|Overall Study||120
2965637|NCT00770809|3679737|FG002|STARTED|Overall Study||67
2965638|NCT00770809|3679735|FG000|COMPLETED|Overall Study||101
2965639|NCT00770809|3679736|FG001|COMPLETED|Overall Study||110
2965640|NCT00770809|3679737|FG002|COMPLETED|Overall Study||44
2965641|NCT00770809|3679735|FG000|NOT COMPLETED|Overall Study||17
2965642|NCT00770809|3679736|FG001|NOT COMPLETED|Overall Study||10
2965643|NCT00770809|3679737|FG002|NOT COMPLETED|Overall Study||23
2965644|NCT00770861|3679747|FG000|STARTED|Overall Study||141
2965645|NCT00770861|3679748|FG001|STARTED|Overall Study||136
2965646|NCT00770861|3679747|FG000|COMPLETED|Overall Study||131
2965647|NCT00770861|3679748|FG001|COMPLETED|Overall Study||120
2965648|NCT00770861|3679747|FG000|NOT COMPLETED|Overall Study||10
2965649|NCT00770861|3679748|FG001|NOT COMPLETED|Overall Study||16
2965650|NCT00770874|3679756|FG000|STARTED|Overall Study||188
2965651|NCT00770874|3679757|FG001|STARTED|Overall Study||176
2965652|NCT00770874|3679756|FG000|COMPLETED|Overall Study||188
2965653|NCT00770874|3679757|FG001|COMPLETED|Overall Study||176
2965654|NCT00770874|3679756|FG000|NOT COMPLETED|Overall Study||0
2965655|NCT00770874|3679757|FG001|NOT COMPLETED|Overall Study||0
2965656|NCT00770913|3679766|FG000|STARTED|Overall Study||113
2965657|NCT00770913|3679767|FG001|STARTED|Overall Study||111
2965658|NCT00770913|3679768|FG002|STARTED|Overall Study||113
2965659|NCT00770913|3679766|FG000|COMPLETED|Overall Study||102
2965660|NCT00770913|3679767|FG001|COMPLETED|Overall Study||103
2965661|NCT00770913|3679768|FG002|COMPLETED|Overall Study||100
2965662|NCT00770913|3679766|FG000|NOT COMPLETED|Overall Study||11
2965663|NCT00770913|3679767|FG001|NOT COMPLETED|Overall Study||8
2965664|NCT00770913|3679768|FG002|NOT COMPLETED|Overall Study||13
2965665|NCT00770991|3679778|FG000|STARTED|Overall Study|34 participants enrolled (signed informed consent). 24 subjects were eligible to be randomized.|12
2965666|NCT00770991|3679779|FG001|STARTED|Overall Study|We anticipated 26-30 subjects with FAP 18 year or olders would need to be enrolled to randomize 18|12
2965667|NCT00770991|3679778|FG000|COMPLETED|Overall Study|7 subjects completed 36 weeks (+/- 10 days)of treatment|7
2965668|NCT00770991|3679779|FG001|COMPLETED|Overall Study|7 subjects completed 36 weeks (+/- 10 days)of treatment|7
2965669|NCT00770991|3679778|FG000|NOT COMPLETED|Overall Study||5
2965670|NCT00770991|3679779|FG001|NOT COMPLETED|Overall Study||5
2965671|NCT00771030|3679797|FG000|STARTED|Overall Study||6
2965672|NCT00771030|3679798|FG001|STARTED|Overall Study||4
2965673|NCT00771030|3679799|FG002|STARTED|Overall Study||6
2965674|NCT00771030|3679800|FG003|STARTED|Overall Study||6
2965675|NCT00771030|3679801|FG004|STARTED|Overall Study||6
2965676|NCT00771030|3679802|FG005|STARTED|Overall Study||6
2965677|NCT00771030|3679803|FG006|STARTED|Overall Study||6
2965678|NCT00771030|3679797|FG000|Received Study Drug|Overall Study||6
2965679|NCT00771030|3679798|FG001|Received Study Drug|Overall Study||4
2965680|NCT00771030|3679799|FG002|Received Study Drug|Overall Study||6
2965681|NCT00771030|3679800|FG003|Received Study Drug|Overall Study||6
2965682|NCT00771030|3679801|FG004|Received Study Drug|Overall Study||6
2965683|NCT00771030|3679802|FG005|Received Study Drug|Overall Study||6
2965684|NCT00771030|3679803|FG006|Received Study Drug|Overall Study||6
2965685|NCT00771030|3679797|FG000|COMPLETED|Overall Study||6
2965686|NCT00771030|3679798|FG001|COMPLETED|Overall Study||3
2965687|NCT00771030|3679799|FG002|COMPLETED|Overall Study||6
2965688|NCT00771030|3679800|FG003|COMPLETED|Overall Study||6
2965689|NCT00771030|3679801|FG004|COMPLETED|Overall Study||6
2965690|NCT00771030|3679802|FG005|COMPLETED|Overall Study||6
2965691|NCT00771030|3679803|FG006|COMPLETED|Overall Study||6
2965692|NCT00771030|3679797|FG000|NOT COMPLETED|Overall Study||0
2965693|NCT00771030|3679798|FG001|NOT COMPLETED|Overall Study||1
2965694|NCT00771030|3679799|FG002|NOT COMPLETED|Overall Study||0
2965695|NCT00771030|3679800|FG003|NOT COMPLETED|Overall Study||0
2965696|NCT00771030|3679801|FG004|NOT COMPLETED|Overall Study||0
2965697|NCT00771030|3679802|FG005|NOT COMPLETED|Overall Study||0
2965698|NCT00771030|3679803|FG006|NOT COMPLETED|Overall Study||0
2965699|NCT00771056|3679824|FG000|STARTED|Overall Study||23
2965700|NCT00771056|3679824|FG000|COMPLETED|Overall Study||18
2965701|NCT00771056|3679824|FG000|NOT COMPLETED|Overall Study||5
2965702|NCT00771173|3679830|FG000|STARTED|Overall Study||129
2965703|NCT00771173|3679831|FG001|STARTED|Overall Study||129
2965704|NCT00771173|3679830|FG000|COMPLETED|Overall Study||107
2965705|NCT00771173|3679831|FG001|COMPLETED|Overall Study||112
2965706|NCT00771173|3679830|FG000|NOT COMPLETED|Overall Study||22
2965707|NCT00771173|3679831|FG001|NOT COMPLETED|Overall Study||17
2965708|NCT00771238|3679839|FG000|STARTED|Overall Study||31
2965709|NCT00771238|3679840|FG001|STARTED|Overall Study||21
2965710|NCT00771238|3679839|FG000|COMPLETED|Overall Study||31
2965711|NCT00771238|3679840|FG001|COMPLETED|Overall Study||21
2965712|NCT00771238|3679839|FG000|NOT COMPLETED|Overall Study||0
2965713|NCT00771238|3679840|FG001|NOT COMPLETED|Overall Study||0
2965714|NCT00771264|3679848|FG000|STARTED|Overall Study||110
2965715|NCT00771264|3679849|FG001|STARTED|Overall Study||110
2965716|NCT00771264|3679848|FG000|COMPLETED|Overall Study||103
2965717|NCT00771264|3679849|FG001|COMPLETED|Overall Study||105
2965718|NCT00771264|3679848|FG000|NOT COMPLETED|Overall Study||7
2965719|NCT00771264|3679849|FG001|NOT COMPLETED|Overall Study||5
2965720|NCT00771277|3679855|FG000|STARTED|Overall Study||6
2965721|NCT00771277|3679855|FG000|COMPLETED|Overall Study||6
2965722|NCT00771277|3679855|FG000|NOT COMPLETED|Overall Study||0
2965723|NCT00771407|3679861|FG000|STARTED|Overall Study||60
2965724|NCT00771407|3679862|FG001|STARTED|Overall Study||60
2965725|NCT00771407|3679861|FG000|COMPLETED|Overall Study||40
2965726|NCT00771407|3679862|FG001|COMPLETED|Overall Study||35
2965727|NCT00771407|3679861|FG000|NOT COMPLETED|Overall Study||20
2965728|NCT00771407|3679862|FG001|NOT COMPLETED|Overall Study||25
2965729|NCT00771472|3679868|FG000|STARTED|Overall Study||6
2965730|NCT00771472|3679869|FG001|STARTED|Overall Study||4
2965731|NCT00771472|3679868|FG000|COMPLETED|Overall Study||0
2965732|NCT00771472|3679869|FG001|COMPLETED|Overall Study||0
2965733|NCT00771472|3679868|FG000|NOT COMPLETED|Overall Study||6
2965734|NCT00771472|3679869|FG001|NOT COMPLETED|Overall Study||4
2965735|NCT00771537|3679890|FG000|STARTED|Overall Study||135
2965736|NCT00771537|3679891|FG001|STARTED|Overall Study||124
2965737|NCT00771537|3679892|FG002|STARTED|Overall Study||151
2965738|NCT00771537|3679893|FG003|STARTED|Overall Study||114
2965739|NCT00771537|3679894|FG004|STARTED|Overall Study||127
2965740|NCT00771537|3679895|FG005|STARTED|Overall Study||118
2965741|NCT00771537|3679896|FG006|STARTED|Overall Study||128
2965742|NCT00771537|3679897|FG007|STARTED|Overall Study||132
2965743|NCT00771537|3679898|FG008|STARTED|Overall Study||115
2965744|NCT00771537|3679899|FG009|STARTED|Overall Study||119
2965745|NCT00771537|3679900|FG010|STARTED|Overall Study||133
2965746|NCT00771537|3679901|FG011|STARTED|Overall Study||137
2965747|NCT00771537|3679902|FG012|STARTED|Overall Study||128
2965748|NCT00771537|3679903|FG013|STARTED|Overall Study||124
2965749|NCT00771537|3679904|FG014|STARTED|Overall Study||124
2965750|NCT00771537|3679905|FG015|STARTED|Overall Study||122
2965751|NCT00771537|3679890|FG000|COMPLETED|Overall Study||135
2965752|NCT00771537|3679891|FG001|COMPLETED|Overall Study||124
2965753|NCT00771537|3679892|FG002|COMPLETED|Overall Study||151
2965754|NCT00771537|3679893|FG003|COMPLETED|Overall Study||114
2965755|NCT00771537|3679894|FG004|COMPLETED|Overall Study||127
2965756|NCT00771537|3679895|FG005|COMPLETED|Overall Study||118
2965757|NCT00771537|3679896|FG006|COMPLETED|Overall Study||128
2965758|NCT00771537|3679897|FG007|COMPLETED|Overall Study||132
2965759|NCT00771537|3679898|FG008|COMPLETED|Overall Study||115
2965760|NCT00771537|3679899|FG009|COMPLETED|Overall Study||119
2965761|NCT00771537|3679900|FG010|COMPLETED|Overall Study||133
2965762|NCT00771537|3679901|FG011|COMPLETED|Overall Study||137
2965763|NCT00771537|3679902|FG012|COMPLETED|Overall Study||128
2965764|NCT00771537|3679903|FG013|COMPLETED|Overall Study||124
2965765|NCT00771537|3679904|FG014|COMPLETED|Overall Study||124
2965766|NCT00771537|3679905|FG015|COMPLETED|Overall Study||122
2965767|NCT00771537|3679890|FG000|NOT COMPLETED|Overall Study||0
2965768|NCT00771537|3679891|FG001|NOT COMPLETED|Overall Study||0
2965769|NCT00771537|3679892|FG002|NOT COMPLETED|Overall Study||0
2965770|NCT00771537|3679893|FG003|NOT COMPLETED|Overall Study||0
2965771|NCT00771537|3679894|FG004|NOT COMPLETED|Overall Study||0
2965772|NCT00771537|3679895|FG005|NOT COMPLETED|Overall Study||0
2965773|NCT00771537|3679896|FG006|NOT COMPLETED|Overall Study||0
2965774|NCT00771537|3679897|FG007|NOT COMPLETED|Overall Study||0
2965775|NCT00771537|3679898|FG008|NOT COMPLETED|Overall Study||0
2965776|NCT00771537|3679899|FG009|NOT COMPLETED|Overall Study||0
2965777|NCT00771537|3679900|FG010|NOT COMPLETED|Overall Study||0
2965778|NCT00771537|3679901|FG011|NOT COMPLETED|Overall Study||0
2965779|NCT00771537|3679902|FG012|NOT COMPLETED|Overall Study||0
2965780|NCT00771537|3679903|FG013|NOT COMPLETED|Overall Study||0
2965781|NCT00771537|3679904|FG014|NOT COMPLETED|Overall Study||0
2965782|NCT00771537|3679905|FG015|NOT COMPLETED|Overall Study||0
2965783|NCT00771615|3679940|FG000|STARTED|Overall Study||49
2965784|NCT00771615|3679941|FG001|STARTED|Overall Study||72
2965785|NCT00771615|3679942|FG002|STARTED|Overall Study||41
2965786|NCT00771615|3679943|FG003|STARTED|Overall Study||60
2965787|NCT00771615|3679944|FG004|STARTED|Overall Study||40
2965788|NCT00771615|3679945|FG005|STARTED|Overall Study||61
2965789|NCT00771615|3679946|FG006|STARTED|Overall Study||46
2965790|NCT00771615|3679947|FG007|STARTED|Overall Study||59
2965791|NCT00771615|3679948|FG008|STARTED|Overall Study||41
2965792|NCT00771615|3679940|FG000|COMPLETED|Overall Study|Up to Day 364|48
2965793|NCT00771615|3679941|FG001|COMPLETED|Overall Study|Up to Day 364|70
2965794|NCT00771615|3679942|FG002|COMPLETED|Overall Study|Up to Day 364|40
2965795|NCT00771615|3679943|FG003|COMPLETED|Overall Study|Up to Day 364|59
2965796|NCT00771615|3679944|FG004|COMPLETED|Overall Study|Up to Day 364|40
2965797|NCT00771615|3679945|FG005|COMPLETED|Overall Study|Up to Day 364|60
2965798|NCT00771615|3679946|FG006|COMPLETED|Overall Study|Up to Day 364|45
2965799|NCT00771615|3679947|FG007|COMPLETED|Overall Study|Up to Day 364|58
2965800|NCT00771615|3679948|FG008|COMPLETED|Overall Study|Up to Day 364|41
2965801|NCT00771615|3679940|FG000|NOT COMPLETED|Overall Study||1
2965802|NCT00771615|3679941|FG001|NOT COMPLETED|Overall Study||2
2965803|NCT00771615|3679942|FG002|NOT COMPLETED|Overall Study||1
2965804|NCT00771615|3679943|FG003|NOT COMPLETED|Overall Study||1
2965805|NCT00771615|3679944|FG004|NOT COMPLETED|Overall Study||0
2965806|NCT00771615|3679945|FG005|NOT COMPLETED|Overall Study||1
2965807|NCT00771615|3679946|FG006|NOT COMPLETED|Overall Study||1
2965808|NCT00771615|3679947|FG007|NOT COMPLETED|Overall Study||1
2965809|NCT00771615|3679948|FG008|NOT COMPLETED|Overall Study||0
2965810|NCT00771667|3679981|FG000|STARTED|Induction Phase||132
2965811|NCT00771667|3679982|FG001|STARTED|Induction Phase||131
2965812|NCT00771667|3679983|FG002|STARTED|Induction Phase||132
2965813|NCT00771667|3679984|FG003|STARTED|Induction Phase||131
2965814|NCT00771667|3679985|FG004|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
2965815|NCT00771667|3679986|FG005|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
2965816|NCT00771667|3679987|FG006|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
2965817|NCT00771667|3679988|FG007|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
2965818|NCT00771667|3679989|FG008|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
2965819|NCT00771667|3679990|FG009|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
2965820|NCT00771667|3679981|FG000|COMPLETED|Induction Phase||113
2965821|NCT00771667|3679982|FG001|COMPLETED|Induction Phase||121
2965822|NCT00771667|3679983|FG002|COMPLETED|Induction Phase||120
2965823|NCT00771667|3679984|FG003|COMPLETED|Induction Phase||123
2965824|NCT00771667|3679985|FG004|COMPLETED|Induction Phase||0
2965825|NCT00771667|3679986|FG005|COMPLETED|Induction Phase||0
2965826|NCT00771667|3679987|FG006|COMPLETED|Induction Phase||0
2965827|NCT00771667|3679988|FG007|COMPLETED|Induction Phase||0
2965828|NCT00771667|3679989|FG008|COMPLETED|Induction Phase||0
2965829|NCT00771667|3679990|FG009|COMPLETED|Induction Phase||0
2965830|NCT00771667|3679981|FG000|NOT COMPLETED|Induction Phase||19
2965831|NCT00771667|3679982|FG001|NOT COMPLETED|Induction Phase||10
2965832|NCT00771667|3679983|FG002|NOT COMPLETED|Induction Phase||12
2965833|NCT00771667|3679984|FG003|NOT COMPLETED|Induction Phase||8
2965834|NCT00771667|3679985|FG004|NOT COMPLETED|Induction Phase||0
2965835|NCT00771667|3679986|FG005|NOT COMPLETED|Induction Phase||0
2965836|NCT00771667|3679987|FG006|NOT COMPLETED|Induction Phase||0
2965837|NCT00771667|3679988|FG007|NOT COMPLETED|Induction Phase||0
2965838|NCT00771667|3679989|FG008|NOT COMPLETED|Induction Phase||0
2965839|NCT00771667|3679990|FG009|NOT COMPLETED|Induction Phase||0
2965840|NCT00771667|3679981|FG000|STARTED|Maintenance Phase|"0 in column indicates this reporting group is not relevant to Maintenance period."|0
2965841|NCT00771667|3679982|FG001|STARTED|Maintenance Phase|"0 in column indicates this reporting group is not relevant to Maintenance period."|0
2965842|NCT00771667|3679983|FG002|STARTED|Maintenance Phase|"0 in column indicates this reporting group is not relevant to Maintenance period."|0
2965843|NCT00771667|3679984|FG003|STARTED|Maintenance Phase|"0 in column indicates this reporting group is not relevant to Maintenance period."|0
2965844|NCT00771667|3679985|FG004|STARTED|Maintenance Phase||28
2965845|NCT00771667|3679986|FG005|STARTED|Maintenance Phase||85
2965846|NCT00771667|3679987|FG006|STARTED|Maintenance Phase||73
2965847|NCT00771667|3679988|FG007|STARTED|Maintenance Phase||72
2965848|NCT00771667|3679989|FG008|STARTED|Maintenance Phase||110
2965849|NCT00771667|3679990|FG009|STARTED|Maintenance Phase||109
2965850|NCT00771667|3679981|FG000|COMPLETED|Maintenance Phase||0
2965851|NCT00771667|3679982|FG001|COMPLETED|Maintenance Phase||0
2965852|NCT00771667|3679983|FG002|COMPLETED|Maintenance Phase||0
2965853|NCT00771667|3679984|FG003|COMPLETED|Maintenance Phase||0
2965854|NCT00771667|3679985|FG004|COMPLETED|Maintenance Phase||26
2965855|NCT00771667|3679986|FG005|COMPLETED|Maintenance Phase||78
2965856|NCT00771667|3679987|FG006|COMPLETED|Maintenance Phase||63
2965857|NCT00771667|3679988|FG007|COMPLETED|Maintenance Phase||67
2965858|NCT00771667|3679989|FG008|COMPLETED|Maintenance Phase||88
2965859|NCT00771667|3679990|FG009|COMPLETED|Maintenance Phase||92
2965860|NCT00771667|3679981|FG000|NOT COMPLETED|Maintenance Phase||0
2965861|NCT00771667|3679982|FG001|NOT COMPLETED|Maintenance Phase||0
2965862|NCT00771667|3679983|FG002|NOT COMPLETED|Maintenance Phase||0
2965863|NCT00771667|3679984|FG003|NOT COMPLETED|Maintenance Phase||0
2965864|NCT00771667|3679985|FG004|NOT COMPLETED|Maintenance Phase||2
2965865|NCT00771667|3679986|FG005|NOT COMPLETED|Maintenance Phase||7
2965866|NCT00771667|3679987|FG006|NOT COMPLETED|Maintenance Phase||10
2965867|NCT00771667|3679988|FG007|NOT COMPLETED|Maintenance Phase||5
2965868|NCT00771667|3679989|FG008|NOT COMPLETED|Maintenance Phase||22
2965869|NCT00771667|3679990|FG009|NOT COMPLETED|Maintenance Phase||17
2965870|NCT00771745|3680010|FG000|STARTED|Overall Study||6
2965871|NCT00771745|3680011|FG001|STARTED|Overall Study||5
2965872|NCT00771745|3680010|FG000|COMPLETED|Overall Study||6
2965873|NCT00771745|3680011|FG001|COMPLETED|Overall Study||5
2965874|NCT00771745|3680010|FG000|NOT COMPLETED|Overall Study||0
2965875|NCT00771745|3680011|FG001|NOT COMPLETED|Overall Study||0
2965876|NCT00771758|3680020|FG000|STARTED|Overall Study||44
2965877|NCT00771758|3680021|FG001|STARTED|Overall Study||43
2965878|NCT00771758|3680022|FG002|STARTED|Overall Study||21
2965879|NCT00771758|3680020|FG000|COMPLETED|Overall Study||36
2965880|NCT00771758|3680021|FG001|COMPLETED|Overall Study||31
2965881|NCT00771758|3680022|FG002|COMPLETED|Overall Study||19
2965882|NCT00771758|3680020|FG000|NOT COMPLETED|Overall Study||8
2965883|NCT00771758|3680021|FG001|NOT COMPLETED|Overall Study||12
2965884|NCT00771758|3680022|FG002|NOT COMPLETED|Overall Study||2
2965885|NCT00771810|3680050|FG000|STARTED|Overall Study||10
2965886|NCT00771810|3680051|FG001|STARTED|Overall Study||11
2965887|NCT00771810|3680052|FG002|STARTED|Overall Study||13
2965888|NCT00771810|3680050|FG000|COMPLETED|Overall Study||5
2965889|NCT00771810|3680051|FG001|COMPLETED|Overall Study||6
2965890|NCT00771810|3680052|FG002|COMPLETED|Overall Study||6
2965891|NCT00771810|3680050|FG000|NOT COMPLETED|Overall Study||5
2965892|NCT00771810|3680051|FG001|NOT COMPLETED|Overall Study||5
2965893|NCT00771810|3680052|FG002|NOT COMPLETED|Overall Study||7
2965894|NCT00771849|3680063|FG000|STARTED|Overall Study||52
2965895|NCT00771849|3680064|FG001|STARTED|Overall Study|One subject was not vaccinated|51
2965896|NCT00771849|3680063|FG000|COMPLETED|Overall Study||50
2965897|NCT00771849|3680064|FG001|COMPLETED|Overall Study||47
2965898|NCT00771849|3680063|FG000|NOT COMPLETED|Overall Study||2
2965899|NCT00771849|3680064|FG001|NOT COMPLETED|Overall Study||4
2965900|NCT00771875|3680073|FG000|STARTED|Overall Study||10
2965901|NCT00771875|3680074|FG001|STARTED|Overall Study||10
2965902|NCT00771875|3680075|FG002|STARTED|Overall Study||10
2965903|NCT00771875|3680073|FG000|COMPLETED|Overall Study||10
2965904|NCT00771875|3680074|FG001|COMPLETED|Overall Study||9
2965905|NCT00771875|3680075|FG002|COMPLETED|Overall Study||10
2965906|NCT00771875|3680073|FG000|NOT COMPLETED|Overall Study||0
2965907|NCT00771875|3680074|FG001|NOT COMPLETED|Overall Study||1
2965908|NCT00771875|3680075|FG002|NOT COMPLETED|Overall Study||0
2965909|NCT00771901|3680086|FG000|STARTED|Overall Study||10
2965910|NCT00771901|3680087|FG001|STARTED|Overall Study||10
2965911|NCT00771901|3680088|FG002|STARTED|Overall Study||10
2965912|NCT00771901|3680086|FG000|COMPLETED|Overall Study||10
2965913|NCT00771901|3680087|FG001|COMPLETED|Overall Study||10
2965914|NCT00771901|3680088|FG002|COMPLETED|Overall Study||6
2965915|NCT00771901|3680086|FG000|NOT COMPLETED|Overall Study||0
2965916|NCT00771901|3680087|FG001|NOT COMPLETED|Overall Study||0
2965917|NCT00771901|3680088|FG002|NOT COMPLETED|Overall Study||4
2965918|NCT00771914|3680100|FG000|STARTED|Overall Study||7
2965919|NCT00771914|3680101|FG001|STARTED|Overall Study||6
2965920|NCT00771914|3680102|FG002|STARTED|Overall Study||6
2965921|NCT00771914|3680103|FG003|STARTED|Overall Study||8
2965922|NCT00771914|3680100|FG000|COMPLETED|Overall Study||7
2965923|NCT00771914|3680101|FG001|COMPLETED|Overall Study||6
2965924|NCT00771914|3680102|FG002|COMPLETED|Overall Study||6
2965925|NCT00771914|3680103|FG003|COMPLETED|Overall Study||6
2965926|NCT00771914|3680100|FG000|NOT COMPLETED|Overall Study||0
2965927|NCT00771914|3680101|FG001|NOT COMPLETED|Overall Study||0
2965928|NCT00771914|3680102|FG002|NOT COMPLETED|Overall Study||0
2965929|NCT00771914|3680103|FG003|NOT COMPLETED|Overall Study||2
2965930|NCT00771927|3680115|FG000|STARTED|Overall Study|Participant Flow and Baseline Characteristics refer to the Safety Set population.|511
2965931|NCT00771927|3680116|FG001|STARTED|Overall Study|Participant Flow and Baseline Characteristics refer to the Safety Set population.|493
2965932|NCT00771927|3680115|FG000|COMPLETED|Overall Study||256
2965933|NCT00771927|3680116|FG001|COMPLETED|Overall Study||256
2965934|NCT00771927|3680115|FG000|NOT COMPLETED|Overall Study||255
2965935|NCT00771927|3680116|FG001|NOT COMPLETED|Overall Study||237
2965936|NCT00771953|3680124|FG000|STARTED|Overall Study||36
2965937|NCT00771953|3680125|FG001|STARTED|Overall Study||36
2965938|NCT00771953|3680124|FG000|COMPLETED|Overall Study||26
2965939|NCT00771953|3680125|FG001|COMPLETED|Overall Study||26
2965940|NCT00771953|3680124|FG000|NOT COMPLETED|Overall Study||10
2965941|NCT00771953|3680125|FG001|NOT COMPLETED|Overall Study||10
2965942|NCT00772005|3680137|FG000|STARTED|Overall Study||71
2965943|NCT00772005|3680138|FG001|STARTED|Overall Study|One patient withdrew before taking any study drug.|70
2965944|NCT00772005|3680139|FG002|STARTED|Overall Study|One patient withdrew before taking any study drug.|72
2965945|NCT00772005|3680140|FG003|STARTED|Overall Study|Two patients withdrew before taking any study drug.|72
2965946|NCT00772005|3680137|FG000|COMPLETED|Overall Study||46
2965947|NCT00772005|3680138|FG001|COMPLETED|Overall Study||40
2965948|NCT00772005|3680139|FG002|COMPLETED|Overall Study||44
2965949|NCT00772005|3680140|FG003|COMPLETED|Overall Study||46
2965950|NCT00772005|3680137|FG000|NOT COMPLETED|Overall Study||25
2965951|NCT00772005|3680138|FG001|NOT COMPLETED|Overall Study||30
2965952|NCT00772005|3680139|FG002|NOT COMPLETED|Overall Study||28
2965953|NCT00772005|3680140|FG003|NOT COMPLETED|Overall Study||26
2965954|NCT00772031|3680152|FG000|STARTED|Overall Study||96
2965955|NCT00772031|3680153|FG001|STARTED|Overall Study||95
2965956|NCT00772031|3680152|FG000|COMPLETED|Overall Study||64
2965957|NCT00772031|3680153|FG001|COMPLETED|Overall Study||52
2965958|NCT00772031|3680152|FG000|NOT COMPLETED|Overall Study||32
2965959|NCT00772031|3680153|FG001|NOT COMPLETED|Overall Study||43
2965960|NCT00772070|3680167|FG000|STARTED|Overall Study||102
2965961|NCT00772070|3680168|FG001|STARTED|Overall Study||71
3301968|NCT02957136|4035631|FG000|COMPLETED|Overall Study||93
3301969|NCT02957136|4035632|FG001|COMPLETED|Overall Study||98
3301970|NCT02957136|4035631|FG000|NOT COMPLETED|Overall Study||2
3301971|NCT02957136|4035632|FG001|NOT COMPLETED|Overall Study||1
2965962|NCT00772070|3680167|FG000|COMPLETED|Overall Study|Two participants had vaccination errors, they were removed from analysis.|100
2965963|NCT00772070|3680168|FG001|COMPLETED|Overall Study||61
2965964|NCT00772070|3680167|FG000|NOT COMPLETED|Overall Study||2
2965965|NCT00772070|3680168|FG001|NOT COMPLETED|Overall Study||10
2965966|NCT00772109|3680178|FG000|STARTED|Overall Study||956
2965967|NCT00772109|3680179|FG001|STARTED|Overall Study||953
2965968|NCT00772109|3680180|FG002|STARTED|Overall Study||955
2965969|NCT00772109|3680181|FG003|STARTED|Overall Study||1428
2965970|NCT00772109|3680178|FG000|COMPLETED|Overall Study||935
2965971|NCT00772109|3680179|FG001|COMPLETED|Overall Study||934
2965972|NCT00772109|3680180|FG002|COMPLETED|Overall Study||936
2965973|NCT00772109|3680181|FG003|COMPLETED|Overall Study||1397
2965974|NCT00772109|3680178|FG000|NOT COMPLETED|Overall Study||21
2965975|NCT00772109|3680179|FG001|NOT COMPLETED|Overall Study||19
2965976|NCT00772109|3680180|FG002|NOT COMPLETED|Overall Study||19
2965977|NCT00772109|3680181|FG003|NOT COMPLETED|Overall Study||31
2965978|NCT00772148|3680193|FG000|STARTED|Pharmacokinetic Phase (14 Days)||29
2965979|NCT00772148|3680194|FG001|STARTED|Pharmacokinetic Phase (14 Days)||29
2965980|NCT00772148|3680193|FG000|COMPLETED|Pharmacokinetic Phase (14 Days)||21
2965981|NCT00772148|3680194|FG001|COMPLETED|Pharmacokinetic Phase (14 Days)||23
2965982|NCT00772148|3680193|FG000|NOT COMPLETED|Pharmacokinetic Phase (14 Days)||8
2965983|NCT00772148|3680194|FG001|NOT COMPLETED|Pharmacokinetic Phase (14 Days)||6
2965984|NCT00772148|3680193|FG000|STARTED|Maintenance Phase (Week 52)||21
2965985|NCT00772148|3680194|FG001|STARTED|Maintenance Phase (Week 52)||23
2965986|NCT00772148|3680193|FG000|COMPLETED|Maintenance Phase (Week 52)||17
2965987|NCT00772148|3680194|FG001|COMPLETED|Maintenance Phase (Week 52)||18
2965988|NCT00772148|3680193|FG000|NOT COMPLETED|Maintenance Phase (Week 52)||4
2965989|NCT00772148|3680194|FG001|NOT COMPLETED|Maintenance Phase (Week 52)||5
2965990|NCT00772304|3680200|FG000|STARTED|Overall Study||102
2965991|NCT00772304|3680200|FG000|COMPLETED|Overall Study||102
2965992|NCT00772304|3680200|FG000|NOT COMPLETED|Overall Study||0
2965993|NCT00772330|3680204|FG000|STARTED|Overall Study||23
2965994|NCT00772330|3680204|FG000|COMPLETED|Overall Study||20
2965995|NCT00772330|3680204|FG000|NOT COMPLETED|Overall Study||3
2965996|NCT00772369|3680211|FG000|STARTED|Overall Study||3214
2965997|NCT00772369|3680211|FG000|COMPLETED|Overall Study||3213
2965998|NCT00772369|3680211|FG000|NOT COMPLETED|Overall Study||1
2965999|NCT00772382|3680215|FG000|STARTED|Overall Study||116
2966000|NCT00772382|3680215|FG000|COMPLETED|Overall Study||61
2966001|NCT00772382|3680215|FG000|NOT COMPLETED|Overall Study||55
2966002|NCT00772447|3680221|FG000|STARTED|Overall Study||131
2966003|NCT00772447|3680222|FG001|STARTED|Overall Study||134
2966004|NCT00772447|3680221|FG000|COMPLETED|Overall Study||111
2966005|NCT00772447|3680222|FG001|COMPLETED|Overall Study||110
2966006|NCT00772447|3680221|FG000|NOT COMPLETED|Overall Study||20
2966007|NCT00772447|3680222|FG001|NOT COMPLETED|Overall Study||24
2966008|NCT00772538|3680231|FG000|STARTED|Overall Study||222
2966009|NCT00772538|3680232|FG001|STARTED|Overall Study||237
2966010|NCT00772538|3680231|FG000|COMPLETED|Overall Study||202
2966011|NCT00772538|3680232|FG001|COMPLETED|Overall Study||211
2966012|NCT00772538|3680231|FG000|NOT COMPLETED|Overall Study||20
2966013|NCT00772538|3680232|FG001|NOT COMPLETED|Overall Study||26
2966014|NCT00772577|3680240|FG000|STARTED|Overall Study||193
2966015|NCT00772577|3680241|FG001|STARTED|Overall Study||193
2966016|NCT00772577|3680240|FG000|COMPLETED|Overall Study||170
2966017|NCT00772577|3680241|FG001|COMPLETED|Overall Study||170
2966018|NCT00772577|3680240|FG000|NOT COMPLETED|Overall Study||23
2966019|NCT00772577|3680241|FG001|NOT COMPLETED|Overall Study||23
2966020|NCT00772590|3680251|FG000|STARTED|Overall Study||19
2966021|NCT00772590|3680252|FG001|STARTED|Overall Study||19
2966022|NCT00772590|3680253|FG002|STARTED|Overall Study||18
2966023|NCT00772590|3680254|FG003|STARTED|Overall Study||17
2966024|NCT00772590|3680251|FG000|COMPLETED|Overall Study||19
2966025|NCT00772590|3680252|FG001|COMPLETED|Overall Study||19
2966026|NCT00772590|3680253|FG002|COMPLETED|Overall Study||18
2966027|NCT00772590|3680254|FG003|COMPLETED|Overall Study||17
2966028|NCT00772590|3680251|FG000|NOT COMPLETED|Overall Study||0
2966029|NCT00772590|3680252|FG001|NOT COMPLETED|Overall Study||0
2966030|NCT00772590|3680253|FG002|NOT COMPLETED|Overall Study||0
2966031|NCT00772590|3680254|FG003|NOT COMPLETED|Overall Study||0
2966032|NCT00772603|3680267|FG000|STARTED|Overall Study||123
2966033|NCT00772603|3680268|FG001|STARTED|Overall Study||122
2966034|NCT00772603|3680269|FG002|STARTED|Overall Study||121
2966035|NCT00772603|3680267|FG000|COMPLETED|Overall Study||71
2966036|NCT00772603|3680268|FG001|COMPLETED|Overall Study||82
2966037|NCT00772603|3680269|FG002|COMPLETED|Overall Study||95
2966038|NCT00772603|3680267|FG000|NOT COMPLETED|Overall Study||52
2966039|NCT00772603|3680268|FG001|NOT COMPLETED|Overall Study||40
2966040|NCT00772603|3680269|FG002|NOT COMPLETED|Overall Study||26
2966041|NCT00772629|3680282|FG000|STARTED|Overall Study||17
2966042|NCT00772629|3680283|FG001|STARTED|Overall Study||1
2966043|NCT00772629|3680282|FG000|COMPLETED|Overall Study||16
2966044|NCT00772629|3680283|FG001|COMPLETED|Overall Study||1
2966045|NCT00772629|3680282|FG000|NOT COMPLETED|Overall Study||1
2966046|NCT00772629|3680283|FG001|NOT COMPLETED|Overall Study||0
2966047|NCT00772668|3680289|FG000|STARTED|Overall Study||3
2966048|NCT00772668|3680289|FG000|COMPLETED|Overall Study||0
2966049|NCT00772668|3680289|FG000|NOT COMPLETED|Overall Study||3
2966050|NCT00772707|3680294|FG000|STARTED|Overall Study||114
2966051|NCT00772707|3680294|FG000|COMPLETED|Overall Study||111
2966052|NCT00772707|3680294|FG000|NOT COMPLETED|Overall Study||3
2966053|NCT00772772|3680298|FG000|STARTED|Overall Study||12
2966054|NCT00772772|3680298|FG000|COMPLETED|Overall Study||12
2966055|NCT00772772|3680298|FG000|NOT COMPLETED|Overall Study||0
2966056|NCT00772889|3680306|FG000|STARTED|Overall Study||375
2966057|NCT00772889|3680307|FG001|STARTED|Overall Study||393
2966058|NCT00772889|3680308|FG002|STARTED|Overall Study||203
2966059|NCT00772889|3680306|FG000|Completed at Day 21|Overall Study||374
2966060|NCT00772889|3680307|FG001|Completed at Day 21|Overall Study||390
2966061|NCT00772889|3680308|FG002|Completed at Day 21|Overall Study||203
2966062|NCT00772889|3680306|FG000|COMPLETED|Overall Study||353
2966063|NCT00772889|3680307|FG001|COMPLETED|Overall Study||375
2966064|NCT00772889|3680308|FG002|COMPLETED|Overall Study||187
2966065|NCT00772889|3680306|FG000|NOT COMPLETED|Overall Study||22
2966066|NCT00772889|3680307|FG001|NOT COMPLETED|Overall Study||18
2966067|NCT00772889|3680308|FG002|NOT COMPLETED|Overall Study||16
2966068|NCT00772915|3680316|FG000|STARTED|Overall Study||38
2966069|NCT00772915|3680316|FG000|COMPLETED|Overall Study||23
2966070|NCT00772915|3680316|FG000|NOT COMPLETED|Overall Study||15
2966071|NCT00772928|3680322|FG000|STARTED|Overall Study||587
2966072|NCT00772928|3680323|FG001|STARTED|Overall Study||579
2966073|NCT00772928|3680322|FG000|COMPLETED|Overall Study||543
2966074|NCT00772928|3680323|FG001|COMPLETED|Overall Study||538
2966075|NCT00772928|3680322|FG000|NOT COMPLETED|Overall Study||44
2966076|NCT00772928|3680323|FG001|NOT COMPLETED|Overall Study||41
2966077|NCT00772941|3680329|FG000|STARTED|Overall Study||3939
2966078|NCT00772941|3680329|FG000|COMPLETED|Overall Study||3257
2966079|NCT00772941|3680329|FG000|NOT COMPLETED|Overall Study||682
2966080|NCT00772954|3680359|FG000|STARTED|Overall Study||12
2966081|NCT00772954|3680360|FG001|STARTED|Overall Study||12
2966082|NCT00772954|3680361|FG002|STARTED|Overall Study||12
2966083|NCT00772954|3680359|FG000|COMPLETED|Overall Study||12
2966084|NCT00772954|3680360|FG001|COMPLETED|Overall Study||12
2966085|NCT00772954|3680361|FG002|COMPLETED|Overall Study||11
2966086|NCT00772954|3680359|FG000|NOT COMPLETED|Overall Study||0
2966087|NCT00772954|3680360|FG001|NOT COMPLETED|Overall Study||0
2966088|NCT00772954|3680361|FG002|NOT COMPLETED|Overall Study||1
2966089|NCT00772967|3680369|FG000|STARTED|Crossover Treatment 1||3
2966090|NCT00772967|3680370|FG001|STARTED|Crossover Treatment 1||5
2966091|NCT00772967|3680371|FG002|STARTED|Crossover Treatment 1||3
2966092|NCT00772967|3680372|FG003|STARTED|Crossover Treatment 1||4
2966093|NCT00772967|3680373|FG004|STARTED|Crossover Treatment 1||4
2966094|NCT00772967|3680374|FG005|STARTED|Crossover Treatment 1||3
2966095|NCT00772967|3680369|FG000|COMPLETED|Crossover Treatment 1||3
2966096|NCT00772967|3680370|FG001|COMPLETED|Crossover Treatment 1||5
2966097|NCT00772967|3680371|FG002|COMPLETED|Crossover Treatment 1||3
2966098|NCT00772967|3680372|FG003|COMPLETED|Crossover Treatment 1|The withdrawal is not included in any outcomes; but is part of the Adverse Event group for placebo|3
2966099|NCT00772967|3680373|FG004|COMPLETED|Crossover Treatment 1||4
2966100|NCT00772967|3680374|FG005|COMPLETED|Crossover Treatment 1||3
2966101|NCT00772967|3680369|FG000|NOT COMPLETED|Crossover Treatment 1||0
2966102|NCT00772967|3680370|FG001|NOT COMPLETED|Crossover Treatment 1||0
2966103|NCT00772967|3680371|FG002|NOT COMPLETED|Crossover Treatment 1||0
2966104|NCT00772967|3680372|FG003|NOT COMPLETED|Crossover Treatment 1||1
3301972|NCT02957305|4035640|FG000|STARTED|Overall Study||106
3301973|NCT02957305|4035641|FG001|STARTED|Overall Study||105
3301974|NCT02957305|4035640|FG000|COMPLETED|Overall Study||106
3301975|NCT02957305|4035641|FG001|COMPLETED|Overall Study||105
3301976|NCT02957305|4035640|FG000|NOT COMPLETED|Overall Study||0
3301977|NCT02957305|4035641|FG001|NOT COMPLETED|Overall Study||0
3301978|NCT02957331|4035649|FG000|STARTED|Overall Study||14
3301979|NCT02957331|4035650|FG001|STARTED|Overall Study||12
2966105|NCT00772967|3680373|FG004|NOT COMPLETED|Crossover Treatment 1||0
2966106|NCT00772967|3680374|FG005|NOT COMPLETED|Crossover Treatment 1||0
2966107|NCT00772967|3680369|FG000|STARTED|Break 1 (4-7 Days)||3
2966108|NCT00772967|3680370|FG001|STARTED|Break 1 (4-7 Days)||5
2966109|NCT00772967|3680371|FG002|STARTED|Break 1 (4-7 Days)||3
2966110|NCT00772967|3680372|FG003|STARTED|Break 1 (4-7 Days)||3
2966111|NCT00772967|3680373|FG004|STARTED|Break 1 (4-7 Days)||4
2966112|NCT00772967|3680374|FG005|STARTED|Break 1 (4-7 Days)||3
2966113|NCT00772967|3680369|FG000|COMPLETED|Break 1 (4-7 Days)||3
2966114|NCT00772967|3680370|FG001|COMPLETED|Break 1 (4-7 Days)||4
2966115|NCT00772967|3680371|FG002|COMPLETED|Break 1 (4-7 Days)||3
2966116|NCT00772967|3680372|FG003|COMPLETED|Break 1 (4-7 Days)||3
2966117|NCT00772967|3680373|FG004|COMPLETED|Break 1 (4-7 Days)||4
2966118|NCT00772967|3680374|FG005|COMPLETED|Break 1 (4-7 Days)||3
2966119|NCT00772967|3680369|FG000|NOT COMPLETED|Break 1 (4-7 Days)||0
2966120|NCT00772967|3680370|FG001|NOT COMPLETED|Break 1 (4-7 Days)||1
2966121|NCT00772967|3680371|FG002|NOT COMPLETED|Break 1 (4-7 Days)||0
2966122|NCT00772967|3680372|FG003|NOT COMPLETED|Break 1 (4-7 Days)||0
2966123|NCT00772967|3680373|FG004|NOT COMPLETED|Break 1 (4-7 Days)||0
2966124|NCT00772967|3680374|FG005|NOT COMPLETED|Break 1 (4-7 Days)||0
2966125|NCT00772967|3680369|FG000|STARTED|Crossover Treatment 2||3
2966126|NCT00772967|3680370|FG001|STARTED|Crossover Treatment 2||4
2966127|NCT00772967|3680371|FG002|STARTED|Crossover Treatment 2||3
2966128|NCT00772967|3680372|FG003|STARTED|Crossover Treatment 2||3
2966129|NCT00772967|3680373|FG004|STARTED|Crossover Treatment 2||4
2966130|NCT00772967|3680374|FG005|STARTED|Crossover Treatment 2||3
2966131|NCT00772967|3680369|FG000|COMPLETED|Crossover Treatment 2||3
2966132|NCT00772967|3680370|FG001|COMPLETED|Crossover Treatment 2||4
2966133|NCT00772967|3680371|FG002|COMPLETED|Crossover Treatment 2||3
2966134|NCT00772967|3680372|FG003|COMPLETED|Crossover Treatment 2||3
2966135|NCT00772967|3680373|FG004|COMPLETED|Crossover Treatment 2||4
2966136|NCT00772967|3680374|FG005|COMPLETED|Crossover Treatment 2||3
2966137|NCT00772967|3680369|FG000|NOT COMPLETED|Crossover Treatment 2||0
2966138|NCT00772967|3680370|FG001|NOT COMPLETED|Crossover Treatment 2||0
3133081|NCT01694485|3858199|FG001|COMPLETED|Overall Study||15
3133082|NCT01694485|3858200|FG002|COMPLETED|Overall Study||27
3133083|NCT01694485|3858201|FG003|COMPLETED|Overall Study||62
3133084|NCT01694485|3858202|FG004|COMPLETED|Overall Study||55
3133085|NCT01694485|3858198|FG000|NOT COMPLETED|Overall Study||33
3133086|NCT01694485|3858199|FG001|NOT COMPLETED|Overall Study||7
2966139|NCT00772967|3680371|FG002|NOT COMPLETED|Crossover Treatment 2||0
2966140|NCT00772967|3680372|FG003|NOT COMPLETED|Crossover Treatment 2||0
2966141|NCT00772967|3680373|FG004|NOT COMPLETED|Crossover Treatment 2||0
2966142|NCT00772967|3680374|FG005|NOT COMPLETED|Crossover Treatment 2||0
2966143|NCT00772967|3680369|FG000|STARTED|Break 2 (4-7 Days)||3
3301980|NCT02957331|4035649|FG000|COMPLETED|Overall Study||13
2966144|NCT00772967|3680370|FG001|STARTED|Break 2 (4-7 Days)||4
2966145|NCT00772967|3680371|FG002|STARTED|Break 2 (4-7 Days)||3
2966146|NCT00772967|3680372|FG003|STARTED|Break 2 (4-7 Days)||3
2966147|NCT00772967|3680373|FG004|STARTED|Break 2 (4-7 Days)||4
2966148|NCT00772967|3680374|FG005|STARTED|Break 2 (4-7 Days)||3
2966149|NCT00772967|3680369|FG000|COMPLETED|Break 2 (4-7 Days)||3
2966150|NCT00772967|3680370|FG001|COMPLETED|Break 2 (4-7 Days)||4
2966151|NCT00772967|3680371|FG002|COMPLETED|Break 2 (4-7 Days)||3
2966152|NCT00772967|3680372|FG003|COMPLETED|Break 2 (4-7 Days)||3
2966153|NCT00772967|3680373|FG004|COMPLETED|Break 2 (4-7 Days)||4
2966154|NCT00772967|3680374|FG005|COMPLETED|Break 2 (4-7 Days)||3
2966155|NCT00772967|3680369|FG000|NOT COMPLETED|Break 2 (4-7 Days)||0
2966156|NCT00772967|3680370|FG001|NOT COMPLETED|Break 2 (4-7 Days)||0
2966157|NCT00772967|3680371|FG002|NOT COMPLETED|Break 2 (4-7 Days)||0
2966158|NCT00772967|3680372|FG003|NOT COMPLETED|Break 2 (4-7 Days)||0
2966159|NCT00772967|3680373|FG004|NOT COMPLETED|Break 2 (4-7 Days)||0
2966160|NCT00772967|3680374|FG005|NOT COMPLETED|Break 2 (4-7 Days)||0
2966161|NCT00772967|3680369|FG000|STARTED|Crossover Treatment 3||3
2966162|NCT00772967|3680370|FG001|STARTED|Crossover Treatment 3||4
2966163|NCT00772967|3680371|FG002|STARTED|Crossover Treatment 3||3
2966164|NCT00772967|3680372|FG003|STARTED|Crossover Treatment 3||3
2966165|NCT00772967|3680373|FG004|STARTED|Crossover Treatment 3||4
2966166|NCT00772967|3680374|FG005|STARTED|Crossover Treatment 3||3
2966167|NCT00772967|3680369|FG000|COMPLETED|Crossover Treatment 3||3
2966168|NCT00772967|3680370|FG001|COMPLETED|Crossover Treatment 3||4
2966169|NCT00772967|3680371|FG002|COMPLETED|Crossover Treatment 3||3
2966170|NCT00772967|3680372|FG003|COMPLETED|Crossover Treatment 3||3
2966171|NCT00772967|3680373|FG004|COMPLETED|Crossover Treatment 3||3
2966172|NCT00772967|3680374|FG005|COMPLETED|Crossover Treatment 3||3
2966173|NCT00772967|3680369|FG000|NOT COMPLETED|Crossover Treatment 3||0
2966174|NCT00772967|3680370|FG001|NOT COMPLETED|Crossover Treatment 3||0
2966175|NCT00772967|3680371|FG002|NOT COMPLETED|Crossover Treatment 3||0
2966176|NCT00772967|3680372|FG003|NOT COMPLETED|Crossover Treatment 3||0
2966177|NCT00772967|3680373|FG004|NOT COMPLETED|Crossover Treatment 3||1
2966178|NCT00772967|3680374|FG005|NOT COMPLETED|Crossover Treatment 3||0
2966179|NCT00773097|3680382|FG000|STARTED|Overall Study||46
2966180|NCT00773097|3680382|FG000|COMPLETED|Overall Study||39
2966181|NCT00773097|3680382|FG000|NOT COMPLETED|Overall Study||7
2966182|NCT00773136|3680386|FG000|STARTED|Overall Study||21
2966183|NCT00773136|3680386|FG000|COMPLETED|Overall Study||19
2966184|NCT00773136|3680386|FG000|NOT COMPLETED|Overall Study||2
2966185|NCT00773175|3680393|FG000|STARTED|Overall Study||73
2966186|NCT00773175|3680394|FG001|STARTED|Overall Study||75
2966187|NCT00773175|3680393|FG000|Initial Fluids Via Randomized Route|Overall Study||73
3163921|NCT01889862|3891339|FG002|STARTED|Part 4 (Up to 274 Weeks)|51, 57, 5 and 89 subjects from 165-301, 165-302 Part 1, 2 & 3 entered 165-302 Part 4 respectively.|0
3163922|NCT01889862|3891340|FG003|STARTED|Part 4 (Up to 274 Weeks)||0
3163923|NCT01889862|3891341|FG004|STARTED|Part 4 (Up to 274 Weeks)|Total of 202 subjects from 165-301, Part 1, 2, 3 entered Part 4 to receive dose of up to 60mg/kg.|202
3163924|NCT01889862|3891337|FG000|COMPLETED|Part 4 (Up to 274 Weeks)||0
3163925|NCT01889862|3891338|FG001|COMPLETED|Part 4 (Up to 274 Weeks)||0
2966188|NCT00773175|3680394|FG001|Initial Fluids Via Randomized Route|Overall Study||59
2966189|NCT00773175|3680393|FG000|Initial Fluids Via Subcutaneous Rescue|Overall Study||0
2966190|NCT00773175|3680394|FG001|Initial Fluids Via Subcutaneous Rescue|Overall Study||15
2966191|NCT00773175|3680393|FG000|No Fluids Received|Overall Study||0
2966192|NCT00773175|3680394|FG001|No Fluids Received|Overall Study||1
2966193|NCT00773175|3680393|FG000|COMPLETED|Overall Study||71
2966194|NCT00773175|3680394|FG001|COMPLETED|Overall Study||73
2966195|NCT00773175|3680393|FG000|NOT COMPLETED|Overall Study||2
2966196|NCT00773175|3680394|FG001|NOT COMPLETED|Overall Study||2
2966197|NCT00773253|3680407|FG000|STARTED|First Intervention (Week 0-24)||5
2966198|NCT00773253|3680408|FG001|STARTED|First Intervention (Week 0-24)||5
2966199|NCT00773253|3680407|FG000|COMPLETED|First Intervention (Week 0-24)||5
2966200|NCT00773253|3680408|FG001|COMPLETED|First Intervention (Week 0-24)||4
2966201|NCT00773253|3680407|FG000|NOT COMPLETED|First Intervention (Week 0-24)||0
2966202|NCT00773253|3680408|FG001|NOT COMPLETED|First Intervention (Week 0-24)||1
2966203|NCT00773253|3680407|FG000|STARTED|Second Intervention (Week 24-48)||5
2966204|NCT00773253|3680408|FG001|STARTED|Second Intervention (Week 24-48)||4
2966205|NCT00773253|3680407|FG000|COMPLETED|Second Intervention (Week 24-48)||5
2966206|NCT00773253|3680408|FG001|COMPLETED|Second Intervention (Week 24-48)||4
2966207|NCT00773253|3680407|FG000|NOT COMPLETED|Second Intervention (Week 24-48)||0
2966208|NCT00773253|3680408|FG001|NOT COMPLETED|Second Intervention (Week 24-48)||0
2966209|NCT00773279|3680416|FG000|STARTED|Period 1||121
2966210|NCT00773279|3680417|FG001|STARTED|Period 1||121
2966211|NCT00773279|3680416|FG000|COMPLETED|Period 1||114
2966212|NCT00773279|3680417|FG001|COMPLETED|Period 1||117
2966213|NCT00773279|3680416|FG000|NOT COMPLETED|Period 1||7
2966214|NCT00773279|3680417|FG001|NOT COMPLETED|Period 1||4
2966215|NCT00773279|3680416|FG000|STARTED|Period 2||114
2966216|NCT00773279|3680417|FG001|STARTED|Period 2||117
2966217|NCT00773279|3680416|FG000|COMPLETED|Period 2||111
2966218|NCT00773279|3680417|FG001|COMPLETED|Period 2||111
2966219|NCT00773279|3680416|FG000|NOT COMPLETED|Period 2||3
2966220|NCT00773279|3680417|FG001|NOT COMPLETED|Period 2||6
2966221|NCT00773292|3680424|FG000|STARTED|Pre-treatment 4 Weeks||7
2966222|NCT00773292|3680424|FG000|COMPLETED|Pre-treatment 4 Weeks||7
2966223|NCT00773292|3680424|FG000|NOT COMPLETED|Pre-treatment 4 Weeks||0
2966224|NCT00773292|3680424|FG000|STARTED|Treatment 48 Weeks||7
2966225|NCT00773292|3680424|FG000|COMPLETED|Treatment 48 Weeks|Two patients discontinued the treatment but remained on the study|5
2966226|NCT00773292|3680424|FG000|NOT COMPLETED|Treatment 48 Weeks||2
2966227|NCT00773292|3680424|FG000|STARTED|Post Treatment 24 Weeks||7
2966228|NCT00773292|3680424|FG000|COMPLETED|Post Treatment 24 Weeks||7
2966229|NCT00773292|3680424|FG000|NOT COMPLETED|Post Treatment 24 Weeks||0
2966230|NCT00773370|3680430|FG000|STARTED|Overall Study||43
2966231|NCT00773370|3680431|FG001|STARTED|Overall Study||33
2966232|NCT00773370|3680430|FG000|COMPLETED|Overall Study||25
2966233|NCT00773370|3680431|FG001|COMPLETED|Overall Study||23
2966234|NCT00773370|3680430|FG000|NOT COMPLETED|Overall Study||18
2966235|NCT00773370|3680431|FG001|NOT COMPLETED|Overall Study||10
2966236|NCT00773383|3680437|FG000|STARTED|Overall Study||35
2966237|NCT00773383|3680437|FG000|Received Study Drug|Overall Study||34
2966238|NCT00773383|3680437|FG000|COMPLETED|Overall Study|this includes at the time of clinical cut-off (2/23/2010) there were 4 patients ongoing|4
2966239|NCT00773383|3680437|FG000|NOT COMPLETED|Overall Study||31
2966240|NCT00773422|3680448|FG000|STARTED|Overall Study||11
2966241|NCT00773422|3680449|FG001|STARTED|Overall Study||9
2966242|NCT00773422|3680450|FG002|STARTED|Overall Study||10
2966243|NCT00773422|3680448|FG000|COMPLETED|Overall Study||11
2966244|NCT00773422|3680449|FG001|COMPLETED|Overall Study||9
2966245|NCT00773422|3680450|FG002|COMPLETED|Overall Study||10
2966246|NCT00773422|3680448|FG000|NOT COMPLETED|Overall Study||0
2966247|NCT00773422|3680449|FG001|NOT COMPLETED|Overall Study||0
2966248|NCT00773422|3680450|FG002|NOT COMPLETED|Overall Study||0
2966249|NCT00773461|3680460|FG000|STARTED|Overall Study||70
2966250|NCT00773461|3680461|FG001|STARTED|Overall Study||139
2966251|NCT00773461|3680460|FG000|COMPLETED|Overall Study||65
2966252|NCT00773461|3680461|FG001|COMPLETED|Overall Study||135
2966253|NCT00773461|3680460|FG000|NOT COMPLETED|Overall Study||5
2966254|NCT00773461|3680461|FG001|NOT COMPLETED|Overall Study||4
3035585|NCT01138501|3754914|FG000|COMPLETED|Overall Study||60
3035586|NCT01138501|3754914|FG000|NOT COMPLETED|Overall Study||5
3035587|NCT01138514|3754921|FG000|STARTED|Overall Study||522
3035588|NCT01138514|3754922|FG001|STARTED|Overall Study||516
3035589|NCT01138514|3754923|FG002|STARTED|Overall Study||517
3035590|NCT01138514|3754921|FG000|COMPLETED|Overall Study||474
3035591|NCT01138514|3754922|FG001|COMPLETED|Overall Study||463
3035592|NCT01138514|3754923|FG002|COMPLETED|Overall Study||424
3035593|NCT01138514|3754921|FG000|NOT COMPLETED|Overall Study||48
3035594|NCT01138514|3754922|FG001|NOT COMPLETED|Overall Study||53
3035595|NCT01138514|3754923|FG002|NOT COMPLETED|Overall Study||93
3035596|NCT01138657|3754934|FG000|STARTED|Overall Study||120
3035597|NCT01138657|3754935|FG001|STARTED|Overall Study||119
3035598|NCT01138657|3754934|FG000|Enrolled in Main Study|Overall Study||112
3035599|NCT01138657|3754935|FG001|Enrolled in Main Study|Overall Study||111
3035600|NCT01138657|3754934|FG000|Enrolled in Japan Sub-study|Overall Study||8
3035601|NCT01138657|3754935|FG001|Enrolled in Japan Sub-study|Overall Study||8
3035602|NCT01138657|3754934|FG000|COMPLETED|Overall Study||112
3035603|NCT01138657|3754935|FG001|COMPLETED|Overall Study||101
3035604|NCT01138657|3754934|FG000|NOT COMPLETED|Overall Study||8
3035605|NCT01138657|3754935|FG001|NOT COMPLETED|Overall Study||18
3035606|NCT01138735|3754945|FG000|STARTED|Overall Study||142
3035607|NCT01138735|3754946|FG001|STARTED|Overall Study||143
3035608|NCT01138735|3754945|FG000|COMPLETED|Overall Study||134
3035609|NCT01138735|3754946|FG001|COMPLETED|Overall Study||126
3035610|NCT01138735|3754945|FG000|NOT COMPLETED|Overall Study||8
3035611|NCT01138735|3754946|FG001|NOT COMPLETED|Overall Study||17
3035612|NCT01138826|3754952|FG000|STARTED|First Intervention Period||3
3035613|NCT01138826|3754953|FG001|STARTED|First Intervention Period||3
3035614|NCT01138826|3754954|FG002|STARTED|First Intervention Period||3
3035615|NCT01138826|3754955|FG003|STARTED|First Intervention Period||3
3035616|NCT01138826|3754956|FG004|STARTED|First Intervention Period||3
3035617|NCT01138826|3754957|FG005|STARTED|First Intervention Period||3
3035618|NCT01138826|3754952|FG000|COMPLETED|First Intervention Period||3
3035619|NCT01138826|3754953|FG001|COMPLETED|First Intervention Period||3
3035620|NCT01138826|3754954|FG002|COMPLETED|First Intervention Period||3
3035621|NCT01138826|3754955|FG003|COMPLETED|First Intervention Period||3
3035622|NCT01138826|3754956|FG004|COMPLETED|First Intervention Period||3
3035623|NCT01138826|3754957|FG005|COMPLETED|First Intervention Period||3
3035624|NCT01138826|3754952|FG000|NOT COMPLETED|First Intervention Period||0
3035625|NCT01138826|3754953|FG001|NOT COMPLETED|First Intervention Period||0
3035626|NCT01138826|3754954|FG002|NOT COMPLETED|First Intervention Period||0
3035627|NCT01138826|3754955|FG003|NOT COMPLETED|First Intervention Period||0
3035628|NCT01138826|3754956|FG004|NOT COMPLETED|First Intervention Period||0
3035629|NCT01138826|3754957|FG005|NOT COMPLETED|First Intervention Period||0
3035630|NCT01138826|3754952|FG000|STARTED|Washout Period I (of 16 Days)||3
3035631|NCT01138826|3754953|FG001|STARTED|Washout Period I (of 16 Days)||3
3035632|NCT01138826|3754954|FG002|STARTED|Washout Period I (of 16 Days)||3
3035633|NCT01138826|3754955|FG003|STARTED|Washout Period I (of 16 Days)||3
3035634|NCT01138826|3754956|FG004|STARTED|Washout Period I (of 16 Days)||3
3035635|NCT01138826|3754957|FG005|STARTED|Washout Period I (of 16 Days)||3
3035636|NCT01138826|3754952|FG000|COMPLETED|Washout Period I (of 16 Days)||2
3035637|NCT01138826|3754953|FG001|COMPLETED|Washout Period I (of 16 Days)||2
3035638|NCT01138826|3754954|FG002|COMPLETED|Washout Period I (of 16 Days)||3
2966255|NCT00773474|3680468|FG000|STARTED|Overall Study||29
2966256|NCT00773474|3680468|FG000|COMPLETED|Overall Study||29
2966257|NCT00773474|3680468|FG000|NOT COMPLETED|Overall Study||0
2966258|NCT00773513|3680474|FG000|STARTED|Overall Study||1413
2966259|NCT00773513|3680475|FG001|STARTED|Overall Study||1412
2966260|NCT00773513|3680474|FG000|Received Study Treatment|Overall Study||1409
2966261|NCT00773513|3680475|FG001|Received Study Treatment|Overall Study||1409
2966262|NCT00773513|3680474|FG000|COMPLETED|Overall Study||312
2966263|NCT00773513|3680475|FG001|COMPLETED|Overall Study||303
2966264|NCT00773513|3680474|FG000|NOT COMPLETED|Overall Study||1101
2966265|NCT00773513|3680475|FG001|NOT COMPLETED|Overall Study||1109
3133087|NCT01694485|3858200|FG002|NOT COMPLETED|Overall Study||13
3133088|NCT01694485|3858201|FG003|NOT COMPLETED|Overall Study||38
3133089|NCT01694485|3858202|FG004|NOT COMPLETED|Overall Study||25
3133090|NCT01694563|3858219|FG000|STARTED|Overall Study||365
3301981|NCT02957331|4035650|FG001|COMPLETED|Overall Study||12
3301982|NCT02957331|4035649|FG000|NOT COMPLETED|Overall Study||1
2966266|NCT00773604|3680481|FG000|STARTED|Overall Study||9
2966267|NCT00773604|3680481|FG000|COMPLETED|Overall Study||9
2966268|NCT00773604|3680481|FG000|NOT COMPLETED|Overall Study||0
2966269|NCT00773734|3680489|FG000|STARTED|Core: Placebo Controlled Phase Week 0-16||88
2966270|NCT00773734|3680490|FG001|STARTED|Core: Placebo Controlled Phase Week 0-16||89
2966271|NCT00773734|3680491|FG002|STARTED|Core: Placebo Controlled Phase Week 0-16||87
2966272|NCT00773734|3680492|FG003|STARTED|Core: Placebo Controlled Phase Week 0-16||88
2966273|NCT00773734|3680493|FG004|STARTED|Core: Placebo Controlled Phase Week 0-16||0
2966274|NCT00773734|3680494|FG005|STARTED|Core: Placebo Controlled Phase Week 0-16||0
2966275|NCT00773734|3680489|FG000|COMPLETED|Core: Placebo Controlled Phase Week 0-16|2 participants completed placebo controlled phase but elected not to continue|72
2966276|NCT00773734|3680490|FG001|COMPLETED|Core: Placebo Controlled Phase Week 0-16|2 participants completed placebo controlled phase but elected not to continue|79
2966277|NCT00773734|3680491|FG002|COMPLETED|Core: Placebo Controlled Phase Week 0-16||66
2966278|NCT00773734|3680492|FG003|COMPLETED|Core: Placebo Controlled Phase Week 0-16|3 participants completed placebo controlled phase but elected not to continue|70
2966279|NCT00773734|3680493|FG004|COMPLETED|Core: Placebo Controlled Phase Week 0-16||0
2966280|NCT00773734|3680494|FG005|COMPLETED|Core: Placebo Controlled Phase Week 0-16||0
2966281|NCT00773734|3680489|FG000|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||16
2966282|NCT00773734|3680490|FG001|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||10
2966283|NCT00773734|3680491|FG002|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||21
2966284|NCT00773734|3680492|FG003|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||18
2966285|NCT00773734|3680493|FG004|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||0
2966286|NCT00773734|3680494|FG005|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||0
2966287|NCT00773734|3680489|FG000|STARTED|Core: Active Treatment Phase Week 16-24|Placebo participants were re-randomized at Week 16 to receive apremilast 20mg or 30mg PO BID.|0
2966288|NCT00773734|3680490|FG001|STARTED|Core: Active Treatment Phase Week 16-24|2 participants elected not to continue from previous period|77
2966289|NCT00773734|3680491|FG002|STARTED|Core: Active Treatment Phase Week 16-24||66
2966290|NCT00773734|3680492|FG003|STARTED|Core: Active Treatment Phase Week 16-24|3 participants elected not to continue from previous period|67
2966291|NCT00773734|3680493|FG004|STARTED|Core: Active Treatment Phase Week 16-24||34
2966292|NCT00773734|3680494|FG005|STARTED|Core: Active Treatment Phase Week 16-24||36
2966293|NCT00773734|3680489|FG000|COMPLETED|Core: Active Treatment Phase Week 16-24||0
2966294|NCT00773734|3680490|FG001|COMPLETED|Core: Active Treatment Phase Week 16-24||65
2966295|NCT00773734|3680491|FG002|COMPLETED|Core: Active Treatment Phase Week 16-24||59
2966296|NCT00773734|3680492|FG003|COMPLETED|Core: Active Treatment Phase Week 16-24||65
2966297|NCT00773734|3680493|FG004|COMPLETED|Core: Active Treatment Phase Week 16-24||33
2966298|NCT00773734|3680494|FG005|COMPLETED|Core: Active Treatment Phase Week 16-24||31
2966299|NCT00773734|3680489|FG000|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||0
2966300|NCT00773734|3680490|FG001|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||12
2966301|NCT00773734|3680491|FG002|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||7
2966302|NCT00773734|3680492|FG003|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||2
2966303|NCT00773734|3680493|FG004|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||1
2966304|NCT00773734|3680494|FG005|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||5
2966305|NCT00773734|3680489|FG000|STARTED|Extension: Active Treatment Week 24-52||0
2966306|NCT00773734|3680490|FG001|STARTED|Extension: Active Treatment Week 24-52||47
2966307|NCT00773734|3680491|FG002|STARTED|Extension: Active Treatment Week 24-52||50
2966308|NCT00773734|3680492|FG003|STARTED|Extension: Active Treatment Week 24-52||58
2966309|NCT00773734|3680493|FG004|STARTED|Extension: Active Treatment Week 24-52||27
2966310|NCT00773734|3680494|FG005|STARTED|Extension: Active Treatment Week 24-52||27
2966311|NCT00773734|3680489|FG000|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||0
2966312|NCT00773734|3680490|FG001|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||5
2966313|NCT00773734|3680491|FG002|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||10
3133091|NCT01694563|3858219|FG000|COMPLETED|Overall Study||278
3133092|NCT01694563|3858219|FG000|NOT COMPLETED|Overall Study||87
3301983|NCT02957331|4035650|FG001|NOT COMPLETED|Overall Study||0
3301984|NCT02957357|4035658|FG000|STARTED|Overall Study||10479
3301985|NCT02957357|4035659|FG001|STARTED|Overall Study||835
3301986|NCT02957357|4035658|FG000|COMPLETED|Overall Study||10479
3301987|NCT02957357|4035659|FG001|COMPLETED|Overall Study||835
3301988|NCT02957357|4035658|FG000|NOT COMPLETED|Overall Study||0
2966314|NCT00773734|3680492|FG003|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||10
2966315|NCT00773734|3680493|FG004|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||4
2966316|NCT00773734|3680494|FG005|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||4
2966317|NCT00773734|3680489|FG000|COMPLETED|Extension: Active Treatment Week 24-52||0
2966318|NCT00773734|3680490|FG001|COMPLETED|Extension: Active Treatment Week 24-52|Those dosed APR 10 mg BID in extension study were randomly assigned APR 20 mg or 30 mg BID in LTE|34
2966319|NCT00773734|3680491|FG002|COMPLETED|Extension: Active Treatment Week 24-52||33
2966320|NCT00773734|3680492|FG003|COMPLETED|Extension: Active Treatment Week 24-52||48
2966321|NCT00773734|3680493|FG004|COMPLETED|Extension: Active Treatment Week 24-52||22
2966322|NCT00773734|3680494|FG005|COMPLETED|Extension: Active Treatment Week 24-52||19
3133093|NCT01694641|3858228|FG000|STARTED|Overall Study||80
3133094|NCT01694641|3858229|FG001|STARTED|Overall Study||81
3133095|NCT01694641|3858228|FG000|COMPLETED|Overall Study||68
3133096|NCT01694641|3858229|FG001|COMPLETED|Overall Study||71
3133097|NCT01694641|3858228|FG000|NOT COMPLETED|Overall Study||12
3133098|NCT01694641|3858229|FG001|NOT COMPLETED|Overall Study||10
3133099|NCT01694667|3858238|FG000|STARTED|Overall Study||29
3133100|NCT01694667|3858239|FG001|STARTED|Overall Study||28
2966323|NCT00773734|3680489|FG000|NOT COMPLETED|Extension: Active Treatment Week 24-52||0
2966324|NCT00773734|3680490|FG001|NOT COMPLETED|Extension: Active Treatment Week 24-52||13
2966325|NCT00773734|3680491|FG002|NOT COMPLETED|Extension: Active Treatment Week 24-52||17
2966326|NCT00773734|3680492|FG003|NOT COMPLETED|Extension: Active Treatment Week 24-52||10
2966327|NCT00773734|3680493|FG004|NOT COMPLETED|Extension: Active Treatment Week 24-52||5
2966328|NCT00773734|3680494|FG005|NOT COMPLETED|Extension: Active Treatment Week 24-52||8
2966329|NCT00773734|3680489|FG000|STARTED|LTE Period: Week 52 to 6 Years||0
2966330|NCT00773734|3680490|FG001|STARTED|LTE Period: Week 52 to 6 Years||0
2966331|NCT00773734|3680491|FG002|STARTED|LTE Period: Week 52 to 6 Years|Those dosed APR 10 mg BID in extension study were randomly assigned APR 20 mg or 30 mg BID in LTE|16
2966332|NCT00773734|3680492|FG003|STARTED|LTE Period: Week 52 to 6 Years|Those dosed APR 10 mg BID in extension study were randomly assigned APR 20 mg or 30 mg BID in LTE|17
2966333|NCT00773734|3680493|FG004|STARTED|LTE Period: Week 52 to 6 Years||0
2966334|NCT00773734|3680494|FG005|STARTED|LTE Period: Week 52 to 6 Years||0
2966335|NCT00773734|3680489|FG000|COMPLETED|LTE Period: Week 52 to 6 Years||0
2966336|NCT00773734|3680490|FG001|COMPLETED|LTE Period: Week 52 to 6 Years||0
2966337|NCT00773734|3680491|FG002|COMPLETED|LTE Period: Week 52 to 6 Years|Completed = Completed Long Term Extension study|4
2966338|NCT00773734|3680492|FG003|COMPLETED|LTE Period: Week 52 to 6 Years|Completed = Completed Long Term Extension study|5
2966339|NCT00773734|3680493|FG004|COMPLETED|LTE Period: Week 52 to 6 Years||0
2966340|NCT00773734|3680494|FG005|COMPLETED|LTE Period: Week 52 to 6 Years||0
2966341|NCT00773734|3680489|FG000|NOT COMPLETED|LTE Period: Week 52 to 6 Years||0
2966342|NCT00773734|3680490|FG001|NOT COMPLETED|LTE Period: Week 52 to 6 Years||0
2966343|NCT00773734|3680491|FG002|NOT COMPLETED|LTE Period: Week 52 to 6 Years||12
2966344|NCT00773734|3680492|FG003|NOT COMPLETED|LTE Period: Week 52 to 6 Years||12
2966345|NCT00773734|3680493|FG004|NOT COMPLETED|LTE Period: Week 52 to 6 Years||0
2966346|NCT00773734|3680494|FG005|NOT COMPLETED|LTE Period: Week 52 to 6 Years||0
2966347|NCT00773747|3680553|FG000|STARTED|Overall Study||317
2966348|NCT00773747|3680554|FG001|STARTED|Overall Study||320
2966349|NCT00773747|3680553|FG000|Treated|Overall Study||315
2966350|NCT00773747|3680554|FG001|Treated|Overall Study||320
2966351|NCT00773747|3680553|FG000|COMPLETED|Overall Study||20
2966352|NCT00773747|3680554|FG001|COMPLETED|Overall Study||24
2966353|NCT00773747|3680553|FG000|NOT COMPLETED|Overall Study||297
2966354|NCT00773747|3680554|FG001|NOT COMPLETED|Overall Study||296
2966355|NCT00773786|3680560|FG000|STARTED|First Intervention (1 Week)||10
2966356|NCT00773786|3680561|FG001|STARTED|First Intervention (1 Week)||10
2966357|NCT00773786|3680560|FG000|COMPLETED|First Intervention (1 Week)||10
2966358|NCT00773786|3680561|FG001|COMPLETED|First Intervention (1 Week)||10
2966359|NCT00773786|3680560|FG000|NOT COMPLETED|First Intervention (1 Week)||0
2966360|NCT00773786|3680561|FG001|NOT COMPLETED|First Intervention (1 Week)||0
2966361|NCT00773786|3680560|FG000|STARTED|Washout (1 Week)||10
2966362|NCT00773786|3680561|FG001|STARTED|Washout (1 Week)||10
2966363|NCT00773786|3680560|FG000|COMPLETED|Washout (1 Week)||10
2966364|NCT00773786|3680561|FG001|COMPLETED|Washout (1 Week)||10
2966365|NCT00773786|3680560|FG000|NOT COMPLETED|Washout (1 Week)||0
2966366|NCT00773786|3680561|FG001|NOT COMPLETED|Washout (1 Week)||0
2966367|NCT00773786|3680560|FG000|STARTED|Second Intervention (1 Week)||10
2966368|NCT00773786|3680561|FG001|STARTED|Second Intervention (1 Week)||10
2966369|NCT00773786|3680560|FG000|COMPLETED|Second Intervention (1 Week)||10
2966370|NCT00773786|3680561|FG001|COMPLETED|Second Intervention (1 Week)||10
2966371|NCT00773786|3680560|FG000|NOT COMPLETED|Second Intervention (1 Week)||0
2966372|NCT00773786|3680561|FG001|NOT COMPLETED|Second Intervention (1 Week)||0
2966373|NCT00773838|3680568|FG000|STARTED|Overall Study||143
2966374|NCT00773838|3680568|FG000|COMPLETED|Overall Study||0
2966375|NCT00773838|3680568|FG000|NOT COMPLETED|Overall Study||143
2966376|NCT00773955|3680572|FG000|STARTED|Overall Study||15
2966377|NCT00773955|3680572|FG000|COMPLETED|Overall Study||15
2966378|NCT00773955|3680572|FG000|NOT COMPLETED|Overall Study||0
2966379|NCT00773968|3680576|FG000|STARTED|Overall Study||140
2966380|NCT00773968|3680576|FG000|Treated|Overall Study||111
2966381|NCT00773968|3680576|FG000|COMPLETED|Overall Study||95
2966382|NCT00773968|3680576|FG000|NOT COMPLETED|Overall Study||45
3133101|NCT01694667|3858238|FG000|COMPLETED|Overall Study||29
2966383|NCT00774046|3680580|FG000|STARTED|Screening||116
2966384|NCT00774046|3680580|FG000|COMPLETED|Screening||60
2966385|NCT00774046|3680580|FG000|NOT COMPLETED|Screening||56
2966386|NCT00774046|3680580|FG000|STARTED|Enrollment||60
2966387|NCT00774046|3680580|FG000|COMPLETED|Enrollment||32
2966388|NCT00774046|3680580|FG000|NOT COMPLETED|Enrollment||28
2966389|NCT00774046|3680580|FG000|STARTED|Induction Therapy||32
2966390|NCT00774046|3680580|FG000|COMPLETED|Induction Therapy||32
2966391|NCT00774046|3680580|FG000|NOT COMPLETED|Induction Therapy||0
2966392|NCT00774046|3680580|FG000|STARTED|Stem Cell Mobilization|For mobilization, the patient must have had a CR and not been a candidate for allogeneic transplant|10
2966393|NCT00774046|3680580|FG000|COMPLETED|Stem Cell Mobilization||7
2966394|NCT00774046|3680580|FG000|NOT COMPLETED|Stem Cell Mobilization||3
2966395|NCT00774046|3680580|FG000|STARTED|Autologous Transplant|2 patients died in remission and 1 relapsed without having received transplant|4
2966396|NCT00774046|3680580|FG000|COMPLETED|Autologous Transplant||4
2966397|NCT00774046|3680580|FG000|NOT COMPLETED|Autologous Transplant||0
2966398|NCT00774163|3680586|FG000|STARTED|Overall Study||30
2966399|NCT00774163|3680587|FG001|STARTED|Overall Study||15
2966400|NCT00774163|3680586|FG000|COMPLETED|Overall Study||30
2966401|NCT00774163|3680587|FG001|COMPLETED|Overall Study||15
2966402|NCT00774163|3680586|FG000|NOT COMPLETED|Overall Study||0
2966403|NCT00774163|3680587|FG001|NOT COMPLETED|Overall Study||0
2966404|NCT00774202|3680595|FG000|STARTED|Overall Study||9
2966405|NCT00774202|3680596|FG001|STARTED|Overall Study||8
2966406|NCT00774202|3680595|FG000|COMPLETED|Overall Study||9
2966407|NCT00774202|3680596|FG001|COMPLETED|Overall Study||8
2966408|NCT00774202|3680595|FG000|NOT COMPLETED|Overall Study||0
2966409|NCT00774202|3680596|FG001|NOT COMPLETED|Overall Study||0
2966410|NCT00774267|3680610|FG000|STARTED|Overall Study||132
2966411|NCT00774267|3680611|FG001|STARTED|Overall Study||111
2966412|NCT00774267|3680612|FG002|STARTED|Overall Study||129
2966413|NCT00774267|3680613|FG003|STARTED|Overall Study||135
2966414|NCT00774267|3680610|FG000|COMPLETED|Overall Study||132
2966415|NCT00774267|3680611|FG001|COMPLETED|Overall Study||111
2966416|NCT00774267|3680612|FG002|COMPLETED|Overall Study||129
2966417|NCT00774267|3680613|FG003|COMPLETED|Overall Study||135
2966418|NCT00774267|3680610|FG000|NOT COMPLETED|Overall Study||0
2966419|NCT00774267|3680611|FG001|NOT COMPLETED|Overall Study||0
2966420|NCT00774267|3680612|FG002|NOT COMPLETED|Overall Study||0
2966421|NCT00774267|3680613|FG003|NOT COMPLETED|Overall Study||0
2966422|NCT00774397|3680630|FG000|STARTED|Overall Study||71
2966423|NCT00774397|3680631|FG001|STARTED|Overall Study||69
2966424|NCT00774397|3680632|FG002|STARTED|Overall Study||143
2966425|NCT00774397|3680633|FG003|STARTED|Overall Study||146
2966426|NCT00774397|3680634|FG004|STARTED|Overall Study||143
2966427|NCT00774397|3680635|FG005|STARTED|Overall Study||76
2966428|NCT00774397|3680636|FG006|STARTED|Overall Study||71
2966429|NCT00774397|3680630|FG000|COMPLETED|Overall Study||57
3133102|NCT01694667|3858239|FG001|COMPLETED|Overall Study||28
3133103|NCT01694667|3858238|FG000|NOT COMPLETED|Overall Study||0
3133104|NCT01694667|3858239|FG001|NOT COMPLETED|Overall Study||0
3133105|NCT01694706|3858245|FG000|STARTED|Overall Study||5
3133106|NCT01694706|3858246|FG001|STARTED|Overall Study||5
3133107|NCT01694706|3858247|FG002|STARTED|Overall Study||5
2966430|NCT00774397|3680631|FG001|COMPLETED|Overall Study||56
2966431|NCT00774397|3680632|FG002|COMPLETED|Overall Study||113
2966432|NCT00774397|3680633|FG003|COMPLETED|Overall Study||129
2966433|NCT00774397|3680634|FG004|COMPLETED|Overall Study||97
2966434|NCT00774397|3680635|FG005|COMPLETED|Overall Study||54
2966435|NCT00774397|3680636|FG006|COMPLETED|Overall Study||41
2966436|NCT00774397|3680630|FG000|NOT COMPLETED|Overall Study||14
2966437|NCT00774397|3680631|FG001|NOT COMPLETED|Overall Study||13
2966438|NCT00774397|3680632|FG002|NOT COMPLETED|Overall Study||30
2966439|NCT00774397|3680633|FG003|NOT COMPLETED|Overall Study||17
2966440|NCT00774397|3680634|FG004|NOT COMPLETED|Overall Study||46
2966441|NCT00774397|3680635|FG005|NOT COMPLETED|Overall Study||22
2966442|NCT00774397|3680636|FG006|NOT COMPLETED|Overall Study||30
2966443|NCT00774566|3680661|FG000|STARTED|Overall Study||159
2966444|NCT00774566|3680662|FG001|STARTED|Overall Study||156
2966445|NCT00774566|3680661|FG000|6 Month Follow up|Overall Study||154
3133108|NCT01694706|3858245|FG000|Received Faldaprevir|Overall Study||5
3133109|NCT01694706|3858246|FG001|Received Faldaprevir|Overall Study||5
3133110|NCT01694706|3858247|FG002|Received Faldaprevir|Overall Study||5
3133111|NCT01694706|3858245|FG000|Received Faldaprevir +OMP|Overall Study||5
3133112|NCT01694706|3858246|FG001|Received Faldaprevir +OMP|Overall Study||5
3133113|NCT01694706|3858247|FG002|Received Faldaprevir +OMP|Overall Study||5
3133114|NCT01694706|3858245|FG000|Received Faldaprevir Fed|Overall Study||4
3133115|NCT01694706|3858246|FG001|Received Faldaprevir Fed|Overall Study||5
2966446|NCT00774566|3680662|FG001|6 Month Follow up|Overall Study||150
2966447|NCT00774566|3680661|FG000|12 Month Follow up|Overall Study||141
2966448|NCT00774566|3680662|FG001|12 Month Follow up|Overall Study||141
2966449|NCT00774566|3680661|FG000|COMPLETED|Overall Study||141
2966450|NCT00774566|3680662|FG001|COMPLETED|Overall Study||141
2966451|NCT00774566|3680661|FG000|NOT COMPLETED|Overall Study||18
2966452|NCT00774566|3680662|FG001|NOT COMPLETED|Overall Study||15
2966453|NCT00774579|3680670|FG000|STARTED|Overall Study||9
2966454|NCT00774579|3680671|FG001|STARTED|Overall Study||9
2966455|NCT00774579|3680670|FG000|COMPLETED|Overall Study||9
2966456|NCT00774579|3680671|FG001|COMPLETED|Overall Study||9
2966457|NCT00774579|3680670|FG000|NOT COMPLETED|Overall Study||0
2966458|NCT00774579|3680671|FG001|NOT COMPLETED|Overall Study||0
2966459|NCT00774748|3680677|FG000|STARTED|Overall Study||21
2966460|NCT00774748|3680677|FG000|COMPLETED|Overall Study||18
2966461|NCT00774748|3680677|FG000|NOT COMPLETED|Overall Study||3
2966462|NCT00774787|3680685|FG000|STARTED|Overall Study||27
2966463|NCT00774787|3680685|FG000|COMPLETED|Overall Study||26
2966464|NCT00774787|3680685|FG000|NOT COMPLETED|Overall Study||1
2966465|NCT00774800|3680689|FG000|STARTED|Intervention 1||22
2966466|NCT00774800|3680689|FG000|Received at Least One Dose of Study Drug|Intervention 1||22
2966467|NCT00774800|3680689|FG000|COMPLETED|Intervention 1||22
2966468|NCT00774800|3680689|FG000|NOT COMPLETED|Intervention 1||0
2966469|NCT00774800|3680689|FG000|STARTED|Washout (3 to 10 Days)||22
2966470|NCT00774800|3680689|FG000|COMPLETED|Washout (3 to 10 Days)||22
2966471|NCT00774800|3680689|FG000|NOT COMPLETED|Washout (3 to 10 Days)||0
2966472|NCT00774800|3680689|FG000|STARTED|Intervention 2||22
2966473|NCT00774800|3680689|FG000|Received at Least One Dose of Study Drug|Intervention 2||22
2966474|NCT00774800|3680689|FG000|COMPLETED|Intervention 2||22
2966475|NCT00774800|3680689|FG000|NOT COMPLETED|Intervention 2||0
2966476|NCT00774800|3680689|FG000|STARTED|Washout (3 to 10 Days)||22
2966477|NCT00774800|3680689|FG000|COMPLETED|Washout (3 to 10 Days)||22
2966478|NCT00774800|3680689|FG000|NOT COMPLETED|Washout (3 to 10 Days)||0
2966479|NCT00774800|3680689|FG000|STARTED|Intervention 3||22
2966480|NCT00774800|3680689|FG000|Received at Least One Dose of Study Drug|Intervention 3||22
2966481|NCT00774800|3680689|FG000|COMPLETED|Intervention 3||22
2966482|NCT00774800|3680689|FG000|NOT COMPLETED|Intervention 3||0
2966483|NCT00774800|3680689|FG000|STARTED|Washout (3 to 10 Days)||22
2966484|NCT00774800|3680689|FG000|COMPLETED|Washout (3 to 10 Days)||22
2966485|NCT00774800|3680689|FG000|NOT COMPLETED|Washout (3 to 10 Days)||0
2966486|NCT00774800|3680689|FG000|STARTED|Intervention 4||22
2966487|NCT00774800|3680689|FG000|Received at Least One Dose of Study Drug|Intervention 4||21
2966488|NCT00774800|3680689|FG000|COMPLETED|Intervention 4||21
2966489|NCT00774800|3680689|FG000|NOT COMPLETED|Intervention 4||1
2966490|NCT00774852|3680701|FG000|STARTED|Overall Study||69
2966491|NCT00774852|3680702|FG001|STARTED|Overall Study||68
2966492|NCT00774852|3680701|FG000|COMPLETED|Overall Study||24
2966493|NCT00774852|3680702|FG001|COMPLETED|Overall Study||27
2966494|NCT00774852|3680701|FG000|NOT COMPLETED|Overall Study||45
2966495|NCT00774852|3680702|FG001|NOT COMPLETED|Overall Study||41
2966496|NCT00774930|3680720|FG000|STARTED|DB Phase|One subject was randomised to receive lanreotide Autogel, but erroneously received placebo.|59
2966497|NCT00774930|3680721|FG001|STARTED|DB Phase|One subject was randomised to receive lanreotide Autogel, but erroneously received placebo.|56
2966498|NCT00774930|3680720|FG000|COMPLETED|DB Phase|Received 4 DB study injections AND continued to IOL phase OR|45
2966499|NCT00774930|3680721|FG001|COMPLETED|DB Phase|had diary data at least up to day 21 after 4th dose, regardless of missing diary data before day 21.|34
2966500|NCT00774930|3680720|FG000|NOT COMPLETED|DB Phase||14
3133116|NCT01694706|3858247|FG002|Received Faldaprevir Fed|Overall Study||5
3133117|NCT01694706|3858245|FG000|COMPLETED|Overall Study||4
3133118|NCT01694706|3858246|FG001|COMPLETED|Overall Study||4
3133119|NCT01694706|3858247|FG002|COMPLETED|Overall Study||5
3133120|NCT01694706|3858245|FG000|NOT COMPLETED|Overall Study||1
3133121|NCT01694706|3858246|FG001|NOT COMPLETED|Overall Study||1
2966501|NCT00774930|3680721|FG001|NOT COMPLETED|DB Phase||22
2966502|NCT00774930|3680720|FG000|STARTED|IOL Phase||56
2966503|NCT00774930|3680721|FG001|STARTED|IOL Phase|Includes 1 subject listed as completing and withdrawing from the DB phase due to brain radiation|46
2966504|NCT00774930|3680720|FG000|COMPLETED|IOL Phase||43
2966505|NCT00774930|3680721|FG001|COMPLETED|IOL Phase||37
2966506|NCT00774930|3680720|FG000|NOT COMPLETED|IOL Phase||13
2966507|NCT00774930|3680721|FG001|NOT COMPLETED|IOL Phase||9
2966508|NCT00774930|3680720|FG000|STARTED|LTOLE Phase|24 subjects from IOL did not enter LTOLE (11 completed IOL, 13 did not complete IOL).|32
2966509|NCT00774930|3680721|FG001|STARTED|LTOLE Phase|20 subjects from IOL did not enter LTOLE (12 completed IOL, 8 did not complete IOL).|25
2966510|NCT00774930|3680720|FG000|COMPLETED|LTOLE Phase||17
2966511|NCT00774930|3680721|FG001|COMPLETED|LTOLE Phase||8
2966512|NCT00774930|3680720|FG000|NOT COMPLETED|LTOLE Phase||15
2966513|NCT00774930|3680721|FG001|NOT COMPLETED|LTOLE Phase||17
2966514|NCT00774995|3680733|FG000|STARTED|Overall Study||9
2966515|NCT00774995|3680734|FG001|STARTED|Overall Study||16
2966516|NCT00774995|3680735|FG002|STARTED|Overall Study||8
2966517|NCT00774995|3680736|FG003|STARTED|Overall Study||16
2966518|NCT00774995|3680733|FG000|COMPLETED|Overall Study||9
2966519|NCT00774995|3680734|FG001|COMPLETED|Overall Study||16
2966520|NCT00774995|3680735|FG002|COMPLETED|Overall Study||7
2966521|NCT00774995|3680736|FG003|COMPLETED|Overall Study||16
2966522|NCT00774995|3680733|FG000|NOT COMPLETED|Overall Study||0
2966523|NCT00774995|3680734|FG001|NOT COMPLETED|Overall Study||0
2966524|NCT00774995|3680735|FG002|NOT COMPLETED|Overall Study||1
2966525|NCT00774995|3680736|FG003|NOT COMPLETED|Overall Study||0
2966526|NCT00775021|3680746|FG000|STARTED|First Intervention||63
2966527|NCT00775021|3680747|FG001|STARTED|First Intervention||60
2966528|NCT00775021|3680746|FG000|COMPLETED|First Intervention||62
2966529|NCT00775021|3680747|FG001|COMPLETED|First Intervention||60
2966530|NCT00775021|3680746|FG000|NOT COMPLETED|First Intervention||1
2966531|NCT00775021|3680747|FG001|NOT COMPLETED|First Intervention||0
2966532|NCT00775021|3680746|FG000|STARTED|Second Intervention||62
2966533|NCT00775021|3680747|FG001|STARTED|Second Intervention||60
2966534|NCT00775021|3680746|FG000|COMPLETED|Second Intervention||62
2966535|NCT00775021|3680747|FG001|COMPLETED|Second Intervention||59
2966536|NCT00775021|3680746|FG000|NOT COMPLETED|Second Intervention||0
2966537|NCT00775021|3680747|FG001|NOT COMPLETED|Second Intervention||1
2966538|NCT00775138|3680757|FG000|STARTED|Overall Study||24
2966539|NCT00775138|3680758|FG001|STARTED|Overall Study||10
2966540|NCT00775138|3680759|FG002|STARTED|Overall Study||20
2966541|NCT00775138|3680760|FG003|STARTED|Overall Study||10
2966542|NCT00775138|3680757|FG000|COMPLETED|Overall Study||24
2966543|NCT00775138|3680758|FG001|COMPLETED|Overall Study||10
2966544|NCT00775138|3680759|FG002|COMPLETED|Overall Study||17
2966545|NCT00775138|3680760|FG003|COMPLETED|Overall Study||8
2966546|NCT00775138|3680757|FG000|NOT COMPLETED|Overall Study||0
2966547|NCT00775138|3680758|FG001|NOT COMPLETED|Overall Study||0
2966548|NCT00775138|3680759|FG002|NOT COMPLETED|Overall Study||3
2966549|NCT00775138|3680760|FG003|NOT COMPLETED|Overall Study||2
2966550|NCT00775203|3680774|FG000|STARTED|Overall Study||206
2966551|NCT00775203|3680775|FG001|STARTED|Overall Study||206
2966552|NCT00775203|3680774|FG000|Received Study Medication|Overall Study||202
2966553|NCT00775203|3680775|FG001|Received Study Medication|Overall Study||204
2966554|NCT00775203|3680774|FG000|COMPLETED|Overall Study||144
2966555|NCT00775203|3680775|FG001|COMPLETED|Overall Study||163
2966556|NCT00775203|3680774|FG000|NOT COMPLETED|Overall Study||62
2966557|NCT00775203|3680775|FG001|NOT COMPLETED|Overall Study||43
2966558|NCT00775229|3680783|FG000|STARTED|Overall Study||25
2966559|NCT00775229|3680784|FG001|STARTED|Overall Study||26
2966560|NCT00775229|3680783|FG000|COMPLETED|Overall Study||20
2966561|NCT00775229|3680784|FG001|COMPLETED|Overall Study||24
2966562|NCT00775229|3680783|FG000|NOT COMPLETED|Overall Study||5
2966563|NCT00775229|3680784|FG001|NOT COMPLETED|Overall Study||2
2966564|NCT00775268|3680792|FG000|STARTED|Baseline||9
2966565|NCT00775268|3680793|FG001|STARTED|Baseline||22
2966566|NCT00775268|3680792|FG000|COMPLETED|Baseline||8
2966567|NCT00775268|3680793|FG001|COMPLETED|Baseline||21
2966568|NCT00775268|3680792|FG000|NOT COMPLETED|Baseline||1
2966569|NCT00775268|3680793|FG001|NOT COMPLETED|Baseline||1
2966570|NCT00775268|3680792|FG000|STARTED|After 2 Cycles||8
2966571|NCT00775268|3680793|FG001|STARTED|After 2 Cycles|These 21 patients were not scanned after 2-cycles in this Arm. They were only scanned at baseline.|0
2966572|NCT00775268|3680792|FG000|COMPLETED|After 2 Cycles||7
2966573|NCT00775268|3680793|FG001|COMPLETED|After 2 Cycles||0
2966574|NCT00775268|3680792|FG000|NOT COMPLETED|After 2 Cycles||1
2966575|NCT00775268|3680793|FG001|NOT COMPLETED|After 2 Cycles||0
2966576|NCT00775268|3680792|FG000|STARTED|After Completion||7
2966577|NCT00775268|3680793|FG001|STARTED|After Completion||0
2966578|NCT00775268|3680792|FG000|COMPLETED|After Completion||6
2966579|NCT00775268|3680793|FG001|COMPLETED|After Completion||0
2966580|NCT00775268|3680792|FG000|NOT COMPLETED|After Completion||1
2966581|NCT00775268|3680793|FG001|NOT COMPLETED|After Completion||0
2966582|NCT00775346|3680810|FG000|STARTED|Overall Study||92
2966583|NCT00775346|3680810|FG000|COMPLETED|Overall Study||92
2966584|NCT00775346|3680810|FG000|NOT COMPLETED|Overall Study||0
2966585|NCT00775411|3680814|FG000|STARTED|Overall Study||44
2966586|NCT00775411|3680814|FG000|COMPLETED|Overall Study||43
2966587|NCT00775411|3680814|FG000|NOT COMPLETED|Overall Study||1
2966588|NCT00775437|3680818|FG000|STARTED|Overall Study||32
2966589|NCT00775437|3680818|FG000|COMPLETED|Overall Study||26
2966590|NCT00775437|3680818|FG000|NOT COMPLETED|Overall Study||6
2966591|NCT00775450|3680827|FG000|STARTED|Overall Study||295
2966592|NCT00775450|3680828|FG001|STARTED|Overall Study||98
2966593|NCT00775450|3680829|FG002|STARTED|Overall Study||105
2966594|NCT00775450|3680830|FG003|STARTED|Overall Study||108
2966595|NCT00775450|3680831|FG004|STARTED|Overall Study||201
2966596|NCT00775450|3680827|FG000|COMPLETED|Overall Study||292
2966597|NCT00775450|3680828|FG001|COMPLETED|Overall Study||98
2966598|NCT00775450|3680829|FG002|COMPLETED|Overall Study||105
2966599|NCT00775450|3680830|FG003|COMPLETED|Overall Study||108
2966600|NCT00775450|3680831|FG004|COMPLETED|Overall Study||199
2966601|NCT00775450|3680827|FG000|NOT COMPLETED|Overall Study||3
2966602|NCT00775450|3680828|FG001|NOT COMPLETED|Overall Study||0
2966603|NCT00775450|3680829|FG002|NOT COMPLETED|Overall Study||0
2966604|NCT00775450|3680830|FG003|NOT COMPLETED|Overall Study||0
2966605|NCT00775450|3680831|FG004|NOT COMPLETED|Overall Study||2
2966606|NCT00775463|3680845|FG000|STARTED|Overall Study||76
2966607|NCT00775463|3680846|FG001|STARTED|Overall Study||72
2966608|NCT00775463|3680845|FG000|COMPLETED|Overall Study||65
2966609|NCT00775463|3680846|FG001|COMPLETED|Overall Study||59
2966610|NCT00775463|3680845|FG000|NOT COMPLETED|Overall Study||11
2966611|NCT00775463|3680846|FG001|NOT COMPLETED|Overall Study||13
2966612|NCT00775528|3680859|FG000|STARTED|Overall Study|Started means number of patients who consented|19
2966613|NCT00775528|3680859|FG000|COMPLETED|Overall Study||18
2966614|NCT00775528|3680859|FG000|NOT COMPLETED|Overall Study||1
2966615|NCT00775593|3680863|FG000|STARTED|Overall Study||60
2966616|NCT00775593|3680863|FG000|COMPLETED|Overall Study||53
2966617|NCT00775593|3680863|FG000|NOT COMPLETED|Overall Study||7
2966618|NCT00775606|3680869|FG000|STARTED|Overall Study||8
2966619|NCT00775606|3680870|FG001|STARTED|Overall Study||5
2966620|NCT00775606|3680869|FG000|COMPLETED|Overall Study||5
2966621|NCT00775606|3680870|FG001|COMPLETED|Overall Study||5
2966622|NCT00775606|3680869|FG000|NOT COMPLETED|Overall Study||3
2966623|NCT00775606|3680870|FG001|NOT COMPLETED|Overall Study||0
2966624|NCT00775645|3680880|FG000|STARTED|Overall Study||208
2966625|NCT00775645|3680881|FG001|STARTED|Overall Study||201
2966626|NCT00775645|3680880|FG000|COMPLETED|Overall Study||191
2966627|NCT00775645|3680881|FG001|COMPLETED|Overall Study||181
2966628|NCT00775645|3680880|FG000|NOT COMPLETED|Overall Study||17
2966629|NCT00775645|3680881|FG001|NOT COMPLETED|Overall Study||20
2966630|NCT00775658|3680887|FG000|STARTED|First Intervention||10
2966631|NCT00775658|3680888|FG001|STARTED|First Intervention||11
2966632|NCT00775658|3680887|FG000|COMPLETED|First Intervention||10
2966633|NCT00775658|3680888|FG001|COMPLETED|First Intervention||11
2966634|NCT00775658|3680887|FG000|NOT COMPLETED|First Intervention||0
2966635|NCT00775658|3680888|FG001|NOT COMPLETED|First Intervention||0
2966636|NCT00775658|3680887|FG000|STARTED|Second Intervention||10
2966637|NCT00775658|3680888|FG001|STARTED|Second Intervention||11
2966638|NCT00775658|3680887|FG000|COMPLETED|Second Intervention||10
2966639|NCT00775658|3680888|FG001|COMPLETED|Second Intervention||11
2966640|NCT00775658|3680887|FG000|NOT COMPLETED|Second Intervention||0
2966641|NCT00775658|3680888|FG001|NOT COMPLETED|Second Intervention||0
2966642|NCT00775671|3680896|FG000|STARTED|Overall Study||23
2966643|NCT00775671|3680897|FG001|STARTED|Overall Study||23
2966644|NCT00775671|3680896|FG000|COMPLETED|Overall Study||23
2966645|NCT00775671|3680897|FG001|COMPLETED|Overall Study||23
2966646|NCT00775671|3680896|FG000|NOT COMPLETED|Overall Study||0
2966647|NCT00775671|3680897|FG001|NOT COMPLETED|Overall Study||0
2966648|NCT00775684|3680906|FG000|STARTED|Overall Study||17
2966649|NCT00775684|3680907|FG001|STARTED|Overall Study||13
2966650|NCT00775684|3680908|FG002|STARTED|Overall Study||17
2966651|NCT00775684|3680906|FG000|COMPLETED|Overall Study||14
2966652|NCT00775684|3680907|FG001|COMPLETED|Overall Study||12
2966653|NCT00775684|3680908|FG002|COMPLETED|Overall Study||14
2966654|NCT00775684|3680906|FG000|NOT COMPLETED|Overall Study||3
2966655|NCT00775684|3680907|FG001|NOT COMPLETED|Overall Study||1
2966656|NCT00775684|3680908|FG002|NOT COMPLETED|Overall Study||3
2966657|NCT00775931|3680927|FG000|STARTED|Overall Study||6
2966658|NCT00775931|3680928|FG001|STARTED|Overall Study||1
2966659|NCT00775931|3680927|FG000|COMPLETED|Overall Study||6
2966660|NCT00775931|3680928|FG001|COMPLETED|Overall Study||1
2966661|NCT00775931|3680927|FG000|NOT COMPLETED|Overall Study||0
2966662|NCT00775931|3680928|FG001|NOT COMPLETED|Overall Study||0
2966663|NCT00775944|3680938|FG000|STARTED|Overall Study||648
2966664|NCT00775944|3680939|FG001|STARTED|Overall Study||647
2966665|NCT00775944|3680940|FG002|STARTED|Overall Study||648
2966666|NCT00775944|3680941|FG003|STARTED|Overall Study||648
2966667|NCT00775944|3680938|FG000|COMPLETED|Overall Study|15 participants withdrew consent|633
2966668|NCT00775944|3680939|FG001|COMPLETED|Overall Study|9 participants withdrew consent|638
2966669|NCT00775944|3680940|FG002|COMPLETED|Overall Study|16 participants withdrew consent|632
2966670|NCT00775944|3680941|FG003|COMPLETED|Overall Study|16 participants withdrew consent|632
2966671|NCT00775944|3680938|FG000|NOT COMPLETED|Overall Study||15
2966672|NCT00775944|3680939|FG001|NOT COMPLETED|Overall Study||9
2966673|NCT00775944|3680940|FG002|NOT COMPLETED|Overall Study||16
2966674|NCT00775944|3680941|FG003|NOT COMPLETED|Overall Study||16
2966675|NCT00775983|3680953|FG000|STARTED|Overall Study||36
2966676|NCT00775983|3680954|FG001|STARTED|Overall Study||36
2966677|NCT00775983|3680953|FG000|COMPLETED|Overall Study||35
2966678|NCT00775983|3680954|FG001|COMPLETED|Overall Study||34
2966679|NCT00775983|3680953|FG000|NOT COMPLETED|Overall Study||1
2966680|NCT00775983|3680954|FG001|NOT COMPLETED|Overall Study||2
2966681|NCT00776009|3680966|FG000|STARTED|Period 1: First Intervention||26
2966682|NCT00776009|3680967|FG001|STARTED|Period 1: First Intervention||28
2966683|NCT00776009|3680968|FG002|STARTED|Period 1: First Intervention||29
2966684|NCT00776009|3680969|FG003|STARTED|Period 1: First Intervention||27
2966685|NCT00776009|3680970|FG004|STARTED|Period 1: First Intervention||28
2966686|NCT00776009|3680971|FG005|STARTED|Period 1: First Intervention||27
2966687|NCT00776009|3680966|FG000|COMPLETED|Period 1: First Intervention||26
2966688|NCT00776009|3680967|FG001|COMPLETED|Period 1: First Intervention||27
2966689|NCT00776009|3680968|FG002|COMPLETED|Period 1: First Intervention||28
2966690|NCT00776009|3680969|FG003|COMPLETED|Period 1: First Intervention||27
2966691|NCT00776009|3680970|FG004|COMPLETED|Period 1: First Intervention||26
2966692|NCT00776009|3680971|FG005|COMPLETED|Period 1: First Intervention||27
2966693|NCT00776009|3680966|FG000|NOT COMPLETED|Period 1: First Intervention||0
2966694|NCT00776009|3680967|FG001|NOT COMPLETED|Period 1: First Intervention||1
2966695|NCT00776009|3680968|FG002|NOT COMPLETED|Period 1: First Intervention||1
2966696|NCT00776009|3680969|FG003|NOT COMPLETED|Period 1: First Intervention||0
2966697|NCT00776009|3680970|FG004|NOT COMPLETED|Period 1: First Intervention||2
2966698|NCT00776009|3680971|FG005|NOT COMPLETED|Period 1: First Intervention||0
2966699|NCT00776009|3680966|FG000|STARTED|Period 2: Second Intervention||26
2966700|NCT00776009|3680967|FG001|STARTED|Period 2: Second Intervention||27
2966701|NCT00776009|3680968|FG002|STARTED|Period 2: Second Intervention||28
2966702|NCT00776009|3680969|FG003|STARTED|Period 2: Second Intervention||27
2966703|NCT00776009|3680970|FG004|STARTED|Period 2: Second Intervention||26
3133122|NCT01694706|3858247|FG002|NOT COMPLETED|Overall Study||0
3133123|NCT01694771|3858258|FG000|STARTED|Overall Study||567
3133124|NCT01694771|3858259|FG001|STARTED|Overall Study||565
3133125|NCT01694771|3858258|FG000|COMPLETED|Overall Study||527
3133126|NCT01694771|3858259|FG001|COMPLETED|Overall Study||525
3133127|NCT01694771|3858258|FG000|NOT COMPLETED|Overall Study||40
3301989|NCT02957357|4035659|FG001|NOT COMPLETED|Overall Study||0
3316999|NCT03122860|4050493|FG000|STARTED|Overall Study||117
3317000|NCT03122860|4050494|FG001|STARTED|Overall Study||116
3317001|NCT03122860|4050495|FG002|STARTED|Overall Study||117
3317002|NCT03122860|4050496|FG003|STARTED|Overall Study||116
2966704|NCT00776009|3680971|FG005|STARTED|Period 2: Second Intervention||27
2966705|NCT00776009|3680966|FG000|COMPLETED|Period 2: Second Intervention||25
2966706|NCT00776009|3680967|FG001|COMPLETED|Period 2: Second Intervention||27
2966707|NCT00776009|3680968|FG002|COMPLETED|Period 2: Second Intervention||27
2966708|NCT00776009|3680969|FG003|COMPLETED|Period 2: Second Intervention||27
2966709|NCT00776009|3680970|FG004|COMPLETED|Period 2: Second Intervention||26
2966710|NCT00776009|3680971|FG005|COMPLETED|Period 2: Second Intervention||26
2966711|NCT00776009|3680966|FG000|NOT COMPLETED|Period 2: Second Intervention||1
2966712|NCT00776009|3680967|FG001|NOT COMPLETED|Period 2: Second Intervention||0
2966713|NCT00776009|3680968|FG002|NOT COMPLETED|Period 2: Second Intervention||1
2966714|NCT00776009|3680969|FG003|NOT COMPLETED|Period 2: Second Intervention||0
2966715|NCT00776009|3680970|FG004|NOT COMPLETED|Period 2: Second Intervention||0
2966716|NCT00776009|3680971|FG005|NOT COMPLETED|Period 2: Second Intervention||1
2966717|NCT00776009|3680966|FG000|STARTED|Period 3: Third Intervention||25
2966718|NCT00776009|3680967|FG001|STARTED|Period 3: Third Intervention||27
2966719|NCT00776009|3680968|FG002|STARTED|Period 3: Third Intervention||27
2966720|NCT00776009|3680969|FG003|STARTED|Period 3: Third Intervention||27
2966721|NCT00776009|3680970|FG004|STARTED|Period 3: Third Intervention||26
2966722|NCT00776009|3680971|FG005|STARTED|Period 3: Third Intervention||26
2966723|NCT00776009|3680966|FG000|COMPLETED|Period 3: Third Intervention||24
2966724|NCT00776009|3680967|FG001|COMPLETED|Period 3: Third Intervention||27
2966725|NCT00776009|3680968|FG002|COMPLETED|Period 3: Third Intervention||27
2966726|NCT00776009|3680969|FG003|COMPLETED|Period 3: Third Intervention||27
2966727|NCT00776009|3680970|FG004|COMPLETED|Period 3: Third Intervention||26
2966728|NCT00776009|3680971|FG005|COMPLETED|Period 3: Third Intervention||26
2966729|NCT00776009|3680966|FG000|NOT COMPLETED|Period 3: Third Intervention||1
2966730|NCT00776009|3680967|FG001|NOT COMPLETED|Period 3: Third Intervention||0
2966731|NCT00776009|3680968|FG002|NOT COMPLETED|Period 3: Third Intervention||0
2966732|NCT00776009|3680969|FG003|NOT COMPLETED|Period 3: Third Intervention||0
2966733|NCT00776009|3680970|FG004|NOT COMPLETED|Period 3: Third Intervention||0
3163926|NCT01889862|3891339|FG002|COMPLETED|Part 4 (Up to 274 Weeks)||0
3163927|NCT01889862|3891340|FG003|COMPLETED|Part 4 (Up to 274 Weeks)||0
3163928|NCT01889862|3891341|FG004|COMPLETED|Part 4 (Up to 274 Weeks)||172
3163929|NCT01889862|3891337|FG000|NOT COMPLETED|Part 4 (Up to 274 Weeks)||0
3163930|NCT01889862|3891338|FG001|NOT COMPLETED|Part 4 (Up to 274 Weeks)||0
3163931|NCT01889862|3891339|FG002|NOT COMPLETED|Part 4 (Up to 274 Weeks)||0
3163932|NCT01889862|3891340|FG003|NOT COMPLETED|Part 4 (Up to 274 Weeks)||0
3163933|NCT01889862|3891341|FG004|NOT COMPLETED|Part 4 (Up to 274 Weeks)||30
3163934|NCT01890031|3891371|FG000|STARTED|Overall Study||50
3163935|NCT01890031|3891372|FG001|STARTED|Overall Study||50
3163936|NCT01890031|3891373|FG002|STARTED|Overall Study||12
3163937|NCT01890031|3891374|FG003|STARTED|Overall Study||11
3163938|NCT01890031|3891375|FG004|STARTED|Overall Study||8
3163939|NCT01890031|3891371|FG000|COMPLETED|Overall Study||50
3163940|NCT01890031|3891372|FG001|COMPLETED|Overall Study||50
3163941|NCT01890031|3891373|FG002|COMPLETED|Overall Study||12
3163942|NCT01890031|3891374|FG003|COMPLETED|Overall Study||11
3163943|NCT01890031|3891375|FG004|COMPLETED|Overall Study||8
3163944|NCT01890031|3891371|FG000|NOT COMPLETED|Overall Study||0
3163945|NCT01890031|3891372|FG001|NOT COMPLETED|Overall Study||0
3163946|NCT01890031|3891373|FG002|NOT COMPLETED|Overall Study||0
3163947|NCT01890031|3891374|FG003|NOT COMPLETED|Overall Study||0
2966734|NCT00776009|3680971|FG005|NOT COMPLETED|Period 3: Third Intervention||0
2966735|NCT00776230|3680982|FG000|STARTED|Overall Study||99
2966736|NCT00776230|3680983|FG001|STARTED|Overall Study||103
2966737|NCT00776230|3680984|FG002|STARTED|Overall Study||102
2966738|NCT00776230|3680982|FG000|Enrolled and Vaccinated at Day 0|Overall Study||98
2966739|NCT00776230|3680983|FG001|Enrolled and Vaccinated at Day 0|Overall Study||103
2966740|NCT00776230|3680984|FG002|Enrolled and Vaccinated at Day 0|Overall Study||102
2966741|NCT00776230|3680982|FG000|COMPLETED|Overall Study||96
2966742|NCT00776230|3680983|FG001|COMPLETED|Overall Study||100
2966743|NCT00776230|3680984|FG002|COMPLETED|Overall Study||97
2966744|NCT00776230|3680982|FG000|NOT COMPLETED|Overall Study||3
2966745|NCT00776230|3680983|FG001|NOT COMPLETED|Overall Study||3
2966746|NCT00776230|3680984|FG002|NOT COMPLETED|Overall Study||5
2966747|NCT00776295|3680992|FG000|STARTED|Overall Study||2
2966748|NCT00776295|3680992|FG000|COMPLETED|Overall Study||2
2966749|NCT00776295|3680992|FG000|NOT COMPLETED|Overall Study||0
2966750|NCT00776594|3680998|FG000|STARTED|Overall Study||66
2966751|NCT00776594|3680999|FG001|STARTED|Overall Study||36
2966752|NCT00776594|3680998|FG000|COMPLETED|Overall Study||62
2966753|NCT00776594|3680999|FG001|COMPLETED|Overall Study||34
2966754|NCT00776594|3680998|FG000|NOT COMPLETED|Overall Study||4
2966755|NCT00776594|3680999|FG001|NOT COMPLETED|Overall Study||2
2966756|NCT00776659|3681007|FG000|STARTED|Overall Study||39
2966757|NCT00776659|3681007|FG000|COMPLETED|Overall Study||13
2966758|NCT00776659|3681007|FG000|NOT COMPLETED|Overall Study||26
2966759|NCT00776789|3681013|FG000|STARTED|Overall Study||20
2966760|NCT00776789|3681014|FG001|STARTED|Overall Study||21
2966761|NCT00776789|3681013|FG000|COMPLETED|Overall Study||17
2966762|NCT00776789|3681014|FG001|COMPLETED|Overall Study||18
2966763|NCT00776789|3681013|FG000|NOT COMPLETED|Overall Study||3
2966764|NCT00776789|3681014|FG001|NOT COMPLETED|Overall Study||3
2966765|NCT00776919|3681026|FG000|STARTED|Overall Study||327
2966766|NCT00776919|3681027|FG001|STARTED|Overall Study||328
2966767|NCT00776919|3681028|FG002|STARTED|Overall Study||328
2966768|NCT00776919|3681029|FG003|STARTED|Overall Study||332
2966769|NCT00776919|3681026|FG000|COMPLETED|Overall Study||300
2966770|NCT00776919|3681027|FG001|COMPLETED|Overall Study||295
2966771|NCT00776919|3681028|FG002|COMPLETED|Overall Study||296
2966772|NCT00776919|3681029|FG003|COMPLETED|Overall Study||293
2966773|NCT00776919|3681026|FG000|NOT COMPLETED|Overall Study||27
2966774|NCT00776919|3681027|FG001|NOT COMPLETED|Overall Study||33
2966775|NCT00776919|3681028|FG002|NOT COMPLETED|Overall Study||32
2966776|NCT00776919|3681029|FG003|NOT COMPLETED|Overall Study||39
2966777|NCT00776984|3681041|FG000|STARTED|Overall Study||234
2966778|NCT00776984|3681042|FG001|STARTED|Overall Study||219
2966779|NCT00776984|3681041|FG000|COMPLETED|Overall Study||203
2966780|NCT00776984|3681042|FG001|COMPLETED|Overall Study||198
2966781|NCT00776984|3681041|FG000|NOT COMPLETED|Overall Study||31
2966782|NCT00776984|3681042|FG001|NOT COMPLETED|Overall Study||21
2966783|NCT00776997|3681048|FG000|STARTED|Overall Study||100
2966784|NCT00776997|3681048|FG000|COMPLETED|Overall Study|98 subjects evaluated at 12-months. Endpoint analysis based on all subjects treated (n=100)|98
2966785|NCT00776997|3681048|FG000|NOT COMPLETED|Overall Study||2
2966786|NCT00777023|3681055|FG000|STARTED|Overall Study|192 patients were randomized, but only 186 received study treatment.|186
2966787|NCT00777023|3681056|FG001|STARTED|Overall Study|190 patients were randomized, and 190 received study treatment.|190
2966788|NCT00777023|3681057|FG002|STARTED|Overall Study|183 patients were randomized, and 183 received study treatment.|183
2966789|NCT00777023|3681055|FG000|COMPLETED|Overall Study||151
2966790|NCT00777023|3681056|FG001|COMPLETED|Overall Study||149
2966791|NCT00777023|3681057|FG002|COMPLETED|Overall Study||146
2966792|NCT00777023|3681055|FG000|NOT COMPLETED|Overall Study||35
2966793|NCT00777023|3681056|FG001|NOT COMPLETED|Overall Study||41
2966794|NCT00777023|3681057|FG002|NOT COMPLETED|Overall Study||37
2966795|NCT00777049|3681067|FG000|STARTED|Overall Study||33
2966796|NCT00777049|3681068|FG001|STARTED|Overall Study||21
2966797|NCT00777049|3681067|FG000|COMPLETED|Overall Study||32
2966798|NCT00777049|3681068|FG001|COMPLETED|Overall Study||20
2966799|NCT00777049|3681067|FG000|NOT COMPLETED|Overall Study||1
2966800|NCT00777049|3681068|FG001|NOT COMPLETED|Overall Study||1
2966801|NCT00777062|3681076|FG000|STARTED|Overall Study||39
2966802|NCT00777062|3681077|FG001|STARTED|Overall Study||41
2966803|NCT00777062|3681076|FG000|COMPLETED|Overall Study||36
2966804|NCT00777062|3681077|FG001|COMPLETED|Overall Study||36
2966805|NCT00777062|3681076|FG000|NOT COMPLETED|Overall Study||3
2966806|NCT00777062|3681077|FG001|NOT COMPLETED|Overall Study||5
2966807|NCT00777088|3681083|FG000|STARTED|Overall Study||108
2966808|NCT00777088|3681083|FG000|COMPLETED|Overall Study||107
2966809|NCT00777088|3681083|FG000|NOT COMPLETED|Overall Study||1
2966810|NCT00777101|3681090|FG000|STARTED|Overall Study||117
2966811|NCT00777101|3681091|FG001|STARTED|Overall Study||116
2966812|NCT00777101|3681090|FG000|Treated|Overall Study||116
2966813|NCT00777101|3681091|FG001|Treated|Overall Study||115
2966814|NCT00777101|3681090|FG000|COMPLETED|Overall Study||55
2966815|NCT00777101|3681091|FG001|COMPLETED|Overall Study||65
2966816|NCT00777101|3681090|FG000|NOT COMPLETED|Overall Study||62
2966817|NCT00777101|3681091|FG001|NOT COMPLETED|Overall Study||51
2966818|NCT00777153|3681101|FG000|STARTED|Overall Study||131
2966819|NCT00777153|3681102|FG001|STARTED|Overall Study||129
2966820|NCT00777153|3681103|FG002|STARTED|Overall Study||65
2966821|NCT00777153|3681101|FG000|COMPLETED|Overall Study||41
3133128|NCT01694771|3858259|FG001|NOT COMPLETED|Overall Study||40
3133129|NCT01694966|3858268|FG000|STARTED|Overall Study||504
2966822|NCT00777153|3681102|FG001|COMPLETED|Overall Study||46
2966823|NCT00777153|3681103|FG002|COMPLETED|Overall Study||28
2966824|NCT00777153|3681101|FG000|NOT COMPLETED|Overall Study||90
2966825|NCT00777153|3681102|FG001|NOT COMPLETED|Overall Study||83
2966826|NCT00777153|3681103|FG002|NOT COMPLETED|Overall Study||37
2966827|NCT00777179|3681117|FG000|STARTED|Overall Study|Number of participants for intent-to-treat (ITT) set population|75
2966828|NCT00777179|3681118|FG001|STARTED|Overall Study|Number of participants for intent-to-treat (ITT) set population|42
2966829|NCT00777179|3681117|FG000|COMPLETED|Overall Study|All participants' data within ITT set were included for final result.|75
2966830|NCT00777179|3681118|FG001|COMPLETED|Overall Study|All participants' data within ITT set were included for final result.|42
2966831|NCT00777179|3681117|FG000|NOT COMPLETED|Overall Study||0
2966832|NCT00777179|3681118|FG001|NOT COMPLETED|Overall Study||0
2966833|NCT00777205|3681126|FG000|STARTED|Overall Study||243
2966834|NCT00777205|3681127|FG001|STARTED|Overall Study||200
2966835|NCT00777205|3681126|FG000|Intervention Interruption|Overall Study||0
2966836|NCT00777205|3681127|FG001|Intervention Interruption|Overall Study|56 participants excluded from main analyses due to 2 mos interruption in study intervention|56
2966837|NCT00777205|3681126|FG000|COMPLETED|Overall Study||212
2966838|NCT00777205|3681127|FG001|COMPLETED|Overall Study||129
2966839|NCT00777205|3681126|FG000|NOT COMPLETED|Overall Study||31
2966840|NCT00777205|3681127|FG001|NOT COMPLETED|Overall Study||71
2966841|NCT00777257|3681138|FG000|STARTED|Overall Study||444
2966842|NCT00777257|3681139|FG001|STARTED|Overall Study||450
2966843|NCT00777257|3681140|FG002|STARTED|Overall Study||451
2966844|NCT00777257|3681138|FG000|COMPLETED|Overall Study||433
2966845|NCT00777257|3681139|FG001|COMPLETED|Overall Study||438
2966846|NCT00777257|3681140|FG002|COMPLETED|Overall Study||442
2966847|NCT00777257|3681138|FG000|NOT COMPLETED|Overall Study||11
2966848|NCT00777257|3681139|FG001|NOT COMPLETED|Overall Study||12
2966849|NCT00777257|3681140|FG002|NOT COMPLETED|Overall Study||9
2966850|NCT00777296|3681152|FG000|STARTED|Overall Study||21
2966851|NCT00777296|3681153|FG001|STARTED|Overall Study||11
2966852|NCT00777296|3681154|FG002|STARTED|Overall Study||23
2966853|NCT00777296|3681155|FG003|STARTED|Overall Study||11
2966854|NCT00777296|3681152|FG000|COMPLETED|Overall Study||20
2966855|NCT00777296|3681153|FG001|COMPLETED|Overall Study||10
2966856|NCT00777296|3681154|FG002|COMPLETED|Overall Study||21
2966857|NCT00777296|3681155|FG003|COMPLETED|Overall Study||10
2966858|NCT00777296|3681152|FG000|NOT COMPLETED|Overall Study||1
2966859|NCT00777296|3681153|FG001|NOT COMPLETED|Overall Study||1
2966860|NCT00777296|3681154|FG002|NOT COMPLETED|Overall Study||2
2966861|NCT00777296|3681155|FG003|NOT COMPLETED|Overall Study||1
2966862|NCT00777335|3681179|FG000|STARTED|Overall Study||2
2966863|NCT00777335|3681180|FG001|STARTED|Overall Study||2
2966864|NCT00777335|3681179|FG000|COMPLETED|Overall Study||2
2966865|NCT00777335|3681180|FG001|COMPLETED|Overall Study||2
2966866|NCT00777335|3681179|FG000|NOT COMPLETED|Overall Study||0
2966867|NCT00777335|3681180|FG001|NOT COMPLETED|Overall Study||0
2966868|NCT00777491|3681188|FG000|STARTED|Overall Study||35
2966869|NCT00777491|3681189|FG001|STARTED|Overall Study||35
3133130|NCT01694966|3858269|FG001|STARTED|Overall Study||247
3133131|NCT01694966|3858270|FG002|STARTED|Overall Study||498
3133132|NCT01694966|3858268|FG000|COMPLETED|Overall Study||470
2966870|NCT00777491|3681188|FG000|Eligible|Overall Study||33
2966871|NCT00777491|3681189|FG001|Eligible|Overall Study||33
2966872|NCT00777491|3681188|FG000|Has 3-year Efficacy Data|Overall Study||27
2966873|NCT00777491|3681189|FG001|Has 3-year Efficacy Data|Overall Study||25
2966874|NCT00777491|3681188|FG000|Started Induction Therapy|Overall Study||33
2966875|NCT00777491|3681189|FG001|Started Induction Therapy|Overall Study||33
2966876|NCT00777491|3681188|FG000|Started Consolidation Therapy|Overall Study||29
2966877|NCT00777491|3681189|FG001|Started Consolidation Therapy|Overall Study||25
2966878|NCT00777491|3681188|FG000|Started Adjuvant Therapy|Overall Study||32
2966879|NCT00777491|3681189|FG001|Started Adjuvant Therapy|Overall Study||31
2966880|NCT00777491|3681188|FG000|Has Adverse Event Data (Treatment)|Overall Study||33
2966881|NCT00777491|3681189|FG001|Has Adverse Event Data (Treatment)|Overall Study||33
2966882|NCT00777491|3681188|FG000|Has Adverse Event Data (Late)|Overall Study||32
2966883|NCT00777491|3681189|FG001|Has Adverse Event Data (Late)|Overall Study||31
2966884|NCT00777491|3681188|FG000|Has 3 Year AUASI Data|Overall Study||6
2966885|NCT00777491|3681189|FG001|Has 3 Year AUASI Data|Overall Study||6
2966886|NCT00777491|3681188|FG000|COMPLETED|Overall Study||33
2966887|NCT00777491|3681189|FG001|COMPLETED|Overall Study||33
2966888|NCT00777491|3681188|FG000|NOT COMPLETED|Overall Study||2
2966889|NCT00777491|3681189|FG001|NOT COMPLETED|Overall Study||2
2966890|NCT00777556|3681195|FG000|STARTED|Overall Study|Enrolled; signed informed consent|343
2966891|NCT00777556|3681195|FG000|Dispensed Product|Overall Study||307
2966892|NCT00777556|3681195|FG000|Safety Population|Overall Study|Participants who used the product; two were given product in error (inappropriately self-selected)|299
2966893|NCT00777556|3681195|FG000|Used Product|Overall Study||297
2966894|NCT00777556|3681195|FG000|COMPLETED|Overall Study|Completed all 3 follow-up visits|277
2966895|NCT00777556|3681195|FG000|NOT COMPLETED|Overall Study||66
2966896|NCT00777608|3681201|FG000|STARTED|Overall Study||53
2966897|NCT00777608|3681202|FG001|STARTED|Overall Study||53
2966898|NCT00777608|3681201|FG000|COMPLETED|Overall Study||49
2966899|NCT00777608|3681202|FG001|COMPLETED|Overall Study||47
2966900|NCT00777608|3681201|FG000|NOT COMPLETED|Overall Study||4
2966901|NCT00777608|3681202|FG001|NOT COMPLETED|Overall Study||6
2966902|NCT00777634|3681210|FG000|STARTED|Overall Study||134
2966903|NCT00777634|3681211|FG001|STARTED|Overall Study||134
2966904|NCT00777634|3681210|FG000|COMPLETED|Overall Study||129
2966905|NCT00777634|3681211|FG001|COMPLETED|Overall Study||133
2966906|NCT00777634|3681210|FG000|NOT COMPLETED|Overall Study||5
2966907|NCT00777634|3681211|FG001|NOT COMPLETED|Overall Study||1
2966908|NCT00777764|3681219|FG000|STARTED|Overall Study||30
3133133|NCT01694966|3858269|FG001|COMPLETED|Overall Study||232
3133134|NCT01694966|3858270|FG002|COMPLETED|Overall Study||464
3133135|NCT01694966|3858268|FG000|NOT COMPLETED|Overall Study||34
3133136|NCT01694966|3858269|FG001|NOT COMPLETED|Overall Study||15
2966909|NCT00777764|3681220|FG001|STARTED|Overall Study||30
2966910|NCT00777764|3681219|FG000|COMPLETED|Overall Study||30
2966911|NCT00777764|3681220|FG001|COMPLETED|Overall Study||29
2966912|NCT00777764|3681219|FG000|NOT COMPLETED|Overall Study||0
2966913|NCT00777764|3681220|FG001|NOT COMPLETED|Overall Study||1
2966914|NCT00777790|3681231|FG000|STARTED|Overall Study||76
2966915|NCT00777790|3681232|FG001|STARTED|Overall Study||77
2966916|NCT00777790|3681233|FG002|STARTED|Overall Study||88
2966917|NCT00777790|3681231|FG000|COMPLETED|Overall Study||76
2966918|NCT00777790|3681232|FG001|COMPLETED|Overall Study||77
2966919|NCT00777790|3681233|FG002|COMPLETED|Overall Study||88
2966920|NCT00777790|3681231|FG000|NOT COMPLETED|Overall Study||0
3133137|NCT01694966|3858270|FG002|NOT COMPLETED|Overall Study||34
3133138|NCT01695044|3858280|FG000|STARTED|Overall Study||119
3133139|NCT01695044|3858280|FG000|COMPLETED|Overall Study||17
3133140|NCT01695044|3858280|FG000|NOT COMPLETED|Overall Study||102
2966921|NCT00777790|3681232|FG001|NOT COMPLETED|Overall Study||0
2966922|NCT00777790|3681233|FG002|NOT COMPLETED|Overall Study||0
2966923|NCT00777803|3681243|FG000|STARTED|Overall Study||284
2966924|NCT00777803|3681244|FG001|STARTED|Overall Study||97
2966925|NCT00777803|3681243|FG000|COMPLETED|Overall Study||269
3133141|NCT01695135|3858290|FG000|STARTED|Double-blind Treatment Phase||71
2966926|NCT00777803|3681244|FG001|COMPLETED|Overall Study||90
2966927|NCT00777803|3681243|FG000|NOT COMPLETED|Overall Study||15
2966928|NCT00777803|3681244|FG001|NOT COMPLETED|Overall Study||7
2966929|NCT00777829|3681250|FG000|STARTED|Overall Study||15
2966930|NCT00777829|3681251|FG001|STARTED|Overall Study||15
2966931|NCT00777829|3681250|FG000|Study Orientation|Overall Study||15
2966932|NCT00777829|3681251|FG001|Study Orientation|Overall Study||13
2966933|NCT00777829|3681250|FG000|COMPLETED|Overall Study||15
2966934|NCT00777829|3681251|FG001|COMPLETED|Overall Study||13
2966935|NCT00777829|3681250|FG000|NOT COMPLETED|Overall Study||0
2966936|NCT00777829|3681251|FG001|NOT COMPLETED|Overall Study||2
2966937|NCT00777855|3681259|FG000|STARTED|First Intervention||5
2966938|NCT00777855|3681260|FG001|STARTED|First Intervention||5
2966939|NCT00777855|3681259|FG000|COMPLETED|First Intervention||5
2966940|NCT00777855|3681260|FG001|COMPLETED|First Intervention||5
2966941|NCT00777855|3681259|FG000|NOT COMPLETED|First Intervention||0
2966942|NCT00777855|3681260|FG001|NOT COMPLETED|First Intervention||0
3133142|NCT01695135|3858291|FG001|STARTED|Double-blind Treatment Phase||143
3133143|NCT01695135|3858292|FG002|STARTED|Double-blind Treatment Phase||0
3133144|NCT01695135|3858293|FG003|STARTED|Double-blind Treatment Phase||0
3133145|NCT01695135|3858290|FG000|COMPLETED|Double-blind Treatment Phase||0
3133146|NCT01695135|3858291|FG001|COMPLETED|Double-blind Treatment Phase||4
2966943|NCT00777855|3681259|FG000|STARTED|Washout Period (>= 14 Days)||5
2966944|NCT00777855|3681260|FG001|STARTED|Washout Period (>= 14 Days)||5
2966945|NCT00777855|3681259|FG000|COMPLETED|Washout Period (>= 14 Days)||5
2966946|NCT00777855|3681260|FG001|COMPLETED|Washout Period (>= 14 Days)||5
2966947|NCT00777855|3681259|FG000|NOT COMPLETED|Washout Period (>= 14 Days)||0
2966948|NCT00777855|3681260|FG001|NOT COMPLETED|Washout Period (>= 14 Days)||0
2966949|NCT00777855|3681259|FG000|STARTED|Second Intervention||5
2966950|NCT00777855|3681260|FG001|STARTED|Second Intervention||5
2966951|NCT00777855|3681259|FG000|COMPLETED|Second Intervention||5
2966952|NCT00777855|3681260|FG001|COMPLETED|Second Intervention||5
2966953|NCT00777855|3681259|FG000|NOT COMPLETED|Second Intervention||0
2966954|NCT00777855|3681260|FG001|NOT COMPLETED|Second Intervention||0
2966955|NCT00777920|3681265|FG000|STARTED|Overall Study||140
2966956|NCT00777920|3681265|FG000|COMPLETED|Overall Study||90
2966957|NCT00777920|3681265|FG000|NOT COMPLETED|Overall Study||50
2966958|NCT00777946|3681272|FG000|STARTED|Overall Study|1 patient in the Aliskiren 300 mg/Amlodipine 10 mg group was randomized in error.|283
2966959|NCT00777946|3681273|FG001|STARTED|Overall Study|1 patient in the Aliskiren 300 mg/Amlodipine 5 mg group was randomized in error.|277
2966960|NCT00777946|3681274|FG002|STARTED|Overall Study||260
2966961|NCT00777946|3681272|FG000|Safety & Full Analysis Sets|Overall Study||282
2966962|NCT00777946|3681273|FG001|Safety & Full Analysis Sets|Overall Study||276
2966963|NCT00777946|3681274|FG002|Safety & Full Analysis Sets|Overall Study||260
2966964|NCT00777946|3681272|FG000|COMPLETED|Overall Study||262
2966965|NCT00777946|3681273|FG001|COMPLETED|Overall Study||271
2966966|NCT00777946|3681274|FG002|COMPLETED|Overall Study||244
2966967|NCT00777946|3681272|FG000|NOT COMPLETED|Overall Study||21
2966968|NCT00777946|3681273|FG001|NOT COMPLETED|Overall Study||6
2966969|NCT00777946|3681274|FG002|NOT COMPLETED|Overall Study||16
2966970|NCT00778102|3681284|FG000|STARTED|Overall Study||39
2966971|NCT00778102|3681285|FG001|STARTED|Overall Study||41
2966972|NCT00778102|3681284|FG000|COMPLETED|Overall Study||18
2966973|NCT00778102|3681285|FG001|COMPLETED|Overall Study||19
2966974|NCT00778102|3681284|FG000|NOT COMPLETED|Overall Study||21
2966975|NCT00778102|3681285|FG001|NOT COMPLETED|Overall Study||22
2966976|NCT00778167|3681294|FG000|STARTED|Overall Study||6
2966977|NCT00778167|3681295|FG001|STARTED|Overall Study||8
2966978|NCT00778167|3681296|FG002|STARTED|Overall Study||4
2966979|NCT00778167|3681294|FG000|COMPLETED|Overall Study||6
2966980|NCT00778167|3681295|FG001|COMPLETED|Overall Study||8
2966981|NCT00778167|3681296|FG002|COMPLETED|Overall Study||4
2966982|NCT00778167|3681294|FG000|NOT COMPLETED|Overall Study||0
2966983|NCT00778167|3681295|FG001|NOT COMPLETED|Overall Study||0
2966984|NCT00778167|3681296|FG002|NOT COMPLETED|Overall Study||0
2966985|NCT00778258|3681313|FG000|STARTED|Overall Study||16
2966986|NCT00778258|3681314|FG001|STARTED|Overall Study||5
2966987|NCT00778258|3681315|FG002|STARTED|Overall Study||20
2966988|NCT00778258|3681316|FG003|STARTED|Overall Study||15
2966989|NCT00778258|3681317|FG004|STARTED|Overall Study||6
2966990|NCT00778258|3681318|FG005|STARTED|Overall Study||23
2966991|NCT00778258|3681319|FG006|STARTED|Overall Study||34
2966992|NCT00778258|3681320|FG007|STARTED|Overall Study||41
2966993|NCT00778258|3681321|FG008|STARTED|Overall Study||10
2966994|NCT00778258|3681313|FG000|COMPLETED|Overall Study||9
2966995|NCT00778258|3681314|FG001|COMPLETED|Overall Study||3
2966996|NCT00778258|3681315|FG002|COMPLETED|Overall Study||10
2966997|NCT00778258|3681316|FG003|COMPLETED|Overall Study||12
2966998|NCT00778258|3681317|FG004|COMPLETED|Overall Study||6
2966999|NCT00778258|3681318|FG005|COMPLETED|Overall Study||13
2967000|NCT00778258|3681319|FG006|COMPLETED|Overall Study||19
2967001|NCT00778258|3681320|FG007|COMPLETED|Overall Study||26
2967002|NCT00778258|3681321|FG008|COMPLETED|Overall Study||6
2967003|NCT00778258|3681313|FG000|NOT COMPLETED|Overall Study||7
2967004|NCT00778258|3681314|FG001|NOT COMPLETED|Overall Study||2
2967005|NCT00778258|3681315|FG002|NOT COMPLETED|Overall Study||10
2967006|NCT00778258|3681316|FG003|NOT COMPLETED|Overall Study||3
2967007|NCT00778258|3681317|FG004|NOT COMPLETED|Overall Study||0
2967008|NCT00778258|3681318|FG005|NOT COMPLETED|Overall Study||10
2967009|NCT00778258|3681319|FG006|NOT COMPLETED|Overall Study||15
2967010|NCT00778258|3681320|FG007|NOT COMPLETED|Overall Study||15
2967011|NCT00778258|3681321|FG008|NOT COMPLETED|Overall Study||4
2967012|NCT00778310|3681349|FG000|STARTED|Overall Study||17
2967013|NCT00778310|3681350|FG001|STARTED|Overall Study||26
2967014|NCT00778310|3681349|FG000|Usable Data|Overall Study||14
2967015|NCT00778310|3681350|FG001|Usable Data|Overall Study||21
2967016|NCT00778310|3681349|FG000|COMPLETED|Overall Study||17
2967017|NCT00778310|3681350|FG001|COMPLETED|Overall Study||26
2967018|NCT00778310|3681349|FG000|NOT COMPLETED|Overall Study||0
2967019|NCT00778310|3681350|FG001|NOT COMPLETED|Overall Study||0
2967020|NCT00778336|3681362|FG000|STARTED|Index Procedure-Discharge||198
2967021|NCT00778336|3681363|FG001|STARTED|Index Procedure-Discharge||170
2967022|NCT00778336|3681364|FG002|STARTED|Index Procedure-Discharge||72
2967023|NCT00778336|3681365|FG003|STARTED|Index Procedure-Discharge||12
2967024|NCT00778336|3681362|FG000|COMPLETED|Index Procedure-Discharge||192
2967025|NCT00778336|3681363|FG001|COMPLETED|Index Procedure-Discharge||167
2967026|NCT00778336|3681364|FG002|COMPLETED|Index Procedure-Discharge||70
2967027|NCT00778336|3681365|FG003|COMPLETED|Index Procedure-Discharge||12
2967028|NCT00778336|3681362|FG000|NOT COMPLETED|Index Procedure-Discharge||6
2967029|NCT00778336|3681363|FG001|NOT COMPLETED|Index Procedure-Discharge||3
2967030|NCT00778336|3681364|FG002|NOT COMPLETED|Index Procedure-Discharge||2
2967031|NCT00778336|3681365|FG003|NOT COMPLETED|Index Procedure-Discharge||0
2967032|NCT00778336|3681362|FG000|STARTED|3 Month Follow Up||192
2967033|NCT00778336|3681363|FG001|STARTED|3 Month Follow Up||167
2967034|NCT00778336|3681364|FG002|STARTED|3 Month Follow Up||70
2967035|NCT00778336|3681365|FG003|STARTED|3 Month Follow Up||12
2967036|NCT00778336|3681362|FG000|COMPLETED|3 Month Follow Up||169
2967037|NCT00778336|3681363|FG001|COMPLETED|3 Month Follow Up||144
2967038|NCT00778336|3681364|FG002|COMPLETED|3 Month Follow Up||65
2967039|NCT00778336|3681365|FG003|COMPLETED|3 Month Follow Up||12
2967040|NCT00778336|3681362|FG000|NOT COMPLETED|3 Month Follow Up||23
2967041|NCT00778336|3681363|FG001|NOT COMPLETED|3 Month Follow Up||23
2967042|NCT00778336|3681364|FG002|NOT COMPLETED|3 Month Follow Up||5
2967043|NCT00778336|3681365|FG003|NOT COMPLETED|3 Month Follow Up||0
2967044|NCT00778375|3681375|FG000|STARTED|Overall Study||122
2967045|NCT00778375|3681375|FG000|COMPLETED|Overall Study||119
2967046|NCT00778375|3681375|FG000|NOT COMPLETED|Overall Study||3
2967047|NCT00778622|3681384|FG000|STARTED|Overall Study||125
2967048|NCT00778622|3681385|FG001|STARTED|Overall Study||122
2967049|NCT00778622|3681386|FG002|STARTED|Overall Study||124
2967050|NCT00778622|3681384|FG000|COMPLETED|Overall Study||109
2967051|NCT00778622|3681385|FG001|COMPLETED|Overall Study||107
2967052|NCT00778622|3681386|FG002|COMPLETED|Overall Study||109
2967053|NCT00778622|3681384|FG000|NOT COMPLETED|Overall Study||16
2967054|NCT00778622|3681385|FG001|NOT COMPLETED|Overall Study||15
2967055|NCT00778622|3681386|FG002|NOT COMPLETED|Overall Study||15
2967056|NCT00778648|3681400|FG000|STARTED|Overall Study||272
2967057|NCT00778648|3681401|FG001|STARTED|Overall Study||271
2967058|NCT00778648|3681400|FG000|COMPLETED|Overall Study||263
2967059|NCT00778648|3681401|FG001|COMPLETED|Overall Study||266
2967060|NCT00778648|3681400|FG000|NOT COMPLETED|Overall Study||9
2967061|NCT00778648|3681401|FG001|NOT COMPLETED|Overall Study||5
2967062|NCT00778817|3681407|FG000|STARTED|Overall Study||20
2967063|NCT00778817|3681407|FG000|COMPLETED|Overall Study||16
2967064|NCT00778817|3681407|FG000|NOT COMPLETED|Overall Study||4
2967065|NCT00778830|3681413|FG000|STARTED|Overall Study||101
2967066|NCT00778830|3681414|FG001|STARTED|Overall Study||188
2967067|NCT00778830|3681413|FG000|COMPLETED|Overall Study||101
2967068|NCT00778830|3681414|FG001|COMPLETED|Overall Study||187
2967069|NCT00778830|3681413|FG000|NOT COMPLETED|Overall Study||0
2967070|NCT00778830|3681414|FG001|NOT COMPLETED|Overall Study||1
2967071|NCT00778869|3681420|FG000|STARTED|Overall Study||10
2967072|NCT00778869|3681420|FG000|COMPLETED|Overall Study||10
2967073|NCT00778869|3681420|FG000|NOT COMPLETED|Overall Study||0
2967074|NCT00778895|3681427|FG000|STARTED|Active Phase||164
2967075|NCT00778895|3681428|FG001|STARTED|Active Phase||167
2967076|NCT00778895|3681429|FG002|STARTED|Active Phase||43
2967077|NCT00778895|3681427|FG000|COMPLETED|Active Phase||157
2967078|NCT00778895|3681428|FG001|COMPLETED|Active Phase||161
2967079|NCT00778895|3681429|FG002|COMPLETED|Active Phase||43
2967080|NCT00778895|3681427|FG000|NOT COMPLETED|Active Phase||7
2967081|NCT00778895|3681428|FG001|NOT COMPLETED|Active Phase||6
2967082|NCT00778895|3681429|FG002|NOT COMPLETED|Active Phase||0
2967083|NCT00778895|3681427|FG000|STARTED|ESFU Phase||164
2967084|NCT00778895|3681428|FG001|STARTED|ESFU Phase||167
2967085|NCT00778895|3681429|FG002|STARTED|ESFU Phase||43
2967086|NCT00778895|3681427|FG000|COMPLETED|ESFU Phase||153
2967087|NCT00778895|3681428|FG001|COMPLETED|ESFU Phase||155
2967088|NCT00778895|3681429|FG002|COMPLETED|ESFU Phase||41
2967089|NCT00778895|3681427|FG000|NOT COMPLETED|ESFU Phase||11
2967090|NCT00778895|3681428|FG001|NOT COMPLETED|ESFU Phase||12
2967091|NCT00778895|3681429|FG002|NOT COMPLETED|ESFU Phase||2
3301990|NCT02957682|4035674|FG000|STARTED|Overall Study||1088
3301991|NCT02957682|4035675|FG001|STARTED|Overall Study||1088
3301992|NCT02957682|4035674|FG000|Randomized and Treated|Overall Study||1085
3301993|NCT02957682|4035675|FG001|Randomized and Treated|Overall Study||1086
3301994|NCT02957682|4035674|FG000|COMPLETED|Overall Study||890
3301995|NCT02957682|4035675|FG001|COMPLETED|Overall Study||919
3301996|NCT02957682|4035674|FG000|NOT COMPLETED|Overall Study||198
3301997|NCT02957682|4035675|FG001|NOT COMPLETED|Overall Study||169
2967092|NCT00778921|3681441|FG000|STARTED|Overall Study||279
2967093|NCT00778921|3681442|FG001|STARTED|Overall Study||285
2967094|NCT00778921|3681443|FG002|STARTED|Overall Study||283
2967095|NCT00778921|3681441|FG000|COMPLETED|Overall Study||261
2967096|NCT00778921|3681442|FG001|COMPLETED|Overall Study||266
2967097|NCT00778921|3681443|FG002|COMPLETED|Overall Study||255
2967098|NCT00778921|3681441|FG000|NOT COMPLETED|Overall Study||18
2967099|NCT00778921|3681442|FG001|NOT COMPLETED|Overall Study||19
2967100|NCT00778921|3681443|FG002|NOT COMPLETED|Overall Study||28
2967101|NCT00779025|3681451|FG000|STARTED|Overall Study||82
2967102|NCT00779025|3681451|FG000|COMPLETED|Overall Study||81
2967103|NCT00779025|3681451|FG000|NOT COMPLETED|Overall Study||1
2967104|NCT00779103|3681456|FG000|STARTED|Overall Study|Initial Phase (First Implant) - 36 Completed|36
2967105|NCT00779103|3681456|FG000|Second & Third Implant|Overall Study|Initial Extension Phase/Extended Access Phase (Second and Third Implant) - 22 Completed|31
2967106|NCT00779103|3681456|FG000|Fourth Implant|Overall Study|Second Extension Phase (4th Implant with Yearly Implantations till no longer required): 11 Completed|13
2967107|NCT00779103|3681456|FG000|No Treatment|Overall Study|Optional Long Term Follow-up Phase (No Treatment)|9
2967108|NCT00779103|3681456|FG000|COMPLETED|Overall Study|Initial Phase (First Implant)|36
2967109|NCT00779103|3681456|FG000|NOT COMPLETED|Overall Study||0
2967110|NCT00779142|3681464|FG000|STARTED|Overall Study|5 patients signed consent and were screened.|5
2967111|NCT00779142|3681464|FG000|COMPLETED|Overall Study|Only 2 patients were actually enrolled.|2
2967112|NCT00779142|3681464|FG000|NOT COMPLETED|Overall Study||3
2967113|NCT00779155|3681471|FG000|STARTED|Overall Study||6
2967114|NCT00779155|3681472|FG001|STARTED|Overall Study||6
2967115|NCT00779155|3681471|FG000|COMPLETED|Overall Study||6
2967116|NCT00779155|3681472|FG001|COMPLETED|Overall Study||6
2967117|NCT00779155|3681471|FG000|NOT COMPLETED|Overall Study||0
2967118|NCT00779155|3681472|FG001|NOT COMPLETED|Overall Study||0
2967119|NCT00779246|3681480|FG000|STARTED|Overall Study||750
2967120|NCT00779246|3681481|FG001|STARTED|Overall Study||768
2967121|NCT00779246|3681480|FG000|COMPLETED|Overall Study||717
2967122|NCT00779246|3681481|FG001|COMPLETED|Overall Study||715
2967123|NCT00779246|3681480|FG000|NOT COMPLETED|Overall Study||33
2967124|NCT00779246|3681481|FG001|NOT COMPLETED|Overall Study||53
3133147|NCT01695135|3858292|FG002|COMPLETED|Double-blind Treatment Phase||0
3133148|NCT01695135|3858293|FG003|COMPLETED|Double-blind Treatment Phase||0
3133149|NCT01695135|3858290|FG000|NOT COMPLETED|Double-blind Treatment Phase||71
3133150|NCT01695135|3858291|FG001|NOT COMPLETED|Double-blind Treatment Phase||139
3133151|NCT01695135|3858292|FG002|NOT COMPLETED|Double-blind Treatment Phase||0
2967125|NCT00779259|3681487|FG000|STARTED|Theophylline Alone||24
2967126|NCT00779259|3681487|FG000|COMPLETED|Theophylline Alone||24
2967127|NCT00779259|3681487|FG000|NOT COMPLETED|Theophylline Alone||0
2967128|NCT00779259|3681487|FG000|STARTED|4 Day Washout Period||24
2967129|NCT00779259|3681487|FG000|COMPLETED|4 Day Washout Period||24
2967130|NCT00779259|3681487|FG000|NOT COMPLETED|4 Day Washout Period||0
2967131|NCT00779259|3681487|FG000|STARTED|Quinine Alone||24
2967132|NCT00779259|3681487|FG000|COMPLETED|Quinine Alone||22
2967133|NCT00779259|3681487|FG000|NOT COMPLETED|Quinine Alone||2
2967134|NCT00779259|3681487|FG000|STARTED|Theophylline With Quinine||22
2967135|NCT00779259|3681487|FG000|COMPLETED|Theophylline With Quinine||22
2967136|NCT00779259|3681487|FG000|NOT COMPLETED|Theophylline With Quinine||0
2967137|NCT00779285|3681505|FG000|STARTED|Overall Study||1
2967138|NCT00779285|3681505|FG000|COMPLETED|Overall Study||1
2967139|NCT00779285|3681505|FG000|NOT COMPLETED|Overall Study||0
2967140|NCT00779311|3681514|FG000|STARTED|Overall Study|2 of 6 patients were not evaluable for DLT assessment and were replaced for a total of 8 enrolled.|8
2967141|NCT00779311|3681515|FG001|STARTED|Overall Study||0
2967142|NCT00779311|3681516|FG002|STARTED|Overall Study||0
2967143|NCT00779311|3681517|FG003|STARTED|Overall Study||0
2967144|NCT00779311|3681518|FG004|STARTED|Overall Study||0
2967145|NCT00779311|3681514|FG000|Dose Limiting Toxicity (DLT) Evaluation|Overall Study||6
2967146|NCT00779311|3681515|FG001|Dose Limiting Toxicity (DLT) Evaluation|Overall Study||0
2967147|NCT00779311|3681516|FG002|Dose Limiting Toxicity (DLT) Evaluation|Overall Study||0
2967148|NCT00779311|3681517|FG003|Dose Limiting Toxicity (DLT) Evaluation|Overall Study||0
2967149|NCT00779311|3681518|FG004|Dose Limiting Toxicity (DLT) Evaluation|Overall Study||0
2967150|NCT00779311|3681514|FG000|COMPLETED|Overall Study||8
2967151|NCT00779311|3681515|FG001|COMPLETED|Overall Study||0
2967152|NCT00779311|3681516|FG002|COMPLETED|Overall Study||0
2967153|NCT00779311|3681517|FG003|COMPLETED|Overall Study||0
2967154|NCT00779311|3681518|FG004|COMPLETED|Overall Study||0
2967155|NCT00779311|3681514|FG000|NOT COMPLETED|Overall Study||0
2967156|NCT00779311|3681515|FG001|NOT COMPLETED|Overall Study||0
2967157|NCT00779311|3681516|FG002|NOT COMPLETED|Overall Study||0
2967158|NCT00779311|3681517|FG003|NOT COMPLETED|Overall Study||0
2967159|NCT00779311|3681518|FG004|NOT COMPLETED|Overall Study||0
2967160|NCT00779324|3681532|FG000|STARTED|Overall Study||82
2967161|NCT00779324|3681533|FG001|STARTED|Overall Study||86
2967162|NCT00779324|3681532|FG000|Completed 28-day Mid-point|Overall Study||80
2967163|NCT00779324|3681533|FG001|Completed 28-day Mid-point|Overall Study||81
2967164|NCT00779324|3681532|FG000|COMPLETED|Overall Study||75
2967165|NCT00779324|3681533|FG001|COMPLETED|Overall Study||82
2967166|NCT00779324|3681532|FG000|NOT COMPLETED|Overall Study||7
2967167|NCT00779324|3681533|FG001|NOT COMPLETED|Overall Study||4
2967168|NCT00779402|3681541|FG000|STARTED|Treatment Phase 1||117
2967169|NCT00779402|3681542|FG001|STARTED|Treatment Phase 1||59
2967170|NCT00779402|3681541|FG000|Received ≥1 Leukapherisis (Safety Set)|Treatment Phase 1||116
2967171|NCT00779402|3681542|FG001|Received ≥1 Leukapherisis (Safety Set)|Treatment Phase 1||59
2967172|NCT00779402|3681541|FG000|Received ≥1 Study Product (Exposure Set)|Treatment Phase 1||113
2967173|NCT00779402|3681542|FG001|Received ≥1 Study Product (Exposure Set)|Treatment Phase 1||59
2967174|NCT00779402|3681541|FG000|Received Booster Infusion|Treatment Phase 1||50
2967175|NCT00779402|3681542|FG001|Received Booster Infusion|Treatment Phase 1||30
2967176|NCT00779402|3681541|FG000|COMPLETED|Treatment Phase 1||84
2967177|NCT00779402|3681542|FG001|COMPLETED|Treatment Phase 1||44
2967178|NCT00779402|3681541|FG000|NOT COMPLETED|Treatment Phase 1||33
2967179|NCT00779402|3681542|FG001|NOT COMPLETED|Treatment Phase 1||15
2967180|NCT00779402|3681541|FG000|STARTED|Surveillance Phase||84
2967181|NCT00779402|3681542|FG001|STARTED|Surveillance Phase||44
2967182|NCT00779402|3681541|FG000|COMPLETED|Surveillance Phase||41
2967183|NCT00779402|3681542|FG001|COMPLETED|Surveillance Phase||13
2967184|NCT00779402|3681541|FG000|NOT COMPLETED|Surveillance Phase||43
2967185|NCT00779402|3681542|FG001|NOT COMPLETED|Surveillance Phase||31
2967186|NCT00779402|3681541|FG000|STARTED|Long-term Follow-up||41
2967187|NCT00779402|3681542|FG001|STARTED|Long-term Follow-up||13
2967188|NCT00779402|3681541|FG000|COMPLETED|Long-term Follow-up||20
2967189|NCT00779402|3681542|FG001|COMPLETED|Long-term Follow-up||7
2967190|NCT00779402|3681541|FG000|NOT COMPLETED|Long-term Follow-up||21
2967191|NCT00779402|3681542|FG001|NOT COMPLETED|Long-term Follow-up||6
2967192|NCT00779467|3681552|FG000|STARTED|Overall Study||53
2967193|NCT00779467|3681553|FG001|STARTED|Overall Study||45
2967194|NCT00779467|3681554|FG002|STARTED|Overall Study||48
2967195|NCT00779467|3681555|FG003|STARTED|Overall Study||54
2967196|NCT00779467|3681552|FG000|COMPLETED|Overall Study||38
2967197|NCT00779467|3681553|FG001|COMPLETED|Overall Study||40
2967198|NCT00779467|3681554|FG002|COMPLETED|Overall Study||38
2967199|NCT00779467|3681555|FG003|COMPLETED|Overall Study||35
2967200|NCT00779467|3681552|FG000|NOT COMPLETED|Overall Study||15
2967201|NCT00779467|3681553|FG001|NOT COMPLETED|Overall Study||5
2967202|NCT00779467|3681554|FG002|NOT COMPLETED|Overall Study||10
2967203|NCT00779467|3681555|FG003|NOT COMPLETED|Overall Study||19
2967204|NCT00779506|3681565|FG000|STARTED|Overall Study||96
2967205|NCT00779506|3681565|FG000|Enrolled|Overall Study||96
2967206|NCT00779506|3681565|FG000|Screen Failed|Overall Study||2
2967207|NCT00779506|3681565|FG000|Assigned|Overall Study||94
2967208|NCT00779506|3681565|FG000|MITT|Overall Study||89
2967209|NCT00779506|3681565|FG000|Treatment Complete|Overall Study||67
2967210|NCT00779506|3681565|FG000|Withdrawal Treatment|Overall Study||27
2967211|NCT00779506|3681565|FG000|COMPLETED|Overall Study||67
2967212|NCT00779506|3681565|FG000|NOT COMPLETED|Overall Study||29
2967213|NCT00779558|3681571|FG000|STARTED|Overall Study||57
2967214|NCT00779558|3681572|FG001|STARTED|Overall Study||44
2967215|NCT00779558|3681571|FG000|COMPLETED|Overall Study||53
2967216|NCT00779558|3681572|FG001|COMPLETED|Overall Study||37
2967217|NCT00779558|3681571|FG000|NOT COMPLETED|Overall Study||4
2967218|NCT00779558|3681572|FG001|NOT COMPLETED|Overall Study||7
2967219|NCT00779584|3681587|FG000|STARTED|Overall Study||3
2967220|NCT00779584|3681588|FG001|STARTED|Overall Study||3
2967221|NCT00779584|3681589|FG002|STARTED|Overall Study||7
2967222|NCT00779584|3681590|FG003|STARTED|Overall Study||6
2967223|NCT00779584|3681591|FG004|STARTED|Overall Study||7
2967224|NCT00779584|3681592|FG005|STARTED|Overall Study||6
3301998|NCT02957747|4035683|FG000|STARTED|Overall Study||76
3301999|NCT02957747|4035684|FG001|STARTED|Overall Study||77
2967225|NCT00779584|3681593|FG006|STARTED|Overall Study||8
2967226|NCT00779584|3681594|FG007|STARTED|Overall Study||3
2967227|NCT00779584|3681595|FG008|STARTED|Overall Study||2
2967228|NCT00779584|3681587|FG000|Treated|Overall Study||3
2967229|NCT00779584|3681588|FG001|Treated|Overall Study||3
2967230|NCT00779584|3681589|FG002|Treated|Overall Study||7
2967231|NCT00779584|3681590|FG003|Treated|Overall Study||6
2967232|NCT00779584|3681591|FG004|Treated|Overall Study||7
2967233|NCT00779584|3681592|FG005|Treated|Overall Study||4
2967234|NCT00779584|3681593|FG006|Treated|Overall Study||8
2967235|NCT00779584|3681594|FG007|Treated|Overall Study||3
2967236|NCT00779584|3681595|FG008|Treated|Overall Study||2
2967237|NCT00779584|3681587|FG000|COMPLETED|Overall Study||0
2967238|NCT00779584|3681588|FG001|COMPLETED|Overall Study||0
2967239|NCT00779584|3681589|FG002|COMPLETED|Overall Study||0
2967240|NCT00779584|3681590|FG003|COMPLETED|Overall Study||0
2967241|NCT00779584|3681591|FG004|COMPLETED|Overall Study||0
2967242|NCT00779584|3681592|FG005|COMPLETED|Overall Study||0
2967243|NCT00779584|3681593|FG006|COMPLETED|Overall Study||0
2967244|NCT00779584|3681594|FG007|COMPLETED|Overall Study||0
2967245|NCT00779584|3681595|FG008|COMPLETED|Overall Study||0
2967246|NCT00779584|3681587|FG000|NOT COMPLETED|Overall Study||3
3133152|NCT01695135|3858293|FG003|NOT COMPLETED|Double-blind Treatment Phase||0
3133153|NCT01695135|3858290|FG000|STARTED|Open Label Extension Treatment Phase||0
3133154|NCT01695135|3858291|FG001|STARTED|Open Label Extension Treatment Phase||0
2967247|NCT00779584|3681588|FG001|NOT COMPLETED|Overall Study||3
2967248|NCT00779584|3681589|FG002|NOT COMPLETED|Overall Study||7
2967249|NCT00779584|3681590|FG003|NOT COMPLETED|Overall Study||6
2967250|NCT00779584|3681591|FG004|NOT COMPLETED|Overall Study||7
2967251|NCT00779584|3681592|FG005|NOT COMPLETED|Overall Study||6
2967252|NCT00779584|3681593|FG006|NOT COMPLETED|Overall Study||8
2967253|NCT00779584|3681594|FG007|NOT COMPLETED|Overall Study||3
2967254|NCT00779584|3681595|FG008|NOT COMPLETED|Overall Study||2
3035639|NCT01138826|3754955|FG003|COMPLETED|Washout Period I (of 16 Days)||3
3035640|NCT01138826|3754956|FG004|COMPLETED|Washout Period I (of 16 Days)||2
2967255|NCT00779675|3681615|FG000|STARTED|Treatment Period|One of the 660 participants did not receive study treatment.|660
2967256|NCT00779675|3681615|FG000|COMPLETED|Treatment Period||328
2967257|NCT00779675|3681615|FG000|NOT COMPLETED|Treatment Period||332
2967258|NCT00779675|3681615|FG000|STARTED|Extended Treatment Period|Clinical responders during the treatment period could enter the extended treatment period.|193
2967259|NCT00779675|3681615|FG000|COMPLETED|Extended Treatment Period||147
2967260|NCT00779675|3681615|FG000|NOT COMPLETED|Extended Treatment Period||46
2967261|NCT00779701|3681623|FG000|STARTED|Overall Study||27
2967262|NCT00779701|3681623|FG000|COMPLETED|Overall Study||27
2967263|NCT00779701|3681623|FG000|NOT COMPLETED|Overall Study||0
2967264|NCT00779766|3681629|FG000|STARTED|Month 24||3026
2967265|NCT00779766|3681630|FG001|STARTED|Month 24||3025
2967266|NCT00779766|3681629|FG000|COMPLETED|Month 24||2694
3133155|NCT01695135|3858292|FG002|STARTED|Open Label Extension Treatment Phase||49
3133156|NCT01695135|3858293|FG003|STARTED|Open Label Extension Treatment Phase||80
3133157|NCT01695135|3858290|FG000|COMPLETED|Open Label Extension Treatment Phase||0
3133158|NCT01695135|3858291|FG001|COMPLETED|Open Label Extension Treatment Phase||0
3133159|NCT01695135|3858292|FG002|COMPLETED|Open Label Extension Treatment Phase||9
3133160|NCT01695135|3858293|FG003|COMPLETED|Open Label Extension Treatment Phase||10
3133161|NCT01695135|3858290|FG000|NOT COMPLETED|Open Label Extension Treatment Phase||0
2967267|NCT00779766|3681630|FG001|COMPLETED|Month 24||2693
2967268|NCT00779766|3681629|FG000|NOT COMPLETED|Month 24||332
2967269|NCT00779766|3681630|FG001|NOT COMPLETED|Month 24||332
2967270|NCT00779766|3681629|FG000|STARTED|Month 48||2703
2967271|NCT00779766|3681630|FG001|STARTED|Month 48||2727
2967272|NCT00779766|3681629|FG000|COMPLETED|Month 48||2529
2967273|NCT00779766|3681630|FG001|COMPLETED|Month 48||2559
2967274|NCT00779766|3681629|FG000|NOT COMPLETED|Month 48||174
2967275|NCT00779766|3681630|FG001|NOT COMPLETED|Month 48||168
2967276|NCT00779766|3681629|FG000|STARTED|Month 72||2319
2967277|NCT00779766|3681630|FG001|STARTED|Month 72||2347
2967278|NCT00779766|3681629|FG000|COMPLETED|Month 72||2134
2967279|NCT00779766|3681630|FG001|COMPLETED|Month 72||2158
2967280|NCT00779766|3681629|FG000|NOT COMPLETED|Month 72||185
2967281|NCT00779766|3681630|FG001|NOT COMPLETED|Month 72||189
2967282|NCT00779779|3681637|FG000|STARTED|Overall Study||522
2967283|NCT00779779|3681637|FG000|COMPLETED|Overall Study||498
2967284|NCT00779779|3681637|FG000|NOT COMPLETED|Overall Study||24
2967285|NCT00779857|3681641|FG000|STARTED|Overall Study|70 patients treated|70
2967286|NCT00779857|3681641|FG000|30 Day Post Procedure|Overall Study|2 missed Visit|68
2967287|NCT00779857|3681641|FG000|3 Month Post Procedure|Overall Study|3 month follow-up, 65 of the subjects were available for evaluation.|65
2967288|NCT00779857|3681641|FG000|COMPLETED|Overall Study|12 Month Post procedure, 64 subjects available for evaluation|64
2967289|NCT00779857|3681641|FG000|NOT COMPLETED|Overall Study||6
2967290|NCT00779870|3681648|FG000|STARTED|Overall Study||5
2967291|NCT00779870|3681649|FG001|STARTED|Overall Study||6
2967292|NCT00779870|3681650|FG002|STARTED|Overall Study||7
2967293|NCT00779870|3681648|FG000|COMPLETED|Overall Study||5
2967294|NCT00779870|3681649|FG001|COMPLETED|Overall Study||6
2967295|NCT00779870|3681650|FG002|COMPLETED|Overall Study||7
2967296|NCT00779870|3681648|FG000|NOT COMPLETED|Overall Study||0
2967297|NCT00779870|3681649|FG001|NOT COMPLETED|Overall Study||0
2967298|NCT00779870|3681650|FG002|NOT COMPLETED|Overall Study||0
2967299|NCT00779909|3681662|FG000|STARTED|Overall Study||10
2967300|NCT00779909|3681663|FG001|STARTED|Overall Study||9
2967301|NCT00779909|3681664|FG002|STARTED|Overall Study||8
2967302|NCT00779909|3681665|FG003|STARTED|Overall Study||8
2967303|NCT00779909|3681662|FG000|COMPLETED|Overall Study||9
2967304|NCT00779909|3681663|FG001|COMPLETED|Overall Study||8
2967305|NCT00779909|3681664|FG002|COMPLETED|Overall Study||8
2967306|NCT00779909|3681665|FG003|COMPLETED|Overall Study||7
2967307|NCT00779909|3681662|FG000|NOT COMPLETED|Overall Study||1
2967308|NCT00779909|3681663|FG001|NOT COMPLETED|Overall Study||1
2967309|NCT00779909|3681664|FG002|NOT COMPLETED|Overall Study||0
2967310|NCT00779909|3681665|FG003|NOT COMPLETED|Overall Study||1
2967311|NCT00780026|3681684|FG000|STARTED|Overall Study||50
2967312|NCT00780026|3681685|FG001|STARTED|Overall Study||50
2967313|NCT00780026|3681684|FG000|COMPLETED|Overall Study||50
2967314|NCT00780026|3681685|FG001|COMPLETED|Overall Study||50
2967315|NCT00780026|3681684|FG000|NOT COMPLETED|Overall Study||0
2967316|NCT00780026|3681685|FG001|NOT COMPLETED|Overall Study||0
2967317|NCT00780143|3681691|FG000|STARTED|Overall Study||3
2967318|NCT00780143|3681691|FG000|COMPLETED|Overall Study||0
2967319|NCT00780143|3681691|FG000|NOT COMPLETED|Overall Study||3
2967320|NCT00780208|3681695|FG000|STARTED|Overall Study||14
2967321|NCT00780208|3681695|FG000|COMPLETED|Overall Study||8
2967322|NCT00780208|3681695|FG000|NOT COMPLETED|Overall Study||6
2967323|NCT00780234|3681701|FG000|STARTED|Overall Study||47
2967324|NCT00780234|3681702|FG001|STARTED|Overall Study||45
2967325|NCT00780234|3681701|FG000|COMPLETED|Overall Study||39
2967326|NCT00780234|3681702|FG001|COMPLETED|Overall Study||37
2967327|NCT00780234|3681701|FG000|NOT COMPLETED|Overall Study||8
2967328|NCT00780234|3681702|FG001|NOT COMPLETED|Overall Study||8
2967329|NCT00780273|3681708|FG000|STARTED|Overall Study||19
2967330|NCT00780273|3681708|FG000|COMPLETED|Overall Study||17
2967331|NCT00780273|3681708|FG000|NOT COMPLETED|Overall Study||2
2967332|NCT00780338|3681715|FG000|STARTED|Baseline to Mid (1 Year)||174
2967333|NCT00780338|3681716|FG001|STARTED|Baseline to Mid (1 Year)||202
2967334|NCT00780338|3681715|FG000|COMPLETED|Baseline to Mid (1 Year)||169
2967335|NCT00780338|3681716|FG001|COMPLETED|Baseline to Mid (1 Year)||164
2967336|NCT00780338|3681715|FG000|NOT COMPLETED|Baseline to Mid (1 Year)||5
2967337|NCT00780338|3681716|FG001|NOT COMPLETED|Baseline to Mid (1 Year)||38
2967338|NCT00780338|3681715|FG000|STARTED|Mid to Post (1 Year; 2 Years in Total)||169
2967339|NCT00780338|3681716|FG001|STARTED|Mid to Post (1 Year; 2 Years in Total)||164
2967340|NCT00780338|3681715|FG000|COMPLETED|Mid to Post (1 Year; 2 Years in Total)||156
2967341|NCT00780338|3681716|FG001|COMPLETED|Mid to Post (1 Year; 2 Years in Total)||159
2967342|NCT00780338|3681715|FG000|NOT COMPLETED|Mid to Post (1 Year; 2 Years in Total)||13
2967343|NCT00780338|3681716|FG001|NOT COMPLETED|Mid to Post (1 Year; 2 Years in Total)||5
2967344|NCT00780416|3681728|FG000|STARTED|Overall Study||126
2967345|NCT00780416|3681729|FG001|STARTED|Overall Study||63
2967346|NCT00780416|3681728|FG000|COMPLETED|Overall Study||114
2967347|NCT00780416|3681729|FG001|COMPLETED|Overall Study||54
2967348|NCT00780416|3681728|FG000|NOT COMPLETED|Overall Study||12
2967349|NCT00780416|3681729|FG001|NOT COMPLETED|Overall Study||9
2967350|NCT00780442|3681737|FG000|STARTED|Overall Study||12
2967351|NCT00780442|3681738|FG001|STARTED|Overall Study||15
2967352|NCT00780442|3681737|FG000|COMPLETED|Overall Study||12
2967353|NCT00780442|3681738|FG001|COMPLETED|Overall Study||15
2967354|NCT00780442|3681737|FG000|NOT COMPLETED|Overall Study||0
2967355|NCT00780442|3681738|FG001|NOT COMPLETED|Overall Study||0
2967356|NCT00780494|3681744|FG000|STARTED|Overall Study||35
2967357|NCT00780494|3681744|FG000|COMPLETED|Overall Study||35
2967358|NCT00780494|3681744|FG000|NOT COMPLETED|Overall Study||0
2967359|NCT00780559|3681750|FG000|STARTED|Overall Study||32
2967360|NCT00780559|3681751|FG001|STARTED|Overall Study||40
2967361|NCT00780559|3681750|FG000|COMPLETED|Overall Study||29
2967362|NCT00780559|3681751|FG001|COMPLETED|Overall Study||33
2967363|NCT00780559|3681750|FG000|NOT COMPLETED|Overall Study||3
2967364|NCT00780559|3681751|FG001|NOT COMPLETED|Overall Study||7
2967365|NCT00780572|3681761|FG000|STARTED|Overall Study||297
2967366|NCT00780572|3681762|FG001|STARTED|Overall Study||298
2967367|NCT00780572|3681761|FG000|COMPLETED|Overall Study||297
2967368|NCT00780572|3681762|FG001|COMPLETED|Overall Study||298
2967369|NCT00780572|3681761|FG000|NOT COMPLETED|Overall Study||0
2967370|NCT00780572|3681762|FG001|NOT COMPLETED|Overall Study||0
2967371|NCT00780676|3681773|FG000|STARTED|Overall Study||9
2967372|NCT00780676|3681774|FG001|STARTED|Overall Study||8
2967373|NCT00780676|3681775|FG002|STARTED|Overall Study||13
2967374|NCT00780676|3681776|FG003|STARTED|Overall Study||0
2967375|NCT00780676|3681777|FG004|STARTED|Overall Study||0
2967376|NCT00780676|3681773|FG000|COMPLETED|Overall Study||9
2967377|NCT00780676|3681774|FG001|COMPLETED|Overall Study||8
2967378|NCT00780676|3681775|FG002|COMPLETED|Overall Study||13
2967379|NCT00780676|3681776|FG003|COMPLETED|Overall Study||0
2967380|NCT00780676|3681777|FG004|COMPLETED|Overall Study||0
2967381|NCT00780676|3681773|FG000|NOT COMPLETED|Overall Study||0
2967382|NCT00780676|3681774|FG001|NOT COMPLETED|Overall Study||0
2967383|NCT00780676|3681775|FG002|NOT COMPLETED|Overall Study||0
2967384|NCT00780676|3681776|FG003|NOT COMPLETED|Overall Study||0
2967385|NCT00780676|3681777|FG004|NOT COMPLETED|Overall Study||0
2967386|NCT00780715|3681787|FG000|STARTED|Overall Study||6
2967387|NCT00780715|3681788|FG001|STARTED|Overall Study||6
2967388|NCT00780715|3681789|FG002|STARTED|Overall Study||6
2967389|NCT00780715|3681790|FG003|STARTED|Overall Study||11
2967390|NCT00780715|3681787|FG000|COMPLETED|Overall Study||6
2967391|NCT00780715|3681788|FG001|COMPLETED|Overall Study||6
2967392|NCT00780715|3681789|FG002|COMPLETED|Overall Study||6
2967393|NCT00780715|3681790|FG003|COMPLETED|Overall Study||11
2967394|NCT00780715|3681787|FG000|NOT COMPLETED|Overall Study||0
2967395|NCT00780715|3681788|FG001|NOT COMPLETED|Overall Study||0
2967396|NCT00780715|3681789|FG002|NOT COMPLETED|Overall Study||0
2967397|NCT00780715|3681790|FG003|NOT COMPLETED|Overall Study||0
2967398|NCT00780741|3681802|FG000|STARTED|Overall Study|randomized|82
2967399|NCT00780741|3681803|FG001|STARTED|Overall Study|randomized|81
2967400|NCT00780741|3681802|FG000|6-Month Visit|Overall Study|6 months (±2 weeks) timed from randomization|73
2967401|NCT00780741|3681803|FG001|6-Month Visit|Overall Study|6 months (±2 weeks) timed from randomization|67
2967402|NCT00780741|3681802|FG000|COMPLETED|Overall Study|18 months of age (±4 weeks)|75
2967403|NCT00780741|3681803|FG001|COMPLETED|Overall Study|18 months of age (±4 weeks)|71
2967404|NCT00780741|3681802|FG000|NOT COMPLETED|Overall Study||7
2967405|NCT00780741|3681803|FG001|NOT COMPLETED|Overall Study||10
2967406|NCT00780910|3681810|FG000|STARTED|Overall Study||109
2967407|NCT00780910|3681810|FG000|COMPLETED|Overall Study||107
2967408|NCT00780910|3681810|FG000|NOT COMPLETED|Overall Study||2
2967409|NCT00780962|3681816|FG000|STARTED|Overall Study||200
2967410|NCT00780962|3681817|FG001|STARTED|Overall Study||199
2967411|NCT00780962|3681816|FG000|Second Blood Draw (Outcome Measurement)|Overall Study||185
2967412|NCT00780962|3681817|FG001|Second Blood Draw (Outcome Measurement)|Overall Study||172
2967413|NCT00780962|3681816|FG000|COMPLETED|Overall Study||185
2967414|NCT00780962|3681817|FG001|COMPLETED|Overall Study||172
2967415|NCT00780962|3681816|FG000|NOT COMPLETED|Overall Study||15
2967416|NCT00780962|3681817|FG001|NOT COMPLETED|Overall Study||27
2967417|NCT00780975|3681823|FG000|STARTED|Overall Study||8
2967418|NCT00780975|3681823|FG000|COMPLETED|Overall Study||0
2967419|NCT00780975|3681823|FG000|NOT COMPLETED|Overall Study||8
2967420|NCT00781079|3681829|FG000|STARTED|Overall Study||149
2967421|NCT00781079|3681830|FG001|STARTED|Overall Study||133
2967422|NCT00781079|3681829|FG000|COMPLETED|Overall Study||122
2967423|NCT00781079|3681830|FG001|COMPLETED|Overall Study||116
2967424|NCT00781079|3681829|FG000|NOT COMPLETED|Overall Study||27
2967425|NCT00781079|3681830|FG001|NOT COMPLETED|Overall Study||17
2967426|NCT00781274|3681836|FG000|STARTED|Overall Study||32
2967427|NCT00781274|3681836|FG000|COMPLETED|Overall Study||30
2967428|NCT00781274|3681836|FG000|NOT COMPLETED|Overall Study||2
2967429|NCT00781326|3681840|FG000|STARTED|Phase I|Nine subjects consented; 3 did not meet eligibility criteria. 6 started antidepressant treatment.|6
2967430|NCT00781326|3681840|FG000|COMPLETED|Phase I||2
2967431|NCT00781326|3681840|FG000|NOT COMPLETED|Phase I||4
2967432|NCT00781326|3681840|FG000|STARTED|Phase 2|Study terminated prior to enrollment into Phase II|0
2967433|NCT00781326|3681840|FG000|COMPLETED|Phase 2||0
2967434|NCT00781326|3681840|FG000|NOT COMPLETED|Phase 2||0
2967435|NCT00781365|3681846|FG000|STARTED|Overall Study||228
2967436|NCT00781365|3681847|FG001|STARTED|Overall Study||222
2967437|NCT00781365|3681846|FG000|COMPLETED|Overall Study|completed both 6 and 12 month follow up|194
2967438|NCT00781365|3681847|FG001|COMPLETED|Overall Study|completed both 6 and 12 month follow up|186
2967439|NCT00781365|3681846|FG000|NOT COMPLETED|Overall Study||34
2967440|NCT00781365|3681847|FG001|NOT COMPLETED|Overall Study||36
2967441|NCT00781391|3681856|FG000|STARTED|Overall Study||7036
2967442|NCT00781391|3681857|FG001|STARTED|Overall Study||7035
2967443|NCT00781391|3681858|FG002|STARTED|Overall Study||7034
2967444|NCT00781391|3681856|FG000|Safety Analysis Set (Received Drug)|Overall Study||7012
2967445|NCT00781391|3681857|FG001|Safety Analysis Set (Received Drug)|Overall Study||7012
2967446|NCT00781391|3681858|FG002|Safety Analysis Set (Received Drug)|Overall Study||7002
2967447|NCT00781391|3681856|FG000|mITT Analysis Set (Received Drug)|Overall Study||7012
2967448|NCT00781391|3681857|FG001|mITT Analysis Set (Received Drug)|Overall Study||7012
2967449|NCT00781391|3681858|FG002|mITT Analysis Set (Received Drug)|Overall Study||7002
2967450|NCT00781391|3681856|FG000|Per Protocol Analysis Set|Overall Study||6993
2967451|NCT00781391|3681857|FG001|Per Protocol Analysis Set|Overall Study||6995
2967452|NCT00781391|3681858|FG002|Per Protocol Analysis Set|Overall Study||6982
2967453|NCT00781391|3681856|FG000|COMPLETED|Overall Study||6157
2967454|NCT00781391|3681857|FG001|COMPLETED|Overall Study||6228
2967455|NCT00781391|3681858|FG002|COMPLETED|Overall Study||6250
2967456|NCT00781391|3681856|FG000|NOT COMPLETED|Overall Study||879
2967457|NCT00781391|3681857|FG001|NOT COMPLETED|Overall Study||807
2967458|NCT00781391|3681858|FG002|NOT COMPLETED|Overall Study||784
2967459|NCT00781456|3681868|FG000|STARTED|Overall Study||58
2967460|NCT00781456|3681869|FG001|STARTED|Overall Study||51
2967461|NCT00781456|3681868|FG000|Received Study Drug|Overall Study||57
2967462|NCT00781456|3681869|FG001|Received Study Drug|Overall Study||49
2967463|NCT00781456|3681868|FG000|COMPLETED|Overall Study||37
2967464|NCT00781456|3681869|FG001|COMPLETED|Overall Study||35
2967465|NCT00781456|3681868|FG000|NOT COMPLETED|Overall Study||21
2967466|NCT00781456|3681869|FG001|NOT COMPLETED|Overall Study||16
2967467|NCT00781508|3681877|FG000|STARTED|Overall Study|"First Intervention (1 day), Washout (48 hours), Second Intervention (1 day)"|5
2967468|NCT00781508|3681878|FG001|STARTED|Overall Study|"First Intervention (1 day), Washout (48 hours), Second Intervention (1 day)"|5
2967469|NCT00781508|3681877|FG000|COMPLETED|Overall Study||5
2967470|NCT00781508|3681878|FG001|COMPLETED|Overall Study||5
2967471|NCT00781508|3681877|FG000|NOT COMPLETED|Overall Study||0
2967472|NCT00781508|3681878|FG001|NOT COMPLETED|Overall Study||0
2967473|NCT00781599|3681888|FG000|STARTED|Overall Study||36
2967474|NCT00781599|3681889|FG001|STARTED|Overall Study||36
2967475|NCT00781599|3681888|FG000|COMPLETED|Overall Study||29
2967476|NCT00781599|3681889|FG001|COMPLETED|Overall Study||32
2967477|NCT00781599|3681888|FG000|NOT COMPLETED|Overall Study||7
2967478|NCT00781599|3681889|FG001|NOT COMPLETED|Overall Study||4
2967479|NCT00781768|3681897|FG000|STARTED|Overall Study||89
2967480|NCT00781768|3681898|FG001|STARTED|Overall Study||92
2967481|NCT00781768|3681897|FG000|COMPLETED|Overall Study||89
2967482|NCT00781768|3681898|FG001|COMPLETED|Overall Study||90
2967483|NCT00781768|3681897|FG000|NOT COMPLETED|Overall Study||0
2967484|NCT00781768|3681898|FG001|NOT COMPLETED|Overall Study||2
2967485|NCT00781859|3681906|FG000|STARTED|Overall Study||219
2967486|NCT00781859|3681907|FG001|STARTED|Overall Study||107
2967487|NCT00781859|3681906|FG000|COMPLETED|Overall Study||200
2967488|NCT00781859|3681907|FG001|COMPLETED|Overall Study||98
2967489|NCT00781859|3681906|FG000|NOT COMPLETED|Overall Study||19
2967490|NCT00781859|3681907|FG001|NOT COMPLETED|Overall Study||9
3163948|NCT01890031|3891375|FG004|NOT COMPLETED|Overall Study||0
3163949|NCT01890109|3891389|FG000|STARTED|Overall Study||52
3163950|NCT01890109|3891390|FG001|STARTED|Overall Study||51
3163951|NCT01890109|3891389|FG000|Received Study Treatment|Overall Study||52
3163952|NCT01890109|3891390|FG001|Received Study Treatment|Overall Study||50
3163953|NCT01890109|3891389|FG000|COMPLETED|Overall Study||51
3163954|NCT01890109|3891390|FG001|COMPLETED|Overall Study||46
3163955|NCT01890109|3891389|FG000|NOT COMPLETED|Overall Study||1
3163956|NCT01890109|3891390|FG001|NOT COMPLETED|Overall Study||5
3163957|NCT01890122|3891401|FG000|STARTED|Overall Study|Started = Enrolled set which included all participants who signed informed consent.|162
3163958|NCT01890122|3891402|FG001|STARTED|Overall Study||163
3163959|NCT01890122|3891403|FG002|STARTED|Overall Study||159
3163960|NCT01890122|3891404|FG003|STARTED|Overall Study||163
3163961|NCT01890122|3891401|FG000|Treated|Overall Study|Treated = Randomized participants who received at least one dose of study drug.|161
3163962|NCT01890122|3891402|FG001|Treated|Overall Study||162
3163963|NCT01890122|3891403|FG002|Treated|Overall Study||159
2967491|NCT00781885|3681913|FG000|STARTED|Overall Study||19
3035641|NCT01138826|3754957|FG005|COMPLETED|Washout Period I (of 16 Days)||3
3163964|NCT01890122|3891404|FG003|Treated|Overall Study||163
3163965|NCT01890122|3891401|FG000|COMPLETED|Overall Study||135
3163966|NCT01890122|3891402|FG001|COMPLETED|Overall Study||126
3163967|NCT01890122|3891403|FG002|COMPLETED|Overall Study||146
3163968|NCT01890122|3891404|FG003|COMPLETED|Overall Study||104
3163969|NCT01890122|3891401|FG000|NOT COMPLETED|Overall Study||27
3163970|NCT01890122|3891402|FG001|NOT COMPLETED|Overall Study||37
3163971|NCT01890122|3891403|FG002|NOT COMPLETED|Overall Study||13
3163972|NCT01890122|3891404|FG003|NOT COMPLETED|Overall Study||59
3163973|NCT01890148|3891414|FG000|STARTED|Overall Study||5
3163974|NCT01890148|3891414|FG000|COMPLETED|Overall Study||4
3163975|NCT01890148|3891414|FG000|NOT COMPLETED|Overall Study||1
3163976|NCT01890226|3891420|FG000|STARTED|Overall Study||155
3163977|NCT01890226|3891421|FG001|STARTED|Overall Study||156
3163978|NCT01890226|3891420|FG000|COMPLETED|Overall Study||155
3163979|NCT01890226|3891421|FG001|COMPLETED|Overall Study||156
3163980|NCT01890226|3891420|FG000|NOT COMPLETED|Overall Study||0
3163981|NCT01890226|3891421|FG001|NOT COMPLETED|Overall Study||0
3163982|NCT01890265|3891433|FG000|STARTED|Overall Study||50
3163983|NCT01890265|3891434|FG001|STARTED|Overall Study||53
3163984|NCT01890265|3891435|FG002|STARTED|Overall Study||24
3163985|NCT01890265|3891436|FG003|STARTED|Overall Study||12
3163986|NCT01890265|3891437|FG004|STARTED|Overall Study||15
3163987|NCT01890265|3891438|FG005|STARTED|Overall Study||6
3163988|NCT01890265|3891433|FG000|Safety Population|Overall Study||50
3163989|NCT01890265|3891434|FG001|Safety Population|Overall Study||53
3163990|NCT01890265|3891435|FG002|Safety Population|Overall Study||24
3163991|NCT01890265|3891436|FG003|Safety Population|Overall Study||12
3163992|NCT01890265|3891437|FG004|Safety Population|Overall Study||15
3163993|NCT01890265|3891438|FG005|Safety Population|Overall Study||6
3163994|NCT01890265|3891433|FG000|Intent-to-Treat (ITT) Population|Overall Study||50
3163995|NCT01890265|3891434|FG001|Intent-to-Treat (ITT) Population|Overall Study||51
3163996|NCT01890265|3891435|FG002|Intent-to-Treat (ITT) Population|Overall Study||24
3163997|NCT01890265|3891436|FG003|Intent-to-Treat (ITT) Population|Overall Study||12
3163998|NCT01890265|3891437|FG004|Intent-to-Treat (ITT) Population|Overall Study||15
3163999|NCT01890265|3891438|FG005|Intent-to-Treat (ITT) Population|Overall Study||6
3164000|NCT01890265|3891433|FG000|COMPLETED|Overall Study||40
3164001|NCT01890265|3891434|FG001|COMPLETED|Overall Study||40
3164002|NCT01890265|3891435|FG002|COMPLETED|Overall Study||20
3164003|NCT01890265|3891436|FG003|COMPLETED|Overall Study||12
3164004|NCT01890265|3891437|FG004|COMPLETED|Overall Study||13
3164005|NCT01890265|3891438|FG005|COMPLETED|Overall Study||6
3164006|NCT01890265|3891433|FG000|NOT COMPLETED|Overall Study||10
3164007|NCT01890265|3891434|FG001|NOT COMPLETED|Overall Study||13
3164008|NCT01890265|3891435|FG002|NOT COMPLETED|Overall Study||4
3164009|NCT01890265|3891436|FG003|NOT COMPLETED|Overall Study||0
3164010|NCT01890265|3891437|FG004|NOT COMPLETED|Overall Study||2
3164011|NCT01890265|3891438|FG005|NOT COMPLETED|Overall Study||0
3164012|NCT01890343|3891451|FG000|STARTED|Overall Study||8
3164013|NCT01890343|3891452|FG001|STARTED|Overall Study||10
3164014|NCT01890343|3891453|FG002|STARTED|Overall Study||10
2967492|NCT00781885|3681913|FG000|Received at Least 1 Dose of Study Drug|Overall Study||19
2967493|NCT00781885|3681913|FG000|COMPLETED|Overall Study||18
2967494|NCT00781885|3681913|FG000|NOT COMPLETED|Overall Study||1
2967495|NCT00781898|3681919|FG000|STARTED|Overall Study||153
2967496|NCT00781898|3681920|FG001|STARTED|Overall Study||155
2967497|NCT00781898|3681919|FG000|COMPLETED|Overall Study||119
2967498|NCT00781898|3681920|FG001|COMPLETED|Overall Study||126
2967499|NCT00781898|3681919|FG000|NOT COMPLETED|Overall Study||34
2967500|NCT00781898|3681920|FG001|NOT COMPLETED|Overall Study||29
2967501|NCT00781911|3681928|FG000|STARTED|Overall Study||31
2967502|NCT00781911|3681929|FG001|STARTED|Overall Study||12
2967503|NCT00781911|3681928|FG000|Received at Least 1 Dose of Study Drug|Overall Study||31
2967504|NCT00781911|3681929|FG001|Received at Least 1 Dose of Study Drug|Overall Study||12
2967505|NCT00781911|3681928|FG000|COMPLETED|Overall Study||25
2967506|NCT00781911|3681929|FG001|COMPLETED|Overall Study||4
2967507|NCT00781911|3681928|FG000|NOT COMPLETED|Overall Study||6
2967508|NCT00781911|3681929|FG001|NOT COMPLETED|Overall Study||8
3133162|NCT01695135|3858291|FG001|NOT COMPLETED|Open Label Extension Treatment Phase||0
3133163|NCT01695135|3858292|FG002|NOT COMPLETED|Open Label Extension Treatment Phase||40
3133164|NCT01695135|3858293|FG003|NOT COMPLETED|Open Label Extension Treatment Phase||70
3133165|NCT01695239|3858305|FG000|STARTED|Double-Blind (DB) Treatment Period||106
3133166|NCT01695239|3858306|FG001|STARTED|Double-Blind (DB) Treatment Period||101
3133167|NCT01695239|3858307|FG002|STARTED|Double-Blind (DB) Treatment Period||107
2967509|NCT00781937|3681939|FG000|STARTED|Main Trial Period Through Week 56||212
2967510|NCT00781937|3681940|FG001|STARTED|Main Trial Period Through Week 56||210
2967511|NCT00781937|3681939|FG000|COMPLETED|Main Trial Period Through Week 56||159
2967512|NCT00781937|3681940|FG001|COMPLETED|Main Trial Period Through Week 56||146
2967513|NCT00781937|3681939|FG000|NOT COMPLETED|Main Trial Period Through Week 56||53
2967514|NCT00781937|3681940|FG001|NOT COMPLETED|Main Trial Period Through Week 56||64
3133168|NCT01695239|3858308|FG003|STARTED|Double-Blind (DB) Treatment Period||103
3133169|NCT01695239|3858309|FG004|STARTED|Double-Blind (DB) Treatment Period||0
3133170|NCT01695239|3858310|FG005|STARTED|Double-Blind (DB) Treatment Period||0
3133171|NCT01695239|3858311|FG006|STARTED|Double-Blind (DB) Treatment Period||0
3133172|NCT01695239|3858312|FG007|STARTED|Double-Blind (DB) Treatment Period||0
3133173|NCT01695239|3858313|FG008|STARTED|Double-Blind (DB) Treatment Period||0
3164015|NCT01890343|3891451|FG000|COMPLETED|Overall Study||8
2967515|NCT00781937|3681939|FG000|STARTED|Follow up Period (Week 56-68)||159
2967516|NCT00781937|3681940|FG001|STARTED|Follow up Period (Week 56-68)||146
2967517|NCT00781937|3681939|FG000|COMPLETED|Follow up Period (Week 56-68)||153
2967518|NCT00781937|3681940|FG001|COMPLETED|Follow up Period (Week 56-68)||141
2967519|NCT00781937|3681939|FG000|NOT COMPLETED|Follow up Period (Week 56-68)||6
2967520|NCT00781937|3681940|FG001|NOT COMPLETED|Follow up Period (Week 56-68)||5
2967521|NCT00781950|3681948|FG000|STARTED|Overall Study||52
2967522|NCT00781950|3681949|FG001|STARTED|Overall Study||58
2967523|NCT00781950|3681948|FG000|COMPLETED|Overall Study||41
2967524|NCT00781950|3681949|FG001|COMPLETED|Overall Study||45
2967525|NCT00781950|3681948|FG000|NOT COMPLETED|Overall Study||11
2967526|NCT00781950|3681949|FG001|NOT COMPLETED|Overall Study||13
2967527|NCT00781963|3681958|FG000|STARTED|Overall Study||106
2967528|NCT00781963|3681959|FG001|STARTED|Overall Study||53
2967529|NCT00781963|3681958|FG000|COMPLETED|Overall Study||89
2967530|NCT00781963|3681959|FG001|COMPLETED|Overall Study||51
2967531|NCT00781963|3681958|FG000|NOT COMPLETED|Overall Study||17
2967532|NCT00781963|3681959|FG001|NOT COMPLETED|Overall Study||2
2967533|NCT00782067|3681965|FG000|STARTED|Overall Study||116
2967534|NCT00782067|3681965|FG000|Safety Set (SS)|Overall Study||116
2967535|NCT00782067|3681965|FG000|Primary Efficacy Population (PEP)|Overall Study||89
2967536|NCT00782067|3681965|FG000|COMPLETED|Overall Study||0
2967537|NCT00782067|3681965|FG000|NOT COMPLETED|Overall Study||116
2967538|NCT00782171|3681971|FG000|STARTED|Overall Study||146
2967539|NCT00782171|3681972|FG001|STARTED|Overall Study||134
2967540|NCT00782171|3681971|FG000|20-23 Weeks|Overall Study||135
2967541|NCT00782171|3681972|FG001|20-23 Weeks|Overall Study||124
2967542|NCT00782171|3681971|FG000|1 Year|Overall Study||131
2967543|NCT00782171|3681972|FG001|1 Year|Overall Study||120
2967544|NCT00782171|3681971|FG000|Surgery (Baseline)|Overall Study||138
2967545|NCT00782171|3681972|FG001|Surgery (Baseline)|Overall Study||128
2967546|NCT00782171|3681971|FG000|COMPLETED|Overall Study||124
2967547|NCT00782171|3681972|FG001|COMPLETED|Overall Study||115
2967548|NCT00782171|3681971|FG000|NOT COMPLETED|Overall Study||22
2967549|NCT00782171|3681972|FG001|NOT COMPLETED|Overall Study||19
2967550|NCT00782210|3681981|FG000|STARTED|Overall Study||209
2967551|NCT00782210|3681982|FG001|STARTED|Overall Study||208
2967552|NCT00782210|3681983|FG002|STARTED|Overall Study||207
2967553|NCT00782210|3681981|FG000|COMPLETED|Overall Study||159
2967554|NCT00782210|3681982|FG001|COMPLETED|Overall Study||173
2967555|NCT00782210|3681983|FG002|COMPLETED|Overall Study||172
2967556|NCT00782210|3681981|FG000|NOT COMPLETED|Overall Study||50
2967557|NCT00782210|3681982|FG001|NOT COMPLETED|Overall Study||35
2967558|NCT00782210|3681983|FG002|NOT COMPLETED|Overall Study||35
2967559|NCT00782275|3682000|FG000|STARTED|Overall Study||41
2967560|NCT00782275|3682000|FG000|Treated|Overall Study||40
2967561|NCT00782275|3682000|FG000|Prior VEGFR Response Evaluable|Overall Study|One patient was unevaluable and therefore excluded from related subgroup analyses.|39
2967562|NCT00782275|3682000|FG000|COMPLETED|Overall Study|Since treatment duration was not fixed, patients were not considered to have completed treatment.|0
2967563|NCT00782275|3682000|FG000|NOT COMPLETED|Overall Study||41
2967564|NCT00782288|3682007|FG000|STARTED|Overall Study||8
2967565|NCT00782288|3682008|FG001|STARTED|Overall Study||8
2967566|NCT00782288|3682009|FG002|STARTED|Overall Study||8
2967567|NCT00782288|3682007|FG000|COMPLETED|Overall Study||8
2967568|NCT00782288|3682008|FG001|COMPLETED|Overall Study||8
2967569|NCT00782288|3682009|FG002|COMPLETED|Overall Study||8
2967570|NCT00782288|3682007|FG000|NOT COMPLETED|Overall Study||0
2967571|NCT00782288|3682008|FG001|NOT COMPLETED|Overall Study||0
2967572|NCT00782288|3682009|FG002|NOT COMPLETED|Overall Study||0
2967573|NCT00782340|3682022|FG000|STARTED|Open Label Titration||263
2967574|NCT00782340|3682023|FG001|STARTED|Open Label Titration||0
2967575|NCT00782340|3682024|FG002|STARTED|Open Label Titration||0
2967576|NCT00782340|3682022|FG000|COMPLETED|Open Label Titration||162
2967577|NCT00782340|3682023|FG001|COMPLETED|Open Label Titration||0
2967578|NCT00782340|3682024|FG002|COMPLETED|Open Label Titration||0
2967579|NCT00782340|3682022|FG000|NOT COMPLETED|Open Label Titration||101
2967580|NCT00782340|3682023|FG001|NOT COMPLETED|Open Label Titration||0
2967581|NCT00782340|3682024|FG002|NOT COMPLETED|Open Label Titration||0
2967582|NCT00782340|3682022|FG000|STARTED|Randomized Double Blind||0
2967583|NCT00782340|3682023|FG001|STARTED|Randomized Double Blind||82
2967584|NCT00782340|3682024|FG002|STARTED|Randomized Double Blind||80
2967585|NCT00782340|3682022|FG000|COMPLETED|Randomized Double Blind||0
2967586|NCT00782340|3682023|FG001|COMPLETED|Randomized Double Blind||82
2967587|NCT00782340|3682024|FG002|COMPLETED|Randomized Double Blind||80
2967588|NCT00782340|3682022|FG000|NOT COMPLETED|Randomized Double Blind||0
2967589|NCT00782340|3682023|FG001|NOT COMPLETED|Randomized Double Blind||0
2967590|NCT00782340|3682024|FG002|NOT COMPLETED|Randomized Double Blind||0
2967591|NCT00782379|3682031|FG000|STARTED|Overall Study||20
2967592|NCT00782379|3682031|FG000|COMPLETED|Overall Study||20
2967593|NCT00782379|3682031|FG000|NOT COMPLETED|Overall Study||0
2967594|NCT00782418|3682035|FG000|STARTED|Period 1 Procedure/Treatment Groups||3
2967595|NCT00782418|3682036|FG001|STARTED|Period 1 Procedure/Treatment Groups||4
2967596|NCT00782418|3682037|FG002|STARTED|Period 1 Procedure/Treatment Groups||4
2967597|NCT00782418|3682038|FG003|STARTED|Period 1 Procedure/Treatment Groups||2
2967598|NCT00782418|3682039|FG004|STARTED|Period 1 Procedure/Treatment Groups||5
2967599|NCT00782418|3682040|FG005|STARTED|Period 1 Procedure/Treatment Groups||5
2967600|NCT00782418|3682041|FG006|STARTED|Period 1 Procedure/Treatment Groups||4
2967601|NCT00782418|3682035|FG000|COMPLETED|Period 1 Procedure/Treatment Groups||1
2967602|NCT00782418|3682036|FG001|COMPLETED|Period 1 Procedure/Treatment Groups||4
2967603|NCT00782418|3682037|FG002|COMPLETED|Period 1 Procedure/Treatment Groups||4
2967604|NCT00782418|3682038|FG003|COMPLETED|Period 1 Procedure/Treatment Groups||2
2967605|NCT00782418|3682039|FG004|COMPLETED|Period 1 Procedure/Treatment Groups||4
2967606|NCT00782418|3682040|FG005|COMPLETED|Period 1 Procedure/Treatment Groups||4
2967607|NCT00782418|3682041|FG006|COMPLETED|Period 1 Procedure/Treatment Groups||4
2967608|NCT00782418|3682035|FG000|NOT COMPLETED|Period 1 Procedure/Treatment Groups||2
2967609|NCT00782418|3682036|FG001|NOT COMPLETED|Period 1 Procedure/Treatment Groups||0
2967610|NCT00782418|3682037|FG002|NOT COMPLETED|Period 1 Procedure/Treatment Groups||0
2967611|NCT00782418|3682038|FG003|NOT COMPLETED|Period 1 Procedure/Treatment Groups||0
2967612|NCT00782418|3682039|FG004|NOT COMPLETED|Period 1 Procedure/Treatment Groups||1
2967613|NCT00782418|3682040|FG005|NOT COMPLETED|Period 1 Procedure/Treatment Groups||1
2967614|NCT00782418|3682041|FG006|NOT COMPLETED|Period 1 Procedure/Treatment Groups||0
2967615|NCT00782418|3682035|FG000|STARTED|Period 2 Procedure/Treatment Groups||3
2967616|NCT00782418|3682036|FG001|STARTED|Period 2 Procedure/Treatment Groups||4
2967617|NCT00782418|3682037|FG002|STARTED|Period 2 Procedure/Treatment Groups||4
2967618|NCT00782418|3682038|FG003|STARTED|Period 2 Procedure/Treatment Groups||1
2967619|NCT00782418|3682039|FG004|STARTED|Period 2 Procedure/Treatment Groups||3
2967620|NCT00782418|3682040|FG005|STARTED|Period 2 Procedure/Treatment Groups||4
2967621|NCT00782418|3682041|FG006|STARTED|Period 2 Procedure/Treatment Groups||4
2967622|NCT00782418|3682035|FG000|COMPLETED|Period 2 Procedure/Treatment Groups||3
2967623|NCT00782418|3682036|FG001|COMPLETED|Period 2 Procedure/Treatment Groups||4
2967624|NCT00782418|3682037|FG002|COMPLETED|Period 2 Procedure/Treatment Groups||4
2967625|NCT00782418|3682038|FG003|COMPLETED|Period 2 Procedure/Treatment Groups||1
2967626|NCT00782418|3682039|FG004|COMPLETED|Period 2 Procedure/Treatment Groups||3
2967627|NCT00782418|3682040|FG005|COMPLETED|Period 2 Procedure/Treatment Groups||4
2967628|NCT00782418|3682041|FG006|COMPLETED|Period 2 Procedure/Treatment Groups||4
2967629|NCT00782418|3682035|FG000|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
2967630|NCT00782418|3682036|FG001|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
2967631|NCT00782418|3682037|FG002|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
2967632|NCT00782418|3682038|FG003|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
2967633|NCT00782418|3682039|FG004|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
2967634|NCT00782418|3682040|FG005|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
2967635|NCT00782418|3682041|FG006|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
2967636|NCT00782496|3682057|FG000|STARTED|Overall Study||106
2967637|NCT00782496|3682058|FG001|STARTED|Overall Study||105
2967638|NCT00782496|3682057|FG000|COMPLETED|Overall Study||92
2967639|NCT00782496|3682058|FG001|COMPLETED|Overall Study||90
2967640|NCT00782496|3682057|FG000|NOT COMPLETED|Overall Study||14
2967641|NCT00782496|3682058|FG001|NOT COMPLETED|Overall Study||15
2967642|NCT00782509|3682068|FG000|STARTED|Overall Study||216
2967643|NCT00782509|3682069|FG001|STARTED|Overall Study||209
2967644|NCT00782509|3682070|FG002|STARTED|Overall Study||217
2967645|NCT00782509|3682068|FG000|COMPLETED|Overall Study||175
2967646|NCT00782509|3682069|FG001|COMPLETED|Overall Study||185
2967647|NCT00782509|3682070|FG002|COMPLETED|Overall Study||181
2967648|NCT00782509|3682068|FG000|NOT COMPLETED|Overall Study||41
2967649|NCT00782509|3682069|FG001|NOT COMPLETED|Overall Study||24
2967650|NCT00782509|3682070|FG002|NOT COMPLETED|Overall Study||36
2967651|NCT00782626|3682085|FG000|STARTED|Overall Study||23
2967652|NCT00782626|3682085|FG000|COMPLETED|Overall Study||16
2967653|NCT00782626|3682085|FG000|NOT COMPLETED|Overall Study||7
2967654|NCT00782639|3682091|FG000|STARTED|Overall Study||12
2967655|NCT00782639|3682092|FG001|STARTED|Overall Study||11
2967656|NCT00782639|3682091|FG000|COMPLETED|Overall Study|This study was terminated due to low enrollment.|12
2967657|NCT00782639|3682092|FG001|COMPLETED|Overall Study|This study was terminated due to low enrollment.|11
2967658|NCT00782639|3682091|FG000|NOT COMPLETED|Overall Study||0
2967659|NCT00782639|3682092|FG001|NOT COMPLETED|Overall Study||0
2967660|NCT00782717|3682102|FG000|STARTED|Overall Study||133
2967661|NCT00782717|3682103|FG001|STARTED|Overall Study||130
2967662|NCT00782717|3682102|FG000|COMPLETED|Overall Study||118
2967663|NCT00782717|3682103|FG001|COMPLETED|Overall Study||102
2967664|NCT00782717|3682102|FG000|NOT COMPLETED|Overall Study||15
2967665|NCT00782717|3682103|FG001|NOT COMPLETED|Overall Study||28
2967666|NCT00782756|3682109|FG000|STARTED|Overall Study||40
2967667|NCT00782756|3682109|FG000|COMPLETED|Overall Study||40
2967668|NCT00782756|3682109|FG000|NOT COMPLETED|Overall Study||0
2967669|NCT00782795|3682115|FG000|STARTED|Overall Study||17
2967670|NCT00782795|3682116|FG001|STARTED|Overall Study||8
2967671|NCT00782795|3682115|FG000|6 Weeks (1st Apptment)|Overall Study||16
2967672|NCT00782795|3682116|FG001|6 Weeks (1st Apptment)|Overall Study||7
2967673|NCT00782795|3682115|FG000|24 Week Appointment|Overall Study||16
2967674|NCT00782795|3682116|FG001|24 Week Appointment|Overall Study||7
2967675|NCT00782795|3682115|FG000|COMPLETED|Overall Study||16
2967676|NCT00782795|3682116|FG001|COMPLETED|Overall Study||6
2967677|NCT00782795|3682115|FG000|NOT COMPLETED|Overall Study||1
2967678|NCT00782795|3682116|FG001|NOT COMPLETED|Overall Study||2
2967679|NCT00782821|3682126|FG000|STARTED|Overall Study||10
2967680|NCT00782821|3682127|FG001|STARTED|Overall Study||10
2967681|NCT00782821|3682128|FG002|STARTED|Overall Study||10
2967682|NCT00782821|3682129|FG003|STARTED|Overall Study||10
2967683|NCT00782821|3682126|FG000|COMPLETED|Overall Study||10
2967684|NCT00782821|3682127|FG001|COMPLETED|Overall Study||10
2967685|NCT00782821|3682128|FG002|COMPLETED|Overall Study||9
2967686|NCT00782821|3682129|FG003|COMPLETED|Overall Study||8
2967687|NCT00782821|3682126|FG000|NOT COMPLETED|Overall Study||0
2967688|NCT00782821|3682127|FG001|NOT COMPLETED|Overall Study||0
2967689|NCT00782821|3682128|FG002|NOT COMPLETED|Overall Study||1
2967690|NCT00782821|3682129|FG003|NOT COMPLETED|Overall Study||2
2967691|NCT00782834|3682146|FG000|STARTED|Screened Patients||15
2967692|NCT00782834|3682146|FG000|COMPLETED|Screened Patients|1 pt ineligible d/t arrhythmia|14
2967693|NCT00782834|3682146|FG000|NOT COMPLETED|Screened Patients||1
2967694|NCT00782834|3682146|FG000|STARTED|Treatment Phase||14
2967695|NCT00782834|3682146|FG000|COMPLETED|Treatment Phase||13
2967696|NCT00782834|3682146|FG000|NOT COMPLETED|Treatment Phase||1
2967697|NCT00783094|3682153|FG000|STARTED|Randomized Double-Blind Treatment Period||142
2967698|NCT00783094|3682154|FG001|STARTED|Randomized Double-Blind Treatment Period||140
2967699|NCT00783094|3682155|FG002|STARTED|Randomized Double-Blind Treatment Period||140
2967700|NCT00783094|3682153|FG000|COMPLETED|Randomized Double-Blind Treatment Period||135
2967701|NCT00783094|3682154|FG001|COMPLETED|Randomized Double-Blind Treatment Period||128
2967702|NCT00783094|3682155|FG002|COMPLETED|Randomized Double-Blind Treatment Period||131
2967703|NCT00783094|3682153|FG000|NOT COMPLETED|Randomized Double-Blind Treatment Period||7
2967704|NCT00783094|3682154|FG001|NOT COMPLETED|Randomized Double-Blind Treatment Period||12
2967705|NCT00783094|3682155|FG002|NOT COMPLETED|Randomized Double-Blind Treatment Period||9
2967706|NCT00783094|3682153|FG000|STARTED|Open-Label Extension Period||135
2967707|NCT00783094|3682154|FG001|STARTED|Open-Label Extension Period||128
2967708|NCT00783094|3682155|FG002|STARTED|Open-Label Extension Period||131
2967709|NCT00783094|3682153|FG000|COMPLETED|Open-Label Extension Period||113
2967710|NCT00783094|3682154|FG001|COMPLETED|Open-Label Extension Period||109
2967711|NCT00783094|3682155|FG002|COMPLETED|Open-Label Extension Period||101
2967712|NCT00783094|3682153|FG000|NOT COMPLETED|Open-Label Extension Period||22
2967713|NCT00783094|3682154|FG001|NOT COMPLETED|Open-Label Extension Period||19
2967714|NCT00783094|3682155|FG002|NOT COMPLETED|Open-Label Extension Period||30
2967715|NCT00783198|3682169|FG000|STARTED|Overall Study||190
2967716|NCT00783198|3682170|FG001|STARTED|Overall Study||187
2967717|NCT00783198|3682171|FG002|STARTED|Overall Study||188
2967718|NCT00783198|3682169|FG000|COMPLETED|Overall Study||133
2967719|NCT00783198|3682170|FG001|COMPLETED|Overall Study||144
2967720|NCT00783198|3682171|FG002|COMPLETED|Overall Study||146
2967721|NCT00783198|3682169|FG000|NOT COMPLETED|Overall Study||57
2967722|NCT00783198|3682170|FG001|NOT COMPLETED|Overall Study||43
2967723|NCT00783198|3682171|FG002|NOT COMPLETED|Overall Study||42
2967724|NCT00783289|3682183|FG000|STARTED|Overall Study||6
2967725|NCT00783289|3682184|FG001|STARTED|Overall Study||7
2967726|NCT00783289|3682185|FG002|STARTED|Overall Study||6
2967727|NCT00783289|3682186|FG003|STARTED|Overall Study||6
2967728|NCT00783289|3682183|FG000|COMPLETED|Overall Study||6
2967729|NCT00783289|3682184|FG001|COMPLETED|Overall Study||6
2967730|NCT00783289|3682185|FG002|COMPLETED|Overall Study||6
2967731|NCT00783289|3682186|FG003|COMPLETED|Overall Study||6
2967732|NCT00783289|3682183|FG000|NOT COMPLETED|Overall Study||0
2967733|NCT00783289|3682184|FG001|NOT COMPLETED|Overall Study||1
2967734|NCT00783289|3682185|FG002|NOT COMPLETED|Overall Study||0
2967735|NCT00783289|3682186|FG003|NOT COMPLETED|Overall Study||0
2967736|NCT00783302|3682199|FG000|STARTED|Overall Study||885
2967737|NCT00783302|3682199|FG000|COMPLETED|Overall Study||850
2967738|NCT00783302|3682199|FG000|NOT COMPLETED|Overall Study||35
2967739|NCT00783367|3682219|FG000|STARTED|Overall Study||27
2967740|NCT00783367|3682220|FG001|STARTED|Overall Study||23
2967741|NCT00783367|3682219|FG000|COMPLETED|Overall Study||27
2967742|NCT00783367|3682220|FG001|COMPLETED|Overall Study||23
2967743|NCT00783367|3682219|FG000|NOT COMPLETED|Overall Study||0
2967744|NCT00783367|3682220|FG001|NOT COMPLETED|Overall Study||0
2967745|NCT00783432|3682228|FG000|STARTED|Overall Study|This includes 2 subjects that received a randomization number but did not receive study drug|430
2967746|NCT00783432|3682229|FG001|STARTED|Overall Study|This includes 2 subjects that received a randomization number but did not receive study drug|432
2967747|NCT00783432|3682228|FG000|COMPLETED|Overall Study||345
2967748|NCT00783432|3682229|FG001|COMPLETED|Overall Study||354
2967749|NCT00783432|3682228|FG000|NOT COMPLETED|Overall Study||85
2967750|NCT00783432|3682229|FG001|NOT COMPLETED|Overall Study||78
2967751|NCT00783614|3682239|FG000|STARTED|Overall Study||6
2967752|NCT00783614|3682240|FG001|STARTED|Overall Study||6
2967753|NCT00783614|3682241|FG002|STARTED|Overall Study||5
2967754|NCT00783614|3682242|FG003|STARTED|Overall Study||5
2967755|NCT00783614|3682239|FG000|COMPLETED|Overall Study||6
2967756|NCT00783614|3682240|FG001|COMPLETED|Overall Study||6
2967757|NCT00783614|3682241|FG002|COMPLETED|Overall Study||5
2967758|NCT00783614|3682242|FG003|COMPLETED|Overall Study||5
2967759|NCT00783614|3682239|FG000|NOT COMPLETED|Overall Study||0
2967760|NCT00783614|3682240|FG001|NOT COMPLETED|Overall Study||0
2967761|NCT00783614|3682241|FG002|NOT COMPLETED|Overall Study||0
2967762|NCT00783614|3682242|FG003|NOT COMPLETED|Overall Study||0
2967763|NCT00783692|3682255|FG000|STARTED|Induction Phase||148
2967764|NCT00783692|3682256|FG001|STARTED|Induction Phase||220
2967765|NCT00783692|3682257|FG002|STARTED|Induction Phase||748
2967766|NCT00783692|3682258|FG003|STARTED|Induction Phase||0
2967767|NCT00783692|3682259|FG004|STARTED|Induction Phase||0
2967768|NCT00783692|3682260|FG005|STARTED|Induction Phase||0
2967769|NCT00783692|3682261|FG006|STARTED|Induction Phase||0
2967770|NCT00783692|3682255|FG000|Treated|Induction Phase||148
2967771|NCT00783692|3682256|FG001|Treated|Induction Phase||220
2967772|NCT00783692|3682257|FG002|Treated|Induction Phase||747
2967773|NCT00783692|3682258|FG003|Treated|Induction Phase||0
2967774|NCT00783692|3682259|FG004|Treated|Induction Phase||0
2967775|NCT00783692|3682260|FG005|Treated|Induction Phase||0
2967776|NCT00783692|3682261|FG006|Treated|Induction Phase||0
2967777|NCT00783692|3682255|FG000|COMPLETED|Induction Phase||137
2967778|NCT00783692|3682256|FG001|COMPLETED|Induction Phase||199
2967779|NCT00783692|3682257|FG002|COMPLETED|Induction Phase||674
2967780|NCT00783692|3682258|FG003|COMPLETED|Induction Phase||0
2967781|NCT00783692|3682259|FG004|COMPLETED|Induction Phase||0
2967782|NCT00783692|3682260|FG005|COMPLETED|Induction Phase||0
2967783|NCT00783692|3682261|FG006|COMPLETED|Induction Phase||0
2967784|NCT00783692|3682255|FG000|NOT COMPLETED|Induction Phase||11
2967785|NCT00783692|3682256|FG001|NOT COMPLETED|Induction Phase||21
2967786|NCT00783692|3682257|FG002|NOT COMPLETED|Induction Phase||74
2967787|NCT00783692|3682258|FG003|NOT COMPLETED|Induction Phase||0
2967788|NCT00783692|3682259|FG004|NOT COMPLETED|Induction Phase||0
2967789|NCT00783692|3682260|FG005|NOT COMPLETED|Induction Phase||0
2967790|NCT00783692|3682261|FG006|NOT COMPLETED|Induction Phase||0
2967791|NCT00783692|3682255|FG000|STARTED|Maintenance Phase||137
2967792|NCT00783692|3682256|FG001|STARTED|Maintenance Phase||0
2967793|NCT00783692|3682257|FG002|STARTED|Maintenance Phase||0
2967794|NCT00783692|3682258|FG003|STARTED|Maintenance Phase||153
2967795|NCT00783692|3682259|FG004|STARTED|Maintenance Phase||154
2967796|NCT00783692|3682260|FG005|STARTED|Maintenance Phase||154
2967797|NCT00783692|3682261|FG006|STARTED|Maintenance Phase||412
2967798|NCT00783692|3682255|FG000|COMPLETED|Maintenance Phase||42
2967799|NCT00783692|3682256|FG001|COMPLETED|Maintenance Phase||0
2967800|NCT00783692|3682257|FG002|COMPLETED|Maintenance Phase||0
2967801|NCT00783692|3682258|FG003|COMPLETED|Maintenance Phase||64
2967802|NCT00783692|3682259|FG004|COMPLETED|Maintenance Phase||73
2967803|NCT00783692|3682260|FG005|COMPLETED|Maintenance Phase||82
2967804|NCT00783692|3682261|FG006|COMPLETED|Maintenance Phase||163
2967805|NCT00783692|3682255|FG000|NOT COMPLETED|Maintenance Phase||95
2967806|NCT00783692|3682256|FG001|NOT COMPLETED|Maintenance Phase||0
2967807|NCT00783692|3682257|FG002|NOT COMPLETED|Maintenance Phase||0
2967808|NCT00783692|3682258|FG003|NOT COMPLETED|Maintenance Phase||89
2967809|NCT00783692|3682259|FG004|NOT COMPLETED|Maintenance Phase||81
2967810|NCT00783692|3682260|FG005|NOT COMPLETED|Maintenance Phase||72
2967811|NCT00783692|3682261|FG006|NOT COMPLETED|Maintenance Phase||249
2967812|NCT00783705|3682276|FG000|STARTED|Overall Study||44
2967813|NCT00783705|3682277|FG001|STARTED|Overall Study||41
2967814|NCT00783705|3682276|FG000|COMPLETED|Overall Study||38
2967815|NCT00783705|3682277|FG001|COMPLETED|Overall Study||36
2967816|NCT00783705|3682276|FG000|NOT COMPLETED|Overall Study||6
2967817|NCT00783705|3682277|FG001|NOT COMPLETED|Overall Study||5
2967818|NCT00783718|3682286|FG000|STARTED|Induction Phase||149
2967819|NCT00783718|3682287|FG001|STARTED|Induction Phase||225
2967820|NCT00783718|3682288|FG002|STARTED|Induction Phase||521
2967821|NCT00783718|3682289|FG003|STARTED|Induction Phase||0
2967822|NCT00783718|3682290|FG004|STARTED|Induction Phase||0
2967823|NCT00783718|3682291|FG005|STARTED|Induction Phase||0
2967824|NCT00783718|3682292|FG006|STARTED|Induction Phase||0
2967825|NCT00783718|3682286|FG000|COMPLETED|Induction Phase||135
2967826|NCT00783718|3682287|FG001|COMPLETED|Induction Phase||218
2967827|NCT00783718|3682288|FG002|COMPLETED|Induction Phase||485
2967828|NCT00783718|3682289|FG003|COMPLETED|Induction Phase||0
2967829|NCT00783718|3682290|FG004|COMPLETED|Induction Phase||0
2967830|NCT00783718|3682291|FG005|COMPLETED|Induction Phase||0
2967831|NCT00783718|3682292|FG006|COMPLETED|Induction Phase||0
3164016|NCT01890343|3891452|FG001|COMPLETED|Overall Study||10
3164017|NCT01890343|3891453|FG002|COMPLETED|Overall Study||10
3164018|NCT01890343|3891451|FG000|NOT COMPLETED|Overall Study||0
3164019|NCT01890343|3891452|FG001|NOT COMPLETED|Overall Study||0
3164020|NCT01890343|3891453|FG002|NOT COMPLETED|Overall Study||0
3164021|NCT01890421|3891461|FG000|STARTED|Overall Study||426
3164022|NCT01890421|3891461|FG000|COMPLETED|Overall Study||415
3164023|NCT01890421|3891461|FG000|NOT COMPLETED|Overall Study||11
3164024|NCT01890434|3891465|FG000|STARTED|Overall Study||478
2967832|NCT00783718|3682286|FG000|NOT COMPLETED|Induction Phase||14
2967833|NCT00783718|3682287|FG001|NOT COMPLETED|Induction Phase||7
2967834|NCT00783718|3682288|FG002|NOT COMPLETED|Induction Phase||36
2967835|NCT00783718|3682289|FG003|NOT COMPLETED|Induction Phase||0
2967836|NCT00783718|3682290|FG004|NOT COMPLETED|Induction Phase||0
2967837|NCT00783718|3682291|FG005|NOT COMPLETED|Induction Phase||0
2967838|NCT00783718|3682292|FG006|NOT COMPLETED|Induction Phase||0
2967839|NCT00783718|3682286|FG000|STARTED|Maintenance Phase||135
2967840|NCT00783718|3682287|FG001|STARTED|Maintenance Phase||0
2967841|NCT00783718|3682288|FG002|STARTED|Maintenance Phase||0
2967842|NCT00783718|3682289|FG003|STARTED|Maintenance Phase||126
2967843|NCT00783718|3682290|FG004|STARTED|Maintenance Phase||122
2967844|NCT00783718|3682291|FG005|STARTED|Maintenance Phase||125
3164025|NCT01890434|3891465|FG000|Evaluated for Efficacy|Overall Study||389
3164026|NCT01890434|3891465|FG000|COMPLETED|Overall Study||458
2967845|NCT00783718|3682292|FG006|STARTED|Maintenance Phase||330
2967846|NCT00783718|3682286|FG000|COMPLETED|Maintenance Phase||30
2967847|NCT00783718|3682287|FG001|COMPLETED|Maintenance Phase||0
2967848|NCT00783718|3682288|FG002|COMPLETED|Maintenance Phase||0
2967849|NCT00783718|3682289|FG003|COMPLETED|Maintenance Phase||48
2967850|NCT00783718|3682290|FG004|COMPLETED|Maintenance Phase||77
2967851|NCT00783718|3682291|FG005|COMPLETED|Maintenance Phase||84
2967852|NCT00783718|3682292|FG006|COMPLETED|Maintenance Phase||135
2967853|NCT00783718|3682286|FG000|NOT COMPLETED|Maintenance Phase||105
2967854|NCT00783718|3682287|FG001|NOT COMPLETED|Maintenance Phase||0
2967855|NCT00783718|3682288|FG002|NOT COMPLETED|Maintenance Phase||0
2967856|NCT00783718|3682289|FG003|NOT COMPLETED|Maintenance Phase||78
2967857|NCT00783718|3682290|FG004|NOT COMPLETED|Maintenance Phase||45
2967858|NCT00783718|3682291|FG005|NOT COMPLETED|Maintenance Phase||41
2967859|NCT00783718|3682292|FG006|NOT COMPLETED|Maintenance Phase||195
2967860|NCT00783796|3682302|FG000|STARTED|Overall Study||150
2967861|NCT00783796|3682302|FG000|COMPLETED|Overall Study||144
2967862|NCT00783796|3682302|FG000|NOT COMPLETED|Overall Study||6
2967863|NCT00783835|3682308|FG000|STARTED|Overall Study||60
2967864|NCT00783835|3682308|FG000|COMPLETED|Overall Study||50
2967865|NCT00783835|3682308|FG000|NOT COMPLETED|Overall Study||10
2967866|NCT00783952|3682312|FG000|STARTED|Overall Study||8
2967867|NCT00783952|3682312|FG000|COMPLETED|Overall Study||8
2967868|NCT00783952|3682312|FG000|NOT COMPLETED|Overall Study||0
2967869|NCT00783965|3682319|FG000|STARTED|First Intervention (12 Months)||5
2967870|NCT00783965|3682320|FG001|STARTED|First Intervention (12 Months)||29
2967871|NCT00783965|3682319|FG000|COMPLETED|First Intervention (12 Months)||2
2967872|NCT00783965|3682320|FG001|COMPLETED|First Intervention (12 Months)||25
2967873|NCT00783965|3682319|FG000|NOT COMPLETED|First Intervention (12 Months)||3
2967874|NCT00783965|3682320|FG001|NOT COMPLETED|First Intervention (12 Months)||4
2967875|NCT00783965|3682319|FG000|STARTED|Second Intervention (24 Months)||2
2967876|NCT00783965|3682320|FG001|STARTED|Second Intervention (24 Months)||25
2967877|NCT00783965|3682319|FG000|COMPLETED|Second Intervention (24 Months)||2
2967878|NCT00783965|3682320|FG001|COMPLETED|Second Intervention (24 Months)||16
2967879|NCT00783965|3682319|FG000|NOT COMPLETED|Second Intervention (24 Months)||0
2967880|NCT00783965|3682320|FG001|NOT COMPLETED|Second Intervention (24 Months)||9
2967881|NCT00784030|3682328|FG000|STARTED|Overall Study||13
2967882|NCT00784030|3682329|FG001|STARTED|Overall Study||10
2967883|NCT00784030|3682328|FG000|COMPLETED|Overall Study||13
2967884|NCT00784030|3682329|FG001|COMPLETED|Overall Study||10
2967885|NCT00784030|3682328|FG000|NOT COMPLETED|Overall Study||0
2967886|NCT00784030|3682329|FG001|NOT COMPLETED|Overall Study||0
2967887|NCT00784095|3682338|FG000|STARTED|Overall Study||12
2967888|NCT00784095|3682339|FG001|STARTED|Overall Study||12
2967889|NCT00784095|3682340|FG002|STARTED|Overall Study||12
2967890|NCT00784095|3682338|FG000|COMPLETED|Overall Study||12
2967891|NCT00784095|3682339|FG001|COMPLETED|Overall Study||11
2967892|NCT00784095|3682340|FG002|COMPLETED|Overall Study||11
2967893|NCT00784095|3682338|FG000|NOT COMPLETED|Overall Study||0
2967894|NCT00784095|3682339|FG001|NOT COMPLETED|Overall Study||1
2967895|NCT00784095|3682340|FG002|NOT COMPLETED|Overall Study||1
2967896|NCT00784134|3682353|FG000|STARTED|Overall Study||249
2967897|NCT00784134|3682354|FG001|STARTED|Overall Study||251
2967898|NCT00784134|3682353|FG000|COMPLETED|Overall Study||246
2967899|NCT00784134|3682354|FG001|COMPLETED|Overall Study||245
2967900|NCT00784134|3682353|FG000|NOT COMPLETED|Overall Study||3
2967901|NCT00784134|3682354|FG001|NOT COMPLETED|Overall Study||6
2967902|NCT00784147|3682362|FG000|STARTED|Overall Study||59
2967903|NCT00784147|3682363|FG001|STARTED|Overall Study||54
2967904|NCT00784147|3682362|FG000|COMPLETED|Overall Study||51
2967905|NCT00784147|3682363|FG001|COMPLETED|Overall Study||45
2967906|NCT00784147|3682362|FG000|NOT COMPLETED|Overall Study||8
2967907|NCT00784147|3682363|FG001|NOT COMPLETED|Overall Study||9
2967908|NCT00784225|3682373|FG000|STARTED|Overall Study||3375
2967909|NCT00784225|3682374|FG001|STARTED|Overall Study||3357
2967910|NCT00784225|3682375|FG002|STARTED|Overall Study||3369
2967911|NCT00784225|3682376|FG003|STARTED|Overall Study||3374
2967912|NCT00784225|3682373|FG000|COMPLETED|Overall Study||3375
2967913|NCT00784225|3682374|FG001|COMPLETED|Overall Study||3357
2967914|NCT00784225|3682375|FG002|COMPLETED|Overall Study||3369
2967915|NCT00784225|3682376|FG003|COMPLETED|Overall Study||3374
2967916|NCT00784225|3682373|FG000|NOT COMPLETED|Overall Study||0
2967917|NCT00784225|3682374|FG001|NOT COMPLETED|Overall Study||0
2967918|NCT00784225|3682375|FG002|NOT COMPLETED|Overall Study||0
2967919|NCT00784225|3682376|FG003|NOT COMPLETED|Overall Study||0
2967920|NCT00784238|3682390|FG000|STARTED|Overall Study||289
2967921|NCT00784238|3682390|FG000|COMPLETED|Overall Study||170
2967922|NCT00784238|3682390|FG000|NOT COMPLETED|Overall Study||119
2967923|NCT00784277|3682401|FG000|STARTED|IR Treatment||148
2967924|NCT00784277|3682402|FG001|STARTED|IR Treatment||151
2967925|NCT00784277|3682403|FG002|STARTED|IR Treatment||154
2967926|NCT00784277|3682404|FG003|STARTED|IR Treatment||143
2967927|NCT00784277|3682405|FG004|STARTED|IR Treatment|"0 in ER column indicates this reporting group is not relevant to IR phase."|0
2967928|NCT00784277|3682406|FG005|STARTED|IR Treatment|"0 in ER column indicates this reporting group is not relevant to IR phase."|0
2967929|NCT00784277|3682407|FG006|STARTED|IR Treatment|"0 in ER column indicates this reporting group is not relevant to IR phase."|0
2967930|NCT00784277|3682401|FG000|COMPLETED|IR Treatment||132
2967931|NCT00784277|3682402|FG001|COMPLETED|IR Treatment||134
2967932|NCT00784277|3682403|FG002|COMPLETED|IR Treatment||126
2967933|NCT00784277|3682404|FG003|COMPLETED|IR Treatment||100
2967934|NCT00784277|3682405|FG004|COMPLETED|IR Treatment||0
2967935|NCT00784277|3682406|FG005|COMPLETED|IR Treatment||0
2967936|NCT00784277|3682407|FG006|COMPLETED|IR Treatment||0
2967937|NCT00784277|3682401|FG000|NOT COMPLETED|IR Treatment||16
2967938|NCT00784277|3682402|FG001|NOT COMPLETED|IR Treatment||17
2967939|NCT00784277|3682403|FG002|NOT COMPLETED|IR Treatment||28
2967940|NCT00784277|3682404|FG003|NOT COMPLETED|IR Treatment||43
2967941|NCT00784277|3682405|FG004|NOT COMPLETED|IR Treatment||0
2967942|NCT00784277|3682406|FG005|NOT COMPLETED|IR Treatment||0
2967943|NCT00784277|3682407|FG006|NOT COMPLETED|IR Treatment||0
2967944|NCT00784277|3682401|FG000|STARTED|ER Treatment|"0 in IR column indicates this reporting group is not relevant to ER phase."|0
2967945|NCT00784277|3682402|FG001|STARTED|ER Treatment|"0 in IR column indicates this reporting group is not relevant to ER phase."|0
2967946|NCT00784277|3682403|FG002|STARTED|ER Treatment|"0 in IR column indicates this reporting group is not relevant to ER phase."|0
2967947|NCT00784277|3682404|FG003|STARTED|ER Treatment|"0 in IR column indicates this reporting group is not relevant to ER phase."|0
2967948|NCT00784277|3682405|FG004|STARTED|ER Treatment|10 participants who had completed IR treatment have not taken any ER treatment.|122
2967949|NCT00784277|3682406|FG005|STARTED|ER Treatment|10 participants who had completed IR treatment have not taken any ER treatment.|250
2967950|NCT00784277|3682407|FG006|STARTED|ER Treatment|9 participants who had completed IR treatment have not taken any ER treatment.|91
2967951|NCT00784277|3682401|FG000|COMPLETED|ER Treatment||0
2967952|NCT00784277|3682402|FG001|COMPLETED|ER Treatment||0
2967953|NCT00784277|3682403|FG002|COMPLETED|ER Treatment||0
2967954|NCT00784277|3682404|FG003|COMPLETED|ER Treatment||0
2967955|NCT00784277|3682405|FG004|COMPLETED|ER Treatment||113
2967956|NCT00784277|3682406|FG005|COMPLETED|ER Treatment||226
2967957|NCT00784277|3682407|FG006|COMPLETED|ER Treatment||76
2967958|NCT00784277|3682401|FG000|NOT COMPLETED|ER Treatment||0
2967959|NCT00784277|3682402|FG001|NOT COMPLETED|ER Treatment||0
2967960|NCT00784277|3682403|FG002|NOT COMPLETED|ER Treatment||0
2967961|NCT00784277|3682404|FG003|NOT COMPLETED|ER Treatment||0
2967962|NCT00784277|3682405|FG004|NOT COMPLETED|ER Treatment||9
2967963|NCT00784277|3682406|FG005|NOT COMPLETED|ER Treatment||24
2967964|NCT00784277|3682407|FG006|NOT COMPLETED|ER Treatment||15
2967965|NCT00784303|3682422|FG000|STARTED|Overall Study||58
2967966|NCT00784303|3682423|FG001|STARTED|Overall Study||59
2967967|NCT00784303|3682422|FG000|COMPLETED|Overall Study||58
2967968|NCT00784303|3682423|FG001|COMPLETED|Overall Study||59
2967969|NCT00784303|3682422|FG000|NOT COMPLETED|Overall Study||0
2967970|NCT00784303|3682423|FG001|NOT COMPLETED|Overall Study||0
2967971|NCT00784368|3682433|FG000|STARTED|Overall Study||16
2967972|NCT00784368|3682434|FG001|STARTED|Overall Study||16
2967973|NCT00784368|3682435|FG002|STARTED|Overall Study||23
2967974|NCT00784368|3682433|FG000|COMPLETED|Overall Study||8
2967975|NCT00784368|3682434|FG001|COMPLETED|Overall Study||5
2967976|NCT00784368|3682435|FG002|COMPLETED|Overall Study||12
2967977|NCT00784368|3682433|FG000|NOT COMPLETED|Overall Study||8
2967978|NCT00784368|3682434|FG001|NOT COMPLETED|Overall Study||11
2967979|NCT00784368|3682435|FG002|NOT COMPLETED|Overall Study||11
2967980|NCT00784459|3682448|FG000|STARTED|Overall Study||11
2967981|NCT00784459|3682449|FG001|STARTED|Overall Study||13
2967982|NCT00784459|3682448|FG000|COMPLETED|Overall Study||11
2967983|NCT00784459|3682449|FG001|COMPLETED|Overall Study||11
2967984|NCT00784459|3682448|FG000|NOT COMPLETED|Overall Study||0
2967985|NCT00784459|3682449|FG001|NOT COMPLETED|Overall Study||2
2967986|NCT00784524|3682455|FG000|STARTED|Overall Study||14
2967987|NCT00784524|3682455|FG000|COMPLETED|Overall Study||14
3133174|NCT01695239|3858314|FG009|STARTED|Double-Blind (DB) Treatment Period||0
3133175|NCT01695239|3858315|FG010|STARTED|Double-Blind (DB) Treatment Period||0
3133176|NCT01695239|3858316|FG011|STARTED|Double-Blind (DB) Treatment Period||0
3133177|NCT01695239|3858317|FG012|STARTED|Double-Blind (DB) Treatment Period||0
2967988|NCT00784524|3682455|FG000|NOT COMPLETED|Overall Study||0
2967989|NCT00784550|3682461|FG000|STARTED|Overall Study||173
2967990|NCT00784550|3682462|FG001|STARTED|Overall Study||169
2967991|NCT00784550|3682461|FG000|COMPLETED|Overall Study||137
2967992|NCT00784550|3682462|FG001|COMPLETED|Overall Study||127
2967993|NCT00784550|3682461|FG000|NOT COMPLETED|Overall Study||36
2967994|NCT00784550|3682462|FG001|NOT COMPLETED|Overall Study||42
2967995|NCT00784563|3682471|FG000|STARTED|Years 1 & 2||21
2967996|NCT00784563|3682472|FG001|STARTED|Years 1 & 2||22
2967997|NCT00784563|3682473|FG002|STARTED|Years 1 & 2||0
2967998|NCT00784563|3682471|FG000|COMPLETED|Years 1 & 2||18
2967999|NCT00784563|3682472|FG001|COMPLETED|Years 1 & 2||17
2968000|NCT00784563|3682473|FG002|COMPLETED|Years 1 & 2||0
2968001|NCT00784563|3682471|FG000|NOT COMPLETED|Years 1 & 2||3
2968002|NCT00784563|3682472|FG001|NOT COMPLETED|Years 1 & 2||5
2968003|NCT00784563|3682473|FG002|NOT COMPLETED|Years 1 & 2||0
2968004|NCT00784563|3682471|FG000|STARTED|Year 3||0
2968005|NCT00784563|3682472|FG001|STARTED|Year 3||0
2968006|NCT00784563|3682473|FG002|STARTED|Year 3||17
2968007|NCT00784563|3682471|FG000|COMPLETED|Year 3||0
2968008|NCT00784563|3682472|FG001|COMPLETED|Year 3||0
2968009|NCT00784563|3682473|FG002|COMPLETED|Year 3||14
2968010|NCT00784563|3682471|FG000|NOT COMPLETED|Year 3||0
2968011|NCT00784563|3682472|FG001|NOT COMPLETED|Year 3||0
2968012|NCT00784563|3682473|FG002|NOT COMPLETED|Year 3||3
2968013|NCT00784641|3682482|FG000|STARTED|Overall Study||189
2968014|NCT00784641|3682483|FG001|STARTED|Overall Study||189
2968015|NCT00784641|3682484|FG002|STARTED|Overall Study||189
2968016|NCT00784641|3682482|FG000|COMPLETED|Overall Study||183
2968017|NCT00784641|3682483|FG001|COMPLETED|Overall Study||186
2968018|NCT00784641|3682484|FG002|COMPLETED|Overall Study||187
2968019|NCT00784641|3682482|FG000|NOT COMPLETED|Overall Study||6
2968020|NCT00784641|3682483|FG001|NOT COMPLETED|Overall Study||3
2968021|NCT00784641|3682484|FG002|NOT COMPLETED|Overall Study||2
2968022|NCT00784654|3682492|FG000|STARTED|Open-Label Period (Non-Randomized)||276
2968023|NCT00784654|3682493|FG001|STARTED|Open-Label Period (Non-Randomized)||0
2968024|NCT00784654|3682494|FG002|STARTED|Open-Label Period (Non-Randomized)||0
2968025|NCT00784654|3682492|FG000|COMPLETED|Open-Label Period (Non-Randomized)||165
2968026|NCT00784654|3682493|FG001|COMPLETED|Open-Label Period (Non-Randomized)||0
2968027|NCT00784654|3682494|FG002|COMPLETED|Open-Label Period (Non-Randomized)||0
2968028|NCT00784654|3682492|FG000|NOT COMPLETED|Open-Label Period (Non-Randomized)||111
2968029|NCT00784654|3682493|FG001|NOT COMPLETED|Open-Label Period (Non-Randomized)||0
2968030|NCT00784654|3682494|FG002|NOT COMPLETED|Open-Label Period (Non-Randomized)||0
2968031|NCT00784654|3682492|FG000|STARTED|Randomized Withdrawal Period||0
2968032|NCT00784654|3682493|FG001|STARTED|Randomized Withdrawal Period||78
2968033|NCT00784654|3682494|FG002|STARTED|Randomized Withdrawal Period||79
2968034|NCT00784654|3682492|FG000|COMPLETED|Randomized Withdrawal Period||0
2968035|NCT00784654|3682493|FG001|COMPLETED|Randomized Withdrawal Period||60
2968036|NCT00784654|3682494|FG002|COMPLETED|Randomized Withdrawal Period||16
2968037|NCT00784654|3682492|FG000|NOT COMPLETED|Randomized Withdrawal Period||0
2968038|NCT00784654|3682493|FG001|NOT COMPLETED|Randomized Withdrawal Period||18
2968039|NCT00784654|3682494|FG002|NOT COMPLETED|Randomized Withdrawal Period||63
2968040|NCT00784693|3682507|FG000|STARTED|Overall Study||23
2968041|NCT00784693|3682508|FG001|STARTED|Overall Study||25
2968042|NCT00784693|3682507|FG000|Treated|Overall Study||22
2968043|NCT00784693|3682508|FG001|Treated|Overall Study||25
2968044|NCT00784693|3682507|FG000|COMPLETED|Overall Study||20
2968045|NCT00784693|3682508|FG001|COMPLETED|Overall Study||19
2968046|NCT00784693|3682507|FG000|NOT COMPLETED|Overall Study||3
2968047|NCT00784693|3682508|FG001|NOT COMPLETED|Overall Study||6
2968048|NCT00784719|3682521|FG000|STARTED|Overall Study||47
2968049|NCT00784719|3682522|FG001|STARTED|Overall Study||46
2968050|NCT00784719|3682523|FG002|STARTED|Overall Study||47
2968051|NCT00784719|3682524|FG003|STARTED|Overall Study||48
2968052|NCT00784719|3682525|FG004|STARTED|Overall Study||48
2968053|NCT00784719|3682526|FG005|STARTED|Overall Study||44
2968054|NCT00784719|3682527|FG006|STARTED|Overall Study||47
2968055|NCT00784719|3682521|FG000|COMPLETED|Overall Study||44
2968056|NCT00784719|3682522|FG001|COMPLETED|Overall Study||43
2968057|NCT00784719|3682523|FG002|COMPLETED|Overall Study||46
2968058|NCT00784719|3682524|FG003|COMPLETED|Overall Study||48
2968059|NCT00784719|3682525|FG004|COMPLETED|Overall Study||42
2968060|NCT00784719|3682526|FG005|COMPLETED|Overall Study||41
2968061|NCT00784719|3682527|FG006|COMPLETED|Overall Study||42
2968062|NCT00784719|3682521|FG000|NOT COMPLETED|Overall Study||3
2968063|NCT00784719|3682522|FG001|NOT COMPLETED|Overall Study||3
2968064|NCT00784719|3682523|FG002|NOT COMPLETED|Overall Study||1
2968065|NCT00784719|3682524|FG003|NOT COMPLETED|Overall Study||0
2968066|NCT00784719|3682525|FG004|NOT COMPLETED|Overall Study||6
2968067|NCT00784719|3682526|FG005|NOT COMPLETED|Overall Study||3
2968068|NCT00784719|3682527|FG006|NOT COMPLETED|Overall Study||5
2968069|NCT00784758|3682545|FG000|STARTED|Overall Study||42
2968070|NCT00784758|3682546|FG001|STARTED|Overall Study||39
2968071|NCT00784758|3682545|FG000|Began Treatment|Overall Study||41
2968072|NCT00784758|3682546|FG001|Began Treatment|Overall Study||39
2968073|NCT00784758|3682545|FG000|Completed Treatment|Overall Study||40
2968074|NCT00784758|3682546|FG001|Completed Treatment|Overall Study||39
2968075|NCT00784758|3682545|FG000|COMPLETED|Overall Study||38
2968076|NCT00784758|3682546|FG001|COMPLETED|Overall Study||39
2968077|NCT00784758|3682545|FG000|NOT COMPLETED|Overall Study||4
2968078|NCT00784758|3682546|FG001|NOT COMPLETED|Overall Study||0
2968079|NCT00784784|3682556|FG000|STARTED|Overall Study||22
2968080|NCT00784784|3682557|FG001|STARTED|Overall Study||42
2968081|NCT00784784|3682556|FG000|COMPLETED|Overall Study||20
2968082|NCT00784784|3682557|FG001|COMPLETED|Overall Study||40
2968083|NCT00784784|3682556|FG000|NOT COMPLETED|Overall Study||2
2968084|NCT00784784|3682557|FG001|NOT COMPLETED|Overall Study||2
2968085|NCT00784810|3682565|FG000|STARTED|Overall Study||124
2968086|NCT00784810|3682566|FG001|STARTED|Overall Study||123
2968087|NCT00784810|3682565|FG000|COMPLETED|Overall Study||61
2968088|NCT00784810|3682566|FG001|COMPLETED|Overall Study||74
2968089|NCT00784810|3682565|FG000|NOT COMPLETED|Overall Study||63
2968090|NCT00784810|3682566|FG001|NOT COMPLETED|Overall Study||49
2968091|NCT00784836|3682572|FG000|STARTED|Overall Study||3
2968092|NCT00784836|3682572|FG000|COMPLETED|Overall Study|The study was terminated early by the Sponsor for business reason not related to safety.|0
2968093|NCT00784836|3682572|FG000|NOT COMPLETED|Overall Study||3
2968094|NCT00784849|3682576|FG000|STARTED|Overall Study||62
2968095|NCT00784849|3682576|FG000|COMPLETED|Overall Study||62
2968096|NCT00784849|3682576|FG000|NOT COMPLETED|Overall Study||0
2968097|NCT00784875|3682584|FG000|STARTED|Period A - Baseline||0
2968098|NCT00784875|3682585|FG001|STARTED|Period A - Baseline||0
2968099|NCT00784875|3682586|FG002|STARTED|Period A - Baseline||0
2968100|NCT00784875|3682587|FG003|STARTED|Period A - Baseline||643
2968101|NCT00784875|3682584|FG000|COMPLETED|Period A - Baseline||0
2968102|NCT00784875|3682585|FG001|COMPLETED|Period A - Baseline||0
2968103|NCT00784875|3682586|FG002|COMPLETED|Period A - Baseline||0
2968104|NCT00784875|3682587|FG003|COMPLETED|Period A - Baseline||461
2968105|NCT00784875|3682584|FG000|NOT COMPLETED|Period A - Baseline||0
2968106|NCT00784875|3682585|FG001|NOT COMPLETED|Period A - Baseline||0
3133178|NCT01695239|3858318|FG013|STARTED|Double-Blind (DB) Treatment Period||0
3133179|NCT01695239|3858305|FG000|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||106
3133180|NCT01695239|3858306|FG001|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||101
2968107|NCT00784875|3682586|FG002|NOT COMPLETED|Period A - Baseline||0
2968108|NCT00784875|3682587|FG003|NOT COMPLETED|Period A - Baseline||182
2968109|NCT00784875|3682584|FG000|STARTED|Period B - Efficacy Endpoint||114
2968110|NCT00784875|3682585|FG001|STARTED|Period B - Efficacy Endpoint||113
2968111|NCT00784875|3682586|FG002|STARTED|Period B - Efficacy Endpoint||117
2968112|NCT00784875|3682587|FG003|STARTED|Period B - Efficacy Endpoint||117
2968113|NCT00784875|3682584|FG000|Cohort 2|Period B - Efficacy Endpoint||102
2968114|NCT00784875|3682585|FG001|Cohort 2|Period B - Efficacy Endpoint||102
2968115|NCT00784875|3682586|FG002|Cohort 2|Period B - Efficacy Endpoint||102
2968116|NCT00784875|3682587|FG003|Cohort 2|Period B - Efficacy Endpoint||101
2968117|NCT00784875|3682584|FG000|COMPLETED|Period B - Efficacy Endpoint||100
2968118|NCT00784875|3682585|FG001|COMPLETED|Period B - Efficacy Endpoint||101
2968119|NCT00784875|3682586|FG002|COMPLETED|Period B - Efficacy Endpoint||96
2968120|NCT00784875|3682587|FG003|COMPLETED|Period B - Efficacy Endpoint||98
2968121|NCT00784875|3682584|FG000|NOT COMPLETED|Period B - Efficacy Endpoint||14
2968122|NCT00784875|3682585|FG001|NOT COMPLETED|Period B - Efficacy Endpoint||12
2968123|NCT00784875|3682586|FG002|NOT COMPLETED|Period B - Efficacy Endpoint||21
2968124|NCT00784875|3682587|FG003|NOT COMPLETED|Period B - Efficacy Endpoint||19
2968125|NCT00784875|3682584|FG000|STARTED|Period C||103
2968126|NCT00784875|3682585|FG001|STARTED|Period C||97
2968127|NCT00784875|3682586|FG002|STARTED|Period C||97
2968128|NCT00784875|3682587|FG003|STARTED|Period C||98
2968129|NCT00784875|3682584|FG000|COMPLETED|Period C||96
2968130|NCT00784875|3682585|FG001|COMPLETED|Period C||91
2968131|NCT00784875|3682586|FG002|COMPLETED|Period C||84
2968132|NCT00784875|3682587|FG003|COMPLETED|Period C||91
2968133|NCT00784875|3682584|FG000|NOT COMPLETED|Period C||7
2968134|NCT00784875|3682585|FG001|NOT COMPLETED|Period C||6
2968135|NCT00784875|3682586|FG002|NOT COMPLETED|Period C||13
2968136|NCT00784875|3682587|FG003|NOT COMPLETED|Period C||7
2968137|NCT00784875|3682584|FG000|STARTED|Period D||91
2968138|NCT00784875|3682585|FG001|STARTED|Period D||89
2968139|NCT00784875|3682586|FG002|STARTED|Period D||94
2968140|NCT00784875|3682587|FG003|STARTED|Period D||88
2968141|NCT00784875|3682584|FG000|COMPLETED|Period D||86
2968142|NCT00784875|3682585|FG001|COMPLETED|Period D||85
2968143|NCT00784875|3682586|FG002|COMPLETED|Period D||88
2968144|NCT00784875|3682587|FG003|COMPLETED|Period D||87
2968145|NCT00784875|3682584|FG000|NOT COMPLETED|Period D||5
2968146|NCT00784875|3682585|FG001|NOT COMPLETED|Period D||4
2968147|NCT00784875|3682586|FG002|NOT COMPLETED|Period D||6
2968148|NCT00784875|3682587|FG003|NOT COMPLETED|Period D||1
2968149|NCT00784927|3682610|FG000|STARTED|Overall Study||36
2968150|NCT00784927|3682610|FG000|COMPLETED|Overall Study||33
2968151|NCT00784927|3682610|FG000|NOT COMPLETED|Overall Study||3
2968152|NCT00784979|3682615|FG000|STARTED|Overall Study||26
2968153|NCT00784979|3682615|FG000|COMPLETED|Overall Study||20
2968154|NCT00784979|3682615|FG000|NOT COMPLETED|Overall Study||6
2968155|NCT00785044|3682619|FG000|STARTED|Overall Study|Eligible to participate in MBG313|964
2968156|NCT00785044|3682619|FG000|Enrolled Participants|Overall Study|Out of 964 from MBG311 and MBG312 HF participants, 471 enrolled into the extension MBG313 study.|471
2968157|NCT00785044|3682619|FG000|COMPLETED|Overall Study|Data for 471 participants (MBG313) combined with data from MBG311 and MBG312 for efficacy analysis|468
2968158|NCT00785044|3682619|FG000|NOT COMPLETED|Overall Study||496
2968159|NCT00785213|3682624|FG000|STARTED|Rosiglitazone Alone||23
2968160|NCT00785213|3682624|FG000|COMPLETED|Rosiglitazone Alone||23
2968161|NCT00785213|3682624|FG000|NOT COMPLETED|Rosiglitazone Alone||0
2968162|NCT00785213|3682624|FG000|STARTED|2 Day Washout Period||23
2968163|NCT00785213|3682624|FG000|COMPLETED|2 Day Washout Period||23
2968164|NCT00785213|3682624|FG000|NOT COMPLETED|2 Day Washout Period||0
2968165|NCT00785213|3682624|FG000|STARTED|Quinine Sulfate Alone||23
2968166|NCT00785213|3682624|FG000|COMPLETED|Quinine Sulfate Alone||19
2968167|NCT00785213|3682624|FG000|NOT COMPLETED|Quinine Sulfate Alone||4
2968168|NCT00785213|3682624|FG000|STARTED|Rosiglitazone With Quinine Sulfate||19
3133181|NCT01695239|3858307|FG002|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||107
3133182|NCT01695239|3858308|FG003|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||102
3133183|NCT01695239|3858309|FG004|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
3136738|NCT01714726|3861991|FG003|STARTED|Open-Label Period||52
2968169|NCT00785213|3682624|FG000|COMPLETED|Rosiglitazone With Quinine Sulfate||18
2968170|NCT00785213|3682624|FG000|NOT COMPLETED|Rosiglitazone With Quinine Sulfate||1
2968171|NCT00785486|3682631|FG000|STARTED|Midazolam Alone||24
2968172|NCT00785486|3682631|FG000|COMPLETED|Midazolam Alone|one participant withdrew for personal reasons after first midazolam dose|23
2968173|NCT00785486|3682631|FG000|NOT COMPLETED|Midazolam Alone||1
2968174|NCT00785486|3682631|FG000|STARTED|3 Day Washout||23
2968175|NCT00785486|3682631|FG000|COMPLETED|3 Day Washout||23
2968176|NCT00785486|3682631|FG000|NOT COMPLETED|3 Day Washout||0
2968177|NCT00785486|3682631|FG000|STARTED|Qualaquin Alone at Steady State||23
2968178|NCT00785486|3682631|FG000|COMPLETED|Qualaquin Alone at Steady State||23
2968179|NCT00785486|3682631|FG000|NOT COMPLETED|Qualaquin Alone at Steady State||0
2968180|NCT00785486|3682631|FG000|STARTED|Midazolam With Qualaquin at Steady State||23
2968181|NCT00785486|3682631|FG000|COMPLETED|Midazolam With Qualaquin at Steady State||23
2968182|NCT00785486|3682631|FG000|NOT COMPLETED|Midazolam With Qualaquin at Steady State||0
2968183|NCT00785512|3682654|FG000|STARTED|Overall Study||102
2968184|NCT00785512|3682655|FG001|STARTED|Overall Study||105
2968185|NCT00785512|3682654|FG000|COMPLETED|Overall Study||99
2968186|NCT00785512|3682655|FG001|COMPLETED|Overall Study||101
2968187|NCT00785512|3682654|FG000|NOT COMPLETED|Overall Study||3
2968188|NCT00785512|3682655|FG001|NOT COMPLETED|Overall Study||4
3035642|NCT01138826|3754952|FG000|NOT COMPLETED|Washout Period I (of 16 Days)||1
3035643|NCT01138826|3754953|FG001|NOT COMPLETED|Washout Period I (of 16 Days)||1
3035644|NCT01138826|3754954|FG002|NOT COMPLETED|Washout Period I (of 16 Days)||0
3035645|NCT01138826|3754955|FG003|NOT COMPLETED|Washout Period I (of 16 Days)||0
3035646|NCT01138826|3754956|FG004|NOT COMPLETED|Washout Period I (of 16 Days)||1
3133184|NCT01695239|3858310|FG005|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
3133185|NCT01695239|3858311|FG006|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
3035647|NCT01138826|3754957|FG005|NOT COMPLETED|Washout Period I (of 16 Days)||0
3035648|NCT01138826|3754952|FG000|STARTED|Second Intervention Period||2
3035649|NCT01138826|3754953|FG001|STARTED|Second Intervention Period||2
3035650|NCT01138826|3754954|FG002|STARTED|Second Intervention Period||3
3035651|NCT01138826|3754955|FG003|STARTED|Second Intervention Period||3
3035652|NCT01138826|3754956|FG004|STARTED|Second Intervention Period||2
3035653|NCT01138826|3754957|FG005|STARTED|Second Intervention Period||3
3035654|NCT01138826|3754952|FG000|COMPLETED|Second Intervention Period||2
3035655|NCT01138826|3754953|FG001|COMPLETED|Second Intervention Period||2
3035656|NCT01138826|3754954|FG002|COMPLETED|Second Intervention Period||3
3035657|NCT01138826|3754955|FG003|COMPLETED|Second Intervention Period||3
3035658|NCT01138826|3754956|FG004|COMPLETED|Second Intervention Period||2
3035659|NCT01138826|3754957|FG005|COMPLETED|Second Intervention Period||3
3035660|NCT01138826|3754952|FG000|NOT COMPLETED|Second Intervention Period||0
3035661|NCT01138826|3754953|FG001|NOT COMPLETED|Second Intervention Period||0
3035662|NCT01138826|3754954|FG002|NOT COMPLETED|Second Intervention Period||0
3035663|NCT01138826|3754955|FG003|NOT COMPLETED|Second Intervention Period||0
3035664|NCT01138826|3754956|FG004|NOT COMPLETED|Second Intervention Period||0
3035665|NCT01138826|3754957|FG005|NOT COMPLETED|Second Intervention Period||0
3035666|NCT01138826|3754952|FG000|STARTED|Washout Period II (of 16 Days)||2
3035667|NCT01138826|3754953|FG001|STARTED|Washout Period II (of 16 Days)||2
3035668|NCT01138826|3754954|FG002|STARTED|Washout Period II (of 16 Days)||3
3035669|NCT01138826|3754955|FG003|STARTED|Washout Period II (of 16 Days)||3
3035670|NCT01138826|3754956|FG004|STARTED|Washout Period II (of 16 Days)||2
3035671|NCT01138826|3754957|FG005|STARTED|Washout Period II (of 16 Days)||3
3035672|NCT01138826|3754952|FG000|COMPLETED|Washout Period II (of 16 Days)||2
3035673|NCT01138826|3754953|FG001|COMPLETED|Washout Period II (of 16 Days)||2
3035674|NCT01138826|3754954|FG002|COMPLETED|Washout Period II (of 16 Days)||3
3035675|NCT01138826|3754955|FG003|COMPLETED|Washout Period II (of 16 Days)||3
3035676|NCT01138826|3754956|FG004|COMPLETED|Washout Period II (of 16 Days)||2
3035677|NCT01138826|3754957|FG005|COMPLETED|Washout Period II (of 16 Days)||3
3035678|NCT01138826|3754952|FG000|NOT COMPLETED|Washout Period II (of 16 Days)||0
3035679|NCT01138826|3754953|FG001|NOT COMPLETED|Washout Period II (of 16 Days)||0
3035680|NCT01138826|3754954|FG002|NOT COMPLETED|Washout Period II (of 16 Days)||0
3035681|NCT01138826|3754955|FG003|NOT COMPLETED|Washout Period II (of 16 Days)||0
3035682|NCT01138826|3754956|FG004|NOT COMPLETED|Washout Period II (of 16 Days)||0
3035683|NCT01138826|3754957|FG005|NOT COMPLETED|Washout Period II (of 16 Days)||0
3035684|NCT01138826|3754952|FG000|STARTED|Third Intervention Period||2
3035685|NCT01138826|3754953|FG001|STARTED|Third Intervention Period||2
3035686|NCT01138826|3754954|FG002|STARTED|Third Intervention Period||3
3035687|NCT01138826|3754955|FG003|STARTED|Third Intervention Period||3
3035688|NCT01138826|3754956|FG004|STARTED|Third Intervention Period||2
3035689|NCT01138826|3754957|FG005|STARTED|Third Intervention Period||3
3035690|NCT01138826|3754952|FG000|COMPLETED|Third Intervention Period||2
3035691|NCT01138826|3754953|FG001|COMPLETED|Third Intervention Period||2
3035692|NCT01138826|3754954|FG002|COMPLETED|Third Intervention Period||3
3035693|NCT01138826|3754955|FG003|COMPLETED|Third Intervention Period||3
3035694|NCT01138826|3754956|FG004|COMPLETED|Third Intervention Period||2
3035695|NCT01138826|3754957|FG005|COMPLETED|Third Intervention Period||3
3035696|NCT01138826|3754952|FG000|NOT COMPLETED|Third Intervention Period||0
3035697|NCT01138826|3754953|FG001|NOT COMPLETED|Third Intervention Period||0
3035698|NCT01138826|3754954|FG002|NOT COMPLETED|Third Intervention Period||0
3035699|NCT01138826|3754955|FG003|NOT COMPLETED|Third Intervention Period||0
3035700|NCT01138826|3754956|FG004|NOT COMPLETED|Third Intervention Period||0
3035701|NCT01138826|3754957|FG005|NOT COMPLETED|Third Intervention Period||0
3035702|NCT01138917|3754965|FG000|STARTED|Overall Study||101
3035703|NCT01138917|3754965|FG000|COMPLETED|Overall Study||77
3035704|NCT01138917|3754965|FG000|NOT COMPLETED|Overall Study||24
3035705|NCT01138969|3754975|FG000|STARTED|Overall Study||83
3035706|NCT01138969|3754976|FG001|STARTED|Overall Study||82
3035707|NCT01138969|3754975|FG000|COMPLETED|Overall Study||83
3035708|NCT01138969|3754976|FG001|COMPLETED|Overall Study||82
3035709|NCT01138969|3754975|FG000|NOT COMPLETED|Overall Study||0
3035710|NCT01138969|3754976|FG001|NOT COMPLETED|Overall Study||0
3035711|NCT01138995|3754984|FG000|STARTED|Overall Study||98
3035712|NCT01138995|3754985|FG001|STARTED|Overall Study||99
3035713|NCT01138995|3754984|FG000|COMPLETED|Overall Study||88
3035714|NCT01138995|3754985|FG001|COMPLETED|Overall Study||74
3035715|NCT01138995|3754984|FG000|NOT COMPLETED|Overall Study||10
3035716|NCT01138995|3754985|FG001|NOT COMPLETED|Overall Study||25
3035717|NCT01139008|3754992|FG000|STARTED|Overall Study||80
3035718|NCT01139008|3754992|FG000|COMPLETED|Overall Study||74
3035719|NCT01139008|3754992|FG000|NOT COMPLETED|Overall Study||6
2968189|NCT00785538|3682666|FG000|STARTED|PK Period||7
2968190|NCT00785538|3682667|FG001|STARTED|PK Period||1
2968191|NCT00785538|3682668|FG002|STARTED|PK Period||1
2968192|NCT00785538|3682669|FG003|STARTED|PK Period||0
2968193|NCT00785538|3682666|FG000|COMPLETED|PK Period||7
2968194|NCT00785538|3682667|FG001|COMPLETED|PK Period||1
2968195|NCT00785538|3682668|FG002|COMPLETED|PK Period||1
2968196|NCT00785538|3682669|FG003|COMPLETED|PK Period||0
2968197|NCT00785538|3682666|FG000|NOT COMPLETED|PK Period||0
2968198|NCT00785538|3682667|FG001|NOT COMPLETED|PK Period||0
2968199|NCT00785538|3682668|FG002|NOT COMPLETED|PK Period||0
2968200|NCT00785538|3682669|FG003|NOT COMPLETED|PK Period||0
2968201|NCT00785538|3682666|FG000|STARTED|Treatment Period||7
2968202|NCT00785538|3682667|FG001|STARTED|Treatment Period||9
2968203|NCT00785538|3682668|FG002|STARTED|Treatment Period||6
2968204|NCT00785538|3682669|FG003|STARTED|Treatment Period||2
2968205|NCT00785538|3682666|FG000|Received at Least 1 Dose of Study Drug|Treatment Period||7
2968206|NCT00785538|3682667|FG001|Received at Least 1 Dose of Study Drug|Treatment Period||9
2968207|NCT00785538|3682668|FG002|Received at Least 1 Dose of Study Drug|Treatment Period||6
2968208|NCT00785538|3682669|FG003|Received at Least 1 Dose of Study Drug|Treatment Period||2
2968209|NCT00785538|3682666|FG000|COMPLETED|Treatment Period||6
2968210|NCT00785538|3682667|FG001|COMPLETED|Treatment Period||7
2968211|NCT00785538|3682668|FG002|COMPLETED|Treatment Period||4
2968212|NCT00785538|3682669|FG003|COMPLETED|Treatment Period||1
2968213|NCT00785538|3682666|FG000|NOT COMPLETED|Treatment Period||1
2968214|NCT00785538|3682667|FG001|NOT COMPLETED|Treatment Period||2
2968215|NCT00785538|3682668|FG002|NOT COMPLETED|Treatment Period||2
2968216|NCT00785538|3682669|FG003|NOT COMPLETED|Treatment Period||1
2968217|NCT00785577|3682685|FG000|STARTED|Study Period 2: Therapy Phase||89
2968218|NCT00785577|3682686|FG001|STARTED|Study Period 2: Therapy Phase||45
2968219|NCT00785577|3682687|FG002|STARTED|Study Period 2: Therapy Phase||43
2968220|NCT00785577|3682688|FG003|STARTED|Study Period 2: Therapy Phase||49
2968221|NCT00785577|3682689|FG004|STARTED|Study Period 2: Therapy Phase||47
2968222|NCT00785577|3682685|FG000|COMPLETED|Study Period 2: Therapy Phase||78
2968223|NCT00785577|3682686|FG001|COMPLETED|Study Period 2: Therapy Phase||36
2968224|NCT00785577|3682687|FG002|COMPLETED|Study Period 2: Therapy Phase||25
2968225|NCT00785577|3682688|FG003|COMPLETED|Study Period 2: Therapy Phase||36
2968226|NCT00785577|3682689|FG004|COMPLETED|Study Period 2: Therapy Phase||27
2968227|NCT00785577|3682685|FG000|NOT COMPLETED|Study Period 2: Therapy Phase||11
2968228|NCT00785577|3682686|FG001|NOT COMPLETED|Study Period 2: Therapy Phase||9
2968229|NCT00785577|3682687|FG002|NOT COMPLETED|Study Period 2: Therapy Phase||18
2968230|NCT00785577|3682688|FG003|NOT COMPLETED|Study Period 2: Therapy Phase||13
2968231|NCT00785577|3682689|FG004|NOT COMPLETED|Study Period 2: Therapy Phase||20
2968232|NCT00785577|3682685|FG000|STARTED|Study Period 3: 1-Week Washout Phase||78
2968233|NCT00785577|3682686|FG001|STARTED|Study Period 3: 1-Week Washout Phase||36
2968234|NCT00785577|3682687|FG002|STARTED|Study Period 3: 1-Week Washout Phase||25
2968235|NCT00785577|3682688|FG003|STARTED|Study Period 3: 1-Week Washout Phase||36
2968236|NCT00785577|3682689|FG004|STARTED|Study Period 3: 1-Week Washout Phase||27
2968237|NCT00785577|3682685|FG000|COMPLETED|Study Period 3: 1-Week Washout Phase||78
2968238|NCT00785577|3682686|FG001|COMPLETED|Study Period 3: 1-Week Washout Phase||36
2968239|NCT00785577|3682687|FG002|COMPLETED|Study Period 3: 1-Week Washout Phase||25
2968240|NCT00785577|3682688|FG003|COMPLETED|Study Period 3: 1-Week Washout Phase||35
2968241|NCT00785577|3682689|FG004|COMPLETED|Study Period 3: 1-Week Washout Phase||26
2968242|NCT00785577|3682685|FG000|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||0
2968243|NCT00785577|3682686|FG001|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||0
2968244|NCT00785577|3682687|FG002|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||0
2968245|NCT00785577|3682688|FG003|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||1
2968246|NCT00785577|3682689|FG004|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||1
2968247|NCT00785629|3682715|FG000|STARTED|Overall Study||30
2968248|NCT00785629|3682716|FG001|STARTED|Overall Study||30
2968249|NCT00785629|3682717|FG002|STARTED|Overall Study||28
2968250|NCT00785629|3682718|FG003|STARTED|Overall Study||57
2968251|NCT00785629|3682715|FG000|COMPLETED|Overall Study|8 not completed|22
2968252|NCT00785629|3682716|FG001|COMPLETED|Overall Study|5 not completed|25
2968253|NCT00785629|3682717|FG002|COMPLETED|Overall Study|10 not completed|18
2968254|NCT00785629|3682718|FG003|COMPLETED|Overall Study|16 not completed|41
2968255|NCT00785629|3682715|FG000|NOT COMPLETED|Overall Study||8
2968256|NCT00785629|3682716|FG001|NOT COMPLETED|Overall Study||5
2968257|NCT00785629|3682717|FG002|NOT COMPLETED|Overall Study||10
2968258|NCT00785629|3682718|FG003|NOT COMPLETED|Overall Study||16
2968259|NCT00785707|3682726|FG000|STARTED|Overall Study||31
2968260|NCT00785707|3682726|FG000|COMPLETED|Overall Study||24
2968261|NCT00785707|3682726|FG000|NOT COMPLETED|Overall Study||7
2968262|NCT00785772|3682730|FG000|STARTED|Overall Study||1
2968263|NCT00785772|3682730|FG000|COMPLETED|Overall Study||1
2968264|NCT00785772|3682730|FG000|NOT COMPLETED|Overall Study||0
2968265|NCT00785785|3682736|FG000|STARTED|Core Phase up to 36 Months||324
2968266|NCT00785785|3682737|FG001|STARTED|Core Phase up to 36 Months||320
2968267|NCT00785785|3682736|FG000|COMPLETED|Core Phase up to 36 Months||0
2968268|NCT00785785|3682737|FG001|COMPLETED|Core Phase up to 36 Months||0
2968269|NCT00785785|3682736|FG000|NOT COMPLETED|Core Phase up to 36 Months||324
2968270|NCT00785785|3682737|FG001|NOT COMPLETED|Core Phase up to 36 Months||320
2968271|NCT00785785|3682736|FG000|STARTED|Optional Extension Phase|crossover extension phase was optional|39
2968272|NCT00785785|3682737|FG001|STARTED|Optional Extension Phase|crossover extension phase was optional|125
2968273|NCT00785785|3682736|FG000|COMPLETED|Optional Extension Phase||0
2968274|NCT00785785|3682737|FG001|COMPLETED|Optional Extension Phase||0
2968275|NCT00785785|3682736|FG000|NOT COMPLETED|Optional Extension Phase||39
2968276|NCT00785785|3682737|FG001|NOT COMPLETED|Optional Extension Phase||125
2968277|NCT00785798|3682745|FG000|STARTED|Overall Study||17
2968278|NCT00785798|3682745|FG000|COMPLETED|Overall Study||16
2968279|NCT00785798|3682745|FG000|NOT COMPLETED|Overall Study||1
2968280|NCT00785928|3682756|FG000|STARTED|Treatment Phase||36
2968281|NCT00785928|3682757|FG001|STARTED|Treatment Phase||30
2968282|NCT00785928|3682758|FG002|STARTED|Treatment Phase||20
2968283|NCT00785928|3682759|FG003|STARTED|Treatment Phase||15
2968284|NCT00785928|3682760|FG004|STARTED|Treatment Phase||18
2968285|NCT00785928|3682761|FG005|STARTED|Treatment Phase||13
2968286|NCT00785928|3682762|FG006|STARTED|Treatment Phase||26
2968287|NCT00785928|3682756|FG000|COMPLETED|Treatment Phase||33
2968288|NCT00785928|3682757|FG001|COMPLETED|Treatment Phase||25
2968289|NCT00785928|3682758|FG002|COMPLETED|Treatment Phase||17
2968290|NCT00785928|3682759|FG003|COMPLETED|Treatment Phase||15
2968291|NCT00785928|3682760|FG004|COMPLETED|Treatment Phase||16
2968292|NCT00785928|3682761|FG005|COMPLETED|Treatment Phase||13
2968293|NCT00785928|3682762|FG006|COMPLETED|Treatment Phase||23
2968294|NCT00785928|3682756|FG000|NOT COMPLETED|Treatment Phase||3
2968295|NCT00785928|3682757|FG001|NOT COMPLETED|Treatment Phase||5
2968296|NCT00785928|3682758|FG002|NOT COMPLETED|Treatment Phase||3
2968297|NCT00785928|3682759|FG003|NOT COMPLETED|Treatment Phase||0
2968298|NCT00785928|3682760|FG004|NOT COMPLETED|Treatment Phase||2
2968299|NCT00785928|3682761|FG005|NOT COMPLETED|Treatment Phase||0
2968300|NCT00785928|3682762|FG006|NOT COMPLETED|Treatment Phase||3
2968301|NCT00785928|3682756|FG000|STARTED|Follow-up Phases (Weeks 24-72)|Participants enrolling in an open-label extension study were not required to be in Follow-up Phase.|8
2968302|NCT00785928|3682757|FG001|STARTED|Follow-up Phases (Weeks 24-72)|Participants enrolling in an open-label extension study were not required to be in Follow-up Phase.|8
2968303|NCT00785928|3682758|FG002|STARTED|Follow-up Phases (Weeks 24-72)|Participants enrolling in an open-label extension study were not required to be in Follow-up Phase.|6
2968304|NCT00785928|3682759|FG003|STARTED|Follow-up Phases (Weeks 24-72)|Participants enrolling in an open-label extension study were not required to be in Follow-up Phase.|4
2968305|NCT00785928|3682760|FG004|STARTED|Follow-up Phases (Weeks 24-72)|Participants enrolling in an open-label extension study were not required to be in Follow-up Phase.|6
2968306|NCT00785928|3682761|FG005|STARTED|Follow-up Phases (Weeks 24-72)|Participants enrolling in an open-label extension study were not required to be in Follow-up Phase.|0
2968307|NCT00785928|3682762|FG006|STARTED|Follow-up Phases (Weeks 24-72)|Participants enrolling in an open-label extension study were not required to be in Follow-up Phase.|14
2968308|NCT00785928|3682756|FG000|COMPLETED|Follow-up Phases (Weeks 24-72)||7
2968309|NCT00785928|3682757|FG001|COMPLETED|Follow-up Phases (Weeks 24-72)||5
2968310|NCT00785928|3682758|FG002|COMPLETED|Follow-up Phases (Weeks 24-72)||4
2968311|NCT00785928|3682759|FG003|COMPLETED|Follow-up Phases (Weeks 24-72)||4
2968312|NCT00785928|3682760|FG004|COMPLETED|Follow-up Phases (Weeks 24-72)||4
2968313|NCT00785928|3682761|FG005|COMPLETED|Follow-up Phases (Weeks 24-72)||0
2968314|NCT00785928|3682762|FG006|COMPLETED|Follow-up Phases (Weeks 24-72)||9
2968315|NCT00785928|3682756|FG000|NOT COMPLETED|Follow-up Phases (Weeks 24-72)||1
2968316|NCT00785928|3682757|FG001|NOT COMPLETED|Follow-up Phases (Weeks 24-72)||3
2968317|NCT00785928|3682758|FG002|NOT COMPLETED|Follow-up Phases (Weeks 24-72)||2
2968318|NCT00785928|3682759|FG003|NOT COMPLETED|Follow-up Phases (Weeks 24-72)||0
2968319|NCT00785928|3682760|FG004|NOT COMPLETED|Follow-up Phases (Weeks 24-72)||2
2968320|NCT00785928|3682761|FG005|NOT COMPLETED|Follow-up Phases (Weeks 24-72)||0
2968321|NCT00785928|3682762|FG006|NOT COMPLETED|Follow-up Phases (Weeks 24-72)||5
2968322|NCT00785980|3682800|FG000|STARTED|Quinine Sulfate Alone||24
2968323|NCT00785980|3682800|FG000|COMPLETED|Quinine Sulfate Alone||24
2968324|NCT00785980|3682800|FG000|NOT COMPLETED|Quinine Sulfate Alone||0
2968325|NCT00785980|3682800|FG000|STARTED|7 Day Washout Period||24
2968326|NCT00785980|3682800|FG000|COMPLETED|7 Day Washout Period||21
2968327|NCT00785980|3682800|FG000|NOT COMPLETED|7 Day Washout Period||3
2968328|NCT00785980|3682800|FG000|STARTED|Ciprofloxacin Alone||21
2968329|NCT00785980|3682800|FG000|COMPLETED|Ciprofloxacin Alone||21
2968330|NCT00785980|3682800|FG000|NOT COMPLETED|Ciprofloxacin Alone||0
2968331|NCT00785980|3682800|FG000|STARTED|Quinine Sulfate With Ciprofloxacin||21
2968332|NCT00785980|3682800|FG000|COMPLETED|Quinine Sulfate With Ciprofloxacin||21
2968333|NCT00785980|3682800|FG000|NOT COMPLETED|Quinine Sulfate With Ciprofloxacin||0
2968334|NCT00786019|3682809|FG000|STARTED|Overall Study||20
2968335|NCT00786019|3682810|FG001|STARTED|Overall Study||27
2968336|NCT00786019|3682809|FG000|COMPLETED|Overall Study||15
2968337|NCT00786019|3682810|FG001|COMPLETED|Overall Study||17
2968338|NCT00786019|3682809|FG000|NOT COMPLETED|Overall Study||5
2968339|NCT00786019|3682810|FG001|NOT COMPLETED|Overall Study||10
2968340|NCT00786032|3682818|FG000|STARTED|Overall Study||27
2968341|NCT00786032|3682818|FG000|Independent Users|Overall Study|All data analyses were based on the 14 independent users.|14
2968342|NCT00786032|3682818|FG000|COMPLETED|Overall Study||3
2968343|NCT00786032|3682818|FG000|NOT COMPLETED|Overall Study||24
2968344|NCT00786188|3682826|FG000|STARTED|Overall Study||50
2968345|NCT00786188|3682827|FG001|STARTED|Overall Study||52
2968346|NCT00786188|3682826|FG000|COMPLETED|Overall Study||45
2968347|NCT00786188|3682827|FG001|COMPLETED|Overall Study||51
2968348|NCT00786188|3682826|FG000|NOT COMPLETED|Overall Study||5
2968349|NCT00786188|3682827|FG001|NOT COMPLETED|Overall Study||1
2968350|NCT00786409|3682835|FG000|STARTED|Overall Study||27
2968351|NCT00786409|3682835|FG000|COMPLETED|Overall Study||20
2968352|NCT00786409|3682835|FG000|NOT COMPLETED|Overall Study||7
2968353|NCT00786422|3682839|FG000|STARTED|Rivaroxaban Treatment||25
2968354|NCT00786422|3682839|FG000|COMPLETED|Rivaroxaban Treatment||14
2968355|NCT00786422|3682839|FG000|NOT COMPLETED|Rivaroxaban Treatment||11
2968356|NCT00786422|3682839|FG000|STARTED|Follow-up Period|Participants entered follow-up period. No reason documents for those not entering this period|20
2968357|NCT00786422|3682839|FG000|COMPLETED|Follow-up Period||17
2968358|NCT00786422|3682839|FG000|NOT COMPLETED|Follow-up Period||3
2968359|NCT00786474|3682847|FG000|STARTED|Overall Study||950
2968360|NCT00786474|3682848|FG001|STARTED|Overall Study||934
2968361|NCT00786474|3682847|FG000|COMPLETED|Overall Study||913
2968362|NCT00786474|3682848|FG001|COMPLETED|Overall Study||891
2968363|NCT00786474|3682847|FG000|NOT COMPLETED|Overall Study||37
2968364|NCT00786474|3682848|FG001|NOT COMPLETED|Overall Study||43
2968365|NCT00786487|3682858|FG000|STARTED|Overall Study||10
2968366|NCT00786487|3682859|FG001|STARTED|Overall Study||7
2968367|NCT00786487|3682860|FG002|STARTED|Overall Study||9
2968368|NCT00786487|3682861|FG003|STARTED|Overall Study||7
2968369|NCT00786487|3682858|FG000|COMPLETED|Overall Study||10
2968370|NCT00786487|3682859|FG001|COMPLETED|Overall Study||7
2968371|NCT00786487|3682860|FG002|COMPLETED|Overall Study||9
2968372|NCT00786487|3682861|FG003|COMPLETED|Overall Study||7
2968373|NCT00786487|3682858|FG000|NOT COMPLETED|Overall Study||0
2968374|NCT00786487|3682859|FG001|NOT COMPLETED|Overall Study||0
2968375|NCT00786487|3682860|FG002|NOT COMPLETED|Overall Study||0
2968376|NCT00786487|3682861|FG003|NOT COMPLETED|Overall Study||0
2968377|NCT00786565|3682871|FG000|STARTED|Enrollment Prior to Surgery||75
2968378|NCT00786565|3682871|FG000|COMPLETED|Enrollment Prior to Surgery|69 participants - Akreos Advanced Optic Lens in one eye and Akreos Adapt Lens in the fellow eye.|69
2968379|NCT00786565|3682871|FG000|NOT COMPLETED|Enrollment Prior to Surgery||6
2968380|NCT00786565|3682871|FG000|STARTED|Post Surgery||69
2968381|NCT00786565|3682871|FG000|COMPLETED|Post Surgery|67 Participants (134 eyes) completed the study.|67
3302000|NCT02957747|4035683|FG000|COMPLETED|Overall Study||66
3302001|NCT02957747|4035684|FG001|COMPLETED|Overall Study||69
3302002|NCT02957747|4035683|FG000|NOT COMPLETED|Overall Study||10
3302003|NCT02957747|4035684|FG001|NOT COMPLETED|Overall Study||8
2968382|NCT00786565|3682871|FG000|NOT COMPLETED|Post Surgery||2
2968383|NCT00786643|3682879|FG000|STARTED|Overall Study||20
2968384|NCT00786643|3682880|FG001|STARTED|Overall Study||28
2968385|NCT00786643|3682879|FG000|COMPLETED|Overall Study||20
2968386|NCT00786643|3682880|FG001|COMPLETED|Overall Study||28
2968387|NCT00786643|3682879|FG000|NOT COMPLETED|Overall Study||0
2968388|NCT00786643|3682880|FG001|NOT COMPLETED|Overall Study||0
2968389|NCT00786799|3682888|FG000|STARTED|Overall Study||14
2968390|NCT00786799|3682889|FG001|STARTED|Overall Study||13
2968391|NCT00786799|3682888|FG000|COMPLETED|Overall Study||13
2968392|NCT00786799|3682889|FG001|COMPLETED|Overall Study||12
2968393|NCT00786799|3682888|FG000|NOT COMPLETED|Overall Study||1
2968394|NCT00786799|3682889|FG001|NOT COMPLETED|Overall Study||1
2968395|NCT00786825|3682902|FG000|STARTED|Overall Study||5
2968396|NCT00786825|3682903|FG001|STARTED|Overall Study||5
2968397|NCT00786825|3682902|FG000|COMPLETED|Overall Study||5
2968398|NCT00786825|3682903|FG001|COMPLETED|Overall Study||5
2968399|NCT00786825|3682902|FG000|NOT COMPLETED|Overall Study||0
2968400|NCT00786825|3682903|FG001|NOT COMPLETED|Overall Study||0
2968401|NCT00786838|3682909|FG000|STARTED|Overall Study||75
2968402|NCT00786838|3682909|FG000|COMPLETED|Overall Study||26
2968403|NCT00786838|3682909|FG000|NOT COMPLETED|Overall Study||49
2968404|NCT00786864|3682920|FG000|STARTED|Overall Study||39
2968405|NCT00786864|3682921|FG001|STARTED|Overall Study||33
2968406|NCT00786864|3682920|FG000|COMPLETED|Overall Study|1 child excluded at the 3 month follow-up, as he sustained a serious back injury|38
2968407|NCT00786864|3682921|FG001|COMPLETED|Overall Study|1 child lost to study immediately post-intervention as she left the school|32
2968408|NCT00786864|3682920|FG000|NOT COMPLETED|Overall Study||1
2968409|NCT00786864|3682921|FG001|NOT COMPLETED|Overall Study||1
2968410|NCT00786916|3682930|FG000|STARTED|Overall Study||39
2968411|NCT00786916|3682931|FG001|STARTED|Overall Study||36
2968412|NCT00786916|3682932|FG002|STARTED|Overall Study||34
2968413|NCT00786916|3682930|FG000|COMPLETED|Overall Study||39
2968414|NCT00786916|3682931|FG001|COMPLETED|Overall Study||36
2968415|NCT00786916|3682932|FG002|COMPLETED|Overall Study||34
2968416|NCT00786916|3682930|FG000|NOT COMPLETED|Overall Study||0
2968417|NCT00786916|3682931|FG001|NOT COMPLETED|Overall Study||0
2968418|NCT00786916|3682932|FG002|NOT COMPLETED|Overall Study||0
2968419|NCT00786994|3682944|FG000|STARTED|Overall Study||57
2968420|NCT00786994|3682945|FG001|STARTED|Overall Study||54
2968421|NCT00786994|3682946|FG002|STARTED|Overall Study||26
2968422|NCT00786994|3682947|FG003|STARTED|Overall Study||28
2968423|NCT00786994|3682944|FG000|ITT|Overall Study||53
2968424|NCT00786994|3682945|FG001|ITT|Overall Study||51
2968425|NCT00786994|3682946|FG002|ITT|Overall Study||25
2968426|NCT00786994|3682947|FG003|ITT|Overall Study||28
2968427|NCT00786994|3682944|FG000|COMPLETED|Overall Study||47
2968428|NCT00786994|3682945|FG001|COMPLETED|Overall Study||39
2968429|NCT00786994|3682946|FG002|COMPLETED|Overall Study||24
2968430|NCT00786994|3682947|FG003|COMPLETED|Overall Study||22
2968431|NCT00786994|3682944|FG000|NOT COMPLETED|Overall Study||10
2968432|NCT00786994|3682945|FG001|NOT COMPLETED|Overall Study||15
2968433|NCT00786994|3682946|FG002|NOT COMPLETED|Overall Study||2
2968434|NCT00786994|3682947|FG003|NOT COMPLETED|Overall Study||6
2968435|NCT00787020|3682958|FG000|STARTED|Overall Study||24
2968436|NCT00787020|3682959|FG001|STARTED|Overall Study||13
2968437|NCT00787020|3682958|FG000|COMPLETED|Overall Study||24
2968438|NCT00787020|3682959|FG001|COMPLETED|Overall Study||13
2968439|NCT00787020|3682958|FG000|NOT COMPLETED|Overall Study||0
2968440|NCT00787020|3682959|FG001|NOT COMPLETED|Overall Study||0
2968441|NCT00787137|3682968|FG000|STARTED|Overall Study||6
2968442|NCT00787137|3682969|FG001|STARTED|Overall Study||6
2968443|NCT00787137|3682970|FG002|STARTED|Overall Study||5
2968444|NCT00787137|3682968|FG000|COMPLETED|Overall Study||6
2968445|NCT00787137|3682969|FG001|COMPLETED|Overall Study||6
2968446|NCT00787137|3682970|FG002|COMPLETED|Overall Study||4
2968447|NCT00787137|3682968|FG000|NOT COMPLETED|Overall Study||0
2968448|NCT00787137|3682969|FG001|NOT COMPLETED|Overall Study||0
2968449|NCT00787137|3682970|FG002|NOT COMPLETED|Overall Study||1
2968450|NCT00787150|3682981|FG000|STARTED|Overall Study|Of 222 participants enrolled 4 discontinued before dosing, made a total of 218 participants started.|75
2968451|NCT00787150|3682982|FG001|STARTED|Overall Study|Of 222 participants enrolled 4 discontinued before dosing, made a total of 218 participants started.|72
2968452|NCT00787150|3682983|FG002|STARTED|Overall Study|Of 222 participants enrolled 4 discontinued before dosing, made a total of 218 participants started.|71
2968453|NCT00787150|3682981|FG000|COMPLETED|Overall Study||66
2968454|NCT00787150|3682982|FG001|COMPLETED|Overall Study||65
2968455|NCT00787150|3682983|FG002|COMPLETED|Overall Study||66
2968456|NCT00787150|3682981|FG000|NOT COMPLETED|Overall Study||9
2968457|NCT00787150|3682982|FG001|NOT COMPLETED|Overall Study||7
2968458|NCT00787150|3682983|FG002|NOT COMPLETED|Overall Study||5
2968459|NCT00787189|3682995|FG000|STARTED|Overall Study||32
2968460|NCT00787189|3682996|FG001|STARTED|Overall Study||32
2968461|NCT00787189|3682995|FG000|COMPLETED|Overall Study|To study end point.|30
2968462|NCT00787189|3682996|FG001|COMPLETED|Overall Study|To study end point.|30
2968463|NCT00787189|3682995|FG000|NOT COMPLETED|Overall Study||2
2968464|NCT00787189|3682996|FG001|NOT COMPLETED|Overall Study||2
2968465|NCT00787202|3683007|FG000|STARTED|Overall Study||49
2968466|NCT00787202|3683008|FG001|STARTED|Overall Study||31
2968467|NCT00787202|3683009|FG002|STARTED|Overall Study||33
2968468|NCT00787202|3683010|FG003|STARTED|Overall Study||33
2968469|NCT00787202|3683011|FG004|STARTED|Overall Study||49
2968470|NCT00787202|3683007|FG000|Treated|Overall Study||48
2968471|NCT00787202|3683008|FG001|Treated|Overall Study||31
2968472|NCT00787202|3683009|FG002|Treated|Overall Study||33
2968473|NCT00787202|3683010|FG003|Treated|Overall Study||33
2968474|NCT00787202|3683011|FG004|Treated|Overall Study||49
2968475|NCT00787202|3683007|FG000|COMPLETED|Overall Study||35
2968476|NCT00787202|3683008|FG001|COMPLETED|Overall Study||20
2968477|NCT00787202|3683009|FG002|COMPLETED|Overall Study||26
2968478|NCT00787202|3683010|FG003|COMPLETED|Overall Study||31
2968479|NCT00787202|3683011|FG004|COMPLETED|Overall Study||45
2968480|NCT00787202|3683007|FG000|NOT COMPLETED|Overall Study||14
2968481|NCT00787202|3683008|FG001|NOT COMPLETED|Overall Study||11
2968482|NCT00787202|3683009|FG002|NOT COMPLETED|Overall Study||7
2968483|NCT00787202|3683010|FG003|NOT COMPLETED|Overall Study||2
2968484|NCT00787202|3683011|FG004|NOT COMPLETED|Overall Study||4
2968485|NCT00787241|3683030|FG000|STARTED|Overall Study||261
2968486|NCT00787241|3683031|FG001|STARTED|Overall Study||143
2968487|NCT00787241|3683032|FG002|STARTED|Overall Study||41
2968488|NCT00787241|3683030|FG000|COMPLETED|Overall Study||261
2968489|NCT00787241|3683031|FG001|COMPLETED|Overall Study||143
2968490|NCT00787241|3683032|FG002|COMPLETED|Overall Study||41
2968491|NCT00787241|3683030|FG000|NOT COMPLETED|Overall Study||0
2968492|NCT00787241|3683031|FG001|NOT COMPLETED|Overall Study||0
2968493|NCT00787241|3683032|FG002|NOT COMPLETED|Overall Study||0
2968494|NCT00787254|3683042|FG000|STARTED|Overall Study||185
2968495|NCT00787254|3683043|FG001|STARTED|Overall Study||181
2968496|NCT00787254|3683042|FG000|COMPLETED|Overall Study||109
2968497|NCT00787254|3683043|FG001|COMPLETED|Overall Study||99
2968498|NCT00787254|3683042|FG000|NOT COMPLETED|Overall Study||76
2968499|NCT00787254|3683043|FG001|NOT COMPLETED|Overall Study||82
2968500|NCT00787267|3683049|FG000|STARTED|Overall Study|Signed a consent form|37
2968501|NCT00787267|3683049|FG000|COMPLETED|Overall Study|Received at least one dose of study drug|25
2968502|NCT00787267|3683049|FG000|NOT COMPLETED|Overall Study||12
2968503|NCT00787319|3683053|FG000|STARTED|Overall Study||108
2968504|NCT00787319|3683053|FG000|COMPLETED|Overall Study||45
2968505|NCT00787319|3683053|FG000|NOT COMPLETED|Overall Study||63
3302004|NCT02957942|4035693|FG000|STARTED|Overall Study||7
3302005|NCT02957942|4035694|FG001|STARTED|Overall Study|7 healthy individuals were recruited as control; 6 were recruited for practicing experiment details.|13
2968506|NCT00787332|3683059|FG000|STARTED|Overall Study||8
2968507|NCT00787332|3683060|FG001|STARTED|Overall Study||8
2968508|NCT00787332|3683059|FG000|COMPLETED|Overall Study||8
2968509|NCT00787332|3683060|FG001|COMPLETED|Overall Study||8
2968510|NCT00787332|3683059|FG000|NOT COMPLETED|Overall Study||0
2968511|NCT00787332|3683060|FG001|NOT COMPLETED|Overall Study||0
2968512|NCT00787527|3683066|FG000|STARTED|Overall Study||14
2968513|NCT00787527|3683066|FG000|COMPLETED|Overall Study||11
2968514|NCT00787527|3683066|FG000|NOT COMPLETED|Overall Study||3
2968515|NCT00787566|3683077|FG000|STARTED|Overall Study||21
2968516|NCT00787566|3683078|FG001|STARTED|Overall Study||25
2968517|NCT00787566|3683079|FG002|STARTED|Overall Study||22
2968518|NCT00787566|3683077|FG000|COMPLETED|Overall Study||21
2968519|NCT00787566|3683078|FG001|COMPLETED|Overall Study|1 patient withdrew from the study due to an AE related to chemotherapy agent administration.|24
2968520|NCT00787566|3683079|FG002|COMPLETED|Overall Study||22
2968521|NCT00787566|3683077|FG000|NOT COMPLETED|Overall Study||0
2968522|NCT00787566|3683078|FG001|NOT COMPLETED|Overall Study||1
2968523|NCT00787566|3683079|FG002|NOT COMPLETED|Overall Study||0
2968524|NCT00787605|3683089|FG000|STARTED|Overall Study||428
2968525|NCT00787605|3683090|FG001|STARTED|Overall Study||432
2968526|NCT00787605|3683089|FG000|COMPLETED|Overall Study||382
2968527|NCT00787605|3683090|FG001|COMPLETED|Overall Study||376
2968528|NCT00787605|3683089|FG000|NOT COMPLETED|Overall Study||46
2968529|NCT00787605|3683090|FG001|NOT COMPLETED|Overall Study||56
2968530|NCT00787644|3683098|FG000|STARTED|Overall Study||12
2968531|NCT00787644|3683099|FG001|STARTED|Overall Study||11
2968532|NCT00787644|3683098|FG000|COMPLETED|Overall Study||10
2968533|NCT00787644|3683099|FG001|COMPLETED|Overall Study||9
2968534|NCT00787644|3683098|FG000|NOT COMPLETED|Overall Study||2
2968535|NCT00787644|3683099|FG001|NOT COMPLETED|Overall Study||2
2968536|NCT00787722|3683105|FG000|STARTED|Overall Study||13
2968537|NCT00787722|3683105|FG000|COMPLETED|Overall Study||12
2968538|NCT00787722|3683105|FG000|NOT COMPLETED|Overall Study||1
2968539|NCT00787761|3683110|FG000|STARTED|Overall Study||24
2968540|NCT00787761|3683110|FG000|COMPLETED|Overall Study||24
2968541|NCT00787761|3683110|FG000|NOT COMPLETED|Overall Study||0
2968542|NCT00787787|3683116|FG000|STARTED|Overall Study||7
2968543|NCT00787787|3683116|FG000|COMPLETED|Overall Study||0
2968544|NCT00787787|3683116|FG000|NOT COMPLETED|Overall Study||7
2968545|NCT00787800|3683122|FG000|STARTED|Overall Study||50
2968546|NCT00787800|3683123|FG001|STARTED|Overall Study||50
2968547|NCT00787800|3683122|FG000|COMPLETED|Overall Study||47
2968548|NCT00787800|3683123|FG001|COMPLETED|Overall Study||43
2968549|NCT00787800|3683122|FG000|NOT COMPLETED|Overall Study||3
2968550|NCT00787800|3683123|FG001|NOT COMPLETED|Overall Study||7
2968551|NCT00787839|3683130|FG000|STARTED|Overall Study||1939
2968552|NCT00787839|3683130|FG000|Consented|Overall Study|consented|1939
2968553|NCT00787839|3683130|FG000|Completed GCT Screening|Overall Study||1876
2968554|NCT00787839|3683130|FG000|Complete GCT, OGTT, A1c, Demographics|Overall Study||1535
2968555|NCT00787839|3683130|FG000|COMPLETED|Overall Study||1535
2968556|NCT00787839|3683130|FG000|NOT COMPLETED|Overall Study||404
2968557|NCT00787852|3683153|FG000|STARTED|Overall Study||6
2968558|NCT00787852|3683154|FG001|STARTED|Overall Study|The study was terminated prior to enrolled to group 2|5
2968559|NCT00787852|3683153|FG000|COMPLETED|Overall Study|1 patient withdrew consent prior to starting|5
2968560|NCT00787852|3683154|FG001|COMPLETED|Overall Study||5
2968561|NCT00787852|3683153|FG000|NOT COMPLETED|Overall Study||1
2968562|NCT00787852|3683154|FG001|NOT COMPLETED|Overall Study||0
2968563|NCT00787891|3683162|FG000|STARTED|Short-term Double-blind Phase (Part 1)||65
2968564|NCT00787891|3683163|FG001|STARTED|Short-term Double-blind Phase (Part 1)||62
2968565|NCT00787891|3683162|FG000|COMPLETED|Short-term Double-blind Phase (Part 1)||55
2968566|NCT00787891|3683163|FG001|COMPLETED|Short-term Double-blind Phase (Part 1)||53
2968567|NCT00787891|3683162|FG000|NOT COMPLETED|Short-term Double-blind Phase (Part 1)||10
2968568|NCT00787891|3683163|FG001|NOT COMPLETED|Short-term Double-blind Phase (Part 1)||9
2968569|NCT00787891|3683162|FG000|STARTED|Maintenance Double-blind Phase (Part 2)||33
2968570|NCT00787891|3683163|FG001|STARTED|Maintenance Double-blind Phase (Part 2)||31
2968571|NCT00787891|3683162|FG000|COMPLETED|Maintenance Double-blind Phase (Part 2)||26
2968572|NCT00787891|3683163|FG001|COMPLETED|Maintenance Double-blind Phase (Part 2)||24
2968573|NCT00787891|3683162|FG000|NOT COMPLETED|Maintenance Double-blind Phase (Part 2)||7
2968574|NCT00787891|3683163|FG001|NOT COMPLETED|Maintenance Double-blind Phase (Part 2)||7
2968575|NCT00787904|3683173|FG000|STARTED|Overall Study||6
2968576|NCT00787904|3683174|FG001|STARTED|Overall Study||13
2968577|NCT00787904|3683173|FG000|COMPLETED|Overall Study||6
2968578|NCT00787904|3683174|FG001|COMPLETED|Overall Study||13
2968579|NCT00787904|3683173|FG000|NOT COMPLETED|Overall Study||0
2968580|NCT00787904|3683174|FG001|NOT COMPLETED|Overall Study||0
2968581|NCT00787930|3683180|FG000|STARTED|Acute Treatment -- 3 Weeks||19
2968582|NCT00787930|3683180|FG000|COMPLETED|Acute Treatment -- 3 Weeks||19
2968583|NCT00787930|3683180|FG000|NOT COMPLETED|Acute Treatment -- 3 Weeks||0
2968584|NCT00787930|3683180|FG000|STARTED|Continuation Treatment -- up to 12 Month||19
2968585|NCT00787930|3683180|FG000|COMPLETED|Continuation Treatment -- up to 12 Month||16
2968586|NCT00787930|3683180|FG000|NOT COMPLETED|Continuation Treatment -- up to 12 Month||3
2968587|NCT00787943|3683190|FG000|STARTED|Overall Study||10
2968588|NCT00787943|3683190|FG000|COMPLETED|Overall Study||10
2968589|NCT00787943|3683190|FG000|NOT COMPLETED|Overall Study||0
2968590|NCT00788008|3683200|FG000|STARTED|Overall Study||98
2968591|NCT00788008|3683201|FG001|STARTED|Overall Study||101
2968592|NCT00788008|3683200|FG000|COMPLETED|Overall Study||98
2968593|NCT00788008|3683201|FG001|COMPLETED|Overall Study||101
2968594|NCT00788008|3683200|FG000|NOT COMPLETED|Overall Study||0
2968595|NCT00788008|3683201|FG001|NOT COMPLETED|Overall Study||0
2968596|NCT00788073|3683209|FG000|STARTED|STX209 Then Placebo||30
2968597|NCT00788073|3683210|FG001|STARTED|STX209 Then Placebo||33
2968598|NCT00788073|3683209|FG000|COMPLETED|STX209 Then Placebo||29
2968599|NCT00788073|3683210|FG001|COMPLETED|STX209 Then Placebo||30
2968600|NCT00788073|3683209|FG000|NOT COMPLETED|STX209 Then Placebo||1
2968601|NCT00788073|3683210|FG001|NOT COMPLETED|STX209 Then Placebo||3
2968602|NCT00788073|3683209|FG000|STARTED|Placebo Then STX209||29
2968603|NCT00788073|3683210|FG001|STARTED|Placebo Then STX209||30
2968604|NCT00788073|3683209|FG000|COMPLETED|Placebo Then STX209||27
2968605|NCT00788073|3683210|FG001|COMPLETED|Placebo Then STX209||29
2968606|NCT00788073|3683209|FG000|NOT COMPLETED|Placebo Then STX209||2
2968607|NCT00788073|3683210|FG001|NOT COMPLETED|Placebo Then STX209||1
2968608|NCT00788151|3683218|FG000|STARTED|Overall Study||200
2968609|NCT00788151|3683219|FG001|STARTED|Overall Study||100
2968610|NCT00788151|3683218|FG000|Received Vaccination 1|Overall Study||199
2968611|NCT00788151|3683219|FG001|Received Vaccination 1|Overall Study||99
2968612|NCT00788151|3683218|FG000|Received Vaccination 2|Overall Study||188
2968613|NCT00788151|3683219|FG001|Received Vaccination 2|Overall Study||92
2968614|NCT00788151|3683218|FG000|Received Vaccination 3|Overall Study||186
2968615|NCT00788151|3683219|FG001|Received Vaccination 3|Overall Study||90
2968616|NCT00788151|3683218|FG000|COMPLETED|Overall Study||186
2968617|NCT00788151|3683219|FG001|COMPLETED|Overall Study||90
2968618|NCT00788151|3683218|FG000|NOT COMPLETED|Overall Study||14
2968619|NCT00788151|3683219|FG001|NOT COMPLETED|Overall Study||10
2968620|NCT00788255|3683225|FG000|STARTED|Overall Study||25
2968621|NCT00788255|3683225|FG000|Oxytocin Infusion 1: 22.5 μU/mL|Overall Study||25
2968622|NCT00788255|3683225|FG000|Oxytocin Infusion 2: 30.1μU/mL|Overall Study||25
2968623|NCT00788255|3683225|FG000|Oxytocin Infusion 3: 32.9μU/mL|Overall Study||25
2968624|NCT00788255|3683225|FG000|Oxytocin: 0 μU/mL|Overall Study||25
2968625|NCT00788255|3683225|FG000|COMPLETED|Overall Study||25
2968626|NCT00788255|3683225|FG000|NOT COMPLETED|Overall Study||0
2968627|NCT00788372|3683232|FG000|STARTED|Period 1 (up to 4 Weeks)||142
2968628|NCT00788372|3683232|FG000|COMPLETED|Period 1 (up to 4 Weeks)||111
3133186|NCT01695239|3858312|FG007|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
3133187|NCT01695239|3858313|FG008|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
3133188|NCT01695239|3858314|FG009|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
3133189|NCT01695239|3858315|FG010|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
3133190|NCT01695239|3858316|FG011|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
3133191|NCT01695239|3858317|FG012|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
3133192|NCT01695239|3858318|FG013|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
3133193|NCT01695239|3858305|FG000|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||27
3133194|NCT01695239|3858306|FG001|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||9
2968629|NCT00788372|3683232|FG000|NOT COMPLETED|Period 1 (up to 4 Weeks)||31
2968630|NCT00788372|3683232|FG000|STARTED|Period 2 (Week 4 to Week 52)||111
2968631|NCT00788372|3683232|FG000|COMPLETED|Period 2 (Week 4 to Week 52)||79
2968632|NCT00788372|3683232|FG000|NOT COMPLETED|Period 2 (Week 4 to Week 52)||32
2968633|NCT00788593|3683236|FG000|STARTED|Placebo Run-in Phase||82
2968634|NCT00788593|3683237|FG001|STARTED|Placebo Run-in Phase||0
2968635|NCT00788593|3683238|FG002|STARTED|Placebo Run-in Phase||0
2968636|NCT00788593|3683236|FG000|COMPLETED|Placebo Run-in Phase||76
2968637|NCT00788593|3683237|FG001|COMPLETED|Placebo Run-in Phase||0
2968638|NCT00788593|3683238|FG002|COMPLETED|Placebo Run-in Phase||0
2968639|NCT00788593|3683236|FG000|NOT COMPLETED|Placebo Run-in Phase||6
2968640|NCT00788593|3683237|FG001|NOT COMPLETED|Placebo Run-in Phase||0
2968641|NCT00788593|3683238|FG002|NOT COMPLETED|Placebo Run-in Phase||0
2968642|NCT00788593|3683236|FG000|STARTED|First Intervention Period||0
2968643|NCT00788593|3683237|FG001|STARTED|First Intervention Period||39
2968644|NCT00788593|3683238|FG002|STARTED|First Intervention Period||37
2968645|NCT00788593|3683236|FG000|COMPLETED|First Intervention Period||0
2968646|NCT00788593|3683237|FG001|COMPLETED|First Intervention Period||38
2968647|NCT00788593|3683238|FG002|COMPLETED|First Intervention Period||37
2968648|NCT00788593|3683236|FG000|NOT COMPLETED|First Intervention Period||0
2968649|NCT00788593|3683237|FG001|NOT COMPLETED|First Intervention Period||1
2968650|NCT00788593|3683238|FG002|NOT COMPLETED|First Intervention Period||0
2968651|NCT00788593|3683236|FG000|STARTED|Second Intervention Period||0
2968652|NCT00788593|3683237|FG001|STARTED|Second Intervention Period||38
2968653|NCT00788593|3683238|FG002|STARTED|Second Intervention Period||37
2968654|NCT00788593|3683236|FG000|COMPLETED|Second Intervention Period||0
2968655|NCT00788593|3683237|FG001|COMPLETED|Second Intervention Period||37
2968656|NCT00788593|3683238|FG002|COMPLETED|Second Intervention Period||36
2968657|NCT00788593|3683236|FG000|NOT COMPLETED|Second Intervention Period||0
2968658|NCT00788593|3683237|FG001|NOT COMPLETED|Second Intervention Period||1
2968659|NCT00788593|3683238|FG002|NOT COMPLETED|Second Intervention Period||1
2968660|NCT00788697|3683248|FG000|STARTED|Overall Study||349
2968661|NCT00788697|3683248|FG000|COMPLETED|Overall Study||240
2968662|NCT00788697|3683248|FG000|NOT COMPLETED|Overall Study||109
2968663|NCT00788775|3683262|FG000|STARTED|Overall Study||11
3133195|NCT01695239|3858307|FG002|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||11
2968664|NCT00788775|3683263|FG001|STARTED|Overall Study||9
2968665|NCT00788775|3683262|FG000|Treated|Overall Study||11
2968666|NCT00788775|3683263|FG001|Treated|Overall Study||8
2968667|NCT00788775|3683262|FG000|COMPLETED|Overall Study||1
2968668|NCT00788775|3683263|FG001|COMPLETED|Overall Study||1
2968669|NCT00788775|3683262|FG000|NOT COMPLETED|Overall Study||10
2968670|NCT00788775|3683263|FG001|NOT COMPLETED|Overall Study||8
2968671|NCT00788827|3683269|FG000|STARTED|Overall Study||7
2968672|NCT00788827|3683269|FG000|COMPLETED|Overall Study||5
2968673|NCT00788827|3683269|FG000|NOT COMPLETED|Overall Study||2
2968674|NCT00788892|3683277|FG000|STARTED|Overall Study||85
2968675|NCT00788892|3683278|FG001|STARTED|Overall Study||41
2968676|NCT00788892|3683277|FG000|COMPLETED|Overall Study||36
2968677|NCT00788892|3683278|FG001|COMPLETED|Overall Study||18
2968678|NCT00788892|3683277|FG000|NOT COMPLETED|Overall Study||49
2968679|NCT00788892|3683278|FG001|NOT COMPLETED|Overall Study||23
2968680|NCT00788957|3683288|FG000|STARTED|Part 1||11
2968681|NCT00788957|3683289|FG001|STARTED|Part 1||0
2968682|NCT00788957|3683290|FG002|STARTED|Part 1||0
2968683|NCT00788957|3683291|FG003|STARTED|Part 1||0
2968684|NCT00788957|3683292|FG004|STARTED|Part 1||0
2968685|NCT00788957|3683293|FG005|STARTED|Part 1||0
2968686|NCT00788957|3683288|FG000|COMPLETED|Part 1|Completed the safety follow-up visit|2
2968687|NCT00788957|3683289|FG001|COMPLETED|Part 1||0
2968688|NCT00788957|3683290|FG002|COMPLETED|Part 1||0
2968689|NCT00788957|3683291|FG003|COMPLETED|Part 1||0
2968690|NCT00788957|3683292|FG004|COMPLETED|Part 1||0
2968691|NCT00788957|3683293|FG005|COMPLETED|Part 1||0
2968692|NCT00788957|3683288|FG000|NOT COMPLETED|Part 1||9
2968693|NCT00788957|3683289|FG001|NOT COMPLETED|Part 1||0
2968694|NCT00788957|3683290|FG002|NOT COMPLETED|Part 1||0
2968695|NCT00788957|3683291|FG003|NOT COMPLETED|Part 1||0
2968696|NCT00788957|3683292|FG004|NOT COMPLETED|Part 1||0
2968697|NCT00788957|3683293|FG005|NOT COMPLETED|Part 1||0
2968698|NCT00788957|3683288|FG000|STARTED|Part 2||0
2968699|NCT00788957|3683289|FG001|STARTED|Part 2||48
2968700|NCT00788957|3683290|FG002|STARTED|Part 2||48
2968701|NCT00788957|3683291|FG003|STARTED|Part 2||46
2968702|NCT00788957|3683292|FG004|STARTED|Part 2||0
2968703|NCT00788957|3683293|FG005|STARTED|Part 2||0
2968704|NCT00788957|3683288|FG000|COMPLETED|Part 2||0
2968705|NCT00788957|3683289|FG001|COMPLETED|Part 2|Completed the safety follow-up visit at the end of the study|6
2968706|NCT00788957|3683290|FG002|COMPLETED|Part 2|Completed the safety follow-up visit|4
2968707|NCT00788957|3683291|FG003|COMPLETED|Part 2|Completed the safety follow-up visit|5
2968708|NCT00788957|3683292|FG004|COMPLETED|Part 2||0
2968709|NCT00788957|3683293|FG005|COMPLETED|Part 2||0
2968710|NCT00788957|3683288|FG000|NOT COMPLETED|Part 2||0
2968711|NCT00788957|3683289|FG001|NOT COMPLETED|Part 2||42
2968712|NCT00788957|3683290|FG002|NOT COMPLETED|Part 2||44
2968713|NCT00788957|3683291|FG003|NOT COMPLETED|Part 2||41
2968714|NCT00788957|3683292|FG004|NOT COMPLETED|Part 2||0
2968715|NCT00788957|3683293|FG005|NOT COMPLETED|Part 2||0
2968716|NCT00788957|3683288|FG000|STARTED|Part 3||0
2968717|NCT00788957|3683289|FG001|STARTED|Part 3||0
2968718|NCT00788957|3683290|FG002|STARTED|Part 3||0
2968719|NCT00788957|3683291|FG003|STARTED|Part 3||0
2968720|NCT00788957|3683292|FG004|STARTED|Part 3||13
2968721|NCT00788957|3683293|FG005|STARTED|Part 3||12
2968722|NCT00788957|3683288|FG000|COMPLETED|Part 3||0
2968723|NCT00788957|3683289|FG001|COMPLETED|Part 3||0
2968724|NCT00788957|3683290|FG002|COMPLETED|Part 3||0
2968725|NCT00788957|3683291|FG003|COMPLETED|Part 3||0
2968726|NCT00788957|3683292|FG004|COMPLETED|Part 3|Completed the safety follow-up visit|4
2968727|NCT00788957|3683293|FG005|COMPLETED|Part 3|Completed the safety follow-up visit|1
2968728|NCT00788957|3683288|FG000|NOT COMPLETED|Part 3||0
2968729|NCT00788957|3683289|FG001|NOT COMPLETED|Part 3||0
2968730|NCT00788957|3683290|FG002|NOT COMPLETED|Part 3||0
2968731|NCT00788957|3683291|FG003|NOT COMPLETED|Part 3||0
2968732|NCT00788957|3683292|FG004|NOT COMPLETED|Part 3||9
2968733|NCT00788957|3683293|FG005|NOT COMPLETED|Part 3||11
2968734|NCT00789035|3683315|FG000|STARTED|Overall Study||82
2968735|NCT00789035|3683316|FG001|STARTED|Overall Study||81
2968736|NCT00789035|3683317|FG002|STARTED|Overall Study||81
2968737|NCT00789035|3683318|FG003|STARTED|Overall Study||82
2968738|NCT00789035|3683319|FG004|STARTED|Overall Study||80
2968739|NCT00789035|3683315|FG000|COMPLETED|Overall Study||76
2968740|NCT00789035|3683316|FG001|COMPLETED|Overall Study||74
2968741|NCT00789035|3683317|FG002|COMPLETED|Overall Study||80
2968742|NCT00789035|3683318|FG003|COMPLETED|Overall Study||81
2968743|NCT00789035|3683319|FG004|COMPLETED|Overall Study||74
2968744|NCT00789035|3683315|FG000|NOT COMPLETED|Overall Study||6
2968745|NCT00789035|3683316|FG001|NOT COMPLETED|Overall Study||7
2968746|NCT00789035|3683317|FG002|NOT COMPLETED|Overall Study||1
2968747|NCT00789035|3683318|FG003|NOT COMPLETED|Overall Study||1
2968748|NCT00789035|3683319|FG004|NOT COMPLETED|Overall Study||6
2968749|NCT00789074|3683336|FG000|STARTED|Overall Study||53
2968750|NCT00789074|3683337|FG001|STARTED|Overall Study||48
2968751|NCT00789074|3683336|FG000|COMPLETED|Overall Study||42
2968752|NCT00789074|3683337|FG001|COMPLETED|Overall Study||35
2968753|NCT00789074|3683336|FG000|NOT COMPLETED|Overall Study||11
2968754|NCT00789074|3683337|FG001|NOT COMPLETED|Overall Study||13
2968755|NCT00789113|3683346|FG000|STARTED|Overall Study||12
2968756|NCT00789113|3683346|FG000|COMPLETED|Overall Study||12
2968757|NCT00789113|3683346|FG000|NOT COMPLETED|Overall Study||0
2968758|NCT00789191|3683353|FG000|STARTED|Overall Study||111
2968759|NCT00789191|3683354|FG001|STARTED|Overall Study||111
2968760|NCT00789191|3683353|FG000|Exposed|Overall Study|2 withdrew informed consent. 1 randomised by mistake. 1 non-compliance|107
2968761|NCT00789191|3683354|FG001|Exposed|Overall Study|1 non-compliance|110
2968762|NCT00789191|3683353|FG000|COMPLETED|Overall Study||97
2968763|NCT00789191|3683354|FG001|COMPLETED|Overall Study||92
2968764|NCT00789191|3683353|FG000|NOT COMPLETED|Overall Study||14
2968765|NCT00789191|3683354|FG001|NOT COMPLETED|Overall Study||19
2968766|NCT00789256|3683362|FG000|STARTED|Overall Study||14
2968767|NCT00789256|3683363|FG001|STARTED|Overall Study||12
2968768|NCT00789256|3683362|FG000|COMPLETED|Overall Study|Strata 1 had 5 responders and continued accrual, but the study was closed due to low accrual.|14
2968769|NCT00789256|3683363|FG001|COMPLETED|Overall Study||12
2968770|NCT00789256|3683362|FG000|NOT COMPLETED|Overall Study||0
2968771|NCT00789256|3683363|FG001|NOT COMPLETED|Overall Study||0
2968772|NCT00789321|3683374|FG000|STARTED|Overall Study||24
2968773|NCT00789321|3683375|FG001|STARTED|Overall Study||23
2968774|NCT00789321|3683374|FG000|COMPLETED|Overall Study||24
2968775|NCT00789321|3683375|FG001|COMPLETED|Overall Study||22
2968776|NCT00789321|3683374|FG000|NOT COMPLETED|Overall Study||0
2968777|NCT00789321|3683375|FG001|NOT COMPLETED|Overall Study||1
2968778|NCT00789360|3683383|FG000|STARTED|Overall Study||15
2968779|NCT00789360|3683384|FG001|STARTED|Overall Study||15
2968780|NCT00789360|3683383|FG000|COMPLETED|Overall Study||12
2968781|NCT00789360|3683384|FG001|COMPLETED|Overall Study||14
2968782|NCT00789360|3683383|FG000|NOT COMPLETED|Overall Study||3
2968783|NCT00789360|3683384|FG001|NOT COMPLETED|Overall Study||1
2968784|NCT00789373|3683391|FG000|STARTED|Induction||939
2968785|NCT00789373|3683392|FG001|STARTED|Induction||0
2968786|NCT00789373|3683393|FG002|STARTED|Induction||0
2968787|NCT00789373|3683391|FG000|COMPLETED|Induction|1 patient received maintenance therapy post-induction but was never randomized.|540
2968788|NCT00789373|3683392|FG001|COMPLETED|Induction||0
2968789|NCT00789373|3683393|FG002|COMPLETED|Induction||0
2968790|NCT00789373|3683391|FG000|NOT COMPLETED|Induction||399
2968791|NCT00789373|3683392|FG001|NOT COMPLETED|Induction||0
2968792|NCT00789373|3683393|FG002|NOT COMPLETED|Induction||0
2968793|NCT00789373|3683391|FG000|STARTED|Maintenance||0
2968794|NCT00789373|3683392|FG001|STARTED|Maintenance||359
2968795|NCT00789373|3683393|FG002|STARTED|Maintenance||180
2968796|NCT00789373|3683391|FG000|COMPLETED|Maintenance||0
2968797|NCT00789373|3683392|FG001|COMPLETED|Maintenance||0
2968798|NCT00789373|3683393|FG002|COMPLETED|Maintenance||0
2968799|NCT00789373|3683391|FG000|NOT COMPLETED|Maintenance||0
2968800|NCT00789373|3683392|FG001|NOT COMPLETED|Maintenance||359
2968801|NCT00789373|3683393|FG002|NOT COMPLETED|Maintenance||180
2968802|NCT00789438|3683407|FG000|STARTED|Overall Study||21
2968803|NCT00789438|3683408|FG001|STARTED|Overall Study||20
2968804|NCT00789438|3683409|FG002|STARTED|Overall Study||28
2968805|NCT00789438|3683407|FG000|COMPLETED|Overall Study||21
2968806|NCT00789438|3683408|FG001|COMPLETED|Overall Study||20
2968807|NCT00789438|3683409|FG002|COMPLETED|Overall Study||28
2968808|NCT00789438|3683407|FG000|NOT COMPLETED|Overall Study||0
2968809|NCT00789438|3683408|FG001|NOT COMPLETED|Overall Study||0
2968810|NCT00789438|3683409|FG002|NOT COMPLETED|Overall Study||0
2968811|NCT00789477|3683422|FG000|STARTED|Overall Study|randomized|44
2968812|NCT00789477|3683423|FG001|STARTED|Overall Study|randomized|44
2968813|NCT00789477|3683424|FG002|STARTED|Overall Study|randomized|44
2968814|NCT00789477|3683425|FG003|STARTED|Overall Study|randomized|44
2968815|NCT00789477|3683426|FG004|STARTED|Overall Study|randomized|45
2968816|NCT00789477|3683422|FG000|Participants Received Treatment|Overall Study|safety analysis set (SAF)|44
2968817|NCT00789477|3683423|FG001|Participants Received Treatment|Overall Study|SAF|44
2968818|NCT00789477|3683424|FG002|Participants Received Treatment|Overall Study|SAF|44
2968819|NCT00789477|3683425|FG003|Participants Received Treatment|Overall Study|SAF|42
2968820|NCT00789477|3683426|FG004|Participants Received Treatment|Overall Study|SAF|45
2968821|NCT00789477|3683422|FG000|COMPLETED|Overall Study||33
2968822|NCT00789477|3683423|FG001|COMPLETED|Overall Study||38
2968823|NCT00789477|3683424|FG002|COMPLETED|Overall Study||33
2968824|NCT00789477|3683425|FG003|COMPLETED|Overall Study||34
2968825|NCT00789477|3683426|FG004|COMPLETED|Overall Study||38
2968826|NCT00789477|3683422|FG000|NOT COMPLETED|Overall Study||11
2968827|NCT00789477|3683423|FG001|NOT COMPLETED|Overall Study||6
2968828|NCT00789477|3683424|FG002|NOT COMPLETED|Overall Study||11
2968829|NCT00789477|3683425|FG003|NOT COMPLETED|Overall Study||10
2968830|NCT00789477|3683426|FG004|NOT COMPLETED|Overall Study||7
2968831|NCT00789529|3683442|FG000|STARTED|Overall Study||16
2968832|NCT00789529|3683443|FG001|STARTED|Overall Study||16
2968833|NCT00789529|3683442|FG000|COMPLETED|Overall Study||15
2968834|NCT00789529|3683443|FG001|COMPLETED|Overall Study||15
2968835|NCT00789529|3683442|FG000|NOT COMPLETED|Overall Study||1
2968836|NCT00789529|3683443|FG001|NOT COMPLETED|Overall Study||1
2968837|NCT00789555|3683452|FG000|STARTED|Overall Study||421
2968838|NCT00789555|3683453|FG001|STARTED|Overall Study||417
2968839|NCT00789555|3683454|FG002|STARTED|Overall Study||422
2968840|NCT00789555|3683452|FG000|COMPLETED|Overall Study||262
2968841|NCT00789555|3683453|FG001|COMPLETED|Overall Study||278
2968842|NCT00789555|3683454|FG002|COMPLETED|Overall Study||263
2968843|NCT00789555|3683452|FG000|NOT COMPLETED|Overall Study||159
2968844|NCT00789555|3683453|FG001|NOT COMPLETED|Overall Study||139
2968845|NCT00789555|3683454|FG002|NOT COMPLETED|Overall Study||159
2968846|NCT00789581|3683464|FG000|STARTED|AC Therapy||306
2968847|NCT00789581|3683465|FG001|STARTED|AC Therapy||308
2968848|NCT00789581|3683464|FG000|COMPLETED|AC Therapy||295
2968849|NCT00789581|3683465|FG001|COMPLETED|AC Therapy||291
2968850|NCT00789581|3683464|FG000|NOT COMPLETED|AC Therapy||11
2968851|NCT00789581|3683465|FG001|NOT COMPLETED|AC Therapy||17
2968852|NCT00789581|3683464|FG000|STARTED|Adjuvant Therapy||295
2968853|NCT00789581|3683465|FG001|STARTED|Adjuvant Therapy||291
2968854|NCT00789581|3683464|FG000|COMPLETED|Adjuvant Therapy||255
2968855|NCT00789581|3683465|FG001|COMPLETED|Adjuvant Therapy||234
2968856|NCT00789581|3683464|FG000|NOT COMPLETED|Adjuvant Therapy||40
2968857|NCT00789581|3683465|FG001|NOT COMPLETED|Adjuvant Therapy||57
2968858|NCT00789672|3683474|FG000|STARTED|Overall Study||16
2968859|NCT00789672|3683475|FG001|STARTED|Overall Study||17
2968860|NCT00789672|3683474|FG000|COMPLETED|Overall Study||16
2968861|NCT00789672|3683475|FG001|COMPLETED|Overall Study||17
2968862|NCT00789672|3683474|FG000|NOT COMPLETED|Overall Study||0
2968863|NCT00789672|3683475|FG001|NOT COMPLETED|Overall Study||0
2968864|NCT00789685|3683481|FG000|STARTED|Overall Study||37
2968865|NCT00789685|3683481|FG000|COMPLETED|Overall Study|Completed the study to Day 28|25
2968866|NCT00789685|3683481|FG000|NOT COMPLETED|Overall Study||12
2968867|NCT00789698|3683489|FG000|STARTED|Overall Study||72
2968868|NCT00789698|3683490|FG001|STARTED|Overall Study||79
2968869|NCT00789698|3683491|FG002|STARTED|Overall Study||56
2968870|NCT00789698|3683492|FG003|STARTED|Overall Study||85
2968871|NCT00789698|3683489|FG000|COMPLETED|Overall Study||32
2968872|NCT00789698|3683490|FG001|COMPLETED|Overall Study||46
2968873|NCT00789698|3683491|FG002|COMPLETED|Overall Study||29
2968874|NCT00789698|3683492|FG003|COMPLETED|Overall Study||33
2968875|NCT00789698|3683489|FG000|NOT COMPLETED|Overall Study||40
2968876|NCT00789698|3683490|FG001|NOT COMPLETED|Overall Study||33
2968877|NCT00789698|3683491|FG002|NOT COMPLETED|Overall Study||27
2968878|NCT00789698|3683492|FG003|NOT COMPLETED|Overall Study||52
2968879|NCT00789724|3683503|FG000|STARTED|Overall Study||5
2968880|NCT00789724|3683504|FG001|STARTED|Overall Study||5
2968881|NCT00789724|3683503|FG000|COMPLETED|Overall Study||5
2968882|NCT00789724|3683504|FG001|COMPLETED|Overall Study||5
2968883|NCT00789724|3683503|FG000|NOT COMPLETED|Overall Study||0
2968884|NCT00789724|3683504|FG001|NOT COMPLETED|Overall Study||0
2968885|NCT00789737|3683512|FG000|STARTED|Overall Study||176
2968886|NCT00789737|3683513|FG001|STARTED|Overall Study||181
2968887|NCT00789737|3683512|FG000|COMPLETED|Overall Study||128
2968888|NCT00789737|3683513|FG001|COMPLETED|Overall Study||126
2968889|NCT00789737|3683512|FG000|NOT COMPLETED|Overall Study||48
2968890|NCT00789737|3683513|FG001|NOT COMPLETED|Overall Study||55
2968891|NCT00789750|3683521|FG000|STARTED|Overall Study||280
2968892|NCT00789750|3683522|FG001|STARTED|Overall Study||282
2968893|NCT00789750|3683521|FG000|Dropped During run-in Period|Overall Study||6
2968894|NCT00789750|3683522|FG001|Dropped During run-in Period|Overall Study||5
2968895|NCT00789750|3683521|FG000|Safety Set|Overall Study||274
2968896|NCT00789750|3683522|FG001|Safety Set|Overall Study||277
2968897|NCT00789750|3683521|FG000|Intent to Treat Set|Overall Study||271
2968898|NCT00789750|3683522|FG001|Intent to Treat Set|Overall Study||276
2968899|NCT00789750|3683521|FG000|COMPLETED|Overall Study||221
2968900|NCT00789750|3683522|FG001|COMPLETED|Overall Study||222
2968901|NCT00789750|3683521|FG000|NOT COMPLETED|Overall Study||59
2968902|NCT00789750|3683522|FG001|NOT COMPLETED|Overall Study||60
2968903|NCT00789776|3683530|FG000|STARTED|Overall Study||5
2968904|NCT00789776|3683531|FG001|STARTED|Overall Study||36
2968905|NCT00789776|3683530|FG000|COMPLETED|Overall Study||5
2968906|NCT00789776|3683531|FG001|COMPLETED|Overall Study||35
2968907|NCT00789776|3683530|FG000|NOT COMPLETED|Overall Study||0
2968908|NCT00789776|3683531|FG001|NOT COMPLETED|Overall Study||1
2968909|NCT00789802|3683540|FG000|STARTED|Overall Study||44
2968910|NCT00789802|3683541|FG001|STARTED|Overall Study||42
2968911|NCT00789802|3683542|FG002|STARTED|Overall Study||43
2968912|NCT00789802|3683540|FG000|COMPLETED|Overall Study||34
2968913|NCT00789802|3683541|FG001|COMPLETED|Overall Study||35
2968914|NCT00789802|3683542|FG002|COMPLETED|Overall Study||37
2968915|NCT00789802|3683540|FG000|NOT COMPLETED|Overall Study||10
2968916|NCT00789802|3683541|FG001|NOT COMPLETED|Overall Study||7
2968917|NCT00789802|3683542|FG002|NOT COMPLETED|Overall Study||6
2968918|NCT00789815|3683555|FG000|STARTED|Overall Study||250
2968919|NCT00789815|3683556|FG001|STARTED|Overall Study||250
2968920|NCT00789815|3683555|FG000|COMPLETED|Overall Study||243
3302006|NCT02957942|4035693|FG000|COMPLETED|Overall Study||7
3302007|NCT02957942|4035694|FG001|COMPLETED|Overall Study||6
3302008|NCT02957942|4035693|FG000|NOT COMPLETED|Overall Study||0
3302009|NCT02957942|4035694|FG001|NOT COMPLETED|Overall Study||7
3302010|NCT02958267|4035702|FG000|STARTED|Enrollment||17
3302011|NCT02958267|4035703|FG001|STARTED|Enrollment||15
3302012|NCT02958267|4035702|FG000|COMPLETED|Enrollment||17
3302013|NCT02958267|4035703|FG001|COMPLETED|Enrollment||15
3302014|NCT02958267|4035702|FG000|NOT COMPLETED|Enrollment||0
3302015|NCT02958267|4035703|FG001|NOT COMPLETED|Enrollment||0
3302016|NCT02958267|4035702|FG000|STARTED|Enrollment to Actual Treatment Complete||17
3302017|NCT02958267|4035703|FG001|STARTED|Enrollment to Actual Treatment Complete||15
3302018|NCT02958267|4035702|FG000|COMPLETED|Enrollment to Actual Treatment Complete||15
3302019|NCT02958267|4035703|FG001|COMPLETED|Enrollment to Actual Treatment Complete||15
3302020|NCT02958267|4035702|FG000|NOT COMPLETED|Enrollment to Actual Treatment Complete||2
3302021|NCT02958267|4035703|FG001|NOT COMPLETED|Enrollment to Actual Treatment Complete||0
3302022|NCT02958267|4035702|FG000|STARTED|Follow-up Visits||15
3302023|NCT02958267|4035703|FG001|STARTED|Follow-up Visits||15
3302024|NCT02958267|4035702|FG000|3 Month Follow-up|Follow-up Visits||15
3302025|NCT02958267|4035703|FG001|3 Month Follow-up|Follow-up Visits||15
3302026|NCT02958267|4035702|FG000|6 Month Follow-up|Follow-up Visits||14
3302027|NCT02958267|4035703|FG001|6 Month Follow-up|Follow-up Visits||14
3302028|NCT02958267|4035702|FG000|12 Month Follow-up|Follow-up Visits||13
3302029|NCT02958267|4035703|FG001|12 Month Follow-up|Follow-up Visits||14
3302030|NCT02958267|4035702|FG000|COMPLETED|Follow-up Visits||13
3302031|NCT02958267|4035703|FG001|COMPLETED|Follow-up Visits||14
3302032|NCT02958267|4035702|FG000|NOT COMPLETED|Follow-up Visits||2
3302033|NCT02958267|4035703|FG001|NOT COMPLETED|Follow-up Visits||1
3302034|NCT02958345|4035711|FG000|STARTED|Overall Study||14
2968921|NCT00789815|3683556|FG001|COMPLETED|Overall Study||249
2968922|NCT00789815|3683555|FG000|NOT COMPLETED|Overall Study||7
2968923|NCT00789815|3683556|FG001|NOT COMPLETED|Overall Study||1
2968924|NCT00789828|3683564|FG000|STARTED|Core Period (48 Weeks)||78
2968925|NCT00789828|3683565|FG001|STARTED|Core Period (48 Weeks)||39
2968926|NCT00789828|3683564|FG000|COMPLETED|Core Period (48 Weeks)||78
2968927|NCT00789828|3683565|FG001|COMPLETED|Core Period (48 Weeks)||33
2968928|NCT00789828|3683564|FG000|NOT COMPLETED|Core Period (48 Weeks)||0
2968929|NCT00789828|3683565|FG001|NOT COMPLETED|Core Period (48 Weeks)||6
2968930|NCT00789828|3683564|FG000|STARTED|Open-label Extension Period (4 Years)|Of 117 participants only 111 completed the core period and continued in the extension period|111
2968931|NCT00789828|3683565|FG001|STARTED|Open-label Extension Period (4 Years)|No participant received placebo.|0
2968932|NCT00789828|3683564|FG000|COMPLETED|Open-label Extension Period (4 Years)||82
2968933|NCT00789828|3683565|FG001|COMPLETED|Open-label Extension Period (4 Years)||0
2968934|NCT00789828|3683564|FG000|NOT COMPLETED|Open-label Extension Period (4 Years)||29
2968935|NCT00789828|3683565|FG001|NOT COMPLETED|Open-label Extension Period (4 Years)||0
2968936|NCT00789854|3683577|FG000|STARTED|Overall Study||228
2968937|NCT00789854|3683578|FG001|STARTED|Overall Study||231
2968938|NCT00789854|3683579|FG002|STARTED|Overall Study||229
2968939|NCT00789854|3683577|FG000|COMPLETED|Overall Study||179
2968940|NCT00789854|3683578|FG001|COMPLETED|Overall Study||196
2968941|NCT00789854|3683579|FG002|COMPLETED|Overall Study||182
2968942|NCT00789854|3683577|FG000|NOT COMPLETED|Overall Study||49
2968943|NCT00789854|3683578|FG001|NOT COMPLETED|Overall Study||35
2968944|NCT00789854|3683579|FG002|NOT COMPLETED|Overall Study||47
2968945|NCT00789867|3683590|FG000|STARTED|Overall Study||17
2968946|NCT00789867|3683591|FG001|STARTED|Overall Study||10
2968947|NCT00789867|3683592|FG002|STARTED|Overall Study||8
2968948|NCT00789867|3683590|FG000|COMPLETED|Overall Study||17
2968949|NCT00789867|3683591|FG001|COMPLETED|Overall Study||10
2968950|NCT00789867|3683592|FG002|COMPLETED|Overall Study||8
2968951|NCT00789867|3683590|FG000|NOT COMPLETED|Overall Study||0
2968952|NCT00789867|3683591|FG001|NOT COMPLETED|Overall Study||0
2968953|NCT00789867|3683592|FG002|NOT COMPLETED|Overall Study||0
2968954|NCT00789880|3683607|FG000|STARTED|Overall Study||16
2968955|NCT00789880|3683608|FG001|STARTED|Overall Study||16
2968956|NCT00789880|3683609|FG002|STARTED|Overall Study||8
2968957|NCT00789880|3683610|FG003|STARTED|Overall Study||16
2968958|NCT00789880|3683611|FG004|STARTED|Overall Study||18
2968959|NCT00789880|3683612|FG005|STARTED|Overall Study||8
2968960|NCT00789880|3683607|FG000|COMPLETED|Overall Study||15
2968961|NCT00789880|3683608|FG001|COMPLETED|Overall Study||15
2968962|NCT00789880|3683609|FG002|COMPLETED|Overall Study||8
2968963|NCT00789880|3683610|FG003|COMPLETED|Overall Study||15
2968964|NCT00789880|3683611|FG004|COMPLETED|Overall Study||15
2968965|NCT00789880|3683612|FG005|COMPLETED|Overall Study||8
2968966|NCT00789880|3683607|FG000|NOT COMPLETED|Overall Study||1
2968967|NCT00789880|3683608|FG001|NOT COMPLETED|Overall Study||1
2968968|NCT00789880|3683609|FG002|NOT COMPLETED|Overall Study||0
2968969|NCT00789880|3683610|FG003|NOT COMPLETED|Overall Study||1
2968970|NCT00789880|3683611|FG004|NOT COMPLETED|Overall Study||3
2968971|NCT00789880|3683612|FG005|NOT COMPLETED|Overall Study||0
2968972|NCT00789958|3683626|FG000|STARTED|Overall Study||105
2968973|NCT00789958|3683626|FG000|Eligible and Analyzable|Overall Study||79
2968974|NCT00789958|3683626|FG000|COMPLETED|Overall Study||68
2968975|NCT00789958|3683626|FG000|NOT COMPLETED|Overall Study||37
2968976|NCT00789997|3683634|FG000|STARTED|Overall Study||41
2968977|NCT00789997|3683635|FG001|STARTED|Overall Study||40
2968978|NCT00789997|3683634|FG000|COMPLETED|Overall Study||40
2968979|NCT00789997|3683635|FG001|COMPLETED|Overall Study||38
2968980|NCT00789997|3683634|FG000|NOT COMPLETED|Overall Study||1
2968981|NCT00789997|3683635|FG001|NOT COMPLETED|Overall Study||2
2968982|NCT00790023|3683644|FG000|STARTED|Overall Study||237
2968983|NCT00790023|3683645|FG001|STARTED|Overall Study||235
2968984|NCT00790023|3683646|FG002|STARTED|Overall Study||235
2968985|NCT00790023|3683644|FG000|COMPLETED|Overall Study||226
2968986|NCT00790023|3683645|FG001|COMPLETED|Overall Study||225
2968987|NCT00790023|3683646|FG002|COMPLETED|Overall Study||214
2968988|NCT00790023|3683644|FG000|NOT COMPLETED|Overall Study||11
2968989|NCT00790023|3683645|FG001|NOT COMPLETED|Overall Study||10
2968990|NCT00790023|3683646|FG002|NOT COMPLETED|Overall Study||21
2968991|NCT00790036|3683657|FG000|STARTED|Overall Study||372
2968992|NCT00790036|3683658|FG001|STARTED|Overall Study||370
2968993|NCT00790036|3683657|FG000|Untreated Participants|Overall Study|not treated due to administrative problems, protocol deviation, and subject withdrawal of consent.|4
2968994|NCT00790036|3683658|FG001|Untreated Participants|Overall Study|not treated due to administrative problems and subject withdrawal of consent.|6
2968995|NCT00790036|3683657|FG000|COMPLETED|Overall Study|completed = treatment duration completed as per protocol|177
2968996|NCT00790036|3683658|FG001|COMPLETED|Overall Study|completed = treatment duration completed as per protocol|249
2968997|NCT00790036|3683657|FG000|NOT COMPLETED|Overall Study||195
2968998|NCT00790036|3683658|FG001|NOT COMPLETED|Overall Study||121
2968999|NCT00790062|3683668|FG000|STARTED|Overall Study||659
2969000|NCT00790062|3683669|FG001|STARTED|Overall Study||481
2969001|NCT00790062|3683670|FG002|STARTED|Overall Study||658
2969002|NCT00790062|3683668|FG000|COMPLETED|Overall Study||659
2969003|NCT00790062|3683669|FG001|COMPLETED|Overall Study||481
2969004|NCT00790062|3683670|FG002|COMPLETED|Overall Study||658
2969005|NCT00790062|3683668|FG000|NOT COMPLETED|Overall Study||0
2969006|NCT00790062|3683669|FG001|NOT COMPLETED|Overall Study||0
2969007|NCT00790062|3683670|FG002|NOT COMPLETED|Overall Study||0
2969008|NCT00790088|3683687|FG000|STARTED|Overall Study||274
2969009|NCT00790088|3683687|FG000|Eligible for Data Analysis|Overall Study|Number of participants minus 11 protocol violation|263
2969010|NCT00790088|3683687|FG000|COMPLETED|Overall Study||235
2969011|NCT00790088|3683687|FG000|NOT COMPLETED|Overall Study||39
2969012|NCT00790192|3683697|FG000|STARTED|Overall Study||125
2969013|NCT00790192|3683698|FG001|STARTED|Overall Study||121
2969014|NCT00790192|3683699|FG002|STARTED|Overall Study||120
2969015|NCT00790192|3683700|FG003|STARTED|Overall Study||122
2969016|NCT00790192|3683697|FG000|COMPLETED|Overall Study||89
2969017|NCT00790192|3683698|FG001|COMPLETED|Overall Study||93
2969018|NCT00790192|3683699|FG002|COMPLETED|Overall Study||97
2969019|NCT00790192|3683700|FG003|COMPLETED|Overall Study||74
2969020|NCT00790192|3683697|FG000|NOT COMPLETED|Overall Study||36
2969021|NCT00790192|3683698|FG001|NOT COMPLETED|Overall Study||28
2969022|NCT00790192|3683699|FG002|NOT COMPLETED|Overall Study||23
2969023|NCT00790192|3683700|FG003|NOT COMPLETED|Overall Study||48
2969024|NCT00790205|3683712|FG000|STARTED|Overall Study||7332
2969025|NCT00790205|3683713|FG001|STARTED|Overall Study||7339
2969026|NCT00790205|3683712|FG000|Treated|Overall Study||7266
2969027|NCT00790205|3683713|FG001|Treated|Overall Study||7274
2969028|NCT00790205|3683712|FG000|COMPLETED|Overall Study||6972
2969029|NCT00790205|3683713|FG001|COMPLETED|Overall Study||6905
2969030|NCT00790205|3683712|FG000|NOT COMPLETED|Overall Study||360
2969031|NCT00790205|3683713|FG001|NOT COMPLETED|Overall Study||434
2969032|NCT00790218|3683719|FG000|STARTED|Overall Study||6
2969033|NCT00790218|3683720|FG001|STARTED|Overall Study||6
2969034|NCT00790218|3683721|FG002|STARTED|Overall Study||7
2969035|NCT00790218|3683719|FG000|COMPLETED|Overall Study||5
2969036|NCT00790218|3683720|FG001|COMPLETED|Overall Study||6
2969037|NCT00790218|3683721|FG002|COMPLETED|Overall Study||7
2969038|NCT00790218|3683719|FG000|NOT COMPLETED|Overall Study||1
2969039|NCT00790218|3683720|FG001|NOT COMPLETED|Overall Study||0
2969040|NCT00790218|3683721|FG002|NOT COMPLETED|Overall Study||0
2969041|NCT00790270|3683732|FG000|STARTED|Overall Study||21
2969042|NCT00790270|3683733|FG001|STARTED|Overall Study||20
2969043|NCT00790270|3683734|FG002|STARTED|Overall Study||20
2969044|NCT00790270|3683732|FG000|COMPLETED|Overall Study||21
2969045|NCT00790270|3683733|FG001|COMPLETED|Overall Study||20
2969046|NCT00790270|3683734|FG002|COMPLETED|Overall Study||20
2969047|NCT00790270|3683732|FG000|NOT COMPLETED|Overall Study||0
2969048|NCT00790270|3683733|FG001|NOT COMPLETED|Overall Study||0
3302035|NCT02958345|4035712|FG001|STARTED|Overall Study||14
3302036|NCT02958345|4035711|FG000|COMPLETED|Overall Study||13
3302037|NCT02958345|4035712|FG001|COMPLETED|Overall Study||13
3302038|NCT02958345|4035711|FG000|NOT COMPLETED|Overall Study||1
3302039|NCT02958345|4035712|FG001|NOT COMPLETED|Overall Study||1
3302040|NCT02958527|4035718|FG000|STARTED|Overall Study||1408
3302041|NCT02958527|4035718|FG000|COMPLETED|Overall Study||1396
3302042|NCT02958527|4035718|FG000|NOT COMPLETED|Overall Study||12
3302043|NCT02958553|4035731|FG000|STARTED|Phase I, 1st Visit -Passive Prosthesis||8
3302044|NCT02958553|4035731|FG000|COMPLETED|Phase I, 1st Visit -Passive Prosthesis||8
3302045|NCT02958553|4035731|FG000|NOT COMPLETED|Phase I, 1st Visit -Passive Prosthesis||0
3302046|NCT02958553|4035731|FG000|STARTED|Phase I, 2nd Visit -Fitted With emPOWER||8
3302047|NCT02958553|4035731|FG000|COMPLETED|Phase I, 2nd Visit -Fitted With emPOWER||8
3302048|NCT02958553|4035731|FG000|NOT COMPLETED|Phase I, 2nd Visit -Fitted With emPOWER||0
3302049|NCT02958553|4035731|FG000|STARTED|Phase I, 3rd Visit -2 Week emPOWER FU||8
3302050|NCT02958553|4035731|FG000|COMPLETED|Phase I, 3rd Visit -2 Week emPOWER FU||7
3302051|NCT02958553|4035731|FG000|NOT COMPLETED|Phase I, 3rd Visit -2 Week emPOWER FU||1
3302052|NCT02958553|4035731|FG000|STARTED|Phase II, 4th Visit -3 Month emPOWER FU|Only 4 subjects started Phase II of the study. Phase II was optional per protocol.|7
3302053|NCT02958553|4035731|FG000|COMPLETED|Phase II, 4th Visit -3 Month emPOWER FU||4
3302054|NCT02958553|4035731|FG000|NOT COMPLETED|Phase II, 4th Visit -3 Month emPOWER FU||3
3302055|NCT02958553|4035731|FG000|STARTED|Phase II, 5th Visit -Crossover Visit||4
3302056|NCT02958553|4035731|FG000|COMPLETED|Phase II, 5th Visit -Crossover Visit||4
3302057|NCT02958553|4035731|FG000|NOT COMPLETED|Phase II, 5th Visit -Crossover Visit||0
3302058|NCT02958553|4035731|FG000|STARTED|Phase II, 6th Visit -6 Month emPOWER FU||4
3302059|NCT02958553|4035731|FG000|COMPLETED|Phase II, 6th Visit -6 Month emPOWER FU||2
2969049|NCT00790270|3683734|FG002|NOT COMPLETED|Overall Study||0
2969050|NCT00790296|3683744|FG000|STARTED|Overall Study||5
2969051|NCT00790296|3683745|FG001|STARTED|Overall Study||6
2969052|NCT00790296|3683744|FG000|COMPLETED|Overall Study||4
2969053|NCT00790296|3683745|FG001|COMPLETED|Overall Study||4
2969054|NCT00790296|3683744|FG000|NOT COMPLETED|Overall Study||1
2969055|NCT00790296|3683745|FG001|NOT COMPLETED|Overall Study||2
2969056|NCT00790335|3683753|FG000|STARTED|Overall Study||337
3164027|NCT01890434|3891465|FG000|NOT COMPLETED|Overall Study||20
3164028|NCT01890473|3891471|FG000|STARTED|Overall Study||111
3164029|NCT01890473|3891472|FG001|STARTED|Overall Study||113
3164030|NCT01890473|3891471|FG000|COMPLETED|Overall Study||109
3164031|NCT01890473|3891472|FG001|COMPLETED|Overall Study||113
3164032|NCT01890473|3891471|FG000|NOT COMPLETED|Overall Study||2
2969057|NCT00790335|3683754|FG001|STARTED|Overall Study||355
2969058|NCT00790335|3683753|FG000|COMPLETED|Overall Study||257
2969059|NCT00790335|3683754|FG001|COMPLETED|Overall Study||243
2969060|NCT00790335|3683753|FG000|NOT COMPLETED|Overall Study||80
2969061|NCT00790335|3683754|FG001|NOT COMPLETED|Overall Study||112
2969062|NCT00790400|3683762|FG000|STARTED|Double-blind Period (Core Phase)||79
3164033|NCT01890473|3891472|FG001|NOT COMPLETED|Overall Study||0
2969063|NCT00790400|3683763|FG001|STARTED|Double-blind Period (Core Phase)||39
2969064|NCT00790400|3683762|FG000|COMPLETED|Double-blind Period (Core Phase)|Completed = Completed the Core phase & moved to Extension phase|72
2969065|NCT00790400|3683763|FG001|COMPLETED|Double-blind Period (Core Phase)|Completed = 1st received Placebo in the Core phase, switched to Everolimus in Extension phase|26
2969066|NCT00790400|3683762|FG000|NOT COMPLETED|Double-blind Period (Core Phase)||7
2969067|NCT00790400|3683763|FG001|NOT COMPLETED|Double-blind Period (Core Phase)||13
2969068|NCT00790400|3683762|FG000|STARTED|Everolimus Period (Core or Extension)|112 pts had Everolimus during core and/or extension (6 from placebo did not switch to Eve. in ext.)|112
2969069|NCT00790400|3683763|FG001|STARTED|Everolimus Period (Core or Extension)|"Placebo randomized patients who switched to Everolimus are reported in Everolimus arm."|0
2969070|NCT00790400|3683762|FG000|COMPLETED|Everolimus Period (Core or Extension)|Treatment duration completed as per protocol|83
2969071|NCT00790400|3683763|FG001|COMPLETED|Everolimus Period (Core or Extension)||0
2969072|NCT00790400|3683762|FG000|NOT COMPLETED|Everolimus Period (Core or Extension)||29
2969073|NCT00790400|3683763|FG001|NOT COMPLETED|Everolimus Period (Core or Extension)||0
2969074|NCT00790556|3683772|FG000|STARTED|Treatment Period 1||8
2969075|NCT00790556|3683773|FG001|STARTED|Treatment Period 1||6
2969076|NCT00790556|3683772|FG000|COMPLETED|Treatment Period 1||6
2969077|NCT00790556|3683773|FG001|COMPLETED|Treatment Period 1||6
2969078|NCT00790556|3683772|FG000|NOT COMPLETED|Treatment Period 1||2
2969079|NCT00790556|3683773|FG001|NOT COMPLETED|Treatment Period 1||0
2969080|NCT00790556|3683772|FG000|STARTED|Washout After Period 1||6
2969081|NCT00790556|3683773|FG001|STARTED|Washout After Period 1||6
2969082|NCT00790556|3683772|FG000|COMPLETED|Washout After Period 1||6
2969083|NCT00790556|3683773|FG001|COMPLETED|Washout After Period 1||6
2969084|NCT00790556|3683772|FG000|NOT COMPLETED|Washout After Period 1||0
2969085|NCT00790556|3683773|FG001|NOT COMPLETED|Washout After Period 1||0
2969086|NCT00790556|3683772|FG000|STARTED|Treatment Period 2||6
2969087|NCT00790556|3683773|FG001|STARTED|Treatment Period 2||6
2969088|NCT00790556|3683772|FG000|COMPLETED|Treatment Period 2||6
2969089|NCT00790556|3683773|FG001|COMPLETED|Treatment Period 2||6
2969090|NCT00790556|3683772|FG000|NOT COMPLETED|Treatment Period 2||0
2969091|NCT00790556|3683773|FG001|NOT COMPLETED|Treatment Period 2||0
2969092|NCT00790569|3683782|FG000|STARTED|End of Treatment (6 Month Interview)||137
2969093|NCT00790569|3683783|FG001|STARTED|End of Treatment (6 Month Interview)||45
2969094|NCT00790569|3683784|FG002|STARTED|End of Treatment (6 Month Interview)||133
2969095|NCT00790569|3683782|FG000|COMPLETED|End of Treatment (6 Month Interview)||115
2969096|NCT00790569|3683783|FG001|COMPLETED|End of Treatment (6 Month Interview)||35
2969097|NCT00790569|3683784|FG002|COMPLETED|End of Treatment (6 Month Interview)||107
2969098|NCT00790569|3683782|FG000|NOT COMPLETED|End of Treatment (6 Month Interview)||22
2969099|NCT00790569|3683783|FG001|NOT COMPLETED|End of Treatment (6 Month Interview)||10
2969100|NCT00790569|3683784|FG002|NOT COMPLETED|End of Treatment (6 Month Interview)||26
2969101|NCT00790569|3683782|FG000|STARTED|End of Study (12 Month Interview)||137
2969102|NCT00790569|3683783|FG001|STARTED|End of Study (12 Month Interview)||45
2969103|NCT00790569|3683784|FG002|STARTED|End of Study (12 Month Interview)||133
2969104|NCT00790569|3683782|FG000|COMPLETED|End of Study (12 Month Interview)||71
2969105|NCT00790569|3683783|FG001|COMPLETED|End of Study (12 Month Interview)||26
2969106|NCT00790569|3683784|FG002|COMPLETED|End of Study (12 Month Interview)||83
2969107|NCT00790569|3683782|FG000|NOT COMPLETED|End of Study (12 Month Interview)||66
2969108|NCT00790569|3683783|FG001|NOT COMPLETED|End of Study (12 Month Interview)||19
2969109|NCT00790569|3683784|FG002|NOT COMPLETED|End of Study (12 Month Interview)||50
3035720|NCT01139021|3755005|FG000|STARTED|Overall Study||152
3035721|NCT01139021|3755006|FG001|STARTED|Overall Study||153
3035722|NCT01139021|3755007|FG002|STARTED|Overall Study||67
3035723|NCT01139021|3755008|FG003|STARTED|Overall Study||19
3035724|NCT01139021|3755009|FG004|STARTED|Overall Study||116
3035725|NCT01139021|3755010|FG005|STARTED|Overall Study||1
3035726|NCT01139021|3755005|FG000|COMPLETED|Overall Study||151
3035727|NCT01139021|3755006|FG001|COMPLETED|Overall Study||153
3035728|NCT01139021|3755007|FG002|COMPLETED|Overall Study||67
3035729|NCT01139021|3755008|FG003|COMPLETED|Overall Study||18
3035730|NCT01139021|3755009|FG004|COMPLETED|Overall Study||107
3035731|NCT01139021|3755010|FG005|COMPLETED|Overall Study||1
3035732|NCT01139021|3755005|FG000|NOT COMPLETED|Overall Study||1
3035733|NCT01139021|3755006|FG001|NOT COMPLETED|Overall Study||0
3035734|NCT01139021|3755007|FG002|NOT COMPLETED|Overall Study||0
3035735|NCT01139021|3755008|FG003|NOT COMPLETED|Overall Study||1
3035736|NCT01139021|3755009|FG004|NOT COMPLETED|Overall Study||9
3035737|NCT01139021|3755010|FG005|NOT COMPLETED|Overall Study||0
3035738|NCT01139047|3755025|FG000|STARTED|Overall Study||77
3035739|NCT01139047|3755025|FG000|COMPLETED|Overall Study||76
3035740|NCT01139047|3755025|FG000|NOT COMPLETED|Overall Study||1
3035741|NCT01139164|3755035|FG000|STARTED|Overall Study||4
3035742|NCT01139164|3755036|FG001|STARTED|Overall Study||67
3035743|NCT01139164|3755037|FG002|STARTED|Overall Study||7
3035744|NCT01139164|3755035|FG000|COMPLETED|Overall Study||4
3035745|NCT01139164|3755036|FG001|COMPLETED|Overall Study||65
3035746|NCT01139164|3755037|FG002|COMPLETED|Overall Study||7
3035747|NCT01139164|3755035|FG000|NOT COMPLETED|Overall Study||0
3035748|NCT01139164|3755036|FG001|NOT COMPLETED|Overall Study||2
3035749|NCT01139164|3755037|FG002|NOT COMPLETED|Overall Study||0
3035750|NCT01139190|3755047|FG000|STARTED|Overall Study||38
3035751|NCT01139190|3755048|FG001|STARTED|Overall Study||39
3035752|NCT01139190|3755047|FG000|COMPLETED|Overall Study||38
2969110|NCT00790582|3683794|FG000|STARTED|Overall Study||109
2969111|NCT00790582|3683795|FG001|STARTED|Overall Study||249
2969112|NCT00790582|3683794|FG000|COMPLETED|Overall Study||78
2969113|NCT00790582|3683795|FG001|COMPLETED|Overall Study||162
2969114|NCT00790582|3683794|FG000|NOT COMPLETED|Overall Study||31
2969115|NCT00790582|3683795|FG001|NOT COMPLETED|Overall Study||87
2969116|NCT00790647|3683803|FG000|STARTED|Overall Study||10
2969117|NCT00790647|3683803|FG000|COMPLETED|Overall Study||9
2969118|NCT00790647|3683803|FG000|NOT COMPLETED|Overall Study||1
2969119|NCT00790673|3683813|FG000|STARTED|Overall Study||6
2969120|NCT00790673|3683814|FG001|STARTED|Overall Study||6
2969121|NCT00790673|3683815|FG002|STARTED|Overall Study||12
2969122|NCT00790673|3683816|FG003|STARTED|Overall Study||8
2969123|NCT00790673|3683813|FG000|COMPLETED|Overall Study||6
2969124|NCT00790673|3683814|FG001|COMPLETED|Overall Study||6
2969125|NCT00790673|3683815|FG002|COMPLETED|Overall Study||12
2969126|NCT00790673|3683816|FG003|COMPLETED|Overall Study||8
2969127|NCT00790673|3683813|FG000|NOT COMPLETED|Overall Study||0
2969128|NCT00790673|3683814|FG001|NOT COMPLETED|Overall Study||0
2969129|NCT00790673|3683815|FG002|NOT COMPLETED|Overall Study||0
2969130|NCT00790673|3683816|FG003|NOT COMPLETED|Overall Study||0
2969131|NCT00790699|3683828|FG000|STARTED|Overall Study||17
2969132|NCT00790699|3683829|FG001|STARTED|Overall Study||14
2969133|NCT00790699|3683828|FG000|COMPLETED|Overall Study||16
2969134|NCT00790699|3683829|FG001|COMPLETED|Overall Study||14
2969135|NCT00790699|3683828|FG000|NOT COMPLETED|Overall Study||1
2969136|NCT00790699|3683829|FG001|NOT COMPLETED|Overall Study||0
2969137|NCT00790738|3683839|FG000|STARTED|Overall Study||5
2969138|NCT00790738|3683840|FG001|STARTED|Overall Study||6
2969139|NCT00790738|3683839|FG000|COMPLETED|Overall Study||3
2969140|NCT00790738|3683840|FG001|COMPLETED|Overall Study||3
2969141|NCT00790738|3683839|FG000|NOT COMPLETED|Overall Study||2
2969142|NCT00790738|3683840|FG001|NOT COMPLETED|Overall Study||3
2969143|NCT00790751|3683850|FG000|STARTED|Overall Study||162
2969144|NCT00790751|3683851|FG001|STARTED|Overall Study||161
2969145|NCT00790751|3683852|FG002|STARTED|Overall Study||161
2969146|NCT00790751|3683853|FG003|STARTED|Overall Study||162
2969147|NCT00790751|3683850|FG000|COMPLETED|Overall Study||137
2969148|NCT00790751|3683851|FG001|COMPLETED|Overall Study||131
2969149|NCT00790751|3683852|FG002|COMPLETED|Overall Study||141
2969150|NCT00790751|3683853|FG003|COMPLETED|Overall Study||141
2969151|NCT00790751|3683850|FG000|NOT COMPLETED|Overall Study||25
2969152|NCT00790751|3683851|FG001|NOT COMPLETED|Overall Study||30
2969153|NCT00790751|3683852|FG002|NOT COMPLETED|Overall Study||20
2969154|NCT00790751|3683853|FG003|NOT COMPLETED|Overall Study||21
2969155|NCT00790790|3683866|FG000|STARTED|Study Period 2: Therapy Phase||49
2969156|NCT00790790|3683867|FG001|STARTED|Study Period 2: Therapy Phase||50
2969157|NCT00790790|3683868|FG002|STARTED|Study Period 2: Therapy Phase||48
2969158|NCT00790790|3683866|FG000|COMPLETED|Study Period 2: Therapy Phase||37
2969159|NCT00790790|3683867|FG001|COMPLETED|Study Period 2: Therapy Phase||32
2969160|NCT00790790|3683868|FG002|COMPLETED|Study Period 2: Therapy Phase||27
2969161|NCT00790790|3683866|FG000|NOT COMPLETED|Study Period 2: Therapy Phase||12
2969162|NCT00790790|3683867|FG001|NOT COMPLETED|Study Period 2: Therapy Phase||18
2969163|NCT00790790|3683868|FG002|NOT COMPLETED|Study Period 2: Therapy Phase||21
2969164|NCT00790790|3683866|FG000|STARTED|Study Period 3: 1-Week Washout Phase||37
2969165|NCT00790790|3683867|FG001|STARTED|Study Period 3: 1-Week Washout Phase||32
2969166|NCT00790790|3683868|FG002|STARTED|Study Period 3: 1-Week Washout Phase||27
2969167|NCT00790790|3683866|FG000|COMPLETED|Study Period 3: 1-Week Washout Phase||37
2969168|NCT00790790|3683867|FG001|COMPLETED|Study Period 3: 1-Week Washout Phase||31
2969169|NCT00790790|3683868|FG002|COMPLETED|Study Period 3: 1-Week Washout Phase||26
2969170|NCT00790790|3683866|FG000|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||0
2969171|NCT00790790|3683867|FG001|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||1
2969172|NCT00790790|3683868|FG002|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||1
2969173|NCT00790803|3683881|FG000|STARTED|Overall Study||5
2969174|NCT00790803|3683881|FG000|COMPLETED|Overall Study||5
2969175|NCT00790803|3683881|FG000|NOT COMPLETED|Overall Study||0
2969176|NCT00790842|3683888|FG000|STARTED|Dose Level 1||6
2969177|NCT00790842|3683889|FG001|STARTED|Dose Level 1||0
2969178|NCT00790842|3683890|FG002|STARTED|Dose Level 1||0
2969179|NCT00790842|3683891|FG003|STARTED|Dose Level 1||3
2969180|NCT00790842|3683892|FG004|STARTED|Dose Level 1||0
2969181|NCT00790842|3683893|FG005|STARTED|Dose Level 1||0
2969182|NCT00790842|3683894|FG006|STARTED|Dose Level 1||0
2969183|NCT00790842|3683895|FG007|STARTED|Dose Level 1||3
2969184|NCT00790842|3683896|FG008|STARTED|Dose Level 1||0
2969185|NCT00790842|3683897|FG009|STARTED|Dose Level 1||0
2969186|NCT00790842|3683898|FG010|STARTED|Dose Level 1||0
2969187|NCT00790842|3683888|FG000|Began Treatment|Dose Level 1||6
2969188|NCT00790842|3683889|FG001|Began Treatment|Dose Level 1||0
2969189|NCT00790842|3683890|FG002|Began Treatment|Dose Level 1||0
2969190|NCT00790842|3683891|FG003|Began Treatment|Dose Level 1||3
2969191|NCT00790842|3683892|FG004|Began Treatment|Dose Level 1||0
2969192|NCT00790842|3683893|FG005|Began Treatment|Dose Level 1||0
2969193|NCT00790842|3683894|FG006|Began Treatment|Dose Level 1||0
2969194|NCT00790842|3683895|FG007|Began Treatment|Dose Level 1||3
2969195|NCT00790842|3683896|FG008|Began Treatment|Dose Level 1||0
2969196|NCT00790842|3683897|FG009|Began Treatment|Dose Level 1||0
2969197|NCT00790842|3683898|FG010|Began Treatment|Dose Level 1||0
2969198|NCT00790842|3683888|FG000|COMPLETED|Dose Level 1||3
3302060|NCT02958553|4035731|FG000|NOT COMPLETED|Phase II, 6th Visit -6 Month emPOWER FU||2
3302061|NCT02958553|4035731|FG000|STARTED|Phase II, 7th Visit -12 Month emPOWER FU||2
3302062|NCT02958553|4035731|FG000|COMPLETED|Phase II, 7th Visit -12 Month emPOWER FU||2
3302063|NCT02958553|4035731|FG000|NOT COMPLETED|Phase II, 7th Visit -12 Month emPOWER FU||0
3302064|NCT02958787|4035736|FG000|STARTED|Overall Study||135
3302065|NCT02958787|4035736|FG000|COMPLETED|Overall Study||135
3302066|NCT02958787|4035736|FG000|NOT COMPLETED|Overall Study||0
3302067|NCT02958826|4035742|FG000|STARTED|Overall Study||80
3302068|NCT02958826|4035743|FG001|STARTED|Overall Study||80
2969199|NCT00790842|3683889|FG001|COMPLETED|Dose Level 1||0
2969200|NCT00790842|3683890|FG002|COMPLETED|Dose Level 1||0
2969201|NCT00790842|3683891|FG003|COMPLETED|Dose Level 1||1
2969202|NCT00790842|3683892|FG004|COMPLETED|Dose Level 1||0
2969203|NCT00790842|3683893|FG005|COMPLETED|Dose Level 1||0
2969204|NCT00790842|3683894|FG006|COMPLETED|Dose Level 1||0
2969205|NCT00790842|3683895|FG007|COMPLETED|Dose Level 1||1
2969206|NCT00790842|3683896|FG008|COMPLETED|Dose Level 1||0
2969207|NCT00790842|3683897|FG009|COMPLETED|Dose Level 1||0
2969208|NCT00790842|3683898|FG010|COMPLETED|Dose Level 1||0
2969209|NCT00790842|3683888|FG000|NOT COMPLETED|Dose Level 1||3
2969210|NCT00790842|3683889|FG001|NOT COMPLETED|Dose Level 1||0
2969211|NCT00790842|3683890|FG002|NOT COMPLETED|Dose Level 1||0
2969212|NCT00790842|3683891|FG003|NOT COMPLETED|Dose Level 1||2
2969213|NCT00790842|3683892|FG004|NOT COMPLETED|Dose Level 1||0
2969214|NCT00790842|3683893|FG005|NOT COMPLETED|Dose Level 1||0
2969215|NCT00790842|3683894|FG006|NOT COMPLETED|Dose Level 1||0
2969216|NCT00790842|3683895|FG007|NOT COMPLETED|Dose Level 1||2
2969217|NCT00790842|3683896|FG008|NOT COMPLETED|Dose Level 1||0
2969218|NCT00790842|3683897|FG009|NOT COMPLETED|Dose Level 1||0
2969219|NCT00790842|3683898|FG010|NOT COMPLETED|Dose Level 1||0
2969220|NCT00790842|3683888|FG000|STARTED|Dose Level 2||0
2969221|NCT00790842|3683889|FG001|STARTED|Dose Level 2||3
2969222|NCT00790842|3683890|FG002|STARTED|Dose Level 2||0
2969223|NCT00790842|3683891|FG003|STARTED|Dose Level 2||0
2969224|NCT00790842|3683892|FG004|STARTED|Dose Level 2||3
2969225|NCT00790842|3683893|FG005|STARTED|Dose Level 2||0
2969226|NCT00790842|3683894|FG006|STARTED|Dose Level 2||0
2969227|NCT00790842|3683895|FG007|STARTED|Dose Level 2||0
2969228|NCT00790842|3683896|FG008|STARTED|Dose Level 2||3
2969229|NCT00790842|3683897|FG009|STARTED|Dose Level 2||0
2969230|NCT00790842|3683898|FG010|STARTED|Dose Level 2||0
2969231|NCT00790842|3683888|FG000|Began Treatment|Dose Level 2||0
2969232|NCT00790842|3683889|FG001|Began Treatment|Dose Level 2||3
2969233|NCT00790842|3683890|FG002|Began Treatment|Dose Level 2||0
2969234|NCT00790842|3683891|FG003|Began Treatment|Dose Level 2||0
2969235|NCT00790842|3683892|FG004|Began Treatment|Dose Level 2||3
2969236|NCT00790842|3683893|FG005|Began Treatment|Dose Level 2||0
2969237|NCT00790842|3683894|FG006|Began Treatment|Dose Level 2||0
2969238|NCT00790842|3683895|FG007|Began Treatment|Dose Level 2||0
2969239|NCT00790842|3683896|FG008|Began Treatment|Dose Level 2||3
2969240|NCT00790842|3683897|FG009|Began Treatment|Dose Level 2||0
2969241|NCT00790842|3683898|FG010|Began Treatment|Dose Level 2||0
2969242|NCT00790842|3683888|FG000|COMPLETED|Dose Level 2||0
2969243|NCT00790842|3683889|FG001|COMPLETED|Dose Level 2||0
2969244|NCT00790842|3683890|FG002|COMPLETED|Dose Level 2||0
2969245|NCT00790842|3683891|FG003|COMPLETED|Dose Level 2||0
2969246|NCT00790842|3683892|FG004|COMPLETED|Dose Level 2||2
2969247|NCT00790842|3683893|FG005|COMPLETED|Dose Level 2||0
2969248|NCT00790842|3683894|FG006|COMPLETED|Dose Level 2||0
2969249|NCT00790842|3683895|FG007|COMPLETED|Dose Level 2||0
2969250|NCT00790842|3683896|FG008|COMPLETED|Dose Level 2||1
2969251|NCT00790842|3683897|FG009|COMPLETED|Dose Level 2||0
2969252|NCT00790842|3683898|FG010|COMPLETED|Dose Level 2||0
2969253|NCT00790842|3683888|FG000|NOT COMPLETED|Dose Level 2||0
2969254|NCT00790842|3683889|FG001|NOT COMPLETED|Dose Level 2||3
2969255|NCT00790842|3683890|FG002|NOT COMPLETED|Dose Level 2||0
2969256|NCT00790842|3683891|FG003|NOT COMPLETED|Dose Level 2||0
2969257|NCT00790842|3683892|FG004|NOT COMPLETED|Dose Level 2||1
2969258|NCT00790842|3683893|FG005|NOT COMPLETED|Dose Level 2||0
2969259|NCT00790842|3683894|FG006|NOT COMPLETED|Dose Level 2||0
2969260|NCT00790842|3683895|FG007|NOT COMPLETED|Dose Level 2||0
2969261|NCT00790842|3683896|FG008|NOT COMPLETED|Dose Level 2||2
2969262|NCT00790842|3683897|FG009|NOT COMPLETED|Dose Level 2||0
2969263|NCT00790842|3683898|FG010|NOT COMPLETED|Dose Level 2||0
2969264|NCT00790842|3683888|FG000|STARTED|Dose Level 3||0
2969265|NCT00790842|3683889|FG001|STARTED|Dose Level 3||0
2969266|NCT00790842|3683890|FG002|STARTED|Dose Level 3||7
2969267|NCT00790842|3683891|FG003|STARTED|Dose Level 3||0
2969268|NCT00790842|3683892|FG004|STARTED|Dose Level 3||0
2969269|NCT00790842|3683893|FG005|STARTED|Dose Level 3||3
3302069|NCT02958826|4035742|FG000|COMPLETED|Overall Study||80
3302070|NCT02958826|4035743|FG001|COMPLETED|Overall Study||80
3302071|NCT02958826|4035742|FG000|NOT COMPLETED|Overall Study||0
2969270|NCT00790842|3683894|FG006|STARTED|Dose Level 3||0
2969271|NCT00790842|3683895|FG007|STARTED|Dose Level 3||0
2969272|NCT00790842|3683896|FG008|STARTED|Dose Level 3||0
2969273|NCT00790842|3683897|FG009|STARTED|Dose Level 3||3
2969274|NCT00790842|3683898|FG010|STARTED|Dose Level 3||0
2969275|NCT00790842|3683888|FG000|Began Treatment|Dose Level 3||0
2969276|NCT00790842|3683889|FG001|Began Treatment|Dose Level 3||0
2969277|NCT00790842|3683890|FG002|Began Treatment|Dose Level 3||6
2969278|NCT00790842|3683891|FG003|Began Treatment|Dose Level 3||0
2969279|NCT00790842|3683892|FG004|Began Treatment|Dose Level 3||0
2969280|NCT00790842|3683893|FG005|Began Treatment|Dose Level 3||3
2969281|NCT00790842|3683894|FG006|Began Treatment|Dose Level 3||0
2969282|NCT00790842|3683895|FG007|Began Treatment|Dose Level 3||0
2969283|NCT00790842|3683896|FG008|Began Treatment|Dose Level 3||0
2969284|NCT00790842|3683897|FG009|Began Treatment|Dose Level 3||3
2969285|NCT00790842|3683898|FG010|Began Treatment|Dose Level 3||0
2969286|NCT00790842|3683888|FG000|COMPLETED|Dose Level 3||0
2969287|NCT00790842|3683889|FG001|COMPLETED|Dose Level 3||0
2969288|NCT00790842|3683890|FG002|COMPLETED|Dose Level 3||2
2969289|NCT00790842|3683891|FG003|COMPLETED|Dose Level 3||0
2969290|NCT00790842|3683892|FG004|COMPLETED|Dose Level 3||0
2969291|NCT00790842|3683893|FG005|COMPLETED|Dose Level 3||2
2969292|NCT00790842|3683894|FG006|COMPLETED|Dose Level 3||0
2969293|NCT00790842|3683895|FG007|COMPLETED|Dose Level 3||0
2969294|NCT00790842|3683896|FG008|COMPLETED|Dose Level 3||0
2969295|NCT00790842|3683897|FG009|COMPLETED|Dose Level 3||1
2969296|NCT00790842|3683898|FG010|COMPLETED|Dose Level 3||0
2969297|NCT00790842|3683888|FG000|NOT COMPLETED|Dose Level 3||0
2969298|NCT00790842|3683889|FG001|NOT COMPLETED|Dose Level 3||0
2969299|NCT00790842|3683890|FG002|NOT COMPLETED|Dose Level 3||5
2969300|NCT00790842|3683891|FG003|NOT COMPLETED|Dose Level 3||0
2969301|NCT00790842|3683892|FG004|NOT COMPLETED|Dose Level 3||0
2969302|NCT00790842|3683893|FG005|NOT COMPLETED|Dose Level 3||1
2969303|NCT00790842|3683894|FG006|NOT COMPLETED|Dose Level 3||0
2969304|NCT00790842|3683895|FG007|NOT COMPLETED|Dose Level 3||0
2969305|NCT00790842|3683896|FG008|NOT COMPLETED|Dose Level 3||0
2969306|NCT00790842|3683897|FG009|NOT COMPLETED|Dose Level 3||2
2969307|NCT00790842|3683898|FG010|NOT COMPLETED|Dose Level 3||0
2969308|NCT00790842|3683888|FG000|STARTED|Dose Level 4||0
2969309|NCT00790842|3683889|FG001|STARTED|Dose Level 4||0
2969310|NCT00790842|3683890|FG002|STARTED|Dose Level 4||0
2969311|NCT00790842|3683891|FG003|STARTED|Dose Level 4||0
2969312|NCT00790842|3683892|FG004|STARTED|Dose Level 4||0
2969313|NCT00790842|3683893|FG005|STARTED|Dose Level 4||0
2969314|NCT00790842|3683894|FG006|STARTED|Dose Level 4||8
2969315|NCT00790842|3683895|FG007|STARTED|Dose Level 4||0
2969316|NCT00790842|3683896|FG008|STARTED|Dose Level 4||0
2969317|NCT00790842|3683897|FG009|STARTED|Dose Level 4||0
2969318|NCT00790842|3683898|FG010|STARTED|Dose Level 4||5
2969319|NCT00790842|3683888|FG000|Began Treatment|Dose Level 4||0
2969320|NCT00790842|3683889|FG001|Began Treatment|Dose Level 4||0
2969321|NCT00790842|3683890|FG002|Began Treatment|Dose Level 4||0
2969322|NCT00790842|3683891|FG003|Began Treatment|Dose Level 4||0
2969323|NCT00790842|3683892|FG004|Began Treatment|Dose Level 4||0
2969324|NCT00790842|3683893|FG005|Began Treatment|Dose Level 4||0
2969325|NCT00790842|3683894|FG006|Began Treatment|Dose Level 4||8
2969326|NCT00790842|3683895|FG007|Began Treatment|Dose Level 4||0
2969327|NCT00790842|3683896|FG008|Began Treatment|Dose Level 4||0
2969328|NCT00790842|3683897|FG009|Began Treatment|Dose Level 4||0
2969329|NCT00790842|3683898|FG010|Began Treatment|Dose Level 4||5
2969330|NCT00790842|3683888|FG000|COMPLETED|Dose Level 4||0
2969331|NCT00790842|3683889|FG001|COMPLETED|Dose Level 4||0
2969332|NCT00790842|3683890|FG002|COMPLETED|Dose Level 4||0
2969333|NCT00790842|3683891|FG003|COMPLETED|Dose Level 4||0
2969334|NCT00790842|3683892|FG004|COMPLETED|Dose Level 4||0
2969335|NCT00790842|3683893|FG005|COMPLETED|Dose Level 4||0
2969336|NCT00790842|3683894|FG006|COMPLETED|Dose Level 4||6
2969337|NCT00790842|3683895|FG007|COMPLETED|Dose Level 4||0
2969338|NCT00790842|3683896|FG008|COMPLETED|Dose Level 4||0
2969339|NCT00790842|3683897|FG009|COMPLETED|Dose Level 4||0
2969340|NCT00790842|3683898|FG010|COMPLETED|Dose Level 4||3
2969341|NCT00790842|3683888|FG000|NOT COMPLETED|Dose Level 4||0
2969342|NCT00790842|3683889|FG001|NOT COMPLETED|Dose Level 4||0
2969343|NCT00790842|3683890|FG002|NOT COMPLETED|Dose Level 4||0
2969344|NCT00790842|3683891|FG003|NOT COMPLETED|Dose Level 4||0
2969345|NCT00790842|3683892|FG004|NOT COMPLETED|Dose Level 4||0
2969346|NCT00790842|3683893|FG005|NOT COMPLETED|Dose Level 4||0
2969347|NCT00790842|3683894|FG006|NOT COMPLETED|Dose Level 4||2
2969348|NCT00790842|3683895|FG007|NOT COMPLETED|Dose Level 4||0
2969349|NCT00790842|3683896|FG008|NOT COMPLETED|Dose Level 4||0
2969350|NCT00790842|3683897|FG009|NOT COMPLETED|Dose Level 4||0
2969351|NCT00790842|3683898|FG010|NOT COMPLETED|Dose Level 4||2
2969352|NCT00790842|3683888|FG000|STARTED|Expansion Cohort||0
2969353|NCT00790842|3683889|FG001|STARTED|Expansion Cohort||0
2969354|NCT00790842|3683890|FG002|STARTED|Expansion Cohort||14
2969355|NCT00790842|3683891|FG003|STARTED|Expansion Cohort||0
2969356|NCT00790842|3683892|FG004|STARTED|Expansion Cohort||0
2969357|NCT00790842|3683893|FG005|STARTED|Expansion Cohort||0
2969358|NCT00790842|3683894|FG006|STARTED|Expansion Cohort||2
2969359|NCT00790842|3683895|FG007|STARTED|Expansion Cohort||0
2969360|NCT00790842|3683896|FG008|STARTED|Expansion Cohort||0
2969361|NCT00790842|3683897|FG009|STARTED|Expansion Cohort||0
2969362|NCT00790842|3683898|FG010|STARTED|Expansion Cohort||0
2969363|NCT00790842|3683888|FG000|Began Treatment|Expansion Cohort||0
2969364|NCT00790842|3683889|FG001|Began Treatment|Expansion Cohort||0
2969365|NCT00790842|3683890|FG002|Began Treatment|Expansion Cohort||14
2969366|NCT00790842|3683891|FG003|Began Treatment|Expansion Cohort||0
2969367|NCT00790842|3683892|FG004|Began Treatment|Expansion Cohort||0
2969368|NCT00790842|3683893|FG005|Began Treatment|Expansion Cohort||0
2969369|NCT00790842|3683894|FG006|Began Treatment|Expansion Cohort||2
2969370|NCT00790842|3683895|FG007|Began Treatment|Expansion Cohort||0
2969371|NCT00790842|3683896|FG008|Began Treatment|Expansion Cohort||0
2969372|NCT00790842|3683897|FG009|Began Treatment|Expansion Cohort||0
2969373|NCT00790842|3683898|FG010|Began Treatment|Expansion Cohort||0
2969374|NCT00790842|3683888|FG000|COMPLETED|Expansion Cohort||0
2969375|NCT00790842|3683889|FG001|COMPLETED|Expansion Cohort||0
2969376|NCT00790842|3683890|FG002|COMPLETED|Expansion Cohort||7
2969377|NCT00790842|3683891|FG003|COMPLETED|Expansion Cohort||0
2969378|NCT00790842|3683892|FG004|COMPLETED|Expansion Cohort||0
2969379|NCT00790842|3683893|FG005|COMPLETED|Expansion Cohort||0
2969380|NCT00790842|3683894|FG006|COMPLETED|Expansion Cohort||1
2969381|NCT00790842|3683895|FG007|COMPLETED|Expansion Cohort||0
2969382|NCT00790842|3683896|FG008|COMPLETED|Expansion Cohort||0
2969383|NCT00790842|3683897|FG009|COMPLETED|Expansion Cohort||0
2969384|NCT00790842|3683898|FG010|COMPLETED|Expansion Cohort||0
2969385|NCT00790842|3683888|FG000|NOT COMPLETED|Expansion Cohort||0
2969386|NCT00790842|3683889|FG001|NOT COMPLETED|Expansion Cohort||0
2969387|NCT00790842|3683890|FG002|NOT COMPLETED|Expansion Cohort||7
2969388|NCT00790842|3683891|FG003|NOT COMPLETED|Expansion Cohort||0
2969389|NCT00790842|3683892|FG004|NOT COMPLETED|Expansion Cohort||0
2969390|NCT00790842|3683893|FG005|NOT COMPLETED|Expansion Cohort||0
2969391|NCT00790842|3683894|FG006|NOT COMPLETED|Expansion Cohort||1
2969392|NCT00790842|3683895|FG007|NOT COMPLETED|Expansion Cohort||0
2969393|NCT00790842|3683896|FG008|NOT COMPLETED|Expansion Cohort||0
2969394|NCT00790842|3683897|FG009|NOT COMPLETED|Expansion Cohort||0
2969395|NCT00790842|3683898|FG010|NOT COMPLETED|Expansion Cohort||0
2969396|NCT00790855|3683946|FG000|STARTED|Overall Study||25
2969397|NCT00790855|3683946|FG000|COMPLETED|Overall Study||25
2969398|NCT00790855|3683946|FG000|NOT COMPLETED|Overall Study||0
2969399|NCT00790868|3683953|FG000|STARTED|Overall Study||88
2969400|NCT00790868|3683954|FG001|STARTED|Overall Study||92
2969401|NCT00790868|3683953|FG000|COMPLETED|Overall Study||82
2969402|NCT00790868|3683954|FG001|COMPLETED|Overall Study||75
2969403|NCT00790868|3683953|FG000|NOT COMPLETED|Overall Study||6
2969404|NCT00790868|3683954|FG001|NOT COMPLETED|Overall Study||17
2969405|NCT00790907|3683965|FG000|STARTED|Overall Study||1209
2969406|NCT00790907|3683966|FG001|STARTED|Overall Study||1024
2969407|NCT00790907|3683967|FG002|STARTED|Overall Study||1002
2969408|NCT00790907|3683965|FG000|COMPLETED|Overall Study||754
2969409|NCT00790907|3683966|FG001|COMPLETED|Overall Study||684
2969410|NCT00790907|3683967|FG002|COMPLETED|Overall Study||663
2969411|NCT00790907|3683965|FG000|NOT COMPLETED|Overall Study||455
2969412|NCT00790907|3683966|FG001|NOT COMPLETED|Overall Study||340
2969413|NCT00790907|3683967|FG002|NOT COMPLETED|Overall Study||339
2969414|NCT00790933|3683979|FG000|STARTED|Overall Study||675
2969415|NCT00790933|3683980|FG001|STARTED|Overall Study||726
2969416|NCT00790933|3683981|FG002|STARTED|Overall Study||384
2969417|NCT00790933|3683982|FG003|STARTED|Overall Study||37
2969418|NCT00790933|3683983|FG004|STARTED|Overall Study||421
2969419|NCT00790933|3683979|FG000|COMPLETED|Overall Study||237
2969420|NCT00790933|3683980|FG001|COMPLETED|Overall Study||246
2969421|NCT00790933|3683981|FG002|COMPLETED|Overall Study||115
2969422|NCT00790933|3683982|FG003|COMPLETED|Overall Study||23
2969423|NCT00790933|3683983|FG004|COMPLETED|Overall Study||145
2969424|NCT00790933|3683979|FG000|NOT COMPLETED|Overall Study||438
2969425|NCT00790933|3683980|FG001|NOT COMPLETED|Overall Study||480
2969426|NCT00790933|3683981|FG002|NOT COMPLETED|Overall Study||269
2969427|NCT00790933|3683982|FG003|NOT COMPLETED|Overall Study||14
2969428|NCT00790933|3683983|FG004|NOT COMPLETED|Overall Study||276
2969429|NCT00791037|3683999|FG000|STARTED|Overall Study||23
2969430|NCT00791037|3683999|FG000|Primary Outcome|Overall Study||19
2969431|NCT00791037|3683999|FG000|Skeletal or Bone-only Disease by FDG-PET|Overall Study||1
2969432|NCT00791037|3683999|FG000|COMPLETED|Overall Study||23
2969433|NCT00791037|3683999|FG000|NOT COMPLETED|Overall Study||0
2969434|NCT00791089|3684007|FG000|STARTED|Overall Study||6
2969435|NCT00791089|3684008|FG001|STARTED|Overall Study||6
2969436|NCT00791089|3684007|FG000|Began Actually Taking Fish Oil or Placeb|Overall Study||6
2969437|NCT00791089|3684008|FG001|Began Actually Taking Fish Oil or Placeb|Overall Study||5
2969438|NCT00791089|3684007|FG000|Six-month Data Collected|Overall Study||6
2969439|NCT00791089|3684008|FG001|Six-month Data Collected|Overall Study||5
2969440|NCT00791089|3684007|FG000|COMPLETED|Overall Study||0
2969441|NCT00791089|3684008|FG001|COMPLETED|Overall Study||0
2969442|NCT00791089|3684007|FG000|NOT COMPLETED|Overall Study||6
2969443|NCT00791089|3684008|FG001|NOT COMPLETED|Overall Study||6
2969444|NCT00791102|3684014|FG000|STARTED|Period 1||10
2969445|NCT00791102|3684015|FG001|STARTED|Period 1||10
3133196|NCT01695239|3858308|FG003|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||10
3133197|NCT01695239|3858309|FG004|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
3133198|NCT01695239|3858310|FG005|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
3133199|NCT01695239|3858311|FG006|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
3133200|NCT01695239|3858312|FG007|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
2969446|NCT00791102|3684014|FG000|COMPLETED|Period 1||10
2969447|NCT00791102|3684015|FG001|COMPLETED|Period 1||10
2969448|NCT00791102|3684014|FG000|NOT COMPLETED|Period 1||0
2969449|NCT00791102|3684015|FG001|NOT COMPLETED|Period 1||0
2969450|NCT00791102|3684014|FG000|STARTED|Washout Period of 2 Weeks||10
2969451|NCT00791102|3684015|FG001|STARTED|Washout Period of 2 Weeks||10
2969452|NCT00791102|3684014|FG000|COMPLETED|Washout Period of 2 Weeks||10
2969453|NCT00791102|3684015|FG001|COMPLETED|Washout Period of 2 Weeks||10
2969454|NCT00791102|3684014|FG000|NOT COMPLETED|Washout Period of 2 Weeks||0
2969455|NCT00791102|3684015|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0
2969456|NCT00791102|3684014|FG000|STARTED|Period 2||10
2969457|NCT00791102|3684015|FG001|STARTED|Period 2||10
2969458|NCT00791102|3684014|FG000|COMPLETED|Period 2||10
2969459|NCT00791102|3684015|FG001|COMPLETED|Period 2||10
2969460|NCT00791102|3684014|FG000|NOT COMPLETED|Period 2||0
2969461|NCT00791102|3684015|FG001|NOT COMPLETED|Period 2||0
2969462|NCT00791128|3684021|FG000|STARTED|Overall Study||22
2969463|NCT00791128|3684021|FG000|COMPLETED|Overall Study||13
2969464|NCT00791128|3684021|FG000|NOT COMPLETED|Overall Study||9
2969465|NCT00791219|3684028|FG000|STARTED|Overall Study||24
2969466|NCT00791219|3684029|FG001|STARTED|Overall Study||76
2969467|NCT00791219|3684030|FG002|STARTED|Overall Study||75
2969468|NCT00791219|3684028|FG000|COMPLETED|Overall Study||19
2969469|NCT00791219|3684029|FG001|COMPLETED|Overall Study||60
2969470|NCT00791219|3684030|FG002|COMPLETED|Overall Study||61
2969471|NCT00791219|3684028|FG000|NOT COMPLETED|Overall Study||5
2969472|NCT00791219|3684029|FG001|NOT COMPLETED|Overall Study||16
2969473|NCT00791219|3684030|FG002|NOT COMPLETED|Overall Study||14
2969474|NCT00791258|3684038|FG000|STARTED|Overall Study||999
2969475|NCT00791258|3684038|FG000|COMPLETED|Overall Study||736
2969476|NCT00791258|3684038|FG000|NOT COMPLETED|Overall Study||263
2969477|NCT00791323|3684044|FG000|STARTED|Overall Study||6
2969478|NCT00791323|3684045|FG001|STARTED|Overall Study||3
2969479|NCT00791323|3684044|FG000|COMPLETED|Overall Study||6
2969480|NCT00791323|3684045|FG001|COMPLETED|Overall Study||3
2969481|NCT00791323|3684044|FG000|NOT COMPLETED|Overall Study||0
2969482|NCT00791323|3684045|FG001|NOT COMPLETED|Overall Study||0
2969483|NCT00791388|3684056|FG000|STARTED|Period 1 - 50 mg Dose Group||3
2969484|NCT00791388|3684057|FG001|STARTED|Period 1 - 50 mg Dose Group||8
2969485|NCT00791388|3684058|FG002|STARTED|Period 1 - 50 mg Dose Group||0
2969486|NCT00791388|3684059|FG003|STARTED|Period 1 - 50 mg Dose Group||0
2969487|NCT00791388|3684060|FG004|STARTED|Period 1 - 50 mg Dose Group||0
2969488|NCT00791388|3684056|FG000|COMPLETED|Period 1 - 50 mg Dose Group||3
2969489|NCT00791388|3684057|FG001|COMPLETED|Period 1 - 50 mg Dose Group||7
2969490|NCT00791388|3684058|FG002|COMPLETED|Period 1 - 50 mg Dose Group||0
2969491|NCT00791388|3684059|FG003|COMPLETED|Period 1 - 50 mg Dose Group||0
2969492|NCT00791388|3684060|FG004|COMPLETED|Period 1 - 50 mg Dose Group||0
2969493|NCT00791388|3684056|FG000|NOT COMPLETED|Period 1 - 50 mg Dose Group||0
2969494|NCT00791388|3684057|FG001|NOT COMPLETED|Period 1 - 50 mg Dose Group||1
2969495|NCT00791388|3684058|FG002|NOT COMPLETED|Period 1 - 50 mg Dose Group||0
2969496|NCT00791388|3684059|FG003|NOT COMPLETED|Period 1 - 50 mg Dose Group||0
2969497|NCT00791388|3684060|FG004|NOT COMPLETED|Period 1 - 50 mg Dose Group||0
2969498|NCT00791388|3684056|FG000|STARTED|Period 2 - 100 mg Dose Group||3
2969499|NCT00791388|3684057|FG001|STARTED|Period 2 - 100 mg Dose Group||0
2969500|NCT00791388|3684058|FG002|STARTED|Period 2 - 100 mg Dose Group||8
2969501|NCT00791388|3684059|FG003|STARTED|Period 2 - 100 mg Dose Group||0
2969502|NCT00791388|3684060|FG004|STARTED|Period 2 - 100 mg Dose Group||0
2969503|NCT00791388|3684056|FG000|COMPLETED|Period 2 - 100 mg Dose Group||2
2969504|NCT00791388|3684057|FG001|COMPLETED|Period 2 - 100 mg Dose Group||0
2969505|NCT00791388|3684058|FG002|COMPLETED|Period 2 - 100 mg Dose Group||8
2969506|NCT00791388|3684059|FG003|COMPLETED|Period 2 - 100 mg Dose Group||0
2969507|NCT00791388|3684060|FG004|COMPLETED|Period 2 - 100 mg Dose Group||0
2969508|NCT00791388|3684056|FG000|NOT COMPLETED|Period 2 - 100 mg Dose Group||1
2969509|NCT00791388|3684057|FG001|NOT COMPLETED|Period 2 - 100 mg Dose Group||0
2969510|NCT00791388|3684058|FG002|NOT COMPLETED|Period 2 - 100 mg Dose Group||0
2969511|NCT00791388|3684059|FG003|NOT COMPLETED|Period 2 - 100 mg Dose Group||0
2969512|NCT00791388|3684060|FG004|NOT COMPLETED|Period 2 - 100 mg Dose Group||0
2969513|NCT00791388|3684056|FG000|STARTED|Period 3 - 200 mg Dose Group||3
2969514|NCT00791388|3684057|FG001|STARTED|Period 3 - 200 mg Dose Group||0
2969515|NCT00791388|3684058|FG002|STARTED|Period 3 - 200 mg Dose Group||0
2969516|NCT00791388|3684059|FG003|STARTED|Period 3 - 200 mg Dose Group||8
2969517|NCT00791388|3684060|FG004|STARTED|Period 3 - 200 mg Dose Group||0
2969518|NCT00791388|3684056|FG000|COMPLETED|Period 3 - 200 mg Dose Group||3
2969519|NCT00791388|3684057|FG001|COMPLETED|Period 3 - 200 mg Dose Group||0
2969520|NCT00791388|3684058|FG002|COMPLETED|Period 3 - 200 mg Dose Group||0
2969521|NCT00791388|3684059|FG003|COMPLETED|Period 3 - 200 mg Dose Group||8
2969522|NCT00791388|3684060|FG004|COMPLETED|Period 3 - 200 mg Dose Group||0
2969523|NCT00791388|3684056|FG000|NOT COMPLETED|Period 3 - 200 mg Dose Group||0
2969524|NCT00791388|3684057|FG001|NOT COMPLETED|Period 3 - 200 mg Dose Group||0
2969525|NCT00791388|3684058|FG002|NOT COMPLETED|Period 3 - 200 mg Dose Group||0
2969526|NCT00791388|3684059|FG003|NOT COMPLETED|Period 3 - 200 mg Dose Group||0
2969527|NCT00791388|3684060|FG004|NOT COMPLETED|Period 3 - 200 mg Dose Group||0
2969528|NCT00791388|3684056|FG000|STARTED|Period 4 - 400 mg Dose Group||4
2969529|NCT00791388|3684057|FG001|STARTED|Period 4 - 400 mg Dose Group||0
2969530|NCT00791388|3684058|FG002|STARTED|Period 4 - 400 mg Dose Group||0
2969531|NCT00791388|3684059|FG003|STARTED|Period 4 - 400 mg Dose Group||0
3133201|NCT01695239|3858313|FG008|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
3133202|NCT01695239|3858314|FG009|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
3133203|NCT01695239|3858315|FG010|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
3133204|NCT01695239|3858316|FG011|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
3164034|NCT01890512|3891480|FG000|STARTED|Overall Study||20
3164035|NCT01890512|3891480|FG000|COMPLETED|Overall Study||17
3164036|NCT01890512|3891480|FG000|NOT COMPLETED|Overall Study||3
3164037|NCT01890642|3891487|FG000|STARTED|Overall Study||56
3164038|NCT01890642|3891488|FG001|STARTED|Overall Study||53
3164039|NCT01890642|3891489|FG002|STARTED|Overall Study||96
3164040|NCT01890642|3891487|FG000|COMPLETED|Overall Study||56
3164041|NCT01890642|3891488|FG001|COMPLETED|Overall Study||53
2969532|NCT00791388|3684060|FG004|STARTED|Period 4 - 400 mg Dose Group||8
2969533|NCT00791388|3684056|FG000|COMPLETED|Period 4 - 400 mg Dose Group||4
2969534|NCT00791388|3684057|FG001|COMPLETED|Period 4 - 400 mg Dose Group||0
2969535|NCT00791388|3684058|FG002|COMPLETED|Period 4 - 400 mg Dose Group||0
2969536|NCT00791388|3684059|FG003|COMPLETED|Period 4 - 400 mg Dose Group||0
2969537|NCT00791388|3684060|FG004|COMPLETED|Period 4 - 400 mg Dose Group||4
2969538|NCT00791388|3684056|FG000|NOT COMPLETED|Period 4 - 400 mg Dose Group||0
2969539|NCT00791388|3684057|FG001|NOT COMPLETED|Period 4 - 400 mg Dose Group||0
2969540|NCT00791388|3684058|FG002|NOT COMPLETED|Period 4 - 400 mg Dose Group||0
2969541|NCT00791388|3684059|FG003|NOT COMPLETED|Period 4 - 400 mg Dose Group||0
2969542|NCT00791388|3684060|FG004|NOT COMPLETED|Period 4 - 400 mg Dose Group||4
2969543|NCT00791479|3684078|FG000|STARTED|Overall Study||35
2969544|NCT00791479|3684079|FG001|STARTED|Overall Study||34
2969545|NCT00791479|3684080|FG002|STARTED|Overall Study||34
2969546|NCT00791479|3684081|FG003|STARTED|Overall Study||29
2969547|NCT00791479|3684082|FG004|STARTED|Overall Study|3mg LY2189265 discont. Replaced with 1.5mg dose based on dose finding Study H9X-MC-GBCF; NCT00734474|3
2969548|NCT00791479|3684083|FG005|STARTED|Overall Study||32
2969549|NCT00791479|3684078|FG000|Received at Least One Dose of Study Drug|Overall Study||35
2969550|NCT00791479|3684079|FG001|Received at Least One Dose of Study Drug|Overall Study||34
2969551|NCT00791479|3684080|FG002|Received at Least One Dose of Study Drug|Overall Study||34
2969552|NCT00791479|3684081|FG003|Received at Least One Dose of Study Drug|Overall Study||29
2969553|NCT00791479|3684082|FG004|Received at Least One Dose of Study Drug|Overall Study||3
2969554|NCT00791479|3684083|FG005|Received at Least One Dose of Study Drug|Overall Study||32
2969555|NCT00791479|3684078|FG000|COMPLETED|Overall Study||33
2969556|NCT00791479|3684079|FG001|COMPLETED|Overall Study||31
2969557|NCT00791479|3684080|FG002|COMPLETED|Overall Study||34
2969558|NCT00791479|3684081|FG003|COMPLETED|Overall Study||25
2969559|NCT00791479|3684082|FG004|COMPLETED|Overall Study||0
2969560|NCT00791479|3684083|FG005|COMPLETED|Overall Study||29
2969561|NCT00791479|3684078|FG000|NOT COMPLETED|Overall Study||2
2969562|NCT00791479|3684079|FG001|NOT COMPLETED|Overall Study||3
2969563|NCT00791479|3684080|FG002|NOT COMPLETED|Overall Study||0
2969564|NCT00791479|3684081|FG003|NOT COMPLETED|Overall Study||4
2969565|NCT00791479|3684082|FG004|NOT COMPLETED|Overall Study||3
2969566|NCT00791479|3684083|FG005|NOT COMPLETED|Overall Study||3
2969567|NCT00791492|3684106|FG000|STARTED|Overall Study||45
2969568|NCT00791492|3684107|FG001|STARTED|Overall Study||41
2969569|NCT00791492|3684106|FG000|TREATED|Overall Study||44
2969570|NCT00791492|3684107|FG001|TREATED|Overall Study||41
2969571|NCT00791492|3684106|FG000|COMPLETED|Overall Study||39
2969572|NCT00791492|3684107|FG001|COMPLETED|Overall Study||38
2969573|NCT00791492|3684106|FG000|NOT COMPLETED|Overall Study||6
2969574|NCT00791492|3684107|FG001|NOT COMPLETED|Overall Study||3
2969575|NCT00791518|3684113|FG000|STARTED|Overall Study||1084
2969576|NCT00791518|3684113|FG000|COMPLETED|Overall Study||991
2969577|NCT00791518|3684113|FG000|NOT COMPLETED|Overall Study||93
2969578|NCT00791557|3684132|FG000|STARTED|Overall Study||2
2969579|NCT00791557|3684132|FG000|COMPLETED|Overall Study||1
2969580|NCT00791557|3684132|FG000|NOT COMPLETED|Overall Study||1
2969581|NCT00791648|3684138|FG000|STARTED|Overall Study||308
2969582|NCT00791648|3684139|FG001|STARTED|Overall Study||309
2969583|NCT00791648|3684138|FG000|COMPLETED|Overall Study||308
2969584|NCT00791648|3684139|FG001|COMPLETED|Overall Study||307
2969585|NCT00791648|3684138|FG000|NOT COMPLETED|Overall Study||0
2969586|NCT00791648|3684139|FG001|NOT COMPLETED|Overall Study||2
2969587|NCT00791661|3684148|FG000|STARTED|Period 1||8
2969588|NCT00791661|3684149|FG001|STARTED|Period 1||8
2969589|NCT00791661|3684150|FG002|STARTED|Period 1||8
2969590|NCT00791661|3684148|FG000|Received MK-1006|Period 1||6
2969591|NCT00791661|3684149|FG001|Received MK-1006|Period 1||6
2969592|NCT00791661|3684150|FG002|Received MK-1006|Period 1||6
2969593|NCT00791661|3684148|FG000|Received Matching Placebo to MK-1006|Period 1||2
2969594|NCT00791661|3684149|FG001|Received Matching Placebo to MK-1006|Period 1||2
2969595|NCT00791661|3684150|FG002|Received Matching Placebo to MK-1006|Period 1||2
2969596|NCT00791661|3684148|FG000|COMPLETED|Period 1||8
2969597|NCT00791661|3684149|FG001|COMPLETED|Period 1||8
2969598|NCT00791661|3684150|FG002|COMPLETED|Period 1||8
2969599|NCT00791661|3684148|FG000|NOT COMPLETED|Period 1||0
2969600|NCT00791661|3684149|FG001|NOT COMPLETED|Period 1||0
2969601|NCT00791661|3684150|FG002|NOT COMPLETED|Period 1||0
2969602|NCT00791661|3684148|FG000|STARTED|7 Day Wash-out||8
2969603|NCT00791661|3684149|FG001|STARTED|7 Day Wash-out||8
2969604|NCT00791661|3684150|FG002|STARTED|7 Day Wash-out||8
2969605|NCT00791661|3684148|FG000|COMPLETED|7 Day Wash-out||8
2969606|NCT00791661|3684149|FG001|COMPLETED|7 Day Wash-out||8
2969607|NCT00791661|3684150|FG002|COMPLETED|7 Day Wash-out||6
2969608|NCT00791661|3684148|FG000|NOT COMPLETED|7 Day Wash-out||0
2969609|NCT00791661|3684149|FG001|NOT COMPLETED|7 Day Wash-out||0
2969610|NCT00791661|3684150|FG002|NOT COMPLETED|7 Day Wash-out||2
3164042|NCT01890642|3891489|FG002|COMPLETED|Overall Study||96
2969611|NCT00791661|3684148|FG000|STARTED|Period 2||8
2969612|NCT00791661|3684149|FG001|STARTED|Period 2||8
2969613|NCT00791661|3684150|FG002|STARTED|Period 2||6
2969614|NCT00791661|3684148|FG000|Received MK-1006|Period 2||6
2969615|NCT00791661|3684149|FG001|Received MK-1006|Period 2||6
2969616|NCT00791661|3684150|FG002|Received MK-1006|Period 2||4
2969617|NCT00791661|3684148|FG000|Received Matching Placebo to MK-1006|Period 2||2
2969618|NCT00791661|3684149|FG001|Received Matching Placebo to MK-1006|Period 2||2
2969619|NCT00791661|3684150|FG002|Received Matching Placebo to MK-1006|Period 2||2
2969620|NCT00791661|3684148|FG000|COMPLETED|Period 2||8
2969621|NCT00791661|3684149|FG001|COMPLETED|Period 2||8
2969622|NCT00791661|3684150|FG002|COMPLETED|Period 2||6
2969623|NCT00791661|3684148|FG000|NOT COMPLETED|Period 2||0
2969624|NCT00791661|3684149|FG001|NOT COMPLETED|Period 2||0
2969625|NCT00791661|3684150|FG002|NOT COMPLETED|Period 2||0
2969626|NCT00791661|3684148|FG000|STARTED|7 Day Wash-out||8
2969627|NCT00791661|3684149|FG001|STARTED|7 Day Wash-out||8
2969628|NCT00791661|3684150|FG002|STARTED|7 Day Wash-out||6
2969629|NCT00791661|3684148|FG000|COMPLETED|7 Day Wash-out||8
2969630|NCT00791661|3684149|FG001|COMPLETED|7 Day Wash-out||8
2969631|NCT00791661|3684150|FG002|COMPLETED|7 Day Wash-out||6
2969632|NCT00791661|3684148|FG000|NOT COMPLETED|7 Day Wash-out||0
2969633|NCT00791661|3684149|FG001|NOT COMPLETED|7 Day Wash-out||0
2969634|NCT00791661|3684150|FG002|NOT COMPLETED|7 Day Wash-out||0
2969635|NCT00791661|3684148|FG000|STARTED|Period 3||8
2969636|NCT00791661|3684149|FG001|STARTED|Period 3||8
2969637|NCT00791661|3684150|FG002|STARTED|Period 3||6
2969638|NCT00791661|3684148|FG000|Received MK-1006|Period 3||6
2969639|NCT00791661|3684149|FG001|Received MK-1006|Period 3||6
2969640|NCT00791661|3684150|FG002|Received MK-1006|Period 3||5
2969641|NCT00791661|3684148|FG000|Received Matching Placebo to MK-1006|Period 3||2
2969642|NCT00791661|3684149|FG001|Received Matching Placebo to MK-1006|Period 3||2
2969643|NCT00791661|3684150|FG002|Received Matching Placebo to MK-1006|Period 3||1
2969644|NCT00791661|3684148|FG000|COMPLETED|Period 3||8
2969645|NCT00791661|3684149|FG001|COMPLETED|Period 3||8
2969646|NCT00791661|3684150|FG002|COMPLETED|Period 3||6
2969647|NCT00791661|3684148|FG000|NOT COMPLETED|Period 3||0
2969648|NCT00791661|3684149|FG001|NOT COMPLETED|Period 3||0
2969649|NCT00791661|3684150|FG002|NOT COMPLETED|Period 3||0
2969650|NCT00791700|3684178|FG000|STARTED|Overall Study||16
2969651|NCT00791700|3684179|FG001|STARTED|Overall Study||31
2969652|NCT00791700|3684180|FG002|STARTED|Overall Study||13
2969653|NCT00791700|3684181|FG003|STARTED|Overall Study||43
2969654|NCT00791700|3684178|FG000|COMPLETED|Overall Study||10
2969655|NCT00791700|3684179|FG001|COMPLETED|Overall Study||20
2969656|NCT00791700|3684180|FG002|COMPLETED|Overall Study||7
2969657|NCT00791700|3684181|FG003|COMPLETED|Overall Study||13
2969658|NCT00791700|3684178|FG000|NOT COMPLETED|Overall Study||6
2969659|NCT00791700|3684179|FG001|NOT COMPLETED|Overall Study||11
2969660|NCT00791700|3684180|FG002|NOT COMPLETED|Overall Study||6
2969661|NCT00791700|3684181|FG003|NOT COMPLETED|Overall Study||30
2969662|NCT00791765|3684204|FG000|STARTED|Weeks 1 to 12||62
2969663|NCT00791765|3684205|FG001|STARTED|Weeks 1 to 12||62
2969664|NCT00791765|3684204|FG000|Treated|Weeks 1 to 12||62
2969665|NCT00791765|3684205|FG001|Treated|Weeks 1 to 12||59
2969666|NCT00791765|3684204|FG000|COMPLETED|Weeks 1 to 12||54
2969667|NCT00791765|3684205|FG001|COMPLETED|Weeks 1 to 12||58
2969668|NCT00791765|3684204|FG000|NOT COMPLETED|Weeks 1 to 12||8
2969669|NCT00791765|3684205|FG001|NOT COMPLETED|Weeks 1 to 12||4
2969670|NCT00791765|3684204|FG000|STARTED|Weeks 13 to 24||54
2969671|NCT00791765|3684205|FG001|STARTED|Weeks 13 to 24|1 participant discontinued due to an adverse event after completing 12 weeks.|57
2969672|NCT00791765|3684204|FG000|COMPLETED|Weeks 13 to 24||49
2969673|NCT00791765|3684205|FG001|COMPLETED|Weeks 13 to 24||49
2969674|NCT00791765|3684204|FG000|NOT COMPLETED|Weeks 13 to 24||5
2969675|NCT00791765|3684205|FG001|NOT COMPLETED|Weeks 13 to 24||8
2969676|NCT00791778|3684213|FG000|STARTED|Double-blind Treatment||123
2969677|NCT00791778|3684214|FG001|STARTED|Double-blind Treatment||123
2969678|NCT00791778|3684213|FG000|COMPLETED|Double-blind Treatment|includes: 42 subjects with progression, 4 subjects transferred to a continuation study|46
2969679|NCT00791778|3684214|FG001|COMPLETED|Double-blind Treatment|includes: 75 subjects with progression|75
2969680|NCT00791778|3684213|FG000|NOT COMPLETED|Double-blind Treatment||77
2969681|NCT00791778|3684214|FG001|NOT COMPLETED|Double-blind Treatment||48
2969682|NCT00791778|3684213|FG000|STARTED|Follow-up||100
2969683|NCT00791778|3684214|FG001|STARTED|Follow-up||91
2969684|NCT00791778|3684213|FG000|COMPLETED|Follow-up|Includes 79 participants with study follow-up terminated by sponsor and 16 deaths|95
2969685|NCT00791778|3684214|FG001|COMPLETED|Follow-up|Includes 78 participants with study follow-up terminated by sponsor and 12 deaths|90
2969686|NCT00791778|3684213|FG000|NOT COMPLETED|Follow-up||5
2969687|NCT00791778|3684214|FG001|NOT COMPLETED|Follow-up||1
2969688|NCT00791817|3684222|FG000|STARTED|1: Single Dose Followed by Week Washout||5
2969689|NCT00791817|3684223|FG001|STARTED|1: Single Dose Followed by Week Washout||5
2969690|NCT00791817|3684222|FG000|COMPLETED|1: Single Dose Followed by Week Washout||5
2969691|NCT00791817|3684223|FG001|COMPLETED|1: Single Dose Followed by Week Washout||5
2969692|NCT00791817|3684222|FG000|NOT COMPLETED|1: Single Dose Followed by Week Washout||0
2969693|NCT00791817|3684223|FG001|NOT COMPLETED|1: Single Dose Followed by Week Washout||0
2969694|NCT00791817|3684222|FG000|STARTED|2: Single Dose||5
2969695|NCT00791817|3684223|FG001|STARTED|2: Single Dose||5
2969696|NCT00791817|3684222|FG000|COMPLETED|2: Single Dose||5
2969697|NCT00791817|3684223|FG001|COMPLETED|2: Single Dose||5
2969698|NCT00791817|3684222|FG000|NOT COMPLETED|2: Single Dose||0
2969699|NCT00791817|3684223|FG001|NOT COMPLETED|2: Single Dose||0
2969700|NCT00791908|3684229|FG000|STARTED|Overall Study||15
2969701|NCT00791908|3684229|FG000|COMPLETED|Overall Study||15
2969702|NCT00791908|3684229|FG000|NOT COMPLETED|Overall Study||0
2969703|NCT00791921|3684239|FG000|STARTED|Overall Study||116
2969704|NCT00791921|3684240|FG001|STARTED|Overall Study||114
2969705|NCT00791921|3684239|FG000|COMPLETED|Overall Study||82
2969706|NCT00791921|3684240|FG001|COMPLETED|Overall Study||18
2969707|NCT00791921|3684239|FG000|NOT COMPLETED|Overall Study||34
2969708|NCT00791921|3684240|FG001|NOT COMPLETED|Overall Study||96
2969709|NCT00791934|3684246|FG000|STARTED|Overall Study||63
2969710|NCT00791934|3684246|FG000|COMPLETED|Overall Study|Follow-up extended to 1 yr. 13 subjects chose not to participate in the extension.|48
2969711|NCT00791934|3684246|FG000|NOT COMPLETED|Overall Study||15
2969712|NCT00791973|3684252|FG000|STARTED|First Intervention (1 Week)||8
2969713|NCT00791973|3684253|FG001|STARTED|First Intervention (1 Week)||7
2969714|NCT00791973|3684252|FG000|COMPLETED|First Intervention (1 Week)||8
2969715|NCT00791973|3684253|FG001|COMPLETED|First Intervention (1 Week)||7
2969716|NCT00791973|3684252|FG000|NOT COMPLETED|First Intervention (1 Week)||0
2969717|NCT00791973|3684253|FG001|NOT COMPLETED|First Intervention (1 Week)||0
2969718|NCT00791973|3684252|FG000|STARTED|Washout (1 Week)||8
2969719|NCT00791973|3684253|FG001|STARTED|Washout (1 Week)||7
2969720|NCT00791973|3684252|FG000|COMPLETED|Washout (1 Week)||8
2969721|NCT00791973|3684253|FG001|COMPLETED|Washout (1 Week)||7
2969722|NCT00791973|3684252|FG000|NOT COMPLETED|Washout (1 Week)||0
2969723|NCT00791973|3684253|FG001|NOT COMPLETED|Washout (1 Week)||0
2969724|NCT00791973|3684252|FG000|STARTED|Second Intervention (1 Week)||8
2969725|NCT00791973|3684253|FG001|STARTED|Second Intervention (1 Week)||7
2969726|NCT00791973|3684252|FG000|COMPLETED|Second Intervention (1 Week)||8
2969727|NCT00791973|3684253|FG001|COMPLETED|Second Intervention (1 Week)||7
2969728|NCT00791973|3684252|FG000|NOT COMPLETED|Second Intervention (1 Week)||0
2969729|NCT00791973|3684253|FG001|NOT COMPLETED|Second Intervention (1 Week)||0
2969730|NCT00791999|3684263|FG000|STARTED|Overall Study||72
2969731|NCT00791999|3684264|FG001|STARTED|Overall Study||82
2969732|NCT00791999|3684265|FG002|STARTED|Overall Study||85
2969733|NCT00791999|3684266|FG003|STARTED|Overall Study||77
2969734|NCT00791999|3684263|FG000|COMPLETED|Overall Study||51
2969735|NCT00791999|3684264|FG001|COMPLETED|Overall Study||66
2969736|NCT00791999|3684265|FG002|COMPLETED|Overall Study||65
2969737|NCT00791999|3684266|FG003|COMPLETED|Overall Study||25
2969738|NCT00791999|3684263|FG000|NOT COMPLETED|Overall Study||21
2969739|NCT00791999|3684264|FG001|NOT COMPLETED|Overall Study||16
2969740|NCT00791999|3684265|FG002|NOT COMPLETED|Overall Study||20
2969741|NCT00791999|3684266|FG003|NOT COMPLETED|Overall Study||52
2969742|NCT00792077|3684276|FG000|STARTED|Overall Study||6
2969743|NCT00792077|3684276|FG000|Day 15+/- 3 Days|Overall Study||6
2969744|NCT00792077|3684276|FG000|Day 29+/-3 Days|Overall Study||6
2969745|NCT00792077|3684276|FG000|Day 43+/-3 Days|Overall Study||6
2969746|NCT00792077|3684276|FG000|Day 57+/-3 Days|Overall Study||6
2969747|NCT00792077|3684276|FG000|COMPLETED|Overall Study||6
2969748|NCT00792077|3684276|FG000|NOT COMPLETED|Overall Study||0
2969749|NCT00792103|3684280|FG000|STARTED|Overall Study|15 subjects were enrolled but did not treat for a total of 183 subjects in the safety population|198
2969750|NCT00792103|3684280|FG000|COMPLETED|Overall Study||65
2969751|NCT00792103|3684280|FG000|NOT COMPLETED|Overall Study||133
2969752|NCT00792142|3684284|FG000|STARTED|Overall Study||45
2969753|NCT00792142|3684284|FG000|COMPLETED|Overall Study||45
2969754|NCT00792142|3684284|FG000|NOT COMPLETED|Overall Study||0
2969755|NCT00792298|3684288|FG000|STARTED|Treatment Period 1||31
2969756|NCT00792298|3684289|FG001|STARTED|Treatment Period 1||32
2969757|NCT00792298|3684290|FG002|STARTED|Treatment Period 1||33
2969758|NCT00792298|3684291|FG003|STARTED|Treatment Period 1||32
2969759|NCT00792298|3684292|FG004|STARTED|Treatment Period 1||32
2969760|NCT00792298|3684293|FG005|STARTED|Treatment Period 1||32
2969761|NCT00792298|3684294|FG006|STARTED|Treatment Period 1||31
2969762|NCT00792298|3684295|FG007|STARTED|Treatment Period 1||31
2969763|NCT00792298|3684288|FG000|COMPLETED|Treatment Period 1||30
2969764|NCT00792298|3684289|FG001|COMPLETED|Treatment Period 1||31
2969765|NCT00792298|3684290|FG002|COMPLETED|Treatment Period 1||31
2969766|NCT00792298|3684291|FG003|COMPLETED|Treatment Period 1||28
2969767|NCT00792298|3684292|FG004|COMPLETED|Treatment Period 1||32
2969768|NCT00792298|3684293|FG005|COMPLETED|Treatment Period 1||29
2969769|NCT00792298|3684294|FG006|COMPLETED|Treatment Period 1||27
2969770|NCT00792298|3684295|FG007|COMPLETED|Treatment Period 1||30
2969771|NCT00792298|3684288|FG000|NOT COMPLETED|Treatment Period 1||1
2969772|NCT00792298|3684289|FG001|NOT COMPLETED|Treatment Period 1||1
2969773|NCT00792298|3684290|FG002|NOT COMPLETED|Treatment Period 1||2
2969774|NCT00792298|3684291|FG003|NOT COMPLETED|Treatment Period 1||4
2969775|NCT00792298|3684292|FG004|NOT COMPLETED|Treatment Period 1||0
2969776|NCT00792298|3684293|FG005|NOT COMPLETED|Treatment Period 1||3
2969777|NCT00792298|3684294|FG006|NOT COMPLETED|Treatment Period 1||4
2969778|NCT00792298|3684295|FG007|NOT COMPLETED|Treatment Period 1||1
2969779|NCT00792298|3684288|FG000|STARTED|Washout||30
2969780|NCT00792298|3684289|FG001|STARTED|Washout||31
2969781|NCT00792298|3684290|FG002|STARTED|Washout|1 participant discontinued therapy during Period 1 but entered the Washout as allowed per protocol|32
2969782|NCT00792298|3684291|FG003|STARTED|Washout||28
2969783|NCT00792298|3684292|FG004|STARTED|Washout||32
2969784|NCT00792298|3684293|FG005|STARTED|Washout||29
2969785|NCT00792298|3684294|FG006|STARTED|Washout|2 participants discontinued therapy during Period 1 but entered the Washout as allowed per protocol|29
2969786|NCT00792298|3684295|FG007|STARTED|Washout||30
2969787|NCT00792298|3684288|FG000|COMPLETED|Washout||30
2969788|NCT00792298|3684289|FG001|COMPLETED|Washout||31
2969789|NCT00792298|3684290|FG002|COMPLETED|Washout||31
2969790|NCT00792298|3684291|FG003|COMPLETED|Washout||28
2969791|NCT00792298|3684292|FG004|COMPLETED|Washout||32
2969792|NCT00792298|3684293|FG005|COMPLETED|Washout||27
2969793|NCT00792298|3684294|FG006|COMPLETED|Washout||29
2969794|NCT00792298|3684295|FG007|COMPLETED|Washout||30
2969795|NCT00792298|3684288|FG000|NOT COMPLETED|Washout||0
2969796|NCT00792298|3684289|FG001|NOT COMPLETED|Washout||0
2969797|NCT00792298|3684290|FG002|NOT COMPLETED|Washout||1
2969798|NCT00792298|3684291|FG003|NOT COMPLETED|Washout||0
2969799|NCT00792298|3684292|FG004|NOT COMPLETED|Washout||0
2969800|NCT00792298|3684293|FG005|NOT COMPLETED|Washout||2
2969801|NCT00792298|3684294|FG006|NOT COMPLETED|Washout||0
2969802|NCT00792298|3684295|FG007|NOT COMPLETED|Washout||0
2969803|NCT00792298|3684288|FG000|STARTED|Treatment Period 2||30
2969804|NCT00792298|3684289|FG001|STARTED|Treatment Period 2||31
2969805|NCT00792298|3684290|FG002|STARTED|Treatment Period 2||31
2969806|NCT00792298|3684291|FG003|STARTED|Treatment Period 2||28
2969807|NCT00792298|3684292|FG004|STARTED|Treatment Period 2||32
2969808|NCT00792298|3684293|FG005|STARTED|Treatment Period 2||27
2969809|NCT00792298|3684294|FG006|STARTED|Treatment Period 2||29
2969810|NCT00792298|3684295|FG007|STARTED|Treatment Period 2||30
2969811|NCT00792298|3684288|FG000|COMPLETED|Treatment Period 2||29
2969812|NCT00792298|3684289|FG001|COMPLETED|Treatment Period 2||30
2969813|NCT00792298|3684290|FG002|COMPLETED|Treatment Period 2||30
2969814|NCT00792298|3684291|FG003|COMPLETED|Treatment Period 2||26
2969815|NCT00792298|3684292|FG004|COMPLETED|Treatment Period 2||30
2969816|NCT00792298|3684293|FG005|COMPLETED|Treatment Period 2||27
2969817|NCT00792298|3684294|FG006|COMPLETED|Treatment Period 2||28
2969818|NCT00792298|3684295|FG007|COMPLETED|Treatment Period 2||28
2969819|NCT00792298|3684288|FG000|NOT COMPLETED|Treatment Period 2||1
2969820|NCT00792298|3684289|FG001|NOT COMPLETED|Treatment Period 2||1
2969821|NCT00792298|3684290|FG002|NOT COMPLETED|Treatment Period 2||1
2969822|NCT00792298|3684291|FG003|NOT COMPLETED|Treatment Period 2||2
2969823|NCT00792298|3684292|FG004|NOT COMPLETED|Treatment Period 2||2
2969824|NCT00792298|3684293|FG005|NOT COMPLETED|Treatment Period 2||0
2969825|NCT00792298|3684294|FG006|NOT COMPLETED|Treatment Period 2||1
2969826|NCT00792298|3684295|FG007|NOT COMPLETED|Treatment Period 2||2
2969827|NCT00792428|3684314|FG000|STARTED|Overall Study||10
2969828|NCT00792428|3684315|FG001|STARTED|Overall Study||10
2969829|NCT00792428|3684314|FG000|COMPLETED|Overall Study||10
2969830|NCT00792428|3684315|FG001|COMPLETED|Overall Study||10
2969831|NCT00792428|3684314|FG000|NOT COMPLETED|Overall Study||0
2969832|NCT00792428|3684315|FG001|NOT COMPLETED|Overall Study||0
2969833|NCT00792467|3684321|FG000|STARTED|Overall Study||24
2969834|NCT00792467|3684321|FG000|COMPLETED|Overall Study||2
2969835|NCT00792467|3684321|FG000|NOT COMPLETED|Overall Study||22
2969836|NCT00792571|3684326|FG000|STARTED|Overall Study||18
2969837|NCT00792571|3684326|FG000|COMPLETED|Overall Study||8
2969838|NCT00792571|3684326|FG000|NOT COMPLETED|Overall Study||10
2969839|NCT00792610|3684330|FG000|STARTED|Overall Study||127
2969840|NCT00792610|3684330|FG000|Youths|Overall Study||127
2969841|NCT00792610|3684330|FG000|COMPLETED|Overall Study||127
2969842|NCT00792610|3684330|FG000|NOT COMPLETED|Overall Study||0
2969843|NCT00792623|3684334|FG000|STARTED|Overall Study||29
2969844|NCT00792623|3684334|FG000|COMPLETED|Overall Study||22
2969845|NCT00792623|3684334|FG000|NOT COMPLETED|Overall Study||7
2969846|NCT00792636|3684342|FG000|STARTED|Overall Study||135
2969847|NCT00792636|3684343|FG001|STARTED|Overall Study||136
2969848|NCT00792636|3684344|FG002|STARTED|Overall Study||136
2969849|NCT00792636|3684342|FG000|COMPLETED|Overall Study||67
2969850|NCT00792636|3684343|FG001|COMPLETED|Overall Study||55
2969851|NCT00792636|3684344|FG002|COMPLETED|Overall Study||55
2969852|NCT00792636|3684342|FG000|NOT COMPLETED|Overall Study||68
2969853|NCT00792636|3684343|FG001|NOT COMPLETED|Overall Study||81
2969854|NCT00792636|3684344|FG002|NOT COMPLETED|Overall Study||81
2969855|NCT00792688|3684357|FG000|STARTED|Overall Study||9
2969856|NCT00792688|3684358|FG001|STARTED|Overall Study||8
2969857|NCT00792688|3684359|FG002|STARTED|Overall Study||9
2969858|NCT00792688|3684357|FG000|COMPLETED|Overall Study||9
2969859|NCT00792688|3684358|FG001|COMPLETED|Overall Study||8
2969860|NCT00792688|3684359|FG002|COMPLETED|Overall Study||9
3302072|NCT02958826|4035743|FG001|NOT COMPLETED|Overall Study||0
3302073|NCT02958956|4035753|FG000|STARTED|Overall Study||38190
3302074|NCT02958956|4035754|FG001|STARTED|Overall Study||198317
3302075|NCT02958956|4035753|FG000|COMPLETED|Overall Study||38190
3302076|NCT02958956|4035754|FG001|COMPLETED|Overall Study||198317
3302077|NCT02958956|4035753|FG000|NOT COMPLETED|Overall Study||0
2969861|NCT00792688|3684357|FG000|NOT COMPLETED|Overall Study||0
2969862|NCT00792688|3684358|FG001|NOT COMPLETED|Overall Study||0
2969863|NCT00792688|3684359|FG002|NOT COMPLETED|Overall Study||0
2969864|NCT00792701|3684369|FG000|STARTED|Overall Study||19
2969865|NCT00792701|3684370|FG001|STARTED|Overall Study||66
2969866|NCT00792701|3684369|FG000|Eligible|Overall Study||18
2969867|NCT00792701|3684370|FG001|Eligible|Overall Study||63
2969868|NCT00792701|3684369|FG000|Eligible and Analyzable|Overall Study||17
2969869|NCT00792701|3684370|FG001|Eligible and Analyzable|Overall Study||44
2969870|NCT00792701|3684369|FG000|COMPLETED|Overall Study||0
2969871|NCT00792701|3684370|FG001|COMPLETED|Overall Study||22
2969872|NCT00792701|3684369|FG000|NOT COMPLETED|Overall Study||19
2969873|NCT00792701|3684370|FG001|NOT COMPLETED|Overall Study||44
2969874|NCT00792805|3684381|FG000|STARTED|Overall Study||188
2969875|NCT00792805|3684382|FG001|STARTED|Overall Study||188
2969876|NCT00792805|3684383|FG002|STARTED|Overall Study||187
2969877|NCT00792805|3684381|FG000|Exposed to Study Medication or Placebo|Overall Study|One patient in this group did not receive any study treatment.|187
2969878|NCT00792805|3684382|FG001|Exposed to Study Medication or Placebo|Overall Study||188
2969879|NCT00792805|3684383|FG002|Exposed to Study Medication or Placebo|Overall Study|One patient in this group did not receive any study treatment.|186
2969880|NCT00792805|3684381|FG000|COMPLETED|Overall Study||166
2969881|NCT00792805|3684382|FG001|COMPLETED|Overall Study||162
2969882|NCT00792805|3684383|FG002|COMPLETED|Overall Study||154
2969883|NCT00792805|3684381|FG000|NOT COMPLETED|Overall Study||22
2969884|NCT00792805|3684382|FG001|NOT COMPLETED|Overall Study||26
2969885|NCT00792805|3684383|FG002|NOT COMPLETED|Overall Study||33
2969886|NCT00792909|3684394|FG000|STARTED|Overall Study||51
2969887|NCT00792909|3684395|FG001|STARTED|Overall Study||59
2969888|NCT00792909|3684396|FG002|STARTED|Overall Study||62
2969889|NCT00792909|3684394|FG000|COMPLETED|Overall Study||51
2969890|NCT00792909|3684395|FG001|COMPLETED|Overall Study||58
2969891|NCT00792909|3684396|FG002|COMPLETED|Overall Study||62
3302078|NCT02958956|4035754|FG001|NOT COMPLETED|Overall Study||0
3302079|NCT02958969|4035761|FG000|STARTED|Overall Study||50
3302080|NCT02958969|4035761|FG000|COMPLETED|Overall Study||50
2969892|NCT00792909|3684394|FG000|NOT COMPLETED|Overall Study||0
2969893|NCT00792909|3684395|FG001|NOT COMPLETED|Overall Study||1
2969894|NCT00792909|3684396|FG002|NOT COMPLETED|Overall Study||0
2969895|NCT00792922|3684411|FG000|STARTED|At Baseline|the trial was conducted at community level and data reported per community basis|
2969896|NCT00792922|3684412|FG001|STARTED|At Baseline|the trial was conducted at community level and data reported per community basis|
2969897|NCT00792922|3684413|FG002|STARTED|At Baseline|the trial was conducted at community level and data reported per community basis|
2969898|NCT00792922|3684414|FG003|STARTED|At Baseline|the trial was conducted at community level and data reported per community basis|
2969899|NCT00792922|3684411|FG000|Niger|At Baseline|the trial was conducted at community level and data reported per community basis|
2969900|NCT00792922|3684412|FG001|Niger|At Baseline|the trial was conducted at community level and data reported per community basis|
2969901|NCT00792922|3684413|FG002|Niger|At Baseline|the trial was conducted at community level and data reported per community basis|
2969902|NCT00792922|3684414|FG003|Niger|At Baseline|the trial was conducted at community level and data reported per community basis|
2969903|NCT00792922|3684411|FG000|Gambia|At Baseline|the trial was conducted at community level and data reported per community basis|
2969904|NCT00792922|3684412|FG001|Gambia|At Baseline|the trial was conducted at community level and data reported per community basis|
2969905|NCT00792922|3684413|FG002|Gambia|At Baseline|the trial was conducted at community level and data reported per community basis|
2969906|NCT00792922|3684414|FG003|Gambia|At Baseline|the trial was conducted at community level and data reported per community basis|
2969907|NCT00792922|3684411|FG000|Tanzania|At Baseline|the trial was conducted at community level and data reported per community basis|
2969908|NCT00792922|3684412|FG001|Tanzania|At Baseline|the trial was conducted at community level and data reported per community basis|
3133205|NCT01695239|3858317|FG012|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
3133206|NCT01695239|3858318|FG013|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
3133207|NCT01695239|3858305|FG000|COMPLETED|Double-Blind (DB) Treatment Period||91
3133208|NCT01695239|3858306|FG001|COMPLETED|Double-Blind (DB) Treatment Period||97
3133209|NCT01695239|3858307|FG002|COMPLETED|Double-Blind (DB) Treatment Period||97
3133210|NCT01695239|3858308|FG003|COMPLETED|Double-Blind (DB) Treatment Period||96
3302081|NCT02958969|4035761|FG000|NOT COMPLETED|Overall Study||0
3302082|NCT02958982|4035776|FG000|STARTED|Cohort 1: 25 mg in SAD Study||1
3302083|NCT02958982|4035777|FG001|STARTED|Cohort 1: 25 mg in SAD Study||3
3302084|NCT02958982|4035778|FG002|STARTED|Cohort 1: 25 mg in SAD Study||0
3302085|NCT02958982|4035779|FG003|STARTED|Cohort 1: 25 mg in SAD Study||0
3302086|NCT02958982|4035780|FG004|STARTED|Cohort 1: 25 mg in SAD Study||0
3302087|NCT02958982|4035781|FG005|STARTED|Cohort 1: 25 mg in SAD Study||0
3302088|NCT02958982|4035782|FG006|STARTED|Cohort 1: 25 mg in SAD Study||0
3302089|NCT02958982|4035783|FG007|STARTED|Cohort 1: 25 mg in SAD Study||0
3302090|NCT02958982|4035784|FG008|STARTED|Cohort 1: 25 mg in SAD Study||0
3302091|NCT02958982|4035785|FG009|STARTED|Cohort 1: 25 mg in SAD Study||0
3302092|NCT02958982|4035786|FG010|STARTED|Cohort 1: 25 mg in SAD Study||0
3302093|NCT02958982|4035776|FG000|COMPLETED|Cohort 1: 25 mg in SAD Study||1
3302094|NCT02958982|4035777|FG001|COMPLETED|Cohort 1: 25 mg in SAD Study||3
3302095|NCT02958982|4035778|FG002|COMPLETED|Cohort 1: 25 mg in SAD Study||0
3302096|NCT02958982|4035779|FG003|COMPLETED|Cohort 1: 25 mg in SAD Study||0
3302097|NCT02958982|4035780|FG004|COMPLETED|Cohort 1: 25 mg in SAD Study||0
3302098|NCT02958982|4035781|FG005|COMPLETED|Cohort 1: 25 mg in SAD Study||0
3302099|NCT02958982|4035782|FG006|COMPLETED|Cohort 1: 25 mg in SAD Study||0
3302100|NCT02958982|4035783|FG007|COMPLETED|Cohort 1: 25 mg in SAD Study||0
3302101|NCT02958982|4035784|FG008|COMPLETED|Cohort 1: 25 mg in SAD Study||0
3302102|NCT02958982|4035785|FG009|COMPLETED|Cohort 1: 25 mg in SAD Study||0
3302103|NCT02958982|4035786|FG010|COMPLETED|Cohort 1: 25 mg in SAD Study||0
3302104|NCT02958982|4035776|FG000|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
3302105|NCT02958982|4035777|FG001|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
3302106|NCT02958982|4035778|FG002|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
2969909|NCT00792922|3684413|FG002|Tanzania|At Baseline|the trial was conducted at community level and data reported per community basis|
2969910|NCT00792922|3684414|FG003|Tanzania|At Baseline|the trial was conducted at community level and data reported per community basis|
2969911|NCT00792922|3684411|FG000|COMPLETED|At Baseline|the trial was conducted at community level and data reported per community basis|
2969912|NCT00792922|3684412|FG001|COMPLETED|At Baseline|the trial was conducted at community level and data reported per community basis|
2969913|NCT00792922|3684413|FG002|COMPLETED|At Baseline|the trial was conducted at community level and data reported per community basis|
2969914|NCT00792922|3684414|FG003|COMPLETED|At Baseline|the trial was conducted at community level and data reported per community basis|
2969915|NCT00792922|3684411|FG000|NOT COMPLETED|At Baseline||
2969916|NCT00792922|3684412|FG001|NOT COMPLETED|At Baseline||
2969917|NCT00792922|3684413|FG002|NOT COMPLETED|At Baseline||
2969918|NCT00792922|3684414|FG003|NOT COMPLETED|At Baseline||
2969919|NCT00792922|3684411|FG000|STARTED|At 3 Years|"In Tanzania, units in treatment arm analyzed with antibiotic arm as tf rate was not <5% by 18 months~the trial was conducted at community level and data reported per community basis"|
2969920|NCT00792922|3684412|FG001|STARTED|At 3 Years|"In Tanzania, units in treatment arm analyzed with antibiotic arm as tf rate was not <5% by 18 months~the trial was conducted at community level and data reported per community basis"|
2969921|NCT00792922|3684413|FG002|STARTED|At 3 Years|"In Tanzania, units in treatment arm analyzed with antibiotic arm as tf rate was not <5% by 18 months~the trial was conducted at community level and data reported per community basis"|
3133211|NCT01695239|3858309|FG004|COMPLETED|Double-Blind (DB) Treatment Period||0
3133212|NCT01695239|3858310|FG005|COMPLETED|Double-Blind (DB) Treatment Period||0
3133213|NCT01695239|3858311|FG006|COMPLETED|Double-Blind (DB) Treatment Period||0
3133214|NCT01695239|3858312|FG007|COMPLETED|Double-Blind (DB) Treatment Period||0
3133215|NCT01695239|3858313|FG008|COMPLETED|Double-Blind (DB) Treatment Period||0
3302107|NCT02958982|4035779|FG003|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
3302108|NCT02958982|4035780|FG004|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
3302109|NCT02958982|4035781|FG005|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
3302110|NCT02958982|4035782|FG006|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
3302111|NCT02958982|4035783|FG007|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
3302112|NCT02958982|4035784|FG008|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
3302113|NCT02958982|4035785|FG009|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
3302114|NCT02958982|4035786|FG010|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
3302115|NCT02958982|4035776|FG000|STARTED|Cohort 2: 50 mg in SAD Study||2
3302116|NCT02958982|4035777|FG001|STARTED|Cohort 2: 50 mg in SAD Study||0
3302117|NCT02958982|4035778|FG002|STARTED|Cohort 2: 50 mg in SAD Study||4
3302118|NCT02958982|4035779|FG003|STARTED|Cohort 2: 50 mg in SAD Study||0
3302119|NCT02958982|4035780|FG004|STARTED|Cohort 2: 50 mg in SAD Study||0
3302120|NCT02958982|4035781|FG005|STARTED|Cohort 2: 50 mg in SAD Study||0
3302121|NCT02958982|4035782|FG006|STARTED|Cohort 2: 50 mg in SAD Study||0
3302122|NCT02958982|4035783|FG007|STARTED|Cohort 2: 50 mg in SAD Study||0
3302123|NCT02958982|4035784|FG008|STARTED|Cohort 2: 50 mg in SAD Study||0
3302124|NCT02958982|4035785|FG009|STARTED|Cohort 2: 50 mg in SAD Study||0
3302125|NCT02958982|4035786|FG010|STARTED|Cohort 2: 50 mg in SAD Study||0
3302126|NCT02958982|4035776|FG000|COMPLETED|Cohort 2: 50 mg in SAD Study||2
3302127|NCT02958982|4035777|FG001|COMPLETED|Cohort 2: 50 mg in SAD Study||0
3302128|NCT02958982|4035778|FG002|COMPLETED|Cohort 2: 50 mg in SAD Study||4
3302129|NCT02958982|4035779|FG003|COMPLETED|Cohort 2: 50 mg in SAD Study||0
3302130|NCT02958982|4035780|FG004|COMPLETED|Cohort 2: 50 mg in SAD Study||0
3302131|NCT02958982|4035781|FG005|COMPLETED|Cohort 2: 50 mg in SAD Study||0
3302132|NCT02958982|4035782|FG006|COMPLETED|Cohort 2: 50 mg in SAD Study||0
3302133|NCT02958982|4035783|FG007|COMPLETED|Cohort 2: 50 mg in SAD Study||0
3302134|NCT02958982|4035784|FG008|COMPLETED|Cohort 2: 50 mg in SAD Study||0
3302135|NCT02958982|4035785|FG009|COMPLETED|Cohort 2: 50 mg in SAD Study||0
3302136|NCT02958982|4035786|FG010|COMPLETED|Cohort 2: 50 mg in SAD Study||0
3302137|NCT02958982|4035776|FG000|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
3302138|NCT02958982|4035777|FG001|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
3302139|NCT02958982|4035778|FG002|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
3302140|NCT02958982|4035779|FG003|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
3302141|NCT02958982|4035780|FG004|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
3302142|NCT02958982|4035781|FG005|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
3302143|NCT02958982|4035782|FG006|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
3302144|NCT02958982|4035783|FG007|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
3302145|NCT02958982|4035784|FG008|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
3302146|NCT02958982|4035785|FG009|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
3302147|NCT02958982|4035786|FG010|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
3302148|NCT02958982|4035776|FG000|STARTED|Cohort 3: 100 mg in SAD Study||2
3302149|NCT02958982|4035777|FG001|STARTED|Cohort 3: 100 mg in SAD Study||0
3302150|NCT02958982|4035778|FG002|STARTED|Cohort 3: 100 mg in SAD Study||0
3302151|NCT02958982|4035779|FG003|STARTED|Cohort 3: 100 mg in SAD Study||4
3302152|NCT02958982|4035780|FG004|STARTED|Cohort 3: 100 mg in SAD Study||0
3302153|NCT02958982|4035781|FG005|STARTED|Cohort 3: 100 mg in SAD Study||0
3302154|NCT02958982|4035782|FG006|STARTED|Cohort 3: 100 mg in SAD Study||0
3302155|NCT02958982|4035783|FG007|STARTED|Cohort 3: 100 mg in SAD Study||0
3302156|NCT02958982|4035784|FG008|STARTED|Cohort 3: 100 mg in SAD Study||0
3302157|NCT02958982|4035785|FG009|STARTED|Cohort 3: 100 mg in SAD Study||0
3302158|NCT02958982|4035786|FG010|STARTED|Cohort 3: 100 mg in SAD Study||0
2969922|NCT00792922|3684414|FG003|STARTED|At 3 Years|"In Tanzania, units in treatment arm analyzed with antibiotic arm as tf rate was not <5% by 18 months~the trial was conducted at community level and data reported per community basis"|
2969923|NCT00792922|3684411|FG000|Niger|At 3 Years|the trial was conducted at community level and data reported per community basis|
2969924|NCT00792922|3684412|FG001|Niger|At 3 Years|the trial was conducted at community level and data reported per community basis|
2969925|NCT00792922|3684413|FG002|Niger|At 3 Years|the trial was conducted at community level and data reported per community basis|
2969926|NCT00792922|3684414|FG003|Niger|At 3 Years|the trial was conducted at community level and data reported per community basis|
2969927|NCT00792922|3684411|FG000|Gambia|At 3 Years|the trial was conducted at community level and data reported per community basis|
2969928|NCT00792922|3684412|FG001|Gambia|At 3 Years|the trial was conducted at community level and data reported per community basis|
2969929|NCT00792922|3684413|FG002|Gambia|At 3 Years|the trial was conducted at community level and data reported per community basis|
2969930|NCT00792922|3684414|FG003|Gambia|At 3 Years|the trial was conducted at community level and data reported per community basis|
2969931|NCT00792922|3684411|FG000|Tanzania|At 3 Years|the trial was conducted at community level and data reported per community basis|
2969932|NCT00792922|3684412|FG001|Tanzania|At 3 Years|the trial was conducted at community level and data reported per community basis|
2969933|NCT00792922|3684413|FG002|Tanzania|At 3 Years|the trial was conducted at community level and data reported per community basis|
2969934|NCT00792922|3684414|FG003|Tanzania|At 3 Years|the trial was conducted at community level and data reported per community basis|
2969935|NCT00792922|3684411|FG000|COMPLETED|At 3 Years|the trial was conducted at community level and data reported per community basis|
2969936|NCT00792922|3684412|FG001|COMPLETED|At 3 Years|the trial was conducted at community level and data reported per community basis|
2969937|NCT00792922|3684413|FG002|COMPLETED|At 3 Years|the trial was conducted at community level and data reported per community basis|
2969938|NCT00792922|3684414|FG003|COMPLETED|At 3 Years|the trial was conducted at community level and data reported per community basis|
2969939|NCT00792922|3684411|FG000|NOT COMPLETED|At 3 Years||
2969940|NCT00792922|3684412|FG001|NOT COMPLETED|At 3 Years||
2969941|NCT00792922|3684413|FG002|NOT COMPLETED|At 3 Years||
2969942|NCT00792922|3684414|FG003|NOT COMPLETED|At 3 Years||
2969943|NCT00792935|3684428|FG000|STARTED|Overall Study||72
2969944|NCT00792935|3684429|FG001|STARTED|Overall Study||71
2969945|NCT00792935|3684428|FG000|COMPLETED|Overall Study||68
2969946|NCT00792935|3684429|FG001|COMPLETED|Overall Study||68
2969947|NCT00792935|3684428|FG000|NOT COMPLETED|Overall Study||4
2969948|NCT00792935|3684429|FG001|NOT COMPLETED|Overall Study||3
2969949|NCT00793104|3684435|FG000|STARTED|Overall Study||10
2969950|NCT00793104|3684435|FG000|COMPLETED|Overall Study||9
2969951|NCT00793104|3684435|FG000|NOT COMPLETED|Overall Study||1
2969952|NCT00793182|3684441|FG000|STARTED|Overall Study||2
2969953|NCT00793182|3684442|FG001|STARTED|Overall Study||4
2969954|NCT00793182|3684441|FG000|COMPLETED|Overall Study||2
2969955|NCT00793182|3684442|FG001|COMPLETED|Overall Study||3
2969956|NCT00793182|3684441|FG000|NOT COMPLETED|Overall Study||0
2969957|NCT00793182|3684442|FG001|NOT COMPLETED|Overall Study||1
2969958|NCT00793325|3684448|FG000|STARTED|Overall Study||909
2969959|NCT00793325|3684448|FG000|COMPLETED|Overall Study||890
2969960|NCT00793325|3684448|FG000|NOT COMPLETED|Overall Study||19
2969961|NCT00793403|3684471|FG000|STARTED|Overall Study||293
2969962|NCT00793403|3684471|FG000|COMPLETED|Overall Study||220
2969963|NCT00793403|3684471|FG000|NOT COMPLETED|Overall Study||73
2969964|NCT00793455|3684477|FG000|STARTED|Overall Study||314
2969965|NCT00793455|3684478|FG001|STARTED|Overall Study||314
2969966|NCT00793455|3684477|FG000|COMPLETED|Overall Study||314
2969967|NCT00793455|3684478|FG001|COMPLETED|Overall Study||314
2969968|NCT00793455|3684477|FG000|NOT COMPLETED|Overall Study||0
2969969|NCT00793455|3684478|FG001|NOT COMPLETED|Overall Study||0
2969970|NCT00793546|3684487|FG000|STARTED|Overall Study||14
2969971|NCT00793546|3684488|FG001|STARTED|Overall Study||28
2969972|NCT00793546|3684487|FG000|COMPLETED|Overall Study||0
2969973|NCT00793546|3684488|FG001|COMPLETED|Overall Study||0
2969974|NCT00793546|3684487|FG000|NOT COMPLETED|Overall Study||14
2969975|NCT00793546|3684488|FG001|NOT COMPLETED|Overall Study||28
2969976|NCT00793572|3684496|FG000|STARTED|Overall Study||32
2969977|NCT00793572|3684496|FG000|COMPLETED|Overall Study||32
2969978|NCT00793572|3684496|FG000|NOT COMPLETED|Overall Study||0
2969979|NCT00793585|3684502|FG000|STARTED|Overall Study||19
2969980|NCT00793585|3684503|FG001|STARTED|Overall Study||21
2969981|NCT00793585|3684502|FG000|COMPLETED|Overall Study||17
2969982|NCT00793585|3684503|FG001|COMPLETED|Overall Study||18
2969983|NCT00793585|3684502|FG000|NOT COMPLETED|Overall Study||2
2969984|NCT00793585|3684503|FG001|NOT COMPLETED|Overall Study||3
2969985|NCT00793598|3684514|FG000|STARTED|Overall Study||1
2969986|NCT00793598|3684515|FG001|STARTED|Overall Study||1
2969987|NCT00793598|3684516|FG002|STARTED|Overall Study||1
2969988|NCT00793598|3684517|FG003|STARTED|Overall Study||2
2969989|NCT00793598|3684518|FG004|STARTED|Overall Study||8
2969990|NCT00793598|3684519|FG005|STARTED|Overall Study||8
2969991|NCT00793598|3684520|FG006|STARTED|Overall Study||4
2969992|NCT00793598|3684521|FG007|STARTED|Overall Study||4
2969993|NCT00793598|3684514|FG000|COMPLETED|Overall Study||1
2969994|NCT00793598|3684515|FG001|COMPLETED|Overall Study||0
2969995|NCT00793598|3684516|FG002|COMPLETED|Overall Study||1
2969996|NCT00793598|3684517|FG003|COMPLETED|Overall Study||2
2969997|NCT00793598|3684518|FG004|COMPLETED|Overall Study||8
2969998|NCT00793598|3684519|FG005|COMPLETED|Overall Study||7
2969999|NCT00793598|3684520|FG006|COMPLETED|Overall Study||4
2970000|NCT00793598|3684521|FG007|COMPLETED|Overall Study||3
2970001|NCT00793598|3684514|FG000|NOT COMPLETED|Overall Study||0
2970002|NCT00793598|3684515|FG001|NOT COMPLETED|Overall Study||1
2970003|NCT00793598|3684516|FG002|NOT COMPLETED|Overall Study||0
2970004|NCT00793598|3684517|FG003|NOT COMPLETED|Overall Study||0
2970005|NCT00793598|3684518|FG004|NOT COMPLETED|Overall Study||0
2970006|NCT00793598|3684519|FG005|NOT COMPLETED|Overall Study||1
2970007|NCT00793598|3684520|FG006|NOT COMPLETED|Overall Study||0
2970008|NCT00793598|3684521|FG007|NOT COMPLETED|Overall Study||1
2970009|NCT00793611|3684545|FG000|STARTED|Overall Study||10
2970010|NCT00793611|3684546|FG001|STARTED|Overall Study||10
2970011|NCT00793611|3684545|FG000|COMPLETED|Overall Study||10
2970012|NCT00793611|3684546|FG001|COMPLETED|Overall Study||10
2970013|NCT00793611|3684545|FG000|NOT COMPLETED|Overall Study||0
2970014|NCT00793611|3684546|FG001|NOT COMPLETED|Overall Study||0
2970015|NCT00793624|3684556|FG000|STARTED|Overall Study||225
2970016|NCT00793624|3684557|FG001|STARTED|Overall Study||227
2970017|NCT00793624|3684558|FG002|STARTED|Overall Study||225
2970018|NCT00793624|3684559|FG003|STARTED|Overall Study||227
2970019|NCT00793624|3684556|FG000|COMPLETED|Overall Study||168
2970020|NCT00793624|3684557|FG001|COMPLETED|Overall Study||191
2970021|NCT00793624|3684558|FG002|COMPLETED|Overall Study||186
2970022|NCT00793624|3684559|FG003|COMPLETED|Overall Study||184
2970023|NCT00793624|3684556|FG000|NOT COMPLETED|Overall Study||57
2970024|NCT00793624|3684557|FG001|NOT COMPLETED|Overall Study||36
2970025|NCT00793624|3684558|FG002|NOT COMPLETED|Overall Study||39
2970026|NCT00793624|3684559|FG003|NOT COMPLETED|Overall Study||43
2970027|NCT00793650|3684579|FG000|STARTED|Overall Study||19
2970028|NCT00793650|3684580|FG001|STARTED|Overall Study||20
2970029|NCT00793650|3684579|FG000|COMPLETED|Overall Study||19
2970030|NCT00793650|3684580|FG001|COMPLETED|Overall Study||20
2970031|NCT00793650|3684579|FG000|NOT COMPLETED|Overall Study||0
2970032|NCT00793650|3684580|FG001|NOT COMPLETED|Overall Study||0
2970033|NCT00793780|3684590|FG000|STARTED|Overall Study||12
2970034|NCT00793780|3684591|FG001|STARTED|Overall Study||12
2970035|NCT00793780|3684590|FG000|Randomization|Overall Study||12
2970036|NCT00793780|3684591|FG001|Randomization|Overall Study||12
2970037|NCT00793780|3684590|FG000|Collected Baseline Data|Overall Study||11
2970038|NCT00793780|3684591|FG001|Collected Baseline Data|Overall Study||12
2970039|NCT00793780|3684590|FG000|COMPLETED|Overall Study||10
2970040|NCT00793780|3684591|FG001|COMPLETED|Overall Study||11
2970041|NCT00793780|3684590|FG000|NOT COMPLETED|Overall Study||2
2970042|NCT00793780|3684591|FG001|NOT COMPLETED|Overall Study||1
2970043|NCT00793793|3684609|FG000|STARTED|Overall Study||8
2970044|NCT00793793|3684610|FG001|STARTED|Overall Study||6
2970045|NCT00793793|3684611|FG002|STARTED|Overall Study||7
2970046|NCT00793793|3684612|FG003|STARTED|Overall Study||7
2970047|NCT00793793|3684613|FG004|STARTED|Overall Study||6
2970048|NCT00793793|3684614|FG005|STARTED|Overall Study||6
2970049|NCT00793793|3684615|FG006|STARTED|Overall Study||7
2970050|NCT00793793|3684616|FG007|STARTED|Overall Study||6
2970051|NCT00793793|3684617|FG008|STARTED|Overall Study||15
2970052|NCT00793793|3684618|FG009|STARTED|Overall Study||15
2970053|NCT00793793|3684619|FG010|STARTED|Overall Study||6
2970054|NCT00793793|3684620|FG011|STARTED|Overall Study||7
2970055|NCT00793793|3684609|FG000|COMPLETED|Overall Study||8
2970056|NCT00793793|3684610|FG001|COMPLETED|Overall Study||5
2970057|NCT00793793|3684611|FG002|COMPLETED|Overall Study||5
2970058|NCT00793793|3684612|FG003|COMPLETED|Overall Study||4
2970059|NCT00793793|3684613|FG004|COMPLETED|Overall Study||4
2970060|NCT00793793|3684614|FG005|COMPLETED|Overall Study||4
2970061|NCT00793793|3684615|FG006|COMPLETED|Overall Study||3
2970062|NCT00793793|3684616|FG007|COMPLETED|Overall Study||6
2970063|NCT00793793|3684617|FG008|COMPLETED|Overall Study||6
2970064|NCT00793793|3684618|FG009|COMPLETED|Overall Study||6
2970065|NCT00793793|3684619|FG010|COMPLETED|Overall Study||3
2970066|NCT00793793|3684620|FG011|COMPLETED|Overall Study||1
2970067|NCT00793793|3684609|FG000|NOT COMPLETED|Overall Study||0
2970068|NCT00793793|3684610|FG001|NOT COMPLETED|Overall Study||1
2970069|NCT00793793|3684611|FG002|NOT COMPLETED|Overall Study||2
2970070|NCT00793793|3684612|FG003|NOT COMPLETED|Overall Study||3
2970071|NCT00793793|3684613|FG004|NOT COMPLETED|Overall Study||2
2970072|NCT00793793|3684614|FG005|NOT COMPLETED|Overall Study||2
2970073|NCT00793793|3684615|FG006|NOT COMPLETED|Overall Study||4
2970074|NCT00793793|3684616|FG007|NOT COMPLETED|Overall Study||0
2970075|NCT00793793|3684617|FG008|NOT COMPLETED|Overall Study||9
2970076|NCT00793793|3684618|FG009|NOT COMPLETED|Overall Study||9
2970077|NCT00793793|3684619|FG010|NOT COMPLETED|Overall Study||3
2970078|NCT00793793|3684620|FG011|NOT COMPLETED|Overall Study||6
2970079|NCT00793819|3684668|FG000|STARTED|Overall Study||111
2970080|NCT00793819|3684669|FG001|STARTED|Overall Study||98
2970081|NCT00793819|3684668|FG000|COMPLETED|Overall Study||97
2970082|NCT00793819|3684669|FG001|COMPLETED|Overall Study||89
2970083|NCT00793819|3684668|FG000|NOT COMPLETED|Overall Study||14
2970084|NCT00793819|3684669|FG001|NOT COMPLETED|Overall Study||9
2970085|NCT00793871|3684675|FG000|STARTED|Overall Study||60
2970086|NCT00793871|3684675|FG000|Received Treatment|Overall Study||59
2970087|NCT00793871|3684675|FG000|COMPLETED|Overall Study||0
2970088|NCT00793871|3684675|FG000|NOT COMPLETED|Overall Study||60
2970089|NCT00793910|3684681|FG000|STARTED|Overall Study||53
2970090|NCT00793910|3684682|FG001|STARTED|Overall Study||53
2970091|NCT00793910|3684681|FG000|COMPLETED|Overall Study||48
2970092|NCT00793910|3684682|FG001|COMPLETED|Overall Study||46
2970093|NCT00793910|3684681|FG000|NOT COMPLETED|Overall Study||5
2970094|NCT00793910|3684682|FG001|NOT COMPLETED|Overall Study||7
2970095|NCT00794040|3684690|FG000|STARTED|Overall Study||25
2970096|NCT00794040|3684691|FG001|STARTED|Overall Study||28
2970097|NCT00794040|3684690|FG000|COMPLETED|Overall Study||22
2970098|NCT00794040|3684691|FG001|COMPLETED|Overall Study||23
2970099|NCT00794040|3684690|FG000|NOT COMPLETED|Overall Study||3
2970100|NCT00794040|3684691|FG001|NOT COMPLETED|Overall Study||5
3164043|NCT01890642|3891487|FG000|NOT COMPLETED|Overall Study||0
3164044|NCT01890642|3891488|FG001|NOT COMPLETED|Overall Study||0
3164045|NCT01890642|3891489|FG002|NOT COMPLETED|Overall Study||0
2970101|NCT00794118|3684697|FG000|STARTED|Overall Study||299
2970102|NCT00794118|3684697|FG000|COMPLETED|Overall Study||272
2970103|NCT00794118|3684697|FG000|NOT COMPLETED|Overall Study||27
2970104|NCT00794144|3684703|FG000|STARTED|Overall Study||66
2970105|NCT00794144|3684704|FG001|STARTED|Overall Study||66
2970106|NCT00794144|3684703|FG000|COMPLETED|Overall Study||63
2970107|NCT00794144|3684704|FG001|COMPLETED|Overall Study||63
2970108|NCT00794144|3684703|FG000|NOT COMPLETED|Overall Study||3
2970109|NCT00794144|3684704|FG001|NOT COMPLETED|Overall Study||3
2970110|NCT00794157|3684713|FG000|STARTED|Overall Study||114
2970111|NCT00794157|3684714|FG001|STARTED|Overall Study||116
2970112|NCT00794157|3684715|FG002|STARTED|Overall Study||117
2970113|NCT00794157|3684713|FG000|COMPLETED|Overall Study||104
2970114|NCT00794157|3684714|FG001|COMPLETED|Overall Study||106
2970115|NCT00794157|3684715|FG002|COMPLETED|Overall Study||98
2970116|NCT00794157|3684713|FG000|NOT COMPLETED|Overall Study||10
2970117|NCT00794157|3684714|FG001|NOT COMPLETED|Overall Study||10
2970118|NCT00794157|3684715|FG002|NOT COMPLETED|Overall Study||19
2970119|NCT00794170|3684725|FG000|STARTED|Overall Study||157
2970120|NCT00794170|3684726|FG001|STARTED|Overall Study||155
2970121|NCT00794170|3684725|FG000|COMPLETED|Overall Study||150
2970122|NCT00794170|3684726|FG001|COMPLETED|Overall Study||152
2970123|NCT00794170|3684725|FG000|NOT COMPLETED|Overall Study||7
2970124|NCT00794170|3684726|FG001|NOT COMPLETED|Overall Study||3
2970125|NCT00794196|3684734|FG000|STARTED|Overall Study||92
2970126|NCT00794196|3684735|FG001|STARTED|Overall Study||87
2970127|NCT00794196|3684734|FG000|COMPLETED|Overall Study||87
2970128|NCT00794196|3684735|FG001|COMPLETED|Overall Study||64
2970129|NCT00794196|3684734|FG000|NOT COMPLETED|Overall Study||5
2970130|NCT00794196|3684735|FG001|NOT COMPLETED|Overall Study||23
2970131|NCT00794313|3684741|FG000|STARTED|Overall Study||1
2970132|NCT00794313|3684742|FG001|STARTED|Overall Study||1
2970133|NCT00794313|3684743|FG002|STARTED|Overall Study||1
2970134|NCT00794313|3684741|FG000|COMPLETED|Overall Study||1
2970135|NCT00794313|3684742|FG001|COMPLETED|Overall Study||1
2970136|NCT00794313|3684743|FG002|COMPLETED|Overall Study||1
2970137|NCT00794313|3684741|FG000|NOT COMPLETED|Overall Study||0
2970138|NCT00794313|3684742|FG001|NOT COMPLETED|Overall Study||0
2970139|NCT00794313|3684743|FG002|NOT COMPLETED|Overall Study||0
2970140|NCT00794339|3684754|FG000|STARTED|Overall Study||73
2970141|NCT00794339|3684754|FG000|Eligible|Overall Study||69
2970142|NCT00794339|3684754|FG000|Evaluable|Overall Study||59
2970143|NCT00794339|3684754|FG000|COMPLETED|Overall Study||59
2970144|NCT00794339|3684754|FG000|NOT COMPLETED|Overall Study||14
2970145|NCT00794365|3684775|FG000|STARTED|Overall Study||330
2970146|NCT00794365|3684775|FG000|COMPLETED|Overall Study||251
2970147|NCT00794365|3684775|FG000|NOT COMPLETED|Overall Study||79
2970148|NCT00794417|3684783|FG000|STARTED|Phase 1: Baseline (Day 1) up to Day 751||4
2970149|NCT00794417|3684784|FG001|STARTED|Phase 1: Baseline (Day 1) up to Day 751||7
2970150|NCT00794417|3684785|FG002|STARTED|Phase 1: Baseline (Day 1) up to Day 751||7
2970151|NCT00794417|3684786|FG003|STARTED|Phase 1: Baseline (Day 1) up to Day 751||0
2970152|NCT00794417|3684783|FG000|COMPLETED|Phase 1: Baseline (Day 1) up to Day 751||1
2970153|NCT00794417|3684784|FG001|COMPLETED|Phase 1: Baseline (Day 1) up to Day 751||4
2970154|NCT00794417|3684785|FG002|COMPLETED|Phase 1: Baseline (Day 1) up to Day 751||4
2970155|NCT00794417|3684786|FG003|COMPLETED|Phase 1: Baseline (Day 1) up to Day 751||0
2970156|NCT00794417|3684783|FG000|NOT COMPLETED|Phase 1: Baseline (Day 1) up to Day 751||3
2970157|NCT00794417|3684784|FG001|NOT COMPLETED|Phase 1: Baseline (Day 1) up to Day 751||3
2970158|NCT00794417|3684785|FG002|NOT COMPLETED|Phase 1: Baseline (Day 1) up to Day 751||3
2970159|NCT00794417|3684786|FG003|NOT COMPLETED|Phase 1: Baseline (Day 1) up to Day 751||0
2970160|NCT00794417|3684783|FG000|STARTED|Phase 2: Baseline (Day 421) to Day 972|Participants enrolled in phase 1 were not eligible for enrollment in phase 2.|0
2970161|NCT00794417|3684784|FG001|STARTED|Phase 2: Baseline (Day 421) to Day 972|Participants enrolled in phase 1 were not eligible for enrollment in phase 2.|0
2970162|NCT00794417|3684785|FG002|STARTED|Phase 2: Baseline (Day 421) to Day 972|Participants enrolled in phase 1 were not eligible for enrollment in phase 2.|0
2970163|NCT00794417|3684786|FG003|STARTED|Phase 2: Baseline (Day 421) to Day 972||42
2970164|NCT00794417|3684783|FG000|COMPLETED|Phase 2: Baseline (Day 421) to Day 972||0
2970165|NCT00794417|3684784|FG001|COMPLETED|Phase 2: Baseline (Day 421) to Day 972||0
2970166|NCT00794417|3684785|FG002|COMPLETED|Phase 2: Baseline (Day 421) to Day 972||0
2970167|NCT00794417|3684786|FG003|COMPLETED|Phase 2: Baseline (Day 421) to Day 972||7
2970168|NCT00794417|3684783|FG000|NOT COMPLETED|Phase 2: Baseline (Day 421) to Day 972||0
2970169|NCT00794417|3684784|FG001|NOT COMPLETED|Phase 2: Baseline (Day 421) to Day 972||0
2970170|NCT00794417|3684785|FG002|NOT COMPLETED|Phase 2: Baseline (Day 421) to Day 972||0
2970171|NCT00794417|3684786|FG003|NOT COMPLETED|Phase 2: Baseline (Day 421) to Day 972||35
2970172|NCT00794469|3684798|FG000|STARTED|Overall Study||21
2970173|NCT00794469|3684798|FG000|COMPLETED|Overall Study||21
2970174|NCT00794469|3684798|FG000|NOT COMPLETED|Overall Study||0
2970175|NCT00794508|3684802|FG000|STARTED|Overall Study||10
2970176|NCT00794508|3684802|FG000|COMPLETED|Overall Study||10
2970177|NCT00794508|3684802|FG000|NOT COMPLETED|Overall Study||0
2970178|NCT00794547|3684806|FG000|STARTED|Overall Study||18
2970179|NCT00794547|3684807|FG001|STARTED|Overall Study||16
2970180|NCT00794547|3684806|FG000|COMPLETED|Overall Study||18
2970181|NCT00794547|3684807|FG001|COMPLETED|Overall Study||16
2970182|NCT00794547|3684806|FG000|NOT COMPLETED|Overall Study||0
2970183|NCT00794547|3684807|FG001|NOT COMPLETED|Overall Study||0
2970184|NCT00794560|3684815|FG000|STARTED|Overall Study||36
2970185|NCT00794560|3684816|FG001|STARTED|Overall Study||36
2970186|NCT00794560|3684817|FG002|STARTED|Overall Study||44
2970187|NCT00794560|3684818|FG003|STARTED|Overall Study||38
2970188|NCT00794560|3684815|FG000|COMPLETED|Overall Study||33
2970189|NCT00794560|3684816|FG001|COMPLETED|Overall Study||32
2970190|NCT00794560|3684817|FG002|COMPLETED|Overall Study||40
2970191|NCT00794560|3684818|FG003|COMPLETED|Overall Study||34
2970192|NCT00794560|3684815|FG000|NOT COMPLETED|Overall Study||3
2970193|NCT00794560|3684816|FG001|NOT COMPLETED|Overall Study||4
2970194|NCT00794560|3684817|FG002|NOT COMPLETED|Overall Study||4
2970195|NCT00794560|3684818|FG003|NOT COMPLETED|Overall Study||4
2970196|NCT00794573|3684830|FG000|STARTED|Overall Study||151
2970197|NCT00794573|3684831|FG001|STARTED|Overall Study||151
2970198|NCT00794573|3684830|FG000|COMPLETED|Overall Study||113
2970199|NCT00794573|3684831|FG001|COMPLETED|Overall Study||106
2970200|NCT00794573|3684830|FG000|NOT COMPLETED|Overall Study||38
2970201|NCT00794573|3684831|FG001|NOT COMPLETED|Overall Study||45
2970202|NCT00794664|3684839|FG000|STARTED|Treatment Period||19
2970203|NCT00794664|3684840|FG001|STARTED|Treatment Period||39
2970204|NCT00794664|3684839|FG000|COMPLETED|Treatment Period|3 participants enrolled in open-label extension study NCT00694109|18
2970205|NCT00794664|3684840|FG001|COMPLETED|Treatment Period|6 participants enrolled in open-label extension study NCT00694109|27
2970206|NCT00794664|3684839|FG000|NOT COMPLETED|Treatment Period||1
2970207|NCT00794664|3684840|FG001|NOT COMPLETED|Treatment Period||12
2970208|NCT00794664|3684839|FG000|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|16
2970209|NCT00794664|3684840|FG001|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|33
2970210|NCT00794664|3684839|FG000|COMPLETED|Follow-up Period||15
2970211|NCT00794664|3684840|FG001|COMPLETED|Follow-up Period||28
2970212|NCT00794664|3684839|FG000|NOT COMPLETED|Follow-up Period||1
2970213|NCT00794664|3684840|FG001|NOT COMPLETED|Follow-up Period||5
2970214|NCT00794820|3684846|FG000|STARTED|Overall Study||66
2970215|NCT00794820|3684846|FG000|COMPLETED|Overall Study||50
2970216|NCT00794820|3684846|FG000|NOT COMPLETED|Overall Study||16
2970217|NCT00794950|3684850|FG000|STARTED|BCG Induction||43
2970218|NCT00794950|3684850|FG000|COMPLETED|BCG Induction||36
2970219|NCT00794950|3684850|FG000|NOT COMPLETED|BCG Induction||7
3302159|NCT02958982|4035776|FG000|COMPLETED|Cohort 3: 100 mg in SAD Study||2
3302160|NCT02958982|4035777|FG001|COMPLETED|Cohort 3: 100 mg in SAD Study||0
3302161|NCT02958982|4035778|FG002|COMPLETED|Cohort 3: 100 mg in SAD Study||0
3302162|NCT02958982|4035779|FG003|COMPLETED|Cohort 3: 100 mg in SAD Study||4
3302163|NCT02958982|4035780|FG004|COMPLETED|Cohort 3: 100 mg in SAD Study||0
3302164|NCT02958982|4035781|FG005|COMPLETED|Cohort 3: 100 mg in SAD Study||0
3302165|NCT02958982|4035782|FG006|COMPLETED|Cohort 3: 100 mg in SAD Study||0
3302166|NCT02958982|4035783|FG007|COMPLETED|Cohort 3: 100 mg in SAD Study||0
3302167|NCT02958982|4035784|FG008|COMPLETED|Cohort 3: 100 mg in SAD Study||0
3302168|NCT02958982|4035785|FG009|COMPLETED|Cohort 3: 100 mg in SAD Study||0
3302169|NCT02958982|4035786|FG010|COMPLETED|Cohort 3: 100 mg in SAD Study||0
3302170|NCT02958982|4035776|FG000|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
3302171|NCT02958982|4035777|FG001|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
3302172|NCT02958982|4035778|FG002|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
3302173|NCT02958982|4035779|FG003|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
3302174|NCT02958982|4035780|FG004|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
3302175|NCT02958982|4035781|FG005|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
3302176|NCT02958982|4035782|FG006|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
3302177|NCT02958982|4035783|FG007|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
3302178|NCT02958982|4035784|FG008|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
3302179|NCT02958982|4035785|FG009|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
3302180|NCT02958982|4035786|FG010|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
3302181|NCT02958982|4035776|FG000|STARTED|Cohort 4: 200 mg in SAD Study||2
3302182|NCT02958982|4035777|FG001|STARTED|Cohort 4: 200 mg in SAD Study||0
3302183|NCT02958982|4035778|FG002|STARTED|Cohort 4: 200 mg in SAD Study||0
3302184|NCT02958982|4035779|FG003|STARTED|Cohort 4: 200 mg in SAD Study||0
3302185|NCT02958982|4035780|FG004|STARTED|Cohort 4: 200 mg in SAD Study||6
3302186|NCT02958982|4035781|FG005|STARTED|Cohort 4: 200 mg in SAD Study||0
3302187|NCT02958982|4035782|FG006|STARTED|Cohort 4: 200 mg in SAD Study||0
3302188|NCT02958982|4035783|FG007|STARTED|Cohort 4: 200 mg in SAD Study||0
3302189|NCT02958982|4035784|FG008|STARTED|Cohort 4: 200 mg in SAD Study||0
3302190|NCT02958982|4035785|FG009|STARTED|Cohort 4: 200 mg in SAD Study||0
3302191|NCT02958982|4035786|FG010|STARTED|Cohort 4: 200 mg in SAD Study||0
3302192|NCT02958982|4035776|FG000|COMPLETED|Cohort 4: 200 mg in SAD Study||2
3302193|NCT02958982|4035777|FG001|COMPLETED|Cohort 4: 200 mg in SAD Study||0
3302194|NCT02958982|4035778|FG002|COMPLETED|Cohort 4: 200 mg in SAD Study||0
3302195|NCT02958982|4035779|FG003|COMPLETED|Cohort 4: 200 mg in SAD Study||0
2970220|NCT00794950|3684850|FG000|STARTED|Beginning Sunitinib Treatment||36
2970221|NCT00794950|3684850|FG000|COMPLETED|Beginning Sunitinib Treatment||24
2970222|NCT00794950|3684850|FG000|NOT COMPLETED|Beginning Sunitinib Treatment||12
2970223|NCT00794963|3684857|FG000|STARTED|Overall Study||4
3133216|NCT01695239|3858314|FG009|COMPLETED|Double-Blind (DB) Treatment Period||0
3302196|NCT02958982|4035780|FG004|COMPLETED|Cohort 4: 200 mg in SAD Study||6
3302197|NCT02958982|4035781|FG005|COMPLETED|Cohort 4: 200 mg in SAD Study||0
2970224|NCT00794963|3684858|FG001|STARTED|Overall Study||4
2970225|NCT00794963|3684857|FG000|COMPLETED|Overall Study||3
2970226|NCT00794963|3684858|FG001|COMPLETED|Overall Study||0
2970227|NCT00794963|3684857|FG000|NOT COMPLETED|Overall Study||1
2970228|NCT00794963|3684858|FG001|NOT COMPLETED|Overall Study||4
2970229|NCT00795002|3684866|FG000|STARTED|Overall Study||37
2970230|NCT00795002|3684867|FG001|STARTED|Overall Study||37
2970231|NCT00795002|3684866|FG000|COMPLETED|Overall Study||37
2970232|NCT00795002|3684867|FG001|COMPLETED|Overall Study||37
2970233|NCT00795002|3684866|FG000|NOT COMPLETED|Overall Study||0
2970234|NCT00795002|3684867|FG001|NOT COMPLETED|Overall Study||0
2970235|NCT00795132|3684873|FG000|STARTED|Overall Study||47
2970236|NCT00795132|3684873|FG000|COMPLETED|Overall Study||44
2970237|NCT00795132|3684873|FG000|NOT COMPLETED|Overall Study||3
2970238|NCT00795145|3684887|FG000|STARTED|Cohort 1||3
2970239|NCT00795145|3684888|FG001|STARTED|Cohort 1||3
2970240|NCT00795145|3684889|FG002|STARTED|Cohort 1||3
2970241|NCT00795145|3684890|FG003|STARTED|Cohort 1||0
2970242|NCT00795145|3684891|FG004|STARTED|Cohort 1||0
2970243|NCT00795145|3684892|FG005|STARTED|Cohort 1||0
2970244|NCT00795145|3684893|FG006|STARTED|Cohort 1||0
2970245|NCT00795145|3684887|FG000|COMPLETED|Cohort 1||3
2970246|NCT00795145|3684888|FG001|COMPLETED|Cohort 1||3
2970247|NCT00795145|3684889|FG002|COMPLETED|Cohort 1||3
2970248|NCT00795145|3684890|FG003|COMPLETED|Cohort 1||0
2970249|NCT00795145|3684891|FG004|COMPLETED|Cohort 1||0
2970250|NCT00795145|3684892|FG005|COMPLETED|Cohort 1||0
2970251|NCT00795145|3684893|FG006|COMPLETED|Cohort 1||0
2970252|NCT00795145|3684887|FG000|NOT COMPLETED|Cohort 1||0
2970253|NCT00795145|3684888|FG001|NOT COMPLETED|Cohort 1||0
2970254|NCT00795145|3684889|FG002|NOT COMPLETED|Cohort 1||0
2970255|NCT00795145|3684890|FG003|NOT COMPLETED|Cohort 1||0
2970256|NCT00795145|3684891|FG004|NOT COMPLETED|Cohort 1||0
2970257|NCT00795145|3684892|FG005|NOT COMPLETED|Cohort 1||0
2970258|NCT00795145|3684893|FG006|NOT COMPLETED|Cohort 1||0
2970259|NCT00795145|3684887|FG000|STARTED|Cohort 2||0
2970260|NCT00795145|3684888|FG001|STARTED|Cohort 2||0
3302198|NCT02958982|4035782|FG006|COMPLETED|Cohort 4: 200 mg in SAD Study||0
3302199|NCT02958982|4035783|FG007|COMPLETED|Cohort 4: 200 mg in SAD Study||0
3302200|NCT02958982|4035784|FG008|COMPLETED|Cohort 4: 200 mg in SAD Study||0
3302201|NCT02958982|4035785|FG009|COMPLETED|Cohort 4: 200 mg in SAD Study||0
3302202|NCT02958982|4035786|FG010|COMPLETED|Cohort 4: 200 mg in SAD Study||0
3302203|NCT02958982|4035776|FG000|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
3302204|NCT02958982|4035777|FG001|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
3302205|NCT02958982|4035778|FG002|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
3302206|NCT02958982|4035779|FG003|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
3302207|NCT02958982|4035780|FG004|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
3302208|NCT02958982|4035781|FG005|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
3302209|NCT02958982|4035782|FG006|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
3302210|NCT02958982|4035783|FG007|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
3302211|NCT02958982|4035784|FG008|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
3302212|NCT02958982|4035785|FG009|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
3302213|NCT02958982|4035786|FG010|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
3302214|NCT02958982|4035776|FG000|STARTED|Cohort 5: 400 mg in SAD Study||2
3302215|NCT02958982|4035777|FG001|STARTED|Cohort 5: 400 mg in SAD Study||0
3302216|NCT02958982|4035778|FG002|STARTED|Cohort 5: 400 mg in SAD Study||0
3302217|NCT02958982|4035779|FG003|STARTED|Cohort 5: 400 mg in SAD Study||0
3302218|NCT02958982|4035780|FG004|STARTED|Cohort 5: 400 mg in SAD Study||0
3302219|NCT02958982|4035781|FG005|STARTED|Cohort 5: 400 mg in SAD Study||6
3302220|NCT02958982|4035782|FG006|STARTED|Cohort 5: 400 mg in SAD Study||0
3302221|NCT02958982|4035783|FG007|STARTED|Cohort 5: 400 mg in SAD Study||0
3302222|NCT02958982|4035784|FG008|STARTED|Cohort 5: 400 mg in SAD Study||0
3302223|NCT02958982|4035785|FG009|STARTED|Cohort 5: 400 mg in SAD Study||0
3302224|NCT02958982|4035786|FG010|STARTED|Cohort 5: 400 mg in SAD Study||0
3302225|NCT02958982|4035776|FG000|COMPLETED|Cohort 5: 400 mg in SAD Study||2
3302226|NCT02958982|4035777|FG001|COMPLETED|Cohort 5: 400 mg in SAD Study||0
3302227|NCT02958982|4035778|FG002|COMPLETED|Cohort 5: 400 mg in SAD Study||0
3302228|NCT02958982|4035779|FG003|COMPLETED|Cohort 5: 400 mg in SAD Study||0
3302229|NCT02958982|4035780|FG004|COMPLETED|Cohort 5: 400 mg in SAD Study||0
3302230|NCT02958982|4035781|FG005|COMPLETED|Cohort 5: 400 mg in SAD Study||6
2970261|NCT00795145|3684889|FG002|STARTED|Cohort 2||0
2970262|NCT00795145|3684890|FG003|STARTED|Cohort 2||10
2970263|NCT00795145|3684891|FG004|STARTED|Cohort 2||10
2970264|NCT00795145|3684892|FG005|STARTED|Cohort 2||10
2970265|NCT00795145|3684893|FG006|STARTED|Cohort 2||10
2970266|NCT00795145|3684887|FG000|COMPLETED|Cohort 2||0
2970267|NCT00795145|3684888|FG001|COMPLETED|Cohort 2||0
2970268|NCT00795145|3684889|FG002|COMPLETED|Cohort 2||0
2970269|NCT00795145|3684890|FG003|COMPLETED|Cohort 2||10
2970270|NCT00795145|3684891|FG004|COMPLETED|Cohort 2||10
2970271|NCT00795145|3684892|FG005|COMPLETED|Cohort 2||10
2970272|NCT00795145|3684893|FG006|COMPLETED|Cohort 2||10
2970273|NCT00795145|3684887|FG000|NOT COMPLETED|Cohort 2||0
2970274|NCT00795145|3684888|FG001|NOT COMPLETED|Cohort 2||0
2970275|NCT00795145|3684889|FG002|NOT COMPLETED|Cohort 2||0
2970276|NCT00795145|3684890|FG003|NOT COMPLETED|Cohort 2||0
2970277|NCT00795145|3684891|FG004|NOT COMPLETED|Cohort 2||0
2970278|NCT00795145|3684892|FG005|NOT COMPLETED|Cohort 2||0
2970279|NCT00795145|3684893|FG006|NOT COMPLETED|Cohort 2||0
2970280|NCT00795184|3684920|FG000|STARTED|Overall Study||65
2970281|NCT00795184|3684921|FG001|STARTED|Overall Study||57
2970282|NCT00795184|3684920|FG000|COMPLETED|Overall Study|57 patients analysable, completed all 3 imaging procedures|57
2970283|NCT00795184|3684921|FG001|COMPLETED|Overall Study|44 patients analysable, completed all 3 imaging procedures|44
2970284|NCT00795184|3684920|FG000|NOT COMPLETED|Overall Study||8
2970285|NCT00795184|3684921|FG001|NOT COMPLETED|Overall Study||13
2970286|NCT00795210|3684933|FG000|STARTED|Overall Study||8
2970287|NCT00795210|3684934|FG001|STARTED|Overall Study||12
2970288|NCT00795210|3684935|FG002|STARTED|Overall Study||5
2970289|NCT00795210|3684933|FG000|COMPLETED|Overall Study||8
2970290|NCT00795210|3684934|FG001|COMPLETED|Overall Study||11
2970291|NCT00795210|3684935|FG002|COMPLETED|Overall Study||3
2970292|NCT00795210|3684933|FG000|NOT COMPLETED|Overall Study||0
2970293|NCT00795210|3684934|FG001|NOT COMPLETED|Overall Study||1
2970294|NCT00795210|3684935|FG002|NOT COMPLETED|Overall Study||2
2970295|NCT00795275|3684945|FG000|STARTED|Overall Study||11
2970296|NCT00795275|3684946|FG001|STARTED|Overall Study||15
2970297|NCT00795275|3684945|FG000|COMPLETED|Overall Study||10
2970298|NCT00795275|3684946|FG001|COMPLETED|Overall Study||13
2970299|NCT00795275|3684945|FG000|NOT COMPLETED|Overall Study||1
2970300|NCT00795275|3684946|FG001|NOT COMPLETED|Overall Study||2
2970301|NCT00795288|3684956|FG000|STARTED|Overall Study||21
2970302|NCT00795288|3684957|FG001|STARTED|Overall Study||21
2970303|NCT00795288|3684956|FG000|COMPLETED|Overall Study||21
2970304|NCT00795288|3684957|FG001|COMPLETED|Overall Study||21
2970305|NCT00795288|3684956|FG000|NOT COMPLETED|Overall Study||0
2970306|NCT00795288|3684957|FG001|NOT COMPLETED|Overall Study||0
2970307|NCT00795340|3684967|FG000|STARTED|Overall Study||153
2970308|NCT00795340|3684968|FG001|STARTED|Overall Study||153
2970309|NCT00795340|3684967|FG000|COMPLETED|Overall Study||146
2970310|NCT00795340|3684968|FG001|COMPLETED|Overall Study||153
2970311|NCT00795340|3684967|FG000|NOT COMPLETED|Overall Study||7
2970312|NCT00795340|3684968|FG001|NOT COMPLETED|Overall Study||0
2970313|NCT00795366|3684976|FG000|STARTED|Overall Study||42
2970314|NCT00795366|3684977|FG001|STARTED|Overall Study||54
2970315|NCT00795366|3684976|FG000|COMPLETED|Overall Study||42
2970316|NCT00795366|3684977|FG001|COMPLETED|Overall Study||54
2970317|NCT00795366|3684976|FG000|NOT COMPLETED|Overall Study||0
2970318|NCT00795366|3684977|FG001|NOT COMPLETED|Overall Study||0
2970319|NCT00795509|3684983|FG000|STARTED|Overall Study||374
2970320|NCT00795509|3684983|FG000|COMPLETED|Overall Study||343
2970321|NCT00795509|3684983|FG000|NOT COMPLETED|Overall Study||31
2970322|NCT00795535|3684987|FG000|STARTED|Overall Study||95
2970323|NCT00795535|3684987|FG000|COMPLETED|Overall Study||75
2970324|NCT00795535|3684987|FG000|NOT COMPLETED|Overall Study||20
2970325|NCT00795600|3684993|FG000|STARTED|Overall Study||25
2970326|NCT00795600|3684994|FG001|STARTED|Overall Study||35
2970327|NCT00795600|3684993|FG000|Exposed to Drug|Overall Study|1 patient did not take study medication because the patient withdrew consent|24
2970328|NCT00795600|3684994|FG001|Exposed to Drug|Overall Study||35
2970329|NCT00795600|3684993|FG000|COMPLETED|Overall Study||21
2970330|NCT00795600|3684994|FG001|COMPLETED|Overall Study||31
2970331|NCT00795600|3684993|FG000|NOT COMPLETED|Overall Study||4
2970332|NCT00795600|3684994|FG001|NOT COMPLETED|Overall Study||4
3035753|NCT01139190|3755048|FG001|COMPLETED|Overall Study||38
3035754|NCT01139190|3755047|FG000|NOT COMPLETED|Overall Study||0
3035755|NCT01139190|3755048|FG001|NOT COMPLETED|Overall Study||1
3035756|NCT01139411|3755056|FG000|STARTED|Overall Study||26
3035757|NCT01139411|3755057|FG001|STARTED|Overall Study||23
3035758|NCT01139411|3755056|FG000|COMPLETED|Overall Study||24
3035759|NCT01139411|3755057|FG001|COMPLETED|Overall Study||19
3035760|NCT01139411|3755056|FG000|NOT COMPLETED|Overall Study||2
3035761|NCT01139411|3755057|FG001|NOT COMPLETED|Overall Study||4
3035762|NCT01139450|3755068|FG000|STARTED|Overall Study||302
3035763|NCT01139450|3755069|FG001|STARTED|Overall Study||297
3035764|NCT01139450|3755070|FG002|STARTED|Overall Study||300
3035765|NCT01139450|3755068|FG000|COMPLETED|Overall Study||275
3035766|NCT01139450|3755069|FG001|COMPLETED|Overall Study||272
3035767|NCT01139450|3755070|FG002|COMPLETED|Overall Study||262
3035768|NCT01139450|3755068|FG000|NOT COMPLETED|Overall Study||27
3035769|NCT01139450|3755069|FG001|NOT COMPLETED|Overall Study||25
3035770|NCT01139450|3755070|FG002|NOT COMPLETED|Overall Study||38
3035771|NCT01139515|3755078|FG000|STARTED|First Intervention Period||4
3035772|NCT01139515|3755079|FG001|STARTED|First Intervention Period||4
3035773|NCT01139515|3755080|FG002|STARTED|First Intervention Period||4
3035774|NCT01139515|3755081|FG003|STARTED|First Intervention Period||4
3035775|NCT01139515|3755078|FG000|COMPLETED|First Intervention Period||4
3035776|NCT01139515|3755079|FG001|COMPLETED|First Intervention Period||4
3035777|NCT01139515|3755080|FG002|COMPLETED|First Intervention Period||4
3035778|NCT01139515|3755081|FG003|COMPLETED|First Intervention Period||4
3035779|NCT01139515|3755078|FG000|NOT COMPLETED|First Intervention Period||0
3035780|NCT01139515|3755079|FG001|NOT COMPLETED|First Intervention Period||0
3035781|NCT01139515|3755080|FG002|NOT COMPLETED|First Intervention Period||0
2970333|NCT00795639|3685002|FG000|STARTED|Overall Study||91
2970334|NCT00795639|3685003|FG001|STARTED|Overall Study||92
2970335|NCT00795639|3685002|FG000|Randomized and Not Treated|Overall Study||0
2970336|NCT00795639|3685003|FG001|Randomized and Not Treated|Overall Study||1
2970337|NCT00795639|3685002|FG000|COMPLETED|Overall Study||70
2970338|NCT00795639|3685003|FG001|COMPLETED|Overall Study||66
2970339|NCT00795639|3685002|FG000|NOT COMPLETED|Overall Study||21
2970340|NCT00795639|3685003|FG001|NOT COMPLETED|Overall Study||26
2970341|NCT00795704|3685011|FG000|STARTED|Overall Study||12
2970342|NCT00795704|3685012|FG001|STARTED|Overall Study||12
2970343|NCT00795704|3685011|FG000|COMPLETED|Overall Study||8
2970344|NCT00795704|3685012|FG001|COMPLETED|Overall Study||9
2970345|NCT00795704|3685011|FG000|NOT COMPLETED|Overall Study||4
2970346|NCT00795704|3685012|FG001|NOT COMPLETED|Overall Study||3
2970347|NCT00795717|3685020|FG000|STARTED|Phase I Followed by Wash Out x 4 Weeks|Randomized to treatment first|20
2970348|NCT00795717|3685021|FG001|STARTED|Phase I Followed by Wash Out x 4 Weeks|Randomized to placebo first|21
2970349|NCT00795717|3685020|FG000|COMPLETED|Phase I Followed by Wash Out x 4 Weeks||18
2970350|NCT00795717|3685021|FG001|COMPLETED|Phase I Followed by Wash Out x 4 Weeks||19
2970351|NCT00795717|3685020|FG000|NOT COMPLETED|Phase I Followed by Wash Out x 4 Weeks||2
2970352|NCT00795717|3685021|FG001|NOT COMPLETED|Phase I Followed by Wash Out x 4 Weeks||2
2970353|NCT00795717|3685020|FG000|STARTED|Phase II||18
2970354|NCT00795717|3685021|FG001|STARTED|Phase II||19
2970355|NCT00795717|3685020|FG000|COMPLETED|Phase II||18
2970356|NCT00795717|3685021|FG001|COMPLETED|Phase II||18
2970357|NCT00795717|3685020|FG000|NOT COMPLETED|Phase II||0
2970358|NCT00795717|3685021|FG001|NOT COMPLETED|Phase II||1
2970359|NCT00795769|3685028|FG000|STARTED|Overall Study||49
2970360|NCT00795769|3685028|FG000|COMPLETED|Overall Study||49
2970361|NCT00795769|3685028|FG000|NOT COMPLETED|Overall Study||0
2970362|NCT00795821|3685034|FG000|STARTED|Acute Treatment Phase||250
2970363|NCT00795821|3685035|FG001|STARTED|Acute Treatment Phase||245
3302231|NCT02958982|4035782|FG006|COMPLETED|Cohort 5: 400 mg in SAD Study||0
3302232|NCT02958982|4035783|FG007|COMPLETED|Cohort 5: 400 mg in SAD Study||0
3302233|NCT02958982|4035784|FG008|COMPLETED|Cohort 5: 400 mg in SAD Study||0
3302234|NCT02958982|4035785|FG009|COMPLETED|Cohort 5: 400 mg in SAD Study||0
3302235|NCT02958982|4035786|FG010|COMPLETED|Cohort 5: 400 mg in SAD Study||0
3302236|NCT02958982|4035776|FG000|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
3302237|NCT02958982|4035777|FG001|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
3302238|NCT02958982|4035778|FG002|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
3302239|NCT02958982|4035779|FG003|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
3302240|NCT02958982|4035780|FG004|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
3302241|NCT02958982|4035781|FG005|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
3302242|NCT02958982|4035782|FG006|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
3302243|NCT02958982|4035783|FG007|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
3302244|NCT02958982|4035784|FG008|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
3302245|NCT02958982|4035785|FG009|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
3302246|NCT02958982|4035786|FG010|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
3302247|NCT02958982|4035776|FG000|STARTED|Cohort 1 : 25 mg in MAD Study||0
3302248|NCT02958982|4035777|FG001|STARTED|Cohort 1 : 25 mg in MAD Study||0
3302249|NCT02958982|4035778|FG002|STARTED|Cohort 1 : 25 mg in MAD Study||0
3302250|NCT02958982|4035779|FG003|STARTED|Cohort 1 : 25 mg in MAD Study||0
3302251|NCT02958982|4035780|FG004|STARTED|Cohort 1 : 25 mg in MAD Study||0
3302252|NCT02958982|4035781|FG005|STARTED|Cohort 1 : 25 mg in MAD Study||0
3302253|NCT02958982|4035782|FG006|STARTED|Cohort 1 : 25 mg in MAD Study||2
3302254|NCT02958982|4035783|FG007|STARTED|Cohort 1 : 25 mg in MAD Study||6
3302255|NCT02958982|4035784|FG008|STARTED|Cohort 1 : 25 mg in MAD Study||0
3302256|NCT02958982|4035785|FG009|STARTED|Cohort 1 : 25 mg in MAD Study||0
3302257|NCT02958982|4035786|FG010|STARTED|Cohort 1 : 25 mg in MAD Study||0
3302258|NCT02958982|4035776|FG000|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
3302259|NCT02958982|4035777|FG001|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
3302260|NCT02958982|4035778|FG002|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
3302261|NCT02958982|4035779|FG003|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
3302262|NCT02958982|4035780|FG004|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
3302263|NCT02958982|4035781|FG005|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
3302264|NCT02958982|4035782|FG006|COMPLETED|Cohort 1 : 25 mg in MAD Study||2
3302265|NCT02958982|4035783|FG007|COMPLETED|Cohort 1 : 25 mg in MAD Study||6
3302266|NCT02958982|4035784|FG008|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
3302267|NCT02958982|4035785|FG009|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
3302268|NCT02958982|4035786|FG010|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
3302269|NCT02958982|4035776|FG000|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
3302270|NCT02958982|4035777|FG001|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
3302271|NCT02958982|4035778|FG002|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
3302272|NCT02958982|4035779|FG003|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
3302273|NCT02958982|4035780|FG004|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
3302274|NCT02958982|4035781|FG005|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
3302275|NCT02958982|4035782|FG006|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
3302276|NCT02958982|4035783|FG007|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
3302277|NCT02958982|4035784|FG008|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
3302278|NCT02958982|4035785|FG009|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
3302279|NCT02958982|4035786|FG010|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
3035782|NCT01139515|3755081|FG003|NOT COMPLETED|First Intervention Period||0
2970364|NCT00795821|3685034|FG000|COMPLETED|Acute Treatment Phase|4 LY-treated participants in the Acute Phase chose not to enter the Long-term Extension Phase.|194
2970365|NCT00795821|3685035|FG001|COMPLETED|Acute Treatment Phase|7 placebo-treated participants in the Acute Phase chose not to enter the Long-term Extension Phase.|214
2970366|NCT00795821|3685034|FG000|NOT COMPLETED|Acute Treatment Phase||56
2970367|NCT00795821|3685035|FG001|NOT COMPLETED|Acute Treatment Phase||31
2970368|NCT00795821|3685034|FG000|STARTED|Long-term Extension Phase||190
2970369|NCT00795821|3685035|FG001|STARTED|Long-term Extension Phase|All placebo-treated participants received LY2216684 in the Long-term Extension Phase.|207
2970370|NCT00795821|3685034|FG000|COMPLETED|Long-term Extension Phase||100
2970371|NCT00795821|3685035|FG001|COMPLETED|Long-term Extension Phase||115
2970372|NCT00795821|3685034|FG000|NOT COMPLETED|Long-term Extension Phase||90
2970373|NCT00795821|3685035|FG001|NOT COMPLETED|Long-term Extension Phase||92
2970374|NCT00795821|3685034|FG000|STARTED|Taper Phase|N=240 participants entered Taper Phases: N=4 from Acute Phase; N=236 from Extension Phase.|240
2970375|NCT00795821|3685035|FG001|STARTED|Taper Phase|N=6 participants entered only Acute Taper Phase.|6
2970376|NCT00795821|3685034|FG000|COMPLETED|Taper Phase|N=231 participants completed Taper Phases: N=3 from Acute Phase; N=228 from Extension Phase.|231
2970377|NCT00795821|3685035|FG001|COMPLETED|Taper Phase|N=6 participants completed only Acute Taper Phase; N=0 participants entered Extension Taper Phase.|6
2970378|NCT00795821|3685034|FG000|NOT COMPLETED|Taper Phase||9
2970379|NCT00795821|3685035|FG001|NOT COMPLETED|Taper Phase||0
2970380|NCT00795886|3685051|FG000|STARTED|Overall Study||63
2970381|NCT00795886|3685051|FG000|COMPLETED|Overall Study||53
2970382|NCT00795886|3685051|FG000|NOT COMPLETED|Overall Study||10
2970383|NCT00795951|3685056|FG000|STARTED|Overall Study||102
2970384|NCT00795951|3685056|FG000|COMPLETED|Overall Study||100
2970385|NCT00795951|3685056|FG000|NOT COMPLETED|Overall Study||2
2970386|NCT00796003|3685063|FG000|STARTED|Overall Study|Number of participants enrolled|3
2970387|NCT00796003|3685064|FG001|STARTED|Overall Study|Number of participants enrolled. Includes 6 participants from Phase I (20 mg/m2) group|36
2970388|NCT00796003|3685063|FG000|Treated|Overall Study|Number of participants treated|3
2970389|NCT00796003|3685064|FG001|Treated|Overall Study|Number of participants treated|34
2970390|NCT00796003|3685063|FG000|COMPLETED|Overall Study||0
2970391|NCT00796003|3685064|FG001|COMPLETED|Overall Study|Includes 2 participants from Phase I (20 mg/m2) group|7
2970392|NCT00796003|3685063|FG000|NOT COMPLETED|Overall Study||3
2970393|NCT00796003|3685064|FG001|NOT COMPLETED|Overall Study||29
2970394|NCT00796120|3685075|FG000|STARTED|Overall Study||61
2970395|NCT00796120|3685076|FG001|STARTED|Overall Study||60
2970396|NCT00796120|3685075|FG000|Treated|Overall Study||61
2970397|NCT00796120|3685076|FG001|Treated|Overall Study||57
2970398|NCT00796120|3685075|FG000|COMPLETED|Overall Study||0
2970399|NCT00796120|3685076|FG001|COMPLETED|Overall Study||0
2970400|NCT00796120|3685075|FG000|NOT COMPLETED|Overall Study||61
2970401|NCT00796120|3685076|FG001|NOT COMPLETED|Overall Study||60
2970402|NCT00796224|3685084|FG000|STARTED|Overall Study||19
2970403|NCT00796224|3685085|FG001|STARTED|Overall Study||19
2970404|NCT00796224|3685084|FG000|COMPLETED|Overall Study||18
2970405|NCT00796224|3685085|FG001|COMPLETED|Overall Study||18
2970406|NCT00796224|3685084|FG000|NOT COMPLETED|Overall Study||1
2970407|NCT00796224|3685085|FG001|NOT COMPLETED|Overall Study||1
2970408|NCT00796302|3685095|FG000|STARTED|Overall Study||84
2970409|NCT00796302|3685096|FG001|STARTED|Overall Study||84
2970410|NCT00796302|3685095|FG000|COMPLETED|Overall Study||71
2970411|NCT00796302|3685096|FG001|COMPLETED|Overall Study||66
2970412|NCT00796302|3685095|FG000|NOT COMPLETED|Overall Study||13
2970413|NCT00796302|3685096|FG001|NOT COMPLETED|Overall Study||18
2970414|NCT00796315|3685103|FG000|STARTED|Overall Study||9
2970415|NCT00796315|3685104|FG001|STARTED|Overall Study||17
2970416|NCT00796315|3685105|FG002|STARTED|Overall Study||15
2970417|NCT00796315|3685103|FG000|COMPLETED|Overall Study||9
2970418|NCT00796315|3685104|FG001|COMPLETED|Overall Study||16
2970419|NCT00796315|3685105|FG002|COMPLETED|Overall Study||15
2970420|NCT00796315|3685103|FG000|NOT COMPLETED|Overall Study||0
2970421|NCT00796315|3685104|FG001|NOT COMPLETED|Overall Study||1
2970422|NCT00796315|3685105|FG002|NOT COMPLETED|Overall Study||0
2970423|NCT00796328|3685116|FG000|STARTED|Overall Study||46
2970424|NCT00796328|3685116|FG000|COMPLETED|Overall Study||40
2970425|NCT00796328|3685116|FG000|NOT COMPLETED|Overall Study||6
2970426|NCT00796367|3685123|FG000|STARTED|Overall Study||227
2970427|NCT00796367|3685124|FG001|STARTED|Overall Study|one participant signed ICF but withdrew from study prior to first dosing in OB-305|154
2970428|NCT00796367|3685125|FG002|STARTED|Overall Study||295
2970429|NCT00796367|3685123|FG000|COMPLETED|Overall Study||197
2970430|NCT00796367|3685124|FG001|COMPLETED|Overall Study||129
3302280|NCT02958982|4035776|FG000|STARTED|Cohort 2: 100 mg in MAD Study||0
3302281|NCT02958982|4035777|FG001|STARTED|Cohort 2: 100 mg in MAD Study||0
3302282|NCT02958982|4035778|FG002|STARTED|Cohort 2: 100 mg in MAD Study||0
3302283|NCT02958982|4035779|FG003|STARTED|Cohort 2: 100 mg in MAD Study||0
3302284|NCT02958982|4035780|FG004|STARTED|Cohort 2: 100 mg in MAD Study||0
3302285|NCT02958982|4035781|FG005|STARTED|Cohort 2: 100 mg in MAD Study||0
3302286|NCT02958982|4035782|FG006|STARTED|Cohort 2: 100 mg in MAD Study||2
3302287|NCT02958982|4035783|FG007|STARTED|Cohort 2: 100 mg in MAD Study||0
3302288|NCT02958982|4035784|FG008|STARTED|Cohort 2: 100 mg in MAD Study||6
3302289|NCT02958982|4035785|FG009|STARTED|Cohort 2: 100 mg in MAD Study||0
3302290|NCT02958982|4035786|FG010|STARTED|Cohort 2: 100 mg in MAD Study||0
3302291|NCT02958982|4035776|FG000|COMPLETED|Cohort 2: 100 mg in MAD Study||0
3302292|NCT02958982|4035777|FG001|COMPLETED|Cohort 2: 100 mg in MAD Study||0
2970431|NCT00796367|3685125|FG002|COMPLETED|Overall Study||248
2970432|NCT00796367|3685123|FG000|NOT COMPLETED|Overall Study||30
2970433|NCT00796367|3685124|FG001|NOT COMPLETED|Overall Study||25
2970434|NCT00796367|3685125|FG002|NOT COMPLETED|Overall Study||47
2970435|NCT00796419|3685135|FG000|STARTED|Overall Study||13
2970436|NCT00796419|3685136|FG001|STARTED|Overall Study||14
2970437|NCT00796419|3685135|FG000|COMPLETED|Overall Study||13
2970438|NCT00796419|3685136|FG001|COMPLETED|Overall Study||13
2970439|NCT00796419|3685135|FG000|NOT COMPLETED|Overall Study||0
2970440|NCT00796419|3685136|FG001|NOT COMPLETED|Overall Study||1
2970441|NCT00796445|3685144|FG000|STARTED|Overall Study||895
2970442|NCT00796445|3685145|FG001|STARTED|Overall Study||450
2970443|NCT00796445|3685144|FG000|COMPLETED|Overall Study||310
2970444|NCT00796445|3685145|FG001|COMPLETED|Overall Study||158
2970445|NCT00796445|3685144|FG000|NOT COMPLETED|Overall Study||585
2970446|NCT00796445|3685145|FG001|NOT COMPLETED|Overall Study||292
2970447|NCT00796549|3685159|FG000|STARTED|Overall Study|Excluding duplicate records for 5 patients who were screened twice|218
2970448|NCT00796549|3685159|FG000|Entered|Overall Study|entered and treated|69
2970449|NCT00796549|3685159|FG000|COMPLETED|Overall Study||0
2970450|NCT00796549|3685159|FG000|NOT COMPLETED|Overall Study||218
2970451|NCT00796562|3685165|FG000|STARTED|Overall Study||96
2970452|NCT00796562|3685165|FG000|COMPLETED|Overall Study||47
2970453|NCT00796562|3685165|FG000|NOT COMPLETED|Overall Study||49
2970454|NCT00796614|3685173|FG000|STARTED|Overall Study||41
2970455|NCT00796614|3685174|FG001|STARTED|Overall Study||40
2970456|NCT00796614|3685175|FG002|STARTED|Overall Study||39
2970457|NCT00796614|3685176|FG003|STARTED|Overall Study||41
2970458|NCT00796614|3685173|FG000|Not Treated|Overall Study||0
2970459|NCT00796614|3685174|FG001|Not Treated|Overall Study||0
2970460|NCT00796614|3685175|FG002|Not Treated|Overall Study||1
2970461|NCT00796614|3685176|FG003|Not Treated|Overall Study||0
2970462|NCT00796614|3685173|FG000|COMPLETED|Overall Study||36
2970463|NCT00796614|3685174|FG001|COMPLETED|Overall Study||36
2970464|NCT00796614|3685175|FG002|COMPLETED|Overall Study||36
2970465|NCT00796614|3685176|FG003|COMPLETED|Overall Study||40
2970466|NCT00796614|3685173|FG000|NOT COMPLETED|Overall Study||5
2970467|NCT00796614|3685174|FG001|NOT COMPLETED|Overall Study||4
2970468|NCT00796614|3685175|FG002|NOT COMPLETED|Overall Study||3
2970469|NCT00796614|3685176|FG003|NOT COMPLETED|Overall Study||1
3302293|NCT02958982|4035778|FG002|COMPLETED|Cohort 2: 100 mg in MAD Study||0
3302294|NCT02958982|4035779|FG003|COMPLETED|Cohort 2: 100 mg in MAD Study||0
3302295|NCT02958982|4035780|FG004|COMPLETED|Cohort 2: 100 mg in MAD Study||0
3302296|NCT02958982|4035781|FG005|COMPLETED|Cohort 2: 100 mg in MAD Study||0
3302297|NCT02958982|4035782|FG006|COMPLETED|Cohort 2: 100 mg in MAD Study||2
3302298|NCT02958982|4035783|FG007|COMPLETED|Cohort 2: 100 mg in MAD Study||0
3302299|NCT02958982|4035784|FG008|COMPLETED|Cohort 2: 100 mg in MAD Study||6
3302300|NCT02958982|4035785|FG009|COMPLETED|Cohort 2: 100 mg in MAD Study||0
3302301|NCT02958982|4035786|FG010|COMPLETED|Cohort 2: 100 mg in MAD Study||0
3302302|NCT02958982|4035776|FG000|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
3302303|NCT02958982|4035777|FG001|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
3302304|NCT02958982|4035778|FG002|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
3302305|NCT02958982|4035779|FG003|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
3302306|NCT02958982|4035780|FG004|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
3302307|NCT02958982|4035781|FG005|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
3302308|NCT02958982|4035782|FG006|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
3302309|NCT02958982|4035783|FG007|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
3302310|NCT02958982|4035784|FG008|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
3302311|NCT02958982|4035785|FG009|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
3302312|NCT02958982|4035786|FG010|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
3302313|NCT02958982|4035776|FG000|STARTED|Cohort 3: 400 mg in MAD Study||0
3302314|NCT02958982|4035777|FG001|STARTED|Cohort 3: 400 mg in MAD Study||0
3302315|NCT02958982|4035778|FG002|STARTED|Cohort 3: 400 mg in MAD Study||0
3302316|NCT02958982|4035779|FG003|STARTED|Cohort 3: 400 mg in MAD Study||0
3302317|NCT02958982|4035780|FG004|STARTED|Cohort 3: 400 mg in MAD Study||0
3302318|NCT02958982|4035781|FG005|STARTED|Cohort 3: 400 mg in MAD Study||0
3302319|NCT02958982|4035782|FG006|STARTED|Cohort 3: 400 mg in MAD Study||2
3302320|NCT02958982|4035783|FG007|STARTED|Cohort 3: 400 mg in MAD Study||0
3302321|NCT02958982|4035784|FG008|STARTED|Cohort 3: 400 mg in MAD Study||0
3302322|NCT02958982|4035785|FG009|STARTED|Cohort 3: 400 mg in MAD Study||6
3302323|NCT02958982|4035786|FG010|STARTED|Cohort 3: 400 mg in MAD Study||0
3302324|NCT02958982|4035776|FG000|COMPLETED|Cohort 3: 400 mg in MAD Study||0
3302325|NCT02958982|4035777|FG001|COMPLETED|Cohort 3: 400 mg in MAD Study||0
3302326|NCT02958982|4035778|FG002|COMPLETED|Cohort 3: 400 mg in MAD Study||0
2970470|NCT00796627|3685188|FG000|STARTED|Overall Study||10
2970471|NCT00796627|3685189|FG001|STARTED|Overall Study||31
2970472|NCT00796627|3685188|FG000|COMPLETED|Overall Study||10
2970473|NCT00796627|3685189|FG001|COMPLETED|Overall Study||31
2970474|NCT00796627|3685188|FG000|NOT COMPLETED|Overall Study||0
2970475|NCT00796627|3685189|FG001|NOT COMPLETED|Overall Study||0
2970476|NCT00796653|3685199|FG000|STARTED|Overall Study||235
2970477|NCT00796653|3685200|FG001|STARTED|Overall Study||232
2970478|NCT00796653|3685201|FG002|STARTED|Overall Study||234
2970479|NCT00796653|3685202|FG003|STARTED|Overall Study||233
2970480|NCT00796653|3685199|FG000|COMPLETED|Overall Study||184
2970481|NCT00796653|3685200|FG001|COMPLETED|Overall Study||195
2970482|NCT00796653|3685201|FG002|COMPLETED|Overall Study||198
3133217|NCT01695239|3858315|FG010|COMPLETED|Double-Blind (DB) Treatment Period||0
3133218|NCT01695239|3858316|FG011|COMPLETED|Double-Blind (DB) Treatment Period||0
3133219|NCT01695239|3858317|FG012|COMPLETED|Double-Blind (DB) Treatment Period||0
3133220|NCT01695239|3858318|FG013|COMPLETED|Double-Blind (DB) Treatment Period||0
3133221|NCT01695239|3858305|FG000|NOT COMPLETED|Double-Blind (DB) Treatment Period||15
3133222|NCT01695239|3858306|FG001|NOT COMPLETED|Double-Blind (DB) Treatment Period||4
3136739|NCT01714726|3861988|FG000|COMPLETED|Open-Label Period||0
3302327|NCT02958982|4035779|FG003|COMPLETED|Cohort 3: 400 mg in MAD Study||0
2970483|NCT00796653|3685202|FG003|COMPLETED|Overall Study||193
2970484|NCT00796653|3685199|FG000|NOT COMPLETED|Overall Study||51
2970485|NCT00796653|3685200|FG001|NOT COMPLETED|Overall Study||37
2970486|NCT00796653|3685201|FG002|NOT COMPLETED|Overall Study||36
2970487|NCT00796653|3685202|FG003|NOT COMPLETED|Overall Study||40
2970488|NCT00796666|3685222|FG000|STARTED|Overall Study||67
2970489|NCT00796666|3685223|FG001|STARTED|Overall Study||64
2970490|NCT00796666|3685222|FG000|Treated|Overall Study||66
2970491|NCT00796666|3685223|FG001|Treated|Overall Study||64
2970492|NCT00796666|3685222|FG000|Randomized and Not Treated|Overall Study||1
2970493|NCT00796666|3685223|FG001|Randomized and Not Treated|Overall Study||0
2970494|NCT00796666|3685222|FG000|COMPLETED|Overall Study||0
2970495|NCT00796666|3685223|FG001|COMPLETED|Overall Study||0
2970496|NCT00796666|3685222|FG000|NOT COMPLETED|Overall Study||67
2970497|NCT00796666|3685223|FG001|NOT COMPLETED|Overall Study||64
2970498|NCT00796705|3685233|FG000|STARTED|Overall Study||3
2970499|NCT00796705|3685234|FG001|STARTED|Overall Study||4
2970500|NCT00796705|3685235|FG002|STARTED|Overall Study||4
2970501|NCT00796705|3685236|FG003|STARTED|Overall Study||2
2970502|NCT00796705|3685233|FG000|COMPLETED|Overall Study||3
2970503|NCT00796705|3685234|FG001|COMPLETED|Overall Study||4
2970504|NCT00796705|3685235|FG002|COMPLETED|Overall Study||4
2970505|NCT00796705|3685236|FG003|COMPLETED|Overall Study||2
2970506|NCT00796705|3685233|FG000|NOT COMPLETED|Overall Study||0
2970507|NCT00796705|3685234|FG001|NOT COMPLETED|Overall Study||0
2970508|NCT00796705|3685235|FG002|NOT COMPLETED|Overall Study||0
2970509|NCT00796705|3685236|FG003|NOT COMPLETED|Overall Study||0
2970510|NCT00796718|3685248|FG000|STARTED|Overall Study||62
2970511|NCT00796718|3685248|FG000|COMPLETED|Overall Study||53
2970512|NCT00796718|3685248|FG000|NOT COMPLETED|Overall Study||9
2970513|NCT00796744|3685255|FG000|STARTED|Overall Study||24
2970514|NCT00796744|3685256|FG001|STARTED|Overall Study||26
2970515|NCT00796744|3685257|FG002|STARTED|Overall Study||28
2970516|NCT00796744|3685255|FG000|COMPLETED|Overall Study||24
2970517|NCT00796744|3685256|FG001|COMPLETED|Overall Study||26
2970518|NCT00796744|3685257|FG002|COMPLETED|Overall Study||27
2970519|NCT00796744|3685255|FG000|NOT COMPLETED|Overall Study||0
2970520|NCT00796744|3685256|FG001|NOT COMPLETED|Overall Study||0
2970521|NCT00796744|3685257|FG002|NOT COMPLETED|Overall Study||1
2970522|NCT00796757|3685267|FG000|STARTED|Overall Study||146
2970523|NCT00796757|3685267|FG000|COMPLETED|Overall Study||60
2970524|NCT00796757|3685267|FG000|NOT COMPLETED|Overall Study||86
2970525|NCT00796822|3685273|FG000|STARTED|Overall Study||13
2970526|NCT00796822|3685274|FG001|STARTED|Overall Study||13
2970527|NCT00796822|3685273|FG000|COMPLETED|Overall Study||10
2970528|NCT00796822|3685274|FG001|COMPLETED|Overall Study||13
2970529|NCT00796822|3685273|FG000|NOT COMPLETED|Overall Study||3
2970530|NCT00796822|3685274|FG001|NOT COMPLETED|Overall Study||0
2970531|NCT00796926|3685282|FG000|STARTED|Overall Study||15
2970532|NCT00796926|3685283|FG001|STARTED|Overall Study||15
2970533|NCT00796926|3685282|FG000|COMPLETED|Overall Study||14
2970534|NCT00796926|3685283|FG001|COMPLETED|Overall Study||15
2970535|NCT00796926|3685282|FG000|NOT COMPLETED|Overall Study||1
2970536|NCT00796926|3685283|FG001|NOT COMPLETED|Overall Study||0
2970537|NCT00796978|3685289|FG000|STARTED|Overall Study||56
2970538|NCT00796978|3685289|FG000|COMPLETED|Overall Study||44
2970539|NCT00796978|3685289|FG000|NOT COMPLETED|Overall Study||12
2970540|NCT00796991|3685296|FG000|STARTED|Overall Study||20
2970541|NCT00796991|3685297|FG001|STARTED|Overall Study||19
2970542|NCT00796991|3685298|FG002|STARTED|Overall Study||20
2970543|NCT00796991|3685296|FG000|COMPLETED|Overall Study|Participants continued treatment into maintenance phase.|5
2970544|NCT00796991|3685297|FG001|COMPLETED|Overall Study|Participants continued treatment into maintenance phase.|7
2970545|NCT00796991|3685298|FG002|COMPLETED|Overall Study|Participants continued treatment into maintenance phase.|6
2970546|NCT00796991|3685296|FG000|NOT COMPLETED|Overall Study||15
2970547|NCT00796991|3685297|FG001|NOT COMPLETED|Overall Study||12
2970548|NCT00796991|3685298|FG002|NOT COMPLETED|Overall Study||14
2970549|NCT00797108|3685309|FG000|STARTED|Overall Study||12
2970550|NCT00797108|3685310|FG001|STARTED|Overall Study||11
2970551|NCT00797108|3685311|FG002|STARTED|Overall Study||12
2970552|NCT00797108|3685309|FG000|Treated|Overall Study||10
2970553|NCT00797108|3685310|FG001|Treated|Overall Study||11
2970554|NCT00797108|3685311|FG002|Treated|Overall Study||12
2970555|NCT00797108|3685309|FG000|COMPLETED|Overall Study||8
2970556|NCT00797108|3685310|FG001|COMPLETED|Overall Study||9
2970557|NCT00797108|3685311|FG002|COMPLETED|Overall Study||6
2970558|NCT00797108|3685309|FG000|NOT COMPLETED|Overall Study||4
3302328|NCT02958982|4035780|FG004|COMPLETED|Cohort 3: 400 mg in MAD Study||0
3302329|NCT02958982|4035781|FG005|COMPLETED|Cohort 3: 400 mg in MAD Study||0
3302330|NCT02958982|4035782|FG006|COMPLETED|Cohort 3: 400 mg in MAD Study||2
2970559|NCT00797108|3685310|FG001|NOT COMPLETED|Overall Study||2
2970560|NCT00797108|3685311|FG002|NOT COMPLETED|Overall Study||6
2970561|NCT00797212|3685319|FG000|STARTED|Overall Study||50
2970562|NCT00797212|3685319|FG000|COMPLETED|Overall Study||50
2970563|NCT00797212|3685319|FG000|NOT COMPLETED|Overall Study||0
2970564|NCT00797225|3685327|FG000|STARTED|Weeks 1 to 12||43
2970565|NCT00797225|3685328|FG001|STARTED|Weeks 1 to 12||43
2970566|NCT00797225|3685329|FG002|STARTED|Weeks 1 to 12||44
2970567|NCT00797225|3685330|FG003|STARTED|Weeks 1 to 12||44
2970568|NCT00797225|3685331|FG004|STARTED|Weeks 1 to 12||0
2970569|NCT00797225|3685332|FG005|STARTED|Weeks 1 to 12||0
2970570|NCT00797225|3685333|FG006|STARTED|Weeks 1 to 12||0
2970571|NCT00797225|3685334|FG007|STARTED|Weeks 1 to 12||0
2970572|NCT00797225|3685327|FG000|Received Study Drug|Weeks 1 to 12||43
2970573|NCT00797225|3685328|FG001|Received Study Drug|Weeks 1 to 12||43
2970574|NCT00797225|3685329|FG002|Received Study Drug|Weeks 1 to 12||44
2970575|NCT00797225|3685330|FG003|Received Study Drug|Weeks 1 to 12||44
2970576|NCT00797225|3685331|FG004|Received Study Drug|Weeks 1 to 12||0
2970577|NCT00797225|3685332|FG005|Received Study Drug|Weeks 1 to 12||0
2970578|NCT00797225|3685333|FG006|Received Study Drug|Weeks 1 to 12||0
2970579|NCT00797225|3685334|FG007|Received Study Drug|Weeks 1 to 12||0
2970580|NCT00797225|3685327|FG000|COMPLETED|Weeks 1 to 12||41
2970581|NCT00797225|3685328|FG001|COMPLETED|Weeks 1 to 12||42
2970582|NCT00797225|3685329|FG002|COMPLETED|Weeks 1 to 12||43
2970583|NCT00797225|3685330|FG003|COMPLETED|Weeks 1 to 12||44
2970584|NCT00797225|3685331|FG004|COMPLETED|Weeks 1 to 12||0
2970585|NCT00797225|3685332|FG005|COMPLETED|Weeks 1 to 12||0
2970586|NCT00797225|3685333|FG006|COMPLETED|Weeks 1 to 12||0
2970587|NCT00797225|3685334|FG007|COMPLETED|Weeks 1 to 12||0
2970588|NCT00797225|3685327|FG000|NOT COMPLETED|Weeks 1 to 12||2
2970589|NCT00797225|3685328|FG001|NOT COMPLETED|Weeks 1 to 12||1
2970590|NCT00797225|3685329|FG002|NOT COMPLETED|Weeks 1 to 12||1
2970591|NCT00797225|3685330|FG003|NOT COMPLETED|Weeks 1 to 12||0
2970592|NCT00797225|3685331|FG004|NOT COMPLETED|Weeks 1 to 12||0
2970593|NCT00797225|3685332|FG005|NOT COMPLETED|Weeks 1 to 12||0
2970594|NCT00797225|3685333|FG006|NOT COMPLETED|Weeks 1 to 12||0
2970595|NCT00797225|3685334|FG007|NOT COMPLETED|Weeks 1 to 12||0
2970596|NCT00797225|3685327|FG000|STARTED|Weeks 13 to 24||0
2970597|NCT00797225|3685328|FG001|STARTED|Weeks 13 to 24||42
3302331|NCT02958982|4035783|FG007|COMPLETED|Cohort 3: 400 mg in MAD Study||0
3302332|NCT02958982|4035784|FG008|COMPLETED|Cohort 3: 400 mg in MAD Study||0
3302333|NCT02958982|4035785|FG009|COMPLETED|Cohort 3: 400 mg in MAD Study||6
3302334|NCT02958982|4035786|FG010|COMPLETED|Cohort 3: 400 mg in MAD Study||0
3302335|NCT02958982|4035776|FG000|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
3302336|NCT02958982|4035777|FG001|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
3302337|NCT02958982|4035778|FG002|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
3302338|NCT02958982|4035779|FG003|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
3302339|NCT02958982|4035780|FG004|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
3302340|NCT02958982|4035781|FG005|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
3302341|NCT02958982|4035782|FG006|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
3302342|NCT02958982|4035783|FG007|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
3302343|NCT02958982|4035784|FG008|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
3302344|NCT02958982|4035785|FG009|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
3302345|NCT02958982|4035786|FG010|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
3302346|NCT02958982|4035776|FG000|STARTED|Proof of Concept Study||0
3302347|NCT02958982|4035777|FG001|STARTED|Proof of Concept Study||0
3302348|NCT02958982|4035778|FG002|STARTED|Proof of Concept Study||0
3302349|NCT02958982|4035779|FG003|STARTED|Proof of Concept Study||0
3302350|NCT02958982|4035780|FG004|STARTED|Proof of Concept Study||0
3302351|NCT02958982|4035781|FG005|STARTED|Proof of Concept Study||0
3302352|NCT02958982|4035782|FG006|STARTED|Proof of Concept Study||0
3302353|NCT02958982|4035783|FG007|STARTED|Proof of Concept Study||0
3302354|NCT02958982|4035784|FG008|STARTED|Proof of Concept Study||0
3302355|NCT02958982|4035785|FG009|STARTED|Proof of Concept Study||0
3302356|NCT02958982|4035786|FG010|STARTED|Proof of Concept Study||1
3302357|NCT02958982|4035776|FG000|COMPLETED|Proof of Concept Study||0
3302358|NCT02958982|4035777|FG001|COMPLETED|Proof of Concept Study||0
3302359|NCT02958982|4035778|FG002|COMPLETED|Proof of Concept Study||0
3302360|NCT02958982|4035779|FG003|COMPLETED|Proof of Concept Study||0
3302361|NCT02958982|4035780|FG004|COMPLETED|Proof of Concept Study||0
3302362|NCT02958982|4035781|FG005|COMPLETED|Proof of Concept Study||0
3302363|NCT02958982|4035782|FG006|COMPLETED|Proof of Concept Study||0
3302364|NCT02958982|4035783|FG007|COMPLETED|Proof of Concept Study||0
3302365|NCT02958982|4035784|FG008|COMPLETED|Proof of Concept Study||0
3302366|NCT02958982|4035785|FG009|COMPLETED|Proof of Concept Study||0
3302367|NCT02958982|4035786|FG010|COMPLETED|Proof of Concept Study||1
3302368|NCT02958982|4035776|FG000|NOT COMPLETED|Proof of Concept Study||0
3302369|NCT02958982|4035777|FG001|NOT COMPLETED|Proof of Concept Study||0
2970598|NCT00797225|3685329|FG002|STARTED|Weeks 13 to 24||43
2970599|NCT00797225|3685330|FG003|STARTED|Weeks 13 to 24||0
2970600|NCT00797225|3685331|FG004|STARTED|Weeks 13 to 24||20
2970601|NCT00797225|3685332|FG005|STARTED|Weeks 13 to 24||21
2970602|NCT00797225|3685333|FG006|STARTED|Weeks 13 to 24||22
2970603|NCT00797225|3685334|FG007|STARTED|Weeks 13 to 24||22
2970604|NCT00797225|3685327|FG000|COMPLETED|Weeks 13 to 24||0
3302370|NCT02958982|4035778|FG002|NOT COMPLETED|Proof of Concept Study||0
3302371|NCT02958982|4035779|FG003|NOT COMPLETED|Proof of Concept Study||0
3302372|NCT02958982|4035780|FG004|NOT COMPLETED|Proof of Concept Study||0
3302373|NCT02958982|4035781|FG005|NOT COMPLETED|Proof of Concept Study||0
3302374|NCT02958982|4035782|FG006|NOT COMPLETED|Proof of Concept Study||0
3133223|NCT01695239|3858307|FG002|NOT COMPLETED|Double-Blind (DB) Treatment Period||10
3133224|NCT01695239|3858308|FG003|NOT COMPLETED|Double-Blind (DB) Treatment Period||7
3133225|NCT01695239|3858309|FG004|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
2970605|NCT00797225|3685328|FG001|COMPLETED|Weeks 13 to 24||38
2970606|NCT00797225|3685329|FG002|COMPLETED|Weeks 13 to 24||41
2970607|NCT00797225|3685330|FG003|COMPLETED|Weeks 13 to 24||0
2970608|NCT00797225|3685331|FG004|COMPLETED|Weeks 13 to 24||19
2970609|NCT00797225|3685332|FG005|COMPLETED|Weeks 13 to 24||21
2970610|NCT00797225|3685333|FG006|COMPLETED|Weeks 13 to 24||20
2970611|NCT00797225|3685334|FG007|COMPLETED|Weeks 13 to 24||22
2970612|NCT00797225|3685327|FG000|NOT COMPLETED|Weeks 13 to 24||0
2970613|NCT00797225|3685328|FG001|NOT COMPLETED|Weeks 13 to 24||4
2970614|NCT00797225|3685329|FG002|NOT COMPLETED|Weeks 13 to 24||2
2970615|NCT00797225|3685330|FG003|NOT COMPLETED|Weeks 13 to 24||0
2970616|NCT00797225|3685331|FG004|NOT COMPLETED|Weeks 13 to 24||1
2970617|NCT00797225|3685332|FG005|NOT COMPLETED|Weeks 13 to 24||0
2970618|NCT00797225|3685333|FG006|NOT COMPLETED|Weeks 13 to 24||2
2970619|NCT00797225|3685334|FG007|NOT COMPLETED|Weeks 13 to 24||0
2970620|NCT00797277|3685352|FG000|STARTED|Overall Study||37
2970621|NCT00797277|3685353|FG001|STARTED|Overall Study||30
2970622|NCT00797277|3685352|FG000|COMPLETED|Overall Study||37
2970623|NCT00797277|3685353|FG001|COMPLETED|Overall Study||30
2970624|NCT00797277|3685352|FG000|NOT COMPLETED|Overall Study||0
2970625|NCT00797277|3685353|FG001|NOT COMPLETED|Overall Study||0
2970626|NCT00797316|3685362|FG000|STARTED|Overall Study||267
2970627|NCT00797316|3685363|FG001|STARTED|Overall Study||265
2970628|NCT00797316|3685362|FG000|COMPLETED|Overall Study||244
2970629|NCT00797316|3685363|FG001|COMPLETED|Overall Study||233
2970630|NCT00797316|3685362|FG000|NOT COMPLETED|Overall Study||23
2970631|NCT00797316|3685363|FG001|NOT COMPLETED|Overall Study||32
2970632|NCT00797459|3685369|FG000|STARTED|Overall Study||60
2970633|NCT00797459|3685369|FG000|COMPLETED|Overall Study||60
2970634|NCT00797459|3685369|FG000|NOT COMPLETED|Overall Study||0
2970635|NCT00797511|3685377|FG000|STARTED|Overall Study||132
2970636|NCT00797511|3685377|FG000|COMPLETED|Overall Study||131
2970637|NCT00797511|3685377|FG000|NOT COMPLETED|Overall Study||1
2970638|NCT00797563|3685382|FG000|STARTED|Overall Study|number of subjects|102
2970639|NCT00797563|3685382|FG000|COMPLETED|Overall Study||101
2970640|NCT00797563|3685382|FG000|NOT COMPLETED|Overall Study||1
2970641|NCT00797667|3685389|FG000|STARTED|Overall Study||265
2970642|NCT00797667|3685390|FG001|STARTED|Overall Study||264
2970643|NCT00797667|3685391|FG002|STARTED|Overall Study||131
2970644|NCT00797667|3685389|FG000|Treated|Overall Study||263
2970645|NCT00797667|3685390|FG001|Treated|Overall Study||263
2970646|NCT00797667|3685391|FG002|Treated|Overall Study||130
2970647|NCT00797667|3685389|FG000|COMPLETED|Overall Study||5
2970648|NCT00797667|3685390|FG001|COMPLETED|Overall Study||5
2970649|NCT00797667|3685391|FG002|COMPLETED|Overall Study||4
2970650|NCT00797667|3685389|FG000|NOT COMPLETED|Overall Study||260
2970651|NCT00797667|3685390|FG001|NOT COMPLETED|Overall Study||259
2970652|NCT00797667|3685391|FG002|NOT COMPLETED|Overall Study||127
2970653|NCT00797732|3685401|FG000|STARTED|Overall Study||21
2970654|NCT00797732|3685402|FG001|STARTED|Overall Study||21
2970655|NCT00797732|3685403|FG002|STARTED|Overall Study||154
2970656|NCT00797732|3685401|FG000|Evaluable at Baseline|Overall Study||18
2970657|NCT00797732|3685402|FG001|Evaluable at Baseline|Overall Study||18
2970658|NCT00797732|3685403|FG002|Evaluable at Baseline|Overall Study||0
2970659|NCT00797732|3685401|FG000|Evaluable at 20 Weeks|Overall Study||17
2970660|NCT00797732|3685402|FG001|Evaluable at 20 Weeks|Overall Study||18
2970661|NCT00797732|3685403|FG002|Evaluable at 20 Weeks|Overall Study||0
2970662|NCT00797732|3685401|FG000|Evaluable at 12 Months|Overall Study||17
2970663|NCT00797732|3685402|FG001|Evaluable at 12 Months|Overall Study||18
2970664|NCT00797732|3685403|FG002|Evaluable at 12 Months|Overall Study||0
2970665|NCT00797732|3685401|FG000|COMPLETED|Overall Study||16
2970666|NCT00797732|3685402|FG001|COMPLETED|Overall Study||18
2970667|NCT00797732|3685403|FG002|COMPLETED|Overall Study||0
2970668|NCT00797732|3685401|FG000|NOT COMPLETED|Overall Study||5
2970669|NCT00797732|3685402|FG001|NOT COMPLETED|Overall Study||3
2970670|NCT00797732|3685403|FG002|NOT COMPLETED|Overall Study||154
2970671|NCT00797797|3685411|FG000|STARTED|Overall Study|Two patients took no background stable dose of pregabalin after randomization and are not included.|178
2970672|NCT00797797|3685412|FG001|STARTED|Overall Study||184
2970673|NCT00797797|3685411|FG000|COMPLETED|Overall Study||123
2970674|NCT00797797|3685412|FG001|COMPLETED|Overall Study||141
2970675|NCT00797797|3685411|FG000|NOT COMPLETED|Overall Study||55
2970676|NCT00797797|3685412|FG001|NOT COMPLETED|Overall Study||43
2970677|NCT00797823|3685421|FG000|STARTED|Pilot Studies|Not involved in pilot studies|0
3133226|NCT01695239|3858310|FG005|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
3133227|NCT01695239|3858311|FG006|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
3133228|NCT01695239|3858312|FG007|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
3133229|NCT01695239|3858313|FG008|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
3133230|NCT01695239|3858314|FG009|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
3133231|NCT01695239|3858315|FG010|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
3133232|NCT01695239|3858316|FG011|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
3133233|NCT01695239|3858317|FG012|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
3133234|NCT01695239|3858318|FG013|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
3133235|NCT01695239|3858305|FG000|STARTED|IR Participants (Week 16 Up To Week 24)|Only inadequate responders were included.|0
3164046|NCT01890707|3891499|FG000|STARTED|Overall Study||11
3164047|NCT01890707|3891500|FG001|STARTED|Overall Study||8
3164048|NCT01890707|3891499|FG000|COMPLETED|Overall Study||10
3164049|NCT01890707|3891500|FG001|COMPLETED|Overall Study||7
3164050|NCT01890707|3891499|FG000|NOT COMPLETED|Overall Study||1
3164051|NCT01890707|3891500|FG001|NOT COMPLETED|Overall Study||1
3164052|NCT01890746|3891508|FG000|STARTED|Overall Study||74
3302375|NCT02958982|4035783|FG007|NOT COMPLETED|Proof of Concept Study||0
3302376|NCT02958982|4035784|FG008|NOT COMPLETED|Proof of Concept Study||0
2970678|NCT00797823|3685422|FG001|STARTED|Pilot Studies|Not involved in pilot studies|0
2970679|NCT00797823|3685423|FG002|STARTED|Pilot Studies||6
2970680|NCT00797823|3685421|FG000|COMPLETED|Pilot Studies||0
2970681|NCT00797823|3685422|FG001|COMPLETED|Pilot Studies||0
2970682|NCT00797823|3685423|FG002|COMPLETED|Pilot Studies||6
2970683|NCT00797823|3685421|FG000|NOT COMPLETED|Pilot Studies||0
2970684|NCT00797823|3685422|FG001|NOT COMPLETED|Pilot Studies||0
2970685|NCT00797823|3685423|FG002|NOT COMPLETED|Pilot Studies||0
2970686|NCT00797823|3685421|FG000|STARTED|First Period (Initial Randomization)||4
2970687|NCT00797823|3685422|FG001|STARTED|First Period (Initial Randomization)||4
2970688|NCT00797823|3685423|FG002|STARTED|First Period (Initial Randomization)|Pilot studies only performed during initial period.|0
2970689|NCT00797823|3685421|FG000|COMPLETED|First Period (Initial Randomization)||3
2970690|NCT00797823|3685422|FG001|COMPLETED|First Period (Initial Randomization)||4
2970691|NCT00797823|3685423|FG002|COMPLETED|First Period (Initial Randomization)||0
2970692|NCT00797823|3685421|FG000|NOT COMPLETED|First Period (Initial Randomization)||1
2970693|NCT00797823|3685422|FG001|NOT COMPLETED|First Period (Initial Randomization)||0
2970694|NCT00797823|3685423|FG002|NOT COMPLETED|First Period (Initial Randomization)||0
2970695|NCT00797823|3685421|FG000|STARTED|Second Period (Crossover)||3
2970696|NCT00797823|3685422|FG001|STARTED|Second Period (Crossover)||4
2970697|NCT00797823|3685423|FG002|STARTED|Second Period (Crossover)||0
2970698|NCT00797823|3685421|FG000|COMPLETED|Second Period (Crossover)||3
2970699|NCT00797823|3685422|FG001|COMPLETED|Second Period (Crossover)||4
2970700|NCT00797823|3685423|FG002|COMPLETED|Second Period (Crossover)||0
2970701|NCT00797823|3685421|FG000|NOT COMPLETED|Second Period (Crossover)||0
2970702|NCT00797823|3685422|FG001|NOT COMPLETED|Second Period (Crossover)||0
2970703|NCT00797823|3685423|FG002|NOT COMPLETED|Second Period (Crossover)||0
2970704|NCT00797862|3685433|FG000|STARTED|Overall Study|3 participants were mis-randomized and discontinued. Only 617 participants received study drug.|620
2970705|NCT00797862|3685434|FG001|STARTED|Overall Study|3 participants were mis-randomized and discontinued. Only 315 participants received study drug.|318
2970706|NCT00797862|3685435|FG002|STARTED|Overall Study|1 participant was mis-randomized and discontinued. Only 315 participants received study drug.|316
2970707|NCT00797862|3685433|FG000|Entered Double-Blind Treatment (FAS)|Overall Study||617
2970708|NCT00797862|3685434|FG001|Entered Double-Blind Treatment (FAS)|Overall Study||315
2970709|NCT00797862|3685435|FG002|Entered Double-Blind Treatment (FAS)|Overall Study||315
2970710|NCT00797862|3685433|FG000|COMPLETED|Overall Study||496
2970711|NCT00797862|3685434|FG001|COMPLETED|Overall Study||250
2970712|NCT00797862|3685435|FG002|COMPLETED|Overall Study||230
2970713|NCT00797862|3685433|FG000|NOT COMPLETED|Overall Study||124
2970714|NCT00797862|3685434|FG001|NOT COMPLETED|Overall Study||68
2970715|NCT00797862|3685435|FG002|NOT COMPLETED|Overall Study||86
2970716|NCT00797966|3685447|FG000|STARTED|Phase A||0
2970717|NCT00797966|3685448|FG001|STARTED|Phase A||0
2970718|NCT00797966|3685449|FG002|STARTED|Phase A||0
2970719|NCT00797966|3685450|FG003|STARTED|Phase A||0
2970720|NCT00797966|3685451|FG004|STARTED|Phase A|850 participants entered Phase A; 849 participants were treated.|849
2970721|NCT00797966|3685452|FG005|STARTED|Phase A||0
2970722|NCT00797966|3685447|FG000|COMPLETED|Phase A||0
2970723|NCT00797966|3685448|FG001|COMPLETED|Phase A||0
2970724|NCT00797966|3685449|FG002|COMPLETED|Phase A||0
2970725|NCT00797966|3685450|FG003|COMPLETED|Phase A||0
2970726|NCT00797966|3685451|FG004|COMPLETED|Phase A||664
2970727|NCT00797966|3685452|FG005|COMPLETED|Phase A||0
2970728|NCT00797966|3685447|FG000|NOT COMPLETED|Phase A||0
2970729|NCT00797966|3685448|FG001|NOT COMPLETED|Phase A||0
2970730|NCT00797966|3685449|FG002|NOT COMPLETED|Phase A||0
2970731|NCT00797966|3685450|FG003|NOT COMPLETED|Phase A||0
2970732|NCT00797966|3685451|FG004|NOT COMPLETED|Phase A||185
2970733|NCT00797966|3685452|FG005|NOT COMPLETED|Phase A||0
2970734|NCT00797966|3685447|FG000|STARTED|Phase B|Randomized participants.|62
2970735|NCT00797966|3685448|FG001|STARTED|Phase B|Randomized participants.|120
2970736|NCT00797966|3685449|FG002|STARTED|Phase B|Randomized participants.|121
2970737|NCT00797966|3685450|FG003|STARTED|Phase B|Randomized participants.|126
2970738|NCT00797966|3685451|FG004|STARTED|Phase B||0
2970739|NCT00797966|3685452|FG005|STARTED|Phase B||0
3302377|NCT02958982|4035785|FG009|NOT COMPLETED|Proof of Concept Study||0
3302378|NCT02958982|4035786|FG010|NOT COMPLETED|Proof of Concept Study||0
3302379|NCT02958995|4035821|FG000|STARTED|Overall Study||2630666
3302380|NCT02958995|4035822|FG001|STARTED|Overall Study||107495
3302381|NCT02958995|4035821|FG000|COMPLETED|Overall Study||2630666
3302382|NCT02958995|4035822|FG001|COMPLETED|Overall Study||107495
3302383|NCT02958995|4035821|FG000|NOT COMPLETED|Overall Study||0
3302384|NCT02958995|4035822|FG001|NOT COMPLETED|Overall Study||0
3302385|NCT02959138|4035831|FG000|STARTED|Overall Study||10
2970740|NCT00797966|3685447|FG000|COMPLETED|Phase B||51
2970741|NCT00797966|3685448|FG001|COMPLETED|Phase B||102
2970742|NCT00797966|3685449|FG002|COMPLETED|Phase B||100
2970743|NCT00797966|3685450|FG003|COMPLETED|Phase B||110
3302386|NCT02959138|4035832|FG001|STARTED|Overall Study||10
2970744|NCT00797966|3685451|FG004|COMPLETED|Phase B||0
2970745|NCT00797966|3685452|FG005|COMPLETED|Phase B||0
2970746|NCT00797966|3685447|FG000|NOT COMPLETED|Phase B||11
2970747|NCT00797966|3685448|FG001|NOT COMPLETED|Phase B||18
2970748|NCT00797966|3685449|FG002|NOT COMPLETED|Phase B||21
2970749|NCT00797966|3685450|FG003|NOT COMPLETED|Phase B||16
2970750|NCT00797966|3685451|FG004|NOT COMPLETED|Phase B||0
2970751|NCT00797966|3685452|FG005|NOT COMPLETED|Phase B||0
2970752|NCT00797966|3685447|FG000|STARTED|Phase A+||0
2970753|NCT00797966|3685448|FG001|STARTED|Phase A+||0
2970754|NCT00797966|3685449|FG002|STARTED|Phase A+||0
2970755|NCT00797966|3685450|FG003|STARTED|Phase A+||0
2970756|NCT00797966|3685451|FG004|STARTED|Phase A+||0
2970757|NCT00797966|3685452|FG005|STARTED|Phase A+||235
2970758|NCT00797966|3685447|FG000|COMPLETED|Phase A+||0
2970759|NCT00797966|3685448|FG001|COMPLETED|Phase A+||0
2970760|NCT00797966|3685449|FG002|COMPLETED|Phase A+||0
2970761|NCT00797966|3685450|FG003|COMPLETED|Phase A+||0
2970762|NCT00797966|3685451|FG004|COMPLETED|Phase A+||0
2970763|NCT00797966|3685452|FG005|COMPLETED|Phase A+||207
2970764|NCT00797966|3685447|FG000|NOT COMPLETED|Phase A+||0
2970765|NCT00797966|3685448|FG001|NOT COMPLETED|Phase A+||0
2970766|NCT00797966|3685449|FG002|NOT COMPLETED|Phase A+||0
2970767|NCT00797966|3685450|FG003|NOT COMPLETED|Phase A+||0
2970768|NCT00797966|3685451|FG004|NOT COMPLETED|Phase A+||0
2970769|NCT00797966|3685452|FG005|NOT COMPLETED|Phase A+||28
2970770|NCT00798018|3685468|FG000|STARTED|Overall Study||25
2970771|NCT00798018|3685469|FG001|STARTED|Overall Study||25
2970772|NCT00798018|3685470|FG002|STARTED|Overall Study||25
2970773|NCT00798018|3685471|FG003|STARTED|Overall Study||25
2970774|NCT00798018|3685468|FG000|COMPLETED|Overall Study||25
2970775|NCT00798018|3685469|FG001|COMPLETED|Overall Study||25
2970776|NCT00798018|3685470|FG002|COMPLETED|Overall Study||25
2970777|NCT00798018|3685471|FG003|COMPLETED|Overall Study||25
2970778|NCT00798018|3685468|FG000|NOT COMPLETED|Overall Study||0
2970779|NCT00798018|3685469|FG001|NOT COMPLETED|Overall Study||0
2970780|NCT00798018|3685470|FG002|NOT COMPLETED|Overall Study||0
2970781|NCT00798018|3685471|FG003|NOT COMPLETED|Overall Study||0
2970782|NCT00798096|3685481|FG000|STARTED|Overall Study|Treatment with 200 mg bid, oral Fostamatanib until disease progression, toxicity or withdrawal|18
2970783|NCT00798096|3685481|FG000|COMPLETED|Overall Study|Completion of Study is defined as a minimum of 8 weeks of treatment or early disease progression|16
2970784|NCT00798096|3685481|FG000|NOT COMPLETED|Overall Study||2
2970785|NCT00798135|3685485|FG000|STARTED|Overall Study||13
2970786|NCT00798135|3685485|FG000|COMPLETED|Overall Study||0
2970787|NCT00798135|3685485|FG000|NOT COMPLETED|Overall Study||13
2970788|NCT00798161|3685496|FG000|STARTED|Overall Study||72
2970789|NCT00798161|3685497|FG001|STARTED|Overall Study||144
2970790|NCT00798161|3685498|FG002|STARTED|Overall Study||147
2970791|NCT00798161|3685499|FG003|STARTED|Overall Study||142
3164053|NCT01890746|3891509|FG001|STARTED|Overall Study||74
3302387|NCT02959138|4035833|FG002|STARTED|Overall Study||16
3302388|NCT02959138|4035831|FG000|COMPLETED|Overall Study||10
3302389|NCT02959138|4035832|FG001|COMPLETED|Overall Study||9
3302390|NCT02959138|4035833|FG002|COMPLETED|Overall Study||16
3302391|NCT02959138|4035831|FG000|NOT COMPLETED|Overall Study||0
3302392|NCT02959138|4035832|FG001|NOT COMPLETED|Overall Study||1
3302393|NCT02959138|4035833|FG002|NOT COMPLETED|Overall Study||0
3302394|NCT02959177|4035848|FG000|STARTED|Double-Blind Treatment Phase||115
3302395|NCT02959177|4035849|FG001|STARTED|Double-Blind Treatment Phase||114
3302396|NCT02959177|4035850|FG002|STARTED|Double-Blind Treatment Phase||230
3302397|NCT02959177|4035848|FG000|Received at Least 1 Dose of Study Drug|Double-Blind Treatment Phase||115
3302398|NCT02959177|4035849|FG001|Received at Least 1 Dose of Study Drug|Double-Blind Treatment Phase||114
3302399|NCT02959177|4035850|FG002|Received at Least 1 Dose of Study Drug|Double-Blind Treatment Phase||230
3302400|NCT02959177|4035848|FG000|COMPLETED|Double-Blind Treatment Phase||104
3302401|NCT02959177|4035849|FG001|COMPLETED|Double-Blind Treatment Phase||111
3302402|NCT02959177|4035850|FG002|COMPLETED|Double-Blind Treatment Phase||225
3302403|NCT02959177|4035848|FG000|NOT COMPLETED|Double-Blind Treatment Phase||11
3302404|NCT02959177|4035849|FG001|NOT COMPLETED|Double-Blind Treatment Phase||3
3302405|NCT02959177|4035850|FG002|NOT COMPLETED|Double-Blind Treatment Phase||5
3302406|NCT02959177|4035848|FG000|STARTED|Follow-up Post Treatment Phase|Not all participants entered Post Treatment Follow-up Phase|52
3302407|NCT02959177|4035849|FG001|STARTED|Follow-up Post Treatment Phase|Not all participants entered Post Treatment Follow-up Phase|52
3302408|NCT02959177|4035850|FG002|STARTED|Follow-up Post Treatment Phase|Not all participants entered Post Treatment Follow-up Phase|100
3302409|NCT02959177|4035848|FG000|COMPLETED|Follow-up Post Treatment Phase||51
3302410|NCT02959177|4035849|FG001|COMPLETED|Follow-up Post Treatment Phase||51
3302411|NCT02959177|4035850|FG002|COMPLETED|Follow-up Post Treatment Phase||98
3302412|NCT02959177|4035848|FG000|NOT COMPLETED|Follow-up Post Treatment Phase||1
3302413|NCT02959177|4035849|FG001|NOT COMPLETED|Follow-up Post Treatment Phase||1
3302414|NCT02959177|4035850|FG002|NOT COMPLETED|Follow-up Post Treatment Phase||2
3302415|NCT02959190|4035868|FG000|STARTED|Open Label||120
3302416|NCT02959190|4035869|FG001|STARTED|Open Label||126
3302417|NCT02959190|4035870|FG002|STARTED|Open Label||32
3302418|NCT02959190|4035871|FG003|STARTED|Open Label||33
3302419|NCT02959190|4035868|FG000|Received at Least 1 Dose of Study Drug|Open Label||120
3302420|NCT02959190|4035869|FG001|Received at Least 1 Dose of Study Drug|Open Label||126
3302421|NCT02959190|4035870|FG002|Received at Least 1 Dose of Study Drug|Open Label||32
2970792|NCT00798161|3685500|FG004|STARTED|Overall Study||143
3164054|NCT01890746|3891508|FG000|COMPLETED|Overall Study||22
3164055|NCT01890746|3891509|FG001|COMPLETED|Overall Study||33
2970793|NCT00798161|3685501|FG005|STARTED|Overall Study||143
2970794|NCT00798161|3685502|FG006|STARTED|Overall Study||66
2970795|NCT00798161|3685496|FG000|COMPLETED|Overall Study||54
2970796|NCT00798161|3685497|FG001|COMPLETED|Overall Study||127
2970797|NCT00798161|3685498|FG002|COMPLETED|Overall Study||126
2970798|NCT00798161|3685499|FG003|COMPLETED|Overall Study||121
2970799|NCT00798161|3685500|FG004|COMPLETED|Overall Study||127
2970800|NCT00798161|3685501|FG005|COMPLETED|Overall Study||132
2970801|NCT00798161|3685502|FG006|COMPLETED|Overall Study||56
2970802|NCT00798161|3685496|FG000|NOT COMPLETED|Overall Study||18
2970803|NCT00798161|3685497|FG001|NOT COMPLETED|Overall Study||17
2970804|NCT00798161|3685498|FG002|NOT COMPLETED|Overall Study||21
2970805|NCT00798161|3685499|FG003|NOT COMPLETED|Overall Study||21
2970806|NCT00798161|3685500|FG004|NOT COMPLETED|Overall Study||16
2970807|NCT00798161|3685501|FG005|NOT COMPLETED|Overall Study||11
2970808|NCT00798161|3685502|FG006|NOT COMPLETED|Overall Study||10
2970809|NCT00798174|3685518|FG000|STARTED|Overall Study||16
2970810|NCT00798174|3685519|FG001|STARTED|Overall Study||16
2970811|NCT00798174|3685518|FG000|COMPLETED|Overall Study||12
2970812|NCT00798174|3685519|FG001|COMPLETED|Overall Study||13
2970813|NCT00798174|3685518|FG000|NOT COMPLETED|Overall Study||4
2970814|NCT00798174|3685519|FG001|NOT COMPLETED|Overall Study||3
2970815|NCT00798304|3685526|FG000|STARTED|Overall Study||14
2970816|NCT00798304|3685527|FG001|STARTED|Overall Study||22
2970817|NCT00798304|3685528|FG002|STARTED|Overall Study||10
2970818|NCT00798304|3685526|FG000|COMPLETED|Overall Study||0
2970819|NCT00798304|3685527|FG001|COMPLETED|Overall Study||0
2970820|NCT00798304|3685528|FG002|COMPLETED|Overall Study||0
2970821|NCT00798304|3685526|FG000|NOT COMPLETED|Overall Study||14
2970822|NCT00798304|3685527|FG001|NOT COMPLETED|Overall Study||22
2970823|NCT00798304|3685528|FG002|NOT COMPLETED|Overall Study||10
2970824|NCT00798317|3685538|FG000|STARTED|Overall Study||245
2970825|NCT00798317|3685539|FG001|STARTED|Overall Study||81
2970826|NCT00798317|3685538|FG000|COMPLETED|Overall Study||235
2970827|NCT00798317|3685539|FG001|COMPLETED|Overall Study||74
2970828|NCT00798317|3685538|FG000|NOT COMPLETED|Overall Study||10
2970829|NCT00798317|3685539|FG001|NOT COMPLETED|Overall Study||7
2970830|NCT00798369|3685551|FG000|STARTED|Overall Study||28
2970831|NCT00798369|3685552|FG001|STARTED|Overall Study||29
2970832|NCT00798369|3685553|FG002|STARTED|Overall Study||29
2970833|NCT00798369|3685554|FG003|STARTED|Overall Study||29
2970834|NCT00798369|3685555|FG004|STARTED|Overall Study||28
2970835|NCT00798369|3685556|FG005|STARTED|Overall Study||57
2970836|NCT00798369|3685551|FG000|COMPLETED|Overall Study||27
2970837|NCT00798369|3685552|FG001|COMPLETED|Overall Study||28
2970838|NCT00798369|3685553|FG002|COMPLETED|Overall Study||27
2970839|NCT00798369|3685554|FG003|COMPLETED|Overall Study||28
2970840|NCT00798369|3685555|FG004|COMPLETED|Overall Study||27
2970841|NCT00798369|3685556|FG005|COMPLETED|Overall Study||54
2970842|NCT00798369|3685551|FG000|NOT COMPLETED|Overall Study||1
2970843|NCT00798369|3685552|FG001|NOT COMPLETED|Overall Study||1
2970844|NCT00798369|3685553|FG002|NOT COMPLETED|Overall Study||2
2970845|NCT00798369|3685554|FG003|NOT COMPLETED|Overall Study||1
2970846|NCT00798369|3685555|FG004|NOT COMPLETED|Overall Study||1
2970847|NCT00798369|3685556|FG005|NOT COMPLETED|Overall Study||3
2970848|NCT00798434|3685573|FG000|STARTED|Double-Blind||396
2970849|NCT00798434|3685574|FG001|STARTED|Double-Blind||398
2970850|NCT00798434|3685573|FG000|Received Treatment|Double-Blind||393
2970851|NCT00798434|3685574|FG001|Received Treatment|Double-Blind||392
2970852|NCT00798434|3685573|FG000|COMPLETED|Double-Blind||341
3302422|NCT02959190|4035871|FG003|Received at Least 1 Dose of Study Drug|Open Label||33
3302423|NCT02959190|4035868|FG000|120mg/120mg Galcanezumab - EM|Open Label||58
3302424|NCT02959190|4035869|FG001|120mg/120mg Galcanezumab - EM|Open Label||0
3302425|NCT02959190|4035870|FG002|120mg/120mg Galcanezumab - EM|Open Label||0
3302426|NCT02959190|4035871|FG003|120mg/120mg Galcanezumab - EM|Open Label||0
3302427|NCT02959190|4035868|FG000|240mg/240mg Galcanezumab - EM|Open Label||0
3302428|NCT02959190|4035869|FG001|240mg/240mg Galcanezumab - EM|Open Label||62
3302429|NCT02959190|4035870|FG002|240mg/240mg Galcanezumab - EM|Open Label||0
3302430|NCT02959190|4035871|FG003|240mg/240mg Galcanezumab - EM|Open Label||0
3302431|NCT02959190|4035868|FG000|Placebo/ 120mg Galcanezumab - EM|Open Label||62
3302432|NCT02959190|4035869|FG001|Placebo/ 120mg Galcanezumab - EM|Open Label||0
3302433|NCT02959190|4035870|FG002|Placebo/ 120mg Galcanezumab - EM|Open Label||0
3302434|NCT02959190|4035871|FG003|Placebo/ 120mg Galcanezumab - EM|Open Label||0
3302435|NCT02959190|4035868|FG000|Placebo/ 240mg Galcanezumab - EM|Open Label||0
3302436|NCT02959190|4035869|FG001|Placebo/ 240mg Galcanezumab - EM|Open Label||64
3302437|NCT02959190|4035870|FG002|Placebo/ 240mg Galcanezumab - EM|Open Label||0
3302438|NCT02959190|4035871|FG003|Placebo/ 240mg Galcanezumab - EM|Open Label||0
3302439|NCT02959190|4035868|FG000|COMPLETED|Open Label||113
3302440|NCT02959190|4035869|FG001|COMPLETED|Open Label||110
3302441|NCT02959190|4035870|FG002|COMPLETED|Open Label||28
3302442|NCT02959190|4035871|FG003|COMPLETED|Open Label||27
3302443|NCT02959190|4035868|FG000|NOT COMPLETED|Open Label||7
3302444|NCT02959190|4035869|FG001|NOT COMPLETED|Open Label||16
3302445|NCT02959190|4035870|FG002|NOT COMPLETED|Open Label||4
2970853|NCT00798434|3685574|FG001|COMPLETED|Double-Blind||314
3164056|NCT01890746|3891508|FG000|NOT COMPLETED|Overall Study||52
2970854|NCT00798434|3685573|FG000|NOT COMPLETED|Double-Blind||55
3164057|NCT01890746|3891509|FG001|NOT COMPLETED|Overall Study||41
2970855|NCT00798434|3685574|FG001|NOT COMPLETED|Double-Blind||84
2970856|NCT00798434|3685573|FG000|STARTED|Open-Label||341
2970857|NCT00798434|3685574|FG001|STARTED|Open-Label||314
2970858|NCT00798434|3685573|FG000|Received Treatment|Open-Label||341
2970859|NCT00798434|3685574|FG001|Received Treatment|Open-Label||313
2970860|NCT00798434|3685573|FG000|COMPLETED|Open-Label||299
2970861|NCT00798434|3685574|FG001|COMPLETED|Open-Label||282
2970862|NCT00798434|3685573|FG000|NOT COMPLETED|Open-Label||42
2970863|NCT00798434|3685574|FG001|NOT COMPLETED|Open-Label||32
2970864|NCT00798486|3685585|FG000|STARTED|Overall Study||110
2970865|NCT00798486|3685585|FG000|COMPLETED|Overall Study||110
2970866|NCT00798486|3685585|FG000|NOT COMPLETED|Overall Study||0
2970867|NCT00798577|3685591|FG000|STARTED|Overall Study||17
2970868|NCT00798577|3685592|FG001|STARTED|Overall Study||7
2970869|NCT00798577|3685591|FG000|COMPLETED|Overall Study||17
2970870|NCT00798577|3685592|FG001|COMPLETED|Overall Study||7
2970871|NCT00798577|3685591|FG000|NOT COMPLETED|Overall Study||0
2970872|NCT00798577|3685592|FG001|NOT COMPLETED|Overall Study||0
2970873|NCT00798603|3685598|FG000|STARTED|Overall Study||62
2970874|NCT00798603|3685598|FG000|COMPLETED|Overall Study||27
2970875|NCT00798603|3685598|FG000|NOT COMPLETED|Overall Study||35
2970876|NCT00798655|3685602|FG000|STARTED|Overall Study||46
2970877|NCT00798655|3685602|FG000|COMPLETED|Overall Study||44
2970878|NCT00798655|3685602|FG000|NOT COMPLETED|Overall Study||2
2970879|NCT00798694|3685608|FG000|STARTED|Overall Study||30
2970880|NCT00798694|3685609|FG001|STARTED|Overall Study||28
2970881|NCT00798694|3685608|FG000|COMPLETED|Overall Study||28
2970882|NCT00798694|3685609|FG001|COMPLETED|Overall Study||27
2970883|NCT00798694|3685608|FG000|NOT COMPLETED|Overall Study||2
2970884|NCT00798694|3685609|FG001|NOT COMPLETED|Overall Study||1
2970885|NCT00798707|3685624|FG000|STARTED|Overall Study||235
2970886|NCT00798707|3685625|FG001|STARTED|Overall Study||237
2970887|NCT00798707|3685626|FG002|STARTED|Overall Study||237
2970888|NCT00798707|3685624|FG000|Treated|Overall Study||231
2970889|NCT00798707|3685625|FG001|Treated|Overall Study||232
2970890|NCT00798707|3685626|FG002|Treated|Overall Study||236
2970891|NCT00798707|3685624|FG000|COMPLETED|Overall Study||209
2970892|NCT00798707|3685625|FG001|COMPLETED|Overall Study||204
2970893|NCT00798707|3685626|FG002|COMPLETED|Overall Study||215
2970894|NCT00798707|3685624|FG000|NOT COMPLETED|Overall Study||26
2970895|NCT00798707|3685625|FG001|NOT COMPLETED|Overall Study||33
2970896|NCT00798707|3685626|FG002|NOT COMPLETED|Overall Study||22
2970897|NCT00798720|3685634|FG000|STARTED|Overall Study||18
2970898|NCT00798720|3685634|FG000|COMPLETED|Overall Study||18
2970899|NCT00798720|3685634|FG000|NOT COMPLETED|Overall Study||0
2970900|NCT00798759|3685640|FG000|STARTED|Overall Study||117
2970901|NCT00798759|3685641|FG001|STARTED|Overall Study||119
2970902|NCT00798759|3685640|FG000|COMPLETED|Overall Study||109
2970903|NCT00798759|3685641|FG001|COMPLETED|Overall Study||106
2970904|NCT00798759|3685640|FG000|NOT COMPLETED|Overall Study||8
2970905|NCT00798759|3685641|FG001|NOT COMPLETED|Overall Study||13
2970906|NCT00798889|3685647|FG000|STARTED|Overall Study||314
2970907|NCT00798889|3685647|FG000|Treated|Overall Study||311
2970908|NCT00798889|3685647|FG000|COMPLETED|Overall Study||0
2970909|NCT00798889|3685647|FG000|NOT COMPLETED|Overall Study||314
2970910|NCT00798967|3685653|FG000|STARTED|Overall Study||43
2970911|NCT00798967|3685654|FG001|STARTED|Overall Study||43
2970912|NCT00798967|3685653|FG000|Discontinued During Dosing Period|Overall Study||4
2970913|NCT00798967|3685654|FG001|Discontinued During Dosing Period|Overall Study||4
2970914|NCT00798967|3685653|FG000|COMPLETED|Overall Study||39
2970915|NCT00798967|3685654|FG001|COMPLETED|Overall Study||39
2970916|NCT00798967|3685653|FG000|NOT COMPLETED|Overall Study||4
2970917|NCT00798967|3685654|FG001|NOT COMPLETED|Overall Study||4
2970918|NCT00799227|3685661|FG000|STARTED|Overall Study||56
2970919|NCT00799227|3685661|FG000|COMPLETED|Overall Study||53
2970920|NCT00799227|3685661|FG000|NOT COMPLETED|Overall Study||3
3302446|NCT02959190|4035871|FG003|NOT COMPLETED|Open Label||6
3302447|NCT02959190|4035868|FG000|STARTED|Post Treatment Follow Up|Participants who discontinued open-label treatment phase had an option to enter post treatment phase|117
3317003|NCT03122860|4050497|FG004|STARTED|Overall Study||117
3317004|NCT03122860|4050498|FG005|STARTED|Overall Study||117
2970921|NCT00799383|3685667|FG000|STARTED|Overall Study||23
2970922|NCT00799383|3685668|FG001|STARTED|Overall Study||24
2970923|NCT00799383|3685667|FG000|COMPLETED|Overall Study||20
2970924|NCT00799383|3685668|FG001|COMPLETED|Overall Study||18
2970925|NCT00799383|3685667|FG000|NOT COMPLETED|Overall Study||3
2970926|NCT00799383|3685668|FG001|NOT COMPLETED|Overall Study||6
2970927|NCT00799409|3685677|FG000|STARTED|Overall Study||7
2970928|NCT00799409|3685678|FG001|STARTED|Overall Study||36
2970929|NCT00799409|3685679|FG002|STARTED|Overall Study||35
2970930|NCT00799409|3685677|FG000|COMPLETED|Overall Study||0
2970931|NCT00799409|3685678|FG001|COMPLETED|Overall Study||36
2970932|NCT00799409|3685679|FG002|COMPLETED|Overall Study||35
2970933|NCT00799409|3685677|FG000|NOT COMPLETED|Overall Study||7
2970934|NCT00799409|3685678|FG001|NOT COMPLETED|Overall Study||0
2970935|NCT00799409|3685679|FG002|NOT COMPLETED|Overall Study||0
2970936|NCT00799422|3685687|FG000|STARTED|First Week of Wear||4
2970937|NCT00799422|3685688|FG001|STARTED|First Week of Wear||4
2970938|NCT00799422|3685689|FG002|STARTED|First Week of Wear||4
2970939|NCT00799422|3685690|FG003|STARTED|First Week of Wear||5
2970940|NCT00799422|3685691|FG004|STARTED|First Week of Wear||4
2970941|NCT00799422|3685692|FG005|STARTED|First Week of Wear||5
2970942|NCT00799422|3685687|FG000|COMPLETED|First Week of Wear||4
2970943|NCT00799422|3685688|FG001|COMPLETED|First Week of Wear||4
2970944|NCT00799422|3685689|FG002|COMPLETED|First Week of Wear||3
2970945|NCT00799422|3685690|FG003|COMPLETED|First Week of Wear||4
2970946|NCT00799422|3685691|FG004|COMPLETED|First Week of Wear||4
2970947|NCT00799422|3685692|FG005|COMPLETED|First Week of Wear||5
2970948|NCT00799422|3685687|FG000|NOT COMPLETED|First Week of Wear||0
2970949|NCT00799422|3685688|FG001|NOT COMPLETED|First Week of Wear||0
2970950|NCT00799422|3685689|FG002|NOT COMPLETED|First Week of Wear||1
2970951|NCT00799422|3685690|FG003|NOT COMPLETED|First Week of Wear||1
2970952|NCT00799422|3685691|FG004|NOT COMPLETED|First Week of Wear||0
2970953|NCT00799422|3685692|FG005|NOT COMPLETED|First Week of Wear||0
2970954|NCT00799422|3685687|FG000|STARTED|Second Week of Wear||4
2970955|NCT00799422|3685688|FG001|STARTED|Second Week of Wear||4
2970956|NCT00799422|3685689|FG002|STARTED|Second Week of Wear||3
2970957|NCT00799422|3685690|FG003|STARTED|Second Week of Wear|One subject discontinued between First and Second 3 weeks (adverse event)|3
2970958|NCT00799422|3685691|FG004|STARTED|Second Week of Wear||4
2970959|NCT00799422|3685692|FG005|STARTED|Second Week of Wear|One subject discontinued between First and Second 3 weeks (adverse event)|4
2970960|NCT00799422|3685687|FG000|COMPLETED|Second Week of Wear||4
2970961|NCT00799422|3685688|FG001|COMPLETED|Second Week of Wear||4
2970962|NCT00799422|3685689|FG002|COMPLETED|Second Week of Wear||3
2970963|NCT00799422|3685690|FG003|COMPLETED|Second Week of Wear||3
2970964|NCT00799422|3685691|FG004|COMPLETED|Second Week of Wear||4
2970965|NCT00799422|3685692|FG005|COMPLETED|Second Week of Wear||4
2970966|NCT00799422|3685687|FG000|NOT COMPLETED|Second Week of Wear||0
2970967|NCT00799422|3685688|FG001|NOT COMPLETED|Second Week of Wear||0
2970968|NCT00799422|3685689|FG002|NOT COMPLETED|Second Week of Wear||0
2970969|NCT00799422|3685690|FG003|NOT COMPLETED|Second Week of Wear||0
2970970|NCT00799422|3685691|FG004|NOT COMPLETED|Second Week of Wear||0
2970971|NCT00799422|3685692|FG005|NOT COMPLETED|Second Week of Wear||0
2970972|NCT00799422|3685687|FG000|STARTED|Third Week of Wear||4
2970973|NCT00799422|3685688|FG001|STARTED|Third Week of Wear||4
2970974|NCT00799422|3685689|FG002|STARTED|Third Week of Wear||3
2970975|NCT00799422|3685690|FG003|STARTED|Third Week of Wear||3
2970976|NCT00799422|3685691|FG004|STARTED|Third Week of Wear||4
2970977|NCT00799422|3685692|FG005|STARTED|Third Week of Wear||4
2970978|NCT00799422|3685687|FG000|COMPLETED|Third Week of Wear||4
2970979|NCT00799422|3685688|FG001|COMPLETED|Third Week of Wear||4
2970980|NCT00799422|3685689|FG002|COMPLETED|Third Week of Wear||3
2970981|NCT00799422|3685690|FG003|COMPLETED|Third Week of Wear||3
2970982|NCT00799422|3685691|FG004|COMPLETED|Third Week of Wear||4
2970983|NCT00799422|3685692|FG005|COMPLETED|Third Week of Wear||4
2970984|NCT00799422|3685687|FG000|NOT COMPLETED|Third Week of Wear||0
2970985|NCT00799422|3685688|FG001|NOT COMPLETED|Third Week of Wear||0
2970986|NCT00799422|3685689|FG002|NOT COMPLETED|Third Week of Wear||0
2970987|NCT00799422|3685690|FG003|NOT COMPLETED|Third Week of Wear||0
2970988|NCT00799422|3685691|FG004|NOT COMPLETED|Third Week of Wear||0
2970989|NCT00799422|3685692|FG005|NOT COMPLETED|Third Week of Wear||0
2970990|NCT00799435|3685702|FG000|STARTED|Overall Study||1
2970991|NCT00799435|3685703|FG001|STARTED|Overall Study||1
2970992|NCT00799435|3685702|FG000|COMPLETED|Overall Study||1
2970993|NCT00799435|3685703|FG001|COMPLETED|Overall Study||1
2970994|NCT00799435|3685702|FG000|NOT COMPLETED|Overall Study||0
2970995|NCT00799435|3685703|FG001|NOT COMPLETED|Overall Study||0
2970996|NCT00799474|3685709|FG000|STARTED|Overall Study||609
2970997|NCT00799474|3685709|FG000|COMPLETED|Overall Study||609
2970998|NCT00799474|3685709|FG000|NOT COMPLETED|Overall Study||0
2970999|NCT00799487|3685716|FG000|STARTED|Dose Adjustment Period||21
2971000|NCT00799487|3685717|FG001|STARTED|Dose Adjustment Period||34
2971001|NCT00799487|3685718|FG002|STARTED|Dose Adjustment Period||34
2971002|NCT00799487|3685716|FG000|COMPLETED|Dose Adjustment Period||0
2971003|NCT00799487|3685717|FG001|COMPLETED|Dose Adjustment Period||34
2971004|NCT00799487|3685718|FG002|COMPLETED|Dose Adjustment Period||34
2971005|NCT00799487|3685716|FG000|NOT COMPLETED|Dose Adjustment Period||21
2971006|NCT00799487|3685717|FG001|NOT COMPLETED|Dose Adjustment Period||0
2971007|NCT00799487|3685718|FG002|NOT COMPLETED|Dose Adjustment Period||0
2971008|NCT00799487|3685716|FG000|STARTED|Double-Blind Assessment Period||0
2971009|NCT00799487|3685717|FG001|STARTED|Double-Blind Assessment Period||34
2971010|NCT00799487|3685718|FG002|STARTED|Double-Blind Assessment Period||34
2971011|NCT00799487|3685716|FG000|COMPLETED|Double-Blind Assessment Period||0
2971012|NCT00799487|3685717|FG001|COMPLETED|Double-Blind Assessment Period||33
2971013|NCT00799487|3685718|FG002|COMPLETED|Double-Blind Assessment Period||32
2971014|NCT00799487|3685716|FG000|NOT COMPLETED|Double-Blind Assessment Period||0
2971015|NCT00799487|3685717|FG001|NOT COMPLETED|Double-Blind Assessment Period||1
2971016|NCT00799487|3685718|FG002|NOT COMPLETED|Double-Blind Assessment Period||2
2971017|NCT00799578|3685729|FG000|STARTED|Overall Study||13
2971018|NCT00799578|3685729|FG000|COMPLETED|Overall Study||11
2971019|NCT00799578|3685729|FG000|NOT COMPLETED|Overall Study||2
2971020|NCT00799591|3685733|FG000|STARTED|Overall Study||156
2971021|NCT00799591|3685733|FG000|COMPLETED|Overall Study||90
2971022|NCT00799591|3685733|FG000|NOT COMPLETED|Overall Study||66
2971023|NCT00799604|3685740|FG000|STARTED|Bolus 1 (Pre-anesthesia)||10
2971024|NCT00799604|3685741|FG001|STARTED|Bolus 1 (Pre-anesthesia)||10
2971025|NCT00799604|3685742|FG002|STARTED|Bolus 1 (Pre-anesthesia)||10
2971026|NCT00799604|3685740|FG000|COMPLETED|Bolus 1 (Pre-anesthesia)||10
2971027|NCT00799604|3685741|FG001|COMPLETED|Bolus 1 (Pre-anesthesia)||10
2971028|NCT00799604|3685742|FG002|COMPLETED|Bolus 1 (Pre-anesthesia)||10
2971029|NCT00799604|3685740|FG000|NOT COMPLETED|Bolus 1 (Pre-anesthesia)||0
2971030|NCT00799604|3685741|FG001|NOT COMPLETED|Bolus 1 (Pre-anesthesia)||0
2971031|NCT00799604|3685742|FG002|NOT COMPLETED|Bolus 1 (Pre-anesthesia)||0
2971032|NCT00799604|3685740|FG000|STARTED|Bolus 2 (With Anesthesia)|Dose determined per discretion of investigator at 250, 500 or 125μg, based on response to Bolus 1.|6
2971033|NCT00799604|3685741|FG001|STARTED|Bolus 2 (With Anesthesia)|Dose determined per discretion of investigator at 250, 500 or 125μg, based on response to Bolus 1.|12
2971034|NCT00799604|3685742|FG002|STARTED|Bolus 2 (With Anesthesia)|Dose determined per discretion of investigator at 250, 500 or 125μg, based on response to Bolus 1.|3
2971035|NCT00799604|3685740|FG000|COMPLETED|Bolus 2 (With Anesthesia)||6
2971036|NCT00799604|3685741|FG001|COMPLETED|Bolus 2 (With Anesthesia)||12
2971037|NCT00799604|3685742|FG002|COMPLETED|Bolus 2 (With Anesthesia)||3
2971038|NCT00799604|3685740|FG000|NOT COMPLETED|Bolus 2 (With Anesthesia)||0
2971039|NCT00799604|3685741|FG001|NOT COMPLETED|Bolus 2 (With Anesthesia)||0
2971040|NCT00799604|3685742|FG002|NOT COMPLETED|Bolus 2 (With Anesthesia)||0
2971041|NCT00799617|3685752|FG000|STARTED|Main Testosterone Trial||395
2971042|NCT00799617|3685753|FG001|STARTED|Main Testosterone Trial||395
2971043|NCT00799617|3685752|FG000|COMPLETED|Main Testosterone Trial|Participants qualified for 1 of the 3 main trials (sexual function, physical function, vitality).|376
2971044|NCT00799617|3685753|FG001|COMPLETED|Main Testosterone Trial||374
2971045|NCT00799617|3685752|FG000|NOT COMPLETED|Main Testosterone Trial||19
2971046|NCT00799617|3685753|FG001|NOT COMPLETED|Main Testosterone Trial||21
2971047|NCT00799617|3685752|FG000|STARTED|Sexual Funtion Trial||234
2971048|NCT00799617|3685753|FG001|STARTED|Sexual Funtion Trial||236
2971049|NCT00799617|3685752|FG000|COMPLETED|Sexual Funtion Trial||218
2971050|NCT00799617|3685753|FG001|COMPLETED|Sexual Funtion Trial||215
2971051|NCT00799617|3685752|FG000|NOT COMPLETED|Sexual Funtion Trial||16
2971052|NCT00799617|3685753|FG001|NOT COMPLETED|Sexual Funtion Trial||21
2971053|NCT00799617|3685752|FG000|STARTED|Physical Function Trial||191
2971054|NCT00799617|3685753|FG001|STARTED|Physical Function Trial||196
2971055|NCT00799617|3685752|FG000|COMPLETED|Physical Function Trial||185
2971056|NCT00799617|3685753|FG001|COMPLETED|Physical Function Trial||185
2971057|NCT00799617|3685752|FG000|NOT COMPLETED|Physical Function Trial||6
2971058|NCT00799617|3685753|FG001|NOT COMPLETED|Physical Function Trial||11
2971059|NCT00799617|3685752|FG000|STARTED|Vitality Trial||236
2971060|NCT00799617|3685753|FG001|STARTED|Vitality Trial||238
2971061|NCT00799617|3685752|FG000|COMPLETED|Vitality Trial||229
2971062|NCT00799617|3685753|FG001|COMPLETED|Vitality Trial||216
2971063|NCT00799617|3685752|FG000|NOT COMPLETED|Vitality Trial||7
2971064|NCT00799617|3685753|FG001|NOT COMPLETED|Vitality Trial||22
2971065|NCT00799617|3685752|FG000|STARTED|Cardiovascular Trial||88
2971066|NCT00799617|3685753|FG001|STARTED|Cardiovascular Trial||82
2971067|NCT00799617|3685752|FG000|COMPLETED|Cardiovascular Trial||73
2971068|NCT00799617|3685753|FG001|COMPLETED|Cardiovascular Trial||65
2971069|NCT00799617|3685752|FG000|NOT COMPLETED|Cardiovascular Trial||15
3164058|NCT01890759|3891517|FG000|STARTED|Overall Study||100
3164059|NCT01890759|3891518|FG001|STARTED|Overall Study||200
3164060|NCT01890759|3891517|FG000|COMPLETED|Overall Study||98
3164061|NCT01890759|3891518|FG001|COMPLETED|Overall Study||188
3164062|NCT01890759|3891517|FG000|NOT COMPLETED|Overall Study||2
3164063|NCT01890759|3891518|FG001|NOT COMPLETED|Overall Study||12
2971070|NCT00799617|3685753|FG001|NOT COMPLETED|Cardiovascular Trial||17
2971071|NCT00799617|3685752|FG000|STARTED|Bone Trial||110
2971072|NCT00799617|3685753|FG001|STARTED|Bone Trial||101
2971073|NCT00799617|3685752|FG000|COMPLETED|Bone Trial||104
2971074|NCT00799617|3685753|FG001|COMPLETED|Bone Trial||85
2971075|NCT00799617|3685752|FG000|NOT COMPLETED|Bone Trial||6
2971076|NCT00799617|3685753|FG001|NOT COMPLETED|Bone Trial||16
2971077|NCT00799617|3685752|FG000|STARTED|Cognitive Function Trial||247
2971078|NCT00799617|3685753|FG001|STARTED|Cognitive Function Trial||246
2971079|NCT00799617|3685752|FG000|COMPLETED|Cognitive Function Trial||247
2971080|NCT00799617|3685753|FG001|COMPLETED|Cognitive Function Trial||245
2971081|NCT00799617|3685752|FG000|NOT COMPLETED|Cognitive Function Trial||0
2971082|NCT00799617|3685753|FG001|NOT COMPLETED|Cognitive Function Trial||1
2971083|NCT00799617|3685752|FG000|STARTED|Anemia Trial||27
2971084|NCT00799617|3685753|FG001|STARTED|Anemia Trial||35
2971085|NCT00799617|3685752|FG000|COMPLETED|Anemia Trial||24
2971086|NCT00799617|3685753|FG001|COMPLETED|Anemia Trial||32
2971087|NCT00799617|3685752|FG000|NOT COMPLETED|Anemia Trial||3
2971088|NCT00799617|3685753|FG001|NOT COMPLETED|Anemia Trial||3
2971089|NCT00799643|3685761|FG000|STARTED|Overall Study||140
2971090|NCT00799643|3685762|FG001|STARTED|Overall Study||146
2971091|NCT00799643|3685761|FG000|COMPLETED|Overall Study||115
2971092|NCT00799643|3685762|FG001|COMPLETED|Overall Study||119
2971093|NCT00799643|3685761|FG000|NOT COMPLETED|Overall Study||25
2971094|NCT00799643|3685762|FG001|NOT COMPLETED|Overall Study||27
2971095|NCT00799708|3685772|FG000|STARTED|Overall Study||10
2971096|NCT00799708|3685773|FG001|STARTED|Overall Study||6
2971097|NCT00799708|3685774|FG002|STARTED|Overall Study||11
2971098|NCT00799708|3685772|FG000|COMPLETED|Overall Study||9
2971099|NCT00799708|3685773|FG001|COMPLETED|Overall Study||6
2971100|NCT00799708|3685774|FG002|COMPLETED|Overall Study||11
2971101|NCT00799708|3685772|FG000|NOT COMPLETED|Overall Study||1
2971102|NCT00799708|3685773|FG001|NOT COMPLETED|Overall Study||0
2971103|NCT00799708|3685774|FG002|NOT COMPLETED|Overall Study||0
2971104|NCT00799812|3685784|FG000|STARTED|Overall Study||335
2971105|NCT00799812|3685784|FG000|CHG Swabstick (3 @ Once)|Overall Study||139
3164064|NCT01890785|3891530|FG000|STARTED|First Intervention||5
2971106|NCT00799812|3685784|FG000|CHG Swabstick Sequential|Overall Study||138
2971107|NCT00799812|3685784|FG000|Hibiclens|Overall Study||133
2971108|NCT00799812|3685784|FG000|Sterile Water Swab (3 @ Once)|Overall Study||132
2971109|NCT00799812|3685784|FG000|Sterile Water Swabstick (Sequential)|Overall Study||126
2971110|NCT00799812|3685784|FG000|COMPLETED|Overall Study||335
2971111|NCT00799812|3685784|FG000|NOT COMPLETED|Overall Study||0
2971112|NCT00799825|3685796|FG000|STARTED|Overall Study||344
2971113|NCT00799825|3685796|FG000|COMPLETED|Overall Study||296
2971114|NCT00799825|3685796|FG000|NOT COMPLETED|Overall Study||48
2971115|NCT00799903|3685802|FG000|STARTED|Overall Study||7904
2971116|NCT00799903|3685803|FG001|STARTED|Overall Study||7924
2971117|NCT00799903|3685802|FG000|COMPLETED|Overall Study||7631
2971118|NCT00799903|3685803|FG001|COMPLETED|Overall Study||7646
2971119|NCT00799903|3685802|FG000|NOT COMPLETED|Overall Study||273
2971120|NCT00799903|3685803|FG001|NOT COMPLETED|Overall Study||278
2971121|NCT00799981|3685809|FG000|STARTED|Overall Study||10
2971122|NCT00799981|3685810|FG001|STARTED|Overall Study||9
2971123|NCT00799981|3685811|FG002|STARTED|Overall Study||10
2971124|NCT00799981|3685812|FG003|STARTED|Overall Study||10
2971125|NCT00799981|3685813|FG004|STARTED|Overall Study||11
2971126|NCT00799981|3685814|FG005|STARTED|Overall Study||10
2971127|NCT00799981|3685809|FG000|COMPLETED|Overall Study||10
2971128|NCT00799981|3685810|FG001|COMPLETED|Overall Study||9
2971129|NCT00799981|3685811|FG002|COMPLETED|Overall Study||10
2971130|NCT00799981|3685812|FG003|COMPLETED|Overall Study||10
2971131|NCT00799981|3685813|FG004|COMPLETED|Overall Study||11
2971132|NCT00799981|3685814|FG005|COMPLETED|Overall Study||10
2971133|NCT00799981|3685809|FG000|NOT COMPLETED|Overall Study||0
2971134|NCT00799981|3685810|FG001|NOT COMPLETED|Overall Study||0
2971135|NCT00799981|3685811|FG002|NOT COMPLETED|Overall Study||0
2971136|NCT00799981|3685812|FG003|NOT COMPLETED|Overall Study||0
2971137|NCT00799981|3685813|FG004|NOT COMPLETED|Overall Study||0
2971138|NCT00799981|3685814|FG005|NOT COMPLETED|Overall Study||0
2971139|NCT00800176|3685829|FG000|STARTED|Overall Study||66
2971140|NCT00800176|3685830|FG001|STARTED|Overall Study||66
2971141|NCT00800176|3685831|FG002|STARTED|Overall Study||65
2971142|NCT00800176|3685832|FG003|STARTED|Overall Study||66
2971143|NCT00800176|3685833|FG004|STARTED|Overall Study||64
2971144|NCT00800176|3685834|FG005|STARTED|Overall Study||67
2971145|NCT00800176|3685829|FG000|COMPLETED|Overall Study||57
2971146|NCT00800176|3685830|FG001|COMPLETED|Overall Study||60
2971147|NCT00800176|3685831|FG002|COMPLETED|Overall Study||65
2971148|NCT00800176|3685832|FG003|COMPLETED|Overall Study||62
2971149|NCT00800176|3685833|FG004|COMPLETED|Overall Study||60
2971150|NCT00800176|3685834|FG005|COMPLETED|Overall Study||62
2971151|NCT00800176|3685829|FG000|NOT COMPLETED|Overall Study||9
2971152|NCT00800176|3685830|FG001|NOT COMPLETED|Overall Study||6
2971153|NCT00800176|3685831|FG002|NOT COMPLETED|Overall Study||0
2971154|NCT00800176|3685832|FG003|NOT COMPLETED|Overall Study||4
2971155|NCT00800176|3685833|FG004|NOT COMPLETED|Overall Study||4
3302448|NCT02959190|4035869|FG001|STARTED|Post Treatment Follow Up|Participants who discontinued open-label treatment phase had an option to enter post treatment phase|120
3302449|NCT02959190|4035870|FG002|STARTED|Post Treatment Follow Up|Participants who discontinued open-label treatment phase had an option to enter post treatment phase|32
3302450|NCT02959190|4035871|FG003|STARTED|Post Treatment Follow Up|Participants who discontinued open-label treatment phase had an option to enter post treatment phase|32
3302451|NCT02959190|4035868|FG000|COMPLETED|Post Treatment Follow Up||114
3302452|NCT02959190|4035869|FG001|COMPLETED|Post Treatment Follow Up||119
3302453|NCT02959190|4035870|FG002|COMPLETED|Post Treatment Follow Up||31
3302454|NCT02959190|4035871|FG003|COMPLETED|Post Treatment Follow Up||32
3302455|NCT02959190|4035868|FG000|NOT COMPLETED|Post Treatment Follow Up||3
3302456|NCT02959190|4035869|FG001|NOT COMPLETED|Post Treatment Follow Up||1
3302457|NCT02959190|4035870|FG002|NOT COMPLETED|Post Treatment Follow Up||1
3302458|NCT02959190|4035871|FG003|NOT COMPLETED|Post Treatment Follow Up||0
3302459|NCT02959307|4035892|FG000|STARTED|Phase 1||18
3302460|NCT02959307|4035893|FG001|STARTED|Phase 1||31
3302461|NCT02959307|4035892|FG000|COMPLETED|Phase 1||15
3302462|NCT02959307|4035893|FG001|COMPLETED|Phase 1||23
3302463|NCT02959307|4035892|FG000|NOT COMPLETED|Phase 1||3
3302464|NCT02959307|4035893|FG001|NOT COMPLETED|Phase 1||8
3302465|NCT02959307|4035892|FG000|STARTED|Phase 2|This group is increased as those in sham were re-randomized to sham or NIR.|28
3302466|NCT02959307|4035893|FG001|STARTED|Phase 2|This group is decreased as those in sham were re-randomized to sham or NIR.|10
3302467|NCT02959307|4035892|FG000|COMPLETED|Phase 2||26
3302468|NCT02959307|4035893|FG001|COMPLETED|Phase 2||10
3302469|NCT02959307|4035892|FG000|NOT COMPLETED|Phase 2||2
3302470|NCT02959307|4035893|FG001|NOT COMPLETED|Phase 2||0
3302471|NCT02959437|4035903|FG000|STARTED|Overall Study||62
3302472|NCT02959437|4035904|FG001|STARTED|Overall Study||8
3302473|NCT02959437|4035905|FG002|STARTED|Overall Study|Due to early termination of the trial Treatment groups B and C were not dosed.|0
3302474|NCT02959437|4035906|FG003|STARTED|Overall Study|Due to early termination of the trial Treatment groups B and C were not dosed.|0
2971156|NCT00800176|3685834|FG005|NOT COMPLETED|Overall Study||5
2971157|NCT00800202|3685850|FG000|STARTED|Overall Study||67
2971158|NCT00800202|3685851|FG001|STARTED|Overall Study||24
2971159|NCT00800202|3685850|FG000|COMPLETED|Overall Study||0
2971160|NCT00800202|3685851|FG001|COMPLETED|Overall Study||0
2971161|NCT00800202|3685850|FG000|NOT COMPLETED|Overall Study||67
2971162|NCT00800202|3685851|FG001|NOT COMPLETED|Overall Study||24
2971163|NCT00800254|3685859|FG000|STARTED|Overall Study||35
2971164|NCT00800254|3685860|FG001|STARTED|Overall Study||31
2971165|NCT00800254|3685859|FG000|3.5 Weeks Post-operatively|Overall Study||31
2971166|NCT00800254|3685860|FG001|3.5 Weeks Post-operatively|Overall Study||31
2971167|NCT00800254|3685859|FG000|COMPLETED|Overall Study||30
2971168|NCT00800254|3685860|FG001|COMPLETED|Overall Study||25
2971169|NCT00800254|3685859|FG000|NOT COMPLETED|Overall Study||5
2971170|NCT00800254|3685860|FG001|NOT COMPLETED|Overall Study||6
2971171|NCT00800345|3685866|FG000|STARTED|Overall Study||33
2971172|NCT00800345|3685866|FG000|COMPLETED|Overall Study||33
2971173|NCT00800345|3685866|FG000|NOT COMPLETED|Overall Study||0
2971174|NCT00800384|3685872|FG000|STARTED|Overall Study||1247
3302475|NCT02959437|4035903|FG000|COMPLETED|Overall Study||0
3302476|NCT02959437|4035904|FG001|COMPLETED|Overall Study||0
3302477|NCT02959437|4035905|FG002|COMPLETED|Overall Study||0
3302478|NCT02959437|4035906|FG003|COMPLETED|Overall Study||0
3302479|NCT02959437|4035903|FG000|NOT COMPLETED|Overall Study||62
3302480|NCT02959437|4035904|FG001|NOT COMPLETED|Overall Study||8
3302481|NCT02959437|4035905|FG002|NOT COMPLETED|Overall Study||0
3302482|NCT02959437|4035906|FG003|NOT COMPLETED|Overall Study||0
3302483|NCT02959671|4035917|FG000|STARTED|Overall Study||34
3302484|NCT02959671|4035917|FG000|COMPLETED|Overall Study||29
3302485|NCT02959671|4035917|FG000|NOT COMPLETED|Overall Study||5
3302486|NCT02959814|4035921|FG000|STARTED|Overall Study|22-02-2017|329
3302487|NCT02959814|4035921|FG000|COMPLETED|Overall Study|17-10-2017|272
3302488|NCT02959814|4035921|FG000|NOT COMPLETED|Overall Study||57
3302489|NCT02959827|4035926|FG000|STARTED|Overall Study||2320
3302490|NCT02959827|4035926|FG000|COMPLETED|Overall Study||2320
3302491|NCT02959827|4035926|FG000|NOT COMPLETED|Overall Study||0
3302492|NCT02959840|4035937|FG000|STARTED|Overall Study||60
3302493|NCT02959840|4035938|FG001|STARTED|Overall Study||60
3302494|NCT02959840|4035939|FG002|STARTED|Overall Study||60
3302495|NCT02959840|4035937|FG000|COMPLETED|Overall Study||60
3302496|NCT02959840|4035938|FG001|COMPLETED|Overall Study||60
3302497|NCT02959840|4035939|FG002|COMPLETED|Overall Study||60
3302498|NCT02959840|4035937|FG000|NOT COMPLETED|Overall Study||0
3302499|NCT02959840|4035938|FG001|NOT COMPLETED|Overall Study||0
3302500|NCT02959840|4035939|FG002|NOT COMPLETED|Overall Study||0
3302501|NCT02959853|4035949|FG000|STARTED|Overall Study||11
3302502|NCT02959853|4035950|FG001|STARTED|Overall Study||12
3302503|NCT02959853|4035949|FG000|COMPLETED|Overall Study||7
3302504|NCT02959853|4035950|FG001|COMPLETED|Overall Study||10
3302505|NCT02959853|4035949|FG000|NOT COMPLETED|Overall Study||4
3302506|NCT02959853|4035950|FG001|NOT COMPLETED|Overall Study||2
3302507|NCT02959866|4035957|FG000|STARTED|Overall Study||59
3302508|NCT02959866|4035957|FG000|Telephone Interview at 1 Month Follow-up|Overall Study||59
3302509|NCT02959866|4035957|FG000|COMPLETED|Overall Study||58
3302510|NCT02959866|4035957|FG000|NOT COMPLETED|Overall Study||1
3302511|NCT02959892|4035964|FG000|STARTED|Overall Study||6
3302512|NCT02959892|4035965|FG001|STARTED|Overall Study||6
3302513|NCT02959892|4035964|FG000|COMPLETED|Overall Study||5
3302514|NCT02959892|4035965|FG001|COMPLETED|Overall Study||5
3302515|NCT02959892|4035964|FG000|NOT COMPLETED|Overall Study||1
3302516|NCT02959892|4035965|FG001|NOT COMPLETED|Overall Study||1
3302517|NCT02959970|4035973|FG000|STARTED|Overall Study||17
3302518|NCT02959970|4035974|FG001|STARTED|Overall Study||83
3302519|NCT02959970|4035973|FG000|COMPLETED|Overall Study||15
3302520|NCT02959970|4035974|FG001|COMPLETED|Overall Study||76
3302521|NCT02959970|4035973|FG000|NOT COMPLETED|Overall Study||2
3302522|NCT02959970|4035974|FG001|NOT COMPLETED|Overall Study||7
3302523|NCT02959983|4035984|FG000|STARTED|Overall Study||172
3302524|NCT02959983|4035985|FG001|STARTED|Overall Study||174
3302525|NCT02959983|4035984|FG000|COMPLETED|Overall Study||146
3302526|NCT02959983|4035985|FG001|COMPLETED|Overall Study||149
3302527|NCT02959983|4035984|FG000|NOT COMPLETED|Overall Study||26
3302528|NCT02959983|4035985|FG001|NOT COMPLETED|Overall Study||25
3302529|NCT02959996|4035993|FG000|STARTED|Overall Study||40
3302530|NCT02959996|4035994|FG001|STARTED|Overall Study||39
3302531|NCT02959996|4035993|FG000|COMPLETED|Overall Study||40
3302532|NCT02959996|4035994|FG001|COMPLETED|Overall Study||39
3302533|NCT02959996|4035993|FG000|NOT COMPLETED|Overall Study||0
3302534|NCT02959996|4035994|FG001|NOT COMPLETED|Overall Study||0
3302535|NCT02960217|4036002|FG000|STARTED|Maintenance Phase: Treatment Period 1||22
3302536|NCT02960217|4036003|FG001|STARTED|Maintenance Phase: Treatment Period 1||21
3302537|NCT02960217|4036002|FG000|COMPLETED|Maintenance Phase: Treatment Period 1||21
3302538|NCT02960217|4036003|FG001|COMPLETED|Maintenance Phase: Treatment Period 1||21
3302539|NCT02960217|4036002|FG000|NOT COMPLETED|Maintenance Phase: Treatment Period 1||1
3302540|NCT02960217|4036003|FG001|NOT COMPLETED|Maintenance Phase: Treatment Period 1||0
3302541|NCT02960217|4036002|FG000|STARTED|Maintenance Phase: Crossover Washout||21
3302542|NCT02960217|4036003|FG001|STARTED|Maintenance Phase: Crossover Washout||21
3302543|NCT02960217|4036002|FG000|COMPLETED|Maintenance Phase: Crossover Washout||21
3302544|NCT02960217|4036003|FG001|COMPLETED|Maintenance Phase: Crossover Washout||21
3302545|NCT02960217|4036002|FG000|NOT COMPLETED|Maintenance Phase: Crossover Washout||0
3302546|NCT02960217|4036003|FG001|NOT COMPLETED|Maintenance Phase: Crossover Washout||0
3302547|NCT02960217|4036002|FG000|STARTED|Maintenance Phase: Treatment Period 2||21
2971175|NCT00800384|3685873|FG001|STARTED|Overall Study||1253
2971176|NCT00800384|3685872|FG000|COMPLETED|Overall Study||1206
2971177|NCT00800384|3685873|FG001|COMPLETED|Overall Study||1210
2971178|NCT00800384|3685872|FG000|NOT COMPLETED|Overall Study||41
2971179|NCT00800384|3685873|FG001|NOT COMPLETED|Overall Study||43
2971180|NCT00800436|3685887|FG000|STARTED|Overall Study||6
2971181|NCT00800436|3685888|FG001|STARTED|Overall Study||6
2971182|NCT00800436|3685889|FG002|STARTED|Overall Study||6
2971183|NCT00800436|3685890|FG003|STARTED|Overall Study||6
2971184|NCT00800436|3685891|FG004|STARTED|Overall Study||6
2971185|NCT00800436|3685892|FG005|STARTED|Overall Study||20
2971186|NCT00800436|3685893|FG006|STARTED|Overall Study||20
2971187|NCT00800436|3685887|FG000|COMPLETED|Overall Study||6
2971188|NCT00800436|3685888|FG001|COMPLETED|Overall Study||6
2971189|NCT00800436|3685889|FG002|COMPLETED|Overall Study||5
2971190|NCT00800436|3685890|FG003|COMPLETED|Overall Study||5
2971191|NCT00800436|3685891|FG004|COMPLETED|Overall Study||6
2971192|NCT00800436|3685892|FG005|COMPLETED|Overall Study||20
2971193|NCT00800436|3685893|FG006|COMPLETED|Overall Study||20
2971194|NCT00800436|3685887|FG000|NOT COMPLETED|Overall Study||0
2971195|NCT00800436|3685888|FG001|NOT COMPLETED|Overall Study||0
2971196|NCT00800436|3685889|FG002|NOT COMPLETED|Overall Study||1
2971197|NCT00800436|3685890|FG003|NOT COMPLETED|Overall Study||1
2971198|NCT00800436|3685891|FG004|NOT COMPLETED|Overall Study||0
2971199|NCT00800436|3685892|FG005|NOT COMPLETED|Overall Study||0
2971200|NCT00800436|3685893|FG006|NOT COMPLETED|Overall Study||0
2971201|NCT00800540|3685909|FG000|STARTED|Period One: 6 Weeks||17
2971202|NCT00800540|3685910|FG001|STARTED|Period One: 6 Weeks||18
2971203|NCT00800540|3685909|FG000|COMPLETED|Period One: 6 Weeks||16
2971204|NCT00800540|3685910|FG001|COMPLETED|Period One: 6 Weeks||17
2971205|NCT00800540|3685909|FG000|NOT COMPLETED|Period One: 6 Weeks||1
2971206|NCT00800540|3685910|FG001|NOT COMPLETED|Period One: 6 Weeks||1
2971207|NCT00800540|3685909|FG000|STARTED|Washout: 4 Weeks||16
2971208|NCT00800540|3685910|FG001|STARTED|Washout: 4 Weeks||17
2971209|NCT00800540|3685909|FG000|COMPLETED|Washout: 4 Weeks||16
2971210|NCT00800540|3685910|FG001|COMPLETED|Washout: 4 Weeks||17
2971211|NCT00800540|3685909|FG000|NOT COMPLETED|Washout: 4 Weeks||0
2971212|NCT00800540|3685910|FG001|NOT COMPLETED|Washout: 4 Weeks||0
2971213|NCT00800540|3685909|FG000|STARTED|Period 2: 6 Weeks||16
3133236|NCT01695239|3858306|FG001|STARTED|IR Participants (Week 16 Up To Week 24)|Only inadequate responders were included.|0
3133237|NCT01695239|3858307|FG002|STARTED|IR Participants (Week 16 Up To Week 24)|Only inadequate responders were included.|0
3302548|NCT02960217|4036003|FG001|STARTED|Maintenance Phase: Treatment Period 2||21
2971214|NCT00800540|3685910|FG001|STARTED|Period 2: 6 Weeks||17
2971215|NCT00800540|3685909|FG000|COMPLETED|Period 2: 6 Weeks||16
2971216|NCT00800540|3685910|FG001|COMPLETED|Period 2: 6 Weeks||16
2971217|NCT00800540|3685909|FG000|NOT COMPLETED|Period 2: 6 Weeks||0
2971218|NCT00800540|3685910|FG001|NOT COMPLETED|Period 2: 6 Weeks||1
2971219|NCT00800683|3685918|FG000|STARTED|Overall Study|Number who started treatment|65
2971220|NCT00800683|3685919|FG001|STARTED|Overall Study|Number who started treatment|68
2971221|NCT00800683|3685918|FG000|COMPLETED|Overall Study|Number who completed treatment|48
2971222|NCT00800683|3685919|FG001|COMPLETED|Overall Study|Number who completed treatment|49
2971223|NCT00800683|3685918|FG000|NOT COMPLETED|Overall Study||17
2971224|NCT00800683|3685919|FG001|NOT COMPLETED|Overall Study||19
2971225|NCT00800735|3685925|FG000|STARTED|Overall Study||30
2971226|NCT00800735|3685925|FG000|COMPLETED|Overall Study||16
2971227|NCT00800735|3685925|FG000|NOT COMPLETED|Overall Study||14
2971228|NCT00800839|3685929|FG000|STARTED|Overall Study||56
2971229|NCT00800839|3685929|FG000|COMPLETED|Overall Study||49
2971230|NCT00800839|3685929|FG000|NOT COMPLETED|Overall Study||7
2971231|NCT00800865|3685935|FG000|STARTED|Overall Study||15
2971232|NCT00800865|3685936|FG001|STARTED|Overall Study||16
2971233|NCT00800865|3685935|FG000|COMPLETED|Overall Study||15
2971234|NCT00800865|3685936|FG001|COMPLETED|Overall Study||16
2971235|NCT00800865|3685935|FG000|NOT COMPLETED|Overall Study||0
2971236|NCT00800865|3685936|FG001|NOT COMPLETED|Overall Study||0
2971237|NCT00800982|3685944|FG000|STARTED|Overall Study||15
2971238|NCT00800982|3685945|FG001|STARTED|Overall Study||15
2971239|NCT00800982|3685944|FG000|COMPLETED|Overall Study||13
2971240|NCT00800982|3685945|FG001|COMPLETED|Overall Study||12
2971241|NCT00800982|3685944|FG000|NOT COMPLETED|Overall Study||2
2971242|NCT00800982|3685945|FG001|NOT COMPLETED|Overall Study||3
3302549|NCT02960217|4036002|FG000|COMPLETED|Maintenance Phase: Treatment Period 2||20
3302550|NCT02960217|4036003|FG001|COMPLETED|Maintenance Phase: Treatment Period 2||18
3302551|NCT02960217|4036002|FG000|NOT COMPLETED|Maintenance Phase: Treatment Period 2||1
3302552|NCT02960217|4036003|FG001|NOT COMPLETED|Maintenance Phase: Treatment Period 2||3
3302553|NCT02960217|4036002|FG000|STARTED|Open-Label Extension Phase||20
3302554|NCT02960217|4036003|FG001|STARTED|Open-Label Extension Phase|5 participants completed the double blind period but did not continue in the open label period.|13
3302555|NCT02960217|4036002|FG000|COMPLETED|Open-Label Extension Phase||0
3302556|NCT02960217|4036003|FG001|COMPLETED|Open-Label Extension Phase||0
3302557|NCT02960217|4036002|FG000|NOT COMPLETED|Open-Label Extension Phase||20
3302558|NCT02960217|4036003|FG001|NOT COMPLETED|Open-Label Extension Phase||13
3302559|NCT02960295|4036013|FG000|STARTED|Overall Study||10
3302560|NCT02960295|4036013|FG000|COMPLETED|Overall Study||10
3302561|NCT02960295|4036013|FG000|NOT COMPLETED|Overall Study||0
3302562|NCT02960438|4036022|FG000|STARTED|Treatment Phase (Double-blind): 24 Weeks||56
3302563|NCT02960438|4036023|FG001|STARTED|Treatment Phase (Double-blind): 24 Weeks||29
3302564|NCT02960438|4036024|FG002|STARTED|Treatment Phase (Double-blind): 24 Weeks||54
3302565|NCT02960438|4036025|FG003|STARTED|Treatment Phase (Double-blind): 24 Weeks||55
2971243|NCT00801099|3685951|FG000|STARTED|Overall Study||276
2971244|NCT00801099|3685951|FG000|COMPLETED|Overall Study||175
2971245|NCT00801099|3685951|FG000|NOT COMPLETED|Overall Study||101
2971246|NCT00801138|3685959|FG000|STARTED|Overall Study||54
2971247|NCT00801138|3685960|FG001|STARTED|Overall Study||56
2971248|NCT00801138|3685961|FG002|STARTED|Overall Study||54
2971249|NCT00801138|3685962|FG003|STARTED|Overall Study||54
2971250|NCT00801138|3685959|FG000|COMPLETED|Overall Study||54
2971251|NCT00801138|3685960|FG001|COMPLETED|Overall Study||56
2971252|NCT00801138|3685961|FG002|COMPLETED|Overall Study||54
2971253|NCT00801138|3685962|FG003|COMPLETED|Overall Study||54
2971254|NCT00801138|3685959|FG000|NOT COMPLETED|Overall Study||0
2971255|NCT00801138|3685960|FG001|NOT COMPLETED|Overall Study||0
2971256|NCT00801138|3685961|FG002|NOT COMPLETED|Overall Study||0
2971257|NCT00801138|3685962|FG003|NOT COMPLETED|Overall Study||0
2971258|NCT00801229|3685974|FG000|STARTED|Signed Consent||38
2971259|NCT00801229|3685975|FG001|STARTED|Signed Consent||37
2971260|NCT00801229|3685974|FG000|COMPLETED|Signed Consent||35
2971261|NCT00801229|3685975|FG001|COMPLETED|Signed Consent||34
2971262|NCT00801229|3685974|FG000|NOT COMPLETED|Signed Consent||3
2971263|NCT00801229|3685975|FG001|NOT COMPLETED|Signed Consent||3
2971264|NCT00801229|3685974|FG000|STARTED|Received Study Drug/Placebo||35
2971265|NCT00801229|3685975|FG001|STARTED|Received Study Drug/Placebo||34
2971266|NCT00801229|3685974|FG000|COMPLETED|Received Study Drug/Placebo||31
2971267|NCT00801229|3685975|FG001|COMPLETED|Received Study Drug/Placebo||30
2971268|NCT00801229|3685974|FG000|NOT COMPLETED|Received Study Drug/Placebo||4
2971269|NCT00801229|3685975|FG001|NOT COMPLETED|Received Study Drug/Placebo||4
2971270|NCT00801242|3685981|FG000|STARTED|Overall Study|Randomized participants.|220
3302566|NCT02960438|4036022|FG000|Treated Participants|Treatment Phase (Double-blind): 24 Weeks||54
3302567|NCT02960438|4036023|FG001|Treated Participants|Treatment Phase (Double-blind): 24 Weeks||28
3302568|NCT02960438|4036024|FG002|Treated Participants|Treatment Phase (Double-blind): 24 Weeks||54
3302569|NCT02960438|4036025|FG003|Treated Participants|Treatment Phase (Double-blind): 24 Weeks||54
3302570|NCT02960438|4036022|FG000|COMPLETED|Treatment Phase (Double-blind): 24 Weeks||47
3302571|NCT02960438|4036023|FG001|COMPLETED|Treatment Phase (Double-blind): 24 Weeks||26
3302572|NCT02960438|4036024|FG002|COMPLETED|Treatment Phase (Double-blind): 24 Weeks||50
3302573|NCT02960438|4036025|FG003|COMPLETED|Treatment Phase (Double-blind): 24 Weeks||46
3302574|NCT02960438|4036022|FG000|NOT COMPLETED|Treatment Phase (Double-blind): 24 Weeks||9
3302575|NCT02960438|4036023|FG001|NOT COMPLETED|Treatment Phase (Double-blind): 24 Weeks||3
3302576|NCT02960438|4036024|FG002|NOT COMPLETED|Treatment Phase (Double-blind): 24 Weeks||4
3302577|NCT02960438|4036025|FG003|NOT COMPLETED|Treatment Phase (Double-blind): 24 Weeks||9
3302578|NCT02960438|4036022|FG000|STARTED|Extension Phase (Open-label): 80 Weeks||47
3302579|NCT02960438|4036023|FG001|STARTED|Extension Phase (Open-label): 80 Weeks||26
3302580|NCT02960438|4036024|FG002|STARTED|Extension Phase (Open-label): 80 Weeks||50
3302581|NCT02960438|4036025|FG003|STARTED|Extension Phase (Open-label): 80 Weeks||46
3302582|NCT02960438|4036022|FG000|COMPLETED|Extension Phase (Open-label): 80 Weeks||36
3302583|NCT02960438|4036023|FG001|COMPLETED|Extension Phase (Open-label): 80 Weeks||17
3302584|NCT02960438|4036024|FG002|COMPLETED|Extension Phase (Open-label): 80 Weeks||36
3302585|NCT02960438|4036025|FG003|COMPLETED|Extension Phase (Open-label): 80 Weeks||35
3302586|NCT02960438|4036022|FG000|NOT COMPLETED|Extension Phase (Open-label): 80 Weeks||11
3302587|NCT02960438|4036023|FG001|NOT COMPLETED|Extension Phase (Open-label): 80 Weeks||9
3302588|NCT02960438|4036024|FG002|NOT COMPLETED|Extension Phase (Open-label): 80 Weeks||14
3302589|NCT02960438|4036025|FG003|NOT COMPLETED|Extension Phase (Open-label): 80 Weeks||11
3302590|NCT02960490|4036045|FG000|STARTED|Treatment Phase(Double-blind): 12 Weeks||34
3302591|NCT02960490|4036046|FG001|STARTED|Treatment Phase(Double-blind): 12 Weeks||32
3302592|NCT02960490|4036047|FG002|STARTED|Treatment Phase(Double-blind): 12 Weeks||0
3302593|NCT02960490|4036048|FG003|STARTED|Treatment Phase(Double-blind): 12 Weeks||0
3302594|NCT02960490|4036049|FG004|STARTED|Treatment Phase(Double-blind): 12 Weeks||0
3302595|NCT02960490|4036050|FG005|STARTED|Treatment Phase(Double-blind): 12 Weeks||0
3302596|NCT02960490|4036051|FG006|STARTED|Treatment Phase(Double-blind): 12 Weeks||0
2971271|NCT00801242|3685981|FG000|Safety Analysis Set|Overall Study|Randomized participants who received ≥1 dose of degarelix.|216
2971272|NCT00801242|3685981|FG000|Full Analysis Set (FAS), Cycle 1|Overall Study|Randomized participants who received ≥1 dose and had ≥1 efficacy assessment.|213
2971273|NCT00801242|3685981|FG000|FAS, Off-treatment Cycle 1|Overall Study|Completed 7 months induction period and were enrolled in the off-treatment period of cycle 1.|191
2971274|NCT00801242|3685981|FG000|Started Cycle 2|Overall Study||35
2971275|NCT00801242|3685981|FG000|Started Cycle 3|Overall Study||2
2971276|NCT00801242|3685981|FG000|COMPLETED|Overall Study|42, 10, and 0 participants withdrew during Cycles 1, 2, and 3 (i.e. 168 completed the trial).|168
2971277|NCT00801242|3685981|FG000|NOT COMPLETED|Overall Study||52
2971278|NCT00801398|3685991|FG000|STARTED|Overall Study||13
2971279|NCT00801398|3685992|FG001|STARTED|Overall Study||9
2971280|NCT00801398|3685993|FG002|STARTED|Overall Study||11
2971281|NCT00801398|3685994|FG003|STARTED|Overall Study||9
2971282|NCT00801398|3685995|FG004|STARTED|Overall Study||8
2971283|NCT00801398|3685996|FG005|STARTED|Overall Study||8
2971284|NCT00801398|3685991|FG000|COMPLETED|Overall Study||7
2971285|NCT00801398|3685992|FG001|COMPLETED|Overall Study||0
3302597|NCT02960490|4036052|FG007|STARTED|Treatment Phase(Double-blind): 12 Weeks||0
3302598|NCT02960490|4036053|FG008|STARTED|Treatment Phase(Double-blind): 12 Weeks||0
3302599|NCT02960490|4036054|FG009|STARTED|Treatment Phase(Double-blind): 12 Weeks||0
3302600|NCT02960490|4036045|FG000|Treated|Treatment Phase(Double-blind): 12 Weeks||33
3302601|NCT02960490|4036046|FG001|Treated|Treatment Phase(Double-blind): 12 Weeks||31
2971286|NCT00801398|3685993|FG002|COMPLETED|Overall Study||4
2971287|NCT00801398|3685994|FG003|COMPLETED|Overall Study||3
2971288|NCT00801398|3685995|FG004|COMPLETED|Overall Study||1
2971289|NCT00801398|3685996|FG005|COMPLETED|Overall Study||5
2971290|NCT00801398|3685991|FG000|NOT COMPLETED|Overall Study||6
2971291|NCT00801398|3685992|FG001|NOT COMPLETED|Overall Study||9
2971292|NCT00801398|3685993|FG002|NOT COMPLETED|Overall Study||7
2971293|NCT00801398|3685994|FG003|NOT COMPLETED|Overall Study||6
2971294|NCT00801398|3685995|FG004|NOT COMPLETED|Overall Study||7
2971295|NCT00801398|3685996|FG005|NOT COMPLETED|Overall Study||3
2971296|NCT00801632|3686024|FG000|STARTED|Overall Study||5
2971297|NCT00801632|3686024|FG000|COMPLETED|Overall Study||4
2971298|NCT00801632|3686024|FG000|NOT COMPLETED|Overall Study||1
2971299|NCT00801684|3686028|FG000|STARTED|Overall Study||24
2971300|NCT00801684|3686028|FG000|COMPLETED|Overall Study||24
2971301|NCT00801684|3686028|FG000|NOT COMPLETED|Overall Study||0
2971302|NCT00801723|3686047|FG000|STARTED|Overall Study||61
2971303|NCT00801723|3686048|FG001|STARTED|Overall Study||62
2971304|NCT00801723|3686047|FG000|COMPLETED|Overall Study||25
2971305|NCT00801723|3686048|FG001|COMPLETED|Overall Study||27
2971306|NCT00801723|3686047|FG000|NOT COMPLETED|Overall Study||36
2971307|NCT00801723|3686048|FG001|NOT COMPLETED|Overall Study||35
3035783|NCT01139515|3755078|FG000|STARTED|Washout Period I (46hrs)||4
3035784|NCT01139515|3755079|FG001|STARTED|Washout Period I (46hrs)||4
3035785|NCT01139515|3755080|FG002|STARTED|Washout Period I (46hrs)||4
3035786|NCT01139515|3755081|FG003|STARTED|Washout Period I (46hrs)||4
3035787|NCT01139515|3755078|FG000|COMPLETED|Washout Period I (46hrs)||4
3035788|NCT01139515|3755079|FG001|COMPLETED|Washout Period I (46hrs)||4
3035789|NCT01139515|3755080|FG002|COMPLETED|Washout Period I (46hrs)||4
3035790|NCT01139515|3755081|FG003|COMPLETED|Washout Period I (46hrs)||4
3035791|NCT01139515|3755078|FG000|NOT COMPLETED|Washout Period I (46hrs)||0
3035792|NCT01139515|3755079|FG001|NOT COMPLETED|Washout Period I (46hrs)||0
3035793|NCT01139515|3755080|FG002|NOT COMPLETED|Washout Period I (46hrs)||0
3035794|NCT01139515|3755081|FG003|NOT COMPLETED|Washout Period I (46hrs)||0
3035795|NCT01139515|3755078|FG000|STARTED|Second Intervention Period||4
3035796|NCT01139515|3755079|FG001|STARTED|Second Intervention Period||4
3035797|NCT01139515|3755080|FG002|STARTED|Second Intervention Period||4
3035798|NCT01139515|3755081|FG003|STARTED|Second Intervention Period||4
3035799|NCT01139515|3755078|FG000|COMPLETED|Second Intervention Period||4
3035800|NCT01139515|3755079|FG001|COMPLETED|Second Intervention Period||4
3035801|NCT01139515|3755080|FG002|COMPLETED|Second Intervention Period||4
3035802|NCT01139515|3755081|FG003|COMPLETED|Second Intervention Period||4
3035803|NCT01139515|3755078|FG000|NOT COMPLETED|Second Intervention Period||0
3035804|NCT01139515|3755079|FG001|NOT COMPLETED|Second Intervention Period||0
3035805|NCT01139515|3755080|FG002|NOT COMPLETED|Second Intervention Period||0
3035806|NCT01139515|3755081|FG003|NOT COMPLETED|Second Intervention Period||0
3035807|NCT01139515|3755078|FG000|STARTED|Washout Period 2 (46 Hrs)||4
3035808|NCT01139515|3755079|FG001|STARTED|Washout Period 2 (46 Hrs)||4
3035809|NCT01139515|3755080|FG002|STARTED|Washout Period 2 (46 Hrs)||4
3035810|NCT01139515|3755081|FG003|STARTED|Washout Period 2 (46 Hrs)||4
3035811|NCT01139515|3755078|FG000|COMPLETED|Washout Period 2 (46 Hrs)||4
3035812|NCT01139515|3755079|FG001|COMPLETED|Washout Period 2 (46 Hrs)||4
3035813|NCT01139515|3755080|FG002|COMPLETED|Washout Period 2 (46 Hrs)||4
3035814|NCT01139515|3755081|FG003|COMPLETED|Washout Period 2 (46 Hrs)||4
3035815|NCT01139515|3755078|FG000|NOT COMPLETED|Washout Period 2 (46 Hrs)||0
3035816|NCT01139515|3755079|FG001|NOT COMPLETED|Washout Period 2 (46 Hrs)||0
3035817|NCT01139515|3755080|FG002|NOT COMPLETED|Washout Period 2 (46 Hrs)||0
3035818|NCT01139515|3755081|FG003|NOT COMPLETED|Washout Period 2 (46 Hrs)||0
3035819|NCT01139515|3755078|FG000|STARTED|Third Intervention Period||4
3035820|NCT01139515|3755079|FG001|STARTED|Third Intervention Period||4
3035821|NCT01139515|3755080|FG002|STARTED|Third Intervention Period||4
3035822|NCT01139515|3755081|FG003|STARTED|Third Intervention Period||4
3035823|NCT01139515|3755078|FG000|COMPLETED|Third Intervention Period||4
3035824|NCT01139515|3755079|FG001|COMPLETED|Third Intervention Period||4
3035825|NCT01139515|3755080|FG002|COMPLETED|Third Intervention Period||4
3035826|NCT01139515|3755081|FG003|COMPLETED|Third Intervention Period||4
3035827|NCT01139515|3755078|FG000|NOT COMPLETED|Third Intervention Period||0
3035828|NCT01139515|3755079|FG001|NOT COMPLETED|Third Intervention Period||0
3035829|NCT01139515|3755080|FG002|NOT COMPLETED|Third Intervention Period||0
3302602|NCT02960490|4036047|FG002|Treated|Treatment Phase(Double-blind): 12 Weeks||0
3302603|NCT02960490|4036048|FG003|Treated|Treatment Phase(Double-blind): 12 Weeks||0
3302604|NCT02960490|4036049|FG004|Treated|Treatment Phase(Double-blind): 12 Weeks||0
3302605|NCT02960490|4036050|FG005|Treated|Treatment Phase(Double-blind): 12 Weeks||0
3302606|NCT02960490|4036051|FG006|Treated|Treatment Phase(Double-blind): 12 Weeks||0
3302607|NCT02960490|4036052|FG007|Treated|Treatment Phase(Double-blind): 12 Weeks||0
3302608|NCT02960490|4036053|FG008|Treated|Treatment Phase(Double-blind): 12 Weeks||0
3302609|NCT02960490|4036054|FG009|Treated|Treatment Phase(Double-blind): 12 Weeks||0
3302610|NCT02960490|4036045|FG000|Full Analysis Set (FAS)|Treatment Phase(Double-blind): 12 Weeks||33
3035830|NCT01139515|3755081|FG003|NOT COMPLETED|Third Intervention Period||0
3035831|NCT01139515|3755078|FG000|STARTED|Washout Period 3 (46 Hrs)||4
3035832|NCT01139515|3755079|FG001|STARTED|Washout Period 3 (46 Hrs)||4
3035833|NCT01139515|3755080|FG002|STARTED|Washout Period 3 (46 Hrs)||4
3035834|NCT01139515|3755081|FG003|STARTED|Washout Period 3 (46 Hrs)||4
3035835|NCT01139515|3755078|FG000|COMPLETED|Washout Period 3 (46 Hrs)||4
2971308|NCT00801801|3686054|FG000|STARTED|Overall Study||5
2971309|NCT00801801|3686054|FG000|COMPLETED|Overall Study||5
2971310|NCT00801801|3686054|FG000|NOT COMPLETED|Overall Study||0
2971311|NCT00801827|3686059|FG000|STARTED|Overall Study|2 others consented but due to scheduling did not complete|5
2971312|NCT00801827|3686059|FG000|COMPLETED|Overall Study||5
2971313|NCT00801827|3686059|FG000|NOT COMPLETED|Overall Study||0
2971314|NCT00801892|3686065|FG000|STARTED|Main Study Period||12
2971315|NCT00801892|3686066|FG001|STARTED|Main Study Period||11
2971316|NCT00801892|3686065|FG000|COMPLETED|Main Study Period||12
3133238|NCT01695239|3858308|FG003|STARTED|IR Participants (Week 16 Up To Week 24)|Only inadequate responders were included.|0
3133239|NCT01695239|3858309|FG004|STARTED|IR Participants (Week 16 Up To Week 24)|IR from placebo who re-randomized to ixeQ4W and IR from ixeQ4W.|24
3133240|NCT01695239|3858310|FG005|STARTED|IR Participants (Week 16 Up To Week 24)|IR from placebo who re-randomized to ixeQ2W and IR from ixeQ2W.|24
3133241|NCT01695239|3858311|FG006|STARTED|IR Participants (Week 16 Up To Week 24)|Adalimumab Q2W (IR) who re-randomized to IxeQ2W or IxeQ4W and PBO for ixe and adalimumab.|9
3133242|NCT01695239|3858312|FG007|STARTED|IR Participants (Week 16 Up To Week 24)||0
3133243|NCT01695239|3858313|FG008|STARTED|IR Participants (Week 16 Up To Week 24)||0
3133244|NCT01695239|3858314|FG009|STARTED|IR Participants (Week 16 Up To Week 24)||0
3133245|NCT01695239|3858315|FG010|STARTED|IR Participants (Week 16 Up To Week 24)||0
3133246|NCT01695239|3858316|FG011|STARTED|IR Participants (Week 16 Up To Week 24)||0
3136740|NCT01714726|3861989|FG001|COMPLETED|Open-Label Period||0
3302611|NCT02960490|4036046|FG001|Full Analysis Set (FAS)|Treatment Phase(Double-blind): 12 Weeks||31
3302612|NCT02960490|4036047|FG002|Full Analysis Set (FAS)|Treatment Phase(Double-blind): 12 Weeks||0
3302613|NCT02960490|4036048|FG003|Full Analysis Set (FAS)|Treatment Phase(Double-blind): 12 Weeks||0
3302614|NCT02960490|4036049|FG004|Full Analysis Set (FAS)|Treatment Phase(Double-blind): 12 Weeks||0
3302615|NCT02960490|4036050|FG005|Full Analysis Set (FAS)|Treatment Phase(Double-blind): 12 Weeks||0
3302616|NCT02960490|4036051|FG006|Full Analysis Set (FAS)|Treatment Phase(Double-blind): 12 Weeks||0
3302617|NCT02960490|4036052|FG007|Full Analysis Set (FAS)|Treatment Phase(Double-blind): 12 Weeks||0
3302618|NCT02960490|4036053|FG008|Full Analysis Set (FAS)|Treatment Phase(Double-blind): 12 Weeks||0
3302619|NCT02960490|4036054|FG009|Full Analysis Set (FAS)|Treatment Phase(Double-blind): 12 Weeks||0
3302620|NCT02960490|4036045|FG000|Safety Analysis Set (SAS)|Treatment Phase(Double-blind): 12 Weeks||33
3302621|NCT02960490|4036046|FG001|Safety Analysis Set (SAS)|Treatment Phase(Double-blind): 12 Weeks||31
3302622|NCT02960490|4036047|FG002|Safety Analysis Set (SAS)|Treatment Phase(Double-blind): 12 Weeks||0
3302623|NCT02960490|4036048|FG003|Safety Analysis Set (SAS)|Treatment Phase(Double-blind): 12 Weeks||0
3302624|NCT02960490|4036049|FG004|Safety Analysis Set (SAS)|Treatment Phase(Double-blind): 12 Weeks||0
3302625|NCT02960490|4036050|FG005|Safety Analysis Set (SAS)|Treatment Phase(Double-blind): 12 Weeks||0
3302626|NCT02960490|4036051|FG006|Safety Analysis Set (SAS)|Treatment Phase(Double-blind): 12 Weeks||0
3302627|NCT02960490|4036052|FG007|Safety Analysis Set (SAS)|Treatment Phase(Double-blind): 12 Weeks||0
3302628|NCT02960490|4036053|FG008|Safety Analysis Set (SAS)|Treatment Phase(Double-blind): 12 Weeks||0
3302629|NCT02960490|4036054|FG009|Safety Analysis Set (SAS)|Treatment Phase(Double-blind): 12 Weeks||0
3302630|NCT02960490|4036045|FG000|COMPLETED|Treatment Phase(Double-blind): 12 Weeks||29
3302631|NCT02960490|4036046|FG001|COMPLETED|Treatment Phase(Double-blind): 12 Weeks||26
3302632|NCT02960490|4036047|FG002|COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
3302633|NCT02960490|4036048|FG003|COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
3302634|NCT02960490|4036049|FG004|COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
3302635|NCT02960490|4036050|FG005|COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
3302636|NCT02960490|4036051|FG006|COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
3302637|NCT02960490|4036052|FG007|COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
3302638|NCT02960490|4036053|FG008|COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
3302639|NCT02960490|4036054|FG009|COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
3302640|NCT02960490|4036045|FG000|NOT COMPLETED|Treatment Phase(Double-blind): 12 Weeks||5
3302641|NCT02960490|4036046|FG001|NOT COMPLETED|Treatment Phase(Double-blind): 12 Weeks||6
3302642|NCT02960490|4036047|FG002|NOT COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
3302643|NCT02960490|4036048|FG003|NOT COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
3302644|NCT02960490|4036049|FG004|NOT COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
3302645|NCT02960490|4036050|FG005|NOT COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
3302646|NCT02960490|4036051|FG006|NOT COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
3302647|NCT02960490|4036052|FG007|NOT COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
3302648|NCT02960490|4036053|FG008|NOT COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
3302649|NCT02960490|4036054|FG009|NOT COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
3302650|NCT02960490|4036045|FG000|STARTED|Re-randomized Participants: 12 Weeks||0
3302651|NCT02960490|4036046|FG001|STARTED|Re-randomized Participants: 12 Weeks||0
3302652|NCT02960490|4036047|FG002|STARTED|Re-randomized Participants: 12 Weeks||15
3302653|NCT02960490|4036048|FG003|STARTED|Re-randomized Participants: 12 Weeks||14
3302654|NCT02960490|4036049|FG004|STARTED|Re-randomized Participants: 12 Weeks||14
3302655|NCT02960490|4036050|FG005|STARTED|Re-randomized Participants: 12 Weeks||12
3302656|NCT02960490|4036051|FG006|STARTED|Re-randomized Participants: 12 Weeks||0
3302657|NCT02960490|4036052|FG007|STARTED|Re-randomized Participants: 12 Weeks||0
3302658|NCT02960490|4036053|FG008|STARTED|Re-randomized Participants: 12 Weeks||0
3302659|NCT02960490|4036054|FG009|STARTED|Re-randomized Participants: 12 Weeks||0
2971317|NCT00801892|3686066|FG001|COMPLETED|Main Study Period||10
2971318|NCT00801892|3686065|FG000|NOT COMPLETED|Main Study Period||0
2971319|NCT00801892|3686066|FG001|NOT COMPLETED|Main Study Period||1
2971320|NCT00801892|3686065|FG000|STARTED|Sham Crossover Period||0
2971321|NCT00801892|3686066|FG001|STARTED|Sham Crossover Period||7
2971322|NCT00801892|3686065|FG000|COMPLETED|Sham Crossover Period||0
2971323|NCT00801892|3686066|FG001|COMPLETED|Sham Crossover Period||5
2971324|NCT00801892|3686065|FG000|NOT COMPLETED|Sham Crossover Period||0
2971325|NCT00801892|3686066|FG001|NOT COMPLETED|Sham Crossover Period||2
2971326|NCT00801983|3686076|FG000|STARTED|Period 1||44
2971327|NCT00801983|3686077|FG001|STARTED|Period 1||41
2971328|NCT00801983|3686076|FG000|COMPLETED|Period 1||40
2971329|NCT00801983|3686077|FG001|COMPLETED|Period 1||33
2971330|NCT00801983|3686076|FG000|NOT COMPLETED|Period 1||4
2971331|NCT00801983|3686077|FG001|NOT COMPLETED|Period 1||8
2971332|NCT00801983|3686076|FG000|STARTED|Period 2||40
2971333|NCT00801983|3686077|FG001|STARTED|Period 2||33
2971334|NCT00801983|3686076|FG000|COMPLETED|Period 2||38
2971335|NCT00801983|3686077|FG001|COMPLETED|Period 2||32
2971336|NCT00801983|3686076|FG000|NOT COMPLETED|Period 2||2
2971337|NCT00801983|3686077|FG001|NOT COMPLETED|Period 2||1
2971338|NCT00802074|3686089|FG000|STARTED|Overall Study||9
2971339|NCT00802074|3686090|FG001|STARTED|Overall Study||8
2971340|NCT00802074|3686091|FG002|STARTED|Overall Study||7
2971341|NCT00802074|3686092|FG003|STARTED|Overall Study||7
2971342|NCT00802074|3686093|FG004|STARTED|Overall Study||7
2971343|NCT00802074|3686094|FG005|STARTED|Overall Study||7
2971344|NCT00802074|3686089|FG000|COMPLETED|Overall Study||7
2971345|NCT00802074|3686090|FG001|COMPLETED|Overall Study||7
2971346|NCT00802074|3686091|FG002|COMPLETED|Overall Study||6
2971347|NCT00802074|3686092|FG003|COMPLETED|Overall Study||7
2971348|NCT00802074|3686093|FG004|COMPLETED|Overall Study||7
2971349|NCT00802074|3686094|FG005|COMPLETED|Overall Study||7
2971350|NCT00802074|3686089|FG000|NOT COMPLETED|Overall Study||2
2971351|NCT00802074|3686090|FG001|NOT COMPLETED|Overall Study||1
2971352|NCT00802074|3686091|FG002|NOT COMPLETED|Overall Study||1
2971353|NCT00802074|3686092|FG003|NOT COMPLETED|Overall Study||0
2971354|NCT00802074|3686093|FG004|NOT COMPLETED|Overall Study||0
2971355|NCT00802074|3686094|FG005|NOT COMPLETED|Overall Study||0
2971356|NCT00802100|3686114|FG000|STARTED|Overall Study||6
2971357|NCT00802100|3686115|FG001|STARTED|Overall Study||9
2971358|NCT00802100|3686116|FG002|STARTED|Overall Study||6
2971359|NCT00802100|3686114|FG000|COMPLETED|Overall Study||0
2971360|NCT00802100|3686115|FG001|COMPLETED|Overall Study||2
2971361|NCT00802100|3686116|FG002|COMPLETED|Overall Study||2
2971362|NCT00802100|3686114|FG000|NOT COMPLETED|Overall Study||6
2971363|NCT00802100|3686115|FG001|NOT COMPLETED|Overall Study||7
2971364|NCT00802100|3686116|FG002|NOT COMPLETED|Overall Study||4
2971365|NCT00802113|3686127|FG000|STARTED|Overall Study||6
2971366|NCT00802113|3686128|FG001|STARTED|Overall Study||17
2971367|NCT00802113|3686127|FG000|COMPLETED|Overall Study||6
2971368|NCT00802113|3686128|FG001|COMPLETED|Overall Study||17
2971369|NCT00802113|3686127|FG000|NOT COMPLETED|Overall Study||0
2971370|NCT00802113|3686128|FG001|NOT COMPLETED|Overall Study||0
2971371|NCT00802178|3686134|FG000|STARTED|Overall Study||2448
2971372|NCT00802178|3686134|FG000|COMPLETED|Overall Study||2335
2971373|NCT00802178|3686134|FG000|NOT COMPLETED|Overall Study||113
2971374|NCT00802204|3686140|FG000|STARTED|Overall Study||9
2971375|NCT00802204|3686141|FG001|STARTED|Overall Study||19
2971376|NCT00802204|3686140|FG000|COMPLETED|Overall Study||8
2971377|NCT00802204|3686141|FG001|COMPLETED|Overall Study||18
2971378|NCT00802204|3686140|FG000|NOT COMPLETED|Overall Study||1
2971379|NCT00802204|3686141|FG001|NOT COMPLETED|Overall Study||1
2971380|NCT00802360|3686154|FG000|STARTED|Overall Study||42
2971381|NCT00802360|3686155|FG001|STARTED|Overall Study||42
2971382|NCT00802360|3686156|FG002|STARTED|Overall Study||42
2971383|NCT00802360|3686157|FG003|STARTED|Overall Study||39
2971384|NCT00802360|3686154|FG000|COMPLETED|Overall Study||18
2971385|NCT00802360|3686155|FG001|COMPLETED|Overall Study||16
2971386|NCT00802360|3686156|FG002|COMPLETED|Overall Study||17
2971387|NCT00802360|3686157|FG003|COMPLETED|Overall Study||17
2971388|NCT00802360|3686154|FG000|NOT COMPLETED|Overall Study||24
2971389|NCT00802360|3686155|FG001|NOT COMPLETED|Overall Study||26
2971390|NCT00802360|3686156|FG002|NOT COMPLETED|Overall Study||25
2971391|NCT00802360|3686157|FG003|NOT COMPLETED|Overall Study||22
2971392|NCT00802412|3686171|FG000|STARTED|Overall Study||65
2971393|NCT00802412|3686172|FG001|STARTED|Overall Study||67
2971394|NCT00802412|3686171|FG000|COMPLETED|Overall Study||63
2971395|NCT00802412|3686172|FG001|COMPLETED|Overall Study||66
2971396|NCT00802412|3686171|FG000|NOT COMPLETED|Overall Study||2
2971397|NCT00802412|3686172|FG001|NOT COMPLETED|Overall Study||1
2971398|NCT00802438|3686178|FG000|STARTED|Overall Study||38
2971399|NCT00802438|3686178|FG000|COMPLETED|Overall Study||10
2971400|NCT00802438|3686178|FG000|NOT COMPLETED|Overall Study||28
2971401|NCT00802464|3686186|FG000|STARTED|Month 0 - Month 8||38
2971402|NCT00802464|3686187|FG001|STARTED|Month 0 - Month 8||73
2971403|NCT00802464|3686188|FG002|STARTED|Month 0 - Month 8||149
2971404|NCT00802464|3686189|FG003|STARTED|Month 0 - Month 8||150
2971405|NCT00802464|3686186|FG000|COMPLETED|Month 0 - Month 8||38
2971406|NCT00802464|3686187|FG001|COMPLETED|Month 0 - Month 8||70
2971407|NCT00802464|3686188|FG002|COMPLETED|Month 0 - Month 8||142
2971408|NCT00802464|3686189|FG003|COMPLETED|Month 0 - Month 8||141
2971409|NCT00802464|3686186|FG000|NOT COMPLETED|Month 0 - Month 8||0
2971410|NCT00802464|3686187|FG001|NOT COMPLETED|Month 0 - Month 8||3
2971411|NCT00802464|3686188|FG002|NOT COMPLETED|Month 0 - Month 8||7
2971412|NCT00802464|3686189|FG003|NOT COMPLETED|Month 0 - Month 8||9
2971413|NCT00802464|3686186|FG000|STARTED|Month 8 - Month 14||34
2971414|NCT00802464|3686187|FG001|STARTED|Month 8 - Month 14||65
2971415|NCT00802464|3686188|FG002|STARTED|Month 8 - Month 14||130
2971416|NCT00802464|3686189|FG003|STARTED|Month 8 - Month 14||126
2971417|NCT00802464|3686186|FG000|COMPLETED|Month 8 - Month 14||33
2971418|NCT00802464|3686187|FG001|COMPLETED|Month 8 - Month 14||63
2971419|NCT00802464|3686188|FG002|COMPLETED|Month 8 - Month 14||129
2971420|NCT00802464|3686189|FG003|COMPLETED|Month 8 - Month 14||126
2971421|NCT00802464|3686186|FG000|NOT COMPLETED|Month 8 - Month 14||1
2971422|NCT00802464|3686187|FG001|NOT COMPLETED|Month 8 - Month 14||2
2971423|NCT00802464|3686188|FG002|NOT COMPLETED|Month 8 - Month 14||1
2971424|NCT00802464|3686189|FG003|NOT COMPLETED|Month 8 - Month 14||0
2971425|NCT00802503|3686203|FG000|STARTED|Overall Study||152
2971426|NCT00802503|3686204|FG001|STARTED|Overall Study||153
2971427|NCT00802503|3686203|FG000|COMPLETED|Overall Study||142
2971428|NCT00802503|3686204|FG001|COMPLETED|Overall Study||133
2971429|NCT00802503|3686203|FG000|NOT COMPLETED|Overall Study||10
2971430|NCT00802503|3686204|FG001|NOT COMPLETED|Overall Study||20
2971431|NCT00802529|3686216|FG000|STARTED|Overall Study||30
2971432|NCT00802529|3686217|FG001|STARTED|Overall Study||30
2971433|NCT00802529|3686216|FG000|COMPLETED|Overall Study|2 patients crossed-over to gentamicin after steroids failed to control vertigo (as per protocol).|30
2971434|NCT00802529|3686217|FG001|COMPLETED|Overall Study||29
2971435|NCT00802529|3686216|FG000|NOT COMPLETED|Overall Study||0
2971436|NCT00802529|3686217|FG001|NOT COMPLETED|Overall Study||1
2971437|NCT00802633|3686225|FG000|STARTED|Overall Study||40
2971438|NCT00802633|3686226|FG001|STARTED|Overall Study||40
2971439|NCT00802633|3686225|FG000|COMPLETED|Overall Study||40
2971440|NCT00802633|3686226|FG001|COMPLETED|Overall Study||40
2971441|NCT00802633|3686225|FG000|NOT COMPLETED|Overall Study||0
2971442|NCT00802633|3686226|FG001|NOT COMPLETED|Overall Study||0
2971443|NCT00802672|3686235|FG000|STARTED|Overall Study||224
2971444|NCT00802672|3686236|FG001|STARTED|Overall Study||226
2971445|NCT00802672|3686237|FG002|STARTED|Overall Study||111
2971446|NCT00802672|3686235|FG000|COMPLETED|Overall Study||156
2971447|NCT00802672|3686236|FG001|COMPLETED|Overall Study||174
2971448|NCT00802672|3686237|FG002|COMPLETED|Overall Study||77
2971449|NCT00802672|3686235|FG000|NOT COMPLETED|Overall Study||68
2971450|NCT00802672|3686236|FG001|NOT COMPLETED|Overall Study||52
2971451|NCT00802672|3686237|FG002|NOT COMPLETED|Overall Study||34
2971452|NCT00802685|3686247|FG000|STARTED|Overall Study||54
2971453|NCT00802685|3686248|FG001|STARTED|Overall Study||51
2971454|NCT00802685|3686247|FG000|COMPLETED|Overall Study||54
2971455|NCT00802685|3686248|FG001|COMPLETED|Overall Study||51
2971456|NCT00802685|3686247|FG000|NOT COMPLETED|Overall Study||0
2971457|NCT00802685|3686248|FG001|NOT COMPLETED|Overall Study||0
2971458|NCT00802737|3686257|FG000|STARTED|Overall Study||17
2971459|NCT00802737|3686258|FG001|STARTED|Overall Study||11
2971460|NCT00802737|3686259|FG002|STARTED|Overall Study||1
2971461|NCT00802737|3686257|FG000|COMPLETED|Overall Study||0
2971462|NCT00802737|3686258|FG001|COMPLETED|Overall Study||0
2971463|NCT00802737|3686259|FG002|COMPLETED|Overall Study||0
2971464|NCT00802737|3686257|FG000|NOT COMPLETED|Overall Study||17
2971465|NCT00802737|3686258|FG001|NOT COMPLETED|Overall Study||11
2971466|NCT00802737|3686259|FG002|NOT COMPLETED|Overall Study||1
2971467|NCT00802841|3686270|FG000|STARTED|Overall Study||96
2971468|NCT00802841|3686271|FG001|STARTED|Overall Study||95
2971469|NCT00802841|3686270|FG000|Full Analysis Set|Overall Study||96
2971470|NCT00802841|3686271|FG001|Full Analysis Set|Overall Study||95
2971471|NCT00802841|3686270|FG000|Safety Set|Overall Study||96
2971472|NCT00802841|3686271|FG001|Safety Set|Overall Study||93
2971473|NCT00802841|3686270|FG000|Cross-over Set|Overall Study||13
2971474|NCT00802841|3686271|FG001|Cross-over Set|Overall Study||56
2971475|NCT00802841|3686270|FG000|COMPLETED|Overall Study||0
2971476|NCT00802841|3686271|FG001|COMPLETED|Overall Study||0
2971477|NCT00802841|3686270|FG000|NOT COMPLETED|Overall Study||96
2971478|NCT00802841|3686271|FG001|NOT COMPLETED|Overall Study||95
2971479|NCT00802854|3686279|FG000|STARTED|Overall Study||244
2971480|NCT00802854|3686279|FG000|COMPLETED|Overall Study||244
2971481|NCT00802854|3686279|FG000|NOT COMPLETED|Overall Study||0
2971482|NCT00802867|3686283|FG000|STARTED|Overall Study||989
2971483|NCT00802867|3686283|FG000|COMPLETED|Overall Study||976
2971484|NCT00802867|3686283|FG000|NOT COMPLETED|Overall Study||13
2971485|NCT00802880|3686287|FG000|STARTED|Overall Study||80
2971486|NCT00802880|3686287|FG000|COMPLETED|Overall Study||80
2971487|NCT00802880|3686287|FG000|NOT COMPLETED|Overall Study||0
2971488|NCT00802919|3686297|FG000|STARTED|Overall Study||45
2971489|NCT00802919|3686298|FG001|STARTED|Overall Study||46
2971490|NCT00802919|3686297|FG000|COMPLETED|Overall Study||42
2971491|NCT00802919|3686298|FG001|COMPLETED|Overall Study||45
2971492|NCT00802919|3686297|FG000|NOT COMPLETED|Overall Study||3
2971493|NCT00802919|3686298|FG001|NOT COMPLETED|Overall Study||1
2971494|NCT00802945|3686307|FG000|STARTED|Overall Study||35
2971495|NCT00802945|3686308|FG001|STARTED|Overall Study||35
2971496|NCT00802945|3686307|FG000|COMPLETED|Overall Study||0
2971497|NCT00802945|3686308|FG001|COMPLETED|Overall Study||0
2971498|NCT00802945|3686307|FG000|NOT COMPLETED|Overall Study||35
2971499|NCT00802945|3686308|FG001|NOT COMPLETED|Overall Study||35
2971500|NCT00802997|3686318|FG000|STARTED|Baseline to 3 Months||34
2971501|NCT00802997|3686319|FG001|STARTED|Baseline to 3 Months||17
2971502|NCT00802997|3686318|FG000|COMPLETED|Baseline to 3 Months||34
2971503|NCT00802997|3686319|FG001|COMPLETED|Baseline to 3 Months||17
2971504|NCT00802997|3686318|FG000|NOT COMPLETED|Baseline to 3 Months||0
2971505|NCT00802997|3686319|FG001|NOT COMPLETED|Baseline to 3 Months||0
2971506|NCT00802997|3686318|FG000|STARTED|3 Months to 6 Months||34
2971507|NCT00802997|3686319|FG001|STARTED|3 Months to 6 Months|Sham subjects unblinded at 3 Months. None continued in sham group.|0
2971508|NCT00802997|3686318|FG000|COMPLETED|3 Months to 6 Months||27
2971509|NCT00802997|3686319|FG001|COMPLETED|3 Months to 6 Months|Sham subjects unblinded at 3 Months. None continued in sham group.|0
2971510|NCT00802997|3686318|FG000|NOT COMPLETED|3 Months to 6 Months||7
2971511|NCT00802997|3686319|FG001|NOT COMPLETED|3 Months to 6 Months||0
2971512|NCT00802997|3686318|FG000|STARTED|6 Month to 9 Months||27
2971513|NCT00802997|3686319|FG001|STARTED|6 Month to 9 Months|Sham subjects unblinded at 3 Months. None continued in sham group.|0
2971514|NCT00802997|3686318|FG000|COMPLETED|6 Month to 9 Months||25
2971515|NCT00802997|3686319|FG001|COMPLETED|6 Month to 9 Months|Sham subjects unblinded at 3 Months. None continued in sham group.|0
2971516|NCT00802997|3686318|FG000|NOT COMPLETED|6 Month to 9 Months||2
2971517|NCT00802997|3686319|FG001|NOT COMPLETED|6 Month to 9 Months||0
2971518|NCT00803010|3686327|FG000|STARTED|Overall Study||37
2971519|NCT00803010|3686328|FG001|STARTED|Overall Study||37
2971520|NCT00803010|3686327|FG000|COMPLETED|Overall Study||37
2971521|NCT00803010|3686328|FG001|COMPLETED|Overall Study||37
2971522|NCT00803010|3686327|FG000|NOT COMPLETED|Overall Study||0
2971523|NCT00803010|3686328|FG001|NOT COMPLETED|Overall Study||0
2971524|NCT00803023|3686338|FG000|STARTED|Overall Study||32
2971525|NCT00803023|3686339|FG001|STARTED|Overall Study||33
2971526|NCT00803023|3686340|FG002|STARTED|Overall Study||31
2971527|NCT00803023|3686341|FG003|STARTED|Overall Study||33
2971528|NCT00803023|3686338|FG000|COMPLETED|Overall Study||27
2971529|NCT00803023|3686339|FG001|COMPLETED|Overall Study||25
2971530|NCT00803023|3686340|FG002|COMPLETED|Overall Study||20
2971531|NCT00803023|3686341|FG003|COMPLETED|Overall Study||25
2971532|NCT00803023|3686338|FG000|NOT COMPLETED|Overall Study||5
2971533|NCT00803023|3686339|FG001|NOT COMPLETED|Overall Study||8
2971534|NCT00803023|3686340|FG002|NOT COMPLETED|Overall Study||11
2971535|NCT00803023|3686341|FG003|NOT COMPLETED|Overall Study||8
2971536|NCT00803049|3686355|FG000|STARTED|Overall Study|Randomized in extension study|129
2971537|NCT00803049|3686356|FG001|STARTED|Overall Study|Randomized in extension study|252
2971538|NCT00803049|3686357|FG002|STARTED|Overall Study|Randomized in extension study|108
2971539|NCT00803049|3686358|FG003|STARTED|Overall Study|Randomized in extension study|253
2971540|NCT00803049|3686355|FG000|Treated|Overall Study||129
2971541|NCT00803049|3686356|FG001|Treated|Overall Study||252
2971542|NCT00803049|3686357|FG002|Treated|Overall Study||108
2971543|NCT00803049|3686358|FG003|Treated|Overall Study||251
2971544|NCT00803049|3686355|FG000|Safety Population|Overall Study||129
2971545|NCT00803049|3686356|FG001|Safety Population|Overall Study|Included 1 participant from Placebo/Teriflunomide 14 mg and 1 from Teriflunomide14 mg/14 mg arm|254
2971546|NCT00803049|3686357|FG002|Safety Population|Overall Study|1 participant received Teriflunomide 7 mg and analysed in Teriflunomide 7 mg/7 mg arm|107
2971547|NCT00803049|3686358|FG003|Safety Population|Overall Study|1 participant received Teriflunomide 7 mg and analysed in Teriflunomide 7 mg/7 mg arm|250
2971548|NCT00803049|3686355|FG000|COMPLETED|Overall Study||68
2971549|NCT00803049|3686356|FG001|COMPLETED|Overall Study||134
2971550|NCT00803049|3686357|FG002|COMPLETED|Overall Study||64
2971551|NCT00803049|3686358|FG003|COMPLETED|Overall Study||151
2971552|NCT00803049|3686355|FG000|NOT COMPLETED|Overall Study||61
2971553|NCT00803049|3686356|FG001|NOT COMPLETED|Overall Study||118
2971554|NCT00803049|3686357|FG002|NOT COMPLETED|Overall Study||44
2971555|NCT00803049|3686358|FG003|NOT COMPLETED|Overall Study||102
2971556|NCT00803062|3686372|FG000|STARTED|Overall Study||114
2971557|NCT00803062|3686373|FG001|STARTED|Overall Study||115
2971558|NCT00803062|3686374|FG002|STARTED|Overall Study||111
2971559|NCT00803062|3686375|FG003|STARTED|Overall Study||112
2971560|NCT00803062|3686372|FG000|COMPLETED|Overall Study||114
2971561|NCT00803062|3686373|FG001|COMPLETED|Overall Study||115
2971562|NCT00803062|3686374|FG002|COMPLETED|Overall Study||111
2971563|NCT00803062|3686375|FG003|COMPLETED|Overall Study||112
2971564|NCT00803062|3686372|FG000|NOT COMPLETED|Overall Study||0
2971565|NCT00803062|3686373|FG001|NOT COMPLETED|Overall Study||0
2971566|NCT00803062|3686374|FG002|NOT COMPLETED|Overall Study||0
2971567|NCT00803062|3686375|FG003|NOT COMPLETED|Overall Study||0
2971568|NCT00803101|3686387|FG000|STARTED|Overall Study||88
2971569|NCT00803101|3686388|FG001|STARTED|Overall Study||88
2971570|NCT00803101|3686387|FG000|COMPLETED|Overall Study||70
2971571|NCT00803101|3686388|FG001|COMPLETED|Overall Study||66
2971572|NCT00803101|3686387|FG000|NOT COMPLETED|Overall Study||18
2971573|NCT00803101|3686388|FG001|NOT COMPLETED|Overall Study||22
2971574|NCT00803205|3686396|FG000|STARTED|Overall Study||120
2971575|NCT00803205|3686397|FG001|STARTED|Overall Study||118
2971576|NCT00803205|3686396|FG000|Completed Week 16|Overall Study||107
2971577|NCT00803205|3686397|FG001|Completed Week 16|Overall Study||113
2971578|NCT00803205|3686396|FG000|Completed Week 24|Overall Study||103
2971579|NCT00803205|3686397|FG001|Completed Week 24|Overall Study||110
2971580|NCT00803205|3686396|FG000|As-Treated Population*|Overall Study||120
2971581|NCT00803205|3686397|FG001|As-Treated Population*|Overall Study||118
2971582|NCT00803205|3686396|FG000|ITT Population|Overall Study||116
2971583|NCT00803205|3686397|FG001|ITT Population|Overall Study||116
2971584|NCT00803205|3686396|FG000|Per Protocol Population|Overall Study||100
2971585|NCT00803205|3686397|FG001|Per Protocol Population|Overall Study||103
2971586|NCT00803205|3686396|FG000|COMPLETED|Overall Study||100
2971587|NCT00803205|3686397|FG001|COMPLETED|Overall Study||104
2971588|NCT00803205|3686396|FG000|NOT COMPLETED|Overall Study||20
2971589|NCT00803205|3686397|FG001|NOT COMPLETED|Overall Study||14
2971590|NCT00803244|3686405|FG000|STARTED|Overall Study||188
2971591|NCT00803244|3686406|FG001|STARTED|Overall Study||193
2971592|NCT00803244|3686405|FG000|COMPLETED|Overall Study||181
2971593|NCT00803244|3686406|FG001|COMPLETED|Overall Study||178
2971594|NCT00803244|3686405|FG000|NOT COMPLETED|Overall Study||7
2971595|NCT00803244|3686406|FG001|NOT COMPLETED|Overall Study||15
2971596|NCT00803270|3686414|FG000|STARTED|Overall Study||13
2971597|NCT00803270|3686415|FG001|STARTED|Overall Study||14
2971598|NCT00803270|3686414|FG000|COMPLETED|Overall Study||12
2971599|NCT00803270|3686415|FG001|COMPLETED|Overall Study||12
2971600|NCT00803270|3686414|FG000|NOT COMPLETED|Overall Study||1
2971601|NCT00803270|3686415|FG001|NOT COMPLETED|Overall Study||2
2971602|NCT00803361|3686423|FG000|STARTED|Overall Study||108
2971603|NCT00803361|3686424|FG001|STARTED|Overall Study||102
2971604|NCT00803361|3686423|FG000|COMPLETED|Overall Study||82
2971605|NCT00803361|3686424|FG001|COMPLETED|Overall Study||74
2971606|NCT00803361|3686423|FG000|NOT COMPLETED|Overall Study||26
2971607|NCT00803361|3686424|FG001|NOT COMPLETED|Overall Study||28
2971608|NCT00803400|3686432|FG000|STARTED|Overall Study||75
2971609|NCT00803400|3686433|FG001|STARTED|Overall Study||75
2971610|NCT00803400|3686432|FG000|COMPLETED|Overall Study||55
2971611|NCT00803400|3686433|FG001|COMPLETED|Overall Study||51
2971612|NCT00803400|3686432|FG000|NOT COMPLETED|Overall Study||20
2971613|NCT00803400|3686433|FG001|NOT COMPLETED|Overall Study||24
2971614|NCT00803452|3686442|FG000|STARTED|Overall Study||9
2971615|NCT00803452|3686443|FG001|STARTED|Overall Study||22
2971616|NCT00803452|3686442|FG000|COMPLETED|Overall Study||9
2971617|NCT00803452|3686443|FG001|COMPLETED|Overall Study||17
2971618|NCT00803452|3686442|FG000|NOT COMPLETED|Overall Study||0
2971619|NCT00803452|3686443|FG001|NOT COMPLETED|Overall Study||5
2971620|NCT00803543|3686451|FG000|STARTED|Overall Study||69
2971621|NCT00803543|3686452|FG001|STARTED|Overall Study||34
2971622|NCT00803543|3686451|FG000|COMPLETED|Overall Study||45
2971623|NCT00803543|3686452|FG001|COMPLETED|Overall Study||22
2971624|NCT00803543|3686451|FG000|NOT COMPLETED|Overall Study||24
2971625|NCT00803543|3686452|FG001|NOT COMPLETED|Overall Study||12
2971626|NCT00803569|3686458|FG000|STARTED|Overall Study||13
2971627|NCT00803569|3686458|FG000|COMPLETED|Overall Study||9
2971628|NCT00803569|3686458|FG000|NOT COMPLETED|Overall Study||4
2971629|NCT00803595|3686465|FG000|STARTED|Overall Study||337
2971630|NCT00803595|3686466|FG001|STARTED|Overall Study||327
2971631|NCT00803595|3686467|FG002|STARTED|Overall Study||338
2971632|NCT00803595|3686465|FG000|COMPLETED|Overall Study||322
2971633|NCT00803595|3686466|FG001|COMPLETED|Overall Study||319
2971634|NCT00803595|3686467|FG002|COMPLETED|Overall Study||322
2971635|NCT00803595|3686465|FG000|NOT COMPLETED|Overall Study||15
2971636|NCT00803595|3686466|FG001|NOT COMPLETED|Overall Study||8
2971637|NCT00803595|3686467|FG002|NOT COMPLETED|Overall Study||16
2971638|NCT00803634|3686477|FG000|STARTED|Overall Study|All patients dosed with clevidipine [Safety population]|51
2971639|NCT00803634|3686478|FG001|STARTED|Overall Study|All patients dosed with SOC antihypertensive therapy [Safety population]|53
3164065|NCT01890785|3891531|FG001|STARTED|First Intervention||5
3164066|NCT01890785|3891532|FG002|STARTED|First Intervention||5
3164067|NCT01890785|3891533|FG003|STARTED|First Intervention||5
2971640|NCT00803634|3686477|FG000|mITT (Dosed & Have Confirmed AHF)|Overall Study|All patients dosed with clevidipine and confirmed to have AHF [mITT population]|44
2971641|NCT00803634|3686478|FG001|mITT (Dosed & Have Confirmed AHF)|Overall Study|All patients dosed with SOC antihypertensive therapy and confirmed to have AHF [mITT population]|41
2971642|NCT00803634|3686477|FG000|COMPLETED|Overall Study|All patients dosed with clevidipine [Safety population]|45
2971643|NCT00803634|3686478|FG001|COMPLETED|Overall Study|All patients dosed with SOC antihypertensive therapy [Safety population]|48
2971644|NCT00803634|3686477|FG000|NOT COMPLETED|Overall Study||6
2971645|NCT00803634|3686478|FG001|NOT COMPLETED|Overall Study||5
2971646|NCT00803647|3686485|FG000|STARTED|Overall Study||20
2971647|NCT00803647|3686485|FG000|COMPLETED|Overall Study||20
2971648|NCT00803647|3686485|FG000|NOT COMPLETED|Overall Study||0
2971649|NCT00803686|3686493|FG000|STARTED|Part 1, Period 1||6
2971650|NCT00803686|3686494|FG001|STARTED|Part 1, Period 1||6
2971651|NCT00803686|3686495|FG002|STARTED|Part 1, Period 1||0
2971652|NCT00803686|3686496|FG003|STARTED|Part 1, Period 1||0
2971653|NCT00803686|3686493|FG000|COMPLETED|Part 1, Period 1||6
2971654|NCT00803686|3686494|FG001|COMPLETED|Part 1, Period 1||6
2971655|NCT00803686|3686495|FG002|COMPLETED|Part 1, Period 1||0
2971656|NCT00803686|3686496|FG003|COMPLETED|Part 1, Period 1||0
2971657|NCT00803686|3686493|FG000|NOT COMPLETED|Part 1, Period 1||0
2971658|NCT00803686|3686494|FG001|NOT COMPLETED|Part 1, Period 1||0
2971659|NCT00803686|3686495|FG002|NOT COMPLETED|Part 1, Period 1||0
2971660|NCT00803686|3686496|FG003|NOT COMPLETED|Part 1, Period 1||0
2971661|NCT00803686|3686493|FG000|STARTED|Part 1, Period 2||6
2971662|NCT00803686|3686494|FG001|STARTED|Part 1, Period 2||6
2971663|NCT00803686|3686495|FG002|STARTED|Part 1, Period 2|No subjects were to be treated until after Periods 1 and 2.|0
2971664|NCT00803686|3686496|FG003|STARTED|Part 1, Period 2|No subjects were to be treated until after Periods 1 and 2.|0
2971665|NCT00803686|3686493|FG000|COMPLETED|Part 1, Period 2||6
2971666|NCT00803686|3686494|FG001|COMPLETED|Part 1, Period 2||6
2971667|NCT00803686|3686495|FG002|COMPLETED|Part 1, Period 2|No subjects treated.|0
3164068|NCT01890785|3891534|FG004|STARTED|First Intervention||5
3164069|NCT01890785|3891535|FG005|STARTED|First Intervention||5
2971668|NCT00803686|3686496|FG003|COMPLETED|Part 1, Period 2|No subjects treated.|0
2971669|NCT00803686|3686493|FG000|NOT COMPLETED|Part 1, Period 2||0
2971670|NCT00803686|3686494|FG001|NOT COMPLETED|Part 1, Period 2||0
2971671|NCT00803686|3686495|FG002|NOT COMPLETED|Part 1, Period 2||0
2971672|NCT00803686|3686496|FG003|NOT COMPLETED|Part 1, Period 2||0
2971673|NCT00803686|3686493|FG000|STARTED|Part 2, Period 3|No subjects were treated in this period|0
2971674|NCT00803686|3686494|FG001|STARTED|Part 2, Period 3|No subjects were treated in this period.|0
2971675|NCT00803686|3686495|FG002|STARTED|Part 2, Period 3|Of the 6 eligible, 1 elected not to continue into Period 3.|5
2971676|NCT00803686|3686496|FG003|STARTED|Part 2, Period 3|Of the 6 eligible, 2 elected not to continue into Period 3.|4
2971677|NCT00803686|3686493|FG000|COMPLETED|Part 2, Period 3|No subjects were treated in this period|0
2971678|NCT00803686|3686494|FG001|COMPLETED|Part 2, Period 3|No subjects were treated in this period.|0
2971679|NCT00803686|3686495|FG002|COMPLETED|Part 2, Period 3|All who started this period completed|5
2971680|NCT00803686|3686496|FG003|COMPLETED|Part 2, Period 3|All who started this period completed|4
2971681|NCT00803686|3686493|FG000|NOT COMPLETED|Part 2, Period 3||0
2971682|NCT00803686|3686494|FG001|NOT COMPLETED|Part 2, Period 3||0
2971683|NCT00803686|3686495|FG002|NOT COMPLETED|Part 2, Period 3||0
2971684|NCT00803686|3686496|FG003|NOT COMPLETED|Part 2, Period 3||0
2971685|NCT00803712|3686510|FG000|STARTED|Overall Study|154 participants were randomized to the cinacalcet group|154
2971686|NCT00803712|3686511|FG001|STARTED|Overall Study|155 participants were randomized to the control group|155
2971687|NCT00803712|3686510|FG000|Full Analysis Set|Overall Study|153 participants randomized and had at least one PTH concentration available after study day 1.|153
2971688|NCT00803712|3686511|FG001|Full Analysis Set|Overall Study|151 participants randomized and had at least one PTH concentration available after study day 1.|151
2971689|NCT00803712|3686510|FG000|Safety Analysis Set|Overall Study|Rz'ed to cinacalcet and received at least 1 dose, or to control but received cinacalcet throughout|155
2971690|NCT00803712|3686511|FG001|Safety Analysis Set|Overall Study|Randomized to the control group|154
2971691|NCT00803712|3686510|FG000|COMPLETED|Overall Study|118 participants randomized to the cinacalcet group completed the study|118
2971692|NCT00803712|3686511|FG001|COMPLETED|Overall Study|128 participants randomized to the control group completed the study|128
2971693|NCT00803712|3686510|FG000|NOT COMPLETED|Overall Study||36
2971694|NCT00803712|3686511|FG001|NOT COMPLETED|Overall Study||27
2971695|NCT00803738|3686519|FG000|STARTED|Overall Study||286
2971696|NCT00803738|3686520|FG001|STARTED|Overall Study||286
2971697|NCT00803738|3686519|FG000|COMPLETED|Overall Study||192
2971698|NCT00803738|3686520|FG001|COMPLETED|Overall Study||176
2971699|NCT00803738|3686519|FG000|NOT COMPLETED|Overall Study||94
2971700|NCT00803738|3686520|FG001|NOT COMPLETED|Overall Study||110
2971701|NCT00803751|3686528|FG000|STARTED|Overall Study||26
2971702|NCT00803751|3686529|FG001|STARTED|Overall Study||23
2971703|NCT00803751|3686528|FG000|COMPLETED|Overall Study||26
2971704|NCT00803751|3686529|FG001|COMPLETED|Overall Study||23
2971705|NCT00803751|3686528|FG000|NOT COMPLETED|Overall Study||0
2971706|NCT00803751|3686529|FG001|NOT COMPLETED|Overall Study||0
2971707|NCT00803777|3686535|FG000|STARTED|Overall Study||147
2971708|NCT00803777|3686535|FG000|COMPLETED|Overall Study||147
2971709|NCT00803777|3686535|FG000|NOT COMPLETED|Overall Study||0
2971710|NCT00803959|3686541|FG000|STARTED|Overall Study||315
3302660|NCT02960490|4036045|FG000|Treated|Re-randomized Participants: 12 Weeks||0
3302661|NCT02960490|4036046|FG001|Treated|Re-randomized Participants: 12 Weeks||0
3302662|NCT02960490|4036047|FG002|Treated|Re-randomized Participants: 12 Weeks||15
3302663|NCT02960490|4036048|FG003|Treated|Re-randomized Participants: 12 Weeks||14
3302664|NCT02960490|4036049|FG004|Treated|Re-randomized Participants: 12 Weeks||14
3302665|NCT02960490|4036050|FG005|Treated|Re-randomized Participants: 12 Weeks||12
3302666|NCT02960490|4036051|FG006|Treated|Re-randomized Participants: 12 Weeks||0
3302667|NCT02960490|4036052|FG007|Treated|Re-randomized Participants: 12 Weeks||0
3302668|NCT02960490|4036053|FG008|Treated|Re-randomized Participants: 12 Weeks||0
3302669|NCT02960490|4036054|FG009|Treated|Re-randomized Participants: 12 Weeks||0
3302670|NCT02960490|4036045|FG000|FAS|Re-randomized Participants: 12 Weeks||0
3302671|NCT02960490|4036046|FG001|FAS|Re-randomized Participants: 12 Weeks||0
3302672|NCT02960490|4036047|FG002|FAS|Re-randomized Participants: 12 Weeks||15
3302673|NCT02960490|4036048|FG003|FAS|Re-randomized Participants: 12 Weeks||14
3302674|NCT02960490|4036049|FG004|FAS|Re-randomized Participants: 12 Weeks||14
3302675|NCT02960490|4036050|FG005|FAS|Re-randomized Participants: 12 Weeks||12
3302676|NCT02960490|4036051|FG006|FAS|Re-randomized Participants: 12 Weeks||0
3302677|NCT02960490|4036052|FG007|FAS|Re-randomized Participants: 12 Weeks||0
3302678|NCT02960490|4036053|FG008|FAS|Re-randomized Participants: 12 Weeks||0
3302679|NCT02960490|4036054|FG009|FAS|Re-randomized Participants: 12 Weeks||0
3302680|NCT02960490|4036045|FG000|SAS|Re-randomized Participants: 12 Weeks||0
3302681|NCT02960490|4036046|FG001|SAS|Re-randomized Participants: 12 Weeks||0
3302682|NCT02960490|4036047|FG002|SAS|Re-randomized Participants: 12 Weeks||15
3302683|NCT02960490|4036048|FG003|SAS|Re-randomized Participants: 12 Weeks||14
3302684|NCT02960490|4036049|FG004|SAS|Re-randomized Participants: 12 Weeks||14
3302685|NCT02960490|4036050|FG005|SAS|Re-randomized Participants: 12 Weeks||12
3302686|NCT02960490|4036051|FG006|SAS|Re-randomized Participants: 12 Weeks||0
3302687|NCT02960490|4036052|FG007|SAS|Re-randomized Participants: 12 Weeks||0
3302688|NCT02960490|4036053|FG008|SAS|Re-randomized Participants: 12 Weeks||0
3302689|NCT02960490|4036054|FG009|SAS|Re-randomized Participants: 12 Weeks||0
3302690|NCT02960490|4036045|FG000|COMPLETED|Re-randomized Participants: 12 Weeks||0
3302691|NCT02960490|4036046|FG001|COMPLETED|Re-randomized Participants: 12 Weeks||0
2971711|NCT00803959|3686542|FG001|STARTED|Overall Study||315
2971712|NCT00803959|3686541|FG000|ITT Analysis With Primary Outcome Data|Overall Study||266
2971713|NCT00803959|3686542|FG001|ITT Analysis With Primary Outcome Data|Overall Study||272
2971714|NCT00803959|3686541|FG000|COMPLETED|Overall Study|Because it is a non-inferiority trial, the PP analysis was the main analysis (n=259).|259
2971715|NCT00803959|3686542|FG001|COMPLETED|Overall Study|Because it is a non-inferiority trial, the PP analysis was the main analysis (n=264).|264
2971716|NCT00803959|3686541|FG000|NOT COMPLETED|Overall Study||56
2971717|NCT00803959|3686542|FG001|NOT COMPLETED|Overall Study||51
3133247|NCT01695239|3858317|FG012|STARTED|IR Participants (Week 16 Up To Week 24)||0
3133248|NCT01695239|3858318|FG013|STARTED|IR Participants (Week 16 Up To Week 24)||0
3133249|NCT01695239|3858305|FG000|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
3133250|NCT01695239|3858306|FG001|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
3302692|NCT02960490|4036047|FG002|COMPLETED|Re-randomized Participants: 12 Weeks||13
3302693|NCT02960490|4036048|FG003|COMPLETED|Re-randomized Participants: 12 Weeks||12
2971718|NCT00804141|3686548|FG000|STARTED|Overall Study||1040
2971719|NCT00804141|3686548|FG000|Received at Least 1 Dose of Study Drug|Overall Study||1034
2971720|NCT00804141|3686548|FG000|COMPLETED|Overall Study||477
2971721|NCT00804141|3686548|FG000|NOT COMPLETED|Overall Study||563
2971722|NCT00804193|3686555|FG000|STARTED|Overall Study||220
2971723|NCT00804193|3686556|FG001|STARTED|Overall Study||224
2971724|NCT00804193|3686557|FG002|STARTED|Overall Study||109
2971725|NCT00804193|3686555|FG000|COMPLETED|Overall Study||181
2971726|NCT00804193|3686556|FG001|COMPLETED|Overall Study||180
3302694|NCT02960490|4036049|FG004|COMPLETED|Re-randomized Participants: 12 Weeks||13
3302695|NCT02960490|4036050|FG005|COMPLETED|Re-randomized Participants: 12 Weeks||10
3302696|NCT02960490|4036051|FG006|COMPLETED|Re-randomized Participants: 12 Weeks||0
3302697|NCT02960490|4036052|FG007|COMPLETED|Re-randomized Participants: 12 Weeks||0
3302698|NCT02960490|4036053|FG008|COMPLETED|Re-randomized Participants: 12 Weeks||0
3302699|NCT02960490|4036054|FG009|COMPLETED|Re-randomized Participants: 12 Weeks||0
3302700|NCT02960490|4036045|FG000|NOT COMPLETED|Re-randomized Participants: 12 Weeks||0
3302701|NCT02960490|4036046|FG001|NOT COMPLETED|Re-randomized Participants: 12 Weeks||0
3302702|NCT02960490|4036047|FG002|NOT COMPLETED|Re-randomized Participants: 12 Weeks||2
3302703|NCT02960490|4036048|FG003|NOT COMPLETED|Re-randomized Participants: 12 Weeks||2
3302704|NCT02960490|4036049|FG004|NOT COMPLETED|Re-randomized Participants: 12 Weeks||1
3302705|NCT02960490|4036050|FG005|NOT COMPLETED|Re-randomized Participants: 12 Weeks||2
3302706|NCT02960490|4036051|FG006|NOT COMPLETED|Re-randomized Participants: 12 Weeks||0
3302707|NCT02960490|4036052|FG007|NOT COMPLETED|Re-randomized Participants: 12 Weeks||0
3302708|NCT02960490|4036053|FG008|NOT COMPLETED|Re-randomized Participants: 12 Weeks||0
3302709|NCT02960490|4036054|FG009|NOT COMPLETED|Re-randomized Participants: 12 Weeks||0
3302710|NCT02960490|4036045|FG000|STARTED|Extension Phase(Open-label): 80 Weeks||0
3302711|NCT02960490|4036046|FG001|STARTED|Extension Phase(Open-label): 80 Weeks||0
3302712|NCT02960490|4036047|FG002|STARTED|Extension Phase(Open-label): 80 Weeks||0
3302713|NCT02960490|4036048|FG003|STARTED|Extension Phase(Open-label): 80 Weeks||0
3302714|NCT02960490|4036049|FG004|STARTED|Extension Phase(Open-label): 80 Weeks||0
3302715|NCT02960490|4036050|FG005|STARTED|Extension Phase(Open-label): 80 Weeks||0
3302716|NCT02960490|4036051|FG006|STARTED|Extension Phase(Open-label): 80 Weeks||13
3302717|NCT02960490|4036052|FG007|STARTED|Extension Phase(Open-label): 80 Weeks|One Participant who completed Core Treatment Phase (Placebo Then E6011 400 mg arm) had inadequate therapeutic effect at Week 24, hence did not started Extension phase.|11
3302718|NCT02960490|4036053|FG008|STARTED|Extension Phase(Open-label): 80 Weeks||13
3302719|NCT02960490|4036054|FG009|STARTED|Extension Phase(Open-label): 80 Weeks||10
3302720|NCT02960490|4036045|FG000|Treated|Extension Phase(Open-label): 80 Weeks||0
3302721|NCT02960490|4036046|FG001|Treated|Extension Phase(Open-label): 80 Weeks||0
3302722|NCT02960490|4036047|FG002|Treated|Extension Phase(Open-label): 80 Weeks||0
3302723|NCT02960490|4036048|FG003|Treated|Extension Phase(Open-label): 80 Weeks||0
3302724|NCT02960490|4036049|FG004|Treated|Extension Phase(Open-label): 80 Weeks||0
3302725|NCT02960490|4036050|FG005|Treated|Extension Phase(Open-label): 80 Weeks||0
3302726|NCT02960490|4036051|FG006|Treated|Extension Phase(Open-label): 80 Weeks||13
3302727|NCT02960490|4036052|FG007|Treated|Extension Phase(Open-label): 80 Weeks||11
3302728|NCT02960490|4036053|FG008|Treated|Extension Phase(Open-label): 80 Weeks||13
3302729|NCT02960490|4036054|FG009|Treated|Extension Phase(Open-label): 80 Weeks||10
3302730|NCT02960490|4036045|FG000|FAS|Extension Phase(Open-label): 80 Weeks||0
3302731|NCT02960490|4036046|FG001|FAS|Extension Phase(Open-label): 80 Weeks||0
3302732|NCT02960490|4036047|FG002|FAS|Extension Phase(Open-label): 80 Weeks||0
3302733|NCT02960490|4036048|FG003|FAS|Extension Phase(Open-label): 80 Weeks||0
3302734|NCT02960490|4036049|FG004|FAS|Extension Phase(Open-label): 80 Weeks||0
3302735|NCT02960490|4036050|FG005|FAS|Extension Phase(Open-label): 80 Weeks||0
3302736|NCT02960490|4036051|FG006|FAS|Extension Phase(Open-label): 80 Weeks||13
3302737|NCT02960490|4036052|FG007|FAS|Extension Phase(Open-label): 80 Weeks||11
3302738|NCT02960490|4036053|FG008|FAS|Extension Phase(Open-label): 80 Weeks||13
3302739|NCT02960490|4036054|FG009|FAS|Extension Phase(Open-label): 80 Weeks||10
3302740|NCT02960490|4036045|FG000|SAS|Extension Phase(Open-label): 80 Weeks||0
3302741|NCT02960490|4036046|FG001|SAS|Extension Phase(Open-label): 80 Weeks||0
3302742|NCT02960490|4036047|FG002|SAS|Extension Phase(Open-label): 80 Weeks||0
3302743|NCT02960490|4036048|FG003|SAS|Extension Phase(Open-label): 80 Weeks||0
3302744|NCT02960490|4036049|FG004|SAS|Extension Phase(Open-label): 80 Weeks||0
3302745|NCT02960490|4036050|FG005|SAS|Extension Phase(Open-label): 80 Weeks||0
3133251|NCT01695239|3858307|FG002|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
3133252|NCT01695239|3858308|FG003|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
3133253|NCT01695239|3858309|FG004|COMPLETED|IR Participants (Week 16 Up To Week 24)||24
3302746|NCT02960490|4036051|FG006|SAS|Extension Phase(Open-label): 80 Weeks||13
2971727|NCT00804193|3686557|FG002|COMPLETED|Overall Study||77
2971728|NCT00804193|3686555|FG000|NOT COMPLETED|Overall Study||39
2971729|NCT00804193|3686556|FG001|NOT COMPLETED|Overall Study||44
2971730|NCT00804193|3686557|FG002|NOT COMPLETED|Overall Study||32
2971731|NCT00804570|3686567|FG000|STARTED|Overall Study||187
2971732|NCT00804570|3686568|FG001|STARTED|Overall Study||188
2971733|NCT00804570|3686567|FG000|COMPLETED|Overall Study||115
2971734|NCT00804570|3686568|FG001|COMPLETED|Overall Study||94
2971735|NCT00804570|3686567|FG000|NOT COMPLETED|Overall Study||72
2971736|NCT00804570|3686568|FG001|NOT COMPLETED|Overall Study||94
2971737|NCT00804596|3686575|FG000|STARTED|Overall Study||74
2971738|NCT00804596|3686575|FG000|COMPLETED|Overall Study||74
2971739|NCT00804596|3686575|FG000|NOT COMPLETED|Overall Study||0
2971740|NCT00804609|3686581|FG000|STARTED|Overall Study||15
2971741|NCT00804609|3686582|FG001|STARTED|Overall Study||15
3302747|NCT02960490|4036052|FG007|SAS|Extension Phase(Open-label): 80 Weeks||11
3302748|NCT02960490|4036053|FG008|SAS|Extension Phase(Open-label): 80 Weeks||13
3302749|NCT02960490|4036054|FG009|SAS|Extension Phase(Open-label): 80 Weeks||10
3302750|NCT02960490|4036045|FG000|COMPLETED|Extension Phase(Open-label): 80 Weeks||0
3302751|NCT02960490|4036046|FG001|COMPLETED|Extension Phase(Open-label): 80 Weeks||0
3302752|NCT02960490|4036047|FG002|COMPLETED|Extension Phase(Open-label): 80 Weeks||0
3302753|NCT02960490|4036048|FG003|COMPLETED|Extension Phase(Open-label): 80 Weeks||0
3302754|NCT02960490|4036049|FG004|COMPLETED|Extension Phase(Open-label): 80 Weeks||0
3302755|NCT02960490|4036050|FG005|COMPLETED|Extension Phase(Open-label): 80 Weeks||0
3302756|NCT02960490|4036051|FG006|COMPLETED|Extension Phase(Open-label): 80 Weeks||4
3302757|NCT02960490|4036052|FG007|COMPLETED|Extension Phase(Open-label): 80 Weeks||5
3302758|NCT02960490|4036053|FG008|COMPLETED|Extension Phase(Open-label): 80 Weeks||9
3302759|NCT02960490|4036054|FG009|COMPLETED|Extension Phase(Open-label): 80 Weeks||3
3302760|NCT02960490|4036045|FG000|NOT COMPLETED|Extension Phase(Open-label): 80 Weeks||0
3302761|NCT02960490|4036046|FG001|NOT COMPLETED|Extension Phase(Open-label): 80 Weeks||0
3302762|NCT02960490|4036047|FG002|NOT COMPLETED|Extension Phase(Open-label): 80 Weeks||0
3302763|NCT02960490|4036048|FG003|NOT COMPLETED|Extension Phase(Open-label): 80 Weeks||0
3302764|NCT02960490|4036049|FG004|NOT COMPLETED|Extension Phase(Open-label): 80 Weeks||0
3302765|NCT02960490|4036050|FG005|NOT COMPLETED|Extension Phase(Open-label): 80 Weeks||0
3302766|NCT02960490|4036051|FG006|NOT COMPLETED|Extension Phase(Open-label): 80 Weeks||9
3302767|NCT02960490|4036052|FG007|NOT COMPLETED|Extension Phase(Open-label): 80 Weeks||6
3302768|NCT02960490|4036053|FG008|NOT COMPLETED|Extension Phase(Open-label): 80 Weeks||4
3302769|NCT02960490|4036054|FG009|NOT COMPLETED|Extension Phase(Open-label): 80 Weeks||7
3302770|NCT02960854|4036078|FG000|STARTED|Overall Study||15
3302771|NCT02960854|4036079|FG001|STARTED|Overall Study||16
3302772|NCT02960854|4036078|FG000|COMPLETED|Overall Study||8
3302773|NCT02960854|4036079|FG001|COMPLETED|Overall Study||7
3302774|NCT02960854|4036078|FG000|NOT COMPLETED|Overall Study||7
3302775|NCT02960854|4036079|FG001|NOT COMPLETED|Overall Study||9
3302776|NCT02960893|4036087|FG000|STARTED|Randomization Phase (8-week)||71
3302777|NCT02960893|4036088|FG001|STARTED|Randomization Phase (8-week)||70
3302778|NCT02960893|4036087|FG000|COMPLETED|Randomization Phase (8-week)||64
3302779|NCT02960893|4036088|FG001|COMPLETED|Randomization Phase (8-week)||68
3302780|NCT02960893|4036087|FG000|NOT COMPLETED|Randomization Phase (8-week)||7
3302781|NCT02960893|4036088|FG001|NOT COMPLETED|Randomization Phase (8-week)||2
3302782|NCT02960893|4036087|FG000|STARTED|Extension Phase (48-week)||64
3302783|NCT02960893|4036088|FG001|STARTED|Extension Phase (48-week)|One participant in placebo arm who completed Randomization Phase did not continue to Extension Phase|67
3302784|NCT02960893|4036087|FG000|COMPLETED|Extension Phase (48-week)||50
3302785|NCT02960893|4036088|FG001|COMPLETED|Extension Phase (48-week)||54
3302786|NCT02960893|4036087|FG000|NOT COMPLETED|Extension Phase (48-week)||14
3302787|NCT02960893|4036088|FG001|NOT COMPLETED|Extension Phase (48-week)||13
3302788|NCT02960997|4036103|FG000|STARTED|First Intervention, 12 Weeks||4
3302789|NCT02960997|4036104|FG001|STARTED|First Intervention, 12 Weeks||4
3302790|NCT02960997|4036103|FG000|COMPLETED|First Intervention, 12 Weeks||4
3302791|NCT02960997|4036104|FG001|COMPLETED|First Intervention, 12 Weeks||4
3302792|NCT02960997|4036103|FG000|NOT COMPLETED|First Intervention, 12 Weeks||0
3302793|NCT02960997|4036104|FG001|NOT COMPLETED|First Intervention, 12 Weeks||0
3302794|NCT02960997|4036103|FG000|STARTED|Washout Period, 4 Weeks||4
3302795|NCT02960997|4036104|FG001|STARTED|Washout Period, 4 Weeks||4
3302796|NCT02960997|4036103|FG000|COMPLETED|Washout Period, 4 Weeks||4
3302797|NCT02960997|4036104|FG001|COMPLETED|Washout Period, 4 Weeks||4
3302798|NCT02960997|4036103|FG000|NOT COMPLETED|Washout Period, 4 Weeks||0
3302799|NCT02960997|4036104|FG001|NOT COMPLETED|Washout Period, 4 Weeks||0
3302800|NCT02960997|4036103|FG000|STARTED|Second Treatment, 12 Weeks||4
3302801|NCT02960997|4036104|FG001|STARTED|Second Treatment, 12 Weeks||4
3302802|NCT02960997|4036103|FG000|COMPLETED|Second Treatment, 12 Weeks||4
3302803|NCT02960997|4036104|FG001|COMPLETED|Second Treatment, 12 Weeks||4
3302804|NCT02960997|4036103|FG000|NOT COMPLETED|Second Treatment, 12 Weeks||0
3302805|NCT02960997|4036104|FG001|NOT COMPLETED|Second Treatment, 12 Weeks||0
3302806|NCT02960997|4036103|FG000|STARTED|Follow-up Period, 4 Weeks||4
2971742|NCT00804609|3686581|FG000|COMPLETED|Overall Study||15
2971743|NCT00804609|3686582|FG001|COMPLETED|Overall Study||14
2971744|NCT00804609|3686581|FG000|NOT COMPLETED|Overall Study||0
2971745|NCT00804609|3686582|FG001|NOT COMPLETED|Overall Study||1
2971746|NCT00804648|3686588|FG000|STARTED|First Intervention||3
2971747|NCT00804648|3686589|FG001|STARTED|First Intervention||5
2971748|NCT00804648|3686590|FG002|STARTED|First Intervention||6
2971749|NCT00804648|3686591|FG003|STARTED|First Intervention||4
2971750|NCT00804648|3686592|FG004|STARTED|First Intervention||4
3302807|NCT02960997|4036104|FG001|STARTED|Follow-up Period, 4 Weeks||4
3302808|NCT02960997|4036103|FG000|COMPLETED|Follow-up Period, 4 Weeks||4
3302809|NCT02960997|4036104|FG001|COMPLETED|Follow-up Period, 4 Weeks||4
3302810|NCT02960997|4036103|FG000|NOT COMPLETED|Follow-up Period, 4 Weeks||0
3302811|NCT02960997|4036104|FG001|NOT COMPLETED|Follow-up Period, 4 Weeks||0
3302812|NCT02961062|4036112|FG000|STARTED|Overall Study||20
3302813|NCT02961062|4036113|FG001|STARTED|Overall Study||20
3302814|NCT02961062|4036112|FG000|COMPLETED|Overall Study||20
3302815|NCT02961062|4036113|FG001|COMPLETED|Overall Study||20
3302816|NCT02961062|4036112|FG000|NOT COMPLETED|Overall Study||0
3302817|NCT02961062|4036113|FG001|NOT COMPLETED|Overall Study||0
3302818|NCT02961218|4036121|FG000|STARTED|Overall Study||25
3302819|NCT02961218|4036122|FG001|STARTED|Overall Study||24
3302820|NCT02961218|4036121|FG000|Safety Analysis Set|Overall Study||25
3302821|NCT02961218|4036122|FG001|Safety Analysis Set|Overall Study||24
3302822|NCT02961218|4036121|FG000|Pharmacokinetics (PK) Analysis Set|Overall Study||25
3302823|NCT02961218|4036122|FG001|Pharmacokinetics (PK) Analysis Set|Overall Study|Placebo patients were excluded from the PK analyses|0
3302824|NCT02961218|4036121|FG000|Primary PD Analysis Set|Overall Study||25
3302825|NCT02961218|4036122|FG001|Primary PD Analysis Set|Overall Study||24
3302826|NCT02961218|4036121|FG000|COMPLETED|Overall Study||22
3302827|NCT02961218|4036122|FG001|COMPLETED|Overall Study||19
3302828|NCT02961218|4036121|FG000|NOT COMPLETED|Overall Study||3
3302829|NCT02961218|4036122|FG001|NOT COMPLETED|Overall Study||5
3302830|NCT02961244|4036132|FG000|STARTED|Overall Study||64
3302831|NCT02961244|4036133|FG001|STARTED|Overall Study||64
3302832|NCT02961244|4036132|FG000|Patients Excluded During Randomization|Overall Study||0
3302833|NCT02961244|4036133|FG001|Patients Excluded During Randomization|Overall Study||1
3302834|NCT02961244|4036132|FG000|COMPLETED|Overall Study||63
3302835|NCT02961244|4036133|FG001|COMPLETED|Overall Study||55
3302836|NCT02961244|4036132|FG000|NOT COMPLETED|Overall Study||1
3302837|NCT02961244|4036133|FG001|NOT COMPLETED|Overall Study||9
3302838|NCT02961374|4036139|FG000|STARTED|Overall Study||46
3302839|NCT02961374|4036139|FG000|COMPLETED|Overall Study||42
3302840|NCT02961374|4036139|FG000|NOT COMPLETED|Overall Study||4
3302841|NCT02961751|4036143|FG000|STARTED|Overall Study||211
3302842|NCT02961751|4036143|FG000|COMPLETED|Overall Study||196
3302843|NCT02961751|4036143|FG000|NOT COMPLETED|Overall Study||15
3302844|NCT02961764|4036149|FG000|STARTED|Overall Study||160
3302845|NCT02961764|4036150|FG001|STARTED|Overall Study||153
3302846|NCT02961764|4036149|FG000|COMPLETED|Overall Study||121
3302847|NCT02961764|4036150|FG001|COMPLETED|Overall Study||128
3302848|NCT02961764|4036149|FG000|NOT COMPLETED|Overall Study||39
3302849|NCT02961764|4036150|FG001|NOT COMPLETED|Overall Study||25
3302850|NCT02961790|4036160|FG000|STARTED|Overall Study||50
3302851|NCT02961790|4036161|FG001|STARTED|Overall Study||51
3302852|NCT02961790|4036162|FG002|STARTED|Overall Study||24
3302853|NCT02961790|4036163|FG003|STARTED|Overall Study||25
3302854|NCT02961790|4036160|FG000|COMPLETED|Overall Study||35
3302855|NCT02961790|4036161|FG001|COMPLETED|Overall Study||40
3302856|NCT02961790|4036162|FG002|COMPLETED|Overall Study||18
3302857|NCT02961790|4036163|FG003|COMPLETED|Overall Study||20
3302858|NCT02961790|4036160|FG000|NOT COMPLETED|Overall Study||15
3302859|NCT02961790|4036161|FG001|NOT COMPLETED|Overall Study||11
3302860|NCT02961790|4036162|FG002|NOT COMPLETED|Overall Study||6
3302861|NCT02961790|4036163|FG003|NOT COMPLETED|Overall Study||5
3302862|NCT02961894|4036174|FG000|STARTED|Overall Study||121
3302863|NCT02961894|4036174|FG000|COMPLETED|Overall Study||121
3302864|NCT02961894|4036174|FG000|NOT COMPLETED|Overall Study||0
3302865|NCT02961920|4036180|FG000|STARTED|Overall Study||25
3302866|NCT02961920|4036181|FG001|STARTED|Overall Study||25
3302867|NCT02961920|4036180|FG000|COMPLETED|Overall Study||24
3302868|NCT02961920|4036181|FG001|COMPLETED|Overall Study||24
3302869|NCT02961920|4036180|FG000|NOT COMPLETED|Overall Study||1
3302870|NCT02961920|4036181|FG001|NOT COMPLETED|Overall Study||1
3302871|NCT02961946|4036190|FG000|STARTED|Overall Study||66
3302872|NCT02961946|4036191|FG001|STARTED|Overall Study||66
3302873|NCT02961946|4036192|FG002|STARTED|Overall Study||66
3302874|NCT02961946|4036190|FG000|COMPLETED|Overall Study||66
3302875|NCT02961946|4036191|FG001|COMPLETED|Overall Study||66
3302876|NCT02961946|4036192|FG002|COMPLETED|Overall Study||66
3302877|NCT02961946|4036190|FG000|NOT COMPLETED|Overall Study||0
3302878|NCT02961946|4036191|FG001|NOT COMPLETED|Overall Study||0
3302879|NCT02961946|4036192|FG002|NOT COMPLETED|Overall Study||0
3302880|NCT02962284|4036202|FG000|STARTED|Overall Study||9
3302881|NCT02962284|4036203|FG001|STARTED|Overall Study||11
3302882|NCT02962284|4036202|FG000|COMPLETED|Overall Study||4
3302883|NCT02962284|4036203|FG001|COMPLETED|Overall Study||8
3302884|NCT02962284|4036202|FG000|NOT COMPLETED|Overall Study||5
3302885|NCT02962284|4036203|FG001|NOT COMPLETED|Overall Study||3
3302886|NCT02962427|4036213|FG000|STARTED|Overall Study||3
3302887|NCT02962427|4036214|FG001|STARTED|Overall Study||1
2971751|NCT00804648|3686593|FG005|STARTED|First Intervention||8
2971752|NCT00804648|3686588|FG000|COMPLETED|First Intervention||3
2971753|NCT00804648|3686589|FG001|COMPLETED|First Intervention||5
2971754|NCT00804648|3686590|FG002|COMPLETED|First Intervention||6
2971755|NCT00804648|3686591|FG003|COMPLETED|First Intervention||4
3133254|NCT01695239|3858310|FG005|COMPLETED|IR Participants (Week 16 Up To Week 24)||24
3133255|NCT01695239|3858311|FG006|COMPLETED|IR Participants (Week 16 Up To Week 24)||9
3133256|NCT01695239|3858312|FG007|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
3133257|NCT01695239|3858313|FG008|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
3133258|NCT01695239|3858314|FG009|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
3302888|NCT02962427|4036213|FG000|COMPLETED|Overall Study||3
3302889|NCT02962427|4036214|FG001|COMPLETED|Overall Study||1
3302890|NCT02962427|4036213|FG000|NOT COMPLETED|Overall Study||0
3302891|NCT02962427|4036214|FG001|NOT COMPLETED|Overall Study||0
3302892|NCT02962609|4036224|FG000|STARTED|Overall Study||38
3302893|NCT02962609|4036225|FG001|STARTED|Overall Study||42
3302894|NCT02962609|4036224|FG000|COMPLETED|Overall Study||38
3302895|NCT02962609|4036225|FG001|COMPLETED|Overall Study||42
3302896|NCT02962609|4036224|FG000|NOT COMPLETED|Overall Study||0
3302897|NCT02962609|4036225|FG001|NOT COMPLETED|Overall Study||0
3302898|NCT02962648|4036231|FG000|STARTED|Overall Study||103
3302899|NCT02962648|4036231|FG000|COMPLETED|Overall Study||94
3302900|NCT02962648|4036231|FG000|NOT COMPLETED|Overall Study||9
3302901|NCT02962674|4036235|FG000|STARTED|Overall Study|"Although a total of 49 subjects were consented to participate in the study, three (3) of those subjects are not included in the study analysis as they did not actually receive treatment. These 3 subjects could not be treated because of their anatomy and therefore are considered treatment attempts. The final enrollment number (treated subjects only)is 46 subjects."|49
3302902|NCT02962674|4036235|FG000|3 Month Endpoint|Overall Study|All treated subjects that completed the 3-month endpoint visit per protocol.|46
3302903|NCT02962674|4036235|FG000|12 Month Durability|Overall Study|All subjects that completed the 12-month follow-up visit per protocol.|46
3302904|NCT02962674|4036235|FG000|24 Month Durability|Overall Study|All subjects that completed the 24-month follow-up visit. Note that at the time of study termination, all subjects would have reached this milestone.|32
3302905|NCT02962674|4036235|FG000|36 Month Durability|Overall Study|All subjects that completed the 36-month follow-up visit. Note that at the time of study termination, not all subjects would have reached this milestone depending on time of enrollment.|18
3302906|NCT02962674|4036235|FG000|48 Month Durability|Overall Study|All subjects that completed the 48-month follow-up visit. Note that at the time of study termination, not all subjects would have reached this milestone depending on time of enrollment.|4
3302907|NCT02962674|4036235|FG000|COMPLETED|Overall Study|Study was terminated by sponsor prior to reaching 60 Month study completion mainly due to COVID-19 effects on subject follow-up.|0
3302908|NCT02962674|4036235|FG000|NOT COMPLETED|Overall Study||49
3302909|NCT02962687|4036243|FG000|STARTED|Overall Study|This number represents 20 dyads (1 Veteran and 1 caregiver in each dyad)|40
3302910|NCT02962687|4036244|FG001|STARTED|Overall Study|This number represents 20 dyads (1 Veteran and 1 caregiver in each dyad)|40
3302911|NCT02962687|4036243|FG000|COMPLETED|Overall Study|This number represents 15 dyads (1 Veteran and 1 caregiver in each dyad)|30
3302912|NCT02962687|4036244|FG001|COMPLETED|Overall Study|This number represents 16 dyads (1 Veteran and 1 caregiver in each dyad)|32
3302913|NCT02962687|4036243|FG000|NOT COMPLETED|Overall Study||10
3302914|NCT02962687|4036244|FG001|NOT COMPLETED|Overall Study||8
3302915|NCT02962739|4036252|FG000|STARTED|Overall Study||6
3302916|NCT02962739|4036253|FG001|STARTED|Overall Study||7
3302917|NCT02962739|4036254|FG002|STARTED|Overall Study||7
3302918|NCT02962739|4036255|FG003|STARTED|Overall Study||6
3302919|NCT02962739|4036256|FG004|STARTED|Overall Study||6
3302920|NCT02962739|4036257|FG005|STARTED|Overall Study||6
3302921|NCT02962739|4036252|FG000|COMPLETED|Overall Study||6
3302922|NCT02962739|4036253|FG001|COMPLETED|Overall Study||6
3302923|NCT02962739|4036254|FG002|COMPLETED|Overall Study||6
3302924|NCT02962739|4036255|FG003|COMPLETED|Overall Study||6
3302925|NCT02962739|4036256|FG004|COMPLETED|Overall Study||5
3302926|NCT02962739|4036257|FG005|COMPLETED|Overall Study||6
3302927|NCT02962739|4036252|FG000|NOT COMPLETED|Overall Study||0
3302928|NCT02962739|4036253|FG001|NOT COMPLETED|Overall Study||1
3302929|NCT02962739|4036254|FG002|NOT COMPLETED|Overall Study||1
3302930|NCT02962739|4036255|FG003|NOT COMPLETED|Overall Study||0
3302931|NCT02962739|4036256|FG004|NOT COMPLETED|Overall Study||1
3302932|NCT02962739|4036257|FG005|NOT COMPLETED|Overall Study||0
3302933|NCT02962765|4036263|FG000|STARTED|Overall Study||78
3302934|NCT02962765|4036263|FG000|FAS Population|Overall Study||78
3302935|NCT02962765|4036263|FG000|SAF Population|Overall Study||78
3302936|NCT02962765|4036263|FG000|Prophylactic Treatment Group|Overall Study||77
3302937|NCT02962765|4036263|FG000|On Demand Treatment Group|Overall Study||2
3302938|NCT02962765|4036263|FG000|SURG Population|Overall Study||4
3302939|NCT02962765|4036263|FG000|COMPLETED|Overall Study||61
3302940|NCT02962765|4036263|FG000|NOT COMPLETED|Overall Study||17
3302941|NCT02962882|4036274|FG000|STARTED|Overall Study||50
3302942|NCT02962882|4036274|FG000|COMPLETED|Overall Study||14
3302943|NCT02962882|4036274|FG000|NOT COMPLETED|Overall Study||36
3302944|NCT02962908|4036283|FG000|STARTED|Overall Study||58
3302945|NCT02962908|4036284|FG001|STARTED|Overall Study||58
3302946|NCT02962908|4036285|FG002|STARTED|Overall Study||32
3302947|NCT02962908|4036286|FG003|STARTED|Overall Study||27
3302948|NCT02962908|4036283|FG000|COMPLETED|Overall Study||58
3133259|NCT01695239|3858315|FG010|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
2971756|NCT00804648|3686592|FG004|COMPLETED|First Intervention||4
2971757|NCT00804648|3686593|FG005|COMPLETED|First Intervention||8
2971758|NCT00804648|3686588|FG000|NOT COMPLETED|First Intervention||0
2971759|NCT00804648|3686589|FG001|NOT COMPLETED|First Intervention||0
2971760|NCT00804648|3686590|FG002|NOT COMPLETED|First Intervention||0
2971761|NCT00804648|3686591|FG003|NOT COMPLETED|First Intervention||0
2971762|NCT00804648|3686592|FG004|NOT COMPLETED|First Intervention||0
2971763|NCT00804648|3686593|FG005|NOT COMPLETED|First Intervention||0
2971764|NCT00804648|3686588|FG000|STARTED|Second Intervention||3
2971765|NCT00804648|3686589|FG001|STARTED|Second Intervention||5
2971766|NCT00804648|3686590|FG002|STARTED|Second Intervention||6
3302949|NCT02962908|4036284|FG001|COMPLETED|Overall Study||50
3302950|NCT02962908|4036285|FG002|COMPLETED|Overall Study||32
3302951|NCT02962908|4036286|FG003|COMPLETED|Overall Study||24
3302952|NCT02962908|4036283|FG000|NOT COMPLETED|Overall Study||0
3302953|NCT02962908|4036284|FG001|NOT COMPLETED|Overall Study||8
3302954|NCT02962908|4036285|FG002|NOT COMPLETED|Overall Study||0
3302955|NCT02962908|4036286|FG003|NOT COMPLETED|Overall Study||3
3302956|NCT02962934|4036304|FG000|STARTED|Overall Study||12
3302957|NCT02962934|4036305|FG001|STARTED|Overall Study||6
3302958|NCT02962934|4036304|FG000|COMPLETED|Overall Study||12
3302959|NCT02962934|4036305|FG001|COMPLETED|Overall Study||6
3302960|NCT02962934|4036304|FG000|NOT COMPLETED|Overall Study||0
3302961|NCT02962934|4036305|FG001|NOT COMPLETED|Overall Study||0
3302962|NCT02962960|4036314|FG000|STARTED|Overall Study||14
3302963|NCT02962960|4036315|FG001|STARTED|Overall Study||13
3302964|NCT02962960|4036316|FG002|STARTED|Overall Study||9
3302965|NCT02962960|4036314|FG000|COMPLETED|Overall Study||11
3302966|NCT02962960|4036315|FG001|COMPLETED|Overall Study||11
3302967|NCT02962960|4036316|FG002|COMPLETED|Overall Study||9
3302968|NCT02962960|4036314|FG000|NOT COMPLETED|Overall Study||3
3302969|NCT02962960|4036315|FG001|NOT COMPLETED|Overall Study||2
3302970|NCT02962960|4036316|FG002|NOT COMPLETED|Overall Study||0
3302971|NCT02963311|4036326|FG000|STARTED|Overall Study||9
3302972|NCT02963311|4036326|FG000|COMPLETED|Overall Study||4
3302973|NCT02963311|4036326|FG000|NOT COMPLETED|Overall Study||5
3302974|NCT02963376|4036334|FG000|STARTED|Overall Study||6
3302975|NCT02963376|4036335|FG001|STARTED|Overall Study||2
3302976|NCT02963376|4036336|FG002|STARTED|Overall Study||6
3302977|NCT02963376|4036337|FG003|STARTED|Overall Study||2
3302978|NCT02963376|4036338|FG004|STARTED|Overall Study||6
3302979|NCT02963376|4036339|FG005|STARTED|Overall Study||2
3302980|NCT02963376|4036334|FG000|COMPLETED|Overall Study||6
3302981|NCT02963376|4036335|FG001|COMPLETED|Overall Study||2
3302982|NCT02963376|4036336|FG002|COMPLETED|Overall Study||6
3302983|NCT02963376|4036337|FG003|COMPLETED|Overall Study||2
3302984|NCT02963376|4036338|FG004|COMPLETED|Overall Study||6
3302985|NCT02963376|4036339|FG005|COMPLETED|Overall Study||2
3302986|NCT02963376|4036334|FG000|NOT COMPLETED|Overall Study||0
3302987|NCT02963376|4036335|FG001|NOT COMPLETED|Overall Study||0
3302988|NCT02963376|4036336|FG002|NOT COMPLETED|Overall Study||0
3302989|NCT02963376|4036337|FG003|NOT COMPLETED|Overall Study||0
3302990|NCT02963376|4036338|FG004|NOT COMPLETED|Overall Study||0
3302991|NCT02963376|4036339|FG005|NOT COMPLETED|Overall Study||0
3302992|NCT02963441|4036361|FG000|STARTED|Overall Study||900
3302993|NCT02963441|4036361|FG000|COMPLETED|Overall Study||819
3302994|NCT02963441|4036361|FG000|NOT COMPLETED|Overall Study||81
3302995|NCT02963506|4036371|FG000|STARTED|Double-Blind Period||60
3302996|NCT02963506|4036372|FG001|STARTED|Double-Blind Period||61
3302997|NCT02963506|4036373|FG002|STARTED|Double-Blind Period||61
3302998|NCT02963506|4036374|FG003|STARTED|Double-Blind Period||60
3302999|NCT02963506|4036375|FG004|STARTED|Double-Blind Period||61
3303000|NCT02963506|4036376|FG005|STARTED|Double-Blind Period||0
3303001|NCT02963506|4036377|FG006|STARTED|Double-Blind Period||0
3303002|NCT02963506|4036378|FG007|STARTED|Double-Blind Period||0
3303003|NCT02963506|4036379|FG008|STARTED|Double-Blind Period||0
3303004|NCT02963506|4036380|FG009|STARTED|Double-Blind Period||0
3303005|NCT02963506|4036381|FG010|STARTED|Double-Blind Period||0
3303006|NCT02963506|4036382|FG011|STARTED|Double-Blind Period||0
3303007|NCT02963506|4036383|FG012|STARTED|Double-Blind Period||0
3303008|NCT02963506|4036371|FG000|Completed Double-Blind Period|Double-Blind Period||60
3303009|NCT02963506|4036372|FG001|Completed Double-Blind Period|Double-Blind Period||59
3303010|NCT02963506|4036373|FG002|Completed Double-Blind Period|Double-Blind Period||59
3303011|NCT02963506|4036374|FG003|Completed Double-Blind Period|Double-Blind Period||58
3303012|NCT02963506|4036375|FG004|Completed Double-Blind Period|Double-Blind Period||61
3303013|NCT02963506|4036376|FG005|Completed Double-Blind Period|Double-Blind Period||0
3303014|NCT02963506|4036377|FG006|Completed Double-Blind Period|Double-Blind Period||0
3303015|NCT02963506|4036378|FG007|Completed Double-Blind Period|Double-Blind Period||0
3303016|NCT02963506|4036379|FG008|Completed Double-Blind Period|Double-Blind Period||0
3303017|NCT02963506|4036380|FG009|Completed Double-Blind Period|Double-Blind Period||0
3303018|NCT02963506|4036381|FG010|Completed Double-Blind Period|Double-Blind Period||0
3303019|NCT02963506|4036382|FG011|Completed Double-Blind Period|Double-Blind Period||0
3303020|NCT02963506|4036383|FG012|Completed Double-Blind Period|Double-Blind Period||0
3303021|NCT02963506|4036371|FG000|Completed Week 12 - Started Dose-Blind|Double-Blind Period||60
3303022|NCT02963506|4036372|FG001|Completed Week 12 - Started Dose-Blind|Double-Blind Period||58
3303023|NCT02963506|4036373|FG002|Completed Week 12 - Started Dose-Blind|Double-Blind Period||59
2971767|NCT00804648|3686591|FG003|STARTED|Second Intervention||4
2971768|NCT00804648|3686592|FG004|STARTED|Second Intervention||4
2971769|NCT00804648|3686593|FG005|STARTED|Second Intervention||8
2971770|NCT00804648|3686588|FG000|COMPLETED|Second Intervention||3
2971771|NCT00804648|3686589|FG001|COMPLETED|Second Intervention||5
2971772|NCT00804648|3686590|FG002|COMPLETED|Second Intervention||6
2971773|NCT00804648|3686591|FG003|COMPLETED|Second Intervention||4
2971774|NCT00804648|3686592|FG004|COMPLETED|Second Intervention||4
2971775|NCT00804648|3686593|FG005|COMPLETED|Second Intervention||8
2971776|NCT00804648|3686588|FG000|NOT COMPLETED|Second Intervention||0
2971777|NCT00804648|3686589|FG001|NOT COMPLETED|Second Intervention||0
2971778|NCT00804648|3686590|FG002|NOT COMPLETED|Second Intervention||0
2971779|NCT00804648|3686591|FG003|NOT COMPLETED|Second Intervention||0
2971780|NCT00804648|3686592|FG004|NOT COMPLETED|Second Intervention||0
2971781|NCT00804648|3686593|FG005|NOT COMPLETED|Second Intervention||0
2971782|NCT00804648|3686588|FG000|STARTED|Third Invervention||3
2971783|NCT00804648|3686589|FG001|STARTED|Third Invervention||5
2971784|NCT00804648|3686590|FG002|STARTED|Third Invervention||6
2971785|NCT00804648|3686591|FG003|STARTED|Third Invervention||4
2971786|NCT00804648|3686592|FG004|STARTED|Third Invervention||4
2971787|NCT00804648|3686593|FG005|STARTED|Third Invervention||8
2971788|NCT00804648|3686588|FG000|COMPLETED|Third Invervention||3
2971789|NCT00804648|3686589|FG001|COMPLETED|Third Invervention||5
3164070|NCT01890785|3891530|FG000|COMPLETED|First Intervention||5
3164071|NCT01890785|3891531|FG001|COMPLETED|First Intervention||5
3303024|NCT02963506|4036374|FG003|Completed Week 12 - Started Dose-Blind|Double-Blind Period||58
2971790|NCT00804648|3686590|FG002|COMPLETED|Third Invervention||6
2971791|NCT00804648|3686591|FG003|COMPLETED|Third Invervention||4
2971792|NCT00804648|3686592|FG004|COMPLETED|Third Invervention||4
2971793|NCT00804648|3686593|FG005|COMPLETED|Third Invervention||8
2971794|NCT00804648|3686588|FG000|NOT COMPLETED|Third Invervention||0
2971795|NCT00804648|3686589|FG001|NOT COMPLETED|Third Invervention||0
2971796|NCT00804648|3686590|FG002|NOT COMPLETED|Third Invervention||0
2971797|NCT00804648|3686591|FG003|NOT COMPLETED|Third Invervention||0
2971798|NCT00804648|3686592|FG004|NOT COMPLETED|Third Invervention||0
2971799|NCT00804648|3686593|FG005|NOT COMPLETED|Third Invervention||0
2971800|NCT00804687|3686601|FG000|STARTED|Period 1: Treatment Period||9
2971801|NCT00804687|3686602|FG001|STARTED|Period 1: Treatment Period||9
2971802|NCT00804687|3686603|FG002|STARTED|Period 1: Treatment Period||9
2971803|NCT00804687|3686604|FG003|STARTED|Period 1: Treatment Period||9
2971804|NCT00804687|3686605|FG004|STARTED|Period 1: Treatment Period||9
2971805|NCT00804687|3686606|FG005|STARTED|Period 1: Treatment Period||8
2971806|NCT00804687|3686601|FG000|COMPLETED|Period 1: Treatment Period||9
2971807|NCT00804687|3686602|FG001|COMPLETED|Period 1: Treatment Period||9
2971808|NCT00804687|3686603|FG002|COMPLETED|Period 1: Treatment Period||9
2971809|NCT00804687|3686604|FG003|COMPLETED|Period 1: Treatment Period||9
2971810|NCT00804687|3686605|FG004|COMPLETED|Period 1: Treatment Period||9
2971811|NCT00804687|3686606|FG005|COMPLETED|Period 1: Treatment Period||8
2971812|NCT00804687|3686601|FG000|NOT COMPLETED|Period 1: Treatment Period||0
2971813|NCT00804687|3686602|FG001|NOT COMPLETED|Period 1: Treatment Period||0
2971814|NCT00804687|3686603|FG002|NOT COMPLETED|Period 1: Treatment Period||0
2971815|NCT00804687|3686604|FG003|NOT COMPLETED|Period 1: Treatment Period||0
2971816|NCT00804687|3686605|FG004|NOT COMPLETED|Period 1: Treatment Period||0
2971817|NCT00804687|3686606|FG005|NOT COMPLETED|Period 1: Treatment Period||0
2971818|NCT00804687|3686601|FG000|STARTED|Period 2: Washout Period||9
2971819|NCT00804687|3686602|FG001|STARTED|Period 2: Washout Period||9
2971820|NCT00804687|3686603|FG002|STARTED|Period 2: Washout Period||9
2971821|NCT00804687|3686604|FG003|STARTED|Period 2: Washout Period||9
2971822|NCT00804687|3686605|FG004|STARTED|Period 2: Washout Period||9
2971823|NCT00804687|3686606|FG005|STARTED|Period 2: Washout Period||8
2971824|NCT00804687|3686601|FG000|COMPLETED|Period 2: Washout Period||9
2971825|NCT00804687|3686602|FG001|COMPLETED|Period 2: Washout Period||9
2971826|NCT00804687|3686603|FG002|COMPLETED|Period 2: Washout Period||9
2971827|NCT00804687|3686604|FG003|COMPLETED|Period 2: Washout Period||9
2971828|NCT00804687|3686605|FG004|COMPLETED|Period 2: Washout Period||9
2971829|NCT00804687|3686606|FG005|COMPLETED|Period 2: Washout Period||8
2971830|NCT00804687|3686601|FG000|NOT COMPLETED|Period 2: Washout Period||0
2971831|NCT00804687|3686602|FG001|NOT COMPLETED|Period 2: Washout Period||0
2971832|NCT00804687|3686603|FG002|NOT COMPLETED|Period 2: Washout Period||0
2971833|NCT00804687|3686604|FG003|NOT COMPLETED|Period 2: Washout Period||0
2971834|NCT00804687|3686605|FG004|NOT COMPLETED|Period 2: Washout Period||0
2971835|NCT00804687|3686606|FG005|NOT COMPLETED|Period 2: Washout Period||0
2971836|NCT00804687|3686601|FG000|STARTED|Period 3: Treatment Period||9
2971837|NCT00804687|3686602|FG001|STARTED|Period 3: Treatment Period||9
2971838|NCT00804687|3686603|FG002|STARTED|Period 3: Treatment Period||9
2971839|NCT00804687|3686604|FG003|STARTED|Period 3: Treatment Period||9
2971840|NCT00804687|3686605|FG004|STARTED|Period 3: Treatment Period||9
2971841|NCT00804687|3686606|FG005|STARTED|Period 3: Treatment Period||8
2971842|NCT00804687|3686601|FG000|COMPLETED|Period 3: Treatment Period||9
2971843|NCT00804687|3686602|FG001|COMPLETED|Period 3: Treatment Period||9
2971844|NCT00804687|3686603|FG002|COMPLETED|Period 3: Treatment Period||9
2971845|NCT00804687|3686604|FG003|COMPLETED|Period 3: Treatment Period||8
2971846|NCT00804687|3686605|FG004|COMPLETED|Period 3: Treatment Period||9
2971847|NCT00804687|3686606|FG005|COMPLETED|Period 3: Treatment Period||8
2971848|NCT00804687|3686601|FG000|NOT COMPLETED|Period 3: Treatment Period||0
3164072|NCT01890785|3891532|FG002|COMPLETED|First Intervention||5
2971849|NCT00804687|3686602|FG001|NOT COMPLETED|Period 3: Treatment Period||0
2971850|NCT00804687|3686603|FG002|NOT COMPLETED|Period 3: Treatment Period||0
2971851|NCT00804687|3686604|FG003|NOT COMPLETED|Period 3: Treatment Period||1
2971852|NCT00804687|3686605|FG004|NOT COMPLETED|Period 3: Treatment Period||0
2971853|NCT00804687|3686606|FG005|NOT COMPLETED|Period 3: Treatment Period||0
2971854|NCT00804687|3686601|FG000|STARTED|Period 4: Washout Period||9
2971855|NCT00804687|3686602|FG001|STARTED|Period 4: Washout Period||9
2971856|NCT00804687|3686603|FG002|STARTED|Period 4: Washout Period||9
2971857|NCT00804687|3686604|FG003|STARTED|Period 4: Washout Period||8
2971858|NCT00804687|3686605|FG004|STARTED|Period 4: Washout Period||9
3303025|NCT02963506|4036375|FG004|Completed Week 12 - Started Dose-Blind|Double-Blind Period||61
3303026|NCT02963506|4036376|FG005|Completed Week 12 - Started Dose-Blind|Double-Blind Period||0
3303027|NCT02963506|4036377|FG006|Completed Week 12 - Started Dose-Blind|Double-Blind Period||0
3303028|NCT02963506|4036378|FG007|Completed Week 12 - Started Dose-Blind|Double-Blind Period||0
3303029|NCT02963506|4036379|FG008|Completed Week 12 - Started Dose-Blind|Double-Blind Period||0
3303030|NCT02963506|4036380|FG009|Completed Week 12 - Started Dose-Blind|Double-Blind Period||0
3303031|NCT02963506|4036381|FG010|Completed Week 12 - Started Dose-Blind|Double-Blind Period||0
3303032|NCT02963506|4036382|FG011|Completed Week 12 - Started Dose-Blind|Double-Blind Period||0
3303033|NCT02963506|4036383|FG012|Completed Week 12 - Started Dose-Blind|Double-Blind Period||0
3303034|NCT02963506|4036371|FG000|COMPLETED|Double-Blind Period||60
3303035|NCT02963506|4036372|FG001|COMPLETED|Double-Blind Period||58
3303036|NCT02963506|4036373|FG002|COMPLETED|Double-Blind Period||59
3303037|NCT02963506|4036374|FG003|COMPLETED|Double-Blind Period||58
3303038|NCT02963506|4036375|FG004|COMPLETED|Double-Blind Period||61
3303039|NCT02963506|4036376|FG005|COMPLETED|Double-Blind Period||0
3303040|NCT02963506|4036377|FG006|COMPLETED|Double-Blind Period||0
3303041|NCT02963506|4036378|FG007|COMPLETED|Double-Blind Period||0
3303042|NCT02963506|4036379|FG008|COMPLETED|Double-Blind Period||0
3303043|NCT02963506|4036380|FG009|COMPLETED|Double-Blind Period||0
3303044|NCT02963506|4036381|FG010|COMPLETED|Double-Blind Period||0
3303045|NCT02963506|4036382|FG011|COMPLETED|Double-Blind Period||0
3303046|NCT02963506|4036383|FG012|COMPLETED|Double-Blind Period||0
3303047|NCT02963506|4036371|FG000|NOT COMPLETED|Double-Blind Period||0
3303048|NCT02963506|4036372|FG001|NOT COMPLETED|Double-Blind Period||3
3303049|NCT02963506|4036373|FG002|NOT COMPLETED|Double-Blind Period||2
3303050|NCT02963506|4036374|FG003|NOT COMPLETED|Double-Blind Period||2
3303051|NCT02963506|4036375|FG004|NOT COMPLETED|Double-Blind Period||0
3303052|NCT02963506|4036376|FG005|NOT COMPLETED|Double-Blind Period||0
3303053|NCT02963506|4036377|FG006|NOT COMPLETED|Double-Blind Period||0
3303054|NCT02963506|4036378|FG007|NOT COMPLETED|Double-Blind Period||0
3303055|NCT02963506|4036379|FG008|NOT COMPLETED|Double-Blind Period||0
3303056|NCT02963506|4036380|FG009|NOT COMPLETED|Double-Blind Period||0
3303057|NCT02963506|4036381|FG010|NOT COMPLETED|Double-Blind Period||0
3303058|NCT02963506|4036382|FG011|NOT COMPLETED|Double-Blind Period||0
3303059|NCT02963506|4036383|FG012|NOT COMPLETED|Double-Blind Period||0
3303060|NCT02963506|4036371|FG000|STARTED|Dose-Blind Period||0
3303061|NCT02963506|4036372|FG001|STARTED|Dose-Blind Period||0
3303062|NCT02963506|4036373|FG002|STARTED|Dose-Blind Period||0
3303063|NCT02963506|4036374|FG003|STARTED|Dose-Blind Period||0
3303064|NCT02963506|4036375|FG004|STARTED|Dose-Blind Period||0
3303065|NCT02963506|4036376|FG005|STARTED|Dose-Blind Period||24
3303066|NCT02963506|4036377|FG006|STARTED|Dose-Blind Period||36
3303067|NCT02963506|4036378|FG007|STARTED|Dose-Blind Period||31
3303068|NCT02963506|4036379|FG008|STARTED|Dose-Blind Period||27
3303069|NCT02963506|4036380|FG009|STARTED|Dose-Blind Period||34
3303070|NCT02963506|4036381|FG010|STARTED|Dose-Blind Period||25
3303071|NCT02963506|4036382|FG011|STARTED|Dose-Blind Period||58
3303072|NCT02963506|4036383|FG012|STARTED|Dose-Blind Period||61
3303073|NCT02963506|4036371|FG000|COMPLETED|Dose-Blind Period||0
3303074|NCT02963506|4036372|FG001|COMPLETED|Dose-Blind Period||0
3303075|NCT02963506|4036373|FG002|COMPLETED|Dose-Blind Period||0
3303076|NCT02963506|4036374|FG003|COMPLETED|Dose-Blind Period||0
3303077|NCT02963506|4036375|FG004|COMPLETED|Dose-Blind Period||0
3303078|NCT02963506|4036376|FG005|COMPLETED|Dose-Blind Period||20
3303079|NCT02963506|4036377|FG006|COMPLETED|Dose-Blind Period||31
3303080|NCT02963506|4036378|FG007|COMPLETED|Dose-Blind Period||26
3303081|NCT02963506|4036379|FG008|COMPLETED|Dose-Blind Period||24
3303082|NCT02963506|4036380|FG009|COMPLETED|Dose-Blind Period||30
3303083|NCT02963506|4036381|FG010|COMPLETED|Dose-Blind Period||24
3303084|NCT02963506|4036382|FG011|COMPLETED|Dose-Blind Period||56
3303085|NCT02963506|4036383|FG012|COMPLETED|Dose-Blind Period||54
3303086|NCT02963506|4036371|FG000|NOT COMPLETED|Dose-Blind Period||0
3303087|NCT02963506|4036372|FG001|NOT COMPLETED|Dose-Blind Period||0
3303088|NCT02963506|4036373|FG002|NOT COMPLETED|Dose-Blind Period||0
3303089|NCT02963506|4036374|FG003|NOT COMPLETED|Dose-Blind Period||0
3303090|NCT02963506|4036375|FG004|NOT COMPLETED|Dose-Blind Period||0
3303091|NCT02963506|4036376|FG005|NOT COMPLETED|Dose-Blind Period||4
3303092|NCT02963506|4036377|FG006|NOT COMPLETED|Dose-Blind Period||5
3303093|NCT02963506|4036378|FG007|NOT COMPLETED|Dose-Blind Period||5
3303094|NCT02963506|4036379|FG008|NOT COMPLETED|Dose-Blind Period||3
3303095|NCT02963506|4036380|FG009|NOT COMPLETED|Dose-Blind Period||4
3303096|NCT02963506|4036381|FG010|NOT COMPLETED|Dose-Blind Period||1
3303097|NCT02963506|4036382|FG011|NOT COMPLETED|Dose-Blind Period||2
3303098|NCT02963506|4036383|FG012|NOT COMPLETED|Dose-Blind Period||7
3303099|NCT02963597|4036402|FG000|STARTED|Overall Study||10
3303100|NCT02963597|4036403|FG001|STARTED|Overall Study||11
2971859|NCT00804687|3686606|FG005|STARTED|Period 4: Washout Period||8
2971860|NCT00804687|3686601|FG000|COMPLETED|Period 4: Washout Period||9
2971861|NCT00804687|3686602|FG001|COMPLETED|Period 4: Washout Period||9
2971862|NCT00804687|3686603|FG002|COMPLETED|Period 4: Washout Period||9
2971863|NCT00804687|3686604|FG003|COMPLETED|Period 4: Washout Period||8
2971864|NCT00804687|3686605|FG004|COMPLETED|Period 4: Washout Period||9
2971865|NCT00804687|3686606|FG005|COMPLETED|Period 4: Washout Period||8
2971866|NCT00804687|3686601|FG000|NOT COMPLETED|Period 4: Washout Period||0
2971867|NCT00804687|3686602|FG001|NOT COMPLETED|Period 4: Washout Period||0
2971868|NCT00804687|3686603|FG002|NOT COMPLETED|Period 4: Washout Period||0
2971869|NCT00804687|3686604|FG003|NOT COMPLETED|Period 4: Washout Period||0
2971870|NCT00804687|3686605|FG004|NOT COMPLETED|Period 4: Washout Period||0
2971871|NCT00804687|3686606|FG005|NOT COMPLETED|Period 4: Washout Period||0
2971872|NCT00804687|3686601|FG000|STARTED|Period 5: Treatment Period||9
2971873|NCT00804687|3686602|FG001|STARTED|Period 5: Treatment Period||9
2971874|NCT00804687|3686603|FG002|STARTED|Period 5: Treatment Period||9
2971875|NCT00804687|3686604|FG003|STARTED|Period 5: Treatment Period||8
2971876|NCT00804687|3686605|FG004|STARTED|Period 5: Treatment Period||9
2971877|NCT00804687|3686606|FG005|STARTED|Period 5: Treatment Period||8
2971878|NCT00804687|3686601|FG000|COMPLETED|Period 5: Treatment Period||8
2971879|NCT00804687|3686602|FG001|COMPLETED|Period 5: Treatment Period||9
2971880|NCT00804687|3686603|FG002|COMPLETED|Period 5: Treatment Period||8
2971881|NCT00804687|3686604|FG003|COMPLETED|Period 5: Treatment Period||8
2971882|NCT00804687|3686605|FG004|COMPLETED|Period 5: Treatment Period||8
2971883|NCT00804687|3686606|FG005|COMPLETED|Period 5: Treatment Period||8
2971884|NCT00804687|3686601|FG000|NOT COMPLETED|Period 5: Treatment Period||1
2971885|NCT00804687|3686602|FG001|NOT COMPLETED|Period 5: Treatment Period||0
2971886|NCT00804687|3686603|FG002|NOT COMPLETED|Period 5: Treatment Period||1
2971887|NCT00804687|3686604|FG003|NOT COMPLETED|Period 5: Treatment Period||0
2971888|NCT00804687|3686605|FG004|NOT COMPLETED|Period 5: Treatment Period||1
2971889|NCT00804687|3686606|FG005|NOT COMPLETED|Period 5: Treatment Period||0
2971890|NCT00804843|3686616|FG000|STARTED|Overall Study||50
2971891|NCT00804843|3686617|FG001|STARTED|Overall Study||50
2971892|NCT00804843|3686616|FG000|COMPLETED|Overall Study||40
2971893|NCT00804843|3686617|FG001|COMPLETED|Overall Study||43
2971894|NCT00804843|3686616|FG000|NOT COMPLETED|Overall Study||10
2971895|NCT00804843|3686617|FG001|NOT COMPLETED|Overall Study||7
2971896|NCT00804908|3686627|FG000|STARTED|Overall Study||115
2971897|NCT00804908|3686628|FG001|STARTED|Overall Study||116
2971898|NCT00804908|3686629|FG002|STARTED|Overall Study||115
2971899|NCT00804908|3686627|FG000|COMPLETED|Overall Study||0
2971900|NCT00804908|3686628|FG001|COMPLETED|Overall Study||0
2971901|NCT00804908|3686629|FG002|COMPLETED|Overall Study||1
2971902|NCT00804908|3686627|FG000|NOT COMPLETED|Overall Study||115
2971903|NCT00804908|3686628|FG001|NOT COMPLETED|Overall Study||116
2971904|NCT00804908|3686629|FG002|NOT COMPLETED|Overall Study||114
2971905|NCT00804973|3686640|FG000|STARTED|Overall Study||40
2971906|NCT00804973|3686641|FG001|STARTED|Overall Study||40
2971907|NCT00804973|3686642|FG002|STARTED|Overall Study||40
2971908|NCT00804973|3686640|FG000|Received at Least 1 Dose of Study Drug|Overall Study||40
2971909|NCT00804973|3686641|FG001|Received at Least 1 Dose of Study Drug|Overall Study||40
2971910|NCT00804973|3686642|FG002|Received at Least 1 Dose of Study Drug|Overall Study||40
2971911|NCT00804973|3686640|FG000|COMPLETED|Overall Study||40
2971912|NCT00804973|3686641|FG001|COMPLETED|Overall Study||40
2971913|NCT00804973|3686642|FG002|COMPLETED|Overall Study||40
2971914|NCT00804973|3686640|FG000|NOT COMPLETED|Overall Study||0
3303101|NCT02963597|4036402|FG000|COMPLETED|Overall Study||10
3303102|NCT02963597|4036403|FG001|COMPLETED|Overall Study||11
3303103|NCT02963597|4036402|FG000|NOT COMPLETED|Overall Study||0
3303104|NCT02963597|4036403|FG001|NOT COMPLETED|Overall Study||0
3303105|NCT02963701|4036411|FG000|STARTED|Period 1 (Including Washout) (2 Days)||28
3303106|NCT02963701|4036412|FG001|STARTED|Period 1 (Including Washout) (2 Days)||28
3303107|NCT02963701|4036411|FG000|COMPLETED|Period 1 (Including Washout) (2 Days)|One subject withdrawn from the study after period 1|27
3303108|NCT02963701|4036412|FG001|COMPLETED|Period 1 (Including Washout) (2 Days)||28
3303109|NCT02963701|4036411|FG000|NOT COMPLETED|Period 1 (Including Washout) (2 Days)||1
2971915|NCT00804973|3686641|FG001|NOT COMPLETED|Overall Study||0
2971916|NCT00804973|3686642|FG002|NOT COMPLETED|Overall Study||0
2971917|NCT00804986|3686656|FG000|STARTED|Overall Study||36
2971918|NCT00804986|3686657|FG001|STARTED|Overall Study||43
2971919|NCT00804986|3686658|FG002|STARTED|Overall Study||42
2971920|NCT00804986|3686659|FG003|STARTED|Overall Study||42
2971921|NCT00804986|3686660|FG004|STARTED|Overall Study||43
2971922|NCT00804986|3686661|FG005|STARTED|Overall Study||41
2971923|NCT00804986|3686656|FG000|COMPLETED|Overall Study||35
2971924|NCT00804986|3686657|FG001|COMPLETED|Overall Study||35
2971925|NCT00804986|3686658|FG002|COMPLETED|Overall Study||40
2971926|NCT00804986|3686659|FG003|COMPLETED|Overall Study||34
2971927|NCT00804986|3686660|FG004|COMPLETED|Overall Study||34
2971928|NCT00804986|3686661|FG005|COMPLETED|Overall Study||31
2971929|NCT00804986|3686656|FG000|NOT COMPLETED|Overall Study||1
2971930|NCT00804986|3686657|FG001|NOT COMPLETED|Overall Study||8
2971931|NCT00804986|3686658|FG002|NOT COMPLETED|Overall Study||2
2971932|NCT00804986|3686659|FG003|NOT COMPLETED|Overall Study||8
2971933|NCT00804986|3686660|FG004|NOT COMPLETED|Overall Study||9
2971934|NCT00804986|3686661|FG005|NOT COMPLETED|Overall Study||10
2971935|NCT00804999|3686679|FG000|STARTED|Overall Study||15
2971936|NCT00804999|3686680|FG001|STARTED|Overall Study||12
2971937|NCT00804999|3686681|FG002|STARTED|Overall Study||14
2971938|NCT00804999|3686682|FG003|STARTED|Overall Study||10
2971939|NCT00804999|3686679|FG000|COMPLETED|Overall Study||15
2971940|NCT00804999|3686680|FG001|COMPLETED|Overall Study||12
2971941|NCT00804999|3686681|FG002|COMPLETED|Overall Study||14
2971942|NCT00804999|3686682|FG003|COMPLETED|Overall Study||10
2971943|NCT00804999|3686679|FG000|NOT COMPLETED|Overall Study||0
2971944|NCT00804999|3686680|FG001|NOT COMPLETED|Overall Study||0
2971945|NCT00804999|3686681|FG002|NOT COMPLETED|Overall Study||0
2971946|NCT00804999|3686682|FG003|NOT COMPLETED|Overall Study||0
2971947|NCT00805025|3686692|FG000|STARTED|Overall Study||131
2971948|NCT00805025|3686692|FG000|Enrolled and Treated|Overall Study||89
2971949|NCT00805025|3686692|FG000|COMPLETED|Overall Study||82
2971950|NCT00805025|3686692|FG000|NOT COMPLETED|Overall Study||49
2971951|NCT00805038|3686698|FG000|STARTED|Overall Study||75
2971952|NCT00805038|3686699|FG001|STARTED|Overall Study||92
2971953|NCT00805038|3686698|FG000|COMPLETED|Overall Study||75
2971954|NCT00805038|3686699|FG001|COMPLETED|Overall Study||92
2971955|NCT00805038|3686698|FG000|NOT COMPLETED|Overall Study||0
2971956|NCT00805038|3686699|FG001|NOT COMPLETED|Overall Study||0
2971957|NCT00805142|3686707|FG000|STARTED|Titration Period||36
2971958|NCT00805142|3686708|FG001|STARTED|Titration Period||42
2971959|NCT00805142|3686707|FG000|COMPLETED|Titration Period||30
2971960|NCT00805142|3686708|FG001|COMPLETED|Titration Period||32
2971961|NCT00805142|3686707|FG000|NOT COMPLETED|Titration Period||6
2971962|NCT00805142|3686708|FG001|NOT COMPLETED|Titration Period||10
2971963|NCT00805142|3686707|FG000|STARTED|Maintenance Period||30
2971964|NCT00805142|3686708|FG001|STARTED|Maintenance Period||32
2971965|NCT00805142|3686707|FG000|COMPLETED|Maintenance Period||30
2971966|NCT00805142|3686708|FG001|COMPLETED|Maintenance Period||30
2971967|NCT00805142|3686707|FG000|NOT COMPLETED|Maintenance Period||0
2971968|NCT00805142|3686708|FG001|NOT COMPLETED|Maintenance Period||2
2971969|NCT00805194|3686723|FG000|STARTED|Overall Study|randomised patients|655
2971970|NCT00805194|3686724|FG001|STARTED|Overall Study|randomised patients|659
2971971|NCT00805194|3686723|FG000|COMPLETED|Overall Study||6
2971972|NCT00805194|3686724|FG001|COMPLETED|Overall Study||5
2971973|NCT00805194|3686723|FG000|NOT COMPLETED|Overall Study||649
2971974|NCT00805194|3686724|FG001|NOT COMPLETED|Overall Study||654
2971975|NCT00805207|3686744|FG000|STARTED|Overall Study||1
2971976|NCT00805207|3686745|FG001|STARTED|Overall Study||9
2971977|NCT00805207|3686746|FG002|STARTED|Overall Study||12
2971978|NCT00805207|3686747|FG003|STARTED|Overall Study||6
2971979|NCT00805207|3686748|FG004|STARTED|Overall Study||3
2971980|NCT00805207|3686749|FG005|STARTED|Overall Study||12
2971981|NCT00805207|3686750|FG006|STARTED|Overall Study||6
2971982|NCT00805207|3686751|FG007|STARTED|Overall Study||6
2971983|NCT00805207|3686752|FG008|STARTED|Overall Study||6
2971984|NCT00805207|3686744|FG000|COMPLETED|Overall Study||1
2971985|NCT00805207|3686745|FG001|COMPLETED|Overall Study||7
2971986|NCT00805207|3686746|FG002|COMPLETED|Overall Study||11
2971987|NCT00805207|3686747|FG003|COMPLETED|Overall Study||6
2971988|NCT00805207|3686748|FG004|COMPLETED|Overall Study||2
2971989|NCT00805207|3686749|FG005|COMPLETED|Overall Study||9
2971990|NCT00805207|3686750|FG006|COMPLETED|Overall Study||6
2971991|NCT00805207|3686751|FG007|COMPLETED|Overall Study||6
2971992|NCT00805207|3686752|FG008|COMPLETED|Overall Study||6
2971993|NCT00805207|3686744|FG000|NOT COMPLETED|Overall Study||0
2971994|NCT00805207|3686745|FG001|NOT COMPLETED|Overall Study||2
2971995|NCT00805207|3686746|FG002|NOT COMPLETED|Overall Study||1
2971996|NCT00805207|3686747|FG003|NOT COMPLETED|Overall Study||0
2971997|NCT00805207|3686748|FG004|NOT COMPLETED|Overall Study||1
2971998|NCT00805207|3686749|FG005|NOT COMPLETED|Overall Study||3
2971999|NCT00805207|3686750|FG006|NOT COMPLETED|Overall Study||0
3303110|NCT02963701|4036412|FG001|NOT COMPLETED|Period 1 (Including Washout) (2 Days)||0
3303111|NCT02963701|4036411|FG000|STARTED|Period 2 (2 Days)||27
3303112|NCT02963701|4036412|FG001|STARTED|Period 2 (2 Days)||28
3303113|NCT02963701|4036411|FG000|COMPLETED|Period 2 (2 Days)||27
3303114|NCT02963701|4036412|FG001|COMPLETED|Period 2 (2 Days)||28
3303115|NCT02963701|4036411|FG000|NOT COMPLETED|Period 2 (2 Days)||0
2972000|NCT00805207|3686751|FG007|NOT COMPLETED|Overall Study||0
2972001|NCT00805207|3686752|FG008|NOT COMPLETED|Overall Study||0
2972002|NCT00805285|3686776|FG000|STARTED|Overall Study||1
2972003|NCT00805285|3686776|FG000|COMPLETED|Overall Study||0
2972004|NCT00805285|3686776|FG000|NOT COMPLETED|Overall Study||1
2972005|NCT00805389|3686785|FG000|STARTED|Overall Study||143
2972006|NCT00805389|3686786|FG001|STARTED|Overall Study||142
2972007|NCT00805389|3686787|FG002|STARTED|Overall Study||141
2972008|NCT00805389|3686788|FG003|STARTED|Overall Study||145
2972009|NCT00805389|3686789|FG004|STARTED|Overall Study||142
2972010|NCT00805389|3686785|FG000|COMPLETED|Overall Study||136
2972011|NCT00805389|3686786|FG001|COMPLETED|Overall Study||137
2972012|NCT00805389|3686787|FG002|COMPLETED|Overall Study||129
2972013|NCT00805389|3686788|FG003|COMPLETED|Overall Study||128
2972014|NCT00805389|3686789|FG004|COMPLETED|Overall Study||129
2972015|NCT00805389|3686785|FG000|NOT COMPLETED|Overall Study||7
2972016|NCT00805389|3686786|FG001|NOT COMPLETED|Overall Study||5
2972017|NCT00805389|3686787|FG002|NOT COMPLETED|Overall Study||12
2972018|NCT00805389|3686788|FG003|NOT COMPLETED|Overall Study||17
2972019|NCT00805389|3686789|FG004|NOT COMPLETED|Overall Study||13
2972020|NCT00805441|3686813|FG000|STARTED|Overall Study||94
2972021|NCT00805441|3686814|FG001|STARTED|Overall Study||96
2972022|NCT00805441|3686813|FG000|Full Analysis Set (FAS)|Overall Study|All randomized participants who received ≥1 dose study drug and contributed to post-baseline data.|92
2972023|NCT00805441|3686814|FG001|Full Analysis Set (FAS)|Overall Study|All randomized participants who received ≥1 dose study drug and contributed to post-baseline data.|91
2972024|NCT00805441|3686813|FG000|COMPLETED|Overall Study||60
2972025|NCT00805441|3686814|FG001|COMPLETED|Overall Study||60
2972026|NCT00805441|3686813|FG000|NOT COMPLETED|Overall Study||34
2972027|NCT00805441|3686814|FG001|NOT COMPLETED|Overall Study||36
2972028|NCT00805467|3686824|FG000|STARTED|Overall Study|Patients who received treatment|1
2972029|NCT00805467|3686825|FG001|STARTED|Overall Study|Patients who received treatment|59
2972030|NCT00805467|3686826|FG002|STARTED|Overall Study|Patients who received treatment|183
2972031|NCT00805467|3686827|FG003|STARTED|Overall Study|Patients who received treatment|381
2972032|NCT00805467|3686824|FG000|Enrolled But Did Not Receive Treatment|Overall Study||0
2972033|NCT00805467|3686825|FG001|Enrolled But Did Not Receive Treatment|Overall Study||0
2972034|NCT00805467|3686826|FG002|Enrolled But Did Not Receive Treatment|Overall Study||0
2972035|NCT00805467|3686827|FG003|Enrolled But Did Not Receive Treatment|Overall Study||0
2972036|NCT00805467|3686824|FG000|COMPLETED|Overall Study|Ongoing when study terminated|1
2972037|NCT00805467|3686825|FG001|COMPLETED|Overall Study|Ongoing when study terminated|25
2972038|NCT00805467|3686826|FG002|COMPLETED|Overall Study|Ongoing when study terminated|80
2972039|NCT00805467|3686827|FG003|COMPLETED|Overall Study|Ongoing when study terminated|144
2972040|NCT00805467|3686824|FG000|NOT COMPLETED|Overall Study||0
2972041|NCT00805467|3686825|FG001|NOT COMPLETED|Overall Study||34
2972042|NCT00805467|3686826|FG002|NOT COMPLETED|Overall Study||103
2972043|NCT00805467|3686827|FG003|NOT COMPLETED|Overall Study||237
2972044|NCT00805480|3686841|FG000|STARTED|Overall Study||30
2972045|NCT00805480|3686842|FG001|STARTED|Overall Study||29
2972046|NCT00805480|3686843|FG002|STARTED|Overall Study||31
2972047|NCT00805480|3686844|FG003|STARTED|Overall Study||10
2972048|NCT00805480|3686841|FG000|Pharmacodynamic Analysis Set|Overall Study||30
2972049|NCT00805480|3686842|FG001|Pharmacodynamic Analysis Set|Overall Study||25
2972050|NCT00805480|3686843|FG002|Pharmacodynamic Analysis Set|Overall Study||29
2972051|NCT00805480|3686844|FG003|Pharmacodynamic Analysis Set|Overall Study||10
2972052|NCT00805480|3686841|FG000|COMPLETED|Overall Study||16
2972053|NCT00805480|3686842|FG001|COMPLETED|Overall Study||22
2972054|NCT00805480|3686843|FG002|COMPLETED|Overall Study||19
2972055|NCT00805480|3686844|FG003|COMPLETED|Overall Study||5
2972056|NCT00805480|3686841|FG000|NOT COMPLETED|Overall Study||14
2972057|NCT00805480|3686842|FG001|NOT COMPLETED|Overall Study||7
2972058|NCT00805480|3686843|FG002|NOT COMPLETED|Overall Study||12
2972059|NCT00805480|3686844|FG003|NOT COMPLETED|Overall Study||5
2972060|NCT00805493|3686857|FG000|STARTED|Overall Study||3
2972061|NCT00805493|3686858|FG001|STARTED|Overall Study||2
2972062|NCT00805493|3686859|FG002|STARTED|Overall Study||1
2972063|NCT00805493|3686857|FG000|COMPLETED|Overall Study||1
2972064|NCT00805493|3686858|FG001|COMPLETED|Overall Study||2
2972065|NCT00805493|3686859|FG002|COMPLETED|Overall Study||0
2972066|NCT00805493|3686857|FG000|NOT COMPLETED|Overall Study||2
2972067|NCT00805493|3686858|FG001|NOT COMPLETED|Overall Study||0
2972068|NCT00805493|3686859|FG002|NOT COMPLETED|Overall Study||1
2972069|NCT00805532|3686872|FG000|STARTED|Overall Study||42
2972070|NCT00805532|3686873|FG001|STARTED|Overall Study||39
2972071|NCT00805532|3686872|FG000|COMPLETED|Overall Study|We did intent-to-treat analyses so 42 participants' data were analyzed.|42
2972072|NCT00805532|3686873|FG001|COMPLETED|Overall Study||38
2972073|NCT00805532|3686872|FG000|NOT COMPLETED|Overall Study||0
2972074|NCT00805532|3686873|FG001|NOT COMPLETED|Overall Study||1
2972075|NCT00805545|3686883|FG000|STARTED|Overall Study||200
2972076|NCT00805545|3686884|FG001|STARTED|Overall Study||200
2972077|NCT00805545|3686883|FG000|COMPLETED|Overall Study||194
2972078|NCT00805545|3686884|FG001|COMPLETED|Overall Study||197
2972079|NCT00805545|3686883|FG000|NOT COMPLETED|Overall Study||6
2972080|NCT00805545|3686884|FG001|NOT COMPLETED|Overall Study||3
2972081|NCT00805675|3686893|FG000|STARTED|Overall Study||16
2972082|NCT00805675|3686894|FG001|STARTED|Overall Study||14
2972083|NCT00805675|3686895|FG002|STARTED|Overall Study||16
2972084|NCT00805675|3686893|FG000|COMPLETED|Overall Study||16
2972085|NCT00805675|3686894|FG001|COMPLETED|Overall Study||14
2972086|NCT00805675|3686895|FG002|COMPLETED|Overall Study||15
2972087|NCT00805675|3686893|FG000|NOT COMPLETED|Overall Study||0
2972088|NCT00805675|3686894|FG001|NOT COMPLETED|Overall Study||0
2972089|NCT00805675|3686895|FG002|NOT COMPLETED|Overall Study||1
2972090|NCT00805740|3686905|FG000|STARTED|Overall Study||28
2972091|NCT00805740|3686906|FG001|STARTED|Overall Study||13
2972092|NCT00805740|3686905|FG000|Treated|Overall Study||26
2972093|NCT00805740|3686906|FG001|Treated|Overall Study||13
2972094|NCT00805740|3686905|FG000|COMPLETED|Overall Study||17
2972095|NCT00805740|3686906|FG001|COMPLETED|Overall Study||9
2972096|NCT00805740|3686905|FG000|NOT COMPLETED|Overall Study||11
2972097|NCT00805740|3686906|FG001|NOT COMPLETED|Overall Study||4
2972098|NCT00805766|3686912|FG000|STARTED|Screening Period||45
2972099|NCT00805766|3686912|FG000|COMPLETED|Screening Period||39
2972100|NCT00805766|3686912|FG000|NOT COMPLETED|Screening Period||6
2972101|NCT00805766|3686912|FG000|STARTED|Increased Dose Period||39
2972102|NCT00805766|3686912|FG000|COMPLETED|Increased Dose Period||26
2972103|NCT00805766|3686912|FG000|NOT COMPLETED|Increased Dose Period||13
2972104|NCT00805792|3686920|FG000|STARTED|Overall Study||33
2972105|NCT00805792|3686920|FG000|COMPLETED|Overall Study||28
2972106|NCT00805792|3686920|FG000|NOT COMPLETED|Overall Study||5
2972107|NCT00805870|3686926|FG000|STARTED|Overall Study||10
2972108|NCT00805870|3686927|FG001|STARTED|Overall Study||10
2972109|NCT00805870|3686926|FG000|COMPLETED|Overall Study||10
2972110|NCT00805870|3686927|FG001|COMPLETED|Overall Study||10
2972111|NCT00805870|3686926|FG000|NOT COMPLETED|Overall Study||0
2972112|NCT00805870|3686927|FG001|NOT COMPLETED|Overall Study||0
2972113|NCT00805935|3686937|FG000|STARTED|Overall Study||25
2972114|NCT00805935|3686938|FG001|STARTED|Overall Study||27
2972115|NCT00805935|3686939|FG002|STARTED|Overall Study||28
2972116|NCT00805935|3686940|FG003|STARTED|Overall Study||30
2972117|NCT00805935|3686937|FG000|COMPLETED|Overall Study||12
2972118|NCT00805935|3686938|FG001|COMPLETED|Overall Study||8
2972119|NCT00805935|3686939|FG002|COMPLETED|Overall Study||13
2972120|NCT00805935|3686940|FG003|COMPLETED|Overall Study||19
2972121|NCT00805935|3686937|FG000|NOT COMPLETED|Overall Study||13
2972122|NCT00805935|3686938|FG001|NOT COMPLETED|Overall Study||19
2972123|NCT00805935|3686939|FG002|NOT COMPLETED|Overall Study||15
2972124|NCT00805935|3686940|FG003|NOT COMPLETED|Overall Study||11
2972125|NCT00805948|3686954|FG000|STARTED|Overall Study||154
2972126|NCT00805948|3686955|FG001|STARTED|Overall Study||195
2972127|NCT00805948|3686954|FG000|COMPLETED|Overall Study||86
2972128|NCT00805948|3686955|FG001|COMPLETED|Overall Study||99
2972129|NCT00805948|3686954|FG000|NOT COMPLETED|Overall Study||68
2972130|NCT00805948|3686955|FG001|NOT COMPLETED|Overall Study||96
2972131|NCT00806026|3686968|FG000|STARTED|Overall Study||185
2972132|NCT00806026|3686969|FG001|STARTED|Overall Study||183
2972133|NCT00806026|3686970|FG002|STARTED|Overall Study||182
2972134|NCT00806026|3686971|FG003|STARTED|Overall Study||61
2972135|NCT00806026|3686972|FG004|STARTED|Overall Study||59
2972136|NCT00806026|3686973|FG005|STARTED|Overall Study||61
2972137|NCT00806026|3686968|FG000|Treated|Overall Study||182
2972138|NCT00806026|3686969|FG001|Treated|Overall Study||178
2972139|NCT00806026|3686970|FG002|Treated|Overall Study||180
2972140|NCT00806026|3686971|FG003|Treated|Overall Study||59
2972141|NCT00806026|3686972|FG004|Treated|Overall Study||59
2972142|NCT00806026|3686973|FG005|Treated|Overall Study||61
2972143|NCT00806026|3686968|FG000|COMPLETED|Overall Study||93
2972144|NCT00806026|3686969|FG001|COMPLETED|Overall Study||82
2972145|NCT00806026|3686970|FG002|COMPLETED|Overall Study||89
2972146|NCT00806026|3686971|FG003|COMPLETED|Overall Study||32
2972147|NCT00806026|3686972|FG004|COMPLETED|Overall Study||29
2972148|NCT00806026|3686973|FG005|COMPLETED|Overall Study||29
2972149|NCT00806026|3686968|FG000|NOT COMPLETED|Overall Study||92
2972150|NCT00806026|3686969|FG001|NOT COMPLETED|Overall Study||101
2972151|NCT00806026|3686970|FG002|NOT COMPLETED|Overall Study||93
2972152|NCT00806026|3686971|FG003|NOT COMPLETED|Overall Study||29
2972153|NCT00806026|3686972|FG004|NOT COMPLETED|Overall Study||30
2972154|NCT00806026|3686973|FG005|NOT COMPLETED|Overall Study||32
2972155|NCT00806078|3686987|FG000|STARTED|First Intervention||9
2972156|NCT00806078|3686988|FG001|STARTED|First Intervention||9
2972157|NCT00806078|3686987|FG000|COMPLETED|First Intervention||9
2972158|NCT00806078|3686988|FG001|COMPLETED|First Intervention||9
2972159|NCT00806078|3686987|FG000|NOT COMPLETED|First Intervention||0
2972160|NCT00806078|3686988|FG001|NOT COMPLETED|First Intervention||0
2972161|NCT00806078|3686987|FG000|STARTED|7 Day Washout Period||9
2972162|NCT00806078|3686988|FG001|STARTED|7 Day Washout Period||9
2972163|NCT00806078|3686987|FG000|COMPLETED|7 Day Washout Period||9
2972164|NCT00806078|3686988|FG001|COMPLETED|7 Day Washout Period||9
2972165|NCT00806078|3686987|FG000|NOT COMPLETED|7 Day Washout Period||0
2972166|NCT00806078|3686988|FG001|NOT COMPLETED|7 Day Washout Period||0
2972167|NCT00806078|3686987|FG000|STARTED|Second Intervention||9
2972168|NCT00806078|3686988|FG001|STARTED|Second Intervention||9
2972169|NCT00806078|3686987|FG000|COMPLETED|Second Intervention||9
2972170|NCT00806078|3686988|FG001|COMPLETED|Second Intervention||9
2972171|NCT00806078|3686987|FG000|NOT COMPLETED|Second Intervention||0
2972172|NCT00806078|3686988|FG001|NOT COMPLETED|Second Intervention||0
2972173|NCT00806156|3686996|FG000|STARTED|Overall Study||39
2972174|NCT00806156|3686997|FG001|STARTED|Overall Study||139
2972175|NCT00806156|3686996|FG000|COMPLETED|Overall Study||0
2972176|NCT00806156|3686997|FG001|COMPLETED|Overall Study||0
2972177|NCT00806156|3686996|FG000|NOT COMPLETED|Overall Study||39
2972178|NCT00806156|3686997|FG001|NOT COMPLETED|Overall Study||139
2972179|NCT00806195|3687019|FG000|STARTED|Overall Study||4363
2972180|NCT00806195|3687020|FG001|STARTED|Overall Study||1483
2972181|NCT00806195|3687021|FG002|STARTED|Overall Study||1409
2972182|NCT00806195|3687022|FG003|STARTED|Overall Study||489
2972183|NCT00806195|3687019|FG000|COMPLETED|Overall Study||3849
2972184|NCT00806195|3687020|FG001|COMPLETED|Overall Study||1321
2972185|NCT00806195|3687021|FG002|COMPLETED|Overall Study||1139
2972186|NCT00806195|3687022|FG003|COMPLETED|Overall Study||383
2972187|NCT00806195|3687019|FG000|NOT COMPLETED|Overall Study||514
2972188|NCT00806195|3687020|FG001|NOT COMPLETED|Overall Study||162
2972189|NCT00806195|3687021|FG002|NOT COMPLETED|Overall Study||270
2972190|NCT00806195|3687022|FG003|NOT COMPLETED|Overall Study||106
2972191|NCT00806221|3687034|FG000|STARTED|Overall Study||22
2972192|NCT00806221|3687034|FG000|COMPLETED|Overall Study||20
2972193|NCT00806221|3687034|FG000|NOT COMPLETED|Overall Study||2
2972194|NCT00806234|3687041|FG000|STARTED|Overall Study||47
2972195|NCT00806234|3687042|FG001|STARTED|Overall Study||31
2972196|NCT00806234|3687043|FG002|STARTED|Overall Study||49
2972197|NCT00806234|3687041|FG000|COMPLETED|Overall Study||34
2972198|NCT00806234|3687042|FG001|COMPLETED|Overall Study||19
2972199|NCT00806234|3687043|FG002|COMPLETED|Overall Study||37
2972200|NCT00806234|3687041|FG000|NOT COMPLETED|Overall Study||13
2972201|NCT00806234|3687042|FG001|NOT COMPLETED|Overall Study||12
2972202|NCT00806234|3687043|FG002|NOT COMPLETED|Overall Study||12
2972203|NCT00806260|3687057|FG000|STARTED|Period 1 (1 Day)||15
2972204|NCT00806260|3687058|FG001|STARTED|Period 1 (1 Day)||8
2972205|NCT00806260|3687059|FG002|STARTED|Period 1 (1 Day)||8
2972206|NCT00806260|3687060|FG003|STARTED|Period 1 (1 Day)||14
2972207|NCT00806260|3687061|FG004|STARTED|Period 1 (1 Day)||18
3133260|NCT01695239|3858316|FG011|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
2972208|NCT00806260|3687062|FG005|STARTED|Period 1 (1 Day)||17
2972209|NCT00806260|3687057|FG000|COMPLETED|Period 1 (1 Day)||15
2972210|NCT00806260|3687058|FG001|COMPLETED|Period 1 (1 Day)||8
2972211|NCT00806260|3687059|FG002|COMPLETED|Period 1 (1 Day)||8
2972212|NCT00806260|3687060|FG003|COMPLETED|Period 1 (1 Day)||14
2972213|NCT00806260|3687061|FG004|COMPLETED|Period 1 (1 Day)|did not move onto Periods 2 and 3 due to adjusted design of study|15
2972214|NCT00806260|3687062|FG005|COMPLETED|Period 1 (1 Day)|did not move onto Periods 2 and 3 due to adjusted design of study|17
2972215|NCT00806260|3687057|FG000|NOT COMPLETED|Period 1 (1 Day)||0
2972216|NCT00806260|3687058|FG001|NOT COMPLETED|Period 1 (1 Day)||0
2972217|NCT00806260|3687059|FG002|NOT COMPLETED|Period 1 (1 Day)||0
2972218|NCT00806260|3687060|FG003|NOT COMPLETED|Period 1 (1 Day)||0
2972219|NCT00806260|3687061|FG004|NOT COMPLETED|Period 1 (1 Day)||3
2972220|NCT00806260|3687062|FG005|NOT COMPLETED|Period 1 (1 Day)||0
2972221|NCT00806260|3687057|FG000|STARTED|Period 2||15
2972222|NCT00806260|3687058|FG001|STARTED|Period 2||8
2972223|NCT00806260|3687059|FG002|STARTED|Period 2||8
2972224|NCT00806260|3687060|FG003|STARTED|Period 2||14
2972225|NCT00806260|3687061|FG004|STARTED|Period 2||0
2972226|NCT00806260|3687062|FG005|STARTED|Period 2||0
2972227|NCT00806260|3687057|FG000|COMPLETED|Period 2||13
2972228|NCT00806260|3687058|FG001|COMPLETED|Period 2||8
2972229|NCT00806260|3687059|FG002|COMPLETED|Period 2||6
2972230|NCT00806260|3687060|FG003|COMPLETED|Period 2||12
2972231|NCT00806260|3687061|FG004|COMPLETED|Period 2||0
2972232|NCT00806260|3687062|FG005|COMPLETED|Period 2||0
2972233|NCT00806260|3687057|FG000|NOT COMPLETED|Period 2||2
2972234|NCT00806260|3687058|FG001|NOT COMPLETED|Period 2||0
2972235|NCT00806260|3687059|FG002|NOT COMPLETED|Period 2||2
2972236|NCT00806260|3687060|FG003|NOT COMPLETED|Period 2||2
2972237|NCT00806260|3687061|FG004|NOT COMPLETED|Period 2||0
2972238|NCT00806260|3687062|FG005|NOT COMPLETED|Period 2||0
2972239|NCT00806260|3687057|FG000|STARTED|Period 3||13
2972240|NCT00806260|3687058|FG001|STARTED|Period 3||8
2972241|NCT00806260|3687059|FG002|STARTED|Period 3||6
2972242|NCT00806260|3687060|FG003|STARTED|Period 3||12
2972243|NCT00806260|3687061|FG004|STARTED|Period 3||0
2972244|NCT00806260|3687062|FG005|STARTED|Period 3||0
2972245|NCT00806260|3687057|FG000|COMPLETED|Period 3||12
2972246|NCT00806260|3687058|FG001|COMPLETED|Period 3||7
2972247|NCT00806260|3687059|FG002|COMPLETED|Period 3||5
2972248|NCT00806260|3687060|FG003|COMPLETED|Period 3||12
2972249|NCT00806260|3687061|FG004|COMPLETED|Period 3||0
2972250|NCT00806260|3687062|FG005|COMPLETED|Period 3||0
2972251|NCT00806260|3687057|FG000|NOT COMPLETED|Period 3||1
2972252|NCT00806260|3687058|FG001|NOT COMPLETED|Period 3||1
2972253|NCT00806260|3687059|FG002|NOT COMPLETED|Period 3||1
2972254|NCT00806260|3687060|FG003|NOT COMPLETED|Period 3||0
2972255|NCT00806260|3687061|FG004|NOT COMPLETED|Period 3||0
2972256|NCT00806260|3687062|FG005|NOT COMPLETED|Period 3||0
2972257|NCT00806286|3687077|FG000|STARTED|Overall Study||54
2972258|NCT00806286|3687078|FG001|STARTED|Overall Study||54
2972259|NCT00806286|3687079|FG002|STARTED|Overall Study||3
2972260|NCT00806286|3687077|FG000|COMPLETED|Overall Study||0
2972261|NCT00806286|3687078|FG001|COMPLETED|Overall Study||0
2972262|NCT00806286|3687079|FG002|COMPLETED|Overall Study||0
2972263|NCT00806286|3687077|FG000|NOT COMPLETED|Overall Study||54
2972264|NCT00806286|3687078|FG001|NOT COMPLETED|Overall Study||54
2972265|NCT00806286|3687079|FG002|NOT COMPLETED|Overall Study||3
2972266|NCT00806351|3687089|FG000|STARTED|Overall Study||15
2972267|NCT00806351|3687090|FG001|STARTED|Overall Study||6
2972268|NCT00806351|3687089|FG000|COMPLETED|Overall Study||10
2972269|NCT00806351|3687090|FG001|COMPLETED|Overall Study||2
2972270|NCT00806351|3687089|FG000|NOT COMPLETED|Overall Study||5
2972271|NCT00806351|3687090|FG001|NOT COMPLETED|Overall Study||4
2972272|NCT00806442|3687096|FG000|STARTED|Overall Study||18
2972273|NCT00806442|3687097|FG001|STARTED|Overall Study||21
2972274|NCT00806442|3687096|FG000|First Intervention (3 Wks)|Overall Study||18
2972275|NCT00806442|3687097|FG001|First Intervention (3 Wks)|Overall Study||21
2972276|NCT00806442|3687096|FG000|Washout (3 Wks)|Overall Study||15
2972277|NCT00806442|3687097|FG001|Washout (3 Wks)|Overall Study||14
2972278|NCT00806442|3687096|FG000|Second Intervention (3 Wks)|Overall Study||15
2972279|NCT00806442|3687097|FG001|Second Intervention (3 Wks)|Overall Study||14
2972280|NCT00806442|3687096|FG000|COMPLETED|Overall Study||14
2972281|NCT00806442|3687097|FG001|COMPLETED|Overall Study||14
2972282|NCT00806442|3687096|FG000|NOT COMPLETED|Overall Study||4
2972283|NCT00806442|3687097|FG001|NOT COMPLETED|Overall Study||7
2972284|NCT00806494|3687105|FG000|STARTED|Overall Study||331
2972285|NCT00806494|3687105|FG000|COMPLETED|Overall Study||251
2972286|NCT00806494|3687105|FG000|NOT COMPLETED|Overall Study||80
2972287|NCT00806546|3687110|FG000|STARTED|Overall Study|35 subjects were enrolled but did not treat for a total of 479 subjects in the safety population|514
2972288|NCT00806546|3687110|FG000|COMPLETED|Overall Study||207
2972289|NCT00806546|3687110|FG000|NOT COMPLETED|Overall Study||307
2972290|NCT00806585|3687119|FG000|STARTED|Overall Study||137
2972291|NCT00806585|3687120|FG001|STARTED|Overall Study||134
2972292|NCT00806585|3687121|FG002|STARTED|Overall Study||141
2972293|NCT00806585|3687122|FG003|STARTED|Overall Study||71
2972294|NCT00806585|3687123|FG004|STARTED|Overall Study||137
2972295|NCT00806585|3687119|FG000|COMPLETED|Overall Study||105
2972296|NCT00806585|3687120|FG001|COMPLETED|Overall Study||103
2972297|NCT00806585|3687121|FG002|COMPLETED|Overall Study||109
2972298|NCT00806585|3687122|FG003|COMPLETED|Overall Study||56
2972299|NCT00806585|3687123|FG004|COMPLETED|Overall Study||106
2972300|NCT00806585|3687119|FG000|NOT COMPLETED|Overall Study||32
2972301|NCT00806585|3687120|FG001|NOT COMPLETED|Overall Study||31
2972302|NCT00806585|3687121|FG002|NOT COMPLETED|Overall Study||32
2972303|NCT00806585|3687122|FG003|NOT COMPLETED|Overall Study||15
2972304|NCT00806585|3687123|FG004|NOT COMPLETED|Overall Study||31
2972305|NCT00806598|3687135|FG000|STARTED|Overall Study||48
2972306|NCT00806598|3687135|FG000|COMPLETED|Overall Study||48
2972307|NCT00806598|3687135|FG000|NOT COMPLETED|Overall Study||0
2972308|NCT00806624|3687142|FG000|STARTED|Overall Study||79
2972309|NCT00806624|3687143|FG001|STARTED|Overall Study||80
2972310|NCT00806624|3687144|FG002|STARTED|Overall Study||75
2972311|NCT00806624|3687142|FG000|COMPLETED|Overall Study||70
2972312|NCT00806624|3687143|FG001|COMPLETED|Overall Study||68
2972313|NCT00806624|3687144|FG002|COMPLETED|Overall Study||69
2972314|NCT00806624|3687142|FG000|NOT COMPLETED|Overall Study||9
2972315|NCT00806624|3687143|FG001|NOT COMPLETED|Overall Study||12
2972316|NCT00806624|3687144|FG002|NOT COMPLETED|Overall Study||6
2972317|NCT00806676|3687155|FG000|STARTED|Overall Study||29
2972318|NCT00806676|3687156|FG001|STARTED|Overall Study||9
2972319|NCT00806676|3687157|FG002|STARTED|Overall Study||29
2972320|NCT00806676|3687155|FG000|COMPLETED|Overall Study||25
2972321|NCT00806676|3687156|FG001|COMPLETED|Overall Study||9
2972322|NCT00806676|3687157|FG002|COMPLETED|Overall Study||23
2972323|NCT00806676|3687155|FG000|NOT COMPLETED|Overall Study||4
2972324|NCT00806676|3687156|FG001|NOT COMPLETED|Overall Study||0
2972325|NCT00806676|3687157|FG002|NOT COMPLETED|Overall Study||6
2972326|NCT00806819|3687168|FG000|STARTED|Overall Study|randomised patients|353
2972327|NCT00806819|3687169|FG001|STARTED|Overall Study|randomised patients|360
2972328|NCT00806819|3687168|FG000|COMPLETED|Overall Study|On-treatment at analysis DBL date (15 February 2013)|7
2972329|NCT00806819|3687169|FG001|COMPLETED|Overall Study|On-treatment at analysis DBL date (15 February 2013)|2
2972330|NCT00806819|3687168|FG000|NOT COMPLETED|Overall Study||346
2972331|NCT00806819|3687169|FG001|NOT COMPLETED|Overall Study||358
2972332|NCT00806988|3687178|FG000|STARTED|Overall Study||150
2972333|NCT00806988|3687179|FG001|STARTED|Overall Study||151
2972334|NCT00806988|3687178|FG000|COMPLETED|Overall Study||123
2972335|NCT00806988|3687179|FG001|COMPLETED|Overall Study||108
2972336|NCT00806988|3687178|FG000|NOT COMPLETED|Overall Study||27
2972337|NCT00806988|3687179|FG001|NOT COMPLETED|Overall Study||43
2972338|NCT00807001|3687190|FG000|STARTED|Overall Study|For all groups, number of subjects who received at least one dose of study drug.|8
2972339|NCT00807001|3687191|FG001|STARTED|Overall Study||8
2972340|NCT00807001|3687192|FG002|STARTED|Overall Study||8
2972341|NCT00807001|3687193|FG003|STARTED|Overall Study||8
2972342|NCT00807001|3687194|FG004|STARTED|Overall Study||9
2972343|NCT00807001|3687190|FG000|COMPLETED|Overall Study||8
2972344|NCT00807001|3687191|FG001|COMPLETED|Overall Study||7
2972345|NCT00807001|3687192|FG002|COMPLETED|Overall Study||8
2972346|NCT00807001|3687193|FG003|COMPLETED|Overall Study||8
2972347|NCT00807001|3687194|FG004|COMPLETED|Overall Study||9
2972348|NCT00807001|3687190|FG000|NOT COMPLETED|Overall Study||0
2972349|NCT00807001|3687191|FG001|NOT COMPLETED|Overall Study||1
2972350|NCT00807001|3687192|FG002|NOT COMPLETED|Overall Study||0
2972351|NCT00807001|3687193|FG003|NOT COMPLETED|Overall Study||0
2972352|NCT00807001|3687194|FG004|NOT COMPLETED|Overall Study||0
2972353|NCT00807014|3687208|FG000|STARTED|Overall Study||83
2972354|NCT00807014|3687209|FG001|STARTED|Overall Study||85
2972355|NCT00807014|3687208|FG000|COMPLETED|Overall Study||56
2972356|NCT00807014|3687209|FG001|COMPLETED|Overall Study||58
2972357|NCT00807014|3687208|FG000|NOT COMPLETED|Overall Study||27
2972358|NCT00807014|3687209|FG001|NOT COMPLETED|Overall Study||27
3035836|NCT01139515|3755079|FG001|COMPLETED|Washout Period 3 (46 Hrs)||4
3035837|NCT01139515|3755080|FG002|COMPLETED|Washout Period 3 (46 Hrs)||4
3035838|NCT01139515|3755081|FG003|COMPLETED|Washout Period 3 (46 Hrs)||4
3035839|NCT01139515|3755078|FG000|NOT COMPLETED|Washout Period 3 (46 Hrs)||0
3035840|NCT01139515|3755079|FG001|NOT COMPLETED|Washout Period 3 (46 Hrs)||0
3035841|NCT01139515|3755080|FG002|NOT COMPLETED|Washout Period 3 (46 Hrs)||0
3035842|NCT01139515|3755081|FG003|NOT COMPLETED|Washout Period 3 (46 Hrs)||0
3035843|NCT01139515|3755078|FG000|STARTED|Fourth Intervention Period||4
3035844|NCT01139515|3755079|FG001|STARTED|Fourth Intervention Period||4
3035845|NCT01139515|3755080|FG002|STARTED|Fourth Intervention Period||4
3035846|NCT01139515|3755081|FG003|STARTED|Fourth Intervention Period||4
3035847|NCT01139515|3755078|FG000|COMPLETED|Fourth Intervention Period||4
3035848|NCT01139515|3755079|FG001|COMPLETED|Fourth Intervention Period||4
3035849|NCT01139515|3755080|FG002|COMPLETED|Fourth Intervention Period||4
3035850|NCT01139515|3755081|FG003|COMPLETED|Fourth Intervention Period||4
3035851|NCT01139515|3755078|FG000|NOT COMPLETED|Fourth Intervention Period||0
3035852|NCT01139515|3755079|FG001|NOT COMPLETED|Fourth Intervention Period||0
3035853|NCT01139515|3755080|FG002|NOT COMPLETED|Fourth Intervention Period||0
2972359|NCT00807040|3687217|FG000|STARTED|Overall Study||126
2972360|NCT00807040|3687218|FG001|STARTED|Overall Study||125
2972361|NCT00807040|3687217|FG000|COMPLETED|Overall Study||90
3133261|NCT01695239|3858317|FG012|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
3133262|NCT01695239|3858318|FG013|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
3133263|NCT01695239|3858305|FG000|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
3133264|NCT01695239|3858306|FG001|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
3133265|NCT01695239|3858307|FG002|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
3133266|NCT01695239|3858308|FG003|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
3133267|NCT01695239|3858309|FG004|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
3133268|NCT01695239|3858310|FG005|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
3164073|NCT01890785|3891533|FG003|COMPLETED|First Intervention||5
3164074|NCT01890785|3891534|FG004|COMPLETED|First Intervention||5
3164075|NCT01890785|3891535|FG005|COMPLETED|First Intervention||5
3164076|NCT01890785|3891530|FG000|NOT COMPLETED|First Intervention||0
2972362|NCT00807040|3687218|FG001|COMPLETED|Overall Study||84
2972363|NCT00807040|3687217|FG000|NOT COMPLETED|Overall Study||36
2972364|NCT00807040|3687218|FG001|NOT COMPLETED|Overall Study||41
2972365|NCT00807092|3687226|FG000|STARTED|Overall Study||72
2972366|NCT00807092|3687227|FG001|STARTED|Overall Study||73
2972367|NCT00807092|3687226|FG000|Exposed to Drug|Overall Study|Subject was randomised, but not exposed to any trial drug|71
2972368|NCT00807092|3687227|FG001|Exposed to Drug|Overall Study||73
2972369|NCT00807092|3687226|FG000|COMPLETED|Overall Study||71
2972370|NCT00807092|3687227|FG001|COMPLETED|Overall Study||69
2972371|NCT00807092|3687226|FG000|NOT COMPLETED|Overall Study||1
2972372|NCT00807092|3687227|FG001|NOT COMPLETED|Overall Study||4
2972373|NCT00807144|3687235|FG000|STARTED|Overall Study||52
2972374|NCT00807144|3687236|FG001|STARTED|Overall Study||50
2972375|NCT00807144|3687235|FG000|COMPLETED|Overall Study||52
2972376|NCT00807144|3687236|FG001|COMPLETED|Overall Study||49
2972377|NCT00807144|3687235|FG000|NOT COMPLETED|Overall Study||0
2972378|NCT00807144|3687236|FG001|NOT COMPLETED|Overall Study||1
2972379|NCT00807209|3687245|FG000|STARTED|Overall Study||1
2972380|NCT00807209|3687246|FG001|STARTED|Overall Study||1
2972381|NCT00807209|3687247|FG002|STARTED|Overall Study||1
2972382|NCT00807209|3687245|FG000|COMPLETED|Overall Study||1
2972383|NCT00807209|3687246|FG001|COMPLETED|Overall Study||1
2972384|NCT00807209|3687247|FG002|COMPLETED|Overall Study||1
2972385|NCT00807209|3687245|FG000|NOT COMPLETED|Overall Study||0
2972386|NCT00807209|3687246|FG001|NOT COMPLETED|Overall Study||0
2972387|NCT00807209|3687247|FG002|NOT COMPLETED|Overall Study||0
2972388|NCT00807235|3687257|FG000|STARTED|Overall Study||11
2972389|NCT00807235|3687258|FG001|STARTED|Overall Study||6
2972390|NCT00807235|3687257|FG000|COMPLETED|Overall Study||10
2972391|NCT00807235|3687258|FG001|COMPLETED|Overall Study||6
2972392|NCT00807235|3687257|FG000|NOT COMPLETED|Overall Study||1
2972393|NCT00807235|3687258|FG001|NOT COMPLETED|Overall Study||0
2972394|NCT00807248|3687268|FG000|STARTED|Overall Study||71
2972395|NCT00807248|3687269|FG001|STARTED|Overall Study||140
2972396|NCT00807248|3687270|FG002|STARTED|Overall Study||139
2972397|NCT00807248|3687271|FG003|STARTED|Overall Study||140
2972398|NCT00807248|3687268|FG000|COMPLETED|Overall Study||50
2972399|NCT00807248|3687269|FG001|COMPLETED|Overall Study||128
2972400|NCT00807248|3687270|FG002|COMPLETED|Overall Study||121
2972401|NCT00807248|3687271|FG003|COMPLETED|Overall Study||126
2972402|NCT00807248|3687268|FG000|NOT COMPLETED|Overall Study||21
2972403|NCT00807248|3687269|FG001|NOT COMPLETED|Overall Study||12
2972404|NCT00807248|3687270|FG002|NOT COMPLETED|Overall Study||18
2972405|NCT00807248|3687271|FG003|NOT COMPLETED|Overall Study||14
2972406|NCT00807456|3687281|FG000|STARTED|Overall Study||65
2972407|NCT00807456|3687281|FG000|COMPLETED|Overall Study||65
2972408|NCT00807456|3687281|FG000|NOT COMPLETED|Overall Study||0
2972409|NCT00807495|3687290|FG000|STARTED|Overall Study||22
2972410|NCT00807495|3687291|FG001|STARTED|Overall Study||13
2972411|NCT00807495|3687292|FG002|STARTED|Overall Study||5
2972412|NCT00807495|3687293|FG003|STARTED|Overall Study||1
2972413|NCT00807495|3687294|FG004|STARTED|Overall Study|An ATL participant had late on-study biopsy and was in DLBL, reducing ATL participants from 8 to 7.|7
2972414|NCT00807495|3687290|FG000|COMPLETED|Overall Study|Completed = participants who completed the study treatment to PD or symptomatic deterioration.|14
2972415|NCT00807495|3687291|FG001|COMPLETED|Overall Study||7
2972416|NCT00807495|3687292|FG002|COMPLETED|Overall Study||1
2972417|NCT00807495|3687293|FG003|COMPLETED|Overall Study||0
2972418|NCT00807495|3687294|FG004|COMPLETED|Overall Study||2
2972419|NCT00807495|3687290|FG000|NOT COMPLETED|Overall Study||8
2972420|NCT00807495|3687291|FG001|NOT COMPLETED|Overall Study||6
2972421|NCT00807495|3687292|FG002|NOT COMPLETED|Overall Study||4
2972422|NCT00807495|3687293|FG003|NOT COMPLETED|Overall Study||1
2972423|NCT00807495|3687294|FG004|NOT COMPLETED|Overall Study||5
2972424|NCT00807560|3687308|FG000|STARTED|Overall Study||38
2972425|NCT00807560|3687309|FG001|STARTED|Overall Study||39
2972426|NCT00807560|3687308|FG000|COMPLETED|Overall Study||38
2972427|NCT00807560|3687309|FG001|COMPLETED|Overall Study||39
2972428|NCT00807560|3687308|FG000|NOT COMPLETED|Overall Study||0
2972429|NCT00807560|3687309|FG001|NOT COMPLETED|Overall Study||0
2972430|NCT00807573|3687315|FG000|STARTED|Overall Study||44
2972431|NCT00807573|3687315|FG000|COMPLETED|Overall Study||42
2972432|NCT00807573|3687315|FG000|NOT COMPLETED|Overall Study||2
2972433|NCT00807586|3687321|FG000|STARTED|Overall Study||60
2972434|NCT00807586|3687322|FG001|STARTED|Overall Study||59
3164077|NCT01890785|3891531|FG001|NOT COMPLETED|First Intervention||0
3164078|NCT01890785|3891532|FG002|NOT COMPLETED|First Intervention||0
2972435|NCT00807586|3687321|FG000|COMPLETED|Overall Study||54
2972436|NCT00807586|3687322|FG001|COMPLETED|Overall Study||58
2972437|NCT00807586|3687321|FG000|NOT COMPLETED|Overall Study||6
2972438|NCT00807586|3687322|FG001|NOT COMPLETED|Overall Study||1
2972439|NCT00807599|3687330|FG000|STARTED|Overall Study||26
2972440|NCT00807599|3687331|FG001|STARTED|Overall Study||24
2972441|NCT00807599|3687332|FG002|STARTED|Overall Study||17
2972442|NCT00807599|3687330|FG000|COMPLETED|Overall Study||26
2972443|NCT00807599|3687331|FG001|COMPLETED|Overall Study||24
2972444|NCT00807599|3687332|FG002|COMPLETED|Overall Study||0
2972445|NCT00807599|3687330|FG000|NOT COMPLETED|Overall Study||0
2972446|NCT00807599|3687331|FG001|NOT COMPLETED|Overall Study||0
2972447|NCT00807599|3687332|FG002|NOT COMPLETED|Overall Study||17
2972448|NCT00807664|3687340|FG000|STARTED|Overall Study||88
2972449|NCT00807664|3687341|FG001|STARTED|Overall Study||94
2972450|NCT00807664|3687340|FG000|COMPLETED|Overall Study||77
2972451|NCT00807664|3687341|FG001|COMPLETED|Overall Study||75
2972452|NCT00807664|3687340|FG000|NOT COMPLETED|Overall Study||11
2972453|NCT00807664|3687341|FG001|NOT COMPLETED|Overall Study||19
2972454|NCT00807742|3687350|FG000|STARTED|Overall Study||172
2972455|NCT00807742|3687351|FG001|STARTED|Overall Study||168
2972456|NCT00807742|3687350|FG000|COMPLETED|Overall Study||126
2972457|NCT00807742|3687351|FG001|COMPLETED|Overall Study||114
2972458|NCT00807742|3687350|FG000|NOT COMPLETED|Overall Study||46
2972459|NCT00807742|3687351|FG001|NOT COMPLETED|Overall Study||54
2972460|NCT00807768|3687359|FG000|STARTED|Overall Study||301
2972461|NCT00807768|3687360|FG001|STARTED|Overall Study||300
2972462|NCT00807768|3687359|FG000|COMPLETED|Overall Study||301
2972463|NCT00807768|3687360|FG001|COMPLETED|Overall Study||300
2972464|NCT00807768|3687359|FG000|NOT COMPLETED|Overall Study||0
2972465|NCT00807768|3687360|FG001|NOT COMPLETED|Overall Study||0
2972466|NCT00807846|3687368|FG000|STARTED|Overall Study||100
2972467|NCT00807846|3687369|FG001|STARTED|Overall Study||98
2972468|NCT00807846|3687368|FG000|COMPLETED|Overall Study||88
2972469|NCT00807846|3687369|FG001|COMPLETED|Overall Study||94
2972470|NCT00807846|3687368|FG000|NOT COMPLETED|Overall Study||12
2972471|NCT00807846|3687369|FG001|NOT COMPLETED|Overall Study||4
2972472|NCT00807885|3687384|FG000|STARTED|Overall Study||10
2972473|NCT00807885|3687385|FG001|STARTED|Overall Study||11
2972474|NCT00807885|3687386|FG002|STARTED|Overall Study||11
2972475|NCT00807885|3687387|FG003|STARTED|Overall Study||10
2972476|NCT00807885|3687388|FG004|STARTED|Overall Study||12
2972477|NCT00807885|3687389|FG005|STARTED|Overall Study||12
2972478|NCT00807885|3687390|FG006|STARTED|Overall Study||12
2972479|NCT00807885|3687391|FG007|STARTED|Overall Study||11
2972480|NCT00807885|3687392|FG008|STARTED|Overall Study||11
2972481|NCT00807885|3687384|FG000|COMPLETED|Overall Study||10
2972482|NCT00807885|3687385|FG001|COMPLETED|Overall Study||11
2972483|NCT00807885|3687386|FG002|COMPLETED|Overall Study||11
2972484|NCT00807885|3687387|FG003|COMPLETED|Overall Study||10
2972485|NCT00807885|3687388|FG004|COMPLETED|Overall Study||12
2972486|NCT00807885|3687389|FG005|COMPLETED|Overall Study|Subject completed treatment, but lost to follow-up|11
2972487|NCT00807885|3687390|FG006|COMPLETED|Overall Study||12
2972488|NCT00807885|3687391|FG007|COMPLETED|Overall Study||11
2972489|NCT00807885|3687392|FG008|COMPLETED|Overall Study||11
2972490|NCT00807885|3687384|FG000|NOT COMPLETED|Overall Study||0
2972491|NCT00807885|3687385|FG001|NOT COMPLETED|Overall Study||0
2972492|NCT00807885|3687386|FG002|NOT COMPLETED|Overall Study||0
2972493|NCT00807885|3687387|FG003|NOT COMPLETED|Overall Study||0
2972494|NCT00807885|3687388|FG004|NOT COMPLETED|Overall Study||0
2972495|NCT00807885|3687389|FG005|NOT COMPLETED|Overall Study||1
2972496|NCT00807885|3687390|FG006|NOT COMPLETED|Overall Study||0
2972497|NCT00807885|3687391|FG007|NOT COMPLETED|Overall Study||0
2972498|NCT00807885|3687392|FG008|NOT COMPLETED|Overall Study||0
2972499|NCT00807937|3687416|FG000|STARTED|Overall Study||93
2972500|NCT00807937|3687417|FG001|STARTED|Overall Study||92
2972501|NCT00807937|3687418|FG002|STARTED|Overall Study||92
2972502|NCT00807937|3687419|FG003|STARTED|Overall Study||92
2972503|NCT00807937|3687416|FG000|COMPLETED|Overall Study||66
2972504|NCT00807937|3687417|FG001|COMPLETED|Overall Study||67
2972505|NCT00807937|3687418|FG002|COMPLETED|Overall Study||78
2972506|NCT00807937|3687419|FG003|COMPLETED|Overall Study||77
2972507|NCT00807937|3687416|FG000|NOT COMPLETED|Overall Study||27
2972508|NCT00807937|3687417|FG001|NOT COMPLETED|Overall Study||25
2972509|NCT00807937|3687418|FG002|NOT COMPLETED|Overall Study||14
2972510|NCT00807937|3687419|FG003|NOT COMPLETED|Overall Study||15
2972511|NCT00807989|3687431|FG000|STARTED|Overall Study||107
2972512|NCT00807989|3687432|FG001|STARTED|Overall Study||100
2972513|NCT00807989|3687431|FG000|COMPLETED|Overall Study||104
2972514|NCT00807989|3687432|FG001|COMPLETED|Overall Study||98
2972515|NCT00807989|3687431|FG000|NOT COMPLETED|Overall Study||3
2972516|NCT00807989|3687432|FG001|NOT COMPLETED|Overall Study||2
2972517|NCT00808015|3687438|FG000|STARTED|Overall Study||1377
2972518|NCT00808015|3687438|FG000|Treated|Overall Study||1373
2972519|NCT00808015|3687438|FG000|COMPLETED|Overall Study||1033
2972520|NCT00808015|3687438|FG000|NOT COMPLETED|Overall Study||344
2972521|NCT00808028|3687446|FG000|STARTED|Stage 1 (6 Months)||121
2972522|NCT00808028|3687447|FG001|STARTED|Stage 1 (6 Months)|Participants in rLP2086 60 mcg group participated only in Stage 1 and were not eligible for Stage 2|22
2972523|NCT00808028|3687448|FG002|STARTED|Stage 1 (6 Months)||198
2972524|NCT00808028|3687449|FG003|STARTED|Stage 1 (6 Months)||198
2972525|NCT00808028|3687446|FG000|COMPLETED|Stage 1 (6 Months)||116
2972526|NCT00808028|3687447|FG001|COMPLETED|Stage 1 (6 Months)|Participants in rLP2086 60 mcg group participated only in Stage 1 and were not eligible for Stage 2|21
2972527|NCT00808028|3687448|FG002|COMPLETED|Stage 1 (6 Months)||191
2972528|NCT00808028|3687449|FG003|COMPLETED|Stage 1 (6 Months)||183
2972529|NCT00808028|3687446|FG000|NOT COMPLETED|Stage 1 (6 Months)||5
2972530|NCT00808028|3687447|FG001|NOT COMPLETED|Stage 1 (6 Months)||1
2972531|NCT00808028|3687448|FG002|NOT COMPLETED|Stage 1 (6 Months)||7
2972532|NCT00808028|3687449|FG003|NOT COMPLETED|Stage 1 (6 Months)||15
2972533|NCT00808028|3687446|FG000|STARTED|Stage 2 (Followed up to 48 Months )|Out of 511 completed participants in Stage 1, 89 did not enter Stage 2|80
2972534|NCT00808028|3687447|FG001|STARTED|Stage 2 (Followed up to 48 Months )||0
2972535|NCT00808028|3687448|FG002|STARTED|Stage 2 (Followed up to 48 Months )||170
2972536|NCT00808028|3687449|FG003|STARTED|Stage 2 (Followed up to 48 Months )||151
2972537|NCT00808028|3687446|FG000|COMPLETED|Stage 2 (Followed up to 48 Months )|Out of 511 completed participants in Stage 1, 89 did not enter Stage 2|69
2972538|NCT00808028|3687447|FG001|COMPLETED|Stage 2 (Followed up to 48 Months )||0
2972539|NCT00808028|3687448|FG002|COMPLETED|Stage 2 (Followed up to 48 Months )||141
2972540|NCT00808028|3687449|FG003|COMPLETED|Stage 2 (Followed up to 48 Months )||128
2972541|NCT00808028|3687446|FG000|NOT COMPLETED|Stage 2 (Followed up to 48 Months )||11
2972542|NCT00808028|3687447|FG001|NOT COMPLETED|Stage 2 (Followed up to 48 Months )||0
2972543|NCT00808028|3687448|FG002|NOT COMPLETED|Stage 2 (Followed up to 48 Months )||29
2972544|NCT00808028|3687449|FG003|NOT COMPLETED|Stage 2 (Followed up to 48 Months )||23
2972545|NCT00808067|3687471|FG000|STARTED|Overall Study|Number of patients which are treated.|2927
2972546|NCT00808067|3687472|FG001|STARTED|Overall Study|Number of patients which are treated.|2956
2972547|NCT00808067|3687471|FG000|COMPLETED|Overall Study||2446
3303116|NCT02963701|4036412|FG001|NOT COMPLETED|Period 2 (2 Days)||0
3303117|NCT02963922|4036420|FG000|STARTED|Overall Study||198
3303118|NCT02963922|4036421|FG001|STARTED|Overall Study||198
3303119|NCT02963922|4036420|FG000|COMPLETED|Overall Study||166
3303120|NCT02963922|4036421|FG001|COMPLETED|Overall Study||168
3303121|NCT02963922|4036420|FG000|NOT COMPLETED|Overall Study||32
3303122|NCT02963922|4036421|FG001|NOT COMPLETED|Overall Study||30
3303123|NCT02963935|4036429|FG000|STARTED|Overall Study||142
3303124|NCT02963935|4036430|FG001|STARTED|Overall Study||140
2972548|NCT00808067|3687472|FG001|COMPLETED|Overall Study||2438
2972549|NCT00808067|3687471|FG000|NOT COMPLETED|Overall Study||481
2972550|NCT00808067|3687472|FG001|NOT COMPLETED|Overall Study||518
2972551|NCT00808132|3687483|FG000|STARTED|Overall Study||455
2972552|NCT00808132|3687484|FG001|STARTED|Overall Study||481
2972553|NCT00808132|3687485|FG002|STARTED|Overall Study||239
3303125|NCT02963935|4036429|FG000|COMPLETED|Overall Study||114
3303126|NCT02963935|4036430|FG001|COMPLETED|Overall Study||103
3303127|NCT02963935|4036429|FG000|NOT COMPLETED|Overall Study||28
3303128|NCT02963935|4036430|FG001|NOT COMPLETED|Overall Study||37
3303129|NCT02963974|4036436|FG000|STARTED|Overall Study||20
3303130|NCT02963974|4036436|FG000|COMPLETED|Overall Study||19
3303131|NCT02963974|4036436|FG000|NOT COMPLETED|Overall Study||1
3303132|NCT02963987|4036440|FG000|STARTED|First Intervention Period||31
3303133|NCT02963987|4036441|FG001|STARTED|First Intervention Period||19
3303134|NCT02963987|4036440|FG000|COMPLETED|First Intervention Period||31
3303135|NCT02963987|4036441|FG001|COMPLETED|First Intervention Period||19
2972554|NCT00808132|3687486|FG003|STARTED|Overall Study||228
2972555|NCT00808132|3687487|FG004|STARTED|Overall Study||483
2972556|NCT00808132|3687483|FG000|Treated|Overall Study||445
2972557|NCT00808132|3687484|FG001|Treated|Overall Study||474
2972558|NCT00808132|3687485|FG002|Treated|Overall Study||230
2972559|NCT00808132|3687486|FG003|Treated|Overall Study||220
2972560|NCT00808132|3687487|FG004|Treated|Overall Study||474
2972561|NCT00808132|3687483|FG000|COMPLETED|Overall Study||357
2972562|NCT00808132|3687484|FG001|COMPLETED|Overall Study||393
2972563|NCT00808132|3687485|FG002|COMPLETED|Overall Study||185
2972564|NCT00808132|3687486|FG003|COMPLETED|Overall Study||159
2972565|NCT00808132|3687487|FG004|COMPLETED|Overall Study||383
2972566|NCT00808132|3687483|FG000|NOT COMPLETED|Overall Study||98
2972567|NCT00808132|3687484|FG001|NOT COMPLETED|Overall Study||88
2972568|NCT00808132|3687485|FG002|NOT COMPLETED|Overall Study||54
2972569|NCT00808132|3687486|FG003|NOT COMPLETED|Overall Study||69
2972570|NCT00808132|3687487|FG004|NOT COMPLETED|Overall Study||100
2972571|NCT00808210|3687501|FG000|STARTED|Study Period + 48 Weeks of Follow-up||15
2972572|NCT00808210|3687502|FG001|STARTED|Study Period + 48 Weeks of Follow-up||13
2972573|NCT00808210|3687501|FG000|COMPLETED|Study Period + 48 Weeks of Follow-up||6
2972574|NCT00808210|3687502|FG001|COMPLETED|Study Period + 48 Weeks of Follow-up||4
2972575|NCT00808210|3687501|FG000|NOT COMPLETED|Study Period + 48 Weeks of Follow-up||9
2972576|NCT00808210|3687502|FG001|NOT COMPLETED|Study Period + 48 Weeks of Follow-up||9
2972577|NCT00808210|3687501|FG000|STARTED|Double-Blind TX Period||15
2972578|NCT00808210|3687502|FG001|STARTED|Double-Blind TX Period||13
2972579|NCT00808210|3687501|FG000|COMPLETED|Double-Blind TX Period||13
2972580|NCT00808210|3687502|FG001|COMPLETED|Double-Blind TX Period||10
2972581|NCT00808210|3687501|FG000|NOT COMPLETED|Double-Blind TX Period||2
2972582|NCT00808210|3687502|FG001|NOT COMPLETED|Double-Blind TX Period||3
2972583|NCT00808210|3687501|FG000|STARTED|Open Label Ocrelizumab Treatment Period||9
2972584|NCT00808210|3687502|FG001|STARTED|Open Label Ocrelizumab Treatment Period||4
3303136|NCT02963987|4036440|FG000|NOT COMPLETED|First Intervention Period||0
3303137|NCT02963987|4036441|FG001|NOT COMPLETED|First Intervention Period||0
2972585|NCT00808210|3687501|FG000|COMPLETED|Open Label Ocrelizumab Treatment Period||0
2972586|NCT00808210|3687502|FG001|COMPLETED|Open Label Ocrelizumab Treatment Period||0
2972587|NCT00808210|3687501|FG000|NOT COMPLETED|Open Label Ocrelizumab Treatment Period||9
2972588|NCT00808210|3687502|FG001|NOT COMPLETED|Open Label Ocrelizumab Treatment Period||4
2972589|NCT00808236|3687510|FG000|STARTED|Overall Study||96
2972590|NCT00808236|3687511|FG001|STARTED|Overall Study||104
2972591|NCT00808236|3687510|FG000|Met Eligibility Criteria|Overall Study|Pre-defined exclusions: DNAR(4); had pulse(2); CVA(2); Drug OD(2); On home oxygen(1); Unwitnessed(1)|84
2972592|NCT00808236|3687511|FG001|Met Eligibility Criteria|Overall Study|Pre-defined exclusions: Terminal(1); Asphyxia(1), In-hospital(1)|101
2972593|NCT00808236|3687510|FG000|Included in Analysis|Overall Study|Lost to Follow-Up: taken to non-participating hospital (1)|83
2972594|NCT00808236|3687511|FG001|Included in Analysis|Overall Study|Crossed over & withdrawn (1); Lost to Follow-Up: taken to non-participating hospital (1)|99
2972595|NCT00808236|3687510|FG000|Achieved ROSC|Overall Study||33
2972596|NCT00808236|3687511|FG001|Achieved ROSC|Overall Study||43
2972597|NCT00808236|3687510|FG000|Admitted to Hospital|Overall Study|Died during transport to hospital(2); DNAR determination was made at hospital(1)|30
2972598|NCT00808236|3687511|FG001|Admitted to Hospital|Overall Study|Died during transport to hospital(1)|42
2972599|NCT00808236|3687510|FG000|COMPLETED|Overall Study||14
2972600|NCT00808236|3687511|FG001|COMPLETED|Overall Study||13
2972601|NCT00808236|3687510|FG000|NOT COMPLETED|Overall Study||82
2972602|NCT00808236|3687511|FG001|NOT COMPLETED|Overall Study||91
2972603|NCT00808249|3687521|FG000|STARTED|Overall Study||107
2972604|NCT00808249|3687522|FG001|STARTED|Overall Study||106
2972605|NCT00808249|3687523|FG002|STARTED|Overall Study||105
2972606|NCT00808249|3687524|FG003|STARTED|Overall Study||106
2972607|NCT00808249|3687521|FG000|COMPLETED|Overall Study||90
2972608|NCT00808249|3687522|FG001|COMPLETED|Overall Study||91
2972609|NCT00808249|3687523|FG002|COMPLETED|Overall Study||83
2972610|NCT00808249|3687524|FG003|COMPLETED|Overall Study||90
2972611|NCT00808249|3687521|FG000|NOT COMPLETED|Overall Study||17
2972612|NCT00808249|3687522|FG001|NOT COMPLETED|Overall Study||15
2972613|NCT00808249|3687523|FG002|NOT COMPLETED|Overall Study||22
2972614|NCT00808249|3687524|FG003|NOT COMPLETED|Overall Study||16
2972615|NCT00808340|3687534|FG000|STARTED|First Intervention||4
2972616|NCT00808340|3687535|FG001|STARTED|First Intervention||9
2972617|NCT00808340|3687536|FG002|STARTED|First Intervention||7
2972618|NCT00808340|3687537|FG003|STARTED|First Intervention||3
2972619|NCT00808340|3687538|FG004|STARTED|First Intervention||5
2972620|NCT00808340|3687539|FG005|STARTED|First Intervention||6
2972621|NCT00808340|3687534|FG000|COMPLETED|First Intervention||4
2972622|NCT00808340|3687535|FG001|COMPLETED|First Intervention||9
2972623|NCT00808340|3687536|FG002|COMPLETED|First Intervention||7
2972624|NCT00808340|3687537|FG003|COMPLETED|First Intervention||3
2972625|NCT00808340|3687538|FG004|COMPLETED|First Intervention||5
2972626|NCT00808340|3687539|FG005|COMPLETED|First Intervention||6
2972627|NCT00808340|3687534|FG000|NOT COMPLETED|First Intervention||0
2972628|NCT00808340|3687535|FG001|NOT COMPLETED|First Intervention||0
2972629|NCT00808340|3687536|FG002|NOT COMPLETED|First Intervention||0
2972630|NCT00808340|3687537|FG003|NOT COMPLETED|First Intervention||0
2972631|NCT00808340|3687538|FG004|NOT COMPLETED|First Intervention||0
2972632|NCT00808340|3687539|FG005|NOT COMPLETED|First Intervention||0
2972633|NCT00808340|3687534|FG000|STARTED|Second Intervention||4
2972634|NCT00808340|3687535|FG001|STARTED|Second Intervention||9
2972635|NCT00808340|3687536|FG002|STARTED|Second Intervention||7
2972636|NCT00808340|3687537|FG003|STARTED|Second Intervention||3
2972637|NCT00808340|3687538|FG004|STARTED|Second Intervention||5
2972638|NCT00808340|3687539|FG005|STARTED|Second Intervention||6
2972639|NCT00808340|3687534|FG000|COMPLETED|Second Intervention||4
2972640|NCT00808340|3687535|FG001|COMPLETED|Second Intervention||9
2972641|NCT00808340|3687536|FG002|COMPLETED|Second Intervention||7
2972642|NCT00808340|3687537|FG003|COMPLETED|Second Intervention||3
2972643|NCT00808340|3687538|FG004|COMPLETED|Second Intervention||5
2972644|NCT00808340|3687539|FG005|COMPLETED|Second Intervention||6
2972645|NCT00808340|3687534|FG000|NOT COMPLETED|Second Intervention||0
2972646|NCT00808340|3687535|FG001|NOT COMPLETED|Second Intervention||0
2972647|NCT00808340|3687536|FG002|NOT COMPLETED|Second Intervention||0
2972648|NCT00808340|3687537|FG003|NOT COMPLETED|Second Intervention||0
2972649|NCT00808340|3687538|FG004|NOT COMPLETED|Second Intervention||0
2972650|NCT00808340|3687539|FG005|NOT COMPLETED|Second Intervention||0
2972651|NCT00808340|3687534|FG000|STARTED|Third Intervention||4
2972652|NCT00808340|3687535|FG001|STARTED|Third Intervention||9
2972653|NCT00808340|3687536|FG002|STARTED|Third Intervention||7
2972654|NCT00808340|3687537|FG003|STARTED|Third Intervention||3
2972655|NCT00808340|3687538|FG004|STARTED|Third Intervention||5
2972656|NCT00808340|3687539|FG005|STARTED|Third Intervention||6
3133269|NCT01695239|3858311|FG006|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
3133270|NCT01695239|3858312|FG007|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
3133271|NCT01695239|3858313|FG008|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
3133272|NCT01695239|3858314|FG009|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
2972657|NCT00808340|3687534|FG000|COMPLETED|Third Intervention||4
2972658|NCT00808340|3687535|FG001|COMPLETED|Third Intervention||9
2972659|NCT00808340|3687536|FG002|COMPLETED|Third Intervention||7
2972660|NCT00808340|3687537|FG003|COMPLETED|Third Intervention||3
2972661|NCT00808340|3687538|FG004|COMPLETED|Third Intervention||5
2972662|NCT00808340|3687539|FG005|COMPLETED|Third Intervention||6
2972663|NCT00808340|3687534|FG000|NOT COMPLETED|Third Intervention||0
2972664|NCT00808340|3687535|FG001|NOT COMPLETED|Third Intervention||0
2972665|NCT00808340|3687536|FG002|NOT COMPLETED|Third Intervention||0
2972666|NCT00808340|3687537|FG003|NOT COMPLETED|Third Intervention||0
2972667|NCT00808340|3687538|FG004|NOT COMPLETED|Third Intervention||0
2972668|NCT00808340|3687539|FG005|NOT COMPLETED|Third Intervention||0
2972669|NCT00808405|3687549|FG000|STARTED|Overall Study||61
2972670|NCT00808405|3687550|FG001|STARTED|Overall Study||27
2972671|NCT00808405|3687549|FG000|COMPLETED|Overall Study||61
2972672|NCT00808405|3687550|FG001|COMPLETED|Overall Study||27
2972673|NCT00808405|3687549|FG000|NOT COMPLETED|Overall Study||0
2972674|NCT00808405|3687550|FG001|NOT COMPLETED|Overall Study||0
2972675|NCT00808444|3687558|FG000|STARTED|Overall Study||233
2972676|NCT00808444|3687559|FG001|STARTED|Overall Study||233
2972677|NCT00808444|3687558|FG000|COMPLETED|Overall Study||232
2972678|NCT00808444|3687559|FG001|COMPLETED|Overall Study||232
2972679|NCT00808444|3687558|FG000|NOT COMPLETED|Overall Study||1
2972680|NCT00808444|3687559|FG001|NOT COMPLETED|Overall Study||1
2972681|NCT00808470|3687567|FG000|STARTED|Overall Study||37
2972682|NCT00808470|3687568|FG001|STARTED|Overall Study||35
2972683|NCT00808470|3687567|FG000|COMPLETED|Overall Study||35
2972684|NCT00808470|3687568|FG001|COMPLETED|Overall Study||35
2972685|NCT00808470|3687567|FG000|NOT COMPLETED|Overall Study||2
2972686|NCT00808470|3687568|FG001|NOT COMPLETED|Overall Study||0
2972687|NCT00808483|3687580|FG000|STARTED|From 3 to 5 Months After Surgery||35
2972688|NCT00808483|3687581|FG001|STARTED|From 3 to 5 Months After Surgery||33
2972689|NCT00808483|3687580|FG000|COMPLETED|From 3 to 5 Months After Surgery||33
2972690|NCT00808483|3687581|FG001|COMPLETED|From 3 to 5 Months After Surgery||32
2972691|NCT00808483|3687580|FG000|NOT COMPLETED|From 3 to 5 Months After Surgery||2
2972692|NCT00808483|3687581|FG001|NOT COMPLETED|From 3 to 5 Months After Surgery||1
2972693|NCT00808483|3687580|FG000|STARTED|From 5 Months to 12 Months||33
2972694|NCT00808483|3687581|FG001|STARTED|From 5 Months to 12 Months||32
2972695|NCT00808483|3687580|FG000|COMPLETED|From 5 Months to 12 Months||32
2972696|NCT00808483|3687581|FG001|COMPLETED|From 5 Months to 12 Months||32
2972697|NCT00808483|3687580|FG000|NOT COMPLETED|From 5 Months to 12 Months||1
2972698|NCT00808483|3687581|FG001|NOT COMPLETED|From 5 Months to 12 Months||0
2972699|NCT00808509|3687596|FG000|STARTED|Randomized Phase||17
2972700|NCT00808509|3687597|FG001|STARTED|Randomized Phase||16
2972701|NCT00808509|3687596|FG000|Received Rescue Therapy|Randomized Phase||0
2972702|NCT00808509|3687597|FG001|Received Rescue Therapy|Randomized Phase||9
2972703|NCT00808509|3687596|FG000|COMPLETED|Randomized Phase||15
2972704|NCT00808509|3687597|FG001|COMPLETED|Randomized Phase|Includes participants who received rescue therapy & follow-up for 12 weeks|11
2972705|NCT00808509|3687596|FG000|NOT COMPLETED|Randomized Phase||2
2972706|NCT00808509|3687597|FG001|NOT COMPLETED|Randomized Phase||5
2972707|NCT00808509|3687596|FG000|STARTED|Observation Phase|The observation phase was open to all participants|16
2972708|NCT00808509|3687597|FG001|STARTED|Observation Phase|The observation phase was open to all participants|15
2972709|NCT00808509|3687596|FG000|COMPLETED|Observation Phase||16
2972710|NCT00808509|3687597|FG001|COMPLETED|Observation Phase||15
2972711|NCT00808509|3687596|FG000|NOT COMPLETED|Observation Phase||0
2972712|NCT00808509|3687597|FG001|NOT COMPLETED|Observation Phase||0
2972713|NCT00808639|3687605|FG000|STARTED|Overall Study||39
2972714|NCT00808639|3687605|FG000|COMPLETED|Overall Study|One patient went off treatment due to disease progression before surgery.|38
2972715|NCT00808639|3687605|FG000|NOT COMPLETED|Overall Study||1
2972716|NCT00808665|3687611|FG000|STARTED|Overall Study||31
2972717|NCT00808665|3687612|FG001|STARTED|Overall Study||32
2972718|NCT00808665|3687611|FG000|Medication Started|Overall Study||30
2972719|NCT00808665|3687612|FG001|Medication Started|Overall Study||32
2972720|NCT00808665|3687611|FG000|Completed Intra-operative Dose|Overall Study||26
2972721|NCT00808665|3687612|FG001|Completed Intra-operative Dose|Overall Study||32
2972722|NCT00808665|3687611|FG000|Completed Post Operative Doses|Overall Study||25
2972723|NCT00808665|3687612|FG001|Completed Post Operative Doses|Overall Study||29
2972724|NCT00808665|3687611|FG000|COMPLETED|Overall Study||25
2972725|NCT00808665|3687612|FG001|COMPLETED|Overall Study||29
2972726|NCT00808665|3687611|FG000|NOT COMPLETED|Overall Study||6
2972727|NCT00808665|3687612|FG001|NOT COMPLETED|Overall Study||3
2972728|NCT00808808|3687621|FG000|STARTED|Overall Study|Started includes all employees at participating sites.|4078
2972729|NCT00808808|3687622|FG001|STARTED|Overall Study|Started includes all employees at participating sites|3757
2972730|NCT00808808|3687623|FG002|STARTED|Overall Study|Started includes all employees at participating sites.|4387
2972731|NCT00808808|3687621|FG000|Vaccinated|Overall Study|Vaccinated includes all employees who were vaccinated at the employee vaccination clinics.|1392
2972732|NCT00808808|3687622|FG001|Vaccinated|Overall Study|Vaccinated includes all employees who were vaccinated at the employee vaccination clinics.|1489
2972733|NCT00808808|3687623|FG002|Vaccinated|Overall Study|Vaccinated includes all employees who were vaccinated at the employee vaccination clinics.|2132
2972734|NCT00808808|3687621|FG000|COMPLETED|Overall Study|Completed includes vaccinated employees who completed surveys.|1261
2972735|NCT00808808|3687622|FG001|COMPLETED|Overall Study|Completed includes vaccinated employees who completed surveys.|1320
2972736|NCT00808808|3687623|FG002|COMPLETED|Overall Study|Completed includes vaccinated employees who completed surveys.|1830
2972737|NCT00808808|3687621|FG000|NOT COMPLETED|Overall Study||2817
2972738|NCT00808808|3687622|FG001|NOT COMPLETED|Overall Study||2437
2972739|NCT00808808|3687623|FG002|NOT COMPLETED|Overall Study||2557
2972740|NCT00808834|3687637|FG000|STARTED|Period 1||97
2972741|NCT00808834|3687638|FG001|STARTED|Period 1||99
2972742|NCT00808834|3687637|FG000|COMPLETED|Period 1||97
2972743|NCT00808834|3687638|FG001|COMPLETED|Period 1||99
2972744|NCT00808834|3687637|FG000|NOT COMPLETED|Period 1||0
2972745|NCT00808834|3687638|FG001|NOT COMPLETED|Period 1||0
2972746|NCT00808834|3687637|FG000|STARTED|Period 2||97
2972747|NCT00808834|3687638|FG001|STARTED|Period 2||99
2972748|NCT00808834|3687637|FG000|COMPLETED|Period 2||97
2972749|NCT00808834|3687638|FG001|COMPLETED|Period 2||99
2972750|NCT00808834|3687637|FG000|NOT COMPLETED|Period 2||0
2972751|NCT00808834|3687638|FG001|NOT COMPLETED|Period 2||0
2972752|NCT00809055|3687646|FG000|STARTED|Overall Study||37
2972753|NCT00809055|3687647|FG001|STARTED|Overall Study||37
2972754|NCT00809055|3687646|FG000|COMPLETED|Overall Study||28
2972755|NCT00809055|3687647|FG001|COMPLETED|Overall Study||30
2972756|NCT00809055|3687646|FG000|NOT COMPLETED|Overall Study||9
2972757|NCT00809055|3687647|FG001|NOT COMPLETED|Overall Study||7
2972758|NCT00809094|3687655|FG000|STARTED|Overall Study||36
2972759|NCT00809094|3687656|FG001|STARTED|Overall Study||34
2972760|NCT00809094|3687655|FG000|COMPLETED|Overall Study||36
2972761|NCT00809094|3687656|FG001|COMPLETED|Overall Study||33
2972762|NCT00809094|3687655|FG000|NOT COMPLETED|Overall Study||0
2972763|NCT00809094|3687656|FG001|NOT COMPLETED|Overall Study||1
2972764|NCT00809133|3687676|FG000|STARTED|Overall Study||3
2972765|NCT00809133|3687677|FG001|STARTED|Overall Study||7
2972766|NCT00809133|3687678|FG002|STARTED|Overall Study||6
2972767|NCT00809133|3687679|FG003|STARTED|Overall Study||3
2972768|NCT00809133|3687680|FG004|STARTED|Overall Study||5
2972769|NCT00809133|3687681|FG005|STARTED|Overall Study||7
2972770|NCT00809133|3687682|FG006|STARTED|Overall Study||6
2972771|NCT00809133|3687683|FG007|STARTED|Overall Study||8
2972772|NCT00809133|3687684|FG008|STARTED|Overall Study||3
2972773|NCT00809133|3687685|FG009|STARTED|Overall Study||9
2972774|NCT00809133|3687686|FG010|STARTED|Overall Study||6
2972775|NCT00809133|3687687|FG011|STARTED|Overall Study||8
2972776|NCT00809133|3687688|FG012|STARTED|Overall Study||5
2972777|NCT00809133|3687689|FG013|STARTED|Overall Study||7
2972778|NCT00809133|3687676|FG000|COMPLETED|Overall Study||0
2972779|NCT00809133|3687677|FG001|COMPLETED|Overall Study||0
2972780|NCT00809133|3687678|FG002|COMPLETED|Overall Study||0
2972781|NCT00809133|3687679|FG003|COMPLETED|Overall Study||0
2972782|NCT00809133|3687680|FG004|COMPLETED|Overall Study||0
2972783|NCT00809133|3687681|FG005|COMPLETED|Overall Study||0
2972784|NCT00809133|3687682|FG006|COMPLETED|Overall Study||0
2972785|NCT00809133|3687683|FG007|COMPLETED|Overall Study||0
2972786|NCT00809133|3687684|FG008|COMPLETED|Overall Study||0
2972787|NCT00809133|3687685|FG009|COMPLETED|Overall Study||0
2972788|NCT00809133|3687686|FG010|COMPLETED|Overall Study||0
2972789|NCT00809133|3687687|FG011|COMPLETED|Overall Study||0
2972790|NCT00809133|3687688|FG012|COMPLETED|Overall Study||0
2972791|NCT00809133|3687689|FG013|COMPLETED|Overall Study||0
2972792|NCT00809133|3687676|FG000|NOT COMPLETED|Overall Study||3
2972793|NCT00809133|3687677|FG001|NOT COMPLETED|Overall Study||7
2972794|NCT00809133|3687678|FG002|NOT COMPLETED|Overall Study||6
2972795|NCT00809133|3687679|FG003|NOT COMPLETED|Overall Study||3
2972796|NCT00809133|3687680|FG004|NOT COMPLETED|Overall Study||5
2972797|NCT00809133|3687681|FG005|NOT COMPLETED|Overall Study||7
2972798|NCT00809133|3687682|FG006|NOT COMPLETED|Overall Study||6
2972799|NCT00809133|3687683|FG007|NOT COMPLETED|Overall Study||8
2972800|NCT00809133|3687684|FG008|NOT COMPLETED|Overall Study||3
2972801|NCT00809133|3687685|FG009|NOT COMPLETED|Overall Study||9
2972802|NCT00809133|3687686|FG010|NOT COMPLETED|Overall Study||6
2972803|NCT00809133|3687687|FG011|NOT COMPLETED|Overall Study||8
2972804|NCT00809133|3687688|FG012|NOT COMPLETED|Overall Study||5
2972805|NCT00809133|3687689|FG013|NOT COMPLETED|Overall Study||7
2972806|NCT00809146|3687734|FG000|STARTED|Overall Study||448
2972807|NCT00809146|3687735|FG001|STARTED|Overall Study||445
2972808|NCT00809146|3687734|FG000|COMPLETED|Overall Study||448
2972809|NCT00809146|3687735|FG001|COMPLETED|Overall Study||445
2972810|NCT00809146|3687734|FG000|NOT COMPLETED|Overall Study||0
2972811|NCT00809146|3687735|FG001|NOT COMPLETED|Overall Study||0
2972812|NCT00809159|3687745|FG000|STARTED|Part 1||24
2972813|NCT00809159|3687746|FG001|STARTED|Part 1||6
2972814|NCT00809159|3687747|FG002|STARTED|Part 1||0
2972815|NCT00809159|3687748|FG003|STARTED|Part 1||0
2972816|NCT00809159|3687749|FG004|STARTED|Part 1||0
2972817|NCT00809159|3687750|FG005|STARTED|Part 1||0
2972818|NCT00809159|3687745|FG000|PK Analysis Set|Part 1||24
2972819|NCT00809159|3687746|FG001|PK Analysis Set|Part 1||6
2972820|NCT00809159|3687747|FG002|PK Analysis Set|Part 1||0
2972821|NCT00809159|3687748|FG003|PK Analysis Set|Part 1||0
2972822|NCT00809159|3687749|FG004|PK Analysis Set|Part 1||0
2972823|NCT00809159|3687750|FG005|PK Analysis Set|Part 1||0
2972824|NCT00809159|3687745|FG000|PD Analysis Set|Part 1||23
2972825|NCT00809159|3687746|FG001|PD Analysis Set|Part 1||6
2972826|NCT00809159|3687747|FG002|PD Analysis Set|Part 1||0
2972827|NCT00809159|3687748|FG003|PD Analysis Set|Part 1||0
2972828|NCT00809159|3687749|FG004|PD Analysis Set|Part 1||0
2972829|NCT00809159|3687750|FG005|PD Analysis Set|Part 1||0
2972830|NCT00809159|3687745|FG000|COMPLETED|Part 1||16
2972831|NCT00809159|3687746|FG001|COMPLETED|Part 1||3
2972832|NCT00809159|3687747|FG002|COMPLETED|Part 1||0
2972833|NCT00809159|3687748|FG003|COMPLETED|Part 1||0
2972834|NCT00809159|3687749|FG004|COMPLETED|Part 1||0
2972835|NCT00809159|3687750|FG005|COMPLETED|Part 1||0
2972836|NCT00809159|3687745|FG000|NOT COMPLETED|Part 1||8
2972837|NCT00809159|3687746|FG001|NOT COMPLETED|Part 1||3
2972838|NCT00809159|3687747|FG002|NOT COMPLETED|Part 1||0
2972839|NCT00809159|3687748|FG003|NOT COMPLETED|Part 1||0
2972840|NCT00809159|3687749|FG004|NOT COMPLETED|Part 1||0
2972841|NCT00809159|3687750|FG005|NOT COMPLETED|Part 1||0
2972842|NCT00809159|3687745|FG000|STARTED|Part 1 and 2||0
2972843|NCT00809159|3687746|FG001|STARTED|Part 1 and 2||0
2972844|NCT00809159|3687747|FG002|STARTED|Part 1 and 2||30
2972845|NCT00809159|3687748|FG003|STARTED|Part 1 and 2||12
2972846|NCT00809159|3687749|FG004|STARTED|Part 1 and 2||12
2972847|NCT00809159|3687750|FG005|STARTED|Part 1 and 2||6
2972848|NCT00809159|3687745|FG000|PK Analysis Set|Part 1 and 2||0
2972849|NCT00809159|3687746|FG001|PK Analysis Set|Part 1 and 2||0
2972850|NCT00809159|3687747|FG002|PK Analysis Set|Part 1 and 2||30
2972851|NCT00809159|3687748|FG003|PK Analysis Set|Part 1 and 2||12
2972852|NCT00809159|3687749|FG004|PK Analysis Set|Part 1 and 2||12
2972853|NCT00809159|3687750|FG005|PK Analysis Set|Part 1 and 2||6
2972854|NCT00809159|3687745|FG000|PD Analysis Set|Part 1 and 2||0
2972855|NCT00809159|3687746|FG001|PD Analysis Set|Part 1 and 2||0
2972856|NCT00809159|3687747|FG002|PD Analysis Set|Part 1 and 2||28
2972857|NCT00809159|3687748|FG003|PD Analysis Set|Part 1 and 2||12
2972858|NCT00809159|3687749|FG004|PD Analysis Set|Part 1 and 2||12
2972859|NCT00809159|3687750|FG005|PD Analysis Set|Part 1 and 2||6
2972860|NCT00809159|3687745|FG000|COMPLETED|Part 1 and 2||0
2972861|NCT00809159|3687746|FG001|COMPLETED|Part 1 and 2||0
2972862|NCT00809159|3687747|FG002|COMPLETED|Part 1 and 2||20
2972863|NCT00809159|3687748|FG003|COMPLETED|Part 1 and 2||7
2972864|NCT00809159|3687749|FG004|COMPLETED|Part 1 and 2||6
2972865|NCT00809159|3687750|FG005|COMPLETED|Part 1 and 2||3
2972866|NCT00809159|3687745|FG000|NOT COMPLETED|Part 1 and 2||0
2972867|NCT00809159|3687746|FG001|NOT COMPLETED|Part 1 and 2||0
2972868|NCT00809159|3687747|FG002|NOT COMPLETED|Part 1 and 2||10
2972869|NCT00809159|3687748|FG003|NOT COMPLETED|Part 1 and 2||5
2972870|NCT00809159|3687749|FG004|NOT COMPLETED|Part 1 and 2||6
2972871|NCT00809159|3687750|FG005|NOT COMPLETED|Part 1 and 2||3
2972872|NCT00809185|3687764|FG000|STARTED|Overall Study||7
2972873|NCT00809185|3687764|FG000|COMPLETED|Overall Study||7
2972874|NCT00809185|3687764|FG000|NOT COMPLETED|Overall Study||0
2972875|NCT00809276|3687769|FG000|STARTED|Overall Study||92
2972876|NCT00809276|3687769|FG000|COMPLETED|Overall Study||92
2972877|NCT00809276|3687769|FG000|NOT COMPLETED|Overall Study||0
2972878|NCT00809328|3687773|FG000|STARTED|Overall Study||102
2972879|NCT00809328|3687773|FG000|COMPLETED|Overall Study||73
2972880|NCT00809328|3687773|FG000|NOT COMPLETED|Overall Study||29
2972881|NCT00809354|3687787|FG000|STARTED|Overall Study||288
2972882|NCT00809354|3687788|FG001|STARTED|Overall Study||289
2972883|NCT00809354|3687789|FG002|STARTED|Overall Study||286
2972884|NCT00809354|3687790|FG003|STARTED|Overall Study||288
2972885|NCT00809354|3687791|FG004|STARTED|Overall Study||288
2972886|NCT00809354|3687792|FG005|STARTED|Overall Study||256
2972887|NCT00809354|3687793|FG006|STARTED|Overall Study||255
2972888|NCT00809354|3687794|FG007|STARTED|Overall Study||257
2972889|NCT00809354|3687795|FG008|STARTED|Overall Study||256
2972890|NCT00809354|3687796|FG009|STARTED|Overall Study||257
2972891|NCT00809354|3687787|FG000|Treated|Overall Study||285
2972892|NCT00809354|3687788|FG001|Treated|Overall Study||288
2972893|NCT00809354|3687789|FG002|Treated|Overall Study||280
2972894|NCT00809354|3687790|FG003|Treated|Overall Study||288
2972895|NCT00809354|3687791|FG004|Treated|Overall Study||283
2972896|NCT00809354|3687792|FG005|Treated|Overall Study||256
2972897|NCT00809354|3687793|FG006|Treated|Overall Study||254
2972898|NCT00809354|3687794|FG007|Treated|Overall Study||256
2972899|NCT00809354|3687795|FG008|Treated|Overall Study||254
2972900|NCT00809354|3687796|FG009|Treated|Overall Study||256
2972901|NCT00809354|3687787|FG000|COMPLETED|Overall Study||33
2972902|NCT00809354|3687788|FG001|COMPLETED|Overall Study||31
2972903|NCT00809354|3687789|FG002|COMPLETED|Overall Study||32
2972904|NCT00809354|3687790|FG003|COMPLETED|Overall Study||32
2972905|NCT00809354|3687791|FG004|COMPLETED|Overall Study||32
2972906|NCT00809354|3687792|FG005|COMPLETED|Overall Study||31
2972907|NCT00809354|3687793|FG006|COMPLETED|Overall Study||32
2972908|NCT00809354|3687794|FG007|COMPLETED|Overall Study||19
3303138|NCT02963987|4036440|FG000|STARTED|Second Intervention Period||31
3303139|NCT02963987|4036441|FG001|STARTED|Second Intervention Period||19
3303140|NCT02963987|4036440|FG000|COMPLETED|Second Intervention Period||31
3303141|NCT02963987|4036441|FG001|COMPLETED|Second Intervention Period||19
3303142|NCT02963987|4036440|FG000|NOT COMPLETED|Second Intervention Period||0
2972909|NCT00809354|3687795|FG008|COMPLETED|Overall Study||28
2972910|NCT00809354|3687796|FG009|COMPLETED|Overall Study||31
2972911|NCT00809354|3687787|FG000|NOT COMPLETED|Overall Study||255
2972912|NCT00809354|3687788|FG001|NOT COMPLETED|Overall Study||258
2972913|NCT00809354|3687789|FG002|NOT COMPLETED|Overall Study||254
2972914|NCT00809354|3687790|FG003|NOT COMPLETED|Overall Study||256
2972915|NCT00809354|3687791|FG004|NOT COMPLETED|Overall Study||256
2972916|NCT00809354|3687792|FG005|NOT COMPLETED|Overall Study||225
2972917|NCT00809354|3687793|FG006|NOT COMPLETED|Overall Study||223
2972918|NCT00809354|3687794|FG007|NOT COMPLETED|Overall Study||238
2972919|NCT00809354|3687795|FG008|NOT COMPLETED|Overall Study||228
2972920|NCT00809354|3687796|FG009|NOT COMPLETED|Overall Study||226
2972921|NCT00809445|3687826|FG000|STARTED|1 Month Follow-up||429
2972922|NCT00809445|3687827|FG001|STARTED|1 Month Follow-up||433
2972923|NCT00809445|3687828|FG002|STARTED|1 Month Follow-up||419
2972924|NCT00809445|3687826|FG000|COMPLETED|1 Month Follow-up||427
2972925|NCT00809445|3687827|FG001|COMPLETED|1 Month Follow-up||429
2972926|NCT00809445|3687828|FG002|COMPLETED|1 Month Follow-up||415
2972927|NCT00809445|3687826|FG000|NOT COMPLETED|1 Month Follow-up||2
2972928|NCT00809445|3687827|FG001|NOT COMPLETED|1 Month Follow-up||4
2972929|NCT00809445|3687828|FG002|NOT COMPLETED|1 Month Follow-up||4
2972930|NCT00809445|3687826|FG000|STARTED|6 Month Follow-up||429
2972931|NCT00809445|3687827|FG001|STARTED|6 Month Follow-up||433
2972932|NCT00809445|3687828|FG002|STARTED|6 Month Follow-up||419
2972933|NCT00809445|3687826|FG000|COMPLETED|6 Month Follow-up||405
2972934|NCT00809445|3687827|FG001|COMPLETED|6 Month Follow-up||410
2972935|NCT00809445|3687828|FG002|COMPLETED|6 Month Follow-up||395
2972936|NCT00809445|3687826|FG000|NOT COMPLETED|6 Month Follow-up||24
2972937|NCT00809445|3687827|FG001|NOT COMPLETED|6 Month Follow-up||23
2972938|NCT00809445|3687828|FG002|NOT COMPLETED|6 Month Follow-up||24
2972939|NCT00809471|3687839|FG000|STARTED|Overall Study||130
2972940|NCT00809471|3687840|FG001|STARTED|Overall Study||129
2972941|NCT00809471|3687841|FG002|STARTED|Overall Study||131
2972942|NCT00809471|3687839|FG000|COMPLETED|Overall Study||110
2972943|NCT00809471|3687840|FG001|COMPLETED|Overall Study||109
2972944|NCT00809471|3687841|FG002|COMPLETED|Overall Study||114
2972945|NCT00809471|3687839|FG000|NOT COMPLETED|Overall Study||20
2972946|NCT00809471|3687840|FG001|NOT COMPLETED|Overall Study||20
2972947|NCT00809471|3687841|FG002|NOT COMPLETED|Overall Study||17
2972948|NCT00809523|3687851|FG000|STARTED|Overall Study||54
2972949|NCT00809523|3687852|FG001|STARTED|Overall Study||52
2972950|NCT00809523|3687851|FG000|COMPLETED|Overall Study||47
2972951|NCT00809523|3687852|FG001|COMPLETED|Overall Study||48
2972952|NCT00809523|3687851|FG000|NOT COMPLETED|Overall Study||7
2972953|NCT00809523|3687852|FG001|NOT COMPLETED|Overall Study||4
2972954|NCT00809614|3687860|FG000|STARTED|Overall Study||28
2972955|NCT00809614|3687861|FG001|STARTED|Overall Study||14
2972956|NCT00809614|3687860|FG000|Pharmacokinetic Safety Set|Overall Study||27
2972957|NCT00809614|3687861|FG001|Pharmacokinetic Safety Set|Overall Study||14
2972958|NCT00809614|3687860|FG000|Pharmacodynamic (PD) Set|Overall Study||24
2972959|NCT00809614|3687861|FG001|Pharmacodynamic (PD) Set|Overall Study||13
2972960|NCT00809614|3687860|FG000|COMPLETED|Overall Study||25
2972961|NCT00809614|3687861|FG001|COMPLETED|Overall Study||10
2972962|NCT00809614|3687860|FG000|NOT COMPLETED|Overall Study||3
2972963|NCT00809614|3687861|FG001|NOT COMPLETED|Overall Study||4
2972964|NCT00809757|3687870|FG000|STARTED|Overall Study||68
2972965|NCT00809757|3687871|FG001|STARTED|Overall Study||65
2972966|NCT00809757|3687872|FG002|STARTED|Overall Study||64
2972967|NCT00809757|3687870|FG000|COMPLETED|Overall Study||62
2972968|NCT00809757|3687871|FG001|COMPLETED|Overall Study||60
2972969|NCT00809757|3687872|FG002|COMPLETED|Overall Study||53
2972970|NCT00809757|3687870|FG000|NOT COMPLETED|Overall Study||6
2972971|NCT00809757|3687871|FG001|NOT COMPLETED|Overall Study||5
2972972|NCT00809757|3687872|FG002|NOT COMPLETED|Overall Study||11
2972973|NCT00809783|3687889|FG000|STARTED|Overall Study||525
2972974|NCT00809783|3687890|FG001|STARTED|Overall Study||832
2972975|NCT00809783|3687891|FG002|STARTED|Overall Study||790
2972976|NCT00809783|3687889|FG000|Treated|Overall Study||522
2972977|NCT00809783|3687890|FG001|Treated|Overall Study||832
2972978|NCT00809783|3687891|FG002|Treated|Overall Study||788
2972979|NCT00809783|3687889|FG000|COMPLETED|Overall Study||0
2972980|NCT00809783|3687890|FG001|COMPLETED|Overall Study||0
2972981|NCT00809783|3687891|FG002|COMPLETED|Overall Study||0
2972982|NCT00809783|3687889|FG000|NOT COMPLETED|Overall Study||525
2972983|NCT00809783|3687890|FG001|NOT COMPLETED|Overall Study||832
2972984|NCT00809783|3687891|FG002|NOT COMPLETED|Overall Study||790
3133273|NCT01695239|3858315|FG010|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
3133274|NCT01695239|3858316|FG011|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
3133275|NCT01695239|3858317|FG012|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
3133276|NCT01695239|3858318|FG013|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
2972985|NCT00809809|3687901|FG000|STARTED|Overall Study||78
2972986|NCT00809809|3687902|FG001|STARTED|Overall Study||79
2972987|NCT00809809|3687901|FG000|COMPLETED|Overall Study|3 dropped from the study when it was discovered they met the exclusion criteria|75
2972988|NCT00809809|3687902|FG001|COMPLETED|Overall Study|2 dropped from the study when it was discovered they met the exclusion criteria|77
2972989|NCT00809809|3687901|FG000|NOT COMPLETED|Overall Study||3
2972990|NCT00809809|3687902|FG001|NOT COMPLETED|Overall Study||2
2972991|NCT00809835|3687912|FG000|STARTED|Overall Study||28
2972992|NCT00809835|3687913|FG001|STARTED|Overall Study||27
2972993|NCT00809835|3687914|FG002|STARTED|Overall Study||38
2972994|NCT00809835|3687915|FG003|STARTED|Overall Study||27
2972995|NCT00809835|3687912|FG000|COMPLETED|Overall Study||20
2972996|NCT00809835|3687913|FG001|COMPLETED|Overall Study||20
2972997|NCT00809835|3687914|FG002|COMPLETED|Overall Study||27
2972998|NCT00809835|3687915|FG003|COMPLETED|Overall Study||25
2972999|NCT00809835|3687912|FG000|NOT COMPLETED|Overall Study||8
2973000|NCT00809835|3687913|FG001|NOT COMPLETED|Overall Study||7
2973001|NCT00809835|3687914|FG002|NOT COMPLETED|Overall Study||11
2973002|NCT00809835|3687915|FG003|NOT COMPLETED|Overall Study||2
2973003|NCT00809848|3687930|FG000|STARTED|Overall Study||36
2973004|NCT00809848|3687931|FG001|STARTED|Overall Study||34
2973005|NCT00809848|3687932|FG002|STARTED|Overall Study||34
2973006|NCT00809848|3687933|FG003|STARTED|Overall Study||31
2973007|NCT00809848|3687934|FG004|STARTED|Overall Study||37
2973008|NCT00809848|3687930|FG000|COMPLETED|Overall Study||36
2973009|NCT00809848|3687931|FG001|COMPLETED|Overall Study||34
2973010|NCT00809848|3687932|FG002|COMPLETED|Overall Study||34
2973011|NCT00809848|3687933|FG003|COMPLETED|Overall Study||30
2973012|NCT00809848|3687934|FG004|COMPLETED|Overall Study||34
2973013|NCT00809848|3687930|FG000|NOT COMPLETED|Overall Study||0
2973014|NCT00809848|3687931|FG001|NOT COMPLETED|Overall Study||0
2973015|NCT00809848|3687932|FG002|NOT COMPLETED|Overall Study||0
2973016|NCT00809848|3687933|FG003|NOT COMPLETED|Overall Study||1
2973017|NCT00809848|3687934|FG004|NOT COMPLETED|Overall Study||3
2973018|NCT00809926|3687949|FG000|STARTED|Overall Study||232
2973019|NCT00809926|3687950|FG001|STARTED|Overall Study||219
2973020|NCT00809926|3687949|FG000|COMPLETED|Overall Study||201
2973021|NCT00809926|3687950|FG001|COMPLETED|Overall Study||196
2973022|NCT00809926|3687949|FG000|NOT COMPLETED|Overall Study||31
2973023|NCT00809926|3687950|FG001|NOT COMPLETED|Overall Study||23
2973024|NCT00809965|3687959|FG000|STARTED|Overall Study||5176
2973025|NCT00809965|3687960|FG001|STARTED|Overall Study||5174
2973026|NCT00809965|3687961|FG002|STARTED|Overall Study||5176
2973027|NCT00809965|3687959|FG000|Treated/Safety Population|Overall Study|All randomized participants who received at least one dose of study drug|5125
2973028|NCT00809965|3687960|FG001|Treated/Safety Population|Overall Study|All randomized participants who received at least one dose of study drug|5115
2973029|NCT00809965|3687961|FG002|Treated/Safety Population|Overall Study|All randomized participants who received at least one dose of study drug|5110
2973030|NCT00809965|3687959|FG000|Modified Intent-to-Treat Population|Overall Study|All randomized participants excluding 3 sites without regard to treatment exposure|5113
2973031|NCT00809965|3687960|FG001|Modified Intent-to-Treat Population|Overall Study|All randomized participants excluding 3 sites without regard to treatment exposure|5114
2973032|NCT00809965|3687961|FG002|Modified Intent-to-Treat Population|Overall Study|All randomized participants excluding 3 sites without regard to treatment exposure|5115
2973033|NCT00809965|3687959|FG000|COMPLETED|Overall Study||4393
2973034|NCT00809965|3687960|FG001|COMPLETED|Overall Study||4399
2973035|NCT00809965|3687961|FG002|COMPLETED|Overall Study||4332
2973036|NCT00809965|3687959|FG000|NOT COMPLETED|Overall Study||783
2973037|NCT00809965|3687960|FG001|NOT COMPLETED|Overall Study||775
2973038|NCT00809965|3687961|FG002|NOT COMPLETED|Overall Study||844
2973039|NCT00810043|3687971|FG000|STARTED|Overall Study||57
2973040|NCT00810043|3687972|FG001|STARTED|Overall Study||55
2973041|NCT00810043|3687973|FG002|STARTED|Overall Study||8
2973042|NCT00810043|3687971|FG000|COMPLETED|Overall Study||53
2973043|NCT00810043|3687972|FG001|COMPLETED|Overall Study||54
2973044|NCT00810043|3687973|FG002|COMPLETED|Overall Study||0
2973045|NCT00810043|3687971|FG000|NOT COMPLETED|Overall Study||4
2973046|NCT00810043|3687972|FG001|NOT COMPLETED|Overall Study||1
2973047|NCT00810043|3687973|FG002|NOT COMPLETED|Overall Study||8
2973048|NCT00810069|3687984|FG000|STARTED|Lead-in Period I||840
2973049|NCT00810069|3687985|FG001|STARTED|Lead-in Period I||0
2973050|NCT00810069|3687986|FG002|STARTED|Lead-in Period I||0
2973051|NCT00810069|3687984|FG000|COMPLETED|Lead-in Period I||566
2973052|NCT00810069|3687985|FG001|COMPLETED|Lead-in Period I||0
2973053|NCT00810069|3687986|FG002|COMPLETED|Lead-in Period I||0
2973054|NCT00810069|3687984|FG000|NOT COMPLETED|Lead-in Period I||274
2973055|NCT00810069|3687985|FG001|NOT COMPLETED|Lead-in Period I||0
2973056|NCT00810069|3687986|FG002|NOT COMPLETED|Lead-in Period I||0
2973057|NCT00810069|3687984|FG000|STARTED|Double-Blind Period II||0
2973058|NCT00810069|3687985|FG001|STARTED|Double-Blind Period II||282
2973059|NCT00810069|3687986|FG002|STARTED|Double-Blind Period II|At Week 8 - delayed intervention divided by response to treatment (nonresponders or responders).|284
2973060|NCT00810069|3687984|FG000|COMPLETED|Double-Blind Period II||0
2973061|NCT00810069|3687985|FG001|COMPLETED|Double-Blind Period II||226
2973062|NCT00810069|3687986|FG002|COMPLETED|Double-Blind Period II||212
2973063|NCT00810069|3687984|FG000|NOT COMPLETED|Double-Blind Period II||0
2973064|NCT00810069|3687985|FG001|NOT COMPLETED|Double-Blind Period II||56
2973065|NCT00810069|3687986|FG002|NOT COMPLETED|Double-Blind Period II||72
2973066|NCT00810082|3687997|FG000|STARTED|Overall Study||34
2973067|NCT00810082|3687998|FG001|STARTED|Overall Study||31
2973068|NCT00810082|3687997|FG000|COMPLETED|Overall Study||34
2973069|NCT00810082|3687998|FG001|COMPLETED|Overall Study||27
2973070|NCT00810082|3687997|FG000|NOT COMPLETED|Overall Study||0
2973071|NCT00810082|3687998|FG001|NOT COMPLETED|Overall Study||4
2973072|NCT00810095|3688004|FG000|STARTED|Overall Study||40
2973073|NCT00810095|3688004|FG000|COMPLETED|Overall Study||40
2973074|NCT00810095|3688004|FG000|NOT COMPLETED|Overall Study||0
2973075|NCT00810108|3688010|FG000|STARTED|Overall Study||6
2973076|NCT00810108|3688011|FG001|STARTED|Overall Study||7
2973077|NCT00810108|3688010|FG000|COMPLETED|Overall Study||5
2973078|NCT00810108|3688011|FG001|COMPLETED|Overall Study||7
2973079|NCT00810108|3688010|FG000|NOT COMPLETED|Overall Study||1
2973080|NCT00810108|3688011|FG001|NOT COMPLETED|Overall Study||0
2973081|NCT00810199|3688018|FG000|STARTED|Overall Study||279
2973082|NCT00810199|3688019|FG001|STARTED|Overall Study||277
2973083|NCT00810199|3688018|FG000|Received Study Drug|Overall Study||277
2973084|NCT00810199|3688019|FG001|Received Study Drug|Overall Study||276
2973085|NCT00810199|3688018|FG000|Completed Week 24|Overall Study||259
2973086|NCT00810199|3688019|FG001|Completed Week 24|Overall Study||250
2973087|NCT00810199|3688018|FG000|Completed Week 52|Overall Study||243
2973088|NCT00810199|3688019|FG001|Completed Week 52|Overall Study||229
2973089|NCT00810199|3688018|FG000|Completed Week 104|Overall Study||222
2973090|NCT00810199|3688019|FG001|Completed Week 104|Overall Study||201
2973091|NCT00810199|3688018|FG000|COMPLETED|Overall Study||220
2973092|NCT00810199|3688019|FG001|COMPLETED|Overall Study|Completed=Completed Treatment|195
2973093|NCT00810199|3688018|FG000|NOT COMPLETED|Overall Study||59
2973094|NCT00810199|3688019|FG001|NOT COMPLETED|Overall Study||82
2973095|NCT00810264|3688031|FG000|STARTED|Overall Study||2499
2973096|NCT00810264|3688031|FG000|COMPLETED|Overall Study||946
2973097|NCT00810264|3688031|FG000|NOT COMPLETED|Overall Study||1553
3303143|NCT02963987|4036441|FG001|NOT COMPLETED|Second Intervention Period||0
3303144|NCT02964234|4036451|FG000|STARTED|Overall Study||76
3303145|NCT02964234|4036452|FG001|STARTED|Overall Study||69
2973098|NCT00810277|3688039|FG000|STARTED|Overall Study||14
2973099|NCT00810277|3688039|FG000|COMPLETED|Overall Study||13
2973100|NCT00810277|3688039|FG000|NOT COMPLETED|Overall Study||1
2973101|NCT00810303|3688043|FG000|STARTED|Efavirenz Alone - Day 1-5||12
2973102|NCT00810303|3688043|FG000|COMPLETED|Efavirenz Alone - Day 1-5||12
2973103|NCT00810303|3688043|FG000|NOT COMPLETED|Efavirenz Alone - Day 1-5||0
2973104|NCT00810303|3688043|FG000|STARTED|Ezetimibe Alone - Day 6-15||12
2973105|NCT00810303|3688043|FG000|COMPLETED|Ezetimibe Alone - Day 6-15||12
2973106|NCT00810303|3688043|FG000|NOT COMPLETED|Ezetimibe Alone - Day 6-15||0
3133277|NCT01695239|3858305|FG000|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
2973107|NCT00810303|3688043|FG000|STARTED|Ezetimibe and Efavirenz - Day 16-20||12
2973108|NCT00810303|3688043|FG000|COMPLETED|Ezetimibe and Efavirenz - Day 16-20||12
2973109|NCT00810303|3688043|FG000|NOT COMPLETED|Ezetimibe and Efavirenz - Day 16-20||0
2973110|NCT00810303|3688043|FG000|STARTED|Ezetimibe and Efavirenz - Day 21-30||12
2973111|NCT00810303|3688043|FG000|COMPLETED|Ezetimibe and Efavirenz - Day 21-30||12
2973112|NCT00810303|3688043|FG000|NOT COMPLETED|Ezetimibe and Efavirenz - Day 21-30||0
2973113|NCT00810342|3688053|FG000|STARTED|Month 1 Follow-up||154
2973114|NCT00810342|3688054|FG001|STARTED|Month 1 Follow-up||157
2973115|NCT00810342|3688053|FG000|COMPLETED|Month 1 Follow-up||149
2973116|NCT00810342|3688054|FG001|COMPLETED|Month 1 Follow-up||155
2973117|NCT00810342|3688053|FG000|NOT COMPLETED|Month 1 Follow-up||5
2973118|NCT00810342|3688054|FG001|NOT COMPLETED|Month 1 Follow-up||2
2973119|NCT00810342|3688053|FG000|STARTED|6-month Follow-up||149
2973120|NCT00810342|3688054|FG001|STARTED|6-month Follow-up||155
2973121|NCT00810342|3688053|FG000|COMPLETED|6-month Follow-up||125
2973122|NCT00810342|3688054|FG001|COMPLETED|6-month Follow-up||147
2973123|NCT00810342|3688053|FG000|NOT COMPLETED|6-month Follow-up||24
2973124|NCT00810342|3688054|FG001|NOT COMPLETED|6-month Follow-up||8
2973125|NCT00810342|3688053|FG000|STARTED|12-month Followup||125
2973126|NCT00810342|3688054|FG001|STARTED|12-month Followup||147
2973127|NCT00810342|3688053|FG000|COMPLETED|12-month Followup||113
2973128|NCT00810342|3688054|FG001|COMPLETED|12-month Followup||136
2973129|NCT00810342|3688053|FG000|NOT COMPLETED|12-month Followup||12
2973130|NCT00810342|3688054|FG001|NOT COMPLETED|12-month Followup||11
2973131|NCT00810355|3688065|FG000|STARTED|Overall Study||25
2973132|NCT00810355|3688066|FG001|STARTED|Overall Study||25
2973133|NCT00810355|3688067|FG002|STARTED|Overall Study||25
2973134|NCT00810355|3688065|FG000|COMPLETED|Overall Study||11
2973135|NCT00810355|3688066|FG001|COMPLETED|Overall Study||8
2973136|NCT00810355|3688067|FG002|COMPLETED|Overall Study||14
2973137|NCT00810355|3688065|FG000|NOT COMPLETED|Overall Study||14
2973138|NCT00810355|3688066|FG001|NOT COMPLETED|Overall Study||17
2973139|NCT00810355|3688067|FG002|NOT COMPLETED|Overall Study||11
2973140|NCT00810368|3688077|FG000|STARTED|Overall Study||18
2973141|NCT00810368|3688078|FG001|STARTED|Overall Study||15
2973142|NCT00810368|3688077|FG000|COMPLETED|Overall Study||12
2973143|NCT00810368|3688078|FG001|COMPLETED|Overall Study||13
2973144|NCT00810368|3688077|FG000|NOT COMPLETED|Overall Study||6
2973145|NCT00810368|3688078|FG001|NOT COMPLETED|Overall Study||2
2973146|NCT00810394|3688086|FG000|STARTED|Overall Study||50
2973147|NCT00810394|3688086|FG000|Cycle 2 600mg Twice Daily|Overall Study||13
2973148|NCT00810394|3688086|FG000|Cycle 2 400mg Once Daily|Overall Study||22
2973149|NCT00810394|3688086|FG000|Cycle 3 800 mg Twice Daily|Overall Study||4
2973150|NCT00810394|3688086|FG000|Cycle 3 400mg Twice Daily|Overall Study||5
2973151|NCT00810394|3688086|FG000|COMPLETED|Overall Study||47
2973152|NCT00810394|3688086|FG000|NOT COMPLETED|Overall Study||3
2973153|NCT00810407|3688090|FG000|STARTED|Overall Study||594
2973154|NCT00810407|3688090|FG000|COMPLETED|Overall Study||588
2973155|NCT00810407|3688090|FG000|NOT COMPLETED|Overall Study||6
2973156|NCT00810459|3688094|FG000|STARTED|Overall Study||4
2973157|NCT00810459|3688095|FG001|STARTED|Overall Study||2
2973158|NCT00810459|3688094|FG000|COMPLETED|Overall Study||4
2973159|NCT00810459|3688095|FG001|COMPLETED|Overall Study||2
2973160|NCT00810459|3688094|FG000|NOT COMPLETED|Overall Study||0
2973161|NCT00810459|3688095|FG001|NOT COMPLETED|Overall Study||0
2973162|NCT00810498|3688102|FG000|STARTED|Overall Study||6
2973163|NCT00810498|3688103|FG001|STARTED|Overall Study||5
2973164|NCT00810498|3688102|FG000|COMPLETED|Overall Study||6
2973165|NCT00810498|3688103|FG001|COMPLETED|Overall Study||5
2973166|NCT00810498|3688102|FG000|NOT COMPLETED|Overall Study||0
2973167|NCT00810498|3688103|FG001|NOT COMPLETED|Overall Study||0
2973168|NCT00810511|3688111|FG000|STARTED|Overall Study||107
2973169|NCT00810511|3688112|FG001|STARTED|Overall Study||106
2973170|NCT00810511|3688111|FG000|COMPLETED|Overall Study||97
2973171|NCT00810511|3688112|FG001|COMPLETED|Overall Study||102
2973172|NCT00810511|3688111|FG000|NOT COMPLETED|Overall Study||10
2973173|NCT00810511|3688112|FG001|NOT COMPLETED|Overall Study||4
2973174|NCT00810576|3688118|FG000|STARTED|Overall Study||1
2973175|NCT00810576|3688118|FG000|COMPLETED|Overall Study||1
2973176|NCT00810576|3688118|FG000|NOT COMPLETED|Overall Study||0
2973177|NCT00810602|3688122|FG000|STARTED|Overall Study||27
2973178|NCT00810602|3688123|FG001|STARTED|Overall Study||34
2973179|NCT00810602|3688122|FG000|COMPLETED|Overall Study||19
2973180|NCT00810602|3688123|FG001|COMPLETED|Overall Study||31
2973181|NCT00810602|3688122|FG000|NOT COMPLETED|Overall Study||8
2973182|NCT00810602|3688123|FG001|NOT COMPLETED|Overall Study||3
2973183|NCT00810615|3688129|FG000|STARTED|Overall Study||25
2973184|NCT00810615|3688130|FG001|STARTED|Overall Study||25
2973185|NCT00810615|3688129|FG000|COMPLETED|Overall Study|One male withdrawal due to personal reasons.|24
2973186|NCT00810615|3688130|FG001|COMPLETED|Overall Study|One male withdrawal due to personal reasons.|24
2973187|NCT00810615|3688129|FG000|NOT COMPLETED|Overall Study||1
2973188|NCT00810615|3688130|FG001|NOT COMPLETED|Overall Study||1
2973189|NCT00810641|3688151|FG000|STARTED|Overall Study||52
2973190|NCT00810641|3688152|FG001|STARTED|Overall Study||54
2973191|NCT00810641|3688153|FG002|STARTED|Overall Study||51
2973192|NCT00810641|3688151|FG000|COMPLETED|Overall Study||52
2973193|NCT00810641|3688152|FG001|COMPLETED|Overall Study||53
2973194|NCT00810641|3688153|FG002|COMPLETED|Overall Study||49
2973195|NCT00810641|3688151|FG000|NOT COMPLETED|Overall Study||0
2973196|NCT00810641|3688152|FG001|NOT COMPLETED|Overall Study||1
2973197|NCT00810641|3688153|FG002|NOT COMPLETED|Overall Study||2
2973198|NCT00810693|3688164|FG000|STARTED|Treatment Period||254
2973199|NCT00810693|3688165|FG001|STARTED|Treatment Period|1 randomized but not treated|64
2973200|NCT00810693|3688166|FG002|STARTED|Treatment Period|1 randomized but not treated|127
2973201|NCT00810693|3688164|FG000|Participants Received Treatment|Treatment Period||254
2973202|NCT00810693|3688165|FG001|Participants Received Treatment|Treatment Period||63
2973203|NCT00810693|3688166|FG002|Participants Received Treatment|Treatment Period||126
2973204|NCT00810693|3688164|FG000|COMPLETED|Treatment Period||237
2973205|NCT00810693|3688165|FG001|COMPLETED|Treatment Period||57
2973206|NCT00810693|3688166|FG002|COMPLETED|Treatment Period||111
2973207|NCT00810693|3688164|FG000|NOT COMPLETED|Treatment Period||17
2973208|NCT00810693|3688165|FG001|NOT COMPLETED|Treatment Period||7
2973209|NCT00810693|3688166|FG002|NOT COMPLETED|Treatment Period||16
2973210|NCT00810693|3688164|FG000|STARTED|Follow-up Period (FUP)|Started FUP only if prematurely withdrawn from trt period or if not entering LTE study.|23
2973211|NCT00810693|3688165|FG001|STARTED|Follow-up Period (FUP)|Started FUP only if prematurely withdrawn from trt period or if not entering LTE study.|7
2973212|NCT00810693|3688166|FG002|STARTED|Follow-up Period (FUP)|Started FUP only if prematurely withdrawn from trt period or if not entering LTE study.|16
2973213|NCT00810693|3688164|FG000|COMPLETED|Follow-up Period (FUP)||15
2973214|NCT00810693|3688165|FG001|COMPLETED|Follow-up Period (FUP)||4
2973215|NCT00810693|3688166|FG002|COMPLETED|Follow-up Period (FUP)||12
2973216|NCT00810693|3688164|FG000|NOT COMPLETED|Follow-up Period (FUP)||8
2973217|NCT00810693|3688165|FG001|NOT COMPLETED|Follow-up Period (FUP)||3
2973218|NCT00810693|3688166|FG002|NOT COMPLETED|Follow-up Period (FUP)||4
2973219|NCT00810719|3688174|FG000|STARTED|Overall Study||30
2973220|NCT00810719|3688174|FG000|COMPLETED|Overall Study||30
2973221|NCT00810719|3688174|FG000|NOT COMPLETED|Overall Study||0
2973222|NCT00810771|3688181|FG000|STARTED|Overall Study||232
2973223|NCT00810771|3688182|FG001|STARTED|Overall Study||234
2973224|NCT00810771|3688183|FG002|STARTED|Overall Study||84
2973225|NCT00810771|3688181|FG000|COMPLETED|Overall Study||232
2973226|NCT00810771|3688182|FG001|COMPLETED|Overall Study||234
2973227|NCT00810771|3688183|FG002|COMPLETED|Overall Study||84
2973228|NCT00810771|3688181|FG000|NOT COMPLETED|Overall Study||0
2973229|NCT00810771|3688182|FG001|NOT COMPLETED|Overall Study||0
2973230|NCT00810771|3688183|FG002|NOT COMPLETED|Overall Study||0
2973231|NCT00810797|3688193|FG000|STARTED|Overall Study||36
2973232|NCT00810797|3688193|FG000|COMPLETED|Overall Study||36
2973233|NCT00810797|3688193|FG000|NOT COMPLETED|Overall Study||0
2973234|NCT00810810|3688201|FG000|STARTED|Overall Study||124
2973235|NCT00810810|3688202|FG001|STARTED|Overall Study||49
2973236|NCT00810810|3688203|FG002|STARTED|Overall Study||56
2973237|NCT00810810|3688204|FG003|STARTED|Overall Study||51
2973238|NCT00810810|3688201|FG000|COMPLETED|Overall Study||124
2973239|NCT00810810|3688202|FG001|COMPLETED|Overall Study||38
2973240|NCT00810810|3688203|FG002|COMPLETED|Overall Study||45
2973241|NCT00810810|3688204|FG003|COMPLETED|Overall Study||38
2973242|NCT00810810|3688201|FG000|NOT COMPLETED|Overall Study||0
2973243|NCT00810810|3688202|FG001|NOT COMPLETED|Overall Study||11
2973244|NCT00810810|3688203|FG002|NOT COMPLETED|Overall Study||11
2973245|NCT00810810|3688204|FG003|NOT COMPLETED|Overall Study||13
2973246|NCT00810888|3688217|FG000|STARTED|Overall Study||10
2973247|NCT00810888|3688218|FG001|STARTED|Overall Study||9
2973248|NCT00810888|3688219|FG002|STARTED|Overall Study||73
2973249|NCT00810888|3688217|FG000|COMPLETED|Overall Study||10
2973250|NCT00810888|3688218|FG001|COMPLETED|Overall Study||9
2973251|NCT00810888|3688219|FG002|COMPLETED|Overall Study||73
2973252|NCT00810888|3688217|FG000|NOT COMPLETED|Overall Study||0
2973253|NCT00810888|3688218|FG001|NOT COMPLETED|Overall Study||0
2973254|NCT00810888|3688219|FG002|NOT COMPLETED|Overall Study||0
2973255|NCT00810901|3688229|FG000|STARTED|Overall Study||253
2973256|NCT00810901|3688230|FG001|STARTED|Overall Study||176
2973257|NCT00810901|3688229|FG000|1-month Follow up|Overall Study||242
2973258|NCT00810901|3688230|FG001|1-month Follow up|Overall Study||146
2973259|NCT00810901|3688229|FG000|6-month Follow-up|Overall Study||181
2973260|NCT00810901|3688230|FG001|6-month Follow-up|Overall Study||122
2973261|NCT00810901|3688229|FG000|COMPLETED|Overall Study||165
2973262|NCT00810901|3688230|FG001|COMPLETED|Overall Study||118
2973263|NCT00810901|3688229|FG000|NOT COMPLETED|Overall Study||88
2973264|NCT00810901|3688230|FG001|NOT COMPLETED|Overall Study||58
2973265|NCT00811018|3688236|FG000|STARTED|Overall Study||1192
2973266|NCT00811018|3688236|FG000|COMPLETED|Overall Study||224
2973267|NCT00811018|3688236|FG000|NOT COMPLETED|Overall Study||968
2973268|NCT00811057|3688243|FG000|STARTED|Overall Study||90
2973269|NCT00811057|3688244|FG001|STARTED|Overall Study||114
2973270|NCT00811057|3688245|FG002|STARTED|Overall Study||97
2973271|NCT00811057|3688243|FG000|COMPLETED|Overall Study||85
2973272|NCT00811057|3688244|FG001|COMPLETED|Overall Study||104
2973273|NCT00811057|3688245|FG002|COMPLETED|Overall Study||87
2973274|NCT00811057|3688243|FG000|NOT COMPLETED|Overall Study||5
2973275|NCT00811057|3688244|FG001|NOT COMPLETED|Overall Study||10
2973276|NCT00811057|3688245|FG002|NOT COMPLETED|Overall Study||10
2973277|NCT00811070|3688259|FG000|STARTED|Overall Study||7
2973278|NCT00811070|3688260|FG001|STARTED|Overall Study||7
2973279|NCT00811070|3688261|FG002|STARTED|Overall Study||3
2973280|NCT00811070|3688262|FG003|STARTED|Overall Study||28
2973281|NCT00811070|3688263|FG004|STARTED|Overall Study||7
2973282|NCT00811070|3688264|FG005|STARTED|Overall Study||11
2973283|NCT00811070|3688259|FG000|COMPLETED|Overall Study||6
2973284|NCT00811070|3688260|FG001|COMPLETED|Overall Study||6
2973285|NCT00811070|3688261|FG002|COMPLETED|Overall Study||3
2973286|NCT00811070|3688262|FG003|COMPLETED|Overall Study||26
2973287|NCT00811070|3688263|FG004|COMPLETED|Overall Study||2
2973288|NCT00811070|3688264|FG005|COMPLETED|Overall Study||10
2973289|NCT00811070|3688259|FG000|NOT COMPLETED|Overall Study||1
2973290|NCT00811070|3688260|FG001|NOT COMPLETED|Overall Study||1
2973291|NCT00811070|3688261|FG002|NOT COMPLETED|Overall Study||0
2973292|NCT00811070|3688262|FG003|NOT COMPLETED|Overall Study||2
2973293|NCT00811070|3688263|FG004|NOT COMPLETED|Overall Study||5
2973294|NCT00811070|3688264|FG005|NOT COMPLETED|Overall Study||1
2973295|NCT00811135|3688280|FG000|STARTED|Overall Study||88
2973296|NCT00811135|3688280|FG000|COMPLETED|Overall Study||0
2973297|NCT00811135|3688280|FG000|NOT COMPLETED|Overall Study||88
2973298|NCT00811174|3688284|FG000|STARTED|Overall Study||5
2973299|NCT00811174|3688284|FG000|COMPLETED|Overall Study||2
2973300|NCT00811174|3688284|FG000|NOT COMPLETED|Overall Study||3
2973301|NCT00811187|3688290|FG000|STARTED|Overall Study||40
2973302|NCT00811187|3688291|FG001|STARTED|Overall Study||40
2973303|NCT00811187|3688290|FG000|COMPLETED|Overall Study||37
2973304|NCT00811187|3688291|FG001|COMPLETED|Overall Study||37
2973305|NCT00811187|3688290|FG000|NOT COMPLETED|Overall Study||3
2973306|NCT00811187|3688291|FG001|NOT COMPLETED|Overall Study||3
2973307|NCT00811252|3688300|FG000|STARTED|Overall Study||145
2973308|NCT00811252|3688301|FG001|STARTED|Overall Study||156
2973309|NCT00811252|3688302|FG002|STARTED|Overall Study||151
2973310|NCT00811252|3688300|FG000|COMPLETED|Overall Study||128
2973311|NCT00811252|3688301|FG001|COMPLETED|Overall Study||136
2973312|NCT00811252|3688302|FG002|COMPLETED|Overall Study||128
2973313|NCT00811252|3688300|FG000|NOT COMPLETED|Overall Study||17
2973314|NCT00811252|3688301|FG001|NOT COMPLETED|Overall Study||20
2973315|NCT00811252|3688302|FG002|NOT COMPLETED|Overall Study||23
2973316|NCT00811317|3688310|FG000|STARTED|Overall Study||11
2973317|NCT00811317|3688310|FG000|COMPLETED|Overall Study||11
2973318|NCT00811317|3688310|FG000|NOT COMPLETED|Overall Study||0
2973319|NCT00811382|3688316|FG000|STARTED|Overall Study||88
2973320|NCT00811382|3688317|FG001|STARTED|Overall Study||75
2973321|NCT00811382|3688316|FG000|COMPLETED|Overall Study||88
2973322|NCT00811382|3688317|FG001|COMPLETED|Overall Study||75
2973323|NCT00811382|3688316|FG000|NOT COMPLETED|Overall Study||0
2973324|NCT00811382|3688317|FG001|NOT COMPLETED|Overall Study||0
2973325|NCT00811395|3688331|FG000|STARTED|Initial Treatment (PDY6045 or PDY6046)||41
2973326|NCT00811395|3688332|FG001|STARTED|Initial Treatment (PDY6045 or PDY6046)|One participant received 7 mg instead of 14 mg as per randomization|37
2973327|NCT00811395|3688333|FG002|STARTED|Initial Treatment (PDY6045 or PDY6046)||38
2973328|NCT00811395|3688334|FG003|STARTED|Initial Treatment (PDY6045 or PDY6046)||40
2973329|NCT00811395|3688335|FG004|STARTED|Initial Treatment (PDY6045 or PDY6046)||42
2973330|NCT00811395|3688336|FG005|STARTED|Initial Treatment (PDY6045 or PDY6046)||41
2973331|NCT00811395|3688331|FG000|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6045/NCT00489489 record)|38
2973332|NCT00811395|3688332|FG001|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6045/NCT00489489 record)|33
2973333|NCT00811395|3688333|FG002|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6045/NCT00489489 record)|36
2973334|NCT00811395|3688334|FG003|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6046/NCT00475865 record)|38
2973335|NCT00811395|3688335|FG004|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6046/NCT00475865 record)|37
2973336|NCT00811395|3688336|FG005|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6046/NCT00475865 record)|35
2973337|NCT00811395|3688331|FG000|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||3
2973338|NCT00811395|3688332|FG001|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||4
2973339|NCT00811395|3688333|FG002|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||2
2973340|NCT00811395|3688334|FG003|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||2
2973341|NCT00811395|3688335|FG004|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||5
2973342|NCT00811395|3688336|FG005|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||6
2973343|NCT00811395|3688331|FG000|STARTED|Extension Treatment|continued initial treatment|31
2973344|NCT00811395|3688332|FG001|STARTED|Extension Treatment|continued initial treatment|28
2973345|NCT00811395|3688333|FG002|STARTED|Extension Treatment|continued initial treatment|27
2973346|NCT00811395|3688334|FG003|STARTED|Extension Treatment|continued initial treatment|37
2973347|NCT00811395|3688335|FG004|STARTED|Extension Treatment|continued initial treatment|30
2973348|NCT00811395|3688336|FG005|STARTED|Extension Treatment|continued initial treatment|29
2973349|NCT00811395|3688331|FG000|COMPLETED|Extension Treatment|completed 48-week treatment|29
2973350|NCT00811395|3688332|FG001|COMPLETED|Extension Treatment|completed 48-week treatment|22
2973351|NCT00811395|3688333|FG002|COMPLETED|Extension Treatment|completed 48-week treatment|24
2973352|NCT00811395|3688334|FG003|COMPLETED|Extension Treatment|completed 48-week treatment|34
2973353|NCT00811395|3688335|FG004|COMPLETED|Extension Treatment|completed 48-week treatment|30
2973354|NCT00811395|3688336|FG005|COMPLETED|Extension Treatment|completed 48-week treatment|27
2973355|NCT00811395|3688331|FG000|NOT COMPLETED|Extension Treatment||2
2973356|NCT00811395|3688332|FG001|NOT COMPLETED|Extension Treatment||6
2973357|NCT00811395|3688333|FG002|NOT COMPLETED|Extension Treatment||3
2973358|NCT00811395|3688334|FG003|NOT COMPLETED|Extension Treatment||3
2973359|NCT00811395|3688335|FG004|NOT COMPLETED|Extension Treatment||0
2973360|NCT00811395|3688336|FG005|NOT COMPLETED|Extension Treatment||2
2973361|NCT00811434|3688353|FG000|STARTED|First Intervention||7
2973362|NCT00811434|3688354|FG001|STARTED|First Intervention||5
2973363|NCT00811434|3688353|FG000|COMPLETED|First Intervention||4
2973364|NCT00811434|3688354|FG001|COMPLETED|First Intervention||5
2973365|NCT00811434|3688353|FG000|NOT COMPLETED|First Intervention||3
2973366|NCT00811434|3688354|FG001|NOT COMPLETED|First Intervention||0
2973367|NCT00811434|3688353|FG000|STARTED|Washout (1 Month)||4
2973368|NCT00811434|3688354|FG001|STARTED|Washout (1 Month)||5
2973369|NCT00811434|3688353|FG000|COMPLETED|Washout (1 Month)||4
2973370|NCT00811434|3688354|FG001|COMPLETED|Washout (1 Month)||5
2973371|NCT00811434|3688353|FG000|NOT COMPLETED|Washout (1 Month)||0
2973372|NCT00811434|3688354|FG001|NOT COMPLETED|Washout (1 Month)||0
2973373|NCT00811434|3688353|FG000|STARTED|Second Intervention||4
2973374|NCT00811434|3688354|FG001|STARTED|Second Intervention||5
2973375|NCT00811434|3688353|FG000|COMPLETED|Second Intervention||4
2973376|NCT00811434|3688354|FG001|COMPLETED|Second Intervention||5
2973377|NCT00811434|3688353|FG000|NOT COMPLETED|Second Intervention||0
2973378|NCT00811434|3688354|FG001|NOT COMPLETED|Second Intervention||0
2973379|NCT00811473|3688363|FG000|STARTED|Overall Study||93
2973380|NCT00811473|3688364|FG001|STARTED|Overall Study||100
2973381|NCT00811473|3688363|FG000|COMPLETED|Overall Study||70
2973382|NCT00811473|3688364|FG001|COMPLETED|Overall Study||74
2973383|NCT00811473|3688363|FG000|NOT COMPLETED|Overall Study||23
2973384|NCT00811473|3688364|FG001|NOT COMPLETED|Overall Study||26
2973385|NCT00811564|3688372|FG000|STARTED|Overall Study||73
2973386|NCT00811564|3688373|FG001|STARTED|Overall Study||75
2973387|NCT00811564|3688372|FG000|COMPLETED|Overall Study||64
2973388|NCT00811564|3688373|FG001|COMPLETED|Overall Study||73
2973389|NCT00811564|3688372|FG000|NOT COMPLETED|Overall Study||9
2973390|NCT00811564|3688373|FG001|NOT COMPLETED|Overall Study||2
2973391|NCT00811577|3688381|FG000|STARTED|Overall Study||126
2973392|NCT00811577|3688382|FG001|STARTED|Overall Study||24
2973393|NCT00811577|3688381|FG000|COMPLETED|Overall Study||116
2973394|NCT00811577|3688382|FG001|COMPLETED|Overall Study||23
2973395|NCT00811577|3688381|FG000|NOT COMPLETED|Overall Study||10
2973396|NCT00811577|3688382|FG001|NOT COMPLETED|Overall Study||1
2973397|NCT00811642|3688431|FG000|STARTED|Overall Study|63 participants were screened and enrolled; 62 participants from Safety Set (SS) started study drug.|62
2973398|NCT00811642|3688431|FG000|COMPLETED|Overall Study|The Per Protocol Set (PPS) includes the 47 participants who completed the study per protocol.|47
2973399|NCT00811642|3688431|FG000|NOT COMPLETED|Overall Study||15
2973400|NCT00811655|3688435|FG000|STARTED|Overall Study||6
2973401|NCT00811655|3688435|FG000|COMPLETED|Overall Study||5
2973402|NCT00811655|3688435|FG000|NOT COMPLETED|Overall Study||1
3035854|NCT01139515|3755081|FG003|NOT COMPLETED|Fourth Intervention Period||0
3035855|NCT01139580|3755093|FG000|STARTED|Overall Study||181
3035856|NCT01139580|3755094|FG001|STARTED|Overall Study||182
3035857|NCT01139580|3755093|FG000|COMPLETED|Overall Study||158
3035858|NCT01139580|3755094|FG001|COMPLETED|Overall Study||164
3035859|NCT01139580|3755093|FG000|NOT COMPLETED|Overall Study||23
3035860|NCT01139580|3755094|FG001|NOT COMPLETED|Overall Study||18
3035861|NCT01139658|3755102|FG000|STARTED|Overall Study||747
3035862|NCT01139658|3755103|FG001|STARTED|Overall Study||929
3035863|NCT01139658|3755102|FG000|COMPLETED|Overall Study||691
3035864|NCT01139658|3755103|FG001|COMPLETED|Overall Study||816
3035865|NCT01139658|3755102|FG000|NOT COMPLETED|Overall Study||56
3035866|NCT01139658|3755103|FG001|NOT COMPLETED|Overall Study||113
3035867|NCT01139762|3755111|FG000|STARTED|Washout and Placebo Lead-In Period||1070
3035868|NCT01139762|3755112|FG001|STARTED|Washout and Placebo Lead-In Period||0
3035869|NCT01139762|3755113|FG002|STARTED|Washout and Placebo Lead-In Period||0
3035870|NCT01139762|3755111|FG000|COMPLETED|Washout and Placebo Lead-In Period||696
3035871|NCT01139762|3755112|FG001|COMPLETED|Washout and Placebo Lead-In Period||0
3035872|NCT01139762|3755113|FG002|COMPLETED|Washout and Placebo Lead-In Period||0
3035873|NCT01139762|3755111|FG000|NOT COMPLETED|Washout and Placebo Lead-In Period||374
3035874|NCT01139762|3755112|FG001|NOT COMPLETED|Washout and Placebo Lead-In Period||0
3035875|NCT01139762|3755113|FG002|NOT COMPLETED|Washout and Placebo Lead-In Period||0
3035876|NCT01139762|3755111|FG000|STARTED|Double-Blind Randomized Active Treatment||0
3035877|NCT01139762|3755112|FG001|STARTED|Double-Blind Randomized Active Treatment||346
2973403|NCT00811720|3688441|FG000|STARTED|All Randomised Patients||298
2973404|NCT00811720|3688442|FG001|STARTED|All Randomised Patients||306
2973405|NCT00811720|3688441|FG000|COMPLETED|All Randomised Patients||296
2973406|NCT00811720|3688442|FG001|COMPLETED|All Randomised Patients||302
2973407|NCT00811720|3688441|FG000|NOT COMPLETED|All Randomised Patients||2
2973408|NCT00811720|3688442|FG001|NOT COMPLETED|All Randomised Patients||4
2973409|NCT00811720|3688441|FG000|STARTED|All Treated Patients||296
2973410|NCT00811720|3688442|FG001|STARTED|All Treated Patients||302
2973411|NCT00811720|3688441|FG000|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|200
2973412|NCT00811720|3688442|FG001|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|138
2973413|NCT00811720|3688441|FG000|NOT COMPLETED|All Treated Patients||96
2973414|NCT00811720|3688442|FG001|NOT COMPLETED|All Treated Patients||164
2973415|NCT00811733|3688450|FG000|STARTED|Overall Study||15
2973416|NCT00811733|3688451|FG001|STARTED|Overall Study||22
2973417|NCT00811733|3688450|FG000|COMPLETED|Overall Study||4
2973418|NCT00811733|3688451|FG001|COMPLETED|Overall Study||12
2973419|NCT00811733|3688450|FG000|NOT COMPLETED|Overall Study||11
2973420|NCT00811733|3688451|FG001|NOT COMPLETED|Overall Study||10
2973421|NCT00811798|3688457|FG000|STARTED|Overall Study||92
2973422|NCT00811798|3688457|FG000|COMPLETED|Overall Study||92
2973423|NCT00811798|3688457|FG000|NOT COMPLETED|Overall Study||0
2973424|NCT00811850|3688461|FG000|STARTED|Treatment Period 1: Combigan® or Cosopt®||15
2973425|NCT00811850|3688461|FG000|COMPLETED|Treatment Period 1: Combigan® or Cosopt®||15
2973426|NCT00811850|3688461|FG000|NOT COMPLETED|Treatment Period 1: Combigan® or Cosopt®||0
2973427|NCT00811850|3688461|FG000|STARTED|Treatment Period 2: Wash Out||15
2973428|NCT00811850|3688461|FG000|COMPLETED|Treatment Period 2: Wash Out||15
2973429|NCT00811850|3688461|FG000|NOT COMPLETED|Treatment Period 2: Wash Out||0
2973430|NCT00811850|3688461|FG000|STARTED|Treatment Period 3: Combigan® or Cosopt®||15
2973431|NCT00811850|3688461|FG000|COMPLETED|Treatment Period 3: Combigan® or Cosopt®||15
2973432|NCT00811850|3688461|FG000|NOT COMPLETED|Treatment Period 3: Combigan® or Cosopt®||0
2973433|NCT00811928|3688469|FG000|STARTED|Overall Study||129
2973434|NCT00811928|3688470|FG001|STARTED|Overall Study||123
2973435|NCT00811928|3688469|FG000|COMPLETED|Overall Study||90
2973436|NCT00811928|3688470|FG001|COMPLETED|Overall Study||90
2973437|NCT00811928|3688469|FG000|NOT COMPLETED|Overall Study||39
2973438|NCT00811928|3688470|FG001|NOT COMPLETED|Overall Study||33
2973439|NCT00811941|3688478|FG000|STARTED|All Randomised Patients||166
2973440|NCT00811941|3688479|FG001|STARTED|All Randomised Patients||509
2973441|NCT00811941|3688478|FG000|COMPLETED|All Randomised Patients||164
2973442|NCT00811941|3688479|FG001|COMPLETED|All Randomised Patients||501
2973443|NCT00811941|3688478|FG000|NOT COMPLETED|All Randomised Patients||2
2973444|NCT00811941|3688479|FG001|NOT COMPLETED|All Randomised Patients||8
2973445|NCT00811941|3688478|FG000|STARTED|All Treated Patients||164
2973446|NCT00811941|3688479|FG001|STARTED|All Treated Patients||501
2973447|NCT00811941|3688478|FG000|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|112
2973448|NCT00811941|3688479|FG001|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|310
2973449|NCT00811941|3688478|FG000|NOT COMPLETED|All Treated Patients||52
2973450|NCT00811941|3688479|FG001|NOT COMPLETED|All Treated Patients||191
2973451|NCT00811954|3688488|FG000|STARTED|Overall Study||605
2973452|NCT00811954|3688489|FG001|STARTED|Overall Study||603
2973453|NCT00811954|3688490|FG002|STARTED|Overall Study||601
2973454|NCT00811954|3688488|FG000|COMPLETED|Overall Study||516
2973455|NCT00811954|3688489|FG001|COMPLETED|Overall Study||531
2973456|NCT00811954|3688490|FG002|COMPLETED|Overall Study||500
2973457|NCT00811954|3688488|FG000|NOT COMPLETED|Overall Study||89
2973458|NCT00811954|3688489|FG001|NOT COMPLETED|Overall Study||72
2973459|NCT00811954|3688490|FG002|NOT COMPLETED|Overall Study||101
2973460|NCT00812097|3688502|FG000|STARTED|Overall Study||572
2973461|NCT00812097|3688503|FG001|STARTED|Overall Study||190
2973462|NCT00812097|3688504|FG002|STARTED|Overall Study||124
2973463|NCT00812097|3688505|FG003|STARTED|Overall Study||69
2973464|NCT00812097|3688502|FG000|COMPLETED|Overall Study||327
2973465|NCT00812097|3688503|FG001|COMPLETED|Overall Study||101
2973466|NCT00812097|3688504|FG002|COMPLETED|Overall Study||67
2973467|NCT00812097|3688505|FG003|COMPLETED|Overall Study||34
2973468|NCT00812097|3688502|FG000|NOT COMPLETED|Overall Study||245
2973469|NCT00812097|3688503|FG001|NOT COMPLETED|Overall Study||89
2973470|NCT00812097|3688504|FG002|NOT COMPLETED|Overall Study||57
2973471|NCT00812097|3688505|FG003|NOT COMPLETED|Overall Study||35
2973472|NCT00812110|3688515|FG000|STARTED|Overall Study||292
2973473|NCT00812110|3688515|FG000|COMPLETED|Overall Study||292
2973474|NCT00812110|3688515|FG000|NOT COMPLETED|Overall Study||0
2973475|NCT00812253|3688521|FG000|STARTED|Overall Study||32
2973476|NCT00812253|3688522|FG001|STARTED|Overall Study||42
2973477|NCT00812253|3688521|FG000|COMPLETED|Overall Study||26
2973478|NCT00812253|3688522|FG001|COMPLETED|Overall Study||39
2973479|NCT00812253|3688521|FG000|NOT COMPLETED|Overall Study||6
2973480|NCT00812253|3688522|FG001|NOT COMPLETED|Overall Study||3
2973481|NCT00812331|3688533|FG000|STARTED|Overall Study||6
2973482|NCT00812331|3688534|FG001|STARTED|Overall Study||8
2973483|NCT00812331|3688535|FG002|STARTED|Overall Study||8
2973484|NCT00812331|3688536|FG003|STARTED|Overall Study||7
2973485|NCT00812331|3688537|FG004|STARTED|Overall Study||8
2973486|NCT00812331|3688533|FG000|COMPLETED|Overall Study||5
2973487|NCT00812331|3688534|FG001|COMPLETED|Overall Study||8
2973488|NCT00812331|3688535|FG002|COMPLETED|Overall Study||8
2973489|NCT00812331|3688536|FG003|COMPLETED|Overall Study||7
2973490|NCT00812331|3688537|FG004|COMPLETED|Overall Study||8
2973491|NCT00812331|3688533|FG000|NOT COMPLETED|Overall Study||1
2973492|NCT00812331|3688534|FG001|NOT COMPLETED|Overall Study||0
2973493|NCT00812331|3688535|FG002|NOT COMPLETED|Overall Study||0
2973494|NCT00812331|3688536|FG003|NOT COMPLETED|Overall Study||0
2973495|NCT00812331|3688537|FG004|NOT COMPLETED|Overall Study||0
2973496|NCT00812461|3688547|FG000|STARTED|All Randomised Patients||360
2973497|NCT00812461|3688548|FG001|STARTED|All Randomised Patients||358
2973498|NCT00812461|3688547|FG000|COMPLETED|All Randomised Patients||337
2973499|NCT00812461|3688548|FG001|COMPLETED|All Randomised Patients||341
2973500|NCT00812461|3688547|FG000|NOT COMPLETED|All Randomised Patients||23
2973501|NCT00812461|3688548|FG001|NOT COMPLETED|All Randomised Patients||17
2973502|NCT00812461|3688547|FG000|STARTED|All Treated Patients||337
2973503|NCT00812461|3688548|FG001|STARTED|All Treated Patients||341
2973504|NCT00812461|3688547|FG000|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|205
2973505|NCT00812461|3688548|FG001|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|194
2973506|NCT00812461|3688547|FG000|NOT COMPLETED|All Treated Patients||132
2973507|NCT00812461|3688548|FG001|NOT COMPLETED|All Treated Patients||147
2973508|NCT00812487|3688556|FG000|STARTED|Overall Study||32
2973509|NCT00812487|3688557|FG001|STARTED|Overall Study||42
2973510|NCT00812487|3688556|FG000|COMPLETED|Overall Study||26
2973511|NCT00812487|3688557|FG001|COMPLETED|Overall Study||39
2973512|NCT00812487|3688556|FG000|NOT COMPLETED|Overall Study||6
2973513|NCT00812487|3688557|FG001|NOT COMPLETED|Overall Study||3
2973514|NCT00812565|3688571|FG000|STARTED|Overall Study||8
2973515|NCT00812565|3688572|FG001|STARTED|Overall Study||7
2973516|NCT00812565|3688573|FG002|STARTED|Overall Study||7
2973517|NCT00812565|3688574|FG003|STARTED|Overall Study||7
2973518|NCT00812565|3688575|FG004|STARTED|Overall Study||7
2973519|NCT00812565|3688576|FG005|STARTED|Overall Study||7
2973520|NCT00812565|3688577|FG006|STARTED|Overall Study||8
2973521|NCT00812565|3688578|FG007|STARTED|Overall Study||7
2973522|NCT00812565|3688571|FG000|COMPLETED|Overall Study||5
2973523|NCT00812565|3688572|FG001|COMPLETED|Overall Study||6
2973524|NCT00812565|3688573|FG002|COMPLETED|Overall Study||7
2973525|NCT00812565|3688574|FG003|COMPLETED|Overall Study||5
2973526|NCT00812565|3688575|FG004|COMPLETED|Overall Study||6
2973527|NCT00812565|3688576|FG005|COMPLETED|Overall Study||6
2973528|NCT00812565|3688577|FG006|COMPLETED|Overall Study||8
3133278|NCT01695239|3858306|FG001|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
3133279|NCT01695239|3858307|FG002|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
3133280|NCT01695239|3858308|FG003|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
3133281|NCT01695239|3858309|FG004|STARTED|Placebo Washout (Week 24 Up To Week 32)|Only included PBO washout participants.|0
3133282|NCT01695239|3858310|FG005|STARTED|Placebo Washout (Week 24 Up To Week 32)|Only included PBO washout participants.|0
3136741|NCT01714726|3861990|FG002|COMPLETED|Open-Label Period||33
2973529|NCT00812565|3688578|FG007|COMPLETED|Overall Study||6
2973530|NCT00812565|3688571|FG000|NOT COMPLETED|Overall Study||3
2973531|NCT00812565|3688572|FG001|NOT COMPLETED|Overall Study||1
2973532|NCT00812565|3688573|FG002|NOT COMPLETED|Overall Study||0
2973533|NCT00812565|3688574|FG003|NOT COMPLETED|Overall Study||2
2973534|NCT00812565|3688575|FG004|NOT COMPLETED|Overall Study||1
2973535|NCT00812565|3688576|FG005|NOT COMPLETED|Overall Study||1
2973536|NCT00812565|3688577|FG006|NOT COMPLETED|Overall Study||0
2973537|NCT00812565|3688578|FG007|NOT COMPLETED|Overall Study||1
2973538|NCT00812604|3688598|FG000|STARTED|Overall Study||28
2973539|NCT00812604|3688599|FG001|STARTED|Overall Study||27
2973540|NCT00812604|3688598|FG000|COMPLETED|Overall Study||23
2973541|NCT00812604|3688599|FG001|COMPLETED|Overall Study||22
2973542|NCT00812604|3688598|FG000|NOT COMPLETED|Overall Study||5
2973543|NCT00812604|3688599|FG001|NOT COMPLETED|Overall Study||5
2973544|NCT00812812|3688607|FG000|STARTED|Overall Study||27
2973545|NCT00812812|3688608|FG001|STARTED|Overall Study||29
2973546|NCT00812812|3688607|FG000|COMPLETED|Overall Study||24
2973547|NCT00812812|3688608|FG001|COMPLETED|Overall Study||25
2973548|NCT00812812|3688607|FG000|NOT COMPLETED|Overall Study||3
2973549|NCT00812812|3688608|FG001|NOT COMPLETED|Overall Study||4
2973550|NCT00812838|3688618|FG000|STARTED|Treatment Period of 16 Weeks||6
2973551|NCT00812838|3688619|FG001|STARTED|Treatment Period of 16 Weeks||6
2973552|NCT00812838|3688618|FG000|COMPLETED|Treatment Period of 16 Weeks||6
2973553|NCT00812838|3688619|FG001|COMPLETED|Treatment Period of 16 Weeks||6
2973554|NCT00812838|3688618|FG000|NOT COMPLETED|Treatment Period of 16 Weeks||0
2973555|NCT00812838|3688619|FG001|NOT COMPLETED|Treatment Period of 16 Weeks||0
2973556|NCT00812838|3688618|FG000|STARTED|Optional Crossover of 16 Weeks||0
2973557|NCT00812838|3688619|FG001|STARTED|Optional Crossover of 16 Weeks||4
2973558|NCT00812838|3688618|FG000|COMPLETED|Optional Crossover of 16 Weeks||0
2973559|NCT00812838|3688619|FG001|COMPLETED|Optional Crossover of 16 Weeks||4
2973560|NCT00812838|3688618|FG000|NOT COMPLETED|Optional Crossover of 16 Weeks||0
2973561|NCT00812838|3688619|FG001|NOT COMPLETED|Optional Crossover of 16 Weeks||0
2973562|NCT00812877|3688629|FG000|STARTED|Overall Study||195
2973563|NCT00812877|3688630|FG001|STARTED|Overall Study||181
2973564|NCT00812877|3688629|FG000|COMPLETED|Overall Study||158
2973565|NCT00812877|3688630|FG001|COMPLETED|Overall Study||130
2973566|NCT00812877|3688629|FG000|NOT COMPLETED|Overall Study||37
2973567|NCT00812877|3688630|FG001|NOT COMPLETED|Overall Study||51
2973568|NCT00812916|3688636|FG000|STARTED|Overall Study|206 enrolled (consented)|206
2973569|NCT00812916|3688636|FG000|Data Available|Overall Study||205
2973570|NCT00812916|3688636|FG000|CFAE - Guided Ablation|Overall Study||203
2973571|NCT00812916|3688636|FG000|COMPLETED|Overall Study||203
2973572|NCT00812916|3688636|FG000|NOT COMPLETED|Overall Study||3
2973573|NCT00812929|3688642|FG000|STARTED|Treatment Period 1||5
2973574|NCT00812929|3688643|FG001|STARTED|Treatment Period 1||4
2973575|NCT00812929|3688644|FG002|STARTED|Treatment Period 1||5
2973576|NCT00812929|3688645|FG003|STARTED|Treatment Period 1||4
2973577|NCT00812929|3688646|FG004|STARTED|Treatment Period 1||5
2973578|NCT00812929|3688647|FG005|STARTED|Treatment Period 1||5
2973579|NCT00812929|3688648|FG006|STARTED|Treatment Period 1||5
2973580|NCT00812929|3688649|FG007|STARTED|Treatment Period 1||5
2973581|NCT00812929|3688650|FG008|STARTED|Treatment Period 1||4
2973582|NCT00812929|3688651|FG009|STARTED|Treatment Period 1||5
2973583|NCT00812929|3688642|FG000|COMPLETED|Treatment Period 1||5
2973584|NCT00812929|3688643|FG001|COMPLETED|Treatment Period 1||4
2973585|NCT00812929|3688644|FG002|COMPLETED|Treatment Period 1||5
2973586|NCT00812929|3688645|FG003|COMPLETED|Treatment Period 1||4
2973587|NCT00812929|3688646|FG004|COMPLETED|Treatment Period 1||5
2973588|NCT00812929|3688647|FG005|COMPLETED|Treatment Period 1||5
2973589|NCT00812929|3688648|FG006|COMPLETED|Treatment Period 1||5
2973590|NCT00812929|3688649|FG007|COMPLETED|Treatment Period 1||5
2973591|NCT00812929|3688650|FG008|COMPLETED|Treatment Period 1||4
2973592|NCT00812929|3688651|FG009|COMPLETED|Treatment Period 1||5
2973593|NCT00812929|3688642|FG000|NOT COMPLETED|Treatment Period 1||0
2973594|NCT00812929|3688643|FG001|NOT COMPLETED|Treatment Period 1||0
2973595|NCT00812929|3688644|FG002|NOT COMPLETED|Treatment Period 1||0
2973596|NCT00812929|3688645|FG003|NOT COMPLETED|Treatment Period 1||0
2973597|NCT00812929|3688646|FG004|NOT COMPLETED|Treatment Period 1||0
2973598|NCT00812929|3688647|FG005|NOT COMPLETED|Treatment Period 1||0
2973599|NCT00812929|3688648|FG006|NOT COMPLETED|Treatment Period 1||0
2973600|NCT00812929|3688649|FG007|NOT COMPLETED|Treatment Period 1||0
2973601|NCT00812929|3688650|FG008|NOT COMPLETED|Treatment Period 1||0
2973602|NCT00812929|3688651|FG009|NOT COMPLETED|Treatment Period 1||0
2973603|NCT00812929|3688642|FG000|STARTED|Washout Period 1 (7 Days)||5
2973604|NCT00812929|3688643|FG001|STARTED|Washout Period 1 (7 Days)||4
2973605|NCT00812929|3688644|FG002|STARTED|Washout Period 1 (7 Days)||5
2973606|NCT00812929|3688645|FG003|STARTED|Washout Period 1 (7 Days)||4
2973607|NCT00812929|3688646|FG004|STARTED|Washout Period 1 (7 Days)||5
2973608|NCT00812929|3688647|FG005|STARTED|Washout Period 1 (7 Days)||5
2973609|NCT00812929|3688648|FG006|STARTED|Washout Period 1 (7 Days)||5
2973610|NCT00812929|3688649|FG007|STARTED|Washout Period 1 (7 Days)||5
2973611|NCT00812929|3688650|FG008|STARTED|Washout Period 1 (7 Days)||4
2973612|NCT00812929|3688651|FG009|STARTED|Washout Period 1 (7 Days)||5
2973613|NCT00812929|3688642|FG000|COMPLETED|Washout Period 1 (7 Days)||5
2973614|NCT00812929|3688643|FG001|COMPLETED|Washout Period 1 (7 Days)||4
2973615|NCT00812929|3688644|FG002|COMPLETED|Washout Period 1 (7 Days)||4
2973616|NCT00812929|3688645|FG003|COMPLETED|Washout Period 1 (7 Days)||4
2973617|NCT00812929|3688646|FG004|COMPLETED|Washout Period 1 (7 Days)||5
2973618|NCT00812929|3688647|FG005|COMPLETED|Washout Period 1 (7 Days)||5
2973619|NCT00812929|3688648|FG006|COMPLETED|Washout Period 1 (7 Days)||5
2973620|NCT00812929|3688649|FG007|COMPLETED|Washout Period 1 (7 Days)||5
2973621|NCT00812929|3688650|FG008|COMPLETED|Washout Period 1 (7 Days)||4
2973622|NCT00812929|3688651|FG009|COMPLETED|Washout Period 1 (7 Days)||5
2973623|NCT00812929|3688642|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0
2973624|NCT00812929|3688643|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0
2973625|NCT00812929|3688644|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||1
2973626|NCT00812929|3688645|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||0
2973627|NCT00812929|3688646|FG004|NOT COMPLETED|Washout Period 1 (7 Days)||0
2973628|NCT00812929|3688647|FG005|NOT COMPLETED|Washout Period 1 (7 Days)||0
2973629|NCT00812929|3688648|FG006|NOT COMPLETED|Washout Period 1 (7 Days)||0
2973630|NCT00812929|3688649|FG007|NOT COMPLETED|Washout Period 1 (7 Days)||0
2973631|NCT00812929|3688650|FG008|NOT COMPLETED|Washout Period 1 (7 Days)||0
2973632|NCT00812929|3688651|FG009|NOT COMPLETED|Washout Period 1 (7 Days)||0
2973633|NCT00812929|3688642|FG000|STARTED|Treatment Period 2||5
2973634|NCT00812929|3688643|FG001|STARTED|Treatment Period 2||4
2973635|NCT00812929|3688644|FG002|STARTED|Treatment Period 2||4
2973636|NCT00812929|3688645|FG003|STARTED|Treatment Period 2||4
2973637|NCT00812929|3688646|FG004|STARTED|Treatment Period 2||5
2973638|NCT00812929|3688647|FG005|STARTED|Treatment Period 2||5
2973639|NCT00812929|3688648|FG006|STARTED|Treatment Period 2||5
2973640|NCT00812929|3688649|FG007|STARTED|Treatment Period 2||5
2973641|NCT00812929|3688650|FG008|STARTED|Treatment Period 2||4
2973642|NCT00812929|3688651|FG009|STARTED|Treatment Period 2||5
2973643|NCT00812929|3688642|FG000|COMPLETED|Treatment Period 2||5
2973644|NCT00812929|3688643|FG001|COMPLETED|Treatment Period 2||4
2973645|NCT00812929|3688644|FG002|COMPLETED|Treatment Period 2||4
2973646|NCT00812929|3688645|FG003|COMPLETED|Treatment Period 2||4
2973647|NCT00812929|3688646|FG004|COMPLETED|Treatment Period 2||5
2973648|NCT00812929|3688647|FG005|COMPLETED|Treatment Period 2||5
2973649|NCT00812929|3688648|FG006|COMPLETED|Treatment Period 2||5
2973650|NCT00812929|3688649|FG007|COMPLETED|Treatment Period 2||5
2973651|NCT00812929|3688650|FG008|COMPLETED|Treatment Period 2||4
2973652|NCT00812929|3688651|FG009|COMPLETED|Treatment Period 2||5
2973653|NCT00812929|3688642|FG000|NOT COMPLETED|Treatment Period 2||0
2973654|NCT00812929|3688643|FG001|NOT COMPLETED|Treatment Period 2||0
2973655|NCT00812929|3688644|FG002|NOT COMPLETED|Treatment Period 2||0
2973656|NCT00812929|3688645|FG003|NOT COMPLETED|Treatment Period 2||0
2973657|NCT00812929|3688646|FG004|NOT COMPLETED|Treatment Period 2||0
2973658|NCT00812929|3688647|FG005|NOT COMPLETED|Treatment Period 2||0
2973659|NCT00812929|3688648|FG006|NOT COMPLETED|Treatment Period 2||0
2973660|NCT00812929|3688649|FG007|NOT COMPLETED|Treatment Period 2||0
2973661|NCT00812929|3688650|FG008|NOT COMPLETED|Treatment Period 2||0
2973662|NCT00812929|3688651|FG009|NOT COMPLETED|Treatment Period 2||0
2973663|NCT00812929|3688642|FG000|STARTED|Washout Period 2 (7 Days)||5
2973664|NCT00812929|3688643|FG001|STARTED|Washout Period 2 (7 Days)||4
2973665|NCT00812929|3688644|FG002|STARTED|Washout Period 2 (7 Days)||4
2973666|NCT00812929|3688645|FG003|STARTED|Washout Period 2 (7 Days)||4
2973667|NCT00812929|3688646|FG004|STARTED|Washout Period 2 (7 Days)||5
2973668|NCT00812929|3688647|FG005|STARTED|Washout Period 2 (7 Days)||5
2973669|NCT00812929|3688648|FG006|STARTED|Washout Period 2 (7 Days)||5
2973670|NCT00812929|3688649|FG007|STARTED|Washout Period 2 (7 Days)||5
2973671|NCT00812929|3688650|FG008|STARTED|Washout Period 2 (7 Days)||4
2973672|NCT00812929|3688651|FG009|STARTED|Washout Period 2 (7 Days)||5
2973673|NCT00812929|3688642|FG000|COMPLETED|Washout Period 2 (7 Days)||5
2973674|NCT00812929|3688643|FG001|COMPLETED|Washout Period 2 (7 Days)||4
2973675|NCT00812929|3688644|FG002|COMPLETED|Washout Period 2 (7 Days)||4
2973676|NCT00812929|3688645|FG003|COMPLETED|Washout Period 2 (7 Days)||4
2973677|NCT00812929|3688646|FG004|COMPLETED|Washout Period 2 (7 Days)||5
2973678|NCT00812929|3688647|FG005|COMPLETED|Washout Period 2 (7 Days)||5
2973679|NCT00812929|3688648|FG006|COMPLETED|Washout Period 2 (7 Days)||5
2973680|NCT00812929|3688649|FG007|COMPLETED|Washout Period 2 (7 Days)||5
2973681|NCT00812929|3688650|FG008|COMPLETED|Washout Period 2 (7 Days)||4
2973682|NCT00812929|3688651|FG009|COMPLETED|Washout Period 2 (7 Days)||4
2973683|NCT00812929|3688642|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||0
2973684|NCT00812929|3688643|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0
2973685|NCT00812929|3688644|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0
2973686|NCT00812929|3688645|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||0
2973687|NCT00812929|3688646|FG004|NOT COMPLETED|Washout Period 2 (7 Days)||0
2973688|NCT00812929|3688647|FG005|NOT COMPLETED|Washout Period 2 (7 Days)||0
2973689|NCT00812929|3688648|FG006|NOT COMPLETED|Washout Period 2 (7 Days)||0
2973690|NCT00812929|3688649|FG007|NOT COMPLETED|Washout Period 2 (7 Days)||0
2973691|NCT00812929|3688650|FG008|NOT COMPLETED|Washout Period 2 (7 Days)||0
2973692|NCT00812929|3688651|FG009|NOT COMPLETED|Washout Period 2 (7 Days)||1
2973693|NCT00812929|3688642|FG000|STARTED|Treatment Period 3||5
2973694|NCT00812929|3688643|FG001|STARTED|Treatment Period 3||4
2973695|NCT00812929|3688644|FG002|STARTED|Treatment Period 3||4
2973696|NCT00812929|3688645|FG003|STARTED|Treatment Period 3||4
2973697|NCT00812929|3688646|FG004|STARTED|Treatment Period 3||5
2973698|NCT00812929|3688647|FG005|STARTED|Treatment Period 3||5
2973699|NCT00812929|3688648|FG006|STARTED|Treatment Period 3||5
2973700|NCT00812929|3688649|FG007|STARTED|Treatment Period 3||5
2973701|NCT00812929|3688650|FG008|STARTED|Treatment Period 3||4
2973702|NCT00812929|3688651|FG009|STARTED|Treatment Period 3||4
2973703|NCT00812929|3688642|FG000|COMPLETED|Treatment Period 3||5
2973704|NCT00812929|3688643|FG001|COMPLETED|Treatment Period 3||4
2973705|NCT00812929|3688644|FG002|COMPLETED|Treatment Period 3||4
2973706|NCT00812929|3688645|FG003|COMPLETED|Treatment Period 3||4
2973707|NCT00812929|3688646|FG004|COMPLETED|Treatment Period 3||5
2973708|NCT00812929|3688647|FG005|COMPLETED|Treatment Period 3||5
2973709|NCT00812929|3688648|FG006|COMPLETED|Treatment Period 3||5
2973710|NCT00812929|3688649|FG007|COMPLETED|Treatment Period 3||5
2973711|NCT00812929|3688650|FG008|COMPLETED|Treatment Period 3||4
2973712|NCT00812929|3688651|FG009|COMPLETED|Treatment Period 3||4
2973713|NCT00812929|3688642|FG000|NOT COMPLETED|Treatment Period 3||0
2973714|NCT00812929|3688643|FG001|NOT COMPLETED|Treatment Period 3||0
2973715|NCT00812929|3688644|FG002|NOT COMPLETED|Treatment Period 3||0
2973716|NCT00812929|3688645|FG003|NOT COMPLETED|Treatment Period 3||0
2973717|NCT00812929|3688646|FG004|NOT COMPLETED|Treatment Period 3||0
2973718|NCT00812929|3688647|FG005|NOT COMPLETED|Treatment Period 3||0
2973719|NCT00812929|3688648|FG006|NOT COMPLETED|Treatment Period 3||0
2973720|NCT00812929|3688649|FG007|NOT COMPLETED|Treatment Period 3||0
2973721|NCT00812929|3688650|FG008|NOT COMPLETED|Treatment Period 3||0
2973722|NCT00812929|3688651|FG009|NOT COMPLETED|Treatment Period 3||0
2973723|NCT00812929|3688642|FG000|STARTED|Washout Period 3 (7 Days)||5
2973724|NCT00812929|3688643|FG001|STARTED|Washout Period 3 (7 Days)||4
2973725|NCT00812929|3688644|FG002|STARTED|Washout Period 3 (7 Days)||4
2973726|NCT00812929|3688645|FG003|STARTED|Washout Period 3 (7 Days)||4
2973727|NCT00812929|3688646|FG004|STARTED|Washout Period 3 (7 Days)||5
2973728|NCT00812929|3688647|FG005|STARTED|Washout Period 3 (7 Days)||5
2973729|NCT00812929|3688648|FG006|STARTED|Washout Period 3 (7 Days)||5
2973730|NCT00812929|3688649|FG007|STARTED|Washout Period 3 (7 Days)||5
2973731|NCT00812929|3688650|FG008|STARTED|Washout Period 3 (7 Days)||4
2973732|NCT00812929|3688651|FG009|STARTED|Washout Period 3 (7 Days)||4
2973733|NCT00812929|3688642|FG000|COMPLETED|Washout Period 3 (7 Days)||5
2973734|NCT00812929|3688643|FG001|COMPLETED|Washout Period 3 (7 Days)||4
2973735|NCT00812929|3688644|FG002|COMPLETED|Washout Period 3 (7 Days)||4
2973736|NCT00812929|3688645|FG003|COMPLETED|Washout Period 3 (7 Days)||4
2973737|NCT00812929|3688646|FG004|COMPLETED|Washout Period 3 (7 Days)||5
2973738|NCT00812929|3688647|FG005|COMPLETED|Washout Period 3 (7 Days)||4
2973739|NCT00812929|3688648|FG006|COMPLETED|Washout Period 3 (7 Days)||5
2973740|NCT00812929|3688649|FG007|COMPLETED|Washout Period 3 (7 Days)||5
2973741|NCT00812929|3688650|FG008|COMPLETED|Washout Period 3 (7 Days)||4
2973742|NCT00812929|3688651|FG009|COMPLETED|Washout Period 3 (7 Days)||4
2973743|NCT00812929|3688642|FG000|NOT COMPLETED|Washout Period 3 (7 Days)||0
2973744|NCT00812929|3688643|FG001|NOT COMPLETED|Washout Period 3 (7 Days)||0
2973745|NCT00812929|3688644|FG002|NOT COMPLETED|Washout Period 3 (7 Days)||0
2973746|NCT00812929|3688645|FG003|NOT COMPLETED|Washout Period 3 (7 Days)||0
2973747|NCT00812929|3688646|FG004|NOT COMPLETED|Washout Period 3 (7 Days)||0
2973748|NCT00812929|3688647|FG005|NOT COMPLETED|Washout Period 3 (7 Days)||1
2973749|NCT00812929|3688648|FG006|NOT COMPLETED|Washout Period 3 (7 Days)||0
2973750|NCT00812929|3688649|FG007|NOT COMPLETED|Washout Period 3 (7 Days)||0
2973751|NCT00812929|3688650|FG008|NOT COMPLETED|Washout Period 3 (7 Days)||0
2973752|NCT00812929|3688651|FG009|NOT COMPLETED|Washout Period 3 (7 Days)||0
2973753|NCT00812929|3688642|FG000|STARTED|Treatment Period 4||5
2973754|NCT00812929|3688643|FG001|STARTED|Treatment Period 4||4
2973755|NCT00812929|3688644|FG002|STARTED|Treatment Period 4||4
2973756|NCT00812929|3688645|FG003|STARTED|Treatment Period 4||4
2973757|NCT00812929|3688646|FG004|STARTED|Treatment Period 4||5
2973758|NCT00812929|3688647|FG005|STARTED|Treatment Period 4||4
2973759|NCT00812929|3688648|FG006|STARTED|Treatment Period 4||5
2973760|NCT00812929|3688649|FG007|STARTED|Treatment Period 4||5
2973761|NCT00812929|3688650|FG008|STARTED|Treatment Period 4||4
2973762|NCT00812929|3688651|FG009|STARTED|Treatment Period 4||4
2973763|NCT00812929|3688642|FG000|COMPLETED|Treatment Period 4||5
2973764|NCT00812929|3688643|FG001|COMPLETED|Treatment Period 4||4
2973765|NCT00812929|3688644|FG002|COMPLETED|Treatment Period 4||4
2973766|NCT00812929|3688645|FG003|COMPLETED|Treatment Period 4||4
2973767|NCT00812929|3688646|FG004|COMPLETED|Treatment Period 4||5
2973768|NCT00812929|3688647|FG005|COMPLETED|Treatment Period 4||4
2973769|NCT00812929|3688648|FG006|COMPLETED|Treatment Period 4||5
2973770|NCT00812929|3688649|FG007|COMPLETED|Treatment Period 4||5
2973771|NCT00812929|3688650|FG008|COMPLETED|Treatment Period 4||4
2973772|NCT00812929|3688651|FG009|COMPLETED|Treatment Period 4||4
2973773|NCT00812929|3688642|FG000|NOT COMPLETED|Treatment Period 4||0
2973774|NCT00812929|3688643|FG001|NOT COMPLETED|Treatment Period 4||0
2973775|NCT00812929|3688644|FG002|NOT COMPLETED|Treatment Period 4||0
2973776|NCT00812929|3688645|FG003|NOT COMPLETED|Treatment Period 4||0
2973777|NCT00812929|3688646|FG004|NOT COMPLETED|Treatment Period 4||0
3164079|NCT01890785|3891533|FG003|NOT COMPLETED|First Intervention||0
3164080|NCT01890785|3891534|FG004|NOT COMPLETED|First Intervention||0
3164081|NCT01890785|3891535|FG005|NOT COMPLETED|First Intervention||0
2973778|NCT00812929|3688647|FG005|NOT COMPLETED|Treatment Period 4||0
2973779|NCT00812929|3688648|FG006|NOT COMPLETED|Treatment Period 4||0
2973780|NCT00812929|3688649|FG007|NOT COMPLETED|Treatment Period 4||0
2973781|NCT00812929|3688650|FG008|NOT COMPLETED|Treatment Period 4||0
2973782|NCT00812929|3688651|FG009|NOT COMPLETED|Treatment Period 4||0
2973783|NCT00812929|3688642|FG000|STARTED|Washout Period 4 (7 Days)||5
2973784|NCT00812929|3688643|FG001|STARTED|Washout Period 4 (7 Days)||4
2973785|NCT00812929|3688644|FG002|STARTED|Washout Period 4 (7 Days)||4
2973786|NCT00812929|3688645|FG003|STARTED|Washout Period 4 (7 Days)||4
2973787|NCT00812929|3688646|FG004|STARTED|Washout Period 4 (7 Days)||5
2973788|NCT00812929|3688647|FG005|STARTED|Washout Period 4 (7 Days)||4
2973789|NCT00812929|3688648|FG006|STARTED|Washout Period 4 (7 Days)||5
2973790|NCT00812929|3688649|FG007|STARTED|Washout Period 4 (7 Days)||5
2973791|NCT00812929|3688650|FG008|STARTED|Washout Period 4 (7 Days)||4
2973792|NCT00812929|3688651|FG009|STARTED|Washout Period 4 (7 Days)||4
2973793|NCT00812929|3688642|FG000|COMPLETED|Washout Period 4 (7 Days)||5
2973794|NCT00812929|3688643|FG001|COMPLETED|Washout Period 4 (7 Days)||4
2973795|NCT00812929|3688644|FG002|COMPLETED|Washout Period 4 (7 Days)||4
2973796|NCT00812929|3688645|FG003|COMPLETED|Washout Period 4 (7 Days)||4
2973797|NCT00812929|3688646|FG004|COMPLETED|Washout Period 4 (7 Days)||5
2973798|NCT00812929|3688647|FG005|COMPLETED|Washout Period 4 (7 Days)||4
2973799|NCT00812929|3688648|FG006|COMPLETED|Washout Period 4 (7 Days)||5
2973800|NCT00812929|3688649|FG007|COMPLETED|Washout Period 4 (7 Days)||5
2973801|NCT00812929|3688650|FG008|COMPLETED|Washout Period 4 (7 Days)||4
2973802|NCT00812929|3688651|FG009|COMPLETED|Washout Period 4 (7 Days)||4
2973803|NCT00812929|3688642|FG000|NOT COMPLETED|Washout Period 4 (7 Days)||0
2973804|NCT00812929|3688643|FG001|NOT COMPLETED|Washout Period 4 (7 Days)||0
2973805|NCT00812929|3688644|FG002|NOT COMPLETED|Washout Period 4 (7 Days)||0
2973806|NCT00812929|3688645|FG003|NOT COMPLETED|Washout Period 4 (7 Days)||0
2973807|NCT00812929|3688646|FG004|NOT COMPLETED|Washout Period 4 (7 Days)||0
2973808|NCT00812929|3688647|FG005|NOT COMPLETED|Washout Period 4 (7 Days)||0
2973809|NCT00812929|3688648|FG006|NOT COMPLETED|Washout Period 4 (7 Days)||0
2973810|NCT00812929|3688649|FG007|NOT COMPLETED|Washout Period 4 (7 Days)||0
2973811|NCT00812929|3688650|FG008|NOT COMPLETED|Washout Period 4 (7 Days)||0
2973812|NCT00812929|3688651|FG009|NOT COMPLETED|Washout Period 4 (7 Days)||0
2973813|NCT00812929|3688642|FG000|STARTED|Treatment Period 5||5
2973814|NCT00812929|3688643|FG001|STARTED|Treatment Period 5||4
2973815|NCT00812929|3688644|FG002|STARTED|Treatment Period 5||4
2973816|NCT00812929|3688645|FG003|STARTED|Treatment Period 5||4
2973817|NCT00812929|3688646|FG004|STARTED|Treatment Period 5||5
2973818|NCT00812929|3688647|FG005|STARTED|Treatment Period 5||4
2973819|NCT00812929|3688648|FG006|STARTED|Treatment Period 5||5
2973820|NCT00812929|3688649|FG007|STARTED|Treatment Period 5||5
2973821|NCT00812929|3688650|FG008|STARTED|Treatment Period 5||4
2973822|NCT00812929|3688651|FG009|STARTED|Treatment Period 5||4
2973823|NCT00812929|3688642|FG000|COMPLETED|Treatment Period 5||5
2973824|NCT00812929|3688643|FG001|COMPLETED|Treatment Period 5||4
2973825|NCT00812929|3688644|FG002|COMPLETED|Treatment Period 5||4
2973826|NCT00812929|3688645|FG003|COMPLETED|Treatment Period 5||4
2973827|NCT00812929|3688646|FG004|COMPLETED|Treatment Period 5||5
2973828|NCT00812929|3688647|FG005|COMPLETED|Treatment Period 5||4
2973829|NCT00812929|3688648|FG006|COMPLETED|Treatment Period 5||5
2973830|NCT00812929|3688649|FG007|COMPLETED|Treatment Period 5||5
2973831|NCT00812929|3688650|FG008|COMPLETED|Treatment Period 5||4
2973832|NCT00812929|3688651|FG009|COMPLETED|Treatment Period 5||4
2973833|NCT00812929|3688642|FG000|NOT COMPLETED|Treatment Period 5||0
2973834|NCT00812929|3688643|FG001|NOT COMPLETED|Treatment Period 5||0
2973835|NCT00812929|3688644|FG002|NOT COMPLETED|Treatment Period 5||0
2973836|NCT00812929|3688645|FG003|NOT COMPLETED|Treatment Period 5||0
3164082|NCT01890785|3891530|FG000|STARTED|Second Intervention||5
3164083|NCT01890785|3891531|FG001|STARTED|Second Intervention||5
3164084|NCT01890785|3891532|FG002|STARTED|Second Intervention||5
3164085|NCT01890785|3891533|FG003|STARTED|Second Intervention||5
3164086|NCT01890785|3891534|FG004|STARTED|Second Intervention||5
3164087|NCT01890785|3891535|FG005|STARTED|Second Intervention||5
2973837|NCT00812929|3688646|FG004|NOT COMPLETED|Treatment Period 5||0
2973838|NCT00812929|3688647|FG005|NOT COMPLETED|Treatment Period 5||0
2973839|NCT00812929|3688648|FG006|NOT COMPLETED|Treatment Period 5||0
2973840|NCT00812929|3688649|FG007|NOT COMPLETED|Treatment Period 5||0
2973841|NCT00812929|3688650|FG008|NOT COMPLETED|Treatment Period 5||0
2973842|NCT00812929|3688651|FG009|NOT COMPLETED|Treatment Period 5||0
2973843|NCT00812955|3688672|FG000|STARTED|Overall Study||119
2973844|NCT00812955|3688673|FG001|STARTED|Overall Study||118
2973845|NCT00812955|3688674|FG002|STARTED|Overall Study||119
2973846|NCT00812955|3688675|FG003|STARTED|Overall Study||118
2973847|NCT00812955|3688672|FG000|COMPLETED|Overall Study||109
2973848|NCT00812955|3688673|FG001|COMPLETED|Overall Study||111
2973849|NCT00812955|3688674|FG002|COMPLETED|Overall Study||113
2973850|NCT00812955|3688675|FG003|COMPLETED|Overall Study||110
2973851|NCT00812955|3688672|FG000|NOT COMPLETED|Overall Study||10
2973852|NCT00812955|3688673|FG001|NOT COMPLETED|Overall Study||7
2973853|NCT00812955|3688674|FG002|NOT COMPLETED|Overall Study||6
2973854|NCT00812955|3688675|FG003|NOT COMPLETED|Overall Study||8
2973855|NCT00812968|3688689|FG000|STARTED|Overall Study||11
2973856|NCT00812968|3688689|FG000|COMPLETED|Overall Study||0
2973857|NCT00812968|3688689|FG000|NOT COMPLETED|Overall Study||11
2973858|NCT00812981|3688697|FG000|STARTED|Overall Study||160
2973859|NCT00812981|3688698|FG001|STARTED|Overall Study||160
2973860|NCT00812981|3688697|FG000|COMPLETED|Overall Study||160
2973861|NCT00812981|3688698|FG001|COMPLETED|Overall Study||159
2973862|NCT00812981|3688697|FG000|NOT COMPLETED|Overall Study||0
2973863|NCT00812981|3688698|FG001|NOT COMPLETED|Overall Study||1
2973864|NCT00813098|3688707|FG000|STARTED|Overall Study||49
2973865|NCT00813098|3688708|FG001|STARTED|Overall Study||54
2973866|NCT00813098|3688709|FG002|STARTED|Overall Study||52
2973867|NCT00813098|3688707|FG000|COMPLETED|Overall Study||46
2973868|NCT00813098|3688708|FG001|COMPLETED|Overall Study||46
2973869|NCT00813098|3688709|FG002|COMPLETED|Overall Study||50
2973870|NCT00813098|3688707|FG000|NOT COMPLETED|Overall Study||3
2973871|NCT00813098|3688708|FG001|NOT COMPLETED|Overall Study||8
2973872|NCT00813098|3688709|FG002|NOT COMPLETED|Overall Study||2
2973873|NCT00813111|3688719|FG000|STARTED|Overall Study||66
2973874|NCT00813111|3688720|FG001|STARTED|Overall Study||70
2973875|NCT00813111|3688719|FG000|COMPLETED|Overall Study||64
2973876|NCT00813111|3688720|FG001|COMPLETED|Overall Study||70
2973877|NCT00813111|3688719|FG000|NOT COMPLETED|Overall Study||2
2973878|NCT00813111|3688720|FG001|NOT COMPLETED|Overall Study||0
2973879|NCT00813124|3688726|FG000|STARTED|Overall Study||24
2973880|NCT00813124|3688726|FG000|COMPLETED|Overall Study||12
2973881|NCT00813124|3688726|FG000|NOT COMPLETED|Overall Study||12
3164088|NCT01890785|3891530|FG000|COMPLETED|Second Intervention||5
3164089|NCT01890785|3891531|FG001|COMPLETED|Second Intervention||5
3164090|NCT01890785|3891532|FG002|COMPLETED|Second Intervention||5
3164091|NCT01890785|3891533|FG003|COMPLETED|Second Intervention||5
3164092|NCT01890785|3891534|FG004|COMPLETED|Second Intervention||5
3164093|NCT01890785|3891535|FG005|COMPLETED|Second Intervention||5
3164094|NCT01890785|3891530|FG000|NOT COMPLETED|Second Intervention||0
3164095|NCT01890785|3891531|FG001|NOT COMPLETED|Second Intervention||0
2973882|NCT00813150|3688732|FG000|STARTED|Treatment Period|Number of randomized and treated participants|46
2973883|NCT00813150|3688733|FG001|STARTED|Treatment Period|Number of randomized and treated participants|47
2973884|NCT00813150|3688732|FG000|Intent-to-treat Participants|Treatment Period||43
2973885|NCT00813150|3688733|FG001|Intent-to-treat Participants|Treatment Period||47
2973886|NCT00813150|3688732|FG000|COMPLETED|Treatment Period|Participants who completed 8 cycles of treatment|14
2973887|NCT00813150|3688733|FG001|COMPLETED|Treatment Period|Participants who completed 8 cycles of treatment|15
2973888|NCT00813150|3688732|FG000|NOT COMPLETED|Treatment Period||32
2973889|NCT00813150|3688733|FG001|NOT COMPLETED|Treatment Period||32
2973890|NCT00813150|3688732|FG000|STARTED|Long Term Follow-up|Number of participants who entered follow-up phase|26
2973891|NCT00813150|3688733|FG001|STARTED|Long Term Follow-up|Number of participants who entered follow-up phase|31
2973892|NCT00813150|3688732|FG000|COMPLETED|Long Term Follow-up|Number of participants who completed follow-up phase|2
3038349|NCT01153815|3757772|FG001|NOT COMPLETED|Overall Study||5
2973893|NCT00813150|3688733|FG001|COMPLETED|Long Term Follow-up|Number of participants who completed follow-up phase|0
2973894|NCT00813150|3688732|FG000|NOT COMPLETED|Long Term Follow-up||24
2973895|NCT00813150|3688733|FG001|NOT COMPLETED|Long Term Follow-up||31
2973896|NCT00813176|3688741|FG000|STARTED|Overall Study||25
2973897|NCT00813176|3688742|FG001|STARTED|Overall Study||25
2973898|NCT00813176|3688741|FG000|COMPLETED|Overall Study||25
2973899|NCT00813176|3688742|FG001|COMPLETED|Overall Study||25
2973900|NCT00813176|3688741|FG000|NOT COMPLETED|Overall Study||0
2973901|NCT00813176|3688742|FG001|NOT COMPLETED|Overall Study||0
2973902|NCT00813293|3688752|FG000|STARTED|Overall Study||10
2973903|NCT00813293|3688753|FG001|STARTED|Overall Study||10
2973904|NCT00813293|3688752|FG000|Started Treatment|Overall Study||9
2973905|NCT00813293|3688753|FG001|Started Treatment|Overall Study||10
2973906|NCT00813293|3688752|FG000|Evaluable RFA|Overall Study||7
2973907|NCT00813293|3688753|FG001|Evaluable RFA|Overall Study||8
2973908|NCT00813293|3688752|FG000|COMPLETED|Overall Study||9
2973909|NCT00813293|3688753|FG001|COMPLETED|Overall Study||9
2973910|NCT00813293|3688752|FG000|NOT COMPLETED|Overall Study||1
2973911|NCT00813293|3688753|FG001|NOT COMPLETED|Overall Study||1
2973912|NCT00813319|3688761|FG000|STARTED|Overall Study||108
2973913|NCT00813319|3688762|FG001|STARTED|Overall Study||108
2973914|NCT00813319|3688761|FG000|COMPLETED|Overall Study|100 out of 108 have complete follow-up data, there were 8 missing charts 7 months post-randomization|108
2973915|NCT00813319|3688762|FG001|COMPLETED|Overall Study|104 out of 108 have complete follow-up data, there were 4 missing charts 7 months post-randomization|108
2973916|NCT00813319|3688761|FG000|NOT COMPLETED|Overall Study||0
2973917|NCT00813319|3688762|FG001|NOT COMPLETED|Overall Study||0
2973918|NCT00813358|3688768|FG000|STARTED|Overall Study||115
2973919|NCT00813358|3688768|FG000|COMPLETED|Overall Study||46
2973920|NCT00813358|3688768|FG000|NOT COMPLETED|Overall Study||69
2973921|NCT00813488|3688772|FG000|STARTED|Titration Period 1||107
2973922|NCT00813488|3688773|FG001|STARTED|Titration Period 1||106
2973923|NCT00813488|3688772|FG000|COMPLETED|Titration Period 1||80
2973924|NCT00813488|3688773|FG001|COMPLETED|Titration Period 1||89
2973925|NCT00813488|3688772|FG000|NOT COMPLETED|Titration Period 1||27
2973926|NCT00813488|3688773|FG001|NOT COMPLETED|Titration Period 1||17
2973927|NCT00813488|3688772|FG000|STARTED|Titration Period 2||80
2973928|NCT00813488|3688773|FG001|STARTED|Titration Period 2||89
2973929|NCT00813488|3688772|FG000|COMPLETED|Titration Period 2||64
2973930|NCT00813488|3688773|FG001|COMPLETED|Titration Period 2||79
2973931|NCT00813488|3688772|FG000|NOT COMPLETED|Titration Period 2||16
2973932|NCT00813488|3688773|FG001|NOT COMPLETED|Titration Period 2||10
2973933|NCT00813488|3688772|FG000|STARTED|Double-blind Treatment Period 1|After titration subjects were re-randomized to these two treatment arms|72
2973934|NCT00813488|3688773|FG001|STARTED|Double-blind Treatment Period 1|After titration subjects were re-randomized to these two treatment arms|71
2973935|NCT00813488|3688772|FG000|COMPLETED|Double-blind Treatment Period 1||71
2973936|NCT00813488|3688773|FG001|COMPLETED|Double-blind Treatment Period 1||66
3303146|NCT02964234|4036451|FG000|COMPLETED|Overall Study||54
3303147|NCT02964234|4036452|FG001|COMPLETED|Overall Study||56
3303148|NCT02964234|4036451|FG000|NOT COMPLETED|Overall Study||22
2973937|NCT00813488|3688772|FG000|NOT COMPLETED|Double-blind Treatment Period 1||1
2973938|NCT00813488|3688773|FG001|NOT COMPLETED|Double-blind Treatment Period 1||5
2973939|NCT00813488|3688772|FG000|STARTED|Double-blind Treatment Period 2||71
2973940|NCT00813488|3688773|FG001|STARTED|Double-blind Treatment Period 2||66
2973941|NCT00813488|3688772|FG000|COMPLETED|Double-blind Treatment Period 2||66
2973942|NCT00813488|3688773|FG001|COMPLETED|Double-blind Treatment Period 2||65
2973943|NCT00813488|3688772|FG000|NOT COMPLETED|Double-blind Treatment Period 2||5
2973944|NCT00813488|3688773|FG001|NOT COMPLETED|Double-blind Treatment Period 2||1
2973945|NCT00813488|3688772|FG000|STARTED|Open-label Extension|Patients completing double-blind periods were randomized to FBT or standard of care for open-label|65
2973946|NCT00813488|3688773|FG001|STARTED|Open-label Extension|Patients completing double-blind periods were randomized to FBT or standard of care for open-label|66
2973947|NCT00813488|3688772|FG000|COMPLETED|Open-label Extension|This group received FBT open--label|53
2973948|NCT00813488|3688773|FG001|COMPLETED|Open-label Extension|This group received standard of care (including immediate-release oxycodone)|59
2973949|NCT00813488|3688772|FG000|NOT COMPLETED|Open-label Extension||12
2973950|NCT00813488|3688773|FG001|NOT COMPLETED|Open-label Extension||7
2973951|NCT00813592|3688783|FG000|STARTED|Overall Study||2
2973952|NCT00813592|3688783|FG000|Treated|Overall Study|Two patients were treated.|2
2973953|NCT00813592|3688783|FG000|Response Assessment|Overall Study|One patient met the response assessment.|1
2973954|NCT00813592|3688783|FG000|COMPLETED|Overall Study||0
2973955|NCT00813592|3688783|FG000|NOT COMPLETED|Overall Study||2
2973956|NCT00813709|3688791|FG000|STARTED|Double Blind Period||84
2973957|NCT00813709|3688792|FG001|STARTED|Double Blind Period||117
2973958|NCT00813709|3688793|FG002|STARTED|Double Blind Period||99
2973959|NCT00813709|3688794|FG003|STARTED|Double Blind Period||0
2973960|NCT00813709|3688795|FG004|STARTED|Double Blind Period||0
2973961|NCT00813709|3688796|FG005|STARTED|Double Blind Period||0
2973962|NCT00813709|3688791|FG000|Treated|Double Blind Period||83
2973963|NCT00813709|3688792|FG001|Treated|Double Blind Period||114
2973964|NCT00813709|3688793|FG002|Treated|Double Blind Period||98
2973965|NCT00813709|3688794|FG003|Treated|Double Blind Period||0
2973966|NCT00813709|3688795|FG004|Treated|Double Blind Period||0
2973967|NCT00813709|3688796|FG005|Treated|Double Blind Period||0
3303149|NCT02964234|4036452|FG001|NOT COMPLETED|Overall Study||13
2973968|NCT00813709|3688791|FG000|COMPLETED|Double Blind Period||53
2973969|NCT00813709|3688792|FG001|COMPLETED|Double Blind Period||76
2973970|NCT00813709|3688793|FG002|COMPLETED|Double Blind Period||68
2973971|NCT00813709|3688794|FG003|COMPLETED|Double Blind Period||0
2973972|NCT00813709|3688795|FG004|COMPLETED|Double Blind Period||0
2973973|NCT00813709|3688796|FG005|COMPLETED|Double Blind Period||0
2973974|NCT00813709|3688791|FG000|NOT COMPLETED|Double Blind Period||31
2973975|NCT00813709|3688792|FG001|NOT COMPLETED|Double Blind Period||41
2973976|NCT00813709|3688793|FG002|NOT COMPLETED|Double Blind Period||31
2973977|NCT00813709|3688794|FG003|NOT COMPLETED|Double Blind Period||0
2973978|NCT00813709|3688795|FG004|NOT COMPLETED|Double Blind Period||0
2973979|NCT00813709|3688796|FG005|NOT COMPLETED|Double Blind Period||0
2973980|NCT00813709|3688791|FG000|STARTED|Open Label Period||0
2973981|NCT00813709|3688792|FG001|STARTED|Open Label Period||0
2973982|NCT00813709|3688793|FG002|STARTED|Open Label Period||0
2973983|NCT00813709|3688794|FG003|STARTED|Open Label Period|49 participants in OL period initially + 9 participants from DB converted to CDMS during the study|58
2973984|NCT00813709|3688795|FG004|STARTED|Open Label Period|25 participants in OL period initially + 26 participants from DB converted to CDMS during the study|51
2973985|NCT00813709|3688796|FG005|STARTED|Open Label Period|28 participants in OL period initially + 18 participants from DB converted to CDMS during the study|46
2973986|NCT00813709|3688791|FG000|Treated|Open Label Period||0
2973987|NCT00813709|3688792|FG001|Treated|Open Label Period||0
2973988|NCT00813709|3688793|FG002|Treated|Open Label Period||0
2973989|NCT00813709|3688794|FG003|Treated|Open Label Period||57
2973990|NCT00813709|3688795|FG004|Treated|Open Label Period||51
2973991|NCT00813709|3688796|FG005|Treated|Open Label Period||45
2973992|NCT00813709|3688791|FG000|COMPLETED|Open Label Period||0
2973993|NCT00813709|3688792|FG001|COMPLETED|Open Label Period||0
2973994|NCT00813709|3688793|FG002|COMPLETED|Open Label Period||0
2973995|NCT00813709|3688794|FG003|COMPLETED|Open Label Period||38
2973996|NCT00813709|3688795|FG004|COMPLETED|Open Label Period||41
2973997|NCT00813709|3688796|FG005|COMPLETED|Open Label Period||35
2973998|NCT00813709|3688791|FG000|NOT COMPLETED|Open Label Period||0
2973999|NCT00813709|3688792|FG001|NOT COMPLETED|Open Label Period||0
2974000|NCT00813709|3688793|FG002|NOT COMPLETED|Open Label Period||0
2974001|NCT00813709|3688794|FG003|NOT COMPLETED|Open Label Period||20
2974002|NCT00813709|3688795|FG004|NOT COMPLETED|Open Label Period||10
2974003|NCT00813709|3688796|FG005|NOT COMPLETED|Open Label Period||11
2974004|NCT00813748|3688827|FG000|STARTED|Main Observational Study||30
2974005|NCT00813748|3688828|FG001|STARTED|Main Observational Study||88
2974006|NCT00813748|3688827|FG000|COMPLETED|Main Observational Study||30
2974007|NCT00813748|3688828|FG001|COMPLETED|Main Observational Study||88
2974008|NCT00813748|3688827|FG000|NOT COMPLETED|Main Observational Study||0
2974009|NCT00813748|3688828|FG001|NOT COMPLETED|Main Observational Study||0
2974010|NCT00813748|3688827|FG000|STARTED|Skin Test Substudy|Included participants who discontinued omalizumab for at least 16 weeks but not more than 18 months.|3
2974011|NCT00813748|3688828|FG001|STARTED|Skin Test Substudy|Included participants who discontinued omalizumab for at least 16 weeks but not more than 18 months.|8
2974012|NCT00813748|3688827|FG000|COMPLETED|Skin Test Substudy||3
2974013|NCT00813748|3688828|FG001|COMPLETED|Skin Test Substudy||7
2974014|NCT00813748|3688827|FG000|NOT COMPLETED|Skin Test Substudy||0
2974015|NCT00813748|3688828|FG001|NOT COMPLETED|Skin Test Substudy||1
2974016|NCT00813761|3688838|FG000|STARTED|Phase 1 (Baseline to 4 Weeks)||121
2974017|NCT00813761|3688839|FG001|STARTED|Phase 1 (Baseline to 4 Weeks)||103
2974018|NCT00813761|3688840|FG002|STARTED|Phase 1 (Baseline to 4 Weeks)||115
2974019|NCT00813761|3688841|FG003|STARTED|Phase 1 (Baseline to 4 Weeks)||107
2974020|NCT00813761|3688838|FG000|COMPLETED|Phase 1 (Baseline to 4 Weeks)||117
2974021|NCT00813761|3688839|FG001|COMPLETED|Phase 1 (Baseline to 4 Weeks)||100
2974022|NCT00813761|3688840|FG002|COMPLETED|Phase 1 (Baseline to 4 Weeks)||103
2974023|NCT00813761|3688841|FG003|COMPLETED|Phase 1 (Baseline to 4 Weeks)||105
2974024|NCT00813761|3688838|FG000|NOT COMPLETED|Phase 1 (Baseline to 4 Weeks)||4
2974025|NCT00813761|3688839|FG001|NOT COMPLETED|Phase 1 (Baseline to 4 Weeks)||3
2974026|NCT00813761|3688840|FG002|NOT COMPLETED|Phase 1 (Baseline to 4 Weeks)||12
2974027|NCT00813761|3688841|FG003|NOT COMPLETED|Phase 1 (Baseline to 4 Weeks)||2
2974028|NCT00813761|3688838|FG000|STARTED|Phase 2 (4 Weeks to 24 Weeks)||117
2974029|NCT00813761|3688839|FG001|STARTED|Phase 2 (4 Weeks to 24 Weeks)||100
2974030|NCT00813761|3688840|FG002|STARTED|Phase 2 (4 Weeks to 24 Weeks)||103
2974031|NCT00813761|3688841|FG003|STARTED|Phase 2 (4 Weeks to 24 Weeks)||105
2974032|NCT00813761|3688838|FG000|COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||101
2974033|NCT00813761|3688839|FG001|COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||91
2974034|NCT00813761|3688840|FG002|COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||94
2974035|NCT00813761|3688841|FG003|COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||100
2974036|NCT00813761|3688838|FG000|NOT COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||16
2974037|NCT00813761|3688839|FG001|NOT COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||9
2974038|NCT00813761|3688840|FG002|NOT COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||9
2974039|NCT00813761|3688841|FG003|NOT COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||5
2974040|NCT00813800|3688857|FG000|STARTED|Overall Study||11
2974041|NCT00813800|3688857|FG000|COMPLETED|Overall Study||5
2974042|NCT00813800|3688857|FG000|NOT COMPLETED|Overall Study||6
2974043|NCT00813813|3688863|FG000|STARTED|Overall Study||7
2974044|NCT00813813|3688864|FG001|STARTED|Overall Study||25
2974045|NCT00813813|3688863|FG000|COMPLETED|Overall Study||4
2974046|NCT00813813|3688864|FG001|COMPLETED|Overall Study||16
2974047|NCT00813813|3688863|FG000|NOT COMPLETED|Overall Study||3
2974048|NCT00813813|3688864|FG001|NOT COMPLETED|Overall Study||9
2974049|NCT00813865|3688870|FG000|STARTED|Overall Study||8
2974050|NCT00813865|3688870|FG000|Safety Population|Overall Study||8
2974051|NCT00813865|3688870|FG000|Pharmacodynamic (PD) Population|Overall Study||8
2974052|NCT00813865|3688870|FG000|COMPLETED|Overall Study||1
2974053|NCT00813865|3688870|FG000|NOT COMPLETED|Overall Study||7
2974054|NCT00813904|3688874|FG000|STARTED|Overall Study||31
2974055|NCT00813904|3688874|FG000|COMPLETED|Overall Study||30
2974056|NCT00813904|3688874|FG000|NOT COMPLETED|Overall Study||1
2974057|NCT00813917|3688880|FG000|STARTED|Overall Study||38
2974058|NCT00813917|3688881|FG001|STARTED|Overall Study||38
2974059|NCT00813917|3688880|FG000|COMPLETED|Overall Study||32
2974060|NCT00813917|3688881|FG001|COMPLETED|Overall Study||32
2974061|NCT00813917|3688880|FG000|NOT COMPLETED|Overall Study||6
2974062|NCT00813917|3688881|FG001|NOT COMPLETED|Overall Study||6
2974063|NCT00813943|3688890|FG000|STARTED|Overall Study||88
2974064|NCT00813943|3688891|FG001|STARTED|Overall Study||88
2974065|NCT00813943|3688892|FG002|STARTED|Overall Study||89
2974066|NCT00813943|3688890|FG000|COMPLETED|Overall Study||83
2974067|NCT00813943|3688891|FG001|COMPLETED|Overall Study||83
2974068|NCT00813943|3688892|FG002|COMPLETED|Overall Study||86
2974069|NCT00813943|3688890|FG000|NOT COMPLETED|Overall Study||5
2974070|NCT00813943|3688891|FG001|NOT COMPLETED|Overall Study||5
2974071|NCT00813943|3688892|FG002|NOT COMPLETED|Overall Study||3
2974072|NCT00813982|3688901|FG000|STARTED|Overall Study||59
2974073|NCT00813982|3688901|FG000|COMPLETED|Overall Study||59
2974074|NCT00813982|3688901|FG000|NOT COMPLETED|Overall Study||0
2974075|NCT00813995|3688909|FG000|STARTED|Overall Study||197
2974076|NCT00813995|3688910|FG001|STARTED|Overall Study||198
2974077|NCT00813995|3688909|FG000|COMPLETED|Overall Study||174
2974078|NCT00813995|3688910|FG001|COMPLETED|Overall Study||182
2974079|NCT00813995|3688909|FG000|NOT COMPLETED|Overall Study||23
2974080|NCT00813995|3688910|FG001|NOT COMPLETED|Overall Study||16
2974081|NCT00814138|3688922|FG000|STARTED|Overall Study||25
2974082|NCT00814138|3688923|FG001|STARTED|Overall Study||25
2974083|NCT00814138|3688922|FG000|COMPLETED|Overall Study||24
2974084|NCT00814138|3688923|FG001|COMPLETED|Overall Study||18
2974085|NCT00814138|3688922|FG000|NOT COMPLETED|Overall Study||1
2974086|NCT00814138|3688923|FG001|NOT COMPLETED|Overall Study||7
2974087|NCT00814164|3688931|FG000|STARTED|Overall Study||21
2974088|NCT00814164|3688931|FG000|COMPLETED|Overall Study||2
2974089|NCT00814164|3688931|FG000|NOT COMPLETED|Overall Study||19
2974090|NCT00814177|3688937|FG000|STARTED|Overall Study||80
2974091|NCT00814177|3688938|FG001|STARTED|Overall Study||80
2974092|NCT00814177|3688937|FG000|COMPLETED|Overall Study||80
2974093|NCT00814177|3688938|FG001|COMPLETED|Overall Study||80
2974094|NCT00814177|3688937|FG000|NOT COMPLETED|Overall Study||0
2974095|NCT00814177|3688938|FG001|NOT COMPLETED|Overall Study||0
2974096|NCT00814255|3688947|FG000|STARTED|Overall Study||8
2974097|NCT00814255|3688948|FG001|STARTED|Overall Study||7
2974098|NCT00814255|3688949|FG002|STARTED|Overall Study||8
2974099|NCT00814255|3688947|FG000|COMPLETED|Overall Study||7
2974100|NCT00814255|3688948|FG001|COMPLETED|Overall Study||7
2974101|NCT00814255|3688949|FG002|COMPLETED|Overall Study||7
2974102|NCT00814255|3688947|FG000|NOT COMPLETED|Overall Study||1
2974103|NCT00814255|3688948|FG001|NOT COMPLETED|Overall Study||0
2974104|NCT00814255|3688949|FG002|NOT COMPLETED|Overall Study||1
2974105|NCT00814307|3688964|FG000|STARTED|Overall Study||244
2974106|NCT00814307|3688965|FG001|STARTED|Overall Study||245
2974107|NCT00814307|3688966|FG002|STARTED|Overall Study||61
2974108|NCT00814307|3688967|FG003|STARTED|Overall Study||61
2974109|NCT00814307|3688964|FG000|Treated|Overall Study||243
2974110|NCT00814307|3688965|FG001|Treated|Overall Study||245
2974111|NCT00814307|3688966|FG002|Treated|Overall Study||61
2974112|NCT00814307|3688967|FG003|Treated|Overall Study||61
2974113|NCT00814307|3688964|FG000|COMPLETED|Overall Study||232
2974114|NCT00814307|3688965|FG001|COMPLETED|Overall Study||218
2974115|NCT00814307|3688966|FG002|COMPLETED|Overall Study||54
2974116|NCT00814307|3688967|FG003|COMPLETED|Overall Study||51
2974117|NCT00814307|3688964|FG000|NOT COMPLETED|Overall Study||12
2974118|NCT00814307|3688965|FG001|NOT COMPLETED|Overall Study||27
2974119|NCT00814307|3688966|FG002|NOT COMPLETED|Overall Study||7
2974120|NCT00814307|3688967|FG003|NOT COMPLETED|Overall Study||10
2974121|NCT00814320|3688981|FG000|STARTED|Epoch 1 (IV Treatment)||14
2974122|NCT00814320|3688982|FG001|STARTED|Epoch 1 (IV Treatment)||73
2974123|NCT00814320|3688981|FG000|COMPLETED|Epoch 1 (IV Treatment)||13
2974124|NCT00814320|3688982|FG001|COMPLETED|Epoch 1 (IV Treatment)||71
2974125|NCT00814320|3688981|FG000|NOT COMPLETED|Epoch 1 (IV Treatment)||1
2974126|NCT00814320|3688982|FG001|NOT COMPLETED|Epoch 1 (IV Treatment)||2
2974127|NCT00814320|3688981|FG000|STARTED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||13
2974128|NCT00814320|3688982|FG001|STARTED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||71
2974129|NCT00814320|3688981|FG000|COMPLETED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||13
2974130|NCT00814320|3688982|FG001|COMPLETED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||70
2974131|NCT00814320|3688981|FG000|NOT COMPLETED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||0
2974132|NCT00814320|3688982|FG001|NOT COMPLETED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||1
2974133|NCT00814320|3688981|FG000|STARTED|"Epoch 2 Ramp-up (Ramp-up)"||13
2974134|NCT00814320|3688982|FG001|STARTED|"Epoch 2 Ramp-up (Ramp-up)"||70
2974135|NCT00814320|3688981|FG000|COMPLETED|"Epoch 2 Ramp-up (Ramp-up)"||11
2974136|NCT00814320|3688982|FG001|COMPLETED|"Epoch 2 Ramp-up (Ramp-up)"||70
2974137|NCT00814320|3688981|FG000|NOT COMPLETED|"Epoch 2 Ramp-up (Ramp-up)"||2
2974138|NCT00814320|3688982|FG001|NOT COMPLETED|"Epoch 2 Ramp-up (Ramp-up)"||0
2974139|NCT00814320|3688981|FG000|STARTED|Epoch 2 After Ramp-up (SC/rHuPH20)||11
2974140|NCT00814320|3688982|FG001|STARTED|Epoch 2 After Ramp-up (SC/rHuPH20)||70
2974141|NCT00814320|3688981|FG000|COMPLETED|Epoch 2 After Ramp-up (SC/rHuPH20)||8
2974142|NCT00814320|3688982|FG001|COMPLETED|Epoch 2 After Ramp-up (SC/rHuPH20)|Three participants who switched to safety follow-up remained in the study.|60
2974143|NCT00814320|3688981|FG000|NOT COMPLETED|Epoch 2 After Ramp-up (SC/rHuPH20)||3
2974144|NCT00814320|3688982|FG001|NOT COMPLETED|Epoch 2 After Ramp-up (SC/rHuPH20)||10
2974145|NCT00814346|3689007|FG000|STARTED|Double-blind Phase (4 Weeks)||23
2974146|NCT00814346|3689008|FG001|STARTED|Double-blind Phase (4 Weeks)||26
2974147|NCT00814346|3689007|FG000|CNE|Double-blind Phase (4 Weeks)||10
2974148|NCT00814346|3689008|FG001|CNE|Double-blind Phase (4 Weeks)||13
2974149|NCT00814346|3689007|FG000|MC|Double-blind Phase (4 Weeks)||10
2974150|NCT00814346|3689008|FG001|MC|Double-blind Phase (4 Weeks)||11
2974151|NCT00814346|3689007|FG000|AD|Double-blind Phase (4 Weeks)||3
2974152|NCT00814346|3689008|FG001|AD|Double-blind Phase (4 Weeks)||2
2974153|NCT00814346|3689007|FG000|COMPLETED|Double-blind Phase (4 Weeks)||23
2974154|NCT00814346|3689008|FG001|COMPLETED|Double-blind Phase (4 Weeks)||23
2974155|NCT00814346|3689007|FG000|NOT COMPLETED|Double-blind Phase (4 Weeks)||0
2974156|NCT00814346|3689008|FG001|NOT COMPLETED|Double-blind Phase (4 Weeks)||3
2974157|NCT00814346|3689007|FG000|STARTED|Open Phase (17 Months)|Open period was treated with EGB761®. 41 subjects accepted follow-up open period(21 in CNE,20 in MC)|41
2974158|NCT00814346|3689008|FG001|STARTED|Open Phase (17 Months)|This was an open period, without placebo arm, the number of subject on placebo is 0.|0
2974159|NCT00814346|3689007|FG000|CNE|Open Phase (17 Months)||21
2974160|NCT00814346|3689008|FG001|CNE|Open Phase (17 Months)||0
2974161|NCT00814346|3689007|FG000|MC|Open Phase (17 Months)||20
2974162|NCT00814346|3689008|FG001|MC|Open Phase (17 Months)||0
2974163|NCT00814346|3689007|FG000|AD|Open Phase (17 Months)|Open period was not proposed to AD subjects.|0
2974164|NCT00814346|3689008|FG001|AD|Open Phase (17 Months)||0
2974165|NCT00814346|3689007|FG000|COMPLETED|Open Phase (17 Months)||31
2974166|NCT00814346|3689008|FG001|COMPLETED|Open Phase (17 Months)||0
2974167|NCT00814346|3689007|FG000|NOT COMPLETED|Open Phase (17 Months)||10
2974168|NCT00814346|3689008|FG001|NOT COMPLETED|Open Phase (17 Months)||0
2974169|NCT00814463|3689027|FG000|STARTED|Overall Study||1
2974170|NCT00814463|3689027|FG000|COMPLETED|Overall Study||0
2974171|NCT00814463|3689027|FG000|NOT COMPLETED|Overall Study||1
2974172|NCT00814489|3689035|FG000|STARTED|Overall Study||15
2974173|NCT00814489|3689036|FG001|STARTED|Overall Study||17
2974174|NCT00814489|3689037|FG002|STARTED|Overall Study||8
2974175|NCT00814489|3689035|FG000|COMPLETED|Overall Study||13
2974176|NCT00814489|3689036|FG001|COMPLETED|Overall Study||17
2974177|NCT00814489|3689037|FG002|COMPLETED|Overall Study||7
2974178|NCT00814489|3689035|FG000|NOT COMPLETED|Overall Study||2
2974179|NCT00814489|3689036|FG001|NOT COMPLETED|Overall Study||0
2974180|NCT00814489|3689037|FG002|NOT COMPLETED|Overall Study||1
2974181|NCT00814502|3689049|FG000|STARTED|Overall Study||8
2974182|NCT00814502|3689050|FG001|STARTED|Overall Study||9
2974183|NCT00814502|3689049|FG000|COMPLETED|Overall Study||7
2974184|NCT00814502|3689050|FG001|COMPLETED|Overall Study||7
2974185|NCT00814502|3689049|FG000|NOT COMPLETED|Overall Study||1
3164096|NCT01890785|3891532|FG002|NOT COMPLETED|Second Intervention||0
3164097|NCT01890785|3891533|FG003|NOT COMPLETED|Second Intervention||0
3164098|NCT01890785|3891534|FG004|NOT COMPLETED|Second Intervention||0
3164099|NCT01890785|3891535|FG005|NOT COMPLETED|Second Intervention||0
3164100|NCT01890785|3891530|FG000|STARTED|Third Intervention||5
3164101|NCT01890785|3891531|FG001|STARTED|Third Intervention||5
2974186|NCT00814502|3689050|FG001|NOT COMPLETED|Overall Study||2
2974187|NCT00814580|3689060|FG000|STARTED|Overall Study||194
2974188|NCT00814580|3689061|FG001|STARTED|Overall Study||188
2974189|NCT00814580|3689060|FG000|COMPLETED|Overall Study||163
2974190|NCT00814580|3689061|FG001|COMPLETED|Overall Study||141
2974191|NCT00814580|3689060|FG000|NOT COMPLETED|Overall Study||31
3164102|NCT01890785|3891532|FG002|STARTED|Third Intervention||5
3164103|NCT01890785|3891533|FG003|STARTED|Third Intervention||5
3164104|NCT01890785|3891534|FG004|STARTED|Third Intervention||5
3164105|NCT01890785|3891535|FG005|STARTED|Third Intervention||5
2974192|NCT00814580|3689061|FG001|NOT COMPLETED|Overall Study||47
2974193|NCT00814632|3689079|FG000|STARTED|Overall Study|Ten were allocated to treatment intervention however one was not treated due to lactose allergy.|9
2974194|NCT00814632|3689079|FG000|COMPLETED|Overall Study|Two subjects withdrew early due to lack of efficacy.|7
2974195|NCT00814632|3689079|FG000|NOT COMPLETED|Overall Study||2
2974196|NCT00814658|3689085|FG000|STARTED|Overall Study||9
2974197|NCT00814658|3689086|FG001|STARTED|Overall Study||12
2974198|NCT00814658|3689085|FG000|COMPLETED|Overall Study||5
2974199|NCT00814658|3689086|FG001|COMPLETED|Overall Study||8
2974200|NCT00814658|3689085|FG000|NOT COMPLETED|Overall Study||4
2974201|NCT00814658|3689086|FG001|NOT COMPLETED|Overall Study||4
2974202|NCT00814671|3689105|FG000|STARTED|Overall Study||54
2974203|NCT00814671|3689106|FG001|STARTED|Overall Study||48
2974204|NCT00814671|3689107|FG002|STARTED|Overall Study||51
2974205|NCT00814671|3689105|FG000|COMPLETED|Overall Study||47
2974206|NCT00814671|3689106|FG001|COMPLETED|Overall Study||44
2974207|NCT00814671|3689107|FG002|COMPLETED|Overall Study||49
2974208|NCT00814671|3689105|FG000|NOT COMPLETED|Overall Study||7
2974209|NCT00814671|3689106|FG001|NOT COMPLETED|Overall Study||4
2974210|NCT00814671|3689107|FG002|NOT COMPLETED|Overall Study||2
3164106|NCT01890785|3891530|FG000|COMPLETED|Third Intervention||5
2974211|NCT00814697|3689119|FG000|STARTED|Overall Study||12
2974212|NCT00814697|3689119|FG000|COMPLETED|Overall Study||12
2974213|NCT00814697|3689119|FG000|NOT COMPLETED|Overall Study||0
2974214|NCT00814710|3689125|FG000|STARTED|Overall Study||240
2974215|NCT00814710|3689126|FG001|STARTED|Overall Study||120
2974216|NCT00814710|3689125|FG000|COMPLETED|Overall Study||232
2974217|NCT00814710|3689126|FG001|COMPLETED|Overall Study||117
2974218|NCT00814710|3689125|FG000|NOT COMPLETED|Overall Study||8
2974219|NCT00814710|3689126|FG001|NOT COMPLETED|Overall Study||3
2974220|NCT00814775|3689134|FG000|STARTED|Overall Study||23
2974221|NCT00814775|3689135|FG001|STARTED|Overall Study||20
2974222|NCT00814775|3689134|FG000|COMPLETED|Overall Study||23
2974223|NCT00814775|3689135|FG001|COMPLETED|Overall Study||20
2974224|NCT00814775|3689134|FG000|NOT COMPLETED|Overall Study||0
2974225|NCT00814775|3689135|FG001|NOT COMPLETED|Overall Study||0
2974226|NCT00814788|3689141|FG000|STARTED|Overall Study||24
2974227|NCT00814788|3689141|FG000|COMPLETED|Overall Study||24
2974228|NCT00814788|3689141|FG000|NOT COMPLETED|Overall Study||0
2974229|NCT00814801|3689150|FG000|STARTED|Overall Study||194
2974230|NCT00814801|3689151|FG001|STARTED|Overall Study||192
2974231|NCT00814801|3689152|FG002|STARTED|Overall Study||194
2974232|NCT00814801|3689150|FG000|COMPLETED|Overall Study||160
2974233|NCT00814801|3689151|FG001|COMPLETED|Overall Study||154
2974234|NCT00814801|3689152|FG002|COMPLETED|Overall Study||151
2974235|NCT00814801|3689150|FG000|NOT COMPLETED|Overall Study||34
2974236|NCT00814801|3689151|FG001|NOT COMPLETED|Overall Study||38
2974237|NCT00814801|3689152|FG002|NOT COMPLETED|Overall Study||43
2974238|NCT00814879|3689162|FG000|STARTED|By Week 24||28
2974239|NCT00814879|3689163|FG001|STARTED|By Week 24||30
2974240|NCT00814879|3689162|FG000|COMPLETED|By Week 24||27
2974241|NCT00814879|3689163|FG001|COMPLETED|By Week 24||29
2974242|NCT00814879|3689162|FG000|NOT COMPLETED|By Week 24||1
2974243|NCT00814879|3689163|FG001|NOT COMPLETED|By Week 24||1
2974244|NCT00814879|3689162|FG000|STARTED|By Week 48||27
2974245|NCT00814879|3689163|FG001|STARTED|By Week 48||29
2974246|NCT00814879|3689162|FG000|COMPLETED|By Week 48||25
2974247|NCT00814879|3689163|FG001|COMPLETED|By Week 48||26
2974248|NCT00814879|3689162|FG000|NOT COMPLETED|By Week 48||2
2974249|NCT00814879|3689163|FG001|NOT COMPLETED|By Week 48||3
2974250|NCT00814970|3689170|FG000|STARTED|Overall Study||196
2974251|NCT00814970|3689170|FG000|COMPLETED|Overall Study||146
2974252|NCT00814970|3689170|FG000|NOT COMPLETED|Overall Study||50
2974253|NCT00815035|3689178|FG000|STARTED|Blinded Phase||10
2974254|NCT00815035|3689179|FG001|STARTED|Blinded Phase||6
2974255|NCT00815035|3689180|FG002|STARTED|Blinded Phase||0
2974256|NCT00815035|3689178|FG000|COMPLETED|Blinded Phase||9
2974257|NCT00815035|3689179|FG001|COMPLETED|Blinded Phase||6
2974258|NCT00815035|3689180|FG002|COMPLETED|Blinded Phase||0
2974259|NCT00815035|3689178|FG000|NOT COMPLETED|Blinded Phase||1
2974260|NCT00815035|3689179|FG001|NOT COMPLETED|Blinded Phase||0
2974261|NCT00815035|3689180|FG002|NOT COMPLETED|Blinded Phase||0
2974262|NCT00815035|3689178|FG000|STARTED|Open Label Extension Phase|After unblinding, subjects completing the blinded phase moved to the open-label phase of the study|0
2974263|NCT00815035|3689179|FG001|STARTED|Open Label Extension Phase|After unblinding, subjects completing the blinded phase moved to the open-label phase of the study|0
2974264|NCT00815035|3689180|FG002|STARTED|Open Label Extension Phase|After unblinding, subjects completing the blinded phase moved to the open-label phase of the study|15
2974265|NCT00815035|3689178|FG000|COMPLETED|Open Label Extension Phase||0
2974266|NCT00815035|3689179|FG001|COMPLETED|Open Label Extension Phase||0
2974267|NCT00815035|3689180|FG002|COMPLETED|Open Label Extension Phase||9
2974268|NCT00815035|3689178|FG000|NOT COMPLETED|Open Label Extension Phase||0
2974269|NCT00815035|3689179|FG001|NOT COMPLETED|Open Label Extension Phase||0
2974270|NCT00815035|3689180|FG002|NOT COMPLETED|Open Label Extension Phase||6
2974271|NCT00815087|3689191|FG000|STARTED|Overall Study||10
2974272|NCT00815087|3689192|FG001|STARTED|Overall Study||10
2974273|NCT00815087|3689191|FG000|COMPLETED|Overall Study||10
2974274|NCT00815087|3689192|FG001|COMPLETED|Overall Study||10
2974275|NCT00815087|3689191|FG000|NOT COMPLETED|Overall Study||0
2974276|NCT00815087|3689192|FG001|NOT COMPLETED|Overall Study||0
2974277|NCT00815191|3689200|FG000|STARTED|Overall Study||38
2974278|NCT00815191|3689201|FG001|STARTED|Overall Study||35
2974279|NCT00815191|3689200|FG000|COMPLETED|Overall Study||37
2974280|NCT00815191|3689201|FG001|COMPLETED|Overall Study||34
2974281|NCT00815191|3689200|FG000|NOT COMPLETED|Overall Study||1
2974282|NCT00815191|3689201|FG001|NOT COMPLETED|Overall Study||1
2974283|NCT00815295|3689210|FG000|STARTED|Overall Study||8
2974284|NCT00815295|3689211|FG001|STARTED|Overall Study||8
2974285|NCT00815295|3689212|FG002|STARTED|Overall Study||12
2974286|NCT00815295|3689210|FG000|COMPLETED|Overall Study||8
2974287|NCT00815295|3689211|FG001|COMPLETED|Overall Study||7
2974288|NCT00815295|3689212|FG002|COMPLETED|Overall Study||9
2974289|NCT00815295|3689210|FG000|NOT COMPLETED|Overall Study||0
2974290|NCT00815295|3689211|FG001|NOT COMPLETED|Overall Study||1
2974291|NCT00815295|3689212|FG002|NOT COMPLETED|Overall Study||3
2974292|NCT00815308|3689220|FG000|STARTED|Overall Study||55
2974293|NCT00815308|3689220|FG000|COMPLETED|Overall Study||45
2974294|NCT00815308|3689220|FG000|NOT COMPLETED|Overall Study||10
2974295|NCT00815347|3689224|FG000|STARTED|Overall Study||11
2974296|NCT00815347|3689224|FG000|COMPLETED|Overall Study||7
2974297|NCT00815347|3689224|FG000|NOT COMPLETED|Overall Study||4
2974298|NCT00815360|3689232|FG000|STARTED|Overall Study||11
2974299|NCT00815360|3689233|FG001|STARTED|Overall Study||11
2974300|NCT00815360|3689232|FG000|COMPLETED|Overall Study||11
2974301|NCT00815360|3689233|FG001|COMPLETED|Overall Study||11
2974302|NCT00815360|3689232|FG000|NOT COMPLETED|Overall Study||0
2974303|NCT00815360|3689233|FG001|NOT COMPLETED|Overall Study||0
2974304|NCT00815490|3689241|FG000|STARTED|Overall Study||9
2974305|NCT00815490|3689242|FG001|STARTED|Overall Study||9
2974306|NCT00815490|3689241|FG000|COMPLETED|Overall Study||9
2974307|NCT00815490|3689242|FG001|COMPLETED|Overall Study||9
2974308|NCT00815490|3689241|FG000|NOT COMPLETED|Overall Study||0
2974309|NCT00815490|3689242|FG001|NOT COMPLETED|Overall Study||0
2974310|NCT00815516|3689250|FG000|STARTED|Overall Study||20
2974311|NCT00815516|3689251|FG001|STARTED|Overall Study||10
2974312|NCT00815516|3689250|FG000|COMPLETED|Overall Study||16
2974313|NCT00815516|3689251|FG001|COMPLETED|Overall Study||9
2974314|NCT00815516|3689250|FG000|NOT COMPLETED|Overall Study||4
2974315|NCT00815516|3689251|FG001|NOT COMPLETED|Overall Study||1
2974316|NCT00815659|3689257|FG000|STARTED|Overall Study||97
2974317|NCT00815659|3689257|FG000|COMPLETED|Overall Study||74
2974318|NCT00815659|3689257|FG000|NOT COMPLETED|Overall Study||23
2974319|NCT00815685|3689261|FG000|STARTED|Overall Study||36
2974320|NCT00815685|3689261|FG000|COMPLETED|Overall Study|Complete pre and post-treatment serum samples were available for 14 participants.|14
2974321|NCT00815685|3689261|FG000|NOT COMPLETED|Overall Study||22
2974322|NCT00815698|3689267|FG000|STARTED|Overall Study||163
2974323|NCT00815698|3689268|FG001|STARTED|Overall Study||171
2974324|NCT00815698|3689267|FG000|COMPLETED|Overall Study||163
2974325|NCT00815698|3689268|FG001|COMPLETED|Overall Study||171
2974326|NCT00815698|3689267|FG000|NOT COMPLETED|Overall Study||0
2974327|NCT00815698|3689268|FG001|NOT COMPLETED|Overall Study||0
2974328|NCT00815776|3689277|FG000|STARTED|Overall Study||60
2974329|NCT00815776|3689278|FG001|STARTED|Overall Study||64
2974330|NCT00815776|3689279|FG002|STARTED|Overall Study||28
2974331|NCT00815776|3689277|FG000|COMPLETED|Overall Study||52
2974332|NCT00815776|3689278|FG001|COMPLETED|Overall Study||56
2974333|NCT00815776|3689279|FG002|COMPLETED|Overall Study||22
2974334|NCT00815776|3689277|FG000|NOT COMPLETED|Overall Study||8
2974335|NCT00815776|3689278|FG001|NOT COMPLETED|Overall Study||8
2974336|NCT00815776|3689279|FG002|NOT COMPLETED|Overall Study||6
2974337|NCT00815919|3689290|FG000|STARTED|Overall Study||22
2974338|NCT00815919|3689290|FG000|COMPLETED|Overall Study||18
2974339|NCT00815919|3689290|FG000|NOT COMPLETED|Overall Study||4
2974340|NCT00815997|3689296|FG000|STARTED|Overall Study||80
2974341|NCT00815997|3689297|FG001|STARTED|Overall Study||80
2974342|NCT00815997|3689296|FG000|COMPLETED|Overall Study||80
2974343|NCT00815997|3689297|FG001|COMPLETED|Overall Study||80
2974344|NCT00815997|3689296|FG000|NOT COMPLETED|Overall Study||0
2974345|NCT00815997|3689297|FG001|NOT COMPLETED|Overall Study||0
2974346|NCT00816023|3689309|FG000|STARTED|Overall Study||71
2974347|NCT00816023|3689310|FG001|STARTED|Overall Study||62
2974348|NCT00816023|3689311|FG002|STARTED|Overall Study||69
2974349|NCT00816023|3689312|FG003|STARTED|Overall Study||74
2974350|NCT00816023|3689309|FG000|Completed Therapy|Overall Study||65
2974351|NCT00816023|3689310|FG001|Completed Therapy|Overall Study||59
2974352|NCT00816023|3689311|FG002|Completed Therapy|Overall Study||61
2974353|NCT00816023|3689312|FG003|Completed Therapy|Overall Study||63
2974354|NCT00816023|3689309|FG000|COMPLETED|Overall Study||62
2974355|NCT00816023|3689310|FG001|COMPLETED|Overall Study||56
2974356|NCT00816023|3689311|FG002|COMPLETED|Overall Study||60
2974357|NCT00816023|3689312|FG003|COMPLETED|Overall Study||62
2974358|NCT00816023|3689309|FG000|NOT COMPLETED|Overall Study||9
2974359|NCT00816023|3689310|FG001|NOT COMPLETED|Overall Study||6
2974360|NCT00816023|3689311|FG002|NOT COMPLETED|Overall Study||9
2974361|NCT00816023|3689312|FG003|NOT COMPLETED|Overall Study||12
2974362|NCT00816036|3689324|FG000|STARTED|Overall Study||503
2974363|NCT00816036|3689325|FG001|STARTED|Overall Study||395
2974364|NCT00816036|3689324|FG000|COMPLETED|Overall Study||327
2974365|NCT00816036|3689325|FG001|COMPLETED|Overall Study||287
2974366|NCT00816036|3689324|FG000|NOT COMPLETED|Overall Study||176
2974367|NCT00816036|3689325|FG001|NOT COMPLETED|Overall Study||108
2974368|NCT00816062|3689331|FG000|STARTED|Overall Study||260
2974369|NCT00816062|3689331|FG000|COMPLETED|Overall Study||133
2974370|NCT00816062|3689331|FG000|NOT COMPLETED|Overall Study||127
2974371|NCT00816101|3689339|FG000|STARTED|Overall Study||13
2974372|NCT00816101|3689340|FG001|STARTED|Overall Study||8
2974373|NCT00816101|3689341|FG002|STARTED|Overall Study||5
2974374|NCT00816101|3689339|FG000|COMPLETED|Overall Study||13
2974375|NCT00816101|3689340|FG001|COMPLETED|Overall Study||8
2974376|NCT00816101|3689341|FG002|COMPLETED|Overall Study||5
2974377|NCT00816101|3689339|FG000|NOT COMPLETED|Overall Study||0
2974378|NCT00816101|3689340|FG001|NOT COMPLETED|Overall Study||0
2974379|NCT00816101|3689341|FG002|NOT COMPLETED|Overall Study||0
2974380|NCT00816166|3689351|FG000|STARTED|Overall Study|Of 59 randomized to Stent Arm, 4 were treated with Medical Therapy Only|59
2974381|NCT00816166|3689352|FG001|STARTED|Overall Study|Of 53 randomized to Medical Therapy Arm, 9 were treated with Stent+Medical Therapy|53
2974382|NCT00816166|3689351|FG000|ITT Population (Met Eligibility)|Overall Study|Of 59 randomized to Stent Arm, 1 subject failed to meet eligibility and was excluded from the ITT|58
2974383|NCT00816166|3689352|FG001|ITT Population (Met Eligibility)|Overall Study||53
2974384|NCT00816166|3689351|FG000|COMPLETED|Overall Study||49
2974385|NCT00816166|3689352|FG001|COMPLETED|Overall Study||41
2974386|NCT00816166|3689351|FG000|NOT COMPLETED|Overall Study||10
2974387|NCT00816166|3689352|FG001|NOT COMPLETED|Overall Study||12
2974388|NCT00816348|3689358|FG000|STARTED|Overall Study||15
2974389|NCT00816348|3689358|FG000|COMPLETED|Overall Study||15
2974390|NCT00816348|3689358|FG000|NOT COMPLETED|Overall Study||0
2974391|NCT00816361|3689369|FG000|STARTED|Overall Study||4
2974392|NCT00816361|3689370|FG001|STARTED|Overall Study||3
2974393|NCT00816361|3689371|FG002|STARTED|Overall Study||4
2974394|NCT00816361|3689372|FG003|STARTED|Overall Study||3
2974395|NCT00816361|3689373|FG004|STARTED|Overall Study||3
2974396|NCT00816361|3689374|FG005|STARTED|Overall Study||3
2974397|NCT00816361|3689375|FG006|STARTED|Overall Study||3
2974398|NCT00816361|3689376|FG007|STARTED|Overall Study||10
2974399|NCT00816361|3689377|FG008|STARTED|Overall Study||10
2974400|NCT00816361|3689369|FG000|COMPLETED|Overall Study||0
2974401|NCT00816361|3689370|FG001|COMPLETED|Overall Study||0
2974402|NCT00816361|3689371|FG002|COMPLETED|Overall Study||1
2974403|NCT00816361|3689372|FG003|COMPLETED|Overall Study||0
2974404|NCT00816361|3689373|FG004|COMPLETED|Overall Study||1
2974405|NCT00816361|3689374|FG005|COMPLETED|Overall Study||0
2974406|NCT00816361|3689375|FG006|COMPLETED|Overall Study||0
2974407|NCT00816361|3689376|FG007|COMPLETED|Overall Study||1
2974408|NCT00816361|3689377|FG008|COMPLETED|Overall Study||0
2974409|NCT00816361|3689369|FG000|NOT COMPLETED|Overall Study||4
2974410|NCT00816361|3689370|FG001|NOT COMPLETED|Overall Study||3
2974411|NCT00816361|3689371|FG002|NOT COMPLETED|Overall Study||3
2974412|NCT00816361|3689372|FG003|NOT COMPLETED|Overall Study||3
2974413|NCT00816361|3689373|FG004|NOT COMPLETED|Overall Study||2
2974414|NCT00816361|3689374|FG005|NOT COMPLETED|Overall Study||3
2974415|NCT00816361|3689375|FG006|NOT COMPLETED|Overall Study||3
2974416|NCT00816361|3689376|FG007|NOT COMPLETED|Overall Study||9
2974417|NCT00816361|3689377|FG008|NOT COMPLETED|Overall Study||10
2974418|NCT00816400|3689407|FG000|STARTED|Overall Study||3
2974419|NCT00816400|3689408|FG001|STARTED|Overall Study||3
2974420|NCT00816400|3689409|FG002|STARTED|Overall Study||5
2974421|NCT00816400|3689410|FG003|STARTED|Overall Study||3
2974422|NCT00816400|3689411|FG004|STARTED|Overall Study||3
2974423|NCT00816400|3689412|FG005|STARTED|Overall Study||3
2974424|NCT00816400|3689413|FG006|STARTED|Overall Study||3
2974425|NCT00816400|3689414|FG007|STARTED|Overall Study||6
2974426|NCT00816400|3689415|FG008|STARTED|Overall Study||6
2974427|NCT00816400|3689407|FG000|COMPLETED|Overall Study||1
2974428|NCT00816400|3689408|FG001|COMPLETED|Overall Study||0
2974429|NCT00816400|3689409|FG002|COMPLETED|Overall Study||0
2974430|NCT00816400|3689410|FG003|COMPLETED|Overall Study||0
2974431|NCT00816400|3689411|FG004|COMPLETED|Overall Study||1
2974432|NCT00816400|3689412|FG005|COMPLETED|Overall Study||0
2974433|NCT00816400|3689413|FG006|COMPLETED|Overall Study||1
2974434|NCT00816400|3689414|FG007|COMPLETED|Overall Study||1
2974435|NCT00816400|3689415|FG008|COMPLETED|Overall Study||0
2974436|NCT00816400|3689407|FG000|NOT COMPLETED|Overall Study||2
2974437|NCT00816400|3689408|FG001|NOT COMPLETED|Overall Study||3
2974438|NCT00816400|3689409|FG002|NOT COMPLETED|Overall Study||5
2974439|NCT00816400|3689410|FG003|NOT COMPLETED|Overall Study||3
2974440|NCT00816400|3689411|FG004|NOT COMPLETED|Overall Study||2
2974441|NCT00816400|3689412|FG005|NOT COMPLETED|Overall Study||3
2974442|NCT00816400|3689413|FG006|NOT COMPLETED|Overall Study||2
2974443|NCT00816400|3689414|FG007|NOT COMPLETED|Overall Study||5
2974444|NCT00816400|3689415|FG008|NOT COMPLETED|Overall Study||6
2974445|NCT00816556|3689439|FG000|STARTED|Overall Study||20
2974446|NCT00816556|3689440|FG001|STARTED|Overall Study||21
2974447|NCT00816556|3689441|FG002|STARTED|Overall Study||22
2974448|NCT00816556|3689439|FG000|COMPLETED|Overall Study||18
2974449|NCT00816556|3689440|FG001|COMPLETED|Overall Study||19
2974450|NCT00816556|3689441|FG002|COMPLETED|Overall Study||19
2974451|NCT00816556|3689439|FG000|NOT COMPLETED|Overall Study||2
2974452|NCT00816556|3689440|FG001|NOT COMPLETED|Overall Study||2
2974453|NCT00816556|3689441|FG002|NOT COMPLETED|Overall Study||3
2974454|NCT00816595|3689451|FG000|STARTED|Overall Study||35
2974455|NCT00816595|3689452|FG001|STARTED|Overall Study||33
2974456|NCT00816595|3689451|FG000|COMPLETED|Overall Study||33
2974457|NCT00816595|3689452|FG001|COMPLETED|Overall Study||33
2974458|NCT00816595|3689451|FG000|NOT COMPLETED|Overall Study||2
2974459|NCT00816595|3689452|FG001|NOT COMPLETED|Overall Study||0
2974460|NCT00816751|3689462|FG000|STARTED|Overall Study||45
2974461|NCT00816751|3689463|FG001|STARTED|Overall Study||44
2974462|NCT00816751|3689462|FG000|COMPLETED|Overall Study||45
2974463|NCT00816751|3689463|FG001|COMPLETED|Overall Study||44
2974464|NCT00816751|3689462|FG000|NOT COMPLETED|Overall Study||0
3164107|NCT01890785|3891531|FG001|COMPLETED|Third Intervention||4
3164108|NCT01890785|3891532|FG002|COMPLETED|Third Intervention||5
3164109|NCT01890785|3891533|FG003|COMPLETED|Third Intervention||5
3164110|NCT01890785|3891534|FG004|COMPLETED|Third Intervention||5
3164111|NCT01890785|3891535|FG005|COMPLETED|Third Intervention||5
2974465|NCT00816751|3689463|FG001|NOT COMPLETED|Overall Study||0
2974466|NCT00816829|3689471|FG000|STARTED|Overall Study||16
2974467|NCT00816829|3689472|FG001|STARTED|Overall Study||18
2974468|NCT00816829|3689471|FG000|COMPLETED|Overall Study||16
2974469|NCT00816829|3689472|FG001|COMPLETED|Overall Study||18
2974470|NCT00816829|3689471|FG000|NOT COMPLETED|Overall Study||0
2974471|NCT00816829|3689472|FG001|NOT COMPLETED|Overall Study||0
2974472|NCT00816907|3689480|FG000|STARTED|Overall Study||71
2974473|NCT00816907|3689481|FG001|STARTED|Overall Study||75
2974474|NCT00816907|3689480|FG000|COMPLETED|Overall Study||58
2974475|NCT00816907|3689481|FG001|COMPLETED|Overall Study||58
2974476|NCT00816907|3689480|FG000|NOT COMPLETED|Overall Study||13
2974477|NCT00816907|3689481|FG001|NOT COMPLETED|Overall Study||17
2974478|NCT00817063|3689491|FG000|STARTED|Overall Study||298
2974479|NCT00817063|3689492|FG001|STARTED|Overall Study||298
2974480|NCT00817063|3689491|FG000|COMPLETED|Overall Study||161
2974481|NCT00817063|3689492|FG001|COMPLETED|Overall Study||128
2974482|NCT00817063|3689491|FG000|NOT COMPLETED|Overall Study||137
2974483|NCT00817063|3689492|FG001|NOT COMPLETED|Overall Study||170
2974484|NCT00817089|3689502|FG000|STARTED|First Alcohol Challenge||6
2974485|NCT00817089|3689503|FG001|STARTED|First Alcohol Challenge||8
2974486|NCT00817089|3689504|FG002|STARTED|First Alcohol Challenge||4
2974487|NCT00817089|3689505|FG003|STARTED|First Alcohol Challenge||6
2974488|NCT00817089|3689502|FG000|COMPLETED|First Alcohol Challenge||6
2974489|NCT00817089|3689503|FG001|COMPLETED|First Alcohol Challenge||8
2974490|NCT00817089|3689504|FG002|COMPLETED|First Alcohol Challenge||4
2974491|NCT00817089|3689505|FG003|COMPLETED|First Alcohol Challenge||5
2974492|NCT00817089|3689502|FG000|NOT COMPLETED|First Alcohol Challenge||0
2974493|NCT00817089|3689503|FG001|NOT COMPLETED|First Alcohol Challenge||0
2974494|NCT00817089|3689504|FG002|NOT COMPLETED|First Alcohol Challenge||0
2974495|NCT00817089|3689505|FG003|NOT COMPLETED|First Alcohol Challenge||1
2974496|NCT00817089|3689502|FG000|STARTED|Second Alcohol Challenge||6
2974497|NCT00817089|3689503|FG001|STARTED|Second Alcohol Challenge||8
2974498|NCT00817089|3689504|FG002|STARTED|Second Alcohol Challenge||4
2974499|NCT00817089|3689505|FG003|STARTED|Second Alcohol Challenge||5
2974500|NCT00817089|3689502|FG000|COMPLETED|Second Alcohol Challenge||6
2974501|NCT00817089|3689503|FG001|COMPLETED|Second Alcohol Challenge||7
2974502|NCT00817089|3689504|FG002|COMPLETED|Second Alcohol Challenge||4
2974503|NCT00817089|3689505|FG003|COMPLETED|Second Alcohol Challenge||5
2974504|NCT00817089|3689502|FG000|NOT COMPLETED|Second Alcohol Challenge||0
2974505|NCT00817089|3689503|FG001|NOT COMPLETED|Second Alcohol Challenge||1
2974506|NCT00817089|3689504|FG002|NOT COMPLETED|Second Alcohol Challenge||0
2974507|NCT00817089|3689505|FG003|NOT COMPLETED|Second Alcohol Challenge||0
2974508|NCT00817206|3689521|FG000|STARTED|Overall Study||163
2974509|NCT00817206|3689522|FG001|STARTED|Overall Study||163
2974510|NCT00817206|3689521|FG000|COMPLETED|Overall Study||142
2974511|NCT00817206|3689522|FG001|COMPLETED|Overall Study||154
2974512|NCT00817206|3689521|FG000|NOT COMPLETED|Overall Study||21
2974513|NCT00817206|3689522|FG001|NOT COMPLETED|Overall Study||9
2974514|NCT00817219|3689528|FG000|STARTED|Overall Study||33
2974515|NCT00817219|3689528|FG000|COMPLETED|Overall Study||33
2974516|NCT00817219|3689528|FG000|NOT COMPLETED|Overall Study||0
2974517|NCT00817336|3689534|FG000|STARTED|Overall Study||8
2974518|NCT00817336|3689535|FG001|STARTED|Overall Study||8
2974519|NCT00817336|3689534|FG000|COMPLETED|Overall Study||7
2974520|NCT00817336|3689535|FG001|COMPLETED|Overall Study||7
2974521|NCT00817336|3689534|FG000|NOT COMPLETED|Overall Study||1
2974522|NCT00817336|3689535|FG001|NOT COMPLETED|Overall Study||1
2974523|NCT00817414|3689545|FG000|STARTED|Overall Study||12
2974524|NCT00817414|3689546|FG001|STARTED|Overall Study||12
2974525|NCT00817414|3689547|FG002|STARTED|Overall Study||13
2974526|NCT00817414|3689548|FG003|STARTED|Overall Study||13
2974527|NCT00817414|3689549|FG004|STARTED|Overall Study||13
2974528|NCT00817414|3689545|FG000|COMPLETED|Overall Study||10
2974529|NCT00817414|3689546|FG001|COMPLETED|Overall Study||9
2974530|NCT00817414|3689547|FG002|COMPLETED|Overall Study||9
2974531|NCT00817414|3689548|FG003|COMPLETED|Overall Study||1
2974532|NCT00817414|3689549|FG004|COMPLETED|Overall Study||11
2974533|NCT00817414|3689545|FG000|NOT COMPLETED|Overall Study||2
2974534|NCT00817414|3689546|FG001|NOT COMPLETED|Overall Study||3
2974535|NCT00817414|3689547|FG002|NOT COMPLETED|Overall Study||4
2974536|NCT00817414|3689548|FG003|NOT COMPLETED|Overall Study||12
2974537|NCT00817414|3689549|FG004|NOT COMPLETED|Overall Study||2
2974538|NCT00817479|3689568|FG000|STARTED|Overall Study||6
2974539|NCT00817479|3689569|FG001|STARTED|Overall Study||14
2974540|NCT00817479|3689568|FG000|COMPLETED|Overall Study||5
2974541|NCT00817479|3689569|FG001|COMPLETED|Overall Study||13
2974542|NCT00817479|3689568|FG000|NOT COMPLETED|Overall Study||1
2974543|NCT00817479|3689569|FG001|NOT COMPLETED|Overall Study||1
3035878|NCT01139762|3755113|FG002|STARTED|Double-Blind Randomized Active Treatment||350
3035879|NCT01139762|3755111|FG000|Received at Least 1 Dose of Study Drug|Double-Blind Randomized Active Treatment||0
3035880|NCT01139762|3755112|FG001|Received at Least 1 Dose of Study Drug|Double-Blind Randomized Active Treatment||345
3035881|NCT01139762|3755113|FG002|Received at Least 1 Dose of Study Drug|Double-Blind Randomized Active Treatment||350
3035882|NCT01139762|3755111|FG000|COMPLETED|Double-Blind Randomized Active Treatment||0
3035883|NCT01139762|3755112|FG001|COMPLETED|Double-Blind Randomized Active Treatment||306
3035884|NCT01139762|3755113|FG002|COMPLETED|Double-Blind Randomized Active Treatment||286
3164112|NCT01890785|3891530|FG000|NOT COMPLETED|Third Intervention||0
3164113|NCT01890785|3891531|FG001|NOT COMPLETED|Third Intervention||1
3164114|NCT01890785|3891532|FG002|NOT COMPLETED|Third Intervention||0
3035885|NCT01139762|3755111|FG000|NOT COMPLETED|Double-Blind Randomized Active Treatment||0
3035886|NCT01139762|3755112|FG001|NOT COMPLETED|Double-Blind Randomized Active Treatment||40
3035887|NCT01139762|3755113|FG002|NOT COMPLETED|Double-Blind Randomized Active Treatment||64
3035888|NCT01139775|3755123|FG000|STARTED|Overall Study||14
3035889|NCT01139775|3755124|FG001|STARTED|Overall Study||39
3035890|NCT01139775|3755125|FG002|STARTED|Overall Study||23
3035891|NCT01139775|3755123|FG000|Received at Least 1 Dose of Study Drug|Overall Study||14
3035892|NCT01139775|3755124|FG001|Received at Least 1 Dose of Study Drug|Overall Study||39
3035893|NCT01139775|3755125|FG002|Received at Least 1 Dose of Study Drug|Overall Study||22
2974544|NCT00817531|3689575|FG000|STARTED|Overall Study|22 patients were eligible for this study and started the treatment.|22
2974545|NCT00817531|3689575|FG000|COMPLETED|Overall Study|20 out of 22 patients finished study treatment. 2 patients stopped the treatment after the 1st week.|20
2974546|NCT00817531|3689575|FG000|NOT COMPLETED|Overall Study||2
2974547|NCT00817596|3689579|FG000|STARTED|Overall Study||110
2974548|NCT00817596|3689579|FG000|COMPLETED|Overall Study||62
2974549|NCT00817596|3689579|FG000|NOT COMPLETED|Overall Study||48
2974550|NCT00817635|3689588|FG000|STARTED|Overall Study||32
2974551|NCT00817635|3689589|FG001|STARTED|Overall Study||26
2974552|NCT00817635|3689590|FG002|STARTED|Overall Study||31
2974553|NCT00817635|3689591|FG003|STARTED|Overall Study||33
2974554|NCT00817635|3689592|FG004|STARTED|Overall Study||33
2974555|NCT00817635|3689588|FG000|COMPLETED|Overall Study||23
2974556|NCT00817635|3689589|FG001|COMPLETED|Overall Study||22
2974557|NCT00817635|3689590|FG002|COMPLETED|Overall Study||28
2974558|NCT00817635|3689591|FG003|COMPLETED|Overall Study||28
2974559|NCT00817635|3689592|FG004|COMPLETED|Overall Study||25
2974560|NCT00817635|3689588|FG000|NOT COMPLETED|Overall Study||9
2974561|NCT00817635|3689589|FG001|NOT COMPLETED|Overall Study||4
2974562|NCT00817635|3689590|FG002|NOT COMPLETED|Overall Study||3
2974563|NCT00817635|3689591|FG003|NOT COMPLETED|Overall Study||5
2974564|NCT00817635|3689592|FG004|NOT COMPLETED|Overall Study||8
2974565|NCT00817778|3689613|FG000|STARTED|Overall Study||19
2974566|NCT00817778|3689614|FG001|STARTED|Overall Study||8
2974567|NCT00817778|3689613|FG000|COMPLETED|Overall Study||16
2974568|NCT00817778|3689614|FG001|COMPLETED|Overall Study||5
2974569|NCT00817778|3689613|FG000|NOT COMPLETED|Overall Study||3
2974570|NCT00817778|3689614|FG001|NOT COMPLETED|Overall Study||3
2974571|NCT00817804|3689622|FG000|STARTED|Overall Study||1
2974572|NCT00817804|3689623|FG001|STARTED|Overall Study||2
2974573|NCT00817804|3689622|FG000|COMPLETED|Overall Study||1
2974574|NCT00817804|3689623|FG001|COMPLETED|Overall Study||2
2974575|NCT00817804|3689622|FG000|NOT COMPLETED|Overall Study||0
2974576|NCT00817804|3689623|FG001|NOT COMPLETED|Overall Study||0
2974577|NCT00817843|3689629|FG000|STARTED|First Period (6 Weeks)||50
2974578|NCT00817843|3689630|FG001|STARTED|First Period (6 Weeks)||50
2974579|NCT00817843|3689629|FG000|COMPLETED|First Period (6 Weeks)|All patients with >=1 postrandomization dose and measurement were analyzed|42
2974580|NCT00817843|3689630|FG001|COMPLETED|First Period (6 Weeks)||46
2974581|NCT00817843|3689629|FG000|NOT COMPLETED|First Period (6 Weeks)||8
2974582|NCT00817843|3689630|FG001|NOT COMPLETED|First Period (6 Weeks)||4
2974583|NCT00817843|3689629|FG000|STARTED|Washout Period (6 Weeks)||42
2974584|NCT00817843|3689630|FG001|STARTED|Washout Period (6 Weeks)||46
2974585|NCT00817843|3689629|FG000|COMPLETED|Washout Period (6 Weeks)||41
2974586|NCT00817843|3689630|FG001|COMPLETED|Washout Period (6 Weeks)||45
2974587|NCT00817843|3689629|FG000|NOT COMPLETED|Washout Period (6 Weeks)||1
2974588|NCT00817843|3689630|FG001|NOT COMPLETED|Washout Period (6 Weeks)||1
2974589|NCT00817843|3689629|FG000|STARTED|Second Period (6 Weeks)||41
2974590|NCT00817843|3689630|FG001|STARTED|Second Period (6 Weeks)||45
2974591|NCT00817843|3689629|FG000|COMPLETED|Second Period (6 Weeks)|All patients with >=1 postrandomization dose and measurement were analyzed|41
2974592|NCT00817843|3689630|FG001|COMPLETED|Second Period (6 Weeks)||44
2974593|NCT00817843|3689629|FG000|NOT COMPLETED|Second Period (6 Weeks)||0
2974594|NCT00817843|3689630|FG001|NOT COMPLETED|Second Period (6 Weeks)||1
2974595|NCT00817999|3689637|FG000|STARTED|Grapefruit Juice||15
2974596|NCT00817999|3689638|FG001|STARTED|Grapefruit Juice||17
2974597|NCT00817999|3689637|FG000|COMPLETED|Grapefruit Juice||15
2974598|NCT00817999|3689638|FG001|COMPLETED|Grapefruit Juice||17
2974599|NCT00817999|3689637|FG000|NOT COMPLETED|Grapefruit Juice||0
2974600|NCT00817999|3689638|FG001|NOT COMPLETED|Grapefruit Juice||0
2974601|NCT00817999|3689637|FG000|STARTED|No Grapefruit Juice||15
2974602|NCT00817999|3689638|FG001|STARTED|No Grapefruit Juice||17
2974603|NCT00817999|3689637|FG000|COMPLETED|No Grapefruit Juice||15
2974604|NCT00817999|3689638|FG001|COMPLETED|No Grapefruit Juice||17
2974605|NCT00817999|3689637|FG000|NOT COMPLETED|No Grapefruit Juice||0
2974606|NCT00817999|3689638|FG001|NOT COMPLETED|No Grapefruit Juice||0
2974607|NCT00818116|3689646|FG000|STARTED|Overall Study||34
2974608|NCT00818116|3689646|FG000|COMPLETED|Overall Study||34
2974609|NCT00818116|3689646|FG000|NOT COMPLETED|Overall Study||0
2974610|NCT00818168|3689650|FG000|STARTED|Overall Study||320
2974611|NCT00818168|3689650|FG000|COMPLETED|Overall Study|Includes 78 participants whose completer/non-completer status was not reported (missing)|250
2974612|NCT00818168|3689650|FG000|NOT COMPLETED|Overall Study||70
2974613|NCT00818207|3689656|FG000|STARTED|Overall Study||696
2974614|NCT00818207|3689657|FG001|STARTED|Overall Study||684
2974615|NCT00818207|3689656|FG000|COMPLETED|Overall Study||474
2974616|NCT00818207|3689657|FG001|COMPLETED|Overall Study||417
2974617|NCT00818207|3689656|FG000|NOT COMPLETED|Overall Study||222
2974618|NCT00818207|3689657|FG001|NOT COMPLETED|Overall Study||267
2974619|NCT00818246|3689663|FG000|STARTED|Overall Study||40
2974620|NCT00818246|3689663|FG000|COMPLETED|Overall Study|split-face study|35
2974621|NCT00818246|3689663|FG000|NOT COMPLETED|Overall Study||5
2974622|NCT00818259|3689674|FG000|STARTED|Randomization||12
2974623|NCT00818259|3689675|FG001|STARTED|Randomization||11
2974624|NCT00818259|3689676|FG002|STARTED|Randomization||19
2974625|NCT00818259|3689677|FG003|STARTED|Randomization||20
2974626|NCT00818259|3689678|FG004|STARTED|Randomization||19
2974627|NCT00818259|3689679|FG005|STARTED|Randomization||0
2974628|NCT00818259|3689680|FG006|STARTED|Randomization||5
2974629|NCT00818259|3689681|FG007|STARTED|Randomization||0
2974630|NCT00818259|3689682|FG008|STARTED|Randomization||6
2974631|NCT00818259|3689674|FG000|COMPLETED|Randomization||12
2974632|NCT00818259|3689675|FG001|COMPLETED|Randomization||11
2974633|NCT00818259|3689676|FG002|COMPLETED|Randomization||19
2974634|NCT00818259|3689677|FG003|COMPLETED|Randomization||20
2974635|NCT00818259|3689678|FG004|COMPLETED|Randomization||19
2974636|NCT00818259|3689679|FG005|COMPLETED|Randomization||0
2974637|NCT00818259|3689680|FG006|COMPLETED|Randomization||5
2974638|NCT00818259|3689681|FG007|COMPLETED|Randomization||0
2974639|NCT00818259|3689682|FG008|COMPLETED|Randomization||6
2974640|NCT00818259|3689674|FG000|NOT COMPLETED|Randomization||0
2974641|NCT00818259|3689675|FG001|NOT COMPLETED|Randomization||0
2974642|NCT00818259|3689676|FG002|NOT COMPLETED|Randomization||0
2974643|NCT00818259|3689677|FG003|NOT COMPLETED|Randomization||0
2974644|NCT00818259|3689678|FG004|NOT COMPLETED|Randomization||0
2974645|NCT00818259|3689679|FG005|NOT COMPLETED|Randomization||0
2974646|NCT00818259|3689680|FG006|NOT COMPLETED|Randomization||0
2974647|NCT00818259|3689681|FG007|NOT COMPLETED|Randomization||0
2974648|NCT00818259|3689682|FG008|NOT COMPLETED|Randomization||0
2974649|NCT00818259|3689674|FG000|STARTED|Part I|Newly enrolled participants|12
2974650|NCT00818259|3689675|FG001|STARTED|Part I|Newly enrolled participants|11
2974651|NCT00818259|3689676|FG002|STARTED|Part I||0
2974652|NCT00818259|3689677|FG003|STARTED|Part I||0
2974653|NCT00818259|3689678|FG004|STARTED|Part I||0
2974654|NCT00818259|3689679|FG005|STARTED|Part I||0
2974655|NCT00818259|3689680|FG006|STARTED|Part I||0
2974656|NCT00818259|3689681|FG007|STARTED|Part I||0
2974657|NCT00818259|3689682|FG008|STARTED|Part I||0
2974658|NCT00818259|3689674|FG000|COMPLETED|Part I||11
2974659|NCT00818259|3689675|FG001|COMPLETED|Part I||11
2974660|NCT00818259|3689676|FG002|COMPLETED|Part I||0
2974661|NCT00818259|3689677|FG003|COMPLETED|Part I||0
2974662|NCT00818259|3689678|FG004|COMPLETED|Part I||0
2974663|NCT00818259|3689679|FG005|COMPLETED|Part I||0
2974664|NCT00818259|3689680|FG006|COMPLETED|Part I||0
2974665|NCT00818259|3689681|FG007|COMPLETED|Part I||0
2974666|NCT00818259|3689682|FG008|COMPLETED|Part I||0
2974667|NCT00818259|3689674|FG000|NOT COMPLETED|Part I||1
2974668|NCT00818259|3689675|FG001|NOT COMPLETED|Part I||0
2974669|NCT00818259|3689676|FG002|NOT COMPLETED|Part I||0
2974670|NCT00818259|3689677|FG003|NOT COMPLETED|Part I||0
2974671|NCT00818259|3689678|FG004|NOT COMPLETED|Part I||0
2974672|NCT00818259|3689679|FG005|NOT COMPLETED|Part I||0
2974673|NCT00818259|3689680|FG006|NOT COMPLETED|Part I||0
2974674|NCT00818259|3689681|FG007|NOT COMPLETED|Part I||0
2974675|NCT00818259|3689682|FG008|NOT COMPLETED|Part I||0
2974676|NCT00818259|3689674|FG000|STARTED|Part II||0
2974677|NCT00818259|3689675|FG001|STARTED|Part II||0
2974678|NCT00818259|3689676|FG002|STARTED|Part II|Newly enrolled participants|19
2974679|NCT00818259|3689677|FG003|STARTED|Part II|Newly enrolled participants|20
2974680|NCT00818259|3689678|FG004|STARTED|Part II||0
2974681|NCT00818259|3689679|FG005|STARTED|Part II||0
2974682|NCT00818259|3689680|FG006|STARTED|Part II||0
2974683|NCT00818259|3689681|FG007|STARTED|Part II||0
2974684|NCT00818259|3689682|FG008|STARTED|Part II||0
2974685|NCT00818259|3689674|FG000|Treated|Part II||0
2974686|NCT00818259|3689675|FG001|Treated|Part II||0
2974687|NCT00818259|3689676|FG002|Treated|Part II||19
2974688|NCT00818259|3689677|FG003|Treated|Part II||19
2974689|NCT00818259|3689678|FG004|Treated|Part II||0
2974690|NCT00818259|3689679|FG005|Treated|Part II||0
2974691|NCT00818259|3689680|FG006|Treated|Part II||0
2974692|NCT00818259|3689681|FG007|Treated|Part II||0
2974693|NCT00818259|3689682|FG008|Treated|Part II||0
2974694|NCT00818259|3689674|FG000|COMPLETED|Part II||0
2974695|NCT00818259|3689675|FG001|COMPLETED|Part II||0
2974696|NCT00818259|3689676|FG002|COMPLETED|Part II||18
2974697|NCT00818259|3689677|FG003|COMPLETED|Part II||18
2974698|NCT00818259|3689678|FG004|COMPLETED|Part II||0
2974699|NCT00818259|3689679|FG005|COMPLETED|Part II||0
2974700|NCT00818259|3689680|FG006|COMPLETED|Part II||0
2974701|NCT00818259|3689681|FG007|COMPLETED|Part II||0
2974702|NCT00818259|3689682|FG008|COMPLETED|Part II||0
2974703|NCT00818259|3689674|FG000|NOT COMPLETED|Part II||0
2974704|NCT00818259|3689675|FG001|NOT COMPLETED|Part II||0
2974705|NCT00818259|3689676|FG002|NOT COMPLETED|Part II||1
2974706|NCT00818259|3689677|FG003|NOT COMPLETED|Part II||2
2974707|NCT00818259|3689678|FG004|NOT COMPLETED|Part II||0
2974708|NCT00818259|3689679|FG005|NOT COMPLETED|Part II||0
2974709|NCT00818259|3689680|FG006|NOT COMPLETED|Part II||0
2974710|NCT00818259|3689681|FG007|NOT COMPLETED|Part II||0
2974711|NCT00818259|3689682|FG008|NOT COMPLETED|Part II||0
2974712|NCT00818259|3689674|FG000|STARTED|Part III||0
2974713|NCT00818259|3689675|FG001|STARTED|Part III||0
2974714|NCT00818259|3689676|FG002|STARTED|Part III||0
2974715|NCT00818259|3689677|FG003|STARTED|Part III||0
2974716|NCT00818259|3689678|FG004|STARTED|Part III|Newly enrolled participants|19
2974717|NCT00818259|3689679|FG005|STARTED|Part III||0
2974718|NCT00818259|3689680|FG006|STARTED|Part III||0
2974719|NCT00818259|3689681|FG007|STARTED|Part III||0
2974720|NCT00818259|3689682|FG008|STARTED|Part III||0
2974721|NCT00818259|3689674|FG000|COMPLETED|Part III||0
2974722|NCT00818259|3689675|FG001|COMPLETED|Part III||0
2974723|NCT00818259|3689676|FG002|COMPLETED|Part III||0
2974724|NCT00818259|3689677|FG003|COMPLETED|Part III||0
2974725|NCT00818259|3689678|FG004|COMPLETED|Part III||19
2974726|NCT00818259|3689679|FG005|COMPLETED|Part III||0
2974727|NCT00818259|3689680|FG006|COMPLETED|Part III||0
2974728|NCT00818259|3689681|FG007|COMPLETED|Part III||0
2974729|NCT00818259|3689682|FG008|COMPLETED|Part III||0
2974730|NCT00818259|3689674|FG000|NOT COMPLETED|Part III||0
2974731|NCT00818259|3689675|FG001|NOT COMPLETED|Part III||0
2974732|NCT00818259|3689676|FG002|NOT COMPLETED|Part III||0
2974733|NCT00818259|3689677|FG003|NOT COMPLETED|Part III||0
2974734|NCT00818259|3689678|FG004|NOT COMPLETED|Part III||0
2974735|NCT00818259|3689679|FG005|NOT COMPLETED|Part III||0
2974736|NCT00818259|3689680|FG006|NOT COMPLETED|Part III||0
2974737|NCT00818259|3689681|FG007|NOT COMPLETED|Part III||0
2974738|NCT00818259|3689682|FG008|NOT COMPLETED|Part III||0
2974739|NCT00818259|3689674|FG000|STARTED|Part IV||0
2974740|NCT00818259|3689675|FG001|STARTED|Part IV||0
2974741|NCT00818259|3689676|FG002|STARTED|Part IV||0
2974742|NCT00818259|3689677|FG003|STARTED|Part IV||0
2974743|NCT00818259|3689678|FG004|STARTED|Part IV||0
2974744|NCT00818259|3689679|FG005|STARTED|Part IV|Participants continuing from Part III|15
2974745|NCT00818259|3689680|FG006|STARTED|Part IV|Newly enrolled participants|5
2974746|NCT00818259|3689681|FG007|STARTED|Part IV||0
2974747|NCT00818259|3689682|FG008|STARTED|Part IV||0
2974748|NCT00818259|3689674|FG000|COMPLETED|Part IV||0
2974749|NCT00818259|3689675|FG001|COMPLETED|Part IV||0
2974750|NCT00818259|3689676|FG002|COMPLETED|Part IV||0
2974751|NCT00818259|3689677|FG003|COMPLETED|Part IV||0
2974752|NCT00818259|3689678|FG004|COMPLETED|Part IV||0
2974753|NCT00818259|3689679|FG005|COMPLETED|Part IV||14
2974754|NCT00818259|3689680|FG006|COMPLETED|Part IV||5
2974755|NCT00818259|3689681|FG007|COMPLETED|Part IV||0
2974756|NCT00818259|3689682|FG008|COMPLETED|Part IV||0
2974757|NCT00818259|3689674|FG000|NOT COMPLETED|Part IV||0
2974758|NCT00818259|3689675|FG001|NOT COMPLETED|Part IV||0
2974759|NCT00818259|3689676|FG002|NOT COMPLETED|Part IV||0
2974760|NCT00818259|3689677|FG003|NOT COMPLETED|Part IV||0
2974761|NCT00818259|3689678|FG004|NOT COMPLETED|Part IV||0
2974762|NCT00818259|3689679|FG005|NOT COMPLETED|Part IV||1
2974763|NCT00818259|3689680|FG006|NOT COMPLETED|Part IV||0
2974764|NCT00818259|3689681|FG007|NOT COMPLETED|Part IV||0
2974765|NCT00818259|3689682|FG008|NOT COMPLETED|Part IV||0
2974766|NCT00818259|3689674|FG000|STARTED|Part V||0
2974767|NCT00818259|3689675|FG001|STARTED|Part V||0
2974768|NCT00818259|3689676|FG002|STARTED|Part V||0
2974769|NCT00818259|3689677|FG003|STARTED|Part V||0
2974770|NCT00818259|3689678|FG004|STARTED|Part V||0
2974771|NCT00818259|3689679|FG005|STARTED|Part V||0
2974772|NCT00818259|3689680|FG006|STARTED|Part V||0
2974773|NCT00818259|3689681|FG007|STARTED|Part V|Participants continuing from Part IV|17
2974774|NCT00818259|3689682|FG008|STARTED|Part V|Newly enrolled participants|6
2974775|NCT00818259|3689674|FG000|COMPLETED|Part V||0
2974776|NCT00818259|3689675|FG001|COMPLETED|Part V||0
2974777|NCT00818259|3689676|FG002|COMPLETED|Part V||0
2974778|NCT00818259|3689677|FG003|COMPLETED|Part V||0
2974779|NCT00818259|3689678|FG004|COMPLETED|Part V||0
2974780|NCT00818259|3689679|FG005|COMPLETED|Part V||0
2974781|NCT00818259|3689680|FG006|COMPLETED|Part V||0
2974782|NCT00818259|3689681|FG007|COMPLETED|Part V||16
2974783|NCT00818259|3689682|FG008|COMPLETED|Part V||6
2974784|NCT00818259|3689674|FG000|NOT COMPLETED|Part V||0
2974785|NCT00818259|3689675|FG001|NOT COMPLETED|Part V||0
2974786|NCT00818259|3689676|FG002|NOT COMPLETED|Part V||0
2974787|NCT00818259|3689677|FG003|NOT COMPLETED|Part V||0
2974788|NCT00818259|3689678|FG004|NOT COMPLETED|Part V||0
2974789|NCT00818259|3689679|FG005|NOT COMPLETED|Part V||0
2974790|NCT00818259|3689680|FG006|NOT COMPLETED|Part V||0
2974791|NCT00818259|3689681|FG007|NOT COMPLETED|Part V||1
2974792|NCT00818259|3689682|FG008|NOT COMPLETED|Part V||0
2974793|NCT00818272|3689698|FG000|STARTED|Overall Study||148
2974794|NCT00818272|3689698|FG000|COMPLETED|Overall Study||74
2974795|NCT00818272|3689698|FG000|NOT COMPLETED|Overall Study||74
2974796|NCT00818324|3689702|FG000|STARTED|Overall Study||154
2974797|NCT00818324|3689702|FG000|COMPLETED|Overall Study||127
2974798|NCT00818324|3689702|FG000|NOT COMPLETED|Overall Study||27
2974799|NCT00818337|3689706|FG000|STARTED|Overall Study||36
2974800|NCT00818337|3689706|FG000|COMPLETED|Overall Study||36
2974801|NCT00818337|3689706|FG000|NOT COMPLETED|Overall Study||0
2974802|NCT00818363|3689713|FG000|STARTED|Overall Study||40
2974803|NCT00818363|3689714|FG001|STARTED|Overall Study||20
2974804|NCT00818363|3689713|FG000|COMPLETED|Overall Study||40
2974805|NCT00818363|3689714|FG001|COMPLETED|Overall Study||19
2974806|NCT00818363|3689713|FG000|NOT COMPLETED|Overall Study||0
2974807|NCT00818363|3689714|FG001|NOT COMPLETED|Overall Study||1
2974808|NCT00818389|3689722|FG000|STARTED|Overall Study||40
2974809|NCT00818389|3689723|FG001|STARTED|Overall Study||44
2974810|NCT00818389|3689722|FG000|COMPLETED|Overall Study|4 subjects terminated study early before 1st interim analysis. Study terminated early for futility.|36
2974811|NCT00818389|3689723|FG001|COMPLETED|Overall Study|6 subjects terminated study early before 1st interim analysis. Study terminated early for futility.|38
2974812|NCT00818389|3689722|FG000|NOT COMPLETED|Overall Study||4
2974813|NCT00818389|3689723|FG001|NOT COMPLETED|Overall Study||6
2974814|NCT00818441|3689731|FG000|STARTED|Overall Study||89
2974815|NCT00818441|3689732|FG001|STARTED|Overall Study||30
2974816|NCT00818441|3689731|FG000|COMPLETED|Overall Study||0
2974817|NCT00818441|3689732|FG001|COMPLETED|Overall Study||0
2974818|NCT00818441|3689731|FG000|NOT COMPLETED|Overall Study||89
2974819|NCT00818441|3689732|FG001|NOT COMPLETED|Overall Study||30
2974820|NCT00818454|3689739|FG000|STARTED|Treatment Period 1||115
2974821|NCT00818454|3689740|FG001|STARTED|Treatment Period 1||111
2974822|NCT00818454|3689741|FG002|STARTED|Treatment Period 1||0
2974823|NCT00818454|3689742|FG003|STARTED|Treatment Period 1||0
2974824|NCT00818454|3689739|FG000|COMPLETED|Treatment Period 1||112
2974825|NCT00818454|3689740|FG001|COMPLETED|Treatment Period 1||110
2974826|NCT00818454|3689741|FG002|COMPLETED|Treatment Period 1||0
2974827|NCT00818454|3689742|FG003|COMPLETED|Treatment Period 1||0
2974828|NCT00818454|3689739|FG000|NOT COMPLETED|Treatment Period 1||3
2974829|NCT00818454|3689740|FG001|NOT COMPLETED|Treatment Period 1||1
2974830|NCT00818454|3689741|FG002|NOT COMPLETED|Treatment Period 1||0
2974831|NCT00818454|3689742|FG003|NOT COMPLETED|Treatment Period 1||0
2974832|NCT00818454|3689739|FG000|STARTED|Washout Period of 1 Week||112
2974833|NCT00818454|3689740|FG001|STARTED|Washout Period of 1 Week||110
2974834|NCT00818454|3689741|FG002|STARTED|Washout Period of 1 Week||0
2974835|NCT00818454|3689742|FG003|STARTED|Washout Period of 1 Week||0
2974836|NCT00818454|3689739|FG000|COMPLETED|Washout Period of 1 Week||108
2974837|NCT00818454|3689740|FG001|COMPLETED|Washout Period of 1 Week||107
2974838|NCT00818454|3689741|FG002|COMPLETED|Washout Period of 1 Week||0
2974839|NCT00818454|3689742|FG003|COMPLETED|Washout Period of 1 Week||0
2974840|NCT00818454|3689739|FG000|NOT COMPLETED|Washout Period of 1 Week||4
2974841|NCT00818454|3689740|FG001|NOT COMPLETED|Washout Period of 1 Week||3
2974842|NCT00818454|3689741|FG002|NOT COMPLETED|Washout Period of 1 Week||0
2974843|NCT00818454|3689742|FG003|NOT COMPLETED|Washout Period of 1 Week||0
2974844|NCT00818454|3689739|FG000|STARTED|Treatment Period 2||108
2974845|NCT00818454|3689740|FG001|STARTED|Treatment Period 2||107
2974846|NCT00818454|3689741|FG002|STARTED|Treatment Period 2||0
2974847|NCT00818454|3689742|FG003|STARTED|Treatment Period 2||0
2974848|NCT00818454|3689739|FG000|COMPLETED|Treatment Period 2||106
2974849|NCT00818454|3689740|FG001|COMPLETED|Treatment Period 2||106
2974850|NCT00818454|3689741|FG002|COMPLETED|Treatment Period 2||0
2974851|NCT00818454|3689742|FG003|COMPLETED|Treatment Period 2||0
2974852|NCT00818454|3689739|FG000|NOT COMPLETED|Treatment Period 2||2
2974853|NCT00818454|3689740|FG001|NOT COMPLETED|Treatment Period 2||1
2974854|NCT00818454|3689741|FG002|NOT COMPLETED|Treatment Period 2||0
2974855|NCT00818454|3689742|FG003|NOT COMPLETED|Treatment Period 2||0
2974856|NCT00818454|3689739|FG000|STARTED|Treatment Period 3||0
2974857|NCT00818454|3689740|FG001|STARTED|Treatment Period 3||0
2974858|NCT00818454|3689741|FG002|STARTED|Treatment Period 3||26
2974859|NCT00818454|3689742|FG003|STARTED|Treatment Period 3||139
2974860|NCT00818454|3689739|FG000|COMPLETED|Treatment Period 3||0
2974861|NCT00818454|3689740|FG001|COMPLETED|Treatment Period 3||0
2974862|NCT00818454|3689741|FG002|COMPLETED|Treatment Period 3||26
2974863|NCT00818454|3689742|FG003|COMPLETED|Treatment Period 3||138
2974864|NCT00818454|3689739|FG000|NOT COMPLETED|Treatment Period 3||0
2974865|NCT00818454|3689740|FG001|NOT COMPLETED|Treatment Period 3||0
2974866|NCT00818454|3689741|FG002|NOT COMPLETED|Treatment Period 3||0
2974867|NCT00818454|3689742|FG003|NOT COMPLETED|Treatment Period 3||1
2974868|NCT00818519|3689754|FG000|STARTED|Overall Study|2 excluded from FAS because study drug intake unknown or never administered|89
2974869|NCT00818519|3689755|FG001|STARTED|Overall Study|4 excluded from FAS because study drug intake unknown or never administered|90
2974870|NCT00818519|3689754|FG000|Participants Received Treatment|Overall Study|= Baseline|87
2974871|NCT00818519|3689755|FG001|Participants Received Treatment|Overall Study|= Baseline|86
2974872|NCT00818519|3689754|FG000|COMPLETED|Overall Study||75
2974873|NCT00818519|3689755|FG001|COMPLETED|Overall Study||71
2974874|NCT00818519|3689754|FG000|NOT COMPLETED|Overall Study||14
2974875|NCT00818519|3689755|FG001|NOT COMPLETED|Overall Study||19
2974876|NCT00818623|3689769|FG000|STARTED|Overall Study||26
2974877|NCT00818623|3689770|FG001|STARTED|Overall Study||12
2974878|NCT00818623|3689771|FG002|STARTED|Overall Study||13
2974879|NCT00818623|3689772|FG003|STARTED|Overall Study||24
2974880|NCT00818623|3689773|FG004|STARTED|Overall Study||27
2974881|NCT00818623|3689774|FG005|STARTED|Overall Study||24
2974882|NCT00818623|3689775|FG006|STARTED|Overall Study||27
2974883|NCT00818623|3689776|FG007|STARTED|Overall Study||27
2974884|NCT00818623|3689769|FG000|Intent-to-treat (ITT) Population|Overall Study|One participant in this group was randomized but never received any treatment.|25
2974885|NCT00818623|3689770|FG001|Intent-to-treat (ITT) Population|Overall Study||12
2974886|NCT00818623|3689771|FG002|Intent-to-treat (ITT) Population|Overall Study|One participant in this group was randomized but never received any treatment.|12
2974887|NCT00818623|3689772|FG003|Intent-to-treat (ITT) Population|Overall Study||24
2974888|NCT00818623|3689773|FG004|Intent-to-treat (ITT) Population|Overall Study|Three participants in this group were randomized but never received any treatment.|24
2974889|NCT00818623|3689774|FG005|Intent-to-treat (ITT) Population|Overall Study||24
2974890|NCT00818623|3689775|FG006|Intent-to-treat (ITT) Population|Overall Study|Three participants in this group were randomized but never received any treatment.|24
2974891|NCT00818623|3689776|FG007|Intent-to-treat (ITT) Population|Overall Study||27
2974892|NCT00818623|3689769|FG000|COMPLETED|Overall Study||24
2974893|NCT00818623|3689770|FG001|COMPLETED|Overall Study||8
2974894|NCT00818623|3689771|FG002|COMPLETED|Overall Study||9
2974895|NCT00818623|3689772|FG003|COMPLETED|Overall Study||19
2974896|NCT00818623|3689773|FG004|COMPLETED|Overall Study||23
2974897|NCT00818623|3689774|FG005|COMPLETED|Overall Study||21
2974898|NCT00818623|3689775|FG006|COMPLETED|Overall Study||23
2974899|NCT00818623|3689776|FG007|COMPLETED|Overall Study||26
2974900|NCT00818623|3689769|FG000|NOT COMPLETED|Overall Study||2
2974901|NCT00818623|3689770|FG001|NOT COMPLETED|Overall Study||4
2974902|NCT00818623|3689771|FG002|NOT COMPLETED|Overall Study||4
2974903|NCT00818623|3689772|FG003|NOT COMPLETED|Overall Study||5
2974904|NCT00818623|3689773|FG004|NOT COMPLETED|Overall Study||4
2974905|NCT00818623|3689774|FG005|NOT COMPLETED|Overall Study||3
2974906|NCT00818623|3689775|FG006|NOT COMPLETED|Overall Study||4
2974907|NCT00818623|3689776|FG007|NOT COMPLETED|Overall Study||1
2974908|NCT00818649|3689794|FG000|STARTED|Overall Study||16
2974909|NCT00818649|3689794|FG000|COMPLETED|Overall Study||12
2974910|NCT00818649|3689794|FG000|NOT COMPLETED|Overall Study||4
2974911|NCT00818662|3689803|FG000|STARTED|Overall Study||127
2974912|NCT00818662|3689804|FG001|STARTED|Overall Study||135
2974913|NCT00818662|3689805|FG002|STARTED|Overall Study||58
2974914|NCT00818662|3689806|FG003|STARTED|Overall Study||63
2974915|NCT00818662|3689803|FG000|COMPLETED|Overall Study||104
2974916|NCT00818662|3689804|FG001|COMPLETED|Overall Study||102
2974917|NCT00818662|3689805|FG002|COMPLETED|Overall Study||49
2974918|NCT00818662|3689806|FG003|COMPLETED|Overall Study||47
2974919|NCT00818662|3689803|FG000|NOT COMPLETED|Overall Study||23
2974920|NCT00818662|3689804|FG001|NOT COMPLETED|Overall Study||33
2974921|NCT00818662|3689805|FG002|NOT COMPLETED|Overall Study||9
2974922|NCT00818662|3689806|FG003|NOT COMPLETED|Overall Study||16
2974923|NCT00818753|3689820|FG000|STARTED|Overall Study|There were 53 participants randomised, but only 51 were treated.|22
2974924|NCT00818753|3689821|FG001|STARTED|Overall Study|There were 53 participants randomised, but only 51 were treated.|21
2974925|NCT00818753|3689822|FG002|STARTED|Overall Study|There were 53 participants randomised, but only 51 were treated.|10
2974926|NCT00818753|3689820|FG000|COMPLETED|Overall Study||19
2974927|NCT00818753|3689821|FG001|COMPLETED|Overall Study||21
2974928|NCT00818753|3689822|FG002|COMPLETED|Overall Study||9
2974929|NCT00818753|3689820|FG000|NOT COMPLETED|Overall Study||3
2974930|NCT00818753|3689821|FG001|NOT COMPLETED|Overall Study||0
2974931|NCT00818753|3689822|FG002|NOT COMPLETED|Overall Study||1
2974932|NCT00818766|3689832|FG000|STARTED|Overall Study||125
2974933|NCT00818766|3689833|FG001|STARTED|Overall Study||126
2974934|NCT00818766|3689832|FG000|Received Allocated Intervention|Overall Study|1 withdrew consent, 1 had active infection and 1 was given open-label antibiotic after surgery.|122
2974935|NCT00818766|3689833|FG001|Received Allocated Intervention|Overall Study||126
2974936|NCT00818766|3689832|FG000|Intent-to-Treat Population|Overall Study|1 participant was randomized twice but only counted once (per first randomization).|121
2974937|NCT00818766|3689833|FG001|Intent-to-Treat Population|Overall Study|2 participants were randomized twice but only counted once (per first randomization).|124
2974938|NCT00818766|3689832|FG000|COMPLETED|Overall Study||110
2974939|NCT00818766|3689833|FG001|COMPLETED|Overall Study||116
2974940|NCT00818766|3689832|FG000|NOT COMPLETED|Overall Study||15
2974941|NCT00818766|3689833|FG001|NOT COMPLETED|Overall Study||10
2974942|NCT00818779|3689841|FG000|STARTED|Overall Study||22
2974943|NCT00818779|3689842|FG001|STARTED|Overall Study||16
2974944|NCT00818779|3689841|FG000|COMPLETED|Overall Study||16
2974945|NCT00818779|3689842|FG001|COMPLETED|Overall Study||15
2974946|NCT00818779|3689841|FG000|NOT COMPLETED|Overall Study||6
2974947|NCT00818779|3689842|FG001|NOT COMPLETED|Overall Study||1
2974948|NCT00818805|3689848|FG000|STARTED|First Intervention||25
2974949|NCT00818805|3689849|FG001|STARTED|First Intervention||25
2974950|NCT00818805|3689848|FG000|COMPLETED|First Intervention||25
2974951|NCT00818805|3689849|FG001|COMPLETED|First Intervention||25
2974952|NCT00818805|3689848|FG000|NOT COMPLETED|First Intervention||0
2974953|NCT00818805|3689849|FG001|NOT COMPLETED|First Intervention||0
2974954|NCT00818805|3689848|FG000|STARTED|Second Intervention||25
2974955|NCT00818805|3689849|FG001|STARTED|Second Intervention||25
2974956|NCT00818805|3689848|FG000|COMPLETED|Second Intervention||25
2974957|NCT00818805|3689849|FG001|COMPLETED|Second Intervention||25
2974958|NCT00818805|3689848|FG000|NOT COMPLETED|Second Intervention||0
2974959|NCT00818805|3689849|FG001|NOT COMPLETED|Second Intervention||0
2974960|NCT00818883|3689861|FG000|STARTED|Overall Study||303
2974961|NCT00818883|3689862|FG001|STARTED|Overall Study||306
2974962|NCT00818883|3689861|FG000|COMPLETED|Overall Study||252
2974963|NCT00818883|3689862|FG001|COMPLETED|Overall Study||260
2974964|NCT00818883|3689861|FG000|NOT COMPLETED|Overall Study||51
2974965|NCT00818883|3689862|FG001|NOT COMPLETED|Overall Study||46
2974966|NCT00818961|3689868|FG000|STARTED|Overall Study||36
2974967|NCT00818961|3689868|FG000|COMPLETED|Overall Study||36
2974968|NCT00818961|3689868|FG000|NOT COMPLETED|Overall Study||0
2974969|NCT00819013|3689876|FG000|STARTED|Overall Study||22
2974970|NCT00819013|3689877|FG001|STARTED|Overall Study||23
2974971|NCT00819013|3689878|FG002|STARTED|Overall Study||21
2974972|NCT00819013|3689879|FG003|STARTED|Overall Study||21
2974973|NCT00819013|3689876|FG000|COMPLETED|Overall Study||19
2974974|NCT00819013|3689877|FG001|COMPLETED|Overall Study||22
2974975|NCT00819013|3689878|FG002|COMPLETED|Overall Study||16
2974976|NCT00819013|3689879|FG003|COMPLETED|Overall Study||17
2974977|NCT00819013|3689876|FG000|NOT COMPLETED|Overall Study||3
2974978|NCT00819013|3689877|FG001|NOT COMPLETED|Overall Study||1
2974979|NCT00819013|3689878|FG002|NOT COMPLETED|Overall Study||5
2974980|NCT00819013|3689879|FG003|NOT COMPLETED|Overall Study||4
2974981|NCT00819039|3689892|FG000|STARTED|Overall Study||46
2974982|NCT00819039|3689893|FG001|STARTED|Overall Study||27
2974983|NCT00819039|3689894|FG002|STARTED|Overall Study||25
2974984|NCT00819039|3689892|FG000|COMPLETED|Overall Study||44
2974985|NCT00819039|3689893|FG001|COMPLETED|Overall Study||27
2974986|NCT00819039|3689894|FG002|COMPLETED|Overall Study||24
2974987|NCT00819039|3689892|FG000|NOT COMPLETED|Overall Study||2
2974988|NCT00819039|3689893|FG001|NOT COMPLETED|Overall Study||0
2974989|NCT00819039|3689894|FG002|NOT COMPLETED|Overall Study||1
2974990|NCT00819052|3689906|FG000|STARTED|Overall Study||148
2974991|NCT00819052|3689907|FG001|STARTED|Overall Study||295
2974992|NCT00819052|3689906|FG000|COMPLETED|Overall Study||142
2974993|NCT00819052|3689907|FG001|COMPLETED|Overall Study||281
2974994|NCT00819052|3689906|FG000|NOT COMPLETED|Overall Study||6
2974995|NCT00819052|3689907|FG001|NOT COMPLETED|Overall Study||14
2974996|NCT00819091|3689918|FG000|STARTED|Overall Study||84
2974997|NCT00819091|3689919|FG001|STARTED|Overall Study||161
2974998|NCT00819091|3689918|FG000|COMPLETED|Overall Study||77
2974999|NCT00819091|3689919|FG001|COMPLETED|Overall Study||151
2975000|NCT00819091|3689918|FG000|NOT COMPLETED|Overall Study||7
2975001|NCT00819091|3689919|FG001|NOT COMPLETED|Overall Study||10
2975002|NCT00819156|3689931|FG000|STARTED|Overall Study||30
2975003|NCT00819156|3689932|FG001|STARTED|Overall Study||33
2975004|NCT00819156|3689933|FG002|STARTED|Overall Study||32
2975005|NCT00819156|3689934|FG003|STARTED|Overall Study||30
2975006|NCT00819156|3689935|FG004|STARTED|Overall Study||33
2975007|NCT00819156|3689936|FG005|STARTED|Overall Study||31
2975008|NCT00819156|3689931|FG000|Randomised and Treated (ITT Population)|Overall Study||30
2975009|NCT00819156|3689932|FG001|Randomised and Treated (ITT Population)|Overall Study||32
2975010|NCT00819156|3689933|FG002|Randomised and Treated (ITT Population)|Overall Study||32
2975011|NCT00819156|3689934|FG003|Randomised and Treated (ITT Population)|Overall Study||30
2975012|NCT00819156|3689935|FG004|Randomised and Treated (ITT Population)|Overall Study||33
2975013|NCT00819156|3689936|FG005|Randomised and Treated (ITT Population)|Overall Study||30
2975014|NCT00819156|3689931|FG000|COMPLETED|Overall Study||20
2975015|NCT00819156|3689932|FG001|COMPLETED|Overall Study||23
2975016|NCT00819156|3689933|FG002|COMPLETED|Overall Study||26
2975017|NCT00819156|3689934|FG003|COMPLETED|Overall Study||28
2975018|NCT00819156|3689935|FG004|COMPLETED|Overall Study||27
2975019|NCT00819156|3689936|FG005|COMPLETED|Overall Study||23
2975020|NCT00819156|3689931|FG000|NOT COMPLETED|Overall Study||10
2975021|NCT00819156|3689932|FG001|NOT COMPLETED|Overall Study||10
2975022|NCT00819156|3689933|FG002|NOT COMPLETED|Overall Study||6
2975023|NCT00819156|3689934|FG003|NOT COMPLETED|Overall Study||2
2975024|NCT00819156|3689935|FG004|NOT COMPLETED|Overall Study||6
2975025|NCT00819156|3689936|FG005|NOT COMPLETED|Overall Study||8
2975026|NCT00819182|3689961|FG000|STARTED|Overall Study|Consented participants allocated to this arm.|88
2975027|NCT00819182|3689962|FG001|STARTED|Overall Study|Consented participants allocated to this arm.|86
2975028|NCT00819182|3689963|FG002|STARTED|Overall Study|Consented participants allocated to this arm.|44
2975029|NCT00819182|3689961|FG000|Week 16 Visit|Overall Study||75
2975030|NCT00819182|3689962|FG001|Week 16 Visit|Overall Study||78
2975031|NCT00819182|3689963|FG002|Week 16 Visit|Overall Study||43
2975032|NCT00819182|3689961|FG000|COMPLETED|Overall Study||75
2975033|NCT00819182|3689962|FG001|COMPLETED|Overall Study||78
2975034|NCT00819182|3689963|FG002|COMPLETED|Overall Study||43
2975035|NCT00819182|3689961|FG000|NOT COMPLETED|Overall Study||13
2975036|NCT00819182|3689962|FG001|NOT COMPLETED|Overall Study||8
2975037|NCT00819182|3689963|FG002|NOT COMPLETED|Overall Study||1
2975038|NCT00819234|3689971|FG000|STARTED|Overall Study||31
2975039|NCT00819234|3689972|FG001|STARTED|Overall Study||35
2975040|NCT00819234|3689973|FG002|STARTED|Overall Study||36
2975041|NCT00819234|3689974|FG003|STARTED|Overall Study||28
2975042|NCT00819234|3689975|FG004|STARTED|Overall Study||13
2975043|NCT00819234|3689976|FG005|STARTED|Overall Study||14
2975044|NCT00819234|3689977|FG006|STARTED|Overall Study||13
2975045|NCT00819234|3689978|FG007|STARTED|Overall Study||29
2975046|NCT00819234|3689979|FG008|STARTED|Overall Study||37
2975047|NCT00819234|3689980|FG009|STARTED|Overall Study||37
2975048|NCT00819234|3689971|FG000|COMPLETED|Overall Study||21
2975049|NCT00819234|3689972|FG001|COMPLETED|Overall Study||20
2975050|NCT00819234|3689973|FG002|COMPLETED|Overall Study||28
2975051|NCT00819234|3689974|FG003|COMPLETED|Overall Study||22
2975052|NCT00819234|3689975|FG004|COMPLETED|Overall Study||12
2975053|NCT00819234|3689976|FG005|COMPLETED|Overall Study||7
2975054|NCT00819234|3689977|FG006|COMPLETED|Overall Study||8
2975055|NCT00819234|3689978|FG007|COMPLETED|Overall Study||20
2975056|NCT00819234|3689979|FG008|COMPLETED|Overall Study||31
2975057|NCT00819234|3689980|FG009|COMPLETED|Overall Study||30
2975058|NCT00819234|3689971|FG000|NOT COMPLETED|Overall Study||10
2975059|NCT00819234|3689972|FG001|NOT COMPLETED|Overall Study||15
2975060|NCT00819234|3689973|FG002|NOT COMPLETED|Overall Study||8
2975061|NCT00819234|3689974|FG003|NOT COMPLETED|Overall Study||6
2975062|NCT00819234|3689975|FG004|NOT COMPLETED|Overall Study||1
2975063|NCT00819234|3689976|FG005|NOT COMPLETED|Overall Study||7
2975064|NCT00819234|3689977|FG006|NOT COMPLETED|Overall Study||5
2975065|NCT00819234|3689978|FG007|NOT COMPLETED|Overall Study||9
2975066|NCT00819234|3689979|FG008|NOT COMPLETED|Overall Study||6
2975067|NCT00819234|3689980|FG009|NOT COMPLETED|Overall Study||7
2975068|NCT00819247|3690038|FG000|STARTED|Overall Study||43
2975069|NCT00819247|3690039|FG001|STARTED|Overall Study||46
2975070|NCT00819247|3690040|FG002|STARTED|Overall Study||40
2975071|NCT00819247|3690038|FG000|Randomized|Overall Study||43
2975072|NCT00819247|3690039|FG001|Randomized|Overall Study||46
2975073|NCT00819247|3690040|FG002|Randomized|Overall Study||40
2975074|NCT00819247|3690038|FG000|Intent-to-treat Population|Overall Study|One randomised participant withdrew at Day 1.|42
2975075|NCT00819247|3690039|FG001|Intent-to-treat Population|Overall Study||46
2975076|NCT00819247|3690040|FG002|Intent-to-treat Population|Overall Study|One randomised participant withdrew at Day 1.|39
2975077|NCT00819247|3690038|FG000|Per Protocol Population|Overall Study|One participant- baseline testosterone outside normal range. Three participants- prohibited drugs.|38
2975078|NCT00819247|3690039|FG001|Per Protocol Population|Overall Study|Two participants - prohibited drugs|44
2975079|NCT00819247|3690040|FG002|Per Protocol Population|Overall Study|One participant - baseline testosterone outside normal range.|38
2975080|NCT00819247|3690038|FG000|COMPLETED|Overall Study||32
2975081|NCT00819247|3690039|FG001|COMPLETED|Overall Study||30
2975082|NCT00819247|3690040|FG002|COMPLETED|Overall Study||26
2975083|NCT00819247|3690038|FG000|NOT COMPLETED|Overall Study||11
2975084|NCT00819247|3690039|FG001|NOT COMPLETED|Overall Study||16
2975085|NCT00819247|3690040|FG002|NOT COMPLETED|Overall Study||14
2975086|NCT00819260|3690048|FG000|STARTED|Overall Study||31
2975087|NCT00819260|3690048|FG000|COMPLETED|Overall Study||31
2975088|NCT00819260|3690048|FG000|NOT COMPLETED|Overall Study||0
2975089|NCT00819286|3690056|FG000|STARTED|Overall Study||70
2975090|NCT00819286|3690057|FG001|STARTED|Overall Study||70
2975091|NCT00819286|3690056|FG000|COMPLETED|Overall Study||56
2975092|NCT00819286|3690057|FG001|COMPLETED|Overall Study||45
2975093|NCT00819286|3690056|FG000|NOT COMPLETED|Overall Study||14
2975094|NCT00819286|3690057|FG001|NOT COMPLETED|Overall Study||25
2975095|NCT00819390|3690067|FG000|STARTED|Overall Study||16
2975096|NCT00819390|3690068|FG001|STARTED|Overall Study||17
2975097|NCT00819390|3690069|FG002|STARTED|Overall Study||18
2975098|NCT00819390|3690070|FG003|STARTED|Overall Study||19
2975099|NCT00819390|3690067|FG000|COMPLETED|Overall Study||13
2975100|NCT00819390|3690068|FG001|COMPLETED|Overall Study||16
2975101|NCT00819390|3690069|FG002|COMPLETED|Overall Study||17
2975102|NCT00819390|3690070|FG003|COMPLETED|Overall Study||19
2975103|NCT00819390|3690067|FG000|NOT COMPLETED|Overall Study||3
2975104|NCT00819390|3690068|FG001|NOT COMPLETED|Overall Study||1
2975105|NCT00819390|3690069|FG002|NOT COMPLETED|Overall Study||1
2975106|NCT00819390|3690070|FG003|NOT COMPLETED|Overall Study||0
2975107|NCT00819403|3690085|FG000|STARTED|First Intervention (6 Weeks)||7
2975108|NCT00819403|3690086|FG001|STARTED|First Intervention (6 Weeks)||8
2975109|NCT00819403|3690085|FG000|COMPLETED|First Intervention (6 Weeks)||7
2975110|NCT00819403|3690086|FG001|COMPLETED|First Intervention (6 Weeks)||8
2975111|NCT00819403|3690085|FG000|NOT COMPLETED|First Intervention (6 Weeks)||0
2975112|NCT00819403|3690086|FG001|NOT COMPLETED|First Intervention (6 Weeks)||0
2975113|NCT00819403|3690085|FG000|STARTED|Washout (14 Days)||7
2975114|NCT00819403|3690086|FG001|STARTED|Washout (14 Days)||8
2975115|NCT00819403|3690085|FG000|COMPLETED|Washout (14 Days)||7
2975116|NCT00819403|3690086|FG001|COMPLETED|Washout (14 Days)||8
2975117|NCT00819403|3690085|FG000|NOT COMPLETED|Washout (14 Days)||0
2975118|NCT00819403|3690086|FG001|NOT COMPLETED|Washout (14 Days)||0
2975119|NCT00819403|3690085|FG000|STARTED|Second Intervention (6 Weeks)||7
2975120|NCT00819403|3690086|FG001|STARTED|Second Intervention (6 Weeks)||8
2975121|NCT00819403|3690085|FG000|COMPLETED|Second Intervention (6 Weeks)||7
2975122|NCT00819403|3690086|FG001|COMPLETED|Second Intervention (6 Weeks)||8
2975123|NCT00819403|3690085|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||0
2975124|NCT00819403|3690086|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||0
2975125|NCT00819507|3690093|FG000|STARTED|Overall Study||25
2975126|NCT00819507|3690093|FG000|COMPLETED|Overall Study||25
2975127|NCT00819507|3690093|FG000|NOT COMPLETED|Overall Study||0
2975128|NCT00819585|3690104|FG000|STARTED|Core Study|Participants who started the core study are included in the randomized and full analysis sets.|55
2975129|NCT00819585|3690105|FG001|STARTED|Core Study||54
2975130|NCT00819585|3690106|FG002|STARTED|Core Study||54
2975131|NCT00819585|3690107|FG003|STARTED|Core Study||54
2975132|NCT00819585|3690108|FG004|STARTED|Core Study||53
2975133|NCT00819585|3690109|FG005|STARTED|Core Study||54
2975134|NCT00819585|3690110|FG006|STARTED|Core Study||108
2975135|NCT00819585|3690111|FG007|STARTED|Core Study|There were no participants in this arm during the core study.|0
2975136|NCT00819585|3690112|FG008|STARTED|Core Study|There were no participants in this arm during the core study.|0
2975137|NCT00819585|3690113|FG009|STARTED|Core Study|There were no participants in this arm during the core study.|0
2975138|NCT00819585|3690114|FG010|STARTED|Core Study|There were no participants in this arm during the core study.|0
2975139|NCT00819585|3690104|FG000|Received Study Medication|Core Study|Participants who received study medication are included in the safety population.|55
2975140|NCT00819585|3690105|FG001|Received Study Medication|Core Study||54
2975141|NCT00819585|3690106|FG002|Received Study Medication|Core Study||54
2975142|NCT00819585|3690107|FG003|Received Study Medication|Core Study||54
2975143|NCT00819585|3690108|FG004|Received Study Medication|Core Study||53
2975144|NCT00819585|3690109|FG005|Received Study Medication|Core Study|One participant in this treatment arm was HIV+ve and did not receive any study medication.|53
2975145|NCT00819585|3690110|FG006|Received Study Medication|Core Study||108
2975146|NCT00819585|3690111|FG007|Received Study Medication|Core Study||0
2975147|NCT00819585|3690112|FG008|Received Study Medication|Core Study||0
2975148|NCT00819585|3690113|FG009|Received Study Medication|Core Study||0
2975149|NCT00819585|3690114|FG010|Received Study Medication|Core Study||0
2975150|NCT00819585|3690104|FG000|COMPLETED|Core Study||49
2975151|NCT00819585|3690105|FG001|COMPLETED|Core Study||48
2975152|NCT00819585|3690106|FG002|COMPLETED|Core Study||48
2975153|NCT00819585|3690107|FG003|COMPLETED|Core Study||49
3164115|NCT01890785|3891533|FG003|NOT COMPLETED|Third Intervention||0
3164116|NCT01890785|3891534|FG004|NOT COMPLETED|Third Intervention||0
3164117|NCT01890785|3891535|FG005|NOT COMPLETED|Third Intervention||0
3164118|NCT01890915|3891546|FG000|STARTED|Overall Study||11
3164119|NCT01890915|3891547|FG001|STARTED|Overall Study||10
3164120|NCT01890915|3891546|FG000|COMPLETED|Overall Study||8
3164121|NCT01890915|3891547|FG001|COMPLETED|Overall Study||9
2975154|NCT00819585|3690108|FG004|COMPLETED|Core Study||50
3164122|NCT01890915|3891546|FG000|NOT COMPLETED|Overall Study||3
3164123|NCT01890915|3891547|FG001|NOT COMPLETED|Overall Study||1
3164124|NCT01890954|3891555|FG000|STARTED|Overall Study||9
3164125|NCT01890954|3891556|FG001|STARTED|Overall Study||8
3164126|NCT01890954|3891555|FG000|COMPLETED|Overall Study||8
3164127|NCT01890954|3891556|FG001|COMPLETED|Overall Study||8
3164128|NCT01890954|3891555|FG000|NOT COMPLETED|Overall Study||1
3164129|NCT01890954|3891556|FG001|NOT COMPLETED|Overall Study||0
3164130|NCT01890967|3891568|FG000|STARTED|Overall Study||88
3164131|NCT01890967|3891569|FG001|STARTED|Overall Study||88
3164132|NCT01890967|3891570|FG002|STARTED|Overall Study||88
3164133|NCT01890967|3891571|FG003|STARTED|Overall Study||88
3164134|NCT01890967|3891572|FG004|STARTED|Overall Study||87
3164135|NCT01890967|3891573|FG005|STARTED|Overall Study||88
3164136|NCT01890967|3891568|FG000|Received at Least One Dose of Study Drug|Overall Study||87
3164137|NCT01890967|3891569|FG001|Received at Least One Dose of Study Drug|Overall Study||87
3164138|NCT01890967|3891570|FG002|Received at Least One Dose of Study Drug|Overall Study||86
3164139|NCT01890967|3891571|FG003|Received at Least One Dose of Study Drug|Overall Study||86
3164140|NCT01890967|3891572|FG004|Received at Least One Dose of Study Drug|Overall Study||86
3164141|NCT01890967|3891573|FG005|Received at Least One Dose of Study Drug|Overall Study||87
3164142|NCT01890967|3891568|FG000|COMPLETED|Overall Study||78
3164143|NCT01890967|3891569|FG001|COMPLETED|Overall Study||77
3164144|NCT01890967|3891570|FG002|COMPLETED|Overall Study||78
3164145|NCT01890967|3891571|FG003|COMPLETED|Overall Study||77
3164146|NCT01890967|3891572|FG004|COMPLETED|Overall Study||77
3164147|NCT01890967|3891573|FG005|COMPLETED|Overall Study||75
3164148|NCT01890967|3891568|FG000|NOT COMPLETED|Overall Study||10
3164149|NCT01890967|3891569|FG001|NOT COMPLETED|Overall Study||11
3164150|NCT01890967|3891570|FG002|NOT COMPLETED|Overall Study||10
3164151|NCT01890967|3891571|FG003|NOT COMPLETED|Overall Study||11
3164152|NCT01890967|3891572|FG004|NOT COMPLETED|Overall Study||10
3164153|NCT01890967|3891573|FG005|NOT COMPLETED|Overall Study||13
3164154|NCT01891305|3891596|FG000|STARTED|Overall Study||12
3303150|NCT02964247|4036460|FG000|STARTED|Overall Study||203
3303151|NCT02964247|4036461|FG001|STARTED|Overall Study||100
3303152|NCT02964247|4036460|FG000|Exposed to Trial Product|Overall Study||202
2975155|NCT00819585|3690109|FG005|COMPLETED|Core Study||52
2975156|NCT00819585|3690110|FG006|COMPLETED|Core Study||95
2975157|NCT00819585|3690111|FG007|COMPLETED|Core Study||0
2975158|NCT00819585|3690112|FG008|COMPLETED|Core Study||0
2975159|NCT00819585|3690113|FG009|COMPLETED|Core Study||0
2975160|NCT00819585|3690114|FG010|COMPLETED|Core Study||0
3303153|NCT02964247|4036461|FG001|Exposed to Trial Product|Overall Study||100
3303154|NCT02964247|4036460|FG000|COMPLETED|Overall Study||200
3303155|NCT02964247|4036461|FG001|COMPLETED|Overall Study||98
3303156|NCT02964247|4036460|FG000|NOT COMPLETED|Overall Study||3
3303157|NCT02964247|4036461|FG001|NOT COMPLETED|Overall Study||2
3303158|NCT02964312|4036467|FG000|STARTED|Overall Study||166
3303159|NCT02964312|4036467|FG000|1-Month Follow-up|Overall Study||164
3303160|NCT02964312|4036467|FG000|3-Month Follow-up|Overall Study||159
3303161|NCT02964312|4036467|FG000|6-Month Follow-up|Overall Study||152
3303162|NCT02964312|4036467|FG000|12-Month Follow-up|Overall Study||139
3303163|NCT02964312|4036467|FG000|18-Month Follow-up|Overall Study||112
3303164|NCT02964312|4036467|FG000|24-Month Follow-up|Overall Study||102
3303165|NCT02964312|4036467|FG000|COMPLETED|Overall Study||102
3303166|NCT02964312|4036467|FG000|NOT COMPLETED|Overall Study||64
3303167|NCT02964325|4036476|FG000|STARTED|Overall Study||164
3303168|NCT02964325|4036477|FG001|STARTED|Overall Study||166
3303169|NCT02964325|4036476|FG000|Full Analysis Set|Overall Study||164
3303170|NCT02964325|4036477|FG001|Full Analysis Set|Overall Study||166
2975161|NCT00819585|3690104|FG000|NOT COMPLETED|Core Study||6
2975162|NCT00819585|3690105|FG001|NOT COMPLETED|Core Study||6
2975163|NCT00819585|3690106|FG002|NOT COMPLETED|Core Study||6
2975164|NCT00819585|3690107|FG003|NOT COMPLETED|Core Study||5
2975165|NCT00819585|3690108|FG004|NOT COMPLETED|Core Study||3
2975166|NCT00819585|3690109|FG005|NOT COMPLETED|Core Study||2
2975167|NCT00819585|3690110|FG006|NOT COMPLETED|Core Study||13
2975168|NCT00819585|3690111|FG007|NOT COMPLETED|Core Study||0
2975169|NCT00819585|3690112|FG008|NOT COMPLETED|Core Study||0
2975170|NCT00819585|3690113|FG009|NOT COMPLETED|Core Study||0
2975171|NCT00819585|3690114|FG010|NOT COMPLETED|Core Study||0
2975172|NCT00819585|3690104|FG000|STARTED|Extension Study|There were no participants in this arm during the extension study.|0
2975173|NCT00819585|3690105|FG001|STARTED|Extension Study|There were no participants in this arm during the extension study.|0
2975174|NCT00819585|3690106|FG002|STARTED|Extension Study|There were no participants in this arm during the extension study.|0
2975175|NCT00819585|3690107|FG003|STARTED|Extension Study|There were no participants in this arm during the extension study.|0
2975176|NCT00819585|3690108|FG004|STARTED|Extension Study|There were no participants in this arm during the extension study.|0
2975177|NCT00819585|3690109|FG005|STARTED|Extension Study|There were no participants in this arm during the extension study.|0
2975178|NCT00819585|3690110|FG006|STARTED|Extension Study|There were no participants in this arm during the extension study.|0
2975179|NCT00819585|3690111|FG007|STARTED|Extension Study||75
2975180|NCT00819585|3690112|FG008|STARTED|Extension Study||181
2975181|NCT00819585|3690113|FG009|STARTED|Extension Study||25
2975182|NCT00819585|3690114|FG010|STARTED|Extension Study||60
2975183|NCT00819585|3690104|FG000|COMPLETED|Extension Study||0
2975184|NCT00819585|3690105|FG001|COMPLETED|Extension Study||0
2975185|NCT00819585|3690106|FG002|COMPLETED|Extension Study||0
2975186|NCT00819585|3690107|FG003|COMPLETED|Extension Study||0
2975187|NCT00819585|3690108|FG004|COMPLETED|Extension Study||0
2975188|NCT00819585|3690109|FG005|COMPLETED|Extension Study||0
2975189|NCT00819585|3690110|FG006|COMPLETED|Extension Study||0
2975190|NCT00819585|3690111|FG007|COMPLETED|Extension Study||75
2975191|NCT00819585|3690112|FG008|COMPLETED|Extension Study||173
2975192|NCT00819585|3690113|FG009|COMPLETED|Extension Study||24
2975193|NCT00819585|3690114|FG010|COMPLETED|Extension Study||58
2975194|NCT00819585|3690104|FG000|NOT COMPLETED|Extension Study||0
2975195|NCT00819585|3690105|FG001|NOT COMPLETED|Extension Study||0
2975196|NCT00819585|3690106|FG002|NOT COMPLETED|Extension Study||0
2975197|NCT00819585|3690107|FG003|NOT COMPLETED|Extension Study||0
2975198|NCT00819585|3690108|FG004|NOT COMPLETED|Extension Study||0
2975199|NCT00819585|3690109|FG005|NOT COMPLETED|Extension Study||0
2975200|NCT00819585|3690110|FG006|NOT COMPLETED|Extension Study||0
2975201|NCT00819585|3690111|FG007|NOT COMPLETED|Extension Study||0
2975202|NCT00819585|3690112|FG008|NOT COMPLETED|Extension Study||8
2975203|NCT00819585|3690113|FG009|NOT COMPLETED|Extension Study||1
2975204|NCT00819585|3690114|FG010|NOT COMPLETED|Extension Study||2
2975205|NCT00819637|3690145|FG000|STARTED|Overall Study||2
2975206|NCT00819637|3690146|FG001|STARTED|Overall Study||0
2975207|NCT00819637|3690147|FG002|STARTED|Overall Study||0
2975208|NCT00819637|3690145|FG000|COMPLETED|Overall Study||2
2975209|NCT00819637|3690146|FG001|COMPLETED|Overall Study||0
2975210|NCT00819637|3690147|FG002|COMPLETED|Overall Study||0
2975211|NCT00819637|3690145|FG000|NOT COMPLETED|Overall Study||0
2975212|NCT00819637|3690146|FG001|NOT COMPLETED|Overall Study||0
2975213|NCT00819637|3690147|FG002|NOT COMPLETED|Overall Study||0
2975214|NCT00819741|3690157|FG000|STARTED|Overall Study||218
2975215|NCT00819741|3690158|FG001|STARTED|Overall Study||215
2975216|NCT00819741|3690157|FG000|Exposed to Drug|Overall Study||218
2975217|NCT00819741|3690158|FG001|Exposed to Drug|Overall Study|One subject after randomisation was not exposed to the treatment due to non-compliance|214
2975218|NCT00819741|3690157|FG000|COMPLETED|Overall Study||196
2975219|NCT00819741|3690158|FG001|COMPLETED|Overall Study||201
2975220|NCT00819741|3690157|FG000|NOT COMPLETED|Overall Study||22
2975221|NCT00819741|3690158|FG001|NOT COMPLETED|Overall Study||14
2975222|NCT00819767|3690166|FG000|STARTED|Overall Study||33
2975223|NCT00819767|3690167|FG001|STARTED|Overall Study||35
2975224|NCT00819767|3690166|FG000|COMPLETED|Overall Study||32
2975225|NCT00819767|3690167|FG001|COMPLETED|Overall Study||33
2975226|NCT00819767|3690166|FG000|NOT COMPLETED|Overall Study||1
2975227|NCT00819767|3690167|FG001|NOT COMPLETED|Overall Study||2
2975228|NCT00819780|3690175|FG000|STARTED|Overall Study||142
2975229|NCT00819780|3690176|FG001|STARTED|Overall Study||143
2975230|NCT00819780|3690175|FG000|Received Study Treatment|Overall Study||139
2975231|NCT00819780|3690176|FG001|Received Study Treatment|Overall Study||139
2975232|NCT00819780|3690175|FG000|COMPLETED|Overall Study|Indicates participants who ended study treatment|114
2975233|NCT00819780|3690176|FG001|COMPLETED|Overall Study|Indicates participants who ended study treatment|122
2975234|NCT00819780|3690175|FG000|NOT COMPLETED|Overall Study||28
2975235|NCT00819780|3690176|FG001|NOT COMPLETED|Overall Study||21
2975236|NCT00819793|3690182|FG000|STARTED|Overall Study||32
2975237|NCT00819793|3690182|FG000|COMPLETED|Overall Study||32
2975238|NCT00819793|3690182|FG000|NOT COMPLETED|Overall Study||0
2975239|NCT00819910|3690191|FG000|STARTED|Overall Study||10
2975240|NCT00819910|3690192|FG001|STARTED|Overall Study||10
2975241|NCT00819910|3690193|FG002|STARTED|Overall Study||10
2975242|NCT00819910|3690194|FG003|STARTED|Overall Study||11
2975243|NCT00819910|3690191|FG000|COMPLETED|Overall Study||8
2975244|NCT00819910|3690192|FG001|COMPLETED|Overall Study||9
2975245|NCT00819910|3690193|FG002|COMPLETED|Overall Study||7
2975246|NCT00819910|3690194|FG003|COMPLETED|Overall Study||10
2975247|NCT00819910|3690191|FG000|NOT COMPLETED|Overall Study||2
2975248|NCT00819910|3690192|FG001|NOT COMPLETED|Overall Study||1
2975249|NCT00819910|3690193|FG002|NOT COMPLETED|Overall Study||3
2975250|NCT00819910|3690194|FG003|NOT COMPLETED|Overall Study||1
2975251|NCT00820040|3690206|FG000|STARTED|Overall Study||10
2975252|NCT00820040|3690206|FG000|Safety Evaluable Population|Overall Study||8
2975253|NCT00820040|3690206|FG000|Full Analysis Set|Overall Study||8
2975254|NCT00820040|3690206|FG000|COMPLETED|Overall Study||7
2975255|NCT00820040|3690206|FG000|NOT COMPLETED|Overall Study||3
2975256|NCT00820170|3690215|FG000|STARTED|Overall Study||3
2975257|NCT00820170|3690216|FG001|STARTED|Overall Study||5
2975258|NCT00820170|3690217|FG002|STARTED|Overall Study||3
2975259|NCT00820170|3690218|FG003|STARTED|Overall Study||40
2975260|NCT00820170|3690219|FG004|STARTED|Overall Study||4
2975261|NCT00820170|3690215|FG000|COMPLETED|Overall Study||3
2975262|NCT00820170|3690216|FG001|COMPLETED|Overall Study||5
2975263|NCT00820170|3690217|FG002|COMPLETED|Overall Study||3
2975264|NCT00820170|3690218|FG003|COMPLETED|Overall Study||40
2975265|NCT00820170|3690219|FG004|COMPLETED|Overall Study||0
2975266|NCT00820170|3690215|FG000|NOT COMPLETED|Overall Study||0
2975267|NCT00820170|3690216|FG001|NOT COMPLETED|Overall Study||0
2975268|NCT00820170|3690217|FG002|NOT COMPLETED|Overall Study||0
2975269|NCT00820170|3690218|FG003|NOT COMPLETED|Overall Study||0
2975270|NCT00820170|3690219|FG004|NOT COMPLETED|Overall Study||4
2975271|NCT00820222|3690238|FG000|STARTED|Overall Study||271
2975272|NCT00820222|3690239|FG001|STARTED|Overall Study||269
2975273|NCT00820222|3690238|FG000|COMPLETED|Overall Study||95
2975274|NCT00820222|3690239|FG001|COMPLETED|Overall Study||79
2975275|NCT00820222|3690238|FG000|NOT COMPLETED|Overall Study||176
2975276|NCT00820222|3690239|FG001|NOT COMPLETED|Overall Study||190
2975277|NCT00820235|3690248|FG000|STARTED|Overall Study||48
2975278|NCT00820235|3690249|FG001|STARTED|Overall Study||49
2975279|NCT00820235|3690250|FG002|STARTED|Overall Study||44
2975280|NCT00820235|3690248|FG000|COMPLETED|Overall Study||33
2975281|NCT00820235|3690249|FG001|COMPLETED|Overall Study||28
2975282|NCT00820235|3690250|FG002|COMPLETED|Overall Study||27
2975283|NCT00820235|3690248|FG000|NOT COMPLETED|Overall Study||15
2975284|NCT00820235|3690249|FG001|NOT COMPLETED|Overall Study||21
2975285|NCT00820235|3690250|FG002|NOT COMPLETED|Overall Study||17
2975286|NCT00820248|3690260|FG000|STARTED|Overall Study||160
2975287|NCT00820248|3690261|FG001|STARTED|Overall Study||160
2975288|NCT00820248|3690260|FG000|Received Protocol Treatment|Overall Study||156
2975289|NCT00820248|3690261|FG001|Received Protocol Treatment|Overall Study||159
2975290|NCT00820248|3690260|FG000|COMPLETED|Overall Study||156
2975291|NCT00820248|3690261|FG001|COMPLETED|Overall Study||159
2975292|NCT00820248|3690260|FG000|NOT COMPLETED|Overall Study||4
2975293|NCT00820248|3690261|FG001|NOT COMPLETED|Overall Study||1
2975294|NCT00820443|3690267|FG000|STARTED|Pre-Op||253
2975295|NCT00820443|3690267|FG000|COMPLETED|Pre-Op||253
2975296|NCT00820443|3690267|FG000|NOT COMPLETED|Pre-Op||0
2975297|NCT00820443|3690267|FG000|STARTED|Op||253
2975298|NCT00820443|3690267|FG000|COMPLETED|Op||253
2975299|NCT00820443|3690267|FG000|NOT COMPLETED|Op||0
2975300|NCT00820443|3690267|FG000|STARTED|Immediately||253
2975301|NCT00820443|3690267|FG000|COMPLETED|Immediately||248
2975302|NCT00820443|3690267|FG000|NOT COMPLETED|Immediately||5
2975303|NCT00820443|3690267|FG000|STARTED|3 Month||253
2975304|NCT00820443|3690267|FG000|COMPLETED|3 Month||244
2975305|NCT00820443|3690267|FG000|NOT COMPLETED|3 Month||9
2975306|NCT00820443|3690267|FG000|STARTED|6 Month||253
2975307|NCT00820443|3690267|FG000|COMPLETED|6 Month||233
2975308|NCT00820443|3690267|FG000|NOT COMPLETED|6 Month||20
2975309|NCT00820443|3690267|FG000|STARTED|12 Month||250
2975310|NCT00820443|3690267|FG000|COMPLETED|12 Month||226
2975311|NCT00820443|3690267|FG000|NOT COMPLETED|12 Month||24
2975312|NCT00820443|3690267|FG000|STARTED|24 Month||245
2975313|NCT00820443|3690267|FG000|COMPLETED|24 Month||202
2975314|NCT00820443|3690267|FG000|NOT COMPLETED|24 Month||43
2975315|NCT00820534|3690274|FG000|STARTED|Overall Study||64
2975316|NCT00820534|3690275|FG001|STARTED|Overall Study||62
2975317|NCT00820534|3690274|FG000|COMPLETED|Overall Study||64
2975318|NCT00820534|3690275|FG001|COMPLETED|Overall Study||62
2975319|NCT00820534|3690274|FG000|NOT COMPLETED|Overall Study||0
2975320|NCT00820534|3690275|FG001|NOT COMPLETED|Overall Study||0
2975321|NCT00820573|3690285|FG000|STARTED|Overall Study||4
2975322|NCT00820573|3690286|FG001|STARTED|Overall Study||4
2975323|NCT00820573|3690287|FG002|STARTED|Overall Study||4
2975324|NCT00820573|3690288|FG003|STARTED|Overall Study||4
2975325|NCT00820573|3690285|FG000|COMPLETED|Overall Study||4
2975326|NCT00820573|3690286|FG001|COMPLETED|Overall Study||4
2975327|NCT00820573|3690287|FG002|COMPLETED|Overall Study||4
3164155|NCT01891305|3891597|FG001|STARTED|Overall Study||12
3164156|NCT01891305|3891598|FG002|STARTED|Overall Study||14
3164157|NCT01891305|3891599|FG003|STARTED|Overall Study||12
3164158|NCT01891305|3891596|FG000|COMPLETED|Overall Study||9
3164159|NCT01891305|3891597|FG001|COMPLETED|Overall Study||11
3164160|NCT01891305|3891598|FG002|COMPLETED|Overall Study||11
2975328|NCT00820573|3690288|FG003|COMPLETED|Overall Study||4
2975329|NCT00820573|3690285|FG000|NOT COMPLETED|Overall Study||0
2975330|NCT00820573|3690286|FG001|NOT COMPLETED|Overall Study||0
2975331|NCT00820573|3690287|FG002|NOT COMPLETED|Overall Study||0
2975332|NCT00820573|3690288|FG003|NOT COMPLETED|Overall Study||0
2975333|NCT00820599|3690307|FG000|STARTED|Overall Study||211
2975334|NCT00820599|3690307|FG000|COMPLETED|Overall Study||80
2975335|NCT00820599|3690307|FG000|NOT COMPLETED|Overall Study||131
2975336|NCT00820612|3690313|FG000|STARTED|Overall Study||307
2975337|NCT00820612|3690314|FG001|STARTED|Overall Study||295
2975338|NCT00820612|3690313|FG000|COMPLETED|Overall Study||307
2975339|NCT00820612|3690314|FG001|COMPLETED|Overall Study||295
2975340|NCT00820612|3690313|FG000|NOT COMPLETED|Overall Study||0
2975341|NCT00820612|3690314|FG001|NOT COMPLETED|Overall Study||0
2975342|NCT00820664|3690323|FG000|STARTED|Overall Study||9
2975343|NCT00820664|3690324|FG001|STARTED|Overall Study||11
2975344|NCT00820664|3690325|FG002|STARTED|Overall Study||9
2975345|NCT00820664|3690323|FG000|COMPLETED|Overall Study||9
2975346|NCT00820664|3690324|FG001|COMPLETED|Overall Study||11
2975347|NCT00820664|3690325|FG002|COMPLETED|Overall Study||9
2975348|NCT00820664|3690323|FG000|NOT COMPLETED|Overall Study||0
2975349|NCT00820664|3690324|FG001|NOT COMPLETED|Overall Study||0
2975350|NCT00820664|3690325|FG002|NOT COMPLETED|Overall Study||0
2975351|NCT00820755|3690333|FG000|STARTED|Period 1: Combination Therapy Phase||583
2975352|NCT00820755|3690334|FG001|STARTED|Period 1: Combination Therapy Phase||0
2975353|NCT00820755|3690335|FG002|STARTED|Period 1: Combination Therapy Phase||0
2975354|NCT00820755|3690333|FG000|COMPLETED|Period 1: Combination Therapy Phase|2 of 313 participants excluded from maintenance phase analysis (reason: not eligible)|313
2975355|NCT00820755|3690334|FG001|COMPLETED|Period 1: Combination Therapy Phase||0
2975356|NCT00820755|3690335|FG002|COMPLETED|Period 1: Combination Therapy Phase||0
2975357|NCT00820755|3690333|FG000|NOT COMPLETED|Period 1: Combination Therapy Phase||270
2975358|NCT00820755|3690334|FG001|NOT COMPLETED|Period 1: Combination Therapy Phase||0
2975359|NCT00820755|3690335|FG002|NOT COMPLETED|Period 1: Combination Therapy Phase||0
2975360|NCT00820755|3690333|FG000|STARTED|Period 2: Maintenance Therapy Phase||0
2975361|NCT00820755|3690334|FG001|STARTED|Period 2: Maintenance Therapy Phase||157
3164161|NCT01891305|3891599|FG003|COMPLETED|Overall Study||12
2975362|NCT00820755|3690335|FG002|STARTED|Period 2: Maintenance Therapy Phase||154
2975363|NCT00820755|3690333|FG000|COMPLETED|Period 2: Maintenance Therapy Phase||0
2975364|NCT00820755|3690334|FG001|COMPLETED|Period 2: Maintenance Therapy Phase||112
2975365|NCT00820755|3690335|FG002|COMPLETED|Period 2: Maintenance Therapy Phase||109
2975366|NCT00820755|3690333|FG000|NOT COMPLETED|Period 2: Maintenance Therapy Phase||0
2975367|NCT00820755|3690334|FG001|NOT COMPLETED|Period 2: Maintenance Therapy Phase||45
2975368|NCT00820755|3690335|FG002|NOT COMPLETED|Period 2: Maintenance Therapy Phase||45
2975369|NCT00820872|3690343|FG000|STARTED|Overall Study||30
2975370|NCT00820872|3690343|FG000|COMPLETED|Overall Study||30
2975371|NCT00820872|3690343|FG000|NOT COMPLETED|Overall Study||0
2975372|NCT00820898|3690347|FG000|STARTED|Overall Study||24
2975373|NCT00820898|3690347|FG000|COMPLETED|Overall Study||23
2975374|NCT00820898|3690347|FG000|NOT COMPLETED|Overall Study||1
2975375|NCT00821015|3690357|FG000|STARTED|Overall Study||27
2975376|NCT00821015|3690357|FG000|COMPLETED|Overall Study||15
2975377|NCT00821015|3690357|FG000|NOT COMPLETED|Overall Study||12
2975378|NCT00821041|3690363|FG000|STARTED|Overall Study||59
2975379|NCT00821041|3690364|FG001|STARTED|Overall Study||59
2975380|NCT00821041|3690363|FG000|COMPLETED|Overall Study||59
2975381|NCT00821041|3690364|FG001|COMPLETED|Overall Study||59
2975382|NCT00821041|3690363|FG000|NOT COMPLETED|Overall Study||0
2975383|NCT00821041|3690364|FG001|NOT COMPLETED|Overall Study||0
2975384|NCT00821093|3690372|FG000|STARTED|Overall Study||560
2975385|NCT00821093|3690373|FG001|STARTED|Overall Study||563
2975386|NCT00821093|3690372|FG000|Exposed to Drug|Overall Study||559
2975387|NCT00821093|3690373|FG001|Exposed to Drug|Overall Study||562
2975388|NCT00821093|3690372|FG000|COMPLETED|Overall Study||511
2975389|NCT00821093|3690373|FG001|COMPLETED|Overall Study||523
2975390|NCT00821093|3690372|FG000|NOT COMPLETED|Overall Study||49
2975391|NCT00821093|3690373|FG001|NOT COMPLETED|Overall Study||40
2975392|NCT00821119|3690381|FG000|STARTED|Overall Study||100
2975393|NCT00821119|3690382|FG001|STARTED|Overall Study||100
2975394|NCT00821119|3690381|FG000|COMPLETED|Overall Study||100
2975395|NCT00821119|3690382|FG001|COMPLETED|Overall Study||100
2975396|NCT00821119|3690381|FG000|NOT COMPLETED|Overall Study||0
2975397|NCT00821119|3690382|FG001|NOT COMPLETED|Overall Study||0
2975398|NCT00821184|3690392|FG000|STARTED|Overall Study||6
2975399|NCT00821184|3690393|FG001|STARTED|Overall Study||6
2975400|NCT00821184|3690392|FG000|COMPLETED|Overall Study||6
2975401|NCT00821184|3690393|FG001|COMPLETED|Overall Study||6
3133283|NCT01695239|3858311|FG006|STARTED|Placebo Washout (Week 24 Up To Week 32)|Only included PBO washout participants.|0
3133284|NCT01695239|3858312|FG007|STARTED|Placebo Washout (Week 24 Up To Week 32)|Adalimumab Q2W responders who re-randomized to IxeQ2W or IxeQ4W and PBO for ixe and adalimumab.|88
3133285|NCT01695239|3858313|FG008|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
3133286|NCT01695239|3858314|FG009|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
3133287|NCT01695239|3858315|FG010|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
3133288|NCT01695239|3858316|FG011|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
3133289|NCT01695239|3858317|FG012|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
3133290|NCT01695239|3858318|FG013|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
3133291|NCT01695239|3858305|FG000|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
3133292|NCT01695239|3858306|FG001|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
2975402|NCT00821184|3690392|FG000|NOT COMPLETED|Overall Study||0
2975403|NCT00821184|3690393|FG001|NOT COMPLETED|Overall Study||0
3035894|NCT01139775|3755123|FG000|COMPLETED|Overall Study||13
3035895|NCT01139775|3755124|FG001|COMPLETED|Overall Study||26
3035896|NCT01139775|3755125|FG002|COMPLETED|Overall Study||17
3035897|NCT01139775|3755123|FG000|NOT COMPLETED|Overall Study||1
3035898|NCT01139775|3755124|FG001|NOT COMPLETED|Overall Study||13
3035899|NCT01139775|3755125|FG002|NOT COMPLETED|Overall Study||6
3035900|NCT01139801|3755137|FG000|STARTED|Overall Study||25
3035901|NCT01139801|3755138|FG001|STARTED|Overall Study||25
3035902|NCT01139801|3755137|FG000|COMPLETED|Overall Study||25
3035903|NCT01139801|3755138|FG001|COMPLETED|Overall Study||25
3035904|NCT01139801|3755137|FG000|NOT COMPLETED|Overall Study||0
3035905|NCT01139801|3755138|FG001|NOT COMPLETED|Overall Study||0
3035906|NCT01139814|3755144|FG000|STARTED|Overall Study||181
3035907|NCT01139814|3755144|FG000|COMPLETED|Overall Study||181
3035908|NCT01139814|3755144|FG000|NOT COMPLETED|Overall Study||0
3035909|NCT01139879|3755149|FG000|STARTED|Overall Study||10
3035910|NCT01139879|3755149|FG000|COMPLETED|Overall Study||10
3035911|NCT01139879|3755149|FG000|NOT COMPLETED|Overall Study||0
3035912|NCT01140061|3755165|FG000|STARTED|Part I|Includes 1 replacement participant|7
3035913|NCT01140061|3755166|FG001|STARTED|Part I||2
3035914|NCT01140061|3755167|FG002|STARTED|Part I||0
3035915|NCT01140061|3755168|FG003|STARTED|Part I||0
3035916|NCT01140061|3755169|FG004|STARTED|Part I||0
3035917|NCT01140061|3755170|FG005|STARTED|Part I||0
3035918|NCT01140061|3755171|FG006|STARTED|Part I||0
3035919|NCT01140061|3755172|FG007|STARTED|Part I||0
3035920|NCT01140061|3755173|FG008|STARTED|Part I||0
3035921|NCT01140061|3755174|FG009|STARTED|Part I||0
3035922|NCT01140061|3755165|FG000|COMPLETED|Part I||6
3035923|NCT01140061|3755166|FG001|COMPLETED|Part I||2
3035924|NCT01140061|3755167|FG002|COMPLETED|Part I||0
3035925|NCT01140061|3755168|FG003|COMPLETED|Part I||0
3035926|NCT01140061|3755169|FG004|COMPLETED|Part I||0
3035927|NCT01140061|3755170|FG005|COMPLETED|Part I||0
3035928|NCT01140061|3755171|FG006|COMPLETED|Part I||0
3035929|NCT01140061|3755172|FG007|COMPLETED|Part I||0
3035930|NCT01140061|3755173|FG008|COMPLETED|Part I||0
2975407|NCT04187989|3690408|FG000|STARTED|Overall Study - 3-Month Follow-Up||76
2975408|NCT04187989|3690409|FG001|STARTED|Overall Study - 3-Month Follow-Up||73
2975409|NCT04187989|3690408|FG000|COMPLETED|Overall Study - 3-Month Follow-Up||70
2975410|NCT04187989|3690409|FG001|COMPLETED|Overall Study - 3-Month Follow-Up||65
2975411|NCT04187989|3690408|FG000|NOT COMPLETED|Overall Study - 3-Month Follow-Up||6
2975412|NCT04187989|3690409|FG001|NOT COMPLETED|Overall Study - 3-Month Follow-Up||8
2975413|NCT04187989|3690408|FG000|STARTED|Overall Study - 6-Month Follow-Up||76
2975414|NCT04187989|3690409|FG001|STARTED|Overall Study - 6-Month Follow-Up||73
2975415|NCT04187989|3690408|FG000|COMPLETED|Overall Study - 6-Month Follow-Up||68
2975416|NCT04187989|3690409|FG001|COMPLETED|Overall Study - 6-Month Follow-Up||65
2975417|NCT04187989|3690408|FG000|NOT COMPLETED|Overall Study - 6-Month Follow-Up||8
2975418|NCT04187989|3690409|FG001|NOT COMPLETED|Overall Study - 6-Month Follow-Up||8
2975419|NCT04109118|3690415|FG000|STARTED|Overall Study||4
2975420|NCT04109118|3690415|FG000|COMPLETED|Overall Study||1
2975421|NCT04109118|3690415|FG000|NOT COMPLETED|Overall Study||3
2975422|NCT04045132|3690422|FG000|STARTED|Overall Study||37
2975423|NCT04045132|3690423|FG001|STARTED|Overall Study||38
2975424|NCT04045132|3690422|FG000|COMPLETED|Overall Study||34
2975425|NCT04045132|3690423|FG001|COMPLETED|Overall Study||31
2975426|NCT04045132|3690422|FG000|NOT COMPLETED|Overall Study||3
2975427|NCT04045132|3690423|FG001|NOT COMPLETED|Overall Study||7
2975428|NCT03846219|3690434|FG000|STARTED|Overall Study||72
2975429|NCT03846219|3690435|FG001|STARTED|Overall Study||69
2975430|NCT03846219|3690436|FG002|STARTED|Overall Study||69
2975431|NCT03846219|3690434|FG000|Patients Treated|Overall Study||71
2975432|NCT03846219|3690435|FG001|Patients Treated|Overall Study||69
2975433|NCT03846219|3690436|FG002|Patients Treated|Overall Study||69
2975434|NCT03846219|3690434|FG000|COMPLETED|Overall Study||69
2975435|NCT03846219|3690435|FG001|COMPLETED|Overall Study||65
2975436|NCT03846219|3690436|FG002|COMPLETED|Overall Study||64
2975437|NCT03846219|3690434|FG000|NOT COMPLETED|Overall Study||3
2975438|NCT03846219|3690435|FG001|NOT COMPLETED|Overall Study||4
2975439|NCT03846219|3690436|FG002|NOT COMPLETED|Overall Study||5
2975440|NCT03758404|3690455|FG000|STARTED|Overall Study||3
2975441|NCT03758404|3690456|FG001|STARTED|Overall Study||3
2975442|NCT03758404|3690457|FG002|STARTED|Overall Study||5
2975443|NCT03758404|3690455|FG000|COMPLETED|Overall Study||3
2975444|NCT03758404|3690456|FG001|COMPLETED|Overall Study||3
2975445|NCT03758404|3690457|FG002|COMPLETED|Overall Study||5
2975446|NCT03758404|3690455|FG000|NOT COMPLETED|Overall Study||0
2975447|NCT03758404|3690456|FG001|NOT COMPLETED|Overall Study||0
2975448|NCT03758404|3690457|FG002|NOT COMPLETED|Overall Study||0
2975449|NCT03698708|3690467|FG000|STARTED|Overall Study||17
2975450|NCT03698708|3690468|FG001|STARTED|Overall Study||20
2975451|NCT03698708|3690467|FG000|COMPLETED|Overall Study||13
2975452|NCT03698708|3690468|FG001|COMPLETED|Overall Study||16
2975453|NCT03698708|3690467|FG000|NOT COMPLETED|Overall Study||4
2975454|NCT03698708|3690468|FG001|NOT COMPLETED|Overall Study||4
2975455|NCT03608696|3690474|FG000|STARTED|Overall Study||10
2975456|NCT03608696|3690474|FG000|COMPLETED|Overall Study||10
2975457|NCT03608696|3690474|FG000|NOT COMPLETED|Overall Study||0
2975458|NCT03606668|3690478|FG000|STARTED|Overall Study||20
2975459|NCT03606668|3690478|FG000|COMPLETED|Overall Study||18
2975460|NCT03606668|3690478|FG000|NOT COMPLETED|Overall Study||2
2975461|NCT03575897|3690484|FG000|STARTED|Overall Study||25
2975462|NCT03575897|3690485|FG001|STARTED|Overall Study||25
2975463|NCT03575897|3690484|FG000|COMPLETED|Overall Study||13
2975464|NCT03575897|3690485|FG001|COMPLETED|Overall Study||12
2975465|NCT03575897|3690484|FG000|NOT COMPLETED|Overall Study||12
2975466|NCT03575897|3690485|FG001|NOT COMPLETED|Overall Study||13
2975467|NCT03441477|3690491|FG000|STARTED|Overall Study||225
2975468|NCT03441477|3690491|FG000|COMPLETED|Overall Study||224
2975469|NCT03441477|3690491|FG000|NOT COMPLETED|Overall Study||1
2975470|NCT03343626|3690504|FG000|STARTED|Overall Study||31
2975471|NCT03343626|3690505|FG001|STARTED|Overall Study||31
2975472|NCT03343626|3690506|FG002|STARTED|Overall Study||31
2975473|NCT03343626|3690507|FG003|STARTED|Overall Study||32
2975474|NCT03343626|3690508|FG004|STARTED|Overall Study||36
2975475|NCT03343626|3690509|FG005|STARTED|Overall Study||37
2975476|NCT03343626|3690510|FG006|STARTED|Overall Study||37
2975477|NCT03343626|3690511|FG007|STARTED|Overall Study||36
2975478|NCT03343626|3690504|FG000|Safety Analysis Set|Overall Study||31
2975479|NCT03343626|3690505|FG001|Safety Analysis Set|Overall Study||31
2975480|NCT03343626|3690506|FG002|Safety Analysis Set|Overall Study||31
2975481|NCT03343626|3690507|FG003|Safety Analysis Set|Overall Study||32
2975482|NCT03343626|3690508|FG004|Safety Analysis Set|Overall Study||36
2975483|NCT03343626|3690509|FG005|Safety Analysis Set|Overall Study||37
2975484|NCT03343626|3690510|FG006|Safety Analysis Set|Overall Study||37
2975485|NCT03343626|3690511|FG007|Safety Analysis Set|Overall Study||36
2975486|NCT03343626|3690504|FG000|Full Analysis Set|Overall Study||30
2975487|NCT03343626|3690505|FG001|Full Analysis Set|Overall Study||28
2975488|NCT03343626|3690506|FG002|Full Analysis Set|Overall Study||31
2975489|NCT03343626|3690507|FG003|Full Analysis Set|Overall Study||30
2975490|NCT03343626|3690508|FG004|Full Analysis Set|Overall Study||34
2975491|NCT03343626|3690509|FG005|Full Analysis Set|Overall Study||34
2975492|NCT03343626|3690510|FG006|Full Analysis Set|Overall Study||34
2975493|NCT03343626|3690511|FG007|Full Analysis Set|Overall Study||34
2975494|NCT03343626|3690504|FG000|Per Protocol Set|Overall Study||28
2975495|NCT03343626|3690505|FG001|Per Protocol Set|Overall Study||25
2975496|NCT03343626|3690506|FG002|Per Protocol Set|Overall Study||29
2975497|NCT03343626|3690507|FG003|Per Protocol Set|Overall Study||30
2975498|NCT03343626|3690508|FG004|Per Protocol Set|Overall Study||34
2975499|NCT03343626|3690509|FG005|Per Protocol Set|Overall Study||33
2975500|NCT03343626|3690510|FG006|Per Protocol Set|Overall Study||34
2975501|NCT03343626|3690511|FG007|Per Protocol Set|Overall Study||33
2975502|NCT03343626|3690504|FG000|COMPLETED|Overall Study||25
2975503|NCT03343626|3690505|FG001|COMPLETED|Overall Study||26
2975504|NCT03343626|3690506|FG002|COMPLETED|Overall Study||29
2975505|NCT03343626|3690507|FG003|COMPLETED|Overall Study||24
2975506|NCT03343626|3690508|FG004|COMPLETED|Overall Study||29
2975507|NCT03343626|3690509|FG005|COMPLETED|Overall Study||32
2975508|NCT03343626|3690510|FG006|COMPLETED|Overall Study||32
2975509|NCT03343626|3690511|FG007|COMPLETED|Overall Study||25
2975510|NCT03343626|3690504|FG000|NOT COMPLETED|Overall Study||6
2975511|NCT03343626|3690505|FG001|NOT COMPLETED|Overall Study||5
2975512|NCT03343626|3690506|FG002|NOT COMPLETED|Overall Study||2
2975513|NCT03343626|3690507|FG003|NOT COMPLETED|Overall Study||8
2975514|NCT03343626|3690508|FG004|NOT COMPLETED|Overall Study||7
2975515|NCT03343626|3690509|FG005|NOT COMPLETED|Overall Study||5
2975516|NCT03343626|3690510|FG006|NOT COMPLETED|Overall Study||5
2975517|NCT03343626|3690511|FG007|NOT COMPLETED|Overall Study||11
3035931|NCT01140061|3755174|FG009|COMPLETED|Part I||0
3035932|NCT01140061|3755165|FG000|NOT COMPLETED|Part I||1
3035933|NCT01140061|3755166|FG001|NOT COMPLETED|Part I||0
3035934|NCT01140061|3755167|FG002|NOT COMPLETED|Part I||0
3035935|NCT01140061|3755168|FG003|NOT COMPLETED|Part I||0
3035936|NCT01140061|3755169|FG004|NOT COMPLETED|Part I||0
3035937|NCT01140061|3755170|FG005|NOT COMPLETED|Part I||0
3035938|NCT01140061|3755171|FG006|NOT COMPLETED|Part I||0
3035939|NCT01140061|3755172|FG007|NOT COMPLETED|Part I||0
3035940|NCT01140061|3755173|FG008|NOT COMPLETED|Part I||0
3035941|NCT01140061|3755174|FG009|NOT COMPLETED|Part I||0
3035942|NCT01140061|3755165|FG000|STARTED|Part II||0
3035943|NCT01140061|3755166|FG001|STARTED|Part II||0
3035944|NCT01140061|3755167|FG002|STARTED|Part II||6
3035945|NCT01140061|3755168|FG003|STARTED|Part II||2
3035946|NCT01140061|3755169|FG004|STARTED|Part II||6
3035947|NCT01140061|3755170|FG005|STARTED|Part II||2
3035948|NCT01140061|3755171|FG006|STARTED|Part II||6
3035949|NCT01140061|3755172|FG007|STARTED|Part II||2
3035950|NCT01140061|3755173|FG008|STARTED|Part II||0
3035951|NCT01140061|3755174|FG009|STARTED|Part II||0
3035952|NCT01140061|3755165|FG000|COMPLETED|Part II||0
3035953|NCT01140061|3755166|FG001|COMPLETED|Part II||0
3035954|NCT01140061|3755167|FG002|COMPLETED|Part II||6
3035955|NCT01140061|3755168|FG003|COMPLETED|Part II||2
3035956|NCT01140061|3755169|FG004|COMPLETED|Part II||6
3035957|NCT01140061|3755170|FG005|COMPLETED|Part II||2
3035958|NCT01140061|3755171|FG006|COMPLETED|Part II||6
3035959|NCT01140061|3755172|FG007|COMPLETED|Part II||2
3035960|NCT01140061|3755173|FG008|COMPLETED|Part II||0
3035961|NCT01140061|3755174|FG009|COMPLETED|Part II||0
3035962|NCT01140061|3755165|FG000|NOT COMPLETED|Part II||0
3035963|NCT01140061|3755166|FG001|NOT COMPLETED|Part II||0
3035964|NCT01140061|3755167|FG002|NOT COMPLETED|Part II||0
3035965|NCT01140061|3755168|FG003|NOT COMPLETED|Part II||0
3164162|NCT01891305|3891596|FG000|NOT COMPLETED|Overall Study||3
3164163|NCT01891305|3891597|FG001|NOT COMPLETED|Overall Study||1
3164164|NCT01891305|3891598|FG002|NOT COMPLETED|Overall Study||3
3164165|NCT01891305|3891599|FG003|NOT COMPLETED|Overall Study||0
3164166|NCT01891331|3891613|FG000|STARTED|Overall Study||14
3164167|NCT01891331|3891614|FG001|STARTED|Overall Study||12
3035966|NCT01140061|3755169|FG004|NOT COMPLETED|Part II||0
3035967|NCT01140061|3755170|FG005|NOT COMPLETED|Part II||0
3035968|NCT01140061|3755171|FG006|NOT COMPLETED|Part II||0
3035969|NCT01140061|3755172|FG007|NOT COMPLETED|Part II||0
3035970|NCT01140061|3755173|FG008|NOT COMPLETED|Part II||0
3035971|NCT01140061|3755174|FG009|NOT COMPLETED|Part II||0
3035972|NCT01140061|3755165|FG000|STARTED|Part III||0
3035973|NCT01140061|3755166|FG001|STARTED|Part III||0
3035974|NCT01140061|3755167|FG002|STARTED|Part III||0
3035975|NCT01140061|3755168|FG003|STARTED|Part III||0
3035976|NCT01140061|3755169|FG004|STARTED|Part III||0
3035977|NCT01140061|3755170|FG005|STARTED|Part III||0
3035978|NCT01140061|3755171|FG006|STARTED|Part III||0
3035979|NCT01140061|3755172|FG007|STARTED|Part III||0
3035980|NCT01140061|3755173|FG008|STARTED|Part III||7
3035981|NCT01140061|3755174|FG009|STARTED|Part III|Includes 1 replacement participant|2
3035982|NCT01140061|3755165|FG000|COMPLETED|Part III||0
3035983|NCT01140061|3755166|FG001|COMPLETED|Part III||0
3035984|NCT01140061|3755167|FG002|COMPLETED|Part III||0
3035985|NCT01140061|3755168|FG003|COMPLETED|Part III||0
3035986|NCT01140061|3755169|FG004|COMPLETED|Part III||0
3035987|NCT01140061|3755170|FG005|COMPLETED|Part III||0
3035988|NCT01140061|3755171|FG006|COMPLETED|Part III||0
3035989|NCT01140061|3755172|FG007|COMPLETED|Part III||0
3035990|NCT01140061|3755173|FG008|COMPLETED|Part III||7
3035991|NCT01140061|3755174|FG009|COMPLETED|Part III||2
3035992|NCT01140061|3755165|FG000|NOT COMPLETED|Part III||0
3035993|NCT01140061|3755166|FG001|NOT COMPLETED|Part III||0
3035994|NCT01140061|3755167|FG002|NOT COMPLETED|Part III||0
3035995|NCT01140061|3755168|FG003|NOT COMPLETED|Part III||0
3035996|NCT01140061|3755169|FG004|NOT COMPLETED|Part III||0
3035997|NCT01140061|3755170|FG005|NOT COMPLETED|Part III||0
2975518|NCT03088930|3690532|FG000|STARTED|Overall Study||3
2975519|NCT03088930|3690532|FG000|COMPLETED|Overall Study||3
2975520|NCT03088930|3690532|FG000|NOT COMPLETED|Overall Study||0
2975521|NCT02960204|3690540|FG000|STARTED|Overall Study||65
2975522|NCT02960204|3690541|FG001|STARTED|Overall Study||65
2975523|NCT02960204|3690542|FG002|STARTED|Overall Study||66
2975524|NCT02960204|3690543|FG003|STARTED|Overall Study||67
2975525|NCT02960204|3690540|FG000|Randomized|Overall Study||65
2975526|NCT02960204|3690541|FG001|Randomized|Overall Study||65
2975527|NCT02960204|3690542|FG002|Randomized|Overall Study||66
2975528|NCT02960204|3690543|FG003|Randomized|Overall Study||67
2975529|NCT02960204|3690540|FG000|Completed Week 24 of Study|Overall Study||62
2975530|NCT02960204|3690541|FG001|Completed Week 24 of Study|Overall Study||62
2975531|NCT02960204|3690542|FG002|Completed Week 24 of Study|Overall Study||60
2975532|NCT02960204|3690543|FG003|Completed Week 24 of Study|Overall Study||66
2975533|NCT02960204|3690540|FG000|Completed Week 48 of Study|Overall Study||55
2975534|NCT02960204|3690541|FG001|Completed Week 48 of Study|Overall Study||55
2975535|NCT02960204|3690542|FG002|Completed Week 48 of Study|Overall Study||50
2975536|NCT02960204|3690543|FG003|Completed Week 48 of Study|Overall Study||59
2975537|NCT02960204|3690540|FG000|COMPLETED|Overall Study||36
2975538|NCT02960204|3690541|FG001|COMPLETED|Overall Study||44
2975539|NCT02960204|3690542|FG002|COMPLETED|Overall Study||37
2975540|NCT02960204|3690543|FG003|COMPLETED|Overall Study||38
2975541|NCT02960204|3690540|FG000|NOT COMPLETED|Overall Study||29
2975542|NCT02960204|3690541|FG001|NOT COMPLETED|Overall Study||21
2975543|NCT02960204|3690542|FG002|NOT COMPLETED|Overall Study||29
2975544|NCT02960204|3690543|FG003|NOT COMPLETED|Overall Study||29
2975545|NCT02856269|3690555|FG000|STARTED|Overall Study||25
2975546|NCT02856269|3690556|FG001|STARTED|Overall Study||27
2975547|NCT02856269|3690555|FG000|COMPLETED|Overall Study||24
2975548|NCT02856269|3690556|FG001|COMPLETED|Overall Study||24
2975549|NCT02856269|3690555|FG000|NOT COMPLETED|Overall Study||1
2975550|NCT02856269|3690556|FG001|NOT COMPLETED|Overall Study||3
2975551|NCT02807363|3690566|FG000|STARTED|Dosing Period||9
2975552|NCT02807363|3690567|FG001|STARTED|Dosing Period||9
2975553|NCT02807363|3690568|FG002|STARTED|Dosing Period||5
2975554|NCT02807363|3690569|FG003|STARTED|Dosing Period||12
2975555|NCT02807363|3690566|FG000|COMPLETED|Dosing Period||9
2975556|NCT02807363|3690567|FG001|COMPLETED|Dosing Period||8
2975557|NCT02807363|3690568|FG002|COMPLETED|Dosing Period||5
2975558|NCT02807363|3690569|FG003|COMPLETED|Dosing Period||12
2975559|NCT02807363|3690566|FG000|NOT COMPLETED|Dosing Period||0
2975560|NCT02807363|3690567|FG001|NOT COMPLETED|Dosing Period||1
2975561|NCT02807363|3690568|FG002|NOT COMPLETED|Dosing Period||0
2975562|NCT02807363|3690569|FG003|NOT COMPLETED|Dosing Period||0
2975563|NCT02807363|3690566|FG000|STARTED|Post- Dosing Period||9
2975564|NCT02807363|3690567|FG001|STARTED|Post- Dosing Period||8
2975565|NCT02807363|3690568|FG002|STARTED|Post- Dosing Period||5
2975566|NCT02807363|3690569|FG003|STARTED|Post- Dosing Period||12
3164168|NCT01891331|3891615|FG002|STARTED|Overall Study||14
3164169|NCT01891331|3891616|FG003|STARTED|Overall Study||15
3164170|NCT01891331|3891613|FG000|COMPLETED|Overall Study||12
3164171|NCT01891331|3891614|FG001|COMPLETED|Overall Study||10
3164172|NCT01891331|3891615|FG002|COMPLETED|Overall Study||13
3164173|NCT01891331|3891616|FG003|COMPLETED|Overall Study||13
2975567|NCT02807363|3690566|FG000|COMPLETED|Post- Dosing Period||9
2975568|NCT02807363|3690567|FG001|COMPLETED|Post- Dosing Period||8
2975569|NCT02807363|3690568|FG002|COMPLETED|Post- Dosing Period||5
2975570|NCT02807363|3690569|FG003|COMPLETED|Post- Dosing Period||12
2975571|NCT02807363|3690566|FG000|NOT COMPLETED|Post- Dosing Period||0
2975572|NCT02807363|3690567|FG001|NOT COMPLETED|Post- Dosing Period||0
2975573|NCT02807363|3690568|FG002|NOT COMPLETED|Post- Dosing Period||0
2975574|NCT02807363|3690569|FG003|NOT COMPLETED|Post- Dosing Period||0
2975575|NCT02756403|3690585|FG000|STARTED|Overall Study||46
2975576|NCT02756403|3690586|FG001|STARTED|Overall Study||45
2975577|NCT02756403|3690587|FG002|STARTED|Overall Study||43
2975578|NCT02756403|3690588|FG003|STARTED|Overall Study||47
2975579|NCT02756403|3690585|FG000|COMPLETED|Overall Study||46
2975580|NCT02756403|3690586|FG001|COMPLETED|Overall Study||42
2975581|NCT02756403|3690587|FG002|COMPLETED|Overall Study||41
2975582|NCT02756403|3690588|FG003|COMPLETED|Overall Study||45
2975583|NCT02756403|3690585|FG000|NOT COMPLETED|Overall Study||0
2975584|NCT02756403|3690586|FG001|NOT COMPLETED|Overall Study||3
2975585|NCT02756403|3690587|FG002|NOT COMPLETED|Overall Study||2
2975586|NCT02756403|3690588|FG003|NOT COMPLETED|Overall Study||2
2975587|NCT02751502|3690598|FG000|STARTED|Overall Study||4
2975588|NCT02751502|3690598|FG000|COMPLETED|Overall Study||0
2975589|NCT02751502|3690598|FG000|NOT COMPLETED|Overall Study||4
2975590|NCT02487797|3690604|FG000|STARTED|Overall Study||502
2975591|NCT02487797|3690605|FG001|STARTED|Overall Study||501
2975592|NCT02487797|3690604|FG000|COMPLETED|Overall Study||502
2975593|NCT02487797|3690605|FG001|COMPLETED|Overall Study||501
2975594|NCT02487797|3690604|FG000|NOT COMPLETED|Overall Study||0
2975595|NCT02487797|3690605|FG001|NOT COMPLETED|Overall Study||0
2975596|NCT02348359|3690615|FG000|STARTED|Overall Study||40
2975597|NCT02348359|3690616|FG001|STARTED|Overall Study||39
2975598|NCT02348359|3690617|FG002|STARTED|Overall Study||39
2975599|NCT02348359|3690618|FG003|STARTED|Overall Study||39
2975600|NCT02348359|3690615|FG000|COMPLETED|Overall Study||29
3164174|NCT01891331|3891613|FG000|NOT COMPLETED|Overall Study||2
3164175|NCT01891331|3891614|FG001|NOT COMPLETED|Overall Study||2
2975601|NCT02348359|3690616|FG001|COMPLETED|Overall Study||22
2975602|NCT02348359|3690617|FG002|COMPLETED|Overall Study||25
2975603|NCT02348359|3690618|FG003|COMPLETED|Overall Study||27
2975604|NCT02348359|3690615|FG000|NOT COMPLETED|Overall Study||11
2975605|NCT02348359|3690616|FG001|NOT COMPLETED|Overall Study||17
2975606|NCT02348359|3690617|FG002|NOT COMPLETED|Overall Study||14
2975607|NCT02348359|3690618|FG003|NOT COMPLETED|Overall Study||12
2975608|NCT02344108|3690628|FG000|STARTED|Overall Study||42
2975609|NCT02344108|3690628|FG000|COMPLETED|Overall Study||42
2975610|NCT02344108|3690628|FG000|NOT COMPLETED|Overall Study||0
2975611|NCT02285062|3690637|FG000|STARTED|Overall Study||285
2975612|NCT02285062|3690638|FG001|STARTED|Overall Study||285
2975613|NCT02285062|3690637|FG000|Received Study Treatment|Overall Study||283
2975614|NCT02285062|3690638|FG001|Received Study Treatment|Overall Study||284
2975615|NCT02285062|3690637|FG000|Ongoing Study Treatment|Overall Study||0
2975616|NCT02285062|3690638|FG001|Ongoing Study Treatment|Overall Study||0
2975617|NCT02285062|3690637|FG000|COMPLETED|Overall Study||207
2975618|NCT02285062|3690638|FG001|COMPLETED|Overall Study||201
2975619|NCT02285062|3690637|FG000|NOT COMPLETED|Overall Study||78
2975620|NCT02285062|3690638|FG001|NOT COMPLETED|Overall Study||84
2975621|NCT02264977|3690644|FG000|STARTED|Overall Study||9
2975622|NCT02264977|3690644|FG000|COMPLETED|Overall Study||4
2975623|NCT02264977|3690644|FG000|NOT COMPLETED|Overall Study||5
3035998|NCT01140061|3755171|FG006|NOT COMPLETED|Part III||0
3035999|NCT01140061|3755172|FG007|NOT COMPLETED|Part III||0
3036000|NCT01140061|3755173|FG008|NOT COMPLETED|Part III||0
3036001|NCT01140061|3755174|FG009|NOT COMPLETED|Part III||0
3036002|NCT01140061|3755165|FG000|STARTED|Extension||0
3036003|NCT01140061|3755166|FG001|STARTED|Extension||0
3036004|NCT01140061|3755167|FG002|STARTED|Extension||0
3036005|NCT01140061|3755168|FG003|STARTED|Extension||0
3036006|NCT01140061|3755169|FG004|STARTED|Extension||0
3036007|NCT01140061|3755170|FG005|STARTED|Extension||0
3036008|NCT01140061|3755171|FG006|STARTED|Extension||0
3036009|NCT01140061|3755172|FG007|STARTED|Extension||0
3036010|NCT01140061|3755173|FG008|STARTED|Extension||7
3036011|NCT01140061|3755174|FG009|STARTED|Extension||2
3036012|NCT01140061|3755165|FG000|COMPLETED|Extension||0
3036013|NCT01140061|3755166|FG001|COMPLETED|Extension||0
3036014|NCT01140061|3755167|FG002|COMPLETED|Extension||0
3036015|NCT01140061|3755168|FG003|COMPLETED|Extension||0
3036016|NCT01140061|3755169|FG004|COMPLETED|Extension||0
3036017|NCT01140061|3755170|FG005|COMPLETED|Extension||0
3036018|NCT01140061|3755171|FG006|COMPLETED|Extension||0
3036019|NCT01140061|3755172|FG007|COMPLETED|Extension||0
3036020|NCT01140061|3755173|FG008|COMPLETED|Extension||7
3036021|NCT01140061|3755174|FG009|COMPLETED|Extension||1
3036022|NCT01140061|3755165|FG000|NOT COMPLETED|Extension||0
3036023|NCT01140061|3755166|FG001|NOT COMPLETED|Extension||0
3036024|NCT01140061|3755167|FG002|NOT COMPLETED|Extension||0
3036025|NCT01140061|3755168|FG003|NOT COMPLETED|Extension||0
3036026|NCT01140061|3755169|FG004|NOT COMPLETED|Extension||0
3036027|NCT01140061|3755170|FG005|NOT COMPLETED|Extension||0
3036028|NCT01140061|3755171|FG006|NOT COMPLETED|Extension||0
3036029|NCT01140061|3755172|FG007|NOT COMPLETED|Extension||0
3036030|NCT01140061|3755173|FG008|NOT COMPLETED|Extension||0
3036031|NCT01140061|3755174|FG009|NOT COMPLETED|Extension||1
3036032|NCT01140191|3755189|FG000|STARTED|Overall Study||1
3036033|NCT01140191|3755189|FG000|COMPLETED|Overall Study||1
3036034|NCT01140191|3755189|FG000|NOT COMPLETED|Overall Study||0
3036035|NCT01140295|3755195|FG000|STARTED|Overall Study||17
3036036|NCT01140295|3755196|FG001|STARTED|Overall Study||16
3036037|NCT01140295|3755195|FG000|COMPLETED|Overall Study||16
3036038|NCT01140295|3755196|FG001|COMPLETED|Overall Study||14
3036039|NCT01140295|3755195|FG000|NOT COMPLETED|Overall Study||1
3036040|NCT01140295|3755196|FG001|NOT COMPLETED|Overall Study||2
3036041|NCT01140347|3755206|FG000|STARTED|Overall Study||283
3036042|NCT01140347|3755207|FG001|STARTED|Overall Study||282
3036043|NCT01140347|3755206|FG000|Received at Least 1 Dose of Study Drug|Overall Study||277
3036044|NCT01140347|3755207|FG001|Received at Least 1 Dose of Study Drug|Overall Study||276
3036045|NCT01140347|3755206|FG000|COMPLETED|Overall Study||265
3036046|NCT01140347|3755207|FG001|COMPLETED|Overall Study||268
3036047|NCT01140347|3755206|FG000|NOT COMPLETED|Overall Study||18
3036048|NCT01140347|3755207|FG001|NOT COMPLETED|Overall Study||14
3036049|NCT01140360|3755213|FG000|STARTED|Overall Study||21
3036050|NCT01140360|3755213|FG000|COMPLETED|Overall Study||15
3036051|NCT01140360|3755213|FG000|NOT COMPLETED|Overall Study||6
3038350|NCT01153841|3757780|FG000|STARTED|Overall Study||199
3038351|NCT01153841|3757781|FG001|STARTED|Overall Study||99
3038352|NCT01153841|3757780|FG000|COMPLETED|Overall Study||193
3038353|NCT01153841|3757781|FG001|COMPLETED|Overall Study||99
3038354|NCT01153841|3757780|FG000|NOT COMPLETED|Overall Study||6
3038355|NCT01153841|3757781|FG001|NOT COMPLETED|Overall Study||0
3038356|NCT01153893|3757789|FG000|STARTED|Overall Study|Issues with the informed consent obtained from one child led to related data not used in this report|68
3038357|NCT01153893|3757790|FG001|STARTED|Overall Study||36
3038358|NCT01153893|3757789|FG000|COMPLETED|Overall Study|Number of subjects who completed the follow-up visit at Month 1.|67
3038359|NCT01153893|3757790|FG001|COMPLETED|Overall Study|Number of subjects who completed the follow-up visit at Month 3.|36
3038360|NCT01153893|3757789|FG000|NOT COMPLETED|Overall Study||1
3038361|NCT01153893|3757790|FG001|NOT COMPLETED|Overall Study||0
3038362|NCT01153958|3757798|FG000|STARTED|Overall Study||66
3038363|NCT01153958|3757799|FG001|STARTED|Overall Study||67
3038364|NCT01153958|3757798|FG000|COMPLETED|Overall Study||30
2975624|NCT01981096|3690650|FG000|STARTED|Overall Study||20
2975625|NCT01981096|3690651|FG001|STARTED|Overall Study||20
2975626|NCT01981096|3690650|FG000|Post-treatment|Overall Study||17
2975627|NCT01981096|3690651|FG001|Post-treatment|Overall Study||19
2975628|NCT01981096|3690650|FG000|COMPLETED|Overall Study||17
2975629|NCT01981096|3690651|FG001|COMPLETED|Overall Study||19
2975630|NCT01981096|3690650|FG000|NOT COMPLETED|Overall Study||3
2975631|NCT01981096|3690651|FG001|NOT COMPLETED|Overall Study||1
2975632|NCT01935336|3690661|FG000|STARTED|Overall Study|Only one subject was treated due to the black box warning RE: ponatinib-associated vascular issues. The protocol was modified with additional inclusion and exclusion criteria, which severely limited the number of cases treated with the drug|6
2975633|NCT01935336|3690662|FG001|STARTED|Overall Study|no subjects were treated in this arm|3
2975634|NCT01935336|3690663|FG002|STARTED|Overall Study|Only three subjects were treated due to the black box warning RE: ponatinib-associated vascular issues. The protocol was modified with additional inclusion and exclusion criteria, which severely limited the number of cases treated with the drug|47
2975635|NCT01935336|3690664|FG003|STARTED|Overall Study|No subjects were treated in this arm|66
2975636|NCT01935336|3690661|FG000|Started Treatment|Overall Study||1
2975637|NCT01935336|3690662|FG001|Started Treatment|Overall Study||0
2975638|NCT01935336|3690663|FG002|Started Treatment|Overall Study||3
2975639|NCT01935336|3690664|FG003|Started Treatment|Overall Study||0
2975640|NCT01935336|3690661|FG000|COMPLETED|Overall Study||0
2975641|NCT01935336|3690662|FG001|COMPLETED|Overall Study||0
2975642|NCT01935336|3690663|FG002|COMPLETED|Overall Study||0
2975643|NCT01935336|3690664|FG003|COMPLETED|Overall Study||0
2975644|NCT01935336|3690661|FG000|NOT COMPLETED|Overall Study||6
2975645|NCT01935336|3690662|FG001|NOT COMPLETED|Overall Study||3
2975646|NCT01935336|3690663|FG002|NOT COMPLETED|Overall Study||47
2975647|NCT01935336|3690664|FG003|NOT COMPLETED|Overall Study||66
2975648|NCT01712490|3690682|FG000|STARTED|Overall Study||664
2975649|NCT01712490|3690683|FG001|STARTED|Overall Study||670
2975650|NCT01712490|3690682|FG000|Treated|Overall Study||662
2975651|NCT01712490|3690683|FG001|Treated|Overall Study||659
2975652|NCT01712490|3690682|FG000|COMPLETED|Overall Study||0
2975653|NCT01712490|3690683|FG001|COMPLETED|Overall Study||0
2975654|NCT01712490|3690682|FG000|NOT COMPLETED|Overall Study||664
2975655|NCT01712490|3690683|FG001|NOT COMPLETED|Overall Study||670
2975656|NCT01702805|3690691|FG000|STARTED|Overall Study||911
2975657|NCT01702805|3690692|FG001|STARTED|Overall Study||913
2975658|NCT01702805|3690691|FG000|Completed Assessment for Neurodevelopmental Impairment|Overall Study||699
2975659|NCT01702805|3690692|FG001|Completed Assessment for Neurodevelopmental Impairment|Overall Study||712
2975660|NCT01702805|3690691|FG000|Died After Discharge|Overall Study||19
2975661|NCT01702805|3690692|FG001|Died After Discharge|Overall Study||10
2975662|NCT01702805|3690691|FG000|Died Before Discharge|Overall Study||127
2975663|NCT01702805|3690692|FG001|Died Before Discharge|Overall Study||125
2975664|NCT01702805|3690691|FG000|Survived to Discharge|Overall Study||781
2975665|NCT01702805|3690692|FG001|Survived to Discharge|Overall Study||781
2975666|NCT01702805|3690691|FG000|COMPLETED|Overall Study||845
2975667|NCT01702805|3690692|FG001|COMPLETED|Overall Study||847
2975668|NCT01702805|3690691|FG000|NOT COMPLETED|Overall Study||66
2975669|NCT01702805|3690692|FG001|NOT COMPLETED|Overall Study||66
2975670|NCT01499160|3690698|FG000|STARTED|Overall Study||7
2975671|NCT01499160|3690698|FG000|COMPLETED|Overall Study|"1 pt-withdrew consent~1pt-had cardiac toxicity"|5
2975672|NCT01499160|3690698|FG000|NOT COMPLETED|Overall Study||2
2975673|NCT01333436|3690705|FG000|STARTED|Overall Study||43
2975674|NCT01333436|3690706|FG001|STARTED|Overall Study||50
2975675|NCT01333436|3690705|FG000|COMPLETED|Overall Study||43
2975676|NCT01333436|3690706|FG001|COMPLETED|Overall Study||50
2975677|NCT01333436|3690705|FG000|NOT COMPLETED|Overall Study||0
2975678|NCT01333436|3690706|FG001|NOT COMPLETED|Overall Study||0
2975679|NCT01307631|3690712|FG000|STARTED|Overall Study||9
2975680|NCT01307631|3690713|FG001|STARTED|Overall Study||28
2975681|NCT01307631|3690712|FG000|COMPLETED|Overall Study||9
2975682|NCT01307631|3690713|FG001|COMPLETED|Overall Study||28
2975683|NCT01307631|3690712|FG000|NOT COMPLETED|Overall Study||0
2975684|NCT01307631|3690713|FG001|NOT COMPLETED|Overall Study||0
2975685|NCT01256086|3690723|FG000|STARTED|Treatment Day 1||11
2975686|NCT01256086|3690724|FG001|STARTED|Treatment Day 1||11
2975687|NCT01256086|3690725|FG002|STARTED|Treatment Day 1||11
2975688|NCT01256086|3690726|FG003|STARTED|Treatment Day 1||11
2975689|NCT01256086|3690723|FG000|COMPLETED|Treatment Day 1||11
2975690|NCT01256086|3690724|FG001|COMPLETED|Treatment Day 1||11
2975691|NCT01256086|3690725|FG002|COMPLETED|Treatment Day 1||11
2975692|NCT01256086|3690726|FG003|COMPLETED|Treatment Day 1||11
2975693|NCT01256086|3690723|FG000|NOT COMPLETED|Treatment Day 1||0
2975694|NCT01256086|3690724|FG001|NOT COMPLETED|Treatment Day 1||0
2975695|NCT01256086|3690725|FG002|NOT COMPLETED|Treatment Day 1||0
2975696|NCT01256086|3690726|FG003|NOT COMPLETED|Treatment Day 1||0
2975697|NCT01256086|3690723|FG000|STARTED|Treatment Day 2||11
2975698|NCT01256086|3690724|FG001|STARTED|Treatment Day 2||10
2975699|NCT01256086|3690725|FG002|STARTED|Treatment Day 2||9
2975700|NCT01256086|3690726|FG003|STARTED|Treatment Day 2||11
2975701|NCT01256086|3690723|FG000|COMPLETED|Treatment Day 2||11
2975702|NCT01256086|3690724|FG001|COMPLETED|Treatment Day 2||10
2975703|NCT01256086|3690725|FG002|COMPLETED|Treatment Day 2||9
2975704|NCT01256086|3690726|FG003|COMPLETED|Treatment Day 2||11
2975705|NCT01256086|3690723|FG000|NOT COMPLETED|Treatment Day 2||0
2975706|NCT01256086|3690724|FG001|NOT COMPLETED|Treatment Day 2||0
2975707|NCT01256086|3690725|FG002|NOT COMPLETED|Treatment Day 2||0
2975708|NCT01256086|3690726|FG003|NOT COMPLETED|Treatment Day 2||0
2975709|NCT01256086|3690723|FG000|STARTED|Treatment Day 3||11
2975710|NCT01256086|3690724|FG001|STARTED|Treatment Day 3||10
2975711|NCT01256086|3690725|FG002|STARTED|Treatment Day 3||9
2975712|NCT01256086|3690726|FG003|STARTED|Treatment Day 3||11
2975713|NCT01256086|3690723|FG000|COMPLETED|Treatment Day 3||11
2975714|NCT01256086|3690724|FG001|COMPLETED|Treatment Day 3||10
2975715|NCT01256086|3690725|FG002|COMPLETED|Treatment Day 3||9
2975716|NCT01256086|3690726|FG003|COMPLETED|Treatment Day 3||11
2975717|NCT01256086|3690723|FG000|NOT COMPLETED|Treatment Day 3||0
2975718|NCT01256086|3690724|FG001|NOT COMPLETED|Treatment Day 3||0
2975719|NCT01256086|3690725|FG002|NOT COMPLETED|Treatment Day 3||0
2975720|NCT01256086|3690726|FG003|NOT COMPLETED|Treatment Day 3||0
2975721|NCT01256086|3690723|FG000|STARTED|Treatment Day 4||11
2975722|NCT01256086|3690724|FG001|STARTED|Treatment Day 4||10
2975723|NCT01256086|3690725|FG002|STARTED|Treatment Day 4||9
2975724|NCT01256086|3690726|FG003|STARTED|Treatment Day 4||11
2975725|NCT01256086|3690723|FG000|COMPLETED|Treatment Day 4||11
2975726|NCT01256086|3690724|FG001|COMPLETED|Treatment Day 4||10
2975727|NCT01256086|3690725|FG002|COMPLETED|Treatment Day 4||9
2975728|NCT01256086|3690726|FG003|COMPLETED|Treatment Day 4||11
2975729|NCT01256086|3690723|FG000|NOT COMPLETED|Treatment Day 4||0
2975730|NCT01256086|3690724|FG001|NOT COMPLETED|Treatment Day 4||0
2975731|NCT01256086|3690725|FG002|NOT COMPLETED|Treatment Day 4||0
2975732|NCT01256086|3690726|FG003|NOT COMPLETED|Treatment Day 4||0
2975733|NCT01061151|3690740|FG000|STARTED|Protocol Version 2.0: 04/2011-09/2012||855
2975734|NCT01061151|3690741|FG001|STARTED|Protocol Version 2.0: 04/2011-09/2012||861
2975735|NCT01061151|3690742|FG002|STARTED|Protocol Version 2.0: 04/2011-09/2012||25
2975736|NCT01061151|3690743|FG003|STARTED|Protocol Version 2.0: 04/2011-09/2012||129
2975737|NCT01061151|3690740|FG000|Mothers That Met All Inclusion Criteria|Protocol Version 2.0: 04/2011-09/2012||853
2975738|NCT01061151|3690741|FG001|Mothers That Met All Inclusion Criteria|Protocol Version 2.0: 04/2011-09/2012||861
2975739|NCT01061151|3690742|FG002|Mothers That Met All Inclusion Criteria|Protocol Version 2.0: 04/2011-09/2012||24
2975740|NCT01061151|3690743|FG003|Mothers That Met All Inclusion Criteria|Protocol Version 2.0: 04/2011-09/2012||129
2975741|NCT01061151|3690740|FG000|COMPLETED|Protocol Version 2.0: 04/2011-09/2012||623
2975742|NCT01061151|3690741|FG001|COMPLETED|Protocol Version 2.0: 04/2011-09/2012||620
2975743|NCT01061151|3690742|FG002|COMPLETED|Protocol Version 2.0: 04/2011-09/2012||16
2975744|NCT01061151|3690743|FG003|COMPLETED|Protocol Version 2.0: 04/2011-09/2012||101
2975745|NCT01061151|3690740|FG000|NOT COMPLETED|Protocol Version 2.0: 04/2011-09/2012||232
2975746|NCT01061151|3690741|FG001|NOT COMPLETED|Protocol Version 2.0: 04/2011-09/2012||241
2975747|NCT01061151|3690742|FG002|NOT COMPLETED|Protocol Version 2.0: 04/2011-09/2012||9
2975748|NCT01061151|3690743|FG003|NOT COMPLETED|Protocol Version 2.0: 04/2011-09/2012||28
2975749|NCT01061151|3690740|FG000|STARTED|Protocol Version 3.0: 10/2012-10/2014||694
2975750|NCT01061151|3690741|FG001|STARTED|Protocol Version 3.0: 10/2012-10/2014||686
2975751|NCT01061151|3690742|FG002|STARTED|Protocol Version 3.0: 10/2012-10/2014||422
2975752|NCT01061151|3690743|FG003|STARTED|Protocol Version 3.0: 10/2012-10/2014||75
2975753|NCT01061151|3690740|FG000|Mothers That Met All Inclusion Criteria|Protocol Version 3.0: 10/2012-10/2014||694
2975754|NCT01061151|3690741|FG001|Mothers That Met All Inclusion Criteria|Protocol Version 3.0: 10/2012-10/2014||684
2975755|NCT01061151|3690742|FG002|Mothers That Met All Inclusion Criteria|Protocol Version 3.0: 10/2012-10/2014||421
2975756|NCT01061151|3690743|FG003|Mothers That Met All Inclusion Criteria|Protocol Version 3.0: 10/2012-10/2014||75
2975757|NCT01061151|3690740|FG000|COMPLETED|Protocol Version 3.0: 10/2012-10/2014||542
2975758|NCT01061151|3690741|FG001|COMPLETED|Protocol Version 3.0: 10/2012-10/2014||548
2975759|NCT01061151|3690742|FG002|COMPLETED|Protocol Version 3.0: 10/2012-10/2014||345
2975760|NCT01061151|3690743|FG003|COMPLETED|Protocol Version 3.0: 10/2012-10/2014||55
2975761|NCT01061151|3690740|FG000|NOT COMPLETED|Protocol Version 3.0: 10/2012-10/2014||152
2975762|NCT01061151|3690741|FG001|NOT COMPLETED|Protocol Version 3.0: 10/2012-10/2014||138
2975763|NCT01061151|3690742|FG002|NOT COMPLETED|Protocol Version 3.0: 10/2012-10/2014||77
2975764|NCT01061151|3690743|FG003|NOT COMPLETED|Protocol Version 3.0: 10/2012-10/2014||20
2975765|NCT00981058|3690765|FG000|STARTED|Overall Study||545
2975766|NCT00981058|3690766|FG001|STARTED|Overall Study||548
2975767|NCT00981058|3690765|FG000|Received at Least 1 Dose of Study Drug|Overall Study||538
2975768|NCT00981058|3690766|FG001|Received at Least 1 Dose of Study Drug|Overall Study||541
2975769|NCT00981058|3690765|FG000|Death Due to Any Cause|Overall Study||418
2975770|NCT00981058|3690766|FG001|Death Due to Any Cause|Overall Study||442
2975771|NCT00981058|3690765|FG000|COMPLETED|Overall Study||425
2975772|NCT00981058|3690766|FG001|COMPLETED|Overall Study||451
2975773|NCT00981058|3690765|FG000|NOT COMPLETED|Overall Study||120
2975774|NCT00981058|3690766|FG001|NOT COMPLETED|Overall Study||97
2975775|NCT00885495|3690774|FG000|STARTED|Overall Study||8
2975776|NCT00885495|3690775|FG001|STARTED|Overall Study||9
2975777|NCT00885495|3690774|FG000|COMPLETED|Overall Study||6
2975778|NCT00885495|3690775|FG001|COMPLETED|Overall Study||6
2975779|NCT00885495|3690774|FG000|NOT COMPLETED|Overall Study||2
2975780|NCT00885495|3690775|FG001|NOT COMPLETED|Overall Study||3
2975781|NCT00084799|3690788|FG000|STARTED|Overall Study||5
2975782|NCT00084799|3690789|FG001|STARTED|Overall Study||5
2975783|NCT00084799|3690788|FG000|COMPLETED|Overall Study||4
2975784|NCT00084799|3690789|FG001|COMPLETED|Overall Study||5
2975785|NCT00084799|3690788|FG000|NOT COMPLETED|Overall Study||1
2975786|NCT00084799|3690789|FG001|NOT COMPLETED|Overall Study||0
2975787|NCT00821236|3690798|FG000|STARTED|Overall Study||40
2975788|NCT00821236|3690798|FG000|COMPLETED|Overall Study||37
2975789|NCT00821236|3690798|FG000|NOT COMPLETED|Overall Study||3
2975790|NCT00821327|3690806|FG000|STARTED|Overall Study||36
2975791|NCT00821327|3690806|FG000|COMPLETED|Overall Study||1
2975792|NCT00821327|3690806|FG000|NOT COMPLETED|Overall Study||35
2975793|NCT00821431|3690812|FG000|STARTED|Overall Study||38
2975794|NCT00821431|3690813|FG001|STARTED|Overall Study||52
2975795|NCT00821431|3690812|FG000|COMPLETED|Overall Study||23
2975796|NCT00821431|3690813|FG001|COMPLETED|Overall Study||47
2975797|NCT00821431|3690812|FG000|NOT COMPLETED|Overall Study||15
2975798|NCT00821431|3690813|FG001|NOT COMPLETED|Overall Study||5
2975799|NCT00821509|3690822|FG000|STARTED|Overall Study||257
2975800|NCT00821509|3690823|FG001|STARTED|Overall Study||202
2975801|NCT00821509|3690824|FG002|STARTED|Overall Study||224
2975802|NCT00821509|3690822|FG000|COMPLETED|Overall Study|This is a result of 56 lost-to-follow-up and 44 new recruits|245
2975803|NCT00821509|3690823|FG001|COMPLETED|Overall Study|This is a result of 57 lost-to-follow-up and 46 new recruits|191
2975804|NCT00821509|3690824|FG002|COMPLETED|Overall Study|This is a result of 50 lost-to-follow-up and 16 new recruits|190
2975805|NCT00821509|3690822|FG000|NOT COMPLETED|Overall Study||12
2975806|NCT00821509|3690823|FG001|NOT COMPLETED|Overall Study||11
2975807|NCT00821509|3690824|FG002|NOT COMPLETED|Overall Study||34
2975808|NCT00821626|3690834|FG000|STARTED|Overall Study||60
2975809|NCT00821626|3690835|FG001|STARTED|Overall Study||33
2975810|NCT00821626|3690834|FG000|COMPLETED|Overall Study||60
2975811|NCT00821626|3690835|FG001|COMPLETED|Overall Study||33
2975812|NCT00821626|3690834|FG000|NOT COMPLETED|Overall Study||0
2975813|NCT00821626|3690835|FG001|NOT COMPLETED|Overall Study||0
2975814|NCT00821678|3690845|FG000|STARTED|Overall Study||133
2975815|NCT00821678|3690846|FG001|STARTED|Overall Study||132
2975816|NCT00821678|3690845|FG000|COMPLETED|Overall Study||112
2975817|NCT00821678|3690846|FG001|COMPLETED|Overall Study||118
2975818|NCT00821678|3690845|FG000|NOT COMPLETED|Overall Study||21
2975819|NCT00821678|3690846|FG001|NOT COMPLETED|Overall Study||14
2975820|NCT00821795|3690856|FG000|STARTED|Overall Study||50
2975821|NCT00821795|3690857|FG001|STARTED|Overall Study||64
2975822|NCT00821795|3690856|FG000|COMPLETED|Overall Study||44
2975823|NCT00821795|3690857|FG001|COMPLETED|Overall Study||60
2975824|NCT00821795|3690856|FG000|NOT COMPLETED|Overall Study||6
2975825|NCT00821795|3690857|FG001|NOT COMPLETED|Overall Study||4
2975826|NCT00821821|3690866|FG000|STARTED|Overall Study||12
2975827|NCT00821821|3690867|FG001|STARTED|Overall Study||13
2975828|NCT00821821|3690868|FG002|STARTED|Overall Study||11
2975829|NCT00821821|3690866|FG000|COMPLETED|Overall Study||12
2975830|NCT00821821|3690867|FG001|COMPLETED|Overall Study||13
2975831|NCT00821821|3690868|FG002|COMPLETED|Overall Study||11
2975832|NCT00821821|3690866|FG000|NOT COMPLETED|Overall Study||0
2975833|NCT00821821|3690867|FG001|NOT COMPLETED|Overall Study||0
2975834|NCT00821821|3690868|FG002|NOT COMPLETED|Overall Study||0
2975835|NCT00821873|3690878|FG000|STARTED|Overall Study||9
2975836|NCT00821873|3690878|FG000|COMPLETED|Overall Study||5
2975837|NCT00821873|3690878|FG000|NOT COMPLETED|Overall Study||4
2975838|NCT00821886|3690882|FG000|STARTED|Overall Study|Two patients were enrolled, but subsequently found to be ineligible|58
2975839|NCT00821886|3690882|FG000|COMPLETED|Overall Study||49
2975840|NCT00821886|3690882|FG000|NOT COMPLETED|Overall Study||9
2975841|NCT00821951|3690886|FG000|STARTED|Overall Study||17
2975842|NCT00821951|3690886|FG000|COMPLETED|Overall Study||12
2975843|NCT00821951|3690886|FG000|NOT COMPLETED|Overall Study||5
2975844|NCT00821964|3690890|FG000|STARTED|Overall Study||15
2975845|NCT00821964|3690890|FG000|Evaluable for Clinical Response|Overall Study||14
2975846|NCT00821964|3690890|FG000|Evaluable for Pathologic Response|Overall Study||7
2975847|NCT00821964|3690890|FG000|COMPLETED|Overall Study||9
2975848|NCT00821964|3690890|FG000|NOT COMPLETED|Overall Study||6
2975849|NCT00822094|3690899|FG000|STARTED|Overall Study||81
2975850|NCT00822094|3690900|FG001|STARTED|Overall Study||45
2975851|NCT00822094|3690899|FG000|COMPLETED|Overall Study||37
2975852|NCT00822094|3690900|FG001|COMPLETED|Overall Study||20
2975853|NCT00822094|3690899|FG000|NOT COMPLETED|Overall Study||44
2975854|NCT00822094|3690900|FG001|NOT COMPLETED|Overall Study||25
2975855|NCT00822107|3690906|FG000|STARTED|Overall Study||5
2975856|NCT00822107|3690906|FG000|COMPLETED|Overall Study||5
2975857|NCT00822107|3690906|FG000|NOT COMPLETED|Overall Study||0
2975858|NCT00822172|3690912|FG000|STARTED|Overall Study||80
2975859|NCT00822172|3690913|FG001|STARTED|Overall Study||83
2975860|NCT00822172|3690912|FG000|COMPLETED|Overall Study||65
2975861|NCT00822172|3690913|FG001|COMPLETED|Overall Study||64
2975862|NCT00822172|3690912|FG000|NOT COMPLETED|Overall Study||15
2975863|NCT00822172|3690913|FG001|NOT COMPLETED|Overall Study||19
2975864|NCT00822185|3690924|FG000|STARTED|Overall Study||6
2975865|NCT00822185|3690925|FG001|STARTED|Overall Study||6
2975866|NCT00822185|3690926|FG002|STARTED|Overall Study||6
2975867|NCT00822185|3690927|FG003|STARTED|Overall Study||6
2975868|NCT00822185|3690928|FG004|STARTED|Overall Study||8
2975869|NCT00822185|3690924|FG000|COMPLETED|Overall Study||6
2975870|NCT00822185|3690925|FG001|COMPLETED|Overall Study||6
2975871|NCT00822185|3690926|FG002|COMPLETED|Overall Study||6
2975872|NCT00822185|3690927|FG003|COMPLETED|Overall Study||6
2975873|NCT00822185|3690928|FG004|COMPLETED|Overall Study||8
2975874|NCT00822185|3690924|FG000|NOT COMPLETED|Overall Study||0
2975875|NCT00822185|3690925|FG001|NOT COMPLETED|Overall Study||0
2975876|NCT00822185|3690926|FG002|NOT COMPLETED|Overall Study||0
2975877|NCT00822185|3690927|FG003|NOT COMPLETED|Overall Study||0
2975878|NCT00822185|3690928|FG004|NOT COMPLETED|Overall Study||0
2975879|NCT00822237|3690942|FG000|STARTED|Dose 1 Vaccination|Number randomized|299
2975880|NCT00822237|3690943|FG001|STARTED|Dose 1 Vaccination|Number randomized|299
2975881|NCT00822237|3690942|FG000|COMPLETED|Dose 1 Vaccination||274
2975882|NCT00822237|3690943|FG001|COMPLETED|Dose 1 Vaccination||273
2975883|NCT00822237|3690942|FG000|NOT COMPLETED|Dose 1 Vaccination||25
2975884|NCT00822237|3690943|FG001|NOT COMPLETED|Dose 1 Vaccination||26
2975885|NCT00822237|3690942|FG000|STARTED|Dose 2 Vaccination|Number who received second dose|274
2975886|NCT00822237|3690943|FG001|STARTED|Dose 2 Vaccination|Number who received second dose|273
2975887|NCT00822237|3690942|FG000|COMPLETED|Dose 2 Vaccination||270
2975888|NCT00822237|3690943|FG001|COMPLETED|Dose 2 Vaccination||262
2975889|NCT00822237|3690942|FG000|NOT COMPLETED|Dose 2 Vaccination||4
2975890|NCT00822237|3690943|FG001|NOT COMPLETED|Dose 2 Vaccination||11
2975891|NCT00822328|3690950|FG000|STARTED|Overall Study||12
2975892|NCT00822328|3690951|FG001|STARTED|Overall Study||12
2975893|NCT00822328|3690950|FG000|COMPLETED|Overall Study||12
2975894|NCT00822328|3690951|FG001|COMPLETED|Overall Study||12
2975895|NCT00822328|3690950|FG000|NOT COMPLETED|Overall Study||0
2975896|NCT00822328|3690951|FG001|NOT COMPLETED|Overall Study||0
2975897|NCT00822354|3690959|FG000|STARTED|First Intervention (28 Days)||5
2975898|NCT00822354|3690960|FG001|STARTED|First Intervention (28 Days)||5
2975899|NCT00822354|3690959|FG000|COMPLETED|First Intervention (28 Days)||4
2975900|NCT00822354|3690960|FG001|COMPLETED|First Intervention (28 Days)||5
2975901|NCT00822354|3690959|FG000|NOT COMPLETED|First Intervention (28 Days)||1
2975902|NCT00822354|3690960|FG001|NOT COMPLETED|First Intervention (28 Days)||0
2975903|NCT00822354|3690959|FG000|STARTED|Washout (7 Days)||4
2975904|NCT00822354|3690960|FG001|STARTED|Washout (7 Days)||5
2975905|NCT00822354|3690959|FG000|COMPLETED|Washout (7 Days)||4
2975906|NCT00822354|3690960|FG001|COMPLETED|Washout (7 Days)||5
2975907|NCT00822354|3690959|FG000|NOT COMPLETED|Washout (7 Days)||0
2975908|NCT00822354|3690960|FG001|NOT COMPLETED|Washout (7 Days)||0
2975909|NCT00822354|3690959|FG000|STARTED|Second Intervention (28 Days)||4
2975910|NCT00822354|3690960|FG001|STARTED|Second Intervention (28 Days)||5
2975911|NCT00822354|3690959|FG000|COMPLETED|Second Intervention (28 Days)||3
2975912|NCT00822354|3690960|FG001|COMPLETED|Second Intervention (28 Days)||5
2975913|NCT00822354|3690959|FG000|NOT COMPLETED|Second Intervention (28 Days)||1
2975914|NCT00822354|3690960|FG001|NOT COMPLETED|Second Intervention (28 Days)||0
2975915|NCT00822510|3690970|FG000|STARTED|Overall Study||38
2975916|NCT00822510|3690971|FG001|STARTED|Overall Study||41
2975917|NCT00822510|3690970|FG000|COMPLETED|Overall Study||35
2975918|NCT00822510|3690971|FG001|COMPLETED|Overall Study||36
2975919|NCT00822510|3690970|FG000|NOT COMPLETED|Overall Study||3
2975920|NCT00822510|3690971|FG001|NOT COMPLETED|Overall Study||5
2975921|NCT00822523|3690982|FG000|STARTED|Overall Study||5
2975922|NCT00822523|3690983|FG001|STARTED|Overall Study||4
2975923|NCT00822523|3690984|FG002|STARTED|Overall Study||4
2975924|NCT00822523|3690982|FG000|COMPLETED|Overall Study||5
2975925|NCT00822523|3690983|FG001|COMPLETED|Overall Study||4
2975926|NCT00822523|3690984|FG002|COMPLETED|Overall Study||4
2975927|NCT00822523|3690982|FG000|NOT COMPLETED|Overall Study||0
2975928|NCT00822523|3690983|FG001|NOT COMPLETED|Overall Study||0
2975929|NCT00822523|3690984|FG002|NOT COMPLETED|Overall Study||0
2975930|NCT00822588|3691002|FG000|STARTED|Overall Study|7 participants excluded before surgery. No baseline data available|113
2975931|NCT00822588|3691003|FG001|STARTED|Overall Study|4 participants excluded before surgery. No baseline data available|114
2975932|NCT00822588|3691002|FG000|COMPLETED|Overall Study|APT/ITT analysis set|106
3164176|NCT01891331|3891615|FG002|NOT COMPLETED|Overall Study||1
3164177|NCT01891331|3891616|FG003|NOT COMPLETED|Overall Study||2
3164178|NCT01891357|3891626|FG000|STARTED|Overall Study||64
3164179|NCT01891357|3891626|FG000|COMPLETED|Overall Study||61
3164180|NCT01891357|3891626|FG000|NOT COMPLETED|Overall Study||3
3164181|NCT01891669|3891640|FG000|STARTED|Overall Study||2
2975933|NCT00822588|3691003|FG001|COMPLETED|Overall Study|APT/ITT analysis set|110
2975934|NCT00822588|3691002|FG000|NOT COMPLETED|Overall Study||7
2975935|NCT00822588|3691003|FG001|NOT COMPLETED|Overall Study||4
2975936|NCT00822692|3691011|FG000|STARTED|Overall Study|July 1, 2008|63
2975937|NCT00822692|3691012|FG001|STARTED|Overall Study|July 1, 2008|76
2975938|NCT00822692|3691011|FG000|COMPLETED|Overall Study|June 1, 2009|46
2975939|NCT00822692|3691012|FG001|COMPLETED|Overall Study|June 1 , 2009|51
2975940|NCT00822692|3691011|FG000|NOT COMPLETED|Overall Study||17
2975941|NCT00822692|3691012|FG001|NOT COMPLETED|Overall Study||25
2975942|NCT00822757|3691020|FG000|STARTED|Overall Study||41
2975943|NCT00822757|3691021|FG001|STARTED|Overall Study||10
2975944|NCT00822757|3691020|FG000|COMPLETED|Overall Study||41
2975945|NCT00822757|3691021|FG001|COMPLETED|Overall Study||10
2975946|NCT00822757|3691020|FG000|NOT COMPLETED|Overall Study||0
2975947|NCT00822757|3691021|FG001|NOT COMPLETED|Overall Study||0
2975948|NCT00822770|3691029|FG000|STARTED|Overall Study||18
2975949|NCT00822770|3691030|FG001|STARTED|Overall Study||29
2975950|NCT00822770|3691029|FG000|COMPLETED|Overall Study||15
2975951|NCT00822770|3691030|FG001|COMPLETED|Overall Study||28
2975952|NCT00822770|3691029|FG000|NOT COMPLETED|Overall Study||3
2975953|NCT00822770|3691030|FG001|NOT COMPLETED|Overall Study||1
2975954|NCT00822900|3691038|FG000|STARTED|Overall Study||442
2975955|NCT00822900|3691039|FG001|STARTED|Overall Study||440
2975956|NCT00822900|3691038|FG000|COMPLETED|Overall Study||334
3164182|NCT01891669|3891641|FG001|STARTED|Overall Study||2
2975957|NCT00822900|3691039|FG001|COMPLETED|Overall Study||347
2975958|NCT00822900|3691038|FG000|NOT COMPLETED|Overall Study||108
2975959|NCT00822900|3691039|FG001|NOT COMPLETED|Overall Study||93
2975960|NCT00822926|3691047|FG000|STARTED|First Injection Visit||2
3133293|NCT01695239|3858307|FG002|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
3133294|NCT01695239|3858308|FG003|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
3133295|NCT01695239|3858309|FG004|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
3133296|NCT01695239|3858310|FG005|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
3133297|NCT01695239|3858311|FG006|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
2975961|NCT00822926|3691048|FG001|STARTED|First Injection Visit||3
2975962|NCT00822926|3691047|FG000|COMPLETED|First Injection Visit||2
2975963|NCT00822926|3691048|FG001|COMPLETED|First Injection Visit||3
2975964|NCT00822926|3691047|FG000|NOT COMPLETED|First Injection Visit||0
2975965|NCT00822926|3691048|FG001|NOT COMPLETED|First Injection Visit||0
2975966|NCT00822926|3691047|FG000|STARTED|Washout (Varies Based on Scheduling)||2
2975967|NCT00822926|3691048|FG001|STARTED|Washout (Varies Based on Scheduling)||3
2975968|NCT00822926|3691047|FG000|COMPLETED|Washout (Varies Based on Scheduling)||2
2975969|NCT00822926|3691048|FG001|COMPLETED|Washout (Varies Based on Scheduling)||3
2975970|NCT00822926|3691047|FG000|NOT COMPLETED|Washout (Varies Based on Scheduling)||0
2975971|NCT00822926|3691048|FG001|NOT COMPLETED|Washout (Varies Based on Scheduling)||0
2975972|NCT00822926|3691047|FG000|STARTED|Second Injection Visit||2
2975973|NCT00822926|3691048|FG001|STARTED|Second Injection Visit||3
2975974|NCT00822926|3691047|FG000|COMPLETED|Second Injection Visit||1
2975975|NCT00822926|3691048|FG001|COMPLETED|Second Injection Visit||2
2975976|NCT00822926|3691047|FG000|NOT COMPLETED|Second Injection Visit||1
2975977|NCT00822926|3691048|FG001|NOT COMPLETED|Second Injection Visit||1
2975978|NCT00823043|3691057|FG000|STARTED|Overall Study||64
2975979|NCT00823043|3691058|FG001|STARTED|Overall Study||39
2975980|NCT00823043|3691057|FG000|COMPLETED|Overall Study||64
2975981|NCT00823043|3691058|FG001|COMPLETED|Overall Study||39
2975982|NCT00823043|3691057|FG000|NOT COMPLETED|Overall Study||0
2975983|NCT00823043|3691058|FG001|NOT COMPLETED|Overall Study||0
2975984|NCT00823069|3691063|FG000|STARTED|Overall Study||60
2975985|NCT00823069|3691063|FG000|COMPLETED|Overall Study||60
2975986|NCT00823069|3691063|FG000|NOT COMPLETED|Overall Study||0
2975987|NCT00823082|3691072|FG000|STARTED|Overall Study||100
2975988|NCT00823082|3691073|FG001|STARTED|Overall Study||100
2975989|NCT00823082|3691072|FG000|Safety Population|Overall Study||100
2975990|NCT00823082|3691073|FG001|Safety Population|Overall Study||99
2975991|NCT00823082|3691072|FG000|Intent-to-Treat/Per Protocol Populations|Overall Study||100
2975992|NCT00823082|3691073|FG001|Intent-to-Treat/Per Protocol Populations|Overall Study||94
2975993|NCT00823082|3691072|FG000|COMPLETED|Overall Study||100
2975994|NCT00823082|3691073|FG001|COMPLETED|Overall Study||99
2975995|NCT00823082|3691072|FG000|NOT COMPLETED|Overall Study||0
2975996|NCT00823082|3691073|FG001|NOT COMPLETED|Overall Study||1
2975997|NCT00823134|3691079|FG000|STARTED|Overall Study||23
2975998|NCT00823134|3691079|FG000|COMPLETED|Overall Study||22
2975999|NCT00823134|3691079|FG000|NOT COMPLETED|Overall Study||1
2976000|NCT00823199|3691084|FG000|STARTED|Overall Study||10
2976001|NCT00823199|3691084|FG000|COMPLETED|Overall Study||8
2976002|NCT00823199|3691084|FG000|NOT COMPLETED|Overall Study||2
2976003|NCT00823212|3691091|FG000|STARTED|Overall Study||762
2976004|NCT00823212|3691092|FG001|STARTED|Overall Study||768
2976005|NCT00823212|3691091|FG000|COMPLETED|Overall Study|12-month follow-up|727
2976006|NCT00823212|3691092|FG001|COMPLETED|Overall Study|12-month follow-up|735
2976007|NCT00823212|3691091|FG000|NOT COMPLETED|Overall Study||35
2976008|NCT00823212|3691092|FG001|NOT COMPLETED|Overall Study||33
2976009|NCT00823264|3691102|FG000|STARTED|Overall Study||10
2976010|NCT00823264|3691103|FG001|STARTED|Overall Study||7
2976011|NCT00823264|3691102|FG000|COMPLETED|Overall Study||8
2976012|NCT00823264|3691103|FG001|COMPLETED|Overall Study||7
2976013|NCT00823264|3691102|FG000|NOT COMPLETED|Overall Study||2
2976014|NCT00823264|3691103|FG001|NOT COMPLETED|Overall Study||0
2976015|NCT00823303|3691111|FG000|STARTED|Overall Study||54
2976016|NCT00823303|3691112|FG001|STARTED|Overall Study||56
2976017|NCT00823303|3691111|FG000|COMPLETED|Overall Study||45
2976018|NCT00823303|3691112|FG001|COMPLETED|Overall Study||45
2976019|NCT00823303|3691111|FG000|NOT COMPLETED|Overall Study||9
2976020|NCT00823303|3691112|FG001|NOT COMPLETED|Overall Study||11
2976021|NCT00823459|3691118|FG000|STARTED|Overall Study||58
2976022|NCT00823459|3691118|FG000|COMPLETED|Overall Study||58
2976023|NCT00823459|3691118|FG000|NOT COMPLETED|Overall Study||0
2976024|NCT00823472|3691125|FG000|STARTED|Overall Study||80
2976025|NCT00823472|3691126|FG001|STARTED|Overall Study||67
2976026|NCT00823472|3691125|FG000|COMPLETED|Overall Study||56
2976027|NCT00823472|3691126|FG001|COMPLETED|Overall Study||39
2976028|NCT00823472|3691125|FG000|NOT COMPLETED|Overall Study||24
2976029|NCT00823472|3691126|FG001|NOT COMPLETED|Overall Study||28
2976030|NCT00823615|3691132|FG000|STARTED|Period 1||19
2976031|NCT00823615|3691133|FG001|STARTED|Period 1||19
2976032|NCT00823615|3691132|FG000|COMPLETED|Period 1||19
2976033|NCT00823615|3691133|FG001|COMPLETED|Period 1||19
2976034|NCT00823615|3691132|FG000|NOT COMPLETED|Period 1||0
2976035|NCT00823615|3691133|FG001|NOT COMPLETED|Period 1||0
2976036|NCT00823615|3691132|FG000|STARTED|Period 2||19
2976037|NCT00823615|3691133|FG001|STARTED|Period 2||19
2976038|NCT00823615|3691132|FG000|COMPLETED|Period 2||16
2976039|NCT00823615|3691133|FG001|COMPLETED|Period 2||17
2976040|NCT00823615|3691132|FG000|NOT COMPLETED|Period 2||3
2976041|NCT00823615|3691133|FG001|NOT COMPLETED|Period 2||2
2976042|NCT00823719|3691141|FG000|STARTED|Overall Study||26
2976043|NCT00823719|3691142|FG001|STARTED|Overall Study||35
2976044|NCT00823719|3691141|FG000|COMPLETED|Overall Study||20
2976045|NCT00823719|3691142|FG001|COMPLETED|Overall Study||24
2976046|NCT00823719|3691141|FG000|NOT COMPLETED|Overall Study||6
2976047|NCT00823719|3691142|FG001|NOT COMPLETED|Overall Study||11
2976048|NCT00823797|3691152|FG000|STARTED|Overall Study||29
2976049|NCT00823797|3691153|FG001|STARTED|Overall Study||16
2976050|NCT00823797|3691152|FG000|COMPLETED|Overall Study||29
2976051|NCT00823797|3691153|FG001|COMPLETED|Overall Study||16
2976052|NCT00823797|3691152|FG000|NOT COMPLETED|Overall Study||0
2976053|NCT00823797|3691153|FG001|NOT COMPLETED|Overall Study||0
2976054|NCT00823823|3691160|FG000|STARTED|Overall Study||109
2976055|NCT00823823|3691161|FG001|STARTED|Overall Study||107
2976056|NCT00823823|3691160|FG000|COMPLETED|Overall Study||101
2976057|NCT00823823|3691161|FG001|COMPLETED|Overall Study||101
2976058|NCT00823823|3691160|FG000|NOT COMPLETED|Overall Study||8
2976059|NCT00823823|3691161|FG001|NOT COMPLETED|Overall Study||6
2976060|NCT00823836|3691169|FG000|STARTED|NV and PR/XR Switching Phases||156
2976061|NCT00823836|3691170|FG001|STARTED|NV and PR/XR Switching Phases||146
2976062|NCT00823836|3691169|FG000|COMPLETED|NV and PR/XR Switching Phases||124
2976063|NCT00823836|3691170|FG001|COMPLETED|NV and PR/XR Switching Phases||117
2976064|NCT00823836|3691169|FG000|NOT COMPLETED|NV and PR/XR Switching Phases||32
2976065|NCT00823836|3691170|FG001|NOT COMPLETED|NV and PR/XR Switching Phases||29
2976066|NCT00823836|3691169|FG000|STARTED|Long-term Phase||73
2976067|NCT00823836|3691170|FG001|STARTED|Long-term Phase||84
2976068|NCT00823836|3691169|FG000|COMPLETED|Long-term Phase||68
2976069|NCT00823836|3691170|FG001|COMPLETED|Long-term Phase||79
2976070|NCT00823836|3691169|FG000|NOT COMPLETED|Long-term Phase||5
2976071|NCT00823836|3691170|FG001|NOT COMPLETED|Long-term Phase||5
2976072|NCT00823901|3691181|FG000|STARTED|Overall Study|Randomized to clindamycin/tretinoin gel|43
2976073|NCT00823901|3691182|FG001|STARTED|Overall Study|Randomized to placebo gel|40
2976074|NCT00823901|3691181|FG000|COMPLETED|Overall Study|Discontinued intervention (n=2) Only baseline completed (n=2)|39
2976075|NCT00823901|3691182|FG001|COMPLETED|Overall Study|Discontinued intervention (n=1) Only baseline completed (n=1)|38
2976076|NCT00823901|3691181|FG000|NOT COMPLETED|Overall Study||4
2976077|NCT00823901|3691182|FG001|NOT COMPLETED|Overall Study||2
2976078|NCT00823966|3691188|FG000|STARTED|Overall Study||3
2976079|NCT00823966|3691188|FG000|COMPLETED|Overall Study||3
2976080|NCT00823966|3691188|FG000|NOT COMPLETED|Overall Study||0
2976081|NCT00823979|3691195|FG000|STARTED|Overall Study||35
2976082|NCT00823979|3691196|FG001|STARTED|Overall Study||35
2976083|NCT00823979|3691197|FG002|STARTED|Overall Study||35
2976084|NCT00823979|3691195|FG000|Treated|Overall Study||31
2976085|NCT00823979|3691196|FG001|Treated|Overall Study||32
2976086|NCT00823979|3691197|FG002|Treated|Overall Study||34
2976087|NCT00823979|3691195|FG000|COMPLETED|Overall Study||6
2976088|NCT00823979|3691196|FG001|COMPLETED|Overall Study||3
2976089|NCT00823979|3691197|FG002|COMPLETED|Overall Study||11
2976090|NCT00823979|3691195|FG000|NOT COMPLETED|Overall Study||29
2976091|NCT00823979|3691196|FG001|NOT COMPLETED|Overall Study||32
2976092|NCT00823979|3691197|FG002|NOT COMPLETED|Overall Study||24
2976093|NCT00824005|3691207|FG000|STARTED|Overall Study||31
2976094|NCT00824005|3691208|FG001|STARTED|Overall Study||61
2976095|NCT00824005|3691207|FG000|COMPLETED|Overall Study||31
2976096|NCT00824005|3691208|FG001|COMPLETED|Overall Study||59
2976097|NCT00824005|3691207|FG000|NOT COMPLETED|Overall Study||0
2976098|NCT00824005|3691208|FG001|NOT COMPLETED|Overall Study||2
2976099|NCT00824044|3691216|FG000|STARTED|Overall Study||23
2976100|NCT00824044|3691217|FG001|STARTED|Overall Study||16
2976101|NCT00824044|3691216|FG000|COMPLETED|Overall Study||14
2976102|NCT00824044|3691217|FG001|COMPLETED|Overall Study||10
2976103|NCT00824044|3691216|FG000|NOT COMPLETED|Overall Study||9
2976104|NCT00824044|3691217|FG001|NOT COMPLETED|Overall Study||6
2976105|NCT00824070|3691230|FG000|STARTED|Overall Study||34
2976106|NCT00824070|3691231|FG001|STARTED|Overall Study||35
2976107|NCT00824070|3691232|FG002|STARTED|Overall Study||36
2976108|NCT00824070|3691230|FG000|COMPLETED|Overall Study||34
2976109|NCT00824070|3691231|FG001|COMPLETED|Overall Study||35
2976110|NCT00824070|3691232|FG002|COMPLETED|Overall Study||36
2976111|NCT00824070|3691230|FG000|NOT COMPLETED|Overall Study||0
2976112|NCT00824070|3691231|FG001|NOT COMPLETED|Overall Study||0
2976113|NCT00824070|3691232|FG002|NOT COMPLETED|Overall Study||0
2976114|NCT00824161|3691240|FG000|STARTED|Overall Study||28
2976115|NCT00824161|3691240|FG000|COMPLETED|Overall Study||26
2976116|NCT00824161|3691240|FG000|NOT COMPLETED|Overall Study||2
3036052|NCT01140477|3755219|FG000|STARTED|Overall Study||153
3036053|NCT01140477|3755220|FG001|STARTED|Overall Study||76
3036054|NCT01140477|3755219|FG000|COMPLETED|Overall Study||145
3036055|NCT01140477|3755220|FG001|COMPLETED|Overall Study||70
3036056|NCT01140477|3755219|FG000|NOT COMPLETED|Overall Study||8
3036057|NCT01140477|3755220|FG001|NOT COMPLETED|Overall Study||6
3036058|NCT01140503|3755226|FG000|STARTED|Overall Study||5
3036059|NCT01140503|3755226|FG000|COMPLETED|Overall Study||4
3036060|NCT01140503|3755226|FG000|NOT COMPLETED|Overall Study||1
3036061|NCT01140568|3755230|FG000|STARTED|Overall Study||38
3036062|NCT01140568|3755230|FG000|Screen Fail|Overall Study||4
3036063|NCT01140568|3755230|FG000|Treated With Study Drug|Overall Study||34
3036064|NCT01140568|3755230|FG000|COMPLETED|Overall Study||2
3036065|NCT01140568|3755230|FG000|NOT COMPLETED|Overall Study||36
3036066|NCT01140646|3755234|FG000|STARTED|Overall Study||43
2976117|NCT00824265|3691247|FG000|STARTED|Treatment Phase||183
2976118|NCT00824265|3691248|FG001|STARTED|Treatment Phase||182
2976119|NCT00824265|3691247|FG000|COMPLETED|Treatment Phase||119
2976120|NCT00824265|3691248|FG001|COMPLETED|Treatment Phase||102
2976121|NCT00824265|3691247|FG000|NOT COMPLETED|Treatment Phase||64
2976122|NCT00824265|3691248|FG001|NOT COMPLETED|Treatment Phase||80
2976123|NCT00824265|3691247|FG000|STARTED|Follow-up Phase||172
2976124|NCT00824265|3691248|FG001|STARTED|Follow-up Phase||160
2976125|NCT00824265|3691247|FG000|COMPLETED|Follow-up Phase||154
2976126|NCT00824265|3691248|FG001|COMPLETED|Follow-up Phase||129
2976127|NCT00824265|3691247|FG000|NOT COMPLETED|Follow-up Phase||18
2976128|NCT00824265|3691248|FG001|NOT COMPLETED|Follow-up Phase||31
2976129|NCT00824265|3691247|FG000|STARTED|Survival Follow-up Phase||96
2976130|NCT00824265|3691248|FG001|STARTED|Survival Follow-up Phase||89
2976131|NCT00824265|3691247|FG000|COMPLETED|Survival Follow-up Phase||87
2976132|NCT00824265|3691248|FG001|COMPLETED|Survival Follow-up Phase||73
2976133|NCT00824265|3691247|FG000|NOT COMPLETED|Survival Follow-up Phase||9
2976134|NCT00824265|3691248|FG001|NOT COMPLETED|Survival Follow-up Phase||16
2976135|NCT00824291|3691260|FG000|STARTED|Overall Study||285
2976136|NCT00824291|3691261|FG001|STARTED|Overall Study||142
2976137|NCT00824291|3691260|FG000|COMPLETED|Overall Study||231
2976138|NCT00824291|3691261|FG001|COMPLETED|Overall Study||107
2976139|NCT00824291|3691260|FG000|NOT COMPLETED|Overall Study||54
2976140|NCT00824291|3691261|FG001|NOT COMPLETED|Overall Study||35
2976141|NCT00824369|3691273|FG000|STARTED|Overall Study||5
2976142|NCT00824369|3691274|FG001|STARTED|Overall Study||4
2976143|NCT00824369|3691275|FG002|STARTED|Overall Study||3
2976144|NCT00824369|3691276|FG003|STARTED|Overall Study||11
2976145|NCT00824369|3691277|FG004|STARTED|Overall Study||12
2976146|NCT00824369|3691278|FG005|STARTED|Overall Study||17
2976147|NCT00824369|3691273|FG000|COMPLETED|Overall Study||4
2976148|NCT00824369|3691274|FG001|COMPLETED|Overall Study||4
2976149|NCT00824369|3691275|FG002|COMPLETED|Overall Study||2
2976150|NCT00824369|3691276|FG003|COMPLETED|Overall Study||9
2976151|NCT00824369|3691277|FG004|COMPLETED|Overall Study||11
2976152|NCT00824369|3691278|FG005|COMPLETED|Overall Study||16
2976153|NCT00824369|3691273|FG000|NOT COMPLETED|Overall Study||1
2976154|NCT00824369|3691274|FG001|NOT COMPLETED|Overall Study||0
2976155|NCT00824369|3691275|FG002|NOT COMPLETED|Overall Study||1
2976156|NCT00824369|3691276|FG003|NOT COMPLETED|Overall Study||2
2976157|NCT00824369|3691277|FG004|NOT COMPLETED|Overall Study||1
2976158|NCT00824369|3691278|FG005|NOT COMPLETED|Overall Study||1
2976159|NCT00824382|3691296|FG000|STARTED|Overall Study||79
2976160|NCT00824382|3691297|FG001|STARTED|Overall Study||84
2976161|NCT00824382|3691298|FG002|STARTED|Overall Study||79
2976162|NCT00824382|3691299|FG003|STARTED|Overall Study||86
2976163|NCT00824382|3691296|FG000|COMPLETED|Overall Study||74
2976164|NCT00824382|3691297|FG001|COMPLETED|Overall Study||82
2976165|NCT00824382|3691298|FG002|COMPLETED|Overall Study||76
2976166|NCT00824382|3691299|FG003|COMPLETED|Overall Study||81
2976167|NCT00824382|3691296|FG000|NOT COMPLETED|Overall Study||5
2976168|NCT00824382|3691297|FG001|NOT COMPLETED|Overall Study||2
2976169|NCT00824382|3691298|FG002|NOT COMPLETED|Overall Study||3
2976170|NCT00824382|3691299|FG003|NOT COMPLETED|Overall Study||5
2976171|NCT00824408|3691316|FG000|STARTED|Run-in Phase||6
2976172|NCT00824408|3691317|FG001|STARTED|Run-in Phase||6
2976173|NCT00824408|3691318|FG002|STARTED|Run-in Phase||0
2976174|NCT00824408|3691319|FG003|STARTED|Run-in Phase||0
2976175|NCT00824408|3691320|FG004|STARTED|Run-in Phase||0
2976176|NCT00824408|3691316|FG000|COMPLETED|Run-in Phase||0
2976177|NCT00824408|3691317|FG001|COMPLETED|Run-in Phase||0
2976178|NCT00824408|3691318|FG002|COMPLETED|Run-in Phase||0
2976179|NCT00824408|3691319|FG003|COMPLETED|Run-in Phase||0
2976180|NCT00824408|3691320|FG004|COMPLETED|Run-in Phase||0
2976181|NCT00824408|3691316|FG000|NOT COMPLETED|Run-in Phase||6
2976182|NCT00824408|3691317|FG001|NOT COMPLETED|Run-in Phase||6
2976183|NCT00824408|3691318|FG002|NOT COMPLETED|Run-in Phase||0
2976184|NCT00824408|3691319|FG003|NOT COMPLETED|Run-in Phase||0
2976185|NCT00824408|3691320|FG004|NOT COMPLETED|Run-in Phase||0
2976186|NCT00824408|3691316|FG000|STARTED|Randomized Phase||0
2976187|NCT00824408|3691317|FG001|STARTED|Randomized Phase||0
2976188|NCT00824408|3691318|FG002|STARTED|Randomized Phase||37
2976189|NCT00824408|3691319|FG003|STARTED|Randomized Phase||47
2976190|NCT00824408|3691320|FG004|STARTED|Randomized Phase||47
2976191|NCT00824408|3691316|FG000|COMPLETED|Randomized Phase||0
2976192|NCT00824408|3691317|FG001|COMPLETED|Randomized Phase||0
2976193|NCT00824408|3691318|FG002|COMPLETED|Randomized Phase|On-treatment at data cutoff (21Dec2012)|1
2976194|NCT00824408|3691319|FG003|COMPLETED|Randomized Phase|On-treatment at data cutoff (21Dec2012)|1
2976195|NCT00824408|3691320|FG004|COMPLETED|Randomized Phase|On-treatment at data cutoff (21Dec2012)|1
2976196|NCT00824408|3691316|FG000|NOT COMPLETED|Randomized Phase||0
2976197|NCT00824408|3691317|FG001|NOT COMPLETED|Randomized Phase||0
2976198|NCT00824408|3691318|FG002|NOT COMPLETED|Randomized Phase||36
2976199|NCT00824408|3691319|FG003|NOT COMPLETED|Randomized Phase||46
2976200|NCT00824408|3691320|FG004|NOT COMPLETED|Randomized Phase||46
2976201|NCT00824421|3691341|FG000|STARTED|Overall Study||66
2976202|NCT00824421|3691342|FG001|STARTED|Overall Study||66
2976203|NCT00824421|3691343|FG002|STARTED|Overall Study||63
2976204|NCT00824421|3691341|FG000|Treated|Overall Study||65
2976205|NCT00824421|3691342|FG001|Treated|Overall Study||65
2976206|NCT00824421|3691343|FG002|Treated|Overall Study||63
2976207|NCT00824421|3691341|FG000|COMPLETED|Overall Study||49
2976208|NCT00824421|3691342|FG001|COMPLETED|Overall Study||44
2976209|NCT00824421|3691343|FG002|COMPLETED|Overall Study||49
2976210|NCT00824421|3691341|FG000|NOT COMPLETED|Overall Study||17
2976211|NCT00824421|3691342|FG001|NOT COMPLETED|Overall Study||22
2976212|NCT00824421|3691343|FG002|NOT COMPLETED|Overall Study||14
2976213|NCT00824434|3691353|FG000|STARTED|Overall Study||100
2976214|NCT00824434|3691353|FG000|COMPLETED|Overall Study||100
2976215|NCT00824434|3691353|FG000|NOT COMPLETED|Overall Study||0
2976216|NCT00824460|3691363|FG000|STARTED|Overall Study||26
2976217|NCT00824460|3691364|FG001|STARTED|Overall Study||26
2976218|NCT00824460|3691365|FG002|STARTED|Overall Study||25
2976219|NCT00824460|3691366|FG003|STARTED|Overall Study||27
2976220|NCT00824460|3691367|FG004|STARTED|Overall Study||24
2976221|NCT00824460|3691368|FG005|STARTED|Overall Study||26
2976222|NCT00824460|3691363|FG000|COMPLETED|Overall Study||18
2976223|NCT00824460|3691364|FG001|COMPLETED|Overall Study||17
2976224|NCT00824460|3691365|FG002|COMPLETED|Overall Study||20
2976225|NCT00824460|3691366|FG003|COMPLETED|Overall Study||15
2976226|NCT00824460|3691367|FG004|COMPLETED|Overall Study||15
2976227|NCT00824460|3691368|FG005|COMPLETED|Overall Study||18
2976228|NCT00824460|3691363|FG000|NOT COMPLETED|Overall Study||8
2976229|NCT00824460|3691364|FG001|NOT COMPLETED|Overall Study||9
2976230|NCT00824460|3691365|FG002|NOT COMPLETED|Overall Study||5
2976231|NCT00824460|3691366|FG003|NOT COMPLETED|Overall Study||12
2976232|NCT00824460|3691367|FG004|NOT COMPLETED|Overall Study||9
2976233|NCT00824460|3691368|FG005|NOT COMPLETED|Overall Study||8
2976234|NCT00824473|3691392|FG000|STARTED|Overall Study|1 subject was randomized in error|255
2976235|NCT00824473|3691393|FG001|STARTED|Overall Study||251
2976236|NCT00824473|3691392|FG000|COMPLETED|Overall Study||240
2976237|NCT00824473|3691393|FG001|COMPLETED|Overall Study||238
2976238|NCT00824473|3691392|FG000|NOT COMPLETED|Overall Study||15
2976239|NCT00824473|3691393|FG001|NOT COMPLETED|Overall Study||13
2976240|NCT00824512|3691401|FG000|STARTED|Overall Study||11
2976241|NCT00824512|3691402|FG001|STARTED|Overall Study||11
2976242|NCT00824512|3691401|FG000|COMPLETED|Overall Study||11
2976243|NCT00824512|3691402|FG001|COMPLETED|Overall Study||11
2976244|NCT00824512|3691401|FG000|NOT COMPLETED|Overall Study||0
2976245|NCT00824512|3691402|FG001|NOT COMPLETED|Overall Study||0
2976246|NCT00824538|3691408|FG000|STARTED|Overall Study|13 patients entered the study|13
2976247|NCT00824538|3691408|FG000|COMPLETED|Overall Study||11
2976248|NCT00824538|3691408|FG000|NOT COMPLETED|Overall Study||2
2976249|NCT00824564|3691415|FG000|STARTED|Overall Study||42
2976250|NCT00824564|3691416|FG001|STARTED|Overall Study||40
2976251|NCT00824564|3691415|FG000|Treated|Overall Study||41
2976252|NCT00824564|3691416|FG001|Treated|Overall Study||40
2976253|NCT00824564|3691415|FG000|COMPLETED|Overall Study||34
2976254|NCT00824564|3691416|FG001|COMPLETED|Overall Study||30
2976255|NCT00824564|3691415|FG000|NOT COMPLETED|Overall Study||8
2976256|NCT00824564|3691416|FG001|NOT COMPLETED|Overall Study||10
2976257|NCT00824616|3691424|FG000|STARTED|Overall Study||34
2976258|NCT00824616|3691425|FG001|STARTED|Overall Study||34
3303171|NCT02964325|4036476|FG000|Modified Intent-to-Treat|Overall Study||145
3303172|NCT02964325|4036477|FG001|Modified Intent-to-Treat|Overall Study||152
3303173|NCT02964325|4036476|FG000|Safety Set|Overall Study||141
3303174|NCT02964325|4036477|FG001|Safety Set|Overall Study||161
3303175|NCT02964325|4036476|FG000|COMPLETED|Overall Study||143
3303176|NCT02964325|4036477|FG001|COMPLETED|Overall Study||143
3303177|NCT02964325|4036476|FG000|NOT COMPLETED|Overall Study||21
3303178|NCT02964325|4036477|FG001|NOT COMPLETED|Overall Study||23
3303179|NCT02964338|4036486|FG000|STARTED|Overall Study||84
3303180|NCT02964338|4036487|FG001|STARTED|Overall Study||88
3303181|NCT02964338|4036488|FG002|STARTED|Overall Study||87
3303182|NCT02964338|4036486|FG000|Safety Analysis Set|Overall Study||83
3303183|NCT02964338|4036487|FG001|Safety Analysis Set|Overall Study||88
3303184|NCT02964338|4036488|FG002|Safety Analysis Set|Overall Study||87
3303185|NCT02964338|4036486|FG000|Full Analysis Set|Overall Study||81
2976259|NCT00824616|3691424|FG000|COMPLETED|Overall Study||28
2976260|NCT00824616|3691425|FG001|COMPLETED|Overall Study||27
2976261|NCT00824616|3691424|FG000|NOT COMPLETED|Overall Study||6
2976262|NCT00824616|3691425|FG001|NOT COMPLETED|Overall Study||7
2976263|NCT00824655|3691433|FG000|STARTED|Infant Series (5 Months of Age)||118
2976264|NCT00824655|3691434|FG001|STARTED|Infant Series (5 Months of Age)||0
2976265|NCT00824655|3691433|FG000|COMPLETED|Infant Series (5 Months of Age)||118
2976266|NCT00824655|3691434|FG001|COMPLETED|Infant Series (5 Months of Age)||0
2976267|NCT00824655|3691433|FG000|NOT COMPLETED|Infant Series (5 Months of Age)||0
2976268|NCT00824655|3691434|FG001|NOT COMPLETED|Infant Series (5 Months of Age)||0
2976269|NCT00824655|3691433|FG000|STARTED|After Infant Dose (6 Months of Age)||118
2976270|NCT00824655|3691434|FG001|STARTED|After Infant Dose (6 Months of Age)||0
2976271|NCT00824655|3691433|FG000|COMPLETED|After Infant Dose (6 Months of Age)||118
2976272|NCT00824655|3691434|FG001|COMPLETED|After Infant Dose (6 Months of Age)||0
2976273|NCT00824655|3691433|FG000|NOT COMPLETED|After Infant Dose (6 Months of Age)||0
2976274|NCT00824655|3691434|FG001|NOT COMPLETED|After Infant Dose (6 Months of Age)||0
2976275|NCT00824655|3691433|FG000|STARTED|Toddler Dose (12 Months of Age)||118
2976276|NCT00824655|3691434|FG001|STARTED|Toddler Dose (12 Months of Age)||116
2976277|NCT00824655|3691433|FG000|COMPLETED|Toddler Dose (12 Months of Age)||116
2976278|NCT00824655|3691434|FG001|COMPLETED|Toddler Dose (12 Months of Age)||116
2976279|NCT00824655|3691433|FG000|NOT COMPLETED|Toddler Dose (12 Months of Age)||2
2976280|NCT00824655|3691434|FG001|NOT COMPLETED|Toddler Dose (12 Months of Age)||0
3036067|NCT01140646|3755234|FG000|COMPLETED|Overall Study||34
2976281|NCT00824720|3691445|FG000|STARTED|Overall Study|3 subjects in the high dose group did not receive device - unable to insert.|19
2976282|NCT00824720|3691446|FG001|STARTED|Overall Study|1 subject in the low dose group did not receive device - unable to insert.|16
2976283|NCT00824720|3691447|FG002|STARTED|Overall Study||20
2976284|NCT00824720|3691445|FG000|COMPLETED|Overall Study||16
2976285|NCT00824720|3691446|FG001|COMPLETED|Overall Study||15
2976286|NCT00824720|3691447|FG002|COMPLETED|Overall Study||19
2976287|NCT00824720|3691445|FG000|NOT COMPLETED|Overall Study||3
2976288|NCT00824720|3691446|FG001|NOT COMPLETED|Overall Study||1
2976289|NCT00824720|3691447|FG002|NOT COMPLETED|Overall Study||1
2976290|NCT00824733|3691455|FG000|STARTED|Overall Study||6
2976291|NCT00824733|3691455|FG000|COMPLETED|Overall Study||6
2976292|NCT00824733|3691455|FG000|NOT COMPLETED|Overall Study||0
2976293|NCT00824746|3691459|FG000|STARTED|Overall Study||23
2976294|NCT00824746|3691459|FG000|COMPLETED|Overall Study||23
2976295|NCT00824746|3691459|FG000|NOT COMPLETED|Overall Study||0
2976296|NCT00824772|3691465|FG000|STARTED|Overall Study||204
2976297|NCT00824772|3691465|FG000|COMPLETED|Overall Study||196
3133298|NCT01695239|3858312|FG007|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||77
3133299|NCT01695239|3858313|FG008|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
2976298|NCT00824772|3691465|FG000|NOT COMPLETED|Overall Study||8
2976299|NCT00824824|3691471|FG000|STARTED|Overall Study||4
2976300|NCT00824824|3691472|FG001|STARTED|Overall Study||3
2976301|NCT00824824|3691471|FG000|COMPLETED|Overall Study||4
2976302|NCT00824824|3691472|FG001|COMPLETED|Overall Study||3
2976303|NCT00824824|3691471|FG000|NOT COMPLETED|Overall Study||0
2976304|NCT00824824|3691472|FG001|NOT COMPLETED|Overall Study||0
2976305|NCT00824850|3691480|FG000|STARTED|Overall Study||38
2976306|NCT00824850|3691481|FG001|STARTED|Overall Study||37
2976307|NCT00824850|3691480|FG000|Received Vaccination 13vPnC|Overall Study||38
2976308|NCT00824850|3691481|FG001|Received Vaccination 13vPnC|Overall Study||36
2976309|NCT00824850|3691480|FG000|COMPLETED|Overall Study||38
2976310|NCT00824850|3691481|FG001|COMPLETED|Overall Study||36
2976311|NCT00824850|3691480|FG000|NOT COMPLETED|Overall Study||0
2976312|NCT00824850|3691481|FG001|NOT COMPLETED|Overall Study||1
2976313|NCT00824993|3691495|FG000|STARTED|Overall Study||39
2976314|NCT00824993|3691496|FG001|STARTED|Overall Study||39
2976315|NCT00824993|3691495|FG000|6 Month Follow up|Overall Study||33
2976316|NCT00824993|3691496|FG001|6 Month Follow up|Overall Study||27
2976317|NCT00824993|3691495|FG000|COMPLETED|Overall Study||25
2976318|NCT00824993|3691496|FG001|COMPLETED|Overall Study||22
2976319|NCT00824993|3691495|FG000|NOT COMPLETED|Overall Study||14
2976320|NCT00824993|3691496|FG001|NOT COMPLETED|Overall Study||17
2976321|NCT00825162|3691505|FG000|STARTED|Overall Study||710
2976322|NCT00825162|3691506|FG001|STARTED|Overall Study||880
2976323|NCT00825162|3691507|FG002|STARTED|Overall Study||402
2976324|NCT00825162|3691505|FG000|COMPLETED|Overall Study||682
2976325|NCT00825162|3691506|FG001|COMPLETED|Overall Study||859
2976326|NCT00825162|3691507|FG002|COMPLETED|Overall Study||396
2976327|NCT00825162|3691505|FG000|NOT COMPLETED|Overall Study||28
2976328|NCT00825162|3691506|FG001|NOT COMPLETED|Overall Study||21
2976329|NCT00825162|3691507|FG002|NOT COMPLETED|Overall Study||6
2976330|NCT00825175|3691522|FG000|STARTED|Overall Study||10
2976331|NCT00825175|3691523|FG001|STARTED|Overall Study||12
2976332|NCT00825175|3691522|FG000|COMPLETED|Overall Study||10
2976333|NCT00825175|3691523|FG001|COMPLETED|Overall Study||7
2976334|NCT00825175|3691522|FG000|NOT COMPLETED|Overall Study||0
2976335|NCT00825175|3691523|FG001|NOT COMPLETED|Overall Study||5
2976336|NCT00825266|3691531|FG000|STARTED|Overall Study||1
2976337|NCT00825266|3691532|FG001|STARTED|Overall Study||1
2976338|NCT00825266|3691531|FG000|COMPLETED|Overall Study||1
2976339|NCT00825266|3691532|FG001|COMPLETED|Overall Study||1
2976340|NCT00825266|3691531|FG000|NOT COMPLETED|Overall Study||0
2976341|NCT00825266|3691532|FG001|NOT COMPLETED|Overall Study||0
2976342|NCT00825305|3691540|FG000|STARTED|Overall Study||550
2976343|NCT00825305|3691541|FG001|STARTED|Overall Study||275
2976344|NCT00825305|3691540|FG000|COMPLETED|Overall Study||533
2976345|NCT00825305|3691541|FG001|COMPLETED|Overall Study||252
2976346|NCT00825305|3691540|FG000|NOT COMPLETED|Overall Study||17
2976347|NCT00825305|3691541|FG001|NOT COMPLETED|Overall Study||23
2976348|NCT00825318|3691547|FG000|STARTED|Overall Study||13
2976349|NCT00825318|3691547|FG000|COMPLETED|Overall Study||12
2976350|NCT00825318|3691547|FG000|NOT COMPLETED|Overall Study||1
2976351|NCT00825344|3691557|FG000|STARTED|Overall Study||34
2976352|NCT00825344|3691558|FG001|STARTED|Overall Study||43
2976353|NCT00825344|3691557|FG000|COMPLETED|Overall Study||33
2976354|NCT00825344|3691558|FG001|COMPLETED|Overall Study||42
2976355|NCT00825344|3691557|FG000|NOT COMPLETED|Overall Study||1
2976356|NCT00825344|3691558|FG001|NOT COMPLETED|Overall Study||1
2976357|NCT00825370|3691566|FG000|STARTED|Overall Study||175
2976358|NCT00825370|3691567|FG001|STARTED|Overall Study||175
2976359|NCT00825370|3691566|FG000|COMPLETED|Overall Study||175
2976360|NCT00825370|3691567|FG001|COMPLETED|Overall Study||175
2976361|NCT00825370|3691566|FG000|NOT COMPLETED|Overall Study||0
2976362|NCT00825370|3691567|FG001|NOT COMPLETED|Overall Study||0
2976363|NCT00825500|3691576|FG000|STARTED|Overall Study||125
2976364|NCT00825500|3691577|FG001|STARTED|Overall Study||121
2976365|NCT00825500|3691578|FG002|STARTED|Overall Study||120
2976366|NCT00825500|3691576|FG000|COMPLETED|Overall Study||125
2976367|NCT00825500|3691577|FG001|COMPLETED|Overall Study||121
2976368|NCT00825500|3691578|FG002|COMPLETED|Overall Study||120
2976369|NCT00825500|3691576|FG000|NOT COMPLETED|Overall Study||0
2976370|NCT00825500|3691577|FG001|NOT COMPLETED|Overall Study||0
2976371|NCT00825500|3691578|FG002|NOT COMPLETED|Overall Study||0
2976372|NCT00825565|3691586|FG000|STARTED|Overall Study||8
2976373|NCT00825565|3691586|FG000|COMPLETED|Overall Study||8
2976374|NCT00825565|3691586|FG000|NOT COMPLETED|Overall Study||0
2976375|NCT00825630|3691600|FG000|STARTED|Overall Study||29
2976376|NCT00825630|3691601|FG001|STARTED|Overall Study||62
2976377|NCT00825630|3691602|FG002|STARTED|Overall Study||19
2976378|NCT00825630|3691603|FG003|STARTED|Overall Study||13
2976379|NCT00825630|3691600|FG000|COMPLETED|Overall Study||29
2976380|NCT00825630|3691601|FG001|COMPLETED|Overall Study||62
2976381|NCT00825630|3691602|FG002|COMPLETED|Overall Study||19
2976382|NCT00825630|3691603|FG003|COMPLETED|Overall Study||13
2976383|NCT00825630|3691600|FG000|NOT COMPLETED|Overall Study||0
2976384|NCT00825630|3691601|FG001|NOT COMPLETED|Overall Study||0
2976385|NCT00825630|3691602|FG002|NOT COMPLETED|Overall Study||0
2976386|NCT00825630|3691603|FG003|NOT COMPLETED|Overall Study||0
2976387|NCT00825682|3691615|FG000|STARTED|Overall Study||47
2976388|NCT00825682|3691616|FG001|STARTED|Overall Study||25
2976389|NCT00825682|3691615|FG000|COMPLETED|Overall Study||34
2976390|NCT00825682|3691616|FG001|COMPLETED|Overall Study||20
2976391|NCT00825682|3691615|FG000|NOT COMPLETED|Overall Study||13
2976392|NCT00825682|3691616|FG001|NOT COMPLETED|Overall Study||5
2976393|NCT00825734|3691623|FG000|STARTED|Phase I||4
2976394|NCT00825734|3691624|FG001|STARTED|Phase I||3
2976395|NCT00825734|3691625|FG002|STARTED|Phase I||3
2976396|NCT00825734|3691623|FG000|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
2976397|NCT00825734|3691624|FG001|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
2976398|NCT00825734|3691625|FG002|COMPLETED|Phase I||3
2976399|NCT00825734|3691623|FG000|NOT COMPLETED|Phase I||4
2976400|NCT00825734|3691624|FG001|NOT COMPLETED|Phase I||3
2976401|NCT00825734|3691625|FG002|NOT COMPLETED|Phase I||0
2976402|NCT00825734|3691623|FG000|STARTED|Phase II||0
2976403|NCT00825734|3691624|FG001|STARTED|Phase II||0
2976404|NCT00825734|3691625|FG002|STARTED|Phase II|Includes patients treated at MTD during Phase I and 73 additional patients enrolled for Phase II|76
2976405|NCT00825734|3691623|FG000|COMPLETED|Phase II||0
2976406|NCT00825734|3691624|FG001|COMPLETED|Phase II||0
2976407|NCT00825734|3691625|FG002|COMPLETED|Phase II||0
2976408|NCT00825734|3691623|FG000|NOT COMPLETED|Phase II||0
2976409|NCT00825734|3691624|FG001|NOT COMPLETED|Phase II||0
2976410|NCT00825734|3691625|FG002|NOT COMPLETED|Phase II||76
2976411|NCT00825786|3691632|FG000|STARTED|Overall Study||52
2976412|NCT00825786|3691633|FG001|STARTED|Overall Study||51
2976413|NCT00825786|3691632|FG000|COMPLETED|Overall Study||52
2976414|NCT00825786|3691633|FG001|COMPLETED|Overall Study||51
2976415|NCT00825786|3691632|FG000|NOT COMPLETED|Overall Study||0
2976416|NCT00825786|3691633|FG001|NOT COMPLETED|Overall Study||0
2976417|NCT00825812|3691643|FG000|STARTED|Overall Study||29
2976418|NCT00825812|3691644|FG001|STARTED|Overall Study||32
2976419|NCT00825812|3691645|FG002|STARTED|Overall Study||126
2976420|NCT00825812|3691646|FG003|STARTED|Overall Study||121
2976421|NCT00825812|3691643|FG000|TREATED|Overall Study||29
2976422|NCT00825812|3691644|FG001|TREATED|Overall Study||31
2976423|NCT00825812|3691645|FG002|TREATED|Overall Study||120
2976424|NCT00825812|3691646|FG003|TREATED|Overall Study||111
2976425|NCT00825812|3691643|FG000|COMPLETED|Overall Study||29
2976426|NCT00825812|3691644|FG001|COMPLETED|Overall Study||31
2976427|NCT00825812|3691645|FG002|COMPLETED|Overall Study||120
2976428|NCT00825812|3691646|FG003|COMPLETED|Overall Study||111
2976429|NCT00825812|3691643|FG000|NOT COMPLETED|Overall Study||0
2976430|NCT00825812|3691644|FG001|NOT COMPLETED|Overall Study||1
2976431|NCT00825812|3691645|FG002|NOT COMPLETED|Overall Study||6
2976432|NCT00825812|3691646|FG003|NOT COMPLETED|Overall Study||10
2976433|NCT00825825|3691656|FG000|STARTED|First Medication Period (14 Days)||6
2976434|NCT00825825|3691657|FG001|STARTED|First Medication Period (14 Days)||4
2976435|NCT00825825|3691658|FG002|STARTED|First Medication Period (14 Days)||3
2976436|NCT00825825|3691659|FG003|STARTED|First Medication Period (14 Days)||5
2976437|NCT00825825|3691660|FG004|STARTED|First Medication Period (14 Days)||4
2976438|NCT00825825|3691661|FG005|STARTED|First Medication Period (14 Days)||5
2976439|NCT00825825|3691656|FG000|COMPLETED|First Medication Period (14 Days)||3
2976440|NCT00825825|3691657|FG001|COMPLETED|First Medication Period (14 Days)||4
2976441|NCT00825825|3691658|FG002|COMPLETED|First Medication Period (14 Days)||2
2976442|NCT00825825|3691659|FG003|COMPLETED|First Medication Period (14 Days)||5
2976443|NCT00825825|3691660|FG004|COMPLETED|First Medication Period (14 Days)||4
2976444|NCT00825825|3691661|FG005|COMPLETED|First Medication Period (14 Days)||3
2976445|NCT00825825|3691656|FG000|NOT COMPLETED|First Medication Period (14 Days)||3
2976446|NCT00825825|3691657|FG001|NOT COMPLETED|First Medication Period (14 Days)||0
2976447|NCT00825825|3691658|FG002|NOT COMPLETED|First Medication Period (14 Days)||1
2976448|NCT00825825|3691659|FG003|NOT COMPLETED|First Medication Period (14 Days)||0
2976449|NCT00825825|3691660|FG004|NOT COMPLETED|First Medication Period (14 Days)||0
2976450|NCT00825825|3691661|FG005|NOT COMPLETED|First Medication Period (14 Days)||2
2976451|NCT00825825|3691656|FG000|STARTED|First Washout Period (14 Days)||3
2976452|NCT00825825|3691657|FG001|STARTED|First Washout Period (14 Days)||4
2976453|NCT00825825|3691658|FG002|STARTED|First Washout Period (14 Days)||2
2976454|NCT00825825|3691659|FG003|STARTED|First Washout Period (14 Days)||5
2976455|NCT00825825|3691660|FG004|STARTED|First Washout Period (14 Days)||4
2976456|NCT00825825|3691661|FG005|STARTED|First Washout Period (14 Days)||3
2976457|NCT00825825|3691656|FG000|COMPLETED|First Washout Period (14 Days)||3
2976458|NCT00825825|3691657|FG001|COMPLETED|First Washout Period (14 Days)||4
2976459|NCT00825825|3691658|FG002|COMPLETED|First Washout Period (14 Days)||2
2976460|NCT00825825|3691659|FG003|COMPLETED|First Washout Period (14 Days)||5
2976461|NCT00825825|3691660|FG004|COMPLETED|First Washout Period (14 Days)||4
2976462|NCT00825825|3691661|FG005|COMPLETED|First Washout Period (14 Days)||3
2976463|NCT00825825|3691656|FG000|NOT COMPLETED|First Washout Period (14 Days)||0
2976464|NCT00825825|3691657|FG001|NOT COMPLETED|First Washout Period (14 Days)||0
2976465|NCT00825825|3691658|FG002|NOT COMPLETED|First Washout Period (14 Days)||0
2976466|NCT00825825|3691659|FG003|NOT COMPLETED|First Washout Period (14 Days)||0
2976467|NCT00825825|3691660|FG004|NOT COMPLETED|First Washout Period (14 Days)||0
2976468|NCT00825825|3691661|FG005|NOT COMPLETED|First Washout Period (14 Days)||0
2976469|NCT00825825|3691656|FG000|STARTED|Second Medication Period (14 Days)||3
2976470|NCT00825825|3691657|FG001|STARTED|Second Medication Period (14 Days)||4
2976471|NCT00825825|3691658|FG002|STARTED|Second Medication Period (14 Days)||2
2976472|NCT00825825|3691659|FG003|STARTED|Second Medication Period (14 Days)||5
2976473|NCT00825825|3691660|FG004|STARTED|Second Medication Period (14 Days)||4
2976474|NCT00825825|3691661|FG005|STARTED|Second Medication Period (14 Days)||3
2976475|NCT00825825|3691656|FG000|COMPLETED|Second Medication Period (14 Days)||1
2976476|NCT00825825|3691657|FG001|COMPLETED|Second Medication Period (14 Days)||4
2976477|NCT00825825|3691658|FG002|COMPLETED|Second Medication Period (14 Days)||2
2976478|NCT00825825|3691659|FG003|COMPLETED|Second Medication Period (14 Days)||3
2976479|NCT00825825|3691660|FG004|COMPLETED|Second Medication Period (14 Days)||3
2976480|NCT00825825|3691661|FG005|COMPLETED|Second Medication Period (14 Days)||3
2976481|NCT00825825|3691656|FG000|NOT COMPLETED|Second Medication Period (14 Days)||2
2976482|NCT00825825|3691657|FG001|NOT COMPLETED|Second Medication Period (14 Days)||0
2976483|NCT00825825|3691658|FG002|NOT COMPLETED|Second Medication Period (14 Days)||0
2976484|NCT00825825|3691659|FG003|NOT COMPLETED|Second Medication Period (14 Days)||2
2976485|NCT00825825|3691660|FG004|NOT COMPLETED|Second Medication Period (14 Days)||1
2976486|NCT00825825|3691661|FG005|NOT COMPLETED|Second Medication Period (14 Days)||0
2976487|NCT00825825|3691656|FG000|STARTED|Second Washout Period (14 Days)||1
2976488|NCT00825825|3691657|FG001|STARTED|Second Washout Period (14 Days)||4
2976489|NCT00825825|3691658|FG002|STARTED|Second Washout Period (14 Days)||2
2976490|NCT00825825|3691659|FG003|STARTED|Second Washout Period (14 Days)||3
2976491|NCT00825825|3691660|FG004|STARTED|Second Washout Period (14 Days)||3
2976492|NCT00825825|3691661|FG005|STARTED|Second Washout Period (14 Days)||3
2976493|NCT00825825|3691656|FG000|COMPLETED|Second Washout Period (14 Days)||1
2976494|NCT00825825|3691657|FG001|COMPLETED|Second Washout Period (14 Days)||4
2976495|NCT00825825|3691658|FG002|COMPLETED|Second Washout Period (14 Days)||2
2976496|NCT00825825|3691659|FG003|COMPLETED|Second Washout Period (14 Days)||3
2976497|NCT00825825|3691660|FG004|COMPLETED|Second Washout Period (14 Days)||3
2976498|NCT00825825|3691661|FG005|COMPLETED|Second Washout Period (14 Days)||3
2976499|NCT00825825|3691656|FG000|NOT COMPLETED|Second Washout Period (14 Days)||0
2976500|NCT00825825|3691657|FG001|NOT COMPLETED|Second Washout Period (14 Days)||0
2976501|NCT00825825|3691658|FG002|NOT COMPLETED|Second Washout Period (14 Days)||0
2976502|NCT00825825|3691659|FG003|NOT COMPLETED|Second Washout Period (14 Days)||0
2976503|NCT00825825|3691660|FG004|NOT COMPLETED|Second Washout Period (14 Days)||0
2976504|NCT00825825|3691661|FG005|NOT COMPLETED|Second Washout Period (14 Days)||0
2976505|NCT00825825|3691656|FG000|STARTED|Third Medication Period (14 Days)||1
2976506|NCT00825825|3691657|FG001|STARTED|Third Medication Period (14 Days)||4
2976507|NCT00825825|3691658|FG002|STARTED|Third Medication Period (14 Days)||2
2976508|NCT00825825|3691659|FG003|STARTED|Third Medication Period (14 Days)||3
2976509|NCT00825825|3691660|FG004|STARTED|Third Medication Period (14 Days)||3
2976510|NCT00825825|3691661|FG005|STARTED|Third Medication Period (14 Days)||3
2976511|NCT00825825|3691656|FG000|COMPLETED|Third Medication Period (14 Days)||1
2976512|NCT00825825|3691657|FG001|COMPLETED|Third Medication Period (14 Days)||2
2976513|NCT00825825|3691658|FG002|COMPLETED|Third Medication Period (14 Days)||2
2976514|NCT00825825|3691659|FG003|COMPLETED|Third Medication Period (14 Days)||3
2976515|NCT00825825|3691660|FG004|COMPLETED|Third Medication Period (14 Days)||3
2976516|NCT00825825|3691661|FG005|COMPLETED|Third Medication Period (14 Days)||1
2976517|NCT00825825|3691656|FG000|NOT COMPLETED|Third Medication Period (14 Days)||0
2976518|NCT00825825|3691657|FG001|NOT COMPLETED|Third Medication Period (14 Days)||2
2976519|NCT00825825|3691658|FG002|NOT COMPLETED|Third Medication Period (14 Days)||0
2976520|NCT00825825|3691659|FG003|NOT COMPLETED|Third Medication Period (14 Days)||0
2976521|NCT00825825|3691660|FG004|NOT COMPLETED|Third Medication Period (14 Days)||0
2976522|NCT00825825|3691661|FG005|NOT COMPLETED|Third Medication Period (14 Days)||2
2976523|NCT00825916|3691671|FG000|STARTED|Overall Study||19
2976524|NCT00825916|3691672|FG001|STARTED|Overall Study||20
2976525|NCT00825916|3691673|FG002|STARTED|Overall Study||20
2976526|NCT00825916|3691671|FG000|COMPLETED|Overall Study||15
2976527|NCT00825916|3691672|FG001|COMPLETED|Overall Study||18
2976528|NCT00825916|3691673|FG002|COMPLETED|Overall Study||19
2976529|NCT00825916|3691671|FG000|NOT COMPLETED|Overall Study||4
2976530|NCT00825916|3691672|FG001|NOT COMPLETED|Overall Study||2
2976531|NCT00825916|3691673|FG002|NOT COMPLETED|Overall Study||1
2976532|NCT00825994|3691714|FG000|STARTED|Overall Study||24
2976533|NCT00825994|3691714|FG000|COMPLETED|Overall Study||19
2976534|NCT00825994|3691714|FG000|NOT COMPLETED|Overall Study||5
2976535|NCT00826007|3691720|FG000|STARTED|Overall Study|Retrospective review|308
2976536|NCT00826007|3691721|FG001|STARTED|Overall Study||279
2976537|NCT00826007|3691720|FG000|COMPLETED|Overall Study|Retrospective review|308
2976538|NCT00826007|3691721|FG001|COMPLETED|Overall Study||279
2976539|NCT00826007|3691720|FG000|NOT COMPLETED|Overall Study||0
2976540|NCT00826007|3691721|FG001|NOT COMPLETED|Overall Study||0
2976541|NCT00826020|3691726|FG000|STARTED|Overall Study||72
2976542|NCT00826020|3691726|FG000|COMPLETED|Overall Study||72
2976543|NCT00826020|3691726|FG000|NOT COMPLETED|Overall Study||0
2976544|NCT00826111|3691732|FG000|STARTED|Overall Study||14
2976545|NCT00826111|3691733|FG001|STARTED|Overall Study||5
2976546|NCT00826111|3691732|FG000|COMPLETED|Overall Study||7
2976547|NCT00826111|3691733|FG001|COMPLETED|Overall Study||3
2976548|NCT00826111|3691732|FG000|NOT COMPLETED|Overall Study||7
2976549|NCT00826111|3691733|FG001|NOT COMPLETED|Overall Study||2
2976550|NCT00826150|3691745|FG000|STARTED|Overall Study||8
2976551|NCT00826150|3691746|FG001|STARTED|Overall Study||3
2976552|NCT00826150|3691747|FG002|STARTED|Overall Study||3
2976553|NCT00826150|3691745|FG000|COMPLETED|Overall Study||2
2976554|NCT00826150|3691746|FG001|COMPLETED|Overall Study||1
2976555|NCT00826150|3691747|FG002|COMPLETED|Overall Study||0
2976556|NCT00826150|3691745|FG000|NOT COMPLETED|Overall Study||6
2976557|NCT00826150|3691746|FG001|NOT COMPLETED|Overall Study||2
2976558|NCT00826150|3691747|FG002|NOT COMPLETED|Overall Study||3
2976559|NCT00826176|3691759|FG000|STARTED|Overall Study|enrolled|128
2976560|NCT00826176|3691760|FG001|STARTED|Overall Study|enrolled|36
2976561|NCT00826176|3691759|FG000|COMPLETED|Overall Study|treated and completed|115
2976562|NCT00826176|3691760|FG001|COMPLETED|Overall Study|treated and completed|36
2976563|NCT00826176|3691759|FG000|NOT COMPLETED|Overall Study||13
2976564|NCT00826176|3691760|FG001|NOT COMPLETED|Overall Study||0
2976565|NCT00826202|3691768|FG000|STARTED|Overall Study||20
2976566|NCT00826202|3691769|FG001|STARTED|Overall Study||24
2976567|NCT00826202|3691768|FG000|Completed Visit 4 (1st Efficacy Visit)|Overall Study||15
2976568|NCT00826202|3691769|FG001|Completed Visit 4 (1st Efficacy Visit)|Overall Study||20
2976569|NCT00826202|3691768|FG000|COMPLETED|Overall Study||10
3303186|NCT02964338|4036487|FG001|Full Analysis Set|Overall Study||86
3303187|NCT02964338|4036488|FG002|Full Analysis Set|Overall Study||87
3303188|NCT02964338|4036486|FG000|COMPLETED|Overall Study||67
3303189|NCT02964338|4036487|FG001|COMPLETED|Overall Study||64
3303190|NCT02964338|4036488|FG002|COMPLETED|Overall Study||68
3303191|NCT02964338|4036486|FG000|NOT COMPLETED|Overall Study||17
3303192|NCT02964338|4036487|FG001|NOT COMPLETED|Overall Study||24
3303193|NCT02964338|4036488|FG002|NOT COMPLETED|Overall Study||19
3303194|NCT02964416|4036498|FG000|STARTED|Overall Study||39
3303195|NCT02964416|4036499|FG001|STARTED|Overall Study||41
3303196|NCT02964416|4036498|FG000|COMPLETED|Overall Study||38
3303197|NCT02964416|4036499|FG001|COMPLETED|Overall Study||41
2976570|NCT00826202|3691769|FG001|COMPLETED|Overall Study||11
2976571|NCT00826202|3691768|FG000|NOT COMPLETED|Overall Study||10
2976572|NCT00826202|3691769|FG001|NOT COMPLETED|Overall Study||13
2976573|NCT00826228|3691775|FG000|STARTED|Overall Study||12
2976574|NCT00826228|3691775|FG000|COMPLETED|Overall Study||11
2976575|NCT00826228|3691775|FG000|NOT COMPLETED|Overall Study||1
2976576|NCT00826241|3691780|FG000|STARTED|Overall Study||58
2976577|NCT00826241|3691780|FG000|COMPLETED|Overall Study||31
2976578|NCT00826241|3691780|FG000|NOT COMPLETED|Overall Study||27
2976579|NCT00826267|3691787|FG000|STARTED|Overall Study||10
2976580|NCT00826267|3691788|FG001|STARTED|Overall Study||8
2976581|NCT00826267|3691789|FG002|STARTED|Overall Study||11
2976582|NCT00826267|3691787|FG000|COMPLETED|Overall Study||9
2976583|NCT00826267|3691788|FG001|COMPLETED|Overall Study||8
2976584|NCT00826267|3691789|FG002|COMPLETED|Overall Study||11
2976585|NCT00826267|3691787|FG000|NOT COMPLETED|Overall Study||1
2976586|NCT00826267|3691788|FG001|NOT COMPLETED|Overall Study||0
2976587|NCT00826267|3691789|FG002|NOT COMPLETED|Overall Study||0
2976588|NCT00826280|3691801|FG000|STARTED|Overall Study||114
2976589|NCT00826280|3691802|FG001|STARTED|Overall Study||116
2976590|NCT00826280|3691803|FG002|STARTED|Overall Study||117
2976591|NCT00826280|3691801|FG000|Safety Analysis Set|Overall Study|Safety Analysis Set (SAF) was all randomized subjects who received at least one dose of regadenoson|113
2976592|NCT00826280|3691802|FG001|Safety Analysis Set|Overall Study|SAF was all randomized subjects who received at least one dose of regadenoson|116
2976593|NCT00826280|3691803|FG002|Safety Analysis Set|Overall Study|SAF was all randomized subjects who received at least one dose of regadenoson|116
2976594|NCT00826280|3691801|FG000|Completed Treatment|Overall Study|Subjects who completed treatment but had ≥ 1 non-interpretable scan were not included in FAS|66
2976595|NCT00826280|3691802|FG001|Completed Treatment|Overall Study|Subjects who completed treatment but had ≥ 1 non-interpretable scan were not included in FAS|71
2976596|NCT00826280|3691803|FG002|Completed Treatment|Overall Study|Subjects who completed treatment but had ≥ 1 non-interpretable scan were not included in FAS|72
3303198|NCT02964416|4036498|FG000|NOT COMPLETED|Overall Study||1
2976597|NCT00826280|3691801|FG000|COMPLETED|Overall Study|Ending Population equals FAS, all randomized subjects with interpretable MPI scans|66
2976598|NCT00826280|3691802|FG001|COMPLETED|Overall Study|Ending Population equals FAS, all randomized subjects with interpretable MPI scans|70
2976599|NCT00826280|3691803|FG002|COMPLETED|Overall Study|Ending Population equals FAS, all randomized subjects with interpretable MPI scans|71
2976600|NCT00826280|3691801|FG000|NOT COMPLETED|Overall Study||48
3303199|NCT02964416|4036499|FG001|NOT COMPLETED|Overall Study||0
3303200|NCT02964767|4036508|FG000|STARTED|Overall Study||171
3303201|NCT02964767|4036509|FG001|STARTED|Overall Study||48
2976601|NCT00826280|3691802|FG001|NOT COMPLETED|Overall Study||46
2976602|NCT00826280|3691803|FG002|NOT COMPLETED|Overall Study||46
2976603|NCT00826449|3691813|FG000|STARTED|Overall Study||47
2976604|NCT00826449|3691813|FG000|Phase I|Overall Study||12
2976605|NCT00826449|3691813|FG000|Phase II|Overall Study||35
2976606|NCT00826449|3691813|FG000|COMPLETED|Overall Study||42
2976607|NCT00826449|3691813|FG000|NOT COMPLETED|Overall Study||5
2976608|NCT00826514|3691820|FG000|STARTED|Overall Study||30
2976609|NCT00826514|3691821|FG001|STARTED|Overall Study||32
2976610|NCT00826514|3691820|FG000|COMPLETED|Overall Study||27
2976611|NCT00826514|3691821|FG001|COMPLETED|Overall Study||27
2976612|NCT00826514|3691820|FG000|NOT COMPLETED|Overall Study||3
2976613|NCT00826514|3691821|FG001|NOT COMPLETED|Overall Study||5
2976614|NCT00826540|3691827|FG000|STARTED|Overall Study||83
2976615|NCT00826540|3691827|FG000|COMPLETED|Overall Study||79
2976616|NCT00826540|3691827|FG000|NOT COMPLETED|Overall Study||4
2976617|NCT00826618|3691831|FG000|STARTED|Overall Study||6
2976618|NCT00826618|3691831|FG000|COMPLETED|Overall Study||5
2976619|NCT00826618|3691831|FG000|NOT COMPLETED|Overall Study||1
2976620|NCT00826748|3691838|FG000|STARTED|Overall Study||6
2976621|NCT00826748|3691839|FG001|STARTED|Overall Study||4
2976622|NCT00826748|3691840|FG002|STARTED|Overall Study||12
2976623|NCT00826748|3691838|FG000|COMPLETED|Overall Study||6
2976624|NCT00826748|3691839|FG001|COMPLETED|Overall Study||4
2976625|NCT00826748|3691840|FG002|COMPLETED|Overall Study||8
2976626|NCT00826748|3691838|FG000|NOT COMPLETED|Overall Study||0
2976627|NCT00826748|3691839|FG001|NOT COMPLETED|Overall Study||0
2976628|NCT00826748|3691840|FG002|NOT COMPLETED|Overall Study||4
2976629|NCT00826800|3691848|FG000|STARTED|Overall Study||2
2976630|NCT00826800|3691848|FG000|COMPLETED|Overall Study||2
2976631|NCT00826800|3691848|FG000|NOT COMPLETED|Overall Study||0
2976632|NCT00826943|3691852|FG000|STARTED|Overall Study||6
2976633|NCT00826943|3691853|FG001|STARTED|Overall Study||6
2976634|NCT00826943|3691854|FG002|STARTED|Overall Study||4
2976635|NCT00826943|3691855|FG003|STARTED|Overall Study||5
2976636|NCT00826943|3691856|FG004|STARTED|Overall Study||7
2976637|NCT00826943|3691857|FG005|STARTED|Overall Study||2
2976638|NCT00826943|3691852|FG000|COMPLETED|Overall Study||6
2976639|NCT00826943|3691853|FG001|COMPLETED|Overall Study||6
2976640|NCT00826943|3691854|FG002|COMPLETED|Overall Study||4
2976641|NCT00826943|3691855|FG003|COMPLETED|Overall Study||5
2976642|NCT00826943|3691856|FG004|COMPLETED|Overall Study||6
2976643|NCT00826943|3691857|FG005|COMPLETED|Overall Study||2
2976644|NCT00826943|3691852|FG000|NOT COMPLETED|Overall Study||0
2976645|NCT00826943|3691853|FG001|NOT COMPLETED|Overall Study||0
2976646|NCT00826943|3691854|FG002|NOT COMPLETED|Overall Study||0
2976647|NCT00826943|3691855|FG003|NOT COMPLETED|Overall Study||0
2976648|NCT00826943|3691856|FG004|NOT COMPLETED|Overall Study||1
2976649|NCT00826943|3691857|FG005|NOT COMPLETED|Overall Study||0
2976650|NCT00827073|3691867|FG000|STARTED|Overall Study||20
2976651|NCT00827073|3691868|FG001|STARTED|Overall Study||20
2976652|NCT00827073|3691867|FG000|COMPLETED|Overall Study||20
2976653|NCT00827073|3691868|FG001|COMPLETED|Overall Study||20
2976654|NCT00827073|3691867|FG000|NOT COMPLETED|Overall Study||0
2976655|NCT00827073|3691868|FG001|NOT COMPLETED|Overall Study||0
2976656|NCT00827099|3691874|FG000|STARTED|Overall Study||5
2976657|NCT00827099|3691874|FG000|COMPLETED|Overall Study||5
2976658|NCT00827099|3691874|FG000|NOT COMPLETED|Overall Study||0
2976659|NCT00827112|3691880|FG000|STARTED|Overall Study||65
2976660|NCT00827112|3691881|FG001|STARTED|Overall Study||64
2976661|NCT00827112|3691880|FG000|Treated|Overall Study||60
2976662|NCT00827112|3691881|FG001|Treated|Overall Study||61
2976663|NCT00827112|3691880|FG000|COMPLETED|Overall Study||50
2976664|NCT00827112|3691881|FG001|COMPLETED|Overall Study||52
2976665|NCT00827112|3691880|FG000|NOT COMPLETED|Overall Study||15
2976666|NCT00827112|3691881|FG001|NOT COMPLETED|Overall Study||12
2976667|NCT00827242|3691889|FG000|STARTED|Overall Study||161
2976668|NCT00827242|3691890|FG001|STARTED|Overall Study||164
2976669|NCT00827242|3691889|FG000|COMPLETED|Overall Study||148
2976670|NCT00827242|3691890|FG001|COMPLETED|Overall Study||152
2976671|NCT00827242|3691889|FG000|NOT COMPLETED|Overall Study||13
2976672|NCT00827242|3691890|FG001|NOT COMPLETED|Overall Study||12
2976673|NCT00827255|3691896|FG000|STARTED|Overall Study||35
2976674|NCT00827255|3691896|FG000|COMPLETED|Overall Study||35
2976675|NCT00827255|3691896|FG000|NOT COMPLETED|Overall Study||0
2976676|NCT00827359|3691900|FG000|STARTED|Overall Study||25
2976677|NCT00827359|3691900|FG000|Treated|Overall Study||24
2976678|NCT00827359|3691900|FG000|COMPLETED|Overall Study||0
2976679|NCT00827359|3691900|FG000|NOT COMPLETED|Overall Study||25
2976680|NCT00827372|3691904|FG000|STARTED|Overall Study||10
2976681|NCT00827372|3691904|FG000|COMPLETED|Overall Study||2
2976682|NCT00827372|3691904|FG000|NOT COMPLETED|Overall Study||8
2976683|NCT00827502|3691909|FG000|STARTED|Overall Study||421
2976684|NCT00827502|3691909|FG000|Received Treatment (Number Treated)|Overall Study||410
2976685|NCT00827502|3691909|FG000|COMPLETED|Overall Study||400
2976686|NCT00827502|3691909|FG000|NOT COMPLETED|Overall Study||21
2976687|NCT00827541|3691915|FG000|STARTED|Overall Study||19
2976688|NCT00827541|3691916|FG001|STARTED|Overall Study||96
2976689|NCT00827541|3691915|FG000|COMPLETED|Overall Study||15
2976690|NCT00827541|3691916|FG001|COMPLETED|Overall Study||85
2976691|NCT00827541|3691915|FG000|NOT COMPLETED|Overall Study||4
2976692|NCT00827541|3691916|FG001|NOT COMPLETED|Overall Study||11
2976693|NCT00827606|3691924|FG000|STARTED|Overall Study||139
2976694|NCT00827606|3691925|FG001|STARTED|Overall Study||132
2976695|NCT00827606|3691924|FG000|COMPLETED|Overall Study||112
2976696|NCT00827606|3691925|FG001|COMPLETED|Overall Study||94
2976697|NCT00827606|3691924|FG000|NOT COMPLETED|Overall Study||27
2976698|NCT00827606|3691925|FG001|NOT COMPLETED|Overall Study||38
2976699|NCT00827632|3691939|FG000|STARTED|Overall Study||128
2976700|NCT00827632|3691940|FG001|STARTED|Overall Study||98
2976701|NCT00827632|3691939|FG000|COMPLETED|Overall Study||106
2976702|NCT00827632|3691940|FG001|COMPLETED|Overall Study||75
2976703|NCT00827632|3691939|FG000|NOT COMPLETED|Overall Study||22
2976704|NCT00827632|3691940|FG001|NOT COMPLETED|Overall Study||23
2976705|NCT00827775|3691948|FG000|STARTED|Overall Study||25
2976706|NCT00827775|3691949|FG001|STARTED|Overall Study||30
2976707|NCT00827775|3691948|FG000|COMPLETED|Overall Study||25
2976708|NCT00827775|3691949|FG001|COMPLETED|Overall Study||25
2976709|NCT00827775|3691948|FG000|NOT COMPLETED|Overall Study||0
2976710|NCT00827775|3691949|FG001|NOT COMPLETED|Overall Study||5
2976711|NCT00827827|3691957|FG000|STARTED|Overall Study||22
2976712|NCT00827827|3691958|FG001|STARTED|Overall Study||16
2976713|NCT00827827|3691957|FG000|COMPLETED|Overall Study||14
2976714|NCT00827827|3691958|FG001|COMPLETED|Overall Study||16
2976715|NCT00827827|3691957|FG000|NOT COMPLETED|Overall Study||8
2976716|NCT00827827|3691958|FG001|NOT COMPLETED|Overall Study||0
2976717|NCT00827918|3691968|FG000|STARTED|Overall Study||86
2976718|NCT00827918|3691969|FG001|STARTED|Overall Study||47
2976719|NCT00827918|3691970|FG002|STARTED|Overall Study||83
2976720|NCT00827918|3691968|FG000|COMPLETED|Overall Study||58
2976721|NCT00827918|3691969|FG001|COMPLETED|Overall Study||38
2976722|NCT00827918|3691970|FG002|COMPLETED|Overall Study||62
2976723|NCT00827918|3691968|FG000|NOT COMPLETED|Overall Study||28
2976724|NCT00827918|3691969|FG001|NOT COMPLETED|Overall Study||9
2976725|NCT00827918|3691970|FG002|NOT COMPLETED|Overall Study||21
2976726|NCT00827931|3691980|FG000|STARTED|Overall Study||49
2976727|NCT00827931|3691981|FG001|STARTED|Overall Study||45
2976728|NCT00827931|3691980|FG000|COMPLETED|Overall Study||43
2976729|NCT00827931|3691981|FG001|COMPLETED|Overall Study||39
2976730|NCT00827931|3691980|FG000|NOT COMPLETED|Overall Study||6
2976731|NCT00827931|3691981|FG001|NOT COMPLETED|Overall Study||6
2976732|NCT00827944|3691989|FG000|STARTED|Overall Study||304
2976733|NCT00827944|3691990|FG001|STARTED|Overall Study||299
2976734|NCT00827944|3691989|FG000|COMPLETED|Overall Study||241
2976735|NCT00827944|3691990|FG001|COMPLETED|Overall Study||240
2976736|NCT00827944|3691989|FG000|NOT COMPLETED|Overall Study||63
2976737|NCT00827944|3691990|FG001|NOT COMPLETED|Overall Study||59
2976738|NCT00827983|3691998|FG000|STARTED|Overall Study|All randomised patients|339
2976739|NCT00827983|3691999|FG001|STARTED|Overall Study|all randomised patients|344
2976740|NCT00827983|3691998|FG000|COMPLETED|Overall Study|patients who performed the pregnancy test|321
2976741|NCT00827983|3691999|FG001|COMPLETED|Overall Study|patients who performed the pregnancy test|328
2976742|NCT00827983|3691998|FG000|NOT COMPLETED|Overall Study||18
2976743|NCT00827983|3691999|FG001|NOT COMPLETED|Overall Study||16
2976744|NCT00828009|3692005|FG000|STARTED|Step 1 - Chemo RT/Consolidation Chemo||70
2976745|NCT00828009|3692005|FG000|Started Treatment|Step 1 - Chemo RT/Consolidation Chemo||68
2976746|NCT00828009|3692005|FG000|COMPLETED|Step 1 - Chemo RT/Consolidation Chemo||39
2976747|NCT00828009|3692005|FG000|NOT COMPLETED|Step 1 - Chemo RT/Consolidation Chemo||31
2976748|NCT00828009|3692005|FG000|STARTED|Step 2 - Maintenance Therapy|Among 39 pts with tx completion, 4 did not register to step 2 and 2 had PD at the end of step 1.|33
2976749|NCT00828009|3692005|FG000|COMPLETED|Step 2 - Maintenance Therapy|Max maintenance therapy was 34 cycles. No patients were off treatment due to completion of 34 cycles|0
2976750|NCT00828009|3692005|FG000|NOT COMPLETED|Step 2 - Maintenance Therapy||33
2976751|NCT00828061|3692010|FG000|STARTED|Period 1||4
2976752|NCT00828061|3692011|FG001|STARTED|Period 1||3
2976753|NCT00828061|3692012|FG002|STARTED|Period 1||3
2976754|NCT00828061|3692013|FG003|STARTED|Period 1||3
2976755|NCT00828061|3692014|FG004|STARTED|Period 1||3
2976756|NCT00828061|3692015|FG005|STARTED|Period 1||3
2976757|NCT00828061|3692010|FG000|COMPLETED|Period 1||4
2976758|NCT00828061|3692011|FG001|COMPLETED|Period 1||3
2976759|NCT00828061|3692012|FG002|COMPLETED|Period 1||3
2976760|NCT00828061|3692013|FG003|COMPLETED|Period 1||3
2976761|NCT00828061|3692014|FG004|COMPLETED|Period 1||3
2976762|NCT00828061|3692015|FG005|COMPLETED|Period 1||3
2976763|NCT00828061|3692010|FG000|NOT COMPLETED|Period 1||0
2976764|NCT00828061|3692011|FG001|NOT COMPLETED|Period 1||0
2976765|NCT00828061|3692012|FG002|NOT COMPLETED|Period 1||0
2976766|NCT00828061|3692013|FG003|NOT COMPLETED|Period 1||0
2976767|NCT00828061|3692014|FG004|NOT COMPLETED|Period 1||0
2976768|NCT00828061|3692015|FG005|NOT COMPLETED|Period 1||0
2976769|NCT00828061|3692010|FG000|STARTED|Period 2||4
2976770|NCT00828061|3692011|FG001|STARTED|Period 2||3
2976771|NCT00828061|3692012|FG002|STARTED|Period 2||3
2976772|NCT00828061|3692013|FG003|STARTED|Period 2||3
2976773|NCT00828061|3692014|FG004|STARTED|Period 2||3
2976774|NCT00828061|3692015|FG005|STARTED|Period 2||3
2976775|NCT00828061|3692010|FG000|COMPLETED|Period 2||4
2976776|NCT00828061|3692011|FG001|COMPLETED|Period 2||3
2976777|NCT00828061|3692012|FG002|COMPLETED|Period 2||3
2976778|NCT00828061|3692013|FG003|COMPLETED|Period 2||3
2976779|NCT00828061|3692014|FG004|COMPLETED|Period 2||3
2976780|NCT00828061|3692015|FG005|COMPLETED|Period 2||3
2976781|NCT00828061|3692010|FG000|NOT COMPLETED|Period 2||0
2976782|NCT00828061|3692011|FG001|NOT COMPLETED|Period 2||0
2976783|NCT00828061|3692012|FG002|NOT COMPLETED|Period 2||0
2976784|NCT00828061|3692013|FG003|NOT COMPLETED|Period 2||0
2976785|NCT00828061|3692014|FG004|NOT COMPLETED|Period 2||0
2976786|NCT00828061|3692015|FG005|NOT COMPLETED|Period 2||0
2976787|NCT00828061|3692010|FG000|STARTED|Period 3||4
2976788|NCT00828061|3692011|FG001|STARTED|Period 3||3
2976789|NCT00828061|3692012|FG002|STARTED|Period 3||3
2976790|NCT00828061|3692013|FG003|STARTED|Period 3||3
2976791|NCT00828061|3692014|FG004|STARTED|Period 3||3
2976792|NCT00828061|3692015|FG005|STARTED|Period 3||3
2976793|NCT00828061|3692010|FG000|COMPLETED|Period 3||4
2976794|NCT00828061|3692011|FG001|COMPLETED|Period 3||3
2976795|NCT00828061|3692012|FG002|COMPLETED|Period 3||3
2976796|NCT00828061|3692013|FG003|COMPLETED|Period 3||3
2976797|NCT00828061|3692014|FG004|COMPLETED|Period 3||3
2976798|NCT00828061|3692015|FG005|COMPLETED|Period 3||3
2976799|NCT00828061|3692010|FG000|NOT COMPLETED|Period 3||0
2976800|NCT00828061|3692011|FG001|NOT COMPLETED|Period 3||0
2976801|NCT00828061|3692012|FG002|NOT COMPLETED|Period 3||0
2976802|NCT00828061|3692013|FG003|NOT COMPLETED|Period 3||0
2976803|NCT00828061|3692014|FG004|NOT COMPLETED|Period 3||0
2976804|NCT00828061|3692015|FG005|NOT COMPLETED|Period 3||0
2976805|NCT00828074|3692025|FG000|STARTED|Overall Study||6
2976806|NCT00828074|3692026|FG001|STARTED|Overall Study||5
2976807|NCT00828074|3692027|FG002|STARTED|Overall Study||35
2976808|NCT00828074|3692025|FG000|COMPLETED|Overall Study||6
2976809|NCT00828074|3692026|FG001|COMPLETED|Overall Study||5
2976810|NCT00828074|3692027|FG002|COMPLETED|Overall Study||35
2976811|NCT00828074|3692025|FG000|NOT COMPLETED|Overall Study||0
2976812|NCT00828074|3692026|FG001|NOT COMPLETED|Overall Study||0
2976813|NCT00828074|3692027|FG002|NOT COMPLETED|Overall Study||0
2976814|NCT00828113|3692039|FG000|STARTED|Overall Study||50
2976815|NCT00828113|3692040|FG001|STARTED|Overall Study||51
2976816|NCT00828113|3692039|FG000|COMPLETED|Overall Study||20
2976817|NCT00828113|3692040|FG001|COMPLETED|Overall Study||20
2976818|NCT00828113|3692039|FG000|NOT COMPLETED|Overall Study||30
2976819|NCT00828113|3692040|FG001|NOT COMPLETED|Overall Study||31
2976820|NCT00828139|3692050|FG000|STARTED|Overall Study||42
2976821|NCT00828139|3692051|FG001|STARTED|Overall Study||41
2976822|NCT00828139|3692052|FG002|STARTED|Overall Study||55
2976823|NCT00828139|3692053|FG003|STARTED|Overall Study||51
2976824|NCT00828139|3692050|FG000|COMPLETED|Overall Study||1
2976825|NCT00828139|3692051|FG001|COMPLETED|Overall Study||0
2976826|NCT00828139|3692052|FG002|COMPLETED|Overall Study||0
2976827|NCT00828139|3692053|FG003|COMPLETED|Overall Study||0
2976828|NCT00828139|3692050|FG000|NOT COMPLETED|Overall Study||41
2976829|NCT00828139|3692051|FG001|NOT COMPLETED|Overall Study||41
2976830|NCT00828139|3692052|FG002|NOT COMPLETED|Overall Study||55
2976831|NCT00828139|3692053|FG003|NOT COMPLETED|Overall Study||51
2976832|NCT00828178|3692065|FG000|STARTED|Overall Study||42
2976833|NCT00828178|3692066|FG001|STARTED|Overall Study|Eighty seven participants were randomized.|45
2976834|NCT00828178|3692065|FG000|COMPLETED|Overall Study||42
2976835|NCT00828178|3692066|FG001|COMPLETED|Overall Study|Two patients did not complete the study.|43
2976836|NCT00828178|3692065|FG000|NOT COMPLETED|Overall Study||0
2976837|NCT00828178|3692066|FG001|NOT COMPLETED|Overall Study||2
2976838|NCT00828191|3692076|FG000|STARTED|Overall Study|Randomized patients|400
2976839|NCT00828191|3692077|FG001|STARTED|Overall Study|Randomized patients|400
2976840|NCT00828191|3692076|FG000|COMPLETED|Overall Study|Patients with at least one embryo transferred.|392
2976841|NCT00828191|3692077|FG001|COMPLETED|Overall Study|Patients with at least one embryo transferred.|390
2976842|NCT00828191|3692076|FG000|NOT COMPLETED|Overall Study||8
2976843|NCT00828191|3692077|FG001|NOT COMPLETED|Overall Study||10
2976844|NCT00828204|3692085|FG000|STARTED|Main Study: Prior to Study Suspension||21
2976845|NCT00828204|3692086|FG001|STARTED|Main Study: Prior to Study Suspension|Main Subset was not enrolled until after study suspension (period 2, below).|0
2976846|NCT00828204|3692085|FG000|Completed Manual Injection|Main Study: Prior to Study Suspension||21
2976847|NCT00828204|3692086|FG001|Completed Manual Injection|Main Study: Prior to Study Suspension||0
2976848|NCT00828204|3692085|FG000|Continued With Autoinjector Injections|Main Study: Prior to Study Suspension||19
2976849|NCT00828204|3692086|FG001|Continued With Autoinjector Injections|Main Study: Prior to Study Suspension||0
2976850|NCT00828204|3692085|FG000|COMPLETED|Main Study: Prior to Study Suspension||7
2976851|NCT00828204|3692086|FG001|COMPLETED|Main Study: Prior to Study Suspension||0
2976852|NCT00828204|3692085|FG000|NOT COMPLETED|Main Study: Prior to Study Suspension||14
2976853|NCT00828204|3692086|FG001|NOT COMPLETED|Main Study: Prior to Study Suspension||0
2976854|NCT00828204|3692085|FG000|STARTED|Main Study: After Study Restart|Initial Subset participants did not continue after the study was suspended.|0
2976855|NCT00828204|3692086|FG001|STARTED|Main Study: After Study Restart|After a protocol amendment, the Main Subset participants were enrolled.|74
2976856|NCT00828204|3692085|FG000|Completed Manual Injection|Main Study: After Study Restart||0
2976857|NCT00828204|3692086|FG001|Completed Manual Injection|Main Study: After Study Restart||74
2976858|NCT00828204|3692085|FG000|Continued With Autoinjector Injections|Main Study: After Study Restart||0
2976859|NCT00828204|3692086|FG001|Continued With Autoinjector Injections|Main Study: After Study Restart||72
2976860|NCT00828204|3692085|FG000|COMPLETED|Main Study: After Study Restart||0
2976861|NCT00828204|3692086|FG001|COMPLETED|Main Study: After Study Restart||71
2976862|NCT00828204|3692085|FG000|NOT COMPLETED|Main Study: After Study Restart||0
2976863|NCT00828204|3692086|FG001|NOT COMPLETED|Main Study: After Study Restart||3
2976864|NCT00828204|3692085|FG000|STARTED|Extension Study|Participation in the Extension Study was not offered to Initial Subset after completing Main Study.|0
2976865|NCT00828204|3692086|FG001|STARTED|Extension Study|Participation in Extension Study was optional for Main Subset participants completing Main Study.|64
2976866|NCT00828204|3692085|FG000|COMPLETED|Extension Study||0
3303202|NCT02964767|4036508|FG000|COMPLETED|Overall Study||171
3303203|NCT02964767|4036509|FG001|COMPLETED|Overall Study||48
3303204|NCT02964767|4036508|FG000|NOT COMPLETED|Overall Study||0
3303205|NCT02964767|4036509|FG001|NOT COMPLETED|Overall Study||0
3303206|NCT02964910|4036518|FG000|STARTED|Overall Study||235
3303207|NCT02964910|4036519|FG001|STARTED|Overall Study||240
3303208|NCT02964910|4036518|FG000|COMPLETED|Overall Study||192
3303209|NCT02964910|4036519|FG001|COMPLETED|Overall Study||196
3303210|NCT02964910|4036518|FG000|NOT COMPLETED|Overall Study||43
2976867|NCT00828204|3692086|FG001|COMPLETED|Extension Study||61
2976868|NCT00828204|3692085|FG000|NOT COMPLETED|Extension Study||0
2976869|NCT00828204|3692086|FG001|NOT COMPLETED|Extension Study||3
2976870|NCT00828295|3692095|FG000|STARTED|Overall Study||75
2976871|NCT00828295|3692096|FG001|STARTED|Overall Study||75
2976872|NCT00828295|3692095|FG000|COMPLETED|Overall Study||75
2976873|NCT00828295|3692096|FG001|COMPLETED|Overall Study||75
2976874|NCT00828295|3692095|FG000|NOT COMPLETED|Overall Study||0
2976875|NCT00828295|3692096|FG001|NOT COMPLETED|Overall Study||0
2976876|NCT00828308|3692102|FG000|STARTED|Overall Study||16
2976877|NCT00828308|3692102|FG000|COMPLETED|Overall Study||16
2976878|NCT00828308|3692102|FG000|NOT COMPLETED|Overall Study||0
2976879|NCT00828347|3692108|FG000|STARTED|Overall Study||12
2976880|NCT00828347|3692109|FG001|STARTED|Overall Study||11
2976881|NCT00828347|3692108|FG000|COMPLETED|Overall Study||12
2976882|NCT00828347|3692109|FG001|COMPLETED|Overall Study||11
2976883|NCT00828347|3692108|FG000|NOT COMPLETED|Overall Study||0
2976884|NCT00828347|3692109|FG001|NOT COMPLETED|Overall Study||0
2976885|NCT00828412|3692117|FG000|STARTED|Overall Study||50
2976886|NCT00828412|3692118|FG001|STARTED|Overall Study||50
2976887|NCT00828412|3692117|FG000|COMPLETED|Overall Study||41
2976888|NCT00828412|3692118|FG001|COMPLETED|Overall Study||48
2976889|NCT00828412|3692117|FG000|NOT COMPLETED|Overall Study||9
2976890|NCT00828412|3692118|FG001|NOT COMPLETED|Overall Study||2
2976891|NCT00828451|3692124|FG000|STARTED|Overall Study||29
2976892|NCT00828451|3692124|FG000|COMPLETED|Overall Study||18
2976893|NCT00828451|3692124|FG000|NOT COMPLETED|Overall Study||11
2976894|NCT00828464|3692128|FG000|STARTED|Overall Study||30
2976895|NCT00828464|3692128|FG000|COMPLETED|Overall Study||29
2976896|NCT00828464|3692128|FG000|NOT COMPLETED|Overall Study||1
2976897|NCT00828516|3692132|FG000|STARTED|Clinical Phase: Series 1||35
2976898|NCT00828516|3692132|FG000|COMPLETED|Clinical Phase: Series 1||33
2976899|NCT00828516|3692132|FG000|NOT COMPLETED|Clinical Phase: Series 1||2
2976900|NCT00828516|3692132|FG000|STARTED|Clinical Phase: Series 2||30
2976901|NCT00828516|3692132|FG000|COMPLETED|Clinical Phase: Series 2||30
3303211|NCT02964910|4036519|FG001|NOT COMPLETED|Overall Study||44
3303212|NCT02965144|4036527|FG000|STARTED|Overall Study||13
3303213|NCT02965144|4036527|FG000|COMPLETED|Overall Study||13
3303214|NCT02965144|4036527|FG000|NOT COMPLETED|Overall Study||0
3303215|NCT02965378|4036536|FG000|STARTED|Overall Study||25
3303216|NCT02965378|4036537|FG001|STARTED|Overall Study||9
3303217|NCT02965378|4036536|FG000|Participants on Docetaxel Re-registered to AZD4547 After Progression.|Overall Study||0
2976902|NCT00828516|3692132|FG000|NOT COMPLETED|Clinical Phase: Series 2||0
2976903|NCT00828542|3692138|FG000|STARTED|Overall Study||23
2976904|NCT00828542|3692139|FG001|STARTED|Overall Study||23
2976905|NCT00828542|3692138|FG000|COMPLETED|Overall Study||20
2976906|NCT00828542|3692139|FG001|COMPLETED|Overall Study||20
2976907|NCT00828542|3692138|FG000|NOT COMPLETED|Overall Study||3
2976908|NCT00828542|3692139|FG001|NOT COMPLETED|Overall Study||3
2976909|NCT00828568|3692148|FG000|STARTED|Randomized||184
2976910|NCT00828568|3692149|FG001|STARTED|Randomized||179
2976911|NCT00828568|3692150|FG002|STARTED|Randomized||62
2976912|NCT00828568|3692148|FG000|COMPLETED|Randomized||183
2976913|NCT00828568|3692149|FG001|COMPLETED|Randomized||179
2976914|NCT00828568|3692150|FG002|COMPLETED|Randomized||60
2976915|NCT00828568|3692148|FG000|NOT COMPLETED|Randomized||1
2976916|NCT00828568|3692149|FG001|NOT COMPLETED|Randomized||0
2976917|NCT00828568|3692150|FG002|NOT COMPLETED|Randomized||2
2976918|NCT00828568|3692148|FG000|STARTED|Treated - Received at Least One Dose||183
2976919|NCT00828568|3692149|FG001|STARTED|Treated - Received at Least One Dose||179
2976920|NCT00828568|3692150|FG002|STARTED|Treated - Received at Least One Dose||60
2976921|NCT00828568|3692148|FG000|COMPLETED|Treated - Received at Least One Dose||153
2976922|NCT00828568|3692149|FG001|COMPLETED|Treated - Received at Least One Dose||150
2976923|NCT00828568|3692150|FG002|COMPLETED|Treated - Received at Least One Dose||55
2976924|NCT00828568|3692148|FG000|NOT COMPLETED|Treated - Received at Least One Dose||30
2976925|NCT00828568|3692149|FG001|NOT COMPLETED|Treated - Received at Least One Dose||29
2976926|NCT00828568|3692150|FG002|NOT COMPLETED|Treated - Received at Least One Dose||5
2976927|NCT00828672|3692161|FG000|STARTED|Pre-treatment (Baseline)||43
2976928|NCT00828672|3692162|FG001|STARTED|Pre-treatment (Baseline)||41
2976929|NCT00828672|3692161|FG000|COMPLETED|Pre-treatment (Baseline)||43
2976930|NCT00828672|3692162|FG001|COMPLETED|Pre-treatment (Baseline)||41
2976931|NCT00828672|3692161|FG000|NOT COMPLETED|Pre-treatment (Baseline)||0
2976932|NCT00828672|3692162|FG001|NOT COMPLETED|Pre-treatment (Baseline)||0
2976933|NCT00828672|3692161|FG000|STARTED|Study Treatment||43
2976934|NCT00828672|3692162|FG001|STARTED|Study Treatment||41
2976935|NCT00828672|3692161|FG000|COMPLETED|Study Treatment||41
2976936|NCT00828672|3692162|FG001|COMPLETED|Study Treatment||39
2976937|NCT00828672|3692161|FG000|NOT COMPLETED|Study Treatment||2
2976938|NCT00828672|3692162|FG001|NOT COMPLETED|Study Treatment||2
2976939|NCT00828672|3692161|FG000|STARTED|Post-surgery (<30 Days)||41
2976940|NCT00828672|3692162|FG001|STARTED|Post-surgery (<30 Days)||39
2976941|NCT00828672|3692161|FG000|COMPLETED|Post-surgery (<30 Days)||41
2976942|NCT00828672|3692162|FG001|COMPLETED|Post-surgery (<30 Days)||38
2976943|NCT00828672|3692161|FG000|NOT COMPLETED|Post-surgery (<30 Days)||0
2976944|NCT00828672|3692162|FG001|NOT COMPLETED|Post-surgery (<30 Days)||1
2976945|NCT00828672|3692161|FG000|STARTED|Follow-up|Patient in Arm 1 with clinical complete response and no surgery is in follow up (joined this period)|42
2976946|NCT00828672|3692162|FG001|STARTED|Follow-up|Patients with no central review material and with adverse event are in followup (joined this period)|41
2976947|NCT00828672|3692161|FG000|COMPLETED|Follow-up||42
2976948|NCT00828672|3692162|FG001|COMPLETED|Follow-up||41
2976949|NCT00828672|3692161|FG000|NOT COMPLETED|Follow-up||0
2976950|NCT00828672|3692162|FG001|NOT COMPLETED|Follow-up||0
2976951|NCT00828711|3692171|FG000|STARTED|Overall Study||118
2976952|NCT00828711|3692172|FG001|STARTED|Overall Study||125
2976953|NCT00828711|3692173|FG002|STARTED|Overall Study||131
2976954|NCT00828711|3692171|FG000|COMPLETED|Overall Study||117
2976955|NCT00828711|3692172|FG001|COMPLETED|Overall Study||125
2976956|NCT00828711|3692173|FG002|COMPLETED|Overall Study||131
2976957|NCT00828711|3692171|FG000|NOT COMPLETED|Overall Study||1
2976958|NCT00828711|3692172|FG001|NOT COMPLETED|Overall Study||0
2976959|NCT00828711|3692173|FG002|NOT COMPLETED|Overall Study||0
2976960|NCT00828750|3692181|FG000|STARTED|Overall Study||19
2976961|NCT00828750|3692181|FG000|COMPLETED|Overall Study||15
2976962|NCT00828750|3692181|FG000|NOT COMPLETED|Overall Study||4
2976963|NCT00828841|3692189|FG000|STARTED|Overall Study||235
2976964|NCT00828841|3692190|FG001|STARTED|Overall Study||236
2976965|NCT00828841|3692191|FG002|STARTED|Overall Study||130
2976966|NCT00828841|3692189|FG000|COMPLETED|Overall Study||231
2976967|NCT00828841|3692190|FG001|COMPLETED|Overall Study||232
2976968|NCT00828841|3692191|FG002|COMPLETED|Overall Study||126
2976969|NCT00828841|3692189|FG000|NOT COMPLETED|Overall Study||4
2976970|NCT00828841|3692190|FG001|NOT COMPLETED|Overall Study||4
2976971|NCT00828841|3692191|FG002|NOT COMPLETED|Overall Study||4
2976972|NCT00828945|3692201|FG000|STARTED|Overall Study||257
2976973|NCT00828945|3692201|FG000|COMPLETED|Overall Study||216
2976974|NCT00828945|3692201|FG000|NOT COMPLETED|Overall Study||41
2976975|NCT00828984|3692208|FG000|STARTED|Overall Study||28
2976976|NCT00828984|3692209|FG001|STARTED|Overall Study||31
2976977|NCT00828984|3692210|FG002|STARTED|Overall Study||28
2976978|NCT00828984|3692208|FG000|Randomization|Overall Study||28
2976979|NCT00828984|3692209|FG001|Randomization|Overall Study||31
2976980|NCT00828984|3692210|FG002|Randomization|Overall Study||28
2976981|NCT00828984|3692208|FG000|Treatment|Overall Study||24
2976982|NCT00828984|3692209|FG001|Treatment|Overall Study||26
2976983|NCT00828984|3692210|FG002|Treatment|Overall Study||24
2976984|NCT00828984|3692208|FG000|Flexible Sigmoidoscopy|Overall Study||20
2976985|NCT00828984|3692209|FG001|Flexible Sigmoidoscopy|Overall Study||19
2976986|NCT00828984|3692210|FG002|Flexible Sigmoidoscopy|Overall Study||19
2976987|NCT00828984|3692208|FG000|Post Intervention Follow-Up|Overall Study||15
2976988|NCT00828984|3692209|FG001|Post Intervention Follow-Up|Overall Study||16
2976989|NCT00828984|3692210|FG002|Post Intervention Follow-Up|Overall Study||19
2976990|NCT00828984|3692208|FG000|COMPLETED|Overall Study||14
2976991|NCT00828984|3692209|FG001|COMPLETED|Overall Study||15
2976992|NCT00828984|3692210|FG002|COMPLETED|Overall Study||19
2976993|NCT00828984|3692208|FG000|NOT COMPLETED|Overall Study||14
2976994|NCT00828984|3692209|FG001|NOT COMPLETED|Overall Study||16
2976995|NCT00828984|3692210|FG002|NOT COMPLETED|Overall Study||9
2976996|NCT00829010|3692223|FG000|STARTED|Overall Study||83
2976997|NCT00829010|3692224|FG001|STARTED|Overall Study||101
2976998|NCT00829010|3692225|FG002|STARTED|Overall Study||100
2976999|NCT00829010|3692226|FG003|STARTED|Overall Study||100
2977000|NCT00829010|3692227|FG004|STARTED|Overall Study||100
2977001|NCT00829010|3692223|FG000|COMPLETED|Overall Study||73
2977002|NCT00829010|3692224|FG001|COMPLETED|Overall Study||92
2977003|NCT00829010|3692225|FG002|COMPLETED|Overall Study||97
2977004|NCT00829010|3692226|FG003|COMPLETED|Overall Study||92
2977005|NCT00829010|3692227|FG004|COMPLETED|Overall Study||98
2977006|NCT00829010|3692223|FG000|NOT COMPLETED|Overall Study||10
2977007|NCT00829010|3692224|FG001|NOT COMPLETED|Overall Study||9
2977008|NCT00829010|3692225|FG002|NOT COMPLETED|Overall Study||3
2977009|NCT00829010|3692226|FG003|NOT COMPLETED|Overall Study||8
2977010|NCT00829010|3692227|FG004|NOT COMPLETED|Overall Study||2
2977011|NCT00829036|3692239|FG000|STARTED|Overall Study||24
2977012|NCT00829036|3692239|FG000|COMPLETED|Overall Study||24
2977013|NCT00829036|3692239|FG000|NOT COMPLETED|Overall Study||0
2977014|NCT00829049|3692245|FG000|STARTED|Overall Study||77
2977015|NCT00829049|3692246|FG001|STARTED|Overall Study||88
2977016|NCT00829049|3692245|FG000|COMPLETED|Overall Study||60
2977017|NCT00829049|3692246|FG001|COMPLETED|Overall Study||68
2977018|NCT00829049|3692245|FG000|NOT COMPLETED|Overall Study||17
2977019|NCT00829049|3692246|FG001|NOT COMPLETED|Overall Study||20
2977020|NCT00829166|3692254|FG000|STARTED|Overall Study||495
2977021|NCT00829166|3692255|FG001|STARTED|Overall Study||496
2977022|NCT00829166|3692254|FG000|Treated|Overall Study||490
2977023|NCT00829166|3692255|FG001|Treated|Overall Study||488
2977024|NCT00829166|3692254|FG000|COMPLETED|Overall Study||0
2977025|NCT00829166|3692255|FG001|COMPLETED|Overall Study||0
2977026|NCT00829166|3692254|FG000|NOT COMPLETED|Overall Study||495
2977027|NCT00829166|3692255|FG001|NOT COMPLETED|Overall Study||496
2977028|NCT00829179|3692262|FG000|STARTED|Overall Study||20
2977029|NCT00829179|3692262|FG000|COMPLETED|Overall Study||19
2977030|NCT00829179|3692262|FG000|NOT COMPLETED|Overall Study||1
3036068|NCT01140646|3755234|FG000|NOT COMPLETED|Overall Study||9
3036069|NCT01140815|3755240|FG000|STARTED|Overall Study||25
3036070|NCT01140815|3755241|FG001|STARTED|Overall Study||25
3036071|NCT01140815|3755240|FG000|COMPLETED|Overall Study||25
3036072|NCT01140815|3755241|FG001|COMPLETED|Overall Study||25
3036073|NCT01140815|3755240|FG000|NOT COMPLETED|Overall Study||0
3036074|NCT01140815|3755241|FG001|NOT COMPLETED|Overall Study||0
3036075|NCT01140880|3755251|FG000|STARTED|Overall Study||70
3036076|NCT01140880|3755252|FG001|STARTED|Overall Study||100
3036077|NCT01140880|3755251|FG000|COMPLETED|Overall Study||56
3036078|NCT01140880|3755252|FG001|COMPLETED|Overall Study||56
3036079|NCT01140880|3755251|FG000|NOT COMPLETED|Overall Study||14
3036080|NCT01140880|3755252|FG001|NOT COMPLETED|Overall Study||44
3036081|NCT01140906|3755262|FG000|STARTED|Overall Study||158
3036082|NCT01140906|3755263|FG001|STARTED|Overall Study||151
3036083|NCT01140906|3755264|FG002|STARTED|Overall Study||151
3036084|NCT01140906|3755265|FG003|STARTED|Overall Study||147
3036085|NCT01140906|3755262|FG000|COMPLETED|Overall Study||133
3036086|NCT01140906|3755263|FG001|COMPLETED|Overall Study||117
3036087|NCT01140906|3755264|FG002|COMPLETED|Overall Study||125
3036088|NCT01140906|3755265|FG003|COMPLETED|Overall Study||131
3036089|NCT01140906|3755262|FG000|NOT COMPLETED|Overall Study||25
3036090|NCT01140906|3755263|FG001|NOT COMPLETED|Overall Study||34
3036091|NCT01140906|3755264|FG002|NOT COMPLETED|Overall Study||26
3036092|NCT01140906|3755265|FG003|NOT COMPLETED|Overall Study||16
3036093|NCT01141049|3755277|FG000|STARTED|Overall Study||19
3036094|NCT01141049|3755278|FG001|STARTED|Overall Study||21
3036095|NCT01141049|3755277|FG000|COMPLETED|Overall Study||14
3036096|NCT01141049|3755278|FG001|COMPLETED|Overall Study||13
3036097|NCT01141049|3755277|FG000|NOT COMPLETED|Overall Study||5
3036098|NCT01141049|3755278|FG001|NOT COMPLETED|Overall Study||8
3036099|NCT01141075|3755284|FG000|STARTED|Cycle 1||11
3036100|NCT01141075|3755284|FG000|Received at Least 1 Dose of Study Drug|Cycle 1||11
3036101|NCT01141075|3755284|FG000|COMPLETED|Cycle 1||11
3036102|NCT01141075|3755284|FG000|NOT COMPLETED|Cycle 1||0
3036103|NCT01141075|3755284|FG000|STARTED|Cycle 2||11
3036104|NCT01141075|3755284|FG000|Received at Least 1 Dose of Study Drug|Cycle 2||11
3036105|NCT01141075|3755284|FG000|COMPLETED|Cycle 2||11
3036106|NCT01141075|3755284|FG000|NOT COMPLETED|Cycle 2||0
3036107|NCT01141205|3755290|FG000|STARTED|Overall Study||18
3036108|NCT01141205|3755291|FG001|STARTED|Overall Study||5
3036109|NCT01141205|3755290|FG000|COMPLETED|Overall Study||15
3036110|NCT01141205|3755291|FG001|COMPLETED|Overall Study||3
3036111|NCT01141205|3755290|FG000|NOT COMPLETED|Overall Study||3
3036112|NCT01141205|3755291|FG001|NOT COMPLETED|Overall Study||2
3036113|NCT01141283|3755301|FG000|STARTED|Overall Study||290
3036114|NCT01141283|3755301|FG000|COMPLETED|Overall Study||202
3036115|NCT01141283|3755301|FG000|NOT COMPLETED|Overall Study||88
3036116|NCT01141374|3755308|FG000|STARTED|Overall Study||26
3036117|NCT01141374|3755309|FG001|STARTED|Overall Study||27
3036118|NCT01141374|3755310|FG002|STARTED|Overall Study||22
3036119|NCT01141374|3755308|FG000|COMPLETED|Overall Study||26
3036120|NCT01141374|3755309|FG001|COMPLETED|Overall Study||27
3036121|NCT01141374|3755310|FG002|COMPLETED|Overall Study||22
3036122|NCT01141374|3755308|FG000|NOT COMPLETED|Overall Study||0
3036123|NCT01141374|3755309|FG001|NOT COMPLETED|Overall Study||0
3036124|NCT01141374|3755310|FG002|NOT COMPLETED|Overall Study||0
3036125|NCT01141478|3755322|FG000|STARTED|Overall Study||4
3036126|NCT01141478|3755323|FG001|STARTED|Overall Study||4
3036127|NCT01141478|3755322|FG000|COMPLETED|Overall Study||3
3036128|NCT01141478|3755323|FG001|COMPLETED|Overall Study||3
3036129|NCT01141478|3755322|FG000|NOT COMPLETED|Overall Study||1
3036130|NCT01141478|3755323|FG001|NOT COMPLETED|Overall Study||1
3036131|NCT01141491|3755331|FG000|STARTED|Overall Study||68
3036132|NCT01141491|3755332|FG001|STARTED|Overall Study||68
3036133|NCT01141491|3755331|FG000|COMPLETED|Overall Study||20
3036134|NCT01141491|3755332|FG001|COMPLETED|Overall Study||21
3036135|NCT01141491|3755331|FG000|NOT COMPLETED|Overall Study||48
3036136|NCT01141491|3755332|FG001|NOT COMPLETED|Overall Study||47
3036137|NCT01141569|3755338|FG000|STARTED|Overall Study||12
3036138|NCT01141569|3755338|FG000|COMPLETED|Overall Study||12
3036139|NCT01141569|3755338|FG000|NOT COMPLETED|Overall Study||0
3036140|NCT01141595|3755342|FG000|STARTED|Overall Study||10
3036141|NCT01141595|3755342|FG000|COMPLETED|Overall Study||8
3036142|NCT01141595|3755342|FG000|NOT COMPLETED|Overall Study||2
3036143|NCT01141608|3755348|FG000|STARTED|Overall Study||152
3036144|NCT01141608|3755349|FG001|STARTED|Overall Study||150
3036145|NCT01141608|3755348|FG000|COMPLETED|Overall Study||152
3036146|NCT01141608|3755349|FG001|COMPLETED|Overall Study||150
3036147|NCT01141608|3755348|FG000|NOT COMPLETED|Overall Study||0
3036148|NCT01141608|3755349|FG001|NOT COMPLETED|Overall Study||0
3036149|NCT01141647|3755355|FG000|STARTED|Overall Study||213
3036150|NCT01141647|3755355|FG000|COMPLETED|Overall Study||167
3036151|NCT01141647|3755355|FG000|NOT COMPLETED|Overall Study||46
3036152|NCT01141660|3755366|FG000|STARTED|Overall Study||71
3036153|NCT01141660|3755367|FG001|STARTED|Overall Study||60
3036154|NCT01141660|3755366|FG000|COMPLETED|Overall Study||71
3036155|NCT01141660|3755367|FG001|COMPLETED|Overall Study||48
3036156|NCT01141660|3755366|FG000|NOT COMPLETED|Overall Study||0
3036157|NCT01141660|3755367|FG001|NOT COMPLETED|Overall Study||12
2977031|NCT00829244|3692268|FG000|STARTED|Overall Study||96
3133300|NCT01695239|3858314|FG009|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
3133301|NCT01695239|3858315|FG010|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
2977032|NCT00829244|3692269|FG001|STARTED|Overall Study||104
2977033|NCT00829244|3692268|FG000|COMPLETED|Overall Study||82
2977034|NCT00829244|3692269|FG001|COMPLETED|Overall Study||83
2977035|NCT00829244|3692268|FG000|NOT COMPLETED|Overall Study||14
2977036|NCT00829244|3692269|FG001|NOT COMPLETED|Overall Study||21
2977037|NCT00829283|3692277|FG000|STARTED|Overall Study||39
2977038|NCT00829283|3692278|FG001|STARTED|Overall Study||152
2977039|NCT00829283|3692277|FG000|COMPLETED|Overall Study||32
2977040|NCT00829283|3692278|FG001|COMPLETED|Overall Study||127
2977041|NCT00829283|3692277|FG000|NOT COMPLETED|Overall Study||7
2977042|NCT00829283|3692278|FG001|NOT COMPLETED|Overall Study||25
2977043|NCT00829296|3692286|FG000|STARTED|Overall Study||34
2977044|NCT00829296|3692287|FG001|STARTED|Overall Study||36
2977045|NCT00829296|3692286|FG000|COMPLETED|Overall Study||29
2977046|NCT00829296|3692287|FG001|COMPLETED|Overall Study||32
2977047|NCT00829296|3692286|FG000|NOT COMPLETED|Overall Study||5
2977048|NCT00829296|3692287|FG001|NOT COMPLETED|Overall Study||4
2977049|NCT00829387|3692295|FG000|STARTED|Overall Study||23
2977050|NCT00829387|3692296|FG001|STARTED|Overall Study||24
2977051|NCT00829387|3692295|FG000|COMPLETED|Overall Study||20
2977052|NCT00829387|3692296|FG001|COMPLETED|Overall Study||21
2977053|NCT00829387|3692295|FG000|NOT COMPLETED|Overall Study||3
2977054|NCT00829387|3692296|FG001|NOT COMPLETED|Overall Study||3
2977055|NCT00829413|3692302|FG000|STARTED|Overall Study||353
2977056|NCT00829413|3692302|FG000|COMPLETED|Overall Study||259
2977057|NCT00829413|3692302|FG000|NOT COMPLETED|Overall Study||94
2977058|NCT00829439|3692313|FG000|STARTED|Overall Study||3
2977059|NCT00829439|3692314|FG001|STARTED|Overall Study||3
2977060|NCT00829439|3692315|FG002|STARTED|Overall Study||6
2977061|NCT00829439|3692316|FG003|STARTED|Overall Study||4
2977062|NCT00829439|3692313|FG000|COMPLETED|Overall Study||3
2977063|NCT00829439|3692314|FG001|COMPLETED|Overall Study||3
2977064|NCT00829439|3692315|FG002|COMPLETED|Overall Study||5
2977065|NCT00829439|3692316|FG003|COMPLETED|Overall Study||4
2977066|NCT00829439|3692313|FG000|NOT COMPLETED|Overall Study||0
2977067|NCT00829439|3692314|FG001|NOT COMPLETED|Overall Study||0
2977068|NCT00829439|3692315|FG002|NOT COMPLETED|Overall Study||1
2977069|NCT00829439|3692316|FG003|NOT COMPLETED|Overall Study||0
2977070|NCT00829621|3692322|FG000|STARTED|Overall Study||8
2977071|NCT00829621|3692323|FG001|STARTED|Overall Study||12
2977072|NCT00829621|3692322|FG000|COMPLETED|Overall Study||4
2977073|NCT00829621|3692323|FG001|COMPLETED|Overall Study||8
2977074|NCT00829621|3692322|FG000|NOT COMPLETED|Overall Study||4
2977075|NCT00829621|3692323|FG001|NOT COMPLETED|Overall Study||4
2977076|NCT00829738|3692329|FG000|STARTED|Overall Study||4188
2977077|NCT00829738|3692329|FG000|COMPLETED|Overall Study||4180
2977078|NCT00829738|3692329|FG000|NOT COMPLETED|Overall Study||8
2977079|NCT00829829|3692337|FG000|STARTED|Overall Study||80
2977080|NCT00829829|3692338|FG001|STARTED|Overall Study||80
2977081|NCT00829829|3692339|FG002|STARTED|Overall Study||81
2977082|NCT00829829|3692337|FG000|Treated|Overall Study||79
2977083|NCT00829829|3692338|FG001|Treated|Overall Study||80
2977084|NCT00829829|3692339|FG002|Treated|Overall Study||81
2977085|NCT00829829|3692337|FG000|COMPLETED|Overall Study||58
2977086|NCT00829829|3692338|FG001|COMPLETED|Overall Study||64
2977087|NCT00829829|3692339|FG002|COMPLETED|Overall Study||70
2977088|NCT00829829|3692337|FG000|NOT COMPLETED|Overall Study||22
2977089|NCT00829829|3692338|FG001|NOT COMPLETED|Overall Study||16
2977090|NCT00829829|3692339|FG002|NOT COMPLETED|Overall Study||11
2977091|NCT00829933|3692352|FG000|STARTED|Overall Study||135
2977092|NCT00829933|3692353|FG001|STARTED|Overall Study||135
2977093|NCT00829933|3692354|FG002|STARTED|Overall Study||132
2977094|NCT00829933|3692355|FG003|STARTED|Overall Study||134
2977095|NCT00829933|3692352|FG000|Baseline Analysis Population|Overall Study||131
2977096|NCT00829933|3692353|FG001|Baseline Analysis Population|Overall Study||134
2977097|NCT00829933|3692354|FG002|Baseline Analysis Population|Overall Study||131
2977098|NCT00829933|3692355|FG003|Baseline Analysis Population|Overall Study||129
2977099|NCT00829933|3692352|FG000|COMPLETED|Overall Study||121
2977100|NCT00829933|3692353|FG001|COMPLETED|Overall Study||122
2977101|NCT00829933|3692354|FG002|COMPLETED|Overall Study||119
2977102|NCT00829933|3692355|FG003|COMPLETED|Overall Study||120
2977103|NCT00829933|3692352|FG000|NOT COMPLETED|Overall Study||14
2977104|NCT00829933|3692353|FG001|NOT COMPLETED|Overall Study||13
2977105|NCT00829933|3692354|FG002|NOT COMPLETED|Overall Study||13
2977106|NCT00829933|3692355|FG003|NOT COMPLETED|Overall Study||14
2977107|NCT00829985|3692367|FG000|STARTED|Overall Study||28
2977108|NCT00829985|3692368|FG001|STARTED|Overall Study||26
2977109|NCT00829985|3692367|FG000|COMPLETED|Overall Study||19
2977110|NCT00829985|3692368|FG001|COMPLETED|Overall Study||22
2977111|NCT00829985|3692367|FG000|NOT COMPLETED|Overall Study||9
2977112|NCT00829985|3692368|FG001|NOT COMPLETED|Overall Study||4
2977113|NCT00830037|3692376|FG000|STARTED|Overall Study||67
2977114|NCT00830037|3692377|FG001|STARTED|Overall Study||69
2977115|NCT00830037|3692376|FG000|COMPLETED|Overall Study||49
2977116|NCT00830037|3692377|FG001|COMPLETED|Overall Study||50
2977117|NCT00830037|3692376|FG000|NOT COMPLETED|Overall Study||18
2977118|NCT00830037|3692377|FG001|NOT COMPLETED|Overall Study||19
2977119|NCT00830063|3692387|FG000|STARTED|Overall Study||208
2977120|NCT00830063|3692388|FG001|STARTED|Overall Study||208
2977121|NCT00830063|3692389|FG002|STARTED|Overall Study||208
2977122|NCT00830063|3692390|FG003|STARTED|Overall Study||208
2977123|NCT00830063|3692387|FG000|Treated|Overall Study||208
2977124|NCT00830063|3692388|FG001|Treated|Overall Study||206
2977125|NCT00830063|3692389|FG002|Treated|Overall Study||208
2977126|NCT00830063|3692390|FG003|Treated|Overall Study||206
2977127|NCT00830063|3692387|FG000|COMPLETED|Overall Study||8
2977128|NCT00830063|3692388|FG001|COMPLETED|Overall Study||16
2977129|NCT00830063|3692389|FG002|COMPLETED|Overall Study||10
2977130|NCT00830063|3692390|FG003|COMPLETED|Overall Study||13
2977131|NCT00830063|3692387|FG000|NOT COMPLETED|Overall Study||200
2977132|NCT00830063|3692388|FG001|NOT COMPLETED|Overall Study||192
2977133|NCT00830063|3692389|FG002|NOT COMPLETED|Overall Study||198
2977134|NCT00830063|3692390|FG003|NOT COMPLETED|Overall Study||195
2977135|NCT00830076|3692402|FG000|STARTED|Sitagliptin + Placebo Metformin||18
2977136|NCT00830076|3692402|FG000|COMPLETED|Sitagliptin + Placebo Metformin||18
2977137|NCT00830076|3692402|FG000|NOT COMPLETED|Sitagliptin + Placebo Metformin||0
2977138|NCT00830076|3692402|FG000|STARTED|7-day Washout||18
2977139|NCT00830076|3692402|FG000|COMPLETED|7-day Washout||18
2977140|NCT00830076|3692402|FG000|NOT COMPLETED|7-day Washout||0
2977141|NCT00830076|3692402|FG000|STARTED|Metformin + Placebo Sitagliptin||18
2977142|NCT00830076|3692402|FG000|COMPLETED|Metformin + Placebo Sitagliptin||18
2977143|NCT00830076|3692402|FG000|NOT COMPLETED|Metformin + Placebo Sitagliptin||0
2977144|NCT00830076|3692402|FG000|STARTED|7-day Washout||18
2977145|NCT00830076|3692402|FG000|COMPLETED|7-day Washout||18
2977146|NCT00830076|3692402|FG000|NOT COMPLETED|7-day Washout||0
2977147|NCT00830076|3692402|FG000|STARTED|Sitagliptin + Metformin||18
2977148|NCT00830076|3692402|FG000|COMPLETED|Sitagliptin + Metformin||18
2977149|NCT00830076|3692402|FG000|NOT COMPLETED|Sitagliptin + Metformin||0
2977150|NCT00830076|3692402|FG000|STARTED|7-day Washout||18
2977151|NCT00830076|3692402|FG000|COMPLETED|7-day Washout||18
2977152|NCT00830076|3692402|FG000|NOT COMPLETED|7-day Washout||0
2977153|NCT00830076|3692402|FG000|STARTED|Placebo Sitagliptin + Placebo Metformin||18
2977154|NCT00830076|3692402|FG000|COMPLETED|Placebo Sitagliptin + Placebo Metformin||18
2977155|NCT00830076|3692402|FG000|NOT COMPLETED|Placebo Sitagliptin + Placebo Metformin||0
2977156|NCT00830115|3692409|FG000|STARTED|Overall Study||1045
2977157|NCT00830115|3692409|FG000|COMPLETED|Overall Study||1042
2977158|NCT00830115|3692409|FG000|NOT COMPLETED|Overall Study||3
2977159|NCT00830128|3692415|FG000|STARTED|Overall Study||106
2977160|NCT00830128|3692415|FG000|COMPLETED|Overall Study||87
2977161|NCT00830128|3692415|FG000|NOT COMPLETED|Overall Study||19
2977162|NCT00830167|3692421|FG000|STARTED|Overall Study|Treated|248
2977163|NCT00830167|3692422|FG001|STARTED|Overall Study|Treated|250
2977164|NCT00830167|3692421|FG000|COMPLETED|Overall Study||208
2977165|NCT00830167|3692422|FG001|COMPLETED|Overall Study||207
2977166|NCT00830167|3692421|FG000|NOT COMPLETED|Overall Study||40
2977167|NCT00830167|3692422|FG001|NOT COMPLETED|Overall Study||43
2977168|NCT00830180|3692428|FG000|STARTED|Overall Study||41
2977169|NCT00830180|3692428|FG000|Received Tanezumab in Parent Study A4091003|Overall Study||19
2977170|NCT00830180|3692428|FG000|Received Placebo in Parent Study A4091003|Overall Study||22
2977171|NCT00830180|3692428|FG000|COMPLETED|Overall Study||15
2977172|NCT00830180|3692428|FG000|NOT COMPLETED|Overall Study||26
2977173|NCT00830232|3692436|FG000|STARTED|Overall Study||20
2977174|NCT00830232|3692437|FG001|STARTED|Overall Study||20
2977175|NCT00830232|3692436|FG000|COMPLETED|Overall Study||20
2977176|NCT00830232|3692437|FG001|COMPLETED|Overall Study||20
2977177|NCT00830232|3692436|FG000|NOT COMPLETED|Overall Study||0
2977178|NCT00830232|3692437|FG001|NOT COMPLETED|Overall Study||0
2977179|NCT00830284|3692443|FG000|STARTED|Overall Study|The study was started in our Medical Surgical ICU October of 2008.|12
2977180|NCT00830284|3692443|FG000|COMPLETED|Overall Study||10
2977181|NCT00830284|3692443|FG000|NOT COMPLETED|Overall Study||2
2977182|NCT00830310|3692447|FG000|STARTED|Overall Study||43
2977183|NCT00830310|3692447|FG000|COMPLETED|Overall Study||30
2977184|NCT00830310|3692447|FG000|NOT COMPLETED|Overall Study||13
2977185|NCT00830362|3692453|FG000|STARTED|Overall Study|They received Propranolol and completed Test Session (Session 1). One subject left after day 1.|27
2977186|NCT00830362|3692454|FG001|STARTED|Overall Study|They received Propranolol and completed Test Session (Session 1). One subject left after day 1.|24
2977187|NCT00830362|3692453|FG000|Completed Sessions 1 and 2|Overall Study|Received propranolol and completed both Test and Retrieval sessions (Session 1 and 2).|26
2977188|NCT00830362|3692454|FG001|Completed Sessions 1 and 2|Overall Study|Received palcebo and completed both Test and Retrieval sessions (Session 1 and 2).|24
2977189|NCT00830362|3692453|FG000|COMPLETED|Overall Study|The enrolled subjects that completed all 3 testing sessions (were not lost to follow-up).|23
2977190|NCT00830362|3692454|FG001|COMPLETED|Overall Study|The enrolled subjects that completed all 3 testing sessions (were not lost to follow-up).|20
2977191|NCT00830362|3692453|FG000|NOT COMPLETED|Overall Study||4
2977192|NCT00830362|3692454|FG001|NOT COMPLETED|Overall Study||4
2977193|NCT00830375|3692460|FG000|STARTED|Overall Study||10
2977194|NCT00830375|3692460|FG000|COMPLETED|Overall Study||9
2977195|NCT00830375|3692460|FG000|NOT COMPLETED|Overall Study||1
2977196|NCT00830388|3692464|FG000|STARTED|Overall Study||11
2977197|NCT00830388|3692464|FG000|COMPLETED|Overall Study||11
2977198|NCT00830388|3692464|FG000|NOT COMPLETED|Overall Study||0
2977199|NCT00830440|3692470|FG000|STARTED|Overall Study||32
2977200|NCT00830440|3692471|FG001|STARTED|Overall Study||11
2977201|NCT00830440|3692470|FG000|Received Device|Overall Study||26
2977202|NCT00830440|3692471|FG001|Received Device|Overall Study||0
2977203|NCT00830440|3692470|FG000|Completed 12 Week Follow up|Overall Study||24
2977204|NCT00830440|3692471|FG001|Completed 12 Week Follow up|Overall Study||11
2977205|NCT00830440|3692470|FG000|Completed 16 Week Follow up|Overall Study||4
2977206|NCT00830440|3692471|FG001|Completed 16 Week Follow up|Overall Study||0
2977207|NCT00830440|3692470|FG000|Completed 24 Week Follow up|Overall Study||3
2977208|NCT00830440|3692471|FG001|Completed 24 Week Follow up|Overall Study||0
2977209|NCT00830440|3692470|FG000|COMPLETED|Overall Study||24
2977210|NCT00830440|3692471|FG001|COMPLETED|Overall Study||11
2977211|NCT00830440|3692470|FG000|NOT COMPLETED|Overall Study||8
2977212|NCT00830440|3692471|FG001|NOT COMPLETED|Overall Study||0
3164183|NCT01891669|3891642|FG002|STARTED|Overall Study||2
3164184|NCT01891669|3891643|FG003|STARTED|Overall Study||2
3164185|NCT01891669|3891644|FG004|STARTED|Overall Study||2
3164186|NCT01891669|3891645|FG005|STARTED|Overall Study||2
3164187|NCT01891669|3891646|FG006|STARTED|Overall Study||2
3164188|NCT01891669|3891647|FG007|STARTED|Overall Study||6
3164189|NCT01891669|3891648|FG008|STARTED|Overall Study||3
3164190|NCT01891669|3891649|FG009|STARTED|Overall Study||3
3164191|NCT01891669|3891640|FG000|COMPLETED|Overall Study||0
3164192|NCT01891669|3891641|FG001|COMPLETED|Overall Study||1
3164193|NCT01891669|3891642|FG002|COMPLETED|Overall Study||2
3164194|NCT01891669|3891643|FG003|COMPLETED|Overall Study||2
3164195|NCT01891669|3891644|FG004|COMPLETED|Overall Study||2
3164196|NCT01891669|3891645|FG005|COMPLETED|Overall Study||2
2977213|NCT00830518|3692480|FG000|STARTED|Overall Study||46
2977214|NCT00830518|3692481|FG001|STARTED|Overall Study||11
2977215|NCT00830518|3692480|FG000|COMPLETED|Overall Study|Completed = participants who completed study treatment.|0
2977216|NCT00830518|3692481|FG001|COMPLETED|Overall Study||0
2977217|NCT00830518|3692480|FG000|NOT COMPLETED|Overall Study||46
2977218|NCT00830518|3692481|FG001|NOT COMPLETED|Overall Study||11
2977219|NCT00830596|3692491|FG000|STARTED|Overall Study||74
2977220|NCT00830596|3692492|FG001|STARTED|Overall Study||74
2977221|NCT00830596|3692493|FG002|STARTED|Overall Study||73
2977222|NCT00830596|3692491|FG000|COMPLETED|Overall Study||72
2977223|NCT00830596|3692492|FG001|COMPLETED|Overall Study||72
2977224|NCT00830596|3692493|FG002|COMPLETED|Overall Study||67
2977225|NCT00830596|3692491|FG000|NOT COMPLETED|Overall Study||2
2977226|NCT00830596|3692492|FG001|NOT COMPLETED|Overall Study||2
2977227|NCT00830596|3692493|FG002|NOT COMPLETED|Overall Study||6
2977228|NCT00830765|3692503|FG000|STARTED|Overall Study||73
2977229|NCT00830765|3692504|FG001|STARTED|Overall Study||71
2977230|NCT00830765|3692503|FG000|COMPLETED|Overall Study||70
2977231|NCT00830765|3692504|FG001|COMPLETED|Overall Study||69
2977232|NCT00830765|3692503|FG000|NOT COMPLETED|Overall Study||3
2977233|NCT00830765|3692504|FG001|NOT COMPLETED|Overall Study||2
2977234|NCT00830791|3692516|FG000|STARTED|Overall Study||8
2977235|NCT00830791|3692517|FG001|STARTED|Overall Study||8
2977236|NCT00830791|3692518|FG002|STARTED|Overall Study||8
2977237|NCT00830791|3692519|FG003|STARTED|Overall Study||8
2977238|NCT00830791|3692520|FG004|STARTED|Overall Study||0
2977239|NCT00830791|3692521|FG005|STARTED|Overall Study||0
2977240|NCT00830791|3692516|FG000|COMPLETED|Overall Study||8
2977241|NCT00830791|3692517|FG001|COMPLETED|Overall Study||8
2977242|NCT00830791|3692518|FG002|COMPLETED|Overall Study||8
2977243|NCT00830791|3692519|FG003|COMPLETED|Overall Study||8
2977244|NCT00830791|3692520|FG004|COMPLETED|Overall Study||0
2977245|NCT00830791|3692521|FG005|COMPLETED|Overall Study||0
2977246|NCT00830791|3692516|FG000|NOT COMPLETED|Overall Study||0
2977247|NCT00830791|3692517|FG001|NOT COMPLETED|Overall Study||0
2977248|NCT00830791|3692518|FG002|NOT COMPLETED|Overall Study||0
2977249|NCT00830791|3692519|FG003|NOT COMPLETED|Overall Study||0
2977250|NCT00830791|3692520|FG004|NOT COMPLETED|Overall Study||0
2977251|NCT00830791|3692521|FG005|NOT COMPLETED|Overall Study||0
2977252|NCT00830804|3692534|FG000|STARTED|Overall Study|113 subjects enrolled. One subject never started study treatment and was excluded in all analysis.|112
2977253|NCT00830804|3692534|FG000|COMPLETED|Overall Study||97
2977254|NCT00830804|3692534|FG000|NOT COMPLETED|Overall Study||15
2977255|NCT00830869|3692551|FG000|STARTED|Period 1: Part 1||1
2977256|NCT00830869|3692552|FG001|STARTED|Period 1: Part 1||1
2977257|NCT00830869|3692553|FG002|STARTED|Period 1: Part 1||1
2977258|NCT00830869|3692554|FG003|STARTED|Period 1: Part 1||7
2977259|NCT00830869|3692555|FG004|STARTED|Period 1: Part 1||4
2977260|NCT00830869|3692556|FG005|STARTED|Period 1: Part 1||6
2977261|NCT00830869|3692557|FG006|STARTED|Period 1: Part 1||3
2977262|NCT00830869|3692558|FG007|STARTED|Period 1: Part 1||0
2977263|NCT00830869|3692559|FG008|STARTED|Period 1: Part 1||0
2977264|NCT00830869|3692560|FG009|STARTED|Period 1: Part 1||0
2977265|NCT00830869|3692561|FG010|STARTED|Period 1: Part 1||0
2977266|NCT00830869|3692562|FG011|STARTED|Period 1: Part 1||0
2977267|NCT00830869|3692551|FG000|COMPLETED|Period 1: Part 1||0
2977268|NCT00830869|3692552|FG001|COMPLETED|Period 1: Part 1||0
2977269|NCT00830869|3692553|FG002|COMPLETED|Period 1: Part 1||0
2977270|NCT00830869|3692554|FG003|COMPLETED|Period 1: Part 1||0
2977271|NCT00830869|3692555|FG004|COMPLETED|Period 1: Part 1||0
3164197|NCT01891669|3891646|FG006|COMPLETED|Overall Study||1
2977272|NCT00830869|3692556|FG005|COMPLETED|Period 1: Part 1||0
2977273|NCT00830869|3692557|FG006|COMPLETED|Period 1: Part 1||0
2977274|NCT00830869|3692558|FG007|COMPLETED|Period 1: Part 1||0
2977275|NCT00830869|3692559|FG008|COMPLETED|Period 1: Part 1||0
2977276|NCT00830869|3692560|FG009|COMPLETED|Period 1: Part 1||0
2977277|NCT00830869|3692561|FG010|COMPLETED|Period 1: Part 1||0
2977278|NCT00830869|3692562|FG011|COMPLETED|Period 1: Part 1||0
3164198|NCT01891669|3891647|FG007|COMPLETED|Overall Study||2
2977279|NCT00830869|3692551|FG000|NOT COMPLETED|Period 1: Part 1||1
2977280|NCT00830869|3692552|FG001|NOT COMPLETED|Period 1: Part 1||1
2977281|NCT00830869|3692553|FG002|NOT COMPLETED|Period 1: Part 1||1
2977282|NCT00830869|3692554|FG003|NOT COMPLETED|Period 1: Part 1||7
2977283|NCT00830869|3692555|FG004|NOT COMPLETED|Period 1: Part 1||4
2977284|NCT00830869|3692556|FG005|NOT COMPLETED|Period 1: Part 1||6
2977285|NCT00830869|3692557|FG006|NOT COMPLETED|Period 1: Part 1||3
2977286|NCT00830869|3692558|FG007|NOT COMPLETED|Period 1: Part 1||0
2977287|NCT00830869|3692559|FG008|NOT COMPLETED|Period 1: Part 1||0
2977288|NCT00830869|3692560|FG009|NOT COMPLETED|Period 1: Part 1||0
2977289|NCT00830869|3692561|FG010|NOT COMPLETED|Period 1: Part 1||0
2977290|NCT00830869|3692562|FG011|NOT COMPLETED|Period 1: Part 1||0
2977291|NCT00830869|3692551|FG000|STARTED|Period 2: Part 2||0
2977292|NCT00830869|3692552|FG001|STARTED|Period 2: Part 2||0
2977293|NCT00830869|3692553|FG002|STARTED|Period 2: Part 2||0
2977294|NCT00830869|3692554|FG003|STARTED|Period 2: Part 2||0
2977295|NCT00830869|3692555|FG004|STARTED|Period 2: Part 2||0
2977296|NCT00830869|3692556|FG005|STARTED|Period 2: Part 2||0
2977297|NCT00830869|3692557|FG006|STARTED|Period 2: Part 2||0
2977298|NCT00830869|3692558|FG007|STARTED|Period 2: Part 2||20
2977299|NCT00830869|3692559|FG008|STARTED|Period 2: Part 2||22
2977300|NCT00830869|3692560|FG009|STARTED|Period 2: Part 2||20
2977301|NCT00830869|3692561|FG010|STARTED|Period 2: Part 2||11
2977302|NCT00830869|3692562|FG011|STARTED|Period 2: Part 2||20
2977303|NCT00830869|3692551|FG000|COMPLETED|Period 2: Part 2||0
2977304|NCT00830869|3692552|FG001|COMPLETED|Period 2: Part 2||0
2977305|NCT00830869|3692553|FG002|COMPLETED|Period 2: Part 2||0
2977306|NCT00830869|3692554|FG003|COMPLETED|Period 2: Part 2||0
2977307|NCT00830869|3692555|FG004|COMPLETED|Period 2: Part 2||0
2977308|NCT00830869|3692556|FG005|COMPLETED|Period 2: Part 2||0
2977309|NCT00830869|3692557|FG006|COMPLETED|Period 2: Part 2||0
2977310|NCT00830869|3692558|FG007|COMPLETED|Period 2: Part 2||0
2977311|NCT00830869|3692559|FG008|COMPLETED|Period 2: Part 2||0
2977312|NCT00830869|3692560|FG009|COMPLETED|Period 2: Part 2||0
2977313|NCT00830869|3692561|FG010|COMPLETED|Period 2: Part 2||0
2977314|NCT00830869|3692562|FG011|COMPLETED|Period 2: Part 2||0
2977315|NCT00830869|3692551|FG000|NOT COMPLETED|Period 2: Part 2||0
2977316|NCT00830869|3692552|FG001|NOT COMPLETED|Period 2: Part 2||0
2977317|NCT00830869|3692553|FG002|NOT COMPLETED|Period 2: Part 2||0
2977318|NCT00830869|3692554|FG003|NOT COMPLETED|Period 2: Part 2||0
2977319|NCT00830869|3692555|FG004|NOT COMPLETED|Period 2: Part 2||0
2977320|NCT00830869|3692556|FG005|NOT COMPLETED|Period 2: Part 2||0
2977321|NCT00830869|3692557|FG006|NOT COMPLETED|Period 2: Part 2||0
2977322|NCT00830869|3692558|FG007|NOT COMPLETED|Period 2: Part 2||20
2977323|NCT00830869|3692559|FG008|NOT COMPLETED|Period 2: Part 2||22
2977324|NCT00830869|3692560|FG009|NOT COMPLETED|Period 2: Part 2||20
2977325|NCT00830869|3692561|FG010|NOT COMPLETED|Period 2: Part 2||11
2977326|NCT00830869|3692562|FG011|NOT COMPLETED|Period 2: Part 2||20
2977327|NCT00830947|3692591|FG000|STARTED|Overall Study||23
2977328|NCT00830947|3692592|FG001|STARTED|Overall Study||22
2977329|NCT00830947|3692591|FG000|COMPLETED|Overall Study||19
2977330|NCT00830947|3692592|FG001|COMPLETED|Overall Study||18
2977331|NCT00830947|3692591|FG000|NOT COMPLETED|Overall Study||4
2977332|NCT00830947|3692592|FG001|NOT COMPLETED|Overall Study||4
2977333|NCT00830960|3692604|FG000|STARTED|Overall Study|"Number of participants STARTED equals the number of participants randomized."|124
2977334|NCT00830960|3692605|FG001|STARTED|Overall Study||124
2977335|NCT00830960|3692606|FG002|STARTED|Overall Study||137
2977336|NCT00830960|3692607|FG003|STARTED|Overall Study||138
2977337|NCT00830960|3692608|FG004|STARTED|Overall Study||96
2977338|NCT00830960|3692609|FG005|STARTED|Overall Study|Total 720 participants were randomized; 1 was not included in a cohort as baseline weight missing.|100
2977339|NCT00830960|3692604|FG000|Received at Least 1 Dose of Study Drug|Overall Study|Baseline Characteristics (below) include those who received ≥1 dose study drug, not all who STARTED.|117
2977340|NCT00830960|3692605|FG001|Received at Least 1 Dose of Study Drug|Overall Study||122
2977341|NCT00830960|3692606|FG002|Received at Least 1 Dose of Study Drug|Overall Study||133
2977342|NCT00830960|3692607|FG003|Received at Least 1 Dose of Study Drug|Overall Study||135
2977343|NCT00830960|3692608|FG004|Received at Least 1 Dose of Study Drug|Overall Study||91
2977344|NCT00830960|3692609|FG005|Received at Least 1 Dose of Study Drug|Overall Study||93
2977345|NCT00830960|3692604|FG000|COMPLETED|Overall Study||91
2977346|NCT00830960|3692605|FG001|COMPLETED|Overall Study||96
2977347|NCT00830960|3692606|FG002|COMPLETED|Overall Study||108
2977348|NCT00830960|3692607|FG003|COMPLETED|Overall Study||106
2977349|NCT00830960|3692608|FG004|COMPLETED|Overall Study|6 participants not completed due to death; 1 additional death occurred after study discontinuation.|64
2977350|NCT00830960|3692609|FG005|COMPLETED|Overall Study||63
2977351|NCT00830960|3692604|FG000|NOT COMPLETED|Overall Study||33
2977352|NCT00830960|3692605|FG001|NOT COMPLETED|Overall Study||28
2977353|NCT00830960|3692606|FG002|NOT COMPLETED|Overall Study||29
2977354|NCT00830960|3692607|FG003|NOT COMPLETED|Overall Study||32
2977355|NCT00830960|3692608|FG004|NOT COMPLETED|Overall Study||32
2977356|NCT00830960|3692609|FG005|NOT COMPLETED|Overall Study||37
2977357|NCT00831129|3692648|FG000|STARTED|Overall Study||20
2977358|NCT00831129|3692649|FG001|STARTED|Overall Study||33
2977359|NCT00831129|3692648|FG000|COMPLETED|Overall Study||20
2977360|NCT00831129|3692649|FG001|COMPLETED|Overall Study||23
2977361|NCT00831129|3692648|FG000|NOT COMPLETED|Overall Study||0
2977362|NCT00831129|3692649|FG001|NOT COMPLETED|Overall Study||10
2977363|NCT00831181|3692655|FG000|STARTED|Overall Study||27
2977364|NCT00831181|3692655|FG000|COMPLETED|Overall Study||15
2977365|NCT00831181|3692655|FG000|NOT COMPLETED|Overall Study||12
2977366|NCT00831233|3692662|FG000|STARTED|Overall Study|Intention-to-treat (ITT) population.|29
2977367|NCT00831233|3692663|FG001|STARTED|Overall Study|ITT population.|13
2977368|NCT00831233|3692662|FG000|Full Analysis Set (FAS)|Overall Study|2 participants were randomised but never treated.|27
2977369|NCT00831233|3692663|FG001|Full Analysis Set (FAS)|Overall Study||13
2977370|NCT00831233|3692662|FG000|Per Protocol (PP) Analysis Set|Overall Study||26
2977371|NCT00831233|3692663|FG001|Per Protocol (PP) Analysis Set|Overall Study||11
2977372|NCT00831233|3692662|FG000|COMPLETED|Overall Study||26
2977373|NCT00831233|3692663|FG001|COMPLETED|Overall Study||12
2977374|NCT00831233|3692662|FG000|NOT COMPLETED|Overall Study||3
2977375|NCT00831233|3692663|FG001|NOT COMPLETED|Overall Study||1
2977376|NCT00831272|3692673|FG000|STARTED|Overall Study||38
2977377|NCT00831272|3692674|FG001|STARTED|Overall Study||44
2977378|NCT00831272|3692675|FG002|STARTED|Overall Study||73
2977379|NCT00831272|3692676|FG003|STARTED|Overall Study||66
2977380|NCT00831272|3692673|FG000|COMPLETED|Overall Study||30
2977381|NCT00831272|3692674|FG001|COMPLETED|Overall Study||37
2977382|NCT00831272|3692675|FG002|COMPLETED|Overall Study||63
2977383|NCT00831272|3692676|FG003|COMPLETED|Overall Study||56
2977384|NCT00831272|3692673|FG000|NOT COMPLETED|Overall Study||8
2977385|NCT00831272|3692674|FG001|NOT COMPLETED|Overall Study||7
2977386|NCT00831272|3692675|FG002|NOT COMPLETED|Overall Study||10
2977387|NCT00831272|3692676|FG003|NOT COMPLETED|Overall Study||10
2977388|NCT00831311|3692688|FG000|STARTED|Overall Study||312
2977389|NCT00831311|3692689|FG001|STARTED|Overall Study||312
2977390|NCT00831311|3692688|FG000|COMPLETED|Overall Study||300
2977391|NCT00831311|3692689|FG001|COMPLETED|Overall Study||304
2977392|NCT00831311|3692688|FG000|NOT COMPLETED|Overall Study||12
2977393|NCT00831311|3692689|FG001|NOT COMPLETED|Overall Study||8
2977394|NCT00831389|3692698|FG000|STARTED|Overall Study||6
2977395|NCT00831389|3692699|FG001|STARTED|Overall Study||7
2977396|NCT00831389|3692698|FG000|COMPLETED|Overall Study||6
2977397|NCT00831389|3692699|FG001|COMPLETED|Overall Study||6
2977398|NCT00831389|3692698|FG000|NOT COMPLETED|Overall Study||0
2977399|NCT00831389|3692699|FG001|NOT COMPLETED|Overall Study||1
2977400|NCT00831415|3692705|FG000|STARTED|Overall Study||304
2977401|NCT00831415|3692705|FG000|"Completers for Exposure"|Overall Study|Participants with ≥ 301 days of exposure to study drug and completed study day 308 evaluations.|227
2977402|NCT00831415|3692705|FG000|"Study Completers"|Overall Study|"Defined as participants whose conclusion of study participation status was study completed."|227
2977403|NCT00831415|3692705|FG000|COMPLETED|Overall Study|In addition to Completers for Study includes 2 participants who discontinued after on-therapy period|229
2977404|NCT00831415|3692705|FG000|NOT COMPLETED|Overall Study||75
2977405|NCT00831428|3692709|FG000|STARTED|Overall Study||97
2977406|NCT00831428|3692709|FG000|COMPLETED|Overall Study||97
2977407|NCT00831428|3692709|FG000|NOT COMPLETED|Overall Study||0
2977408|NCT00831441|3692715|FG000|STARTED|Randomized||3687
2977409|NCT00831441|3692716|FG001|STARTED|Randomized||3705
2977410|NCT00831441|3692715|FG000|Treated|Randomized||3643
2977411|NCT00831441|3692716|FG001|Treated|Randomized||3672
2977412|NCT00831441|3692715|FG000|COMPLETED|Randomized||0
2977413|NCT00831441|3692716|FG001|COMPLETED|Randomized||0
2977414|NCT00831441|3692715|FG000|NOT COMPLETED|Randomized||3687
2977415|NCT00831441|3692716|FG001|NOT COMPLETED|Randomized||3705
2977416|NCT00831441|3692715|FG000|STARTED|Follow Up (30 Days)|3508 participants entered the follow up period.|3508
2977417|NCT00831441|3692716|FG001|STARTED|Follow Up (30 Days)|3529 participants entered the follow up period.|3529
2977418|NCT00831441|3692715|FG000|COMPLETED|Follow Up (30 Days)||3375
2977419|NCT00831441|3692716|FG001|COMPLETED|Follow Up (30 Days)||3355
2977420|NCT00831441|3692715|FG000|NOT COMPLETED|Follow Up (30 Days)||133
2977421|NCT00831441|3692716|FG001|NOT COMPLETED|Follow Up (30 Days)||174
2977422|NCT00831480|3692723|FG000|STARTED|Overall Study||9
2977423|NCT00831480|3692723|FG000|COMPLETED|Overall Study||7
2977424|NCT00831480|3692723|FG000|NOT COMPLETED|Overall Study||2
2977425|NCT00831493|3692727|FG000|STARTED|Overall Study||3
2977426|NCT00831493|3692727|FG000|COMPLETED|Overall Study||2
2977427|NCT00831493|3692727|FG000|NOT COMPLETED|Overall Study||1
2977428|NCT00831675|3692733|FG000|STARTED|Overall Study||12
2977429|NCT00831675|3692734|FG001|STARTED|Overall Study||18
2977430|NCT00831675|3692733|FG000|COMPLETED|Overall Study||12
2977431|NCT00831675|3692734|FG001|COMPLETED|Overall Study||18
2977432|NCT00831675|3692733|FG000|NOT COMPLETED|Overall Study||0
2977433|NCT00831675|3692734|FG001|NOT COMPLETED|Overall Study||0
2977434|NCT00831701|3692742|FG000|STARTED|Overall Study||50
2977435|NCT00831701|3692743|FG001|STARTED|Overall Study||50
2977436|NCT00831701|3692742|FG000|COMPLETED|Overall Study||45
2977437|NCT00831701|3692743|FG001|COMPLETED|Overall Study||45
2977438|NCT00831701|3692742|FG000|NOT COMPLETED|Overall Study||5
2977439|NCT00831701|3692743|FG001|NOT COMPLETED|Overall Study||5
2977440|NCT00831753|3692751|FG000|STARTED|Overall Study||132
2977441|NCT00831753|3692752|FG001|STARTED|Overall Study||131
2977442|NCT00831753|3692751|FG000|COMPLETED|Overall Study||132
2977443|NCT00831753|3692752|FG001|COMPLETED|Overall Study||131
2977444|NCT00831753|3692751|FG000|NOT COMPLETED|Overall Study||0
2977445|NCT00831753|3692752|FG001|NOT COMPLETED|Overall Study||0
2977446|NCT00831766|3692760|FG000|STARTED|Overall Study||23
2977447|NCT00831766|3692761|FG001|STARTED|Overall Study||28
2977448|NCT00831766|3692760|FG000|COMPLETED|Overall Study||23
2977449|NCT00831766|3692761|FG001|COMPLETED|Overall Study||28
2977450|NCT00831766|3692760|FG000|NOT COMPLETED|Overall Study||0
2977451|NCT00831766|3692761|FG001|NOT COMPLETED|Overall Study||0
2977452|NCT00831779|3692770|FG000|STARTED|Overall Study||21
2977453|NCT00831779|3692771|FG001|STARTED|Overall Study||23
2977454|NCT00831779|3692770|FG000|COMPLETED|Overall Study||20
2977455|NCT00831779|3692771|FG001|COMPLETED|Overall Study||22
2977456|NCT00831779|3692770|FG000|NOT COMPLETED|Overall Study||1
2977457|NCT00831779|3692771|FG001|NOT COMPLETED|Overall Study||1
2977458|NCT00831792|3692777|FG000|STARTED|Overall Study||46
2977459|NCT00831792|3692777|FG000|COMPLETED|Overall Study||40
2977460|NCT00831792|3692777|FG000|NOT COMPLETED|Overall Study||6
2977461|NCT00831844|3692791|FG000|STARTED|Overall Study||10
2977462|NCT00831844|3692792|FG001|STARTED|Overall Study||12
2977463|NCT00831844|3692793|FG002|STARTED|Overall Study||21
2977464|NCT00831844|3692794|FG003|STARTED|Overall Study||10
2977465|NCT00831844|3692795|FG004|STARTED|Overall Study||14
2977466|NCT00831844|3692796|FG005|STARTED|Overall Study||20
2977467|NCT00831844|3692797|FG006|STARTED|Overall Study||10
2977468|NCT00831844|3692798|FG007|STARTED|Overall Study||10
2977469|NCT00831844|3692799|FG008|STARTED|Overall Study||9
2977470|NCT00831844|3692800|FG009|STARTED|Overall Study||0
2977471|NCT00831844|3692791|FG000|COMPLETED|Overall Study||0
2977472|NCT00831844|3692792|FG001|COMPLETED|Overall Study||0
2977473|NCT00831844|3692793|FG002|COMPLETED|Overall Study||1
2977474|NCT00831844|3692794|FG003|COMPLETED|Overall Study||0
2977475|NCT00831844|3692795|FG004|COMPLETED|Overall Study||0
2977476|NCT00831844|3692796|FG005|COMPLETED|Overall Study||1
2977477|NCT00831844|3692797|FG006|COMPLETED|Overall Study||0
2977478|NCT00831844|3692798|FG007|COMPLETED|Overall Study||0
2977479|NCT00831844|3692799|FG008|COMPLETED|Overall Study||0
2977480|NCT00831844|3692800|FG009|COMPLETED|Overall Study||0
2977481|NCT00831844|3692791|FG000|NOT COMPLETED|Overall Study||10
2977482|NCT00831844|3692792|FG001|NOT COMPLETED|Overall Study||12
2977483|NCT00831844|3692793|FG002|NOT COMPLETED|Overall Study||20
2977484|NCT00831844|3692794|FG003|NOT COMPLETED|Overall Study||10
2977485|NCT00831844|3692795|FG004|NOT COMPLETED|Overall Study||14
2977486|NCT00831844|3692796|FG005|NOT COMPLETED|Overall Study||19
2977487|NCT00831844|3692797|FG006|NOT COMPLETED|Overall Study||10
2977488|NCT00831844|3692798|FG007|NOT COMPLETED|Overall Study||10
2977489|NCT00831844|3692799|FG008|NOT COMPLETED|Overall Study||9
2977490|NCT00831844|3692800|FG009|NOT COMPLETED|Overall Study||0
2977491|NCT00831987|3692824|FG000|STARTED|Overall Study||60
2977492|NCT00831987|3692825|FG001|STARTED|Overall Study||60
2977493|NCT00831987|3692824|FG000|COMPLETED|Overall Study||60
2977494|NCT00831987|3692825|FG001|COMPLETED|Overall Study||60
2977495|NCT00831987|3692824|FG000|NOT COMPLETED|Overall Study||0
2977496|NCT00831987|3692825|FG001|NOT COMPLETED|Overall Study||0
2977497|NCT00832000|3692831|FG000|STARTED|Overall Study|Mexiletine 200 mg orally three times daily|29
2977498|NCT00832000|3692832|FG001|STARTED|Overall Study|Placebo|30
2977499|NCT00832000|3692831|FG000|Crossed Over to Opposite Intervention|Overall Study|Placebo|25
2977500|NCT00832000|3692832|FG001|Crossed Over to Opposite Intervention|Overall Study|Mexiletine 200 mg orally three times daily|29
2977501|NCT00832000|3692831|FG000|COMPLETED|Overall Study||23
2977502|NCT00832000|3692832|FG001|COMPLETED|Overall Study||29
2977503|NCT00832000|3692831|FG000|NOT COMPLETED|Overall Study||6
2977504|NCT00832000|3692832|FG001|NOT COMPLETED|Overall Study||1
2977505|NCT00832078|3692867|FG000|STARTED|Test Day 1- 1 Period||13
2977506|NCT00832078|3692868|FG001|STARTED|Test Day 1- 1 Period||12
2977507|NCT00832078|3692867|FG000|COMPLETED|Test Day 1- 1 Period||13
2977508|NCT00832078|3692868|FG001|COMPLETED|Test Day 1- 1 Period||12
2977509|NCT00832078|3692867|FG000|NOT COMPLETED|Test Day 1- 1 Period||0
2977510|NCT00832078|3692868|FG001|NOT COMPLETED|Test Day 1- 1 Period||0
2977511|NCT00832078|3692867|FG000|STARTED|Test Day 1-2 Period||13
2977512|NCT00832078|3692868|FG001|STARTED|Test Day 1-2 Period||12
2977513|NCT00832078|3692867|FG000|COMPLETED|Test Day 1-2 Period||13
3164199|NCT01891669|3891648|FG008|COMPLETED|Overall Study||2
3164200|NCT01891669|3891649|FG009|COMPLETED|Overall Study||1
3164201|NCT01891669|3891640|FG000|NOT COMPLETED|Overall Study||2
3164202|NCT01891669|3891641|FG001|NOT COMPLETED|Overall Study||1
3164203|NCT01891669|3891642|FG002|NOT COMPLETED|Overall Study||0
3164204|NCT01891669|3891643|FG003|NOT COMPLETED|Overall Study||0
3164205|NCT01891669|3891644|FG004|NOT COMPLETED|Overall Study||0
3164206|NCT01891669|3891645|FG005|NOT COMPLETED|Overall Study||0
3164207|NCT01891669|3891646|FG006|NOT COMPLETED|Overall Study||1
3164208|NCT01891669|3891647|FG007|NOT COMPLETED|Overall Study||4
3164209|NCT01891669|3891648|FG008|NOT COMPLETED|Overall Study||1
3164210|NCT01891669|3891649|FG009|NOT COMPLETED|Overall Study||2
3164211|NCT01891721|3891683|FG000|STARTED|Overall Study||39
3164212|NCT01891721|3891684|FG001|STARTED|Overall Study||40
3164213|NCT01891721|3891685|FG002|STARTED|Overall Study||20
3164214|NCT01891721|3891683|FG000|COMPLETED|Overall Study||29
3164215|NCT01891721|3891684|FG001|COMPLETED|Overall Study||35
2977514|NCT00832078|3692868|FG001|COMPLETED|Test Day 1-2 Period||10
2977515|NCT00832078|3692867|FG000|NOT COMPLETED|Test Day 1-2 Period||0
2977516|NCT00832078|3692868|FG001|NOT COMPLETED|Test Day 1-2 Period||2
2977517|NCT00832078|3692867|FG000|STARTED|Test Day 2 - 1 Period||13
2977518|NCT00832078|3692868|FG001|STARTED|Test Day 2 - 1 Period||10
2977519|NCT00832078|3692867|FG000|COMPLETED|Test Day 2 - 1 Period||13
3164216|NCT01891721|3891685|FG002|COMPLETED|Overall Study||19
3164217|NCT01891721|3891683|FG000|NOT COMPLETED|Overall Study||10
3164218|NCT01891721|3891684|FG001|NOT COMPLETED|Overall Study||5
3164219|NCT01891721|3891685|FG002|NOT COMPLETED|Overall Study||1
2977520|NCT00832078|3692868|FG001|COMPLETED|Test Day 2 - 1 Period||10
2977521|NCT00832078|3692867|FG000|NOT COMPLETED|Test Day 2 - 1 Period||0
2977522|NCT00832078|3692868|FG001|NOT COMPLETED|Test Day 2 - 1 Period||0
2977523|NCT00832078|3692867|FG000|STARTED|Test Day 2 - 2 Period||13
2977524|NCT00832078|3692868|FG001|STARTED|Test Day 2 - 2 Period||10
2977525|NCT00832078|3692867|FG000|COMPLETED|Test Day 2 - 2 Period||12
2977526|NCT00832078|3692868|FG001|COMPLETED|Test Day 2 - 2 Period||10
2977527|NCT00832078|3692867|FG000|NOT COMPLETED|Test Day 2 - 2 Period||1
2977528|NCT00832078|3692868|FG001|NOT COMPLETED|Test Day 2 - 2 Period||0
2977529|NCT00832091|3692876|FG000|STARTED|Overall Study||17
2977530|NCT00832091|3692877|FG001|STARTED|Overall Study||55
2977531|NCT00832091|3692876|FG000|COMPLETED|Overall Study||12
2977532|NCT00832091|3692877|FG001|COMPLETED|Overall Study||53
2977533|NCT00832091|3692876|FG000|NOT COMPLETED|Overall Study||5
2977534|NCT00832091|3692877|FG001|NOT COMPLETED|Overall Study||2
2977535|NCT00832117|3692885|FG000|STARTED|Overall Study||29
2977536|NCT00832117|3692885|FG000|COMPLETED|Overall Study||17
2977537|NCT00832117|3692885|FG000|NOT COMPLETED|Overall Study||12
2977538|NCT00832130|3692894|FG000|STARTED|Overall Study||69
2977539|NCT00832130|3692895|FG001|STARTED|Overall Study||70
2977540|NCT00832130|3692894|FG000|COMPLETED|Overall Study||69
2977541|NCT00832130|3692895|FG001|COMPLETED|Overall Study||70
2977542|NCT00832130|3692894|FG000|NOT COMPLETED|Overall Study||0
2977543|NCT00832130|3692895|FG001|NOT COMPLETED|Overall Study||0
2977544|NCT00832260|3692901|FG000|STARTED|Overall Study||70
2977545|NCT00832260|3692901|FG000|COMPLETED|Overall Study||70
2977546|NCT00832260|3692901|FG000|NOT COMPLETED|Overall Study||0
2977547|NCT00832338|3692905|FG000|STARTED|Overall Study||23
2977548|NCT00832338|3692905|FG000|COMPLETED|Overall Study||23
2977549|NCT00832338|3692905|FG000|NOT COMPLETED|Overall Study||0
2977550|NCT00832377|3692909|FG000|STARTED|Overall Study||37
2977551|NCT00832377|3692909|FG000|COMPLETED|Overall Study||36
2977552|NCT00832377|3692909|FG000|NOT COMPLETED|Overall Study||1
2977553|NCT00832390|3692916|FG000|STARTED|Overall Study||12
2977554|NCT00832390|3692917|FG001|STARTED|Overall Study||16
2977555|NCT00832390|3692918|FG002|STARTED|Overall Study||1
2977556|NCT00832390|3692916|FG000|COMPLETED|Overall Study||12
2977557|NCT00832390|3692917|FG001|COMPLETED|Overall Study||16
2977558|NCT00832390|3692918|FG002|COMPLETED|Overall Study||1
2977559|NCT00832390|3692916|FG000|NOT COMPLETED|Overall Study||0
2977560|NCT00832390|3692917|FG001|NOT COMPLETED|Overall Study||0
2977561|NCT00832390|3692918|FG002|NOT COMPLETED|Overall Study||0
2977562|NCT00832416|3692930|FG000|STARTED|Overall Study||110
2977563|NCT00832416|3692931|FG001|STARTED|Overall Study||113
2977564|NCT00832416|3692932|FG002|STARTED|Overall Study||115
2977565|NCT00832416|3692933|FG003|STARTED|Overall Study||227
2977566|NCT00832416|3692930|FG000|COMPLETED|Overall Study||64
2977567|NCT00832416|3692931|FG001|COMPLETED|Overall Study||60
2977568|NCT00832416|3692932|FG002|COMPLETED|Overall Study||54
2977569|NCT00832416|3692933|FG003|COMPLETED|Overall Study||144
2977570|NCT00832416|3692930|FG000|NOT COMPLETED|Overall Study||46
2977571|NCT00832416|3692931|FG001|NOT COMPLETED|Overall Study||53
2977572|NCT00832416|3692932|FG002|NOT COMPLETED|Overall Study||61
2977573|NCT00832416|3692933|FG003|NOT COMPLETED|Overall Study||83
2977574|NCT00832585|3692943|FG000|STARTED|Overall Study|Eight subjects were screened but only 5 started the study and received study drug.|5
2977575|NCT00832585|3692943|FG000|COMPLETED|Overall Study|Only three subjects completed all of the visits for the study as per protocol.|3
2977576|NCT00832585|3692943|FG000|NOT COMPLETED|Overall Study||2
2977577|NCT00832637|3692947|FG000|STARTED|Overall Study||33
2977578|NCT00832637|3692947|FG000|COMPLETED|Overall Study||33
2977579|NCT00832637|3692947|FG000|NOT COMPLETED|Overall Study||0
2977580|NCT00832650|3692954|FG000|STARTED|Overall Study||25
2977581|NCT00832650|3692955|FG001|STARTED|Overall Study||12
2977582|NCT00832650|3692956|FG002|STARTED|Overall Study||23
2977583|NCT00832650|3692954|FG000|Treated|Overall Study||25
2977584|NCT00832650|3692955|FG001|Treated|Overall Study||12
2977585|NCT00832650|3692956|FG002|Treated|Overall Study||22
2977586|NCT00832650|3692954|FG000|COMPLETED|Overall Study||25
2977587|NCT00832650|3692955|FG001|COMPLETED|Overall Study||12
2977588|NCT00832650|3692956|FG002|COMPLETED|Overall Study||22
2977589|NCT00832650|3692954|FG000|NOT COMPLETED|Overall Study||0
2977590|NCT00832650|3692955|FG001|NOT COMPLETED|Overall Study||0
2977591|NCT00832650|3692956|FG002|NOT COMPLETED|Overall Study||1
2977592|NCT00832767|3692966|FG000|STARTED|Overall Study||121
2977593|NCT00832767|3692967|FG001|STARTED|Overall Study||81
2977594|NCT00832767|3692966|FG000|COMPLETED|Overall Study||99
2977595|NCT00832767|3692967|FG001|COMPLETED|Overall Study||63
2977596|NCT00832767|3692966|FG000|NOT COMPLETED|Overall Study||22
2977597|NCT00832767|3692967|FG001|NOT COMPLETED|Overall Study||18
2977598|NCT00832780|3692975|FG000|STARTED|Overall Study||44
2977599|NCT00832780|3692975|FG000|COMPLETED|Overall Study||19
2977600|NCT00832780|3692975|FG000|NOT COMPLETED|Overall Study||25
2977601|NCT00832819|3692982|FG000|STARTED|Overall Study||6
2977602|NCT00832819|3692983|FG001|STARTED|Overall Study||6
2977603|NCT00832819|3692984|FG002|STARTED|Overall Study||16
2977604|NCT00832819|3692982|FG000|COMPLETED|Overall Study||6
2977605|NCT00832819|3692983|FG001|COMPLETED|Overall Study||5
2977606|NCT00832819|3692984|FG002|COMPLETED|Overall Study||15
2977607|NCT00832819|3692982|FG000|NOT COMPLETED|Overall Study||0
2977608|NCT00832819|3692983|FG001|NOT COMPLETED|Overall Study||1
2977609|NCT00832819|3692984|FG002|NOT COMPLETED|Overall Study||1
2977610|NCT00832871|3692990|FG000|STARTED|Overall Study||4
2977611|NCT00832871|3692990|FG000|COMPLETED|Overall Study||4
2977612|NCT00832871|3692990|FG000|NOT COMPLETED|Overall Study||0
2977613|NCT00832975|3692994|FG000|STARTED|Overall Study||157
2977614|NCT00832975|3692994|FG000|COMPLETED|Overall Study||118
2977615|NCT00832975|3692994|FG000|NOT COMPLETED|Overall Study||39
2977616|NCT00833027|3692998|FG000|STARTED|Overall Study||608
2977617|NCT00833027|3692998|FG000|COMPLETED|Overall Study||397
2977618|NCT00833027|3692998|FG000|NOT COMPLETED|Overall Study||211
2977619|NCT00833040|3693002|FG000|STARTED|Overall Study||6
2977620|NCT00833040|3693003|FG001|STARTED|Overall Study||6
2977621|NCT00833040|3693004|FG002|STARTED|Overall Study||6
2977622|NCT00833040|3693005|FG003|STARTED|Overall Study||6
2977623|NCT00833040|3693006|FG004|STARTED|Overall Study||5
2977624|NCT00833040|3693007|FG005|STARTED|Overall Study||5
2977625|NCT00833040|3693002|FG000|COMPLETED|Overall Study||6
2977626|NCT00833040|3693003|FG001|COMPLETED|Overall Study||6
2977627|NCT00833040|3693004|FG002|COMPLETED|Overall Study||6
2977628|NCT00833040|3693005|FG003|COMPLETED|Overall Study||6
2977629|NCT00833040|3693006|FG004|COMPLETED|Overall Study||5
2977630|NCT00833040|3693007|FG005|COMPLETED|Overall Study||4
2977631|NCT00833040|3693002|FG000|NOT COMPLETED|Overall Study||0
2977632|NCT00833040|3693003|FG001|NOT COMPLETED|Overall Study||0
2977633|NCT00833040|3693004|FG002|NOT COMPLETED|Overall Study||0
2977634|NCT00833040|3693005|FG003|NOT COMPLETED|Overall Study||0
2977635|NCT00833040|3693006|FG004|NOT COMPLETED|Overall Study||0
2977636|NCT00833040|3693007|FG005|NOT COMPLETED|Overall Study||1
2977637|NCT00833053|3693014|FG000|STARTED|Overall Study||19
2977638|NCT00833053|3693015|FG001|STARTED|Overall Study||20
2977639|NCT00833053|3693014|FG000|COMPLETED|Overall Study||10
2977640|NCT00833053|3693015|FG001|COMPLETED|Overall Study||17
2977641|NCT00833053|3693014|FG000|NOT COMPLETED|Overall Study||9
2977642|NCT00833053|3693015|FG001|NOT COMPLETED|Overall Study||3
2977643|NCT00833092|3693023|FG000|STARTED|Overall Study||54
2977644|NCT00833092|3693024|FG001|STARTED|Overall Study||57
2977645|NCT00833092|3693023|FG000|COMPLETED|Overall Study||50
2977646|NCT00833092|3693024|FG001|COMPLETED|Overall Study||50
2977647|NCT00833092|3693023|FG000|NOT COMPLETED|Overall Study||4
2977648|NCT00833092|3693024|FG001|NOT COMPLETED|Overall Study||7
2977649|NCT00833105|3693030|FG000|STARTED|Overall Study||13
2977650|NCT00833105|3693030|FG000|COMPLETED|Overall Study||10
2977651|NCT00833105|3693030|FG000|NOT COMPLETED|Overall Study||3
2977652|NCT00833248|3693038|FG000|STARTED|Overall Study||181
2977653|NCT00833248|3693039|FG001|STARTED|Overall Study||65
2977654|NCT00833248|3693038|FG000|Full Analysis Set (FAS)|Overall Study||180
2977655|NCT00833248|3693039|FG001|Full Analysis Set (FAS)|Overall Study||64
2977656|NCT00833248|3693038|FG000|Per Protocol (PP) Analysis Set|Overall Study||164
2977657|NCT00833248|3693039|FG001|Per Protocol (PP) Analysis Set|Overall Study||57
2977658|NCT00833248|3693038|FG000|Safety Analysis Set|Overall Study||181
2977659|NCT00833248|3693039|FG001|Safety Analysis Set|Overall Study||64
2977660|NCT00833248|3693038|FG000|COMPLETED|Overall Study||177
2977661|NCT00833248|3693039|FG001|COMPLETED|Overall Study||62
2977662|NCT00833248|3693038|FG000|NOT COMPLETED|Overall Study||4
2977663|NCT00833248|3693039|FG001|NOT COMPLETED|Overall Study||3
2977664|NCT00833261|3693045|FG000|STARTED|Overall Study||37
2977665|NCT00833261|3693045|FG000|COMPLETED|Overall Study|3 patients withdrew from the study prior to treatment & 1 receiving it did not complete the course.|33
2977666|NCT00833261|3693045|FG000|NOT COMPLETED|Overall Study||4
2977667|NCT00833365|3693051|FG000|STARTED|Overall Study||9
2977668|NCT00833365|3693052|FG001|STARTED|Overall Study||6
2977669|NCT00833365|3693051|FG000|COMPLETED|Overall Study||9
2977670|NCT00833365|3693052|FG001|COMPLETED|Overall Study||6
2977671|NCT00833365|3693051|FG000|NOT COMPLETED|Overall Study||0
2977672|NCT00833365|3693052|FG001|NOT COMPLETED|Overall Study||0
2977673|NCT00833417|3693060|FG000|STARTED|Overall Study||33
2977674|NCT00833417|3693061|FG001|STARTED|Overall Study||71
2977675|NCT00833417|3693060|FG000|COMPLETED|Overall Study||0
2977676|NCT00833417|3693061|FG001|COMPLETED|Overall Study||0
2977677|NCT00833417|3693060|FG000|NOT COMPLETED|Overall Study||33
2977678|NCT00833417|3693061|FG001|NOT COMPLETED|Overall Study||71
2977679|NCT00833443|3693070|FG000|STARTED|Overall Study||41
2977680|NCT00833443|3693071|FG001|STARTED|Overall Study||43
2977681|NCT00833443|3693070|FG000|COMPLETED|Overall Study||21
2977682|NCT00833443|3693071|FG001|COMPLETED|Overall Study||15
2977683|NCT00833443|3693070|FG000|NOT COMPLETED|Overall Study||20
2977684|NCT00833443|3693071|FG001|NOT COMPLETED|Overall Study||28
2977685|NCT00833469|3693079|FG000|STARTED|Overall Study||5
2977686|NCT00833469|3693079|FG000|COMPLETED|Overall Study||3
2977687|NCT00833469|3693079|FG000|NOT COMPLETED|Overall Study||2
2977688|NCT00833482|3693085|FG000|STARTED|Days 1-3|Participants who received treatment|24
2977689|NCT00833482|3693086|FG001|STARTED|Days 1-3|Participants who received treatment|0
2977690|NCT00833482|3693087|FG002|STARTED|Days 1-3||0
2977691|NCT00833482|3693088|FG003|STARTED|Days 1-3||8
2977692|NCT00833482|3693089|FG004|STARTED|Days 1-3||0
2977693|NCT00833482|3693090|FG005|STARTED|Days 1-3||0
2977694|NCT00833482|3693085|FG000|COMPLETED|Days 1-3||24
2977695|NCT00833482|3693086|FG001|COMPLETED|Days 1-3||0
2977696|NCT00833482|3693087|FG002|COMPLETED|Days 1-3||0
2977697|NCT00833482|3693088|FG003|COMPLETED|Days 1-3||8
2977698|NCT00833482|3693089|FG004|COMPLETED|Days 1-3||0
2977699|NCT00833482|3693090|FG005|COMPLETED|Days 1-3||0
2977700|NCT00833482|3693085|FG000|NOT COMPLETED|Days 1-3||0
2977701|NCT00833482|3693086|FG001|NOT COMPLETED|Days 1-3||0
2977702|NCT00833482|3693087|FG002|NOT COMPLETED|Days 1-3||0
2977703|NCT00833482|3693088|FG003|NOT COMPLETED|Days 1-3||0
2977704|NCT00833482|3693089|FG004|NOT COMPLETED|Days 1-3||0
2977705|NCT00833482|3693090|FG005|NOT COMPLETED|Days 1-3||0
2977706|NCT00833482|3693085|FG000|STARTED|Days 11-20||0
2977707|NCT00833482|3693086|FG001|STARTED|Days 11-20|Participants who received treatment.|24
2977708|NCT00833482|3693087|FG002|STARTED|Days 11-20||0
2977709|NCT00833482|3693088|FG003|STARTED|Days 11-20||0
2977710|NCT00833482|3693089|FG004|STARTED|Days 11-20||0
2977711|NCT00833482|3693090|FG005|STARTED|Days 11-20|Participants who received treatment.|8
2977712|NCT00833482|3693085|FG000|COMPLETED|Days 11-20||0
2977713|NCT00833482|3693086|FG001|COMPLETED|Days 11-20||21
2977714|NCT00833482|3693087|FG002|COMPLETED|Days 11-20||0
2977715|NCT00833482|3693088|FG003|COMPLETED|Days 11-20||0
2977716|NCT00833482|3693089|FG004|COMPLETED|Days 11-20||0
2977717|NCT00833482|3693090|FG005|COMPLETED|Days 11-20||8
2977718|NCT00833482|3693085|FG000|NOT COMPLETED|Days 11-20||0
2977719|NCT00833482|3693086|FG001|NOT COMPLETED|Days 11-20||3
2977720|NCT00833482|3693087|FG002|NOT COMPLETED|Days 11-20||0
2977721|NCT00833482|3693088|FG003|NOT COMPLETED|Days 11-20||0
2977722|NCT00833482|3693089|FG004|NOT COMPLETED|Days 11-20||0
2977723|NCT00833482|3693090|FG005|NOT COMPLETED|Days 11-20||0
2977724|NCT00833482|3693085|FG000|STARTED|Days 21-30||0
2977725|NCT00833482|3693086|FG001|STARTED|Days 21-30||0
2977726|NCT00833482|3693087|FG002|STARTED|Days 21-30||21
2977727|NCT00833482|3693088|FG003|STARTED|Days 21-30||0
2977728|NCT00833482|3693089|FG004|STARTED|Days 21-30||8
2977729|NCT00833482|3693090|FG005|STARTED|Days 21-30||0
2977730|NCT00833482|3693085|FG000|COMPLETED|Days 21-30||0
2977731|NCT00833482|3693086|FG001|COMPLETED|Days 21-30||0
2977732|NCT00833482|3693087|FG002|COMPLETED|Days 21-30||20
2977733|NCT00833482|3693088|FG003|COMPLETED|Days 21-30||0
2977734|NCT00833482|3693089|FG004|COMPLETED|Days 21-30||7
2977735|NCT00833482|3693090|FG005|COMPLETED|Days 21-30||0
2977736|NCT00833482|3693085|FG000|NOT COMPLETED|Days 21-30||0
2977737|NCT00833482|3693086|FG001|NOT COMPLETED|Days 21-30||0
2977738|NCT00833482|3693087|FG002|NOT COMPLETED|Days 21-30||1
2977739|NCT00833482|3693088|FG003|NOT COMPLETED|Days 21-30||0
2977740|NCT00833482|3693089|FG004|NOT COMPLETED|Days 21-30||1
2977741|NCT00833482|3693090|FG005|NOT COMPLETED|Days 21-30||0
2977742|NCT00833547|3693114|FG000|STARTED|Overall Study||13
2977743|NCT00833547|3693115|FG001|STARTED|Overall Study||12
2977744|NCT00833547|3693114|FG000|COMPLETED|Overall Study||11
2977745|NCT00833547|3693115|FG001|COMPLETED|Overall Study||10
2977746|NCT00833547|3693114|FG000|NOT COMPLETED|Overall Study||2
2977747|NCT00833547|3693115|FG001|NOT COMPLETED|Overall Study||2
2977748|NCT00833560|3693121|FG000|STARTED|Overall Study||395
2977749|NCT00833560|3693121|FG000|COMPLETED|Overall Study||353
2977750|NCT00833560|3693121|FG000|NOT COMPLETED|Overall Study||42
2977751|NCT00833638|3693128|FG000|STARTED|Phase 2: Double-blind Treatment Phase||121
2977752|NCT00833638|3693129|FG001|STARTED|Phase 2: Double-blind Treatment Phase||118
2977753|NCT00833638|3693130|FG002|STARTED|Phase 2: Double-blind Treatment Phase||133
2977754|NCT00833638|3693128|FG000|COMPLETED|Phase 2: Double-blind Treatment Phase||111
2977755|NCT00833638|3693129|FG001|COMPLETED|Phase 2: Double-blind Treatment Phase||108
2977756|NCT00833638|3693130|FG002|COMPLETED|Phase 2: Double-blind Treatment Phase||124
2977757|NCT00833638|3693128|FG000|NOT COMPLETED|Phase 2: Double-blind Treatment Phase||10
2977758|NCT00833638|3693129|FG001|NOT COMPLETED|Phase 2: Double-blind Treatment Phase||10
2977759|NCT00833638|3693130|FG002|NOT COMPLETED|Phase 2: Double-blind Treatment Phase||9
2977760|NCT00833638|3693128|FG000|STARTED|Phase 3: Open-label Extension Phase||111
2977761|NCT00833638|3693129|FG001|STARTED|Phase 3: Open-label Extension Phase||108
2977762|NCT00833638|3693130|FG002|STARTED|Phase 3: Open-label Extension Phase||124
2977763|NCT00833638|3693128|FG000|COMPLETED|Phase 3: Open-label Extension Phase||110
2977764|NCT00833638|3693129|FG001|COMPLETED|Phase 3: Open-label Extension Phase||105
2977765|NCT00833638|3693130|FG002|COMPLETED|Phase 3: Open-label Extension Phase||122
2977766|NCT00833638|3693128|FG000|NOT COMPLETED|Phase 3: Open-label Extension Phase||1
2977767|NCT00833638|3693129|FG001|NOT COMPLETED|Phase 3: Open-label Extension Phase||3
2977768|NCT00833638|3693130|FG002|NOT COMPLETED|Phase 3: Open-label Extension Phase||2
2977769|NCT00833690|3693149|FG000|STARTED|Overall Study||25
2977770|NCT00833690|3693150|FG001|STARTED|Overall Study||24
2977771|NCT00833690|3693151|FG002|STARTED|Overall Study||26
2977772|NCT00833690|3693149|FG000|COMPLETED|Overall Study||21
2977773|NCT00833690|3693150|FG001|COMPLETED|Overall Study||22
2977774|NCT00833690|3693151|FG002|COMPLETED|Overall Study||26
2977775|NCT00833690|3693149|FG000|NOT COMPLETED|Overall Study||4
2977776|NCT00833690|3693150|FG001|NOT COMPLETED|Overall Study||2
2977777|NCT00833690|3693151|FG002|NOT COMPLETED|Overall Study||0
2977778|NCT00833703|3693161|FG000|STARTED|Overall Study|Included|23
2977779|NCT00833703|3693162|FG001|STARTED|Overall Study|Included|26
2977780|NCT00833703|3693161|FG000|Treated|Overall Study||23
2977781|NCT00833703|3693162|FG001|Treated|Overall Study||26
3133302|NCT01695239|3858316|FG011|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
3133303|NCT01695239|3858317|FG012|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
3133304|NCT01695239|3858318|FG013|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
3133305|NCT01695239|3858305|FG000|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
3133306|NCT01695239|3858306|FG001|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
2977782|NCT00833703|3693161|FG000|Completed Treatment|Overall Study||22
2977783|NCT00833703|3693162|FG001|Completed Treatment|Overall Study||24
2977784|NCT00833703|3693161|FG000|COMPLETED|Overall Study|Completed follow-up|23
2977785|NCT00833703|3693162|FG001|COMPLETED|Overall Study|Completed follow-up|25
2977786|NCT00833703|3693161|FG000|NOT COMPLETED|Overall Study||0
2977787|NCT00833703|3693162|FG001|NOT COMPLETED|Overall Study||1
2977788|NCT00833755|3693172|FG000|STARTED|Overall Study||16
2977789|NCT00833755|3693173|FG001|STARTED|Overall Study||18
2977790|NCT00833755|3693174|FG002|STARTED|Overall Study||22
2977791|NCT00833755|3693175|FG003|STARTED|Overall Study||23
2977792|NCT00833755|3693172|FG000|COMPLETED|Overall Study||12
2977793|NCT00833755|3693173|FG001|COMPLETED|Overall Study||13
2977794|NCT00833755|3693174|FG002|COMPLETED|Overall Study||20
2977795|NCT00833755|3693175|FG003|COMPLETED|Overall Study||17
2977796|NCT00833755|3693172|FG000|NOT COMPLETED|Overall Study||4
2977797|NCT00833755|3693173|FG001|NOT COMPLETED|Overall Study||5
2977798|NCT00833755|3693174|FG002|NOT COMPLETED|Overall Study||2
2977799|NCT00833755|3693175|FG003|NOT COMPLETED|Overall Study||6
2977800|NCT00833781|3693188|FG000|STARTED|Overall Study||10
2977801|NCT00833781|3693189|FG001|STARTED|Overall Study||5
2977802|NCT00833781|3693188|FG000|COMPLETED|Overall Study||10
2977803|NCT00833781|3693189|FG001|COMPLETED|Overall Study||5
2977804|NCT00833781|3693188|FG000|NOT COMPLETED|Overall Study||0
2977805|NCT00833781|3693189|FG001|NOT COMPLETED|Overall Study||0
2977806|NCT00833794|3693196|FG000|STARTED|Open-label Phase|Enrolled. Population described in the baseline characteristics is 1023 patients (Open-Label safety).|1028
2977807|NCT00833794|3693197|FG001|STARTED|Open-label Phase|No Placebo arm during open-label phase.|0
2977808|NCT00833794|3693196|FG000|Entered run-in Period|Open-label Phase||1027
2977809|NCT00833794|3693197|FG001|Entered run-in Period|Open-label Phase||0
2977810|NCT00833794|3693196|FG000|Received Open-Label Treatment|Open-label Phase||1023
2977811|NCT00833794|3693197|FG001|Received Open-Label Treatment|Open-label Phase||0
2977812|NCT00833794|3693196|FG000|COMPLETED|Open-label Phase|Randomized in double-blind phase|646
2977813|NCT00833794|3693197|FG001|COMPLETED|Open-label Phase||0
2977814|NCT00833794|3693196|FG000|NOT COMPLETED|Open-label Phase||382
2977815|NCT00833794|3693197|FG001|NOT COMPLETED|Open-label Phase||0
2977816|NCT00833794|3693196|FG000|STARTED|Double-blind Phase|Of the 646 patients who completed the Open-Label phase, 432 were randomized to Tramadol Once A Day|432
2977817|NCT00833794|3693197|FG001|STARTED|Double-blind Phase|Of the 646 patients who completed the Open-Label phase, 214 were randomized to Placebo|214
2977818|NCT00833794|3693196|FG000|COMPLETED|Double-blind Phase||326
2977819|NCT00833794|3693197|FG001|COMPLETED|Double-blind Phase||165
2977820|NCT00833794|3693196|FG000|NOT COMPLETED|Double-blind Phase||106
2977821|NCT00833794|3693197|FG001|NOT COMPLETED|Double-blind Phase||49
2977822|NCT00833833|3693211|FG000|STARTED|Phase 1 (as of 01 April 2011)||6
2977823|NCT00833833|3693212|FG001|STARTED|Phase 1 (as of 01 April 2011)||8
2977824|NCT00833833|3693213|FG002|STARTED|Phase 1 (as of 01 April 2011)||14
2977825|NCT00833833|3693214|FG003|STARTED|Phase 1 (as of 01 April 2011)||10
2977826|NCT00833833|3693215|FG004|STARTED|Phase 1 (as of 01 April 2011)||0
2977827|NCT00833833|3693216|FG005|STARTED|Phase 1 (as of 01 April 2011)||0
2977828|NCT00833833|3693211|FG000|COMPLETED|Phase 1 (as of 01 April 2011)|Confirmed progressive disease|2
2977829|NCT00833833|3693212|FG001|COMPLETED|Phase 1 (as of 01 April 2011)|Confirmed progressive disease|3
2977830|NCT00833833|3693213|FG002|COMPLETED|Phase 1 (as of 01 April 2011)|Confirmed progressive disease|5
2977831|NCT00833833|3693214|FG003|COMPLETED|Phase 1 (as of 01 April 2011)|Confirmed progressive disease|4
2977832|NCT00833833|3693215|FG004|COMPLETED|Phase 1 (as of 01 April 2011)||0
2977833|NCT00833833|3693216|FG005|COMPLETED|Phase 1 (as of 01 April 2011)||0
2977834|NCT00833833|3693211|FG000|NOT COMPLETED|Phase 1 (as of 01 April 2011)||4
2977835|NCT00833833|3693212|FG001|NOT COMPLETED|Phase 1 (as of 01 April 2011)||5
2977836|NCT00833833|3693213|FG002|NOT COMPLETED|Phase 1 (as of 01 April 2011)||9
2977837|NCT00833833|3693214|FG003|NOT COMPLETED|Phase 1 (as of 01 April 2011)||6
2977838|NCT00833833|3693215|FG004|NOT COMPLETED|Phase 1 (as of 01 April 2011)||0
2977839|NCT00833833|3693216|FG005|NOT COMPLETED|Phase 1 (as of 01 April 2011)||0
2977840|NCT00833833|3693211|FG000|STARTED|Phase 2 (as of 01 April 2011)||0
2977841|NCT00833833|3693212|FG001|STARTED|Phase 2 (as of 01 April 2011)||0
2977842|NCT00833833|3693213|FG002|STARTED|Phase 2 (as of 01 April 2011)||0
2977843|NCT00833833|3693214|FG003|STARTED|Phase 2 (as of 01 April 2011)||0
2977844|NCT00833833|3693215|FG004|STARTED|Phase 2 (as of 01 April 2011)||113
2977845|NCT00833833|3693216|FG005|STARTED|Phase 2 (as of 01 April 2011)||108
2977846|NCT00833833|3693211|FG000|Safety Population|Phase 2 (as of 01 April 2011)||0
2977847|NCT00833833|3693212|FG001|Safety Population|Phase 2 (as of 01 April 2011)||0
2977848|NCT00833833|3693213|FG002|Safety Population|Phase 2 (as of 01 April 2011)||0
2977849|NCT00833833|3693214|FG003|Safety Population|Phase 2 (as of 01 April 2011)||0
2977850|NCT00833833|3693215|FG004|Safety Population|Phase 2 (as of 01 April 2011)||112
2977851|NCT00833833|3693216|FG005|Safety Population|Phase 2 (as of 01 April 2011)||107
2977852|NCT00833833|3693211|FG000|COMPLETED|Phase 2 (as of 01 April 2011)||0
2977853|NCT00833833|3693212|FG001|COMPLETED|Phase 2 (as of 01 April 2011)||0
2977854|NCT00833833|3693213|FG002|COMPLETED|Phase 2 (as of 01 April 2011)||0
2977855|NCT00833833|3693214|FG003|COMPLETED|Phase 2 (as of 01 April 2011)||0
2977856|NCT00833833|3693215|FG004|COMPLETED|Phase 2 (as of 01 April 2011)|Confirmed progressive disease|58
2977857|NCT00833833|3693216|FG005|COMPLETED|Phase 2 (as of 01 April 2011)|Confirmed progressive disease|47
2977858|NCT00833833|3693211|FG000|NOT COMPLETED|Phase 2 (as of 01 April 2011)||0
2977859|NCT00833833|3693212|FG001|NOT COMPLETED|Phase 2 (as of 01 April 2011)||0
2977860|NCT00833833|3693213|FG002|NOT COMPLETED|Phase 2 (as of 01 April 2011)||0
2977861|NCT00833833|3693214|FG003|NOT COMPLETED|Phase 2 (as of 01 April 2011)||0
2977862|NCT00833833|3693215|FG004|NOT COMPLETED|Phase 2 (as of 01 April 2011)||55
2977863|NCT00833833|3693216|FG005|NOT COMPLETED|Phase 2 (as of 01 April 2011)||61
2977864|NCT00833898|3693238|FG000|STARTED|Overall Study||74
2977865|NCT00833898|3693239|FG001|STARTED|Overall Study||74
2977866|NCT00833898|3693238|FG000|Month 1 (Post Transplantation)|Overall Study||72
2977867|NCT00833898|3693239|FG001|Month 1 (Post Transplantation)|Overall Study||74
2977868|NCT00833898|3693238|FG000|Month 3 (Post Transplantation)|Overall Study||66
2977869|NCT00833898|3693239|FG001|Month 3 (Post Transplantation)|Overall Study||64
2977870|NCT00833898|3693238|FG000|Month 6 (Post Transplantation)|Overall Study||59
2977871|NCT00833898|3693239|FG001|Month 6 (Post Transplantation)|Overall Study||54
2977872|NCT00833898|3693238|FG000|Month 12 (Post Transplantation)|Overall Study||50
2977873|NCT00833898|3693239|FG001|Month 12 (Post Transplantation)|Overall Study||50
2977874|NCT00833898|3693238|FG000|COMPLETED|Overall Study||34
2977875|NCT00833898|3693239|FG001|COMPLETED|Overall Study||38
2977876|NCT00833898|3693238|FG000|NOT COMPLETED|Overall Study||40
2977877|NCT00833898|3693239|FG001|NOT COMPLETED|Overall Study||36
2977878|NCT00833911|3693245|FG000|STARTED|Titration||392
2977879|NCT00833911|3693245|FG000|COMPLETED|Titration||371
2977880|NCT00833911|3693245|FG000|NOT COMPLETED|Titration||21
2977881|NCT00833911|3693245|FG000|STARTED|Maintenance Phase I||371
2977882|NCT00833911|3693245|FG000|COMPLETED|Maintenance Phase I||273
2977883|NCT00833911|3693245|FG000|NOT COMPLETED|Maintenance Phase I||98
2977884|NCT00833911|3693245|FG000|STARTED|Maintenance Phase II|97 patients chose not to continue into Maintenance Phase II|176
2977885|NCT00833911|3693245|FG000|COMPLETED|Maintenance Phase II||166
2977886|NCT00833911|3693245|FG000|NOT COMPLETED|Maintenance Phase II||10
2977887|NCT00833924|3693253|FG000|STARTED|Overall Study||120
2977888|NCT00833924|3693253|FG000|30-day|Overall Study||120
2977889|NCT00833924|3693253|FG000|12-month|Overall Study||113
2977890|NCT00833924|3693253|FG000|COMPLETED|Overall Study||11
2977891|NCT00833924|3693253|FG000|NOT COMPLETED|Overall Study||109
2977892|NCT00833976|3693257|FG000|STARTED|Overall Study||65
2977893|NCT00833976|3693257|FG000|COMPLETED|Overall Study||14
2977894|NCT00833976|3693257|FG000|NOT COMPLETED|Overall Study||51
2977895|NCT00833989|3693265|FG000|STARTED|Overall Study||17
2977896|NCT00833989|3693266|FG001|STARTED|Overall Study||8
2977897|NCT00833989|3693267|FG002|STARTED|Overall Study||9
2977898|NCT00833989|3693268|FG003|STARTED|Overall Study||8
2977899|NCT00833989|3693265|FG000|COMPLETED|Overall Study||14
2977900|NCT00833989|3693266|FG001|COMPLETED|Overall Study||8
2977901|NCT00833989|3693267|FG002|COMPLETED|Overall Study||8
2977902|NCT00833989|3693268|FG003|COMPLETED|Overall Study||6
2977903|NCT00833989|3693265|FG000|NOT COMPLETED|Overall Study||3
2977904|NCT00833989|3693266|FG001|NOT COMPLETED|Overall Study||0
2977905|NCT00833989|3693267|FG002|NOT COMPLETED|Overall Study||1
2977906|NCT00833989|3693268|FG003|NOT COMPLETED|Overall Study||2
2977907|NCT00834041|3693283|FG000|STARTED|Overall Study||19
2977908|NCT00834041|3693284|FG001|STARTED|Overall Study||20
2977909|NCT00834041|3693283|FG000|COMPLETED|Overall Study||18
2977910|NCT00834041|3693284|FG001|COMPLETED|Overall Study||19
2977911|NCT00834041|3693283|FG000|NOT COMPLETED|Overall Study||1
2977912|NCT00834041|3693284|FG001|NOT COMPLETED|Overall Study||1
2977913|NCT00834080|3693290|FG000|STARTED|Overall Study||38
2977914|NCT00834080|3693290|FG000|COMPLETED|Overall Study||15
2977915|NCT00834080|3693290|FG000|NOT COMPLETED|Overall Study||23
2977916|NCT00834106|3693296|FG000|STARTED|Base Study (Day 1 to Month 30)|Randomized participants|1503
2977917|NCT00834106|3693297|FG001|STARTED|Base Study (Day 1 to Month 30)|Randomized participants|1503
2977918|NCT00834106|3693296|FG000|Vaccinated|Base Study (Day 1 to Month 30)||1503
2977919|NCT00834106|3693297|FG001|Vaccinated|Base Study (Day 1 to Month 30)||1503
2977920|NCT00834106|3693296|FG000|Completed Vaccinations|Base Study (Day 1 to Month 30)||1473
2977921|NCT00834106|3693297|FG001|Completed Vaccinations|Base Study (Day 1 to Month 30)||1463
2977922|NCT00834106|3693296|FG000|COMPLETED|Base Study (Day 1 to Month 30)|Completed Month 30 follow-up|1401
2977923|NCT00834106|3693297|FG001|COMPLETED|Base Study (Day 1 to Month 30)|Completed Month 30 follow-up|1358
2977924|NCT00834106|3693296|FG000|NOT COMPLETED|Base Study (Day 1 to Month 30)||102
2977925|NCT00834106|3693297|FG001|NOT COMPLETED|Base Study (Day 1 to Month 30)||145
3164220|NCT01891734|3891695|FG000|STARTED|Overall Study||17
3164221|NCT01891734|3891696|FG001|STARTED|Overall Study||16
3164222|NCT01891734|3891695|FG000|COMPLETED|Overall Study||14
3164223|NCT01891734|3891696|FG001|COMPLETED|Overall Study||13
3164224|NCT01891734|3891695|FG000|NOT COMPLETED|Overall Study||3
3164225|NCT01891734|3891696|FG001|NOT COMPLETED|Overall Study||3
2977926|NCT00834106|3693296|FG000|STARTED|Extension Study (Month 42 to Month 90)|Some participants missed the Month 30 visit but returned for the Month 42 visit|1404
2977927|NCT00834106|3693297|FG001|STARTED|Extension Study (Month 42 to Month 90)|Some participants missed the Month 30 visit but returned for the Month 42 visit|1368
2977928|NCT00834106|3693296|FG000|COMPLETED|Extension Study (Month 42 to Month 90)||1308
2977929|NCT00834106|3693297|FG001|COMPLETED|Extension Study (Month 42 to Month 90)||1294
2977930|NCT00834106|3693296|FG000|NOT COMPLETED|Extension Study (Month 42 to Month 90)||96
2977931|NCT00834106|3693297|FG001|NOT COMPLETED|Extension Study (Month 42 to Month 90)||74
2977932|NCT00834171|3693305|FG000|STARTED|Overall Study||43
2977933|NCT00834171|3693306|FG001|STARTED|Overall Study||7
3303218|NCT02965378|4036537|FG001|Participants on Docetaxel Re-registered to AZD4547 After Progression.|Overall Study||2
3303219|NCT02965378|4036536|FG000|COMPLETED|Overall Study||0
3303220|NCT02965378|4036537|FG001|COMPLETED|Overall Study||0
3303221|NCT02965378|4036536|FG000|NOT COMPLETED|Overall Study||25
2977934|NCT00834171|3693305|FG000|COMPLETED|Overall Study||43
2977935|NCT00834171|3693306|FG001|COMPLETED|Overall Study||7
2977936|NCT00834171|3693305|FG000|NOT COMPLETED|Overall Study||0
2977937|NCT00834171|3693306|FG001|NOT COMPLETED|Overall Study||0
3036158|NCT01141725|3755373|FG000|STARTED|Overall Study||3
3036159|NCT01141725|3755374|FG001|STARTED|Overall Study||33
3036160|NCT01141725|3755375|FG002|STARTED|Overall Study||3
3036161|NCT01141725|3755373|FG000|COMPLETED|Overall Study||3
3036162|NCT01141725|3755374|FG001|COMPLETED|Overall Study||33
3036163|NCT01141725|3755375|FG002|COMPLETED|Overall Study||3
3036164|NCT01141725|3755373|FG000|NOT COMPLETED|Overall Study||0
3036165|NCT01141725|3755374|FG001|NOT COMPLETED|Overall Study||0
3036166|NCT01141725|3755375|FG002|NOT COMPLETED|Overall Study||0
3036167|NCT01141907|3755384|FG000|STARTED|Overall Study||6
3036168|NCT01141907|3755385|FG001|STARTED|Overall Study||5
3036169|NCT01141907|3755384|FG000|COMPLETED|Overall Study||6
3036170|NCT01141907|3755385|FG001|COMPLETED|Overall Study||5
3036171|NCT01141907|3755384|FG000|NOT COMPLETED|Overall Study||0
3036172|NCT01141907|3755385|FG001|NOT COMPLETED|Overall Study||0
3036173|NCT01142089|3755393|FG000|STARTED|Overall Study||65
3036174|NCT01142089|3755394|FG001|STARTED|Overall Study||199
3036175|NCT01142089|3755393|FG000|COMPLETED|Overall Study||53
3133307|NCT01695239|3858307|FG002|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
3133308|NCT01695239|3858308|FG003|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
3133309|NCT01695239|3858309|FG004|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
3133310|NCT01695239|3858310|FG005|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
3133311|NCT01695239|3858311|FG006|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
3133312|NCT01695239|3858312|FG007|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||11
3133313|NCT01695239|3858313|FG008|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
3133314|NCT01695239|3858314|FG009|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
3303222|NCT02965378|4036537|FG001|NOT COMPLETED|Overall Study||9
3303223|NCT02965456|4036545|FG000|STARTED|Overall Study||413
3303224|NCT02965456|4036546|FG001|STARTED|Overall Study||407
3303225|NCT02965456|4036545|FG000|Intent-to-treat (ITT) Population|Overall Study||413
3303226|NCT02965456|4036546|FG001|Intent-to-treat (ITT) Population|Overall Study||407
3303227|NCT02965456|4036545|FG000|Safety Population|Overall Study||389
3303228|NCT02965456|4036546|FG001|Safety Population|Overall Study||398
3303229|NCT02965456|4036545|FG000|COMPLETED|Overall Study||342
3303230|NCT02965456|4036546|FG001|COMPLETED|Overall Study||364
3303231|NCT02965456|4036545|FG000|NOT COMPLETED|Overall Study||71
3303232|NCT02965456|4036546|FG001|NOT COMPLETED|Overall Study||43
3303233|NCT02965534|4036552|FG000|STARTED|Overall Study|test period: 14 days with each test glasses|45
3303234|NCT02965534|4036553|FG001|STARTED|Overall Study|test period: 14 days with each test glasses|55
3303235|NCT02965534|4036552|FG000|COMPLETED|Overall Study||45
3303236|NCT02965534|4036553|FG001|COMPLETED|Overall Study||55
3303237|NCT02965534|4036552|FG000|NOT COMPLETED|Overall Study||0
3303238|NCT02965534|4036553|FG001|NOT COMPLETED|Overall Study||0
3303239|NCT02965573|4036562|FG000|STARTED|Overall Study||12
3303240|NCT02965573|4036563|FG001|STARTED|Overall Study||12
3303241|NCT02965573|4036562|FG000|COMPLETED|Overall Study||11
3303242|NCT02965573|4036563|FG001|COMPLETED|Overall Study||12
3303243|NCT02965573|4036562|FG000|NOT COMPLETED|Overall Study||1
3303244|NCT02965573|4036563|FG001|NOT COMPLETED|Overall Study||0
3303245|NCT02965599|4036571|FG000|STARTED|Overall Study||2
3036176|NCT01142089|3755394|FG001|COMPLETED|Overall Study||178
3036177|NCT01142089|3755393|FG000|NOT COMPLETED|Overall Study||12
3036178|NCT01142089|3755394|FG001|NOT COMPLETED|Overall Study||21
3036179|NCT01142115|3755400|FG000|STARTED|First Intervention||21
3036180|NCT01142115|3755401|FG001|STARTED|First Intervention||20
3036181|NCT01142115|3755400|FG000|COMPLETED|First Intervention||19
3036182|NCT01142115|3755401|FG001|COMPLETED|First Intervention||19
3036183|NCT01142115|3755400|FG000|NOT COMPLETED|First Intervention||2
3036184|NCT01142115|3755401|FG001|NOT COMPLETED|First Intervention||1
3036185|NCT01142115|3755400|FG000|STARTED|Second Intervention||19
3036186|NCT01142115|3755401|FG001|STARTED|Second Intervention||19
3036187|NCT01142115|3755400|FG000|COMPLETED|Second Intervention||19
3036188|NCT01142115|3755401|FG001|COMPLETED|Second Intervention||19
3036189|NCT01142115|3755400|FG000|NOT COMPLETED|Second Intervention||0
3036190|NCT01142115|3755401|FG001|NOT COMPLETED|Second Intervention||0
3036191|NCT01142193|3755408|FG000|STARTED|Overall Study||124
3036192|NCT01142193|3755409|FG001|STARTED|Overall Study||125
3036193|NCT01142193|3755408|FG000|COMPLETED|Overall Study||103
3036194|NCT01142193|3755409|FG001|COMPLETED|Overall Study||114
3036195|NCT01142193|3755408|FG000|NOT COMPLETED|Overall Study||21
3303246|NCT02965599|4036572|FG001|STARTED|Overall Study||1
3303247|NCT02965599|4036571|FG000|COMPLETED|Overall Study||1
3303248|NCT02965599|4036572|FG001|COMPLETED|Overall Study||1
3036196|NCT01142193|3755409|FG001|NOT COMPLETED|Overall Study||11
3036197|NCT01142232|3755420|FG000|STARTED|Overall Study||3
3036198|NCT01142232|3755421|FG001|STARTED|Overall Study||4
3036199|NCT01142232|3755422|FG002|STARTED|Overall Study||3
3036200|NCT01142232|3755423|FG003|STARTED|Overall Study||6
3036201|NCT01142232|3755424|FG004|STARTED|Overall Study||44
3036202|NCT01142232|3755420|FG000|COMPLETED|Overall Study||0
3036203|NCT01142232|3755421|FG001|COMPLETED|Overall Study||0
3303249|NCT02965599|4036571|FG000|NOT COMPLETED|Overall Study||1
3303250|NCT02965599|4036572|FG001|NOT COMPLETED|Overall Study||0
3036204|NCT01142232|3755422|FG002|COMPLETED|Overall Study||0
3036205|NCT01142232|3755423|FG003|COMPLETED|Overall Study||1
2977938|NCT00834210|3693314|FG000|STARTED|Overall Study||86
2977939|NCT00834210|3693315|FG001|STARTED|Overall Study||85
2977940|NCT00834210|3693314|FG000|COMPLETED|Overall Study||83
2977941|NCT00834210|3693315|FG001|COMPLETED|Overall Study||77
2977942|NCT00834210|3693314|FG000|NOT COMPLETED|Overall Study||3
2977943|NCT00834210|3693315|FG001|NOT COMPLETED|Overall Study||8
2977944|NCT00834236|3693323|FG000|STARTED|Overall Study||29
2977945|NCT00834236|3693324|FG001|STARTED|Overall Study||47
2977946|NCT00834236|3693323|FG000|COMPLETED|Overall Study||29
2977947|NCT00834236|3693324|FG001|COMPLETED|Overall Study||47
2977948|NCT00834236|3693323|FG000|NOT COMPLETED|Overall Study||0
2977949|NCT00834236|3693324|FG001|NOT COMPLETED|Overall Study||0
2977950|NCT00834288|3693332|FG000|STARTED|Treatment Phase I||13
2977951|NCT00834288|3693333|FG001|STARTED|Treatment Phase I||13
2977952|NCT00834288|3693332|FG000|COMPLETED|Treatment Phase I||13
2977953|NCT00834288|3693333|FG001|COMPLETED|Treatment Phase I||13
2977954|NCT00834288|3693332|FG000|NOT COMPLETED|Treatment Phase I||0
2977955|NCT00834288|3693333|FG001|NOT COMPLETED|Treatment Phase I||0
2977956|NCT00834288|3693332|FG000|STARTED|Treatment Phase II||13
2977957|NCT00834288|3693333|FG001|STARTED|Treatment Phase II||13
2977958|NCT00834288|3693332|FG000|COMPLETED|Treatment Phase II||13
2977959|NCT00834288|3693333|FG001|COMPLETED|Treatment Phase II||13
2977960|NCT00834288|3693332|FG000|NOT COMPLETED|Treatment Phase II||0
2977961|NCT00834288|3693333|FG001|NOT COMPLETED|Treatment Phase II||0
2977962|NCT00834366|3693341|FG000|STARTED|Treatment Period 1||13
2977963|NCT00834366|3693342|FG001|STARTED|Treatment Period 1||13
2977964|NCT00834366|3693341|FG000|COMPLETED|Treatment Period 1||12
2977965|NCT00834366|3693342|FG001|COMPLETED|Treatment Period 1||12
2977966|NCT00834366|3693341|FG000|NOT COMPLETED|Treatment Period 1||1
2977967|NCT00834366|3693342|FG001|NOT COMPLETED|Treatment Period 1||1
2977968|NCT00834366|3693341|FG000|STARTED|Treatment Period 2||12
2977969|NCT00834366|3693342|FG001|STARTED|Treatment Period 2||12
2977970|NCT00834366|3693341|FG000|COMPLETED|Treatment Period 2||12
2977971|NCT00834366|3693342|FG001|COMPLETED|Treatment Period 2||12
2977972|NCT00834366|3693341|FG000|NOT COMPLETED|Treatment Period 2||0
2977973|NCT00834366|3693342|FG001|NOT COMPLETED|Treatment Period 2||0
2977974|NCT00834483|3693350|FG000|STARTED|Overall Study||31
2977975|NCT00834483|3693351|FG001|STARTED|Overall Study||29
2977976|NCT00834483|3693350|FG000|COMPLETED|Overall Study||31
2977977|NCT00834483|3693351|FG001|COMPLETED|Overall Study||29
2977978|NCT00834483|3693350|FG000|NOT COMPLETED|Overall Study||0
2977979|NCT00834483|3693351|FG001|NOT COMPLETED|Overall Study||0
2977980|NCT00834626|3693357|FG000|STARTED|Overall Study||30
2977981|NCT00834626|3693357|FG000|1 Year Follow-up|Overall Study||30
2977982|NCT00834626|3693357|FG000|COMPLETED|Overall Study||30
2977983|NCT00834626|3693357|FG000|NOT COMPLETED|Overall Study||0
2977984|NCT00834652|3693364|FG000|STARTED|Overall Study||104
2977985|NCT00834652|3693365|FG001|STARTED|Overall Study||102
2977986|NCT00834652|3693364|FG000|COMPLETED|Overall Study||66
2977987|NCT00834652|3693365|FG001|COMPLETED|Overall Study||62
2977988|NCT00834652|3693364|FG000|NOT COMPLETED|Overall Study||38
2977989|NCT00834652|3693365|FG001|NOT COMPLETED|Overall Study||40
2977990|NCT00834678|3693371|FG000|STARTED|Overall Study||11
2977991|NCT00834678|3693371|FG000|COMPLETED|Overall Study||11
2977992|NCT00834678|3693371|FG000|NOT COMPLETED|Overall Study||0
2977993|NCT00834808|3693380|FG000|STARTED|Treatment Period 1 (Day 1)||9
2977994|NCT00834808|3693381|FG001|STARTED|Treatment Period 1 (Day 1)||9
2977995|NCT00834808|3693382|FG002|STARTED|Treatment Period 1 (Day 1)||9
2977996|NCT00834808|3693380|FG000|COMPLETED|Treatment Period 1 (Day 1)||9
2977997|NCT00834808|3693381|FG001|COMPLETED|Treatment Period 1 (Day 1)||9
2977998|NCT00834808|3693382|FG002|COMPLETED|Treatment Period 1 (Day 1)||9
2977999|NCT00834808|3693380|FG000|NOT COMPLETED|Treatment Period 1 (Day 1)||0
2978000|NCT00834808|3693381|FG001|NOT COMPLETED|Treatment Period 1 (Day 1)||0
2978001|NCT00834808|3693382|FG002|NOT COMPLETED|Treatment Period 1 (Day 1)||0
2978002|NCT00834808|3693380|FG000|STARTED|Treatment Period 2 (Day 8)||9
2978003|NCT00834808|3693381|FG001|STARTED|Treatment Period 2 (Day 8)||9
2978004|NCT00834808|3693382|FG002|STARTED|Treatment Period 2 (Day 8)||9
2978005|NCT00834808|3693380|FG000|COMPLETED|Treatment Period 2 (Day 8)||9
2978006|NCT00834808|3693381|FG001|COMPLETED|Treatment Period 2 (Day 8)||9
2978007|NCT00834808|3693382|FG002|COMPLETED|Treatment Period 2 (Day 8)||9
2978008|NCT00834808|3693380|FG000|NOT COMPLETED|Treatment Period 2 (Day 8)||0
3133315|NCT01695239|3858315|FG010|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
3133316|NCT01695239|3858316|FG011|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
3133317|NCT01695239|3858317|FG012|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
3133318|NCT01695239|3858318|FG013|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
2978009|NCT00834808|3693381|FG001|NOT COMPLETED|Treatment Period 2 (Day 8)||0
2978010|NCT00834808|3693382|FG002|NOT COMPLETED|Treatment Period 2 (Day 8)||0
2978011|NCT00834808|3693380|FG000|STARTED|Treatment Period 3 (Day 15)||9
2978012|NCT00834808|3693381|FG001|STARTED|Treatment Period 3 (Day 15)||9
2978013|NCT00834808|3693382|FG002|STARTED|Treatment Period 3 (Day 15)||9
2978014|NCT00834808|3693380|FG000|COMPLETED|Treatment Period 3 (Day 15)||9
2978015|NCT00834808|3693381|FG001|COMPLETED|Treatment Period 3 (Day 15)||9
2978016|NCT00834808|3693382|FG002|COMPLETED|Treatment Period 3 (Day 15)||9
2978017|NCT00834808|3693380|FG000|NOT COMPLETED|Treatment Period 3 (Day 15)||0
2978018|NCT00834808|3693381|FG001|NOT COMPLETED|Treatment Period 3 (Day 15)||0
2978019|NCT00834808|3693382|FG002|NOT COMPLETED|Treatment Period 3 (Day 15)||0
2978020|NCT00834834|3693392|FG000|STARTED|Overall Study||42
2978021|NCT00834834|3693393|FG001|STARTED|Overall Study||42
2978022|NCT00834834|3693392|FG000|COMPLETED|Overall Study||38
2978023|NCT00834834|3693393|FG001|COMPLETED|Overall Study||39
2978024|NCT00834834|3693392|FG000|NOT COMPLETED|Overall Study||4
2978025|NCT00834834|3693393|FG001|NOT COMPLETED|Overall Study||3
2978026|NCT00834886|3693403|FG000|STARTED|Overall Study||10
2978027|NCT00834886|3693404|FG001|STARTED|Overall Study||10
2978028|NCT00834886|3693405|FG002|STARTED|Overall Study||10
2978029|NCT00834886|3693406|FG003|STARTED|Overall Study||10
2978030|NCT00834886|3693403|FG000|COMPLETED|Overall Study||10
2978031|NCT00834886|3693404|FG001|COMPLETED|Overall Study||9
2978032|NCT00834886|3693405|FG002|COMPLETED|Overall Study||9
2978033|NCT00834886|3693406|FG003|COMPLETED|Overall Study||10
2978034|NCT00834886|3693403|FG000|NOT COMPLETED|Overall Study||0
2978035|NCT00834886|3693404|FG001|NOT COMPLETED|Overall Study||1
2978036|NCT00834886|3693405|FG002|NOT COMPLETED|Overall Study||1
2978037|NCT00834886|3693406|FG003|NOT COMPLETED|Overall Study||0
2978038|NCT00834899|3693418|FG000|STARTED|Overall Study||9
2978039|NCT00834899|3693419|FG001|STARTED|Overall Study||4
2978040|NCT00834899|3693418|FG000|COMPLETED|Overall Study|One patient withdrew consent following completion of the study drug infusion.|8
2978041|NCT00834899|3693419|FG001|COMPLETED|Overall Study|One patient was withdrawn early because she did not meet eligibility criteria.|3
2978042|NCT00834899|3693418|FG000|NOT COMPLETED|Overall Study||1
2978043|NCT00834899|3693419|FG001|NOT COMPLETED|Overall Study||1
2978044|NCT00834912|3693431|FG000|STARTED|Treatment Period 1||6
2978045|NCT00834912|3693432|FG001|STARTED|Treatment Period 1||6
2978046|NCT00834912|3693433|FG002|STARTED|Treatment Period 1||6
2978047|NCT00834912|3693434|FG003|STARTED|Treatment Period 1||6
2978048|NCT00834912|3693435|FG004|STARTED|Treatment Period 1||6
2978049|NCT00834912|3693436|FG005|STARTED|Treatment Period 1||6
2978050|NCT00834912|3693431|FG000|COMPLETED|Treatment Period 1||6
2978051|NCT00834912|3693432|FG001|COMPLETED|Treatment Period 1|One subject completed all of treatment period 1 assessments but did not enter treatment period 2|5
2978052|NCT00834912|3693433|FG002|COMPLETED|Treatment Period 1||6
2978053|NCT00834912|3693434|FG003|COMPLETED|Treatment Period 1|One subject completed all of treatment period 1 assessments but did not enter treatment period 2|5
2978054|NCT00834912|3693435|FG004|COMPLETED|Treatment Period 1||6
2978055|NCT00834912|3693436|FG005|COMPLETED|Treatment Period 1||6
2978056|NCT00834912|3693431|FG000|NOT COMPLETED|Treatment Period 1||0
2978057|NCT00834912|3693432|FG001|NOT COMPLETED|Treatment Period 1||1
2978058|NCT00834912|3693433|FG002|NOT COMPLETED|Treatment Period 1||0
2978059|NCT00834912|3693434|FG003|NOT COMPLETED|Treatment Period 1||1
2978060|NCT00834912|3693435|FG004|NOT COMPLETED|Treatment Period 1||0
2978061|NCT00834912|3693436|FG005|NOT COMPLETED|Treatment Period 1||0
2978062|NCT00834912|3693431|FG000|STARTED|Treatment Period 2||6
2978063|NCT00834912|3693432|FG001|STARTED|Treatment Period 2||5
2978064|NCT00834912|3693433|FG002|STARTED|Treatment Period 2||6
2978065|NCT00834912|3693434|FG003|STARTED|Treatment Period 2||5
2978066|NCT00834912|3693435|FG004|STARTED|Treatment Period 2||6
2978067|NCT00834912|3693436|FG005|STARTED|Treatment Period 2||6
2978068|NCT00834912|3693431|FG000|COMPLETED|Treatment Period 2||6
2978069|NCT00834912|3693432|FG001|COMPLETED|Treatment Period 2||5
2978070|NCT00834912|3693433|FG002|COMPLETED|Treatment Period 2|One subject completed treatment period 2 but did not enter treatment period 3|5
2978071|NCT00834912|3693434|FG003|COMPLETED|Treatment Period 2||5
2978072|NCT00834912|3693435|FG004|COMPLETED|Treatment Period 2|One subject completed treatment period 2 but did not enter treatment period 3|5
2978073|NCT00834912|3693436|FG005|COMPLETED|Treatment Period 2||6
2978074|NCT00834912|3693431|FG000|NOT COMPLETED|Treatment Period 2||0
2978075|NCT00834912|3693432|FG001|NOT COMPLETED|Treatment Period 2||0
2978076|NCT00834912|3693433|FG002|NOT COMPLETED|Treatment Period 2||1
2978077|NCT00834912|3693434|FG003|NOT COMPLETED|Treatment Period 2||0
2978078|NCT00834912|3693435|FG004|NOT COMPLETED|Treatment Period 2||1
2978079|NCT00834912|3693436|FG005|NOT COMPLETED|Treatment Period 2||0
2978080|NCT00834912|3693431|FG000|STARTED|Treatment Period 3||6
2978081|NCT00834912|3693432|FG001|STARTED|Treatment Period 3||5
2978082|NCT00834912|3693433|FG002|STARTED|Treatment Period 3||5
2978083|NCT00834912|3693434|FG003|STARTED|Treatment Period 3||5
2978084|NCT00834912|3693435|FG004|STARTED|Treatment Period 3||5
2978085|NCT00834912|3693436|FG005|STARTED|Treatment Period 3||6
2978086|NCT00834912|3693431|FG000|COMPLETED|Treatment Period 3||6
2978087|NCT00834912|3693432|FG001|COMPLETED|Treatment Period 3||5
2978088|NCT00834912|3693433|FG002|COMPLETED|Treatment Period 3||5
2978089|NCT00834912|3693434|FG003|COMPLETED|Treatment Period 3||5
2978090|NCT00834912|3693435|FG004|COMPLETED|Treatment Period 3||5
2978091|NCT00834912|3693436|FG005|COMPLETED|Treatment Period 3||6
2978092|NCT00834912|3693431|FG000|NOT COMPLETED|Treatment Period 3||0
2978093|NCT00834912|3693432|FG001|NOT COMPLETED|Treatment Period 3||0
2978094|NCT00834912|3693433|FG002|NOT COMPLETED|Treatment Period 3||0
2978095|NCT00834912|3693434|FG003|NOT COMPLETED|Treatment Period 3||0
2978096|NCT00834912|3693435|FG004|NOT COMPLETED|Treatment Period 3||0
2978097|NCT00834912|3693436|FG005|NOT COMPLETED|Treatment Period 3||0
2978098|NCT00835003|3693446|FG000|STARTED|Overall Study||636
2978099|NCT00835003|3693447|FG001|STARTED|Overall Study||638
2978100|NCT00835003|3693446|FG000|COMPLETED|Overall Study||636
2978101|NCT00835003|3693447|FG001|COMPLETED|Overall Study||638
2978102|NCT00835003|3693446|FG000|NOT COMPLETED|Overall Study||0
2978103|NCT00835003|3693447|FG001|NOT COMPLETED|Overall Study||0
2978104|NCT00835068|3693455|FG000|STARTED|Overall Study||57
2978105|NCT00835068|3693456|FG001|STARTED|Overall Study||1
2978106|NCT00835068|3693455|FG000|COMPLETED|Overall Study||47
2978107|NCT00835068|3693456|FG001|COMPLETED|Overall Study||0
2978108|NCT00835068|3693455|FG000|NOT COMPLETED|Overall Study||10
2978109|NCT00835068|3693456|FG001|NOT COMPLETED|Overall Study||1
2978110|NCT00835120|3693462|FG000|STARTED|Overall Study||34
2978111|NCT00835120|3693462|FG000|COMPLETED|Overall Study||26
2978112|NCT00835120|3693462|FG000|NOT COMPLETED|Overall Study||8
2978113|NCT00835159|3693468|FG000|STARTED|Overall Study||11
2978114|NCT00835159|3693469|FG001|STARTED|Overall Study||17
2978115|NCT00835159|3693468|FG000|COMPLETED|Overall Study||11
2978116|NCT00835159|3693469|FG001|COMPLETED|Overall Study||17
2978117|NCT00835159|3693468|FG000|NOT COMPLETED|Overall Study||0
2978118|NCT00835159|3693469|FG001|NOT COMPLETED|Overall Study||0
2978119|NCT00835185|3693475|FG000|STARTED|Overall Study||44
2978120|NCT00835185|3693475|FG000|Received at Least 1 Dose of Study Drug|Overall Study||44
2978121|NCT00835185|3693475|FG000|COMPLETED|Overall Study||44
2978122|NCT00835185|3693475|FG000|NOT COMPLETED|Overall Study||0
2978123|NCT00835198|3693482|FG000|STARTED|Overall Study||82
2978124|NCT00835198|3693483|FG001|STARTED|Overall Study||81
2978125|NCT00835198|3693482|FG000|COMPLETED|Overall Study||74
2978126|NCT00835198|3693483|FG001|COMPLETED|Overall Study||74
2978127|NCT00835198|3693482|FG000|NOT COMPLETED|Overall Study||8
2978128|NCT00835198|3693483|FG001|NOT COMPLETED|Overall Study||7
2978129|NCT00835224|3693489|FG000|STARTED|Overall Study||34
2978130|NCT00835224|3693489|FG000|COMPLETED|Overall Study||24
2978131|NCT00835224|3693489|FG000|NOT COMPLETED|Overall Study||10
2978132|NCT00835237|3693505|FG000|STARTED|Overall Study||887
2978133|NCT00835237|3693506|FG001|STARTED|Overall Study||445
2978134|NCT00835237|3693505|FG000|COMPLETED|Overall Study||881
2978135|NCT00835237|3693506|FG001|COMPLETED|Overall Study||445
2978136|NCT00835237|3693505|FG000|NOT COMPLETED|Overall Study||6
2978137|NCT00835237|3693506|FG001|NOT COMPLETED|Overall Study||0
2978138|NCT00835341|3693514|FG000|STARTED|Overall Study||35
2978139|NCT00835341|3693515|FG001|STARTED|Overall Study||58
2978140|NCT00835341|3693514|FG000|COMPLETED|Overall Study||32
2978141|NCT00835341|3693515|FG001|COMPLETED|Overall Study||46
2978142|NCT00835341|3693514|FG000|NOT COMPLETED|Overall Study||3
2978143|NCT00835341|3693515|FG001|NOT COMPLETED|Overall Study||12
2978144|NCT00835380|3693521|FG000|STARTED|Overall Study||80
2978145|NCT00835380|3693521|FG000|COMPLETED|Overall Study||78
2978146|NCT00835380|3693521|FG000|NOT COMPLETED|Overall Study||2
2978147|NCT00835510|3693528|FG000|STARTED|Overall Study||219
2978148|NCT00835510|3693529|FG001|STARTED|Overall Study||221
2978149|NCT00835510|3693530|FG002|STARTED|Overall Study||108
2978150|NCT00835510|3693528|FG000|Positive Fungal Culture|Overall Study||149
2978151|NCT00835510|3693529|FG001|Positive Fungal Culture|Overall Study||155
2978152|NCT00835510|3693530|FG002|Positive Fungal Culture|Overall Study||71
2978153|NCT00835510|3693528|FG000|COMPLETED|Overall Study||143
2978154|NCT00835510|3693529|FG001|COMPLETED|Overall Study||152
2978155|NCT00835510|3693530|FG002|COMPLETED|Overall Study||70
2978156|NCT00835510|3693528|FG000|NOT COMPLETED|Overall Study||76
2978157|NCT00835510|3693529|FG001|NOT COMPLETED|Overall Study||69
2978158|NCT00835510|3693530|FG002|NOT COMPLETED|Overall Study||38
2978159|NCT00835731|3693540|FG000|STARTED|Overall Study||64
2978160|NCT00835731|3693541|FG001|STARTED|Overall Study||61
2978161|NCT00835731|3693540|FG000|COMPLETED|Overall Study||62
2978162|NCT00835731|3693541|FG001|COMPLETED|Overall Study||60
2978163|NCT00835731|3693540|FG000|NOT COMPLETED|Overall Study||2
2978164|NCT00835731|3693541|FG001|NOT COMPLETED|Overall Study||1
2978165|NCT00835770|3693549|FG000|STARTED|Overall Study||868
2978166|NCT00835770|3693550|FG001|STARTED|Overall Study||868
2978167|NCT00835770|3693549|FG000|COMPLETED|Overall Study||384
2978168|NCT00835770|3693550|FG001|COMPLETED|Overall Study||375
2978169|NCT00835770|3693549|FG000|NOT COMPLETED|Overall Study||484
2978170|NCT00835770|3693550|FG001|NOT COMPLETED|Overall Study||493
2978171|NCT00835861|3693564|FG000|STARTED|Overall Study||15
2978172|NCT00835861|3693565|FG001|STARTED|Overall Study||16
2978173|NCT00835861|3693564|FG000|COMPLETED|Overall Study||14
2978174|NCT00835861|3693565|FG001|COMPLETED|Overall Study||14
2978175|NCT00835861|3693564|FG000|NOT COMPLETED|Overall Study||1
2978176|NCT00835861|3693565|FG001|NOT COMPLETED|Overall Study||2
2978177|NCT00835900|3693573|FG000|STARTED|Overall Study||32
2978178|NCT00835900|3693574|FG001|STARTED|Overall Study||28
2978179|NCT00835900|3693573|FG000|COMPLETED|Overall Study||27
2978180|NCT00835900|3693574|FG001|COMPLETED|Overall Study||22
2978181|NCT00835900|3693573|FG000|NOT COMPLETED|Overall Study||5
2978182|NCT00835900|3693574|FG001|NOT COMPLETED|Overall Study||6
2978183|NCT00835926|3693582|FG000|STARTED|Overall Study||61
2978184|NCT00835926|3693583|FG001|STARTED|Overall Study||60
2978185|NCT00835926|3693582|FG000|COMPLETED|Overall Study||61
2978186|NCT00835926|3693583|FG001|COMPLETED|Overall Study||60
2978187|NCT00835926|3693582|FG000|NOT COMPLETED|Overall Study||0
2978188|NCT00835926|3693583|FG001|NOT COMPLETED|Overall Study||0
2978189|NCT00835978|3693593|FG000|STARTED|Overall Study||56
2978190|NCT00835978|3693594|FG001|STARTED|Overall Study||56
2978191|NCT00835978|3693595|FG002|STARTED|Overall Study||91
2978192|NCT00835978|3693596|FG003|STARTED|Overall Study||10
2978193|NCT00835978|3693593|FG000|Treated|Overall Study||56
2978194|NCT00835978|3693594|FG001|Treated|Overall Study||56
2978195|NCT00835978|3693595|FG002|Treated|Overall Study||91
2978196|NCT00835978|3693596|FG003|Treated|Overall Study||10
3036206|NCT01142232|3755424|FG004|COMPLETED|Overall Study||10
3133319|NCT01695239|3858305|FG000|STARTED|Extension Long-Term Extension Periods||0
2978197|NCT00835978|3693593|FG000|COMPLETED|Overall Study|Study Completion: 29 Feb 2016. Treatment discontinued due to objective progression/relapse & death|0
2978198|NCT00835978|3693594|FG001|COMPLETED|Overall Study|Study Completion: 29 Feb 2016. Treatment discontinued due to objective progression/relapse & death|0
2978199|NCT00835978|3693595|FG002|COMPLETED|Overall Study|Study Completion: 29 Feb 2016. Treatment discontinued due to objective progression/relapse & death|0
2978200|NCT00835978|3693596|FG003|COMPLETED|Overall Study|Study Completion: 29 Feb 2016. Treatment discontinued due to objective progression/relapse & death|0
2978201|NCT00835978|3693593|FG000|NOT COMPLETED|Overall Study||56
2978202|NCT00835978|3693594|FG001|NOT COMPLETED|Overall Study||56
2978203|NCT00835978|3693595|FG002|NOT COMPLETED|Overall Study||91
2978204|NCT00835978|3693596|FG003|NOT COMPLETED|Overall Study||10
2978205|NCT00836017|3693611|FG000|STARTED|Overall Study||1046
3133320|NCT01695239|3858306|FG001|STARTED|Extension Long-Term Extension Periods||0
2978206|NCT00836017|3693611|FG000|COMPLETED|Overall Study||502
2978207|NCT00836017|3693611|FG000|NOT COMPLETED|Overall Study||544
2978208|NCT00836095|3693617|FG000|STARTED|Overall Study||22
2978209|NCT00836095|3693618|FG001|STARTED|Overall Study||30
2978210|NCT00836095|3693617|FG000|COMPLETED|Overall Study||22
2978211|NCT00836095|3693618|FG001|COMPLETED|Overall Study||27
2978212|NCT00836095|3693617|FG000|NOT COMPLETED|Overall Study||0
2978213|NCT00836095|3693618|FG001|NOT COMPLETED|Overall Study||3
2978214|NCT00836186|3693624|FG000|STARTED|Overall Study||82
2978215|NCT00836186|3693624|FG000|COMPLETED|Overall Study||81
2978216|NCT00836186|3693624|FG000|NOT COMPLETED|Overall Study||1
2978217|NCT00836277|3693629|FG000|STARTED|Overall Study||24
2978218|NCT00836277|3693629|FG000|COMPLETED|Overall Study||18
2978219|NCT00836277|3693629|FG000|NOT COMPLETED|Overall Study||6
2978220|NCT00836342|3693636|FG000|STARTED|Overall Study||22
2978221|NCT00836342|3693637|FG001|STARTED|Overall Study||23
2978222|NCT00836342|3693638|FG002|STARTED|Overall Study||36
2978223|NCT00836342|3693636|FG000|COMPLETED|Overall Study||22
2978224|NCT00836342|3693637|FG001|COMPLETED|Overall Study||23
2978225|NCT00836342|3693638|FG002|COMPLETED|Overall Study||36
2978226|NCT00836342|3693636|FG000|NOT COMPLETED|Overall Study||0
2978227|NCT00836342|3693637|FG001|NOT COMPLETED|Overall Study||0
2978228|NCT00836342|3693638|FG002|NOT COMPLETED|Overall Study||0
2978229|NCT00836407|3693650|FG000|STARTED|Overall Study||15
2978230|NCT00836407|3693651|FG001|STARTED|Overall Study||15
2978231|NCT00836407|3693650|FG000|COMPLETED|Overall Study||4
2978232|NCT00836407|3693651|FG001|COMPLETED|Overall Study||7
2978233|NCT00836407|3693650|FG000|NOT COMPLETED|Overall Study||11
2978234|NCT00836407|3693651|FG001|NOT COMPLETED|Overall Study||8
2978235|NCT00836433|3693659|FG000|STARTED|Overall Study||361
2978236|NCT00836433|3693660|FG001|STARTED|Overall Study||328
2978237|NCT00836433|3693659|FG000|COMPLETED|Overall Study||349
2978238|NCT00836433|3693660|FG001|COMPLETED|Overall Study||321
2978239|NCT00836433|3693659|FG000|NOT COMPLETED|Overall Study||12
2978240|NCT00836433|3693660|FG001|NOT COMPLETED|Overall Study||7
2978241|NCT00836498|3693670|FG000|STARTED|Overall Study||44
2978242|NCT00836498|3693671|FG001|STARTED|Overall Study||22
2978243|NCT00836498|3693670|FG000|COMPLETED|Overall Study|Participant who discontinued the study vaccination due to AE completed the 180-day safety follow-up.|40
2978244|NCT00836498|3693671|FG001|COMPLETED|Overall Study||21
2978245|NCT00836498|3693670|FG000|NOT COMPLETED|Overall Study||4
2978246|NCT00836498|3693671|FG001|NOT COMPLETED|Overall Study||1
2978247|NCT00836589|3693678|FG000|STARTED|Overall Study||1997
2978248|NCT00836589|3693678|FG000|COMPLETED|Overall Study||731
2978249|NCT00836589|3693678|FG000|NOT COMPLETED|Overall Study||1266
2978250|NCT00836641|3693692|FG000|STARTED|Overall Study||36
2978251|NCT00836641|3693693|FG001|STARTED|Overall Study||34
2978252|NCT00836641|3693692|FG000|COMPLETED|Overall Study||36
2978253|NCT00836641|3693693|FG001|COMPLETED|Overall Study||34
2978254|NCT00836641|3693692|FG000|NOT COMPLETED|Overall Study||0
2978255|NCT00836641|3693693|FG001|NOT COMPLETED|Overall Study||0
2978256|NCT00836693|3693700|FG000|STARTED|Overall Study||147
2978257|NCT00836693|3693701|FG001|STARTED|Overall Study||70
2978258|NCT00836693|3693700|FG000|COMPLETED|Overall Study||130
2978259|NCT00836693|3693701|FG001|COMPLETED|Overall Study||64
2978260|NCT00836693|3693700|FG000|NOT COMPLETED|Overall Study||17
2978261|NCT00836693|3693701|FG001|NOT COMPLETED|Overall Study||6
2978262|NCT00836719|3693707|FG000|STARTED|Overall Study||10
2978263|NCT00836719|3693707|FG000|COMPLETED|Overall Study||10
2978264|NCT00836719|3693707|FG000|NOT COMPLETED|Overall Study||0
2978265|NCT00836745|3693711|FG000|STARTED|Overall Study||36
2978266|NCT00836745|3693711|FG000|COMPLETED|Overall Study||15
2978267|NCT00836745|3693711|FG000|NOT COMPLETED|Overall Study||21
2978268|NCT00836758|3693715|FG000|STARTED|Overall Study||115
2978269|NCT00836758|3693715|FG000|COMPLETED|Overall Study||115
2978270|NCT00836758|3693715|FG000|NOT COMPLETED|Overall Study||0
2978271|NCT00836810|3693723|FG000|STARTED|Overall Study||5
2978272|NCT00836810|3693724|FG001|STARTED|Overall Study||6
2978273|NCT00836810|3693723|FG000|COMPLETED|Overall Study|1 patient was subsequently diagnosed with SLE and, per protocol, was not included.|4
2978274|NCT00836810|3693724|FG001|COMPLETED|Overall Study||6
2978275|NCT00836810|3693723|FG000|NOT COMPLETED|Overall Study||1
2978276|NCT00836810|3693724|FG001|NOT COMPLETED|Overall Study||0
2978277|NCT00836875|3693732|FG000|STARTED|Overall Study||11
2978278|NCT00836875|3693733|FG001|STARTED|Overall Study||20
2978279|NCT00836875|3693732|FG000|COMPLETED|Overall Study||8
2978280|NCT00836875|3693733|FG001|COMPLETED|Overall Study||17
2978281|NCT00836875|3693732|FG000|NOT COMPLETED|Overall Study||3
2978282|NCT00836875|3693733|FG001|NOT COMPLETED|Overall Study||3
2978283|NCT00836888|3693743|FG000|STARTED|Overall Study||3
2978284|NCT00836888|3693744|FG001|STARTED|Overall Study||5
2978285|NCT00836888|3693745|FG002|STARTED|Overall Study||6
2978286|NCT00836888|3693746|FG003|STARTED|Overall Study||3
2978287|NCT00836888|3693743|FG000|COMPLETED|Overall Study||0
2978288|NCT00836888|3693744|FG001|COMPLETED|Overall Study||2
2978289|NCT00836888|3693745|FG002|COMPLETED|Overall Study||0
2978290|NCT00836888|3693746|FG003|COMPLETED|Overall Study||0
2978291|NCT00836888|3693743|FG000|NOT COMPLETED|Overall Study||3
2978292|NCT00836888|3693744|FG001|NOT COMPLETED|Overall Study||3
2978293|NCT00836888|3693745|FG002|NOT COMPLETED|Overall Study||6
2978294|NCT00836888|3693746|FG003|NOT COMPLETED|Overall Study||3
2978295|NCT00836927|3693761|FG000|STARTED|Overall Study||3
2978296|NCT00836927|3693762|FG001|STARTED|Overall Study||1
2978297|NCT00836927|3693763|FG002|STARTED|Overall Study|One participant received ridaforolimus 3 mg IV infusion before being switched to the oral tablet.|1
2978298|NCT00836927|3693764|FG003|STARTED|Overall Study||1
2978299|NCT00836927|3693765|FG004|STARTED|Overall Study||1
2978300|NCT00836927|3693761|FG000|Completed Dosing Through 03 Apr 2017|Overall Study||0
2978301|NCT00836927|3693762|FG001|Completed Dosing Through 03 Apr 2017|Overall Study|Participant continued to receive study drug past the data cut-off date of 03 Apr 2017|1
2978302|NCT00836927|3693763|FG002|Completed Dosing Through 03 Apr 2017|Overall Study|Participant continued to receive study drug past the data cut-off date of 03 Apr 2017|1
2978303|NCT00836927|3693764|FG003|Completed Dosing Through 03 Apr 2017|Overall Study||0
2978304|NCT00836927|3693765|FG004|Completed Dosing Through 03 Apr 2017|Overall Study||0
2978305|NCT00836927|3693761|FG000|COMPLETED|Overall Study||0
2978306|NCT00836927|3693762|FG001|COMPLETED|Overall Study|Participant completed treatment by 04 Feb 2018|1
2978307|NCT00836927|3693763|FG002|COMPLETED|Overall Study|Participant completed treatment by 04 Feb 2018|1
2978308|NCT00836927|3693764|FG003|COMPLETED|Overall Study||0
2978309|NCT00836927|3693765|FG004|COMPLETED|Overall Study||0
2978310|NCT00836927|3693761|FG000|NOT COMPLETED|Overall Study||3
2978311|NCT00836927|3693762|FG001|NOT COMPLETED|Overall Study||0
2978312|NCT00836927|3693763|FG002|NOT COMPLETED|Overall Study||0
2978313|NCT00836927|3693764|FG003|NOT COMPLETED|Overall Study||1
2978314|NCT00836927|3693765|FG004|NOT COMPLETED|Overall Study||1
2978315|NCT00836953|3693779|FG000|STARTED|Overall Study||33
2978316|NCT00836953|3693779|FG000|COMPLETED|Overall Study||31
2978317|NCT00836953|3693779|FG000|NOT COMPLETED|Overall Study||2
2978318|NCT00837031|3693783|FG000|STARTED|Overall Study||72
2978319|NCT00837031|3693783|FG000|COMPLETED|Overall Study||72
2978320|NCT00837031|3693783|FG000|NOT COMPLETED|Overall Study||0
2978321|NCT00837096|3693789|FG000|STARTED|Overall Study||10
2978322|NCT00837096|3693790|FG001|STARTED|Overall Study||9
2978323|NCT00837096|3693789|FG000|COMPLETED|Overall Study||0
2978324|NCT00837096|3693790|FG001|COMPLETED|Overall Study||0
2978325|NCT00837096|3693789|FG000|NOT COMPLETED|Overall Study||10
2978326|NCT00837096|3693790|FG001|NOT COMPLETED|Overall Study||9
2978327|NCT00837148|3693796|FG000|STARTED|Overall Study||37
2978328|NCT00837148|3693796|FG000|COMPLETED|Overall Study||35
2978329|NCT00837148|3693796|FG000|NOT COMPLETED|Overall Study||2
2978330|NCT00837161|3693800|FG000|STARTED|Overall Study||11
2978331|NCT00837161|3693800|FG000|COMPLETED|Overall Study||9
2978332|NCT00837161|3693800|FG000|NOT COMPLETED|Overall Study||2
2978333|NCT00837200|3693804|FG000|STARTED|Overall Study||13
2978334|NCT00837200|3693804|FG000|COMPLETED|Overall Study||13
2978335|NCT00837200|3693804|FG000|NOT COMPLETED|Overall Study||0
2978336|NCT00837213|3693810|FG000|STARTED|Overall Study||16
2978337|NCT00837213|3693811|FG001|STARTED|Overall Study||17
2978338|NCT00837213|3693810|FG000|COMPLETED|Overall Study||10
2978339|NCT00837213|3693811|FG001|COMPLETED|Overall Study||12
2978340|NCT00837213|3693810|FG000|NOT COMPLETED|Overall Study||6
2978341|NCT00837213|3693811|FG001|NOT COMPLETED|Overall Study||5
2978342|NCT00837252|3693817|FG000|STARTED|Overall Study||5
2978343|NCT00837252|3693817|FG000|COMPLETED|Overall Study||5
2978344|NCT00837252|3693817|FG000|NOT COMPLETED|Overall Study||0
2978345|NCT00837330|3693823|FG000|STARTED|Overall Study||10
2978346|NCT00837330|3693824|FG001|STARTED|Overall Study||10
2978347|NCT00837330|3693823|FG000|COMPLETED|Overall Study||9
2978348|NCT00837330|3693824|FG001|COMPLETED|Overall Study||7
2978349|NCT00837330|3693823|FG000|NOT COMPLETED|Overall Study||1
2978350|NCT00837330|3693824|FG001|NOT COMPLETED|Overall Study||3
2978351|NCT00837434|3693832|FG000|STARTED|Overall Study||43
2978352|NCT00837434|3693833|FG001|STARTED|Overall Study||20
2978353|NCT00837434|3693832|FG000|COMPLETED|Overall Study||34
2978354|NCT00837434|3693833|FG001|COMPLETED|Overall Study||19
2978355|NCT00837434|3693832|FG000|NOT COMPLETED|Overall Study||9
2978356|NCT00837434|3693833|FG001|NOT COMPLETED|Overall Study||1
2978357|NCT00837447|3693839|FG000|STARTED|Overall Study|Each of the 54 pts received a Nexgen CR on one side and a Nexgen CR-Flex on the contralateral side.|54
3164226|NCT01891864|3891706|FG000|STARTED|Treatment Period 1||264
3164227|NCT01891864|3891707|FG001|STARTED|Treatment Period 1||267
3164228|NCT01891864|3891708|FG002|STARTED|Treatment Period 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
3164229|NCT01891864|3891709|FG003|STARTED|Treatment Period 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
2978358|NCT00837447|3693839|FG000|COMPLETED|Overall Study|Each of the 54 pts received a Nexgen CR on one side and a Nexgen CR-Flex on the contralateral side.|54
3303251|NCT02965781|4036582|FG000|STARTED|Overall Study||46
2978359|NCT00837447|3693839|FG000|NOT COMPLETED|Overall Study||0
2978360|NCT00837473|3693844|FG000|STARTED|Overall Study||15
2978361|NCT00837473|3693844|FG000|COMPLETED|Overall Study||12
2978362|NCT00837473|3693844|FG000|NOT COMPLETED|Overall Study||3
2978363|NCT00837486|3693850|FG000|STARTED|Blinded-treatment Phase||16
2978364|NCT00837486|3693851|FG001|STARTED|Blinded-treatment Phase||14
2978365|NCT00837486|3693850|FG000|COMPLETED|Blinded-treatment Phase|One subject did not receive the allocated intervention.|15
2978366|NCT00837486|3693851|FG001|COMPLETED|Blinded-treatment Phase||14
2978367|NCT00837486|3693850|FG000|NOT COMPLETED|Blinded-treatment Phase||1
2978368|NCT00837486|3693851|FG001|NOT COMPLETED|Blinded-treatment Phase||0
2978369|NCT00837486|3693850|FG000|STARTED|Long-term Follow-up Phase - Open Label|All subjects received open-label stimulation during this phase.|29
2978370|NCT00837486|3693851|FG001|STARTED|Long-term Follow-up Phase - Open Label||0
2978371|NCT00837486|3693850|FG000|COMPLETED|Long-term Follow-up Phase - Open Label||24
2978372|NCT00837486|3693851|FG001|COMPLETED|Long-term Follow-up Phase - Open Label||0
2978373|NCT00837486|3693850|FG000|NOT COMPLETED|Long-term Follow-up Phase - Open Label||5
2978374|NCT00837486|3693851|FG001|NOT COMPLETED|Long-term Follow-up Phase - Open Label||0
2978375|NCT00837512|3693859|FG000|STARTED|First Intervention (6hrs) - RANDOMIZED||8
2978376|NCT00837512|3693860|FG001|STARTED|First Intervention (6hrs) - RANDOMIZED||8
2978377|NCT00837512|3693859|FG000|COMPLETED|First Intervention (6hrs) - RANDOMIZED||8
2978378|NCT00837512|3693860|FG001|COMPLETED|First Intervention (6hrs) - RANDOMIZED||8
2978379|NCT00837512|3693859|FG000|NOT COMPLETED|First Intervention (6hrs) - RANDOMIZED||0
2978380|NCT00837512|3693860|FG001|NOT COMPLETED|First Intervention (6hrs) - RANDOMIZED||0
2978381|NCT00837512|3693859|FG000|STARTED|Both Arms: Washout (7-28 Days)||8
2978382|NCT00837512|3693860|FG001|STARTED|Both Arms: Washout (7-28 Days)||8
2978383|NCT00837512|3693859|FG000|COMPLETED|Both Arms: Washout (7-28 Days)||8
2978384|NCT00837512|3693860|FG001|COMPLETED|Both Arms: Washout (7-28 Days)||8
2978385|NCT00837512|3693859|FG000|NOT COMPLETED|Both Arms: Washout (7-28 Days)||0
2978386|NCT00837512|3693860|FG001|NOT COMPLETED|Both Arms: Washout (7-28 Days)||0
2978387|NCT00837512|3693859|FG000|STARTED|2nd Intervention (6 Hrs) - RANDOMIZED||8
2978388|NCT00837512|3693860|FG001|STARTED|2nd Intervention (6 Hrs) - RANDOMIZED||8
2978389|NCT00837512|3693859|FG000|COMPLETED|2nd Intervention (6 Hrs) - RANDOMIZED||8
2978390|NCT00837512|3693860|FG001|COMPLETED|2nd Intervention (6 Hrs) - RANDOMIZED||8
2978391|NCT00837512|3693859|FG000|NOT COMPLETED|2nd Intervention (6 Hrs) - RANDOMIZED||0
2978392|NCT00837512|3693860|FG001|NOT COMPLETED|2nd Intervention (6 Hrs) - RANDOMIZED||0
2978393|NCT00837577|3693868|FG000|STARTED|Double-blind Period||70
2978394|NCT00837577|3693869|FG001|STARTED|Double-blind Period||63
2978395|NCT00837577|3693868|FG000|COMPLETED|Double-blind Period||68
2978396|NCT00837577|3693869|FG001|COMPLETED|Double-blind Period||63
2978397|NCT00837577|3693868|FG000|NOT COMPLETED|Double-blind Period||2
2978398|NCT00837577|3693869|FG001|NOT COMPLETED|Double-blind Period||0
2978399|NCT00837577|3693868|FG000|STARTED|Open-label Period||68
2978400|NCT00837577|3693869|FG001|STARTED|Open-label Period||63
2978401|NCT00837577|3693868|FG000|COMPLETED|Open-label Period||60
2978402|NCT00837577|3693869|FG001|COMPLETED|Open-label Period||54
2978403|NCT00837577|3693868|FG000|NOT COMPLETED|Open-label Period||8
2978404|NCT00837577|3693869|FG001|NOT COMPLETED|Open-label Period||9
2978405|NCT00837590|3693879|FG000|STARTED|Overall Study||6
2978406|NCT00837590|3693880|FG001|STARTED|Overall Study||5
2978407|NCT00837590|3693881|FG002|STARTED|Overall Study||5
2978408|NCT00837590|3693879|FG000|COMPLETED|Overall Study||6
2978409|NCT00837590|3693880|FG001|COMPLETED|Overall Study||4
2978410|NCT00837590|3693881|FG002|COMPLETED|Overall Study||4
2978411|NCT00837590|3693879|FG000|NOT COMPLETED|Overall Study||0
2978412|NCT00837590|3693880|FG001|NOT COMPLETED|Overall Study||1
2978413|NCT00837590|3693881|FG002|NOT COMPLETED|Overall Study||1
2978414|NCT00837616|3693891|FG000|STARTED|Overall Study||20
2978415|NCT00837616|3693892|FG001|STARTED|Overall Study||21
2978416|NCT00837616|3693891|FG000|COMPLETED|Overall Study||20
2978417|NCT00837616|3693892|FG001|COMPLETED|Overall Study||20
2978418|NCT00837616|3693891|FG000|NOT COMPLETED|Overall Study||0
2978419|NCT00837616|3693892|FG001|NOT COMPLETED|Overall Study||1
2978420|NCT00837694|3693904|FG000|STARTED|Overall Study||10
2978421|NCT00837694|3693905|FG001|STARTED|Overall Study||11
2978422|NCT00837694|3693906|FG002|STARTED|Overall Study||10
2978423|NCT00837694|3693907|FG003|STARTED|Overall Study||11
2978424|NCT00837694|3693908|FG004|STARTED|Overall Study||12
3303252|NCT02965781|4036583|FG001|STARTED|Overall Study||46
3303253|NCT02965781|4036584|FG002|STARTED|Overall Study||47
3303254|NCT02965781|4036582|FG000|COMPLETED|Overall Study||46
3303255|NCT02965781|4036583|FG001|COMPLETED|Overall Study||46
3303256|NCT02965781|4036584|FG002|COMPLETED|Overall Study||47
3303257|NCT02965781|4036582|FG000|NOT COMPLETED|Overall Study||0
3303258|NCT02965781|4036583|FG001|NOT COMPLETED|Overall Study||0
3303259|NCT02965781|4036584|FG002|NOT COMPLETED|Overall Study||0
2978425|NCT00837694|3693909|FG005|STARTED|Overall Study||11
2978426|NCT00837694|3693904|FG000|COMPLETED|Overall Study||8
2978427|NCT00837694|3693905|FG001|COMPLETED|Overall Study||11
2978428|NCT00837694|3693906|FG002|COMPLETED|Overall Study||8
2978429|NCT00837694|3693907|FG003|COMPLETED|Overall Study||10
2978430|NCT00837694|3693908|FG004|COMPLETED|Overall Study||11
2978431|NCT00837694|3693909|FG005|COMPLETED|Overall Study||10
2978432|NCT00837694|3693904|FG000|NOT COMPLETED|Overall Study||2
2978433|NCT00837694|3693905|FG001|NOT COMPLETED|Overall Study||0
2978434|NCT00837694|3693906|FG002|NOT COMPLETED|Overall Study||2
2978435|NCT00837694|3693907|FG003|NOT COMPLETED|Overall Study||1
2978436|NCT00837694|3693908|FG004|NOT COMPLETED|Overall Study||1
2978437|NCT00837694|3693909|FG005|NOT COMPLETED|Overall Study||1
2978438|NCT00837759|3693923|FG000|STARTED|Overall Study||7
2978439|NCT00837759|3693923|FG000|COMPLETED|Overall Study||3
2978440|NCT00837759|3693923|FG000|NOT COMPLETED|Overall Study||4
2978441|NCT00837811|3693930|FG000|STARTED|Overall Study||60
2978442|NCT00837811|3693931|FG001|STARTED|Overall Study||121
2978443|NCT00837811|3693932|FG002|STARTED|Overall Study||1
2978444|NCT00837811|3693930|FG000|Received Any Amount of Study Drug|Overall Study||60
2978445|NCT00837811|3693931|FG001|Received Any Amount of Study Drug|Overall Study||121
2978446|NCT00837811|3693932|FG002|Received Any Amount of Study Drug|Overall Study||1
2978447|NCT00837811|3693930|FG000|Had at Least 1 Efficacy Assessment|Overall Study||59
2978448|NCT00837811|3693931|FG001|Had at Least 1 Efficacy Assessment|Overall Study||121
2978449|NCT00837811|3693932|FG002|Had at Least 1 Efficacy Assessment|Overall Study||1
2978450|NCT00837811|3693930|FG000|Included in Efficacy Analyses|Overall Study||59
2978451|NCT00837811|3693931|FG001|Included in Efficacy Analyses|Overall Study|Excludes participant from site with Good Clinical Practice (GCP) violations.|120
2978452|NCT00837811|3693932|FG002|Included in Efficacy Analyses|Overall Study||1
2978453|NCT00837811|3693930|FG000|COMPLETED|Overall Study||53
2978454|NCT00837811|3693931|FG001|COMPLETED|Overall Study||87
2978455|NCT00837811|3693932|FG002|COMPLETED|Overall Study||0
2978456|NCT00837811|3693930|FG000|NOT COMPLETED|Overall Study||7
2978457|NCT00837811|3693931|FG001|NOT COMPLETED|Overall Study||34
2978458|NCT00837811|3693932|FG002|NOT COMPLETED|Overall Study||1
2978459|NCT00837824|3693951|FG000|STARTED|Overall Study||11
2978460|NCT00837824|3693952|FG001|STARTED|Overall Study||9
2978461|NCT00837824|3693951|FG000|COMPLETED|Overall Study||11
2978462|NCT00837824|3693952|FG001|COMPLETED|Overall Study||9
2978463|NCT00837824|3693951|FG000|NOT COMPLETED|Overall Study||0
2978464|NCT00837824|3693952|FG001|NOT COMPLETED|Overall Study||0
2978465|NCT00837876|3693959|FG000|STARTED|Overall Study||37
2978466|NCT00837876|3693959|FG000|COMPLETED|Overall Study||0
2978467|NCT00837876|3693959|FG000|NOT COMPLETED|Overall Study||37
2978468|NCT00837902|3693965|FG000|STARTED|Overall Study||85
2978469|NCT00837902|3693966|FG001|STARTED|Overall Study||69
2978470|NCT00837902|3693965|FG000|COMPLETED|Overall Study||85
2978471|NCT00837902|3693966|FG001|COMPLETED|Overall Study||69
2978472|NCT00837902|3693965|FG000|NOT COMPLETED|Overall Study||0
2978473|NCT00837902|3693966|FG001|NOT COMPLETED|Overall Study||0
2978474|NCT00837967|3693973|FG000|STARTED|First Intervention||13
2978475|NCT00837967|3693974|FG001|STARTED|First Intervention||12
2978476|NCT00837967|3693973|FG000|COMPLETED|First Intervention||13
2978477|NCT00837967|3693974|FG001|COMPLETED|First Intervention||12
2978478|NCT00837967|3693973|FG000|NOT COMPLETED|First Intervention||0
2978479|NCT00837967|3693974|FG001|NOT COMPLETED|First Intervention||0
2978480|NCT00837967|3693973|FG000|STARTED|Washout Period of 7 - 14 Days||13
2978481|NCT00837967|3693974|FG001|STARTED|Washout Period of 7 - 14 Days||12
2978482|NCT00837967|3693973|FG000|COMPLETED|Washout Period of 7 - 14 Days||11
2978483|NCT00837967|3693974|FG001|COMPLETED|Washout Period of 7 - 14 Days||12
2978484|NCT00837967|3693973|FG000|NOT COMPLETED|Washout Period of 7 - 14 Days||2
2978485|NCT00837967|3693974|FG001|NOT COMPLETED|Washout Period of 7 - 14 Days||0
2978486|NCT00837967|3693973|FG000|STARTED|Second Intervention||11
2978487|NCT00837967|3693974|FG001|STARTED|Second Intervention||12
2978488|NCT00837967|3693973|FG000|COMPLETED|Second Intervention||11
2978489|NCT00837967|3693974|FG001|COMPLETED|Second Intervention||12
2978490|NCT00837967|3693973|FG000|NOT COMPLETED|Second Intervention||0
2978491|NCT00837967|3693974|FG001|NOT COMPLETED|Second Intervention||0
2978492|NCT00838006|3693983|FG000|STARTED|Overall Study||102
2978493|NCT00838006|3693984|FG001|STARTED|Overall Study||98
2978494|NCT00838006|3693985|FG002|STARTED|Overall Study||142
2978495|NCT00838006|3693983|FG000|3-month Post-deployment Follow-up|Overall Study||92
2978496|NCT00838006|3693984|FG001|3-month Post-deployment Follow-up|Overall Study||80
2978497|NCT00838006|3693985|FG002|3-month Post-deployment Follow-up|Overall Study||135
2978498|NCT00838006|3693983|FG000|COMPLETED|Overall Study||68
2978499|NCT00838006|3693984|FG001|COMPLETED|Overall Study||72
2978500|NCT00838006|3693985|FG002|COMPLETED|Overall Study||94
2978501|NCT00838006|3693983|FG000|NOT COMPLETED|Overall Study||34
2978502|NCT00838006|3693984|FG001|NOT COMPLETED|Overall Study||26
2978503|NCT00838006|3693985|FG002|NOT COMPLETED|Overall Study||48
2978504|NCT00838097|3693995|FG000|STARTED|Overall Study||321
2978505|NCT00838097|3693995|FG000|Received Darbepoetin Alfa|Overall Study||319
2978506|NCT00838097|3693995|FG000|COMPLETED|Overall Study||145
2978507|NCT00838097|3693995|FG000|NOT COMPLETED|Overall Study||176
2978508|NCT00838110|3694001|FG000|STARTED|Overall Study||127
2978509|NCT00838110|3694002|FG001|STARTED|Overall Study||128
2978510|NCT00838110|3694003|FG002|STARTED|Overall Study||243
2978511|NCT00838110|3694004|FG003|STARTED|Overall Study||244
2978512|NCT00838110|3694001|FG000|Treated|Overall Study||127
2978513|NCT00838110|3694002|FG001|Treated|Overall Study||127
2978514|NCT00838110|3694003|FG002|Treated|Overall Study||243
2978515|NCT00838110|3694004|FG003|Treated|Overall Study||244
2978516|NCT00838110|3694001|FG000|COMPLETED|Overall Study||105
2978517|NCT00838110|3694002|FG001|COMPLETED|Overall Study||106
2978518|NCT00838110|3694003|FG002|COMPLETED|Overall Study||226
2978519|NCT00838110|3694004|FG003|COMPLETED|Overall Study||226
2978520|NCT00838110|3694001|FG000|NOT COMPLETED|Overall Study||22
2978521|NCT00838110|3694002|FG001|NOT COMPLETED|Overall Study||22
2978522|NCT00838110|3694003|FG002|NOT COMPLETED|Overall Study||17
2978523|NCT00838110|3694004|FG003|NOT COMPLETED|Overall Study||18
2978524|NCT00838162|3694018|FG000|STARTED|Overall Study||9
2978525|NCT00838162|3694019|FG001|STARTED|Overall Study||8
2978526|NCT00838162|3694020|FG002|STARTED|Overall Study||8
2978527|NCT00838162|3694021|FG003|STARTED|Overall Study||8
2978528|NCT00838162|3694018|FG000|COMPLETED|Overall Study||9
2978529|NCT00838162|3694019|FG001|COMPLETED|Overall Study||8
2978530|NCT00838162|3694020|FG002|COMPLETED|Overall Study||8
2978531|NCT00838162|3694021|FG003|COMPLETED|Overall Study||8
2978532|NCT00838162|3694018|FG000|NOT COMPLETED|Overall Study||0
2978533|NCT00838162|3694019|FG001|NOT COMPLETED|Overall Study||0
2978534|NCT00838162|3694020|FG002|NOT COMPLETED|Overall Study||0
2978535|NCT00838162|3694021|FG003|NOT COMPLETED|Overall Study||0
2978536|NCT00838201|3694033|FG000|STARTED|Overall Study||186
2978537|NCT00838201|3694034|FG001|STARTED|Overall Study||198
2978538|NCT00838201|3694033|FG000|COMPLETED|Overall Study||144
2978539|NCT00838201|3694034|FG001|COMPLETED|Overall Study||145
2978540|NCT00838201|3694033|FG000|NOT COMPLETED|Overall Study||42
2978541|NCT00838201|3694034|FG001|NOT COMPLETED|Overall Study||53
2978542|NCT00838331|3694040|FG000|STARTED|Fresh Blood Transfusion||17
2978543|NCT00838331|3694040|FG000|COMPLETED|Fresh Blood Transfusion||17
2978544|NCT00838331|3694040|FG000|NOT COMPLETED|Fresh Blood Transfusion||0
2978545|NCT00838331|3694040|FG000|STARTED|Aged Blood Transfusion||17
2978546|NCT00838331|3694040|FG000|COMPLETED|Aged Blood Transfusion||8
2978547|NCT00838331|3694040|FG000|NOT COMPLETED|Aged Blood Transfusion||9
2978548|NCT00838435|3694044|FG000|STARTED|Part 1 (4 Weeks)||95
2978549|NCT00838435|3694044|FG000|COMPLETED|Part 1 (4 Weeks)||95
2978550|NCT00838435|3694044|FG000|NOT COMPLETED|Part 1 (4 Weeks)||0
2978551|NCT00838435|3694044|FG000|STARTED|PK Sub-Study 2 (4 Weeks)|1 subject declined participation in the PK Sub-Study.|94
2978552|NCT00838435|3694044|FG000|COMPLETED|PK Sub-Study 2 (4 Weeks)||93
2978553|NCT00838435|3694044|FG000|NOT COMPLETED|PK Sub-Study 2 (4 Weeks)||1
2978554|NCT00838435|3694044|FG000|STARTED|Safety/Efficacy Sub-Study 1 (6 Months)|65 of 95 subjects in Part 1 were determined responders & eligible for the Safety/Efficacy Sub-study.|65
2978555|NCT00838435|3694044|FG000|COMPLETED|Safety/Efficacy Sub-Study 1 (6 Months)||63
2978556|NCT00838435|3694044|FG000|NOT COMPLETED|Safety/Efficacy Sub-Study 1 (6 Months)||2
2978557|NCT00838435|3694044|FG000|STARTED|Part 2 (7 Years)|65 of 95 subjects in Part 1 were determined responders & eligible for the Part 2 of the study.|65
2978558|NCT00838435|3694044|FG000|COMPLETED|Part 2 (7 Years)||49
2978559|NCT00838435|3694044|FG000|NOT COMPLETED|Part 2 (7 Years)||16
2978560|NCT00838513|3694051|FG000|STARTED|Screening Period||23
2978561|NCT00838513|3694051|FG000|COMPLETED|Screening Period||20
2978562|NCT00838513|3694051|FG000|NOT COMPLETED|Screening Period||3
2978563|NCT00838513|3694051|FG000|STARTED|Observation Period (8 Weeks)||20
2978564|NCT00838513|3694051|FG000|COMPLETED|Observation Period (8 Weeks)||20
2978565|NCT00838513|3694051|FG000|NOT COMPLETED|Observation Period (8 Weeks)||0
2978566|NCT00838513|3694051|FG000|STARTED|Treatment Period (26 Weeks)||20
2978567|NCT00838513|3694051|FG000|COMPLETED|Treatment Period (26 Weeks)||20
2978568|NCT00838513|3694051|FG000|NOT COMPLETED|Treatment Period (26 Weeks)||0
2978569|NCT00838513|3694051|FG000|STARTED|Extension Treatment Period||19
2978570|NCT00838513|3694051|FG000|COMPLETED|Extension Treatment Period||18
2978571|NCT00838513|3694051|FG000|NOT COMPLETED|Extension Treatment Period||1
2978572|NCT00838513|3694051|FG000|STARTED|Post Treatment Period (Patients Who Disc||5
2978573|NCT00838513|3694051|FG000|COMPLETED|Post Treatment Period (Patients Who Disc||4
2978574|NCT00838513|3694051|FG000|NOT COMPLETED|Post Treatment Period (Patients Who Disc||1
2978575|NCT00838526|3694057|FG000|STARTED|Overall Study|Treated|59
2978576|NCT00838526|3694058|FG001|STARTED|Overall Study|Treated|176
2978577|NCT00838526|3694057|FG000|COMPLETED|Overall Study||35
2978578|NCT00838526|3694058|FG001|COMPLETED|Overall Study||137
2978579|NCT00838526|3694057|FG000|NOT COMPLETED|Overall Study||24
2978580|NCT00838526|3694058|FG001|NOT COMPLETED|Overall Study||39
2978581|NCT00838539|3694076|FG000|STARTED|Overall Study||3
2978582|NCT00838539|3694077|FG001|STARTED|Overall Study||6
2978583|NCT00838539|3694078|FG002|STARTED|Overall Study||5
2978584|NCT00838539|3694079|FG003|STARTED|Overall Study||4
2978585|NCT00838539|3694080|FG004|STARTED|Overall Study||6
2978586|NCT00838539|3694081|FG005|STARTED|Overall Study||4
2978587|NCT00838539|3694082|FG006|STARTED|Overall Study||7
2978588|NCT00838539|3694083|FG007|STARTED|Overall Study||6
2978589|NCT00838539|3694084|FG008|STARTED|Overall Study||5
2978590|NCT00838539|3694085|FG009|STARTED|Overall Study||8
2978591|NCT00838539|3694086|FG010|STARTED|Overall Study||5
2978592|NCT00838539|3694087|FG011|STARTED|Overall Study||4
2978593|NCT00838539|3694076|FG000|Received Treatment|Overall Study||3
2978594|NCT00838539|3694077|FG001|Received Treatment|Overall Study||5
2978595|NCT00838539|3694078|FG002|Received Treatment|Overall Study||5
2978596|NCT00838539|3694079|FG003|Received Treatment|Overall Study||4
2978597|NCT00838539|3694080|FG004|Received Treatment|Overall Study||4
2978598|NCT00838539|3694081|FG005|Received Treatment|Overall Study||4
2978599|NCT00838539|3694082|FG006|Received Treatment|Overall Study||7
2978600|NCT00838539|3694083|FG007|Received Treatment|Overall Study||6
2978601|NCT00838539|3694084|FG008|Received Treatment|Overall Study||5
2978602|NCT00838539|3694085|FG009|Received Treatment|Overall Study||8
2978603|NCT00838539|3694086|FG010|Received Treatment|Overall Study||5
2978604|NCT00838539|3694087|FG011|Received Treatment|Overall Study||4
2978605|NCT00838539|3694076|FG000|COMPLETED|Overall Study||0
2978606|NCT00838539|3694077|FG001|COMPLETED|Overall Study||0
2978607|NCT00838539|3694078|FG002|COMPLETED|Overall Study||0
2978608|NCT00838539|3694079|FG003|COMPLETED|Overall Study||0
2978609|NCT00838539|3694080|FG004|COMPLETED|Overall Study||0
2978610|NCT00838539|3694081|FG005|COMPLETED|Overall Study||0
2978611|NCT00838539|3694082|FG006|COMPLETED|Overall Study||2
2978612|NCT00838539|3694083|FG007|COMPLETED|Overall Study||0
2978613|NCT00838539|3694084|FG008|COMPLETED|Overall Study||0
2978614|NCT00838539|3694085|FG009|COMPLETED|Overall Study||0
2978615|NCT00838539|3694086|FG010|COMPLETED|Overall Study||0
2978616|NCT00838539|3694087|FG011|COMPLETED|Overall Study||0
2978617|NCT00838539|3694076|FG000|NOT COMPLETED|Overall Study||3
2978618|NCT00838539|3694077|FG001|NOT COMPLETED|Overall Study||6
2978619|NCT00838539|3694078|FG002|NOT COMPLETED|Overall Study||5
2978620|NCT00838539|3694079|FG003|NOT COMPLETED|Overall Study||4
2978621|NCT00838539|3694080|FG004|NOT COMPLETED|Overall Study||6
2978622|NCT00838539|3694081|FG005|NOT COMPLETED|Overall Study||4
2978623|NCT00838539|3694082|FG006|NOT COMPLETED|Overall Study||5
2978624|NCT00838539|3694083|FG007|NOT COMPLETED|Overall Study||6
2978625|NCT00838539|3694084|FG008|NOT COMPLETED|Overall Study||5
2978626|NCT00838539|3694085|FG009|NOT COMPLETED|Overall Study||8
2978627|NCT00838539|3694086|FG010|NOT COMPLETED|Overall Study||5
2978628|NCT00838539|3694087|FG011|NOT COMPLETED|Overall Study||4
2978629|NCT00838565|3694133|FG000|STARTED|Overall Study||9
2978630|NCT00838565|3694134|FG001|STARTED|Overall Study||7
2978631|NCT00838565|3694135|FG002|STARTED|Overall Study||6
2978632|NCT00838565|3694136|FG003|STARTED|Overall Study||6
2978633|NCT00838565|3694137|FG004|STARTED|Overall Study||6
2978634|NCT00838565|3694138|FG005|STARTED|Overall Study||7
2978635|NCT00838565|3694133|FG000|Treated|Overall Study||9
2978636|NCT00838565|3694134|FG001|Treated|Overall Study||6
2978637|NCT00838565|3694135|FG002|Treated|Overall Study||6
2978638|NCT00838565|3694136|FG003|Treated|Overall Study||6
2978639|NCT00838565|3694137|FG004|Treated|Overall Study||6
2978640|NCT00838565|3694138|FG005|Treated|Overall Study||7
2978641|NCT00838565|3694133|FG000|COMPLETED|Overall Study||9
2978642|NCT00838565|3694134|FG001|COMPLETED|Overall Study||4
2978643|NCT00838565|3694135|FG002|COMPLETED|Overall Study||5
2978644|NCT00838565|3694136|FG003|COMPLETED|Overall Study||6
2978645|NCT00838565|3694137|FG004|COMPLETED|Overall Study||6
2978646|NCT00838565|3694138|FG005|COMPLETED|Overall Study||5
2978647|NCT00838565|3694133|FG000|NOT COMPLETED|Overall Study||0
2978648|NCT00838565|3694134|FG001|NOT COMPLETED|Overall Study||3
2978649|NCT00838565|3694135|FG002|NOT COMPLETED|Overall Study||1
2978650|NCT00838565|3694136|FG003|NOT COMPLETED|Overall Study||0
2978651|NCT00838565|3694137|FG004|NOT COMPLETED|Overall Study||0
2978652|NCT00838565|3694138|FG005|NOT COMPLETED|Overall Study||2
2978653|NCT00838578|3694157|FG000|STARTED|Overall Study|In this Ph 1/2 study, 65 subjects were enrolled; 2 were protocol violators, so only 63 treated.|65
2978654|NCT00838578|3694157|FG000|COMPLETED|Overall Study||63
2978655|NCT00838578|3694157|FG000|NOT COMPLETED|Overall Study||2
2978656|NCT00838682|3694167|FG000|STARTED|Overall Study||54
2978657|NCT00838682|3694168|FG001|STARTED|Overall Study||52
2978658|NCT00838682|3694167|FG000|COMPLETED|Overall Study||29
2978659|NCT00838682|3694168|FG001|COMPLETED|Overall Study||33
2978660|NCT00838682|3694167|FG000|NOT COMPLETED|Overall Study||25
2978661|NCT00838682|3694168|FG001|NOT COMPLETED|Overall Study||19
2978662|NCT00838695|3694176|FG000|STARTED|Overall Study||42
2978663|NCT00838695|3694177|FG001|STARTED|Overall Study||64
2978664|NCT00838695|3694176|FG000|COMPLETED|Overall Study||42
2978665|NCT00838695|3694177|FG001|COMPLETED|Overall Study||64
2978666|NCT00838695|3694176|FG000|NOT COMPLETED|Overall Study||0
2978667|NCT00838695|3694177|FG001|NOT COMPLETED|Overall Study||0
3164230|NCT01891864|3891710|FG004|STARTED|Treatment Period 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
2978668|NCT00838903|3694187|FG000|STARTED|Treatment Period (156 Weeks)||101
2978669|NCT00838903|3694188|FG001|STARTED|Treatment Period (156 Weeks)||302
2978670|NCT00838903|3694189|FG002|STARTED|Treatment Period (156 Weeks)||307
2978671|NCT00838903|3694190|FG003|STARTED|Treatment Period (156 Weeks)||302
2978672|NCT00838903|3694187|FG000|Missing Active Treatment Status|Treatment Period (156 Weeks)||1
2978673|NCT00838903|3694188|FG001|Missing Active Treatment Status|Treatment Period (156 Weeks)||0
2978674|NCT00838903|3694189|FG002|Missing Active Treatment Status|Treatment Period (156 Weeks)||0
2978675|NCT00838903|3694190|FG003|Missing Active Treatment Status|Treatment Period (156 Weeks)||0
2978676|NCT00838903|3694187|FG000|COMPLETED|Treatment Period (156 Weeks)||55
2978677|NCT00838903|3694188|FG001|COMPLETED|Treatment Period (156 Weeks)||190
2978678|NCT00838903|3694189|FG002|COMPLETED|Treatment Period (156 Weeks)||191
2978679|NCT00838903|3694190|FG003|COMPLETED|Treatment Period (156 Weeks)||192
2978680|NCT00838903|3694187|FG000|NOT COMPLETED|Treatment Period (156 Weeks)||46
2978681|NCT00838903|3694188|FG001|NOT COMPLETED|Treatment Period (156 Weeks)||112
2978682|NCT00838903|3694189|FG002|NOT COMPLETED|Treatment Period (156 Weeks)||116
2978683|NCT00838903|3694190|FG003|NOT COMPLETED|Treatment Period (156 Weeks)||110
2978684|NCT00838903|3694187|FG000|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|101
2978685|NCT00838903|3694188|FG001|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|302
2978686|NCT00838903|3694189|FG002|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|307
2978687|NCT00838903|3694190|FG003|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|302
2978688|NCT00838903|3694187|FG000|COMPLETED|Follow-up Period (8 Weeks)||75
2978689|NCT00838903|3694188|FG001|COMPLETED|Follow-up Period (8 Weeks)||237
2978690|NCT00838903|3694189|FG002|COMPLETED|Follow-up Period (8 Weeks)||243
2978691|NCT00838903|3694190|FG003|COMPLETED|Follow-up Period (8 Weeks)||244
2978692|NCT00838903|3694187|FG000|NOT COMPLETED|Follow-up Period (8 Weeks)||26
2978693|NCT00838903|3694188|FG001|NOT COMPLETED|Follow-up Period (8 Weeks)||65
2978694|NCT00838903|3694189|FG002|NOT COMPLETED|Follow-up Period (8 Weeks)||64
2978695|NCT00838903|3694190|FG003|NOT COMPLETED|Follow-up Period (8 Weeks)||58
2978696|NCT00838916|3694202|FG000|STARTED|Treatment Period (156 Weeks)||504
2978697|NCT00838916|3694203|FG001|STARTED|Treatment Period (156 Weeks)||241
2978698|NCT00838916|3694202|FG000|COMPLETED|Treatment Period (156 Weeks)||308
2978699|NCT00838916|3694203|FG001|COMPLETED|Treatment Period (156 Weeks)||164
2978700|NCT00838916|3694202|FG000|NOT COMPLETED|Treatment Period (156 Weeks)||196
2978701|NCT00838916|3694203|FG001|NOT COMPLETED|Treatment Period (156 Weeks)||77
2978702|NCT00838916|3694202|FG000|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|504
2978703|NCT00838916|3694203|FG001|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|241
2978704|NCT00838916|3694202|FG000|COMPLETED|Follow-up Period (8 Weeks)||408
2978705|NCT00838916|3694203|FG001|COMPLETED|Follow-up Period (8 Weeks)||190
2978706|NCT00838916|3694202|FG000|NOT COMPLETED|Follow-up Period (8 Weeks)||96
2978707|NCT00838916|3694203|FG001|NOT COMPLETED|Follow-up Period (8 Weeks)||51
2978708|NCT00838929|3694212|FG000|STARTED|Overall Study||3
2978709|NCT00838929|3694213|FG001|STARTED|Overall Study||8
2978710|NCT00838929|3694214|FG002|STARTED|Overall Study||6
2978711|NCT00838929|3694212|FG000|COMPLETED|Overall Study||3
2978712|NCT00838929|3694213|FG001|COMPLETED|Overall Study||5
2978713|NCT00838929|3694214|FG002|COMPLETED|Overall Study||5
2978714|NCT00838929|3694212|FG000|NOT COMPLETED|Overall Study||0
2978715|NCT00838929|3694213|FG001|NOT COMPLETED|Overall Study||3
2978716|NCT00838929|3694214|FG002|NOT COMPLETED|Overall Study||1
2978717|NCT00839072|3694220|FG000|STARTED|First Intervention Period||12
2978718|NCT00839072|3694221|FG001|STARTED|First Intervention Period||12
2978719|NCT00839072|3694220|FG000|COMPLETED|First Intervention Period||10
2978720|NCT00839072|3694221|FG001|COMPLETED|First Intervention Period||11
2978721|NCT00839072|3694220|FG000|NOT COMPLETED|First Intervention Period||2
2978722|NCT00839072|3694221|FG001|NOT COMPLETED|First Intervention Period||1
2978723|NCT00839072|3694220|FG000|STARTED|Washout Period of 7 Days||10
2978724|NCT00839072|3694221|FG001|STARTED|Washout Period of 7 Days||11
2978725|NCT00839072|3694220|FG000|COMPLETED|Washout Period of 7 Days||10
2978726|NCT00839072|3694221|FG001|COMPLETED|Washout Period of 7 Days||11
3164231|NCT01891864|3891711|FG005|STARTED|Treatment Period 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
3164232|NCT01891864|3891706|FG000|COMPLETED|Treatment Period 1|6 patients discontinued after completion of Treatment Period 1 and did NOT start Treatment Period 2|256
3164233|NCT01891864|3891707|FG001|COMPLETED|Treatment Period 1|8 patients discontinued after completion of Treatment Period 1 and did NOT start Treatment Period 2|255
3164234|NCT01891864|3891708|FG002|COMPLETED|Treatment Period 1||0
2978727|NCT00839072|3694220|FG000|NOT COMPLETED|Washout Period of 7 Days||0
2978728|NCT00839072|3694221|FG001|NOT COMPLETED|Washout Period of 7 Days||0
2978729|NCT00839072|3694220|FG000|STARTED|Second Intervention Period||10
2978730|NCT00839072|3694221|FG001|STARTED|Second Intervention Period||11
2978731|NCT00839072|3694220|FG000|COMPLETED|Second Intervention Period||9
2978732|NCT00839072|3694221|FG001|COMPLETED|Second Intervention Period||11
2978733|NCT00839072|3694220|FG000|NOT COMPLETED|Second Intervention Period||1
2978734|NCT00839072|3694221|FG001|NOT COMPLETED|Second Intervention Period||0
2978735|NCT00839098|3694230|FG000|STARTED|Overall Study||3
2978736|NCT00839098|3694231|FG001|STARTED|Overall Study||12
2978737|NCT00839098|3694232|FG002|STARTED|Overall Study||13
2978738|NCT00839098|3694230|FG000|COMPLETED|Overall Study||1
2978739|NCT00839098|3694231|FG001|COMPLETED|Overall Study||11
2978740|NCT00839098|3694232|FG002|COMPLETED|Overall Study||6
2978741|NCT00839098|3694230|FG000|NOT COMPLETED|Overall Study||2
2978742|NCT00839098|3694231|FG001|NOT COMPLETED|Overall Study||1
2978743|NCT00839098|3694232|FG002|NOT COMPLETED|Overall Study||7
2978744|NCT00839241|3694242|FG000|STARTED|Overall Study||20
2978745|NCT00839241|3694243|FG001|STARTED|Overall Study||25
2978746|NCT00839241|3694242|FG000|COMPLETED|Overall Study||15
2978747|NCT00839241|3694243|FG001|COMPLETED|Overall Study||8
2978748|NCT00839241|3694242|FG000|NOT COMPLETED|Overall Study||5
2978749|NCT00839241|3694243|FG001|NOT COMPLETED|Overall Study||17
2978750|NCT00839254|3694257|FG000|STARTED|Overall Study||1849
2978751|NCT00839254|3694258|FG001|STARTED|Overall Study||1316
2978752|NCT00839254|3694259|FG002|STARTED|Overall Study||1069
2978753|NCT00839254|3694260|FG003|STARTED|Overall Study||859
2978754|NCT00839254|3694261|FG004|STARTED|Overall Study||241
2978755|NCT00839254|3694262|FG005|STARTED|Overall Study||204
2978756|NCT00839254|3694263|FG006|STARTED|Overall Study||368
2978757|NCT00839254|3694264|FG007|STARTED|Overall Study||271
2978758|NCT00839254|3694257|FG000|COMPLETED|Overall Study||1696
2978759|NCT00839254|3694258|FG001|COMPLETED|Overall Study||1224
2978760|NCT00839254|3694259|FG002|COMPLETED|Overall Study||979
2978761|NCT00839254|3694260|FG003|COMPLETED|Overall Study||797
2978762|NCT00839254|3694261|FG004|COMPLETED|Overall Study||204
2978763|NCT00839254|3694262|FG005|COMPLETED|Overall Study||178
2978764|NCT00839254|3694263|FG006|COMPLETED|Overall Study||340
2978765|NCT00839254|3694264|FG007|COMPLETED|Overall Study||256
2978766|NCT00839254|3694257|FG000|NOT COMPLETED|Overall Study||153
2978767|NCT00839254|3694258|FG001|NOT COMPLETED|Overall Study||92
2978768|NCT00839254|3694259|FG002|NOT COMPLETED|Overall Study||90
2978769|NCT00839254|3694260|FG003|NOT COMPLETED|Overall Study||62
2978770|NCT00839254|3694261|FG004|NOT COMPLETED|Overall Study||37
2978771|NCT00839254|3694262|FG005|NOT COMPLETED|Overall Study||26
2978772|NCT00839254|3694263|FG006|NOT COMPLETED|Overall Study||28
2978773|NCT00839254|3694264|FG007|NOT COMPLETED|Overall Study||15
2978774|NCT00839306|3694315|FG000|STARTED|Overall Study|Treated|60
2978775|NCT00839306|3694316|FG001|STARTED|Overall Study|Treated|177
2978776|NCT00839306|3694315|FG000|COMPLETED|Overall Study||35
2978777|NCT00839306|3694316|FG001|COMPLETED|Overall Study||134
2978778|NCT00839306|3694315|FG000|NOT COMPLETED|Overall Study||25
2978779|NCT00839306|3694316|FG001|NOT COMPLETED|Overall Study||43
2978780|NCT00839319|3694328|FG000|STARTED|Overall Study||8
2978781|NCT00839319|3694329|FG001|STARTED|Overall Study||8
2978782|NCT00839319|3694330|FG002|STARTED|Overall Study||8
2978783|NCT00839319|3694331|FG003|STARTED|Overall Study||8
2978784|NCT00839319|3694332|FG004|STARTED|Overall Study||8
2978785|NCT00839319|3694328|FG000|COMPLETED|Overall Study|1 withdrew consent prior to procedures; 1 excluded from analysis (low serum LH)|6
2978786|NCT00839319|3694329|FG001|COMPLETED|Overall Study|1 excluded from analysis (low serum LH)|7
2978787|NCT00839319|3694330|FG002|COMPLETED|Overall Study|1 dropped out after Day 1 visit, 2 excluded from analysis (low serum LH)|5
2978788|NCT00839319|3694331|FG003|COMPLETED|Overall Study|1 withdrawn by investigator for syncopal reaction , 2 excluded from analysis (low serum LH)|5
2978789|NCT00839319|3694332|FG004|COMPLETED|Overall Study||8
2978790|NCT00839319|3694328|FG000|NOT COMPLETED|Overall Study||2
2978791|NCT00839319|3694329|FG001|NOT COMPLETED|Overall Study||1
2978792|NCT00839319|3694330|FG002|NOT COMPLETED|Overall Study||3
2978793|NCT00839319|3694331|FG003|NOT COMPLETED|Overall Study||3
2978794|NCT00839319|3694332|FG004|NOT COMPLETED|Overall Study||0
2978795|NCT00839332|3694347|FG000|STARTED|Phase 1||50
2978796|NCT00839332|3694348|FG001|STARTED|Phase 1|Participants in Phase 2 did not participate in Phase 1.|0
2978797|NCT00839332|3694349|FG002|STARTED|Phase 1|Participants in Phase 2 did not participate in Phase 1.|0
2978798|NCT00839332|3694347|FG000|Received at Least 1 Dose of Study Drug|Phase 1||50
2978799|NCT00839332|3694348|FG001|Received at Least 1 Dose of Study Drug|Phase 1||0
2978800|NCT00839332|3694349|FG002|Received at Least 1 Dose of Study Drug|Phase 1||0
2978801|NCT00839332|3694347|FG000|COMPLETED|Phase 1||0
2978802|NCT00839332|3694348|FG001|COMPLETED|Phase 1||0
2978803|NCT00839332|3694349|FG002|COMPLETED|Phase 1||0
2978804|NCT00839332|3694347|FG000|NOT COMPLETED|Phase 1||50
2978805|NCT00839332|3694348|FG001|NOT COMPLETED|Phase 1||0
2978806|NCT00839332|3694349|FG002|NOT COMPLETED|Phase 1||0
2978807|NCT00839332|3694347|FG000|STARTED|Phase 2|Participants in Phase 1 did not participate in Phase 2.|0
2978808|NCT00839332|3694348|FG001|STARTED|Phase 2||68
2978809|NCT00839332|3694349|FG002|STARTED|Phase 2||39
2978810|NCT00839332|3694347|FG000|Received at Least 1 Dose of Study Drug|Phase 2||0
2978811|NCT00839332|3694348|FG001|Received at Least 1 Dose of Study Drug|Phase 2||65
2978812|NCT00839332|3694349|FG002|Received at Least 1 Dose of Study Drug|Phase 2||34
2978813|NCT00839332|3694347|FG000|COMPLETED|Phase 2||0
2978814|NCT00839332|3694348|FG001|COMPLETED|Phase 2||0
2978815|NCT00839332|3694349|FG002|COMPLETED|Phase 2||0
2978816|NCT00839332|3694347|FG000|NOT COMPLETED|Phase 2||0
2978817|NCT00839332|3694348|FG001|NOT COMPLETED|Phase 2||68
3303260|NCT02965820|4036592|FG000|STARTED|Period 1, First 30 Days||59
3303261|NCT02965820|4036593|FG001|STARTED|Period 1, First 30 Days||62
3303262|NCT02965820|4036592|FG000|COMPLETED|Period 1, First 30 Days||59
3303263|NCT02965820|4036593|FG001|COMPLETED|Period 1, First 30 Days||62
3303264|NCT02965820|4036592|FG000|NOT COMPLETED|Period 1, First 30 Days||0
3303265|NCT02965820|4036593|FG001|NOT COMPLETED|Period 1, First 30 Days||0
3303266|NCT02965820|4036592|FG000|STARTED|Period 2, Second 30 Days|One subject discontinued due to an AE after completion of Period 1 but before beginning Period 2.|58
3303267|NCT02965820|4036593|FG001|STARTED|Period 2, Second 30 Days||62
3303268|NCT02965820|4036592|FG000|COMPLETED|Period 2, Second 30 Days||57
3303269|NCT02965820|4036593|FG001|COMPLETED|Period 2, Second 30 Days||61
3303270|NCT02965820|4036592|FG000|NOT COMPLETED|Period 2, Second 30 Days||1
3303271|NCT02965820|4036593|FG001|NOT COMPLETED|Period 2, Second 30 Days||1
3303272|NCT02965833|4036599|FG000|STARTED|Period 1, First 30 Days of Wear||67
3303273|NCT02965833|4036600|FG001|STARTED|Period 1, First 30 Days of Wear||54
3303274|NCT02965833|4036599|FG000|COMPLETED|Period 1, First 30 Days of Wear||64
2978818|NCT00839332|3694349|FG002|NOT COMPLETED|Phase 2||39
2978819|NCT00839423|3694362|FG000|STARTED|Overall Study||105
2978820|NCT00839423|3694363|FG001|STARTED|Overall Study||108
2978821|NCT00839423|3694364|FG002|STARTED|Overall Study||100
2978822|NCT00839423|3694365|FG003|STARTED|Overall Study||113
2978823|NCT00839423|3694362|FG000|COMPLETED|Overall Study||87
2978824|NCT00839423|3694363|FG001|COMPLETED|Overall Study||98
2978825|NCT00839423|3694364|FG002|COMPLETED|Overall Study||82
2978826|NCT00839423|3694365|FG003|COMPLETED|Overall Study||93
3303275|NCT02965833|4036600|FG001|COMPLETED|Period 1, First 30 Days of Wear||52
2978827|NCT00839423|3694362|FG000|NOT COMPLETED|Overall Study||18
2978828|NCT00839423|3694363|FG001|NOT COMPLETED|Overall Study||10
2978829|NCT00839423|3694364|FG002|NOT COMPLETED|Overall Study||18
2978830|NCT00839423|3694365|FG003|NOT COMPLETED|Overall Study||20
2978831|NCT00839436|3694378|FG000|STARTED|Overall Study||3
2978832|NCT00839436|3694379|FG001|STARTED|Overall Study||5
3317005|NCT03122860|4050493|FG000|Full Analysis Set|Overall Study||116
2978833|NCT00839436|3694380|FG002|STARTED|Overall Study||1
2978834|NCT00839436|3694378|FG000|COMPLETED|Overall Study||2
2978835|NCT00839436|3694379|FG001|COMPLETED|Overall Study||4
2978836|NCT00839436|3694380|FG002|COMPLETED|Overall Study||0
2978837|NCT00839436|3694378|FG000|NOT COMPLETED|Overall Study||1
2978838|NCT00839436|3694379|FG001|NOT COMPLETED|Overall Study||1
2978839|NCT00839436|3694380|FG002|NOT COMPLETED|Overall Study||1
2978840|NCT00839527|3694391|FG000|STARTED|Treatment Period (TP) (156 Weeks)||115
2978841|NCT00839527|3694392|FG001|STARTED|Treatment Period (TP) (156 Weeks)||277
2978842|NCT00839527|3694393|FG002|STARTED|Treatment Period (TP) (156 Weeks)||271
2978843|NCT00839527|3694391|FG000|COMPLETED|Treatment Period (TP) (156 Weeks)||55
2978844|NCT00839527|3694392|FG001|COMPLETED|Treatment Period (TP) (156 Weeks)||159
2978845|NCT00839527|3694393|FG002|COMPLETED|Treatment Period (TP) (156 Weeks)||152
2978846|NCT00839527|3694391|FG000|NOT COMPLETED|Treatment Period (TP) (156 Weeks)||60
2978847|NCT00839527|3694392|FG001|NOT COMPLETED|Treatment Period (TP) (156 Weeks)||118
2978848|NCT00839527|3694393|FG002|NOT COMPLETED|Treatment Period (TP) (156 Weeks)||119
2978849|NCT00839527|3694391|FG000|STARTED|Follow-up Period (FUP) (8 Weeks)|Par. withdrawing from the TP could enter the FUP. One par. did not participate in the FUP.|114
2978850|NCT00839527|3694392|FG001|STARTED|Follow-up Period (FUP) (8 Weeks)|Par. withdrawing from the TP could enter the FUP. Four par. did not participate in the FUP.|273
2978851|NCT00839527|3694393|FG002|STARTED|Follow-up Period (FUP) (8 Weeks)|Par. withdrawing from the TP could enter the FUP. Five par. did not participate in the FUP.|266
2978852|NCT00839527|3694391|FG000|COMPLETED|Follow-up Period (FUP) (8 Weeks)||86
2978853|NCT00839527|3694392|FG001|COMPLETED|Follow-up Period (FUP) (8 Weeks)||217
2978854|NCT00839527|3694393|FG002|COMPLETED|Follow-up Period (FUP) (8 Weeks)||204
2978855|NCT00839527|3694391|FG000|NOT COMPLETED|Follow-up Period (FUP) (8 Weeks)||28
2978856|NCT00839527|3694392|FG001|NOT COMPLETED|Follow-up Period (FUP) (8 Weeks)||56
2978857|NCT00839527|3694393|FG002|NOT COMPLETED|Follow-up Period (FUP) (8 Weeks)||62
2978858|NCT00839540|3694406|FG000|STARTED|Overall Study||8
2978859|NCT00839540|3694407|FG001|STARTED|Overall Study||8
2978860|NCT00839540|3694408|FG002|STARTED|Overall Study||5
2978861|NCT00839540|3694406|FG000|COMPLETED|Overall Study||8
2978862|NCT00839540|3694407|FG001|COMPLETED|Overall Study||8
2978863|NCT00839540|3694408|FG002|COMPLETED|Overall Study||5
2978864|NCT00839540|3694406|FG000|NOT COMPLETED|Overall Study||0
2978865|NCT00839540|3694407|FG001|NOT COMPLETED|Overall Study||0
2978866|NCT00839540|3694408|FG002|NOT COMPLETED|Overall Study||0
3036207|NCT01142232|3755420|FG000|NOT COMPLETED|Overall Study||3
3036208|NCT01142232|3755421|FG001|NOT COMPLETED|Overall Study||4
3036209|NCT01142232|3755422|FG002|NOT COMPLETED|Overall Study||3
3036210|NCT01142232|3755423|FG003|NOT COMPLETED|Overall Study||5
3036211|NCT01142232|3755424|FG004|NOT COMPLETED|Overall Study||34
3036212|NCT01142297|3755436|FG000|STARTED|Overall Study||24
3036213|NCT01142297|3755436|FG000|COMPLETED|Overall Study||18
3036214|NCT01142297|3755436|FG000|NOT COMPLETED|Overall Study||6
3036215|NCT01142310|3755445|FG000|STARTED|Overall Study||26
3036216|NCT01142310|3755446|FG001|STARTED|Overall Study||28
3133321|NCT01695239|3858307|FG002|STARTED|Extension Long-Term Extension Periods||0
3133322|NCT01695239|3858308|FG003|STARTED|Extension Long-Term Extension Periods||0
3036217|NCT01142310|3755445|FG000|COMPLETED|Overall Study||17
3036218|NCT01142310|3755446|FG001|COMPLETED|Overall Study||16
3036219|NCT01142310|3755445|FG000|NOT COMPLETED|Overall Study||9
3036220|NCT01142310|3755446|FG001|NOT COMPLETED|Overall Study||12
3036221|NCT01142323|3755452|FG000|STARTED|Overall Study||8
3036222|NCT01142323|3755452|FG000|COMPLETED|Overall Study||8
3036223|NCT01142323|3755452|FG000|NOT COMPLETED|Overall Study||0
3036224|NCT01142336|3755460|FG000|STARTED|Overall Study||26
3036225|NCT01142336|3755461|FG001|STARTED|Overall Study||23
3036226|NCT01142336|3755460|FG000|COMPLETED|Overall Study||25
3036227|NCT01142336|3755461|FG001|COMPLETED|Overall Study||21
3036228|NCT01142336|3755460|FG000|NOT COMPLETED|Overall Study||1
3036229|NCT01142336|3755461|FG001|NOT COMPLETED|Overall Study||2
3036230|NCT01142388|3755472|FG000|STARTED|Overall Study||47
3036231|NCT01142388|3755473|FG001|STARTED|Overall Study||47
3036232|NCT01142388|3755472|FG000|Eligible|Overall Study||43
3036233|NCT01142388|3755473|FG001|Eligible|Overall Study||44
3036234|NCT01142388|3755472|FG000|Treated|Overall Study||40
3036235|NCT01142388|3755473|FG001|Treated|Overall Study||44
3036236|NCT01142388|3755472|FG000|COMPLETED|Overall Study|Treatment continued until disease progression or intolerable toxicity.|0
3036237|NCT01142388|3755473|FG001|COMPLETED|Overall Study||0
3036238|NCT01142388|3755472|FG000|NOT COMPLETED|Overall Study||47
3036239|NCT01142388|3755473|FG001|NOT COMPLETED|Overall Study||47
3036240|NCT01142466|3755481|FG000|STARTED|Overall Study||15
3036241|NCT01142466|3755482|FG001|STARTED|Overall Study||15
3036242|NCT01142466|3755481|FG000|COMPLETED|Overall Study||12
3036243|NCT01142466|3755482|FG001|COMPLETED|Overall Study||13
3036244|NCT01142466|3755481|FG000|NOT COMPLETED|Overall Study||3
3036245|NCT01142466|3755482|FG001|NOT COMPLETED|Overall Study||2
3036246|NCT01142661|3755488|FG000|STARTED|Overall Study||9
3036247|NCT01142661|3755488|FG000|COMPLETED|Overall Study||5
3036248|NCT01142661|3755488|FG000|NOT COMPLETED|Overall Study||4
3036249|NCT01142726|3755495|FG000|STARTED|Treatment Phase: Day 1 Through Month 12||119
3036250|NCT01142726|3755496|FG001|STARTED|Treatment Phase: Day 1 Through Month 12||116
3036251|NCT01142726|3755497|FG002|STARTED|Treatment Phase: Day 1 Through Month 12||116
3036252|NCT01142726|3755495|FG000|COMPLETED|Treatment Phase: Day 1 Through Month 12||103
3036253|NCT01142726|3755496|FG001|COMPLETED|Treatment Phase: Day 1 Through Month 12||91
3036254|NCT01142726|3755497|FG002|COMPLETED|Treatment Phase: Day 1 Through Month 12||96
3036255|NCT01142726|3755495|FG000|NOT COMPLETED|Treatment Phase: Day 1 Through Month 12||16
2978867|NCT00839800|3694418|FG000|STARTED|Overall Study||1049
2978868|NCT00839800|3694419|FG001|STARTED|Overall Study||1042
2978869|NCT00839800|3694418|FG000|COMPLETED|Overall Study||956
2978870|NCT00839800|3694419|FG001|COMPLETED|Overall Study||932
2978871|NCT00839800|3694418|FG000|NOT COMPLETED|Overall Study||93
2978872|NCT00839800|3694419|FG001|NOT COMPLETED|Overall Study||110
2978873|NCT00839852|3694425|FG000|STARTED|Overall Study||93
2978874|NCT00839852|3694425|FG000|COMPLETED|Overall Study||46
2978875|NCT00839852|3694425|FG000|NOT COMPLETED|Overall Study||47
2978876|NCT00839917|3694431|FG000|STARTED|Overall Study||13
2978877|NCT00839917|3694432|FG001|STARTED|Overall Study||17
2978878|NCT00839917|3694431|FG000|COMPLETED|Overall Study|Study completers were randomized participants who received study vaccination and had follow-up data|12
2978879|NCT00839917|3694432|FG001|COMPLETED|Overall Study|Study completers were randomized participants who received study vaccination and had follow-up data|16
2978880|NCT00839917|3694431|FG000|NOT COMPLETED|Overall Study||1
2978881|NCT00839917|3694432|FG001|NOT COMPLETED|Overall Study||1
2978882|NCT00839956|3694438|FG000|STARTED|Overall Study||31
2978883|NCT00839956|3694438|FG000|COMPLETED|Overall Study||19
2978884|NCT00839956|3694438|FG000|NOT COMPLETED|Overall Study||12
2978885|NCT00839982|3694442|FG000|STARTED|Overall Study||4
2978886|NCT00839982|3694443|FG001|STARTED|Overall Study||26
2978887|NCT00839982|3694444|FG002|STARTED|Overall Study||2
2978888|NCT00839982|3694445|FG003|STARTED|Overall Study||3
2978889|NCT00839982|3694442|FG000|COMPLETED|Overall Study||4
2978890|NCT00839982|3694443|FG001|COMPLETED|Overall Study||26
2978891|NCT00839982|3694444|FG002|COMPLETED|Overall Study||2
2978892|NCT00839982|3694445|FG003|COMPLETED|Overall Study||3
2978893|NCT00839982|3694442|FG000|NOT COMPLETED|Overall Study||0
2978894|NCT00839982|3694443|FG001|NOT COMPLETED|Overall Study||0
2978895|NCT00839982|3694444|FG002|NOT COMPLETED|Overall Study||0
2978896|NCT00839982|3694445|FG003|NOT COMPLETED|Overall Study||0
2978897|NCT00840034|3694455|FG000|STARTED|Acute Treatment Phase||111
2978898|NCT00840034|3694456|FG001|STARTED|Acute Treatment Phase||116
2978899|NCT00840034|3694455|FG000|COMPLETED|Acute Treatment Phase||90
2978900|NCT00840034|3694456|FG001|COMPLETED|Acute Treatment Phase||80
2978901|NCT00840034|3694455|FG000|NOT COMPLETED|Acute Treatment Phase||21
2978902|NCT00840034|3694456|FG001|NOT COMPLETED|Acute Treatment Phase||36
2978903|NCT00840034|3694455|FG000|STARTED|Taper Phase|Completed Acute Treatment (AT) or discontinued ≥4 weeks of AT and chose to participate in Taper.|90
2978904|NCT00840034|3694456|FG001|STARTED|Taper Phase|Completed Acute Treatment (AT) or discontinued ≥4 weeks of AT and chose to participate in Taper.|82
2978905|NCT00840034|3694455|FG000|COMPLETED|Taper Phase||87
2978906|NCT00840034|3694456|FG001|COMPLETED|Taper Phase||80
2978907|NCT00840034|3694455|FG000|NOT COMPLETED|Taper Phase||3
2978908|NCT00840034|3694456|FG001|NOT COMPLETED|Taper Phase||2
2978909|NCT00840060|3694466|FG000|STARTED|Overall Study||20
2978910|NCT00840060|3694467|FG001|STARTED|Overall Study||20
2978911|NCT00840060|3694466|FG000|COMPLETED|Overall Study||19
2978912|NCT00840060|3694467|FG001|COMPLETED|Overall Study||19
2978913|NCT00840060|3694466|FG000|NOT COMPLETED|Overall Study||1
2978914|NCT00840060|3694467|FG001|NOT COMPLETED|Overall Study||1
2978915|NCT00840086|3694473|FG000|STARTED|Overall Study||150
2978916|NCT00840086|3694473|FG000|COMPLETED|Overall Study||146
2978917|NCT00840086|3694473|FG000|NOT COMPLETED|Overall Study||4
2978918|NCT00840294|3694482|FG000|STARTED|Overall Study||42
2978919|NCT00840294|3694483|FG001|STARTED|Overall Study||43
2978920|NCT00840294|3694482|FG000|COMPLETED|Overall Study|These are the subjects included in the baseline, outcomes, and adverse events tables|39
2978921|NCT00840294|3694483|FG001|COMPLETED|Overall Study|These are the subjects included in the baseline, outcomes, and adverse events tables|38
2978922|NCT00840294|3694482|FG000|NOT COMPLETED|Overall Study||3
2978923|NCT00840294|3694483|FG001|NOT COMPLETED|Overall Study||5
2978924|NCT00840307|3694489|FG000|STARTED|Overall Study||20
2978925|NCT00840307|3694489|FG000|COMPLETED|Overall Study||16
2978926|NCT00840307|3694489|FG000|NOT COMPLETED|Overall Study||4
2978927|NCT00840450|3694493|FG000|STARTED|Overall Study||12
2978928|NCT00840450|3694493|FG000|COMPLETED|Overall Study||9
2978929|NCT00840450|3694493|FG000|NOT COMPLETED|Overall Study||3
2978930|NCT00840463|3694499|FG000|STARTED|Overall Study||3
2978931|NCT00840463|3694500|FG001|STARTED|Overall Study||1
2978932|NCT00840463|3694499|FG000|COMPLETED|Overall Study||2
2978933|NCT00840463|3694500|FG001|COMPLETED|Overall Study||1
2978934|NCT00840463|3694499|FG000|NOT COMPLETED|Overall Study||1
2978935|NCT00840463|3694500|FG001|NOT COMPLETED|Overall Study||0
2978936|NCT00840658|3694510|FG000|STARTED|Overall Study||144
2978937|NCT00840658|3694511|FG001|STARTED|Overall Study||146
2978938|NCT00840658|3694512|FG002|STARTED|Overall Study||148
2978939|NCT00840658|3694513|FG003|STARTED|Overall Study||146
2978940|NCT00840658|3694510|FG000|COMPLETED|Overall Study|"We defined completed as having at least one follow-up visit"|139
2978941|NCT00840658|3694511|FG001|COMPLETED|Overall Study|"We defined completed as having at least one follow-up visit"|143
2978942|NCT00840658|3694512|FG002|COMPLETED|Overall Study|"We defined completed as having at least one follow-up visit"|143
2978943|NCT00840658|3694513|FG003|COMPLETED|Overall Study|"We defined completed as having at least one follow-up visit"|142
2978944|NCT00840658|3694510|FG000|NOT COMPLETED|Overall Study||5
2978945|NCT00840658|3694511|FG001|NOT COMPLETED|Overall Study||3
2978946|NCT00840658|3694512|FG002|NOT COMPLETED|Overall Study||5
2978947|NCT00840658|3694513|FG003|NOT COMPLETED|Overall Study||4
2978948|NCT00840749|3694529|FG000|STARTED|Overall Study|includes patients who were screened but did not end up treated on protocol|31
3038365|NCT01153958|3757799|FG001|COMPLETED|Overall Study||35
2978949|NCT00840749|3694530|FG001|STARTED|Overall Study|includes patients who were screened but did not end up treated on protocol|27
2978950|NCT00840749|3694529|FG000|Treatment|Overall Study||20
2978951|NCT00840749|3694530|FG001|Treatment|Overall Study||16
2978952|NCT00840749|3694529|FG000|1 Month Post tx|Overall Study||19
2978953|NCT00840749|3694530|FG001|1 Month Post tx|Overall Study||15
2978954|NCT00840749|3694529|FG000|6 Months Post tx|Overall Study||16
2978955|NCT00840749|3694530|FG001|6 Months Post tx|Overall Study||10
2978956|NCT00840749|3694529|FG000|12 Months Post tx|Overall Study||14
2978957|NCT00840749|3694530|FG001|12 Months Post tx|Overall Study||7
2978958|NCT00840749|3694529|FG000|18 Months Post tx|Overall Study||12
2978959|NCT00840749|3694530|FG001|18 Months Post tx|Overall Study||6
2978960|NCT00840749|3694529|FG000|24 Months Post tx|Overall Study||9
2978961|NCT00840749|3694530|FG001|24 Months Post tx|Overall Study||3
2978962|NCT00840749|3694529|FG000|36 Months Post tx|Overall Study||1
2978963|NCT00840749|3694530|FG001|36 Months Post tx|Overall Study||0
2978964|NCT00840749|3694529|FG000|COMPLETED|Overall Study||0
2978965|NCT00840749|3694530|FG001|COMPLETED|Overall Study||0
2978966|NCT00840749|3694529|FG000|NOT COMPLETED|Overall Study||31
2978967|NCT00840749|3694530|FG001|NOT COMPLETED|Overall Study||27
2978968|NCT00840970|3694536|FG000|STARTED|Overall Study||7
2978969|NCT00840970|3694537|FG001|STARTED|Overall Study||38
2978970|NCT00840970|3694538|FG002|STARTED|Overall Study||5
2978971|NCT00840970|3694536|FG000|COMPLETED|Overall Study||7
2978972|NCT00840970|3694537|FG001|COMPLETED|Overall Study||38
2978973|NCT00840970|3694538|FG002|COMPLETED|Overall Study||4
2978974|NCT00840970|3694536|FG000|NOT COMPLETED|Overall Study||0
2978975|NCT00840970|3694537|FG001|NOT COMPLETED|Overall Study||0
2978976|NCT00840970|3694538|FG002|NOT COMPLETED|Overall Study||1
2978977|NCT00840996|3694550|FG000|STARTED|Overall Study||58
2978978|NCT00840996|3694551|FG001|STARTED|Overall Study||58
2978979|NCT00840996|3694550|FG000|COMPLETED|Overall Study||57
2978980|NCT00840996|3694551|FG001|COMPLETED|Overall Study||58
2978981|NCT00840996|3694550|FG000|NOT COMPLETED|Overall Study||1
2978982|NCT00840996|3694551|FG001|NOT COMPLETED|Overall Study||0
2978983|NCT00841087|3694559|FG000|STARTED|Overall Study||33
2978984|NCT00841087|3694560|FG001|STARTED|Overall Study||32
2978985|NCT00841087|3694559|FG000|COMPLETED|Overall Study||33
2978986|NCT00841087|3694560|FG001|COMPLETED|Overall Study||32
2978987|NCT00841087|3694559|FG000|NOT COMPLETED|Overall Study||0
2978988|NCT00841087|3694560|FG001|NOT COMPLETED|Overall Study||0
2978989|NCT00841100|3694566|FG000|STARTED|Acute Component (24 Hours)||21
2978990|NCT00841100|3694566|FG000|COMPLETED|Acute Component (24 Hours)||21
2978991|NCT00841100|3694566|FG000|NOT COMPLETED|Acute Component (24 Hours)||0
2978992|NCT00841100|3694566|FG000|STARTED|Phase 1 (28 Days)|3 participants from the acute phase elected not to continue to the Phase 1 component of the study.|18
2978993|NCT00841100|3694566|FG000|COMPLETED|Phase 1 (28 Days)||15
2978994|NCT00841100|3694566|FG000|NOT COMPLETED|Phase 1 (28 Days)||3
2978995|NCT00841100|3694566|FG000|STARTED|Phase 2 (2 Weeks)|Participants who were non-responsive on the Phase 1 component of the study continued on to Phase 2.|5
2978996|NCT00841100|3694566|FG000|COMPLETED|Phase 2 (2 Weeks)||5
2978997|NCT00841100|3694566|FG000|NOT COMPLETED|Phase 2 (2 Weeks)||0
2978998|NCT00841100|3694566|FG000|STARTED|Phase 3 (28 Days)|Participants who achieved a fasting blood phenylalanine of <600 umol/l can continue to Phase 3.|4
2978999|NCT00841100|3694566|FG000|COMPLETED|Phase 3 (28 Days)||4
2979000|NCT00841100|3694566|FG000|NOT COMPLETED|Phase 3 (28 Days)||0
2979001|NCT00841204|3694572|FG000|STARTED|Overall Study||25
2979002|NCT00841204|3694573|FG001|STARTED|Overall Study||25
2979003|NCT00841204|3694572|FG000|COMPLETED|Overall Study||25
2979004|NCT00841204|3694573|FG001|COMPLETED|Overall Study||25
2979005|NCT00841204|3694572|FG000|NOT COMPLETED|Overall Study||0
2979006|NCT00841204|3694573|FG001|NOT COMPLETED|Overall Study||0
2979007|NCT00841269|3694583|FG000|STARTED|Overall Study||20
2979008|NCT00841269|3694584|FG001|STARTED|Overall Study||22
2979009|NCT00841269|3694583|FG000|COMPLETED|Overall Study||12
2979010|NCT00841269|3694584|FG001|COMPLETED|Overall Study||13
2979011|NCT00841269|3694583|FG000|NOT COMPLETED|Overall Study||8
2979012|NCT00841269|3694584|FG001|NOT COMPLETED|Overall Study||9
2979013|NCT00841321|3694591|FG000|STARTED|Overall Study||59
2979014|NCT00841321|3694592|FG001|STARTED|Overall Study||61
2979015|NCT00841321|3694591|FG000|COMPLETED|Overall Study||58
2979016|NCT00841321|3694592|FG001|COMPLETED|Overall Study||58
2979017|NCT00841321|3694591|FG000|NOT COMPLETED|Overall Study||1
2979018|NCT00841321|3694592|FG001|NOT COMPLETED|Overall Study||3
2979019|NCT00841412|3694600|FG000|STARTED|Overall Study|200 of 222 consented residents completed baseline assessments across both groups.|120
2979020|NCT00841412|3694601|FG001|STARTED|Overall Study|80 residents were in the delayed intervention group, but all residents received intervention.|80
2979021|NCT00841412|3694600|FG000|COMPLETED|Overall Study|130 residents completed all study phases across both groups, including follow-up.|80
2979022|NCT00841412|3694601|FG001|COMPLETED|Overall Study||50
2979023|NCT00841412|3694600|FG000|NOT COMPLETED|Overall Study||40
2979024|NCT00841412|3694601|FG001|NOT COMPLETED|Overall Study||30
2979025|NCT00841555|3694608|FG000|STARTED|Overall Study||3
2979026|NCT00841555|3694609|FG001|STARTED|Overall Study||3
2979027|NCT00841555|3694610|FG002|STARTED|Overall Study||3
2979028|NCT00841555|3694608|FG000|COMPLETED|Overall Study||3
2979029|NCT00841555|3694609|FG001|COMPLETED|Overall Study||3
2979030|NCT00841555|3694610|FG002|COMPLETED|Overall Study||3
2979031|NCT00841555|3694608|FG000|NOT COMPLETED|Overall Study||0
2979032|NCT00841555|3694609|FG001|NOT COMPLETED|Overall Study||0
2979033|NCT00841555|3694610|FG002|NOT COMPLETED|Overall Study||0
2979034|NCT00841568|3694616|FG000|STARTED|Overall Study||17
2979035|NCT00841568|3694616|FG000|COMPLETED|Overall Study||12
2979036|NCT00841568|3694616|FG000|NOT COMPLETED|Overall Study||5
2979037|NCT00841672|3694626|FG000|STARTED|Overall Study|One patient was mis-randomized and was not treated in the double-blind treatment period.|244
2979038|NCT00841672|3694627|FG001|STARTED|Overall Study||241
2979039|NCT00841672|3694626|FG000|COMPLETED|Overall Study||224
2979040|NCT00841672|3694627|FG001|COMPLETED|Overall Study||209
2979041|NCT00841672|3694626|FG000|NOT COMPLETED|Overall Study||20
2979042|NCT00841672|3694627|FG001|NOT COMPLETED|Overall Study||32
2979043|NCT00841763|3694635|FG000|STARTED|Overall Study||2691
2979044|NCT00841763|3694636|FG001|STARTED|Overall Study||681
2979045|NCT00841763|3694637|FG002|STARTED|Overall Study||219
2979046|NCT00841763|3694638|FG003|STARTED|Overall Study||56
2979047|NCT00841763|3694635|FG000|COMPLETED|Overall Study||2529
2979048|NCT00841763|3694636|FG001|COMPLETED|Overall Study||624
2979049|NCT00841763|3694637|FG002|COMPLETED|Overall Study||211
2979050|NCT00841763|3694638|FG003|COMPLETED|Overall Study||53
2979051|NCT00841763|3694635|FG000|NOT COMPLETED|Overall Study||162
2979052|NCT00841763|3694636|FG001|NOT COMPLETED|Overall Study||57
2979053|NCT00841763|3694637|FG002|NOT COMPLETED|Overall Study||8
2979054|NCT00841763|3694638|FG003|NOT COMPLETED|Overall Study||3
2979055|NCT00841776|3694685|FG000|STARTED|Overall Study||27
2979056|NCT00841776|3694686|FG001|STARTED|Overall Study||27
2979057|NCT00841776|3694685|FG000|COMPLETED|Overall Study||25
2979058|NCT00841776|3694686|FG001|COMPLETED|Overall Study||24
2979059|NCT00841776|3694685|FG000|NOT COMPLETED|Overall Study||2
2979060|NCT00841776|3694686|FG001|NOT COMPLETED|Overall Study||3
2979061|NCT00841828|3694694|FG000|STARTED|Overall Study||52
2979062|NCT00841828|3694695|FG001|STARTED|Overall Study||50
2979063|NCT00841828|3694694|FG000|COMPLETED|Overall Study||42
2979064|NCT00841828|3694695|FG001|COMPLETED|Overall Study||48
2979065|NCT00841828|3694694|FG000|NOT COMPLETED|Overall Study||10
2979066|NCT00841828|3694695|FG001|NOT COMPLETED|Overall Study||2
2979067|NCT00841906|3694705|FG000|STARTED|Overall Study||18
2979068|NCT00841906|3694706|FG001|STARTED|Overall Study||14
2979069|NCT00841906|3694705|FG000|COMPLETED|Overall Study||16
2979070|NCT00841906|3694706|FG001|COMPLETED|Overall Study||14
2979071|NCT00841906|3694705|FG000|NOT COMPLETED|Overall Study||2
2979072|NCT00841906|3694706|FG001|NOT COMPLETED|Overall Study||0
2979073|NCT00841971|3694716|FG000|STARTED|Overall Study||100
2979074|NCT00841971|3694717|FG001|STARTED|Overall Study||100
2979075|NCT00841971|3694716|FG000|COMPLETED|Overall Study||98
2979076|NCT00841971|3694717|FG001|COMPLETED|Overall Study||99
2979077|NCT00841971|3694716|FG000|NOT COMPLETED|Overall Study||2
2979078|NCT00841971|3694717|FG001|NOT COMPLETED|Overall Study||1
2979079|NCT00842023|3694725|FG000|STARTED|Overall Study||45
3133323|NCT01695239|3858309|FG004|STARTED|Extension Long-Term Extension Periods||0
3133324|NCT01695239|3858310|FG005|STARTED|Extension Long-Term Extension Periods||0
2979080|NCT00842023|3694726|FG001|STARTED|Overall Study||44
2979081|NCT00842023|3694725|FG000|COMPLETED|Overall Study||45
2979082|NCT00842023|3694726|FG001|COMPLETED|Overall Study||44
2979083|NCT00842023|3694725|FG000|NOT COMPLETED|Overall Study||0
2979084|NCT00842023|3694726|FG001|NOT COMPLETED|Overall Study||0
2979085|NCT00842075|3694737|FG000|STARTED|Overall Study||5
2979086|NCT00842075|3694738|FG001|STARTED|Overall Study||5
2979087|NCT00842075|3694737|FG000|COMPLETED|Overall Study||5
2979088|NCT00842075|3694738|FG001|COMPLETED|Overall Study||5
2979089|NCT00842075|3694737|FG000|NOT COMPLETED|Overall Study||0
2979090|NCT00842075|3694738|FG001|NOT COMPLETED|Overall Study||0
2979091|NCT00842153|3694746|FG000|STARTED|Overall Study||28
2979092|NCT00842153|3694747|FG001|STARTED|Overall Study||30
2979093|NCT00842153|3694746|FG000|COMPLETED|Overall Study||27
2979094|NCT00842153|3694747|FG001|COMPLETED|Overall Study||27
2979095|NCT00842153|3694746|FG000|NOT COMPLETED|Overall Study||1
2979096|NCT00842153|3694747|FG001|NOT COMPLETED|Overall Study||3
2979097|NCT00842231|3694753|FG000|STARTED|Overall Study||40
2979098|NCT00842231|3694753|FG000|COMPLETED|Overall Study||40
2979099|NCT00842231|3694753|FG000|NOT COMPLETED|Overall Study||0
2979100|NCT00842244|3694757|FG000|STARTED|Overall Study||22
2979101|NCT00842244|3694757|FG000|COMPLETED|Overall Study||1
2979102|NCT00842244|3694757|FG000|NOT COMPLETED|Overall Study||21
2979103|NCT00842257|3694764|FG000|STARTED|Overall Study||20
2979104|NCT00842257|3694764|FG000|COMPLETED|Overall Study||19
2979105|NCT00842257|3694764|FG000|NOT COMPLETED|Overall Study||1
2979106|NCT00842296|3694768|FG000|STARTED|Overall Study||326
2979107|NCT00842296|3694768|FG000|COMPLETED|Overall Study||326
2979108|NCT00842296|3694768|FG000|NOT COMPLETED|Overall Study||0
2979109|NCT00842309|3694774|FG000|STARTED|Overall Study|14 randomized. 2 withdrew prior to initiating DCS-not included in modified intent-to-treat analyses.|14
2979110|NCT00842309|3694775|FG001|STARTED|Overall Study||14
2979111|NCT00842309|3694774|FG000|COMPLETED|Overall Study||11
2979112|NCT00842309|3694775|FG001|COMPLETED|Overall Study||13
2979113|NCT00842309|3694774|FG000|NOT COMPLETED|Overall Study||3
2979114|NCT00842309|3694775|FG001|NOT COMPLETED|Overall Study||1
2979115|NCT00842335|3694781|FG000|STARTED|Overall Study||18
2979116|NCT00842335|3694781|FG000|COMPLETED|Overall Study||18
2979117|NCT00842335|3694781|FG000|NOT COMPLETED|Overall Study||0
2979118|NCT00842348|3694789|FG000|STARTED|Patients Randomised in Study 726||101
2979119|NCT00842348|3694790|FG001|STARTED|Patients Randomised in Study 726||103
2979120|NCT00842348|3694789|FG000|COMPLETED|Patients Randomised in Study 726|41 patients had stable disease and 1 patient had progressive disease.|42
2979121|NCT00842348|3694790|FG001|COMPLETED|Patients Randomised in Study 726|15 patients had stable disease and 32 patients had progressive disease.|47
2979122|NCT00842348|3694789|FG000|NOT COMPLETED|Patients Randomised in Study 726||59
2979123|NCT00842348|3694790|FG001|NOT COMPLETED|Patients Randomised in Study 726||56
2979124|NCT00842348|3694789|FG000|STARTED|Study 729||42
2979125|NCT00842348|3694790|FG001|STARTED|Study 729||47
2979126|NCT00842348|3694789|FG000|COMPLETED|Study 729|Enrolled in Study 729 and received at least one dose of open label lanreotide Autogel.|16
2979127|NCT00842348|3694790|FG001|COMPLETED|Study 729|Enrolled in Study 729 and received at least one dose of open label lanreotide Autogel.|9
2979128|NCT00842348|3694789|FG000|NOT COMPLETED|Study 729||26
2979129|NCT00842348|3694790|FG001|NOT COMPLETED|Study 729||38
2979130|NCT00842361|3694802|FG000|STARTED|Overall Study||33
2979131|NCT00842361|3694803|FG001|STARTED|Overall Study||33
2979132|NCT00842361|3694802|FG000|Exposed|Overall Study||33
2979133|NCT00842361|3694803|FG001|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|32
2979134|NCT00842361|3694802|FG000|COMPLETED|Overall Study||32
2979135|NCT00842361|3694803|FG001|COMPLETED|Overall Study||31
2979136|NCT00842361|3694802|FG000|NOT COMPLETED|Overall Study||1
2979137|NCT00842361|3694803|FG001|NOT COMPLETED|Overall Study||2
2979138|NCT00842530|3694811|FG000|STARTED|Overall Study||2669
2979139|NCT00842530|3694812|FG001|STARTED|Overall Study||1333
2979140|NCT00842530|3694811|FG000|Received Vaccination 1|Overall Study||2666
2979141|NCT00842530|3694812|FG001|Received Vaccination 1|Overall Study||1331
2979142|NCT00842530|3694811|FG000|Received Vaccination 2|Overall Study||2584
2979143|NCT00842530|3694812|FG001|Received Vaccination 2|Overall Study||1300
2979144|NCT00842530|3694811|FG000|Received Vaccination 3|Overall Study||2557
2979145|NCT00842530|3694812|FG001|Received Vaccination 3|Overall Study||1282
2979146|NCT00842530|3694811|FG000|COMPLETED|Overall Study||2552
2979147|NCT00842530|3694812|FG001|COMPLETED|Overall Study||1276
2979148|NCT00842530|3694811|FG000|NOT COMPLETED|Overall Study||117
2979149|NCT00842530|3694812|FG001|NOT COMPLETED|Overall Study||57
2979150|NCT00842543|3694823|FG000|STARTED|Overall Study||13
2979151|NCT00842543|3694824|FG001|STARTED|Overall Study||5
2979152|NCT00842543|3694825|FG002|STARTED|Overall Study||13
2979153|NCT00842543|3694826|FG003|STARTED|Overall Study||8
2979154|NCT00842543|3694823|FG000|COMPLETED|Overall Study||11
2979155|NCT00842543|3694824|FG001|COMPLETED|Overall Study||5
2979156|NCT00842543|3694825|FG002|COMPLETED|Overall Study||10
2979157|NCT00842543|3694826|FG003|COMPLETED|Overall Study||4
2979158|NCT00842543|3694823|FG000|NOT COMPLETED|Overall Study||2
2979159|NCT00842543|3694824|FG001|NOT COMPLETED|Overall Study||0
2979160|NCT00842543|3694825|FG002|NOT COMPLETED|Overall Study||3
2979161|NCT00842543|3694826|FG003|NOT COMPLETED|Overall Study||4
2979162|NCT00842608|3694842|FG000|STARTED|Overall Study||174
2979163|NCT00842608|3694843|FG001|STARTED|Overall Study||177
2979164|NCT00842608|3694844|FG002|STARTED|Overall Study||99
2979165|NCT00842608|3694845|FG003|STARTED|Overall Study||101
2979166|NCT00842608|3694842|FG000|COMPLETED|Overall Study||170
2979167|NCT00842608|3694843|FG001|COMPLETED|Overall Study||176
2979168|NCT00842608|3694844|FG002|COMPLETED|Overall Study||99
2979169|NCT00842608|3694845|FG003|COMPLETED|Overall Study||100
2979170|NCT00842608|3694842|FG000|NOT COMPLETED|Overall Study||4
2979171|NCT00842608|3694843|FG001|NOT COMPLETED|Overall Study||1
2979172|NCT00842608|3694844|FG002|NOT COMPLETED|Overall Study||0
2979173|NCT00842608|3694845|FG003|NOT COMPLETED|Overall Study||1
2979174|NCT00842712|3694862|FG000|STARTED|Safety Run-in Part||3
2979175|NCT00842712|3694863|FG001|STARTED|Safety Run-in Part||3
2979176|NCT00842712|3694864|FG002|STARTED|Safety Run-in Part||3
2979177|NCT00842712|3694865|FG003|STARTED|Safety Run-in Part||3
2979178|NCT00842712|3694866|FG004|STARTED|Safety Run-in Part||0
2979179|NCT00842712|3694867|FG005|STARTED|Safety Run-in Part||0
2979180|NCT00842712|3694868|FG006|STARTED|Safety Run-in Part||0
2979181|NCT00842712|3694862|FG000|COMPLETED|Safety Run-in Part||0
2979182|NCT00842712|3694863|FG001|COMPLETED|Safety Run-in Part||1
2979183|NCT00842712|3694864|FG002|COMPLETED|Safety Run-in Part||3
2979184|NCT00842712|3694865|FG003|COMPLETED|Safety Run-in Part||2
2979185|NCT00842712|3694866|FG004|COMPLETED|Safety Run-in Part||0
2979186|NCT00842712|3694867|FG005|COMPLETED|Safety Run-in Part||0
2979187|NCT00842712|3694868|FG006|COMPLETED|Safety Run-in Part||0
2979188|NCT00842712|3694862|FG000|NOT COMPLETED|Safety Run-in Part||3
2979189|NCT00842712|3694863|FG001|NOT COMPLETED|Safety Run-in Part||2
2979190|NCT00842712|3694864|FG002|NOT COMPLETED|Safety Run-in Part||0
2979191|NCT00842712|3694865|FG003|NOT COMPLETED|Safety Run-in Part||1
2979192|NCT00842712|3694866|FG004|NOT COMPLETED|Safety Run-in Part||0
2979193|NCT00842712|3694867|FG005|NOT COMPLETED|Safety Run-in Part||0
2979194|NCT00842712|3694868|FG006|NOT COMPLETED|Safety Run-in Part||0
2979195|NCT00842712|3694862|FG000|STARTED|Randomized Part||0
2979196|NCT00842712|3694863|FG001|STARTED|Randomized Part||0
2979197|NCT00842712|3694864|FG002|STARTED|Randomized Part||0
2979198|NCT00842712|3694865|FG003|STARTED|Randomized Part||0
2979199|NCT00842712|3694866|FG004|STARTED|Randomized Part||85
2979200|NCT00842712|3694867|FG005|STARTED|Randomized Part||51
2979201|NCT00842712|3694868|FG006|STARTED|Randomized Part||84
2979202|NCT00842712|3694862|FG000|Treated|Randomized Part||0
2979203|NCT00842712|3694863|FG001|Treated|Randomized Part||0
2979204|NCT00842712|3694864|FG002|Treated|Randomized Part||0
2979205|NCT00842712|3694865|FG003|Treated|Randomized Part||0
2979206|NCT00842712|3694866|FG004|Treated|Randomized Part||85
2979207|NCT00842712|3694867|FG005|Treated|Randomized Part||50
2979208|NCT00842712|3694868|FG006|Treated|Randomized Part||80
2979209|NCT00842712|3694862|FG000|COMPLETED|Randomized Part||0
2979210|NCT00842712|3694863|FG001|COMPLETED|Randomized Part||0
2979211|NCT00842712|3694864|FG002|COMPLETED|Randomized Part||0
2979212|NCT00842712|3694865|FG003|COMPLETED|Randomized Part||0
2979213|NCT00842712|3694866|FG004|COMPLETED|Randomized Part||85
2979214|NCT00842712|3694867|FG005|COMPLETED|Randomized Part||50
2979215|NCT00842712|3694868|FG006|COMPLETED|Randomized Part||78
2979216|NCT00842712|3694862|FG000|NOT COMPLETED|Randomized Part||0
2979217|NCT00842712|3694863|FG001|NOT COMPLETED|Randomized Part||0
2979218|NCT00842712|3694864|FG002|NOT COMPLETED|Randomized Part||0
2979219|NCT00842712|3694865|FG003|NOT COMPLETED|Randomized Part||0
2979220|NCT00842712|3694866|FG004|NOT COMPLETED|Randomized Part||0
2979221|NCT00842712|3694867|FG005|NOT COMPLETED|Randomized Part||1
2979222|NCT00842712|3694868|FG006|NOT COMPLETED|Randomized Part||6
2979223|NCT00842751|3694884|FG000|STARTED|Overall Study||11
2979224|NCT00842751|3694884|FG000|COMPLETED|Overall Study||11
2979225|NCT00842751|3694884|FG000|NOT COMPLETED|Overall Study||0
2979226|NCT00842764|3694897|FG000|STARTED|Overall Study||7
2979227|NCT00842764|3694897|FG000|COMPLETED|Overall Study||5
2979228|NCT00842764|3694897|FG000|NOT COMPLETED|Overall Study||2
2979229|NCT00842829|3694903|FG000|STARTED|Dose Titration Period||156
2979230|NCT00842829|3694904|FG001|STARTED|Dose Titration Period||174
2979231|NCT00842829|3694905|FG002|STARTED|Dose Titration Period||0
2979232|NCT00842829|3694903|FG000|Titration Safety Analysis Set|Dose Titration Period|Received at least one dose of study drug|145
2979233|NCT00842829|3694904|FG001|Titration Safety Analysis Set|Dose Titration Period|Received at least one dose of study drug|167
2979234|NCT00842829|3694905|FG002|Titration Safety Analysis Set|Dose Titration Period||0
3133325|NCT01695239|3858311|FG006|STARTED|Extension Long-Term Extension Periods||0
3133326|NCT01695239|3858312|FG007|STARTED|Extension Long-Term Extension Periods|Only included combined extension participants.|0
3133327|NCT01695239|3858313|FG008|STARTED|Extension Long-Term Extension Periods|IxeQ4W who re-randomized to ixeQ4W.|187
2979235|NCT00842829|3694903|FG000|COMPLETED|Dose Titration Period||130
2979236|NCT00842829|3694904|FG001|COMPLETED|Dose Titration Period||151
2979237|NCT00842829|3694905|FG002|COMPLETED|Dose Titration Period||0
2979238|NCT00842829|3694903|FG000|NOT COMPLETED|Dose Titration Period||26
2979239|NCT00842829|3694904|FG001|NOT COMPLETED|Dose Titration Period||23
2979240|NCT00842829|3694905|FG002|NOT COMPLETED|Dose Titration Period||0
2979241|NCT00842829|3694903|FG000|STARTED|Treatment Period||0
2979242|NCT00842829|3694904|FG001|STARTED|Treatment Period||0
2979243|NCT00842829|3694905|FG002|STARTED|Treatment Period||281
2979244|NCT00842829|3694903|FG000|Safety Analysis Set|Treatment Period||0
2979245|NCT00842829|3694904|FG001|Safety Analysis Set|Treatment Period||0
2979246|NCT00842829|3694905|FG002|Safety Analysis Set|Treatment Period|Received at least one dose of study drug|223
2979247|NCT00842829|3694903|FG000|COMPLETED|Treatment Period||0
2979248|NCT00842829|3694904|FG001|COMPLETED|Treatment Period||0
2979249|NCT00842829|3694905|FG002|COMPLETED|Treatment Period||218
2979250|NCT00842829|3694903|FG000|NOT COMPLETED|Treatment Period||0
2979251|NCT00842829|3694904|FG001|NOT COMPLETED|Treatment Period||0
2979252|NCT00842829|3694905|FG002|NOT COMPLETED|Treatment Period||63
2979253|NCT00842829|3694903|FG000|STARTED|Continuation Period||0
2979254|NCT00842829|3694904|FG001|STARTED|Continuation Period||0
2979255|NCT00842829|3694905|FG002|STARTED|Continuation Period|Eligible for Continuation Period|88
2979256|NCT00842829|3694903|FG000|Continuation Safety Analysis Set|Continuation Period||0
2979257|NCT00842829|3694904|FG001|Continuation Safety Analysis Set|Continuation Period||0
2979258|NCT00842829|3694905|FG002|Continuation Safety Analysis Set|Continuation Period|Received at least one dose of study drug|87
2979259|NCT00842829|3694903|FG000|COMPLETED|Continuation Period||0
2979260|NCT00842829|3694904|FG001|COMPLETED|Continuation Period||0
2979261|NCT00842829|3694905|FG002|COMPLETED|Continuation Period||27
2979262|NCT00842829|3694903|FG000|NOT COMPLETED|Continuation Period||0
2979263|NCT00842829|3694904|FG001|NOT COMPLETED|Continuation Period||0
2979264|NCT00842829|3694905|FG002|NOT COMPLETED|Continuation Period||61
3133328|NCT01695239|3858314|FG009|STARTED|Extension Long-Term Extension Periods|IxeQ2W who re-randomized to ixeQ2W.|183
3133329|NCT01695239|3858315|FG010|STARTED|Extension Long-Term Extension Periods||0
3133330|NCT01695239|3858316|FG011|STARTED|Extension Long-Term Extension Periods||0
3303276|NCT02965833|4036599|FG000|NOT COMPLETED|Period 1, First 30 Days of Wear||3
3303277|NCT02965833|4036600|FG001|NOT COMPLETED|Period 1, First 30 Days of Wear||2
3303278|NCT02965833|4036599|FG000|STARTED|Period 2, Second 30 Days of Wear||64
3303279|NCT02965833|4036600|FG001|STARTED|Period 2, Second 30 Days of Wear||52
3303280|NCT02965833|4036599|FG000|COMPLETED|Period 2, Second 30 Days of Wear||62
3303281|NCT02965833|4036600|FG001|COMPLETED|Period 2, Second 30 Days of Wear||52
3303282|NCT02965833|4036599|FG000|NOT COMPLETED|Period 2, Second 30 Days of Wear||2
3303283|NCT02965833|4036600|FG001|NOT COMPLETED|Period 2, Second 30 Days of Wear||0
3303284|NCT02965924|4036606|FG000|STARTED|Overall Study||20
3303285|NCT02965924|4036606|FG000|COMPLETED|Overall Study||20
3303286|NCT02965924|4036606|FG000|NOT COMPLETED|Overall Study||0
3303287|NCT02965989|4036612|FG000|STARTED|Overall Study||26
3133331|NCT01695239|3858317|FG012|STARTED|Extension Long-Term Extension Periods||0
3133332|NCT01695239|3858318|FG013|STARTED|Extension Long-Term Extension Periods||0
3133333|NCT01695239|3858305|FG000|COMPLETED|Extension Long-Term Extension Periods||0
3133334|NCT01695239|3858306|FG001|COMPLETED|Extension Long-Term Extension Periods||0
3303288|NCT02965989|4036613|FG001|STARTED|Overall Study||22
3303289|NCT02965989|4036612|FG000|COMPLETED|Overall Study||26
3303290|NCT02965989|4036613|FG001|COMPLETED|Overall Study||22
3164235|NCT01891864|3891709|FG003|COMPLETED|Treatment Period 1||0
2979265|NCT00842946|3694919|FG000|STARTED|Overall Study||21
2979266|NCT00842946|3694920|FG001|STARTED|Overall Study||24
2979267|NCT00842946|3694919|FG000|COMPLETED|Overall Study||16
2979268|NCT00842946|3694920|FG001|COMPLETED|Overall Study||19
2979269|NCT00842946|3694919|FG000|NOT COMPLETED|Overall Study||5
2979270|NCT00842946|3694920|FG001|NOT COMPLETED|Overall Study||5
2979271|NCT00842985|3694926|FG000|STARTED|Screening||53
2979272|NCT00842985|3694926|FG000|COMPLETED|Screening||26
2979273|NCT00842985|3694926|FG000|NOT COMPLETED|Screening||27
2979274|NCT00842985|3694926|FG000|STARTED|First Intervention|Signed Consent|26
2979275|NCT00842985|3694926|FG000|COMPLETED|First Intervention|Completed 1st Intervention|20
2979276|NCT00842985|3694926|FG000|NOT COMPLETED|First Intervention||6
2979277|NCT00842985|3694926|FG000|STARTED|Washout Period of GE 4 Days||20
2979278|NCT00842985|3694926|FG000|COMPLETED|Washout Period of GE 4 Days||18
2979279|NCT00842985|3694926|FG000|NOT COMPLETED|Washout Period of GE 4 Days||2
2979280|NCT00842985|3694926|FG000|STARTED|Second Intervention||18
2979281|NCT00842985|3694926|FG000|COMPLETED|Second Intervention||17
2979282|NCT00842985|3694926|FG000|NOT COMPLETED|Second Intervention||1
2979283|NCT00842985|3694926|FG000|STARTED|Washout Period of GE 4 Days||17
2979284|NCT00842985|3694926|FG000|COMPLETED|Washout Period of GE 4 Days||15
2979285|NCT00842985|3694926|FG000|NOT COMPLETED|Washout Period of GE 4 Days||2
2979286|NCT00842985|3694926|FG000|STARTED|Third Intervention||15
2979287|NCT00842985|3694926|FG000|COMPLETED|Third Intervention||15
2979288|NCT00842985|3694926|FG000|NOT COMPLETED|Third Intervention||0
2979289|NCT00842985|3694926|FG000|STARTED|Washout Period of GE 4 Days||15
2979290|NCT00842985|3694926|FG000|COMPLETED|Washout Period of GE 4 Days||15
2979291|NCT00842985|3694926|FG000|NOT COMPLETED|Washout Period of GE 4 Days||0
2979292|NCT00842985|3694926|FG000|STARTED|Fourth Intervention||15
2979293|NCT00842985|3694926|FG000|COMPLETED|Fourth Intervention||15
2979294|NCT00842985|3694926|FG000|NOT COMPLETED|Fourth Intervention||0
2979295|NCT00843024|3694937|FG000|STARTED|Single-blind Placebo Run-In Phase||408
2979296|NCT00843024|3694938|FG001|STARTED|Single-blind Placebo Run-In Phase||457
2979297|NCT00843024|3694939|FG002|STARTED|Single-blind Placebo Run-In Phase||0
2979298|NCT00843024|3694940|FG003|STARTED|Single-blind Placebo Run-In Phase||0
2979299|NCT00843024|3694941|FG004|STARTED|Single-blind Placebo Run-In Phase||0
2979300|NCT00843024|3694942|FG005|STARTED|Single-blind Placebo Run-In Phase||0
2979301|NCT00843024|3694937|FG000|COMPLETED|Single-blind Placebo Run-In Phase||268
2979302|NCT00843024|3694938|FG001|COMPLETED|Single-blind Placebo Run-In Phase||321
2979303|NCT00843024|3694939|FG002|COMPLETED|Single-blind Placebo Run-In Phase||0
2979304|NCT00843024|3694940|FG003|COMPLETED|Single-blind Placebo Run-In Phase||0
2979305|NCT00843024|3694941|FG004|COMPLETED|Single-blind Placebo Run-In Phase||0
2979306|NCT00843024|3694942|FG005|COMPLETED|Single-blind Placebo Run-In Phase||0
2979307|NCT00843024|3694937|FG000|NOT COMPLETED|Single-blind Placebo Run-In Phase||140
2979308|NCT00843024|3694938|FG001|NOT COMPLETED|Single-blind Placebo Run-In Phase||136
2979309|NCT00843024|3694939|FG002|NOT COMPLETED|Single-blind Placebo Run-In Phase||0
2979310|NCT00843024|3694940|FG003|NOT COMPLETED|Single-blind Placebo Run-In Phase||0
2979311|NCT00843024|3694941|FG004|NOT COMPLETED|Single-blind Placebo Run-In Phase||0
2979312|NCT00843024|3694942|FG005|NOT COMPLETED|Single-blind Placebo Run-In Phase||0
2979313|NCT00843024|3694937|FG000|STARTED|Double-blind Treatment Phase||0
2979314|NCT00843024|3694938|FG001|STARTED|Double-blind Treatment Phase||0
2979315|NCT00843024|3694939|FG002|STARTED|Double-blind Treatment Phase||176
2979316|NCT00843024|3694940|FG003|STARTED|Double-blind Treatment Phase||119
2979317|NCT00843024|3694941|FG004|STARTED|Double-blind Treatment Phase||117
2979318|NCT00843024|3694942|FG005|STARTED|Double-blind Treatment Phase||177
2979319|NCT00843024|3694937|FG000|COMPLETED|Double-blind Treatment Phase||0
2979320|NCT00843024|3694938|FG001|COMPLETED|Double-blind Treatment Phase||0
2979321|NCT00843024|3694939|FG002|COMPLETED|Double-blind Treatment Phase||145
2979322|NCT00843024|3694940|FG003|COMPLETED|Double-blind Treatment Phase||96
2979323|NCT00843024|3694941|FG004|COMPLETED|Double-blind Treatment Phase||97
2979324|NCT00843024|3694942|FG005|COMPLETED|Double-blind Treatment Phase||152
2979325|NCT00843024|3694937|FG000|NOT COMPLETED|Double-blind Treatment Phase||0
2979326|NCT00843024|3694938|FG001|NOT COMPLETED|Double-blind Treatment Phase||0
2979327|NCT00843024|3694939|FG002|NOT COMPLETED|Double-blind Treatment Phase||31
2979328|NCT00843024|3694940|FG003|NOT COMPLETED|Double-blind Treatment Phase||23
2979329|NCT00843024|3694941|FG004|NOT COMPLETED|Double-blind Treatment Phase||20
2979330|NCT00843024|3694942|FG005|NOT COMPLETED|Double-blind Treatment Phase||25
2979331|NCT00843115|3694955|FG000|STARTED|Overall Study||370
2979332|NCT00843115|3694955|FG000|COMPLETED|Overall Study||304
2979333|NCT00843115|3694955|FG000|NOT COMPLETED|Overall Study||66
2979334|NCT00843167|3694961|FG000|STARTED|Treatment Period||27
2979335|NCT00843167|3694962|FG001|STARTED|Treatment Period||27
2979336|NCT00843167|3694961|FG000|COMPLETED|Treatment Period||24
2979337|NCT00843167|3694962|FG001|COMPLETED|Treatment Period||19
2979338|NCT00843167|3694961|FG000|NOT COMPLETED|Treatment Period||3
2979339|NCT00843167|3694962|FG001|NOT COMPLETED|Treatment Period||8
2979340|NCT00843167|3694961|FG000|STARTED|Follow-up||24
2979341|NCT00843167|3694962|FG001|STARTED|Follow-up||24
2979342|NCT00843167|3694961|FG000|Completed Final Visit|Follow-up||24
2979343|NCT00843167|3694962|FG001|Completed Final Visit|Follow-up||24
2979344|NCT00843167|3694961|FG000|COMPLETED|Follow-up||24
2979345|NCT00843167|3694962|FG001|COMPLETED|Follow-up||24
2979346|NCT00843167|3694961|FG000|NOT COMPLETED|Follow-up||0
2979347|NCT00843167|3694962|FG001|NOT COMPLETED|Follow-up||0
2979348|NCT00843180|3694974|FG000|STARTED|Overall Study||16
2979349|NCT00843180|3694975|FG001|STARTED|Overall Study||7
2979350|NCT00843180|3694974|FG000|COMPLETED|Overall Study||16
2979351|NCT00843180|3694975|FG001|COMPLETED|Overall Study||7
2979352|NCT00843180|3694974|FG000|NOT COMPLETED|Overall Study||0
2979353|NCT00843180|3694975|FG001|NOT COMPLETED|Overall Study||0
2979354|NCT00843193|3694983|FG000|STARTED|Overall Study||99
2979355|NCT00843193|3694984|FG001|STARTED|Overall Study||99
2979356|NCT00843193|3694983|FG000|COMPLETED|Overall Study||91
2979357|NCT00843193|3694984|FG001|COMPLETED|Overall Study||88
2979358|NCT00843193|3694983|FG000|NOT COMPLETED|Overall Study||8
2979359|NCT00843193|3694984|FG001|NOT COMPLETED|Overall Study||11
2979360|NCT00843284|3694991|FG000|STARTED|Overall Study||691
2979361|NCT00843284|3694991|FG000|COMPLETED|Overall Study||619
2979362|NCT00843284|3694991|FG000|NOT COMPLETED|Overall Study||72
2979363|NCT00843349|3694999|FG000|STARTED|Overall Study||11
2979364|NCT00843349|3695000|FG001|STARTED|Overall Study||11
2979365|NCT00843349|3695001|FG002|STARTED|Overall Study||10
2979366|NCT00843349|3695002|FG003|STARTED|Overall Study||11
2979367|NCT00843349|3694999|FG000|COMPLETED|Overall Study||8
2979368|NCT00843349|3695000|FG001|COMPLETED|Overall Study||11
2979369|NCT00843349|3695001|FG002|COMPLETED|Overall Study||10
2979370|NCT00843349|3695002|FG003|COMPLETED|Overall Study||10
2979371|NCT00843349|3694999|FG000|NOT COMPLETED|Overall Study||3
2979372|NCT00843349|3695000|FG001|NOT COMPLETED|Overall Study||0
2979373|NCT00843349|3695001|FG002|NOT COMPLETED|Overall Study||0
2979374|NCT00843349|3695002|FG003|NOT COMPLETED|Overall Study||1
2979375|NCT00843466|3695014|FG000|STARTED|Overall Study||24
2979376|NCT00843466|3695015|FG001|STARTED|Overall Study||18
2979377|NCT00843466|3695014|FG000|COMPLETED|Overall Study||24
2979378|NCT00843466|3695015|FG001|COMPLETED|Overall Study||18
2979379|NCT00843466|3695014|FG000|NOT COMPLETED|Overall Study||0
2979380|NCT00843466|3695015|FG001|NOT COMPLETED|Overall Study||0
2979381|NCT00843479|3695023|FG000|STARTED|Overall Study||12
2979382|NCT00843479|3695024|FG001|STARTED|Overall Study||12
2979383|NCT00843479|3695023|FG000|COMPLETED|Overall Study||12
2979384|NCT00843479|3695024|FG001|COMPLETED|Overall Study||12
2979385|NCT00843479|3695023|FG000|NOT COMPLETED|Overall Study||0
2979386|NCT00843479|3695024|FG001|NOT COMPLETED|Overall Study||0
2979387|NCT00843492|3695034|FG000|STARTED|Overall Study||622
2979388|NCT00843492|3695035|FG001|STARTED|Overall Study||621
2979389|NCT00843492|3695034|FG000|COMPLETED|Overall Study||614
2979390|NCT00843492|3695035|FG001|COMPLETED|Overall Study||607
2979391|NCT00843492|3695034|FG000|NOT COMPLETED|Overall Study||8
2979392|NCT00843492|3695035|FG001|NOT COMPLETED|Overall Study||14
2979393|NCT00843518|3695043|FG000|STARTED|Period 2 (Double-blind Treatment)||63
2979394|NCT00843518|3695044|FG001|STARTED|Period 2 (Double-blind Treatment)||69
2979395|NCT00843518|3695043|FG000|COMPLETED|Period 2 (Double-blind Treatment)||43
2979396|NCT00843518|3695044|FG001|COMPLETED|Period 2 (Double-blind Treatment)||49
2979397|NCT00843518|3695043|FG000|NOT COMPLETED|Period 2 (Double-blind Treatment)||20
2979398|NCT00843518|3695044|FG001|NOT COMPLETED|Period 2 (Double-blind Treatment)||20
2979399|NCT00843518|3695043|FG000|STARTED|Period 3 (Single-blind Washout)|1 LY451395 participant completed double-blind treatment, but did not enter washout period.|42
2979400|NCT00843518|3695044|FG001|STARTED|Period 3 (Single-blind Washout)||49
2979401|NCT00843518|3695043|FG000|COMPLETED|Period 3 (Single-blind Washout)||42
2979402|NCT00843518|3695044|FG001|COMPLETED|Period 3 (Single-blind Washout)||49
2979403|NCT00843518|3695043|FG000|NOT COMPLETED|Period 3 (Single-blind Washout)||0
2979404|NCT00843518|3695044|FG001|NOT COMPLETED|Period 3 (Single-blind Washout)||0
3133335|NCT01695239|3858307|FG002|COMPLETED|Extension Long-Term Extension Periods||0
3133336|NCT01695239|3858308|FG003|COMPLETED|Extension Long-Term Extension Periods||0
3133337|NCT01695239|3858309|FG004|COMPLETED|Extension Long-Term Extension Periods||0
3133338|NCT01695239|3858310|FG005|COMPLETED|Extension Long-Term Extension Periods||0
3133339|NCT01695239|3858311|FG006|COMPLETED|Extension Long-Term Extension Periods||0
3133340|NCT01695239|3858312|FG007|COMPLETED|Extension Long-Term Extension Periods||0
3136742|NCT01714726|3861991|FG003|COMPLETED|Open-Label Period||24
2979405|NCT00843531|3695054|FG000|STARTED|Overall Study||17
2979406|NCT00843531|3695054|FG000|COMPLETED|Overall Study||17
2979407|NCT00843531|3695054|FG000|NOT COMPLETED|Overall Study||0
2979408|NCT00843622|3695064|FG000|STARTED|Overall Study||125
2979409|NCT00843622|3695065|FG001|STARTED|Overall Study||125
2979410|NCT00843622|3695064|FG000|COMPLETED|Overall Study||82
2979411|NCT00843622|3695065|FG001|COMPLETED|Overall Study||70
2979412|NCT00843622|3695064|FG000|NOT COMPLETED|Overall Study||43
2979413|NCT00843622|3695065|FG001|NOT COMPLETED|Overall Study||55
2979414|NCT00843635|3695074|FG000|STARTED|Overall Study||15
2979415|NCT00843635|3695075|FG001|STARTED|Overall Study||15
2979416|NCT00843635|3695076|FG002|STARTED|Overall Study||5
2979417|NCT00843635|3695074|FG000|COMPLETED|Overall Study||13
2979418|NCT00843635|3695075|FG001|COMPLETED|Overall Study||13
2979419|NCT00843635|3695076|FG002|COMPLETED|Overall Study||5
2979420|NCT00843635|3695074|FG000|NOT COMPLETED|Overall Study||2
2979421|NCT00843635|3695075|FG001|NOT COMPLETED|Overall Study||2
2979422|NCT00843635|3695076|FG002|NOT COMPLETED|Overall Study||0
2979423|NCT00843713|3695090|FG000|STARTED|Overall Study||30
2979424|NCT00843713|3695091|FG001|STARTED|Overall Study||26
2979425|NCT00843713|3695090|FG000|COMPLETED|Overall Study||30
2979426|NCT00843713|3695091|FG001|COMPLETED|Overall Study||26
2979427|NCT00843713|3695090|FG000|NOT COMPLETED|Overall Study||0
2979428|NCT00843713|3695091|FG001|NOT COMPLETED|Overall Study||0
2979429|NCT00843726|3695099|FG000|STARTED|Overall Study||49
2979430|NCT00843726|3695100|FG001|STARTED|Overall Study||49
2979431|NCT00843726|3695099|FG000|COMPLETED|Overall Study||48
2979432|NCT00843726|3695100|FG001|COMPLETED|Overall Study||48
2979433|NCT00843726|3695099|FG000|NOT COMPLETED|Overall Study||1
2979434|NCT00843726|3695100|FG001|NOT COMPLETED|Overall Study||1
2979435|NCT00843778|3695107|FG000|STARTED|Overall Study||131
2979436|NCT00843778|3695107|FG000|COMPLETED|Overall Study||96
2979437|NCT00843778|3695107|FG000|NOT COMPLETED|Overall Study||35
2979438|NCT00843843|3695113|FG000|STARTED|Overall Study||8
2979439|NCT00843843|3695114|FG001|STARTED|Overall Study||8
2979440|NCT00843843|3695113|FG000|COMPLETED|Overall Study||6
2979441|NCT00843843|3695114|FG001|COMPLETED|Overall Study||6
2979442|NCT00843843|3695113|FG000|NOT COMPLETED|Overall Study||2
2979443|NCT00843843|3695114|FG001|NOT COMPLETED|Overall Study||2
2979444|NCT00843856|3695122|FG000|STARTED|Overall Study||20
2979445|NCT00843856|3695123|FG001|STARTED|Overall Study||20
2979446|NCT00843856|3695122|FG000|COMPLETED|Overall Study||19
2979447|NCT00843856|3695123|FG001|COMPLETED|Overall Study||18
2979448|NCT00843856|3695122|FG000|NOT COMPLETED|Overall Study||1
2979449|NCT00843856|3695123|FG001|NOT COMPLETED|Overall Study||2
2979450|NCT00844051|3695131|FG000|STARTED|Overall Study||2087
2979451|NCT00844051|3695132|FG001|STARTED|Overall Study||2368
2979452|NCT00844051|3695131|FG000|COMPLETED|Overall Study||2087
2979453|NCT00844051|3695132|FG001|COMPLETED|Overall Study||2368
2979454|NCT00844051|3695131|FG000|NOT COMPLETED|Overall Study||0
2979455|NCT00844051|3695132|FG001|NOT COMPLETED|Overall Study||0
2979456|NCT00844090|3695140|FG000|STARTED|Overall Study||52
2979457|NCT00844090|3695141|FG001|STARTED|Overall Study||54
2979458|NCT00844090|3695140|FG000|COMPLETED|Overall Study||46
2979459|NCT00844090|3695141|FG001|COMPLETED|Overall Study||46
2979460|NCT00844090|3695140|FG000|NOT COMPLETED|Overall Study||6
2979461|NCT00844090|3695141|FG001|NOT COMPLETED|Overall Study||8
2979462|NCT00844194|3695149|FG000|STARTED|Overall Study||78
2979463|NCT00844194|3695150|FG001|STARTED|Overall Study||30
2979464|NCT00844194|3695149|FG000|COMPLETED|Overall Study||53
2979465|NCT00844194|3695150|FG001|COMPLETED|Overall Study||22
2979466|NCT00844194|3695149|FG000|NOT COMPLETED|Overall Study||25
2979467|NCT00844194|3695150|FG001|NOT COMPLETED|Overall Study||8
2979468|NCT00844298|3695160|FG000|STARTED|Overall Study||91
2979469|NCT00844298|3695160|FG000|COMPLETED|Overall Study||91
2979470|NCT00844298|3695160|FG000|NOT COMPLETED|Overall Study||0
2979471|NCT00844376|3695164|FG000|STARTED|Period 1: First Intervention||6
2979472|NCT00844376|3695165|FG001|STARTED|Period 1: First Intervention||6
2979473|NCT00844376|3695164|FG000|COMPLETED|Period 1: First Intervention||5
2979474|NCT00844376|3695165|FG001|COMPLETED|Period 1: First Intervention||6
2979475|NCT00844376|3695164|FG000|NOT COMPLETED|Period 1: First Intervention||1
2979476|NCT00844376|3695165|FG001|NOT COMPLETED|Period 1: First Intervention||0
2979477|NCT00844376|3695164|FG000|STARTED|Period 2: Second Intervention||5
2979478|NCT00844376|3695165|FG001|STARTED|Period 2: Second Intervention||6
2979479|NCT00844376|3695164|FG000|COMPLETED|Period 2: Second Intervention|Total subjects administered Test drug = 12; total subjects administered Reference drug = 11.|5
2979480|NCT00844376|3695165|FG001|COMPLETED|Period 2: Second Intervention||6
2979481|NCT00844376|3695164|FG000|NOT COMPLETED|Period 2: Second Intervention||0
2979482|NCT00844376|3695165|FG001|NOT COMPLETED|Period 2: Second Intervention||0
2979483|NCT00844415|3695171|FG000|STARTED|Overall Study|Entered and treated.|9
2979484|NCT00844415|3695171|FG000|Pat. Received 75mg Followed by 100mg|Overall Study||3
2979485|NCT00844415|3695171|FG000|Pat. Received 100mg Followed by 125mg|Overall Study||3
2979486|NCT00844415|3695171|FG000|Pat. Received 125mg Followed by 150mg|Overall Study||2
2979487|NCT00844415|3695171|FG000|Pat. Received Single Dose 75mg|Overall Study||1
2979488|NCT00844415|3695171|FG000|COMPLETED|Overall Study|Completed.|8
2979489|NCT00844415|3695171|FG000|NOT COMPLETED|Overall Study||1
2979490|NCT00844428|3695176|FG000|STARTED|Screening Period||23
2979491|NCT00844428|3695176|FG000|COMPLETED|Screening Period||20
2979492|NCT00844428|3695176|FG000|NOT COMPLETED|Screening Period||3
2979493|NCT00844428|3695176|FG000|STARTED|Observation Period (8 Weeks)||20
2979494|NCT00844428|3695176|FG000|COMPLETED|Observation Period (8 Weeks)||20
2979495|NCT00844428|3695176|FG000|NOT COMPLETED|Observation Period (8 Weeks)||0
2979496|NCT00844428|3695176|FG000|STARTED|Treatment Period (26 Weeks)||20
2979497|NCT00844428|3695176|FG000|COMPLETED|Treatment Period (26 Weeks)||20
2979498|NCT00844428|3695176|FG000|NOT COMPLETED|Treatment Period (26 Weeks)||0
2979499|NCT00844428|3695176|FG000|STARTED|Extension Treatment Period||19
2979500|NCT00844428|3695176|FG000|COMPLETED|Extension Treatment Period||18
2979501|NCT00844428|3695176|FG000|NOT COMPLETED|Extension Treatment Period||1
2979502|NCT00844428|3695176|FG000|STARTED|Post Treatment Period (Patients Who Disc||5
2979503|NCT00844428|3695176|FG000|COMPLETED|Post Treatment Period (Patients Who Disc||4
2979504|NCT00844428|3695176|FG000|NOT COMPLETED|Post Treatment Period (Patients Who Disc||1
2979505|NCT00844519|3695182|FG000|STARTED|Overall Study||26
2979506|NCT00844519|3695183|FG001|STARTED|Overall Study||26
2979507|NCT00844519|3695182|FG000|COMPLETED|Overall Study||24
2979508|NCT00844519|3695183|FG001|COMPLETED|Overall Study||25
2979509|NCT00844519|3695182|FG000|NOT COMPLETED|Overall Study||2
2979510|NCT00844519|3695183|FG001|NOT COMPLETED|Overall Study||1
2979511|NCT00844532|3695189|FG000|STARTED|Overall Study||151
2979512|NCT00844532|3695189|FG000|COMPLETED|Overall Study||112
2979513|NCT00844532|3695189|FG000|NOT COMPLETED|Overall Study||39
2979514|NCT00844545|3695193|FG000|STARTED|Screening Period||17
2979515|NCT00844545|3695193|FG000|COMPLETED|Screening Period||17
2979516|NCT00844545|3695193|FG000|NOT COMPLETED|Screening Period||0
2979517|NCT00844545|3695193|FG000|STARTED|Treatment Period (26 Weeks)||17
2979518|NCT00844545|3695193|FG000|COMPLETED|Treatment Period (26 Weeks)||15
2979519|NCT00844545|3695193|FG000|NOT COMPLETED|Treatment Period (26 Weeks)||2
2979520|NCT00844545|3695193|FG000|STARTED|Extension Treatment Period||13
2979521|NCT00844545|3695193|FG000|COMPLETED|Extension Treatment Period||11
2979522|NCT00844545|3695193|FG000|NOT COMPLETED|Extension Treatment Period||2
2979523|NCT00844545|3695193|FG000|STARTED|Post Treatment Period||6
2979524|NCT00844545|3695193|FG000|COMPLETED|Post Treatment Period||5
2979525|NCT00844545|3695193|FG000|NOT COMPLETED|Post Treatment Period||1
2979526|NCT00844558|3695200|FG000|STARTED|Overall Study|"Received allocated intervention (n=33)~Did not receive allocated intervention (n=3)"|36
2979527|NCT00844558|3695201|FG001|STARTED|Overall Study|"Received allocated intervention (n=21)~Did not receive allocated intervention (n=1)"|22
2979528|NCT00844558|3695200|FG000|Received Allocated Intervention|Overall Study||33
2979529|NCT00844558|3695201|FG001|Received Allocated Intervention|Overall Study||21
2979530|NCT00844558|3695200|FG000|3 Month Visit|Overall Study|Discontinued intervention (n=4)|29
2979531|NCT00844558|3695201|FG001|3 Month Visit|Overall Study|"Lost to follow-up (n=1)~Discontinued Intervention (n=1)"|19
2979532|NCT00844558|3695200|FG000|6 Month Visit|Overall Study|Discontinued intervention (n=1)|28
2979533|NCT00844558|3695201|FG001|6 Month Visit|Overall Study|-Discontinued intervention (n=1)|18
2979534|NCT00844558|3695200|FG000|12 Month Visit|Overall Study|Discontinued intervention (n=4)|24
2979535|NCT00844558|3695201|FG001|12 Month Visit|Overall Study|-Discontinued intervention (n=0)|18
2979536|NCT00844558|3695200|FG000|COMPLETED|Overall Study||24
2979537|NCT00844558|3695201|FG001|COMPLETED|Overall Study||18
2979538|NCT00844558|3695200|FG000|NOT COMPLETED|Overall Study||12
2979539|NCT00844558|3695201|FG001|NOT COMPLETED|Overall Study||4
2979540|NCT00844597|3695218|FG000|STARTED|Overall Study||4
2979541|NCT00844597|3695219|FG001|STARTED|Overall Study||2
2979542|NCT00844597|3695220|FG002|STARTED|Overall Study||2
2979543|NCT00844597|3695221|FG003|STARTED|Overall Study||3
2979544|NCT00844597|3695222|FG004|STARTED|Overall Study||4
2979545|NCT00844597|3695223|FG005|STARTED|Overall Study||4
2979546|NCT00844597|3695218|FG000|COMPLETED|Overall Study||4
2979547|NCT00844597|3695219|FG001|COMPLETED|Overall Study||2
2979548|NCT00844597|3695220|FG002|COMPLETED|Overall Study||2
2979549|NCT00844597|3695221|FG003|COMPLETED|Overall Study||2
2979550|NCT00844597|3695222|FG004|COMPLETED|Overall Study||4
2979551|NCT00844597|3695223|FG005|COMPLETED|Overall Study||4
2979552|NCT00844597|3695218|FG000|NOT COMPLETED|Overall Study||0
2979553|NCT00844597|3695219|FG001|NOT COMPLETED|Overall Study||0
2979554|NCT00844597|3695220|FG002|NOT COMPLETED|Overall Study||0
2979555|NCT00844597|3695221|FG003|NOT COMPLETED|Overall Study||1
2979556|NCT00844597|3695222|FG004|NOT COMPLETED|Overall Study||0
2979557|NCT00844597|3695223|FG005|NOT COMPLETED|Overall Study||0
2979558|NCT00844649|3695241|FG000|STARTED|Overall Study|Started = Intent to Treat Population and includes all randomized participants|431
2979559|NCT00844649|3695242|FG001|STARTED|Overall Study|Started = Intent to Treat Population and includes all randomized participants|430
2979560|NCT00844649|3695241|FG000|Treated Population|Overall Study|Treated population = all randomized patients who received at least one dose of study drug|421
2979561|NCT00844649|3695242|FG001|Treated Population|Overall Study|Treated population = all randomized patients who received at least one dose of study drug|402
2979562|NCT00844649|3695241|FG000|COMPLETED|Overall Study|Completed = participants remaining on treatment at the time of the data cut off 17 Sept 2012|26
2979563|NCT00844649|3695242|FG001|COMPLETED|Overall Study|Completed = participants remaining on treatment at the time of the data cut off 17 Sept 2012|12
2979564|NCT00844649|3695241|FG000|NOT COMPLETED|Overall Study||405
2979565|NCT00844649|3695242|FG001|NOT COMPLETED|Overall Study||418
2979566|NCT00844714|3695250|FG000|STARTED|Overall Study||20
2979567|NCT00844714|3695250|FG000|COMPLETED|Overall Study||20
2979568|NCT00844714|3695250|FG000|NOT COMPLETED|Overall Study||0
2979569|NCT00844753|3695258|FG000|STARTED|Overall Study||32
2979570|NCT00844753|3695259|FG001|STARTED|Overall Study||32
2979571|NCT00844753|3695260|FG002|STARTED|Overall Study||32
2979572|NCT00844753|3695261|FG003|STARTED|Overall Study||32
2979573|NCT00844753|3695258|FG000|COMPLETED|Overall Study||24
2979574|NCT00844753|3695259|FG001|COMPLETED|Overall Study||29
2979575|NCT00844753|3695260|FG002|COMPLETED|Overall Study||25
2979576|NCT00844753|3695261|FG003|COMPLETED|Overall Study||21
2979577|NCT00844753|3695258|FG000|NOT COMPLETED|Overall Study||8
2979578|NCT00844753|3695259|FG001|NOT COMPLETED|Overall Study||3
2979579|NCT00844753|3695260|FG002|NOT COMPLETED|Overall Study||7
2979580|NCT00844753|3695261|FG003|NOT COMPLETED|Overall Study||11
2979581|NCT00844805|3695271|FG000|STARTED|Treatment Phase||106
2979582|NCT00844805|3695272|FG001|STARTED|Treatment Phase||52
2979583|NCT00844805|3695273|FG002|STARTED|Treatment Phase||0
2979584|NCT00844805|3695274|FG003|STARTED|Treatment Phase||0
2979585|NCT00844805|3695271|FG000|COMPLETED|Treatment Phase||96
2979586|NCT00844805|3695272|FG001|COMPLETED|Treatment Phase||45
3133341|NCT01695239|3858313|FG008|COMPLETED|Extension Long-Term Extension Periods||121
3133342|NCT01695239|3858314|FG009|COMPLETED|Extension Long-Term Extension Periods||122
3133343|NCT01695239|3858315|FG010|COMPLETED|Extension Long-Term Extension Periods||0
3133344|NCT01695239|3858316|FG011|COMPLETED|Extension Long-Term Extension Periods||0
3133345|NCT01695239|3858317|FG012|COMPLETED|Extension Long-Term Extension Periods||0
3133346|NCT01695239|3858318|FG013|COMPLETED|Extension Long-Term Extension Periods||0
3133347|NCT01695239|3858305|FG000|NOT COMPLETED|Extension Long-Term Extension Periods||0
2979587|NCT00844805|3695273|FG002|COMPLETED|Treatment Phase||0
2979588|NCT00844805|3695274|FG003|COMPLETED|Treatment Phase||0
2979589|NCT00844805|3695271|FG000|NOT COMPLETED|Treatment Phase||10
2979590|NCT00844805|3695272|FG001|NOT COMPLETED|Treatment Phase||7
2979591|NCT00844805|3695273|FG002|NOT COMPLETED|Treatment Phase||0
2979592|NCT00844805|3695274|FG003|NOT COMPLETED|Treatment Phase||0
2979593|NCT00844805|3695271|FG000|STARTED|Follow-Up Phase||0
2979594|NCT00844805|3695272|FG001|STARTED|Follow-Up Phase||0
2979595|NCT00844805|3695273|FG002|STARTED|Follow-Up Phase|Participants who met partial remission criteria at the end of treatment entered the Follow-Up Phase.|41
2979596|NCT00844805|3695274|FG003|STARTED|Follow-Up Phase|Participants who met partial remission criteria at the end of treatment entered the Follow-Up Phase.|41
2979597|NCT00844805|3695271|FG000|COMPLETED|Follow-Up Phase||0
2979598|NCT00844805|3695272|FG001|COMPLETED|Follow-Up Phase||0
2979599|NCT00844805|3695273|FG002|COMPLETED|Follow-Up Phase||32
2979600|NCT00844805|3695274|FG003|COMPLETED|Follow-Up Phase||32
2979601|NCT00844805|3695271|FG000|NOT COMPLETED|Follow-Up Phase||0
2979602|NCT00844805|3695272|FG001|NOT COMPLETED|Follow-Up Phase||0
2979603|NCT00844805|3695273|FG002|NOT COMPLETED|Follow-Up Phase||9
2979604|NCT00844805|3695274|FG003|NOT COMPLETED|Follow-Up Phase||9
2979605|NCT00844831|3695285|FG000|STARTED|Overall Study||25
2979606|NCT00844831|3695285|FG000|COMPLETED|Overall Study||19
2979607|NCT00844831|3695285|FG000|NOT COMPLETED|Overall Study||6
2979608|NCT00844844|3695293|FG000|STARTED|Screening Period||17
2979609|NCT00844844|3695293|FG000|COMPLETED|Screening Period||17
2979610|NCT00844844|3695293|FG000|NOT COMPLETED|Screening Period||0
2979611|NCT00844844|3695293|FG000|STARTED|Treatment Period (26 Weeks)||17
2979612|NCT00844844|3695293|FG000|COMPLETED|Treatment Period (26 Weeks)||15
2979613|NCT00844844|3695293|FG000|NOT COMPLETED|Treatment Period (26 Weeks)||2
2979614|NCT00844844|3695293|FG000|STARTED|Extension Treatment Period||13
2979615|NCT00844844|3695293|FG000|COMPLETED|Extension Treatment Period||11
2979616|NCT00844844|3695293|FG000|NOT COMPLETED|Extension Treatment Period||2
2979617|NCT00844844|3695293|FG000|STARTED|Post Treatment Period||6
2979618|NCT00844844|3695293|FG000|COMPLETED|Post Treatment Period||5
2979619|NCT00844844|3695293|FG000|NOT COMPLETED|Post Treatment Period||1
2979620|NCT00844857|3695299|FG000|STARTED|Overall Study||194
2979621|NCT00844857|3695300|FG001|STARTED|Overall Study||97
2979622|NCT00844857|3695299|FG000|Population Analyzed|Overall Study|Randomized participants who took at least 1 dose of study drug excluding 2 GCP noncompliant sites.|170
2979623|NCT00844857|3695300|FG001|Population Analyzed|Overall Study|randomized participants who took at least 1 dose of study drug excluding 2 GCP noncompliant sites.|85
2979624|NCT00844857|3695299|FG000|COMPLETED|Overall Study||116
2979625|NCT00844857|3695300|FG001|COMPLETED|Overall Study||60
3164236|NCT01891864|3891710|FG004|COMPLETED|Treatment Period 1||0
3164237|NCT01891864|3891711|FG005|COMPLETED|Treatment Period 1||0
2979626|NCT00844857|3695299|FG000|NOT COMPLETED|Overall Study||78
2979627|NCT00844857|3695300|FG001|NOT COMPLETED|Overall Study||37
2979628|NCT00844883|3695309|FG000|STARTED|Overall Study||50
2979629|NCT00844883|3695309|FG000|Patients Who Received TACE|Overall Study|2 patients withdrawn at Week 1 prior to TACE for intolerance to sorafenib|48
2979630|NCT00844883|3695309|FG000|COMPLETED|Overall Study||46
2979631|NCT00844883|3695309|FG000|NOT COMPLETED|Overall Study||4
2979632|NCT00844896|3695315|FG000|STARTED|Overall Study||29
2979633|NCT00844896|3695316|FG001|STARTED|Overall Study||28
2979634|NCT00844896|3695315|FG000|COMPLETED|Overall Study||17
2979635|NCT00844896|3695316|FG001|COMPLETED|Overall Study||11
2979636|NCT00844896|3695315|FG000|NOT COMPLETED|Overall Study||12
2979637|NCT00844896|3695316|FG001|NOT COMPLETED|Overall Study||17
2979638|NCT00845000|3695329|FG000|STARTED|Period 1||2
2979639|NCT00845000|3695330|FG001|STARTED|Period 1||2
2979640|NCT00845000|3695331|FG002|STARTED|Period 1||2
2979641|NCT00845000|3695332|FG003|STARTED|Period 1||2
2979642|NCT00845000|3695333|FG004|STARTED|Period 1||2
2979643|NCT00845000|3695334|FG005|STARTED|Period 1||2
2979644|NCT00845000|3695329|FG000|COMPLETED|Period 1||2
2979645|NCT00845000|3695330|FG001|COMPLETED|Period 1||2
2979646|NCT00845000|3695331|FG002|COMPLETED|Period 1||2
2979647|NCT00845000|3695332|FG003|COMPLETED|Period 1||2
2979648|NCT00845000|3695333|FG004|COMPLETED|Period 1||2
2979649|NCT00845000|3695334|FG005|COMPLETED|Period 1||2
2979650|NCT00845000|3695329|FG000|NOT COMPLETED|Period 1||0
2979651|NCT00845000|3695330|FG001|NOT COMPLETED|Period 1||0
2979652|NCT00845000|3695331|FG002|NOT COMPLETED|Period 1||0
2979653|NCT00845000|3695332|FG003|NOT COMPLETED|Period 1||0
2979654|NCT00845000|3695333|FG004|NOT COMPLETED|Period 1||0
2979655|NCT00845000|3695334|FG005|NOT COMPLETED|Period 1||0
2979656|NCT00845000|3695329|FG000|STARTED|Period 2||2
2979657|NCT00845000|3695330|FG001|STARTED|Period 2||2
2979658|NCT00845000|3695331|FG002|STARTED|Period 2||2
2979659|NCT00845000|3695332|FG003|STARTED|Period 2||2
2979660|NCT00845000|3695333|FG004|STARTED|Period 2||2
2979661|NCT00845000|3695334|FG005|STARTED|Period 2||2
2979662|NCT00845000|3695329|FG000|COMPLETED|Period 2||2
2979663|NCT00845000|3695330|FG001|COMPLETED|Period 2||2
2979664|NCT00845000|3695331|FG002|COMPLETED|Period 2||2
2979665|NCT00845000|3695332|FG003|COMPLETED|Period 2||2
2979666|NCT00845000|3695333|FG004|COMPLETED|Period 2||2
2979667|NCT00845000|3695334|FG005|COMPLETED|Period 2||2
2979668|NCT00845000|3695329|FG000|NOT COMPLETED|Period 2||0
2979669|NCT00845000|3695330|FG001|NOT COMPLETED|Period 2||0
2979670|NCT00845000|3695331|FG002|NOT COMPLETED|Period 2||0
2979671|NCT00845000|3695332|FG003|NOT COMPLETED|Period 2||0
2979672|NCT00845000|3695333|FG004|NOT COMPLETED|Period 2||0
2979673|NCT00845000|3695334|FG005|NOT COMPLETED|Period 2||0
2979674|NCT00845000|3695329|FG000|STARTED|Period 3||2
2979675|NCT00845000|3695330|FG001|STARTED|Period 3||2
2979676|NCT00845000|3695331|FG002|STARTED|Period 3||2
2979677|NCT00845000|3695332|FG003|STARTED|Period 3||2
2979678|NCT00845000|3695333|FG004|STARTED|Period 3||2
2979679|NCT00845000|3695334|FG005|STARTED|Period 3||2
2979680|NCT00845000|3695329|FG000|COMPLETED|Period 3||2
2979681|NCT00845000|3695330|FG001|COMPLETED|Period 3||2
2979682|NCT00845000|3695331|FG002|COMPLETED|Period 3||2
2979683|NCT00845000|3695332|FG003|COMPLETED|Period 3||2
2979684|NCT00845000|3695333|FG004|COMPLETED|Period 3||2
2979685|NCT00845000|3695334|FG005|COMPLETED|Period 3||2
2979686|NCT00845000|3695329|FG000|NOT COMPLETED|Period 3||0
2979687|NCT00845000|3695330|FG001|NOT COMPLETED|Period 3||0
2979688|NCT00845000|3695331|FG002|NOT COMPLETED|Period 3||0
2979689|NCT00845000|3695332|FG003|NOT COMPLETED|Period 3||0
2979690|NCT00845000|3695333|FG004|NOT COMPLETED|Period 3||0
2979691|NCT00845000|3695334|FG005|NOT COMPLETED|Period 3||0
2979692|NCT00845039|3695344|FG000|STARTED|Overall Study||2
2979693|NCT00845039|3695345|FG001|STARTED|Overall Study||2
2979694|NCT00845039|3695344|FG000|Received at Least 1 Dose of Study Drug|Overall Study||2
2979695|NCT00845039|3695345|FG001|Received at Least 1 Dose of Study Drug|Overall Study||2
2979696|NCT00845039|3695344|FG000|COMPLETED|Overall Study||2
2979697|NCT00845039|3695345|FG001|COMPLETED|Overall Study||2
2979698|NCT00845039|3695344|FG000|NOT COMPLETED|Overall Study||0
2979699|NCT00845039|3695345|FG001|NOT COMPLETED|Overall Study||0
2979700|NCT00845065|3695355|FG000|STARTED|Overall Study||67
2979701|NCT00845065|3695356|FG001|STARTED|Overall Study||134
2979702|NCT00845065|3695355|FG000|COMPLETED|Overall Study||20
2979703|NCT00845065|3695356|FG001|COMPLETED|Overall Study||79
2979704|NCT00845065|3695355|FG000|NOT COMPLETED|Overall Study||47
2979705|NCT00845065|3695356|FG001|NOT COMPLETED|Overall Study||55
2979706|NCT00845130|3695364|FG000|STARTED|Overall Study||20
2979707|NCT00845130|3695365|FG001|STARTED|Overall Study||22
2979708|NCT00845130|3695364|FG000|COMPLETED|Overall Study||16
2979709|NCT00845130|3695365|FG001|COMPLETED|Overall Study||19
2979710|NCT00845130|3695364|FG000|NOT COMPLETED|Overall Study||4
2979711|NCT00845130|3695365|FG001|NOT COMPLETED|Overall Study||3
2979712|NCT00845182|3695376|FG000|STARTED|Overall Study||13
2979713|NCT00845182|3695377|FG001|STARTED|Overall Study||15
2979714|NCT00845182|3695378|FG002|STARTED|Overall Study||15
2979715|NCT00845182|3695376|FG000|COMPLETED|Overall Study||10
2979716|NCT00845182|3695377|FG001|COMPLETED|Overall Study||11
2979717|NCT00845182|3695378|FG002|COMPLETED|Overall Study||9
2979718|NCT00845182|3695376|FG000|NOT COMPLETED|Overall Study||3
2979719|NCT00845182|3695377|FG001|NOT COMPLETED|Overall Study||4
2979720|NCT00845182|3695378|FG002|NOT COMPLETED|Overall Study||6
2979721|NCT00845195|3695392|FG000|STARTED|Overall Study||75
2979722|NCT00845195|3695393|FG001|STARTED|Overall Study||75
2979723|NCT00845195|3695392|FG000|COMPLETED|Overall Study||75
2979724|NCT00845195|3695393|FG001|COMPLETED|Overall Study||75
2979725|NCT00845195|3695392|FG000|NOT COMPLETED|Overall Study||0
2979726|NCT00845195|3695393|FG001|NOT COMPLETED|Overall Study||0
2979727|NCT00845429|3695402|FG000|STARTED|Overall Study||244
2979728|NCT00845429|3695403|FG001|STARTED|Overall Study||241
2979729|NCT00845429|3695404|FG002|STARTED|Overall Study||244
2979730|NCT00845429|3695402|FG000|COMPLETED|Overall Study||230
2979731|NCT00845429|3695403|FG001|COMPLETED|Overall Study||226
2979732|NCT00845429|3695404|FG002|COMPLETED|Overall Study||224
2979733|NCT00845429|3695402|FG000|NOT COMPLETED|Overall Study||14
2979734|NCT00845429|3695403|FG001|NOT COMPLETED|Overall Study||15
2979735|NCT00845429|3695404|FG002|NOT COMPLETED|Overall Study||20
2979736|NCT00845481|3695412|FG000|STARTED|Overall Study||24
2979737|NCT00845481|3695412|FG000|COMPLETED|Overall Study||24
2979738|NCT00845481|3695412|FG000|NOT COMPLETED|Overall Study||0
2979739|NCT00845507|3695423|FG000|STARTED|Overall Study||24
2979740|NCT00845507|3695424|FG001|STARTED|Overall Study||30
2979741|NCT00845507|3695423|FG000|COMPLETED|Overall Study||22
2979742|NCT00845507|3695424|FG001|COMPLETED|Overall Study||29
2979743|NCT00845507|3695423|FG000|NOT COMPLETED|Overall Study||2
2979744|NCT00845507|3695424|FG001|NOT COMPLETED|Overall Study||1
2979745|NCT00845520|3695433|FG000|STARTED|Overall Study||25
2979746|NCT00845520|3695434|FG001|STARTED|Overall Study||25
2979747|NCT00845520|3695435|FG002|STARTED|Overall Study||24
2979748|NCT00845520|3695433|FG000|COMPLETED|Overall Study||23
2979749|NCT00845520|3695434|FG001|COMPLETED|Overall Study||23
2979750|NCT00845520|3695435|FG002|COMPLETED|Overall Study||23
2979751|NCT00845520|3695433|FG000|NOT COMPLETED|Overall Study||2
2979752|NCT00845520|3695434|FG001|NOT COMPLETED|Overall Study||2
2979753|NCT00845520|3695435|FG002|NOT COMPLETED|Overall Study||1
3036256|NCT01142726|3755496|FG001|NOT COMPLETED|Treatment Phase: Day 1 Through Month 12||25
3036257|NCT01142726|3755497|FG002|NOT COMPLETED|Treatment Phase: Day 1 Through Month 12||20
3036258|NCT01142726|3755495|FG000|STARTED|Withdrawal Phase: Months 12 up to 24||84
3036259|NCT01142726|3755496|FG001|STARTED|Withdrawal Phase: Months 12 up to 24||66
3036260|NCT01142726|3755497|FG002|STARTED|Withdrawal Phase: Months 12 up to 24||75
3036261|NCT01142726|3755495|FG000|COMPLETED|Withdrawal Phase: Months 12 up to 24||14
3036262|NCT01142726|3755496|FG001|COMPLETED|Withdrawal Phase: Months 12 up to 24||10
3036263|NCT01142726|3755497|FG002|COMPLETED|Withdrawal Phase: Months 12 up to 24||17
3036264|NCT01142726|3755495|FG000|NOT COMPLETED|Withdrawal Phase: Months 12 up to 24||70
3036265|NCT01142726|3755496|FG001|NOT COMPLETED|Withdrawal Phase: Months 12 up to 24||56
2979754|NCT00845650|3695455|FG000|STARTED|Overall Study|1 subject not dosed|31
2979755|NCT00845650|3695456|FG001|STARTED|Overall Study||5
2979756|NCT00845650|3695457|FG002|STARTED|Overall Study||31
2979757|NCT00845650|3695458|FG003|STARTED|Overall Study||14
2979758|NCT00845650|3695459|FG004|STARTED|Overall Study|2 subjects not dosed|31
2979759|NCT00845650|3695460|FG005|STARTED|Overall Study|1 subject not dosed|17
2979760|NCT00845650|3695455|FG000|COMPLETED|Overall Study||30
2979761|NCT00845650|3695456|FG001|COMPLETED|Overall Study||5
2979762|NCT00845650|3695457|FG002|COMPLETED|Overall Study||28
2979763|NCT00845650|3695458|FG003|COMPLETED|Overall Study||13
2979764|NCT00845650|3695459|FG004|COMPLETED|Overall Study||28
2979765|NCT00845650|3695460|FG005|COMPLETED|Overall Study||15
2979766|NCT00845650|3695455|FG000|NOT COMPLETED|Overall Study||1
2979767|NCT00845650|3695456|FG001|NOT COMPLETED|Overall Study||0
2979768|NCT00845650|3695457|FG002|NOT COMPLETED|Overall Study||3
2979769|NCT00845650|3695458|FG003|NOT COMPLETED|Overall Study||1
2979770|NCT00845650|3695459|FG004|NOT COMPLETED|Overall Study||3
2979771|NCT00845650|3695460|FG005|NOT COMPLETED|Overall Study||2
2979772|NCT00845663|3695478|FG000|STARTED|Overall Study||49
2979773|NCT00845663|3695479|FG001|STARTED|Overall Study||49
2979774|NCT00845663|3695478|FG000|COMPLETED|Overall Study||49
2979775|NCT00845663|3695479|FG001|COMPLETED|Overall Study||49
2979776|NCT00845663|3695478|FG000|NOT COMPLETED|Overall Study||0
2979777|NCT00845663|3695479|FG001|NOT COMPLETED|Overall Study||0
2979778|NCT00845676|3695485|FG000|STARTED|Overall Study||21
2979779|NCT00845676|3695485|FG000|COMPLETED|Overall Study||19
2979780|NCT00845676|3695485|FG000|NOT COMPLETED|Overall Study||2
2979781|NCT00845728|3695492|FG000|STARTED|Overall Study||1723
2979782|NCT00845728|3695493|FG001|STARTED|Overall Study||1721
2979783|NCT00845728|3695492|FG000|Exposed|Overall Study||1721
2979784|NCT00845728|3695493|FG001|Exposed|Overall Study||1718
2979785|NCT00845728|3695492|FG000|COMPLETED|Overall Study||1337
2979786|NCT00845728|3695493|FG001|COMPLETED|Overall Study||1379
2979787|NCT00845728|3695492|FG000|NOT COMPLETED|Overall Study||386
2979788|NCT00845728|3695493|FG001|NOT COMPLETED|Overall Study||342
2979789|NCT00845832|3695502|FG000|STARTED|Treatment Period||4
2979790|NCT00845832|3695503|FG001|STARTED|Treatment Period||10
2979791|NCT00845832|3695504|FG002|STARTED|Treatment Period||10
2979792|NCT00845832|3695502|FG000|COMPLETED|Treatment Period||3
2979793|NCT00845832|3695503|FG001|COMPLETED|Treatment Period||7
2979794|NCT00845832|3695504|FG002|COMPLETED|Treatment Period||10
2979795|NCT00845832|3695502|FG000|NOT COMPLETED|Treatment Period||1
2979796|NCT00845832|3695503|FG001|NOT COMPLETED|Treatment Period||3
2979797|NCT00845832|3695504|FG002|NOT COMPLETED|Treatment Period||0
2979798|NCT00845832|3695502|FG000|STARTED|Safety Follow-Up|One participant from this group was re-assigned to TCZ (4 mg/kg) group.|3
2979799|NCT00845832|3695503|FG001|STARTED|Safety Follow-Up|All participants who withdrew from study were asked to return for safety follow-up.|9
2979800|NCT00845832|3695504|FG002|STARTED|Safety Follow-Up|One participant each from the placebo and TCZ (2 mg/kg) groups were re-assigned to this group.|12
2979801|NCT00845832|3695502|FG000|COMPLETED|Safety Follow-Up||2
2979802|NCT00845832|3695503|FG001|COMPLETED|Safety Follow-Up|One participant from this group was re-assigned to TCZ (4 mg/kg) group.|9
2979803|NCT00845832|3695504|FG002|COMPLETED|Safety Follow-Up||12
2979804|NCT00845832|3695502|FG000|NOT COMPLETED|Safety Follow-Up||1
2979805|NCT00845832|3695503|FG001|NOT COMPLETED|Safety Follow-Up||0
2979806|NCT00845832|3695504|FG002|NOT COMPLETED|Safety Follow-Up||0
2979807|NCT00845832|3695502|FG000|STARTED|Extended Safety Follow-Up||2
2979808|NCT00845832|3695503|FG001|STARTED|Extended Safety Follow-Up|Only participants who remained B cell depleted required extended safety follow-up.|5
2979809|NCT00845832|3695504|FG002|STARTED|Extended Safety Follow-Up|Only participants who remained B cell depleted required extended safety follow-up.|7
2979810|NCT00845832|3695502|FG000|COMPLETED|Extended Safety Follow-Up||2
2979811|NCT00845832|3695503|FG001|COMPLETED|Extended Safety Follow-Up||5
2979812|NCT00845832|3695504|FG002|COMPLETED|Extended Safety Follow-Up||0
2979813|NCT00845832|3695502|FG000|NOT COMPLETED|Extended Safety Follow-Up||0
2979814|NCT00845832|3695503|FG001|NOT COMPLETED|Extended Safety Follow-Up||0
2979815|NCT00845832|3695504|FG002|NOT COMPLETED|Extended Safety Follow-Up||7
2979816|NCT00845858|3695515|FG000|STARTED|Overall Study|"95 subjects received allocated intervention.~1 subject withdrew consent and was not dosed."|96
2979817|NCT00845858|3695516|FG001|STARTED|Overall Study|"95 subjects received allocated intervention.~1 subject was not eligible and was not dosed."|96
2979818|NCT00845858|3695517|FG002|STARTED|Overall Study||95
2979819|NCT00845858|3695515|FG000|COMPLETED|Overall Study||88
2979820|NCT00845858|3695516|FG001|COMPLETED|Overall Study||84
2979821|NCT00845858|3695517|FG002|COMPLETED|Overall Study||87
3133348|NCT01695239|3858306|FG001|NOT COMPLETED|Extension Long-Term Extension Periods||0
3133349|NCT01695239|3858307|FG002|NOT COMPLETED|Extension Long-Term Extension Periods||0
3133350|NCT01695239|3858308|FG003|NOT COMPLETED|Extension Long-Term Extension Periods||0
3133351|NCT01695239|3858309|FG004|NOT COMPLETED|Extension Long-Term Extension Periods||0
2979822|NCT00845858|3695515|FG000|NOT COMPLETED|Overall Study||8
2979823|NCT00845858|3695516|FG001|NOT COMPLETED|Overall Study||12
2979824|NCT00845858|3695517|FG002|NOT COMPLETED|Overall Study||8
2979825|NCT00845871|3695528|FG000|STARTED|Run-in Period||65
2979826|NCT00845871|3695528|FG000|COMPLETED|Run-in Period||65
2979827|NCT00845871|3695528|FG000|NOT COMPLETED|Run-in Period||0
2979828|NCT00845871|3695528|FG000|STARTED|Assessment Period||65
2979829|NCT00845871|3695528|FG000|COMPLETED|Assessment Period||58
2979830|NCT00845871|3695528|FG000|NOT COMPLETED|Assessment Period||7
2979831|NCT00845897|3695555|FG000|STARTED|Overall Study||5
2979832|NCT00845897|3695556|FG001|STARTED|Overall Study||7
2979833|NCT00845897|3695557|FG002|STARTED|Overall Study||5
2979834|NCT00845897|3695555|FG000|COMPLETED|Overall Study||3
2979835|NCT00845897|3695556|FG001|COMPLETED|Overall Study||2
2979836|NCT00845897|3695557|FG002|COMPLETED|Overall Study||2
2979837|NCT00845897|3695555|FG000|NOT COMPLETED|Overall Study||2
2979838|NCT00845897|3695556|FG001|NOT COMPLETED|Overall Study||5
2979839|NCT00845897|3695557|FG002|NOT COMPLETED|Overall Study||3
2979840|NCT00845975|3695567|FG000|STARTED|Overall Study||9
2979841|NCT00845975|3695568|FG001|STARTED|Overall Study||9
2979842|NCT00845975|3695567|FG000|COMPLETED|Overall Study||9
2979843|NCT00845975|3695568|FG001|COMPLETED|Overall Study||9
2979844|NCT00845975|3695567|FG000|NOT COMPLETED|Overall Study||0
2979845|NCT00845975|3695568|FG001|NOT COMPLETED|Overall Study||0
3164238|NCT01891864|3891706|FG000|NOT COMPLETED|Treatment Period 1||8
3164239|NCT01891864|3891707|FG001|NOT COMPLETED|Treatment Period 1||12
3164240|NCT01891864|3891708|FG002|NOT COMPLETED|Treatment Period 1||0
3164241|NCT01891864|3891709|FG003|NOT COMPLETED|Treatment Period 1||0
3164242|NCT01891864|3891710|FG004|NOT COMPLETED|Treatment Period 1||0
3164243|NCT01891864|3891711|FG005|NOT COMPLETED|Treatment Period 1||0
2979846|NCT00846027|3695574|FG000|STARTED|Overall Study||90
2979847|NCT00846027|3695574|FG000|Received Treatment|Overall Study||83
2979848|NCT00846027|3695574|FG000|COMPLETED|Overall Study||0
2979849|NCT00846027|3695574|FG000|NOT COMPLETED|Overall Study||90
2979850|NCT00846040|3695581|FG000|STARTED|Baseline: Days 1-5||10
2979851|NCT00846040|3695582|FG001|STARTED|Baseline: Days 1-5||10
2979852|NCT00846040|3695583|FG002|STARTED|Baseline: Days 1-5||23
2979853|NCT00846040|3695581|FG000|COMPLETED|Baseline: Days 1-5||9
2979854|NCT00846040|3695582|FG001|COMPLETED|Baseline: Days 1-5||10
2979855|NCT00846040|3695583|FG002|COMPLETED|Baseline: Days 1-5||23
2979856|NCT00846040|3695581|FG000|NOT COMPLETED|Baseline: Days 1-5||1
2979857|NCT00846040|3695582|FG001|NOT COMPLETED|Baseline: Days 1-5||0
2979858|NCT00846040|3695583|FG002|NOT COMPLETED|Baseline: Days 1-5||0
2979859|NCT00846040|3695581|FG000|STARTED|First Treatment Period: Days 6-14||9
2979860|NCT00846040|3695582|FG001|STARTED|First Treatment Period: Days 6-14||10
2979861|NCT00846040|3695583|FG002|STARTED|First Treatment Period: Days 6-14|This group participated in only the baseline period|0
2979862|NCT00846040|3695581|FG000|COMPLETED|First Treatment Period: Days 6-14||9
2979863|NCT00846040|3695582|FG001|COMPLETED|First Treatment Period: Days 6-14||10
2979864|NCT00846040|3695583|FG002|COMPLETED|First Treatment Period: Days 6-14||0
2979865|NCT00846040|3695581|FG000|NOT COMPLETED|First Treatment Period: Days 6-14||0
3164244|NCT01891864|3891706|FG000|STARTED|Treatment Period 2|Treatment arm applicable for Treatment Period 1 only (patients re-randomized in Treatment Period 2)|0
3164245|NCT01891864|3891707|FG001|STARTED|Treatment Period 2|Treatment arm applicable for Treatment Period 1 only (patients re-randomized in Treatment Period 2)|0
3171766|NCT01936948|3898955|FG002|NOT COMPLETED|Overall Study||3
2979866|NCT00846040|3695582|FG001|NOT COMPLETED|First Treatment Period: Days 6-14||0
2979867|NCT00846040|3695583|FG002|NOT COMPLETED|First Treatment Period: Days 6-14||0
2979868|NCT00846040|3695581|FG000|STARTED|Washout: 2 Weeks to 10 Weeks||9
2979869|NCT00846040|3695582|FG001|STARTED|Washout: 2 Weeks to 10 Weeks||10
2979870|NCT00846040|3695583|FG002|STARTED|Washout: 2 Weeks to 10 Weeks||0
2979871|NCT00846040|3695581|FG000|COMPLETED|Washout: 2 Weeks to 10 Weeks||9
2979872|NCT00846040|3695582|FG001|COMPLETED|Washout: 2 Weeks to 10 Weeks||8
2979873|NCT00846040|3695583|FG002|COMPLETED|Washout: 2 Weeks to 10 Weeks||0
2979874|NCT00846040|3695581|FG000|NOT COMPLETED|Washout: 2 Weeks to 10 Weeks||0
2979875|NCT00846040|3695582|FG001|NOT COMPLETED|Washout: 2 Weeks to 10 Weeks||2
2979876|NCT00846040|3695583|FG002|NOT COMPLETED|Washout: 2 Weeks to 10 Weeks||0
2979877|NCT00846040|3695581|FG000|STARTED|Second Treatment: After Washout, 14 Day||9
2979878|NCT00846040|3695582|FG001|STARTED|Second Treatment: After Washout, 14 Day||8
2979879|NCT00846040|3695583|FG002|STARTED|Second Treatment: After Washout, 14 Day||0
3133352|NCT01695239|3858310|FG005|NOT COMPLETED|Extension Long-Term Extension Periods||0
3133353|NCT01695239|3858311|FG006|NOT COMPLETED|Extension Long-Term Extension Periods||0
3133354|NCT01695239|3858312|FG007|NOT COMPLETED|Extension Long-Term Extension Periods||0
3133355|NCT01695239|3858313|FG008|NOT COMPLETED|Extension Long-Term Extension Periods||66
3133356|NCT01695239|3858314|FG009|NOT COMPLETED|Extension Long-Term Extension Periods||61
3133357|NCT01695239|3858315|FG010|NOT COMPLETED|Extension Long-Term Extension Periods||0
3133358|NCT01695239|3858316|FG011|NOT COMPLETED|Extension Long-Term Extension Periods||0
3133359|NCT01695239|3858317|FG012|NOT COMPLETED|Extension Long-Term Extension Periods||0
3133360|NCT01695239|3858318|FG013|NOT COMPLETED|Extension Long-Term Extension Periods||0
3133361|NCT01695239|3858305|FG000|STARTED|Post-Treatment Follow-Up Period||0
3133362|NCT01695239|3858306|FG001|STARTED|Post-Treatment Follow-Up Period||0
3133363|NCT01695239|3858307|FG002|STARTED|Post-Treatment Follow-Up Period||0
3133364|NCT01695239|3858308|FG003|STARTED|Post-Treatment Follow-Up Period||0
3133365|NCT01695239|3858309|FG004|STARTED|Post-Treatment Follow-Up Period||0
3133366|NCT01695239|3858310|FG005|STARTED|Post-Treatment Follow-Up Period||0
3133367|NCT01695239|3858311|FG006|STARTED|Post-Treatment Follow-Up Period||0
2979880|NCT00846040|3695581|FG000|COMPLETED|Second Treatment: After Washout, 14 Day||9
2979881|NCT00846040|3695582|FG001|COMPLETED|Second Treatment: After Washout, 14 Day||8
2979882|NCT00846040|3695583|FG002|COMPLETED|Second Treatment: After Washout, 14 Day||0
2979883|NCT00846040|3695581|FG000|NOT COMPLETED|Second Treatment: After Washout, 14 Day||0
2979884|NCT00846040|3695582|FG001|NOT COMPLETED|Second Treatment: After Washout, 14 Day||0
2979885|NCT00846040|3695583|FG002|NOT COMPLETED|Second Treatment: After Washout, 14 Day||0
2979886|NCT00846053|3695594|FG000|STARTED|Overall Study|No milestones. Enrollment continued until end of study.|13
2979887|NCT00846053|3695595|FG001|STARTED|Overall Study||8
2979888|NCT00846053|3695594|FG000|COMPLETED|Overall Study|No milestones. Enrollment continued until end of study. 21 subjects enrolled.|10
2979889|NCT00846053|3695595|FG001|COMPLETED|Overall Study||8
2979890|NCT00846053|3695594|FG000|NOT COMPLETED|Overall Study||3
2979891|NCT00846053|3695595|FG001|NOT COMPLETED|Overall Study||0
2979892|NCT00846066|3695605|FG000|STARTED|Overall Study||27
2979893|NCT00846066|3695606|FG001|STARTED|Overall Study||29
2979894|NCT00846066|3695605|FG000|COMPLETED|Overall Study||27
2979895|NCT00846066|3695606|FG001|COMPLETED|Overall Study||29
2979896|NCT00846066|3695605|FG000|NOT COMPLETED|Overall Study||0
2979897|NCT00846066|3695606|FG001|NOT COMPLETED|Overall Study||0
2979898|NCT00846287|3695615|FG000|STARTED|Overall Study||16
2979899|NCT00846287|3695616|FG001|STARTED|Overall Study||15
2979900|NCT00846287|3695615|FG000|COMPLETED|Overall Study||6
2979901|NCT00846287|3695616|FG001|COMPLETED|Overall Study||10
2979902|NCT00846287|3695615|FG000|NOT COMPLETED|Overall Study||10
2979903|NCT00846287|3695616|FG001|NOT COMPLETED|Overall Study||5
2979904|NCT00846365|3695625|FG000|STARTED|Overall Study||372
2979905|NCT00846365|3695626|FG001|STARTED|Overall Study||357
2979906|NCT00846365|3695627|FG002|STARTED|Overall Study||356
2979907|NCT00846365|3695625|FG000|COMPLETED|Overall Study||317
2979908|NCT00846365|3695626|FG001|COMPLETED|Overall Study||308
2979909|NCT00846365|3695627|FG002|COMPLETED|Overall Study||323
2979910|NCT00846365|3695625|FG000|NOT COMPLETED|Overall Study||55
2979911|NCT00846365|3695626|FG001|NOT COMPLETED|Overall Study||49
2979912|NCT00846365|3695627|FG002|NOT COMPLETED|Overall Study||33
2979913|NCT00846391|3695638|FG000|STARTED|Overall Study||4
2979914|NCT00846391|3695639|FG001|STARTED|Overall Study||4
2979915|NCT00846391|3695640|FG002|STARTED|Overall Study||6
2979916|NCT00846391|3695638|FG000|COMPLETED|Overall Study||3
2979917|NCT00846391|3695639|FG001|COMPLETED|Overall Study||2
2979918|NCT00846391|3695640|FG002|COMPLETED|Overall Study||3
2979919|NCT00846391|3695638|FG000|NOT COMPLETED|Overall Study||1
2979920|NCT00846391|3695639|FG001|NOT COMPLETED|Overall Study||2
2979921|NCT00846391|3695640|FG002|NOT COMPLETED|Overall Study||3
2979922|NCT00846482|3695648|FG000|STARTED|Overall Study||64
2979923|NCT00846482|3695648|FG000|COMPLETED|Overall Study||54
2979924|NCT00846482|3695648|FG000|NOT COMPLETED|Overall Study||10
2979925|NCT00846495|3695655|FG000|STARTED|Overall Study||28
2979926|NCT00846495|3695656|FG001|STARTED|Overall Study||27
2979927|NCT00846495|3695655|FG000|COMPLETED|Overall Study||20
2979928|NCT00846495|3695656|FG001|COMPLETED|Overall Study||24
2979929|NCT00846495|3695655|FG000|NOT COMPLETED|Overall Study||8
2979930|NCT00846495|3695656|FG001|NOT COMPLETED|Overall Study||3
2979931|NCT00846521|3695662|FG000|STARTED|Overall Study||23
2979932|NCT00846521|3695662|FG000|COMPLETED|Overall Study||12
2979933|NCT00846521|3695662|FG000|NOT COMPLETED|Overall Study||11
2979934|NCT00846547|3695666|FG000|STARTED|Overall Study||32
2979935|NCT00846547|3695666|FG000|COMPLETED|Overall Study||25
2979936|NCT00846547|3695666|FG000|NOT COMPLETED|Overall Study||7
2979937|NCT00846573|3695673|FG000|STARTED|Overall Study||5
2979938|NCT00846573|3695674|FG001|STARTED|Overall Study||2
2979939|NCT00846573|3695675|FG002|STARTED|Overall Study||7
2979940|NCT00846573|3695676|FG003|STARTED|Overall Study||0
2979941|NCT00846573|3695673|FG000|COMPLETED|Overall Study||5
2979942|NCT00846573|3695674|FG001|COMPLETED|Overall Study||2
2979943|NCT00846573|3695675|FG002|COMPLETED|Overall Study||7
2979944|NCT00846573|3695676|FG003|COMPLETED|Overall Study||0
2979945|NCT00846573|3695673|FG000|NOT COMPLETED|Overall Study||0
2979946|NCT00846573|3695674|FG001|NOT COMPLETED|Overall Study||0
2979947|NCT00846573|3695675|FG002|NOT COMPLETED|Overall Study||0
2979948|NCT00846573|3695676|FG003|NOT COMPLETED|Overall Study||0
2979949|NCT00846586|3695686|FG000|STARTED|Overall Study||570
2979950|NCT00846586|3695687|FG001|STARTED|Overall Study||564
2979951|NCT00846586|3695686|FG000|Received Study Drug|Overall Study||570
2979952|NCT00846586|3695687|FG001|Received Study Drug|Overall Study|Three patients were not exposed to study treatment in this group.|561
2979953|NCT00846586|3695686|FG000|COMPLETED|Overall Study||531
2979954|NCT00846586|3695687|FG001|COMPLETED|Overall Study||529
2979955|NCT00846586|3695686|FG000|NOT COMPLETED|Overall Study||39
2979956|NCT00846586|3695687|FG001|NOT COMPLETED|Overall Study||35
2979957|NCT00846651|3695695|FG000|STARTED|Overall Study||41
2979958|NCT00846651|3695696|FG001|STARTED|Overall Study||41
2979959|NCT00846651|3695695|FG000|COMPLETED|Overall Study||37
2979960|NCT00846651|3695696|FG001|COMPLETED|Overall Study||37
2979961|NCT00846651|3695695|FG000|NOT COMPLETED|Overall Study||4
2979962|NCT00846651|3695696|FG001|NOT COMPLETED|Overall Study||4
2979963|NCT00846742|3695704|FG000|STARTED|Overall Study||85
2979964|NCT00846742|3695704|FG000|With Radiation Therapy (RT)|Overall Study||17
2979965|NCT00846742|3695704|FG000|Without Radiation Therapy (RT)|Overall Study||68
2979966|NCT00846742|3695704|FG000|COMPLETED|Overall Study||84
2979967|NCT00846742|3695704|FG000|NOT COMPLETED|Overall Study||1
2979968|NCT00846768|3695709|FG000|STARTED|Overall Study||11
2979969|NCT00846768|3695710|FG001|STARTED|Overall Study||12
2979970|NCT00846768|3695711|FG002|STARTED|Overall Study||12
2979971|NCT00846768|3695712|FG003|STARTED|Overall Study||12
2979972|NCT00846768|3695709|FG000|COMPLETED|Overall Study||11
2979973|NCT00846768|3695710|FG001|COMPLETED|Overall Study||11
2979974|NCT00846768|3695711|FG002|COMPLETED|Overall Study||12
2979975|NCT00846768|3695712|FG003|COMPLETED|Overall Study||12
2979976|NCT00846768|3695709|FG000|NOT COMPLETED|Overall Study||0
2979977|NCT00846768|3695710|FG001|NOT COMPLETED|Overall Study||1
2979978|NCT00846768|3695711|FG002|NOT COMPLETED|Overall Study||0
2979979|NCT00846768|3695712|FG003|NOT COMPLETED|Overall Study||0
2979980|NCT00846807|3695722|FG000|STARTED|Overall Study|Entered and treated.|5292
2979981|NCT00846807|3695722|FG000|COMPLETED|Overall Study|Completed treatment.|4660
2979982|NCT00846807|3695722|FG000|NOT COMPLETED|Overall Study||632
2979983|NCT00846846|3695726|FG000|STARTED|Overall Study||1018
2979984|NCT00846846|3695726|FG000|COMPLETED|Overall Study|Study ongoing but not recruiting participants.|943
2979985|NCT00846846|3695726|FG000|NOT COMPLETED|Overall Study||75
2979986|NCT00847015|3695730|FG000|STARTED|Overall Study||18
2979987|NCT00847015|3695730|FG000|COMPLETED|Overall Study||15
2979988|NCT00847015|3695730|FG000|NOT COMPLETED|Overall Study||3
2979989|NCT00847132|3695736|FG000|STARTED|Overall Study||90
2979990|NCT00847132|3695737|FG001|STARTED|Overall Study||85
2979991|NCT00847132|3695736|FG000|COMPLETED|Overall Study||89
2979992|NCT00847132|3695737|FG001|COMPLETED|Overall Study||84
2979993|NCT00847132|3695736|FG000|NOT COMPLETED|Overall Study||1
2979994|NCT00847132|3695737|FG001|NOT COMPLETED|Overall Study||1
2979995|NCT00847145|3695751|FG000|STARTED|Overall Study||629
2979996|NCT00847145|3695752|FG001|STARTED|Overall Study||633
2979997|NCT00847145|3695753|FG002|STARTED|Overall Study||285
2979998|NCT00847145|3695754|FG003|STARTED|Overall Study||117
2979999|NCT00847145|3695755|FG004|STARTED|Overall Study||137
2980000|NCT00847145|3695756|FG005|STARTED|Overall Study||156
2980001|NCT00847145|3695757|FG006|STARTED|Overall Study||152
3133368|NCT01695239|3858312|FG007|STARTED|Post-Treatment Follow-Up Period||0
3133369|NCT01695239|3858313|FG008|STARTED|Post-Treatment Follow-Up Period|Only included post-treatment follow-up participants.|0
3133370|NCT01695239|3858314|FG009|STARTED|Post-Treatment Follow-Up Period|Only included post-treatment follow-up participants.|0
3133371|NCT01695239|3858315|FG010|STARTED|Post-Treatment Follow-Up Period|Participants who discontinued early and received PBO.|20
3133372|NCT01695239|3858316|FG011|STARTED|Post-Treatment Follow-Up Period|Participants who discontinued early and received adalimumab.|1
3133373|NCT01695239|3858317|FG012|STARTED|Post-Treatment Follow-Up Period|IxeQ4W participants who entered post-treatment follow-up.|165
3133374|NCT01695239|3858318|FG013|STARTED|Post-Treatment Follow-Up Period|IxeQ2W participants who entered post-treatment follow-up.|171
3133375|NCT01695239|3858305|FG000|COMPLETED|Post-Treatment Follow-Up Period||0
3133376|NCT01695239|3858306|FG001|COMPLETED|Post-Treatment Follow-Up Period||0
2980002|NCT00847145|3695758|FG007|STARTED|Overall Study||140
2980003|NCT00847145|3695751|FG000|COMPLETED|Overall Study||623
2980004|NCT00847145|3695752|FG001|COMPLETED|Overall Study||627
2980005|NCT00847145|3695753|FG002|COMPLETED|Overall Study||274
2980006|NCT00847145|3695754|FG003|COMPLETED|Overall Study||116
2980007|NCT00847145|3695755|FG004|COMPLETED|Overall Study||131
2980008|NCT00847145|3695756|FG005|COMPLETED|Overall Study||152
2980009|NCT00847145|3695757|FG006|COMPLETED|Overall Study||143
2980010|NCT00847145|3695758|FG007|COMPLETED|Overall Study||136
2980011|NCT00847145|3695751|FG000|NOT COMPLETED|Overall Study||6
2980012|NCT00847145|3695752|FG001|NOT COMPLETED|Overall Study||6
2980013|NCT00847145|3695753|FG002|NOT COMPLETED|Overall Study||11
2980014|NCT00847145|3695754|FG003|NOT COMPLETED|Overall Study||1
2980015|NCT00847145|3695755|FG004|NOT COMPLETED|Overall Study||6
2980016|NCT00847145|3695756|FG005|NOT COMPLETED|Overall Study||4
2980017|NCT00847145|3695757|FG006|NOT COMPLETED|Overall Study||9
2980018|NCT00847145|3695758|FG007|NOT COMPLETED|Overall Study||4
2980019|NCT00847171|3695785|FG000|STARTED|Overall Study||20
2980020|NCT00847171|3695785|FG000|COMPLETED|Overall Study||20
2980021|NCT00847171|3695785|FG000|NOT COMPLETED|Overall Study||0
2980022|NCT00847197|3695792|FG000|STARTED|Overall Study||116
2980023|NCT00847197|3695793|FG001|STARTED|Overall Study||75
2980024|NCT00847197|3695792|FG000|COMPLETED|Overall Study||92
2980025|NCT00847197|3695793|FG001|COMPLETED|Overall Study||70
2980026|NCT00847197|3695792|FG000|NOT COMPLETED|Overall Study||24
2980027|NCT00847197|3695793|FG001|NOT COMPLETED|Overall Study||5
2980028|NCT00847210|3695801|FG000|STARTED|Overall Study||18
2980029|NCT00847210|3695802|FG001|STARTED|Overall Study||18
2980030|NCT00847210|3695801|FG000|COMPLETED|Overall Study||18
2980031|NCT00847210|3695802|FG001|COMPLETED|Overall Study||18
2980032|NCT00847210|3695801|FG000|NOT COMPLETED|Overall Study||0
2980033|NCT00847210|3695802|FG001|NOT COMPLETED|Overall Study||0
2980034|NCT00847288|3695810|FG000|STARTED|Overall Study||841
2980035|NCT00847288|3695811|FG001|STARTED|Overall Study||827
2980036|NCT00847288|3695810|FG000|COMPLETED|Overall Study||811
2980037|NCT00847288|3695811|FG001|COMPLETED|Overall Study||780
2980038|NCT00847288|3695810|FG000|NOT COMPLETED|Overall Study||30
2980039|NCT00847288|3695811|FG001|NOT COMPLETED|Overall Study||47
2980040|NCT00847301|3695817|FG000|STARTED|Overall Study||428
2980041|NCT00847301|3695817|FG000|COMPLETED|Overall Study||374
2980042|NCT00847301|3695817|FG000|NOT COMPLETED|Overall Study||54
2980043|NCT00847379|3695824|FG000|STARTED|Overall Study||59
2980044|NCT00847379|3695825|FG001|STARTED|Overall Study||57
2980045|NCT00847379|3695826|FG002|STARTED|Overall Study||57
2980046|NCT00847379|3695824|FG000|As-treated Population|Overall Study||59
2980047|NCT00847379|3695825|FG001|As-treated Population|Overall Study||57
2980048|NCT00847379|3695826|FG002|As-treated Population|Overall Study||57
2980049|NCT00847379|3695824|FG000|COMPLETED|Overall Study||0
2980050|NCT00847379|3695825|FG001|COMPLETED|Overall Study||0
2980051|NCT00847379|3695826|FG002|COMPLETED|Overall Study||0
2980052|NCT00847379|3695824|FG000|NOT COMPLETED|Overall Study||59
2980053|NCT00847379|3695825|FG001|NOT COMPLETED|Overall Study||57
2980054|NCT00847379|3695826|FG002|NOT COMPLETED|Overall Study||57
2980055|NCT00847522|3695836|FG000|STARTED|Overall Study||90
2980056|NCT00847522|3695836|FG000|Phase I|Overall Study||10
2980057|NCT00847522|3695836|FG000|Phase II|Overall Study||80
2980058|NCT00847522|3695836|FG000|COMPLETED|Overall Study||90
2980059|NCT00847522|3695836|FG000|NOT COMPLETED|Overall Study||0
2980060|NCT00847535|3695840|FG000|STARTED|Overall Study||24
2980061|NCT00847535|3695841|FG001|STARTED|Overall Study||24
2980062|NCT00847535|3695842|FG002|STARTED|Overall Study||16
2980063|NCT00847535|3695840|FG000|10 Million AMDC|Overall Study||8
2980064|NCT00847535|3695841|FG001|10 Million AMDC|Overall Study||8
2980065|NCT00847535|3695842|FG002|10 Million AMDC|Overall Study||0
2980066|NCT00847535|3695840|FG000|50 Million AMDC|Overall Study||8
2980067|NCT00847535|3695841|FG001|50 Million AMDC|Overall Study||8
2980068|NCT00847535|3695842|FG002|50 Million AMDC|Overall Study||0
2980069|NCT00847535|3695840|FG000|100 Million AMDC|Overall Study||8
2980070|NCT00847535|3695841|FG001|100 Million AMDC|Overall Study||8
2980071|NCT00847535|3695842|FG002|100 Million AMDC|Overall Study||8
2980072|NCT00847535|3695840|FG000|200 Million AMDC|Overall Study||0
2980073|NCT00847535|3695841|FG001|200 Million AMDC|Overall Study||0
2980074|NCT00847535|3695842|FG002|200 Million AMDC|Overall Study||8
2980075|NCT00847535|3695840|FG000|COMPLETED|Overall Study||22
2980076|NCT00847535|3695841|FG001|COMPLETED|Overall Study||22
2980077|NCT00847535|3695842|FG002|COMPLETED|Overall Study||15
2980078|NCT00847535|3695840|FG000|NOT COMPLETED|Overall Study||2
2980079|NCT00847535|3695841|FG001|NOT COMPLETED|Overall Study||2
2980080|NCT00847535|3695842|FG002|NOT COMPLETED|Overall Study||1
2980081|NCT00847561|3695849|FG000|STARTED|Overall Study||70
2980082|NCT00847561|3695850|FG001|STARTED|Overall Study||66
2980083|NCT00847561|3695849|FG000|COMPLETED|Overall Study||57
2980084|NCT00847561|3695850|FG001|COMPLETED|Overall Study||62
2980085|NCT00847561|3695849|FG000|NOT COMPLETED|Overall Study||13
2980086|NCT00847561|3695850|FG001|NOT COMPLETED|Overall Study||4
2980087|NCT00847587|3695858|FG000|STARTED|Overall Study||35
2980088|NCT00847587|3695859|FG001|STARTED|Overall Study||34
2980089|NCT00847587|3695858|FG000|COMPLETED|Overall Study|Patient declined study after randomization.|34
2980090|NCT00847587|3695859|FG001|COMPLETED|Overall Study||34
2980091|NCT00847587|3695858|FG000|NOT COMPLETED|Overall Study||1
2980092|NCT00847587|3695859|FG001|NOT COMPLETED|Overall Study||0
2980093|NCT00847613|3695869|FG000|STARTED|Overall Study||321
2980094|NCT00847613|3695870|FG001|STARTED|Overall Study||319
2980095|NCT00847613|3695871|FG002|STARTED|Overall Study||81
2980096|NCT00847613|3695872|FG003|STARTED|Overall Study||79
2980097|NCT00847613|3695869|FG000|Treated|Overall Study||321
2980098|NCT00847613|3695870|FG001|Treated|Overall Study||316
2980099|NCT00847613|3695871|FG002|Treated|Overall Study||81
2980100|NCT00847613|3695872|FG003|Treated|Overall Study||79
2980101|NCT00847613|3695869|FG000|COMPLETED|Overall Study||0
2980102|NCT00847613|3695870|FG001|COMPLETED|Overall Study||0
2980103|NCT00847613|3695871|FG002|COMPLETED|Overall Study||0
2980104|NCT00847613|3695872|FG003|COMPLETED|Overall Study||0
2980105|NCT00847613|3695869|FG000|NOT COMPLETED|Overall Study||321
2980106|NCT00847613|3695870|FG001|NOT COMPLETED|Overall Study||319
2980107|NCT00847613|3695871|FG002|NOT COMPLETED|Overall Study||81
2980108|NCT00847613|3695872|FG003|NOT COMPLETED|Overall Study||79
2980109|NCT00847626|3695900|FG000|STARTED|Overall Study||156
2980110|NCT00847626|3695901|FG001|STARTED|Overall Study||154
2980111|NCT00847626|3695902|FG002|STARTED|Overall Study|Includes participant who was randomized but did not receive study medication.|147
2980112|NCT00847626|3695903|FG003|STARTED|Overall Study||156
2980113|NCT00847626|3695904|FG004|STARTED|Overall Study||153
2980114|NCT00847626|3695905|FG005|STARTED|Overall Study|Includes participant who was randomized but did not receive study medication.|162
2980115|NCT00847626|3695906|FG006|STARTED|Overall Study|Includes participant who was randomized but did not receive study medication.|157
2980116|NCT00847626|3695907|FG007|STARTED|Overall Study|Includes participant who was treated with double-blind study medication but not randomized.|160
2980117|NCT00847626|3695908|FG008|STARTED|Overall Study||155
2980118|NCT00847626|3695909|FG009|STARTED|Overall Study||153
2980119|NCT00847626|3695910|FG010|STARTED|Overall Study||162
2980120|NCT00847626|3695900|FG000|COMPLETED|Overall Study||135
2980121|NCT00847626|3695901|FG001|COMPLETED|Overall Study||131
2980122|NCT00847626|3695902|FG002|COMPLETED|Overall Study||131
2980123|NCT00847626|3695903|FG003|COMPLETED|Overall Study||125
2980124|NCT00847626|3695904|FG004|COMPLETED|Overall Study||125
2980125|NCT00847626|3695905|FG005|COMPLETED|Overall Study||125
2980126|NCT00847626|3695906|FG006|COMPLETED|Overall Study||135
2980127|NCT00847626|3695907|FG007|COMPLETED|Overall Study||141
2980128|NCT00847626|3695908|FG008|COMPLETED|Overall Study||141
2980129|NCT00847626|3695909|FG009|COMPLETED|Overall Study||139
2980130|NCT00847626|3695910|FG010|COMPLETED|Overall Study||142
2980131|NCT00847626|3695900|FG000|NOT COMPLETED|Overall Study||21
2980132|NCT00847626|3695901|FG001|NOT COMPLETED|Overall Study||23
2980133|NCT00847626|3695902|FG002|NOT COMPLETED|Overall Study||16
2980134|NCT00847626|3695903|FG003|NOT COMPLETED|Overall Study||31
2980135|NCT00847626|3695904|FG004|NOT COMPLETED|Overall Study||28
2980136|NCT00847626|3695905|FG005|NOT COMPLETED|Overall Study||37
2980137|NCT00847626|3695906|FG006|NOT COMPLETED|Overall Study||22
2980138|NCT00847626|3695907|FG007|NOT COMPLETED|Overall Study||19
2980139|NCT00847626|3695908|FG008|NOT COMPLETED|Overall Study||14
2980140|NCT00847626|3695909|FG009|NOT COMPLETED|Overall Study||14
2980141|NCT00847626|3695910|FG010|NOT COMPLETED|Overall Study||20
2980142|NCT00847665|3695939|FG000|STARTED|Overall Study||165
2980143|NCT00847665|3695940|FG001|STARTED|Overall Study||165
2980144|NCT00847665|3695939|FG000|COMPLETED|Overall Study||164
2980145|NCT00847665|3695940|FG001|COMPLETED|Overall Study||165
2980146|NCT00847665|3695939|FG000|NOT COMPLETED|Overall Study||1
2980147|NCT00847665|3695940|FG001|NOT COMPLETED|Overall Study||0
2980148|NCT00847704|3695946|FG000|STARTED|Overall Study||3
2980149|NCT00847704|3695946|FG000|COMPLETED|Overall Study||2
2980150|NCT00847704|3695946|FG000|NOT COMPLETED|Overall Study||1
2980151|NCT00847730|3695950|FG000|STARTED|Overall Study||33
2980152|NCT00847730|3695950|FG000|COMPLETED|Overall Study||25
2980153|NCT00847730|3695950|FG000|NOT COMPLETED|Overall Study||8
2980154|NCT00847808|3695954|FG000|STARTED|Overall Study||178
2980155|NCT00847808|3695954|FG000|COMPLETED|Overall Study||163
2980156|NCT00847808|3695954|FG000|NOT COMPLETED|Overall Study||15
2980157|NCT00847886|3695960|FG000|STARTED|Overall Study||12
2980158|NCT00847886|3695961|FG001|STARTED|Overall Study||4
2980159|NCT00847886|3695960|FG000|COMPLETED|Overall Study||12
2980160|NCT00847886|3695961|FG001|COMPLETED|Overall Study||3
2980161|NCT00847886|3695960|FG000|NOT COMPLETED|Overall Study||0
2980162|NCT00847886|3695961|FG001|NOT COMPLETED|Overall Study||1
2980163|NCT00847912|3695969|FG000|STARTED|Overall Study||477
2980164|NCT00847912|3695970|FG001|STARTED|Overall Study||477
2980165|NCT00847912|3695969|FG000|COMPLETED|Overall Study||468
2980166|NCT00847912|3695970|FG001|COMPLETED|Overall Study||464
2980167|NCT00847912|3695969|FG000|NOT COMPLETED|Overall Study||9
2980168|NCT00847912|3695970|FG001|NOT COMPLETED|Overall Study||13
2980169|NCT00847938|3695981|FG000|STARTED|Overall Study||16
2980170|NCT00847938|3695982|FG001|STARTED|Overall Study||15
2980171|NCT00847938|3695983|FG002|STARTED|Overall Study||16
2980172|NCT00847938|3695984|FG003|STARTED|Overall Study||15
2980173|NCT00847938|3695981|FG000|COMPLETED|Overall Study||16
2980174|NCT00847938|3695982|FG001|COMPLETED|Overall Study||14
2980175|NCT00847938|3695983|FG002|COMPLETED|Overall Study||15
2980176|NCT00847938|3695984|FG003|COMPLETED|Overall Study||15
2980177|NCT00847938|3695981|FG000|NOT COMPLETED|Overall Study||0
2980178|NCT00847938|3695982|FG001|NOT COMPLETED|Overall Study||1
2980179|NCT00847938|3695983|FG002|NOT COMPLETED|Overall Study||1
2980180|NCT00847938|3695984|FG003|NOT COMPLETED|Overall Study||0
2980181|NCT00848016|3695994|FG000|STARTED|Overall Study||29
2980182|NCT00848016|3695994|FG000|COMPLETED|Overall Study||29
2980183|NCT00848016|3695994|FG000|NOT COMPLETED|Overall Study||0
2980184|NCT00848042|3696001|FG000|STARTED|Overall Study||5
2980185|NCT00848042|3696002|FG001|STARTED|Overall Study||5
2980186|NCT00848042|3696003|FG002|STARTED|Overall Study||1
2980187|NCT00848042|3696001|FG000|Day 1|Overall Study||5
2980188|NCT00848042|3696002|FG001|Day 1|Overall Study||5
2980189|NCT00848042|3696003|FG002|Day 1|Overall Study||1
2980190|NCT00848042|3696001|FG000|Day 2|Overall Study||5
2980191|NCT00848042|3696002|FG001|Day 2|Overall Study||5
2980192|NCT00848042|3696003|FG002|Day 2|Overall Study||1
2980193|NCT00848042|3696001|FG000|Day 3|Overall Study||5
2980194|NCT00848042|3696002|FG001|Day 3|Overall Study||5
2980195|NCT00848042|3696003|FG002|Day 3|Overall Study||1
2980196|NCT00848042|3696001|FG000|Day 8|Overall Study||5
2980197|NCT00848042|3696002|FG001|Day 8|Overall Study||5
2980198|NCT00848042|3696003|FG002|Day 8|Overall Study||1
2980199|NCT00848042|3696001|FG000|Day 15|Overall Study||4
2980200|NCT00848042|3696002|FG001|Day 15|Overall Study||5
2980201|NCT00848042|3696003|FG002|Day 15|Overall Study||1
2980202|NCT00848042|3696001|FG000|Month 1|Overall Study||4
2980203|NCT00848042|3696002|FG001|Month 1|Overall Study||5
2980204|NCT00848042|3696003|FG002|Month 1|Overall Study||1
2980205|NCT00848042|3696001|FG000|Month 2|Overall Study||1
2980206|NCT00848042|3696002|FG001|Month 2|Overall Study||5
2980207|NCT00848042|3696003|FG002|Month 2|Overall Study||1
2980208|NCT00848042|3696001|FG000|Month 3|Overall Study||1
2980209|NCT00848042|3696002|FG001|Month 3|Overall Study||4
2980210|NCT00848042|3696003|FG002|Month 3|Overall Study||1
2980211|NCT00848042|3696001|FG000|Month 4|Overall Study||1
2980212|NCT00848042|3696002|FG001|Month 4|Overall Study||4
2980213|NCT00848042|3696003|FG002|Month 4|Overall Study||1
2980214|NCT00848042|3696001|FG000|Month 5|Overall Study||1
2980215|NCT00848042|3696002|FG001|Month 5|Overall Study||3
2980216|NCT00848042|3696003|FG002|Month 5|Overall Study||1
2980217|NCT00848042|3696001|FG000|Month 6|Overall Study||1
2980218|NCT00848042|3696002|FG001|Month 6|Overall Study||3
2980219|NCT00848042|3696003|FG002|Month 6|Overall Study||1
2980220|NCT00848042|3696001|FG000|COMPLETED|Overall Study||1
2980221|NCT00848042|3696002|FG001|COMPLETED|Overall Study||3
2980222|NCT00848042|3696003|FG002|COMPLETED|Overall Study||1
2980223|NCT00848042|3696001|FG000|NOT COMPLETED|Overall Study||4
2980224|NCT00848042|3696002|FG001|NOT COMPLETED|Overall Study||2
2980225|NCT00848042|3696003|FG002|NOT COMPLETED|Overall Study||0
2980226|NCT00848081|3696013|FG000|STARTED|Overall Study||160
2980227|NCT00848081|3696014|FG001|STARTED|Overall Study||158
2980228|NCT00848081|3696013|FG000|COMPLETED|Overall Study||140
2980229|NCT00848081|3696014|FG001|COMPLETED|Overall Study||140
2980230|NCT00848081|3696013|FG000|NOT COMPLETED|Overall Study||20
2980231|NCT00848081|3696014|FG001|NOT COMPLETED|Overall Study||18
2980232|NCT00848107|3696020|FG000|STARTED|Overall Study||115
2980233|NCT00848107|3696020|FG000|COMPLETED|Overall Study||94
2980234|NCT00848107|3696020|FG000|NOT COMPLETED|Overall Study||21
2980235|NCT00848120|3696024|FG000|STARTED|Overall Study||29
2980236|NCT00848120|3696024|FG000|COMPLETED|Overall Study||28
2980237|NCT00848120|3696024|FG000|NOT COMPLETED|Overall Study||1
2980238|NCT00848172|3696030|FG000|STARTED|Visit 2 - Drug Administration||10
2980239|NCT00848172|3696031|FG001|STARTED|Visit 2 - Drug Administration||9
2980240|NCT00848172|3696030|FG000|COMPLETED|Visit 2 - Drug Administration||10
2980241|NCT00848172|3696031|FG001|COMPLETED|Visit 2 - Drug Administration||8
2980242|NCT00848172|3696030|FG000|NOT COMPLETED|Visit 2 - Drug Administration||0
2980243|NCT00848172|3696031|FG001|NOT COMPLETED|Visit 2 - Drug Administration||1
2980244|NCT00848172|3696030|FG000|STARTED|Visit 3 - Follow Up||10
2980245|NCT00848172|3696031|FG001|STARTED|Visit 3 - Follow Up||8
2980246|NCT00848172|3696030|FG000|COMPLETED|Visit 3 - Follow Up||10
2980247|NCT00848172|3696031|FG001|COMPLETED|Visit 3 - Follow Up||8
2980248|NCT00848172|3696030|FG000|NOT COMPLETED|Visit 3 - Follow Up||0
2980249|NCT00848172|3696031|FG001|NOT COMPLETED|Visit 3 - Follow Up||0
2980250|NCT00848185|3696043|FG000|STARTED|Overall Study||32
2980251|NCT00848185|3696044|FG001|STARTED|Overall Study||32
2980252|NCT00848185|3696045|FG002|STARTED|Overall Study||32
2980253|NCT00848185|3696043|FG000|COMPLETED|Overall Study||32
2980254|NCT00848185|3696044|FG001|COMPLETED|Overall Study||32
2980255|NCT00848185|3696045|FG002|COMPLETED|Overall Study||32
2980256|NCT00848185|3696043|FG000|NOT COMPLETED|Overall Study||0
2980257|NCT00848185|3696044|FG001|NOT COMPLETED|Overall Study||0
2980258|NCT00848185|3696045|FG002|NOT COMPLETED|Overall Study||0
2980259|NCT00848198|3696053|FG000|STARTED|Overall Study||314
2980260|NCT00848198|3696053|FG000|COMPLETED|Overall Study||299
2980261|NCT00848198|3696053|FG000|NOT COMPLETED|Overall Study||15
2980262|NCT00848211|3696065|FG000|STARTED|Overall Study||6
3133377|NCT01695239|3858307|FG002|COMPLETED|Post-Treatment Follow-Up Period||0
2980263|NCT00848211|3696066|FG001|STARTED|Overall Study||7
2980264|NCT00848211|3696067|FG002|STARTED|Overall Study||6
2980265|NCT00848211|3696068|FG003|STARTED|Overall Study||5
2980266|NCT00848211|3696065|FG000|COMPLETED|Overall Study||6
2980267|NCT00848211|3696066|FG001|COMPLETED|Overall Study||6
2980268|NCT00848211|3696067|FG002|COMPLETED|Overall Study||5
2980269|NCT00848211|3696068|FG003|COMPLETED|Overall Study||5
2980270|NCT00848211|3696065|FG000|NOT COMPLETED|Overall Study||0
2980271|NCT00848211|3696066|FG001|NOT COMPLETED|Overall Study||1
2980272|NCT00848211|3696067|FG002|NOT COMPLETED|Overall Study||1
2980273|NCT00848211|3696068|FG003|NOT COMPLETED|Overall Study||0
2980274|NCT00848237|3696078|FG000|STARTED|Overall Study||5521
2980275|NCT00848237|3696078|FG000|COMPLETED|Overall Study||4982
2980276|NCT00848237|3696078|FG000|NOT COMPLETED|Overall Study||539
2980277|NCT00848250|3696084|FG000|STARTED|Overall Study||11
2980278|NCT00848250|3696085|FG001|STARTED|Overall Study||10
2980279|NCT00848250|3696084|FG000|COMPLETED|Overall Study||11
2980280|NCT00848250|3696085|FG001|COMPLETED|Overall Study||9
2980281|NCT00848250|3696084|FG000|NOT COMPLETED|Overall Study||0
2980282|NCT00848250|3696085|FG001|NOT COMPLETED|Overall Study||1
2980283|NCT00848354|3696094|FG000|STARTED|Phase 1|One participant was randomized to the Etanercept + Methotrexate group but received SSZ in error.|281
2980284|NCT00848354|3696095|FG001|STARTED|Phase 1||143
2980285|NCT00848354|3696094|FG000|COMPLETED|Phase 1||269
2980286|NCT00848354|3696095|FG001|COMPLETED|Phase 1||129
2980287|NCT00848354|3696094|FG000|NOT COMPLETED|Phase 1||12
2980288|NCT00848354|3696095|FG001|NOT COMPLETED|Phase 1||14
2980289|NCT00848354|3696094|FG000|STARTED|Phase 2 Year 1|Randomized Phase 1 treatment assignment. 9 participants discontinued between Phase 1 and Phase 2.|260
2980290|NCT00848354|3696095|FG001|STARTED|Phase 2 Year 1|Randomized Phase 1 treatment assignment. 3 participants discontinued between Phase 1 and Phase 2.|126
2980291|NCT00848354|3696094|FG000|COMPLETED|Phase 2 Year 1||242
2980292|NCT00848354|3696095|FG001|COMPLETED|Phase 2 Year 1||120
2980293|NCT00848354|3696094|FG000|NOT COMPLETED|Phase 2 Year 1||18
2980294|NCT00848354|3696095|FG001|NOT COMPLETED|Phase 2 Year 1||6
2980295|NCT00848354|3696094|FG000|STARTED|Phase 2 Year 2|"Randomized Phase 1 treatment assignment.~1 participant discontinued between Year 1 and Year 2."|241
2980296|NCT00848354|3696095|FG001|STARTED|Phase 2 Year 2|Randomized Phase 1 treatment assignment.|120
2980297|NCT00848354|3696094|FG000|COMPLETED|Phase 2 Year 2||218
2980298|NCT00848354|3696095|FG001|COMPLETED|Phase 2 Year 2||113
2980299|NCT00848354|3696094|FG000|NOT COMPLETED|Phase 2 Year 2||23
2980300|NCT00848354|3696095|FG001|NOT COMPLETED|Phase 2 Year 2||7
2980301|NCT00848367|3696107|FG000|STARTED|Overall Study||52
2980302|NCT00848367|3696108|FG001|STARTED|Overall Study||50
2980303|NCT00848367|3696107|FG000|COMPLETED|Overall Study||43
2980304|NCT00848367|3696108|FG001|COMPLETED|Overall Study||41
2980305|NCT00848367|3696107|FG000|NOT COMPLETED|Overall Study||9
2980306|NCT00848367|3696108|FG001|NOT COMPLETED|Overall Study||9
2980307|NCT00848393|3696119|FG000|STARTED|Overall Study||17
2980308|NCT00848393|3696120|FG001|STARTED|Overall Study||16
2980309|NCT00848393|3696121|FG002|STARTED|Overall Study||18
2980310|NCT00848393|3696119|FG000|COMPLETED|Overall Study||17
2980311|NCT00848393|3696120|FG001|COMPLETED|Overall Study||16
2980312|NCT00848393|3696121|FG002|COMPLETED|Overall Study||15
2980313|NCT00848393|3696119|FG000|NOT COMPLETED|Overall Study||0
2980314|NCT00848393|3696120|FG001|NOT COMPLETED|Overall Study||0
2980315|NCT00848393|3696121|FG002|NOT COMPLETED|Overall Study||3
2980316|NCT00848484|3696135|FG000|STARTED|First Intervention (Treatment Period 1)||27
2980317|NCT00848484|3696136|FG001|STARTED|First Intervention (Treatment Period 1)||27
3133378|NCT01695239|3858308|FG003|COMPLETED|Post-Treatment Follow-Up Period||0
2980318|NCT00848484|3696135|FG000|With Reduced Dose at Treatment Period 1|First Intervention (Treatment Period 1)||2
2980319|NCT00848484|3696136|FG001|With Reduced Dose at Treatment Period 1|First Intervention (Treatment Period 1)||1
2980320|NCT00848484|3696135|FG000|COMPLETED|First Intervention (Treatment Period 1)||25
2980321|NCT00848484|3696136|FG001|COMPLETED|First Intervention (Treatment Period 1)||24
2980322|NCT00848484|3696135|FG000|NOT COMPLETED|First Intervention (Treatment Period 1)||2
2980323|NCT00848484|3696136|FG001|NOT COMPLETED|First Intervention (Treatment Period 1)||3
2980324|NCT00848484|3696135|FG000|STARTED|Washout Period of Two Weeks||25
3133379|NCT01695239|3858309|FG004|COMPLETED|Post-Treatment Follow-Up Period||0
3133380|NCT01695239|3858310|FG005|COMPLETED|Post-Treatment Follow-Up Period||0
3133381|NCT01695239|3858311|FG006|COMPLETED|Post-Treatment Follow-Up Period||0
3133382|NCT01695239|3858312|FG007|COMPLETED|Post-Treatment Follow-Up Period||0
3133383|NCT01695239|3858313|FG008|COMPLETED|Post-Treatment Follow-Up Period||0
3133384|NCT01695239|3858314|FG009|COMPLETED|Post-Treatment Follow-Up Period||0
3133385|NCT01695239|3858315|FG010|COMPLETED|Post-Treatment Follow-Up Period||20
2980325|NCT00848484|3696136|FG001|STARTED|Washout Period of Two Weeks||24
2980326|NCT00848484|3696135|FG000|COMPLETED|Washout Period of Two Weeks||25
2980327|NCT00848484|3696136|FG001|COMPLETED|Washout Period of Two Weeks||21
2980328|NCT00848484|3696135|FG000|NOT COMPLETED|Washout Period of Two Weeks||0
2980329|NCT00848484|3696136|FG001|NOT COMPLETED|Washout Period of Two Weeks||3
2980330|NCT00848484|3696135|FG000|STARTED|Second Intervention (Treatment Period 2)||25
2980331|NCT00848484|3696136|FG001|STARTED|Second Intervention (Treatment Period 2)||21
2980332|NCT00848484|3696135|FG000|With Reduced Dose at Treatment Period 2|Second Intervention (Treatment Period 2)||0
2980333|NCT00848484|3696136|FG001|With Reduced Dose at Treatment Period 2|Second Intervention (Treatment Period 2)||0
2980334|NCT00848484|3696135|FG000|COMPLETED|Second Intervention (Treatment Period 2)||25
2980335|NCT00848484|3696136|FG001|COMPLETED|Second Intervention (Treatment Period 2)||20
2980336|NCT00848484|3696135|FG000|NOT COMPLETED|Second Intervention (Treatment Period 2)||0
2980337|NCT00848484|3696136|FG001|NOT COMPLETED|Second Intervention (Treatment Period 2)||1
2980338|NCT00848497|3696144|FG000|STARTED|Overall Study||2
2980339|NCT00848497|3696145|FG001|STARTED|Overall Study|Completed Visit 4|1
2980340|NCT00848497|3696144|FG000|COMPLETED|Overall Study||0
2980341|NCT00848497|3696145|FG001|COMPLETED|Overall Study||0
2980342|NCT00848497|3696144|FG000|NOT COMPLETED|Overall Study||2
2980343|NCT00848497|3696145|FG001|NOT COMPLETED|Overall Study||1
2980344|NCT00848510|3696157|FG000|STARTED|Overall Study||10
2980345|NCT00848510|3696158|FG001|STARTED|Overall Study||13
2980346|NCT00848510|3696159|FG002|STARTED|Overall Study||8
2980347|NCT00848510|3696160|FG003|STARTED|Overall Study||10
2980348|NCT00848510|3696157|FG000|COMPLETED|Overall Study||10
2980349|NCT00848510|3696158|FG001|COMPLETED|Overall Study||13
2980350|NCT00848510|3696159|FG002|COMPLETED|Overall Study||8
2980351|NCT00848510|3696160|FG003|COMPLETED|Overall Study||10
2980352|NCT00848510|3696157|FG000|NOT COMPLETED|Overall Study||0
2980353|NCT00848510|3696158|FG001|NOT COMPLETED|Overall Study||0
2980354|NCT00848510|3696159|FG002|NOT COMPLETED|Overall Study||0
2980355|NCT00848510|3696160|FG003|NOT COMPLETED|Overall Study||0
2980356|NCT00848536|3696172|FG000|STARTED|Overall Study||185
2980357|NCT00848536|3696173|FG001|STARTED|Overall Study||186
2980358|NCT00848536|3696172|FG000|COMPLETED|Overall Study||181
2980359|NCT00848536|3696173|FG001|COMPLETED|Overall Study||179
2980360|NCT00848536|3696172|FG000|NOT COMPLETED|Overall Study||4
2980361|NCT00848536|3696173|FG001|NOT COMPLETED|Overall Study||7
2980362|NCT00848549|3696181|FG000|STARTED|E2090-E044-310 (Base Study) Disposition||282
2980363|NCT00848549|3696182|FG001|STARTED|E2090-E044-310 (Base Study) Disposition||301
2980364|NCT00848549|3696181|FG000|COMPLETED|E2090-E044-310 (Base Study) Disposition||161
2980365|NCT00848549|3696182|FG001|COMPLETED|E2090-E044-310 (Base Study) Disposition||192
2980366|NCT00848549|3696181|FG000|NOT COMPLETED|E2090-E044-310 (Base Study) Disposition||121
2980367|NCT00848549|3696182|FG001|NOT COMPLETED|E2090-E044-310 (Base Study) Disposition||109
2980368|NCT00848549|3696181|FG000|STARTED|E2090-E044-310 (Base Study) Transition||161
2980369|NCT00848549|3696182|FG001|STARTED|E2090-E044-310 (Base Study) Transition||192
2980370|NCT00848549|3696181|FG000|COMPLETED|E2090-E044-310 (Base Study) Transition||137
2980371|NCT00848549|3696182|FG001|COMPLETED|E2090-E044-310 (Base Study) Transition||158
2980372|NCT00848549|3696181|FG000|NOT COMPLETED|E2090-E044-310 (Base Study) Transition||24
2980373|NCT00848549|3696182|FG001|NOT COMPLETED|E2090-E044-310 (Base Study) Transition||34
2980374|NCT00848549|3696181|FG000|STARTED|E2090-E044-314 (Extension Study)||137
2980375|NCT00848549|3696182|FG001|STARTED|E2090-E044-314 (Extension Study)||158
2980376|NCT00848549|3696181|FG000|COMPLETED|E2090-E044-314 (Extension Study)||120
2980377|NCT00848549|3696182|FG001|COMPLETED|E2090-E044-314 (Extension Study)||134
2980378|NCT00848549|3696181|FG000|NOT COMPLETED|E2090-E044-314 (Extension Study)||17
2980379|NCT00848549|3696182|FG001|NOT COMPLETED|E2090-E044-314 (Extension Study)||24
2980380|NCT00848718|3696203|FG000|STARTED|Overall Study||7
2980381|NCT00848718|3696204|FG001|STARTED|Overall Study||9
2980382|NCT00848718|3696205|FG002|STARTED|Overall Study||6
2980383|NCT00848718|3696206|FG003|STARTED|Overall Study||5
2980384|NCT00848718|3696207|FG004|STARTED|Overall Study||6
2980385|NCT00848718|3696208|FG005|STARTED|Overall Study||5
2980386|NCT00848718|3696209|FG006|STARTED|Overall Study||3
2980387|NCT00848718|3696210|FG007|STARTED|Overall Study||5
2980388|NCT00848718|3696211|FG008|STARTED|Overall Study||4
2980389|NCT00848718|3696212|FG009|STARTED|Overall Study||9
2980390|NCT00848718|3696213|FG010|STARTED|Overall Study||4
2980391|NCT00848718|3696214|FG011|STARTED|Overall Study||6
2980392|NCT00848718|3696215|FG012|STARTED|Overall Study||8
3038366|NCT01153958|3757798|FG000|NOT COMPLETED|Overall Study||36
2980393|NCT00848718|3696203|FG000|Treated|Overall Study|1 participant was allocated but did not receive treatment due to progression of disease|6
2980394|NCT00848718|3696204|FG001|Treated|Overall Study||9
2980395|NCT00848718|3696205|FG002|Treated|Overall Study|1 participant was allocated but did not receive treatment due to progression of disease|5
2980396|NCT00848718|3696206|FG003|Treated|Overall Study||5
2980397|NCT00848718|3696207|FG004|Treated|Overall Study||6
2980398|NCT00848718|3696208|FG005|Treated|Overall Study||5
2980399|NCT00848718|3696209|FG006|Treated|Overall Study||3
2980400|NCT00848718|3696210|FG007|Treated|Overall Study|1 participant was allocated but did not receive treatment due to progression of disease|4
2980401|NCT00848718|3696211|FG008|Treated|Overall Study||4
2980402|NCT00848718|3696212|FG009|Treated|Overall Study||9
2980403|NCT00848718|3696213|FG010|Treated|Overall Study||4
2980404|NCT00848718|3696214|FG011|Treated|Overall Study||6
2980405|NCT00848718|3696215|FG012|Treated|Overall Study|2 participants were allocated but did not receive treatment due to progression of disease|6
2980406|NCT00848718|3696203|FG000|COMPLETED|Overall Study||0
2980407|NCT00848718|3696204|FG001|COMPLETED|Overall Study||0
2980408|NCT00848718|3696205|FG002|COMPLETED|Overall Study||0
2980409|NCT00848718|3696206|FG003|COMPLETED|Overall Study||0
2980410|NCT00848718|3696207|FG004|COMPLETED|Overall Study||0
2980411|NCT00848718|3696208|FG005|COMPLETED|Overall Study||0
2980412|NCT00848718|3696209|FG006|COMPLETED|Overall Study||0
2980413|NCT00848718|3696210|FG007|COMPLETED|Overall Study||0
2980414|NCT00848718|3696211|FG008|COMPLETED|Overall Study||0
2980415|NCT00848718|3696212|FG009|COMPLETED|Overall Study||0
2980416|NCT00848718|3696213|FG010|COMPLETED|Overall Study||0
2980417|NCT00848718|3696214|FG011|COMPLETED|Overall Study||0
2980418|NCT00848718|3696215|FG012|COMPLETED|Overall Study||0
2980419|NCT00848718|3696203|FG000|NOT COMPLETED|Overall Study||7
2980420|NCT00848718|3696204|FG001|NOT COMPLETED|Overall Study||9
2980421|NCT00848718|3696205|FG002|NOT COMPLETED|Overall Study||6
2980422|NCT00848718|3696206|FG003|NOT COMPLETED|Overall Study||5
2980423|NCT00848718|3696207|FG004|NOT COMPLETED|Overall Study||6
2980424|NCT00848718|3696208|FG005|NOT COMPLETED|Overall Study||5
2980425|NCT00848718|3696209|FG006|NOT COMPLETED|Overall Study||3
2980426|NCT00848718|3696210|FG007|NOT COMPLETED|Overall Study||5
2980427|NCT00848718|3696211|FG008|NOT COMPLETED|Overall Study||4
2980428|NCT00848718|3696212|FG009|NOT COMPLETED|Overall Study||9
2980429|NCT00848718|3696213|FG010|NOT COMPLETED|Overall Study||4
2980430|NCT00848718|3696214|FG011|NOT COMPLETED|Overall Study||6
2980431|NCT00848718|3696215|FG012|NOT COMPLETED|Overall Study||8
2980432|NCT00848744|3696249|FG000|STARTED|Overall Study||10
2980433|NCT00848744|3696249|FG000|COMPLETED|Overall Study||10
2980434|NCT00848744|3696249|FG000|NOT COMPLETED|Overall Study||0
2980435|NCT00848783|3696257|FG000|STARTED|Overall Study||4
2980436|NCT00848783|3696258|FG001|STARTED|Overall Study||3
2980437|NCT00848783|3696259|FG002|STARTED|Overall Study||1
2980438|NCT00848783|3696257|FG000|COMPLETED|Overall Study||1
2980439|NCT00848783|3696258|FG001|COMPLETED|Overall Study||1
2980440|NCT00848783|3696259|FG002|COMPLETED|Overall Study||1
2980441|NCT00848783|3696257|FG000|NOT COMPLETED|Overall Study||3
2980442|NCT00848783|3696258|FG001|NOT COMPLETED|Overall Study||2
2980443|NCT00848783|3696259|FG002|NOT COMPLETED|Overall Study||0
2980444|NCT00848926|3696266|FG000|STARTED|Treatment Period||102
2980445|NCT00848926|3696266|FG000|COMPLETED|Treatment Period|Number who completed 16 cycles of treatment|18
2980446|NCT00848926|3696266|FG000|NOT COMPLETED|Treatment Period||84
2980447|NCT00848926|3696266|FG000|STARTED|Follow-up Period|All participants were to be followed after treatment|102
2980448|NCT00848926|3696266|FG000|COMPLETED|Follow-up Period|Completed survival follow-up due to death [57] or study termination by sponsor [33]|90
2980449|NCT00848926|3696266|FG000|NOT COMPLETED|Follow-up Period||12
2980450|NCT00848965|3696270|FG000|STARTED|Overall Study||59
2980451|NCT00848965|3696270|FG000|COMPLETED|Overall Study||57
2980452|NCT00848965|3696270|FG000|NOT COMPLETED|Overall Study||2
2980453|NCT00849017|3696285|FG000|STARTED|Treatment Period (156 Weeks)||101
2980454|NCT00849017|3696286|FG001|STARTED|Treatment Period (156 Weeks)||101
2980455|NCT00849017|3696287|FG002|STARTED|Treatment Period (156 Weeks)||99
2980456|NCT00849017|3696285|FG000|COMPLETED|Treatment Period (156 Weeks)||58
2980457|NCT00849017|3696286|FG001|COMPLETED|Treatment Period (156 Weeks)||68
2980458|NCT00849017|3696287|FG002|COMPLETED|Treatment Period (156 Weeks)||57
2980459|NCT00849017|3696285|FG000|NOT COMPLETED|Treatment Period (156 Weeks)||43
2980460|NCT00849017|3696286|FG001|NOT COMPLETED|Treatment Period (156 Weeks)||33
2980461|NCT00849017|3696287|FG002|NOT COMPLETED|Treatment Period (156 Weeks)||42
2980462|NCT00849017|3696285|FG000|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|101
2980463|NCT00849017|3696286|FG001|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|101
3036266|NCT01142726|3755497|FG002|NOT COMPLETED|Withdrawal Phase: Months 12 up to 24||58
3036267|NCT01142726|3755495|FG000|STARTED|Re-Exposure Phase: Months 24 up to 30||55
3036268|NCT01142726|3755496|FG001|STARTED|Re-Exposure Phase: Months 24 up to 30||48
3036269|NCT01142726|3755497|FG002|STARTED|Re-Exposure Phase: Months 24 up to 30||43
3036270|NCT01142726|3755495|FG000|COMPLETED|Re-Exposure Phase: Months 24 up to 30||54
3036271|NCT01142726|3755496|FG001|COMPLETED|Re-Exposure Phase: Months 24 up to 30||46
3036272|NCT01142726|3755497|FG002|COMPLETED|Re-Exposure Phase: Months 24 up to 30||40
3036273|NCT01142726|3755495|FG000|NOT COMPLETED|Re-Exposure Phase: Months 24 up to 30||1
3036274|NCT01142726|3755496|FG001|NOT COMPLETED|Re-Exposure Phase: Months 24 up to 30||2
2980464|NCT00849017|3696287|FG002|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|99
2980465|NCT00849017|3696285|FG000|COMPLETED|Follow-up Period (8 Weeks)||76
2980466|NCT00849017|3696286|FG001|COMPLETED|Follow-up Period (8 Weeks)||83
2980467|NCT00849017|3696287|FG002|COMPLETED|Follow-up Period (8 Weeks)||74
2980468|NCT00849017|3696285|FG000|NOT COMPLETED|Follow-up Period (8 Weeks)||25
2980469|NCT00849017|3696286|FG001|NOT COMPLETED|Follow-up Period (8 Weeks)||18
2980470|NCT00849017|3696287|FG002|NOT COMPLETED|Follow-up Period (8 Weeks)||25
2980471|NCT00849056|3696301|FG000|STARTED|Treatment Period (TP) (156 Weeks)||151
2980472|NCT00849056|3696302|FG001|STARTED|Treatment Period (TP) (156 Weeks)||150
2980473|NCT00849056|3696301|FG000|COMPLETED|Treatment Period (TP) (156 Weeks)||88
2980474|NCT00849056|3696302|FG001|COMPLETED|Treatment Period (TP) (156 Weeks)||100
2980475|NCT00849056|3696301|FG000|NOT COMPLETED|Treatment Period (TP) (156 Weeks)||63
2980476|NCT00849056|3696302|FG001|NOT COMPLETED|Treatment Period (TP) (156 Weeks)||50
2980477|NCT00849056|3696301|FG000|STARTED|Follow-up Period (FUP) (8 Weeks)|Par. withdrawing from the TP could enter the FUP. Two par. did not participate in the FUP.|149
2980478|NCT00849056|3696302|FG001|STARTED|Follow-up Period (FUP) (8 Weeks)|Par. withdrawing from the TP could enter the FUP. One par. did not participate in the FUP.|149
2980479|NCT00849056|3696301|FG000|COMPLETED|Follow-up Period (FUP) (8 Weeks)||122
2980480|NCT00849056|3696302|FG001|COMPLETED|Follow-up Period (FUP) (8 Weeks)||124
2980481|NCT00849056|3696301|FG000|NOT COMPLETED|Follow-up Period (FUP) (8 Weeks)||27
2980482|NCT00849056|3696302|FG001|NOT COMPLETED|Follow-up Period (FUP) (8 Weeks)||25
3164246|NCT01891864|3891708|FG002|STARTED|Treatment Period 2|"Part of the patients re-randomized from GP2015 Etanercept treatment arm in Treatment Period 1"|150
3164247|NCT01891864|3891709|FG003|STARTED|Treatment Period 2|"Part of the patients re-randomized from Enbrel ® Etanercept treatment arm in Treatment Period 1"|151
3171767|NCT01936948|3898956|FG003|NOT COMPLETED|Overall Study||3
2980483|NCT00849108|3696311|FG000|STARTED|Cohort 1 Dose Ranging and Dose Interval||33
2980484|NCT00849108|3696312|FG001|STARTED|Cohort 1 Dose Ranging and Dose Interval|Cohort 2(Pharm Stress) subjects did not participate in dose range, dose frequency|0
2980485|NCT00849108|3696311|FG000|COMPLETED|Cohort 1 Dose Ranging and Dose Interval||32
2980486|NCT00849108|3696312|FG001|COMPLETED|Cohort 1 Dose Ranging and Dose Interval||0
2980487|NCT00849108|3696311|FG000|NOT COMPLETED|Cohort 1 Dose Ranging and Dose Interval||1
2980488|NCT00849108|3696312|FG001|NOT COMPLETED|Cohort 1 Dose Ranging and Dose Interval||0
2980489|NCT00849108|3696311|FG000|STARTED|Cohort 2 Efficacy|Cohort 1 subjects did not participate in period 2: efficacy|0
2980490|NCT00849108|3696312|FG001|STARTED|Cohort 2 Efficacy||143
2980491|NCT00849108|3696311|FG000|COMPLETED|Cohort 2 Efficacy||0
2980492|NCT00849108|3696312|FG001|COMPLETED|Cohort 2 Efficacy||133
2980493|NCT00849108|3696311|FG000|NOT COMPLETED|Cohort 2 Efficacy||0
2980494|NCT00849108|3696312|FG001|NOT COMPLETED|Cohort 2 Efficacy||10
2980495|NCT00849121|3696322|FG000|STARTED|Overall Study||8
2980496|NCT00849121|3696323|FG001|STARTED|Overall Study||9
2980497|NCT00849121|3696322|FG000|COMPLETED|Overall Study||8
2980498|NCT00849121|3696323|FG001|COMPLETED|Overall Study||9
2980499|NCT00849121|3696322|FG000|NOT COMPLETED|Overall Study||0
2980500|NCT00849121|3696323|FG001|NOT COMPLETED|Overall Study||0
2980501|NCT00849147|3696329|FG000|STARTED|Overall Study||55
2980502|NCT00849147|3696329|FG000|COMPLETED|Overall Study||50
2980503|NCT00849147|3696329|FG000|NOT COMPLETED|Overall Study||5
2980504|NCT00849186|3696333|FG000|STARTED|Overall Study||26
2980505|NCT00849186|3696333|FG000|COMPLETED|Overall Study||16
2980506|NCT00849186|3696333|FG000|NOT COMPLETED|Overall Study||10
2980507|NCT00849212|3696338|FG000|STARTED|Overall Study||30
2980508|NCT00849212|3696338|FG000|COMPLETED|Overall Study||23
2980509|NCT00849212|3696338|FG000|NOT COMPLETED|Overall Study||7
2980510|NCT00849251|3696342|FG000|STARTED|Overall Study||6
2980511|NCT00849251|3696343|FG001|STARTED|Overall Study||25
2980512|NCT00849251|3696342|FG000|COMPLETED|Overall Study||5
2980513|NCT00849251|3696343|FG001|COMPLETED|Overall Study||24
2980514|NCT00849251|3696342|FG000|NOT COMPLETED|Overall Study||1
2980515|NCT00849251|3696343|FG001|NOT COMPLETED|Overall Study||1
2980516|NCT00849290|3696349|FG000|STARTED|Overall Study||113
2980517|NCT00849290|3696349|FG000|COMPLETED|Overall Study||58
2980518|NCT00849290|3696349|FG000|NOT COMPLETED|Overall Study||55
2980519|NCT00849381|3696353|FG000|STARTED|Overall Study|Out of the subjects who started, 243 were enrolled at the center having compliance issues.|1237
2980520|NCT00849381|3696353|FG000|COMPLETED|Overall Study|Out of the subjects who completed, 167 were enrolled at the center having compliance issues.|1092
2980521|NCT00849381|3696353|FG000|NOT COMPLETED|Overall Study||145
2980522|NCT00849472|3696357|FG000|STARTED|Doxorubicin and Cyclophosphamide (AC)||101
2980523|NCT00849472|3696357|FG000|COMPLETED|Doxorubicin and Cyclophosphamide (AC)||95
2980524|NCT00849472|3696357|FG000|NOT COMPLETED|Doxorubicin and Cyclophosphamide (AC)||6
2980525|NCT00849472|3696357|FG000|STARTED|Weekly Paclitaxel|One par. was deemed ineligible after completing AC therapy and did not start paclitaxel+pazopanib.|94
2980526|NCT00849472|3696357|FG000|COMPLETED|Weekly Paclitaxel||78
2980527|NCT00849472|3696357|FG000|NOT COMPLETED|Weekly Paclitaxel||16
2980528|NCT00849472|3696357|FG000|STARTED|Pazopanib Presurgery Treatment (PPT)||94
2980529|NCT00849472|3696357|FG000|COMPLETED|Pazopanib Presurgery Treatment (PPT)||36
2980530|NCT00849472|3696357|FG000|NOT COMPLETED|Pazopanib Presurgery Treatment (PPT)||58
2980531|NCT00849472|3696357|FG000|STARTED|Pazopanib Postsurgery Treatment|36 participants completed PPT; 7 participants who discontinued PPT resumed treatment postsurgery.|42
2980532|NCT00849472|3696357|FG000|COMPLETED|Pazopanib Postsurgery Treatment||16
2980533|NCT00849472|3696357|FG000|NOT COMPLETED|Pazopanib Postsurgery Treatment||26
2980534|NCT00849680|3696370|FG000|STARTED|Overall Study||27
2980535|NCT00849680|3696371|FG001|STARTED|Overall Study||13
2980536|NCT00849680|3696372|FG002|STARTED|Overall Study||42
2980537|NCT00849680|3696373|FG003|STARTED|Overall Study||42
2980538|NCT00849680|3696374|FG004|STARTED|Overall Study||42
2980539|NCT00849680|3696375|FG005|STARTED|Overall Study||42
2980540|NCT00849680|3696376|FG006|STARTED|Overall Study||78
2980541|NCT00849680|3696377|FG007|STARTED|Overall Study||31
2980542|NCT00849680|3696370|FG000|COMPLETED|Overall Study||16
2980543|NCT00849680|3696371|FG001|COMPLETED|Overall Study||10
2980544|NCT00849680|3696372|FG002|COMPLETED|Overall Study||27
2980545|NCT00849680|3696373|FG003|COMPLETED|Overall Study||28
2980546|NCT00849680|3696374|FG004|COMPLETED|Overall Study||32
2980547|NCT00849680|3696375|FG005|COMPLETED|Overall Study||27
2980548|NCT00849680|3696376|FG006|COMPLETED|Overall Study||61
2980549|NCT00849680|3696377|FG007|COMPLETED|Overall Study||23
2980550|NCT00849680|3696370|FG000|NOT COMPLETED|Overall Study||11
2980551|NCT00849680|3696371|FG001|NOT COMPLETED|Overall Study||3
2980552|NCT00849680|3696372|FG002|NOT COMPLETED|Overall Study||15
2980553|NCT00849680|3696373|FG003|NOT COMPLETED|Overall Study||14
2980554|NCT00849680|3696374|FG004|NOT COMPLETED|Overall Study||10
2980555|NCT00849680|3696375|FG005|NOT COMPLETED|Overall Study||15
2980556|NCT00849680|3696376|FG006|NOT COMPLETED|Overall Study||17
2980557|NCT00849680|3696377|FG007|NOT COMPLETED|Overall Study||8
2980558|NCT00849693|3696399|FG000|STARTED|Acute Treatment Phase||108
2980559|NCT00849693|3696400|FG001|STARTED|Acute Treatment Phase||116
2980560|NCT00849693|3696401|FG002|STARTED|Acute Treatment Phase||117
2980561|NCT00849693|3696402|FG003|STARTED|Acute Treatment Phase||122
2980562|NCT00849693|3696399|FG000|COMPLETED|Acute Treatment Phase|2 didn't enter extension phase.|75
2980563|NCT00849693|3696400|FG001|COMPLETED|Acute Treatment Phase|1 didn't enter extension phase|81
2980564|NCT00849693|3696401|FG002|COMPLETED|Acute Treatment Phase||84
2980565|NCT00849693|3696402|FG003|COMPLETED|Acute Treatment Phase|3 didn't enter extension phase|85
2980566|NCT00849693|3696399|FG000|NOT COMPLETED|Acute Treatment Phase||33
2980567|NCT00849693|3696400|FG001|NOT COMPLETED|Acute Treatment Phase||35
2980568|NCT00849693|3696401|FG002|NOT COMPLETED|Acute Treatment Phase||33
2980569|NCT00849693|3696402|FG003|NOT COMPLETED|Acute Treatment Phase||37
2980570|NCT00849693|3696399|FG000|STARTED|Extension Phase||73
2980571|NCT00849693|3696400|FG001|STARTED|Extension Phase||80
2980572|NCT00849693|3696401|FG002|STARTED|Extension Phase||84
2980573|NCT00849693|3696402|FG003|STARTED|Extension Phase||82
2980574|NCT00849693|3696399|FG000|COMPLETED|Extension Phase||43
2980575|NCT00849693|3696400|FG001|COMPLETED|Extension Phase||50
2980576|NCT00849693|3696401|FG002|COMPLETED|Extension Phase||49
2980577|NCT00849693|3696402|FG003|COMPLETED|Extension Phase||44
2980578|NCT00849693|3696399|FG000|NOT COMPLETED|Extension Phase||30
2980579|NCT00849693|3696400|FG001|NOT COMPLETED|Extension Phase||30
2980580|NCT00849693|3696401|FG002|NOT COMPLETED|Extension Phase||35
2980581|NCT00849693|3696402|FG003|NOT COMPLETED|Extension Phase||38
2980582|NCT00849810|3696424|FG000|STARTED|Overall Study||1
2980583|NCT00849810|3696424|FG000|COMPLETED|Overall Study||1
2980584|NCT00849810|3696424|FG000|NOT COMPLETED|Overall Study||0
2980585|NCT00849875|3696431|FG000|STARTED|Overall Study||48
2980586|NCT00849875|3696431|FG000|COMPLETED|Overall Study||1
2980587|NCT00849875|3696431|FG000|NOT COMPLETED|Overall Study||47
2980588|NCT00849901|3696445|FG000|STARTED|Acute Treatment Phase||117
2980589|NCT00849901|3696446|FG001|STARTED|Acute Treatment Phase||117
2980590|NCT00849901|3696447|FG002|STARTED|Acute Treatment Phase||103
2980591|NCT00849901|3696445|FG000|COMPLETED|Acute Treatment Phase|4 didn't enter extension phase.|87
2980592|NCT00849901|3696446|FG001|COMPLETED|Acute Treatment Phase||91
2980593|NCT00849901|3696447|FG002|COMPLETED|Acute Treatment Phase|1 didn't enter extension phase.|87
2980594|NCT00849901|3696445|FG000|NOT COMPLETED|Acute Treatment Phase||30
2980595|NCT00849901|3696446|FG001|NOT COMPLETED|Acute Treatment Phase||26
2980596|NCT00849901|3696447|FG002|NOT COMPLETED|Acute Treatment Phase||16
2980597|NCT00849901|3696445|FG000|STARTED|Extension Phase||83
2980598|NCT00849901|3696446|FG001|STARTED|Extension Phase||91
2980599|NCT00849901|3696447|FG002|STARTED|Extension Phase||86
2980600|NCT00849901|3696445|FG000|COMPLETED|Extension Phase||56
2980601|NCT00849901|3696446|FG001|COMPLETED|Extension Phase||65
2980602|NCT00849901|3696447|FG002|COMPLETED|Extension Phase||69
2980603|NCT00849901|3696445|FG000|NOT COMPLETED|Extension Phase||27
2980604|NCT00849901|3696446|FG001|NOT COMPLETED|Extension Phase||26
2980605|NCT00849901|3696447|FG002|NOT COMPLETED|Extension Phase||17
2980606|NCT00849940|3696461|FG000|STARTED|Overall Study||72
2980607|NCT00849940|3696461|FG000|COMPLETED|Overall Study||68
2980608|NCT00849940|3696461|FG000|NOT COMPLETED|Overall Study||4
2980609|NCT00850031|3696465|FG000|STARTED|Overall Study||118
2980610|NCT00850031|3696465|FG000|COMPLETED|Overall Study||101
2980611|NCT00850031|3696465|FG000|NOT COMPLETED|Overall Study||17
2980612|NCT00850070|3696471|FG000|STARTED|Overall Study||23
2980613|NCT00850070|3696472|FG001|STARTED|Overall Study||23
2980614|NCT00850070|3696471|FG000|COMPLETED|Overall Study||20
2980615|NCT00850070|3696472|FG001|COMPLETED|Overall Study||22
2980616|NCT00850070|3696471|FG000|NOT COMPLETED|Overall Study||3
2980617|NCT00850070|3696472|FG001|NOT COMPLETED|Overall Study||1
2980618|NCT00850096|3696485|FG000|STARTED|Overall Study||47
2980619|NCT00850096|3696486|FG001|STARTED|Overall Study||47
2980620|NCT00850096|3696485|FG000|COMPLETED|Overall Study||44
2980621|NCT00850096|3696486|FG001|COMPLETED|Overall Study||45
2980622|NCT00850096|3696485|FG000|NOT COMPLETED|Overall Study||3
2980623|NCT00850096|3696486|FG001|NOT COMPLETED|Overall Study||2
2980624|NCT00850135|3696492|FG000|STARTED|Overall Study||57
2980625|NCT00850135|3696492|FG000|COMPLETED|Overall Study||56
2980626|NCT00850135|3696492|FG000|NOT COMPLETED|Overall Study||1
2980627|NCT00850200|3696498|FG000|STARTED|Overall Study||20
2980628|NCT00850200|3696498|FG000|COMPLETED|Overall Study||15
2980629|NCT00850200|3696498|FG000|NOT COMPLETED|Overall Study||5
2980630|NCT00850343|3696509|FG000|STARTED|Overall Study||110
2980631|NCT00850343|3696510|FG001|STARTED|Overall Study||12
2980632|NCT00850343|3696511|FG002|STARTED|Overall Study||43
2980633|NCT00850343|3696512|FG003|STARTED|Overall Study||43
2980634|NCT00850343|3696509|FG000|Completed Week 24|Overall Study||94
2980635|NCT00850343|3696510|FG001|Completed Week 24|Overall Study||12
2980636|NCT00850343|3696511|FG002|Completed Week 24|Overall Study||39
2980637|NCT00850343|3696512|FG003|Completed Week 24|Overall Study||39
2980638|NCT00850343|3696509|FG000|Completed Week 52|Overall Study||88
2980639|NCT00850343|3696510|FG001|Completed Week 52|Overall Study||11
2980640|NCT00850343|3696511|FG002|Completed Week 52|Overall Study||37
2980641|NCT00850343|3696512|FG003|Completed Week 52|Overall Study||37
2980642|NCT00850343|3696509|FG000|COMPLETED|Overall Study||64
2980643|NCT00850343|3696510|FG001|COMPLETED|Overall Study||9
2980644|NCT00850343|3696511|FG002|COMPLETED|Overall Study||29
2980645|NCT00850343|3696512|FG003|COMPLETED|Overall Study||30
2980646|NCT00850343|3696509|FG000|NOT COMPLETED|Overall Study||46
2980647|NCT00850343|3696510|FG001|NOT COMPLETED|Overall Study||3
2980648|NCT00850343|3696511|FG002|NOT COMPLETED|Overall Study||14
2980649|NCT00850343|3696512|FG003|NOT COMPLETED|Overall Study||13
2980650|NCT00850395|3696522|FG000|STARTED|Overall Study||79
2980651|NCT00850395|3696522|FG000|COMPLETED|Overall Study||69
2980652|NCT00850395|3696522|FG000|NOT COMPLETED|Overall Study||10
2980653|NCT00850460|3696528|FG000|STARTED|Overall Study||7
2980654|NCT00850460|3696529|FG001|STARTED|Overall Study||7
2980655|NCT00850460|3696528|FG000|Started - Week 0|Overall Study||7
2980656|NCT00850460|3696529|FG001|Started - Week 0|Overall Study||7
2980657|NCT00850460|3696528|FG000|Completion - Week 8|Overall Study||3
2980658|NCT00850460|3696529|FG001|Completion - Week 8|Overall Study||3
2980659|NCT00850460|3696528|FG000|COMPLETED|Overall Study||3
2980660|NCT00850460|3696529|FG001|COMPLETED|Overall Study||3
2980661|NCT00850460|3696528|FG000|NOT COMPLETED|Overall Study||4
2980662|NCT00850460|3696529|FG001|NOT COMPLETED|Overall Study||4
2980663|NCT00850473|3696535|FG000|STARTED|Overall Study||3
2980664|NCT00850473|3696535|FG000|COMPLETED|Overall Study||3
2980665|NCT00850473|3696535|FG000|NOT COMPLETED|Overall Study||0
2980666|NCT00850499|3696541|FG000|STARTED|Overall Study||4
2980667|NCT00850499|3696542|FG001|STARTED|Overall Study||8
2980668|NCT00850499|3696541|FG000|COMPLETED|Overall Study||1
2980669|NCT00850499|3696542|FG001|COMPLETED|Overall Study||6
2980670|NCT00850499|3696541|FG000|NOT COMPLETED|Overall Study||3
2980671|NCT00850499|3696542|FG001|NOT COMPLETED|Overall Study||2
3036275|NCT01142726|3755497|FG002|NOT COMPLETED|Re-Exposure Phase: Months 24 up to 30||3
3036276|NCT01142791|3755513|FG000|STARTED|Overall Study||115
3036277|NCT01142791|3755514|FG001|STARTED|Overall Study|6 participants receiving only 1 sonication were included only in adverse events reporting.|6
3036278|NCT01142791|3755513|FG000|Safety|Overall Study||115
3036279|NCT01142791|3755514|FG001|Safety|Overall Study|Safety data only was reported for 6 participants receiving only 1 sonication.|6
3036280|NCT01142791|3755513|FG000|COMPLETED|Overall Study||108
3036281|NCT01142791|3755514|FG001|COMPLETED|Overall Study||0
3036282|NCT01142791|3755513|FG000|NOT COMPLETED|Overall Study||7
3036283|NCT01142791|3755514|FG001|NOT COMPLETED|Overall Study||6
3036284|NCT01142908|3755520|FG000|STARTED|Overall Study||215
3036285|NCT01142908|3755521|FG001|STARTED|Overall Study||213
3036286|NCT01142908|3755520|FG000|6 Month f/u|Overall Study||188
3036287|NCT01142908|3755521|FG001|6 Month f/u|Overall Study||196
3036288|NCT01142908|3755520|FG000|COMPLETED|Overall Study||183
3036289|NCT01142908|3755521|FG001|COMPLETED|Overall Study||191
3036290|NCT01142908|3755520|FG000|NOT COMPLETED|Overall Study||32
3036291|NCT01142908|3755521|FG001|NOT COMPLETED|Overall Study||22
3036292|NCT01142947|3755527|FG000|STARTED|Overall Study||362
3036293|NCT01142947|3755527|FG000|COMPLETED|Overall Study||244
3036294|NCT01142947|3755527|FG000|NOT COMPLETED|Overall Study||118
3036295|NCT01143038|3755531|FG000|STARTED|Overall Study||75
3036296|NCT01143038|3755531|FG000|COMPLETED|Overall Study|Defined as completion of romiplostim treatment|59
3036297|NCT01143038|3755531|FG000|NOT COMPLETED|Overall Study||16
3036298|NCT01143051|3755541|FG000|STARTED|Visit 1||4
3036299|NCT01143051|3755542|FG001|STARTED|Visit 1||4
3036300|NCT01143051|3755543|FG002|STARTED|Visit 1||4
3036301|NCT01143051|3755544|FG003|STARTED|Visit 1||4
3036302|NCT01143051|3755545|FG004|STARTED|Visit 1||4
3036303|NCT01143051|3755546|FG005|STARTED|Visit 1||4
3036304|NCT01143051|3755541|FG000|COMPLETED|Visit 1||4
3036305|NCT01143051|3755542|FG001|COMPLETED|Visit 1||4
3036306|NCT01143051|3755543|FG002|COMPLETED|Visit 1||4
3036307|NCT01143051|3755544|FG003|COMPLETED|Visit 1||4
3036308|NCT01143051|3755545|FG004|COMPLETED|Visit 1||4
3036309|NCT01143051|3755546|FG005|COMPLETED|Visit 1||4
3036310|NCT01143051|3755541|FG000|NOT COMPLETED|Visit 1||0
3036311|NCT01143051|3755542|FG001|NOT COMPLETED|Visit 1||0
3133386|NCT01695239|3858316|FG011|COMPLETED|Post-Treatment Follow-Up Period||0
3133387|NCT01695239|3858317|FG012|COMPLETED|Post-Treatment Follow-Up Period||156
3133388|NCT01695239|3858318|FG013|COMPLETED|Post-Treatment Follow-Up Period||166
3133389|NCT01695239|3858305|FG000|NOT COMPLETED|Post-Treatment Follow-Up Period||0
3133390|NCT01695239|3858306|FG001|NOT COMPLETED|Post-Treatment Follow-Up Period||0
3036312|NCT01143051|3755543|FG002|NOT COMPLETED|Visit 1||0
2980672|NCT00850538|3696548|FG000|STARTED|Overall Study||101
2980673|NCT00850538|3696548|FG000|COMPLETED|Overall Study||60
2980674|NCT00850538|3696548|FG000|NOT COMPLETED|Overall Study||41
2980675|NCT00850564|3696552|FG000|STARTED|Overall Study||15
2980676|NCT00850564|3696552|FG000|COMPLETED|Overall Study||13
2980677|NCT00850564|3696552|FG000|NOT COMPLETED|Overall Study||2
2980678|NCT00850603|3696561|FG000|STARTED|Overall Study||34
2980679|NCT00850603|3696562|FG001|STARTED|Overall Study||34
2980680|NCT00850603|3696563|FG002|STARTED|Overall Study||34
2980681|NCT00850603|3696564|FG003|STARTED|Overall Study||34
2980682|NCT00850603|3696565|FG004|STARTED|Overall Study||34
2980683|NCT00850603|3696561|FG000|COMPLETED|Overall Study||34
2980684|NCT00850603|3696562|FG001|COMPLETED|Overall Study||34
2980685|NCT00850603|3696563|FG002|COMPLETED|Overall Study||34
2980686|NCT00850603|3696564|FG003|COMPLETED|Overall Study||34
2980687|NCT00850603|3696565|FG004|COMPLETED|Overall Study||34
2980688|NCT00850603|3696561|FG000|NOT COMPLETED|Overall Study||0
2980689|NCT00850603|3696562|FG001|NOT COMPLETED|Overall Study||0
2980690|NCT00850603|3696563|FG002|NOT COMPLETED|Overall Study||0
2980691|NCT00850603|3696564|FG003|NOT COMPLETED|Overall Study||0
2980692|NCT00850603|3696565|FG004|NOT COMPLETED|Overall Study||0
2980693|NCT00850642|3696579|FG000|STARTED|Overall Study||3
2980694|NCT00850642|3696580|FG001|STARTED|Overall Study||4
2980695|NCT00850642|3696579|FG000|COMPLETED|Overall Study||3
2980696|NCT00850642|3696580|FG001|COMPLETED|Overall Study||4
2980697|NCT00850642|3696579|FG000|NOT COMPLETED|Overall Study||0
2980698|NCT00850642|3696580|FG001|NOT COMPLETED|Overall Study||0
2980699|NCT00850759|3696595|FG000|STARTED|Overall Study||59
2980700|NCT00850759|3696596|FG001|STARTED|Overall Study||57
2980701|NCT00850759|3696597|FG002|STARTED|Overall Study||57
2980702|NCT00850759|3696598|FG003|STARTED|Overall Study||58
2980703|NCT00850759|3696595|FG000|COMPLETED|Overall Study||52
2980704|NCT00850759|3696596|FG001|COMPLETED|Overall Study||52
2980705|NCT00850759|3696597|FG002|COMPLETED|Overall Study||52
2980706|NCT00850759|3696598|FG003|COMPLETED|Overall Study||55
2980707|NCT00850759|3696595|FG000|NOT COMPLETED|Overall Study||7
2980708|NCT00850759|3696596|FG001|NOT COMPLETED|Overall Study||5
2980709|NCT00850759|3696597|FG002|NOT COMPLETED|Overall Study||5
2980710|NCT00850759|3696598|FG003|NOT COMPLETED|Overall Study||3
2980711|NCT00850889|3696608|FG000|STARTED|Overall Study||32
2980712|NCT00850889|3696608|FG000|COMPLETED|Overall Study||32
2980713|NCT00850889|3696608|FG000|NOT COMPLETED|Overall Study||0
2980714|NCT00850993|3696619|FG000|STARTED|Overall Study||17
2980715|NCT00850993|3696620|FG001|STARTED|Overall Study||18
2980716|NCT00850993|3696621|FG002|STARTED|Overall Study||8
2980717|NCT00850993|3696622|FG003|STARTED|Overall Study||15
2980718|NCT00850993|3696619|FG000|Safety|Overall Study||17
2980719|NCT00850993|3696620|FG001|Safety|Overall Study||18
2980720|NCT00850993|3696621|FG002|Safety|Overall Study||8
2980721|NCT00850993|3696622|FG003|Safety|Overall Study||15
2980722|NCT00850993|3696619|FG000|Intent-to-treat|Overall Study||17
2980723|NCT00850993|3696620|FG001|Intent-to-treat|Overall Study||18
2980724|NCT00850993|3696621|FG002|Intent-to-treat|Overall Study||8
2980725|NCT00850993|3696622|FG003|Intent-to-treat|Overall Study||15
2980726|NCT00850993|3696619|FG000|Received Phototherapy|Overall Study||3
2980727|NCT00850993|3696620|FG001|Received Phototherapy|Overall Study||6
2980728|NCT00850993|3696621|FG002|Received Phototherapy|Overall Study||2
2980729|NCT00850993|3696622|FG003|Received Phototherapy|Overall Study||8
2980730|NCT00850993|3696619|FG000|Per Protocol|Overall Study||10
2980731|NCT00850993|3696620|FG001|Per Protocol|Overall Study||13
2980732|NCT00850993|3696621|FG002|Per Protocol|Overall Study||5
2980733|NCT00850993|3696622|FG003|Per Protocol|Overall Study||13
2980734|NCT00850993|3696619|FG000|COMPLETED|Overall Study||16
2980735|NCT00850993|3696620|FG001|COMPLETED|Overall Study||18
2980736|NCT00850993|3696621|FG002|COMPLETED|Overall Study||8
2980737|NCT00850993|3696622|FG003|COMPLETED|Overall Study||14
2980738|NCT00850993|3696619|FG000|NOT COMPLETED|Overall Study||1
2980739|NCT00850993|3696620|FG001|NOT COMPLETED|Overall Study||0
2980740|NCT00850993|3696621|FG002|NOT COMPLETED|Overall Study||0
2980741|NCT00850993|3696622|FG003|NOT COMPLETED|Overall Study||1
2980742|NCT00851006|3696632|FG000|STARTED|Overall Study||7
2980743|NCT00851006|3696633|FG001|STARTED|Overall Study||6
2980744|NCT00851006|3696632|FG000|COMPLETED|Overall Study||7
2980745|NCT00851006|3696633|FG001|COMPLETED|Overall Study||6
2980746|NCT00851006|3696632|FG000|NOT COMPLETED|Overall Study||0
2980747|NCT00851006|3696633|FG001|NOT COMPLETED|Overall Study||0
2980748|NCT00851084|3696642|FG000|STARTED|Overall Study||117
2980749|NCT00851084|3696643|FG001|STARTED|Overall Study||119
2980750|NCT00851084|3696642|FG000|COMPLETED|Overall Study|Participants continued treatment until they met treatment discontinuation criteria.|0
2980751|NCT00851084|3696643|FG001|COMPLETED|Overall Study|Participants continued treatment until they met treatment discontinuation criteria.|0
2980752|NCT00851084|3696642|FG000|NOT COMPLETED|Overall Study||117
2980753|NCT00851084|3696643|FG001|NOT COMPLETED|Overall Study||119
2980754|NCT00851253|3696653|FG000|STARTED|Overall Study||2
2980755|NCT00851253|3696654|FG001|STARTED|Overall Study||10
2980756|NCT00851253|3696653|FG000|COMPLETED|Overall Study||1
2980757|NCT00851253|3696654|FG001|COMPLETED|Overall Study||10
2980758|NCT00851253|3696653|FG000|NOT COMPLETED|Overall Study||1
2980759|NCT00851253|3696654|FG001|NOT COMPLETED|Overall Study||0
2980760|NCT00851279|3696660|FG000|STARTED|Overall Study||53
2980761|NCT00851279|3696660|FG000|COMPLETED|Overall Study||53
2980762|NCT00851279|3696660|FG000|NOT COMPLETED|Overall Study||0
2980763|NCT00851318|3696668|FG000|STARTED|Overall Study||81
2980764|NCT00851318|3696669|FG001|STARTED|Overall Study||19
2980765|NCT00851318|3696670|FG002|STARTED|Overall Study||93
2980766|NCT00851318|3696671|FG003|STARTED|Overall Study||92
2980767|NCT00851318|3696668|FG000|Completed Week 24|Overall Study||69
2980768|NCT00851318|3696669|FG001|Completed Week 24|Overall Study||17
2980769|NCT00851318|3696670|FG002|Completed Week 24|Overall Study||90
2980770|NCT00851318|3696671|FG003|Completed Week 24|Overall Study||87
2980771|NCT00851318|3696668|FG000|Completed Week 52|Overall Study||64
2980772|NCT00851318|3696669|FG001|Completed Week 52|Overall Study||16
2980773|NCT00851318|3696670|FG002|Completed Week 52|Overall Study||87
2980774|NCT00851318|3696671|FG003|Completed Week 52|Overall Study||85
2980775|NCT00851318|3696668|FG000|COMPLETED|Overall Study||51
2980776|NCT00851318|3696669|FG001|COMPLETED|Overall Study||14
2980777|NCT00851318|3696670|FG002|COMPLETED|Overall Study||72
2980778|NCT00851318|3696671|FG003|COMPLETED|Overall Study||73
2980779|NCT00851318|3696668|FG000|NOT COMPLETED|Overall Study||30
2980780|NCT00851318|3696669|FG001|NOT COMPLETED|Overall Study||5
2980781|NCT00851318|3696670|FG002|NOT COMPLETED|Overall Study||21
2980782|NCT00851318|3696671|FG003|NOT COMPLETED|Overall Study||19
2980783|NCT00851357|3696684|FG000|STARTED|Overall Study||1200
2980784|NCT00851357|3696685|FG001|STARTED|Overall Study||1201
2980785|NCT00851357|3696686|FG002|STARTED|Overall Study||1799
2980786|NCT00851357|3696684|FG000|COMPLETED|Overall Study||1200
2980787|NCT00851357|3696685|FG001|COMPLETED|Overall Study||1201
2980788|NCT00851357|3696686|FG002|COMPLETED|Overall Study||1799
2980789|NCT00851357|3696684|FG000|NOT COMPLETED|Overall Study||0
2980790|NCT00851357|3696685|FG001|NOT COMPLETED|Overall Study||0
2980791|NCT00851357|3696686|FG002|NOT COMPLETED|Overall Study||0
2980792|NCT00851409|3696694|FG000|STARTED|Overall Study||25
2980793|NCT00851409|3696694|FG000|COMPLETED|Overall Study||25
2980794|NCT00851409|3696694|FG000|NOT COMPLETED|Overall Study||0
2980795|NCT00851630|3696701|FG000|STARTED|Overall Study||35
2980796|NCT00851630|3696702|FG001|STARTED|Overall Study||35
2980797|NCT00851630|3696701|FG000|COMPLETED|Overall Study||33
2980798|NCT00851630|3696702|FG001|COMPLETED|Overall Study||33
2980799|NCT00851630|3696701|FG000|NOT COMPLETED|Overall Study||2
2980800|NCT00851630|3696702|FG001|NOT COMPLETED|Overall Study||2
2980801|NCT00851643|3696714|FG000|STARTED|Base Study (Up to 12 Months)||15
2980802|NCT00851643|3696715|FG001|STARTED|Base Study (Up to 12 Months)||30
2980803|NCT00851643|3696716|FG002|STARTED|Base Study (Up to 12 Months)||30
2980804|NCT00851643|3696717|FG003|STARTED|Base Study (Up to 12 Months)||15
2980805|NCT00851643|3696718|FG004|STARTED|Base Study (Up to 12 Months)||30
2980806|NCT00851643|3696719|FG005|STARTED|Base Study (Up to 12 Months)||30
2980807|NCT00851643|3696714|FG000|COMPLETED|Base Study (Up to 12 Months)||14
2980808|NCT00851643|3696715|FG001|COMPLETED|Base Study (Up to 12 Months)||30
2980809|NCT00851643|3696716|FG002|COMPLETED|Base Study (Up to 12 Months)||30
2980810|NCT00851643|3696717|FG003|COMPLETED|Base Study (Up to 12 Months)||15
2980811|NCT00851643|3696718|FG004|COMPLETED|Base Study (Up to 12 Months)||30
2980812|NCT00851643|3696719|FG005|COMPLETED|Base Study (Up to 12 Months)||29
2980813|NCT00851643|3696714|FG000|NOT COMPLETED|Base Study (Up to 12 Months)||1
2980814|NCT00851643|3696715|FG001|NOT COMPLETED|Base Study (Up to 12 Months)||0
2980815|NCT00851643|3696716|FG002|NOT COMPLETED|Base Study (Up to 12 Months)||0
2980816|NCT00851643|3696717|FG003|NOT COMPLETED|Base Study (Up to 12 Months)||0
2980817|NCT00851643|3696718|FG004|NOT COMPLETED|Base Study (Up to 12 Months)||0
2980818|NCT00851643|3696719|FG005|NOT COMPLETED|Base Study (Up to 12 Months)||1
2980819|NCT00851643|3696714|FG000|STARTED|Extension Study (Up to 36 Months)||10
2980820|NCT00851643|3696715|FG001|STARTED|Extension Study (Up to 36 Months)||19
2980821|NCT00851643|3696716|FG002|STARTED|Extension Study (Up to 36 Months)||19
2980822|NCT00851643|3696717|FG003|STARTED|Extension Study (Up to 36 Months)||7
2980823|NCT00851643|3696718|FG004|STARTED|Extension Study (Up to 36 Months)||21
2980824|NCT00851643|3696719|FG005|STARTED|Extension Study (Up to 36 Months)||15
2980825|NCT00851643|3696714|FG000|COMPLETED|Extension Study (Up to 36 Months)||6
3133391|NCT01695239|3858307|FG002|NOT COMPLETED|Post-Treatment Follow-Up Period||0
3133392|NCT01695239|3858308|FG003|NOT COMPLETED|Post-Treatment Follow-Up Period||0
3133393|NCT01695239|3858309|FG004|NOT COMPLETED|Post-Treatment Follow-Up Period||0
3133394|NCT01695239|3858310|FG005|NOT COMPLETED|Post-Treatment Follow-Up Period||0
3133395|NCT01695239|3858311|FG006|NOT COMPLETED|Post-Treatment Follow-Up Period||0
2980826|NCT00851643|3696715|FG001|COMPLETED|Extension Study (Up to 36 Months)||15
2980827|NCT00851643|3696716|FG002|COMPLETED|Extension Study (Up to 36 Months)||14
2980828|NCT00851643|3696717|FG003|COMPLETED|Extension Study (Up to 36 Months)||5
2980829|NCT00851643|3696718|FG004|COMPLETED|Extension Study (Up to 36 Months)||19
2980830|NCT00851643|3696719|FG005|COMPLETED|Extension Study (Up to 36 Months)||14
2980831|NCT00851643|3696714|FG000|NOT COMPLETED|Extension Study (Up to 36 Months)||4
2980832|NCT00851643|3696715|FG001|NOT COMPLETED|Extension Study (Up to 36 Months)||4
2980833|NCT00851643|3696716|FG002|NOT COMPLETED|Extension Study (Up to 36 Months)||5
2980834|NCT00851643|3696717|FG003|NOT COMPLETED|Extension Study (Up to 36 Months)||2
2980835|NCT00851643|3696718|FG004|NOT COMPLETED|Extension Study (Up to 36 Months)||2
2980836|NCT00851643|3696719|FG005|NOT COMPLETED|Extension Study (Up to 36 Months)||1
2980837|NCT00851721|3696734|FG000|STARTED|Overall Study||19
2980838|NCT00851721|3696735|FG001|STARTED|Overall Study||17
2980839|NCT00851721|3696734|FG000|COMPLETED|Overall Study||17
2980840|NCT00851721|3696735|FG001|COMPLETED|Overall Study||16
2980841|NCT00851721|3696734|FG000|NOT COMPLETED|Overall Study||2
2980842|NCT00851721|3696735|FG001|NOT COMPLETED|Overall Study||1
2980843|NCT00851786|3696749|FG000|STARTED|Overall Study|One subject cannot adhere to protocol requirement and was off study with no vaccine.|296
2980844|NCT00851786|3696750|FG001|STARTED|Overall Study|Two subjects (one found ineligible and one withdrew consent) were off study with no vaccine.|99
2980845|NCT00851786|3696749|FG000|COMPLETED|Overall Study||291
2980846|NCT00851786|3696750|FG001|COMPLETED|Overall Study||97
2980847|NCT00851786|3696749|FG000|NOT COMPLETED|Overall Study||5
2980848|NCT00851786|3696750|FG001|NOT COMPLETED|Overall Study||2
2980849|NCT00851799|3696759|FG000|STARTED|Overall Study||109
2980850|NCT00851799|3696760|FG001|STARTED|Overall Study||106
2980851|NCT00851799|3696761|FG002|STARTED|Overall Study||113
2980852|NCT00851799|3696759|FG000|COMPLETED|Overall Study||93
2980853|NCT00851799|3696760|FG001|COMPLETED|Overall Study||93
2980854|NCT00851799|3696761|FG002|COMPLETED|Overall Study||89
2980855|NCT00851799|3696759|FG000|NOT COMPLETED|Overall Study||16
2980856|NCT00851799|3696760|FG001|NOT COMPLETED|Overall Study||13
2980857|NCT00851799|3696761|FG002|NOT COMPLETED|Overall Study||24
2980858|NCT00851877|3696769|FG000|STARTED|Phase I-1||7
2980859|NCT00851877|3696770|FG001|STARTED|Phase I-1||0
2980860|NCT00851877|3696771|FG002|STARTED|Phase I-1||0
2980861|NCT00851877|3696769|FG000|COMPLETED|Phase I-1||6
2980862|NCT00851877|3696770|FG001|COMPLETED|Phase I-1||0
2980863|NCT00851877|3696771|FG002|COMPLETED|Phase I-1||0
2980864|NCT00851877|3696769|FG000|NOT COMPLETED|Phase I-1||1
2980865|NCT00851877|3696770|FG001|NOT COMPLETED|Phase I-1||0
2980866|NCT00851877|3696771|FG002|NOT COMPLETED|Phase I-1||0
2980867|NCT00851877|3696769|FG000|STARTED|Phase I-2||0
2980868|NCT00851877|3696770|FG001|STARTED|Phase I-2||5
2980869|NCT00851877|3696771|FG002|STARTED|Phase I-2||0
2980870|NCT00851877|3696769|FG000|COMPLETED|Phase I-2||0
2980871|NCT00851877|3696770|FG001|COMPLETED|Phase I-2||5
2980872|NCT00851877|3696771|FG002|COMPLETED|Phase I-2||0
2980873|NCT00851877|3696769|FG000|NOT COMPLETED|Phase I-2||0
2980874|NCT00851877|3696770|FG001|NOT COMPLETED|Phase I-2||0
2980875|NCT00851877|3696771|FG002|NOT COMPLETED|Phase I-2||0
2980876|NCT00851877|3696769|FG000|STARTED|Phase II||0
2980877|NCT00851877|3696770|FG001|STARTED|Phase II||0
2980878|NCT00851877|3696771|FG002|STARTED|Phase II||25
2980879|NCT00851877|3696769|FG000|COMPLETED|Phase II||0
2980880|NCT00851877|3696770|FG001|COMPLETED|Phase II||0
2980881|NCT00851877|3696771|FG002|COMPLETED|Phase II||22
2980882|NCT00851877|3696769|FG000|NOT COMPLETED|Phase II||0
2980883|NCT00851877|3696770|FG001|NOT COMPLETED|Phase II||0
2980884|NCT00851877|3696771|FG002|NOT COMPLETED|Phase II||3
2980885|NCT00851890|3696781|FG000|STARTED|Overall Study||8
2980886|NCT00851890|3696782|FG001|STARTED|Overall Study||8
2980887|NCT00851890|3696783|FG002|STARTED|Overall Study||8
2980888|NCT00851890|3696784|FG003|STARTED|Overall Study||6
2980889|NCT00851890|3696781|FG000|COMPLETED|Overall Study||8
2980890|NCT00851890|3696782|FG001|COMPLETED|Overall Study||7
2980891|NCT00851890|3696783|FG002|COMPLETED|Overall Study||8
2980892|NCT00851890|3696784|FG003|COMPLETED|Overall Study||5
2980893|NCT00851890|3696781|FG000|NOT COMPLETED|Overall Study||0
2980894|NCT00851890|3696782|FG001|NOT COMPLETED|Overall Study||1
2980895|NCT00851890|3696783|FG002|NOT COMPLETED|Overall Study||0
2980896|NCT00851890|3696784|FG003|NOT COMPLETED|Overall Study||1
2980897|NCT00851903|3696794|FG000|STARTED|Overall Study||112
2980898|NCT00851903|3696794|FG000|Safety Population|Overall Study|patients treated with at least one dose of insulin glargine OR one dose of sitagliptin|112
2980899|NCT00851903|3696794|FG000|Treated by Combination|Overall Study|patients treated with at least one dose of insulin glargine AND one dose of sitagliptin|111
2980900|NCT00851903|3696794|FG000|Modified Intent-To-Treat Population|Overall Study|mITT population: patients treated by combination with at least 1 on-treatment efficacy measure|111
2980901|NCT00851903|3696794|FG000|COMPLETED|Overall Study||110
2980902|NCT00851903|3696794|FG000|NOT COMPLETED|Overall Study||2
2980903|NCT00852137|3696800|FG000|STARTED|Overall Study||13
2980904|NCT00852137|3696801|FG001|STARTED|Overall Study||3
2980905|NCT00852137|3696800|FG000|COMPLETED|Overall Study||13
2980906|NCT00852137|3696801|FG001|COMPLETED|Overall Study||3
2980907|NCT00852137|3696800|FG000|NOT COMPLETED|Overall Study||0
2980908|NCT00852137|3696801|FG001|NOT COMPLETED|Overall Study||0
2980909|NCT00852202|3696810|FG000|STARTED|Overall Study||77
2980910|NCT00852202|3696811|FG001|STARTED|Overall Study||75
2980911|NCT00852202|3696812|FG002|STARTED|Overall Study||75
2980912|NCT00852202|3696810|FG000|COMPLETED|Overall Study||60
2980913|NCT00852202|3696811|FG001|COMPLETED|Overall Study||63
2980914|NCT00852202|3696812|FG002|COMPLETED|Overall Study||49
2980915|NCT00852202|3696810|FG000|NOT COMPLETED|Overall Study||17
2980916|NCT00852202|3696811|FG001|NOT COMPLETED|Overall Study||12
2980917|NCT00852202|3696812|FG002|NOT COMPLETED|Overall Study||26
2980918|NCT00852397|3696824|FG000|STARTED|Overall Study||52
2980919|NCT00852397|3696825|FG001|STARTED|Overall Study||49
2980920|NCT00852397|3696826|FG002|STARTED|Overall Study||50
2980921|NCT00852397|3696824|FG000|Treated Participants|Overall Study||51
2980922|NCT00852397|3696825|FG001|Treated Participants|Overall Study||49
2980923|NCT00852397|3696826|FG002|Treated Participants|Overall Study||49
2980924|NCT00852397|3696824|FG000|COMPLETED|Overall Study||41
2980925|NCT00852397|3696825|FG001|COMPLETED|Overall Study||41
3303291|NCT02965989|4036612|FG000|NOT COMPLETED|Overall Study||0
3303292|NCT02965989|4036613|FG001|NOT COMPLETED|Overall Study||0
2980926|NCT00852397|3696826|FG002|COMPLETED|Overall Study||36
2980927|NCT00852397|3696824|FG000|NOT COMPLETED|Overall Study||11
2980928|NCT00852397|3696825|FG001|NOT COMPLETED|Overall Study||8
2980929|NCT00852397|3696826|FG002|NOT COMPLETED|Overall Study||14
2980930|NCT00852475|3696836|FG000|STARTED|Overall Study||26
2980931|NCT00852475|3696837|FG001|STARTED|Overall Study||20
2980932|NCT00852475|3696836|FG000|COMPLETED|Overall Study||23
2980933|NCT00852475|3696837|FG001|COMPLETED|Overall Study||16
2980934|NCT00852475|3696836|FG000|NOT COMPLETED|Overall Study||3
2980935|NCT00852475|3696837|FG001|NOT COMPLETED|Overall Study||4
2980936|NCT00852527|3696845|FG000|STARTED|Overall Study||196
2980937|NCT00852527|3696846|FG001|STARTED|Overall Study||242
2980938|NCT00852527|3696845|FG000|COMPLETED|Overall Study||196
2980939|NCT00852527|3696846|FG001|COMPLETED|Overall Study||242
2980940|NCT00852527|3696845|FG000|NOT COMPLETED|Overall Study||0
2980941|NCT00852527|3696846|FG001|NOT COMPLETED|Overall Study||0
2980942|NCT00852540|3696853|FG000|STARTED|Overall Study||270
2980943|NCT00852540|3696854|FG001|STARTED|Overall Study||140
2980944|NCT00852540|3696853|FG000|COMPLETED|Overall Study||234
2980945|NCT00852540|3696854|FG001|COMPLETED|Overall Study||122
2980946|NCT00852540|3696853|FG000|NOT COMPLETED|Overall Study||36
2980947|NCT00852540|3696854|FG001|NOT COMPLETED|Overall Study||18
2980948|NCT00852592|3696863|FG000|STARTED|Overall Study||23
2980949|NCT00852592|3696864|FG001|STARTED|Overall Study||23
2980950|NCT00852592|3696863|FG000|COMPLETED|Overall Study||20
2980951|NCT00852592|3696864|FG001|COMPLETED|Overall Study||19
2980952|NCT00852592|3696863|FG000|NOT COMPLETED|Overall Study||3
2980953|NCT00852592|3696864|FG001|NOT COMPLETED|Overall Study||4
2980954|NCT00852631|3696870|FG000|STARTED|Overall Study||28
2980955|NCT00852631|3696870|FG000|COMPLETED|Overall Study||17
2980956|NCT00852631|3696870|FG000|NOT COMPLETED|Overall Study||11
2980957|NCT00852644|3696874|FG000|STARTED|Overall Study||3
2980958|NCT00852644|3696875|FG001|STARTED|Overall Study||3
2980959|NCT00852644|3696876|FG002|STARTED|Overall Study||0
2980960|NCT00852644|3696877|FG003|STARTED|Overall Study||3
2980961|NCT00852644|3696878|FG004|STARTED|Overall Study||0
2980962|NCT00852644|3696879|FG005|STARTED|Overall Study||0
2980963|NCT00852644|3696874|FG000|COMPLETED|Overall Study||3
2980964|NCT00852644|3696875|FG001|COMPLETED|Overall Study||3
2980965|NCT00852644|3696876|FG002|COMPLETED|Overall Study||0
2980966|NCT00852644|3696877|FG003|COMPLETED|Overall Study||3
2980967|NCT00852644|3696878|FG004|COMPLETED|Overall Study||0
2980968|NCT00852644|3696879|FG005|COMPLETED|Overall Study||0
2980969|NCT00852644|3696874|FG000|NOT COMPLETED|Overall Study||0
2980970|NCT00852644|3696875|FG001|NOT COMPLETED|Overall Study||0
2980971|NCT00852644|3696876|FG002|NOT COMPLETED|Overall Study||0
2980972|NCT00852644|3696877|FG003|NOT COMPLETED|Overall Study||0
2980973|NCT00852644|3696878|FG004|NOT COMPLETED|Overall Study||0
2980974|NCT00852644|3696879|FG005|NOT COMPLETED|Overall Study||0
2980975|NCT00852761|3696896|FG000|STARTED|Overall Study||17
2980976|NCT00852761|3696897|FG001|STARTED|Overall Study||17
2980977|NCT00852761|3696896|FG000|COMPLETED|Overall Study||17
2980978|NCT00852761|3696897|FG001|COMPLETED|Overall Study||17
2980979|NCT00852761|3696896|FG000|NOT COMPLETED|Overall Study||0
2980980|NCT00852761|3696897|FG001|NOT COMPLETED|Overall Study||0
2980981|NCT00852917|3696907|FG000|STARTED|Overall Study||106
2980982|NCT00852917|3696908|FG001|STARTED|Overall Study||111
2980983|NCT00852917|3696909|FG002|STARTED|Overall Study||108
2980984|NCT00852917|3696910|FG003|STARTED|Overall Study||227
2980985|NCT00852917|3696907|FG000|COMPLETED|Overall Study||62
2980986|NCT00852917|3696908|FG001|COMPLETED|Overall Study||65
2980987|NCT00852917|3696909|FG002|COMPLETED|Overall Study||50
2980988|NCT00852917|3696910|FG003|COMPLETED|Overall Study||134
2980989|NCT00852917|3696907|FG000|NOT COMPLETED|Overall Study||44
2980990|NCT00852917|3696908|FG001|NOT COMPLETED|Overall Study||46
2980991|NCT00852917|3696909|FG002|NOT COMPLETED|Overall Study||58
2980992|NCT00852917|3696910|FG003|NOT COMPLETED|Overall Study||93
2980993|NCT00852930|3696923|FG000|STARTED|Overall Study||16
2980994|NCT00852930|3696924|FG001|STARTED|Overall Study||17
2980995|NCT00852930|3696925|FG002|STARTED|Overall Study||17
2980996|NCT00852930|3696923|FG000|COMPLETED|Overall Study||15
2980997|NCT00852930|3696924|FG001|COMPLETED|Overall Study||16
2980998|NCT00852930|3696925|FG002|COMPLETED|Overall Study||15
2980999|NCT00852930|3696923|FG000|NOT COMPLETED|Overall Study||1
2981000|NCT00852930|3696924|FG001|NOT COMPLETED|Overall Study||1
2981001|NCT00852930|3696925|FG002|NOT COMPLETED|Overall Study||2
2981002|NCT00852969|3696936|FG000|STARTED|Overall Study||15
2981003|NCT00852969|3696937|FG001|STARTED|Overall Study||15
2981004|NCT00852969|3696936|FG000|COMPLETED|Overall Study||15
2981005|NCT00852969|3696937|FG001|COMPLETED|Overall Study||13
2981006|NCT00852969|3696936|FG000|NOT COMPLETED|Overall Study||0
2981007|NCT00852969|3696937|FG001|NOT COMPLETED|Overall Study||2
2981008|NCT00852995|3696948|FG000|STARTED|Overall Study||46
2981009|NCT00852995|3696949|FG001|STARTED|Overall Study||43
2981010|NCT00852995|3696950|FG002|STARTED|Overall Study||44
2981011|NCT00852995|3696951|FG003|STARTED|Overall Study||45
2981012|NCT00852995|3696952|FG004|STARTED|Overall Study||50
2981013|NCT00852995|3696948|FG000|COMPLETED|Overall Study||38
2981014|NCT00852995|3696949|FG001|COMPLETED|Overall Study||42
2981015|NCT00852995|3696950|FG002|COMPLETED|Overall Study||39
2981016|NCT00852995|3696951|FG003|COMPLETED|Overall Study||40
2981017|NCT00852995|3696952|FG004|COMPLETED|Overall Study||46
2981018|NCT00852995|3696948|FG000|NOT COMPLETED|Overall Study||8
2981019|NCT00852995|3696949|FG001|NOT COMPLETED|Overall Study||1
2981020|NCT00852995|3696950|FG002|NOT COMPLETED|Overall Study||5
2981021|NCT00852995|3696951|FG003|NOT COMPLETED|Overall Study||5
2981022|NCT00852995|3696952|FG004|NOT COMPLETED|Overall Study||4
2981023|NCT00853021|3696969|FG000|STARTED|Overall Study||26
2981024|NCT00853021|3696969|FG000|COMPLETED|Overall Study||21
2981025|NCT00853021|3696969|FG000|NOT COMPLETED|Overall Study||5
2981026|NCT00853047|3696978|FG000|STARTED|Core Phase||5
2981027|NCT00853047|3696979|FG001|STARTED|Core Phase||3
2981028|NCT00853047|3696980|FG002|STARTED|Core Phase||3
2981029|NCT00853047|3696981|FG003|STARTED|Core Phase||3
2981030|NCT00853047|3696982|FG004|STARTED|Core Phase||9
2981031|NCT00853047|3696983|FG005|STARTED|Core Phase||0
2981032|NCT00853047|3696978|FG000|COMPLETED|Core Phase||5
2981033|NCT00853047|3696979|FG001|COMPLETED|Core Phase||3
2981034|NCT00853047|3696980|FG002|COMPLETED|Core Phase||3
2981035|NCT00853047|3696981|FG003|COMPLETED|Core Phase||2
2981036|NCT00853047|3696982|FG004|COMPLETED|Core Phase||9
2981037|NCT00853047|3696983|FG005|COMPLETED|Core Phase||0
2981038|NCT00853047|3696978|FG000|NOT COMPLETED|Core Phase||0
2981039|NCT00853047|3696979|FG001|NOT COMPLETED|Core Phase||0
2981040|NCT00853047|3696980|FG002|NOT COMPLETED|Core Phase||0
2981041|NCT00853047|3696981|FG003|NOT COMPLETED|Core Phase||1
2981042|NCT00853047|3696982|FG004|NOT COMPLETED|Core Phase||0
2981043|NCT00853047|3696983|FG005|NOT COMPLETED|Core Phase||0
2981044|NCT00853047|3696978|FG000|STARTED|Open-Label Extension Phase||0
2981045|NCT00853047|3696979|FG001|STARTED|Open-Label Extension Phase||0
2981046|NCT00853047|3696980|FG002|STARTED|Open-Label Extension Phase||0
2981047|NCT00853047|3696981|FG003|STARTED|Open-Label Extension Phase||0
2981048|NCT00853047|3696982|FG004|STARTED|Open-Label Extension Phase||0
2981049|NCT00853047|3696983|FG005|STARTED|Open-Label Extension Phase|19 of the 22 participants who completed the Core Phase entered the optional Open-Label Extension.|19
2981050|NCT00853047|3696978|FG000|Completed 8-week Extension Period|Open-Label Extension Phase||0
2981051|NCT00853047|3696979|FG001|Completed 8-week Extension Period|Open-Label Extension Phase||0
2981052|NCT00853047|3696980|FG002|Completed 8-week Extension Period|Open-Label Extension Phase||0
2981053|NCT00853047|3696981|FG003|Completed 8-week Extension Period|Open-Label Extension Phase||0
2981054|NCT00853047|3696982|FG004|Completed 8-week Extension Period|Open-Label Extension Phase||0
2981055|NCT00853047|3696983|FG005|Completed 8-week Extension Period|Open-Label Extension Phase||16
2981056|NCT00853047|3696978|FG000|COMPLETED|Open-Label Extension Phase||0
2981057|NCT00853047|3696979|FG001|COMPLETED|Open-Label Extension Phase||0
2981058|NCT00853047|3696980|FG002|COMPLETED|Open-Label Extension Phase||0
2981059|NCT00853047|3696981|FG003|COMPLETED|Open-Label Extension Phase||0
2981060|NCT00853047|3696982|FG004|COMPLETED|Open-Label Extension Phase||0
2981061|NCT00853047|3696983|FG005|COMPLETED|Open-Label Extension Phase||2
2981062|NCT00853047|3696978|FG000|NOT COMPLETED|Open-Label Extension Phase||0
3133396|NCT01695239|3858312|FG007|NOT COMPLETED|Post-Treatment Follow-Up Period||0
3133397|NCT01695239|3858313|FG008|NOT COMPLETED|Post-Treatment Follow-Up Period||0
3133398|NCT01695239|3858314|FG009|NOT COMPLETED|Post-Treatment Follow-Up Period||0
3133399|NCT01695239|3858315|FG010|NOT COMPLETED|Post-Treatment Follow-Up Period||0
2981063|NCT00853047|3696979|FG001|NOT COMPLETED|Open-Label Extension Phase||0
2981064|NCT00853047|3696980|FG002|NOT COMPLETED|Open-Label Extension Phase||0
2981065|NCT00853047|3696981|FG003|NOT COMPLETED|Open-Label Extension Phase||0
2981066|NCT00853047|3696982|FG004|NOT COMPLETED|Open-Label Extension Phase||0
2981067|NCT00853047|3696983|FG005|NOT COMPLETED|Open-Label Extension Phase||17
2981068|NCT00853073|3697000|FG000|STARTED|Overall Study||32
2981069|NCT00853073|3697001|FG001|STARTED|Overall Study||31
2981070|NCT00853073|3697000|FG000|COMPLETED|Overall Study||29
2981071|NCT00853073|3697001|FG001|COMPLETED|Overall Study||29
2981072|NCT00853073|3697000|FG000|NOT COMPLETED|Overall Study||3
2981073|NCT00853073|3697001|FG001|NOT COMPLETED|Overall Study||2
2981074|NCT00853099|3697010|FG000|STARTED|Double-blind Period||96
2981075|NCT00853099|3697011|FG001|STARTED|Double-blind Period||87
2981076|NCT00853099|3697012|FG002|STARTED|Double-blind Period||91
2981077|NCT00853099|3697013|FG003|STARTED|Double-blind Period||0
2981078|NCT00853099|3697010|FG000|Treated|Double-blind Period||96
2981079|NCT00853099|3697011|FG001|Treated|Double-blind Period||87
2981080|NCT00853099|3697012|FG002|Treated|Double-blind Period|1 participant, incorrectly treated with open-label (rescue) study drug at Week 0, was excluded.|90
2981081|NCT00853099|3697013|FG003|Treated|Double-blind Period||0
2981082|NCT00853099|3697010|FG000|Completed Week 8|Double-blind Period||92
2981083|NCT00853099|3697011|FG001|Completed Week 8|Double-blind Period||85
2981084|NCT00853099|3697012|FG002|Completed Week 8|Double-blind Period||86
2981085|NCT00853099|3697013|FG003|Completed Week 8|Double-blind Period||0
2981086|NCT00853099|3697010|FG000|COMPLETED|Double-blind Period|Participants who completed Week 52.|73
2981087|NCT00853099|3697011|FG001|COMPLETED|Double-blind Period|Participants who completed Week 52.|58
2981088|NCT00853099|3697012|FG002|COMPLETED|Double-blind Period|Participants who completed Week 52.|60
2981089|NCT00853099|3697013|FG003|COMPLETED|Double-blind Period||0
2981090|NCT00853099|3697010|FG000|NOT COMPLETED|Double-blind Period||23
2981091|NCT00853099|3697011|FG001|NOT COMPLETED|Double-blind Period||29
2981092|NCT00853099|3697012|FG002|NOT COMPLETED|Double-blind Period||31
2981093|NCT00853099|3697013|FG003|NOT COMPLETED|Double-blind Period||0
2981094|NCT00853099|3697010|FG000|STARTED|Double-blind + Open-label Periods||0
2981095|NCT00853099|3697011|FG001|STARTED|Double-blind + Open-label Periods||0
2981096|NCT00853099|3697012|FG002|STARTED|Double-blind + Open-label Periods||0
2981097|NCT00853099|3697013|FG003|STARTED|Double-blind + Open-label Periods|7 participants randomized to placebo did not receive any adalimumab; 1 participant was excluded.|266
2981098|NCT00853099|3697010|FG000|COMPLETED|Double-blind + Open-label Periods||0
2981099|NCT00853099|3697011|FG001|COMPLETED|Double-blind + Open-label Periods||0
2981100|NCT00853099|3697012|FG002|COMPLETED|Double-blind + Open-label Periods||0
2981101|NCT00853099|3697013|FG003|COMPLETED|Double-blind + Open-label Periods||119
2981102|NCT00853099|3697010|FG000|NOT COMPLETED|Double-blind + Open-label Periods||0
2981103|NCT00853099|3697011|FG001|NOT COMPLETED|Double-blind + Open-label Periods||0
2981104|NCT00853099|3697012|FG002|NOT COMPLETED|Double-blind + Open-label Periods||0
3303293|NCT02966002|4036625|FG000|STARTED|Overall Study||9
3303294|NCT02966002|4036625|FG000|COMPLETED|Overall Study||5
3303295|NCT02966002|4036625|FG000|NOT COMPLETED|Overall Study||4
3303296|NCT02966015|4036631|FG000|STARTED|Inclusion Visit||95
3303297|NCT02966015|4036632|FG001|STARTED|Inclusion Visit||58
3303298|NCT02966015|4036631|FG000|COMPLETED|Inclusion Visit||87
2981105|NCT00853099|3697013|FG003|NOT COMPLETED|Double-blind + Open-label Periods||147
2981106|NCT00853112|3697030|FG000|STARTED|Overall Study||6
2981107|NCT00853112|3697031|FG001|STARTED|Overall Study||7
3303299|NCT02966015|4036632|FG001|COMPLETED|Inclusion Visit||55
3303300|NCT02966015|4036631|FG000|NOT COMPLETED|Inclusion Visit||8
3303301|NCT02966015|4036632|FG001|NOT COMPLETED|Inclusion Visit||3
3303302|NCT02966015|4036631|FG000|STARTED|Test Period||87
2981108|NCT00853112|3697032|FG002|STARTED|Overall Study||7
2981109|NCT00853112|3697033|FG003|STARTED|Overall Study||8
2981110|NCT00853112|3697034|FG004|STARTED|Overall Study||6
2981111|NCT00853112|3697035|FG005|STARTED|Overall Study||7
2981112|NCT00853112|3697036|FG006|STARTED|Overall Study||7
2981113|NCT00853112|3697030|FG000|Treated|Overall Study||6
2981114|NCT00853112|3697031|FG001|Treated|Overall Study||6
2981115|NCT00853112|3697032|FG002|Treated|Overall Study||7
2981116|NCT00853112|3697033|FG003|Treated|Overall Study||6
2981117|NCT00853112|3697034|FG004|Treated|Overall Study||6
2981118|NCT00853112|3697035|FG005|Treated|Overall Study||7
2981119|NCT00853112|3697036|FG006|Treated|Overall Study||6
2981120|NCT00853112|3697030|FG000|COMPLETED|Overall Study||6
2981121|NCT00853112|3697031|FG001|COMPLETED|Overall Study||6
2981122|NCT00853112|3697032|FG002|COMPLETED|Overall Study||7
2981123|NCT00853112|3697033|FG003|COMPLETED|Overall Study||6
2981124|NCT00853112|3697034|FG004|COMPLETED|Overall Study||6
2981125|NCT00853112|3697035|FG005|COMPLETED|Overall Study||7
2981126|NCT00853112|3697036|FG006|COMPLETED|Overall Study||6
2981127|NCT00853112|3697030|FG000|NOT COMPLETED|Overall Study||0
2981128|NCT00853112|3697031|FG001|NOT COMPLETED|Overall Study||1
2981129|NCT00853112|3697032|FG002|NOT COMPLETED|Overall Study||0
2981130|NCT00853112|3697033|FG003|NOT COMPLETED|Overall Study||2
2981131|NCT00853112|3697034|FG004|NOT COMPLETED|Overall Study||0
2981132|NCT00853112|3697035|FG005|NOT COMPLETED|Overall Study||0
2981133|NCT00853112|3697036|FG006|NOT COMPLETED|Overall Study||1
2981134|NCT00853125|3697052|FG000|STARTED|Overall Study||10
2981135|NCT00853125|3697052|FG000|COMPLETED|Overall Study||9
2981136|NCT00853125|3697052|FG000|NOT COMPLETED|Overall Study||1
2981137|NCT00853151|3697061|FG000|STARTED|Overall Study||38
2981138|NCT00853151|3697062|FG001|STARTED|Overall Study||37
2981139|NCT00853151|3697063|FG002|STARTED|Overall Study||38
2981140|NCT00853151|3697064|FG003|STARTED|Overall Study||18
2981141|NCT00853151|3697061|FG000|COMPLETED|Overall Study||28
2981142|NCT00853151|3697062|FG001|COMPLETED|Overall Study||24
2981143|NCT00853151|3697063|FG002|COMPLETED|Overall Study||30
2981144|NCT00853151|3697064|FG003|COMPLETED|Overall Study||15
2981145|NCT00853151|3697061|FG000|NOT COMPLETED|Overall Study||10
2981146|NCT00853151|3697062|FG001|NOT COMPLETED|Overall Study||13
2981147|NCT00853151|3697063|FG002|NOT COMPLETED|Overall Study||8
2981148|NCT00853151|3697064|FG003|NOT COMPLETED|Overall Study||3
2981149|NCT00853242|3697084|FG000|STARTED|Overall Study||50
2981150|NCT00853242|3697085|FG001|STARTED|Overall Study||50
2981151|NCT00853242|3697086|FG002|STARTED|Overall Study||49
2981152|NCT00853242|3697087|FG003|STARTED|Overall Study||50
2981153|NCT00853242|3697088|FG004|STARTED|Overall Study||50
2981154|NCT00853242|3697089|FG005|STARTED|Overall Study||51
2981155|NCT00853242|3697090|FG006|STARTED|Overall Study||49
2981156|NCT00853242|3697084|FG000|Treated|Overall Study||50
2981157|NCT00853242|3697085|FG001|Treated|Overall Study||49
2981158|NCT00853242|3697086|FG002|Treated|Overall Study||48
2981159|NCT00853242|3697087|FG003|Treated|Overall Study||50
2981160|NCT00853242|3697088|FG004|Treated|Overall Study||50
2981161|NCT00853242|3697089|FG005|Treated|Overall Study||51
2981162|NCT00853242|3697090|FG006|Treated|Overall Study||48
2981163|NCT00853242|3697084|FG000|COMPLETED|Overall Study||47
2981164|NCT00853242|3697085|FG001|COMPLETED|Overall Study||47
2981165|NCT00853242|3697086|FG002|COMPLETED|Overall Study||46
2981166|NCT00853242|3697087|FG003|COMPLETED|Overall Study||46
2981167|NCT00853242|3697088|FG004|COMPLETED|Overall Study||46
2981168|NCT00853242|3697089|FG005|COMPLETED|Overall Study||49
2981169|NCT00853242|3697090|FG006|COMPLETED|Overall Study||44
2981170|NCT00853242|3697084|FG000|NOT COMPLETED|Overall Study||3
2981171|NCT00853242|3697085|FG001|NOT COMPLETED|Overall Study||3
2981172|NCT00853242|3697086|FG002|NOT COMPLETED|Overall Study||3
2981173|NCT00853242|3697087|FG003|NOT COMPLETED|Overall Study||4
2981174|NCT00853242|3697088|FG004|NOT COMPLETED|Overall Study||4
2981175|NCT00853242|3697089|FG005|NOT COMPLETED|Overall Study||2
2981176|NCT00853242|3697090|FG006|NOT COMPLETED|Overall Study||5
2981177|NCT00853307|3697114|FG000|STARTED|Overall Study||6
2981178|NCT00853307|3697115|FG001|STARTED|Overall Study||25
2981179|NCT00853307|3697114|FG000|COMPLETED|Overall Study|Completed = participants who completed the study treatment.|4
3303303|NCT02966015|4036632|FG001|STARTED|Test Period||55
2981180|NCT00853307|3697115|FG001|COMPLETED|Overall Study||20
2981181|NCT00853307|3697114|FG000|NOT COMPLETED|Overall Study||2
2981182|NCT00853307|3697115|FG001|NOT COMPLETED|Overall Study||5
2981183|NCT00853333|3697124|FG000|STARTED|Overall Study||28
2981184|NCT00853333|3697125|FG001|STARTED|Overall Study||27
2981185|NCT00853333|3697126|FG002|STARTED|Overall Study||31
2981186|NCT00853333|3697124|FG000|COMPLETED|Overall Study||28
2981187|NCT00853333|3697125|FG001|COMPLETED|Overall Study||27
2981188|NCT00853333|3697126|FG002|COMPLETED|Overall Study||31
2981189|NCT00853333|3697124|FG000|NOT COMPLETED|Overall Study||0
3303304|NCT02966015|4036631|FG000|COMPLETED|Test Period||87
3303305|NCT02966015|4036632|FG001|COMPLETED|Test Period||55
3303306|NCT02966015|4036631|FG000|NOT COMPLETED|Test Period||0
3303307|NCT02966015|4036632|FG001|NOT COMPLETED|Test Period||0
3303308|NCT02966028|4036641|FG000|STARTED|Overall Study||92
3303309|NCT02966028|4036642|FG001|STARTED|Overall Study||91
3303310|NCT02966028|4036643|FG002|STARTED|Overall Study||91
3303311|NCT02966028|4036641|FG000|COMPLETED|Overall Study||68
3303312|NCT02966028|4036642|FG001|COMPLETED|Overall Study||57
3303313|NCT02966028|4036643|FG002|COMPLETED|Overall Study||60
2981190|NCT00853333|3697125|FG001|NOT COMPLETED|Overall Study||0
2981191|NCT00853333|3697126|FG002|NOT COMPLETED|Overall Study||0
2981192|NCT00853372|3697136|FG000|STARTED|Overall Study||43
2981193|NCT00853372|3697137|FG001|STARTED|Overall Study||42
2981194|NCT00853372|3697136|FG000|COMPLETED|Overall Study||11
2981195|NCT00853372|3697137|FG001|COMPLETED|Overall Study||13
2981196|NCT00853372|3697136|FG000|NOT COMPLETED|Overall Study||32
2981197|NCT00853372|3697137|FG001|NOT COMPLETED|Overall Study||29
2981198|NCT00853385|3697148|FG000|STARTED|Overall Study||204
2981199|NCT00853385|3697149|FG001|STARTED|Overall Study||201
2981200|NCT00853385|3697150|FG002|STARTED|Overall Study||56
2981201|NCT00853385|3697151|FG003|STARTED|Overall Study||52
2981202|NCT00853385|3697152|FG004|STARTED|Overall Study||204
2981203|NCT00853385|3697148|FG000|COMPLETED|Overall Study||150
2981204|NCT00853385|3697149|FG001|COMPLETED|Overall Study||158
2981205|NCT00853385|3697150|FG002|COMPLETED|Overall Study||47
2981206|NCT00853385|3697151|FG003|COMPLETED|Overall Study||39
2981207|NCT00853385|3697152|FG004|COMPLETED|Overall Study||162
2981208|NCT00853385|3697148|FG000|NOT COMPLETED|Overall Study||54
2981209|NCT00853385|3697149|FG001|NOT COMPLETED|Overall Study||43
2981210|NCT00853385|3697150|FG002|NOT COMPLETED|Overall Study||9
2981211|NCT00853385|3697151|FG003|NOT COMPLETED|Overall Study||13
2981212|NCT00853385|3697152|FG004|NOT COMPLETED|Overall Study||42
2981213|NCT00853489|3697176|FG000|STARTED|Overall Study||16
2981214|NCT00853489|3697177|FG001|STARTED|Overall Study||14
2981215|NCT00853489|3697176|FG000|COMPLETED|Overall Study||11
2981216|NCT00853489|3697177|FG001|COMPLETED|Overall Study||12
2981217|NCT00853489|3697176|FG000|NOT COMPLETED|Overall Study||5
2981218|NCT00853489|3697177|FG001|NOT COMPLETED|Overall Study||2
2981219|NCT00853580|3697185|FG000|STARTED|Overall Study||74
2981220|NCT00853580|3697186|FG001|STARTED|Overall Study||72
2981221|NCT00853580|3697185|FG000|COMPLETED|Overall Study||67
2981222|NCT00853580|3697186|FG001|COMPLETED|Overall Study||56
2981223|NCT00853580|3697185|FG000|NOT COMPLETED|Overall Study||7
2981224|NCT00853580|3697186|FG001|NOT COMPLETED|Overall Study||16
2981225|NCT00853593|3697192|FG000|STARTED|Overall Study||197
2981226|NCT00853593|3697192|FG000|Implant Attempted|Overall Study||193
2981227|NCT00853593|3697192|FG000|Model 4396 Lead Attempted|Overall Study||164
2981228|NCT00853593|3697192|FG000|COMPLETED|Overall Study||152
2981229|NCT00853593|3697192|FG000|NOT COMPLETED|Overall Study||45
2981230|NCT00853606|3697213|FG000|STARTED|Overall Study||712
2981231|NCT00853606|3697213|FG000|COMPLETED|Overall Study||492
2981232|NCT00853606|3697213|FG000|NOT COMPLETED|Overall Study||220
2981233|NCT00853645|3697217|FG000|STARTED|Overall Study||6
2981234|NCT00853645|3697217|FG000|COMPLETED|Overall Study||6
2981235|NCT00853645|3697217|FG000|NOT COMPLETED|Overall Study||0
2981236|NCT00853658|3697224|FG000|STARTED|Overall Study||2354
2981237|NCT00853658|3697225|FG001|STARTED|Overall Study||2356
2981238|NCT00853658|3697226|FG002|STARTED|Overall Study||2354
2981239|NCT00853658|3697224|FG000|Full Analysis Set (FAS)|Overall Study||2340
2981240|NCT00853658|3697225|FG001|Full Analysis Set (FAS)|Overall Study||2340
2981241|NCT00853658|3697226|FG002|Full Analysis Set (FAS)|Overall Study||2336
2981242|NCT00853658|3697224|FG000|Safety Set|Overall Study||2347
2981243|NCT00853658|3697225|FG001|Safety Set|Overall Study||2348
2981244|NCT00853658|3697226|FG002|Safety Set|Overall Study||2345
2981245|NCT00853658|3697224|FG000|COMPLETED|Overall Study||1567
2981246|NCT00853658|3697225|FG001|COMPLETED|Overall Study||1524
2981247|NCT00853658|3697226|FG002|COMPLETED|Overall Study||1539
2981248|NCT00853658|3697224|FG000|NOT COMPLETED|Overall Study||787
2981249|NCT00853658|3697225|FG001|NOT COMPLETED|Overall Study||832
2981250|NCT00853658|3697226|FG002|NOT COMPLETED|Overall Study||815
2981251|NCT00853671|3697234|FG000|STARTED|Overall Study||50
2981252|NCT00853671|3697234|FG000|COMPLETED|Overall Study||50
2981253|NCT00853671|3697234|FG000|NOT COMPLETED|Overall Study||0
2981254|NCT00853723|3697241|FG000|STARTED|Overall Study||35
2981255|NCT00853723|3697242|FG001|STARTED|Overall Study||35
2981256|NCT00853723|3697243|FG002|STARTED|Overall Study||35
2981257|NCT00853723|3697241|FG000|COMPLETED|Overall Study||29
2981258|NCT00853723|3697242|FG001|COMPLETED|Overall Study||28
2981259|NCT00853723|3697243|FG002|COMPLETED|Overall Study||33
2981260|NCT00853723|3697241|FG000|NOT COMPLETED|Overall Study||6
2981261|NCT00853723|3697242|FG001|NOT COMPLETED|Overall Study||7
2981262|NCT00853723|3697243|FG002|NOT COMPLETED|Overall Study||2
2981263|NCT00853749|3697256|FG000|STARTED|Overall Study||50
2981264|NCT00853749|3697257|FG001|STARTED|Overall Study||39
2981265|NCT00853749|3697256|FG000|Vaccinated|Overall Study||50
2981266|NCT00853749|3697257|FG001|Vaccinated|Overall Study||39
2981267|NCT00853749|3697256|FG000|COMPLETED|Overall Study||50
2981268|NCT00853749|3697257|FG001|COMPLETED|Overall Study||38
2981269|NCT00853749|3697256|FG000|NOT COMPLETED|Overall Study||0
2981270|NCT00853749|3697257|FG001|NOT COMPLETED|Overall Study||1
2981271|NCT00853762|3697267|FG000|STARTED|Overall Study||16
2981272|NCT00853762|3697268|FG001|STARTED|Overall Study||19
2981273|NCT00853762|3697269|FG002|STARTED|Overall Study||17
2981274|NCT00853762|3697270|FG003|STARTED|Overall Study||22
2981275|NCT00853762|3697267|FG000|COMPLETED|Overall Study||0
2981276|NCT00853762|3697268|FG001|COMPLETED|Overall Study||0
2981277|NCT00853762|3697269|FG002|COMPLETED|Overall Study||0
2981278|NCT00853762|3697270|FG003|COMPLETED|Overall Study||0
2981279|NCT00853762|3697267|FG000|NOT COMPLETED|Overall Study||16
2981280|NCT00853762|3697268|FG001|NOT COMPLETED|Overall Study||19
2981281|NCT00853762|3697269|FG002|NOT COMPLETED|Overall Study||17
2981282|NCT00853762|3697270|FG003|NOT COMPLETED|Overall Study||22
3133400|NCT01695239|3858316|FG011|NOT COMPLETED|Post-Treatment Follow-Up Period||1
3133401|NCT01695239|3858317|FG012|NOT COMPLETED|Post-Treatment Follow-Up Period||9
3133402|NCT01695239|3858318|FG013|NOT COMPLETED|Post-Treatment Follow-Up Period||5
2981283|NCT00853827|3697282|FG000|STARTED|Single Blind Period (1 Week)|Enrolled patients in single blind|652
2981284|NCT00853827|3697283|FG001|STARTED|Single Blind Period (1 Week)|This arm was only used in double blind period|0
2981285|NCT00853827|3697282|FG000|COMPLETED|Single Blind Period (1 Week)|Completed patients in single blind period|613
2981286|NCT00853827|3697283|FG001|COMPLETED|Single Blind Period (1 Week)||0
2981287|NCT00853827|3697282|FG000|NOT COMPLETED|Single Blind Period (1 Week)||39
2981288|NCT00853827|3697283|FG001|NOT COMPLETED|Single Blind Period (1 Week)||0
2981289|NCT00853827|3697282|FG000|STARTED|Double Blind Period (103 Weeks)|"Started indicates number of patients in randomized set, full analysis set (FAS) and safety set."|305
2981290|NCT00853827|3697283|FG001|STARTED|Double Blind Period (103 Weeks)||308
2981291|NCT00853827|3697282|FG000|Modified Full Analysis Set (mFAS)|Double Blind Period (103 Weeks)||225
2981292|NCT00853827|3697283|FG001|Modified Full Analysis Set (mFAS)|Double Blind Period (103 Weeks)||233
2981293|NCT00853827|3697282|FG000|COMPLETED|Double Blind Period (103 Weeks)||201
2981294|NCT00853827|3697283|FG001|COMPLETED|Double Blind Period (103 Weeks)||199
2981295|NCT00853827|3697282|FG000|NOT COMPLETED|Double Blind Period (103 Weeks)||104
2981296|NCT00853827|3697283|FG001|NOT COMPLETED|Double Blind Period (103 Weeks)||109
2981297|NCT00853840|3697289|FG000|STARTED|Period 1||9
2981298|NCT00853840|3697290|FG001|STARTED|Period 1||9
2981299|NCT00853840|3697289|FG000|Maraviroc (Days 1 - 4)|Period 1||9
2981300|NCT00853840|3697290|FG001|Maraviroc (Days 1 - 4)|Period 1||9
2981301|NCT00853840|3697289|FG000|Vardenafil or Placebo (Day 4)|Period 1|Administered 1 hour post Maraviroc dosing|9
2981302|NCT00853840|3697290|FG001|Vardenafil or Placebo (Day 4)|Period 1|Administered 1 hour post Maraviroc dosing|9
2981303|NCT00853840|3697289|FG000|COMPLETED|Period 1||9
2981304|NCT00853840|3697290|FG001|COMPLETED|Period 1||9
2981305|NCT00853840|3697289|FG000|NOT COMPLETED|Period 1||0
2981306|NCT00853840|3697290|FG001|NOT COMPLETED|Period 1||0
2981307|NCT00853840|3697289|FG000|STARTED|Period 2||9
2981308|NCT00853840|3697290|FG001|STARTED|Period 2||9
2981309|NCT00853840|3697289|FG000|Maraviroc (Days 1 - 3)|Period 2||9
2981310|NCT00853840|3697290|FG001|Maraviroc (Days 1 - 3)|Period 2||9
2981311|NCT00853840|3697289|FG000|Vardenafil or Placebo (Day 3)|Period 2|Administered 1 hour post Maraviroc dosing|9
2981312|NCT00853840|3697290|FG001|Vardenafil or Placebo (Day 3)|Period 2|Administered 1 hour post Maraviroc dosing|9
2981313|NCT00853840|3697289|FG000|COMPLETED|Period 2||9
2981314|NCT00853840|3697290|FG001|COMPLETED|Period 2||9
2981315|NCT00853840|3697289|FG000|NOT COMPLETED|Period 2||0
2981316|NCT00853840|3697290|FG001|NOT COMPLETED|Period 2||0
2981317|NCT00853905|3697299|FG000|STARTED|Overall Study||37
2981318|NCT00853905|3697300|FG001|STARTED|Overall Study||40
2981319|NCT00853905|3697299|FG000|COMPLETED|Overall Study||35
2981320|NCT00853905|3697300|FG001|COMPLETED|Overall Study||36
2981321|NCT00853905|3697299|FG000|NOT COMPLETED|Overall Study||2
2981322|NCT00853905|3697300|FG001|NOT COMPLETED|Overall Study||4
2981323|NCT00853957|3697311|FG000|STARTED|Overall Study||220
2981324|NCT00853957|3697312|FG001|STARTED|Overall Study||223
2981325|NCT00853957|3697311|FG000|COMPLETED|Overall Study||206
2981326|NCT00853957|3697312|FG001|COMPLETED|Overall Study||204
2981327|NCT00853957|3697311|FG000|NOT COMPLETED|Overall Study||14
2981328|NCT00853957|3697312|FG001|NOT COMPLETED|Overall Study||19
2981329|NCT00853970|3697320|FG000|STARTED|Overall Study||152
2981330|NCT00853970|3697321|FG001|STARTED|Overall Study||147
2981331|NCT00853970|3697320|FG000|COMPLETED|Overall Study||146
2981332|NCT00853970|3697321|FG001|COMPLETED|Overall Study||144
2981333|NCT00853970|3697320|FG000|NOT COMPLETED|Overall Study||6
2981334|NCT00853970|3697321|FG001|NOT COMPLETED|Overall Study||3
3133403|NCT01695291|3858342|FG000|STARTED|Overall Study||10
3133404|NCT01695291|3858343|FG001|STARTED|Overall Study||21
3133405|NCT01695291|3858342|FG000|COMPLETED|Overall Study||8
3133406|NCT01695291|3858343|FG001|COMPLETED|Overall Study||14
3133407|NCT01695291|3858342|FG000|NOT COMPLETED|Overall Study||2
3133408|NCT01695291|3858343|FG001|NOT COMPLETED|Overall Study||7
3133409|NCT01695304|3858351|FG000|STARTED|Overall Study||120
3133410|NCT01695304|3858352|FG001|STARTED|Overall Study||120
2981335|NCT00853996|3697327|FG000|STARTED|Overall Study||25
2981336|NCT00853996|3697327|FG000|COMPLETED|Overall Study||25
2981337|NCT00853996|3697327|FG000|NOT COMPLETED|Overall Study||0
2981338|NCT00854061|3697331|FG000|STARTED|Overall Study||172
2981339|NCT00854061|3697331|FG000|Completed 1st Surgery (T-PRED in One Eye and Pred Forte in the Other Eye)|Overall Study||162
2981340|NCT00854061|3697331|FG000|Completed 2nd Surgery (T-PRED and Pred Forte in Opposite Eyes Compared to 1st Surgery)|Overall Study||149
2981341|NCT00854061|3697331|FG000|COMPLETED|Overall Study||149
2981342|NCT00854061|3697331|FG000|NOT COMPLETED|Overall Study||23
2981343|NCT00854087|3697339|FG000|STARTED|Overall Study||59
2981344|NCT00854087|3697340|FG001|STARTED|Overall Study||59
2981345|NCT00854087|3697339|FG000|COMPLETED|Overall Study||40
2981346|NCT00854087|3697340|FG001|COMPLETED|Overall Study||40
2981347|NCT00854087|3697339|FG000|NOT COMPLETED|Overall Study||19
2981348|NCT00854087|3697340|FG001|NOT COMPLETED|Overall Study||19
2981349|NCT00854100|3697349|FG000|STARTED|Overall Study||81
2981350|NCT00854100|3697350|FG001|STARTED|Overall Study||76
2981351|NCT00854100|3697351|FG002|STARTED|Overall Study||74
2981352|NCT00854100|3697349|FG000|COMPLETED|Overall Study||72
2981353|NCT00854100|3697350|FG001|COMPLETED|Overall Study||70
2981354|NCT00854100|3697351|FG002|COMPLETED|Overall Study||63
2981355|NCT00854100|3697349|FG000|NOT COMPLETED|Overall Study||9
2981356|NCT00854100|3697350|FG001|NOT COMPLETED|Overall Study||6
2981357|NCT00854100|3697351|FG002|NOT COMPLETED|Overall Study||11
2981358|NCT00854113|3697371|FG000|STARTED|Overall Study||6
2981359|NCT00854113|3697372|FG001|STARTED|Overall Study||6
2981360|NCT00854113|3697373|FG002|STARTED|Overall Study||6
2981361|NCT00854113|3697374|FG003|STARTED|Overall Study||6
2981362|NCT00854113|3697375|FG004|STARTED|Overall Study||6
2981363|NCT00854113|3697376|FG005|STARTED|Overall Study||6
2981364|NCT00854113|3697377|FG006|STARTED|Overall Study||12
2981365|NCT00854113|3697378|FG007|STARTED|Overall Study||8
2981366|NCT00854113|3697379|FG008|STARTED|Overall Study||8
2981367|NCT00854113|3697380|FG009|STARTED|Overall Study||8
2981368|NCT00854113|3697381|FG010|STARTED|Overall Study||6
2981369|NCT00854113|3697371|FG000|COMPLETED|Overall Study||6
2981370|NCT00854113|3697372|FG001|COMPLETED|Overall Study||6
2981371|NCT00854113|3697373|FG002|COMPLETED|Overall Study||6
2981372|NCT00854113|3697374|FG003|COMPLETED|Overall Study||6
2981373|NCT00854113|3697375|FG004|COMPLETED|Overall Study||6
2981374|NCT00854113|3697376|FG005|COMPLETED|Overall Study||6
2981375|NCT00854113|3697377|FG006|COMPLETED|Overall Study||12
2981376|NCT00854113|3697378|FG007|COMPLETED|Overall Study||5
2981377|NCT00854113|3697379|FG008|COMPLETED|Overall Study||7
2981378|NCT00854113|3697380|FG009|COMPLETED|Overall Study||8
2981379|NCT00854113|3697381|FG010|COMPLETED|Overall Study||6
2981380|NCT00854113|3697371|FG000|NOT COMPLETED|Overall Study||0
2981381|NCT00854113|3697372|FG001|NOT COMPLETED|Overall Study||0
2981382|NCT00854113|3697373|FG002|NOT COMPLETED|Overall Study||0
2981383|NCT00854113|3697374|FG003|NOT COMPLETED|Overall Study||0
2981384|NCT00854113|3697375|FG004|NOT COMPLETED|Overall Study||0
2981385|NCT00854113|3697376|FG005|NOT COMPLETED|Overall Study||0
2981386|NCT00854113|3697377|FG006|NOT COMPLETED|Overall Study||0
2981387|NCT00854113|3697378|FG007|NOT COMPLETED|Overall Study||3
2981388|NCT00854113|3697379|FG008|NOT COMPLETED|Overall Study||1
2981389|NCT00854113|3697380|FG009|NOT COMPLETED|Overall Study||0
2981390|NCT00854113|3697381|FG010|NOT COMPLETED|Overall Study||0
2981391|NCT00854308|3697407|FG000|STARTED|Overall Study||69
2981392|NCT00854308|3697408|FG001|STARTED|Overall Study||68
2981393|NCT00854308|3697407|FG000|Received Study Drug|Overall Study||69
2981394|NCT00854308|3697408|FG001|Received Study Drug|Overall Study||67
2981395|NCT00854308|3697407|FG000|COMPLETED|Overall Study|Completed participants in both arms were still receiving study drug when analyses were performed.|7
2981396|NCT00854308|3697408|FG001|COMPLETED|Overall Study||1
2981397|NCT00854308|3697407|FG000|NOT COMPLETED|Overall Study||62
2981398|NCT00854308|3697408|FG001|NOT COMPLETED|Overall Study||67
2981399|NCT00854360|3697418|FG000|STARTED|Overall Study||118
2981400|NCT00854360|3697419|FG001|STARTED|Overall Study||123
2981401|NCT00854360|3697420|FG002|STARTED|Overall Study||122
2981402|NCT00854360|3697421|FG003|STARTED|Overall Study||124
2981403|NCT00854360|3697418|FG000|Intent to Treat / Safety Population|Overall Study||118
2981404|NCT00854360|3697419|FG001|Intent to Treat / Safety Population|Overall Study||123
2981405|NCT00854360|3697420|FG002|Intent to Treat / Safety Population|Overall Study||122
2981406|NCT00854360|3697421|FG003|Intent to Treat / Safety Population|Overall Study|One patient did not receive any double-blind study medication.|123
2981407|NCT00854360|3697418|FG000|COMPLETED|Overall Study||116
2981408|NCT00854360|3697419|FG001|COMPLETED|Overall Study|One patient discontinued due to both an AE and study medication discontinuation.|120
2981409|NCT00854360|3697420|FG002|COMPLETED|Overall Study||120
2981410|NCT00854360|3697421|FG003|COMPLETED|Overall Study||114
2981411|NCT00854360|3697418|FG000|NOT COMPLETED|Overall Study||2
2981412|NCT00854360|3697419|FG001|NOT COMPLETED|Overall Study||3
2981413|NCT00854360|3697420|FG002|NOT COMPLETED|Overall Study||2
2981414|NCT00854360|3697421|FG003|NOT COMPLETED|Overall Study||10
2981415|NCT00854373|3697433|FG000|STARTED|Overall Study||95
2981416|NCT00854373|3697434|FG001|STARTED|Overall Study||93
2981417|NCT00854373|3697433|FG000|COMPLETED|Overall Study||93
2981418|NCT00854373|3697434|FG001|COMPLETED|Overall Study||89
2981419|NCT00854373|3697433|FG000|NOT COMPLETED|Overall Study||2
2981420|NCT00854373|3697434|FG001|NOT COMPLETED|Overall Study||4
2981421|NCT00854581|3697440|FG000|STARTED|Induction (Up to Day 21)||13
2981422|NCT00854581|3697440|FG000|COMPLETED|Induction (Up to Day 21)||7
2981423|NCT00854581|3697440|FG000|NOT COMPLETED|Induction (Up to Day 21)||6
2981424|NCT00854581|3697440|FG000|STARTED|Part 1 Maintenance (Up to Day 60)||7
2981425|NCT00854581|3697440|FG000|COMPLETED|Part 1 Maintenance (Up to Day 60)||5
2981426|NCT00854581|3697440|FG000|NOT COMPLETED|Part 1 Maintenance (Up to Day 60)||2
2981427|NCT00854581|3697440|FG000|STARTED|Part 2 Maintenance (Up to 12 Months)||5
2981428|NCT00854581|3697440|FG000|COMPLETED|Part 2 Maintenance (Up to 12 Months)||2
2981429|NCT00854581|3697440|FG000|NOT COMPLETED|Part 2 Maintenance (Up to 12 Months)||3
2981430|NCT00854594|3697451|FG000|STARTED|Overall Study|9 sites randomized to control arm, providers completed surveys before and/or after study period|48
2981431|NCT00854594|3697452|FG001|STARTED|Overall Study|9 sites randomized to intervention, providers completed surveys before and/or after study period|69
2981432|NCT00854594|3697451|FG000|COMPLETED|Overall Study||48
2981433|NCT00854594|3697452|FG001|COMPLETED|Overall Study||69
2981434|NCT00854594|3697451|FG000|NOT COMPLETED|Overall Study||0
2981435|NCT00854594|3697452|FG001|NOT COMPLETED|Overall Study||0
2981436|NCT00854607|3697458|FG000|STARTED|Enrollment||116
2981437|NCT00854607|3697458|FG000|COMPLETED|Enrollment||116
2981438|NCT00854607|3697458|FG000|NOT COMPLETED|Enrollment||0
2981439|NCT00854607|3697458|FG000|STARTED|2 Weeks After Start Anti-fungal Therapy||116
2981440|NCT00854607|3697458|FG000|COMPLETED|2 Weeks After Start Anti-fungal Therapy||51
2981441|NCT00854607|3697458|FG000|NOT COMPLETED|2 Weeks After Start Anti-fungal Therapy||65
2981442|NCT00854620|3697469|FG000|STARTED|Overall Study||9
2981443|NCT00854620|3697469|FG000|COMPLETED|Overall Study||8
2981444|NCT00854620|3697469|FG000|NOT COMPLETED|Overall Study||1
2981445|NCT00854724|3697475|FG000|STARTED|First Intervention||8
2981446|NCT00854724|3697476|FG001|STARTED|First Intervention||8
2981447|NCT00854724|3697475|FG000|COMPLETED|First Intervention||7
2981448|NCT00854724|3697476|FG001|COMPLETED|First Intervention||7
2981449|NCT00854724|3697475|FG000|NOT COMPLETED|First Intervention||1
2981450|NCT00854724|3697476|FG001|NOT COMPLETED|First Intervention||1
2981451|NCT00854724|3697475|FG000|STARTED|Washout||7
2981452|NCT00854724|3697476|FG001|STARTED|Washout||7
2981453|NCT00854724|3697475|FG000|COMPLETED|Washout||6
2981454|NCT00854724|3697476|FG001|COMPLETED|Washout||6
2981455|NCT00854724|3697475|FG000|NOT COMPLETED|Washout||1
2981456|NCT00854724|3697476|FG001|NOT COMPLETED|Washout||1
2981457|NCT00854724|3697475|FG000|STARTED|Second Intervention||6
2981458|NCT00854724|3697476|FG001|STARTED|Second Intervention||6
2981459|NCT00854724|3697475|FG000|COMPLETED|Second Intervention||5
2981460|NCT00854724|3697476|FG001|COMPLETED|Second Intervention||5
2981461|NCT00854724|3697475|FG000|NOT COMPLETED|Second Intervention||1
2981462|NCT00854724|3697476|FG001|NOT COMPLETED|Second Intervention||1
2981463|NCT00854828|3697486|FG000|STARTED|Overall Study|6 patients crossed over to non-operative intervention.|30
2981464|NCT00854828|3697487|FG001|STARTED|Overall Study||33
2981465|NCT00854828|3697488|FG002|STARTED|Overall Study||112
2981466|NCT00854828|3697489|FG003|STARTED|Overall Study||111
2981467|NCT00854828|3697486|FG000|3 Months Post Intervention|Overall Study|6 missed visits|24
2981468|NCT00854828|3697487|FG001|3 Months Post Intervention|Overall Study|1 missed visit|32
2981469|NCT00854828|3697488|FG002|3 Months Post Intervention|Overall Study|112 (100%) of patients underwent operative treatment.|112
2981470|NCT00854828|3697489|FG003|3 Months Post Intervention|Overall Study|2 missed visits. 3 withdrew.|106
2981471|NCT00854828|3697486|FG000|12 Months Post Intervention|Overall Study|"2 missed visits.~1 withdrew.~1 deceased."|26
2981472|NCT00854828|3697487|FG001|12 Months Post Intervention|Overall Study|1 withdrew. 15 (45%) crossed over to operative treatment.|32
2981473|NCT00854828|3697488|FG002|12 Months Post Intervention|Overall Study||112
2981474|NCT00854828|3697489|FG003|12 Months Post Intervention|Overall Study|4 missed visits. 6 withdrew. 6 (5%) crossed over to operative treatment.|101
2981475|NCT00854828|3697486|FG000|24 Months Post Intervention|Overall Study|"1 missed visit.~1 withdrew.~1 deceased. 24 patients (80%) underwent surgery."|27
2981476|NCT00854828|3697487|FG001|24 Months Post Intervention|Overall Study|"1 missed visit.~1 withdrew. 21 (64%) crossed over to operative treatment."|31
2981477|NCT00854828|3697488|FG002|24 Months Post Intervention|Overall Study|8 missed visits.|104
2981478|NCT00854828|3697489|FG003|24 Months Post Intervention|Overall Study|8 missed visits. 9 withdrew. 14 (13%) crossed over to operative treatment.|94
2981479|NCT00854828|3697486|FG000|COMPLETED|Overall Study||27
2981480|NCT00854828|3697487|FG001|COMPLETED|Overall Study||31
2981481|NCT00854828|3697488|FG002|COMPLETED|Overall Study||104
2981482|NCT00854828|3697489|FG003|COMPLETED|Overall Study||94
2981483|NCT00854828|3697486|FG000|NOT COMPLETED|Overall Study||3
2981484|NCT00854828|3697487|FG001|NOT COMPLETED|Overall Study||2
2981485|NCT00854828|3697488|FG002|NOT COMPLETED|Overall Study||8
2981486|NCT00854828|3697489|FG003|NOT COMPLETED|Overall Study||17
2981487|NCT00854906|3697499|FG000|STARTED|Overall Study|There were 26 participants whose eyes were measured in the KTBUT group.|26
2981488|NCT00854906|3697499|FG000|COMPLETED|Overall Study|There were 26 participants in this group. One person was excluded be causes of no ocular history.|25
2981489|NCT00854906|3697499|FG000|NOT COMPLETED|Overall Study||1
2981490|NCT00855010|3697508|FG000|STARTED|Overall Study||23
2981491|NCT00855010|3697509|FG001|STARTED|Overall Study||19
2981492|NCT00855010|3697508|FG000|COMPLETED|Overall Study||19
2981493|NCT00855010|3697509|FG001|COMPLETED|Overall Study||18
2981494|NCT00855010|3697508|FG000|NOT COMPLETED|Overall Study||4
2981495|NCT00855010|3697509|FG001|NOT COMPLETED|Overall Study||1
2981496|NCT00855062|3697521|FG000|STARTED|Step1||36
2981497|NCT00855062|3697522|FG001|STARTED|Step1||37
2981498|NCT00855062|3697521|FG000|COMPLETED|Step1||26
2981499|NCT00855062|3697522|FG001|COMPLETED|Step1||26
2981500|NCT00855062|3697521|FG000|NOT COMPLETED|Step1||10
2981501|NCT00855062|3697522|FG001|NOT COMPLETED|Step1||11
2981502|NCT00855062|3697521|FG000|STARTED|Step2|26 participants completed STEP1; however, only 19 out of the 26 decided to enroll in STEP2.|19
2981503|NCT00855062|3697522|FG001|STARTED|Step2|26 participants completed STEP1; however, only 21 out of the 26 decided to enroll in STEP2.|21
2981504|NCT00855062|3697521|FG000|COMPLETED|Step2||13
2981505|NCT00855062|3697522|FG001|COMPLETED|Step2||15
2981506|NCT00855062|3697521|FG000|NOT COMPLETED|Step2||6
2981507|NCT00855062|3697522|FG001|NOT COMPLETED|Step2||6
2981508|NCT00855166|3697530|FG000|STARTED|Overall Study||91
2981509|NCT00855166|3697531|FG001|STARTED|Overall Study|Of the 91 randomized participants only 89 were included in the full analysis set.|91
2981510|NCT00855166|3697530|FG000|COMPLETED|Overall Study||86
2981511|NCT00855166|3697531|FG001|COMPLETED|Overall Study||83
2981512|NCT00855166|3697530|FG000|NOT COMPLETED|Overall Study||5
2981513|NCT00855166|3697531|FG001|NOT COMPLETED|Overall Study||8
2981514|NCT00855218|3697541|FG000|STARTED|Overall Study||154
2981515|NCT00855218|3697542|FG001|STARTED|Overall Study||153
2981516|NCT00855218|3697541|FG000|Participants Received Treatment|Overall Study||153
2981517|NCT00855218|3697542|FG001|Participants Received Treatment|Overall Study||151
2981518|NCT00855218|3697541|FG000|COMPLETED|Overall Study||0
2981519|NCT00855218|3697542|FG001|COMPLETED|Overall Study||0
2981520|NCT00855218|3697541|FG000|NOT COMPLETED|Overall Study||154
2981521|NCT00855218|3697542|FG001|NOT COMPLETED|Overall Study||153
2981522|NCT00855309|3697550|FG000|STARTED|Overall Study||57
2981523|NCT00855309|3697551|FG001|STARTED|Overall Study||55
2981524|NCT00855309|3697550|FG000|COMPLETED|Overall Study||56
2981525|NCT00855309|3697551|FG001|COMPLETED|Overall Study||55
2981526|NCT00855309|3697550|FG000|NOT COMPLETED|Overall Study||1
2981527|NCT00855309|3697551|FG001|NOT COMPLETED|Overall Study||0
2981528|NCT00855335|3697562|FG000|STARTED|Overall Study||18
2981529|NCT00855335|3697563|FG001|STARTED|Overall Study||18
2981530|NCT00855335|3697564|FG002|STARTED|Overall Study||15
2981531|NCT00855335|3697565|FG003|STARTED|Overall Study||19
2981532|NCT00855335|3697566|FG004|STARTED|Overall Study||7
2981533|NCT00855335|3697562|FG000|COMPLETED|Overall Study||13
2981534|NCT00855335|3697563|FG001|COMPLETED|Overall Study||16
2981535|NCT00855335|3697564|FG002|COMPLETED|Overall Study||10
2981536|NCT00855335|3697565|FG003|COMPLETED|Overall Study||12
2981537|NCT00855335|3697566|FG004|COMPLETED|Overall Study||6
2981538|NCT00855335|3697562|FG000|NOT COMPLETED|Overall Study||5
2981539|NCT00855335|3697563|FG001|NOT COMPLETED|Overall Study||2
2981540|NCT00855335|3697564|FG002|NOT COMPLETED|Overall Study||5
2981541|NCT00855335|3697565|FG003|NOT COMPLETED|Overall Study||7
2981542|NCT00855335|3697566|FG004|NOT COMPLETED|Overall Study||1
2981543|NCT00855413|3697591|FG000|STARTED|Overall Study||15
2981544|NCT00855413|3697591|FG000|COMPLETED|Overall Study||15
2981545|NCT00855413|3697591|FG000|NOT COMPLETED|Overall Study||0
2981546|NCT00855439|3697597|FG000|STARTED|Overall Study||22
2981547|NCT00855439|3697598|FG001|STARTED|Overall Study||24
2981548|NCT00855439|3697597|FG000|COMPLETED|Overall Study||19
2981549|NCT00855439|3697598|FG001|COMPLETED|Overall Study||24
3303314|NCT02966028|4036641|FG000|NOT COMPLETED|Overall Study||24
3303315|NCT02966028|4036642|FG001|NOT COMPLETED|Overall Study||34
3303316|NCT02966028|4036643|FG002|NOT COMPLETED|Overall Study||31
3303317|NCT02966275|4036655|FG000|STARTED|Overall Study||10
3303318|NCT02966275|4036655|FG000|COMPLETED|Overall Study||10
3303319|NCT02966275|4036655|FG000|NOT COMPLETED|Overall Study||0
3303320|NCT02966314|4036664|FG000|STARTED|Overall Study||5
3303321|NCT02966314|4036665|FG001|STARTED|Overall Study||5
3303322|NCT02966314|4036664|FG000|COMPLETED|Overall Study||4
3303323|NCT02966314|4036665|FG001|COMPLETED|Overall Study||5
3303324|NCT02966314|4036664|FG000|NOT COMPLETED|Overall Study||1
3303325|NCT02966314|4036665|FG001|NOT COMPLETED|Overall Study||0
3303326|NCT02966340|4036671|FG000|STARTED|Overall Study||37
3303327|NCT02966340|4036672|FG001|STARTED|Overall Study||33
3303328|NCT02966340|4036671|FG000|COMPLETED|Overall Study||34
3303329|NCT02966340|4036672|FG001|COMPLETED|Overall Study||30
3303330|NCT02966340|4036671|FG000|NOT COMPLETED|Overall Study||3
3303331|NCT02966340|4036672|FG001|NOT COMPLETED|Overall Study||3
3303332|NCT02966353|4036678|FG000|STARTED|Overall Study||51
3303333|NCT02966353|4036678|FG000|Completed After Data Cutoff|Overall Study||1
3303334|NCT02966353|4036678|FG000|COMPLETED|Overall Study||29
2981550|NCT00855439|3697597|FG000|NOT COMPLETED|Overall Study||3
2981551|NCT00855439|3697598|FG001|NOT COMPLETED|Overall Study||0
2981552|NCT00855465|3697606|FG000|STARTED|Treatment Period||174
2981553|NCT00855465|3697607|FG001|STARTED|Treatment Period||88
2981554|NCT00855465|3697606|FG000|Participants Received Treatment|Treatment Period|1 subject randomized but not treated|173
2981555|NCT00855465|3697607|FG001|Participants Received Treatment|Treatment Period||88
2981556|NCT00855465|3697606|FG000|COMPLETED|Treatment Period||160
2981557|NCT00855465|3697607|FG001|COMPLETED|Treatment Period||83
2981558|NCT00855465|3697606|FG000|NOT COMPLETED|Treatment Period||14
2981559|NCT00855465|3697607|FG001|NOT COMPLETED|Treatment Period||5
2981560|NCT00855465|3697606|FG000|STARTED|Follow-up Period (FUP)|Started FUP only if prematurely withdrawn from trt period or if not entering LTE study.|17
2981561|NCT00855465|3697607|FG001|STARTED|Follow-up Period (FUP)|Started FUP only if prematurely withdrawn from trt period or if not entering LTE study.|4
2981562|NCT00855465|3697606|FG000|COMPLETED|Follow-up Period (FUP)||9
3164248|NCT01891864|3891710|FG004|STARTED|Treatment Period 2|"Part of the patients re-randomized from GP2015 Etanercept treatment arm in Treatment Period 1"|100
3171813|NCT01937312|3899017|FG000|NOT COMPLETED|Overall Study||11
3303335|NCT02966353|4036678|FG000|NOT COMPLETED|Overall Study||22
3164249|NCT01891864|3891711|FG005|STARTED|Treatment Period 2|"Part of the patients re-randomized from Enbrel ® Etanercept treatment arm in Treatment Period 1"|96
3164250|NCT01891864|3891706|FG000|COMPLETED|Treatment Period 2||0
3164251|NCT01891864|3891707|FG001|COMPLETED|Treatment Period 2||0
3164252|NCT01891864|3891708|FG002|COMPLETED|Treatment Period 2||143
3164253|NCT01891864|3891709|FG003|COMPLETED|Treatment Period 2||142
3164254|NCT01891864|3891710|FG004|COMPLETED|Treatment Period 2||96
3164255|NCT01891864|3891711|FG005|COMPLETED|Treatment Period 2||91
3164256|NCT01891864|3891706|FG000|NOT COMPLETED|Treatment Period 2||0
3164257|NCT01891864|3891707|FG001|NOT COMPLETED|Treatment Period 2||0
3164258|NCT01891864|3891708|FG002|NOT COMPLETED|Treatment Period 2||7
3164259|NCT01891864|3891709|FG003|NOT COMPLETED|Treatment Period 2||9
3164260|NCT01891864|3891710|FG004|NOT COMPLETED|Treatment Period 2||4
3164261|NCT01891864|3891711|FG005|NOT COMPLETED|Treatment Period 2||5
3164262|NCT01891864|3891706|FG000|STARTED|Extension Period||0
3164263|NCT01891864|3891707|FG001|STARTED|Extension Period||0
3164264|NCT01891864|3891708|FG002|STARTED|Extension Period|2 patients withdrew consent 1 patient lost to FU between Treatment Period 2 and the Extension period|140
3164265|NCT01891864|3891709|FG003|STARTED|Extension Period||142
3164266|NCT01891864|3891710|FG004|STARTED|Extension Period|1 patient discontinued between Treatment Period 2 and Extension Period due to lack of efficacy|95
3164267|NCT01891864|3891711|FG005|STARTED|Extension Period|1 patient discontinued between Treatment Period 2 and Extension Period due to an adverse event|90
3164268|NCT01891864|3891706|FG000|COMPLETED|Extension Period||0
3164269|NCT01891864|3891707|FG001|COMPLETED|Extension Period||0
3164270|NCT01891864|3891708|FG002|COMPLETED|Extension Period||132
3164271|NCT01891864|3891709|FG003|COMPLETED|Extension Period||137
3164272|NCT01891864|3891710|FG004|COMPLETED|Extension Period||88
3164273|NCT01891864|3891711|FG005|COMPLETED|Extension Period||90
3164274|NCT01891864|3891706|FG000|NOT COMPLETED|Extension Period||0
3164275|NCT01891864|3891707|FG001|NOT COMPLETED|Extension Period||0
3164276|NCT01891864|3891708|FG002|NOT COMPLETED|Extension Period||8
3164277|NCT01891864|3891709|FG003|NOT COMPLETED|Extension Period||5
3164278|NCT01891864|3891710|FG004|NOT COMPLETED|Extension Period||7
3164279|NCT01891864|3891711|FG005|NOT COMPLETED|Extension Period||0
3164280|NCT01891890|3891726|FG000|STARTED|Overall Study||24
3164281|NCT01891890|3891727|FG001|STARTED|Overall Study||27
3164282|NCT01891890|3891728|FG002|STARTED|Overall Study||21
3164283|NCT01891890|3891726|FG000|COMPLETED|Overall Study||17
3164284|NCT01891890|3891727|FG001|COMPLETED|Overall Study||24
3164285|NCT01891890|3891728|FG002|COMPLETED|Overall Study||14
3164286|NCT01891890|3891726|FG000|NOT COMPLETED|Overall Study||7
3164287|NCT01891890|3891727|FG001|NOT COMPLETED|Overall Study||3
3164288|NCT01891890|3891728|FG002|NOT COMPLETED|Overall Study||7
3164289|NCT01891968|3891736|FG000|STARTED|Overall Study||15
3164290|NCT01891968|3891736|FG000|COMPLETED|Overall Study||15
3164291|NCT01891968|3891736|FG000|NOT COMPLETED|Overall Study||0
3164292|NCT01891994|3891740|FG000|STARTED|Overall Study||40
3164293|NCT01891994|3891740|FG000|COMPLETED|Overall Study||40
3164294|NCT01891994|3891740|FG000|NOT COMPLETED|Overall Study||0
3164295|NCT01892007|3891746|FG000|STARTED|Overall Study||27
2981563|NCT00855465|3697607|FG001|COMPLETED|Follow-up Period (FUP)||2
2981564|NCT00855465|3697606|FG000|NOT COMPLETED|Follow-up Period (FUP)||8
2981565|NCT00855465|3697607|FG001|NOT COMPLETED|Follow-up Period (FUP)||2
2981566|NCT00855582|3697616|FG000|STARTED|Overall Study||198
2981567|NCT00855582|3697617|FG001|STARTED|Overall Study||208
2981568|NCT00855582|3697618|FG002|STARTED|Overall Study||200
2981569|NCT00855582|3697616|FG000|COMPLETED|Overall Study||172
2981570|NCT00855582|3697617|FG001|COMPLETED|Overall Study||184
2981571|NCT00855582|3697618|FG002|COMPLETED|Overall Study||170
2981572|NCT00855582|3697616|FG000|NOT COMPLETED|Overall Study||26
2981573|NCT00855582|3697617|FG001|NOT COMPLETED|Overall Study||24
2981574|NCT00855582|3697618|FG002|NOT COMPLETED|Overall Study||30
2981575|NCT00855595|3697631|FG000|STARTED|Overall Study||106
2981576|NCT00855595|3697632|FG001|STARTED|Overall Study||101
2981577|NCT00855595|3697631|FG000|COMPLETED|Overall Study||100
2981578|NCT00855595|3697632|FG001|COMPLETED|Overall Study||94
2981579|NCT00855595|3697631|FG000|NOT COMPLETED|Overall Study||6
2981580|NCT00855595|3697632|FG001|NOT COMPLETED|Overall Study||7
2981581|NCT00855738|3697638|FG000|STARTED|Overall Study||111
2981582|NCT00855738|3697638|FG000|At Least 1 Dose and 1 Endpoint|Overall Study|Received at least 1 dose of study drug and had data for at least 1 efficacy endpoint.|108
2981583|NCT00855738|3697638|FG000|COMPLETED|Overall Study||106
2981584|NCT00855738|3697638|FG000|NOT COMPLETED|Overall Study||5
2981585|NCT00855816|3697646|FG000|STARTED|Overall Study||47
2981586|NCT00855816|3697647|FG001|STARTED|Overall Study||33
2981587|NCT00855816|3697646|FG000|COMPLETED|Overall Study||21
2981588|NCT00855816|3697647|FG001|COMPLETED|Overall Study||12
2981589|NCT00855816|3697646|FG000|NOT COMPLETED|Overall Study||26
2981590|NCT00855816|3697647|FG001|NOT COMPLETED|Overall Study||21
2981591|NCT00855842|3697653|FG000|STARTED|Overall Study||4
2981592|NCT00855842|3697653|FG000|COMPLETED|Overall Study||4
2981593|NCT00855842|3697653|FG000|NOT COMPLETED|Overall Study||0
2981594|NCT00855868|3697659|FG000|STARTED|Overall Study||13
3164296|NCT01892007|3891747|FG001|STARTED|Overall Study||30
3164297|NCT01892007|3891746|FG000|COMPLETED|Overall Study||27
3164298|NCT01892007|3891747|FG001|COMPLETED|Overall Study||30
3164299|NCT01892007|3891746|FG000|NOT COMPLETED|Overall Study||0
3164300|NCT01892007|3891747|FG001|NOT COMPLETED|Overall Study||0
3164301|NCT01892020|3891753|FG000|STARTED|Period 1||81
3164302|NCT01892020|3891754|FG001|STARTED|Period 1||80
2981595|NCT00855868|3697660|FG001|STARTED|Overall Study||15
2981596|NCT00855868|3697659|FG000|COMPLETED|Overall Study||12
2981597|NCT00855868|3697660|FG001|COMPLETED|Overall Study||14
2981598|NCT00855868|3697659|FG000|NOT COMPLETED|Overall Study||1
2981599|NCT00855868|3697660|FG001|NOT COMPLETED|Overall Study||1
2981600|NCT00855894|3697666|FG000|STARTED|Overall Study||41
2981601|NCT00855894|3697666|FG000|COMPLETED|Overall Study||8
2981602|NCT00855894|3697666|FG000|NOT COMPLETED|Overall Study||33
2981603|NCT00855920|3697673|FG000|STARTED|Overall Study||76
2981604|NCT00855920|3697674|FG001|STARTED|Overall Study||74
2981605|NCT00855920|3697675|FG002|STARTED|Overall Study||75
2981606|NCT00855920|3697673|FG000|Safety Population|Overall Study|1 participant from Rilonacept+Indomethacin arm received Placebo (for Rilonacept)+Indomethacin|77
2981607|NCT00855920|3697674|FG001|Safety Population|Overall Study|1 participant from Rilonacept+Indomethacin arm received Placebo (for Rilonacept)+Indomethacin|73
2981608|NCT00855920|3697675|FG002|Safety Population|Overall Study||75
2981609|NCT00855920|3697673|FG000|COMPLETED|Overall Study||68
2981610|NCT00855920|3697674|FG001|COMPLETED|Overall Study||65
2981611|NCT00855920|3697675|FG002|COMPLETED|Overall Study||64
2981612|NCT00855920|3697673|FG000|NOT COMPLETED|Overall Study||8
2981613|NCT00855920|3697674|FG001|NOT COMPLETED|Overall Study||9
2981614|NCT00855920|3697675|FG002|NOT COMPLETED|Overall Study||11
2981615|NCT00855933|3697685|FG000|STARTED|Overall Study||30
2981616|NCT00855933|3697686|FG001|STARTED|Overall Study||30
2981617|NCT00855933|3697685|FG000|COMPLETED|Overall Study||30
2981618|NCT00855933|3697686|FG001|COMPLETED|Overall Study||29
2981619|NCT00855933|3697685|FG000|NOT COMPLETED|Overall Study||0
2981620|NCT00855933|3697686|FG001|NOT COMPLETED|Overall Study||1
2981621|NCT00855959|3697692|FG000|STARTED|Overall Study||108
2981622|NCT00855959|3697692|FG000|Patients Who Received Pulmicort Respules|Overall Study||105
2981623|NCT00855959|3697692|FG000|COMPLETED|Overall Study||99
2981624|NCT00855959|3697692|FG000|NOT COMPLETED|Overall Study||9
2981625|NCT00856024|3697696|FG000|STARTED|Overall Study||902
2981626|NCT00856024|3697696|FG000|COMPLETED|Overall Study||902
2981627|NCT00856024|3697696|FG000|NOT COMPLETED|Overall Study||0
2981628|NCT00856050|3697702|FG000|STARTED|Overall Study||26
3164303|NCT01892020|3891753|FG000|COMPLETED|Period 1||78
3164304|NCT01892020|3891754|FG001|COMPLETED|Period 1||74
3164305|NCT01892020|3891753|FG000|NOT COMPLETED|Period 1||3
3164306|NCT01892020|3891754|FG001|NOT COMPLETED|Period 1||6
3164307|NCT01892020|3891753|FG000|STARTED|Period 2||78
3164308|NCT01892020|3891754|FG001|STARTED|Period 2||74
3164309|NCT01892020|3891753|FG000|COMPLETED|Period 2||77
3164310|NCT01892020|3891754|FG001|COMPLETED|Period 2||74
3303336|NCT02966509|4036684|FG000|STARTED|Baseline Satisfaction Survey||105
3303337|NCT02966509|4036685|FG001|STARTED|Baseline Satisfaction Survey||108
3303338|NCT02966509|4036684|FG000|COMPLETED|Baseline Satisfaction Survey||101
3303339|NCT02966509|4036685|FG001|COMPLETED|Baseline Satisfaction Survey||101
2981629|NCT00856050|3697702|FG000|COMPLETED|Overall Study||26
2981630|NCT00856050|3697702|FG000|NOT COMPLETED|Overall Study||0
2981631|NCT00856180|3697706|FG000|STARTED|Overall Study||20
2981632|NCT00856180|3697706|FG000|COMPLETED|Overall Study||0
2981633|NCT00856180|3697706|FG000|NOT COMPLETED|Overall Study||20
3036313|NCT01143051|3755544|FG003|NOT COMPLETED|Visit 1||0
3036314|NCT01143051|3755545|FG004|NOT COMPLETED|Visit 1||0
3036315|NCT01143051|3755546|FG005|NOT COMPLETED|Visit 1||0
3036316|NCT01143051|3755541|FG000|STARTED|3-14 Day Washout||4
3036317|NCT01143051|3755542|FG001|STARTED|3-14 Day Washout||4
3036318|NCT01143051|3755543|FG002|STARTED|3-14 Day Washout||4
3036319|NCT01143051|3755544|FG003|STARTED|3-14 Day Washout||4
3036320|NCT01143051|3755545|FG004|STARTED|3-14 Day Washout||4
3036321|NCT01143051|3755546|FG005|STARTED|3-14 Day Washout||4
3036322|NCT01143051|3755541|FG000|COMPLETED|3-14 Day Washout||4
3036323|NCT01143051|3755542|FG001|COMPLETED|3-14 Day Washout||4
3036324|NCT01143051|3755543|FG002|COMPLETED|3-14 Day Washout||3
3036325|NCT01143051|3755544|FG003|COMPLETED|3-14 Day Washout||4
3036326|NCT01143051|3755545|FG004|COMPLETED|3-14 Day Washout||4
3036327|NCT01143051|3755546|FG005|COMPLETED|3-14 Day Washout||4
3036328|NCT01143051|3755541|FG000|NOT COMPLETED|3-14 Day Washout||0
3036329|NCT01143051|3755542|FG001|NOT COMPLETED|3-14 Day Washout||0
3036330|NCT01143051|3755543|FG002|NOT COMPLETED|3-14 Day Washout||1
3036331|NCT01143051|3755544|FG003|NOT COMPLETED|3-14 Day Washout||0
3036332|NCT01143051|3755545|FG004|NOT COMPLETED|3-14 Day Washout||0
3036333|NCT01143051|3755546|FG005|NOT COMPLETED|3-14 Day Washout||0
3303340|NCT02966509|4036684|FG000|NOT COMPLETED|Baseline Satisfaction Survey||4
3303341|NCT02966509|4036685|FG001|NOT COMPLETED|Baseline Satisfaction Survey||7
3303342|NCT02966509|4036684|FG000|STARTED|6 Month Satisfaction Decision Survey||105
3303343|NCT02966509|4036685|FG001|STARTED|6 Month Satisfaction Decision Survey||108
3303344|NCT02966509|4036684|FG000|COMPLETED|6 Month Satisfaction Decision Survey||80
3303345|NCT02966509|4036685|FG001|COMPLETED|6 Month Satisfaction Decision Survey||77
3303346|NCT02966509|4036684|FG000|NOT COMPLETED|6 Month Satisfaction Decision Survey||25
3303347|NCT02966509|4036685|FG001|NOT COMPLETED|6 Month Satisfaction Decision Survey||31
3164311|NCT01892020|3891753|FG000|NOT COMPLETED|Period 2||1
3164312|NCT01892020|3891754|FG001|NOT COMPLETED|Period 2||0
3164313|NCT01892163|3891762|FG000|STARTED|Overall Study||50
3164314|NCT01892163|3891763|FG001|STARTED|Overall Study||50
3164315|NCT01892163|3891762|FG000|COMPLETED|Overall Study||48
3036334|NCT01143051|3755541|FG000|STARTED|Visit 2||4
3036335|NCT01143051|3755542|FG001|STARTED|Visit 2||4
3036336|NCT01143051|3755543|FG002|STARTED|Visit 2||3
2981634|NCT00856193|3697712|FG000|STARTED|Period 1||16
2981635|NCT00856193|3697713|FG001|STARTED|Period 1||17
2981636|NCT00856193|3697712|FG000|COMPLETED|Period 1||16
2981637|NCT00856193|3697713|FG001|COMPLETED|Period 1||17
2981638|NCT00856193|3697712|FG000|NOT COMPLETED|Period 1||0
2981639|NCT00856193|3697713|FG001|NOT COMPLETED|Period 1||0
2981640|NCT00856193|3697712|FG000|STARTED|Period 2||16
2981641|NCT00856193|3697713|FG001|STARTED|Period 2||17
2981642|NCT00856193|3697712|FG000|COMPLETED|Period 2||16
2981643|NCT00856193|3697713|FG001|COMPLETED|Period 2||15
2981644|NCT00856193|3697712|FG000|NOT COMPLETED|Period 2||0
2981645|NCT00856193|3697713|FG001|NOT COMPLETED|Period 2||2
2981646|NCT00856206|3697721|FG000|STARTED|Overall Study||330
2981647|NCT00856206|3697722|FG001|STARTED|Overall Study||985
2981648|NCT00856206|3697721|FG000|COMPLETED|Overall Study||276
2981649|NCT00856206|3697722|FG001|COMPLETED|Overall Study||824
2981650|NCT00856206|3697721|FG000|NOT COMPLETED|Overall Study||54
2981651|NCT00856206|3697722|FG001|NOT COMPLETED|Overall Study||161
2981652|NCT00856232|3697731|FG000|STARTED|Overall Study||26
2981653|NCT00856232|3697732|FG001|STARTED|Overall Study||29
2981654|NCT00856232|3697733|FG002|STARTED|Overall Study||36
2981655|NCT00856232|3697731|FG000|COMPLETED|Overall Study||26
2981656|NCT00856232|3697732|FG001|COMPLETED|Overall Study||29
2981657|NCT00856232|3697733|FG002|COMPLETED|Overall Study||36
2981658|NCT00856232|3697731|FG000|NOT COMPLETED|Overall Study||0
2981659|NCT00856232|3697732|FG001|NOT COMPLETED|Overall Study||0
2981660|NCT00856232|3697733|FG002|NOT COMPLETED|Overall Study||0
2981661|NCT00856245|3697743|FG000|STARTED|Overall Study||19
2981662|NCT00856245|3697743|FG000|COMPLETED|Overall Study||14
2981663|NCT00856245|3697743|FG000|NOT COMPLETED|Overall Study||5
2981664|NCT00856284|3697750|FG000|STARTED|Overall Study||880
2981665|NCT00856284|3697751|FG001|STARTED|Overall Study||885
2981666|NCT00856284|3697752|FG002|STARTED|Overall Study||874
2981667|NCT00856284|3697750|FG000|Received Study Drug|Overall Study||873
2981668|NCT00856284|3697751|FG001|Received Study Drug|Overall Study||878
2981669|NCT00856284|3697752|FG002|Received Study Drug|Overall Study||869
2981670|NCT00856284|3697750|FG000|COMPLETED|Overall Study||472
2981671|NCT00856284|3697751|FG001|COMPLETED|Overall Study||493
2981672|NCT00856284|3697752|FG002|COMPLETED|Overall Study||427
2981673|NCT00856284|3697750|FG000|NOT COMPLETED|Overall Study||408
2981674|NCT00856284|3697751|FG001|NOT COMPLETED|Overall Study||392
2981675|NCT00856284|3697752|FG002|NOT COMPLETED|Overall Study||447
2981676|NCT00856297|3697765|FG000|STARTED|Overall Study||131
2981677|NCT00856297|3697766|FG001|STARTED|Overall Study||76
2981678|NCT00856297|3697767|FG002|STARTED|Overall Study||107
2981679|NCT00856297|3697768|FG003|STARTED|Overall Study||44
2981680|NCT00856297|3697769|FG004|STARTED|Overall Study||31
2981681|NCT00856297|3697765|FG000|COMPLETED|Overall Study||129
2981682|NCT00856297|3697766|FG001|COMPLETED|Overall Study||76
2981683|NCT00856297|3697767|FG002|COMPLETED|Overall Study||107
2981684|NCT00856297|3697768|FG003|COMPLETED|Overall Study||44
2981685|NCT00856297|3697769|FG004|COMPLETED|Overall Study||31
2981686|NCT00856297|3697765|FG000|NOT COMPLETED|Overall Study||2
2981687|NCT00856297|3697766|FG001|NOT COMPLETED|Overall Study||0
2981688|NCT00856297|3697767|FG002|NOT COMPLETED|Overall Study||0
2981689|NCT00856297|3697768|FG003|NOT COMPLETED|Overall Study||0
2981690|NCT00856297|3697769|FG004|NOT COMPLETED|Overall Study||0
2981691|NCT00856323|3697786|FG000|STARTED|Overall Study||53
2981692|NCT00856323|3697786|FG000|COMPLETED|Overall Study||51
2981693|NCT00856323|3697786|FG000|NOT COMPLETED|Overall Study||2
2981694|NCT00856349|3697790|FG000|STARTED|Overall Study||4132
2981695|NCT00856349|3697790|FG000|12 Month Follow-up|Overall Study||3228
2981696|NCT00856349|3697790|FG000|18 Month Follow-up|Overall Study||2467
2981697|NCT00856349|3697790|FG000|24 Month Follow-up|Overall Study||1698
2981698|NCT00856349|3697790|FG000|COMPLETED|Overall Study||3111
2981699|NCT00856349|3697790|FG000|NOT COMPLETED|Overall Study||1021
2981700|NCT00856375|3697798|FG000|STARTED|Overall Study||42
2981701|NCT00856375|3697799|FG001|STARTED|Overall Study||41
3164316|NCT01892163|3891763|FG001|COMPLETED|Overall Study||49
3164317|NCT01892163|3891762|FG000|NOT COMPLETED|Overall Study||2
3164318|NCT01892163|3891763|FG001|NOT COMPLETED|Overall Study||1
2981702|NCT00856375|3697798|FG000|COMPLETED|Overall Study||0
2981703|NCT00856375|3697799|FG001|COMPLETED|Overall Study||0
2981704|NCT00856375|3697798|FG000|NOT COMPLETED|Overall Study||42
2981705|NCT00856375|3697799|FG001|NOT COMPLETED|Overall Study||41
2981706|NCT00856388|3697805|FG000|STARTED|Overall Study||62
2981707|NCT00856388|3697805|FG000|COMPLETED|Overall Study||61
2981708|NCT00856388|3697805|FG000|NOT COMPLETED|Overall Study||1
2981709|NCT00856414|3697810|FG000|STARTED|Overall Study||45
2981710|NCT00856414|3697810|FG000|COMPLETED|Overall Study||45
2981711|NCT00856414|3697810|FG000|NOT COMPLETED|Overall Study||0
2981712|NCT00856492|3697817|FG000|STARTED|Overall Study||99
2981713|NCT00856492|3697818|FG001|STARTED|Overall Study||63
2981714|NCT00856492|3697819|FG002|STARTED|Overall Study||53
2981715|NCT00856492|3697817|FG000|Toxicity Eval|Overall Study||96
2981716|NCT00856492|3697818|FG001|Toxicity Eval|Overall Study||60
2981717|NCT00856492|3697819|FG002|Toxicity Eval|Overall Study||51
2981718|NCT00856492|3697817|FG000|COMPLETED|Overall Study||98
2981719|NCT00856492|3697818|FG001|COMPLETED|Overall Study||62
2981720|NCT00856492|3697819|FG002|COMPLETED|Overall Study||51
2981721|NCT00856492|3697817|FG000|NOT COMPLETED|Overall Study||1
2981722|NCT00856492|3697818|FG001|NOT COMPLETED|Overall Study||1
2981723|NCT00856492|3697819|FG002|NOT COMPLETED|Overall Study||2
2981724|NCT00856518|3697832|FG000|STARTED|Overall Study||24
2981725|NCT00856518|3697833|FG001|STARTED|Overall Study||18
2981726|NCT00856518|3697832|FG000|COMPLETED|Overall Study||20
2981727|NCT00856518|3697833|FG001|COMPLETED|Overall Study||16
2981728|NCT00856518|3697832|FG000|NOT COMPLETED|Overall Study||4
2981729|NCT00856518|3697833|FG001|NOT COMPLETED|Overall Study||2
2981730|NCT00856544|3697845|FG000|STARTED|Overall Study||318
2981731|NCT00856544|3697846|FG001|STARTED|Overall Study||318
2981732|NCT00856544|3697847|FG002|STARTED|Overall Study||79
2981733|NCT00856544|3697848|FG003|STARTED|Overall Study||80
2981734|NCT00856544|3697845|FG000|Treated|Overall Study||315
2981735|NCT00856544|3697846|FG001|Treated|Overall Study||318
2981736|NCT00856544|3697847|FG002|Treated|Overall Study||79
2981737|NCT00856544|3697848|FG003|Treated|Overall Study||80
2981738|NCT00856544|3697845|FG000|COMPLETED|Overall Study||261
2981739|NCT00856544|3697846|FG001|COMPLETED|Overall Study||252
2981740|NCT00856544|3697847|FG002|COMPLETED|Overall Study||71
2981741|NCT00856544|3697848|FG003|COMPLETED|Overall Study||67
2981742|NCT00856544|3697845|FG000|NOT COMPLETED|Overall Study||57
2981743|NCT00856544|3697846|FG001|NOT COMPLETED|Overall Study||66
2981744|NCT00856544|3697847|FG002|NOT COMPLETED|Overall Study||8
2981745|NCT00856544|3697848|FG003|NOT COMPLETED|Overall Study||13
2981746|NCT00856557|3697872|FG000|STARTED|Overall Study||62
2981747|NCT00856557|3697873|FG001|STARTED|Overall Study||76
2981748|NCT00856557|3697872|FG000|Received Intervention/Control|Overall Study||62
2981749|NCT00856557|3697873|FG001|Received Intervention/Control|Overall Study||76
2981750|NCT00856557|3697872|FG000|Tested With Standardized Patients|Overall Study||62
2981751|NCT00856557|3697873|FG001|Tested With Standardized Patients|Overall Study||76
2981752|NCT00856557|3697872|FG000|With Patients With Contextual Flags|Overall Study||50
2981753|NCT00856557|3697873|FG001|With Patients With Contextual Flags|Overall Study||60
2981754|NCT00856557|3697872|FG000|COMPLETED|Overall Study||50
2981755|NCT00856557|3697873|FG001|COMPLETED|Overall Study||60
2981756|NCT00856557|3697872|FG000|NOT COMPLETED|Overall Study||12
2981757|NCT00856557|3697873|FG001|NOT COMPLETED|Overall Study||16
2981758|NCT00856583|3697881|FG000|STARTED|Overall Study|Patients treated|4905
2981759|NCT00856583|3697882|FG001|STARTED|Overall Study|Patients treated|4904
2981760|NCT00856583|3697881|FG000|COMPLETED|Overall Study|Patients who were still on study drug at the time of study closure|1768
2981761|NCT00856583|3697882|FG001|COMPLETED|Overall Study|Patients who were still on study drug at the time of study closure|2307
2981762|NCT00856583|3697881|FG000|NOT COMPLETED|Overall Study||3137
2981763|NCT00856583|3697882|FG001|NOT COMPLETED|Overall Study||2597
2981764|NCT00856609|3697890|FG000|STARTED|Overall Study||41
2981765|NCT00856609|3697891|FG001|STARTED|Overall Study||39
2981766|NCT00856609|3697890|FG000|COMPLETED|Overall Study||40
2981767|NCT00856609|3697891|FG001|COMPLETED|Overall Study||39
2981768|NCT00856609|3697890|FG000|NOT COMPLETED|Overall Study||1
2981769|NCT00856609|3697891|FG001|NOT COMPLETED|Overall Study||0
2981770|NCT00856635|3697899|FG000|STARTED|Overall Study||22
2981771|NCT00856635|3697900|FG001|STARTED|Overall Study||22
2981772|NCT00856635|3697899|FG000|Received Study Drug|Overall Study||20
2981773|NCT00856635|3697900|FG001|Received Study Drug|Overall Study||20
2981774|NCT00856635|3697899|FG000|COMPLETED|Overall Study||12
2981775|NCT00856635|3697900|FG001|COMPLETED|Overall Study||14
2981776|NCT00856635|3697899|FG000|NOT COMPLETED|Overall Study||10
2981777|NCT00856635|3697900|FG001|NOT COMPLETED|Overall Study||8
2981778|NCT00856661|3697910|FG000|STARTED|Overall Study|Randomised|135
2981779|NCT00856661|3697911|FG001|STARTED|Overall Study|Randomised|135
2981780|NCT00856661|3697910|FG000|Treated|Overall Study||126
2981781|NCT00856661|3697911|FG001|Treated|Overall Study||131
2981782|NCT00856661|3697910|FG000|Randomized Not Treated|Overall Study||9
2981783|NCT00856661|3697911|FG001|Randomized Not Treated|Overall Study||4
2981784|NCT00856661|3697910|FG000|COMPLETED|Overall Study||108
2981785|NCT00856661|3697911|FG001|COMPLETED|Overall Study||106
2981786|NCT00856661|3697910|FG000|NOT COMPLETED|Overall Study||27
2981787|NCT00856661|3697911|FG001|NOT COMPLETED|Overall Study||29
2981788|NCT00856726|3697917|FG000|STARTED|Overall Study||26
2981789|NCT00856726|3697917|FG000|COMPLETED|Overall Study||26
2981790|NCT00856726|3697917|FG000|NOT COMPLETED|Overall Study||0
2981791|NCT00856739|3697924|FG000|STARTED|Overall Study||70
2981792|NCT00856739|3697925|FG001|STARTED|Overall Study||52
2981793|NCT00856739|3697926|FG002|STARTED|Overall Study||55
2981794|NCT00856739|3697924|FG000|COMPLETED|Overall Study||70
2981795|NCT00856739|3697925|FG001|COMPLETED|Overall Study||52
2981796|NCT00856739|3697926|FG002|COMPLETED|Overall Study||55
2981797|NCT00856739|3697924|FG000|NOT COMPLETED|Overall Study||0
2981798|NCT00856739|3697925|FG001|NOT COMPLETED|Overall Study||0
2981799|NCT00856739|3697926|FG002|NOT COMPLETED|Overall Study||0
2981800|NCT00856778|3697937|FG000|STARTED|Overall Study||98
2981801|NCT00856778|3697937|FG000|COMPLETED|Overall Study||74
2981802|NCT00856778|3697937|FG000|NOT COMPLETED|Overall Study||24
2981803|NCT00856791|3697941|FG000|STARTED|Overall Study||1
2981804|NCT00856791|3697941|FG000|COMPLETED|Overall Study||1
2981805|NCT00856791|3697941|FG000|NOT COMPLETED|Overall Study||0
2981806|NCT00856830|3697949|FG000|STARTED|Irinotecan & Bendamustine||3
2981807|NCT00856830|3697950|FG001|STARTED|Irinotecan & Bendamustine||6
2981808|NCT00856830|3697951|FG002|STARTED|Irinotecan & Bendamustine||6
2981809|NCT00856830|3697952|FG003|STARTED|Irinotecan & Bendamustine||15
2981810|NCT00856830|3697949|FG000|Maximum Tolerated Dose|Irinotecan & Bendamustine||3
2981811|NCT00856830|3697950|FG001|Maximum Tolerated Dose|Irinotecan & Bendamustine||6
2981812|NCT00856830|3697951|FG002|Maximum Tolerated Dose|Irinotecan & Bendamustine||6
2981813|NCT00856830|3697952|FG003|Maximum Tolerated Dose|Irinotecan & Bendamustine||12
2981814|NCT00856830|3697949|FG000|COMPLETED|Irinotecan & Bendamustine||3
2981815|NCT00856830|3697950|FG001|COMPLETED|Irinotecan & Bendamustine||6
2981816|NCT00856830|3697951|FG002|COMPLETED|Irinotecan & Bendamustine||6
2981817|NCT00856830|3697952|FG003|COMPLETED|Irinotecan & Bendamustine||12
2981818|NCT00856830|3697949|FG000|NOT COMPLETED|Irinotecan & Bendamustine||0
2981819|NCT00856830|3697950|FG001|NOT COMPLETED|Irinotecan & Bendamustine||0
2981820|NCT00856830|3697951|FG002|NOT COMPLETED|Irinotecan & Bendamustine||0
2981821|NCT00856830|3697952|FG003|NOT COMPLETED|Irinotecan & Bendamustine||3
2981822|NCT00856830|3697949|FG000|STARTED|Regimen - B (Carboplatin & Etoposide)||3
2981823|NCT00856830|3697950|FG001|STARTED|Regimen - B (Carboplatin & Etoposide)||6
2981824|NCT00856830|3697951|FG002|STARTED|Regimen - B (Carboplatin & Etoposide)||6
2981825|NCT00856830|3697952|FG003|STARTED|Regimen - B (Carboplatin & Etoposide)||12
2981826|NCT00856830|3697949|FG000|COMPLETED|Regimen - B (Carboplatin & Etoposide)||3
2981827|NCT00856830|3697950|FG001|COMPLETED|Regimen - B (Carboplatin & Etoposide)||6
2981828|NCT00856830|3697951|FG002|COMPLETED|Regimen - B (Carboplatin & Etoposide)||6
2981829|NCT00856830|3697952|FG003|COMPLETED|Regimen - B (Carboplatin & Etoposide)||12
2981830|NCT00856830|3697949|FG000|NOT COMPLETED|Regimen - B (Carboplatin & Etoposide)||0
2981831|NCT00856830|3697950|FG001|NOT COMPLETED|Regimen - B (Carboplatin & Etoposide)||0
2981832|NCT00856830|3697951|FG002|NOT COMPLETED|Regimen - B (Carboplatin & Etoposide)||0
2981833|NCT00856830|3697952|FG003|NOT COMPLETED|Regimen - B (Carboplatin & Etoposide)||0
2981834|NCT00856843|3697959|FG000|STARTED|Overall Study||68
2981835|NCT00856843|3697960|FG001|STARTED|Overall Study||68
2981836|NCT00856843|3697959|FG000|COMPLETED|Overall Study||66
2981837|NCT00856843|3697960|FG001|COMPLETED|Overall Study||63
2981838|NCT00856843|3697959|FG000|NOT COMPLETED|Overall Study||2
2981839|NCT00856843|3697960|FG001|NOT COMPLETED|Overall Study||5
2981840|NCT00856856|3697966|FG000|STARTED|Baseline||101
2981841|NCT00856856|3697966|FG000|COMPLETED|Baseline||101
2981842|NCT00856856|3697966|FG000|NOT COMPLETED|Baseline||0
2981843|NCT00856856|3697966|FG000|STARTED|30-day Clinical Follow-up||101
2981844|NCT00856856|3697966|FG000|COMPLETED|30-day Clinical Follow-up||101
2981845|NCT00856856|3697966|FG000|NOT COMPLETED|30-day Clinical Follow-up||0
2981846|NCT00856856|3697966|FG000|STARTED|180-day Clinical Follow-up||101
2981847|NCT00856856|3697966|FG000|COMPLETED|180-day Clinical Follow-up||101
2981848|NCT00856856|3697966|FG000|NOT COMPLETED|180-day Clinical Follow-up||0
2981849|NCT00856856|3697966|FG000|STARTED|270-day Clinical Follow-up||101
2981850|NCT00856856|3697966|FG000|COMPLETED|270-day Clinical Follow-up||101
2981851|NCT00856856|3697966|FG000|NOT COMPLETED|270-day Clinical Follow-up||0
2981852|NCT00856856|3697966|FG000|STARTED|1-year Clinical Follow-up||101
2981853|NCT00856856|3697966|FG000|COMPLETED|1-year Clinical Follow-up||101
2981854|NCT00856856|3697966|FG000|NOT COMPLETED|1-year Clinical Follow-up||0
2981855|NCT00856856|3697966|FG000|STARTED|2-year Clinical Follow-up||101
2981856|NCT00856856|3697966|FG000|COMPLETED|2-year Clinical Follow-up||100
2981857|NCT00856856|3697966|FG000|NOT COMPLETED|2-year Clinical Follow-up||1
2981858|NCT00856856|3697966|FG000|STARTED|3-year Clinical Follow-up||100
2981859|NCT00856856|3697966|FG000|COMPLETED|3-year Clinical Follow-up||100
2981860|NCT00856856|3697966|FG000|NOT COMPLETED|3-year Clinical Follow-up||0
2981861|NCT00856856|3697966|FG000|STARTED|4-year Clinical Follow-up||100
2981862|NCT00856856|3697966|FG000|COMPLETED|4-year Clinical Follow-up||99
2981863|NCT00856856|3697966|FG000|NOT COMPLETED|4-year Clinical Follow-up||1
2981864|NCT00856856|3697966|FG000|STARTED|5-year Clinical Follow-up||100
2981865|NCT00856856|3697966|FG000|COMPLETED|5-year Clinical Follow-up|One patient missed the 4-year clinical follow-up but returned at 5 year.|100
2981866|NCT00856856|3697966|FG000|NOT COMPLETED|5-year Clinical Follow-up||0
2981867|NCT00856908|3697977|FG000|STARTED|Overall Study||15
2981868|NCT00856908|3697978|FG001|STARTED|Overall Study||5
2981869|NCT00856908|3697977|FG000|COMPLETED|Overall Study||14
2981870|NCT00856908|3697978|FG001|COMPLETED|Overall Study||5
2981871|NCT00856908|3697977|FG000|NOT COMPLETED|Overall Study||1
2981872|NCT00856908|3697978|FG001|NOT COMPLETED|Overall Study||0
2981873|NCT00856973|3697987|FG000|STARTED|Overall Study||162
2981874|NCT00856973|3697988|FG001|STARTED|Overall Study||163
2981875|NCT00856973|3697989|FG002|STARTED|Overall Study||161
2981876|NCT00856973|3697987|FG000|COMPLETED|Overall Study||126
2981877|NCT00856973|3697988|FG001|COMPLETED|Overall Study||122
2981878|NCT00856973|3697989|FG002|COMPLETED|Overall Study||123
2981879|NCT00856973|3697987|FG000|NOT COMPLETED|Overall Study||36
2981880|NCT00856973|3697988|FG001|NOT COMPLETED|Overall Study||41
2981881|NCT00856973|3697989|FG002|NOT COMPLETED|Overall Study||38
2981882|NCT00856986|3698006|FG000|STARTED|Run-in Period, Weeks -12-0||161
2981883|NCT00856986|3698007|FG001|STARTED|Run-in Period, Weeks -12-0||162
2981884|NCT00856986|3698008|FG002|STARTED|Run-in Period, Weeks -12-0||498
2981885|NCT00856986|3698009|FG003|STARTED|Run-in Period, Weeks -12-0||167
2981886|NCT00856986|3698010|FG004|STARTED|Run-in Period, Weeks -12-0||0
2981887|NCT00856986|3698006|FG000|COMPLETED|Run-in Period, Weeks -12-0||161
2981888|NCT00856986|3698007|FG001|COMPLETED|Run-in Period, Weeks -12-0||162
2981889|NCT00856986|3698008|FG002|COMPLETED|Run-in Period, Weeks -12-0||498
2981890|NCT00856986|3698009|FG003|COMPLETED|Run-in Period, Weeks -12-0|Subjects who withdrew during run-in and before randomisation were Early Withdrawals|0
2981891|NCT00856986|3698010|FG004|COMPLETED|Run-in Period, Weeks -12-0||0
2981892|NCT00856986|3698006|FG000|NOT COMPLETED|Run-in Period, Weeks -12-0||0
2981893|NCT00856986|3698007|FG001|NOT COMPLETED|Run-in Period, Weeks -12-0||0
2981894|NCT00856986|3698008|FG002|NOT COMPLETED|Run-in Period, Weeks -12-0||0
2981895|NCT00856986|3698009|FG003|NOT COMPLETED|Run-in Period, Weeks -12-0||167
2981896|NCT00856986|3698010|FG004|NOT COMPLETED|Run-in Period, Weeks -12-0||0
2981897|NCT00856986|3698006|FG000|STARTED|Main Period, Weeks 0-26||161
2981898|NCT00856986|3698007|FG001|STARTED|Main Period, Weeks 0-26||162
2981899|NCT00856986|3698008|FG002|STARTED|Main Period, Weeks 0-26||498
2981900|NCT00856986|3698009|FG003|STARTED|Main Period, Weeks 0-26||0
2981901|NCT00856986|3698010|FG004|STARTED|Main Period, Weeks 0-26||0
2981902|NCT00856986|3698006|FG000|COMPLETED|Main Period, Weeks 0-26||127
2981903|NCT00856986|3698007|FG001|COMPLETED|Main Period, Weeks 0-26||144
2981904|NCT00856986|3698008|FG002|COMPLETED|Main Period, Weeks 0-26||470
2981905|NCT00856986|3698009|FG003|COMPLETED|Main Period, Weeks 0-26||0
2981906|NCT00856986|3698010|FG004|COMPLETED|Main Period, Weeks 0-26||0
2981907|NCT00856986|3698006|FG000|NOT COMPLETED|Main Period, Weeks 0-26||34
2981908|NCT00856986|3698007|FG001|NOT COMPLETED|Main Period, Weeks 0-26||18
2981909|NCT00856986|3698008|FG002|NOT COMPLETED|Main Period, Weeks 0-26||28
2981910|NCT00856986|3698009|FG003|NOT COMPLETED|Main Period, Weeks 0-26||0
2981911|NCT00856986|3698010|FG004|NOT COMPLETED|Main Period, Weeks 0-26||0
2981912|NCT00856986|3698006|FG000|STARTED|Extension Period, Weeks 26-52|Subjects with HbA1c ≥8.0% who accepted intensification with detemir = 17 (Intensified Group)|127
2981913|NCT00856986|3698007|FG001|STARTED|Extension Period, Weeks 26-52||144
2981914|NCT00856986|3698008|FG002|STARTED|Extension Period, Weeks 26-52|Subjects with HbA1c ≥8.0% who accepted intensification with detemir = 7 (Intensified Group)|470
2981915|NCT00856986|3698009|FG003|STARTED|Extension Period, Weeks 26-52||0
2981916|NCT00856986|3698010|FG004|STARTED|Extension Period, Weeks 26-52||0
2981917|NCT00856986|3698006|FG000|Enrolled in Extension|Extension Period, Weeks 26-52||122
2981918|NCT00856986|3698007|FG001|Enrolled in Extension|Extension Period, Weeks 26-52||140
2981919|NCT00856986|3698008|FG002|Enrolled in Extension|Extension Period, Weeks 26-52||461
2981920|NCT00856986|3698009|FG003|Enrolled in Extension|Extension Period, Weeks 26-52||0
2981921|NCT00856986|3698010|FG004|Enrolled in Extension|Extension Period, Weeks 26-52||0
2981922|NCT00856986|3698006|FG000|COMPLETED|Extension Period, Weeks 26-52||108
2981923|NCT00856986|3698007|FG001|COMPLETED|Extension Period, Weeks 26-52||130
2981924|NCT00856986|3698008|FG002|COMPLETED|Extension Period, Weeks 26-52||432
2981925|NCT00856986|3698009|FG003|COMPLETED|Extension Period, Weeks 26-52||0
2981926|NCT00856986|3698010|FG004|COMPLETED|Extension Period, Weeks 26-52||0
2981927|NCT00856986|3698006|FG000|NOT COMPLETED|Extension Period, Weeks 26-52||19
2981928|NCT00856986|3698007|FG001|NOT COMPLETED|Extension Period, Weeks 26-52||14
2981929|NCT00856986|3698008|FG002|NOT COMPLETED|Extension Period, Weeks 26-52||38
2981930|NCT00856986|3698009|FG003|NOT COMPLETED|Extension Period, Weeks 26-52||0
2981931|NCT00856986|3698010|FG004|NOT COMPLETED|Extension Period, Weeks 26-52||0
2981932|NCT00856999|3698022|FG000|STARTED|Overall Study||50
2981933|NCT00856999|3698022|FG000|COMPLETED|Overall Study||45
2981934|NCT00856999|3698022|FG000|NOT COMPLETED|Overall Study||5
2981935|NCT00857207|3698029|FG000|STARTED|Overall Study||48
2981936|NCT00857207|3698030|FG001|STARTED|Overall Study||3
2981937|NCT00857207|3698029|FG000|COMPLETED|Overall Study||14
2981938|NCT00857207|3698030|FG001|COMPLETED|Overall Study||3
2981939|NCT00857207|3698029|FG000|NOT COMPLETED|Overall Study||34
2981940|NCT00857207|3698030|FG001|NOT COMPLETED|Overall Study||0
2981941|NCT00857220|3698037|FG000|STARTED|Overall Study||304
2981942|NCT00857220|3698037|FG000|COMPLETED|Overall Study||121
2981943|NCT00857220|3698037|FG000|NOT COMPLETED|Overall Study||183
2981944|NCT00857233|3698041|FG000|STARTED|Overall Study||297
2981945|NCT00857233|3698041|FG000|COMPLETED|Overall Study||242
2981946|NCT00857233|3698041|FG000|NOT COMPLETED|Overall Study||55
2981947|NCT00857246|3698045|FG000|STARTED|Induction Regimen||30
2981948|NCT00857246|3698045|FG000|COMPLETED|Induction Regimen||27
2981949|NCT00857246|3698045|FG000|NOT COMPLETED|Induction Regimen||3
2981950|NCT00857246|3698045|FG000|STARTED|Surgery (Curative)||27
2981951|NCT00857246|3698045|FG000|COMPLETED|Surgery (Curative)||21
2981952|NCT00857246|3698045|FG000|NOT COMPLETED|Surgery (Curative)||6
2981953|NCT00857246|3698045|FG000|STARTED|ChemoRT|6 did not start adjuvant therapy due to disease-related complications or patient withdrawal.|15
2981954|NCT00857246|3698045|FG000|COMPLETED|ChemoRT||12
2981955|NCT00857246|3698045|FG000|NOT COMPLETED|ChemoRT||3
2981956|NCT00857259|3698055|FG000|STARTED|Overall Study||8
2981957|NCT00857259|3698056|FG001|STARTED|Overall Study||1
2981958|NCT00857259|3698057|FG002|STARTED|Overall Study||7
2981959|NCT00857259|3698055|FG000|COMPLETED|Overall Study||7
2981960|NCT00857259|3698056|FG001|COMPLETED|Overall Study||1
2981961|NCT00857259|3698057|FG002|COMPLETED|Overall Study||6
2981962|NCT00857259|3698055|FG000|NOT COMPLETED|Overall Study||1
2981963|NCT00857259|3698056|FG001|NOT COMPLETED|Overall Study||0
2981964|NCT00857259|3698057|FG002|NOT COMPLETED|Overall Study||1
2981965|NCT00857272|3698069|FG000|STARTED|Overall Study|Includes 6 non-ITT patients that withdrew consent|154
2981966|NCT00857272|3698070|FG001|STARTED|Overall Study|Includes 7 non-ITT patients that withdrew consent|154
2981967|NCT00857272|3698069|FG000|COMPLETED|Overall Study||145
2981968|NCT00857272|3698070|FG001|COMPLETED|Overall Study||145
2981969|NCT00857272|3698069|FG000|NOT COMPLETED|Overall Study||9
2981970|NCT00857272|3698070|FG001|NOT COMPLETED|Overall Study||9
2981971|NCT00857311|3698080|FG000|STARTED|Overall Study||9
2981972|NCT00857311|3698081|FG001|STARTED|Overall Study||0
2981973|NCT00857311|3698082|FG002|STARTED|Overall Study||8
2981974|NCT00857311|3698083|FG003|STARTED|Overall Study||0
2981975|NCT00857311|3698080|FG000|COMPLETED|Overall Study||8
2981976|NCT00857311|3698081|FG001|COMPLETED|Overall Study||0
2981977|NCT00857311|3698082|FG002|COMPLETED|Overall Study||8
2981978|NCT00857311|3698083|FG003|COMPLETED|Overall Study||0
2981979|NCT00857311|3698080|FG000|NOT COMPLETED|Overall Study||1
2981980|NCT00857311|3698081|FG001|NOT COMPLETED|Overall Study||0
2981981|NCT00857311|3698082|FG002|NOT COMPLETED|Overall Study||0
2981982|NCT00857311|3698083|FG003|NOT COMPLETED|Overall Study||0
2981983|NCT00857389|3698089|FG000|STARTED|Overall Study||60
2981984|NCT00857389|3698089|FG000|COMPLETED|Overall Study||58
2981985|NCT00857389|3698089|FG000|NOT COMPLETED|Overall Study||2
2981986|NCT00857415|3698095|FG000|STARTED|Overall Study||152
2981987|NCT00857415|3698096|FG001|STARTED|Overall Study||74
2981988|NCT00857415|3698095|FG000|Deceased Within One Year of AV-45 Scan|Overall Study||37
2981989|NCT00857415|3698096|FG001|Deceased Within One Year of AV-45 Scan|Overall Study|Subjects in the specificity cohort were not followed to autopsy|0
2981990|NCT00857415|3698095|FG000|COMPLETED|Overall Study||35
2981991|NCT00857415|3698096|FG001|COMPLETED|Overall Study||74
2981992|NCT00857415|3698095|FG000|NOT COMPLETED|Overall Study||117
2981993|NCT00857415|3698096|FG001|NOT COMPLETED|Overall Study||0
2981994|NCT00857454|3698102|FG000|STARTED|Overall Study||71
2981995|NCT00857454|3698102|FG000|COMPLETED|Overall Study||51
2981996|NCT00857454|3698102|FG000|NOT COMPLETED|Overall Study||20
2981997|NCT00857493|3698108|FG000|STARTED|Overall Study||62
2981998|NCT00857493|3698109|FG001|STARTED|Overall Study||58
2981999|NCT00857493|3698108|FG000|COMPLETED|Overall Study||59
2982000|NCT00857493|3698109|FG001|COMPLETED|Overall Study||58
2982001|NCT00857493|3698108|FG000|NOT COMPLETED|Overall Study||3
2982002|NCT00857493|3698109|FG001|NOT COMPLETED|Overall Study||0
2982003|NCT00857506|3698118|FG000|STARTED|Overall Study||31
2982004|NCT00857506|3698119|FG001|STARTED|Overall Study||52
2982005|NCT00857506|3698120|FG002|STARTED|Overall Study||69
2982006|NCT00857506|3698118|FG000|COMPLETED|Overall Study||16
2982007|NCT00857506|3698119|FG001|COMPLETED|Overall Study||37
2982008|NCT00857506|3698120|FG002|COMPLETED|Overall Study||51
2982009|NCT00857506|3698118|FG000|NOT COMPLETED|Overall Study||15
2982010|NCT00857506|3698119|FG001|NOT COMPLETED|Overall Study||15
2982011|NCT00857506|3698120|FG002|NOT COMPLETED|Overall Study||18
2982012|NCT00857532|3698140|FG000|STARTED|Overall Study||31
2982013|NCT00857532|3698140|FG000|COMPLETED|Overall Study||31
2982014|NCT00857532|3698140|FG000|NOT COMPLETED|Overall Study||0
2982015|NCT00857545|3698149|FG000|STARTED|Overall Study||86
2982016|NCT00857545|3698150|FG001|STARTED|Overall Study||85
2982017|NCT00857545|3698149|FG000|COMPLETED|Overall Study|Enrolled and randomized participants.|86
2982018|NCT00857545|3698150|FG001|COMPLETED|Overall Study||85
2982019|NCT00857545|3698149|FG000|NOT COMPLETED|Overall Study||0
2982020|NCT00857545|3698150|FG001|NOT COMPLETED|Overall Study||0
2982021|NCT00857584|3698158|FG000|STARTED|Overall Study||14
2982022|NCT00857584|3698159|FG001|STARTED|Overall Study||13
2982023|NCT00857584|3698158|FG000|Week 1|Overall Study||14
2982024|NCT00857584|3698159|FG001|Week 1|Overall Study||13
2982025|NCT00857584|3698158|FG000|Week 2|Overall Study||14
2982026|NCT00857584|3698159|FG001|Week 2|Overall Study||11
2982027|NCT00857584|3698158|FG000|Week 4|Overall Study||11
2982028|NCT00857584|3698159|FG001|Week 4|Overall Study||9
2982029|NCT00857584|3698158|FG000|Week 8|Overall Study||10
2982030|NCT00857584|3698159|FG001|Week 8|Overall Study||8
2982031|NCT00857584|3698158|FG000|COMPLETED|Overall Study||10
2982032|NCT00857584|3698159|FG001|COMPLETED|Overall Study||8
2982033|NCT00857584|3698158|FG000|NOT COMPLETED|Overall Study||4
2982034|NCT00857584|3698159|FG001|NOT COMPLETED|Overall Study||5
2982035|NCT00857623|3698167|FG000|STARTED|Overall Study||62
2982036|NCT00857623|3698168|FG001|STARTED|Overall Study||65
2982037|NCT00857623|3698167|FG000|COMPLETED|Overall Study||48
2982038|NCT00857623|3698168|FG001|COMPLETED|Overall Study||55
2982039|NCT00857623|3698167|FG000|NOT COMPLETED|Overall Study||14
2982040|NCT00857623|3698168|FG001|NOT COMPLETED|Overall Study||10
2982041|NCT00857649|3698176|FG000|STARTED|Overall Study||182
2982042|NCT00857649|3698177|FG001|STARTED|Overall Study||187
2982043|NCT00857649|3698176|FG000|COMPLETED|Overall Study||151
2982044|NCT00857649|3698177|FG001|COMPLETED|Overall Study||155
2982045|NCT00857649|3698176|FG000|NOT COMPLETED|Overall Study||31
2982046|NCT00857649|3698177|FG001|NOT COMPLETED|Overall Study||32
2982047|NCT00857714|3698183|FG000|STARTED|Overall Study||1
2982048|NCT00857714|3698183|FG000|COMPLETED|Overall Study||1
2982049|NCT00857714|3698183|FG000|NOT COMPLETED|Overall Study||0
2982050|NCT00857727|3698189|FG000|STARTED|Overall Study||14
2982051|NCT00857727|3698190|FG001|STARTED|Overall Study||14
2982052|NCT00857727|3698189|FG000|COMPLETED|Overall Study||14
2982053|NCT00857727|3698190|FG001|COMPLETED|Overall Study||14
2982054|NCT00857727|3698189|FG000|NOT COMPLETED|Overall Study||0
2982055|NCT00857727|3698190|FG001|NOT COMPLETED|Overall Study||0
2982056|NCT00857766|3698198|FG000|STARTED|Overall Study||123
2982057|NCT00857766|3698199|FG001|STARTED|Overall Study||126
2982058|NCT00857766|3698198|FG000|COMPLETED|Overall Study||92
2982059|NCT00857766|3698199|FG001|COMPLETED|Overall Study||96
2982060|NCT00857766|3698198|FG000|NOT COMPLETED|Overall Study||31
2982061|NCT00857766|3698199|FG001|NOT COMPLETED|Overall Study||30
2982062|NCT00857792|3698205|FG000|STARTED|Overall Study||120
2982063|NCT00857792|3698205|FG000|COMPLETED|Overall Study||108
2982064|NCT00857792|3698205|FG000|NOT COMPLETED|Overall Study||12
2982065|NCT00857818|3698211|FG000|STARTED|Overall Study||14
2982066|NCT00857818|3698212|FG001|STARTED|Overall Study||14
2982067|NCT00857818|3698211|FG000|Received Treatment|Overall Study||14
2982068|NCT00857818|3698212|FG001|Received Treatment|Overall Study||12
2982069|NCT00857818|3698211|FG000|COMPLETED|Overall Study||3
2982070|NCT00857818|3698212|FG001|COMPLETED|Overall Study||6
2982071|NCT00857818|3698211|FG000|NOT COMPLETED|Overall Study||11
2982072|NCT00857818|3698212|FG001|NOT COMPLETED|Overall Study||8
2982073|NCT00857857|3698218|FG000|STARTED|Overall Study||24
2982074|NCT00857857|3698218|FG000|COMPLETED|Overall Study||24
2982075|NCT00857857|3698218|FG000|NOT COMPLETED|Overall Study||0
2982076|NCT00857896|3698230|FG000|STARTED|Baseline to Week 4||21
2982077|NCT00857896|3698230|FG000|COMPLETED|Baseline to Week 4||20
2982078|NCT00857896|3698230|FG000|NOT COMPLETED|Baseline to Week 4||1
2982079|NCT00857896|3698230|FG000|STARTED|Week 5 to Week 8||20
2982080|NCT00857896|3698230|FG000|COMPLETED|Week 5 to Week 8||20
2982081|NCT00857896|3698230|FG000|NOT COMPLETED|Week 5 to Week 8||0
2982082|NCT00857948|3698239|FG000|STARTED|Overall Study||18
2982083|NCT00857948|3698240|FG001|STARTED|Overall Study||18
2982084|NCT00857948|3698241|FG002|STARTED|Overall Study||19
2982085|NCT00857948|3698242|FG003|STARTED|Overall Study||23
2982086|NCT00857948|3698239|FG000|COMPLETED|Overall Study||15
2982087|NCT00857948|3698240|FG001|COMPLETED|Overall Study||18
2982088|NCT00857948|3698241|FG002|COMPLETED|Overall Study||18
2982089|NCT00857948|3698242|FG003|COMPLETED|Overall Study||23
2982090|NCT00857948|3698239|FG000|NOT COMPLETED|Overall Study||3
2982091|NCT00857948|3698240|FG001|NOT COMPLETED|Overall Study||0
2982092|NCT00857948|3698241|FG002|NOT COMPLETED|Overall Study||1
2982093|NCT00857948|3698242|FG003|NOT COMPLETED|Overall Study||0
2982094|NCT00857961|3698252|FG000|STARTED|Overall Study||21
2982095|NCT00857961|3698252|FG000|COMPLETED|Overall Study||21
2982096|NCT00857961|3698252|FG000|NOT COMPLETED|Overall Study||0
2982097|NCT00858013|3698264|FG000|STARTED|Overall Study||46
2982098|NCT00858013|3698265|FG001|STARTED|Overall Study||42
2982099|NCT00858013|3698264|FG000|COMPLETED|Overall Study||24
2982100|NCT00858013|3698265|FG001|COMPLETED|Overall Study||23
2982101|NCT00858013|3698264|FG000|NOT COMPLETED|Overall Study||22
2982102|NCT00858013|3698265|FG001|NOT COMPLETED|Overall Study||19
2982103|NCT00858117|3698271|FG000|STARTED|Treatment on Study||30
2982104|NCT00858117|3698271|FG000|Completed 18 Weeks of Treatment|Treatment on Study||28
2982105|NCT00858117|3698271|FG000|COMPLETED|Treatment on Study||28
2982106|NCT00858117|3698271|FG000|NOT COMPLETED|Treatment on Study||2
2982107|NCT00858117|3698271|FG000|STARTED|Follow up for 5 Years|All patients who receive at least one dose of drug under the protocol go into follow up for survival|30
2982108|NCT00858117|3698271|FG000|COMPLETED|Follow up for 5 Years||17
2982109|NCT00858117|3698271|FG000|NOT COMPLETED|Follow up for 5 Years||13
2982110|NCT00858130|3698275|FG000|STARTED|Overall Study||12
2982111|NCT00858130|3698275|FG000|COMPLETED|Overall Study||12
2982112|NCT00858130|3698275|FG000|NOT COMPLETED|Overall Study||0
2982113|NCT00858143|3698280|FG000|STARTED|Overall Study|Baseline|311
2982114|NCT00858143|3698280|FG000|COMPLETED|Overall Study||261
2982115|NCT00858143|3698280|FG000|NOT COMPLETED|Overall Study||50
2982116|NCT00858208|3698284|FG000|STARTED|Overall Study||85
2982117|NCT00858208|3698284|FG000|COMPLETED|Overall Study||6
2982118|NCT00858208|3698284|FG000|NOT COMPLETED|Overall Study||79
2982119|NCT00858234|3698288|FG000|STARTED|Overall Study||9
2982120|NCT00858234|3698288|FG000|COMPLETED|Overall Study||0
2982121|NCT00858234|3698288|FG000|NOT COMPLETED|Overall Study||9
2982122|NCT00858247|3698294|FG000|STARTED|Baseline Assessment||25
2982123|NCT00858247|3698295|FG001|STARTED|Baseline Assessment||26
2982124|NCT00858247|3698294|FG000|COMPLETED|Baseline Assessment||23
2982125|NCT00858247|3698295|FG001|COMPLETED|Baseline Assessment||24
2982126|NCT00858247|3698294|FG000|NOT COMPLETED|Baseline Assessment||2
3303348|NCT02966509|4036684|FG000|STARTED|6 Month Satisfaction Survey||105
3303349|NCT02966509|4036685|FG001|STARTED|6 Month Satisfaction Survey||108
3303350|NCT02966509|4036684|FG000|COMPLETED|6 Month Satisfaction Survey||58
3303351|NCT02966509|4036685|FG001|COMPLETED|6 Month Satisfaction Survey||60
3303352|NCT02966509|4036684|FG000|NOT COMPLETED|6 Month Satisfaction Survey||47
3303353|NCT02966509|4036685|FG001|NOT COMPLETED|6 Month Satisfaction Survey||48
3303354|NCT02966509|4036684|FG000|STARTED|6-Month Utilization and Cost||105
3303355|NCT02966509|4036685|FG001|STARTED|6-Month Utilization and Cost||108
3303356|NCT02966509|4036684|FG000|COMPLETED|6-Month Utilization and Cost||105
3303357|NCT02966509|4036685|FG001|COMPLETED|6-Month Utilization and Cost||108
3303358|NCT02966509|4036684|FG000|NOT COMPLETED|6-Month Utilization and Cost||0
3303359|NCT02966509|4036685|FG001|NOT COMPLETED|6-Month Utilization and Cost||0
3303360|NCT02966509|4036684|FG000|STARTED|15-Month Utilization and Cost||105
3303361|NCT02966509|4036685|FG001|STARTED|15-Month Utilization and Cost||108
3303362|NCT02966509|4036684|FG000|COMPLETED|15-Month Utilization and Cost||105
3303363|NCT02966509|4036685|FG001|COMPLETED|15-Month Utilization and Cost||108
3303364|NCT02966509|4036684|FG000|NOT COMPLETED|15-Month Utilization and Cost||0
3303365|NCT02966509|4036685|FG001|NOT COMPLETED|15-Month Utilization and Cost||0
3303366|NCT02966509|4036684|FG000|STARTED|End of Life Utilization and Cost 6 Month||105
3303367|NCT02966509|4036685|FG001|STARTED|End of Life Utilization and Cost 6 Month||108
3303368|NCT02966509|4036684|FG000|COMPLETED|End of Life Utilization and Cost 6 Month||36
3303369|NCT02966509|4036685|FG001|COMPLETED|End of Life Utilization and Cost 6 Month||33
3303370|NCT02966509|4036684|FG000|NOT COMPLETED|End of Life Utilization and Cost 6 Month||69
3303371|NCT02966509|4036685|FG001|NOT COMPLETED|End of Life Utilization and Cost 6 Month||75
3303372|NCT02966509|4036684|FG000|STARTED|End of Life Utilization and Cost 15month||105
3303373|NCT02966509|4036685|FG001|STARTED|End of Life Utilization and Cost 15month||108
2982127|NCT00858247|3698295|FG001|NOT COMPLETED|Baseline Assessment||2
2982128|NCT00858247|3698294|FG000|STARTED|Week 12 Follow-up||23
2982129|NCT00858247|3698295|FG001|STARTED|Week 12 Follow-up||24
2982130|NCT00858247|3698294|FG000|COMPLETED|Week 12 Follow-up||23
2982131|NCT00858247|3698295|FG001|COMPLETED|Week 12 Follow-up||23
2982132|NCT00858247|3698294|FG000|NOT COMPLETED|Week 12 Follow-up||0
2982133|NCT00858247|3698295|FG001|NOT COMPLETED|Week 12 Follow-up||1
2982134|NCT00858364|3698303|FG000|STARTED|Overall Study||846
2982135|NCT00858364|3698304|FG001|STARTED|Overall Study||1703
2982136|NCT00858364|3698303|FG000|Received Study Drug|Overall Study||837
2982137|NCT00858364|3698304|FG001|Received Study Drug|Overall Study||1681
2982138|NCT00858364|3698303|FG000|COMPLETED|Overall Study||642
2982139|NCT00858364|3698304|FG001|COMPLETED|Overall Study||1246
2982140|NCT00858364|3698303|FG000|NOT COMPLETED|Overall Study||204
2982141|NCT00858364|3698304|FG001|NOT COMPLETED|Overall Study||457
2982142|NCT00858390|3698312|FG000|STARTED|Overall Study||18
2982143|NCT00858390|3698313|FG001|STARTED|Overall Study||18
2982144|NCT00858390|3698312|FG000|COMPLETED|Overall Study||18
2982145|NCT00858390|3698313|FG001|COMPLETED|Overall Study||18
2982146|NCT00858390|3698312|FG000|NOT COMPLETED|Overall Study||0
2982147|NCT00858390|3698313|FG001|NOT COMPLETED|Overall Study||0
2982148|NCT00858403|3698319|FG000|STARTED|Overall Study||7
2982149|NCT00858403|3698319|FG000|COMPLETED|Overall Study||2
2982150|NCT00858403|3698319|FG000|NOT COMPLETED|Overall Study||5
2982151|NCT00858442|3698325|FG000|STARTED|From Surgery to Start Compression;||21
2982152|NCT00858442|3698326|FG001|STARTED|From Surgery to Start Compression;||23
2982153|NCT00858442|3698325|FG000|COMPLETED|From Surgery to Start Compression;||21
2982154|NCT00858442|3698326|FG001|COMPLETED|From Surgery to Start Compression;||23
2982155|NCT00858442|3698325|FG000|NOT COMPLETED|From Surgery to Start Compression;||0
2982156|NCT00858442|3698326|FG001|NOT COMPLETED|From Surgery to Start Compression;||0
2982157|NCT00858442|3698325|FG000|STARTED|Compression:Start to Finish||21
2982158|NCT00858442|3698326|FG001|STARTED|Compression:Start to Finish||23
2982159|NCT00858442|3698325|FG000|COMPLETED|Compression:Start to Finish||20
2982160|NCT00858442|3698326|FG001|COMPLETED|Compression:Start to Finish||20
2982161|NCT00858442|3698325|FG000|NOT COMPLETED|Compression:Start to Finish||1
2982162|NCT00858442|3698326|FG001|NOT COMPLETED|Compression:Start to Finish||3
2982163|NCT00858468|3698335|FG000|STARTED|Overall Study|1 enrolled participant was not vaccinated and removed from analysis|201
2982164|NCT00858468|3698336|FG001|STARTED|Overall Study||192
2982165|NCT00858468|3698335|FG000|COMPLETED|Overall Study||201
2982166|NCT00858468|3698336|FG001|COMPLETED|Overall Study||192
2982167|NCT00858468|3698335|FG000|NOT COMPLETED|Overall Study||0
2982168|NCT00858468|3698336|FG001|NOT COMPLETED|Overall Study||0
2982169|NCT00858494|3698342|FG000|STARTED|Overall Study||49
2982170|NCT00858494|3698342|FG000|COMPLETED|Overall Study|2 participants dropped out before giving study medication. Symptoms resolved without a dose in 2.|45
2982171|NCT00858494|3698342|FG000|NOT COMPLETED|Overall Study||4
2982172|NCT00858507|3698348|FG000|STARTED|Overall Study||105
2982173|NCT00858507|3698349|FG001|STARTED|Overall Study||116
2982174|NCT00858507|3698348|FG000|COMPLETED|Overall Study||83
2982175|NCT00858507|3698349|FG001|COMPLETED|Overall Study||101
2982176|NCT00858507|3698348|FG000|NOT COMPLETED|Overall Study||22
2982177|NCT00858507|3698349|FG001|NOT COMPLETED|Overall Study||15
2982178|NCT00858637|3698357|FG000|STARTED|Active Comparison Phase||127
2982179|NCT00858637|3698358|FG001|STARTED|Active Comparison Phase||0
2982180|NCT00858637|3698359|FG002|STARTED|Active Comparison Phase||0
2982181|NCT00858637|3698360|FG003|STARTED|Active Comparison Phase||133
2982182|NCT00858637|3698361|FG004|STARTED|Active Comparison Phase||0
2982183|NCT00858637|3698362|FG005|STARTED|Active Comparison Phase||0
2982184|NCT00858637|3698357|FG000|COMPLETED|Active Comparison Phase||103
2982185|NCT00858637|3698358|FG001|COMPLETED|Active Comparison Phase||0
2982186|NCT00858637|3698359|FG002|COMPLETED|Active Comparison Phase||0
2982187|NCT00858637|3698360|FG003|COMPLETED|Active Comparison Phase||115
2982188|NCT00858637|3698361|FG004|COMPLETED|Active Comparison Phase||0
2982189|NCT00858637|3698362|FG005|COMPLETED|Active Comparison Phase||0
2982190|NCT00858637|3698357|FG000|NOT COMPLETED|Active Comparison Phase||24
2982191|NCT00858637|3698358|FG001|NOT COMPLETED|Active Comparison Phase||0
2982192|NCT00858637|3698359|FG002|NOT COMPLETED|Active Comparison Phase||0
2982193|NCT00858637|3698360|FG003|NOT COMPLETED|Active Comparison Phase||18
2982194|NCT00858637|3698361|FG004|NOT COMPLETED|Active Comparison Phase||0
2982195|NCT00858637|3698362|FG005|NOT COMPLETED|Active Comparison Phase||0
2982196|NCT00858637|3698357|FG000|STARTED|Placebo-controlled Withdrawal Phase||0
2982197|NCT00858637|3698358|FG001|STARTED|Placebo-controlled Withdrawal Phase||49
2982198|NCT00858637|3698359|FG002|STARTED|Placebo-controlled Withdrawal Phase||54
2982199|NCT00858637|3698360|FG003|STARTED|Placebo-controlled Withdrawal Phase||0
2982200|NCT00858637|3698361|FG004|STARTED|Placebo-controlled Withdrawal Phase||56
2982201|NCT00858637|3698362|FG005|STARTED|Placebo-controlled Withdrawal Phase||59
2982202|NCT00858637|3698357|FG000|COMPLETED|Placebo-controlled Withdrawal Phase||0
2982203|NCT00858637|3698358|FG001|COMPLETED|Placebo-controlled Withdrawal Phase||49
2982204|NCT00858637|3698359|FG002|COMPLETED|Placebo-controlled Withdrawal Phase||53
2982205|NCT00858637|3698360|FG003|COMPLETED|Placebo-controlled Withdrawal Phase||0
2982206|NCT00858637|3698361|FG004|COMPLETED|Placebo-controlled Withdrawal Phase||55
2982207|NCT00858637|3698362|FG005|COMPLETED|Placebo-controlled Withdrawal Phase||58
2982208|NCT00858637|3698357|FG000|NOT COMPLETED|Placebo-controlled Withdrawal Phase||0
2982209|NCT00858637|3698358|FG001|NOT COMPLETED|Placebo-controlled Withdrawal Phase||0
2982210|NCT00858637|3698359|FG002|NOT COMPLETED|Placebo-controlled Withdrawal Phase||1
2982211|NCT00858637|3698360|FG003|NOT COMPLETED|Placebo-controlled Withdrawal Phase||0
2982212|NCT00858637|3698361|FG004|NOT COMPLETED|Placebo-controlled Withdrawal Phase||1
2982213|NCT00858637|3698362|FG005|NOT COMPLETED|Placebo-controlled Withdrawal Phase||1
2982214|NCT00858689|3698372|FG000|STARTED|Overall Study||20
2982215|NCT00858689|3698372|FG000|COMPLETED|Overall Study||19
2982216|NCT00858689|3698372|FG000|NOT COMPLETED|Overall Study||1
2982217|NCT00858780|3698376|FG000|STARTED|Open-Label (OL) Run-In(Week-8 to Week 0)||91
2982218|NCT00858780|3698377|FG001|STARTED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
2982219|NCT00858780|3698378|FG002|STARTED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
2982220|NCT00858780|3698379|FG003|STARTED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
2982221|NCT00858780|3698380|FG004|STARTED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
2982222|NCT00858780|3698376|FG000|COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||73
2982223|NCT00858780|3698377|FG001|COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
2982224|NCT00858780|3698378|FG002|COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
2982225|NCT00858780|3698379|FG003|COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
2982226|NCT00858780|3698380|FG004|COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
2982227|NCT00858780|3698376|FG000|NOT COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||18
2982228|NCT00858780|3698377|FG001|NOT COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
2982229|NCT00858780|3698378|FG002|NOT COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
2982230|NCT00858780|3698379|FG003|NOT COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
2982231|NCT00858780|3698380|FG004|NOT COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
2982232|NCT00858780|3698376|FG000|STARTED|Double-Blind (Week 0 to Failure/Week 48)||0
2982233|NCT00858780|3698377|FG001|STARTED|Double-Blind (Week 0 to Failure/Week 48)||23
2982234|NCT00858780|3698378|FG002|STARTED|Double-Blind (Week 0 to Failure/Week 48)||27
2982235|NCT00858780|3698379|FG003|STARTED|Double-Blind (Week 0 to Failure/Week 48)||23
2982236|NCT00858780|3698380|FG004|STARTED|Double-Blind (Week 0 to Failure/Week 48)||0
2982237|NCT00858780|3698376|FG000|COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||0
2982238|NCT00858780|3698377|FG001|COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||21
2982239|NCT00858780|3698378|FG002|COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||25
2982240|NCT00858780|3698379|FG003|COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||22
2982241|NCT00858780|3698380|FG004|COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||0
2982242|NCT00858780|3698376|FG000|NOT COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||0
2982243|NCT00858780|3698377|FG001|NOT COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||2
2982244|NCT00858780|3698378|FG002|NOT COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||2
2982245|NCT00858780|3698379|FG003|NOT COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||1
2982246|NCT00858780|3698380|FG004|NOT COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||0
2982247|NCT00858780|3698376|FG000|STARTED|OL Re-Treatment (Failure to Week 48)||0
2982248|NCT00858780|3698377|FG001|STARTED|OL Re-Treatment (Failure to Week 48)||0
2982249|NCT00858780|3698378|FG002|STARTED|OL Re-Treatment (Failure to Week 48)||0
2982250|NCT00858780|3698379|FG003|STARTED|OL Re-Treatment (Failure to Week 48)||0
2982251|NCT00858780|3698380|FG004|STARTED|OL Re-Treatment (Failure to Week 48)|43 participants showed treatment failure in Period 2 and entered in Period 3.|43
2982252|NCT00858780|3698376|FG000|COMPLETED|OL Re-Treatment (Failure to Week 48)||0
2982253|NCT00858780|3698377|FG001|COMPLETED|OL Re-Treatment (Failure to Week 48)||0
2982254|NCT00858780|3698378|FG002|COMPLETED|OL Re-Treatment (Failure to Week 48)||0
2982255|NCT00858780|3698379|FG003|COMPLETED|OL Re-Treatment (Failure to Week 48)||0
2982256|NCT00858780|3698380|FG004|COMPLETED|OL Re-Treatment (Failure to Week 48)||41
2982257|NCT00858780|3698376|FG000|NOT COMPLETED|OL Re-Treatment (Failure to Week 48)||0
3303374|NCT02966509|4036684|FG000|COMPLETED|End of Life Utilization and Cost 15month||60
3303375|NCT02966509|4036685|FG001|COMPLETED|End of Life Utilization and Cost 15month||60
3303376|NCT02966509|4036684|FG000|NOT COMPLETED|End of Life Utilization and Cost 15month||45
3303377|NCT02966509|4036685|FG001|NOT COMPLETED|End of Life Utilization and Cost 15month||48
3303378|NCT02966795|4036693|FG000|STARTED|Overall Study||23
3303379|NCT02966795|4036694|FG001|STARTED|Overall Study||61
3303380|NCT02966795|4036693|FG000|COMPLETED|Overall Study||23
3303381|NCT02966795|4036694|FG001|COMPLETED|Overall Study||60
3303382|NCT02966795|4036693|FG000|NOT COMPLETED|Overall Study||0
3303383|NCT02966795|4036694|FG001|NOT COMPLETED|Overall Study||1
3303384|NCT02966834|4036705|FG000|STARTED|Main Study Period (Up to 12 Weeks)||36
3303385|NCT02966834|4036706|FG001|STARTED|Main Study Period (Up to 12 Weeks)||16
3303386|NCT02966834|4036707|FG002|STARTED|Main Study Period (Up to 12 Weeks)||23
3303387|NCT02966834|4036708|FG003|STARTED|Main Study Period (Up to 12 Weeks)||27
3303388|NCT02966834|4036709|FG004|STARTED|Main Study Period (Up to 12 Weeks)||23
3303389|NCT02966834|4036710|FG005|STARTED|Main Study Period (Up to 12 Weeks)||22
3303390|NCT02966834|4036705|FG000|COMPLETED|Main Study Period (Up to 12 Weeks)||35
3303391|NCT02966834|4036706|FG001|COMPLETED|Main Study Period (Up to 12 Weeks)||16
3303392|NCT02966834|4036707|FG002|COMPLETED|Main Study Period (Up to 12 Weeks)||19
3303393|NCT02966834|4036708|FG003|COMPLETED|Main Study Period (Up to 12 Weeks)||19
3303394|NCT02966834|4036709|FG004|COMPLETED|Main Study Period (Up to 12 Weeks)||22
3303395|NCT02966834|4036710|FG005|COMPLETED|Main Study Period (Up to 12 Weeks)||17
3303396|NCT02966834|4036705|FG000|NOT COMPLETED|Main Study Period (Up to 12 Weeks)||1
3303397|NCT02966834|4036706|FG001|NOT COMPLETED|Main Study Period (Up to 12 Weeks)||0
3303398|NCT02966834|4036707|FG002|NOT COMPLETED|Main Study Period (Up to 12 Weeks)||4
3303399|NCT02966834|4036708|FG003|NOT COMPLETED|Main Study Period (Up to 12 Weeks)||8
3303400|NCT02966834|4036709|FG004|NOT COMPLETED|Main Study Period (Up to 12 Weeks)||1
3303401|NCT02966834|4036710|FG005|NOT COMPLETED|Main Study Period (Up to 12 Weeks)||5
3303402|NCT02966834|4036705|FG000|STARTED|Final Study Period (Up to 4 Weeks)||35
2982258|NCT00858780|3698377|FG001|NOT COMPLETED|OL Re-Treatment (Failure to Week 48)||0
2982259|NCT00858780|3698378|FG002|NOT COMPLETED|OL Re-Treatment (Failure to Week 48)||0
2982260|NCT00858780|3698379|FG003|NOT COMPLETED|OL Re-Treatment (Failure to Week 48)||0
2982261|NCT00858780|3698380|FG004|NOT COMPLETED|OL Re-Treatment (Failure to Week 48)||2
2982262|NCT00858832|3698392|FG000|STARTED|Overall Study|study terminated early due to enrollment deficiencies|21
2982263|NCT00858832|3698393|FG001|STARTED|Overall Study||23
2982264|NCT00858832|3698392|FG000|COMPLETED|Overall Study||20
2982265|NCT00858832|3698393|FG001|COMPLETED|Overall Study||22
2982266|NCT00858832|3698392|FG000|NOT COMPLETED|Overall Study||1
2982267|NCT00858832|3698393|FG001|NOT COMPLETED|Overall Study||1
2982268|NCT00858845|3698401|FG000|STARTED|Overall Study||5
2982269|NCT00858845|3698402|FG001|STARTED|Overall Study||6
2982270|NCT00858845|3698401|FG000|COMPLETED|Overall Study||5
2982271|NCT00858845|3698402|FG001|COMPLETED|Overall Study||5
2982272|NCT00858845|3698401|FG000|NOT COMPLETED|Overall Study||0
2982273|NCT00858845|3698402|FG001|NOT COMPLETED|Overall Study||1
2982274|NCT00858858|3698408|FG000|STARTED|Overall Study||60
2982275|NCT00858858|3698408|FG000|COMPLETED|Overall Study||42
2982276|NCT00858858|3698408|FG000|NOT COMPLETED|Overall Study||18
2982277|NCT00858962|3698412|FG000|STARTED|Overall Study||12
2982278|NCT00858962|3698412|FG000|COMPLETED|Overall Study||12
2982279|NCT00858962|3698412|FG000|NOT COMPLETED|Overall Study||0
2982280|NCT00858988|3698418|FG000|STARTED|Randomized and Allocation||74
2982281|NCT00858988|3698419|FG001|STARTED|Randomized and Allocation||73
2982282|NCT00858988|3698418|FG000|COMPLETED|Randomized and Allocation||74
2982283|NCT00858988|3698419|FG001|COMPLETED|Randomized and Allocation||73
2982284|NCT00858988|3698418|FG000|NOT COMPLETED|Randomized and Allocation||0
2982285|NCT00858988|3698419|FG001|NOT COMPLETED|Randomized and Allocation||0
2982286|NCT00858988|3698418|FG000|STARTED|Analysis||74
2982287|NCT00858988|3698419|FG001|STARTED|Analysis||73
2982288|NCT00858988|3698418|FG000|COMPLETED|Analysis||72
2982289|NCT00858988|3698419|FG001|COMPLETED|Analysis||72
2982290|NCT00858988|3698418|FG000|NOT COMPLETED|Analysis||2
2982291|NCT00858988|3698419|FG001|NOT COMPLETED|Analysis||1
2982292|NCT00859014|3698425|FG000|STARTED|Overall Study||25
2982293|NCT00859014|3698425|FG000|COMPLETED|Overall Study||20
2982294|NCT00859014|3698425|FG000|NOT COMPLETED|Overall Study||5
2982295|NCT00859027|3698431|FG000|STARTED|Overall Study||25
2982296|NCT00859027|3698432|FG001|STARTED|Overall Study||25
2982297|NCT00859027|3698431|FG000|COMPLETED|Overall Study||20
2982298|NCT00859027|3698432|FG001|COMPLETED|Overall Study||20
2982299|NCT00859027|3698431|FG000|NOT COMPLETED|Overall Study||5
2982300|NCT00859027|3698432|FG001|NOT COMPLETED|Overall Study||5
2982301|NCT00859040|3698440|FG000|STARTED|Overall Study||18
2982302|NCT00859040|3698441|FG001|STARTED|Overall Study||16
2982303|NCT00859040|3698440|FG000|COMPLETED|Overall Study||18
2982304|NCT00859040|3698441|FG001|COMPLETED|Overall Study||16
2982305|NCT00859040|3698440|FG000|NOT COMPLETED|Overall Study||0
2982306|NCT00859040|3698441|FG001|NOT COMPLETED|Overall Study||0
2982307|NCT00859053|3698451|FG000|STARTED|Overall Study||6
2982308|NCT00859053|3698452|FG001|STARTED|Overall Study||6
2982309|NCT00859053|3698453|FG002|STARTED|Overall Study||6
2982310|NCT00859053|3698454|FG003|STARTED|Overall Study||12
2982311|NCT00859053|3698451|FG000|COMPLETED|Overall Study||6
2982312|NCT00859053|3698452|FG001|COMPLETED|Overall Study||6
2982313|NCT00859053|3698453|FG002|COMPLETED|Overall Study||6
2982314|NCT00859053|3698454|FG003|COMPLETED|Overall Study||12
2982315|NCT00859053|3698451|FG000|NOT COMPLETED|Overall Study||0
2982316|NCT00859053|3698452|FG001|NOT COMPLETED|Overall Study||0
2982317|NCT00859053|3698453|FG002|NOT COMPLETED|Overall Study||0
2982318|NCT00859053|3698454|FG003|NOT COMPLETED|Overall Study||0
2982319|NCT00859131|3698466|FG000|STARTED|Overall Study||102
3303403|NCT02966834|4036706|FG001|STARTED|Final Study Period (Up to 4 Weeks)||16
3303404|NCT02966834|4036707|FG002|STARTED|Final Study Period (Up to 4 Weeks)||19
3303405|NCT02966834|4036708|FG003|STARTED|Final Study Period (Up to 4 Weeks)||19
3303406|NCT02966834|4036709|FG004|STARTED|Final Study Period (Up to 4 Weeks)|One participant did not enter Final Study Period.|21
3303407|NCT02966834|4036710|FG005|STARTED|Final Study Period (Up to 4 Weeks)||17
3303408|NCT02966834|4036705|FG000|COMPLETED|Final Study Period (Up to 4 Weeks)||35
3303409|NCT02966834|4036706|FG001|COMPLETED|Final Study Period (Up to 4 Weeks)||16
3303410|NCT02966834|4036707|FG002|COMPLETED|Final Study Period (Up to 4 Weeks)||19
3303411|NCT02966834|4036708|FG003|COMPLETED|Final Study Period (Up to 4 Weeks)||19
3303412|NCT02966834|4036709|FG004|COMPLETED|Final Study Period (Up to 4 Weeks)||21
3303413|NCT02966834|4036710|FG005|COMPLETED|Final Study Period (Up to 4 Weeks)||17
3303414|NCT02966834|4036705|FG000|NOT COMPLETED|Final Study Period (Up to 4 Weeks)||0
3303415|NCT02966834|4036706|FG001|NOT COMPLETED|Final Study Period (Up to 4 Weeks)||0
3303416|NCT02966834|4036707|FG002|NOT COMPLETED|Final Study Period (Up to 4 Weeks)||0
3303417|NCT02966834|4036708|FG003|NOT COMPLETED|Final Study Period (Up to 4 Weeks)||0
3303418|NCT02966834|4036709|FG004|NOT COMPLETED|Final Study Period (Up to 4 Weeks)||0
3303419|NCT02966834|4036710|FG005|NOT COMPLETED|Final Study Period (Up to 4 Weeks)||0
2982320|NCT00859131|3698467|FG001|STARTED|Overall Study||98
2982321|NCT00859131|3698466|FG000|COMPLETED|Overall Study||102
2982322|NCT00859131|3698467|FG001|COMPLETED|Overall Study||98
2982323|NCT00859131|3698466|FG000|NOT COMPLETED|Overall Study||0
2982324|NCT00859131|3698467|FG001|NOT COMPLETED|Overall Study||0
2982325|NCT00859222|3698476|FG000|STARTED|Overall Study||3
2982326|NCT00859222|3698477|FG001|STARTED|Overall Study||3
2982327|NCT00859222|3698478|FG002|STARTED|Overall Study||6
2982328|NCT00859222|3698479|FG003|STARTED|Overall Study||24
2982329|NCT00859222|3698480|FG004|STARTED|Overall Study||15
2982330|NCT00859222|3698476|FG000|COMPLETED|Overall Study||0
2982331|NCT00859222|3698477|FG001|COMPLETED|Overall Study||0
2982332|NCT00859222|3698478|FG002|COMPLETED|Overall Study||0
2982333|NCT00859222|3698479|FG003|COMPLETED|Overall Study||0
2982334|NCT00859222|3698480|FG004|COMPLETED|Overall Study||0
2982335|NCT00859222|3698476|FG000|NOT COMPLETED|Overall Study||3
2982336|NCT00859222|3698477|FG001|NOT COMPLETED|Overall Study||3
2982337|NCT00859222|3698478|FG002|NOT COMPLETED|Overall Study||6
2982338|NCT00859222|3698479|FG003|NOT COMPLETED|Overall Study||24
2982339|NCT00859222|3698480|FG004|NOT COMPLETED|Overall Study||15
2982340|NCT00859313|3698495|FG000|STARTED|Overall Study||30
2982341|NCT00859313|3698495|FG000|COMPLETED|Overall Study||26
2982342|NCT00859313|3698495|FG000|NOT COMPLETED|Overall Study||4
2982343|NCT00859339|3698499|FG000|STARTED|Overall Study||9
2982344|NCT00859339|3698499|FG000|COMPLETED|Overall Study||9
2982345|NCT00859339|3698499|FG000|NOT COMPLETED|Overall Study||0
2982346|NCT00859456|3698503|FG000|STARTED|Overall Study||9
2982347|NCT00859456|3698503|FG000|COMPLETED|Overall Study||1
2982348|NCT00859456|3698503|FG000|NOT COMPLETED|Overall Study||8
2982349|NCT00859469|3698507|FG000|STARTED|Overall Study||29
2982350|NCT00859469|3698507|FG000|6 Cycles|Overall Study||16
2982351|NCT00859469|3698507|FG000|COMPLETED|Overall Study||1
2982352|NCT00859469|3698507|FG000|NOT COMPLETED|Overall Study||28
2982353|NCT00859495|3698511|FG000|STARTED|Overall Study||9
2982354|NCT00859495|3698511|FG000|COMPLETED|Overall Study||9
2982355|NCT00859495|3698511|FG000|NOT COMPLETED|Overall Study||0
2982356|NCT00859508|3698517|FG000|STARTED|Overall Study||68
2982357|NCT00859508|3698518|FG001|STARTED|Overall Study||37
2982358|NCT00859508|3698517|FG000|COMPLETED|Overall Study||62
2982359|NCT00859508|3698518|FG001|COMPLETED|Overall Study||37
2982360|NCT00859508|3698517|FG000|NOT COMPLETED|Overall Study||6
2982361|NCT00859508|3698518|FG001|NOT COMPLETED|Overall Study||0
2982362|NCT00859547|3698524|FG000|STARTED|Overall Study||30
2982363|NCT00859547|3698524|FG000|COMPLETED|Overall Study||28
2982364|NCT00859547|3698524|FG000|NOT COMPLETED|Overall Study||2
2982365|NCT00859573|3698530|FG000|STARTED|Overall Study||6
2982366|NCT00859573|3698531|FG001|STARTED|Overall Study||3
2982367|NCT00859573|3698530|FG000|COMPLETED|Overall Study||1
2982368|NCT00859573|3698531|FG001|COMPLETED|Overall Study||1
2982369|NCT00859573|3698530|FG000|NOT COMPLETED|Overall Study||5
2982370|NCT00859573|3698531|FG001|NOT COMPLETED|Overall Study||2
2982371|NCT00859586|3698537|FG000|STARTED|Overall Study||8
2982372|NCT00859586|3698537|FG000|COMPLETED|Overall Study||4
2982373|NCT00859586|3698537|FG000|NOT COMPLETED|Overall Study||4
2982374|NCT00859638|3698543|FG000|STARTED|Overall Study||65
2982375|NCT00859638|3698544|FG001|STARTED|Overall Study||59
2982376|NCT00859638|3698543|FG000|COMPLETED|Overall Study||55
2982377|NCT00859638|3698544|FG001|COMPLETED|Overall Study||55
2982378|NCT00859638|3698543|FG000|NOT COMPLETED|Overall Study||10
2982379|NCT00859638|3698544|FG001|NOT COMPLETED|Overall Study||4
2982380|NCT00859651|3698552|FG000|STARTED|Overall Study||18
2982381|NCT00859651|3698553|FG001|STARTED|Overall Study||22
2982382|NCT00859651|3698552|FG000|COMPLETED|Overall Study||18
2982383|NCT00859651|3698553|FG001|COMPLETED|Overall Study||22
2982384|NCT00859651|3698552|FG000|NOT COMPLETED|Overall Study||0
2982385|NCT00859651|3698553|FG001|NOT COMPLETED|Overall Study||0
2982386|NCT00859833|3698559|FG000|STARTED|Overall Study||30
2982387|NCT00859833|3698559|FG000|COMPLETED|Overall Study||30
2982388|NCT00859833|3698559|FG000|NOT COMPLETED|Overall Study||0
2982389|NCT00859898|3698567|FG000|STARTED|Overall Study||211
2982390|NCT00859898|3698568|FG001|STARTED|Overall Study||219
2982391|NCT00859898|3698569|FG002|STARTED|Overall Study||208
2982392|NCT00859898|3698567|FG000|COMPLETED|Overall Study||183
2982393|NCT00859898|3698568|FG001|COMPLETED|Overall Study||188
2982394|NCT00859898|3698569|FG002|COMPLETED|Overall Study||181
2982395|NCT00859898|3698567|FG000|NOT COMPLETED|Overall Study||28
2982396|NCT00859898|3698568|FG001|NOT COMPLETED|Overall Study||31
2982397|NCT00859898|3698569|FG002|NOT COMPLETED|Overall Study||27
2982398|NCT00859937|3698580|FG000|STARTED|Overall Study||41
2982399|NCT00859937|3698581|FG001|STARTED|Overall Study||14
2982400|NCT00859937|3698580|FG000|COMPLETED|Overall Study||40
2982401|NCT00859937|3698581|FG001|COMPLETED|Overall Study||14
2982402|NCT00859937|3698580|FG000|NOT COMPLETED|Overall Study||1
2982403|NCT00859937|3698581|FG001|NOT COMPLETED|Overall Study||0
2982404|NCT00859950|3698589|FG000|STARTED|Overall Study||49
2982405|NCT00859950|3698590|FG001|STARTED|Overall Study||21
2982406|NCT00859950|3698589|FG000|COMPLETED|Overall Study||49
2982407|NCT00859950|3698590|FG001|COMPLETED|Overall Study||21
2982408|NCT00859950|3698589|FG000|NOT COMPLETED|Overall Study||0
2982409|NCT00859950|3698590|FG001|NOT COMPLETED|Overall Study||0
2982410|NCT00859976|3698598|FG000|STARTED|Overall Study||82
2982411|NCT00859976|3698599|FG001|STARTED|Overall Study||85
2982412|NCT00859976|3698598|FG000|COMPLETED|Overall Study||66
2982413|NCT00859976|3698599|FG001|COMPLETED|Overall Study||67
2982414|NCT00859976|3698598|FG000|NOT COMPLETED|Overall Study||16
2982415|NCT00859976|3698599|FG001|NOT COMPLETED|Overall Study||18
3036337|NCT01143051|3755544|FG003|STARTED|Visit 2||4
3036338|NCT01143051|3755545|FG004|STARTED|Visit 2||4
3036339|NCT01143051|3755546|FG005|STARTED|Visit 2||4
3036340|NCT01143051|3755541|FG000|COMPLETED|Visit 2||4
3036341|NCT01143051|3755542|FG001|COMPLETED|Visit 2||4
2982416|NCT00860015|3698605|FG000|STARTED|Overall Study||12
2982417|NCT00860015|3698605|FG000|COMPLETED|Overall Study||12
2982418|NCT00860015|3698605|FG000|NOT COMPLETED|Overall Study||0
2982419|NCT00860028|3698611|FG000|STARTED|Placebo Controlled Pretreatment Period||15
2982420|NCT00860028|3698612|FG001|STARTED|Placebo Controlled Pretreatment Period||15
2982421|NCT00860028|3698611|FG000|COMPLETED|Placebo Controlled Pretreatment Period||13
2982422|NCT00860028|3698612|FG001|COMPLETED|Placebo Controlled Pretreatment Period||14
2982423|NCT00860028|3698611|FG000|NOT COMPLETED|Placebo Controlled Pretreatment Period||2
2982424|NCT00860028|3698612|FG001|NOT COMPLETED|Placebo Controlled Pretreatment Period||1
2982425|NCT00860028|3698611|FG000|STARTED|Smoking Cessation Phase||13
2982426|NCT00860028|3698612|FG001|STARTED|Smoking Cessation Phase||14
2982427|NCT00860028|3698611|FG000|COMPLETED|Smoking Cessation Phase||13
2982428|NCT00860028|3698612|FG001|COMPLETED|Smoking Cessation Phase||12
2982429|NCT00860028|3698611|FG000|NOT COMPLETED|Smoking Cessation Phase||0
2982430|NCT00860028|3698612|FG001|NOT COMPLETED|Smoking Cessation Phase||2
2982431|NCT00860067|3698623|FG000|STARTED|Overall Study||1200
2982432|NCT00860067|3698624|FG001|STARTED|Overall Study||299
2982433|NCT00860067|3698625|FG002|STARTED|Overall Study||301
2982434|NCT00860067|3698623|FG000|COMPLETED|Overall Study||1149
2982435|NCT00860067|3698624|FG001|COMPLETED|Overall Study||290
2982436|NCT00860067|3698625|FG002|COMPLETED|Overall Study||292
2982437|NCT00860067|3698623|FG000|NOT COMPLETED|Overall Study||51
2982438|NCT00860067|3698624|FG001|NOT COMPLETED|Overall Study||9
2982439|NCT00860067|3698625|FG002|NOT COMPLETED|Overall Study||9
2982440|NCT00860171|3698636|FG000|STARTED|Overall Study||16
2982441|NCT00860171|3698636|FG000|COMPLETED|Overall Study||16
2982442|NCT00860171|3698636|FG000|NOT COMPLETED|Overall Study||0
2982443|NCT00860262|3698643|FG000|STARTED|Overall Study||421
2982444|NCT00860262|3698644|FG001|STARTED|Overall Study||217
2982445|NCT00860262|3698645|FG002|STARTED|Overall Study||220
2982446|NCT00860262|3698643|FG000|COMPLETED|Overall Study||401
2982447|NCT00860262|3698644|FG001|COMPLETED|Overall Study||195
2982448|NCT00860262|3698645|FG002|COMPLETED|Overall Study||202
2982449|NCT00860262|3698643|FG000|NOT COMPLETED|Overall Study||20
2982450|NCT00860262|3698644|FG001|NOT COMPLETED|Overall Study||22
2982451|NCT00860262|3698645|FG002|NOT COMPLETED|Overall Study||18
2982452|NCT00860314|3698657|FG000|STARTED|Overall Study||48
2982453|NCT00860314|3698658|FG001|STARTED|Overall Study||48
2982454|NCT00860314|3698657|FG000|COMPLETED|Overall Study||48
2982455|NCT00860314|3698658|FG001|COMPLETED|Overall Study||48
2982456|NCT00860314|3698657|FG000|NOT COMPLETED|Overall Study||0
2982457|NCT00860314|3698658|FG001|NOT COMPLETED|Overall Study||0
2982458|NCT00860379|3698667|FG000|STARTED|Overall Study||4
2982459|NCT00860379|3698668|FG001|STARTED|Overall Study||6
2982460|NCT00860379|3698669|FG002|STARTED|Overall Study||4
2982461|NCT00860379|3698667|FG000|COMPLETED|Overall Study||4
2982462|NCT00860379|3698668|FG001|COMPLETED|Overall Study||6
2982463|NCT00860379|3698669|FG002|COMPLETED|Overall Study||4
2982464|NCT00860379|3698667|FG000|NOT COMPLETED|Overall Study||0
2982465|NCT00860379|3698668|FG001|NOT COMPLETED|Overall Study||0
2982466|NCT00860379|3698669|FG002|NOT COMPLETED|Overall Study||0
2982467|NCT00860405|3698679|FG000|STARTED|Overall Study||31
2982468|NCT00860405|3698680|FG001|STARTED|Overall Study||30
2982469|NCT00860405|3698679|FG000|Completed Treatment|Overall Study||31
2982470|NCT00860405|3698680|FG001|Completed Treatment|Overall Study||29
2982471|NCT00860405|3698679|FG000|Day 28 Follow-up Performed|Overall Study||31
2982472|NCT00860405|3698680|FG001|Day 28 Follow-up Performed|Overall Study||29
2982473|NCT00860405|3698679|FG000|COMPLETED|Overall Study|completed overall study|26
2982474|NCT00860405|3698680|FG001|COMPLETED|Overall Study||26
2982475|NCT00860405|3698679|FG000|NOT COMPLETED|Overall Study||5
2982476|NCT00860405|3698680|FG001|NOT COMPLETED|Overall Study||4
2982477|NCT00860457|3698686|FG000|STARTED|Overall Study||22
2982478|NCT00860457|3698686|FG000|COMPLETED|Overall Study||11
2982479|NCT00860457|3698686|FG000|NOT COMPLETED|Overall Study||11
2982480|NCT00860470|3698692|FG000|STARTED|Overall Study||22162
2982481|NCT00860470|3698693|FG001|STARTED|Overall Study||22405
2982482|NCT00860470|3698692|FG000|COMPLETED|Overall Study||22114
2982483|NCT00860470|3698693|FG001|COMPLETED|Overall Study||22346
2982484|NCT00860470|3698692|FG000|NOT COMPLETED|Overall Study||48
2982485|NCT00860470|3698693|FG001|NOT COMPLETED|Overall Study||59
2982486|NCT00860535|3698699|FG000|STARTED|Overall Study||9
2982487|NCT00860535|3698699|FG000|DISCONTINUED|Overall Study|Participant did not meet inclusion criteria and did not complete the study.|1
2982488|NCT00860535|3698699|FG000|COMPLETED|Overall Study||8
2982489|NCT00860535|3698699|FG000|NOT COMPLETED|Overall Study||1
2982490|NCT00860574|3698703|FG000|STARTED|Overall Study||96
2982491|NCT00860574|3698703|FG000|COMPLETED|Overall Study||93
2982492|NCT00860574|3698703|FG000|NOT COMPLETED|Overall Study||3
2982493|NCT00860743|3698713|FG000|STARTED|Overall Study||40
2982494|NCT00860743|3698714|FG001|STARTED|Overall Study||23
2982495|NCT00860743|3698713|FG000|COMPLETED|Overall Study||37
2982496|NCT00860743|3698714|FG001|COMPLETED|Overall Study||23
2982497|NCT00860743|3698713|FG000|NOT COMPLETED|Overall Study||3
2982498|NCT00860743|3698714|FG001|NOT COMPLETED|Overall Study||0
2982499|NCT00860795|3698722|FG000|STARTED|Overall Study||10
2982500|NCT00860795|3698723|FG001|STARTED|Overall Study||10
2982501|NCT00860795|3698722|FG000|Number to Complete Study Medication|Overall Study||9
2982502|NCT00860795|3698723|FG001|Number to Complete Study Medication|Overall Study||10
2982503|NCT00860795|3698722|FG000|COMPLETED|Overall Study|One participant discontinued study medication on day 5, but completed safety evaluations|10
2982504|NCT00860795|3698723|FG001|COMPLETED|Overall Study||10
2982505|NCT00860795|3698722|FG000|NOT COMPLETED|Overall Study||0
2982506|NCT00860795|3698723|FG001|NOT COMPLETED|Overall Study||0
2982507|NCT00860847|3698731|FG000|STARTED|Overall Study||32
2982508|NCT00860847|3698732|FG001|STARTED|Overall Study||33
2982509|NCT00860847|3698731|FG000|COMPLETED|Overall Study||28
2982510|NCT00860847|3698732|FG001|COMPLETED|Overall Study||28
2982511|NCT00860847|3698731|FG000|NOT COMPLETED|Overall Study||4
2982512|NCT00860847|3698732|FG001|NOT COMPLETED|Overall Study||5
2982513|NCT00860938|3698740|FG000|STARTED|Overall Study||45
2982514|NCT00860938|3698741|FG001|STARTED|Overall Study||45
2982515|NCT00860938|3698740|FG000|COMPLETED|Overall Study||31
2982516|NCT00860938|3698741|FG001|COMPLETED|Overall Study||37
2982517|NCT00860938|3698740|FG000|NOT COMPLETED|Overall Study||14
2982518|NCT00860938|3698741|FG001|NOT COMPLETED|Overall Study||8
2982519|NCT00860951|3698747|FG000|STARTED|Overall Study||29
2982520|NCT00860951|3698747|FG000|COMPLETED|Overall Study||22
2982521|NCT00860951|3698747|FG000|NOT COMPLETED|Overall Study||7
2982522|NCT00861146|3698755|FG000|STARTED|Overall Study||105
2982523|NCT00861146|3698756|FG001|STARTED|Overall Study||46
2982524|NCT00861146|3698755|FG000|Week 2 Assessment|Overall Study||97
2982525|NCT00861146|3698756|FG001|Week 2 Assessment|Overall Study||45
2982526|NCT00861146|3698755|FG000|Week 13 Assessment|Overall Study||85
2982527|NCT00861146|3698756|FG001|Week 13 Assessment|Overall Study||38
2982528|NCT00861146|3698755|FG000|COMPLETED|Overall Study||85
2982529|NCT00861146|3698756|FG001|COMPLETED|Overall Study||38
2982530|NCT00861146|3698755|FG000|NOT COMPLETED|Overall Study||20
2982531|NCT00861146|3698756|FG001|NOT COMPLETED|Overall Study||8
2982532|NCT00861198|3698762|FG000|STARTED|Overall Study||75
2982533|NCT00861198|3698762|FG000|COMPLETED|Overall Study||70
2982534|NCT00861198|3698762|FG000|NOT COMPLETED|Overall Study||5
2982535|NCT00861263|3698766|FG000|STARTED|Overall Study||193
2982536|NCT00861263|3698766|FG000|COMPLETED|Overall Study||193
2982537|NCT00861263|3698766|FG000|NOT COMPLETED|Overall Study||0
2982538|NCT00861341|3698770|FG000|STARTED|Overall Study||40
2982539|NCT00861341|3698770|FG000|COMPLETED|Overall Study||38
2982540|NCT00861341|3698770|FG000|NOT COMPLETED|Overall Study||2
2982541|NCT00861380|3698781|FG000|STARTED|Overall Study||8427
2982542|NCT00861380|3698782|FG001|STARTED|Overall Study||9112
2982543|NCT00861380|3698783|FG002|STARTED|Overall Study||8872
2982544|NCT00861380|3698784|FG003|STARTED|Overall Study||3689
2982545|NCT00861380|3698785|FG004|STARTED|Overall Study||1812
2982546|NCT00861380|3698786|FG005|STARTED|Overall Study||6249
2982547|NCT00861380|3698787|FG006|STARTED|Overall Study||3020
2982548|NCT00861380|3698781|FG000|COMPLETED|Overall Study||0
2982549|NCT00861380|3698782|FG001|COMPLETED|Overall Study||0
2982550|NCT00861380|3698783|FG002|COMPLETED|Overall Study||0
2982551|NCT00861380|3698784|FG003|COMPLETED|Overall Study||0
2982552|NCT00861380|3698785|FG004|COMPLETED|Overall Study||0
2982553|NCT00861380|3698786|FG005|COMPLETED|Overall Study||0
2982554|NCT00861380|3698787|FG006|COMPLETED|Overall Study||0
2982555|NCT00861380|3698781|FG000|NOT COMPLETED|Overall Study||8427
2982556|NCT00861380|3698782|FG001|NOT COMPLETED|Overall Study||9112
2982557|NCT00861380|3698783|FG002|NOT COMPLETED|Overall Study||8872
2982558|NCT00861380|3698784|FG003|NOT COMPLETED|Overall Study||3689
2982559|NCT00861380|3698785|FG004|NOT COMPLETED|Overall Study||1812
2982560|NCT00861380|3698786|FG005|NOT COMPLETED|Overall Study||6249
2982561|NCT00861380|3698787|FG006|NOT COMPLETED|Overall Study||3020
2982562|NCT00861471|3698820|FG000|STARTED|Overall Study||12
2982563|NCT00861471|3698820|FG000|COMPLETED|Overall Study||3
2982564|NCT00861471|3698820|FG000|NOT COMPLETED|Overall Study||9
2982565|NCT00861601|3698827|FG000|STARTED|Overall Study||12
2982566|NCT00861601|3698828|FG001|STARTED|Overall Study||14
2982567|NCT00861601|3698829|FG002|STARTED|Overall Study||12
2982568|NCT00861601|3698827|FG000|COMPLETED|Overall Study||12
2982569|NCT00861601|3698828|FG001|COMPLETED|Overall Study||14
2982570|NCT00861601|3698829|FG002|COMPLETED|Overall Study||12
2982571|NCT00861601|3698827|FG000|NOT COMPLETED|Overall Study||0
2982572|NCT00861601|3698828|FG001|NOT COMPLETED|Overall Study||0
2982573|NCT00861601|3698829|FG002|NOT COMPLETED|Overall Study||0
2982574|NCT00861614|3698842|FG000|STARTED|Overall Study||393
2982575|NCT00861614|3698843|FG001|STARTED|Overall Study||396
2982576|NCT00861614|3698842|FG000|COMPLETED|Overall Study||22
2982577|NCT00861614|3698843|FG001|COMPLETED|Overall Study||28
2982578|NCT00861614|3698842|FG000|NOT COMPLETED|Overall Study||371
2982579|NCT00861614|3698843|FG001|NOT COMPLETED|Overall Study||368
2982580|NCT00861692|3698849|FG000|STARTED|Overall Study||20
2982581|NCT00861692|3698849|FG000|COMPLETED|Overall Study||14
2982582|NCT00861692|3698849|FG000|NOT COMPLETED|Overall Study||6
2982583|NCT00861744|3698857|FG000|STARTED|Overall Study||304
2982584|NCT00861744|3698858|FG001|STARTED|Overall Study||304
2982585|NCT00861744|3698859|FG002|STARTED|Overall Study||304
2982586|NCT00861744|3698860|FG003|STARTED|Overall Study||308
2982587|NCT00861744|3698857|FG000|COMPLETED|Overall Study||287
2982588|NCT00861744|3698858|FG001|COMPLETED|Overall Study||275
2982589|NCT00861744|3698859|FG002|COMPLETED|Overall Study||280
2982590|NCT00861744|3698860|FG003|COMPLETED|Overall Study||275
2982591|NCT00861744|3698857|FG000|NOT COMPLETED|Overall Study||17
2982592|NCT00861744|3698858|FG001|NOT COMPLETED|Overall Study||29
2982593|NCT00861744|3698859|FG002|NOT COMPLETED|Overall Study||24
2982594|NCT00861744|3698860|FG003|NOT COMPLETED|Overall Study||33
2982595|NCT00861757|3698874|FG000|STARTED|Overall Study||154
2982596|NCT00861757|3698875|FG001|STARTED|Overall Study||151
2982597|NCT00861757|3698876|FG002|STARTED|Overall Study||155
2982598|NCT00861757|3698877|FG003|STARTED|Overall Study||152
2982599|NCT00861757|3698874|FG000|COMPLETED|Overall Study||145
3303420|NCT02966834|4036705|FG000|STARTED|Follow-up (Up to 4 Weeks)||35
3303421|NCT02966834|4036706|FG001|STARTED|Follow-up (Up to 4 Weeks)||16
3303422|NCT02966834|4036707|FG002|STARTED|Follow-up (Up to 4 Weeks)|4 participants discontinued study treatment in Main study period and directly entered follow-up.|23
3303423|NCT02966834|4036708|FG003|STARTED|Follow-up (Up to 4 Weeks)|8 participants discontinued study treatment in Main Study period and directly entered follow-up.|27
3317006|NCT03122860|4050494|FG001|Full Analysis Set|Overall Study||115
2982600|NCT00861757|3698875|FG001|COMPLETED|Overall Study||136
2982601|NCT00861757|3698876|FG002|COMPLETED|Overall Study||137
2982602|NCT00861757|3698877|FG003|COMPLETED|Overall Study||143
2982603|NCT00861757|3698874|FG000|NOT COMPLETED|Overall Study||9
2982604|NCT00861757|3698875|FG001|NOT COMPLETED|Overall Study||15
2982605|NCT00861757|3698876|FG002|NOT COMPLETED|Overall Study||18
2982606|NCT00861757|3698877|FG003|NOT COMPLETED|Overall Study||9
2982607|NCT00861913|3698891|FG000|STARTED|Overall Study||13
2982608|NCT00861913|3698891|FG000|COMPLETED|Overall Study||13
2982609|NCT00861913|3698891|FG000|NOT COMPLETED|Overall Study||0
2982610|NCT00862082|3698897|FG000|STARTED|Overall Study||8
2982611|NCT00862082|3698898|FG001|STARTED|Overall Study||6
2982612|NCT00862082|3698897|FG000|COMPLETED|Overall Study||3
2982613|NCT00862082|3698898|FG001|COMPLETED|Overall Study||5
2982614|NCT00862082|3698897|FG000|NOT COMPLETED|Overall Study||5
2982615|NCT00862082|3698898|FG001|NOT COMPLETED|Overall Study||1
2982616|NCT00862121|3698913|FG000|STARTED|Overall Study||8
2982617|NCT00862121|3698914|FG001|STARTED|Overall Study|Randomised, intent-to-treat (ITT)|12
2982618|NCT00862121|3698913|FG000|Full Analysis Set (FAS)|Overall Study|One participant had no evaluable post-baseline CDAI score.|7
3164319|NCT01892189|3891778|FG000|STARTED|First Intervention Period (1 Day)||3
3164320|NCT01892189|3891779|FG001|STARTED|First Intervention Period (1 Day)||3
3164321|NCT01892189|3891780|FG002|STARTED|First Intervention Period (1 Day)||3
3164322|NCT01892189|3891781|FG003|STARTED|First Intervention Period (1 Day)||3
3164323|NCT01892189|3891782|FG004|STARTED|First Intervention Period (1 Day)||3
3164324|NCT01892189|3891783|FG005|STARTED|First Intervention Period (1 Day)||3
3164325|NCT01892189|3891784|FG006|STARTED|First Intervention Period (1 Day)||3
3164326|NCT01892189|3891785|FG007|STARTED|First Intervention Period (1 Day)||3
3164327|NCT01892189|3891786|FG008|STARTED|First Intervention Period (1 Day)||3
3164328|NCT01892189|3891778|FG000|COMPLETED|First Intervention Period (1 Day)||3
3164329|NCT01892189|3891779|FG001|COMPLETED|First Intervention Period (1 Day)||3
3164330|NCT01892189|3891780|FG002|COMPLETED|First Intervention Period (1 Day)||3
2982619|NCT00862121|3698914|FG001|Full Analysis Set (FAS)|Overall Study|One participant randomised in error (no IMP taken).|11
2982620|NCT00862121|3698913|FG000|Safety Analysis Set|Overall Study|The participant with no evaluable post-baseline CDAI score was included in the Safety Analysis Set.|8
2982621|NCT00862121|3698914|FG001|Safety Analysis Set|Overall Study||11
2982622|NCT00862121|3698913|FG000|COMPLETED|Overall Study||7
2982623|NCT00862121|3698914|FG001|COMPLETED|Overall Study||4
2982624|NCT00862121|3698913|FG000|NOT COMPLETED|Overall Study||1
2982625|NCT00862121|3698914|FG001|NOT COMPLETED|Overall Study||8
2982626|NCT00862134|3698922|FG000|STARTED|Overall Study||19
2982627|NCT00862134|3698923|FG001|STARTED|Overall Study||23
2982628|NCT00862134|3698922|FG000|COMPLETED|Overall Study||8
2982629|NCT00862134|3698923|FG001|COMPLETED|Overall Study||11
2982630|NCT00862134|3698922|FG000|NOT COMPLETED|Overall Study||11
2982631|NCT00862134|3698923|FG001|NOT COMPLETED|Overall Study||12
2982632|NCT00862186|3698929|FG000|STARTED|Overall Study||15
2982633|NCT00862186|3698929|FG000|COMPLETED|Overall Study||15
2982634|NCT00862186|3698929|FG000|NOT COMPLETED|Overall Study||0
3164331|NCT01892189|3891781|FG003|COMPLETED|First Intervention Period (1 Day)||3
3164332|NCT01892189|3891782|FG004|COMPLETED|First Intervention Period (1 Day)||3
2982635|NCT00862277|3698937|FG000|STARTED|Overall Study||561
2982636|NCT00862277|3698938|FG001|STARTED|Overall Study||96
2982637|NCT00862277|3698939|FG002|STARTED|Overall Study||105
2982638|NCT00862277|3698937|FG000|COMPLETED|Overall Study||560
2982639|NCT00862277|3698938|FG001|COMPLETED|Overall Study||94
2982640|NCT00862277|3698939|FG002|COMPLETED|Overall Study||100
2982641|NCT00862277|3698937|FG000|NOT COMPLETED|Overall Study||1
2982642|NCT00862277|3698938|FG001|NOT COMPLETED|Overall Study||2
2982643|NCT00862277|3698939|FG002|NOT COMPLETED|Overall Study||5
2982644|NCT00862446|3698947|FG000|STARTED|Overall Study||48
2982645|NCT00862446|3698947|FG000|COMPLETED|Overall Study||48
2982646|NCT00862446|3698947|FG000|NOT COMPLETED|Overall Study||0
2982647|NCT00862459|3698954|FG000|STARTED|Overall Study||72
2982648|NCT00862459|3698955|FG001|STARTED|Overall Study||93
2982649|NCT00862459|3698956|FG002|STARTED|Overall Study||72
2982650|NCT00862459|3698954|FG000|Participants Received Treatment|Overall Study|Number reflects all treated participants of whom 67 received Gadobutrol and 70 received OptiMARK|70
2982651|NCT00862459|3698955|FG001|Participants Received Treatment|Overall Study|Number reflects all treated participants of whom 90 received Gadobutrol and 88 received OptiMARK|90
2982652|NCT00862459|3698956|FG002|Participants Received Treatment|Overall Study|Number reflects all treated participants of whom 68 received Gadobutrol and 69 received OptiMARK|69
2982653|NCT00862459|3698954|FG000|COMPLETED|Overall Study||66
2982654|NCT00862459|3698955|FG001|COMPLETED|Overall Study||85
2982655|NCT00862459|3698956|FG002|COMPLETED|Overall Study||66
2982656|NCT00862459|3698954|FG000|NOT COMPLETED|Overall Study||6
2982657|NCT00862459|3698955|FG001|NOT COMPLETED|Overall Study||8
2982658|NCT00862459|3698956|FG002|NOT COMPLETED|Overall Study||6
2982659|NCT00862537|3698965|FG000|STARTED|Overall Study||18
2982660|NCT00862537|3698965|FG000|COMPLETED|Overall Study||11
2982661|NCT00862537|3698965|FG000|NOT COMPLETED|Overall Study||7
2982662|NCT00862563|3698973|FG000|STARTED|Overall Study||19
2982663|NCT00862563|3698974|FG001|STARTED|Overall Study||21
2982664|NCT00862563|3698975|FG002|STARTED|Overall Study||21
2982665|NCT00862563|3698976|FG003|STARTED|Overall Study||24
2982666|NCT00862563|3698973|FG000|COMPLETED|Overall Study||15
2982667|NCT00862563|3698974|FG001|COMPLETED|Overall Study||17
2982668|NCT00862563|3698975|FG002|COMPLETED|Overall Study||15
2982669|NCT00862563|3698976|FG003|COMPLETED|Overall Study||19
2982670|NCT00862563|3698973|FG000|NOT COMPLETED|Overall Study||4
2982671|NCT00862563|3698974|FG001|NOT COMPLETED|Overall Study||4
2982672|NCT00862563|3698975|FG002|NOT COMPLETED|Overall Study||6
2982673|NCT00862563|3698976|FG003|NOT COMPLETED|Overall Study||5
2982674|NCT00862641|3698999|FG000|STARTED|Overall Study||177
2982675|NCT00862641|3699000|FG001|STARTED|Overall Study||360
2982676|NCT00862641|3699001|FG002|STARTED|Overall Study||152
2982677|NCT00862641|3699002|FG003|STARTED|Overall Study||320
2982678|NCT00862641|3698999|FG000|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|176
2982679|NCT00862641|3699000|FG001|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|356
2982680|NCT00862641|3699001|FG002|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|151
2982681|NCT00862641|3699002|FG003|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|316
2982682|NCT00862641|3698999|FG000|NOT COMPLETED|Overall Study||1
2982683|NCT00862641|3699000|FG001|NOT COMPLETED|Overall Study||4
2982684|NCT00862641|3699001|FG002|NOT COMPLETED|Overall Study||1
2982685|NCT00862641|3699002|FG003|NOT COMPLETED|Overall Study||4
2982686|NCT00862654|3699016|FG000|STARTED|Overall Study||82
2982687|NCT00862654|3699017|FG001|STARTED|Overall Study||82
2982688|NCT00862654|3699018|FG002|STARTED|Overall Study||82
2982689|NCT00862654|3699019|FG003|STARTED|Overall Study||80
2982690|NCT00862654|3699016|FG000|COMPLETED|Overall Study||76
2982691|NCT00862654|3699017|FG001|COMPLETED|Overall Study||74
2982692|NCT00862654|3699018|FG002|COMPLETED|Overall Study||76
2982693|NCT00862654|3699019|FG003|COMPLETED|Overall Study||74
2982694|NCT00862654|3699016|FG000|NOT COMPLETED|Overall Study||6
2982695|NCT00862654|3699017|FG001|NOT COMPLETED|Overall Study||8
2982696|NCT00862654|3699018|FG002|NOT COMPLETED|Overall Study||6
2982697|NCT00862654|3699019|FG003|NOT COMPLETED|Overall Study||6
2982698|NCT00862719|3699033|FG000|STARTED|Overall Study||17
2982699|NCT00862719|3699034|FG001|STARTED|Overall Study||7
2982700|NCT00862719|3699035|FG002|STARTED|Overall Study||4
2982701|NCT00862719|3699036|FG003|STARTED|Overall Study||1
2982702|NCT00862719|3699033|FG000|COMPLETED|Overall Study||7
2982703|NCT00862719|3699034|FG001|COMPLETED|Overall Study||1
2982704|NCT00862719|3699035|FG002|COMPLETED|Overall Study||0
2982705|NCT00862719|3699036|FG003|COMPLETED|Overall Study||0
2982706|NCT00862719|3699033|FG000|NOT COMPLETED|Overall Study||10
2982707|NCT00862719|3699034|FG001|NOT COMPLETED|Overall Study||6
2982708|NCT00862719|3699035|FG002|NOT COMPLETED|Overall Study||4
2982709|NCT00862719|3699036|FG003|NOT COMPLETED|Overall Study||1
2982710|NCT00862745|3699048|FG000|STARTED|Randomized Control Trial||322
2982711|NCT00862745|3699049|FG001|STARTED|Randomized Control Trial||323
2982712|NCT00862745|3699048|FG000|COMPLETED|Randomized Control Trial||284
2982713|NCT00862745|3699049|FG001|COMPLETED|Randomized Control Trial||284
2982714|NCT00862745|3699048|FG000|NOT COMPLETED|Randomized Control Trial||38
2982715|NCT00862745|3699049|FG001|NOT COMPLETED|Randomized Control Trial||39
2982716|NCT00862745|3699048|FG000|STARTED|Open-label Follow-up|19 participants elected not to enter the open-label portion of the study after completing the RCT.|268
2982717|NCT00862745|3699049|FG001|STARTED|Open-label Follow-up|10 participants elected not to enter the open-label portion of the study after completing the RCT.|274
2982718|NCT00862745|3699048|FG000|COMPLETED|Open-label Follow-up||229
2982719|NCT00862745|3699049|FG001|COMPLETED|Open-label Follow-up||225
2982720|NCT00862745|3699048|FG000|NOT COMPLETED|Open-label Follow-up||39
2982721|NCT00862745|3699049|FG001|NOT COMPLETED|Open-label Follow-up||49
3133411|NCT01695304|3858351|FG000|COMPLETED|Overall Study|2 deaths & 1 drop out in the intervention group, contributed some information over the 26 weeks|120
3133412|NCT01695304|3858352|FG001|COMPLETED|Overall Study|3 deaths & 2 drop out in the intervention group, contributed some information over the 26 weeks|120
3133413|NCT01695304|3858351|FG000|NOT COMPLETED|Overall Study||0
3133414|NCT01695304|3858352|FG001|NOT COMPLETED|Overall Study||0
3133415|NCT01695330|3858360|FG000|STARTED|Overall Study||52
3133416|NCT01695330|3858361|FG001|STARTED|Overall Study||0
2982722|NCT00862784|3699055|FG000|STARTED|Overall Study||48
2982723|NCT00862784|3699055|FG000|Received Any Amount of Study Drug|Overall Study||48
2982724|NCT00862784|3699055|FG000|COMPLETED|Overall Study||48
2982725|NCT00862784|3699055|FG000|NOT COMPLETED|Overall Study||0
2982726|NCT00862810|3699061|FG000|STARTED|Overall Study||33
2982727|NCT00862810|3699062|FG001|STARTED|Overall Study||39
2982728|NCT00862810|3699061|FG000|COMPLETED|Overall Study||29
3133417|NCT01695330|3858360|FG000|COMPLETED|Overall Study||5
3133418|NCT01695330|3858361|FG001|COMPLETED|Overall Study||0
3133419|NCT01695330|3858360|FG000|NOT COMPLETED|Overall Study||47
2982729|NCT00862810|3699062|FG001|COMPLETED|Overall Study||35
2982730|NCT00862810|3699061|FG000|NOT COMPLETED|Overall Study||4
2982731|NCT00862810|3699062|FG001|NOT COMPLETED|Overall Study||4
2982732|NCT00862823|3699068|FG000|STARTED|First Intervention||6
2982733|NCT00862823|3699069|FG001|STARTED|First Intervention||10
2982734|NCT00862823|3699068|FG000|COMPLETED|First Intervention||5
2982735|NCT00862823|3699069|FG001|COMPLETED|First Intervention||9
2982736|NCT00862823|3699068|FG000|NOT COMPLETED|First Intervention||1
2982737|NCT00862823|3699069|FG001|NOT COMPLETED|First Intervention||1
2982738|NCT00862823|3699068|FG000|STARTED|Washout Period of 2 Weeks||5
2982739|NCT00862823|3699069|FG001|STARTED|Washout Period of 2 Weeks||9
2982740|NCT00862823|3699068|FG000|COMPLETED|Washout Period of 2 Weeks||5
2982741|NCT00862823|3699069|FG001|COMPLETED|Washout Period of 2 Weeks||9
2982742|NCT00862823|3699068|FG000|NOT COMPLETED|Washout Period of 2 Weeks||0
2982743|NCT00862823|3699069|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0
2982744|NCT00862823|3699068|FG000|STARTED|Second Intervention||5
2982745|NCT00862823|3699069|FG001|STARTED|Second Intervention||9
2982746|NCT00862823|3699068|FG000|COMPLETED|Second Intervention||5
2982747|NCT00862823|3699069|FG001|COMPLETED|Second Intervention||9
2982748|NCT00862823|3699068|FG000|NOT COMPLETED|Second Intervention||0
2982749|NCT00862823|3699069|FG001|NOT COMPLETED|Second Intervention||0
2982750|NCT00862836|3699074|FG000|STARTED|Overall Study||15
2982751|NCT00862836|3699074|FG000|Evaluable for Safety/Toxicity|Overall Study|1 patient withdrew consent before first cycle|14
2982752|NCT00862836|3699074|FG000|Evaluable for Activity (Tumour Response)|Overall Study||10
2982753|NCT00862836|3699074|FG000|COMPLETED|Overall Study||14
2982754|NCT00862836|3699074|FG000|NOT COMPLETED|Overall Study||1
2982755|NCT00862849|3699078|FG000|STARTED|Intervention 1||3
2982756|NCT00862849|3699079|FG001|STARTED|Intervention 1||5
2982757|NCT00862849|3699080|FG002|STARTED|Intervention 1||3
2982758|NCT00862849|3699081|FG003|STARTED|Intervention 1||4
2982759|NCT00862849|3699082|FG004|STARTED|Intervention 1||4
2982760|NCT00862849|3699083|FG005|STARTED|Intervention 1||3
2982761|NCT00862849|3699078|FG000|Received at Least One Dose of Study Drug|Intervention 1||3
2982762|NCT00862849|3699079|FG001|Received at Least One Dose of Study Drug|Intervention 1||5
2982763|NCT00862849|3699080|FG002|Received at Least One Dose of Study Drug|Intervention 1||3
2982764|NCT00862849|3699081|FG003|Received at Least One Dose of Study Drug|Intervention 1||4
2982765|NCT00862849|3699082|FG004|Received at Least One Dose of Study Drug|Intervention 1||4
2982766|NCT00862849|3699083|FG005|Received at Least One Dose of Study Drug|Intervention 1||3
2982767|NCT00862849|3699078|FG000|COMPLETED|Intervention 1||3
2982768|NCT00862849|3699079|FG001|COMPLETED|Intervention 1||5
2982769|NCT00862849|3699080|FG002|COMPLETED|Intervention 1||3
2982770|NCT00862849|3699081|FG003|COMPLETED|Intervention 1||4
2982771|NCT00862849|3699082|FG004|COMPLETED|Intervention 1||4
2982772|NCT00862849|3699083|FG005|COMPLETED|Intervention 1||3
2982773|NCT00862849|3699078|FG000|NOT COMPLETED|Intervention 1||0
2982774|NCT00862849|3699079|FG001|NOT COMPLETED|Intervention 1||0
2982775|NCT00862849|3699080|FG002|NOT COMPLETED|Intervention 1||0
2982776|NCT00862849|3699081|FG003|NOT COMPLETED|Intervention 1||0
2982777|NCT00862849|3699082|FG004|NOT COMPLETED|Intervention 1||0
2982778|NCT00862849|3699083|FG005|NOT COMPLETED|Intervention 1||0
2982779|NCT00862849|3699078|FG000|STARTED|Washout 1 (3 to 14 Days)||3
2982780|NCT00862849|3699079|FG001|STARTED|Washout 1 (3 to 14 Days)||5
2982781|NCT00862849|3699080|FG002|STARTED|Washout 1 (3 to 14 Days)||3
2982782|NCT00862849|3699081|FG003|STARTED|Washout 1 (3 to 14 Days)||4
2982783|NCT00862849|3699082|FG004|STARTED|Washout 1 (3 to 14 Days)||4
2982784|NCT00862849|3699083|FG005|STARTED|Washout 1 (3 to 14 Days)||3
2982785|NCT00862849|3699078|FG000|COMPLETED|Washout 1 (3 to 14 Days)||3
2982786|NCT00862849|3699079|FG001|COMPLETED|Washout 1 (3 to 14 Days)||4
2982787|NCT00862849|3699080|FG002|COMPLETED|Washout 1 (3 to 14 Days)||3
2982788|NCT00862849|3699081|FG003|COMPLETED|Washout 1 (3 to 14 Days)||4
2982789|NCT00862849|3699082|FG004|COMPLETED|Washout 1 (3 to 14 Days)||4
2982790|NCT00862849|3699083|FG005|COMPLETED|Washout 1 (3 to 14 Days)||3
2982791|NCT00862849|3699078|FG000|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
2982792|NCT00862849|3699079|FG001|NOT COMPLETED|Washout 1 (3 to 14 Days)||1
2982793|NCT00862849|3699080|FG002|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
2982794|NCT00862849|3699081|FG003|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
2982795|NCT00862849|3699082|FG004|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
2982796|NCT00862849|3699083|FG005|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
2982797|NCT00862849|3699078|FG000|STARTED|Intervention 2||3
2982798|NCT00862849|3699079|FG001|STARTED|Intervention 2||4
2982799|NCT00862849|3699080|FG002|STARTED|Intervention 2||3
2982800|NCT00862849|3699081|FG003|STARTED|Intervention 2||4
2982801|NCT00862849|3699082|FG004|STARTED|Intervention 2||4
2982802|NCT00862849|3699083|FG005|STARTED|Intervention 2||3
2982803|NCT00862849|3699078|FG000|COMPLETED|Intervention 2||3
2982804|NCT00862849|3699079|FG001|COMPLETED|Intervention 2||4
2982805|NCT00862849|3699080|FG002|COMPLETED|Intervention 2||3
2982806|NCT00862849|3699081|FG003|COMPLETED|Intervention 2||4
2982807|NCT00862849|3699082|FG004|COMPLETED|Intervention 2||4
2982808|NCT00862849|3699083|FG005|COMPLETED|Intervention 2||3
2982809|NCT00862849|3699078|FG000|NOT COMPLETED|Intervention 2||0
2982810|NCT00862849|3699079|FG001|NOT COMPLETED|Intervention 2||0
2982811|NCT00862849|3699080|FG002|NOT COMPLETED|Intervention 2||0
2982812|NCT00862849|3699081|FG003|NOT COMPLETED|Intervention 2||0
2982813|NCT00862849|3699082|FG004|NOT COMPLETED|Intervention 2||0
2982814|NCT00862849|3699083|FG005|NOT COMPLETED|Intervention 2||0
2982815|NCT00862849|3699078|FG000|STARTED|Washout 2 (3 to 14 Days)||3
2982816|NCT00862849|3699079|FG001|STARTED|Washout 2 (3 to 14 Days)||4
2982817|NCT00862849|3699080|FG002|STARTED|Washout 2 (3 to 14 Days)||3
2982818|NCT00862849|3699081|FG003|STARTED|Washout 2 (3 to 14 Days)||4
2982819|NCT00862849|3699082|FG004|STARTED|Washout 2 (3 to 14 Days)||4
2982820|NCT00862849|3699083|FG005|STARTED|Washout 2 (3 to 14 Days)||3
2982821|NCT00862849|3699078|FG000|COMPLETED|Washout 2 (3 to 14 Days)||3
2982822|NCT00862849|3699079|FG001|COMPLETED|Washout 2 (3 to 14 Days)||3
2982823|NCT00862849|3699080|FG002|COMPLETED|Washout 2 (3 to 14 Days)||3
2982824|NCT00862849|3699081|FG003|COMPLETED|Washout 2 (3 to 14 Days)||4
2982825|NCT00862849|3699082|FG004|COMPLETED|Washout 2 (3 to 14 Days)||4
2982826|NCT00862849|3699083|FG005|COMPLETED|Washout 2 (3 to 14 Days)||3
2982827|NCT00862849|3699078|FG000|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
2982828|NCT00862849|3699079|FG001|NOT COMPLETED|Washout 2 (3 to 14 Days)||1
2982829|NCT00862849|3699080|FG002|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
2982830|NCT00862849|3699081|FG003|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
2982831|NCT00862849|3699082|FG004|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
2982832|NCT00862849|3699083|FG005|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
2982833|NCT00862849|3699078|FG000|STARTED|Intervention 3||3
2982834|NCT00862849|3699079|FG001|STARTED|Intervention 3||3
2982835|NCT00862849|3699080|FG002|STARTED|Intervention 3||3
2982836|NCT00862849|3699081|FG003|STARTED|Intervention 3||4
2982837|NCT00862849|3699082|FG004|STARTED|Intervention 3||4
2982838|NCT00862849|3699083|FG005|STARTED|Intervention 3||3
2982839|NCT00862849|3699078|FG000|COMPLETED|Intervention 3||3
2982840|NCT00862849|3699079|FG001|COMPLETED|Intervention 3||3
2982841|NCT00862849|3699080|FG002|COMPLETED|Intervention 3||3
2982842|NCT00862849|3699081|FG003|COMPLETED|Intervention 3||4
2982843|NCT00862849|3699082|FG004|COMPLETED|Intervention 3||4
2982844|NCT00862849|3699083|FG005|COMPLETED|Intervention 3||3
2982845|NCT00862849|3699078|FG000|NOT COMPLETED|Intervention 3||0
2982846|NCT00862849|3699079|FG001|NOT COMPLETED|Intervention 3||0
2982847|NCT00862849|3699080|FG002|NOT COMPLETED|Intervention 3||0
2982848|NCT00862849|3699081|FG003|NOT COMPLETED|Intervention 3||0
2982849|NCT00862849|3699082|FG004|NOT COMPLETED|Intervention 3||0
2982850|NCT00862849|3699083|FG005|NOT COMPLETED|Intervention 3||0
2982851|NCT00862849|3699078|FG000|STARTED|Washout 3 (3 to 14 Days)||3
2982852|NCT00862849|3699079|FG001|STARTED|Washout 3 (3 to 14 Days)||3
2982853|NCT00862849|3699080|FG002|STARTED|Washout 3 (3 to 14 Days)||3
2982854|NCT00862849|3699081|FG003|STARTED|Washout 3 (3 to 14 Days)||4
2982855|NCT00862849|3699082|FG004|STARTED|Washout 3 (3 to 14 Days)||4
2982856|NCT00862849|3699083|FG005|STARTED|Washout 3 (3 to 14 Days)||3
2982857|NCT00862849|3699078|FG000|COMPLETED|Washout 3 (3 to 14 Days)||3
2982858|NCT00862849|3699079|FG001|COMPLETED|Washout 3 (3 to 14 Days)||3
2982859|NCT00862849|3699080|FG002|COMPLETED|Washout 3 (3 to 14 Days)||3
2982860|NCT00862849|3699081|FG003|COMPLETED|Washout 3 (3 to 14 Days)||4
2982861|NCT00862849|3699082|FG004|COMPLETED|Washout 3 (3 to 14 Days)||4
2982862|NCT00862849|3699083|FG005|COMPLETED|Washout 3 (3 to 14 Days)||3
2982863|NCT00862849|3699078|FG000|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
2982864|NCT00862849|3699079|FG001|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
2982865|NCT00862849|3699080|FG002|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
2982866|NCT00862849|3699081|FG003|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
2982867|NCT00862849|3699082|FG004|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
2982868|NCT00862849|3699083|FG005|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
2982869|NCT00862849|3699078|FG000|STARTED|Intervention 4||3
2982870|NCT00862849|3699079|FG001|STARTED|Intervention 4||3
2982871|NCT00862849|3699080|FG002|STARTED|Intervention 4||3
2982872|NCT00862849|3699081|FG003|STARTED|Intervention 4||4
2982873|NCT00862849|3699082|FG004|STARTED|Intervention 4||4
2982874|NCT00862849|3699083|FG005|STARTED|Intervention 4||3
2982875|NCT00862849|3699078|FG000|COMPLETED|Intervention 4||3
2982876|NCT00862849|3699079|FG001|COMPLETED|Intervention 4||3
2982877|NCT00862849|3699080|FG002|COMPLETED|Intervention 4||3
2982878|NCT00862849|3699081|FG003|COMPLETED|Intervention 4||4
2982879|NCT00862849|3699082|FG004|COMPLETED|Intervention 4||4
2982880|NCT00862849|3699083|FG005|COMPLETED|Intervention 4||3
2982881|NCT00862849|3699078|FG000|NOT COMPLETED|Intervention 4||0
2982882|NCT00862849|3699079|FG001|NOT COMPLETED|Intervention 4||0
2982883|NCT00862849|3699080|FG002|NOT COMPLETED|Intervention 4||0
2982884|NCT00862849|3699081|FG003|NOT COMPLETED|Intervention 4||0
2982885|NCT00862849|3699082|FG004|NOT COMPLETED|Intervention 4||0
2982886|NCT00862849|3699083|FG005|NOT COMPLETED|Intervention 4||0
2982887|NCT00862849|3699078|FG000|STARTED|Washout 4 (3 to 14 Days)||3
2982888|NCT00862849|3699079|FG001|STARTED|Washout 4 (3 to 14 Days)||3
2982889|NCT00862849|3699080|FG002|STARTED|Washout 4 (3 to 14 Days)||3
2982890|NCT00862849|3699081|FG003|STARTED|Washout 4 (3 to 14 Days)||4
2982891|NCT00862849|3699082|FG004|STARTED|Washout 4 (3 to 14 Days)||4
2982892|NCT00862849|3699083|FG005|STARTED|Washout 4 (3 to 14 Days)||3
2982893|NCT00862849|3699078|FG000|COMPLETED|Washout 4 (3 to 14 Days)||3
2982894|NCT00862849|3699079|FG001|COMPLETED|Washout 4 (3 to 14 Days)||3
2982895|NCT00862849|3699080|FG002|COMPLETED|Washout 4 (3 to 14 Days)||3
2982896|NCT00862849|3699081|FG003|COMPLETED|Washout 4 (3 to 14 Days)||4
2982897|NCT00862849|3699082|FG004|COMPLETED|Washout 4 (3 to 14 Days)||4
2982898|NCT00862849|3699083|FG005|COMPLETED|Washout 4 (3 to 14 Days)||3
2982899|NCT00862849|3699078|FG000|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
2982900|NCT00862849|3699079|FG001|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
2982901|NCT00862849|3699080|FG002|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
2982902|NCT00862849|3699081|FG003|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
2982903|NCT00862849|3699082|FG004|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
2982904|NCT00862849|3699083|FG005|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
2982905|NCT00862849|3699078|FG000|STARTED|Intervention 5||3
2982906|NCT00862849|3699079|FG001|STARTED|Intervention 5||3
3133420|NCT01695330|3858361|FG001|NOT COMPLETED|Overall Study||0
3133421|NCT01695369|3858365|FG000|STARTED|Overall Study||61
3303424|NCT02966834|4036709|FG004|STARTED|Follow-up (Up to 4 Weeks)|1 participant who completed main study period directly entered follow-up in this arm|22
2982907|NCT00862849|3699080|FG002|STARTED|Intervention 5||3
2982908|NCT00862849|3699081|FG003|STARTED|Intervention 5||4
2982909|NCT00862849|3699082|FG004|STARTED|Intervention 5||4
2982910|NCT00862849|3699083|FG005|STARTED|Intervention 5||3
2982911|NCT00862849|3699078|FG000|COMPLETED|Intervention 5||3
2982912|NCT00862849|3699079|FG001|COMPLETED|Intervention 5||3
3303425|NCT02966834|4036710|FG005|STARTED|Follow-up (Up to 4 Weeks)|5 participants discontinued study treatment in Main study period and directly entered follow-up|22
3303426|NCT02966834|4036705|FG000|COMPLETED|Follow-up (Up to 4 Weeks)||35
3303427|NCT02966834|4036706|FG001|COMPLETED|Follow-up (Up to 4 Weeks)||16
3303428|NCT02966834|4036707|FG002|COMPLETED|Follow-up (Up to 4 Weeks)||22
3303429|NCT02966834|4036708|FG003|COMPLETED|Follow-up (Up to 4 Weeks)||22
3303430|NCT02966834|4036709|FG004|COMPLETED|Follow-up (Up to 4 Weeks)||22
3303431|NCT02966834|4036710|FG005|COMPLETED|Follow-up (Up to 4 Weeks)||21
3303432|NCT02966834|4036705|FG000|NOT COMPLETED|Follow-up (Up to 4 Weeks)||0
3303433|NCT02966834|4036706|FG001|NOT COMPLETED|Follow-up (Up to 4 Weeks)||0
2982913|NCT00862849|3699080|FG002|COMPLETED|Intervention 5||3
2982914|NCT00862849|3699081|FG003|COMPLETED|Intervention 5||4
2982915|NCT00862849|3699082|FG004|COMPLETED|Intervention 5||4
2982916|NCT00862849|3699083|FG005|COMPLETED|Intervention 5||3
2982917|NCT00862849|3699078|FG000|NOT COMPLETED|Intervention 5||0
2982918|NCT00862849|3699079|FG001|NOT COMPLETED|Intervention 5||0
2982919|NCT00862849|3699080|FG002|NOT COMPLETED|Intervention 5||0
2982920|NCT00862849|3699081|FG003|NOT COMPLETED|Intervention 5||0
2982921|NCT00862849|3699082|FG004|NOT COMPLETED|Intervention 5||0
2982922|NCT00862849|3699083|FG005|NOT COMPLETED|Intervention 5||0
2982923|NCT00862849|3699078|FG000|STARTED|Washout 5 (3 to 14 Days)||3
2982924|NCT00862849|3699079|FG001|STARTED|Washout 5 (3 to 14 Days)||3
2982925|NCT00862849|3699080|FG002|STARTED|Washout 5 (3 to 14 Days)||3
2982926|NCT00862849|3699081|FG003|STARTED|Washout 5 (3 to 14 Days)||4
2982927|NCT00862849|3699082|FG004|STARTED|Washout 5 (3 to 14 Days)||4
2982928|NCT00862849|3699083|FG005|STARTED|Washout 5 (3 to 14 Days)||3
2982929|NCT00862849|3699078|FG000|COMPLETED|Washout 5 (3 to 14 Days)||3
2982930|NCT00862849|3699079|FG001|COMPLETED|Washout 5 (3 to 14 Days)||3
2982931|NCT00862849|3699080|FG002|COMPLETED|Washout 5 (3 to 14 Days)||3
2982932|NCT00862849|3699081|FG003|COMPLETED|Washout 5 (3 to 14 Days)||4
2982933|NCT00862849|3699082|FG004|COMPLETED|Washout 5 (3 to 14 Days)||4
2982934|NCT00862849|3699083|FG005|COMPLETED|Washout 5 (3 to 14 Days)||3
2982935|NCT00862849|3699078|FG000|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
2982936|NCT00862849|3699079|FG001|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
2982937|NCT00862849|3699080|FG002|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
2982938|NCT00862849|3699081|FG003|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
2982939|NCT00862849|3699082|FG004|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
2982940|NCT00862849|3699083|FG005|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
2982941|NCT00862849|3699078|FG000|STARTED|Intervention 6||3
2982942|NCT00862849|3699079|FG001|STARTED|Intervention 6||3
2982943|NCT00862849|3699080|FG002|STARTED|Intervention 6||3
2982944|NCT00862849|3699081|FG003|STARTED|Intervention 6||4
2982945|NCT00862849|3699082|FG004|STARTED|Intervention 6||4
3303434|NCT02966834|4036707|FG002|NOT COMPLETED|Follow-up (Up to 4 Weeks)||1
3303435|NCT02966834|4036708|FG003|NOT COMPLETED|Follow-up (Up to 4 Weeks)||5
3303436|NCT02966834|4036709|FG004|NOT COMPLETED|Follow-up (Up to 4 Weeks)||0
3303437|NCT02966834|4036710|FG005|NOT COMPLETED|Follow-up (Up to 4 Weeks)||1
3303438|NCT02967016|4036761|FG000|STARTED|Overall Study||25
3303439|NCT02967016|4036762|FG001|STARTED|Overall Study||25
3303440|NCT02967016|4036761|FG000|COMPLETED|Overall Study||25
3303441|NCT02967016|4036762|FG001|COMPLETED|Overall Study||25
3303442|NCT02967016|4036761|FG000|NOT COMPLETED|Overall Study||0
3303443|NCT02967016|4036762|FG001|NOT COMPLETED|Overall Study||0
3303444|NCT02967055|4036768|FG000|STARTED|Overall Study|Assessed for eligibility|54
3303445|NCT02967055|4036768|FG000|In-person Screening|Overall Study||14
3303446|NCT02967055|4036768|FG000|Enrolled|Overall Study|Enrolled|9
3303447|NCT02967055|4036768|FG000|Completed 4 Week Follow-up Visit|Overall Study||8
3303448|NCT02967055|4036768|FG000|COMPLETED|Overall Study||5
3303449|NCT02967055|4036768|FG000|NOT COMPLETED|Overall Study||49
3303450|NCT02967354|4036777|FG000|STARTED|Overall Study||8
3303451|NCT02967354|4036778|FG001|STARTED|Overall Study||7
3303452|NCT02967354|4036779|FG002|STARTED|Overall Study||9
3303453|NCT02967354|4036780|FG003|STARTED|Overall Study||7
3303454|NCT02967354|4036781|FG004|STARTED|Overall Study||8
3303455|NCT02967354|4036777|FG000|COMPLETED|Overall Study||8
3303456|NCT02967354|4036778|FG001|COMPLETED|Overall Study||7
2982946|NCT00862849|3699083|FG005|STARTED|Intervention 6||3
2982947|NCT00862849|3699078|FG000|COMPLETED|Intervention 6||3
2982948|NCT00862849|3699079|FG001|COMPLETED|Intervention 6||3
2982949|NCT00862849|3699080|FG002|COMPLETED|Intervention 6||3
2982950|NCT00862849|3699081|FG003|COMPLETED|Intervention 6||4
2982951|NCT00862849|3699082|FG004|COMPLETED|Intervention 6||4
2982952|NCT00862849|3699083|FG005|COMPLETED|Intervention 6||3
2982953|NCT00862849|3699078|FG000|NOT COMPLETED|Intervention 6||0
2982954|NCT00862849|3699079|FG001|NOT COMPLETED|Intervention 6||0
2982955|NCT00862849|3699080|FG002|NOT COMPLETED|Intervention 6||0
2982956|NCT00862849|3699081|FG003|NOT COMPLETED|Intervention 6||0
2982957|NCT00862849|3699082|FG004|NOT COMPLETED|Intervention 6||0
3133422|NCT01695369|3858365|FG000|COMPLETED|Overall Study||61
2982958|NCT00862849|3699083|FG005|NOT COMPLETED|Intervention 6||0
2982959|NCT00862940|3699093|FG000|STARTED|Overall Study||133
2982960|NCT00862940|3699094|FG001|STARTED|Overall Study||144
2982961|NCT00862940|3699093|FG000|COMPLETED|Overall Study||103
2982962|NCT00862940|3699094|FG001|COMPLETED|Overall Study||114
2982963|NCT00862940|3699093|FG000|NOT COMPLETED|Overall Study||30
2982964|NCT00862940|3699094|FG001|NOT COMPLETED|Overall Study||30
2982965|NCT00862979|3699102|FG000|STARTED|Overall Study||84
2982966|NCT00862979|3699103|FG001|STARTED|Overall Study||78
2982967|NCT00862979|3699102|FG000|Full Analysis Set (FAS)|Overall Study||74
2982968|NCT00862979|3699103|FG001|Full Analysis Set (FAS)|Overall Study||71
2982969|NCT00862979|3699102|FG000|COMPLETED|Overall Study||76
2982970|NCT00862979|3699103|FG001|COMPLETED|Overall Study||71
2982971|NCT00862979|3699102|FG000|NOT COMPLETED|Overall Study||8
2982972|NCT00862979|3699103|FG001|NOT COMPLETED|Overall Study||7
2982973|NCT00862992|3699112|FG000|STARTED|Overall Study||12
2982974|NCT00862992|3699113|FG001|STARTED|Overall Study||10
2982975|NCT00862992|3699114|FG002|STARTED|Overall Study||12
2982976|NCT00862992|3699112|FG000|COMPLETED|Overall Study||9
2982977|NCT00862992|3699113|FG001|COMPLETED|Overall Study||9
2982978|NCT00862992|3699114|FG002|COMPLETED|Overall Study||9
2982979|NCT00862992|3699112|FG000|NOT COMPLETED|Overall Study||3
3133423|NCT01695369|3858365|FG000|NOT COMPLETED|Overall Study||0
3133424|NCT01695473|3858371|FG000|STARTED|Overall Study||11
3133425|NCT01695473|3858371|FG000|COMPLETED|Overall Study||11
3133426|NCT01695473|3858371|FG000|NOT COMPLETED|Overall Study||0
3133427|NCT01695668|3858378|FG000|STARTED|Overall Study||38
3133428|NCT01695668|3858379|FG001|STARTED|Overall Study||37
2982980|NCT00862992|3699113|FG001|NOT COMPLETED|Overall Study||1
2982981|NCT00862992|3699114|FG002|NOT COMPLETED|Overall Study||3
2982982|NCT00863057|3699126|FG000|STARTED|Milestones Period 1 (Weeks 0-5)||4
2982983|NCT00863057|3699127|FG001|STARTED|Milestones Period 1 (Weeks 0-5)||4
2982984|NCT00863057|3699128|FG002|STARTED|Milestones Period 1 (Weeks 0-5)||3
2982985|NCT00863057|3699129|FG003|STARTED|Milestones Period 1 (Weeks 0-5)||4
2982986|NCT00863057|3699126|FG000|COMPLETED|Milestones Period 1 (Weeks 0-5)||3
2982987|NCT00863057|3699127|FG001|COMPLETED|Milestones Period 1 (Weeks 0-5)||2
2982988|NCT00863057|3699128|FG002|COMPLETED|Milestones Period 1 (Weeks 0-5)||3
2982989|NCT00863057|3699129|FG003|COMPLETED|Milestones Period 1 (Weeks 0-5)||3
2982990|NCT00863057|3699126|FG000|NOT COMPLETED|Milestones Period 1 (Weeks 0-5)||1
2982991|NCT00863057|3699127|FG001|NOT COMPLETED|Milestones Period 1 (Weeks 0-5)||2
2982992|NCT00863057|3699128|FG002|NOT COMPLETED|Milestones Period 1 (Weeks 0-5)||0
2982993|NCT00863057|3699129|FG003|NOT COMPLETED|Milestones Period 1 (Weeks 0-5)||1
2982994|NCT00863057|3699126|FG000|STARTED|Period 2 (Weeks 6-10)||3
2982995|NCT00863057|3699127|FG001|STARTED|Period 2 (Weeks 6-10)||2
2982996|NCT00863057|3699128|FG002|STARTED|Period 2 (Weeks 6-10)||3
2982997|NCT00863057|3699129|FG003|STARTED|Period 2 (Weeks 6-10)||3
2982998|NCT00863057|3699126|FG000|COMPLETED|Period 2 (Weeks 6-10)||3
2982999|NCT00863057|3699127|FG001|COMPLETED|Period 2 (Weeks 6-10)||1
2983000|NCT00863057|3699128|FG002|COMPLETED|Period 2 (Weeks 6-10)||2
2983001|NCT00863057|3699129|FG003|COMPLETED|Period 2 (Weeks 6-10)||2
2983002|NCT00863057|3699126|FG000|NOT COMPLETED|Period 2 (Weeks 6-10)||0
2983003|NCT00863057|3699127|FG001|NOT COMPLETED|Period 2 (Weeks 6-10)||1
2983004|NCT00863057|3699128|FG002|NOT COMPLETED|Period 2 (Weeks 6-10)||1
2983005|NCT00863057|3699129|FG003|NOT COMPLETED|Period 2 (Weeks 6-10)||1
2983006|NCT00863057|3699126|FG000|STARTED|Period 3 (Weeks 11-15)||3
2983007|NCT00863057|3699127|FG001|STARTED|Period 3 (Weeks 11-15)||1
2983008|NCT00863057|3699128|FG002|STARTED|Period 3 (Weeks 11-15)||2
2983009|NCT00863057|3699129|FG003|STARTED|Period 3 (Weeks 11-15)||2
2983010|NCT00863057|3699126|FG000|COMPLETED|Period 3 (Weeks 11-15)||3
2983011|NCT00863057|3699127|FG001|COMPLETED|Period 3 (Weeks 11-15)||1
2983012|NCT00863057|3699128|FG002|COMPLETED|Period 3 (Weeks 11-15)||2
2983013|NCT00863057|3699129|FG003|COMPLETED|Period 3 (Weeks 11-15)||2
2983014|NCT00863057|3699126|FG000|NOT COMPLETED|Period 3 (Weeks 11-15)||0
2983015|NCT00863057|3699127|FG001|NOT COMPLETED|Period 3 (Weeks 11-15)||0
2983016|NCT00863057|3699128|FG002|NOT COMPLETED|Period 3 (Weeks 11-15)||0
2983017|NCT00863057|3699129|FG003|NOT COMPLETED|Period 3 (Weeks 11-15)||0
2983018|NCT00863057|3699126|FG000|STARTED|Period 4 (Weeks 16-20)||3
3133429|NCT01695668|3858378|FG000|COMPLETED|Overall Study||23
3133430|NCT01695668|3858379|FG001|COMPLETED|Overall Study||20
3133431|NCT01695668|3858378|FG000|NOT COMPLETED|Overall Study||15
3133432|NCT01695668|3858379|FG001|NOT COMPLETED|Overall Study||17
3303457|NCT02967354|4036779|FG002|COMPLETED|Overall Study||9
3303458|NCT02967354|4036780|FG003|COMPLETED|Overall Study||7
3303459|NCT02967354|4036781|FG004|COMPLETED|Overall Study||8
3303460|NCT02967354|4036777|FG000|NOT COMPLETED|Overall Study||0
3303461|NCT02967354|4036778|FG001|NOT COMPLETED|Overall Study||0
3303462|NCT02967354|4036779|FG002|NOT COMPLETED|Overall Study||0
3303463|NCT02967354|4036780|FG003|NOT COMPLETED|Overall Study||0
3303464|NCT02967354|4036781|FG004|NOT COMPLETED|Overall Study||0
3303465|NCT02967367|4036798|FG000|STARTED|Overall Study||36
2983019|NCT00863057|3699127|FG001|STARTED|Period 4 (Weeks 16-20)||1
2983020|NCT00863057|3699128|FG002|STARTED|Period 4 (Weeks 16-20)||2
2983021|NCT00863057|3699129|FG003|STARTED|Period 4 (Weeks 16-20)||2
2983022|NCT00863057|3699126|FG000|COMPLETED|Period 4 (Weeks 16-20)||3
2983023|NCT00863057|3699127|FG001|COMPLETED|Period 4 (Weeks 16-20)||1
3133433|NCT01695746|3858385|FG000|STARTED|Overall Study||108
3133434|NCT01695746|3858385|FG000|COMPLETED|Overall Study||96
3133435|NCT01695746|3858385|FG000|NOT COMPLETED|Overall Study||12
2983024|NCT00863057|3699128|FG002|COMPLETED|Period 4 (Weeks 16-20)||2
2983025|NCT00863057|3699129|FG003|COMPLETED|Period 4 (Weeks 16-20)||2
2983026|NCT00863057|3699126|FG000|NOT COMPLETED|Period 4 (Weeks 16-20)||0
2983027|NCT00863057|3699127|FG001|NOT COMPLETED|Period 4 (Weeks 16-20)||0
2983028|NCT00863057|3699128|FG002|NOT COMPLETED|Period 4 (Weeks 16-20)||0
2983029|NCT00863057|3699129|FG003|NOT COMPLETED|Period 4 (Weeks 16-20)||0
2983030|NCT00863109|3699145|FG000|STARTED|Treatment Period||130
2983031|NCT00863109|3699145|FG000|COMPLETED|Treatment Period||53
2983032|NCT00863109|3699145|FG000|NOT COMPLETED|Treatment Period||77
2983033|NCT00863109|3699145|FG000|STARTED|Follow-up Period|Follow-up performed on 53 who completed Treatment Period plus 6 who discontinued treatment|59
2983034|NCT00863109|3699145|FG000|COMPLETED|Follow-up Period||48
2983035|NCT00863109|3699145|FG000|NOT COMPLETED|Follow-up Period||11
2983036|NCT00863122|3699153|FG000|STARTED|Overall Study||19
2983037|NCT00863122|3699154|FG001|STARTED|Overall Study||7
2983038|NCT00863122|3699153|FG000|COMPLETED|Overall Study||19
2983039|NCT00863122|3699154|FG001|COMPLETED|Overall Study||7
2983040|NCT00863122|3699153|FG000|NOT COMPLETED|Overall Study||0
2983041|NCT00863122|3699154|FG001|NOT COMPLETED|Overall Study||0
2983042|NCT00863265|3699164|FG000|STARTED|Overall Study||4
2983043|NCT00863265|3699165|FG001|STARTED|Overall Study||3
2983044|NCT00863265|3699166|FG002|STARTED|Overall Study||4
2983045|NCT00863265|3699167|FG003|STARTED|Overall Study||4
2983046|NCT00863265|3699168|FG004|STARTED|Overall Study||4
2983047|NCT00863265|3699169|FG005|STARTED|Overall Study||3
2983048|NCT00863265|3699164|FG000|COMPLETED|Overall Study||4
2983049|NCT00863265|3699165|FG001|COMPLETED|Overall Study||3
2983050|NCT00863265|3699166|FG002|COMPLETED|Overall Study||4
2983051|NCT00863265|3699167|FG003|COMPLETED|Overall Study||4
2983052|NCT00863265|3699168|FG004|COMPLETED|Overall Study||3
2983053|NCT00863265|3699169|FG005|COMPLETED|Overall Study||3
2983054|NCT00863265|3699164|FG000|NOT COMPLETED|Overall Study||0
2983055|NCT00863265|3699165|FG001|NOT COMPLETED|Overall Study||0
2983056|NCT00863265|3699166|FG002|NOT COMPLETED|Overall Study||0
2983057|NCT00863265|3699167|FG003|NOT COMPLETED|Overall Study||0
2983058|NCT00863265|3699168|FG004|NOT COMPLETED|Overall Study||1
2983059|NCT00863265|3699169|FG005|NOT COMPLETED|Overall Study||0
2983060|NCT00863304|3699187|FG000|STARTED|Overall Study||212
2983061|NCT00863304|3699188|FG001|STARTED|Overall Study||212
2983062|NCT00863304|3699189|FG002|STARTED|Overall Study||213
2983063|NCT00863304|3699190|FG003|STARTED|Overall Study||212
2983064|NCT00863304|3699187|FG000|Treated|Overall Study||209
2983065|NCT00863304|3699188|FG001|Treated|Overall Study||211
2983066|NCT00863304|3699189|FG002|Treated|Overall Study||209
2983067|NCT00863304|3699190|FG003|Treated|Overall Study||211
2983068|NCT00863304|3699187|FG000|COMPLETED|Overall Study||18
2983069|NCT00863304|3699188|FG001|COMPLETED|Overall Study||27
2983070|NCT00863304|3699189|FG002|COMPLETED|Overall Study||26
2983071|NCT00863304|3699190|FG003|COMPLETED|Overall Study||21
2983072|NCT00863304|3699187|FG000|NOT COMPLETED|Overall Study||194
2983073|NCT00863304|3699188|FG001|NOT COMPLETED|Overall Study||185
2983074|NCT00863304|3699189|FG002|NOT COMPLETED|Overall Study||187
2983075|NCT00863304|3699190|FG003|NOT COMPLETED|Overall Study||191
2983076|NCT00863317|3699204|FG000|STARTED|Overall Study||68
2983077|NCT00863317|3699205|FG001|STARTED|Overall Study||73
2983078|NCT00863317|3699204|FG000|COMPLETED|Overall Study||60
2983079|NCT00863317|3699205|FG001|COMPLETED|Overall Study||64
2983080|NCT00863317|3699204|FG000|NOT COMPLETED|Overall Study||8
2983081|NCT00863317|3699205|FG001|NOT COMPLETED|Overall Study||9
2983082|NCT00863343|3699213|FG000|STARTED|Overall Study||17
2983083|NCT00863343|3699214|FG001|STARTED|Overall Study||374
2983084|NCT00863343|3699213|FG000|COMPLETED|Overall Study||17
2983085|NCT00863343|3699214|FG001|COMPLETED|Overall Study||374
2983086|NCT00863343|3699213|FG000|NOT COMPLETED|Overall Study||0
2983087|NCT00863343|3699214|FG001|NOT COMPLETED|Overall Study||0
2983088|NCT00863356|3699222|FG000|STARTED|Overall Study||20
2983089|NCT00863356|3699222|FG000|COMPLETED|Overall Study||20
2983090|NCT00863356|3699222|FG000|NOT COMPLETED|Overall Study||0
2983091|NCT00863434|3699226|FG000|STARTED|Overall Study||2
2983092|NCT00863434|3699226|FG000|COMPLETED|Overall Study||2
2983093|NCT00863434|3699226|FG000|NOT COMPLETED|Overall Study||0
2983094|NCT00863551|3699230|FG000|STARTED|Overall Study||12
2983095|NCT00863551|3699230|FG000|COMPLETED|Overall Study||12
2983096|NCT00863551|3699230|FG000|NOT COMPLETED|Overall Study||0
2983097|NCT00863655|3699236|FG000|STARTED|Overall Study||485
2983098|NCT00863655|3699237|FG001|STARTED|Overall Study||239
2983099|NCT00863655|3699236|FG000|COMPLETED|Overall Study|Completed means discontinued the treatment period.|0
2983100|NCT00863655|3699237|FG001|COMPLETED|Overall Study|Completed means discontinued the treatment period.|0
2983101|NCT00863655|3699236|FG000|NOT COMPLETED|Overall Study||485
2983102|NCT00863655|3699237|FG001|NOT COMPLETED|Overall Study||239
2983103|NCT00863681|3699246|FG000|STARTED|Overall Study||231
2983104|NCT00863681|3699247|FG001|STARTED|Overall Study||109
2983105|NCT00863681|3699248|FG002|STARTED|Overall Study||56
2983106|NCT00863681|3699246|FG000|COMPLETED|Overall Study|Completed treatment|140
2983107|NCT00863681|3699247|FG001|COMPLETED|Overall Study|Completed treatment|66
2983108|NCT00863681|3699248|FG002|COMPLETED|Overall Study|Completed treatment|38
2983109|NCT00863681|3699246|FG000|NOT COMPLETED|Overall Study||91
2983110|NCT00863681|3699247|FG001|NOT COMPLETED|Overall Study||43
2983111|NCT00863681|3699248|FG002|NOT COMPLETED|Overall Study||18
2983112|NCT00863707|3699258|FG000|STARTED|Overall Study||174
2983113|NCT00863707|3699259|FG001|STARTED|Overall Study||337
2983114|NCT00863707|3699258|FG000|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|170
2983115|NCT00863707|3699259|FG001|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|334
2983116|NCT00863707|3699258|FG000|NOT COMPLETED|Overall Study||4
2983117|NCT00863707|3699259|FG001|NOT COMPLETED|Overall Study||3
2983118|NCT00863746|3699267|FG000|STARTED|Treatment||350
2983119|NCT00863746|3699268|FG001|STARTED|Treatment||353
2983120|NCT00863746|3699267|FG000|Participants Received Treatment|Treatment|Safety population|346
2983121|NCT00863746|3699268|FG001|Participants Received Treatment|Treatment|Safety population|351
2983122|NCT00863746|3699267|FG000|COMPLETED|Treatment||279
2983123|NCT00863746|3699268|FG001|COMPLETED|Treatment||318
2983124|NCT00863746|3699267|FG000|NOT COMPLETED|Treatment||71
2983125|NCT00863746|3699268|FG001|NOT COMPLETED|Treatment||35
2983126|NCT00863746|3699267|FG000|STARTED|Survival Follow up|298 patients of 317 patients (= 346 randomized - 29 deaths) entered the survival follow-up|298
2983127|NCT00863746|3699268|FG001|STARTED|Survival Follow up|331 patients of 339 patients (=353 randomized - 14 death) entered the survival follow-up.|331
2983128|NCT00863746|3699267|FG000|COMPLETED|Survival Follow up||45
2983129|NCT00863746|3699268|FG001|COMPLETED|Survival Follow up||51
2983130|NCT00863746|3699267|FG000|NOT COMPLETED|Survival Follow up||253
2983131|NCT00863746|3699268|FG001|NOT COMPLETED|Survival Follow up||280
2983132|NCT00863772|3699277|FG000|STARTED|Overall Study||74
2983133|NCT00863772|3699278|FG001|STARTED|Overall Study||74
2983134|NCT00863772|3699279|FG002|STARTED|Overall Study||72
2983135|NCT00863772|3699277|FG000|Treated|Overall Study||73
2983136|NCT00863772|3699278|FG001|Treated|Overall Study||74
2983137|NCT00863772|3699279|FG002|Treated|Overall Study||72
2983138|NCT00863772|3699277|FG000|COMPLETED|Overall Study||6
2983139|NCT00863772|3699278|FG001|COMPLETED|Overall Study||9
2983140|NCT00863772|3699279|FG002|COMPLETED|Overall Study||11
2983141|NCT00863772|3699277|FG000|NOT COMPLETED|Overall Study||68
3303466|NCT02967367|4036798|FG000|COMPLETED|Overall Study||22
3303467|NCT02967367|4036798|FG000|NOT COMPLETED|Overall Study||14
3317007|NCT03122860|4050495|FG002|Full Analysis Set|Overall Study||115
3317008|NCT03122860|4050496|FG003|Full Analysis Set|Overall Study||116
3317009|NCT03122860|4050497|FG004|Full Analysis Set|Overall Study||116
3317010|NCT03122860|4050498|FG005|Full Analysis Set|Overall Study||117
3317011|NCT03122860|4050493|FG000|COMPLETED|Overall Study||107
3317012|NCT03122860|4050494|FG001|COMPLETED|Overall Study||111
3133436|NCT01695772|3858390|FG000|STARTED|Overall Study||50
3133437|NCT01695772|3858390|FG000|COMPLETED|Overall Study||12
3133438|NCT01695772|3858390|FG000|NOT COMPLETED|Overall Study||38
3133439|NCT01695954|3858396|FG000|STARTED|Overall Study||18
3133440|NCT01695954|3858397|FG001|STARTED|Overall Study||16
3133441|NCT01695954|3858396|FG000|COMPLETED|Overall Study||14
3317013|NCT03122860|4050495|FG002|COMPLETED|Overall Study||105
2983142|NCT00863772|3699278|FG001|NOT COMPLETED|Overall Study||65
2983143|NCT00863772|3699279|FG002|NOT COMPLETED|Overall Study||61
2983144|NCT00863798|3699290|FG000|STARTED|Overall Study||227
2983145|NCT00863798|3699291|FG001|STARTED|Overall Study||228
2983146|NCT00863798|3699292|FG002|STARTED|Overall Study||227
2983147|NCT00863798|3699290|FG000|Treated|Overall Study||223
2983148|NCT00863798|3699291|FG001|Treated|Overall Study||226
2983149|NCT00863798|3699292|FG002|Treated|Overall Study||224
2983150|NCT00863798|3699290|FG000|COMPLETED|Overall Study||195
2983151|NCT00863798|3699291|FG001|COMPLETED|Overall Study||198
2983152|NCT00863798|3699292|FG002|COMPLETED|Overall Study||202
2983153|NCT00863798|3699290|FG000|NOT COMPLETED|Overall Study||32
2983154|NCT00863798|3699291|FG001|NOT COMPLETED|Overall Study||30
2983155|NCT00863798|3699292|FG002|NOT COMPLETED|Overall Study||25
2983156|NCT00863928|3699302|FG000|STARTED|Overall Study||94
2983157|NCT00863928|3699303|FG001|STARTED|Overall Study||41
3133442|NCT01695954|3858397|FG001|COMPLETED|Overall Study||14
3133443|NCT01695954|3858396|FG000|NOT COMPLETED|Overall Study||4
3133444|NCT01695954|3858397|FG001|NOT COMPLETED|Overall Study||2
3133445|NCT01695993|3858408|FG000|STARTED|Overall Study||81
3317014|NCT03122860|4050496|FG003|COMPLETED|Overall Study||105
3317015|NCT03122860|4050497|FG004|COMPLETED|Overall Study||102
3317016|NCT03122860|4050498|FG005|COMPLETED|Overall Study||105
3317017|NCT03122860|4050493|FG000|NOT COMPLETED|Overall Study||10
3317018|NCT03122860|4050494|FG001|NOT COMPLETED|Overall Study||5
3317019|NCT03122860|4050495|FG002|NOT COMPLETED|Overall Study||12
3317020|NCT03122860|4050496|FG003|NOT COMPLETED|Overall Study||11
3317021|NCT03122860|4050497|FG004|NOT COMPLETED|Overall Study||15
3317022|NCT03122860|4050498|FG005|NOT COMPLETED|Overall Study||12
3317023|NCT03122886|4050515|FG000|STARTED|Overall Study||10
3317024|NCT03122886|4050516|FG001|STARTED|Overall Study||9
3317025|NCT03122886|4050515|FG000|COMPLETED|Overall Study||9
3317026|NCT03122886|4050516|FG001|COMPLETED|Overall Study||7
3317027|NCT03122886|4050515|FG000|NOT COMPLETED|Overall Study||1
3317028|NCT03122886|4050516|FG001|NOT COMPLETED|Overall Study||2
3317029|NCT03123055|4050522|FG000|STARTED|Overall Study||28
3317030|NCT03123055|4050522|FG000|COMPLETED|Overall Study||28
3317031|NCT03123055|4050522|FG000|NOT COMPLETED|Overall Study||0
3317032|NCT03123068|4050529|FG000|STARTED|Overall Study||22
3317033|NCT03123068|4050530|FG001|STARTED|Overall Study||20
3133446|NCT01695993|3858409|FG001|STARTED|Overall Study||80
3133447|NCT01695993|3858410|FG002|STARTED|Overall Study||81
3133448|NCT01695993|3858408|FG000|COMPLETED|Overall Study||76
3133449|NCT01695993|3858409|FG001|COMPLETED|Overall Study||75
3133450|NCT01695993|3858410|FG002|COMPLETED|Overall Study||75
3317034|NCT03123068|4050529|FG000|COMPLETED|Overall Study||22
2983158|NCT00863928|3699302|FG000|COMPLETED|Overall Study||58
2983159|NCT00863928|3699303|FG001|COMPLETED|Overall Study||41
2983160|NCT00863928|3699302|FG000|NOT COMPLETED|Overall Study||36
2983161|NCT00863928|3699303|FG001|NOT COMPLETED|Overall Study||0
2983162|NCT00864032|3699309|FG000|STARTED|Overall Study||3
2983163|NCT00864032|3699310|FG001|STARTED|Overall Study||5
2983164|NCT00864032|3699311|FG002|STARTED|Overall Study||0
2983165|NCT00864032|3699309|FG000|COMPLETED|Overall Study||3
2983166|NCT00864032|3699310|FG001|COMPLETED|Overall Study||5
2983167|NCT00864032|3699311|FG002|COMPLETED|Overall Study||0
2983168|NCT00864032|3699309|FG000|NOT COMPLETED|Overall Study||0
2983169|NCT00864032|3699310|FG001|NOT COMPLETED|Overall Study||0
2983170|NCT00864032|3699311|FG002|NOT COMPLETED|Overall Study||0
2983171|NCT00864084|3699317|FG000|STARTED|Overall Study||14
2983172|NCT00864084|3699317|FG000|COMPLETED|Overall Study||11
2983173|NCT00864084|3699317|FG000|NOT COMPLETED|Overall Study||3
2983174|NCT00864097|3699330|FG000|STARTED|Overall Study||154
2983175|NCT00864097|3699331|FG001|STARTED|Overall Study||157
2983176|NCT00864097|3699332|FG002|STARTED|Overall Study||151
2983177|NCT00864097|3699333|FG003|STARTED|Overall Study||145
2983178|NCT00864097|3699330|FG000|Treated|Overall Study||152
2983179|NCT00864097|3699331|FG001|Treated|Overall Study||157
2983180|NCT00864097|3699332|FG002|Treated|Overall Study||150
2983181|NCT00864097|3699333|FG003|Treated|Overall Study||145
2983182|NCT00864097|3699330|FG000|COMPLETED|Overall Study||15
2983183|NCT00864097|3699331|FG001|COMPLETED|Overall Study||20
2983184|NCT00864097|3699332|FG002|COMPLETED|Overall Study||19
2983185|NCT00864097|3699333|FG003|COMPLETED|Overall Study||20
2983186|NCT00864097|3699330|FG000|NOT COMPLETED|Overall Study||139
2983187|NCT00864097|3699331|FG001|NOT COMPLETED|Overall Study||137
2983188|NCT00864097|3699332|FG002|NOT COMPLETED|Overall Study||132
2983189|NCT00864097|3699333|FG003|NOT COMPLETED|Overall Study||125
2983190|NCT00864123|3699345|FG000|STARTED|Overall Study||15
2983191|NCT00864123|3699346|FG001|STARTED|Overall Study||15
2983192|NCT00864123|3699345|FG000|COMPLETED|Overall Study||15
2983193|NCT00864123|3699346|FG001|COMPLETED|Overall Study||15
2983194|NCT00864123|3699345|FG000|NOT COMPLETED|Overall Study||0
2983195|NCT00864123|3699346|FG001|NOT COMPLETED|Overall Study||0
2983196|NCT00864253|3699354|FG000|STARTED|Overall Study||264
2983197|NCT00864253|3699355|FG001|STARTED|Overall Study||265
2983198|NCT00864253|3699354|FG000|Treated|Overall Study||257
2983199|NCT00864253|3699355|FG001|Treated|Overall Study||258
2983200|NCT00864253|3699354|FG000|COMPLETED|Overall Study|Completed = defined as discontinuation due to progressive disease|165
3133451|NCT01695993|3858408|FG000|NOT COMPLETED|Overall Study||5
3133452|NCT01695993|3858409|FG001|NOT COMPLETED|Overall Study||5
3133453|NCT01695993|3858410|FG002|NOT COMPLETED|Overall Study||6
3303468|NCT02967393|4036804|FG000|STARTED|Overall Study||20
3303469|NCT02967393|4036805|FG001|STARTED|Overall Study||20
3303470|NCT02967393|4036804|FG000|COMPLETED|Overall Study||20
3303471|NCT02967393|4036805|FG001|COMPLETED|Overall Study||20
3303472|NCT02967393|4036804|FG000|NOT COMPLETED|Overall Study||0
3303473|NCT02967393|4036805|FG001|NOT COMPLETED|Overall Study||0
3303474|NCT02967458|4036813|FG000|STARTED|Overall Study||55
3303475|NCT02967458|4036813|FG000|COMPLETED|Overall Study||55
3303476|NCT02967458|4036813|FG000|NOT COMPLETED|Overall Study||0
3303477|NCT02967510|4036822|FG000|STARTED|Overall Study||70
3303478|NCT02967510|4036823|FG001|STARTED|Overall Study||70
3303479|NCT02967510|4036824|FG002|STARTED|Overall Study||72
3303480|NCT02967510|4036825|FG003|STARTED|Overall Study||71
3303481|NCT02967510|4036822|FG000|COMPLETED|Overall Study||66
3303482|NCT02967510|4036823|FG001|COMPLETED|Overall Study||67
3303483|NCT02967510|4036824|FG002|COMPLETED|Overall Study||65
3303484|NCT02967510|4036825|FG003|COMPLETED|Overall Study||63
3303485|NCT02967510|4036822|FG000|NOT COMPLETED|Overall Study||4
3303486|NCT02967510|4036823|FG001|NOT COMPLETED|Overall Study||3
3303487|NCT02967510|4036824|FG002|NOT COMPLETED|Overall Study||7
3303488|NCT02967510|4036825|FG003|NOT COMPLETED|Overall Study||8
3303489|NCT02967562|4036837|FG000|STARTED|Overall Study||32
3303490|NCT02967562|4036838|FG001|STARTED|Overall Study||31
3303491|NCT02967562|4036837|FG000|COMPLETED|Overall Study||30
3303492|NCT02967562|4036838|FG001|COMPLETED|Overall Study||30
3303493|NCT02967562|4036837|FG000|NOT COMPLETED|Overall Study||2
3303494|NCT02967562|4036838|FG001|NOT COMPLETED|Overall Study||1
3303495|NCT02967679|4036844|FG000|STARTED|Overall Study||15
3303496|NCT02967679|4036844|FG000|COMPLETED|Overall Study||14
3303497|NCT02967679|4036844|FG000|NOT COMPLETED|Overall Study||1
3303498|NCT02967991|4036848|FG000|STARTED|Overall Study|First Intervention: 10 minutes Washout: 1 minute Second Intervention: 10 minutes|10
3303499|NCT02967991|4036849|FG001|STARTED|Overall Study|First Intervention: 10 minutes Washout: 1 minute Second Intervention: 10 minutes|10
3303500|NCT02967991|4036848|FG000|COMPLETED|Overall Study||10
3303501|NCT02967991|4036849|FG001|COMPLETED|Overall Study||10
3303502|NCT02967991|4036848|FG000|NOT COMPLETED|Overall Study||0
3303503|NCT02967991|4036849|FG001|NOT COMPLETED|Overall Study||0
3303504|NCT02968004|4036861|FG000|STARTED|Overall Study||109
2983201|NCT00864253|3699355|FG001|COMPLETED|Overall Study|Completed = defined as discontinuation due to progressive disease|207
2983202|NCT00864253|3699354|FG000|NOT COMPLETED|Overall Study||99
2983203|NCT00864253|3699355|FG001|NOT COMPLETED|Overall Study||58
2983204|NCT00864383|3699366|FG000|STARTED|Per- Protocol||640
3303505|NCT02968004|4036862|FG001|STARTED|Overall Study||115
3303506|NCT02968004|4036861|FG000|COMPLETED|Overall Study||108
3303507|NCT02968004|4036862|FG001|COMPLETED|Overall Study||114
2983205|NCT00864383|3699367|FG001|STARTED|Per- Protocol||655
2983206|NCT00864383|3699368|FG002|STARTED|Per- Protocol||636
2983207|NCT00864383|3699366|FG000|COMPLETED|Per- Protocol||510
2983208|NCT00864383|3699367|FG001|COMPLETED|Per- Protocol||514
2983209|NCT00864383|3699368|FG002|COMPLETED|Per- Protocol||524
2983210|NCT00864383|3699366|FG000|NOT COMPLETED|Per- Protocol||130
2983211|NCT00864383|3699367|FG001|NOT COMPLETED|Per- Protocol||141
2983212|NCT00864383|3699368|FG002|NOT COMPLETED|Per- Protocol||112
2983213|NCT00864383|3699366|FG000|STARTED|Modified Intent to Treat||640
2983214|NCT00864383|3699367|FG001|STARTED|Modified Intent to Treat||655
2983215|NCT00864383|3699368|FG002|STARTED|Modified Intent to Treat||636
2983216|NCT00864383|3699366|FG000|COMPLETED|Modified Intent to Treat||555
2983217|NCT00864383|3699367|FG001|COMPLETED|Modified Intent to Treat||568
2983218|NCT00864383|3699368|FG002|COMPLETED|Modified Intent to Treat||551
2983219|NCT00864383|3699366|FG000|NOT COMPLETED|Modified Intent to Treat||85
2983220|NCT00864383|3699367|FG001|NOT COMPLETED|Modified Intent to Treat||87
2983221|NCT00864383|3699368|FG002|NOT COMPLETED|Modified Intent to Treat||85
2983222|NCT00864513|3699376|FG000|STARTED|Overall Study||15
2983223|NCT00864513|3699376|FG000|COMPLETED|Overall Study||12
2983224|NCT00864513|3699376|FG000|NOT COMPLETED|Overall Study||3
2983225|NCT00864539|3699386|FG000|STARTED|Overall Study||104
2983226|NCT00864539|3699387|FG001|STARTED|Overall Study||95
2983227|NCT00864539|3699388|FG002|STARTED|Overall Study||102
2983228|NCT00864539|3699389|FG003|STARTED|Overall Study||96
2983229|NCT00864539|3699390|FG004|STARTED|Overall Study||103
2983230|NCT00864539|3699391|FG005|STARTED|Overall Study||85
2983231|NCT00864539|3699386|FG000|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|95
2983232|NCT00864539|3699387|FG001|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|72
2983233|NCT00864539|3699388|FG002|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|92
3303508|NCT02968004|4036861|FG000|NOT COMPLETED|Overall Study||1
3303509|NCT02968004|4036862|FG001|NOT COMPLETED|Overall Study||1
3303510|NCT02968134|4036868|FG000|STARTED|Overall Study||8
3303511|NCT02968134|4036868|FG000|COMPLETED|Overall Study||8
3303512|NCT02968134|4036868|FG000|NOT COMPLETED|Overall Study||0
3303513|NCT02968173|4036872|FG000|STARTED|Overall Study||50
3303514|NCT02968173|4036872|FG000|COMPLETED|Overall Study||49
3303515|NCT02968173|4036872|FG000|NOT COMPLETED|Overall Study||1
2983234|NCT00864539|3699389|FG003|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|89
2983235|NCT00864539|3699390|FG004|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|81
2983236|NCT00864539|3699391|FG005|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|71
2983237|NCT00864539|3699386|FG000|NOT COMPLETED|Overall Study||9
2983238|NCT00864539|3699387|FG001|NOT COMPLETED|Overall Study||23
2983239|NCT00864539|3699388|FG002|NOT COMPLETED|Overall Study||10
2983240|NCT00864539|3699389|FG003|NOT COMPLETED|Overall Study||7
2983241|NCT00864539|3699390|FG004|NOT COMPLETED|Overall Study||22
2983242|NCT00864539|3699391|FG005|NOT COMPLETED|Overall Study||14
2983243|NCT00864682|3699408|FG000|STARTED|Overall Study||52
2983244|NCT00864682|3699409|FG001|STARTED|Overall Study||51
2983245|NCT00864682|3699410|FG002|STARTED|Overall Study||53
2983246|NCT00864682|3699408|FG000|COMPLETED|Overall Study||50
2983247|NCT00864682|3699409|FG001|COMPLETED|Overall Study||50
2983248|NCT00864682|3699410|FG002|COMPLETED|Overall Study||51
2983249|NCT00864682|3699408|FG000|NOT COMPLETED|Overall Study||2
2983250|NCT00864682|3699409|FG001|NOT COMPLETED|Overall Study||1
2983251|NCT00864682|3699410|FG002|NOT COMPLETED|Overall Study||2
2983252|NCT00864708|3699418|FG000|STARTED|Overall Study||1
2983253|NCT00864708|3699418|FG000|COMPLETED|Overall Study||1
2983254|NCT00864708|3699418|FG000|NOT COMPLETED|Overall Study||0
3133454|NCT01696032|3858422|FG000|STARTED|Overall Study||14
3133455|NCT01696032|3858423|FG001|STARTED|Overall Study||6
3133456|NCT01696032|3858424|FG002|STARTED|Overall Study||51
3133457|NCT01696032|3858425|FG003|STARTED|Overall Study||49
3133458|NCT01696032|3858422|FG000|COMPLETED|Overall Study||0
3303516|NCT02968277|4036880|FG000|STARTED|Overall Study||10
3303517|NCT02968277|4036881|FG001|STARTED|Overall Study||7
3303518|NCT02968277|4036882|FG002|STARTED|Overall Study||13
3303519|NCT02968277|4036880|FG000|COMPLETED|Overall Study||10
3303520|NCT02968277|4036881|FG001|COMPLETED|Overall Study||7
3303521|NCT02968277|4036882|FG002|COMPLETED|Overall Study||13
3303522|NCT02968277|4036880|FG000|NOT COMPLETED|Overall Study||0
3303523|NCT02968277|4036881|FG001|NOT COMPLETED|Overall Study||0
3303524|NCT02968277|4036882|FG002|NOT COMPLETED|Overall Study||0
3303525|NCT02968368|4036896|FG000|STARTED|Double Blind Phase||111
3303526|NCT02968368|4036897|FG001|STARTED|Double Blind Phase||56
3303527|NCT02968368|4036896|FG000|COMPLETED|Double Blind Phase||90
3303528|NCT02968368|4036897|FG001|COMPLETED|Double Blind Phase||39
3303529|NCT02968368|4036896|FG000|NOT COMPLETED|Double Blind Phase||21
2983255|NCT00864721|3699424|FG000|STARTED|Overall Study||63
2983256|NCT00864721|3699424|FG000|COMPLETED|Overall Study||29
2983257|NCT00864721|3699424|FG000|NOT COMPLETED|Overall Study||34
2983258|NCT00864851|3699431|FG000|STARTED|Overall Study||20
2983259|NCT00864851|3699432|FG001|STARTED|Overall Study||19
2983260|NCT00864851|3699433|FG002|STARTED|Overall Study||5
2983261|NCT00864851|3699431|FG000|COMPLETED|Overall Study||17
2983262|NCT00864851|3699432|FG001|COMPLETED|Overall Study||18
3133459|NCT01696032|3858423|FG001|COMPLETED|Overall Study||0
3303530|NCT02968368|4036897|FG001|NOT COMPLETED|Double Blind Phase||17
3303531|NCT02968368|4036896|FG000|STARTED|Open Label Phase||86
2983263|NCT00864851|3699433|FG002|COMPLETED|Overall Study||5
2983264|NCT00864851|3699431|FG000|NOT COMPLETED|Overall Study||3
2983265|NCT00864851|3699432|FG001|NOT COMPLETED|Overall Study||1
2983266|NCT00864851|3699433|FG002|NOT COMPLETED|Overall Study||0
2983267|NCT00864916|3699445|FG000|STARTED|Overall Study||10
2983268|NCT00864916|3699446|FG001|STARTED|Overall Study||9
2983269|NCT00864916|3699445|FG000|COMPLETED|Overall Study||4
2983270|NCT00864916|3699446|FG001|COMPLETED|Overall Study||5
2983271|NCT00864916|3699445|FG000|NOT COMPLETED|Overall Study||6
2983272|NCT00864916|3699446|FG001|NOT COMPLETED|Overall Study||4
2983273|NCT00865020|3699454|FG000|STARTED|Overall Study||414
2983274|NCT00865020|3699455|FG001|STARTED|Overall Study||408
2983275|NCT00865020|3699454|FG000|COMPLETED|Overall Study||365
2983276|NCT00865020|3699455|FG001|COMPLETED|Overall Study||357
2983277|NCT00865020|3699454|FG000|NOT COMPLETED|Overall Study||49
2983278|NCT00865020|3699455|FG001|NOT COMPLETED|Overall Study||51
2983279|NCT00865046|3699464|FG000|STARTED|Overall Study||63
2983280|NCT00865046|3699465|FG001|STARTED|Overall Study||64
2983281|NCT00865046|3699466|FG002|STARTED|Overall Study||63
2983282|NCT00865046|3699464|FG000|COMPLETED|Overall Study||57
2983283|NCT00865046|3699465|FG001|COMPLETED|Overall Study||59
2983284|NCT00865046|3699466|FG002|COMPLETED|Overall Study||62
2983285|NCT00865046|3699464|FG000|NOT COMPLETED|Overall Study||6
2983286|NCT00865046|3699465|FG001|NOT COMPLETED|Overall Study||5
2983287|NCT00865046|3699466|FG002|NOT COMPLETED|Overall Study||1
2983288|NCT00865098|3699474|FG000|STARTED|Overall Study||22
2983289|NCT00865098|3699474|FG000|COMPLETED|Overall Study|Discontinued from the study due to progressive disease, after completing planned treatment schedule|21
2983290|NCT00865098|3699474|FG000|NOT COMPLETED|Overall Study||1
2983291|NCT00865124|3699481|FG000|STARTED|Overall Study||27
2983292|NCT00865124|3699482|FG001|STARTED|Overall Study||25
2983293|NCT00865124|3699483|FG002|STARTED|Overall Study||17
3303532|NCT02968368|4036897|FG001|STARTED|Open Label Phase||39
3303533|NCT02968368|4036896|FG000|COMPLETED|Open Label Phase||67
3303534|NCT02968368|4036897|FG001|COMPLETED|Open Label Phase||25
3303535|NCT02968368|4036896|FG000|NOT COMPLETED|Open Label Phase||19
3303536|NCT02968368|4036897|FG001|NOT COMPLETED|Open Label Phase||14
3303537|NCT02968420|4036908|FG000|STARTED|Overall Study||6
3303538|NCT02968420|4036909|FG001|STARTED|Overall Study||6
3303539|NCT02968420|4036910|FG002|STARTED|Overall Study||6
3303540|NCT02968420|4036908|FG000|COMPLETED|Overall Study||6
3303541|NCT02968420|4036909|FG001|COMPLETED|Overall Study||6
3303542|NCT02968420|4036910|FG002|COMPLETED|Overall Study||6
3303543|NCT02968420|4036908|FG000|NOT COMPLETED|Overall Study||0
3303544|NCT02968420|4036909|FG001|NOT COMPLETED|Overall Study||0
3303545|NCT02968420|4036910|FG002|NOT COMPLETED|Overall Study||0
3303546|NCT02968433|4036918|FG000|STARTED|Overall Study||16
3303547|NCT02968433|4036918|FG000|COMPLETED|Overall Study||15
3303548|NCT02968433|4036918|FG000|NOT COMPLETED|Overall Study||1
3303549|NCT02968576|4036928|FG000|STARTED|Overall Study||11
3303550|NCT02968576|4036929|FG001|STARTED|Overall Study||14
3303551|NCT02968576|4036928|FG000|COMPLETED|Overall Study||11
3303552|NCT02968576|4036929|FG001|COMPLETED|Overall Study||13
3303553|NCT02968576|4036928|FG000|NOT COMPLETED|Overall Study||0
3303554|NCT02968576|4036929|FG001|NOT COMPLETED|Overall Study||1
3303555|NCT02968758|4036935|FG000|STARTED|Overall Study||797
3303556|NCT02968758|4036936|FG001|STARTED|Overall Study||1664
3303557|NCT02968758|4036935|FG000|COMPLETED|Overall Study||797
3303558|NCT02968758|4036936|FG001|COMPLETED|Overall Study||1664
3303559|NCT02968758|4036935|FG000|NOT COMPLETED|Overall Study||0
3303560|NCT02968758|4036936|FG001|NOT COMPLETED|Overall Study||0
3303561|NCT02968914|4036943|FG000|STARTED|Overall Study||90
3303562|NCT02968914|4036944|FG001|STARTED|Overall Study||90
3303563|NCT02968914|4036943|FG000|COMPLETED|Overall Study||90
3303564|NCT02968914|4036944|FG001|COMPLETED|Overall Study||90
3303565|NCT02968914|4036943|FG000|NOT COMPLETED|Overall Study||0
3303566|NCT02968914|4036944|FG001|NOT COMPLETED|Overall Study||0
3303567|NCT02968979|4036950|FG000|STARTED|Overall Study||539
3303568|NCT02968979|4036950|FG000|COMPLETED|Overall Study|This cross-sectional study had only 1 visit.|531
3303569|NCT02968979|4036950|FG000|NOT COMPLETED|Overall Study||8
3303570|NCT02968992|4037002|FG000|STARTED|Overall Study||18
3303571|NCT02968992|4037003|FG001|STARTED|Overall Study||18
3303572|NCT02968992|4037002|FG000|COMPLETED|Overall Study||18
3303573|NCT02968992|4037003|FG001|COMPLETED|Overall Study||17
3303574|NCT02968992|4037002|FG000|NOT COMPLETED|Overall Study||0
3303575|NCT02968992|4037003|FG001|NOT COMPLETED|Overall Study||1
3303576|NCT02969018|4037017|FG000|STARTED|Overall Study||25
3303577|NCT02969018|4037018|FG001|STARTED|Overall Study||29
3303578|NCT02969018|4037019|FG002|STARTED|Overall Study||26
2983294|NCT00865124|3699481|FG000|COMPLETED|Overall Study||23
2983295|NCT00865124|3699482|FG001|COMPLETED|Overall Study||24
2983296|NCT00865124|3699483|FG002|COMPLETED|Overall Study||17
2983297|NCT00865124|3699481|FG000|NOT COMPLETED|Overall Study||4
3303579|NCT02969018|4037020|FG003|STARTED|Overall Study||25
3303580|NCT02969018|4037021|FG004|STARTED|Overall Study||29
3303581|NCT02969018|4037022|FG005|STARTED|Overall Study||25
3303582|NCT02969018|4037023|FG006|STARTED|Overall Study||30
2983298|NCT00865124|3699482|FG001|NOT COMPLETED|Overall Study||1
2983299|NCT00865124|3699483|FG002|NOT COMPLETED|Overall Study||0
2983300|NCT00865189|3699493|FG000|STARTED|Overall Study||46
2983301|NCT00865189|3699494|FG001|STARTED|Overall Study||45
3303583|NCT02969018|4037024|FG007|STARTED|Overall Study||23
3303584|NCT02969018|4037017|FG000|COMPLETED|Overall Study||21
2983302|NCT00865189|3699493|FG000|COMPLETED|Overall Study||34
2983303|NCT00865189|3699494|FG001|COMPLETED|Overall Study||26
2983304|NCT00865189|3699493|FG000|NOT COMPLETED|Overall Study||12
2983305|NCT00865189|3699494|FG001|NOT COMPLETED|Overall Study||19
2983306|NCT00865202|3699502|FG000|STARTED|Overall Study||152
2983307|NCT00865202|3699503|FG001|STARTED|Overall Study||149
2983308|NCT00865202|3699502|FG000|COMPLETED|Overall Study||152
2983309|NCT00865202|3699503|FG001|COMPLETED|Overall Study||149
2983310|NCT00865202|3699502|FG000|NOT COMPLETED|Overall Study||0
2983311|NCT00865202|3699503|FG001|NOT COMPLETED|Overall Study||0
2983312|NCT00865280|3699512|FG000|STARTED|Overall Study||70
2983313|NCT00865280|3699513|FG001|STARTED|Overall Study||73
2983314|NCT00865280|3699512|FG000|COMPLETED|Overall Study||64
2983315|NCT00865280|3699513|FG001|COMPLETED|Overall Study||70
2983316|NCT00865280|3699512|FG000|NOT COMPLETED|Overall Study||6
2983317|NCT00865280|3699513|FG001|NOT COMPLETED|Overall Study||3
2983318|NCT00865306|3699521|FG000|STARTED|Controlled Trial|35 assigned to CBT. One child in trial had 0 anxiety disorders, so we excluded her from analysis.|34
2983319|NCT00865306|3699522|FG001|STARTED|Controlled Trial||30
2983320|NCT00865306|3699521|FG000|COMPLETED|Controlled Trial||29
2983321|NCT00865306|3699522|FG001|COMPLETED|Controlled Trial||28
2983322|NCT00865306|3699521|FG000|NOT COMPLETED|Controlled Trial||5
2983323|NCT00865306|3699522|FG001|NOT COMPLETED|Controlled Trial||2
2983324|NCT00865306|3699521|FG000|STARTED|One-Year Follow-Up||29
2983325|NCT00865306|3699522|FG001|STARTED|One-Year Follow-Up|Only controls who opted for CBT after the waitlist (n=17) were included. 2 were lost (15 included).|15
2983326|NCT00865306|3699521|FG000|COMPLETED|One-Year Follow-Up||29
2983327|NCT00865306|3699522|FG001|COMPLETED|One-Year Follow-Up||15
2983328|NCT00865306|3699521|FG000|NOT COMPLETED|One-Year Follow-Up||0
2983329|NCT00865306|3699522|FG001|NOT COMPLETED|One-Year Follow-Up||0
2983330|NCT00865345|3699528|FG000|STARTED|Overall Study||63
2983331|NCT00865345|3699528|FG000|COMPLETED|Overall Study||61
2983332|NCT00865345|3699528|FG000|NOT COMPLETED|Overall Study||2
2983333|NCT00865566|3699534|FG000|STARTED|Overall Study||1253
2983334|NCT00865566|3699535|FG001|STARTED|Overall Study||1251
2983335|NCT00865566|3699534|FG000|Modified Intent-to-Treat Population|Overall Study||1251
2983336|NCT00865566|3699535|FG001|Modified Intent-to-Treat Population|Overall Study||1245
2983337|NCT00865566|3699534|FG000|COMPLETED|Overall Study||629
2983338|NCT00865566|3699535|FG001|COMPLETED|Overall Study||564
2983339|NCT00865566|3699534|FG000|NOT COMPLETED|Overall Study||624
2983340|NCT00865566|3699535|FG001|NOT COMPLETED|Overall Study||687
2983341|NCT00865709|3699543|FG000|STARTED|Treatment||97
2983342|NCT00865709|3699544|FG001|STARTED|Treatment||101
2983343|NCT00865709|3699543|FG000|Received Treatment|Treatment|Safety population|97
2983344|NCT00865709|3699544|FG001|Received Treatment|Treatment|Safety population|101
2983345|NCT00865709|3699543|FG000|COMPLETED|Treatment|Patients who continued treatment at data cut-off or discontinued treatment due to PD or death|67
2983346|NCT00865709|3699544|FG001|COMPLETED|Treatment|Patients who continued treatment at data cut-off or discontinued treatment due to PD or death|83
2983347|NCT00865709|3699543|FG000|NOT COMPLETED|Treatment||30
2983348|NCT00865709|3699544|FG001|NOT COMPLETED|Treatment||18
3133460|NCT01696032|3858424|FG002|COMPLETED|Overall Study||0
3133461|NCT01696032|3858425|FG003|COMPLETED|Overall Study||27
3133462|NCT01696032|3858422|FG000|NOT COMPLETED|Overall Study||14
3303585|NCT02969018|4037018|FG001|COMPLETED|Overall Study||21
3303586|NCT02969018|4037019|FG002|COMPLETED|Overall Study||20
3303587|NCT02969018|4037020|FG003|COMPLETED|Overall Study||20
3303588|NCT02969018|4037021|FG004|COMPLETED|Overall Study||27
3303589|NCT02969018|4037022|FG005|COMPLETED|Overall Study||17
3303590|NCT02969018|4037023|FG006|COMPLETED|Overall Study||22
3303591|NCT02969018|4037024|FG007|COMPLETED|Overall Study||16
3303592|NCT02969018|4037017|FG000|NOT COMPLETED|Overall Study||4
3303593|NCT02969018|4037018|FG001|NOT COMPLETED|Overall Study||8
3303594|NCT02969018|4037019|FG002|NOT COMPLETED|Overall Study||6
3303595|NCT02969018|4037020|FG003|NOT COMPLETED|Overall Study||5
3303596|NCT02969018|4037021|FG004|NOT COMPLETED|Overall Study||2
3303597|NCT02969018|4037022|FG005|NOT COMPLETED|Overall Study||8
3303598|NCT02969018|4037023|FG006|NOT COMPLETED|Overall Study||8
3303599|NCT02969018|4037024|FG007|NOT COMPLETED|Overall Study||7
3303600|NCT02969031|4037047|FG000|STARTED|Enrolled and Randomized||73
3303601|NCT02969031|4037048|FG001|STARTED|Enrolled and Randomized||75
3303602|NCT02969031|4037047|FG000|COMPLETED|Enrolled and Randomized||73
3303603|NCT02969031|4037048|FG001|COMPLETED|Enrolled and Randomized||75
3303604|NCT02969031|4037047|FG000|NOT COMPLETED|Enrolled and Randomized||0
3303605|NCT02969031|4037048|FG001|NOT COMPLETED|Enrolled and Randomized||0
3303606|NCT02969031|4037047|FG000|STARTED|Collection of Baseline Surveys||73
3303607|NCT02969031|4037048|FG001|STARTED|Collection of Baseline Surveys||75
3303608|NCT02969031|4037047|FG000|COMPLETED|Collection of Baseline Surveys||34
3303609|NCT02969031|4037048|FG001|COMPLETED|Collection of Baseline Surveys||23
3303610|NCT02969031|4037047|FG000|NOT COMPLETED|Collection of Baseline Surveys||39
3303611|NCT02969031|4037048|FG001|NOT COMPLETED|Collection of Baseline Surveys||52
3303612|NCT02969031|4037047|FG000|STARTED|Collection of Baseline Recordings||34
3303613|NCT02969031|4037048|FG001|STARTED|Collection of Baseline Recordings||23
2983349|NCT00865709|3699543|FG000|STARTED|Active Follow-up||25
2983350|NCT00865709|3699544|FG001|STARTED|Active Follow-up||16
2983351|NCT00865709|3699543|FG000|COMPLETED|Active Follow-up||17
2983352|NCT00865709|3699544|FG001|COMPLETED|Active Follow-up||15
2983353|NCT00865709|3699543|FG000|NOT COMPLETED|Active Follow-up||8
2983354|NCT00865709|3699544|FG001|NOT COMPLETED|Active Follow-up||1
2983355|NCT00865709|3699543|FG000|STARTED|Long Term Follow-up||70
2983356|NCT00865709|3699544|FG001|STARTED|Long Term Follow-up||82
2983357|NCT00865709|3699543|FG000|COMPLETED|Long Term Follow-up||24
2983358|NCT00865709|3699544|FG001|COMPLETED|Long Term Follow-up||33
2983359|NCT00865709|3699543|FG000|NOT COMPLETED|Long Term Follow-up||46
2983360|NCT00865709|3699544|FG001|NOT COMPLETED|Long Term Follow-up||49
2983361|NCT00865904|3699557|FG000|STARTED|Overall Study|Randomized.|19
2983362|NCT00865904|3699558|FG001|STARTED|Overall Study|Randomized.|18
2983363|NCT00865904|3699559|FG002|STARTED|Overall Study|Randomized.|18
2983364|NCT00865904|3699560|FG003|STARTED|Overall Study|Randomized.|18
2983365|NCT00865904|3699561|FG004|STARTED|Overall Study|Randomized.|20
2983366|NCT00865904|3699557|FG000|COMPLETED|Overall Study|Completed 14-day follow-up.|17
2983367|NCT00865904|3699558|FG001|COMPLETED|Overall Study|Completed 14-day follow-up.|18
2983368|NCT00865904|3699559|FG002|COMPLETED|Overall Study|Completed 14-day follow-up.|18
2983369|NCT00865904|3699560|FG003|COMPLETED|Overall Study|Completed 14-day follow-up.|17
2983370|NCT00865904|3699561|FG004|COMPLETED|Overall Study|Completed 14-day follow-up.|19
2983371|NCT00865904|3699557|FG000|NOT COMPLETED|Overall Study||2
2983372|NCT00865904|3699558|FG001|NOT COMPLETED|Overall Study||0
2983373|NCT00865904|3699559|FG002|NOT COMPLETED|Overall Study||0
2983374|NCT00865904|3699560|FG003|NOT COMPLETED|Overall Study||1
2983375|NCT00865904|3699561|FG004|NOT COMPLETED|Overall Study||1
2983376|NCT00865969|3699577|FG000|STARTED|Overall Study||129
2983377|NCT00865969|3699577|FG000|COMPLETED|Overall Study||129
2983378|NCT00865969|3699577|FG000|NOT COMPLETED|Overall Study||0
2983379|NCT00866034|3699583|FG000|STARTED|Overall Study||308
2983380|NCT00866034|3699584|FG001|STARTED|Overall Study||309
2983381|NCT00866034|3699583|FG000|COMPLETED|Overall Study||292
2983382|NCT00866034|3699584|FG001|COMPLETED|Overall Study||301
2983383|NCT00866034|3699583|FG000|NOT COMPLETED|Overall Study||16
2983384|NCT00866034|3699584|FG001|NOT COMPLETED|Overall Study||8
2983385|NCT00866047|3699590|FG000|STARTED|Treatment Period||58
2983386|NCT00866047|3699590|FG000|COMPLETED|Treatment Period|Number who completed 16 cycles of treatment|10
2983387|NCT00866047|3699590|FG000|NOT COMPLETED|Treatment Period||48
2983388|NCT00866047|3699590|FG000|STARTED|Follow-up Period|All participants were to be followed after treatment|58
2983389|NCT00866047|3699590|FG000|COMPLETED|Follow-up Period|Completed survival follow-up due to death [25] or study completion [28]|53
2983390|NCT00866047|3699590|FG000|NOT COMPLETED|Follow-up Period||5
2983391|NCT00866177|3699594|FG000|STARTED|Overall Study||167
2983392|NCT00866177|3699594|FG000|COMPLETED|Overall Study||15
2983393|NCT00866177|3699594|FG000|NOT COMPLETED|Overall Study||152
2983394|NCT00866281|3699600|FG000|STARTED|Overall Study||7
2983395|NCT00866281|3699601|FG001|STARTED|Overall Study||15
2983396|NCT00866281|3699600|FG000|COMPLETED|Overall Study||0
2983397|NCT00866281|3699601|FG001|COMPLETED|Overall Study||0
2983398|NCT00866281|3699600|FG000|NOT COMPLETED|Overall Study||7
2983399|NCT00866281|3699601|FG001|NOT COMPLETED|Overall Study||15
2983400|NCT00866294|3699613|FG000|STARTED|Overall Study||172
2983401|NCT00866294|3699614|FG001|STARTED|Overall Study||161
2983402|NCT00866294|3699615|FG002|STARTED|Overall Study||83
2983403|NCT00866294|3699613|FG000|COMPLETED|Overall Study||139
2983404|NCT00866294|3699614|FG001|COMPLETED|Overall Study||141
2983405|NCT00866294|3699615|FG002|COMPLETED|Overall Study||72
2983406|NCT00866294|3699613|FG000|NOT COMPLETED|Overall Study||33
2983407|NCT00866294|3699614|FG001|NOT COMPLETED|Overall Study||20
2983408|NCT00866294|3699615|FG002|NOT COMPLETED|Overall Study||11
2983409|NCT00866307|3699631|FG000|STARTED|Induction||104
2983410|NCT00866307|3699632|FG001|STARTED|Induction||0
2983411|NCT00866307|3699633|FG002|STARTED|Induction||0
2983412|NCT00866307|3699631|FG000|COMPLETED|Induction||84
2983413|NCT00866307|3699632|FG001|COMPLETED|Induction||0
2983414|NCT00866307|3699633|FG002|COMPLETED|Induction||0
2983415|NCT00866307|3699631|FG000|NOT COMPLETED|Induction||20
2983416|NCT00866307|3699632|FG001|NOT COMPLETED|Induction||0
2983417|NCT00866307|3699633|FG002|NOT COMPLETED|Induction||0
2983418|NCT00866307|3699631|FG000|STARTED|Consolidation/Maintenance||0
2983419|NCT00866307|3699632|FG001|STARTED|Consolidation/Maintenance||54
2983420|NCT00866307|3699633|FG002|STARTED|Consolidation/Maintenance||30
2983421|NCT00866307|3699631|FG000|COMPLETED|Consolidation/Maintenance||0
2983422|NCT00866307|3699632|FG001|COMPLETED|Consolidation/Maintenance||45
2983423|NCT00866307|3699633|FG002|COMPLETED|Consolidation/Maintenance||14
2983424|NCT00866307|3699631|FG000|NOT COMPLETED|Consolidation/Maintenance||0
2983425|NCT00866307|3699632|FG001|NOT COMPLETED|Consolidation/Maintenance||9
2983426|NCT00866307|3699633|FG002|NOT COMPLETED|Consolidation/Maintenance||16
2983427|NCT00866320|3699639|FG000|STARTED|Overall Study||49
2983428|NCT00866320|3699639|FG000|COMPLETED|Overall Study|All patients that received treatment were analyzed.|43
2983429|NCT00866320|3699639|FG000|NOT COMPLETED|Overall Study||6
3036342|NCT01143051|3755543|FG002|COMPLETED|Visit 2||3
3036343|NCT01143051|3755544|FG003|COMPLETED|Visit 2||4
3036344|NCT01143051|3755545|FG004|COMPLETED|Visit 2||4
3036345|NCT01143051|3755546|FG005|COMPLETED|Visit 2||4
3036346|NCT01143051|3755541|FG000|NOT COMPLETED|Visit 2||0
3036347|NCT01143051|3755542|FG001|NOT COMPLETED|Visit 2||0
3036348|NCT01143051|3755543|FG002|NOT COMPLETED|Visit 2||0
3036349|NCT01143051|3755544|FG003|NOT COMPLETED|Visit 2||0
3036350|NCT01143051|3755545|FG004|NOT COMPLETED|Visit 2||0
3036351|NCT01143051|3755546|FG005|NOT COMPLETED|Visit 2||0
3036352|NCT01143051|3755541|FG000|STARTED|3-14 Day Washout||4
3036353|NCT01143051|3755542|FG001|STARTED|3-14 Day Washout||4
3036354|NCT01143051|3755543|FG002|STARTED|3-14 Day Washout||3
3036355|NCT01143051|3755544|FG003|STARTED|3-14 Day Washout||4
2983430|NCT00866333|3699648|FG000|STARTED|Overall Study||16
2983431|NCT00866333|3699649|FG001|STARTED|Overall Study||17
2983432|NCT00866333|3699650|FG002|STARTED|Overall Study||16
2983433|NCT00866333|3699648|FG000|COMPLETED|Overall Study||11
2983434|NCT00866333|3699649|FG001|COMPLETED|Overall Study||10
2983435|NCT00866333|3699650|FG002|COMPLETED|Overall Study||4
2983436|NCT00866333|3699648|FG000|NOT COMPLETED|Overall Study||5
2983437|NCT00866333|3699649|FG001|NOT COMPLETED|Overall Study||7
2983438|NCT00866333|3699650|FG002|NOT COMPLETED|Overall Study||12
2983439|NCT00866359|3699660|FG000|STARTED|Treatment Phase (Days 1 to 85)||56
2983440|NCT00866359|3699661|FG001|STARTED|Treatment Phase (Days 1 to 85)||55
2983441|NCT00866359|3699662|FG002|STARTED|Treatment Phase (Days 1 to 85)||0
2983442|NCT00866359|3699663|FG003|STARTED|Treatment Phase (Days 1 to 85)||0
2983443|NCT00866359|3699660|FG000|COMPLETED|Treatment Phase (Days 1 to 85)||45
2983444|NCT00866359|3699661|FG001|COMPLETED|Treatment Phase (Days 1 to 85)||50
2983445|NCT00866359|3699662|FG002|COMPLETED|Treatment Phase (Days 1 to 85)||0
2983446|NCT00866359|3699663|FG003|COMPLETED|Treatment Phase (Days 1 to 85)||0
3303614|NCT02969031|4037047|FG000|COMPLETED|Collection of Baseline Recordings||22
3303615|NCT02969031|4037048|FG001|COMPLETED|Collection of Baseline Recordings||18
3303616|NCT02969031|4037047|FG000|NOT COMPLETED|Collection of Baseline Recordings||12
3303617|NCT02969031|4037048|FG001|NOT COMPLETED|Collection of Baseline Recordings||5
3303618|NCT02969031|4037047|FG000|STARTED|Completed Intervention||22
3303619|NCT02969031|4037048|FG001|STARTED|Completed Intervention||18
3303620|NCT02969031|4037047|FG000|COMPLETED|Completed Intervention||15
3303621|NCT02969031|4037048|FG001|COMPLETED|Completed Intervention||14
3303622|NCT02969031|4037047|FG000|NOT COMPLETED|Completed Intervention||7
3303623|NCT02969031|4037048|FG001|NOT COMPLETED|Completed Intervention||4
3303624|NCT02969031|4037047|FG000|STARTED|Collection of Follow-Up Surveys||15
3303625|NCT02969031|4037048|FG001|STARTED|Collection of Follow-Up Surveys||14
3303626|NCT02969031|4037047|FG000|COMPLETED|Collection of Follow-Up Surveys||15
3303627|NCT02969031|4037048|FG001|COMPLETED|Collection of Follow-Up Surveys||12
3303628|NCT02969031|4037047|FG000|NOT COMPLETED|Collection of Follow-Up Surveys||0
3303629|NCT02969031|4037048|FG001|NOT COMPLETED|Collection of Follow-Up Surveys||2
3303630|NCT02969031|4037047|FG000|STARTED|Collection of Follow-Up Recordings||15
3303631|NCT02969031|4037048|FG001|STARTED|Collection of Follow-Up Recordings||12
3303632|NCT02969031|4037047|FG000|COMPLETED|Collection of Follow-Up Recordings||15
3303633|NCT02969031|4037048|FG001|COMPLETED|Collection of Follow-Up Recordings||12
3303634|NCT02969031|4037047|FG000|NOT COMPLETED|Collection of Follow-Up Recordings||0
3303635|NCT02969031|4037048|FG001|NOT COMPLETED|Collection of Follow-Up Recordings||0
3303636|NCT02969031|4037047|FG000|STARTED|Completed and Analyzed||15
3303637|NCT02969031|4037048|FG001|STARTED|Completed and Analyzed||12
3303638|NCT02969031|4037047|FG000|COMPLETED|Completed and Analyzed||15
3303639|NCT02969031|4037048|FG001|COMPLETED|Completed and Analyzed||12
3303640|NCT02969031|4037047|FG000|NOT COMPLETED|Completed and Analyzed||0
3303641|NCT02969031|4037048|FG001|NOT COMPLETED|Completed and Analyzed||0
3303642|NCT02969044|4037056|FG000|STARTED|Overall Study||42
3303643|NCT02969044|4037057|FG001|STARTED|Overall Study||28
3303644|NCT02969044|4037056|FG000|COMPLETED|Overall Study||37
3303645|NCT02969044|4037057|FG001|COMPLETED|Overall Study||22
3303646|NCT02969044|4037056|FG000|NOT COMPLETED|Overall Study||5
3303647|NCT02969044|4037057|FG001|NOT COMPLETED|Overall Study||6
3303648|NCT02969187|4037065|FG000|STARTED|Overall Study||63
3303649|NCT02969187|4037066|FG001|STARTED|Overall Study||63
3303650|NCT02969187|4037065|FG000|COMPLETED|Overall Study||51
3303651|NCT02969187|4037066|FG001|COMPLETED|Overall Study||50
3303652|NCT02969187|4037065|FG000|NOT COMPLETED|Overall Study||12
3303653|NCT02969187|4037066|FG001|NOT COMPLETED|Overall Study||13
3303654|NCT02969317|4037074|FG000|STARTED|Overall Study||12
3303655|NCT02969317|4037074|FG000|COMPLETED|Overall Study||12
3303656|NCT02969317|4037074|FG000|NOT COMPLETED|Overall Study||0
3303657|NCT02969356|4037079|FG000|STARTED|Overall Study||157
3303658|NCT02969356|4037079|FG000|Intent-to-Treat (ITT) Population|Overall Study||153
3303659|NCT02969356|4037079|FG000|COMPLETED|Overall Study||134
3303660|NCT02969356|4037079|FG000|NOT COMPLETED|Overall Study||23
3303661|NCT02969382|4037085|FG000|STARTED|Overall Study||125
3303662|NCT02969382|4037086|FG001|STARTED|Overall Study||120
3303663|NCT02969382|4037085|FG000|Subjects Continued Into Extension Study|Overall Study||79
3303664|NCT02969382|4037086|FG001|Subjects Continued Into Extension Study|Overall Study||78
3303665|NCT02969382|4037085|FG000|COMPLETED|Overall Study||99
3303666|NCT02969382|4037086|FG001|COMPLETED|Overall Study||94
3303667|NCT02969382|4037085|FG000|NOT COMPLETED|Overall Study||26
3303668|NCT02969382|4037086|FG001|NOT COMPLETED|Overall Study||26
3303669|NCT02969408|4037092|FG000|STARTED|Overall Study||397
3303670|NCT02969408|4037092|FG000|Used ABS eMDPI at Least Once|Overall Study||370
3303671|NCT02969408|4037092|FG000|COMPLETED|Overall Study||381
3303672|NCT02969408|4037092|FG000|NOT COMPLETED|Overall Study||16
3303673|NCT02969421|4037098|FG000|STARTED|Overall Study||33
3303674|NCT02969421|4037099|FG001|STARTED|Overall Study||33
3303675|NCT02969421|4037098|FG000|COMPLETED|Overall Study||33
3303676|NCT02969421|4037099|FG001|COMPLETED|Overall Study||33
3303677|NCT02969421|4037098|FG000|NOT COMPLETED|Overall Study||0
3303678|NCT02969421|4037099|FG001|NOT COMPLETED|Overall Study||0
3303679|NCT02969499|4037105|FG000|STARTED|Overall Study||33
2983447|NCT00866359|3699660|FG000|NOT COMPLETED|Treatment Phase (Days 1 to 85)||11
2983448|NCT00866359|3699661|FG001|NOT COMPLETED|Treatment Phase (Days 1 to 85)||5
2983449|NCT00866359|3699662|FG002|NOT COMPLETED|Treatment Phase (Days 1 to 85)||0
3303680|NCT02969499|4037105|FG000|COMPLETED|Overall Study||33
3303681|NCT02969499|4037105|FG000|NOT COMPLETED|Overall Study||0
3303682|NCT02969525|4037114|FG000|STARTED|Double-Blind Period||42
3303683|NCT02969525|4037115|FG001|STARTED|Double-Blind Period||41
3303684|NCT02969525|4037116|FG002|STARTED|Double-Blind Period||41
3303685|NCT02969525|4037117|FG003|STARTED|Double-Blind Period||41
3303686|NCT02969525|4037118|FG004|STARTED|Double-Blind Period||41
3303687|NCT02969525|4037119|FG005|STARTED|Double-Blind Period||0
2983450|NCT00866359|3699663|FG003|NOT COMPLETED|Treatment Phase (Days 1 to 85)||0
2983451|NCT00866359|3699660|FG000|STARTED|Extension Phase (Day 86 to 169)||0
2983452|NCT00866359|3699661|FG001|STARTED|Extension Phase (Day 86 to 169)||0
2983453|NCT00866359|3699662|FG002|STARTED|Extension Phase (Day 86 to 169)||45
2983454|NCT00866359|3699663|FG003|STARTED|Extension Phase (Day 86 to 169)||50
2983455|NCT00866359|3699660|FG000|COMPLETED|Extension Phase (Day 86 to 169)||0
2983456|NCT00866359|3699661|FG001|COMPLETED|Extension Phase (Day 86 to 169)||0
2983457|NCT00866359|3699662|FG002|COMPLETED|Extension Phase (Day 86 to 169)||44
2983458|NCT00866359|3699663|FG003|COMPLETED|Extension Phase (Day 86 to 169)||47
2983459|NCT00866359|3699660|FG000|NOT COMPLETED|Extension Phase (Day 86 to 169)||0
2983460|NCT00866359|3699661|FG001|NOT COMPLETED|Extension Phase (Day 86 to 169)||0
2983461|NCT00866359|3699662|FG002|NOT COMPLETED|Extension Phase (Day 86 to 169)||1
2983462|NCT00866359|3699663|FG003|NOT COMPLETED|Extension Phase (Day 86 to 169)||3
2983463|NCT00866359|3699660|FG000|STARTED|Observational Follow-Up Phase||0
2983464|NCT00866359|3699661|FG001|STARTED|Observational Follow-Up Phase||0
2983465|NCT00866359|3699662|FG002|STARTED|Observational Follow-Up Phase|Includes those who entered the follow-up phase from both the placebo controlled or extension phase.|54
2983466|NCT00866359|3699663|FG003|STARTED|Observational Follow-Up Phase|Includes those who entered the follow-up phase from both the placebo controlled or extension phase.|54
2983467|NCT00866359|3699660|FG000|COMPLETED|Observational Follow-Up Phase||0
2983468|NCT00866359|3699661|FG001|COMPLETED|Observational Follow-Up Phase||0
2983469|NCT00866359|3699662|FG002|COMPLETED|Observational Follow-Up Phase||54
2983470|NCT00866359|3699663|FG003|COMPLETED|Observational Follow-Up Phase||54
2983471|NCT00866359|3699660|FG000|NOT COMPLETED|Observational Follow-Up Phase||0
3303688|NCT02969525|4037120|FG006|STARTED|Double-Blind Period||0
3303689|NCT02969525|4037121|FG007|STARTED|Double-Blind Period||0
3303690|NCT02969525|4037122|FG008|STARTED|Double-Blind Period||0
3303691|NCT02969525|4037123|FG009|STARTED|Double-Blind Period||0
3303692|NCT02969525|4037124|FG010|STARTED|Double-Blind Period||0
3303693|NCT02969525|4037125|FG011|STARTED|Double-Blind Period||0
3303694|NCT02969525|4037114|FG000|Completed Double-Blind Period|Double-Blind Period||42
3303695|NCT02969525|4037115|FG001|Completed Double-Blind Period|Double-Blind Period||41
3303696|NCT02969525|4037116|FG002|Completed Double-Blind Period|Double-Blind Period||40
3303697|NCT02969525|4037117|FG003|Completed Double-Blind Period|Double-Blind Period||39
3303698|NCT02969525|4037118|FG004|Completed Double-Blind Period|Double-Blind Period||41
3303699|NCT02969525|4037119|FG005|Completed Double-Blind Period|Double-Blind Period||0
3303700|NCT02969525|4037120|FG006|Completed Double-Blind Period|Double-Blind Period||0
3303701|NCT02969525|4037121|FG007|Completed Double-Blind Period|Double-Blind Period||0
3303702|NCT02969525|4037122|FG008|Completed Double-Blind Period|Double-Blind Period||0
3303703|NCT02969525|4037123|FG009|Completed Double-Blind Period|Double-Blind Period||0
3303704|NCT02969525|4037124|FG010|Completed Double-Blind Period|Double-Blind Period||0
3303705|NCT02969525|4037125|FG011|Completed Double-Blind Period|Double-Blind Period||0
3303706|NCT02969525|4037114|FG000|Completed Wk12 and Started Dose-Blind|Double-Blind Period||40
3303707|NCT02969525|4037115|FG001|Completed Wk12 and Started Dose-Blind|Double-Blind Period||41
3303708|NCT02969525|4037116|FG002|Completed Wk12 and Started Dose-Blind|Double-Blind Period||40
3303709|NCT02969525|4037117|FG003|Completed Wk12 and Started Dose-Blind|Double-Blind Period||37
3303710|NCT02969525|4037118|FG004|Completed Wk12 and Started Dose-Blind|Double-Blind Period||41
3303711|NCT02969525|4037119|FG005|Completed Wk12 and Started Dose-Blind|Double-Blind Period||0
3303712|NCT02969525|4037120|FG006|Completed Wk12 and Started Dose-Blind|Double-Blind Period||0
3303713|NCT02969525|4037121|FG007|Completed Wk12 and Started Dose-Blind|Double-Blind Period||0
3303714|NCT02969525|4037122|FG008|Completed Wk12 and Started Dose-Blind|Double-Blind Period||0
3303715|NCT02969525|4037123|FG009|Completed Wk12 and Started Dose-Blind|Double-Blind Period||0
3303716|NCT02969525|4037124|FG010|Completed Wk12 and Started Dose-Blind|Double-Blind Period||0
3303717|NCT02969525|4037125|FG011|Completed Wk12 and Started Dose-Blind|Double-Blind Period||0
3303718|NCT02969525|4037114|FG000|COMPLETED|Double-Blind Period||40
3303719|NCT02969525|4037115|FG001|COMPLETED|Double-Blind Period||41
3303720|NCT02969525|4037116|FG002|COMPLETED|Double-Blind Period||40
3303721|NCT02969525|4037117|FG003|COMPLETED|Double-Blind Period||37
3303722|NCT02969525|4037118|FG004|COMPLETED|Double-Blind Period||41
3303723|NCT02969525|4037119|FG005|COMPLETED|Double-Blind Period||0
3303724|NCT02969525|4037120|FG006|COMPLETED|Double-Blind Period||0
3303725|NCT02969525|4037121|FG007|COMPLETED|Double-Blind Period||0
3303726|NCT02969525|4037122|FG008|COMPLETED|Double-Blind Period||0
3303727|NCT02969525|4037123|FG009|COMPLETED|Double-Blind Period||0
3303728|NCT02969525|4037124|FG010|COMPLETED|Double-Blind Period||0
3303729|NCT02969525|4037125|FG011|COMPLETED|Double-Blind Period||0
3303730|NCT02969525|4037114|FG000|NOT COMPLETED|Double-Blind Period||2
3303731|NCT02969525|4037115|FG001|NOT COMPLETED|Double-Blind Period||0
3303732|NCT02969525|4037116|FG002|NOT COMPLETED|Double-Blind Period||1
3303733|NCT02969525|4037117|FG003|NOT COMPLETED|Double-Blind Period||4
3303734|NCT02969525|4037118|FG004|NOT COMPLETED|Double-Blind Period||0
3303735|NCT02969525|4037119|FG005|NOT COMPLETED|Double-Blind Period||0
2983472|NCT00866359|3699661|FG001|NOT COMPLETED|Observational Follow-Up Phase||0
2983473|NCT00866359|3699662|FG002|NOT COMPLETED|Observational Follow-Up Phase||0
2983474|NCT00866359|3699663|FG003|NOT COMPLETED|Observational Follow-Up Phase||0
2983475|NCT00866606|3699690|FG000|STARTED|Overall Study||35
2983476|NCT00866606|3699690|FG000|COMPLETED|Overall Study||31
2983477|NCT00866606|3699690|FG000|NOT COMPLETED|Overall Study||4
2983478|NCT00866619|3699698|FG000|STARTED|Overall Study||5948
2983479|NCT00866619|3699699|FG001|STARTED|Overall Study||4358
2983480|NCT00866619|3699700|FG002|STARTED|Overall Study||2974
2983481|NCT00866619|3699701|FG003|STARTED|Overall Study||2179
2983482|NCT00866619|3699698|FG000|COMPLETED|Overall Study||4102
2983483|NCT00866619|3699699|FG001|COMPLETED|Overall Study||3088
2983484|NCT00866619|3699700|FG002|COMPLETED|Overall Study||2085
2983485|NCT00866619|3699701|FG003|COMPLETED|Overall Study||1549
2983486|NCT00866619|3699698|FG000|NOT COMPLETED|Overall Study||1846
2983487|NCT00866619|3699699|FG001|NOT COMPLETED|Overall Study||1270
2983488|NCT00866619|3699700|FG002|NOT COMPLETED|Overall Study||889
2983489|NCT00866619|3699701|FG003|NOT COMPLETED|Overall Study||630
2983490|NCT00866658|3699738|FG000|STARTED|Overall Study|Randomized.|157
2983491|NCT00866658|3699739|FG001|STARTED|Overall Study||154
2983492|NCT00866658|3699738|FG000|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|157
2983493|NCT00866658|3699739|FG001|Safety Population|Overall Study||154
2983494|NCT00866658|3699738|FG000|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|157
2983495|NCT00866658|3699739|FG001|Modified Intent-to-Treat(mITT)Population|Overall Study||154
2983496|NCT00866658|3699738|FG000|COMPLETED|Overall Study||144
2983497|NCT00866658|3699739|FG001|COMPLETED|Overall Study||133
2983498|NCT00866658|3699738|FG000|NOT COMPLETED|Overall Study||13
2983499|NCT00866658|3699739|FG001|NOT COMPLETED|Overall Study||21
2983500|NCT00866697|3699747|FG000|STARTED|Overall Study||468
2983501|NCT00866697|3699748|FG001|STARTED|Overall Study||472
2983502|NCT00866697|3699747|FG000|COMPLETED|Overall Study||254
2983503|NCT00866697|3699748|FG001|COMPLETED|Overall Study||244
2983504|NCT00866697|3699747|FG000|NOT COMPLETED|Overall Study||214
2983505|NCT00866697|3699748|FG001|NOT COMPLETED|Overall Study||228
2983506|NCT00866723|3699754|FG000|STARTED|Overall Study||5
2983507|NCT00866723|3699754|FG000|COMPLETED|Overall Study||0
2983508|NCT00866723|3699754|FG000|NOT COMPLETED|Overall Study||5
2983509|NCT00866749|3699758|FG000|STARTED|Overall Study||120
2983510|NCT00866749|3699758|FG000|COMPLETED|Overall Study||120
2983511|NCT00866749|3699758|FG000|NOT COMPLETED|Overall Study||0
2983512|NCT00866775|3699764|FG000|STARTED|Overall Study||65
2983513|NCT00866775|3699765|FG001|STARTED|Overall Study||128
2983514|NCT00866775|3699764|FG000|COMPLETED|Overall Study||29
2983515|NCT00866775|3699765|FG001|COMPLETED|Overall Study||76
2983516|NCT00866775|3699764|FG000|NOT COMPLETED|Overall Study||36
2983517|NCT00866775|3699765|FG001|NOT COMPLETED|Overall Study||52
3133463|NCT01696032|3858423|FG001|NOT COMPLETED|Overall Study||6
3133464|NCT01696032|3858424|FG002|NOT COMPLETED|Overall Study||51
3303736|NCT02969525|4037120|FG006|NOT COMPLETED|Double-Blind Period||0
3303737|NCT02969525|4037121|FG007|NOT COMPLETED|Double-Blind Period||0
3303738|NCT02969525|4037122|FG008|NOT COMPLETED|Double-Blind Period||0
3303739|NCT02969525|4037123|FG009|NOT COMPLETED|Double-Blind Period||0
3303740|NCT02969525|4037124|FG010|NOT COMPLETED|Double-Blind Period||0
3303741|NCT02969525|4037125|FG011|NOT COMPLETED|Double-Blind Period||0
3303742|NCT02969525|4037114|FG000|STARTED|Dose-Blind Period||0
3303743|NCT02969525|4037115|FG001|STARTED|Dose-Blind Period||0
3303744|NCT02969525|4037116|FG002|STARTED|Dose-Blind Period||0
3303745|NCT02969525|4037117|FG003|STARTED|Dose-Blind Period||0
3303746|NCT02969525|4037118|FG004|STARTED|Dose-Blind Period||0
3303747|NCT02969525|4037119|FG005|STARTED|Dose-Blind Period||20
3303748|NCT02969525|4037120|FG006|STARTED|Dose-Blind Period||20
3303749|NCT02969525|4037121|FG007|STARTED|Dose-Blind Period||22
3303750|NCT02969525|4037122|FG008|STARTED|Dose-Blind Period||19
3303751|NCT02969525|4037123|FG009|STARTED|Dose-Blind Period||37
3303752|NCT02969525|4037124|FG010|STARTED|Dose-Blind Period||40
3303753|NCT02969525|4037125|FG011|STARTED|Dose-Blind Period||41
3303754|NCT02969525|4037114|FG000|COMPLETED|Dose-Blind Period||0
3303755|NCT02969525|4037115|FG001|COMPLETED|Dose-Blind Period||0
3303756|NCT02969525|4037116|FG002|COMPLETED|Dose-Blind Period||0
3303757|NCT02969525|4037117|FG003|COMPLETED|Dose-Blind Period||0
3303758|NCT02969525|4037118|FG004|COMPLETED|Dose-Blind Period||0
3303759|NCT02969525|4037119|FG005|COMPLETED|Dose-Blind Period||20
3303760|NCT02969525|4037120|FG006|COMPLETED|Dose-Blind Period||18
3303761|NCT02969525|4037121|FG007|COMPLETED|Dose-Blind Period||22
3303762|NCT02969525|4037122|FG008|COMPLETED|Dose-Blind Period||18
3303763|NCT02969525|4037123|FG009|COMPLETED|Dose-Blind Period||34
3303764|NCT02969525|4037124|FG010|COMPLETED|Dose-Blind Period||38
3303765|NCT02969525|4037125|FG011|COMPLETED|Dose-Blind Period||39
3303766|NCT02969525|4037114|FG000|NOT COMPLETED|Dose-Blind Period||0
3303767|NCT02969525|4037115|FG001|NOT COMPLETED|Dose-Blind Period||0
3303768|NCT02969525|4037116|FG002|NOT COMPLETED|Dose-Blind Period||0
3303769|NCT02969525|4037117|FG003|NOT COMPLETED|Dose-Blind Period||0
2983518|NCT00866788|3699777|FG000|STARTED|Overall Study||21
2983519|NCT00866788|3699778|FG001|STARTED|Overall Study||23
2983520|NCT00866788|3699779|FG002|STARTED|Overall Study||25
3303770|NCT02969525|4037118|FG004|NOT COMPLETED|Dose-Blind Period||0
2983521|NCT00866788|3699780|FG003|STARTED|Overall Study||21
2983522|NCT00866788|3699777|FG000|COMPLETED|Overall Study||15
3133465|NCT01696032|3858425|FG003|NOT COMPLETED|Overall Study||22
2983523|NCT00866788|3699778|FG001|COMPLETED|Overall Study||17
2983524|NCT00866788|3699779|FG002|COMPLETED|Overall Study||23
2983525|NCT00866788|3699780|FG003|COMPLETED|Overall Study||16
2983526|NCT00866788|3699777|FG000|NOT COMPLETED|Overall Study||6
2983527|NCT00866788|3699778|FG001|NOT COMPLETED|Overall Study||6
2983528|NCT00866788|3699779|FG002|NOT COMPLETED|Overall Study||2
2983529|NCT00866788|3699780|FG003|NOT COMPLETED|Overall Study||5
2983530|NCT00866814|3699793|FG000|STARTED|Overall Study||119
2983531|NCT00866814|3699793|FG000|COMPLETED|Overall Study||99
2983532|NCT00866814|3699793|FG000|NOT COMPLETED|Overall Study||20
2983533|NCT00866879|3699799|FG000|STARTED|Overall Study||90
2983534|NCT00866879|3699800|FG001|STARTED|Overall Study||185
2983535|NCT00866879|3699799|FG000|COMPLETED|Overall Study||90
2983536|NCT00866879|3699800|FG001|COMPLETED|Overall Study||185
2983537|NCT00866879|3699799|FG000|NOT COMPLETED|Overall Study||0
2983538|NCT00866879|3699800|FG001|NOT COMPLETED|Overall Study||0
2983539|NCT00866905|3699806|FG000|STARTED|Overall Study||168
2983540|NCT00866905|3699806|FG000|COMPLETED|Overall Study||135
2983541|NCT00866905|3699806|FG000|NOT COMPLETED|Overall Study||33
2983542|NCT00866918|3699814|FG000|STARTED|Overall Study||69
2983543|NCT00866918|3699815|FG001|STARTED|Overall Study||39
2983544|NCT00866918|3699814|FG000|COMPLETED|Overall Study||53
2983545|NCT00866918|3699815|FG001|COMPLETED|Overall Study||27
3133466|NCT01696045|3858441|FG000|STARTED|Overall Study||4
3133467|NCT01696045|3858442|FG001|STARTED|Overall Study||8
3133468|NCT01696045|3858441|FG000|COMPLETED|Overall Study||1
3133469|NCT01696045|3858442|FG001|COMPLETED|Overall Study||1
3133470|NCT01696045|3858441|FG000|NOT COMPLETED|Overall Study||3
3133471|NCT01696045|3858442|FG001|NOT COMPLETED|Overall Study||7
2983546|NCT00866918|3699814|FG000|NOT COMPLETED|Overall Study||16
2983547|NCT00866918|3699815|FG001|NOT COMPLETED|Overall Study||12
2983548|NCT00867009|3699821|FG000|STARTED|Induction Period|Participants with Stage IIIB/IV non-squamous (NS) non-small cell lung cancer (NSCLC)|113
2983549|NCT00867009|3699821|FG000|Received at Least 1 Dose of Study Drug|Induction Period||113
2983550|NCT00867009|3699821|FG000|Protocol Qualified (PQ) Population|Induction Period|Stage IIIB/IV NS-NSCLC, no concurrent chemotherapy, measurable disease, ≥1 dose study drug.|109
2983551|NCT00867009|3699821|FG000|COMPLETED|Induction Period|Participants continued on the study in the Maintenance Period.|51
2983552|NCT00867009|3699821|FG000|NOT COMPLETED|Induction Period||62
2983553|NCT00867009|3699821|FG000|STARTED|Maintenance Period||51
2983554|NCT00867009|3699821|FG000|COMPLETED|Maintenance Period|Participant was considered completed if they had PD, death, or stopped receiving study drug.|47
2983555|NCT00867009|3699821|FG000|NOT COMPLETED|Maintenance Period||4
2983556|NCT00867035|3699827|FG000|STARTED|Baseline to 1 Hour||13
2983557|NCT00867035|3699828|FG001|STARTED|Baseline to 1 Hour||9
2983558|NCT00867035|3699827|FG000|COMPLETED|Baseline to 1 Hour||12
2983559|NCT00867035|3699828|FG001|COMPLETED|Baseline to 1 Hour||8
2983560|NCT00867035|3699827|FG000|NOT COMPLETED|Baseline to 1 Hour||1
2983561|NCT00867035|3699828|FG001|NOT COMPLETED|Baseline to 1 Hour||1
2983562|NCT00867035|3699827|FG000|STARTED|Baseline to 2 Hours||12
3303771|NCT02969525|4037119|FG005|NOT COMPLETED|Dose-Blind Period||0
3303772|NCT02969525|4037120|FG006|NOT COMPLETED|Dose-Blind Period||2
3303773|NCT02969525|4037121|FG007|NOT COMPLETED|Dose-Blind Period||0
3303774|NCT02969525|4037122|FG008|NOT COMPLETED|Dose-Blind Period||1
3303775|NCT02969525|4037123|FG009|NOT COMPLETED|Dose-Blind Period||3
3303776|NCT02969525|4037124|FG010|NOT COMPLETED|Dose-Blind Period||2
3303777|NCT02969525|4037125|FG011|NOT COMPLETED|Dose-Blind Period||2
3303778|NCT02969590|4037147|FG000|STARTED|Screening Period||5
3303779|NCT02969590|4037148|FG001|STARTED|Screening Period||0
3303780|NCT02969590|4037149|FG002|STARTED|Screening Period||0
3303781|NCT02969590|4037147|FG000|COMPLETED|Screening Period||4
3303782|NCT02969590|4037148|FG001|COMPLETED|Screening Period||0
3303783|NCT02969590|4037149|FG002|COMPLETED|Screening Period||0
3303784|NCT02969590|4037147|FG000|NOT COMPLETED|Screening Period||1
3303785|NCT02969590|4037148|FG001|NOT COMPLETED|Screening Period||0
3303786|NCT02969590|4037149|FG002|NOT COMPLETED|Screening Period||0
3303787|NCT02969590|4037147|FG000|STARTED|Treatment Period 1||0
3303788|NCT02969590|4037148|FG001|STARTED|Treatment Period 1||2
3303789|NCT02969590|4037149|FG002|STARTED|Treatment Period 1||2
3303790|NCT02969590|4037147|FG000|COMPLETED|Treatment Period 1||0
3303791|NCT02969590|4037148|FG001|COMPLETED|Treatment Period 1||2
3303792|NCT02969590|4037149|FG002|COMPLETED|Treatment Period 1||2
3303793|NCT02969590|4037147|FG000|NOT COMPLETED|Treatment Period 1||0
3303794|NCT02969590|4037148|FG001|NOT COMPLETED|Treatment Period 1||0
3303795|NCT02969590|4037149|FG002|NOT COMPLETED|Treatment Period 1||0
3303796|NCT02969590|4037147|FG000|STARTED|Treatment Period 2||0
3303797|NCT02969590|4037148|FG001|STARTED|Treatment Period 2||2
3303798|NCT02969590|4037149|FG002|STARTED|Treatment Period 2||2
3303799|NCT02969590|4037147|FG000|COMPLETED|Treatment Period 2||0
3303800|NCT02969590|4037148|FG001|COMPLETED|Treatment Period 2||2
3303801|NCT02969590|4037149|FG002|COMPLETED|Treatment Period 2||2
3303802|NCT02969590|4037147|FG000|NOT COMPLETED|Treatment Period 2||0
3303803|NCT02969590|4037148|FG001|NOT COMPLETED|Treatment Period 2||0
3303804|NCT02969590|4037149|FG002|NOT COMPLETED|Treatment Period 2||0
3303805|NCT02969655|4037161|FG000|STARTED|Overall Study||136
3303806|NCT02969655|4037162|FG001|STARTED|Overall Study||135
3303807|NCT02969655|4037161|FG000|COMPLETED|Overall Study||115
3303808|NCT02969655|4037162|FG001|COMPLETED|Overall Study||120
3303809|NCT02969655|4037161|FG000|NOT COMPLETED|Overall Study||21
3303810|NCT02969655|4037162|FG001|NOT COMPLETED|Overall Study||15
2983563|NCT00867035|3699828|FG001|STARTED|Baseline to 2 Hours||8
2983564|NCT00867035|3699827|FG000|COMPLETED|Baseline to 2 Hours||12
2983565|NCT00867035|3699828|FG001|COMPLETED|Baseline to 2 Hours||8
2983566|NCT00867035|3699827|FG000|NOT COMPLETED|Baseline to 2 Hours||0
2983567|NCT00867035|3699828|FG001|NOT COMPLETED|Baseline to 2 Hours||0
2983568|NCT00867035|3699827|FG000|STARTED|Baseline to 4 Hours||12
2983569|NCT00867035|3699828|FG001|STARTED|Baseline to 4 Hours||8
2983570|NCT00867035|3699827|FG000|COMPLETED|Baseline to 4 Hours||12
2983571|NCT00867035|3699828|FG001|COMPLETED|Baseline to 4 Hours||8
2983572|NCT00867035|3699827|FG000|NOT COMPLETED|Baseline to 4 Hours||0
2983573|NCT00867035|3699828|FG001|NOT COMPLETED|Baseline to 4 Hours||0
2983574|NCT00867035|3699827|FG000|STARTED|Baseline to 1 Week||12
2983575|NCT00867035|3699828|FG001|STARTED|Baseline to 1 Week||8
2983576|NCT00867035|3699827|FG000|COMPLETED|Baseline to 1 Week||11
2983577|NCT00867035|3699828|FG001|COMPLETED|Baseline to 1 Week||8
2983578|NCT00867035|3699827|FG000|NOT COMPLETED|Baseline to 1 Week||1
2983579|NCT00867035|3699828|FG001|NOT COMPLETED|Baseline to 1 Week||0
2983580|NCT00867087|3699834|FG000|STARTED|Overall Study||63
2983581|NCT00867087|3699834|FG000|COMPLETED|Overall Study||21
2983582|NCT00867087|3699834|FG000|NOT COMPLETED|Overall Study||42
2983583|NCT00867100|3699851|FG000|STARTED|Overall Study||5
2983584|NCT00867100|3699852|FG001|STARTED|Overall Study||5
2983585|NCT00867100|3699853|FG002|STARTED|Overall Study||8
2983586|NCT00867100|3699854|FG003|STARTED|Overall Study||8
2983587|NCT00867100|3699855|FG004|STARTED|Overall Study||14
2983588|NCT00867100|3699856|FG005|STARTED|Overall Study||6
2983589|NCT00867100|3699857|FG006|STARTED|Overall Study||7
2983590|NCT00867100|3699858|FG007|STARTED|Overall Study||3
2983591|NCT00867100|3699859|FG008|STARTED|Overall Study||6
2983592|NCT00867100|3699860|FG009|STARTED|Overall Study||6
2983593|NCT00867100|3699861|FG010|STARTED|Overall Study||4
2983594|NCT00867100|3699862|FG011|STARTED|Overall Study||6
2983595|NCT00867100|3699863|FG012|STARTED|Overall Study||6
2983596|NCT00867100|3699851|FG000|COMPLETED|Overall Study||5
2983597|NCT00867100|3699852|FG001|COMPLETED|Overall Study||4
2983598|NCT00867100|3699853|FG002|COMPLETED|Overall Study||8
2983599|NCT00867100|3699854|FG003|COMPLETED|Overall Study||8
2983600|NCT00867100|3699855|FG004|COMPLETED|Overall Study||14
2983601|NCT00867100|3699856|FG005|COMPLETED|Overall Study||6
2983602|NCT00867100|3699857|FG006|COMPLETED|Overall Study||6
2983603|NCT00867100|3699858|FG007|COMPLETED|Overall Study||3
2983604|NCT00867100|3699859|FG008|COMPLETED|Overall Study||6
2983605|NCT00867100|3699860|FG009|COMPLETED|Overall Study||6
2983606|NCT00867100|3699861|FG010|COMPLETED|Overall Study||3
2983607|NCT00867100|3699862|FG011|COMPLETED|Overall Study||6
2983608|NCT00867100|3699863|FG012|COMPLETED|Overall Study||6
2983609|NCT00867100|3699851|FG000|NOT COMPLETED|Overall Study||0
2983610|NCT00867100|3699852|FG001|NOT COMPLETED|Overall Study||1
2983611|NCT00867100|3699853|FG002|NOT COMPLETED|Overall Study||0
2983612|NCT00867100|3699854|FG003|NOT COMPLETED|Overall Study||0
2983613|NCT00867100|3699855|FG004|NOT COMPLETED|Overall Study||0
2983614|NCT00867100|3699856|FG005|NOT COMPLETED|Overall Study||0
2983615|NCT00867100|3699857|FG006|NOT COMPLETED|Overall Study||1
2983616|NCT00867100|3699858|FG007|NOT COMPLETED|Overall Study||0
2983617|NCT00867100|3699859|FG008|NOT COMPLETED|Overall Study||0
2983618|NCT00867100|3699860|FG009|NOT COMPLETED|Overall Study||0
2983619|NCT00867100|3699861|FG010|NOT COMPLETED|Overall Study||1
2983620|NCT00867100|3699862|FG011|NOT COMPLETED|Overall Study||0
2983621|NCT00867100|3699863|FG012|NOT COMPLETED|Overall Study||0
2983622|NCT00867113|3699895|FG000|STARTED|Treatment Period||91
2983623|NCT00867113|3699895|FG000|Safety Set|Treatment Period||91
2983624|NCT00867113|3699895|FG000|Full Analysis Set (FAS)|Treatment Period||91
2983625|NCT00867113|3699895|FG000|COMPLETED|Treatment Period||46
2983626|NCT00867113|3699895|FG000|NOT COMPLETED|Treatment Period||45
2983627|NCT00867113|3699895|FG000|STARTED|Post Treatment After Survival Follow-up||68
2983628|NCT00867113|3699895|FG000|COMPLETED|Post Treatment After Survival Follow-up||57
2983629|NCT00867113|3699895|FG000|NOT COMPLETED|Post Treatment After Survival Follow-up||11
2983630|NCT00867139|3699902|FG000|STARTED|Overall Study||2
2983631|NCT00867139|3699903|FG001|STARTED|Overall Study||1
2983632|NCT00867139|3699904|FG002|STARTED|Overall Study||4
2983633|NCT00867139|3699902|FG000|COMPLETED|Overall Study||2
2983634|NCT00867139|3699903|FG001|COMPLETED|Overall Study||1
2983635|NCT00867139|3699904|FG002|COMPLETED|Overall Study|One open-labeled patient withdrew on day 5.|3
2983636|NCT00867139|3699902|FG000|NOT COMPLETED|Overall Study||0
2983637|NCT00867139|3699903|FG001|NOT COMPLETED|Overall Study||0
2983638|NCT00867139|3699904|FG002|NOT COMPLETED|Overall Study||1
2983639|NCT00867217|3699922|FG000|STARTED|Overall Study||80
2983640|NCT00867217|3699923|FG001|STARTED|Overall Study||80
2983641|NCT00867217|3699922|FG000|COMPLETED|Overall Study||77
2983642|NCT00867217|3699923|FG001|COMPLETED|Overall Study||70
2983643|NCT00867217|3699922|FG000|NOT COMPLETED|Overall Study||3
2983644|NCT00867217|3699923|FG001|NOT COMPLETED|Overall Study||10
2983645|NCT00867308|3699931|FG000|STARTED|Overall Study||9
2983646|NCT00867308|3699932|FG001|STARTED|Overall Study||18
2983647|NCT00867308|3699931|FG000|COMPLETED|Overall Study||0
2983648|NCT00867308|3699932|FG001|COMPLETED|Overall Study||0
2983649|NCT00867308|3699931|FG000|NOT COMPLETED|Overall Study||9
2983650|NCT00867308|3699932|FG001|NOT COMPLETED|Overall Study||18
2983651|NCT00867321|3699941|FG000|STARTED|Overall Study||4
2983652|NCT00867321|3699942|FG001|STARTED|Overall Study||3
2983653|NCT00867321|3699943|FG002|STARTED|Overall Study||3
2983654|NCT00867321|3699944|FG003|STARTED|Overall Study||6
2983655|NCT00867321|3699945|FG004|STARTED|Overall Study||5
2983656|NCT00867321|3699946|FG005|STARTED|Overall Study||3
2983657|NCT00867321|3699941|FG000|COMPLETED|Overall Study||4
2983658|NCT00867321|3699942|FG001|COMPLETED|Overall Study||2
2983659|NCT00867321|3699943|FG002|COMPLETED|Overall Study||3
2983660|NCT00867321|3699944|FG003|COMPLETED|Overall Study||6
2983661|NCT00867321|3699945|FG004|COMPLETED|Overall Study||5
2983662|NCT00867321|3699946|FG005|COMPLETED|Overall Study||3
2983663|NCT00867321|3699941|FG000|NOT COMPLETED|Overall Study||0
2983664|NCT00867321|3699942|FG001|NOT COMPLETED|Overall Study||1
2983665|NCT00867321|3699943|FG002|NOT COMPLETED|Overall Study||0
2983666|NCT00867321|3699944|FG003|NOT COMPLETED|Overall Study||0
2983667|NCT00867321|3699945|FG004|NOT COMPLETED|Overall Study||0
2983668|NCT00867321|3699946|FG005|NOT COMPLETED|Overall Study||0
2983669|NCT00867334|3699962|FG000|STARTED|Overall Study||6
2983670|NCT00867334|3699963|FG001|STARTED|Overall Study||1
2983671|NCT00867334|3699962|FG000|COMPLETED|Overall Study||4
2983672|NCT00867334|3699963|FG001|COMPLETED|Overall Study||0
2983673|NCT00867334|3699962|FG000|NOT COMPLETED|Overall Study||2
2983674|NCT00867334|3699963|FG001|NOT COMPLETED|Overall Study||1
2983675|NCT00867360|3699971|FG000|STARTED|Overall Study||4
3303811|NCT02969707|4037171|FG000|STARTED|Overall Study||49
3303812|NCT02969707|4037172|FG001|STARTED|Overall Study||52
3303813|NCT02969707|4037171|FG000|COMPLETED|Overall Study||41
3303814|NCT02969707|4037172|FG001|COMPLETED|Overall Study||44
3303815|NCT02969707|4037171|FG000|NOT COMPLETED|Overall Study||8
3303816|NCT02969707|4037172|FG001|NOT COMPLETED|Overall Study||8
3303817|NCT02969863|4037183|FG000|STARTED|Overall Study||4
3303818|NCT02969863|4037184|FG001|STARTED|Overall Study||4
3303819|NCT02969863|4037185|FG002|STARTED|Overall Study||4
3303820|NCT02969863|4037186|FG003|STARTED|Overall Study||4
3303821|NCT02969863|4037187|FG004|STARTED|Overall Study||4
3303822|NCT02969863|4037188|FG005|STARTED|Overall Study||4
3303823|NCT02969863|4037183|FG000|COMPLETED|Overall Study||3
3303824|NCT02969863|4037184|FG001|COMPLETED|Overall Study||4
3303825|NCT02969863|4037185|FG002|COMPLETED|Overall Study||4
3303826|NCT02969863|4037186|FG003|COMPLETED|Overall Study||4
3303827|NCT02969863|4037187|FG004|COMPLETED|Overall Study||4
3303828|NCT02969863|4037188|FG005|COMPLETED|Overall Study||4
3303829|NCT02969863|4037183|FG000|NOT COMPLETED|Overall Study||1
3303830|NCT02969863|4037184|FG001|NOT COMPLETED|Overall Study||0
3303831|NCT02969863|4037185|FG002|NOT COMPLETED|Overall Study||0
3303832|NCT02969863|4037186|FG003|NOT COMPLETED|Overall Study||0
3303833|NCT02969863|4037187|FG004|NOT COMPLETED|Overall Study||0
3303834|NCT02969863|4037188|FG005|NOT COMPLETED|Overall Study||0
3303835|NCT02969876|4037202|FG000|STARTED|Overall Study||2
3303836|NCT02969876|4037202|FG000|COMPLETED|Overall Study||2
3303837|NCT02969876|4037202|FG000|NOT COMPLETED|Overall Study||0
3303838|NCT02970006|4037207|FG000|STARTED|Overall Study||15
3303839|NCT02970006|4037207|FG000|COMPLETED|Overall Study||14
3303840|NCT02970006|4037207|FG000|NOT COMPLETED|Overall Study||1
3303841|NCT02970032|4037211|FG000|STARTED|Standard Heparin Dose||20
3303842|NCT02970032|4037211|FG000|COMPLETED|Standard Heparin Dose||20
3303843|NCT02970032|4037211|FG000|NOT COMPLETED|Standard Heparin Dose||0
3303844|NCT02970032|4037211|FG000|STARTED|Real Time Heparin Dose Adjustment||20
3303845|NCT02970032|4037211|FG000|COMPLETED|Real Time Heparin Dose Adjustment||20
3303846|NCT02970032|4037211|FG000|NOT COMPLETED|Real Time Heparin Dose Adjustment||0
3303847|NCT02970162|4037218|FG000|STARTED|Overall Study||13
3303848|NCT02970162|4037219|FG001|STARTED|Overall Study||13
3303849|NCT02970162|4037218|FG000|COMPLETED|Overall Study||13
3303850|NCT02970162|4037219|FG001|COMPLETED|Overall Study||13
3303851|NCT02970162|4037218|FG000|NOT COMPLETED|Overall Study||0
3303852|NCT02970162|4037219|FG001|NOT COMPLETED|Overall Study||0
3303853|NCT02970292|4037227|FG000|STARTED|Overall Study||198
3303854|NCT02970292|4037228|FG001|STARTED|Overall Study||198
3303855|NCT02970292|4037227|FG000|COMPLETED|Overall Study||174
3303856|NCT02970292|4037228|FG001|COMPLETED|Overall Study||190
3303857|NCT02970292|4037227|FG000|NOT COMPLETED|Overall Study||24
3303858|NCT02970292|4037228|FG001|NOT COMPLETED|Overall Study||8
3303859|NCT02970305|4037236|FG000|STARTED|Overall Study||201
3303860|NCT02970305|4037237|FG001|STARTED|Overall Study||202
3303861|NCT02970305|4037236|FG000|COMPLETED|Overall Study||172
3303862|NCT02970305|4037237|FG001|COMPLETED|Overall Study||174
3303863|NCT02970305|4037236|FG000|NOT COMPLETED|Overall Study||29
3303864|NCT02970305|4037237|FG001|NOT COMPLETED|Overall Study||28
3303865|NCT02970422|4037243|FG000|STARTED|Overall Study||200
3303866|NCT02970422|4037243|FG000|COMPLETED|Overall Study||200
3303867|NCT02970422|4037243|FG000|NOT COMPLETED|Overall Study||0
3303868|NCT02970552|4037268|FG000|STARTED|Overall Study||70
3303869|NCT02970552|4037269|FG001|STARTED|Overall Study||70
3303870|NCT02970552|4037268|FG000|COMPLETED|Overall Study||67
3303871|NCT02970552|4037269|FG001|COMPLETED|Overall Study||67
3303872|NCT02970552|4037268|FG000|NOT COMPLETED|Overall Study||3
3303873|NCT02970552|4037269|FG001|NOT COMPLETED|Overall Study||3
3303874|NCT02970669|4037281|FG000|STARTED|Double-blind Period||70
3303875|NCT02970669|4037282|FG001|STARTED|Double-blind Period||70
3303876|NCT02970669|4037281|FG000|COMPLETED|Double-blind Period||62
3303877|NCT02970669|4037282|FG001|COMPLETED|Double-blind Period||64
2983676|NCT00867360|3699972|FG001|STARTED|Overall Study||6
2983677|NCT00867360|3699971|FG000|COMPLETED|Overall Study||3
2983678|NCT00867360|3699972|FG001|COMPLETED|Overall Study||5
2983679|NCT00867360|3699971|FG000|NOT COMPLETED|Overall Study||1
2983680|NCT00867360|3699972|FG001|NOT COMPLETED|Overall Study||1
2983681|NCT00867451|3699981|FG000|STARTED|Overall Study||4
2983682|NCT00867451|3699982|FG001|STARTED|Overall Study||4
2983683|NCT00867451|3699981|FG000|COMPLETED|Overall Study||4
2983684|NCT00867451|3699982|FG001|COMPLETED|Overall Study||4
2983685|NCT00867451|3699981|FG000|NOT COMPLETED|Overall Study||0
2983686|NCT00867451|3699982|FG001|NOT COMPLETED|Overall Study||0
2983687|NCT00867490|3699992|FG000|STARTED|Phase 1 - Candesartan+HCTZ||186
2983688|NCT00867490|3699992|FG000|COMPLETED|Phase 1 - Candesartan+HCTZ||176
2983689|NCT00867490|3699992|FG000|NOT COMPLETED|Phase 1 - Candesartan+HCTZ||10
2983690|NCT00867490|3699992|FG000|STARTED|Phase 2 - Aliskiren+HCTZ|Only patients with mean sitting diastolic BP ≥ 90 mmHg at the end of Phase 1 entered this phase.|123
2983691|NCT00867490|3699992|FG000|COMPLETED|Phase 2 - Aliskiren+HCTZ||120
2983692|NCT00867490|3699992|FG000|NOT COMPLETED|Phase 2 - Aliskiren+HCTZ||3
2983693|NCT00867490|3699992|FG000|STARTED|Phase 3 - Aliskiren+HCTZ+Amlodipine|The first 60 patients with systolic BP ≥ 140 mmHg or diastolic BP ≥ 90 mmHg entered this phase.|61
2983694|NCT00867490|3699992|FG000|COMPLETED|Phase 3 - Aliskiren+HCTZ+Amlodipine||61
2983695|NCT00867490|3699992|FG000|NOT COMPLETED|Phase 3 - Aliskiren+HCTZ+Amlodipine||0
2983696|NCT00867503|3699999|FG000|STARTED|Overall Study||10
2983697|NCT00867503|3699999|FG000|COMPLETED|Overall Study||9
2983698|NCT00867503|3699999|FG000|NOT COMPLETED|Overall Study||1
2983699|NCT00867529|3700005|FG000|STARTED|Overall Study||63
2983700|NCT00867529|3700005|FG000|COMPLETED|Overall Study||63
2983701|NCT00867529|3700005|FG000|NOT COMPLETED|Overall Study||0
2983702|NCT00867568|3700009|FG000|STARTED|Overall Study||18
2983703|NCT00867568|3700009|FG000|COMPLETED|Overall Study||3
2983704|NCT00867568|3700009|FG000|NOT COMPLETED|Overall Study||15
2983705|NCT00867659|3700013|FG000|STARTED|Overall Study|October 2009|20
2983706|NCT00867659|3700013|FG000|COMPLETED|Overall Study|January 2010|20
2983707|NCT00867659|3700013|FG000|NOT COMPLETED|Overall Study||0
2983708|NCT00867789|3700020|FG000|STARTED|Overall Study||70
2983709|NCT00867789|3700021|FG001|STARTED|Overall Study||70
2983710|NCT00867789|3700020|FG000|COMPLETED|Overall Study||68
2983711|NCT00867789|3700021|FG001|COMPLETED|Overall Study||70
2983712|NCT00867789|3700020|FG000|NOT COMPLETED|Overall Study||2
2983713|NCT00867789|3700021|FG001|NOT COMPLETED|Overall Study||0
2983714|NCT00867815|3700027|FG000|STARTED|Overall Study||10
2983715|NCT00867815|3700027|FG000|COMPLETED|Overall Study||9
2983716|NCT00867815|3700027|FG000|NOT COMPLETED|Overall Study||1
2983717|NCT00867932|3700031|FG000|STARTED|Overall Study||7
2983718|NCT00867932|3700031|FG000|Induction Phase|Overall Study||7
2983719|NCT00867932|3700031|FG000|Maintenance Phase|Overall Study||7
2983720|NCT00867932|3700031|FG000|Received at Least 1 Dose of Study Drug|Overall Study||7
2983721|NCT00867932|3700031|FG000|Intent-to-Treat (ITT) Population|Overall Study||7
2983722|NCT00867932|3700031|FG000|COMPLETED|Overall Study||7
2983723|NCT00867932|3700031|FG000|NOT COMPLETED|Overall Study||0
2983724|NCT00868101|3700037|FG000|STARTED|Overall Study||12
2983725|NCT00868101|3700038|FG001|STARTED|Overall Study||10
2983726|NCT00868101|3700037|FG000|COMPLETED|Overall Study||12
2983727|NCT00868101|3700038|FG001|COMPLETED|Overall Study||10
2983728|NCT00868101|3700037|FG000|NOT COMPLETED|Overall Study||0
2983729|NCT00868101|3700038|FG001|NOT COMPLETED|Overall Study||0
2983730|NCT00868140|3700048|FG000|STARTED|Overall Study||26
2983731|NCT00868140|3700049|FG001|STARTED|Overall Study||25
2983732|NCT00868140|3700048|FG000|COMPLETED|Overall Study||26
2983733|NCT00868140|3700049|FG001|COMPLETED|Overall Study||25
2983734|NCT00868140|3700048|FG000|NOT COMPLETED|Overall Study||0
2983735|NCT00868140|3700049|FG001|NOT COMPLETED|Overall Study||0
2983736|NCT00868166|3700059|FG000|STARTED|Overall Study||259
2983737|NCT00868166|3700060|FG001|STARTED|Overall Study||253
2983738|NCT00868166|3700059|FG000|COMPLETED|Overall Study||147
2983739|NCT00868166|3700060|FG001|COMPLETED|Overall Study||139
2983740|NCT00868166|3700059|FG000|NOT COMPLETED|Overall Study||112
2983741|NCT00868166|3700060|FG001|NOT COMPLETED|Overall Study||114
2983742|NCT00868192|3700066|FG000|STARTED|Overall Study||38
2983743|NCT00868192|3700066|FG000|COMPLETED|Overall Study||34
2983744|NCT00868192|3700066|FG000|NOT COMPLETED|Overall Study||4
2983745|NCT00868218|3700074|FG000|STARTED|Overall Study||15
2983746|NCT00868218|3700075|FG001|STARTED|Overall Study||15
2983747|NCT00868218|3700076|FG002|STARTED|Overall Study||15
2983748|NCT00868218|3700077|FG003|STARTED|Overall Study||15
2983749|NCT00868218|3700074|FG000|COMPLETED|Overall Study||15
2983750|NCT00868218|3700075|FG001|COMPLETED|Overall Study||15
2983751|NCT00868218|3700076|FG002|COMPLETED|Overall Study||15
2983752|NCT00868218|3700077|FG003|COMPLETED|Overall Study||15
2983753|NCT00868218|3700074|FG000|NOT COMPLETED|Overall Study||0
2983754|NCT00868218|3700075|FG001|NOT COMPLETED|Overall Study||0
2983755|NCT00868218|3700076|FG002|NOT COMPLETED|Overall Study||0
2983756|NCT00868218|3700077|FG003|NOT COMPLETED|Overall Study||0
2983757|NCT00868231|3700091|FG000|STARTED|Treatment Period 1||5
2983758|NCT00868231|3700092|FG001|STARTED|Treatment Period 1||5
2983759|NCT00868231|3700093|FG002|STARTED|Treatment Period 1||5
2983760|NCT00868231|3700094|FG003|STARTED|Treatment Period 1||5
2983761|NCT00868231|3700095|FG004|STARTED|Treatment Period 1||5
2983762|NCT00868231|3700096|FG005|STARTED|Treatment Period 1||5
2983763|NCT00868231|3700091|FG000|COMPLETED|Treatment Period 1||5
2983764|NCT00868231|3700092|FG001|COMPLETED|Treatment Period 1||5
2983765|NCT00868231|3700093|FG002|COMPLETED|Treatment Period 1||5
2983766|NCT00868231|3700094|FG003|COMPLETED|Treatment Period 1||5
2983767|NCT00868231|3700095|FG004|COMPLETED|Treatment Period 1||4
2983768|NCT00868231|3700096|FG005|COMPLETED|Treatment Period 1||5
2983769|NCT00868231|3700091|FG000|NOT COMPLETED|Treatment Period 1||0
2983770|NCT00868231|3700092|FG001|NOT COMPLETED|Treatment Period 1||0
2983771|NCT00868231|3700093|FG002|NOT COMPLETED|Treatment Period 1||0
2983772|NCT00868231|3700094|FG003|NOT COMPLETED|Treatment Period 1||0
2983773|NCT00868231|3700095|FG004|NOT COMPLETED|Treatment Period 1||1
2983774|NCT00868231|3700096|FG005|NOT COMPLETED|Treatment Period 1||0
2983775|NCT00868231|3700091|FG000|STARTED|Treatment Period 2||5
2983776|NCT00868231|3700092|FG001|STARTED|Treatment Period 2||5
2983777|NCT00868231|3700093|FG002|STARTED|Treatment Period 2||5
2983778|NCT00868231|3700094|FG003|STARTED|Treatment Period 2||5
2983779|NCT00868231|3700095|FG004|STARTED|Treatment Period 2||4
2983780|NCT00868231|3700096|FG005|STARTED|Treatment Period 2||5
2983781|NCT00868231|3700091|FG000|COMPLETED|Treatment Period 2||4
2983782|NCT00868231|3700092|FG001|COMPLETED|Treatment Period 2||5
2983783|NCT00868231|3700093|FG002|COMPLETED|Treatment Period 2||5
2983784|NCT00868231|3700094|FG003|COMPLETED|Treatment Period 2||5
2983785|NCT00868231|3700095|FG004|COMPLETED|Treatment Period 2||4
2983786|NCT00868231|3700096|FG005|COMPLETED|Treatment Period 2||5
2983787|NCT00868231|3700091|FG000|NOT COMPLETED|Treatment Period 2||1
2983788|NCT00868231|3700092|FG001|NOT COMPLETED|Treatment Period 2||0
2983789|NCT00868231|3700093|FG002|NOT COMPLETED|Treatment Period 2||0
2983790|NCT00868231|3700094|FG003|NOT COMPLETED|Treatment Period 2||0
2983791|NCT00868231|3700095|FG004|NOT COMPLETED|Treatment Period 2||0
2983792|NCT00868231|3700096|FG005|NOT COMPLETED|Treatment Period 2||0
2983793|NCT00868231|3700091|FG000|STARTED|Treatment Period 3||4
2983794|NCT00868231|3700092|FG001|STARTED|Treatment Period 3||5
2983795|NCT00868231|3700093|FG002|STARTED|Treatment Period 3||5
2983796|NCT00868231|3700094|FG003|STARTED|Treatment Period 3||5
2983797|NCT00868231|3700095|FG004|STARTED|Treatment Period 3||4
2983798|NCT00868231|3700096|FG005|STARTED|Treatment Period 3||5
2983799|NCT00868231|3700091|FG000|COMPLETED|Treatment Period 3||4
2983800|NCT00868231|3700092|FG001|COMPLETED|Treatment Period 3||5
2983801|NCT00868231|3700093|FG002|COMPLETED|Treatment Period 3||4
2983802|NCT00868231|3700094|FG003|COMPLETED|Treatment Period 3||5
2983803|NCT00868231|3700095|FG004|COMPLETED|Treatment Period 3||4
2983804|NCT00868231|3700096|FG005|COMPLETED|Treatment Period 3||5
2983805|NCT00868231|3700091|FG000|NOT COMPLETED|Treatment Period 3||0
2983806|NCT00868231|3700092|FG001|NOT COMPLETED|Treatment Period 3||0
2983807|NCT00868231|3700093|FG002|NOT COMPLETED|Treatment Period 3||1
2983808|NCT00868231|3700094|FG003|NOT COMPLETED|Treatment Period 3||0
3303878|NCT02970669|4037281|FG000|NOT COMPLETED|Double-blind Period||8
3303879|NCT02970669|4037282|FG001|NOT COMPLETED|Double-blind Period||6
3303880|NCT02970669|4037281|FG000|STARTED|Open-label Period||62
3303881|NCT02970669|4037282|FG001|STARTED|Open-label Period||64
3303882|NCT02970669|4037281|FG000|COMPLETED|Open-label Period||58
3303883|NCT02970669|4037282|FG001|COMPLETED|Open-label Period||62
3303884|NCT02970669|4037281|FG000|NOT COMPLETED|Open-label Period||4
3303885|NCT02970669|4037282|FG001|NOT COMPLETED|Open-label Period||2
3303886|NCT02970812|4037292|FG000|STARTED|Overall Study||30
3303887|NCT02970812|4037293|FG001|STARTED|Overall Study||30
3303888|NCT02970812|4037292|FG000|COMPLETED|Overall Study||22
3303889|NCT02970812|4037293|FG001|COMPLETED|Overall Study||28
3303890|NCT02970812|4037292|FG000|NOT COMPLETED|Overall Study||8
3303891|NCT02970812|4037293|FG001|NOT COMPLETED|Overall Study||2
3303892|NCT02970942|4037303|FG000|STARTED|Overall Study||80
3303893|NCT02970942|4037304|FG001|STARTED|Overall Study||78
3303894|NCT02970942|4037305|FG002|STARTED|Overall Study||82
3303895|NCT02970942|4037306|FG003|STARTED|Overall Study||80
3303896|NCT02970942|4037303|FG000|Full Analysis Set|Overall Study||80
3303897|NCT02970942|4037304|FG001|Full Analysis Set|Overall Study||78
3303898|NCT02970942|4037305|FG002|Full Analysis Set|Overall Study||82
3303899|NCT02970942|4037306|FG003|Full Analysis Set|Overall Study||80
3303900|NCT02970942|4037303|FG000|Safety Analysis Set|Overall Study||80
3303901|NCT02970942|4037304|FG001|Safety Analysis Set|Overall Study||78
3303902|NCT02970942|4037305|FG002|Safety Analysis Set|Overall Study||81
3303903|NCT02970942|4037306|FG003|Safety Analysis Set|Overall Study||80
3303904|NCT02970942|4037303|FG000|Exposed|Overall Study||80
3303905|NCT02970942|4037304|FG001|Exposed|Overall Study||78
3303906|NCT02970942|4037305|FG002|Exposed|Overall Study||81
3303907|NCT02970942|4037306|FG003|Exposed|Overall Study||80
3303908|NCT02970942|4037303|FG000|COMPLETED|Overall Study||76
3303909|NCT02970942|4037304|FG001|COMPLETED|Overall Study||72
3303910|NCT02970942|4037305|FG002|COMPLETED|Overall Study||77
3303911|NCT02970942|4037306|FG003|COMPLETED|Overall Study||77
3303912|NCT02970942|4037303|FG000|NOT COMPLETED|Overall Study||4
3303913|NCT02970942|4037304|FG001|NOT COMPLETED|Overall Study||6
3303914|NCT02970942|4037305|FG002|NOT COMPLETED|Overall Study||5
3303915|NCT02970942|4037306|FG003|NOT COMPLETED|Overall Study||3
3303916|NCT02971007|4037319|FG000|STARTED|Overall Study||46
3303917|NCT02971007|4037320|FG001|STARTED|Overall Study||45
3303918|NCT02971007|4037321|FG002|STARTED|Overall Study||46
3303919|NCT02971007|4037319|FG000|COMPLETED|Overall Study||44
3303920|NCT02971007|4037320|FG001|COMPLETED|Overall Study||42
3303921|NCT02971007|4037321|FG002|COMPLETED|Overall Study||45
3303922|NCT02971007|4037319|FG000|NOT COMPLETED|Overall Study||2
2983809|NCT00868231|3700095|FG004|NOT COMPLETED|Treatment Period 3||0
2983810|NCT00868231|3700096|FG005|NOT COMPLETED|Treatment Period 3||0
2983811|NCT00868296|3700106|FG000|STARTED|Overall Study||12
2983812|NCT00868296|3700107|FG001|STARTED|Overall Study||46
2983813|NCT00868296|3700106|FG000|COMPLETED|Overall Study||12
2983814|NCT00868296|3700107|FG001|COMPLETED|Overall Study||43
2983815|NCT00868296|3700106|FG000|NOT COMPLETED|Overall Study||0
2983816|NCT00868296|3700107|FG001|NOT COMPLETED|Overall Study||3
2983817|NCT00868309|3700115|FG000|STARTED|Overall Study||6
2983818|NCT00868309|3700116|FG001|STARTED|Overall Study||6
2983819|NCT00868309|3700115|FG000|COMPLETED|Overall Study||6
2983820|NCT00868309|3700116|FG001|COMPLETED|Overall Study||6
2983821|NCT00868309|3700115|FG000|NOT COMPLETED|Overall Study||0
2983822|NCT00868309|3700116|FG001|NOT COMPLETED|Overall Study||0
2983823|NCT00868348|3700124|FG000|STARTED|Overall Study||30
2983824|NCT00868348|3700125|FG001|STARTED|Overall Study||30
2983825|NCT00868348|3700124|FG000|COMPLETED|Overall Study||30
2983826|NCT00868348|3700125|FG001|COMPLETED|Overall Study||30
2983827|NCT00868348|3700124|FG000|NOT COMPLETED|Overall Study||0
2983828|NCT00868348|3700125|FG001|NOT COMPLETED|Overall Study||0
2983829|NCT00868374|3700133|FG000|STARTED|Overall Study||12
2983830|NCT00868374|3700134|FG001|STARTED|Overall Study||11
2983831|NCT00868374|3700133|FG000|COMPLETED|Overall Study||5
2983832|NCT00868374|3700134|FG001|COMPLETED|Overall Study||4
2983833|NCT00868374|3700133|FG000|NOT COMPLETED|Overall Study||7
2983834|NCT00868374|3700134|FG001|NOT COMPLETED|Overall Study||7
2983835|NCT00868439|3700142|FG000|STARTED|Overall Study||56
2983836|NCT00868439|3700143|FG001|STARTED|Overall Study||49
2983837|NCT00868439|3700142|FG000|COMPLETED|Overall Study||48
2983838|NCT00868439|3700143|FG001|COMPLETED|Overall Study||40
2983839|NCT00868439|3700142|FG000|NOT COMPLETED|Overall Study||8
2983840|NCT00868439|3700143|FG001|NOT COMPLETED|Overall Study||9
2983841|NCT00868452|3700151|FG000|STARTED|Overall Study||183
2983842|NCT00868452|3700152|FG001|STARTED|Overall Study||165
2983843|NCT00868452|3700151|FG000|COMPLETED|Overall Study||143
2983844|NCT00868452|3700152|FG001|COMPLETED|Overall Study||136
2983845|NCT00868452|3700151|FG000|NOT COMPLETED|Overall Study||40
2983846|NCT00868452|3700152|FG001|NOT COMPLETED|Overall Study||29
2983847|NCT00868517|3700162|FG000|STARTED|Overall Study||12
2983848|NCT00868517|3700163|FG001|STARTED|Overall Study||12
2983849|NCT00868517|3700164|FG002|STARTED|Overall Study||11
2983850|NCT00868517|3700162|FG000|COMPLETED|Overall Study||8
2983851|NCT00868517|3700163|FG001|COMPLETED|Overall Study||8
2983852|NCT00868517|3700164|FG002|COMPLETED|Overall Study||9
2983853|NCT00868517|3700162|FG000|NOT COMPLETED|Overall Study||4
2983854|NCT00868517|3700163|FG001|NOT COMPLETED|Overall Study||4
2983855|NCT00868517|3700164|FG002|NOT COMPLETED|Overall Study||2
2983856|NCT00868530|3700172|FG000|STARTED|Overall Study||53
2983857|NCT00868530|3700172|FG000|COMPLETED|Overall Study||49
2983858|NCT00868530|3700172|FG000|NOT COMPLETED|Overall Study||4
2983859|NCT00868608|3700179|FG000|STARTED|Overall Study||72
2983860|NCT00868608|3700180|FG001|STARTED|Overall Study||4
3303923|NCT02971007|4037320|FG001|NOT COMPLETED|Overall Study||3
3303924|NCT02971007|4037321|FG002|NOT COMPLETED|Overall Study||1
3303925|NCT02971163|4037331|FG000|STARTED|Overall Study||24
3303926|NCT02971163|4037332|FG001|STARTED|Overall Study||26
3303927|NCT02971163|4037331|FG000|COMPLETED|Overall Study||20
3303928|NCT02971163|4037332|FG001|COMPLETED|Overall Study||24
3303929|NCT02971163|4037331|FG000|NOT COMPLETED|Overall Study||4
3303930|NCT02971163|4037332|FG001|NOT COMPLETED|Overall Study||2
3303931|NCT02971202|4037341|FG000|STARTED|Overall Study||12
3303932|NCT02971202|4037342|FG001|STARTED|Overall Study||10
3303933|NCT02971202|4037343|FG002|STARTED|Overall Study||11
3303934|NCT02971202|4037341|FG000|Started Study|Overall Study||11
3303935|NCT02971202|4037342|FG001|Started Study|Overall Study||10
3303936|NCT02971202|4037343|FG002|Started Study|Overall Study||10
3303937|NCT02971202|4037341|FG000|COMPLETED|Overall Study||10
3303938|NCT02971202|4037342|FG001|COMPLETED|Overall Study||10
3303939|NCT02971202|4037343|FG002|COMPLETED|Overall Study||10
3303940|NCT02971202|4037341|FG000|NOT COMPLETED|Overall Study||2
3303941|NCT02971202|4037342|FG001|NOT COMPLETED|Overall Study||0
3303942|NCT02971202|4037343|FG002|NOT COMPLETED|Overall Study||1
3303943|NCT02971228|4037351|FG000|STARTED|Overall Study||1
3303944|NCT02971228|4037352|FG001|STARTED|Overall Study||7
3303945|NCT02971228|4037353|FG002|STARTED|Overall Study||5
3303946|NCT02971228|4037354|FG003|STARTED|Overall Study|Due to iLet unavailability, trial was stopped upon completion of Part 1. Part 2 was not conducted.|0
3303947|NCT02971228|4037355|FG004|STARTED|Overall Study|Due to iLet unavailability, trial was stopped upon completion of Part 1. Part 2 was not conducted.|0
3303948|NCT02971228|4037351|FG000|Randomized and Treated|Overall Study||0
3303949|NCT02971228|4037352|FG001|Randomized and Treated|Overall Study||7
3303950|NCT02971228|4037353|FG002|Randomized and Treated|Overall Study||5
3303951|NCT02971228|4037354|FG003|Randomized and Treated|Overall Study||0
3303952|NCT02971228|4037355|FG004|Randomized and Treated|Overall Study||0
3303953|NCT02971228|4037351|FG000|COMPLETED|Overall Study||0
3303954|NCT02971228|4037352|FG001|COMPLETED|Overall Study||5
3303955|NCT02971228|4037353|FG002|COMPLETED|Overall Study||5
3303956|NCT02971228|4037354|FG003|COMPLETED|Overall Study|Due to iLet unavailability, trial was stopped upon completion of Part 1. Part 2 was not conducted.|0
3317035|NCT03123068|4050530|FG001|COMPLETED|Overall Study||20
2983861|NCT00868608|3700181|FG002|STARTED|Overall Study||5
2983862|NCT00868608|3700179|FG000|COMPLETED|Overall Study||49
2983863|NCT00868608|3700180|FG001|COMPLETED|Overall Study||1
2983864|NCT00868608|3700181|FG002|COMPLETED|Overall Study||0
2983865|NCT00868608|3700179|FG000|NOT COMPLETED|Overall Study||23
2983866|NCT00868608|3700180|FG001|NOT COMPLETED|Overall Study||3
2983867|NCT00868608|3700181|FG002|NOT COMPLETED|Overall Study||5
2983868|NCT00868699|3700192|FG000|STARTED|Overall Study||170
2983869|NCT00868699|3700193|FG001|STARTED|Overall Study||169
2983870|NCT00868699|3700194|FG002|STARTED|Overall Study||166
2983871|NCT00868699|3700192|FG000|Intent-to-Treat Population|Overall Study||162
2983872|NCT00868699|3700193|FG001|Intent-to-Treat Population|Overall Study||162
2983873|NCT00868699|3700194|FG002|Intent-to-Treat Population|Overall Study||161
2983874|NCT00868699|3700192|FG000|Safety Population|Overall Study||168
3133472|NCT01696058|3858450|FG000|STARTED|Overall Study||566
3133473|NCT01696058|3858451|FG001|STARTED|Overall Study||569
3133474|NCT01696058|3858450|FG000|COMPLETED|Overall Study||523
3133475|NCT01696058|3858451|FG001|COMPLETED|Overall Study||538
3303957|NCT02971228|4037355|FG004|COMPLETED|Overall Study|Due to iLet unavailability, trial was stopped upon completion of Part 1. Part 2 was not conducted.|0
3303958|NCT02971228|4037351|FG000|NOT COMPLETED|Overall Study||1
2983875|NCT00868699|3700193|FG001|Safety Population|Overall Study||167
2983876|NCT00868699|3700194|FG002|Safety Population|Overall Study||164
2983877|NCT00868699|3700192|FG000|COMPLETED|Overall Study||127
2983878|NCT00868699|3700193|FG001|COMPLETED|Overall Study||124
2983879|NCT00868699|3700194|FG002|COMPLETED|Overall Study||123
2983880|NCT00868699|3700192|FG000|NOT COMPLETED|Overall Study||43
2983881|NCT00868699|3700193|FG001|NOT COMPLETED|Overall Study||45
2983882|NCT00868699|3700194|FG002|NOT COMPLETED|Overall Study||43
2983883|NCT00868712|3700205|FG000|STARTED|Overall Study||31
2983884|NCT00868712|3700206|FG001|STARTED|Overall Study||11
2983885|NCT00868712|3700207|FG002|STARTED|Overall Study||28
2983886|NCT00868712|3700205|FG000|COMPLETED|Overall Study||31
2983887|NCT00868712|3700206|FG001|COMPLETED|Overall Study||11
2983888|NCT00868712|3700207|FG002|COMPLETED|Overall Study||28
2983889|NCT00868712|3700205|FG000|NOT COMPLETED|Overall Study||0
2983890|NCT00868712|3700206|FG001|NOT COMPLETED|Overall Study||0
2983891|NCT00868712|3700207|FG002|NOT COMPLETED|Overall Study||0
3303959|NCT02971228|4037352|FG001|NOT COMPLETED|Overall Study||2
3303960|NCT02971228|4037353|FG002|NOT COMPLETED|Overall Study||0
3303961|NCT02971228|4037354|FG003|NOT COMPLETED|Overall Study||0
3303962|NCT02971228|4037355|FG004|NOT COMPLETED|Overall Study||0
3303963|NCT02971293|4037366|FG000|STARTED|Overall Study||42
3303964|NCT02971293|4037366|FG000|COMPLETED|Overall Study||31
3303965|NCT02971293|4037366|FG000|NOT COMPLETED|Overall Study||11
3303966|NCT02971488|4037374|FG000|STARTED|Overall Study||529
3303967|NCT02971488|4037374|FG000|COMPLETED|Overall Study||529
3303968|NCT02971488|4037374|FG000|NOT COMPLETED|Overall Study||0
3303969|NCT02971605|4037381|FG000|STARTED|Overall Study||13
3303970|NCT02971605|4037381|FG000|COMPLETED|Overall Study||12
3303971|NCT02971605|4037381|FG000|NOT COMPLETED|Overall Study||1
3303972|NCT02971631|4037387|FG000|STARTED|First Intervention - One Day||3
3303973|NCT02971631|4037388|FG001|STARTED|First Intervention - One Day||2
3303974|NCT02971631|4037387|FG000|COMPLETED|First Intervention - One Day||3
3303975|NCT02971631|4037388|FG001|COMPLETED|First Intervention - One Day||2
3303976|NCT02971631|4037387|FG000|NOT COMPLETED|First Intervention - One Day||0
3303977|NCT02971631|4037388|FG001|NOT COMPLETED|First Intervention - One Day||0
3303978|NCT02971631|4037387|FG000|STARTED|Second Intervention - One Day||3
3303979|NCT02971631|4037388|FG001|STARTED|Second Intervention - One Day||2
3303980|NCT02971631|4037387|FG000|COMPLETED|Second Intervention - One Day||3
3303981|NCT02971631|4037388|FG001|COMPLETED|Second Intervention - One Day||2
3303982|NCT02971631|4037387|FG000|NOT COMPLETED|Second Intervention - One Day||0
3303983|NCT02971631|4037388|FG001|NOT COMPLETED|Second Intervention - One Day||0
3303984|NCT02971670|4037399|FG000|STARTED|Overall Study||13
3303985|NCT02971670|4037400|FG001|STARTED|Overall Study||2
3303986|NCT02971670|4037401|FG002|STARTED|Overall Study||5
3303987|NCT02971670|4037402|FG003|STARTED|Overall Study||3
3303988|NCT02971670|4037399|FG000|COMPLETED|Overall Study||9
3303989|NCT02971670|4037400|FG001|COMPLETED|Overall Study||1
3303990|NCT02971670|4037401|FG002|COMPLETED|Overall Study||4
3303991|NCT02971670|4037402|FG003|COMPLETED|Overall Study||1
3303992|NCT02971670|4037399|FG000|NOT COMPLETED|Overall Study||4
3303993|NCT02971670|4037400|FG001|NOT COMPLETED|Overall Study||1
3303994|NCT02971670|4037401|FG002|NOT COMPLETED|Overall Study||1
3303995|NCT02971670|4037402|FG003|NOT COMPLETED|Overall Study||2
3303996|NCT02971683|4037414|FG000|STARTED|Overall Study||75
3303997|NCT02971683|4037415|FG001|STARTED|Overall Study||73
3303998|NCT02971683|4037414|FG000|COMPLETED|Overall Study||69
3303999|NCT02971683|4037415|FG001|COMPLETED|Overall Study||65
3304000|NCT02971683|4037414|FG000|NOT COMPLETED|Overall Study||6
3304001|NCT02971683|4037415|FG001|NOT COMPLETED|Overall Study||8
3304002|NCT02971735|4037423|FG000|STARTED|Overall Study||30
3304003|NCT02971735|4037424|FG001|STARTED|Overall Study||30
3304004|NCT02971735|4037423|FG000|COMPLETED|Overall Study||30
3304005|NCT02971735|4037424|FG001|COMPLETED|Overall Study||30
3304006|NCT02971735|4037423|FG000|NOT COMPLETED|Overall Study||0
3304007|NCT02971735|4037424|FG001|NOT COMPLETED|Overall Study||0
3304008|NCT02971800|4037430|FG000|STARTED|Overall Study||37
3304009|NCT02971800|4037430|FG000|COMPLETED|Overall Study||30
3304010|NCT02971800|4037430|FG000|NOT COMPLETED|Overall Study||7
3304011|NCT02972242|4037436|FG000|STARTED|Overall Study||82
3304012|NCT02972242|4037437|FG001|STARTED|Overall Study||93
3304013|NCT02972242|4037436|FG000|COMPLETED|Overall Study||81
3304014|NCT02972242|4037437|FG001|COMPLETED|Overall Study||93
2983892|NCT00868751|3700215|FG000|STARTED|Overall Study||1
3133476|NCT01696058|3858450|FG000|NOT COMPLETED|Overall Study||43
2983893|NCT00868751|3700215|FG000|COMPLETED|Overall Study||0
2983894|NCT00868751|3700215|FG000|NOT COMPLETED|Overall Study||1
2983895|NCT00868790|3700219|FG000|STARTED|Period 1||11
2983896|NCT00868790|3700220|FG001|STARTED|Period 1||8
2983897|NCT00868790|3700221|FG002|STARTED|Period 1||4
2983898|NCT00868790|3700222|FG003|STARTED|Period 1||4
2983899|NCT00868790|3700223|FG004|STARTED|Period 1||19
2983900|NCT00868790|3700224|FG005|STARTED|Period 1||3
2983901|NCT00868790|3700225|FG006|STARTED|Period 1||4
2983902|NCT00868790|3700226|FG007|STARTED|Period 1||20
2983903|NCT00868790|3700227|FG008|STARTED|Period 1||11
2983904|NCT00868790|3700228|FG009|STARTED|Period 1||3
2983905|NCT00868790|3700229|FG010|STARTED|Period 1||9
2983906|NCT00868790|3700230|FG011|STARTED|Period 1||4
2983907|NCT00868790|3700231|FG012|STARTED|Period 1||7
2983908|NCT00868790|3700232|FG013|STARTED|Period 1||11
2983909|NCT00868790|3700219|FG000|COMPLETED|Period 1||9
2983910|NCT00868790|3700220|FG001|COMPLETED|Period 1||7
2983911|NCT00868790|3700221|FG002|COMPLETED|Period 1||4
2983912|NCT00868790|3700222|FG003|COMPLETED|Period 1||4
2983913|NCT00868790|3700223|FG004|COMPLETED|Period 1||18
2983914|NCT00868790|3700224|FG005|COMPLETED|Period 1||2
2983915|NCT00868790|3700225|FG006|COMPLETED|Period 1||4
2983916|NCT00868790|3700226|FG007|COMPLETED|Period 1||17
2983917|NCT00868790|3700227|FG008|COMPLETED|Period 1||10
2983918|NCT00868790|3700228|FG009|COMPLETED|Period 1||3
2983919|NCT00868790|3700229|FG010|COMPLETED|Period 1||9
2983920|NCT00868790|3700230|FG011|COMPLETED|Period 1||4
2983921|NCT00868790|3700231|FG012|COMPLETED|Period 1||7
2983922|NCT00868790|3700232|FG013|COMPLETED|Period 1||9
2983923|NCT00868790|3700219|FG000|NOT COMPLETED|Period 1||2
2983924|NCT00868790|3700220|FG001|NOT COMPLETED|Period 1||1
2983925|NCT00868790|3700221|FG002|NOT COMPLETED|Period 1||0
2983926|NCT00868790|3700222|FG003|NOT COMPLETED|Period 1||0
2983927|NCT00868790|3700223|FG004|NOT COMPLETED|Period 1||1
2983928|NCT00868790|3700224|FG005|NOT COMPLETED|Period 1||1
2983929|NCT00868790|3700225|FG006|NOT COMPLETED|Period 1||0
2983930|NCT00868790|3700226|FG007|NOT COMPLETED|Period 1||3
2983931|NCT00868790|3700227|FG008|NOT COMPLETED|Period 1||1
2983932|NCT00868790|3700228|FG009|NOT COMPLETED|Period 1||0
2983933|NCT00868790|3700229|FG010|NOT COMPLETED|Period 1||0
2983934|NCT00868790|3700230|FG011|NOT COMPLETED|Period 1||0
3304015|NCT02972242|4037436|FG000|NOT COMPLETED|Overall Study||1
3304016|NCT02972242|4037437|FG001|NOT COMPLETED|Overall Study||0
3304017|NCT02972359|4037443|FG000|STARTED|Overall Study||318
3304018|NCT02972359|4037443|FG000|COMPLETED|Overall Study||247
3304019|NCT02972359|4037443|FG000|NOT COMPLETED|Overall Study||71
3304020|NCT02972502|4037449|FG000|STARTED|Overall Study||35
3304021|NCT02972502|4037450|FG001|STARTED|Overall Study||31
3304022|NCT02972502|4037449|FG000|COMPLETED|Overall Study||31
3304023|NCT02972502|4037450|FG001|COMPLETED|Overall Study||29
3304024|NCT02972502|4037449|FG000|NOT COMPLETED|Overall Study||4
3304025|NCT02972502|4037450|FG001|NOT COMPLETED|Overall Study||2
3304026|NCT02972515|4037456|FG000|STARTED|Overall Study||166
3304027|NCT02972515|4037456|FG000|COMPLETED|Overall Study||88
3304028|NCT02972515|4037456|FG000|NOT COMPLETED|Overall Study||78
3304029|NCT02972554|4037462|FG000|STARTED|Overall Study||44
3304030|NCT02972554|4037463|FG001|STARTED|Overall Study||48
3304031|NCT02972554|4037462|FG000|COMPLETED|Overall Study||44
3304032|NCT02972554|4037463|FG001|COMPLETED|Overall Study||48
3304033|NCT02972554|4037462|FG000|NOT COMPLETED|Overall Study||0
3304034|NCT02972554|4037463|FG001|NOT COMPLETED|Overall Study||0
3304035|NCT02972632|4037469|FG000|STARTED|Overall Study||123
3304036|NCT02972632|4037469|FG000|Safety Analysis Set|Overall Study||122
3304037|NCT02972632|4037469|FG000|COMPLETED|Overall Study||106
3304038|NCT02972632|4037469|FG000|NOT COMPLETED|Overall Study||17
3304039|NCT02972658|4037477|FG000|STARTED|Overall Study||76
3304040|NCT02972658|4037478|FG001|STARTED|Overall Study||139
3304041|NCT02972658|4037479|FG002|STARTED|Overall Study||75
3304042|NCT02972658|4037480|FG003|STARTED|Overall Study||131
3304043|NCT02972658|4037477|FG000|Received at Least 1 Dose of Study Drug|Overall Study||76
3304044|NCT02972658|4037478|FG001|Received at Least 1 Dose of Study Drug|Overall Study||139
3304045|NCT02972658|4037479|FG002|Received at Least 1 Dose of Study Drug|Overall Study||74
3304046|NCT02972658|4037480|FG003|Received at Least 1 Dose of Study Drug|Overall Study||131
3304047|NCT02972658|4037477|FG000|COMPLETED|Overall Study||0
3304048|NCT02972658|4037478|FG001|COMPLETED|Overall Study|"1 participant was incorrectly marked as Completed rather than study terminated by Sponsor."|1
3304049|NCT02972658|4037479|FG002|COMPLETED|Overall Study||0
3304050|NCT02972658|4037480|FG003|COMPLETED|Overall Study||0
3304051|NCT02972658|4037477|FG000|NOT COMPLETED|Overall Study||76
3304052|NCT02972658|4037478|FG001|NOT COMPLETED|Overall Study||138
3304053|NCT02972658|4037479|FG002|NOT COMPLETED|Overall Study||75
3304054|NCT02972658|4037480|FG003|NOT COMPLETED|Overall Study||131
3304055|NCT02973048|4037492|FG000|STARTED|Overall Study||20
3304056|NCT02973048|4037493|FG001|STARTED|Overall Study||20
3304057|NCT02973048|4037492|FG000|COMPLETED|Overall Study||19
3304058|NCT02973048|4037493|FG001|COMPLETED|Overall Study||17
3304059|NCT02973048|4037492|FG000|NOT COMPLETED|Overall Study||1
3304060|NCT02973048|4037493|FG001|NOT COMPLETED|Overall Study||3
2983935|NCT00868790|3700231|FG012|NOT COMPLETED|Period 1||0
2983936|NCT00868790|3700232|FG013|NOT COMPLETED|Period 1||2
2983937|NCT00868790|3700219|FG000|STARTED|Period 2||9
2983938|NCT00868790|3700220|FG001|STARTED|Period 2||7
2983939|NCT00868790|3700221|FG002|STARTED|Period 2||4
2983940|NCT00868790|3700222|FG003|STARTED|Period 2||4
2983941|NCT00868790|3700223|FG004|STARTED|Period 2||18
2983942|NCT00868790|3700224|FG005|STARTED|Period 2||2
2983943|NCT00868790|3700225|FG006|STARTED|Period 2||4
2983944|NCT00868790|3700226|FG007|STARTED|Period 2||17
2983945|NCT00868790|3700227|FG008|STARTED|Period 2||10
2983946|NCT00868790|3700228|FG009|STARTED|Period 2||3
2983947|NCT00868790|3700229|FG010|STARTED|Period 2||9
2983948|NCT00868790|3700230|FG011|STARTED|Period 2||4
2983949|NCT00868790|3700231|FG012|STARTED|Period 2||7
2983950|NCT00868790|3700232|FG013|STARTED|Period 2||9
2983951|NCT00868790|3700219|FG000|COMPLETED|Period 2||9
2983952|NCT00868790|3700220|FG001|COMPLETED|Period 2||6
2983953|NCT00868790|3700221|FG002|COMPLETED|Period 2||4
2983954|NCT00868790|3700222|FG003|COMPLETED|Period 2||4
2983955|NCT00868790|3700223|FG004|COMPLETED|Period 2||18
2983956|NCT00868790|3700224|FG005|COMPLETED|Period 2||1
2983957|NCT00868790|3700225|FG006|COMPLETED|Period 2||4
2983958|NCT00868790|3700226|FG007|COMPLETED|Period 2||17
2983959|NCT00868790|3700227|FG008|COMPLETED|Period 2||8
2983960|NCT00868790|3700228|FG009|COMPLETED|Period 2||3
2983961|NCT00868790|3700229|FG010|COMPLETED|Period 2||9
2983962|NCT00868790|3700230|FG011|COMPLETED|Period 2||4
2983963|NCT00868790|3700231|FG012|COMPLETED|Period 2||7
2983964|NCT00868790|3700232|FG013|COMPLETED|Period 2||8
2983965|NCT00868790|3700219|FG000|NOT COMPLETED|Period 2||0
2983966|NCT00868790|3700220|FG001|NOT COMPLETED|Period 2||1
2983967|NCT00868790|3700221|FG002|NOT COMPLETED|Period 2||0
2983968|NCT00868790|3700222|FG003|NOT COMPLETED|Period 2||0
2983969|NCT00868790|3700223|FG004|NOT COMPLETED|Period 2||0
2983970|NCT00868790|3700224|FG005|NOT COMPLETED|Period 2||1
2983971|NCT00868790|3700225|FG006|NOT COMPLETED|Period 2||0
2983972|NCT00868790|3700226|FG007|NOT COMPLETED|Period 2||0
2983973|NCT00868790|3700227|FG008|NOT COMPLETED|Period 2||2
2983974|NCT00868790|3700228|FG009|NOT COMPLETED|Period 2||0
2983975|NCT00868790|3700229|FG010|NOT COMPLETED|Period 2||0
2983976|NCT00868790|3700230|FG011|NOT COMPLETED|Period 2||0
3304061|NCT02973087|4037501|FG000|STARTED|Overall Study||13
3304062|NCT02973087|4037502|FG001|STARTED|Overall Study||10
3304063|NCT02973087|4037501|FG000|COMPLETED|Overall Study||9
3304064|NCT02973087|4037502|FG001|COMPLETED|Overall Study||8
3304065|NCT02973087|4037501|FG000|NOT COMPLETED|Overall Study||4
3304066|NCT02973087|4037502|FG001|NOT COMPLETED|Overall Study||2
3304067|NCT02973100|4037513|FG000|STARTED|Overall Study||82
3304068|NCT02973100|4037514|FG001|STARTED|Overall Study||81
3304069|NCT02973100|4037515|FG002|STARTED|Overall Study||79
3304070|NCT02973100|4037516|FG003|STARTED|Overall Study||76
3304071|NCT02973100|4037513|FG000|Received at Least 1 Dose of Study Drug|Overall Study||81
3304072|NCT02973100|4037514|FG001|Received at Least 1 Dose of Study Drug|Overall Study||81
3304073|NCT02973100|4037515|FG002|Received at Least 1 Dose of Study Drug|Overall Study||79
3304074|NCT02973100|4037516|FG003|Received at Least 1 Dose of Study Drug|Overall Study||76
3304075|NCT02973100|4037513|FG000|COMPLETED|Overall Study||75
3304076|NCT02973100|4037514|FG001|COMPLETED|Overall Study||73
3304077|NCT02973100|4037515|FG002|COMPLETED|Overall Study||75
3304078|NCT02973100|4037516|FG003|COMPLETED|Overall Study||69
3304079|NCT02973100|4037513|FG000|NOT COMPLETED|Overall Study||7
3304080|NCT02973100|4037514|FG001|NOT COMPLETED|Overall Study||8
3304081|NCT02973100|4037515|FG002|NOT COMPLETED|Overall Study||4
3304082|NCT02973100|4037516|FG003|NOT COMPLETED|Overall Study||7
3304083|NCT02973321|4037534|FG000|STARTED|Overall Study||33
3304084|NCT02973321|4037535|FG001|STARTED|Overall Study||66
3304085|NCT02973321|4037536|FG002|STARTED|Overall Study||66
3304086|NCT02973321|4037537|FG003|STARTED|Overall Study||64
3304087|NCT02973321|4037538|FG004|STARTED|Overall Study||67
3304088|NCT02973321|4037534|FG000|COMPLETED|Overall Study||32
3304089|NCT02973321|4037535|FG001|COMPLETED|Overall Study||51
3304090|NCT02973321|4037536|FG002|COMPLETED|Overall Study||52
3304091|NCT02973321|4037537|FG003|COMPLETED|Overall Study||48
3304092|NCT02973321|4037538|FG004|COMPLETED|Overall Study||62
3304093|NCT02973321|4037534|FG000|NOT COMPLETED|Overall Study||1
3304094|NCT02973321|4037535|FG001|NOT COMPLETED|Overall Study||15
3304095|NCT02973321|4037536|FG002|NOT COMPLETED|Overall Study||14
3304096|NCT02973321|4037537|FG003|NOT COMPLETED|Overall Study||16
3304097|NCT02973321|4037538|FG004|NOT COMPLETED|Overall Study||5
3304098|NCT02973438|4037555|FG000|STARTED|First Treatment Session (4 Days)||2
3304099|NCT02973438|4037556|FG001|STARTED|First Treatment Session (4 Days)||1
3304100|NCT02973438|4037557|FG002|STARTED|First Treatment Session (4 Days)||2
3304101|NCT02973438|4037558|FG003|STARTED|First Treatment Session (4 Days)||1
3304102|NCT02973438|4037555|FG000|COMPLETED|First Treatment Session (4 Days)||2
2983977|NCT00868790|3700231|FG012|NOT COMPLETED|Period 2||0
2983978|NCT00868790|3700232|FG013|NOT COMPLETED|Period 2||1
2983979|NCT00868790|3700219|FG000|STARTED|Period 3||9
2983980|NCT00868790|3700220|FG001|STARTED|Period 3||6
2983981|NCT00868790|3700221|FG002|STARTED|Period 3||4
2983982|NCT00868790|3700222|FG003|STARTED|Period 3||4
2983983|NCT00868790|3700223|FG004|STARTED|Period 3||18
2983984|NCT00868790|3700224|FG005|STARTED|Period 3||1
2983985|NCT00868790|3700225|FG006|STARTED|Period 3||4
2983986|NCT00868790|3700226|FG007|STARTED|Period 3||17
2983987|NCT00868790|3700227|FG008|STARTED|Period 3||8
2983988|NCT00868790|3700228|FG009|STARTED|Period 3||3
2983989|NCT00868790|3700229|FG010|STARTED|Period 3||9
2983990|NCT00868790|3700230|FG011|STARTED|Period 3||4
2983991|NCT00868790|3700231|FG012|STARTED|Period 3||7
2983992|NCT00868790|3700232|FG013|STARTED|Period 3||8
2983993|NCT00868790|3700219|FG000|COMPLETED|Period 3||9
2983994|NCT00868790|3700220|FG001|COMPLETED|Period 3||6
2983995|NCT00868790|3700221|FG002|COMPLETED|Period 3||4
2983996|NCT00868790|3700222|FG003|COMPLETED|Period 3||3
2983997|NCT00868790|3700223|FG004|COMPLETED|Period 3||18
2983998|NCT00868790|3700224|FG005|COMPLETED|Period 3||1
2983999|NCT00868790|3700225|FG006|COMPLETED|Period 3||4
2984000|NCT00868790|3700226|FG007|COMPLETED|Period 3||17
2984001|NCT00868790|3700227|FG008|COMPLETED|Period 3||8
2984002|NCT00868790|3700228|FG009|COMPLETED|Period 3||2
2984003|NCT00868790|3700229|FG010|COMPLETED|Period 3||8
2984004|NCT00868790|3700230|FG011|COMPLETED|Period 3||4
2984005|NCT00868790|3700231|FG012|COMPLETED|Period 3||7
2984006|NCT00868790|3700232|FG013|COMPLETED|Period 3||8
2984007|NCT00868790|3700219|FG000|NOT COMPLETED|Period 3||0
2984008|NCT00868790|3700220|FG001|NOT COMPLETED|Period 3||0
2984009|NCT00868790|3700221|FG002|NOT COMPLETED|Period 3||0
2984010|NCT00868790|3700222|FG003|NOT COMPLETED|Period 3||1
2984011|NCT00868790|3700223|FG004|NOT COMPLETED|Period 3||0
2984012|NCT00868790|3700224|FG005|NOT COMPLETED|Period 3||0
2984013|NCT00868790|3700225|FG006|NOT COMPLETED|Period 3||0
2984014|NCT00868790|3700226|FG007|NOT COMPLETED|Period 3||0
2984015|NCT00868790|3700227|FG008|NOT COMPLETED|Period 3||0
2984016|NCT00868790|3700228|FG009|NOT COMPLETED|Period 3||1
2984017|NCT00868790|3700229|FG010|NOT COMPLETED|Period 3||1
2984018|NCT00868790|3700230|FG011|NOT COMPLETED|Period 3||0
2984019|NCT00868790|3700231|FG012|NOT COMPLETED|Period 3||0
2984020|NCT00868790|3700232|FG013|NOT COMPLETED|Period 3||0
2984021|NCT00868790|3700219|FG000|STARTED|Period 4||9
2984022|NCT00868790|3700220|FG001|STARTED|Period 4||6
2984023|NCT00868790|3700221|FG002|STARTED|Period 4||4
2984024|NCT00868790|3700222|FG003|STARTED|Period 4||3
2984025|NCT00868790|3700223|FG004|STARTED|Period 4||18
2984026|NCT00868790|3700224|FG005|STARTED|Period 4||1
2984027|NCT00868790|3700225|FG006|STARTED|Period 4||4
2984028|NCT00868790|3700226|FG007|STARTED|Period 4||17
2984029|NCT00868790|3700227|FG008|STARTED|Period 4||8
2984030|NCT00868790|3700228|FG009|STARTED|Period 4||2
2984031|NCT00868790|3700229|FG010|STARTED|Period 4||8
2984032|NCT00868790|3700230|FG011|STARTED|Period 4||4
2984033|NCT00868790|3700231|FG012|STARTED|Period 4||7
2984034|NCT00868790|3700232|FG013|STARTED|Period 4||8
2984035|NCT00868790|3700219|FG000|COMPLETED|Period 4||7
2984036|NCT00868790|3700220|FG001|COMPLETED|Period 4||6
2984037|NCT00868790|3700221|FG002|COMPLETED|Period 4|One non-completion due to abnormal alanine aminotransferase/aspartate aminotransferase (ALT/AST)|3
2984038|NCT00868790|3700222|FG003|COMPLETED|Period 4||3
2984039|NCT00868790|3700223|FG004|COMPLETED|Period 4||18
2984040|NCT00868790|3700224|FG005|COMPLETED|Period 4||1
2984041|NCT00868790|3700225|FG006|COMPLETED|Period 4||4
2984042|NCT00868790|3700226|FG007|COMPLETED|Period 4||14
2984043|NCT00868790|3700227|FG008|COMPLETED|Period 4||6
2984044|NCT00868790|3700228|FG009|COMPLETED|Period 4||2
2984045|NCT00868790|3700229|FG010|COMPLETED|Period 4||5
2984046|NCT00868790|3700230|FG011|COMPLETED|Period 4||3
2984047|NCT00868790|3700231|FG012|COMPLETED|Period 4||6
2984048|NCT00868790|3700232|FG013|COMPLETED|Period 4||7
2984049|NCT00868790|3700219|FG000|NOT COMPLETED|Period 4||2
2984050|NCT00868790|3700220|FG001|NOT COMPLETED|Period 4||0
2984051|NCT00868790|3700221|FG002|NOT COMPLETED|Period 4||1
2984052|NCT00868790|3700222|FG003|NOT COMPLETED|Period 4||0
2984053|NCT00868790|3700223|FG004|NOT COMPLETED|Period 4||0
2984054|NCT00868790|3700224|FG005|NOT COMPLETED|Period 4||0
2984055|NCT00868790|3700225|FG006|NOT COMPLETED|Period 4||0
2984056|NCT00868790|3700226|FG007|NOT COMPLETED|Period 4||3
2984057|NCT00868790|3700227|FG008|NOT COMPLETED|Period 4||2
2984058|NCT00868790|3700228|FG009|NOT COMPLETED|Period 4||0
2984059|NCT00868790|3700229|FG010|NOT COMPLETED|Period 4||3
2984060|NCT00868790|3700230|FG011|NOT COMPLETED|Period 4||1
2984061|NCT00868790|3700231|FG012|NOT COMPLETED|Period 4||1
2984062|NCT00868790|3700232|FG013|NOT COMPLETED|Period 4||1
2984063|NCT00868790|3700219|FG000|STARTED|Post-study||7
2984064|NCT00868790|3700220|FG001|STARTED|Post-study||6
2984065|NCT00868790|3700221|FG002|STARTED|Post-study||3
2984066|NCT00868790|3700222|FG003|STARTED|Post-study||3
2984067|NCT00868790|3700223|FG004|STARTED|Post-study||18
2984068|NCT00868790|3700224|FG005|STARTED|Post-study||1
2984069|NCT00868790|3700225|FG006|STARTED|Post-study||4
2984070|NCT00868790|3700226|FG007|STARTED|Post-study||14
3304103|NCT02973438|4037556|FG001|COMPLETED|First Treatment Session (4 Days)||1
3304104|NCT02973438|4037557|FG002|COMPLETED|First Treatment Session (4 Days)||2
3304105|NCT02973438|4037558|FG003|COMPLETED|First Treatment Session (4 Days)||1
2984071|NCT00868790|3700227|FG008|STARTED|Post-study||6
2984072|NCT00868790|3700228|FG009|STARTED|Post-study||2
2984073|NCT00868790|3700229|FG010|STARTED|Post-study||5
2984074|NCT00868790|3700230|FG011|STARTED|Post-study||3
2984075|NCT00868790|3700231|FG012|STARTED|Post-study||6
2984076|NCT00868790|3700232|FG013|STARTED|Post-study||7
2984077|NCT00868790|3700219|FG000|COMPLETED|Post-study||7
2984078|NCT00868790|3700220|FG001|COMPLETED|Post-study||6
2984079|NCT00868790|3700221|FG002|COMPLETED|Post-study||3
2984080|NCT00868790|3700222|FG003|COMPLETED|Post-study||3
2984081|NCT00868790|3700223|FG004|COMPLETED|Post-study||17
2984082|NCT00868790|3700224|FG005|COMPLETED|Post-study||1
2984083|NCT00868790|3700225|FG006|COMPLETED|Post-study||4
2984084|NCT00868790|3700226|FG007|COMPLETED|Post-study||12
2984085|NCT00868790|3700227|FG008|COMPLETED|Post-study||6
2984086|NCT00868790|3700228|FG009|COMPLETED|Post-study||1
2984087|NCT00868790|3700229|FG010|COMPLETED|Post-study||5
2984088|NCT00868790|3700230|FG011|COMPLETED|Post-study||3
2984089|NCT00868790|3700231|FG012|COMPLETED|Post-study||6
2984090|NCT00868790|3700232|FG013|COMPLETED|Post-study||7
2984091|NCT00868790|3700219|FG000|NOT COMPLETED|Post-study||0
2984092|NCT00868790|3700220|FG001|NOT COMPLETED|Post-study||0
2984093|NCT00868790|3700221|FG002|NOT COMPLETED|Post-study||0
2984094|NCT00868790|3700222|FG003|NOT COMPLETED|Post-study||0
2984095|NCT00868790|3700223|FG004|NOT COMPLETED|Post-study||1
2984096|NCT00868790|3700224|FG005|NOT COMPLETED|Post-study||0
2984097|NCT00868790|3700225|FG006|NOT COMPLETED|Post-study||0
2984098|NCT00868790|3700226|FG007|NOT COMPLETED|Post-study||2
2984099|NCT00868790|3700227|FG008|NOT COMPLETED|Post-study||0
2984100|NCT00868790|3700228|FG009|NOT COMPLETED|Post-study||1
2984101|NCT00868790|3700229|FG010|NOT COMPLETED|Post-study||0
2984102|NCT00868790|3700230|FG011|NOT COMPLETED|Post-study||0
2984103|NCT00868790|3700231|FG012|NOT COMPLETED|Post-study||0
2984104|NCT00868790|3700232|FG013|NOT COMPLETED|Post-study||0
2984105|NCT00868959|3700248|FG000|STARTED|Overall Study|817 represents total number of subjects who provided informed consent.|817
2984106|NCT00868959|3700248|FG000|COMPLETED|Overall Study||559
2984107|NCT00868959|3700248|FG000|NOT COMPLETED|Overall Study||258
3304106|NCT02973438|4037555|FG000|NOT COMPLETED|First Treatment Session (4 Days)||0
3304107|NCT02973438|4037556|FG001|NOT COMPLETED|First Treatment Session (4 Days)||0
3304108|NCT02973438|4037557|FG002|NOT COMPLETED|First Treatment Session (4 Days)||0
3304109|NCT02973438|4037558|FG003|NOT COMPLETED|First Treatment Session (4 Days)||0
3304110|NCT02973438|4037555|FG000|STARTED|Washout (Three Weeks)||2
3304111|NCT02973438|4037556|FG001|STARTED|Washout (Three Weeks)||1
3304112|NCT02973438|4037557|FG002|STARTED|Washout (Three Weeks)||2
3304113|NCT02973438|4037558|FG003|STARTED|Washout (Three Weeks)||1
3304114|NCT02973438|4037555|FG000|COMPLETED|Washout (Three Weeks)||2
3304115|NCT02973438|4037556|FG001|COMPLETED|Washout (Three Weeks)||1
3304116|NCT02973438|4037557|FG002|COMPLETED|Washout (Three Weeks)||2
3304117|NCT02973438|4037558|FG003|COMPLETED|Washout (Three Weeks)||1
3304118|NCT02973438|4037555|FG000|NOT COMPLETED|Washout (Three Weeks)||0
3304119|NCT02973438|4037556|FG001|NOT COMPLETED|Washout (Three Weeks)||0
3304120|NCT02973438|4037557|FG002|NOT COMPLETED|Washout (Three Weeks)||0
3304121|NCT02973438|4037558|FG003|NOT COMPLETED|Washout (Three Weeks)||0
3304122|NCT02973438|4037555|FG000|STARTED|Second Treatment Session (4 Days)||2
3304123|NCT02973438|4037556|FG001|STARTED|Second Treatment Session (4 Days)||1
3304124|NCT02973438|4037557|FG002|STARTED|Second Treatment Session (4 Days)||2
3304125|NCT02973438|4037558|FG003|STARTED|Second Treatment Session (4 Days)||1
3304126|NCT02973438|4037555|FG000|COMPLETED|Second Treatment Session (4 Days)||2
3304127|NCT02973438|4037556|FG001|COMPLETED|Second Treatment Session (4 Days)||1
3304128|NCT02973438|4037557|FG002|COMPLETED|Second Treatment Session (4 Days)||2
3304129|NCT02973438|4037558|FG003|COMPLETED|Second Treatment Session (4 Days)||1
3304130|NCT02973438|4037555|FG000|NOT COMPLETED|Second Treatment Session (4 Days)||0
3304131|NCT02973438|4037556|FG001|NOT COMPLETED|Second Treatment Session (4 Days)||0
3304132|NCT02973438|4037557|FG002|NOT COMPLETED|Second Treatment Session (4 Days)||0
3304133|NCT02973438|4037558|FG003|NOT COMPLETED|Second Treatment Session (4 Days)||0
3304134|NCT02973477|4037571|FG000|STARTED|First Intervention||19
3304135|NCT02973477|4037572|FG001|STARTED|First Intervention||26
3304136|NCT02973477|4037571|FG000|COMPLETED|First Intervention||19
3304137|NCT02973477|4037572|FG001|COMPLETED|First Intervention||24
3304138|NCT02973477|4037571|FG000|NOT COMPLETED|First Intervention||0
3304139|NCT02973477|4037572|FG001|NOT COMPLETED|First Intervention||2
3304140|NCT02973477|4037571|FG000|STARTED|Washout||19
3304141|NCT02973477|4037572|FG001|STARTED|Washout||24
3304142|NCT02973477|4037571|FG000|COMPLETED|Washout||18
3304143|NCT02973477|4037572|FG001|COMPLETED|Washout||24
3304144|NCT02973477|4037571|FG000|NOT COMPLETED|Washout||1
3304145|NCT02973477|4037572|FG001|NOT COMPLETED|Washout||0
3304146|NCT02973477|4037571|FG000|STARTED|Second Intervention||18
3304147|NCT02973477|4037572|FG001|STARTED|Second Intervention||24
3304148|NCT02973477|4037571|FG000|COMPLETED|Second Intervention||17
3304149|NCT02973477|4037572|FG001|COMPLETED|Second Intervention||24
3304150|NCT02973477|4037571|FG000|NOT COMPLETED|Second Intervention||1
3304151|NCT02973477|4037572|FG001|NOT COMPLETED|Second Intervention||0
3304152|NCT02973503|4037584|FG000|STARTED|Overall Study||117
3304153|NCT02973503|4037584|FG000|COMPLETED|Overall Study||117
3304154|NCT02973503|4037584|FG000|NOT COMPLETED|Overall Study||0
3304155|NCT02973516|4037595|FG000|STARTED|Overall Study||30
3304156|NCT02973516|4037596|FG001|STARTED|Overall Study||10
3304157|NCT02973516|4037595|FG000|COMPLETED|Overall Study||30
3304158|NCT02973516|4037596|FG001|COMPLETED|Overall Study||10
3304159|NCT02973516|4037595|FG000|NOT COMPLETED|Overall Study||0
3304160|NCT02973516|4037596|FG001|NOT COMPLETED|Overall Study||0
3304161|NCT02973802|4037602|FG000|STARTED|Overall Study||12
3304162|NCT02973802|4037602|FG000|COMPLETED|Overall Study||10
3304163|NCT02973802|4037602|FG000|NOT COMPLETED|Overall Study||2
3304164|NCT02974010|4037611|FG000|STARTED|Overall Study||12
3304165|NCT02974010|4037612|FG001|STARTED|Overall Study||5
3304166|NCT02974010|4037613|FG002|STARTED|Overall Study||4
3304167|NCT02974010|4037614|FG003|STARTED|Overall Study||1
3304168|NCT02974010|4037611|FG000|COMPLETED|Overall Study||6
3304169|NCT02974010|4037612|FG001|COMPLETED|Overall Study||2
3304170|NCT02974010|4037613|FG002|COMPLETED|Overall Study||2
2984108|NCT00869024|3700254|FG000|STARTED|Overall Study||16
3304171|NCT02974010|4037614|FG003|COMPLETED|Overall Study||1
3304172|NCT02974010|4037611|FG000|NOT COMPLETED|Overall Study||6
2984109|NCT00869024|3700255|FG001|STARTED|Overall Study|One patient intent to treat, did not receive study product|9
2984110|NCT00869024|3700254|FG000|COMPLETED|Overall Study||14
2984111|NCT00869024|3700255|FG001|COMPLETED|Overall Study||4
2984112|NCT00869024|3700254|FG000|NOT COMPLETED|Overall Study||2
2984113|NCT00869024|3700255|FG001|NOT COMPLETED|Overall Study||5
2984114|NCT00869050|3700261|FG000|STARTED|Overall Study||41
2984115|NCT00869050|3700261|FG000|COMPLETED|Overall Study||38
2984116|NCT00869050|3700261|FG000|NOT COMPLETED|Overall Study||3
2984117|NCT00869089|3700265|FG000|STARTED|Overall Study||5
2984118|NCT00869089|3700265|FG000|COMPLETED|Overall Study||2
2984119|NCT00869089|3700265|FG000|NOT COMPLETED|Overall Study||3
2984120|NCT00869141|3700271|FG000|STARTED|Overall Study||26
3304173|NCT02974010|4037612|FG001|NOT COMPLETED|Overall Study||3
3304174|NCT02974010|4037613|FG002|NOT COMPLETED|Overall Study||2
3304175|NCT02974010|4037614|FG003|NOT COMPLETED|Overall Study||0
3304176|NCT02974088|4037626|FG000|STARTED|Overall Study||23
3304177|NCT02974088|4037627|FG001|STARTED|Overall Study||24
3304178|NCT02974088|4037626|FG000|COMPLETED|Overall Study||23
3304179|NCT02974088|4037627|FG001|COMPLETED|Overall Study|Nurse left without notice and took CRFs and data for 2 subjects.|21
3304180|NCT02974088|4037626|FG000|NOT COMPLETED|Overall Study||0
3304181|NCT02974088|4037627|FG001|NOT COMPLETED|Overall Study||3
3304182|NCT02974114|4037636|FG000|STARTED|Overall Study||6
3304183|NCT02974114|4037637|FG001|STARTED|Overall Study||7
3304184|NCT02974114|4037638|FG002|STARTED|Overall Study||8
3304185|NCT02974114|4037636|FG000|COMPLETED|Overall Study||6
3304186|NCT02974114|4037637|FG001|COMPLETED|Overall Study||6
3304187|NCT02974114|4037638|FG002|COMPLETED|Overall Study||6
3304188|NCT02974114|4037636|FG000|NOT COMPLETED|Overall Study||0
3304189|NCT02974114|4037637|FG001|NOT COMPLETED|Overall Study||1
3304190|NCT02974114|4037638|FG002|NOT COMPLETED|Overall Study||2
3304191|NCT02974140|4037648|FG000|STARTED|Overall Study||39
3304192|NCT02974140|4037648|FG000|CRS (Left or Right Eye)|Overall Study||38
3304193|NCT02974140|4037648|FG000|Manual (Fellow Eye)|Overall Study||38
3304194|NCT02974140|4037648|FG000|COMPLETED|Overall Study||0
3304195|NCT02974140|4037648|FG000|NOT COMPLETED|Overall Study||39
3304196|NCT02974153|4037658|FG000|STARTED|Overall Study||374
3304197|NCT02974153|4037659|FG001|STARTED|Overall Study||372
3304198|NCT02974153|4037660|FG002|STARTED|Overall Study||375
3304199|NCT02974153|4037658|FG000|Participants Treated|Overall Study||350
3304200|NCT02974153|4037659|FG001|Participants Treated|Overall Study||356
3304201|NCT02974153|4037660|FG002|Participants Treated|Overall Study||366
3304202|NCT02974153|4037658|FG000|COMPLETED|Overall Study||322
3304203|NCT02974153|4037659|FG001|COMPLETED|Overall Study||324
3304204|NCT02974153|4037660|FG002|COMPLETED|Overall Study||325
3304205|NCT02974153|4037658|FG000|NOT COMPLETED|Overall Study||52
3304206|NCT02974153|4037659|FG001|NOT COMPLETED|Overall Study||48
3304207|NCT02974153|4037660|FG002|NOT COMPLETED|Overall Study||50
3304208|NCT02974296|4037670|FG000|STARTED|Overall Study||10
3304209|NCT02974296|4037671|FG001|STARTED|Overall Study||23
3304210|NCT02974296|4037670|FG000|COMPLETED|Overall Study||10
3304211|NCT02974296|4037671|FG001|COMPLETED|Overall Study||22
3304212|NCT02974296|4037670|FG000|NOT COMPLETED|Overall Study||0
3304213|NCT02974296|4037671|FG001|NOT COMPLETED|Overall Study||1
3304214|NCT02974543|4037679|FG000|STARTED|Overall Study||11
3304215|NCT02974543|4037680|FG001|STARTED|Overall Study||10
3304216|NCT02974543|4037679|FG000|Began Washout Period|Overall Study||10
3304217|NCT02974543|4037680|FG001|Began Washout Period|Overall Study||10
3304218|NCT02974543|4037679|FG000|Began Crossover Assignment|Overall Study||10
3304219|NCT02974543|4037680|FG001|Began Crossover Assignment|Overall Study||10
3304220|NCT02974543|4037679|FG000|COMPLETED|Overall Study||10
3304221|NCT02974543|4037680|FG001|COMPLETED|Overall Study||10
3304222|NCT02974543|4037679|FG000|NOT COMPLETED|Overall Study||1
3304223|NCT02974543|4037680|FG001|NOT COMPLETED|Overall Study||0
3304224|NCT02974634|4037696|FG000|STARTED|Overall Study||106
3304225|NCT02974634|4037697|FG001|STARTED|Overall Study||110
3304226|NCT02974634|4037696|FG000|COMPLETED|Overall Study||78
3304227|NCT02974634|4037697|FG001|COMPLETED|Overall Study||89
3304228|NCT02974634|4037696|FG000|NOT COMPLETED|Overall Study||28
3304229|NCT02974634|4037697|FG001|NOT COMPLETED|Overall Study||21
3304230|NCT02974842|4037704|FG000|STARTED|Overall Study|Participants|50
3304231|NCT02974842|4037704|FG000|COMPLETED|Overall Study||42
3304232|NCT02974842|4037704|FG000|NOT COMPLETED|Overall Study||8
3304233|NCT02974855|4037712|FG000|STARTED|Overall Study||7
3304234|NCT02974855|4037713|FG001|STARTED|Overall Study||6
3304235|NCT02974855|4037714|FG002|STARTED|Overall Study||6
3304236|NCT02974855|4037715|FG003|STARTED|Overall Study||7
3304237|NCT02974855|4037712|FG000|COMPLETED|Overall Study||7
3304238|NCT02974855|4037713|FG001|COMPLETED|Overall Study||5
3304239|NCT02974855|4037714|FG002|COMPLETED|Overall Study||6
3304240|NCT02974855|4037715|FG003|COMPLETED|Overall Study||6
3304241|NCT02974855|4037712|FG000|NOT COMPLETED|Overall Study||0
3304242|NCT02974855|4037713|FG001|NOT COMPLETED|Overall Study||1
3304243|NCT02974855|4037714|FG002|NOT COMPLETED|Overall Study||0
3304244|NCT02974855|4037715|FG003|NOT COMPLETED|Overall Study||1
3304245|NCT02974868|4037732|FG000|STARTED|Initial 24-Week Treatment Period (TP)||24
3304246|NCT02974868|4037733|FG001|STARTED|Initial 24-Week Treatment Period (TP)||23
3304247|NCT02974868|4037734|FG002|STARTED|Initial 24-Week Treatment Period (TP)||48
3304248|NCT02974868|4037735|FG003|STARTED|Initial 24-Week Treatment Period (TP)||47
2984121|NCT00869141|3700272|FG001|STARTED|Overall Study||26
2984122|NCT00869141|3700271|FG000|COMPLETED|Overall Study||26
2984123|NCT00869141|3700272|FG001|COMPLETED|Overall Study||26
2984124|NCT00869141|3700271|FG000|NOT COMPLETED|Overall Study||0
2984125|NCT00869141|3700272|FG001|NOT COMPLETED|Overall Study||0
2984126|NCT00869167|3700282|FG000|STARTED|Overall Study||2
2984127|NCT00869167|3700283|FG001|STARTED|Overall Study||1
2984128|NCT00869167|3700282|FG000|COMPLETED|Overall Study||2
2984129|NCT00869167|3700283|FG001|COMPLETED|Overall Study||0
2984130|NCT00869167|3700282|FG000|NOT COMPLETED|Overall Study||0
2984131|NCT00869167|3700283|FG001|NOT COMPLETED|Overall Study||1
2984132|NCT00869206|3700293|FG000|STARTED|Overall Study||911
2984133|NCT00869206|3700294|FG001|STARTED|Overall Study||911
2984134|NCT00869206|3700293|FG000|COMPLETED|Overall Study||882
2984135|NCT00869206|3700294|FG001|COMPLETED|Overall Study||884
2984136|NCT00869206|3700293|FG000|NOT COMPLETED|Overall Study||29
2984137|NCT00869206|3700294|FG001|NOT COMPLETED|Overall Study||27
2984138|NCT00869323|3700306|FG000|STARTED|Induction Therapy||3
2984139|NCT00869323|3700306|FG000|COMPLETED|Induction Therapy||3
2984140|NCT00869323|3700306|FG000|NOT COMPLETED|Induction Therapy||0
2984141|NCT00869323|3700306|FG000|STARTED|Maintenance Therapy|One participant removed from study after completing induction therapy due to progressive disease.|2
2984142|NCT00869323|3700306|FG000|COMPLETED|Maintenance Therapy||1
2984143|NCT00869323|3700306|FG000|NOT COMPLETED|Maintenance Therapy||1
2984144|NCT00869349|3700312|FG000|STARTED|Overall Study||39
2984145|NCT00869349|3700313|FG001|STARTED|Overall Study||40
2984146|NCT00869349|3700312|FG000|COMPLETED|Overall Study||32
2984147|NCT00869349|3700313|FG001|COMPLETED|Overall Study||36
2984148|NCT00869349|3700312|FG000|NOT COMPLETED|Overall Study||7
2984149|NCT00869349|3700313|FG001|NOT COMPLETED|Overall Study||4
2984150|NCT00869362|3700321|FG000|STARTED|Overall Study||15
2984151|NCT00869362|3700322|FG001|STARTED|Overall Study||16
2984152|NCT00869362|3700321|FG000|COMPLETED|Overall Study||14
2984153|NCT00869362|3700322|FG001|COMPLETED|Overall Study||11
2984154|NCT00869362|3700321|FG000|NOT COMPLETED|Overall Study||1
2984155|NCT00869362|3700322|FG001|NOT COMPLETED|Overall Study||5
2984156|NCT00869375|3700331|FG000|STARTED|Overall Study||3
2984157|NCT00869375|3700332|FG001|STARTED|Overall Study||3
2984158|NCT00869375|3700331|FG000|COMPLETED|Overall Study||3
2984159|NCT00869375|3700332|FG001|COMPLETED|Overall Study||3
2984160|NCT00869375|3700331|FG000|NOT COMPLETED|Overall Study||0
2984161|NCT00869375|3700332|FG001|NOT COMPLETED|Overall Study||0
2984162|NCT00869401|3700343|FG000|STARTED|Overall Study||3
2984163|NCT00869401|3700344|FG001|STARTED|Overall Study||3
3304249|NCT02974868|4037732|FG000|COMPLETED|Initial 24-Week Treatment Period (TP)||20
3304250|NCT02974868|4037733|FG001|COMPLETED|Initial 24-Week Treatment Period (TP)||14
3304251|NCT02974868|4037734|FG002|COMPLETED|Initial 24-Week Treatment Period (TP)||45
3304252|NCT02974868|4037735|FG003|COMPLETED|Initial 24-Week Treatment Period (TP)||35
3304253|NCT02974868|4037732|FG000|NOT COMPLETED|Initial 24-Week Treatment Period (TP)||4
3304254|NCT02974868|4037733|FG001|NOT COMPLETED|Initial 24-Week Treatment Period (TP)||9
3304255|NCT02974868|4037734|FG002|NOT COMPLETED|Initial 24-Week Treatment Period (TP)||3
3304256|NCT02974868|4037735|FG003|NOT COMPLETED|Initial 24-Week Treatment Period (TP)||12
3304257|NCT02974868|4037732|FG000|STARTED|Single-Blind Extension (SBE) Period||17
3304258|NCT02974868|4037733|FG001|STARTED|Single-Blind Extension (SBE) Period||12
3304259|NCT02974868|4037734|FG002|STARTED|Single-Blind Extension (SBE) Period||38
3304260|NCT02974868|4037735|FG003|STARTED|Single-Blind Extension (SBE) Period||29
3304261|NCT02974868|4037732|FG000|COMPLETED|Single-Blind Extension (SBE) Period||15
3304262|NCT02974868|4037733|FG001|COMPLETED|Single-Blind Extension (SBE) Period||11
3304263|NCT02974868|4037734|FG002|COMPLETED|Single-Blind Extension (SBE) Period||27
3304264|NCT02974868|4037735|FG003|COMPLETED|Single-Blind Extension (SBE) Period||23
3304265|NCT02974868|4037732|FG000|NOT COMPLETED|Single-Blind Extension (SBE) Period||2
3304266|NCT02974868|4037733|FG001|NOT COMPLETED|Single-Blind Extension (SBE) Period||1
3304267|NCT02974868|4037734|FG002|NOT COMPLETED|Single-Blind Extension (SBE) Period||11
3304268|NCT02974868|4037735|FG003|NOT COMPLETED|Single-Blind Extension (SBE) Period||6
3304269|NCT02974868|4037732|FG000|STARTED|Cross-Over Extension (COE) Period||7
3304270|NCT02974868|4037733|FG001|STARTED|Cross-Over Extension (COE) Period||2
3304271|NCT02974868|4037734|FG002|STARTED|Cross-Over Extension (COE) Period||11
3304272|NCT02974868|4037735|FG003|STARTED|Cross-Over Extension (COE) Period||3
3304273|NCT02974868|4037732|FG000|COMPLETED|Cross-Over Extension (COE) Period||5
3304274|NCT02974868|4037733|FG001|COMPLETED|Cross-Over Extension (COE) Period||1
3304275|NCT02974868|4037734|FG002|COMPLETED|Cross-Over Extension (COE) Period||8
3304276|NCT02974868|4037735|FG003|COMPLETED|Cross-Over Extension (COE) Period||3
3304277|NCT02974868|4037732|FG000|NOT COMPLETED|Cross-Over Extension (COE) Period||2
3304278|NCT02974868|4037733|FG001|NOT COMPLETED|Cross-Over Extension (COE) Period||1
3304279|NCT02974868|4037734|FG002|NOT COMPLETED|Cross-Over Extension (COE) Period||3
3304280|NCT02974868|4037735|FG003|NOT COMPLETED|Cross-Over Extension (COE) Period||0
3304281|NCT02975206|4037779|FG000|STARTED|Overall Study||161
3304282|NCT02975206|4037780|FG001|STARTED|Overall Study||161
3304283|NCT02975206|4037781|FG002|STARTED|Overall Study||162
3304284|NCT02975206|4037779|FG000|COMPLETED|Overall Study||134
2984164|NCT00869401|3700345|FG002|STARTED|Overall Study||7
2984165|NCT00869401|3700346|FG003|STARTED|Overall Study||138
2984166|NCT00869401|3700347|FG004|STARTED|Overall Study||66
2984167|NCT00869401|3700343|FG000|COMPLETED|Overall Study||3
2984168|NCT00869401|3700344|FG001|COMPLETED|Overall Study||3
2984169|NCT00869401|3700345|FG002|COMPLETED|Overall Study||7
2984170|NCT00869401|3700346|FG003|COMPLETED|Overall Study||133
2984171|NCT00869401|3700347|FG004|COMPLETED|Overall Study||63
2984172|NCT00869401|3700343|FG000|NOT COMPLETED|Overall Study||0
2984173|NCT00869401|3700344|FG001|NOT COMPLETED|Overall Study||0
2984174|NCT00869401|3700345|FG002|NOT COMPLETED|Overall Study||0
2984175|NCT00869401|3700346|FG003|NOT COMPLETED|Overall Study||5
2984176|NCT00869401|3700347|FG004|NOT COMPLETED|Overall Study||3
2984177|NCT00869440|3700363|FG000|STARTED|Overall Study||25
2984178|NCT00869440|3700364|FG001|STARTED|Overall Study||25
2984179|NCT00869440|3700365|FG002|STARTED|Overall Study||25
2984180|NCT00869440|3700366|FG003|STARTED|Overall Study||25
2984181|NCT00869440|3700363|FG000|COMPLETED|Overall Study||23
2984182|NCT00869440|3700364|FG001|COMPLETED|Overall Study||24
2984183|NCT00869440|3700365|FG002|COMPLETED|Overall Study||25
2984184|NCT00869440|3700366|FG003|COMPLETED|Overall Study||25
2984185|NCT00869440|3700363|FG000|NOT COMPLETED|Overall Study||2
2984186|NCT00869440|3700364|FG001|NOT COMPLETED|Overall Study||1
2984187|NCT00869440|3700365|FG002|NOT COMPLETED|Overall Study||0
2984188|NCT00869440|3700366|FG003|NOT COMPLETED|Overall Study||0
2984189|NCT00869518|3700378|FG000|STARTED|Overall Study||6
2984190|NCT00869518|3700379|FG001|STARTED|Overall Study||6
2984191|NCT00869518|3700378|FG000|COMPLETED|Overall Study||5
2984192|NCT00869518|3700379|FG001|COMPLETED|Overall Study||5
2984193|NCT00869518|3700378|FG000|NOT COMPLETED|Overall Study||1
2984194|NCT00869518|3700379|FG001|NOT COMPLETED|Overall Study||1
2984195|NCT00869557|3700387|FG000|STARTED|Randomized Phase||48
2984196|NCT00869557|3700388|FG001|STARTED|Randomized Phase||23
2984197|NCT00869557|3700387|FG000|COMPLETED|Randomized Phase||45
2984198|NCT00869557|3700388|FG001|COMPLETED|Randomized Phase||21
2984199|NCT00869557|3700387|FG000|NOT COMPLETED|Randomized Phase||3
2984200|NCT00869557|3700388|FG001|NOT COMPLETED|Randomized Phase||2
2984201|NCT00869557|3700387|FG000|STARTED|Extension Phase||45
3304285|NCT02975206|4037780|FG001|COMPLETED|Overall Study||144
3304286|NCT02975206|4037781|FG002|COMPLETED|Overall Study||145
3304287|NCT02975206|4037779|FG000|NOT COMPLETED|Overall Study||27
3304288|NCT02975206|4037780|FG001|NOT COMPLETED|Overall Study||17
3304289|NCT02975206|4037781|FG002|NOT COMPLETED|Overall Study||17
3304290|NCT02975297|4037791|FG000|STARTED|Overall Study||41
3304291|NCT02975297|4037792|FG001|STARTED|Overall Study||41
3304292|NCT02975297|4037791|FG000|COMPLETED|Overall Study||34
3304293|NCT02975297|4037792|FG001|COMPLETED|Overall Study||35
3304294|NCT02975297|4037791|FG000|NOT COMPLETED|Overall Study||7
3304295|NCT02975297|4037792|FG001|NOT COMPLETED|Overall Study||6
3304296|NCT02975336|4037802|FG000|STARTED|DBPC (52 Weeks)||117
3304297|NCT02975336|4037803|FG001|STARTED|DBPC (52 Weeks)||118
3304298|NCT02975336|4037804|FG002|STARTED|DBPC (52 Weeks)||117
3304299|NCT02975336|4037805|FG003|STARTED|DBPC (52 Weeks)||117
3304300|NCT02975336|4037806|FG004|STARTED|DBPC (52 Weeks)||0
3304301|NCT02975336|4037807|FG005|STARTED|DBPC (52 Weeks)||0
3304302|NCT02975336|4037808|FG006|STARTED|DBPC (52 Weeks)||0
3304303|NCT02975336|4037809|FG007|STARTED|DBPC (52 Weeks)||0
3304304|NCT02975336|4037802|FG000|COMPLETED|DBPC (52 Weeks)||85
3304305|NCT02975336|4037803|FG001|COMPLETED|DBPC (52 Weeks)||89
3304306|NCT02975336|4037804|FG002|COMPLETED|DBPC (52 Weeks)||90
3304307|NCT02975336|4037805|FG003|COMPLETED|DBPC (52 Weeks)||84
3304308|NCT02975336|4037806|FG004|COMPLETED|DBPC (52 Weeks)||0
3304309|NCT02975336|4037807|FG005|COMPLETED|DBPC (52 Weeks)||0
3304310|NCT02975336|4037808|FG006|COMPLETED|DBPC (52 Weeks)||0
3304311|NCT02975336|4037809|FG007|COMPLETED|DBPC (52 Weeks)||0
3304312|NCT02975336|4037802|FG000|NOT COMPLETED|DBPC (52 Weeks)||32
3304313|NCT02975336|4037803|FG001|NOT COMPLETED|DBPC (52 Weeks)||29
3304314|NCT02975336|4037804|FG002|NOT COMPLETED|DBPC (52 Weeks)||27
3304315|NCT02975336|4037805|FG003|NOT COMPLETED|DBPC (52 Weeks)||33
3304316|NCT02975336|4037806|FG004|NOT COMPLETED|DBPC (52 Weeks)||0
3304317|NCT02975336|4037807|FG005|NOT COMPLETED|DBPC (52 Weeks)||0
3304318|NCT02975336|4037808|FG006|NOT COMPLETED|DBPC (52 Weeks)||0
3304319|NCT02975336|4037809|FG007|NOT COMPLETED|DBPC (52 Weeks)||0
3304320|NCT02975336|4037802|FG000|STARTED|LTE (104 Weeks)||0
3304321|NCT02975336|4037803|FG001|STARTED|LTE (104 Weeks)||0
3304322|NCT02975336|4037804|FG002|STARTED|LTE (104 Weeks)||0
3304323|NCT02975336|4037805|FG003|STARTED|LTE (104 Weeks)||0
3304324|NCT02975336|4037806|FG004|STARTED|LTE (104 Weeks)||62
3304325|NCT02975336|4037807|FG005|STARTED|LTE (104 Weeks)||69
3304326|NCT02975336|4037808|FG006|STARTED|LTE (104 Weeks)||80
3304327|NCT02975336|4037809|FG007|STARTED|LTE (104 Weeks)||72
3304328|NCT02975336|4037802|FG000|COMPLETED|LTE (104 Weeks)||0
3304329|NCT02975336|4037803|FG001|COMPLETED|LTE (104 Weeks)||0
3304330|NCT02975336|4037804|FG002|COMPLETED|LTE (104 Weeks)||0
3304331|NCT02975336|4037805|FG003|COMPLETED|LTE (104 Weeks)||0
3304332|NCT02975336|4037806|FG004|COMPLETED|LTE (104 Weeks)||0
3304333|NCT02975336|4037807|FG005|COMPLETED|LTE (104 Weeks)||0
3304334|NCT02975336|4037808|FG006|COMPLETED|LTE (104 Weeks)||0
3304335|NCT02975336|4037809|FG007|COMPLETED|LTE (104 Weeks)||0
3304336|NCT02975336|4037802|FG000|NOT COMPLETED|LTE (104 Weeks)||0
3304337|NCT02975336|4037803|FG001|NOT COMPLETED|LTE (104 Weeks)||0
3304338|NCT02975336|4037804|FG002|NOT COMPLETED|LTE (104 Weeks)||0
3304339|NCT02975336|4037805|FG003|NOT COMPLETED|LTE (104 Weeks)||0
3304340|NCT02975336|4037806|FG004|NOT COMPLETED|LTE (104 Weeks)||62
2984202|NCT00869557|3700388|FG001|STARTED|Extension Phase|Seven participants completing randomized Atripla treatment did not enter open-label extension phase.|14
3304341|NCT02975336|4037807|FG005|NOT COMPLETED|LTE (104 Weeks)||69
3304342|NCT02975336|4037808|FG006|NOT COMPLETED|LTE (104 Weeks)||80
3304343|NCT02975336|4037809|FG007|NOT COMPLETED|LTE (104 Weeks)||72
2984203|NCT00869557|3700387|FG000|COMPLETED|Extension Phase||35
2984204|NCT00869557|3700388|FG001|COMPLETED|Extension Phase||11
2984205|NCT00869557|3700387|FG000|NOT COMPLETED|Extension Phase||10
2984206|NCT00869557|3700388|FG001|NOT COMPLETED|Extension Phase||3
2984207|NCT00869609|3700397|FG000|STARTED|Overall Study||31
2984208|NCT00869609|3700398|FG001|STARTED|Overall Study||29
2984209|NCT00869609|3700397|FG000|COMPLETED|Overall Study||25
2984210|NCT00869609|3700398|FG001|COMPLETED|Overall Study||26
2984211|NCT00869609|3700397|FG000|NOT COMPLETED|Overall Study||6
2984212|NCT00869609|3700398|FG001|NOT COMPLETED|Overall Study||3
2984213|NCT00869622|3700406|FG000|STARTED|Overall Study||40
2984214|NCT00869622|3700407|FG001|STARTED|Overall Study||40
2984215|NCT00869622|3700406|FG000|COMPLETED|Overall Study||27
2984216|NCT00869622|3700407|FG001|COMPLETED|Overall Study||26
2984217|NCT00869622|3700406|FG000|NOT COMPLETED|Overall Study||13
3304344|NCT02975349|4037828|FG000|STARTED|Active Treatment Period (24 Weeks)||54
3304345|NCT02975349|4037829|FG001|STARTED|Active Treatment Period (24 Weeks)||0
3304346|NCT02975349|4037830|FG002|STARTED|Active Treatment Period (24 Weeks)||52
3304347|NCT02975349|4037831|FG003|STARTED|Active Treatment Period (24 Weeks)||53
3304348|NCT02975349|4037832|FG004|STARTED|Active Treatment Period (24 Weeks)||54
3304349|NCT02975349|4037833|FG005|STARTED|Active Treatment Period (24 Weeks)||54
3304350|NCT02975349|4037828|FG000|COMPLETED|Active Treatment Period (24 Weeks)||49
3304351|NCT02975349|4037829|FG001|COMPLETED|Active Treatment Period (24 Weeks)||0
3304352|NCT02975349|4037830|FG002|COMPLETED|Active Treatment Period (24 Weeks)||47
3304353|NCT02975349|4037831|FG003|COMPLETED|Active Treatment Period (24 Weeks)||48
3304354|NCT02975349|4037832|FG004|COMPLETED|Active Treatment Period (24 Weeks)||48
3304355|NCT02975349|4037833|FG005|COMPLETED|Active Treatment Period (24 Weeks)||52
3304356|NCT02975349|4037828|FG000|NOT COMPLETED|Active Treatment Period (24 Weeks)||5
3304357|NCT02975349|4037829|FG001|NOT COMPLETED|Active Treatment Period (24 Weeks)||0
3304358|NCT02975349|4037830|FG002|NOT COMPLETED|Active Treatment Period (24 Weeks)||5
3304359|NCT02975349|4037831|FG003|NOT COMPLETED|Active Treatment Period (24 Weeks)||5
3304360|NCT02975349|4037832|FG004|NOT COMPLETED|Active Treatment Period (24 Weeks)||6
3304361|NCT02975349|4037833|FG005|NOT COMPLETED|Active Treatment Period (24 Weeks)||2
3304362|NCT02975349|4037828|FG000|STARTED|Blinded Extension Period (24 Weeks)||0
3304363|NCT02975349|4037829|FG001|STARTED|Blinded Extension Period (24 Weeks)||49
3304364|NCT02975349|4037830|FG002|STARTED|Blinded Extension Period (24 Weeks)||47
3304365|NCT02975349|4037831|FG003|STARTED|Blinded Extension Period (24 Weeks)||48
3304366|NCT02975349|4037832|FG004|STARTED|Blinded Extension Period (24 Weeks)||48
3304367|NCT02975349|4037833|FG005|STARTED|Blinded Extension Period (24 Weeks)||52
3304368|NCT02975349|4037828|FG000|COMPLETED|Blinded Extension Period (24 Weeks)||0
3304369|NCT02975349|4037829|FG001|COMPLETED|Blinded Extension Period (24 Weeks)||42
3304370|NCT02975349|4037830|FG002|COMPLETED|Blinded Extension Period (24 Weeks)||43
3304371|NCT02975349|4037831|FG003|COMPLETED|Blinded Extension Period (24 Weeks)||44
3304372|NCT02975349|4037832|FG004|COMPLETED|Blinded Extension Period (24 Weeks)||46
3304373|NCT02975349|4037833|FG005|COMPLETED|Blinded Extension Period (24 Weeks)||52
3304374|NCT02975349|4037828|FG000|NOT COMPLETED|Blinded Extension Period (24 Weeks)||0
3304375|NCT02975349|4037829|FG001|NOT COMPLETED|Blinded Extension Period (24 Weeks)||7
3304376|NCT02975349|4037830|FG002|NOT COMPLETED|Blinded Extension Period (24 Weeks)||4
3304377|NCT02975349|4037831|FG003|NOT COMPLETED|Blinded Extension Period (24 Weeks)||4
3304378|NCT02975349|4037832|FG004|NOT COMPLETED|Blinded Extension Period (24 Weeks)||2
3304379|NCT02975349|4037833|FG005|NOT COMPLETED|Blinded Extension Period (24 Weeks)||0
3304380|NCT02975557|4037855|FG000|STARTED|Overall Study||4
3304381|NCT02975557|4037856|FG001|STARTED|Overall Study||5
3304382|NCT02975557|4037857|FG002|STARTED|Overall Study||6
3304383|NCT02975557|4037855|FG000|COMPLETED|Overall Study||3
3304384|NCT02975557|4037856|FG001|COMPLETED|Overall Study||2
3304385|NCT02975557|4037857|FG002|COMPLETED|Overall Study||5
3304386|NCT02975557|4037855|FG000|NOT COMPLETED|Overall Study||1
3304387|NCT02975557|4037856|FG001|NOT COMPLETED|Overall Study||3
3304388|NCT02975557|4037857|FG002|NOT COMPLETED|Overall Study||1
3304389|NCT02975700|4037865|FG000|STARTED|Overall Study||6
3304390|NCT02975700|4037865|FG000|COMPLETED|Overall Study||0
3304391|NCT02975700|4037865|FG000|NOT COMPLETED|Overall Study||6
3304392|NCT02975804|4037871|FG000|STARTED|Overall Study||9
3304393|NCT02975804|4037872|FG001|STARTED|Overall Study||9
3304394|NCT02975804|4037871|FG000|COMPLETED|Overall Study||9
3304395|NCT02975804|4037872|FG001|COMPLETED|Overall Study||9
3304396|NCT02975804|4037871|FG000|NOT COMPLETED|Overall Study||0
3304397|NCT02975804|4037872|FG001|NOT COMPLETED|Overall Study||0
3304398|NCT02975973|4037882|FG000|STARTED|Overall Study||1
3304399|NCT02975973|4037883|FG001|STARTED|Overall Study||2
3304400|NCT02975973|4037884|FG002|STARTED|Overall Study||1
3304401|NCT02975973|4037885|FG003|STARTED|Overall Study||4
3304402|NCT02975973|4037882|FG000|COMPLETED|Overall Study||0
3304403|NCT02975973|4037883|FG001|COMPLETED|Overall Study||1
3304404|NCT02975973|4037884|FG002|COMPLETED|Overall Study||0
3304405|NCT02975973|4037885|FG003|COMPLETED|Overall Study||4
3304406|NCT02975973|4037882|FG000|NOT COMPLETED|Overall Study||1
3304407|NCT02975973|4037883|FG001|NOT COMPLETED|Overall Study||1
3304408|NCT02975973|4037884|FG002|NOT COMPLETED|Overall Study||1
3304409|NCT02975973|4037885|FG003|NOT COMPLETED|Overall Study||0
3304410|NCT02976103|4037897|FG000|STARTED|Overall Study||67
3304411|NCT02976103|4037898|FG001|STARTED|Overall Study||72
2984218|NCT00869622|3700407|FG001|NOT COMPLETED|Overall Study||14
2984219|NCT00869778|3700417|FG000|STARTED|Overall Study||120
2984220|NCT00869778|3700418|FG001|STARTED|Overall Study||120
2984221|NCT00869778|3700419|FG002|STARTED|Overall Study||120
2984222|NCT00869778|3700417|FG000|COMPLETED|Overall Study||108
2984223|NCT00869778|3700418|FG001|COMPLETED|Overall Study||113
2984224|NCT00869778|3700419|FG002|COMPLETED|Overall Study||110
2984225|NCT00869778|3700417|FG000|NOT COMPLETED|Overall Study||12
2984226|NCT00869778|3700418|FG001|NOT COMPLETED|Overall Study||7
2984227|NCT00869778|3700419|FG002|NOT COMPLETED|Overall Study||10
2984228|NCT00869791|3700430|FG000|STARTED|Period 1 Treatment for 7 Days||14
2984229|NCT00869791|3700431|FG001|STARTED|Period 1 Treatment for 7 Days||13
2984230|NCT00869791|3700430|FG000|COMPLETED|Period 1 Treatment for 7 Days||14
2984231|NCT00869791|3700431|FG001|COMPLETED|Period 1 Treatment for 7 Days||13
2984232|NCT00869791|3700430|FG000|NOT COMPLETED|Period 1 Treatment for 7 Days||0
2984233|NCT00869791|3700431|FG001|NOT COMPLETED|Period 1 Treatment for 7 Days||0
2984234|NCT00869791|3700430|FG000|STARTED|Period 2 Treatment for 7 Days||14
2984235|NCT00869791|3700431|FG001|STARTED|Period 2 Treatment for 7 Days||13
2984236|NCT00869791|3700430|FG000|COMPLETED|Period 2 Treatment for 7 Days||14
2984237|NCT00869791|3700431|FG001|COMPLETED|Period 2 Treatment for 7 Days||13
2984238|NCT00869791|3700430|FG000|NOT COMPLETED|Period 2 Treatment for 7 Days||0
2984239|NCT00869791|3700431|FG001|NOT COMPLETED|Period 2 Treatment for 7 Days||0
2984240|NCT00869947|3700439|FG000|STARTED|Overall Study||8
2984241|NCT00869947|3700440|FG001|STARTED|Overall Study||8
2984242|NCT00869947|3700439|FG000|COMPLETED|Overall Study||8
2984243|NCT00869947|3700440|FG001|COMPLETED|Overall Study||8
2984244|NCT00869947|3700439|FG000|NOT COMPLETED|Overall Study||0
2984245|NCT00869947|3700440|FG001|NOT COMPLETED|Overall Study||0
2984246|NCT00869960|3700448|FG000|STARTED|Overall Study||24
2984247|NCT00869960|3700448|FG000|COMPLETED|Overall Study||22
2984248|NCT00869960|3700448|FG000|NOT COMPLETED|Overall Study||2
2984249|NCT00869999|3700452|FG000|STARTED|Overall Study||26
3164333|NCT01892189|3891783|FG005|COMPLETED|First Intervention Period (1 Day)||3
3164334|NCT01892189|3891784|FG006|COMPLETED|First Intervention Period (1 Day)||3
3164335|NCT01892189|3891785|FG007|COMPLETED|First Intervention Period (1 Day)||3
3164336|NCT01892189|3891786|FG008|COMPLETED|First Intervention Period (1 Day)||3
3164337|NCT01892189|3891778|FG000|NOT COMPLETED|First Intervention Period (1 Day)||0
3164338|NCT01892189|3891779|FG001|NOT COMPLETED|First Intervention Period (1 Day)||0
3164339|NCT01892189|3891780|FG002|NOT COMPLETED|First Intervention Period (1 Day)||0
3164340|NCT01892189|3891781|FG003|NOT COMPLETED|First Intervention Period (1 Day)||0
3164341|NCT01892189|3891782|FG004|NOT COMPLETED|First Intervention Period (1 Day)||0
3164342|NCT01892189|3891783|FG005|NOT COMPLETED|First Intervention Period (1 Day)||0
3164343|NCT01892189|3891784|FG006|NOT COMPLETED|First Intervention Period (1 Day)||0
3164344|NCT01892189|3891785|FG007|NOT COMPLETED|First Intervention Period (1 Day)||0
3164345|NCT01892189|3891786|FG008|NOT COMPLETED|First Intervention Period (1 Day)||0
3164346|NCT01892189|3891778|FG000|STARTED|Washout Period 1 (7 Days)||3
3164347|NCT01892189|3891779|FG001|STARTED|Washout Period 1 (7 Days)||3
3164348|NCT01892189|3891780|FG002|STARTED|Washout Period 1 (7 Days)||3
3164349|NCT01892189|3891781|FG003|STARTED|Washout Period 1 (7 Days)||3
3164350|NCT01892189|3891782|FG004|STARTED|Washout Period 1 (7 Days)||3
3164351|NCT01892189|3891783|FG005|STARTED|Washout Period 1 (7 Days)||3
3164352|NCT01892189|3891784|FG006|STARTED|Washout Period 1 (7 Days)||3
3164353|NCT01892189|3891785|FG007|STARTED|Washout Period 1 (7 Days)||3
3164354|NCT01892189|3891786|FG008|STARTED|Washout Period 1 (7 Days)||3
2984250|NCT00869999|3700452|FG000|COMPLETED|Overall Study||24
2984251|NCT00869999|3700452|FG000|NOT COMPLETED|Overall Study||2
2984252|NCT00870103|3700456|FG000|STARTED|Overall Study||64
2984253|NCT00870103|3700456|FG000|COMPLETED|Overall Study||60
2984254|NCT00870103|3700456|FG000|NOT COMPLETED|Overall Study||4
2984255|NCT00870194|3700462|FG000|STARTED|Overall Study||127
2984256|NCT00870194|3700463|FG001|STARTED|Overall Study||128
2984257|NCT00870194|3700462|FG000|Per Protocol Set|Overall Study||97
2984258|NCT00870194|3700463|FG001|Per Protocol Set|Overall Study||111
2984259|NCT00870194|3700462|FG000|COMPLETED|Overall Study||101
2984260|NCT00870194|3700463|FG001|COMPLETED|Overall Study||114
2984261|NCT00870194|3700462|FG000|NOT COMPLETED|Overall Study||26
2984262|NCT00870194|3700463|FG001|NOT COMPLETED|Overall Study||14
2984263|NCT00870233|3700469|FG000|STARTED|Overall Study||120
2984264|NCT00870233|3700469|FG000|COMPLETED|Overall Study||96
2984265|NCT00870233|3700469|FG000|NOT COMPLETED|Overall Study||24
2984266|NCT00870363|3700478|FG000|STARTED|Overall Study||10
2984267|NCT00870363|3700479|FG001|STARTED|Overall Study||11
2984268|NCT00870363|3700480|FG002|STARTED|Overall Study||11
2984269|NCT00870363|3700481|FG003|STARTED|Overall Study||12
2984270|NCT00870363|3700478|FG000|COMPLETED|Overall Study||10
2984271|NCT00870363|3700479|FG001|COMPLETED|Overall Study||8
2984272|NCT00870363|3700480|FG002|COMPLETED|Overall Study||8
2984273|NCT00870363|3700481|FG003|COMPLETED|Overall Study||12
2984274|NCT00870363|3700478|FG000|NOT COMPLETED|Overall Study||0
2984275|NCT00870363|3700479|FG001|NOT COMPLETED|Overall Study||3
2984276|NCT00870363|3700480|FG002|NOT COMPLETED|Overall Study||3
2984277|NCT00870363|3700481|FG003|NOT COMPLETED|Overall Study||0
2984278|NCT00870467|3700493|FG000|STARTED|Double-blind||171
2984279|NCT00870467|3700494|FG001|STARTED|Double-blind||163
2984280|NCT00870467|3700495|FG002|STARTED|Double-blind||0
2984281|NCT00870467|3700496|FG003|STARTED|Double-blind||0
2984282|NCT00870467|3700497|FG004|STARTED|Double-blind||0
2984283|NCT00870467|3700498|FG005|STARTED|Double-blind||0
3304412|NCT02976103|4037897|FG000|COMPLETED|Overall Study|54 participants answered final (T3) questionnaire|54
3304413|NCT02976103|4037898|FG001|COMPLETED|Overall Study|64 participants answered final (T3 questionnaire)|64
3304414|NCT02976103|4037897|FG000|NOT COMPLETED|Overall Study||13
3304415|NCT02976103|4037898|FG001|NOT COMPLETED|Overall Study||8
2984284|NCT00870467|3700493|FG000|COMPLETED|Double-blind|10 participants who completed 26 weeks received open-label adalimumab 40 mg eow as rescue therapy|155
2984285|NCT00870467|3700494|FG001|COMPLETED|Double-blind|24 participants who completed 26 weeks received open-label adalimumab 40 mg eow as rescue therapy|151
2984286|NCT00870467|3700495|FG002|COMPLETED|Double-blind||0
2984287|NCT00870467|3700496|FG003|COMPLETED|Double-blind||0
2984288|NCT00870467|3700497|FG004|COMPLETED|Double-blind||0
2984289|NCT00870467|3700498|FG005|COMPLETED|Double-blind||0
2984290|NCT00870467|3700493|FG000|NOT COMPLETED|Double-blind||16
2984291|NCT00870467|3700494|FG001|NOT COMPLETED|Double-blind||12
2984292|NCT00870467|3700495|FG002|NOT COMPLETED|Double-blind||0
3304416|NCT02976181|4037905|FG000|STARTED|Overall Study||113
3304417|NCT02976181|4037905|FG000|COMPLETED|Overall Study||112
3304418|NCT02976181|4037905|FG000|NOT COMPLETED|Overall Study||1
3304419|NCT02976519|4037917|FG000|STARTED|Treatment Period 1 (Part 1 and Part 2)||8
3304420|NCT02976519|4037918|FG001|STARTED|Treatment Period 1 (Part 1 and Part 2)||8
3304421|NCT02976519|4037919|FG002|STARTED|Treatment Period 1 (Part 1 and Part 2)||8
3304422|NCT02976519|4037920|FG003|STARTED|Treatment Period 1 (Part 1 and Part 2)||8
3304423|NCT02976519|4037921|FG004|STARTED|Treatment Period 1 (Part 1 and Part 2)||8
3304424|NCT02976519|4037922|FG005|STARTED|Treatment Period 1 (Part 1 and Part 2)||12
3304425|NCT02976519|4037923|FG006|STARTED|Treatment Period 1 (Part 1 and Part 2)||12
3304426|NCT02976519|4037917|FG000|COMPLETED|Treatment Period 1 (Part 1 and Part 2)||8
3304427|NCT02976519|4037918|FG001|COMPLETED|Treatment Period 1 (Part 1 and Part 2)||7
3304428|NCT02976519|4037919|FG002|COMPLETED|Treatment Period 1 (Part 1 and Part 2)||8
3304429|NCT02976519|4037920|FG003|COMPLETED|Treatment Period 1 (Part 1 and Part 2)||7
3304430|NCT02976519|4037921|FG004|COMPLETED|Treatment Period 1 (Part 1 and Part 2)||8
3304431|NCT02976519|4037922|FG005|COMPLETED|Treatment Period 1 (Part 1 and Part 2)||12
3304432|NCT02976519|4037923|FG006|COMPLETED|Treatment Period 1 (Part 1 and Part 2)||12
3304433|NCT02976519|4037917|FG000|NOT COMPLETED|Treatment Period 1 (Part 1 and Part 2)||0
3304434|NCT02976519|4037918|FG001|NOT COMPLETED|Treatment Period 1 (Part 1 and Part 2)||1
3304435|NCT02976519|4037919|FG002|NOT COMPLETED|Treatment Period 1 (Part 1 and Part 2)||0
3304436|NCT02976519|4037920|FG003|NOT COMPLETED|Treatment Period 1 (Part 1 and Part 2)||1
3304437|NCT02976519|4037921|FG004|NOT COMPLETED|Treatment Period 1 (Part 1 and Part 2)||0
3304438|NCT02976519|4037922|FG005|NOT COMPLETED|Treatment Period 1 (Part 1 and Part 2)||0
3304439|NCT02976519|4037923|FG006|NOT COMPLETED|Treatment Period 1 (Part 1 and Part 2)||0
3304440|NCT02976519|4037917|FG000|STARTED|Wash-out Period (Part 2 Only)||0
3304441|NCT02976519|4037918|FG001|STARTED|Wash-out Period (Part 2 Only)||0
3304442|NCT02976519|4037919|FG002|STARTED|Wash-out Period (Part 2 Only)||0
3304443|NCT02976519|4037920|FG003|STARTED|Wash-out Period (Part 2 Only)||0
3304444|NCT02976519|4037921|FG004|STARTED|Wash-out Period (Part 2 Only)||0
3304445|NCT02976519|4037922|FG005|STARTED|Wash-out Period (Part 2 Only)||12
3304446|NCT02976519|4037923|FG006|STARTED|Wash-out Period (Part 2 Only)||12
3304447|NCT02976519|4037917|FG000|COMPLETED|Wash-out Period (Part 2 Only)||0
3304448|NCT02976519|4037918|FG001|COMPLETED|Wash-out Period (Part 2 Only)||0
3304449|NCT02976519|4037919|FG002|COMPLETED|Wash-out Period (Part 2 Only)||0
3304450|NCT02976519|4037920|FG003|COMPLETED|Wash-out Period (Part 2 Only)||0
3304451|NCT02976519|4037921|FG004|COMPLETED|Wash-out Period (Part 2 Only)||0
3304452|NCT02976519|4037922|FG005|COMPLETED|Wash-out Period (Part 2 Only)||12
3304453|NCT02976519|4037923|FG006|COMPLETED|Wash-out Period (Part 2 Only)||10
3304454|NCT02976519|4037917|FG000|NOT COMPLETED|Wash-out Period (Part 2 Only)||0
3304455|NCT02976519|4037918|FG001|NOT COMPLETED|Wash-out Period (Part 2 Only)||0
3304456|NCT02976519|4037919|FG002|NOT COMPLETED|Wash-out Period (Part 2 Only)||0
3304457|NCT02976519|4037920|FG003|NOT COMPLETED|Wash-out Period (Part 2 Only)||0
3304458|NCT02976519|4037921|FG004|NOT COMPLETED|Wash-out Period (Part 2 Only)||0
3304459|NCT02976519|4037922|FG005|NOT COMPLETED|Wash-out Period (Part 2 Only)||0
3304460|NCT02976519|4037923|FG006|NOT COMPLETED|Wash-out Period (Part 2 Only)||2
3304461|NCT02976519|4037917|FG000|STARTED|Treatment Period 2 (Part 2 Only)||0
3304462|NCT02976519|4037918|FG001|STARTED|Treatment Period 2 (Part 2 Only)||0
3304463|NCT02976519|4037919|FG002|STARTED|Treatment Period 2 (Part 2 Only)||0
3304464|NCT02976519|4037920|FG003|STARTED|Treatment Period 2 (Part 2 Only)||0
3304465|NCT02976519|4037921|FG004|STARTED|Treatment Period 2 (Part 2 Only)||0
3304466|NCT02976519|4037922|FG005|STARTED|Treatment Period 2 (Part 2 Only)||12
3304467|NCT02976519|4037923|FG006|STARTED|Treatment Period 2 (Part 2 Only)||10
3304468|NCT02976519|4037917|FG000|COMPLETED|Treatment Period 2 (Part 2 Only)||0
3304469|NCT02976519|4037918|FG001|COMPLETED|Treatment Period 2 (Part 2 Only)||0
3304470|NCT02976519|4037919|FG002|COMPLETED|Treatment Period 2 (Part 2 Only)||0
3304471|NCT02976519|4037920|FG003|COMPLETED|Treatment Period 2 (Part 2 Only)||0
3304472|NCT02976519|4037921|FG004|COMPLETED|Treatment Period 2 (Part 2 Only)||0
3304473|NCT02976519|4037922|FG005|COMPLETED|Treatment Period 2 (Part 2 Only)||12
3304474|NCT02976519|4037923|FG006|COMPLETED|Treatment Period 2 (Part 2 Only)||9
3304475|NCT02976519|4037917|FG000|NOT COMPLETED|Treatment Period 2 (Part 2 Only)||0
3304476|NCT02976519|4037918|FG001|NOT COMPLETED|Treatment Period 2 (Part 2 Only)||0
3304477|NCT02976519|4037919|FG002|NOT COMPLETED|Treatment Period 2 (Part 2 Only)||0
3304478|NCT02976519|4037920|FG003|NOT COMPLETED|Treatment Period 2 (Part 2 Only)||0
2984293|NCT00870467|3700496|FG003|NOT COMPLETED|Double-blind||0
2984294|NCT00870467|3700497|FG004|NOT COMPLETED|Double-blind||0
2984295|NCT00870467|3700498|FG005|NOT COMPLETED|Double-blind||0
2984296|NCT00870467|3700493|FG000|STARTED|Open-label||0
2984297|NCT00870467|3700494|FG001|STARTED|Open-label||0
2984298|NCT00870467|3700495|FG002|STARTED|Open-label||145
2984299|NCT00870467|3700496|FG003|STARTED|Open-label||127
2984300|NCT00870467|3700497|FG004|STARTED|Open-label||10
2984301|NCT00870467|3700498|FG005|STARTED|Open-label||24
2984302|NCT00870467|3700493|FG000|COMPLETED|Open-label||0
2984303|NCT00870467|3700494|FG001|COMPLETED|Open-label||0
2984304|NCT00870467|3700495|FG002|COMPLETED|Open-label||132
2984305|NCT00870467|3700496|FG003|COMPLETED|Open-label||120
2984306|NCT00870467|3700497|FG004|COMPLETED|Open-label||5
2984307|NCT00870467|3700498|FG005|COMPLETED|Open-label||21
2984308|NCT00870467|3700493|FG000|NOT COMPLETED|Open-label||0
2984309|NCT00870467|3700494|FG001|NOT COMPLETED|Open-label||0
3304479|NCT02976519|4037921|FG004|NOT COMPLETED|Treatment Period 2 (Part 2 Only)||0
3304480|NCT02976519|4037922|FG005|NOT COMPLETED|Treatment Period 2 (Part 2 Only)||0
3304481|NCT02976519|4037923|FG006|NOT COMPLETED|Treatment Period 2 (Part 2 Only)||1
3304482|NCT02977507|4037943|FG000|STARTED|Overall Study||8
3304483|NCT02977507|4037944|FG001|STARTED|Overall Study||10
3304484|NCT02977507|4037943|FG000|COMPLETED|Overall Study||6
3304485|NCT02977507|4037944|FG001|COMPLETED|Overall Study||10
3304486|NCT02977507|4037943|FG000|NOT COMPLETED|Overall Study||2
3304487|NCT02977507|4037944|FG001|NOT COMPLETED|Overall Study||0
3304488|NCT02977572|4037953|FG000|STARTED|Overall Study||58
3304489|NCT02977572|4037954|FG001|STARTED|Overall Study||56
3304490|NCT02977572|4037953|FG000|COMPLETED|Overall Study||56
3304491|NCT02977572|4037954|FG001|COMPLETED|Overall Study||54
3304492|NCT02977572|4037953|FG000|NOT COMPLETED|Overall Study||2
3304493|NCT02977572|4037954|FG001|NOT COMPLETED|Overall Study||2
3304494|NCT02978157|4037966|FG000|STARTED|Overall Study||52
3304495|NCT02978157|4037967|FG001|STARTED|Overall Study||50
3304496|NCT02978157|4037966|FG000|COMPLETED|Overall Study||52
3304497|NCT02978157|4037967|FG001|COMPLETED|Overall Study||50
3304498|NCT02978157|4037966|FG000|NOT COMPLETED|Overall Study||0
3304499|NCT02978157|4037967|FG001|NOT COMPLETED|Overall Study||0
3304500|NCT02978183|4037975|FG000|STARTED|Overall Study||34
3304501|NCT02978183|4037976|FG001|STARTED|Overall Study||36
3304502|NCT02978183|4037975|FG000|COMPLETED|Overall Study||34
3304503|NCT02978183|4037976|FG001|COMPLETED|Overall Study||36
3304504|NCT02978183|4037975|FG000|NOT COMPLETED|Overall Study||0
3304505|NCT02978183|4037976|FG001|NOT COMPLETED|Overall Study||0
3304506|NCT02978339|4037982|FG000|STARTED|Overall Study||15
3304507|NCT02978339|4037982|FG000|COMPLETED|Overall Study||15
3304508|NCT02978339|4037982|FG000|NOT COMPLETED|Overall Study||0
3304509|NCT02978417|4037988|FG000|STARTED|Overall Study||5
3304510|NCT02978417|4037989|FG001|STARTED|Overall Study||5
3304511|NCT02978417|4037988|FG000|COMPLETED|Overall Study||3
3304512|NCT02978417|4037989|FG001|COMPLETED|Overall Study||3
3304513|NCT02978417|4037988|FG000|NOT COMPLETED|Overall Study||2
3304514|NCT02978417|4037989|FG001|NOT COMPLETED|Overall Study||2
3317036|NCT03123068|4050529|FG000|NOT COMPLETED|Overall Study||0
3317037|NCT03123068|4050530|FG001|NOT COMPLETED|Overall Study||0
3317038|NCT03123120|4050538|FG000|STARTED|Overall Study||8
3317039|NCT03123120|4050539|FG001|STARTED|Overall Study||14
3317040|NCT03123120|4050538|FG000|Safety Analysis Set (SAF)|Overall Study||7
3317041|NCT03123120|4050539|FG001|Safety Analysis Set (SAF)|Overall Study||15
3317042|NCT03123120|4050538|FG000|COMPLETED|Overall Study||8
3317043|NCT03123120|4050539|FG001|COMPLETED|Overall Study||12
3317044|NCT03123120|4050538|FG000|NOT COMPLETED|Overall Study||0
3317045|NCT03123120|4050539|FG001|NOT COMPLETED|Overall Study||2
3317046|NCT03123263|4050547|FG000|STARTED|Overall Study||60
3317047|NCT03123263|4050547|FG000|COMPLETED|Overall Study||60
3317048|NCT03123263|4050547|FG000|NOT COMPLETED|Overall Study||0
3317049|NCT03123354|4050554|FG000|STARTED|Overall Study||44
3317050|NCT03123354|4050554|FG000|COMPLETED|Overall Study||38
3317051|NCT03123354|4050554|FG000|NOT COMPLETED|Overall Study||6
3317052|NCT03123471|4050560|FG000|STARTED|Placebo-controlled Phase||102
3317053|NCT03123471|4050561|FG001|STARTED|Placebo-controlled Phase||201
3317054|NCT03123471|4050560|FG000|Received at Least 1 Dose of Study Drug|Placebo-controlled Phase||102
3317055|NCT03123471|4050561|FG001|Received at Least 1 Dose of Study Drug|Placebo-controlled Phase||200
3317056|NCT03123471|4050560|FG000|COMPLETED|Placebo-controlled Phase||84
3317057|NCT03123471|4050561|FG001|COMPLETED|Placebo-controlled Phase||168
3317058|NCT03123471|4050560|FG000|NOT COMPLETED|Placebo-controlled Phase||18
3317059|NCT03123471|4050561|FG001|NOT COMPLETED|Placebo-controlled Phase||33
3317060|NCT03123471|4050560|FG000|STARTED|Apremilast Extension Phase||84
3317061|NCT03123471|4050561|FG001|STARTED|Apremilast Extension Phase|3 participants completed the first phase; did not enter in extension phase|165
3317062|NCT03123471|4050560|FG000|Received at Least 1 Dose of Study Drug|Apremilast Extension Phase||84
3317063|NCT03123471|4050561|FG001|Received at Least 1 Dose of Study Drug|Apremilast Extension Phase||163
3317064|NCT03123471|4050560|FG000|COMPLETED|Apremilast Extension Phase||76
3317065|NCT03123471|4050561|FG001|COMPLETED|Apremilast Extension Phase||140
3317066|NCT03123471|4050560|FG000|NOT COMPLETED|Apremilast Extension Phase||8
3317067|NCT03123471|4050561|FG001|NOT COMPLETED|Apremilast Extension Phase||25
2984310|NCT00870467|3700495|FG002|NOT COMPLETED|Open-label||13
3317068|NCT03123588|4050575|FG000|STARTED|Overall Study||6
3317069|NCT03123588|4050576|FG001|STARTED|Overall Study||6
2984311|NCT00870467|3700496|FG003|NOT COMPLETED|Open-label||7
2984312|NCT00870467|3700497|FG004|NOT COMPLETED|Open-label||5
2984313|NCT00870467|3700498|FG005|NOT COMPLETED|Open-label||3
2984314|NCT00870545|3700510|FG000|STARTED|Overall Study||86
2984315|NCT00870545|3700510|FG000|COMPLETED|Overall Study||69
2984316|NCT00870545|3700510|FG000|NOT COMPLETED|Overall Study||17
2984317|NCT00870584|3700516|FG000|STARTED|Overall Study||136
2984318|NCT00870584|3700517|FG001|STARTED|Overall Study||135
2984319|NCT00870584|3700516|FG000|COMPLETED|Overall Study||120
2984320|NCT00870584|3700517|FG001|COMPLETED|Overall Study||122
2984321|NCT00870584|3700516|FG000|NOT COMPLETED|Overall Study||16
2984322|NCT00870584|3700517|FG001|NOT COMPLETED|Overall Study||13
2984323|NCT00870727|3700525|FG000|STARTED|Overall Study||17
2984324|NCT00870727|3700526|FG001|STARTED|Overall Study||16
2984325|NCT00870727|3700525|FG000|COMPLETED|Overall Study||16
3304515|NCT02978508|4037997|FG000|STARTED|Overall Study||70
3304516|NCT02978508|4037998|FG001|STARTED|Overall Study||70
3304517|NCT02978508|4037997|FG000|COMPLETED|Overall Study||70
3304518|NCT02978508|4037998|FG001|COMPLETED|Overall Study||70
3304519|NCT02978508|4037997|FG000|NOT COMPLETED|Overall Study||0
3304520|NCT02978508|4037998|FG001|NOT COMPLETED|Overall Study||0
3304521|NCT02979054|4038006|FG000|STARTED|Overall Study||71
3304522|NCT02979054|4038007|FG001|STARTED|Overall Study||64
3304523|NCT02979054|4038006|FG000|COMPLETED|Overall Study||71
3304524|NCT02979054|4038007|FG001|COMPLETED|Overall Study||64
3304525|NCT02979054|4038006|FG000|NOT COMPLETED|Overall Study||0
3304526|NCT02979054|4038007|FG001|NOT COMPLETED|Overall Study||0
3304527|NCT02979197|4038016|FG000|STARTED|Overall Study||48
3304528|NCT02979197|4038017|FG001|STARTED|Overall Study||49
3304529|NCT02979197|4038018|FG002|STARTED|Overall Study||8
3164355|NCT01892189|3891778|FG000|COMPLETED|Washout Period 1 (7 Days)||3
3164356|NCT01892189|3891779|FG001|COMPLETED|Washout Period 1 (7 Days)||3
3164357|NCT01892189|3891780|FG002|COMPLETED|Washout Period 1 (7 Days)||1
3164358|NCT01892189|3891781|FG003|COMPLETED|Washout Period 1 (7 Days)||2
3164359|NCT01892189|3891782|FG004|COMPLETED|Washout Period 1 (7 Days)||3
3164360|NCT01892189|3891783|FG005|COMPLETED|Washout Period 1 (7 Days)||2
3164361|NCT01892189|3891784|FG006|COMPLETED|Washout Period 1 (7 Days)||2
3164362|NCT01892189|3891785|FG007|COMPLETED|Washout Period 1 (7 Days)||3
3164363|NCT01892189|3891786|FG008|COMPLETED|Washout Period 1 (7 Days)||1
3164364|NCT01892189|3891778|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0
3304530|NCT02979197|4038016|FG000|COMPLETED|Overall Study||44
3304531|NCT02979197|4038017|FG001|COMPLETED|Overall Study||45
3304532|NCT02979197|4038018|FG002|COMPLETED|Overall Study||8
3304533|NCT02979197|4038016|FG000|NOT COMPLETED|Overall Study||4
3304534|NCT02979197|4038017|FG001|NOT COMPLETED|Overall Study||4
3304535|NCT02979197|4038018|FG002|NOT COMPLETED|Overall Study||0
3304536|NCT02979249|4038026|FG000|STARTED|Overall Study||16
3304537|NCT02979249|4038026|FG000|COMPLETED|Overall Study||10
3304538|NCT02979249|4038026|FG000|NOT COMPLETED|Overall Study||6
3304539|NCT02979262|4038032|FG000|STARTED|Overall Study||33
3304540|NCT02979262|4038033|FG001|STARTED|Overall Study||29
3304541|NCT02979262|4038032|FG000|Received Allocated Intervention|Overall Study||30
3304542|NCT02979262|4038033|FG001|Received Allocated Intervention|Overall Study||27
3304543|NCT02979262|4038032|FG000|COMPLETED|Overall Study||21
3304544|NCT02979262|4038033|FG001|COMPLETED|Overall Study||20
3304545|NCT02979262|4038032|FG000|NOT COMPLETED|Overall Study||12
3304546|NCT02979262|4038033|FG001|NOT COMPLETED|Overall Study||9
3304547|NCT02979301|4038041|FG000|STARTED|Overall Study||11
3304548|NCT02979301|4038042|FG001|STARTED|Overall Study||11
3304549|NCT02979301|4038041|FG000|COMPLETED|Overall Study||10
3304550|NCT02979301|4038042|FG001|COMPLETED|Overall Study||11
3304551|NCT02979301|4038041|FG000|NOT COMPLETED|Overall Study||1
3304552|NCT02979301|4038042|FG001|NOT COMPLETED|Overall Study||0
3304553|NCT02979431|4038052|FG000|STARTED|Overall Study||44
3304554|NCT02979431|4038053|FG001|STARTED|Overall Study||46
3304555|NCT02979431|4038054|FG002|STARTED|Overall Study||45
3304556|NCT02979431|4038055|FG003|STARTED|Overall Study||45
3304557|NCT02979431|4038052|FG000|Included in the mITT Population|Overall Study||42
3304558|NCT02979431|4038053|FG001|Included in the mITT Population|Overall Study||45
3304559|NCT02979431|4038054|FG002|Included in the mITT Population|Overall Study||43
3304560|NCT02979431|4038055|FG003|Included in the mITT Population|Overall Study||45
3304561|NCT02979431|4038052|FG000|Included in the Safety Population|Overall Study||40
3304562|NCT02979431|4038053|FG001|Included in the Safety Population|Overall Study||45
3304563|NCT02979431|4038054|FG002|Included in the Safety Population|Overall Study|Includes a subject that was randomized to placebo but received a dose of ALX-0171 6.0 mg/kg|44
3304564|NCT02979431|4038055|FG003|Included in the Safety Population|Overall Study|Includes a subject that was randomized to placebo but received a dose of ALX-0171 9.0 mg/kg|46
3304565|NCT02979431|4038052|FG000|COMPLETED|Overall Study||40
3304566|NCT02979431|4038053|FG001|COMPLETED|Overall Study||44
3304567|NCT02979431|4038054|FG002|COMPLETED|Overall Study||43
3304568|NCT02979431|4038055|FG003|COMPLETED|Overall Study||44
3304569|NCT02979431|4038052|FG000|NOT COMPLETED|Overall Study||4
3304570|NCT02979431|4038053|FG001|NOT COMPLETED|Overall Study||2
3304571|NCT02979431|4038054|FG002|NOT COMPLETED|Overall Study||2
3304572|NCT02979431|4038055|FG003|NOT COMPLETED|Overall Study||1
3304573|NCT02979444|4038068|FG000|STARTED|Overall Study||405
3304574|NCT02979444|4038069|FG001|STARTED|Overall Study||310
3304575|NCT02979444|4038070|FG002|STARTED|Overall Study||159
3304576|NCT02979444|4038068|FG000|COMPLETED|Overall Study||382
3304577|NCT02979444|4038069|FG001|COMPLETED|Overall Study||293
2984326|NCT00870727|3700526|FG001|COMPLETED|Overall Study||11
2984327|NCT00870727|3700525|FG000|NOT COMPLETED|Overall Study||1
2984328|NCT00870727|3700526|FG001|NOT COMPLETED|Overall Study||5
2984329|NCT00870740|3700538|FG000|STARTED|Overall Study|number randomized and dosed|86
2984330|NCT00870740|3700539|FG001|STARTED|Overall Study|number randomized and dosed|84
2984331|NCT00870740|3700540|FG002|STARTED|Overall Study|number randomized and dosed|86
2984332|NCT00870740|3700541|FG003|STARTED|Overall Study|number randomized and dosed|86
3304578|NCT02979444|4038070|FG002|COMPLETED|Overall Study||149
3304579|NCT02979444|4038068|FG000|NOT COMPLETED|Overall Study||23
3304580|NCT02979444|4038069|FG001|NOT COMPLETED|Overall Study||17
3304581|NCT02979444|4038070|FG002|NOT COMPLETED|Overall Study||10
3304582|NCT02979522|4038080|FG000|STARTED|Period 1: Phase 1||8
3304583|NCT02979522|4038081|FG001|STARTED|Period 1: Phase 1||0
3304584|NCT02979522|4038080|FG000|COMPLETED|Period 1: Phase 1||8
3304585|NCT02979522|4038081|FG001|COMPLETED|Period 1: Phase 1||0
3304586|NCT02979522|4038080|FG000|NOT COMPLETED|Period 1: Phase 1||0
3304587|NCT02979522|4038081|FG001|NOT COMPLETED|Period 1: Phase 1||0
3304588|NCT02979522|4038080|FG000|STARTED|Period 2: Phase 2||0
3304589|NCT02979522|4038081|FG001|STARTED|Period 2: Phase 2|Participants treated in Phase 1 entered Phase 2 along with additional participants enrolled in Phase 2.|59
3304590|NCT02979522|4038080|FG000|COMPLETED|Period 2: Phase 2||0
3304591|NCT02979522|4038081|FG001|COMPLETED|Period 2: Phase 2||59
3304592|NCT02979522|4038080|FG000|NOT COMPLETED|Period 2: Phase 2||0
3304593|NCT02979522|4038081|FG001|NOT COMPLETED|Period 2: Phase 2||0
3304594|NCT02979535|4038089|FG000|STARTED|Overall Study||239
3304595|NCT02979535|4038090|FG001|STARTED|Overall Study||241
3304596|NCT02979535|4038089|FG000|Safety Analysis Set|Overall Study||237
3304597|NCT02979535|4038090|FG001|Safety Analysis Set|Overall Study||241
3304598|NCT02979535|4038089|FG000|COMPLETED|Overall Study||144
3304599|NCT02979535|4038090|FG001|COMPLETED|Overall Study||140
3304600|NCT02979535|4038089|FG000|NOT COMPLETED|Overall Study||95
3304601|NCT02979535|4038090|FG001|NOT COMPLETED|Overall Study||101
3304602|NCT02979613|4038098|FG000|STARTED|Double-Blind Phase||245
3304603|NCT02979613|4038099|FG001|STARTED|Double-Blind Phase||245
3304604|NCT02979613|4038098|FG000|COMPLETED|Double-Blind Phase||235
3304605|NCT02979613|4038099|FG001|COMPLETED|Double-Blind Phase||237
3304606|NCT02979613|4038098|FG000|NOT COMPLETED|Double-Blind Phase||10
3304607|NCT02979613|4038099|FG001|NOT COMPLETED|Double-Blind Phase||8
3304608|NCT02979613|4038098|FG000|STARTED|Open-Label Extension (OLE) Phase||235
3304609|NCT02979613|4038099|FG001|STARTED|Open-Label Extension (OLE) Phase||237
3304610|NCT02979613|4038098|FG000|COMPLETED|Open-Label Extension (OLE) Phase||232
3304611|NCT02979613|4038099|FG001|COMPLETED|Open-Label Extension (OLE) Phase||231
3304612|NCT02979613|4038098|FG000|NOT COMPLETED|Open-Label Extension (OLE) Phase||3
3304613|NCT02979613|4038099|FG001|NOT COMPLETED|Open-Label Extension (OLE) Phase||6
3304614|NCT02979626|4038109|FG000|STARTED|Overall Study||313
3304615|NCT02979626|4038110|FG001|STARTED|Overall Study||98
3304616|NCT02979626|4038109|FG000|COMPLETED|Overall Study||313
3304617|NCT02979626|4038110|FG001|COMPLETED|Overall Study||98
3304618|NCT02979626|4038109|FG000|NOT COMPLETED|Overall Study||0
3304619|NCT02979626|4038110|FG001|NOT COMPLETED|Overall Study||0
3304620|NCT02979639|4038116|FG000|STARTED|Overall Study||401
3304621|NCT02979639|4038116|FG000|COMPLETED|Overall Study||387
3304622|NCT02979639|4038116|FG000|NOT COMPLETED|Overall Study||14
3304623|NCT02979899|4038122|FG000|STARTED|Overall Study||64
3304624|NCT02979899|4038123|FG001|STARTED|Overall Study||64
3304625|NCT02979899|4038122|FG000|COMPLETED|Overall Study||64
3304626|NCT02979899|4038123|FG001|COMPLETED|Overall Study||64
3304627|NCT02979899|4038122|FG000|NOT COMPLETED|Overall Study||0
3304628|NCT02979899|4038123|FG001|NOT COMPLETED|Overall Study||0
3304629|NCT02979925|4038131|FG000|STARTED|Overall Study||28
3304630|NCT02979925|4038132|FG001|STARTED|Overall Study||29
3304631|NCT02979925|4038131|FG000|COMPLETED|Overall Study||28
3304632|NCT02979925|4038132|FG001|COMPLETED|Overall Study||23
3304633|NCT02979925|4038131|FG000|NOT COMPLETED|Overall Study||0
3304634|NCT02979925|4038132|FG001|NOT COMPLETED|Overall Study||6
3304635|NCT02980042|4038140|FG000|STARTED|Overall Study||100
3304636|NCT02980042|4038141|FG001|STARTED|Overall Study||100
3304637|NCT02980042|4038140|FG000|COMPLETED|Overall Study|All 100 subjects completed their Week 24 infusion. 7 subjects did not complete the 12 month visit.|93
3304638|NCT02980042|4038141|FG001|COMPLETED|Overall Study||100
3304639|NCT02980042|4038140|FG000|NOT COMPLETED|Overall Study||7
3304640|NCT02980042|4038141|FG001|NOT COMPLETED|Overall Study||0
3304641|NCT02980107|4038161|FG000|STARTED|Overall Study||105
3304642|NCT02980107|4038162|FG001|STARTED|Overall Study||107
3304643|NCT02980107|4038161|FG000|COMPLETED|Overall Study||54
3304644|NCT02980107|4038162|FG001|COMPLETED|Overall Study||45
3304645|NCT02980107|4038161|FG000|NOT COMPLETED|Overall Study||51
3304646|NCT02980107|4038162|FG001|NOT COMPLETED|Overall Study||62
3304647|NCT02980133|4038172|FG000|STARTED|Overall Study||209
3304648|NCT02980133|4038173|FG001|STARTED|Overall Study||211
3304649|NCT02980133|4038174|FG002|STARTED|Overall Study||210
3304650|NCT02980133|4038175|FG003|STARTED|Overall Study||211
3304651|NCT02980133|4038172|FG000|Received at Least 1 Dose of Study Drug|Overall Study||209
3304652|NCT02980133|4038173|FG001|Received at Least 1 Dose of Study Drug|Overall Study||211
3304653|NCT02980133|4038174|FG002|Received at Least 1 Dose of Study Drug|Overall Study||208
3304654|NCT02980133|4038175|FG003|Received at Least 1 Dose of Study Drug|Overall Study||211
3304655|NCT02980133|4038172|FG000|COMPLETED|Overall Study||202
3304656|NCT02980133|4038173|FG001|COMPLETED|Overall Study||206
3304657|NCT02980133|4038174|FG002|COMPLETED|Overall Study||203
3304658|NCT02980133|4038175|FG003|COMPLETED|Overall Study||205
2984333|NCT00870740|3700542|FG004|STARTED|Overall Study|number randomized and dosed|88
2984334|NCT00870740|3700543|FG005|STARTED|Overall Study|number randomized and dosed|87
2984335|NCT00870740|3700538|FG000|COMPLETED|Overall Study||74
2984336|NCT00870740|3700539|FG001|COMPLETED|Overall Study||75
2984337|NCT00870740|3700540|FG002|COMPLETED|Overall Study||76
2984338|NCT00870740|3700541|FG003|COMPLETED|Overall Study||74
2984339|NCT00870740|3700542|FG004|COMPLETED|Overall Study||77
2984340|NCT00870740|3700543|FG005|COMPLETED|Overall Study||70
2984341|NCT00870740|3700538|FG000|NOT COMPLETED|Overall Study||12
3304659|NCT02980133|4038172|FG000|NOT COMPLETED|Overall Study||7
3304660|NCT02980133|4038173|FG001|NOT COMPLETED|Overall Study||5
3304661|NCT02980133|4038174|FG002|NOT COMPLETED|Overall Study||7
3304662|NCT02980133|4038175|FG003|NOT COMPLETED|Overall Study||6
3304663|NCT02980211|4038188|FG000|STARTED|Overall Study||17
3304664|NCT02980211|4038188|FG000|COMPLETED|Overall Study||17
3304665|NCT02980211|4038188|FG000|NOT COMPLETED|Overall Study||0
3304666|NCT02980224|4038194|FG000|STARTED|Overall Study||89
3304667|NCT02980224|4038195|FG001|STARTED|Overall Study||91
3304668|NCT02980224|4038194|FG000|COMPLETED|Overall Study||85
3304669|NCT02980224|4038195|FG001|COMPLETED|Overall Study||88
3304670|NCT02980224|4038194|FG000|NOT COMPLETED|Overall Study||4
3304671|NCT02980224|4038195|FG001|NOT COMPLETED|Overall Study||3
3304672|NCT02980523|4038206|FG000|STARTED|Overall Study||30
3304673|NCT02980523|4038207|FG001|STARTED|Overall Study||30
3304674|NCT02980523|4038208|FG002|STARTED|Overall Study||30
3304675|NCT02980523|4038209|FG003|STARTED|Overall Study||30
3304676|NCT02980523|4038210|FG004|STARTED|Overall Study||30
3304677|NCT02980523|4038206|FG000|COMPLETED|Overall Study||27
3304678|NCT02980523|4038207|FG001|COMPLETED|Overall Study||19
3304679|NCT02980523|4038208|FG002|COMPLETED|Overall Study||24
3304680|NCT02980523|4038209|FG003|COMPLETED|Overall Study||21
3304681|NCT02980523|4038210|FG004|COMPLETED|Overall Study||20
3304682|NCT02980523|4038206|FG000|NOT COMPLETED|Overall Study||3
3304683|NCT02980523|4038207|FG001|NOT COMPLETED|Overall Study||11
3304684|NCT02980523|4038208|FG002|NOT COMPLETED|Overall Study||6
3304685|NCT02980523|4038209|FG003|NOT COMPLETED|Overall Study||9
3304686|NCT02980523|4038210|FG004|NOT COMPLETED|Overall Study||10
3304687|NCT02980601|4038227|FG000|STARTED|Overall Study||6
3304688|NCT02980601|4038228|FG001|STARTED|Overall Study||4
3304689|NCT02980601|4038227|FG000|COMPLETED|Overall Study||1
3304690|NCT02980601|4038228|FG001|COMPLETED|Overall Study||1
3304691|NCT02980601|4038227|FG000|NOT COMPLETED|Overall Study||5
3304692|NCT02980601|4038228|FG001|NOT COMPLETED|Overall Study||3
3304693|NCT02980692|4038239|FG000|STARTED|Overall Study||78
3304694|NCT02980692|4038240|FG001|STARTED|Overall Study||79
3304695|NCT02980692|4038241|FG002|STARTED|Overall Study||77
3304696|NCT02980692|4038242|FG003|STARTED|Overall Study||78
3304697|NCT02980692|4038243|FG004|STARTED|Overall Study||79
3304698|NCT02980692|4038239|FG000|COMPLETED|Overall Study||69
3304699|NCT02980692|4038240|FG001|COMPLETED|Overall Study||73
3304700|NCT02980692|4038241|FG002|COMPLETED|Overall Study||65
3304701|NCT02980692|4038242|FG003|COMPLETED|Overall Study||69
3304702|NCT02980692|4038243|FG004|COMPLETED|Overall Study||68
3304703|NCT02980692|4038239|FG000|NOT COMPLETED|Overall Study||9
3304704|NCT02980692|4038240|FG001|NOT COMPLETED|Overall Study||6
3304705|NCT02980692|4038241|FG002|NOT COMPLETED|Overall Study||12
3304706|NCT02980692|4038242|FG003|NOT COMPLETED|Overall Study||9
3304707|NCT02980692|4038243|FG004|NOT COMPLETED|Overall Study||11
3304708|NCT02980705|4038258|FG000|STARTED|Overall Study||50
3304709|NCT02980705|4038259|FG001|STARTED|Overall Study||51
3304710|NCT02980705|4038258|FG000|COMPLETED|Overall Study||42
3304711|NCT02980705|4038259|FG001|COMPLETED|Overall Study||40
3304712|NCT02980705|4038258|FG000|NOT COMPLETED|Overall Study||8
3304713|NCT02980705|4038259|FG001|NOT COMPLETED|Overall Study||11
3304714|NCT02980783|4038266|FG000|STARTED|Overall Study||53
3304715|NCT02980783|4038266|FG000|COMPLETED|Overall Study||52
3304716|NCT02980783|4038266|FG000|NOT COMPLETED|Overall Study||1
3304717|NCT02980874|4038272|FG000|STARTED|Overall Study||231
3304718|NCT02980874|4038273|FG001|STARTED|Overall Study||229
3304719|NCT02980874|4038272|FG000|COMPLETED|Overall Study||128
3304720|NCT02980874|4038273|FG001|COMPLETED|Overall Study||127
3304721|NCT02980874|4038272|FG000|NOT COMPLETED|Overall Study||103
3304722|NCT02980874|4038273|FG001|NOT COMPLETED|Overall Study||102
3304723|NCT02980978|4038281|FG000|STARTED|Overall Study||60
3304724|NCT02980978|4038282|FG001|STARTED|Overall Study||58
3304725|NCT02980978|4038281|FG000|COMPLETED|Overall Study||54
3304726|NCT02980978|4038282|FG001|COMPLETED|Overall Study||50
3304727|NCT02980978|4038281|FG000|NOT COMPLETED|Overall Study||6
3304728|NCT02980978|4038282|FG001|NOT COMPLETED|Overall Study||8
3304729|NCT02981342|4038292|FG000|STARTED|Overall Study||7
3304730|NCT02981342|4038293|FG001|STARTED|Overall Study||33
3304731|NCT02981342|4038294|FG002|STARTED|Overall Study||33
3304732|NCT02981342|4038295|FG003|STARTED|Overall Study||33
3304733|NCT02981342|4038292|FG000|Received at Least One Dose of Study Drug|Overall Study||7
3304734|NCT02981342|4038293|FG001|Received at Least One Dose of Study Drug|Overall Study||32
3304735|NCT02981342|4038294|FG002|Received at Least One Dose of Study Drug|Overall Study||33
3304736|NCT02981342|4038295|FG003|Received at Least One Dose of Study Drug|Overall Study||26
3304737|NCT02981342|4038292|FG000|COMPLETED|Overall Study||7
3304738|NCT02981342|4038293|FG001|COMPLETED|Overall Study||22
3304739|NCT02981342|4038294|FG002|COMPLETED|Overall Study||20
3304740|NCT02981342|4038295|FG003|COMPLETED|Overall Study||19
3304741|NCT02981342|4038292|FG000|NOT COMPLETED|Overall Study||0
2984342|NCT00870740|3700539|FG001|NOT COMPLETED|Overall Study||9
2984343|NCT00870740|3700540|FG002|NOT COMPLETED|Overall Study||10
2984344|NCT00870740|3700541|FG003|NOT COMPLETED|Overall Study||12
2984345|NCT00870740|3700542|FG004|NOT COMPLETED|Overall Study||11
2984346|NCT00870740|3700543|FG005|NOT COMPLETED|Overall Study||17
2984347|NCT00870870|3700572|FG000|STARTED|Overall Study||4
2984348|NCT00870870|3700573|FG001|STARTED|Overall Study||6
2984349|NCT00870870|3700574|FG002|STARTED|Overall Study||29
2984350|NCT00870870|3700575|FG003|STARTED|Overall Study||25
2984351|NCT00870870|3700572|FG000|COMPLETED|Overall Study||4
2984352|NCT00870870|3700573|FG001|COMPLETED|Overall Study||5
2984353|NCT00870870|3700574|FG002|COMPLETED|Overall Study||26
2984354|NCT00870870|3700575|FG003|COMPLETED|Overall Study||20
2984355|NCT00870870|3700572|FG000|NOT COMPLETED|Overall Study||0
2984356|NCT00870870|3700573|FG001|NOT COMPLETED|Overall Study||1
2984357|NCT00870870|3700574|FG002|NOT COMPLETED|Overall Study||3
2984358|NCT00870870|3700575|FG003|NOT COMPLETED|Overall Study||5
2984359|NCT00870896|3700590|FG000|STARTED|Overall Study||5
2984360|NCT00870896|3700590|FG000|COMPLETED|Overall Study||5
2984361|NCT00870896|3700590|FG000|NOT COMPLETED|Overall Study||0
2984362|NCT00871000|3700598|FG000|STARTED|Overall Study||151
2984363|NCT00871000|3700599|FG001|STARTED|Overall Study||152
2984364|NCT00871000|3700598|FG000|COMPLETED|Overall Study||150
2984365|NCT00871000|3700599|FG001|COMPLETED|Overall Study||152
2984366|NCT00871000|3700598|FG000|NOT COMPLETED|Overall Study||1
2984367|NCT00871000|3700599|FG001|NOT COMPLETED|Overall Study||0
2984368|NCT00871117|3700607|FG000|STARTED|Overall Study||239
2984369|NCT00871117|3700608|FG001|STARTED|Overall Study||237
2984370|NCT00871117|3700607|FG000|COMPLETED|Overall Study||234
2984371|NCT00871117|3700608|FG001|COMPLETED|Overall Study||227
2984372|NCT00871117|3700607|FG000|NOT COMPLETED|Overall Study||5
2984373|NCT00871117|3700608|FG001|NOT COMPLETED|Overall Study||10
2984374|NCT00871143|3700617|FG000|STARTED|Overall Study||21
3133477|NCT01696058|3858451|FG001|NOT COMPLETED|Overall Study||31
3133478|NCT01696071|3858457|FG000|STARTED|Treatment Period 1: 4 Weeks||51
2984375|NCT00871143|3700618|FG001|STARTED|Overall Study||25
2984376|NCT00871143|3700617|FG000|COMPLETED|Overall Study||21
2984377|NCT00871143|3700618|FG001|COMPLETED|Overall Study||25
2984378|NCT00871143|3700617|FG000|NOT COMPLETED|Overall Study||0
2984379|NCT00871143|3700618|FG001|NOT COMPLETED|Overall Study||0
2984380|NCT00871169|3700624|FG000|STARTED|Overall Study||61
2984381|NCT00871169|3700624|FG000|COMPLETED|Overall Study||58
2984382|NCT00871169|3700624|FG000|NOT COMPLETED|Overall Study||3
2984383|NCT00871234|3700628|FG000|STARTED|Overall Study||28
2984384|NCT00871234|3700628|FG000|COMPLETED|Overall Study||23
2984385|NCT00871234|3700628|FG000|NOT COMPLETED|Overall Study||5
2984386|NCT00871260|3700632|FG000|STARTED|Overall Study||20
2984387|NCT00871260|3700632|FG000|COMPLETED|Overall Study||20
2984388|NCT00871260|3700632|FG000|NOT COMPLETED|Overall Study||0
2984389|NCT00871286|3700638|FG000|STARTED|Overall Study||20
2984390|NCT00871286|3700639|FG001|STARTED|Overall Study||20
2984391|NCT00871286|3700638|FG000|COMPLETED|Overall Study||20
2984392|NCT00871286|3700639|FG001|COMPLETED|Overall Study||14
2984393|NCT00871286|3700638|FG000|NOT COMPLETED|Overall Study||0
2984394|NCT00871286|3700639|FG001|NOT COMPLETED|Overall Study||6
2984395|NCT00871338|3700647|FG000|STARTED|Prior to Booster||142
2984396|NCT00871338|3700648|FG001|STARTED|Prior to Booster||142
2984397|NCT00871338|3700647|FG000|COMPLETED|Prior to Booster||140
2984398|NCT00871338|3700648|FG001|COMPLETED|Prior to Booster||139
2984399|NCT00871338|3700647|FG000|NOT COMPLETED|Prior to Booster||2
2984400|NCT00871338|3700648|FG001|NOT COMPLETED|Prior to Booster||3
2984401|NCT00871338|3700647|FG000|STARTED|After Booster||139
2984402|NCT00871338|3700648|FG001|STARTED|After Booster||135
2984403|NCT00871338|3700647|FG000|COMPLETED|After Booster||139
2984404|NCT00871338|3700648|FG001|COMPLETED|After Booster||135
2984405|NCT00871338|3700647|FG000|NOT COMPLETED|After Booster||0
2984406|NCT00871338|3700648|FG001|NOT COMPLETED|After Booster||0
2984407|NCT00871377|3700654|FG000|STARTED|First Intervention (10 Weeks)||3
2984408|NCT00871377|3700655|FG001|STARTED|First Intervention (10 Weeks)||4
2984409|NCT00871377|3700656|FG002|STARTED|First Intervention (10 Weeks)||4
2984410|NCT00871377|3700657|FG003|STARTED|First Intervention (10 Weeks)||4
2984411|NCT00871377|3700658|FG004|STARTED|First Intervention (10 Weeks)||4
2984412|NCT00871377|3700659|FG005|STARTED|First Intervention (10 Weeks)||5
2984413|NCT00871377|3700654|FG000|COMPLETED|First Intervention (10 Weeks)||3
2984414|NCT00871377|3700655|FG001|COMPLETED|First Intervention (10 Weeks)||4
2984415|NCT00871377|3700656|FG002|COMPLETED|First Intervention (10 Weeks)||3
2984416|NCT00871377|3700657|FG003|COMPLETED|First Intervention (10 Weeks)||4
2984417|NCT00871377|3700658|FG004|COMPLETED|First Intervention (10 Weeks)||4
2984418|NCT00871377|3700659|FG005|COMPLETED|First Intervention (10 Weeks)||4
2984419|NCT00871377|3700654|FG000|NOT COMPLETED|First Intervention (10 Weeks)||0
2984420|NCT00871377|3700655|FG001|NOT COMPLETED|First Intervention (10 Weeks)||0
2984421|NCT00871377|3700656|FG002|NOT COMPLETED|First Intervention (10 Weeks)||1
2984422|NCT00871377|3700657|FG003|NOT COMPLETED|First Intervention (10 Weeks)||0
2984423|NCT00871377|3700658|FG004|NOT COMPLETED|First Intervention (10 Weeks)||0
2984424|NCT00871377|3700659|FG005|NOT COMPLETED|First Intervention (10 Weeks)||1
2984425|NCT00871377|3700654|FG000|STARTED|Washout (6 Weeks)||3
2984426|NCT00871377|3700655|FG001|STARTED|Washout (6 Weeks)||4
2984427|NCT00871377|3700656|FG002|STARTED|Washout (6 Weeks)||3
2984428|NCT00871377|3700657|FG003|STARTED|Washout (6 Weeks)||4
2984429|NCT00871377|3700658|FG004|STARTED|Washout (6 Weeks)||4
2984430|NCT00871377|3700659|FG005|STARTED|Washout (6 Weeks)||4
2984431|NCT00871377|3700654|FG000|COMPLETED|Washout (6 Weeks)||2
2984432|NCT00871377|3700655|FG001|COMPLETED|Washout (6 Weeks)||4
2984433|NCT00871377|3700656|FG002|COMPLETED|Washout (6 Weeks)||3
2984434|NCT00871377|3700657|FG003|COMPLETED|Washout (6 Weeks)||4
2984435|NCT00871377|3700658|FG004|COMPLETED|Washout (6 Weeks)||4
2984436|NCT00871377|3700659|FG005|COMPLETED|Washout (6 Weeks)||4
2984437|NCT00871377|3700654|FG000|NOT COMPLETED|Washout (6 Weeks)||1
2984438|NCT00871377|3700655|FG001|NOT COMPLETED|Washout (6 Weeks)||0
2984439|NCT00871377|3700656|FG002|NOT COMPLETED|Washout (6 Weeks)||0
2984440|NCT00871377|3700657|FG003|NOT COMPLETED|Washout (6 Weeks)||0
2984441|NCT00871377|3700658|FG004|NOT COMPLETED|Washout (6 Weeks)||0
2984442|NCT00871377|3700659|FG005|NOT COMPLETED|Washout (6 Weeks)||0
2984443|NCT00871377|3700654|FG000|STARTED|Second Intervention (10 Weeks)||2
2984444|NCT00871377|3700655|FG001|STARTED|Second Intervention (10 Weeks)||4
2984445|NCT00871377|3700656|FG002|STARTED|Second Intervention (10 Weeks)||3
2984446|NCT00871377|3700657|FG003|STARTED|Second Intervention (10 Weeks)||4
2984447|NCT00871377|3700658|FG004|STARTED|Second Intervention (10 Weeks)||4
2984448|NCT00871377|3700659|FG005|STARTED|Second Intervention (10 Weeks)||4
2984449|NCT00871377|3700654|FG000|COMPLETED|Second Intervention (10 Weeks)||2
2984450|NCT00871377|3700655|FG001|COMPLETED|Second Intervention (10 Weeks)||4
2984451|NCT00871377|3700656|FG002|COMPLETED|Second Intervention (10 Weeks)||3
2984452|NCT00871377|3700657|FG003|COMPLETED|Second Intervention (10 Weeks)||4
2984453|NCT00871377|3700658|FG004|COMPLETED|Second Intervention (10 Weeks)||4
2984454|NCT00871377|3700659|FG005|COMPLETED|Second Intervention (10 Weeks)||4
2984455|NCT00871377|3700654|FG000|NOT COMPLETED|Second Intervention (10 Weeks)||0
2984456|NCT00871377|3700655|FG001|NOT COMPLETED|Second Intervention (10 Weeks)||0
2984457|NCT00871377|3700656|FG002|NOT COMPLETED|Second Intervention (10 Weeks)||0
2984458|NCT00871377|3700657|FG003|NOT COMPLETED|Second Intervention (10 Weeks)||0
2984459|NCT00871377|3700658|FG004|NOT COMPLETED|Second Intervention (10 Weeks)||0
2984460|NCT00871377|3700659|FG005|NOT COMPLETED|Second Intervention (10 Weeks)||0
2984461|NCT00871377|3700654|FG000|STARTED|Washout (6 Weeks)||2
2984462|NCT00871377|3700655|FG001|STARTED|Washout (6 Weeks)||4
2984463|NCT00871377|3700656|FG002|STARTED|Washout (6 Weeks)||3
2984464|NCT00871377|3700657|FG003|STARTED|Washout (6 Weeks)||4
2984465|NCT00871377|3700658|FG004|STARTED|Washout (6 Weeks)||4
2984466|NCT00871377|3700659|FG005|STARTED|Washout (6 Weeks)||4
2984467|NCT00871377|3700654|FG000|COMPLETED|Washout (6 Weeks)||2
2984468|NCT00871377|3700655|FG001|COMPLETED|Washout (6 Weeks)||4
2984469|NCT00871377|3700656|FG002|COMPLETED|Washout (6 Weeks)||3
2984470|NCT00871377|3700657|FG003|COMPLETED|Washout (6 Weeks)||4
2984471|NCT00871377|3700658|FG004|COMPLETED|Washout (6 Weeks)||4
2984472|NCT00871377|3700659|FG005|COMPLETED|Washout (6 Weeks)||3
2984473|NCT00871377|3700654|FG000|NOT COMPLETED|Washout (6 Weeks)||0
2984474|NCT00871377|3700655|FG001|NOT COMPLETED|Washout (6 Weeks)||0
2984475|NCT00871377|3700656|FG002|NOT COMPLETED|Washout (6 Weeks)||0
2984476|NCT00871377|3700657|FG003|NOT COMPLETED|Washout (6 Weeks)||0
2984477|NCT00871377|3700658|FG004|NOT COMPLETED|Washout (6 Weeks)||0
2984478|NCT00871377|3700659|FG005|NOT COMPLETED|Washout (6 Weeks)||1
2984479|NCT00871377|3700654|FG000|STARTED|Third Intervention (10 Weeks)||2
2984480|NCT00871377|3700655|FG001|STARTED|Third Intervention (10 Weeks)||4
2984481|NCT00871377|3700656|FG002|STARTED|Third Intervention (10 Weeks)||3
2984482|NCT00871377|3700657|FG003|STARTED|Third Intervention (10 Weeks)||4
2984483|NCT00871377|3700658|FG004|STARTED|Third Intervention (10 Weeks)||4
2984484|NCT00871377|3700659|FG005|STARTED|Third Intervention (10 Weeks)||3
2984485|NCT00871377|3700654|FG000|COMPLETED|Third Intervention (10 Weeks)||2
2984486|NCT00871377|3700655|FG001|COMPLETED|Third Intervention (10 Weeks)||4
2984487|NCT00871377|3700656|FG002|COMPLETED|Third Intervention (10 Weeks)||3
2984488|NCT00871377|3700657|FG003|COMPLETED|Third Intervention (10 Weeks)||3
2984489|NCT00871377|3700658|FG004|COMPLETED|Third Intervention (10 Weeks)||4
2984490|NCT00871377|3700659|FG005|COMPLETED|Third Intervention (10 Weeks)||3
2984491|NCT00871377|3700654|FG000|NOT COMPLETED|Third Intervention (10 Weeks)||0
2984492|NCT00871377|3700655|FG001|NOT COMPLETED|Third Intervention (10 Weeks)||0
2984493|NCT00871377|3700656|FG002|NOT COMPLETED|Third Intervention (10 Weeks)||0
2984494|NCT00871377|3700657|FG003|NOT COMPLETED|Third Intervention (10 Weeks)||1
2984495|NCT00871377|3700658|FG004|NOT COMPLETED|Third Intervention (10 Weeks)||0
2984496|NCT00871377|3700659|FG005|NOT COMPLETED|Third Intervention (10 Weeks)||0
2984497|NCT00871403|3700670|FG000|STARTED|Combination Treatment Phase||9
2984498|NCT00871403|3700671|FG001|STARTED|Combination Treatment Phase||62
2984499|NCT00871403|3700672|FG002|STARTED|Combination Treatment Phase||35
2984500|NCT00871403|3700670|FG000|COMPLETED|Combination Treatment Phase|No particiapants completed Combination Treatement.|0
2984501|NCT00871403|3700671|FG001|COMPLETED|Combination Treatment Phase|These participants completed combination treatment|13
2984502|NCT00871403|3700672|FG002|COMPLETED|Combination Treatment Phase|These participants completed combination treatment|23
2984503|NCT00871403|3700670|FG000|NOT COMPLETED|Combination Treatment Phase||9
2984504|NCT00871403|3700671|FG001|NOT COMPLETED|Combination Treatment Phase||49
2984505|NCT00871403|3700672|FG002|NOT COMPLETED|Combination Treatment Phase||12
2984506|NCT00871403|3700670|FG000|STARTED|Monotherapy Treatment Phase||0
2984507|NCT00871403|3700671|FG001|STARTED|Monotherapy Treatment Phase||13
2984508|NCT00871403|3700672|FG002|STARTED|Monotherapy Treatment Phase||1
2984509|NCT00871403|3700670|FG000|COMPLETED|Monotherapy Treatment Phase||0
2984510|NCT00871403|3700671|FG001|COMPLETED|Monotherapy Treatment Phase||0
2984511|NCT00871403|3700672|FG002|COMPLETED|Monotherapy Treatment Phase||0
2984512|NCT00871403|3700670|FG000|NOT COMPLETED|Monotherapy Treatment Phase||0
2984513|NCT00871403|3700671|FG001|NOT COMPLETED|Monotherapy Treatment Phase||13
2984514|NCT00871403|3700672|FG002|NOT COMPLETED|Monotherapy Treatment Phase||1
2984515|NCT00871429|3700679|FG000|STARTED|Overall Study||99
2984516|NCT00871429|3700679|FG000|COMPLETED|Overall Study||75
2984517|NCT00871429|3700679|FG000|NOT COMPLETED|Overall Study||24
2984518|NCT00871494|3700687|FG000|STARTED|Overall Study||76
2984519|NCT00871494|3700687|FG000|COMPLETED|Overall Study||62
2984520|NCT00871494|3700687|FG000|NOT COMPLETED|Overall Study||14
2984521|NCT00871572|3700695|FG000|STARTED|Overall Study||10
2984522|NCT00871572|3700696|FG001|STARTED|Overall Study||17
2984523|NCT00871572|3700697|FG002|STARTED|Overall Study||34
2984524|NCT00871572|3700698|FG003|STARTED|Overall Study||26
2984525|NCT00871572|3700695|FG000|≥1 Post Baseline Value by Assigned Group|Overall Study||9
2984526|NCT00871572|3700696|FG001|≥1 Post Baseline Value by Assigned Group|Overall Study||17
2984527|NCT00871572|3700697|FG002|≥1 Post Baseline Value by Assigned Group|Overall Study||34
2984528|NCT00871572|3700698|FG003|≥1 Post Baseline Value by Assigned Group|Overall Study||25
2984529|NCT00871572|3700695|FG000|Received at Least 1 Dose of Study Drug|Overall Study||9
2984530|NCT00871572|3700696|FG001|Received at Least 1 Dose of Study Drug|Overall Study||17
2984531|NCT00871572|3700697|FG002|Received at Least 1 Dose of Study Drug|Overall Study||34
2984532|NCT00871572|3700698|FG003|Received at Least 1 Dose of Study Drug|Overall Study||25
2984533|NCT00871572|3700695|FG000|COMPLETED|Overall Study||8
2984534|NCT00871572|3700696|FG001|COMPLETED|Overall Study||11
2984535|NCT00871572|3700697|FG002|COMPLETED|Overall Study||30
2984536|NCT00871572|3700698|FG003|COMPLETED|Overall Study||19
2984537|NCT00871572|3700695|FG000|NOT COMPLETED|Overall Study||2
2984538|NCT00871572|3700696|FG001|NOT COMPLETED|Overall Study||6
2984539|NCT00871572|3700697|FG002|NOT COMPLETED|Overall Study||4
2984540|NCT00871572|3700698|FG003|NOT COMPLETED|Overall Study||7
2984541|NCT00871624|3700710|FG000|STARTED|Overall Study||18
2984542|NCT00871624|3700711|FG001|STARTED|Overall Study||18
2984543|NCT00871624|3700710|FG000|COMPLETED|Overall Study||16
2984544|NCT00871624|3700711|FG001|COMPLETED|Overall Study||17
2984545|NCT00871624|3700710|FG000|NOT COMPLETED|Overall Study||2
2984546|NCT00871624|3700711|FG001|NOT COMPLETED|Overall Study||1
3036356|NCT01143051|3755545|FG004|STARTED|3-14 Day Washout||4
3036357|NCT01143051|3755546|FG005|STARTED|3-14 Day Washout||4
3036358|NCT01143051|3755541|FG000|COMPLETED|3-14 Day Washout||4
3036359|NCT01143051|3755542|FG001|COMPLETED|3-14 Day Washout||4
3036360|NCT01143051|3755543|FG002|COMPLETED|3-14 Day Washout||3
3036361|NCT01143051|3755544|FG003|COMPLETED|3-14 Day Washout||4
3036362|NCT01143051|3755545|FG004|COMPLETED|3-14 Day Washout||4
3036363|NCT01143051|3755546|FG005|COMPLETED|3-14 Day Washout||3
3036364|NCT01143051|3755541|FG000|NOT COMPLETED|3-14 Day Washout||0
3036365|NCT01143051|3755542|FG001|NOT COMPLETED|3-14 Day Washout||0
3036366|NCT01143051|3755543|FG002|NOT COMPLETED|3-14 Day Washout||0
3036367|NCT01143051|3755544|FG003|NOT COMPLETED|3-14 Day Washout||0
3036368|NCT01143051|3755545|FG004|NOT COMPLETED|3-14 Day Washout||0
3133479|NCT01696071|3858458|FG001|STARTED|Treatment Period 1: 4 Weeks||47
3133480|NCT01696071|3858457|FG000|COMPLETED|Treatment Period 1: 4 Weeks||51
3036369|NCT01143051|3755546|FG005|NOT COMPLETED|3-14 Day Washout||1
3036370|NCT01143051|3755541|FG000|STARTED|Visit 3||4
3036371|NCT01143051|3755542|FG001|STARTED|Visit 3||4
3036372|NCT01143051|3755543|FG002|STARTED|Visit 3||3
3036373|NCT01143051|3755544|FG003|STARTED|Visit 3||4
3036374|NCT01143051|3755545|FG004|STARTED|Visit 3||4
3036375|NCT01143051|3755546|FG005|STARTED|Visit 3||3
3036376|NCT01143051|3755541|FG000|COMPLETED|Visit 3||4
3036377|NCT01143051|3755542|FG001|COMPLETED|Visit 3||4
3036378|NCT01143051|3755543|FG002|COMPLETED|Visit 3||3
3036379|NCT01143051|3755544|FG003|COMPLETED|Visit 3||4
3036380|NCT01143051|3755545|FG004|COMPLETED|Visit 3||4
3036381|NCT01143051|3755546|FG005|COMPLETED|Visit 3||3
3036382|NCT01143051|3755541|FG000|NOT COMPLETED|Visit 3||0
3036383|NCT01143051|3755542|FG001|NOT COMPLETED|Visit 3||0
3036384|NCT01143051|3755543|FG002|NOT COMPLETED|Visit 3||0
3036385|NCT01143051|3755544|FG003|NOT COMPLETED|Visit 3||0
3036386|NCT01143051|3755545|FG004|NOT COMPLETED|Visit 3||0
3036387|NCT01143051|3755546|FG005|NOT COMPLETED|Visit 3||0
3036388|NCT01143077|3755559|FG000|STARTED|Overall Study||74
3036389|NCT01143077|3755560|FG001|STARTED|Overall Study||88
3036390|NCT01143077|3755561|FG002|STARTED|Overall Study||82
3036391|NCT01143077|3755559|FG000|COMPLETED|Overall Study||58
3036392|NCT01143077|3755560|FG001|COMPLETED|Overall Study||73
3036393|NCT01143077|3755561|FG002|COMPLETED|Overall Study||67
3036394|NCT01143077|3755559|FG000|NOT COMPLETED|Overall Study||16
3036395|NCT01143077|3755560|FG001|NOT COMPLETED|Overall Study||15
3036396|NCT01143077|3755561|FG002|NOT COMPLETED|Overall Study||15
3036397|NCT01143090|3755569|FG000|STARTED|Overall Study||149
3036398|NCT01143090|3755569|FG000|COMPLETED|Overall Study||98
3036399|NCT01143090|3755569|FG000|NOT COMPLETED|Overall Study||51
3036400|NCT01143142|3755575|FG000|STARTED|Overall Study||36
3036401|NCT01143142|3755576|FG001|STARTED|Overall Study||34
3036402|NCT01143142|3755575|FG000|COMPLETED|Overall Study||36
3036403|NCT01143142|3755576|FG001|COMPLETED|Overall Study||34
3036404|NCT01143142|3755575|FG000|NOT COMPLETED|Overall Study||0
3036405|NCT01143142|3755576|FG001|NOT COMPLETED|Overall Study||0
3036406|NCT01143181|3755586|FG000|STARTED|Overall Study||30
3036407|NCT01143181|3755587|FG001|STARTED|Overall Study||38
3036408|NCT01143181|3755588|FG002|STARTED|Overall Study||102
3133481|NCT01696071|3858458|FG001|COMPLETED|Treatment Period 1: 4 Weeks||47
3133482|NCT01696071|3858457|FG000|NOT COMPLETED|Treatment Period 1: 4 Weeks||0
3133483|NCT01696071|3858458|FG001|NOT COMPLETED|Treatment Period 1: 4 Weeks||0
3133484|NCT01696071|3858457|FG000|STARTED|Treatment Period 2: 4 Weeks||51
3133485|NCT01696071|3858458|FG001|STARTED|Treatment Period 2: 4 Weeks||47
3133486|NCT01696071|3858457|FG000|COMPLETED|Treatment Period 2: 4 Weeks||50
3133487|NCT01696071|3858458|FG001|COMPLETED|Treatment Period 2: 4 Weeks||47
3133488|NCT01696071|3858457|FG000|NOT COMPLETED|Treatment Period 2: 4 Weeks||1
2984547|NCT00871689|3700719|FG000|STARTED|Overall Study||2
2984548|NCT00871689|3700719|FG000|COMPLETED|Overall Study||2
2984549|NCT00871689|3700719|FG000|NOT COMPLETED|Overall Study||0
2984550|NCT00871715|3700726|FG000|STARTED|Overall Study||119
2984551|NCT00871715|3700727|FG001|STARTED|Overall Study||120
2984552|NCT00871715|3700728|FG002|STARTED|Overall Study||122
2984553|NCT00871715|3700726|FG000|Post-Intervention|Overall Study||112
2984554|NCT00871715|3700727|FG001|Post-Intervention|Overall Study||115
2984555|NCT00871715|3700728|FG002|Post-Intervention|Overall Study||115
2984556|NCT00871715|3700726|FG000|6-mo Follow-up|Overall Study||110
2984557|NCT00871715|3700727|FG001|6-mo Follow-up|Overall Study||113
2984558|NCT00871715|3700728|FG002|6-mo Follow-up|Overall Study||112
2984559|NCT00871715|3700726|FG000|COMPLETED|Overall Study|"Completed refers to participants who completed the primary outcome, Wolf Motor Function Test."|104
2984560|NCT00871715|3700727|FG001|COMPLETED|Overall Study|"Completed refers to participants who completed the primary outcome, Wolf Motor Function Test."|104
2984561|NCT00871715|3700728|FG002|COMPLETED|Overall Study|"Completed refers to participants who completed the primary outcome, Wolf Motor Function Test."|96
2984562|NCT00871715|3700726|FG000|NOT COMPLETED|Overall Study||15
2984563|NCT00871715|3700727|FG001|NOT COMPLETED|Overall Study||16
2984564|NCT00871715|3700728|FG002|NOT COMPLETED|Overall Study||26
2984565|NCT00871728|3700737|FG000|STARTED|Overall Study||132
2984566|NCT00871728|3700737|FG000|Treated|Overall Study||130
2984567|NCT00871728|3700737|FG000|COMPLETED|Overall Study||112
2984568|NCT00871728|3700737|FG000|NOT COMPLETED|Overall Study||20
2984569|NCT00871741|3700743|FG000|STARTED|Overall Study||9
2984570|NCT00871741|3700744|FG001|STARTED|Overall Study||7
2984571|NCT00871741|3700743|FG000|COMPLETED|Overall Study||0
2984572|NCT00871741|3700744|FG001|COMPLETED|Overall Study||0
2984573|NCT00871741|3700743|FG000|NOT COMPLETED|Overall Study||9
2984574|NCT00871741|3700744|FG001|NOT COMPLETED|Overall Study||7
2984575|NCT00871780|3700750|FG000|STARTED|Overall Study|number enrolled|224
2984576|NCT00871780|3700750|FG000|Safety Analysis Population|Overall Study|participants who had ≥1 infusion of natalizumab during the study|218
2984577|NCT00871780|3700750|FG000|Efficacy Analysis Population|Overall Study|participants who had ≥1 infusion of natalizumab and completed at least 1 on-treatment evaluation|215
2984578|NCT00871780|3700750|FG000|COMPLETED|Overall Study||197
2984579|NCT00871780|3700750|FG000|NOT COMPLETED|Overall Study||27
2984580|NCT00871819|3700757|FG000|STARTED|Overall Study||20
2984581|NCT00871819|3700757|FG000|COMPLETED|Overall Study||20
2984582|NCT00871819|3700757|FG000|NOT COMPLETED|Overall Study||0
2984583|NCT00871845|3700763|FG000|STARTED|Overall Study||11
2984584|NCT00871845|3700764|FG001|STARTED|Overall Study||25
2984585|NCT00871845|3700763|FG000|COMPLETED|Overall Study||11
2984586|NCT00871845|3700764|FG001|COMPLETED|Overall Study||25
2984587|NCT00871845|3700763|FG000|NOT COMPLETED|Overall Study||0
2984588|NCT00871845|3700764|FG001|NOT COMPLETED|Overall Study||0
2984589|NCT00871858|3700776|FG000|STARTED|Overall Study||61
2984590|NCT00871858|3700777|FG001|STARTED|Overall Study||59
2984591|NCT00871858|3700776|FG000|Evaluable for Safety|Overall Study|1 patient refused to continue study and therefore did not received treatment.|60
2984592|NCT00871858|3700777|FG001|Evaluable for Safety|Overall Study|1 patient refused to continue study after randomization and therefore did not received treatment.|58
2984593|NCT00871858|3700776|FG000|COMPLETED|Overall Study||56
2984594|NCT00871858|3700777|FG001|COMPLETED|Overall Study||52
2984595|NCT00871858|3700776|FG000|NOT COMPLETED|Overall Study||5
2984596|NCT00871858|3700777|FG001|NOT COMPLETED|Overall Study||7
2984597|NCT00871871|3700785|FG000|STARTED|Part I||18
2984598|NCT00871871|3700786|FG001|STARTED|Part I||18
2984599|NCT00871871|3700787|FG002|STARTED|Part I||0
2984600|NCT00871871|3700788|FG003|STARTED|Part I||0
2984601|NCT00871871|3700785|FG000|COMPLETED|Part I||15
2984602|NCT00871871|3700786|FG001|COMPLETED|Part I||15
2984603|NCT00871871|3700787|FG002|COMPLETED|Part I||0
2984604|NCT00871871|3700788|FG003|COMPLETED|Part I||0
2984605|NCT00871871|3700785|FG000|NOT COMPLETED|Part I||3
2984606|NCT00871871|3700786|FG001|NOT COMPLETED|Part I||3
2984607|NCT00871871|3700787|FG002|NOT COMPLETED|Part I||0
2984608|NCT00871871|3700788|FG003|NOT COMPLETED|Part I||0
2984609|NCT00871871|3700785|FG000|STARTED|Part II||0
2984610|NCT00871871|3700786|FG001|STARTED|Part II||0
2984611|NCT00871871|3700787|FG002|STARTED|Part II||13
2984612|NCT00871871|3700788|FG003|STARTED|Part II||15
2984613|NCT00871871|3700785|FG000|COMPLETED|Part II||0
2984614|NCT00871871|3700786|FG001|COMPLETED|Part II||0
2984615|NCT00871871|3700787|FG002|COMPLETED|Part II||9
3133489|NCT01696071|3858458|FG001|NOT COMPLETED|Treatment Period 2: 4 Weeks||0
3133490|NCT01696084|3858467|FG000|STARTED|Overall Study||153
3133491|NCT01696084|3858468|FG001|STARTED|Overall Study||156
2984616|NCT00871871|3700788|FG003|COMPLETED|Part II||11
2984617|NCT00871871|3700785|FG000|NOT COMPLETED|Part II||0
2984618|NCT00871871|3700786|FG001|NOT COMPLETED|Part II||0
2984619|NCT00871871|3700787|FG002|NOT COMPLETED|Part II||4
2984620|NCT00871871|3700788|FG003|NOT COMPLETED|Part II||4
3133492|NCT01696084|3858467|FG000|COMPLETED|Overall Study||22
2984621|NCT00871923|3700798|FG000|STARTED|Overall Study||44
2984622|NCT00871923|3700798|FG000|COMPLETED|Overall Study||42
2984623|NCT00871923|3700798|FG000|NOT COMPLETED|Overall Study||2
2984624|NCT00871975|3700802|FG000|STARTED|Overall Study||155
3164365|NCT01892189|3891779|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0
3164366|NCT01892189|3891780|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||2
3164367|NCT01892189|3891781|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||1
3164368|NCT01892189|3891782|FG004|NOT COMPLETED|Washout Period 1 (7 Days)||0
3164369|NCT01892189|3891783|FG005|NOT COMPLETED|Washout Period 1 (7 Days)||1
3164370|NCT01892189|3891784|FG006|NOT COMPLETED|Washout Period 1 (7 Days)||1
3164371|NCT01892189|3891785|FG007|NOT COMPLETED|Washout Period 1 (7 Days)||0
3164372|NCT01892189|3891786|FG008|NOT COMPLETED|Washout Period 1 (7 Days)||2
2984625|NCT00871975|3700802|FG000|COMPLETED|Overall Study||133
2984626|NCT00871975|3700802|FG000|NOT COMPLETED|Overall Study||22
2984627|NCT00872001|3700808|FG000|STARTED|Overall Study||1536
2984628|NCT00872001|3700809|FG001|STARTED|Overall Study||1544
2984629|NCT00872001|3700808|FG000|COMPLETED|Overall Study||1400
2984630|NCT00872001|3700809|FG001|COMPLETED|Overall Study||1413
2984631|NCT00872001|3700808|FG000|NOT COMPLETED|Overall Study||136
2984632|NCT00872001|3700809|FG001|NOT COMPLETED|Overall Study||131
2984633|NCT00872027|3700819|FG000|STARTED|Overall Study||7
2984634|NCT00872027|3700820|FG001|STARTED|Overall Study||8
2984635|NCT00872027|3700819|FG000|COMPLETED|Overall Study||7
2984636|NCT00872027|3700820|FG001|COMPLETED|Overall Study||8
2984637|NCT00872027|3700819|FG000|NOT COMPLETED|Overall Study||0
2984638|NCT00872027|3700820|FG001|NOT COMPLETED|Overall Study||0
2984639|NCT00872079|3700826|FG000|STARTED|Overall Study||175
2984640|NCT00872079|3700826|FG000|COMPLETED|Overall Study||175
2984641|NCT00872079|3700826|FG000|NOT COMPLETED|Overall Study||0
2984642|NCT00872170|3700832|FG000|STARTED|Overall Study||14
2984643|NCT00872170|3700833|FG001|STARTED|Overall Study||13
2984644|NCT00872170|3700832|FG000|COMPLETED|Overall Study|One patient withdrew from study at week 2.|13
2984645|NCT00872170|3700833|FG001|COMPLETED|Overall Study||13
2984646|NCT00872170|3700832|FG000|NOT COMPLETED|Overall Study||1
2984647|NCT00872170|3700833|FG001|NOT COMPLETED|Overall Study||0
2984648|NCT00872339|3700841|FG000|STARTED|Overall Study||201
2984649|NCT00872339|3700842|FG001|STARTED|Overall Study||14
2984650|NCT00872339|3700843|FG002|STARTED|Overall Study||37
2984651|NCT00872339|3700841|FG000|COMPLETED|Overall Study||201
2984652|NCT00872339|3700842|FG001|COMPLETED|Overall Study||14
2984653|NCT00872339|3700843|FG002|COMPLETED|Overall Study||37
2984654|NCT00872339|3700841|FG000|NOT COMPLETED|Overall Study||0
2984655|NCT00872339|3700842|FG001|NOT COMPLETED|Overall Study||0
2984656|NCT00872339|3700843|FG002|NOT COMPLETED|Overall Study||0
2984657|NCT00872521|3700854|FG000|STARTED|Completed PAD Induction|Received allocated treatment|26
2984658|NCT00872521|3700855|FG001|STARTED|Completed PAD Induction|Received allocated treatment|72
2984659|NCT00872521|3700856|FG002|STARTED|Completed PAD Induction|Received allocated treatment|9
2984660|NCT00872521|3700854|FG000|COMPLETED|Completed PAD Induction|Completed PAD induction|21
2984661|NCT00872521|3700855|FG001|COMPLETED|Completed PAD Induction|Completed PAD induction|68
2984662|NCT00872521|3700856|FG002|COMPLETED|Completed PAD Induction|Completed PAD induction|9
2984663|NCT00872521|3700854|FG000|NOT COMPLETED|Completed PAD Induction||5
2984664|NCT00872521|3700855|FG001|NOT COMPLETED|Completed PAD Induction||4
2984665|NCT00872521|3700856|FG002|NOT COMPLETED|Completed PAD Induction||0
2984666|NCT00872521|3700854|FG000|STARTED|Primary Endpoint Analysis|Completed PAD induction|21
2984667|NCT00872521|3700855|FG001|STARTED|Primary Endpoint Analysis|Completed PAD induction|68
2984668|NCT00872521|3700856|FG002|STARTED|Primary Endpoint Analysis|Completed PAD induction|9
2984669|NCT00872521|3700854|FG000|COMPLETED|Primary Endpoint Analysis|participants analyzed|20
2984670|NCT00872521|3700855|FG001|COMPLETED|Primary Endpoint Analysis|participants analyzed|63
2984671|NCT00872521|3700856|FG002|COMPLETED|Primary Endpoint Analysis|participants analyzed|8
2984672|NCT00872521|3700854|FG000|NOT COMPLETED|Primary Endpoint Analysis||1
2984673|NCT00872521|3700855|FG001|NOT COMPLETED|Primary Endpoint Analysis||5
2984674|NCT00872521|3700856|FG002|NOT COMPLETED|Primary Endpoint Analysis||1
2984675|NCT00872521|3700854|FG000|STARTED|Completed 3-month Follow up|Participants analyzed for primary endpoint|20
2984676|NCT00872521|3700855|FG001|STARTED|Completed 3-month Follow up|Participants analyzed for primary endpoint|63
2984677|NCT00872521|3700856|FG002|STARTED|Completed 3-month Follow up|Participants analyzed for primary endpoint|8
2984678|NCT00872521|3700854|FG000|COMPLETED|Completed 3-month Follow up|Completed 3-month follow-up|20
2984679|NCT00872521|3700855|FG001|COMPLETED|Completed 3-month Follow up|Completed 3-month follow-up|60
2984680|NCT00872521|3700856|FG002|COMPLETED|Completed 3-month Follow up|Completed 3-month follow-up|8
2984681|NCT00872521|3700854|FG000|NOT COMPLETED|Completed 3-month Follow up||0
2984682|NCT00872521|3700855|FG001|NOT COMPLETED|Completed 3-month Follow up||3
2984683|NCT00872521|3700856|FG002|NOT COMPLETED|Completed 3-month Follow up||0
2984684|NCT00872521|3700854|FG000|STARTED|Secondary Endpoint Analysis|Completed 3-month follow-up|20
2984685|NCT00872521|3700855|FG001|STARTED|Secondary Endpoint Analysis|Completed 3-month follow-up|60
2984686|NCT00872521|3700856|FG002|STARTED|Secondary Endpoint Analysis|Completed 3-month follow-up|8
2984687|NCT00872521|3700854|FG000|COMPLETED|Secondary Endpoint Analysis|Participants analyzed for secondary endpoint|20
2984688|NCT00872521|3700855|FG001|COMPLETED|Secondary Endpoint Analysis|Participants analyzed for secondary endpoint|58
2984689|NCT00872521|3700856|FG002|COMPLETED|Secondary Endpoint Analysis|Participants analyzed for secondary endpoint|7
2984690|NCT00872521|3700854|FG000|NOT COMPLETED|Secondary Endpoint Analysis||0
2984691|NCT00872521|3700855|FG001|NOT COMPLETED|Secondary Endpoint Analysis||2
2984692|NCT00872521|3700856|FG002|NOT COMPLETED|Secondary Endpoint Analysis||1
2984693|NCT00872534|3700877|FG000|STARTED|Overall Study||100
2984694|NCT00872534|3700878|FG001|STARTED|Overall Study||104
2984695|NCT00872534|3700877|FG000|COMPLETED|Overall Study||97
2984696|NCT00872534|3700878|FG001|COMPLETED|Overall Study||101
2984697|NCT00872534|3700877|FG000|NOT COMPLETED|Overall Study||3
2984698|NCT00872534|3700878|FG001|NOT COMPLETED|Overall Study||3
2984699|NCT00872599|3700884|FG000|STARTED|First Washout Period After Low Salt||16
2984700|NCT00872599|3700885|FG001|STARTED|First Washout Period After Low Salt||17
2984701|NCT00872599|3700884|FG000|COMPLETED|First Washout Period After Low Salt||16
2984702|NCT00872599|3700885|FG001|COMPLETED|First Washout Period After Low Salt||17
2984703|NCT00872599|3700884|FG000|NOT COMPLETED|First Washout Period After Low Salt||0
2984704|NCT00872599|3700885|FG001|NOT COMPLETED|First Washout Period After Low Salt||0
2984705|NCT00872599|3700884|FG000|STARTED|First Drug During High Salt Intake||16
2984706|NCT00872599|3700885|FG001|STARTED|First Drug During High Salt Intake||17
2984707|NCT00872599|3700884|FG000|COMPLETED|First Drug During High Salt Intake||16
2984708|NCT00872599|3700885|FG001|COMPLETED|First Drug During High Salt Intake||17
2984709|NCT00872599|3700884|FG000|NOT COMPLETED|First Drug During High Salt Intake||0
2984710|NCT00872599|3700885|FG001|NOT COMPLETED|First Drug During High Salt Intake||0
2984711|NCT00872599|3700884|FG000|STARTED|Second Washout Period||16
2984712|NCT00872599|3700885|FG001|STARTED|Second Washout Period||17
2984713|NCT00872599|3700884|FG000|COMPLETED|Second Washout Period||15
2984714|NCT00872599|3700885|FG001|COMPLETED|Second Washout Period||16
2984715|NCT00872599|3700884|FG000|NOT COMPLETED|Second Washout Period||1
2984716|NCT00872599|3700885|FG001|NOT COMPLETED|Second Washout Period||1
2984717|NCT00872599|3700884|FG000|STARTED|Second Drug During High Salt Intake||15
2984718|NCT00872599|3700885|FG001|STARTED|Second Drug During High Salt Intake||16
2984719|NCT00872599|3700884|FG000|COMPLETED|Second Drug During High Salt Intake||15
2984720|NCT00872599|3700885|FG001|COMPLETED|Second Drug During High Salt Intake||16
2984721|NCT00872599|3700884|FG000|NOT COMPLETED|Second Drug During High Salt Intake||0
2984722|NCT00872599|3700885|FG001|NOT COMPLETED|Second Drug During High Salt Intake||0
2984723|NCT00872729|3700891|FG000|STARTED|Overall Study||9
2984724|NCT00872729|3700891|FG000|COMPLETED|Overall Study||9
2984725|NCT00872729|3700891|FG000|NOT COMPLETED|Overall Study||0
2984726|NCT00872833|3700917|FG000|STARTED|Overall Study||15
2984727|NCT00872833|3700918|FG001|STARTED|Overall Study||17
2984728|NCT00872833|3700917|FG000|COMPLETED|Overall Study||15
2984729|NCT00872833|3700918|FG001|COMPLETED|Overall Study||17
2984730|NCT00872833|3700917|FG000|NOT COMPLETED|Overall Study||0
2984731|NCT00872833|3700918|FG001|NOT COMPLETED|Overall Study||0
2984732|NCT00872898|3700930|FG000|STARTED|Part One - Open Label, Pharmacokinetics||0
2984733|NCT00872898|3700931|FG001|STARTED|Part One - Open Label, Pharmacokinetics||4
2984734|NCT00872898|3700930|FG000|COMPLETED|Part One - Open Label, Pharmacokinetics||0
2984735|NCT00872898|3700931|FG001|COMPLETED|Part One - Open Label, Pharmacokinetics||4
2984736|NCT00872898|3700930|FG000|NOT COMPLETED|Part One - Open Label, Pharmacokinetics||0
2984737|NCT00872898|3700931|FG001|NOT COMPLETED|Part One - Open Label, Pharmacokinetics||0
2984738|NCT00872898|3700930|FG000|STARTED|Part Two - Double Blind||61
2984739|NCT00872898|3700931|FG001|STARTED|Part Two - Double Blind||60
2984740|NCT00872898|3700930|FG000|COMPLETED|Part Two - Double Blind||50
2984741|NCT00872898|3700931|FG001|COMPLETED|Part Two - Double Blind||54
2984742|NCT00872898|3700930|FG000|NOT COMPLETED|Part Two - Double Blind||11
2984743|NCT00872898|3700931|FG001|NOT COMPLETED|Part Two - Double Blind||6
2984744|NCT00872989|3700942|FG000|STARTED|Overall Study||66
2984745|NCT00872989|3700943|FG001|STARTED|Overall Study||63
2984746|NCT00872989|3700942|FG000|COMPLETED|Overall Study||1
2984747|NCT00872989|3700943|FG001|COMPLETED|Overall Study||0
2984748|NCT00872989|3700942|FG000|NOT COMPLETED|Overall Study||65
2984749|NCT00872989|3700943|FG001|NOT COMPLETED|Overall Study||63
2984750|NCT00873015|3700959|FG000|STARTED|Overall Study||9
2984751|NCT00873015|3700960|FG001|STARTED|Overall Study||4
2984752|NCT00873015|3700961|FG002|STARTED|Overall Study||3
2984753|NCT00873015|3700962|FG003|STARTED|Overall Study||3
2984754|NCT00873015|3700959|FG000|COMPLETED|Overall Study||9
2984755|NCT00873015|3700960|FG001|COMPLETED|Overall Study||3
2984756|NCT00873015|3700961|FG002|COMPLETED|Overall Study||3
2984757|NCT00873015|3700962|FG003|COMPLETED|Overall Study||3
2984758|NCT00873015|3700959|FG000|NOT COMPLETED|Overall Study||0
2984759|NCT00873015|3700960|FG001|NOT COMPLETED|Overall Study||1
2984760|NCT00873015|3700961|FG002|NOT COMPLETED|Overall Study||0
2984761|NCT00873015|3700962|FG003|NOT COMPLETED|Overall Study||0
2984762|NCT00873041|3700974|FG000|STARTED|Core Study||55
2984763|NCT00873041|3700975|FG001|STARTED|Core Study||55
2984764|NCT00873041|3700976|FG002|STARTED|Core Study||56
2984765|NCT00873041|3700974|FG000|COMPLETED|Core Study||48
2984766|NCT00873041|3700975|FG001|COMPLETED|Core Study||49
2984767|NCT00873041|3700976|FG002|COMPLETED|Core Study||51
2984768|NCT00873041|3700974|FG000|NOT COMPLETED|Core Study||7
2984769|NCT00873041|3700975|FG001|NOT COMPLETED|Core Study||6
2984770|NCT00873041|3700976|FG002|NOT COMPLETED|Core Study||5
2984771|NCT00873041|3700974|FG000|STARTED|Extension Study||41
2984772|NCT00873041|3700975|FG001|STARTED|Extension Study||44
2984773|NCT00873041|3700976|FG002|STARTED|Extension Study||48
2984774|NCT00873041|3700974|FG000|COMPLETED|Extension Study||40
2984775|NCT00873041|3700975|FG001|COMPLETED|Extension Study||44
2984776|NCT00873041|3700976|FG002|COMPLETED|Extension Study||46
2984777|NCT00873041|3700974|FG000|NOT COMPLETED|Extension Study||1
2984778|NCT00873041|3700975|FG001|NOT COMPLETED|Extension Study||0
2984779|NCT00873041|3700976|FG002|NOT COMPLETED|Extension Study||2
2984780|NCT00873093|3700996|FG000|STARTED|Overall Study||4
2984781|NCT00873093|3700997|FG001|STARTED|Overall Study||62
2984782|NCT00873093|3700998|FG002|STARTED|Overall Study||49
2984783|NCT00873093|3700999|FG003|STARTED|Overall Study||23
2984784|NCT00873093|3701000|FG004|STARTED|Overall Study||10
2984785|NCT00873093|3700996|FG000|COMPLETED|Overall Study||3
2984786|NCT00873093|3700997|FG001|COMPLETED|Overall Study||35
2984787|NCT00873093|3700998|FG002|COMPLETED|Overall Study||33
2984788|NCT00873093|3700999|FG003|COMPLETED|Overall Study||12
2984789|NCT00873093|3701000|FG004|COMPLETED|Overall Study||8
2984790|NCT00873093|3700996|FG000|NOT COMPLETED|Overall Study||1
2984791|NCT00873093|3700997|FG001|NOT COMPLETED|Overall Study||27
2984792|NCT00873093|3700998|FG002|NOT COMPLETED|Overall Study||16
2984793|NCT00873093|3700999|FG003|NOT COMPLETED|Overall Study||11
2984794|NCT00873093|3701000|FG004|NOT COMPLETED|Overall Study||2
2984795|NCT00873119|3701024|FG000|STARTED|Overall Study||44
2984796|NCT00873119|3701025|FG001|STARTED|Overall Study||45
2984797|NCT00873119|3701024|FG000|COMPLETED|Overall Study|Of 42 patients treated with belinostat, 23 patients received 6 or more treatment cycles.|0
2984798|NCT00873119|3701025|FG001|COMPLETED|Overall Study||19
2984799|NCT00873119|3701024|FG000|NOT COMPLETED|Overall Study||44
2984800|NCT00873119|3701025|FG001|NOT COMPLETED|Overall Study||26
2984801|NCT00873327|3701031|FG000|STARTED|Overall Study||32
2984802|NCT00873327|3701031|FG000|COMPLETED|Overall Study||32
2984803|NCT00873327|3701031|FG000|NOT COMPLETED|Overall Study||0
2984804|NCT00873457|3701035|FG000|STARTED|Overall Study||16
2984805|NCT00873457|3701035|FG000|COMPLETED|Overall Study||16
2984806|NCT00873457|3701035|FG000|NOT COMPLETED|Overall Study||0
2984807|NCT00873730|3701041|FG000|STARTED|Overall Study||54
2984808|NCT00873730|3701042|FG001|STARTED|Overall Study||54
2984809|NCT00873730|3701041|FG000|COMPLETED|Overall Study||48
2984810|NCT00873730|3701042|FG001|COMPLETED|Overall Study||49
2984811|NCT00873730|3701041|FG000|NOT COMPLETED|Overall Study||6
2984812|NCT00873730|3701042|FG001|NOT COMPLETED|Overall Study||5
2984813|NCT00873782|3701048|FG000|STARTED|Overall Study||16
2984814|NCT00873782|3701048|FG000|COMPLETED|Overall Study||16
2984815|NCT00873782|3701048|FG000|NOT COMPLETED|Overall Study||0
2984816|NCT00873821|3701054|FG000|STARTED|Overall Study||22
2984817|NCT00873821|3701055|FG001|STARTED|Overall Study||22
2984818|NCT00873821|3701054|FG000|COMPLETED|Overall Study||22
2984819|NCT00873821|3701055|FG001|COMPLETED|Overall Study||22
3304742|NCT02981342|4038293|FG001|NOT COMPLETED|Overall Study||11
3304743|NCT02981342|4038294|FG002|NOT COMPLETED|Overall Study||13
3304744|NCT02981342|4038295|FG003|NOT COMPLETED|Overall Study||14
3304745|NCT02981368|4038309|FG000|STARTED|Overall Study||268
3304746|NCT02981368|4038310|FG001|STARTED|Overall Study||117
3304747|NCT02981368|4038309|FG000|COMPLETED|Overall Study||248
3304748|NCT02981368|4038310|FG001|COMPLETED|Overall Study||102
2984820|NCT00873821|3701054|FG000|NOT COMPLETED|Overall Study||0
2984821|NCT00873821|3701055|FG001|NOT COMPLETED|Overall Study||0
2984822|NCT00873860|3701065|FG000|STARTED|Overall Study||48
2984823|NCT00873860|3701066|FG001|STARTED|Overall Study||47
2984824|NCT00873860|3701067|FG002|STARTED|Overall Study||51
2984825|NCT00873860|3701068|FG003|STARTED|Overall Study||48
2984826|NCT00873860|3701065|FG000|Treated|Overall Study||47
2984827|NCT00873860|3701066|FG001|Treated|Overall Study||47
2984828|NCT00873860|3701067|FG002|Treated|Overall Study||51
2984829|NCT00873860|3701068|FG003|Treated|Overall Study||48
2984830|NCT00873860|3701065|FG000|COMPLETED|Overall Study||44
2984831|NCT00873860|3701066|FG001|COMPLETED|Overall Study||47
2984832|NCT00873860|3701067|FG002|COMPLETED|Overall Study||48
2984833|NCT00873860|3701068|FG003|COMPLETED|Overall Study||47
2984834|NCT00873860|3701065|FG000|NOT COMPLETED|Overall Study||4
2984835|NCT00873860|3701066|FG001|NOT COMPLETED|Overall Study||0
2984836|NCT00873860|3701067|FG002|NOT COMPLETED|Overall Study||3
2984837|NCT00873860|3701068|FG003|NOT COMPLETED|Overall Study||1
2984838|NCT00873873|3701085|FG000|STARTED|Overall Study||20
2984839|NCT00873873|3701086|FG001|STARTED|Overall Study||8
2984840|NCT00873873|3701087|FG002|STARTED|Overall Study||9
2984841|NCT00873873|3701088|FG003|STARTED|Overall Study||18
2984842|NCT00873873|3701085|FG000|COMPLETED|Overall Study||20
2984843|NCT00873873|3701086|FG001|COMPLETED|Overall Study||8
2984844|NCT00873873|3701087|FG002|COMPLETED|Overall Study||9
2984845|NCT00873873|3701088|FG003|COMPLETED|Overall Study||18
2984846|NCT00873873|3701085|FG000|NOT COMPLETED|Overall Study||0
2984847|NCT00873873|3701086|FG001|NOT COMPLETED|Overall Study||0
2984848|NCT00873873|3701087|FG002|NOT COMPLETED|Overall Study||0
2984849|NCT00873873|3701088|FG003|NOT COMPLETED|Overall Study||0
2984850|NCT00873912|3701100|FG000|STARTED|Overall Study||240
2984851|NCT00873912|3701101|FG001|STARTED|Overall Study||60
2984852|NCT00873912|3701100|FG000|COMPLETED|Overall Study||237
2984853|NCT00873912|3701101|FG001|COMPLETED|Overall Study||60
2984854|NCT00873912|3701100|FG000|NOT COMPLETED|Overall Study||3
2984855|NCT00873912|3701101|FG001|NOT COMPLETED|Overall Study||0
2984856|NCT00874029|3701107|FG000|STARTED|Overall Study||137
2984857|NCT00874029|3701107|FG000|COMPLETED|Overall Study||116
2984858|NCT00874029|3701107|FG000|NOT COMPLETED|Overall Study||21
2984859|NCT00874094|3701121|FG000|STARTED|Overall Study||15
2984860|NCT00874094|3701121|FG000|COMPLETED|Overall Study||15
2984861|NCT00874094|3701121|FG000|NOT COMPLETED|Overall Study||0
2984862|NCT00874120|3701127|FG000|STARTED|First Intervention||58
2984863|NCT00874120|3701128|FG001|STARTED|First Intervention||58
2984864|NCT00874120|3701127|FG000|COMPLETED|First Intervention||52
2984865|NCT00874120|3701128|FG001|COMPLETED|First Intervention||56
2984866|NCT00874120|3701127|FG000|NOT COMPLETED|First Intervention||6
2984867|NCT00874120|3701128|FG001|NOT COMPLETED|First Intervention||2
2984868|NCT00874120|3701127|FG000|STARTED|Wash-out Period||52
2984869|NCT00874120|3701128|FG001|STARTED|Wash-out Period||56
2984870|NCT00874120|3701127|FG000|COMPLETED|Wash-out Period||52
2984871|NCT00874120|3701128|FG001|COMPLETED|Wash-out Period||56
2984872|NCT00874120|3701127|FG000|NOT COMPLETED|Wash-out Period||0
2984873|NCT00874120|3701128|FG001|NOT COMPLETED|Wash-out Period||0
2984874|NCT00874120|3701127|FG000|STARTED|Second Intervention||52
2984875|NCT00874120|3701128|FG001|STARTED|Second Intervention||56
2984876|NCT00874120|3701127|FG000|COMPLETED|Second Intervention||50
2984877|NCT00874120|3701128|FG001|COMPLETED|Second Intervention||56
2984878|NCT00874120|3701127|FG000|NOT COMPLETED|Second Intervention||2
2984879|NCT00874120|3701128|FG001|NOT COMPLETED|Second Intervention||0
2984880|NCT00874237|3701134|FG000|STARTED|Overall Study||8
2984881|NCT00874237|3701135|FG001|STARTED|Overall Study||8
2984882|NCT00874237|3701136|FG002|STARTED|Overall Study||8
2984883|NCT00874237|3701137|FG003|STARTED|Overall Study||8
2984884|NCT00874237|3701138|FG004|STARTED|Overall Study||8
2984885|NCT00874237|3701139|FG005|STARTED|Overall Study||8
2984886|NCT00874237|3701134|FG000|COMPLETED|Overall Study||8
2984887|NCT00874237|3701135|FG001|COMPLETED|Overall Study||7
2984888|NCT00874237|3701136|FG002|COMPLETED|Overall Study||7
2984889|NCT00874237|3701137|FG003|COMPLETED|Overall Study||8
2984890|NCT00874237|3701138|FG004|COMPLETED|Overall Study||8
2984891|NCT00874237|3701139|FG005|COMPLETED|Overall Study||8
2984892|NCT00874237|3701134|FG000|NOT COMPLETED|Overall Study||0
2984893|NCT00874237|3701135|FG001|NOT COMPLETED|Overall Study||1
2984894|NCT00874237|3701136|FG002|NOT COMPLETED|Overall Study||1
2984895|NCT00874237|3701137|FG003|NOT COMPLETED|Overall Study||0
2984896|NCT00874237|3701138|FG004|NOT COMPLETED|Overall Study||0
2984897|NCT00874237|3701139|FG005|NOT COMPLETED|Overall Study||0
2984898|NCT00874250|3701149|FG000|STARTED|Overall Study||51
2984899|NCT00874250|3701149|FG000|COMPLETED|Overall Study||0
2984900|NCT00874250|3701149|FG000|NOT COMPLETED|Overall Study||51
2984901|NCT00874276|3701156|FG000|STARTED|Overall Study||6
2984902|NCT00874276|3701157|FG001|STARTED|Overall Study||8
2984903|NCT00874276|3701156|FG000|COMPLETED|Overall Study||5
2984904|NCT00874276|3701157|FG001|COMPLETED|Overall Study||7
2984905|NCT00874276|3701156|FG000|NOT COMPLETED|Overall Study||1
2984906|NCT00874276|3701157|FG001|NOT COMPLETED|Overall Study||1
2984907|NCT00874432|3701169|FG000|STARTED|Overall Study||8
2984908|NCT00874432|3701170|FG001|STARTED|Overall Study||4
2984909|NCT00874432|3701171|FG002|STARTED|Overall Study||17
2984910|NCT00874432|3701172|FG003|STARTED|Overall Study||14
2984911|NCT00874432|3701169|FG000|COMPLETED|Overall Study||5
2984912|NCT00874432|3701170|FG001|COMPLETED|Overall Study||2
2984913|NCT00874432|3701171|FG002|COMPLETED|Overall Study||9
2984914|NCT00874432|3701172|FG003|COMPLETED|Overall Study||11
2984915|NCT00874432|3701169|FG000|NOT COMPLETED|Overall Study||3
2984916|NCT00874432|3701170|FG001|NOT COMPLETED|Overall Study||2
2984917|NCT00874432|3701171|FG002|NOT COMPLETED|Overall Study||8
2984918|NCT00874432|3701172|FG003|NOT COMPLETED|Overall Study||3
2984919|NCT00874497|3701186|FG000|STARTED|Overall Study|This is the number of participants who were treated and were considered as safety population.|51
2984920|NCT00874497|3701187|FG001|STARTED|Overall Study|This is the number of participants who were treated and were considered as safety population.|33
2984921|NCT00874497|3701186|FG000|COMPLETED|Overall Study||23
2984922|NCT00874497|3701187|FG001|COMPLETED|Overall Study||15
2984923|NCT00874497|3701186|FG000|NOT COMPLETED|Overall Study||28
2984924|NCT00874497|3701187|FG001|NOT COMPLETED|Overall Study||18
2984925|NCT00874510|3701195|FG000|STARTED|Year 1||88
2984926|NCT00874510|3701196|FG001|STARTED|Year 1||85
2984927|NCT00874510|3701195|FG000|COMPLETED|Year 1||88
2984928|NCT00874510|3701196|FG001|COMPLETED|Year 1||85
2984929|NCT00874510|3701195|FG000|NOT COMPLETED|Year 1||0
2984930|NCT00874510|3701196|FG001|NOT COMPLETED|Year 1||0
2984931|NCT00874510|3701195|FG000|STARTED|Year 2||92
2984932|NCT00874510|3701196|FG001|STARTED|Year 2||87
3304749|NCT02981368|4038309|FG000|NOT COMPLETED|Overall Study||20
3304750|NCT02981368|4038310|FG001|NOT COMPLETED|Overall Study||15
3304751|NCT02981524|4038343|FG000|STARTED|Overall Study||17
3304752|NCT02981524|4038343|FG000|COMPLETED|Overall Study||0
3304753|NCT02981524|4038343|FG000|NOT COMPLETED|Overall Study||17
3304754|NCT02981602|4038352|FG000|STARTED|Overall Study||6
3304755|NCT02981602|4038353|FG001|STARTED|Overall Study||12
3304756|NCT02981602|4038354|FG002|STARTED|Overall Study||6
3304757|NCT02981602|4038355|FG003|STARTED|Overall Study||5
2984933|NCT00874510|3701195|FG000|COMPLETED|Year 2||92
2984934|NCT00874510|3701196|FG001|COMPLETED|Year 2||87
2984935|NCT00874510|3701195|FG000|NOT COMPLETED|Year 2||0
2984936|NCT00874510|3701196|FG001|NOT COMPLETED|Year 2||0
2984937|NCT00874549|3701206|FG000|STARTED|Overall Study||51
2984938|NCT00874549|3701207|FG001|STARTED|Overall Study||56
2984939|NCT00874549|3701208|FG002|STARTED|Overall Study||51
2984940|NCT00874549|3701209|FG003|STARTED|Overall Study||58
2984941|NCT00874549|3701206|FG000|COMPLETED|Overall Study||50
2984942|NCT00874549|3701207|FG001|COMPLETED|Overall Study||55
2984943|NCT00874549|3701208|FG002|COMPLETED|Overall Study||47
2984944|NCT00874549|3701209|FG003|COMPLETED|Overall Study||56
2984945|NCT00874549|3701206|FG000|NOT COMPLETED|Overall Study||1
2984946|NCT00874549|3701207|FG001|NOT COMPLETED|Overall Study||1
2984947|NCT00874549|3701208|FG002|NOT COMPLETED|Overall Study||4
2984948|NCT00874549|3701209|FG003|NOT COMPLETED|Overall Study||2
2984949|NCT00874614|3701219|FG000|STARTED|Overall Study||74
2984950|NCT00874614|3701219|FG000|Received at Least One Therapeutic Dose|Overall Study||68
2984951|NCT00874614|3701219|FG000|Received Two Therapeutic Doses|Overall Study||50
2984952|NCT00874614|3701219|FG000|COMPLETED|Overall Study|As of December 2017|16
2984953|NCT00874614|3701219|FG000|NOT COMPLETED|Overall Study||58
2984954|NCT00874731|3701225|FG000|STARTED|Part 1, Day 1: Placebo||23
2984955|NCT00874731|3701226|FG001|STARTED|Part 1, Day 1: Placebo||0
2984956|NCT00874731|3701227|FG002|STARTED|Part 1, Day 1: Placebo||0
2984957|NCT00874731|3701225|FG000|COMPLETED|Part 1, Day 1: Placebo||22
2984958|NCT00874731|3701226|FG001|COMPLETED|Part 1, Day 1: Placebo||0
2984959|NCT00874731|3701227|FG002|COMPLETED|Part 1, Day 1: Placebo||0
2984960|NCT00874731|3701225|FG000|NOT COMPLETED|Part 1, Day 1: Placebo||1
2984961|NCT00874731|3701226|FG001|NOT COMPLETED|Part 1, Day 1: Placebo||0
2984962|NCT00874731|3701227|FG002|NOT COMPLETED|Part 1, Day 1: Placebo||0
2984963|NCT00874731|3701225|FG000|STARTED|Part 1, Day 2: Ridaforolimus 100 mg|"Participants completing Pt 1, Day 1, enter into the Pt 1, Day 2. Ridaforolimus 100 mg arm."|0
2984964|NCT00874731|3701226|FG001|STARTED|Part 1, Day 2: Ridaforolimus 100 mg|"Participants completing Pt 1, Day 1, started this period in Pt 1, Day 2. Ridaforolimus 100 mg arm."|22
2984965|NCT00874731|3701227|FG002|STARTED|Part 1, Day 2: Ridaforolimus 100 mg||0
2984966|NCT00874731|3701225|FG000|COMPLETED|Part 1, Day 2: Ridaforolimus 100 mg||0
2984967|NCT00874731|3701226|FG001|COMPLETED|Part 1, Day 2: Ridaforolimus 100 mg||22
2984968|NCT00874731|3701227|FG002|COMPLETED|Part 1, Day 2: Ridaforolimus 100 mg||0
2984969|NCT00874731|3701225|FG000|NOT COMPLETED|Part 1, Day 2: Ridaforolimus 100 mg||0
2984970|NCT00874731|3701226|FG001|NOT COMPLETED|Part 1, Day 2: Ridaforolimus 100 mg||0
2984971|NCT00874731|3701227|FG002|NOT COMPLETED|Part 1, Day 2: Ridaforolimus 100 mg||0
2984972|NCT00874731|3701225|FG000|STARTED|Washout Period||0
2984973|NCT00874731|3701226|FG001|STARTED|Washout Period||22
2984974|NCT00874731|3701227|FG002|STARTED|Washout Period||0
2984975|NCT00874731|3701225|FG000|COMPLETED|Washout Period||0
2984976|NCT00874731|3701226|FG001|COMPLETED|Washout Period||22
2984977|NCT00874731|3701227|FG002|COMPLETED|Washout Period||0
2984978|NCT00874731|3701225|FG000|NOT COMPLETED|Washout Period||0
2984979|NCT00874731|3701226|FG001|NOT COMPLETED|Washout Period||0
2984980|NCT00874731|3701227|FG002|NOT COMPLETED|Washout Period||0
2984981|NCT00874731|3701225|FG000|STARTED|Part 2: Ridaforolimus 40 mg||0
2984982|NCT00874731|3701226|FG001|STARTED|Part 2: Ridaforolimus 40 mg|"Participants completing Pt 1 and washout, enter into the Pt 2. Ridaforolimus 40 mg arm."|0
2984983|NCT00874731|3701227|FG002|STARTED|Part 2: Ridaforolimus 40 mg|"Participants completing Pt 1 and washout, started this period in Pt 2. Ridaforolimus 40 mg arm."|22
2984984|NCT00874731|3701225|FG000|COMPLETED|Part 2: Ridaforolimus 40 mg||0
2984985|NCT00874731|3701226|FG001|COMPLETED|Part 2: Ridaforolimus 40 mg||0
2984986|NCT00874731|3701227|FG002|COMPLETED|Part 2: Ridaforolimus 40 mg||0
2984987|NCT00874731|3701225|FG000|NOT COMPLETED|Part 2: Ridaforolimus 40 mg||0
2984988|NCT00874731|3701226|FG001|NOT COMPLETED|Part 2: Ridaforolimus 40 mg||0
2984989|NCT00874731|3701227|FG002|NOT COMPLETED|Part 2: Ridaforolimus 40 mg||22
2984990|NCT00874770|3701239|FG000|STARTED|Overall Study||12
2984991|NCT00874770|3701240|FG001|STARTED|Overall Study||12
2984992|NCT00874770|3701241|FG002|STARTED|Overall Study||12
2984993|NCT00874770|3701242|FG003|STARTED|Overall Study||12
2984994|NCT00874770|3701239|FG000|COMPLETED|Overall Study||7
2984995|NCT00874770|3701240|FG001|COMPLETED|Overall Study||11
2984996|NCT00874770|3701241|FG002|COMPLETED|Overall Study||8
2984997|NCT00874770|3701242|FG003|COMPLETED|Overall Study||7
2984998|NCT00874770|3701239|FG000|NOT COMPLETED|Overall Study||5
2984999|NCT00874770|3701240|FG001|NOT COMPLETED|Overall Study||1
2985000|NCT00874770|3701241|FG002|NOT COMPLETED|Overall Study||4
2985001|NCT00874770|3701242|FG003|NOT COMPLETED|Overall Study||5
2985002|NCT00874822|3701262|FG000|STARTED|Overall Study||216
2985003|NCT00874822|3701262|FG000|COMPLETED|Overall Study||208
2985004|NCT00874822|3701262|FG000|NOT COMPLETED|Overall Study||8
2985005|NCT00874848|3701268|FG000|STARTED|Overall Study||59
2985006|NCT00874848|3701269|FG001|STARTED|Overall Study||29
2985007|NCT00874848|3701268|FG000|Discontinued|Overall Study||59
2985008|NCT00874848|3701269|FG001|Discontinued|Overall Study||28
2985009|NCT00874848|3701268|FG000|COMPLETED|Overall Study|Pts who completed 18 tx cycles without progressive disease were defined as completing treatment.|0
2985010|NCT00874848|3701269|FG001|COMPLETED|Overall Study|Pts who completed 18 tx cycles without progressive disease were defined as completing treatment.|1
2985011|NCT00874848|3701268|FG000|NOT COMPLETED|Overall Study||59
2985012|NCT00874848|3701269|FG001|NOT COMPLETED|Overall Study||28
2985013|NCT00874887|3701277|FG000|STARTED|Overall Study||32
2985014|NCT00874887|3701278|FG001|STARTED|Overall Study||34
2985015|NCT00874887|3701277|FG000|COMPLETED|Overall Study||32
2985016|NCT00874887|3701278|FG001|COMPLETED|Overall Study||34
2985017|NCT00874887|3701277|FG000|NOT COMPLETED|Overall Study||0
2985018|NCT00874887|3701278|FG001|NOT COMPLETED|Overall Study||0
2985019|NCT00875017|3701290|FG000|STARTED|First Intervention||5
2985020|NCT00875017|3701291|FG001|STARTED|First Intervention||5
2985021|NCT00875017|3701292|FG002|STARTED|First Intervention||5
2985022|NCT00875017|3701293|FG003|STARTED|First Intervention||6
2985023|NCT00875017|3701294|FG004|STARTED|First Intervention||5
2985024|NCT00875017|3701295|FG005|STARTED|First Intervention||5
2985025|NCT00875017|3701290|FG000|COMPLETED|First Intervention||3
2985026|NCT00875017|3701291|FG001|COMPLETED|First Intervention||5
2985027|NCT00875017|3701292|FG002|COMPLETED|First Intervention||4
2985028|NCT00875017|3701293|FG003|COMPLETED|First Intervention||5
2985029|NCT00875017|3701294|FG004|COMPLETED|First Intervention||4
2985030|NCT00875017|3701295|FG005|COMPLETED|First Intervention||5
2985031|NCT00875017|3701290|FG000|NOT COMPLETED|First Intervention||2
2985032|NCT00875017|3701291|FG001|NOT COMPLETED|First Intervention||0
2985033|NCT00875017|3701292|FG002|NOT COMPLETED|First Intervention||1
2985034|NCT00875017|3701293|FG003|NOT COMPLETED|First Intervention||1
2985035|NCT00875017|3701294|FG004|NOT COMPLETED|First Intervention||1
2985036|NCT00875017|3701295|FG005|NOT COMPLETED|First Intervention||0
2985037|NCT00875017|3701290|FG000|STARTED|Washout||3
2985038|NCT00875017|3701291|FG001|STARTED|Washout||5
2985039|NCT00875017|3701292|FG002|STARTED|Washout||4
2985040|NCT00875017|3701293|FG003|STARTED|Washout||5
2985041|NCT00875017|3701294|FG004|STARTED|Washout||4
2985042|NCT00875017|3701295|FG005|STARTED|Washout||5
2985043|NCT00875017|3701290|FG000|COMPLETED|Washout||3
2985044|NCT00875017|3701291|FG001|COMPLETED|Washout||5
2985045|NCT00875017|3701292|FG002|COMPLETED|Washout||3
2985046|NCT00875017|3701293|FG003|COMPLETED|Washout||5
2985047|NCT00875017|3701294|FG004|COMPLETED|Washout||4
2985048|NCT00875017|3701295|FG005|COMPLETED|Washout||5
2985049|NCT00875017|3701290|FG000|NOT COMPLETED|Washout||0
2985050|NCT00875017|3701291|FG001|NOT COMPLETED|Washout||0
2985051|NCT00875017|3701292|FG002|NOT COMPLETED|Washout||1
2985052|NCT00875017|3701293|FG003|NOT COMPLETED|Washout||0
2985053|NCT00875017|3701294|FG004|NOT COMPLETED|Washout||0
2985054|NCT00875017|3701295|FG005|NOT COMPLETED|Washout||0
2985055|NCT00875017|3701290|FG000|STARTED|Second Intervention||3
2985056|NCT00875017|3701291|FG001|STARTED|Second Intervention||5
2985057|NCT00875017|3701292|FG002|STARTED|Second Intervention||3
2985058|NCT00875017|3701293|FG003|STARTED|Second Intervention||5
2985059|NCT00875017|3701294|FG004|STARTED|Second Intervention||4
2985060|NCT00875017|3701295|FG005|STARTED|Second Intervention||5
3164373|NCT01892189|3891778|FG000|STARTED|Second Intervention Period (1 Day)||3
3164374|NCT01892189|3891779|FG001|STARTED|Second Intervention Period (1 Day)||3
3164375|NCT01892189|3891780|FG002|STARTED|Second Intervention Period (1 Day)||1
3164376|NCT01892189|3891781|FG003|STARTED|Second Intervention Period (1 Day)||2
3164377|NCT01892189|3891782|FG004|STARTED|Second Intervention Period (1 Day)||3
3164378|NCT01892189|3891783|FG005|STARTED|Second Intervention Period (1 Day)||2
3164379|NCT01892189|3891784|FG006|STARTED|Second Intervention Period (1 Day)||2
3164380|NCT01892189|3891785|FG007|STARTED|Second Intervention Period (1 Day)||3
3164381|NCT01892189|3891786|FG008|STARTED|Second Intervention Period (1 Day)||1
3164382|NCT01892189|3891778|FG000|COMPLETED|Second Intervention Period (1 Day)||3
3171814|NCT01937312|3899018|FG001|NOT COMPLETED|Overall Study||3
2985061|NCT00875017|3701290|FG000|COMPLETED|Second Intervention||3
2985062|NCT00875017|3701291|FG001|COMPLETED|Second Intervention||5
2985063|NCT00875017|3701292|FG002|COMPLETED|Second Intervention||3
2985064|NCT00875017|3701293|FG003|COMPLETED|Second Intervention||4
2985065|NCT00875017|3701294|FG004|COMPLETED|Second Intervention||4
2985066|NCT00875017|3701295|FG005|COMPLETED|Second Intervention||5
2985067|NCT00875017|3701290|FG000|NOT COMPLETED|Second Intervention||0
2985068|NCT00875017|3701291|FG001|NOT COMPLETED|Second Intervention||0
2985069|NCT00875017|3701292|FG002|NOT COMPLETED|Second Intervention||0
2985070|NCT00875017|3701293|FG003|NOT COMPLETED|Second Intervention||1
2985071|NCT00875017|3701294|FG004|NOT COMPLETED|Second Intervention||0
2985072|NCT00875017|3701295|FG005|NOT COMPLETED|Second Intervention||0
2985073|NCT00875017|3701290|FG000|STARTED|Washout||3
2985074|NCT00875017|3701291|FG001|STARTED|Washout||5
2985075|NCT00875017|3701292|FG002|STARTED|Washout||3
2985076|NCT00875017|3701293|FG003|STARTED|Washout||4
2985077|NCT00875017|3701294|FG004|STARTED|Washout||4
2985078|NCT00875017|3701295|FG005|STARTED|Washout||5
2985079|NCT00875017|3701290|FG000|COMPLETED|Washout||3
2985080|NCT00875017|3701291|FG001|COMPLETED|Washout||4
2985081|NCT00875017|3701292|FG002|COMPLETED|Washout||3
2985082|NCT00875017|3701293|FG003|COMPLETED|Washout||4
2985083|NCT00875017|3701294|FG004|COMPLETED|Washout||4
2985084|NCT00875017|3701295|FG005|COMPLETED|Washout||5
2985085|NCT00875017|3701290|FG000|NOT COMPLETED|Washout||0
2985086|NCT00875017|3701291|FG001|NOT COMPLETED|Washout||1
2985087|NCT00875017|3701292|FG002|NOT COMPLETED|Washout||0
2985088|NCT00875017|3701293|FG003|NOT COMPLETED|Washout||0
2985089|NCT00875017|3701294|FG004|NOT COMPLETED|Washout||0
2985090|NCT00875017|3701295|FG005|NOT COMPLETED|Washout||0
2985091|NCT00875017|3701290|FG000|STARTED|Third Intervention||3
2985092|NCT00875017|3701291|FG001|STARTED|Third Intervention||4
2985093|NCT00875017|3701292|FG002|STARTED|Third Intervention||3
2985094|NCT00875017|3701293|FG003|STARTED|Third Intervention||4
2985095|NCT00875017|3701294|FG004|STARTED|Third Intervention||4
2985096|NCT00875017|3701295|FG005|STARTED|Third Intervention||5
2985097|NCT00875017|3701290|FG000|COMPLETED|Third Intervention||3
2985098|NCT00875017|3701291|FG001|COMPLETED|Third Intervention||3
2985099|NCT00875017|3701292|FG002|COMPLETED|Third Intervention||2
2985100|NCT00875017|3701293|FG003|COMPLETED|Third Intervention||4
2985101|NCT00875017|3701294|FG004|COMPLETED|Third Intervention||4
2985102|NCT00875017|3701295|FG005|COMPLETED|Third Intervention||5
2985103|NCT00875017|3701290|FG000|NOT COMPLETED|Third Intervention||0
2985104|NCT00875017|3701291|FG001|NOT COMPLETED|Third Intervention||1
2985105|NCT00875017|3701292|FG002|NOT COMPLETED|Third Intervention||1
2985106|NCT00875017|3701293|FG003|NOT COMPLETED|Third Intervention||0
2985107|NCT00875017|3701294|FG004|NOT COMPLETED|Third Intervention||0
2985108|NCT00875017|3701295|FG005|NOT COMPLETED|Third Intervention||0
2985109|NCT00875017|3701290|FG000|STARTED|Washout||3
2985110|NCT00875017|3701291|FG001|STARTED|Washout||3
2985111|NCT00875017|3701292|FG002|STARTED|Washout||2
2985112|NCT00875017|3701293|FG003|STARTED|Washout||4
2985113|NCT00875017|3701294|FG004|STARTED|Washout||4
2985114|NCT00875017|3701295|FG005|STARTED|Washout||5
2985115|NCT00875017|3701290|FG000|COMPLETED|Washout||3
2985116|NCT00875017|3701291|FG001|COMPLETED|Washout||3
2985117|NCT00875017|3701292|FG002|COMPLETED|Washout||2
2985118|NCT00875017|3701293|FG003|COMPLETED|Washout||4
2985119|NCT00875017|3701294|FG004|COMPLETED|Washout||3
2985120|NCT00875017|3701295|FG005|COMPLETED|Washout||5
2985121|NCT00875017|3701290|FG000|NOT COMPLETED|Washout||0
2985122|NCT00875017|3701291|FG001|NOT COMPLETED|Washout||0
2985123|NCT00875017|3701292|FG002|NOT COMPLETED|Washout||0
2985124|NCT00875017|3701293|FG003|NOT COMPLETED|Washout||0
2985125|NCT00875017|3701294|FG004|NOT COMPLETED|Washout||1
2985126|NCT00875017|3701295|FG005|NOT COMPLETED|Washout||0
2985127|NCT00875017|3701290|FG000|STARTED|Fourth Intervention||3
2985128|NCT00875017|3701291|FG001|STARTED|Fourth Intervention||3
2985129|NCT00875017|3701292|FG002|STARTED|Fourth Intervention||2
2985130|NCT00875017|3701293|FG003|STARTED|Fourth Intervention||4
2985131|NCT00875017|3701294|FG004|STARTED|Fourth Intervention||3
2985132|NCT00875017|3701295|FG005|STARTED|Fourth Intervention||5
2985133|NCT00875017|3701290|FG000|COMPLETED|Fourth Intervention||3
2985134|NCT00875017|3701291|FG001|COMPLETED|Fourth Intervention||3
2985135|NCT00875017|3701292|FG002|COMPLETED|Fourth Intervention||2
2985136|NCT00875017|3701293|FG003|COMPLETED|Fourth Intervention||4
2985137|NCT00875017|3701294|FG004|COMPLETED|Fourth Intervention||3
2985138|NCT00875017|3701295|FG005|COMPLETED|Fourth Intervention||4
2985139|NCT00875017|3701290|FG000|NOT COMPLETED|Fourth Intervention||0
2985140|NCT00875017|3701291|FG001|NOT COMPLETED|Fourth Intervention||0
2985141|NCT00875017|3701292|FG002|NOT COMPLETED|Fourth Intervention||0
2985142|NCT00875017|3701293|FG003|NOT COMPLETED|Fourth Intervention||0
2985143|NCT00875017|3701294|FG004|NOT COMPLETED|Fourth Intervention||0
2985144|NCT00875017|3701295|FG005|NOT COMPLETED|Fourth Intervention||1
2985145|NCT00875056|3701311|FG000|STARTED|Overall Study||39
2985146|NCT00875056|3701312|FG001|STARTED|Overall Study||11
2985147|NCT00875056|3701313|FG002|STARTED|Overall Study||6
2985148|NCT00875056|3701311|FG000|COMPLETED|Overall Study||16
2985149|NCT00875056|3701312|FG001|COMPLETED|Overall Study||2
2985150|NCT00875056|3701313|FG002|COMPLETED|Overall Study||0
2985151|NCT00875056|3701311|FG000|NOT COMPLETED|Overall Study||23
2985152|NCT00875056|3701312|FG001|NOT COMPLETED|Overall Study||9
2985153|NCT00875056|3701313|FG002|NOT COMPLETED|Overall Study||6
2985154|NCT00875212|3701321|FG000|STARTED|Placebo Dentifrice||12
2985155|NCT00875212|3701321|FG000|COMPLETED|Placebo Dentifrice|all participants completed this group|12
2985156|NCT00875212|3701321|FG000|NOT COMPLETED|Placebo Dentifrice||0
2985157|NCT00875212|3701321|FG000|STARTED|CaGP Only Dentifrice||12
2985158|NCT00875212|3701321|FG000|COMPLETED|CaGP Only Dentifrice||12
2985159|NCT00875212|3701321|FG000|NOT COMPLETED|CaGP Only Dentifrice||0
2985160|NCT00875212|3701321|FG000|STARTED|Fluoride Only Dentifrice||12
3164383|NCT01892189|3891779|FG001|COMPLETED|Second Intervention Period (1 Day)||3
3164384|NCT01892189|3891780|FG002|COMPLETED|Second Intervention Period (1 Day)||1
3164385|NCT01892189|3891781|FG003|COMPLETED|Second Intervention Period (1 Day)||2
3164386|NCT01892189|3891782|FG004|COMPLETED|Second Intervention Period (1 Day)||3
3164387|NCT01892189|3891783|FG005|COMPLETED|Second Intervention Period (1 Day)||2
2985161|NCT00875212|3701321|FG000|COMPLETED|Fluoride Only Dentifrice||12
2985162|NCT00875212|3701321|FG000|NOT COMPLETED|Fluoride Only Dentifrice||0
2985163|NCT00875212|3701321|FG000|STARTED|CaGP and Fluoride Dentifrice||12
2985164|NCT00875212|3701321|FG000|COMPLETED|CaGP and Fluoride Dentifrice||12
2985165|NCT00875212|3701321|FG000|NOT COMPLETED|CaGP and Fluoride Dentifrice||0
2985166|NCT00875277|3701332|FG000|STARTED|Overall Study||24
2985167|NCT00875277|3701332|FG000|COMPLETED|Overall Study||24
2985168|NCT00875277|3701332|FG000|NOT COMPLETED|Overall Study||0
2985169|NCT00875329|3701343|FG000|STARTED|Overall Study||97
2985170|NCT00875329|3701343|FG000|COMPLETED|Overall Study||97
2985171|NCT00875329|3701343|FG000|NOT COMPLETED|Overall Study||0
2985172|NCT00875342|3701349|FG000|STARTED|Overall Study||20
2985173|NCT00875342|3701350|FG001|STARTED|Overall Study||21
2985174|NCT00875342|3701349|FG000|COMPLETED|Overall Study||16
2985175|NCT00875342|3701350|FG001|COMPLETED|Overall Study||16
2985176|NCT00875342|3701349|FG000|NOT COMPLETED|Overall Study||4
2985177|NCT00875342|3701350|FG001|NOT COMPLETED|Overall Study||5
2985178|NCT00875420|3701361|FG000|STARTED|Overall Study||22
2985179|NCT00875420|3701362|FG001|STARTED|Overall Study||20
2985180|NCT00875420|3701363|FG002|STARTED|Overall Study||21
2985181|NCT00875420|3701364|FG003|STARTED|Overall Study||18
2985182|NCT00875420|3701365|FG004|STARTED|Overall Study||19
2985183|NCT00875420|3701361|FG000|COMPLETED|Overall Study||20
2985184|NCT00875420|3701362|FG001|COMPLETED|Overall Study||18
2985185|NCT00875420|3701363|FG002|COMPLETED|Overall Study||18
2985186|NCT00875420|3701364|FG003|COMPLETED|Overall Study||16
2985187|NCT00875420|3701365|FG004|COMPLETED|Overall Study||17
2985188|NCT00875420|3701361|FG000|NOT COMPLETED|Overall Study||2
2985189|NCT00875420|3701362|FG001|NOT COMPLETED|Overall Study||2
2985190|NCT00875420|3701363|FG002|NOT COMPLETED|Overall Study||3
2985191|NCT00875420|3701364|FG003|NOT COMPLETED|Overall Study||2
2985192|NCT00875420|3701365|FG004|NOT COMPLETED|Overall Study||2
2985193|NCT00875433|3701377|FG000|STARTED|Overall Study|Treated|60
2985194|NCT00875433|3701377|FG000|COMPLETED|Overall Study||0
2985195|NCT00875433|3701377|FG000|NOT COMPLETED|Overall Study||60
2985196|NCT00875485|3701383|FG000|STARTED|Year 11||99
2985197|NCT00875485|3701384|FG001|STARTED|Year 11||111
2985198|NCT00875485|3701383|FG000|COMPLETED|Year 11||99
2985199|NCT00875485|3701384|FG001|COMPLETED|Year 11||111
2985200|NCT00875485|3701383|FG000|NOT COMPLETED|Year 11||0
2985201|NCT00875485|3701384|FG001|NOT COMPLETED|Year 11||0
2985202|NCT00875485|3701383|FG000|STARTED|Year 12||101
2985203|NCT00875485|3701384|FG001|STARTED|Year 12||109
2985204|NCT00875485|3701383|FG000|COMPLETED|Year 12||101
2985205|NCT00875485|3701384|FG001|COMPLETED|Year 12||109
2985206|NCT00875485|3701383|FG000|NOT COMPLETED|Year 12||0
2985207|NCT00875485|3701384|FG001|NOT COMPLETED|Year 12||0
2985208|NCT00875485|3701383|FG000|STARTED|Year 13||102
2985209|NCT00875485|3701384|FG001|STARTED|Year 13||113
2985210|NCT00875485|3701383|FG000|COMPLETED|Year 13||102
2985211|NCT00875485|3701384|FG001|COMPLETED|Year 13||113
2985212|NCT00875485|3701383|FG000|NOT COMPLETED|Year 13||0
2985213|NCT00875485|3701384|FG001|NOT COMPLETED|Year 13||0
2985214|NCT00875485|3701383|FG000|STARTED|Year 14||100
2985215|NCT00875485|3701384|FG001|STARTED|Year 14||113
2985216|NCT00875485|3701383|FG000|COMPLETED|Year 14||100
2985217|NCT00875485|3701384|FG001|COMPLETED|Year 14||113
2985218|NCT00875485|3701383|FG000|NOT COMPLETED|Year 14||0
2985219|NCT00875485|3701384|FG001|NOT COMPLETED|Year 14||0
2985220|NCT00875485|3701383|FG000|STARTED|Year 15||98
2985221|NCT00875485|3701384|FG001|STARTED|Year 15||111
2985222|NCT00875485|3701383|FG000|COMPLETED|Year 15||98
2985223|NCT00875485|3701384|FG001|COMPLETED|Year 15||111
2985224|NCT00875485|3701383|FG000|NOT COMPLETED|Year 15||0
2985225|NCT00875485|3701384|FG001|NOT COMPLETED|Year 15||0
2985226|NCT00875485|3701383|FG000|STARTED|Challenge Dose Epoch||8
2985227|NCT00875485|3701384|FG001|STARTED|Challenge Dose Epoch||11
2985228|NCT00875485|3701383|FG000|COMPLETED|Challenge Dose Epoch||7
2985229|NCT00875485|3701384|FG001|COMPLETED|Challenge Dose Epoch||11
2985230|NCT00875485|3701383|FG000|NOT COMPLETED|Challenge Dose Epoch||1
2985231|NCT00875485|3701384|FG001|NOT COMPLETED|Challenge Dose Epoch||0
2985232|NCT00875524|3701392|FG000|STARTED|Overall Study||120
2985233|NCT00875524|3701393|FG001|STARTED|Overall Study||60
2985234|NCT00875524|3701392|FG000|Received Vaccination 1|Overall Study||120
2985235|NCT00875524|3701393|FG001|Received Vaccination 1|Overall Study||60
2985236|NCT00875524|3701392|FG000|Received Vaccination 2|Overall Study||116
2985237|NCT00875524|3701393|FG001|Received Vaccination 2|Overall Study||58
3133493|NCT01696084|3858468|FG001|COMPLETED|Overall Study||10
3133494|NCT01696084|3858467|FG000|NOT COMPLETED|Overall Study||131
3304758|NCT02981602|4038356|FG004|STARTED|Overall Study||2
3304759|NCT02981602|4038352|FG000|COMPLETED|Overall Study||6
3304760|NCT02981602|4038353|FG001|COMPLETED|Overall Study||12
3304761|NCT02981602|4038354|FG002|COMPLETED|Overall Study||6
3304762|NCT02981602|4038355|FG003|COMPLETED|Overall Study||4
3304763|NCT02981602|4038356|FG004|COMPLETED|Overall Study||2
3304764|NCT02981602|4038352|FG000|NOT COMPLETED|Overall Study||0
2985238|NCT00875524|3701392|FG000|Received Vaccination 3|Overall Study||114
2985239|NCT00875524|3701393|FG001|Received Vaccination 3|Overall Study||58
2985240|NCT00875524|3701392|FG000|COMPLETED|Overall Study||112
2985241|NCT00875524|3701393|FG001|COMPLETED|Overall Study||54
2985242|NCT00875524|3701392|FG000|NOT COMPLETED|Overall Study||8
2985243|NCT00875524|3701393|FG001|NOT COMPLETED|Overall Study||6
2985244|NCT00875550|3701401|FG000|STARTED|Overall Study||89
2985245|NCT00875550|3701402|FG001|STARTED|Overall Study||86
2985246|NCT00875550|3701401|FG000|COMPLETED|Overall Study||77
2985247|NCT00875550|3701402|FG001|COMPLETED|Overall Study||76
2985248|NCT00875550|3701401|FG000|NOT COMPLETED|Overall Study||12
2985249|NCT00875550|3701402|FG001|NOT COMPLETED|Overall Study||10
2985250|NCT00875563|3701410|FG000|STARTED|Overall Study||42
2985251|NCT00875563|3701410|FG000|COMPLETED|Overall Study||18
2985252|NCT00875563|3701410|FG000|NOT COMPLETED|Overall Study||24
2985253|NCT00875589|3701416|FG000|STARTED|Overall Study||15
2985254|NCT00875589|3701417|FG001|STARTED|Overall Study||11
2985255|NCT00875589|3701416|FG000|COMPLETED|Overall Study||15
2985256|NCT00875589|3701417|FG001|COMPLETED|Overall Study||11
2985257|NCT00875589|3701416|FG000|NOT COMPLETED|Overall Study||0
2985258|NCT00875589|3701417|FG001|NOT COMPLETED|Overall Study||0
2985259|NCT00875615|3701423|FG000|STARTED|Overall Study||11
2985260|NCT00875615|3701423|FG000|COMPLETED|Overall Study||10
2985261|NCT00875615|3701423|FG000|NOT COMPLETED|Overall Study||1
2985262|NCT00875641|3701430|FG000|STARTED|Overall Study||57931
3304765|NCT02981602|4038353|FG001|NOT COMPLETED|Overall Study||0
3304766|NCT02981602|4038354|FG002|NOT COMPLETED|Overall Study||0
3304767|NCT02981602|4038355|FG003|NOT COMPLETED|Overall Study||1
3304768|NCT02981602|4038356|FG004|NOT COMPLETED|Overall Study||0
3304769|NCT02981953|4038369|FG000|STARTED|Overall Study||40
2985263|NCT00875641|3701431|FG001|STARTED|Overall Study||173384
2985264|NCT00875641|3701432|FG002|STARTED|Overall Study||159344
2985265|NCT00875641|3701430|FG000|COMPLETED|Overall Study||57931
3133495|NCT01696084|3858468|FG001|NOT COMPLETED|Overall Study||146
2985266|NCT00875641|3701431|FG001|COMPLETED|Overall Study||173384
2985267|NCT00875641|3701432|FG002|COMPLETED|Overall Study||159344
2985268|NCT00875641|3701430|FG000|NOT COMPLETED|Overall Study||0
2985269|NCT00875641|3701431|FG001|NOT COMPLETED|Overall Study||0
2985270|NCT00875641|3701432|FG002|NOT COMPLETED|Overall Study||0
2985271|NCT00875667|3701442|FG000|STARTED|Overall Study||170
2985272|NCT00875667|3701443|FG001|STARTED|Overall Study||84
2985273|NCT00875667|3701442|FG000|Crossover From IC to Lenalidomide|Overall Study|NA = Participants in the IC arm were able to crossover to lenalidomide|0
3133496|NCT01696188|3858476|FG000|STARTED|Overall Study||41
3133497|NCT01696188|3858477|FG001|STARTED|Overall Study||43
2985274|NCT00875667|3701443|FG001|Crossover From IC to Lenalidomide|Overall Study|Upon disease progression, participants crossed over to lenalidomide|40
2985275|NCT00875667|3701442|FG000|Participants Treated|Overall Study||167
2985276|NCT00875667|3701443|FG001|Participants Treated|Overall Study||83
2985277|NCT00875667|3701442|FG000|COMPLETED|Overall Study||0
2985278|NCT00875667|3701443|FG001|COMPLETED|Overall Study|Participants completed 6 cycles of IC single agent cytarabine, fludarabine, or gemcitabine.|11
2985279|NCT00875667|3701442|FG000|NOT COMPLETED|Overall Study||170
2985280|NCT00875667|3701443|FG001|NOT COMPLETED|Overall Study||73
3036409|NCT01143181|3755589|FG003|STARTED|Overall Study||40
3036410|NCT01143181|3755586|FG000|COMPLETED|Overall Study||14
3036411|NCT01143181|3755587|FG001|COMPLETED|Overall Study||22
3036412|NCT01143181|3755588|FG002|COMPLETED|Overall Study||58
3036413|NCT01143181|3755589|FG003|COMPLETED|Overall Study||17
3036414|NCT01143181|3755586|FG000|NOT COMPLETED|Overall Study||16
3036415|NCT01143181|3755587|FG001|NOT COMPLETED|Overall Study||16
3036416|NCT01143181|3755588|FG002|NOT COMPLETED|Overall Study||44
3036417|NCT01143181|3755589|FG003|NOT COMPLETED|Overall Study||23
3036418|NCT01143207|3755599|FG000|STARTED|Overall Study||26
3036419|NCT01143207|3755599|FG000|COMPLETED|Overall Study||24
3036420|NCT01143207|3755599|FG000|NOT COMPLETED|Overall Study||2
3036421|NCT01143259|3755605|FG000|STARTED|Overall Study||136
3036422|NCT01143259|3755606|FG001|STARTED|Overall Study||138
3036423|NCT01143259|3755605|FG000|COMPLETED|Overall Study||113
3036424|NCT01143259|3755606|FG001|COMPLETED|Overall Study||118
3036425|NCT01143259|3755605|FG000|NOT COMPLETED|Overall Study||23
3036426|NCT01143259|3755606|FG001|NOT COMPLETED|Overall Study||20
3036427|NCT01143272|3755614|FG000|STARTED|Overall Study||246
3036428|NCT01143272|3755615|FG001|STARTED|Overall Study||231
3036429|NCT01143272|3755614|FG000|COMPLETED|Overall Study||246
3036430|NCT01143272|3755615|FG001|COMPLETED|Overall Study||231
3036431|NCT01143272|3755614|FG000|NOT COMPLETED|Overall Study||0
3036432|NCT01143272|3755615|FG001|NOT COMPLETED|Overall Study||0
3036433|NCT01143324|3755621|FG000|STARTED|Overall Study||252
3036434|NCT01143324|3755621|FG000|COMPLETED|Overall Study||233
3036435|NCT01143324|3755621|FG000|NOT COMPLETED|Overall Study||19
3036436|NCT01143337|3755627|FG000|STARTED|Overall Study||49
3036437|NCT01143337|3755628|FG001|STARTED|Overall Study||50
3036438|NCT01143337|3755629|FG002|STARTED|Overall Study||13
3036439|NCT01143337|3755627|FG000|COMPLETED|Overall Study||39
3036440|NCT01143337|3755628|FG001|COMPLETED|Overall Study||39
3036441|NCT01143337|3755629|FG002|COMPLETED|Overall Study|Frequency of this arm AE was higher than assumption before study initiation.|1
3036442|NCT01143337|3755627|FG000|NOT COMPLETED|Overall Study||10
3036443|NCT01143337|3755628|FG001|NOT COMPLETED|Overall Study||11
3036444|NCT01143337|3755629|FG002|NOT COMPLETED|Overall Study||12
3036445|NCT01143389|3755637|FG000|STARTED|Overall Study||253
3036446|NCT01143389|3755638|FG001|STARTED|Overall Study||257
3036447|NCT01143389|3755637|FG000|COMPLETED|Overall Study||227
3036448|NCT01143389|3755638|FG001|COMPLETED|Overall Study||232
3036449|NCT01143389|3755637|FG000|NOT COMPLETED|Overall Study||26
3036450|NCT01143389|3755638|FG001|NOT COMPLETED|Overall Study||25
3036451|NCT01143402|3755647|FG000|STARTED|Overall Study||51
3036452|NCT01143402|3755648|FG001|STARTED|Overall Study||50
3036453|NCT01143402|3755649|FG002|STARTED|Overall Study||19
3036454|NCT01143402|3755647|FG000|COMPLETED|Overall Study||50
3036455|NCT01143402|3755648|FG001|COMPLETED|Overall Study||49
3036456|NCT01143402|3755649|FG002|COMPLETED|Overall Study||18
3036457|NCT01143402|3755647|FG000|NOT COMPLETED|Overall Study||1
3036458|NCT01143402|3755648|FG001|NOT COMPLETED|Overall Study||1
3036459|NCT01143402|3755649|FG002|NOT COMPLETED|Overall Study||1
3036460|NCT01143610|3755658|FG000|STARTED|Overall Study||7
3036461|NCT01143610|3755659|FG001|STARTED|Overall Study||8
3036462|NCT01143610|3755658|FG000|COMPLETED|Overall Study||7
3036463|NCT01143610|3755659|FG001|COMPLETED|Overall Study||8
3036464|NCT01143610|3755658|FG000|NOT COMPLETED|Overall Study||0
3036465|NCT01143610|3755659|FG001|NOT COMPLETED|Overall Study||0
3036466|NCT01143636|3755668|FG000|STARTED|Overall Study||6
3036467|NCT01143636|3755669|FG001|STARTED|Overall Study||5
3036468|NCT01143636|3755670|FG002|STARTED|Overall Study||8
3036469|NCT01143636|3755671|FG003|STARTED|Overall Study||7
3036470|NCT01143636|3755668|FG000|COMPLETED|Overall Study||5
3036471|NCT01143636|3755669|FG001|COMPLETED|Overall Study||4
3036472|NCT01143636|3755670|FG002|COMPLETED|Overall Study||8
3036473|NCT01143636|3755671|FG003|COMPLETED|Overall Study||7
3036474|NCT01143636|3755668|FG000|NOT COMPLETED|Overall Study||1
3036475|NCT01143636|3755669|FG001|NOT COMPLETED|Overall Study||1
3036476|NCT01143636|3755670|FG002|NOT COMPLETED|Overall Study||0
3036477|NCT01143636|3755671|FG003|NOT COMPLETED|Overall Study||0
3036478|NCT01143649|3755686|FG000|STARTED|Overall Study||7
3036479|NCT01143649|3755687|FG001|STARTED|Overall Study||7
3036480|NCT01143649|3755688|FG002|STARTED|Overall Study||10
3036481|NCT01143649|3755689|FG003|STARTED|Overall Study||10
3036482|NCT01143649|3755690|FG004|STARTED|Overall Study||5
3036483|NCT01143649|3755691|FG005|STARTED|Overall Study||5
3036484|NCT01143649|3755686|FG000|COMPLETED|Overall Study||7
3036485|NCT01143649|3755687|FG001|COMPLETED|Overall Study||7
3036486|NCT01143649|3755688|FG002|COMPLETED|Overall Study||10
3036487|NCT01143649|3755689|FG003|COMPLETED|Overall Study||10
3036488|NCT01143649|3755690|FG004|COMPLETED|Overall Study||4
3036489|NCT01143649|3755691|FG005|COMPLETED|Overall Study||3
3133498|NCT01696188|3858476|FG000|COMPLETED|Overall Study||40
2985281|NCT00875706|3701452|FG000|STARTED|Overall Study||8
2985282|NCT00875706|3701453|FG001|STARTED|Overall Study||24
2985283|NCT00875706|3701454|FG002|STARTED|Overall Study||13
2985284|NCT00875706|3701452|FG000|COMPLETED|Overall Study||7
2985285|NCT00875706|3701453|FG001|COMPLETED|Overall Study||24
2985286|NCT00875706|3701454|FG002|COMPLETED|Overall Study||13
2985287|NCT00875706|3701452|FG000|NOT COMPLETED|Overall Study||1
2985288|NCT00875706|3701453|FG001|NOT COMPLETED|Overall Study||0
2985289|NCT00875706|3701454|FG002|NOT COMPLETED|Overall Study||0
2985290|NCT00875797|3701464|FG000|STARTED|Overall Study||45
2985291|NCT00875797|3701465|FG001|STARTED|Overall Study||45
2985292|NCT00875797|3701464|FG000|COMPLETED|Overall Study||39
2985293|NCT00875797|3701465|FG001|COMPLETED|Overall Study||42
2985294|NCT00875797|3701464|FG000|NOT COMPLETED|Overall Study||6
2985295|NCT00875797|3701465|FG001|NOT COMPLETED|Overall Study||3
2985296|NCT00875810|3701474|FG000|STARTED|Overall Study||194
2985297|NCT00875810|3701474|FG000|Implanted|Overall Study||190
2985298|NCT00875810|3701474|FG000|Discharged|Overall Study||177
2985299|NCT00875810|3701474|FG000|3 Months Follow up|Overall Study||175
2985300|NCT00875810|3701474|FG000|6 Months Follow up|Overall Study||80
2985301|NCT00875810|3701474|FG000|12 Months Follow up|Overall Study||112
2985302|NCT00875810|3701474|FG000|24 Months Follow up|Overall Study||148
2985303|NCT00875810|3701474|FG000|COMPLETED|Overall Study||148
2985304|NCT00875810|3701474|FG000|NOT COMPLETED|Overall Study||46
2985305|NCT00875836|3701480|FG000|STARTED|Overall Study||88
2985306|NCT00875836|3701481|FG001|STARTED|Overall Study||87
2985307|NCT00875836|3701480|FG000|COMPLETED|Overall Study||45
2985308|NCT00875836|3701481|FG001|COMPLETED|Overall Study||47
2985309|NCT00875836|3701480|FG000|NOT COMPLETED|Overall Study||43
2985310|NCT00875836|3701481|FG001|NOT COMPLETED|Overall Study||40
2985311|NCT00875979|3701489|FG000|STARTED|Dose Escalation Phase - 3.0 mg/kg||3
2985312|NCT00875979|3701490|FG001|STARTED|Dose Escalation Phase - 3.0 mg/kg||0
2985313|NCT00875979|3701489|FG000|COMPLETED|Dose Escalation Phase - 3.0 mg/kg||0
2985314|NCT00875979|3701490|FG001|COMPLETED|Dose Escalation Phase - 3.0 mg/kg||0
2985315|NCT00875979|3701489|FG000|NOT COMPLETED|Dose Escalation Phase - 3.0 mg/kg||3
2985316|NCT00875979|3701490|FG001|NOT COMPLETED|Dose Escalation Phase - 3.0 mg/kg||0
2985317|NCT00875979|3701489|FG000|STARTED|Dose Escalation Phase - 3.6 mg/kg||0
2985318|NCT00875979|3701490|FG001|STARTED|Dose Escalation Phase - 3.6 mg/kg||6
2985319|NCT00875979|3701489|FG000|COMPLETED|Dose Escalation Phase - 3.6 mg/kg||0
2985320|NCT00875979|3701490|FG001|COMPLETED|Dose Escalation Phase - 3.6 mg/kg||0
2985321|NCT00875979|3701489|FG000|NOT COMPLETED|Dose Escalation Phase - 3.6 mg/kg||0
2985322|NCT00875979|3701490|FG001|NOT COMPLETED|Dose Escalation Phase - 3.6 mg/kg||6
2985323|NCT00875979|3701489|FG000|STARTED|Dose Expansion Phase - 3.6 mg/kg||0
2985324|NCT00875979|3701490|FG001|STARTED|Dose Expansion Phase - 3.6 mg/kg||58
2985325|NCT00875979|3701489|FG000|COMPLETED|Dose Expansion Phase - 3.6 mg/kg||0
2985326|NCT00875979|3701490|FG001|COMPLETED|Dose Expansion Phase - 3.6 mg/kg||11
2985327|NCT00875979|3701489|FG000|NOT COMPLETED|Dose Expansion Phase - 3.6 mg/kg||0
2985328|NCT00875979|3701490|FG001|NOT COMPLETED|Dose Expansion Phase - 3.6 mg/kg||47
2985329|NCT00876018|3701499|FG000|STARTED|Overall Study||100
2985330|NCT00876018|3701500|FG001|STARTED|Overall Study||100
2985331|NCT00876018|3701501|FG002|STARTED|Overall Study||100
2985332|NCT00876018|3701499|FG000|COMPLETED|Overall Study||95
2985333|NCT00876018|3701500|FG001|COMPLETED|Overall Study||95
2985334|NCT00876018|3701501|FG002|COMPLETED|Overall Study||97
2985335|NCT00876018|3701499|FG000|NOT COMPLETED|Overall Study||5
2985336|NCT00876018|3701500|FG001|NOT COMPLETED|Overall Study||5
2985337|NCT00876018|3701501|FG002|NOT COMPLETED|Overall Study||3
2985338|NCT00876187|3701516|FG000|STARTED|Overall Study||233
2985339|NCT00876187|3701517|FG001|STARTED|Overall Study||233
2985340|NCT00876187|3701518|FG002|STARTED|Overall Study||298
2985341|NCT00876187|3701519|FG003|STARTED|Overall Study||297
2985342|NCT00876187|3701520|FG004|STARTED|Overall Study||298
2985343|NCT00876187|3701516|FG000|Treated|Overall Study||230
2985344|NCT00876187|3701517|FG001|Treated|Overall Study||232
2985345|NCT00876187|3701518|FG002|Treated|Overall Study||295
2985346|NCT00876187|3701519|FG003|Treated|Overall Study||295
2985347|NCT00876187|3701520|FG004|Treated|Overall Study||295
2985348|NCT00876187|3701516|FG000|Completed Treatment|Overall Study|Participants who completed treatment at Week 16 visit.|128
2985349|NCT00876187|3701517|FG001|Completed Treatment|Overall Study|Participants who completed treatment at Week 16 visit.|146
2985350|NCT00876187|3701518|FG002|Completed Treatment|Overall Study|Participants who completed treatment at Week 16 visit.|193
2985351|NCT00876187|3701519|FG003|Completed Treatment|Overall Study|Participants who completed treatment at Week 16 visit.|188
2985352|NCT00876187|3701520|FG004|Completed Treatment|Overall Study|Participants who completed treatment at Week 16 visit.|185
2985353|NCT00876187|3701516|FG000|COMPLETED|Overall Study||23
2985354|NCT00876187|3701517|FG001|COMPLETED|Overall Study||18
2985355|NCT00876187|3701518|FG002|COMPLETED|Overall Study||19
2985356|NCT00876187|3701519|FG003|COMPLETED|Overall Study||22
2985357|NCT00876187|3701520|FG004|COMPLETED|Overall Study||27
2985358|NCT00876187|3701516|FG000|NOT COMPLETED|Overall Study||210
2985359|NCT00876187|3701517|FG001|NOT COMPLETED|Overall Study||215
2985360|NCT00876187|3701518|FG002|NOT COMPLETED|Overall Study||279
2985361|NCT00876187|3701519|FG003|NOT COMPLETED|Overall Study||275
2985362|NCT00876187|3701520|FG004|NOT COMPLETED|Overall Study||271
2985363|NCT00876200|3701537|FG000|STARTED|Overall Study||9
2985364|NCT00876200|3701538|FG001|STARTED|Overall Study||12
2985365|NCT00876200|3701537|FG000|COMPLETED|Overall Study||8
2985366|NCT00876200|3701538|FG001|COMPLETED|Overall Study||9
2985367|NCT00876200|3701537|FG000|NOT COMPLETED|Overall Study||1
2985368|NCT00876200|3701538|FG001|NOT COMPLETED|Overall Study||3
2985369|NCT00876265|3701544|FG000|STARTED|Overall Study||118
2985370|NCT00876265|3701544|FG000|COMPLETED|Overall Study||106
2985371|NCT00876265|3701544|FG000|NOT COMPLETED|Overall Study||12
2985372|NCT00876343|3701553|FG000|STARTED|Overall Study||194
2985373|NCT00876343|3701554|FG001|STARTED|Overall Study||197
2985374|NCT00876343|3701555|FG002|STARTED|Overall Study||195
2985375|NCT00876343|3701553|FG000|COMPLETED|Overall Study||177
2985376|NCT00876343|3701554|FG001|COMPLETED|Overall Study||180
2985377|NCT00876343|3701555|FG002|COMPLETED|Overall Study||183
2985378|NCT00876343|3701553|FG000|NOT COMPLETED|Overall Study||17
2985379|NCT00876343|3701554|FG001|NOT COMPLETED|Overall Study||17
2985380|NCT00876343|3701555|FG002|NOT COMPLETED|Overall Study||12
2985381|NCT00876395|3701565|FG000|STARTED|Overall Study||480
2985382|NCT00876395|3701566|FG001|STARTED|Overall Study||239
2985383|NCT00876395|3701565|FG000|Untreated|Overall Study||8
2985384|NCT00876395|3701566|FG001|Untreated|Overall Study||1
2985385|NCT00876395|3701565|FG000|COMPLETED|Overall Study||0
2985386|NCT00876395|3701566|FG001|COMPLETED|Overall Study||0
2985387|NCT00876395|3701565|FG000|NOT COMPLETED|Overall Study||480
2985388|NCT00876395|3701566|FG001|NOT COMPLETED|Overall Study||239
2985389|NCT00876447|3701579|FG000|STARTED|Overall Study||185
2985390|NCT00876447|3701580|FG001|STARTED|Overall Study||203
2985391|NCT00876447|3701579|FG000|COMPLETED|Overall Study||105
2985392|NCT00876447|3701580|FG001|COMPLETED|Overall Study||122
2985393|NCT00876447|3701579|FG000|NOT COMPLETED|Overall Study||80
2985394|NCT00876447|3701580|FG001|NOT COMPLETED|Overall Study||81
2985395|NCT00876460|3701618|FG000|STARTED|Combination Therapy Phase||3
2985396|NCT00876460|3701619|FG001|STARTED|Combination Therapy Phase||7
2985397|NCT00876460|3701620|FG002|STARTED|Combination Therapy Phase||3
2985398|NCT00876460|3701621|FG003|STARTED|Combination Therapy Phase||6
2985399|NCT00876460|3701622|FG004|STARTED|Combination Therapy Phase||7
2985400|NCT00876460|3701623|FG005|STARTED|Combination Therapy Phase||3
2985401|NCT00876460|3701624|FG006|STARTED|Combination Therapy Phase||8
2985402|NCT00876460|3701625|FG007|STARTED|Combination Therapy Phase||6
2985403|NCT00876460|3701618|FG000|COMPLETED|Combination Therapy Phase||0
2985404|NCT00876460|3701619|FG001|COMPLETED|Combination Therapy Phase||0
2985405|NCT00876460|3701620|FG002|COMPLETED|Combination Therapy Phase||0
2985406|NCT00876460|3701621|FG003|COMPLETED|Combination Therapy Phase||0
2985407|NCT00876460|3701622|FG004|COMPLETED|Combination Therapy Phase||0
2985408|NCT00876460|3701623|FG005|COMPLETED|Combination Therapy Phase||0
2985409|NCT00876460|3701624|FG006|COMPLETED|Combination Therapy Phase||0
2985410|NCT00876460|3701625|FG007|COMPLETED|Combination Therapy Phase||0
2985411|NCT00876460|3701618|FG000|NOT COMPLETED|Combination Therapy Phase||3
2985412|NCT00876460|3701619|FG001|NOT COMPLETED|Combination Therapy Phase||7
2985413|NCT00876460|3701620|FG002|NOT COMPLETED|Combination Therapy Phase||3
2985414|NCT00876460|3701621|FG003|NOT COMPLETED|Combination Therapy Phase||6
2985415|NCT00876460|3701622|FG004|NOT COMPLETED|Combination Therapy Phase||7
2985416|NCT00876460|3701623|FG005|NOT COMPLETED|Combination Therapy Phase||3
2985417|NCT00876460|3701624|FG006|NOT COMPLETED|Combination Therapy Phase||8
2985418|NCT00876460|3701625|FG007|NOT COMPLETED|Combination Therapy Phase||6
2985419|NCT00876460|3701618|FG000|STARTED|Mono Therapy Phase||0
2985420|NCT00876460|3701619|FG001|STARTED|Mono Therapy Phase|One patient started mono therapy phase after discontinued from combination therapy phase.|1
2985421|NCT00876460|3701620|FG002|STARTED|Mono Therapy Phase||0
2985422|NCT00876460|3701621|FG003|STARTED|Mono Therapy Phase|One patient started mono therapy phase after discontinued from combination therapy phase.|1
2985423|NCT00876460|3701622|FG004|STARTED|Mono Therapy Phase|Two patients started mono therapy phase after discontinued from combination therapy phase.|2
2985424|NCT00876460|3701623|FG005|STARTED|Mono Therapy Phase||0
2985425|NCT00876460|3701624|FG006|STARTED|Mono Therapy Phase|One patient started mono therapy phase after discontinued from combination therapy phase.|1
2985426|NCT00876460|3701625|FG007|STARTED|Mono Therapy Phase|Three patients started mono therapy phase after discontinued from combination therapy phase.|3
2985427|NCT00876460|3701618|FG000|COMPLETED|Mono Therapy Phase||0
2985428|NCT00876460|3701619|FG001|COMPLETED|Mono Therapy Phase||0
2985429|NCT00876460|3701620|FG002|COMPLETED|Mono Therapy Phase||0
2985430|NCT00876460|3701621|FG003|COMPLETED|Mono Therapy Phase||0
2985431|NCT00876460|3701622|FG004|COMPLETED|Mono Therapy Phase||0
2985432|NCT00876460|3701623|FG005|COMPLETED|Mono Therapy Phase||0
2985433|NCT00876460|3701624|FG006|COMPLETED|Mono Therapy Phase||0
2985434|NCT00876460|3701625|FG007|COMPLETED|Mono Therapy Phase||0
2985435|NCT00876460|3701618|FG000|NOT COMPLETED|Mono Therapy Phase||0
2985436|NCT00876460|3701619|FG001|NOT COMPLETED|Mono Therapy Phase||1
2985437|NCT00876460|3701620|FG002|NOT COMPLETED|Mono Therapy Phase||0
2985438|NCT00876460|3701621|FG003|NOT COMPLETED|Mono Therapy Phase||1
2985439|NCT00876460|3701622|FG004|NOT COMPLETED|Mono Therapy Phase||2
2985440|NCT00876460|3701623|FG005|NOT COMPLETED|Mono Therapy Phase||0
2985441|NCT00876460|3701624|FG006|NOT COMPLETED|Mono Therapy Phase||1
2985442|NCT00876460|3701625|FG007|NOT COMPLETED|Mono Therapy Phase||3
2985443|NCT00876694|3701657|FG000|STARTED|Overall Study||125
2985444|NCT00876694|3701658|FG001|STARTED|Overall Study||61
2985445|NCT00876694|3701657|FG000|COMPLETED|Overall Study||104
2985446|NCT00876694|3701658|FG001|COMPLETED|Overall Study||49
2985447|NCT00876694|3701657|FG000|NOT COMPLETED|Overall Study||21
2985448|NCT00876694|3701658|FG001|NOT COMPLETED|Overall Study||12
2985449|NCT00876733|3701668|FG000|STARTED|Overall Study||288
2985450|NCT00876733|3701669|FG001|STARTED|Overall Study||203
2985451|NCT00876733|3701670|FG002|STARTED|Overall Study||93
2985452|NCT00876733|3701671|FG003|STARTED|Overall Study||21
2985453|NCT00876733|3701668|FG000|COMPLETED|Overall Study||197
2985454|NCT00876733|3701669|FG001|COMPLETED|Overall Study||161
2985455|NCT00876733|3701670|FG002|COMPLETED|Overall Study||63
2985456|NCT00876733|3701671|FG003|COMPLETED|Overall Study||14
2985457|NCT00876733|3701668|FG000|NOT COMPLETED|Overall Study||91
2985458|NCT00876733|3701669|FG001|NOT COMPLETED|Overall Study||42
2985459|NCT00876733|3701670|FG002|NOT COMPLETED|Overall Study||30
2985460|NCT00876733|3701671|FG003|NOT COMPLETED|Overall Study||7
2985461|NCT00876915|3701684|FG000|STARTED|Overall Study||50
2985462|NCT00876915|3701685|FG001|STARTED|Overall Study||48
2985463|NCT00876915|3701686|FG002|STARTED|Overall Study||101
2985464|NCT00876915|3701684|FG000|Week 4|Overall Study||38
2985465|NCT00876915|3701685|FG001|Week 4|Overall Study||45
2985466|NCT00876915|3701686|FG002|Week 4|Overall Study||0
2985467|NCT00876915|3701684|FG000|Week 8|Overall Study||33
2985468|NCT00876915|3701685|FG001|Week 8|Overall Study||36
2985469|NCT00876915|3701686|FG002|Week 8|Overall Study||0
2985470|NCT00876915|3701684|FG000|COMPLETED|Overall Study||31
2985471|NCT00876915|3701685|FG001|COMPLETED|Overall Study||34
2985472|NCT00876915|3701686|FG002|COMPLETED|Overall Study||101
2985473|NCT00876915|3701684|FG000|NOT COMPLETED|Overall Study||19
2985474|NCT00876915|3701685|FG001|NOT COMPLETED|Overall Study||14
2985475|NCT00876915|3701686|FG002|NOT COMPLETED|Overall Study||0
2985476|NCT00876928|3701696|FG000|STARTED|Overall Study||56
2985477|NCT00876928|3701697|FG001|STARTED|Overall Study||61
2985478|NCT00876928|3701696|FG000|COMPLETED|Overall Study||53
2985479|NCT00876928|3701697|FG001|COMPLETED|Overall Study||56
2985480|NCT00876928|3701696|FG000|NOT COMPLETED|Overall Study||3
2985481|NCT00876928|3701697|FG001|NOT COMPLETED|Overall Study||5
2985482|NCT00876993|3701708|FG000|STARTED|Overall Study||5
2985483|NCT00876993|3701709|FG001|STARTED|Overall Study||6
2985484|NCT00876993|3701710|FG002|STARTED|Overall Study||5
2985485|NCT00876993|3701711|FG003|STARTED|Overall Study||5
2985486|NCT00876993|3701712|FG004|STARTED|Overall Study||5
2985487|NCT00876993|3701708|FG000|COMPLETED|Overall Study||4
2985488|NCT00876993|3701709|FG001|COMPLETED|Overall Study||6
2985489|NCT00876993|3701710|FG002|COMPLETED|Overall Study||3
2985490|NCT00876993|3701711|FG003|COMPLETED|Overall Study||5
2985491|NCT00876993|3701712|FG004|COMPLETED|Overall Study||3
2985492|NCT00876993|3701708|FG000|NOT COMPLETED|Overall Study||1
2985493|NCT00876993|3701709|FG001|NOT COMPLETED|Overall Study||0
2985494|NCT00876993|3701710|FG002|NOT COMPLETED|Overall Study||2
2985495|NCT00876993|3701711|FG003|NOT COMPLETED|Overall Study||0
2985496|NCT00876993|3701712|FG004|NOT COMPLETED|Overall Study||2
2985497|NCT00877006|3701728|FG000|STARTED|Treatment Period||224
2985498|NCT00877006|3701729|FG001|STARTED|Treatment Period||223
2985499|NCT00877006|3701728|FG000|COMPLETED|Treatment Period||199
2985500|NCT00877006|3701729|FG001|COMPLETED|Treatment Period||196
2985501|NCT00877006|3701728|FG000|NOT COMPLETED|Treatment Period||25
2985502|NCT00877006|3701729|FG001|NOT COMPLETED|Treatment Period||27
2985503|NCT00877006|3701728|FG000|STARTED|Long-Term Follow-up Period||210
2985504|NCT00877006|3701729|FG001|STARTED|Long-Term Follow-up Period||209
2985505|NCT00877006|3701728|FG000|COMPLETED|Long-Term Follow-up Period||157
2985506|NCT00877006|3701729|FG001|COMPLETED|Long-Term Follow-up Period||154
2985507|NCT00877006|3701728|FG000|NOT COMPLETED|Long-Term Follow-up Period||53
2985508|NCT00877006|3701729|FG001|NOT COMPLETED|Long-Term Follow-up Period||55
2985509|NCT00877032|3701744|FG000|STARTED|Overall Study||6
2985510|NCT00877032|3701745|FG001|STARTED|Overall Study||6
2985511|NCT00877032|3701746|FG002|STARTED|Overall Study||6
2985512|NCT00877032|3701747|FG003|STARTED|Overall Study||7
2985513|NCT00877032|3701748|FG004|STARTED|Overall Study||6
2985514|NCT00877032|3701749|FG005|STARTED|Overall Study||6
2985515|NCT00877032|3701750|FG006|STARTED|Overall Study||20
2985516|NCT00877032|3701744|FG000|Treated|Overall Study||6
2985517|NCT00877032|3701745|FG001|Treated|Overall Study||6
2985518|NCT00877032|3701746|FG002|Treated|Overall Study||6
2985519|NCT00877032|3701747|FG003|Treated|Overall Study||6
2985520|NCT00877032|3701748|FG004|Treated|Overall Study||6
2985521|NCT00877032|3701749|FG005|Treated|Overall Study||6
2985522|NCT00877032|3701750|FG006|Treated|Overall Study||18
2985523|NCT00877032|3701744|FG000|COMPLETED|Overall Study||6
2985524|NCT00877032|3701745|FG001|COMPLETED|Overall Study||6
2985525|NCT00877032|3701746|FG002|COMPLETED|Overall Study||6
2985526|NCT00877032|3701747|FG003|COMPLETED|Overall Study||6
2985527|NCT00877032|3701748|FG004|COMPLETED|Overall Study||6
2985528|NCT00877032|3701749|FG005|COMPLETED|Overall Study||6
2985529|NCT00877032|3701750|FG006|COMPLETED|Overall Study||18
2985530|NCT00877032|3701744|FG000|NOT COMPLETED|Overall Study||0
2985531|NCT00877032|3701745|FG001|NOT COMPLETED|Overall Study||0
2985532|NCT00877032|3701746|FG002|NOT COMPLETED|Overall Study||0
2985533|NCT00877032|3701747|FG003|NOT COMPLETED|Overall Study||1
2985534|NCT00877032|3701748|FG004|NOT COMPLETED|Overall Study||0
2985535|NCT00877032|3701749|FG005|NOT COMPLETED|Overall Study||0
2985536|NCT00877032|3701750|FG006|NOT COMPLETED|Overall Study||2
2985537|NCT00877058|3701769|FG000|STARTED|Overall Study||174
2985538|NCT00877058|3701770|FG001|STARTED|Overall Study||171
2985539|NCT00877058|3701771|FG002|STARTED|Overall Study||114
2985540|NCT00877058|3701769|FG000|COMPLETED|Overall Study||137
2985541|NCT00877058|3701770|FG001|COMPLETED|Overall Study||131
2985542|NCT00877058|3701771|FG002|COMPLETED|Overall Study||75
2985543|NCT00877058|3701769|FG000|NOT COMPLETED|Overall Study||37
2985544|NCT00877058|3701770|FG001|NOT COMPLETED|Overall Study||40
2985545|NCT00877058|3701771|FG002|NOT COMPLETED|Overall Study||39
2985546|NCT00877370|3701779|FG000|STARTED|Overall Study||8
2985547|NCT00877370|3701779|FG000|COMPLETED|Overall Study||8
2985548|NCT00877370|3701779|FG000|NOT COMPLETED|Overall Study||0
2985549|NCT00877383|3701785|FG000|STARTED|Overall Study||572
2985550|NCT00877383|3701786|FG001|STARTED|Overall Study||570
2985551|NCT00877383|3701785|FG000|COMPLETED|Overall Study||543
2985552|NCT00877383|3701786|FG001|COMPLETED|Overall Study||533
2985553|NCT00877383|3701785|FG000|NOT COMPLETED|Overall Study||29
2985554|NCT00877383|3701786|FG001|NOT COMPLETED|Overall Study||37
2985555|NCT00877448|3701799|FG000|STARTED|Overall Study||10
2985556|NCT00877448|3701800|FG001|STARTED|Overall Study||10
2985557|NCT00877448|3701801|FG002|STARTED|Overall Study||10
2985558|NCT00877448|3701802|FG003|STARTED|Overall Study||10
2985559|NCT00877448|3701803|FG004|STARTED|Overall Study||10
2985560|NCT00877448|3701804|FG005|STARTED|Overall Study||10
2985561|NCT00877448|3701805|FG006|STARTED|Overall Study||3
2985562|NCT00877448|3701799|FG000|COMPLETED|Overall Study||10
2985563|NCT00877448|3701800|FG001|COMPLETED|Overall Study||9
2985564|NCT00877448|3701801|FG002|COMPLETED|Overall Study||10
2985565|NCT00877448|3701802|FG003|COMPLETED|Overall Study||9
2985566|NCT00877448|3701803|FG004|COMPLETED|Overall Study||10
2985567|NCT00877448|3701804|FG005|COMPLETED|Overall Study||9
2985568|NCT00877448|3701805|FG006|COMPLETED|Overall Study||3
3304770|NCT02981953|4038369|FG000|COMPLETED|Overall Study||29
3304771|NCT02981953|4038369|FG000|NOT COMPLETED|Overall Study||11
3304772|NCT02982018|4038375|FG000|STARTED|Overall Study||67
3304773|NCT02982018|4038376|FG001|STARTED|Overall Study||64
3304774|NCT02982018|4038375|FG000|COMPLETED|Overall Study||62
2985569|NCT00877448|3701799|FG000|NOT COMPLETED|Overall Study||0
2985570|NCT00877448|3701800|FG001|NOT COMPLETED|Overall Study||1
2985571|NCT00877448|3701801|FG002|NOT COMPLETED|Overall Study||0
2985572|NCT00877448|3701802|FG003|NOT COMPLETED|Overall Study||1
2985573|NCT00877448|3701803|FG004|NOT COMPLETED|Overall Study||0
2985574|NCT00877448|3701804|FG005|NOT COMPLETED|Overall Study||1
2985575|NCT00877448|3701805|FG006|NOT COMPLETED|Overall Study||0
2985576|NCT00877487|3701821|FG000|STARTED|Open-label Treatment Phase||123
2985577|NCT00877487|3701822|FG001|STARTED|Open-label Treatment Phase||0
2985578|NCT00877487|3701821|FG000|COMPLETED|Open-label Treatment Phase||116
2985579|NCT00877487|3701822|FG001|COMPLETED|Open-label Treatment Phase||0
2985580|NCT00877487|3701821|FG000|NOT COMPLETED|Open-label Treatment Phase||7
2985581|NCT00877487|3701822|FG001|NOT COMPLETED|Open-label Treatment Phase||0
2985582|NCT00877487|3701821|FG000|STARTED|Double-blind Randomized Withdrawal Phase||56
2985583|NCT00877487|3701822|FG001|STARTED|Double-blind Randomized Withdrawal Phase||60
2985584|NCT00877487|3701821|FG000|COMPLETED|Double-blind Randomized Withdrawal Phase||50
2985585|NCT00877487|3701822|FG001|COMPLETED|Double-blind Randomized Withdrawal Phase||13
2985586|NCT00877487|3701821|FG000|NOT COMPLETED|Double-blind Randomized Withdrawal Phase||6
2985587|NCT00877487|3701822|FG001|NOT COMPLETED|Double-blind Randomized Withdrawal Phase||47
2985588|NCT00877604|3701830|FG000|STARTED|Overall Study||17
2985589|NCT00877604|3701831|FG001|STARTED|Overall Study||17
2985590|NCT00877604|3701830|FG000|COMPLETED|Overall Study||15
2985591|NCT00877604|3701831|FG001|COMPLETED|Overall Study||14
2985592|NCT00877604|3701830|FG000|NOT COMPLETED|Overall Study||2
2985593|NCT00877604|3701831|FG001|NOT COMPLETED|Overall Study||3
2985594|NCT00877773|3701837|FG000|STARTED|Overall Study||44
2985595|NCT00877773|3701837|FG000|COMPLETED|Overall Study|No participant reached to first restaging.|0
2985596|NCT00877773|3701837|FG000|NOT COMPLETED|Overall Study||44
2985597|NCT00877799|3701846|FG000|STARTED|Cohort 1: 24 Hours After Surgery (Day 1)||25
2985598|NCT00877799|3701847|FG001|STARTED|Cohort 1: 24 Hours After Surgery (Day 1)||22
2985599|NCT00877799|3701848|FG002|STARTED|Cohort 1: 24 Hours After Surgery (Day 1)||21
2985600|NCT00877799|3701849|FG003|STARTED|Cohort 1: 24 Hours After Surgery (Day 1)||0
2985601|NCT00877799|3701850|FG004|STARTED|Cohort 1: 24 Hours After Surgery (Day 1)||0
2985602|NCT00877799|3701846|FG000|COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||22
2985603|NCT00877799|3701847|FG001|COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||17
2985604|NCT00877799|3701848|FG002|COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||18
2985605|NCT00877799|3701849|FG003|COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||0
2985606|NCT00877799|3701850|FG004|COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||0
2985607|NCT00877799|3701846|FG000|NOT COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||3
2985608|NCT00877799|3701847|FG001|NOT COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||5
2985609|NCT00877799|3701848|FG002|NOT COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||3
2985610|NCT00877799|3701849|FG003|NOT COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||0
2985611|NCT00877799|3701850|FG004|NOT COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||0
2985612|NCT00877799|3701846|FG000|STARTED|Cohort 2: Immediately Post-op (Day 0)||0
2985613|NCT00877799|3701847|FG001|STARTED|Cohort 2: Immediately Post-op (Day 0)||0
2985614|NCT00877799|3701848|FG002|STARTED|Cohort 2: Immediately Post-op (Day 0)||0
2985615|NCT00877799|3701849|FG003|STARTED|Cohort 2: Immediately Post-op (Day 0)||26
2985616|NCT00877799|3701850|FG004|STARTED|Cohort 2: Immediately Post-op (Day 0)||20
2985617|NCT00877799|3701846|FG000|COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
2985618|NCT00877799|3701847|FG001|COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
2985619|NCT00877799|3701848|FG002|COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
2985620|NCT00877799|3701849|FG003|COMPLETED|Cohort 2: Immediately Post-op (Day 0)||24
2985621|NCT00877799|3701850|FG004|COMPLETED|Cohort 2: Immediately Post-op (Day 0)||19
2985622|NCT00877799|3701846|FG000|NOT COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
2985623|NCT00877799|3701847|FG001|NOT COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
2985624|NCT00877799|3701848|FG002|NOT COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
2985625|NCT00877799|3701849|FG003|NOT COMPLETED|Cohort 2: Immediately Post-op (Day 0)||2
2985626|NCT00877799|3701850|FG004|NOT COMPLETED|Cohort 2: Immediately Post-op (Day 0)||1
2985627|NCT00877877|3701861|FG000|STARTED|Year 5||397
2985628|NCT00877877|3701861|FG000|COMPLETED|Year 5||397
2985629|NCT00877877|3701861|FG000|NOT COMPLETED|Year 5||0
2985630|NCT00877877|3701861|FG000|STARTED|Year 6||529
2985631|NCT00877877|3701861|FG000|COMPLETED|Year 6||529
2985632|NCT00877877|3701861|FG000|NOT COMPLETED|Year 6||0
2985633|NCT00877877|3701861|FG000|STARTED|Year 7||523
2985634|NCT00877877|3701861|FG000|COMPLETED|Year 7||523
2985635|NCT00877877|3701861|FG000|NOT COMPLETED|Year 7||0
2985636|NCT00877877|3701861|FG000|STARTED|Year 8||522
2985637|NCT00877877|3701861|FG000|COMPLETED|Year 8||522
2985638|NCT00877877|3701861|FG000|NOT COMPLETED|Year 8||0
2985639|NCT00877877|3701861|FG000|STARTED|Year 9||507
2985640|NCT00877877|3701861|FG000|COMPLETED|Year 9||507
2985641|NCT00877877|3701861|FG000|NOT COMPLETED|Year 9||0
2985642|NCT00877877|3701861|FG000|STARTED|Year 10||495
2985643|NCT00877877|3701861|FG000|COMPLETED|Year 10||495
2985644|NCT00877877|3701861|FG000|NOT COMPLETED|Year 10||0
2985645|NCT00877890|3701872|FG000|STARTED|Overall Study||129
2985646|NCT00877890|3701873|FG001|STARTED|Overall Study||125
2985647|NCT00877890|3701872|FG000|Intent to Treat (ITT)|Overall Study||129
2985648|NCT00877890|3701873|FG001|Intent to Treat (ITT)|Overall Study||123
2985649|NCT00877890|3701872|FG000|COMPLETED|Overall Study||109
2985650|NCT00877890|3701873|FG001|COMPLETED|Overall Study||95
2985651|NCT00877890|3701872|FG000|NOT COMPLETED|Overall Study||20
2985652|NCT00877890|3701873|FG001|NOT COMPLETED|Overall Study||30
2985653|NCT00877929|3701885|FG000|STARTED|Overall Study||352
2985654|NCT00877929|3701886|FG001|STARTED|Overall Study||354
2985655|NCT00877929|3701885|FG000|COMPLETED|Overall Study||332
2985656|NCT00877929|3701886|FG001|COMPLETED|Overall Study||319
2985657|NCT00877929|3701885|FG000|NOT COMPLETED|Overall Study||20
2985658|NCT00877929|3701886|FG001|NOT COMPLETED|Overall Study||35
2985659|NCT00878072|3701896|FG000|STARTED|Overall Study||53
2985660|NCT00878072|3701896|FG000|COMPLETED|Overall Study||51
2985661|NCT00878072|3701896|FG000|NOT COMPLETED|Overall Study||2
2985662|NCT00878189|3701907|FG000|STARTED|Overall Study||3
2985663|NCT00878189|3701908|FG001|STARTED|Overall Study||3
2985664|NCT00878189|3701909|FG002|STARTED|Overall Study||4
2985665|NCT00878189|3701910|FG003|STARTED|Overall Study||8
2985666|NCT00878189|3701911|FG004|STARTED|Overall Study||4
2985667|NCT00878189|3701912|FG005|STARTED|Overall Study||23
2985668|NCT00878189|3701913|FG006|STARTED|Overall Study||16
2985669|NCT00878189|3701914|FG007|STARTED|Overall Study||3
2985670|NCT00878189|3701915|FG008|STARTED|Overall Study||8
2985671|NCT00878189|3701907|FG000|COMPLETED|Overall Study||0
2985672|NCT00878189|3701908|FG001|COMPLETED|Overall Study||0
2985673|NCT00878189|3701909|FG002|COMPLETED|Overall Study||0
2985674|NCT00878189|3701910|FG003|COMPLETED|Overall Study||0
2985675|NCT00878189|3701911|FG004|COMPLETED|Overall Study||0
2985676|NCT00878189|3701912|FG005|COMPLETED|Overall Study||0
2985677|NCT00878189|3701913|FG006|COMPLETED|Overall Study||0
2985678|NCT00878189|3701914|FG007|COMPLETED|Overall Study||0
2985679|NCT00878189|3701915|FG008|COMPLETED|Overall Study||0
2985680|NCT00878189|3701907|FG000|NOT COMPLETED|Overall Study||3
2985681|NCT00878189|3701908|FG001|NOT COMPLETED|Overall Study||3
2985682|NCT00878189|3701909|FG002|NOT COMPLETED|Overall Study||4
2985683|NCT00878189|3701910|FG003|NOT COMPLETED|Overall Study||8
2985684|NCT00878189|3701911|FG004|NOT COMPLETED|Overall Study||4
2985685|NCT00878189|3701912|FG005|NOT COMPLETED|Overall Study||23
2985686|NCT00878189|3701913|FG006|NOT COMPLETED|Overall Study||16
2985687|NCT00878189|3701914|FG007|NOT COMPLETED|Overall Study||3
2985688|NCT00878189|3701915|FG008|NOT COMPLETED|Overall Study||8
3036490|NCT01143649|3755686|FG000|NOT COMPLETED|Overall Study||0
3036491|NCT01143649|3755687|FG001|NOT COMPLETED|Overall Study||0
3036492|NCT01143649|3755688|FG002|NOT COMPLETED|Overall Study||0
3036493|NCT01143649|3755689|FG003|NOT COMPLETED|Overall Study||0
3036494|NCT01143649|3755690|FG004|NOT COMPLETED|Overall Study||1
3036495|NCT01143649|3755691|FG005|NOT COMPLETED|Overall Study||2
3036496|NCT01143688|3755705|FG000|STARTED|Overall Study||39
3036497|NCT01143688|3755705|FG000|COMPLETED|Overall Study||39
3036498|NCT01143688|3755705|FG000|NOT COMPLETED|Overall Study||0
3036499|NCT01143701|3755717|FG000|STARTED|Overall Study||258
3036500|NCT01143701|3755718|FG001|STARTED|Overall Study||319
3036501|NCT01143701|3755717|FG000|COMPLETED|Overall Study|Number of patients for whom at least one set of post-baseline parent-ratings were collected|235
3036502|NCT01143701|3755718|FG001|COMPLETED|Overall Study|Number of patients for whom at least one set of post-baseline parent-ratings were collected|287
3036503|NCT01143701|3755717|FG000|NOT COMPLETED|Overall Study||23
3036504|NCT01143701|3755718|FG001|NOT COMPLETED|Overall Study||32
3036505|NCT01143714|3755726|FG000|STARTED|Overall Study||29
3036506|NCT01143714|3755727|FG001|STARTED|Overall Study||28
3036507|NCT01143714|3755726|FG000|COMPLETED|Overall Study||22
3036508|NCT01143714|3755727|FG001|COMPLETED|Overall Study||25
3036509|NCT01143714|3755726|FG000|NOT COMPLETED|Overall Study||7
3036510|NCT01143714|3755727|FG001|NOT COMPLETED|Overall Study||3
3036511|NCT01143727|3755735|FG000|STARTED|Overall Study||9
3036512|NCT01143727|3755736|FG001|STARTED|Overall Study||8
3036513|NCT01143727|3755735|FG000|COMPLETED|Overall Study||9
3133499|NCT01696188|3858477|FG001|COMPLETED|Overall Study||42
3133500|NCT01696188|3858476|FG000|NOT COMPLETED|Overall Study||1
3133501|NCT01696188|3858477|FG001|NOT COMPLETED|Overall Study||1
3133502|NCT01696214|3858487|FG000|STARTED|Overall Study||5
3133503|NCT01696214|3858488|FG001|STARTED|Overall Study||5
3133504|NCT01696214|3858489|FG002|STARTED|Overall Study||5
3133505|NCT01696214|3858490|FG003|STARTED|Overall Study||5
3133506|NCT01696214|3858487|FG000|COMPLETED|Overall Study||4
3133507|NCT01696214|3858488|FG001|COMPLETED|Overall Study||5
3133508|NCT01696214|3858489|FG002|COMPLETED|Overall Study||5
3133509|NCT01696214|3858490|FG003|COMPLETED|Overall Study||5
3133510|NCT01696214|3858487|FG000|NOT COMPLETED|Overall Study||1
3133511|NCT01696214|3858488|FG001|NOT COMPLETED|Overall Study||0
2985689|NCT00878215|3701953|FG000|STARTED|Overall Study||21
2985690|NCT00878215|3701954|FG001|STARTED|Overall Study||19
2985691|NCT00878215|3701955|FG002|STARTED|Overall Study|Phase 3 not performed because the liver imaging system became commercially available|0
2985692|NCT00878215|3701956|FG003|STARTED|Overall Study|Phase 4 not performed because the liver imaging system became commercially available|0
2985693|NCT00878215|3701953|FG000|COMPLETED|Overall Study||21
2985694|NCT00878215|3701954|FG001|COMPLETED|Overall Study||9
2985695|NCT00878215|3701955|FG002|COMPLETED|Overall Study||0
2985696|NCT00878215|3701956|FG003|COMPLETED|Overall Study||0
2985697|NCT00878215|3701953|FG000|NOT COMPLETED|Overall Study||0
2985698|NCT00878215|3701954|FG001|NOT COMPLETED|Overall Study||10
2985699|NCT00878215|3701955|FG002|NOT COMPLETED|Overall Study||0
2985700|NCT00878215|3701956|FG003|NOT COMPLETED|Overall Study||0
2985701|NCT00878228|3701968|FG000|STARTED|Overall Study||49
2985702|NCT00878228|3701969|FG001|STARTED|Overall Study||49
2985703|NCT00878228|3701968|FG000|COMPLETED|Overall Study||39
2985704|NCT00878228|3701969|FG001|COMPLETED|Overall Study||37
2985705|NCT00878228|3701968|FG000|NOT COMPLETED|Overall Study||10
2985706|NCT00878228|3701969|FG001|NOT COMPLETED|Overall Study||12
2985707|NCT00878436|3701977|FG000|STARTED|Overall Study||28
2985708|NCT00878436|3701978|FG001|STARTED|Overall Study||24
2985709|NCT00878436|3701977|FG000|Completed 2 Cycles|Overall Study||21
2985710|NCT00878436|3701978|FG001|Completed 2 Cycles|Overall Study||20
2985711|NCT00878436|3701977|FG000|6 Months|Overall Study||8
2985712|NCT00878436|3701978|FG001|6 Months|Overall Study||0
2985713|NCT00878436|3701977|FG000|COMPLETED|Overall Study||5
2985714|NCT00878436|3701978|FG001|COMPLETED|Overall Study||0
2985715|NCT00878436|3701977|FG000|NOT COMPLETED|Overall Study||23
2985716|NCT00878436|3701978|FG001|NOT COMPLETED|Overall Study||24
2985717|NCT00878501|3701987|FG000|STARTED|Overall Study|One of these patients did not receive study drug since incorrectly enrolled (mis-randomisation)|104
2985718|NCT00878501|3701988|FG001|STARTED|Overall Study||44
2985719|NCT00878501|3701989|FG002|STARTED|Overall Study||93
2985720|NCT00878501|3701987|FG000|Interim Analysis|Overall Study||83
2985721|NCT00878501|3701988|FG001|Interim Analysis|Overall Study||37
2985722|NCT00878501|3701989|FG002|Interim Analysis|Overall Study||81
2985723|NCT00878501|3701987|FG000|COMPLETED|Overall Study||87
2985724|NCT00878501|3701988|FG001|COMPLETED|Overall Study||37
2985725|NCT00878501|3701989|FG002|COMPLETED|Overall Study||85
2985726|NCT00878501|3701987|FG000|NOT COMPLETED|Overall Study||17
2985727|NCT00878501|3701988|FG001|NOT COMPLETED|Overall Study||7
2985728|NCT00878501|3701989|FG002|NOT COMPLETED|Overall Study||8
2985729|NCT00878553|3702001|FG000|STARTED|Sleep Study|This Intention to Treat population includes all randomized patients; one dropped prior to treatment.|67
2985730|NCT00878553|3702002|FG001|STARTED|Sleep Study||0
2985731|NCT00878553|3702003|FG002|STARTED|Sleep Study||0
2985732|NCT00878553|3702004|FG003|STARTED|Sleep Study||0
2985733|NCT00878553|3702005|FG004|STARTED|Sleep Study||0
2985734|NCT00878553|3702001|FG000|Number of Patients Receiving Placebo|Sleep Study||66
2985735|NCT00878553|3702002|FG001|Number of Patients Receiving Placebo|Sleep Study||0
2985736|NCT00878553|3702003|FG002|Number of Patients Receiving Placebo|Sleep Study||0
2985737|NCT00878553|3702004|FG003|Number of Patients Receiving Placebo|Sleep Study||0
2985738|NCT00878553|3702005|FG004|Number of Patients Receiving Placebo|Sleep Study||0
2985739|NCT00878553|3702001|FG000|Number of Patients Receiving 10mg|Sleep Study||65
2985740|NCT00878553|3702002|FG001|Number of Patients Receiving 10mg|Sleep Study||0
2985741|NCT00878553|3702003|FG002|Number of Patients Receiving 10mg|Sleep Study||0
2985742|NCT00878553|3702004|FG003|Number of Patients Receiving 10mg|Sleep Study||0
2985743|NCT00878553|3702005|FG004|Number of Patients Receiving 10mg|Sleep Study||0
2985744|NCT00878553|3702001|FG000|Number of Patients Receiving 15mg|Sleep Study||65
2985745|NCT00878553|3702002|FG001|Number of Patients Receiving 15mg|Sleep Study||0
2985746|NCT00878553|3702003|FG002|Number of Patients Receiving 15mg|Sleep Study||0
2985747|NCT00878553|3702004|FG003|Number of Patients Receiving 15mg|Sleep Study||0
2985748|NCT00878553|3702005|FG004|Number of Patients Receiving 15mg|Sleep Study||0
2985749|NCT00878553|3702001|FG000|Number of Patients Receiving 20mg|Sleep Study||65
2985750|NCT00878553|3702002|FG001|Number of Patients Receiving 20mg|Sleep Study||0
2985751|NCT00878553|3702003|FG002|Number of Patients Receiving 20mg|Sleep Study||0
2985752|NCT00878553|3702004|FG003|Number of Patients Receiving 20mg|Sleep Study||0
2985753|NCT00878553|3702005|FG004|Number of Patients Receiving 20mg|Sleep Study||0
3133512|NCT01696214|3858489|FG002|NOT COMPLETED|Overall Study||0
3133513|NCT01696214|3858490|FG003|NOT COMPLETED|Overall Study||0
3133514|NCT01696279|3858508|FG000|STARTED|Part 1: Single Dose Lanthanum Carbonate||20
3133515|NCT01696279|3858509|FG001|STARTED|Part 1: Single Dose Lanthanum Carbonate||0
3133516|NCT01696279|3858510|FG002|STARTED|Part 1: Single Dose Lanthanum Carbonate||0
2985754|NCT00878553|3702001|FG000|COMPLETED|Sleep Study|5 patient withdraws result in greater than 5 lost patient data across groups due to CROSSOVER design|62
2985755|NCT00878553|3702002|FG001|COMPLETED|Sleep Study||0
2985756|NCT00878553|3702003|FG002|COMPLETED|Sleep Study||0
2985757|NCT00878553|3702004|FG003|COMPLETED|Sleep Study||0
2985758|NCT00878553|3702005|FG004|COMPLETED|Sleep Study||0
2985759|NCT00878553|3702001|FG000|NOT COMPLETED|Sleep Study||5
2985760|NCT00878553|3702002|FG001|NOT COMPLETED|Sleep Study||0
2985761|NCT00878553|3702003|FG002|NOT COMPLETED|Sleep Study||0
2985762|NCT00878553|3702004|FG003|NOT COMPLETED|Sleep Study||0
2985763|NCT00878553|3702005|FG004|NOT COMPLETED|Sleep Study||0
2985764|NCT00878553|3702001|FG000|STARTED|PK Study|A total of 62 randomized patients started this parallel group, single dose PK substudy.|0
2985765|NCT00878553|3702002|FG001|STARTED|PK Study|During the PK period, 16 randomized participants received one bedtime dose of SKP-1041 placebo.|16
2985766|NCT00878553|3702003|FG002|STARTED|PK Study|During the PK period, 17 randomized participants received one bedtime dose of 10mg SKP-1041.|17
2985767|NCT00878553|3702004|FG003|STARTED|PK Study|During the PK period, 14 participants were randomized to receive one bedtime dose of 15mg SKP-1041.|14
2985768|NCT00878553|3702005|FG004|STARTED|PK Study|During the PK period, 15 randomized participants received one bedtime dose of 20mg SKP-1041.|15
2985769|NCT00878553|3702001|FG000|COMPLETED|PK Study|A total of 61 randomized patients completed this parallel group, single dose PK substudy.|0
2985770|NCT00878553|3702002|FG001|COMPLETED|PK Study||16
2985771|NCT00878553|3702003|FG002|COMPLETED|PK Study||17
2985772|NCT00878553|3702004|FG003|COMPLETED|PK Study|One patient withdrew consent after completing the Sleep Substudy and prior to starting PK substudy.|13
2985773|NCT00878553|3702005|FG004|COMPLETED|PK Study||15
2985774|NCT00878553|3702001|FG000|NOT COMPLETED|PK Study||0
2985775|NCT00878553|3702002|FG001|NOT COMPLETED|PK Study||0
2985776|NCT00878553|3702003|FG002|NOT COMPLETED|PK Study||0
2985777|NCT00878553|3702004|FG003|NOT COMPLETED|PK Study||1
2985778|NCT00878553|3702005|FG004|NOT COMPLETED|PK Study||0
2985779|NCT00878644|3702024|FG000|STARTED|Overall Study||155
2985780|NCT00878644|3702025|FG001|STARTED|Overall Study||140
2985781|NCT00878644|3702024|FG000|COMPLETED|Overall Study||151
2985782|NCT00878644|3702025|FG001|COMPLETED|Overall Study||136
2985783|NCT00878644|3702024|FG000|NOT COMPLETED|Overall Study||4
2985784|NCT00878644|3702025|FG001|NOT COMPLETED|Overall Study||4
2985785|NCT00878709|3702033|FG000|STARTED|Overall Study||1420
2985786|NCT00878709|3702034|FG001|STARTED|Overall Study||1420
2985787|NCT00878709|3702033|FG000|COMPLETED|Overall Study||1095
2985788|NCT00878709|3702034|FG001|COMPLETED|Overall Study||1183
2985789|NCT00878709|3702033|FG000|NOT COMPLETED|Overall Study||325
2985790|NCT00878709|3702034|FG001|NOT COMPLETED|Overall Study||237
2985791|NCT00878722|3702049|FG000|STARTED|Overall Study||3
2985792|NCT00878722|3702050|FG001|STARTED|Overall Study||3
2985793|NCT00878722|3702051|FG002|STARTED|Overall Study||3
2985794|NCT00878722|3702052|FG003|STARTED|Overall Study||9
2985795|NCT00878722|3702053|FG004|STARTED|Overall Study||7
2985796|NCT00878722|3702054|FG005|STARTED|Overall Study||3
2985797|NCT00878722|3702055|FG006|STARTED|Overall Study||6
2985798|NCT00878722|3702056|FG007|STARTED|Overall Study||7
2985799|NCT00878722|3702049|FG000|COMPLETED|Overall Study||0
2985800|NCT00878722|3702050|FG001|COMPLETED|Overall Study||0
2985801|NCT00878722|3702051|FG002|COMPLETED|Overall Study||0
2985802|NCT00878722|3702052|FG003|COMPLETED|Overall Study||0
2985803|NCT00878722|3702053|FG004|COMPLETED|Overall Study||0
2985804|NCT00878722|3702054|FG005|COMPLETED|Overall Study||1
2985805|NCT00878722|3702055|FG006|COMPLETED|Overall Study||0
2985806|NCT00878722|3702056|FG007|COMPLETED|Overall Study||0
2985807|NCT00878722|3702049|FG000|NOT COMPLETED|Overall Study||3
2985808|NCT00878722|3702050|FG001|NOT COMPLETED|Overall Study||3
2985809|NCT00878722|3702051|FG002|NOT COMPLETED|Overall Study||3
2985810|NCT00878722|3702052|FG003|NOT COMPLETED|Overall Study||9
2985811|NCT00878722|3702053|FG004|NOT COMPLETED|Overall Study||7
2985812|NCT00878722|3702054|FG005|NOT COMPLETED|Overall Study||2
2985813|NCT00878722|3702055|FG006|NOT COMPLETED|Overall Study||6
2985814|NCT00878722|3702056|FG007|NOT COMPLETED|Overall Study||7
2985815|NCT00878800|3702082|FG000|STARTED|Overall Study||3
2985816|NCT00878800|3702083|FG001|STARTED|Overall Study||7
2985817|NCT00878800|3702084|FG002|STARTED|Overall Study||9
2985818|NCT00878800|3702085|FG003|STARTED|Overall Study||6
2985819|NCT00878800|3702086|FG004|STARTED|Overall Study||16
2985820|NCT00878800|3702082|FG000|COMPLETED|Overall Study|Mean number of cycles administered: 4.0|0
2985821|NCT00878800|3702083|FG001|COMPLETED|Overall Study|Mean number of cycles administered: 4.6|0
2985822|NCT00878800|3702084|FG002|COMPLETED|Overall Study|Mean number of cycles administered: 3.0|0
2985823|NCT00878800|3702085|FG003|COMPLETED|Overall Study|Mean number of cycles administered: 5.3|0
2985824|NCT00878800|3702086|FG004|COMPLETED|Overall Study|Mean number of cycles administered: 6.4|0
2985825|NCT00878800|3702082|FG000|NOT COMPLETED|Overall Study||3
2985826|NCT00878800|3702083|FG001|NOT COMPLETED|Overall Study||7
2985827|NCT00878800|3702084|FG002|NOT COMPLETED|Overall Study||9
2985828|NCT00878800|3702085|FG003|NOT COMPLETED|Overall Study||6
2985829|NCT00878800|3702086|FG004|NOT COMPLETED|Overall Study||16
2985830|NCT00878826|3702100|FG000|STARTED|Overall Study||3
2985831|NCT00878826|3702101|FG001|STARTED|Overall Study||6
2985832|NCT00878826|3702102|FG002|STARTED|Overall Study||2
2985833|NCT00878826|3702100|FG000|COMPLETED|Overall Study||3
2985834|NCT00878826|3702101|FG001|COMPLETED|Overall Study||6
2985835|NCT00878826|3702102|FG002|COMPLETED|Overall Study||2
2985836|NCT00878826|3702100|FG000|NOT COMPLETED|Overall Study||0
2985837|NCT00878826|3702101|FG001|NOT COMPLETED|Overall Study||0
2985838|NCT00878826|3702102|FG002|NOT COMPLETED|Overall Study||0
2985839|NCT00878878|3702112|FG000|STARTED|Overall Study||15
2985840|NCT00878878|3702113|FG001|STARTED|Overall Study||15
2985841|NCT00878878|3702112|FG000|COMPLETED|Overall Study||15
2985842|NCT00878878|3702113|FG001|COMPLETED|Overall Study||15
2985843|NCT00878878|3702112|FG000|NOT COMPLETED|Overall Study||0
2985844|NCT00878878|3702113|FG001|NOT COMPLETED|Overall Study||0
2985845|NCT00878995|3702123|FG000|STARTED|Baseline Study - Midpoint Study||12
2985846|NCT00878995|3702124|FG001|STARTED|Baseline Study - Midpoint Study||12
2985847|NCT00878995|3702123|FG000|Baseline Study|Baseline Study - Midpoint Study||12
2985848|NCT00878995|3702124|FG001|Baseline Study|Baseline Study - Midpoint Study||12
2985849|NCT00878995|3702123|FG000|COMPLETED|Baseline Study - Midpoint Study||12
2985850|NCT00878995|3702124|FG001|COMPLETED|Baseline Study - Midpoint Study|2 subjects dropped after the baseline study. They decided to seek treatment closer to home.|10
2985851|NCT00878995|3702123|FG000|NOT COMPLETED|Baseline Study - Midpoint Study||0
2985852|NCT00878995|3702124|FG001|NOT COMPLETED|Baseline Study - Midpoint Study||2
2985853|NCT00878995|3702123|FG000|STARTED|Midpoint Study - Post Study||12
2985854|NCT00878995|3702124|FG001|STARTED|Midpoint Study - Post Study||10
2985855|NCT00878995|3702123|FG000|COMPLETED|Midpoint Study - Post Study||12
2985856|NCT00878995|3702124|FG001|COMPLETED|Midpoint Study - Post Study||10
2985857|NCT00878995|3702123|FG000|NOT COMPLETED|Midpoint Study - Post Study||0
2985858|NCT00878995|3702124|FG001|NOT COMPLETED|Midpoint Study - Post Study||0
2985859|NCT00879034|3702130|FG000|STARTED|Overall Study||5
2985860|NCT00879034|3702130|FG000|Received Treatment|Overall Study||4
2985861|NCT00879034|3702130|FG000|COMPLETED|Overall Study||5
2985862|NCT00879034|3702130|FG000|NOT COMPLETED|Overall Study||0
2985863|NCT00879060|3702136|FG000|STARTED|Overall Study||26
2985864|NCT00879060|3702137|FG001|STARTED|Overall Study||27
2985865|NCT00879060|3702136|FG000|COMPLETED|Overall Study||26
2985866|NCT00879060|3702137|FG001|COMPLETED|Overall Study||27
2985867|NCT00879060|3702136|FG000|NOT COMPLETED|Overall Study||0
2985868|NCT00879060|3702137|FG001|NOT COMPLETED|Overall Study||0
2985869|NCT00879190|3702148|FG000|STARTED|Overall Study||43
2985870|NCT00879190|3702149|FG001|STARTED|Overall Study||49
2985871|NCT00879190|3702148|FG000|COMPLETED|Overall Study||43
2985872|NCT00879190|3702149|FG001|COMPLETED|Overall Study||49
2985873|NCT00879190|3702148|FG000|NOT COMPLETED|Overall Study||0
2985874|NCT00879190|3702149|FG001|NOT COMPLETED|Overall Study||0
2985875|NCT00879229|3702157|FG000|STARTED|Overall Study||25
2985876|NCT00879229|3702158|FG001|STARTED|Overall Study||15
2985877|NCT00879229|3702157|FG000|COMPLETED|Overall Study||3
2985878|NCT00879229|3702158|FG001|COMPLETED|Overall Study||1
2985879|NCT00879229|3702157|FG000|NOT COMPLETED|Overall Study||22
2985880|NCT00879229|3702158|FG001|NOT COMPLETED|Overall Study||14
2985881|NCT00879255|3702166|FG000|STARTED|Overall Study||61
2985882|NCT00879255|3702167|FG001|STARTED|Overall Study||64
2985883|NCT00879255|3702166|FG000|Received Allocated Intervention:|Overall Study||51
2985884|NCT00879255|3702167|FG001|Received Allocated Intervention:|Overall Study||56
2985885|NCT00879255|3702166|FG000|Completed Posttreatment Follow-up|Overall Study||50
2985886|NCT00879255|3702167|FG001|Completed Posttreatment Follow-up|Overall Study||55
2985887|NCT00879255|3702166|FG000|Completed 3-mo Follow-up|Overall Study||48
2985888|NCT00879255|3702167|FG001|Completed 3-mo Follow-up|Overall Study||49
2985889|NCT00879255|3702166|FG000|COMPLETED|Overall Study|Completed 6-mo follow-up|45
2985890|NCT00879255|3702167|FG001|COMPLETED|Overall Study|Completed 6-mo follow-up|45
2985891|NCT00879255|3702166|FG000|NOT COMPLETED|Overall Study||16
2985892|NCT00879255|3702167|FG001|NOT COMPLETED|Overall Study||19
2985893|NCT00879333|3702175|FG000|STARTED|Overall Study||439
2985894|NCT00879333|3702176|FG001|STARTED|Overall Study||217
2985895|NCT00879333|3702175|FG000|Discontinued Study Treatment|Overall Study||428
2985896|NCT00879333|3702176|FG001|Discontinued Study Treatment|Overall Study||217
2985897|NCT00879333|3702175|FG000|COMPLETED|Overall Study|Completed=Patients Still on Treatment; At data cutoff final analysis, 11 patients were on treatment|11
2985898|NCT00879333|3702176|FG001|COMPLETED|Overall Study||0
2985899|NCT00879333|3702175|FG000|NOT COMPLETED|Overall Study||428
2985900|NCT00879333|3702176|FG001|NOT COMPLETED|Overall Study||217
2985901|NCT00879359|3702184|FG000|STARTED|Overall Study||15
2985902|NCT00879359|3702184|FG000|COMPLETED|Overall Study||15
2985903|NCT00879359|3702184|FG000|NOT COMPLETED|Overall Study||0
2985904|NCT00879398|3702189|FG000|STARTED|Overall Study||3109
2985905|NCT00879398|3702189|FG000|COMPLETED|Overall Study||2434
2985906|NCT00879398|3702189|FG000|NOT COMPLETED|Overall Study||675
2985907|NCT00879411|3702193|FG000|STARTED|Overall Study||701
2985908|NCT00879411|3702193|FG000|COMPLETED|Overall Study||539
2985909|NCT00879411|3702193|FG000|NOT COMPLETED|Overall Study||162
2985910|NCT00879437|3702197|FG000|STARTED|Overall Study||20
2985911|NCT00879437|3702198|FG001|STARTED|Overall Study||18
2985912|NCT00879437|3702197|FG000|COMPLETED|Overall Study||19
2985913|NCT00879437|3702198|FG001|COMPLETED|Overall Study||17
2985914|NCT00879437|3702197|FG000|NOT COMPLETED|Overall Study||1
2985915|NCT00879437|3702198|FG001|NOT COMPLETED|Overall Study||1
2985916|NCT00879645|3702210|FG000|STARTED|Overall Study||9
2985917|NCT00879645|3702211|FG001|STARTED|Overall Study||6
2985918|NCT00879645|3702212|FG002|STARTED|Overall Study||6
2985919|NCT00879645|3702213|FG003|STARTED|Overall Study||7
2985920|NCT00879645|3702210|FG000|COMPLETED|Overall Study||8
2985921|NCT00879645|3702211|FG001|COMPLETED|Overall Study||6
2985922|NCT00879645|3702212|FG002|COMPLETED|Overall Study||6
2985923|NCT00879645|3702213|FG003|COMPLETED|Overall Study||7
2985924|NCT00879645|3702210|FG000|NOT COMPLETED|Overall Study||1
2985925|NCT00879645|3702211|FG001|NOT COMPLETED|Overall Study||0
2985926|NCT00879645|3702212|FG002|NOT COMPLETED|Overall Study||0
2985927|NCT00879645|3702213|FG003|NOT COMPLETED|Overall Study||0
2985928|NCT00879658|3702230|FG000|STARTED|Overall Study||50
2985929|NCT00879658|3702231|FG001|STARTED|Overall Study||49
2985930|NCT00879658|3702232|FG002|STARTED|Overall Study||43
2985931|NCT00879658|3702233|FG003|STARTED|Overall Study||46
2985932|NCT00879658|3702234|FG004|STARTED|Overall Study||42
2985933|NCT00879658|3702235|FG005|STARTED|Overall Study||51
2985934|NCT00879658|3702236|FG006|STARTED|Overall Study||16
2985935|NCT00879658|3702230|FG000|COMPLETED|Overall Study||35
2985936|NCT00879658|3702231|FG001|COMPLETED|Overall Study||44
2985937|NCT00879658|3702232|FG002|COMPLETED|Overall Study||36
2985938|NCT00879658|3702233|FG003|COMPLETED|Overall Study||42
2985939|NCT00879658|3702234|FG004|COMPLETED|Overall Study||40
2985940|NCT00879658|3702235|FG005|COMPLETED|Overall Study||50
2985941|NCT00879658|3702236|FG006|COMPLETED|Overall Study||16
2985942|NCT00879658|3702230|FG000|NOT COMPLETED|Overall Study||15
2985943|NCT00879658|3702231|FG001|NOT COMPLETED|Overall Study||5
2985944|NCT00879658|3702232|FG002|NOT COMPLETED|Overall Study||7
2985945|NCT00879658|3702233|FG003|NOT COMPLETED|Overall Study||4
2985946|NCT00879658|3702234|FG004|NOT COMPLETED|Overall Study||2
2985947|NCT00879658|3702235|FG005|NOT COMPLETED|Overall Study||1
2985948|NCT00879658|3702236|FG006|NOT COMPLETED|Overall Study||0
2985949|NCT00879684|3702258|FG000|STARTED|Stage 1: Dose Escalation||3
2985950|NCT00879684|3702259|FG001|STARTED|Stage 1: Dose Escalation||3
2985951|NCT00879684|3702260|FG002|STARTED|Stage 1: Dose Escalation||3
2985952|NCT00879684|3702261|FG003|STARTED|Stage 1: Dose Escalation||6
2985953|NCT00879684|3702262|FG004|STARTED|Stage 1: Dose Escalation||3
2985954|NCT00879684|3702263|FG005|STARTED|Stage 1: Dose Escalation||3
2985955|NCT00879684|3702264|FG006|STARTED|Stage 1: Dose Escalation||0
2985956|NCT00879684|3702258|FG000|COMPLETED|Stage 1: Dose Escalation||0
2985957|NCT00879684|3702259|FG001|COMPLETED|Stage 1: Dose Escalation||0
2985958|NCT00879684|3702260|FG002|COMPLETED|Stage 1: Dose Escalation||0
3164388|NCT01892189|3891784|FG006|COMPLETED|Second Intervention Period (1 Day)||2
3164389|NCT01892189|3891785|FG007|COMPLETED|Second Intervention Period (1 Day)||3
3164390|NCT01892189|3891786|FG008|COMPLETED|Second Intervention Period (1 Day)||1
3164391|NCT01892189|3891778|FG000|NOT COMPLETED|Second Intervention Period (1 Day)||0
3164392|NCT01892189|3891779|FG001|NOT COMPLETED|Second Intervention Period (1 Day)||0
3164393|NCT01892189|3891780|FG002|NOT COMPLETED|Second Intervention Period (1 Day)||0
3164394|NCT01892189|3891781|FG003|NOT COMPLETED|Second Intervention Period (1 Day)||0
2985959|NCT00879684|3702261|FG003|COMPLETED|Stage 1: Dose Escalation||0
2985960|NCT00879684|3702262|FG004|COMPLETED|Stage 1: Dose Escalation||0
2985961|NCT00879684|3702263|FG005|COMPLETED|Stage 1: Dose Escalation||0
2985962|NCT00879684|3702264|FG006|COMPLETED|Stage 1: Dose Escalation||0
2985963|NCT00879684|3702258|FG000|NOT COMPLETED|Stage 1: Dose Escalation||3
2985964|NCT00879684|3702259|FG001|NOT COMPLETED|Stage 1: Dose Escalation||3
2985965|NCT00879684|3702260|FG002|NOT COMPLETED|Stage 1: Dose Escalation||3
2985966|NCT00879684|3702261|FG003|NOT COMPLETED|Stage 1: Dose Escalation||6
2985967|NCT00879684|3702262|FG004|NOT COMPLETED|Stage 1: Dose Escalation||3
2985968|NCT00879684|3702263|FG005|NOT COMPLETED|Stage 1: Dose Escalation||3
2985969|NCT00879684|3702264|FG006|NOT COMPLETED|Stage 1: Dose Escalation||0
2985970|NCT00879684|3702258|FG000|STARTED|Stage 2: Expanded Cohort||0
2985971|NCT00879684|3702259|FG001|STARTED|Stage 2: Expanded Cohort||0
2985972|NCT00879684|3702260|FG002|STARTED|Stage 2: Expanded Cohort||0
2985973|NCT00879684|3702261|FG003|STARTED|Stage 2: Expanded Cohort||0
2985974|NCT00879684|3702262|FG004|STARTED|Stage 2: Expanded Cohort||0
2985975|NCT00879684|3702263|FG005|STARTED|Stage 2: Expanded Cohort||0
2985976|NCT00879684|3702264|FG006|STARTED|Stage 2: Expanded Cohort||13
2985977|NCT00879684|3702258|FG000|COMPLETED|Stage 2: Expanded Cohort||0
2985978|NCT00879684|3702259|FG001|COMPLETED|Stage 2: Expanded Cohort||0
2985979|NCT00879684|3702260|FG002|COMPLETED|Stage 2: Expanded Cohort||0
2985980|NCT00879684|3702261|FG003|COMPLETED|Stage 2: Expanded Cohort||0
2985981|NCT00879684|3702262|FG004|COMPLETED|Stage 2: Expanded Cohort||0
2985982|NCT00879684|3702263|FG005|COMPLETED|Stage 2: Expanded Cohort||0
2985983|NCT00879684|3702264|FG006|COMPLETED|Stage 2: Expanded Cohort||0
2985984|NCT00879684|3702258|FG000|NOT COMPLETED|Stage 2: Expanded Cohort||0
2985985|NCT00879684|3702259|FG001|NOT COMPLETED|Stage 2: Expanded Cohort||0
2985986|NCT00879684|3702260|FG002|NOT COMPLETED|Stage 2: Expanded Cohort||0
2985987|NCT00879684|3702261|FG003|NOT COMPLETED|Stage 2: Expanded Cohort||0
2985988|NCT00879684|3702262|FG004|NOT COMPLETED|Stage 2: Expanded Cohort||0
2985989|NCT00879684|3702263|FG005|NOT COMPLETED|Stage 2: Expanded Cohort||0
2985990|NCT00879684|3702264|FG006|NOT COMPLETED|Stage 2: Expanded Cohort||13
2985991|NCT00879697|3702285|FG000|STARTED|Overall Study|Seventeen patients achieved inclusion and exclusion criteria|17
2985992|NCT00879697|3702286|FG001|STARTED|Overall Study|Seventeen patients achieved inclusion and exclusion criteria|17
2985993|NCT00879697|3702285|FG000|COMPLETED|Overall Study|Two patients did not finish the trial|15
2985994|NCT00879697|3702286|FG001|COMPLETED|Overall Study|Two patients did not finish the trial|15
2985995|NCT00879697|3702285|FG000|NOT COMPLETED|Overall Study||2
2985996|NCT00879697|3702286|FG001|NOT COMPLETED|Overall Study||2
2985997|NCT00879710|3702294|FG000|STARTED|Phase 1 - 6 Weeks|Started with simvastatin 40 mg as the starting drug|12
3036514|NCT01143727|3755736|FG001|COMPLETED|Overall Study||8
2985998|NCT00879710|3702295|FG001|STARTED|Phase 1 - 6 Weeks|Started with simvastatin 40 mg as the starting drug|17
2985999|NCT00879710|3702296|FG002|STARTED|Phase 1 - 6 Weeks|Started with ezetimibe 10 mg as the starting drug|11
2986000|NCT00879710|3702297|FG003|STARTED|Phase 1 - 6 Weeks|Started with ezetimibe 10 mg as the starting drug|17
2986001|NCT00879710|3702294|FG000|COMPLETED|Phase 1 - 6 Weeks||10
2986002|NCT00879710|3702295|FG001|COMPLETED|Phase 1 - 6 Weeks||14
2986003|NCT00879710|3702296|FG002|COMPLETED|Phase 1 - 6 Weeks||9
2986004|NCT00879710|3702297|FG003|COMPLETED|Phase 1 - 6 Weeks||13
2986005|NCT00879710|3702294|FG000|NOT COMPLETED|Phase 1 - 6 Weeks||2
2986006|NCT00879710|3702295|FG001|NOT COMPLETED|Phase 1 - 6 Weeks||3
2986007|NCT00879710|3702296|FG002|NOT COMPLETED|Phase 1 - 6 Weeks||2
2986008|NCT00879710|3702297|FG003|NOT COMPLETED|Phase 1 - 6 Weeks||4
2986009|NCT00879710|3702294|FG000|STARTED|Wash Out Period of 4 Weeks||10
2986010|NCT00879710|3702295|FG001|STARTED|Wash Out Period of 4 Weeks||14
2986011|NCT00879710|3702296|FG002|STARTED|Wash Out Period of 4 Weeks|The person who did not complete ezetimibe arm came back to complete simvastatin arm.|10
2986012|NCT00879710|3702297|FG003|STARTED|Wash Out Period of 4 Weeks||13
2986013|NCT00879710|3702294|FG000|COMPLETED|Wash Out Period of 4 Weeks||10
2986014|NCT00879710|3702295|FG001|COMPLETED|Wash Out Period of 4 Weeks||14
2986015|NCT00879710|3702296|FG002|COMPLETED|Wash Out Period of 4 Weeks||10
2986016|NCT00879710|3702297|FG003|COMPLETED|Wash Out Period of 4 Weeks||13
2986017|NCT00879710|3702294|FG000|NOT COMPLETED|Wash Out Period of 4 Weeks||0
2986018|NCT00879710|3702295|FG001|NOT COMPLETED|Wash Out Period of 4 Weeks||0
2986019|NCT00879710|3702296|FG002|NOT COMPLETED|Wash Out Period of 4 Weeks||0
2986020|NCT00879710|3702297|FG003|NOT COMPLETED|Wash Out Period of 4 Weeks||0
2986021|NCT00879710|3702294|FG000|STARTED|Phase 2 6 Weeks||10
2986022|NCT00879710|3702295|FG001|STARTED|Phase 2 6 Weeks||14
2986023|NCT00879710|3702296|FG002|STARTED|Phase 2 6 Weeks||10
2986024|NCT00879710|3702297|FG003|STARTED|Phase 2 6 Weeks||13
2986025|NCT00879710|3702294|FG000|COMPLETED|Phase 2 6 Weeks||10
2986026|NCT00879710|3702295|FG001|COMPLETED|Phase 2 6 Weeks||14
2986027|NCT00879710|3702296|FG002|COMPLETED|Phase 2 6 Weeks||10
2986028|NCT00879710|3702297|FG003|COMPLETED|Phase 2 6 Weeks||13
2986029|NCT00879710|3702294|FG000|NOT COMPLETED|Phase 2 6 Weeks||0
2986030|NCT00879710|3702295|FG001|NOT COMPLETED|Phase 2 6 Weeks||0
2986031|NCT00879710|3702296|FG002|NOT COMPLETED|Phase 2 6 Weeks||0
2986032|NCT00879710|3702297|FG003|NOT COMPLETED|Phase 2 6 Weeks||0
2986033|NCT00879775|3702307|FG000|STARTED|Overall Study||20
2986034|NCT00879775|3702308|FG001|STARTED|Overall Study||21
2986035|NCT00879775|3702307|FG000|COMPLETED|Overall Study||18
2986036|NCT00879775|3702308|FG001|COMPLETED|Overall Study||20
2986037|NCT00879775|3702307|FG000|NOT COMPLETED|Overall Study||2
2986038|NCT00879775|3702308|FG001|NOT COMPLETED|Overall Study||1
2986039|NCT00879814|3702318|FG000|STARTED|Overall Study||12
2986040|NCT00879814|3702319|FG001|STARTED|Overall Study||12
2986041|NCT00879814|3702320|FG002|STARTED|Overall Study||12
2986042|NCT00879814|3702321|FG003|STARTED|Overall Study||12
2986043|NCT00879814|3702318|FG000|COMPLETED|Overall Study||8
2986044|NCT00879814|3702319|FG001|COMPLETED|Overall Study||10
2986045|NCT00879814|3702320|FG002|COMPLETED|Overall Study||9
2986046|NCT00879814|3702321|FG003|COMPLETED|Overall Study||7
2986047|NCT00879814|3702318|FG000|NOT COMPLETED|Overall Study||4
3304775|NCT02982018|4038376|FG001|COMPLETED|Overall Study||61
3304776|NCT02982018|4038375|FG000|NOT COMPLETED|Overall Study||5
3304777|NCT02982018|4038376|FG001|NOT COMPLETED|Overall Study||3
3304778|NCT02982187|4038384|FG000|STARTED|Overall Study||20
3304779|NCT02982187|4038385|FG001|STARTED|Overall Study||20
3304780|NCT02982187|4038386|FG002|STARTED|Overall Study||20
3304781|NCT02982187|4038387|FG003|STARTED|Overall Study||20
3304782|NCT02982187|4038388|FG004|STARTED|Overall Study||20
3304783|NCT02982187|4038389|FG005|STARTED|Overall Study||20
3304784|NCT02982187|4038390|FG006|STARTED|Overall Study||20
3304785|NCT02982187|4038391|FG007|STARTED|Overall Study||20
3304786|NCT02982187|4038384|FG000|COMPLETED|Overall Study||20
3304787|NCT02982187|4038385|FG001|COMPLETED|Overall Study||20
3304788|NCT02982187|4038386|FG002|COMPLETED|Overall Study||20
3304789|NCT02982187|4038387|FG003|COMPLETED|Overall Study||20
3304790|NCT02982187|4038388|FG004|COMPLETED|Overall Study||20
3304791|NCT02982187|4038389|FG005|COMPLETED|Overall Study||20
3304792|NCT02982187|4038390|FG006|COMPLETED|Overall Study||19
3304793|NCT02982187|4038391|FG007|COMPLETED|Overall Study||20
3304794|NCT02982187|4038384|FG000|NOT COMPLETED|Overall Study||0
3304795|NCT02982187|4038385|FG001|NOT COMPLETED|Overall Study||0
3304796|NCT02982187|4038386|FG002|NOT COMPLETED|Overall Study||0
3304797|NCT02982187|4038387|FG003|NOT COMPLETED|Overall Study||0
3304798|NCT02982187|4038388|FG004|NOT COMPLETED|Overall Study||0
3304799|NCT02982187|4038389|FG005|NOT COMPLETED|Overall Study||0
3304800|NCT02982187|4038390|FG006|NOT COMPLETED|Overall Study||1
3304801|NCT02982187|4038391|FG007|NOT COMPLETED|Overall Study||0
3304802|NCT02982213|4038403|FG000|STARTED|Overall Study||75
3304803|NCT02982213|4038404|FG001|STARTED|Overall Study||75
3304804|NCT02982213|4038403|FG000|COMPLETED|Overall Study||70
3304805|NCT02982213|4038404|FG001|COMPLETED|Overall Study||74
3304806|NCT02982213|4038403|FG000|NOT COMPLETED|Overall Study||5
3304807|NCT02982213|4038404|FG001|NOT COMPLETED|Overall Study||1
3304808|NCT02982239|4038412|FG000|STARTED|Overall Study||20
3304809|NCT02982239|4038413|FG001|STARTED|Overall Study||20
3304810|NCT02982239|4038412|FG000|COMPLETED|Overall Study||17
3304811|NCT02982239|4038413|FG001|COMPLETED|Overall Study||18
3304812|NCT02982239|4038412|FG000|NOT COMPLETED|Overall Study||3
2986048|NCT00879814|3702319|FG001|NOT COMPLETED|Overall Study||2
2986049|NCT00879814|3702320|FG002|NOT COMPLETED|Overall Study||3
2986050|NCT00879814|3702321|FG003|NOT COMPLETED|Overall Study||5
2986051|NCT00879879|3702331|FG000|STARTED|Overall Study||20
2986052|NCT00879879|3702331|FG000|COMPLETED|Overall Study||17
2986053|NCT00879879|3702331|FG000|NOT COMPLETED|Overall Study||3
2986054|NCT00879970|3702340|FG000|STARTED|Period 1 TZD Randomization||541
2986055|NCT00879970|3702341|FG001|STARTED|Period 1 TZD Randomization||392
2986056|NCT00879970|3702342|FG002|STARTED|Period 1 TZD Randomization||399
2986057|NCT00879970|3702343|FG003|STARTED|Period 1 TZD Randomization||0
2986058|NCT00879970|3702344|FG004|STARTED|Period 1 TZD Randomization||0
2986059|NCT00879970|3702340|FG000|COMPLETED|Period 1 TZD Randomization||533
2986060|NCT00879970|3702341|FG001|COMPLETED|Period 1 TZD Randomization||388
2986061|NCT00879970|3702342|FG002|COMPLETED|Period 1 TZD Randomization||393
2986062|NCT00879970|3702343|FG003|COMPLETED|Period 1 TZD Randomization||0
2986063|NCT00879970|3702344|FG004|COMPLETED|Period 1 TZD Randomization||0
2986064|NCT00879970|3702340|FG000|NOT COMPLETED|Period 1 TZD Randomization||8
2986065|NCT00879970|3702341|FG001|NOT COMPLETED|Period 1 TZD Randomization||4
2986066|NCT00879970|3702342|FG002|NOT COMPLETED|Period 1 TZD Randomization||6
2986067|NCT00879970|3702343|FG003|NOT COMPLETED|Period 1 TZD Randomization||0
2986068|NCT00879970|3702344|FG004|NOT COMPLETED|Period 1 TZD Randomization||0
2986069|NCT00879970|3702340|FG000|STARTED|Period 2 Vitamin D Randomization||0
2986070|NCT00879970|3702341|FG001|STARTED|Period 2 Vitamin D Randomization||0
2986071|NCT00879970|3702342|FG002|STARTED|Period 2 Vitamin D Randomization||0
2986072|NCT00879970|3702343|FG003|STARTED|Period 2 Vitamin D Randomization||614
2986073|NCT00879970|3702344|FG004|STARTED|Period 2 Vitamin D Randomization||607
2986074|NCT00879970|3702340|FG000|COMPLETED|Period 2 Vitamin D Randomization||0
2986075|NCT00879970|3702341|FG001|COMPLETED|Period 2 Vitamin D Randomization||0
2986076|NCT00879970|3702342|FG002|COMPLETED|Period 2 Vitamin D Randomization||0
2986077|NCT00879970|3702343|FG003|COMPLETED|Period 2 Vitamin D Randomization||610
2986078|NCT00879970|3702344|FG004|COMPLETED|Period 2 Vitamin D Randomization||600
2986079|NCT00879970|3702340|FG000|NOT COMPLETED|Period 2 Vitamin D Randomization||0
2986080|NCT00879970|3702341|FG001|NOT COMPLETED|Period 2 Vitamin D Randomization||0
2986081|NCT00879970|3702342|FG002|NOT COMPLETED|Period 2 Vitamin D Randomization||0
2986082|NCT00879970|3702343|FG003|NOT COMPLETED|Period 2 Vitamin D Randomization||4
2986083|NCT00879970|3702344|FG004|NOT COMPLETED|Period 2 Vitamin D Randomization||7
2986084|NCT00879996|3702364|FG000|STARTED|Overall Study||28
2986085|NCT00879996|3702365|FG001|STARTED|Overall Study||26
2986086|NCT00879996|3702364|FG000|COMPLETED|Overall Study||13
2986087|NCT00879996|3702365|FG001|COMPLETED|Overall Study||13
2986088|NCT00879996|3702364|FG000|NOT COMPLETED|Overall Study||15
2986089|NCT00879996|3702365|FG001|NOT COMPLETED|Overall Study||13
2986090|NCT00880009|3702373|FG000|STARTED|Overall Study||16
2986091|NCT00880009|3702373|FG000|COMPLETED|Overall Study||0
2986092|NCT00880009|3702373|FG000|NOT COMPLETED|Overall Study||16
2986093|NCT00880022|3702382|FG000|STARTED|Overall Study||23
2986094|NCT00880022|3702383|FG001|STARTED|Overall Study||24
2986095|NCT00880022|3702382|FG000|COMPLETED|Overall Study||21
2986096|NCT00880022|3702383|FG001|COMPLETED|Overall Study||21
2986097|NCT00880022|3702382|FG000|NOT COMPLETED|Overall Study||2
2986098|NCT00880022|3702383|FG001|NOT COMPLETED|Overall Study||3
2986099|NCT00880048|3702394|FG000|STARTED|Overall Study||116
2986100|NCT00880048|3702395|FG001|STARTED|Overall Study||115
2986101|NCT00880048|3702396|FG002|STARTED|Overall Study||112
2986102|NCT00880048|3702394|FG000|COMPLETED|Overall Study||88
2986103|NCT00880048|3702395|FG001|COMPLETED|Overall Study||82
2986104|NCT00880048|3702396|FG002|COMPLETED|Overall Study||77
2986105|NCT00880048|3702394|FG000|NOT COMPLETED|Overall Study||28
2986106|NCT00880048|3702395|FG001|NOT COMPLETED|Overall Study||33
2986107|NCT00880048|3702396|FG002|NOT COMPLETED|Overall Study||35
2986108|NCT00880087|3702406|FG000|STARTED|Overall Study|Among the 166 Started, 161 received Therapeutic Hypothermia and 5 received no treatment.|166
2986109|NCT00880087|3702407|FG001|STARTED|Overall Study|Among the 163 Started, 160 received Therapeutic Normothermia and 3 received no treatment.|163
2986110|NCT00880087|3702406|FG000|COMPLETED|Overall Study|1-year vital status available for all 166 Started patients.|166
2986111|NCT00880087|3702407|FG001|COMPLETED|Overall Study|Of 161 with 1-year vital status, 158 had received Therapeutic Normothermia, 3 received no treatment.|161
2986112|NCT00880087|3702406|FG000|NOT COMPLETED|Overall Study||0
2986113|NCT00880087|3702407|FG001|NOT COMPLETED|Overall Study||2
2986114|NCT00880100|3702413|FG000|STARTED|Baseline Phase-Usual Pancreatic Enzymes||49
2986115|NCT00880100|3702413|FG000|COMPLETED|Baseline Phase-Usual Pancreatic Enzymes||48
2986116|NCT00880100|3702413|FG000|NOT COMPLETED|Baseline Phase-Usual Pancreatic Enzymes||1
2986117|NCT00880100|3702413|FG000|STARTED|Treatment Phase With Ultrase® MT12||48
2986118|NCT00880100|3702413|FG000|COMPLETED|Treatment Phase With Ultrase® MT12||45
2986119|NCT00880100|3702413|FG000|NOT COMPLETED|Treatment Phase With Ultrase® MT12||3
2986120|NCT00880165|3702419|FG000|STARTED|Overall Study||148
2986121|NCT00880165|3702420|FG001|STARTED|Overall Study||148
2986122|NCT00880165|3702419|FG000|COMPLETED|Overall Study||86
2986123|NCT00880165|3702420|FG001|COMPLETED|Overall Study||98
2986124|NCT00880165|3702419|FG000|NOT COMPLETED|Overall Study||62
2986125|NCT00880165|3702420|FG001|NOT COMPLETED|Overall Study||50
2986126|NCT00880191|3702428|FG000|STARTED|Overall Study||207
2986127|NCT00880191|3702429|FG001|STARTED|Overall Study||206
2986128|NCT00880191|3702428|FG000|Available for Primary Endpoint Analysis|Overall Study||207
3036515|NCT01143727|3755735|FG000|NOT COMPLETED|Overall Study||0
2986129|NCT00880191|3702429|FG001|Available for Primary Endpoint Analysis|Overall Study||206
2986130|NCT00880191|3702428|FG000|COMPLETED|Overall Study||194
3164395|NCT01892189|3891782|FG004|NOT COMPLETED|Second Intervention Period (1 Day)||0
3164396|NCT01892189|3891783|FG005|NOT COMPLETED|Second Intervention Period (1 Day)||0
3164397|NCT01892189|3891784|FG006|NOT COMPLETED|Second Intervention Period (1 Day)||0
3164398|NCT01892189|3891785|FG007|NOT COMPLETED|Second Intervention Period (1 Day)||0
3164399|NCT01892189|3891786|FG008|NOT COMPLETED|Second Intervention Period (1 Day)||0
3164400|NCT01892189|3891778|FG000|STARTED|Washout Period 2 (7 Days)||3
3164401|NCT01892189|3891779|FG001|STARTED|Washout Period 2 (7 Days)||3
3164402|NCT01892189|3891780|FG002|STARTED|Washout Period 2 (7 Days)||1
3164403|NCT01892189|3891781|FG003|STARTED|Washout Period 2 (7 Days)||2
3164404|NCT01892189|3891782|FG004|STARTED|Washout Period 2 (7 Days)||3
2986131|NCT00880191|3702429|FG001|COMPLETED|Overall Study||198
2986132|NCT00880191|3702428|FG000|NOT COMPLETED|Overall Study||13
2986133|NCT00880191|3702429|FG001|NOT COMPLETED|Overall Study||8
2986134|NCT00880230|3702435|FG000|STARTED|Overall Study||141
2986135|NCT00880230|3702435|FG000|COMPLETED|Overall Study||134
2986136|NCT00880230|3702435|FG000|NOT COMPLETED|Overall Study||7
2986137|NCT00880256|3702439|FG000|STARTED|Overall Study||93
2986138|NCT00880256|3702439|FG000|COMPLETED|Overall Study||65
2986139|NCT00880256|3702439|FG000|NOT COMPLETED|Overall Study||28
3164405|NCT01892189|3891783|FG005|STARTED|Washout Period 2 (7 Days)||2
3164406|NCT01892189|3891784|FG006|STARTED|Washout Period 2 (7 Days)||2
3164407|NCT01892189|3891785|FG007|STARTED|Washout Period 2 (7 Days)||3
3164408|NCT01892189|3891786|FG008|STARTED|Washout Period 2 (7 Days)||1
3164409|NCT01892189|3891778|FG000|COMPLETED|Washout Period 2 (7 Days)||3
3164410|NCT01892189|3891779|FG001|COMPLETED|Washout Period 2 (7 Days)||3
2986140|NCT00880269|3702445|FG000|STARTED|Overall Study||32
2986141|NCT00880269|3702446|FG001|STARTED|Overall Study||27
2986142|NCT00880269|3702445|FG000|Discontinued Treatment|Overall Study||32
2986143|NCT00880269|3702446|FG001|Discontinued Treatment|Overall Study||27
2986144|NCT00880269|3702445|FG000|COMPLETED|Overall Study||0
2986145|NCT00880269|3702446|FG001|COMPLETED|Overall Study||0
2986146|NCT00880269|3702445|FG000|NOT COMPLETED|Overall Study||32
2986147|NCT00880269|3702446|FG001|NOT COMPLETED|Overall Study||27
2986148|NCT00880334|3702454|FG000|STARTED|Randomized Phase||74
2986149|NCT00880334|3702455|FG001|STARTED|Randomized Phase||75
2986150|NCT00880334|3702454|FG000|Eligible & Treated|Randomized Phase||70
2986151|NCT00880334|3702455|FG001|Eligible & Treated|Randomized Phase||72
2986152|NCT00880334|3702454|FG000|COMPLETED|Randomized Phase||70
2986153|NCT00880334|3702455|FG001|COMPLETED|Randomized Phase||35
2986154|NCT00880334|3702454|FG000|NOT COMPLETED|Randomized Phase||4
2986155|NCT00880334|3702455|FG001|NOT COMPLETED|Randomized Phase||40
2986156|NCT00880334|3702454|FG000|STARTED|Crossover Phase||0
2986157|NCT00880334|3702455|FG001|STARTED|Crossover Phase|Only participants randomized to placebo and docetaxel potentially received crossover treatment.|37
2986158|NCT00880334|3702454|FG000|COMPLETED|Crossover Phase||0
2986159|NCT00880334|3702455|FG001|COMPLETED|Crossover Phase||37
2986160|NCT00880334|3702454|FG000|NOT COMPLETED|Crossover Phase||0
2986161|NCT00880334|3702455|FG001|NOT COMPLETED|Crossover Phase||0
2986162|NCT00880360|3702465|FG000|STARTED|Overall Study||19
2986163|NCT00880360|3702465|FG000|COMPLETED|Overall Study||19
2986164|NCT00880360|3702465|FG000|NOT COMPLETED|Overall Study||0
2986165|NCT00880399|3702473|FG000|STARTED|Overall Study||108
2986166|NCT00880399|3702474|FG001|STARTED|Overall Study||113
2986167|NCT00880399|3702475|FG002|STARTED|Overall Study||107
2986168|NCT00880399|3702473|FG000|COMPLETED|Overall Study||77
2986169|NCT00880399|3702474|FG001|COMPLETED|Overall Study||84
2986170|NCT00880399|3702475|FG002|COMPLETED|Overall Study||81
2986171|NCT00880399|3702473|FG000|NOT COMPLETED|Overall Study||31
2986172|NCT00880399|3702474|FG001|NOT COMPLETED|Overall Study||29
2986173|NCT00880399|3702475|FG002|NOT COMPLETED|Overall Study||26
2986174|NCT00880425|3702483|FG000|STARTED|Overall Study||18
2986175|NCT00880425|3702484|FG001|STARTED|Overall Study||27
2986176|NCT00880425|3702483|FG000|COMPLETED|Overall Study||18
2986177|NCT00880425|3702484|FG001|COMPLETED|Overall Study||27
2986178|NCT00880425|3702483|FG000|NOT COMPLETED|Overall Study||0
2986179|NCT00880425|3702484|FG001|NOT COMPLETED|Overall Study||0
2986180|NCT00880464|3702490|FG000|STARTED|Overall Study||7
2986181|NCT00880464|3702490|FG000|COMPLETED|Overall Study||7
2986182|NCT00880464|3702490|FG000|NOT COMPLETED|Overall Study||0
2986183|NCT00880555|3702497|FG000|STARTED|Overall Study||23
2986184|NCT00880555|3702498|FG001|STARTED|Overall Study||40
2986185|NCT00880555|3702499|FG002|STARTED|Overall Study||11
2986186|NCT00880555|3702500|FG003|STARTED|Overall Study||2
2986187|NCT00880555|3702501|FG004|STARTED|Overall Study||1
2986188|NCT00880555|3702502|FG005|STARTED|Overall Study||1
2986189|NCT00880555|3702497|FG000|COMPLETED|Overall Study||13
2986190|NCT00880555|3702498|FG001|COMPLETED|Overall Study||23
2986191|NCT00880555|3702499|FG002|COMPLETED|Overall Study||6
2986192|NCT00880555|3702500|FG003|COMPLETED|Overall Study||0
2986193|NCT00880555|3702501|FG004|COMPLETED|Overall Study||0
2986194|NCT00880555|3702502|FG005|COMPLETED|Overall Study||0
2986195|NCT00880555|3702497|FG000|NOT COMPLETED|Overall Study||10
2986196|NCT00880555|3702498|FG001|NOT COMPLETED|Overall Study||17
2986197|NCT00880555|3702499|FG002|NOT COMPLETED|Overall Study||5
2986198|NCT00880555|3702500|FG003|NOT COMPLETED|Overall Study||2
2986199|NCT00880555|3702501|FG004|NOT COMPLETED|Overall Study||1
2986200|NCT00880555|3702502|FG005|NOT COMPLETED|Overall Study||1
2986201|NCT00880568|3702522|FG000|STARTED|Overall Study||3
2986202|NCT00880568|3702523|FG001|STARTED|Overall Study||3
2986203|NCT00880568|3702524|FG002|STARTED|Overall Study||3
2986204|NCT00880568|3702525|FG003|STARTED|Overall Study||1
2986205|NCT00880568|3702526|FG004|STARTED|Overall Study||3
2986206|NCT00880568|3702527|FG005|STARTED|Overall Study||3
2986207|NCT00880568|3702528|FG006|STARTED|Overall Study||6
3304813|NCT02982239|4038413|FG001|NOT COMPLETED|Overall Study||2
3304814|NCT02982590|4038422|FG000|STARTED|Overall Study||13
3304815|NCT02982590|4038423|FG001|STARTED|Overall Study||14
3304816|NCT02982590|4038422|FG000|COMPLETED|Overall Study||9
3304817|NCT02982590|4038423|FG001|COMPLETED|Overall Study||13
3304818|NCT02982590|4038422|FG000|NOT COMPLETED|Overall Study||4
3304819|NCT02982590|4038423|FG001|NOT COMPLETED|Overall Study||1
2986208|NCT00880568|3702529|FG007|STARTED|Overall Study||2
2986209|NCT00880568|3702530|FG008|STARTED|Overall Study||3
2986210|NCT00880568|3702522|FG000|COMPLETED|Overall Study||0
2986211|NCT00880568|3702523|FG001|COMPLETED|Overall Study||0
2986212|NCT00880568|3702524|FG002|COMPLETED|Overall Study||0
2986213|NCT00880568|3702525|FG003|COMPLETED|Overall Study||0
2986214|NCT00880568|3702526|FG004|COMPLETED|Overall Study||0
2986215|NCT00880568|3702527|FG005|COMPLETED|Overall Study||0
2986216|NCT00880568|3702528|FG006|COMPLETED|Overall Study||0
2986217|NCT00880568|3702529|FG007|COMPLETED|Overall Study||0
2986218|NCT00880568|3702530|FG008|COMPLETED|Overall Study||0
2986219|NCT00880568|3702522|FG000|NOT COMPLETED|Overall Study||3
2986220|NCT00880568|3702523|FG001|NOT COMPLETED|Overall Study||3
2986221|NCT00880568|3702524|FG002|NOT COMPLETED|Overall Study||3
2986222|NCT00880568|3702525|FG003|NOT COMPLETED|Overall Study||1
2986223|NCT00880568|3702526|FG004|NOT COMPLETED|Overall Study||3
2986224|NCT00880568|3702527|FG005|NOT COMPLETED|Overall Study||3
2986225|NCT00880568|3702528|FG006|NOT COMPLETED|Overall Study||6
2986226|NCT00880568|3702529|FG007|NOT COMPLETED|Overall Study||2
2986227|NCT00880568|3702530|FG008|NOT COMPLETED|Overall Study||3
2986228|NCT00880581|3702555|FG000|STARTED|Cycle 1||30
2986229|NCT00880581|3702555|FG000|COMPLETED|Cycle 1||30
2986230|NCT00880581|3702555|FG000|NOT COMPLETED|Cycle 1||0
2986231|NCT00880581|3702555|FG000|STARTED|Cycle 2 Re-treatment|6 subjects with progessive disease were not treated and evaluated in Cycle 2|24
2986232|NCT00880581|3702555|FG000|COMPLETED|Cycle 2 Re-treatment||24
2986233|NCT00880581|3702555|FG000|NOT COMPLETED|Cycle 2 Re-treatment||0
2986234|NCT00880607|3702561|FG000|STARTED|Overall Study||44
2986235|NCT00880607|3702562|FG001|STARTED|Overall Study||37
2986236|NCT00880607|3702561|FG000|Observation After Receiving Medication|Overall Study||42
2986237|NCT00880607|3702562|FG001|Observation After Receiving Medication|Overall Study||35
2986238|NCT00880607|3702561|FG000|COMPLETED|Overall Study||37
2986239|NCT00880607|3702562|FG001|COMPLETED|Overall Study||34
2986240|NCT00880607|3702561|FG000|NOT COMPLETED|Overall Study||7
2986241|NCT00880607|3702562|FG001|NOT COMPLETED|Overall Study||3
2986242|NCT00880620|3702574|FG000|STARTED|Overall Study||92
2986243|NCT00880620|3702575|FG001|STARTED|Overall Study||87
2986244|NCT00880620|3702576|FG002|STARTED|Overall Study||104
2986245|NCT00880620|3702577|FG003|STARTED|Overall Study||98
2986246|NCT00880620|3702574|FG000|Week 4|Overall Study||88
2986247|NCT00880620|3702575|FG001|Week 4|Overall Study||79
2986248|NCT00880620|3702576|FG002|Week 4|Overall Study||94
2986249|NCT00880620|3702577|FG003|Week 4|Overall Study||86
2986250|NCT00880620|3702574|FG000|Week 9|Overall Study||80
2986251|NCT00880620|3702575|FG001|Week 9|Overall Study||73
2986252|NCT00880620|3702576|FG002|Week 9|Overall Study||88
2986253|NCT00880620|3702577|FG003|Week 9|Overall Study||78
2986254|NCT00880620|3702574|FG000|Week 16|Overall Study||74
2986255|NCT00880620|3702575|FG001|Week 16|Overall Study||73
2986256|NCT00880620|3702576|FG002|Week 16|Overall Study||87
2986257|NCT00880620|3702577|FG003|Week 16|Overall Study||74
2986258|NCT00880620|3702574|FG000|Week 23|Overall Study||71
2986259|NCT00880620|3702575|FG001|Week 23|Overall Study||72
2986260|NCT00880620|3702576|FG002|Week 23|Overall Study||85
2986261|NCT00880620|3702577|FG003|Week 23|Overall Study||74
2986262|NCT00880620|3702574|FG000|COMPLETED|Overall Study||71
2986263|NCT00880620|3702575|FG001|COMPLETED|Overall Study||72
2986264|NCT00880620|3702576|FG002|COMPLETED|Overall Study||83
2986265|NCT00880620|3702577|FG003|COMPLETED|Overall Study||74
2986266|NCT00880620|3702574|FG000|NOT COMPLETED|Overall Study||21
2986267|NCT00880620|3702575|FG001|NOT COMPLETED|Overall Study||15
2986268|NCT00880620|3702576|FG002|NOT COMPLETED|Overall Study||21
2986269|NCT00880620|3702577|FG003|NOT COMPLETED|Overall Study||24
2986270|NCT00880685|3702591|FG000|STARTED|Memantine 10mg||12
2986271|NCT00880685|3702591|FG000|COMPLETED|Memantine 10mg||10
2986272|NCT00880685|3702591|FG000|NOT COMPLETED|Memantine 10mg||2
2986273|NCT00880685|3702591|FG000|STARTED|Memantine 20mg||10
2986274|NCT00880685|3702591|FG000|COMPLETED|Memantine 20mg||9
2986275|NCT00880685|3702591|FG000|NOT COMPLETED|Memantine 20mg||1
2986276|NCT00880685|3702591|FG000|STARTED|Memantine 30mg||9
2986277|NCT00880685|3702591|FG000|COMPLETED|Memantine 30mg||9
2986278|NCT00880685|3702591|FG000|NOT COMPLETED|Memantine 30mg||0
2986279|NCT00880698|3702602|FG000|STARTED|Overall Study||62
2986280|NCT00880698|3702603|FG001|STARTED|Overall Study||64
2986281|NCT00880698|3702604|FG002|STARTED|Overall Study||37
2986282|NCT00880698|3702605|FG003|STARTED|Overall Study||39
2986283|NCT00880698|3702602|FG000|COMPLETED|Overall Study||61
3304820|NCT02982772|4038431|FG000|STARTED|Enrollment||245
2986284|NCT00880698|3702603|FG001|COMPLETED|Overall Study||61
2986285|NCT00880698|3702604|FG002|COMPLETED|Overall Study||36
2986286|NCT00880698|3702605|FG003|COMPLETED|Overall Study||36
2986287|NCT00880698|3702602|FG000|NOT COMPLETED|Overall Study||1
2986288|NCT00880698|3702603|FG001|NOT COMPLETED|Overall Study||3
2986289|NCT00880698|3702604|FG002|NOT COMPLETED|Overall Study||1
2986290|NCT00880698|3702605|FG003|NOT COMPLETED|Overall Study||3
2986291|NCT00880750|3702619|FG000|STARTED|First Intervention||39
2986292|NCT00880750|3702620|FG001|STARTED|First Intervention||33
2986293|NCT00880750|3702619|FG000|COMPLETED|First Intervention||30
2986294|NCT00880750|3702620|FG001|COMPLETED|First Intervention||32
2986295|NCT00880750|3702619|FG000|NOT COMPLETED|First Intervention||9
2986296|NCT00880750|3702620|FG001|NOT COMPLETED|First Intervention||1
2986297|NCT00880750|3702619|FG000|STARTED|Washout Period||30
2986298|NCT00880750|3702620|FG001|STARTED|Washout Period||32
2986299|NCT00880750|3702619|FG000|COMPLETED|Washout Period||30
2986300|NCT00880750|3702620|FG001|COMPLETED|Washout Period||32
2986301|NCT00880750|3702619|FG000|NOT COMPLETED|Washout Period||0
2986302|NCT00880750|3702620|FG001|NOT COMPLETED|Washout Period||0
2986303|NCT00880750|3702619|FG000|STARTED|Second Intervention||30
2986304|NCT00880750|3702620|FG001|STARTED|Second Intervention||32
2986305|NCT00880750|3702619|FG000|COMPLETED|Second Intervention||26
2986306|NCT00880750|3702620|FG001|COMPLETED|Second Intervention||30
2986307|NCT00880750|3702619|FG000|NOT COMPLETED|Second Intervention||4
2986308|NCT00880750|3702620|FG001|NOT COMPLETED|Second Intervention||2
2986309|NCT00880763|3702630|FG000|STARTED|Initial Treatment Period (Part 1)||23
2986310|NCT00880763|3702631|FG001|STARTED|Initial Treatment Period (Part 1)||22
2986311|NCT00880763|3702632|FG002|STARTED|Initial Treatment Period (Part 1)||23
2986312|NCT00880763|3702633|FG003|STARTED|Initial Treatment Period (Part 1)||22
2986313|NCT00880763|3702630|FG000|COMPLETED|Initial Treatment Period (Part 1)||23
2986314|NCT00880763|3702631|FG001|COMPLETED|Initial Treatment Period (Part 1)||22
2986315|NCT00880763|3702632|FG002|COMPLETED|Initial Treatment Period (Part 1)||23
2986316|NCT00880763|3702633|FG003|COMPLETED|Initial Treatment Period (Part 1)||22
2986317|NCT00880763|3702630|FG000|NOT COMPLETED|Initial Treatment Period (Part 1)||0
2986318|NCT00880763|3702631|FG001|NOT COMPLETED|Initial Treatment Period (Part 1)||0
2986319|NCT00880763|3702632|FG002|NOT COMPLETED|Initial Treatment Period (Part 1)||0
2986320|NCT00880763|3702633|FG003|NOT COMPLETED|Initial Treatment Period (Part 1)||0
2986321|NCT00880763|3702630|FG000|STARTED|Extension Period (Part 2)||23
2986322|NCT00880763|3702631|FG001|STARTED|Extension Period (Part 2)||22
2986323|NCT00880763|3702632|FG002|STARTED|Extension Period (Part 2)||23
2986324|NCT00880763|3702633|FG003|STARTED|Extension Period (Part 2)||22
2986325|NCT00880763|3702630|FG000|COMPLETED|Extension Period (Part 2)||23
2986326|NCT00880763|3702631|FG001|COMPLETED|Extension Period (Part 2)||19
2986327|NCT00880763|3702632|FG002|COMPLETED|Extension Period (Part 2)||20
2986328|NCT00880763|3702633|FG003|COMPLETED|Extension Period (Part 2)||19
2986329|NCT00880763|3702630|FG000|NOT COMPLETED|Extension Period (Part 2)||0
2986330|NCT00880763|3702631|FG001|NOT COMPLETED|Extension Period (Part 2)||3
2986331|NCT00880763|3702632|FG002|NOT COMPLETED|Extension Period (Part 2)||3
2986332|NCT00880763|3702633|FG003|NOT COMPLETED|Extension Period (Part 2)||3
2986333|NCT00880893|3702645|FG000|STARTED|Overall Study||898
2986334|NCT00880893|3702646|FG001|STARTED|Overall Study||300
2986335|NCT00880893|3702645|FG000|COMPLETED|Overall Study||791
2986336|NCT00880893|3702646|FG001|COMPLETED|Overall Study||255
2986337|NCT00880893|3702645|FG000|NOT COMPLETED|Overall Study||107
2986338|NCT00880893|3702646|FG001|NOT COMPLETED|Overall Study||45
2986339|NCT00880906|3702654|FG000|STARTED|Overall Study||29
2986340|NCT00880906|3702655|FG001|STARTED|Overall Study||21
2986341|NCT00880906|3702654|FG000|COMPLETED|Overall Study||17
2986342|NCT00880906|3702655|FG001|COMPLETED|Overall Study||14
2986343|NCT00880906|3702654|FG000|NOT COMPLETED|Overall Study||12
2986344|NCT00880906|3702655|FG001|NOT COMPLETED|Overall Study||7
2986345|NCT00880919|3702664|FG000|STARTED|Overall Study||33
2986346|NCT00880919|3702665|FG001|STARTED|Overall Study||33
2986347|NCT00880919|3702666|FG002|STARTED|Overall Study||29
2986348|NCT00880919|3702664|FG000|COMPLETED|Overall Study||18
2986349|NCT00880919|3702665|FG001|COMPLETED|Overall Study||19
2986350|NCT00880919|3702666|FG002|COMPLETED|Overall Study||23
2986351|NCT00880919|3702664|FG000|NOT COMPLETED|Overall Study||15
2986352|NCT00880919|3702665|FG001|NOT COMPLETED|Overall Study||14
2986353|NCT00880919|3702666|FG002|NOT COMPLETED|Overall Study||6
2986354|NCT00880997|3702680|FG000|STARTED|Overall Study||9
2986355|NCT00880997|3702681|FG001|STARTED|Overall Study||8
2986356|NCT00880997|3702682|FG002|STARTED|Overall Study||13
2986357|NCT00880997|3702680|FG000|COMPLETED|Overall Study||6
2986358|NCT00880997|3702681|FG001|COMPLETED|Overall Study||6
2986359|NCT00880997|3702682|FG002|COMPLETED|Overall Study||5
2986360|NCT00880997|3702680|FG000|NOT COMPLETED|Overall Study||3
2986361|NCT00880997|3702681|FG001|NOT COMPLETED|Overall Study||2
2986362|NCT00880997|3702682|FG002|NOT COMPLETED|Overall Study||8
2986363|NCT00881335|3702692|FG000|STARTED|Overall Study||30
2986364|NCT00881335|3702693|FG001|STARTED|Overall Study||30
2986365|NCT00881335|3702692|FG000|COMPLETED|Overall Study|3 participants did not complete the period|27
2986366|NCT00881335|3702693|FG001|COMPLETED|Overall Study|2 participants did not complete the period|28
2986367|NCT00881335|3702692|FG000|NOT COMPLETED|Overall Study||3
2986368|NCT00881335|3702693|FG001|NOT COMPLETED|Overall Study||2
2986369|NCT00881361|3702701|FG000|STARTED|Overall Study||707
2986370|NCT00881361|3702702|FG001|STARTED|Overall Study||47
2986371|NCT00881361|3702703|FG002|STARTED|Overall Study||2
2986372|NCT00881361|3702701|FG000|COMPLETED|Overall Study||663
2986373|NCT00881361|3702702|FG001|COMPLETED|Overall Study||38
2986374|NCT00881361|3702703|FG002|COMPLETED|Overall Study||0
2986375|NCT00881361|3702701|FG000|NOT COMPLETED|Overall Study||44
2986376|NCT00881361|3702702|FG001|NOT COMPLETED|Overall Study||9
2986377|NCT00881361|3702703|FG002|NOT COMPLETED|Overall Study||2
2986378|NCT00881465|3702714|FG000|STARTED|Overall Study||16
2986379|NCT00881465|3702715|FG001|STARTED|Overall Study||15
2986380|NCT00881465|3702714|FG000|COMPLETED|Overall Study||14
2986381|NCT00881465|3702715|FG001|COMPLETED|Overall Study||15
2986382|NCT00881465|3702714|FG000|NOT COMPLETED|Overall Study||2
2986383|NCT00881465|3702715|FG001|NOT COMPLETED|Overall Study||0
2986384|NCT00881504|3702721|FG000|STARTED|Overall Study||9
2986385|NCT00881504|3702721|FG000|COMPLETED|Overall Study||8
2986386|NCT00881504|3702721|FG000|NOT COMPLETED|Overall Study||1
2986387|NCT00881530|3702731|FG000|STARTED|Overall Study||106
2986388|NCT00881530|3702732|FG001|STARTED|Overall Study||109
2986389|NCT00881530|3702733|FG002|STARTED|Overall Study||56
2986390|NCT00881530|3702734|FG003|STARTED|Overall Study||166
2986391|NCT00881530|3702735|FG004|STARTED|Overall Study||166
2986392|NCT00881530|3702736|FG005|STARTED|Overall Study||56
2986393|NCT00881530|3702731|FG000|COMPLETED|Overall Study||92
2986394|NCT00881530|3702732|FG001|COMPLETED|Overall Study||104
2986395|NCT00881530|3702733|FG002|COMPLETED|Overall Study||51
2986396|NCT00881530|3702734|FG003|COMPLETED|Overall Study||157
2986397|NCT00881530|3702735|FG004|COMPLETED|Overall Study||152
2986398|NCT00881530|3702736|FG005|COMPLETED|Overall Study||51
2986399|NCT00881530|3702731|FG000|NOT COMPLETED|Overall Study||14
2986400|NCT00881530|3702732|FG001|NOT COMPLETED|Overall Study||5
2986401|NCT00881530|3702733|FG002|NOT COMPLETED|Overall Study||5
2986402|NCT00881530|3702734|FG003|NOT COMPLETED|Overall Study||9
2986403|NCT00881530|3702735|FG004|NOT COMPLETED|Overall Study||14
2986404|NCT00881530|3702736|FG005|NOT COMPLETED|Overall Study||5
2986405|NCT00881569|3702752|FG000|STARTED|Overall Study||1
2986406|NCT00881569|3702753|FG001|STARTED|Overall Study||1
2986407|NCT00881569|3702752|FG000|COMPLETED|Overall Study||0
2986408|NCT00881569|3702753|FG001|COMPLETED|Overall Study||0
2986409|NCT00881569|3702752|FG000|NOT COMPLETED|Overall Study||1
2986410|NCT00881569|3702753|FG001|NOT COMPLETED|Overall Study||1
2986411|NCT00881621|3702759|FG000|STARTED|Overall Study||51
2986412|NCT00881621|3702759|FG000|COMPLETED|Overall Study||17
2986413|NCT00881621|3702759|FG000|NOT COMPLETED|Overall Study||34
2986414|NCT00881647|3702765|FG000|STARTED|Overall Study||29
2986415|NCT00881647|3702766|FG001|STARTED|Overall Study||16
2986416|NCT00881647|3702765|FG000|COMPLETED|Overall Study||27
2986417|NCT00881647|3702766|FG001|COMPLETED|Overall Study||15
2986418|NCT00881647|3702765|FG000|NOT COMPLETED|Overall Study||2
2986419|NCT00881647|3702766|FG001|NOT COMPLETED|Overall Study||1
2986420|NCT00881712|3702775|FG000|STARTED|Overall Study||15
2986421|NCT00881712|3702776|FG001|STARTED|Overall Study|This arm was non-randomized and no enrolled patients fit the inclusion criteria for this group.|0
2986422|NCT00881712|3702777|FG002|STARTED|Overall Study|This arm was non-randomized and no enrolled patients fit the inclusion criteria for this group.|0
2986423|NCT00881712|3702775|FG000|COMPLETED|Overall Study||13
2986424|NCT00881712|3702776|FG001|COMPLETED|Overall Study||0
2986425|NCT00881712|3702777|FG002|COMPLETED|Overall Study||0
2986426|NCT00881712|3702775|FG000|NOT COMPLETED|Overall Study||2
2986427|NCT00881712|3702776|FG001|NOT COMPLETED|Overall Study||0
2986428|NCT00881712|3702777|FG002|NOT COMPLETED|Overall Study||0
2986429|NCT00881751|3702787|FG000|STARTED|Overall Study||47
2986430|NCT00881751|3702788|FG001|STARTED|Overall Study||48
2986431|NCT00881751|3702787|FG000|COMPLETED|Overall Study||47
2986432|NCT00881751|3702788|FG001|COMPLETED|Overall Study||43
2986433|NCT00881751|3702787|FG000|NOT COMPLETED|Overall Study||0
2986434|NCT00881751|3702788|FG001|NOT COMPLETED|Overall Study||5
2986435|NCT00881868|3702796|FG000|STARTED|Overall Study||41
2986436|NCT00881868|3702797|FG001|STARTED|Overall Study||40
2986437|NCT00881868|3702796|FG000|COMPLETED|Overall Study||33
2986438|NCT00881868|3702797|FG001|COMPLETED|Overall Study||38
2986439|NCT00881868|3702796|FG000|NOT COMPLETED|Overall Study||8
2986440|NCT00881868|3702797|FG001|NOT COMPLETED|Overall Study||2
2986441|NCT00881894|3702805|FG000|STARTED|Overall Study||26
2986442|NCT00881894|3702806|FG001|STARTED|Overall Study||26
2986443|NCT00881894|3702805|FG000|Pharmacokinetic Set (PKS)|Overall Study|Patients with an insufficient patch adhesiveness were excluded from the PKS.|23
2986444|NCT00881894|3702806|FG001|Pharmacokinetic Set (PKS)|Overall Study|Patients with an insufficient patch adhesiveness were excluded from the PKS.|21
2986445|NCT00881894|3702805|FG000|COMPLETED|Overall Study||25
2986446|NCT00881894|3702806|FG001|COMPLETED|Overall Study||23
2986447|NCT00881894|3702805|FG000|NOT COMPLETED|Overall Study||1
2986448|NCT00881894|3702806|FG001|NOT COMPLETED|Overall Study||3
2986449|NCT00881959|3702814|FG000|STARTED|Overall Study||38
2986450|NCT00881959|3702815|FG001|STARTED|Overall Study||42
2986451|NCT00881959|3702814|FG000|COMPLETED|Overall Study||36
2986452|NCT00881959|3702815|FG001|COMPLETED|Overall Study||38
2986453|NCT00881959|3702814|FG000|NOT COMPLETED|Overall Study||2
2986454|NCT00881959|3702815|FG001|NOT COMPLETED|Overall Study||4
2986455|NCT00882102|3702821|FG000|STARTED|Overall Study||40
2986456|NCT00882102|3702821|FG000|COMPLETED|Overall Study||40
2986457|NCT00882102|3702821|FG000|NOT COMPLETED|Overall Study||0
2986458|NCT00882115|3702825|FG000|STARTED|Overall Study||38
2986459|NCT00882115|3702825|FG000|COMPLETED|Overall Study||29
2986460|NCT00882115|3702825|FG000|NOT COMPLETED|Overall Study||9
2986461|NCT00882206|3702829|FG000|STARTED|Overall Study||13
2986462|NCT00882206|3702829|FG000|COMPLETED|Overall Study||13
2986463|NCT00882206|3702829|FG000|NOT COMPLETED|Overall Study||0
2986464|NCT00882362|3702836|FG000|STARTED|Overall Study||122
2986465|NCT00882362|3702837|FG001|STARTED|Overall Study||33
2986466|NCT00882362|3702836|FG000|COMPLETED|Overall Study||73
2986467|NCT00882362|3702837|FG001|COMPLETED|Overall Study||10
2986468|NCT00882362|3702836|FG000|NOT COMPLETED|Overall Study||49
2986469|NCT00882362|3702837|FG001|NOT COMPLETED|Overall Study||23
2986470|NCT00882518|3702845|FG000|STARTED|Overall Study||196
2986471|NCT00882518|3702846|FG001|STARTED|Overall Study||192
2986472|NCT00882518|3702845|FG000|COMPLETED|Overall Study||158
2986473|NCT00882518|3702846|FG001|COMPLETED|Overall Study||148
2986474|NCT00882518|3702845|FG000|NOT COMPLETED|Overall Study||38
2986475|NCT00882518|3702846|FG001|NOT COMPLETED|Overall Study||44
2986476|NCT00882557|3702854|FG000|STARTED|Overall Study||8
2986477|NCT00882557|3702855|FG001|STARTED|Overall Study||8
2986478|NCT00882557|3702854|FG000|Completed Dose 1|Overall Study||8
2986479|NCT00882557|3702855|FG001|Completed Dose 1|Overall Study||7
2986480|NCT00882557|3702854|FG000|Completed Dose 2|Overall Study||6
2986481|NCT00882557|3702855|FG001|Completed Dose 2|Overall Study||7
2986482|NCT00882557|3702854|FG000|COMPLETED|Overall Study||6
2986483|NCT00882557|3702855|FG001|COMPLETED|Overall Study||7
2986484|NCT00882557|3702854|FG000|NOT COMPLETED|Overall Study||2
2986485|NCT00882557|3702855|FG001|NOT COMPLETED|Overall Study||1
2986486|NCT00882583|3702863|FG000|STARTED|Overall Study||7
2986487|NCT00882583|3702864|FG001|STARTED|Overall Study||12
2986488|NCT00882583|3702863|FG000|COMPLETED|Overall Study||6
2986489|NCT00882583|3702864|FG001|COMPLETED|Overall Study||11
2986490|NCT00882583|3702863|FG000|NOT COMPLETED|Overall Study||1
2986491|NCT00882583|3702864|FG001|NOT COMPLETED|Overall Study||1
2986492|NCT00882661|3702873|FG000|STARTED|Investigational Training||89
2986493|NCT00882661|3702874|FG001|STARTED|Investigational Training||0
2986494|NCT00882661|3702873|FG000|COMPLETED|Investigational Training||79
2986495|NCT00882661|3702874|FG001|COMPLETED|Investigational Training||0
2986496|NCT00882661|3702873|FG000|NOT COMPLETED|Investigational Training||10
2986497|NCT00882661|3702874|FG001|NOT COMPLETED|Investigational Training||0
2986498|NCT00882661|3702873|FG000|STARTED|Treatment||151
2986499|NCT00882661|3702874|FG001|STARTED|Treatment||140
2986500|NCT00882661|3702873|FG000|COMPLETED|Treatment||141
2986501|NCT00882661|3702874|FG001|COMPLETED|Treatment||114
2986502|NCT00882661|3702873|FG000|NOT COMPLETED|Treatment||10
2986503|NCT00882661|3702874|FG001|NOT COMPLETED|Treatment||26
2986504|NCT00882687|3702886|FG000|STARTED|Overall Study||15
2986505|NCT00882687|3702887|FG001|STARTED|Overall Study||15
2986506|NCT00882687|3702888|FG002|STARTED|Overall Study||15
2986507|NCT00882687|3702889|FG003|STARTED|Overall Study||15
2986508|NCT00882687|3702886|FG000|COMPLETED|Overall Study||13
2986509|NCT00882687|3702887|FG001|COMPLETED|Overall Study||13
2986510|NCT00882687|3702888|FG002|COMPLETED|Overall Study||12
2986511|NCT00882687|3702889|FG003|COMPLETED|Overall Study||13
2986512|NCT00882687|3702886|FG000|NOT COMPLETED|Overall Study||2
2986513|NCT00882687|3702887|FG001|NOT COMPLETED|Overall Study||2
2986514|NCT00882687|3702888|FG002|NOT COMPLETED|Overall Study||3
2986515|NCT00882687|3702889|FG003|NOT COMPLETED|Overall Study||2
2986516|NCT00882713|3702899|FG000|STARTED|Overall Study||194
2986517|NCT00882713|3702899|FG000|COMPLETED|Overall Study||172
2986518|NCT00882713|3702899|FG000|NOT COMPLETED|Overall Study||22
2986519|NCT00882778|3702904|FG000|STARTED|Overall Study||86
2986520|NCT00882778|3702904|FG000|COMPLETED|Overall Study||86
2986521|NCT00882778|3702904|FG000|NOT COMPLETED|Overall Study||0
2986522|NCT00882908|3702913|FG000|STARTED|Overall Study||78
2986523|NCT00882908|3702914|FG001|STARTED|Overall Study||75
2986524|NCT00882908|3702915|FG002|STARTED|Overall Study||77
2986525|NCT00882908|3702916|FG003|STARTED|Overall Study||79
2986526|NCT00882908|3702917|FG004|STARTED|Overall Study||77
2986527|NCT00882908|3702913|FG000|COMPLETED|Overall Study||75
2986528|NCT00882908|3702914|FG001|COMPLETED|Overall Study||69
2986529|NCT00882908|3702915|FG002|COMPLETED|Overall Study||70
2986530|NCT00882908|3702916|FG003|COMPLETED|Overall Study||72
2986531|NCT00882908|3702917|FG004|COMPLETED|Overall Study||71
2986532|NCT00882908|3702913|FG000|NOT COMPLETED|Overall Study||3
2986533|NCT00882908|3702914|FG001|NOT COMPLETED|Overall Study||6
2986534|NCT00882908|3702915|FG002|NOT COMPLETED|Overall Study||7
2986535|NCT00882908|3702916|FG003|NOT COMPLETED|Overall Study||7
2986536|NCT00882908|3702917|FG004|NOT COMPLETED|Overall Study||6
2986537|NCT00882921|3702930|FG000|STARTED|Overall Study||26
3164411|NCT01892189|3891780|FG002|COMPLETED|Washout Period 2 (7 Days)||1
3164412|NCT01892189|3891781|FG003|COMPLETED|Washout Period 2 (7 Days)||2
2986538|NCT00882921|3702930|FG000|COMPLETED|Overall Study||15
2986539|NCT00882921|3702930|FG000|NOT COMPLETED|Overall Study||11
2986540|NCT00882999|3702942|FG000|STARTED|Overall Study||35
2986541|NCT00882999|3702943|FG001|STARTED|Overall Study||34
2986542|NCT00882999|3702944|FG002|STARTED|Overall Study||34
2986543|NCT00882999|3702945|FG003|STARTED|Overall Study||36
2986544|NCT00882999|3702946|FG004|STARTED|Overall Study||36
2986545|NCT00882999|3702947|FG005|STARTED|Overall Study||35
2986546|NCT00882999|3702948|FG006|STARTED|Overall Study||35
2986547|NCT00882999|3702942|FG000|Received Any Amount of Study Drug|Overall Study||35
2986548|NCT00882999|3702943|FG001|Received Any Amount of Study Drug|Overall Study||34
2986549|NCT00882999|3702944|FG002|Received Any Amount of Study Drug|Overall Study||34
2986550|NCT00882999|3702945|FG003|Received Any Amount of Study Drug|Overall Study||36
2986551|NCT00882999|3702946|FG004|Received Any Amount of Study Drug|Overall Study||36
2986552|NCT00882999|3702947|FG005|Received Any Amount of Study Drug|Overall Study||35
2986553|NCT00882999|3702948|FG006|Received Any Amount of Study Drug|Overall Study||35
2986554|NCT00882999|3702942|FG000|Completed Study Treatment|Overall Study||29
2986555|NCT00882999|3702943|FG001|Completed Study Treatment|Overall Study||29
2986556|NCT00882999|3702944|FG002|Completed Study Treatment|Overall Study||31
2986557|NCT00882999|3702945|FG003|Completed Study Treatment|Overall Study||33
2986558|NCT00882999|3702946|FG004|Completed Study Treatment|Overall Study||29
2986559|NCT00882999|3702947|FG005|Completed Study Treatment|Overall Study||30
2986560|NCT00882999|3702948|FG006|Completed Study Treatment|Overall Study||31
2986561|NCT00882999|3702942|FG000|COMPLETED|Overall Study||27
2986562|NCT00882999|3702943|FG001|COMPLETED|Overall Study||26
2986563|NCT00882999|3702944|FG002|COMPLETED|Overall Study||30
2986564|NCT00882999|3702945|FG003|COMPLETED|Overall Study||31
2986565|NCT00882999|3702946|FG004|COMPLETED|Overall Study||28
3164413|NCT01892189|3891782|FG004|COMPLETED|Washout Period 2 (7 Days)||3
3164414|NCT01892189|3891783|FG005|COMPLETED|Washout Period 2 (7 Days)||2
3164415|NCT01892189|3891784|FG006|COMPLETED|Washout Period 2 (7 Days)||2
3164416|NCT01892189|3891785|FG007|COMPLETED|Washout Period 2 (7 Days)||3
3164417|NCT01892189|3891786|FG008|COMPLETED|Washout Period 2 (7 Days)||1
2986566|NCT00882999|3702947|FG005|COMPLETED|Overall Study||28
2986567|NCT00882999|3702948|FG006|COMPLETED|Overall Study||27
2986568|NCT00882999|3702942|FG000|NOT COMPLETED|Overall Study||8
2986569|NCT00882999|3702943|FG001|NOT COMPLETED|Overall Study||8
2986570|NCT00882999|3702944|FG002|NOT COMPLETED|Overall Study||4
2986571|NCT00882999|3702945|FG003|NOT COMPLETED|Overall Study||5
2986572|NCT00882999|3702946|FG004|NOT COMPLETED|Overall Study||8
2986573|NCT00882999|3702947|FG005|NOT COMPLETED|Overall Study||7
2986574|NCT00882999|3702948|FG006|NOT COMPLETED|Overall Study||8
2986575|NCT00883051|3702976|FG000|STARTED|Overall Study||106
2986576|NCT00883051|3702977|FG001|STARTED|Overall Study||104
2986577|NCT00883051|3702978|FG002|STARTED|Overall Study||100
2986578|NCT00883051|3702979|FG003|STARTED|Overall Study||99
2986579|NCT00883051|3702980|FG004|STARTED|Overall Study||103
2986580|NCT00883051|3702976|FG000|No Study Medication Used|Overall Study||24
2986581|NCT00883051|3702977|FG001|No Study Medication Used|Overall Study||22
2986582|NCT00883051|3702978|FG002|No Study Medication Used|Overall Study||29
2986583|NCT00883051|3702979|FG003|No Study Medication Used|Overall Study||29
2986584|NCT00883051|3702980|FG004|No Study Medication Used|Overall Study||17
2986585|NCT00883051|3702976|FG000|Received at Least 1 Dose of Study Drug|Overall Study||82
2986586|NCT00883051|3702977|FG001|Received at Least 1 Dose of Study Drug|Overall Study||82
2986587|NCT00883051|3702978|FG002|Received at Least 1 Dose of Study Drug|Overall Study||71
2986588|NCT00883051|3702979|FG003|Received at Least 1 Dose of Study Drug|Overall Study||70
2986589|NCT00883051|3702980|FG004|Received at Least 1 Dose of Study Drug|Overall Study||86
2986590|NCT00883051|3702976|FG000|COMPLETED|Overall Study||82
2986591|NCT00883051|3702977|FG001|COMPLETED|Overall Study||82
2986592|NCT00883051|3702978|FG002|COMPLETED|Overall Study||71
2986593|NCT00883051|3702979|FG003|COMPLETED|Overall Study||70
2986594|NCT00883051|3702980|FG004|COMPLETED|Overall Study|One participant was lost to follow up and did not provide adverse event data.|85
2986595|NCT00883051|3702976|FG000|NOT COMPLETED|Overall Study||24
2986596|NCT00883051|3702977|FG001|NOT COMPLETED|Overall Study||22
2986597|NCT00883051|3702978|FG002|NOT COMPLETED|Overall Study||29
2986598|NCT00883051|3702979|FG003|NOT COMPLETED|Overall Study||29
2986599|NCT00883051|3702980|FG004|NOT COMPLETED|Overall Study||18
2986600|NCT00883090|3702992|FG000|STARTED|Overall Study|Of the 15 participants started, 14 were administered FXIII|15
2986601|NCT00883090|3702992|FG000|COMPLETED|Overall Study||13
2986602|NCT00883090|3702992|FG000|NOT COMPLETED|Overall Study||2
2986603|NCT00883103|3702998|FG000|STARTED|Overall Study||69
2986604|NCT00883103|3702999|FG001|STARTED|Overall Study||68
2986605|NCT00883103|3702998|FG000|COMPLETED|Overall Study||69
2986606|NCT00883103|3702999|FG001|COMPLETED|Overall Study||68
2986607|NCT00883103|3702998|FG000|NOT COMPLETED|Overall Study||0
2986608|NCT00883103|3702999|FG001|NOT COMPLETED|Overall Study||0
2986609|NCT00883116|3703007|FG000|STARTED|Overall Study||248
2986610|NCT00883116|3703008|FG001|STARTED|Overall Study||248
2986611|NCT00883116|3703007|FG000|Received Treatment|Overall Study||248
2986612|NCT00883116|3703008|FG001|Received Treatment|Overall Study||239
2986613|NCT00883116|3703007|FG000|COMPLETED|Overall Study||39
2986614|NCT00883116|3703008|FG001|COMPLETED|Overall Study||29
2986615|NCT00883116|3703007|FG000|NOT COMPLETED|Overall Study||209
2986616|NCT00883116|3703008|FG001|NOT COMPLETED|Overall Study||219
2986617|NCT00883129|3703018|FG000|STARTED|Overall Study||69
2986618|NCT00883129|3703019|FG001|STARTED|Overall Study||73
2986619|NCT00883129|3703018|FG000|COMPLETED|Overall Study|53 subjects provided a 24 month outcome, 4 of whom had prematurely withdrawn from drug treatment.|49
2986620|NCT00883129|3703019|FG001|COMPLETED|Overall Study|53 subjects provided a 24 month outcome, 16 of whom had prematurely withdrawn from drug treatment.|37
2986621|NCT00883129|3703018|FG000|NOT COMPLETED|Overall Study||20
2986622|NCT00883129|3703019|FG001|NOT COMPLETED|Overall Study||36
2986623|NCT00883168|3703029|FG000|STARTED|Overall Study||448
2986624|NCT00883168|3703030|FG001|STARTED|Overall Study||445
2986625|NCT00883168|3703031|FG002|STARTED|Overall Study||450
2986626|NCT00883168|3703032|FG003|STARTED|Overall Study||448
2986627|NCT00883168|3703029|FG000|COMPLETED|Overall Study||434
2986628|NCT00883168|3703030|FG001|COMPLETED|Overall Study||430
2986629|NCT00883168|3703031|FG002|COMPLETED|Overall Study||431
2986630|NCT00883168|3703032|FG003|COMPLETED|Overall Study||433
2986631|NCT00883168|3703029|FG000|NOT COMPLETED|Overall Study||14
2986632|NCT00883168|3703030|FG001|NOT COMPLETED|Overall Study||15
2986633|NCT00883168|3703031|FG002|NOT COMPLETED|Overall Study||19
2986634|NCT00883168|3703032|FG003|NOT COMPLETED|Overall Study||15
2986635|NCT00883181|3703042|FG000|STARTED|Overall Study|Full analysis set|1347
2986636|NCT00883181|3703042|FG000|COMPLETED|Overall Study|Completed planned chemotherapy|1069
2986637|NCT00883181|3703042|FG000|NOT COMPLETED|Overall Study||278
2986638|NCT00883233|3703063|FG000|STARTED|Overall Study||32
2986639|NCT00883233|3703064|FG001|STARTED|Overall Study||32
2986640|NCT00883233|3703065|FG002|STARTED|Overall Study||29
2986641|NCT00883233|3703066|FG003|STARTED|Overall Study||30
2986642|NCT00883233|3703063|FG000|COMPLETED|Overall Study||27
2986643|NCT00883233|3703064|FG001|COMPLETED|Overall Study||28
2986644|NCT00883233|3703065|FG002|COMPLETED|Overall Study||25
2986645|NCT00883233|3703066|FG003|COMPLETED|Overall Study||25
2986646|NCT00883233|3703063|FG000|NOT COMPLETED|Overall Study||5
2986647|NCT00883233|3703064|FG001|NOT COMPLETED|Overall Study||4
2986648|NCT00883233|3703065|FG002|NOT COMPLETED|Overall Study||4
2986649|NCT00883233|3703066|FG003|NOT COMPLETED|Overall Study||5
2986650|NCT00883246|3703076|FG000|STARTED|Overall Study||799
2986651|NCT00883246|3703076|FG000|COMPLETED|Overall Study||626
2986652|NCT00883246|3703076|FG000|NOT COMPLETED|Overall Study||173
2986653|NCT00883337|3703089|FG000|STARTED|Core Treatment Period||109
2986654|NCT00883337|3703090|FG001|STARTED|Core Treatment Period||111
2986655|NCT00883337|3703091|FG002|STARTED|Core Treatment Period||104
2986656|NCT00883337|3703089|FG000|Treated|Core Treatment Period||109
2986657|NCT00883337|3703090|FG001|Treated|Core Treatment Period|One participant received teriflunomide 7 mg instead of teriflunomide 14 mg|111
2986658|NCT00883337|3703091|FG002|Treated|Core Treatment Period|3 participants refused treatment with Rebif®|101
2986659|NCT00883337|3703089|FG000|COMPLETED|Core Treatment Period||89
2986660|NCT00883337|3703090|FG001|COMPLETED|Core Treatment Period||89
2986661|NCT00883337|3703091|FG002|COMPLETED|Core Treatment Period||71
2986662|NCT00883337|3703089|FG000|NOT COMPLETED|Core Treatment Period||20
2986663|NCT00883337|3703090|FG001|NOT COMPLETED|Core Treatment Period||22
2986664|NCT00883337|3703091|FG002|NOT COMPLETED|Core Treatment Period||33
2986665|NCT00883337|3703089|FG000|STARTED|Extension Treatment Period||89
2986666|NCT00883337|3703090|FG001|STARTED|Extension Treatment Period||89
2986667|NCT00883337|3703091|FG002|STARTED|Extension Treatment Period|12 participants completed the core period but didn't enter the extension period.|59
2986668|NCT00883337|3703089|FG000|COMPLETED|Extension Treatment Period||61
2986669|NCT00883337|3703090|FG001|COMPLETED|Extension Treatment Period||66
2986670|NCT00883337|3703091|FG002|COMPLETED|Extension Treatment Period||40
2986671|NCT00883337|3703089|FG000|NOT COMPLETED|Extension Treatment Period||28
2986672|NCT00883337|3703090|FG001|NOT COMPLETED|Extension Treatment Period||23
2986673|NCT00883337|3703091|FG002|NOT COMPLETED|Extension Treatment Period||19
2986674|NCT00883389|3703105|FG000|STARTED|Overall Study||26
3164418|NCT01892189|3891778|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||0
3164419|NCT01892189|3891779|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0
2986675|NCT00883389|3703105|FG000|COMPLETED|Overall Study||26
2986676|NCT00883389|3703105|FG000|NOT COMPLETED|Overall Study||0
2986677|NCT00883415|3703109|FG000|STARTED|Overall Study||20
2986678|NCT00883415|3703109|FG000|COMPLETED|Overall Study||18
2986679|NCT00883415|3703109|FG000|NOT COMPLETED|Overall Study||2
2986680|NCT00883493|3703115|FG000|STARTED|Overall Study||212
2986681|NCT00883493|3703116|FG001|STARTED|Overall Study||209
2986682|NCT00883493|3703115|FG000|Intention To Treat Analysis Population|Overall Study||204
2986683|NCT00883493|3703116|FG001|Intention To Treat Analysis Population|Overall Study||195
2986684|NCT00883493|3703115|FG000|Per Protocol Analysis Population|Overall Study||162
2986685|NCT00883493|3703116|FG001|Per Protocol Analysis Population|Overall Study||155
2986686|NCT00883493|3703115|FG000|COMPLETED|Overall Study||166
2986687|NCT00883493|3703116|FG001|COMPLETED|Overall Study||159
2986688|NCT00883493|3703115|FG000|NOT COMPLETED|Overall Study||46
2986689|NCT00883493|3703116|FG001|NOT COMPLETED|Overall Study||50
3036516|NCT01143727|3755736|FG001|NOT COMPLETED|Overall Study||0
3036517|NCT01143766|3755744|FG000|STARTED|Overall Study||25
3036518|NCT01143766|3755745|FG001|STARTED|Overall Study||31
3036519|NCT01143766|3755744|FG000|COMPLETED|Overall Study||25
3036520|NCT01143766|3755745|FG001|COMPLETED|Overall Study||31
3036521|NCT01143766|3755744|FG000|NOT COMPLETED|Overall Study||0
3036522|NCT01143766|3755745|FG001|NOT COMPLETED|Overall Study||0
3036523|NCT01143792|3755756|FG000|STARTED|Overall Study||93
3036524|NCT01143792|3755757|FG001|STARTED|Overall Study||86
3036525|NCT01143792|3755758|FG002|STARTED|Overall Study||91
3036526|NCT01143792|3755756|FG000|COMPLETED|Overall Study||93
3036527|NCT01143792|3755757|FG001|COMPLETED|Overall Study||86
3036528|NCT01143792|3755758|FG002|COMPLETED|Overall Study||91
3036529|NCT01143792|3755756|FG000|NOT COMPLETED|Overall Study||0
3036530|NCT01143792|3755757|FG001|NOT COMPLETED|Overall Study||0
3036531|NCT01143792|3755758|FG002|NOT COMPLETED|Overall Study||0
3036532|NCT01143818|3755777|FG000|STARTED|Overall Study|A total of 1053 participants were enrolled but only 1049 received study drug.|1049
3036533|NCT01143818|3755777|FG000|COMPLETED|Overall Study||799
3036534|NCT01143818|3755777|FG000|NOT COMPLETED|Overall Study||250
3036535|NCT01143870|3755784|FG000|STARTED|Overall Study||58
3036536|NCT01143870|3755785|FG001|STARTED|Overall Study||58
3036537|NCT01143870|3755786|FG002|STARTED|Overall Study||61
3036538|NCT01143870|3755784|FG000|Post-intervention Survey|Overall Study||53
3036539|NCT01143870|3755785|FG001|Post-intervention Survey|Overall Study||50
3036540|NCT01143870|3755786|FG002|Post-intervention Survey|Overall Study||61
3036541|NCT01143870|3755784|FG000|Had Available 6-month A1C|Overall Study||27
2986690|NCT00883558|3703122|FG000|STARTED|Titration Period (Weeks 0 to 4)||48
2986691|NCT00883558|3703123|FG001|STARTED|Titration Period (Weeks 0 to 4)||0
2986692|NCT00883558|3703124|FG002|STARTED|Titration Period (Weeks 0 to 4)||0
2986693|NCT00883558|3703122|FG000|COMPLETED|Titration Period (Weeks 0 to 4)||46
2986694|NCT00883558|3703123|FG001|COMPLETED|Titration Period (Weeks 0 to 4)||0
2986695|NCT00883558|3703124|FG002|COMPLETED|Titration Period (Weeks 0 to 4)||0
2986696|NCT00883558|3703122|FG000|NOT COMPLETED|Titration Period (Weeks 0 to 4)||2
2986697|NCT00883558|3703123|FG001|NOT COMPLETED|Titration Period (Weeks 0 to 4)||0
2986698|NCT00883558|3703124|FG002|NOT COMPLETED|Titration Period (Weeks 0 to 4)||0
2986699|NCT00883558|3703122|FG000|STARTED|First Treatment Cycle (Weeks 4 to 16)||0
2986700|NCT00883558|3703123|FG001|STARTED|First Treatment Cycle (Weeks 4 to 16)||22
2986701|NCT00883558|3703124|FG002|STARTED|First Treatment Cycle (Weeks 4 to 16)||24
2986702|NCT00883558|3703122|FG000|Received at Least 1 Dose of Study Drug|First Treatment Cycle (Weeks 4 to 16)||0
2986703|NCT00883558|3703123|FG001|Received at Least 1 Dose of Study Drug|First Treatment Cycle (Weeks 4 to 16)||22
2986704|NCT00883558|3703124|FG002|Received at Least 1 Dose of Study Drug|First Treatment Cycle (Weeks 4 to 16)||24
2986705|NCT00883558|3703122|FG000|COMPLETED|First Treatment Cycle (Weeks 4 to 16)||0
2986706|NCT00883558|3703123|FG001|COMPLETED|First Treatment Cycle (Weeks 4 to 16)||19
2986707|NCT00883558|3703124|FG002|COMPLETED|First Treatment Cycle (Weeks 4 to 16)||23
2986708|NCT00883558|3703122|FG000|NOT COMPLETED|First Treatment Cycle (Weeks 4 to 16)||0
2986709|NCT00883558|3703123|FG001|NOT COMPLETED|First Treatment Cycle (Weeks 4 to 16)||3
2986710|NCT00883558|3703124|FG002|NOT COMPLETED|First Treatment Cycle (Weeks 4 to 16)||1
2986711|NCT00883558|3703122|FG000|STARTED|Second Treatment Cycle (Weeks 16 to 28)||0
2986712|NCT00883558|3703123|FG001|STARTED|Second Treatment Cycle (Weeks 16 to 28)||19
2986713|NCT00883558|3703124|FG002|STARTED|Second Treatment Cycle (Weeks 16 to 28)||23
3304821|NCT02982772|4038432|FG001|STARTED|Enrollment||243
3304822|NCT02982772|4038431|FG000|COMPLETED|Enrollment||245
3304823|NCT02982772|4038432|FG001|COMPLETED|Enrollment||243
3304824|NCT02982772|4038431|FG000|NOT COMPLETED|Enrollment||0
3304825|NCT02982772|4038432|FG001|NOT COMPLETED|Enrollment||0
3304826|NCT02982772|4038431|FG000|STARTED|Intervention||245
3304827|NCT02982772|4038432|FG001|STARTED|Intervention||243
3304828|NCT02982772|4038431|FG000|COMPLETED|Intervention||226
2986714|NCT00883558|3703122|FG000|Received at Least 1 Dose of Study Drug|Second Treatment Cycle (Weeks 16 to 28)||0
2986715|NCT00883558|3703123|FG001|Received at Least 1 Dose of Study Drug|Second Treatment Cycle (Weeks 16 to 28)||19
2986716|NCT00883558|3703124|FG002|Received at Least 1 Dose of Study Drug|Second Treatment Cycle (Weeks 16 to 28)||23
2986717|NCT00883558|3703122|FG000|COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||0
2986718|NCT00883558|3703123|FG001|COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||19
2986719|NCT00883558|3703124|FG002|COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||22
2986720|NCT00883558|3703122|FG000|NOT COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||0
2986721|NCT00883558|3703123|FG001|NOT COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||0
2986722|NCT00883558|3703124|FG002|NOT COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||1
2986723|NCT00883675|3703130|FG000|STARTED|Overall Study||133
2986724|NCT00883675|3703130|FG000|COMPLETED|Overall Study||133
2986725|NCT00883675|3703130|FG000|NOT COMPLETED|Overall Study||0
2986726|NCT00883688|3703134|FG000|STARTED|Overall Study||24
2986727|NCT00883688|3703134|FG000|COMPLETED|Overall Study||22
2986728|NCT00883688|3703134|FG000|NOT COMPLETED|Overall Study||2
2986729|NCT00883740|3703138|FG000|STARTED|First Intervention||60
2986730|NCT00883740|3703139|FG001|STARTED|First Intervention||59
2986731|NCT00883740|3703138|FG000|COMPLETED|First Intervention|1 participant not crossed to period 2 but continued on period 1, sponsor terminated as noncompliance|53
2986732|NCT00883740|3703139|FG001|COMPLETED|First Intervention||51
2986733|NCT00883740|3703138|FG000|NOT COMPLETED|First Intervention||7
2986734|NCT00883740|3703139|FG001|NOT COMPLETED|First Intervention||8
2986735|NCT00883740|3703138|FG000|STARTED|Taper and Washout Period (2 Weeks)|1 participant not crossed to period 2 but continued on period 1, sponsor terminated as noncompliance|54
2986736|NCT00883740|3703139|FG001|STARTED|Taper and Washout Period (2 Weeks)||51
2986737|NCT00883740|3703138|FG000|COMPLETED|Taper and Washout Period (2 Weeks)||54
2986738|NCT00883740|3703139|FG001|COMPLETED|Taper and Washout Period (2 Weeks)||51
2986739|NCT00883740|3703138|FG000|NOT COMPLETED|Taper and Washout Period (2 Weeks)||0
2986740|NCT00883740|3703139|FG001|NOT COMPLETED|Taper and Washout Period (2 Weeks)||0
2986741|NCT00883740|3703138|FG000|STARTED|Second Intervention|1 participant not crossed to period 2 but continued on period 1, sponsor terminated as noncompliance|53
2986742|NCT00883740|3703139|FG001|STARTED|Second Intervention||51
2986743|NCT00883740|3703138|FG000|COMPLETED|Second Intervention||52
2986744|NCT00883740|3703139|FG001|COMPLETED|Second Intervention||50
2986745|NCT00883740|3703138|FG000|NOT COMPLETED|Second Intervention||1
2986746|NCT00883740|3703139|FG001|NOT COMPLETED|Second Intervention||1
2986747|NCT00883753|3703145|FG000|STARTED|Overall Study||934
2986748|NCT00883753|3703145|FG000|COMPLETED|Overall Study||827
2986749|NCT00883753|3703145|FG000|NOT COMPLETED|Overall Study||107
2986750|NCT00883779|3703154|FG000|STARTED|Primary Study Treatment Phase||225
2986751|NCT00883779|3703155|FG001|STARTED|Primary Study Treatment Phase||226
2986752|NCT00883779|3703154|FG000|COMPLETED|Primary Study Treatment Phase||120
2986753|NCT00883779|3703155|FG001|COMPLETED|Primary Study Treatment Phase||140
2986754|NCT00883779|3703154|FG000|NOT COMPLETED|Primary Study Treatment Phase||105
2986755|NCT00883779|3703155|FG001|NOT COMPLETED|Primary Study Treatment Phase||86
3304829|NCT02982772|4038432|FG001|COMPLETED|Intervention||230
3304830|NCT02982772|4038431|FG000|NOT COMPLETED|Intervention||19
2986756|NCT00883779|3703154|FG000|STARTED|Post-Study Treatment Phase||112
2986757|NCT00883779|3703155|FG001|STARTED|Post-Study Treatment Phase||135
2986758|NCT00883779|3703154|FG000|COMPLETED|Post-Study Treatment Phase||0
2986759|NCT00883779|3703155|FG001|COMPLETED|Post-Study Treatment Phase||0
2986760|NCT00883779|3703154|FG000|NOT COMPLETED|Post-Study Treatment Phase||112
2986761|NCT00883779|3703155|FG001|NOT COMPLETED|Post-Study Treatment Phase||135
2986762|NCT00883779|3703154|FG000|STARTED|Off-study Phase||209
2986763|NCT00883779|3703155|FG001|STARTED|Off-study Phase||202
2986764|NCT00883779|3703154|FG000|COMPLETED|Off-study Phase||0
2986765|NCT00883779|3703155|FG001|COMPLETED|Off-study Phase||0
2986766|NCT00883779|3703154|FG000|NOT COMPLETED|Off-study Phase||209
2986767|NCT00883779|3703155|FG001|NOT COMPLETED|Off-study Phase||202
2986768|NCT00884039|3703163|FG000|STARTED|Overall Study||5
2986769|NCT00884039|3703164|FG001|STARTED|Overall Study||2
2986770|NCT00884039|3703163|FG000|COMPLETED|Overall Study||3
2986771|NCT00884039|3703164|FG001|COMPLETED|Overall Study||1
2986772|NCT00884039|3703163|FG000|NOT COMPLETED|Overall Study||2
2986773|NCT00884039|3703164|FG001|NOT COMPLETED|Overall Study||1
2986774|NCT00884052|3703170|FG000|STARTED|Overall Study||6
2986775|NCT00884052|3703171|FG001|STARTED|Overall Study||12
2986776|NCT00884052|3703170|FG000|COMPLETED|Overall Study||6
2986777|NCT00884052|3703171|FG001|COMPLETED|Overall Study||12
2986778|NCT00884052|3703170|FG000|NOT COMPLETED|Overall Study||0
2986779|NCT00884052|3703171|FG001|NOT COMPLETED|Overall Study||0
2986780|NCT00884065|3703179|FG000|STARTED|Overall Study||25
2986781|NCT00884065|3703180|FG001|STARTED|Overall Study||25
2986782|NCT00884065|3703179|FG000|COMPLETED|Overall Study||25
2986783|NCT00884065|3703180|FG001|COMPLETED|Overall Study||25
2986784|NCT00884065|3703179|FG000|NOT COMPLETED|Overall Study||0
2986785|NCT00884065|3703180|FG001|NOT COMPLETED|Overall Study||0
2986786|NCT00884117|3703186|FG000|STARTED|Overall Study||4561
2986787|NCT00884117|3703186|FG000|COMPLETED|Overall Study|Defined as Day 6 visit for those enrolled before Amendment D; thereafter defined as Day 10 visit.|4312
2986788|NCT00884117|3703186|FG000|NOT COMPLETED|Overall Study||249
2986789|NCT00884221|3703205|FG000|STARTED|Overall Study||374
2986790|NCT00884221|3703206|FG001|STARTED|Overall Study||375
2986791|NCT00884221|3703205|FG000|COMPLETED|Overall Study||340
2986792|NCT00884221|3703206|FG001|COMPLETED|Overall Study||343
2986793|NCT00884221|3703205|FG000|NOT COMPLETED|Overall Study||34
2986794|NCT00884221|3703206|FG001|NOT COMPLETED|Overall Study||32
2986795|NCT00884273|3703216|FG000|STARTED|Overall Study|Intention-to-treat (ITT) population.|84
2986796|NCT00884273|3703217|FG001|STARTED|Overall Study|ITT population.|98
2986797|NCT00884273|3703216|FG000|Full Analysis Set (FAS)|Overall Study|Two participants did not have any post-dose efficacy assessment and were excluded from the FAS.|82
2986798|NCT00884273|3703217|FG001|Full Analysis Set (FAS)|Overall Study|One participant did not have any post-dose efficacy assessment and was excluded from the FAS.|97
2986799|NCT00884273|3703216|FG000|Per Protocol (PP) Analysis Set|Overall Study||81
2986800|NCT00884273|3703217|FG001|Per Protocol (PP) Analysis Set|Overall Study||92
2986801|NCT00884273|3703216|FG000|Safety Analysis Set|Overall Study||84
2986802|NCT00884273|3703217|FG001|Safety Analysis Set|Overall Study||98
2986803|NCT00884273|3703216|FG000|COMPLETED|Overall Study||82
2986804|NCT00884273|3703217|FG001|COMPLETED|Overall Study||93
2986805|NCT00884273|3703216|FG000|NOT COMPLETED|Overall Study||2
2986806|NCT00884273|3703217|FG001|NOT COMPLETED|Overall Study||5
2986807|NCT00884286|3703225|FG000|STARTED|Overall Study||34
2986808|NCT00884286|3703226|FG001|STARTED|Overall Study||33
2986809|NCT00884286|3703225|FG000|COMPLETED|Overall Study||2
2986810|NCT00884286|3703226|FG001|COMPLETED|Overall Study||0
2986811|NCT00884286|3703225|FG000|NOT COMPLETED|Overall Study||32
2986812|NCT00884286|3703226|FG001|NOT COMPLETED|Overall Study||33
2986813|NCT00884312|3703235|FG000|STARTED|Overall Study||9
2986814|NCT00884312|3703236|FG001|STARTED|Overall Study||92
2986815|NCT00884312|3703235|FG000|Received Treatment|Overall Study||9
2986816|NCT00884312|3703236|FG001|Received Treatment|Overall Study||91
2986817|NCT00884312|3703235|FG000|COMPLETED|Overall Study||7
2986818|NCT00884312|3703236|FG001|COMPLETED|Overall Study||67
2986819|NCT00884312|3703235|FG000|NOT COMPLETED|Overall Study||2
2986820|NCT00884312|3703236|FG001|NOT COMPLETED|Overall Study||25
2986821|NCT00884325|3703244|FG000|STARTED|Overall Study||20
2986822|NCT00884325|3703245|FG001|STARTED|Overall Study||20
2986823|NCT00884325|3703244|FG000|COMPLETED|Overall Study||17
2986824|NCT00884325|3703245|FG001|COMPLETED|Overall Study||16
2986825|NCT00884325|3703244|FG000|NOT COMPLETED|Overall Study||3
2986826|NCT00884325|3703245|FG001|NOT COMPLETED|Overall Study||4
2986827|NCT00884377|3703253|FG000|STARTED|Overall Study|1 not treated because infecting parasite could not be confirmed as L. major on rapid PCR testing,|28
2986828|NCT00884377|3703254|FG001|STARTED|Overall Study|1 was not treated due to concerns arising from the location of cutaneous leishmaniasis lesion|28
2986829|NCT00884377|3703253|FG000|COMPLETED|Overall Study|1 received full course of therapy,withdrew consent before completion of the 12 month follow up|26
2986830|NCT00884377|3703254|FG001|COMPLETED|Overall Study||27
2986831|NCT00884377|3703253|FG000|NOT COMPLETED|Overall Study||2
2986832|NCT00884377|3703254|FG001|NOT COMPLETED|Overall Study||1
2986833|NCT00884390|3703268|FG000|STARTED|Overall Study||146
2986834|NCT00884390|3703269|FG001|STARTED|Overall Study||62
2986835|NCT00884390|3703268|FG000|COMPLETED|Overall Study||123
2986836|NCT00884390|3703269|FG001|COMPLETED|Overall Study||54
2986837|NCT00884390|3703268|FG000|NOT COMPLETED|Overall Study||23
2986838|NCT00884390|3703269|FG001|NOT COMPLETED|Overall Study||8
2986839|NCT00884585|3703285|FG000|STARTED|Double-Masked Phase (Day 1-Month 3)||89
2986840|NCT00884585|3703286|FG001|STARTED|Double-Masked Phase (Day 1-Month 3)||87
2986841|NCT00884585|3703285|FG000|COMPLETED|Double-Masked Phase (Day 1-Month 3)||79
2986842|NCT00884585|3703286|FG001|COMPLETED|Double-Masked Phase (Day 1-Month 3)|All placebo patients who completed the double-masked phase received COS in the open-label phase.|83
2986843|NCT00884585|3703285|FG000|NOT COMPLETED|Double-Masked Phase (Day 1-Month 3)||10
2986844|NCT00884585|3703286|FG001|NOT COMPLETED|Double-Masked Phase (Day 1-Month 3)||4
2986845|NCT00884585|3703285|FG000|STARTED|Open-Label Phase (Months 3-9)|All patients who completed the double-masked phase received COS in the open-label phase.|162
2986846|NCT00884585|3703286|FG001|STARTED|Open-Label Phase (Months 3-9)|All placebo patients who completed the double-masked phase received COS in the open-label phase.|0
2986847|NCT00884585|3703285|FG000|COMPLETED|Open-Label Phase (Months 3-9)||147
2986848|NCT00884585|3703286|FG001|COMPLETED|Open-Label Phase (Months 3-9)||0
2986849|NCT00884585|3703285|FG000|NOT COMPLETED|Open-Label Phase (Months 3-9)||15
2986850|NCT00884585|3703286|FG001|NOT COMPLETED|Open-Label Phase (Months 3-9)||0
2986851|NCT00884585|3703285|FG000|STARTED|Open-Label Maintenance (Months 9-12)||147
2986852|NCT00884585|3703286|FG001|STARTED|Open-Label Maintenance (Months 9-12)||0
2986853|NCT00884585|3703285|FG000|COMPLETED|Open-Label Maintenance (Months 9-12)||144
2986854|NCT00884585|3703286|FG001|COMPLETED|Open-Label Maintenance (Months 9-12)||0
2986855|NCT00884585|3703285|FG000|NOT COMPLETED|Open-Label Maintenance (Months 9-12)||3
2986856|NCT00884585|3703286|FG001|NOT COMPLETED|Open-Label Maintenance (Months 9-12)||0
2986857|NCT00884611|3703292|FG000|STARTED|Overall Study||20
2986858|NCT00884611|3703292|FG000|Enrolled, Not Treated|Overall Study||1
2986859|NCT00884611|3703292|FG000|COMPLETED|Overall Study||19
2986860|NCT00884611|3703292|FG000|NOT COMPLETED|Overall Study||1
2986861|NCT00884650|3703304|FG000|STARTED|Overall Study||25
2986862|NCT00884650|3703305|FG001|STARTED|Overall Study||29
2986863|NCT00884650|3703304|FG000|COMPLETED|Overall Study||16
2986864|NCT00884650|3703305|FG001|COMPLETED|Overall Study||21
2986865|NCT00884650|3703304|FG000|NOT COMPLETED|Overall Study||9
2986866|NCT00884650|3703305|FG001|NOT COMPLETED|Overall Study||8
2986867|NCT00884741|3703315|FG000|STARTED|Step 1 Registration: Tissue Screening||978
2986868|NCT00884741|3703316|FG001|STARTED|Step 1 Registration: Tissue Screening||0
2986869|NCT00884741|3703317|FG002|STARTED|Step 1 Registration: Tissue Screening||0
2986870|NCT00884741|3703318|FG003|STARTED|Step 1 Registration: Tissue Screening||0
2986871|NCT00884741|3703315|FG000|COMPLETED|Step 1 Registration: Tissue Screening||666
2986872|NCT00884741|3703316|FG001|COMPLETED|Step 1 Registration: Tissue Screening||0
2986873|NCT00884741|3703317|FG002|COMPLETED|Step 1 Registration: Tissue Screening||0
2986874|NCT00884741|3703318|FG003|COMPLETED|Step 1 Registration: Tissue Screening||0
2986875|NCT00884741|3703315|FG000|NOT COMPLETED|Step 1 Registration: Tissue Screening||312
2986876|NCT00884741|3703316|FG001|NOT COMPLETED|Step 1 Registration: Tissue Screening||0
2986877|NCT00884741|3703317|FG002|NOT COMPLETED|Step 1 Registration: Tissue Screening||0
2986878|NCT00884741|3703318|FG003|NOT COMPLETED|Step 1 Registration: Tissue Screening||0
2986879|NCT00884741|3703315|FG000|STARTED|Step 2 Registration: Tissue Analysis|Step 1 Registration Arm goes to Step 2 Registration Arm|0
2986880|NCT00884741|3703316|FG001|STARTED|Step 2 Registration: Tissue Analysis|These patients completed the previous period on the Step 1 Registration arm.|666
2986881|NCT00884741|3703317|FG002|STARTED|Step 2 Registration: Tissue Analysis||0
2986882|NCT00884741|3703318|FG003|STARTED|Step 2 Registration: Tissue Analysis||0
2986883|NCT00884741|3703315|FG000|COMPLETED|Step 2 Registration: Tissue Analysis||0
2986884|NCT00884741|3703316|FG001|COMPLETED|Step 2 Registration: Tissue Analysis||637
2986885|NCT00884741|3703317|FG002|COMPLETED|Step 2 Registration: Tissue Analysis||0
2986886|NCT00884741|3703318|FG003|COMPLETED|Step 2 Registration: Tissue Analysis||0
2986887|NCT00884741|3703315|FG000|NOT COMPLETED|Step 2 Registration: Tissue Analysis||0
2986888|NCT00884741|3703316|FG001|NOT COMPLETED|Step 2 Registration: Tissue Analysis||29
2986889|NCT00884741|3703317|FG002|NOT COMPLETED|Step 2 Registration: Tissue Analysis||0
2986890|NCT00884741|3703318|FG003|NOT COMPLETED|Step 2 Registration: Tissue Analysis||0
2986891|NCT00884741|3703315|FG000|STARTED|Randomization||0
2986892|NCT00884741|3703316|FG001|STARTED|Randomization|Step 2 Registration Arm goes to a randomized arm.|0
2986893|NCT00884741|3703317|FG002|STARTED|Randomization|These patients completed the previous period on the Step 2 Registration arm.|317
2986894|NCT00884741|3703318|FG003|STARTED|Randomization|These patients completed the previous period on the Step 2 Registration arm.|320
2986895|NCT00884741|3703315|FG000|COMPLETED|Randomization||0
2986896|NCT00884741|3703316|FG001|COMPLETED|Randomization||0
2986897|NCT00884741|3703317|FG002|COMPLETED|Randomization|Patients with data available for the primary analysis are considered to have completed the study.|309
2986898|NCT00884741|3703318|FG003|COMPLETED|Randomization|Patients with data available for the primary analysis are considered to have completed the study.|312
2986899|NCT00884741|3703315|FG000|NOT COMPLETED|Randomization||0
2986900|NCT00884741|3703316|FG001|NOT COMPLETED|Randomization||0
2986901|NCT00884741|3703317|FG002|NOT COMPLETED|Randomization||8
2986902|NCT00884741|3703318|FG003|NOT COMPLETED|Randomization||8
2986903|NCT00884754|3703327|FG000|STARTED|Overall Study||30
2986904|NCT00884754|3703328|FG001|STARTED|Overall Study||30
2986905|NCT00884754|3703327|FG000|COMPLETED|Overall Study||30
2986906|NCT00884754|3703328|FG001|COMPLETED|Overall Study||30
2986907|NCT00884754|3703327|FG000|NOT COMPLETED|Overall Study||0
2986908|NCT00884754|3703328|FG001|NOT COMPLETED|Overall Study||0
2986909|NCT00884793|3703334|FG000|STARTED|Overall Study||8
2986910|NCT00884793|3703334|FG000|COMPLETED|Overall Study||7
2986911|NCT00884793|3703334|FG000|NOT COMPLETED|Overall Study||1
2986912|NCT00884806|3703338|FG000|STARTED|Overall Study||110
2986913|NCT00884806|3703338|FG000|COMPLETED|Overall Study||110
2986914|NCT00884806|3703338|FG000|NOT COMPLETED|Overall Study||0
2986915|NCT00884832|3703344|FG000|STARTED|Overall Study||22
2986916|NCT00884832|3703345|FG001|STARTED|Overall Study||22
2986917|NCT00884832|3703344|FG000|COMPLETED|Overall Study||22
2986918|NCT00884832|3703345|FG001|COMPLETED|Overall Study||21
2986919|NCT00884832|3703344|FG000|NOT COMPLETED|Overall Study||0
2986920|NCT00884832|3703345|FG001|NOT COMPLETED|Overall Study||1
2986921|NCT00884897|3703353|FG000|STARTED|Overall Study||13
2986922|NCT00884897|3703354|FG001|STARTED|Overall Study||15
2986923|NCT00884897|3703353|FG000|COMPLETED|Overall Study||13
2986924|NCT00884897|3703354|FG001|COMPLETED|Overall Study||15
2986925|NCT00884897|3703353|FG000|NOT COMPLETED|Overall Study||0
2986926|NCT00884897|3703354|FG001|NOT COMPLETED|Overall Study||0
2986927|NCT00884910|3703360|FG000|STARTED|Overall Study||33
2986928|NCT00884910|3703360|FG000|COMPLETED|Overall Study|patient diagnosed with primary pulmonary tumor during study|32
2986929|NCT00884910|3703360|FG000|NOT COMPLETED|Overall Study||1
2986930|NCT00884949|3703364|FG000|STARTED|Weeks 1-12: 0.1 mg/kg/Week||20
2986931|NCT00884949|3703364|FG000|COMPLETED|Weeks 1-12: 0.1 mg/kg/Week||18
2986932|NCT00884949|3703364|FG000|NOT COMPLETED|Weeks 1-12: 0.1 mg/kg/Week||2
2986933|NCT00884949|3703364|FG000|STARTED|Weeks 13-24: 1.0 mg/kg/Week||18
2986934|NCT00884949|3703364|FG000|COMPLETED|Weeks 13-24: 1.0 mg/kg/Week||18
2986935|NCT00884949|3703364|FG000|NOT COMPLETED|Weeks 13-24: 1.0 mg/kg/Week||0
2986936|NCT00884949|3703364|FG000|STARTED|Weeks 25-36: 2.0 mg/kg/Week||18
2986937|NCT00884949|3703364|FG000|COMPLETED|Weeks 25-36: 2.0 mg/kg/Week||18
2986938|NCT00884949|3703364|FG000|NOT COMPLETED|Weeks 25-36: 2.0 mg/kg/Week||0
2986939|NCT00884949|3703364|FG000|STARTED|Continuation Period||18
2986940|NCT00884949|3703364|FG000|COMPLETED|Continuation Period||18
2986941|NCT00884949|3703364|FG000|NOT COMPLETED|Continuation Period||0
2986942|NCT00885079|3703379|FG000|STARTED|Overall Study||93
2986943|NCT00885079|3703380|FG001|STARTED|Overall Study||95
2986944|NCT00885079|3703379|FG000|COMPLETED|Overall Study||91
2986945|NCT00885079|3703380|FG001|COMPLETED|Overall Study||91
2986946|NCT00885079|3703379|FG000|NOT COMPLETED|Overall Study||2
2986947|NCT00885079|3703380|FG001|NOT COMPLETED|Overall Study||4
2986948|NCT00885092|3703388|FG000|STARTED|Period 1, 7 Days||20
2986949|NCT00885092|3703389|FG001|STARTED|Period 1, 7 Days||20
2986950|NCT00885092|3703388|FG000|COMPLETED|Period 1, 7 Days||20
2986951|NCT00885092|3703389|FG001|COMPLETED|Period 1, 7 Days||20
2986952|NCT00885092|3703388|FG000|NOT COMPLETED|Period 1, 7 Days||0
2986953|NCT00885092|3703389|FG001|NOT COMPLETED|Period 1, 7 Days||0
2986954|NCT00885092|3703388|FG000|STARTED|Period 2, 7 Days||20
2986955|NCT00885092|3703389|FG001|STARTED|Period 2, 7 Days||20
3304831|NCT02982772|4038432|FG001|NOT COMPLETED|Intervention||13
3304832|NCT02982772|4038431|FG000|STARTED|1M Follow-Up||226
2986956|NCT00885092|3703388|FG000|COMPLETED|Period 2, 7 Days||20
2986957|NCT00885092|3703389|FG001|COMPLETED|Period 2, 7 Days||20
2986958|NCT00885092|3703388|FG000|NOT COMPLETED|Period 2, 7 Days||0
2986959|NCT00885092|3703389|FG001|NOT COMPLETED|Period 2, 7 Days||0
2986960|NCT00885105|3703397|FG000|STARTED|Overall Study||112
2986961|NCT00885105|3703398|FG001|STARTED|Overall Study||130
2986962|NCT00885105|3703397|FG000|COMPLETED|Overall Study||111
2986963|NCT00885105|3703398|FG001|COMPLETED|Overall Study||120
2986964|NCT00885105|3703397|FG000|NOT COMPLETED|Overall Study||1
2986965|NCT00885105|3703398|FG001|NOT COMPLETED|Overall Study||10
2986966|NCT00885118|3703409|FG000|STARTED|Overall Study||21
2986967|NCT00885118|3703410|FG001|STARTED|Overall Study||19
2986968|NCT00885118|3703411|FG002|STARTED|Overall Study||21
2986969|NCT00885118|3703412|FG003|STARTED|Overall Study||20
2986970|NCT00885118|3703413|FG004|STARTED|Overall Study||19
2986971|NCT00885118|3703409|FG000|COMPLETED|Overall Study||20
2986972|NCT00885118|3703410|FG001|COMPLETED|Overall Study||19
2986973|NCT00885118|3703411|FG002|COMPLETED|Overall Study||20
2986974|NCT00885118|3703412|FG003|COMPLETED|Overall Study||20
2986975|NCT00885118|3703413|FG004|COMPLETED|Overall Study||18
2986976|NCT00885118|3703409|FG000|NOT COMPLETED|Overall Study||1
2986977|NCT00885118|3703410|FG001|NOT COMPLETED|Overall Study||0
2986978|NCT00885118|3703411|FG002|NOT COMPLETED|Overall Study||1
2986979|NCT00885118|3703412|FG003|NOT COMPLETED|Overall Study||0
2986980|NCT00885118|3703413|FG004|NOT COMPLETED|Overall Study||1
2986981|NCT00885170|3703431|FG000|STARTED|Overall Study||124
2986982|NCT00885170|3703432|FG001|STARTED|Overall Study||122
2986983|NCT00885170|3703431|FG000|Treated|Overall Study||122
2986984|NCT00885170|3703432|FG001|Treated|Overall Study||121
2986985|NCT00885170|3703431|FG000|COMPLETED|Overall Study||86
2986986|NCT00885170|3703432|FG001|COMPLETED|Overall Study||99
2986987|NCT00885170|3703431|FG000|NOT COMPLETED|Overall Study||38
2986988|NCT00885170|3703432|FG001|NOT COMPLETED|Overall Study||23
2986989|NCT00885352|3703440|FG000|STARTED|Overall Study||157
2986990|NCT00885352|3703441|FG001|STARTED|Overall Study||156
2986991|NCT00885352|3703440|FG000|COMPLETED|Overall Study||149
2986992|NCT00885352|3703441|FG001|COMPLETED|Overall Study||136
2986993|NCT00885352|3703440|FG000|NOT COMPLETED|Overall Study||8
2986994|NCT00885352|3703441|FG001|NOT COMPLETED|Overall Study||20
2986995|NCT00885365|3703449|FG000|STARTED|4 Weeks ON Treatment||159
2986996|NCT00885365|3703450|FG001|STARTED|4 Weeks ON Treatment||165
2986997|NCT00885365|3703449|FG000|Intent-to-Treat Population|4 Weeks ON Treatment|Participants who took 1 dose of study medication and had baseline and at least 1 post-treatment FEV1|158
2986998|NCT00885365|3703450|FG001|Intent-to-Treat Population|4 Weeks ON Treatment||163
2986999|NCT00885365|3703449|FG000|Safety Population|4 Weeks ON Treatment|Nine participants randomized to Bramitob were administered TOBI.|156
2987000|NCT00885365|3703450|FG001|Safety Population|4 Weeks ON Treatment|Six participants randomized to TOBI were administered Bramitob|168
2987001|NCT00885365|3703449|FG000|COMPLETED|4 Weeks ON Treatment||155
2987002|NCT00885365|3703450|FG001|COMPLETED|4 Weeks ON Treatment||159
2987003|NCT00885365|3703449|FG000|NOT COMPLETED|4 Weeks ON Treatment||4
2987004|NCT00885365|3703450|FG001|NOT COMPLETED|4 Weeks ON Treatment||6
2987005|NCT00885365|3703449|FG000|STARTED|4 Weeks OFF Treatment||155
2987006|NCT00885365|3703450|FG001|STARTED|4 Weeks OFF Treatment||159
2987007|NCT00885365|3703449|FG000|COMPLETED|4 Weeks OFF Treatment||155
2987008|NCT00885365|3703450|FG001|COMPLETED|4 Weeks OFF Treatment||159
2987009|NCT00885365|3703449|FG000|NOT COMPLETED|4 Weeks OFF Treatment||0
2987010|NCT00885365|3703450|FG001|NOT COMPLETED|4 Weeks OFF Treatment||0
2987011|NCT00885378|3703458|FG000|STARTED|Overall Study|Number randomized.|74
2987012|NCT00885378|3703459|FG001|STARTED|Overall Study|Number randomized.|86
2987013|NCT00885378|3703458|FG000|COMPLETED|Overall Study||66
2987014|NCT00885378|3703459|FG001|COMPLETED|Overall Study||78
2987015|NCT00885378|3703458|FG000|NOT COMPLETED|Overall Study||8
2987016|NCT00885378|3703459|FG001|NOT COMPLETED|Overall Study||8
2987017|NCT00885482|3703465|FG000|STARTED|Overall Study||40
2987018|NCT00885482|3703465|FG000|COMPLETED|Overall Study||36
2987019|NCT00885482|3703465|FG000|NOT COMPLETED|Overall Study||4
2987020|NCT00885534|3703469|FG000|STARTED|Overall Study||7
2987021|NCT00885534|3703469|FG000|COMPLETED|Overall Study||6
2987022|NCT00885534|3703469|FG000|NOT COMPLETED|Overall Study||1
2987023|NCT00885638|3703473|FG000|STARTED|Overall Study||6
2987024|NCT00885638|3703474|FG001|STARTED|Overall Study||6
2987025|NCT00885638|3703473|FG000|COMPLETED|Overall Study||6
2987026|NCT00885638|3703474|FG001|COMPLETED|Overall Study||6
2987027|NCT00885638|3703473|FG000|NOT COMPLETED|Overall Study||0
2987028|NCT00885638|3703474|FG001|NOT COMPLETED|Overall Study||0
2987029|NCT00885677|3703483|FG000|STARTED|Overall Study||462
2987030|NCT00885677|3703484|FG001|STARTED|Overall Study||455
2987031|NCT00885677|3703483|FG000|Intention To Treat|Overall Study||437
2987032|NCT00885677|3703484|FG001|Intention To Treat|Overall Study||428
2987033|NCT00885677|3703483|FG000|COMPLETED|Overall Study||279
2987034|NCT00885677|3703484|FG001|COMPLETED|Overall Study||277
2987035|NCT00885677|3703483|FG000|NOT COMPLETED|Overall Study||183
2987036|NCT00885677|3703484|FG001|NOT COMPLETED|Overall Study||178
2987037|NCT00885703|3703497|FG000|STARTED|Overall Study||22
2987038|NCT00885703|3703498|FG001|STARTED|Overall Study||26
2987039|NCT00885703|3703499|FG002|STARTED|Overall Study||24
2987040|NCT00885703|3703500|FG003|STARTED|Overall Study||24
2987041|NCT00885703|3703501|FG004|STARTED|Overall Study||24
2987042|NCT00885703|3703502|FG005|STARTED|Overall Study||24
2987043|NCT00885703|3703503|FG006|STARTED|Overall Study||24
2987044|NCT00885703|3703497|FG000|COMPLETED|Overall Study||12
2987045|NCT00885703|3703498|FG001|COMPLETED|Overall Study||16
2987046|NCT00885703|3703499|FG002|COMPLETED|Overall Study||13
2987047|NCT00885703|3703500|FG003|COMPLETED|Overall Study||15
2987048|NCT00885703|3703501|FG004|COMPLETED|Overall Study||12
2987049|NCT00885703|3703502|FG005|COMPLETED|Overall Study||11
2987050|NCT00885703|3703503|FG006|COMPLETED|Overall Study||18
2987051|NCT00885703|3703497|FG000|NOT COMPLETED|Overall Study||10
2987052|NCT00885703|3703498|FG001|NOT COMPLETED|Overall Study||10
2987053|NCT00885703|3703499|FG002|NOT COMPLETED|Overall Study||11
2987054|NCT00885703|3703500|FG003|NOT COMPLETED|Overall Study||9
2987055|NCT00885703|3703501|FG004|NOT COMPLETED|Overall Study||12
2987056|NCT00885703|3703502|FG005|NOT COMPLETED|Overall Study||13
2987057|NCT00885703|3703503|FG006|NOT COMPLETED|Overall Study||6
2987058|NCT00885742|3703523|FG000|STARTED|Overall Study||41
2987059|NCT00885742|3703523|FG000|COMPLETED|Overall Study||41
2987060|NCT00885742|3703523|FG000|NOT COMPLETED|Overall Study||0
2987061|NCT00885755|3703530|FG000|STARTED|Part I: Trastuzumab+Taxane||31
2987062|NCT00885755|3703531|FG001|STARTED|Part I: Trastuzumab+Taxane||1
2987063|NCT00885755|3703532|FG002|STARTED|Part I: Trastuzumab+Taxane||1
2987064|NCT00885755|3703530|FG000|COMPLETED|Part I: Trastuzumab+Taxane||13
2987065|NCT00885755|3703531|FG001|COMPLETED|Part I: Trastuzumab+Taxane||1
2987066|NCT00885755|3703532|FG002|COMPLETED|Part I: Trastuzumab+Taxane||0
2987067|NCT00885755|3703530|FG000|NOT COMPLETED|Part I: Trastuzumab+Taxane||18
2987068|NCT00885755|3703531|FG001|NOT COMPLETED|Part I: Trastuzumab+Taxane||0
2987069|NCT00885755|3703532|FG002|NOT COMPLETED|Part I: Trastuzumab+Taxane||1
2987070|NCT00885755|3703530|FG000|STARTED|Part II: Trastuzumab + Capecitabine.||13
2987071|NCT00885755|3703531|FG001|STARTED|Part II: Trastuzumab + Capecitabine.||1
2987072|NCT00885755|3703532|FG002|STARTED|Part II: Trastuzumab + Capecitabine.||0
2987073|NCT00885755|3703530|FG000|COMPLETED|Part II: Trastuzumab + Capecitabine.||8
2987074|NCT00885755|3703531|FG001|COMPLETED|Part II: Trastuzumab + Capecitabine.||1
2987075|NCT00885755|3703532|FG002|COMPLETED|Part II: Trastuzumab + Capecitabine.||0
2987076|NCT00885755|3703530|FG000|NOT COMPLETED|Part II: Trastuzumab + Capecitabine.||5
2987077|NCT00885755|3703531|FG001|NOT COMPLETED|Part II: Trastuzumab + Capecitabine.||0
2987078|NCT00885755|3703532|FG002|NOT COMPLETED|Part II: Trastuzumab + Capecitabine.||0
2987079|NCT00885768|3703540|FG000|STARTED|Overall Study|all patients with coronary artery stenosis on angiography entered the study|146
2987080|NCT00885768|3703540|FG000|COMPLETED|Overall Study|all patients with including criteria completed the study|146
2987081|NCT00885768|3703540|FG000|NOT COMPLETED|Overall Study||0
2987082|NCT00885846|3703547|FG000|STARTED|Overall Study|Cohort 1 = 5 Cohort 2 = 6|11
2987083|NCT00885846|3703548|FG001|STARTED|Overall Study|Cohort 1 = 6 Cohort 2 = 5|11
2987084|NCT00885846|3703549|FG002|STARTED|Overall Study|Cohort 1 = 4 Cohort 2 = 6|10
2987085|NCT00885846|3703547|FG000|COMPLETED|Overall Study|Cohort 1 = 3 Cohort 2 = 6|9
2987086|NCT00885846|3703548|FG001|COMPLETED|Overall Study|Cohort 1 = 1 Cohort 2 = 5|6
2987087|NCT00885846|3703549|FG002|COMPLETED|Overall Study|Cohort 1 = 4 Cohort 2 = 6|8
2987088|NCT00885846|3703547|FG000|NOT COMPLETED|Overall Study||2
2987089|NCT00885846|3703548|FG001|NOT COMPLETED|Overall Study||5
2987090|NCT00885846|3703549|FG002|NOT COMPLETED|Overall Study||2
2987091|NCT00886015|3703559|FG000|STARTED|Overall Study|1674 eyes; 960 participants|1674
2987092|NCT00886015|3703560|FG001|STARTED|Overall Study|1671 eyes; 957 participants|1671
2987093|NCT00886015|3703559|FG000|COMPLETED|Overall Study|1674 eyes; 960 participants|1674
2987094|NCT00886015|3703560|FG001|COMPLETED|Overall Study|1669 eyes; 956 participants|1669
2987095|NCT00886015|3703559|FG000|NOT COMPLETED|Overall Study||0
2987096|NCT00886015|3703560|FG001|NOT COMPLETED|Overall Study||2
2987097|NCT00886119|3703566|FG000|STARTED|Period 1||24
2987098|NCT00886119|3703567|FG001|STARTED|Period 1||22
2987099|NCT00886119|3703566|FG000|COMPLETED|Period 1||23
2987100|NCT00886119|3703567|FG001|COMPLETED|Period 1||22
2987101|NCT00886119|3703566|FG000|NOT COMPLETED|Period 1||1
2987102|NCT00886119|3703567|FG001|NOT COMPLETED|Period 1||0
2987103|NCT00886119|3703566|FG000|STARTED|Period 2||23
2987104|NCT00886119|3703567|FG001|STARTED|Period 2||22
2987105|NCT00886119|3703566|FG000|COMPLETED|Period 2||23
2987106|NCT00886119|3703567|FG001|COMPLETED|Period 2||22
2987107|NCT00886119|3703566|FG000|NOT COMPLETED|Period 2||0
2987108|NCT00886119|3703567|FG001|NOT COMPLETED|Period 2||0
2987109|NCT00886145|3703573|FG000|STARTED|Overall Study||1
2987110|NCT00886145|3703573|FG000|COMPLETED|Overall Study||1
2987111|NCT00886145|3703573|FG000|NOT COMPLETED|Overall Study||0
2987112|NCT00886236|3703582|FG000|STARTED|Overall Study||20
2987113|NCT00886236|3703583|FG001|STARTED|Overall Study||21
2987114|NCT00886236|3703584|FG002|STARTED|Overall Study||21
2987115|NCT00886236|3703582|FG000|COMPLETED|Overall Study||18
2987116|NCT00886236|3703583|FG001|COMPLETED|Overall Study||17
2987117|NCT00886236|3703584|FG002|COMPLETED|Overall Study||17
2987118|NCT00886236|3703582|FG000|NOT COMPLETED|Overall Study||2
2987119|NCT00886236|3703583|FG001|NOT COMPLETED|Overall Study||4
2987120|NCT00886236|3703584|FG002|NOT COMPLETED|Overall Study||4
2987121|NCT00886262|3703594|FG000|STARTED|Overall Study||8
2987122|NCT00886262|3703595|FG001|STARTED|Overall Study||10
2987123|NCT00886262|3703594|FG000|COMPLETED|Overall Study||8
2987124|NCT00886262|3703595|FG001|COMPLETED|Overall Study||7
2987125|NCT00886262|3703594|FG000|NOT COMPLETED|Overall Study||0
2987126|NCT00886262|3703595|FG001|NOT COMPLETED|Overall Study||3
2987127|NCT00886288|3703603|FG000|STARTED|Overall Study|Baseline Population|2027
2987128|NCT00886288|3703604|FG001|STARTED|Overall Study|Baseline Population|684
2987129|NCT00886288|3703603|FG000|COMPLETED|Overall Study||1284
2987130|NCT00886288|3703604|FG001|COMPLETED|Overall Study||457
2987131|NCT00886288|3703603|FG000|NOT COMPLETED|Overall Study||743
2987132|NCT00886288|3703604|FG001|NOT COMPLETED|Overall Study||227
2987133|NCT00886340|3703614|FG000|STARTED|Overall Study||27
2987134|NCT00886340|3703615|FG001|STARTED|Overall Study||31
2987135|NCT00886340|3703614|FG000|COMPLETED|Overall Study||27
2987136|NCT00886340|3703615|FG001|COMPLETED|Overall Study||24
2987137|NCT00886340|3703614|FG000|NOT COMPLETED|Overall Study||0
2987138|NCT00886340|3703615|FG001|NOT COMPLETED|Overall Study||7
2987139|NCT00886379|3703626|FG000|STARTED|Overall Study||104
2987140|NCT00886379|3703627|FG001|STARTED|Overall Study||143
2987141|NCT00886379|3703628|FG002|STARTED|Overall Study||143
2987142|NCT00886379|3703629|FG003|STARTED|Overall Study||112
2987143|NCT00886379|3703630|FG004|STARTED|Overall Study||95
2987144|NCT00886379|3703626|FG000|COMPLETED|Overall Study||101
2987145|NCT00886379|3703627|FG001|COMPLETED|Overall Study||140
2987146|NCT00886379|3703628|FG002|COMPLETED|Overall Study||137
2987147|NCT00886379|3703629|FG003|COMPLETED|Overall Study||109
2987148|NCT00886379|3703630|FG004|COMPLETED|Overall Study||92
2987149|NCT00886379|3703626|FG000|NOT COMPLETED|Overall Study||3
2987150|NCT00886379|3703627|FG001|NOT COMPLETED|Overall Study||3
2987151|NCT00886379|3703628|FG002|NOT COMPLETED|Overall Study||6
2987152|NCT00886379|3703629|FG003|NOT COMPLETED|Overall Study||3
2987153|NCT00886379|3703630|FG004|NOT COMPLETED|Overall Study||3
2987154|NCT00886483|3703644|FG000|STARTED|Overall Study||26
2987155|NCT00886483|3703645|FG001|STARTED|Overall Study||13
2987156|NCT00886483|3703644|FG000|Completed 20 Treatments|Overall Study||25
2987157|NCT00886483|3703645|FG001|Completed 20 Treatments|Overall Study||11
2987158|NCT00886483|3703644|FG000|COMPLETED|Overall Study||24
2987159|NCT00886483|3703645|FG001|COMPLETED|Overall Study||10
2987160|NCT00886483|3703644|FG000|NOT COMPLETED|Overall Study||2
2987161|NCT00886483|3703645|FG001|NOT COMPLETED|Overall Study||3
2987162|NCT00886587|3703661|FG000|STARTED|Overall Study||41
2987163|NCT00886587|3703662|FG001|STARTED|Overall Study||41
2987164|NCT00886587|3703661|FG000|COMPLETED|Overall Study||37
2987165|NCT00886587|3703662|FG001|COMPLETED|Overall Study||39
2987166|NCT00886587|3703661|FG000|NOT COMPLETED|Overall Study||4
2987167|NCT00886587|3703662|FG001|NOT COMPLETED|Overall Study||2
2987168|NCT00886613|3703671|FG000|STARTED|Overall Study||41
2987169|NCT00886613|3703672|FG001|STARTED|Overall Study||39
2987170|NCT00886613|3703673|FG002|STARTED|Overall Study||40
2987171|NCT00886613|3703671|FG000|COMPLETED|Overall Study||39
2987172|NCT00886613|3703672|FG001|COMPLETED|Overall Study||39
2987173|NCT00886613|3703673|FG002|COMPLETED|Overall Study||37
2987174|NCT00886613|3703671|FG000|NOT COMPLETED|Overall Study||2
2987175|NCT00886613|3703672|FG001|NOT COMPLETED|Overall Study||0
2987176|NCT00886613|3703673|FG002|NOT COMPLETED|Overall Study||3
2987177|NCT00886626|3703684|FG000|STARTED|Period 1 (90 Days)||6
2987178|NCT00886626|3703685|FG001|STARTED|Period 1 (90 Days)||6
2987179|NCT00886626|3703684|FG000|COMPLETED|Period 1 (90 Days)||5
2987180|NCT00886626|3703685|FG001|COMPLETED|Period 1 (90 Days)||6
2987181|NCT00886626|3703684|FG000|NOT COMPLETED|Period 1 (90 Days)||1
2987182|NCT00886626|3703685|FG001|NOT COMPLETED|Period 1 (90 Days)||0
2987183|NCT00886626|3703684|FG000|STARTED|Period 2 (90 Days)||5
2987184|NCT00886626|3703685|FG001|STARTED|Period 2 (90 Days)||6
2987185|NCT00886626|3703684|FG000|COMPLETED|Period 2 (90 Days)||5
2987186|NCT00886626|3703685|FG001|COMPLETED|Period 2 (90 Days)||6
2987187|NCT00886626|3703684|FG000|NOT COMPLETED|Period 2 (90 Days)||0
2987188|NCT00886626|3703685|FG001|NOT COMPLETED|Period 2 (90 Days)||0
2987189|NCT00886639|3703691|FG000|STARTED|Overall Study||127
2987190|NCT00886639|3703691|FG000|COMPLETED|Overall Study||111
2987191|NCT00886639|3703691|FG000|NOT COMPLETED|Overall Study||16
2987192|NCT00886704|3703697|FG000|STARTED|Overall Study||40
2987193|NCT00886704|3703698|FG001|STARTED|Overall Study||10
2987194|NCT00886704|3703697|FG000|COMPLETED|Overall Study||40
2987195|NCT00886704|3703698|FG001|COMPLETED|Overall Study||10
2987196|NCT00886704|3703697|FG000|NOT COMPLETED|Overall Study||0
2987197|NCT00886704|3703698|FG001|NOT COMPLETED|Overall Study||0
2987198|NCT00886743|3703706|FG000|STARTED|Overall Study|Received treatment|19
2987199|NCT00886743|3703706|FG000|COMPLETED|Overall Study||15
2987200|NCT00886743|3703706|FG000|NOT COMPLETED|Overall Study||4
3304833|NCT02982772|4038432|FG001|STARTED|1M Follow-Up||230
3304834|NCT02982772|4038431|FG000|COMPLETED|1M Follow-Up||205
3304835|NCT02982772|4038432|FG001|COMPLETED|1M Follow-Up||212
3304836|NCT02982772|4038431|FG000|NOT COMPLETED|1M Follow-Up||21
3304837|NCT02982772|4038432|FG001|NOT COMPLETED|1M Follow-Up||18
3304838|NCT02982772|4038431|FG000|STARTED|3M Follow-Up||205
3304839|NCT02982772|4038432|FG001|STARTED|3M Follow-Up||212
3304840|NCT02982772|4038431|FG000|COMPLETED|3M Follow-Up||188
3304841|NCT02982772|4038432|FG001|COMPLETED|3M Follow-Up||201
3304842|NCT02982772|4038431|FG000|NOT COMPLETED|3M Follow-Up||17
3304843|NCT02982772|4038432|FG001|NOT COMPLETED|3M Follow-Up||11
2987201|NCT00886769|3703712|FG000|STARTED|Overall Study||43
2987202|NCT00886769|3703713|FG001|STARTED|Overall Study||41
2987203|NCT00886769|3703712|FG000|COMPLETED|Overall Study||37
2987204|NCT00886769|3703713|FG001|COMPLETED|Overall Study||4
2987205|NCT00886769|3703712|FG000|NOT COMPLETED|Overall Study||6
2987206|NCT00886769|3703713|FG001|NOT COMPLETED|Overall Study||37
2987207|NCT00886795|3703719|FG000|STARTED|Overall Study||4
2987208|NCT00886795|3703719|FG000|COMPLETED|Overall Study||3
2987209|NCT00886795|3703719|FG000|NOT COMPLETED|Overall Study||1
2987210|NCT00886821|3703738|FG000|STARTED|Stage 1||7
2987211|NCT00886821|3703739|FG001|STARTED|Stage 1||6
2987212|NCT00886821|3703740|FG002|STARTED|Stage 1||6
2987213|NCT00886821|3703741|FG003|STARTED|Stage 1||7
2987214|NCT00886821|3703742|FG004|STARTED|Stage 1||6
2987215|NCT00886821|3703743|FG005|STARTED|Stage 1||6
2987216|NCT00886821|3703744|FG006|STARTED|Stage 1||6
2987217|NCT00886821|3703745|FG007|STARTED|Stage 1||6
2987218|NCT00886821|3703746|FG008|STARTED|Stage 1||6
2987219|NCT00886821|3703747|FG009|STARTED|Stage 1||18
2987220|NCT00886821|3703748|FG010|STARTED|Stage 1||0
2987221|NCT00886821|3703749|FG011|STARTED|Stage 1||0
2987222|NCT00886821|3703750|FG012|STARTED|Stage 1||0
2987223|NCT00886821|3703751|FG013|STARTED|Stage 1||0
2987224|NCT00886821|3703738|FG000|COMPLETED|Stage 1||7
2987225|NCT00886821|3703739|FG001|COMPLETED|Stage 1||6
2987226|NCT00886821|3703740|FG002|COMPLETED|Stage 1||6
2987227|NCT00886821|3703741|FG003|COMPLETED|Stage 1||7
2987228|NCT00886821|3703742|FG004|COMPLETED|Stage 1||6
2987229|NCT00886821|3703743|FG005|COMPLETED|Stage 1||6
2987230|NCT00886821|3703744|FG006|COMPLETED|Stage 1||6
2987231|NCT00886821|3703745|FG007|COMPLETED|Stage 1||6
2987232|NCT00886821|3703746|FG008|COMPLETED|Stage 1||6
2987233|NCT00886821|3703747|FG009|COMPLETED|Stage 1||18
2987234|NCT00886821|3703748|FG010|COMPLETED|Stage 1||0
2987235|NCT00886821|3703749|FG011|COMPLETED|Stage 1||0
2987236|NCT00886821|3703750|FG012|COMPLETED|Stage 1||0
2987237|NCT00886821|3703751|FG013|COMPLETED|Stage 1||0
2987238|NCT00886821|3703738|FG000|NOT COMPLETED|Stage 1||0
2987239|NCT00886821|3703739|FG001|NOT COMPLETED|Stage 1||0
2987240|NCT00886821|3703740|FG002|NOT COMPLETED|Stage 1||0
2987241|NCT00886821|3703741|FG003|NOT COMPLETED|Stage 1||0
2987242|NCT00886821|3703742|FG004|NOT COMPLETED|Stage 1||0
2987243|NCT00886821|3703743|FG005|NOT COMPLETED|Stage 1||0
2987244|NCT00886821|3703744|FG006|NOT COMPLETED|Stage 1||0
2987245|NCT00886821|3703745|FG007|NOT COMPLETED|Stage 1||0
2987246|NCT00886821|3703746|FG008|NOT COMPLETED|Stage 1||0
2987247|NCT00886821|3703747|FG009|NOT COMPLETED|Stage 1||0
2987248|NCT00886821|3703748|FG010|NOT COMPLETED|Stage 1||0
2987249|NCT00886821|3703749|FG011|NOT COMPLETED|Stage 1||0
2987250|NCT00886821|3703750|FG012|NOT COMPLETED|Stage 1||0
2987251|NCT00886821|3703751|FG013|NOT COMPLETED|Stage 1||0
2987252|NCT00886821|3703738|FG000|STARTED|Stage 2||0
2987253|NCT00886821|3703739|FG001|STARTED|Stage 2||0
2987254|NCT00886821|3703740|FG002|STARTED|Stage 2||0
2987255|NCT00886821|3703741|FG003|STARTED|Stage 2||0
2987256|NCT00886821|3703742|FG004|STARTED|Stage 2||0
2987257|NCT00886821|3703743|FG005|STARTED|Stage 2||0
2987258|NCT00886821|3703744|FG006|STARTED|Stage 2||0
2987259|NCT00886821|3703745|FG007|STARTED|Stage 2||0
2987260|NCT00886821|3703746|FG008|STARTED|Stage 2||0
2987261|NCT00886821|3703747|FG009|STARTED|Stage 2||0
2987262|NCT00886821|3703748|FG010|STARTED|Stage 2||9
2987263|NCT00886821|3703749|FG011|STARTED|Stage 2||9
2987264|NCT00886821|3703750|FG012|STARTED|Stage 2||13
2987265|NCT00886821|3703751|FG013|STARTED|Stage 2||9
2987266|NCT00886821|3703738|FG000|COMPLETED|Stage 2||0
2987267|NCT00886821|3703739|FG001|COMPLETED|Stage 2||0
2987268|NCT00886821|3703740|FG002|COMPLETED|Stage 2||0
2987269|NCT00886821|3703741|FG003|COMPLETED|Stage 2||0
2987270|NCT00886821|3703742|FG004|COMPLETED|Stage 2||0
2987271|NCT00886821|3703743|FG005|COMPLETED|Stage 2||0
2987272|NCT00886821|3703744|FG006|COMPLETED|Stage 2||0
2987273|NCT00886821|3703745|FG007|COMPLETED|Stage 2||0
2987274|NCT00886821|3703746|FG008|COMPLETED|Stage 2||0
2987275|NCT00886821|3703747|FG009|COMPLETED|Stage 2||0
2987276|NCT00886821|3703748|FG010|COMPLETED|Stage 2||9
2987277|NCT00886821|3703749|FG011|COMPLETED|Stage 2||8
2987278|NCT00886821|3703750|FG012|COMPLETED|Stage 2||8
2987279|NCT00886821|3703751|FG013|COMPLETED|Stage 2||8
2987280|NCT00886821|3703738|FG000|NOT COMPLETED|Stage 2||0
2987281|NCT00886821|3703739|FG001|NOT COMPLETED|Stage 2||0
2987282|NCT00886821|3703740|FG002|NOT COMPLETED|Stage 2||0
2987283|NCT00886821|3703741|FG003|NOT COMPLETED|Stage 2||0
2987284|NCT00886821|3703742|FG004|NOT COMPLETED|Stage 2||0
2987285|NCT00886821|3703743|FG005|NOT COMPLETED|Stage 2||0
2987286|NCT00886821|3703744|FG006|NOT COMPLETED|Stage 2||0
2987287|NCT00886821|3703745|FG007|NOT COMPLETED|Stage 2||0
2987288|NCT00886821|3703746|FG008|NOT COMPLETED|Stage 2||0
2987289|NCT00886821|3703747|FG009|NOT COMPLETED|Stage 2||0
2987290|NCT00886821|3703748|FG010|NOT COMPLETED|Stage 2||0
2987291|NCT00886821|3703749|FG011|NOT COMPLETED|Stage 2||1
2987292|NCT00886821|3703750|FG012|NOT COMPLETED|Stage 2||5
2987293|NCT00886821|3703751|FG013|NOT COMPLETED|Stage 2||1
2987294|NCT00886834|3703797|FG000|STARTED|Overall Study||54
3304844|NCT02982772|4038431|FG000|STARTED|6M Follow-Up||188
3304845|NCT02982772|4038432|FG001|STARTED|6M Follow-Up||201
3304846|NCT02982772|4038431|FG000|COMPLETED|6M Follow-Up||177
2987295|NCT00886834|3703798|FG001|STARTED|Overall Study||54
2987296|NCT00886834|3703797|FG000|COMPLETED|Overall Study||54
2987297|NCT00886834|3703798|FG001|COMPLETED|Overall Study||51
2987298|NCT00886834|3703797|FG000|NOT COMPLETED|Overall Study||0
2987299|NCT00886834|3703798|FG001|NOT COMPLETED|Overall Study||3
2987300|NCT00886899|3703804|FG000|STARTED|Overall Study||147
2987301|NCT00886899|3703804|FG000|COMPLETED|Overall Study||147
2987302|NCT00886899|3703804|FG000|NOT COMPLETED|Overall Study||0
2987303|NCT00886938|3703808|FG000|STARTED|Overall Study||12
2987304|NCT00886938|3703808|FG000|COMPLETED|Overall Study||10
2987305|NCT00886938|3703808|FG000|NOT COMPLETED|Overall Study||2
2987306|NCT00887068|3703814|FG000|STARTED|Overall Study||93
2987307|NCT00887068|3703815|FG001|STARTED|Overall Study||94
2987308|NCT00887068|3703814|FG000|COMPLETED|Overall Study||87
2987309|NCT00887068|3703815|FG001|COMPLETED|Overall Study||94
2987310|NCT00887068|3703814|FG000|NOT COMPLETED|Overall Study||6
2987311|NCT00887068|3703815|FG001|NOT COMPLETED|Overall Study||0
2987312|NCT00887159|3703824|FG000|STARTED|Overall Study||56
2987313|NCT00887159|3703825|FG001|STARTED|Overall Study||56
2987314|NCT00887159|3703826|FG002|STARTED|Overall Study||56
2987315|NCT00887159|3703824|FG000|Patients Who Started Assigned Treatment|Overall Study||53
2987316|NCT00887159|3703825|FG001|Patients Who Started Assigned Treatment|Overall Study||53
2987317|NCT00887159|3703826|FG002|Patients Who Started Assigned Treatment|Overall Study||52
2987318|NCT00887159|3703824|FG000|Eligible and Treated Patients|Overall Study||48
2987319|NCT00887159|3703825|FG001|Eligible and Treated Patients|Overall Study||52
2987320|NCT00887159|3703826|FG002|Eligible and Treated Patients|Overall Study||52
2987321|NCT00887159|3703824|FG000|Eligible/Treated Pts With CTCs Results|Overall Study||40
2987322|NCT00887159|3703825|FG001|Eligible/Treated Pts With CTCs Results|Overall Study||42
2987323|NCT00887159|3703826|FG002|Eligible/Treated Pts With CTCs Results|Overall Study||38
2987324|NCT00887159|3703824|FG000|COMPLETED|Overall Study||27
2987325|NCT00887159|3703825|FG001|COMPLETED|Overall Study|Treatment continued until disease progression or unacceptable toxicity.|0
2987326|NCT00887159|3703826|FG002|COMPLETED|Overall Study|Treatment continued until disease progression or unacceptable toxicity.|0
2987327|NCT00887159|3703824|FG000|NOT COMPLETED|Overall Study||29
2987328|NCT00887159|3703825|FG001|NOT COMPLETED|Overall Study||56
2987329|NCT00887159|3703826|FG002|NOT COMPLETED|Overall Study||56
2987330|NCT00887198|3703838|FG000|STARTED|Randomized Period||546
2987331|NCT00887198|3703839|FG001|STARTED|Randomized Period||542
2987332|NCT00887198|3703840|FG002|STARTED|Randomized Period||0
2987333|NCT00887198|3703838|FG000|Treated|Randomized Period||542
2987334|NCT00887198|3703839|FG001|Treated|Randomized Period||540
2987335|NCT00887198|3703840|FG002|Treated|Randomized Period||0
2987336|NCT00887198|3703838|FG000|COMPLETED|Randomized Period||0
2987337|NCT00887198|3703839|FG001|COMPLETED|Randomized Period||0
2987338|NCT00887198|3703840|FG002|COMPLETED|Randomized Period||0
2987339|NCT00887198|3703838|FG000|NOT COMPLETED|Randomized Period||546
2987340|NCT00887198|3703839|FG001|NOT COMPLETED|Randomized Period||542
2987341|NCT00887198|3703840|FG002|NOT COMPLETED|Randomized Period||0
2987342|NCT00887198|3703838|FG000|STARTED|Cross Over (Placebo to AA)||0
2987343|NCT00887198|3703839|FG001|STARTED|Cross Over (Placebo to AA)||0
2987344|NCT00887198|3703840|FG002|STARTED|Cross Over (Placebo to AA)|93= 51 participants(crossed over under amendment 3)+42 participants (crossed over under amendment 4)|93
2987345|NCT00887198|3703838|FG000|COMPLETED|Cross Over (Placebo to AA)||0
2987346|NCT00887198|3703839|FG001|COMPLETED|Cross Over (Placebo to AA)||0
2987347|NCT00887198|3703840|FG002|COMPLETED|Cross Over (Placebo to AA)||0
2987348|NCT00887198|3703838|FG000|NOT COMPLETED|Cross Over (Placebo to AA)||0
2987349|NCT00887198|3703839|FG001|NOT COMPLETED|Cross Over (Placebo to AA)||0
2987350|NCT00887198|3703840|FG002|NOT COMPLETED|Cross Over (Placebo to AA)||93
2987351|NCT00887224|3703851|FG000|STARTED|Open-label Response (OLR) Phase||874
2987352|NCT00887224|3703852|FG001|STARTED|Open-label Response (OLR) Phase||0
2987353|NCT00887224|3703853|FG002|STARTED|Open-label Response (OLR) Phase||0
2987354|NCT00887224|3703851|FG000|COMPLETED|Open-label Response (OLR) Phase||752
2987355|NCT00887224|3703852|FG001|COMPLETED|Open-label Response (OLR) Phase||0
2987356|NCT00887224|3703853|FG002|COMPLETED|Open-label Response (OLR) Phase||0
2987357|NCT00887224|3703851|FG000|NOT COMPLETED|Open-label Response (OLR) Phase||122
2987358|NCT00887224|3703852|FG001|NOT COMPLETED|Open-label Response (OLR) Phase||0
2987359|NCT00887224|3703853|FG002|NOT COMPLETED|Open-label Response (OLR) Phase||0
2987360|NCT00887224|3703851|FG000|STARTED|Between OLR and OLS Phases||752
2987361|NCT00887224|3703852|FG001|STARTED|Between OLR and OLS Phases||0
2987362|NCT00887224|3703853|FG002|STARTED|Between OLR and OLS Phases||0
2987363|NCT00887224|3703851|FG000|COMPLETED|Between OLR and OLS Phases||659
2987364|NCT00887224|3703852|FG001|COMPLETED|Between OLR and OLS Phases||0
2987365|NCT00887224|3703853|FG002|COMPLETED|Between OLR and OLS Phases||0
2987366|NCT00887224|3703851|FG000|NOT COMPLETED|Between OLR and OLS Phases||93
2987367|NCT00887224|3703852|FG001|NOT COMPLETED|Between OLR and OLS Phases||0
2987368|NCT00887224|3703853|FG002|NOT COMPLETED|Between OLR and OLS Phases||0
2987369|NCT00887224|3703851|FG000|STARTED|Open-label Stability (OLS) Phase||659
2987370|NCT00887224|3703852|FG001|STARTED|Open-label Stability (OLS) Phase||0
2987371|NCT00887224|3703853|FG002|STARTED|Open-label Stability (OLS) Phase||0
2987372|NCT00887224|3703851|FG000|COMPLETED|Open-label Stability (OLS) Phase||576
2987373|NCT00887224|3703852|FG001|COMPLETED|Open-label Stability (OLS) Phase||0
2987374|NCT00887224|3703853|FG002|COMPLETED|Open-label Stability (OLS) Phase||0
2987375|NCT00887224|3703851|FG000|NOT COMPLETED|Open-label Stability (OLS) Phase||83
2987376|NCT00887224|3703852|FG001|NOT COMPLETED|Open-label Stability (OLS) Phase||0
2987377|NCT00887224|3703853|FG002|NOT COMPLETED|Open-label Stability (OLS) Phase||0
2987378|NCT00887224|3703851|FG000|STARTED|Between OLS and DB Phases||576
2987379|NCT00887224|3703852|FG001|STARTED|Between OLS and DB Phases||0
2987380|NCT00887224|3703853|FG002|STARTED|Between OLS and DB Phases||0
2987381|NCT00887224|3703851|FG000|COMPLETED|Between OLS and DB Phases||548
2987382|NCT00887224|3703852|FG001|COMPLETED|Between OLS and DB Phases||0
2987383|NCT00887224|3703853|FG002|COMPLETED|Between OLS and DB Phases||0
2987384|NCT00887224|3703851|FG000|NOT COMPLETED|Between OLS and DB Phases||28
2987385|NCT00887224|3703852|FG001|NOT COMPLETED|Between OLS and DB Phases||0
2987386|NCT00887224|3703853|FG002|NOT COMPLETED|Between OLS and DB Phases||0
2987387|NCT00887224|3703851|FG000|STARTED|OL Taper Phase / OL Follow Up|Could have entered 7-day taper period at any time during either the OLR phase or OLS phase.|307
2987388|NCT00887224|3703852|FG001|STARTED|OL Taper Phase / OL Follow Up||0
2987389|NCT00887224|3703853|FG002|STARTED|OL Taper Phase / OL Follow Up||0
2987390|NCT00887224|3703851|FG000|Discontinued Open-label Taper|OL Taper Phase / OL Follow Up|Could have discontinued at any time during OL taper phase or OL Follow-up (7 days after last dose).|144
2987391|NCT00887224|3703852|FG001|Discontinued Open-label Taper|OL Taper Phase / OL Follow Up||0
2987392|NCT00887224|3703853|FG002|Discontinued Open-label Taper|OL Taper Phase / OL Follow Up||0
2987393|NCT00887224|3703851|FG000|COMPLETED|OL Taper Phase / OL Follow Up||163
2987394|NCT00887224|3703852|FG001|COMPLETED|OL Taper Phase / OL Follow Up||0
2987395|NCT00887224|3703853|FG002|COMPLETED|OL Taper Phase / OL Follow Up||0
2987396|NCT00887224|3703851|FG000|NOT COMPLETED|OL Taper Phase / OL Follow Up||144
2987397|NCT00887224|3703852|FG001|NOT COMPLETED|OL Taper Phase / OL Follow Up||0
2987398|NCT00887224|3703853|FG002|NOT COMPLETED|OL Taper Phase / OL Follow Up||0
2987399|NCT00887224|3703851|FG000|STARTED|Double-blind (DB) Phase||0
2987400|NCT00887224|3703852|FG001|STARTED|Double-blind (DB) Phase|2 participants randomized in error to DB, then entered OL Taper; counted in OL Taper and DB phases.|276
2987401|NCT00887224|3703853|FG002|STARTED|Double-blind (DB) Phase||272
2987402|NCT00887224|3703851|FG000|COMPLETED|Double-blind (DB) Phase||0
2987403|NCT00887224|3703852|FG001|COMPLETED|Double-blind (DB) Phase||176
2987404|NCT00887224|3703853|FG002|COMPLETED|Double-blind (DB) Phase||210
2987405|NCT00887224|3703851|FG000|NOT COMPLETED|Double-blind (DB) Phase||0
2987406|NCT00887224|3703852|FG001|NOT COMPLETED|Double-blind (DB) Phase||100
2987407|NCT00887224|3703853|FG002|NOT COMPLETED|Double-blind (DB) Phase||62
2987408|NCT00887224|3703851|FG000|STARTED|DB Taper Phase / Post Study Follow Up||0
2987409|NCT00887224|3703852|FG001|STARTED|DB Taper Phase / Post Study Follow Up|Double-blind participants (DBp) could have entered 7-day taper period at any time during DB phase.|267
2987410|NCT00887224|3703853|FG002|STARTED|DB Taper Phase / Post Study Follow Up||265
2987411|NCT00887224|3703851|FG000|Did Not Enter DB Taper|DB Taper Phase / Post Study Follow Up||0
2987412|NCT00887224|3703852|FG001|Did Not Enter DB Taper|DB Taper Phase / Post Study Follow Up||9
2987413|NCT00887224|3703853|FG002|Did Not Enter DB Taper|DB Taper Phase / Post Study Follow Up||7
2987414|NCT00887224|3703851|FG000|Discontinued DB Taper|DB Taper Phase / Post Study Follow Up||0
2987415|NCT00887224|3703852|FG001|Discontinued DB Taper|DB Taper Phase / Post Study Follow Up|DBp could have discontinued at anytime during DB taper period or Follow-up (7 days after last dose).|41
2987416|NCT00887224|3703853|FG002|Discontinued DB Taper|DB Taper Phase / Post Study Follow Up||30
3136743|NCT01714726|3861988|FG000|NOT COMPLETED|Open-Label Period||0
2987417|NCT00887224|3703851|FG000|COMPLETED|DB Taper Phase / Post Study Follow Up||0
3036542|NCT01143870|3755785|FG001|Had Available 6-month A1C|Overall Study||29
2987418|NCT00887224|3703852|FG001|COMPLETED|DB Taper Phase / Post Study Follow Up||226
2987419|NCT00887224|3703853|FG002|COMPLETED|DB Taper Phase / Post Study Follow Up||235
2987420|NCT00887224|3703851|FG000|NOT COMPLETED|DB Taper Phase / Post Study Follow Up||0
2987421|NCT00887224|3703852|FG001|NOT COMPLETED|DB Taper Phase / Post Study Follow Up||41
2987422|NCT00887224|3703853|FG002|NOT COMPLETED|DB Taper Phase / Post Study Follow Up||30
2987423|NCT00887289|3703865|FG000|STARTED|Overall Study||1504
2987424|NCT00887289|3703865|FG000|COMPLETED|Overall Study||1409
2987425|NCT00887289|3703865|FG000|NOT COMPLETED|Overall Study||95
2987426|NCT00887341|3703871|FG000|STARTED|Overall Study||37
2987427|NCT00887341|3703872|FG001|STARTED|Overall Study||39
2987428|NCT00887341|3703871|FG000|COMPLETED|Overall Study||35
2987429|NCT00887341|3703872|FG001|COMPLETED|Overall Study||36
2987430|NCT00887341|3703871|FG000|NOT COMPLETED|Overall Study||2
2987431|NCT00887341|3703872|FG001|NOT COMPLETED|Overall Study||3
2987432|NCT00887354|3703880|FG000|STARTED|Treatment Phase (Week 0 to Week 26)||111
2987433|NCT00887354|3703881|FG001|STARTED|Treatment Phase (Week 0 to Week 26)||113
2987434|NCT00887354|3703880|FG000|Received at Least 1 Dose of Study Drug|Treatment Phase (Week 0 to Week 26)||106
2987435|NCT00887354|3703881|FG001|Received at Least 1 Dose of Study Drug|Treatment Phase (Week 0 to Week 26)||110
2987436|NCT00887354|3703880|FG000|Included in Full Analysis Set|Treatment Phase (Week 0 to Week 26)||86
2987437|NCT00887354|3703881|FG001|Included in Full Analysis Set|Treatment Phase (Week 0 to Week 26)||85
2987438|NCT00887354|3703880|FG000|COMPLETED|Treatment Phase (Week 0 to Week 26)||60
2987439|NCT00887354|3703881|FG001|COMPLETED|Treatment Phase (Week 0 to Week 26)||65
2987440|NCT00887354|3703880|FG000|NOT COMPLETED|Treatment Phase (Week 0 to Week 26)||51
2987441|NCT00887354|3703881|FG001|NOT COMPLETED|Treatment Phase (Week 0 to Week 26)||48
2987442|NCT00887354|3703880|FG000|STARTED|Open Label Phase (Week 26 to Week 78)||60
2987443|NCT00887354|3703881|FG001|STARTED|Open Label Phase (Week 26 to Week 78)||65
2987444|NCT00887354|3703880|FG000|COMPLETED|Open Label Phase (Week 26 to Week 78)||57
2987445|NCT00887354|3703881|FG001|COMPLETED|Open Label Phase (Week 26 to Week 78)||59
2987446|NCT00887354|3703880|FG000|NOT COMPLETED|Open Label Phase (Week 26 to Week 78)||3
2987447|NCT00887354|3703881|FG001|NOT COMPLETED|Open Label Phase (Week 26 to Week 78)||6
2987448|NCT00887432|3703890|FG000|STARTED|Overall Study||58
2987449|NCT00887432|3703891|FG001|STARTED|Overall Study||74
2987450|NCT00887432|3703890|FG000|COMPLETED|Overall Study||43
2987451|NCT00887432|3703891|FG001|COMPLETED|Overall Study||60
2987452|NCT00887432|3703890|FG000|NOT COMPLETED|Overall Study||15
2987453|NCT00887432|3703891|FG001|NOT COMPLETED|Overall Study||14
2987454|NCT00887458|3703899|FG000|STARTED|Overall Study||17
2987455|NCT00887458|3703900|FG001|STARTED|Overall Study||29
2987456|NCT00887458|3703899|FG000|COMPLETED|Overall Study||17
2987457|NCT00887458|3703900|FG001|COMPLETED|Overall Study||25
2987458|NCT00887458|3703899|FG000|NOT COMPLETED|Overall Study||0
2987459|NCT00887458|3703900|FG001|NOT COMPLETED|Overall Study||4
2987460|NCT00887471|3703910|FG000|STARTED|Overall Study||15
2987461|NCT00887471|3703911|FG001|STARTED|Overall Study||15
2987462|NCT00887471|3703910|FG000|COMPLETED|Overall Study||15
2987463|NCT00887471|3703911|FG001|COMPLETED|Overall Study||15
2987464|NCT00887471|3703910|FG000|NOT COMPLETED|Overall Study||0
2987465|NCT00887471|3703911|FG001|NOT COMPLETED|Overall Study||0
2987466|NCT00887484|3703917|FG000|STARTED|Split Face Treatment (Weeks 1 and 2)||48
2987467|NCT00887484|3703917|FG000|COMPLETED|Split Face Treatment (Weeks 1 and 2)||48
2987468|NCT00887484|3703917|FG000|NOT COMPLETED|Split Face Treatment (Weeks 1 and 2)||0
2987469|NCT00887484|3703917|FG000|STARTED|Full Face Treatment (Weeks 5 and 8)||48
2987470|NCT00887484|3703917|FG000|COMPLETED|Full Face Treatment (Weeks 5 and 8)||45
2987471|NCT00887484|3703917|FG000|NOT COMPLETED|Full Face Treatment (Weeks 5 and 8)||3
2987472|NCT00887510|3703928|FG000|STARTED|Overall Study||12
2987473|NCT00887510|3703929|FG001|STARTED|Overall Study||12
2987474|NCT00887510|3703928|FG000|COMPLETED|Overall Study||12
2987475|NCT00887510|3703929|FG001|COMPLETED|Overall Study||12
2987476|NCT00887510|3703928|FG000|NOT COMPLETED|Overall Study||0
2987477|NCT00887510|3703929|FG001|NOT COMPLETED|Overall Study||0
2987478|NCT00887549|3703935|FG000|STARTED|Induction Therapy||70
2987479|NCT00887549|3703935|FG000|COMPLETED|Induction Therapy||43
2987480|NCT00887549|3703935|FG000|NOT COMPLETED|Induction Therapy||27
2987481|NCT00887549|3703935|FG000|STARTED|Maintenance Therapy||43
2987482|NCT00887549|3703935|FG000|COMPLETED|Maintenance Therapy||0
2987483|NCT00887549|3703935|FG000|NOT COMPLETED|Maintenance Therapy||43
2987484|NCT00887562|3703942|FG000|STARTED|Overall Study||10
2987485|NCT00887562|3703943|FG001|STARTED|Overall Study||9
2987486|NCT00887562|3703944|FG002|STARTED|Overall Study||8
2987487|NCT00887562|3703942|FG000|COMPLETED|Overall Study||7
2987488|NCT00887562|3703943|FG001|COMPLETED|Overall Study||7
2987489|NCT00887562|3703944|FG002|COMPLETED|Overall Study||7
2987490|NCT00887562|3703942|FG000|NOT COMPLETED|Overall Study||3
2987491|NCT00887562|3703943|FG001|NOT COMPLETED|Overall Study||2
2987492|NCT00887562|3703944|FG002|NOT COMPLETED|Overall Study||1
2987493|NCT00887575|3703954|FG000|STARTED|Phase I||6
2987494|NCT00887575|3703955|FG001|STARTED|Phase I||6
2987495|NCT00887575|3703956|FG002|STARTED|Phase I||3
2987496|NCT00887575|3703954|FG000|COMPLETED|Phase I||6
2987497|NCT00887575|3703955|FG001|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
2987498|NCT00887575|3703956|FG002|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
2987499|NCT00887575|3703954|FG000|NOT COMPLETED|Phase I||0
2987500|NCT00887575|3703955|FG001|NOT COMPLETED|Phase I||6
2987501|NCT00887575|3703956|FG002|NOT COMPLETED|Phase I||3
2987502|NCT00887575|3703954|FG000|STARTED|Phase II - Neoadjuvant Therapy|Includes patients treated at MTD during Phase I, 39 additional patients enrolled, 4 were not treated|41
2987503|NCT00887575|3703955|FG001|STARTED|Phase II - Neoadjuvant Therapy||0
2987504|NCT00887575|3703956|FG002|STARTED|Phase II - Neoadjuvant Therapy||0
2987505|NCT00887575|3703954|FG000|COMPLETED|Phase II - Neoadjuvant Therapy||16
2987506|NCT00887575|3703955|FG001|COMPLETED|Phase II - Neoadjuvant Therapy||0
2987507|NCT00887575|3703956|FG002|COMPLETED|Phase II - Neoadjuvant Therapy||0
2987508|NCT00887575|3703954|FG000|NOT COMPLETED|Phase II - Neoadjuvant Therapy||25
2987509|NCT00887575|3703955|FG001|NOT COMPLETED|Phase II - Neoadjuvant Therapy||0
2987510|NCT00887575|3703956|FG002|NOT COMPLETED|Phase II - Neoadjuvant Therapy||0
2987511|NCT00887575|3703954|FG000|STARTED|Phase II - Maintenance Therapy|Pts who completed 6 cycles of Neoadjuvant Therapy & underwent surgery were eligible for maintenance|8
2987512|NCT00887575|3703955|FG001|STARTED|Phase II - Maintenance Therapy||0
2987513|NCT00887575|3703956|FG002|STARTED|Phase II - Maintenance Therapy||0
2987514|NCT00887575|3703954|FG000|COMPLETED|Phase II - Maintenance Therapy||6
2987515|NCT00887575|3703955|FG001|COMPLETED|Phase II - Maintenance Therapy||0
2987516|NCT00887575|3703956|FG002|COMPLETED|Phase II - Maintenance Therapy||0
2987517|NCT00887575|3703954|FG000|NOT COMPLETED|Phase II - Maintenance Therapy||2
2987518|NCT00887575|3703955|FG001|NOT COMPLETED|Phase II - Maintenance Therapy||0
2987519|NCT00887575|3703956|FG002|NOT COMPLETED|Phase II - Maintenance Therapy||0
2987520|NCT00887588|3703963|FG000|STARTED|Core Period||149
2987521|NCT00887588|3703964|FG001|STARTED|Core Period||152
2987522|NCT00887588|3703963|FG000|Extension Efficacy Set|Core Period||127
2987523|NCT00887588|3703964|FG001|Extension Efficacy Set|Core Period||125
2987524|NCT00887588|3703963|FG000|Full Analysis Set|Core Period||148
2987525|NCT00887588|3703964|FG001|Full Analysis Set|Core Period||146
3304847|NCT02982772|4038432|FG001|COMPLETED|6M Follow-Up||192
3304848|NCT02982772|4038431|FG000|NOT COMPLETED|6M Follow-Up||11
2987526|NCT00887588|3703963|FG000|Arterial Stiffness Set|Core Period||86
2987527|NCT00887588|3703964|FG001|Arterial Stiffness Set|Core Period||94
2987528|NCT00887588|3703963|FG000|COMPLETED|Core Period||130
2987529|NCT00887588|3703964|FG001|COMPLETED|Core Period||131
2987530|NCT00887588|3703963|FG000|NOT COMPLETED|Core Period||19
2987531|NCT00887588|3703964|FG001|NOT COMPLETED|Core Period||21
2987532|NCT00887588|3703963|FG000|STARTED|Extension Period||127
2987533|NCT00887588|3703964|FG001|STARTED|Extension Period||125
2987534|NCT00887588|3703963|FG000|Arterial Stiffness Set|Extension Period||86
2987535|NCT00887588|3703964|FG001|Arterial Stiffness Set|Extension Period||94
2987536|NCT00887588|3703963|FG000|COMPLETED|Extension Period||121
2987537|NCT00887588|3703964|FG001|COMPLETED|Extension Period||120
2987538|NCT00887588|3703963|FG000|NOT COMPLETED|Extension Period||6
2987539|NCT00887588|3703964|FG001|NOT COMPLETED|Extension Period||5
2987540|NCT00887640|3703970|FG000|STARTED|Overall Study||11
2987541|NCT00887640|3703970|FG000|COMPLETED|Overall Study||11
2987542|NCT00887640|3703970|FG000|NOT COMPLETED|Overall Study||0
2987543|NCT00887653|3703974|FG000|STARTED|Overall Study||20
2987544|NCT00887653|3703974|FG000|COMPLETED|Overall Study||20
2987545|NCT00887653|3703974|FG000|NOT COMPLETED|Overall Study||0
2987546|NCT00887679|3703978|FG000|STARTED|Overall Study||30
2987547|NCT00887679|3703978|FG000|COMPLETED|Overall Study|20 subjects completed the study.|20
2987548|NCT00887679|3703978|FG000|NOT COMPLETED|Overall Study||10
2987549|NCT00887744|3703983|FG000|STARTED|Overall Study|162 patients signed an informed consent but only 157 patients were treated with the Aperius.|162
2987550|NCT00887744|3703983|FG000|COMPLETED|Overall Study||128
2987551|NCT00887744|3703983|FG000|NOT COMPLETED|Overall Study||34
2987552|NCT00887783|3703989|FG000|STARTED|Overall Study||58
2987553|NCT00887783|3703990|FG001|STARTED|Overall Study||59
2987554|NCT00887783|3703989|FG000|COMPLETED|Overall Study||58
2987555|NCT00887783|3703990|FG001|COMPLETED|Overall Study||59
2987556|NCT00887783|3703989|FG000|NOT COMPLETED|Overall Study||0
2987557|NCT00887783|3703990|FG001|NOT COMPLETED|Overall Study||0
2987558|NCT00887809|3703998|FG000|STARTED|Overall Study||37
2987559|NCT00887809|3703999|FG001|STARTED|Overall Study||10
2987560|NCT00887809|3703998|FG000|COMPLETED|Overall Study||33
2987561|NCT00887809|3703999|FG001|COMPLETED|Overall Study||10
2987562|NCT00887809|3703998|FG000|NOT COMPLETED|Overall Study||4
2987563|NCT00887809|3703999|FG001|NOT COMPLETED|Overall Study||0
2987564|NCT00887822|3704007|FG000|STARTED|Overall Study||100
2987565|NCT00887822|3704008|FG001|STARTED|Overall Study||102
2987566|NCT00887822|3704007|FG000|Treated (Safety Population)|Overall Study||100
2987567|NCT00887822|3704008|FG001|Treated (Safety Population)|Overall Study||101
2987568|NCT00887822|3704007|FG000|COMPLETED|Overall Study||3
2987569|NCT00887822|3704008|FG001|COMPLETED|Overall Study||0
2987570|NCT00887822|3704007|FG000|NOT COMPLETED|Overall Study||97
2987571|NCT00887822|3704008|FG001|NOT COMPLETED|Overall Study||102
2987572|NCT00887913|3704014|FG000|STARTED|Overall Study||69
2987573|NCT00887913|3704014|FG000|COMPLETED|Overall Study||63
2987574|NCT00887913|3704014|FG000|NOT COMPLETED|Overall Study||6
2987575|NCT00887926|3704022|FG000|STARTED|Overall Study||3
2987576|NCT00887926|3704023|FG001|STARTED|Overall Study||14
2987577|NCT00887926|3704024|FG002|STARTED|Overall Study||3
2987578|NCT00887926|3704025|FG003|STARTED|Overall Study||5
2987579|NCT00887926|3704022|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
2987580|NCT00887926|3704023|FG001|Received at Least 1 Dose of Study Drug|Overall Study||13
2987581|NCT00887926|3704024|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3
2987582|NCT00887926|3704025|FG003|Received at Least 1 Dose of Study Drug|Overall Study||5
2987583|NCT00887926|3704022|FG000|COMPLETED|Overall Study||3
2987584|NCT00887926|3704023|FG001|COMPLETED|Overall Study||13
2987585|NCT00887926|3704024|FG002|COMPLETED|Overall Study||3
2987586|NCT00887926|3704025|FG003|COMPLETED|Overall Study||5
2987587|NCT00887926|3704022|FG000|NOT COMPLETED|Overall Study||0
2987588|NCT00887926|3704023|FG001|NOT COMPLETED|Overall Study||1
2987589|NCT00887926|3704024|FG002|NOT COMPLETED|Overall Study||0
2987590|NCT00887926|3704025|FG003|NOT COMPLETED|Overall Study||0
2987591|NCT00887965|3704037|FG000|STARTED|Overall Study||15
2987592|NCT00887965|3704037|FG000|COMPLETED|Overall Study||15
2987593|NCT00887965|3704037|FG000|NOT COMPLETED|Overall Study||0
2987594|NCT00887978|3704043|FG000|STARTED|Overall Study||157
2987595|NCT00887978|3704044|FG001|STARTED|Overall Study||153
2987596|NCT00887978|3704043|FG000|COMPLETED|Overall Study||132
2987597|NCT00887978|3704044|FG001|COMPLETED|Overall Study||138
2987598|NCT00887978|3704043|FG000|NOT COMPLETED|Overall Study||25
2987599|NCT00887978|3704044|FG001|NOT COMPLETED|Overall Study||15
2987600|NCT00888134|3704050|FG000|STARTED|Treatment With Study Drug||28
2987601|NCT00888134|3704050|FG000|COMPLETED|Treatment With Study Drug|21 had progressive disease; 5 had unacceptable toxicity; 1 finished treatment|27
2987602|NCT00888134|3704050|FG000|NOT COMPLETED|Treatment With Study Drug||1
2987603|NCT00888134|3704050|FG000|STARTED|Follow-up||27
2987604|NCT00888134|3704050|FG000|COMPLETED|Follow-up|23 died; 3 were lost-to-follow-up|26
2987605|NCT00888134|3704050|FG000|NOT COMPLETED|Follow-up||1
2987606|NCT00888173|3704055|FG000|STARTED|Overall Study||45
2987607|NCT00888173|3704055|FG000|COMPLETED|Overall Study||43
2987608|NCT00888173|3704055|FG000|NOT COMPLETED|Overall Study||2
2987609|NCT00888238|3704059|FG000|STARTED|First Period of Treatment Intervention||4
2987610|NCT00888238|3704060|FG001|STARTED|First Period of Treatment Intervention||4
2987611|NCT00888238|3704061|FG002|STARTED|First Period of Treatment Intervention||4
2987612|NCT00888238|3704059|FG000|COMPLETED|First Period of Treatment Intervention||4
2987613|NCT00888238|3704060|FG001|COMPLETED|First Period of Treatment Intervention||4
2987614|NCT00888238|3704061|FG002|COMPLETED|First Period of Treatment Intervention||4
2987615|NCT00888238|3704059|FG000|NOT COMPLETED|First Period of Treatment Intervention||0
2987616|NCT00888238|3704060|FG001|NOT COMPLETED|First Period of Treatment Intervention||0
2987617|NCT00888238|3704061|FG002|NOT COMPLETED|First Period of Treatment Intervention||0
2987618|NCT00888238|3704059|FG000|STARTED|Washout Period After Period 1||4
2987619|NCT00888238|3704060|FG001|STARTED|Washout Period After Period 1||4
2987620|NCT00888238|3704061|FG002|STARTED|Washout Period After Period 1||4
2987621|NCT00888238|3704059|FG000|COMPLETED|Washout Period After Period 1||4
2987622|NCT00888238|3704060|FG001|COMPLETED|Washout Period After Period 1||4
2987623|NCT00888238|3704061|FG002|COMPLETED|Washout Period After Period 1||4
2987624|NCT00888238|3704059|FG000|NOT COMPLETED|Washout Period After Period 1||0
2987625|NCT00888238|3704060|FG001|NOT COMPLETED|Washout Period After Period 1||0
2987626|NCT00888238|3704061|FG002|NOT COMPLETED|Washout Period After Period 1||0
2987627|NCT00888238|3704059|FG000|STARTED|Second Period of Treatment Intervention||4
2987628|NCT00888238|3704060|FG001|STARTED|Second Period of Treatment Intervention||4
2987629|NCT00888238|3704061|FG002|STARTED|Second Period of Treatment Intervention||4
2987630|NCT00888238|3704059|FG000|COMPLETED|Second Period of Treatment Intervention||4
2987631|NCT00888238|3704060|FG001|COMPLETED|Second Period of Treatment Intervention||4
2987632|NCT00888238|3704061|FG002|COMPLETED|Second Period of Treatment Intervention||4
2987633|NCT00888238|3704059|FG000|NOT COMPLETED|Second Period of Treatment Intervention||0
2987634|NCT00888238|3704060|FG001|NOT COMPLETED|Second Period of Treatment Intervention||0
2987635|NCT00888238|3704061|FG002|NOT COMPLETED|Second Period of Treatment Intervention||0
2987636|NCT00888238|3704059|FG000|STARTED|Washout Period After Period 2||4
2987637|NCT00888238|3704060|FG001|STARTED|Washout Period After Period 2||4
2987638|NCT00888238|3704061|FG002|STARTED|Washout Period After Period 2||4
2987639|NCT00888238|3704059|FG000|COMPLETED|Washout Period After Period 2||4
2987640|NCT00888238|3704060|FG001|COMPLETED|Washout Period After Period 2||4
2987641|NCT00888238|3704061|FG002|COMPLETED|Washout Period After Period 2||3
2987642|NCT00888238|3704059|FG000|NOT COMPLETED|Washout Period After Period 2||0
2987643|NCT00888238|3704060|FG001|NOT COMPLETED|Washout Period After Period 2||0
2987644|NCT00888238|3704061|FG002|NOT COMPLETED|Washout Period After Period 2||1
2987645|NCT00888238|3704059|FG000|STARTED|Third Period of Treatment Intervention||4
2987646|NCT00888238|3704060|FG001|STARTED|Third Period of Treatment Intervention||4
2987647|NCT00888238|3704061|FG002|STARTED|Third Period of Treatment Intervention||3
2987648|NCT00888238|3704059|FG000|COMPLETED|Third Period of Treatment Intervention||4
2987649|NCT00888238|3704060|FG001|COMPLETED|Third Period of Treatment Intervention||4
2987650|NCT00888238|3704061|FG002|COMPLETED|Third Period of Treatment Intervention||3
2987651|NCT00888238|3704059|FG000|NOT COMPLETED|Third Period of Treatment Intervention||0
2987652|NCT00888238|3704060|FG001|NOT COMPLETED|Third Period of Treatment Intervention||0
2987653|NCT00888238|3704061|FG002|NOT COMPLETED|Third Period of Treatment Intervention||0
2987654|NCT00888329|3704069|FG000|STARTED|Overall Study||125
2987655|NCT00888329|3704070|FG001|STARTED|Overall Study||131
2987656|NCT00888329|3704069|FG000|COMPLETED|Overall Study||119
2987657|NCT00888329|3704070|FG001|COMPLETED|Overall Study||122
2987658|NCT00888329|3704069|FG000|NOT COMPLETED|Overall Study||6
2987659|NCT00888329|3704070|FG001|NOT COMPLETED|Overall Study||9
2987660|NCT00888381|3704078|FG000|STARTED|Overall Study||60
2987661|NCT00888381|3704079|FG001|STARTED|Overall Study||60
2987662|NCT00888381|3704078|FG000|COMPLETED|Overall Study||60
2987663|NCT00888381|3704079|FG001|COMPLETED|Overall Study||59
2987664|NCT00888381|3704078|FG000|NOT COMPLETED|Overall Study||0
2987665|NCT00888381|3704079|FG001|NOT COMPLETED|Overall Study||1
2987666|NCT00888433|3704087|FG000|STARTED|Overall Study||52
2987667|NCT00888433|3704088|FG001|STARTED|Overall Study||54
2987668|NCT00888433|3704087|FG000|COMPLETED|Overall Study||49
2987669|NCT00888433|3704088|FG001|COMPLETED|Overall Study||51
2987670|NCT00888433|3704087|FG000|NOT COMPLETED|Overall Study||3
2987671|NCT00888433|3704088|FG001|NOT COMPLETED|Overall Study||3
2987672|NCT00888459|3704096|FG000|STARTED|Overall Study||30
2987673|NCT00888459|3704097|FG001|STARTED|Overall Study||30
2987674|NCT00888459|3704096|FG000|COMPLETED|Overall Study||30
2987675|NCT00888459|3704097|FG001|COMPLETED|Overall Study||30
2987676|NCT00888459|3704096|FG000|NOT COMPLETED|Overall Study||0
2987677|NCT00888459|3704097|FG001|NOT COMPLETED|Overall Study||0
3036543|NCT01143870|3755786|FG002|Had Available 6-month A1C|Overall Study||31
3036544|NCT01143870|3755784|FG000|A1C Imputed|Overall Study||31
3036545|NCT01143870|3755785|FG001|A1C Imputed|Overall Study||29
3036546|NCT01143870|3755786|FG002|A1C Imputed|Overall Study||30
3036547|NCT01143870|3755784|FG000|COMPLETED|Overall Study||58
3036548|NCT01143870|3755785|FG001|COMPLETED|Overall Study||58
3036549|NCT01143870|3755786|FG002|COMPLETED|Overall Study||61
3036550|NCT01143870|3755784|FG000|NOT COMPLETED|Overall Study||0
3036551|NCT01143870|3755785|FG001|NOT COMPLETED|Overall Study||0
3036552|NCT01143870|3755786|FG002|NOT COMPLETED|Overall Study||0
3036553|NCT01143883|3755796|FG000|STARTED|Overall Study||55
3036554|NCT01143883|3755797|FG001|STARTED|Overall Study||55
3036555|NCT01143883|3755796|FG000|COMPLETED|Overall Study||55
3036556|NCT01143883|3755797|FG001|COMPLETED|Overall Study||55
3036557|NCT01143883|3755796|FG000|NOT COMPLETED|Overall Study||0
3036558|NCT01143883|3755797|FG001|NOT COMPLETED|Overall Study||0
3304849|NCT02982772|4038432|FG001|NOT COMPLETED|6M Follow-Up||9
3304850|NCT02982772|4038431|FG000|STARTED|12M Follow-Up||177
3304851|NCT02982772|4038432|FG001|STARTED|12M Follow-Up||192
3304852|NCT02982772|4038431|FG000|COMPLETED|12M Follow-Up||166
3304853|NCT02982772|4038432|FG001|COMPLETED|12M Follow-Up||187
3036559|NCT01143896|3755805|FG000|STARTED|Overall Study||156
3036560|NCT01143896|3755806|FG001|STARTED|Overall Study||153
3036561|NCT01143896|3755805|FG000|COMPLETED|Overall Study||114
3036562|NCT01143896|3755806|FG001|COMPLETED|Overall Study||128
3036563|NCT01143896|3755805|FG000|NOT COMPLETED|Overall Study||42
3036564|NCT01143896|3755806|FG001|NOT COMPLETED|Overall Study||25
3036565|NCT01144026|3755815|FG000|STARTED|Overall Study||10
3036566|NCT01144026|3755816|FG001|STARTED|Overall Study||5
3036567|NCT01144026|3755815|FG000|COMPLETED|Overall Study||10
3036568|NCT01144026|3755816|FG001|COMPLETED|Overall Study||5
3036569|NCT01144026|3755815|FG000|NOT COMPLETED|Overall Study||0
3036570|NCT01144026|3755816|FG001|NOT COMPLETED|Overall Study||0
3036571|NCT01144052|3755824|FG000|STARTED|Overall Study||10
3036572|NCT01144052|3755825|FG001|STARTED|Overall Study||9
3036573|NCT01144052|3755824|FG000|COMPLETED|Overall Study||9
3036574|NCT01144052|3755825|FG001|COMPLETED|Overall Study||8
3036575|NCT01144052|3755824|FG000|NOT COMPLETED|Overall Study||1
3036576|NCT01144052|3755825|FG001|NOT COMPLETED|Overall Study||1
3036577|NCT01144143|3755836|FG000|STARTED|Overall Study||8
3036578|NCT01144143|3755837|FG001|STARTED|Overall Study||4
3036579|NCT01144143|3755838|FG002|STARTED|Overall Study||4
3036580|NCT01144143|3755836|FG000|COMPLETED|Overall Study||8
3036581|NCT01144143|3755837|FG001|COMPLETED|Overall Study||4
3036582|NCT01144143|3755838|FG002|COMPLETED|Overall Study||4
3036583|NCT01144143|3755836|FG000|NOT COMPLETED|Overall Study||0
3036584|NCT01144143|3755837|FG001|NOT COMPLETED|Overall Study||0
3036585|NCT01144143|3755838|FG002|NOT COMPLETED|Overall Study||0
3036586|NCT01144182|3755852|FG000|STARTED|Overall Study||68
3036587|NCT01144182|3755853|FG001|STARTED|Overall Study||68
3036588|NCT01144182|3755852|FG000|COMPLETED|Overall Study||51
3036589|NCT01144182|3755853|FG001|COMPLETED|Overall Study||47
3036590|NCT01144182|3755852|FG000|NOT COMPLETED|Overall Study||17
3036591|NCT01144182|3755853|FG001|NOT COMPLETED|Overall Study||21
3036592|NCT01144286|3755864|FG000|STARTED|Overall Study||57
3036593|NCT01144286|3755865|FG001|STARTED|Overall Study||58
3036594|NCT01144286|3755866|FG002|STARTED|Overall Study||58
3036595|NCT01144286|3755867|FG003|STARTED|Overall Study||56
3036596|NCT01144286|3755864|FG000|COMPLETED|Overall Study||57
3036597|NCT01144286|3755865|FG001|COMPLETED|Overall Study||58
3036598|NCT01144286|3755866|FG002|COMPLETED|Overall Study||58
3036599|NCT01144286|3755867|FG003|COMPLETED|Overall Study||56
3036600|NCT01144286|3755864|FG000|NOT COMPLETED|Overall Study||0
3036601|NCT01144286|3755865|FG001|NOT COMPLETED|Overall Study||0
3036602|NCT01144286|3755866|FG002|NOT COMPLETED|Overall Study||0
3036603|NCT01144286|3755867|FG003|NOT COMPLETED|Overall Study||0
3036604|NCT01144299|3755879|FG000|STARTED|Overall Study||60
3036605|NCT01144299|3755880|FG001|STARTED|Overall Study||54
3036606|NCT01144299|3755879|FG000|COMPLETED|Overall Study||58
3036607|NCT01144299|3755880|FG001|COMPLETED|Overall Study||54
3036608|NCT01144299|3755879|FG000|NOT COMPLETED|Overall Study||2
3036609|NCT01144299|3755880|FG001|NOT COMPLETED|Overall Study||0
3036610|NCT01144338|3755888|FG000|STARTED|Overall Study||7396
3036611|NCT01144338|3755889|FG001|STARTED|Overall Study||7356
3036612|NCT01144338|3755888|FG000|COMPLETED|Overall Study||7093
3036613|NCT01144338|3755889|FG001|COMPLETED|Overall Study||7094
3036614|NCT01144338|3755888|FG000|NOT COMPLETED|Overall Study||303
3036615|NCT01144338|3755889|FG001|NOT COMPLETED|Overall Study||262
3036616|NCT01144364|3755897|FG000|STARTED|Induction Phase||234
3036617|NCT01144364|3755898|FG001|STARTED|Induction Phase||0
2987678|NCT00888511|3704103|FG000|STARTED|Overall Study||15
2987679|NCT00888511|3704103|FG000|COMPLETED|Overall Study||15
2987680|NCT00888511|3704103|FG000|NOT COMPLETED|Overall Study||0
2987681|NCT00888615|3704107|FG000|STARTED|Overall Study||58
2987682|NCT00888615|3704107|FG000|COMPLETED|Overall Study||56
2987683|NCT00888615|3704107|FG000|NOT COMPLETED|Overall Study||2
2987684|NCT00888628|3704111|FG000|STARTED|Overall Study||7
2987685|NCT00888628|3704111|FG000|Enrolled|Overall Study||7
2987686|NCT00888628|3704111|FG000|Screen Failure|Overall Study||2
2987687|NCT00888628|3704111|FG000|Withdrawn|Overall Study||1
2987688|NCT00888628|3704111|FG000|Transplanted|Overall Study||4
2987689|NCT00888628|3704111|FG000|COMPLETED|Overall Study||4
2987690|NCT00888628|3704111|FG000|NOT COMPLETED|Overall Study||3
2987691|NCT00888654|3704115|FG000|STARTED|Overall Study||41
2987692|NCT00888654|3704115|FG000|COMPLETED|Overall Study||31
2987693|NCT00888654|3704115|FG000|NOT COMPLETED|Overall Study||10
2987694|NCT00888849|3704121|FG000|STARTED|Overall Study||142
2987695|NCT00888849|3704122|FG001|STARTED|Overall Study||138
2987696|NCT00888849|3704121|FG000|COMPLETED|Overall Study||137
2987697|NCT00888849|3704122|FG001|COMPLETED|Overall Study||129
2987698|NCT00888849|3704121|FG000|NOT COMPLETED|Overall Study||5
2987699|NCT00888849|3704122|FG001|NOT COMPLETED|Overall Study||9
2987700|NCT00888927|3704132|FG000|STARTED|Overall Study||3
2987701|NCT00888927|3704133|FG001|STARTED|Overall Study||3
2987702|NCT00888927|3704134|FG002|STARTED|Overall Study||3
2987703|NCT00888927|3704135|FG003|STARTED|Overall Study||33
2987704|NCT00888927|3704132|FG000|COMPLETED|Overall Study||3
2987705|NCT00888927|3704133|FG001|COMPLETED|Overall Study||3
2987706|NCT00888927|3704134|FG002|COMPLETED|Overall Study||3
2987707|NCT00888927|3704135|FG003|COMPLETED|Overall Study||31
2987708|NCT00888927|3704132|FG000|NOT COMPLETED|Overall Study||0
2987709|NCT00888927|3704133|FG001|NOT COMPLETED|Overall Study||0
2987710|NCT00888927|3704134|FG002|NOT COMPLETED|Overall Study||0
2987711|NCT00888927|3704135|FG003|NOT COMPLETED|Overall Study||2
2987712|NCT00888940|3704147|FG000|STARTED|Overall Study||120
2987713|NCT00888940|3704148|FG001|STARTED|Overall Study||122
2987714|NCT00888940|3704147|FG000|Completed Therapy|Overall Study||107
2987715|NCT00888940|3704148|FG001|Completed Therapy|Overall Study||106
2987716|NCT00888940|3704147|FG000|COMPLETED|Overall Study||92
2987717|NCT00888940|3704148|FG001|COMPLETED|Overall Study||101
2987718|NCT00888940|3704147|FG000|NOT COMPLETED|Overall Study||28
2987719|NCT00888940|3704148|FG001|NOT COMPLETED|Overall Study||21
2987720|NCT00888979|3704154|FG000|STARTED|Overall Study||10
2987721|NCT00888979|3704154|FG000|Received the Inhaler/Counseling|Overall Study||8
2987722|NCT00888979|3704154|FG000|COMPLETED|Overall Study||6
2987723|NCT00888979|3704154|FG000|NOT COMPLETED|Overall Study||4
2987724|NCT00889005|3704160|FG000|STARTED|Overall Study||65
2987725|NCT00889005|3704161|FG001|STARTED|Overall Study||74
2987726|NCT00889005|3704160|FG000|COMPLETED|Overall Study||57
2987727|NCT00889005|3704161|FG001|COMPLETED|Overall Study||72
2987728|NCT00889005|3704160|FG000|NOT COMPLETED|Overall Study||8
2987729|NCT00889005|3704161|FG001|NOT COMPLETED|Overall Study||2
2987730|NCT00889187|3704167|FG000|STARTED|Overall Study||3
2987731|NCT00889187|3704168|FG001|STARTED|Overall Study||3
2987732|NCT00889187|3704169|FG002|STARTED|Overall Study||4
2987733|NCT00889187|3704170|FG003|STARTED|Overall Study||0
2987734|NCT00889187|3704167|FG000|COMPLETED|Overall Study||3
2987735|NCT00889187|3704168|FG001|COMPLETED|Overall Study||3
2987736|NCT00889187|3704169|FG002|COMPLETED|Overall Study||4
2987737|NCT00889187|3704170|FG003|COMPLETED|Overall Study||0
2987738|NCT00889187|3704167|FG000|NOT COMPLETED|Overall Study||0
2987739|NCT00889187|3704168|FG001|NOT COMPLETED|Overall Study||0
2987740|NCT00889187|3704169|FG002|NOT COMPLETED|Overall Study||0
2987741|NCT00889187|3704170|FG003|NOT COMPLETED|Overall Study||0
2987742|NCT00889200|3704180|FG000|STARTED|Overall Study||12
2987743|NCT00889200|3704180|FG000|COMPLETED|Overall Study||12
2987744|NCT00889200|3704180|FG000|NOT COMPLETED|Overall Study||0
2987745|NCT00889226|3704186|FG000|STARTED|Overall Study||83
2987746|NCT00889226|3704187|FG001|STARTED|Overall Study||78
2987747|NCT00889226|3704186|FG000|COMPLETED|Overall Study||58
2987748|NCT00889226|3704187|FG001|COMPLETED|Overall Study||43
2987749|NCT00889226|3704186|FG000|NOT COMPLETED|Overall Study||25
2987750|NCT00889226|3704187|FG001|NOT COMPLETED|Overall Study||35
2987751|NCT00889252|3704195|FG000|STARTED|Overall Study||168
2987752|NCT00889252|3704196|FG001|STARTED|Overall Study||82
2987753|NCT00889252|3704195|FG000|COMPLETED|Overall Study||161
2987754|NCT00889252|3704196|FG001|COMPLETED|Overall Study||78
2987755|NCT00889252|3704195|FG000|NOT COMPLETED|Overall Study||7
2987756|NCT00889252|3704196|FG001|NOT COMPLETED|Overall Study||4
2987757|NCT00889265|3704202|FG000|STARTED|Overall Study|Date Enrollment Started: 07/21/2009 Date Enrollment Completed: 02/15/2011 Total enrolled: 51|51
2987758|NCT00889265|3704202|FG000|COMPLETED|Overall Study||44
2987759|NCT00889265|3704202|FG000|NOT COMPLETED|Overall Study||7
2987760|NCT00889330|3704208|FG000|STARTED|Overall Study||30
2987761|NCT00889330|3704209|FG001|STARTED|Overall Study||30
2987762|NCT00889330|3704208|FG000|COMPLETED|Overall Study||30
2987763|NCT00889330|3704209|FG001|COMPLETED|Overall Study||30
2987764|NCT00889330|3704208|FG000|NOT COMPLETED|Overall Study||0
2987765|NCT00889330|3704209|FG001|NOT COMPLETED|Overall Study||0
2987766|NCT00889512|3704217|FG000|STARTED|Overall Study||5
2987767|NCT00889512|3704218|FG001|STARTED|Overall Study||9
2987768|NCT00889512|3704217|FG000|COMPLETED|Overall Study||5
2987769|NCT00889512|3704218|FG001|COMPLETED|Overall Study||9
2987770|NCT00889512|3704217|FG000|NOT COMPLETED|Overall Study||0
2987771|NCT00889512|3704218|FG001|NOT COMPLETED|Overall Study||0
2987772|NCT00889603|3704224|FG000|STARTED|Overall Study||370
2987773|NCT00889603|3704224|FG000|COMPLETED|Overall Study||333
2987774|NCT00889603|3704224|FG000|NOT COMPLETED|Overall Study||37
2987775|NCT00889681|3704228|FG000|STARTED|Overall Study||81
2987776|NCT00889681|3704228|FG000|Received Treatment|Overall Study||78
2987777|NCT00889681|3704228|FG000|COMPLETED|Overall Study||78
2987778|NCT00889681|3704228|FG000|NOT COMPLETED|Overall Study||3
2987779|NCT00889707|3704234|FG000|STARTED|Overall Study||61
2987780|NCT00889707|3704235|FG001|STARTED|Overall Study||31
2987781|NCT00889707|3704234|FG000|COMPLETED|Overall Study||54
2987782|NCT00889707|3704235|FG001|COMPLETED|Overall Study||21
2987783|NCT00889707|3704234|FG000|NOT COMPLETED|Overall Study||7
2987784|NCT00889707|3704235|FG001|NOT COMPLETED|Overall Study||10
2987785|NCT00889720|3704241|FG000|STARTED|Overall Study||16
2987786|NCT00889720|3704241|FG000|Surgical Population|Overall Study||12
2987787|NCT00889720|3704241|FG000|COMPLETED|Overall Study||8
2987788|NCT00889720|3704241|FG000|NOT COMPLETED|Overall Study||8
2987789|NCT00889824|3704245|FG000|STARTED|Overall Study||5
2987790|NCT00889824|3704245|FG000|COMPLETED|Overall Study||5
2987791|NCT00889824|3704245|FG000|NOT COMPLETED|Overall Study||0
2987792|NCT00889863|3704249|FG000|STARTED|Part I: Open Label||177
2987793|NCT00889863|3704250|FG001|STARTED|Part I: Open Label|No participants received placebo in Part I.|0
2987794|NCT00889863|3704249|FG000|Entered Part Ia|Part I: Open Label||145
2987795|NCT00889863|3704250|FG001|Entered Part Ia|Part I: Open Label||0
2987796|NCT00889863|3704249|FG000|Entered Part Ib|Part I: Open Label||142
2987797|NCT00889863|3704250|FG001|Entered Part Ib|Part I: Open Label||0
2987798|NCT00889863|3704249|FG000|Entered Part Ic|Part I: Open Label|Patients steroid free at study entry entered Part Id directly and did not participate in Part Ic.|92
2987799|NCT00889863|3704250|FG001|Entered Part Ic|Part I: Open Label||0
2987800|NCT00889863|3704249|FG000|Entered Part 1d|Part I: Open Label||103
2987801|NCT00889863|3704250|FG001|Entered Part 1d|Part I: Open Label||0
2987802|NCT00889863|3704249|FG000|COMPLETED|Part I: Open Label||100
2987803|NCT00889863|3704250|FG001|COMPLETED|Part I: Open Label||0
2987804|NCT00889863|3704249|FG000|NOT COMPLETED|Part I: Open Label||77
2987805|NCT00889863|3704250|FG001|NOT COMPLETED|Part I: Open Label||0
2987806|NCT00889863|3704249|FG000|STARTED|Part II: Randomized Double Blind||50
2987807|NCT00889863|3704250|FG001|STARTED|Part II: Randomized Double Blind||50
2987808|NCT00889863|3704249|FG000|COMPLETED|Part II: Randomized Double Blind||39
2987809|NCT00889863|3704250|FG001|COMPLETED|Part II: Randomized Double Blind||24
2987810|NCT00889863|3704249|FG000|NOT COMPLETED|Part II: Randomized Double Blind||11
2987811|NCT00889863|3704250|FG001|NOT COMPLETED|Part II: Randomized Double Blind||26
2987812|NCT00889915|3704262|FG000|STARTED|Overall Study||37
2987813|NCT00889915|3704263|FG001|STARTED|Overall Study||76
2987814|NCT00889915|3704264|FG002|STARTED|Overall Study||67
2987815|NCT00889915|3704265|FG003|STARTED|Overall Study||48
2987816|NCT00889915|3704262|FG000|COMPLETED|Overall Study||35
2987817|NCT00889915|3704263|FG001|COMPLETED|Overall Study||71
2987818|NCT00889915|3704264|FG002|COMPLETED|Overall Study||54
2987819|NCT00889915|3704265|FG003|COMPLETED|Overall Study||40
2987820|NCT00889915|3704262|FG000|NOT COMPLETED|Overall Study||2
2987821|NCT00889915|3704263|FG001|NOT COMPLETED|Overall Study||5
2987822|NCT00889915|3704264|FG002|NOT COMPLETED|Overall Study||13
2987823|NCT00889915|3704265|FG003|NOT COMPLETED|Overall Study||8
2987824|NCT00889928|3704275|FG000|STARTED|Overall Study||7
2987825|NCT00889928|3704275|FG000|COMPLETED|Overall Study||7
2987826|NCT00889928|3704275|FG000|NOT COMPLETED|Overall Study||0
2987827|NCT00890045|3704281|FG000|STARTED|Overall Study||20
2987828|NCT00890045|3704282|FG001|STARTED|Overall Study|Of the 52 subjects randomized to the HeRO Graft, two implants were abandoned.|52
2987829|NCT00890045|3704281|FG000|COMPLETED|Overall Study||15
2987830|NCT00890045|3704282|FG001|COMPLETED|Overall Study||42
2987831|NCT00890045|3704281|FG000|NOT COMPLETED|Overall Study||5
2987832|NCT00890045|3704282|FG001|NOT COMPLETED|Overall Study||10
2987833|NCT00890084|3704288|FG000|STARTED|Overall Study||2913
2987834|NCT00890084|3704288|FG000|COMPLETED|Overall Study||2771
2987835|NCT00890084|3704288|FG000|NOT COMPLETED|Overall Study||142
2987836|NCT00890097|3704295|FG000|STARTED|Overall Study||252
2987837|NCT00890097|3704296|FG001|STARTED|Overall Study||259
2987838|NCT00890097|3704297|FG002|STARTED|Overall Study||261
2987839|NCT00890097|3704295|FG000|COMPLETED|Overall Study||184
2987840|NCT00890097|3704296|FG001|COMPLETED|Overall Study||173
2987841|NCT00890097|3704297|FG002|COMPLETED|Overall Study||184
2987842|NCT00890097|3704295|FG000|NOT COMPLETED|Overall Study||68
2987843|NCT00890097|3704296|FG001|NOT COMPLETED|Overall Study||86
2987844|NCT00890097|3704297|FG002|NOT COMPLETED|Overall Study||77
2987845|NCT00890162|3704307|FG000|STARTED|Overall Study||8
2987846|NCT00890162|3704308|FG001|STARTED|Overall Study||8
2987847|NCT00890162|3704307|FG000|COMPLETED|Overall Study||6
2987848|NCT00890162|3704308|FG001|COMPLETED|Overall Study||7
2987849|NCT00890162|3704307|FG000|NOT COMPLETED|Overall Study||2
2987850|NCT00890162|3704308|FG001|NOT COMPLETED|Overall Study||1
2987851|NCT00890201|3704316|FG000|STARTED|Overall Study|5 patients with gastric cancer and gallstone disease|38
2987852|NCT00890201|3704317|FG001|STARTED|Overall Study|41 patients with acute cholecystitis and 15 patients with common bile duct stones|159
2987853|NCT00890201|3704316|FG000|COMPLETED|Overall Study|33 patients with gastric cancer and without gallstone disease|33
2987854|NCT00890201|3704317|FG001|COMPLETED|Overall Study|103 patients without acute cholecystitis or common bile duct stones|103
2987855|NCT00890201|3704316|FG000|NOT COMPLETED|Overall Study||5
2987856|NCT00890201|3704317|FG001|NOT COMPLETED|Overall Study||56
2987857|NCT00890396|3704325|FG000|STARTED|Overall Study||127
2987858|NCT00890396|3704326|FG001|STARTED|Overall Study||36
2987859|NCT00890396|3704325|FG000|COMPLETED|Overall Study||122
2987860|NCT00890396|3704326|FG001|COMPLETED|Overall Study||34
2987861|NCT00890396|3704325|FG000|NOT COMPLETED|Overall Study||5
2987862|NCT00890396|3704326|FG001|NOT COMPLETED|Overall Study||2
2987863|NCT00890552|3704335|FG000|STARTED|Enrollment and Pre-treatment||25
2987864|NCT00890552|3704335|FG000|COMPLETED|Enrollment and Pre-treatment||24
2987865|NCT00890552|3704335|FG000|NOT COMPLETED|Enrollment and Pre-treatment||1
2987866|NCT00890552|3704335|FG000|STARTED|On-treatment||24
2987867|NCT00890552|3704335|FG000|COMPLETED|On-treatment||14
2987868|NCT00890552|3704335|FG000|NOT COMPLETED|On-treatment||10
2987869|NCT00890617|3704339|FG000|STARTED|Overall Study||9
2987870|NCT00890617|3704339|FG000|COMPLETED|Overall Study||9
2987871|NCT00890617|3704339|FG000|NOT COMPLETED|Overall Study||0
2987872|NCT00890656|3704343|FG000|STARTED|Overall Study||90
2987873|NCT00890656|3704343|FG000|COMPLETED|Overall Study||90
2987874|NCT00890656|3704343|FG000|NOT COMPLETED|Overall Study||0
2987875|NCT00890682|3704349|FG000|STARTED|Overall Study||97
2987876|NCT00890682|3704350|FG001|STARTED|Overall Study||96
2987877|NCT00890682|3704349|FG000|COMPLETED|Overall Study||93
2987878|NCT00890682|3704350|FG001|COMPLETED|Overall Study||94
2987879|NCT00890682|3704349|FG000|NOT COMPLETED|Overall Study||4
2987880|NCT00890682|3704350|FG001|NOT COMPLETED|Overall Study||2
2987881|NCT00890695|3704358|FG000|STARTED|Overall Study||32
2987882|NCT00890695|3704359|FG001|STARTED|Overall Study||33
2987883|NCT00890695|3704358|FG000|COMPLETED|Overall Study||31
2987884|NCT00890695|3704359|FG001|COMPLETED|Overall Study||33
2987885|NCT00890695|3704358|FG000|NOT COMPLETED|Overall Study||1
2987886|NCT00890695|3704359|FG001|NOT COMPLETED|Overall Study||0
2987887|NCT00890721|3704367|FG000|STARTED|Overall Study||95
2987888|NCT00890721|3704368|FG001|STARTED|Overall Study||94
2987889|NCT00890721|3704367|FG000|COMPLETED|Overall Study||94
2987890|NCT00890721|3704368|FG001|COMPLETED|Overall Study||93
2987891|NCT00890721|3704367|FG000|NOT COMPLETED|Overall Study||1
2987892|NCT00890721|3704368|FG001|NOT COMPLETED|Overall Study||1
2987893|NCT00890825|3704376|FG000|STARTED|Overall Study||44
2987894|NCT00890825|3704377|FG001|STARTED|Overall Study|A patient randomized to this arm was excluded from the safety population for not receiving treatment|43
2987895|NCT00890825|3704376|FG000|COMPLETED|Overall Study||30
2987896|NCT00890825|3704377|FG001|COMPLETED|Overall Study||29
2987897|NCT00890825|3704376|FG000|NOT COMPLETED|Overall Study||14
2987898|NCT00890825|3704377|FG001|NOT COMPLETED|Overall Study||14
2987899|NCT00890916|3704383|FG000|STARTED|"Rehab - Neuroprosthesis (NP) On"|First Implanted Stimulator-Telemeter (IST-12) Implant.|10
2987900|NCT00890916|3704383|FG000|"Grasp Release Pre-Test ON"|"Rehab - Neuroprosthesis (NP) On"||10
2987901|NCT00890916|3704383|FG000|COMPLETED|"Rehab - Neuroprosthesis (NP) On"||10
2987902|NCT00890916|3704383|FG000|NOT COMPLETED|"Rehab - Neuroprosthesis (NP) On"||0
2987903|NCT00890916|3704383|FG000|STARTED|"Rehab - NP Off"||10
2987904|NCT00890916|3704383|FG000|"Grasp Release Pre-Test OFF"|"Rehab - NP Off"||10
2987905|NCT00890916|3704383|FG000|COMPLETED|"Rehab - NP Off"||10
2987906|NCT00890916|3704383|FG000|NOT COMPLETED|"Rehab - NP Off"||0
2987907|NCT00890929|3704387|FG000|STARTED|Overall Study||45
2987908|NCT00890929|3704387|FG000|Consented & Enrolled|Overall Study||45
2987909|NCT00890929|3704387|FG000|Initiated Treatment|Overall Study||43
2987910|NCT00890929|3704387|FG000|COMPLETED|Overall Study||39
2987911|NCT00890929|3704387|FG000|NOT COMPLETED|Overall Study||6
2987912|NCT00890981|3704393|FG000|STARTED|Overall Study||39
2987913|NCT00890981|3704394|FG001|STARTED|Overall Study||40
2987914|NCT00890981|3704393|FG000|COMPLETED|Overall Study||39
2987915|NCT00890981|3704394|FG001|COMPLETED|Overall Study||40
2987916|NCT00890981|3704393|FG000|NOT COMPLETED|Overall Study||0
2987917|NCT00890981|3704394|FG001|NOT COMPLETED|Overall Study||0
2987918|NCT00891020|3704403|FG000|STARTED|24 Week Treatment Period||163
3133517|NCT01696279|3858511|FG003|STARTED|Part 1: Single Dose Lanthanum Carbonate||0
3133518|NCT01696279|3858508|FG000|Safety Analysis Set 1|Part 1: Single Dose Lanthanum Carbonate||20
3133519|NCT01696279|3858509|FG001|Safety Analysis Set 1|Part 1: Single Dose Lanthanum Carbonate||0
3133520|NCT01696279|3858510|FG002|Safety Analysis Set 1|Part 1: Single Dose Lanthanum Carbonate||0
3136744|NCT01714726|3861989|FG001|NOT COMPLETED|Open-Label Period||0
2987919|NCT00891020|3704404|FG001|STARTED|24 Week Treatment Period||363
2987920|NCT00891020|3704405|FG002|STARTED|24 Week Treatment Period||360
2987921|NCT00891020|3704403|FG000|Intent-to-Treat (ITT)|24 Week Treatment Period||163
2987922|NCT00891020|3704404|FG001|Intent-to-Treat (ITT)|24 Week Treatment Period||362
2987923|NCT00891020|3704405|FG002|Intent-to-Treat (ITT)|24 Week Treatment Period||358
2987924|NCT00891020|3704403|FG000|Safety Set|24 Week Treatment Period|4 patients from 8 mg/kg +DMARD arm did not receive DMARD, included in Monotherapy arm for safety.|138
2987925|NCT00891020|3704404|FG001|Safety Set|24 Week Treatment Period|1 patient from Monotherapy arm and 1 from 8 mg/kg +DMARD, included in 4 mg/kg +DMARD arm for safety.|364
2987926|NCT00891020|3704405|FG002|Safety Set|24 Week Treatment Period|28 patients from Monotherapy arm received DMARD, included in 8 mg/kg +DMARD arm for safety.|381
2987927|NCT00891020|3704403|FG000|COMPLETED|24 Week Treatment Period||126
2987928|NCT00891020|3704404|FG001|COMPLETED|24 Week Treatment Period||303
2987929|NCT00891020|3704405|FG002|COMPLETED|24 Week Treatment Period||302
2987930|NCT00891020|3704403|FG000|NOT COMPLETED|24 Week Treatment Period||37
2987931|NCT00891020|3704404|FG001|NOT COMPLETED|24 Week Treatment Period||60
2987932|NCT00891020|3704405|FG002|NOT COMPLETED|24 Week Treatment Period||58
2987933|NCT00891020|3704403|FG000|STARTED|Long-term Extension Period||55
2987934|NCT00891020|3704404|FG001|STARTED|Long-term Extension Period||196
2987935|NCT00891020|3704405|FG002|STARTED|Long-term Extension Period||193
2987936|NCT00891020|3704403|FG000|COMPLETED|Long-term Extension Period||49
2987937|NCT00891020|3704404|FG001|COMPLETED|Long-term Extension Period||172
2987938|NCT00891020|3704405|FG002|COMPLETED|Long-term Extension Period||170
2987939|NCT00891020|3704403|FG000|NOT COMPLETED|Long-term Extension Period||6
2987940|NCT00891020|3704404|FG001|NOT COMPLETED|Long-term Extension Period||24
2987941|NCT00891020|3704405|FG002|NOT COMPLETED|Long-term Extension Period||23
2987942|NCT00891046|3704420|FG000|STARTED|Overall Study||33
2987943|NCT00891046|3704421|FG001|STARTED|Overall Study||63
2987944|NCT00891046|3704422|FG002|STARTED|Overall Study||40
2987945|NCT00891046|3704423|FG003|STARTED|Overall Study||11
2987946|NCT00891046|3704424|FG004|STARTED|Overall Study||123
2987947|NCT00891046|3704420|FG000|COMPLETED|Overall Study||21
3133521|NCT01696279|3858511|FG003|Safety Analysis Set 1|Part 1: Single Dose Lanthanum Carbonate||0
3133522|NCT01696279|3858508|FG000|Entered Part 2a|Part 1: Single Dose Lanthanum Carbonate||19
3133523|NCT01696279|3858509|FG001|Entered Part 2a|Part 1: Single Dose Lanthanum Carbonate||0
3133524|NCT01696279|3858510|FG002|Entered Part 2a|Part 1: Single Dose Lanthanum Carbonate||0
3133525|NCT01696279|3858511|FG003|Entered Part 2a|Part 1: Single Dose Lanthanum Carbonate||0
3133526|NCT01696279|3858508|FG000|COMPLETED|Part 1: Single Dose Lanthanum Carbonate||19
2987948|NCT00891046|3704421|FG001|COMPLETED|Overall Study||54
2987949|NCT00891046|3704422|FG002|COMPLETED|Overall Study||17
2987950|NCT00891046|3704423|FG003|COMPLETED|Overall Study||8
2987951|NCT00891046|3704424|FG004|COMPLETED|Overall Study||84
2987952|NCT00891046|3704420|FG000|NOT COMPLETED|Overall Study||12
2987953|NCT00891046|3704421|FG001|NOT COMPLETED|Overall Study||9
2987954|NCT00891046|3704422|FG002|NOT COMPLETED|Overall Study||23
2987955|NCT00891046|3704423|FG003|NOT COMPLETED|Overall Study||3
2987956|NCT00891046|3704424|FG004|NOT COMPLETED|Overall Study||39
2987957|NCT00891176|3704455|FG000|STARTED|At 3 Years of Age||144
2987958|NCT00891176|3704456|FG001|STARTED|At 3 Years of Age||147
2987959|NCT00891176|3704457|FG002|STARTED|At 3 Years of Age||149
2987960|NCT00891176|3704458|FG003|STARTED|At 3 Years of Age||141
2987961|NCT00891176|3704455|FG000|COMPLETED|At 3 Years of Age||144
2987962|NCT00891176|3704456|FG001|COMPLETED|At 3 Years of Age||147
2987963|NCT00891176|3704457|FG002|COMPLETED|At 3 Years of Age||149
2987964|NCT00891176|3704458|FG003|COMPLETED|At 3 Years of Age||141
2987965|NCT00891176|3704455|FG000|NOT COMPLETED|At 3 Years of Age||0
2987966|NCT00891176|3704456|FG001|NOT COMPLETED|At 3 Years of Age||0
2987967|NCT00891176|3704457|FG002|NOT COMPLETED|At 3 Years of Age||0
2987968|NCT00891176|3704458|FG003|NOT COMPLETED|At 3 Years of Age||0
2987969|NCT00891176|3704455|FG000|STARTED|At 4 Years of Age||140
2987970|NCT00891176|3704456|FG001|STARTED|At 4 Years of Age||142
2987971|NCT00891176|3704457|FG002|STARTED|At 4 Years of Age||142
2987972|NCT00891176|3704458|FG003|STARTED|At 4 Years of Age||137
2987973|NCT00891176|3704455|FG000|COMPLETED|At 4 Years of Age||140
2987974|NCT00891176|3704456|FG001|COMPLETED|At 4 Years of Age||142
2987975|NCT00891176|3704457|FG002|COMPLETED|At 4 Years of Age||142
2987976|NCT00891176|3704458|FG003|COMPLETED|At 4 Years of Age||137
2987977|NCT00891176|3704455|FG000|NOT COMPLETED|At 4 Years of Age||0
2987978|NCT00891176|3704456|FG001|NOT COMPLETED|At 4 Years of Age||0
2987979|NCT00891176|3704457|FG002|NOT COMPLETED|At 4 Years of Age||0
2987980|NCT00891176|3704458|FG003|NOT COMPLETED|At 4 Years of Age||0
2987981|NCT00891176|3704455|FG000|STARTED|At 6 Years of Age||131
2987982|NCT00891176|3704456|FG001|STARTED|At 6 Years of Age||138
2987983|NCT00891176|3704457|FG002|STARTED|At 6 Years of Age||135
2987984|NCT00891176|3704458|FG003|STARTED|At 6 Years of Age||135
2987985|NCT00891176|3704455|FG000|COMPLETED|At 6 Years of Age||131
2987986|NCT00891176|3704456|FG001|COMPLETED|At 6 Years of Age||138
2987987|NCT00891176|3704457|FG002|COMPLETED|At 6 Years of Age||135
2987988|NCT00891176|3704458|FG003|COMPLETED|At 6 Years of Age||135
2987989|NCT00891176|3704455|FG000|NOT COMPLETED|At 6 Years of Age||0
2987990|NCT00891176|3704456|FG001|NOT COMPLETED|At 6 Years of Age||0
2987991|NCT00891176|3704457|FG002|NOT COMPLETED|At 6 Years of Age||0
2987992|NCT00891176|3704458|FG003|NOT COMPLETED|At 6 Years of Age||0
2987993|NCT00891202|3704476|FG000|STARTED|PAP (Up To Week 39)||20
2987994|NCT00891202|3704477|FG001|STARTED|PAP (Up To Week 39)||20
2987995|NCT00891202|3704478|FG002|STARTED|PAP (Up To Week 39)||0
2987996|NCT00891202|3704479|FG003|STARTED|PAP (Up To Week 39)||0
2987997|NCT00891202|3704476|FG000|COMPLETED|PAP (Up To Week 39)||19
2987998|NCT00891202|3704477|FG001|COMPLETED|PAP (Up To Week 39)||20
2987999|NCT00891202|3704478|FG002|COMPLETED|PAP (Up To Week 39)||0
2988000|NCT00891202|3704479|FG003|COMPLETED|PAP (Up To Week 39)||0
2988001|NCT00891202|3704476|FG000|NOT COMPLETED|PAP (Up To Week 39)||1
2988002|NCT00891202|3704477|FG001|NOT COMPLETED|PAP (Up To Week 39)||0
2988003|NCT00891202|3704478|FG002|NOT COMPLETED|PAP (Up To Week 39)||0
2988004|NCT00891202|3704479|FG003|NOT COMPLETED|PAP (Up To Week 39)||0
2988005|NCT00891202|3704476|FG000|STARTED|LTTP (Post-Week 39 up to Week 312)||0
2988006|NCT00891202|3704477|FG001|STARTED|LTTP (Post-Week 39 up to Week 312)||0
2988007|NCT00891202|3704478|FG002|STARTED|LTTP (Post-Week 39 up to Week 312)||19
2988008|NCT00891202|3704479|FG003|STARTED|LTTP (Post-Week 39 up to Week 312)||20
2988009|NCT00891202|3704476|FG000|COMPLETED|LTTP (Post-Week 39 up to Week 312)||0
2988010|NCT00891202|3704477|FG001|COMPLETED|LTTP (Post-Week 39 up to Week 312)||0
2988011|NCT00891202|3704478|FG002|COMPLETED|LTTP (Post-Week 39 up to Week 312)||12
2988012|NCT00891202|3704479|FG003|COMPLETED|LTTP (Post-Week 39 up to Week 312)||15
2988013|NCT00891202|3704476|FG000|NOT COMPLETED|LTTP (Post-Week 39 up to Week 312)||0
2988014|NCT00891202|3704477|FG001|NOT COMPLETED|LTTP (Post-Week 39 up to Week 312)||0
2988015|NCT00891202|3704478|FG002|NOT COMPLETED|LTTP (Post-Week 39 up to Week 312)||7
2988016|NCT00891202|3704479|FG003|NOT COMPLETED|LTTP (Post-Week 39 up to Week 312)||5
2988017|NCT00891228|3704490|FG000|STARTED|Overall Study||32
2988018|NCT00891228|3704491|FG001|STARTED|Overall Study||33
2988019|NCT00891228|3704492|FG002|STARTED|Overall Study||34
2988020|NCT00891228|3704490|FG000|COMPLETED|Overall Study||21
2988021|NCT00891228|3704491|FG001|COMPLETED|Overall Study||20
2988022|NCT00891228|3704492|FG002|COMPLETED|Overall Study||19
2988023|NCT00891228|3704490|FG000|NOT COMPLETED|Overall Study||11
2988024|NCT00891228|3704491|FG001|NOT COMPLETED|Overall Study||13
2988025|NCT00891228|3704492|FG002|NOT COMPLETED|Overall Study||15
2988026|NCT00891293|3704500|FG000|STARTED|Overall Study|93 participants were enrolled; baseline data are provided for 89 participants (Safety Population).|93
2988027|NCT00891293|3704500|FG000|COMPLETED|Overall Study||9
2988028|NCT00891293|3704500|FG000|NOT COMPLETED|Overall Study||84
2988029|NCT00891319|3704506|FG000|STARTED|Overall Study||40
2988030|NCT00891319|3704507|FG001|STARTED|Overall Study||40
2988031|NCT00891319|3704506|FG000|COMPLETED|Overall Study||32
2988032|NCT00891319|3704507|FG001|COMPLETED|Overall Study||40
2988033|NCT00891319|3704506|FG000|NOT COMPLETED|Overall Study||8
2988034|NCT00891319|3704507|FG001|NOT COMPLETED|Overall Study||0
2988035|NCT00891371|3704513|FG000|STARTED|Pre-assignment||42
2988036|NCT00891371|3704513|FG000|COMPLETED|Pre-assignment||36
2988037|NCT00891371|3704513|FG000|NOT COMPLETED|Pre-assignment||6
2988038|NCT00891371|3704513|FG000|STARTED|Treatment||36
2988039|NCT00891371|3704513|FG000|COMPLETED|Treatment||27
2988040|NCT00891371|3704513|FG000|NOT COMPLETED|Treatment||9
2988041|NCT00891436|3704519|FG000|STARTED|Overall Study||10
2988042|NCT00891436|3704520|FG001|STARTED|Overall Study||10
2988043|NCT00891436|3704519|FG000|COMPLETED|Overall Study||10
2988044|NCT00891436|3704520|FG001|COMPLETED|Overall Study||10
2988045|NCT00891436|3704519|FG000|NOT COMPLETED|Overall Study||0
2988046|NCT00891436|3704520|FG001|NOT COMPLETED|Overall Study||0
2988047|NCT00891462|3704529|FG000|STARTED|Overall Study||186
2988048|NCT00891462|3704530|FG001|STARTED|Overall Study||185
2988049|NCT00891462|3704531|FG002|STARTED|Overall Study||190
2988050|NCT00891462|3704529|FG000|COMPLETED|Overall Study||149
2988051|NCT00891462|3704530|FG001|COMPLETED|Overall Study||152
2988052|NCT00891462|3704531|FG002|COMPLETED|Overall Study||166
2988053|NCT00891462|3704529|FG000|NOT COMPLETED|Overall Study||37
2988054|NCT00891462|3704530|FG001|NOT COMPLETED|Overall Study||33
2988055|NCT00891462|3704531|FG002|NOT COMPLETED|Overall Study||24
2988056|NCT00891527|3704541|FG000|STARTED|Overall Study||50
2988057|NCT00891527|3704541|FG000|COMPLETED|Overall Study||48
2988058|NCT00891527|3704541|FG000|NOT COMPLETED|Overall Study||2
2988059|NCT00891618|3704546|FG000|STARTED|Overall Study||21
2988060|NCT00891618|3704546|FG000|COMPLETED|Overall Study||20
2988061|NCT00891618|3704546|FG000|NOT COMPLETED|Overall Study||1
2988062|NCT00891657|3704552|FG000|STARTED|Overall Study||9
2988063|NCT00891657|3704553|FG001|STARTED|Overall Study||6
2988064|NCT00891657|3704552|FG000|COMPLETED|Overall Study||8
2988065|NCT00891657|3704553|FG001|COMPLETED|Overall Study||5
2988066|NCT00891657|3704552|FG000|NOT COMPLETED|Overall Study||1
2988067|NCT00891657|3704553|FG001|NOT COMPLETED|Overall Study||1
2988068|NCT00891735|3704563|FG000|STARTED|Overall Study||275
2988069|NCT00891735|3704564|FG001|STARTED|Overall Study||274
2988070|NCT00891735|3704565|FG002|STARTED|Overall Study||275
2988071|NCT00891735|3704566|FG003|STARTED|Overall Study||273
2988072|NCT00891735|3704563|FG000|COMPLETED|Overall Study||258
2988073|NCT00891735|3704564|FG001|COMPLETED|Overall Study||258
2988074|NCT00891735|3704565|FG002|COMPLETED|Overall Study||263
2988075|NCT00891735|3704566|FG003|COMPLETED|Overall Study||258
2988076|NCT00891735|3704563|FG000|NOT COMPLETED|Overall Study||17
2988077|NCT00891735|3704564|FG001|NOT COMPLETED|Overall Study||16
2988078|NCT00891735|3704565|FG002|NOT COMPLETED|Overall Study||12
2988079|NCT00891735|3704566|FG003|NOT COMPLETED|Overall Study||15
2988080|NCT00891774|3704576|FG000|STARTED|Overall Study||172
2988081|NCT00891774|3704576|FG000|COMPLETED|Overall Study||158
2988082|NCT00891774|3704576|FG000|NOT COMPLETED|Overall Study||14
2988083|NCT00891813|3704580|FG000|STARTED|Overall Study||100
2988084|NCT00891813|3704580|FG000|COMPLETED|Overall Study||88
2988085|NCT00891813|3704580|FG000|NOT COMPLETED|Overall Study||12
2988086|NCT00891839|3704584|FG000|STARTED|Overall Study||45
2988087|NCT00891839|3704584|FG000|COMPLETED|Overall Study|completed treatment|38
2988088|NCT00891839|3704584|FG000|NOT COMPLETED|Overall Study||7
2988089|NCT00891878|3704590|FG000|STARTED|Overall Study||6
2988090|NCT00891878|3704591|FG001|STARTED|Overall Study||6
2988091|NCT00891878|3704590|FG000|COMPLETED|Overall Study||6
2988092|NCT00891878|3704591|FG001|COMPLETED|Overall Study||6
2988093|NCT00891878|3704590|FG000|NOT COMPLETED|Overall Study||0
2988094|NCT00891878|3704591|FG001|NOT COMPLETED|Overall Study||0
2988095|NCT00891930|3704597|FG000|STARTED|Part 1: Panitumumab +Irinotecan||76
2988096|NCT00891930|3704597|FG000|Received Treatment|Part 1: Panitumumab +Irinotecan||74
2988097|NCT00891930|3704597|FG000|COMPLETED|Part 1: Panitumumab +Irinotecan||36
2988098|NCT00891930|3704597|FG000|NOT COMPLETED|Part 1: Panitumumab +Irinotecan||40
2988099|NCT00891930|3704597|FG000|STARTED|Part 2: Panitumumab + Ganitumab||36
2988100|NCT00891930|3704597|FG000|COMPLETED|Part 2: Panitumumab + Ganitumab||5
2988101|NCT00891930|3704597|FG000|NOT COMPLETED|Part 2: Panitumumab + Ganitumab||31
3304854|NCT02982772|4038431|FG000|NOT COMPLETED|12M Follow-Up||11
3304855|NCT02982772|4038432|FG001|NOT COMPLETED|12M Follow-Up||5
3304856|NCT02982863|4038445|FG000|STARTED|Overall Study||5745
2988102|NCT00891982|3704607|FG000|STARTED|Overall Study||30
2988103|NCT00891982|3704608|FG001|STARTED|Overall Study||31
2988104|NCT00891982|3704607|FG000|COMPLETED|Overall Study||28
2988105|NCT00891982|3704608|FG001|COMPLETED|Overall Study||30
2988106|NCT00891982|3704607|FG000|NOT COMPLETED|Overall Study||2
2988107|NCT00891982|3704608|FG001|NOT COMPLETED|Overall Study||1
2988108|NCT00891995|3704616|FG000|STARTED|Overall Study||50
2988109|NCT00891995|3704617|FG001|STARTED|Overall Study||21
2988110|NCT00891995|3704616|FG000|COMPLETED|Overall Study||50
2988111|NCT00891995|3704617|FG001|COMPLETED|Overall Study||21
2988112|NCT00891995|3704616|FG000|NOT COMPLETED|Overall Study||0
2988113|NCT00891995|3704617|FG001|NOT COMPLETED|Overall Study||0
2988114|NCT00892008|3704623|FG000|STARTED|Overall Study||2278
2988115|NCT00892008|3704623|FG000|COMPLETED|Overall Study||1713
2988116|NCT00892008|3704623|FG000|NOT COMPLETED|Overall Study||565
2988117|NCT00892047|3704629|FG000|STARTED|Overall Study||91
2988118|NCT00892047|3704630|FG001|STARTED|Overall Study||90
2988119|NCT00892047|3704629|FG000|COMPLETED|Overall Study||87
2988120|NCT00892047|3704630|FG001|COMPLETED|Overall Study||83
2988121|NCT00892047|3704629|FG000|NOT COMPLETED|Overall Study||4
2988122|NCT00892047|3704630|FG001|NOT COMPLETED|Overall Study||7
2988123|NCT00892099|3704641|FG000|STARTED|Overall Study||36
2988124|NCT00892099|3704642|FG001|STARTED|Overall Study||33
2988125|NCT00892099|3704643|FG002|STARTED|Overall Study||36
2988126|NCT00892099|3704641|FG000|COMPLETED|Overall Study||31
2988127|NCT00892099|3704642|FG001|COMPLETED|Overall Study||32
2988128|NCT00892099|3704643|FG002|COMPLETED|Overall Study||29
2988129|NCT00892099|3704641|FG000|NOT COMPLETED|Overall Study||5
2988130|NCT00892099|3704642|FG001|NOT COMPLETED|Overall Study||1
2988131|NCT00892099|3704643|FG002|NOT COMPLETED|Overall Study||7
2988132|NCT00892151|3704651|FG000|STARTED|Overall Study||51
2988133|NCT00892151|3704651|FG000|COMPLETED|Overall Study||50
2988134|NCT00892151|3704651|FG000|NOT COMPLETED|Overall Study||1
2988135|NCT00892177|3704658|FG000|STARTED|Phase I: Dose Level 0||3
2988136|NCT00892177|3704659|FG001|STARTED|Phase I: Dose Level 0||0
2988137|NCT00892177|3704660|FG002|STARTED|Phase I: Dose Level 0||0
3304857|NCT02982863|4038446|FG001|STARTED|Overall Study||16745
3304858|NCT02982863|4038447|FG002|STARTED|Overall Study||13238
3304859|NCT02982863|4038448|FG003|STARTED|Overall Study||10158
3304860|NCT02982863|4038449|FG004|STARTED|Overall Study||2760
3304861|NCT02982863|4038445|FG000|COMPLETED|Overall Study||4936
3304862|NCT02982863|4038446|FG001|COMPLETED|Overall Study||12484
3304863|NCT02982863|4038447|FG002|COMPLETED|Overall Study||11386
3304864|NCT02982863|4038448|FG003|COMPLETED|Overall Study||8758
3304865|NCT02982863|4038449|FG004|COMPLETED|Overall Study||2268
3304866|NCT02982863|4038445|FG000|NOT COMPLETED|Overall Study||809
3304867|NCT02982863|4038446|FG001|NOT COMPLETED|Overall Study||4261
3304868|NCT02982863|4038447|FG002|NOT COMPLETED|Overall Study||1852
2988138|NCT00892177|3704661|FG003|STARTED|Phase I: Dose Level 0||0
2988139|NCT00892177|3704662|FG004|STARTED|Phase I: Dose Level 0||0
2988140|NCT00892177|3704663|FG005|STARTED|Phase I: Dose Level 0||0
2988141|NCT00892177|3704658|FG000|COMPLETED|Phase I: Dose Level 0||3
2988142|NCT00892177|3704659|FG001|COMPLETED|Phase I: Dose Level 0||0
2988143|NCT00892177|3704660|FG002|COMPLETED|Phase I: Dose Level 0||0
2988144|NCT00892177|3704661|FG003|COMPLETED|Phase I: Dose Level 0||0
2988145|NCT00892177|3704662|FG004|COMPLETED|Phase I: Dose Level 0||0
2988146|NCT00892177|3704663|FG005|COMPLETED|Phase I: Dose Level 0||0
2988147|NCT00892177|3704658|FG000|NOT COMPLETED|Phase I: Dose Level 0||0
2988148|NCT00892177|3704659|FG001|NOT COMPLETED|Phase I: Dose Level 0||0
2988149|NCT00892177|3704660|FG002|NOT COMPLETED|Phase I: Dose Level 0||0
2988150|NCT00892177|3704661|FG003|NOT COMPLETED|Phase I: Dose Level 0||0
2988151|NCT00892177|3704662|FG004|NOT COMPLETED|Phase I: Dose Level 0||0
2988152|NCT00892177|3704663|FG005|NOT COMPLETED|Phase I: Dose Level 0||0
2988153|NCT00892177|3704658|FG000|STARTED|Phase I: Dose Level 1||0
2988154|NCT00892177|3704659|FG001|STARTED|Phase I: Dose Level 1||4
2988155|NCT00892177|3704660|FG002|STARTED|Phase I: Dose Level 1||0
2988156|NCT00892177|3704661|FG003|STARTED|Phase I: Dose Level 1||0
2988157|NCT00892177|3704662|FG004|STARTED|Phase I: Dose Level 1||0
2988158|NCT00892177|3704663|FG005|STARTED|Phase I: Dose Level 1||0
2988159|NCT00892177|3704658|FG000|COMPLETED|Phase I: Dose Level 1||0
2988160|NCT00892177|3704659|FG001|COMPLETED|Phase I: Dose Level 1||4
2988161|NCT00892177|3704660|FG002|COMPLETED|Phase I: Dose Level 1||0
2988162|NCT00892177|3704661|FG003|COMPLETED|Phase I: Dose Level 1||0
2988163|NCT00892177|3704662|FG004|COMPLETED|Phase I: Dose Level 1||0
3304869|NCT02982863|4038448|FG003|NOT COMPLETED|Overall Study||1400
3304870|NCT02982863|4038449|FG004|NOT COMPLETED|Overall Study||492
3304871|NCT02982928|4038465|FG000|STARTED|Overall Study||11
2988164|NCT00892177|3704663|FG005|COMPLETED|Phase I: Dose Level 1||0
2988165|NCT00892177|3704658|FG000|NOT COMPLETED|Phase I: Dose Level 1||0
2988166|NCT00892177|3704659|FG001|NOT COMPLETED|Phase I: Dose Level 1||0
2988167|NCT00892177|3704660|FG002|NOT COMPLETED|Phase I: Dose Level 1||0
2988168|NCT00892177|3704661|FG003|NOT COMPLETED|Phase I: Dose Level 1||0
2988169|NCT00892177|3704662|FG004|NOT COMPLETED|Phase I: Dose Level 1||0
2988170|NCT00892177|3704663|FG005|NOT COMPLETED|Phase I: Dose Level 1||0
2988171|NCT00892177|3704658|FG000|STARTED|Phase I: Dose Level 2||0
2988172|NCT00892177|3704659|FG001|STARTED|Phase I: Dose Level 2||0
2988173|NCT00892177|3704660|FG002|STARTED|Phase I: Dose Level 2||3
2988174|NCT00892177|3704661|FG003|STARTED|Phase I: Dose Level 2||0
2988175|NCT00892177|3704662|FG004|STARTED|Phase I: Dose Level 2||0
2988176|NCT00892177|3704663|FG005|STARTED|Phase I: Dose Level 2||0
2988177|NCT00892177|3704658|FG000|COMPLETED|Phase I: Dose Level 2||0
2988178|NCT00892177|3704659|FG001|COMPLETED|Phase I: Dose Level 2||0
2988179|NCT00892177|3704660|FG002|COMPLETED|Phase I: Dose Level 2||3
2988180|NCT00892177|3704661|FG003|COMPLETED|Phase I: Dose Level 2||0
2988181|NCT00892177|3704662|FG004|COMPLETED|Phase I: Dose Level 2||0
2988182|NCT00892177|3704663|FG005|COMPLETED|Phase I: Dose Level 2||0
2988183|NCT00892177|3704658|FG000|NOT COMPLETED|Phase I: Dose Level 2||0
2988184|NCT00892177|3704659|FG001|NOT COMPLETED|Phase I: Dose Level 2||0
2988185|NCT00892177|3704660|FG002|NOT COMPLETED|Phase I: Dose Level 2||0
2988186|NCT00892177|3704661|FG003|NOT COMPLETED|Phase I: Dose Level 2||0
2988187|NCT00892177|3704662|FG004|NOT COMPLETED|Phase I: Dose Level 2||0
2988188|NCT00892177|3704663|FG005|NOT COMPLETED|Phase I: Dose Level 2||0
2988189|NCT00892177|3704658|FG000|STARTED|Phase I: Dose Level 3||0
2988190|NCT00892177|3704659|FG001|STARTED|Phase I: Dose Level 3||0
2988191|NCT00892177|3704660|FG002|STARTED|Phase I: Dose Level 3||0
2988192|NCT00892177|3704661|FG003|STARTED|Phase I: Dose Level 3||6
2988193|NCT00892177|3704662|FG004|STARTED|Phase I: Dose Level 3||0
2988194|NCT00892177|3704663|FG005|STARTED|Phase I: Dose Level 3||0
2988195|NCT00892177|3704658|FG000|COMPLETED|Phase I: Dose Level 3||0
2988196|NCT00892177|3704659|FG001|COMPLETED|Phase I: Dose Level 3||0
2988197|NCT00892177|3704660|FG002|COMPLETED|Phase I: Dose Level 3||0
2988198|NCT00892177|3704661|FG003|COMPLETED|Phase I: Dose Level 3||6
2988199|NCT00892177|3704662|FG004|COMPLETED|Phase I: Dose Level 3||0
2988200|NCT00892177|3704663|FG005|COMPLETED|Phase I: Dose Level 3||0
2988201|NCT00892177|3704658|FG000|NOT COMPLETED|Phase I: Dose Level 3||0
2988202|NCT00892177|3704659|FG001|NOT COMPLETED|Phase I: Dose Level 3||0
2988203|NCT00892177|3704660|FG002|NOT COMPLETED|Phase I: Dose Level 3||0
2988204|NCT00892177|3704661|FG003|NOT COMPLETED|Phase I: Dose Level 3||0
2988205|NCT00892177|3704662|FG004|NOT COMPLETED|Phase I: Dose Level 3||0
2988206|NCT00892177|3704663|FG005|NOT COMPLETED|Phase I: Dose Level 3||0
3164420|NCT01892189|3891780|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0
3164421|NCT01892189|3891781|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||0
3164422|NCT01892189|3891782|FG004|NOT COMPLETED|Washout Period 2 (7 Days)||0
3164423|NCT01892189|3891783|FG005|NOT COMPLETED|Washout Period 2 (7 Days)||0
3164424|NCT01892189|3891784|FG006|NOT COMPLETED|Washout Period 2 (7 Days)||0
3164425|NCT01892189|3891785|FG007|NOT COMPLETED|Washout Period 2 (7 Days)||0
3164426|NCT01892189|3891786|FG008|NOT COMPLETED|Washout Period 2 (7 Days)||0
3164427|NCT01892189|3891778|FG000|STARTED|Third Intervention Period (1 Day)||3
3164428|NCT01892189|3891779|FG001|STARTED|Third Intervention Period (1 Day)||3
3164429|NCT01892189|3891780|FG002|STARTED|Third Intervention Period (1 Day)||1
3164430|NCT01892189|3891781|FG003|STARTED|Third Intervention Period (1 Day)||2
2988207|NCT00892177|3704658|FG000|STARTED|Phase II||0
2988208|NCT00892177|3704659|FG001|STARTED|Phase II||0
2988209|NCT00892177|3704660|FG002|STARTED|Phase II||0
2988210|NCT00892177|3704661|FG003|STARTED|Phase II||0
2988211|NCT00892177|3704662|FG004|STARTED|Phase II||88
2988212|NCT00892177|3704663|FG005|STARTED|Phase II||40
2988213|NCT00892177|3704658|FG000|COMPLETED|Phase II||0
2988214|NCT00892177|3704659|FG001|COMPLETED|Phase II||0
2988215|NCT00892177|3704660|FG002|COMPLETED|Phase II||0
2988216|NCT00892177|3704661|FG003|COMPLETED|Phase II||0
2988217|NCT00892177|3704662|FG004|COMPLETED|Phase II||83
2988218|NCT00892177|3704663|FG005|COMPLETED|Phase II||38
2988219|NCT00892177|3704658|FG000|NOT COMPLETED|Phase II||0
2988220|NCT00892177|3704659|FG001|NOT COMPLETED|Phase II||0
2988221|NCT00892177|3704660|FG002|NOT COMPLETED|Phase II||0
2988222|NCT00892177|3704661|FG003|NOT COMPLETED|Phase II||0
2988223|NCT00892177|3704662|FG004|NOT COMPLETED|Phase II||5
2988224|NCT00892177|3704663|FG005|NOT COMPLETED|Phase II||2
2988225|NCT00892281|3704680|FG000|STARTED|Overall Study||1197
2988226|NCT00892281|3704681|FG001|STARTED|Overall Study||224
2988227|NCT00892281|3704680|FG000|COMPLETED|Overall Study||930
2988228|NCT00892281|3704681|FG001|COMPLETED|Overall Study||187
2988229|NCT00892281|3704680|FG000|NOT COMPLETED|Overall Study||267
2988230|NCT00892281|3704681|FG001|NOT COMPLETED|Overall Study||37
2988231|NCT00892437|3704689|FG000|STARTED|Randomized Phase||56
2988232|NCT00892437|3704690|FG001|STARTED|Randomized Phase||29
2988233|NCT00892437|3704689|FG000|Randomized and Treated|Randomized Phase||50
2988234|NCT00892437|3704690|FG001|Randomized and Treated|Randomized Phase||29
2988235|NCT00892437|3704689|FG000|COMPLETED|Randomized Phase||45
2988236|NCT00892437|3704690|FG001|COMPLETED|Randomized Phase||24
2988237|NCT00892437|3704689|FG000|NOT COMPLETED|Randomized Phase||11
2988238|NCT00892437|3704690|FG001|NOT COMPLETED|Randomized Phase||5
2988239|NCT00892437|3704689|FG000|STARTED|Open-Label Extension Phase|1 participant completed the randomized phase but did not enter the open-label extension phase.|44
2988240|NCT00892437|3704690|FG001|STARTED|Open-Label Extension Phase|5 participants completed the randomized phase but did not enter the open-label extension phase.|19
2988241|NCT00892437|3704689|FG000|COMPLETED|Open-Label Extension Phase||32
2988242|NCT00892437|3704690|FG001|COMPLETED|Open-Label Extension Phase||15
2988243|NCT00892437|3704689|FG000|NOT COMPLETED|Open-Label Extension Phase||12
2988244|NCT00892437|3704690|FG001|NOT COMPLETED|Open-Label Extension Phase||4
2988245|NCT00892606|3704699|FG000|STARTED|Overall Study||38
2988246|NCT00892606|3704700|FG001|STARTED|Overall Study||37
3164431|NCT01892189|3891782|FG004|STARTED|Third Intervention Period (1 Day)||3
3164432|NCT01892189|3891783|FG005|STARTED|Third Intervention Period (1 Day)||2
2988247|NCT00892606|3704699|FG000|COMPLETED|Overall Study||33
2988248|NCT00892606|3704700|FG001|COMPLETED|Overall Study||33
2988249|NCT00892606|3704699|FG000|NOT COMPLETED|Overall Study||5
2988250|NCT00892606|3704700|FG001|NOT COMPLETED|Overall Study||4
2988251|NCT00892697|3704706|FG000|STARTED|Overall Study||15
2988252|NCT00892697|3704706|FG000|COMPLETED|Overall Study||15
2988253|NCT00892697|3704706|FG000|NOT COMPLETED|Overall Study||0
2988254|NCT00892710|3704714|FG000|STARTED|Overall Study||48
2988255|NCT00892710|3704715|FG001|STARTED|Overall Study||59
2988256|NCT00892710|3704716|FG002|STARTED|Overall Study||55
2988257|NCT00892710|3704714|FG000|COMPLETED|Overall Study|Patients remained on study until disease progression or intolerable toxicity occurred|0
2988258|NCT00892710|3704715|FG001|COMPLETED|Overall Study|Patients remained on study until disease progression or intolerable toxicity occurred|0
2988259|NCT00892710|3704716|FG002|COMPLETED|Overall Study|Patients remained on study until disease progression or intolerable toxicity occurred|0
2988260|NCT00892710|3704714|FG000|NOT COMPLETED|Overall Study||48
2988261|NCT00892710|3704715|FG001|NOT COMPLETED|Overall Study||59
2988262|NCT00892710|3704716|FG002|NOT COMPLETED|Overall Study||55
2988263|NCT00892723|3704727|FG000|STARTED|Overall Study||21
2988264|NCT00892723|3704728|FG001|STARTED|Overall Study||19
2988265|NCT00892723|3704729|FG002|STARTED|Overall Study||19
2988266|NCT00892723|3704727|FG000|COMPLETED|Overall Study||19
2988267|NCT00892723|3704728|FG001|COMPLETED|Overall Study||15
2988268|NCT00892723|3704729|FG002|COMPLETED|Overall Study||17
2988269|NCT00892723|3704727|FG000|NOT COMPLETED|Overall Study||2
2988270|NCT00892723|3704728|FG001|NOT COMPLETED|Overall Study||4
2988271|NCT00892723|3704729|FG002|NOT COMPLETED|Overall Study||2
2988272|NCT00892775|3704772|FG000|STARTED|Overall Study||332
2988273|NCT00892775|3704773|FG001|STARTED|Overall Study||166
2988274|NCT00892775|3704772|FG000|COMPLETED|Overall Study||327
2988275|NCT00892775|3704773|FG001|COMPLETED|Overall Study||165
2988276|NCT00892775|3704772|FG000|NOT COMPLETED|Overall Study||5
2988277|NCT00892775|3704773|FG001|NOT COMPLETED|Overall Study||1
3133527|NCT01696279|3858509|FG001|COMPLETED|Part 1: Single Dose Lanthanum Carbonate||0
3133528|NCT01696279|3858510|FG002|COMPLETED|Part 1: Single Dose Lanthanum Carbonate||0
3133529|NCT01696279|3858511|FG003|COMPLETED|Part 1: Single Dose Lanthanum Carbonate||0
3133530|NCT01696279|3858508|FG000|NOT COMPLETED|Part 1: Single Dose Lanthanum Carbonate||1
3133531|NCT01696279|3858509|FG001|NOT COMPLETED|Part 1: Single Dose Lanthanum Carbonate||0
2988278|NCT00892957|3704781|FG000|STARTED|Intraoperative Day 0||70
2988279|NCT00892957|3704782|FG001|STARTED|Intraoperative Day 0||70
2988280|NCT00892957|3704781|FG000|COMPLETED|Intraoperative Day 0||70
2988281|NCT00892957|3704782|FG001|COMPLETED|Intraoperative Day 0||70
2988282|NCT00892957|3704781|FG000|NOT COMPLETED|Intraoperative Day 0||0
2988283|NCT00892957|3704782|FG001|NOT COMPLETED|Intraoperative Day 0||0
2988284|NCT00892957|3704781|FG000|STARTED|Postoperative Day 1 Assessment||70
2988285|NCT00892957|3704782|FG001|STARTED|Postoperative Day 1 Assessment||70
2988286|NCT00892957|3704781|FG000|COMPLETED|Postoperative Day 1 Assessment||70
2988287|NCT00892957|3704782|FG001|COMPLETED|Postoperative Day 1 Assessment||70
2988288|NCT00892957|3704781|FG000|NOT COMPLETED|Postoperative Day 1 Assessment||0
2988289|NCT00892957|3704782|FG001|NOT COMPLETED|Postoperative Day 1 Assessment||0
2988290|NCT00892957|3704781|FG000|STARTED|Between Postoperative Day 1 and Day 14||70
2988291|NCT00892957|3704782|FG001|STARTED|Between Postoperative Day 1 and Day 14||70
2988292|NCT00892957|3704781|FG000|COMPLETED|Between Postoperative Day 1 and Day 14||70
2988293|NCT00892957|3704782|FG001|COMPLETED|Between Postoperative Day 1 and Day 14||66
2988294|NCT00892957|3704781|FG000|NOT COMPLETED|Between Postoperative Day 1 and Day 14||0
2988295|NCT00892957|3704782|FG001|NOT COMPLETED|Between Postoperative Day 1 and Day 14||4
2988296|NCT00892957|3704781|FG000|STARTED|Postoperative Day 14 Assessment|Two participants missed postoperative Day 14 assessment, both returned for Day 30 postop assessment|68
2988297|NCT00892957|3704782|FG001|STARTED|Postoperative Day 14 Assessment||66
2988298|NCT00892957|3704781|FG000|COMPLETED|Postoperative Day 14 Assessment||68
2988299|NCT00892957|3704782|FG001|COMPLETED|Postoperative Day 14 Assessment||66
2988300|NCT00892957|3704781|FG000|NOT COMPLETED|Postoperative Day 14 Assessment||0
2988301|NCT00892957|3704782|FG001|NOT COMPLETED|Postoperative Day 14 Assessment||0
2988302|NCT00892957|3704781|FG000|STARTED|Postoperative Day 30 Assessment|Two participants missed postoperative Day 14 assessment, both returned for Day 30 postop assessment|70
2988303|NCT00892957|3704782|FG001|STARTED|Postoperative Day 30 Assessment||66
2988304|NCT00892957|3704781|FG000|COMPLETED|Postoperative Day 30 Assessment||70
2988305|NCT00892957|3704782|FG001|COMPLETED|Postoperative Day 30 Assessment||66
2988306|NCT00892957|3704781|FG000|NOT COMPLETED|Postoperative Day 30 Assessment||0
2988307|NCT00892957|3704782|FG001|NOT COMPLETED|Postoperative Day 30 Assessment||0
2988308|NCT00893074|3704802|FG000|STARTED|Overall Study||24
2988309|NCT00893074|3704802|FG000|COMPLETED|Overall Study||13
2988310|NCT00893074|3704802|FG000|NOT COMPLETED|Overall Study||11
2988311|NCT00893113|3704819|FG000|STARTED|Overall Study||36
2988312|NCT00893113|3704820|FG001|STARTED|Overall Study||38
2988313|NCT00893113|3704819|FG000|COMPLETED|Overall Study||23
2988314|NCT00893113|3704820|FG001|COMPLETED|Overall Study||22
2988315|NCT00893113|3704819|FG000|NOT COMPLETED|Overall Study||13
2988316|NCT00893113|3704820|FG001|NOT COMPLETED|Overall Study||16
2988317|NCT00893152|3704828|FG000|STARTED|Overall Study||47
2988318|NCT00893152|3704829|FG001|STARTED|Overall Study||36
2988319|NCT00893152|3704828|FG000|COMPLETED|Overall Study||47
2988320|NCT00893152|3704829|FG001|COMPLETED|Overall Study||36
2988321|NCT00893152|3704828|FG000|NOT COMPLETED|Overall Study||0
2988322|NCT00893152|3704829|FG001|NOT COMPLETED|Overall Study||0
2988323|NCT00893464|3704843|FG000|STARTED|Overall Study||1
2988324|NCT00893464|3704844|FG001|STARTED|Overall Study||1
2988325|NCT00893464|3704845|FG002|STARTED|Overall Study||1
2988326|NCT00893464|3704846|FG003|STARTED|Overall Study||1
2988327|NCT00893464|3704847|FG004|STARTED|Overall Study||4
2988328|NCT00893464|3704848|FG005|STARTED|Overall Study||7
2988329|NCT00893464|3704849|FG006|STARTED|Overall Study||10
2988330|NCT00893464|3704850|FG007|STARTED|Overall Study||5
2988331|NCT00893464|3704843|FG000|COMPLETED|Overall Study||1
2988332|NCT00893464|3704844|FG001|COMPLETED|Overall Study||1
2988333|NCT00893464|3704845|FG002|COMPLETED|Overall Study||1
2988334|NCT00893464|3704846|FG003|COMPLETED|Overall Study||1
2988335|NCT00893464|3704847|FG004|COMPLETED|Overall Study||4
2988336|NCT00893464|3704848|FG005|COMPLETED|Overall Study||7
2988337|NCT00893464|3704849|FG006|COMPLETED|Overall Study||8
2988338|NCT00893464|3704850|FG007|COMPLETED|Overall Study||3
2988339|NCT00893464|3704843|FG000|NOT COMPLETED|Overall Study||0
2988340|NCT00893464|3704844|FG001|NOT COMPLETED|Overall Study||0
2988341|NCT00893464|3704845|FG002|NOT COMPLETED|Overall Study||0
2988342|NCT00893464|3704846|FG003|NOT COMPLETED|Overall Study||0
2988343|NCT00893464|3704847|FG004|NOT COMPLETED|Overall Study||0
2988344|NCT00893464|3704848|FG005|NOT COMPLETED|Overall Study||0
2988345|NCT00893464|3704849|FG006|NOT COMPLETED|Overall Study||2
2988346|NCT00893464|3704850|FG007|NOT COMPLETED|Overall Study||2
2988347|NCT00893737|3704873|FG000|STARTED|Overall Study||147
2988348|NCT00893737|3704873|FG000|COMPLETED|Overall Study||135
2988349|NCT00893737|3704873|FG000|NOT COMPLETED|Overall Study||12
2988350|NCT00893763|3704879|FG000|STARTED|Overall Study||157
2988351|NCT00893763|3704880|FG001|STARTED|Overall Study||157
2988352|NCT00893763|3704879|FG000|COMPLETED|Overall Study||47
2988353|NCT00893763|3704880|FG001|COMPLETED|Overall Study||47
2988354|NCT00893763|3704879|FG000|NOT COMPLETED|Overall Study||110
2988355|NCT00893763|3704880|FG001|NOT COMPLETED|Overall Study||110
2988356|NCT00893971|3704888|FG000|STARTED|Overall Study||16
2988357|NCT00893971|3704888|FG000|Placebo + GP MDI (PT001)|Overall Study||15
2988358|NCT00893971|3704888|FG000|Placebo + GFF MDI (PT003)|Overall Study||15
2988359|NCT00893971|3704888|FG000|Placebo + FF MDI (PT005)|Overall Study||13
2988360|NCT00893971|3704888|FG000|GP MDI (PT001) + FF MDI (PT005)|Overall Study||16
2988361|NCT00893971|3704888|FG000|COMPLETED|Overall Study||13
2988362|NCT00893971|3704888|FG000|NOT COMPLETED|Overall Study||3
2988363|NCT00893984|3704901|FG000|STARTED|Overall Study||6
2988364|NCT00893984|3704901|FG000|COMPLETED|Overall Study||0
2988365|NCT00893984|3704901|FG000|NOT COMPLETED|Overall Study||6
2988366|NCT00893997|3704905|FG000|STARTED|Overall Study||10
2988367|NCT00893997|3704905|FG000|COMPLETED|Overall Study||10
2988368|NCT00893997|3704905|FG000|NOT COMPLETED|Overall Study||0
2988369|NCT00894127|3704909|FG000|STARTED|Overall Study||128
2988370|NCT00894127|3704909|FG000|COMPLETED|Overall Study||128
2988371|NCT00894127|3704909|FG000|NOT COMPLETED|Overall Study||0
2988372|NCT00894166|3704921|FG000|STARTED|Overall Study||132
2988373|NCT00894166|3704922|FG001|STARTED|Overall Study||109
2988374|NCT00894166|3704923|FG002|STARTED|Overall Study||112
2988375|NCT00894166|3704924|FG003|STARTED|Overall Study||114
2988376|NCT00894166|3704925|FG004|STARTED|Overall Study||34
2988377|NCT00894166|3704926|FG005|STARTED|Overall Study||36
2988378|NCT00894166|3704927|FG006|STARTED|Overall Study||35
2988379|NCT00894166|3704928|FG007|STARTED|Overall Study||34
2988380|NCT00894166|3704921|FG000|COMPLETED|Overall Study||71
2988381|NCT00894166|3704922|FG001|COMPLETED|Overall Study||46
2988382|NCT00894166|3704923|FG002|COMPLETED|Overall Study||50
2988383|NCT00894166|3704924|FG003|COMPLETED|Overall Study||45
2988384|NCT00894166|3704925|FG004|COMPLETED|Overall Study||10
2988385|NCT00894166|3704926|FG005|COMPLETED|Overall Study||20
2988386|NCT00894166|3704927|FG006|COMPLETED|Overall Study||19
2988387|NCT00894166|3704928|FG007|COMPLETED|Overall Study||0
2988388|NCT00894166|3704921|FG000|NOT COMPLETED|Overall Study||61
2988389|NCT00894166|3704922|FG001|NOT COMPLETED|Overall Study||63
2988390|NCT00894166|3704923|FG002|NOT COMPLETED|Overall Study||62
2988391|NCT00894166|3704924|FG003|NOT COMPLETED|Overall Study||69
2988392|NCT00894166|3704925|FG004|NOT COMPLETED|Overall Study||24
2988393|NCT00894166|3704926|FG005|NOT COMPLETED|Overall Study||16
2988394|NCT00894166|3704927|FG006|NOT COMPLETED|Overall Study||16
2988395|NCT00894166|3704928|FG007|NOT COMPLETED|Overall Study||34
2988396|NCT00894322|3704954|FG000|STARTED|Overall Study||30
2988397|NCT00894322|3704955|FG001|STARTED|Overall Study||23
2988398|NCT00894322|3704956|FG002|STARTED|Overall Study||12
2988399|NCT00894322|3704954|FG000|COMPLETED|Overall Study||29
2988400|NCT00894322|3704955|FG001|COMPLETED|Overall Study||23
2988401|NCT00894322|3704956|FG002|COMPLETED|Overall Study||12
2988402|NCT00894322|3704954|FG000|NOT COMPLETED|Overall Study||1
2988403|NCT00894322|3704955|FG001|NOT COMPLETED|Overall Study||0
2988404|NCT00894322|3704956|FG002|NOT COMPLETED|Overall Study||0
2988405|NCT00894361|3704968|FG000|STARTED|Overall Study||200
2988406|NCT00894361|3704969|FG001|STARTED|Overall Study||200
2988407|NCT00894361|3704968|FG000|COMPLETED|Overall Study||176
2988408|NCT00894361|3704969|FG001|COMPLETED|Overall Study||136
2988409|NCT00894361|3704968|FG000|NOT COMPLETED|Overall Study||24
2988410|NCT00894361|3704969|FG001|NOT COMPLETED|Overall Study||64
2988411|NCT00894387|3704979|FG000|STARTED|Overall Study|"Started indicates all randomized patients"|821
2988412|NCT00894387|3704980|FG001|STARTED|Overall Study||818
2988413|NCT00894387|3704979|FG000|Safety Set|Overall Study||808
2988414|NCT00894387|3704980|FG001|Safety Set|Overall Study||810
2988415|NCT00894387|3704979|FG000|Full Analysis Set|Overall Study||808
2988416|NCT00894387|3704980|FG001|Full Analysis Set|Overall Study||807
2988417|NCT00894387|3704979|FG000|Completed Primary Efficacy Phase (6 m)|Overall Study||717
2988418|NCT00894387|3704980|FG001|Completed Primary Efficacy Phase (6 m)|Overall Study||707
2988419|NCT00894387|3704979|FG000|Completed Secondary Efficacy Phase (12m)|Overall Study||654
2988420|NCT00894387|3704980|FG001|Completed Secondary Efficacy Phase (12m)|Overall Study||640
2988421|NCT00894387|3704979|FG000|COMPLETED|Overall Study|"Completed indicates patients whose treatment duration completed as per protocol"|646
2988422|NCT00894387|3704980|FG001|COMPLETED|Overall Study||643
2988423|NCT00894387|3704979|FG000|NOT COMPLETED|Overall Study||175
2988424|NCT00894387|3704980|FG001|NOT COMPLETED|Overall Study||175
2988425|NCT00894413|3704988|FG000|STARTED|Overall Study||15
2988426|NCT00894413|3704989|FG001|STARTED|Overall Study||25
2988427|NCT00894413|3704988|FG000|COMPLETED|Overall Study||15
2988428|NCT00894413|3704989|FG001|COMPLETED|Overall Study||17
2988429|NCT00894413|3704988|FG000|NOT COMPLETED|Overall Study||0
2988430|NCT00894413|3704989|FG001|NOT COMPLETED|Overall Study||8
2988431|NCT00894465|3704997|FG000|STARTED|Overall Study||22
2988432|NCT00894465|3704998|FG001|STARTED|Overall Study||22
2988433|NCT00894465|3704997|FG000|COMPLETED|Overall Study||22
2988434|NCT00894465|3704998|FG001|COMPLETED|Overall Study||22
2988435|NCT00894465|3704997|FG000|NOT COMPLETED|Overall Study||0
2988436|NCT00894465|3704998|FG001|NOT COMPLETED|Overall Study||0
2988437|NCT00894504|3705006|FG000|STARTED|Overall Study||71
2988438|NCT00894504|3705006|FG000|COMPLETED|Overall Study||0
2988439|NCT00894504|3705006|FG000|NOT COMPLETED|Overall Study||71
2988440|NCT00894517|3705022|FG000|STARTED|Overall Study||30
2988441|NCT00894517|3705023|FG001|STARTED|Overall Study||31
2988442|NCT00894517|3705022|FG000|COMPLETED|Overall Study||28
2988443|NCT00894517|3705023|FG001|COMPLETED|Overall Study||26
2988444|NCT00894517|3705022|FG000|NOT COMPLETED|Overall Study||2
2988445|NCT00894517|3705023|FG001|NOT COMPLETED|Overall Study||5
3133532|NCT01696279|3858510|FG002|NOT COMPLETED|Part 1: Single Dose Lanthanum Carbonate||0
3133533|NCT01696279|3858511|FG003|NOT COMPLETED|Part 1: Single Dose Lanthanum Carbonate||0
3133534|NCT01696279|3858508|FG000|STARTED|Part 2a: Calcium Carbonate + Lanthanum||0
2988446|NCT00894543|3705031|FG000|STARTED|Baseline||104
2988447|NCT00894543|3705032|FG001|STARTED|Baseline||101
2988448|NCT00894543|3705031|FG000|COMPLETED|Baseline||104
2988449|NCT00894543|3705032|FG001|COMPLETED|Baseline||101
2988450|NCT00894543|3705031|FG000|NOT COMPLETED|Baseline||0
2988451|NCT00894543|3705032|FG001|NOT COMPLETED|Baseline||0
2988452|NCT00894543|3705031|FG000|STARTED|Baseline to Week 4||104
2988453|NCT00894543|3705032|FG001|STARTED|Baseline to Week 4||101
2988454|NCT00894543|3705031|FG000|COMPLETED|Baseline to Week 4||101
2988455|NCT00894543|3705032|FG001|COMPLETED|Baseline to Week 4||99
2988456|NCT00894543|3705031|FG000|NOT COMPLETED|Baseline to Week 4||3
2988457|NCT00894543|3705032|FG001|NOT COMPLETED|Baseline to Week 4||2
2988458|NCT00894543|3705031|FG000|STARTED|Week 4 to Week 8||101
2988459|NCT00894543|3705032|FG001|STARTED|Week 4 to Week 8||99
2988460|NCT00894543|3705031|FG000|COMPLETED|Week 4 to Week 8||97
2988461|NCT00894543|3705032|FG001|COMPLETED|Week 4 to Week 8||97
2988462|NCT00894543|3705031|FG000|NOT COMPLETED|Week 4 to Week 8||4
2988463|NCT00894543|3705032|FG001|NOT COMPLETED|Week 4 to Week 8||2
2988464|NCT00894647|3705040|FG000|STARTED|Overall Study||121
2988465|NCT00894647|3705041|FG001|STARTED|Overall Study||126
2988466|NCT00894647|3705040|FG000|COMPLETED|Overall Study||111
2988467|NCT00894647|3705041|FG001|COMPLETED|Overall Study||112
2988468|NCT00894647|3705040|FG000|NOT COMPLETED|Overall Study||10
2988469|NCT00894647|3705041|FG001|NOT COMPLETED|Overall Study||14
2988470|NCT00894686|3705047|FG000|STARTED|Overall Study||179
2988471|NCT00894686|3705047|FG000|COMPLETED|Overall Study||123
2988472|NCT00894686|3705047|FG000|NOT COMPLETED|Overall Study||56
2988473|NCT00894699|3705053|FG000|STARTED|Overall Study||21
2988474|NCT00894699|3705054|FG001|STARTED|Overall Study||19
2988475|NCT00894699|3705053|FG000|COMPLETED|Overall Study||21
2988476|NCT00894699|3705054|FG001|COMPLETED|Overall Study||19
2988477|NCT00894699|3705053|FG000|NOT COMPLETED|Overall Study||0
2988478|NCT00894699|3705054|FG001|NOT COMPLETED|Overall Study||0
2988479|NCT00894738|3705062|FG000|STARTED|Overall Study||25
2988480|NCT00894738|3705063|FG001|STARTED|Overall Study||19
2988481|NCT00894738|3705062|FG000|COMPLETED|Overall Study||25
2988482|NCT00894738|3705063|FG001|COMPLETED|Overall Study||19
2988483|NCT00894738|3705062|FG000|NOT COMPLETED|Overall Study||0
3133535|NCT01696279|3858509|FG001|STARTED|Part 2a: Calcium Carbonate + Lanthanum|19 participants enrolled from Part 1 and 34 new participants enrolled in Part 2a|53
3133536|NCT01696279|3858510|FG002|STARTED|Part 2a: Calcium Carbonate + Lanthanum||0
3133537|NCT01696279|3858511|FG003|STARTED|Part 2a: Calcium Carbonate + Lanthanum||0
3133538|NCT01696279|3858508|FG000|Safety Completer Set|Part 2a: Calcium Carbonate + Lanthanum||0
2988484|NCT00894738|3705063|FG001|NOT COMPLETED|Overall Study||0
2988485|NCT00894803|3705071|FG000|STARTED|Overall Study||101
2988486|NCT00894803|3705072|FG001|STARTED|Overall Study||25
2988487|NCT00894803|3705071|FG000|COMPLETED|Overall Study||81
2988488|NCT00894803|3705072|FG001|COMPLETED|Overall Study||20
2988489|NCT00894803|3705071|FG000|NOT COMPLETED|Overall Study||20
2988490|NCT00894803|3705072|FG001|NOT COMPLETED|Overall Study||5
2988491|NCT00894933|3705078|FG000|STARTED|Overall Study||33
2988492|NCT00894933|3705078|FG000|COMPLETED|Overall Study||29
2988493|NCT00894933|3705078|FG000|NOT COMPLETED|Overall Study||4
2988494|NCT00895011|3705085|FG000|STARTED|Overall Study||100
2988495|NCT00895011|3705086|FG001|STARTED|Overall Study||99
2988496|NCT00895011|3705087|FG002|STARTED|Overall Study||99
2988497|NCT00895011|3705085|FG000|COMPLETED|Overall Study||76
2988498|NCT00895011|3705086|FG001|COMPLETED|Overall Study||85
2988499|NCT00895011|3705087|FG002|COMPLETED|Overall Study||91
2988500|NCT00895011|3705085|FG000|NOT COMPLETED|Overall Study||24
2988501|NCT00895011|3705086|FG001|NOT COMPLETED|Overall Study||14
2988502|NCT00895011|3705087|FG002|NOT COMPLETED|Overall Study||8
3036618|NCT01144364|3755899|FG002|STARTED|Induction Phase||0
3036619|NCT01144364|3755897|FG000|COMPLETED|Induction Phase||202
3036620|NCT01144364|3755898|FG001|COMPLETED|Induction Phase||0
3036621|NCT01144364|3755899|FG002|COMPLETED|Induction Phase||0
3036622|NCT01144364|3755897|FG000|NOT COMPLETED|Induction Phase||32
3036623|NCT01144364|3755898|FG001|NOT COMPLETED|Induction Phase||0
3036624|NCT01144364|3755899|FG002|NOT COMPLETED|Induction Phase||0
3036625|NCT01144364|3755897|FG000|STARTED|Follow-Up/Maintenance Phase||0
3036626|NCT01144364|3755898|FG001|STARTED|Follow-Up/Maintenance Phase||101
3036627|NCT01144364|3755899|FG002|STARTED|Follow-Up/Maintenance Phase||101
3036628|NCT01144364|3755897|FG000|COMPLETED|Follow-Up/Maintenance Phase||0
3036629|NCT01144364|3755898|FG001|COMPLETED|Follow-Up/Maintenance Phase||66
3036630|NCT01144364|3755899|FG002|COMPLETED|Follow-Up/Maintenance Phase||60
3036631|NCT01144364|3755897|FG000|NOT COMPLETED|Follow-Up/Maintenance Phase||0
3036632|NCT01144364|3755898|FG001|NOT COMPLETED|Follow-Up/Maintenance Phase||35
3036633|NCT01144364|3755899|FG002|NOT COMPLETED|Follow-Up/Maintenance Phase||41
3036634|NCT01144377|3755914|FG000|STARTED|52 Week Treatment Period||31
3036635|NCT01144377|3755915|FG001|STARTED|52 Week Treatment Period||30
3036636|NCT01144377|3755916|FG002|STARTED|52 Week Treatment Period||30
3036637|NCT01144377|3755917|FG003|STARTED|52 Week Treatment Period||26
3036638|NCT01144377|3755918|FG004|STARTED|52 Week Treatment Period||37
3036639|NCT01144377|3755914|FG000|Received at Least One Dose of Study Drug|52 Week Treatment Period||31
3036640|NCT01144377|3755915|FG001|Received at Least One Dose of Study Drug|52 Week Treatment Period||30
3036641|NCT01144377|3755916|FG002|Received at Least One Dose of Study Drug|52 Week Treatment Period||30
3036642|NCT01144377|3755917|FG003|Received at Least One Dose of Study Drug|52 Week Treatment Period||25
3036643|NCT01144377|3755918|FG004|Received at Least One Dose of Study Drug|52 Week Treatment Period||37
3036644|NCT01144377|3755914|FG000|COMPLETED|52 Week Treatment Period||26
3036645|NCT01144377|3755915|FG001|COMPLETED|52 Week Treatment Period||29
3036646|NCT01144377|3755916|FG002|COMPLETED|52 Week Treatment Period||25
3036647|NCT01144377|3755917|FG003|COMPLETED|52 Week Treatment Period||22
3036648|NCT01144377|3755918|FG004|COMPLETED|52 Week Treatment Period||34
3036649|NCT01144377|3755914|FG000|NOT COMPLETED|52 Week Treatment Period||5
3036650|NCT01144377|3755915|FG001|NOT COMPLETED|52 Week Treatment Period||1
3036651|NCT01144377|3755916|FG002|NOT COMPLETED|52 Week Treatment Period||5
3036652|NCT01144377|3755917|FG003|NOT COMPLETED|52 Week Treatment Period||4
3036653|NCT01144377|3755918|FG004|NOT COMPLETED|52 Week Treatment Period||3
3036654|NCT01144377|3755914|FG000|STARTED|12 Week Safety Follow-up Period||26
3036655|NCT01144377|3755915|FG001|STARTED|12 Week Safety Follow-up Period||29
3036656|NCT01144377|3755916|FG002|STARTED|12 Week Safety Follow-up Period||25
3036657|NCT01144377|3755917|FG003|STARTED|12 Week Safety Follow-up Period||22
3036658|NCT01144377|3755918|FG004|STARTED|12 Week Safety Follow-up Period||34
3036659|NCT01144377|3755914|FG000|COMPLETED|12 Week Safety Follow-up Period|Of the 26 participants who completed this Period, 22 continued to the Optional 40 Week follow-up.|26
3036660|NCT01144377|3755915|FG001|COMPLETED|12 Week Safety Follow-up Period|Of the 29 participants who completed this Period, 25 continued to the Optional 40 Week follow-up.|29
3036661|NCT01144377|3755916|FG002|COMPLETED|12 Week Safety Follow-up Period|Of the 25 participants who completed this Period, 23 continued to the Optional 40 Week follow-up.|25
3036662|NCT01144377|3755917|FG003|COMPLETED|12 Week Safety Follow-up Period|Of the 22 participants who completed this Period, 3 continued to the Optional 40 Week follow-up.|22
3036663|NCT01144377|3755918|FG004|COMPLETED|12 Week Safety Follow-up Period|Of the 34 participants who completed this Period, 23 continued to the Optional 40 Week follow-up.|34
3036664|NCT01144377|3755914|FG000|NOT COMPLETED|12 Week Safety Follow-up Period||0
3036665|NCT01144377|3755915|FG001|NOT COMPLETED|12 Week Safety Follow-up Period||0
3036666|NCT01144377|3755916|FG002|NOT COMPLETED|12 Week Safety Follow-up Period||0
3036667|NCT01144377|3755917|FG003|NOT COMPLETED|12 Week Safety Follow-up Period||0
3036668|NCT01144377|3755918|FG004|NOT COMPLETED|12 Week Safety Follow-up Period||0
3036669|NCT01144377|3755914|FG000|STARTED|Optional 40 Week Safety Follow-up Period||22
3036670|NCT01144377|3755915|FG001|STARTED|Optional 40 Week Safety Follow-up Period||25
3036671|NCT01144377|3755916|FG002|STARTED|Optional 40 Week Safety Follow-up Period||23
3036672|NCT01144377|3755917|FG003|STARTED|Optional 40 Week Safety Follow-up Period||3
3036673|NCT01144377|3755918|FG004|STARTED|Optional 40 Week Safety Follow-up Period||23
3036674|NCT01144377|3755914|FG000|COMPLETED|Optional 40 Week Safety Follow-up Period||21
3036675|NCT01144377|3755915|FG001|COMPLETED|Optional 40 Week Safety Follow-up Period||24
3036676|NCT01144377|3755916|FG002|COMPLETED|Optional 40 Week Safety Follow-up Period||23
3036677|NCT01144377|3755917|FG003|COMPLETED|Optional 40 Week Safety Follow-up Period||3
3036678|NCT01144377|3755918|FG004|COMPLETED|Optional 40 Week Safety Follow-up Period||21
3036679|NCT01144377|3755914|FG000|NOT COMPLETED|Optional 40 Week Safety Follow-up Period||1
3036680|NCT01144377|3755915|FG001|NOT COMPLETED|Optional 40 Week Safety Follow-up Period||1
3036681|NCT01144377|3755916|FG002|NOT COMPLETED|Optional 40 Week Safety Follow-up Period||0
3036682|NCT01144377|3755917|FG003|NOT COMPLETED|Optional 40 Week Safety Follow-up Period||0
3036683|NCT01144377|3755918|FG004|NOT COMPLETED|Optional 40 Week Safety Follow-up Period||2
2988503|NCT00895037|3705099|FG000|STARTED|Overall Study||22
2988504|NCT00895037|3705100|FG001|STARTED|Overall Study||77
2988505|NCT00895037|3705101|FG002|STARTED|Overall Study||2
2988506|NCT00895037|3705099|FG000|COMPLETED|Overall Study||22
2988507|NCT00895037|3705100|FG001|COMPLETED|Overall Study||75
2988508|NCT00895037|3705101|FG002|COMPLETED|Overall Study||1
2988509|NCT00895037|3705099|FG000|NOT COMPLETED|Overall Study||0
2988510|NCT00895037|3705100|FG001|NOT COMPLETED|Overall Study||2
2988511|NCT00895037|3705101|FG002|NOT COMPLETED|Overall Study||1
2988512|NCT00895154|3705111|FG000|STARTED|Overall Study||8
2988513|NCT00895154|3705112|FG001|STARTED|Overall Study||10
2988514|NCT00895154|3705111|FG000|Follow Up|Overall Study||7
2988515|NCT00895154|3705112|FG001|Follow Up|Overall Study||8
2988516|NCT00895154|3705111|FG000|COMPLETED|Overall Study||7
2988517|NCT00895154|3705112|FG001|COMPLETED|Overall Study||8
2988518|NCT00895154|3705111|FG000|NOT COMPLETED|Overall Study||1
2988519|NCT00895154|3705112|FG001|NOT COMPLETED|Overall Study||2
2988520|NCT00895180|3705120|FG000|STARTED|Overall Study||40
2988521|NCT00895180|3705121|FG001|STARTED|Overall Study||40
2988522|NCT00895180|3705120|FG000|Received at Least 1 Dose of Study Drug|Overall Study||40
2988523|NCT00895180|3705121|FG001|Received at Least 1 Dose of Study Drug|Overall Study||40
2988524|NCT00895180|3705120|FG000|COMPLETED|Overall Study||40
2988525|NCT00895180|3705121|FG001|COMPLETED|Overall Study||40
2988526|NCT00895180|3705120|FG000|NOT COMPLETED|Overall Study||0
2988527|NCT00895180|3705121|FG001|NOT COMPLETED|Overall Study||0
2988528|NCT00895193|3705133|FG000|STARTED|Overall Study||25
2988529|NCT00895193|3705134|FG001|STARTED|Overall Study||25
2988530|NCT00895193|3705135|FG002|STARTED|Overall Study||25
2988531|NCT00895193|3705136|FG003|STARTED|Overall Study||25
2988532|NCT00895193|3705133|FG000|COMPLETED|Overall Study||25
2988533|NCT00895193|3705134|FG001|COMPLETED|Overall Study||25
2988534|NCT00895193|3705135|FG002|COMPLETED|Overall Study||25
2988535|NCT00895193|3705136|FG003|COMPLETED|Overall Study||25
2988536|NCT00895193|3705133|FG000|NOT COMPLETED|Overall Study||0
2988537|NCT00895193|3705134|FG001|NOT COMPLETED|Overall Study||0
2988538|NCT00895193|3705135|FG002|NOT COMPLETED|Overall Study||0
2988539|NCT00895193|3705136|FG003|NOT COMPLETED|Overall Study||0
2988540|NCT00895232|3705149|FG000|STARTED|Overall Study||7
2988541|NCT00895232|3705150|FG001|STARTED|Overall Study||6
2988542|NCT00895232|3705151|FG002|STARTED|Overall Study||8
2988543|NCT00895232|3705149|FG000|COMPLETED|Overall Study||4
2988544|NCT00895232|3705150|FG001|COMPLETED|Overall Study||2
2988545|NCT00895232|3705151|FG002|COMPLETED|Overall Study||3
2988546|NCT00895232|3705149|FG000|NOT COMPLETED|Overall Study||3
2988547|NCT00895232|3705150|FG001|NOT COMPLETED|Overall Study||4
2988548|NCT00895232|3705151|FG002|NOT COMPLETED|Overall Study||5
2988549|NCT00895245|3705159|FG000|STARTED|Overall Study||6
2988550|NCT00895245|3705159|FG000|COMPLETED|Overall Study||0
2988551|NCT00895245|3705159|FG000|NOT COMPLETED|Overall Study||6
2988552|NCT00895310|3705163|FG000|STARTED|Overall Study||30
2988553|NCT00895310|3705163|FG000|COMPLETED|Overall Study||29
2988554|NCT00895310|3705163|FG000|NOT COMPLETED|Overall Study||1
2988555|NCT00895414|3705167|FG000|STARTED|First Intervention (14 Days)||9
2988556|NCT00895414|3705168|FG001|STARTED|First Intervention (14 Days)||10
2988557|NCT00895414|3705167|FG000|COMPLETED|First Intervention (14 Days)||8
2988558|NCT00895414|3705168|FG001|COMPLETED|First Intervention (14 Days)||9
2988559|NCT00895414|3705167|FG000|NOT COMPLETED|First Intervention (14 Days)||1
2988560|NCT00895414|3705168|FG001|NOT COMPLETED|First Intervention (14 Days)||1
2988561|NCT00895414|3705167|FG000|STARTED|Second Intervention (14 Days)||8
2988562|NCT00895414|3705168|FG001|STARTED|Second Intervention (14 Days)||9
3304872|NCT02982928|4038465|FG000|COMPLETED|Overall Study||11
3304873|NCT02982928|4038465|FG000|NOT COMPLETED|Overall Study||0
3304874|NCT02982954|4038473|FG000|STARTED|Treatment Period||106
3304875|NCT02982954|4038474|FG001|STARTED|Treatment Period||52
3304876|NCT02982954|4038475|FG002|STARTED|Treatment Period||28
3304877|NCT02982954|4038476|FG003|STARTED|Treatment Period||25
3304878|NCT02982954|4038473|FG000|COMPLETED|Treatment Period||0
3304879|NCT02982954|4038474|FG001|COMPLETED|Treatment Period||0
2988563|NCT00895414|3705167|FG000|COMPLETED|Second Intervention (14 Days)||8
2988564|NCT00895414|3705168|FG001|COMPLETED|Second Intervention (14 Days)||9
2988565|NCT00895414|3705167|FG000|NOT COMPLETED|Second Intervention (14 Days)||0
2988566|NCT00895414|3705168|FG001|NOT COMPLETED|Second Intervention (14 Days)||0
2988567|NCT00895453|3705177|FG000|STARTED|Overall Study||48
2988568|NCT00895453|3705178|FG001|STARTED|Overall Study||50
2988569|NCT00895453|3705179|FG002|STARTED|Overall Study||46
2988570|NCT00895453|3705177|FG000|COMPLETED|Overall Study||23
2988571|NCT00895453|3705178|FG001|COMPLETED|Overall Study||25
2988572|NCT00895453|3705179|FG002|COMPLETED|Overall Study||23
2988573|NCT00895453|3705177|FG000|NOT COMPLETED|Overall Study||25
2988574|NCT00895453|3705178|FG001|NOT COMPLETED|Overall Study||25
3304880|NCT02982954|4038475|FG002|COMPLETED|Treatment Period||0
3304881|NCT02982954|4038476|FG003|COMPLETED|Treatment Period||0
2988575|NCT00895453|3705179|FG002|NOT COMPLETED|Overall Study||23
2988576|NCT00895531|3705189|FG000|STARTED|Overall Study||38
2988577|NCT00895531|3705190|FG001|STARTED|Overall Study||37
2988578|NCT00895531|3705189|FG000|COMPLETED|Overall Study||38
2988579|NCT00895531|3705190|FG001|COMPLETED|Overall Study||37
2988580|NCT00895531|3705189|FG000|NOT COMPLETED|Overall Study||0
2988581|NCT00895531|3705190|FG001|NOT COMPLETED|Overall Study||0
2988582|NCT00895583|3705198|FG000|STARTED|Overall Study||131
2988583|NCT00895583|3705199|FG001|STARTED|Overall Study||123
2988584|NCT00895583|3705198|FG000|COMPLETED|Overall Study||87
2988585|NCT00895583|3705199|FG001|COMPLETED|Overall Study||111
2988586|NCT00895583|3705198|FG000|NOT COMPLETED|Overall Study||44
2988587|NCT00895583|3705199|FG001|NOT COMPLETED|Overall Study||12
2988588|NCT00895622|3705208|FG000|STARTED|Overall Study||65
2988589|NCT00895622|3705209|FG001|STARTED|Overall Study||56
2988590|NCT00895622|3705210|FG002|STARTED|Overall Study||57
2988591|NCT00895622|3705208|FG000|COMPLETED|Overall Study||60
2988592|NCT00895622|3705209|FG001|COMPLETED|Overall Study||52
2988593|NCT00895622|3705210|FG002|COMPLETED|Overall Study||53
2988594|NCT00895622|3705208|FG000|NOT COMPLETED|Overall Study||5
2988595|NCT00895622|3705209|FG001|NOT COMPLETED|Overall Study||4
2988596|NCT00895622|3705210|FG002|NOT COMPLETED|Overall Study||4
2988597|NCT00895661|3705226|FG000|STARTED|Overall Study||40
2988598|NCT00895661|3705226|FG000|COMPLETED|Overall Study||37
2988599|NCT00895661|3705226|FG000|NOT COMPLETED|Overall Study||3
2988600|NCT00895752|3705230|FG000|STARTED|Overall Study||6
2988601|NCT00895752|3705230|FG000|COMPLETED|Overall Study||6
2988602|NCT00895752|3705230|FG000|NOT COMPLETED|Overall Study||0
2988603|NCT00895817|3705238|FG000|STARTED|Overall Study||21
2988604|NCT00895817|3705239|FG001|STARTED|Overall Study||21
2988605|NCT00895817|3705238|FG000|COMPLETED|Overall Study||21
2988606|NCT00895817|3705239|FG001|COMPLETED|Overall Study||21
2988607|NCT00895817|3705238|FG000|NOT COMPLETED|Overall Study||0
2988608|NCT00895817|3705239|FG001|NOT COMPLETED|Overall Study||0
2988609|NCT00895830|3705250|FG000|STARTED|Overall Study||51
2988610|NCT00895830|3705251|FG001|STARTED|Overall Study||50
2988611|NCT00895830|3705252|FG002|STARTED|Overall Study||49
2988612|NCT00895830|3705253|FG003|STARTED|Overall Study||52
2988613|NCT00895830|3705254|FG004|STARTED|Overall Study||55
2988614|NCT00895830|3705250|FG000|COMPLETED|Overall Study||51
2988615|NCT00895830|3705251|FG001|COMPLETED|Overall Study||50
2988616|NCT00895830|3705252|FG002|COMPLETED|Overall Study||49
2988617|NCT00895830|3705253|FG003|COMPLETED|Overall Study||52
2988618|NCT00895830|3705254|FG004|COMPLETED|Overall Study||55
2988619|NCT00895830|3705250|FG000|NOT COMPLETED|Overall Study||0
2988620|NCT00895830|3705251|FG001|NOT COMPLETED|Overall Study||0
2988621|NCT00895830|3705252|FG002|NOT COMPLETED|Overall Study||0
2988622|NCT00895830|3705253|FG003|NOT COMPLETED|Overall Study||0
2988623|NCT00895830|3705254|FG004|NOT COMPLETED|Overall Study||0
2988624|NCT00895843|3705268|FG000|STARTED|Overall Study||60
2988625|NCT00895843|3705269|FG001|STARTED|Overall Study||62
2988626|NCT00895843|3705268|FG000|COMPLETED|Overall Study||48
2988627|NCT00895843|3705269|FG001|COMPLETED|Overall Study||50
2988628|NCT00895843|3705268|FG000|NOT COMPLETED|Overall Study||12
2988629|NCT00895843|3705269|FG001|NOT COMPLETED|Overall Study||12
2988630|NCT00895895|3705280|FG000|STARTED|Period 1||107
2988631|NCT00895895|3705281|FG001|STARTED|Period 1||105
2988632|NCT00895895|3705282|FG002|STARTED|Period 1||104
2988633|NCT00895895|3705283|FG003|STARTED|Period 1||104
2988634|NCT00895895|3705284|FG004|STARTED|Period 1||106
2988635|NCT00895895|3705280|FG000|Randomized But Not Treated|Period 1||1
2988636|NCT00895895|3705281|FG001|Randomized But Not Treated|Period 1||3
2988637|NCT00895895|3705282|FG002|Randomized But Not Treated|Period 1||1
2988638|NCT00895895|3705283|FG003|Randomized But Not Treated|Period 1||1
2988639|NCT00895895|3705284|FG004|Randomized But Not Treated|Period 1||2
2988640|NCT00895895|3705280|FG000|COMPLETED|Period 1||86
2988641|NCT00895895|3705281|FG001|COMPLETED|Period 1||84
2988642|NCT00895895|3705282|FG002|COMPLETED|Period 1||84
2988643|NCT00895895|3705283|FG003|COMPLETED|Period 1||91
2988644|NCT00895895|3705284|FG004|COMPLETED|Period 1||86
2988645|NCT00895895|3705280|FG000|NOT COMPLETED|Period 1||21
2988646|NCT00895895|3705281|FG001|NOT COMPLETED|Period 1||21
2988647|NCT00895895|3705282|FG002|NOT COMPLETED|Period 1||20
2988648|NCT00895895|3705283|FG003|NOT COMPLETED|Period 1||13
2988649|NCT00895895|3705284|FG004|NOT COMPLETED|Period 1||20
2988650|NCT00895895|3705280|FG000|STARTED|After Period 1, Prior to Period 2||86
2988651|NCT00895895|3705281|FG001|STARTED|After Period 1, Prior to Period 2||84
2988652|NCT00895895|3705282|FG002|STARTED|After Period 1, Prior to Period 2||84
2988653|NCT00895895|3705283|FG003|STARTED|After Period 1, Prior to Period 2||91
2988654|NCT00895895|3705284|FG004|STARTED|After Period 1, Prior to Period 2||86
2988655|NCT00895895|3705280|FG000|COMPLETED|After Period 1, Prior to Period 2||86
2988656|NCT00895895|3705281|FG001|COMPLETED|After Period 1, Prior to Period 2||84
2988657|NCT00895895|3705282|FG002|COMPLETED|After Period 1, Prior to Period 2||82
2988658|NCT00895895|3705283|FG003|COMPLETED|After Period 1, Prior to Period 2||91
2988659|NCT00895895|3705284|FG004|COMPLETED|After Period 1, Prior to Period 2||84
2988660|NCT00895895|3705280|FG000|NOT COMPLETED|After Period 1, Prior to Period 2||0
2988661|NCT00895895|3705281|FG001|NOT COMPLETED|After Period 1, Prior to Period 2||0
2988662|NCT00895895|3705282|FG002|NOT COMPLETED|After Period 1, Prior to Period 2||2
2988663|NCT00895895|3705283|FG003|NOT COMPLETED|After Period 1, Prior to Period 2||0
2988664|NCT00895895|3705284|FG004|NOT COMPLETED|After Period 1, Prior to Period 2||2
2988665|NCT00895895|3705280|FG000|STARTED|Period 2||86
2988666|NCT00895895|3705281|FG001|STARTED|Period 2||84
2988667|NCT00895895|3705282|FG002|STARTED|Period 2||82
2988668|NCT00895895|3705283|FG003|STARTED|Period 2||91
2988669|NCT00895895|3705284|FG004|STARTED|Period 2||84
2988670|NCT00895895|3705280|FG000|COMPLETED|Period 2||30
2988671|NCT00895895|3705281|FG001|COMPLETED|Period 2||31
2988672|NCT00895895|3705282|FG002|COMPLETED|Period 2||33
2988673|NCT00895895|3705283|FG003|COMPLETED|Period 2||37
2988674|NCT00895895|3705284|FG004|COMPLETED|Period 2||35
2988675|NCT00895895|3705280|FG000|NOT COMPLETED|Period 2||56
2988676|NCT00895895|3705281|FG001|NOT COMPLETED|Period 2||53
2988677|NCT00895895|3705282|FG002|NOT COMPLETED|Period 2||49
2988678|NCT00895895|3705283|FG003|NOT COMPLETED|Period 2||54
2988679|NCT00895895|3705284|FG004|NOT COMPLETED|Period 2||49
2988680|NCT00895921|3705304|FG000|STARTED|Overall Study||15
2988681|NCT00895921|3705305|FG001|STARTED|Overall Study||15
2988682|NCT00895921|3705304|FG000|COMPLETED|Overall Study||15
2988683|NCT00895921|3705305|FG001|COMPLETED|Overall Study||15
2988684|NCT00895921|3705304|FG000|NOT COMPLETED|Overall Study||0
2988685|NCT00895921|3705305|FG001|NOT COMPLETED|Overall Study||0
2988686|NCT00895934|3705313|FG000|STARTED|Dose Escalation||3
2988687|NCT00895934|3705314|FG001|STARTED|Dose Escalation||3
2988688|NCT00895934|3705315|FG002|STARTED|Dose Escalation||3
2988689|NCT00895934|3705316|FG003|STARTED|Dose Escalation||6
2988690|NCT00895934|3705313|FG000|COMPLETED|Dose Escalation||3
2988691|NCT00895934|3705314|FG001|COMPLETED|Dose Escalation||3
2988692|NCT00895934|3705315|FG002|COMPLETED|Dose Escalation||3
2988693|NCT00895934|3705316|FG003|COMPLETED|Dose Escalation||6
2988694|NCT00895934|3705313|FG000|NOT COMPLETED|Dose Escalation||0
2988695|NCT00895934|3705314|FG001|NOT COMPLETED|Dose Escalation||0
2988696|NCT00895934|3705315|FG002|NOT COMPLETED|Dose Escalation||0
2988697|NCT00895934|3705316|FG003|NOT COMPLETED|Dose Escalation||0
2988698|NCT00895934|3705313|FG000|STARTED|Efficacy of Most Tolerated Dose||0
2988699|NCT00895934|3705314|FG001|STARTED|Efficacy of Most Tolerated Dose||0
2988700|NCT00895934|3705315|FG002|STARTED|Efficacy of Most Tolerated Dose||0
2988701|NCT00895934|3705316|FG003|STARTED|Efficacy of Most Tolerated Dose||37
2988702|NCT00895934|3705313|FG000|COMPLETED|Efficacy of Most Tolerated Dose||0
2988703|NCT00895934|3705314|FG001|COMPLETED|Efficacy of Most Tolerated Dose||0
2988704|NCT00895934|3705315|FG002|COMPLETED|Efficacy of Most Tolerated Dose||0
2988705|NCT00895934|3705316|FG003|COMPLETED|Efficacy of Most Tolerated Dose||37
2988706|NCT00895934|3705313|FG000|NOT COMPLETED|Efficacy of Most Tolerated Dose||0
2988707|NCT00895934|3705314|FG001|NOT COMPLETED|Efficacy of Most Tolerated Dose||0
2988708|NCT00895934|3705315|FG002|NOT COMPLETED|Efficacy of Most Tolerated Dose||0
2988709|NCT00895934|3705316|FG003|NOT COMPLETED|Efficacy of Most Tolerated Dose||0
2988710|NCT00895947|3705329|FG000|STARTED|Overall Study||100
2988711|NCT00895947|3705330|FG001|STARTED|Overall Study||100
2988712|NCT00895947|3705329|FG000|COMPLETED|Overall Study||88
2988713|NCT00895947|3705330|FG001|COMPLETED|Overall Study||90
2988714|NCT00895947|3705329|FG000|NOT COMPLETED|Overall Study||12
2988715|NCT00895947|3705330|FG001|NOT COMPLETED|Overall Study||10
2988716|NCT00896012|3705338|FG000|STARTED|Overall Study||29
2988717|NCT00896012|3705339|FG001|STARTED|Overall Study||23
2988718|NCT00896012|3705338|FG000|COMPLETED|Overall Study||18
2988719|NCT00896012|3705339|FG001|COMPLETED|Overall Study||12
2988720|NCT00896012|3705338|FG000|NOT COMPLETED|Overall Study||11
2988721|NCT00896012|3705339|FG001|NOT COMPLETED|Overall Study||11
2988722|NCT00896038|3705347|FG000|STARTED|Overall Study||30
2988723|NCT00896038|3705348|FG001|STARTED|Overall Study||28
2988724|NCT00896038|3705347|FG000|COMPLETED|Overall Study||26
2988725|NCT00896038|3705348|FG001|COMPLETED|Overall Study||27
2988726|NCT00896038|3705347|FG000|NOT COMPLETED|Overall Study||4
2988727|NCT00896038|3705348|FG001|NOT COMPLETED|Overall Study||1
2988728|NCT00896051|3705356|FG000|STARTED|Overall Study||25
2988729|NCT00896051|3705357|FG001|STARTED|Overall Study||25
2988730|NCT00896051|3705356|FG000|COMPLETED|Overall Study||15
2988731|NCT00896051|3705357|FG001|COMPLETED|Overall Study||16
2988732|NCT00896051|3705356|FG000|NOT COMPLETED|Overall Study||10
2988733|NCT00896051|3705357|FG001|NOT COMPLETED|Overall Study||9
2988734|NCT00896064|3705374|FG000|STARTED|Overall Study||22
2988735|NCT00896064|3705375|FG001|STARTED|Overall Study||21
2988736|NCT00896064|3705374|FG000|COMPLETED|Overall Study||22
2988737|NCT00896064|3705375|FG001|COMPLETED|Overall Study||21
2988738|NCT00896064|3705374|FG000|NOT COMPLETED|Overall Study||0
2988739|NCT00896064|3705375|FG001|NOT COMPLETED|Overall Study||0
2988740|NCT00896168|3705383|FG000|STARTED|Overall Study||104
2988741|NCT00896168|3705384|FG001|STARTED|Overall Study||130
2988742|NCT00896168|3705383|FG000|COMPLETED|Overall Study||90
2988743|NCT00896168|3705384|FG001|COMPLETED|Overall Study||111
2988744|NCT00896168|3705383|FG000|NOT COMPLETED|Overall Study||14
2988745|NCT00896168|3705384|FG001|NOT COMPLETED|Overall Study||19
2988746|NCT00896181|3705390|FG000|STARTED|Overall Study||26
2988747|NCT00896181|3705390|FG000|COMPLETED|Overall Study||26
2988748|NCT00896181|3705390|FG000|NOT COMPLETED|Overall Study||0
2988749|NCT00896233|3705394|FG000|STARTED|Overall Study||10
2988750|NCT00896233|3705394|FG000|COMPLETED|Overall Study||9
2988751|NCT00896233|3705394|FG000|NOT COMPLETED|Overall Study||1
2988752|NCT00896298|3705401|FG000|STARTED|Overall Study||13
2988753|NCT00896298|3705402|FG001|STARTED|Overall Study||12
2988754|NCT00896298|3705401|FG000|COMPLETED|Overall Study||10
2988755|NCT00896298|3705402|FG001|COMPLETED|Overall Study||9
2988756|NCT00896298|3705401|FG000|NOT COMPLETED|Overall Study||3
2988757|NCT00896298|3705402|FG001|NOT COMPLETED|Overall Study||3
2988758|NCT00896337|3705408|FG000|STARTED|Overall Study||125
2988759|NCT00896337|3705408|FG000|COMPLETED|Overall Study||100
2988760|NCT00896337|3705408|FG000|NOT COMPLETED|Overall Study||25
2988761|NCT00896363|3705420|FG000|STARTED|Overall Study||31
2988762|NCT00896363|3705421|FG001|STARTED|Overall Study||36
2988763|NCT00896363|3705422|FG002|STARTED|Overall Study||32
2988764|NCT00896363|3705420|FG000|COMPLETED|Overall Study||25
2988765|NCT00896363|3705421|FG001|COMPLETED|Overall Study||25
2988766|NCT00896363|3705422|FG002|COMPLETED|Overall Study||24
3304882|NCT02982954|4038473|FG000|NOT COMPLETED|Treatment Period||106
3304883|NCT02982954|4038474|FG001|NOT COMPLETED|Treatment Period||52
3304884|NCT02982954|4038475|FG002|NOT COMPLETED|Treatment Period||28
3304885|NCT02982954|4038476|FG003|NOT COMPLETED|Treatment Period||25
3304886|NCT02982954|4038473|FG000|STARTED|Continuing in Study||106
3304887|NCT02982954|4038474|FG001|STARTED|Continuing in Study||52
2988767|NCT00896363|3705420|FG000|NOT COMPLETED|Overall Study||6
2988768|NCT00896363|3705421|FG001|NOT COMPLETED|Overall Study||11
2988769|NCT00896363|3705422|FG002|NOT COMPLETED|Overall Study||8
2988770|NCT00896389|3705433|FG000|STARTED|Salt Loading||124
2988771|NCT00896389|3705433|FG000|COMPLETED|Salt Loading||124
2988772|NCT00896389|3705433|FG000|NOT COMPLETED|Salt Loading||0
2988773|NCT00896389|3705433|FG000|STARTED|HCTZ Low Dose|Only subjects with SBP > 120 mmHg and agreeable to the HCTZ protocol continued to the next period.|28
2988774|NCT00896389|3705433|FG000|COMPLETED|HCTZ Low Dose||28
2988775|NCT00896389|3705433|FG000|NOT COMPLETED|HCTZ Low Dose||0
2988776|NCT00896389|3705433|FG000|STARTED|HCTZ High Dose||25
2988777|NCT00896389|3705433|FG000|COMPLETED|HCTZ High Dose||25
2988778|NCT00896389|3705433|FG000|NOT COMPLETED|HCTZ High Dose||0
2988779|NCT00896441|3705441|FG000|STARTED|Overall Study||17
2988780|NCT00896441|3705442|FG001|STARTED|Overall Study||9
2988781|NCT00896441|3705441|FG000|COMPLETED|Overall Study||15
2988782|NCT00896441|3705442|FG001|COMPLETED|Overall Study||9
2988783|NCT00896441|3705441|FG000|NOT COMPLETED|Overall Study||2
2988784|NCT00896441|3705442|FG001|NOT COMPLETED|Overall Study||0
2988785|NCT00896454|3705447|FG000|STARTED|Overall Study||33
2988786|NCT00896454|3705447|FG000|COMPLETED|Overall Study||0
2988787|NCT00896454|3705447|FG000|NOT COMPLETED|Overall Study||33
2988788|NCT00896480|3705451|FG000|STARTED|Overall Study||24
2988789|NCT00896480|3705451|FG000|COMPLETED|Overall Study||3
2988790|NCT00896480|3705451|FG000|NOT COMPLETED|Overall Study||21
2988791|NCT00896532|3705466|FG000|STARTED|Months 1-24: Romosozumab Treatment Phase||52
2988792|NCT00896532|3705467|FG001|STARTED|Months 1-24: Romosozumab Treatment Phase||51
2988793|NCT00896532|3705468|FG002|STARTED|Months 1-24: Romosozumab Treatment Phase||55
2988794|NCT00896532|3705469|FG003|STARTED|Months 1-24: Romosozumab Treatment Phase||51
2988795|NCT00896532|3705470|FG004|STARTED|Months 1-24: Romosozumab Treatment Phase||54
2988796|NCT00896532|3705471|FG005|STARTED|Months 1-24: Romosozumab Treatment Phase||51
2988797|NCT00896532|3705472|FG006|STARTED|Months 1-24: Romosozumab Treatment Phase||53
2988798|NCT00896532|3705473|FG007|STARTED|Months 1-24: Romosozumab Treatment Phase||52
2988799|NCT00896532|3705474|FG008|STARTED|Months 1-24: Romosozumab Treatment Phase||0
2988800|NCT00896532|3705475|FG009|STARTED|Months 1-24: Romosozumab Treatment Phase||0
2988801|NCT00896532|3705476|FG010|STARTED|Months 1-24: Romosozumab Treatment Phase||0
2988802|NCT00896532|3705477|FG011|STARTED|Months 1-24: Romosozumab Treatment Phase||0
2988803|NCT00896532|3705478|FG012|STARTED|Months 1-24: Romosozumab Treatment Phase||0
2988804|NCT00896532|3705479|FG013|STARTED|Months 1-24: Romosozumab Treatment Phase||0
2988805|NCT00896532|3705480|FG014|STARTED|Months 1-24: Romosozumab Treatment Phase||0
2988806|NCT00896532|3705481|FG015|STARTED|Months 1-24: Romosozumab Treatment Phase||0
2988807|NCT00896532|3705482|FG016|STARTED|Months 1-24: Romosozumab Treatment Phase||0
2988808|NCT00896532|3705483|FG017|STARTED|Months 1-24: Romosozumab Treatment Phase||0
2988809|NCT00896532|3705484|FG018|STARTED|Months 1-24: Romosozumab Treatment Phase||0
2988810|NCT00896532|3705485|FG019|STARTED|Months 1-24: Romosozumab Treatment Phase||0
2988811|NCT00896532|3705486|FG020|STARTED|Months 1-24: Romosozumab Treatment Phase||0
2988812|NCT00896532|3705487|FG021|STARTED|Months 1-24: Romosozumab Treatment Phase||0
2988813|NCT00896532|3705488|FG022|STARTED|Months 1-24: Romosozumab Treatment Phase||0
2988814|NCT00896532|3705466|FG000|Received Treatment|Months 1-24: Romosozumab Treatment Phase|One participant received 1 dose of romosozumab 70 mg in error|51
2988815|NCT00896532|3705467|FG001|Received Treatment|Months 1-24: Romosozumab Treatment Phase||51
2988816|NCT00896532|3705468|FG002|Received Treatment|Months 1-24: Romosozumab Treatment Phase||54
2988817|NCT00896532|3705469|FG003|Received Treatment|Months 1-24: Romosozumab Treatment Phase||49
2988818|NCT00896532|3705470|FG004|Received Treatment|Months 1-24: Romosozumab Treatment Phase||53
2988819|NCT00896532|3705471|FG005|Received Treatment|Months 1-24: Romosozumab Treatment Phase||48
2988820|NCT00896532|3705472|FG006|Received Treatment|Months 1-24: Romosozumab Treatment Phase||53
2988821|NCT00896532|3705473|FG007|Received Treatment|Months 1-24: Romosozumab Treatment Phase||51
2988822|NCT00896532|3705474|FG008|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
2988823|NCT00896532|3705475|FG009|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
2988824|NCT00896532|3705476|FG010|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
2988825|NCT00896532|3705477|FG011|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
2988826|NCT00896532|3705478|FG012|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
2988827|NCT00896532|3705479|FG013|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
2988828|NCT00896532|3705480|FG014|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
2988829|NCT00896532|3705481|FG015|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
2988830|NCT00896532|3705482|FG016|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
2988831|NCT00896532|3705483|FG017|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
2988832|NCT00896532|3705484|FG018|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
2988833|NCT00896532|3705485|FG019|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
2988834|NCT00896532|3705486|FG020|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
2988835|NCT00896532|3705487|FG021|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
2988836|NCT00896532|3705488|FG022|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
2988837|NCT00896532|3705466|FG000|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||47
2988838|NCT00896532|3705467|FG001|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||49
2988839|NCT00896532|3705468|FG002|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||46
2988840|NCT00896532|3705469|FG003|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||45
2988841|NCT00896532|3705470|FG004|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||50
2988842|NCT00896532|3705471|FG005|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||46
2988843|NCT00896532|3705472|FG006|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||51
2988844|NCT00896532|3705473|FG007|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||49
2988845|NCT00896532|3705474|FG008|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
2988846|NCT00896532|3705475|FG009|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
2988847|NCT00896532|3705476|FG010|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
2988848|NCT00896532|3705477|FG011|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
2988849|NCT00896532|3705478|FG012|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
2988850|NCT00896532|3705479|FG013|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
2988851|NCT00896532|3705480|FG014|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
2988852|NCT00896532|3705481|FG015|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
2988853|NCT00896532|3705482|FG016|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
2988854|NCT00896532|3705483|FG017|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
2988855|NCT00896532|3705484|FG018|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
2988856|NCT00896532|3705485|FG019|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
2988857|NCT00896532|3705486|FG020|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
2988858|NCT00896532|3705487|FG021|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
2988859|NCT00896532|3705488|FG022|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
2988860|NCT00896532|3705466|FG000|COMPLETED|Months 1-24: Romosozumab Treatment Phase||46
2988861|NCT00896532|3705467|FG001|COMPLETED|Months 1-24: Romosozumab Treatment Phase||45
2988862|NCT00896532|3705468|FG002|COMPLETED|Months 1-24: Romosozumab Treatment Phase||46
2988863|NCT00896532|3705469|FG003|COMPLETED|Months 1-24: Romosozumab Treatment Phase||39
2988864|NCT00896532|3705470|FG004|COMPLETED|Months 1-24: Romosozumab Treatment Phase||46
2988865|NCT00896532|3705471|FG005|COMPLETED|Months 1-24: Romosozumab Treatment Phase||43
2988866|NCT00896532|3705472|FG006|COMPLETED|Months 1-24: Romosozumab Treatment Phase||48
2988867|NCT00896532|3705473|FG007|COMPLETED|Months 1-24: Romosozumab Treatment Phase||48
2988868|NCT00896532|3705474|FG008|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
2988869|NCT00896532|3705475|FG009|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
2988870|NCT00896532|3705476|FG010|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
2988871|NCT00896532|3705477|FG011|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
2988872|NCT00896532|3705478|FG012|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
2988873|NCT00896532|3705479|FG013|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
2988874|NCT00896532|3705480|FG014|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
2988875|NCT00896532|3705481|FG015|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
2988876|NCT00896532|3705482|FG016|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
2988877|NCT00896532|3705483|FG017|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
2988878|NCT00896532|3705484|FG018|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
2988879|NCT00896532|3705485|FG019|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
2988880|NCT00896532|3705486|FG020|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
2988881|NCT00896532|3705487|FG021|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
2988882|NCT00896532|3705488|FG022|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
2988883|NCT00896532|3705466|FG000|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||6
2988884|NCT00896532|3705467|FG001|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||6
2988885|NCT00896532|3705468|FG002|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||9
2988886|NCT00896532|3705469|FG003|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||12
2988887|NCT00896532|3705470|FG004|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||8
2988888|NCT00896532|3705471|FG005|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||8
2988889|NCT00896532|3705472|FG006|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||5
2988890|NCT00896532|3705473|FG007|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||4
2988891|NCT00896532|3705474|FG008|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
2988892|NCT00896532|3705475|FG009|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
2988893|NCT00896532|3705476|FG010|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
2988894|NCT00896532|3705477|FG011|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
2988895|NCT00896532|3705478|FG012|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
2988896|NCT00896532|3705479|FG013|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
2988897|NCT00896532|3705480|FG014|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
2988898|NCT00896532|3705481|FG015|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
2988899|NCT00896532|3705482|FG016|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
2988900|NCT00896532|3705483|FG017|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
2988901|NCT00896532|3705484|FG018|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
2988902|NCT00896532|3705485|FG019|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
2988903|NCT00896532|3705486|FG020|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
2988904|NCT00896532|3705487|FG021|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
2988905|NCT00896532|3705488|FG022|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
2988906|NCT00896532|3705466|FG000|STARTED|Months 24-36: Denosumab Extension Phase||0
2988907|NCT00896532|3705467|FG001|STARTED|Months 24-36: Denosumab Extension Phase||0
2988908|NCT00896532|3705468|FG002|STARTED|Months 24-36: Denosumab Extension Phase||0
2988909|NCT00896532|3705469|FG003|STARTED|Months 24-36: Denosumab Extension Phase||0
2988910|NCT00896532|3705470|FG004|STARTED|Months 24-36: Denosumab Extension Phase||0
2988911|NCT00896532|3705471|FG005|STARTED|Months 24-36: Denosumab Extension Phase||0
2988912|NCT00896532|3705472|FG006|STARTED|Months 24-36: Denosumab Extension Phase||0
2988913|NCT00896532|3705473|FG007|STARTED|Months 24-36: Denosumab Extension Phase||0
2988914|NCT00896532|3705474|FG008|STARTED|Months 24-36: Denosumab Extension Phase||18
2988915|NCT00896532|3705475|FG009|STARTED|Months 24-36: Denosumab Extension Phase||18
2988916|NCT00896532|3705476|FG010|STARTED|Months 24-36: Denosumab Extension Phase||20
2988917|NCT00896532|3705477|FG011|STARTED|Months 24-36: Denosumab Extension Phase||21
2988918|NCT00896532|3705478|FG012|STARTED|Months 24-36: Denosumab Extension Phase||93
2988919|NCT00896532|3705479|FG013|STARTED|Months 24-36: Denosumab Extension Phase||90
2988920|NCT00896532|3705480|FG014|STARTED|Months 24-36: Denosumab Extension Phase||0
2988921|NCT00896532|3705481|FG015|STARTED|Months 24-36: Denosumab Extension Phase||0
2988922|NCT00896532|3705482|FG016|STARTED|Months 24-36: Denosumab Extension Phase||0
2988923|NCT00896532|3705483|FG017|STARTED|Months 24-36: Denosumab Extension Phase||0
2988924|NCT00896532|3705484|FG018|STARTED|Months 24-36: Denosumab Extension Phase||0
2988925|NCT00896532|3705485|FG019|STARTED|Months 24-36: Denosumab Extension Phase||0
2988926|NCT00896532|3705486|FG020|STARTED|Months 24-36: Denosumab Extension Phase||0
2988927|NCT00896532|3705487|FG021|STARTED|Months 24-36: Denosumab Extension Phase||0
2988928|NCT00896532|3705488|FG022|STARTED|Months 24-36: Denosumab Extension Phase||0
2988929|NCT00896532|3705466|FG000|Received Treatment|Months 24-36: Denosumab Extension Phase||0
2988930|NCT00896532|3705467|FG001|Received Treatment|Months 24-36: Denosumab Extension Phase||0
2988931|NCT00896532|3705468|FG002|Received Treatment|Months 24-36: Denosumab Extension Phase||0
2988932|NCT00896532|3705469|FG003|Received Treatment|Months 24-36: Denosumab Extension Phase||0
2988933|NCT00896532|3705470|FG004|Received Treatment|Months 24-36: Denosumab Extension Phase||0
2988934|NCT00896532|3705471|FG005|Received Treatment|Months 24-36: Denosumab Extension Phase||0
2988935|NCT00896532|3705472|FG006|Received Treatment|Months 24-36: Denosumab Extension Phase||0
2988936|NCT00896532|3705473|FG007|Received Treatment|Months 24-36: Denosumab Extension Phase||0
2988937|NCT00896532|3705474|FG008|Received Treatment|Months 24-36: Denosumab Extension Phase||18
2988938|NCT00896532|3705475|FG009|Received Treatment|Months 24-36: Denosumab Extension Phase|Includes one participant who received 1 dose of romosozumab 70 mg in error in first 12 months|18
2988939|NCT00896532|3705476|FG010|Received Treatment|Months 24-36: Denosumab Extension Phase||19
2988940|NCT00896532|3705477|FG011|Received Treatment|Months 24-36: Denosumab Extension Phase||19
2988941|NCT00896532|3705478|FG012|Received Treatment|Months 24-36: Denosumab Extension Phase||90
2988942|NCT00896532|3705479|FG013|Received Treatment|Months 24-36: Denosumab Extension Phase||88
2988943|NCT00896532|3705480|FG014|Received Treatment|Months 24-36: Denosumab Extension Phase||0
2988944|NCT00896532|3705481|FG015|Received Treatment|Months 24-36: Denosumab Extension Phase||0
2988945|NCT00896532|3705482|FG016|Received Treatment|Months 24-36: Denosumab Extension Phase||0
2988946|NCT00896532|3705483|FG017|Received Treatment|Months 24-36: Denosumab Extension Phase||0
2988947|NCT00896532|3705484|FG018|Received Treatment|Months 24-36: Denosumab Extension Phase||0
2988948|NCT00896532|3705485|FG019|Received Treatment|Months 24-36: Denosumab Extension Phase||0
2988949|NCT00896532|3705486|FG020|Received Treatment|Months 24-36: Denosumab Extension Phase||0
2988950|NCT00896532|3705487|FG021|Received Treatment|Months 24-36: Denosumab Extension Phase||0
2988951|NCT00896532|3705488|FG022|Received Treatment|Months 24-36: Denosumab Extension Phase||0
2988952|NCT00896532|3705466|FG000|COMPLETED|Months 24-36: Denosumab Extension Phase||0
2988953|NCT00896532|3705467|FG001|COMPLETED|Months 24-36: Denosumab Extension Phase||0
2988954|NCT00896532|3705468|FG002|COMPLETED|Months 24-36: Denosumab Extension Phase||0
2988955|NCT00896532|3705469|FG003|COMPLETED|Months 24-36: Denosumab Extension Phase||0
2988956|NCT00896532|3705470|FG004|COMPLETED|Months 24-36: Denosumab Extension Phase||0
2988957|NCT00896532|3705471|FG005|COMPLETED|Months 24-36: Denosumab Extension Phase||0
2988958|NCT00896532|3705472|FG006|COMPLETED|Months 24-36: Denosumab Extension Phase||0
2988959|NCT00896532|3705473|FG007|COMPLETED|Months 24-36: Denosumab Extension Phase||0
2988960|NCT00896532|3705474|FG008|COMPLETED|Months 24-36: Denosumab Extension Phase||17
2988961|NCT00896532|3705475|FG009|COMPLETED|Months 24-36: Denosumab Extension Phase||18
2988962|NCT00896532|3705476|FG010|COMPLETED|Months 24-36: Denosumab Extension Phase||18
2988963|NCT00896532|3705477|FG011|COMPLETED|Months 24-36: Denosumab Extension Phase||19
2988964|NCT00896532|3705478|FG012|COMPLETED|Months 24-36: Denosumab Extension Phase||88
2988965|NCT00896532|3705479|FG013|COMPLETED|Months 24-36: Denosumab Extension Phase||88
2988966|NCT00896532|3705480|FG014|COMPLETED|Months 24-36: Denosumab Extension Phase||0
3133539|NCT01696279|3858509|FG001|Safety Completer Set|Part 2a: Calcium Carbonate + Lanthanum||37
3133540|NCT01696279|3858510|FG002|Safety Completer Set|Part 2a: Calcium Carbonate + Lanthanum||0
3133541|NCT01696279|3858511|FG003|Safety Completer Set|Part 2a: Calcium Carbonate + Lanthanum||0
3133542|NCT01696279|3858508|FG000|Full Analysis Set|Part 2a: Calcium Carbonate + Lanthanum||0
3133543|NCT01696279|3858509|FG001|Full Analysis Set|Part 2a: Calcium Carbonate + Lanthanum||53
3133544|NCT01696279|3858510|FG002|Full Analysis Set|Part 2a: Calcium Carbonate + Lanthanum||0
2988967|NCT00896532|3705481|FG015|COMPLETED|Months 24-36: Denosumab Extension Phase||0
2988968|NCT00896532|3705482|FG016|COMPLETED|Months 24-36: Denosumab Extension Phase||0
2988969|NCT00896532|3705483|FG017|COMPLETED|Months 24-36: Denosumab Extension Phase||0
2988970|NCT00896532|3705484|FG018|COMPLETED|Months 24-36: Denosumab Extension Phase||0
2988971|NCT00896532|3705485|FG019|COMPLETED|Months 24-36: Denosumab Extension Phase||0
2988972|NCT00896532|3705486|FG020|COMPLETED|Months 24-36: Denosumab Extension Phase||0
2988973|NCT00896532|3705487|FG021|COMPLETED|Months 24-36: Denosumab Extension Phase||0
2988974|NCT00896532|3705488|FG022|COMPLETED|Months 24-36: Denosumab Extension Phase||0
2988975|NCT00896532|3705466|FG000|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
2988976|NCT00896532|3705467|FG001|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
2988977|NCT00896532|3705468|FG002|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
2988978|NCT00896532|3705469|FG003|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
2988979|NCT00896532|3705470|FG004|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
2988980|NCT00896532|3705471|FG005|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
2988981|NCT00896532|3705472|FG006|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
2988982|NCT00896532|3705473|FG007|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
2988983|NCT00896532|3705474|FG008|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||1
2988984|NCT00896532|3705475|FG009|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
2988985|NCT00896532|3705476|FG010|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||2
2988986|NCT00896532|3705477|FG011|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||2
2988987|NCT00896532|3705478|FG012|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||5
2988988|NCT00896532|3705479|FG013|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||2
2988989|NCT00896532|3705480|FG014|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
2988990|NCT00896532|3705481|FG015|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
2988991|NCT00896532|3705482|FG016|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
2988992|NCT00896532|3705483|FG017|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
2988993|NCT00896532|3705484|FG018|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
2988994|NCT00896532|3705485|FG019|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
2988995|NCT00896532|3705486|FG020|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
2988996|NCT00896532|3705487|FG021|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
2988997|NCT00896532|3705488|FG022|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
2988998|NCT00896532|3705466|FG000|STARTED|Months 36-48: Romosozumab Retreatment||0
2988999|NCT00896532|3705467|FG001|STARTED|Months 36-48: Romosozumab Retreatment||0
2989000|NCT00896532|3705468|FG002|STARTED|Months 36-48: Romosozumab Retreatment||0
2989001|NCT00896532|3705469|FG003|STARTED|Months 36-48: Romosozumab Retreatment||0
2989002|NCT00896532|3705470|FG004|STARTED|Months 36-48: Romosozumab Retreatment||0
2989003|NCT00896532|3705471|FG005|STARTED|Months 36-48: Romosozumab Retreatment||0
2989004|NCT00896532|3705472|FG006|STARTED|Months 36-48: Romosozumab Retreatment||0
2989005|NCT00896532|3705473|FG007|STARTED|Months 36-48: Romosozumab Retreatment||0
2989006|NCT00896532|3705474|FG008|STARTED|Months 36-48: Romosozumab Retreatment||0
2989007|NCT00896532|3705475|FG009|STARTED|Months 36-48: Romosozumab Retreatment||0
2989008|NCT00896532|3705476|FG010|STARTED|Months 36-48: Romosozumab Retreatment||0
2989009|NCT00896532|3705477|FG011|STARTED|Months 36-48: Romosozumab Retreatment||0
2989010|NCT00896532|3705478|FG012|STARTED|Months 36-48: Romosozumab Retreatment||0
2989011|NCT00896532|3705479|FG013|STARTED|Months 36-48: Romosozumab Retreatment||0
2989012|NCT00896532|3705480|FG014|STARTED|Months 36-48: Romosozumab Retreatment||12
2989013|NCT00896532|3705481|FG015|STARTED|Months 36-48: Romosozumab Retreatment||16
2989014|NCT00896532|3705482|FG016|STARTED|Months 36-48: Romosozumab Retreatment||72
2989015|NCT00896532|3705483|FG017|STARTED|Months 36-48: Romosozumab Retreatment||67
2989016|NCT00896532|3705484|FG018|STARTED|Months 36-48: Romosozumab Retreatment||0
2989017|NCT00896532|3705485|FG019|STARTED|Months 36-48: Romosozumab Retreatment||0
2989018|NCT00896532|3705486|FG020|STARTED|Months 36-48: Romosozumab Retreatment||0
2989019|NCT00896532|3705487|FG021|STARTED|Months 36-48: Romosozumab Retreatment||0
2989020|NCT00896532|3705488|FG022|STARTED|Months 36-48: Romosozumab Retreatment||0
2989021|NCT00896532|3705466|FG000|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
2989022|NCT00896532|3705467|FG001|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
2989023|NCT00896532|3705468|FG002|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
2989024|NCT00896532|3705469|FG003|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
2989025|NCT00896532|3705470|FG004|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
2989026|NCT00896532|3705471|FG005|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
2989027|NCT00896532|3705472|FG006|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
2989028|NCT00896532|3705473|FG007|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
2989029|NCT00896532|3705474|FG008|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
2989030|NCT00896532|3705475|FG009|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
2989031|NCT00896532|3705476|FG010|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
2989032|NCT00896532|3705477|FG011|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
2989033|NCT00896532|3705478|FG012|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
2989034|NCT00896532|3705479|FG013|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
2989035|NCT00896532|3705480|FG014|Received Romosozumab|Months 36-48: Romosozumab Retreatment||12
3036684|NCT01144403|3755932|FG000|STARTED|Overall Study||8
3036685|NCT01144403|3755932|FG000|COMPLETED|Overall Study||3
2989036|NCT00896532|3705481|FG015|Received Romosozumab|Months 36-48: Romosozumab Retreatment|Includes one participant who received 1 dose of romosozumab 70 mg in error in first 12 months|16
2989037|NCT00896532|3705482|FG016|Received Romosozumab|Months 36-48: Romosozumab Retreatment||72
2989038|NCT00896532|3705483|FG017|Received Romosozumab|Months 36-48: Romosozumab Retreatment||67
2989039|NCT00896532|3705484|FG018|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
2989040|NCT00896532|3705485|FG019|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
2989041|NCT00896532|3705486|FG020|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
2989042|NCT00896532|3705487|FG021|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
2989043|NCT00896532|3705488|FG022|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
2989044|NCT00896532|3705466|FG000|COMPLETED|Months 36-48: Romosozumab Retreatment||0
2989045|NCT00896532|3705467|FG001|COMPLETED|Months 36-48: Romosozumab Retreatment||0
2989046|NCT00896532|3705468|FG002|COMPLETED|Months 36-48: Romosozumab Retreatment||0
2989047|NCT00896532|3705469|FG003|COMPLETED|Months 36-48: Romosozumab Retreatment||0
2989048|NCT00896532|3705470|FG004|COMPLETED|Months 36-48: Romosozumab Retreatment||0
2989049|NCT00896532|3705471|FG005|COMPLETED|Months 36-48: Romosozumab Retreatment||0
2989050|NCT00896532|3705472|FG006|COMPLETED|Months 36-48: Romosozumab Retreatment||0
2989051|NCT00896532|3705473|FG007|COMPLETED|Months 36-48: Romosozumab Retreatment||0
2989052|NCT00896532|3705474|FG008|COMPLETED|Months 36-48: Romosozumab Retreatment||0
2989053|NCT00896532|3705475|FG009|COMPLETED|Months 36-48: Romosozumab Retreatment||0
2989054|NCT00896532|3705476|FG010|COMPLETED|Months 36-48: Romosozumab Retreatment||0
2989055|NCT00896532|3705477|FG011|COMPLETED|Months 36-48: Romosozumab Retreatment||0
2989056|NCT00896532|3705478|FG012|COMPLETED|Months 36-48: Romosozumab Retreatment||0
2989057|NCT00896532|3705479|FG013|COMPLETED|Months 36-48: Romosozumab Retreatment||0
2989058|NCT00896532|3705480|FG014|COMPLETED|Months 36-48: Romosozumab Retreatment||12
2989059|NCT00896532|3705481|FG015|COMPLETED|Months 36-48: Romosozumab Retreatment||14
2989060|NCT00896532|3705482|FG016|COMPLETED|Months 36-48: Romosozumab Retreatment||65
2989061|NCT00896532|3705483|FG017|COMPLETED|Months 36-48: Romosozumab Retreatment||64
2989062|NCT00896532|3705484|FG018|COMPLETED|Months 36-48: Romosozumab Retreatment||0
2989063|NCT00896532|3705485|FG019|COMPLETED|Months 36-48: Romosozumab Retreatment||0
2989064|NCT00896532|3705486|FG020|COMPLETED|Months 36-48: Romosozumab Retreatment||0
2989065|NCT00896532|3705487|FG021|COMPLETED|Months 36-48: Romosozumab Retreatment||0
2989066|NCT00896532|3705488|FG022|COMPLETED|Months 36-48: Romosozumab Retreatment||0
2989067|NCT00896532|3705466|FG000|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
2989068|NCT00896532|3705467|FG001|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
2989069|NCT00896532|3705468|FG002|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
2989070|NCT00896532|3705469|FG003|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
2989071|NCT00896532|3705470|FG004|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
2989072|NCT00896532|3705471|FG005|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
2989073|NCT00896532|3705472|FG006|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
2989074|NCT00896532|3705473|FG007|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
2989075|NCT00896532|3705474|FG008|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
2989076|NCT00896532|3705475|FG009|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
2989077|NCT00896532|3705476|FG010|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
2989078|NCT00896532|3705477|FG011|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
2989079|NCT00896532|3705478|FG012|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
2989080|NCT00896532|3705479|FG013|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
2989081|NCT00896532|3705480|FG014|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
2989082|NCT00896532|3705481|FG015|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||2
2989083|NCT00896532|3705482|FG016|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||7
2989084|NCT00896532|3705483|FG017|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||3
2989085|NCT00896532|3705484|FG018|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
2989086|NCT00896532|3705485|FG019|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
2989087|NCT00896532|3705486|FG020|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
2989088|NCT00896532|3705487|FG021|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
2989089|NCT00896532|3705488|FG022|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
2989090|NCT00896532|3705466|FG000|STARTED|Months 48-72: Follow-on Phase||0
2989091|NCT00896532|3705467|FG001|STARTED|Months 48-72: Follow-on Phase||0
2989092|NCT00896532|3705468|FG002|STARTED|Months 48-72: Follow-on Phase||0
2989093|NCT00896532|3705469|FG003|STARTED|Months 48-72: Follow-on Phase||0
2989094|NCT00896532|3705470|FG004|STARTED|Months 48-72: Follow-on Phase||0
2989095|NCT00896532|3705471|FG005|STARTED|Months 48-72: Follow-on Phase||0
2989096|NCT00896532|3705472|FG006|STARTED|Months 48-72: Follow-on Phase||0
2989097|NCT00896532|3705473|FG007|STARTED|Months 48-72: Follow-on Phase||0
2989098|NCT00896532|3705474|FG008|STARTED|Months 48-72: Follow-on Phase||0
2989099|NCT00896532|3705475|FG009|STARTED|Months 48-72: Follow-on Phase||0
2989100|NCT00896532|3705476|FG010|STARTED|Months 48-72: Follow-on Phase||0
2989101|NCT00896532|3705477|FG011|STARTED|Months 48-72: Follow-on Phase||0
2989102|NCT00896532|3705478|FG012|STARTED|Months 48-72: Follow-on Phase||0
2989103|NCT00896532|3705479|FG013|STARTED|Months 48-72: Follow-on Phase||0
2989104|NCT00896532|3705480|FG014|STARTED|Months 48-72: Follow-on Phase||0
2989105|NCT00896532|3705481|FG015|STARTED|Months 48-72: Follow-on Phase||0
2989106|NCT00896532|3705482|FG016|STARTED|Months 48-72: Follow-on Phase||0
2989107|NCT00896532|3705483|FG017|STARTED|Months 48-72: Follow-on Phase||0
2989108|NCT00896532|3705484|FG018|STARTED|Months 48-72: Follow-on Phase||51
2989109|NCT00896532|3705485|FG019|STARTED|Months 48-72: Follow-on Phase||11
2989110|NCT00896532|3705486|FG020|STARTED|Months 48-72: Follow-on Phase||12
2989111|NCT00896532|3705487|FG021|STARTED|Months 48-72: Follow-on Phase||59
2989112|NCT00896532|3705488|FG022|STARTED|Months 48-72: Follow-on Phase||8
2989113|NCT00896532|3705466|FG000|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
2989114|NCT00896532|3705467|FG001|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
2989115|NCT00896532|3705468|FG002|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
2989116|NCT00896532|3705469|FG003|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
2989117|NCT00896532|3705470|FG004|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
2989118|NCT00896532|3705471|FG005|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
2989119|NCT00896532|3705472|FG006|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
2989120|NCT00896532|3705473|FG007|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
2989121|NCT00896532|3705474|FG008|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
2989122|NCT00896532|3705475|FG009|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
2989123|NCT00896532|3705476|FG010|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
2989124|NCT00896532|3705477|FG011|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
2989125|NCT00896532|3705478|FG012|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
2989126|NCT00896532|3705479|FG013|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
2989127|NCT00896532|3705480|FG014|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
2989128|NCT00896532|3705481|FG015|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
2989129|NCT00896532|3705482|FG016|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
2989130|NCT00896532|3705483|FG017|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
2989131|NCT00896532|3705484|FG018|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
2989132|NCT00896532|3705485|FG019|Received Zoledronic Acid|Months 48-72: Follow-on Phase||11
2989133|NCT00896532|3705486|FG020|Received Zoledronic Acid|Months 48-72: Follow-on Phase||12
2989134|NCT00896532|3705487|FG021|Received Zoledronic Acid|Months 48-72: Follow-on Phase||56
2989135|NCT00896532|3705488|FG022|Received Zoledronic Acid|Months 48-72: Follow-on Phase||8
2989136|NCT00896532|3705466|FG000|COMPLETED|Months 48-72: Follow-on Phase||0
2989137|NCT00896532|3705467|FG001|COMPLETED|Months 48-72: Follow-on Phase||0
2989138|NCT00896532|3705468|FG002|COMPLETED|Months 48-72: Follow-on Phase||0
2989139|NCT00896532|3705469|FG003|COMPLETED|Months 48-72: Follow-on Phase||0
2989140|NCT00896532|3705470|FG004|COMPLETED|Months 48-72: Follow-on Phase||0
2989141|NCT00896532|3705471|FG005|COMPLETED|Months 48-72: Follow-on Phase||0
2989142|NCT00896532|3705472|FG006|COMPLETED|Months 48-72: Follow-on Phase||0
2989143|NCT00896532|3705473|FG007|COMPLETED|Months 48-72: Follow-on Phase||0
2989144|NCT00896532|3705474|FG008|COMPLETED|Months 48-72: Follow-on Phase||0
2989145|NCT00896532|3705475|FG009|COMPLETED|Months 48-72: Follow-on Phase||0
2989146|NCT00896532|3705476|FG010|COMPLETED|Months 48-72: Follow-on Phase||0
2989147|NCT00896532|3705477|FG011|COMPLETED|Months 48-72: Follow-on Phase||0
2989148|NCT00896532|3705478|FG012|COMPLETED|Months 48-72: Follow-on Phase||0
2989149|NCT00896532|3705479|FG013|COMPLETED|Months 48-72: Follow-on Phase||0
2989150|NCT00896532|3705480|FG014|COMPLETED|Months 48-72: Follow-on Phase||0
2989151|NCT00896532|3705481|FG015|COMPLETED|Months 48-72: Follow-on Phase||0
2989152|NCT00896532|3705482|FG016|COMPLETED|Months 48-72: Follow-on Phase||0
2989153|NCT00896532|3705483|FG017|COMPLETED|Months 48-72: Follow-on Phase||0
2989154|NCT00896532|3705484|FG018|COMPLETED|Months 48-72: Follow-on Phase||50
2989155|NCT00896532|3705485|FG019|COMPLETED|Months 48-72: Follow-on Phase||11
2989156|NCT00896532|3705486|FG020|COMPLETED|Months 48-72: Follow-on Phase||12
2989157|NCT00896532|3705487|FG021|COMPLETED|Months 48-72: Follow-on Phase||57
2989158|NCT00896532|3705488|FG022|COMPLETED|Months 48-72: Follow-on Phase||8
2989159|NCT00896532|3705466|FG000|NOT COMPLETED|Months 48-72: Follow-on Phase||0
2989160|NCT00896532|3705467|FG001|NOT COMPLETED|Months 48-72: Follow-on Phase||0
2989161|NCT00896532|3705468|FG002|NOT COMPLETED|Months 48-72: Follow-on Phase||0
2989162|NCT00896532|3705469|FG003|NOT COMPLETED|Months 48-72: Follow-on Phase||0
2989163|NCT00896532|3705470|FG004|NOT COMPLETED|Months 48-72: Follow-on Phase||0
2989164|NCT00896532|3705471|FG005|NOT COMPLETED|Months 48-72: Follow-on Phase||0
2989165|NCT00896532|3705472|FG006|NOT COMPLETED|Months 48-72: Follow-on Phase||0
2989166|NCT00896532|3705473|FG007|NOT COMPLETED|Months 48-72: Follow-on Phase||0
2989167|NCT00896532|3705474|FG008|NOT COMPLETED|Months 48-72: Follow-on Phase||0
2989168|NCT00896532|3705475|FG009|NOT COMPLETED|Months 48-72: Follow-on Phase||0
2989169|NCT00896532|3705476|FG010|NOT COMPLETED|Months 48-72: Follow-on Phase||0
2989170|NCT00896532|3705477|FG011|NOT COMPLETED|Months 48-72: Follow-on Phase||0
2989171|NCT00896532|3705478|FG012|NOT COMPLETED|Months 48-72: Follow-on Phase||0
2989172|NCT00896532|3705479|FG013|NOT COMPLETED|Months 48-72: Follow-on Phase||0
2989173|NCT00896532|3705480|FG014|NOT COMPLETED|Months 48-72: Follow-on Phase||0
2989174|NCT00896532|3705481|FG015|NOT COMPLETED|Months 48-72: Follow-on Phase||0
2989175|NCT00896532|3705482|FG016|NOT COMPLETED|Months 48-72: Follow-on Phase||0
2989176|NCT00896532|3705483|FG017|NOT COMPLETED|Months 48-72: Follow-on Phase||0
2989177|NCT00896532|3705484|FG018|NOT COMPLETED|Months 48-72: Follow-on Phase||1
3304888|NCT02982954|4038475|FG002|STARTED|Continuing in Study||28
3304889|NCT02982954|4038476|FG003|STARTED|Continuing in Study||25
3304890|NCT02982954|4038473|FG000|COMPLETED|Continuing in Study||52
3304891|NCT02982954|4038474|FG001|COMPLETED|Continuing in Study||19
3304892|NCT02982954|4038475|FG002|COMPLETED|Continuing in Study||17
3304893|NCT02982954|4038476|FG003|COMPLETED|Continuing in Study||7
2989178|NCT00896532|3705485|FG019|NOT COMPLETED|Months 48-72: Follow-on Phase||0
2989179|NCT00896532|3705486|FG020|NOT COMPLETED|Months 48-72: Follow-on Phase||0
2989180|NCT00896532|3705487|FG021|NOT COMPLETED|Months 48-72: Follow-on Phase||2
2989181|NCT00896532|3705488|FG022|NOT COMPLETED|Months 48-72: Follow-on Phase||0
2989182|NCT00896649|3705535|FG000|STARTED|Overall Study||193
2989183|NCT00896649|3705535|FG000|COMPLETED|Overall Study||188
2989184|NCT00896649|3705535|FG000|NOT COMPLETED|Overall Study||5
2989185|NCT00896779|3705542|FG000|STARTED|Overall Study||8
2989186|NCT00896779|3705543|FG001|STARTED|Overall Study||12
2989187|NCT00896779|3705542|FG000|COMPLETED|Overall Study||8
2989188|NCT00896779|3705543|FG001|COMPLETED|Overall Study||11
2989189|NCT00896779|3705542|FG000|NOT COMPLETED|Overall Study||0
2989190|NCT00896779|3705543|FG001|NOT COMPLETED|Overall Study||1
2989191|NCT00897390|3705549|FG000|STARTED|Overall Study||24
2989192|NCT00897390|3705549|FG000|COMPLETED|Overall Study||18
2989193|NCT00897390|3705549|FG000|NOT COMPLETED|Overall Study||6
2989194|NCT00897676|3705560|FG000|STARTED|Intervention 1(6 Hours)||9
2989195|NCT00897676|3705561|FG001|STARTED|Intervention 1(6 Hours)||7
2989196|NCT00897676|3705560|FG000|COMPLETED|Intervention 1(6 Hours)||9
2989197|NCT00897676|3705561|FG001|COMPLETED|Intervention 1(6 Hours)||7
2989198|NCT00897676|3705560|FG000|NOT COMPLETED|Intervention 1(6 Hours)||0
2989199|NCT00897676|3705561|FG001|NOT COMPLETED|Intervention 1(6 Hours)||0
2989200|NCT00897676|3705560|FG000|STARTED|Intervention 2(6 Hours)||9
2989201|NCT00897676|3705561|FG001|STARTED|Intervention 2(6 Hours)||7
2989202|NCT00897676|3705560|FG000|COMPLETED|Intervention 2(6 Hours)||9
2989203|NCT00897676|3705561|FG001|COMPLETED|Intervention 2(6 Hours)||7
2989204|NCT00897676|3705560|FG000|NOT COMPLETED|Intervention 2(6 Hours)||0
2989205|NCT00897676|3705561|FG001|NOT COMPLETED|Intervention 2(6 Hours)||0
2989206|NCT00897715|3705576|FG000|STARTED|Overall Study||8
2989207|NCT00897715|3705577|FG001|STARTED|Overall Study||7
2989208|NCT00897715|3705576|FG000|COMPLETED|Overall Study||6
2989209|NCT00897715|3705577|FG001|COMPLETED|Overall Study||6
2989210|NCT00897715|3705576|FG000|NOT COMPLETED|Overall Study||2
2989211|NCT00897715|3705577|FG001|NOT COMPLETED|Overall Study||1
2989212|NCT00897897|3705583|FG000|STARTED|Overall Study||33
2989213|NCT00897897|3705583|FG000|COMPLETED|Overall Study||33
2989214|NCT00897897|3705583|FG000|NOT COMPLETED|Overall Study||0
2989215|NCT00898222|3705587|FG000|STARTED|Overall Study||4
2989216|NCT00898222|3705587|FG000|COMPLETED|Overall Study||4
2989217|NCT00898222|3705587|FG000|NOT COMPLETED|Overall Study||0
2989218|NCT00898443|3705593|FG000|STARTED|Overall Study||10
2989219|NCT00898443|3705594|FG001|STARTED|Overall Study||8
2989220|NCT00898443|3705593|FG000|COMPLETED|Overall Study||9
2989221|NCT00898443|3705594|FG001|COMPLETED|Overall Study||8
2989222|NCT00898443|3705593|FG000|NOT COMPLETED|Overall Study||1
2989223|NCT00898443|3705594|FG001|NOT COMPLETED|Overall Study||0
2989224|NCT00898560|3705600|FG000|STARTED|Overall Study||20
2989225|NCT00898560|3705600|FG000|COMPLETED|Overall Study||19
2989226|NCT00898560|3705600|FG000|NOT COMPLETED|Overall Study||1
2989227|NCT00898807|3705608|FG000|STARTED|Overall Study||94
2989228|NCT00898807|3705609|FG001|STARTED|Overall Study||92
2989229|NCT00898807|3705608|FG000|COMPLETED|Overall Study||86
2989230|NCT00898807|3705609|FG001|COMPLETED|Overall Study||83
2989231|NCT00898807|3705608|FG000|NOT COMPLETED|Overall Study||8
2989232|NCT00898807|3705609|FG001|NOT COMPLETED|Overall Study||9
2989233|NCT00898937|3705618|FG000|STARTED|Overall Study||25
2989234|NCT00898937|3705619|FG001|STARTED|Overall Study||21
2989235|NCT00898937|3705620|FG002|STARTED|Overall Study||9
2989236|NCT00898937|3705618|FG000|COMPLETED|Overall Study||25
2989237|NCT00898937|3705619|FG001|COMPLETED|Overall Study||21
2989238|NCT00898937|3705620|FG002|COMPLETED|Overall Study||9
2989239|NCT00898937|3705618|FG000|NOT COMPLETED|Overall Study||0
2989240|NCT00898937|3705619|FG001|NOT COMPLETED|Overall Study||0
2989241|NCT00898937|3705620|FG002|NOT COMPLETED|Overall Study||0
2989242|NCT00899353|3705628|FG000|STARTED|Overall Study||16
2989243|NCT00899353|3705628|FG000|COMPLETED|Overall Study||11
2989244|NCT00899353|3705628|FG000|NOT COMPLETED|Overall Study||5
2989245|NCT00899392|3705651|FG000|STARTED|Overall Study||68
2989246|NCT00899392|3705652|FG001|STARTED|Overall Study||74
2989247|NCT00899392|3705651|FG000|COMPLETED|Overall Study|Subjects:PerVariableStudied Consent:47-EAC 50-FBC Anxiety:60-EAC 3-FBC Satisfaction:63-EAC 67-FBC|47
2989248|NCT00899392|3705652|FG001|COMPLETED|Overall Study|Subjects:PerVariableStudied Consent:47-EAC 50-FBC Anxiety:60-EAC 3-FBC Satisfaction:63-EAC 67-FBC|50
2989249|NCT00899392|3705651|FG000|NOT COMPLETED|Overall Study||21
2989250|NCT00899392|3705652|FG001|NOT COMPLETED|Overall Study||24
2989251|NCT00899431|3705661|FG000|STARTED|Overall Study||22
2989252|NCT00899431|3705662|FG001|STARTED|Overall Study||8
2989253|NCT00899431|3705663|FG002|STARTED|Overall Study||9
2989254|NCT00899431|3705661|FG000|COMPLETED|Overall Study||21
2989255|NCT00899431|3705662|FG001|COMPLETED|Overall Study||8
2989256|NCT00899431|3705663|FG002|COMPLETED|Overall Study||9
2989257|NCT00899431|3705661|FG000|NOT COMPLETED|Overall Study||1
2989258|NCT00899431|3705662|FG001|NOT COMPLETED|Overall Study||0
2989259|NCT00899431|3705663|FG002|NOT COMPLETED|Overall Study||0
2989260|NCT00899470|3705674|FG000|STARTED|First Therapy||6
2989261|NCT00899470|3705675|FG001|STARTED|First Therapy||6
2989262|NCT00899470|3705676|FG002|STARTED|First Therapy||6
2989263|NCT00899470|3705677|FG003|STARTED|First Therapy||6
2989264|NCT00899470|3705674|FG000|COMPLETED|First Therapy||6
2989265|NCT00899470|3705675|FG001|COMPLETED|First Therapy||6
2989266|NCT00899470|3705676|FG002|COMPLETED|First Therapy||6
2989267|NCT00899470|3705677|FG003|COMPLETED|First Therapy||6
2989268|NCT00899470|3705674|FG000|NOT COMPLETED|First Therapy||0
2989269|NCT00899470|3705675|FG001|NOT COMPLETED|First Therapy||0
2989270|NCT00899470|3705676|FG002|NOT COMPLETED|First Therapy||0
2989271|NCT00899470|3705677|FG003|NOT COMPLETED|First Therapy||0
2989272|NCT00899470|3705674|FG000|STARTED|First Washout Period||6
2989273|NCT00899470|3705675|FG001|STARTED|First Washout Period||6
2989274|NCT00899470|3705676|FG002|STARTED|First Washout Period||6
2989275|NCT00899470|3705677|FG003|STARTED|First Washout Period||6
2989276|NCT00899470|3705674|FG000|COMPLETED|First Washout Period||6
2989277|NCT00899470|3705675|FG001|COMPLETED|First Washout Period||6
2989278|NCT00899470|3705676|FG002|COMPLETED|First Washout Period||6
2989279|NCT00899470|3705677|FG003|COMPLETED|First Washout Period||6
2989280|NCT00899470|3705674|FG000|NOT COMPLETED|First Washout Period||0
2989281|NCT00899470|3705675|FG001|NOT COMPLETED|First Washout Period||0
2989282|NCT00899470|3705676|FG002|NOT COMPLETED|First Washout Period||0
2989283|NCT00899470|3705677|FG003|NOT COMPLETED|First Washout Period||0
2989284|NCT00899470|3705674|FG000|STARTED|Second Therapy||6
2989285|NCT00899470|3705675|FG001|STARTED|Second Therapy||6
2989286|NCT00899470|3705676|FG002|STARTED|Second Therapy||6
2989287|NCT00899470|3705677|FG003|STARTED|Second Therapy||6
2989288|NCT00899470|3705674|FG000|COMPLETED|Second Therapy||6
2989289|NCT00899470|3705675|FG001|COMPLETED|Second Therapy||6
2989290|NCT00899470|3705676|FG002|COMPLETED|Second Therapy||6
2989291|NCT00899470|3705677|FG003|COMPLETED|Second Therapy||6
2989292|NCT00899470|3705674|FG000|NOT COMPLETED|Second Therapy||0
2989293|NCT00899470|3705675|FG001|NOT COMPLETED|Second Therapy||0
2989294|NCT00899470|3705676|FG002|NOT COMPLETED|Second Therapy||0
2989295|NCT00899470|3705677|FG003|NOT COMPLETED|Second Therapy||0
2989296|NCT00899470|3705674|FG000|STARTED|Second Washout||6
2989297|NCT00899470|3705675|FG001|STARTED|Second Washout||6
2989298|NCT00899470|3705676|FG002|STARTED|Second Washout||6
2989299|NCT00899470|3705677|FG003|STARTED|Second Washout||6
2989300|NCT00899470|3705674|FG000|COMPLETED|Second Washout||6
2989301|NCT00899470|3705675|FG001|COMPLETED|Second Washout||6
2989302|NCT00899470|3705676|FG002|COMPLETED|Second Washout||6
2989303|NCT00899470|3705677|FG003|COMPLETED|Second Washout||6
2989304|NCT00899470|3705674|FG000|NOT COMPLETED|Second Washout||0
2989305|NCT00899470|3705675|FG001|NOT COMPLETED|Second Washout||0
2989306|NCT00899470|3705676|FG002|NOT COMPLETED|Second Washout||0
2989307|NCT00899470|3705677|FG003|NOT COMPLETED|Second Washout||0
2989308|NCT00899470|3705674|FG000|STARTED|Third Therapy||6
2989309|NCT00899470|3705675|FG001|STARTED|Third Therapy||6
2989310|NCT00899470|3705676|FG002|STARTED|Third Therapy||6
2989311|NCT00899470|3705677|FG003|STARTED|Third Therapy||6
2989312|NCT00899470|3705674|FG000|COMPLETED|Third Therapy||6
2989313|NCT00899470|3705675|FG001|COMPLETED|Third Therapy||6
2989314|NCT00899470|3705676|FG002|COMPLETED|Third Therapy||6
2989315|NCT00899470|3705677|FG003|COMPLETED|Third Therapy||6
2989316|NCT00899470|3705674|FG000|NOT COMPLETED|Third Therapy||0
2989317|NCT00899470|3705675|FG001|NOT COMPLETED|Third Therapy||0
2989318|NCT00899470|3705676|FG002|NOT COMPLETED|Third Therapy||0
2989319|NCT00899470|3705677|FG003|NOT COMPLETED|Third Therapy||0
2989320|NCT00899470|3705674|FG000|STARTED|Third Washout||6
2989321|NCT00899470|3705675|FG001|STARTED|Third Washout||6
2989322|NCT00899470|3705676|FG002|STARTED|Third Washout||6
2989323|NCT00899470|3705677|FG003|STARTED|Third Washout||6
2989324|NCT00899470|3705674|FG000|COMPLETED|Third Washout||6
2989325|NCT00899470|3705675|FG001|COMPLETED|Third Washout||6
2989326|NCT00899470|3705676|FG002|COMPLETED|Third Washout||6
2989327|NCT00899470|3705677|FG003|COMPLETED|Third Washout||6
2989328|NCT00899470|3705674|FG000|NOT COMPLETED|Third Washout||0
2989329|NCT00899470|3705675|FG001|NOT COMPLETED|Third Washout||0
2989330|NCT00899470|3705676|FG002|NOT COMPLETED|Third Washout||0
2989331|NCT00899470|3705677|FG003|NOT COMPLETED|Third Washout||0
2989332|NCT00899470|3705674|FG000|STARTED|Fourth Therapy||6
2989333|NCT00899470|3705675|FG001|STARTED|Fourth Therapy||6
2989334|NCT00899470|3705676|FG002|STARTED|Fourth Therapy||6
2989335|NCT00899470|3705677|FG003|STARTED|Fourth Therapy||6
2989336|NCT00899470|3705674|FG000|COMPLETED|Fourth Therapy||6
2989337|NCT00899470|3705675|FG001|COMPLETED|Fourth Therapy||6
2989338|NCT00899470|3705676|FG002|COMPLETED|Fourth Therapy||6
2989339|NCT00899470|3705677|FG003|COMPLETED|Fourth Therapy||6
2989340|NCT00899470|3705674|FG000|NOT COMPLETED|Fourth Therapy||0
2989341|NCT00899470|3705675|FG001|NOT COMPLETED|Fourth Therapy||0
2989342|NCT00899470|3705676|FG002|NOT COMPLETED|Fourth Therapy||0
2989343|NCT00899470|3705677|FG003|NOT COMPLETED|Fourth Therapy||0
2989344|NCT00899548|3705692|FG000|STARTED|Overall Study||182
2989345|NCT00899548|3705692|FG000|COMPLETED|Overall Study||179
2989346|NCT00899548|3705692|FG000|NOT COMPLETED|Overall Study||3
3164433|NCT01892189|3891784|FG006|STARTED|Third Intervention Period (1 Day)||2
3164434|NCT01892189|3891785|FG007|STARTED|Third Intervention Period (1 Day)||3
2989347|NCT00899574|3705700|FG000|STARTED|Overall Study||10
2989348|NCT00899574|3705700|FG000|COMPLETED|Overall Study||10
2989349|NCT00899574|3705700|FG000|NOT COMPLETED|Overall Study||0
2989350|NCT00899600|3705706|FG000|STARTED|Overall Study||50
2989351|NCT00899600|3705707|FG001|STARTED|Overall Study||52
2989352|NCT00899600|3705706|FG000|COMPLETED|Overall Study||50
2989353|NCT00899600|3705707|FG001|COMPLETED|Overall Study||52
2989354|NCT00899600|3705706|FG000|NOT COMPLETED|Overall Study||0
2989355|NCT00899600|3705707|FG001|NOT COMPLETED|Overall Study||0
3164435|NCT01892189|3891786|FG008|STARTED|Third Intervention Period (1 Day)||1
2989356|NCT00899678|3705716|FG000|STARTED|Induction Period (Weeks 0 to 6)|Induction only includes subjects that discontinued before Maintenance Period.|27
2989357|NCT00899678|3705717|FG001|STARTED|Induction Period (Weeks 0 to 6)||37
2989358|NCT00899678|3705718|FG002|STARTED|Induction Period (Weeks 0 to 6)||35
2989359|NCT00899678|3705716|FG000|COMPLETED|Induction Period (Weeks 0 to 6)|2 subjects completed the Induction Phase, but discontinued prior to receiving any Maintenance doses.|2
2989360|NCT00899678|3705717|FG001|COMPLETED|Induction Period (Weeks 0 to 6)||37
2989361|NCT00899678|3705718|FG002|COMPLETED|Induction Period (Weeks 0 to 6)||35
2989362|NCT00899678|3705716|FG000|NOT COMPLETED|Induction Period (Weeks 0 to 6)||25
2989363|NCT00899678|3705717|FG001|NOT COMPLETED|Induction Period (Weeks 0 to 6)||0
2989364|NCT00899678|3705718|FG002|NOT COMPLETED|Induction Period (Weeks 0 to 6)||0
2989365|NCT00899678|3705716|FG000|STARTED|Maintenance Period (Weeks 8 to 62)|Induction only includes subjects that discontinued before Maintenance Period.|0
2989366|NCT00899678|3705717|FG001|STARTED|Maintenance Period (Weeks 8 to 62)||37
2989367|NCT00899678|3705718|FG002|STARTED|Maintenance Period (Weeks 8 to 62)||35
2989368|NCT00899678|3705716|FG000|COMPLETED|Maintenance Period (Weeks 8 to 62)||0
2989369|NCT00899678|3705717|FG001|COMPLETED|Maintenance Period (Weeks 8 to 62)||12
2989370|NCT00899678|3705718|FG002|COMPLETED|Maintenance Period (Weeks 8 to 62)||7
2989371|NCT00899678|3705716|FG000|NOT COMPLETED|Maintenance Period (Weeks 8 to 62)||0
2989372|NCT00899678|3705717|FG001|NOT COMPLETED|Maintenance Period (Weeks 8 to 62)||25
2989373|NCT00899678|3705718|FG002|NOT COMPLETED|Maintenance Period (Weeks 8 to 62)||28
2989374|NCT00899717|3705728|FG000|STARTED|Overall Study||10
2989375|NCT00899717|3705729|FG001|STARTED|Overall Study||11
2989376|NCT00899717|3705728|FG000|COMPLETED|Overall Study||10
2989377|NCT00899717|3705729|FG001|COMPLETED|Overall Study||11
2989378|NCT00899717|3705728|FG000|NOT COMPLETED|Overall Study||0
2989379|NCT00899717|3705729|FG001|NOT COMPLETED|Overall Study||0
2989380|NCT00899847|3705741|FG000|STARTED|Overall Study||9
2989381|NCT00899847|3705741|FG000|COMPLETED|Overall Study||7
2989382|NCT00899847|3705741|FG000|NOT COMPLETED|Overall Study||2
2989383|NCT00900029|3705752|FG000|STARTED|Overall Study||38
2989384|NCT00900029|3705753|FG001|STARTED|Overall Study||41
2989385|NCT00900029|3705754|FG002|STARTED|Overall Study||41
2989386|NCT00900029|3705755|FG003|STARTED|Overall Study||42
2989387|NCT00900029|3705756|FG004|STARTED|Overall Study||44
2989388|NCT00900029|3705752|FG000|COMPLETED|Overall Study||35
2989389|NCT00900029|3705753|FG001|COMPLETED|Overall Study||37
2989390|NCT00900029|3705754|FG002|COMPLETED|Overall Study||38
2989391|NCT00900029|3705755|FG003|COMPLETED|Overall Study||35
2989392|NCT00900029|3705756|FG004|COMPLETED|Overall Study||38
2989393|NCT00900029|3705752|FG000|NOT COMPLETED|Overall Study||3
2989394|NCT00900029|3705753|FG001|NOT COMPLETED|Overall Study||4
2989395|NCT00900029|3705754|FG002|NOT COMPLETED|Overall Study||3
2989396|NCT00900029|3705755|FG003|NOT COMPLETED|Overall Study||7
2989397|NCT00900029|3705756|FG004|NOT COMPLETED|Overall Study||6
2989398|NCT00900146|3705773|FG000|STARTED|Dose Finding: Period II (4 Months)||93
2989399|NCT00900146|3705774|FG001|STARTED|Dose Finding: Period II (4 Months)||95
2989400|NCT00900146|3705775|FG002|STARTED|Dose Finding: Period II (4 Months)||92
2989401|NCT00900146|3705776|FG003|STARTED|Dose Finding: Period II (4 Months)||92
2989402|NCT00900146|3705777|FG004|STARTED|Dose Finding: Period II (4 Months)||179
2989403|NCT00900146|3705773|FG000|Full Analysis Set (FAS)/Safety|Dose Finding: Period II (4 Months)||93
2989404|NCT00900146|3705774|FG001|Full Analysis Set (FAS)/Safety|Dose Finding: Period II (4 Months)||95
2989405|NCT00900146|3705775|FG002|Full Analysis Set (FAS)/Safety|Dose Finding: Period II (4 Months)||92
2989406|NCT00900146|3705776|FG003|Full Analysis Set (FAS)/Safety|Dose Finding: Period II (4 Months)||92
2989407|NCT00900146|3705777|FG004|Full Analysis Set (FAS)/Safety|Dose Finding: Period II (4 Months)||179
2989408|NCT00900146|3705773|FG000|COMPLETED|Dose Finding: Period II (4 Months)||88
2989409|NCT00900146|3705774|FG001|COMPLETED|Dose Finding: Period II (4 Months)||93
2989410|NCT00900146|3705775|FG002|COMPLETED|Dose Finding: Period II (4 Months)||87
2989411|NCT00900146|3705776|FG003|COMPLETED|Dose Finding: Period II (4 Months)||90
2989412|NCT00900146|3705777|FG004|COMPLETED|Dose Finding: Period II (4 Months)|Placebo also included 1 patient with no study completion page.|167
2989413|NCT00900146|3705773|FG000|NOT COMPLETED|Dose Finding: Period II (4 Months)||5
2989414|NCT00900146|3705774|FG001|NOT COMPLETED|Dose Finding: Period II (4 Months)||2
2989415|NCT00900146|3705775|FG002|NOT COMPLETED|Dose Finding: Period II (4 Months)||5
2989416|NCT00900146|3705776|FG003|NOT COMPLETED|Dose Finding: Period II (4 Months)||2
2989417|NCT00900146|3705777|FG004|NOT COMPLETED|Dose Finding: Period II (4 Months)||12
2989418|NCT00900146|3705773|FG000|STARTED|Intermediate: Period III||87
2989419|NCT00900146|3705774|FG001|STARTED|Intermediate: Period III||93
2989420|NCT00900146|3705775|FG002|STARTED|Intermediate: Period III||84
2989421|NCT00900146|3705776|FG003|STARTED|Intermediate: Period III||90
2989422|NCT00900146|3705777|FG004|STARTED|Intermediate: Period III||167
2989423|NCT00900146|3705773|FG000|Safety Set|Intermediate: Period III||86
2989424|NCT00900146|3705774|FG001|Safety Set|Intermediate: Period III||92
2989425|NCT00900146|3705775|FG002|Safety Set|Intermediate: Period III||84
2989426|NCT00900146|3705776|FG003|Safety Set|Intermediate: Period III||90
2989427|NCT00900146|3705777|FG004|Safety Set|Intermediate: Period III||166
2989428|NCT00900146|3705773|FG000|COMPLETED|Intermediate: Period III||0
2989429|NCT00900146|3705774|FG001|COMPLETED|Intermediate: Period III||0
2989430|NCT00900146|3705775|FG002|COMPLETED|Intermediate: Period III||0
2989431|NCT00900146|3705776|FG003|COMPLETED|Intermediate: Period III||0
2989432|NCT00900146|3705777|FG004|COMPLETED|Intermediate: Period III||0
3136745|NCT01714726|3861990|FG002|NOT COMPLETED|Open-Label Period||19
2989433|NCT00900146|3705773|FG000|NOT COMPLETED|Intermediate: Period III||87
2989434|NCT00900146|3705774|FG001|NOT COMPLETED|Intermediate: Period III||93
2989435|NCT00900146|3705775|FG002|NOT COMPLETED|Intermediate: Period III||84
2989436|NCT00900146|3705776|FG003|NOT COMPLETED|Intermediate: Period III||90
2989437|NCT00900146|3705777|FG004|NOT COMPLETED|Intermediate: Period III||167
2989438|NCT00900159|3705791|FG000|STARTED|First Intervention||11
2989439|NCT00900159|3705792|FG001|STARTED|First Intervention||13
2989440|NCT00900159|3705791|FG000|COMPLETED|First Intervention||11
2989441|NCT00900159|3705792|FG001|COMPLETED|First Intervention||13
2989442|NCT00900159|3705791|FG000|NOT COMPLETED|First Intervention||0
2989443|NCT00900159|3705792|FG001|NOT COMPLETED|First Intervention||0
2989444|NCT00900159|3705791|FG000|STARTED|Washout||11
2989445|NCT00900159|3705792|FG001|STARTED|Washout||13
2989446|NCT00900159|3705791|FG000|COMPLETED|Washout||11
2989447|NCT00900159|3705792|FG001|COMPLETED|Washout||13
2989448|NCT00900159|3705791|FG000|NOT COMPLETED|Washout||0
2989449|NCT00900159|3705792|FG001|NOT COMPLETED|Washout||0
2989450|NCT00900159|3705791|FG000|STARTED|Second Intervention||11
2989451|NCT00900159|3705792|FG001|STARTED|Second Intervention||13
2989452|NCT00900159|3705791|FG000|COMPLETED|Second Intervention||10
2989453|NCT00900159|3705792|FG001|COMPLETED|Second Intervention||13
2989454|NCT00900159|3705791|FG000|NOT COMPLETED|Second Intervention||1
2989455|NCT00900159|3705792|FG001|NOT COMPLETED|Second Intervention||0
2989456|NCT00900237|3705800|FG000|STARTED|Overall Study||7
2989457|NCT00900237|3705801|FG001|STARTED|Overall Study||7
2989458|NCT00900237|3705800|FG000|COMPLETED|Overall Study||7
2989459|NCT00900237|3705801|FG001|COMPLETED|Overall Study||7
2989460|NCT00900237|3705800|FG000|NOT COMPLETED|Overall Study||0
2989461|NCT00900237|3705801|FG001|NOT COMPLETED|Overall Study||0
2989462|NCT00900562|3705809|FG000|STARTED|Overall Study||12
2989463|NCT00900562|3705810|FG001|STARTED|Overall Study||7
2989464|NCT00900562|3705809|FG000|COMPLETED|Overall Study||0
2989465|NCT00900562|3705810|FG001|COMPLETED|Overall Study||0
2989466|NCT00900562|3705809|FG000|NOT COMPLETED|Overall Study||12
2989467|NCT00900562|3705810|FG001|NOT COMPLETED|Overall Study||7
2989468|NCT00900601|3705817|FG000|STARTED|Overall Study||9
2989469|NCT00900601|3705817|FG000|COMPLETED|Overall Study||8
2989470|NCT00900601|3705817|FG000|NOT COMPLETED|Overall Study||1
2989471|NCT00900627|3705827|FG000|STARTED|Overall Study||6
2989472|NCT00900627|3705828|FG001|STARTED|Overall Study||2
2989473|NCT00900627|3705829|FG002|STARTED|Overall Study||6
2989474|NCT00900627|3705830|FG003|STARTED|Overall Study||6
2989475|NCT00900627|3705831|FG004|STARTED|Overall Study|The values under 'Not Completed' are based on the time of the primary analysis|94
2989476|NCT00900627|3705832|FG005|STARTED|Overall Study|The values under 'Not Completed' are based on the time of the primary analysis|96
2989477|NCT00900627|3705827|FG000|COMPLETED|Overall Study|No set completion, patients were to remain in study until withdrawn|0
2989478|NCT00900627|3705828|FG001|COMPLETED|Overall Study|No set completion, patients were to remain in study until withdrawn|0
2989479|NCT00900627|3705829|FG002|COMPLETED|Overall Study|No set completion, patients were to remain in study until withdrawn|0
2989480|NCT00900627|3705830|FG003|COMPLETED|Overall Study|No set completion, patients were to remain in study until withdrawn|0
2989481|NCT00900627|3705831|FG004|COMPLETED|Overall Study|No set completion, pts were to remain in study until withdrawn|65
2989482|NCT00900627|3705832|FG005|COMPLETED|Overall Study|No set completion, patients were to remain in study until withdrawn|70
3164436|NCT01892189|3891778|FG000|COMPLETED|Third Intervention Period (1 Day)||3
3164437|NCT01892189|3891779|FG001|COMPLETED|Third Intervention Period (1 Day)||3
3164438|NCT01892189|3891780|FG002|COMPLETED|Third Intervention Period (1 Day)||1
3164439|NCT01892189|3891781|FG003|COMPLETED|Third Intervention Period (1 Day)||2
3164440|NCT01892189|3891782|FG004|COMPLETED|Third Intervention Period (1 Day)||3
2989483|NCT00900627|3705827|FG000|NOT COMPLETED|Overall Study||6
2989484|NCT00900627|3705828|FG001|NOT COMPLETED|Overall Study||2
2989485|NCT00900627|3705829|FG002|NOT COMPLETED|Overall Study||6
2989486|NCT00900627|3705830|FG003|NOT COMPLETED|Overall Study||6
2989487|NCT00900627|3705831|FG004|NOT COMPLETED|Overall Study||29
2989488|NCT00900627|3705832|FG005|NOT COMPLETED|Overall Study||26
2989489|NCT00900666|3705848|FG000|STARTED|Overall Study||10
2989490|NCT00900666|3705849|FG001|STARTED|Overall Study||9
2989491|NCT00900666|3705848|FG000|COMPLETED|Overall Study||10
2989492|NCT00900666|3705849|FG001|COMPLETED|Overall Study||9
2989493|NCT00900666|3705848|FG000|NOT COMPLETED|Overall Study||0
2989494|NCT00900666|3705849|FG001|NOT COMPLETED|Overall Study||0
2989495|NCT00900731|3705857|FG000|STARTED|Overall Study|Randomized participants|797
2989496|NCT00900731|3705858|FG001|STARTED|Overall Study||801
2989497|NCT00900731|3705857|FG000|Safety Set: Received Study Drug|Overall Study||794
2989498|NCT00900731|3705858|FG001|Safety Set: Received Study Drug|Overall Study||799
2989499|NCT00900731|3705857|FG000|COMPLETED|Overall Study||737
2989500|NCT00900731|3705858|FG001|COMPLETED|Overall Study||740
2989501|NCT00900731|3705857|FG000|NOT COMPLETED|Overall Study||60
2989502|NCT00900731|3705858|FG001|NOT COMPLETED|Overall Study||61
2989503|NCT00900757|3705864|FG000|STARTED|Overall Study||57
2989504|NCT00900757|3705864|FG000|COMPLETED|Overall Study||38
2989505|NCT00900757|3705864|FG000|NOT COMPLETED|Overall Study||19
2989506|NCT00900796|3705868|FG000|STARTED|Phase 1||132
2989507|NCT00900796|3705868|FG000|COMPLETED|Phase 1||121
3164441|NCT01892189|3891783|FG005|COMPLETED|Third Intervention Period (1 Day)||2
3164442|NCT01892189|3891784|FG006|COMPLETED|Third Intervention Period (1 Day)||2
3164443|NCT01892189|3891785|FG007|COMPLETED|Third Intervention Period (1 Day)||3
2989508|NCT00900796|3705868|FG000|NOT COMPLETED|Phase 1||11
2989509|NCT00900796|3705868|FG000|STARTED|Between Phase 1 and Phase 2||121
2989510|NCT00900796|3705868|FG000|COMPLETED|Between Phase 1 and Phase 2||11
2989511|NCT00900796|3705868|FG000|NOT COMPLETED|Between Phase 1 and Phase 2||110
2989512|NCT00900796|3705868|FG000|STARTED|Phase 2||11
2989513|NCT00900796|3705868|FG000|COMPLETED|Phase 2||6
2989514|NCT00900796|3705868|FG000|NOT COMPLETED|Phase 2||5
2989515|NCT00900822|3705873|FG000|STARTED|9 Months Histological Evaluation||11
2989516|NCT00900822|3705873|FG000|COMPLETED|9 Months Histological Evaluation||11
2989517|NCT00900822|3705873|FG000|NOT COMPLETED|9 Months Histological Evaluation||0
2989518|NCT00900822|3705873|FG000|STARTED|12 Months Clinical Evaluation||11
2989519|NCT00900822|3705873|FG000|COMPLETED|12 Months Clinical Evaluation||11
2989520|NCT00900822|3705873|FG000|NOT COMPLETED|12 Months Clinical Evaluation||0
2989521|NCT00901017|3705880|FG000|STARTED|Overall Study||14
2989522|NCT00901017|3705880|FG000|COMPLETED|Overall Study||14
2989523|NCT00901017|3705880|FG000|NOT COMPLETED|Overall Study||0
2989524|NCT00901186|3705889|FG000|STARTED|Overall Study||40
2989525|NCT00901186|3705890|FG001|STARTED|Overall Study||43
2989526|NCT00901186|3705889|FG000|Safety Set|Overall Study|One participant did not receive one intravitreal RFB002 injection.|39
2989527|NCT00901186|3705890|FG001|Safety Set|Overall Study||43
2989528|NCT00901186|3705889|FG000|Intent to Treat|Overall Study|Four treated participants did not have at least a baseline and one post-treatment BCVA.|35
2989529|NCT00901186|3705890|FG001|Intent to Treat|Overall Study|Five treated participants did not have at least a baseline and one post-treatment BCVA.|38
2989530|NCT00901186|3705889|FG000|COMPLETED|Overall Study||31
2989531|NCT00901186|3705890|FG001|COMPLETED|Overall Study||32
2989532|NCT00901186|3705889|FG000|NOT COMPLETED|Overall Study||9
2989533|NCT00901186|3705890|FG001|NOT COMPLETED|Overall Study||11
2989534|NCT00901199|3705896|FG000|STARTED|Overall Study||22
2989535|NCT00901199|3705896|FG000|COMPLETED|Overall Study||18
2989536|NCT00901199|3705896|FG000|NOT COMPLETED|Overall Study||4
2989537|NCT00901225|3705900|FG000|STARTED|Overall Study||21
2989538|NCT00901225|3705900|FG000|COMPLETED|Overall Study||20
2989539|NCT00901225|3705900|FG000|NOT COMPLETED|Overall Study||1
2989540|NCT00901316|3705906|FG000|STARTED|Overall Study||492
2989541|NCT00901316|3705907|FG001|STARTED|Overall Study||495
2989542|NCT00901316|3705906|FG000|COMPLETED|Overall Study||492
2989543|NCT00901316|3705907|FG001|COMPLETED|Overall Study||495
2989544|NCT00901316|3705906|FG000|NOT COMPLETED|Overall Study||0
2989545|NCT00901316|3705907|FG001|NOT COMPLETED|Overall Study||0
2989546|NCT00901342|3705913|FG000|STARTED|Overall Study||104
2989547|NCT00901342|3705913|FG000|Received at Least 1 Infusion|Overall Study||98
2989548|NCT00901342|3705913|FG000|COMPLETED|Overall Study|89 subjects completed the study completion visit|89
2989549|NCT00901342|3705913|FG000|NOT COMPLETED|Overall Study||15
2989550|NCT00901394|3705920|FG000|STARTED|Overall Study||21
2989551|NCT00901394|3705921|FG001|STARTED|Overall Study||20
2989552|NCT00901394|3705922|FG002|STARTED|Overall Study||22
2989553|NCT00901394|3705920|FG000|COMPLETED|Overall Study||20
2989554|NCT00901394|3705921|FG001|COMPLETED|Overall Study||19
2989555|NCT00901394|3705922|FG002|COMPLETED|Overall Study||20
2989556|NCT00901394|3705920|FG000|NOT COMPLETED|Overall Study||1
3304894|NCT02982954|4038473|FG000|NOT COMPLETED|Continuing in Study||54
3304895|NCT02982954|4038474|FG001|NOT COMPLETED|Continuing in Study||33
3304896|NCT02982954|4038475|FG002|NOT COMPLETED|Continuing in Study||11
3304897|NCT02982954|4038476|FG003|NOT COMPLETED|Continuing in Study||18
3304898|NCT02983058|4038488|FG000|STARTED|Overall Study||7
3304899|NCT02983058|4038489|FG001|STARTED|Overall Study||5
3304900|NCT02983058|4038488|FG000|COMPLETED|Overall Study||2
3304901|NCT02983058|4038489|FG001|COMPLETED|Overall Study||2
3304902|NCT02983058|4038488|FG000|NOT COMPLETED|Overall Study||5
3304903|NCT02983058|4038489|FG001|NOT COMPLETED|Overall Study||3
3304904|NCT02983227|4038497|FG000|STARTED|Overall Study||410
3304905|NCT02983227|4038498|FG001|STARTED|Overall Study||86
3304906|NCT02983227|4038497|FG000|COMPLETED|Overall Study||351
3304907|NCT02983227|4038498|FG001|COMPLETED|Overall Study||72
3304908|NCT02983227|4038497|FG000|NOT COMPLETED|Overall Study||59
3304909|NCT02983227|4038498|FG001|NOT COMPLETED|Overall Study||14
2989557|NCT00901394|3705921|FG001|NOT COMPLETED|Overall Study||1
2989558|NCT00901394|3705922|FG002|NOT COMPLETED|Overall Study||2
2989559|NCT00901459|3705930|FG000|STARTED|Overall Study||21
2989560|NCT00901459|3705930|FG000|COMPLETED|Overall Study||15
2989561|NCT00901459|3705930|FG000|NOT COMPLETED|Overall Study||6
2989562|NCT00901485|3705941|FG000|STARTED|Overall Study||10
2989563|NCT00901485|3705942|FG001|STARTED|Overall Study||13
2989564|NCT00901485|3705941|FG000|COMPLETED|Overall Study||9
2989565|NCT00901485|3705942|FG001|COMPLETED|Overall Study||9
2989566|NCT00901485|3705941|FG000|NOT COMPLETED|Overall Study||1
2989567|NCT00901485|3705942|FG001|NOT COMPLETED|Overall Study||4
2989568|NCT00901576|3705954|FG000|STARTED|First Intervention||6
2989569|NCT00901576|3705955|FG001|STARTED|First Intervention||7
2989570|NCT00901576|3705956|FG002|STARTED|First Intervention||7
2989571|NCT00901576|3705957|FG003|STARTED|First Intervention||6
2989572|NCT00901576|3705958|FG004|STARTED|First Intervention||6
2989573|NCT00901576|3705959|FG005|STARTED|First Intervention||6
2989574|NCT00901576|3705954|FG000|COMPLETED|First Intervention||6
2989575|NCT00901576|3705955|FG001|COMPLETED|First Intervention||7
2989576|NCT00901576|3705956|FG002|COMPLETED|First Intervention||7
3304910|NCT02983305|4038506|FG000|STARTED|Overall Study||12
3304911|NCT02983305|4038507|FG001|STARTED|Overall Study||10
3304912|NCT02983305|4038506|FG000|COMPLETED|Overall Study||10
2989577|NCT00901576|3705957|FG003|COMPLETED|First Intervention||6
2989578|NCT00901576|3705958|FG004|COMPLETED|First Intervention||6
2989579|NCT00901576|3705959|FG005|COMPLETED|First Intervention||6
2989580|NCT00901576|3705954|FG000|NOT COMPLETED|First Intervention||0
2989581|NCT00901576|3705955|FG001|NOT COMPLETED|First Intervention||0
2989582|NCT00901576|3705956|FG002|NOT COMPLETED|First Intervention||0
2989583|NCT00901576|3705957|FG003|NOT COMPLETED|First Intervention||0
2989584|NCT00901576|3705958|FG004|NOT COMPLETED|First Intervention||0
2989585|NCT00901576|3705959|FG005|NOT COMPLETED|First Intervention||0
2989586|NCT00901576|3705954|FG000|STARTED|Washout||6
2989587|NCT00901576|3705955|FG001|STARTED|Washout||7
3304913|NCT02983305|4038507|FG001|COMPLETED|Overall Study||10
3304914|NCT02983305|4038506|FG000|NOT COMPLETED|Overall Study||2
3304915|NCT02983305|4038507|FG001|NOT COMPLETED|Overall Study||0
3304916|NCT02983448|4038513|FG000|STARTED|Overall Study||12
3304917|NCT02983448|4038514|FG001|STARTED|Overall Study||12
3304918|NCT02983448|4038513|FG000|COMPLETED|Overall Study||12
2989588|NCT00901576|3705956|FG002|STARTED|Washout||7
2989589|NCT00901576|3705957|FG003|STARTED|Washout||6
2989590|NCT00901576|3705958|FG004|STARTED|Washout||6
2989591|NCT00901576|3705959|FG005|STARTED|Washout||6
2989592|NCT00901576|3705954|FG000|COMPLETED|Washout||6
2989593|NCT00901576|3705955|FG001|COMPLETED|Washout||7
2989594|NCT00901576|3705956|FG002|COMPLETED|Washout||7
2989595|NCT00901576|3705957|FG003|COMPLETED|Washout||6
2989596|NCT00901576|3705958|FG004|COMPLETED|Washout||6
2989597|NCT00901576|3705959|FG005|COMPLETED|Washout||6
2989598|NCT00901576|3705954|FG000|NOT COMPLETED|Washout||0
2989599|NCT00901576|3705955|FG001|NOT COMPLETED|Washout||0
2989600|NCT00901576|3705956|FG002|NOT COMPLETED|Washout||0
2989601|NCT00901576|3705957|FG003|NOT COMPLETED|Washout||0
2989602|NCT00901576|3705958|FG004|NOT COMPLETED|Washout||0
2989603|NCT00901576|3705959|FG005|NOT COMPLETED|Washout||0
2989604|NCT00901576|3705954|FG000|STARTED|Second Intervention||6
2989605|NCT00901576|3705955|FG001|STARTED|Second Intervention||7
2989606|NCT00901576|3705956|FG002|STARTED|Second Intervention||7
2989607|NCT00901576|3705957|FG003|STARTED|Second Intervention||6
2989608|NCT00901576|3705958|FG004|STARTED|Second Intervention||6
2989609|NCT00901576|3705959|FG005|STARTED|Second Intervention||6
2989610|NCT00901576|3705954|FG000|COMPLETED|Second Intervention||5
2989611|NCT00901576|3705955|FG001|COMPLETED|Second Intervention||7
2989612|NCT00901576|3705956|FG002|COMPLETED|Second Intervention||7
2989613|NCT00901576|3705957|FG003|COMPLETED|Second Intervention||5
2989614|NCT00901576|3705958|FG004|COMPLETED|Second Intervention||6
2989615|NCT00901576|3705959|FG005|COMPLETED|Second Intervention||5
2989616|NCT00901576|3705954|FG000|NOT COMPLETED|Second Intervention||1
2989617|NCT00901576|3705955|FG001|NOT COMPLETED|Second Intervention||0
2989618|NCT00901576|3705956|FG002|NOT COMPLETED|Second Intervention||0
2989619|NCT00901576|3705957|FG003|NOT COMPLETED|Second Intervention||1
2989620|NCT00901576|3705958|FG004|NOT COMPLETED|Second Intervention||0
2989621|NCT00901576|3705959|FG005|NOT COMPLETED|Second Intervention||1
2989622|NCT00901576|3705954|FG000|STARTED|Washout||5
2989623|NCT00901576|3705955|FG001|STARTED|Washout||7
2989624|NCT00901576|3705956|FG002|STARTED|Washout||7
2989625|NCT00901576|3705957|FG003|STARTED|Washout||5
2989626|NCT00901576|3705958|FG004|STARTED|Washout||6
2989627|NCT00901576|3705959|FG005|STARTED|Washout||5
2989628|NCT00901576|3705954|FG000|COMPLETED|Washout||5
2989629|NCT00901576|3705955|FG001|COMPLETED|Washout||7
2989630|NCT00901576|3705956|FG002|COMPLETED|Washout||7
2989631|NCT00901576|3705957|FG003|COMPLETED|Washout||5
2989632|NCT00901576|3705958|FG004|COMPLETED|Washout||6
2989633|NCT00901576|3705959|FG005|COMPLETED|Washout||5
2989634|NCT00901576|3705954|FG000|NOT COMPLETED|Washout||0
2989635|NCT00901576|3705955|FG001|NOT COMPLETED|Washout||0
2989636|NCT00901576|3705956|FG002|NOT COMPLETED|Washout||0
2989637|NCT00901576|3705957|FG003|NOT COMPLETED|Washout||0
2989638|NCT00901576|3705958|FG004|NOT COMPLETED|Washout||0
2989639|NCT00901576|3705959|FG005|NOT COMPLETED|Washout||0
2989640|NCT00901576|3705954|FG000|STARTED|Third Intervention||5
2989641|NCT00901576|3705955|FG001|STARTED|Third Intervention||7
2989642|NCT00901576|3705956|FG002|STARTED|Third Intervention||7
2989643|NCT00901576|3705957|FG003|STARTED|Third Intervention||5
2989644|NCT00901576|3705958|FG004|STARTED|Third Intervention||6
2989645|NCT00901576|3705959|FG005|STARTED|Third Intervention||5
2989646|NCT00901576|3705954|FG000|COMPLETED|Third Intervention||5
2989647|NCT00901576|3705955|FG001|COMPLETED|Third Intervention||7
2989648|NCT00901576|3705956|FG002|COMPLETED|Third Intervention||7
2989649|NCT00901576|3705957|FG003|COMPLETED|Third Intervention||5
2989650|NCT00901576|3705958|FG004|COMPLETED|Third Intervention||6
2989651|NCT00901576|3705959|FG005|COMPLETED|Third Intervention||5
2989652|NCT00901576|3705954|FG000|NOT COMPLETED|Third Intervention||0
2989653|NCT00901576|3705955|FG001|NOT COMPLETED|Third Intervention||0
2989654|NCT00901576|3705956|FG002|NOT COMPLETED|Third Intervention||0
2989655|NCT00901576|3705957|FG003|NOT COMPLETED|Third Intervention||0
2989656|NCT00901576|3705958|FG004|NOT COMPLETED|Third Intervention||0
2989657|NCT00901576|3705959|FG005|NOT COMPLETED|Third Intervention||0
2989658|NCT00901628|3705969|FG000|STARTED|Overall Study||49
2989659|NCT00901628|3705970|FG001|STARTED|Overall Study||52
2989660|NCT00901628|3705969|FG000|COMPLETED|Overall Study||45
2989661|NCT00901628|3705970|FG001|COMPLETED|Overall Study||42
2989662|NCT00901628|3705969|FG000|NOT COMPLETED|Overall Study||4
2989663|NCT00901628|3705970|FG001|NOT COMPLETED|Overall Study||10
2989664|NCT00901901|3705978|FG000|STARTED|Treatment Period||362
2989665|NCT00901901|3705979|FG001|STARTED|Treatment Period||358
2989666|NCT00901901|3705978|FG000|Participants Received Treatment|Treatment Period||362
2989667|NCT00901901|3705979|FG001|Participants Received Treatment|Treatment Period||355
2989668|NCT00901901|3705978|FG000|COMPLETED|Treatment Period||193
2989669|NCT00901901|3705979|FG001|COMPLETED|Treatment Period||181
2989670|NCT00901901|3705978|FG000|NOT COMPLETED|Treatment Period||169
2989671|NCT00901901|3705979|FG001|NOT COMPLETED|Treatment Period||177
2989672|NCT00901901|3705978|FG000|STARTED|Follow-up Period||340
2989673|NCT00901901|3705979|FG001|STARTED|Follow-up Period||341
2989674|NCT00901901|3705978|FG000|COMPLETED|Follow-up Period||0
2989675|NCT00901901|3705979|FG001|COMPLETED|Follow-up Period||0
2989676|NCT00901901|3705978|FG000|NOT COMPLETED|Follow-up Period||340
3133545|NCT01696279|3858511|FG003|Full Analysis Set|Part 2a: Calcium Carbonate + Lanthanum||0
3133546|NCT01696279|3858508|FG000|Per-protocol Set 1|Part 2a: Calcium Carbonate + Lanthanum||0
3133547|NCT01696279|3858509|FG001|Per-protocol Set 1|Part 2a: Calcium Carbonate + Lanthanum||17
2989677|NCT00901901|3705979|FG001|NOT COMPLETED|Follow-up Period||341
2989678|NCT00901927|3705987|FG000|STARTED|Overall Study||14
2989679|NCT00901927|3705987|FG000|COMPLETED|Overall Study||8
2989680|NCT00901927|3705987|FG000|NOT COMPLETED|Overall Study||6
2989681|NCT00902018|3705994|FG000|STARTED|Overall Study||7
2989682|NCT00902018|3705995|FG001|STARTED|Overall Study||3
2989683|NCT00902018|3705996|FG002|STARTED|Overall Study||10
2989684|NCT00902018|3705994|FG000|COMPLETED|Overall Study||7
2989685|NCT00902018|3705995|FG001|COMPLETED|Overall Study||3
2989686|NCT00902018|3705996|FG002|COMPLETED|Overall Study||10
2989687|NCT00902018|3705994|FG000|NOT COMPLETED|Overall Study||0
2989688|NCT00902018|3705995|FG001|NOT COMPLETED|Overall Study||0
2989689|NCT00902018|3705996|FG002|NOT COMPLETED|Overall Study||0
2989690|NCT00902161|3706012|FG000|STARTED|Pre-study Washout/Propanolol Run-in||0
2989691|NCT00902161|3706013|FG001|STARTED|Pre-study Washout/Propanolol Run-in||0
2989692|NCT00902161|3706014|FG002|STARTED|Pre-study Washout/Propanolol Run-in||22
2989693|NCT00902161|3706012|FG000|COMPLETED|Pre-study Washout/Propanolol Run-in||0
2989694|NCT00902161|3706013|FG001|COMPLETED|Pre-study Washout/Propanolol Run-in||0
2989695|NCT00902161|3706014|FG002|COMPLETED|Pre-study Washout/Propanolol Run-in||22
2989696|NCT00902161|3706012|FG000|NOT COMPLETED|Pre-study Washout/Propanolol Run-in||0
2989697|NCT00902161|3706013|FG001|NOT COMPLETED|Pre-study Washout/Propanolol Run-in||0
2989698|NCT00902161|3706014|FG002|NOT COMPLETED|Pre-study Washout/Propanolol Run-in||0
2989699|NCT00902161|3706012|FG000|STARTED|Period 1||12
2989700|NCT00902161|3706013|FG001|STARTED|Period 1||10
2989701|NCT00902161|3706014|FG002|STARTED|Period 1||0
2989702|NCT00902161|3706012|FG000|COMPLETED|Period 1||12
2989703|NCT00902161|3706013|FG001|COMPLETED|Period 1||10
2989704|NCT00902161|3706014|FG002|COMPLETED|Period 1||0
2989705|NCT00902161|3706012|FG000|NOT COMPLETED|Period 1||0
2989706|NCT00902161|3706013|FG001|NOT COMPLETED|Period 1||0
2989707|NCT00902161|3706014|FG002|NOT COMPLETED|Period 1||0
2989708|NCT00902161|3706012|FG000|STARTED|Post-clamp Washout||0
2989709|NCT00902161|3706013|FG001|STARTED|Post-clamp Washout||0
2989710|NCT00902161|3706014|FG002|STARTED|Post-clamp Washout||22
2989711|NCT00902161|3706012|FG000|COMPLETED|Post-clamp Washout||0
2989712|NCT00902161|3706013|FG001|COMPLETED|Post-clamp Washout||0
2989713|NCT00902161|3706014|FG002|COMPLETED|Post-clamp Washout|2 participants discontinued washout and were replaced; 1 due to an AE and 1 due to lack of efficacy|22
2989714|NCT00902161|3706012|FG000|NOT COMPLETED|Post-clamp Washout||0
2989715|NCT00902161|3706013|FG001|NOT COMPLETED|Post-clamp Washout||0
2989716|NCT00902161|3706014|FG002|NOT COMPLETED|Post-clamp Washout||0
2989717|NCT00902161|3706012|FG000|STARTED|Period 2||8
2989718|NCT00902161|3706013|FG001|STARTED|Period 2||9
2989719|NCT00902161|3706014|FG002|STARTED|Period 2||0
2989720|NCT00902161|3706012|FG000|COMPLETED|Period 2|2 participants discontinued and were replaced; 1 due to protocol deviation and 1 withdrew consent|8
2989721|NCT00902161|3706013|FG001|COMPLETED|Period 2||9
2989722|NCT00902161|3706014|FG002|COMPLETED|Period 2||0
2989723|NCT00902161|3706012|FG000|NOT COMPLETED|Period 2||0
2989724|NCT00902161|3706013|FG001|NOT COMPLETED|Period 2||0
2989725|NCT00902161|3706014|FG002|NOT COMPLETED|Period 2||0
2989726|NCT00902174|3706026|FG000|STARTED|Overall Study||103
2989727|NCT00902174|3706027|FG001|STARTED|Overall Study||99
2989728|NCT00902174|3706026|FG000|COMPLETED|Overall Study||69
2989729|NCT00902174|3706027|FG001|COMPLETED|Overall Study||81
2989730|NCT00902174|3706026|FG000|NOT COMPLETED|Overall Study||34
2989731|NCT00902174|3706027|FG001|NOT COMPLETED|Overall Study||18
2989732|NCT00902226|3706036|FG000|STARTED|Overall Study||30
2989733|NCT00902226|3706036|FG000|COMPLETED|Overall Study||30
2989734|NCT00902226|3706036|FG000|NOT COMPLETED|Overall Study||0
2989735|NCT00902265|3706040|FG000|STARTED|Overall Study||138
2989736|NCT00902265|3706040|FG000|Participants Who Received Treatment|Overall Study||137
2989737|NCT00902265|3706040|FG000|COMPLETED|Overall Study||132
2989738|NCT00902265|3706040|FG000|NOT COMPLETED|Overall Study||6
2989739|NCT00902278|3706049|FG000|STARTED|Overall Study||54
2989740|NCT00902278|3706050|FG001|STARTED|Overall Study||36
2989741|NCT00902278|3706051|FG002|STARTED|Overall Study||54
2989742|NCT00902278|3706052|FG003|STARTED|Overall Study||12
2989743|NCT00902278|3706053|FG004|STARTED|Overall Study||37
2989744|NCT00902278|3706049|FG000|COMPLETED|Overall Study||50
2989745|NCT00902278|3706050|FG001|COMPLETED|Overall Study||34
2989746|NCT00902278|3706051|FG002|COMPLETED|Overall Study||49
2989747|NCT00902278|3706052|FG003|COMPLETED|Overall Study||12
2989748|NCT00902278|3706053|FG004|COMPLETED|Overall Study||35
2989749|NCT00902278|3706049|FG000|NOT COMPLETED|Overall Study||4
2989750|NCT00902278|3706050|FG001|NOT COMPLETED|Overall Study||2
2989751|NCT00902278|3706051|FG002|NOT COMPLETED|Overall Study||5
2989752|NCT00902278|3706052|FG003|NOT COMPLETED|Overall Study||0
2989753|NCT00902278|3706053|FG004|NOT COMPLETED|Overall Study||2
2989754|NCT00902304|3706068|FG000|STARTED|Overall Study||524
2989755|NCT00902304|3706069|FG001|STARTED|Overall Study||360
2989756|NCT00902304|3706070|FG002|STARTED|Overall Study||678
2989757|NCT00902304|3706068|FG000|COMPLETED|Overall Study||466
2989758|NCT00902304|3706069|FG001|COMPLETED|Overall Study||289
2989759|NCT00902304|3706070|FG002|COMPLETED|Overall Study||568
2989760|NCT00902304|3706068|FG000|NOT COMPLETED|Overall Study||58
2989761|NCT00902304|3706069|FG001|NOT COMPLETED|Overall Study||71
2989762|NCT00902304|3706070|FG002|NOT COMPLETED|Overall Study||110
2989763|NCT00902330|3706081|FG000|STARTED|Overall Study||81
2989764|NCT00902330|3706082|FG001|STARTED|Overall Study||80
2989765|NCT00902330|3706081|FG000|COMPLETED|Overall Study||77
2989766|NCT00902330|3706082|FG001|COMPLETED|Overall Study||75
2989767|NCT00902330|3706081|FG000|NOT COMPLETED|Overall Study||4
2989768|NCT00902330|3706082|FG001|NOT COMPLETED|Overall Study||5
2989769|NCT00902486|3706095|FG000|STARTED|Treatment Period (Weeks 0 Through 12)||31
2989770|NCT00902486|3706096|FG001|STARTED|Treatment Period (Weeks 0 Through 12)||0
2989771|NCT00902486|3706097|FG002|STARTED|Treatment Period (Weeks 0 Through 12)||0
2989772|NCT00902486|3706098|FG003|STARTED|Treatment Period (Weeks 0 Through 12)||32
2989773|NCT00902486|3706099|FG004|STARTED|Treatment Period (Weeks 0 Through 12)||32
2989774|NCT00902486|3706100|FG005|STARTED|Treatment Period (Weeks 0 Through 12)||32
2989775|NCT00902486|3706095|FG000|Safety Evaluable Participants|Treatment Period (Weeks 0 Through 12)||31
2989776|NCT00902486|3706096|FG001|Safety Evaluable Participants|Treatment Period (Weeks 0 Through 12)||0
2989777|NCT00902486|3706097|FG002|Safety Evaluable Participants|Treatment Period (Weeks 0 Through 12)||0
2989778|NCT00902486|3706098|FG003|Safety Evaluable Participants|Treatment Period (Weeks 0 Through 12)||31
2989779|NCT00902486|3706099|FG004|Safety Evaluable Participants|Treatment Period (Weeks 0 Through 12)||32
2989780|NCT00902486|3706100|FG005|Safety Evaluable Participants|Treatment Period (Weeks 0 Through 12)||31
2989781|NCT00902486|3706095|FG000|Modified Intent-to-Treat Participants|Treatment Period (Weeks 0 Through 12)||31
2989782|NCT00902486|3706096|FG001|Modified Intent-to-Treat Participants|Treatment Period (Weeks 0 Through 12)||0
2989783|NCT00902486|3706097|FG002|Modified Intent-to-Treat Participants|Treatment Period (Weeks 0 Through 12)||0
2989784|NCT00902486|3706098|FG003|Modified Intent-to-Treat Participants|Treatment Period (Weeks 0 Through 12)||31
2989785|NCT00902486|3706099|FG004|Modified Intent-to-Treat Participants|Treatment Period (Weeks 0 Through 12)||32
2989786|NCT00902486|3706100|FG005|Modified Intent-to-Treat Participants|Treatment Period (Weeks 0 Through 12)||30
2989787|NCT00902486|3706095|FG000|COMPLETED|Treatment Period (Weeks 0 Through 12)||29
2989788|NCT00902486|3706096|FG001|COMPLETED|Treatment Period (Weeks 0 Through 12)||0
2989789|NCT00902486|3706097|FG002|COMPLETED|Treatment Period (Weeks 0 Through 12)||0
2989790|NCT00902486|3706098|FG003|COMPLETED|Treatment Period (Weeks 0 Through 12)||29
2989791|NCT00902486|3706099|FG004|COMPLETED|Treatment Period (Weeks 0 Through 12)||30
2989792|NCT00902486|3706100|FG005|COMPLETED|Treatment Period (Weeks 0 Through 12)||27
2989793|NCT00902486|3706095|FG000|NOT COMPLETED|Treatment Period (Weeks 0 Through 12)||2
2989794|NCT00902486|3706096|FG001|NOT COMPLETED|Treatment Period (Weeks 0 Through 12)||0
2989795|NCT00902486|3706097|FG002|NOT COMPLETED|Treatment Period (Weeks 0 Through 12)||0
2989796|NCT00902486|3706098|FG003|NOT COMPLETED|Treatment Period (Weeks 0 Through 12)||3
2989797|NCT00902486|3706099|FG004|NOT COMPLETED|Treatment Period (Weeks 0 Through 12)||2
2989798|NCT00902486|3706100|FG005|NOT COMPLETED|Treatment Period (Weeks 0 Through 12)||5
2989799|NCT00902486|3706095|FG000|STARTED|Extension Period (Weeks 12 Through 24)||0
2989800|NCT00902486|3706096|FG001|STARTED|Extension Period (Weeks 12 Through 24)||14
2989801|NCT00902486|3706097|FG002|STARTED|Extension Period (Weeks 12 Through 24)||15
2989802|NCT00902486|3706098|FG003|STARTED|Extension Period (Weeks 12 Through 24)||29
2989803|NCT00902486|3706099|FG004|STARTED|Extension Period (Weeks 12 Through 24)||30
2989804|NCT00902486|3706100|FG005|STARTED|Extension Period (Weeks 12 Through 24)||27
2989805|NCT00902486|3706095|FG000|COMPLETED|Extension Period (Weeks 12 Through 24)||0
2989806|NCT00902486|3706096|FG001|COMPLETED|Extension Period (Weeks 12 Through 24)||14
2989807|NCT00902486|3706097|FG002|COMPLETED|Extension Period (Weeks 12 Through 24)||13
2989808|NCT00902486|3706098|FG003|COMPLETED|Extension Period (Weeks 12 Through 24)||27
2989809|NCT00902486|3706099|FG004|COMPLETED|Extension Period (Weeks 12 Through 24)||29
2989810|NCT00902486|3706100|FG005|COMPLETED|Extension Period (Weeks 12 Through 24)||24
2989811|NCT00902486|3706095|FG000|NOT COMPLETED|Extension Period (Weeks 12 Through 24)||0
2989812|NCT00902486|3706096|FG001|NOT COMPLETED|Extension Period (Weeks 12 Through 24)||0
2989813|NCT00902486|3706097|FG002|NOT COMPLETED|Extension Period (Weeks 12 Through 24)||2
2989814|NCT00902486|3706098|FG003|NOT COMPLETED|Extension Period (Weeks 12 Through 24)||2
2989815|NCT00902486|3706099|FG004|NOT COMPLETED|Extension Period (Weeks 12 Through 24)||1
2989816|NCT00902486|3706100|FG005|NOT COMPLETED|Extension Period (Weeks 12 Through 24)||3
2989817|NCT00902486|3706095|FG000|STARTED|Follow-up (After Week 24)||0
2989818|NCT00902486|3706096|FG001|STARTED|Follow-up (After Week 24)||14
2989819|NCT00902486|3706097|FG002|STARTED|Follow-up (After Week 24)||13
2989820|NCT00902486|3706098|FG003|STARTED|Follow-up (After Week 24)||27
2989821|NCT00902486|3706099|FG004|STARTED|Follow-up (After Week 24)||29
2989822|NCT00902486|3706100|FG005|STARTED|Follow-up (After Week 24)||24
2989823|NCT00902486|3706095|FG000|Safety Evaluable Participants|Follow-up (After Week 24)||0
2989824|NCT00902486|3706096|FG001|Safety Evaluable Participants|Follow-up (After Week 24)||14
3304919|NCT02983448|4038514|FG001|COMPLETED|Overall Study||12
3304920|NCT02983448|4038513|FG000|NOT COMPLETED|Overall Study||0
3304921|NCT02983448|4038514|FG001|NOT COMPLETED|Overall Study||0
3304922|NCT02983552|4038526|FG000|STARTED|Overall Study||69
3304923|NCT02983552|4038527|FG001|STARTED|Overall Study||69
3304924|NCT02983552|4038528|FG002|STARTED|Overall Study||92
3304925|NCT02983552|4038529|FG003|STARTED|Overall Study||90
2989825|NCT00902486|3706097|FG002|Safety Evaluable Participants|Follow-up (After Week 24)||15
2989826|NCT00902486|3706098|FG003|Safety Evaluable Participants|Follow-up (After Week 24)||29
2989827|NCT00902486|3706099|FG004|Safety Evaluable Participants|Follow-up (After Week 24)||30
2989828|NCT00902486|3706100|FG005|Safety Evaluable Participants|Follow-up (After Week 24)||27
2989829|NCT00902486|3706095|FG000|COMPLETED|Follow-up (After Week 24)||0
2989830|NCT00902486|3706096|FG001|COMPLETED|Follow-up (After Week 24)||14
2989831|NCT00902486|3706097|FG002|COMPLETED|Follow-up (After Week 24)||13
2989832|NCT00902486|3706098|FG003|COMPLETED|Follow-up (After Week 24)||26
2989833|NCT00902486|3706099|FG004|COMPLETED|Follow-up (After Week 24)||29
2989834|NCT00902486|3706100|FG005|COMPLETED|Follow-up (After Week 24)||24
2989835|NCT00902486|3706095|FG000|NOT COMPLETED|Follow-up (After Week 24)||0
2989836|NCT00902486|3706096|FG001|NOT COMPLETED|Follow-up (After Week 24)||0
2989837|NCT00902486|3706097|FG002|NOT COMPLETED|Follow-up (After Week 24)||0
2989838|NCT00902486|3706098|FG003|NOT COMPLETED|Follow-up (After Week 24)||1
2989839|NCT00902486|3706099|FG004|NOT COMPLETED|Follow-up (After Week 24)||0
2989840|NCT00902486|3706100|FG005|NOT COMPLETED|Follow-up (After Week 24)||0
2989841|NCT00902538|3706133|FG000|STARTED|1-Single-blind, Run-in, Single-Treatment||2204
2989842|NCT00902538|3706134|FG001|STARTED|1-Single-blind, Run-in, Single-Treatment||0
2989843|NCT00902538|3706135|FG002|STARTED|1-Single-blind, Run-in, Single-Treatment||0
2989844|NCT00902538|3706136|FG003|STARTED|1-Single-blind, Run-in, Single-Treatment||0
2989845|NCT00902538|3706137|FG004|STARTED|1-Single-blind, Run-in, Single-Treatment||0
2989846|NCT00902538|3706138|FG005|STARTED|1-Single-blind, Run-in, Single-Treatment||0
2989847|NCT00902538|3706133|FG000|COMPLETED|1-Single-blind, Run-in, Single-Treatment||2086
2989848|NCT00902538|3706134|FG001|COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
2989849|NCT00902538|3706135|FG002|COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
2989850|NCT00902538|3706136|FG003|COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
2989851|NCT00902538|3706137|FG004|COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
2989852|NCT00902538|3706138|FG005|COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
2989853|NCT00902538|3706133|FG000|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||118
2989854|NCT00902538|3706134|FG001|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
2989855|NCT00902538|3706135|FG002|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
2989856|NCT00902538|3706136|FG003|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
2989857|NCT00902538|3706137|FG004|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
2989858|NCT00902538|3706138|FG005|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
2989859|NCT00902538|3706133|FG000|STARTED|2-Randomized Double-blind 3 Treatments|Only 808 began Period 2 because the others finishing Period 1 did not meet the entry criteria.|269
2989860|NCT00902538|3706134|FG001|STARTED|2-Randomized Double-blind 3 Treatments||269
2989861|NCT00902538|3706135|FG002|STARTED|2-Randomized Double-blind 3 Treatments||270
2989862|NCT00902538|3706136|FG003|STARTED|2-Randomized Double-blind 3 Treatments||0
2989863|NCT00902538|3706137|FG004|STARTED|2-Randomized Double-blind 3 Treatments||0
2989864|NCT00902538|3706138|FG005|STARTED|2-Randomized Double-blind 3 Treatments||0
2989865|NCT00902538|3706133|FG000|COMPLETED|2-Randomized Double-blind 3 Treatments||260
2989866|NCT00902538|3706134|FG001|COMPLETED|2-Randomized Double-blind 3 Treatments||263
2989867|NCT00902538|3706135|FG002|COMPLETED|2-Randomized Double-blind 3 Treatments||262
2989868|NCT00902538|3706136|FG003|COMPLETED|2-Randomized Double-blind 3 Treatments||0
2989869|NCT00902538|3706137|FG004|COMPLETED|2-Randomized Double-blind 3 Treatments||0
2989870|NCT00902538|3706138|FG005|COMPLETED|2-Randomized Double-blind 3 Treatments||0
2989871|NCT00902538|3706133|FG000|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||9
2989872|NCT00902538|3706134|FG001|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||6
2989873|NCT00902538|3706135|FG002|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||8
2989874|NCT00902538|3706136|FG003|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||0
2989875|NCT00902538|3706137|FG004|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||0
2989876|NCT00902538|3706138|FG005|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||0
2989877|NCT00902538|3706133|FG000|STARTED|3-Single-blind, Single Treatment||0
2989878|NCT00902538|3706134|FG001|STARTED|3-Single-blind, Single Treatment|Number starting is < total completing previous arm since 3 subjects did not receive at least 1 dose.|782
2989879|NCT00902538|3706135|FG002|STARTED|3-Single-blind, Single Treatment||0
2989880|NCT00902538|3706136|FG003|STARTED|3-Single-blind, Single Treatment||0
2989881|NCT00902538|3706137|FG004|STARTED|3-Single-blind, Single Treatment||0
2989882|NCT00902538|3706138|FG005|STARTED|3-Single-blind, Single Treatment||0
2989883|NCT00902538|3706133|FG000|COMPLETED|3-Single-blind, Single Treatment||0
2989884|NCT00902538|3706134|FG001|COMPLETED|3-Single-blind, Single Treatment||767
2989885|NCT00902538|3706135|FG002|COMPLETED|3-Single-blind, Single Treatment||0
2989886|NCT00902538|3706136|FG003|COMPLETED|3-Single-blind, Single Treatment||0
2989887|NCT00902538|3706137|FG004|COMPLETED|3-Single-blind, Single Treatment||0
2989888|NCT00902538|3706138|FG005|COMPLETED|3-Single-blind, Single Treatment||0
3304926|NCT02983552|4038526|FG000|4 Week Visit|Overall Study||69
3304927|NCT02983552|4038527|FG001|4 Week Visit|Overall Study||67
3304928|NCT02983552|4038528|FG002|4 Week Visit|Overall Study||85
2989889|NCT00902538|3706133|FG000|NOT COMPLETED|3-Single-blind, Single Treatment||0
2989890|NCT00902538|3706134|FG001|NOT COMPLETED|3-Single-blind, Single Treatment||15
2989891|NCT00902538|3706135|FG002|NOT COMPLETED|3-Single-blind, Single Treatment||0
2989892|NCT00902538|3706136|FG003|NOT COMPLETED|3-Single-blind, Single Treatment||0
2989893|NCT00902538|3706137|FG004|NOT COMPLETED|3-Single-blind, Single Treatment||0
2989894|NCT00902538|3706138|FG005|NOT COMPLETED|3-Single-blind, Single Treatment||0
2989895|NCT00902538|3706133|FG000|STARTED|4-Randomized Double-blind 2 Treatments||0
2989896|NCT00902538|3706134|FG001|STARTED|4-Randomized Double-blind 2 Treatments||0
2989897|NCT00902538|3706135|FG002|STARTED|4-Randomized Double-blind 2 Treatments||0
2989898|NCT00902538|3706136|FG003|STARTED|4-Randomized Double-blind 2 Treatments|Period 3 responders were continued on OLM 40-AML 10-HCTZ 12.5|467
2989899|NCT00902538|3706137|FG004|STARTED|4-Randomized Double-blind 2 Treatments|Period 3 non-responders were randomized to OLM 40-AML 10-HCTZ 12.5 or 25 in a 2:1 ratio|97
2989900|NCT00902538|3706138|FG005|STARTED|4-Randomized Double-blind 2 Treatments||197
2989901|NCT00902538|3706133|FG000|COMPLETED|4-Randomized Double-blind 2 Treatments||0
2989902|NCT00902538|3706134|FG001|COMPLETED|4-Randomized Double-blind 2 Treatments||0
2989903|NCT00902538|3706135|FG002|COMPLETED|4-Randomized Double-blind 2 Treatments||0
2989904|NCT00902538|3706136|FG003|COMPLETED|4-Randomized Double-blind 2 Treatments||458
2989905|NCT00902538|3706137|FG004|COMPLETED|4-Randomized Double-blind 2 Treatments||95
2989906|NCT00902538|3706138|FG005|COMPLETED|4-Randomized Double-blind 2 Treatments||196
2989907|NCT00902538|3706133|FG000|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||0
2989908|NCT00902538|3706134|FG001|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||0
2989909|NCT00902538|3706135|FG002|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||0
2989910|NCT00902538|3706136|FG003|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||9
2989911|NCT00902538|3706137|FG004|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||2
2989912|NCT00902538|3706138|FG005|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||1
2989913|NCT00902564|3706150|FG000|STARTED|Overall Study||30
2989914|NCT00902564|3706150|FG000|COMPLETED|Overall Study||28
2989915|NCT00902564|3706150|FG000|NOT COMPLETED|Overall Study||2
2989916|NCT00902577|3706154|FG000|STARTED|Overall Study||50
2989917|NCT00902577|3706154|FG000|FMISO/PET|Overall Study||38
2989918|NCT00902577|3706154|FG000|DCE MRI|Overall Study||31
2989919|NCT00902577|3706154|FG000|DSE MRI|Overall Study||37
2989920|NCT00902577|3706154|FG000|DWI MRI|Overall Study||39
2989921|NCT00902577|3706154|FG000|COMPLETED|Overall Study||42
2989922|NCT00902577|3706154|FG000|NOT COMPLETED|Overall Study||8
2989923|NCT00902746|3706177|FG000|STARTED|Overall Study||149
2989924|NCT00902746|3706177|FG000|Initiation of Study Drug Administration|Overall Study||148
2989925|NCT00902746|3706177|FG000|Transfer to Step 2|Overall Study||133
2989926|NCT00902746|3706177|FG000|COMPLETED|Overall Study||113
2989927|NCT00902746|3706177|FG000|NOT COMPLETED|Overall Study||36
2989928|NCT00902850|3706183|FG000|STARTED|Overall Study||14
2989929|NCT00902850|3706184|FG001|STARTED|Overall Study||14
2989930|NCT00902850|3706183|FG000|COMPLETED|Overall Study||12
2989931|NCT00902850|3706184|FG001|COMPLETED|Overall Study||12
2989932|NCT00902850|3706183|FG000|NOT COMPLETED|Overall Study||2
2989933|NCT00902850|3706184|FG001|NOT COMPLETED|Overall Study||2
2989934|NCT00903032|3706192|FG000|STARTED|Overall Study||129
2989935|NCT00903032|3706193|FG001|STARTED|Overall Study||124
2989936|NCT00903032|3706192|FG000|COMPLETED|Overall Study||122
2989937|NCT00903032|3706193|FG001|COMPLETED|Overall Study||119
2989938|NCT00903032|3706192|FG000|NOT COMPLETED|Overall Study||7
2989939|NCT00903032|3706193|FG001|NOT COMPLETED|Overall Study||5
3304929|NCT02983552|4038529|FG003|4 Week Visit|Overall Study||84
3304930|NCT02983552|4038526|FG000|8 Week Visit|Overall Study||67
3304931|NCT02983552|4038527|FG001|8 Week Visit|Overall Study||68
3304932|NCT02983552|4038528|FG002|8 Week Visit|Overall Study||85
3304933|NCT02983552|4038529|FG003|8 Week Visit|Overall Study||84
3304934|NCT02983552|4038526|FG000|16 Week Visit|Overall Study|The 16 week visit was elective for those who were originally assigned to continued spectacle correction. After completing 8 weeks of continued spectacle correction, participants were able to complete 8 weeks of binocular therapy. Values are not provided for the binocular computer game treatment cohorts as this visit was not applicable.|0
3304935|NCT02983552|4038527|FG001|16 Week Visit|Overall Study||66
3304936|NCT02983552|4038528|FG002|16 Week Visit|Overall Study|The 16 week visit was elective for those who were originally assigned to continued spectacle correction. After completing 8 weeks of continued spectacle correction, participants were able to complete 8 weeks of binocular therapy. Values are not provided for the binocular computer game treatment cohorts as this visit was not applicable.|0
3304937|NCT02983552|4038529|FG003|16 Week Visit|Overall Study||72
3304938|NCT02983552|4038526|FG000|COMPLETED|Overall Study||69
3304939|NCT02983552|4038527|FG001|COMPLETED|Overall Study||67
3304940|NCT02983552|4038528|FG002|COMPLETED|Overall Study||92
3304941|NCT02983552|4038529|FG003|COMPLETED|Overall Study||90
3304942|NCT02983552|4038526|FG000|NOT COMPLETED|Overall Study||0
3304943|NCT02983552|4038527|FG001|NOT COMPLETED|Overall Study||2
3304944|NCT02983552|4038528|FG002|NOT COMPLETED|Overall Study||0
2989940|NCT00903162|3706199|FG000|STARTED|Overall Study||16
2989941|NCT00903162|3706199|FG000|COMPLETED|Overall Study||12
2989942|NCT00903162|3706199|FG000|NOT COMPLETED|Overall Study||4
2989943|NCT00903175|3706205|FG000|STARTED|Period 1 - First Line||238
2989944|NCT00903175|3706206|FG001|STARTED|Period 1 - First Line||231
2989945|NCT00903175|3706205|FG000|COMPLETED|Period 1 - First Line|Completed = Disease progression (completed 1L)|161
2989946|NCT00903175|3706206|FG001|COMPLETED|Period 1 - First Line|Completed = Disease progression (completed 1L)|142
2989947|NCT00903175|3706205|FG000|NOT COMPLETED|Period 1 - First Line||77
2989948|NCT00903175|3706206|FG001|NOT COMPLETED|Period 1 - First Line||89
2989949|NCT00903175|3706205|FG000|STARTED|Period 2 - Second Line|139 from everolimus 1L planned to enter 2L period and cross over to sunitinib but only 128 did.|128
2989950|NCT00903175|3706206|FG001|STARTED|Period 2 - Second Line|130 from Sunitinib 1L planned to enter 2L period and cross over to everolimus but only 116 did.|116
2989951|NCT00903175|3706205|FG000|COMPLETED|Period 2 - Second Line|Completed = Disease progression - (completed 2L)|79
2989952|NCT00903175|3706206|FG001|COMPLETED|Period 2 - Second Line|Completed = Disease progression - (completed 2L)|80
2989953|NCT00903175|3706205|FG000|NOT COMPLETED|Period 2 - Second Line||49
2989954|NCT00903175|3706206|FG001|NOT COMPLETED|Period 2 - Second Line||36
2989955|NCT00903201|3706215|FG000|STARTED|Overall Study||61
2989956|NCT00903201|3706216|FG001|STARTED|Overall Study||44
2989957|NCT00903201|3706217|FG002|STARTED|Overall Study||41
2989958|NCT00903201|3706215|FG000|COMPLETED|Overall Study||56
2989959|NCT00903201|3706216|FG001|COMPLETED|Overall Study||38
2989960|NCT00903201|3706217|FG002|COMPLETED|Overall Study||39
2989961|NCT00903201|3706215|FG000|NOT COMPLETED|Overall Study||5
2989962|NCT00903201|3706216|FG001|NOT COMPLETED|Overall Study||6
2989963|NCT00903201|3706217|FG002|NOT COMPLETED|Overall Study||2
3036686|NCT01144403|3755932|FG000|NOT COMPLETED|Overall Study||5
3036687|NCT01144442|3755937|FG000|STARTED|Overall Study||10
3036688|NCT01144442|3755937|FG000|COMPLETED|Overall Study||10
3036689|NCT01144442|3755937|FG000|NOT COMPLETED|Overall Study||0
3036690|NCT01144455|3755944|FG000|STARTED|Overall Study||69
3036691|NCT01144455|3755945|FG001|STARTED|Overall Study||71
3036692|NCT01144455|3755946|FG002|STARTED|Overall Study||74
3036693|NCT01144455|3755944|FG000|COMPLETED|Overall Study||19
3036694|NCT01144455|3755945|FG001|COMPLETED|Overall Study||29
3036695|NCT01144455|3755946|FG002|COMPLETED|Overall Study||38
3036696|NCT01144455|3755944|FG000|NOT COMPLETED|Overall Study||50
3036697|NCT01144455|3755945|FG001|NOT COMPLETED|Overall Study||42
3036698|NCT01144455|3755946|FG002|NOT COMPLETED|Overall Study||36
3036699|NCT01144494|3755954|FG000|STARTED|Overall Study||15
3036700|NCT01144494|3755955|FG001|STARTED|Overall Study||18
3036701|NCT01144494|3755954|FG000|COMPLETED|Overall Study||15
3036702|NCT01144494|3755955|FG001|COMPLETED|Overall Study||14
3036703|NCT01144494|3755954|FG000|NOT COMPLETED|Overall Study||0
3036704|NCT01144494|3755955|FG001|NOT COMPLETED|Overall Study||4
3036705|NCT01144598|3755966|FG000|STARTED|Overall Study||356
3036706|NCT01144598|3755966|FG000|Analysis Population|Overall Study||356
3036707|NCT01144598|3755966|FG000|COMPLETED|Overall Study||356
3036708|NCT01144598|3755966|FG000|NOT COMPLETED|Overall Study||0
3036709|NCT01144624|3755973|FG000|STARTED|Overall Study||7
3036710|NCT01144624|3755974|FG001|STARTED|Overall Study||7
3036711|NCT01144624|3755975|FG002|STARTED|Overall Study||6
3036712|NCT01144624|3755973|FG000|Received Treatment|Overall Study||7
3133548|NCT01696279|3858510|FG002|Per-protocol Set 1|Part 2a: Calcium Carbonate + Lanthanum||0
3133549|NCT01696279|3858511|FG003|Per-protocol Set 1|Part 2a: Calcium Carbonate + Lanthanum||0
3133550|NCT01696279|3858508|FG000|Per-protocol Set 2|Part 2a: Calcium Carbonate + Lanthanum||0
3136746|NCT01714726|3861991|FG003|NOT COMPLETED|Open-Label Period||28
3036713|NCT01144624|3755974|FG001|Received Treatment|Overall Study||7
3036714|NCT01144624|3755975|FG002|Received Treatment|Overall Study||6
3036715|NCT01144624|3755973|FG000|Completed Treatment|Overall Study|One patient died after completing the full course of study treatment.|7
3036716|NCT01144624|3755974|FG001|Completed Treatment|Overall Study||7
3036717|NCT01144624|3755975|FG002|Completed Treatment|Overall Study|Two patients died during the dosing period. Death was not a reason for treatment discontinuation.|6
3036718|NCT01144624|3755973|FG000|COMPLETED|Overall Study|One patient died during the study. Death was not a reason for treatment or study discontinuation.|7
3036719|NCT01144624|3755974|FG001|COMPLETED|Overall Study||7
3036720|NCT01144624|3755975|FG002|COMPLETED|Overall Study|Two patients died during the study. Death was not a reason for treatment or study discontinuation.|6
3036721|NCT01144624|3755973|FG000|NOT COMPLETED|Overall Study||0
3036722|NCT01144624|3755974|FG001|NOT COMPLETED|Overall Study||0
3036723|NCT01144624|3755975|FG002|NOT COMPLETED|Overall Study||0
3036724|NCT01144637|3755987|FG000|STARTED|Overall Study||999
3036725|NCT01144637|3755988|FG001|STARTED|Overall Study||1005
3036726|NCT01144637|3755989|FG002|STARTED|Overall Study||999
3036727|NCT01144637|3755990|FG003|STARTED|Overall Study||1002
3036728|NCT01144637|3755987|FG000|COMPLETED|Overall Study||925
3036729|NCT01144637|3755988|FG001|COMPLETED|Overall Study||929
3036730|NCT01144637|3755989|FG002|COMPLETED|Overall Study||939
3036731|NCT01144637|3755990|FG003|COMPLETED|Overall Study||946
3036732|NCT01144637|3755987|FG000|NOT COMPLETED|Overall Study||74
3036733|NCT01144637|3755988|FG001|NOT COMPLETED|Overall Study||76
3036734|NCT01144637|3755989|FG002|NOT COMPLETED|Overall Study||60
3036735|NCT01144637|3755990|FG003|NOT COMPLETED|Overall Study||56
3036736|NCT01144663|3756004|FG000|STARTED|Primary Vaccination Phase||528
3036737|NCT01144663|3756005|FG001|STARTED|Primary Vaccination Phase||524
3036738|NCT01144663|3756006|FG002|STARTED|Primary Vaccination Phase||516
3036739|NCT01144663|3756007|FG003|STARTED|Primary Vaccination Phase||527
3036740|NCT01144663|3756004|FG000|COMPLETED|Primary Vaccination Phase||508
3036741|NCT01144663|3756005|FG001|COMPLETED|Primary Vaccination Phase||517
3036742|NCT01144663|3756006|FG002|COMPLETED|Primary Vaccination Phase||508
3036743|NCT01144663|3756007|FG003|COMPLETED|Primary Vaccination Phase||509
3036744|NCT01144663|3756004|FG000|NOT COMPLETED|Primary Vaccination Phase||20
3036745|NCT01144663|3756005|FG001|NOT COMPLETED|Primary Vaccination Phase||7
3036746|NCT01144663|3756006|FG002|NOT COMPLETED|Primary Vaccination Phase||8
2989964|NCT00903331|3706229|FG000|STARTED|Overall Study||59
2989965|NCT00903331|3706230|FG001|STARTED|Overall Study||119
2989966|NCT00903331|3706229|FG000|COMPLETED|Overall Study||54
2989967|NCT00903331|3706230|FG001|COMPLETED|Overall Study||101
2989968|NCT00903331|3706229|FG000|NOT COMPLETED|Overall Study||5
2989969|NCT00903331|3706230|FG001|NOT COMPLETED|Overall Study||18
2989970|NCT00903344|3706238|FG000|STARTED|Overall Study||12
2989971|NCT00903344|3706239|FG001|STARTED|Overall Study||10
2989972|NCT00903344|3706238|FG000|3 Month Visit|Overall Study||10
2989973|NCT00903344|3706239|FG001|3 Month Visit|Overall Study||10
2989974|NCT00903344|3706238|FG000|6 Month Visit|Overall Study||9
2989975|NCT00903344|3706239|FG001|6 Month Visit|Overall Study||10
2989976|NCT00903344|3706238|FG000|COMPLETED|Overall Study||7
2989977|NCT00903344|3706239|FG001|COMPLETED|Overall Study||7
2989978|NCT00903344|3706238|FG000|NOT COMPLETED|Overall Study||5
2989979|NCT00903344|3706239|FG001|NOT COMPLETED|Overall Study||3
2989980|NCT00903357|3706245|FG000|STARTED|First Intervention||27
2989981|NCT00903357|3706246|FG001|STARTED|First Intervention||27
2989982|NCT00903357|3706245|FG000|COMPLETED|First Intervention||22
2989983|NCT00903357|3706246|FG001|COMPLETED|First Intervention||23
2989984|NCT00903357|3706245|FG000|NOT COMPLETED|First Intervention||5
2989985|NCT00903357|3706246|FG001|NOT COMPLETED|First Intervention||4
2989986|NCT00903357|3706245|FG000|STARTED|Wash Out Period of 2 Weeks||22
2989987|NCT00903357|3706246|FG001|STARTED|Wash Out Period of 2 Weeks||23
2989988|NCT00903357|3706245|FG000|COMPLETED|Wash Out Period of 2 Weeks||22
2989989|NCT00903357|3706246|FG001|COMPLETED|Wash Out Period of 2 Weeks||22
2989990|NCT00903357|3706245|FG000|NOT COMPLETED|Wash Out Period of 2 Weeks||0
2989991|NCT00903357|3706246|FG001|NOT COMPLETED|Wash Out Period of 2 Weeks||1
2989992|NCT00903357|3706245|FG000|STARTED|Second Intervention||22
2989993|NCT00903357|3706246|FG001|STARTED|Second Intervention||22
2989994|NCT00903357|3706245|FG000|COMPLETED|Second Intervention||21
2989995|NCT00903357|3706246|FG001|COMPLETED|Second Intervention||22
2989996|NCT00903357|3706245|FG000|NOT COMPLETED|Second Intervention||1
2989997|NCT00903357|3706246|FG001|NOT COMPLETED|Second Intervention||0
2989998|NCT00903370|3706258|FG000|STARTED|Overall Study||127
2989999|NCT00903370|3706259|FG001|STARTED|Overall Study||133
2990000|NCT00903370|3706258|FG000|COMPLETED|Overall Study||99
2990001|NCT00903370|3706259|FG001|COMPLETED|Overall Study||109
2990002|NCT00903370|3706258|FG000|NOT COMPLETED|Overall Study||28
2990003|NCT00903370|3706259|FG001|NOT COMPLETED|Overall Study||24
2990004|NCT00903383|3706269|FG000|STARTED|Overall Study||55
2990005|NCT00903383|3706270|FG001|STARTED|Overall Study||54
2990006|NCT00903383|3706271|FG002|STARTED|Overall Study||50
2990007|NCT00903383|3706272|FG003|STARTED|Overall Study||49
2990008|NCT00903383|3706269|FG000|COMPLETED|Overall Study||48
2990009|NCT00903383|3706270|FG001|COMPLETED|Overall Study||48
2990010|NCT00903383|3706271|FG002|COMPLETED|Overall Study||47
2990011|NCT00903383|3706272|FG003|COMPLETED|Overall Study||44
2990012|NCT00903383|3706269|FG000|NOT COMPLETED|Overall Study||7
2990013|NCT00903383|3706270|FG001|NOT COMPLETED|Overall Study||6
2990014|NCT00903383|3706271|FG002|NOT COMPLETED|Overall Study||3
2990015|NCT00903383|3706272|FG003|NOT COMPLETED|Overall Study||5
2990016|NCT00903409|3706284|FG000|STARTED|Overall Study||88
2990017|NCT00903409|3706285|FG001|STARTED|Overall Study||100
2990018|NCT00903409|3706284|FG000|COMPLETED|Overall Study||62
2990019|NCT00903409|3706285|FG001|COMPLETED|Overall Study||73
2990020|NCT00903409|3706284|FG000|NOT COMPLETED|Overall Study||26
2990021|NCT00903409|3706285|FG001|NOT COMPLETED|Overall Study||27
2990022|NCT00903448|3706293|FG000|STARTED|Period 1: 5 Days Then 10 Day Washout||20
2990023|NCT00903448|3706294|FG001|STARTED|Period 1: 5 Days Then 10 Day Washout||20
2990024|NCT00903448|3706293|FG000|COMPLETED|Period 1: 5 Days Then 10 Day Washout||20
2990025|NCT00903448|3706294|FG001|COMPLETED|Period 1: 5 Days Then 10 Day Washout||20
2990026|NCT00903448|3706293|FG000|NOT COMPLETED|Period 1: 5 Days Then 10 Day Washout||0
2990027|NCT00903448|3706294|FG001|NOT COMPLETED|Period 1: 5 Days Then 10 Day Washout||0
2990028|NCT00903448|3706293|FG000|STARTED|Period 2: 5 Days Then 10 Day Washout||20
2990029|NCT00903448|3706294|FG001|STARTED|Period 2: 5 Days Then 10 Day Washout||20
2990030|NCT00903448|3706293|FG000|COMPLETED|Period 2: 5 Days Then 10 Day Washout||20
3304945|NCT02983552|4038529|FG003|NOT COMPLETED|Overall Study||0
3304946|NCT02983604|4038547|FG000|STARTED|Overall Study||4
3304947|NCT02983604|4038548|FG001|STARTED|Overall Study||3
3304948|NCT02983604|4038549|FG002|STARTED|Overall Study||4
3304949|NCT02983604|4038550|FG003|STARTED|Overall Study||3
2990031|NCT00903448|3706294|FG001|COMPLETED|Period 2: 5 Days Then 10 Day Washout||20
2990032|NCT00903448|3706293|FG000|NOT COMPLETED|Period 2: 5 Days Then 10 Day Washout||0
2990033|NCT00903448|3706294|FG001|NOT COMPLETED|Period 2: 5 Days Then 10 Day Washout||0
2990034|NCT00903448|3706293|FG000|STARTED|Period 3: 5 Days||20
2990035|NCT00903448|3706294|FG001|STARTED|Period 3: 5 Days||20
2990036|NCT00903448|3706293|FG000|COMPLETED|Period 3: 5 Days||20
2990037|NCT00903448|3706294|FG001|COMPLETED|Period 3: 5 Days||20
2990038|NCT00903448|3706293|FG000|NOT COMPLETED|Period 3: 5 Days||0
2990039|NCT00903448|3706294|FG001|NOT COMPLETED|Period 3: 5 Days||0
2990040|NCT00903617|3706304|FG000|STARTED|Overall Study||19
2990041|NCT00903617|3706305|FG001|STARTED|Overall Study||20
3304950|NCT02983604|4038547|FG000|COMPLETED|Overall Study||4
3304951|NCT02983604|4038548|FG001|COMPLETED|Overall Study||3
2990042|NCT00903617|3706306|FG002|STARTED|Overall Study||20
2990043|NCT00903617|3706307|FG003|STARTED|Overall Study||21
2990044|NCT00903617|3706304|FG000|COMPLETED|Overall Study||16
2990045|NCT00903617|3706305|FG001|COMPLETED|Overall Study||15
3304952|NCT02983604|4038549|FG002|COMPLETED|Overall Study||3
3304953|NCT02983604|4038550|FG003|COMPLETED|Overall Study||3
3304954|NCT02983604|4038547|FG000|NOT COMPLETED|Overall Study||0
3304955|NCT02983604|4038548|FG001|NOT COMPLETED|Overall Study||0
3304956|NCT02983604|4038549|FG002|NOT COMPLETED|Overall Study||1
3304957|NCT02983604|4038550|FG003|NOT COMPLETED|Overall Study||0
3304958|NCT02983825|4038560|FG000|STARTED|Overall Study|Of 21 enrolled subjects, 9 became ineligible for between consent and intervention|12
3304959|NCT02983825|4038560|FG000|COMPLETED|Overall Study|Of 12 subjects starting intervention, 3 met specified stopping critieria|9
3304960|NCT02983825|4038560|FG000|NOT COMPLETED|Overall Study||3
3304961|NCT02983877|4038564|FG000|STARTED|Overall Study||38
3304962|NCT02983877|4038564|FG000|COMPLETED|Overall Study||38
2990046|NCT00903617|3706306|FG002|COMPLETED|Overall Study||15
2990047|NCT00903617|3706307|FG003|COMPLETED|Overall Study||20
2990048|NCT00903617|3706304|FG000|NOT COMPLETED|Overall Study||3
2990049|NCT00903617|3706305|FG001|NOT COMPLETED|Overall Study||5
2990050|NCT00903617|3706306|FG002|NOT COMPLETED|Overall Study||5
2990051|NCT00903617|3706307|FG003|NOT COMPLETED|Overall Study||1
2990052|NCT00903630|3706321|FG000|STARTED|Phase l||6
2990053|NCT00903630|3706322|FG001|STARTED|Phase l||5
2990054|NCT00903630|3706323|FG002|STARTED|Phase l||0
2990055|NCT00903630|3706321|FG000|COMPLETED|Phase l||6
2990056|NCT00903630|3706322|FG001|COMPLETED|Phase l||5
2990057|NCT00903630|3706323|FG002|COMPLETED|Phase l||0
2990058|NCT00903630|3706321|FG000|NOT COMPLETED|Phase l||0
2990059|NCT00903630|3706322|FG001|NOT COMPLETED|Phase l||0
2990060|NCT00903630|3706323|FG002|NOT COMPLETED|Phase l||0
2990061|NCT00903630|3706321|FG000|STARTED|Phase 2||6
2990062|NCT00903630|3706322|FG001|STARTED|Phase 2||0
2990063|NCT00903630|3706323|FG002|STARTED|Phase 2||4
2990064|NCT00903630|3706321|FG000|COMPLETED|Phase 2||6
2990065|NCT00903630|3706322|FG001|COMPLETED|Phase 2||0
2990066|NCT00903630|3706323|FG002|COMPLETED|Phase 2|One participant was removed from the study after 2 weeks of treatment due to skin toxicity.|3
2990067|NCT00903630|3706321|FG000|NOT COMPLETED|Phase 2||0
2990068|NCT00903630|3706322|FG001|NOT COMPLETED|Phase 2||0
2990069|NCT00903630|3706323|FG002|NOT COMPLETED|Phase 2||1
2990070|NCT00903682|3706335|FG000|STARTED|Overall Study||79
2990071|NCT00903682|3706336|FG001|STARTED|Overall Study||78
2990072|NCT00903682|3706335|FG000|COMPLETED|Overall Study||63
2990073|NCT00903682|3706336|FG001|COMPLETED|Overall Study||63
2990074|NCT00903682|3706335|FG000|NOT COMPLETED|Overall Study||16
2990075|NCT00903682|3706336|FG001|NOT COMPLETED|Overall Study||15
2990076|NCT00903695|3706344|FG000|STARTED|Overall Study||8
2990077|NCT00903695|3706345|FG001|STARTED|Overall Study||2
2990078|NCT00903695|3706344|FG000|COMPLETED|Overall Study||6
2990079|NCT00903695|3706345|FG001|COMPLETED|Overall Study||2
2990080|NCT00903695|3706344|FG000|NOT COMPLETED|Overall Study||2
2990081|NCT00903695|3706345|FG001|NOT COMPLETED|Overall Study||0
2990082|NCT00903760|3706355|FG000|STARTED|Overall Study||19
2990083|NCT00903760|3706356|FG001|STARTED|Overall Study||18
2990084|NCT00903760|3706355|FG000|COMPLETED|Overall Study|Completed all 24 courses|0
2990085|NCT00903760|3706356|FG001|COMPLETED|Overall Study|Completed all 24 courses|2
2990086|NCT00903760|3706355|FG000|NOT COMPLETED|Overall Study||19
2990087|NCT00903760|3706356|FG001|NOT COMPLETED|Overall Study||16
2990088|NCT00903786|3706362|FG000|STARTED|Overall Study||21
2990089|NCT00903786|3706362|FG000|COMPLETED|Overall Study||6
2990090|NCT00903786|3706362|FG000|NOT COMPLETED|Overall Study||15
2990091|NCT00903877|3706367|FG000|STARTED|Overall Study||51
2990092|NCT00903877|3706367|FG000|COMPLETED|Overall Study||8
2990093|NCT00903877|3706367|FG000|NOT COMPLETED|Overall Study||43
2990094|NCT00903929|3706371|FG000|STARTED|Overall Study||3
2990095|NCT00903929|3706372|FG001|STARTED|Overall Study||3
2990096|NCT00903929|3706373|FG002|STARTED|Overall Study|Participants who did not complete the study were replaced with additional participants.|4
2990097|NCT00903929|3706374|FG003|STARTED|Overall Study|Participants who did not complete the study were replaced with additional participants.|9
2990098|NCT00903929|3706371|FG000|COMPLETED|Overall Study||3
2990099|NCT00903929|3706372|FG001|COMPLETED|Overall Study||3
2990100|NCT00903929|3706373|FG002|COMPLETED|Overall Study||3
2990101|NCT00903929|3706374|FG003|COMPLETED|Overall Study||6
2990102|NCT00903929|3706371|FG000|NOT COMPLETED|Overall Study||0
2990103|NCT00903929|3706372|FG001|NOT COMPLETED|Overall Study||0
2990104|NCT00903929|3706373|FG002|NOT COMPLETED|Overall Study||1
2990105|NCT00903929|3706374|FG003|NOT COMPLETED|Overall Study||3
2990106|NCT00903968|3706381|FG000|STARTED|Overall Study||3
2990107|NCT00903968|3706382|FG001|STARTED|Overall Study||3
2990108|NCT00903968|3706383|FG002|STARTED|Overall Study||3
2990109|NCT00903968|3706384|FG003|STARTED|Overall Study||3
2990110|NCT00903968|3706385|FG004|STARTED|Overall Study||4
2990111|NCT00903968|3706386|FG005|STARTED|Overall Study||6
2990112|NCT00903968|3706387|FG006|STARTED|Overall Study||3
2990113|NCT00903968|3706388|FG007|STARTED|Overall Study||33
2990114|NCT00903968|3706381|FG000|COMPLETED|Overall Study||0
2990115|NCT00903968|3706382|FG001|COMPLETED|Overall Study||0
2990116|NCT00903968|3706383|FG002|COMPLETED|Overall Study||0
2990117|NCT00903968|3706384|FG003|COMPLETED|Overall Study||0
2990118|NCT00903968|3706385|FG004|COMPLETED|Overall Study||0
3304963|NCT02983877|4038564|FG000|NOT COMPLETED|Overall Study||0
3304964|NCT02983981|4038569|FG000|STARTED|Overall Study||20
2990119|NCT00903968|3706386|FG005|COMPLETED|Overall Study||0
2990120|NCT00903968|3706387|FG006|COMPLETED|Overall Study||0
2990121|NCT00903968|3706388|FG007|COMPLETED|Overall Study||0
2990122|NCT00903968|3706381|FG000|NOT COMPLETED|Overall Study||3
2990123|NCT00903968|3706382|FG001|NOT COMPLETED|Overall Study||3
2990124|NCT00903968|3706383|FG002|NOT COMPLETED|Overall Study||3
2990125|NCT00903968|3706384|FG003|NOT COMPLETED|Overall Study||3
2990126|NCT00903968|3706385|FG004|NOT COMPLETED|Overall Study||4
2990127|NCT00903968|3706386|FG005|NOT COMPLETED|Overall Study||6
2990128|NCT00903968|3706387|FG006|NOT COMPLETED|Overall Study||3
2990129|NCT00903968|3706388|FG007|NOT COMPLETED|Overall Study||33
2990130|NCT00904007|3706411|FG000|STARTED|Overall Study||55
2990131|NCT00904007|3706412|FG001|STARTED|Overall Study||56
2990132|NCT00904007|3706411|FG000|COMPLETED|Overall Study||55
2990133|NCT00904007|3706412|FG001|COMPLETED|Overall Study||56
2990134|NCT00904007|3706411|FG000|NOT COMPLETED|Overall Study||0
2990135|NCT00904007|3706412|FG001|NOT COMPLETED|Overall Study||0
2990136|NCT00904033|3706424|FG000|STARTED|Overall Study||10
2990137|NCT00904033|3706425|FG001|STARTED|Overall Study||10
2990138|NCT00904033|3706426|FG002|STARTED|Overall Study||10
2990139|NCT00904033|3706427|FG003|STARTED|Overall Study||11
2990140|NCT00904033|3706424|FG000|COMPLETED|Overall Study||9
2990141|NCT00904033|3706425|FG001|COMPLETED|Overall Study||9
2990142|NCT00904033|3706426|FG002|COMPLETED|Overall Study||9
2990143|NCT00904033|3706427|FG003|COMPLETED|Overall Study||9
2990144|NCT00904033|3706424|FG000|NOT COMPLETED|Overall Study||1
2990145|NCT00904033|3706425|FG001|NOT COMPLETED|Overall Study||1
2990146|NCT00904033|3706426|FG002|NOT COMPLETED|Overall Study||1
2990147|NCT00904033|3706427|FG003|NOT COMPLETED|Overall Study||2
2990148|NCT00904150|3706440|FG000|STARTED|Saliva Samples (DNA)||285
2990149|NCT00904150|3706441|FG001|STARTED|Saliva Samples (DNA)||300
2990150|NCT00904150|3706440|FG000|COMPLETED|Saliva Samples (DNA)||282
2990151|NCT00904150|3706441|FG001|COMPLETED|Saliva Samples (DNA)||155
2990152|NCT00904150|3706440|FG000|NOT COMPLETED|Saliva Samples (DNA)||3
2990153|NCT00904150|3706441|FG001|NOT COMPLETED|Saliva Samples (DNA)||145
2990154|NCT00904150|3706440|FG000|STARTED|Blood Samples (RNA): Follicular Phase||37
2990155|NCT00904150|3706441|FG001|STARTED|Blood Samples (RNA): Follicular Phase||32
2990156|NCT00904150|3706440|FG000|COMPLETED|Blood Samples (RNA): Follicular Phase||37
2990157|NCT00904150|3706441|FG001|COMPLETED|Blood Samples (RNA): Follicular Phase||32
2990158|NCT00904150|3706440|FG000|NOT COMPLETED|Blood Samples (RNA): Follicular Phase||0
2990159|NCT00904150|3706441|FG001|NOT COMPLETED|Blood Samples (RNA): Follicular Phase||0
2990160|NCT00904150|3706440|FG000|STARTED|Blood Samples (RNA): Luteal Phase||34
2990161|NCT00904150|3706441|FG001|STARTED|Blood Samples (RNA): Luteal Phase||30
2990162|NCT00904150|3706440|FG000|COMPLETED|Blood Samples (RNA): Luteal Phase||34
2990163|NCT00904150|3706441|FG001|COMPLETED|Blood Samples (RNA): Luteal Phase||30
2990164|NCT00904150|3706440|FG000|NOT COMPLETED|Blood Samples (RNA): Luteal Phase||0
2990165|NCT00904150|3706441|FG001|NOT COMPLETED|Blood Samples (RNA): Luteal Phase||0
2990166|NCT00904215|3706447|FG000|STARTED|Overall Study||1095
2990167|NCT00904215|3706447|FG000|COMPLETED|Overall Study||960
2990168|NCT00904215|3706447|FG000|NOT COMPLETED|Overall Study||135
2990169|NCT00904345|3706451|FG000|STARTED|Overall Study||21
2990170|NCT00904345|3706451|FG000|Stopped or Modified Treatment Due to Toxicity|Overall Study||3
2990171|NCT00904345|3706451|FG000|COMPLETED|Overall Study||18
2990172|NCT00904345|3706451|FG000|NOT COMPLETED|Overall Study||3
2990173|NCT00904371|3706455|FG000|STARTED|Overall Study||211
2990174|NCT00904371|3706455|FG000|COMPLETED|Overall Study||202
2990175|NCT00904371|3706455|FG000|NOT COMPLETED|Overall Study||9
2990176|NCT00904488|3706461|FG000|STARTED|Overall Study||5
2990177|NCT00904488|3706462|FG001|STARTED|Overall Study||6
2990178|NCT00904488|3706461|FG000|COMPLETED|Overall Study||5
2990179|NCT00904488|3706462|FG001|COMPLETED|Overall Study||6
2990180|NCT00904488|3706461|FG000|NOT COMPLETED|Overall Study||0
2990181|NCT00904488|3706462|FG001|NOT COMPLETED|Overall Study||0
2990182|NCT00904618|3706468|FG000|STARTED|Overall Study||48
2990183|NCT00904618|3706468|FG000|COMPLETED|Overall Study||48
2990184|NCT00904618|3706468|FG000|NOT COMPLETED|Overall Study||0
2990185|NCT00904670|3706475|FG000|STARTED|Open Label Phase||23
2990186|NCT00904670|3706476|FG001|STARTED|Open Label Phase||22
2990187|NCT00904670|3706475|FG000|COMPLETED|Open Label Phase||17
2990188|NCT00904670|3706476|FG001|COMPLETED|Open Label Phase||22
2990189|NCT00904670|3706475|FG000|NOT COMPLETED|Open Label Phase||6
2990190|NCT00904670|3706476|FG001|NOT COMPLETED|Open Label Phase||0
2990191|NCT00904670|3706475|FG000|STARTED|First Intervention Period||17
2990192|NCT00904670|3706476|FG001|STARTED|First Intervention Period||22
2990193|NCT00904670|3706475|FG000|COMPLETED|First Intervention Period||17
2990194|NCT00904670|3706476|FG001|COMPLETED|First Intervention Period||22
2990195|NCT00904670|3706475|FG000|NOT COMPLETED|First Intervention Period||0
2990196|NCT00904670|3706476|FG001|NOT COMPLETED|First Intervention Period||0
2990197|NCT00904670|3706475|FG000|STARTED|Second Intervention Period||17
2990198|NCT00904670|3706476|FG001|STARTED|Second Intervention Period||22
2990199|NCT00904670|3706475|FG000|COMPLETED|Second Intervention Period||17
2990200|NCT00904670|3706476|FG001|COMPLETED|Second Intervention Period||22
2990201|NCT00904670|3706475|FG000|NOT COMPLETED|Second Intervention Period||0
2990202|NCT00904670|3706476|FG001|NOT COMPLETED|Second Intervention Period||0
2990203|NCT00904722|3706484|FG000|STARTED|Overall Study||30
2990204|NCT00904722|3706484|FG000|COMPLETED|Overall Study||29
2990205|NCT00904722|3706484|FG000|NOT COMPLETED|Overall Study||1
2990206|NCT00904748|3706488|FG000|STARTED|Overall Study||8
2990207|NCT00904748|3706489|FG001|STARTED|Overall Study||8
2990208|NCT00904748|3706490|FG002|STARTED|Overall Study||8
2990209|NCT00904748|3706491|FG003|STARTED|Overall Study||8
2990210|NCT00904748|3706492|FG004|STARTED|Overall Study|1 participant randomized to this sequence discontinued prior to receipt of study medication.|8
2990211|NCT00904748|3706493|FG005|STARTED|Overall Study||8
2990212|NCT00904748|3706488|FG000|Received Treatment|Overall Study||8
2990213|NCT00904748|3706489|FG001|Received Treatment|Overall Study||8
2990214|NCT00904748|3706490|FG002|Received Treatment|Overall Study||8
2990215|NCT00904748|3706491|FG003|Received Treatment|Overall Study||8
2990216|NCT00904748|3706492|FG004|Received Treatment|Overall Study||7
2990217|NCT00904748|3706493|FG005|Received Treatment|Overall Study||8
2990218|NCT00904748|3706488|FG000|COMPLETED|Overall Study||7
2990219|NCT00904748|3706489|FG001|COMPLETED|Overall Study||7
2990220|NCT00904748|3706490|FG002|COMPLETED|Overall Study||7
2990221|NCT00904748|3706491|FG003|COMPLETED|Overall Study||6
2990222|NCT00904748|3706492|FG004|COMPLETED|Overall Study||7
2990223|NCT00904748|3706493|FG005|COMPLETED|Overall Study||8
2990224|NCT00904748|3706488|FG000|NOT COMPLETED|Overall Study||1
2990225|NCT00904748|3706489|FG001|NOT COMPLETED|Overall Study||1
2990226|NCT00904748|3706490|FG002|NOT COMPLETED|Overall Study||1
2990227|NCT00904748|3706491|FG003|NOT COMPLETED|Overall Study||2
2990228|NCT00904748|3706492|FG004|NOT COMPLETED|Overall Study||1
2990229|NCT00904748|3706493|FG005|NOT COMPLETED|Overall Study||0
2990230|NCT00904813|3706507|FG000|STARTED|Overall Study||129
3133551|NCT01696279|3858509|FG001|Per-protocol Set 2|Part 2a: Calcium Carbonate + Lanthanum||25
3133552|NCT01696279|3858510|FG002|Per-protocol Set 2|Part 2a: Calcium Carbonate + Lanthanum||0
3133553|NCT01696279|3858511|FG003|Per-protocol Set 2|Part 2a: Calcium Carbonate + Lanthanum||0
2990231|NCT00904813|3706508|FG001|STARTED|Overall Study||128
2990232|NCT00904813|3706509|FG002|STARTED|Overall Study||128
2990233|NCT00904813|3706510|FG003|STARTED|Overall Study||228
2990234|NCT00904813|3706511|FG004|STARTED|Overall Study||227
2990235|NCT00904813|3706507|FG000|COMPLETED|Overall Study||129
2990236|NCT00904813|3706508|FG001|COMPLETED|Overall Study||128
2990237|NCT00904813|3706509|FG002|COMPLETED|Overall Study||128
2990238|NCT00904813|3706510|FG003|COMPLETED|Overall Study||228
2990239|NCT00904813|3706511|FG004|COMPLETED|Overall Study||227
2990240|NCT00904813|3706507|FG000|NOT COMPLETED|Overall Study||0
2990241|NCT00904813|3706508|FG001|NOT COMPLETED|Overall Study||0
2990242|NCT00904813|3706509|FG002|NOT COMPLETED|Overall Study||0
2990243|NCT00904813|3706510|FG003|NOT COMPLETED|Overall Study||0
2990244|NCT00904813|3706511|FG004|NOT COMPLETED|Overall Study||0
2990245|NCT00904826|3706534|FG000|STARTED|Overall Study||14
2990246|NCT00904826|3706534|FG000|COMPLETED|Overall Study||14
2990247|NCT00904826|3706534|FG000|NOT COMPLETED|Overall Study||0
2990248|NCT00904839|3706540|FG000|STARTED|Overall Study|All 4 patients were randomised to Maximum Tolerable Dose analysis set.|4
2990249|NCT00904839|3706541|FG001|STARTED|Overall Study|11 patients were randomised to Maximum Tolerable Dose analysis set.|82
2990250|NCT00904839|3706542|FG002|STARTED|Overall Study|Randomised|42
2990251|NCT00904839|3706540|FG000|COMPLETED|Overall Study||3
2990252|NCT00904839|3706541|FG001|COMPLETED|Overall Study||64
2990253|NCT00904839|3706542|FG002|COMPLETED|Overall Study||27
2990254|NCT00904839|3706540|FG000|NOT COMPLETED|Overall Study||1
2990255|NCT00904839|3706541|FG001|NOT COMPLETED|Overall Study||18
2990256|NCT00904839|3706542|FG002|NOT COMPLETED|Overall Study||15
2990257|NCT00904917|3706557|FG000|STARTED|Overall Study||7
2990258|NCT00904917|3706558|FG001|STARTED|Overall Study||11
2990259|NCT00904917|3706559|FG002|STARTED|Overall Study||8
2990260|NCT00904917|3706560|FG003|STARTED|Overall Study||8
2990261|NCT00904917|3706557|FG000|COMPLETED|Overall Study||5
2990262|NCT00904917|3706558|FG001|COMPLETED|Overall Study||9
2990263|NCT00904917|3706559|FG002|COMPLETED|Overall Study||6
2990264|NCT00904917|3706560|FG003|COMPLETED|Overall Study||6
2990265|NCT00904917|3706557|FG000|NOT COMPLETED|Overall Study||2
2990266|NCT00904917|3706558|FG001|NOT COMPLETED|Overall Study||2
2990267|NCT00904917|3706559|FG002|NOT COMPLETED|Overall Study||2
2990268|NCT00904917|3706560|FG003|NOT COMPLETED|Overall Study||2
2990269|NCT00904969|3706573|FG000|STARTED|Overall Study|Number of patients with an attempted implant; 1 subject with procedure aborted|50
2990270|NCT00904969|3706573|FG000|COMPLETED|Overall Study|# of Implanted Subjects Who Completed the Study|31
2990271|NCT00904969|3706573|FG000|NOT COMPLETED|Overall Study||19
2990272|NCT00904982|3706596|FG000|STARTED|Overall Study||68
2990273|NCT00904982|3706597|FG001|STARTED|Overall Study||67
2990274|NCT00904982|3706598|FG002|STARTED|Overall Study||67
2990275|NCT00904982|3706599|FG003|STARTED|Overall Study||68
2990276|NCT00904982|3706596|FG000|COMPLETED|Overall Study||66
2990277|NCT00904982|3706597|FG001|COMPLETED|Overall Study||67
2990278|NCT00904982|3706598|FG002|COMPLETED|Overall Study||67
2990279|NCT00904982|3706599|FG003|COMPLETED|Overall Study||68
2990280|NCT00904982|3706596|FG000|NOT COMPLETED|Overall Study||2
2990281|NCT00904982|3706597|FG001|NOT COMPLETED|Overall Study||0
2990282|NCT00904982|3706598|FG002|NOT COMPLETED|Overall Study||0
2990283|NCT00904982|3706599|FG003|NOT COMPLETED|Overall Study||0
2990284|NCT00904995|3706611|FG000|STARTED|Overall Study||10
2990285|NCT00904995|3706612|FG001|STARTED|Overall Study||11
2990286|NCT00904995|3706611|FG000|COMPLETED|Overall Study||10
2990287|NCT00904995|3706612|FG001|COMPLETED|Overall Study||11
2990288|NCT00904995|3706611|FG000|NOT COMPLETED|Overall Study||0
2990289|NCT00904995|3706612|FG001|NOT COMPLETED|Overall Study||0
2990290|NCT00905021|3706618|FG000|STARTED|Overall Study||4
2990291|NCT00905021|3706618|FG000|COMPLETED|Overall Study|2 patients were off study due to AE.|2
2990292|NCT00905021|3706618|FG000|NOT COMPLETED|Overall Study||2
2990293|NCT00905034|3706623|FG000|STARTED|Overall Study||37
2990294|NCT00905034|3706623|FG000|COMPLETED|Overall Study||36
2990295|NCT00905034|3706623|FG000|NOT COMPLETED|Overall Study||1
2990296|NCT00905060|3706627|FG000|STARTED|Surgical Resection||70
2990297|NCT00905060|3706627|FG000|COMPLETED|Surgical Resection||46
2990298|NCT00905060|3706627|FG000|NOT COMPLETED|Surgical Resection||24
2990299|NCT00905060|3706627|FG000|STARTED|Vaccination Treatment Period||46
2990300|NCT00905060|3706627|FG000|COMPLETED|Vaccination Treatment Period||46
2990301|NCT00905060|3706627|FG000|NOT COMPLETED|Vaccination Treatment Period||0
2990302|NCT00905125|3706633|FG000|STARTED|Overall Study||46
2990303|NCT00905125|3706634|FG001|STARTED|Overall Study||56
2990304|NCT00905125|3706633|FG000|COMPLETED|Overall Study||42
2990305|NCT00905125|3706634|FG001|COMPLETED|Overall Study||53
2990306|NCT00905125|3706633|FG000|NOT COMPLETED|Overall Study||4
2990307|NCT00905125|3706634|FG001|NOT COMPLETED|Overall Study||3
2990308|NCT00905151|3706640|FG000|STARTED|Overall Study||206
2990309|NCT00905151|3706640|FG000|COMPLETED|Overall Study||200
2990310|NCT00905151|3706640|FG000|NOT COMPLETED|Overall Study||6
2990311|NCT00905255|3706646|FG000|STARTED|Overall Study|Randomized.|33
2990312|NCT00905255|3706647|FG001|STARTED|Overall Study||36
2990313|NCT00905255|3706646|FG000|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|33
2990314|NCT00905255|3706647|FG001|Safety Population|Overall Study||36
2990315|NCT00905255|3706646|FG000|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|33
2990316|NCT00905255|3706647|FG001|Modified Intent-to-Treat(mITT)Population|Overall Study||36
2990317|NCT00905255|3706646|FG000|COMPLETED|Overall Study||20
2990318|NCT00905255|3706647|FG001|COMPLETED|Overall Study||27
2990319|NCT00905255|3706646|FG000|NOT COMPLETED|Overall Study||13
2990320|NCT00905255|3706647|FG001|NOT COMPLETED|Overall Study||9
2990321|NCT00905268|3706658|FG000|STARTED|Overall Study||57
2990322|NCT00905268|3706659|FG001|STARTED|Overall Study||57
2990323|NCT00905268|3706660|FG002|STARTED|Overall Study||59
2990324|NCT00905268|3706661|FG003|STARTED|Overall Study||59
2990325|NCT00905268|3706658|FG000|COMPLETED|Overall Study||53
2990326|NCT00905268|3706659|FG001|COMPLETED|Overall Study||56
2990327|NCT00905268|3706660|FG002|COMPLETED|Overall Study||59
2990328|NCT00905268|3706661|FG003|COMPLETED|Overall Study||57
2990329|NCT00905268|3706658|FG000|NOT COMPLETED|Overall Study||4
2990330|NCT00905268|3706659|FG001|NOT COMPLETED|Overall Study||1
2990331|NCT00905268|3706660|FG002|NOT COMPLETED|Overall Study||0
2990332|NCT00905268|3706661|FG003|NOT COMPLETED|Overall Study||2
2990333|NCT00905307|3706677|FG000|STARTED|Overall Study||42
2990334|NCT00905307|3706678|FG001|STARTED|Overall Study||89
3164444|NCT01892189|3891786|FG008|COMPLETED|Third Intervention Period (1 Day)||1
3164445|NCT01892189|3891778|FG000|NOT COMPLETED|Third Intervention Period (1 Day)||0
3164446|NCT01892189|3891779|FG001|NOT COMPLETED|Third Intervention Period (1 Day)||0
3164447|NCT01892189|3891780|FG002|NOT COMPLETED|Third Intervention Period (1 Day)||0
3164448|NCT01892189|3891781|FG003|NOT COMPLETED|Third Intervention Period (1 Day)||0
3164449|NCT01892189|3891782|FG004|NOT COMPLETED|Third Intervention Period (1 Day)||0
3164450|NCT01892189|3891783|FG005|NOT COMPLETED|Third Intervention Period (1 Day)||0
2990335|NCT00905307|3706679|FG002|STARTED|Overall Study||90
2990336|NCT00905307|3706680|FG003|STARTED|Overall Study||93
2990337|NCT00905307|3706681|FG004|STARTED|Overall Study||50
2990338|NCT00905307|3706682|FG005|STARTED|Overall Study||95
2990339|NCT00905307|3706677|FG000|COMPLETED|Overall Study||20
2990340|NCT00905307|3706678|FG001|COMPLETED|Overall Study||52
2990341|NCT00905307|3706679|FG002|COMPLETED|Overall Study||53
2990342|NCT00905307|3706680|FG003|COMPLETED|Overall Study||56
2990343|NCT00905307|3706681|FG004|COMPLETED|Overall Study||34
2990344|NCT00905307|3706682|FG005|COMPLETED|Overall Study||53
2990345|NCT00905307|3706677|FG000|NOT COMPLETED|Overall Study||22
2990346|NCT00905307|3706678|FG001|NOT COMPLETED|Overall Study||37
2990347|NCT00905307|3706679|FG002|NOT COMPLETED|Overall Study||37
2990348|NCT00905307|3706680|FG003|NOT COMPLETED|Overall Study||37
2990349|NCT00905307|3706681|FG004|NOT COMPLETED|Overall Study||16
2990350|NCT00905307|3706682|FG005|NOT COMPLETED|Overall Study||42
2990351|NCT00905359|3706711|FG000|STARTED|Overall Study||82
2990352|NCT00905359|3706712|FG001|STARTED|Overall Study||81
2990353|NCT00905359|3706711|FG000|12 Months Follow up|Overall Study||68
2990354|NCT00905359|3706712|FG001|12 Months Follow up|Overall Study||72
2990355|NCT00905359|3706711|FG000|24 Months Follow up|Overall Study||58
2990356|NCT00905359|3706712|FG001|24 Months Follow up|Overall Study||65
2990357|NCT00905359|3706711|FG000|COMPLETED|Overall Study||58
2990358|NCT00905359|3706712|FG001|COMPLETED|Overall Study||65
2990359|NCT00905359|3706711|FG000|NOT COMPLETED|Overall Study||24
2990360|NCT00905359|3706712|FG001|NOT COMPLETED|Overall Study||16
2990361|NCT00905424|3706720|FG000|STARTED|Overall Study||89
2990362|NCT00905424|3706721|FG001|STARTED|Overall Study||88
2990363|NCT00905424|3706720|FG000|COMPLETED|Overall Study||78
2990364|NCT00905424|3706721|FG001|COMPLETED|Overall Study||79
2990365|NCT00905424|3706720|FG000|NOT COMPLETED|Overall Study||11
2990366|NCT00905424|3706721|FG001|NOT COMPLETED|Overall Study||9
2990367|NCT00905437|3706731|FG000|STARTED|Overall Study||35
2990368|NCT00905437|3706732|FG001|STARTED|Overall Study||37
2990369|NCT00905437|3706731|FG000|COMPLETED|Overall Study||27
2990370|NCT00905437|3706732|FG001|COMPLETED|Overall Study||27
2990371|NCT00905437|3706731|FG000|NOT COMPLETED|Overall Study||8
2990372|NCT00905437|3706732|FG001|NOT COMPLETED|Overall Study||10
2990373|NCT00905450|3706746|FG000|STARTED|Overall Study||60
2990374|NCT00905450|3706747|FG001|STARTED|Overall Study||28
2990375|NCT00905450|3706748|FG002|STARTED|Overall Study||28
2990376|NCT00905450|3706749|FG003|STARTED|Overall Study||60
2990377|NCT00905450|3706750|FG004|STARTED|Overall Study||59
2990378|NCT00905450|3706751|FG005|STARTED|Overall Study||60
2990379|NCT00905450|3706752|FG006|STARTED|Overall Study||60
2990380|NCT00905450|3706753|FG007|STARTED|Overall Study||60
2990381|NCT00905450|3706746|FG000|COMPLETED|Overall Study||59
2990382|NCT00905450|3706747|FG001|COMPLETED|Overall Study||27
2990383|NCT00905450|3706748|FG002|COMPLETED|Overall Study||28
2990384|NCT00905450|3706749|FG003|COMPLETED|Overall Study||60
2990385|NCT00905450|3706750|FG004|COMPLETED|Overall Study||59
2990386|NCT00905450|3706751|FG005|COMPLETED|Overall Study||58
2990387|NCT00905450|3706752|FG006|COMPLETED|Overall Study||58
2990388|NCT00905450|3706753|FG007|COMPLETED|Overall Study||59
2990389|NCT00905450|3706746|FG000|NOT COMPLETED|Overall Study||1
2990390|NCT00905450|3706747|FG001|NOT COMPLETED|Overall Study||1
2990391|NCT00905450|3706748|FG002|NOT COMPLETED|Overall Study||0
2990392|NCT00905450|3706749|FG003|NOT COMPLETED|Overall Study||0
2990393|NCT00905450|3706750|FG004|NOT COMPLETED|Overall Study||0
2990394|NCT00905450|3706751|FG005|NOT COMPLETED|Overall Study||2
2990395|NCT00905450|3706752|FG006|NOT COMPLETED|Overall Study||2
2990396|NCT00905450|3706753|FG007|NOT COMPLETED|Overall Study||1
2990397|NCT00905489|3706771|FG000|STARTED|Pharmaco-kinetic (PK) Phase||85
2990398|NCT00905489|3706771|FG000|COMPLETED|Pharmaco-kinetic (PK) Phase||80
2990399|NCT00905489|3706771|FG000|NOT COMPLETED|Pharmaco-kinetic (PK) Phase||5
2990400|NCT00905489|3706771|FG000|STARTED|Optional Extension Phase (OEP)|Includes only subjects who chose to continue trt with nevirapine XR after completing the PK phase.|40
2990401|NCT00905489|3706771|FG000|COMPLETED|Optional Extension Phase (OEP)||39
2990402|NCT00905489|3706771|FG000|NOT COMPLETED|Optional Extension Phase (OEP)||1
2990403|NCT00905515|3706783|FG000|STARTED|Overall Study||21
2990404|NCT00905515|3706784|FG001|STARTED|Overall Study||20
2990405|NCT00905515|3706785|FG002|STARTED|Overall Study||22
2990406|NCT00905515|3706783|FG000|COMPLETED|Overall Study||19
2990407|NCT00905515|3706784|FG001|COMPLETED|Overall Study||20
2990408|NCT00905515|3706785|FG002|COMPLETED|Overall Study||20
2990409|NCT00905515|3706783|FG000|NOT COMPLETED|Overall Study||2
2990410|NCT00905515|3706784|FG001|NOT COMPLETED|Overall Study||0
2990411|NCT00905515|3706785|FG002|NOT COMPLETED|Overall Study||2
3164451|NCT01892189|3891784|FG006|NOT COMPLETED|Third Intervention Period (1 Day)||0
3164452|NCT01892189|3891785|FG007|NOT COMPLETED|Third Intervention Period (1 Day)||0
3164453|NCT01892189|3891786|FG008|NOT COMPLETED|Third Intervention Period (1 Day)||0
3164454|NCT01892267|3891803|FG000|STARTED|Overall Study||9
3164455|NCT01892267|3891804|FG001|STARTED|Overall Study||10
3164456|NCT01892267|3891803|FG000|COMPLETED|Overall Study||9
3164457|NCT01892267|3891804|FG001|COMPLETED|Overall Study||10
3164458|NCT01892267|3891803|FG000|NOT COMPLETED|Overall Study||0
3164459|NCT01892267|3891804|FG001|NOT COMPLETED|Overall Study||0
3164460|NCT01892293|3891810|FG000|STARTED|Overall Study||6
3164461|NCT01892293|3891810|FG000|Received T-cell|Overall Study||2
3164462|NCT01892293|3891810|FG000|COMPLETED|Overall Study||2
3164463|NCT01892293|3891810|FG000|NOT COMPLETED|Overall Study||4
3164464|NCT01892306|3891816|FG000|STARTED|Overall Study||13
3164465|NCT01892306|3891817|FG001|STARTED|Overall Study||16
3164466|NCT01892306|3891816|FG000|COMPLETED|Overall Study||8
3164467|NCT01892306|3891817|FG001|COMPLETED|Overall Study||10
3164468|NCT01892306|3891816|FG000|NOT COMPLETED|Overall Study||5
3164469|NCT01892306|3891817|FG001|NOT COMPLETED|Overall Study||6
3164470|NCT01892345|3891825|FG000|STARTED|Overall Study||96
3164471|NCT01892345|3891826|FG001|STARTED|Overall Study||47
3164472|NCT01892345|3891825|FG000|Received At Least 1 Dose Of Study Drug|Overall Study||96
3164473|NCT01892345|3891826|FG001|Received At Least 1 Dose Of Study Drug|Overall Study||47
3164474|NCT01892345|3891825|FG000|COMPLETED|Overall Study||80
2990412|NCT00905554|3706795|FG000|STARTED|Overall Study||116
2990413|NCT00905554|3706796|FG001|STARTED|Overall Study||114
2990414|NCT00905554|3706795|FG000|COMPLETED|Overall Study||116
2990415|NCT00905554|3706796|FG001|COMPLETED|Overall Study||114
2990416|NCT00905554|3706795|FG000|NOT COMPLETED|Overall Study||0
2990417|NCT00905554|3706796|FG001|NOT COMPLETED|Overall Study||0
2990418|NCT00905580|3706804|FG000|STARTED|Overall Study||49
3164475|NCT01892345|3891826|FG001|COMPLETED|Overall Study||44
3164476|NCT01892345|3891825|FG000|NOT COMPLETED|Overall Study||16
3164477|NCT01892345|3891826|FG001|NOT COMPLETED|Overall Study||3
3164478|NCT01892436|3891836|FG000|STARTED|Overall Study||147
3164479|NCT01892436|3891837|FG001|STARTED|Overall Study||161
3164480|NCT01892436|3891838|FG002|STARTED|Overall Study||74
3164481|NCT01892436|3891839|FG003|STARTED|Overall Study||75
3164482|NCT01892436|3891836|FG000|COMPLETED|Overall Study||124
3164483|NCT01892436|3891837|FG001|COMPLETED|Overall Study||132
2990419|NCT00905580|3706805|FG001|STARTED|Overall Study||50
2990420|NCT00905580|3706804|FG000|COMPLETED|Overall Study||47
2990421|NCT00905580|3706805|FG001|COMPLETED|Overall Study||47
2990422|NCT00905580|3706804|FG000|NOT COMPLETED|Overall Study||2
3164484|NCT01892436|3891838|FG002|COMPLETED|Overall Study||63
3164485|NCT01892436|3891839|FG003|COMPLETED|Overall Study||61
3164486|NCT01892436|3891836|FG000|NOT COMPLETED|Overall Study||23
3164487|NCT01892436|3891837|FG001|NOT COMPLETED|Overall Study||29
3164488|NCT01892436|3891838|FG002|NOT COMPLETED|Overall Study||11
3164489|NCT01892436|3891839|FG003|NOT COMPLETED|Overall Study||14
3164490|NCT01892501|3891849|FG000|STARTED|Overall Study||75
3171815|NCT01937351|3899027|FG000|STARTED|Overall Study||134
2990423|NCT00905580|3706805|FG001|NOT COMPLETED|Overall Study||3
2990424|NCT00905632|3706818|FG000|STARTED|Overall Study||8
3164491|NCT01892501|3891849|FG000|Group A : Biopsy Surgically Possible|Overall Study||72
3164492|NCT01892501|3891849|FG000|Group B : Biopsy Not Surgically Possible|Overall Study||3
3164493|NCT01892501|3891849|FG000|COMPLETED|Overall Study||47
3164494|NCT01892501|3891849|FG000|NOT COMPLETED|Overall Study||28
3164495|NCT01892540|3891856|FG000|STARTED|Overall Study||15
3164496|NCT01892540|3891857|FG001|STARTED|Overall Study||0
2990425|NCT00905632|3706819|FG001|STARTED|Overall Study||6
2990426|NCT00905632|3706820|FG002|STARTED|Overall Study||7
2990427|NCT00905632|3706821|FG003|STARTED|Overall Study||6
2990428|NCT00905632|3706822|FG004|STARTED|Overall Study||10
2990429|NCT00905632|3706823|FG005|STARTED|Overall Study||9
2990430|NCT00905632|3706824|FG006|STARTED|Overall Study||11
2990431|NCT00905632|3706818|FG000|COMPLETED|Overall Study||8
2990432|NCT00905632|3706819|FG001|COMPLETED|Overall Study||6
2990433|NCT00905632|3706820|FG002|COMPLETED|Overall Study||7
2990434|NCT00905632|3706821|FG003|COMPLETED|Overall Study||6
2990435|NCT00905632|3706822|FG004|COMPLETED|Overall Study||10
2990436|NCT00905632|3706823|FG005|COMPLETED|Overall Study||8
2990437|NCT00905632|3706824|FG006|COMPLETED|Overall Study||7
2990438|NCT00905632|3706818|FG000|NOT COMPLETED|Overall Study||0
2990439|NCT00905632|3706819|FG001|NOT COMPLETED|Overall Study||0
2990440|NCT00905632|3706820|FG002|NOT COMPLETED|Overall Study||0
2990441|NCT00905632|3706821|FG003|NOT COMPLETED|Overall Study||0
2990442|NCT00905632|3706822|FG004|NOT COMPLETED|Overall Study||0
2990443|NCT00905632|3706823|FG005|NOT COMPLETED|Overall Study||1
2990444|NCT00905632|3706824|FG006|NOT COMPLETED|Overall Study||4
2990445|NCT00905827|3706850|FG000|STARTED|Overall Study||70
2990446|NCT00905827|3706851|FG001|STARTED|Overall Study||69
2990447|NCT00905827|3706852|FG002|STARTED|Overall Study||73
2990448|NCT00905827|3706850|FG000|COMPLETED|Overall Study||70
2990449|NCT00905827|3706851|FG001|COMPLETED|Overall Study||69
2990450|NCT00905827|3706852|FG002|COMPLETED|Overall Study||73
2990451|NCT00905827|3706850|FG000|NOT COMPLETED|Overall Study||0
2990452|NCT00905827|3706851|FG001|NOT COMPLETED|Overall Study||0
2990453|NCT00905827|3706852|FG002|NOT COMPLETED|Overall Study||0
2990454|NCT00905840|3706860|FG000|STARTED|Overall Study||91
2990455|NCT00905840|3706860|FG000|COMPLETED|Overall Study||75
2990456|NCT00905840|3706860|FG000|NOT COMPLETED|Overall Study||16
2990457|NCT00906074|3706869|FG000|STARTED|Overall Study||90
2990458|NCT00906074|3706870|FG001|STARTED|Overall Study||90
2990459|NCT00906074|3706869|FG000|COMPLETED|Overall Study||90
2990460|NCT00906074|3706870|FG001|COMPLETED|Overall Study||90
2990461|NCT00906074|3706869|FG000|NOT COMPLETED|Overall Study||0
2990462|NCT00906074|3706870|FG001|NOT COMPLETED|Overall Study||0
2990463|NCT00906087|3706876|FG000|STARTED|Initial Washout||14
2990464|NCT00906087|3706876|FG000|Completed Screening|Initial Washout||14
2990465|NCT00906087|3706876|FG000|Begin Washout|Initial Washout||13
2990466|NCT00906087|3706876|FG000|Completed Washout and Continue Protocol|Initial Washout||12
2990467|NCT00906087|3706876|FG000|COMPLETED|Initial Washout||12
2990468|NCT00906087|3706876|FG000|NOT COMPLETED|Initial Washout||2
2990469|NCT00906087|3706876|FG000|STARTED|Cosopt Treatment 6 Weeks||12
2990470|NCT00906087|3706876|FG000|COMPLETED|Cosopt Treatment 6 Weeks||12
2990471|NCT00906087|3706876|FG000|NOT COMPLETED|Cosopt Treatment 6 Weeks||0
2990472|NCT00906087|3706876|FG000|STARTED|Final Washout Period 4 Weeks||12
2990473|NCT00906087|3706876|FG000|COMPLETED|Final Washout Period 4 Weeks||12
2990474|NCT00906087|3706876|FG000|NOT COMPLETED|Final Washout Period 4 Weeks||0
2990475|NCT00906165|3706885|FG000|STARTED|Overall Study||14
2990476|NCT00906165|3706886|FG001|STARTED|Overall Study||14
2990477|NCT00906165|3706885|FG000|COMPLETED|Overall Study||10
2990478|NCT00906165|3706886|FG001|COMPLETED|Overall Study||14
2990479|NCT00906165|3706885|FG000|NOT COMPLETED|Overall Study||4
2990480|NCT00906165|3706886|FG001|NOT COMPLETED|Overall Study||0
2990481|NCT00906178|3706894|FG000|STARTED|Overall Study||183
2990482|NCT00906178|3706895|FG001|STARTED|Overall Study||183
2990483|NCT00906178|3706894|FG000|COMPLETED|Overall Study||168
2990484|NCT00906178|3706895|FG001|COMPLETED|Overall Study||167
2990485|NCT00906178|3706894|FG000|NOT COMPLETED|Overall Study||15
2990486|NCT00906178|3706895|FG001|NOT COMPLETED|Overall Study||16
2990487|NCT00906204|3706903|FG000|STARTED|Primary Endpoint (Early Safety)||45
2990488|NCT00906204|3706904|FG001|STARTED|Primary Endpoint (Early Safety)||52
2990489|NCT00906204|3706903|FG000|COMPLETED|Primary Endpoint (Early Safety)||43
2990490|NCT00906204|3706904|FG001|COMPLETED|Primary Endpoint (Early Safety)||51
2990491|NCT00906204|3706903|FG000|NOT COMPLETED|Primary Endpoint (Early Safety)||2
2990492|NCT00906204|3706904|FG001|NOT COMPLETED|Primary Endpoint (Early Safety)||1
2990493|NCT00906204|3706903|FG000|STARTED|Secondary Endpoints (Long-term Safety)||43
2990494|NCT00906204|3706904|FG001|STARTED|Secondary Endpoints (Long-term Safety)||51
2990495|NCT00906204|3706903|FG000|COMPLETED|Secondary Endpoints (Long-term Safety)||41
2990496|NCT00906204|3706904|FG001|COMPLETED|Secondary Endpoints (Long-term Safety)||48
2990497|NCT00906204|3706903|FG000|NOT COMPLETED|Secondary Endpoints (Long-term Safety)||2
2990498|NCT00906204|3706904|FG001|NOT COMPLETED|Secondary Endpoints (Long-term Safety)||3
2990499|NCT00906243|3706910|FG000|STARTED|Overall Study||6
2990500|NCT00906243|3706910|FG000|COMPLETED|Overall Study||6
2990501|NCT00906243|3706910|FG000|NOT COMPLETED|Overall Study||0
2990502|NCT00906282|3706914|FG000|STARTED|Preoperative Chemotherapy||46
3164497|NCT01892540|3891858|FG002|STARTED|Overall Study||28
3164498|NCT01892540|3891856|FG000|COMPLETED|Overall Study||15
2990503|NCT00906282|3706914|FG000|COMPLETED|Preoperative Chemotherapy|2 of 27 patients completed less than 4 cycles and were deemed surgical candidates.|27
2990504|NCT00906282|3706914|FG000|NOT COMPLETED|Preoperative Chemotherapy||19
2990505|NCT00906282|3706914|FG000|STARTED|Surgical Resection||27
2990506|NCT00906282|3706914|FG000|COMPLETED|Surgical Resection||27
2990507|NCT00906282|3706914|FG000|NOT COMPLETED|Surgical Resection||0
2990508|NCT00906347|3706921|FG000|STARTED|Randomized||176
2990509|NCT00906347|3706922|FG001|STARTED|Randomized||174
2990510|NCT00906347|3706921|FG000|COMPLETED|Randomized||176
2990511|NCT00906347|3706922|FG001|COMPLETED|Randomized||174
2990512|NCT00906347|3706921|FG000|NOT COMPLETED|Randomized||0
2990513|NCT00906347|3706922|FG001|NOT COMPLETED|Randomized||0
2990514|NCT00906347|3706921|FG000|STARTED|Received Study Drug||176
2990515|NCT00906347|3706922|FG001|STARTED|Received Study Drug||174
2990516|NCT00906347|3706921|FG000|COMPLETED|Received Study Drug||136
2990517|NCT00906347|3706922|FG001|COMPLETED|Received Study Drug||143
2990518|NCT00906347|3706921|FG000|NOT COMPLETED|Received Study Drug||40
2990519|NCT00906347|3706922|FG001|NOT COMPLETED|Received Study Drug||31
2990520|NCT00906373|3706930|FG000|STARTED|Overall Study||6
2990521|NCT00906373|3706931|FG001|STARTED|Overall Study||41
2990522|NCT00906373|3706930|FG000|Received Any Amount of Study Drug|Overall Study||6
2990523|NCT00906373|3706931|FG001|Received Any Amount of Study Drug|Overall Study||41
2990524|NCT00906373|3706930|FG000|COMPLETED|Overall Study||6
2990525|NCT00906373|3706931|FG001|COMPLETED|Overall Study||33
2990526|NCT00906373|3706930|FG000|NOT COMPLETED|Overall Study||0
2990527|NCT00906373|3706931|FG001|NOT COMPLETED|Overall Study||8
2990528|NCT00906399|3706941|FG000|STARTED|Year 1||500
2990529|NCT00906399|3706942|FG001|STARTED|Year 1||501
2990530|NCT00906399|3706943|FG002|STARTED|Year 1||515
2990531|NCT00906399|3706944|FG003|STARTED|Year 1||0
2990532|NCT00906399|3706945|FG004|STARTED|Year 1||0
2990533|NCT00906399|3706946|FG005|STARTED|Year 1||0
2990534|NCT00906399|3706947|FG006|STARTED|Year 1||0
2990535|NCT00906399|3706941|FG000|Completed Year 1 Study Treatment|Year 1||456
2990536|NCT00906399|3706942|FG001|Completed Year 1 Study Treatment|Year 1||438
2990537|NCT00906399|3706943|FG002|Completed Year 1 Study Treatment|Year 1||438
2990538|NCT00906399|3706944|FG003|Completed Year 1 Study Treatment|Year 1||0
2990539|NCT00906399|3706945|FG004|Completed Year 1 Study Treatment|Year 1||0
2990540|NCT00906399|3706946|FG005|Completed Year 1 Study Treatment|Year 1||0
2990541|NCT00906399|3706947|FG006|Completed Year 1 Study Treatment|Year 1||0
2990542|NCT00906399|3706941|FG000|COMPLETED|Year 1||456
2990543|NCT00906399|3706942|FG001|COMPLETED|Year 1||438
2990544|NCT00906399|3706943|FG002|COMPLETED|Year 1|1 participant discontinued treatment before end of study period but remained to complete follow-up.|439
2990545|NCT00906399|3706944|FG003|COMPLETED|Year 1||0
2990546|NCT00906399|3706945|FG004|COMPLETED|Year 1||0
2990547|NCT00906399|3706946|FG005|COMPLETED|Year 1||0
2990548|NCT00906399|3706947|FG006|COMPLETED|Year 1||0
2990549|NCT00906399|3706941|FG000|NOT COMPLETED|Year 1||44
2990550|NCT00906399|3706942|FG001|NOT COMPLETED|Year 1||63
2990551|NCT00906399|3706943|FG002|NOT COMPLETED|Year 1||76
2990552|NCT00906399|3706944|FG003|NOT COMPLETED|Year 1||0
2990553|NCT00906399|3706945|FG004|NOT COMPLETED|Year 1||0
2990554|NCT00906399|3706946|FG005|NOT COMPLETED|Year 1||0
2990555|NCT00906399|3706947|FG006|NOT COMPLETED|Year 1||0
2990556|NCT00906399|3706941|FG000|STARTED|Year 2||0
2990557|NCT00906399|3706942|FG001|STARTED|Year 2||0
2990558|NCT00906399|3706943|FG002|STARTED|Year 2||0
2990559|NCT00906399|3706944|FG003|STARTED|Year 2||228
2990560|NCT00906399|3706945|FG004|STARTED|Year 2||228
2990561|NCT00906399|3706946|FG005|STARTED|Year 2||438
2990562|NCT00906399|3706947|FG006|STARTED|Year 2||438
2990563|NCT00906399|3706941|FG000|Completed Year 2 Study Treatment|Year 2||0
2990564|NCT00906399|3706942|FG001|Completed Year 2 Study Treatment|Year 2||0
2990565|NCT00906399|3706943|FG002|Completed Year 2 Study Treatment|Year 2||0
2990566|NCT00906399|3706944|FG003|Completed Year 2 Study Treatment|Year 2||200
2990567|NCT00906399|3706945|FG004|Completed Year 2 Study Treatment|Year 2||196
2990568|NCT00906399|3706946|FG005|Completed Year 2 Study Treatment|Year 2||391
2990569|NCT00906399|3706947|FG006|Completed Year 2 Study Treatment|Year 2||411
2990570|NCT00906399|3706941|FG000|COMPLETED|Year 2||0
2990571|NCT00906399|3706942|FG001|COMPLETED|Year 2||0
2990572|NCT00906399|3706943|FG002|COMPLETED|Year 2||0
2990573|NCT00906399|3706944|FG003|COMPLETED|Year 2||198
2990574|NCT00906399|3706945|FG004|COMPLETED|Year 2||193
2990575|NCT00906399|3706946|FG005|COMPLETED|Year 2||391
2990576|NCT00906399|3706947|FG006|COMPLETED|Year 2||409
2990577|NCT00906399|3706941|FG000|NOT COMPLETED|Year 2||0
2990578|NCT00906399|3706942|FG001|NOT COMPLETED|Year 2||0
2990579|NCT00906399|3706943|FG002|NOT COMPLETED|Year 2||0
2990580|NCT00906399|3706944|FG003|NOT COMPLETED|Year 2||30
2990581|NCT00906399|3706945|FG004|NOT COMPLETED|Year 2||35
2990582|NCT00906399|3706946|FG005|NOT COMPLETED|Year 2||47
2990583|NCT00906399|3706947|FG006|NOT COMPLETED|Year 2||29
2990584|NCT00906425|3706961|FG000|STARTED|Overall Study||73
2990585|NCT00906425|3706962|FG001|STARTED|Overall Study||72
2990586|NCT00906425|3706961|FG000|6 Months|Overall Study|ITT population|69
2990587|NCT00906425|3706962|FG001|6 Months|Overall Study|ITT population|64
2990588|NCT00906425|3706961|FG000|1 Year|Overall Study|ITT population|67
2990589|NCT00906425|3706962|FG001|1 Year|Overall Study|ITT population|60
2990590|NCT00906425|3706961|FG000|2 Year|Overall Study|ITT population|62
2990591|NCT00906425|3706962|FG001|2 Year|Overall Study|ITT population|58
2990592|NCT00906425|3706961|FG000|COMPLETED|Overall Study|Clinical Trial expected to be completed in 2013|0
3036747|NCT01144663|3756007|FG003|NOT COMPLETED|Primary Vaccination Phase||18
2990593|NCT00906425|3706962|FG001|COMPLETED|Overall Study|Clinical Trial expected to be completed in 2013|0
2990594|NCT00906425|3706961|FG000|NOT COMPLETED|Overall Study||73
2990595|NCT00906425|3706962|FG001|NOT COMPLETED|Overall Study||72
2990596|NCT00906503|3706968|FG000|STARTED|Overall Study||9
2990597|NCT00906503|3706968|FG000|COMPLETED|Overall Study||9
2990598|NCT00906503|3706968|FG000|NOT COMPLETED|Overall Study||0
2990599|NCT00906698|3706978|FG000|STARTED|Overall Study||3
2990600|NCT00906698|3706979|FG001|STARTED|Overall Study||19
2990601|NCT00906698|3706980|FG002|STARTED|Overall Study||6
2990602|NCT00906698|3706981|FG003|STARTED|Overall Study||4
2990603|NCT00906698|3706982|FG004|STARTED|Overall Study||18
2990604|NCT00906698|3706983|FG005|STARTED|Overall Study||5
2990605|NCT00906698|3706978|FG000|COMPLETED|Overall Study||0
2990606|NCT00906698|3706979|FG001|COMPLETED|Overall Study||0
2990607|NCT00906698|3706980|FG002|COMPLETED|Overall Study||0
2990608|NCT00906698|3706981|FG003|COMPLETED|Overall Study||0
2990609|NCT00906698|3706982|FG004|COMPLETED|Overall Study||0
2990610|NCT00906698|3706983|FG005|COMPLETED|Overall Study||0
2990611|NCT00906698|3706978|FG000|NOT COMPLETED|Overall Study||3
2990612|NCT00906698|3706979|FG001|NOT COMPLETED|Overall Study||19
2990613|NCT00906698|3706980|FG002|NOT COMPLETED|Overall Study||6
2990614|NCT00906698|3706981|FG003|NOT COMPLETED|Overall Study||4
2990615|NCT00906698|3706982|FG004|NOT COMPLETED|Overall Study||18
2990616|NCT00906698|3706983|FG005|NOT COMPLETED|Overall Study||5
2990617|NCT00906776|3707017|FG000|STARTED|Overall Study||11
2990618|NCT00906776|3707018|FG001|STARTED|Overall Study||8
2990619|NCT00906776|3707017|FG000|COMPLETED|Overall Study||11
2990620|NCT00906776|3707018|FG001|COMPLETED|Overall Study||8
2990621|NCT00906776|3707017|FG000|NOT COMPLETED|Overall Study||0
2990622|NCT00906776|3707018|FG001|NOT COMPLETED|Overall Study||0
2990623|NCT00906789|3707024|FG000|STARTED|Overall Study|Radiologists served as own control. Total enrollment is 15 radiologists.|15
2990624|NCT00906789|3707024|FG000|COMPLETED|Overall Study||15
2990625|NCT00906789|3707024|FG000|NOT COMPLETED|Overall Study||0
2990626|NCT00906945|3707035|FG000|STARTED|Overall Study||3
2990627|NCT00906945|3707036|FG001|STARTED|Overall Study||3
2990628|NCT00906945|3707037|FG002|STARTED|Overall Study||3
2990629|NCT00906945|3707038|FG003|STARTED|Overall Study||7
2990630|NCT00906945|3707039|FG004|STARTED|Overall Study||7
2990631|NCT00906945|3707040|FG005|STARTED|Overall Study||16
2990632|NCT00906945|3707035|FG000|COMPLETED|Overall Study||3
2990633|NCT00906945|3707036|FG001|COMPLETED|Overall Study||3
2990634|NCT00906945|3707037|FG002|COMPLETED|Overall Study||3
2990635|NCT00906945|3707038|FG003|COMPLETED|Overall Study||6
2990636|NCT00906945|3707039|FG004|COMPLETED|Overall Study||6
2990637|NCT00906945|3707040|FG005|COMPLETED|Overall Study||14
2990638|NCT00906945|3707035|FG000|NOT COMPLETED|Overall Study||0
2990639|NCT00906945|3707036|FG001|NOT COMPLETED|Overall Study||0
2990640|NCT00906945|3707037|FG002|NOT COMPLETED|Overall Study||0
2990641|NCT00906945|3707038|FG003|NOT COMPLETED|Overall Study||1
2990642|NCT00906945|3707039|FG004|NOT COMPLETED|Overall Study||1
2990643|NCT00906945|3707040|FG005|NOT COMPLETED|Overall Study||2
2990644|NCT00906958|3707056|FG000|STARTED|Overall Study||10
2990645|NCT00906958|3707057|FG001|STARTED|Overall Study||10
2990646|NCT00906958|3707056|FG000|COMPLETED|Overall Study||10
2990647|NCT00906958|3707057|FG001|COMPLETED|Overall Study||10
2990648|NCT00906958|3707056|FG000|NOT COMPLETED|Overall Study||0
2990649|NCT00906958|3707057|FG001|NOT COMPLETED|Overall Study||0
2990650|NCT00906971|3707067|FG000|STARTED|Overall Study||36
2990651|NCT00906971|3707068|FG001|STARTED|Overall Study||36
2990652|NCT00906971|3707067|FG000|COMPLETED|Overall Study||28
2990653|NCT00906971|3707068|FG001|COMPLETED|Overall Study||33
2990654|NCT00906971|3707067|FG000|NOT COMPLETED|Overall Study||8
2990655|NCT00906971|3707068|FG001|NOT COMPLETED|Overall Study||3
2990656|NCT00907088|3707076|FG000|STARTED|Overall Study||122
2990657|NCT00907088|3707077|FG001|STARTED|Overall Study||129
2990658|NCT00907088|3707076|FG000|COMPLETED|Overall Study||102
2990659|NCT00907088|3707077|FG001|COMPLETED|Overall Study||99
2990660|NCT00907088|3707076|FG000|NOT COMPLETED|Overall Study||20
2990661|NCT00907088|3707077|FG001|NOT COMPLETED|Overall Study||30
2990662|NCT00907101|3707083|FG000|STARTED|Overall Study||30
2990663|NCT00907101|3707083|FG000|COMPLETED|Overall Study||30
2990664|NCT00907101|3707083|FG000|NOT COMPLETED|Overall Study||0
2990665|NCT00907153|3707089|FG000|STARTED|Overall Study||13
2990666|NCT00907153|3707090|FG001|STARTED|Overall Study||15
2990667|NCT00907153|3707089|FG000|COMPLETED|Overall Study||11
2990668|NCT00907153|3707090|FG001|COMPLETED|Overall Study||11
2990669|NCT00907153|3707089|FG000|NOT COMPLETED|Overall Study||2
2990670|NCT00907153|3707090|FG001|NOT COMPLETED|Overall Study||4
2990671|NCT00907257|3707098|FG000|STARTED|Overall Study||123
2990672|NCT00907257|3707099|FG001|STARTED|Overall Study||124
2990673|NCT00907257|3707098|FG000|COMPLETED|Overall Study||110
2990674|NCT00907257|3707099|FG001|COMPLETED|Overall Study||112
2990675|NCT00907257|3707098|FG000|NOT COMPLETED|Overall Study||13
2990676|NCT00907257|3707099|FG001|NOT COMPLETED|Overall Study||12
2990677|NCT00907296|3707115|FG000|STARTED|Overall Study||103
2990678|NCT00907296|3707116|FG001|STARTED|Overall Study||34
2990679|NCT00907296|3707117|FG002|STARTED|Overall Study||34
2990680|NCT00907296|3707118|FG003|STARTED|Overall Study||33
2990681|NCT00907296|3707119|FG004|STARTED|Overall Study||33
2990682|NCT00907296|3707120|FG005|STARTED|Overall Study||33
2990683|NCT00907296|3707121|FG006|STARTED|Overall Study||33
2990684|NCT00907296|3707122|FG007|STARTED|Overall Study||33
2990685|NCT00907296|3707123|FG008|STARTED|Overall Study||31
2990686|NCT00907296|3707124|FG009|STARTED|Overall Study||35
2990687|NCT00907296|3707115|FG000|Received Treatment|Overall Study||100
2990688|NCT00907296|3707116|FG001|Received Treatment|Overall Study||34
2990689|NCT00907296|3707117|FG002|Received Treatment|Overall Study||34
2990690|NCT00907296|3707118|FG003|Received Treatment|Overall Study||32
2990691|NCT00907296|3707119|FG004|Received Treatment|Overall Study||33
2990692|NCT00907296|3707120|FG005|Received Treatment|Overall Study||32
2990693|NCT00907296|3707121|FG006|Received Treatment|Overall Study||31
2990694|NCT00907296|3707122|FG007|Received Treatment|Overall Study||32
2990695|NCT00907296|3707123|FG008|Received Treatment|Overall Study||30
2990696|NCT00907296|3707124|FG009|Received Treatment|Overall Study||35
2990697|NCT00907296|3707115|FG000|COMPLETED|Overall Study||83
2990698|NCT00907296|3707116|FG001|COMPLETED|Overall Study||29
2990699|NCT00907296|3707117|FG002|COMPLETED|Overall Study||32
2990700|NCT00907296|3707118|FG003|COMPLETED|Overall Study||29
2990701|NCT00907296|3707119|FG004|COMPLETED|Overall Study||32
2990702|NCT00907296|3707120|FG005|COMPLETED|Overall Study||24
2990703|NCT00907296|3707121|FG006|COMPLETED|Overall Study||27
2990704|NCT00907296|3707122|FG007|COMPLETED|Overall Study||26
2990705|NCT00907296|3707123|FG008|COMPLETED|Overall Study||27
2990706|NCT00907296|3707124|FG009|COMPLETED|Overall Study||28
2990707|NCT00907296|3707115|FG000|NOT COMPLETED|Overall Study||20
2990708|NCT00907296|3707116|FG001|NOT COMPLETED|Overall Study||5
2990709|NCT00907296|3707117|FG002|NOT COMPLETED|Overall Study||2
2990710|NCT00907296|3707118|FG003|NOT COMPLETED|Overall Study||4
2990711|NCT00907296|3707119|FG004|NOT COMPLETED|Overall Study||1
2990712|NCT00907296|3707120|FG005|NOT COMPLETED|Overall Study||9
2990713|NCT00907296|3707121|FG006|NOT COMPLETED|Overall Study||6
2990714|NCT00907296|3707122|FG007|NOT COMPLETED|Overall Study||7
2990715|NCT00907296|3707123|FG008|NOT COMPLETED|Overall Study||4
2990716|NCT00907296|3707124|FG009|NOT COMPLETED|Overall Study||7
2990717|NCT00907335|3707148|FG000|STARTED|Overall Study||55
2990718|NCT00907335|3707149|FG001|STARTED|Overall Study||55
2990719|NCT00907335|3707148|FG000|COMPLETED|Overall Study||47
2990720|NCT00907335|3707149|FG001|COMPLETED|Overall Study||54
2990721|NCT00907335|3707148|FG000|NOT COMPLETED|Overall Study||8
2990722|NCT00907335|3707149|FG001|NOT COMPLETED|Overall Study||1
2990723|NCT00907374|3707157|FG000|STARTED|Overall Study||14
2990724|NCT00907374|3707158|FG001|STARTED|Overall Study||13
2990725|NCT00907374|3707157|FG000|COMPLETED|Overall Study||12
2990726|NCT00907374|3707158|FG001|COMPLETED|Overall Study||11
2990727|NCT00907374|3707157|FG000|NOT COMPLETED|Overall Study||2
2990728|NCT00907374|3707158|FG001|NOT COMPLETED|Overall Study||2
2990729|NCT00907426|3707167|FG000|STARTED|Treatment Period 1 (0 to 6 Months)||215
2990730|NCT00907426|3707168|FG001|STARTED|Treatment Period 1 (0 to 6 Months)||60
2990731|NCT00907426|3707169|FG002|STARTED|Treatment Period 1 (0 to 6 Months)||93
2990732|NCT00907426|3707167|FG000|COMPLETED|Treatment Period 1 (0 to 6 Months)||195
2990733|NCT00907426|3707168|FG001|COMPLETED|Treatment Period 1 (0 to 6 Months)||55
2990734|NCT00907426|3707169|FG002|COMPLETED|Treatment Period 1 (0 to 6 Months)||84
2990735|NCT00907426|3707167|FG000|NOT COMPLETED|Treatment Period 1 (0 to 6 Months)||20
2990736|NCT00907426|3707168|FG001|NOT COMPLETED|Treatment Period 1 (0 to 6 Months)||5
2990737|NCT00907426|3707169|FG002|NOT COMPLETED|Treatment Period 1 (0 to 6 Months)||9
2990738|NCT00907426|3707167|FG000|STARTED|Treatment Period 2 (6 to 12 Months)||195
2990739|NCT00907426|3707168|FG001|STARTED|Treatment Period 2 (6 to 12 Months)||55
2990740|NCT00907426|3707169|FG002|STARTED|Treatment Period 2 (6 to 12 Months)||84
2990741|NCT00907426|3707167|FG000|COMPLETED|Treatment Period 2 (6 to 12 Months)||184
2990742|NCT00907426|3707168|FG001|COMPLETED|Treatment Period 2 (6 to 12 Months)||52
2990743|NCT00907426|3707169|FG002|COMPLETED|Treatment Period 2 (6 to 12 Months)||77
2990744|NCT00907426|3707167|FG000|NOT COMPLETED|Treatment Period 2 (6 to 12 Months)||11
2990745|NCT00907426|3707168|FG001|NOT COMPLETED|Treatment Period 2 (6 to 12 Months)||3
2990746|NCT00907426|3707169|FG002|NOT COMPLETED|Treatment Period 2 (6 to 12 Months)||7
2990747|NCT00907478|3707179|FG000|STARTED|Overall Study||50
2990748|NCT00907478|3707180|FG001|STARTED|Overall Study||50
2990749|NCT00907478|3707181|FG002|STARTED|Overall Study||69
2990750|NCT00907478|3707179|FG000|COMPLETED|Overall Study|Defined as participants who completed the full 3 years and completed the end of study visit.|23
2990751|NCT00907478|3707180|FG001|COMPLETED|Overall Study|Defined as participants who completed the full 3 years and completed the end of study visit.|33
2990752|NCT00907478|3707181|FG002|COMPLETED|Overall Study|Defined as participants who completed the full 3 years and completed the end of study visit.|47
2990753|NCT00907478|3707179|FG000|NOT COMPLETED|Overall Study||27
2990754|NCT00907478|3707180|FG001|NOT COMPLETED|Overall Study||17
2990755|NCT00907478|3707181|FG002|NOT COMPLETED|Overall Study||22
2990756|NCT00907517|3707196|FG000|STARTED|Overall Study||3
2990757|NCT00907517|3707197|FG001|STARTED|Overall Study||3
2990758|NCT00907517|3707198|FG002|STARTED|Overall Study||6
2990759|NCT00907517|3707199|FG003|STARTED|Overall Study||6
2990760|NCT00907517|3707200|FG004|STARTED|Overall Study||6
2990761|NCT00907517|3707196|FG000|COMPLETED|Overall Study||0
2990762|NCT00907517|3707197|FG001|COMPLETED|Overall Study||0
2990763|NCT00907517|3707198|FG002|COMPLETED|Overall Study||2
2990764|NCT00907517|3707199|FG003|COMPLETED|Overall Study||2
2990765|NCT00907517|3707200|FG004|COMPLETED|Overall Study||1
2990766|NCT00907517|3707196|FG000|NOT COMPLETED|Overall Study||3
2990767|NCT00907517|3707197|FG001|NOT COMPLETED|Overall Study||3
2990768|NCT00907517|3707198|FG002|NOT COMPLETED|Overall Study||4
2990769|NCT00907517|3707199|FG003|NOT COMPLETED|Overall Study||4
2990770|NCT00907517|3707200|FG004|NOT COMPLETED|Overall Study||5
2990771|NCT00907621|3707214|FG000|STARTED|Overall Study||45
2990772|NCT00907621|3707215|FG001|STARTED|Overall Study||45
2990773|NCT00907621|3707214|FG000|COMPLETED|Overall Study||38
2990774|NCT00907621|3707215|FG001|COMPLETED|Overall Study||41
2990775|NCT00907621|3707214|FG000|NOT COMPLETED|Overall Study||7
2990776|NCT00907621|3707215|FG001|NOT COMPLETED|Overall Study||4
2990777|NCT00907738|3707226|FG000|STARTED|Overall Study||13
2990778|NCT00907738|3707227|FG001|STARTED|Overall Study||1
2990779|NCT00907738|3707228|FG002|STARTED|Overall Study||7
2990780|NCT00907738|3707229|FG003|STARTED|Overall Study||4
2990781|NCT00907738|3707230|FG004|STARTED|Overall Study||2
2990782|NCT00907738|3707226|FG000|COMPLETED|Overall Study||0
2990783|NCT00907738|3707227|FG001|COMPLETED|Overall Study||0
2990784|NCT00907738|3707228|FG002|COMPLETED|Overall Study||0
2990785|NCT00907738|3707229|FG003|COMPLETED|Overall Study||0
2990786|NCT00907738|3707230|FG004|COMPLETED|Overall Study||0
2990787|NCT00907738|3707226|FG000|NOT COMPLETED|Overall Study||13
2990788|NCT00907738|3707227|FG001|NOT COMPLETED|Overall Study||1
2990789|NCT00907738|3707228|FG002|NOT COMPLETED|Overall Study||7
2990790|NCT00907738|3707229|FG003|NOT COMPLETED|Overall Study||4
2990791|NCT00907738|3707230|FG004|NOT COMPLETED|Overall Study||2
2990792|NCT00907777|3707248|FG000|STARTED|Overall Study||25
2990793|NCT00907777|3707249|FG001|STARTED|Overall Study||27
2990794|NCT00907777|3707248|FG000|COMPLETED|Overall Study||25
2990795|NCT00907777|3707249|FG001|COMPLETED|Overall Study||26
2990796|NCT00907777|3707248|FG000|NOT COMPLETED|Overall Study||0
2990797|NCT00907777|3707249|FG001|NOT COMPLETED|Overall Study||1
2990798|NCT00907803|3707258|FG000|STARTED|Overall Study||45
2990799|NCT00907803|3707259|FG001|STARTED|Overall Study||46
2990800|NCT00907803|3707260|FG002|STARTED|Overall Study||16
2990801|NCT00907803|3707258|FG000|COMPLETED|Overall Study||42
2990802|NCT00907803|3707259|FG001|COMPLETED|Overall Study||43
2990803|NCT00907803|3707260|FG002|COMPLETED|Overall Study||16
2990804|NCT00907803|3707258|FG000|NOT COMPLETED|Overall Study||3
2990805|NCT00907803|3707259|FG001|NOT COMPLETED|Overall Study||3
2990806|NCT00907803|3707260|FG002|NOT COMPLETED|Overall Study||0
2990807|NCT00907881|3707268|FG000|STARTED|Overall Study||1069
2990808|NCT00907881|3707268|FG000|COMPLETED|Overall Study||984
2990809|NCT00907881|3707268|FG000|NOT COMPLETED|Overall Study||85
2990810|NCT00908011|3707274|FG000|STARTED|Overall Study||23
2990811|NCT00908011|3707275|FG001|STARTED|Overall Study||20
2990812|NCT00908011|3707274|FG000|COMPLETED|Overall Study||21
2990813|NCT00908011|3707275|FG001|COMPLETED|Overall Study||18
2990814|NCT00908011|3707274|FG000|NOT COMPLETED|Overall Study||2
2990815|NCT00908011|3707275|FG001|NOT COMPLETED|Overall Study||2
2990816|NCT00908037|3707288|FG000|STARTED|Part1 (24 Week Dose-Finding Period)||5
2990817|NCT00908037|3707289|FG001|STARTED|Part1 (24 Week Dose-Finding Period)||5
2990818|NCT00908037|3707290|FG002|STARTED|Part1 (24 Week Dose-Finding Period)||5
2990819|NCT00908037|3707291|FG003|STARTED|Part1 (24 Week Dose-Finding Period)||0
2990820|NCT00908037|3707292|FG004|STARTED|Part1 (24 Week Dose-Finding Period)||0
2990821|NCT00908037|3707293|FG005|STARTED|Part1 (24 Week Dose-Finding Period)||0
2990822|NCT00908037|3707294|FG006|STARTED|Part1 (24 Week Dose-Finding Period)||0
2990823|NCT00908037|3707295|FG007|STARTED|Part1 (24 Week Dose-Finding Period)||0
2990824|NCT00908037|3707296|FG008|STARTED|Part1 (24 Week Dose-Finding Period)||0
2990825|NCT00908037|3707297|FG009|STARTED|Part1 (24 Week Dose-Finding Period)||0
2990826|NCT00908037|3707298|FG010|STARTED|Part1 (24 Week Dose-Finding Period)||0
2990827|NCT00908037|3707299|FG011|STARTED|Part1 (24 Week Dose-Finding Period)||0
2990828|NCT00908037|3707288|FG000|COMPLETED|Part1 (24 Week Dose-Finding Period)|Participants who completed Part 1 did not enroll in Parts 2 or 2/3|5
2990829|NCT00908037|3707289|FG001|COMPLETED|Part1 (24 Week Dose-Finding Period)|Participants who completed Part 1 did not enroll in Parts 2 or 2/3|5
2990830|NCT00908037|3707290|FG002|COMPLETED|Part1 (24 Week Dose-Finding Period)|Participants who completed Part 1 did not enroll in Parts 2 or 2/3|5
2990831|NCT00908037|3707291|FG003|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
2990832|NCT00908037|3707292|FG004|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
2990833|NCT00908037|3707293|FG005|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
2990834|NCT00908037|3707294|FG006|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
2990835|NCT00908037|3707295|FG007|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
2990836|NCT00908037|3707296|FG008|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
2990837|NCT00908037|3707297|FG009|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
2990838|NCT00908037|3707298|FG010|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
2990839|NCT00908037|3707299|FG011|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
2990840|NCT00908037|3707288|FG000|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
2990841|NCT00908037|3707289|FG001|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
2990842|NCT00908037|3707290|FG002|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
2990843|NCT00908037|3707291|FG003|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
2990844|NCT00908037|3707292|FG004|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
2990845|NCT00908037|3707293|FG005|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
2990846|NCT00908037|3707294|FG006|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
2990847|NCT00908037|3707295|FG007|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
2990848|NCT00908037|3707296|FG008|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
2990849|NCT00908037|3707297|FG009|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
2990850|NCT00908037|3707298|FG010|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
2990851|NCT00908037|3707299|FG011|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
2990852|NCT00908037|3707288|FG000|STARTED|Part 2 (7 Week Randomized Period)||0
2990853|NCT00908037|3707289|FG001|STARTED|Part 2 (7 Week Randomized Period)||0
2990854|NCT00908037|3707290|FG002|STARTED|Part 2 (7 Week Randomized Period)||0
2990855|NCT00908037|3707291|FG003|STARTED|Part 2 (7 Week Randomized Period)||8
2990856|NCT00908037|3707292|FG004|STARTED|Part 2 (7 Week Randomized Period)||16
2990857|NCT00908037|3707293|FG005|STARTED|Part 2 (7 Week Randomized Period)||9
2990858|NCT00908037|3707294|FG006|STARTED|Part 2 (7 Week Randomized Period)||19
2990859|NCT00908037|3707295|FG007|STARTED|Part 2 (7 Week Randomized Period)||5
2990860|NCT00908037|3707296|FG008|STARTED|Part 2 (7 Week Randomized Period)||10
2990861|NCT00908037|3707297|FG009|STARTED|Part 2 (7 Week Randomized Period)||0
2990862|NCT00908037|3707298|FG010|STARTED|Part 2 (7 Week Randomized Period)||0
3304965|NCT02983981|4038569|FG000|COMPLETED|Overall Study||20
3304966|NCT02983981|4038569|FG000|NOT COMPLETED|Overall Study||0
3304967|NCT02984267|4038575|FG000|STARTED|Overall Study||8
3304968|NCT02984267|4038576|FG001|STARTED|Overall Study||10
3304969|NCT02984267|4038575|FG000|COMPLETED|Overall Study||7
3304970|NCT02984267|4038576|FG001|COMPLETED|Overall Study||9
3304971|NCT02984267|4038575|FG000|NOT COMPLETED|Overall Study||1
3304972|NCT02984267|4038576|FG001|NOT COMPLETED|Overall Study||1
3304973|NCT02984644|4038584|FG000|STARTED|Overall Study||20
3304974|NCT02984644|4038585|FG001|STARTED|Overall Study||10
2990863|NCT00908037|3707299|FG011|STARTED|Part 2 (7 Week Randomized Period)||0
2990864|NCT00908037|3707288|FG000|COMPLETED|Part 2 (7 Week Randomized Period)||0
2990865|NCT00908037|3707289|FG001|COMPLETED|Part 2 (7 Week Randomized Period)||0
2990866|NCT00908037|3707290|FG002|COMPLETED|Part 2 (7 Week Randomized Period)||0
2990867|NCT00908037|3707291|FG003|COMPLETED|Part 2 (7 Week Randomized Period)||7
2990868|NCT00908037|3707292|FG004|COMPLETED|Part 2 (7 Week Randomized Period)||13
2990869|NCT00908037|3707293|FG005|COMPLETED|Part 2 (7 Week Randomized Period)||9
2990870|NCT00908037|3707294|FG006|COMPLETED|Part 2 (7 Week Randomized Period)||15
2990871|NCT00908037|3707295|FG007|COMPLETED|Part 2 (7 Week Randomized Period)||5
2990872|NCT00908037|3707296|FG008|COMPLETED|Part 2 (7 Week Randomized Period)||5
2990873|NCT00908037|3707297|FG009|COMPLETED|Part 2 (7 Week Randomized Period)||0
2990874|NCT00908037|3707298|FG010|COMPLETED|Part 2 (7 Week Randomized Period)||0
2990875|NCT00908037|3707299|FG011|COMPLETED|Part 2 (7 Week Randomized Period)||0
2990876|NCT00908037|3707288|FG000|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
2990877|NCT00908037|3707289|FG001|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
2990878|NCT00908037|3707290|FG002|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
2990879|NCT00908037|3707291|FG003|NOT COMPLETED|Part 2 (7 Week Randomized Period)||1
2990880|NCT00908037|3707292|FG004|NOT COMPLETED|Part 2 (7 Week Randomized Period)||3
2990881|NCT00908037|3707293|FG005|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
2990882|NCT00908037|3707294|FG006|NOT COMPLETED|Part 2 (7 Week Randomized Period)||4
2990883|NCT00908037|3707295|FG007|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
2990884|NCT00908037|3707296|FG008|NOT COMPLETED|Part 2 (7 Week Randomized Period)||5
2990885|NCT00908037|3707297|FG009|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
2990886|NCT00908037|3707298|FG010|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
2990887|NCT00908037|3707299|FG011|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
2990888|NCT00908037|3707288|FG000|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
2990889|NCT00908037|3707289|FG001|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
2990890|NCT00908037|3707290|FG002|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
2990891|NCT00908037|3707291|FG003|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
2990892|NCT00908037|3707292|FG004|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
2990893|NCT00908037|3707293|FG005|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
2990894|NCT00908037|3707294|FG006|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
2990895|NCT00908037|3707295|FG007|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
2990896|NCT00908037|3707296|FG008|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
2990897|NCT00908037|3707297|FG009|STARTED|Part 2/3(Eltrombopag Open-Label Period)||24
2990898|NCT00908037|3707298|FG010|STARTED|Part 2/3(Eltrombopag Open-Label Period)|Two participants were randomized but did not receive treatment.|28
2990899|NCT00908037|3707299|FG011|STARTED|Part 2/3(Eltrombopag Open-Label Period)||15
2990900|NCT00908037|3707288|FG000|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
2990901|NCT00908037|3707289|FG001|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
3164499|NCT01892540|3891857|FG001|COMPLETED|Overall Study||0
3164500|NCT01892540|3891858|FG002|COMPLETED|Overall Study||25
3164501|NCT01892540|3891856|FG000|NOT COMPLETED|Overall Study||0
3164502|NCT01892540|3891857|FG001|NOT COMPLETED|Overall Study||0
3164503|NCT01892540|3891858|FG002|NOT COMPLETED|Overall Study||3
3164504|NCT01892657|3891866|FG000|STARTED|Overall Study||128
3164505|NCT01892657|3891866|FG000|COMPLETED|Overall Study||110
3164506|NCT01892657|3891866|FG000|NOT COMPLETED|Overall Study||18
3164507|NCT01892709|3891882|FG000|STARTED|Overall Study||215
3164508|NCT01892709|3891882|FG000|COMPLETED|Overall Study||215
3164509|NCT01892709|3891882|FG000|NOT COMPLETED|Overall Study||0
3164510|NCT01892865|3891892|FG000|STARTED|Overall Study|107 operative days scheduled with the Historical Means method were included|356
3164511|NCT01892865|3891893|FG001|STARTED|Overall Study|100 operative days scheduled with the Predictive Modeling System method were included|379
3164512|NCT01892865|3891892|FG000|COMPLETED|Overall Study||356
3164513|NCT01892865|3891893|FG001|COMPLETED|Overall Study||379
3304975|NCT02984644|4038584|FG000|COMPLETED|Overall Study||20
2990902|NCT00908037|3707290|FG002|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
2990903|NCT00908037|3707291|FG003|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
3164514|NCT01892865|3891892|FG000|NOT COMPLETED|Overall Study||0
2990904|NCT00908037|3707292|FG004|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
2990905|NCT00908037|3707293|FG005|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
2990906|NCT00908037|3707294|FG006|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
2990907|NCT00908037|3707295|FG007|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
2990908|NCT00908037|3707296|FG008|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
2990909|NCT00908037|3707297|FG009|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||21
2990910|NCT00908037|3707298|FG010|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)|Two participants were randomized but did not receive treatment.|24
2990911|NCT00908037|3707299|FG011|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||12
2990912|NCT00908037|3707288|FG000|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
2990913|NCT00908037|3707289|FG001|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
2990914|NCT00908037|3707290|FG002|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
2990915|NCT00908037|3707291|FG003|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
2990916|NCT00908037|3707292|FG004|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
2990917|NCT00908037|3707293|FG005|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
2990918|NCT00908037|3707294|FG006|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
2990919|NCT00908037|3707295|FG007|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
2990920|NCT00908037|3707296|FG008|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
2990921|NCT00908037|3707297|FG009|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||3
2990922|NCT00908037|3707298|FG010|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||4
2990923|NCT00908037|3707299|FG011|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||3
2990924|NCT00908076|3707353|FG000|STARTED|Overall Study||27
2990925|NCT00908076|3707354|FG001|STARTED|Overall Study||27
2990926|NCT00908076|3707353|FG000|COMPLETED|Overall Study||26
2990927|NCT00908076|3707354|FG001|COMPLETED|Overall Study||26
2990928|NCT00908076|3707353|FG000|NOT COMPLETED|Overall Study||1
2990929|NCT00908076|3707354|FG001|NOT COMPLETED|Overall Study||1
2990930|NCT00908115|3707360|FG000|STARTED|Overall Study||1258
2990931|NCT00908115|3707360|FG000|COMPLETED|Overall Study||1244
2990932|NCT00908115|3707360|FG000|NOT COMPLETED|Overall Study||14
2990933|NCT00908141|3707366|FG000|STARTED|Overall Study||8
2990934|NCT00908141|3707367|FG001|STARTED|Overall Study||9
2990935|NCT00908141|3707366|FG000|COMPLETED|Overall Study||8
2990936|NCT00908141|3707367|FG001|COMPLETED|Overall Study||8
2990937|NCT00908141|3707366|FG000|NOT COMPLETED|Overall Study||0
2990938|NCT00908141|3707367|FG001|NOT COMPLETED|Overall Study||1
2990939|NCT00908232|3707373|FG000|STARTED|Cycle 1 to 4|All participants started VD treatment for 4 cycles prior to local site response assessments|163
2990940|NCT00908232|3707374|FG001|STARTED|Cycle 1 to 4||0
2990941|NCT00908232|3707375|FG002|STARTED|Cycle 1 to 4||0
2990942|NCT00908232|3707376|FG003|STARTED|Cycle 1 to 4||0
2990943|NCT00908232|3707373|FG000|COMPLETED|Cycle 1 to 4|Of those completed, 120 subjects were assessed for response, 117 w/ Response or SD continued.|135
2990944|NCT00908232|3707374|FG001|COMPLETED|Cycle 1 to 4||0
2990945|NCT00908232|3707375|FG002|COMPLETED|Cycle 1 to 4||0
2990946|NCT00908232|3707376|FG003|COMPLETED|Cycle 1 to 4||0
2990947|NCT00908232|3707373|FG000|NOT COMPLETED|Cycle 1 to 4||28
2990948|NCT00908232|3707374|FG001|NOT COMPLETED|Cycle 1 to 4||0
2990949|NCT00908232|3707375|FG002|NOT COMPLETED|Cycle 1 to 4||0
2990950|NCT00908232|3707376|FG003|NOT COMPLETED|Cycle 1 to 4||0
2990951|NCT00908232|3707373|FG000|STARTED|Randomization (Cycle 5) to Cycle 8|Responding patients (not randomized) who received 4 more cycles of VD|98
2990952|NCT00908232|3707374|FG001|STARTED|Randomization (Cycle 5) to Cycle 8||7
2990953|NCT00908232|3707375|FG002|STARTED|Randomization (Cycle 5) to Cycle 8||8
2990954|NCT00908232|3707376|FG003|STARTED|Randomization (Cycle 5) to Cycle 8||4
2990955|NCT00908232|3707373|FG000|COMPLETED|Randomization (Cycle 5) to Cycle 8||63
2990956|NCT00908232|3707374|FG001|COMPLETED|Randomization (Cycle 5) to Cycle 8||4
2990957|NCT00908232|3707375|FG002|COMPLETED|Randomization (Cycle 5) to Cycle 8||7
2990958|NCT00908232|3707376|FG003|COMPLETED|Randomization (Cycle 5) to Cycle 8||4
2990959|NCT00908232|3707373|FG000|NOT COMPLETED|Randomization (Cycle 5) to Cycle 8||35
2990960|NCT00908232|3707374|FG001|NOT COMPLETED|Randomization (Cycle 5) to Cycle 8||3
2990961|NCT00908232|3707375|FG002|NOT COMPLETED|Randomization (Cycle 5) to Cycle 8||1
2990962|NCT00908232|3707376|FG003|NOT COMPLETED|Randomization (Cycle 5) to Cycle 8||0
2990963|NCT00908310|3707382|FG000|STARTED|Overall Study||213
2990964|NCT00908310|3707382|FG000|COMPLETED|Overall Study||153
2990965|NCT00908310|3707382|FG000|NOT COMPLETED|Overall Study||60
2990966|NCT00908349|3707386|FG000|STARTED|Overall Study||214
2990967|NCT00908349|3707386|FG000|COMPLETED|Overall Study||179
2990968|NCT00908349|3707386|FG000|NOT COMPLETED|Overall Study||35
2990969|NCT00908375|3707392|FG000|STARTED|Overall Study||20
2990970|NCT00908375|3707393|FG001|STARTED|Overall Study||19
2990971|NCT00908375|3707392|FG000|COMPLETED|Overall Study||10
2990972|NCT00908375|3707393|FG001|COMPLETED|Overall Study||9
2990973|NCT00908375|3707392|FG000|NOT COMPLETED|Overall Study||10
2990974|NCT00908375|3707393|FG001|NOT COMPLETED|Overall Study||10
2990975|NCT00908388|3707399|FG000|STARTED|Overall Study||50
2990976|NCT00908388|3707399|FG000|COMPLETED|Overall Study||40
2990977|NCT00908388|3707399|FG000|NOT COMPLETED|Overall Study||10
2990978|NCT00908466|3707405|FG000|STARTED|Overall Study||15
2990979|NCT00908466|3707406|FG001|STARTED|Overall Study||15
2990980|NCT00908466|3707405|FG000|COMPLETED|Overall Study||14
2990981|NCT00908466|3707406|FG001|COMPLETED|Overall Study||14
2990982|NCT00908466|3707405|FG000|NOT COMPLETED|Overall Study||1
2990983|NCT00908466|3707406|FG001|NOT COMPLETED|Overall Study||1
2990984|NCT00908544|3707414|FG000|STARTED|Overall Study||20
2990985|NCT00908544|3707415|FG001|STARTED|Overall Study||22
2990986|NCT00908544|3707414|FG000|COMPLETED|Overall Study||15
2990987|NCT00908544|3707415|FG001|COMPLETED|Overall Study||16
2990988|NCT00908544|3707414|FG000|NOT COMPLETED|Overall Study||5
2990989|NCT00908544|3707415|FG001|NOT COMPLETED|Overall Study||6
2990990|NCT00908583|3707421|FG000|STARTED|Phase 1||20
2990991|NCT00908583|3707421|FG000|COMPLETED|Phase 1||15
2990992|NCT00908583|3707421|FG000|NOT COMPLETED|Phase 1||5
2990993|NCT00908583|3707421|FG000|STARTED|Phase 2||12
2990994|NCT00908583|3707421|FG000|COMPLETED|Phase 2||10
2990995|NCT00908583|3707421|FG000|NOT COMPLETED|Phase 2||2
2990996|NCT00908583|3707421|FG000|STARTED|Phase 3||10
2990997|NCT00908583|3707421|FG000|COMPLETED|Phase 3||8
2990998|NCT00908583|3707421|FG000|NOT COMPLETED|Phase 3||2
2990999|NCT00908583|3707421|FG000|STARTED|Phase 4||5
2991000|NCT00908583|3707421|FG000|COMPLETED|Phase 4||3
2991001|NCT00908583|3707421|FG000|NOT COMPLETED|Phase 4||2
2991002|NCT00908583|3707421|FG000|STARTED|Phase 5||5
2991003|NCT00908583|3707421|FG000|COMPLETED|Phase 5||2
2991004|NCT00908583|3707421|FG000|NOT COMPLETED|Phase 5||3
2991005|NCT00908596|3707443|FG000|STARTED|Overall Study||47
2991006|NCT00908596|3707444|FG001|STARTED|Overall Study||32
2991007|NCT00908596|3707445|FG002|STARTED|Overall Study||193
2991008|NCT00908596|3707446|FG003|STARTED|Overall Study||85
2991009|NCT00908596|3707443|FG000|COMPLETED|Overall Study||0
2991010|NCT00908596|3707444|FG001|COMPLETED|Overall Study||19
2991011|NCT00908596|3707445|FG002|COMPLETED|Overall Study||119
2991012|NCT00908596|3707446|FG003|COMPLETED|Overall Study||48
2991013|NCT00908596|3707443|FG000|NOT COMPLETED|Overall Study||47
2991014|NCT00908596|3707444|FG001|NOT COMPLETED|Overall Study||13
2991015|NCT00908596|3707445|FG002|NOT COMPLETED|Overall Study||74
2991016|NCT00908596|3707446|FG003|NOT COMPLETED|Overall Study||37
3036748|NCT01144663|3756004|FG000|STARTED|Booster Vaccination Phase||497
3036749|NCT01144663|3756005|FG001|STARTED|Booster Vaccination Phase||511
3036750|NCT01144663|3756006|FG002|STARTED|Booster Vaccination Phase||503
3036751|NCT01144663|3756007|FG003|STARTED|Booster Vaccination Phase||506
3036752|NCT01144663|3756004|FG000|COMPLETED|Booster Vaccination Phase||494
3036753|NCT01144663|3756005|FG001|COMPLETED|Booster Vaccination Phase||509
3036754|NCT01144663|3756006|FG002|COMPLETED|Booster Vaccination Phase||498
3036755|NCT01144663|3756007|FG003|COMPLETED|Booster Vaccination Phase||505
3036756|NCT01144663|3756004|FG000|NOT COMPLETED|Booster Vaccination Phase||3
3036757|NCT01144663|3756005|FG001|NOT COMPLETED|Booster Vaccination Phase||2
3036758|NCT01144663|3756006|FG002|NOT COMPLETED|Booster Vaccination Phase||5
3036759|NCT01144663|3756007|FG003|NOT COMPLETED|Booster Vaccination Phase||1
3036760|NCT01144663|3756004|FG000|STARTED|Extended Safety Follow-Up (ESFU)||497
3036761|NCT01144663|3756005|FG001|STARTED|Extended Safety Follow-Up (ESFU)||511
3036762|NCT01144663|3756006|FG002|STARTED|Extended Safety Follow-Up (ESFU)||503
3036763|NCT01144663|3756007|FG003|STARTED|Extended Safety Follow-Up (ESFU)||506
3036764|NCT01144663|3756004|FG000|COMPLETED|Extended Safety Follow-Up (ESFU)||492
3036765|NCT01144663|3756005|FG001|COMPLETED|Extended Safety Follow-Up (ESFU)||502
3036766|NCT01144663|3756006|FG002|COMPLETED|Extended Safety Follow-Up (ESFU)||496
3036767|NCT01144663|3756007|FG003|COMPLETED|Extended Safety Follow-Up (ESFU)||505
3036768|NCT01144663|3756004|FG000|NOT COMPLETED|Extended Safety Follow-Up (ESFU)||5
3036769|NCT01144663|3756005|FG001|NOT COMPLETED|Extended Safety Follow-Up (ESFU)||9
3036770|NCT01144663|3756006|FG002|NOT COMPLETED|Extended Safety Follow-Up (ESFU)||7
3036771|NCT01144663|3756007|FG003|NOT COMPLETED|Extended Safety Follow-Up (ESFU)||1
3036772|NCT01144715|3756019|FG000|STARTED|Overall Study||51
3036773|NCT01144715|3756020|FG001|STARTED|Overall Study||48
3036774|NCT01144715|3756019|FG000|COMPLETED|Overall Study||47
3036775|NCT01144715|3756020|FG001|COMPLETED|Overall Study||45
3036776|NCT01144715|3756019|FG000|NOT COMPLETED|Overall Study||4
3036777|NCT01144715|3756020|FG001|NOT COMPLETED|Overall Study||3
3036778|NCT01144949|3756028|FG000|STARTED|Overall Study||119
3036779|NCT01144949|3756029|FG001|STARTED|Overall Study||120
3036780|NCT01144949|3756028|FG000|COMPLETED|Overall Study||108
3036781|NCT01144949|3756029|FG001|COMPLETED|Overall Study||106
3036782|NCT01144949|3756028|FG000|NOT COMPLETED|Overall Study||11
3036783|NCT01144949|3756029|FG001|NOT COMPLETED|Overall Study||14
3036784|NCT01145001|3756039|FG000|STARTED|Overall Study||36
3036785|NCT01145001|3756040|FG001|STARTED|Overall Study||37
3036786|NCT01145001|3756041|FG002|STARTED|Overall Study||44
3036787|NCT01145001|3756042|FG003|STARTED|Overall Study||37
3036788|NCT01145001|3756039|FG000|COMPLETED|Overall Study||28
3036789|NCT01145001|3756040|FG001|COMPLETED|Overall Study||31
3036790|NCT01145001|3756041|FG002|COMPLETED|Overall Study||39
3036791|NCT01145001|3756042|FG003|COMPLETED|Overall Study||31
3036792|NCT01145001|3756039|FG000|NOT COMPLETED|Overall Study||8
3036793|NCT01145001|3756040|FG001|NOT COMPLETED|Overall Study||6
3036794|NCT01145001|3756041|FG002|NOT COMPLETED|Overall Study||5
3036795|NCT01145001|3756042|FG003|NOT COMPLETED|Overall Study||6
3036796|NCT01145053|3756052|FG000|STARTED|Overall Study||341
3036797|NCT01145053|3756052|FG000|COMPLETED|Overall Study||248
3036798|NCT01145053|3756052|FG000|NOT COMPLETED|Overall Study||93
3036799|NCT01145066|3756059|FG000|STARTED|Overall Study||26
3036800|NCT01145066|3756060|FG001|STARTED|Overall Study||20
3036801|NCT01145066|3756061|FG002|STARTED|Overall Study||25
3036802|NCT01145066|3756059|FG000|COMPLETED|Overall Study||22
3036803|NCT01145066|3756060|FG001|COMPLETED|Overall Study||16
3036804|NCT01145066|3756061|FG002|COMPLETED|Overall Study||21
3036805|NCT01145066|3756059|FG000|NOT COMPLETED|Overall Study||4
3036806|NCT01145066|3756060|FG001|NOT COMPLETED|Overall Study||4
2991017|NCT00908791|3707456|FG000|STARTED|Overall Study||24
2991018|NCT00908791|3707456|FG000|COMPLETED|Overall Study||24
2991019|NCT00908791|3707456|FG000|NOT COMPLETED|Overall Study||0
2991020|NCT00908830|3707471|FG000|STARTED|Overall Study||5
2991021|NCT00908830|3707472|FG001|STARTED|Overall Study||5
2991022|NCT00908830|3707471|FG000|COMPLETED|Overall Study||5
2991023|NCT00908830|3707472|FG001|COMPLETED|Overall Study||5
2991024|NCT00908830|3707471|FG000|NOT COMPLETED|Overall Study||0
2991025|NCT00908830|3707472|FG001|NOT COMPLETED|Overall Study||0
2991026|NCT00908882|3707480|FG000|STARTED|Overall Study||89
2991027|NCT00908882|3707481|FG001|STARTED|Overall Study||89
2991028|NCT00908882|3707480|FG000|COMPLETED|Overall Study||61
2991029|NCT00908882|3707481|FG001|COMPLETED|Overall Study||59
2991030|NCT00908882|3707480|FG000|NOT COMPLETED|Overall Study||28
2991031|NCT00908882|3707481|FG001|NOT COMPLETED|Overall Study||30
2991032|NCT00908895|3707489|FG000|STARTED|Overall Study||57
2991033|NCT00908895|3707490|FG001|STARTED|Overall Study||63
2991034|NCT00908895|3707489|FG000|COMPLETED|Overall Study||53
2991035|NCT00908895|3707490|FG001|COMPLETED|Overall Study||57
2991036|NCT00908895|3707489|FG000|NOT COMPLETED|Overall Study||4
2991037|NCT00908895|3707490|FG001|NOT COMPLETED|Overall Study||6
2991038|NCT00908908|3707496|FG000|STARTED|Overall Study||6
2991039|NCT00908908|3707496|FG000|Adverse Event|Overall Study||0
3133554|NCT01696279|3858508|FG000|Entered Part 3|Part 2a: Calcium Carbonate + Lanthanum||0
3136747|NCT01714804|3862003|FG000|STARTED|Overall Study||30
2991040|NCT00908908|3707496|FG000|Withdrawl by Subject|Overall Study||0
2991041|NCT00908908|3707496|FG000|Administrative/Other|Overall Study||0
2991042|NCT00908908|3707496|FG000|Physician Decision|Overall Study||0
2991043|NCT00908908|3707496|FG000|COMPLETED|Overall Study||6
2991044|NCT00908908|3707496|FG000|NOT COMPLETED|Overall Study||0
2991045|NCT00908947|3707500|FG000|STARTED|Overall Study||173
2991046|NCT00908947|3707500|FG000|COMPLETED|Overall Study||83
2991047|NCT00908947|3707500|FG000|NOT COMPLETED|Overall Study||90
2991048|NCT00908960|3707508|FG000|STARTED|Overall Study||24
2991049|NCT00908960|3707509|FG001|STARTED|Overall Study||12
2991050|NCT00908960|3707510|FG002|STARTED|Overall Study||34
2991051|NCT00908960|3707508|FG000|Evaluable|Overall Study||23
2991052|NCT00908960|3707509|FG001|Evaluable|Overall Study||11
2991053|NCT00908960|3707510|FG002|Evaluable|Overall Study||32
2991054|NCT00908960|3707508|FG000|COMPLETED|Overall Study||23
2991055|NCT00908960|3707509|FG001|COMPLETED|Overall Study||11
2991056|NCT00908960|3707510|FG002|COMPLETED|Overall Study||32
2991057|NCT00908960|3707508|FG000|NOT COMPLETED|Overall Study||1
2991058|NCT00908960|3707509|FG001|NOT COMPLETED|Overall Study||1
2991059|NCT00908960|3707510|FG002|NOT COMPLETED|Overall Study||2
2991060|NCT00909038|3707518|FG000|STARTED|Overall Study||2411
2991061|NCT00909038|3707518|FG000|COMPLETED|Overall Study||1994
2991062|NCT00909038|3707518|FG000|NOT COMPLETED|Overall Study||417
2991063|NCT00909064|3707522|FG000|STARTED|Overall Study||114
2991064|NCT00909064|3707522|FG000|COMPLETED|Overall Study||114
2991065|NCT00909064|3707522|FG000|NOT COMPLETED|Overall Study||0
2991066|NCT00909090|3707528|FG000|STARTED|Overall Study||53
2991067|NCT00909090|3707529|FG001|STARTED|Overall Study||56
2991068|NCT00909090|3707528|FG000|COMPLETED|Overall Study||36
2991069|NCT00909090|3707529|FG001|COMPLETED|Overall Study||39
2991070|NCT00909090|3707528|FG000|NOT COMPLETED|Overall Study||17
2991071|NCT00909090|3707529|FG001|NOT COMPLETED|Overall Study||17
2991072|NCT00909155|3707541|FG000|STARTED|Overall Study||15
2991073|NCT00909155|3707542|FG001|STARTED|Overall Study||14
2991074|NCT00909155|3707543|FG002|STARTED|Overall Study||21
2991075|NCT00909155|3707541|FG000|COMPLETED|Overall Study||12
2991076|NCT00909155|3707542|FG001|COMPLETED|Overall Study||9
2991077|NCT00909155|3707543|FG002|COMPLETED|Overall Study||14
2991078|NCT00909155|3707541|FG000|NOT COMPLETED|Overall Study||3
2991079|NCT00909155|3707542|FG001|NOT COMPLETED|Overall Study||5
2991080|NCT00909155|3707543|FG002|NOT COMPLETED|Overall Study||7
2991081|NCT00909181|3707557|FG000|STARTED|Overall Study||210
2991082|NCT00909181|3707558|FG001|STARTED|Overall Study||214
2991083|NCT00909181|3707559|FG002|STARTED|Overall Study||202
2991084|NCT00909181|3707557|FG000|COMPLETED|Overall Study||171
2991085|NCT00909181|3707558|FG001|COMPLETED|Overall Study||196
2991086|NCT00909181|3707559|FG002|COMPLETED|Overall Study||169
2991087|NCT00909181|3707557|FG000|NOT COMPLETED|Overall Study||39
2991088|NCT00909181|3707558|FG001|NOT COMPLETED|Overall Study||18
2991089|NCT00909181|3707559|FG002|NOT COMPLETED|Overall Study||33
2991090|NCT00909220|3707569|FG000|STARTED|Overall Study|Started enrolling participants May 2009|41
2991091|NCT00909220|3707570|FG001|STARTED|Overall Study|Started enrolling participants May 2009|36
2991092|NCT00909220|3707569|FG000|Data Entry|Overall Study||41
2991093|NCT00909220|3707570|FG001|Data Entry|Overall Study||36
2991094|NCT00909220|3707569|FG000|Data Analyses|Overall Study||41
2991095|NCT00909220|3707570|FG001|Data Analyses|Overall Study||36
2991096|NCT00909220|3707569|FG000|Submission for Publication|Overall Study||41
2991097|NCT00909220|3707570|FG001|Submission for Publication|Overall Study||36
2991098|NCT00909220|3707569|FG000|COMPLETED|Overall Study||41
2991099|NCT00909220|3707570|FG001|COMPLETED|Overall Study||36
2991100|NCT00909220|3707569|FG000|NOT COMPLETED|Overall Study||0
2991101|NCT00909220|3707570|FG001|NOT COMPLETED|Overall Study||0
2991102|NCT00909324|3707580|FG000|STARTED|Overall Study||72
2991103|NCT00909324|3707581|FG001|STARTED|Overall Study||90
2991104|NCT00909324|3707580|FG000|COMPLETED|Overall Study||72
2991105|NCT00909324|3707581|FG001|COMPLETED|Overall Study||90
2991106|NCT00909324|3707580|FG000|NOT COMPLETED|Overall Study||0
2991107|NCT00909324|3707581|FG001|NOT COMPLETED|Overall Study||0
2991108|NCT00909363|3707590|FG000|STARTED|Overall Study||11
2991109|NCT00909363|3707591|FG001|STARTED|Overall Study||8
2991110|NCT00909363|3707592|FG002|STARTED|Overall Study||5
2991111|NCT00909363|3707590|FG000|COMPLETED|Overall Study|1 patient started bleeding 3 days after starting eltrombopag; he underwent bone marrow transplant|9
2991112|NCT00909363|3707591|FG001|COMPLETED|Overall Study||8
2991113|NCT00909363|3707592|FG002|COMPLETED|Overall Study||5
2991114|NCT00909363|3707590|FG000|NOT COMPLETED|Overall Study||2
2991115|NCT00909363|3707591|FG001|NOT COMPLETED|Overall Study||0
2991116|NCT00909363|3707592|FG002|NOT COMPLETED|Overall Study||0
2991117|NCT00909428|3707606|FG000|STARTED|Overall Study||18
2991118|NCT00909428|3707607|FG001|STARTED|Overall Study||15
2991119|NCT00909428|3707608|FG002|STARTED|Overall Study||9
2991120|NCT00909428|3707606|FG000|COMPLETED|Overall Study||5
2991121|NCT00909428|3707607|FG001|COMPLETED|Overall Study||5
2991122|NCT00909428|3707608|FG002|COMPLETED|Overall Study||0
2991123|NCT00909428|3707606|FG000|NOT COMPLETED|Overall Study||13
2991124|NCT00909428|3707607|FG001|NOT COMPLETED|Overall Study||10
2991125|NCT00909428|3707608|FG002|NOT COMPLETED|Overall Study||9
2991126|NCT00909480|3707617|FG000|STARTED|Overall Study||228
2991127|NCT00909480|3707618|FG001|STARTED|Overall Study||229
2991128|NCT00909480|3707617|FG000|Exposed|Overall Study|2 subjects withdrew before exposure to trial insulin|226
2991129|NCT00909480|3707618|FG001|Exposed|Overall Study|2 subjects withdrew before exposure to trial insulin|227
2991130|NCT00909480|3707617|FG000|COMPLETED|Overall Study||190
2991131|NCT00909480|3707618|FG001|COMPLETED|Overall Study||188
2991132|NCT00909480|3707617|FG000|NOT COMPLETED|Overall Study||38
2991133|NCT00909480|3707618|FG001|NOT COMPLETED|Overall Study||41
2991134|NCT00909532|3707626|FG000|STARTED|Overall Study|All subjects who received at least 1 dose of study drug (placebo).|78
2991135|NCT00909532|3707627|FG001|STARTED|Overall Study|All subjects who received at least 1 dose of study drug (ivacaftor).|83
2991136|NCT00909532|3707626|FG000|Completed Treatment Period, Week 24|Overall Study||71
2991137|NCT00909532|3707627|FG001|Completed Treatment Period, Week 24|Overall Study||80
2991138|NCT00909532|3707626|FG000|COMPLETED|Overall Study|Completed Treatment and Extension Periods (Through Week 48)|68
2991139|NCT00909532|3707627|FG001|COMPLETED|Overall Study|Completed Treatment and Extension Periods (Through Week 48)|77
2991140|NCT00909532|3707626|FG000|NOT COMPLETED|Overall Study||10
2991141|NCT00909532|3707627|FG001|NOT COMPLETED|Overall Study||6
2991142|NCT00909545|3707638|FG000|STARTED|Overall Study||26
2991143|NCT00909545|3707639|FG001|STARTED|Overall Study||23
2991144|NCT00909545|3707640|FG002|STARTED|Overall Study||26
2991145|NCT00909545|3707641|FG003|STARTED|Overall Study||24
2991146|NCT00909545|3707638|FG000|COMPLETED|Overall Study||25
2991147|NCT00909545|3707639|FG001|COMPLETED|Overall Study||22
2991148|NCT00909545|3707640|FG002|COMPLETED|Overall Study||25
2991149|NCT00909545|3707641|FG003|COMPLETED|Overall Study||19
2991150|NCT00909545|3707638|FG000|NOT COMPLETED|Overall Study||1
2991151|NCT00909545|3707639|FG001|NOT COMPLETED|Overall Study||1
2991152|NCT00909545|3707640|FG002|NOT COMPLETED|Overall Study||1
2991153|NCT00909545|3707641|FG003|NOT COMPLETED|Overall Study||5
2991154|NCT00909727|3707654|FG000|STARTED|Overall Study|All subjects who received at least 1 dose of study drug (placebo)|26
2991155|NCT00909727|3707655|FG001|STARTED|Overall Study|All subjects who received at least 1 dose of study drug (ivacaftor)|26
2991156|NCT00909727|3707654|FG000|Completed Treatment Period, Week 24|Overall Study||23
2991157|NCT00909727|3707655|FG001|Completed Treatment Period, Week 24|Overall Study||26
2991158|NCT00909727|3707654|FG000|COMPLETED|Overall Study|Completed Treatment and Extension Periods (through Week 48)|22
2991159|NCT00909727|3707655|FG001|COMPLETED|Overall Study|Completed Treatment and Extension Periods (through Week 48)|26
2991160|NCT00909727|3707654|FG000|NOT COMPLETED|Overall Study||4
2991161|NCT00909727|3707655|FG001|NOT COMPLETED|Overall Study||0
2991162|NCT00909779|3707663|FG000|STARTED|Overall Study||421
2991163|NCT00909779|3707664|FG001|STARTED|Overall Study||420
2991164|NCT00909779|3707663|FG000|COMPLETED|Overall Study|All subjects but 47 were followed for 12 months/until death (whichever was earlier).|211
2991165|NCT00909779|3707664|FG001|COMPLETED|Overall Study|All subjects but 42 were followed for 12 months/until death (whichever was earlier).|255
2991166|NCT00909779|3707663|FG000|NOT COMPLETED|Overall Study||210
2991167|NCT00909779|3707664|FG001|NOT COMPLETED|Overall Study||165
2991168|NCT00909792|3707672|FG000|STARTED|Period 1||130
2991169|NCT00909792|3707673|FG001|STARTED|Period 1||128
2991170|NCT00909792|3707672|FG000|COMPLETED|Period 1||130
2991171|NCT00909792|3707673|FG001|COMPLETED|Period 1||127
2991172|NCT00909792|3707672|FG000|NOT COMPLETED|Period 1||0
2991173|NCT00909792|3707673|FG001|NOT COMPLETED|Period 1||1
2991174|NCT00909792|3707672|FG000|STARTED|Period 2|One participant discontinued between Period 1 and Period 2 due to lack of efficacy.|129
2991175|NCT00909792|3707673|FG001|STARTED|Period 2|Two discontinuations between P1 & P2: 1 for fail inc/exc criteria; 1 for lack of efficacy.|125
2991176|NCT00909792|3707672|FG000|COMPLETED|Period 2||128
2991177|NCT00909792|3707673|FG001|COMPLETED|Period 2||124
2991178|NCT00909792|3707672|FG000|NOT COMPLETED|Period 2||1
2991179|NCT00909792|3707673|FG001|NOT COMPLETED|Period 2||1
2991180|NCT00909844|3707679|FG000|STARTED|Overall Study||35
3133555|NCT01696279|3858509|FG001|Entered Part 3|Part 2a: Calcium Carbonate + Lanthanum||34
3133556|NCT01696279|3858510|FG002|Entered Part 3|Part 2a: Calcium Carbonate + Lanthanum||0
3133557|NCT01696279|3858511|FG003|Entered Part 3|Part 2a: Calcium Carbonate + Lanthanum||0
3133558|NCT01696279|3858508|FG000|COMPLETED|Part 2a: Calcium Carbonate + Lanthanum||0
2991181|NCT00909844|3707679|FG000|COMPLETED|Overall Study||31
2991182|NCT00909844|3707679|FG000|NOT COMPLETED|Overall Study||4
2991183|NCT00909857|3707686|FG000|STARTED|Overall Study||253
2991184|NCT00909857|3707687|FG001|STARTED|Overall Study||254
2991185|NCT00909857|3707686|FG000|Treated|Overall Study||234
2991186|NCT00909857|3707687|FG001|Treated|Overall Study||230
2991187|NCT00909857|3707686|FG000|COMPLETED|Overall Study||217
2991188|NCT00909857|3707687|FG001|COMPLETED|Overall Study||209
2991189|NCT00909857|3707686|FG000|NOT COMPLETED|Overall Study||36
2991190|NCT00909857|3707687|FG001|NOT COMPLETED|Overall Study||45
2991191|NCT00909870|3707695|FG000|STARTED|Overall Study||274
2991192|NCT00909870|3707696|FG001|STARTED|Overall Study||263
2991193|NCT00909870|3707695|FG000|COMPLETED|Overall Study||251
2991194|NCT00909870|3707696|FG001|COMPLETED|Overall Study||236
2991195|NCT00909870|3707695|FG000|NOT COMPLETED|Overall Study||23
2991196|NCT00909870|3707696|FG001|NOT COMPLETED|Overall Study||27
2991197|NCT00910000|3707709|FG000|STARTED|Overall Study||3
2991198|NCT00910000|3707710|FG001|STARTED|Overall Study||3
3133559|NCT01696279|3858509|FG001|COMPLETED|Part 2a: Calcium Carbonate + Lanthanum||34
3133560|NCT01696279|3858510|FG002|COMPLETED|Part 2a: Calcium Carbonate + Lanthanum||0
3133561|NCT01696279|3858511|FG003|COMPLETED|Part 2a: Calcium Carbonate + Lanthanum||0
3133562|NCT01696279|3858508|FG000|NOT COMPLETED|Part 2a: Calcium Carbonate + Lanthanum||0
2991199|NCT00910000|3707711|FG002|STARTED|Overall Study||3
2991200|NCT00910000|3707712|FG003|STARTED|Overall Study||2
2991201|NCT00910000|3707713|FG004|STARTED|Overall Study||3
2991202|NCT00910000|3707714|FG005|STARTED|Overall Study||1
2991203|NCT00910000|3707709|FG000|COMPLETED|Overall Study||3
2991204|NCT00910000|3707710|FG001|COMPLETED|Overall Study||0
2991205|NCT00910000|3707711|FG002|COMPLETED|Overall Study||0
2991206|NCT00910000|3707712|FG003|COMPLETED|Overall Study||0
2991207|NCT00910000|3707713|FG004|COMPLETED|Overall Study||2
2991208|NCT00910000|3707714|FG005|COMPLETED|Overall Study||0
2991209|NCT00910000|3707709|FG000|NOT COMPLETED|Overall Study||0
2991210|NCT00910000|3707710|FG001|NOT COMPLETED|Overall Study||3
2991211|NCT00910000|3707711|FG002|NOT COMPLETED|Overall Study||3
2991212|NCT00910000|3707712|FG003|NOT COMPLETED|Overall Study||2
2991213|NCT00910000|3707713|FG004|NOT COMPLETED|Overall Study||1
2991214|NCT00910000|3707714|FG005|NOT COMPLETED|Overall Study||1
2991215|NCT00910039|3707724|FG000|STARTED|Overall Study||14
2991216|NCT00910039|3707724|FG000|COMPLETED|Overall Study||13
2991217|NCT00910039|3707724|FG000|NOT COMPLETED|Overall Study||1
2991218|NCT00910091|3707731|FG000|STARTED|Pre-assignment||36
2991219|NCT00910091|3707732|FG001|STARTED|Pre-assignment||37
2991220|NCT00910091|3707731|FG000|COMPLETED|Pre-assignment||36
2991221|NCT00910091|3707732|FG001|COMPLETED|Pre-assignment||35
2991222|NCT00910091|3707731|FG000|NOT COMPLETED|Pre-assignment||0
2991223|NCT00910091|3707732|FG001|NOT COMPLETED|Pre-assignment||2
2991224|NCT00910091|3707731|FG000|STARTED|Treatment and Survival||36
2991225|NCT00910091|3707732|FG001|STARTED|Treatment and Survival||35
2991226|NCT00910091|3707731|FG000|COMPLETED|Treatment and Survival||32
2991227|NCT00910091|3707732|FG001|COMPLETED|Treatment and Survival||31
2991228|NCT00910091|3707731|FG000|NOT COMPLETED|Treatment and Survival||4
2991229|NCT00910091|3707732|FG001|NOT COMPLETED|Treatment and Survival||4
2991230|NCT00910208|3707742|FG000|STARTED|Overall Study||69
2991231|NCT00910208|3707743|FG001|STARTED|Overall Study||72
2991232|NCT00910208|3707744|FG002|STARTED|Overall Study||70
2991233|NCT00910208|3707742|FG000|COMPLETED|Overall Study||67
2991234|NCT00910208|3707743|FG001|COMPLETED|Overall Study||70
2991235|NCT00910208|3707744|FG002|COMPLETED|Overall Study||69
2991236|NCT00910208|3707742|FG000|NOT COMPLETED|Overall Study||2
2991237|NCT00910208|3707743|FG001|NOT COMPLETED|Overall Study||2
2991238|NCT00910208|3707744|FG002|NOT COMPLETED|Overall Study||1
2991239|NCT00910247|3707752|FG000|STARTED|Overall Study||274
2991240|NCT00910247|3707752|FG000|COMPLETED|Overall Study||205
2991241|NCT00910247|3707752|FG000|NOT COMPLETED|Overall Study||69
2991242|NCT00910273|3707758|FG000|STARTED|Overall Study||18
2991243|NCT00910273|3707759|FG001|STARTED|Overall Study||16
2991244|NCT00910273|3707758|FG000|COMPLETED|Overall Study||0
2991245|NCT00910273|3707759|FG001|COMPLETED|Overall Study||3
2991246|NCT00910273|3707758|FG000|NOT COMPLETED|Overall Study||18
2991247|NCT00910273|3707759|FG001|NOT COMPLETED|Overall Study||13
2991248|NCT00910299|3707767|FG000|STARTED|Overall Study||212
2991249|NCT00910299|3707768|FG001|STARTED|Overall Study||211
2991250|NCT00910299|3707767|FG000|Received at Least 1 Dose of Study Drug|Overall Study||210
2991251|NCT00910299|3707768|FG001|Received at Least 1 Dose of Study Drug|Overall Study||210
2991252|NCT00910299|3707767|FG000|COMPLETED|Overall Study||136
2991253|NCT00910299|3707768|FG001|COMPLETED|Overall Study|"1 participant died of sepsis while on study drug and was considered a protocol completer."|137
2991254|NCT00910299|3707767|FG000|NOT COMPLETED|Overall Study||76
2991255|NCT00910299|3707768|FG001|NOT COMPLETED|Overall Study||74
2991256|NCT00910429|3707776|FG000|STARTED|Overall Study||155
2991257|NCT00910429|3707777|FG001|STARTED|Overall Study||82
2991258|NCT00910429|3707776|FG000|COMPLETED|Overall Study|Completed treatment|116
2991259|NCT00910429|3707777|FG001|COMPLETED|Overall Study|Completed treatment|61
2991260|NCT00910429|3707776|FG000|NOT COMPLETED|Overall Study||39
2991261|NCT00910429|3707777|FG001|NOT COMPLETED|Overall Study||21
2991262|NCT00910481|3707785|FG000|STARTED|Overall Study||151
2991263|NCT00910481|3707786|FG001|STARTED|Overall Study||150
2991264|NCT00910481|3707785|FG000|COMPLETED|Overall Study||151
2991265|NCT00910481|3707786|FG001|COMPLETED|Overall Study||150
2991266|NCT00910481|3707785|FG000|NOT COMPLETED|Overall Study||0
2991267|NCT00910481|3707786|FG001|NOT COMPLETED|Overall Study||0
2991268|NCT00910520|3707794|FG000|STARTED|Treatment Cycle 1||277
2991269|NCT00910520|3707795|FG001|STARTED|Treatment Cycle 1||271
3164515|NCT01892865|3891893|FG001|NOT COMPLETED|Overall Study||0
3164516|NCT01893203|3891899|FG000|STARTED|Overall Study||14
3164517|NCT01893203|3891899|FG000|COMPLETED|Overall Study||13
3164518|NCT01893203|3891899|FG000|NOT COMPLETED|Overall Study||1
3164519|NCT01893281|3891903|FG000|STARTED|Overall Study||78
3164520|NCT01893281|3891903|FG000|Received at Least 1 Dose of Study Drug|Overall Study||78
3164521|NCT01893281|3891903|FG000|COMPLETED|Overall Study||75
3164522|NCT01893281|3891903|FG000|NOT COMPLETED|Overall Study||3
3164523|NCT01893346|3891911|FG000|STARTED|Overall Study||11
3164524|NCT01893346|3891912|FG001|STARTED|Overall Study||8
2991270|NCT00910520|3707794|FG000|COMPLETED|Treatment Cycle 1||257
2991271|NCT00910520|3707795|FG001|COMPLETED|Treatment Cycle 1||247
2991272|NCT00910520|3707794|FG000|NOT COMPLETED|Treatment Cycle 1||20
2991273|NCT00910520|3707795|FG001|NOT COMPLETED|Treatment Cycle 1||24
2991274|NCT00910520|3707794|FG000|STARTED|Treatment Cycle 2|Not all participants who completed Treatment Cycle 1 went onto Treatment Cycle 2|163
2991275|NCT00910520|3707795|FG001|STARTED|Treatment Cycle 2|Not all participants who completed Treatment Cycle 1 went onto Treatment Cycle 2|223
2991276|NCT00910520|3707794|FG000|COMPLETED|Treatment Cycle 2||156
2991277|NCT00910520|3707795|FG001|COMPLETED|Treatment Cycle 2||215
2991278|NCT00910520|3707794|FG000|NOT COMPLETED|Treatment Cycle 2||7
2991279|NCT00910520|3707795|FG001|NOT COMPLETED|Treatment Cycle 2||8
2991280|NCT00910624|3707805|FG000|STARTED|Treatment Phase||52
2991281|NCT00910624|3707806|FG001|STARTED|Treatment Phase||85
2991282|NCT00910624|3707807|FG002|STARTED|Treatment Phase||29
2991283|NCT00910624|3707808|FG003|STARTED|Treatment Phase||2
2991284|NCT00910624|3707805|FG000|COMPLETED|Treatment Phase||22
2991285|NCT00910624|3707806|FG001|COMPLETED|Treatment Phase||64
2991286|NCT00910624|3707807|FG002|COMPLETED|Treatment Phase||20
2991287|NCT00910624|3707808|FG003|COMPLETED|Treatment Phase||2
2991288|NCT00910624|3707805|FG000|NOT COMPLETED|Treatment Phase||30
2991289|NCT00910624|3707806|FG001|NOT COMPLETED|Treatment Phase||21
2991290|NCT00910624|3707807|FG002|NOT COMPLETED|Treatment Phase||9
2991291|NCT00910624|3707808|FG003|NOT COMPLETED|Treatment Phase||0
2991292|NCT00910624|3707805|FG000|STARTED|Follow-Up Phase||48
2991293|NCT00910624|3707806|FG001|STARTED|Follow-Up Phase||80
2991294|NCT00910624|3707807|FG002|STARTED|Follow-Up Phase||29
2991295|NCT00910624|3707808|FG003|STARTED|Follow-Up Phase||2
2991296|NCT00910624|3707805|FG000|COMPLETED|Follow-Up Phase||42
2991297|NCT00910624|3707806|FG001|COMPLETED|Follow-Up Phase||76
2991298|NCT00910624|3707807|FG002|COMPLETED|Follow-Up Phase||25
2991299|NCT00910624|3707808|FG003|COMPLETED|Follow-Up Phase||2
2991300|NCT00910624|3707805|FG000|NOT COMPLETED|Follow-Up Phase||6
2991301|NCT00910624|3707806|FG001|NOT COMPLETED|Follow-Up Phase||4
2991302|NCT00910624|3707807|FG002|NOT COMPLETED|Follow-Up Phase||4
2991303|NCT00910624|3707808|FG003|NOT COMPLETED|Follow-Up Phase||0
2991304|NCT00910663|3707818|FG000|STARTED|Period 1||30
2991305|NCT00910663|3707819|FG001|STARTED|Period 1||30
2991306|NCT00910663|3707818|FG000|COMPLETED|Period 1||30
2991307|NCT00910663|3707819|FG001|COMPLETED|Period 1||29
2991308|NCT00910663|3707818|FG000|NOT COMPLETED|Period 1||0
2991309|NCT00910663|3707819|FG001|NOT COMPLETED|Period 1||1
2991310|NCT00910663|3707818|FG000|STARTED|Period 2||30
2991311|NCT00910663|3707819|FG001|STARTED|Period 2||29
2991312|NCT00910663|3707818|FG000|COMPLETED|Period 2||30
2991313|NCT00910663|3707819|FG001|COMPLETED|Period 2||29
2991314|NCT00910663|3707818|FG000|NOT COMPLETED|Period 2||0
2991315|NCT00910663|3707819|FG001|NOT COMPLETED|Period 2||0
2991316|NCT00910689|3707829|FG000|STARTED|Month 1: Optimal Acute Therapy Run in||55
2991317|NCT00910689|3707830|FG001|STARTED|Month 1: Optimal Acute Therapy Run in||53
2991318|NCT00910689|3707831|FG002|STARTED|Month 1: Optimal Acute Therapy Run in||55
2991319|NCT00910689|3707832|FG003|STARTED|Month 1: Optimal Acute Therapy Run in||69
2991320|NCT00910689|3707829|FG000|COMPLETED|Month 1: Optimal Acute Therapy Run in||53
2991321|NCT00910689|3707830|FG001|COMPLETED|Month 1: Optimal Acute Therapy Run in||52
2991322|NCT00910689|3707831|FG002|COMPLETED|Month 1: Optimal Acute Therapy Run in||50
2991323|NCT00910689|3707832|FG003|COMPLETED|Month 1: Optimal Acute Therapy Run in||59
2991324|NCT00910689|3707829|FG000|NOT COMPLETED|Month 1: Optimal Acute Therapy Run in||2
2991325|NCT00910689|3707830|FG001|NOT COMPLETED|Month 1: Optimal Acute Therapy Run in||1
2991326|NCT00910689|3707831|FG002|NOT COMPLETED|Month 1: Optimal Acute Therapy Run in||5
2991327|NCT00910689|3707832|FG003|NOT COMPLETED|Month 1: Optimal Acute Therapy Run in||10
3164525|NCT01893346|3891913|FG002|STARTED|Overall Study||8
3164526|NCT01893346|3891914|FG003|STARTED|Overall Study||8
3304976|NCT02984644|4038585|FG001|COMPLETED|Overall Study||10
3304977|NCT02984644|4038584|FG000|NOT COMPLETED|Overall Study||0
3304978|NCT02984644|4038585|FG001|NOT COMPLETED|Overall Study||0
3304979|NCT02984683|4038614|FG000|STARTED|Overall Study||11
3304980|NCT02984683|4038615|FG001|STARTED|Overall Study||12
3304981|NCT02984683|4038614|FG000|COMPLETED|Overall Study||0
3304982|NCT02984683|4038615|FG001|COMPLETED|Overall Study||0
3304983|NCT02984683|4038614|FG000|NOT COMPLETED|Overall Study||11
3304984|NCT02984683|4038615|FG001|NOT COMPLETED|Overall Study||12
3304985|NCT02984709|4038623|FG000|STARTED|Overall Study|We enrolled 24 adolescent-parent dyads.|24
3304986|NCT02984709|4038624|FG001|STARTED|Overall Study|We enrolled 24 adolescent-parent dyads.|24
2991328|NCT00910689|3707829|FG000|STARTED|Month 2- 4: Treatment Period||53
2991329|NCT00910689|3707830|FG001|STARTED|Month 2- 4: Treatment Period||52
3133563|NCT01696279|3858509|FG001|NOT COMPLETED|Part 2a: Calcium Carbonate + Lanthanum||19
3133564|NCT01696279|3858510|FG002|NOT COMPLETED|Part 2a: Calcium Carbonate + Lanthanum||0
3133565|NCT01696279|3858511|FG003|NOT COMPLETED|Part 2a: Calcium Carbonate + Lanthanum||0
2991330|NCT00910689|3707831|FG002|STARTED|Month 2- 4: Treatment Period||50
2991331|NCT00910689|3707832|FG003|STARTED|Month 2- 4: Treatment Period||59
2991332|NCT00910689|3707829|FG000|COMPLETED|Month 2- 4: Treatment Period||44
2991333|NCT00910689|3707830|FG001|COMPLETED|Month 2- 4: Treatment Period||42
2991334|NCT00910689|3707831|FG002|COMPLETED|Month 2- 4: Treatment Period||42
2991335|NCT00910689|3707832|FG003|COMPLETED|Month 2- 4: Treatment Period||48
2991336|NCT00910689|3707829|FG000|NOT COMPLETED|Month 2- 4: Treatment Period||9
2991337|NCT00910689|3707830|FG001|NOT COMPLETED|Month 2- 4: Treatment Period||10
2991338|NCT00910689|3707831|FG002|NOT COMPLETED|Month 2- 4: Treatment Period||8
2991339|NCT00910689|3707832|FG003|NOT COMPLETED|Month 2- 4: Treatment Period||11
2991340|NCT00910689|3707829|FG000|STARTED|Months 5 - 10: Evaluation Period I||44
2991341|NCT00910689|3707830|FG001|STARTED|Months 5 - 10: Evaluation Period I||42
2991342|NCT00910689|3707831|FG002|STARTED|Months 5 - 10: Evaluation Period I||42
2991343|NCT00910689|3707832|FG003|STARTED|Months 5 - 10: Evaluation Period I||48
2991344|NCT00910689|3707829|FG000|COMPLETED|Months 5 - 10: Evaluation Period I||40
2991345|NCT00910689|3707830|FG001|COMPLETED|Months 5 - 10: Evaluation Period I||35
2991346|NCT00910689|3707831|FG002|COMPLETED|Months 5 - 10: Evaluation Period I||35
2991347|NCT00910689|3707832|FG003|COMPLETED|Months 5 - 10: Evaluation Period I||41
2991348|NCT00910689|3707829|FG000|NOT COMPLETED|Months 5 - 10: Evaluation Period I||4
2991349|NCT00910689|3707830|FG001|NOT COMPLETED|Months 5 - 10: Evaluation Period I||7
2991350|NCT00910689|3707831|FG002|NOT COMPLETED|Months 5 - 10: Evaluation Period I||7
2991351|NCT00910689|3707832|FG003|NOT COMPLETED|Months 5 - 10: Evaluation Period I||7
2991352|NCT00910689|3707829|FG000|STARTED|Months 11- 16: Evaluation Period II||40
2991353|NCT00910689|3707830|FG001|STARTED|Months 11- 16: Evaluation Period II||35
2991354|NCT00910689|3707831|FG002|STARTED|Months 11- 16: Evaluation Period II||35
2991355|NCT00910689|3707832|FG003|STARTED|Months 11- 16: Evaluation Period II||41
2991356|NCT00910689|3707829|FG000|COMPLETED|Months 11- 16: Evaluation Period II||30
2991357|NCT00910689|3707830|FG001|COMPLETED|Months 11- 16: Evaluation Period II||25
2991358|NCT00910689|3707831|FG002|COMPLETED|Months 11- 16: Evaluation Period II||28
2991359|NCT00910689|3707832|FG003|COMPLETED|Months 11- 16: Evaluation Period II||35
2991360|NCT00910689|3707829|FG000|NOT COMPLETED|Months 11- 16: Evaluation Period II||10
2991361|NCT00910689|3707830|FG001|NOT COMPLETED|Months 11- 16: Evaluation Period II||10
2991362|NCT00910689|3707831|FG002|NOT COMPLETED|Months 11- 16: Evaluation Period II||7
2991363|NCT00910689|3707832|FG003|NOT COMPLETED|Months 11- 16: Evaluation Period II||6
2991364|NCT00910715|3707845|FG000|STARTED|Overall Study||108
2991365|NCT00910715|3707846|FG001|STARTED|Overall Study||117
2991366|NCT00910715|3707847|FG002|STARTED|Overall Study||81
2991367|NCT00910715|3707845|FG000|COMPLETED|Overall Study||86
2991368|NCT00910715|3707846|FG001|COMPLETED|Overall Study||91
2991369|NCT00910715|3707847|FG002|COMPLETED|Overall Study||81
2991370|NCT00910715|3707845|FG000|NOT COMPLETED|Overall Study||22
2991371|NCT00910715|3707846|FG001|NOT COMPLETED|Overall Study||26
2991372|NCT00910715|3707847|FG002|NOT COMPLETED|Overall Study||0
2991373|NCT00910728|3707866|FG000|STARTED|Overall Study||6
2991374|NCT00910728|3707867|FG001|STARTED|Overall Study||3
2991375|NCT00910728|3707868|FG002|STARTED|Overall Study||3
2991376|NCT00910728|3707869|FG003|STARTED|Overall Study||3
2991377|NCT00910728|3707870|FG004|STARTED|Overall Study||6
2991378|NCT00910728|3707871|FG005|STARTED|Overall Study||1
2991379|NCT00910728|3707872|FG006|STARTED|Overall Study||6
2991380|NCT00910728|3707873|FG007|STARTED|Overall Study||4
2991381|NCT00910728|3707874|FG008|STARTED|Overall Study||3
2991382|NCT00910728|3707866|FG000|COMPLETED|Overall Study||0
2991383|NCT00910728|3707867|FG001|COMPLETED|Overall Study||0
2991384|NCT00910728|3707868|FG002|COMPLETED|Overall Study||0
2991385|NCT00910728|3707869|FG003|COMPLETED|Overall Study||0
2991386|NCT00910728|3707870|FG004|COMPLETED|Overall Study||1
2991387|NCT00910728|3707871|FG005|COMPLETED|Overall Study||0
2991388|NCT00910728|3707872|FG006|COMPLETED|Overall Study||0
2991389|NCT00910728|3707873|FG007|COMPLETED|Overall Study||1
2991390|NCT00910728|3707874|FG008|COMPLETED|Overall Study||0
2991391|NCT00910728|3707866|FG000|NOT COMPLETED|Overall Study||6
2991392|NCT00910728|3707867|FG001|NOT COMPLETED|Overall Study||3
2991393|NCT00910728|3707868|FG002|NOT COMPLETED|Overall Study||3
2991394|NCT00910728|3707869|FG003|NOT COMPLETED|Overall Study||3
2991395|NCT00910728|3707870|FG004|NOT COMPLETED|Overall Study||5
2991396|NCT00910728|3707871|FG005|NOT COMPLETED|Overall Study||1
2991397|NCT00910728|3707872|FG006|NOT COMPLETED|Overall Study||6
2991398|NCT00910728|3707873|FG007|NOT COMPLETED|Overall Study||3
2991399|NCT00910728|3707874|FG008|NOT COMPLETED|Overall Study||3
2991400|NCT00910845|3707896|FG000|STARTED|Treatment Cycle 1||280
2991401|NCT00910845|3707897|FG001|STARTED|Treatment Cycle 1||277
2991402|NCT00910845|3707896|FG000|COMPLETED|Treatment Cycle 1||249
2991403|NCT00910845|3707897|FG001|COMPLETED|Treatment Cycle 1||243
2991404|NCT00910845|3707896|FG000|NOT COMPLETED|Treatment Cycle 1||31
2991405|NCT00910845|3707897|FG001|NOT COMPLETED|Treatment Cycle 1||34
2991406|NCT00910845|3707896|FG000|STARTED|Treatment Cycle 2|Not all participants who completed Treatment Cycle 1 went onto Treatment Cycle 2|141
2991407|NCT00910845|3707897|FG001|STARTED|Treatment Cycle 2|Not all participants who completed Treatment Cycle 1 went onto Treatment Cycle 2|212
2991408|NCT00910845|3707896|FG000|COMPLETED|Treatment Cycle 2||136
2991409|NCT00910845|3707897|FG001|COMPLETED|Treatment Cycle 2||203
2991410|NCT00910845|3707896|FG000|NOT COMPLETED|Treatment Cycle 2||5
2991411|NCT00910845|3707897|FG001|NOT COMPLETED|Treatment Cycle 2||9
2991412|NCT00910858|3707906|FG000|STARTED|Pharmacokinetic Phase||9
2991413|NCT00910858|3707907|FG001|STARTED|Pharmacokinetic Phase||0
2991414|NCT00910858|3707908|FG002|STARTED|Pharmacokinetic Phase||3
2991415|NCT00910858|3707906|FG000|COMPLETED|Pharmacokinetic Phase||8
2991416|NCT00910858|3707907|FG001|COMPLETED|Pharmacokinetic Phase||0
2991417|NCT00910858|3707908|FG002|COMPLETED|Pharmacokinetic Phase||3
2991418|NCT00910858|3707906|FG000|NOT COMPLETED|Pharmacokinetic Phase||1
2991419|NCT00910858|3707907|FG001|NOT COMPLETED|Pharmacokinetic Phase||0
2991420|NCT00910858|3707908|FG002|NOT COMPLETED|Pharmacokinetic Phase||0
2991421|NCT00910858|3707906|FG000|STARTED|Monotherapy Phase|Includes 8 participants from the PK Phase and 9 newly enrolled participants.|17
2991422|NCT00910858|3707907|FG001|STARTED|Monotherapy Phase|All 15 participants were newly enrolled into the Monotherapy Phase.|15
2991423|NCT00910858|3707908|FG002|STARTED|Monotherapy Phase|Includes 3 participants from the PK Phase and 4 newly enrolled participants.|7
2991424|NCT00910858|3707906|FG000|Safety Population|Monotherapy Phase|All patients who took at least 1 dose of study drug during Monotherapy or Combined Treatment Phase.|17
2991425|NCT00910858|3707907|FG001|Safety Population|Monotherapy Phase|All patients who took at least 1 dose of study drug during Monotherapy or Combined Treatment Phase.|15
2991426|NCT00910858|3707908|FG002|Safety Population|Monotherapy Phase|All patients who took at least 1 dose of study drug during Monotherapy or Combined Treatment Phase.|7
2991427|NCT00910858|3707906|FG000|Pharmacokinetic Population|Monotherapy Phase||17
2991428|NCT00910858|3707907|FG001|Pharmacokinetic Population|Monotherapy Phase|Patients in the 15 mg Non-del 5q group were not included in the pharmacokinetic assessment.|0
2991429|NCT00910858|3707908|FG002|Pharmacokinetic Population|Monotherapy Phase||7
2991430|NCT00910858|3707906|FG000|COMPLETED|Monotherapy Phase||0
2991431|NCT00910858|3707907|FG001|COMPLETED|Monotherapy Phase||0
2991432|NCT00910858|3707908|FG002|COMPLETED|Monotherapy Phase||0
2991433|NCT00910858|3707906|FG000|NOT COMPLETED|Monotherapy Phase||17
2991434|NCT00910858|3707907|FG001|NOT COMPLETED|Monotherapy Phase||15
2991435|NCT00910858|3707908|FG002|NOT COMPLETED|Monotherapy Phase||7
2991436|NCT00910858|3707906|FG000|STARTED|Combined Treatment Phase|Patients who discontinued the Monotherapy Phase due to erythroid non-response or erythroid relapse.|9
2991437|NCT00910858|3707907|FG001|STARTED|Combined Treatment Phase|Patients who discontinued the Monotherapy Phase due to erythroid non-response or erythroid relapse.|10
2991438|NCT00910858|3707908|FG002|STARTED|Combined Treatment Phase|Patients who discontinued the Monotherapy Phase due to erythroid non-response or erythroid relapse.|4
2991439|NCT00910858|3707906|FG000|COMPLETED|Combined Treatment Phase||0
2991440|NCT00910858|3707907|FG001|COMPLETED|Combined Treatment Phase||0
2991441|NCT00910858|3707908|FG002|COMPLETED|Combined Treatment Phase||0
2991442|NCT00910858|3707906|FG000|NOT COMPLETED|Combined Treatment Phase||9
2991443|NCT00910858|3707907|FG001|NOT COMPLETED|Combined Treatment Phase||10
2991444|NCT00910858|3707908|FG002|NOT COMPLETED|Combined Treatment Phase||4
2991445|NCT00910871|3707924|FG000|STARTED|Overall Study||233
2991446|NCT00910871|3707924|FG000|COMPLETED|Overall Study||179
2991447|NCT00910871|3707924|FG000|NOT COMPLETED|Overall Study||54
2991448|NCT00910910|3707930|FG000|STARTED|Overall Study||225
2991449|NCT00910910|3707931|FG001|STARTED|Overall Study||225
2991450|NCT00910910|3707930|FG000|Safety Population|Overall Study|All randomized participants who received at least 1 dose of the either lenalidomide or chlorambucil|224
2991451|NCT00910910|3707931|FG001|Safety Population|Overall Study|All randomized participants who received at least 1 dose of the either lenalidomide or chlorambucil|223
2991452|NCT00910910|3707930|FG000|COMPLETED|Overall Study|Completed includes participants who continued with ongoing treatment|0
2991453|NCT00910910|3707931|FG001|COMPLETED|Overall Study|Completed includes participants who continued with ongoing treatment|1
2991454|NCT00910910|3707930|FG000|NOT COMPLETED|Overall Study||225
2991455|NCT00910910|3707931|FG001|NOT COMPLETED|Overall Study||224
2991456|NCT00910962|3707940|FG000|STARTED|Overall Study||135
2991457|NCT00910962|3707941|FG001|STARTED|Overall Study||199
2991458|NCT00910962|3707942|FG002|STARTED|Overall Study||192
2991459|NCT00910962|3707940|FG000|COMPLETED|Overall Study||92
2991460|NCT00910962|3707941|FG001|COMPLETED|Overall Study||121
2991461|NCT00910962|3707942|FG002|COMPLETED|Overall Study||116
2991462|NCT00910962|3707940|FG000|NOT COMPLETED|Overall Study||43
2991463|NCT00910962|3707941|FG001|NOT COMPLETED|Overall Study||78
2991464|NCT00910962|3707942|FG002|NOT COMPLETED|Overall Study||76
2991465|NCT00910988|3707956|FG000|STARTED|Overall Study||16
2991466|NCT00910988|3707957|FG001|STARTED|Overall Study||16
2991467|NCT00910988|3707958|FG002|STARTED|Overall Study||8
2991468|NCT00910988|3707959|FG003|STARTED|Overall Study||6
2991469|NCT00910988|3707956|FG000|COMPLETED|Overall Study||14
2991470|NCT00910988|3707957|FG001|COMPLETED|Overall Study||12
2991471|NCT00910988|3707958|FG002|COMPLETED|Overall Study||5
2991472|NCT00910988|3707959|FG003|COMPLETED|Overall Study||6
3133566|NCT01696279|3858508|FG000|STARTED|Part 2b: Lanthanum Carbonate (8 Weeks)||0
3133567|NCT01696279|3858509|FG001|STARTED|Part 2b: Lanthanum Carbonate (8 Weeks)||0
3133568|NCT01696279|3858510|FG002|STARTED|Part 2b: Lanthanum Carbonate (8 Weeks)|9 new participants were enrolled in Part 2b|9
3133569|NCT01696279|3858511|FG003|STARTED|Part 2b: Lanthanum Carbonate (8 Weeks)||0
3133570|NCT01696279|3858508|FG000|Safety Completer Set|Part 2b: Lanthanum Carbonate (8 Weeks)||0
3133571|NCT01696279|3858509|FG001|Safety Completer Set|Part 2b: Lanthanum Carbonate (8 Weeks)||0
3133572|NCT01696279|3858510|FG002|Safety Completer Set|Part 2b: Lanthanum Carbonate (8 Weeks)||9
2991473|NCT00910988|3707956|FG000|NOT COMPLETED|Overall Study||2
2991474|NCT00910988|3707957|FG001|NOT COMPLETED|Overall Study||4
2991475|NCT00910988|3707958|FG002|NOT COMPLETED|Overall Study||3
2991476|NCT00910988|3707959|FG003|NOT COMPLETED|Overall Study||0
2991477|NCT00911144|3707987|FG000|STARTED|Overall Study||335
2991478|NCT00911144|3707988|FG001|STARTED|Overall Study||113
2991479|NCT00911144|3707987|FG000|COMPLETED|Overall Study||319
2991480|NCT00911144|3707988|FG001|COMPLETED|Overall Study||108
2991481|NCT00911144|3707987|FG000|NOT COMPLETED|Overall Study||16
2991482|NCT00911144|3707988|FG001|NOT COMPLETED|Overall Study||5
2991483|NCT00911157|3707996|FG000|STARTED|Overall Study||29
2991484|NCT00911157|3707997|FG001|STARTED|Overall Study||10
2991485|NCT00911157|3707996|FG000|COMPLETED|Overall Study||22
2991486|NCT00911157|3707997|FG001|COMPLETED|Overall Study||8
2991487|NCT00911157|3707996|FG000|NOT COMPLETED|Overall Study||7
2991488|NCT00911157|3707997|FG001|NOT COMPLETED|Overall Study||2
2991489|NCT00911170|3708005|FG000|STARTED|Treatment Period||424
2991490|NCT00911170|3708006|FG001|STARTED|Treatment Period||423
2991491|NCT00911170|3708005|FG000|Received Chemotherapy|Treatment Period|Primary Analysis Set|423
2991492|NCT00911170|3708006|FG001|Received Chemotherapy|Treatment Period|Primary Analysis Set|422
2991493|NCT00911170|3708005|FG000|Received Bevacizumab|Treatment Period||423
2991494|NCT00911170|3708006|FG001|Received Bevacizumab|Treatment Period||420
2991495|NCT00911170|3708005|FG000|Received Investigational Product|Treatment Period|Includes one participant who received pegfilgrastim in error.|422
2991496|NCT00911170|3708006|FG001|Received Investigational Product|Treatment Period||419
2991497|NCT00911170|3708005|FG000|COMPLETED|Treatment Period|Completed 4 cycles of treatment including chemotherapy, bevacizumab and investigational product.|397
2991498|NCT00911170|3708006|FG001|COMPLETED|Treatment Period|Completed 4 cycles of treatment including chemotherapy, bevacizumab and investigational product.|386
2991499|NCT00911170|3708005|FG000|NOT COMPLETED|Treatment Period||27
2991500|NCT00911170|3708006|FG001|NOT COMPLETED|Treatment Period||37
2991501|NCT00911170|3708005|FG000|STARTED|Long Term Follow-Up|Participants who received treatment in the Treatment Period|423
2991502|NCT00911170|3708006|FG001|STARTED|Long Term Follow-Up|Participants who received treatment in the Treatment Period|422
2991503|NCT00911170|3708005|FG000|COMPLETED|Long Term Follow-Up|As of the data cut-off date of 8 June 2012|0
2991504|NCT00911170|3708006|FG001|COMPLETED|Long Term Follow-Up|As of the data cut-off date of 8 June 2012|0
2991505|NCT00911170|3708005|FG000|NOT COMPLETED|Long Term Follow-Up||423
2991506|NCT00911170|3708006|FG001|NOT COMPLETED|Long Term Follow-Up||422
2991507|NCT00911300|3708014|FG000|STARTED|Overall Study||175
2991508|NCT00911300|3708015|FG001|STARTED|Overall Study||174
2991509|NCT00911300|3708014|FG000|COMPLETED|Overall Study||140
2991510|NCT00911300|3708015|FG001|COMPLETED|Overall Study||131
2991511|NCT00911300|3708014|FG000|NOT COMPLETED|Overall Study||35
2991512|NCT00911300|3708015|FG001|NOT COMPLETED|Overall Study||43
2991513|NCT00911326|3708022|FG000|STARTED|Overall Study||101
2991514|NCT00911326|3708022|FG000|COMPLETED|Overall Study||85
2991515|NCT00911326|3708022|FG000|NOT COMPLETED|Overall Study||16
2991516|NCT00911495|3708026|FG000|STARTED|Overall Study||15
2991517|NCT00911495|3708026|FG000|COMPLETED|Overall Study||14
2991518|NCT00911495|3708026|FG000|NOT COMPLETED|Overall Study||1
2991519|NCT00911508|3708032|FG000|STARTED|Overall Study||1108
2991520|NCT00911508|3708033|FG001|STARTED|Overall Study||1096
2991521|NCT00911508|3708032|FG000|COMPLETED|Overall Study||1002
2991522|NCT00911508|3708033|FG001|COMPLETED|Overall Study||966
2991523|NCT00911508|3708032|FG000|NOT COMPLETED|Overall Study||106
2991524|NCT00911508|3708033|FG001|NOT COMPLETED|Overall Study||130
2991525|NCT00911534|3708041|FG000|STARTED|Overall Study|Randomized (treated)|147
2991526|NCT00911534|3708042|FG001|STARTED|Overall Study|Randomized (treated)|153
2991527|NCT00911534|3708041|FG000|COMPLETED|Overall Study||132
2991528|NCT00911534|3708042|FG001|COMPLETED|Overall Study||137
2991529|NCT00911534|3708041|FG000|NOT COMPLETED|Overall Study||15
2991530|NCT00911534|3708042|FG001|NOT COMPLETED|Overall Study||16
2991531|NCT00911586|3708048|FG000|STARTED|Overall Study||15
2991532|NCT00911586|3708048|FG000|COMPLETED|Overall Study||15
2991533|NCT00911586|3708048|FG000|NOT COMPLETED|Overall Study||0
2991534|NCT00911612|3708055|FG000|STARTED|Overall Study||12
2991535|NCT00911612|3708056|FG001|STARTED|Overall Study||12
2991536|NCT00911612|3708055|FG000|COMPLETED|Overall Study||12
2991537|NCT00911612|3708056|FG001|COMPLETED|Overall Study||12
2991538|NCT00911612|3708055|FG000|NOT COMPLETED|Overall Study||0
2991539|NCT00911612|3708056|FG001|NOT COMPLETED|Overall Study||0
2991540|NCT00911625|3708064|FG000|STARTED|Overall Study||57
2991541|NCT00911625|3708065|FG001|STARTED|Overall Study||57
2991542|NCT00911625|3708064|FG000|COMPLETED|Overall Study||50
2991543|NCT00911625|3708065|FG001|COMPLETED|Overall Study||57
2991544|NCT00911625|3708064|FG000|NOT COMPLETED|Overall Study||7
2991545|NCT00911625|3708065|FG001|NOT COMPLETED|Overall Study||0
2991546|NCT00911742|3708073|FG000|STARTED|Treatment Phase I||13
2991547|NCT00911742|3708074|FG001|STARTED|Treatment Phase I||13
2991548|NCT00911742|3708073|FG000|COMPLETED|Treatment Phase I||13
2991549|NCT00911742|3708074|FG001|COMPLETED|Treatment Phase I||13
2991550|NCT00911742|3708073|FG000|NOT COMPLETED|Treatment Phase I||0
2991551|NCT00911742|3708074|FG001|NOT COMPLETED|Treatment Phase I||0
2991552|NCT00911742|3708073|FG000|STARTED|Treatment Phase II||13
2991553|NCT00911742|3708074|FG001|STARTED|Treatment Phase II||13
2991554|NCT00911742|3708073|FG000|COMPLETED|Treatment Phase II||13
2991555|NCT00911742|3708074|FG001|COMPLETED|Treatment Phase II||13
2991556|NCT00911742|3708073|FG000|NOT COMPLETED|Treatment Phase II||0
2991557|NCT00911742|3708074|FG001|NOT COMPLETED|Treatment Phase II||0
2991558|NCT00911768|3708082|FG000|STARTED|Overall Study||50
2991559|NCT00911768|3708083|FG001|STARTED|Overall Study||50
2991560|NCT00911768|3708082|FG000|COMPLETED|Overall Study||44
2991561|NCT00911768|3708083|FG001|COMPLETED|Overall Study||46
3304987|NCT02984709|4038623|FG000|COMPLETED|Overall Study||24
3304988|NCT02984709|4038624|FG001|COMPLETED|Overall Study||24
3304989|NCT02984709|4038623|FG000|NOT COMPLETED|Overall Study||0
3304990|NCT02984709|4038624|FG001|NOT COMPLETED|Overall Study||0
3304991|NCT02984878|4038634|FG000|STARTED|Overall Study||30
3304992|NCT02984878|4038635|FG001|STARTED|Overall Study||41
3304993|NCT02984878|4038634|FG000|COMPLETED|Overall Study||30
3304994|NCT02984878|4038635|FG001|COMPLETED|Overall Study||41
3304995|NCT02984878|4038634|FG000|NOT COMPLETED|Overall Study||0
3304996|NCT02984878|4038635|FG001|NOT COMPLETED|Overall Study||0
3304997|NCT02984943|4038644|FG000|STARTED|Overall Study||14
3304998|NCT02984943|4038644|FG000|COMPLETED|Overall Study||10
3304999|NCT02984943|4038644|FG000|NOT COMPLETED|Overall Study||4
3305000|NCT02984982|4038650|FG000|STARTED|Overall Study||102
3305001|NCT02984982|4038651|FG001|STARTED|Overall Study||104
3305002|NCT02984982|4038650|FG000|Treated|Overall Study||102
3305003|NCT02984982|4038651|FG001|Treated|Overall Study||103
3305004|NCT02984982|4038650|FG000|COMPLETED|Overall Study||94
3305005|NCT02984982|4038651|FG001|COMPLETED|Overall Study||94
3305006|NCT02984982|4038650|FG000|NOT COMPLETED|Overall Study||8
3305007|NCT02984982|4038651|FG001|NOT COMPLETED|Overall Study||10
3305008|NCT02984995|4038660|FG000|STARTED|Overall Study||34
3305009|NCT02984995|4038661|FG001|STARTED|Overall Study||3
3305010|NCT02984995|4038660|FG000|COMPLETED|Overall Study||9
3305011|NCT02984995|4038661|FG001|COMPLETED|Overall Study||0
3305012|NCT02984995|4038660|FG000|NOT COMPLETED|Overall Study||25
3305013|NCT02984995|4038661|FG001|NOT COMPLETED|Overall Study||3
3305014|NCT02985021|4038673|FG000|STARTED|Overall Study||2
3305015|NCT02985021|4038673|FG000|COMPLETED|Overall Study||1
3305016|NCT02985021|4038673|FG000|NOT COMPLETED|Overall Study||1
3305017|NCT02985398|4038677|FG000|STARTED|Overall Study||128
3305018|NCT02985398|4038677|FG000|Participants Treated|Overall Study||128
3305019|NCT02985398|4038677|FG000|COMPLETED|Overall Study||106
3305020|NCT02985398|4038677|FG000|NOT COMPLETED|Overall Study||22
3305021|NCT02985450|4038681|FG000|STARTED|Overall Study||82
3305022|NCT02985450|4038681|FG000|COMPLETED|Overall Study||75
3305023|NCT02985450|4038681|FG000|NOT COMPLETED|Overall Study||7
3305024|NCT02985710|4038690|FG000|STARTED|Overall Study||69
3305025|NCT02985710|4038691|FG001|STARTED|Overall Study||33
3305026|NCT02985710|4038690|FG000|COMPLETED|Overall Study||65
3305027|NCT02985710|4038691|FG001|COMPLETED|Overall Study||33
3305028|NCT02985710|4038690|FG000|NOT COMPLETED|Overall Study||4
3305029|NCT02985710|4038691|FG001|NOT COMPLETED|Overall Study||0
3305030|NCT02985827|4038699|FG000|STARTED|Overall Study||33
3305031|NCT02985827|4038700|FG001|STARTED|Overall Study||15
3305032|NCT02985827|4038699|FG000|COMPLETED|Overall Study||33
3305033|NCT02985827|4038700|FG001|COMPLETED|Overall Study||15
2991562|NCT00911768|3708082|FG000|NOT COMPLETED|Overall Study||6
2991563|NCT00911768|3708083|FG001|NOT COMPLETED|Overall Study||4
2991564|NCT00911807|3708092|FG000|STARTED|Overall Study||72
2991565|NCT00911807|3708093|FG001|STARTED|Overall Study||70
2991566|NCT00911807|3708094|FG002|STARTED|Overall Study||75
2991567|NCT00911807|3708092|FG000|COMPLETED|Overall Study||55
2991568|NCT00911807|3708093|FG001|COMPLETED|Overall Study||52
2991569|NCT00911807|3708094|FG002|COMPLETED|Overall Study||52
2991570|NCT00911807|3708092|FG000|NOT COMPLETED|Overall Study||17
2991571|NCT00911807|3708093|FG001|NOT COMPLETED|Overall Study||18
2991572|NCT00911807|3708094|FG002|NOT COMPLETED|Overall Study||23
2991573|NCT00911820|3708104|FG000|STARTED|Overall Study||45
2991574|NCT00911820|3708105|FG001|STARTED|Overall Study||43
2991575|NCT00911820|3708104|FG000|Treated|Overall Study|Randomized patients not treated: unable to confirm pathology (n=1)|44
2991576|NCT00911820|3708105|FG001|Treated|Overall Study|Randomized patients not treated: withdrew consent (n=2)|41
2991577|NCT00911820|3708104|FG000|COMPLETED|Overall Study||0
2991578|NCT00911820|3708105|FG001|COMPLETED|Overall Study||0
2991579|NCT00911820|3708104|FG000|NOT COMPLETED|Overall Study||45
2991580|NCT00911820|3708105|FG001|NOT COMPLETED|Overall Study||43
2991581|NCT00911859|3708114|FG000|STARTED|Treatment Period||12
2991582|NCT00911859|3708115|FG001|STARTED|Treatment Period||54
2991583|NCT00911859|3708116|FG002|STARTED|Treatment Period||52
2991584|NCT00911859|3708114|FG000|Received Treatment|Treatment Period||12
2991585|NCT00911859|3708115|FG001|Received Treatment|Treatment Period||53
2991586|NCT00911859|3708116|FG002|Received Treatment|Treatment Period||52
2991587|NCT00911859|3708114|FG000|COMPLETED|Treatment Period||4
2991588|NCT00911859|3708115|FG001|COMPLETED|Treatment Period||33
2991589|NCT00911859|3708116|FG002|COMPLETED|Treatment Period||27
2991590|NCT00911859|3708114|FG000|NOT COMPLETED|Treatment Period||8
3305034|NCT02985827|4038699|FG000|NOT COMPLETED|Overall Study||0
3305035|NCT02985827|4038700|FG001|NOT COMPLETED|Overall Study||0
3305036|NCT02985879|4038709|FG000|STARTED|Overall Study||126
3305037|NCT02985879|4038710|FG001|STARTED|Overall Study||127
3305038|NCT02985879|4038711|FG002|STARTED|Overall Study||125
3305039|NCT02985879|4038709|FG000|COMPLETED|Overall Study||50
3305040|NCT02985879|4038710|FG001|COMPLETED|Overall Study||52
3305041|NCT02985879|4038711|FG002|COMPLETED|Overall Study||48
3305042|NCT02985879|4038709|FG000|NOT COMPLETED|Overall Study||76
3305043|NCT02985879|4038710|FG001|NOT COMPLETED|Overall Study||75
3305044|NCT02985879|4038711|FG002|NOT COMPLETED|Overall Study||77
3305045|NCT02985996|4038730|FG000|STARTED|Overall Study||5
2991591|NCT00911859|3708115|FG001|NOT COMPLETED|Treatment Period||21
2991592|NCT00911859|3708116|FG002|NOT COMPLETED|Treatment Period||25
2991593|NCT00911859|3708114|FG000|STARTED|Maintainance Period||0
2991594|NCT00911859|3708115|FG001|STARTED|Maintainance Period||0
2991595|NCT00911859|3708116|FG002|STARTED|Maintainance Period|Participants who received siltuximab only during the 18-month maintenance period|21
2991596|NCT00911859|3708114|FG000|COMPLETED|Maintainance Period||0
2991597|NCT00911859|3708115|FG001|COMPLETED|Maintainance Period||0
2991598|NCT00911859|3708116|FG002|COMPLETED|Maintainance Period||0
2991599|NCT00911859|3708114|FG000|NOT COMPLETED|Maintainance Period||0
2991600|NCT00911859|3708115|FG001|NOT COMPLETED|Maintainance Period||0
2991601|NCT00911859|3708116|FG002|NOT COMPLETED|Maintainance Period||21
2991602|NCT00911859|3708114|FG000|STARTED|Follow-up Period|Participants followed until death or 3.5 years after the last participant was assigned to treatment|12
2991603|NCT00911859|3708115|FG001|STARTED|Follow-up Period|Participants followed until death or 3.5 years after the last participant was assigned to treatment|53
2991604|NCT00911859|3708116|FG002|STARTED|Follow-up Period|Participants followed until death or 3.5 years after the last participant was assigned to treatment|52
2991605|NCT00911859|3708114|FG000|COMPLETED|Follow-up Period||1
2991606|NCT00911859|3708115|FG001|COMPLETED|Follow-up Period||7
2991607|NCT00911859|3708116|FG002|COMPLETED|Follow-up Period||11
2991608|NCT00911859|3708114|FG000|NOT COMPLETED|Follow-up Period||11
2991609|NCT00911859|3708115|FG001|NOT COMPLETED|Follow-up Period||46
2991610|NCT00911859|3708116|FG002|NOT COMPLETED|Follow-up Period||41
2991611|NCT00911898|3708124|FG000|STARTED|Overall Study||20
2991612|NCT00911898|3708124|FG000|COMPLETED|Overall Study||20
2991613|NCT00911898|3708124|FG000|NOT COMPLETED|Overall Study||0
2991614|NCT00911937|3708130|FG000|STARTED|Overall Study||487
2991615|NCT00911937|3708131|FG001|STARTED|Overall Study||476
2991616|NCT00911937|3708130|FG000|Treated|Overall Study||474
2991617|NCT00911937|3708131|FG001|Treated|Overall Study||463
2991618|NCT00911937|3708130|FG000|COMPLETED|Overall Study||400
2991619|NCT00911937|3708131|FG001|COMPLETED|Overall Study||381
2991620|NCT00911937|3708130|FG000|NOT COMPLETED|Overall Study||87
2991621|NCT00911937|3708131|FG001|NOT COMPLETED|Overall Study||95
2991622|NCT00911989|3708137|FG000|STARTED|Overall Study||4
2991623|NCT00911989|3708137|FG000|COMPLETED|Overall Study||3
2991624|NCT00911989|3708137|FG000|NOT COMPLETED|Overall Study||1
2991625|NCT00912002|3708141|FG000|STARTED|Overall Study||6
2991626|NCT00912002|3708141|FG000|COMPLETED|Overall Study||6
2991627|NCT00912002|3708141|FG000|NOT COMPLETED|Overall Study||0
2991628|NCT00912015|3708150|FG000|STARTED|Overall Study|Dose at which a patient spent the longest time.|141
2991629|NCT00912015|3708151|FG001|STARTED|Overall Study|Dose at which a patient spent the longest time.|70
2991630|NCT00912015|3708152|FG002|STARTED|Overall Study|Dose at which a patient spent the longest time.|25
2991631|NCT00912015|3708153|FG003|STARTED|Overall Study|Two patients took 100 mg against instructions in protocol that the minimum daily dose was 200 mg.|2
2991632|NCT00912015|3708150|FG000|COMPLETED|Overall Study||125
2991633|NCT00912015|3708151|FG001|COMPLETED|Overall Study||62
2991634|NCT00912015|3708152|FG002|COMPLETED|Overall Study||22
2991635|NCT00912015|3708153|FG003|COMPLETED|Overall Study||0
2991636|NCT00912015|3708150|FG000|NOT COMPLETED|Overall Study||16
2991637|NCT00912015|3708151|FG001|NOT COMPLETED|Overall Study||8
2991638|NCT00912015|3708152|FG002|NOT COMPLETED|Overall Study||3
3133573|NCT01696279|3858511|FG003|Safety Completer Set|Part 2b: Lanthanum Carbonate (8 Weeks)||0
3133574|NCT01696279|3858508|FG000|Full Analysis Set|Part 2b: Lanthanum Carbonate (8 Weeks)||0
3133575|NCT01696279|3858509|FG001|Full Analysis Set|Part 2b: Lanthanum Carbonate (8 Weeks)||0
3133576|NCT01696279|3858510|FG002|Full Analysis Set|Part 2b: Lanthanum Carbonate (8 Weeks)||9
3133577|NCT01696279|3858511|FG003|Full Analysis Set|Part 2b: Lanthanum Carbonate (8 Weeks)||0
3133578|NCT01696279|3858508|FG000|Per-protocol Set 1|Part 2b: Lanthanum Carbonate (8 Weeks)||0
3133579|NCT01696279|3858509|FG001|Per-protocol Set 1|Part 2b: Lanthanum Carbonate (8 Weeks)||0
3133580|NCT01696279|3858510|FG002|Per-protocol Set 1|Part 2b: Lanthanum Carbonate (8 Weeks)||0
3133581|NCT01696279|3858511|FG003|Per-protocol Set 1|Part 2b: Lanthanum Carbonate (8 Weeks)||0
3133582|NCT01696279|3858508|FG000|Per-protocol Set 2|Part 2b: Lanthanum Carbonate (8 Weeks)||0
3133583|NCT01696279|3858509|FG001|Per-protocol Set 2|Part 2b: Lanthanum Carbonate (8 Weeks)||0
3133584|NCT01696279|3858510|FG002|Per-protocol Set 2|Part 2b: Lanthanum Carbonate (8 Weeks)||9
3133585|NCT01696279|3858511|FG003|Per-protocol Set 2|Part 2b: Lanthanum Carbonate (8 Weeks)||0
3133586|NCT01696279|3858508|FG000|COMPLETED|Part 2b: Lanthanum Carbonate (8 Weeks)||0
3133587|NCT01696279|3858509|FG001|COMPLETED|Part 2b: Lanthanum Carbonate (8 Weeks)||0
3133588|NCT01696279|3858510|FG002|COMPLETED|Part 2b: Lanthanum Carbonate (8 Weeks)||8
3133589|NCT01696279|3858511|FG003|COMPLETED|Part 2b: Lanthanum Carbonate (8 Weeks)||0
3133590|NCT01696279|3858508|FG000|NOT COMPLETED|Part 2b: Lanthanum Carbonate (8 Weeks)||0
3133591|NCT01696279|3858509|FG001|NOT COMPLETED|Part 2b: Lanthanum Carbonate (8 Weeks)||0
3133592|NCT01696279|3858510|FG002|NOT COMPLETED|Part 2b: Lanthanum Carbonate (8 Weeks)||1
2991639|NCT00912015|3708153|FG003|NOT COMPLETED|Overall Study||2
2991640|NCT00912028|3708166|FG000|STARTED|Overall Study||35
2991641|NCT00912028|3708167|FG001|STARTED|Overall Study||3
2991642|NCT00912028|3708168|FG002|STARTED|Overall Study||13
2991643|NCT00912028|3708169|FG003|STARTED|Overall Study||17
3133593|NCT01696279|3858511|FG003|NOT COMPLETED|Part 2b: Lanthanum Carbonate (8 Weeks)||0
3133594|NCT01696279|3858508|FG000|STARTED|Part 3: Lanthanum Carbonate (6 Months)||0
3133595|NCT01696279|3858509|FG001|STARTED|Part 3: Lanthanum Carbonate (6 Months)||0
3133596|NCT01696279|3858510|FG002|STARTED|Part 3: Lanthanum Carbonate (6 Months)||0
2991644|NCT00912028|3708170|FG004|STARTED|Overall Study||3
2991645|NCT00912028|3708166|FG000|COMPLETED|Overall Study||30
2991646|NCT00912028|3708167|FG001|COMPLETED|Overall Study||0
2991647|NCT00912028|3708168|FG002|COMPLETED|Overall Study||13
2991648|NCT00912028|3708169|FG003|COMPLETED|Overall Study||16
2991649|NCT00912028|3708170|FG004|COMPLETED|Overall Study||0
2991650|NCT00912028|3708166|FG000|NOT COMPLETED|Overall Study||5
2991651|NCT00912028|3708167|FG001|NOT COMPLETED|Overall Study||3
2991652|NCT00912028|3708168|FG002|NOT COMPLETED|Overall Study||0
2991653|NCT00912028|3708169|FG003|NOT COMPLETED|Overall Study||1
2991654|NCT00912028|3708170|FG004|NOT COMPLETED|Overall Study||3
2991655|NCT00912093|3708185|FG000|STARTED|The Controlled Phase||43
2991656|NCT00912093|3708186|FG001|STARTED|The Controlled Phase||45
2991657|NCT00912093|3708187|FG002|STARTED|The Controlled Phase||3
2991658|NCT00912093|3708188|FG003|STARTED|The Controlled Phase||2
2991659|NCT00912093|3708189|FG004|STARTED|The Controlled Phase||5
2991660|NCT00912093|3708185|FG000|COMPLETED|The Controlled Phase||43
2991661|NCT00912093|3708186|FG001|COMPLETED|The Controlled Phase||43
2991662|NCT00912093|3708187|FG002|COMPLETED|The Controlled Phase||3
2991663|NCT00912093|3708188|FG003|COMPLETED|The Controlled Phase||2
2991664|NCT00912093|3708189|FG004|COMPLETED|The Controlled Phase||4
2991665|NCT00912093|3708185|FG000|NOT COMPLETED|The Controlled Phase||0
2991666|NCT00912093|3708186|FG001|NOT COMPLETED|The Controlled Phase||2
2991667|NCT00912093|3708187|FG002|NOT COMPLETED|The Controlled Phase||0
2991668|NCT00912093|3708188|FG003|NOT COMPLETED|The Controlled Phase||0
2991669|NCT00912093|3708189|FG004|NOT COMPLETED|The Controlled Phase||1
2991670|NCT00912093|3708185|FG000|STARTED|The Open Label Extension (OLE) Phase||38
2991671|NCT00912093|3708186|FG001|STARTED|The Open Label Extension (OLE) Phase||35
2991672|NCT00912093|3708187|FG002|STARTED|The Open Label Extension (OLE) Phase||3
2991673|NCT00912093|3708188|FG003|STARTED|The Open Label Extension (OLE) Phase||2
2991674|NCT00912093|3708189|FG004|STARTED|The Open Label Extension (OLE) Phase||4
2991675|NCT00912093|3708185|FG000|COMPLETED|The Open Label Extension (OLE) Phase||38
2991676|NCT00912093|3708186|FG001|COMPLETED|The Open Label Extension (OLE) Phase||35
2991677|NCT00912093|3708187|FG002|COMPLETED|The Open Label Extension (OLE) Phase||3
2991678|NCT00912093|3708188|FG003|COMPLETED|The Open Label Extension (OLE) Phase||2
2991679|NCT00912093|3708189|FG004|COMPLETED|The Open Label Extension (OLE) Phase||4
2991680|NCT00912093|3708185|FG000|NOT COMPLETED|The Open Label Extension (OLE) Phase||0
2991681|NCT00912093|3708186|FG001|NOT COMPLETED|The Open Label Extension (OLE) Phase||0
2991682|NCT00912093|3708187|FG002|NOT COMPLETED|The Open Label Extension (OLE) Phase||0
2991683|NCT00912093|3708188|FG003|NOT COMPLETED|The Open Label Extension (OLE) Phase||0
2991684|NCT00912093|3708189|FG004|NOT COMPLETED|The Open Label Extension (OLE) Phase||0
2991685|NCT00912197|3708199|FG000|STARTED|Overall Study||15
2991686|NCT00912197|3708200|FG001|STARTED|Overall Study||13
2991687|NCT00912197|3708199|FG000|COMPLETED|Overall Study||12
2991688|NCT00912197|3708200|FG001|COMPLETED|Overall Study||10
2991689|NCT00912197|3708199|FG000|NOT COMPLETED|Overall Study||3
3133597|NCT01696279|3858511|FG003|STARTED|Part 3: Lanthanum Carbonate (6 Months)|34 participants from Part 2a and 8 participants from Part 2b continued to Part 3|42
3133598|NCT01696279|3858508|FG000|COMPLETED|Part 3: Lanthanum Carbonate (6 Months)||0
3133599|NCT01696279|3858509|FG001|COMPLETED|Part 3: Lanthanum Carbonate (6 Months)||0
3133600|NCT01696279|3858510|FG002|COMPLETED|Part 3: Lanthanum Carbonate (6 Months)||0
3133601|NCT01696279|3858511|FG003|COMPLETED|Part 3: Lanthanum Carbonate (6 Months)||34
3133602|NCT01696279|3858508|FG000|NOT COMPLETED|Part 3: Lanthanum Carbonate (6 Months)||0
2991690|NCT00912197|3708200|FG001|NOT COMPLETED|Overall Study||3
2991691|NCT00912288|3708210|FG000|STARTED|Overall Study||44
2991692|NCT00912288|3708211|FG001|STARTED|Overall Study||42
2991693|NCT00912288|3708210|FG000|COMPLETED|Overall Study||3
2991694|NCT00912288|3708211|FG001|COMPLETED|Overall Study||2
2991695|NCT00912288|3708210|FG000|NOT COMPLETED|Overall Study||41
2991696|NCT00912288|3708211|FG001|NOT COMPLETED|Overall Study||40
2991697|NCT00912301|3708220|FG000|STARTED|Overall Study||11
2991698|NCT00912301|3708221|FG001|STARTED|Overall Study||12
2991699|NCT00912301|3708222|FG002|STARTED|Overall Study||13
2991700|NCT00912301|3708220|FG000|COMPLETED|Overall Study||11
2991701|NCT00912301|3708221|FG001|COMPLETED|Overall Study||12
2991702|NCT00912301|3708222|FG002|COMPLETED|Overall Study||13
2991703|NCT00912301|3708220|FG000|NOT COMPLETED|Overall Study||0
2991704|NCT00912301|3708221|FG001|NOT COMPLETED|Overall Study||0
2991705|NCT00912301|3708222|FG002|NOT COMPLETED|Overall Study||0
2991706|NCT00912340|3708233|FG000|STARTED|Overall Study||24
3133603|NCT01696279|3858509|FG001|NOT COMPLETED|Part 3: Lanthanum Carbonate (6 Months)||0
3133604|NCT01696279|3858510|FG002|NOT COMPLETED|Part 3: Lanthanum Carbonate (6 Months)||0
3133605|NCT01696279|3858511|FG003|NOT COMPLETED|Part 3: Lanthanum Carbonate (6 Months)||8
3133606|NCT01696357|3858522|FG000|STARTED|Overall Study||42
3133607|NCT01696357|3858523|FG001|STARTED|Overall Study||42
3133608|NCT01696357|3858522|FG000|COMPLETED|Overall Study||40
3133609|NCT01696357|3858523|FG001|COMPLETED|Overall Study||41
3133610|NCT01696357|3858522|FG000|NOT COMPLETED|Overall Study||2
2991707|NCT00912340|3708234|FG001|STARTED|Overall Study||30
2991708|NCT00912340|3708235|FG002|STARTED|Overall Study||4
2991709|NCT00912340|3708233|FG000|COMPLETED|Overall Study||22
2991710|NCT00912340|3708234|FG001|COMPLETED|Overall Study||26
2991711|NCT00912340|3708235|FG002|COMPLETED|Overall Study||0
2991712|NCT00912340|3708233|FG000|NOT COMPLETED|Overall Study||2
2991713|NCT00912340|3708234|FG001|NOT COMPLETED|Overall Study||4
2991714|NCT00912340|3708235|FG002|NOT COMPLETED|Overall Study||4
2991715|NCT00912405|3708243|FG000|STARTED|Overall Study||50
2991716|NCT00912405|3708243|FG000|COMPLETED|Overall Study||45
2991717|NCT00912405|3708243|FG000|NOT COMPLETED|Overall Study||5
2991718|NCT00912509|3708249|FG000|STARTED|Overall Study||20
2991719|NCT00912509|3708250|FG001|STARTED|Overall Study||10
2991720|NCT00912509|3708249|FG000|COMPLETED|Overall Study||15
2991721|NCT00912509|3708250|FG001|COMPLETED|Overall Study||7
2991722|NCT00912509|3708249|FG000|NOT COMPLETED|Overall Study||5
2991723|NCT00912509|3708250|FG001|NOT COMPLETED|Overall Study||3
2991724|NCT00912743|3708259|FG000|STARTED|Overall Study||13
2991725|NCT00912743|3708260|FG001|STARTED|Overall Study||20
2991726|NCT00912743|3708259|FG000|COMPLETED|Overall Study||0
2991727|NCT00912743|3708260|FG001|COMPLETED|Overall Study||0
2991728|NCT00912743|3708259|FG000|NOT COMPLETED|Overall Study||13
2991729|NCT00912743|3708260|FG001|NOT COMPLETED|Overall Study||20
2991730|NCT00912782|3708268|FG000|STARTED|Overall Study||27
2991731|NCT00912782|3708269|FG001|STARTED|Overall Study||25
2991732|NCT00912782|3708268|FG000|COMPLETED|Overall Study||24
2991733|NCT00912782|3708269|FG001|COMPLETED|Overall Study||20
2991734|NCT00912782|3708268|FG000|NOT COMPLETED|Overall Study||3
2991735|NCT00912782|3708269|FG001|NOT COMPLETED|Overall Study||5
2991736|NCT00912795|3708277|FG000|STARTED|Overall Study||76
2991737|NCT00912795|3708278|FG001|STARTED|Overall Study||75
2991738|NCT00912795|3708277|FG000|COMPLETED|Overall Study||29
2991739|NCT00912795|3708278|FG001|COMPLETED|Overall Study||17
2991740|NCT00912795|3708277|FG000|NOT COMPLETED|Overall Study||47
2991741|NCT00912795|3708278|FG001|NOT COMPLETED|Overall Study||58
2991742|NCT00912808|3708286|FG000|STARTED|First Intervention (6 Weeks)||11
2991743|NCT00912808|3708287|FG001|STARTED|First Intervention (6 Weeks)||12
2991744|NCT00912808|3708286|FG000|Received Intervention|First Intervention (6 Weeks)||11
2991745|NCT00912808|3708287|FG001|Received Intervention|First Intervention (6 Weeks)||12
2991746|NCT00912808|3708286|FG000|COMPLETED|First Intervention (6 Weeks)||9
2991747|NCT00912808|3708287|FG001|COMPLETED|First Intervention (6 Weeks)||11
2991748|NCT00912808|3708286|FG000|NOT COMPLETED|First Intervention (6 Weeks)||2
2991749|NCT00912808|3708287|FG001|NOT COMPLETED|First Intervention (6 Weeks)||1
2991750|NCT00912808|3708286|FG000|STARTED|Washout||9
2991751|NCT00912808|3708287|FG001|STARTED|Washout||11
2991752|NCT00912808|3708286|FG000|COMPLETED|Washout||9
2991753|NCT00912808|3708287|FG001|COMPLETED|Washout||10
2991754|NCT00912808|3708286|FG000|NOT COMPLETED|Washout||0
2991755|NCT00912808|3708287|FG001|NOT COMPLETED|Washout||1
2991756|NCT00912808|3708286|FG000|STARTED|Second Intervention (6 Weeks)||9
2991757|NCT00912808|3708287|FG001|STARTED|Second Intervention (6 Weeks)||10
2991758|NCT00912808|3708286|FG000|Received Intervention|Second Intervention (6 Weeks)||9
2991759|NCT00912808|3708287|FG001|Received Intervention|Second Intervention (6 Weeks)||10
2991760|NCT00912808|3708286|FG000|COMPLETED|Second Intervention (6 Weeks)||8
2991761|NCT00912808|3708287|FG001|COMPLETED|Second Intervention (6 Weeks)||9
2991762|NCT00912808|3708286|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||1
2991763|NCT00912808|3708287|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||1
2991764|NCT00912873|3708296|FG000|STARTED|Overall Study||26
2991765|NCT00912873|3708297|FG001|STARTED|Overall Study||24
2991766|NCT00912873|3708296|FG000|COMPLETED|Overall Study||26
2991767|NCT00912873|3708297|FG001|COMPLETED|Overall Study||24
2991768|NCT00912873|3708296|FG000|NOT COMPLETED|Overall Study||0
2991769|NCT00912873|3708297|FG001|NOT COMPLETED|Overall Study||0
2991770|NCT00912912|3708307|FG000|STARTED|Overall Study||5
2991771|NCT00912912|3708307|FG000|COMPLETED|Overall Study||1
2991772|NCT00912912|3708307|FG000|NOT COMPLETED|Overall Study||4
2991773|NCT00912925|3708313|FG000|STARTED|Overall Study||23
2991774|NCT00912925|3708314|FG001|STARTED|Overall Study||22
2991775|NCT00912925|3708313|FG000|COMPLETED|Overall Study||23
2991776|NCT00912925|3708314|FG001|COMPLETED|Overall Study||22
2991777|NCT00912925|3708313|FG000|NOT COMPLETED|Overall Study||0
2991778|NCT00912925|3708314|FG001|NOT COMPLETED|Overall Study||0
3164527|NCT01893346|3891911|FG000|Patients Who Received Full Infusion|Overall Study||8
3164528|NCT01893346|3891912|FG001|Patients Who Received Full Infusion|Overall Study||8
3164529|NCT01893346|3891913|FG002|Patients Who Received Full Infusion|Overall Study||8
3164530|NCT01893346|3891914|FG003|Patients Who Received Full Infusion|Overall Study||8
3164531|NCT01893346|3891911|FG000|COMPLETED|Overall Study||8
3164532|NCT01893346|3891912|FG001|COMPLETED|Overall Study||7
3164533|NCT01893346|3891913|FG002|COMPLETED|Overall Study||8
3164534|NCT01893346|3891914|FG003|COMPLETED|Overall Study||8
3164535|NCT01893346|3891911|FG000|NOT COMPLETED|Overall Study||3
3164536|NCT01893346|3891912|FG001|NOT COMPLETED|Overall Study||1
3164537|NCT01893346|3891913|FG002|NOT COMPLETED|Overall Study||0
3164538|NCT01893346|3891914|FG003|NOT COMPLETED|Overall Study||0
3164539|NCT01893372|3891926|FG000|STARTED|Overall Study||7
3164540|NCT01893372|3891927|FG001|STARTED|Overall Study||22
2991779|NCT00912964|3708323|FG000|STARTED|Overall Study||433
2991780|NCT00912964|3708324|FG001|STARTED|Overall Study||433
2991781|NCT00912964|3708325|FG002|STARTED|Overall Study||440
2991782|NCT00912964|3708323|FG000|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|433
2991783|NCT00912964|3708324|FG001|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|432
2991784|NCT00912964|3708325|FG002|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|440
3036807|NCT01145066|3756061|FG002|NOT COMPLETED|Overall Study||4
2991785|NCT00912964|3708323|FG000|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 post-baseline micturition measurement.|415
2991786|NCT00912964|3708324|FG001|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 post-baseline micturition measurement.|410
2991787|NCT00912964|3708325|FG002|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 post-baseline micturition measurement.|426
2991788|NCT00912964|3708323|FG000|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at Baseline.|262
2991789|NCT00912964|3708324|FG001|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at Baseline.|254
2991790|NCT00912964|3708325|FG002|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at Baseline.|257
2991791|NCT00912964|3708323|FG000|COMPLETED|Overall Study||367
2991792|NCT00912964|3708324|FG001|COMPLETED|Overall Study||387
2991793|NCT00912964|3708325|FG002|COMPLETED|Overall Study||386
2991794|NCT00912964|3708323|FG000|NOT COMPLETED|Overall Study||66
2991795|NCT00912964|3708324|FG001|NOT COMPLETED|Overall Study||46
2991796|NCT00912964|3708325|FG002|NOT COMPLETED|Overall Study||54
2991797|NCT00912990|3708335|FG000|STARTED|Overall Study||16
2991798|NCT00912990|3708336|FG001|STARTED|Overall Study||18
2991799|NCT00912990|3708335|FG000|COMPLETED|Overall Study||16
2991800|NCT00912990|3708336|FG001|COMPLETED|Overall Study||18
2991801|NCT00912990|3708335|FG000|NOT COMPLETED|Overall Study||0
2991802|NCT00912990|3708336|FG001|NOT COMPLETED|Overall Study||0
2991803|NCT00913003|3708344|FG000|STARTED|Overall Study||11
2991804|NCT00913003|3708345|FG001|STARTED|Overall Study||11
2991805|NCT00913003|3708344|FG000|COMPLETED|Overall Study||11
2991806|NCT00913003|3708345|FG001|COMPLETED|Overall Study||11
2991807|NCT00913003|3708344|FG000|NOT COMPLETED|Overall Study||0
2991808|NCT00913003|3708345|FG001|NOT COMPLETED|Overall Study||0
2991809|NCT00913068|3708353|FG000|STARTED|Overall Study||56
2991810|NCT00913068|3708354|FG001|STARTED|Overall Study||54
2991811|NCT00913068|3708353|FG000|COMPLETED|Overall Study||48
2991812|NCT00913068|3708354|FG001|COMPLETED|Overall Study||46
2991813|NCT00913068|3708353|FG000|NOT COMPLETED|Overall Study||8
2991814|NCT00913068|3708354|FG001|NOT COMPLETED|Overall Study||8
2991815|NCT00913081|3708360|FG000|STARTED|Quercetin 500 mg + Niacin 500 mg (1day)||17
2991816|NCT00913081|3708360|FG000|COMPLETED|Quercetin 500 mg + Niacin 500 mg (1day)||17
2991817|NCT00913081|3708360|FG000|NOT COMPLETED|Quercetin 500 mg + Niacin 500 mg (1day)||0
2991818|NCT00913081|3708360|FG000|STARTED|Washout #1 (7 Days)||17
2991819|NCT00913081|3708360|FG000|COMPLETED|Washout #1 (7 Days)||17
2991820|NCT00913081|3708360|FG000|NOT COMPLETED|Washout #1 (7 Days)||0
2991821|NCT00913081|3708360|FG000|STARTED|Quercetin 1000 mg + Niacin 500 mg (1day)||17
2991822|NCT00913081|3708360|FG000|COMPLETED|Quercetin 1000 mg + Niacin 500 mg (1day)||17
2991823|NCT00913081|3708360|FG000|NOT COMPLETED|Quercetin 1000 mg + Niacin 500 mg (1day)||0
2991824|NCT00913081|3708360|FG000|STARTED|Washout #2 (7 Days)||17
2991825|NCT00913081|3708360|FG000|COMPLETED|Washout #2 (7 Days)||17
2991826|NCT00913081|3708360|FG000|NOT COMPLETED|Washout #2 (7 Days)||0
2991827|NCT00913081|3708360|FG000|STARTED|Quercetin 2000 mg + Niacin 500 mg (1day)||17
2991828|NCT00913081|3708360|FG000|COMPLETED|Quercetin 2000 mg + Niacin 500 mg (1day)||17
2991829|NCT00913081|3708360|FG000|NOT COMPLETED|Quercetin 2000 mg + Niacin 500 mg (1day)||0
2991830|NCT00913081|3708360|FG000|STARTED|Washout #3 (7days)||17
2991831|NCT00913081|3708360|FG000|COMPLETED|Washout #3 (7days)||17
2991832|NCT00913081|3708360|FG000|NOT COMPLETED|Washout #3 (7days)||0
2991833|NCT00913081|3708360|FG000|STARTED|Placebo + Niacin 500 mg (1day)||17
2991834|NCT00913081|3708360|FG000|COMPLETED|Placebo + Niacin 500 mg (1day)||17
2991835|NCT00913081|3708360|FG000|NOT COMPLETED|Placebo + Niacin 500 mg (1day)||0
2991836|NCT00913133|3708370|FG000|STARTED|Overall Study||516
2991837|NCT00913133|3708370|FG000|COMPLETED|Overall Study||516
2991838|NCT00913133|3708370|FG000|NOT COMPLETED|Overall Study||0
2991839|NCT00913263|3708374|FG000|STARTED|Overall Study||24
2991840|NCT00913263|3708374|FG000|COMPLETED|Overall Study||24
2991841|NCT00913263|3708374|FG000|NOT COMPLETED|Overall Study||0
2991842|NCT00913380|3708384|FG000|STARTED|CT Examination||444
2991843|NCT00913380|3708385|FG001|STARTED|CT Examination||447
2991844|NCT00913380|3708384|FG000|COMPLETED|CT Examination||444
2991845|NCT00913380|3708385|FG001|COMPLETED|CT Examination||447
2991846|NCT00913380|3708384|FG000|NOT COMPLETED|CT Examination||0
2991847|NCT00913380|3708385|FG001|NOT COMPLETED|CT Examination||0
2991848|NCT00913380|3708384|FG000|STARTED|Clinical Outcomes||444
2991849|NCT00913380|3708385|FG001|STARTED|Clinical Outcomes||447
2991850|NCT00913380|3708384|FG000|COMPLETED|Clinical Outcomes||438
2991851|NCT00913380|3708385|FG001|COMPLETED|Clinical Outcomes||441
2991852|NCT00913380|3708384|FG000|NOT COMPLETED|Clinical Outcomes||6
2991853|NCT00913380|3708385|FG001|NOT COMPLETED|Clinical Outcomes||6
2991854|NCT00913458|3708391|FG000|STARTED|Phase 1||306
2991855|NCT00913458|3708392|FG001|STARTED|Phase 1|This arm is part of Phase 2 study|0
2991856|NCT00913458|3708393|FG002|STARTED|Phase 1|This arm is part of Phase 2 study|0
2991857|NCT00913458|3708394|FG003|STARTED|Phase 1|This arm is part of Phase 2 study|0
2991858|NCT00913458|3708395|FG004|STARTED|Phase 1|This arm is part of Phase 3 study|0
2991859|NCT00913458|3708396|FG005|STARTED|Phase 1|This arm is part of Phase 3 study|0
2991860|NCT00913458|3708397|FG006|STARTED|Phase 1|This arm is part of Phase 3 study|0
2991861|NCT00913458|3708391|FG000|COMPLETED|Phase 1|194 continued to Phase 2 but 1 was randomized in error leaving 193 in the phase 2 analysis.|194
2991862|NCT00913458|3708392|FG001|COMPLETED|Phase 1|This arm is part of Phase 2 study|0
3133611|NCT01696357|3858523|FG001|NOT COMPLETED|Overall Study||1
2991863|NCT00913458|3708393|FG002|COMPLETED|Phase 1|This arm is part of Phase 2 study|0
2991864|NCT00913458|3708394|FG003|COMPLETED|Phase 1|This arm is part of Phase 2 study|0
2991865|NCT00913458|3708395|FG004|COMPLETED|Phase 1|This arm is part of Phase 3 study|0
2991866|NCT00913458|3708396|FG005|COMPLETED|Phase 1|This arm is part of Phase 3 study|0
2991867|NCT00913458|3708397|FG006|COMPLETED|Phase 1|This arm is part of Phase 3 study|0
2991868|NCT00913458|3708391|FG000|NOT COMPLETED|Phase 1||112
2991869|NCT00913458|3708392|FG001|NOT COMPLETED|Phase 1||0
2991870|NCT00913458|3708393|FG002|NOT COMPLETED|Phase 1||0
2991871|NCT00913458|3708394|FG003|NOT COMPLETED|Phase 1||0
2991872|NCT00913458|3708395|FG004|NOT COMPLETED|Phase 1||0
2991873|NCT00913458|3708396|FG005|NOT COMPLETED|Phase 1||0
2991874|NCT00913458|3708397|FG006|NOT COMPLETED|Phase 1||0
2991875|NCT00913458|3708391|FG000|STARTED|Phase 2|This arm is part of Phase 1 of the study.|0
2991876|NCT00913458|3708392|FG001|STARTED|Phase 2||63
2991877|NCT00913458|3708393|FG002|STARTED|Phase 2||65
2991878|NCT00913458|3708394|FG003|STARTED|Phase 2||65
2991879|NCT00913458|3708395|FG004|STARTED|Phase 2||0
2991880|NCT00913458|3708396|FG005|STARTED|Phase 2||0
2991881|NCT00913458|3708397|FG006|STARTED|Phase 2||0
2991882|NCT00913458|3708391|FG000|COMPLETED|Phase 2|This arm is part of Phase 1 of the study.|0
2991883|NCT00913458|3708392|FG001|COMPLETED|Phase 2|Participants randomized into Phase 3 of study.|53
2991884|NCT00913458|3708393|FG002|COMPLETED|Phase 2|Participants randomized into Phase 3 of study.|46
2991885|NCT00913458|3708394|FG003|COMPLETED|Phase 2|Participants randomized into Phase 3 of study.|32
2991886|NCT00913458|3708395|FG004|COMPLETED|Phase 2||0
2991887|NCT00913458|3708396|FG005|COMPLETED|Phase 2||0
2991888|NCT00913458|3708397|FG006|COMPLETED|Phase 2||0
2991889|NCT00913458|3708391|FG000|NOT COMPLETED|Phase 2||0
2991890|NCT00913458|3708392|FG001|NOT COMPLETED|Phase 2||10
2991891|NCT00913458|3708393|FG002|NOT COMPLETED|Phase 2||19
2991892|NCT00913458|3708394|FG003|NOT COMPLETED|Phase 2||33
2991893|NCT00913458|3708395|FG004|NOT COMPLETED|Phase 2||0
2991894|NCT00913458|3708396|FG005|NOT COMPLETED|Phase 2||0
2991895|NCT00913458|3708397|FG006|NOT COMPLETED|Phase 2||0
2991896|NCT00913458|3708391|FG000|STARTED|Phase 3|This arm is part of Phase 1 of the study.|0
2991897|NCT00913458|3708392|FG001|STARTED|Phase 3||0
2991898|NCT00913458|3708393|FG002|STARTED|Phase 3||0
2991899|NCT00913458|3708394|FG003|STARTED|Phase 3||0
2991900|NCT00913458|3708395|FG004|STARTED|Phase 3|Participants who completed Phase 2 study|53
2991901|NCT00913458|3708396|FG005|STARTED|Phase 3|Participants who completed Phase 2 study|46
2991902|NCT00913458|3708397|FG006|STARTED|Phase 3|Participants who completed Phase 2 study|32
2991903|NCT00913458|3708391|FG000|COMPLETED|Phase 3|This arm is part of Phase 1 of the study.|0
2991904|NCT00913458|3708392|FG001|COMPLETED|Phase 3||0
2991905|NCT00913458|3708393|FG002|COMPLETED|Phase 3||0
2991906|NCT00913458|3708394|FG003|COMPLETED|Phase 3||0
2991907|NCT00913458|3708395|FG004|COMPLETED|Phase 3||31
2991908|NCT00913458|3708396|FG005|COMPLETED|Phase 3||28
2991909|NCT00913458|3708397|FG006|COMPLETED|Phase 3||24
2991910|NCT00913458|3708391|FG000|NOT COMPLETED|Phase 3||0
2991911|NCT00913458|3708392|FG001|NOT COMPLETED|Phase 3||0
2991912|NCT00913458|3708393|FG002|NOT COMPLETED|Phase 3||0
2991913|NCT00913458|3708394|FG003|NOT COMPLETED|Phase 3||0
2991914|NCT00913458|3708395|FG004|NOT COMPLETED|Phase 3||22
2991915|NCT00913458|3708396|FG005|NOT COMPLETED|Phase 3||18
2991916|NCT00913458|3708397|FG006|NOT COMPLETED|Phase 3||8
2991917|NCT00913510|3708416|FG000|STARTED|Overall Study||13
2991918|NCT00913510|3708417|FG001|STARTED|Overall Study||7
2991919|NCT00913510|3708416|FG000|COMPLETED|Overall Study||5
2991920|NCT00913510|3708417|FG001|COMPLETED|Overall Study||3
2991921|NCT00913510|3708416|FG000|NOT COMPLETED|Overall Study||8
2991922|NCT00913510|3708417|FG001|NOT COMPLETED|Overall Study||4
3133612|NCT01696396|3858533|FG000|STARTED|Overall Study||100
3133613|NCT01696396|3858534|FG001|STARTED|Overall Study||27
2991923|NCT00913523|3708426|FG000|STARTED|Overall Study||162
2991924|NCT00913523|3708427|FG001|STARTED|Overall Study||159
2991925|NCT00913523|3708428|FG002|STARTED|Overall Study||161
2991926|NCT00913523|3708426|FG000|COMPLETED|Overall Study||144
2991927|NCT00913523|3708427|FG001|COMPLETED|Overall Study||143
2991928|NCT00913523|3708428|FG002|COMPLETED|Overall Study||147
2991929|NCT00913523|3708426|FG000|NOT COMPLETED|Overall Study||18
2991930|NCT00913523|3708427|FG001|NOT COMPLETED|Overall Study||16
2991931|NCT00913523|3708428|FG002|NOT COMPLETED|Overall Study||14
2991932|NCT00913627|3708440|FG000|STARTED|Overall Study||29
2991933|NCT00913627|3708441|FG001|STARTED|Overall Study||53
2991934|NCT00913627|3708442|FG002|STARTED|Overall Study||56
2991935|NCT00913627|3708443|FG003|STARTED|Overall Study||58
2991936|NCT00913627|3708440|FG000|COMPLETED|Overall Study||29
2991937|NCT00913627|3708441|FG001|COMPLETED|Overall Study||53
2991938|NCT00913627|3708442|FG002|COMPLETED|Overall Study||56
2991939|NCT00913627|3708443|FG003|COMPLETED|Overall Study||58
2991940|NCT00913627|3708440|FG000|NOT COMPLETED|Overall Study||0
2991941|NCT00913627|3708441|FG001|NOT COMPLETED|Overall Study||0
2991942|NCT00913627|3708442|FG002|NOT COMPLETED|Overall Study||0
2991943|NCT00913627|3708443|FG003|NOT COMPLETED|Overall Study||0
2991944|NCT00913744|3708455|FG000|STARTED|Overall Study||75
2991945|NCT00913744|3708456|FG001|STARTED|Overall Study||25
2991946|NCT00913744|3708455|FG000|COMPLETED|Overall Study||70
2991947|NCT00913744|3708456|FG001|COMPLETED|Overall Study||24
2991948|NCT00913744|3708455|FG000|NOT COMPLETED|Overall Study||5
2991949|NCT00913744|3708456|FG001|NOT COMPLETED|Overall Study||1
2991950|NCT00913770|3708465|FG000|STARTED|Overall Study||104
3133614|NCT01696396|3858535|FG002|STARTED|Overall Study||85
2991951|NCT00913770|3708466|FG001|STARTED|Overall Study||111
2991952|NCT00913770|3708467|FG002|STARTED|Overall Study||114
2991953|NCT00913770|3708465|FG000|COMPLETED|Overall Study||69
2991954|NCT00913770|3708466|FG001|COMPLETED|Overall Study||82
2991955|NCT00913770|3708467|FG002|COMPLETED|Overall Study||93
2991956|NCT00913770|3708465|FG000|NOT COMPLETED|Overall Study||35
2991957|NCT00913770|3708466|FG001|NOT COMPLETED|Overall Study||29
2991958|NCT00913770|3708467|FG002|NOT COMPLETED|Overall Study||21
2991959|NCT00913835|3708477|FG000|STARTED|Olara+Lip Dox and Lip Dox Monotherapy||63
2991960|NCT00913835|3708478|FG001|STARTED|Olara+Lip Dox and Lip Dox Monotherapy||62
2991961|NCT00913835|3708477|FG000|Received Any Study Drug|Olara+Lip Dox and Lip Dox Monotherapy||62
2991962|NCT00913835|3708478|FG001|Received Any Study Drug|Olara+Lip Dox and Lip Dox Monotherapy||61
2991963|NCT00913835|3708477|FG000|COMPLETED|Olara+Lip Dox and Lip Dox Monotherapy||55
2991964|NCT00913835|3708478|FG001|COMPLETED|Olara+Lip Dox and Lip Dox Monotherapy||55
2991965|NCT00913835|3708477|FG000|NOT COMPLETED|Olara+Lip Dox and Lip Dox Monotherapy||8
2991966|NCT00913835|3708478|FG001|NOT COMPLETED|Olara+Lip Dox and Lip Dox Monotherapy||7
2991967|NCT00913835|3708477|FG000|STARTED|Lip Dox: Olaratumab Monotherapy||0
2991968|NCT00913835|3708478|FG001|STARTED|Lip Dox: Olaratumab Monotherapy||28
2991969|NCT00913835|3708477|FG000|Received at Least 1 Dose of Study Drug|Lip Dox: Olaratumab Monotherapy||0
2991970|NCT00913835|3708478|FG001|Received at Least 1 Dose of Study Drug|Lip Dox: Olaratumab Monotherapy||28
2991971|NCT00913835|3708477|FG000|COMPLETED|Lip Dox: Olaratumab Monotherapy||0
2991972|NCT00913835|3708478|FG001|COMPLETED|Lip Dox: Olaratumab Monotherapy||25
2991973|NCT00913835|3708477|FG000|NOT COMPLETED|Lip Dox: Olaratumab Monotherapy||0
2991974|NCT00913835|3708478|FG001|NOT COMPLETED|Lip Dox: Olaratumab Monotherapy||3
2991975|NCT00913913|3708491|FG000|STARTED|Overall Study||8
2991976|NCT00913913|3708491|FG000|COMPLETED|Overall Study||0
2991977|NCT00913913|3708491|FG000|NOT COMPLETED|Overall Study||8
2991978|NCT00913978|3708497|FG000|STARTED|Overall Study||26
2991979|NCT00913978|3708498|FG001|STARTED|Overall Study||24
2991980|NCT00913978|3708497|FG000|COMPLETED|Overall Study||25
2991981|NCT00913978|3708498|FG001|COMPLETED|Overall Study||21
2991982|NCT00913978|3708497|FG000|NOT COMPLETED|Overall Study||1
2991983|NCT00913978|3708498|FG001|NOT COMPLETED|Overall Study||3
2991984|NCT00914069|3708506|FG000|STARTED|Overall Study||84
2991985|NCT00914069|3708507|FG001|STARTED|Overall Study||88
2991986|NCT00914069|3708506|FG000|COMPLETED|Overall Study||84
2991987|NCT00914069|3708507|FG001|COMPLETED|Overall Study||88
2991988|NCT00914069|3708506|FG000|NOT COMPLETED|Overall Study||0
2991989|NCT00914069|3708507|FG001|NOT COMPLETED|Overall Study||0
3036808|NCT01145183|3756073|FG000|STARTED|Overall Study||21
3036809|NCT01145183|3756074|FG001|STARTED|Overall Study||26
3036810|NCT01145183|3756075|FG002|STARTED|Overall Study||19
3036811|NCT01145183|3756076|FG003|STARTED|Overall Study||10
3036812|NCT01145183|3756073|FG000|COMPLETED|Overall Study||21
3036813|NCT01145183|3756074|FG001|COMPLETED|Overall Study||26
3036814|NCT01145183|3756075|FG002|COMPLETED|Overall Study||19
3036815|NCT01145183|3756076|FG003|COMPLETED|Overall Study||10
3036816|NCT01145183|3756073|FG000|NOT COMPLETED|Overall Study||0
3036817|NCT01145183|3756074|FG001|NOT COMPLETED|Overall Study||0
3036818|NCT01145183|3756075|FG002|NOT COMPLETED|Overall Study||0
3036819|NCT01145183|3756076|FG003|NOT COMPLETED|Overall Study||0
3036820|NCT01145209|3756088|FG000|STARTED|Overall Study||13
3036821|NCT01145209|3756089|FG001|STARTED|Overall Study||19
3036822|NCT01145209|3756088|FG000|COMPLETED|Overall Study||10
3036823|NCT01145209|3756089|FG001|COMPLETED|Overall Study||18
3036824|NCT01145209|3756088|FG000|NOT COMPLETED|Overall Study||3
3036825|NCT01145209|3756089|FG001|NOT COMPLETED|Overall Study||1
3036826|NCT01145222|3756099|FG000|STARTED|Overall Study||40
3036827|NCT01145222|3756100|FG001|STARTED|Overall Study||40
3036828|NCT01145222|3756101|FG002|STARTED|Overall Study||41
3036829|NCT01145222|3756102|FG003|STARTED|Overall Study||41
3036830|NCT01145222|3756099|FG000|Safety Population|Overall Study||40
3036831|NCT01145222|3756100|FG001|Safety Population|Overall Study||40
3305046|NCT02985996|4038731|FG001|STARTED|Overall Study||8
3305047|NCT02985996|4038732|FG002|STARTED|Overall Study||10
3305048|NCT02985996|4038733|FG003|STARTED|Overall Study||7
3305049|NCT02985996|4038734|FG004|STARTED|Overall Study||9
3305050|NCT02985996|4038730|FG000|COMPLETED|Overall Study||5
3305051|NCT02985996|4038731|FG001|COMPLETED|Overall Study||7
3305052|NCT02985996|4038732|FG002|COMPLETED|Overall Study||9
3305053|NCT02985996|4038733|FG003|COMPLETED|Overall Study||7
3305054|NCT02985996|4038734|FG004|COMPLETED|Overall Study||9
3305055|NCT02985996|4038730|FG000|NOT COMPLETED|Overall Study||0
3305056|NCT02985996|4038731|FG001|NOT COMPLETED|Overall Study||1
3036832|NCT01145222|3756101|FG002|Safety Population|Overall Study||40
3036833|NCT01145222|3756102|FG003|Safety Population|Overall Study||41
3036834|NCT01145222|3756099|FG000|Intention to Treat (ITT) Population|Overall Study||40
3036835|NCT01145222|3756100|FG001|Intention to Treat (ITT) Population|Overall Study||40
3036836|NCT01145222|3756101|FG002|Intention to Treat (ITT) Population|Overall Study||40
3036837|NCT01145222|3756102|FG003|Intention to Treat (ITT) Population|Overall Study||40
3036838|NCT01145222|3756099|FG000|COMPLETED|Overall Study||40
3036839|NCT01145222|3756100|FG001|COMPLETED|Overall Study||40
3036840|NCT01145222|3756101|FG002|COMPLETED|Overall Study||40
3036841|NCT01145222|3756102|FG003|COMPLETED|Overall Study||40
3305057|NCT02985996|4038732|FG002|NOT COMPLETED|Overall Study||1
3305058|NCT02985996|4038733|FG003|NOT COMPLETED|Overall Study||0
3305059|NCT02985996|4038734|FG004|NOT COMPLETED|Overall Study||0
2991990|NCT00914186|3708517|FG000|STARTED|Overall Study||31
2991991|NCT00914186|3708518|FG001|STARTED|Overall Study||30
2991992|NCT00914186|3708519|FG002|STARTED|Overall Study||31
2991993|NCT00914186|3708520|FG003|STARTED|Overall Study||30
2991994|NCT00914186|3708517|FG000|COMPLETED|Overall Study||28
2991995|NCT00914186|3708518|FG001|COMPLETED|Overall Study||28
2991996|NCT00914186|3708519|FG002|COMPLETED|Overall Study||29
2991997|NCT00914186|3708520|FG003|COMPLETED|Overall Study||20
2991998|NCT00914186|3708517|FG000|NOT COMPLETED|Overall Study||3
2991999|NCT00914186|3708518|FG001|NOT COMPLETED|Overall Study||2
2992000|NCT00914186|3708519|FG002|NOT COMPLETED|Overall Study||2
2992001|NCT00914186|3708520|FG003|NOT COMPLETED|Overall Study||10
2992002|NCT00914316|3708535|FG000|STARTED|Phase 1||7
2992003|NCT00914316|3708536|FG001|STARTED|Phase 1||6
2992004|NCT00914316|3708537|FG002|STARTED|Phase 1||8
2992005|NCT00914316|3708538|FG003|STARTED|Phase 1||8
2992006|NCT00914316|3708535|FG000|COMPLETED|Phase 1||2
2992007|NCT00914316|3708536|FG001|COMPLETED|Phase 1||4
2992008|NCT00914316|3708537|FG002|COMPLETED|Phase 1||3
2992009|NCT00914316|3708538|FG003|COMPLETED|Phase 1||6
2992010|NCT00914316|3708535|FG000|NOT COMPLETED|Phase 1||5
2992011|NCT00914316|3708536|FG001|NOT COMPLETED|Phase 1||2
2992012|NCT00914316|3708537|FG002|NOT COMPLETED|Phase 1||5
2992013|NCT00914316|3708538|FG003|NOT COMPLETED|Phase 1||2
2992014|NCT00914316|3708535|FG000|STARTED|Phase 2||2
2992015|NCT00914316|3708536|FG001|STARTED|Phase 2||4
2992016|NCT00914316|3708537|FG002|STARTED|Phase 2||3
2992017|NCT00914316|3708538|FG003|STARTED|Phase 2||6
2992018|NCT00914316|3708535|FG000|COMPLETED|Phase 2||1
2992019|NCT00914316|3708536|FG001|COMPLETED|Phase 2||4
2992020|NCT00914316|3708537|FG002|COMPLETED|Phase 2||2
2992021|NCT00914316|3708538|FG003|COMPLETED|Phase 2||6
2992022|NCT00914316|3708535|FG000|NOT COMPLETED|Phase 2||1
2992023|NCT00914316|3708536|FG001|NOT COMPLETED|Phase 2||0
2992024|NCT00914316|3708537|FG002|NOT COMPLETED|Phase 2||1
2992025|NCT00914316|3708538|FG003|NOT COMPLETED|Phase 2||0
2992026|NCT00914459|3708550|FG000|STARTED|Overall Study||18
2992027|NCT00914459|3708551|FG001|STARTED|Overall Study||19
2992028|NCT00914459|3708550|FG000|COMPLETED|Overall Study||17
2992029|NCT00914459|3708551|FG001|COMPLETED|Overall Study||18
2992030|NCT00914459|3708550|FG000|NOT COMPLETED|Overall Study||1
2992031|NCT00914459|3708551|FG001|NOT COMPLETED|Overall Study||1
2992032|NCT00914485|3708559|FG000|STARTED|Overall Study||369
2992033|NCT00914485|3708559|FG000|COMPLETED|Overall Study||369
2992034|NCT00914485|3708559|FG000|NOT COMPLETED|Overall Study||0
2992035|NCT00914589|3708566|FG000|STARTED|Overall Study||128
2992036|NCT00914589|3708567|FG001|STARTED|Overall Study||143
2992037|NCT00914589|3708568|FG002|STARTED|Overall Study||138
2992038|NCT00914589|3708566|FG000|COMPLETED|Overall Study||103
2992039|NCT00914589|3708567|FG001|COMPLETED|Overall Study||127
2992040|NCT00914589|3708568|FG002|COMPLETED|Overall Study||126
2992041|NCT00914589|3708566|FG000|NOT COMPLETED|Overall Study||25
2992042|NCT00914589|3708567|FG001|NOT COMPLETED|Overall Study||16
2992043|NCT00914589|3708568|FG002|NOT COMPLETED|Overall Study||12
2992044|NCT00914628|3708578|FG000|STARTED|Overall Study|Referred to all randomized patient|64
2992045|NCT00914628|3708579|FG001|STARTED|Overall Study|Referred to all randomized patient|28
2992046|NCT00914628|3708578|FG000|COMPLETED|Overall Study|Early termination of the Study|0
2992047|NCT00914628|3708579|FG001|COMPLETED|Overall Study|Early termination of the Study|0
2992048|NCT00914628|3708578|FG000|NOT COMPLETED|Overall Study||64
2992049|NCT00914628|3708579|FG001|NOT COMPLETED|Overall Study||28
2992050|NCT00914732|3708592|FG000|STARTED|Overall Study||165
2992051|NCT00914732|3708593|FG001|STARTED|Overall Study||167
2992052|NCT00914732|3708594|FG002|STARTED|Overall Study||191
2992053|NCT00914732|3708592|FG000|Received Second Vaccination|Overall Study||150
2992054|NCT00914732|3708593|FG001|Received Second Vaccination|Overall Study||157
2992055|NCT00914732|3708594|FG002|Received Second Vaccination|Overall Study||153
2992056|NCT00914732|3708592|FG000|COMPLETED|Overall Study||155
2992057|NCT00914732|3708593|FG001|COMPLETED|Overall Study||160
2992058|NCT00914732|3708594|FG002|COMPLETED|Overall Study||180
2992059|NCT00914732|3708592|FG000|NOT COMPLETED|Overall Study||10
2992060|NCT00914732|3708593|FG001|NOT COMPLETED|Overall Study||7
2992061|NCT00914732|3708594|FG002|NOT COMPLETED|Overall Study||11
2992062|NCT00914810|3708605|FG000|STARTED|Overall Study||20
2992063|NCT00914810|3708606|FG001|STARTED|Overall Study||19
2992064|NCT00914810|3708605|FG000|COMPLETED|Overall Study||18
2992065|NCT00914810|3708606|FG001|COMPLETED|Overall Study||18
2992066|NCT00914810|3708605|FG000|NOT COMPLETED|Overall Study||2
2992067|NCT00914810|3708606|FG001|NOT COMPLETED|Overall Study||1
2992068|NCT00914849|3708614|FG000|STARTED|Overall Study||34
2992069|NCT00914849|3708615|FG001|STARTED|Overall Study||34
2992070|NCT00914849|3708614|FG000|COMPLETED|Overall Study||33
2992071|NCT00914849|3708615|FG001|COMPLETED|Overall Study||33
2992072|NCT00914849|3708614|FG000|NOT COMPLETED|Overall Study||1
2992073|NCT00914849|3708615|FG001|NOT COMPLETED|Overall Study||1
2992074|NCT00914862|3708626|FG000|STARTED|Overall Study||6
2992075|NCT00914862|3708627|FG001|STARTED|Overall Study||6
2992076|NCT00914862|3708628|FG002|STARTED|Overall Study||8
2992077|NCT00914862|3708629|FG003|STARTED|Overall Study||8
2992078|NCT00914862|3708630|FG004|STARTED|Overall Study||28
2992079|NCT00914862|3708626|FG000|COMPLETED|Overall Study||6
2992080|NCT00914862|3708627|FG001|COMPLETED|Overall Study||6
2992081|NCT00914862|3708628|FG002|COMPLETED|Overall Study||8
2992082|NCT00914862|3708629|FG003|COMPLETED|Overall Study||8
2992083|NCT00914862|3708630|FG004|COMPLETED|Overall Study||28
2992084|NCT00914862|3708626|FG000|NOT COMPLETED|Overall Study||0
2992085|NCT00914862|3708627|FG001|NOT COMPLETED|Overall Study||0
2992086|NCT00914862|3708628|FG002|NOT COMPLETED|Overall Study||0
2992087|NCT00914862|3708629|FG003|NOT COMPLETED|Overall Study||0
2992088|NCT00914862|3708630|FG004|NOT COMPLETED|Overall Study||0
2992089|NCT00914927|3708649|FG000|STARTED|Overall Study||18
2992090|NCT00914927|3708650|FG001|STARTED|Overall Study||16
2992091|NCT00914927|3708651|FG002|STARTED|Overall Study||17
2992092|NCT00914927|3708652|FG003|STARTED|Overall Study||16
2992093|NCT00914927|3708653|FG004|STARTED|Overall Study||21
2992094|NCT00914927|3708654|FG005|STARTED|Overall Study||21
2992095|NCT00914927|3708655|FG006|STARTED|Overall Study||21
2992096|NCT00914927|3708649|FG000|COMPLETED|Overall Study||16
2992097|NCT00914927|3708650|FG001|COMPLETED|Overall Study||14
2992098|NCT00914927|3708651|FG002|COMPLETED|Overall Study||17
2992099|NCT00914927|3708652|FG003|COMPLETED|Overall Study||14
2992100|NCT00914927|3708653|FG004|COMPLETED|Overall Study||19
2992101|NCT00914927|3708654|FG005|COMPLETED|Overall Study||21
2992102|NCT00914927|3708655|FG006|COMPLETED|Overall Study||21
2992103|NCT00914927|3708649|FG000|NOT COMPLETED|Overall Study||2
2992104|NCT00914927|3708650|FG001|NOT COMPLETED|Overall Study||2
2992105|NCT00914927|3708651|FG002|NOT COMPLETED|Overall Study||0
2992106|NCT00914927|3708652|FG003|NOT COMPLETED|Overall Study||2
2992107|NCT00914927|3708653|FG004|NOT COMPLETED|Overall Study||2
2992108|NCT00914927|3708654|FG005|NOT COMPLETED|Overall Study||0
2992109|NCT00914927|3708655|FG006|NOT COMPLETED|Overall Study||0
2992110|NCT00914940|3708680|FG000|STARTED|D0 to D100 Post-transplant||41
2992111|NCT00914940|3708680|FG000|COMPLETED|D0 to D100 Post-transplant||39
2992112|NCT00914940|3708680|FG000|NOT COMPLETED|D0 to D100 Post-transplant||2
2992113|NCT00914940|3708680|FG000|STARTED|D101 to 2 Years Post-transplant||39
2992114|NCT00914940|3708680|FG000|COMPLETED|D101 to 2 Years Post-transplant||31
2992115|NCT00914940|3708680|FG000|NOT COMPLETED|D101 to 2 Years Post-transplant||8
2992116|NCT00914940|3708680|FG000|STARTED|2 Years to 5 Years Post-transplant||31
2992117|NCT00914940|3708680|FG000|COMPLETED|2 Years to 5 Years Post-transplant||28
2992118|NCT00914940|3708680|FG000|NOT COMPLETED|2 Years to 5 Years Post-transplant||3
2992119|NCT00914966|3708684|FG000|STARTED|Step 1: 1500 Units||20
2992120|NCT00914966|3708684|FG000|COMPLETED|Step 1: 1500 Units|5/18 subjects completing Step 1 (1500 Units) entered the 3 month follow-up and did not dose escalate|18
2992121|NCT00914966|3708684|FG000|NOT COMPLETED|Step 1: 1500 Units||2
2992122|NCT00914966|3708684|FG000|STARTED|Step 2: 2000 Units||13
2992123|NCT00914966|3708684|FG000|COMPLETED|Step 2: 2000 Units||12
2992124|NCT00914966|3708684|FG000|NOT COMPLETED|Step 2: 2000 Units||1
2992125|NCT00914966|3708684|FG000|STARTED|Step 3: 2500 Units||12
2992126|NCT00914966|3708684|FG000|COMPLETED|Step 3: 2500 Units||12
2992127|NCT00914966|3708684|FG000|NOT COMPLETED|Step 3: 2500 Units||0
2992128|NCT00915005|3708695|FG000|STARTED|Overall Study||105
2992129|NCT00915005|3708696|FG001|STARTED|Overall Study||76
2992130|NCT00915005|3708695|FG000|COMPLETED|Overall Study||92
2992131|NCT00915005|3708696|FG001|COMPLETED|Overall Study||57
2992132|NCT00915005|3708695|FG000|NOT COMPLETED|Overall Study||13
2992133|NCT00915005|3708696|FG001|NOT COMPLETED|Overall Study||19
2992134|NCT00915018|3708704|FG000|STARTED|Overall Study||242
2992135|NCT00915018|3708705|FG001|STARTED|Overall Study||237
2992136|NCT00915018|3708704|FG000|Received Treatment|Overall Study||240
2992137|NCT00915018|3708705|FG001|Received Treatment|Overall Study||234
2992138|NCT00915018|3708704|FG000|COMPLETED|Overall Study||27
2992139|NCT00915018|3708705|FG001|COMPLETED|Overall Study||30
2992140|NCT00915018|3708704|FG000|NOT COMPLETED|Overall Study||215
2992141|NCT00915018|3708705|FG001|NOT COMPLETED|Overall Study||207
2992142|NCT00915031|3708713|FG000|STARTED|Overall Study||714
2992143|NCT00915031|3708714|FG001|STARTED|Overall Study||24
2992144|NCT00915031|3708713|FG000|COMPLETED|Overall Study||714
2992145|NCT00915031|3708714|FG001|COMPLETED|Overall Study||24
2992146|NCT00915031|3708713|FG000|NOT COMPLETED|Overall Study||0
2992147|NCT00915031|3708714|FG001|NOT COMPLETED|Overall Study||0
2992148|NCT00915148|3708719|FG000|STARTED|Overall Study|October 2009|110
2992149|NCT00915148|3708719|FG000|COMPLETED|Overall Study|August 2010|110
2992150|NCT00915148|3708719|FG000|NOT COMPLETED|Overall Study||0
2992151|NCT00915278|3708730|FG000|STARTED|Overall Study||8
2992152|NCT00915278|3708731|FG001|STARTED|Overall Study||5
2992153|NCT00915278|3708732|FG002|STARTED|Overall Study||3
2992154|NCT00915278|3708733|FG003|STARTED|Overall Study||5
2992155|NCT00915278|3708734|FG004|STARTED|Overall Study||3
2992156|NCT00915278|3708735|FG005|STARTED|Overall Study||9
2992157|NCT00915278|3708730|FG000|COMPLETED|Overall Study||3
2992158|NCT00915278|3708731|FG001|COMPLETED|Overall Study||2
2992159|NCT00915278|3708732|FG002|COMPLETED|Overall Study||2
2992160|NCT00915278|3708733|FG003|COMPLETED|Overall Study||2
2992161|NCT00915278|3708734|FG004|COMPLETED|Overall Study||1
2992162|NCT00915278|3708735|FG005|COMPLETED|Overall Study||1
2992163|NCT00915278|3708730|FG000|NOT COMPLETED|Overall Study||5
2992164|NCT00915278|3708731|FG001|NOT COMPLETED|Overall Study||3
2992165|NCT00915278|3708732|FG002|NOT COMPLETED|Overall Study||1
2992166|NCT00915278|3708733|FG003|NOT COMPLETED|Overall Study||3
2992167|NCT00915278|3708734|FG004|NOT COMPLETED|Overall Study||2
2992168|NCT00915278|3708735|FG005|NOT COMPLETED|Overall Study||8
2992169|NCT00915343|3708749|FG000|STARTED|Part A - First Intervention Period||32
2992170|NCT00915343|3708750|FG001|STARTED|Part A - First Intervention Period||32
2992171|NCT00915343|3708751|FG002|STARTED|Part A - First Intervention Period||0
2992172|NCT00915343|3708749|FG000|COMPLETED|Part A - First Intervention Period||32
2992173|NCT00915343|3708750|FG001|COMPLETED|Part A - First Intervention Period||32
2992174|NCT00915343|3708751|FG002|COMPLETED|Part A - First Intervention Period||0
2992175|NCT00915343|3708749|FG000|NOT COMPLETED|Part A - First Intervention Period||0
2992176|NCT00915343|3708750|FG001|NOT COMPLETED|Part A - First Intervention Period||0
2992177|NCT00915343|3708751|FG002|NOT COMPLETED|Part A - First Intervention Period||0
2992178|NCT00915343|3708749|FG000|STARTED|Part A - Second Intervention Period||32
2992179|NCT00915343|3708750|FG001|STARTED|Part A - Second Intervention Period||32
2992180|NCT00915343|3708751|FG002|STARTED|Part A - Second Intervention Period||0
2992181|NCT00915343|3708749|FG000|COMPLETED|Part A - Second Intervention Period||32
2992182|NCT00915343|3708750|FG001|COMPLETED|Part A - Second Intervention Period||32
2992183|NCT00915343|3708751|FG002|COMPLETED|Part A - Second Intervention Period||0
2992184|NCT00915343|3708749|FG000|NOT COMPLETED|Part A - Second Intervention Period||0
2992185|NCT00915343|3708750|FG001|NOT COMPLETED|Part A - Second Intervention Period||0
2992186|NCT00915343|3708751|FG002|NOT COMPLETED|Part A - Second Intervention Period||0
2992187|NCT00915343|3708749|FG000|STARTED|Part B - Open Label Period||0
2992188|NCT00915343|3708750|FG001|STARTED|Part B - Open Label Period||0
2992189|NCT00915343|3708751|FG002|STARTED|Part B - Open Label Period||59
2992190|NCT00915343|3708749|FG000|COMPLETED|Part B - Open Label Period||0
2992191|NCT00915343|3708750|FG001|COMPLETED|Part B - Open Label Period||0
2992192|NCT00915343|3708751|FG002|COMPLETED|Part B - Open Label Period||57
2992193|NCT00915343|3708749|FG000|NOT COMPLETED|Part B - Open Label Period||0
2992194|NCT00915343|3708750|FG001|NOT COMPLETED|Part B - Open Label Period||0
2992195|NCT00915343|3708751|FG002|NOT COMPLETED|Part B - Open Label Period||2
2992196|NCT00915356|3708768|FG000|STARTED|Overall Study||26
2992197|NCT00915356|3708769|FG001|STARTED|Overall Study||45
2992198|NCT00915356|3708770|FG002|STARTED|Overall Study||45
2992199|NCT00915356|3708771|FG003|STARTED|Overall Study||12
2992200|NCT00915356|3708772|FG004|STARTED|Overall Study||43
2992201|NCT00915356|3708768|FG000|COMPLETED|Overall Study||25
2992202|NCT00915356|3708769|FG001|COMPLETED|Overall Study||45
2992203|NCT00915356|3708770|FG002|COMPLETED|Overall Study||45
2992204|NCT00915356|3708771|FG003|COMPLETED|Overall Study||12
2992205|NCT00915356|3708772|FG004|COMPLETED|Overall Study||43
2992206|NCT00915356|3708768|FG000|NOT COMPLETED|Overall Study||1
2992207|NCT00915356|3708769|FG001|NOT COMPLETED|Overall Study||0
2992208|NCT00915356|3708770|FG002|NOT COMPLETED|Overall Study||0
2992209|NCT00915356|3708771|FG003|NOT COMPLETED|Overall Study||0
2992210|NCT00915356|3708772|FG004|NOT COMPLETED|Overall Study||0
2992211|NCT00915473|3708786|FG000|STARTED|Screening||35
2992212|NCT00915473|3708787|FG001|STARTED|Screening||35
2992213|NCT00915473|3708786|FG000|COMPLETED|Screening||34
2992214|NCT00915473|3708787|FG001|COMPLETED|Screening||35
2992215|NCT00915473|3708786|FG000|NOT COMPLETED|Screening||1
2992216|NCT00915473|3708787|FG001|NOT COMPLETED|Screening||0
2992217|NCT00915473|3708786|FG000|STARTED|Injection||34
2992218|NCT00915473|3708787|FG001|STARTED|Injection||35
2992219|NCT00915473|3708786|FG000|COMPLETED|Injection||34
2992220|NCT00915473|3708787|FG001|COMPLETED|Injection||35
2992221|NCT00915473|3708786|FG000|NOT COMPLETED|Injection||0
2992222|NCT00915473|3708787|FG001|NOT COMPLETED|Injection||0
2992223|NCT00915473|3708786|FG000|STARTED|4-week Follow Up||34
2992224|NCT00915473|3708787|FG001|STARTED|4-week Follow Up||35
2992225|NCT00915473|3708786|FG000|COMPLETED|4-week Follow Up||33
2992226|NCT00915473|3708787|FG001|COMPLETED|4-week Follow Up||30
2992227|NCT00915473|3708786|FG000|NOT COMPLETED|4-week Follow Up||1
2992228|NCT00915473|3708787|FG001|NOT COMPLETED|4-week Follow Up||5
2992229|NCT00915499|3708795|FG000|STARTED|Overall Study||33
2992230|NCT00915499|3708796|FG001|STARTED|Overall Study||33
2992231|NCT00915499|3708795|FG000|COMPLETED|Overall Study||29
2992232|NCT00915499|3708796|FG001|COMPLETED|Overall Study||31
2992233|NCT00915499|3708795|FG000|NOT COMPLETED|Overall Study||4
2992234|NCT00915499|3708796|FG001|NOT COMPLETED|Overall Study||2
2992235|NCT00915525|3708804|FG000|STARTED|Overall Study||543
2992236|NCT00915525|3708805|FG001|STARTED|Overall Study||286
2992237|NCT00915525|3708804|FG000|COMPLETED|Overall Study||278
2992238|NCT00915525|3708805|FG001|COMPLETED|Overall Study||151
2992239|NCT00915525|3708804|FG000|NOT COMPLETED|Overall Study||265
2992240|NCT00915525|3708805|FG001|NOT COMPLETED|Overall Study||135
2992241|NCT00915538|3708833|FG000|STARTED|Overall Study||8
2992242|NCT00915538|3708834|FG001|STARTED|Overall Study||8
2992243|NCT00915538|3708833|FG000|COMPLETED|Overall Study||8
2992244|NCT00915538|3708834|FG001|COMPLETED|Overall Study||8
2992245|NCT00915538|3708833|FG000|NOT COMPLETED|Overall Study||0
2992246|NCT00915538|3708834|FG001|NOT COMPLETED|Overall Study||0
2992247|NCT00915551|3708844|FG000|STARTED|Overall Study||142
2992248|NCT00915551|3708845|FG001|STARTED|Overall Study||136
2992249|NCT00915551|3708844|FG000|COMPLETED|Overall Study||142
2992250|NCT00915551|3708845|FG001|COMPLETED|Overall Study||135
2992251|NCT00915551|3708844|FG000|NOT COMPLETED|Overall Study||0
2992252|NCT00915551|3708845|FG001|NOT COMPLETED|Overall Study||1
2992253|NCT00915590|3708853|FG000|STARTED|Overall Study||5
2992254|NCT00915590|3708854|FG001|STARTED|Overall Study||5
2992255|NCT00915590|3708853|FG000|COMPLETED|Overall Study||3
2992256|NCT00915590|3708854|FG001|COMPLETED|Overall Study||4
2992257|NCT00915590|3708853|FG000|NOT COMPLETED|Overall Study||2
2992258|NCT00915590|3708854|FG001|NOT COMPLETED|Overall Study||1
2992259|NCT00915603|3708867|FG000|STARTED|Overall Study|One patient enrolled/randomized but did not start treatment|56
2992260|NCT00915603|3708868|FG001|STARTED|Overall Study|One patient enrolled/randomized but did not start treatment|55
2992261|NCT00915603|3708867|FG000|COMPLETED|Overall Study||0
2992262|NCT00915603|3708868|FG001|COMPLETED|Overall Study||0
2992263|NCT00915603|3708867|FG000|NOT COMPLETED|Overall Study||56
2992264|NCT00915603|3708868|FG001|NOT COMPLETED|Overall Study||55
2992265|NCT00915655|3708874|FG000|STARTED|Overall Study||12
2992266|NCT00915655|3708874|FG000|COMPLETED|Overall Study|'Completed' represents patients who have not discontinued at time of cut-off for Week 24 analysis|12
2992267|NCT00915655|3708874|FG000|NOT COMPLETED|Overall Study||0
2992268|NCT00915759|3708878|FG000|STARTED|Overall Study|number of participants|40
2992269|NCT00915759|3708878|FG000|COMPLETED|Overall Study|number of participants|40
2992270|NCT00915759|3708878|FG000|NOT COMPLETED|Overall Study||0
2992271|NCT00915772|3708891|FG000|STARTED|Overall Study||170
2992272|NCT00915772|3708892|FG001|STARTED|Overall Study||225
2992273|NCT00915772|3708893|FG002|STARTED|Overall Study||171
2992274|NCT00915772|3708891|FG000|COMPLETED|Overall Study||134
2992275|NCT00915772|3708892|FG001|COMPLETED|Overall Study||179
2992276|NCT00915772|3708893|FG002|COMPLETED|Overall Study||142
2992277|NCT00915772|3708891|FG000|NOT COMPLETED|Overall Study||36
2992278|NCT00915772|3708892|FG001|NOT COMPLETED|Overall Study||46
2992279|NCT00915772|3708893|FG002|NOT COMPLETED|Overall Study||29
2992280|NCT00915798|3708906|FG000|STARTED|Overall Study||19
2992281|NCT00915798|3708907|FG001|STARTED|Overall Study||21
2992282|NCT00915798|3708908|FG002|STARTED|Overall Study||23
2992283|NCT00915798|3708909|FG003|STARTED|Overall Study||26
2992284|NCT00915798|3708906|FG000|COMPLETED|Overall Study||19
2992285|NCT00915798|3708907|FG001|COMPLETED|Overall Study||21
2992286|NCT00915798|3708908|FG002|COMPLETED|Overall Study||23
2992287|NCT00915798|3708909|FG003|COMPLETED|Overall Study||26
2992288|NCT00915798|3708906|FG000|NOT COMPLETED|Overall Study||0
2992289|NCT00915798|3708907|FG001|NOT COMPLETED|Overall Study||0
2992290|NCT00915798|3708908|FG002|NOT COMPLETED|Overall Study||0
2992291|NCT00915798|3708909|FG003|NOT COMPLETED|Overall Study||0
2992292|NCT00915876|3708931|FG000|STARTED|Overall Study||20
2992293|NCT00915876|3708932|FG001|STARTED|Overall Study||21
2992294|NCT00915876|3708931|FG000|Moving Beyond First Dose|Overall Study||20
2992295|NCT00915876|3708932|FG001|Moving Beyond First Dose|Overall Study||20
2992296|NCT00915876|3708931|FG000|COMPLETED|Overall Study||20
2992297|NCT00915876|3708932|FG001|COMPLETED|Overall Study||20
2992298|NCT00915876|3708931|FG000|NOT COMPLETED|Overall Study||0
2992299|NCT00915876|3708932|FG001|NOT COMPLETED|Overall Study||1
2992300|NCT00915902|3708940|FG000|STARTED|1st Treatment Period||20
2992301|NCT00915902|3708941|FG001|STARTED|1st Treatment Period||22
2992302|NCT00915902|3708940|FG000|COMPLETED|1st Treatment Period||19
2992303|NCT00915902|3708941|FG001|COMPLETED|1st Treatment Period||22
2992304|NCT00915902|3708940|FG000|NOT COMPLETED|1st Treatment Period||1
2992305|NCT00915902|3708941|FG001|NOT COMPLETED|1st Treatment Period||0
2992306|NCT00915902|3708940|FG000|STARTED|Washout (4 Weeks)||19
2992307|NCT00915902|3708941|FG001|STARTED|Washout (4 Weeks)||22
2992308|NCT00915902|3708940|FG000|COMPLETED|Washout (4 Weeks)||19
2992309|NCT00915902|3708941|FG001|COMPLETED|Washout (4 Weeks)||21
2992310|NCT00915902|3708940|FG000|NOT COMPLETED|Washout (4 Weeks)||0
2992311|NCT00915902|3708941|FG001|NOT COMPLETED|Washout (4 Weeks)||1
2992312|NCT00915902|3708940|FG000|STARTED|2nd Treatment Period||19
2992313|NCT00915902|3708941|FG001|STARTED|2nd Treatment Period||21
2992314|NCT00915902|3708940|FG000|COMPLETED|2nd Treatment Period||19
2992315|NCT00915902|3708941|FG001|COMPLETED|2nd Treatment Period||20
2992316|NCT00915902|3708940|FG000|NOT COMPLETED|2nd Treatment Period||0
2992317|NCT00915902|3708941|FG001|NOT COMPLETED|2nd Treatment Period||1
2992318|NCT00915928|3708951|FG000|STARTED|Overall Study||25
2992319|NCT00915928|3708952|FG001|STARTED|Overall Study||22
2992320|NCT00915928|3708951|FG000|COMPLETED|Overall Study||25
2992321|NCT00915928|3708952|FG001|COMPLETED|Overall Study||22
2992322|NCT00915928|3708951|FG000|NOT COMPLETED|Overall Study||0
2992323|NCT00915928|3708952|FG001|NOT COMPLETED|Overall Study||0
2992324|NCT00915954|3708962|FG000|STARTED|Overall Study||10
2992325|NCT00915954|3708963|FG001|STARTED|Overall Study||8
2992326|NCT00915954|3708964|FG002|STARTED|Overall Study||10
2992327|NCT00915954|3708962|FG000|COMPLETED|Overall Study||10
2992328|NCT00915954|3708963|FG001|COMPLETED|Overall Study||8
2992329|NCT00915954|3708964|FG002|COMPLETED|Overall Study||10
2992330|NCT00915954|3708962|FG000|NOT COMPLETED|Overall Study||0
2992331|NCT00915954|3708963|FG001|NOT COMPLETED|Overall Study||0
2992332|NCT00915954|3708964|FG002|NOT COMPLETED|Overall Study||0
2992333|NCT00915967|3708974|FG000|STARTED|Overall Study||98
2992334|NCT00915967|3708975|FG001|STARTED|Overall Study||100
2992335|NCT00915967|3708974|FG000|COMPLETED|Overall Study||97
2992336|NCT00915967|3708975|FG001|COMPLETED|Overall Study||98
2992337|NCT00915967|3708974|FG000|NOT COMPLETED|Overall Study||1
2992338|NCT00915967|3708975|FG001|NOT COMPLETED|Overall Study||2
2992339|NCT00916006|3708983|FG000|STARTED|Overall Study||135
2992340|NCT00916006|3708984|FG001|STARTED|Overall Study||134
2992341|NCT00916006|3708983|FG000|COMPLETED|Overall Study||132
2992342|NCT00916006|3708984|FG001|COMPLETED|Overall Study||127
2992343|NCT00916006|3708983|FG000|NOT COMPLETED|Overall Study||3
2992344|NCT00916006|3708984|FG001|NOT COMPLETED|Overall Study||7
2992345|NCT00916032|3708990|FG000|STARTED|Overall Study||12
2992346|NCT00916032|3708991|FG001|STARTED|Overall Study||11
2992347|NCT00916032|3708990|FG000|COMPLETED|Overall Study||12
2992348|NCT00916032|3708991|FG001|COMPLETED|Overall Study||11
2992349|NCT00916032|3708990|FG000|NOT COMPLETED|Overall Study||0
2992350|NCT00916032|3708991|FG001|NOT COMPLETED|Overall Study||0
2992351|NCT00916058|3709004|FG000|STARTED|Phase 1||3
2992352|NCT00916058|3709005|FG001|STARTED|Phase 1||6
2992353|NCT00916058|3709006|FG002|STARTED|Phase 1||3
2992354|NCT00916058|3709007|FG003|STARTED|Phase 1||3
2992355|NCT00916058|3709008|FG004|STARTED|Phase 1||3
2992356|NCT00916058|3709009|FG005|STARTED|Phase 1||8
2992357|NCT00916058|3709010|FG006|STARTED|Phase 1||0
2992358|NCT00916058|3709004|FG000|COMPLETED|Phase 1||3
2992359|NCT00916058|3709005|FG001|COMPLETED|Phase 1||6
2992360|NCT00916058|3709006|FG002|COMPLETED|Phase 1||3
2992361|NCT00916058|3709007|FG003|COMPLETED|Phase 1||3
2992362|NCT00916058|3709008|FG004|COMPLETED|Phase 1||3
2992363|NCT00916058|3709009|FG005|COMPLETED|Phase 1||7
2992364|NCT00916058|3709010|FG006|COMPLETED|Phase 1||0
2992365|NCT00916058|3709004|FG000|NOT COMPLETED|Phase 1||0
2992366|NCT00916058|3709005|FG001|NOT COMPLETED|Phase 1||0
2992367|NCT00916058|3709006|FG002|NOT COMPLETED|Phase 1||0
2992368|NCT00916058|3709007|FG003|NOT COMPLETED|Phase 1||0
2992369|NCT00916058|3709008|FG004|NOT COMPLETED|Phase 1||0
2992370|NCT00916058|3709009|FG005|NOT COMPLETED|Phase 1||1
2992371|NCT00916058|3709010|FG006|NOT COMPLETED|Phase 1||0
2992372|NCT00916058|3709004|FG000|STARTED|Phase 2||0
2992373|NCT00916058|3709005|FG001|STARTED|Phase 2||0
2992374|NCT00916058|3709006|FG002|STARTED|Phase 2||0
2992375|NCT00916058|3709007|FG003|STARTED|Phase 2||0
2992376|NCT00916058|3709008|FG004|STARTED|Phase 2||0
2992377|NCT00916058|3709009|FG005|STARTED|Phase 2||0
2992378|NCT00916058|3709010|FG006|STARTED|Phase 2||31
2992379|NCT00916058|3709004|FG000|COMPLETED|Phase 2||0
2992380|NCT00916058|3709005|FG001|COMPLETED|Phase 2||0
2992381|NCT00916058|3709006|FG002|COMPLETED|Phase 2||0
2992382|NCT00916058|3709007|FG003|COMPLETED|Phase 2||0
2992383|NCT00916058|3709008|FG004|COMPLETED|Phase 2||0
2992384|NCT00916058|3709009|FG005|COMPLETED|Phase 2||0
2992385|NCT00916058|3709010|FG006|COMPLETED|Phase 2||28
2992386|NCT00916058|3709004|FG000|NOT COMPLETED|Phase 2||0
2992387|NCT00916058|3709005|FG001|NOT COMPLETED|Phase 2||0
2992388|NCT00916058|3709006|FG002|NOT COMPLETED|Phase 2||0
2992389|NCT00916058|3709007|FG003|NOT COMPLETED|Phase 2||0
2992390|NCT00916058|3709008|FG004|NOT COMPLETED|Phase 2||0
2992391|NCT00916058|3709009|FG005|NOT COMPLETED|Phase 2||0
2992392|NCT00916058|3709010|FG006|NOT COMPLETED|Phase 2||3
2992393|NCT00916136|3709030|FG000|STARTED|Overall Study||37
2992394|NCT00916136|3709031|FG001|STARTED|Overall Study||29
2992395|NCT00916136|3709030|FG000|COMPLETED|Overall Study||37
2992396|NCT00916136|3709031|FG001|COMPLETED|Overall Study||29
2992397|NCT00916136|3709030|FG000|NOT COMPLETED|Overall Study||0
2992398|NCT00916136|3709031|FG001|NOT COMPLETED|Overall Study||0
2992399|NCT00916149|3709040|FG000|STARTED|Overall Study||16
2992400|NCT00916149|3709041|FG001|STARTED|Overall Study||10
2992401|NCT00916149|3709042|FG002|STARTED|Overall Study||5
2992402|NCT00916149|3709040|FG000|COMPLETED|Overall Study||12
2992403|NCT00916149|3709041|FG001|COMPLETED|Overall Study||8
2992404|NCT00916149|3709042|FG002|COMPLETED|Overall Study||5
2992405|NCT00916149|3709040|FG000|NOT COMPLETED|Overall Study||4
2992406|NCT00916149|3709041|FG001|NOT COMPLETED|Overall Study||2
2992407|NCT00916149|3709042|FG002|NOT COMPLETED|Overall Study||0
2992408|NCT00916279|3709049|FG000|STARTED|Overall Study||41
2992409|NCT00916279|3709049|FG000|30 Days|Overall Study||41
2992410|NCT00916279|3709049|FG000|6 Months|Overall Study||41
2992411|NCT00916279|3709049|FG000|24 Months|Overall Study||37
2992412|NCT00916279|3709049|FG000|COMPLETED|Overall Study||37
2992413|NCT00916279|3709049|FG000|NOT COMPLETED|Overall Study||4
2992414|NCT00916305|3709058|FG000|STARTED|Overall Study||28
2992415|NCT00916305|3709059|FG001|STARTED|Overall Study||37
2992416|NCT00916305|3709058|FG000|COMPLETED|Overall Study||7
2992417|NCT00916305|3709059|FG001|COMPLETED|Overall Study||9
2992418|NCT00916305|3709058|FG000|NOT COMPLETED|Overall Study||21
2992419|NCT00916305|3709059|FG001|NOT COMPLETED|Overall Study||28
2992420|NCT00916344|3709065|FG000|STARTED|Overall Study||175
2992421|NCT00916344|3709065|FG000|COMPLETED|Overall Study||167
2992422|NCT00916344|3709065|FG000|NOT COMPLETED|Overall Study||8
2992423|NCT00916357|3709069|FG000|STARTED|Period 1||4
2992424|NCT00916357|3709070|FG001|STARTED|Period 1||4
2992425|NCT00916357|3709071|FG002|STARTED|Period 1||4
2992426|NCT00916357|3709072|FG003|STARTED|Period 1||4
2992427|NCT00916357|3709073|FG004|STARTED|Period 1||3
2992428|NCT00916357|3709074|FG005|STARTED|Period 1||4
2992429|NCT00916357|3709069|FG000|Received at Least 1 Dose of Study Drug|Period 1||4
2992430|NCT00916357|3709070|FG001|Received at Least 1 Dose of Study Drug|Period 1||4
2992431|NCT00916357|3709071|FG002|Received at Least 1 Dose of Study Drug|Period 1||4
2992432|NCT00916357|3709072|FG003|Received at Least 1 Dose of Study Drug|Period 1||4
2992433|NCT00916357|3709073|FG004|Received at Least 1 Dose of Study Drug|Period 1||3
2992434|NCT00916357|3709074|FG005|Received at Least 1 Dose of Study Drug|Period 1||4
2992435|NCT00916357|3709069|FG000|COMPLETED|Period 1||3
2992436|NCT00916357|3709070|FG001|COMPLETED|Period 1||4
2992437|NCT00916357|3709071|FG002|COMPLETED|Period 1||4
2992438|NCT00916357|3709072|FG003|COMPLETED|Period 1||4
2992439|NCT00916357|3709073|FG004|COMPLETED|Period 1||3
2992440|NCT00916357|3709074|FG005|COMPLETED|Period 1||4
2992441|NCT00916357|3709069|FG000|NOT COMPLETED|Period 1||1
2992442|NCT00916357|3709070|FG001|NOT COMPLETED|Period 1||0
2992443|NCT00916357|3709071|FG002|NOT COMPLETED|Period 1||0
2992444|NCT00916357|3709072|FG003|NOT COMPLETED|Period 1||0
2992445|NCT00916357|3709073|FG004|NOT COMPLETED|Period 1||0
2992446|NCT00916357|3709074|FG005|NOT COMPLETED|Period 1||0
2992447|NCT00916357|3709069|FG000|STARTED|Washout (3 to 14 Days)||3
2992448|NCT00916357|3709070|FG001|STARTED|Washout (3 to 14 Days)||4
2992449|NCT00916357|3709071|FG002|STARTED|Washout (3 to 14 Days)||4
2992450|NCT00916357|3709072|FG003|STARTED|Washout (3 to 14 Days)||4
2992451|NCT00916357|3709073|FG004|STARTED|Washout (3 to 14 Days)||3
2992452|NCT00916357|3709074|FG005|STARTED|Washout (3 to 14 Days)||4
2992453|NCT00916357|3709069|FG000|COMPLETED|Washout (3 to 14 Days)||3
2992454|NCT00916357|3709070|FG001|COMPLETED|Washout (3 to 14 Days)||4
2992455|NCT00916357|3709071|FG002|COMPLETED|Washout (3 to 14 Days)||4
2992456|NCT00916357|3709072|FG003|COMPLETED|Washout (3 to 14 Days)||4
2992457|NCT00916357|3709073|FG004|COMPLETED|Washout (3 to 14 Days)||3
2992458|NCT00916357|3709074|FG005|COMPLETED|Washout (3 to 14 Days)||4
2992459|NCT00916357|3709069|FG000|NOT COMPLETED|Washout (3 to 14 Days)||0
2992460|NCT00916357|3709070|FG001|NOT COMPLETED|Washout (3 to 14 Days)||0
2992461|NCT00916357|3709071|FG002|NOT COMPLETED|Washout (3 to 14 Days)||0
2992462|NCT00916357|3709072|FG003|NOT COMPLETED|Washout (3 to 14 Days)||0
2992463|NCT00916357|3709073|FG004|NOT COMPLETED|Washout (3 to 14 Days)||0
2992464|NCT00916357|3709074|FG005|NOT COMPLETED|Washout (3 to 14 Days)||0
2992465|NCT00916357|3709069|FG000|STARTED|Period 2||3
2992466|NCT00916357|3709070|FG001|STARTED|Period 2||4
2992467|NCT00916357|3709071|FG002|STARTED|Period 2||4
2992468|NCT00916357|3709072|FG003|STARTED|Period 2||4
2992469|NCT00916357|3709073|FG004|STARTED|Period 2||3
2992470|NCT00916357|3709074|FG005|STARTED|Period 2||4
2992471|NCT00916357|3709069|FG000|COMPLETED|Period 2||3
2992472|NCT00916357|3709070|FG001|COMPLETED|Period 2||4
2992473|NCT00916357|3709071|FG002|COMPLETED|Period 2||4
2992474|NCT00916357|3709072|FG003|COMPLETED|Period 2||3
2992475|NCT00916357|3709073|FG004|COMPLETED|Period 2||3
2992476|NCT00916357|3709074|FG005|COMPLETED|Period 2||4
2992477|NCT00916357|3709069|FG000|NOT COMPLETED|Period 2||0
2992478|NCT00916357|3709070|FG001|NOT COMPLETED|Period 2||0
2992479|NCT00916357|3709071|FG002|NOT COMPLETED|Period 2||0
2992480|NCT00916357|3709072|FG003|NOT COMPLETED|Period 2||1
2992481|NCT00916357|3709073|FG004|NOT COMPLETED|Period 2||0
2992482|NCT00916357|3709074|FG005|NOT COMPLETED|Period 2||0
2992483|NCT00916357|3709069|FG000|STARTED|Washout (3 to 14 Days)||3
2992484|NCT00916357|3709070|FG001|STARTED|Washout (3 to 14 Days)||4
2992485|NCT00916357|3709071|FG002|STARTED|Washout (3 to 14 Days)||4
2992486|NCT00916357|3709072|FG003|STARTED|Washout (3 to 14 Days)||3
2992487|NCT00916357|3709073|FG004|STARTED|Washout (3 to 14 Days)||3
2992488|NCT00916357|3709074|FG005|STARTED|Washout (3 to 14 Days)||4
2992489|NCT00916357|3709069|FG000|COMPLETED|Washout (3 to 14 Days)||3
2992490|NCT00916357|3709070|FG001|COMPLETED|Washout (3 to 14 Days)||4
2992491|NCT00916357|3709071|FG002|COMPLETED|Washout (3 to 14 Days)||4
2992492|NCT00916357|3709072|FG003|COMPLETED|Washout (3 to 14 Days)||3
2992493|NCT00916357|3709073|FG004|COMPLETED|Washout (3 to 14 Days)||3
2992494|NCT00916357|3709074|FG005|COMPLETED|Washout (3 to 14 Days)||4
2992495|NCT00916357|3709069|FG000|NOT COMPLETED|Washout (3 to 14 Days)||0
2992496|NCT00916357|3709070|FG001|NOT COMPLETED|Washout (3 to 14 Days)||0
2992497|NCT00916357|3709071|FG002|NOT COMPLETED|Washout (3 to 14 Days)||0
2992498|NCT00916357|3709072|FG003|NOT COMPLETED|Washout (3 to 14 Days)||0
2992499|NCT00916357|3709073|FG004|NOT COMPLETED|Washout (3 to 14 Days)||0
2992500|NCT00916357|3709074|FG005|NOT COMPLETED|Washout (3 to 14 Days)||0
2992501|NCT00916357|3709069|FG000|STARTED|Period 3||3
2992502|NCT00916357|3709070|FG001|STARTED|Period 3||4
2992503|NCT00916357|3709071|FG002|STARTED|Period 3||4
2992504|NCT00916357|3709072|FG003|STARTED|Period 3||3
2992505|NCT00916357|3709073|FG004|STARTED|Period 3||3
2992506|NCT00916357|3709074|FG005|STARTED|Period 3||4
2992507|NCT00916357|3709069|FG000|COMPLETED|Period 3||3
2992508|NCT00916357|3709070|FG001|COMPLETED|Period 3||4
2992509|NCT00916357|3709071|FG002|COMPLETED|Period 3||4
2992510|NCT00916357|3709072|FG003|COMPLETED|Period 3||3
2992511|NCT00916357|3709073|FG004|COMPLETED|Period 3||3
2992512|NCT00916357|3709074|FG005|COMPLETED|Period 3||4
3164541|NCT01893372|3891926|FG000|COMPLETED|Overall Study||7
3164542|NCT01893372|3891927|FG001|COMPLETED|Overall Study||22
3164543|NCT01893372|3891926|FG000|NOT COMPLETED|Overall Study||0
3164544|NCT01893372|3891927|FG001|NOT COMPLETED|Overall Study||0
3164545|NCT01893411|3891936|FG000|STARTED|Overall Study||156
3164546|NCT01893411|3891937|FG001|STARTED|Overall Study||77
3164547|NCT01893411|3891938|FG002|STARTED|Overall Study||78
3305060|NCT02986074|4038750|FG000|STARTED|First Trial Period||26
2992513|NCT00916357|3709069|FG000|NOT COMPLETED|Period 3||0
2992514|NCT00916357|3709070|FG001|NOT COMPLETED|Period 3||0
2992515|NCT00916357|3709071|FG002|NOT COMPLETED|Period 3||0
2992516|NCT00916357|3709072|FG003|NOT COMPLETED|Period 3||0
2992517|NCT00916357|3709073|FG004|NOT COMPLETED|Period 3||0
2992518|NCT00916357|3709074|FG005|NOT COMPLETED|Period 3||0
2992519|NCT00916370|3709085|FG000|STARTED|Overall Study||401
2992520|NCT00916370|3709086|FG001|STARTED|Overall Study||104
2992521|NCT00916370|3709085|FG000|COMPLETED|Overall Study||396
2992522|NCT00916370|3709086|FG001|COMPLETED|Overall Study||102
2992523|NCT00916370|3709085|FG000|NOT COMPLETED|Overall Study||5
2992524|NCT00916370|3709086|FG001|NOT COMPLETED|Overall Study||2
2992525|NCT00916383|3709093|FG000|STARTED|Overall Study||49
2992526|NCT00916383|3709093|FG000|COMPLETED|Overall Study||46
2992527|NCT00916383|3709093|FG000|NOT COMPLETED|Overall Study||3
2992528|NCT00916539|3709103|FG000|STARTED|Overall Study||31
2992529|NCT00916539|3709104|FG001|STARTED|Overall Study||31
3164548|NCT01893411|3891936|FG000|COMPLETED|Overall Study||139
2992530|NCT00916539|3709103|FG000|COMPLETED|Overall Study||31
2992531|NCT00916539|3709104|FG001|COMPLETED|Overall Study||31
2992532|NCT00916539|3709103|FG000|NOT COMPLETED|Overall Study||0
2992533|NCT00916539|3709104|FG001|NOT COMPLETED|Overall Study||0
2992534|NCT00916578|3709110|FG000|STARTED|Overall Study||33
2992535|NCT00916578|3709110|FG000|COMPLETED|Overall Study||26
2992536|NCT00916578|3709110|FG000|NOT COMPLETED|Overall Study||7
2992537|NCT00916617|3709118|FG000|STARTED|Overall Study||24
2992538|NCT00916617|3709119|FG001|STARTED|Overall Study||21
2992539|NCT00916617|3709120|FG002|STARTED|Overall Study||10
2992540|NCT00916617|3709121|FG003|STARTED|Overall Study||7
2992541|NCT00916617|3709118|FG000|COMPLETED|Overall Study||1
2992542|NCT00916617|3709119|FG001|COMPLETED|Overall Study||0
2992543|NCT00916617|3709120|FG002|COMPLETED|Overall Study||0
2992544|NCT00916617|3709121|FG003|COMPLETED|Overall Study||0
2992545|NCT00916617|3709118|FG000|NOT COMPLETED|Overall Study||23
2992546|NCT00916617|3709119|FG001|NOT COMPLETED|Overall Study||21
2992547|NCT00916617|3709120|FG002|NOT COMPLETED|Overall Study||10
2992548|NCT00916617|3709121|FG003|NOT COMPLETED|Overall Study||7
2992549|NCT00916643|3709131|FG000|STARTED|Overall Study||113
2992550|NCT00916643|3709131|FG000|COMPLETED|Overall Study||113
2992551|NCT00916643|3709131|FG000|NOT COMPLETED|Overall Study||0
2992552|NCT00916721|3709137|FG000|STARTED|Overall Study||35
2992553|NCT00916721|3709138|FG001|STARTED|Overall Study||39
2992554|NCT00916721|3709137|FG000|COMPLETED|Overall Study||25
2992555|NCT00916721|3709138|FG001|COMPLETED|Overall Study||29
2992556|NCT00916721|3709137|FG000|NOT COMPLETED|Overall Study||10
2992557|NCT00916721|3709138|FG001|NOT COMPLETED|Overall Study||10
2992558|NCT00916929|3709146|FG000|STARTED|Overall Study||80
2992559|NCT00916929|3709147|FG001|STARTED|Overall Study||82
2992560|NCT00916929|3709146|FG000|COMPLETED|Overall Study||70
2992561|NCT00916929|3709147|FG001|COMPLETED|Overall Study||53
2992562|NCT00916929|3709146|FG000|NOT COMPLETED|Overall Study||10
2992563|NCT00916929|3709147|FG001|NOT COMPLETED|Overall Study||29
2992564|NCT00917124|3709157|FG000|STARTED|Overall Study||100
2992565|NCT00917124|3709158|FG001|STARTED|Overall Study||100
2992566|NCT00917124|3709157|FG000|COMPLETED|Overall Study||96
2992567|NCT00917124|3709158|FG001|COMPLETED|Overall Study||94
2992568|NCT00917124|3709157|FG000|NOT COMPLETED|Overall Study||4
2992569|NCT00917124|3709158|FG001|NOT COMPLETED|Overall Study||6
2992570|NCT00917150|3709168|FG000|STARTED|Overall Study||192
2992571|NCT00917150|3709169|FG001|STARTED|Overall Study||198
2992572|NCT00917150|3709170|FG002|STARTED|Overall Study||191
2992573|NCT00917150|3709171|FG003|STARTED|Overall Study||190
2992574|NCT00917150|3709168|FG000|COMPLETED|Overall Study||155
2992575|NCT00917150|3709169|FG001|COMPLETED|Overall Study||161
2992576|NCT00917150|3709170|FG002|COMPLETED|Overall Study||149
2992577|NCT00917150|3709171|FG003|COMPLETED|Overall Study||156
2992578|NCT00917150|3709168|FG000|NOT COMPLETED|Overall Study||37
2992579|NCT00917150|3709169|FG001|NOT COMPLETED|Overall Study||37
2992580|NCT00917150|3709170|FG002|NOT COMPLETED|Overall Study||42
2992581|NCT00917150|3709171|FG003|NOT COMPLETED|Overall Study||34
2992582|NCT00917267|3709183|FG000|STARTED|Overall Study||346
2992583|NCT00917267|3709184|FG001|STARTED|Overall Study||345
2992584|NCT00917267|3709183|FG000|Intent to Treat (ITT)|Overall Study||340
2992585|NCT00917267|3709184|FG001|Intent to Treat (ITT)|Overall Study||338
2992586|NCT00917267|3709183|FG000|COMPLETED|Overall Study||307
2992587|NCT00917267|3709184|FG001|COMPLETED|Overall Study||266
2992588|NCT00917267|3709183|FG000|NOT COMPLETED|Overall Study||39
2992589|NCT00917267|3709184|FG001|NOT COMPLETED|Overall Study||79
2992590|NCT00917384|3709196|FG000|STARTED|Overall Study||238
2992591|NCT00917384|3709197|FG001|STARTED|Overall Study||117
2992592|NCT00917384|3709196|FG000|Received at Least 1 Dose of Study Drug|Overall Study||236
2992593|NCT00917384|3709197|FG001|Received at Least 1 Dose of Study Drug|Overall Study||115
2992594|NCT00917384|3709196|FG000|COMPLETED|Overall Study||224
2992595|NCT00917384|3709197|FG001|COMPLETED|Overall Study||113
2992596|NCT00917384|3709196|FG000|NOT COMPLETED|Overall Study||14
2992597|NCT00917384|3709197|FG001|NOT COMPLETED|Overall Study||4
2992598|NCT00917462|3709203|FG000|STARTED|Overall Study||35
2992599|NCT00917462|3709203|FG000|COMPLETED|Overall Study||34
2992600|NCT00917462|3709203|FG000|NOT COMPLETED|Overall Study||1
2992601|NCT00917501|3709209|FG000|STARTED|Overall Study||29
2992602|NCT00917501|3709210|FG001|STARTED|Overall Study||26
2992603|NCT00917501|3709209|FG000|COMPLETED|Overall Study||21
2992604|NCT00917501|3709210|FG001|COMPLETED|Overall Study||21
2992605|NCT00917501|3709209|FG000|NOT COMPLETED|Overall Study||8
2992606|NCT00917501|3709210|FG001|NOT COMPLETED|Overall Study||5
2992607|NCT00917553|3709218|FG000|STARTED|Overall Study||17
2992608|NCT00917553|3709219|FG001|STARTED|Overall Study||16
2992609|NCT00917553|3709218|FG000|COMPLETED|Overall Study||15
2992610|NCT00917553|3709219|FG001|COMPLETED|Overall Study||15
2992611|NCT00917553|3709218|FG000|NOT COMPLETED|Overall Study||2
2992612|NCT00917553|3709219|FG001|NOT COMPLETED|Overall Study||1
2992613|NCT00917579|3709225|FG000|STARTED|Period 1: 1st Intervention||39
2992614|NCT00917579|3709226|FG001|STARTED|Period 1: 1st Intervention||37
2992615|NCT00917579|3709225|FG000|COMPLETED|Period 1: 1st Intervention||39
2992616|NCT00917579|3709226|FG001|COMPLETED|Period 1: 1st Intervention||37
2992617|NCT00917579|3709225|FG000|NOT COMPLETED|Period 1: 1st Intervention||0
2992618|NCT00917579|3709226|FG001|NOT COMPLETED|Period 1: 1st Intervention||0
2992619|NCT00917579|3709225|FG000|STARTED|Washout >= 2 Weeks||39
2992620|NCT00917579|3709226|FG001|STARTED|Washout >= 2 Weeks||37
2992621|NCT00917579|3709225|FG000|COMPLETED|Washout >= 2 Weeks||37
2992622|NCT00917579|3709226|FG001|COMPLETED|Washout >= 2 Weeks||37
2992623|NCT00917579|3709225|FG000|NOT COMPLETED|Washout >= 2 Weeks||2
2992624|NCT00917579|3709226|FG001|NOT COMPLETED|Washout >= 2 Weeks||0
2992625|NCT00917579|3709225|FG000|STARTED|Period 2: 2nd Intervention||37
2992626|NCT00917579|3709226|FG001|STARTED|Period 2: 2nd Intervention||37
2992627|NCT00917579|3709225|FG000|COMPLETED|Period 2: 2nd Intervention||37
2992628|NCT00917579|3709226|FG001|COMPLETED|Period 2: 2nd Intervention||37
2992629|NCT00917579|3709225|FG000|NOT COMPLETED|Period 2: 2nd Intervention||0
2992630|NCT00917579|3709226|FG001|NOT COMPLETED|Period 2: 2nd Intervention||0
2992631|NCT00917644|3709232|FG000|STARTED|Period 1: First Intervention||39
2992632|NCT00917644|3709233|FG001|STARTED|Period 1: First Intervention||37
2992633|NCT00917644|3709232|FG000|COMPLETED|Period 1: First Intervention||39
2992634|NCT00917644|3709233|FG001|COMPLETED|Period 1: First Intervention||37
2992635|NCT00917644|3709232|FG000|NOT COMPLETED|Period 1: First Intervention||0
2992636|NCT00917644|3709233|FG001|NOT COMPLETED|Period 1: First Intervention||0
2992637|NCT00917644|3709232|FG000|STARTED|Period: Washout Period of > = 2 Weeks||39
2992638|NCT00917644|3709233|FG001|STARTED|Period: Washout Period of > = 2 Weeks||37
2992639|NCT00917644|3709232|FG000|COMPLETED|Period: Washout Period of > = 2 Weeks||37
2992640|NCT00917644|3709233|FG001|COMPLETED|Period: Washout Period of > = 2 Weeks||37
2992641|NCT00917644|3709232|FG000|NOT COMPLETED|Period: Washout Period of > = 2 Weeks||2
2992642|NCT00917644|3709233|FG001|NOT COMPLETED|Period: Washout Period of > = 2 Weeks||0
2992643|NCT00917644|3709232|FG000|STARTED|Period 2: Second Intervention|Washout: Test drug 1st, completed = 37; 2nd period: Test drug 2nd, completed = 37.|37
2992644|NCT00917644|3709233|FG001|STARTED|Period 2: Second Intervention|Washout: Reference drug (Ref) 1st, completed = 37; 2nd period: Ref drug 2nd, completed = 36.|37
2992645|NCT00917644|3709232|FG000|COMPLETED|Period 2: Second Intervention|Total number of subjects completed Test drug = 74.|36
2992646|NCT00917644|3709233|FG001|COMPLETED|Period 2: Second Intervention|Total number of subjects completed Ref drug = 73.|37
2992647|NCT00917644|3709232|FG000|NOT COMPLETED|Period 2: Second Intervention||1
2992648|NCT00917644|3709233|FG001|NOT COMPLETED|Period 2: Second Intervention||0
2992649|NCT00917735|3709241|FG000|STARTED|Overall Study||538
2992650|NCT00917735|3709242|FG001|STARTED|Overall Study||537
2992651|NCT00917735|3709241|FG000|COMPLETED|Overall Study||463
2992652|NCT00917735|3709242|FG001|COMPLETED|Overall Study||474
2992653|NCT00917735|3709241|FG000|NOT COMPLETED|Overall Study||75
2992654|NCT00917735|3709242|FG001|NOT COMPLETED|Overall Study||63
2992655|NCT00917852|3709248|FG000|STARTED|Overall Study||51
2992656|NCT00917852|3709248|FG000|COMPLETED|Overall Study||45
2992657|NCT00917852|3709248|FG000|NOT COMPLETED|Overall Study||6
2992658|NCT00917865|3709253|FG000|STARTED|Overall Study||11
2992659|NCT00917865|3709253|FG000|COMPLETED|Overall Study||11
2992660|NCT00917865|3709253|FG000|NOT COMPLETED|Overall Study||0
2992661|NCT00918125|3709266|FG000|STARTED|Overall Study||20
2992662|NCT00918125|3709267|FG001|STARTED|Overall Study||39
2992663|NCT00918125|3709266|FG000|COMPLETED|Overall Study||20
2992664|NCT00918125|3709267|FG001|COMPLETED|Overall Study||39
2992665|NCT00918125|3709266|FG000|NOT COMPLETED|Overall Study||0
2992666|NCT00918125|3709267|FG001|NOT COMPLETED|Overall Study||0
2992667|NCT00918138|3709278|FG000|STARTED|Overall Study||46
2992668|NCT00918138|3709279|FG001|STARTED|Overall Study||47
2992669|NCT00918138|3709278|FG000|COMPLETED|Overall Study||44
2992670|NCT00918138|3709279|FG001|COMPLETED|Overall Study||46
2992671|NCT00918138|3709278|FG000|NOT COMPLETED|Overall Study||2
2992672|NCT00918138|3709279|FG001|NOT COMPLETED|Overall Study||1
2992673|NCT00918203|3709287|FG000|STARTED|Treatment With or Without Olaratumab||70
2992674|NCT00918203|3709288|FG001|STARTED|Treatment With or Without Olaratumab||67
2992675|NCT00918203|3709289|FG002|STARTED|Treatment With or Without Olaratumab||0
2992676|NCT00918203|3709287|FG000|Received at Least 1 Dose of Study Drug|Treatment With or Without Olaratumab||67
2992677|NCT00918203|3709288|FG001|Received at Least 1 Dose of Study Drug|Treatment With or Without Olaratumab||64
2992678|NCT00918203|3709289|FG002|Received at Least 1 Dose of Study Drug|Treatment With or Without Olaratumab||0
2992679|NCT00918203|3709287|FG000|Death Due to Any Cause|Treatment With or Without Olaratumab||53
2992680|NCT00918203|3709288|FG001|Death Due to Any Cause|Treatment With or Without Olaratumab||47
2992681|NCT00918203|3709289|FG002|Death Due to Any Cause|Treatment With or Without Olaratumab||0
2992682|NCT00918203|3709287|FG000|Alive/On Study at End/Off Treatment|Treatment With or Without Olaratumab||11
2992683|NCT00918203|3709288|FG001|Alive/On Study at End/Off Treatment|Treatment With or Without Olaratumab||10
2992684|NCT00918203|3709289|FG002|Alive/On Study at End/Off Treatment|Treatment With or Without Olaratumab||0
2992685|NCT00918203|3709287|FG000|COMPLETED|Treatment With or Without Olaratumab||64
2992686|NCT00918203|3709288|FG001|COMPLETED|Treatment With or Without Olaratumab||57
2992687|NCT00918203|3709289|FG002|COMPLETED|Treatment With or Without Olaratumab||0
2992688|NCT00918203|3709287|FG000|NOT COMPLETED|Treatment With or Without Olaratumab||6
2992689|NCT00918203|3709288|FG001|NOT COMPLETED|Treatment With or Without Olaratumab||10
2992690|NCT00918203|3709289|FG002|NOT COMPLETED|Treatment With or Without Olaratumab||0
2992691|NCT00918203|3709287|FG000|STARTED|Crossover to Olaratumab Monotherapy||0
2992692|NCT00918203|3709288|FG001|STARTED|Crossover to Olaratumab Monotherapy||0
2992693|NCT00918203|3709289|FG002|STARTED|Crossover to Olaratumab Monotherapy|18 participants who had progressive disease crossed over to monotherapy.|18
2992694|NCT00918203|3709287|FG000|COMPLETED|Crossover to Olaratumab Monotherapy||0
2992695|NCT00918203|3709288|FG001|COMPLETED|Crossover to Olaratumab Monotherapy||0
2992696|NCT00918203|3709289|FG002|COMPLETED|Crossover to Olaratumab Monotherapy||18
2992697|NCT00918203|3709287|FG000|NOT COMPLETED|Crossover to Olaratumab Monotherapy||0
2992698|NCT00918203|3709288|FG001|NOT COMPLETED|Crossover to Olaratumab Monotherapy||0
2992699|NCT00918203|3709289|FG002|NOT COMPLETED|Crossover to Olaratumab Monotherapy||0
2992700|NCT00918229|3709301|FG000|STARTED|Overall Study||24
2992701|NCT00918229|3709301|FG000|COMPLETED|Overall Study||24
2992702|NCT00918229|3709301|FG000|NOT COMPLETED|Overall Study||0
2992703|NCT00918255|3709308|FG000|STARTED|Overall Study||51
2992704|NCT00918255|3709309|FG001|STARTED|Overall Study||52
2992705|NCT00918255|3709310|FG002|STARTED|Overall Study||51
2992706|NCT00918255|3709308|FG000|COMPLETED|Overall Study||45
2992707|NCT00918255|3709309|FG001|COMPLETED|Overall Study||52
2992708|NCT00918255|3709310|FG002|COMPLETED|Overall Study||46
2992709|NCT00918255|3709308|FG000|NOT COMPLETED|Overall Study||6
2992710|NCT00918255|3709309|FG001|NOT COMPLETED|Overall Study||0
2992711|NCT00918255|3709310|FG002|NOT COMPLETED|Overall Study||5
2992712|NCT00918281|3709318|FG000|STARTED|Overall Study||70
2992713|NCT00918281|3709318|FG000|COMPLETED|Overall Study||41
2992714|NCT00918281|3709318|FG000|NOT COMPLETED|Overall Study||29
2992715|NCT00918333|3709327|FG000|STARTED|Overall Study||26
2992716|NCT00918333|3709328|FG001|STARTED|Overall Study||98
2992717|NCT00918333|3709327|FG000|COMPLETED|Overall Study||23
2992718|NCT00918333|3709328|FG001|COMPLETED|Overall Study||93
2992719|NCT00918333|3709327|FG000|NOT COMPLETED|Overall Study||3
2992720|NCT00918333|3709328|FG001|NOT COMPLETED|Overall Study||5
2992721|NCT00918346|3709337|FG000|STARTED|First Treatment Period (4 Weeks)||21
2992722|NCT00918346|3709338|FG001|STARTED|First Treatment Period (4 Weeks)||22
2992723|NCT00918346|3709337|FG000|COMPLETED|First Treatment Period (4 Weeks)||21
2992724|NCT00918346|3709338|FG001|COMPLETED|First Treatment Period (4 Weeks)|A patient completed the first treatment period but discontinued thereafter (did not start washout).|21
2992725|NCT00918346|3709337|FG000|NOT COMPLETED|First Treatment Period (4 Weeks)||0
2992726|NCT00918346|3709338|FG001|NOT COMPLETED|First Treatment Period (4 Weeks)||1
2992727|NCT00918346|3709337|FG000|STARTED|Washout (at Least 4 Weeks)||21
2992728|NCT00918346|3709338|FG001|STARTED|Washout (at Least 4 Weeks)||21
2992729|NCT00918346|3709337|FG000|COMPLETED|Washout (at Least 4 Weeks)||21
2992730|NCT00918346|3709338|FG001|COMPLETED|Washout (at Least 4 Weeks)||21
2992731|NCT00918346|3709337|FG000|NOT COMPLETED|Washout (at Least 4 Weeks)||0
2992732|NCT00918346|3709338|FG001|NOT COMPLETED|Washout (at Least 4 Weeks)||0
2992733|NCT00918346|3709337|FG000|STARTED|Second Treatment Period (4 Weeks)||21
2992734|NCT00918346|3709338|FG001|STARTED|Second Treatment Period (4 Weeks)||21
2992735|NCT00918346|3709337|FG000|COMPLETED|Second Treatment Period (4 Weeks)||21
2992736|NCT00918346|3709338|FG001|COMPLETED|Second Treatment Period (4 Weeks)||21
2992737|NCT00918346|3709337|FG000|NOT COMPLETED|Second Treatment Period (4 Weeks)||0
2992738|NCT00918346|3709338|FG001|NOT COMPLETED|Second Treatment Period (4 Weeks)||0
2992739|NCT00918346|3709337|FG000|STARTED|Post Study Period||21
2992740|NCT00918346|3709338|FG001|STARTED|Post Study Period||21
2992741|NCT00918346|3709337|FG000|COMPLETED|Post Study Period||21
2992742|NCT00918346|3709338|FG001|COMPLETED|Post Study Period||21
2992743|NCT00918346|3709337|FG000|NOT COMPLETED|Post Study Period||0
2992744|NCT00918346|3709338|FG001|NOT COMPLETED|Post Study Period||0
2992745|NCT00918385|3709349|FG000|STARTED|Monotherapy||14
2992746|NCT00918385|3709350|FG001|STARTED|Monotherapy||17
2992747|NCT00918385|3709349|FG000|COMPLETED|Monotherapy|Completed = received treatment until first disease progression on single agent.|12
2992748|NCT00918385|3709350|FG001|COMPLETED|Monotherapy|Completed = received treatment until first disease progression on single agent.|11
2992749|NCT00918385|3709349|FG000|NOT COMPLETED|Monotherapy||2
2992750|NCT00918385|3709350|FG001|NOT COMPLETED|Monotherapy||6
2992751|NCT00918385|3709349|FG000|STARTED|Combination Nilutamide and Dasatinib||12
2992752|NCT00918385|3709350|FG001|STARTED|Combination Nilutamide and Dasatinib||11
2992753|NCT00918385|3709349|FG000|COMPLETED|Combination Nilutamide and Dasatinib||6
2992754|NCT00918385|3709350|FG001|COMPLETED|Combination Nilutamide and Dasatinib||3
2992755|NCT00918385|3709349|FG000|NOT COMPLETED|Combination Nilutamide and Dasatinib||6
2992756|NCT00918385|3709350|FG001|NOT COMPLETED|Combination Nilutamide and Dasatinib||8
2992757|NCT00918567|3709360|FG000|STARTED|Overall Study||29
2992758|NCT00918567|3709361|FG001|STARTED|Overall Study||27
2992759|NCT00918567|3709360|FG000|COMPLETED|Overall Study||24
2992760|NCT00918567|3709361|FG001|COMPLETED|Overall Study||25
2992761|NCT00918567|3709360|FG000|NOT COMPLETED|Overall Study||5
2992762|NCT00918567|3709361|FG001|NOT COMPLETED|Overall Study||2
2992763|NCT00918580|3709367|FG000|STARTED|Up to 6-month Follow-up(FU)||158
2992764|NCT00918580|3709367|FG000|Vaccinated Dose 1|Up to 6-month Follow-up(FU)||158
2992765|NCT00918580|3709367|FG000|Vaccinated Dose 2|Up to 6-month Follow-up(FU)||146
2992766|NCT00918580|3709367|FG000|COMPLETED|Up to 6-month Follow-up(FU)|Completed include 1 participant:withdrew before Dose 2 (protocol violation) but completed 6-month FU|147
2992767|NCT00918580|3709367|FG000|NOT COMPLETED|Up to 6-month Follow-up(FU)||11
2992768|NCT00918580|3709367|FG000|STARTED|After 6-month FU to 1-year FU||147
2992769|NCT00918580|3709367|FG000|Continued After 6-Month FU|After 6-month FU to 1-year FU||89
2992770|NCT00918580|3709367|FG000|COMPLETED|After 6-month FU to 1-year FU||87
2992771|NCT00918580|3709367|FG000|NOT COMPLETED|After 6-month FU to 1-year FU||60
2992772|NCT00918671|3709374|FG000|STARTED|Overall Study||60
2992773|NCT00918671|3709374|FG000|COMPLETED|Overall Study||60
2992774|NCT00918671|3709374|FG000|NOT COMPLETED|Overall Study||0
2992775|NCT00918684|3709378|FG000|STARTED|Two Week Drug Washout and Placebo Phase||106
2992776|NCT00918684|3709378|FG000|COMPLETED|Two Week Drug Washout and Placebo Phase||90
2992777|NCT00918684|3709378|FG000|NOT COMPLETED|Two Week Drug Washout and Placebo Phase||16
2992778|NCT00918684|3709378|FG000|STARTED|Treatment Phase||90
2992779|NCT00918684|3709378|FG000|COMPLETED|Treatment Phase||65
2992780|NCT00918684|3709378|FG000|NOT COMPLETED|Treatment Phase||25
2992781|NCT00918723|3709382|FG000|STARTED|Overall Study||40
2992782|NCT00918723|3709382|FG000|COMPLETED|Overall Study||40
2992783|NCT00918723|3709382|FG000|NOT COMPLETED|Overall Study||0
2992784|NCT00918736|3709388|FG000|STARTED|Overall Study|October, 2007|50
2992785|NCT00918736|3709388|FG000|COMPLETED|Overall Study|October, 2008|46
2992786|NCT00918736|3709388|FG000|NOT COMPLETED|Overall Study||4
2992787|NCT00918749|3709395|FG000|STARTED|Overall Study||70
2992788|NCT00918749|3709396|FG001|STARTED|Overall Study||66
2992789|NCT00918749|3709397|FG002|STARTED|Overall Study||69
2992790|NCT00918749|3709395|FG000|ITT (Intent to Treat) Population|Overall Study|One subject took no study drug and was not included in ITT Population|69
2992791|NCT00918749|3709396|FG001|ITT (Intent to Treat) Population|Overall Study||66
2992792|NCT00918749|3709397|FG002|ITT (Intent to Treat) Population|Overall Study||69
2992793|NCT00918749|3709395|FG000|COMPLETED|Overall Study||63
2992794|NCT00918749|3709396|FG001|COMPLETED|Overall Study||63
2992795|NCT00918749|3709397|FG002|COMPLETED|Overall Study||62
2992796|NCT00918749|3709395|FG000|NOT COMPLETED|Overall Study||7
2992797|NCT00918749|3709396|FG001|NOT COMPLETED|Overall Study||3
2992798|NCT00918749|3709397|FG002|NOT COMPLETED|Overall Study||7
2992799|NCT00918866|3709407|FG000|STARTED|Overall Study||16
2992800|NCT00918866|3709408|FG001|STARTED|Overall Study||16
2992801|NCT00918866|3709407|FG000|COMPLETED|Overall Study||16
2992802|NCT00918866|3709408|FG001|COMPLETED|Overall Study||16
2992803|NCT00918866|3709407|FG000|NOT COMPLETED|Overall Study||0
2992804|NCT00918866|3709408|FG001|NOT COMPLETED|Overall Study||0
2992805|NCT00918879|3709416|FG000|STARTED|Overall Study|Randomized and treated|107
2992806|NCT00918879|3709417|FG001|STARTED|Overall Study|Randomized and treated|106
2992807|NCT00918879|3709416|FG000|COMPLETED|Overall Study|Completed 24 weeks of treatment|101
2992808|NCT00918879|3709417|FG001|COMPLETED|Overall Study|Completed 24 weeks of treatment|100
2992809|NCT00918879|3709416|FG000|NOT COMPLETED|Overall Study||6
2992810|NCT00918879|3709417|FG001|NOT COMPLETED|Overall Study||6
2992811|NCT00918931|3709423|FG000|STARTED|Overall Study||3
2992812|NCT00918931|3709423|FG000|COMPLETED|Overall Study||3
2992813|NCT00918931|3709423|FG000|NOT COMPLETED|Overall Study||0
2992814|NCT00918957|3709429|FG000|STARTED|Overall Study||32
2992815|NCT00918957|3709430|FG001|STARTED|Overall Study||30
2992816|NCT00918957|3709429|FG000|COMPLETED|Overall Study||29
2992817|NCT00918957|3709430|FG001|COMPLETED|Overall Study||30
2992818|NCT00918957|3709429|FG000|NOT COMPLETED|Overall Study||3
2992819|NCT00918957|3709430|FG001|NOT COMPLETED|Overall Study||0
2992820|NCT00919035|3709436|FG000|STARTED|Overall Study||21
2992821|NCT00919035|3709436|FG000|COMPLETED|Overall Study||21
3164549|NCT01893411|3891937|FG001|COMPLETED|Overall Study||70
3164550|NCT01893411|3891938|FG002|COMPLETED|Overall Study||69
3164551|NCT01893411|3891936|FG000|NOT COMPLETED|Overall Study||17
3164552|NCT01893411|3891937|FG001|NOT COMPLETED|Overall Study||7
3164553|NCT01893411|3891938|FG002|NOT COMPLETED|Overall Study||9
3164554|NCT01893567|3891946|FG000|STARTED|Overall Study||28
3164555|NCT01893567|3891946|FG000|COMPLETED|Overall Study||28
3164556|NCT01893567|3891946|FG000|NOT COMPLETED|Overall Study||0
3164557|NCT01893632|3891952|FG000|STARTED|Overall Study||1
3164558|NCT01893632|3891953|FG001|STARTED|Overall Study||1
3164559|NCT01893632|3891952|FG000|COMPLETED|Overall Study||1
3164560|NCT01893632|3891953|FG001|COMPLETED|Overall Study||1
3164561|NCT01893632|3891952|FG000|NOT COMPLETED|Overall Study||0
3164562|NCT01893632|3891953|FG001|NOT COMPLETED|Overall Study||0
2992822|NCT00919035|3709436|FG000|NOT COMPLETED|Overall Study||0
2992823|NCT00919061|3709440|FG000|STARTED|Overall Study||39
2992824|NCT00919061|3709440|FG000|COMPLETED|Overall Study||37
2992825|NCT00919061|3709440|FG000|NOT COMPLETED|Overall Study||2
2992826|NCT00919100|3709446|FG000|STARTED|Overall Study||40
2992827|NCT00919100|3709447|FG001|STARTED|Overall Study||41
2992828|NCT00919100|3709446|FG000|COMPLETED|Overall Study||40
2992829|NCT00919100|3709447|FG001|COMPLETED|Overall Study||41
2992830|NCT00919100|3709446|FG000|NOT COMPLETED|Overall Study||0
2992831|NCT00919100|3709447|FG001|NOT COMPLETED|Overall Study||0
2992832|NCT00919113|3709455|FG000|STARTED|Overall Study||50
2992833|NCT00919113|3709456|FG001|STARTED|Overall Study||48
2992834|NCT00919113|3709455|FG000|Received Uracyst|Overall Study|One subject was misrandomized. Actual treatment was used for Demographic and Safety analysis.|49
2992835|NCT00919113|3709456|FG001|Received Uracyst|Overall Study||0
2992836|NCT00919113|3709455|FG000|Received Placebo|Overall Study||0
2992837|NCT00919113|3709456|FG001|Received Placebo|Overall Study|One subject was misrandomized. Actual treatment was used for Demographic and Safety analysis.|49
2992838|NCT00919113|3709455|FG000|COMPLETED|Overall Study||41
3164563|NCT01893801|3891959|FG000|STARTED|Overall Study||25
3164564|NCT01893801|3891959|FG000|COMPLETED|Overall Study||25
2992839|NCT00919113|3709456|FG001|COMPLETED|Overall Study||40
2992840|NCT00919113|3709455|FG000|NOT COMPLETED|Overall Study||9
2992841|NCT00919113|3709456|FG001|NOT COMPLETED|Overall Study||8
2992842|NCT00919126|3709465|FG000|STARTED|Overall Study||32
2992843|NCT00919126|3709466|FG001|STARTED|Overall Study||37
2992844|NCT00919126|3709467|FG002|STARTED|Overall Study||33
2992845|NCT00919126|3709465|FG000|COMPLETED|Overall Study||31
2992846|NCT00919126|3709466|FG001|COMPLETED|Overall Study||32
2992847|NCT00919126|3709467|FG002|COMPLETED|Overall Study||32
2992848|NCT00919126|3709465|FG000|NOT COMPLETED|Overall Study||1
2992849|NCT00919126|3709466|FG001|NOT COMPLETED|Overall Study||5
2992850|NCT00919126|3709467|FG002|NOT COMPLETED|Overall Study||1
2992851|NCT00919191|3709476|FG000|STARTED|Overall Study||26
2992852|NCT00919191|3709476|FG000|COMPLETED|Overall Study||26
2992853|NCT00919191|3709476|FG000|NOT COMPLETED|Overall Study||0
2992854|NCT00919503|3709484|FG000|STARTED|Overall Study||84
2992855|NCT00919503|3709485|FG001|STARTED|Overall Study||14
2992856|NCT00919503|3709484|FG000|COMPLETED|Overall Study||84
2992857|NCT00919503|3709485|FG001|COMPLETED|Overall Study||14
2992858|NCT00919503|3709484|FG000|NOT COMPLETED|Overall Study||0
2992859|NCT00919503|3709485|FG001|NOT COMPLETED|Overall Study||0
2992860|NCT00919633|3709495|FG000|STARTED|Overall Study||28
2992861|NCT00919633|3709496|FG001|STARTED|Overall Study||25
2992862|NCT00919633|3709497|FG002|STARTED|Overall Study||27
2992863|NCT00919633|3709498|FG003|STARTED|Overall Study||26
2992864|NCT00919633|3709495|FG000|COMPLETED|Overall Study||6
2992865|NCT00919633|3709496|FG001|COMPLETED|Overall Study||10
2992866|NCT00919633|3709497|FG002|COMPLETED|Overall Study||4
2992867|NCT00919633|3709498|FG003|COMPLETED|Overall Study||5
2992868|NCT00919633|3709495|FG000|NOT COMPLETED|Overall Study||22
2992869|NCT00919633|3709496|FG001|NOT COMPLETED|Overall Study||15
2992870|NCT00919633|3709497|FG002|NOT COMPLETED|Overall Study||23
2992871|NCT00919633|3709498|FG003|NOT COMPLETED|Overall Study||21
2992872|NCT00919711|3709510|FG000|STARTED|Overall Study||435
2992873|NCT00919711|3709511|FG001|STARTED|Overall Study||435
2992874|NCT00919711|3709510|FG000|COMPLETED|Overall Study||402
2992875|NCT00919711|3709511|FG001|COMPLETED|Overall Study||422
2992876|NCT00919711|3709510|FG000|NOT COMPLETED|Overall Study||33
2992877|NCT00919711|3709511|FG001|NOT COMPLETED|Overall Study||13
2992878|NCT00919724|3709519|FG000|STARTED|Overall Study||45
2992879|NCT00919724|3709520|FG001|STARTED|Overall Study||44
2992880|NCT00919724|3709519|FG000|COMPLETED|Overall Study||45
2992881|NCT00919724|3709520|FG001|COMPLETED|Overall Study||44
2992882|NCT00919724|3709519|FG000|NOT COMPLETED|Overall Study||0
2992883|NCT00919724|3709520|FG001|NOT COMPLETED|Overall Study||0
2992884|NCT00919763|3709528|FG000|STARTED|Overall Study||53
2992885|NCT00919763|3709529|FG001|STARTED|Overall Study||49
2992886|NCT00919763|3709528|FG000|COMPLETED|Overall Study||41
2992887|NCT00919763|3709529|FG001|COMPLETED|Overall Study||45
2992888|NCT00919763|3709528|FG000|NOT COMPLETED|Overall Study||12
2992889|NCT00919763|3709529|FG001|NOT COMPLETED|Overall Study||4
2992890|NCT00919802|3709535|FG000|STARTED|First Intervention - (24 Hours)||12
2992891|NCT00919802|3709536|FG001|STARTED|First Intervention - (24 Hours)||13
2992892|NCT00919802|3709535|FG000|COMPLETED|First Intervention - (24 Hours)||12
2992893|NCT00919802|3709536|FG001|COMPLETED|First Intervention - (24 Hours)||13
2992894|NCT00919802|3709535|FG000|NOT COMPLETED|First Intervention - (24 Hours)||0
2992895|NCT00919802|3709536|FG001|NOT COMPLETED|First Intervention - (24 Hours)||0
2992896|NCT00919802|3709535|FG000|STARTED|Second Intervention - (24 Hours)||12
2992897|NCT00919802|3709536|FG001|STARTED|Second Intervention - (24 Hours)||13
2992898|NCT00919802|3709535|FG000|COMPLETED|Second Intervention - (24 Hours)||12
2992899|NCT00919802|3709536|FG001|COMPLETED|Second Intervention - (24 Hours)||13
2992900|NCT00919802|3709535|FG000|NOT COMPLETED|Second Intervention - (24 Hours)||0
2992901|NCT00919802|3709536|FG001|NOT COMPLETED|Second Intervention - (24 Hours)||0
2992902|NCT00919854|3709542|FG000|STARTED|Overall Study||21
2992903|NCT00919854|3709542|FG000|COMPLETED|Overall Study|'Completed' represents the patients that are ongoing at the time of cut-off for the Week 24 analysis|20
2992904|NCT00919854|3709542|FG000|NOT COMPLETED|Overall Study||1
2992905|NCT00919867|3709552|FG000|STARTED|First Intervention||7
2992906|NCT00919867|3709553|FG001|STARTED|First Intervention||7
2992907|NCT00919867|3709554|FG002|STARTED|First Intervention||7
2992908|NCT00919867|3709555|FG003|STARTED|First Intervention||7
2992909|NCT00919867|3709556|FG004|STARTED|First Intervention||7
2992910|NCT00919867|3709557|FG005|STARTED|First Intervention||7
2992911|NCT00919867|3709552|FG000|COMPLETED|First Intervention||7
2992912|NCT00919867|3709553|FG001|COMPLETED|First Intervention||7
2992913|NCT00919867|3709554|FG002|COMPLETED|First Intervention||6
2992914|NCT00919867|3709555|FG003|COMPLETED|First Intervention||7
2992915|NCT00919867|3709556|FG004|COMPLETED|First Intervention||7
2992916|NCT00919867|3709557|FG005|COMPLETED|First Intervention||6
2992917|NCT00919867|3709552|FG000|NOT COMPLETED|First Intervention||0
2992918|NCT00919867|3709553|FG001|NOT COMPLETED|First Intervention||0
2992919|NCT00919867|3709554|FG002|NOT COMPLETED|First Intervention||1
2992920|NCT00919867|3709555|FG003|NOT COMPLETED|First Intervention||0
2992921|NCT00919867|3709556|FG004|NOT COMPLETED|First Intervention||0
2992922|NCT00919867|3709557|FG005|NOT COMPLETED|First Intervention||1
2992923|NCT00919867|3709552|FG000|STARTED|Washout||7
2992924|NCT00919867|3709553|FG001|STARTED|Washout||7
2992925|NCT00919867|3709554|FG002|STARTED|Washout||6
2992926|NCT00919867|3709555|FG003|STARTED|Washout||7
2992927|NCT00919867|3709556|FG004|STARTED|Washout||7
2992928|NCT00919867|3709557|FG005|STARTED|Washout||6
2992929|NCT00919867|3709552|FG000|COMPLETED|Washout||7
2992930|NCT00919867|3709553|FG001|COMPLETED|Washout||7
2992931|NCT00919867|3709554|FG002|COMPLETED|Washout||6
2992932|NCT00919867|3709555|FG003|COMPLETED|Washout||7
2992933|NCT00919867|3709556|FG004|COMPLETED|Washout||7
2992934|NCT00919867|3709557|FG005|COMPLETED|Washout||6
2992935|NCT00919867|3709552|FG000|NOT COMPLETED|Washout||0
2992936|NCT00919867|3709553|FG001|NOT COMPLETED|Washout||0
2992937|NCT00919867|3709554|FG002|NOT COMPLETED|Washout||0
2992938|NCT00919867|3709555|FG003|NOT COMPLETED|Washout||0
2992939|NCT00919867|3709556|FG004|NOT COMPLETED|Washout||0
2992940|NCT00919867|3709557|FG005|NOT COMPLETED|Washout||0
2992941|NCT00919867|3709552|FG000|STARTED|Second Intervention||7
2992942|NCT00919867|3709553|FG001|STARTED|Second Intervention||7
2992943|NCT00919867|3709554|FG002|STARTED|Second Intervention||6
2992944|NCT00919867|3709555|FG003|STARTED|Second Intervention||7
2992945|NCT00919867|3709556|FG004|STARTED|Second Intervention||7
2992946|NCT00919867|3709557|FG005|STARTED|Second Intervention||6
2992947|NCT00919867|3709552|FG000|COMPLETED|Second Intervention||7
2992948|NCT00919867|3709553|FG001|COMPLETED|Second Intervention||7
2992949|NCT00919867|3709554|FG002|COMPLETED|Second Intervention||6
2992950|NCT00919867|3709555|FG003|COMPLETED|Second Intervention||7
2992951|NCT00919867|3709556|FG004|COMPLETED|Second Intervention||7
2992952|NCT00919867|3709557|FG005|COMPLETED|Second Intervention||6
2992953|NCT00919867|3709552|FG000|NOT COMPLETED|Second Intervention||0
2992954|NCT00919867|3709553|FG001|NOT COMPLETED|Second Intervention||0
2992955|NCT00919867|3709554|FG002|NOT COMPLETED|Second Intervention||0
2992956|NCT00919867|3709555|FG003|NOT COMPLETED|Second Intervention||0
2992957|NCT00919867|3709556|FG004|NOT COMPLETED|Second Intervention||0
2992958|NCT00919867|3709557|FG005|NOT COMPLETED|Second Intervention||0
2992959|NCT00919867|3709552|FG000|STARTED|Washout||7
2992960|NCT00919867|3709553|FG001|STARTED|Washout||7
2992961|NCT00919867|3709554|FG002|STARTED|Washout||6
2992962|NCT00919867|3709555|FG003|STARTED|Washout||7
2992963|NCT00919867|3709556|FG004|STARTED|Washout||7
2992964|NCT00919867|3709557|FG005|STARTED|Washout||6
2992965|NCT00919867|3709552|FG000|COMPLETED|Washout||7
2992966|NCT00919867|3709553|FG001|COMPLETED|Washout||7
2992967|NCT00919867|3709554|FG002|COMPLETED|Washout||6
2992968|NCT00919867|3709555|FG003|COMPLETED|Washout||7
2992969|NCT00919867|3709556|FG004|COMPLETED|Washout||7
2992970|NCT00919867|3709557|FG005|COMPLETED|Washout||6
2992971|NCT00919867|3709552|FG000|NOT COMPLETED|Washout||0
2992972|NCT00919867|3709553|FG001|NOT COMPLETED|Washout||0
2992973|NCT00919867|3709554|FG002|NOT COMPLETED|Washout||0
2992974|NCT00919867|3709555|FG003|NOT COMPLETED|Washout||0
2992975|NCT00919867|3709556|FG004|NOT COMPLETED|Washout||0
2992976|NCT00919867|3709557|FG005|NOT COMPLETED|Washout||0
2992977|NCT00919867|3709552|FG000|STARTED|Third Intervention||7
2992978|NCT00919867|3709553|FG001|STARTED|Third Intervention||7
2992979|NCT00919867|3709554|FG002|STARTED|Third Intervention||6
2992980|NCT00919867|3709555|FG003|STARTED|Third Intervention||7
2992981|NCT00919867|3709556|FG004|STARTED|Third Intervention||7
2992982|NCT00919867|3709557|FG005|STARTED|Third Intervention||6
2992983|NCT00919867|3709552|FG000|COMPLETED|Third Intervention||7
2992984|NCT00919867|3709553|FG001|COMPLETED|Third Intervention||7
2992985|NCT00919867|3709554|FG002|COMPLETED|Third Intervention||6
2992986|NCT00919867|3709555|FG003|COMPLETED|Third Intervention||7
2992987|NCT00919867|3709556|FG004|COMPLETED|Third Intervention||7
2992988|NCT00919867|3709557|FG005|COMPLETED|Third Intervention||6
2992989|NCT00919867|3709552|FG000|NOT COMPLETED|Third Intervention||0
2992990|NCT00919867|3709553|FG001|NOT COMPLETED|Third Intervention||0
2992991|NCT00919867|3709554|FG002|NOT COMPLETED|Third Intervention||0
2992992|NCT00919867|3709555|FG003|NOT COMPLETED|Third Intervention||0
2992993|NCT00919867|3709556|FG004|NOT COMPLETED|Third Intervention||0
2992994|NCT00919867|3709557|FG005|NOT COMPLETED|Third Intervention||0
2992995|NCT00919932|3709567|FG000|STARTED|Overall Study||4
2992996|NCT00919932|3709568|FG001|STARTED|Overall Study||5
2992997|NCT00919932|3709567|FG000|COMPLETED|Overall Study||4
2992998|NCT00919932|3709568|FG001|COMPLETED|Overall Study||5
2992999|NCT00919932|3709567|FG000|NOT COMPLETED|Overall Study||0
2993000|NCT00919932|3709568|FG001|NOT COMPLETED|Overall Study||0
3036842|NCT01145222|3756099|FG000|NOT COMPLETED|Overall Study||0
3036843|NCT01145222|3756100|FG001|NOT COMPLETED|Overall Study||0
3036844|NCT01145222|3756101|FG002|NOT COMPLETED|Overall Study||1
3036845|NCT01145222|3756102|FG003|NOT COMPLETED|Overall Study||1
3036846|NCT01145352|3756112|FG000|STARTED|Overall Study||113
3036847|NCT01145352|3756112|FG000|COMPLETED|Overall Study||102
3036848|NCT01145352|3756112|FG000|NOT COMPLETED|Overall Study||11
3036849|NCT01145391|3756118|FG000|STARTED|Overall Study||293
3036850|NCT01145391|3756119|FG001|STARTED|Overall Study||298
3036851|NCT01145391|3756118|FG000|9 Months Post-randomization|Overall Study||293
3036852|NCT01145391|3756119|FG001|9 Months Post-randomization|Overall Study||298
3036853|NCT01145391|3756118|FG000|COMPLETED|Overall Study||293
3036854|NCT01145391|3756119|FG001|COMPLETED|Overall Study||298
3036855|NCT01145391|3756118|FG000|NOT COMPLETED|Overall Study||0
3036856|NCT01145391|3756119|FG001|NOT COMPLETED|Overall Study||0
3036857|NCT01145417|3756129|FG000|STARTED|Overall Study||108
3036858|NCT01145417|3756130|FG001|STARTED|Overall Study||109
3036859|NCT01145417|3756129|FG000|COMPLETED|Overall Study||67
3036860|NCT01145417|3756130|FG001|COMPLETED|Overall Study||62
3036861|NCT01145417|3756129|FG000|NOT COMPLETED|Overall Study||41
3036862|NCT01145417|3756130|FG001|NOT COMPLETED|Overall Study||47
3036863|NCT01145482|3756138|FG000|STARTED|First Intervention (1 Day)||6
3036864|NCT01145482|3756139|FG001|STARTED|First Intervention (1 Day)||6
3036865|NCT01145482|3756138|FG000|COMPLETED|First Intervention (1 Day)||6
3036866|NCT01145482|3756139|FG001|COMPLETED|First Intervention (1 Day)||5
3036867|NCT01145482|3756138|FG000|NOT COMPLETED|First Intervention (1 Day)||0
3036868|NCT01145482|3756139|FG001|NOT COMPLETED|First Intervention (1 Day)||1
3036869|NCT01145482|3756138|FG000|STARTED|Second Intervention (1 Day)||5
3036870|NCT01145482|3756139|FG001|STARTED|Second Intervention (1 Day)||6
2993001|NCT00920023|3709574|FG000|STARTED|Overall Study||15
2993002|NCT00920023|3709574|FG000|COMPLETED|Overall Study||15
2993003|NCT00920023|3709574|FG000|NOT COMPLETED|Overall Study||0
2993004|NCT00920075|3709578|FG000|STARTED|Last Study, 25 Pts Invited,11 Responded||11
2993005|NCT00920075|3709578|FG000|COMPLETED|Last Study, 25 Pts Invited,11 Responded||11
2993006|NCT00920075|3709578|FG000|NOT COMPLETED|Last Study, 25 Pts Invited,11 Responded||0
2993007|NCT00920075|3709578|FG000|STARTED|Post Study, 11 Pts Responded||11
2993008|NCT00920075|3709578|FG000|COMPLETED|Post Study, 11 Pts Responded||11
2993009|NCT00920075|3709578|FG000|NOT COMPLETED|Post Study, 11 Pts Responded||0
2993010|NCT00920140|3709587|FG000|STARTED|Phase 1 (Dose Escalation)||5
2993011|NCT00920140|3709588|FG001|STARTED|Phase 1 (Dose Escalation)||9
2993012|NCT00920140|3709589|FG002|STARTED|Phase 1 (Dose Escalation)||0
2993013|NCT00920140|3709590|FG003|STARTED|Phase 1 (Dose Escalation)||0
2993014|NCT00920140|3709591|FG004|STARTED|Phase 1 (Dose Escalation)||0
3164565|NCT01893801|3891959|FG000|NOT COMPLETED|Overall Study||0
3164566|NCT01893827|3891967|FG000|STARTED|Overall Study||117
3164567|NCT01893827|3891968|FG001|STARTED|Overall Study||120
3164568|NCT01893827|3891967|FG000|COMPLETED|Overall Study||98
3164569|NCT01893827|3891968|FG001|COMPLETED|Overall Study||94
2993015|NCT00920140|3709587|FG000|COMPLETED|Phase 1 (Dose Escalation)||0
2993016|NCT00920140|3709588|FG001|COMPLETED|Phase 1 (Dose Escalation)||0
2993017|NCT00920140|3709589|FG002|COMPLETED|Phase 1 (Dose Escalation)||0
2993018|NCT00920140|3709590|FG003|COMPLETED|Phase 1 (Dose Escalation)||0
2993019|NCT00920140|3709591|FG004|COMPLETED|Phase 1 (Dose Escalation)||0
2993020|NCT00920140|3709587|FG000|NOT COMPLETED|Phase 1 (Dose Escalation)||5
2993021|NCT00920140|3709588|FG001|NOT COMPLETED|Phase 1 (Dose Escalation)||9
2993022|NCT00920140|3709589|FG002|NOT COMPLETED|Phase 1 (Dose Escalation)||0
2993023|NCT00920140|3709590|FG003|NOT COMPLETED|Phase 1 (Dose Escalation)||0
2993024|NCT00920140|3709591|FG004|NOT COMPLETED|Phase 1 (Dose Escalation)||0
2993025|NCT00920140|3709587|FG000|STARTED|Phase 2||0
2993026|NCT00920140|3709588|FG001|STARTED|Phase 2||0
2993027|NCT00920140|3709589|FG002|STARTED|Phase 2||50
2993028|NCT00920140|3709590|FG003|STARTED|Phase 2||22
2993029|NCT00920140|3709591|FG004|STARTED|Phase 2||11
2993030|NCT00920140|3709587|FG000|COMPLETED|Phase 2||0
2993031|NCT00920140|3709588|FG001|COMPLETED|Phase 2||0
2993032|NCT00920140|3709589|FG002|COMPLETED|Phase 2||0
2993033|NCT00920140|3709590|FG003|COMPLETED|Phase 2||0
2993034|NCT00920140|3709591|FG004|COMPLETED|Phase 2||0
2993035|NCT00920140|3709587|FG000|NOT COMPLETED|Phase 2||0
2993036|NCT00920140|3709588|FG001|NOT COMPLETED|Phase 2||0
2993037|NCT00920140|3709589|FG002|NOT COMPLETED|Phase 2||50
2993038|NCT00920140|3709590|FG003|NOT COMPLETED|Phase 2||22
2993039|NCT00920140|3709591|FG004|NOT COMPLETED|Phase 2||11
2993040|NCT00920218|3709608|FG000|STARTED|Overall Study||30
2993041|NCT00920218|3709609|FG001|STARTED|Overall Study||29
2993042|NCT00920218|3709610|FG002|STARTED|Overall Study||31
2993043|NCT00920218|3709611|FG003|STARTED|Overall Study||30
2993044|NCT00920218|3709608|FG000|COMPLETED|Overall Study||28
2993045|NCT00920218|3709609|FG001|COMPLETED|Overall Study||24
2993046|NCT00920218|3709610|FG002|COMPLETED|Overall Study||23
2993047|NCT00920218|3709611|FG003|COMPLETED|Overall Study||23
2993048|NCT00920218|3709608|FG000|NOT COMPLETED|Overall Study||2
2993049|NCT00920218|3709609|FG001|NOT COMPLETED|Overall Study||5
2993050|NCT00920218|3709610|FG002|NOT COMPLETED|Overall Study||8
2993051|NCT00920218|3709611|FG003|NOT COMPLETED|Overall Study||7
2993052|NCT00920231|3709627|FG000|STARTED|Overall Study||8
2993053|NCT00920231|3709628|FG001|STARTED|Overall Study||8
2993054|NCT00920231|3709627|FG000|COMPLETED|Overall Study||8
2993055|NCT00920231|3709628|FG001|COMPLETED|Overall Study||8
2993056|NCT00920231|3709627|FG000|NOT COMPLETED|Overall Study||0
2993057|NCT00920231|3709628|FG001|NOT COMPLETED|Overall Study||0
2993058|NCT00920374|3709638|FG000|STARTED|Overall Study||61
2993059|NCT00920374|3709639|FG001|STARTED|Overall Study||57
2993060|NCT00920374|3709638|FG000|COMPLETED|Overall Study||61
2993061|NCT00920374|3709639|FG001|COMPLETED|Overall Study||57
2993062|NCT00920374|3709638|FG000|NOT COMPLETED|Overall Study||0
2993063|NCT00920374|3709639|FG001|NOT COMPLETED|Overall Study||0
2993064|NCT00920426|3709648|FG000|STARTED|ITZ111451||8
2993065|NCT00920426|3709649|FG001|STARTED|ITZ111451||0
2993066|NCT00920426|3709650|FG002|STARTED|ITZ111451||0
2993067|NCT00920426|3709651|FG003|STARTED|ITZ111451||0
2993068|NCT00920426|3709648|FG000|COMPLETED|ITZ111451||7
2993069|NCT00920426|3709649|FG001|COMPLETED|ITZ111451||0
2993070|NCT00920426|3709650|FG002|COMPLETED|ITZ111451||0
2993071|NCT00920426|3709651|FG003|COMPLETED|ITZ111451||0
2993072|NCT00920426|3709648|FG000|NOT COMPLETED|ITZ111451||1
2993073|NCT00920426|3709649|FG001|NOT COMPLETED|ITZ111451||0
2993074|NCT00920426|3709650|FG002|NOT COMPLETED|ITZ111451||0
2993075|NCT00920426|3709651|FG003|NOT COMPLETED|ITZ111451||0
2993076|NCT00920426|3709648|FG000|STARTED|ITZ112929: Randomized Regimen||0
2993077|NCT00920426|3709649|FG001|STARTED|ITZ112929: Randomized Regimen||7
2993078|NCT00920426|3709650|FG002|STARTED|ITZ112929: Randomized Regimen||2
2993079|NCT00920426|3709651|FG003|STARTED|ITZ112929: Randomized Regimen||0
2993080|NCT00920426|3709648|FG000|COMPLETED|ITZ112929: Randomized Regimen||0
2993081|NCT00920426|3709649|FG001|COMPLETED|ITZ112929: Randomized Regimen||7
2993082|NCT00920426|3709650|FG002|COMPLETED|ITZ112929: Randomized Regimen||2
2993083|NCT00920426|3709651|FG003|COMPLETED|ITZ112929: Randomized Regimen||0
2993084|NCT00920426|3709648|FG000|NOT COMPLETED|ITZ112929: Randomized Regimen||0
3164570|NCT01893827|3891967|FG000|NOT COMPLETED|Overall Study||19
2993085|NCT00920426|3709649|FG001|NOT COMPLETED|ITZ112929: Randomized Regimen||0
2993086|NCT00920426|3709650|FG002|NOT COMPLETED|ITZ112929: Randomized Regimen||0
2993087|NCT00920426|3709651|FG003|NOT COMPLETED|ITZ112929: Randomized Regimen||0
2993088|NCT00920426|3709648|FG000|STARTED|ITZ112929: Optimized Therapy (OT)||0
2993089|NCT00920426|3709649|FG001|STARTED|ITZ112929: Optimized Therapy (OT)||0
2993090|NCT00920426|3709650|FG002|STARTED|ITZ112929: Optimized Therapy (OT)||0
2993091|NCT00920426|3709651|FG003|STARTED|ITZ112929: Optimized Therapy (OT)|Out of 9 participants receiving randomized regimen, 8 participants continued to receive OT.|8
2993092|NCT00920426|3709648|FG000|COMPLETED|ITZ112929: Optimized Therapy (OT)||0
2993093|NCT00920426|3709649|FG001|COMPLETED|ITZ112929: Optimized Therapy (OT)||0
2993094|NCT00920426|3709650|FG002|COMPLETED|ITZ112929: Optimized Therapy (OT)||0
2993095|NCT00920426|3709651|FG003|COMPLETED|ITZ112929: Optimized Therapy (OT)||8
2993096|NCT00920426|3709648|FG000|NOT COMPLETED|ITZ112929: Optimized Therapy (OT)||0
2993097|NCT00920426|3709649|FG001|NOT COMPLETED|ITZ112929: Optimized Therapy (OT)||0
2993098|NCT00920426|3709650|FG002|NOT COMPLETED|ITZ112929: Optimized Therapy (OT)||0
2993099|NCT00920426|3709651|FG003|NOT COMPLETED|ITZ112929: Optimized Therapy (OT)||0
2993100|NCT00920439|3709663|FG000|STARTED|Overall Study||25
2993101|NCT00920439|3709663|FG000|COMPLETED|Overall Study||25
2993102|NCT00920439|3709663|FG000|NOT COMPLETED|Overall Study||0
2993103|NCT00920556|3709667|FG000|STARTED|Overall Study||24
2993104|NCT00920556|3709667|FG000|COMPLETED|Overall Study||0
2993105|NCT00920556|3709667|FG000|NOT COMPLETED|Overall Study||24
2993106|NCT00920621|3709679|FG000|STARTED|Overall Study||440
2993107|NCT00920621|3709680|FG001|STARTED|Overall Study||436
2993108|NCT00920621|3709681|FG002|STARTED|Overall Study||440
2993109|NCT00920621|3709682|FG003|STARTED|Overall Study||436
2993110|NCT00920621|3709679|FG000|COMPLETED|Overall Study||386
2993111|NCT00920621|3709680|FG001|COMPLETED|Overall Study||391
2993112|NCT00920621|3709681|FG002|COMPLETED|Overall Study||405
2993113|NCT00920621|3709682|FG003|COMPLETED|Overall Study||401
2993114|NCT00920621|3709679|FG000|NOT COMPLETED|Overall Study||54
2993115|NCT00920621|3709680|FG001|NOT COMPLETED|Overall Study||45
2993116|NCT00920621|3709681|FG002|NOT COMPLETED|Overall Study||35
2993117|NCT00920621|3709682|FG003|NOT COMPLETED|Overall Study||35
2993118|NCT00920647|3709697|FG000|STARTED|Overall Study||4
2993119|NCT00920647|3709698|FG001|STARTED|Overall Study||4
2993120|NCT00920647|3709699|FG002|STARTED|Overall Study||4
2993121|NCT00920647|3709700|FG003|STARTED|Overall Study||4
2993122|NCT00920647|3709697|FG000|COMPLETED|Overall Study||4
2993123|NCT00920647|3709698|FG001|COMPLETED|Overall Study||4
2993124|NCT00920647|3709699|FG002|COMPLETED|Overall Study||4
2993125|NCT00920647|3709700|FG003|COMPLETED|Overall Study||4
2993126|NCT00920647|3709697|FG000|NOT COMPLETED|Overall Study||0
2993127|NCT00920647|3709698|FG001|NOT COMPLETED|Overall Study||0
2993128|NCT00920647|3709699|FG002|NOT COMPLETED|Overall Study||0
2993129|NCT00920647|3709700|FG003|NOT COMPLETED|Overall Study||0
2993130|NCT00920686|3709723|FG000|STARTED|Overall Study||82
2993131|NCT00920686|3709724|FG001|STARTED|Overall Study||82
2993132|NCT00920686|3709725|FG002|STARTED|Overall Study||75
2993133|NCT00920686|3709723|FG000|COMPLETED|Overall Study||63
2993134|NCT00920686|3709724|FG001|COMPLETED|Overall Study||60
2993135|NCT00920686|3709725|FG002|COMPLETED|Overall Study||62
2993136|NCT00920686|3709723|FG000|NOT COMPLETED|Overall Study||19
2993137|NCT00920686|3709724|FG001|NOT COMPLETED|Overall Study||22
2993138|NCT00920686|3709725|FG002|NOT COMPLETED|Overall Study||13
2993139|NCT00920699|3709740|FG000|STARTED|Overall Study||29
2993140|NCT00920699|3709741|FG001|STARTED|Overall Study||30
2993141|NCT00920699|3709742|FG002|STARTED|Overall Study||32
2993142|NCT00920699|3709740|FG000|COMPLETED|Overall Study||27
2993143|NCT00920699|3709741|FG001|COMPLETED|Overall Study||29
2993144|NCT00920699|3709742|FG002|COMPLETED|Overall Study||28
2993145|NCT00920699|3709740|FG000|NOT COMPLETED|Overall Study||2
2993146|NCT00920699|3709741|FG001|NOT COMPLETED|Overall Study||1
2993147|NCT00920699|3709742|FG002|NOT COMPLETED|Overall Study||4
2993148|NCT00920790|3709750|FG000|STARTED|Overall Study||27
2993149|NCT00920790|3709750|FG000|COMPLETED|Overall Study||13
2993150|NCT00920790|3709750|FG000|NOT COMPLETED|Overall Study||14
2993151|NCT00920816|3709758|FG000|STARTED|Overall Study||192
2993152|NCT00920816|3709759|FG001|STARTED|Overall Study||96
2993153|NCT00920816|3709760|FG002|STARTED|Overall Study||135
2993154|NCT00920816|3709761|FG003|STARTED|Overall Study||69
2993155|NCT00920816|3709758|FG000|Treated|Overall Study||189
2993156|NCT00920816|3709759|FG001|Treated|Overall Study||96
2993157|NCT00920816|3709760|FG002|Treated|Overall Study||135
2993158|NCT00920816|3709761|FG003|Treated|Overall Study||69
2993159|NCT00920816|3709758|FG000|COMPLETED|Overall Study||0
2993160|NCT00920816|3709759|FG001|COMPLETED|Overall Study||0
2993161|NCT00920816|3709760|FG002|COMPLETED|Overall Study||0
2993162|NCT00920816|3709761|FG003|COMPLETED|Overall Study||0
2993163|NCT00920816|3709758|FG000|NOT COMPLETED|Overall Study||192
2993164|NCT00920816|3709759|FG001|NOT COMPLETED|Overall Study||96
2993165|NCT00920816|3709760|FG002|NOT COMPLETED|Overall Study||135
2993166|NCT00920816|3709761|FG003|NOT COMPLETED|Overall Study||69
2993167|NCT00920829|3709775|FG000|STARTED|Allocation||38
2993168|NCT00920829|3709776|FG001|STARTED|Allocation||39
2993169|NCT00920829|3709777|FG002|STARTED|Allocation||38
2993170|NCT00920829|3709778|FG003|STARTED|Allocation||37
2993171|NCT00920829|3709775|FG000|COMPLETED|Allocation||35
2993172|NCT00920829|3709776|FG001|COMPLETED|Allocation||38
2993173|NCT00920829|3709777|FG002|COMPLETED|Allocation||38
2993174|NCT00920829|3709778|FG003|COMPLETED|Allocation||35
2993175|NCT00920829|3709775|FG000|NOT COMPLETED|Allocation||3
2993176|NCT00920829|3709776|FG001|NOT COMPLETED|Allocation||1
2993177|NCT00920829|3709777|FG002|NOT COMPLETED|Allocation||0
2993178|NCT00920829|3709778|FG003|NOT COMPLETED|Allocation||2
2993179|NCT00920829|3709775|FG000|STARTED|Available for Analysis||35
2993180|NCT00920829|3709776|FG001|STARTED|Available for Analysis||38
2993181|NCT00920829|3709777|FG002|STARTED|Available for Analysis||38
2993182|NCT00920829|3709778|FG003|STARTED|Available for Analysis||35
2993183|NCT00920829|3709775|FG000|COMPLETED|Available for Analysis||27
2993184|NCT00920829|3709776|FG001|COMPLETED|Available for Analysis||27
2993185|NCT00920829|3709777|FG002|COMPLETED|Available for Analysis||28
2993186|NCT00920829|3709778|FG003|COMPLETED|Available for Analysis||24
2993187|NCT00920829|3709775|FG000|NOT COMPLETED|Available for Analysis||8
2993188|NCT00920829|3709776|FG001|NOT COMPLETED|Available for Analysis||11
2993189|NCT00920829|3709777|FG002|NOT COMPLETED|Available for Analysis||10
2993190|NCT00920829|3709778|FG003|NOT COMPLETED|Available for Analysis||11
2993191|NCT00920855|3709791|FG000|STARTED|Overall Study||5
2993192|NCT00920855|3709792|FG001|STARTED|Overall Study||4
2993193|NCT00920855|3709793|FG002|STARTED|Overall Study||31
2993194|NCT00920855|3709791|FG000|Safety and Efficacy Populations|Overall Study||5
2993195|NCT00920855|3709792|FG001|Safety and Efficacy Populations|Overall Study||4
2993196|NCT00920855|3709793|FG002|Safety and Efficacy Populations|Overall Study||31
2993197|NCT00920855|3709791|FG000|COMPLETED|Overall Study|completed eight cycles of treatment|0
2993198|NCT00920855|3709792|FG001|COMPLETED|Overall Study|completed eight cycles of treatment|1
2993199|NCT00920855|3709793|FG002|COMPLETED|Overall Study|completed eight cycles of treatment|9
2993200|NCT00920855|3709791|FG000|NOT COMPLETED|Overall Study||5
2993201|NCT00920855|3709792|FG001|NOT COMPLETED|Overall Study||3
2993202|NCT00920855|3709793|FG002|NOT COMPLETED|Overall Study||22
2993203|NCT00920907|3709804|FG000|STARTED|Induction Period||37
2993204|NCT00920907|3709805|FG001|STARTED|Induction Period||38
2993205|NCT00920907|3709804|FG000|COMPLETED|Induction Period||15
2993206|NCT00920907|3709805|FG001|COMPLETED|Induction Period||16
2993207|NCT00920907|3709804|FG000|NOT COMPLETED|Induction Period||22
2993208|NCT00920907|3709805|FG001|NOT COMPLETED|Induction Period||22
2993209|NCT00920907|3709804|FG000|STARTED|Maintenance Period||15
2993210|NCT00920907|3709805|FG001|STARTED|Maintenance Period|1 patient completed Induction phase but discontinued the study prior to start of maintenance phase.|15
2993211|NCT00920907|3709804|FG000|COMPLETED|Maintenance Period|All participants who entered Maintenance were treated with study drug.|3
2993212|NCT00920907|3709805|FG001|COMPLETED|Maintenance Period|2 participants who entered Maintenance Period did not receive study drug during the period.|2
2993213|NCT00920907|3709804|FG000|NOT COMPLETED|Maintenance Period||12
2993214|NCT00920907|3709805|FG001|NOT COMPLETED|Maintenance Period||13
2993215|NCT00921024|3709815|FG000|STARTED|Overall Study||85
2993216|NCT00921024|3709816|FG001|STARTED|Overall Study||42
2993217|NCT00921024|3709815|FG000|COMPLETED|Overall Study||81
2993218|NCT00921024|3709816|FG001|COMPLETED|Overall Study||39
2993219|NCT00921024|3709815|FG000|NOT COMPLETED|Overall Study||4
2993220|NCT00921024|3709816|FG001|NOT COMPLETED|Overall Study||3
2993221|NCT00921115|3709822|FG000|STARTED|Overall Study||42
2993222|NCT00921115|3709822|FG000|COMPLETED|Overall Study||42
2993223|NCT00921115|3709822|FG000|NOT COMPLETED|Overall Study||0
2993224|NCT00921310|3709828|FG000|STARTED|Overall Study||2
2993225|NCT00921310|3709829|FG001|STARTED|Overall Study||6
2993226|NCT00921310|3709830|FG002|STARTED|Overall Study||4
2993227|NCT00921310|3709828|FG000|COMPLETED|Overall Study||2
2993228|NCT00921310|3709829|FG001|COMPLETED|Overall Study||6
2993229|NCT00921310|3709830|FG002|COMPLETED|Overall Study||4
2993230|NCT00921310|3709828|FG000|NOT COMPLETED|Overall Study||0
2993231|NCT00921310|3709829|FG001|NOT COMPLETED|Overall Study||0
2993232|NCT00921310|3709830|FG002|NOT COMPLETED|Overall Study||0
2993233|NCT00921518|3709844|FG000|STARTED|Overall Study||48
2993234|NCT00921518|3709845|FG001|STARTED|Overall Study||44
2993235|NCT00921518|3709844|FG000|COMPLETED|Overall Study||48
2993236|NCT00921518|3709845|FG001|COMPLETED|Overall Study||44
2993237|NCT00921518|3709844|FG000|NOT COMPLETED|Overall Study||0
2993238|NCT00921518|3709845|FG001|NOT COMPLETED|Overall Study||0
2993239|NCT00921557|3709854|FG000|STARTED|Weeks 0-48 (on Study Treatment)||17
2993240|NCT00921557|3709855|FG001|STARTED|Weeks 0-48 (on Study Treatment)||17
2993241|NCT00921557|3709856|FG002|STARTED|Weeks 0-48 (on Study Treatment)||18
2993242|NCT00921557|3709854|FG000|COMPLETED|Weeks 0-48 (on Study Treatment)|Completed 48 weeks|15
2993243|NCT00921557|3709855|FG001|COMPLETED|Weeks 0-48 (on Study Treatment)|Completed 48 weeks|17
2993244|NCT00921557|3709856|FG002|COMPLETED|Weeks 0-48 (on Study Treatment)|Completed 48 weeks|18
2993245|NCT00921557|3709854|FG000|NOT COMPLETED|Weeks 0-48 (on Study Treatment)||2
2993246|NCT00921557|3709855|FG001|NOT COMPLETED|Weeks 0-48 (on Study Treatment)||0
2993247|NCT00921557|3709856|FG002|NOT COMPLETED|Weeks 0-48 (on Study Treatment)||0
2993248|NCT00921557|3709854|FG000|STARTED|Weeks 48-96 (on Study Treatment)||15
2993249|NCT00921557|3709855|FG001|STARTED|Weeks 48-96 (on Study Treatment)||17
2993250|NCT00921557|3709856|FG002|STARTED|Weeks 48-96 (on Study Treatment)||18
2993251|NCT00921557|3709854|FG000|COMPLETED|Weeks 48-96 (on Study Treatment)||15
2993252|NCT00921557|3709855|FG001|COMPLETED|Weeks 48-96 (on Study Treatment)||16
2993253|NCT00921557|3709856|FG002|COMPLETED|Weeks 48-96 (on Study Treatment)||17
3133615|NCT01696396|3858536|FG003|STARTED|Overall Study||42
3133616|NCT01696396|3858533|FG000|Received Study Drug|Overall Study||98
2993254|NCT00921557|3709854|FG000|NOT COMPLETED|Weeks 48-96 (on Study Treatment)||0
2993255|NCT00921557|3709855|FG001|NOT COMPLETED|Weeks 48-96 (on Study Treatment)||1
2993256|NCT00921557|3709856|FG002|NOT COMPLETED|Weeks 48-96 (on Study Treatment)||1
2993257|NCT00921557|3709854|FG000|STARTED|Weeks 96-144 (Off Study Treatment)||15
2993258|NCT00921557|3709855|FG001|STARTED|Weeks 96-144 (Off Study Treatment)||16
2993259|NCT00921557|3709856|FG002|STARTED|Weeks 96-144 (Off Study Treatment)||17
2993260|NCT00921557|3709854|FG000|COMPLETED|Weeks 96-144 (Off Study Treatment)||12
2993261|NCT00921557|3709855|FG001|COMPLETED|Weeks 96-144 (Off Study Treatment)||15
2993262|NCT00921557|3709856|FG002|COMPLETED|Weeks 96-144 (Off Study Treatment)||16
2993263|NCT00921557|3709854|FG000|NOT COMPLETED|Weeks 96-144 (Off Study Treatment)||3
2993264|NCT00921557|3709855|FG001|NOT COMPLETED|Weeks 96-144 (Off Study Treatment)||1
2993265|NCT00921557|3709856|FG002|NOT COMPLETED|Weeks 96-144 (Off Study Treatment)||1
2993266|NCT00921687|3709871|FG000|STARTED|Overall Study|eligible patients seen in clinic between 1/1/09 and 1/1/10|418
2993267|NCT00921687|3709872|FG001|STARTED|Overall Study||363
2993268|NCT00921687|3709871|FG000|COMPLETED|Overall Study||418
2993269|NCT00921687|3709872|FG001|COMPLETED|Overall Study||363
2993270|NCT00921687|3709871|FG000|NOT COMPLETED|Overall Study||0
2993271|NCT00921687|3709872|FG001|NOT COMPLETED|Overall Study||0
2993272|NCT00921843|3709882|FG000|STARTED|Overall Study||10
2993273|NCT00921843|3709883|FG001|STARTED|Overall Study||10
2993274|NCT00921843|3709884|FG002|STARTED|Overall Study||11
2993275|NCT00921843|3709885|FG003|STARTED|Overall Study||30
2993276|NCT00921843|3709882|FG000|COMPLETED|Overall Study||10
2993277|NCT00921843|3709883|FG001|COMPLETED|Overall Study||10
2993278|NCT00921843|3709884|FG002|COMPLETED|Overall Study||11
2993279|NCT00921843|3709885|FG003|COMPLETED|Overall Study||30
3164571|NCT01893827|3891968|FG001|NOT COMPLETED|Overall Study||26
3164572|NCT01893879|3891976|FG000|STARTED|Overall Study||7
3164573|NCT01893879|3891977|FG001|STARTED|Overall Study||7
3164574|NCT01893879|3891976|FG000|COMPLETED|Overall Study||5
3164575|NCT01893879|3891977|FG001|COMPLETED|Overall Study||4
3164576|NCT01893879|3891976|FG000|NOT COMPLETED|Overall Study||2
3164577|NCT01893879|3891977|FG001|NOT COMPLETED|Overall Study||3
3164578|NCT01893905|3891985|FG000|STARTED|Overall Study||80
3164579|NCT01893905|3891986|FG001|STARTED|Overall Study||78
3164580|NCT01893905|3891985|FG000|COMPLETED|Overall Study||55
3164581|NCT01893905|3891986|FG001|COMPLETED|Overall Study||64
2993280|NCT00921843|3709882|FG000|NOT COMPLETED|Overall Study||0
2993281|NCT00921843|3709883|FG001|NOT COMPLETED|Overall Study||0
2993282|NCT00921843|3709884|FG002|NOT COMPLETED|Overall Study||0
2993283|NCT00921843|3709885|FG003|NOT COMPLETED|Overall Study||0
2993284|NCT00921895|3709895|FG000|STARTED|Overall Study||128
2993285|NCT00921895|3709895|FG000|COMPLETED|Overall Study||128
2993286|NCT00921895|3709895|FG000|NOT COMPLETED|Overall Study||0
2993287|NCT00921934|3709900|FG000|STARTED|Overall Study||68
2993288|NCT00921934|3709900|FG000|COMPLETED|Overall Study||68
2993289|NCT00921934|3709900|FG000|NOT COMPLETED|Overall Study||0
2993290|NCT00921947|3709906|FG000|STARTED|Day 0||30
2993291|NCT00921947|3709907|FG001|STARTED|Day 0||30
2993292|NCT00921947|3709906|FG000|COMPLETED|Day 0||30
2993293|NCT00921947|3709907|FG001|COMPLETED|Day 0||30
2993294|NCT00921947|3709906|FG000|NOT COMPLETED|Day 0||0
2993295|NCT00921947|3709907|FG001|NOT COMPLETED|Day 0||0
2993296|NCT00921947|3709906|FG000|STARTED|Day 28|2 subjects were lost to follow-up and did not receive the 2nd vaccination of 1.0 ug i.m.|28
2993297|NCT00921947|3709907|FG001|STARTED|Day 28||30
2993298|NCT00921947|3709906|FG000|COMPLETED|Day 28||28
2993299|NCT00921947|3709907|FG001|COMPLETED|Day 28||30
2993300|NCT00921947|3709906|FG000|NOT COMPLETED|Day 28||0
2993301|NCT00921947|3709907|FG001|NOT COMPLETED|Day 28||0
2993302|NCT00922116|3709913|FG000|STARTED|Overall Study||191
2993303|NCT00922116|3709913|FG000|COMPLETED|Overall Study||176
2993304|NCT00922116|3709913|FG000|NOT COMPLETED|Overall Study||15
2993305|NCT00922194|3709917|FG000|STARTED|Metformin in Maximum Tolerated Dose|February 2006|102
2993306|NCT00922194|3709917|FG000|COMPLETED|Metformin in Maximum Tolerated Dose|June 2009|102
2993307|NCT00922194|3709917|FG000|NOT COMPLETED|Metformin in Maximum Tolerated Dose||0
2993308|NCT00922194|3709917|FG000|STARTED|Metformin for 12 Months or More|Gradually increasing dose of Extended Release Metformin|102
2993309|NCT00922194|3709917|FG000|COMPLETED|Metformin for 12 Months or More||102
2993310|NCT00922194|3709917|FG000|NOT COMPLETED|Metformin for 12 Months or More||0
2993311|NCT00922207|3709924|FG000|STARTED|Overall Study||91
2993312|NCT00922207|3709925|FG001|STARTED|Overall Study||95
2993313|NCT00922207|3709926|FG002|STARTED|Overall Study||94
2993314|NCT00922207|3709924|FG000|COMPLETED|Overall Study||85
2993315|NCT00922207|3709925|FG001|COMPLETED|Overall Study||88
2993316|NCT00922207|3709926|FG002|COMPLETED|Overall Study||90
2993317|NCT00922207|3709924|FG000|NOT COMPLETED|Overall Study||6
2993318|NCT00922207|3709925|FG001|NOT COMPLETED|Overall Study||7
2993319|NCT00922207|3709926|FG002|NOT COMPLETED|Overall Study||4
2993320|NCT00922233|3709934|FG000|STARTED|Overall Study||72
2993321|NCT00922233|3709934|FG000|COMPLETED|Overall Study||68
2993322|NCT00922233|3709934|FG000|NOT COMPLETED|Overall Study||4
2993323|NCT00922272|3709939|FG000|STARTED|Open-label Phase||92
2993324|NCT00922272|3709940|FG001|STARTED|Open-label Phase||0
2993325|NCT00922272|3709939|FG000|COMPLETED|Open-label Phase||69
3164582|NCT01893905|3891985|FG000|NOT COMPLETED|Overall Study||25
3164583|NCT01893905|3891986|FG001|NOT COMPLETED|Overall Study||14
2993326|NCT00922272|3709940|FG001|COMPLETED|Open-label Phase||0
2993327|NCT00922272|3709939|FG000|NOT COMPLETED|Open-label Phase||23
2993328|NCT00922272|3709940|FG001|NOT COMPLETED|Open-label Phase||0
2993329|NCT00922272|3709939|FG000|STARTED|Double-blind Phase||34
2993330|NCT00922272|3709940|FG001|STARTED|Double-blind Phase||35
2993331|NCT00922272|3709939|FG000|COMPLETED|Double-blind Phase||27
2993332|NCT00922272|3709940|FG001|COMPLETED|Double-blind Phase||29
2993333|NCT00922272|3709939|FG000|NOT COMPLETED|Double-blind Phase||7
2993334|NCT00922272|3709940|FG001|NOT COMPLETED|Double-blind Phase||6
2993335|NCT00922428|3709948|FG000|STARTED|Overall Study|13 patients were completely not analysed, 2 not for demographic or efficacy but for safety|1389
2993336|NCT00922428|3709948|FG000|COMPLETED|Overall Study|for 11 participants no gender was given|1374
2993337|NCT00922428|3709948|FG000|NOT COMPLETED|Overall Study||15
2993338|NCT00922441|3709961|FG000|STARTED|Overall Study||30
2993339|NCT00922441|3709962|FG001|STARTED|Overall Study||30
2993340|NCT00922441|3709963|FG002|STARTED|Overall Study||32
2993341|NCT00922441|3709961|FG000|COMPLETED|Overall Study||30
2993342|NCT00922441|3709962|FG001|COMPLETED|Overall Study||30
2993343|NCT00922441|3709963|FG002|COMPLETED|Overall Study||29
2993344|NCT00922441|3709961|FG000|NOT COMPLETED|Overall Study||0
2993345|NCT00922441|3709962|FG001|NOT COMPLETED|Overall Study||0
2993346|NCT00922441|3709963|FG002|NOT COMPLETED|Overall Study||3
2993347|NCT00922480|3709973|FG000|STARTED|Main Study||250
2993348|NCT00922480|3709974|FG001|STARTED|Main Study||255
2993349|NCT00922480|3709973|FG000|COMPLETED|Main Study||213
2993350|NCT00922480|3709974|FG001|COMPLETED|Main Study||226
2993351|NCT00922480|3709973|FG000|NOT COMPLETED|Main Study||37
2993352|NCT00922480|3709974|FG001|NOT COMPLETED|Main Study||29
2993353|NCT00922480|3709973|FG000|STARTED|Extension Study||73
2993354|NCT00922480|3709974|FG001|STARTED|Extension Study||85
2993355|NCT00922480|3709973|FG000|COMPLETED|Extension Study||68
2993356|NCT00922480|3709974|FG001|COMPLETED|Extension Study||82
2993357|NCT00922480|3709973|FG000|NOT COMPLETED|Extension Study||5
2993358|NCT00922480|3709974|FG001|NOT COMPLETED|Extension Study||3
2993359|NCT00922623|3709982|FG000|STARTED|Overall Study||93
2993360|NCT00922623|3709982|FG000|COMPLETED|Overall Study||88
2993361|NCT00922623|3709982|FG000|NOT COMPLETED|Overall Study||5
2993362|NCT00922636|3709993|FG000|STARTED|Overall Study||36
2993363|NCT00922636|3709994|FG001|STARTED|Overall Study||78
2993364|NCT00922636|3709995|FG002|STARTED|Overall Study||76
2993365|NCT00922636|3709996|FG003|STARTED|Overall Study||75
2993366|NCT00922636|3709997|FG004|STARTED|Overall Study||75
2993367|NCT00922636|3709993|FG000|Entered Optional Taper Phase|Overall Study||4
2993368|NCT00922636|3709994|FG001|Entered Optional Taper Phase|Overall Study||10
2993369|NCT00922636|3709995|FG002|Entered Optional Taper Phase|Overall Study||15
2993370|NCT00922636|3709996|FG003|Entered Optional Taper Phase|Overall Study||7
2993371|NCT00922636|3709997|FG004|Entered Optional Taper Phase|Overall Study||12
2993372|NCT00922636|3709993|FG000|COMPLETED|Overall Study||29
2993373|NCT00922636|3709994|FG001|COMPLETED|Overall Study||62
2993374|NCT00922636|3709995|FG002|COMPLETED|Overall Study||56
2993375|NCT00922636|3709996|FG003|COMPLETED|Overall Study||58
2993376|NCT00922636|3709997|FG004|COMPLETED|Overall Study||59
2993377|NCT00922636|3709993|FG000|NOT COMPLETED|Overall Study||7
2993378|NCT00922636|3709994|FG001|NOT COMPLETED|Overall Study||16
2993379|NCT00922636|3709995|FG002|NOT COMPLETED|Overall Study||20
2993380|NCT00922636|3709996|FG003|NOT COMPLETED|Overall Study||17
2993381|NCT00922636|3709997|FG004|NOT COMPLETED|Overall Study||16
2993382|NCT00922701|3710014|FG000|STARTED|Overall Study||4
2993383|NCT00922701|3710014|FG000|COMPLETED|Overall Study||4
2993384|NCT00922701|3710014|FG000|NOT COMPLETED|Overall Study||0
2993385|NCT00922766|3710018|FG000|STARTED|Overall Study||617
2993386|NCT00922766|3710018|FG000|COMPLETED|Overall Study||610
2993387|NCT00922766|3710018|FG000|NOT COMPLETED|Overall Study||7
2993388|NCT00922779|3710022|FG000|STARTED|Overall Study||6661
2993389|NCT00922779|3710022|FG000|COMPLETED|Overall Study||4334
2993390|NCT00922779|3710022|FG000|NOT COMPLETED|Overall Study||2327
3305061|NCT02986074|4038751|FG001|STARTED|First Trial Period||29
3305062|NCT02986074|4038752|FG002|STARTED|First Trial Period||0
3305063|NCT02986074|4038753|FG003|STARTED|First Trial Period||0
3305064|NCT02986074|4038750|FG000|COMPLETED|First Trial Period||25
3305065|NCT02986074|4038751|FG001|COMPLETED|First Trial Period||29
3305066|NCT02986074|4038752|FG002|COMPLETED|First Trial Period||0
2993391|NCT00922883|3710026|FG000|STARTED|Overall Study||43
2993392|NCT00922883|3710026|FG000|COMPLETED|Overall Study||43
2993393|NCT00922883|3710026|FG000|NOT COMPLETED|Overall Study||0
2993394|NCT00922935|3710033|FG000|STARTED|Overall Study||10
2993395|NCT00922935|3710034|FG001|STARTED|Overall Study||16
2993396|NCT00922935|3710035|FG002|STARTED|Overall Study||10
2993397|NCT00922935|3710033|FG000|COMPLETED|Overall Study||9
2993398|NCT00922935|3710034|FG001|COMPLETED|Overall Study||11
2993399|NCT00922935|3710035|FG002|COMPLETED|Overall Study||10
2993400|NCT00922935|3710033|FG000|NOT COMPLETED|Overall Study||1
2993401|NCT00922935|3710034|FG001|NOT COMPLETED|Overall Study||5
2993402|NCT00922935|3710035|FG002|NOT COMPLETED|Overall Study||0
2993403|NCT00922974|3710046|FG000|STARTED|Phase II Component||46
2993404|NCT00922974|3710047|FG001|STARTED|Phase II Component||0
2993405|NCT00922974|3710046|FG000|Eligible|Phase II Component||44
2993406|NCT00922974|3710047|FG001|Eligible|Phase II Component||0
2993407|NCT00922974|3710046|FG000|Eligible and Started Treatment|Phase II Component||39
2993408|NCT00922974|3710047|FG001|Eligible and Started Treatment|Phase II Component||0
2993409|NCT00922974|3710046|FG000|Eligible, Treated, Adverse Event Data|Phase II Component||34
2993410|NCT00922974|3710047|FG001|Eligible, Treated, Adverse Event Data|Phase II Component||0
2993411|NCT00922974|3710046|FG000|COMPLETED|Phase II Component|These subjects do not participate in the phase III component.|39
3305067|NCT02986074|4038753|FG003|COMPLETED|First Trial Period||0
2993412|NCT00922974|3710047|FG001|COMPLETED|Phase II Component||0
2993413|NCT00922974|3710046|FG000|NOT COMPLETED|Phase II Component||7
2993414|NCT00922974|3710047|FG001|NOT COMPLETED|Phase II Component||0
2993415|NCT00922974|3710046|FG000|STARTED|Phase III Component|The phase III component accrues new subjects; these are not continuing phase II subjects.|217
2993416|NCT00922974|3710047|FG001|STARTED|Phase III Component||136
2993417|NCT00922974|3710046|FG000|Eligible|Phase III Component||209
2993418|NCT00922974|3710047|FG001|Eligible|Phase III Component||130
2993419|NCT00922974|3710046|FG000|Eligible With 3 mo. NRPS Data|Phase III Component||139
2993420|NCT00922974|3710047|FG001|Eligible With 3 mo. NRPS Data|Phase III Component||76
2993421|NCT00922974|3710046|FG000|Eligible With 3 mo. FACT-G Data|Phase III Component||87
2993422|NCT00922974|3710047|FG001|Eligible With 3 mo. FACT-G Data|Phase III Component||58
2993423|NCT00922974|3710046|FG000|Eligible With Adverse Event Data|Phase III Component||202
2993424|NCT00922974|3710047|FG001|Eligible With Adverse Event Data|Phase III Component||117
2993425|NCT00922974|3710046|FG000|Eligible, Treated, Adverse Event Data|Phase III Component||148
2993426|NCT00922974|3710047|FG001|Eligible, Treated, Adverse Event Data|Phase III Component||83
2993427|NCT00922974|3710046|FG000|Eligible and Consented to Quality of Life Participate in Quality of Life (QOL) Study Component|Phase III Component||152
2993428|NCT00922974|3710047|FG001|Eligible and Consented to Quality of Life Participate in Quality of Life (QOL) Study Component|Phase III Component||100
2993429|NCT00922974|3710046|FG000|COMPLETED|Phase III Component||209
2993430|NCT00922974|3710047|FG001|COMPLETED|Phase III Component||130
2993431|NCT00922974|3710046|FG000|NOT COMPLETED|Phase III Component||8
2993432|NCT00922974|3710047|FG001|NOT COMPLETED|Phase III Component||6
2993433|NCT00922987|3710055|FG000|STARTED|Overall Study||281
2993434|NCT00922987|3710055|FG000|COMPLETED|Overall Study||277
2993435|NCT00922987|3710055|FG000|NOT COMPLETED|Overall Study||4
2993436|NCT00923078|3710062|FG000|STARTED|First Intervention (Weeks 1-4)||20
2993437|NCT00923078|3710063|FG001|STARTED|First Intervention (Weeks 1-4)||20
2993438|NCT00923078|3710064|FG002|STARTED|First Intervention (Weeks 1-4)||20
2993439|NCT00923078|3710062|FG000|COMPLETED|First Intervention (Weeks 1-4)||19
2993440|NCT00923078|3710063|FG001|COMPLETED|First Intervention (Weeks 1-4)||19
2993441|NCT00923078|3710064|FG002|COMPLETED|First Intervention (Weeks 1-4)||0
2993442|NCT00923078|3710062|FG000|NOT COMPLETED|First Intervention (Weeks 1-4)||1
2993443|NCT00923078|3710063|FG001|NOT COMPLETED|First Intervention (Weeks 1-4)||1
2993444|NCT00923078|3710064|FG002|NOT COMPLETED|First Intervention (Weeks 1-4)||20
2993445|NCT00923078|3710062|FG000|STARTED|Second Intervention (Weeks 5-8)||19
2993446|NCT00923078|3710063|FG001|STARTED|Second Intervention (Weeks 5-8)||19
2993447|NCT00923078|3710064|FG002|STARTED|Second Intervention (Weeks 5-8)|Healthy Comparison sample subjects completed only a single test session (baseline)|0
2993448|NCT00923078|3710062|FG000|COMPLETED|Second Intervention (Weeks 5-8)||19
2993449|NCT00923078|3710063|FG001|COMPLETED|Second Intervention (Weeks 5-8)||19
2993450|NCT00923078|3710064|FG002|COMPLETED|Second Intervention (Weeks 5-8)||0
2993451|NCT00923078|3710062|FG000|NOT COMPLETED|Second Intervention (Weeks 5-8)||0
2993452|NCT00923078|3710063|FG001|NOT COMPLETED|Second Intervention (Weeks 5-8)||0
2993453|NCT00923078|3710064|FG002|NOT COMPLETED|Second Intervention (Weeks 5-8)||0
2993454|NCT00923091|3710079|FG000|STARTED|PeriodI-II (Randomized, Double-Blind)||335
2993455|NCT00923091|3710080|FG001|STARTED|PeriodI-II (Randomized, Double-Blind)||336
2993456|NCT00923091|3710081|FG002|STARTED|PeriodI-II (Randomized, Double-Blind)||336
2993457|NCT00923091|3710082|FG003|STARTED|PeriodI-II (Randomized, Double-Blind)||336
2993458|NCT00923091|3710083|FG004|STARTED|PeriodI-II (Randomized, Double-Blind)||336
2993459|NCT00923091|3710084|FG005|STARTED|PeriodI-II (Randomized, Double-Blind)||337
2993460|NCT00923091|3710085|FG006|STARTED|PeriodI-II (Randomized, Double-Blind)||337
2993461|NCT00923091|3710086|FG007|STARTED|PeriodI-II (Randomized, Double-Blind)||336
2993462|NCT00923091|3710087|FG008|STARTED|PeriodI-II (Randomized, Double-Blind)||0
2993463|NCT00923091|3710088|FG009|STARTED|PeriodI-II (Randomized, Double-Blind)||0
2993464|NCT00923091|3710089|FG010|STARTED|PeriodI-II (Randomized, Double-Blind)||0
2993465|NCT00923091|3710090|FG011|STARTED|PeriodI-II (Randomized, Double-Blind)||0
2993466|NCT00923091|3710091|FG012|STARTED|PeriodI-II (Randomized, Double-Blind)||0
2993467|NCT00923091|3710079|FG000|COMPLETED|PeriodI-II (Randomized, Double-Blind)||319
2993468|NCT00923091|3710080|FG001|COMPLETED|PeriodI-II (Randomized, Double-Blind)||325
2993469|NCT00923091|3710081|FG002|COMPLETED|PeriodI-II (Randomized, Double-Blind)||323
2993470|NCT00923091|3710082|FG003|COMPLETED|PeriodI-II (Randomized, Double-Blind)||309
2993471|NCT00923091|3710083|FG004|COMPLETED|PeriodI-II (Randomized, Double-Blind)||315
2993472|NCT00923091|3710084|FG005|COMPLETED|PeriodI-II (Randomized, Double-Blind)||322
2993473|NCT00923091|3710085|FG006|COMPLETED|PeriodI-II (Randomized, Double-Blind)||319
2993474|NCT00923091|3710086|FG007|COMPLETED|PeriodI-II (Randomized, Double-Blind)||311
2993475|NCT00923091|3710087|FG008|COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
2993476|NCT00923091|3710088|FG009|COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
2993477|NCT00923091|3710089|FG010|COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
2993478|NCT00923091|3710090|FG011|COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
2993479|NCT00923091|3710091|FG012|COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
2993480|NCT00923091|3710079|FG000|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||16
3164584|NCT01893983|3891994|FG000|STARTED|Overall Study||140
3164585|NCT01893983|3891995|FG001|STARTED|Overall Study||140
3164586|NCT01893983|3891994|FG000|COMPLETED|Overall Study||130
3164587|NCT01893983|3891995|FG001|COMPLETED|Overall Study||134
3164588|NCT01893983|3891994|FG000|NOT COMPLETED|Overall Study||10
3164589|NCT01893983|3891995|FG001|NOT COMPLETED|Overall Study||6
3164590|NCT01894022|3892003|FG000|STARTED|Overall Study||9
3164591|NCT01894022|3892004|FG001|STARTED|Overall Study||10
3164592|NCT01894022|3892003|FG000|COMPLETED|Overall Study||0
3164593|NCT01894022|3892004|FG001|COMPLETED|Overall Study||0
3164594|NCT01894022|3892003|FG000|NOT COMPLETED|Overall Study||9
3164595|NCT01894022|3892004|FG001|NOT COMPLETED|Overall Study||10
3164596|NCT01894087|3892013|FG000|STARTED|Overall Study||102
2993481|NCT00923091|3710080|FG001|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||11
2993482|NCT00923091|3710081|FG002|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||13
2993483|NCT00923091|3710082|FG003|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||27
2993484|NCT00923091|3710083|FG004|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||21
2993485|NCT00923091|3710084|FG005|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||15
2993486|NCT00923091|3710085|FG006|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||18
2993487|NCT00923091|3710086|FG007|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||25
2993488|NCT00923091|3710087|FG008|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
2993489|NCT00923091|3710088|FG009|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
2993490|NCT00923091|3710089|FG010|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
2993491|NCT00923091|3710090|FG011|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
2993492|NCT00923091|3710091|FG012|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
2993493|NCT00923091|3710079|FG000|STARTED|Period III (Single-Blind)|2543 completed Period 2. Three decided not to continue in the study=2540.|2540
2993494|NCT00923091|3710080|FG001|STARTED|Period III (Single-Blind)||0
2993495|NCT00923091|3710081|FG002|STARTED|Period III (Single-Blind)||0
2993496|NCT00923091|3710082|FG003|STARTED|Period III (Single-Blind)||0
2993497|NCT00923091|3710083|FG004|STARTED|Period III (Single-Blind)||0
2993498|NCT00923091|3710084|FG005|STARTED|Period III (Single-Blind)||0
2993499|NCT00923091|3710085|FG006|STARTED|Period III (Single-Blind)||0
3305068|NCT02986074|4038750|FG000|NOT COMPLETED|First Trial Period||1
3305069|NCT02986074|4038751|FG001|NOT COMPLETED|First Trial Period||0
3305070|NCT02986074|4038752|FG002|NOT COMPLETED|First Trial Period||0
3305071|NCT02986074|4038753|FG003|NOT COMPLETED|First Trial Period||0
3305072|NCT02986074|4038750|FG000|STARTED|Second Trial Period||25
3305073|NCT02986074|4038751|FG001|STARTED|Second Trial Period||29
3305074|NCT02986074|4038752|FG002|STARTED|Second Trial Period||0
3305075|NCT02986074|4038753|FG003|STARTED|Second Trial Period||0
3305076|NCT02986074|4038750|FG000|COMPLETED|Second Trial Period||25
3305077|NCT02986074|4038751|FG001|COMPLETED|Second Trial Period||29
3305078|NCT02986074|4038752|FG002|COMPLETED|Second Trial Period||0
3305079|NCT02986074|4038753|FG003|COMPLETED|Second Trial Period||0
3305080|NCT02986074|4038750|FG000|NOT COMPLETED|Second Trial Period||0
3305081|NCT02986074|4038751|FG001|NOT COMPLETED|Second Trial Period||0
3305082|NCT02986074|4038752|FG002|NOT COMPLETED|Second Trial Period||0
3305083|NCT02986074|4038753|FG003|NOT COMPLETED|Second Trial Period||0
3305084|NCT02986074|4038750|FG000|STARTED|Follow up Period||0
3305085|NCT02986074|4038751|FG001|STARTED|Follow up Period||0
3305086|NCT02986074|4038752|FG002|STARTED|Follow up Period||21
3305087|NCT02986074|4038753|FG003|STARTED|Follow up Period||22
3305088|NCT02986074|4038750|FG000|3 Month Follow up|Follow up Period||0
3305089|NCT02986074|4038751|FG001|3 Month Follow up|Follow up Period||0
3305090|NCT02986074|4038752|FG002|3 Month Follow up|Follow up Period||21
3305091|NCT02986074|4038753|FG003|3 Month Follow up|Follow up Period||21
3305092|NCT02986074|4038750|FG000|6 Month Follow up|Follow up Period||0
3305093|NCT02986074|4038751|FG001|6 Month Follow up|Follow up Period||0
3305094|NCT02986074|4038752|FG002|6 Month Follow up|Follow up Period||21
2993500|NCT00923091|3710086|FG007|STARTED|Period III (Single-Blind)||0
2993501|NCT00923091|3710087|FG008|STARTED|Period III (Single-Blind)||0
2993502|NCT00923091|3710088|FG009|STARTED|Period III (Single-Blind)||0
2993503|NCT00923091|3710089|FG010|STARTED|Period III (Single-Blind)||0
2993504|NCT00923091|3710090|FG011|STARTED|Period III (Single-Blind)||0
2993505|NCT00923091|3710091|FG012|STARTED|Period III (Single-Blind)||0
2993506|NCT00923091|3710079|FG000|COMPLETED|Period III (Single-Blind)||2520
2993507|NCT00923091|3710080|FG001|COMPLETED|Period III (Single-Blind)||0
2993508|NCT00923091|3710081|FG002|COMPLETED|Period III (Single-Blind)||0
2993509|NCT00923091|3710082|FG003|COMPLETED|Period III (Single-Blind)||0
2993510|NCT00923091|3710083|FG004|COMPLETED|Period III (Single-Blind)||0
2993511|NCT00923091|3710084|FG005|COMPLETED|Period III (Single-Blind)||0
2993512|NCT00923091|3710085|FG006|COMPLETED|Period III (Single-Blind)||0
2993513|NCT00923091|3710086|FG007|COMPLETED|Period III (Single-Blind)||0
2993514|NCT00923091|3710087|FG008|COMPLETED|Period III (Single-Blind)||0
2993515|NCT00923091|3710088|FG009|COMPLETED|Period III (Single-Blind)||0
2993516|NCT00923091|3710089|FG010|COMPLETED|Period III (Single-Blind)||0
2993517|NCT00923091|3710090|FG011|COMPLETED|Period III (Single-Blind)||0
2993518|NCT00923091|3710091|FG012|COMPLETED|Period III (Single-Blind)||0
2993519|NCT00923091|3710079|FG000|NOT COMPLETED|Period III (Single-Blind)||20
2993520|NCT00923091|3710080|FG001|NOT COMPLETED|Period III (Single-Blind)||0
2993521|NCT00923091|3710081|FG002|NOT COMPLETED|Period III (Single-Blind)||0
2993522|NCT00923091|3710082|FG003|NOT COMPLETED|Period III (Single-Blind)||0
3164597|NCT01894087|3892014|FG001|STARTED|Overall Study||102
3305095|NCT02986074|4038753|FG003|6 Month Follow up|Follow up Period||20
3305096|NCT02986074|4038750|FG000|COMPLETED|Follow up Period||0
3305097|NCT02986074|4038751|FG001|COMPLETED|Follow up Period||0
3305098|NCT02986074|4038752|FG002|COMPLETED|Follow up Period||20
3305099|NCT02986074|4038753|FG003|COMPLETED|Follow up Period||19
3305100|NCT02986074|4038750|FG000|NOT COMPLETED|Follow up Period||0
2993523|NCT00923091|3710083|FG004|NOT COMPLETED|Period III (Single-Blind)||0
2993524|NCT00923091|3710084|FG005|NOT COMPLETED|Period III (Single-Blind)||0
2993525|NCT00923091|3710085|FG006|NOT COMPLETED|Period III (Single-Blind)||0
2993526|NCT00923091|3710086|FG007|NOT COMPLETED|Period III (Single-Blind)||0
2993527|NCT00923091|3710087|FG008|NOT COMPLETED|Period III (Single-Blind)||0
2993528|NCT00923091|3710088|FG009|NOT COMPLETED|Period III (Single-Blind)||0
2993529|NCT00923091|3710089|FG010|NOT COMPLETED|Period III (Single-Blind)||0
2993530|NCT00923091|3710090|FG011|NOT COMPLETED|Period III (Single-Blind)||0
2993531|NCT00923091|3710091|FG012|NOT COMPLETED|Period III (Single-Blind)||0
2993532|NCT00923091|3710079|FG000|STARTED|Period IV (Double-Blind)|2 did not continue in the study and 1837 responders went directly to Period VI. 228+453+2+1837=2520|228
2993533|NCT00923091|3710080|FG001|STARTED|Period IV (Double-Blind)||453
2993534|NCT00923091|3710081|FG002|STARTED|Period IV (Double-Blind)||0
2993535|NCT00923091|3710082|FG003|STARTED|Period IV (Double-Blind)||0
2993536|NCT00923091|3710083|FG004|STARTED|Period IV (Double-Blind)||0
2993537|NCT00923091|3710084|FG005|STARTED|Period IV (Double-Blind)||0
2993538|NCT00923091|3710085|FG006|STARTED|Period IV (Double-Blind)||0
2993539|NCT00923091|3710086|FG007|STARTED|Period IV (Double-Blind)||0
2993540|NCT00923091|3710087|FG008|STARTED|Period IV (Double-Blind)||0
2993541|NCT00923091|3710088|FG009|STARTED|Period IV (Double-Blind)||0
2993542|NCT00923091|3710089|FG010|STARTED|Period IV (Double-Blind)||0
2993543|NCT00923091|3710090|FG011|STARTED|Period IV (Double-Blind)||0
2993544|NCT00923091|3710091|FG012|STARTED|Period IV (Double-Blind)||0
2993545|NCT00923091|3710079|FG000|COMPLETED|Period IV (Double-Blind)||226
2993546|NCT00923091|3710080|FG001|COMPLETED|Period IV (Double-Blind)||451
2993547|NCT00923091|3710081|FG002|COMPLETED|Period IV (Double-Blind)||0
2993548|NCT00923091|3710082|FG003|COMPLETED|Period IV (Double-Blind)||0
2993549|NCT00923091|3710083|FG004|COMPLETED|Period IV (Double-Blind)||0
2993550|NCT00923091|3710084|FG005|COMPLETED|Period IV (Double-Blind)||0
2993551|NCT00923091|3710085|FG006|COMPLETED|Period IV (Double-Blind)||0
2993552|NCT00923091|3710086|FG007|COMPLETED|Period IV (Double-Blind)||0
2993553|NCT00923091|3710087|FG008|COMPLETED|Period IV (Double-Blind)||0
2993554|NCT00923091|3710088|FG009|COMPLETED|Period IV (Double-Blind)||0
2993555|NCT00923091|3710089|FG010|COMPLETED|Period IV (Double-Blind)||0
2993556|NCT00923091|3710090|FG011|COMPLETED|Period IV (Double-Blind)||0
2993557|NCT00923091|3710091|FG012|COMPLETED|Period IV (Double-Blind)||0
2993558|NCT00923091|3710079|FG000|NOT COMPLETED|Period IV (Double-Blind)||2
2993559|NCT00923091|3710080|FG001|NOT COMPLETED|Period IV (Double-Blind)||2
2993560|NCT00923091|3710081|FG002|NOT COMPLETED|Period IV (Double-Blind)||0
2993561|NCT00923091|3710082|FG003|NOT COMPLETED|Period IV (Double-Blind)||0
2993562|NCT00923091|3710083|FG004|NOT COMPLETED|Period IV (Double-Blind)||0
2993563|NCT00923091|3710084|FG005|NOT COMPLETED|Period IV (Double-Blind)||0
2993564|NCT00923091|3710085|FG006|NOT COMPLETED|Period IV (Double-Blind)||0
2993565|NCT00923091|3710086|FG007|NOT COMPLETED|Period IV (Double-Blind)||0
2993566|NCT00923091|3710087|FG008|NOT COMPLETED|Period IV (Double-Blind)||0
2993567|NCT00923091|3710088|FG009|NOT COMPLETED|Period IV (Double-Blind)||0
2993568|NCT00923091|3710089|FG010|NOT COMPLETED|Period IV (Double-Blind)||0
2993569|NCT00923091|3710090|FG011|NOT COMPLETED|Period IV (Double-Blind)||0
2993570|NCT00923091|3710091|FG012|NOT COMPLETED|Period IV (Double-Blind)||0
2993571|NCT00923091|3710079|FG000|STARTED|Period V (Double -Blind)|677 completed Period 4. 1 did not continue and 2 erroneously responders were not counted = 674|0
2993572|NCT00923091|3710080|FG001|STARTED|Period V (Double -Blind)||0
2993573|NCT00923091|3710081|FG002|STARTED|Period V (Double -Blind)||0
2993574|NCT00923091|3710082|FG003|STARTED|Period V (Double -Blind)||0
2993575|NCT00923091|3710083|FG004|STARTED|Period V (Double -Blind)||0
2993576|NCT00923091|3710084|FG005|STARTED|Period V (Double -Blind)||0
2993577|NCT00923091|3710085|FG006|STARTED|Period V (Double -Blind)||0
2993578|NCT00923091|3710086|FG007|STARTED|Period V (Double -Blind)||0
2993579|NCT00923091|3710087|FG008|STARTED|Period V (Double -Blind)||135
2993580|NCT00923091|3710088|FG009|STARTED|Period V (Double -Blind)||119
2993581|NCT00923091|3710089|FG010|STARTED|Period V (Double -Blind)||194
2993582|NCT00923091|3710090|FG011|STARTED|Period V (Double -Blind)||151
2993583|NCT00923091|3710091|FG012|STARTED|Period V (Double -Blind)||75
2993584|NCT00923091|3710079|FG000|COMPLETED|Period V (Double -Blind)||0
2993585|NCT00923091|3710080|FG001|COMPLETED|Period V (Double -Blind)||0
2993586|NCT00923091|3710081|FG002|COMPLETED|Period V (Double -Blind)||0
2993587|NCT00923091|3710082|FG003|COMPLETED|Period V (Double -Blind)||0
2993588|NCT00923091|3710083|FG004|COMPLETED|Period V (Double -Blind)||0
2993589|NCT00923091|3710084|FG005|COMPLETED|Period V (Double -Blind)||0
2993590|NCT00923091|3710085|FG006|COMPLETED|Period V (Double -Blind)||0
2993591|NCT00923091|3710086|FG007|COMPLETED|Period V (Double -Blind)||0
2993592|NCT00923091|3710087|FG008|COMPLETED|Period V (Double -Blind)||134
3164598|NCT01894087|3892013|FG000|COMPLETED|Overall Study||96
3164599|NCT01894087|3892014|FG001|COMPLETED|Overall Study||102
3164600|NCT01894087|3892013|FG000|NOT COMPLETED|Overall Study||6
3164601|NCT01894087|3892014|FG001|NOT COMPLETED|Overall Study||0
3171768|NCT01937026|3898964|FG000|STARTED|Period 1 (Day 1 Through Predose Day 3)||18
2993593|NCT00923091|3710088|FG009|COMPLETED|Period V (Double -Blind)||119
2993594|NCT00923091|3710089|FG010|COMPLETED|Period V (Double -Blind)||193
2993595|NCT00923091|3710090|FG011|COMPLETED|Period V (Double -Blind)||151
2993596|NCT00923091|3710091|FG012|COMPLETED|Period V (Double -Blind)||73
2993597|NCT00923091|3710079|FG000|NOT COMPLETED|Period V (Double -Blind)||0
3171769|NCT01937026|3898964|FG000|Received Baricitinib|Period 1 (Day 1 Through Predose Day 3)||18
2993598|NCT00923091|3710080|FG001|NOT COMPLETED|Period V (Double -Blind)||0
2993599|NCT00923091|3710081|FG002|NOT COMPLETED|Period V (Double -Blind)||0
2993600|NCT00923091|3710082|FG003|NOT COMPLETED|Period V (Double -Blind)||0
2993601|NCT00923091|3710083|FG004|NOT COMPLETED|Period V (Double -Blind)||0
2993602|NCT00923091|3710084|FG005|NOT COMPLETED|Period V (Double -Blind)||0
2993603|NCT00923091|3710085|FG006|NOT COMPLETED|Period V (Double -Blind)||0
2993604|NCT00923091|3710086|FG007|NOT COMPLETED|Period V (Double -Blind)||0
2993605|NCT00923091|3710087|FG008|NOT COMPLETED|Period V (Double -Blind)||1
2993606|NCT00923091|3710088|FG009|NOT COMPLETED|Period V (Double -Blind)||0
2993607|NCT00923091|3710089|FG010|NOT COMPLETED|Period V (Double -Blind)||1
2993608|NCT00923091|3710090|FG011|NOT COMPLETED|Period V (Double -Blind)||0
2993609|NCT00923091|3710091|FG012|NOT COMPLETED|Period V (Double -Blind)||2
2993610|NCT00923091|3710079|FG000|STARTED|Period VI (Open-Label)|1837 from Period III+2 from Period IV + 670 from Period 5 = 2509|1447
2993611|NCT00923091|3710080|FG001|STARTED|Period VI (Open-Label)||272
2993612|NCT00923091|3710081|FG002|STARTED|Period VI (Open-Label)||480
2993613|NCT00923091|3710082|FG003|STARTED|Period VI (Open-Label)||146
2993614|NCT00923091|3710083|FG004|STARTED|Period VI (Open-Label)||164
2993615|NCT00923091|3710084|FG005|STARTED|Period VI (Open-Label)||0
2993616|NCT00923091|3710085|FG006|STARTED|Period VI (Open-Label)||0
2993617|NCT00923091|3710086|FG007|STARTED|Period VI (Open-Label)||0
2993618|NCT00923091|3710087|FG008|STARTED|Period VI (Open-Label)||0
2993619|NCT00923091|3710088|FG009|STARTED|Period VI (Open-Label)||0
2993620|NCT00923091|3710089|FG010|STARTED|Period VI (Open-Label)||0
2993621|NCT00923091|3710090|FG011|STARTED|Period VI (Open-Label)||0
2993622|NCT00923091|3710091|FG012|STARTED|Period VI (Open-Label)||0
2993623|NCT00923091|3710079|FG000|COMPLETED|Period VI (Open-Label)||1408
2993624|NCT00923091|3710080|FG001|COMPLETED|Period VI (Open-Label)||264
2993625|NCT00923091|3710081|FG002|COMPLETED|Period VI (Open-Label)||467
2993626|NCT00923091|3710082|FG003|COMPLETED|Period VI (Open-Label)||143
2993627|NCT00923091|3710083|FG004|COMPLETED|Period VI (Open-Label)||157
2993628|NCT00923091|3710084|FG005|COMPLETED|Period VI (Open-Label)||0
2993629|NCT00923091|3710085|FG006|COMPLETED|Period VI (Open-Label)||0
2993630|NCT00923091|3710086|FG007|COMPLETED|Period VI (Open-Label)||0
2993631|NCT00923091|3710087|FG008|COMPLETED|Period VI (Open-Label)||0
2993632|NCT00923091|3710088|FG009|COMPLETED|Period VI (Open-Label)||0
2993633|NCT00923091|3710089|FG010|COMPLETED|Period VI (Open-Label)||0
2993634|NCT00923091|3710090|FG011|COMPLETED|Period VI (Open-Label)||0
2993635|NCT00923091|3710091|FG012|COMPLETED|Period VI (Open-Label)||0
2993636|NCT00923091|3710079|FG000|NOT COMPLETED|Period VI (Open-Label)||39
2993637|NCT00923091|3710080|FG001|NOT COMPLETED|Period VI (Open-Label)||8
2993638|NCT00923091|3710081|FG002|NOT COMPLETED|Period VI (Open-Label)||13
2993639|NCT00923091|3710082|FG003|NOT COMPLETED|Period VI (Open-Label)||3
2993640|NCT00923091|3710083|FG004|NOT COMPLETED|Period VI (Open-Label)||7
2993641|NCT00923091|3710084|FG005|NOT COMPLETED|Period VI (Open-Label)||0
2993642|NCT00923091|3710085|FG006|NOT COMPLETED|Period VI (Open-Label)||0
2993643|NCT00923091|3710086|FG007|NOT COMPLETED|Period VI (Open-Label)||0
2993644|NCT00923091|3710087|FG008|NOT COMPLETED|Period VI (Open-Label)||0
2993645|NCT00923091|3710088|FG009|NOT COMPLETED|Period VI (Open-Label)||0
2993646|NCT00923091|3710089|FG010|NOT COMPLETED|Period VI (Open-Label)||0
2993647|NCT00923091|3710090|FG011|NOT COMPLETED|Period VI (Open-Label)||0
2993648|NCT00923091|3710091|FG012|NOT COMPLETED|Period VI (Open-Label)||0
2993649|NCT00923117|3710118|FG000|STARTED|Overall Study||44
2993650|NCT00923117|3710119|FG001|STARTED|Overall Study||43
2993651|NCT00923117|3710118|FG000|COMPLETED|Overall Study||44
2993652|NCT00923117|3710119|FG001|COMPLETED|Overall Study||43
2993653|NCT00923117|3710118|FG000|NOT COMPLETED|Overall Study||0
2993654|NCT00923117|3710119|FG001|NOT COMPLETED|Overall Study||0
2993655|NCT00923130|3710125|FG000|STARTED|Overall Study||30
2993656|NCT00923130|3710125|FG000|COMPLETED|Overall Study||5
2993657|NCT00923130|3710125|FG000|NOT COMPLETED|Overall Study||25
2993658|NCT00923156|3710132|FG000|STARTED|Overall Study|"Started indicates randomized, safety and pharmacodynamic population"|40
2993659|NCT00923156|3710133|FG001|STARTED|Overall Study||42
2993660|NCT00923156|3710134|FG002|STARTED|Overall Study||41
2993661|NCT00923156|3710132|FG000|COMPLETED|Overall Study||40
2993662|NCT00923156|3710133|FG001|COMPLETED|Overall Study||38
2993663|NCT00923156|3710134|FG002|COMPLETED|Overall Study||38
2993664|NCT00923156|3710132|FG000|NOT COMPLETED|Overall Study||0
2993665|NCT00923156|3710133|FG001|NOT COMPLETED|Overall Study||4
2993666|NCT00923156|3710134|FG002|NOT COMPLETED|Overall Study||3
2993667|NCT00923195|3710144|FG000|STARTED|Overall Study||2
2993668|NCT00923195|3710145|FG001|STARTED|Overall Study||2
2993669|NCT00923195|3710144|FG000|COMPLETED|Overall Study||2
2993670|NCT00923195|3710145|FG001|COMPLETED|Overall Study||1
2993671|NCT00923195|3710144|FG000|NOT COMPLETED|Overall Study||0
2993672|NCT00923195|3710145|FG001|NOT COMPLETED|Overall Study||1
2993673|NCT00923260|3710153|FG000|STARTED|Overall Study||12
2993674|NCT00923260|3710154|FG001|STARTED|Overall Study||12
2993675|NCT00923260|3710153|FG000|COMPLETED|Overall Study|Patient didn't complete the follow-up period after surgery|11
2993676|NCT00923260|3710154|FG001|COMPLETED|Overall Study|Patient didn't complete the follow-up period after surgery|11
2993677|NCT00923260|3710153|FG000|NOT COMPLETED|Overall Study||1
2993678|NCT00923260|3710154|FG001|NOT COMPLETED|Overall Study||1
2993679|NCT00923273|3710165|FG000|STARTED|Phase I Treatment Period|The phase I portion will establish the maximum tolerated dose. 4 subjects peme naive.|4
2993680|NCT00923273|3710166|FG001|STARTED|Phase I Treatment Period|3 subjects peme naive.|3
2993681|NCT00923273|3710167|FG002|STARTED|Phase I Treatment Period|3 subjects peme naive.|3
2993682|NCT00923273|3710168|FG003|STARTED|Phase I Treatment Period|3 subjects initially enrolled and 4 subjects added after dose level 5; peme naive.|7
2993683|NCT00923273|3710169|FG004|STARTED|Phase I Treatment Period|5 subjects peme naive.|5
2993684|NCT00923273|3710165|FG000|COMPLETED|Phase I Treatment Period||4
2993685|NCT00923273|3710166|FG001|COMPLETED|Phase I Treatment Period||3
3164602|NCT01894100|3892022|FG000|STARTED|Overall Study||15
3164603|NCT01894100|3892023|FG001|STARTED|Overall Study||15
2993686|NCT00923273|3710167|FG002|COMPLETED|Phase I Treatment Period||3
2993687|NCT00923273|3710168|FG003|COMPLETED|Phase I Treatment Period||7
2993688|NCT00923273|3710169|FG004|COMPLETED|Phase I Treatment Period||5
2993689|NCT00923273|3710165|FG000|NOT COMPLETED|Phase I Treatment Period||0
2993690|NCT00923273|3710166|FG001|NOT COMPLETED|Phase I Treatment Period||0
2993691|NCT00923273|3710167|FG002|NOT COMPLETED|Phase I Treatment Period||0
2993692|NCT00923273|3710168|FG003|NOT COMPLETED|Phase I Treatment Period||0
2993693|NCT00923273|3710169|FG004|NOT COMPLETED|Phase I Treatment Period||0
2993694|NCT00923273|3710165|FG000|STARTED|Phase II Treatment Period|The phase II portion will utilize the MTD from the phase I portion.|0
2993695|NCT00923273|3710166|FG001|STARTED|Phase II Treatment Period||0
2993696|NCT00923273|3710167|FG002|STARTED|Phase II Treatment Period||0
2993697|NCT00923273|3710168|FG003|STARTED|Phase II Treatment Period|Includes 8 subjects with prior peme;12 subjects who were peme naive; 7 subjects rolled over from phI|27
2993698|NCT00923273|3710169|FG004|STARTED|Phase II Treatment Period||0
2993699|NCT00923273|3710165|FG000|COMPLETED|Phase II Treatment Period||0
2993700|NCT00923273|3710166|FG001|COMPLETED|Phase II Treatment Period||0
2993701|NCT00923273|3710167|FG002|COMPLETED|Phase II Treatment Period||0
2993702|NCT00923273|3710168|FG003|COMPLETED|Phase II Treatment Period||20
2993703|NCT00923273|3710169|FG004|COMPLETED|Phase II Treatment Period||0
2993704|NCT00923273|3710165|FG000|NOT COMPLETED|Phase II Treatment Period||0
2993705|NCT00923273|3710166|FG001|NOT COMPLETED|Phase II Treatment Period||0
2993706|NCT00923273|3710167|FG002|NOT COMPLETED|Phase II Treatment Period||0
2993707|NCT00923273|3710168|FG003|NOT COMPLETED|Phase II Treatment Period||7
2993708|NCT00923273|3710169|FG004|NOT COMPLETED|Phase II Treatment Period||0
2993709|NCT00923351|3710189|FG000|STARTED|Overall Study||6
2993710|NCT00923351|3710190|FG001|STARTED|Overall Study||26
2993711|NCT00923351|3710191|FG002|STARTED|Overall Study||12
2993712|NCT00923351|3710189|FG000|COMPLETED|Overall Study||6
2993713|NCT00923351|3710190|FG001|COMPLETED|Overall Study||26
2993714|NCT00923351|3710191|FG002|COMPLETED|Overall Study||0
2993715|NCT00923351|3710189|FG000|NOT COMPLETED|Overall Study||0
2993716|NCT00923351|3710190|FG001|NOT COMPLETED|Overall Study||0
2993717|NCT00923351|3710191|FG002|NOT COMPLETED|Overall Study||12
2993718|NCT00923364|3710197|FG000|STARTED|Overall Study||14
2993719|NCT00923364|3710198|FG001|STARTED|Overall Study||5
2993720|NCT00923364|3710197|FG000|COMPLETED|Overall Study||10
2993721|NCT00923364|3710198|FG001|COMPLETED|Overall Study||5
2993722|NCT00923364|3710197|FG000|NOT COMPLETED|Overall Study||4
2993723|NCT00923364|3710198|FG001|NOT COMPLETED|Overall Study||0
2993724|NCT00923481|3710203|FG000|STARTED|Overall Study||37
2993725|NCT00923481|3710203|FG000|COMPLETED|Overall Study||37
2993726|NCT00923481|3710203|FG000|NOT COMPLETED|Overall Study||0
2993727|NCT00923559|3710209|FG000|STARTED|Overall Study||40
2993728|NCT00923559|3710210|FG001|STARTED|Overall Study||40
2993729|NCT00923559|3710209|FG000|COMPLETED|Overall Study||38
2993730|NCT00923559|3710210|FG001|COMPLETED|Overall Study||37
2993731|NCT00923559|3710209|FG000|NOT COMPLETED|Overall Study||2
2993732|NCT00923559|3710210|FG001|NOT COMPLETED|Overall Study||3
2993733|NCT00923598|3710220|FG000|STARTED|Overall Study||23
2993734|NCT00923598|3710221|FG001|STARTED|Overall Study||22
2993735|NCT00923598|3710220|FG000|COMPLETED|Overall Study||19
2993736|NCT00923598|3710221|FG001|COMPLETED|Overall Study||17
2993737|NCT00923598|3710220|FG000|NOT COMPLETED|Overall Study||4
2993738|NCT00923598|3710221|FG001|NOT COMPLETED|Overall Study||5
2993739|NCT00923845|3710229|FG000|STARTED|Donor Lymphocyte Harvest||13
2993740|NCT00923845|3710230|FG001|STARTED|Donor Lymphocyte Harvest||0
2993741|NCT00923845|3710229|FG000|COMPLETED|Donor Lymphocyte Harvest||13
2993742|NCT00923845|3710230|FG001|COMPLETED|Donor Lymphocyte Harvest||0
2993743|NCT00923845|3710229|FG000|NOT COMPLETED|Donor Lymphocyte Harvest||0
2993744|NCT00923845|3710230|FG001|NOT COMPLETED|Donor Lymphocyte Harvest||0
2993745|NCT00923845|3710229|FG000|STARTED|Donor Hematopoietic Stem Cell Harvest||13
2993746|NCT00923845|3710230|FG001|STARTED|Donor Hematopoietic Stem Cell Harvest||0
2993747|NCT00923845|3710229|FG000|COMPLETED|Donor Hematopoietic Stem Cell Harvest||13
2993748|NCT00923845|3710230|FG001|COMPLETED|Donor Hematopoietic Stem Cell Harvest||0
2993749|NCT00923845|3710229|FG000|NOT COMPLETED|Donor Hematopoietic Stem Cell Harvest||0
2993750|NCT00923845|3710230|FG001|NOT COMPLETED|Donor Hematopoietic Stem Cell Harvest||0
2993751|NCT00923845|3710229|FG000|STARTED|Induction Therapy||0
2993752|NCT00923845|3710230|FG001|STARTED|Induction Therapy||12
2993753|NCT00923845|3710229|FG000|COMPLETED|Induction Therapy||0
2993754|NCT00923845|3710230|FG001|COMPLETED|Induction Therapy||10
2993755|NCT00923845|3710229|FG000|NOT COMPLETED|Induction Therapy||0
2993756|NCT00923845|3710230|FG001|NOT COMPLETED|Induction Therapy||2
2993757|NCT00923845|3710229|FG000|STARTED|Allogeneic Stem Cell Therapy||0
2993758|NCT00923845|3710230|FG001|STARTED|Allogeneic Stem Cell Therapy||10
2993759|NCT00923845|3710229|FG000|Received Each of 3 Planned T-Rapa DLI|Allogeneic Stem Cell Therapy||0
2993760|NCT00923845|3710230|FG001|Received Each of 3 Planned T-Rapa DLI|Allogeneic Stem Cell Therapy||8
2993761|NCT00923845|3710229|FG000|Received More Unmanipulated DLI for PD|Allogeneic Stem Cell Therapy||0
2993762|NCT00923845|3710230|FG001|Received More Unmanipulated DLI for PD|Allogeneic Stem Cell Therapy||6
2993763|NCT00923845|3710229|FG000|COMPLETED|Allogeneic Stem Cell Therapy||0
2993764|NCT00923845|3710230|FG001|COMPLETED|Allogeneic Stem Cell Therapy||10
2993765|NCT00923845|3710229|FG000|NOT COMPLETED|Allogeneic Stem Cell Therapy||0
2993766|NCT00923845|3710230|FG001|NOT COMPLETED|Allogeneic Stem Cell Therapy||0
2993767|NCT00923910|3710239|FG000|STARTED|Period 1||5
2993768|NCT00923910|3710240|FG001|STARTED|Period 1||5
2993769|NCT00923910|3710239|FG000|COMPLETED|Period 1||5
2993770|NCT00923910|3710240|FG001|COMPLETED|Period 1||5
2993771|NCT00923910|3710239|FG000|NOT COMPLETED|Period 1||0
2993772|NCT00923910|3710240|FG001|NOT COMPLETED|Period 1||0
2993773|NCT00923910|3710239|FG000|STARTED|Period 2||5
2993774|NCT00923910|3710240|FG001|STARTED|Period 2||5
2993775|NCT00923910|3710239|FG000|COMPLETED|Period 2||5
2993776|NCT00923910|3710240|FG001|COMPLETED|Period 2||5
2993777|NCT00923910|3710239|FG000|NOT COMPLETED|Period 2||0
2993778|NCT00923910|3710240|FG001|NOT COMPLETED|Period 2||0
2993779|NCT00923936|3710247|FG000|STARTED|Overall Study||10
2993780|NCT00923936|3710248|FG001|STARTED|Overall Study||6
2993781|NCT00923936|3710247|FG000|COMPLETED|Overall Study||2
2993782|NCT00923936|3710248|FG001|COMPLETED|Overall Study||3
2993783|NCT00923936|3710247|FG000|NOT COMPLETED|Overall Study||8
2993784|NCT00923936|3710248|FG001|NOT COMPLETED|Overall Study||3
2993785|NCT00923949|3710256|FG000|STARTED|Overall Study||1
2993786|NCT00923949|3710256|FG000|COMPLETED|Overall Study||1
2993787|NCT00923949|3710256|FG000|NOT COMPLETED|Overall Study||0
2993788|NCT00923975|3710260|FG000|STARTED|Overall Study||51
2993789|NCT00923975|3710260|FG000|COMPLETED|Overall Study|One subject did not meet inclusion criteria; the data was not used in analysis.|50
2993790|NCT00923975|3710260|FG000|NOT COMPLETED|Overall Study||1
2993791|NCT00924001|3710264|FG000|STARTED|Overall Study||1
2993792|NCT00924001|3710264|FG000|COMPLETED|Overall Study||1
2993793|NCT00924001|3710264|FG000|NOT COMPLETED|Overall Study||0
2993794|NCT00924040|3710268|FG000|STARTED|Overall Study||1
2993795|NCT00924040|3710268|FG000|COMPLETED|Overall Study||1
2993796|NCT00924040|3710268|FG000|NOT COMPLETED|Overall Study||0
2993797|NCT00924053|3710276|FG000|STARTED|Overall Study||6
2993798|NCT00924053|3710277|FG001|STARTED|Overall Study||6
2993799|NCT00924053|3710278|FG002|STARTED|Overall Study||6
2993800|NCT00924053|3710279|FG003|STARTED|Overall Study||6
2993801|NCT00924053|3710276|FG000|COMPLETED|Overall Study||6
2993802|NCT00924053|3710277|FG001|COMPLETED|Overall Study||6
2993803|NCT00924053|3710278|FG002|COMPLETED|Overall Study||6
2993804|NCT00924053|3710279|FG003|COMPLETED|Overall Study||6
2993805|NCT00924053|3710276|FG000|NOT COMPLETED|Overall Study||0
2993806|NCT00924053|3710277|FG001|NOT COMPLETED|Overall Study||0
2993807|NCT00924053|3710278|FG002|NOT COMPLETED|Overall Study||0
2993808|NCT00924053|3710279|FG003|NOT COMPLETED|Overall Study||0
2993809|NCT00924066|3710289|FG000|STARTED|Overall Study||41
2993810|NCT00924066|3710289|FG000|COMPLETED|Overall Study||41
2993811|NCT00924066|3710289|FG000|NOT COMPLETED|Overall Study||0
2993812|NCT00924118|3710296|FG000|STARTED|Overall Study||15
2993813|NCT00924118|3710297|FG001|STARTED|Overall Study||15
2993814|NCT00924118|3710296|FG000|COMPLETED|Overall Study||15
2993815|NCT00924118|3710297|FG001|COMPLETED|Overall Study||15
2993816|NCT00924118|3710296|FG000|NOT COMPLETED|Overall Study||0
2993817|NCT00924118|3710297|FG001|NOT COMPLETED|Overall Study||0
2993818|NCT00924209|3710303|FG000|STARTED|Overall Study||7
2993819|NCT00924209|3710303|FG000|COMPLETED|Overall Study||7
2993820|NCT00924209|3710303|FG000|NOT COMPLETED|Overall Study||0
2993821|NCT00924287|3710307|FG000|STARTED|Overall Study||1
2993822|NCT00924287|3710307|FG000|COMPLETED|Overall Study||0
2993823|NCT00924287|3710307|FG000|NOT COMPLETED|Overall Study||1
2993824|NCT00924313|3710311|FG000|STARTED|Overall Study||40
2993825|NCT00924313|3710311|FG000|COMPLETED|Overall Study||39
2993826|NCT00924313|3710311|FG000|NOT COMPLETED|Overall Study||1
2993827|NCT00924352|3710315|FG000|STARTED|Overall Study||12
2993828|NCT00924352|3710316|FG001|STARTED|Overall Study||44
2993829|NCT00924352|3710315|FG000|COMPLETED|Overall Study||12
2993830|NCT00924352|3710316|FG001|COMPLETED|Overall Study||44
2993831|NCT00924352|3710315|FG000|NOT COMPLETED|Overall Study||0
2993832|NCT00924352|3710316|FG001|NOT COMPLETED|Overall Study||0
2993833|NCT00924404|3710325|FG000|STARTED|Overall Study||27
2993834|NCT00924404|3710326|FG001|STARTED|Overall Study||26
2993835|NCT00924404|3710325|FG000|COMPLETED|Overall Study||21
2993836|NCT00924404|3710326|FG001|COMPLETED|Overall Study||22
2993837|NCT00924404|3710325|FG000|NOT COMPLETED|Overall Study||6
2993838|NCT00924404|3710326|FG001|NOT COMPLETED|Overall Study||4
2993839|NCT00924443|3710332|FG000|STARTED|Overall Study||69
2993840|NCT00924443|3710332|FG000|Full Analysis Set (Received Study Drug)|Overall Study||66
2993841|NCT00924443|3710332|FG000|COMPLETED|Overall Study||66
2993842|NCT00924443|3710332|FG000|NOT COMPLETED|Overall Study||3
2993843|NCT00924469|3710338|FG000|STARTED|Overall Study||30
2993844|NCT00924469|3710339|FG001|STARTED|Overall Study||28
2993845|NCT00924469|3710338|FG000|COMPLETED|Overall Study||28
2993846|NCT00924469|3710339|FG001|COMPLETED|Overall Study||26
2993847|NCT00924469|3710338|FG000|NOT COMPLETED|Overall Study||2
2993848|NCT00924469|3710339|FG001|NOT COMPLETED|Overall Study||2
2993849|NCT00924482|3710345|FG000|STARTED|Overall Study||261
2993850|NCT00924482|3710345|FG000|COMPLETED|Overall Study||261
2993851|NCT00924482|3710345|FG000|NOT COMPLETED|Overall Study||0
2993852|NCT00924508|3710350|FG000|STARTED|Overall Study||23
2993853|NCT00924508|3710350|FG000|COMPLETED|Overall Study||20
2993854|NCT00924508|3710350|FG000|NOT COMPLETED|Overall Study||3
2993855|NCT00924560|3710360|FG000|STARTED|Overall Study||458
2993856|NCT00924560|3710361|FG001|STARTED|Overall Study||448
2993857|NCT00924560|3710362|FG002|STARTED|Overall Study||455
2993858|NCT00924560|3710360|FG000|Received Treatment|Overall Study|Excludes 7 participants at 1 site that was closed. One participant received 28-day OC in error.|422
2993859|NCT00924560|3710361|FG001|Received Treatment|Overall Study|Excludes 9 participants from one site that was closed due to audit findings.|411
2993860|NCT00924560|3710362|FG002|Received Treatment|Overall Study||0
2993861|NCT00924560|3710360|FG000|COMPLETED|Overall Study||247
2993862|NCT00924560|3710361|FG001|COMPLETED|Overall Study||240
2993863|NCT00924560|3710362|FG002|COMPLETED|Overall Study||372
2993864|NCT00924560|3710360|FG000|NOT COMPLETED|Overall Study||211
2993865|NCT00924560|3710361|FG001|NOT COMPLETED|Overall Study||208
2993866|NCT00924560|3710362|FG002|NOT COMPLETED|Overall Study||83
2993867|NCT00924612|3710372|FG000|STARTED|Overall Study||4
2993868|NCT00924612|3710373|FG001|STARTED|Overall Study||4
2993869|NCT00924612|3710374|FG002|STARTED|Overall Study||4
2993870|NCT00924612|3710375|FG003|STARTED|Overall Study||4
2993871|NCT00924612|3710372|FG000|COMPLETED|Overall Study||4
2993872|NCT00924612|3710373|FG001|COMPLETED|Overall Study||4
2993873|NCT00924612|3710374|FG002|COMPLETED|Overall Study||4
2993874|NCT00924612|3710375|FG003|COMPLETED|Overall Study||4
2993875|NCT00924612|3710372|FG000|NOT COMPLETED|Overall Study||0
2993876|NCT00924612|3710373|FG001|NOT COMPLETED|Overall Study||0
2993877|NCT00924612|3710374|FG002|NOT COMPLETED|Overall Study||0
2993878|NCT00924612|3710375|FG003|NOT COMPLETED|Overall Study||0
2993879|NCT00924638|3710389|FG000|STARTED|Overall Study|Randomized to Continuous Monitoring Arm|221
2993880|NCT00924638|3710390|FG001|STARTED|Overall Study|Randomized to Control Arm|220
2993881|NCT00924638|3710389|FG000|COMPLETED|Overall Study|Completed 6 months of follow-up|209
2993882|NCT00924638|3710390|FG001|COMPLETED|Overall Study|Completed 6 months of follow-up|207
2993883|NCT00924638|3710389|FG000|NOT COMPLETED|Overall Study||12
2993884|NCT00924638|3710390|FG001|NOT COMPLETED|Overall Study||13
2993885|NCT00924651|3710398|FG000|STARTED|Overall Study||356
2993886|NCT00924651|3710399|FG001|STARTED|Overall Study||337
2993887|NCT00924651|3710398|FG000|COMPLETED|Overall Study||331
2993888|NCT00924651|3710399|FG001|COMPLETED|Overall Study||312
2993889|NCT00924651|3710398|FG000|NOT COMPLETED|Overall Study||25
2993890|NCT00924651|3710399|FG001|NOT COMPLETED|Overall Study||25
2993891|NCT00924664|3710407|FG000|STARTED|Overall Study||322
2993892|NCT00924664|3710408|FG001|STARTED|Overall Study||527
2993893|NCT00924664|3710407|FG000|Treated|Overall Study||321
2993894|NCT00924664|3710408|FG001|Treated|Overall Study||527
2993895|NCT00924664|3710407|FG000|COMPLETED|Overall Study||0
2993896|NCT00924664|3710408|FG001|COMPLETED|Overall Study||0
2993897|NCT00924664|3710407|FG000|NOT COMPLETED|Overall Study||322
2993898|NCT00924664|3710408|FG001|NOT COMPLETED|Overall Study||527
2993899|NCT00924703|3710414|FG000|STARTED|Overall Study||68
2993900|NCT00924703|3710414|FG000|COMPLETED|Overall Study||46
2993901|NCT00924703|3710414|FG000|NOT COMPLETED|Overall Study||22
2993902|NCT00924729|3710420|FG000|STARTED|Overall Study||25
2993903|NCT00924729|3710421|FG001|STARTED|Overall Study||25
2993904|NCT00924729|3710420|FG000|COMPLETED|Overall Study||23
2993905|NCT00924729|3710421|FG001|COMPLETED|Overall Study||25
2993906|NCT00924729|3710420|FG000|NOT COMPLETED|Overall Study||2
2993907|NCT00924729|3710421|FG001|NOT COMPLETED|Overall Study||0
2993908|NCT00924781|3710433|FG000|STARTED|Overall Study||20
2993909|NCT00924781|3710434|FG001|STARTED|Overall Study||19
2993910|NCT00924781|3710433|FG000|COMPLETED|Overall Study||8
2993911|NCT00924781|3710434|FG001|COMPLETED|Overall Study||9
2993912|NCT00924781|3710433|FG000|NOT COMPLETED|Overall Study||12
2993913|NCT00924781|3710434|FG001|NOT COMPLETED|Overall Study||10
2993914|NCT00924820|3710450|FG000|STARTED|Overall Study||20
2993915|NCT00924820|3710450|FG000|COMPLETED|Overall Study||13
2993916|NCT00924820|3710450|FG000|NOT COMPLETED|Overall Study||7
2993917|NCT00924885|3710456|FG000|STARTED|Overall Study||129
2993918|NCT00924885|3710457|FG001|STARTED|Overall Study||128
2993919|NCT00924885|3710456|FG000|COMPLETED|Overall Study||126
2993920|NCT00924885|3710457|FG001|COMPLETED|Overall Study||124
2993921|NCT00924885|3710456|FG000|NOT COMPLETED|Overall Study||3
2993922|NCT00924885|3710457|FG001|NOT COMPLETED|Overall Study||4
2993923|NCT00924898|3710465|FG000|STARTED|Overall Study||92
2993924|NCT00924898|3710465|FG000|COMPLETED|Overall Study||90
2993925|NCT00924898|3710465|FG000|NOT COMPLETED|Overall Study||2
2993926|NCT00924950|3710474|FG000|STARTED|Overall Study||30
2993927|NCT00924950|3710474|FG000|COMPLETED|Overall Study||28
2993928|NCT00924950|3710474|FG000|NOT COMPLETED|Overall Study||2
2993929|NCT00925002|3710484|FG000|STARTED|Overall Study||38
2993930|NCT00925002|3710485|FG001|STARTED|Overall Study||37
2993931|NCT00925002|3710486|FG002|STARTED|Overall Study||18
2993932|NCT00925002|3710484|FG000|Treated|Overall Study||38
2993933|NCT00925002|3710485|FG001|Treated|Overall Study||37
2993934|NCT00925002|3710486|FG002|Treated|Overall Study||18
2993935|NCT00925002|3710484|FG000|COMPLETED|Overall Study||32
2993936|NCT00925002|3710485|FG001|COMPLETED|Overall Study||28
2993937|NCT00925002|3710486|FG002|COMPLETED|Overall Study||8
2993938|NCT00925002|3710484|FG000|NOT COMPLETED|Overall Study||6
2993939|NCT00925002|3710485|FG001|NOT COMPLETED|Overall Study||9
2993940|NCT00925002|3710486|FG002|NOT COMPLETED|Overall Study||10
2993941|NCT00925015|3710498|FG000|STARTED|Overall Study||8
2993942|NCT00925015|3710499|FG001|STARTED|Overall Study||6
2993943|NCT00925015|3710500|FG002|STARTED|Overall Study||6
2993944|NCT00925015|3710498|FG000|COMPLETED|Overall Study||0
2993945|NCT00925015|3710499|FG001|COMPLETED|Overall Study||0
2993946|NCT00925015|3710500|FG002|COMPLETED|Overall Study||0
2993947|NCT00925015|3710498|FG000|NOT COMPLETED|Overall Study||8
2993948|NCT00925015|3710499|FG001|NOT COMPLETED|Overall Study||6
2993949|NCT00925015|3710500|FG002|NOT COMPLETED|Overall Study||6
2993950|NCT00925054|3710517|FG000|STARTED|Overall Study||7
2993951|NCT00925054|3710518|FG001|STARTED|Overall Study||9
2993952|NCT00925054|3710519|FG002|STARTED|Overall Study||13
2993953|NCT00925054|3710520|FG003|STARTED|Overall Study||1
2993954|NCT00925054|3710521|FG004|STARTED|Overall Study||10
2993955|NCT00925054|3710517|FG000|COMPLETED|Overall Study||7
3305101|NCT02986074|4038751|FG001|NOT COMPLETED|Follow up Period||0
3305102|NCT02986074|4038752|FG002|NOT COMPLETED|Follow up Period||1
3305103|NCT02986074|4038753|FG003|NOT COMPLETED|Follow up Period||3
3305104|NCT02986139|4038760|FG000|STARTED|Overall Study||56
2993956|NCT00925054|3710518|FG001|COMPLETED|Overall Study||8
2993957|NCT00925054|3710519|FG002|COMPLETED|Overall Study||12
2993958|NCT00925054|3710520|FG003|COMPLETED|Overall Study||0
2993959|NCT00925054|3710521|FG004|COMPLETED|Overall Study||10
2993960|NCT00925054|3710517|FG000|NOT COMPLETED|Overall Study||0
2993961|NCT00925054|3710518|FG001|NOT COMPLETED|Overall Study||1
2993962|NCT00925054|3710519|FG002|NOT COMPLETED|Overall Study||1
2993963|NCT00925054|3710520|FG003|NOT COMPLETED|Overall Study||1
2993964|NCT00925054|3710521|FG004|NOT COMPLETED|Overall Study||0
2993965|NCT00925119|3710534|FG000|STARTED|Overall Study||31
2993966|NCT00925119|3710534|FG000|COMPLETED|Overall Study||19
2993967|NCT00925119|3710534|FG000|NOT COMPLETED|Overall Study||12
2993968|NCT00925132|3710538|FG000|STARTED|Overall Study||5
2993969|NCT00925132|3710539|FG001|STARTED|Overall Study||4
2993970|NCT00925132|3710540|FG002|STARTED|Overall Study||4
2993971|NCT00925132|3710541|FG003|STARTED|Overall Study||4
2993972|NCT00925132|3710542|FG004|STARTED|Overall Study||22
2993973|NCT00925132|3710538|FG000|COMPLETED|Overall Study||3
2993974|NCT00925132|3710539|FG001|COMPLETED|Overall Study||4
2993975|NCT00925132|3710540|FG002|COMPLETED|Overall Study||4
2993976|NCT00925132|3710541|FG003|COMPLETED|Overall Study||4
2993977|NCT00925132|3710542|FG004|COMPLETED|Overall Study||17
2993978|NCT00925132|3710538|FG000|NOT COMPLETED|Overall Study||2
2993979|NCT00925132|3710539|FG001|NOT COMPLETED|Overall Study||0
2993980|NCT00925132|3710540|FG002|NOT COMPLETED|Overall Study||0
2993981|NCT00925132|3710541|FG003|NOT COMPLETED|Overall Study||0
2993982|NCT00925132|3710542|FG004|NOT COMPLETED|Overall Study||5
2993983|NCT00925288|3710550|FG000|STARTED|Overall Study||100
2993984|NCT00925288|3710551|FG001|STARTED|Overall Study||100
2993985|NCT00925288|3710550|FG000|COMPLETED|Overall Study||91
2993986|NCT00925288|3710551|FG001|COMPLETED|Overall Study||93
2993987|NCT00925288|3710550|FG000|NOT COMPLETED|Overall Study||9
2993988|NCT00925288|3710551|FG001|NOT COMPLETED|Overall Study||7
2993989|NCT00925301|3710561|FG000|STARTED|6-Month Double-blind (Stage 1)||34
2993990|NCT00925301|3710562|FG001|STARTED|6-Month Double-blind (Stage 1)||33
2993991|NCT00925301|3710563|FG002|STARTED|6-Month Double-blind (Stage 1)|Zero participants noted because participants did not start Stage 2 yet.|0
2993992|NCT00925301|3710564|FG003|STARTED|6-Month Double-blind (Stage 1)|Zero participants noted because participants did not start the OLE yet.|0
2993993|NCT00925301|3710561|FG000|Received at Least 1 Dose of Study Drug|6-Month Double-blind (Stage 1)||34
2993994|NCT00925301|3710562|FG001|Received at Least 1 Dose of Study Drug|6-Month Double-blind (Stage 1)||33
2993995|NCT00925301|3710563|FG002|Received at Least 1 Dose of Study Drug|6-Month Double-blind (Stage 1)||0
2993996|NCT00925301|3710564|FG003|Received at Least 1 Dose of Study Drug|6-Month Double-blind (Stage 1)||0
2993997|NCT00925301|3710561|FG000|Intent-to-Treat (ITT)|6-Month Double-blind (Stage 1)||34
2993998|NCT00925301|3710562|FG001|Intent-to-Treat (ITT)|6-Month Double-blind (Stage 1)||33
2993999|NCT00925301|3710563|FG002|Intent-to-Treat (ITT)|6-Month Double-blind (Stage 1)||0
2994000|NCT00925301|3710564|FG003|Intent-to-Treat (ITT)|6-Month Double-blind (Stage 1)||0
2994001|NCT00925301|3710561|FG000|Modified Intent-to-Treat (mITT)|6-Month Double-blind (Stage 1)||30
2994002|NCT00925301|3710562|FG001|Modified Intent-to-Treat (mITT)|6-Month Double-blind (Stage 1)||30
2994003|NCT00925301|3710563|FG002|Modified Intent-to-Treat (mITT)|6-Month Double-blind (Stage 1)||0
2994004|NCT00925301|3710564|FG003|Modified Intent-to-Treat (mITT)|6-Month Double-blind (Stage 1)||0
2994005|NCT00925301|3710561|FG000|COMPLETED|6-Month Double-blind (Stage 1)||34
2994006|NCT00925301|3710562|FG001|COMPLETED|6-Month Double-blind (Stage 1)||30
2994007|NCT00925301|3710563|FG002|COMPLETED|6-Month Double-blind (Stage 1)||0
2994008|NCT00925301|3710564|FG003|COMPLETED|6-Month Double-blind (Stage 1)||0
2994009|NCT00925301|3710561|FG000|NOT COMPLETED|6-Month Double-blind (Stage 1)||0
2994010|NCT00925301|3710562|FG001|NOT COMPLETED|6-Month Double-blind (Stage 1)||3
2994011|NCT00925301|3710563|FG002|NOT COMPLETED|6-Month Double-blind (Stage 1)||0
2994012|NCT00925301|3710564|FG003|NOT COMPLETED|6-Month Double-blind (Stage 1)||0
2994013|NCT00925301|3710561|FG000|STARTED|6-Month Open-label (Stage 2)|Zero participants noted because participants had completed Stage 1.|0
2994014|NCT00925301|3710562|FG001|STARTED|6-Month Open-label (Stage 2)|Zero participants noted because participants had completed Stage 1.|0
2994015|NCT00925301|3710563|FG002|STARTED|6-Month Open-label (Stage 2)|One participant (Migalastat [0-6 Months]) withdrew consent after completing Month 6.|63
2994016|NCT00925301|3710564|FG003|STARTED|6-Month Open-label (Stage 2)|Zero participants noted because participants did not start the OLE yet.|0
3305105|NCT02986139|4038761|FG001|STARTED|Overall Study||55
3133617|NCT01696396|3858534|FG001|Received Study Drug|Overall Study||26
3133618|NCT01696396|3858535|FG002|Received Study Drug|Overall Study||84
3133619|NCT01696396|3858536|FG003|Received Study Drug|Overall Study||41
2994017|NCT00925301|3710561|FG000|ITT-amenable|6-Month Open-label (Stage 2)||0
2994018|NCT00925301|3710562|FG001|ITT-amenable|6-Month Open-label (Stage 2)||0
2994019|NCT00925301|3710563|FG002|ITT-amenable|6-Month Open-label (Stage 2)||47
2994020|NCT00925301|3710564|FG003|ITT-amenable|6-Month Open-label (Stage 2)||0
2994021|NCT00925301|3710561|FG000|COMPLETED|6-Month Open-label (Stage 2)||0
2994022|NCT00925301|3710562|FG001|COMPLETED|6-Month Open-label (Stage 2)||0
2994023|NCT00925301|3710563|FG002|COMPLETED|6-Month Open-label (Stage 2)||60
2994024|NCT00925301|3710564|FG003|COMPLETED|6-Month Open-label (Stage 2)||0
2994025|NCT00925301|3710561|FG000|NOT COMPLETED|6-Month Open-label (Stage 2)||0
2994026|NCT00925301|3710562|FG001|NOT COMPLETED|6-Month Open-label (Stage 2)||0
2994027|NCT00925301|3710563|FG002|NOT COMPLETED|6-Month Open-label (Stage 2)||3
2994028|NCT00925301|3710564|FG003|NOT COMPLETED|6-Month Open-label (Stage 2)||0
2994029|NCT00925301|3710561|FG000|STARTED|12-Month Open-label Extension (Optional)|Zero participants noted because participants had completed Stage 1.|0
2994030|NCT00925301|3710562|FG001|STARTED|12-Month Open-label Extension (Optional)|Zero participants noted because participants had completed Stage 1.|0
2994031|NCT00925301|3710563|FG002|STARTED|12-Month Open-label Extension (Optional)|Zero participants noted because participants had completed Stage 2.|0
2994032|NCT00925301|3710564|FG003|STARTED|12-Month Open-label Extension (Optional)|The OLE was optional for those who completed Stage 2. Reasons for not entering were not recorded.|57
2994033|NCT00925301|3710561|FG000|ITT-amenable|12-Month Open-label Extension (Optional)||0
2994034|NCT00925301|3710562|FG001|ITT-amenable|12-Month Open-label Extension (Optional)||0
2994035|NCT00925301|3710563|FG002|ITT-amenable|12-Month Open-label Extension (Optional)||0
2994036|NCT00925301|3710564|FG003|ITT-amenable|12-Month Open-label Extension (Optional)||42
2994037|NCT00925301|3710561|FG000|COMPLETED|12-Month Open-label Extension (Optional)||0
2994038|NCT00925301|3710562|FG001|COMPLETED|12-Month Open-label Extension (Optional)||0
2994039|NCT00925301|3710563|FG002|COMPLETED|12-Month Open-label Extension (Optional)||0
2994040|NCT00925301|3710564|FG003|COMPLETED|12-Month Open-label Extension (Optional)||54
2994041|NCT00925301|3710561|FG000|NOT COMPLETED|12-Month Open-label Extension (Optional)||0
2994042|NCT00925301|3710562|FG001|NOT COMPLETED|12-Month Open-label Extension (Optional)||0
2994043|NCT00925301|3710563|FG002|NOT COMPLETED|12-Month Open-label Extension (Optional)||0
2994044|NCT00925301|3710564|FG003|NOT COMPLETED|12-Month Open-label Extension (Optional)||3
2994045|NCT00925353|3710575|FG000|STARTED|Overall Study||13
2994046|NCT00925353|3710575|FG000|COMPLETED|Overall Study||10
2994047|NCT00925353|3710575|FG000|NOT COMPLETED|Overall Study||3
2994048|NCT00925522|3710579|FG000|STARTED|Overall Study||20
2994049|NCT00925522|3710579|FG000|COMPLETED|Overall Study||0
2994050|NCT00925522|3710579|FG000|NOT COMPLETED|Overall Study||20
2994051|NCT00925587|3710585|FG000|STARTED|Overall Study||178
2994052|NCT00925587|3710586|FG001|STARTED|Overall Study||180
2994053|NCT00925587|3710585|FG000|COMPLETED|Overall Study||142
2994054|NCT00925587|3710586|FG001|COMPLETED|Overall Study||155
2994055|NCT00925587|3710585|FG000|NOT COMPLETED|Overall Study||36
2994056|NCT00925587|3710586|FG001|NOT COMPLETED|Overall Study||25
2994057|NCT00925600|3710594|FG000|STARTED|Overall Study||386
2994058|NCT00925600|3710595|FG001|STARTED|Overall Study||383
2994059|NCT00925600|3710594|FG000|Received Treatment|Overall Study|Three participants received at least 1 dose of denosumab in error|383
2994060|NCT00925600|3710595|FG001|Received Treatment|Overall Study||382
2994061|NCT00925600|3710594|FG000|COMPLETED|Overall Study||354
2994062|NCT00925600|3710595|FG001|COMPLETED|Overall Study||355
2994063|NCT00925600|3710594|FG000|NOT COMPLETED|Overall Study||32
2994064|NCT00925600|3710595|FG001|NOT COMPLETED|Overall Study||28
3036871|NCT01145482|3756138|FG000|COMPLETED|Second Intervention (1 Day)||5
3036872|NCT01145482|3756139|FG001|COMPLETED|Second Intervention (1 Day)||6
3036873|NCT01145482|3756138|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
3036874|NCT01145482|3756139|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
3036875|NCT01145508|3756147|FG000|STARTED|Overall Study||7
3036876|NCT01145508|3756148|FG001|STARTED|Overall Study||3
3036877|NCT01145508|3756147|FG000|Treated|Overall Study||6
3036878|NCT01145508|3756148|FG001|Treated|Overall Study||2
3036879|NCT01145508|3756147|FG000|COMPLETED|Overall Study||2
3036880|NCT01145508|3756148|FG001|COMPLETED|Overall Study||1
3036881|NCT01145508|3756147|FG000|NOT COMPLETED|Overall Study||5
3036882|NCT01145508|3756148|FG001|NOT COMPLETED|Overall Study||2
3036883|NCT01145547|3756154|FG000|STARTED|Overall Study||4
3036884|NCT01145547|3756155|FG001|STARTED|Overall Study||3
3036885|NCT01145547|3756154|FG000|COMPLETED|Overall Study||4
3036886|NCT01145547|3756155|FG001|COMPLETED|Overall Study||3
3036887|NCT01145547|3756154|FG000|NOT COMPLETED|Overall Study||0
3036888|NCT01145547|3756155|FG001|NOT COMPLETED|Overall Study||0
3036889|NCT01145560|3756164|FG000|STARTED|Overall Study||100
3036890|NCT01145560|3756165|FG001|STARTED|Overall Study||100
3036891|NCT01145560|3756166|FG002|STARTED|Overall Study||100
3036892|NCT01145560|3756164|FG000|Received Treatment|Overall Study||99
3036893|NCT01145560|3756165|FG001|Received Treatment|Overall Study||98
3036894|NCT01145560|3756166|FG002|Received Treatment|Overall Study||99
3036895|NCT01145560|3756164|FG000|Completed Treatment|Overall Study|9 patients died during the treatment period without completing the full course of treatment.|69
3133620|NCT01696396|3858533|FG000|Entered Open-label Period|Overall Study||84
3133621|NCT01696396|3858534|FG001|Entered Open-label Period|Overall Study||21
3133622|NCT01696396|3858535|FG002|Entered Open-label Period|Overall Study||75
2994065|NCT00925704|3710611|FG000|STARTED|First Intervention||6
2994066|NCT00925704|3710612|FG001|STARTED|First Intervention||7
2994067|NCT00925704|3710613|FG002|STARTED|First Intervention||7
2994068|NCT00925704|3710614|FG003|STARTED|First Intervention||7
2994069|NCT00925704|3710615|FG004|STARTED|First Intervention||7
2994070|NCT00925704|3710616|FG005|STARTED|First Intervention||7
2994071|NCT00925704|3710611|FG000|COMPLETED|First Intervention||6
2994072|NCT00925704|3710612|FG001|COMPLETED|First Intervention||7
2994073|NCT00925704|3710613|FG002|COMPLETED|First Intervention||7
2994074|NCT00925704|3710614|FG003|COMPLETED|First Intervention||6
2994075|NCT00925704|3710615|FG004|COMPLETED|First Intervention||6
2994076|NCT00925704|3710616|FG005|COMPLETED|First Intervention||7
2994077|NCT00925704|3710611|FG000|NOT COMPLETED|First Intervention||0
2994078|NCT00925704|3710612|FG001|NOT COMPLETED|First Intervention||0
2994079|NCT00925704|3710613|FG002|NOT COMPLETED|First Intervention||0
2994080|NCT00925704|3710614|FG003|NOT COMPLETED|First Intervention||1
2994081|NCT00925704|3710615|FG004|NOT COMPLETED|First Intervention||1
2994082|NCT00925704|3710616|FG005|NOT COMPLETED|First Intervention||0
2994083|NCT00925704|3710611|FG000|STARTED|Washout||6
2994084|NCT00925704|3710612|FG001|STARTED|Washout||7
2994085|NCT00925704|3710613|FG002|STARTED|Washout||7
2994086|NCT00925704|3710614|FG003|STARTED|Washout||6
2994087|NCT00925704|3710615|FG004|STARTED|Washout||6
2994088|NCT00925704|3710616|FG005|STARTED|Washout||7
2994089|NCT00925704|3710611|FG000|COMPLETED|Washout||6
2994090|NCT00925704|3710612|FG001|COMPLETED|Washout||7
2994091|NCT00925704|3710613|FG002|COMPLETED|Washout||7
2994092|NCT00925704|3710614|FG003|COMPLETED|Washout||6
2994093|NCT00925704|3710615|FG004|COMPLETED|Washout||6
2994094|NCT00925704|3710616|FG005|COMPLETED|Washout||7
2994095|NCT00925704|3710611|FG000|NOT COMPLETED|Washout||0
2994096|NCT00925704|3710612|FG001|NOT COMPLETED|Washout||0
2994097|NCT00925704|3710613|FG002|NOT COMPLETED|Washout||0
2994098|NCT00925704|3710614|FG003|NOT COMPLETED|Washout||0
2994099|NCT00925704|3710615|FG004|NOT COMPLETED|Washout||0
2994100|NCT00925704|3710616|FG005|NOT COMPLETED|Washout||0
2994101|NCT00925704|3710611|FG000|STARTED|Second Intervention||6
2994102|NCT00925704|3710612|FG001|STARTED|Second Intervention||7
2994103|NCT00925704|3710613|FG002|STARTED|Second Intervention||7
2994104|NCT00925704|3710614|FG003|STARTED|Second Intervention||6
2994105|NCT00925704|3710615|FG004|STARTED|Second Intervention||6
2994106|NCT00925704|3710616|FG005|STARTED|Second Intervention||7
2994107|NCT00925704|3710611|FG000|COMPLETED|Second Intervention||5
2994108|NCT00925704|3710612|FG001|COMPLETED|Second Intervention||7
2994109|NCT00925704|3710613|FG002|COMPLETED|Second Intervention||7
2994110|NCT00925704|3710614|FG003|COMPLETED|Second Intervention||6
2994111|NCT00925704|3710615|FG004|COMPLETED|Second Intervention||5
2994112|NCT00925704|3710616|FG005|COMPLETED|Second Intervention||7
2994113|NCT00925704|3710611|FG000|NOT COMPLETED|Second Intervention||1
2994114|NCT00925704|3710612|FG001|NOT COMPLETED|Second Intervention||0
2994115|NCT00925704|3710613|FG002|NOT COMPLETED|Second Intervention||0
2994116|NCT00925704|3710614|FG003|NOT COMPLETED|Second Intervention||0
2994117|NCT00925704|3710615|FG004|NOT COMPLETED|Second Intervention||1
2994118|NCT00925704|3710616|FG005|NOT COMPLETED|Second Intervention||0
2994119|NCT00925704|3710611|FG000|STARTED|Washout||5
2994120|NCT00925704|3710612|FG001|STARTED|Washout||7
2994121|NCT00925704|3710613|FG002|STARTED|Washout||7
2994122|NCT00925704|3710614|FG003|STARTED|Washout||6
2994123|NCT00925704|3710615|FG004|STARTED|Washout||5
2994124|NCT00925704|3710616|FG005|STARTED|Washout||7
2994125|NCT00925704|3710611|FG000|COMPLETED|Washout||5
2994126|NCT00925704|3710612|FG001|COMPLETED|Washout||7
2994127|NCT00925704|3710613|FG002|COMPLETED|Washout||7
2994128|NCT00925704|3710614|FG003|COMPLETED|Washout||6
2994129|NCT00925704|3710615|FG004|COMPLETED|Washout||5
2994130|NCT00925704|3710616|FG005|COMPLETED|Washout||7
2994131|NCT00925704|3710611|FG000|NOT COMPLETED|Washout||0
2994132|NCT00925704|3710612|FG001|NOT COMPLETED|Washout||0
2994133|NCT00925704|3710613|FG002|NOT COMPLETED|Washout||0
2994134|NCT00925704|3710614|FG003|NOT COMPLETED|Washout||0
2994135|NCT00925704|3710615|FG004|NOT COMPLETED|Washout||0
2994136|NCT00925704|3710616|FG005|NOT COMPLETED|Washout||0
2994137|NCT00925704|3710611|FG000|STARTED|Third Intervention||5
2994138|NCT00925704|3710612|FG001|STARTED|Third Intervention||7
2994139|NCT00925704|3710613|FG002|STARTED|Third Intervention||7
2994140|NCT00925704|3710614|FG003|STARTED|Third Intervention||6
2994141|NCT00925704|3710615|FG004|STARTED|Third Intervention||5
2994142|NCT00925704|3710616|FG005|STARTED|Third Intervention||7
2994143|NCT00925704|3710611|FG000|COMPLETED|Third Intervention||5
2994144|NCT00925704|3710612|FG001|COMPLETED|Third Intervention||7
2994145|NCT00925704|3710613|FG002|COMPLETED|Third Intervention||7
2994146|NCT00925704|3710614|FG003|COMPLETED|Third Intervention||6
2994147|NCT00925704|3710615|FG004|COMPLETED|Third Intervention||5
2994148|NCT00925704|3710616|FG005|COMPLETED|Third Intervention||6
2994149|NCT00925704|3710611|FG000|NOT COMPLETED|Third Intervention||0
2994150|NCT00925704|3710612|FG001|NOT COMPLETED|Third Intervention||0
2994151|NCT00925704|3710613|FG002|NOT COMPLETED|Third Intervention||0
2994152|NCT00925704|3710614|FG003|NOT COMPLETED|Third Intervention||0
2994153|NCT00925704|3710615|FG004|NOT COMPLETED|Third Intervention||0
2994154|NCT00925704|3710616|FG005|NOT COMPLETED|Third Intervention||1
2994155|NCT00925756|3710627|FG000|STARTED|Overall Study||32
2994156|NCT00925756|3710627|FG000|COMPLETED|Overall Study||32
2994157|NCT00925756|3710627|FG000|NOT COMPLETED|Overall Study||0
2994158|NCT00925769|3710631|FG000|STARTED|Overall Study||6
2994159|NCT00925769|3710632|FG001|STARTED|Overall Study||6
2994160|NCT00925769|3710633|FG002|STARTED|Overall Study||6
2994161|NCT00925769|3710634|FG003|STARTED|Overall Study||6
2994162|NCT00925769|3710635|FG004|STARTED|Overall Study||3
2994163|NCT00925769|3710636|FG005|STARTED|Overall Study||3
2994164|NCT00925769|3710631|FG000|COMPLETED|Overall Study||0
2994165|NCT00925769|3710632|FG001|COMPLETED|Overall Study||0
2994166|NCT00925769|3710633|FG002|COMPLETED|Overall Study||0
2994167|NCT00925769|3710634|FG003|COMPLETED|Overall Study||0
2994168|NCT00925769|3710635|FG004|COMPLETED|Overall Study||0
2994169|NCT00925769|3710636|FG005|COMPLETED|Overall Study||0
2994170|NCT00925769|3710631|FG000|NOT COMPLETED|Overall Study||6
2994171|NCT00925769|3710632|FG001|NOT COMPLETED|Overall Study||6
2994172|NCT00925769|3710633|FG002|NOT COMPLETED|Overall Study||6
2994173|NCT00925769|3710634|FG003|NOT COMPLETED|Overall Study||6
3133623|NCT01696396|3858536|FG003|Entered Open-label Period|Overall Study||37
3133624|NCT01696396|3858533|FG000|COMPLETED|Overall Study||69
3133625|NCT01696396|3858534|FG001|COMPLETED|Overall Study||20
2994174|NCT00925769|3710635|FG004|NOT COMPLETED|Overall Study||3
2994175|NCT00925769|3710636|FG005|NOT COMPLETED|Overall Study||3
2994176|NCT00925782|3710652|FG000|STARTED|Pretreatment (Day -30 to Day -3)||12
2994177|NCT00925782|3710653|FG001|STARTED|Pretreatment (Day -30 to Day -3)||12
2994178|NCT00925782|3710652|FG000|COMPLETED|Pretreatment (Day -30 to Day -3)||12
2994179|NCT00925782|3710653|FG001|COMPLETED|Pretreatment (Day -30 to Day -3)||12
2994180|NCT00925782|3710652|FG000|NOT COMPLETED|Pretreatment (Day -30 to Day -3)||0
2994181|NCT00925782|3710653|FG001|NOT COMPLETED|Pretreatment (Day -30 to Day -3)||0
2994182|NCT00925782|3710652|FG000|STARTED|Study Period (Day -3 to Day 0)||12
2994183|NCT00925782|3710653|FG001|STARTED|Study Period (Day -3 to Day 0)||12
2994184|NCT00925782|3710652|FG000|COMPLETED|Study Period (Day -3 to Day 0)||12
2994185|NCT00925782|3710653|FG001|COMPLETED|Study Period (Day -3 to Day 0)||12
2994186|NCT00925782|3710652|FG000|NOT COMPLETED|Study Period (Day -3 to Day 0)||0
2994187|NCT00925782|3710653|FG001|NOT COMPLETED|Study Period (Day -3 to Day 0)||0
2994188|NCT00925782|3710652|FG000|STARTED|Follow-up(Day +1 to Date of Engraftment)||12
2994189|NCT00925782|3710653|FG001|STARTED|Follow-up(Day +1 to Date of Engraftment)||12
2994190|NCT00925782|3710652|FG000|COMPLETED|Follow-up(Day +1 to Date of Engraftment)||12
2994191|NCT00925782|3710653|FG001|COMPLETED|Follow-up(Day +1 to Date of Engraftment)||12
2994192|NCT00925782|3710652|FG000|NOT COMPLETED|Follow-up(Day +1 to Date of Engraftment)||0
2994193|NCT00925782|3710653|FG001|NOT COMPLETED|Follow-up(Day +1 to Date of Engraftment)||0
3164604|NCT01894100|3892022|FG000|COMPLETED|Overall Study||12
3164605|NCT01894100|3892023|FG001|COMPLETED|Overall Study||14
2994194|NCT00925899|3710662|FG000|STARTED|Part 1||34
2994195|NCT00925899|3710663|FG001|STARTED|Part 1||38
2994196|NCT00925899|3710662|FG000|COMPLETED|Part 1||23
2994197|NCT00925899|3710663|FG001|COMPLETED|Part 1||27
2994198|NCT00925899|3710662|FG000|NOT COMPLETED|Part 1||11
2994199|NCT00925899|3710663|FG001|NOT COMPLETED|Part 1||11
2994200|NCT00925899|3710662|FG000|STARTED|Part 2|All patients received the same intervention in the second part of the study (20 mg melatonin)|15
2994201|NCT00925899|3710663|FG001|STARTED|Part 2|Nine patients withdrew because they did not wish to continue in the study|21
2994202|NCT00925899|3710662|FG000|COMPLETED|Part 2||9
2994203|NCT00925899|3710663|FG001|COMPLETED|Part 2||9
2994204|NCT00925899|3710662|FG000|NOT COMPLETED|Part 2||6
2994205|NCT00925899|3710663|FG001|NOT COMPLETED|Part 2||12
2994206|NCT00925938|3710673|FG000|STARTED|Overall Study||9
2994207|NCT00925938|3710674|FG001|STARTED|Overall Study||25
2994208|NCT00925938|3710675|FG002|STARTED|Overall Study||17
2994209|NCT00925938|3710673|FG000|COMPLETED|Overall Study||9
2994210|NCT00925938|3710674|FG001|COMPLETED|Overall Study||25
2994211|NCT00925938|3710675|FG002|COMPLETED|Overall Study||17
2994212|NCT00925938|3710673|FG000|NOT COMPLETED|Overall Study||0
2994213|NCT00925938|3710674|FG001|NOT COMPLETED|Overall Study||0
2994214|NCT00925938|3710675|FG002|NOT COMPLETED|Overall Study||0
2994215|NCT00925990|3710685|FG000|STARTED|Overall Study||35
2994216|NCT00925990|3710686|FG001|STARTED|Overall Study||35
2994217|NCT00925990|3710685|FG000|COMPLETED|Overall Study||30
2994218|NCT00925990|3710686|FG001|COMPLETED|Overall Study||24
2994219|NCT00925990|3710685|FG000|NOT COMPLETED|Overall Study||5
2994220|NCT00925990|3710686|FG001|NOT COMPLETED|Overall Study||11
2994221|NCT00926003|3710695|FG000|STARTED|Baseline||53
2994222|NCT00926003|3710696|FG001|STARTED|Baseline||54
2994223|NCT00926003|3710697|FG002|STARTED|Baseline||52
2994224|NCT00926003|3710695|FG000|COMPLETED|Baseline||53
2994225|NCT00926003|3710696|FG001|COMPLETED|Baseline||54
2994226|NCT00926003|3710697|FG002|COMPLETED|Baseline||52
2994227|NCT00926003|3710695|FG000|NOT COMPLETED|Baseline||0
2994228|NCT00926003|3710696|FG001|NOT COMPLETED|Baseline||0
2994229|NCT00926003|3710697|FG002|NOT COMPLETED|Baseline||0
3133626|NCT01696396|3858535|FG002|COMPLETED|Overall Study||59
3133627|NCT01696396|3858536|FG003|COMPLETED|Overall Study||28
3133628|NCT01696396|3858533|FG000|NOT COMPLETED|Overall Study||31
3133629|NCT01696396|3858534|FG001|NOT COMPLETED|Overall Study||7
3133630|NCT01696396|3858535|FG002|NOT COMPLETED|Overall Study||26
3133631|NCT01696396|3858536|FG003|NOT COMPLETED|Overall Study||14
3133632|NCT01696643|3858552|FG000|STARTED|Overall Study||703
3133633|NCT01696643|3858553|FG001|STARTED|Overall Study||704
3133634|NCT01696643|3858552|FG000|Received at Least 1 Dose of Study Drug|Overall Study||701
2994230|NCT00926003|3710695|FG000|STARTED|Post-Training Evaluation||53
3136748|NCT01714804|3862004|FG001|STARTED|Overall Study||30
3136749|NCT01714804|3862003|FG000|COMPLETED|Overall Study||29
2994231|NCT00926003|3710696|FG001|STARTED|Post-Training Evaluation||54
2994232|NCT00926003|3710697|FG002|STARTED|Post-Training Evaluation||52
2994233|NCT00926003|3710695|FG000|COMPLETED|Post-Training Evaluation||52
2994234|NCT00926003|3710696|FG001|COMPLETED|Post-Training Evaluation||54
2994235|NCT00926003|3710697|FG002|COMPLETED|Post-Training Evaluation||52
2994236|NCT00926003|3710695|FG000|NOT COMPLETED|Post-Training Evaluation||1
2994237|NCT00926003|3710696|FG001|NOT COMPLETED|Post-Training Evaluation||0
2994238|NCT00926003|3710697|FG002|NOT COMPLETED|Post-Training Evaluation||0
2994239|NCT00926003|3710695|FG000|STARTED|Post-Training 3-month Follow-up||52
2994240|NCT00926003|3710696|FG001|STARTED|Post-Training 3-month Follow-up||54
2994241|NCT00926003|3710697|FG002|STARTED|Post-Training 3-month Follow-up||52
2994242|NCT00926003|3710695|FG000|COMPLETED|Post-Training 3-month Follow-up||51
2994243|NCT00926003|3710696|FG001|COMPLETED|Post-Training 3-month Follow-up||54
2994244|NCT00926003|3710697|FG002|COMPLETED|Post-Training 3-month Follow-up||52
2994245|NCT00926003|3710695|FG000|NOT COMPLETED|Post-Training 3-month Follow-up||1
2994246|NCT00926003|3710696|FG001|NOT COMPLETED|Post-Training 3-month Follow-up||0
2994247|NCT00926003|3710697|FG002|NOT COMPLETED|Post-Training 3-month Follow-up||0
2994248|NCT00926029|3710708|FG000|STARTED|Overall Study||34
2994249|NCT00926029|3710709|FG001|STARTED|Overall Study||34
2994250|NCT00926029|3710710|FG002|STARTED|Overall Study||34
2994251|NCT00926029|3710708|FG000|COMPLETED|Overall Study||32
2994252|NCT00926029|3710709|FG001|COMPLETED|Overall Study||33
2994253|NCT00926029|3710710|FG002|COMPLETED|Overall Study||33
2994254|NCT00926029|3710708|FG000|NOT COMPLETED|Overall Study||2
2994255|NCT00926029|3710709|FG001|NOT COMPLETED|Overall Study||1
2994256|NCT00926029|3710710|FG002|NOT COMPLETED|Overall Study||1
2994257|NCT00926185|3710724|FG000|STARTED|Overall Study||57
2994258|NCT00926185|3710725|FG001|STARTED|Overall Study||57
2994259|NCT00926185|3710726|FG002|STARTED|Overall Study||58
2994260|NCT00926185|3710727|FG003|STARTED|Overall Study||58
2994261|NCT00926185|3710724|FG000|COMPLETED|Overall Study||54
2994262|NCT00926185|3710725|FG001|COMPLETED|Overall Study||51
2994263|NCT00926185|3710726|FG002|COMPLETED|Overall Study||48
2994264|NCT00926185|3710727|FG003|COMPLETED|Overall Study||48
2994265|NCT00926185|3710724|FG000|NOT COMPLETED|Overall Study||3
2994266|NCT00926185|3710725|FG001|NOT COMPLETED|Overall Study||6
2994267|NCT00926185|3710726|FG002|NOT COMPLETED|Overall Study||10
2994268|NCT00926185|3710727|FG003|NOT COMPLETED|Overall Study||10
2994269|NCT00926211|3710737|FG000|STARTED|Overall Study|One additional subject was not randomized and did not receive the treatment procedure.|36
2994270|NCT00926211|3710737|FG000|COMPLETED|Overall Study||35
2994271|NCT00926211|3710737|FG000|NOT COMPLETED|Overall Study||1
2994272|NCT00926237|3710742|FG000|STARTED|Overall Study|Two subjects withdrew after receiving sham rTMS but before receiving active rTMS.|19
2994273|NCT00926237|3710743|FG001|STARTED|Overall Study|One subjects withdrew after receiving sham rTMS but before receiving active rTMS.|20
2994274|NCT00926237|3710742|FG000|COMPLETED|Overall Study||17
2994275|NCT00926237|3710743|FG001|COMPLETED|Overall Study||19
2994276|NCT00926237|3710742|FG000|NOT COMPLETED|Overall Study||2
2994277|NCT00926237|3710743|FG001|NOT COMPLETED|Overall Study||1
2994278|NCT00926263|3710755|FG000|STARTED|Overall Study||16
2994279|NCT00926263|3710756|FG001|STARTED|Overall Study||12
2994280|NCT00926263|3710755|FG000|COMPLETED|Overall Study||16
3133635|NCT01696643|3858553|FG001|Received at Least 1 Dose of Study Drug|Overall Study|2 participants randomized to placebo took CB-5945. Their results are included in the CB-5945 group.|702
3133636|NCT01696643|3858552|FG000|COMPLETED|Overall Study||174
3133637|NCT01696643|3858553|FG001|COMPLETED|Overall Study||169
2994281|NCT00926263|3710756|FG001|COMPLETED|Overall Study||12
2994282|NCT00926263|3710755|FG000|NOT COMPLETED|Overall Study||0
2994283|NCT00926263|3710756|FG001|NOT COMPLETED|Overall Study||0
2994284|NCT00926289|3710765|FG000|STARTED|Overall Study|Number of treated patients|294
2994285|NCT00926289|3710766|FG001|STARTED|Overall Study|Number of treated patients|594
2994286|NCT00926289|3710765|FG000|COMPLETED|Overall Study||269
2994287|NCT00926289|3710766|FG001|COMPLETED|Overall Study||558
2994288|NCT00926289|3710765|FG000|NOT COMPLETED|Overall Study||25
2994289|NCT00926289|3710766|FG001|NOT COMPLETED|Overall Study||36
2994290|NCT00926328|3710774|FG000|STARTED|Overall Study||60
2994291|NCT00926328|3710775|FG001|STARTED|Overall Study||60
2994292|NCT00926328|3710774|FG000|COMPLETED|Overall Study||48
2994293|NCT00926328|3710775|FG001|COMPLETED|Overall Study||46
2994294|NCT00926328|3710774|FG000|NOT COMPLETED|Overall Study||12
2994295|NCT00926328|3710775|FG001|NOT COMPLETED|Overall Study||14
2994296|NCT00926367|3710783|FG000|STARTED|Overall Study||25
2994297|NCT00926367|3710784|FG001|STARTED|Overall Study||27
2994298|NCT00926367|3710783|FG000|COMPLETED|Overall Study||23
2994299|NCT00926367|3710784|FG001|COMPLETED|Overall Study||24
2994300|NCT00926367|3710783|FG000|NOT COMPLETED|Overall Study||2
2994301|NCT00926367|3710784|FG001|NOT COMPLETED|Overall Study||3
2994302|NCT00926380|3710795|FG000|STARTED|Year 1||33
2994303|NCT00926380|3710796|FG001|STARTED|Year 1||31
2994304|NCT00926380|3710797|FG002|STARTED|Year 1||30
2994305|NCT00926380|3710795|FG000|COMPLETED|Year 1||33
2994306|NCT00926380|3710796|FG001|COMPLETED|Year 1||30
2994307|NCT00926380|3710797|FG002|COMPLETED|Year 1||29
2994308|NCT00926380|3710795|FG000|NOT COMPLETED|Year 1||0
2994309|NCT00926380|3710796|FG001|NOT COMPLETED|Year 1||1
2994310|NCT00926380|3710797|FG002|NOT COMPLETED|Year 1||1
2994311|NCT00926380|3710795|FG000|STARTED|Year 2||33
2994312|NCT00926380|3710796|FG001|STARTED|Year 2||30
2994313|NCT00926380|3710797|FG002|STARTED|Year 2||29
2994314|NCT00926380|3710795|FG000|COMPLETED|Year 2||31
2994315|NCT00926380|3710796|FG001|COMPLETED|Year 2||28
2994316|NCT00926380|3710797|FG002|COMPLETED|Year 2||24
2994317|NCT00926380|3710795|FG000|NOT COMPLETED|Year 2||2
2994318|NCT00926380|3710796|FG001|NOT COMPLETED|Year 2||2
2994319|NCT00926380|3710797|FG002|NOT COMPLETED|Year 2||5
2994320|NCT00926393|3710807|FG000|STARTED|Overall Study||69
2994321|NCT00926393|3710808|FG001|STARTED|Overall Study||70
2994322|NCT00926393|3710807|FG000|COMPLETED|Overall Study||67
2994323|NCT00926393|3710808|FG001|COMPLETED|Overall Study||67
2994324|NCT00926393|3710807|FG000|NOT COMPLETED|Overall Study||2
2994325|NCT00926393|3710808|FG001|NOT COMPLETED|Overall Study||3
2994326|NCT00926497|3710816|FG000|STARTED|Overall Study||60
2994327|NCT00926497|3710817|FG001|STARTED|Overall Study||61
2994328|NCT00926497|3710816|FG000|COMPLETED|Overall Study||60
2994329|NCT00926497|3710817|FG001|COMPLETED|Overall Study||61
2994330|NCT00926497|3710816|FG000|NOT COMPLETED|Overall Study||0
2994331|NCT00926497|3710817|FG001|NOT COMPLETED|Overall Study||0
2994332|NCT00926536|3710825|FG000|STARTED|Overall Study||44
2994333|NCT00926536|3710826|FG001|STARTED|Overall Study||43
2994334|NCT00926536|3710825|FG000|COMPLETED|Overall Study||43
2994335|NCT00926536|3710826|FG001|COMPLETED|Overall Study||41
2994336|NCT00926536|3710825|FG000|NOT COMPLETED|Overall Study||1
2994337|NCT00926536|3710826|FG001|NOT COMPLETED|Overall Study||2
2994338|NCT00926588|3710834|FG000|STARTED|Overall Study||124
2994339|NCT00926588|3710835|FG001|STARTED|Overall Study||126
2994340|NCT00926588|3710834|FG000|COMPLETED|Overall Study||116
2994341|NCT00926588|3710835|FG001|COMPLETED|Overall Study||122
2994342|NCT00926588|3710834|FG000|NOT COMPLETED|Overall Study||8
2994343|NCT00926588|3710835|FG001|NOT COMPLETED|Overall Study||4
2994344|NCT00926783|3710843|FG000|STARTED|Overall Study||42
2994345|NCT00926783|3710844|FG001|STARTED|Overall Study||41
2994346|NCT00926783|3710843|FG000|COMPLETED|Overall Study||39
2994347|NCT00926783|3710844|FG001|COMPLETED|Overall Study||38
2994348|NCT00926783|3710843|FG000|NOT COMPLETED|Overall Study||3
2994349|NCT00926783|3710844|FG001|NOT COMPLETED|Overall Study||3
2994350|NCT00926796|3710852|FG000|STARTED|Overall Study|Number randomized|309
2994351|NCT00926796|3710853|FG001|STARTED|Overall Study|Number randomized|305
2994352|NCT00926796|3710852|FG000|COMPLETED|Overall Study|Number eligible and in the full analysis set|202
2994353|NCT00926796|3710853|FG001|COMPLETED|Overall Study|Number eligible and in the full analysis set|199
2994354|NCT00926796|3710852|FG000|NOT COMPLETED|Overall Study||107
2994355|NCT00926796|3710853|FG001|NOT COMPLETED|Overall Study||106
2994356|NCT00926848|3710863|FG000|STARTED|Overall Study||34
2994357|NCT00926848|3710864|FG001|STARTED|Overall Study||34
2994358|NCT00926848|3710863|FG000|COMPLETED|Overall Study||34
2994359|NCT00926848|3710864|FG001|COMPLETED|Overall Study||34
2994360|NCT00926848|3710863|FG000|NOT COMPLETED|Overall Study||0
2994361|NCT00926848|3710864|FG001|NOT COMPLETED|Overall Study||0
2994362|NCT00926887|3710882|FG000|STARTED|Overall Study||54
2994363|NCT00926887|3710883|FG001|STARTED|Overall Study||50
2994364|NCT00926887|3710882|FG000|COMPLETED|Overall Study||54
2994365|NCT00926887|3710883|FG001|COMPLETED|Overall Study||50
2994366|NCT00926887|3710882|FG000|NOT COMPLETED|Overall Study||0
2994367|NCT00926887|3710883|FG001|NOT COMPLETED|Overall Study||0
2994368|NCT00926952|3710889|FG000|STARTED|Overall Study||20
2994369|NCT00926952|3710889|FG000|COMPLETED|Overall Study||20
2994370|NCT00926952|3710889|FG000|NOT COMPLETED|Overall Study||0
2994371|NCT00927069|3710895|FG000|STARTED|Week 0 to Week 12||50
2994372|NCT00927069|3710896|FG001|STARTED|Week 0 to Week 12||35
2994373|NCT00927069|3710897|FG002|STARTED|Week 0 to Week 12||0
2994374|NCT00927069|3710898|FG003|STARTED|Week 0 to Week 12||0
2994375|NCT00927069|3710895|FG000|COMPLETED|Week 0 to Week 12||49
2994376|NCT00927069|3710896|FG001|COMPLETED|Week 0 to Week 12||34
2994377|NCT00927069|3710897|FG002|COMPLETED|Week 0 to Week 12||0
2994378|NCT00927069|3710898|FG003|COMPLETED|Week 0 to Week 12||0
2994379|NCT00927069|3710895|FG000|NOT COMPLETED|Week 0 to Week 12||1
2994380|NCT00927069|3710896|FG001|NOT COMPLETED|Week 0 to Week 12||1
2994381|NCT00927069|3710897|FG002|NOT COMPLETED|Week 0 to Week 12||0
2994382|NCT00927069|3710898|FG003|NOT COMPLETED|Week 0 to Week 12||0
3305106|NCT02986139|4038760|FG000|Received Etanercept|Overall Study||56
3305107|NCT02986139|4038761|FG001|Received Etanercept|Overall Study||53
3305108|NCT02986139|4038760|FG000|COMPLETED|Overall Study||55
3305109|NCT02986139|4038761|FG001|COMPLETED|Overall Study||51
3305110|NCT02986139|4038760|FG000|NOT COMPLETED|Overall Study||1
3305111|NCT02986139|4038761|FG001|NOT COMPLETED|Overall Study||4
3305112|NCT02986282|4038771|FG000|STARTED|Overall Study||115
3305113|NCT02986282|4038771|FG000|COMPLETED|Overall Study||99
3305114|NCT02986282|4038771|FG000|NOT COMPLETED|Overall Study||16
3305115|NCT02986373|4038775|FG000|STARTED|Overall Study||145
3305116|NCT02986373|4038775|FG000|COMPLETED|Overall Study||106
3305117|NCT02986373|4038775|FG000|NOT COMPLETED|Overall Study||39
3305118|NCT02986711|4038781|FG000|STARTED|Overall Study||78
3305119|NCT02986711|4038782|FG001|STARTED|Overall Study||80
3305120|NCT02986711|4038781|FG000|COMPLETED|Overall Study||70
2994383|NCT00927069|3710895|FG000|STARTED|Week 12 to Week 24|17 patients stayed at the same dose. One patient withdrew at Week 12 and also had no dose increase|18
2994384|NCT00927069|3710896|FG001|STARTED|Week 12 to Week 24|11 patients stayed at the same dose of 40 mg Adalimumab every other week|11
3038367|NCT01153958|3757799|FG001|NOT COMPLETED|Overall Study||32
3305121|NCT02986711|4038782|FG001|COMPLETED|Overall Study||70
3305122|NCT02986711|4038781|FG000|NOT COMPLETED|Overall Study||8
3305123|NCT02986711|4038782|FG001|NOT COMPLETED|Overall Study||10
3305124|NCT02986802|4038792|FG000|STARTED|Overall Study||1360
2994385|NCT00927069|3710897|FG002|STARTED|Week 12 to Week 24|31 Pts. from Group A had a dose incr. since they did not respond to 40mg adalimumab every other week|31
2994386|NCT00927069|3710898|FG003|STARTED|Week 12 to Week 24|23 Pts. from Group B had a dose incr. since they did not respond to 40mg adalimumab every other week|23
2994387|NCT00927069|3710895|FG000|COMPLETED|Week 12 to Week 24||16
2994388|NCT00927069|3710896|FG001|COMPLETED|Week 12 to Week 24||11
2994389|NCT00927069|3710897|FG002|COMPLETED|Week 12 to Week 24||28
2994390|NCT00927069|3710898|FG003|COMPLETED|Week 12 to Week 24||20
2994391|NCT00927069|3710895|FG000|NOT COMPLETED|Week 12 to Week 24||2
2994392|NCT00927069|3710896|FG001|NOT COMPLETED|Week 12 to Week 24||0
2994393|NCT00927069|3710897|FG002|NOT COMPLETED|Week 12 to Week 24||3
2994394|NCT00927069|3710898|FG003|NOT COMPLETED|Week 12 to Week 24||3
2994395|NCT00927082|3710912|FG000|STARTED|Overall Study||91
2994396|NCT00927082|3710913|FG001|STARTED|Overall Study||87
2994397|NCT00927082|3710914|FG002|STARTED|Overall Study||108
2994398|NCT00927082|3710915|FG003|STARTED|Overall Study||97
2994399|NCT00927082|3710912|FG000|COMPLETED|Overall Study||79
2994400|NCT00927082|3710913|FG001|COMPLETED|Overall Study||77
2994401|NCT00927082|3710914|FG002|COMPLETED|Overall Study||86
2994402|NCT00927082|3710915|FG003|COMPLETED|Overall Study||78
2994403|NCT00927082|3710912|FG000|NOT COMPLETED|Overall Study||12
2994404|NCT00927082|3710913|FG001|NOT COMPLETED|Overall Study||10
2994405|NCT00927082|3710914|FG002|NOT COMPLETED|Overall Study||22
2994406|NCT00927082|3710915|FG003|NOT COMPLETED|Overall Study||19
2994407|NCT00927095|3710932|FG000|STARTED|Overall Study||22
2994408|NCT00927095|3710933|FG001|STARTED|Overall Study||21
2994409|NCT00927095|3710934|FG002|STARTED|Overall Study||24
2994410|NCT00927095|3710932|FG000|COMPLETED|Overall Study||16
2994411|NCT00927095|3710933|FG001|COMPLETED|Overall Study||17
3164606|NCT01894100|3892022|FG000|NOT COMPLETED|Overall Study||3
3164607|NCT01894100|3892023|FG001|NOT COMPLETED|Overall Study||1
3164608|NCT01894152|3892029|FG000|STARTED|Overall Study||2002
3164609|NCT01894152|3892029|FG000|COMPLETED|Overall Study||1851
2994412|NCT00927095|3710934|FG002|COMPLETED|Overall Study||22
2994413|NCT00927095|3710932|FG000|NOT COMPLETED|Overall Study||6
2994414|NCT00927095|3710933|FG001|NOT COMPLETED|Overall Study||4
2994415|NCT00927095|3710934|FG002|NOT COMPLETED|Overall Study||2
2994416|NCT00927160|3710944|FG000|STARTED|Overall Study||173
2994417|NCT00927160|3710945|FG001|STARTED|Overall Study||173
2994418|NCT00927160|3710944|FG000|COMPLETED|Overall Study||173
2994419|NCT00927160|3710945|FG001|COMPLETED|Overall Study||173
2994420|NCT00927160|3710944|FG000|NOT COMPLETED|Overall Study||0
2994421|NCT00927160|3710945|FG001|NOT COMPLETED|Overall Study||0
2994422|NCT00927186|3710953|FG000|STARTED|12 Months Primary Study||34
2994423|NCT00927186|3710954|FG001|STARTED|12 Months Primary Study||35
2994424|NCT00927186|3710953|FG000|Completed 6 Months Double Blind Phase|12 Months Primary Study||28
2994425|NCT00927186|3710954|FG001|Completed 6 Months Double Blind Phase|12 Months Primary Study||31
2994426|NCT00927186|3710953|FG000|COMPLETED|12 Months Primary Study||27
2994427|NCT00927186|3710954|FG001|COMPLETED|12 Months Primary Study||31
2994428|NCT00927186|3710953|FG000|NOT COMPLETED|12 Months Primary Study||7
2994429|NCT00927186|3710954|FG001|NOT COMPLETED|12 Months Primary Study||4
2994430|NCT00927186|3710953|FG000|STARTED|12 - 24 Months Extension Treatment|Not all participants who completed 12 months of primary study chose to enter 12-month extension.|10
2994431|NCT00927186|3710954|FG001|STARTED|12 - 24 Months Extension Treatment|Not all participants who completed 12 months of primary study chose to enter 12-month extension.|11
2994432|NCT00927186|3710953|FG000|COMPLETED|12 - 24 Months Extension Treatment||10
2994433|NCT00927186|3710954|FG001|COMPLETED|12 - 24 Months Extension Treatment||11
2994434|NCT00927186|3710953|FG000|NOT COMPLETED|12 - 24 Months Extension Treatment||0
2994435|NCT00927186|3710954|FG001|NOT COMPLETED|12 - 24 Months Extension Treatment||0
2994436|NCT00927251|3710963|FG000|STARTED|Overall Study||90
2994437|NCT00927251|3710963|FG000|COMPLETED|Overall Study||82
2994438|NCT00927251|3710963|FG000|NOT COMPLETED|Overall Study||8
2994439|NCT00927264|3710969|FG000|STARTED|Overall Study||165
2994440|NCT00927264|3710970|FG001|STARTED|Overall Study||165
2994441|NCT00927264|3710969|FG000|COMPLETED|Overall Study||109
2994442|NCT00927264|3710970|FG001|COMPLETED|Overall Study||140
2994443|NCT00927264|3710969|FG000|NOT COMPLETED|Overall Study||56
2994444|NCT00927264|3710970|FG001|NOT COMPLETED|Overall Study||25
2994445|NCT00927355|3710980|FG000|STARTED|Overall Study||5
2994446|NCT00927355|3710981|FG001|STARTED|Overall Study||5
2994447|NCT00927355|3710980|FG000|COMPLETED|Overall Study||4
2994448|NCT00927355|3710981|FG001|COMPLETED|Overall Study||4
2994449|NCT00927355|3710980|FG000|NOT COMPLETED|Overall Study||1
2994450|NCT00927355|3710981|FG001|NOT COMPLETED|Overall Study||1
2994451|NCT00927368|3711002|FG000|STARTED|Overall Study||153
2994452|NCT00927368|3711003|FG001|STARTED|Overall Study||157
2994453|NCT00927368|3711004|FG002|STARTED|Overall Study||143
2994454|NCT00927368|3711002|FG000|COMPLETED|Overall Study||147
2994455|NCT00927368|3711003|FG001|COMPLETED|Overall Study||152
2994456|NCT00927368|3711004|FG002|COMPLETED|Overall Study||138
2994457|NCT00927368|3711002|FG000|NOT COMPLETED|Overall Study||6
2994458|NCT00927368|3711003|FG001|NOT COMPLETED|Overall Study||5
2994459|NCT00927368|3711004|FG002|NOT COMPLETED|Overall Study||5
2994460|NCT00927394|3711014|FG000|STARTED|Overall Study||575
2994461|NCT00927394|3711015|FG001|STARTED|Overall Study|One patient was randomized in error and was discontinued by site.|568
3038368|NCT01153971|3757805|FG000|STARTED|Induction Phase (Months 1 to 7 of Study)||47
3164610|NCT01894152|3892029|FG000|NOT COMPLETED|Overall Study||151
3164611|NCT01894178|3892035|FG000|STARTED|Overall Study||30
2994462|NCT00927394|3711014|FG000|Cohort 1 (Randomized)|Overall Study|Cohort 1 includes patients with specific eligibility criteria mentioned in protocol section|157
2994463|NCT00927394|3711015|FG001|Cohort 1 (Randomized)|Overall Study||165
2994464|NCT00927394|3711014|FG000|Cohort 2 (Randomized)|Overall Study|Cohort 2 includes patients with specific eligibility criteria mentioned in protocol section|418
2994465|NCT00927394|3711015|FG001|Cohort 2 (Randomized)|Overall Study||403
2994466|NCT00927394|3711014|FG000|Combined Safety Set (Cohort 1 and 2)|Overall Study||574
2994467|NCT00927394|3711015|FG001|Combined Safety Set (Cohort 1 and 2)|Overall Study||565
2994468|NCT00927394|3711014|FG000|Cohort 1: Full Analysis Set 1 (FAS 1)|Overall Study|FAS 1 includes all patients in Cohort 1 to whom study treatments were given through randomization.|157
2994469|NCT00927394|3711015|FG001|Cohort 1: Full Analysis Set 1 (FAS 1)|Overall Study||164
2994470|NCT00927394|3711014|FG000|Cohort 2: Full Analysis Set 2 (FAS 2)|Overall Study|FAS 2= all patients randomized to Cohort 2 and who had a valid baseline assessment of 24 hours ABPM.|417
2994471|NCT00927394|3711015|FG001|Cohort 2: Full Analysis Set 2 (FAS 2)|Overall Study||398
2994472|NCT00927394|3711014|FG000|FAS 2 :Ambulatory Blood Pressure Monitor|Overall Study|consists of all patients in FAS 2 who had both valid baseline and post-baseline ABPM assessments.|342
2994473|NCT00927394|3711015|FG001|FAS 2 :Ambulatory Blood Pressure Monitor|Overall Study||323
2994474|NCT00927394|3711014|FG000|Combined Full Analysis Set (FAS 1+FAS 2)|Overall Study||574
2994475|NCT00927394|3711015|FG001|Combined Full Analysis Set (FAS 1+FAS 2)|Overall Study||562
2994476|NCT00927394|3711014|FG000|COMPLETED|Overall Study||498
2994477|NCT00927394|3711015|FG001|COMPLETED|Overall Study||483
2994478|NCT00927394|3711014|FG000|NOT COMPLETED|Overall Study||77
2994479|NCT00927394|3711015|FG001|NOT COMPLETED|Overall Study||85
3164612|NCT01894178|3892036|FG001|STARTED|Overall Study||30
3164613|NCT01894178|3892035|FG000|COMPLETED|Overall Study||30
3164614|NCT01894178|3892036|FG001|COMPLETED|Overall Study||30
3164615|NCT01894178|3892035|FG000|NOT COMPLETED|Overall Study||0
3164616|NCT01894178|3892036|FG001|NOT COMPLETED|Overall Study||0
3164617|NCT01894230|3892044|FG000|STARTED|Overall Study||83
3164618|NCT01894230|3892045|FG001|STARTED|Overall Study||76
3164619|NCT01894230|3892044|FG000|COMPLETED|Overall Study||76
3164620|NCT01894230|3892045|FG001|COMPLETED|Overall Study||69
2994480|NCT00927472|3711024|FG000|STARTED|Overall Study||126
2994481|NCT00927472|3711025|FG001|STARTED|Overall Study||128
2994482|NCT00927472|3711024|FG000|COMPLETED|Overall Study||115
2994483|NCT00927472|3711025|FG001|COMPLETED|Overall Study||106
2994484|NCT00927472|3711024|FG000|NOT COMPLETED|Overall Study||11
2994485|NCT00927472|3711025|FG001|NOT COMPLETED|Overall Study||22
2994486|NCT00927485|3711033|FG000|STARTED|Overall Study||21
2994487|NCT00927485|3711034|FG001|STARTED|Overall Study||23
2994488|NCT00927485|3711033|FG000|COMPLETED|Overall Study||15
2994489|NCT00927485|3711034|FG001|COMPLETED|Overall Study||19
2994490|NCT00927485|3711033|FG000|NOT COMPLETED|Overall Study||6
2994491|NCT00927485|3711034|FG001|NOT COMPLETED|Overall Study||4
2994492|NCT00927563|3711040|FG000|STARTED|Overall Study||24
2994493|NCT00927563|3711040|FG000|COMPLETED|Overall Study||22
2994494|NCT00927563|3711040|FG000|NOT COMPLETED|Overall Study||2
2994495|NCT00927576|3711046|FG000|STARTED|Overall Study||237
2994496|NCT00927576|3711047|FG001|STARTED|Overall Study||28
2994497|NCT00927576|3711046|FG000|Cognitive Testing|Overall Study||237
2994498|NCT00927576|3711047|FG001|Cognitive Testing|Overall Study||28
2994499|NCT00927576|3711046|FG000|COMPLETED|Overall Study||237
2994500|NCT00927576|3711047|FG001|COMPLETED|Overall Study||28
2994501|NCT00927576|3711046|FG000|NOT COMPLETED|Overall Study||0
2994502|NCT00927576|3711047|FG001|NOT COMPLETED|Overall Study||0
2994503|NCT00927589|3711052|FG000|STARTED|Overall Study||59
2994504|NCT00927589|3711052|FG000|COMPLETED|Overall Study|Participants were considered to have completed the study after receiving 3 cycles of treatment.|43
2994505|NCT00927589|3711052|FG000|NOT COMPLETED|Overall Study||16
2994506|NCT00927758|3711056|FG000|STARTED|Treatment Cycle 1 (Day 1 - Day 7)|"Started  indicates randomized as well as safety set."|4
2994507|NCT00927758|3711057|FG001|STARTED|Treatment Cycle 1 (Day 1 - Day 7)||4
2994508|NCT00927758|3711058|FG002|STARTED|Treatment Cycle 1 (Day 1 - Day 7)||4
2994509|NCT00927758|3711059|FG003|STARTED|Treatment Cycle 1 (Day 1 - Day 7)||3
2994510|NCT00927758|3711060|FG004|STARTED|Treatment Cycle 1 (Day 1 - Day 7)||3
2994511|NCT00927758|3711061|FG005|STARTED|Treatment Cycle 1 (Day 1 - Day 7)||4
2994512|NCT00927758|3711056|FG000|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||4
2994513|NCT00927758|3711057|FG001|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||4
2994514|NCT00927758|3711058|FG002|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||4
2994515|NCT00927758|3711059|FG003|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||2
2994516|NCT00927758|3711060|FG004|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||3
2994517|NCT00927758|3711061|FG005|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||3
2994518|NCT00927758|3711056|FG000|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||4
3164621|NCT01894230|3892044|FG000|NOT COMPLETED|Overall Study||7
2994519|NCT00927758|3711057|FG001|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||4
2994520|NCT00927758|3711058|FG002|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||4
2994521|NCT00927758|3711059|FG003|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||2
2994522|NCT00927758|3711060|FG004|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||3
2994523|NCT00927758|3711061|FG005|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||3
2994524|NCT00927758|3711056|FG000|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||0
2994525|NCT00927758|3711057|FG001|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||0
3164622|NCT01894230|3892045|FG001|NOT COMPLETED|Overall Study||7
3164623|NCT01894243|3892054|FG000|STARTED|Overall Study||13
3164624|NCT01894243|3892055|FG001|STARTED|Overall Study||10
2994526|NCT00927758|3711058|FG002|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||0
2994527|NCT00927758|3711059|FG003|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||1
2994528|NCT00927758|3711060|FG004|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||0
2994529|NCT00927758|3711061|FG005|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||1
2994530|NCT00927758|3711056|FG000|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||4
2994531|NCT00927758|3711057|FG001|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||4
2994532|NCT00927758|3711058|FG002|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||4
2994533|NCT00927758|3711059|FG003|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||2
2994534|NCT00927758|3711060|FG004|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||3
2994535|NCT00927758|3711061|FG005|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||3
2994536|NCT00927758|3711056|FG000|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||4
2994537|NCT00927758|3711057|FG001|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||4
2994538|NCT00927758|3711058|FG002|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||3
2994539|NCT00927758|3711059|FG003|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||1
2994540|NCT00927758|3711060|FG004|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||3
2994541|NCT00927758|3711061|FG005|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||2
2994542|NCT00927758|3711056|FG000|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||4
2994543|NCT00927758|3711057|FG001|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||4
2994544|NCT00927758|3711058|FG002|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||3
2994545|NCT00927758|3711059|FG003|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||1
2994546|NCT00927758|3711060|FG004|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||3
2994547|NCT00927758|3711061|FG005|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||2
2994548|NCT00927758|3711056|FG000|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||0
2994549|NCT00927758|3711057|FG001|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||0
2994550|NCT00927758|3711058|FG002|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||1
2994551|NCT00927758|3711059|FG003|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||1
2994552|NCT00927758|3711060|FG004|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||0
2994553|NCT00927758|3711061|FG005|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||1
2994554|NCT00927758|3711056|FG000|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||4
2994555|NCT00927758|3711057|FG001|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||4
2994556|NCT00927758|3711058|FG002|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||3
2994557|NCT00927758|3711059|FG003|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||1
2994558|NCT00927758|3711060|FG004|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||3
2994559|NCT00927758|3711061|FG005|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||2
2994560|NCT00927758|3711056|FG000|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||4
2994561|NCT00927758|3711057|FG001|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||4
2994562|NCT00927758|3711058|FG002|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||3
2994563|NCT00927758|3711059|FG003|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||1
2994564|NCT00927758|3711060|FG004|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||3
2994565|NCT00927758|3711061|FG005|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||2
2994566|NCT00927758|3711056|FG000|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
2994567|NCT00927758|3711057|FG001|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
2994568|NCT00927758|3711058|FG002|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
2994569|NCT00927758|3711059|FG003|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
2994570|NCT00927758|3711060|FG004|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
2994571|NCT00927758|3711061|FG005|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
2994572|NCT00927784|3711071|FG000|STARTED|Overall Study||8
2994573|NCT00927784|3711072|FG001|STARTED|Overall Study||2
2994574|NCT00927784|3711071|FG000|COMPLETED|Overall Study||6
2994575|NCT00927784|3711072|FG001|COMPLETED|Overall Study||2
2994576|NCT00927784|3711071|FG000|NOT COMPLETED|Overall Study||2
2994577|NCT00927784|3711072|FG001|NOT COMPLETED|Overall Study||0
2994578|NCT00927810|3711082|FG000|STARTED|Overall Study||75
2994579|NCT00927810|3711083|FG001|STARTED|Overall Study||181
2994580|NCT00927810|3711084|FG002|STARTED|Overall Study||25
2994581|NCT00927810|3711085|FG003|STARTED|Overall Study||60
2994582|NCT00927810|3711082|FG000|COMPLETED|Overall Study||75
2994583|NCT00927810|3711083|FG001|COMPLETED|Overall Study||173
2994584|NCT00927810|3711084|FG002|COMPLETED|Overall Study||24
2994585|NCT00927810|3711085|FG003|COMPLETED|Overall Study||58
2994586|NCT00927810|3711082|FG000|NOT COMPLETED|Overall Study||0
2994587|NCT00927810|3711083|FG001|NOT COMPLETED|Overall Study||8
2994588|NCT00927810|3711084|FG002|NOT COMPLETED|Overall Study||1
2994589|NCT00927810|3711085|FG003|NOT COMPLETED|Overall Study||2
2994590|NCT00927823|3711103|FG000|STARTED|Lead-In Period||3
2994591|NCT00927823|3711104|FG001|STARTED|Lead-In Period||3
2994592|NCT00927823|3711105|FG002|STARTED|Lead-In Period||26
2994593|NCT00927823|3711106|FG003|STARTED|Lead-In Period||5
2994594|NCT00927823|3711103|FG000|COMPLETED|Lead-In Period||3
2994595|NCT00927823|3711104|FG001|COMPLETED|Lead-In Period||3
2994596|NCT00927823|3711105|FG002|COMPLETED|Lead-In Period||26
2994597|NCT00927823|3711106|FG003|COMPLETED|Lead-In Period||5
2994598|NCT00927823|3711103|FG000|NOT COMPLETED|Lead-In Period||0
2994599|NCT00927823|3711104|FG001|NOT COMPLETED|Lead-In Period||0
2994600|NCT00927823|3711105|FG002|NOT COMPLETED|Lead-In Period||0
2994601|NCT00927823|3711106|FG003|NOT COMPLETED|Lead-In Period||0
3164625|NCT01894243|3892056|FG002|STARTED|Overall Study||8
3164626|NCT01894243|3892054|FG000|Completed Treatment in Part A|Overall Study||13
3164627|NCT01894243|3892055|FG001|Completed Treatment in Part A|Overall Study||10
3305125|NCT02986802|4038793|FG001|STARTED|Overall Study||2839
3305126|NCT02986802|4038794|FG002|STARTED|Overall Study||1873
2994602|NCT00927823|3711103|FG000|STARTED|Continuous Dosing Period||3
2994603|NCT00927823|3711104|FG001|STARTED|Continuous Dosing Period||3
2994604|NCT00927823|3711105|FG002|STARTED|Continuous Dosing Period||26
2994605|NCT00927823|3711106|FG003|STARTED|Continuous Dosing Period||5
2994606|NCT00927823|3711103|FG000|Treated|Continuous Dosing Period||3
2994607|NCT00927823|3711104|FG001|Treated|Continuous Dosing Period||3
2994608|NCT00927823|3711105|FG002|Treated|Continuous Dosing Period||23
2994609|NCT00927823|3711106|FG003|Treated|Continuous Dosing Period||5
2994610|NCT00927823|3711103|FG000|COMPLETED|Continuous Dosing Period||0
2994611|NCT00927823|3711104|FG001|COMPLETED|Continuous Dosing Period||0
2994612|NCT00927823|3711105|FG002|COMPLETED|Continuous Dosing Period||0
2994613|NCT00927823|3711106|FG003|COMPLETED|Continuous Dosing Period||0
2994614|NCT00927823|3711103|FG000|NOT COMPLETED|Continuous Dosing Period||3
2994615|NCT00927823|3711104|FG001|NOT COMPLETED|Continuous Dosing Period||3
2994616|NCT00927823|3711105|FG002|NOT COMPLETED|Continuous Dosing Period||26
2994617|NCT00927823|3711106|FG003|NOT COMPLETED|Continuous Dosing Period||5
2994618|NCT00927849|3711126|FG000|STARTED|Overall Study||21
2994619|NCT00927849|3711127|FG001|STARTED|Overall Study||21
2994620|NCT00927849|3711128|FG002|STARTED|Overall Study||21
2994621|NCT00927849|3711126|FG000|COMPLETED|Overall Study||21
2994622|NCT00927849|3711127|FG001|COMPLETED|Overall Study||21
2994623|NCT00927849|3711128|FG002|COMPLETED|Overall Study||21
2994624|NCT00927849|3711126|FG000|NOT COMPLETED|Overall Study||0
2994625|NCT00927849|3711127|FG001|NOT COMPLETED|Overall Study||0
2994626|NCT00927849|3711128|FG002|NOT COMPLETED|Overall Study||0
2994627|NCT00927862|3711138|FG000|STARTED|Overall Study||504
2994628|NCT00927862|3711139|FG001|STARTED|Overall Study||1911
2994629|NCT00927862|3711138|FG000|COMPLETED|Overall Study|477 patients evaluated in primary analyses and 488 evaluated in secondary analyses.|477
2994630|NCT00927862|3711139|FG001|COMPLETED|Overall Study||1866
2994631|NCT00927862|3711138|FG000|NOT COMPLETED|Overall Study||27
2994632|NCT00927862|3711139|FG001|NOT COMPLETED|Overall Study||45
2994633|NCT00927888|3711149|FG000|STARTED|Overall Study||29
2994634|NCT00927888|3711150|FG001|STARTED|Overall Study||27
2994635|NCT00927888|3711149|FG000|COMPLETED|Overall Study||29
2994636|NCT00927888|3711150|FG001|COMPLETED|Overall Study||27
2994637|NCT00927888|3711149|FG000|NOT COMPLETED|Overall Study||0
2994638|NCT00927888|3711150|FG001|NOT COMPLETED|Overall Study||0
2994639|NCT00927901|3711158|FG000|STARTED|Treatment Period 1||7
2994640|NCT00927901|3711159|FG001|STARTED|Treatment Period 1||7
2994641|NCT00927901|3711160|FG002|STARTED|Treatment Period 1||7
2994642|NCT00927901|3711161|FG003|STARTED|Treatment Period 1||9
2994643|NCT00927901|3711158|FG000|COMPLETED|Treatment Period 1||7
2994644|NCT00927901|3711159|FG001|COMPLETED|Treatment Period 1||7
2994645|NCT00927901|3711160|FG002|COMPLETED|Treatment Period 1||6
2994646|NCT00927901|3711161|FG003|COMPLETED|Treatment Period 1||9
2994647|NCT00927901|3711158|FG000|NOT COMPLETED|Treatment Period 1||0
2994648|NCT00927901|3711159|FG001|NOT COMPLETED|Treatment Period 1||0
2994649|NCT00927901|3711160|FG002|NOT COMPLETED|Treatment Period 1||1
2994650|NCT00927901|3711161|FG003|NOT COMPLETED|Treatment Period 1||0
2994651|NCT00927901|3711158|FG000|STARTED|Treatment Period 2||7
2994652|NCT00927901|3711159|FG001|STARTED|Treatment Period 2||7
2994653|NCT00927901|3711160|FG002|STARTED|Treatment Period 2||6
2994654|NCT00927901|3711161|FG003|STARTED|Treatment Period 2||9
2994655|NCT00927901|3711158|FG000|COMPLETED|Treatment Period 2||7
2994656|NCT00927901|3711159|FG001|COMPLETED|Treatment Period 2||7
2994657|NCT00927901|3711160|FG002|COMPLETED|Treatment Period 2||6
2994658|NCT00927901|3711161|FG003|COMPLETED|Treatment Period 2||9
2994659|NCT00927901|3711158|FG000|NOT COMPLETED|Treatment Period 2||0
2994660|NCT00927901|3711159|FG001|NOT COMPLETED|Treatment Period 2||0
2994661|NCT00927901|3711160|FG002|NOT COMPLETED|Treatment Period 2||0
2994662|NCT00927901|3711161|FG003|NOT COMPLETED|Treatment Period 2||0
2994663|NCT00927901|3711158|FG000|STARTED|Treatment Period 3||7
2994664|NCT00927901|3711159|FG001|STARTED|Treatment Period 3||7
2994665|NCT00927901|3711160|FG002|STARTED|Treatment Period 3||6
2994666|NCT00927901|3711161|FG003|STARTED|Treatment Period 3||9
2994667|NCT00927901|3711158|FG000|COMPLETED|Treatment Period 3||7
2994668|NCT00927901|3711159|FG001|COMPLETED|Treatment Period 3||7
2994669|NCT00927901|3711160|FG002|COMPLETED|Treatment Period 3||6
2994670|NCT00927901|3711161|FG003|COMPLETED|Treatment Period 3||9
2994671|NCT00927901|3711158|FG000|NOT COMPLETED|Treatment Period 3||0
2994672|NCT00927901|3711159|FG001|NOT COMPLETED|Treatment Period 3||0
2994673|NCT00927901|3711160|FG002|NOT COMPLETED|Treatment Period 3||0
2994674|NCT00927901|3711161|FG003|NOT COMPLETED|Treatment Period 3||0
2994675|NCT00927901|3711158|FG000|STARTED|Treatment Period 4||7
2994676|NCT00927901|3711159|FG001|STARTED|Treatment Period 4||7
2994677|NCT00927901|3711160|FG002|STARTED|Treatment Period 4||6
2994678|NCT00927901|3711161|FG003|STARTED|Treatment Period 4||9
2994679|NCT00927901|3711158|FG000|COMPLETED|Treatment Period 4||7
2994680|NCT00927901|3711159|FG001|COMPLETED|Treatment Period 4||7
2994681|NCT00927901|3711160|FG002|COMPLETED|Treatment Period 4||5
2994682|NCT00927901|3711161|FG003|COMPLETED|Treatment Period 4||8
2994683|NCT00927901|3711158|FG000|NOT COMPLETED|Treatment Period 4||0
2994684|NCT00927901|3711159|FG001|NOT COMPLETED|Treatment Period 4||0
2994685|NCT00927901|3711160|FG002|NOT COMPLETED|Treatment Period 4||1
2994686|NCT00927901|3711161|FG003|NOT COMPLETED|Treatment Period 4||1
2994687|NCT00927927|3711189|FG000|STARTED|Overall Study||3
2994688|NCT00927927|3711190|FG001|STARTED|Overall Study||3
2994689|NCT00927927|3711191|FG002|STARTED|Overall Study||3
2994690|NCT00927927|3711192|FG003|STARTED|Overall Study||3
2994691|NCT00927927|3711193|FG004|STARTED|Overall Study||3
2994692|NCT00927927|3711194|FG005|STARTED|Overall Study||3
2994693|NCT00927927|3711195|FG006|STARTED|Overall Study||3
2994694|NCT00927927|3711196|FG007|STARTED|Overall Study||3
2994695|NCT00927927|3711197|FG008|STARTED|Overall Study||8
2994696|NCT00927927|3711198|FG009|STARTED|Overall Study||3
2994697|NCT00927927|3711199|FG010|STARTED|Overall Study||5
2994698|NCT00927927|3711200|FG011|STARTED|Overall Study||6
2994699|NCT00927927|3711201|FG012|STARTED|Overall Study||5
2994700|NCT00927927|3711202|FG013|STARTED|Overall Study||5
2994701|NCT00927927|3711203|FG014|STARTED|Overall Study||9
2994702|NCT00927927|3711189|FG000|Exposed|Overall Study||3
2994703|NCT00927927|3711190|FG001|Exposed|Overall Study||3
2994704|NCT00927927|3711191|FG002|Exposed|Overall Study||3
2994705|NCT00927927|3711192|FG003|Exposed|Overall Study||3
2994706|NCT00927927|3711193|FG004|Exposed|Overall Study||3
2994707|NCT00927927|3711194|FG005|Exposed|Overall Study||3
2994708|NCT00927927|3711195|FG006|Exposed|Overall Study||3
2994709|NCT00927927|3711196|FG007|Exposed|Overall Study||3
2994710|NCT00927927|3711197|FG008|Exposed|Overall Study||8
2994711|NCT00927927|3711198|FG009|Exposed|Overall Study||3
2994712|NCT00927927|3711199|FG010|Exposed|Overall Study||5
2994713|NCT00927927|3711200|FG011|Exposed|Overall Study||5
2994714|NCT00927927|3711201|FG012|Exposed|Overall Study||5
2994715|NCT00927927|3711202|FG013|Exposed|Overall Study||5
2994716|NCT00927927|3711203|FG014|Exposed|Overall Study||9
2994717|NCT00927927|3711189|FG000|COMPLETED|Overall Study||3
2994718|NCT00927927|3711190|FG001|COMPLETED|Overall Study||3
2994719|NCT00927927|3711191|FG002|COMPLETED|Overall Study||3
2994720|NCT00927927|3711192|FG003|COMPLETED|Overall Study||3
2994721|NCT00927927|3711193|FG004|COMPLETED|Overall Study||3
2994722|NCT00927927|3711194|FG005|COMPLETED|Overall Study||3
2994723|NCT00927927|3711195|FG006|COMPLETED|Overall Study||3
2994724|NCT00927927|3711196|FG007|COMPLETED|Overall Study||1
2994725|NCT00927927|3711197|FG008|COMPLETED|Overall Study||8
2994726|NCT00927927|3711198|FG009|COMPLETED|Overall Study||3
2994727|NCT00927927|3711199|FG010|COMPLETED|Overall Study||5
2994728|NCT00927927|3711200|FG011|COMPLETED|Overall Study|One subject withdrew consent after being randomised but before receiving any trial product.|4
2994729|NCT00927927|3711201|FG012|COMPLETED|Overall Study||5
2994730|NCT00927927|3711202|FG013|COMPLETED|Overall Study||5
2994731|NCT00927927|3711203|FG014|COMPLETED|Overall Study||9
2994732|NCT00927927|3711189|FG000|NOT COMPLETED|Overall Study||0
2994733|NCT00927927|3711190|FG001|NOT COMPLETED|Overall Study||0
2994734|NCT00927927|3711191|FG002|NOT COMPLETED|Overall Study||0
2994735|NCT00927927|3711192|FG003|NOT COMPLETED|Overall Study||0
2994736|NCT00927927|3711193|FG004|NOT COMPLETED|Overall Study||0
2994737|NCT00927927|3711194|FG005|NOT COMPLETED|Overall Study||0
2994738|NCT00927927|3711195|FG006|NOT COMPLETED|Overall Study||0
2994739|NCT00927927|3711196|FG007|NOT COMPLETED|Overall Study||2
2994740|NCT00927927|3711197|FG008|NOT COMPLETED|Overall Study||0
2994741|NCT00927927|3711198|FG009|NOT COMPLETED|Overall Study||0
2994742|NCT00927927|3711199|FG010|NOT COMPLETED|Overall Study||0
2994743|NCT00927927|3711200|FG011|NOT COMPLETED|Overall Study||2
2994744|NCT00927927|3711201|FG012|NOT COMPLETED|Overall Study||0
2994745|NCT00927927|3711202|FG013|NOT COMPLETED|Overall Study||0
2994746|NCT00927927|3711203|FG014|NOT COMPLETED|Overall Study||0
2994747|NCT00927940|3711235|FG000|STARTED|Overall Study||100
2994748|NCT00927940|3711235|FG000|COMPLETED|Overall Study|A patient died before 30 days follow up. This pasitent is excluded from primary analysis.|99
2994749|NCT00927940|3711235|FG000|NOT COMPLETED|Overall Study||1
2994750|NCT00927992|3711240|FG000|STARTED|Overall Study||11
2994751|NCT00927992|3711240|FG000|COMPLETED|Overall Study||11
2994752|NCT00927992|3711240|FG000|NOT COMPLETED|Overall Study||0
2994753|NCT00928018|3711246|FG000|STARTED|Overall Study|One Arm A patient withdrew consent, treated as Arm B, but analyzed on Arm A based on intent-to-treat|66
2994754|NCT00928018|3711247|FG001|STARTED|Overall Study||73
2994755|NCT00928018|3711246|FG000|COMPLETED|Overall Study||65
2994756|NCT00928018|3711247|FG001|COMPLETED|Overall Study||73
2994757|NCT00928018|3711246|FG000|NOT COMPLETED|Overall Study||1
2994758|NCT00928018|3711247|FG001|NOT COMPLETED|Overall Study||0
2994759|NCT00928057|3711259|FG000|STARTED|Overall Study||84
2994760|NCT00928057|3711260|FG001|STARTED|Overall Study||89
2994761|NCT00928057|3711259|FG000|COMPLETED|Overall Study||82
2994762|NCT00928057|3711260|FG001|COMPLETED|Overall Study||85
2994763|NCT00928057|3711259|FG000|NOT COMPLETED|Overall Study||2
2994764|NCT00928057|3711260|FG001|NOT COMPLETED|Overall Study||4
2994765|NCT00928070|3711278|FG000|STARTED|Overall Study||283
2994766|NCT00928070|3711279|FG001|STARTED|Overall Study||283
2994767|NCT00928070|3711278|FG000|Treated|Overall Study||281
2994768|NCT00928070|3711279|FG001|Treated|Overall Study||281
2994769|NCT00928070|3711278|FG000|COMPLETED|Overall Study||220
2994770|NCT00928070|3711279|FG001|COMPLETED|Overall Study||226
2994771|NCT00928070|3711278|FG000|NOT COMPLETED|Overall Study||63
2994772|NCT00928070|3711279|FG001|NOT COMPLETED|Overall Study||57
2994773|NCT00928083|3711288|FG000|STARTED|Overall Study||10
2994774|NCT00928083|3711289|FG001|STARTED|Overall Study||8
2994775|NCT00928083|3711290|FG002|STARTED|Overall Study||8
2994776|NCT00928083|3711291|FG003|STARTED|Overall Study||6
2994777|NCT00928083|3711292|FG004|STARTED|Overall Study||7
2994778|NCT00928083|3711293|FG005|STARTED|Overall Study||6
2994779|NCT00928083|3711294|FG006|STARTED|Overall Study||6
2994780|NCT00928083|3711295|FG007|STARTED|Overall Study||6
2994781|NCT00928083|3711296|FG008|STARTED|Overall Study||6
2994782|NCT00928083|3711288|FG000|COMPLETED|Overall Study||6
2994783|NCT00928083|3711289|FG001|COMPLETED|Overall Study||8
2994784|NCT00928083|3711290|FG002|COMPLETED|Overall Study||8
2994785|NCT00928083|3711291|FG003|COMPLETED|Overall Study||5
2994786|NCT00928083|3711292|FG004|COMPLETED|Overall Study||6
2994787|NCT00928083|3711293|FG005|COMPLETED|Overall Study||6
2994788|NCT00928083|3711294|FG006|COMPLETED|Overall Study||6
2994789|NCT00928083|3711295|FG007|COMPLETED|Overall Study||6
2994790|NCT00928083|3711296|FG008|COMPLETED|Overall Study||6
2994791|NCT00928083|3711288|FG000|NOT COMPLETED|Overall Study||4
2994792|NCT00928083|3711289|FG001|NOT COMPLETED|Overall Study||0
2994793|NCT00928083|3711290|FG002|NOT COMPLETED|Overall Study||0
2994794|NCT00928083|3711291|FG003|NOT COMPLETED|Overall Study||1
2994795|NCT00928083|3711292|FG004|NOT COMPLETED|Overall Study||1
2994796|NCT00928083|3711293|FG005|NOT COMPLETED|Overall Study||0
2994797|NCT00928083|3711294|FG006|NOT COMPLETED|Overall Study||0
2994798|NCT00928083|3711295|FG007|NOT COMPLETED|Overall Study||0
2994799|NCT00928083|3711296|FG008|NOT COMPLETED|Overall Study||0
2994800|NCT00928135|3711347|FG000|STARTED|Overall Study||30
2994801|NCT00928135|3711348|FG001|STARTED|Overall Study||30
2994802|NCT00928135|3711347|FG000|COMPLETED|Overall Study||29
2994803|NCT00928135|3711348|FG001|COMPLETED|Overall Study||30
2994804|NCT00928135|3711347|FG000|NOT COMPLETED|Overall Study||1
2994805|NCT00928135|3711348|FG001|NOT COMPLETED|Overall Study||0
2994806|NCT00928174|3711354|FG000|STARTED|Overall Study||27
2994807|NCT00928174|3711354|FG000|COMPLETED|Overall Study|3 withdrawn before start of participation|22
2994808|NCT00928174|3711354|FG000|NOT COMPLETED|Overall Study||5
2994809|NCT00928187|3711361|FG000|STARTED|Overall Study||152
2994810|NCT00928187|3711362|FG001|STARTED|Overall Study||147
2994811|NCT00928187|3711363|FG002|STARTED|Overall Study||155
2994812|NCT00928187|3711361|FG000|Analysed|Overall Study||152
2994813|NCT00928187|3711362|FG001|Analysed|Overall Study||145
2994814|NCT00928187|3711363|FG002|Analysed|Overall Study||154
2994815|NCT00928187|3711361|FG000|COMPLETED|Overall Study||150
2994816|NCT00928187|3711362|FG001|COMPLETED|Overall Study||141
2994817|NCT00928187|3711363|FG002|COMPLETED|Overall Study||150
2994818|NCT00928187|3711361|FG000|NOT COMPLETED|Overall Study||2
2994819|NCT00928187|3711362|FG001|NOT COMPLETED|Overall Study||6
2994820|NCT00928187|3711363|FG002|NOT COMPLETED|Overall Study||5
2994821|NCT00928200|3711371|FG000|STARTED|Overall Study||1
2994822|NCT00928200|3711371|FG000|COMPLETED|Overall Study||1
2994823|NCT00928200|3711371|FG000|NOT COMPLETED|Overall Study||0
2994824|NCT00928252|3711375|FG000|STARTED|Overall Study||45
2994825|NCT00928252|3711375|FG000|COMPLETED|Overall Study||42
2994826|NCT00928252|3711375|FG000|NOT COMPLETED|Overall Study||3
2994827|NCT00928304|3711381|FG000|STARTED|Overall Study||39
2994828|NCT00928304|3711382|FG001|STARTED|Overall Study||70
2994829|NCT00928304|3711381|FG000|COMPLETED|Overall Study||39
2994830|NCT00928304|3711382|FG001|COMPLETED|Overall Study||70
2994831|NCT00928304|3711381|FG000|NOT COMPLETED|Overall Study||0
2994832|NCT00928304|3711382|FG001|NOT COMPLETED|Overall Study||0
2994833|NCT00928395|3711394|FG000|STARTED|Overall Study||50
2994834|NCT00928395|3711394|FG000|COMPLETED|Overall Study||29
2994835|NCT00928395|3711394|FG000|NOT COMPLETED|Overall Study||21
2994836|NCT00928408|3711398|FG000|STARTED|Overall Study|Number Enrolled|305
2994837|NCT00928408|3711398|FG000|Full Analysis Set|Overall Study|All enrolled participants who fulfilled the study inclusion/exclusion criteria|303
2994838|NCT00928408|3711398|FG000|COMPLETED|Overall Study||282
2994839|NCT00928408|3711398|FG000|NOT COMPLETED|Overall Study||23
2994840|NCT00928421|3711402|FG000|STARTED|Overall Study||16
2994841|NCT00928421|3711402|FG000|Treated With Study Drug|Overall Study||16
2994842|NCT00928421|3711402|FG000|COMPLETED|Overall Study||16
2994843|NCT00928421|3711402|FG000|NOT COMPLETED|Overall Study||0
2994844|NCT00928434|3711409|FG000|STARTED|Overall Study|Full Analysis Set Patients|175
2994845|NCT00928434|3711410|FG001|STARTED|Overall Study|Full Analysis Set Patients|50
2994846|NCT00928434|3711411|FG002|STARTED|Overall Study|Full Analysis Set Patients|178
2994847|NCT00928434|3711409|FG000|Full Phase B Analysis Set|Overall Study|Patients completing 7 months treatment with PSA<2 ng/mL, and having one primary efficacy assessment.|137
2994848|NCT00928434|3711410|FG001|Full Phase B Analysis Set|Overall Study|Patients completing 7 months treatment with PSA<2 ng/mL, and having one primary efficacy assessment.|41
2994849|NCT00928434|3711411|FG002|Full Phase B Analysis Set|Overall Study|Patients completing 7 months treatment with PSA<2 ng/mL, and having one primary efficacy assessment.|150
3164628|NCT01894243|3892056|FG002|Completed Treatment in Part A|Overall Study||8
3164629|NCT01894243|3892054|FG000|Ongoing Into Part B|Overall Study||13
3164630|NCT01894243|3892055|FG001|Ongoing Into Part B|Overall Study||10
3164631|NCT01894243|3892056|FG002|Ongoing Into Part B|Overall Study||8
3164632|NCT01894243|3892054|FG000|COMPLETED|Overall Study||0
3164633|NCT01894243|3892055|FG001|COMPLETED|Overall Study||0
3164634|NCT01894243|3892056|FG002|COMPLETED|Overall Study||0
3164635|NCT01894243|3892054|FG000|NOT COMPLETED|Overall Study||13
3164636|NCT01894243|3892055|FG001|NOT COMPLETED|Overall Study||10
3164637|NCT01894243|3892056|FG002|NOT COMPLETED|Overall Study||8
2994850|NCT00928434|3711409|FG000|COMPLETED|Overall Study||131
2994851|NCT00928434|3711410|FG001|COMPLETED|Overall Study||36
2994852|NCT00928434|3711411|FG002|COMPLETED|Overall Study||134
2994853|NCT00928434|3711409|FG000|NOT COMPLETED|Overall Study||44
2994854|NCT00928434|3711410|FG001|NOT COMPLETED|Overall Study||14
2994855|NCT00928434|3711411|FG002|NOT COMPLETED|Overall Study||44
2994856|NCT00928486|3711427|FG000|STARTED|Overall Study||25
3164638|NCT01894256|3892074|FG000|STARTED|Part A||15
3164639|NCT01894256|3892075|FG001|STARTED|Part A||15
2994857|NCT00928486|3711427|FG000|Efficacy Evaluable (EE)|Overall Study|EE population = given at least 1 dose of study drug, evaluated for efficacy and met eligibility|24
2994858|NCT00928486|3711427|FG000|COMPLETED|Overall Study|Completed = those who continued responding to treatment; upon marketing approval, given lenalidomide|15
2994859|NCT00928486|3711427|FG000|NOT COMPLETED|Overall Study||10
2994860|NCT00928512|3711436|FG000|STARTED|Overall Study||41
2994861|NCT00928512|3711437|FG001|STARTED|Overall Study||43
2994862|NCT00928512|3711438|FG002|STARTED|Overall Study||49
2994863|NCT00928512|3711439|FG003|STARTED|Overall Study||54
2994864|NCT00928512|3711440|FG004|STARTED|Overall Study||50
2994865|NCT00928512|3711436|FG000|Discontinued Prior to Week 16|Overall Study||3
2994866|NCT00928512|3711437|FG001|Discontinued Prior to Week 16|Overall Study||0
2994867|NCT00928512|3711438|FG002|Discontinued Prior to Week 16|Overall Study||2
2994868|NCT00928512|3711439|FG003|Discontinued Prior to Week 16|Overall Study||6
2994869|NCT00928512|3711440|FG004|Discontinued Prior to Week 16|Overall Study||5
2994870|NCT00928512|3711436|FG000|Reassigned at Week 20 (Non-responders)|Overall Study|All patients in the 300 mg group at Week 20 remained at this dose in this group.|0
2994871|NCT00928512|3711437|FG001|Reassigned at Week 20 (Non-responders)|Overall Study|Non-responders in the AIN457 150 mg group were reassigned treatment to the 300 mg group.|23
2994872|NCT00928512|3711438|FG002|Reassigned at Week 20 (Non-responders)|Overall Study|Non-responders in the AIN457 75 mg group were reassigned treatment to the 150 mg group.|23
2994873|NCT00928512|3711439|FG003|Reassigned at Week 20 (Non-responders)|Overall Study|Non-responders in the AIN457 25 mg group were reassigned treatment to the 150 mg group.|27
2994874|NCT00928512|3711440|FG004|Reassigned at Week 20 (Non-responders)|Overall Study|All placebo patients (responders & non-responders) were reassigned treatment to the 150 mg group.|45
2994875|NCT00928512|3711436|FG000|Not Reassigned at Week 20 (Responders)|Overall Study||37
2994876|NCT00928512|3711437|FG001|Not Reassigned at Week 20 (Responders)|Overall Study||20
2994877|NCT00928512|3711438|FG002|Not Reassigned at Week 20 (Responders)|Overall Study||23
2994878|NCT00928512|3711439|FG003|Not Reassigned at Week 20 (Responders)|Overall Study||18
2994879|NCT00928512|3711440|FG004|Not Reassigned at Week 20 (Responders)|Overall Study||0
2994880|NCT00928512|3711436|FG000|New Groups After Reassignment|Overall Study|1 patient in this group continued at Week 16 but did not receive any study drug at Week 20.|60
2994881|NCT00928512|3711437|FG001|New Groups After Reassignment|Overall Study||115
2994882|NCT00928512|3711438|FG002|New Groups After Reassignment|Overall Study|1 patient in this group continued at Week 16 but did not receive any study drug at Week 20.|23
2994883|NCT00928512|3711439|FG003|New Groups After Reassignment|Overall Study|2 patients in this group continued at Week 16 but did not receive any study drug at Week 20|18
2994884|NCT00928512|3711440|FG004|New Groups After Reassignment|Overall Study||0
2994885|NCT00928512|3711436|FG000|Completed Week 16|Overall Study||38
2994886|NCT00928512|3711437|FG001|Completed Week 16|Overall Study||43
3164640|NCT01894256|3892076|FG002|STARTED|Part A||14
3164641|NCT01894256|3892074|FG000|COMPLETED|Part A||15
2994887|NCT00928512|3711438|FG002|Completed Week 16|Overall Study||47
2994888|NCT00928512|3711439|FG003|Completed Week 16|Overall Study||48
2994889|NCT00928512|3711440|FG004|Completed Week 16|Overall Study||45
2994890|NCT00928512|3711436|FG000|Entered/Continued to Week 20 (All)|Overall Study||37
2994891|NCT00928512|3711437|FG001|Entered/Continued to Week 20 (All)|Overall Study||43
2994892|NCT00928512|3711438|FG002|Entered/Continued to Week 20 (All)|Overall Study||46
2994893|NCT00928512|3711439|FG003|Entered/Continued to Week 20 (All)|Overall Study||45
2994894|NCT00928512|3711440|FG004|Entered/Continued to Week 20 (All)|Overall Study||45
2994895|NCT00928512|3711436|FG000|COMPLETED|Overall Study||31
2994896|NCT00928512|3711437|FG001|COMPLETED|Overall Study||37
2994897|NCT00928512|3711438|FG002|COMPLETED|Overall Study||38
2994898|NCT00928512|3711439|FG003|COMPLETED|Overall Study||33
2994899|NCT00928512|3711440|FG004|COMPLETED|Overall Study||35
2994900|NCT00928512|3711436|FG000|NOT COMPLETED|Overall Study||10
2994901|NCT00928512|3711437|FG001|NOT COMPLETED|Overall Study||6
2994902|NCT00928512|3711438|FG002|NOT COMPLETED|Overall Study||11
2994903|NCT00928512|3711439|FG003|NOT COMPLETED|Overall Study||21
2994904|NCT00928512|3711440|FG004|NOT COMPLETED|Overall Study||15
2994905|NCT00928564|3711458|FG000|STARTED|Overall Study||28
2994906|NCT00928564|3711459|FG001|STARTED|Overall Study||12
2994907|NCT00928564|3711458|FG000|COMPLETED|Overall Study||22
2994908|NCT00928564|3711459|FG001|COMPLETED|Overall Study||12
2994909|NCT00928564|3711458|FG000|NOT COMPLETED|Overall Study||6
2994910|NCT00928564|3711459|FG001|NOT COMPLETED|Overall Study||0
2994911|NCT00928642|3711465|FG000|STARTED|Overall Study||8
2994912|NCT00928642|3711465|FG000|COMPLETED|Overall Study|1 subject withdrew after 1st cycle but before disease assessment. 7 of 8 are evaluable for response|8
2994913|NCT00928642|3711465|FG000|NOT COMPLETED|Overall Study||0
2994914|NCT00928668|3711472|FG000|STARTED|Overall Study||7
2994915|NCT00928668|3711473|FG001|STARTED|Overall Study||7
2994916|NCT00928668|3711474|FG002|STARTED|Overall Study||7
2994917|NCT00928668|3711475|FG003|STARTED|Overall Study||4
2994918|NCT00928668|3711476|FG004|STARTED|Overall Study||6
2994919|NCT00928668|3711472|FG000|COMPLETED|Overall Study||6
2994920|NCT00928668|3711473|FG001|COMPLETED|Overall Study||6
2994921|NCT00928668|3711474|FG002|COMPLETED|Overall Study||6
2994922|NCT00928668|3711475|FG003|COMPLETED|Overall Study||3
2994923|NCT00928668|3711476|FG004|COMPLETED|Overall Study||5
2994924|NCT00928668|3711472|FG000|NOT COMPLETED|Overall Study||1
2994925|NCT00928668|3711473|FG001|NOT COMPLETED|Overall Study||1
3164642|NCT01894256|3892075|FG001|COMPLETED|Part A||14
2994926|NCT00928668|3711474|FG002|NOT COMPLETED|Overall Study||1
2994927|NCT00928668|3711475|FG003|NOT COMPLETED|Overall Study||1
2994928|NCT00928668|3711476|FG004|NOT COMPLETED|Overall Study||1
3164643|NCT01894256|3892076|FG002|COMPLETED|Part A||14
3164644|NCT01894256|3892074|FG000|NOT COMPLETED|Part A||0
3164645|NCT01894256|3892075|FG001|NOT COMPLETED|Part A||1
3164646|NCT01894256|3892076|FG002|NOT COMPLETED|Part A||0
3164647|NCT01894256|3892074|FG000|STARTED|Part B||15
3164648|NCT01894256|3892075|FG001|STARTED|Part B||14
2994929|NCT00928694|3711493|FG000|STARTED|First Intervention||7
2994930|NCT00928694|3711494|FG001|STARTED|First Intervention||7
2994931|NCT00928694|3711493|FG000|COMPLETED|First Intervention||7
2994932|NCT00928694|3711494|FG001|COMPLETED|First Intervention||7
3164649|NCT01894256|3892076|FG002|STARTED|Part B||14
3164650|NCT01894256|3892074|FG000|COMPLETED|Part B||0
3164651|NCT01894256|3892075|FG001|COMPLETED|Part B||0
3164652|NCT01894256|3892076|FG002|COMPLETED|Part B||0
3164653|NCT01894256|3892074|FG000|NOT COMPLETED|Part B||15
3164654|NCT01894256|3892075|FG001|NOT COMPLETED|Part B||14
2994933|NCT00928694|3711493|FG000|NOT COMPLETED|First Intervention||0
2994934|NCT00928694|3711494|FG001|NOT COMPLETED|First Intervention||0
2994935|NCT00928694|3711493|FG000|STARTED|Second Intervention||7
2994936|NCT00928694|3711494|FG001|STARTED|Second Intervention||7
2994937|NCT00928694|3711493|FG000|COMPLETED|Second Intervention||7
2994938|NCT00928694|3711494|FG001|COMPLETED|Second Intervention||7
2994939|NCT00928694|3711493|FG000|NOT COMPLETED|Second Intervention||0
2994940|NCT00928694|3711494|FG001|NOT COMPLETED|Second Intervention||0
2994941|NCT00928707|3711502|FG000|STARTED|Overall Study||23
2994942|NCT00928707|3711503|FG001|STARTED|Overall Study||22
2994943|NCT00928707|3711502|FG000|COMPLETED|Overall Study||22
2994944|NCT00928707|3711503|FG001|COMPLETED|Overall Study||22
2994945|NCT00928707|3711502|FG000|NOT COMPLETED|Overall Study||1
2994946|NCT00928707|3711503|FG001|NOT COMPLETED|Overall Study||0
2994947|NCT00928720|3711512|FG000|STARTED|Overall Study||19
2994948|NCT00928720|3711513|FG001|STARTED|Overall Study||20
2994949|NCT00928720|3711514|FG002|STARTED|Overall Study||18
2994950|NCT00928720|3711512|FG000|COMPLETED|Overall Study||17
2994951|NCT00928720|3711513|FG001|COMPLETED|Overall Study||14
2994952|NCT00928720|3711514|FG002|COMPLETED|Overall Study||15
2994953|NCT00928720|3711512|FG000|NOT COMPLETED|Overall Study||2
2994954|NCT00928720|3711513|FG001|NOT COMPLETED|Overall Study||6
2994955|NCT00928720|3711514|FG002|NOT COMPLETED|Overall Study||3
2994956|NCT00928746|3711525|FG000|STARTED|Overall Study||142
2994957|NCT00928746|3711525|FG000|COMPLETED|Overall Study||136
2994958|NCT00928746|3711525|FG000|NOT COMPLETED|Overall Study||6
2994959|NCT00928772|3711534|FG000|STARTED|Overall Study||39
2994960|NCT00928772|3711535|FG001|STARTED|Overall Study||38
2994961|NCT00928772|3711536|FG002|STARTED|Overall Study||38
2994962|NCT00928772|3711534|FG000|COMPLETED|Overall Study||39
2994963|NCT00928772|3711535|FG001|COMPLETED|Overall Study||38
2994964|NCT00928772|3711536|FG002|COMPLETED|Overall Study||38
2994965|NCT00928772|3711534|FG000|NOT COMPLETED|Overall Study||0
2994966|NCT00928772|3711535|FG001|NOT COMPLETED|Overall Study||0
2994967|NCT00928772|3711536|FG002|NOT COMPLETED|Overall Study||0
2994968|NCT00928889|3711546|FG000|STARTED|Overall Study||80
2994969|NCT00928889|3711547|FG001|STARTED|Overall Study||80
2994970|NCT00928889|3711546|FG000|COMPLETED|Overall Study||75
2994971|NCT00928889|3711547|FG001|COMPLETED|Overall Study||78
2994972|NCT00928889|3711546|FG000|NOT COMPLETED|Overall Study||5
2994973|NCT00928889|3711547|FG001|NOT COMPLETED|Overall Study||2
2994974|NCT00928954|3711553|FG000|STARTED|Overall Study||4
2994975|NCT00928954|3711554|FG001|STARTED|Overall Study||6
2994976|NCT00928954|3711553|FG000|COMPLETED|Overall Study||4
2994977|NCT00928954|3711554|FG001|COMPLETED|Overall Study||6
2994978|NCT00928954|3711553|FG000|NOT COMPLETED|Overall Study||0
2994979|NCT00928954|3711554|FG001|NOT COMPLETED|Overall Study||0
2994980|NCT00929071|3711560|FG000|STARTED|Overall Study||10
2994981|NCT00929071|3711560|FG000|COMPLETED|Overall Study||10
2994982|NCT00929071|3711560|FG000|NOT COMPLETED|Overall Study||0
2994983|NCT00929110|3711570|FG000|STARTED|Overall Study||529
2994984|NCT00929110|3711571|FG001|STARTED|Overall Study||269
2994985|NCT00929110|3711572|FG002|STARTED|Overall Study||268
2994986|NCT00929110|3711570|FG000|COMPLETED|Overall Study||411
2994987|NCT00929110|3711571|FG001|COMPLETED|Overall Study||193
2994988|NCT00929110|3711572|FG002|COMPLETED|Overall Study||206
2994989|NCT00929110|3711570|FG000|NOT COMPLETED|Overall Study||118
3164655|NCT01894256|3892076|FG002|NOT COMPLETED|Part B||14
3164656|NCT01894477|3892089|FG000|STARTED|Overall Study||35
3164657|NCT01894477|3892090|FG001|STARTED|Overall Study||67
2994990|NCT00929110|3711571|FG001|NOT COMPLETED|Overall Study||76
2994991|NCT00929110|3711572|FG002|NOT COMPLETED|Overall Study||62
2994992|NCT00929162|3711582|FG000|STARTED|Overall Study||59
2994993|NCT00929162|3711583|FG001|STARTED|Overall Study||61
2994994|NCT00929162|3711582|FG000|Patients Who Received Treatment|Overall Study||58
2994995|NCT00929162|3711583|FG001|Patients Who Received Treatment|Overall Study||58
2994996|NCT00929162|3711582|FG000|COMPLETED|Overall Study||11
2994997|NCT00929162|3711583|FG001|COMPLETED|Overall Study||19
2994998|NCT00929162|3711582|FG000|NOT COMPLETED|Overall Study||48
2994999|NCT00929162|3711583|FG001|NOT COMPLETED|Overall Study||42
2995000|NCT00929201|3711589|FG000|STARTED|Period 1||30
2995001|NCT00929201|3711590|FG001|STARTED|Period 1||31
2995002|NCT00929201|3711589|FG000|COMPLETED|Period 1||30
2995003|NCT00929201|3711590|FG001|COMPLETED|Period 1||30
3164658|NCT01894477|3892089|FG000|COMPLETED|Overall Study||35
2995004|NCT00929201|3711589|FG000|NOT COMPLETED|Period 1||0
2995005|NCT00929201|3711590|FG001|NOT COMPLETED|Period 1||1
2995006|NCT00929201|3711589|FG000|STARTED|7-day Washout||30
2995007|NCT00929201|3711590|FG001|STARTED|7-day Washout||30
2995008|NCT00929201|3711589|FG000|COMPLETED|7-day Washout||30
2995009|NCT00929201|3711590|FG001|COMPLETED|7-day Washout||30
2995010|NCT00929201|3711589|FG000|NOT COMPLETED|7-day Washout||0
2995011|NCT00929201|3711590|FG001|NOT COMPLETED|7-day Washout||0
2995012|NCT00929201|3711589|FG000|STARTED|Period 2||30
2995013|NCT00929201|3711590|FG001|STARTED|Period 2||30
2995014|NCT00929201|3711589|FG000|COMPLETED|Period 2||30
2995015|NCT00929201|3711590|FG001|COMPLETED|Period 2||30
2995016|NCT00929201|3711589|FG000|NOT COMPLETED|Period 2||0
2995017|NCT00929201|3711590|FG001|NOT COMPLETED|Period 2||0
2995018|NCT00929240|3711597|FG000|STARTED|Initial Treatment Phase|Includes only the participants that received Initial Phase Treatment.|284
2995019|NCT00929240|3711598|FG001|STARTED|Initial Treatment Phase|Participants were randomized to 1 of 2 treatment groups at the end of the initial treatment phase.|0
2995020|NCT00929240|3711599|FG002|STARTED|Initial Treatment Phase||0
2995021|NCT00929240|3711597|FG000|COMPLETED|Initial Treatment Phase|Participants were randomized to 1 of 2 treatment groups at the end of the initial treatment phase.|185
2995022|NCT00929240|3711598|FG001|COMPLETED|Initial Treatment Phase||0
2995023|NCT00929240|3711599|FG002|COMPLETED|Initial Treatment Phase||0
2995024|NCT00929240|3711597|FG000|NOT COMPLETED|Initial Treatment Phase||99
2995025|NCT00929240|3711598|FG001|NOT COMPLETED|Initial Treatment Phase||0
2995026|NCT00929240|3711599|FG002|NOT COMPLETED|Initial Treatment Phase||0
2995027|NCT00929240|3711597|FG000|STARTED|Maintenance Phase|Participants were randomized to 1 of 2 treatment groups at the end of the initial treatment phase.|0
2995028|NCT00929240|3711598|FG001|STARTED|Maintenance Phase||94
2995029|NCT00929240|3711599|FG002|STARTED|Maintenance Phase||91
2995030|NCT00929240|3711597|FG000|COMPLETED|Maintenance Phase||0
2995031|NCT00929240|3711598|FG001|COMPLETED|Maintenance Phase||0
2995032|NCT00929240|3711599|FG002|COMPLETED|Maintenance Phase||0
2995033|NCT00929240|3711597|FG000|NOT COMPLETED|Maintenance Phase||0
2995034|NCT00929240|3711598|FG001|NOT COMPLETED|Maintenance Phase||94
2995035|NCT00929240|3711599|FG002|NOT COMPLETED|Maintenance Phase||91
2995036|NCT00929305|3711610|FG000|STARTED|Overall Study||43
2995037|NCT00929305|3711611|FG001|STARTED|Overall Study||43
2995038|NCT00929305|3711610|FG000|COMPLETED|Overall Study||43
2995039|NCT00929305|3711611|FG001|COMPLETED|Overall Study||43
2995040|NCT00929305|3711610|FG000|NOT COMPLETED|Overall Study||0
2995041|NCT00929305|3711611|FG001|NOT COMPLETED|Overall Study||0
2995042|NCT00929331|3711620|FG000|STARTED|Overall Study||55
2995043|NCT00929331|3711621|FG001|STARTED|Overall Study||55
2995044|NCT00929331|3711620|FG000|COMPLETED|Overall Study||55
2995045|NCT00929331|3711621|FG001|COMPLETED|Overall Study||55
2995046|NCT00929331|3711620|FG000|NOT COMPLETED|Overall Study||0
2995047|NCT00929331|3711621|FG001|NOT COMPLETED|Overall Study||0
2995048|NCT00929344|3711630|FG000|STARTED|Overall Study||50
2995049|NCT00929344|3711631|FG001|STARTED|Overall Study||50
2995050|NCT00929344|3711632|FG002|STARTED|Overall Study||50
2995051|NCT00929344|3711630|FG000|COMPLETED|Overall Study||28
2995052|NCT00929344|3711631|FG001|COMPLETED|Overall Study||37
2995053|NCT00929344|3711632|FG002|COMPLETED|Overall Study||29
2995054|NCT00929344|3711630|FG000|NOT COMPLETED|Overall Study||22
2995055|NCT00929344|3711631|FG001|NOT COMPLETED|Overall Study||13
2995056|NCT00929344|3711632|FG002|NOT COMPLETED|Overall Study||21
2995057|NCT00929357|3711642|FG000|STARTED|Overall Study||92
2995058|NCT00929357|3711643|FG001|STARTED|Overall Study||64
2995059|NCT00929357|3711642|FG000|COMPLETED|Overall Study||92
2995060|NCT00929357|3711643|FG001|COMPLETED|Overall Study||64
2995061|NCT00929357|3711642|FG000|NOT COMPLETED|Overall Study||0
2995062|NCT00929357|3711643|FG001|NOT COMPLETED|Overall Study||0
2995063|NCT00929383|3711649|FG000|STARTED|Overall Study||82
2995064|NCT00929383|3711649|FG000|COMPLETED|Overall Study||67
2995065|NCT00929383|3711649|FG000|NOT COMPLETED|Overall Study||15
2995066|NCT00929500|3711655|FG000|STARTED|Overall Study||8
2995067|NCT00929500|3711656|FG001|STARTED|Overall Study||4
2995068|NCT00929500|3711655|FG000|COMPLETED|Overall Study||4
2995069|NCT00929500|3711656|FG001|COMPLETED|Overall Study||4
2995070|NCT00929500|3711655|FG000|NOT COMPLETED|Overall Study||4
2995071|NCT00929500|3711656|FG001|NOT COMPLETED|Overall Study||0
2995072|NCT00929526|3711664|FG000|STARTED|Overall Study||375
2995073|NCT00929526|3711665|FG001|STARTED|Overall Study||377
2995074|NCT00929526|3711664|FG000|COMPLETED|Overall Study||358
2995075|NCT00929526|3711665|FG001|COMPLETED|Overall Study||348
2995076|NCT00929526|3711664|FG000|NOT COMPLETED|Overall Study||17
2995077|NCT00929526|3711665|FG001|NOT COMPLETED|Overall Study||29
2995078|NCT00929578|3711671|FG000|STARTED|Overall Study||15
2995079|NCT00929578|3711671|FG000|COMPLETED|Overall Study||15
2995080|NCT00929578|3711671|FG000|NOT COMPLETED|Overall Study||0
2995081|NCT00929643|3711680|FG000|STARTED|Overall Study||203
2995082|NCT00929643|3711680|FG000|COMPLETED|Overall Study||201
2995083|NCT00929643|3711680|FG000|NOT COMPLETED|Overall Study||2
2995084|NCT00929656|3711686|FG000|STARTED|Overall Study||13
2995085|NCT00929656|3711687|FG001|STARTED|Overall Study||9
2995086|NCT00929656|3711686|FG000|COMPLETED|Overall Study||13
2995087|NCT00929656|3711687|FG001|COMPLETED|Overall Study||8
2995088|NCT00929656|3711686|FG000|NOT COMPLETED|Overall Study||0
2995089|NCT00929656|3711687|FG001|NOT COMPLETED|Overall Study||1
2995090|NCT00929669|3711693|FG000|STARTED|Overall Study||2
2995091|NCT00929669|3711693|FG000|COMPLETED|Overall Study||1
2995092|NCT00929669|3711693|FG000|NOT COMPLETED|Overall Study||1
2995093|NCT00929695|3711699|FG000|STARTED|Overall Study||81
2995094|NCT00929695|3711700|FG001|STARTED|Overall Study||83
2995095|NCT00929695|3711699|FG000|COMPLETED|Overall Study||73
2995096|NCT00929695|3711700|FG001|COMPLETED|Overall Study||77
2995097|NCT00929695|3711699|FG000|NOT COMPLETED|Overall Study||8
2995098|NCT00929695|3711700|FG001|NOT COMPLETED|Overall Study||6
2995099|NCT00929708|3711716|FG000|STARTED|Overall Study||65
2995100|NCT00929708|3711717|FG001|STARTED|Overall Study||69
2995101|NCT00929708|3711718|FG002|STARTED|Overall Study||65
2995102|NCT00929708|3711719|FG003|STARTED|Overall Study||67
2995103|NCT00929708|3711720|FG004|STARTED|Overall Study||63
2995104|NCT00929708|3711716|FG000|COMPLETED|Overall Study||61
2995105|NCT00929708|3711717|FG001|COMPLETED|Overall Study||66
2995106|NCT00929708|3711718|FG002|COMPLETED|Overall Study||62
2995107|NCT00929708|3711719|FG003|COMPLETED|Overall Study||61
2995108|NCT00929708|3711720|FG004|COMPLETED|Overall Study||57
2995109|NCT00929708|3711716|FG000|NOT COMPLETED|Overall Study||4
2995110|NCT00929708|3711717|FG001|NOT COMPLETED|Overall Study||3
2995111|NCT00929708|3711718|FG002|NOT COMPLETED|Overall Study||3
2995112|NCT00929708|3711719|FG003|NOT COMPLETED|Overall Study||6
2995113|NCT00929708|3711720|FG004|NOT COMPLETED|Overall Study||6
2995114|NCT00929734|3711734|FG000|STARTED|Overall Study||49
2995115|NCT00929734|3711735|FG001|STARTED|Overall Study||50
2995116|NCT00929734|3711734|FG000|COMPLETED|Overall Study||47
2995117|NCT00929734|3711735|FG001|COMPLETED|Overall Study||47
2995118|NCT00929734|3711734|FG000|NOT COMPLETED|Overall Study||2
2995119|NCT00929734|3711735|FG001|NOT COMPLETED|Overall Study||3
2995120|NCT00929773|3711743|FG000|STARTED|Overall Study||50
2995121|NCT00929773|3711744|FG001|STARTED|Overall Study||50
2995122|NCT00929773|3711743|FG000|COMPLETED|Overall Study||50
2995123|NCT00929773|3711744|FG001|COMPLETED|Overall Study||50
2995124|NCT00929773|3711743|FG000|NOT COMPLETED|Overall Study||0
2995125|NCT00929773|3711744|FG001|NOT COMPLETED|Overall Study||0
2995126|NCT00929838|3711755|FG000|STARTED|Overall Study||63
2995127|NCT00929838|3711756|FG001|STARTED|Overall Study||65
2995128|NCT00929838|3711757|FG002|STARTED|Overall Study||63
2995129|NCT00929838|3711758|FG003|STARTED|Overall Study||64
2995130|NCT00929838|3711755|FG000|COMPLETED|Overall Study||53
2995131|NCT00929838|3711756|FG001|COMPLETED|Overall Study||56
2995132|NCT00929838|3711757|FG002|COMPLETED|Overall Study||53
2995133|NCT00929838|3711758|FG003|COMPLETED|Overall Study||55
2995134|NCT00929838|3711755|FG000|NOT COMPLETED|Overall Study||10
2995135|NCT00929838|3711756|FG001|NOT COMPLETED|Overall Study||9
2995136|NCT00929838|3711757|FG002|NOT COMPLETED|Overall Study||10
2995137|NCT00929838|3711758|FG003|NOT COMPLETED|Overall Study||9
2995138|NCT00929864|3711770|FG000|STARTED|Overall Study||318
2995139|NCT00929864|3711771|FG001|STARTED|Overall Study||328
2995140|NCT00929864|3711770|FG000|COMPLETED|Overall Study||252
2995141|NCT00929864|3711771|FG001|COMPLETED|Overall Study||245
2995142|NCT00929864|3711770|FG000|NOT COMPLETED|Overall Study||66
2995143|NCT00929864|3711771|FG001|NOT COMPLETED|Overall Study||83
3036896|NCT01145560|3756165|FG001|Completed Treatment|Overall Study|8 patients died during the treatment period without completing the full course of treatment.|85
3036897|NCT01145560|3756166|FG002|Completed Treatment|Overall Study|7 patients died during the treatment period without completing the full course of treatment.|78
3036898|NCT01145560|3756164|FG000|COMPLETED|Overall Study|20 patients died during the study. Death was not a reason for treatment or study discontinuation.|96
3036899|NCT01145560|3756165|FG001|COMPLETED|Overall Study|33 patients died during the study. Death was not a reason for treatment or study discontinuation.|96
3036900|NCT01145560|3756166|FG002|COMPLETED|Overall Study|27 patients died during the study. Death was not a reason for treatment or study discontinuation.|98
3036901|NCT01145560|3756164|FG000|NOT COMPLETED|Overall Study||4
3036902|NCT01145560|3756165|FG001|NOT COMPLETED|Overall Study||4
3036903|NCT01145560|3756166|FG002|NOT COMPLETED|Overall Study||2
3036904|NCT01145625|3756176|FG000|STARTED|Overall Study||161
3036905|NCT01145625|3756177|FG001|STARTED|Overall Study||161
3036906|NCT01145625|3756176|FG000|COMPLETED|Overall Study||137
3036907|NCT01145625|3756177|FG001|COMPLETED|Overall Study||130
3036908|NCT01145625|3756176|FG000|NOT COMPLETED|Overall Study||24
3036909|NCT01145625|3756177|FG001|NOT COMPLETED|Overall Study||31
3036910|NCT01145638|3756185|FG000|STARTED|Overall Study||231
3036911|NCT01145638|3756186|FG001|STARTED|Overall Study||119
3036912|NCT01145638|3756185|FG000|COMPLETED|Overall Study||141
3036913|NCT01145638|3756186|FG001|COMPLETED|Overall Study||62
3036914|NCT01145638|3756185|FG000|NOT COMPLETED|Overall Study||90
3036915|NCT01145638|3756186|FG001|NOT COMPLETED|Overall Study||57
3036916|NCT01145755|3756195|FG000|STARTED|Overall Study||40
3036917|NCT01145755|3756196|FG001|STARTED|Overall Study||47
3036918|NCT01145755|3756197|FG002|STARTED|Overall Study||44
3036919|NCT01145755|3756195|FG000|COMPLETED|Overall Study||20
3036920|NCT01145755|3756196|FG001|COMPLETED|Overall Study||19
3036921|NCT01145755|3756197|FG002|COMPLETED|Overall Study||19
3036922|NCT01145755|3756195|FG000|NOT COMPLETED|Overall Study||20
3036923|NCT01145755|3756196|FG001|NOT COMPLETED|Overall Study||28
3036924|NCT01145755|3756197|FG002|NOT COMPLETED|Overall Study||25
3036925|NCT01145833|3756207|FG000|STARTED|Overall Study||25
3036926|NCT01145833|3756208|FG001|STARTED|Overall Study||25
3036927|NCT01145833|3756207|FG000|COMPLETED|Overall Study||22
3036928|NCT01145833|3756208|FG001|COMPLETED|Overall Study||25
3036929|NCT01145833|3756207|FG000|NOT COMPLETED|Overall Study||3
3036930|NCT01145833|3756208|FG001|NOT COMPLETED|Overall Study||0
3036931|NCT01145885|3756214|FG000|STARTED|Overall Study||7
3036932|NCT01145885|3756214|FG000|COMPLETED|Overall Study||0
2995144|NCT00929981|3711777|FG000|STARTED|Overall Study||80
2995145|NCT00929981|3711777|FG000|COMPLETED|Overall Study||80
2995146|NCT00929981|3711777|FG000|NOT COMPLETED|Overall Study||0
2995147|NCT00929994|3711781|FG000|STARTED|Overall Study||20
2995148|NCT00929994|3711781|FG000|COMPLETED|Overall Study||14
2995149|NCT00929994|3711781|FG000|NOT COMPLETED|Overall Study||6
2995150|NCT00930046|3711790|FG000|STARTED|Overall Study||8
2995151|NCT00930046|3711791|FG001|STARTED|Overall Study||7
2995152|NCT00930046|3711790|FG000|COMPLETED|Overall Study||7
2995153|NCT00930046|3711791|FG001|COMPLETED|Overall Study||5
2995154|NCT00930046|3711790|FG000|NOT COMPLETED|Overall Study||1
2995155|NCT00930046|3711791|FG001|NOT COMPLETED|Overall Study||2
2995156|NCT00930059|3711799|FG000|STARTED|Overall Study||100
2995157|NCT00930059|3711800|FG001|STARTED|Overall Study||91
2995158|NCT00930059|3711799|FG000|COMPLETED|Overall Study||92
2995159|NCT00930059|3711800|FG001|COMPLETED|Overall Study||79
2995160|NCT00930059|3711799|FG000|NOT COMPLETED|Overall Study||8
2995161|NCT00930059|3711800|FG001|NOT COMPLETED|Overall Study||12
2995162|NCT00930176|3711806|FG000|STARTED|Overall Study||16
2995163|NCT00930176|3711806|FG000|COMPLETED|Overall Study||15
2995164|NCT00930176|3711806|FG000|NOT COMPLETED|Overall Study||1
2995165|NCT00930293|3711812|FG000|STARTED|Overall Study||24
2995166|NCT00930293|3711813|FG001|STARTED|Overall Study||26
2995167|NCT00930293|3711812|FG000|COMPLETED|Overall Study||17
2995168|NCT00930293|3711813|FG001|COMPLETED|Overall Study||19
2995169|NCT00930293|3711812|FG000|NOT COMPLETED|Overall Study||7
2995170|NCT00930293|3711813|FG001|NOT COMPLETED|Overall Study||7
2995171|NCT00930553|3711819|FG000|STARTED|Overall Study||1314
2995172|NCT00930553|3711819|FG000|Participants Entered From CAMMS223|Overall Study||141
2995173|NCT00930553|3711819|FG000|Participants Entered From CAMMS323|Overall Study||488
2995174|NCT00930553|3711819|FG000|Participants Entered From CAMMS324|Overall Study||685
2995175|NCT00930553|3711819|FG000|COMPLETED|Overall Study||1091
2995176|NCT00930553|3711819|FG000|NOT COMPLETED|Overall Study||223
2995177|NCT00930644|3711841|FG000|STARTED|Overall Study||88
2995178|NCT00930644|3711841|FG000|COMPLETED|Overall Study||65
2995179|NCT00930644|3711841|FG000|NOT COMPLETED|Overall Study||23
2995180|NCT00930761|3711850|FG000|STARTED|Overall Study||50
2995181|NCT00930761|3711851|FG001|STARTED|Overall Study||51
2995182|NCT00930761|3711850|FG000|COMPLETED|Overall Study||46
2995183|NCT00930761|3711851|FG001|COMPLETED|Overall Study||48
2995184|NCT00930761|3711850|FG000|NOT COMPLETED|Overall Study||4
2995185|NCT00930761|3711851|FG001|NOT COMPLETED|Overall Study||3
2995186|NCT00930774|3711861|FG000|STARTED|Overall Study||25
2995187|NCT00930774|3711862|FG001|STARTED|Overall Study||25
2995188|NCT00930774|3711863|FG002|STARTED|Overall Study||24
2995189|NCT00930774|3711864|FG003|STARTED|Overall Study||25
2995190|NCT00930774|3711861|FG000|COMPLETED|Overall Study||24
2995191|NCT00930774|3711862|FG001|COMPLETED|Overall Study||16
2995192|NCT00930774|3711863|FG002|COMPLETED|Overall Study||22
2995193|NCT00930774|3711864|FG003|COMPLETED|Overall Study||25
2995194|NCT00930774|3711861|FG000|NOT COMPLETED|Overall Study||1
2995195|NCT00930774|3711862|FG001|NOT COMPLETED|Overall Study||9
2995196|NCT00930774|3711863|FG002|NOT COMPLETED|Overall Study||2
2995197|NCT00930774|3711864|FG003|NOT COMPLETED|Overall Study||0
2995198|NCT00930813|3711877|FG000|STARTED|Overall Study||49
2995199|NCT00930813|3711878|FG001|STARTED|Overall Study||52
2995200|NCT00930813|3711877|FG000|COMPLETED|Overall Study||41
2995201|NCT00930813|3711878|FG001|COMPLETED|Overall Study||38
2995202|NCT00930813|3711877|FG000|NOT COMPLETED|Overall Study||8
2995203|NCT00930813|3711878|FG001|NOT COMPLETED|Overall Study||14
2995204|NCT00930930|3711888|FG000|STARTED|Overall Study||96
2995205|NCT00930930|3711889|FG001|STARTED|Overall Study||49
2995206|NCT00930930|3711888|FG000|COMPLETED|Overall Study||75
2995207|NCT00930930|3711889|FG001|COMPLETED|Overall Study||40
2995208|NCT00930930|3711888|FG000|NOT COMPLETED|Overall Study||21
2995209|NCT00930930|3711889|FG001|NOT COMPLETED|Overall Study||9
2995210|NCT00930969|3711895|FG000|STARTED|Overall Study||175
2995211|NCT00930969|3711895|FG000|COMPLETED|Overall Study||137
2995212|NCT00930969|3711895|FG000|NOT COMPLETED|Overall Study||38
2995213|NCT00930982|3711901|FG000|STARTED|Overall Study||60
2995214|NCT00930982|3711902|FG001|STARTED|Overall Study||64
2995215|NCT00930982|3711901|FG000|COMPLETED|Overall Study||39
2995216|NCT00930982|3711902|FG001|COMPLETED|Overall Study||35
2995217|NCT00930982|3711901|FG000|NOT COMPLETED|Overall Study||21
2995218|NCT00930982|3711902|FG001|NOT COMPLETED|Overall Study||29
2995219|NCT00931164|3711908|FG000|STARTED|Overall Study||6
2995220|NCT00931164|3711908|FG000|COMPLETED|Overall Study||6
2995221|NCT00931164|3711908|FG000|NOT COMPLETED|Overall Study||0
2995222|NCT00931242|3711914|FG000|STARTED|Overall Study||10
2995223|NCT00931242|3711915|FG001|STARTED|Overall Study||2
2995224|NCT00931242|3711914|FG000|COMPLETED|Overall Study||5
2995225|NCT00931242|3711915|FG001|COMPLETED|Overall Study||0
2995226|NCT00931242|3711914|FG000|NOT COMPLETED|Overall Study||5
2995227|NCT00931242|3711915|FG001|NOT COMPLETED|Overall Study||2
2995228|NCT00931255|3711921|FG000|STARTED|Overall Study||17
2995229|NCT00931255|3711922|FG001|STARTED|Overall Study||15
2995230|NCT00931255|3711921|FG000|COMPLETED|Overall Study||15
2995231|NCT00931255|3711922|FG001|COMPLETED|Overall Study||12
2995232|NCT00931255|3711921|FG000|NOT COMPLETED|Overall Study||2
2995233|NCT00931255|3711922|FG001|NOT COMPLETED|Overall Study||3
2995234|NCT00931268|3711928|FG000|STARTED|Overall Study||10
2995235|NCT00931268|3711928|FG000|COMPLETED|Overall Study||4
2995236|NCT00931268|3711928|FG000|NOT COMPLETED|Overall Study||6
2995237|NCT00931307|3711932|FG000|STARTED|Overall Study||22
2995238|NCT00931307|3711932|FG000|COMPLETED|Overall Study||9
2995239|NCT00931307|3711932|FG000|NOT COMPLETED|Overall Study||13
2995240|NCT00931359|3711938|FG000|STARTED|Overall Study||39
2995241|NCT00931359|3711939|FG001|STARTED|Overall Study||81
2995242|NCT00931359|3711938|FG000|COMPLETED|Overall Study||33
2995243|NCT00931359|3711939|FG001|COMPLETED|Overall Study||68
2995244|NCT00931359|3711938|FG000|NOT COMPLETED|Overall Study||6
2995245|NCT00931359|3711939|FG001|NOT COMPLETED|Overall Study||13
2995246|NCT00931385|3711945|FG000|STARTED|Overall Study||25
2995247|NCT00931385|3711946|FG001|STARTED|Overall Study||23
2995248|NCT00931385|3711947|FG002|STARTED|Overall Study||25
2995249|NCT00931385|3711948|FG003|STARTED|Overall Study||26
2995250|NCT00931385|3711945|FG000|COMPLETED|Overall Study||23
2995251|NCT00931385|3711946|FG001|COMPLETED|Overall Study||21
2995252|NCT00931385|3711947|FG002|COMPLETED|Overall Study||24
2995253|NCT00931385|3711948|FG003|COMPLETED|Overall Study||21
2995254|NCT00931385|3711945|FG000|NOT COMPLETED|Overall Study||2
2995255|NCT00931385|3711946|FG001|NOT COMPLETED|Overall Study||2
2995256|NCT00931385|3711947|FG002|NOT COMPLETED|Overall Study||1
2995257|NCT00931385|3711948|FG003|NOT COMPLETED|Overall Study||5
2995258|NCT00931411|3711964|FG000|STARTED|First Intervention - 42 Days||35
2995259|NCT00931411|3711965|FG001|STARTED|First Intervention - 42 Days||38
2995260|NCT00931411|3711964|FG000|COMPLETED|First Intervention - 42 Days||31
2995261|NCT00931411|3711965|FG001|COMPLETED|First Intervention - 42 Days||35
2995262|NCT00931411|3711964|FG000|NOT COMPLETED|First Intervention - 42 Days||4
2995263|NCT00931411|3711965|FG001|NOT COMPLETED|First Intervention - 42 Days||3
2995264|NCT00931411|3711964|FG000|STARTED|After Crossover - 14 Days (up to Day 56)||31
2995265|NCT00931411|3711965|FG001|STARTED|After Crossover - 14 Days (up to Day 56)||35
2995266|NCT00931411|3711964|FG000|COMPLETED|After Crossover - 14 Days (up to Day 56)||31
3164659|NCT01894477|3892090|FG001|COMPLETED|Overall Study||65
3164660|NCT01894477|3892089|FG000|NOT COMPLETED|Overall Study||0
3164661|NCT01894477|3892090|FG001|NOT COMPLETED|Overall Study||2
3164662|NCT01894503|3892096|FG000|STARTED|Overall Study||5
2995267|NCT00931411|3711965|FG001|COMPLETED|After Crossover - 14 Days (up to Day 56)||34
2995268|NCT00931411|3711964|FG000|NOT COMPLETED|After Crossover - 14 Days (up to Day 56)||0
2995269|NCT00931411|3711965|FG001|NOT COMPLETED|After Crossover - 14 Days (up to Day 56)||1
2995270|NCT00931463|3711977|FG000|STARTED|Overall Study||271
2995271|NCT00931463|3711978|FG001|STARTED|Overall Study||270
2995272|NCT00931463|3711977|FG000|COMPLETED|Overall Study||254
2995273|NCT00931463|3711978|FG001|COMPLETED|Overall Study||265
2995274|NCT00931463|3711977|FG000|NOT COMPLETED|Overall Study||17
2995275|NCT00931463|3711978|FG001|NOT COMPLETED|Overall Study||5
2995276|NCT00931489|3711989|FG000|STARTED|Overall Study||40
2995277|NCT00931489|3711990|FG001|STARTED|Overall Study||40
2995278|NCT00931489|3711991|FG002|STARTED|Overall Study||5
2995279|NCT00931489|3711992|FG003|STARTED|Overall Study||39
2995280|NCT00931489|3711993|FG004|STARTED|Overall Study||7
2995281|NCT00931489|3711989|FG000|COMPLETED|Overall Study||40
2995282|NCT00931489|3711990|FG001|COMPLETED|Overall Study||40
2995283|NCT00931489|3711991|FG002|COMPLETED|Overall Study|3 subjects enrolled in Group 1 (responders) were moved to Group 3 (non-responders)|5
2995284|NCT00931489|3711992|FG003|COMPLETED|Overall Study||39
2995285|NCT00931489|3711993|FG004|COMPLETED|Overall Study||7
2995286|NCT00931489|3711989|FG000|NOT COMPLETED|Overall Study||0
2995287|NCT00931489|3711990|FG001|NOT COMPLETED|Overall Study||0
2995288|NCT00931489|3711991|FG002|NOT COMPLETED|Overall Study||0
2995289|NCT00931489|3711992|FG003|NOT COMPLETED|Overall Study||0
2995290|NCT00931489|3711993|FG004|NOT COMPLETED|Overall Study||0
2995291|NCT00931515|3712006|FG000|STARTED|Overall Study||15
2995292|NCT00931515|3712007|FG001|STARTED|Overall Study||15
2995293|NCT00931515|3712006|FG000|COMPLETED|Overall Study||13
2995294|NCT00931515|3712007|FG001|COMPLETED|Overall Study||10
2995295|NCT00931515|3712006|FG000|NOT COMPLETED|Overall Study||2
2995296|NCT00931515|3712007|FG001|NOT COMPLETED|Overall Study||5
2995297|NCT00931528|3712015|FG000|STARTED|Overall Study||121
2995298|NCT00931528|3712016|FG001|STARTED|Overall Study||121
2995299|NCT00931528|3712015|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|80
2995300|NCT00931528|3712016|FG001|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|61
2995301|NCT00931528|3712015|FG000|NOT COMPLETED|Overall Study||41
2995302|NCT00931528|3712016|FG001|NOT COMPLETED|Overall Study||60
2995303|NCT00931632|3712025|FG000|STARTED|Overall Study|Randomized|229
2995304|NCT00931632|3712026|FG001|STARTED|Overall Study|Randomized|222
2995305|NCT00931632|3712025|FG000|COMPLETED|Overall Study|Completed at 36 weeks Postmenstrual Age (PMA)|208
2995306|NCT00931632|3712026|FG001|COMPLETED|Overall Study|Completed at 36 weeks Postmenstrual Age (PMA)|204
2995307|NCT00931632|3712025|FG000|NOT COMPLETED|Overall Study||21
2995308|NCT00931632|3712026|FG001|NOT COMPLETED|Overall Study||18
2995309|NCT00931710|3712034|FG000|STARTED|Overall Study||241
2995310|NCT00931710|3712035|FG001|STARTED|Overall Study||247
2995311|NCT00931710|3712034|FG000|COMPLETED|Overall Study||207
2995312|NCT00931710|3712035|FG001|COMPLETED|Overall Study||209
2995313|NCT00931710|3712034|FG000|NOT COMPLETED|Overall Study||34
2995314|NCT00931710|3712035|FG001|NOT COMPLETED|Overall Study||38
2995315|NCT00931723|3712043|FG000|STARTED|Overall Study||173
2995316|NCT00931723|3712044|FG001|STARTED|Overall Study||183
2995317|NCT00931723|3712043|FG000|COMPLETED|Overall Study||147
3164663|NCT01894503|3892096|FG000|COMPLETED|Overall Study||5
3305127|NCT02986802|4038795|FG003|STARTED|Overall Study||83060
2995318|NCT00931723|3712044|FG001|COMPLETED|Overall Study||144
2995319|NCT00931723|3712043|FG000|NOT COMPLETED|Overall Study||26
2995320|NCT00931723|3712044|FG001|NOT COMPLETED|Overall Study||39
2995321|NCT00931762|3712050|FG000|STARTED|Overall Study||35
2995322|NCT00931762|3712050|FG000|COMPLETED|Overall Study||0
2995323|NCT00931762|3712050|FG000|NOT COMPLETED|Overall Study||35
2995324|NCT00931801|3712057|FG000|STARTED|Overall Study||14
2995325|NCT00931801|3712058|FG001|STARTED|Overall Study||15
2995326|NCT00931801|3712059|FG002|STARTED|Overall Study||14
2995327|NCT00931801|3712057|FG000|COMPLETED|Overall Study||13
2995328|NCT00931801|3712058|FG001|COMPLETED|Overall Study||14
2995329|NCT00931801|3712059|FG002|COMPLETED|Overall Study||10
2995330|NCT00931801|3712057|FG000|NOT COMPLETED|Overall Study||1
2995331|NCT00931801|3712058|FG001|NOT COMPLETED|Overall Study||1
2995332|NCT00931801|3712059|FG002|NOT COMPLETED|Overall Study||4
2995333|NCT00931879|3712073|FG000|STARTED|Overall Study||22
2995334|NCT00931879|3712074|FG001|STARTED|Overall Study||22
2995335|NCT00931879|3712073|FG000|COMPLETED|Overall Study||19
2995336|NCT00931879|3712074|FG001|COMPLETED|Overall Study||19
2995337|NCT00931879|3712073|FG000|NOT COMPLETED|Overall Study||3
2995338|NCT00931879|3712074|FG001|NOT COMPLETED|Overall Study||3
2995339|NCT00931892|3712083|FG000|STARTED|Completed Gluten Challenge||10
2995340|NCT00931892|3712084|FG001|STARTED|Completed Gluten Challenge||10
2995341|NCT00931892|3712083|FG000|COMPLETED|Completed Gluten Challenge||10
2995342|NCT00931892|3712084|FG001|COMPLETED|Completed Gluten Challenge||10
2995343|NCT00931892|3712083|FG000|NOT COMPLETED|Completed Gluten Challenge||0
2995344|NCT00931892|3712084|FG001|NOT COMPLETED|Completed Gluten Challenge||0
2995345|NCT00931892|3712083|FG000|STARTED|Completed Endoscopies||10
2995346|NCT00931892|3712084|FG001|STARTED|Completed Endoscopies||10
2995347|NCT00931892|3712083|FG000|First Endoscopy|Completed Endoscopies||10
2995348|NCT00931892|3712084|FG001|First Endoscopy|Completed Endoscopies||10
2995349|NCT00931892|3712083|FG000|Second Endoscopy|Completed Endoscopies||10
2995350|NCT00931892|3712084|FG001|Second Endoscopy|Completed Endoscopies||10
2995351|NCT00931892|3712083|FG000|Third Endoscopy|Completed Endoscopies||10
2995352|NCT00931892|3712084|FG001|Third Endoscopy|Completed Endoscopies||9
2995353|NCT00931892|3712083|FG000|COMPLETED|Completed Endoscopies||10
2995354|NCT00931892|3712084|FG001|COMPLETED|Completed Endoscopies||9
2995355|NCT00931892|3712083|FG000|NOT COMPLETED|Completed Endoscopies||0
2995356|NCT00931892|3712084|FG001|NOT COMPLETED|Completed Endoscopies||1
3305128|NCT02986802|4038792|FG000|COMPLETED|Overall Study||1360
3305129|NCT02986802|4038793|FG001|COMPLETED|Overall Study||2839
3305130|NCT02986802|4038794|FG002|COMPLETED|Overall Study||1873
2995357|NCT00931918|3712132|FG000|STARTED|Overall Study||103
2995358|NCT00931918|3712133|FG001|STARTED|Overall Study||103
2995359|NCT00931918|3712132|FG000|Safety Population: Received Study Drug|Overall Study||100
2995360|NCT00931918|3712133|FG001|Safety Population: Received Study Drug|Overall Study||101
2995361|NCT00931918|3712132|FG000|COMPLETED|Overall Study|Completed the maximum of 6 cycles.|86
2995362|NCT00931918|3712133|FG001|COMPLETED|Overall Study|Completed the maximum of 6 cycles.|86
2995363|NCT00931918|3712132|FG000|NOT COMPLETED|Overall Study||17
3305131|NCT02986802|4038795|FG003|COMPLETED|Overall Study||83060
3305132|NCT02986802|4038792|FG000|NOT COMPLETED|Overall Study||0
3305133|NCT02986802|4038793|FG001|NOT COMPLETED|Overall Study||0
3305134|NCT02986802|4038794|FG002|NOT COMPLETED|Overall Study||0
3305135|NCT02986802|4038795|FG003|NOT COMPLETED|Overall Study||0
3305136|NCT02986854|4038808|FG000|STARTED|Overall Study||301
3305137|NCT02986854|4038809|FG001|STARTED|Overall Study||300
3305138|NCT02986854|4038810|FG002|STARTED|Overall Study||100
3305139|NCT02986854|4038808|FG000|COMPLETED|Overall Study||298
3305140|NCT02986854|4038809|FG001|COMPLETED|Overall Study||288
3305141|NCT02986854|4038810|FG002|COMPLETED|Overall Study||97
3305142|NCT02986854|4038808|FG000|NOT COMPLETED|Overall Study||3
3305143|NCT02986854|4038809|FG001|NOT COMPLETED|Overall Study||12
3305144|NCT02986854|4038810|FG002|NOT COMPLETED|Overall Study||3
3305145|NCT02986958|4038822|FG000|STARTED|Overall Study||49
3305146|NCT02986958|4038823|FG001|STARTED|Overall Study||44
3305147|NCT02986958|4038822|FG000|COMPLETED|Overall Study||49
3305148|NCT02986958|4038823|FG001|COMPLETED|Overall Study||44
3305149|NCT02986958|4038822|FG000|NOT COMPLETED|Overall Study||0
3305150|NCT02986958|4038823|FG001|NOT COMPLETED|Overall Study||0
3305151|NCT02987205|4038829|FG000|STARTED|Overall Study||163
3305152|NCT02987205|4038829|FG000|Treated - Bilateral NLF Injection|Overall Study||163
3305153|NCT02987205|4038829|FG000|COMPLETED|Overall Study|Treatment is bilateral, subject lost to Restylane AE was lost to further Revanesse Ultra treatment|159
3305154|NCT02987205|4038829|FG000|NOT COMPLETED|Overall Study||4
3305155|NCT02987231|4038837|FG000|STARTED|Overall Study||30
3305156|NCT02987231|4038838|FG001|STARTED|Overall Study||30
3305157|NCT02987231|4038837|FG000|COMPLETED|Overall Study||30
3305158|NCT02987231|4038838|FG001|COMPLETED|Overall Study||30
3305159|NCT02987231|4038837|FG000|NOT COMPLETED|Overall Study||0
3305160|NCT02987231|4038838|FG001|NOT COMPLETED|Overall Study||0
3305161|NCT02987374|4038844|FG000|STARTED|Overall Study||10
2995364|NCT00931918|3712133|FG001|NOT COMPLETED|Overall Study||17
2995365|NCT00931944|3712139|FG000|STARTED|Overall Study||74
3305162|NCT02987374|4038844|FG000|COMPLETED|Overall Study||10
3305163|NCT02987374|4038844|FG000|NOT COMPLETED|Overall Study||0
3305164|NCT02987543|4038852|FG000|STARTED|Overall Study||162
3305165|NCT02987543|4038853|FG001|STARTED|Overall Study||83
3305166|NCT02987543|4038854|FG002|STARTED|Overall Study||94
2995366|NCT00931944|3712139|FG000|COMPLETED|Overall Study||19
2995367|NCT00931944|3712139|FG000|NOT COMPLETED|Overall Study||55
2995368|NCT00931996|3712143|FG000|STARTED|Overall Study||12
2995369|NCT00931996|3712143|FG000|COMPLETED|Overall Study||5
2995370|NCT00931996|3712143|FG000|NOT COMPLETED|Overall Study||7
3133638|NCT01696643|3858552|FG000|NOT COMPLETED|Overall Study||529
3133639|NCT01696643|3858553|FG001|NOT COMPLETED|Overall Study||535
3133640|NCT01696695|3858559|FG000|STARTED|Overall Study||882
3133641|NCT01696695|3858559|FG000|COMPLETED|Overall Study||0
3133642|NCT01696695|3858559|FG000|NOT COMPLETED|Overall Study||882
3133643|NCT01696760|3858565|FG000|STARTED|Overall Study||9
2995371|NCT00932022|3712149|FG000|STARTED|Overall Study||64
2995372|NCT00932022|3712150|FG001|STARTED|Overall Study||63
2995373|NCT00932022|3712149|FG000|COMPLETED|Overall Study||59
2995374|NCT00932022|3712150|FG001|COMPLETED|Overall Study||59
2995375|NCT00932022|3712149|FG000|NOT COMPLETED|Overall Study||5
2995376|NCT00932022|3712150|FG001|NOT COMPLETED|Overall Study||4
2995377|NCT00932035|3712158|FG000|STARTED|Overall Study||18
2995378|NCT00932035|3712159|FG001|STARTED|Overall Study||21
2995379|NCT00932035|3712158|FG000|COMPLETED|Overall Study||18
2995380|NCT00932035|3712159|FG001|COMPLETED|Overall Study||21
2995381|NCT00932035|3712158|FG000|NOT COMPLETED|Overall Study||0
2995382|NCT00932035|3712159|FG001|NOT COMPLETED|Overall Study||0
2995383|NCT00932113|3712167|FG000|STARTED|Overall Study||15
2995384|NCT00932113|3712168|FG001|STARTED|Overall Study||15
2995385|NCT00932113|3712167|FG000|COMPLETED|Overall Study||14
2995386|NCT00932113|3712168|FG001|COMPLETED|Overall Study||15
2995387|NCT00932113|3712167|FG000|NOT COMPLETED|Overall Study||1
2995388|NCT00932113|3712168|FG001|NOT COMPLETED|Overall Study||0
2995389|NCT00932126|3712174|FG000|STARTED|Overall Study||3
2995390|NCT00932126|3712175|FG001|STARTED|Overall Study||3
2995391|NCT00932126|3712176|FG002|STARTED|Overall Study||3
2995392|NCT00932126|3712177|FG003|STARTED|Overall Study||3
2995393|NCT00932126|3712178|FG004|STARTED|Overall Study||5
2995394|NCT00932126|3712179|FG005|STARTED|Overall Study||3
2995395|NCT00932126|3712180|FG006|STARTED|Overall Study||5
2995396|NCT00932126|3712181|FG007|STARTED|Overall Study||10
2995397|NCT00932126|3712174|FG000|COMPLETED|Overall Study||0
2995398|NCT00932126|3712175|FG001|COMPLETED|Overall Study||0
2995399|NCT00932126|3712176|FG002|COMPLETED|Overall Study||0
2995400|NCT00932126|3712177|FG003|COMPLETED|Overall Study||0
2995401|NCT00932126|3712178|FG004|COMPLETED|Overall Study||0
2995402|NCT00932126|3712179|FG005|COMPLETED|Overall Study||0
2995403|NCT00932126|3712180|FG006|COMPLETED|Overall Study||0
2995404|NCT00932126|3712181|FG007|COMPLETED|Overall Study||0
2995405|NCT00932126|3712174|FG000|NOT COMPLETED|Overall Study||3
2995406|NCT00932126|3712175|FG001|NOT COMPLETED|Overall Study||3
2995407|NCT00932126|3712176|FG002|NOT COMPLETED|Overall Study||3
2995408|NCT00932126|3712177|FG003|NOT COMPLETED|Overall Study||3
2995409|NCT00932126|3712178|FG004|NOT COMPLETED|Overall Study||5
2995410|NCT00932126|3712179|FG005|NOT COMPLETED|Overall Study||3
2995411|NCT00932126|3712180|FG006|NOT COMPLETED|Overall Study||5
2995412|NCT00932126|3712181|FG007|NOT COMPLETED|Overall Study||10
2995413|NCT00932165|3712201|FG000|STARTED|Overall Study||451
2995414|NCT00932165|3712201|FG000|COMPLETED|Overall Study||450
2995415|NCT00932165|3712201|FG000|NOT COMPLETED|Overall Study||1
2995416|NCT00932282|3712208|FG000|STARTED|Pre-OIT Anti-IgE Therapy Phase||7
2995417|NCT00932282|3712209|FG001|STARTED|Pre-OIT Anti-IgE Therapy Phase||6
2995418|NCT00932282|3712208|FG000|COMPLETED|Pre-OIT Anti-IgE Therapy Phase||6
2995419|NCT00932282|3712209|FG001|COMPLETED|Pre-OIT Anti-IgE Therapy Phase||5
2995420|NCT00932282|3712208|FG000|NOT COMPLETED|Pre-OIT Anti-IgE Therapy Phase||1
2995421|NCT00932282|3712209|FG001|NOT COMPLETED|Pre-OIT Anti-IgE Therapy Phase||1
2995422|NCT00932282|3712208|FG000|STARTED|Modified OIT Rush Desensitization Phase||6
2995423|NCT00932282|3712209|FG001|STARTED|Modified OIT Rush Desensitization Phase||5
2995424|NCT00932282|3712208|FG000|COMPLETED|Modified OIT Rush Desensitization Phase||6
2995425|NCT00932282|3712209|FG001|COMPLETED|Modified OIT Rush Desensitization Phase||5
2995426|NCT00932282|3712208|FG000|NOT COMPLETED|Modified OIT Rush Desensitization Phase||0
2995427|NCT00932282|3712209|FG001|NOT COMPLETED|Modified OIT Rush Desensitization Phase||0
2995428|NCT00932282|3712208|FG000|STARTED|Biweekly OIT Buildup Phase||6
2995429|NCT00932282|3712209|FG001|STARTED|Biweekly OIT Buildup Phase||5
2995430|NCT00932282|3712208|FG000|COMPLETED|Biweekly OIT Buildup Phase||5
2995431|NCT00932282|3712209|FG001|COMPLETED|Biweekly OIT Buildup Phase||4
2995432|NCT00932282|3712208|FG000|NOT COMPLETED|Biweekly OIT Buildup Phase||1
2995433|NCT00932282|3712209|FG001|NOT COMPLETED|Biweekly OIT Buildup Phase||1
2995434|NCT00932282|3712208|FG000|STARTED|OIT Maintenance Phase||5
2995435|NCT00932282|3712209|FG001|STARTED|OIT Maintenance Phase||4
2995436|NCT00932282|3712208|FG000|COMPLETED|OIT Maintenance Phase||4
2995437|NCT00932282|3712209|FG001|COMPLETED|OIT Maintenance Phase||2
2995438|NCT00932282|3712208|FG000|NOT COMPLETED|OIT Maintenance Phase||1
2995439|NCT00932282|3712209|FG001|NOT COMPLETED|OIT Maintenance Phase||2
2995440|NCT00932321|3712217|FG000|STARTED|Overall Study||751
2995441|NCT00932321|3712218|FG001|STARTED|Overall Study||187
2995442|NCT00932321|3712217|FG000|MITT Population|Overall Study||705
2995443|NCT00932321|3712218|FG001|MITT Population|Overall Study||181
2995444|NCT00932321|3712217|FG000|COMPLETED|Overall Study||580
2995445|NCT00932321|3712218|FG001|COMPLETED|Overall Study||141
3133644|NCT01696760|3858566|FG001|STARTED|Overall Study||3
3133645|NCT01696760|3858565|FG000|COMPLETED|Overall Study||9
3133646|NCT01696760|3858566|FG001|COMPLETED|Overall Study||3
2995446|NCT00932321|3712217|FG000|NOT COMPLETED|Overall Study||171
2995447|NCT00932321|3712218|FG001|NOT COMPLETED|Overall Study||46
2995448|NCT00932360|3712224|FG000|STARTED|1: Visit 1/Week1||10
2995449|NCT00932360|3712225|FG001|STARTED|1: Visit 1/Week1||6
2995450|NCT00932360|3712226|FG002|STARTED|1: Visit 1/Week1||3
2995451|NCT00932360|3712227|FG003|STARTED|1: Visit 1/Week1||13
2995452|NCT00932360|3712228|FG004|STARTED|1: Visit 1/Week1||4
2995453|NCT00932360|3712229|FG005|STARTED|1: Visit 1/Week1||7
2995454|NCT00932360|3712224|FG000|COMPLETED|1: Visit 1/Week1||10
2995455|NCT00932360|3712225|FG001|COMPLETED|1: Visit 1/Week1||6
2995456|NCT00932360|3712226|FG002|COMPLETED|1: Visit 1/Week1||3
2995457|NCT00932360|3712227|FG003|COMPLETED|1: Visit 1/Week1||13
2995458|NCT00932360|3712228|FG004|COMPLETED|1: Visit 1/Week1||4
2995459|NCT00932360|3712229|FG005|COMPLETED|1: Visit 1/Week1||7
2995460|NCT00932360|3712224|FG000|NOT COMPLETED|1: Visit 1/Week1||0
2995461|NCT00932360|3712225|FG001|NOT COMPLETED|1: Visit 1/Week1||0
2995462|NCT00932360|3712226|FG002|NOT COMPLETED|1: Visit 1/Week1||0
2995463|NCT00932360|3712227|FG003|NOT COMPLETED|1: Visit 1/Week1||0
2995464|NCT00932360|3712228|FG004|NOT COMPLETED|1: Visit 1/Week1||0
2995465|NCT00932360|3712229|FG005|NOT COMPLETED|1: Visit 1/Week1||0
2995466|NCT00932360|3712224|FG000|STARTED|Washout (One Week)||10
2995467|NCT00932360|3712225|FG001|STARTED|Washout (One Week)||6
2995468|NCT00932360|3712226|FG002|STARTED|Washout (One Week)||3
2995469|NCT00932360|3712227|FG003|STARTED|Washout (One Week)||13
2995470|NCT00932360|3712228|FG004|STARTED|Washout (One Week)||4
2995471|NCT00932360|3712229|FG005|STARTED|Washout (One Week)||7
2995472|NCT00932360|3712224|FG000|COMPLETED|Washout (One Week)||10
2995473|NCT00932360|3712225|FG001|COMPLETED|Washout (One Week)||6
2995474|NCT00932360|3712226|FG002|COMPLETED|Washout (One Week)||3
2995475|NCT00932360|3712227|FG003|COMPLETED|Washout (One Week)||13
2995476|NCT00932360|3712228|FG004|COMPLETED|Washout (One Week)||2
2995477|NCT00932360|3712229|FG005|COMPLETED|Washout (One Week)||7
2995478|NCT00932360|3712224|FG000|NOT COMPLETED|Washout (One Week)||0
2995479|NCT00932360|3712225|FG001|NOT COMPLETED|Washout (One Week)||0
2995480|NCT00932360|3712226|FG002|NOT COMPLETED|Washout (One Week)||0
2995481|NCT00932360|3712227|FG003|NOT COMPLETED|Washout (One Week)||0
2995482|NCT00932360|3712228|FG004|NOT COMPLETED|Washout (One Week)||2
2995483|NCT00932360|3712229|FG005|NOT COMPLETED|Washout (One Week)||0
2995484|NCT00932360|3712224|FG000|STARTED|Visit 2/Week 2||10
2995485|NCT00932360|3712225|FG001|STARTED|Visit 2/Week 2||6
2995486|NCT00932360|3712226|FG002|STARTED|Visit 2/Week 2||3
2995487|NCT00932360|3712227|FG003|STARTED|Visit 2/Week 2||13
2995488|NCT00932360|3712228|FG004|STARTED|Visit 2/Week 2||2
2995489|NCT00932360|3712229|FG005|STARTED|Visit 2/Week 2||7
2995490|NCT00932360|3712224|FG000|COMPLETED|Visit 2/Week 2||10
2995491|NCT00932360|3712225|FG001|COMPLETED|Visit 2/Week 2||6
2995492|NCT00932360|3712226|FG002|COMPLETED|Visit 2/Week 2||3
2995493|NCT00932360|3712227|FG003|COMPLETED|Visit 2/Week 2||13
2995494|NCT00932360|3712228|FG004|COMPLETED|Visit 2/Week 2||2
2995495|NCT00932360|3712229|FG005|COMPLETED|Visit 2/Week 2||7
2995496|NCT00932360|3712224|FG000|NOT COMPLETED|Visit 2/Week 2||0
2995497|NCT00932360|3712225|FG001|NOT COMPLETED|Visit 2/Week 2||0
2995498|NCT00932360|3712226|FG002|NOT COMPLETED|Visit 2/Week 2||0
2995499|NCT00932360|3712227|FG003|NOT COMPLETED|Visit 2/Week 2||0
2995500|NCT00932360|3712228|FG004|NOT COMPLETED|Visit 2/Week 2||0
2995501|NCT00932360|3712229|FG005|NOT COMPLETED|Visit 2/Week 2||0
2995502|NCT00932360|3712224|FG000|STARTED|Washout (One Week)||10
2995503|NCT00932360|3712225|FG001|STARTED|Washout (One Week)||6
2995504|NCT00932360|3712226|FG002|STARTED|Washout (One Week)||3
2995505|NCT00932360|3712227|FG003|STARTED|Washout (One Week)||13
2995506|NCT00932360|3712228|FG004|STARTED|Washout (One Week)||2
2995507|NCT00932360|3712229|FG005|STARTED|Washout (One Week)||7
2995508|NCT00932360|3712224|FG000|COMPLETED|Washout (One Week)||10
2995509|NCT00932360|3712225|FG001|COMPLETED|Washout (One Week)||6
2995510|NCT00932360|3712226|FG002|COMPLETED|Washout (One Week)||3
2995511|NCT00932360|3712227|FG003|COMPLETED|Washout (One Week)||13
2995512|NCT00932360|3712228|FG004|COMPLETED|Washout (One Week)||2
2995513|NCT00932360|3712229|FG005|COMPLETED|Washout (One Week)||7
2995514|NCT00932360|3712224|FG000|NOT COMPLETED|Washout (One Week)||0
2995515|NCT00932360|3712225|FG001|NOT COMPLETED|Washout (One Week)||0
2995516|NCT00932360|3712226|FG002|NOT COMPLETED|Washout (One Week)||0
2995517|NCT00932360|3712227|FG003|NOT COMPLETED|Washout (One Week)||0
2995518|NCT00932360|3712228|FG004|NOT COMPLETED|Washout (One Week)||0
2995519|NCT00932360|3712229|FG005|NOT COMPLETED|Washout (One Week)||0
2995520|NCT00932360|3712224|FG000|STARTED|Visit 3/Week 3||10
2995521|NCT00932360|3712225|FG001|STARTED|Visit 3/Week 3||6
2995522|NCT00932360|3712226|FG002|STARTED|Visit 3/Week 3||3
2995523|NCT00932360|3712227|FG003|STARTED|Visit 3/Week 3||13
2995524|NCT00932360|3712228|FG004|STARTED|Visit 3/Week 3||2
2995525|NCT00932360|3712229|FG005|STARTED|Visit 3/Week 3||7
2995526|NCT00932360|3712224|FG000|COMPLETED|Visit 3/Week 3||10
2995527|NCT00932360|3712225|FG001|COMPLETED|Visit 3/Week 3||6
2995528|NCT00932360|3712226|FG002|COMPLETED|Visit 3/Week 3||3
2995529|NCT00932360|3712227|FG003|COMPLETED|Visit 3/Week 3||13
2995530|NCT00932360|3712228|FG004|COMPLETED|Visit 3/Week 3||2
2995531|NCT00932360|3712229|FG005|COMPLETED|Visit 3/Week 3||7
2995532|NCT00932360|3712224|FG000|NOT COMPLETED|Visit 3/Week 3||0
2995533|NCT00932360|3712225|FG001|NOT COMPLETED|Visit 3/Week 3||0
2995534|NCT00932360|3712226|FG002|NOT COMPLETED|Visit 3/Week 3||0
2995535|NCT00932360|3712227|FG003|NOT COMPLETED|Visit 3/Week 3||0
2995536|NCT00932360|3712228|FG004|NOT COMPLETED|Visit 3/Week 3||0
2995537|NCT00932360|3712229|FG005|NOT COMPLETED|Visit 3/Week 3||0
2995538|NCT00932373|3712254|FG000|STARTED|Overall Study||3
2995539|NCT00932373|3712255|FG001|STARTED|Overall Study||1
2995540|NCT00932373|3712256|FG002|STARTED|Overall Study||1
2995541|NCT00932373|3712257|FG003|STARTED|Overall Study||1
2995542|NCT00932373|3712258|FG004|STARTED|Overall Study||15
2995543|NCT00932373|3712259|FG005|STARTED|Overall Study||3
2995544|NCT00932373|3712260|FG006|STARTED|Overall Study||3
2995545|NCT00932373|3712261|FG007|STARTED|Overall Study||3
2995546|NCT00932373|3712262|FG008|STARTED|Overall Study||3
2995547|NCT00932373|3712263|FG009|STARTED|Overall Study||16
2995548|NCT00932373|3712264|FG010|STARTED|Overall Study||3
2995549|NCT00932373|3712254|FG000|COMPLETED|Overall Study||0
2995550|NCT00932373|3712255|FG001|COMPLETED|Overall Study||0
2995551|NCT00932373|3712256|FG002|COMPLETED|Overall Study||0
2995552|NCT00932373|3712257|FG003|COMPLETED|Overall Study||1
2995553|NCT00932373|3712258|FG004|COMPLETED|Overall Study||1
2995554|NCT00932373|3712259|FG005|COMPLETED|Overall Study||0
2995555|NCT00932373|3712260|FG006|COMPLETED|Overall Study||2
2995556|NCT00932373|3712261|FG007|COMPLETED|Overall Study||0
2995557|NCT00932373|3712262|FG008|COMPLETED|Overall Study||1
2995558|NCT00932373|3712263|FG009|COMPLETED|Overall Study||3
2995559|NCT00932373|3712264|FG010|COMPLETED|Overall Study||0
2995560|NCT00932373|3712254|FG000|NOT COMPLETED|Overall Study||3
2995561|NCT00932373|3712255|FG001|NOT COMPLETED|Overall Study||1
2995562|NCT00932373|3712256|FG002|NOT COMPLETED|Overall Study||1
2995563|NCT00932373|3712257|FG003|NOT COMPLETED|Overall Study||0
2995564|NCT00932373|3712258|FG004|NOT COMPLETED|Overall Study||14
2995565|NCT00932373|3712259|FG005|NOT COMPLETED|Overall Study||3
2995566|NCT00932373|3712260|FG006|NOT COMPLETED|Overall Study||1
2995567|NCT00932373|3712261|FG007|NOT COMPLETED|Overall Study||3
2995568|NCT00932373|3712262|FG008|NOT COMPLETED|Overall Study||2
2995569|NCT00932373|3712263|FG009|NOT COMPLETED|Overall Study||13
2995570|NCT00932373|3712264|FG010|NOT COMPLETED|Overall Study||3
2995571|NCT00932399|3712298|FG000|STARTED|Overall Study||759
2995572|NCT00932399|3712299|FG001|STARTED|Overall Study||3790
2995573|NCT00932399|3712298|FG000|COMPLETED|Overall Study||759
2995574|NCT00932399|3712299|FG001|COMPLETED|Overall Study||3790
2995575|NCT00932399|3712298|FG000|NOT COMPLETED|Overall Study||0
2995576|NCT00932399|3712299|FG001|NOT COMPLETED|Overall Study||0
2995577|NCT00932425|3712307|FG000|STARTED|Overall Study||20
2995578|NCT00932425|3712308|FG001|STARTED|Overall Study||20
2995579|NCT00932425|3712307|FG000|COMPLETED|Overall Study||20
2995580|NCT00932425|3712308|FG001|COMPLETED|Overall Study||18
2995581|NCT00932425|3712307|FG000|NOT COMPLETED|Overall Study||0
2995582|NCT00932425|3712308|FG001|NOT COMPLETED|Overall Study||2
2995583|NCT00932438|3712316|FG000|STARTED|Overall Study||40
2995584|NCT00932438|3712317|FG001|STARTED|Overall Study||30
2995585|NCT00932438|3712316|FG000|COMPLETED|Overall Study||39
2995586|NCT00932438|3712317|FG001|COMPLETED|Overall Study||30
2995587|NCT00932438|3712316|FG000|NOT COMPLETED|Overall Study||1
2995588|NCT00932438|3712317|FG001|NOT COMPLETED|Overall Study||0
2995589|NCT00932451|3712325|FG000|STARTED|Overall Study||1066
2995590|NCT00932451|3712325|FG000|COMPLETED|Overall Study||244
2995591|NCT00932451|3712325|FG000|NOT COMPLETED|Overall Study||822
2995592|NCT00932477|3712333|FG000|STARTED|Treatment 1||7
2995593|NCT00932477|3712334|FG001|STARTED|Treatment 1||8
2995594|NCT00932477|3712335|FG002|STARTED|Treatment 1||9
2995595|NCT00932477|3712336|FG003|STARTED|Treatment 1||7
2995596|NCT00932477|3712337|FG004|STARTED|Treatment 1||8
2995597|NCT00932477|3712338|FG005|STARTED|Treatment 1||8
2995598|NCT00932477|3712333|FG000|COMPLETED|Treatment 1||7
2995599|NCT00932477|3712334|FG001|COMPLETED|Treatment 1||8
2995600|NCT00932477|3712335|FG002|COMPLETED|Treatment 1||9
2995601|NCT00932477|3712336|FG003|COMPLETED|Treatment 1||7
2995602|NCT00932477|3712337|FG004|COMPLETED|Treatment 1||8
2995603|NCT00932477|3712338|FG005|COMPLETED|Treatment 1||8
2995604|NCT00932477|3712333|FG000|NOT COMPLETED|Treatment 1||0
2995605|NCT00932477|3712334|FG001|NOT COMPLETED|Treatment 1||0
2995606|NCT00932477|3712335|FG002|NOT COMPLETED|Treatment 1||0
2995607|NCT00932477|3712336|FG003|NOT COMPLETED|Treatment 1||0
2995608|NCT00932477|3712337|FG004|NOT COMPLETED|Treatment 1||0
2995609|NCT00932477|3712338|FG005|NOT COMPLETED|Treatment 1||0
2995610|NCT00932477|3712333|FG000|STARTED|Treatment 2||7
2995611|NCT00932477|3712334|FG001|STARTED|Treatment 2||8
2995612|NCT00932477|3712335|FG002|STARTED|Treatment 2||9
2995613|NCT00932477|3712336|FG003|STARTED|Treatment 2||7
2995614|NCT00932477|3712337|FG004|STARTED|Treatment 2||8
2995615|NCT00932477|3712338|FG005|STARTED|Treatment 2||8
2995616|NCT00932477|3712333|FG000|COMPLETED|Treatment 2||7
2995617|NCT00932477|3712334|FG001|COMPLETED|Treatment 2||8
2995618|NCT00932477|3712335|FG002|COMPLETED|Treatment 2||9
2995619|NCT00932477|3712336|FG003|COMPLETED|Treatment 2||7
2995620|NCT00932477|3712337|FG004|COMPLETED|Treatment 2||8
2995621|NCT00932477|3712338|FG005|COMPLETED|Treatment 2||8
2995622|NCT00932477|3712333|FG000|NOT COMPLETED|Treatment 2||0
2995623|NCT00932477|3712334|FG001|NOT COMPLETED|Treatment 2||0
2995624|NCT00932477|3712335|FG002|NOT COMPLETED|Treatment 2||0
2995625|NCT00932477|3712336|FG003|NOT COMPLETED|Treatment 2||0
2995626|NCT00932477|3712337|FG004|NOT COMPLETED|Treatment 2||0
2995627|NCT00932477|3712338|FG005|NOT COMPLETED|Treatment 2||0
2995628|NCT00932477|3712333|FG000|STARTED|Treatment 3||7
2995629|NCT00932477|3712334|FG001|STARTED|Treatment 3||8
2995630|NCT00932477|3712335|FG002|STARTED|Treatment 3||9
2995631|NCT00932477|3712336|FG003|STARTED|Treatment 3||7
2995632|NCT00932477|3712337|FG004|STARTED|Treatment 3||8
2995633|NCT00932477|3712338|FG005|STARTED|Treatment 3||8
2995634|NCT00932477|3712333|FG000|COMPLETED|Treatment 3||7
2995635|NCT00932477|3712334|FG001|COMPLETED|Treatment 3||8
2995636|NCT00932477|3712335|FG002|COMPLETED|Treatment 3||9
2995637|NCT00932477|3712336|FG003|COMPLETED|Treatment 3||7
2995638|NCT00932477|3712337|FG004|COMPLETED|Treatment 3||8
2995639|NCT00932477|3712338|FG005|COMPLETED|Treatment 3||8
2995640|NCT00932477|3712333|FG000|NOT COMPLETED|Treatment 3||0
2995641|NCT00932477|3712334|FG001|NOT COMPLETED|Treatment 3||0
2995642|NCT00932477|3712335|FG002|NOT COMPLETED|Treatment 3||0
2995643|NCT00932477|3712336|FG003|NOT COMPLETED|Treatment 3||0
2995644|NCT00932477|3712337|FG004|NOT COMPLETED|Treatment 3||0
2995645|NCT00932477|3712338|FG005|NOT COMPLETED|Treatment 3||0
2995646|NCT00932620|3712348|FG000|STARTED|Overall Study||50
2995647|NCT00932620|3712349|FG001|STARTED|Overall Study||50
2995648|NCT00932620|3712348|FG000|COMPLETED|Overall Study||50
2995649|NCT00932620|3712349|FG001|COMPLETED|Overall Study||50
2995650|NCT00932620|3712348|FG000|NOT COMPLETED|Overall Study||0
2995651|NCT00932620|3712349|FG001|NOT COMPLETED|Overall Study||0
2995652|NCT00932646|3712357|FG000|STARTED|Overall Study||25
2995653|NCT00932646|3712358|FG001|STARTED|Overall Study||25
2995654|NCT00932646|3712359|FG002|STARTED|Overall Study||25
2995655|NCT00932646|3712360|FG003|STARTED|Overall Study||25
2995656|NCT00932646|3712357|FG000|COMPLETED|Overall Study||20
2995657|NCT00932646|3712358|FG001|COMPLETED|Overall Study||22
2995658|NCT00932646|3712359|FG002|COMPLETED|Overall Study||21
2995659|NCT00932646|3712360|FG003|COMPLETED|Overall Study||24
2995660|NCT00932646|3712357|FG000|NOT COMPLETED|Overall Study||5
2995661|NCT00932646|3712358|FG001|NOT COMPLETED|Overall Study||3
2995662|NCT00932646|3712359|FG002|NOT COMPLETED|Overall Study||4
2995663|NCT00932646|3712360|FG003|NOT COMPLETED|Overall Study||1
2995664|NCT00932659|3712374|FG000|STARTED|Overall Study||8
2995665|NCT00932659|3712374|FG000|COMPLETED|Overall Study||8
2995666|NCT00932659|3712374|FG000|NOT COMPLETED|Overall Study||0
2995667|NCT00932698|3712389|FG000|STARTED|Part 1 (Dose Escalation)||3
2995668|NCT00932698|3712390|FG001|STARTED|Part 1 (Dose Escalation)||3
2995669|NCT00932698|3712391|FG002|STARTED|Part 1 (Dose Escalation)||3
2995670|NCT00932698|3712392|FG003|STARTED|Part 1 (Dose Escalation)||3
2995671|NCT00932698|3712393|FG004|STARTED|Part 1 (Dose Escalation)||3
2995672|NCT00932698|3712394|FG005|STARTED|Part 1 (Dose Escalation)||7
2995673|NCT00932698|3712395|FG006|STARTED|Part 1 (Dose Escalation)||4
2995674|NCT00932698|3712396|FG007|STARTED|Part 1 (Dose Escalation)||0
2995675|NCT00932698|3712397|FG008|STARTED|Part 1 (Dose Escalation)||0
2995676|NCT00932698|3712398|FG009|STARTED|Part 1 (Dose Escalation)||0
2995677|NCT00932698|3712399|FG010|STARTED|Part 1 (Dose Escalation)||0
2995678|NCT00932698|3712389|FG000|COMPLETED|Part 1 (Dose Escalation)||0
2995679|NCT00932698|3712390|FG001|COMPLETED|Part 1 (Dose Escalation)||0
2995680|NCT00932698|3712391|FG002|COMPLETED|Part 1 (Dose Escalation)||0
2995681|NCT00932698|3712392|FG003|COMPLETED|Part 1 (Dose Escalation)||0
2995682|NCT00932698|3712393|FG004|COMPLETED|Part 1 (Dose Escalation)||0
2995683|NCT00932698|3712394|FG005|COMPLETED|Part 1 (Dose Escalation)|6 participants from 2.0 mg/m^2 dose cohort transitioned to dose expansion cohort: 5 in RR, 1 in VR.|0
2995684|NCT00932698|3712395|FG006|COMPLETED|Part 1 (Dose Escalation)||0
2995685|NCT00932698|3712396|FG007|COMPLETED|Part 1 (Dose Escalation)||0
2995686|NCT00932698|3712397|FG008|COMPLETED|Part 1 (Dose Escalation)||0
2995687|NCT00932698|3712398|FG009|COMPLETED|Part 1 (Dose Escalation)||0
2995688|NCT00932698|3712399|FG010|COMPLETED|Part 1 (Dose Escalation)||0
2995689|NCT00932698|3712389|FG000|NOT COMPLETED|Part 1 (Dose Escalation)||3
2995690|NCT00932698|3712390|FG001|NOT COMPLETED|Part 1 (Dose Escalation)||3
2995691|NCT00932698|3712391|FG002|NOT COMPLETED|Part 1 (Dose Escalation)||3
2995692|NCT00932698|3712392|FG003|NOT COMPLETED|Part 1 (Dose Escalation)||3
2995693|NCT00932698|3712393|FG004|NOT COMPLETED|Part 1 (Dose Escalation)||3
2995694|NCT00932698|3712394|FG005|NOT COMPLETED|Part 1 (Dose Escalation)||7
2995695|NCT00932698|3712395|FG006|NOT COMPLETED|Part 1 (Dose Escalation)||4
2995696|NCT00932698|3712396|FG007|NOT COMPLETED|Part 1 (Dose Escalation)||0
2995697|NCT00932698|3712397|FG008|NOT COMPLETED|Part 1 (Dose Escalation)||0
2995698|NCT00932698|3712398|FG009|NOT COMPLETED|Part 1 (Dose Escalation)||0
2995699|NCT00932698|3712399|FG010|NOT COMPLETED|Part 1 (Dose Escalation)||0
2995700|NCT00932698|3712389|FG000|STARTED|Part 2 (Dose Expansion)||0
2995701|NCT00932698|3712390|FG001|STARTED|Part 2 (Dose Expansion)||0
2995702|NCT00932698|3712391|FG002|STARTED|Part 2 (Dose Expansion)||0
2995703|NCT00932698|3712392|FG003|STARTED|Part 2 (Dose Expansion)||0
2995704|NCT00932698|3712393|FG004|STARTED|Part 2 (Dose Expansion)||0
2995705|NCT00932698|3712394|FG005|STARTED|Part 2 (Dose Expansion)||0
2995706|NCT00932698|3712395|FG006|STARTED|Part 2 (Dose Expansion)||0
2995707|NCT00932698|3712396|FG007|STARTED|Part 2 (Dose Expansion)||20
2995708|NCT00932698|3712397|FG008|STARTED|Part 2 (Dose Expansion)||12
2995709|NCT00932698|3712398|FG009|STARTED|Part 2 (Dose Expansion)||6
2995710|NCT00932698|3712399|FG010|STARTED|Part 2 (Dose Expansion)||2
2995711|NCT00932698|3712389|FG000|COMPLETED|Part 2 (Dose Expansion)||0
2995712|NCT00932698|3712390|FG001|COMPLETED|Part 2 (Dose Expansion)||0
2995713|NCT00932698|3712391|FG002|COMPLETED|Part 2 (Dose Expansion)||0
2995714|NCT00932698|3712392|FG003|COMPLETED|Part 2 (Dose Expansion)||0
2995715|NCT00932698|3712393|FG004|COMPLETED|Part 2 (Dose Expansion)||0
2995716|NCT00932698|3712394|FG005|COMPLETED|Part 2 (Dose Expansion)||0
2995717|NCT00932698|3712395|FG006|COMPLETED|Part 2 (Dose Expansion)||0
2995718|NCT00932698|3712396|FG007|COMPLETED|Part 2 (Dose Expansion)||0
2995719|NCT00932698|3712397|FG008|COMPLETED|Part 2 (Dose Expansion)||0
2995720|NCT00932698|3712398|FG009|COMPLETED|Part 2 (Dose Expansion)||0
2995721|NCT00932698|3712399|FG010|COMPLETED|Part 2 (Dose Expansion)||0
2995722|NCT00932698|3712389|FG000|NOT COMPLETED|Part 2 (Dose Expansion)||0
2995723|NCT00932698|3712390|FG001|NOT COMPLETED|Part 2 (Dose Expansion)||0
2995724|NCT00932698|3712391|FG002|NOT COMPLETED|Part 2 (Dose Expansion)||0
2995725|NCT00932698|3712392|FG003|NOT COMPLETED|Part 2 (Dose Expansion)||0
3164664|NCT01894503|3892096|FG000|NOT COMPLETED|Overall Study||0
3164665|NCT01894516|3892105|FG000|STARTED|Period 1 (Baseline up to Week 12)||72
3305167|NCT02987543|4038855|FG003|STARTED|Overall Study||48
2995726|NCT00932698|3712393|FG004|NOT COMPLETED|Part 2 (Dose Expansion)||0
2995727|NCT00932698|3712394|FG005|NOT COMPLETED|Part 2 (Dose Expansion)||0
2995728|NCT00932698|3712395|FG006|NOT COMPLETED|Part 2 (Dose Expansion)||0
2995729|NCT00932698|3712396|FG007|NOT COMPLETED|Part 2 (Dose Expansion)||20
2995730|NCT00932698|3712397|FG008|NOT COMPLETED|Part 2 (Dose Expansion)||12
2995731|NCT00932698|3712398|FG009|NOT COMPLETED|Part 2 (Dose Expansion)||6
2995732|NCT00932698|3712399|FG010|NOT COMPLETED|Part 2 (Dose Expansion)||2
2995733|NCT00932828|3712425|FG000|STARTED|Overall Study||37
2995734|NCT00932828|3712425|FG000|COMPLETED|Overall Study|5 subjects who did not complete the protocol were considered in an ITT analysis.|32
2995735|NCT00932828|3712425|FG000|NOT COMPLETED|Overall Study||5
2995736|NCT00932893|3712431|FG000|STARTED|Overall Study||173
2995737|NCT00932893|3712432|FG001|STARTED|Overall Study||174
2995738|NCT00932893|3712431|FG000|Treated|Overall Study||172
2995739|NCT00932893|3712432|FG001|Treated|Overall Study||171
2995740|NCT00932893|3712431|FG000|COMPLETED|Overall Study||40
2995741|NCT00932893|3712432|FG001|COMPLETED|Overall Study||4
2995742|NCT00932893|3712431|FG000|NOT COMPLETED|Overall Study||133
2995743|NCT00932893|3712432|FG001|NOT COMPLETED|Overall Study||170
2995744|NCT00933166|3712439|FG000|STARTED|Overall Study||169
2995745|NCT00933166|3712439|FG000|COMPLETED|Overall Study||151
2995746|NCT00933166|3712439|FG000|NOT COMPLETED|Overall Study||18
2995747|NCT00933244|3712446|FG000|STARTED|Overall Study||79
2995748|NCT00933244|3712447|FG001|STARTED|Overall Study||75
2995749|NCT00933244|3712448|FG002|STARTED|Overall Study||76
2995750|NCT00933244|3712446|FG000|COMPLETED|Overall Study||74
2995751|NCT00933244|3712447|FG001|COMPLETED|Overall Study||74
2995752|NCT00933244|3712448|FG002|COMPLETED|Overall Study||73
2995753|NCT00933244|3712446|FG000|NOT COMPLETED|Overall Study||5
2995754|NCT00933244|3712447|FG001|NOT COMPLETED|Overall Study||1
2995755|NCT00933244|3712448|FG002|NOT COMPLETED|Overall Study||3
2995756|NCT00933270|3712456|FG000|STARTED|Overall Study|ITT population|264
2995757|NCT00933270|3712456|FG000|COMPLETED|Overall Study||177
2995758|NCT00933270|3712456|FG000|NOT COMPLETED|Overall Study||87
2995759|NCT00933335|3712463|FG000|STARTED|Overall Study||2
2995760|NCT00933335|3712464|FG001|STARTED|Overall Study|35/36 participants who received 3 cycles of fludarabine later received a DD and TD of TST/I 131 TST.|36
2995761|NCT00933335|3712463|FG000|COMPLETED|Overall Study||0
2995762|NCT00933335|3712464|FG001|COMPLETED|Overall Study||20
2995763|NCT00933335|3712463|FG000|NOT COMPLETED|Overall Study||2
2995764|NCT00933335|3712464|FG001|NOT COMPLETED|Overall Study||16
2995765|NCT00933491|3712478|FG000|STARTED|Overall Study||14
2995766|NCT00933491|3712479|FG001|STARTED|Overall Study||18
2995767|NCT00933491|3712478|FG000|COMPLETED|Overall Study||14
3305168|NCT02987543|4038852|FG000|COMPLETED|Overall Study||0
3305169|NCT02987543|4038853|FG001|COMPLETED|Overall Study||0
3305170|NCT02987543|4038854|FG002|COMPLETED|Overall Study||0
3305171|NCT02987543|4038855|FG003|COMPLETED|Overall Study||0
3305172|NCT02987543|4038852|FG000|NOT COMPLETED|Overall Study||162
2995768|NCT00933491|3712479|FG001|COMPLETED|Overall Study||18
2995769|NCT00933491|3712478|FG000|NOT COMPLETED|Overall Study||0
2995770|NCT00933491|3712479|FG001|NOT COMPLETED|Overall Study||0
2995771|NCT00933543|3712487|FG000|STARTED|Overall Study||54
2995772|NCT00933543|3712488|FG001|STARTED|Overall Study||53
2995773|NCT00933543|3712487|FG000|COMPLETED|Overall Study||51
2995774|NCT00933543|3712488|FG001|COMPLETED|Overall Study||46
2995775|NCT00933543|3712487|FG000|NOT COMPLETED|Overall Study||3
2995776|NCT00933543|3712488|FG001|NOT COMPLETED|Overall Study||7
2995777|NCT00933608|3712496|FG000|STARTED|Overall Study||7
2995778|NCT00933608|3712497|FG001|STARTED|Overall Study||10
2995779|NCT00933608|3712496|FG000|COMPLETED|Overall Study||2
2995780|NCT00933608|3712497|FG001|COMPLETED|Overall Study||8
2995781|NCT00933608|3712496|FG000|NOT COMPLETED|Overall Study||5
2995782|NCT00933608|3712497|FG001|NOT COMPLETED|Overall Study||2
2995783|NCT00933686|3712505|FG000|STARTED|Overall Study||55
2995784|NCT00933686|3712506|FG001|STARTED|Overall Study||58
2995785|NCT00933686|3712505|FG000|COMPLETED|Overall Study||45
2995786|NCT00933686|3712506|FG001|COMPLETED|Overall Study||47
2995787|NCT00933686|3712505|FG000|NOT COMPLETED|Overall Study||10
2995788|NCT00933686|3712506|FG001|NOT COMPLETED|Overall Study||11
2995789|NCT00933933|3712517|FG000|STARTED|General Population From 16 to 89 Years||6164
2995790|NCT00933933|3712518|FG001|STARTED|General Population From 16 to 89 Years||1287
2995791|NCT00933933|3712519|FG002|STARTED|General Population From 16 to 89 Years||1206
2995792|NCT00933933|3712517|FG000|COMPLETED|General Population From 16 to 89 Years||6164
2995793|NCT00933933|3712518|FG001|COMPLETED|General Population From 16 to 89 Years||1267
3305173|NCT02987543|4038853|FG001|NOT COMPLETED|Overall Study||83
3305174|NCT02987543|4038854|FG002|NOT COMPLETED|Overall Study||94
3305175|NCT02987543|4038855|FG003|NOT COMPLETED|Overall Study||48
3305176|NCT02987621|4038861|FG000|STARTED|Overall Study||7
3305177|NCT02987621|4038862|FG001|STARTED|Overall Study||7
2995794|NCT00933933|3712519|FG002|COMPLETED|General Population From 16 to 89 Years||1206
2995795|NCT00933933|3712517|FG000|NOT COMPLETED|General Population From 16 to 89 Years||0
2995796|NCT00933933|3712518|FG001|NOT COMPLETED|General Population From 16 to 89 Years||20
2995797|NCT00933933|3712519|FG002|NOT COMPLETED|General Population From 16 to 89 Years||0
2995798|NCT00933933|3712517|FG000|STARTED|Pregnant Females Between 16-44 Years||448
2995799|NCT00933933|3712518|FG001|STARTED|Pregnant Females Between 16-44 Years||67
2995800|NCT00933933|3712519|FG002|STARTED|Pregnant Females Between 16-44 Years||203
2995801|NCT00933933|3712517|FG000|COMPLETED|Pregnant Females Between 16-44 Years||448
2995802|NCT00933933|3712518|FG001|COMPLETED|Pregnant Females Between 16-44 Years||65
2995803|NCT00933933|3712519|FG002|COMPLETED|Pregnant Females Between 16-44 Years||203
2995804|NCT00933933|3712517|FG000|NOT COMPLETED|Pregnant Females Between 16-44 Years||0
2995805|NCT00933933|3712518|FG001|NOT COMPLETED|Pregnant Females Between 16-44 Years||2
2995806|NCT00933933|3712519|FG002|NOT COMPLETED|Pregnant Females Between 16-44 Years||0
2995807|NCT00933933|3712517|FG000|STARTED|Pediatric From 2 to 21 Years||588
2995808|NCT00933933|3712518|FG001|STARTED|Pediatric From 2 to 21 Years||64
2995809|NCT00933933|3712519|FG002|STARTED|Pediatric From 2 to 21 Years|Specimens from individuals 16-21 years included reactivity for general population or pregnant women.|0
2995810|NCT00933933|3712517|FG000|COMPLETED|Pediatric From 2 to 21 Years||588
2995811|NCT00933933|3712518|FG001|COMPLETED|Pediatric From 2 to 21 Years||64
2995812|NCT00933933|3712519|FG002|COMPLETED|Pediatric From 2 to 21 Years|Specimens from individuals 16-21 years included reactivity for general population or pregnant women|0
2995813|NCT00933933|3712517|FG000|NOT COMPLETED|Pediatric From 2 to 21 Years||0
2995814|NCT00933933|3712518|FG001|NOT COMPLETED|Pediatric From 2 to 21 Years||0
2995815|NCT00933933|3712519|FG002|NOT COMPLETED|Pediatric From 2 to 21 Years||0
2995816|NCT00934024|3712537|FG000|STARTED|Overall Study||10
2995817|NCT00934024|3712538|FG001|STARTED|Overall Study||11
2995818|NCT00934024|3712537|FG000|COMPLETED|Overall Study||10
2995819|NCT00934024|3712538|FG001|COMPLETED|Overall Study||6
2995820|NCT00934024|3712537|FG000|NOT COMPLETED|Overall Study||0
2995821|NCT00934024|3712538|FG001|NOT COMPLETED|Overall Study||5
2995822|NCT00934050|3712549|FG000|STARTED|Enrolled Prior to 15 Dec 2009||12
2995823|NCT00934050|3712550|FG001|STARTED|Enrolled Prior to 15 Dec 2009||12
2995824|NCT00934050|3712551|FG002|STARTED|Enrolled Prior to 15 Dec 2009||12
2995825|NCT00934050|3712552|FG003|STARTED|Enrolled Prior to 15 Dec 2009||14
2995826|NCT00934050|3712553|FG004|STARTED|Enrolled Prior to 15 Dec 2009||0
2995827|NCT00934050|3712554|FG005|STARTED|Enrolled Prior to 15 Dec 2009||0
2995828|NCT00934050|3712549|FG000|COMPLETED|Enrolled Prior to 15 Dec 2009||0
2995829|NCT00934050|3712550|FG001|COMPLETED|Enrolled Prior to 15 Dec 2009||0
2995830|NCT00934050|3712551|FG002|COMPLETED|Enrolled Prior to 15 Dec 2009||0
2995831|NCT00934050|3712552|FG003|COMPLETED|Enrolled Prior to 15 Dec 2009||0
2995832|NCT00934050|3712553|FG004|COMPLETED|Enrolled Prior to 15 Dec 2009||0
2995833|NCT00934050|3712554|FG005|COMPLETED|Enrolled Prior to 15 Dec 2009||0
2995834|NCT00934050|3712549|FG000|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||12
2995835|NCT00934050|3712550|FG001|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||12
2995836|NCT00934050|3712551|FG002|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||12
2995837|NCT00934050|3712552|FG003|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||14
2995838|NCT00934050|3712553|FG004|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||0
2995839|NCT00934050|3712554|FG005|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||0
2995840|NCT00934050|3712549|FG000|STARTED|Enrolled After 15 Dec 2009||0
2995841|NCT00934050|3712550|FG001|STARTED|Enrolled After 15 Dec 2009||0
2995842|NCT00934050|3712551|FG002|STARTED|Enrolled After 15 Dec 2009||0
2995843|NCT00934050|3712552|FG003|STARTED|Enrolled After 15 Dec 2009||0
2995844|NCT00934050|3712553|FG004|STARTED|Enrolled After 15 Dec 2009||26
2995845|NCT00934050|3712554|FG005|STARTED|Enrolled After 15 Dec 2009||27
2995846|NCT00934050|3712549|FG000|COMPLETED|Enrolled After 15 Dec 2009||0
2995847|NCT00934050|3712550|FG001|COMPLETED|Enrolled After 15 Dec 2009||0
2995848|NCT00934050|3712551|FG002|COMPLETED|Enrolled After 15 Dec 2009||0
2995849|NCT00934050|3712552|FG003|COMPLETED|Enrolled After 15 Dec 2009||0
2995850|NCT00934050|3712553|FG004|COMPLETED|Enrolled After 15 Dec 2009||19
2995851|NCT00934050|3712554|FG005|COMPLETED|Enrolled After 15 Dec 2009||23
2995852|NCT00934050|3712549|FG000|NOT COMPLETED|Enrolled After 15 Dec 2009||0
2995853|NCT00934050|3712550|FG001|NOT COMPLETED|Enrolled After 15 Dec 2009||0
2995854|NCT00934050|3712551|FG002|NOT COMPLETED|Enrolled After 15 Dec 2009||0
2995855|NCT00934050|3712552|FG003|NOT COMPLETED|Enrolled After 15 Dec 2009||0
2995856|NCT00934050|3712553|FG004|NOT COMPLETED|Enrolled After 15 Dec 2009||7
2995857|NCT00934050|3712554|FG005|NOT COMPLETED|Enrolled After 15 Dec 2009||4
2995858|NCT00934089|3712566|FG000|STARTED|First Intervention Period (14 Days)||15
2995859|NCT00934089|3712567|FG001|STARTED|First Intervention Period (14 Days)||16
2995860|NCT00934089|3712566|FG000|Treated|First Intervention Period (14 Days)||14
2995861|NCT00934089|3712567|FG001|Treated|First Intervention Period (14 Days)||16
2995862|NCT00934089|3712566|FG000|COMPLETED|First Intervention Period (14 Days)||13
2995863|NCT00934089|3712567|FG001|COMPLETED|First Intervention Period (14 Days)||16
2995864|NCT00934089|3712566|FG000|NOT COMPLETED|First Intervention Period (14 Days)||2
2995865|NCT00934089|3712567|FG001|NOT COMPLETED|First Intervention Period (14 Days)||0
2995866|NCT00934089|3712566|FG000|STARTED|Washout Period (28 Days)||13
2995867|NCT00934089|3712567|FG001|STARTED|Washout Period (28 Days)||16
2995868|NCT00934089|3712566|FG000|COMPLETED|Washout Period (28 Days)||13
3305178|NCT02987621|4038861|FG000|COMPLETED|Overall Study||7
3305179|NCT02987621|4038862|FG001|COMPLETED|Overall Study||7
2995869|NCT00934089|3712567|FG001|COMPLETED|Washout Period (28 Days)||16
2995870|NCT00934089|3712566|FG000|NOT COMPLETED|Washout Period (28 Days)||0
2995871|NCT00934089|3712567|FG001|NOT COMPLETED|Washout Period (28 Days)||0
2995872|NCT00934089|3712566|FG000|STARTED|Second Intervention Period (14 Days)||13
2995873|NCT00934089|3712567|FG001|STARTED|Second Intervention Period (14 Days)||16
2995874|NCT00934089|3712566|FG000|COMPLETED|Second Intervention Period (14 Days)||13
2995875|NCT00934089|3712567|FG001|COMPLETED|Second Intervention Period (14 Days)||16
2995876|NCT00934089|3712566|FG000|NOT COMPLETED|Second Intervention Period (14 Days)||0
2995877|NCT00934089|3712567|FG001|NOT COMPLETED|Second Intervention Period (14 Days)||0
2995878|NCT00934102|3712573|FG000|STARTED|Period 1, One Night of Wear||16
2995879|NCT00934102|3712574|FG001|STARTED|Period 1, One Night of Wear||15
2995880|NCT00934102|3712575|FG002|STARTED|Period 1, One Night of Wear||15
2995881|NCT00934102|3712573|FG000|COMPLETED|Period 1, One Night of Wear||15
2995882|NCT00934102|3712574|FG001|COMPLETED|Period 1, One Night of Wear||15
2995883|NCT00934102|3712575|FG002|COMPLETED|Period 1, One Night of Wear||15
2995884|NCT00934102|3712573|FG000|NOT COMPLETED|Period 1, One Night of Wear||1
2995885|NCT00934102|3712574|FG001|NOT COMPLETED|Period 1, One Night of Wear||0
2995886|NCT00934102|3712575|FG002|NOT COMPLETED|Period 1, One Night of Wear||0
2995887|NCT00934102|3712573|FG000|STARTED|Period 2, 7 Days/6 Nights of Wear||15
2995888|NCT00934102|3712574|FG001|STARTED|Period 2, 7 Days/6 Nights of Wear||15
2995889|NCT00934102|3712575|FG002|STARTED|Period 2, 7 Days/6 Nights of Wear||15
2995890|NCT00934102|3712573|FG000|COMPLETED|Period 2, 7 Days/6 Nights of Wear||15
2995891|NCT00934102|3712574|FG001|COMPLETED|Period 2, 7 Days/6 Nights of Wear||15
2995892|NCT00934102|3712575|FG002|COMPLETED|Period 2, 7 Days/6 Nights of Wear||15
2995893|NCT00934102|3712573|FG000|NOT COMPLETED|Period 2, 7 Days/6 Nights of Wear||0
2995894|NCT00934102|3712574|FG001|NOT COMPLETED|Period 2, 7 Days/6 Nights of Wear||0
2995895|NCT00934102|3712575|FG002|NOT COMPLETED|Period 2, 7 Days/6 Nights of Wear||0
2995896|NCT00934128|3712585|FG000|STARTED|First Intervention (2 Hours)||15
2995897|NCT00934128|3712586|FG001|STARTED|First Intervention (2 Hours)||15
2995898|NCT00934128|3712585|FG000|COMPLETED|First Intervention (2 Hours)||10
2995899|NCT00934128|3712586|FG001|COMPLETED|First Intervention (2 Hours)||13
2995900|NCT00934128|3712585|FG000|NOT COMPLETED|First Intervention (2 Hours)||5
2995901|NCT00934128|3712586|FG001|NOT COMPLETED|First Intervention (2 Hours)||2
2995902|NCT00934128|3712585|FG000|STARTED|Washout Period (1 Hour)||10
2995903|NCT00934128|3712586|FG001|STARTED|Washout Period (1 Hour)||13
2995904|NCT00934128|3712585|FG000|COMPLETED|Washout Period (1 Hour)||3
2995905|NCT00934128|3712586|FG001|COMPLETED|Washout Period (1 Hour)||8
2995906|NCT00934128|3712585|FG000|NOT COMPLETED|Washout Period (1 Hour)||7
2995907|NCT00934128|3712586|FG001|NOT COMPLETED|Washout Period (1 Hour)||5
2995908|NCT00934128|3712585|FG000|STARTED|Second Intervention (2 Hours)||3
2995909|NCT00934128|3712586|FG001|STARTED|Second Intervention (2 Hours)||8
2995910|NCT00934128|3712585|FG000|COMPLETED|Second Intervention (2 Hours)||3
2995911|NCT00934128|3712586|FG001|COMPLETED|Second Intervention (2 Hours)||5
2995912|NCT00934128|3712585|FG000|NOT COMPLETED|Second Intervention (2 Hours)||0
2995913|NCT00934128|3712586|FG001|NOT COMPLETED|Second Intervention (2 Hours)||3
2995914|NCT00934141|3712596|FG000|STARTED|Overall Study||49
2995915|NCT00934141|3712597|FG001|STARTED|Overall Study||50
2995916|NCT00934141|3712598|FG002|STARTED|Overall Study||48
2995917|NCT00934141|3712599|FG003|STARTED|Overall Study||54
2995918|NCT00934141|3712596|FG000|COMPLETED|Overall Study||45
2995919|NCT00934141|3712597|FG001|COMPLETED|Overall Study||47
2995920|NCT00934141|3712598|FG002|COMPLETED|Overall Study||48
2995921|NCT00934141|3712599|FG003|COMPLETED|Overall Study||51
2995922|NCT00934141|3712596|FG000|NOT COMPLETED|Overall Study||4
2995923|NCT00934141|3712597|FG001|NOT COMPLETED|Overall Study||3
2995924|NCT00934141|3712598|FG002|NOT COMPLETED|Overall Study||0
2995925|NCT00934141|3712599|FG003|NOT COMPLETED|Overall Study||3
2995926|NCT00934362|3712613|FG000|STARTED|Overall Study||8
2995927|NCT00934362|3712614|FG001|STARTED|Overall Study||8
2995928|NCT00934362|3712613|FG000|COMPLETED|Overall Study||7
2995929|NCT00934362|3712614|FG001|COMPLETED|Overall Study||8
2995930|NCT00934362|3712613|FG000|NOT COMPLETED|Overall Study||1
2995931|NCT00934362|3712614|FG001|NOT COMPLETED|Overall Study||0
2995932|NCT00934375|3712622|FG000|STARTED|Overall Study||68
2995933|NCT00934375|3712623|FG001|STARTED|Overall Study||77
2995934|NCT00934375|3712622|FG000|COMPLETED|Overall Study||55
2995935|NCT00934375|3712623|FG001|COMPLETED|Overall Study||55
2995936|NCT00934375|3712622|FG000|NOT COMPLETED|Overall Study||13
2995937|NCT00934375|3712623|FG001|NOT COMPLETED|Overall Study||22
2995938|NCT00934440|3712629|FG000|STARTED|Overall Study||11
2995939|NCT00934440|3712629|FG000|COMPLETED|Overall Study||10
3164666|NCT01894516|3892106|FG001|STARTED|Period 1 (Baseline up to Week 12)||72
3164667|NCT01894516|3892107|FG002|STARTED|Period 1 (Baseline up to Week 12)||70
3164668|NCT01894516|3892108|FG003|STARTED|Period 1 (Baseline up to Week 12)||69
3164669|NCT01894516|3892105|FG000|COMPLETED|Period 1 (Baseline up to Week 12)||65
2995940|NCT00934440|3712629|FG000|NOT COMPLETED|Overall Study||1
2995941|NCT00934544|3712636|FG000|STARTED|Primary Endpoint Analysis (Interim)||146
2995942|NCT00934544|3712637|FG001|STARTED|Primary Endpoint Analysis (Interim)||73
2995943|NCT00934544|3712638|FG002|STARTED|Primary Endpoint Analysis (Interim)||0
2995944|NCT00934544|3712636|FG000|COMPLETED|Primary Endpoint Analysis (Interim)||91
2995945|NCT00934544|3712637|FG001|COMPLETED|Primary Endpoint Analysis (Interim)||31
2995946|NCT00934544|3712638|FG002|COMPLETED|Primary Endpoint Analysis (Interim)||0
2995947|NCT00934544|3712636|FG000|NOT COMPLETED|Primary Endpoint Analysis (Interim)||55
2995948|NCT00934544|3712637|FG001|NOT COMPLETED|Primary Endpoint Analysis (Interim)||42
2995949|NCT00934544|3712638|FG002|NOT COMPLETED|Primary Endpoint Analysis (Interim)||0
2995950|NCT00934544|3712636|FG000|STARTED|Overall Disposition at 5 Year Follow-up||146
2995951|NCT00934544|3712637|FG001|STARTED|Overall Disposition at 5 Year Follow-up||28
2995952|NCT00934544|3712638|FG002|STARTED|Overall Disposition at 5 Year Follow-up||45
2995953|NCT00934544|3712636|FG000|Crossed Over After Qualifying Event|Overall Disposition at 5 Year Follow-up||0
2995954|NCT00934544|3712637|FG001|Crossed Over After Qualifying Event|Overall Disposition at 5 Year Follow-up||0
2995955|NCT00934544|3712638|FG002|Crossed Over After Qualifying Event|Overall Disposition at 5 Year Follow-up||27
2995956|NCT00934544|3712636|FG000|Crossed Over After AMEND 5|Overall Disposition at 5 Year Follow-up||0
2995957|NCT00934544|3712637|FG001|Crossed Over After AMEND 5|Overall Disposition at 5 Year Follow-up||0
2995958|NCT00934544|3712638|FG002|Crossed Over After AMEND 5|Overall Disposition at 5 Year Follow-up||12
2995959|NCT00934544|3712636|FG000|Crossed Over: Other|Overall Disposition at 5 Year Follow-up||0
2995960|NCT00934544|3712637|FG001|Crossed Over: Other|Overall Disposition at 5 Year Follow-up||0
2995961|NCT00934544|3712638|FG002|Crossed Over: Other|Overall Disposition at 5 Year Follow-up||6
2995962|NCT00934544|3712636|FG000|COMPLETED|Overall Disposition at 5 Year Follow-up||39
2995963|NCT00934544|3712637|FG001|COMPLETED|Overall Disposition at 5 Year Follow-up||0
2995964|NCT00934544|3712638|FG002|COMPLETED|Overall Disposition at 5 Year Follow-up||11
2995965|NCT00934544|3712636|FG000|NOT COMPLETED|Overall Disposition at 5 Year Follow-up||107
2995966|NCT00934544|3712637|FG001|NOT COMPLETED|Overall Disposition at 5 Year Follow-up||28
2995967|NCT00934544|3712638|FG002|NOT COMPLETED|Overall Disposition at 5 Year Follow-up||34
2995968|NCT00934596|3712657|FG000|STARTED|Overall Study|Twenty patients were prospectively randomly assigned to the two arms|10
2995969|NCT00934596|3712658|FG001|STARTED|Overall Study||10
2995970|NCT00934596|3712657|FG000|COMPLETED|Overall Study||10
2995971|NCT00934596|3712658|FG001|COMPLETED|Overall Study||10
2995972|NCT00934596|3712657|FG000|NOT COMPLETED|Overall Study||0
2995973|NCT00934596|3712658|FG001|NOT COMPLETED|Overall Study||0
2995974|NCT00934622|3712668|FG000|STARTED|Overall Study||76
2995975|NCT00934622|3712668|FG000|COMPLETED|Overall Study||68
2995976|NCT00934622|3712668|FG000|NOT COMPLETED|Overall Study||8
2995977|NCT00934635|3712681|FG000|STARTED|Overall Study||0
2995978|NCT00934635|3712682|FG001|STARTED|Overall Study||1
2995979|NCT00934635|3712683|FG002|STARTED|Overall Study||0
2995980|NCT00934635|3712684|FG003|STARTED|Overall Study||0
2995981|NCT00934635|3712685|FG004|STARTED|Overall Study||0
2995982|NCT00934635|3712686|FG005|STARTED|Overall Study||0
2995983|NCT00934635|3712687|FG006|STARTED|Overall Study||0
2995984|NCT00934635|3712688|FG007|STARTED|Overall Study||0
2995985|NCT00934635|3712689|FG008|STARTED|Overall Study||1
2995986|NCT00934635|3712681|FG000|COMPLETED|Overall Study||0
2995987|NCT00934635|3712682|FG001|COMPLETED|Overall Study||1
2995988|NCT00934635|3712683|FG002|COMPLETED|Overall Study||0
2995989|NCT00934635|3712684|FG003|COMPLETED|Overall Study||0
2995990|NCT00934635|3712685|FG004|COMPLETED|Overall Study||0
2995991|NCT00934635|3712686|FG005|COMPLETED|Overall Study||0
2995992|NCT00934635|3712687|FG006|COMPLETED|Overall Study||0
2995993|NCT00934635|3712688|FG007|COMPLETED|Overall Study||0
2995994|NCT00934635|3712689|FG008|COMPLETED|Overall Study||1
2995995|NCT00934635|3712681|FG000|NOT COMPLETED|Overall Study||0
2995996|NCT00934635|3712682|FG001|NOT COMPLETED|Overall Study||0
2995997|NCT00934635|3712683|FG002|NOT COMPLETED|Overall Study||0
2995998|NCT00934635|3712684|FG003|NOT COMPLETED|Overall Study||0
2995999|NCT00934635|3712685|FG004|NOT COMPLETED|Overall Study||0
2996000|NCT00934635|3712686|FG005|NOT COMPLETED|Overall Study||0
2996001|NCT00934635|3712687|FG006|NOT COMPLETED|Overall Study||0
2996002|NCT00934635|3712688|FG007|NOT COMPLETED|Overall Study||0
2996003|NCT00934635|3712689|FG008|NOT COMPLETED|Overall Study||0
2996004|NCT00934648|3712709|FG000|STARTED|Overall Study||15
2996005|NCT00934648|3712709|FG000|COMPLETED|Overall Study||6
2996006|NCT00934648|3712709|FG000|NOT COMPLETED|Overall Study||9
2996007|NCT00934661|3712715|FG000|STARTED|Overall Study||20
2996008|NCT00934661|3712716|FG001|STARTED|Overall Study||20
2996009|NCT00934661|3712715|FG000|COMPLETED|Overall Study||19
2996010|NCT00934661|3712716|FG001|COMPLETED|Overall Study||20
2996011|NCT00934661|3712715|FG000|NOT COMPLETED|Overall Study||1
2996012|NCT00934661|3712716|FG001|NOT COMPLETED|Overall Study||0
2996013|NCT00934843|3712724|FG000|STARTED|Overall Study||37
2996014|NCT00934843|3712725|FG001|STARTED|Overall Study||40
2996015|NCT00934843|3712724|FG000|COMPLETED|Overall Study||37
2996016|NCT00934843|3712725|FG001|COMPLETED|Overall Study|1 subject discontinued intervention, surgery plan changed and did not require CPB|39
2996017|NCT00934843|3712724|FG000|NOT COMPLETED|Overall Study||0
2996018|NCT00934843|3712725|FG001|NOT COMPLETED|Overall Study||1
2996019|NCT00934856|3712737|FG000|STARTED|Feasibility Part||6
2996020|NCT00934856|3712738|FG001|STARTED|Feasibility Part||6
2996021|NCT00934856|3712739|FG002|STARTED|Feasibility Part||3
3305180|NCT02987621|4038861|FG000|NOT COMPLETED|Overall Study||0
3305181|NCT02987621|4038862|FG001|NOT COMPLETED|Overall Study||0
3305182|NCT02987660|4038872|FG000|STARTED|Overall Study||10
3305183|NCT02987660|4038873|FG001|STARTED|Overall Study||10
3305184|NCT02987660|4038872|FG000|COMPLETED|Overall Study||0
3305185|NCT02987660|4038873|FG001|COMPLETED|Overall Study||0
3305186|NCT02987660|4038872|FG000|NOT COMPLETED|Overall Study||10
3305187|NCT02987660|4038873|FG001|NOT COMPLETED|Overall Study||10
3305188|NCT02987829|4038885|FG000|STARTED|Overall Study||1
3305189|NCT02987829|4038886|FG001|STARTED|Overall Study||1
2996022|NCT00934856|3712740|FG003|STARTED|Feasibility Part||6
2996023|NCT00934856|3712741|FG004|STARTED|Feasibility Part||12
2996024|NCT00934856|3712742|FG005|STARTED|Feasibility Part||9
2996025|NCT00934856|3712737|FG000|COMPLETED|Feasibility Part||1
2996026|NCT00934856|3712738|FG001|COMPLETED|Feasibility Part||1
2996027|NCT00934856|3712739|FG002|COMPLETED|Feasibility Part||0
2996028|NCT00934856|3712740|FG003|COMPLETED|Feasibility Part||1
2996029|NCT00934856|3712741|FG004|COMPLETED|Feasibility Part||12
2996030|NCT00934856|3712742|FG005|COMPLETED|Feasibility Part||6
2996031|NCT00934856|3712737|FG000|NOT COMPLETED|Feasibility Part||5
2996032|NCT00934856|3712738|FG001|NOT COMPLETED|Feasibility Part||5
2996033|NCT00934856|3712739|FG002|NOT COMPLETED|Feasibility Part||3
2996034|NCT00934856|3712740|FG003|NOT COMPLETED|Feasibility Part||5
2996035|NCT00934856|3712741|FG004|NOT COMPLETED|Feasibility Part||0
2996036|NCT00934856|3712742|FG005|NOT COMPLETED|Feasibility Part||3
2996037|NCT00934856|3712737|FG000|STARTED|Extension Part||0
2996038|NCT00934856|3712738|FG001|STARTED|Extension Part||0
2996039|NCT00934856|3712739|FG002|STARTED|Extension Part||0
2996040|NCT00934856|3712740|FG003|STARTED|Extension Part|New participants were enrolled in the extension part.|4
2996041|NCT00934856|3712741|FG004|STARTED|Extension Part|New participants were enrolled in the extension part.|28
2996042|NCT00934856|3712742|FG005|STARTED|Extension Part|New participants were enrolled in the extension part.|24
2996043|NCT00934856|3712737|FG000|COMPLETED|Extension Part||0
2996044|NCT00934856|3712738|FG001|COMPLETED|Extension Part||0
2996045|NCT00934856|3712739|FG002|COMPLETED|Extension Part||0
2996046|NCT00934856|3712740|FG003|COMPLETED|Extension Part||2
2996047|NCT00934856|3712741|FG004|COMPLETED|Extension Part||24
2996048|NCT00934856|3712742|FG005|COMPLETED|Extension Part||19
2996049|NCT00934856|3712737|FG000|NOT COMPLETED|Extension Part||0
2996050|NCT00934856|3712738|FG001|NOT COMPLETED|Extension Part||0
2996051|NCT00934856|3712739|FG002|NOT COMPLETED|Extension Part||0
2996052|NCT00934856|3712740|FG003|NOT COMPLETED|Extension Part||2
2996053|NCT00934856|3712741|FG004|NOT COMPLETED|Extension Part||4
2996054|NCT00934856|3712742|FG005|NOT COMPLETED|Extension Part||5
2996055|NCT00934934|3712776|FG000|STARTED|Overall Study||30
2996056|NCT00934934|3712777|FG001|STARTED|Overall Study||31
2996057|NCT00934934|3712776|FG000|COMPLETED|Overall Study||29
2996058|NCT00934934|3712777|FG001|COMPLETED|Overall Study||31
2996059|NCT00934934|3712776|FG000|NOT COMPLETED|Overall Study||1
2996060|NCT00934934|3712777|FG001|NOT COMPLETED|Overall Study||0
2996061|NCT00934947|3712788|FG000|STARTED|Overall Study||23
2996062|NCT00934947|3712789|FG001|STARTED|Overall Study||22
2996063|NCT00934947|3712788|FG000|COMPLETED|Overall Study||23
2996064|NCT00934947|3712789|FG001|COMPLETED|Overall Study||20
2996065|NCT00934947|3712788|FG000|NOT COMPLETED|Overall Study||0
2996066|NCT00934947|3712789|FG001|NOT COMPLETED|Overall Study||2
2996067|NCT00935012|3712797|FG000|STARTED|Overall Study||31
2996068|NCT00935012|3712797|FG000|COMPLETED|Overall Study||2
2996069|NCT00935012|3712797|FG000|NOT COMPLETED|Overall Study||29
2996070|NCT00935064|3712803|FG000|STARTED|Overall Study||30
2996071|NCT00935064|3712804|FG001|STARTED|Overall Study||30
2996072|NCT00935064|3712803|FG000|COMPLETED|Overall Study||30
2996073|NCT00935064|3712804|FG001|COMPLETED|Overall Study||30
2996074|NCT00935064|3712803|FG000|NOT COMPLETED|Overall Study||0
2996075|NCT00935064|3712804|FG001|NOT COMPLETED|Overall Study||0
2996076|NCT00935220|3712810|FG000|STARTED|Overall Study||41
2996077|NCT00935220|3712810|FG000|COMPLETED|Overall Study||39
2996078|NCT00935220|3712810|FG000|NOT COMPLETED|Overall Study||2
2996079|NCT00935259|3712814|FG000|STARTED|Period 1||16
2996080|NCT00935259|3712815|FG001|STARTED|Period 1||15
2996081|NCT00935259|3712814|FG000|COMPLETED|Period 1||15
2996082|NCT00935259|3712815|FG001|COMPLETED|Period 1||14
2996083|NCT00935259|3712814|FG000|NOT COMPLETED|Period 1||1
2996084|NCT00935259|3712815|FG001|NOT COMPLETED|Period 1||1
2996085|NCT00935259|3712814|FG000|STARTED|Period 2||15
2996086|NCT00935259|3712815|FG001|STARTED|Period 2||14
2996087|NCT00935259|3712814|FG000|COMPLETED|Period 2||15
2996088|NCT00935259|3712815|FG001|COMPLETED|Period 2||14
2996089|NCT00935259|3712814|FG000|NOT COMPLETED|Period 2||0
2996090|NCT00935259|3712815|FG001|NOT COMPLETED|Period 2||0
2996091|NCT00935272|3712825|FG000|STARTED|Overall Study||135
2996092|NCT00935272|3712826|FG001|STARTED|Overall Study||45
2996093|NCT00935272|3712825|FG000|COMPLETED|Overall Study||116
2996094|NCT00935272|3712826|FG001|COMPLETED|Overall Study||39
2996095|NCT00935272|3712825|FG000|NOT COMPLETED|Overall Study||19
2996096|NCT00935272|3712826|FG001|NOT COMPLETED|Overall Study||6
2996097|NCT00935311|3712836|FG000|STARTED|Overall Study||43
2996098|NCT00935311|3712837|FG001|STARTED|Overall Study||39
2996099|NCT00935311|3712838|FG002|STARTED|Overall Study||40
2996100|NCT00935311|3712836|FG000|COMPLETED|Overall Study||43
2996101|NCT00935311|3712837|FG001|COMPLETED|Overall Study||39
2996102|NCT00935311|3712838|FG002|COMPLETED|Overall Study||40
2996103|NCT00935311|3712836|FG000|NOT COMPLETED|Overall Study||0
2996104|NCT00935311|3712837|FG001|NOT COMPLETED|Overall Study||0
2996105|NCT00935311|3712838|FG002|NOT COMPLETED|Overall Study||0
2996106|NCT00935428|3712846|FG000|STARTED|Overall Study||231
2996107|NCT00935428|3712846|FG000|COMPLETED|Overall Study||231
2996108|NCT00935428|3712846|FG000|NOT COMPLETED|Overall Study||0
2996109|NCT00935493|3712859|FG000|STARTED|Overall Study||41
2996110|NCT00935493|3712860|FG001|STARTED|Overall Study||41
2996111|NCT00935493|3712861|FG002|STARTED|Overall Study||41
2996112|NCT00935493|3712859|FG000|COMPLETED|Overall Study||40
2996113|NCT00935493|3712860|FG001|COMPLETED|Overall Study||39
2996114|NCT00935493|3712861|FG002|COMPLETED|Overall Study||40
2996115|NCT00935493|3712859|FG000|NOT COMPLETED|Overall Study||1
2996116|NCT00935493|3712860|FG001|NOT COMPLETED|Overall Study||2
2996117|NCT00935493|3712861|FG002|NOT COMPLETED|Overall Study||1
2996118|NCT00935532|3712871|FG000|STARTED|Overall Study||215
2996119|NCT00935532|3712872|FG001|STARTED|Overall Study||212
2996120|NCT00935532|3712871|FG000|COMPLETED|Overall Study||193
2996121|NCT00935532|3712872|FG001|COMPLETED|Overall Study||201
2996122|NCT00935532|3712871|FG000|NOT COMPLETED|Overall Study||22
2996123|NCT00935532|3712872|FG001|NOT COMPLETED|Overall Study||11
2996124|NCT00935584|3712880|FG000|STARTED|Overall Study|Out of 128 participants consented, 2 patients had no data collected, as the clinic was cancelled.|126
2996125|NCT00935584|3712881|FG001|STARTED|Overall Study||23
2996126|NCT00935584|3712880|FG000|COMPLETED|Overall Study||77
2996127|NCT00935584|3712881|FG001|COMPLETED|Overall Study||19
2996128|NCT00935584|3712880|FG000|NOT COMPLETED|Overall Study||49
2996129|NCT00935584|3712881|FG001|NOT COMPLETED|Overall Study||4
2996130|NCT00935701|3712885|FG000|STARTED|Overall Study||10
2996131|NCT00935701|3712885|FG000|Transition Acupressure to Acupuncture|Overall Study||9
2996132|NCT00935701|3712885|FG000|COMPLETED|Overall Study||9
2996133|NCT00935701|3712885|FG000|NOT COMPLETED|Overall Study||1
2996134|NCT00935766|3712892|FG000|STARTED|Overall Study||42
2996135|NCT00935766|3712893|FG001|STARTED|Overall Study||34
2996136|NCT00935766|3712892|FG000|COMPLETED|Overall Study||35
2996137|NCT00935766|3712893|FG001|COMPLETED|Overall Study||27
2996138|NCT00935766|3712892|FG000|NOT COMPLETED|Overall Study||7
2996139|NCT00935766|3712893|FG001|NOT COMPLETED|Overall Study||7
2996140|NCT00935792|3712902|FG000|STARTED|Overall Study||7
2996141|NCT00935792|3712903|FG001|STARTED|Overall Study||9
2996142|NCT00935792|3712904|FG002|STARTED|Overall Study||12
2996143|NCT00935792|3712902|FG000|COMPLETED|Overall Study||6
2996144|NCT00935792|3712903|FG001|COMPLETED|Overall Study||6
2996145|NCT00935792|3712904|FG002|COMPLETED|Overall Study||12
2996146|NCT00935792|3712902|FG000|NOT COMPLETED|Overall Study||1
2996147|NCT00935792|3712903|FG001|NOT COMPLETED|Overall Study||3
2996148|NCT00935792|3712904|FG002|NOT COMPLETED|Overall Study||0
2996149|NCT00935818|3712916|FG000|STARTED|Overall Study||249
2996150|NCT00935818|3712917|FG001|STARTED|Overall Study||257
2996151|NCT00935818|3712916|FG000|End of Medication Phase|Overall Study||182
2996152|NCT00935818|3712917|FG001|End of Medication Phase|Overall Study||184
2996153|NCT00935818|3712916|FG000|COMPLETED|Overall Study||158
2996154|NCT00935818|3712917|FG001|COMPLETED|Overall Study||157
2996155|NCT00935818|3712916|FG000|NOT COMPLETED|Overall Study||91
2996156|NCT00935818|3712917|FG001|NOT COMPLETED|Overall Study||100
2996157|NCT00935857|3712925|FG000|STARTED|Overall Study||14
2996158|NCT00935857|3712926|FG001|STARTED|Overall Study||16
2996159|NCT00935857|3712925|FG000|COMPLETED|Overall Study||14
2996160|NCT00935857|3712926|FG001|COMPLETED|Overall Study||16
2996161|NCT00935857|3712925|FG000|NOT COMPLETED|Overall Study||0
2996162|NCT00935857|3712926|FG001|NOT COMPLETED|Overall Study||0
3164670|NCT01894516|3892106|FG001|COMPLETED|Period 1 (Baseline up to Week 12)||67
3164671|NCT01894516|3892107|FG002|COMPLETED|Period 1 (Baseline up to Week 12)||67
3305190|NCT02987829|4038887|FG002|STARTED|Overall Study||2
3305191|NCT02987829|4038888|FG003|STARTED|Overall Study||7
3305192|NCT02987829|4038889|FG004|STARTED|Overall Study||51
3305193|NCT02987829|4038890|FG005|STARTED|Overall Study||10
3305194|NCT02987829|4038885|FG000|COMPLETED|Overall Study||1
3305195|NCT02987829|4038886|FG001|COMPLETED|Overall Study||1
3305196|NCT02987829|4038887|FG002|COMPLETED|Overall Study||2
3305197|NCT02987829|4038888|FG003|COMPLETED|Overall Study||7
3305198|NCT02987829|4038889|FG004|COMPLETED|Overall Study||51
3305199|NCT02987829|4038890|FG005|COMPLETED|Overall Study||10
3305200|NCT02987829|4038885|FG000|NOT COMPLETED|Overall Study||0
3305201|NCT02987829|4038886|FG001|NOT COMPLETED|Overall Study||0
3305202|NCT02987829|4038887|FG002|NOT COMPLETED|Overall Study||0
3305203|NCT02987829|4038888|FG003|NOT COMPLETED|Overall Study||0
3305204|NCT02987829|4038889|FG004|NOT COMPLETED|Overall Study||0
3305205|NCT02987829|4038890|FG005|NOT COMPLETED|Overall Study||0
3305206|NCT02987868|4038907|FG000|STARTED|First Intervention||8
3305207|NCT02987868|4038908|FG001|STARTED|First Intervention||8
3305208|NCT02987868|4038907|FG000|COMPLETED|First Intervention||8
3305209|NCT02987868|4038908|FG001|COMPLETED|First Intervention||8
3305210|NCT02987868|4038907|FG000|NOT COMPLETED|First Intervention||0
3305211|NCT02987868|4038908|FG001|NOT COMPLETED|First Intervention||0
3305212|NCT02987868|4038907|FG000|STARTED|Wash Out Period 1 Week||8
3305213|NCT02987868|4038908|FG001|STARTED|Wash Out Period 1 Week||8
3305214|NCT02987868|4038907|FG000|COMPLETED|Wash Out Period 1 Week||8
3305215|NCT02987868|4038908|FG001|COMPLETED|Wash Out Period 1 Week||8
3305216|NCT02987868|4038907|FG000|NOT COMPLETED|Wash Out Period 1 Week||0
3305217|NCT02987868|4038908|FG001|NOT COMPLETED|Wash Out Period 1 Week||0
3305218|NCT02987868|4038907|FG000|STARTED|Second Intervention||8
3305219|NCT02987868|4038908|FG001|STARTED|Second Intervention||8
3305220|NCT02987868|4038907|FG000|COMPLETED|Second Intervention||8
3305221|NCT02987868|4038908|FG001|COMPLETED|Second Intervention||8
3305222|NCT02987868|4038907|FG000|NOT COMPLETED|Second Intervention||0
3305223|NCT02987868|4038908|FG001|NOT COMPLETED|Second Intervention||0
3305224|NCT02987959|4038914|FG000|STARTED|Overall Study||6
3305225|NCT02987959|4038914|FG000|COMPLETED|Overall Study||0
3305226|NCT02987959|4038914|FG000|NOT COMPLETED|Overall Study||6
3305227|NCT02987972|4038921|FG000|STARTED|Overall Study||351
3305228|NCT02987972|4038922|FG001|STARTED|Overall Study||350
2996163|NCT00935883|3712934|FG000|STARTED|Treatment Period||20
2996164|NCT00935883|3712935|FG001|STARTED|Treatment Period||40
2996165|NCT00935883|3712934|FG000|COMPLETED|Treatment Period||19
2996166|NCT00935883|3712935|FG001|COMPLETED|Treatment Period||38
2996167|NCT00935883|3712934|FG000|NOT COMPLETED|Treatment Period||1
2996168|NCT00935883|3712935|FG001|NOT COMPLETED|Treatment Period||2
2996169|NCT00935883|3712934|FG000|STARTED|Follow-Up Period||19
2996170|NCT00935883|3712935|FG001|STARTED|Follow-Up Period||38
2996171|NCT00935883|3712934|FG000|COMPLETED|Follow-Up Period||19
2996172|NCT00935883|3712935|FG001|COMPLETED|Follow-Up Period||38
2996173|NCT00935883|3712934|FG000|NOT COMPLETED|Follow-Up Period||0
2996174|NCT00935883|3712935|FG001|NOT COMPLETED|Follow-Up Period||0
3036933|NCT01145885|3756214|FG000|NOT COMPLETED|Overall Study||7
3036934|NCT01145898|3756226|FG000|STARTED|6-month Treatment||12
3036935|NCT01145898|3756227|FG001|STARTED|6-month Treatment||44
3036936|NCT01145898|3756226|FG000|COMPLETED|6-month Treatment||12
3036937|NCT01145898|3756227|FG001|COMPLETED|6-month Treatment||44
3036938|NCT01145898|3756226|FG000|NOT COMPLETED|6-month Treatment||0
3036939|NCT01145898|3756227|FG001|NOT COMPLETED|6-month Treatment||0
3036940|NCT01145898|3756226|FG000|STARTED|3-year Treatment||12
3036941|NCT01145898|3756227|FG001|STARTED|3-year Treatment||44
3036942|NCT01145898|3756226|FG000|COMPLETED|3-year Treatment||9
3036943|NCT01145898|3756227|FG001|COMPLETED|3-year Treatment||28
3036944|NCT01145898|3756226|FG000|NOT COMPLETED|3-year Treatment||3
3036945|NCT01145898|3756227|FG001|NOT COMPLETED|3-year Treatment||16
3038369|NCT01153971|3757805|FG000|COMPLETED|Induction Phase (Months 1 to 7 of Study)||44
3038370|NCT01153971|3757805|FG000|NOT COMPLETED|Induction Phase (Months 1 to 7 of Study)||3
3038371|NCT01153971|3757805|FG000|STARTED|Maintenance Phase (Months 8-16 of Study)||44
3038372|NCT01153971|3757805|FG000|COMPLETED|Maintenance Phase (Months 8-16 of Study)||41
3038373|NCT01153971|3757805|FG000|NOT COMPLETED|Maintenance Phase (Months 8-16 of Study)||3
3038374|NCT01153971|3757805|FG000|STARTED|Follow-up (Months 17-40 of Study)||41
3038375|NCT01153971|3757805|FG000|COMPLETED|Follow-up (Months 17-40 of Study)||37
3038376|NCT01153971|3757805|FG000|NOT COMPLETED|Follow-up (Months 17-40 of Study)||4
3038377|NCT01153984|3757809|FG000|STARTED|Overall Study||23
3038378|NCT01153984|3757809|FG000|COMPLETED|Overall Study||21
3038379|NCT01153984|3757809|FG000|NOT COMPLETED|Overall Study||2
3038380|NCT01154010|3757815|FG000|STARTED|Overall Study||9
3038381|NCT01154010|3757816|FG001|STARTED|Overall Study||9
3038382|NCT01154010|3757815|FG000|COMPLETED|Overall Study||9
3038383|NCT01154010|3757816|FG001|COMPLETED|Overall Study||8
3038384|NCT01154010|3757815|FG000|NOT COMPLETED|Overall Study||0
3038385|NCT01154010|3757816|FG001|NOT COMPLETED|Overall Study||1
3038386|NCT01154088|3757825|FG000|STARTED|Overall Study||390
3038387|NCT01154088|3757826|FG001|STARTED|Overall Study||390
3038388|NCT01154088|3757827|FG002|STARTED|Overall Study||390
3038389|NCT01154088|3757825|FG000|COMPLETED|Overall Study||386
3038390|NCT01154088|3757826|FG001|COMPLETED|Overall Study||384
3038391|NCT01154088|3757827|FG002|COMPLETED|Overall Study||383
3038392|NCT01154088|3757825|FG000|NOT COMPLETED|Overall Study||4
3305229|NCT02987972|4038923|FG002|STARTED|Overall Study||350
3305230|NCT02987972|4038921|FG000|Vaccination 1|Overall Study||350
3305231|NCT02987972|4038922|FG001|Vaccination 1|Overall Study||347
3305232|NCT02987972|4038923|FG002|Vaccination 1|Overall Study||347
3305233|NCT02987972|4038921|FG000|Vaccination 2|Overall Study||333
3305234|NCT02987972|4038922|FG001|Vaccination 2|Overall Study||335
3305235|NCT02987972|4038923|FG002|Vaccination 2|Overall Study||335
3305236|NCT02987972|4038921|FG000|Vaccination 3|Overall Study||330
3305237|NCT02987972|4038922|FG001|Vaccination 3|Overall Study||331
3305238|NCT02987972|4038923|FG002|Vaccination 3|Overall Study||332
3305239|NCT02987972|4038921|FG000|Vaccination 4|Overall Study||310
3305240|NCT02987972|4038922|FG001|Vaccination 4|Overall Study||306
3305241|NCT02987972|4038923|FG002|Vaccination 4|Overall Study||311
3305242|NCT02987972|4038921|FG000|COMPLETED|Overall Study||308
3305243|NCT02987972|4038922|FG001|COMPLETED|Overall Study||305
3305244|NCT02987972|4038923|FG002|COMPLETED|Overall Study||308
3305245|NCT02987972|4038921|FG000|NOT COMPLETED|Overall Study||43
3305246|NCT02987972|4038922|FG001|NOT COMPLETED|Overall Study||45
3305247|NCT02987972|4038923|FG002|NOT COMPLETED|Overall Study||42
3305248|NCT02988050|4038933|FG000|STARTED|Overall Study||30
3305249|NCT02988050|4038934|FG001|STARTED|Overall Study||30
3305250|NCT02988050|4038933|FG000|COMPLETED|Overall Study||30
3305251|NCT02988050|4038934|FG001|COMPLETED|Overall Study||30
3305252|NCT02988050|4038933|FG000|NOT COMPLETED|Overall Study||0
3305253|NCT02988050|4038934|FG001|NOT COMPLETED|Overall Study||0
3305254|NCT02988115|4038942|FG000|STARTED|Overall Study||234
3305255|NCT02988115|4038943|FG001|STARTED|Overall Study||111
3305256|NCT02988115|4038942|FG000|COMPLETED|Overall Study||220
3305257|NCT02988115|4038943|FG001|COMPLETED|Overall Study||107
3305258|NCT02988115|4038942|FG000|NOT COMPLETED|Overall Study||14
3305259|NCT02988115|4038943|FG001|NOT COMPLETED|Overall Study||4
3305260|NCT02988193|4038951|FG000|STARTED|Overall Study||12
3305261|NCT02988193|4038952|FG001|STARTED|Overall Study||16
3305262|NCT02988193|4038951|FG000|COMPLETED|Overall Study||12
3305263|NCT02988193|4038952|FG001|COMPLETED|Overall Study||16
3305264|NCT02988193|4038951|FG000|NOT COMPLETED|Overall Study||0
3305265|NCT02988193|4038952|FG001|NOT COMPLETED|Overall Study||0
3305266|NCT02988219|4038960|FG000|STARTED|Overall Study||25
3305267|NCT02988219|4038961|FG001|STARTED|Overall Study||25
3305268|NCT02988219|4038960|FG000|COMPLETED|Overall Study||24
3305269|NCT02988219|4038961|FG001|COMPLETED|Overall Study||22
2996175|NCT00936065|3712944|FG000|STARTED|Overall Study||21
2996176|NCT00936065|3712945|FG001|STARTED|Overall Study||20
2996177|NCT00936065|3712946|FG002|STARTED|Overall Study||19
2996178|NCT00936065|3712944|FG000|Received Treatment|Overall Study||21
2996179|NCT00936065|3712945|FG001|Received Treatment|Overall Study||20
2996180|NCT00936065|3712946|FG002|Received Treatment|Overall Study||18
2996181|NCT00936065|3712944|FG000|Study Assessments Performed|Overall Study||21
2996182|NCT00936065|3712945|FG001|Study Assessments Performed|Overall Study||19
2996183|NCT00936065|3712946|FG002|Study Assessments Performed|Overall Study||18
2996184|NCT00936065|3712944|FG000|COMPLETED|Overall Study||17
2996185|NCT00936065|3712945|FG001|COMPLETED|Overall Study||16
2996186|NCT00936065|3712946|FG002|COMPLETED|Overall Study||12
2996187|NCT00936065|3712944|FG000|NOT COMPLETED|Overall Study||4
2996188|NCT00936065|3712945|FG001|NOT COMPLETED|Overall Study||4
2996189|NCT00936065|3712946|FG002|NOT COMPLETED|Overall Study||7
2996190|NCT00936117|3712954|FG000|STARTED|Overall Study||20
2996191|NCT00936117|3712954|FG000|COMPLETED|Overall Study|Completed 42 days on study drug|10
2996192|NCT00936117|3712954|FG000|NOT COMPLETED|Overall Study||10
2996193|NCT00936208|3712961|FG000|STARTED|Overall Study||1499
2996194|NCT00936208|3712962|FG001|STARTED|Overall Study||1596
2996195|NCT00936208|3712961|FG000|COMPLETED|Overall Study||1462
2996196|NCT00936208|3712962|FG001|COMPLETED|Overall Study||1574
2996197|NCT00936208|3712961|FG000|NOT COMPLETED|Overall Study||37
2996198|NCT00936208|3712962|FG001|NOT COMPLETED|Overall Study||22
2996199|NCT00936221|3712970|FG000|STARTED|Overall Study||45
2996200|NCT00936221|3712971|FG001|STARTED|Overall Study||46
2996201|NCT00936221|3712970|FG000|Received Treatment|Overall Study||44
2996202|NCT00936221|3712971|FG001|Received Treatment|Overall Study||45
2996203|NCT00936221|3712970|FG000|COMPLETED|Overall Study|13 patients ongoing cutoff + 31 patients who had died.|44
2996204|NCT00936221|3712971|FG001|COMPLETED|Overall Study|10 patients ongoing at data cutoff + 35 patients who had died.|45
2996205|NCT00936221|3712970|FG000|NOT COMPLETED|Overall Study||1
2996206|NCT00936221|3712971|FG001|NOT COMPLETED|Overall Study||1
2996207|NCT00936299|3712979|FG000|STARTED|Overall Study||53
2996208|NCT00936299|3712980|FG001|STARTED|Overall Study||52
2996209|NCT00936299|3712979|FG000|COMPLETED|Overall Study||40
2996210|NCT00936299|3712980|FG001|COMPLETED|Overall Study||40
2996211|NCT00936299|3712979|FG000|NOT COMPLETED|Overall Study||13
2996212|NCT00936299|3712980|FG001|NOT COMPLETED|Overall Study||12
2996213|NCT00936351|3712990|FG000|STARTED|Overall Study||18
2996214|NCT00936351|3712991|FG001|STARTED|Overall Study||16
2996215|NCT00936351|3712990|FG000|COMPLETED|Overall Study||15
2996216|NCT00936351|3712991|FG001|COMPLETED|Overall Study||14
2996217|NCT00936351|3712990|FG000|NOT COMPLETED|Overall Study||3
2996218|NCT00936351|3712991|FG001|NOT COMPLETED|Overall Study||2
2996219|NCT00936377|3713000|FG000|STARTED|Overall Study||8
2996220|NCT00936377|3713001|FG001|STARTED|Overall Study||8
2996221|NCT00936377|3713002|FG002|STARTED|Overall Study||8
2996222|NCT00936377|3713000|FG000|COMPLETED|Overall Study||8
2996223|NCT00936377|3713001|FG001|COMPLETED|Overall Study||8
2996224|NCT00936377|3713002|FG002|COMPLETED|Overall Study||8
2996225|NCT00936377|3713000|FG000|NOT COMPLETED|Overall Study||0
2996226|NCT00936377|3713001|FG001|NOT COMPLETED|Overall Study||0
2996227|NCT00936377|3713002|FG002|NOT COMPLETED|Overall Study||0
2996228|NCT00936455|3713012|FG000|STARTED|Overall Study||37
2996229|NCT00936455|3713013|FG001|STARTED|Overall Study||38
2996230|NCT00936455|3713012|FG000|COMPLETED|Overall Study||37
2996231|NCT00936455|3713013|FG001|COMPLETED|Overall Study||38
2996232|NCT00936455|3713012|FG000|NOT COMPLETED|Overall Study||0
2996233|NCT00936455|3713013|FG001|NOT COMPLETED|Overall Study||0
2996234|NCT00936481|3713027|FG000|STARTED|Overall Study||17
2996235|NCT00936481|3713028|FG001|STARTED|Overall Study||17
2996236|NCT00936481|3713027|FG000|COMPLETED|Overall Study||17
2996237|NCT00936481|3713028|FG001|COMPLETED|Overall Study||17
2996238|NCT00936481|3713027|FG000|NOT COMPLETED|Overall Study||0
2996239|NCT00936481|3713028|FG001|NOT COMPLETED|Overall Study||0
3305270|NCT02988219|4038960|FG000|NOT COMPLETED|Overall Study||1
3305271|NCT02988219|4038961|FG001|NOT COMPLETED|Overall Study||3
3305272|NCT02988349|4038969|FG000|STARTED|Overall Study||21
3305273|NCT02988349|4038970|FG001|STARTED|Overall Study||21
3305274|NCT02988349|4038969|FG000|COMPLETED|Overall Study||21
3305275|NCT02988349|4038970|FG001|COMPLETED|Overall Study||21
3305276|NCT02988349|4038969|FG000|NOT COMPLETED|Overall Study||0
3305277|NCT02988349|4038970|FG001|NOT COMPLETED|Overall Study||0
3305278|NCT02988622|4038976|FG000|STARTED|Overall Study||100
3305279|NCT02988622|4038976|FG000|COMPLETED|Overall Study||83
3305280|NCT02988622|4038976|FG000|NOT COMPLETED|Overall Study||17
3305281|NCT02988843|4038982|FG000|STARTED|Overall Study||1
3305282|NCT02988843|4038982|FG000|COMPLETED|Overall Study||1
3305283|NCT02988843|4038982|FG000|NOT COMPLETED|Overall Study||0
2996240|NCT00936611|3713034|FG000|STARTED|Overall Study||39
2996241|NCT00936611|3713034|FG000|Treated|Overall Study||36
2996242|NCT00936611|3713034|FG000|Starting Dose Reduction: 30 mg to 25 mg|Overall Study||12
3305284|NCT02988856|4038986|FG000|STARTED|Overall Study||11
3305285|NCT02988856|4038986|FG000|COMPLETED|Overall Study||8
3305286|NCT02988856|4038986|FG000|NOT COMPLETED|Overall Study||3
3305287|NCT02988882|4038992|FG000|STARTED|Overall Study||44
3305288|NCT02988882|4038993|FG001|STARTED|Overall Study||42
3305289|NCT02988882|4038992|FG000|COMPLETED|Overall Study||41
3305290|NCT02988882|4038993|FG001|COMPLETED|Overall Study||40
3305291|NCT02988882|4038992|FG000|NOT COMPLETED|Overall Study||3
3305292|NCT02988882|4038993|FG001|NOT COMPLETED|Overall Study||2
3305293|NCT02988986|4038999|FG000|STARTED|Overall Study||28
3305294|NCT02988986|4038999|FG000|COMPLETED|Overall Study||25
3305295|NCT02988986|4038999|FG000|NOT COMPLETED|Overall Study||3
3305296|NCT02989168|4039006|FG000|STARTED|Overall Study||11
3305297|NCT02989168|4039007|FG001|STARTED|Overall Study||3
3305298|NCT02989168|4039006|FG000|COMPLETED|Overall Study||7
3305299|NCT02989168|4039007|FG001|COMPLETED|Overall Study||0
3305300|NCT02989168|4039006|FG000|NOT COMPLETED|Overall Study||4
3305301|NCT02989168|4039007|FG001|NOT COMPLETED|Overall Study||3
3305302|NCT02989246|4039015|FG000|STARTED|Overall Study||32
3305303|NCT02989246|4039015|FG000|COMPLETED|Overall Study||32
3305304|NCT02989246|4039015|FG000|NOT COMPLETED|Overall Study||0
3305305|NCT02989389|4039029|FG000|STARTED|Period 1||3
3305306|NCT02989389|4039030|FG001|STARTED|Period 1||4
3305307|NCT02989389|4039031|FG002|STARTED|Period 1||3
3305308|NCT02989389|4039032|FG003|STARTED|Period 1||3
3305309|NCT02989389|4039033|FG004|STARTED|Period 1||3
3305310|NCT02989389|4039034|FG005|STARTED|Period 1||3
3305311|NCT02989389|4039035|FG006|STARTED|Period 1||6
3305312|NCT02989389|4039036|FG007|STARTED|Period 1||5
3305313|NCT02989389|4039037|FG008|STARTED|Period 1||6
3305314|NCT02989389|4039038|FG009|STARTED|Period 1||6
3305315|NCT02989389|4039029|FG000|Received at Least 1 Dose of Study Drug|Period 1||3
3305316|NCT02989389|4039030|FG001|Received at Least 1 Dose of Study Drug|Period 1||4
3305317|NCT02989389|4039031|FG002|Received at Least 1 Dose of Study Drug|Period 1||3
3305318|NCT02989389|4039032|FG003|Received at Least 1 Dose of Study Drug|Period 1||3
3305319|NCT02989389|4039033|FG004|Received at Least 1 Dose of Study Drug|Period 1||3
3305320|NCT02989389|4039034|FG005|Received at Least 1 Dose of Study Drug|Period 1||3
3305321|NCT02989389|4039035|FG006|Received at Least 1 Dose of Study Drug|Period 1||6
3305322|NCT02989389|4039036|FG007|Received at Least 1 Dose of Study Drug|Period 1||5
3305323|NCT02989389|4039037|FG008|Received at Least 1 Dose of Study Drug|Period 1||6
3305324|NCT02989389|4039038|FG009|Received at Least 1 Dose of Study Drug|Period 1||6
3305325|NCT02989389|4039029|FG000|COMPLETED|Period 1||3
3305326|NCT02989389|4039030|FG001|COMPLETED|Period 1||3
3305327|NCT02989389|4039031|FG002|COMPLETED|Period 1||3
3305328|NCT02989389|4039032|FG003|COMPLETED|Period 1||3
3305329|NCT02989389|4039033|FG004|COMPLETED|Period 1||3
3305330|NCT02989389|4039034|FG005|COMPLETED|Period 1||3
3305331|NCT02989389|4039035|FG006|COMPLETED|Period 1||6
3305332|NCT02989389|4039036|FG007|COMPLETED|Period 1||5
3305333|NCT02989389|4039037|FG008|COMPLETED|Period 1||5
3305334|NCT02989389|4039038|FG009|COMPLETED|Period 1||6
3305335|NCT02989389|4039029|FG000|NOT COMPLETED|Period 1||0
2996243|NCT00936611|3713034|FG000|COMPLETED|Overall Study||0
2996244|NCT00936611|3713034|FG000|NOT COMPLETED|Overall Study||39
2996245|NCT00936663|3713040|FG000|STARTED|Overall Study||1
2996246|NCT00936663|3713041|FG001|STARTED|Overall Study||2
2996247|NCT00936663|3713040|FG000|COMPLETED|Overall Study||1
2996248|NCT00936663|3713041|FG001|COMPLETED|Overall Study||2
2996249|NCT00936663|3713040|FG000|NOT COMPLETED|Overall Study||0
2996250|NCT00936663|3713041|FG001|NOT COMPLETED|Overall Study||0
2996251|NCT00936702|3713047|FG000|STARTED|Overall Study||46
2996252|NCT00936702|3713047|FG000|COMPLETED|Overall Study||0
2996253|NCT00936702|3713047|FG000|NOT COMPLETED|Overall Study||46
2996254|NCT00936715|3713051|FG000|STARTED|Overall Study||24
2996255|NCT00936715|3713051|FG000|COMPLETED|Overall Study||18
2996256|NCT00936715|3713051|FG000|NOT COMPLETED|Overall Study||6
2996257|NCT00936741|3713055|FG000|STARTED|Overall Study||30
2996258|NCT00936741|3713055|FG000|COMPLETED|Overall Study||21
2996259|NCT00936741|3713055|FG000|NOT COMPLETED|Overall Study||9
2996260|NCT00936858|3713059|FG000|STARTED|Overall Study||50
2996261|NCT00936858|3713059|FG000|Participants With Medullary Thyroid Cancer|Overall Study||10
2996262|NCT00936858|3713059|FG000|COMPLETED|Overall Study||0
2996263|NCT00936858|3713059|FG000|NOT COMPLETED|Overall Study||50
2996264|NCT00936884|3713066|FG000|STARTED|Double-blind|Twenty-five subjects received MNTX, and 24 had ≥ 1 post baseline diary assessment.|25
2996265|NCT00936884|3713067|FG001|STARTED|Double-blind|Twenty-four subjects received placebo, and 23 had ≥ 1 post baseline diary assessment.|25
2996266|NCT00936884|3713068|FG002|STARTED|Double-blind|Thirteen subjects from the MNTX group and 18 from the placebo group entered the 12-week extension.|0
2996267|NCT00936884|3713066|FG000|COMPLETED|Double-blind||13
2996268|NCT00936884|3713067|FG001|COMPLETED|Double-blind||18
2996269|NCT00936884|3713068|FG002|COMPLETED|Double-blind||0
2996270|NCT00936884|3713066|FG000|NOT COMPLETED|Double-blind||12
2996271|NCT00936884|3713067|FG001|NOT COMPLETED|Double-blind||7
2996272|NCT00936884|3713068|FG002|NOT COMPLETED|Double-blind||0
2996273|NCT00936884|3713066|FG000|STARTED|Open-label||0
2996274|NCT00936884|3713067|FG001|STARTED|Open-label||0
2996275|NCT00936884|3713068|FG002|STARTED|Open-label||31
2996276|NCT00936884|3713066|FG000|COMPLETED|Open-label||0
3305336|NCT02989389|4039030|FG001|NOT COMPLETED|Period 1||1
3305337|NCT02989389|4039031|FG002|NOT COMPLETED|Period 1||0
3305338|NCT02989389|4039032|FG003|NOT COMPLETED|Period 1||0
3305339|NCT02989389|4039033|FG004|NOT COMPLETED|Period 1||0
3305340|NCT02989389|4039034|FG005|NOT COMPLETED|Period 1||0
3305341|NCT02989389|4039035|FG006|NOT COMPLETED|Period 1||0
3305342|NCT02989389|4039036|FG007|NOT COMPLETED|Period 1||0
3305343|NCT02989389|4039037|FG008|NOT COMPLETED|Period 1||1
3305344|NCT02989389|4039038|FG009|NOT COMPLETED|Period 1||0
3305345|NCT02989389|4039029|FG000|STARTED|Period 2||3
3305346|NCT02989389|4039030|FG001|STARTED|Period 2||3
3305347|NCT02989389|4039031|FG002|STARTED|Period 2||3
3305348|NCT02989389|4039032|FG003|STARTED|Period 2||3
2996277|NCT00936884|3713067|FG001|COMPLETED|Open-label||0
2996278|NCT00936884|3713068|FG002|COMPLETED|Open-label||12
2996279|NCT00936884|3713066|FG000|NOT COMPLETED|Open-label||0
2996280|NCT00936884|3713067|FG001|NOT COMPLETED|Open-label||0
2996281|NCT00936884|3713068|FG002|NOT COMPLETED|Open-label||19
2996282|NCT00936897|3713077|FG000|STARTED|Overall Study|Randomized|417
2996283|NCT00936897|3713078|FG001|STARTED|Overall Study|Randomized|416
2996284|NCT00936897|3713077|FG000|COMPLETED|Overall Study||398
2996285|NCT00936897|3713078|FG001|COMPLETED|Overall Study||356
2996286|NCT00936897|3713077|FG000|NOT COMPLETED|Overall Study||19
2996287|NCT00936897|3713078|FG001|NOT COMPLETED|Overall Study||60
2996288|NCT00936910|3713084|FG000|STARTED|Overall Study||13
2996289|NCT00936910|3713084|FG000|COMPLETED|Overall Study|The primary endpt. of 2 (-) cultures within 5 d of lock therapy was met for 10 patients|10
2996290|NCT00936910|3713084|FG000|NOT COMPLETED|Overall Study||3
2996291|NCT00936975|3713089|FG000|STARTED|Overall Study||18
2996292|NCT00936975|3713089|FG000|COMPLETED|Overall Study||12
2996293|NCT00936975|3713089|FG000|NOT COMPLETED|Overall Study||6
2996294|NCT00937040|3713096|FG000|STARTED|Overall Study||179
2996295|NCT00937040|3713097|FG001|STARTED|Overall Study||178
2996296|NCT00937040|3713096|FG000|COMPLETED|Overall Study||138
2996297|NCT00937040|3713097|FG001|COMPLETED|Overall Study||141
2996298|NCT00937040|3713096|FG000|NOT COMPLETED|Overall Study||41
2996299|NCT00937040|3713097|FG001|NOT COMPLETED|Overall Study||37
2996300|NCT00937105|3713105|FG000|STARTED|Overall Study||109
2996301|NCT00937105|3713106|FG001|STARTED|Overall Study||109
2996302|NCT00937105|3713105|FG000|COMPLETED|Overall Study||69
2996303|NCT00937105|3713106|FG001|COMPLETED|Overall Study||70
2996304|NCT00937105|3713105|FG000|NOT COMPLETED|Overall Study||40
2996305|NCT00937105|3713106|FG001|NOT COMPLETED|Overall Study||39
2996306|NCT00937118|3713121|FG000|STARTED|Overall Study||41
2996307|NCT00937118|3713121|FG000|COMPLETED|Overall Study||41
2996308|NCT00937118|3713121|FG000|NOT COMPLETED|Overall Study||0
2996309|NCT00937157|3713128|FG000|STARTED|Overall Study||12
2996310|NCT00937157|3713128|FG000|COMPLETED|Overall Study||8
2996311|NCT00937157|3713128|FG000|NOT COMPLETED|Overall Study||4
2996312|NCT00937235|3713134|FG000|STARTED|Overall Study||72
2996313|NCT00937235|3713135|FG001|STARTED|Overall Study||70
2996314|NCT00937235|3713134|FG000|COMPLETED|Overall Study||72
2996315|NCT00937235|3713135|FG001|COMPLETED|Overall Study||70
2996316|NCT00937235|3713134|FG000|NOT COMPLETED|Overall Study||0
2996317|NCT00937235|3713135|FG001|NOT COMPLETED|Overall Study||0
2996318|NCT00937326|3713146|FG000|STARTED|Overall Study||46
2996319|NCT00937326|3713147|FG001|STARTED|Overall Study||45
2996320|NCT00937326|3713148|FG002|STARTED|Overall Study||46
2996321|NCT00937326|3713149|FG003|STARTED|Overall Study||45
2996322|NCT00937326|3713150|FG004|STARTED|Overall Study||45
2996323|NCT00937326|3713146|FG000|COMPLETED|Overall Study||43
2996324|NCT00937326|3713147|FG001|COMPLETED|Overall Study||38
2996325|NCT00937326|3713148|FG002|COMPLETED|Overall Study||42
2996326|NCT00937326|3713149|FG003|COMPLETED|Overall Study||40
2996327|NCT00937326|3713150|FG004|COMPLETED|Overall Study||40
2996328|NCT00937326|3713146|FG000|NOT COMPLETED|Overall Study||3
2996329|NCT00937326|3713147|FG001|NOT COMPLETED|Overall Study||7
2996330|NCT00937326|3713148|FG002|NOT COMPLETED|Overall Study||4
2996331|NCT00937326|3713149|FG003|NOT COMPLETED|Overall Study||5
2996332|NCT00937326|3713150|FG004|NOT COMPLETED|Overall Study||5
2996333|NCT00937378|3713169|FG000|STARTED|Overall Study||167
2996334|NCT00937378|3713170|FG001|STARTED|Overall Study||159
3305349|NCT02989389|4039033|FG004|STARTED|Period 2||3
3305350|NCT02989389|4039034|FG005|STARTED|Period 2||3
3305351|NCT02989389|4039035|FG006|STARTED|Period 2|Part B was planned as a single period study.|0
3305352|NCT02989389|4039036|FG007|STARTED|Period 2|Part B was planned as a single period study.|0
3305353|NCT02989389|4039037|FG008|STARTED|Period 2|Part B was planned as a single period study.|0
3305354|NCT02989389|4039038|FG009|STARTED|Period 2|Part B was planned as a single period study.|0
3305355|NCT02989389|4039029|FG000|COMPLETED|Period 2||3
3305356|NCT02989389|4039030|FG001|COMPLETED|Period 2||3
3305357|NCT02989389|4039031|FG002|COMPLETED|Period 2||3
3305358|NCT02989389|4039032|FG003|COMPLETED|Period 2||3
3305359|NCT02989389|4039033|FG004|COMPLETED|Period 2||3
3305360|NCT02989389|4039034|FG005|COMPLETED|Period 2||3
3305361|NCT02989389|4039035|FG006|COMPLETED|Period 2||0
3305362|NCT02989389|4039036|FG007|COMPLETED|Period 2||0
3305363|NCT02989389|4039037|FG008|COMPLETED|Period 2||0
3305364|NCT02989389|4039038|FG009|COMPLETED|Period 2||0
3305365|NCT02989389|4039029|FG000|NOT COMPLETED|Period 2||0
3305366|NCT02989389|4039030|FG001|NOT COMPLETED|Period 2||0
3305367|NCT02989389|4039031|FG002|NOT COMPLETED|Period 2||0
3305368|NCT02989389|4039032|FG003|NOT COMPLETED|Period 2||0
3305369|NCT02989389|4039033|FG004|NOT COMPLETED|Period 2||0
3305370|NCT02989389|4039034|FG005|NOT COMPLETED|Period 2||0
3305371|NCT02989389|4039035|FG006|NOT COMPLETED|Period 2||0
3305372|NCT02989389|4039036|FG007|NOT COMPLETED|Period 2||0
3305373|NCT02989389|4039037|FG008|NOT COMPLETED|Period 2||0
3305374|NCT02989389|4039038|FG009|NOT COMPLETED|Period 2||0
3305375|NCT02989389|4039029|FG000|STARTED|Period 3||3
3305376|NCT02989389|4039030|FG001|STARTED|Period 3||3
3305377|NCT02989389|4039031|FG002|STARTED|Period 3||3
3305378|NCT02989389|4039032|FG003|STARTED|Period 3||3
3305379|NCT02989389|4039033|FG004|STARTED|Period 3||3
3305380|NCT02989389|4039034|FG005|STARTED|Period 3||3
3305381|NCT02989389|4039035|FG006|STARTED|Period 3||0
3305382|NCT02989389|4039036|FG007|STARTED|Period 3||0
3305383|NCT02989389|4039037|FG008|STARTED|Period 3||0
2996335|NCT00937378|3713169|FG000|COMPLETED|Overall Study||149
2996336|NCT00937378|3713170|FG001|COMPLETED|Overall Study||141
2996337|NCT00937378|3713169|FG000|NOT COMPLETED|Overall Study||18
2996338|NCT00937378|3713170|FG001|NOT COMPLETED|Overall Study||18
2996339|NCT00937391|3713178|FG000|STARTED|Stage 1||20
2996340|NCT00937391|3713178|FG000|Treated|Stage 1|Valid for Full Analysis Set (FAS); includes all participants administered Magnevist Injection|20
2996341|NCT00937391|3713178|FG000|COMPLETED|Stage 1||20
2996342|NCT00937391|3713178|FG000|NOT COMPLETED|Stage 1||0
2996343|NCT00937391|3713178|FG000|STARTED|Stage 2|Stage 1 and Stage 2 are independent each enrolling a different set of participants|34
2996344|NCT00937391|3713178|FG000|Treated|Stage 2|Valid for Full Analysis Set; participants administered correct Magnevist dose based on body weight|34
2996345|NCT00937391|3713178|FG000|COMPLETED|Stage 2|The number completed includes participants within the FAS and Per Protocol Set (PPS)|33
2996346|NCT00937391|3713178|FG000|NOT COMPLETED|Stage 2||1
2996347|NCT00937404|3713195|FG000|STARTED|Overall Study||25
2996348|NCT00937404|3713195|FG000|COMPLETED|Overall Study||23
3164672|NCT01894516|3892108|FG003|COMPLETED|Period 1 (Baseline up to Week 12)||66
3164673|NCT01894516|3892105|FG000|NOT COMPLETED|Period 1 (Baseline up to Week 12)||7
3305384|NCT02989389|4039038|FG009|STARTED|Period 3||0
2996349|NCT00937404|3713195|FG000|NOT COMPLETED|Overall Study||2
2996350|NCT00937495|3713199|FG000|STARTED|Overall Study||16
2996351|NCT00937495|3713199|FG000|COMPLETED|Overall Study||14
2996352|NCT00937495|3713199|FG000|NOT COMPLETED|Overall Study||2
2996353|NCT00937521|3713211|FG000|STARTED|Overall Study - Prior to Booster Dose||188
2996354|NCT00937521|3713212|FG001|STARTED|Overall Study - Prior to Booster Dose||190
2996355|NCT00937521|3713213|FG002|STARTED|Overall Study - Prior to Booster Dose||192
2996356|NCT00937521|3713214|FG003|STARTED|Overall Study - Prior to Booster Dose||188
2996357|NCT00937521|3713215|FG004|STARTED|Overall Study - Prior to Booster Dose||191
2996358|NCT00937521|3713216|FG005|STARTED|Overall Study - Prior to Booster Dose||188
2996359|NCT00937521|3713217|FG006|STARTED|Overall Study - Prior to Booster Dose||186
2996360|NCT00937521|3713218|FG007|STARTED|Overall Study - Prior to Booster Dose||184
2996361|NCT00937521|3713211|FG000|Premature Withdrawal|Overall Study - Prior to Booster Dose||3
2996362|NCT00937521|3713212|FG001|Premature Withdrawal|Overall Study - Prior to Booster Dose||5
2996363|NCT00937521|3713213|FG002|Premature Withdrawal|Overall Study - Prior to Booster Dose||6
2996364|NCT00937521|3713214|FG003|Premature Withdrawal|Overall Study - Prior to Booster Dose||1
2996365|NCT00937521|3713215|FG004|Premature Withdrawal|Overall Study - Prior to Booster Dose||3
2996366|NCT00937521|3713216|FG005|Premature Withdrawal|Overall Study - Prior to Booster Dose||1
2996367|NCT00937521|3713217|FG006|Premature Withdrawal|Overall Study - Prior to Booster Dose||5
2996368|NCT00937521|3713218|FG007|Premature Withdrawal|Overall Study - Prior to Booster Dose||1
2996369|NCT00937521|3713211|FG000|COMPLETED|Overall Study - Prior to Booster Dose||185
2996370|NCT00937521|3713212|FG001|COMPLETED|Overall Study - Prior to Booster Dose||185
2996371|NCT00937521|3713213|FG002|COMPLETED|Overall Study - Prior to Booster Dose||186
2996372|NCT00937521|3713214|FG003|COMPLETED|Overall Study - Prior to Booster Dose||187
2996373|NCT00937521|3713215|FG004|COMPLETED|Overall Study - Prior to Booster Dose||188
2996374|NCT00937521|3713216|FG005|COMPLETED|Overall Study - Prior to Booster Dose||187
2996375|NCT00937521|3713217|FG006|COMPLETED|Overall Study - Prior to Booster Dose||181
2996376|NCT00937521|3713218|FG007|COMPLETED|Overall Study - Prior to Booster Dose||183
2996377|NCT00937521|3713211|FG000|NOT COMPLETED|Overall Study - Prior to Booster Dose||3
2996378|NCT00937521|3713212|FG001|NOT COMPLETED|Overall Study - Prior to Booster Dose||5
2996379|NCT00937521|3713213|FG002|NOT COMPLETED|Overall Study - Prior to Booster Dose||6
2996380|NCT00937521|3713214|FG003|NOT COMPLETED|Overall Study - Prior to Booster Dose||1
2996381|NCT00937521|3713215|FG004|NOT COMPLETED|Overall Study - Prior to Booster Dose||3
2996382|NCT00937521|3713216|FG005|NOT COMPLETED|Overall Study - Prior to Booster Dose||1
2996383|NCT00937521|3713217|FG006|NOT COMPLETED|Overall Study - Prior to Booster Dose||5
2996384|NCT00937521|3713218|FG007|NOT COMPLETED|Overall Study - Prior to Booster Dose||1
2996385|NCT00937521|3713211|FG000|STARTED|Booster Phase||155
2996386|NCT00937521|3713212|FG001|STARTED|Booster Phase||163
2996387|NCT00937521|3713213|FG002|STARTED|Booster Phase||169
2996388|NCT00937521|3713214|FG003|STARTED|Booster Phase||170
2996389|NCT00937521|3713215|FG004|STARTED|Booster Phase||168
2996390|NCT00937521|3713216|FG005|STARTED|Booster Phase||165
2996391|NCT00937521|3713217|FG006|STARTED|Booster Phase||165
2996392|NCT00937521|3713218|FG007|STARTED|Booster Phase||161
2996393|NCT00937521|3713211|FG000|Premature Withdrawal|Booster Phase||3
2996394|NCT00937521|3713212|FG001|Premature Withdrawal|Booster Phase||2
2996395|NCT00937521|3713213|FG002|Premature Withdrawal|Booster Phase||5
2996396|NCT00937521|3713214|FG003|Premature Withdrawal|Booster Phase||3
2996397|NCT00937521|3713215|FG004|Premature Withdrawal|Booster Phase||5
2996398|NCT00937521|3713216|FG005|Premature Withdrawal|Booster Phase||5
2996399|NCT00937521|3713217|FG006|Premature Withdrawal|Booster Phase||5
3164674|NCT01894516|3892106|FG001|NOT COMPLETED|Period 1 (Baseline up to Week 12)||5
3305385|NCT02989389|4039029|FG000|COMPLETED|Period 3||3
3305386|NCT02989389|4039030|FG001|COMPLETED|Period 3||3
3305387|NCT02989389|4039031|FG002|COMPLETED|Period 3||3
3305388|NCT02989389|4039032|FG003|COMPLETED|Period 3||3
3305389|NCT02989389|4039033|FG004|COMPLETED|Period 3||3
3305390|NCT02989389|4039034|FG005|COMPLETED|Period 3||3
3305391|NCT02989389|4039035|FG006|COMPLETED|Period 3||0
3305392|NCT02989389|4039036|FG007|COMPLETED|Period 3||0
3305393|NCT02989389|4039037|FG008|COMPLETED|Period 3||0
3305394|NCT02989389|4039038|FG009|COMPLETED|Period 3||0
3305395|NCT02989389|4039029|FG000|NOT COMPLETED|Period 3||0
3305396|NCT02989389|4039030|FG001|NOT COMPLETED|Period 3||0
3305397|NCT02989389|4039031|FG002|NOT COMPLETED|Period 3||0
3305398|NCT02989389|4039032|FG003|NOT COMPLETED|Period 3||0
3305399|NCT02989389|4039033|FG004|NOT COMPLETED|Period 3||0
3305400|NCT02989389|4039034|FG005|NOT COMPLETED|Period 3||0
3305401|NCT02989389|4039035|FG006|NOT COMPLETED|Period 3||0
3305402|NCT02989389|4039036|FG007|NOT COMPLETED|Period 3||0
3305403|NCT02989389|4039037|FG008|NOT COMPLETED|Period 3||0
3305404|NCT02989389|4039038|FG009|NOT COMPLETED|Period 3||0
3305405|NCT02989493|4039080|FG000|STARTED|Overall Study||29
3305406|NCT02989493|4039081|FG001|STARTED|Overall Study||32
3305407|NCT02989493|4039080|FG000|COMPLETED|Overall Study||29
3305408|NCT02989493|4039081|FG001|COMPLETED|Overall Study||32
3305409|NCT02989493|4039080|FG000|NOT COMPLETED|Overall Study||0
3305410|NCT02989493|4039081|FG001|NOT COMPLETED|Overall Study||0
3305411|NCT02989545|4039087|FG000|STARTED|Control Period - no Intervention||20
3305412|NCT02989545|4039087|FG000|COMPLETED|Control Period - no Intervention||20
2996400|NCT00937521|3713218|FG007|Premature Withdrawal|Booster Phase||2
2996401|NCT00937521|3713211|FG000|COMPLETED|Booster Phase||152
2996402|NCT00937521|3713212|FG001|COMPLETED|Booster Phase||161
2996403|NCT00937521|3713213|FG002|COMPLETED|Booster Phase||164
2996404|NCT00937521|3713214|FG003|COMPLETED|Booster Phase||167
2996405|NCT00937521|3713215|FG004|COMPLETED|Booster Phase||163
3164675|NCT01894516|3892107|FG002|NOT COMPLETED|Period 1 (Baseline up to Week 12)||3
3164676|NCT01894516|3892108|FG003|NOT COMPLETED|Period 1 (Baseline up to Week 12)||3
3164677|NCT01894516|3892105|FG000|STARTED|Period 2 (Week 13 to Week 24)|All participants from Placebo moved to 100 mg QD (65 participants) group.|0
3164678|NCT01894516|3892106|FG001|STARTED|Period 2 (Week 13 to Week 24)|Nonresponders from 50 mg QD group moved to 100 mg QD group (15 participants).|52
3171770|NCT01937026|3898964|FG000|COMPLETED|Period 1 (Day 1 Through Predose Day 3)||18
3305413|NCT02989545|4039087|FG000|NOT COMPLETED|Control Period - no Intervention||0
2996406|NCT00937521|3713216|FG005|COMPLETED|Booster Phase||160
2996407|NCT00937521|3713217|FG006|COMPLETED|Booster Phase||160
2996408|NCT00937521|3713218|FG007|COMPLETED|Booster Phase||159
2996409|NCT00937521|3713211|FG000|NOT COMPLETED|Booster Phase||3
2996410|NCT00937521|3713212|FG001|NOT COMPLETED|Booster Phase||2
2996411|NCT00937521|3713213|FG002|NOT COMPLETED|Booster Phase||5
2996412|NCT00937521|3713214|FG003|NOT COMPLETED|Booster Phase||3
2996413|NCT00937521|3713215|FG004|NOT COMPLETED|Booster Phase||5
2996414|NCT00937521|3713216|FG005|NOT COMPLETED|Booster Phase||5
2996415|NCT00937521|3713217|FG006|NOT COMPLETED|Booster Phase||5
2996416|NCT00937521|3713218|FG007|NOT COMPLETED|Booster Phase||2
2996417|NCT00937547|3713254|FG000|STARTED|Overall Study||96
2996418|NCT00937547|3713255|FG001|STARTED|Overall Study||84
2996419|NCT00937547|3713256|FG002|STARTED|Overall Study||149
2996420|NCT00937547|3713254|FG000|Histological Samples|Overall Study||95
2996421|NCT00937547|3713255|FG001|Histological Samples|Overall Study||78
3305414|NCT02989545|4039087|FG000|STARTED|Treatment Period - Anal Tape Provided||20
3305415|NCT02989545|4039087|FG000|COMPLETED|Treatment Period - Anal Tape Provided||20
3305416|NCT02989545|4039087|FG000|NOT COMPLETED|Treatment Period - Anal Tape Provided||0
3305417|NCT02989610|4039095|FG000|STARTED|Overall Study||234
3305418|NCT02989610|4039095|FG000|COMPLETED|Overall Study||195
3305419|NCT02989610|4039095|FG000|NOT COMPLETED|Overall Study||39
3305420|NCT02989649|4039099|FG000|STARTED|Overall Study||593
3305421|NCT02989649|4039099|FG000|Started But Not Treated|Overall Study||84
3305422|NCT02989649|4039099|FG000|Eligible to Enter Into Treatment Period|Overall Study||509
3305423|NCT02989649|4039099|FG000|COMPLETED|Overall Study||173
2996422|NCT00937547|3713256|FG002|Histological Samples|Overall Study||142
2996423|NCT00937547|3713254|FG000|COMPLETED|Overall Study||95
2996424|NCT00937547|3713255|FG001|COMPLETED|Overall Study||78
2996425|NCT00937547|3713256|FG002|COMPLETED|Overall Study||142
2996426|NCT00937547|3713254|FG000|NOT COMPLETED|Overall Study||1
2996427|NCT00937547|3713255|FG001|NOT COMPLETED|Overall Study||6
2996428|NCT00937547|3713256|FG002|NOT COMPLETED|Overall Study||7
2996429|NCT00937560|3713264|FG000|STARTED|Initial Treatment||189
2996430|NCT00937560|3713264|FG000|Received Treatment|Initial Treatment||189
2996431|NCT00937560|3713264|FG000|COMPLETED|Initial Treatment||168
2996432|NCT00937560|3713264|FG000|NOT COMPLETED|Initial Treatment||21
2996433|NCT00937560|3713264|FG000|STARTED|Maintenance Treatment||168
2996434|NCT00937560|3713264|FG000|COMPLETED|Maintenance Treatment||150
2996435|NCT00937560|3713264|FG000|NOT COMPLETED|Maintenance Treatment||18
2996436|NCT00937768|3713270|FG000|STARTED|Overall Study||8
3305424|NCT02989649|4039099|FG000|NOT COMPLETED|Overall Study||420
3317070|NCT03123588|4050575|FG000|COMPLETED|Overall Study||0
3317071|NCT03123588|4050576|FG001|COMPLETED|Overall Study||0
3317072|NCT03123588|4050575|FG000|NOT COMPLETED|Overall Study||6
3317073|NCT03123588|4050576|FG001|NOT COMPLETED|Overall Study||6
3317074|NCT03123614|4050585|FG000|STARTED|Overall Study||57
2996437|NCT00937768|3713271|FG001|STARTED|Overall Study||8
2996438|NCT00937768|3713270|FG000|COMPLETED|Overall Study||0
2996439|NCT00937768|3713271|FG001|COMPLETED|Overall Study||0
3317075|NCT03123614|4050586|FG001|STARTED|Overall Study||74
3317076|NCT03123614|4050585|FG000|COMPLETED|Overall Study||57
3317077|NCT03123614|4050586|FG001|COMPLETED|Overall Study||74
3317078|NCT03123614|4050585|FG000|NOT COMPLETED|Overall Study||0
3317079|NCT03123614|4050586|FG001|NOT COMPLETED|Overall Study||0
3317080|NCT03123848|4050592|FG000|STARTED|Overall Study||8
3317081|NCT03123848|4050592|FG000|COMPLETED|Overall Study||8
2996440|NCT00937768|3713270|FG000|NOT COMPLETED|Overall Study||8
2996441|NCT00937768|3713271|FG001|NOT COMPLETED|Overall Study||8
2996442|NCT00937794|3713277|FG000|STARTED|Overall Study||33
2996443|NCT00937794|3713277|FG000|COMPLETED|Overall Study||33
2996444|NCT00937794|3713277|FG000|NOT COMPLETED|Overall Study||0
2996445|NCT00937833|3713283|FG000|STARTED|Overall Study||73
2996446|NCT00937833|3713284|FG001|STARTED|Overall Study||77
2996447|NCT00937833|3713283|FG000|COMPLETED|Overall Study||58
2996448|NCT00937833|3713284|FG001|COMPLETED|Overall Study||60
2996449|NCT00937833|3713283|FG000|NOT COMPLETED|Overall Study||15
2996450|NCT00937833|3713284|FG001|NOT COMPLETED|Overall Study||17
2996451|NCT00937859|3713292|FG000|STARTED|Overall Study||148
2996452|NCT00937859|3713293|FG001|STARTED|Overall Study||153
2996453|NCT00937859|3713292|FG000|COMPLETED|Overall Study||129
2996454|NCT00937859|3713293|FG001|COMPLETED|Overall Study||134
2996455|NCT00937859|3713292|FG000|NOT COMPLETED|Overall Study||19
2996456|NCT00937859|3713293|FG001|NOT COMPLETED|Overall Study||19
2996457|NCT00937950|3713299|FG000|STARTED|Overall Study||2003
2996458|NCT00937950|3713299|FG000|COMPLETED|Overall Study||1787
2996459|NCT00937950|3713299|FG000|NOT COMPLETED|Overall Study||216
2996460|NCT00938015|3713303|FG000|STARTED|Overall Study||303
2996461|NCT00938015|3713303|FG000|COMPLETED|Overall Study||156
2996462|NCT00938015|3713303|FG000|NOT COMPLETED|Overall Study||147
2996463|NCT00938041|3713307|FG000|STARTED|Overall Study||32
2996464|NCT00938041|3713307|FG000|COMPLETED|Overall Study||5
2996465|NCT00938041|3713307|FG000|NOT COMPLETED|Overall Study||27
2996466|NCT00938314|3713315|FG000|STARTED|Cohort 1||24
2996467|NCT00938314|3713316|FG001|STARTED|Cohort 1||0
2996468|NCT00938314|3713317|FG002|STARTED|Cohort 1||0
2996469|NCT00938314|3713318|FG003|STARTED|Cohort 1||8
2996470|NCT00938314|3713315|FG000|COMPLETED|Cohort 1||22
2996471|NCT00938314|3713316|FG001|COMPLETED|Cohort 1||0
2996472|NCT00938314|3713317|FG002|COMPLETED|Cohort 1||0
2996473|NCT00938314|3713318|FG003|COMPLETED|Cohort 1||6
2996474|NCT00938314|3713315|FG000|NOT COMPLETED|Cohort 1||2
2996475|NCT00938314|3713316|FG001|NOT COMPLETED|Cohort 1||0
2996476|NCT00938314|3713317|FG002|NOT COMPLETED|Cohort 1||0
2996477|NCT00938314|3713318|FG003|NOT COMPLETED|Cohort 1||2
2996478|NCT00938314|3713315|FG000|STARTED|Cohort 2||0
2996479|NCT00938314|3713316|FG001|STARTED|Cohort 2||24
2996480|NCT00938314|3713317|FG002|STARTED|Cohort 2||0
2996481|NCT00938314|3713318|FG003|STARTED|Cohort 2||8
2996482|NCT00938314|3713315|FG000|COMPLETED|Cohort 2||0
2996483|NCT00938314|3713316|FG001|COMPLETED|Cohort 2||18
2996484|NCT00938314|3713317|FG002|COMPLETED|Cohort 2||0
2996485|NCT00938314|3713318|FG003|COMPLETED|Cohort 2||6
2996486|NCT00938314|3713315|FG000|NOT COMPLETED|Cohort 2||0
2996487|NCT00938314|3713316|FG001|NOT COMPLETED|Cohort 2||6
2996488|NCT00938314|3713317|FG002|NOT COMPLETED|Cohort 2||0
2996489|NCT00938314|3713318|FG003|NOT COMPLETED|Cohort 2||2
2996490|NCT00938314|3713315|FG000|STARTED|Cohort 3||0
2996491|NCT00938314|3713316|FG001|STARTED|Cohort 3||0
2996492|NCT00938314|3713317|FG002|STARTED|Cohort 3||24
2996493|NCT00938314|3713318|FG003|STARTED|Cohort 3||8
2996494|NCT00938314|3713315|FG000|COMPLETED|Cohort 3||0
2996495|NCT00938314|3713316|FG001|COMPLETED|Cohort 3||0
2996496|NCT00938314|3713317|FG002|COMPLETED|Cohort 3||20
2996497|NCT00938314|3713318|FG003|COMPLETED|Cohort 3||7
2996498|NCT00938314|3713315|FG000|NOT COMPLETED|Cohort 3||0
2996499|NCT00938314|3713316|FG001|NOT COMPLETED|Cohort 3||0
2996500|NCT00938314|3713317|FG002|NOT COMPLETED|Cohort 3||4
2996501|NCT00938314|3713318|FG003|NOT COMPLETED|Cohort 3||1
2996502|NCT00938327|3713328|FG000|STARTED|Overall Study||332
2996503|NCT00938327|3713328|FG000|COMPLETED|Overall Study||272
2996504|NCT00938327|3713328|FG000|NOT COMPLETED|Overall Study||60
2996505|NCT00938340|3713332|FG000|STARTED|Overall Study||20
2996506|NCT00938340|3713332|FG000|Received Whole Walnut Intervention|Overall Study||16
2996507|NCT00938340|3713332|FG000|Received Walnut Nutmeat Intervention|Overall Study||19
2996508|NCT00938340|3713332|FG000|Received Walnut Skins Intervention|Overall Study||15
2996509|NCT00938340|3713332|FG000|Received Walnut Oil Intervention|Overall Study||15
2996510|NCT00938340|3713332|FG000|COMPLETED|Overall Study||15
2996511|NCT00938340|3713332|FG000|NOT COMPLETED|Overall Study||5
2996512|NCT00938366|3713380|FG000|STARTED|Overall Study||9
2996513|NCT00938366|3713381|FG001|STARTED|Overall Study||9
2996514|NCT00938366|3713380|FG000|COMPLETED|Overall Study||8
2996515|NCT00938366|3713381|FG001|COMPLETED|Overall Study||9
2996516|NCT00938366|3713380|FG000|NOT COMPLETED|Overall Study||1
2996517|NCT00938366|3713381|FG001|NOT COMPLETED|Overall Study||0
2996518|NCT00938392|3713389|FG000|STARTED|Overall Study||362
2996519|NCT00938392|3713390|FG001|STARTED|Overall Study||362
2996520|NCT00938392|3713389|FG000|COMPLETED|Overall Study||360
2996521|NCT00938392|3713390|FG001|COMPLETED|Overall Study||358
2996522|NCT00938392|3713389|FG000|NOT COMPLETED|Overall Study||2
2996523|NCT00938392|3713390|FG001|NOT COMPLETED|Overall Study||4
2996524|NCT00938431|3713399|FG000|STARTED|Overall Study||15
2996525|NCT00938431|3713400|FG001|STARTED|Overall Study||23
2996526|NCT00938431|3713401|FG002|STARTED|Overall Study||9
2996527|NCT00938431|3713399|FG000|COMPLETED|Overall Study||9
2996528|NCT00938431|3713400|FG001|COMPLETED|Overall Study||14
2996529|NCT00938431|3713401|FG002|COMPLETED|Overall Study||1
2996530|NCT00938431|3713399|FG000|NOT COMPLETED|Overall Study||6
2996531|NCT00938431|3713400|FG001|NOT COMPLETED|Overall Study||9
2996532|NCT00938431|3713401|FG002|NOT COMPLETED|Overall Study||8
2996533|NCT00938457|3713413|FG000|STARTED|Overall Study||3
2996534|NCT00938457|3713413|FG000|COMPLETED|Overall Study||3
2996535|NCT00938457|3713413|FG000|NOT COMPLETED|Overall Study||0
2996536|NCT00938470|3713419|FG000|STARTED|Overall Study||34
2996537|NCT00938470|3713420|FG001|STARTED|Overall Study||28
2996538|NCT00938470|3713419|FG000|COMPLETED|Overall Study||27
3164679|NCT01894516|3892107|FG002|STARTED|Period 2 (Week 13 to Week 24)|Nonresponders from Placebo(65 participants) and 50 mg QD (15 participants) moved to 100 mg QD group.|147
3164680|NCT01894516|3892108|FG003|STARTED|Period 2 (Week 13 to Week 24)||66
3164681|NCT01894516|3892105|FG000|COMPLETED|Period 2 (Week 13 to Week 24)||0
3164682|NCT01894516|3892106|FG001|COMPLETED|Period 2 (Week 13 to Week 24)||50
3305425|NCT02989714|4039103|FG000|STARTED|Overall Study||13
3305426|NCT02989714|4039103|FG000|Started Nivolumab|Overall Study||12
2996539|NCT00938470|3713420|FG001|COMPLETED|Overall Study||25
2996540|NCT00938470|3713419|FG000|NOT COMPLETED|Overall Study||7
2996541|NCT00938470|3713420|FG001|NOT COMPLETED|Overall Study||3
2996542|NCT00938548|3713428|FG000|STARTED|Overall Study||35
2996543|NCT00938548|3713429|FG001|STARTED|Overall Study||35
2996544|NCT00938548|3713428|FG000|COMPLETED|Overall Study||35
2996545|NCT00938548|3713429|FG001|COMPLETED|Overall Study||35
2996546|NCT00938548|3713428|FG000|NOT COMPLETED|Overall Study||0
2996547|NCT00938548|3713429|FG001|NOT COMPLETED|Overall Study||0
2996548|NCT00938639|3713437|FG000|STARTED|Overall Study||120
2996549|NCT00938639|3713438|FG001|STARTED|Overall Study||120
2996550|NCT00938639|3713437|FG000|COMPLETED|Overall Study||117
2996551|NCT00938639|3713438|FG001|COMPLETED|Overall Study||116
2996552|NCT00938639|3713437|FG000|NOT COMPLETED|Overall Study||3
2996553|NCT00938639|3713438|FG001|NOT COMPLETED|Overall Study||4
2996554|NCT00938704|3713450|FG000|STARTED|Overall Study||33
2996555|NCT00938704|3713451|FG001|STARTED|Overall Study||37
2996556|NCT00938704|3713450|FG000|COMPLETED|Overall Study||33
2996557|NCT00938704|3713451|FG001|COMPLETED|Overall Study||37
2996558|NCT00938704|3713450|FG000|NOT COMPLETED|Overall Study||0
2996559|NCT00938704|3713451|FG001|NOT COMPLETED|Overall Study||0
2996560|NCT00938717|3713459|FG000|STARTED|Overall Study||403
2996561|NCT00938717|3713460|FG001|STARTED|Overall Study||402
2996562|NCT00938717|3713459|FG000|COMPLETED|Overall Study||305
2996563|NCT00938717|3713460|FG001|COMPLETED|Overall Study||294
2996564|NCT00938717|3713459|FG000|NOT COMPLETED|Overall Study||98
2996565|NCT00938717|3713460|FG001|NOT COMPLETED|Overall Study||108
2996566|NCT00938782|3713468|FG000|STARTED|Overall Study|Pre-induction of anesthesia|32
2996567|NCT00938782|3713469|FG001|STARTED|Overall Study|Monitoring started pre-induction of anesthesia|35
2996568|NCT00938782|3713468|FG000|COMPLETED|Overall Study|Upon discharge from PACU|32
2996569|NCT00938782|3713469|FG001|COMPLETED|Overall Study|Upon discharge from PACU|35
2996570|NCT00938782|3713468|FG000|NOT COMPLETED|Overall Study||0
2996571|NCT00938782|3713469|FG001|NOT COMPLETED|Overall Study||0
2996572|NCT00938860|3713477|FG000|STARTED|Overall Study|Intent-to-Treat (ITT) population. ITT population consisted of all randomized patients|50
2996573|NCT00938860|3713478|FG001|STARTED|Overall Study||42
2996574|NCT00938860|3713477|FG000|Efficacy Population|Overall Study||40
2996575|NCT00938860|3713478|FG001|Efficacy Population|Overall Study||41
2996576|NCT00938860|3713477|FG000|COMPLETED|Overall Study||25
2996577|NCT00938860|3713478|FG001|COMPLETED|Overall Study||25
2996578|NCT00938860|3713477|FG000|NOT COMPLETED|Overall Study||25
2996579|NCT00938860|3713478|FG001|NOT COMPLETED|Overall Study||17
2996580|NCT00938886|3713486|FG000|STARTED|Overall Study||75
2996581|NCT00938886|3713487|FG001|STARTED|Overall Study||75
2996582|NCT00938886|3713486|FG000|Attended 1 Counseling Session|Overall Study||70
2996583|NCT00938886|3713487|FG001|Attended 1 Counseling Session|Overall Study||70
2996584|NCT00938886|3713486|FG000|COMPLETED|Overall Study||68
2996585|NCT00938886|3713487|FG001|COMPLETED|Overall Study||65
2996586|NCT00938886|3713486|FG000|NOT COMPLETED|Overall Study||7
2996587|NCT00938886|3713487|FG001|NOT COMPLETED|Overall Study||10
2996588|NCT00938964|3713495|FG000|STARTED|Overall Study||241
2996589|NCT00938964|3713496|FG001|STARTED|Overall Study||237
3305427|NCT02989714|4039103|FG000|COMPLETED|Overall Study||12
3305428|NCT02989714|4039103|FG000|NOT COMPLETED|Overall Study||1
3305429|NCT02989727|4039112|FG000|STARTED|Overall Study||46
3305430|NCT02989727|4039113|FG001|STARTED|Overall Study||44
3305431|NCT02989727|4039114|FG002|STARTED|Overall Study||30
3305432|NCT02989727|4039115|FG003|STARTED|Overall Study||30
3305433|NCT02989727|4039112|FG000|COMPLETED|Overall Study||46
3305434|NCT02989727|4039113|FG001|COMPLETED|Overall Study||44
3305435|NCT02989727|4039114|FG002|COMPLETED|Overall Study||30
3305436|NCT02989727|4039115|FG003|COMPLETED|Overall Study||30
3305437|NCT02989727|4039112|FG000|NOT COMPLETED|Overall Study||0
3305438|NCT02989727|4039113|FG001|NOT COMPLETED|Overall Study||0
3305439|NCT02989727|4039114|FG002|NOT COMPLETED|Overall Study||0
3305440|NCT02989727|4039115|FG003|NOT COMPLETED|Overall Study||0
3305441|NCT02989805|4039125|FG000|STARTED|Overall Study||160
3305442|NCT02989805|4039126|FG001|STARTED|Overall Study||166
3305443|NCT02989805|4039125|FG000|COMPLETED|Overall Study||154
3305444|NCT02989805|4039126|FG001|COMPLETED|Overall Study||162
3305445|NCT02989805|4039125|FG000|NOT COMPLETED|Overall Study||6
3305446|NCT02989805|4039126|FG001|NOT COMPLETED|Overall Study||4
3305447|NCT02990000|4039134|FG000|STARTED|Overall Study|155 patients were randomly assigned to the Pragmatic Match condition|155
3305448|NCT02990000|4039135|FG001|STARTED|Overall Study|133 patients were randomly assigned to the Scientific Match condition|133
3305449|NCT02990000|4039134|FG000|Begin Treatment|Overall Study|119 Pragmatic Match patients actually began treatment (attended at least 1 session)|119
3305450|NCT02990000|4039135|FG001|Begin Treatment|Overall Study|99 Scientifically Matched patients actually began treatment (attended at least one session)|99
2996590|NCT00938964|3713495|FG000|COMPLETED|Overall Study||211
2996591|NCT00938964|3713496|FG001|COMPLETED|Overall Study||209
2996592|NCT00938964|3713495|FG000|NOT COMPLETED|Overall Study||30
2996593|NCT00938964|3713496|FG001|NOT COMPLETED|Overall Study||28
2996594|NCT00939003|3713504|FG000|STARTED|Double-blind Treatment Period||97
2996595|NCT00939003|3713505|FG001|STARTED|Double-blind Treatment Period||95
2996596|NCT00939003|3713504|FG000|COMPLETED|Double-blind Treatment Period||95
2996597|NCT00939003|3713505|FG001|COMPLETED|Double-blind Treatment Period||91
2996598|NCT00939003|3713504|FG000|NOT COMPLETED|Double-blind Treatment Period||2
2996599|NCT00939003|3713505|FG001|NOT COMPLETED|Double-blind Treatment Period||4
2996600|NCT00939003|3713504|FG000|STARTED|Open-label Treatment Period||95
2996601|NCT00939003|3713505|FG001|STARTED|Open-label Treatment Period||91
2996602|NCT00939003|3713504|FG000|COMPLETED|Open-label Treatment Period||66
2996603|NCT00939003|3713505|FG001|COMPLETED|Open-label Treatment Period||62
2996604|NCT00939003|3713504|FG000|NOT COMPLETED|Open-label Treatment Period||29
2996605|NCT00939003|3713505|FG001|NOT COMPLETED|Open-label Treatment Period||29
2996606|NCT00939029|3713516|FG000|STARTED|Overall Study||25
2996607|NCT00939029|3713517|FG001|STARTED|Overall Study||27
2996608|NCT00939029|3713516|FG000|COMPLETED|Overall Study||19
2996609|NCT00939029|3713517|FG001|COMPLETED|Overall Study||15
2996610|NCT00939029|3713516|FG000|NOT COMPLETED|Overall Study||6
2996611|NCT00939029|3713517|FG001|NOT COMPLETED|Overall Study||12
2996612|NCT00939055|3713525|FG000|STARTED|Overall Study||73
2996613|NCT00939055|3713526|FG001|STARTED|Overall Study||39
2996614|NCT00939055|3713525|FG000|COMPLETED|Overall Study||69
2996615|NCT00939055|3713526|FG001|COMPLETED|Overall Study||39
2996616|NCT00939055|3713525|FG000|NOT COMPLETED|Overall Study||4
2996617|NCT00939055|3713526|FG001|NOT COMPLETED|Overall Study||0
2996618|NCT00939094|3713535|FG000|STARTED|Overall Study||42
2996619|NCT00939094|3713536|FG001|STARTED|Overall Study||45
2996620|NCT00939094|3713535|FG000|COMPLETED|Overall Study||28
2996621|NCT00939094|3713536|FG001|COMPLETED|Overall Study||35
2996622|NCT00939094|3713535|FG000|NOT COMPLETED|Overall Study||14
2996623|NCT00939094|3713536|FG001|NOT COMPLETED|Overall Study||10
2996624|NCT00939107|3713544|FG000|STARTED|Overall Study||175
2996625|NCT00939107|3713545|FG001|STARTED|Overall Study||175
2996626|NCT00939107|3713544|FG000|12 Months Follow-up|Overall Study||161
2996627|NCT00939107|3713545|FG001|12 Months Follow-up|Overall Study||163
2996628|NCT00939107|3713544|FG000|COMPLETED|Overall Study||161
2996629|NCT00939107|3713545|FG001|COMPLETED|Overall Study||163
2996630|NCT00939107|3713544|FG000|NOT COMPLETED|Overall Study||14
2996631|NCT00939107|3713545|FG001|NOT COMPLETED|Overall Study||12
2996632|NCT00939120|3713553|FG000|STARTED|Overall Study||23
2996633|NCT00939120|3713554|FG001|STARTED|Overall Study||23
2996634|NCT00939120|3713553|FG000|COMPLETED|Overall Study||15
2996635|NCT00939120|3713554|FG001|COMPLETED|Overall Study||18
2996636|NCT00939120|3713553|FG000|NOT COMPLETED|Overall Study||8
2996637|NCT00939120|3713554|FG001|NOT COMPLETED|Overall Study||5
2996638|NCT00939159|3713560|FG000|STARTED|Overall Study||13
2996639|NCT00939159|3713560|FG000|COMPLETED|Overall Study||13
2996640|NCT00939159|3713560|FG000|NOT COMPLETED|Overall Study||0
2996641|NCT00939185|3713564|FG000|STARTED|Overall Study||400
2996642|NCT00939185|3713564|FG000|Received Treatment|Overall Study||390
2996643|NCT00939185|3713564|FG000|COMPLETED|Overall Study||375
2996644|NCT00939185|3713564|FG000|NOT COMPLETED|Overall Study||25
2996645|NCT00939198|3713568|FG000|STARTED|Overall Study||87
2996646|NCT00939198|3713568|FG000|COMPLETED|Overall Study||87
2996647|NCT00939198|3713568|FG000|NOT COMPLETED|Overall Study||0
2996648|NCT00939211|3713573|FG000|STARTED|AZD9164 100 Mcg First, Then Placebo|Cross-over study|28
2996649|NCT00939211|3713573|FG000|COMPLETED|AZD9164 100 Mcg First, Then Placebo||28
2996650|NCT00939211|3713573|FG000|NOT COMPLETED|AZD9164 100 Mcg First, Then Placebo||0
2996651|NCT00939211|3713573|FG000|STARTED|AZD9164 400 Mcg First, Then Placebo||28
2996652|NCT00939211|3713573|FG000|COMPLETED|AZD9164 400 Mcg First, Then Placebo||28
2996653|NCT00939211|3713573|FG000|NOT COMPLETED|AZD9164 400 Mcg First, Then Placebo||0
2996654|NCT00939211|3713573|FG000|STARTED|AZD9164 1200 Mcg First, Then Placebo||28
2996655|NCT00939211|3713573|FG000|COMPLETED|AZD9164 1200 Mcg First, Then Placebo||28
2996656|NCT00939211|3713573|FG000|NOT COMPLETED|AZD9164 1200 Mcg First, Then Placebo||0
2996657|NCT00939211|3713573|FG000|STARTED|Spiriva 18 Mcg First, Then Placebo||28
2996658|NCT00939211|3713573|FG000|COMPLETED|Spiriva 18 Mcg First, Then Placebo||28
2996659|NCT00939211|3713573|FG000|NOT COMPLETED|Spiriva 18 Mcg First, Then Placebo||0
2996660|NCT00939211|3713573|FG000|STARTED|Placebo||28
2996661|NCT00939211|3713573|FG000|COMPLETED|Placebo||28
2996662|NCT00939211|3713573|FG000|NOT COMPLETED|Placebo||0
2996663|NCT00939341|3713585|FG000|STARTED|Overall Study|1022 participants were enrolled. There were 160 screen failures, 862 proceeded to treatment period.|862
2996664|NCT00939341|3713585|FG000|COMPLETED|Overall Study|862 participants entered into the 12-week treatment,66 discontinued, 796 completed the treatment.|796
2996665|NCT00939341|3713585|FG000|NOT COMPLETED|Overall Study||66
2996666|NCT00939367|3713589|FG000|STARTED|First Intervention||15
2996667|NCT00939367|3713590|FG001|STARTED|First Intervention||15
2996668|NCT00939367|3713589|FG000|COMPLETED|First Intervention||15
2996669|NCT00939367|3713590|FG001|COMPLETED|First Intervention||15
2996670|NCT00939367|3713589|FG000|NOT COMPLETED|First Intervention||0
2996671|NCT00939367|3713590|FG001|NOT COMPLETED|First Intervention||0
2996672|NCT00939367|3713589|FG000|STARTED|Second Intervention||15
2996673|NCT00939367|3713590|FG001|STARTED|Second Intervention||15
2996674|NCT00939367|3713589|FG000|COMPLETED|Second Intervention||15
2996675|NCT00939367|3713590|FG001|COMPLETED|Second Intervention||15
2996676|NCT00939367|3713589|FG000|NOT COMPLETED|Second Intervention||0
2996677|NCT00939367|3713590|FG001|NOT COMPLETED|Second Intervention||0
2996678|NCT00939393|3713598|FG000|STARTED|Overall Study||37
2996679|NCT00939393|3713599|FG001|STARTED|Overall Study||35
2996680|NCT00939393|3713598|FG000|COMPLETED|Overall Study||33
2996681|NCT00939393|3713599|FG001|COMPLETED|Overall Study||35
2996682|NCT00939393|3713598|FG000|NOT COMPLETED|Overall Study||4
2996683|NCT00939393|3713599|FG001|NOT COMPLETED|Overall Study||0
2996684|NCT00939471|3713607|FG000|STARTED|Overall Study||44
2996685|NCT00939471|3713607|FG000|COMPLETED|Overall Study||33
2996686|NCT00939471|3713607|FG000|NOT COMPLETED|Overall Study||11
2996687|NCT00939484|3713614|FG000|STARTED|Overall Study||8
2996688|NCT00939484|3713615|FG001|STARTED|Overall Study||20
2996689|NCT00939484|3713616|FG002|STARTED|Overall Study||3
2996690|NCT00939484|3713614|FG000|COMPLETED|Overall Study||0
2996691|NCT00939484|3713615|FG001|COMPLETED|Overall Study||0
2996692|NCT00939484|3713616|FG002|COMPLETED|Overall Study||0
2996693|NCT00939484|3713614|FG000|NOT COMPLETED|Overall Study||8
2996694|NCT00939484|3713615|FG001|NOT COMPLETED|Overall Study||20
2996695|NCT00939484|3713616|FG002|NOT COMPLETED|Overall Study||3
2996696|NCT00939510|3713626|FG000|STARTED|Overall Study||32
2996697|NCT00939510|3713626|FG000|COMPLETED|Overall Study||31
2996698|NCT00939510|3713626|FG000|NOT COMPLETED|Overall Study||1
2996699|NCT00939523|3713630|FG000|STARTED|Overall Study||9
2996700|NCT00939523|3713630|FG000|COMPLETED|Overall Study||6
2996701|NCT00939523|3713630|FG000|NOT COMPLETED|Overall Study||3
2996702|NCT00939536|3713636|FG000|STARTED|First Intervention||12
2996703|NCT00939536|3713637|FG001|STARTED|First Intervention||12
2996704|NCT00939536|3713636|FG000|COMPLETED|First Intervention||12
2996705|NCT00939536|3713637|FG001|COMPLETED|First Intervention||12
2996706|NCT00939536|3713636|FG000|NOT COMPLETED|First Intervention||0
2996707|NCT00939536|3713637|FG001|NOT COMPLETED|First Intervention||0
2996708|NCT00939536|3713636|FG000|STARTED|Second Intervention||12
2996709|NCT00939536|3713637|FG001|STARTED|Second Intervention||12
2996710|NCT00939536|3713636|FG000|COMPLETED|Second Intervention||12
2996711|NCT00939536|3713637|FG001|COMPLETED|Second Intervention||12
2996712|NCT00939536|3713636|FG000|NOT COMPLETED|Second Intervention||0
2996713|NCT00939536|3713637|FG001|NOT COMPLETED|Second Intervention||0
2996714|NCT00939562|3713643|FG000|STARTED|Period 1||12
2996715|NCT00939562|3713644|FG001|STARTED|Period 1||12
2996716|NCT00939562|3713643|FG000|COMPLETED|Period 1||12
2996717|NCT00939562|3713644|FG001|COMPLETED|Period 1||12
2996718|NCT00939562|3713643|FG000|NOT COMPLETED|Period 1||0
2996719|NCT00939562|3713644|FG001|NOT COMPLETED|Period 1||0
2996720|NCT00939562|3713643|FG000|STARTED|Period 2||12
2996721|NCT00939562|3713644|FG001|STARTED|Period 2||12
2996722|NCT00939562|3713643|FG000|COMPLETED|Period 2||12
2996723|NCT00939562|3713644|FG001|COMPLETED|Period 2||12
2996724|NCT00939562|3713643|FG000|NOT COMPLETED|Period 2||0
2996725|NCT00939562|3713644|FG001|NOT COMPLETED|Period 2||0
2996726|NCT00939627|3713652|FG000|STARTED|Overall Study||27
2996727|NCT00939627|3713653|FG001|STARTED|Overall Study||28
2996728|NCT00939627|3713654|FG002|STARTED|Overall Study||0
2996729|NCT00939627|3713652|FG000|COMPLETED|Overall Study||0
2996730|NCT00939627|3713653|FG001|COMPLETED|Overall Study||0
2996731|NCT00939627|3713654|FG002|COMPLETED|Overall Study||0
2996732|NCT00939627|3713652|FG000|NOT COMPLETED|Overall Study||27
2996733|NCT00939627|3713653|FG001|NOT COMPLETED|Overall Study||28
2996734|NCT00939627|3713654|FG002|NOT COMPLETED|Overall Study||0
2996735|NCT00939640|3713660|FG000|STARTED|Overall Study||14
2996736|NCT00939640|3713660|FG000|COMPLETED|Overall Study||13
2996737|NCT00939640|3713660|FG000|NOT COMPLETED|Overall Study||1
2996738|NCT00939653|3713669|FG000|STARTED|Treatment Course 1||6
2996739|NCT00939653|3713669|FG000|COMPLETED|Treatment Course 1||6
2996740|NCT00939653|3713669|FG000|NOT COMPLETED|Treatment Course 1||0
2996741|NCT00939653|3713669|FG000|STARTED|Treatment Course 2||2
2996742|NCT00939653|3713669|FG000|COMPLETED|Treatment Course 2||2
2996743|NCT00939653|3713669|FG000|NOT COMPLETED|Treatment Course 2||0
2996744|NCT00939653|3713669|FG000|STARTED|Treatment Course 3||0
2996745|NCT00939653|3713669|FG000|COMPLETED|Treatment Course 3||0
2996746|NCT00939653|3713669|FG000|NOT COMPLETED|Treatment Course 3||0
2996747|NCT00939653|3713669|FG000|STARTED|Treatment Course 4||0
2996748|NCT00939653|3713669|FG000|COMPLETED|Treatment Course 4||0
2996749|NCT00939653|3713669|FG000|NOT COMPLETED|Treatment Course 4||0
2996750|NCT00939692|3713676|FG000|STARTED|Period 1 - First Intervention - 5 Days||13
2996751|NCT00939692|3713677|FG001|STARTED|Period 1 - First Intervention - 5 Days||13
2996752|NCT00939692|3713676|FG000|COMPLETED|Period 1 - First Intervention - 5 Days||12
2996753|NCT00939692|3713677|FG001|COMPLETED|Period 1 - First Intervention - 5 Days||13
2996754|NCT00939692|3713676|FG000|NOT COMPLETED|Period 1 - First Intervention - 5 Days||1
2996755|NCT00939692|3713677|FG001|NOT COMPLETED|Period 1 - First Intervention - 5 Days||0
2996756|NCT00939692|3713676|FG000|STARTED|Period 2 - Second Intervent - 5 Days||12
2996757|NCT00939692|3713677|FG001|STARTED|Period 2 - Second Intervent - 5 Days||13
2996758|NCT00939692|3713676|FG000|COMPLETED|Period 2 - Second Intervent - 5 Days||12
2996759|NCT00939692|3713677|FG001|COMPLETED|Period 2 - Second Intervent - 5 Days||12
2996760|NCT00939692|3713676|FG000|NOT COMPLETED|Period 2 - Second Intervent - 5 Days||0
2996761|NCT00939692|3713677|FG001|NOT COMPLETED|Period 2 - Second Intervent - 5 Days||1
2996762|NCT00939705|3713685|FG000|STARTED|Period 1 - First Intervention - 5 Days||9
2996763|NCT00939705|3713686|FG001|STARTED|Period 1 - First Intervention - 5 Days||9
2996764|NCT00939705|3713685|FG000|COMPLETED|Period 1 - First Intervention - 5 Days||9
2996765|NCT00939705|3713686|FG001|COMPLETED|Period 1 - First Intervention - 5 Days||9
2996766|NCT00939705|3713685|FG000|NOT COMPLETED|Period 1 - First Intervention - 5 Days||0
2996767|NCT00939705|3713686|FG001|NOT COMPLETED|Period 1 - First Intervention - 5 Days||0
2996768|NCT00939705|3713685|FG000|STARTED|Period 2 - Washout Period - 21 Days||9
2996769|NCT00939705|3713686|FG001|STARTED|Period 2 - Washout Period - 21 Days||9
2996770|NCT00939705|3713685|FG000|COMPLETED|Period 2 - Washout Period - 21 Days||9
2996771|NCT00939705|3713686|FG001|COMPLETED|Period 2 - Washout Period - 21 Days||9
2996772|NCT00939705|3713685|FG000|NOT COMPLETED|Period 2 - Washout Period - 21 Days||0
2996773|NCT00939705|3713686|FG001|NOT COMPLETED|Period 2 - Washout Period - 21 Days||0
2996774|NCT00939705|3713685|FG000|STARTED|Period 3 - Second Intervent - 5 Days||9
2996775|NCT00939705|3713686|FG001|STARTED|Period 3 - Second Intervent - 5 Days||9
2996776|NCT00939705|3713685|FG000|COMPLETED|Period 3 - Second Intervent - 5 Days||9
2996777|NCT00939705|3713686|FG001|COMPLETED|Period 3 - Second Intervent - 5 Days||9
2996778|NCT00939705|3713685|FG000|NOT COMPLETED|Period 3 - Second Intervent - 5 Days||0
2996779|NCT00939705|3713686|FG001|NOT COMPLETED|Period 3 - Second Intervent - 5 Days||0
2996780|NCT00939731|3713692|FG000|STARTED|First Intervention Period||12
2996781|NCT00939731|3713693|FG001|STARTED|First Intervention Period||12
2996782|NCT00939731|3713692|FG000|COMPLETED|First Intervention Period||12
2996783|NCT00939731|3713693|FG001|COMPLETED|First Intervention Period||12
2996784|NCT00939731|3713692|FG000|NOT COMPLETED|First Intervention Period||0
2996785|NCT00939731|3713693|FG001|NOT COMPLETED|First Intervention Period||0
2996786|NCT00939731|3713692|FG000|STARTED|Washout Period (at Least 14 Days)||12
2996787|NCT00939731|3713693|FG001|STARTED|Washout Period (at Least 14 Days)||12
2996788|NCT00939731|3713692|FG000|COMPLETED|Washout Period (at Least 14 Days)||12
2996789|NCT00939731|3713693|FG001|COMPLETED|Washout Period (at Least 14 Days)||12
2996790|NCT00939731|3713692|FG000|NOT COMPLETED|Washout Period (at Least 14 Days)||0
2996791|NCT00939731|3713693|FG001|NOT COMPLETED|Washout Period (at Least 14 Days)||0
2996792|NCT00939731|3713692|FG000|STARTED|Second Intervention Period||12
2996793|NCT00939731|3713693|FG001|STARTED|Second Intervention Period||12
2996794|NCT00939731|3713692|FG000|COMPLETED|Second Intervention Period||12
2996795|NCT00939731|3713693|FG001|COMPLETED|Second Intervention Period||12
2996796|NCT00939731|3713692|FG000|NOT COMPLETED|Second Intervention Period||0
2996797|NCT00939731|3713693|FG001|NOT COMPLETED|Second Intervention Period||0
2996798|NCT00939770|3713707|FG000|STARTED|Overall Study||6
2996799|NCT00939770|3713708|FG001|STARTED|Overall Study||8
2996800|NCT00939770|3713709|FG002|STARTED|Overall Study||23
2996801|NCT00939770|3713710|FG003|STARTED|Overall Study||12
2996802|NCT00939770|3713711|FG004|STARTED|Overall Study||38
2996803|NCT00939770|3713712|FG005|STARTED|Overall Study||11
2996804|NCT00939770|3713713|FG006|STARTED|Overall Study||14
2996805|NCT00939770|3713714|FG007|STARTED|Overall Study||10
2996806|NCT00939770|3713707|FG000|COMPLETED|Overall Study||1
2996807|NCT00939770|3713708|FG001|COMPLETED|Overall Study||0
2996808|NCT00939770|3713709|FG002|COMPLETED|Overall Study||3
2996809|NCT00939770|3713710|FG003|COMPLETED|Overall Study||1
2996810|NCT00939770|3713711|FG004|COMPLETED|Overall Study||1
2996811|NCT00939770|3713712|FG005|COMPLETED|Overall Study||0
2996812|NCT00939770|3713713|FG006|COMPLETED|Overall Study||0
2996813|NCT00939770|3713714|FG007|COMPLETED|Overall Study||0
2996814|NCT00939770|3713707|FG000|NOT COMPLETED|Overall Study||5
2996815|NCT00939770|3713708|FG001|NOT COMPLETED|Overall Study||8
2996816|NCT00939770|3713709|FG002|NOT COMPLETED|Overall Study||20
2996817|NCT00939770|3713710|FG003|NOT COMPLETED|Overall Study||11
2996818|NCT00939770|3713711|FG004|NOT COMPLETED|Overall Study||37
2996819|NCT00939770|3713712|FG005|NOT COMPLETED|Overall Study||11
2996820|NCT00939770|3713713|FG006|NOT COMPLETED|Overall Study||14
3305451|NCT02990000|4039134|FG000|COMPLETED|Overall Study|119 patients provided naturalistic treatment data and were included in analyses|119
3305452|NCT02990000|4039135|FG001|COMPLETED|Overall Study|99 patients provided naturalistic treatment data and were included in analyses|99
3305453|NCT02990000|4039134|FG000|NOT COMPLETED|Overall Study||36
3305454|NCT02990000|4039135|FG001|NOT COMPLETED|Overall Study||34
3305455|NCT02990338|4039143|FG000|STARTED|Overall Study||153
3305456|NCT02990338|4039144|FG001|STARTED|Overall Study||154
3305457|NCT02990338|4039143|FG000|Treated|Overall Study||149
3305458|NCT02990338|4039144|FG001|Treated|Overall Study||152
3305459|NCT02990338|4039143|FG000|Ongoing|Overall Study||35
3305460|NCT02990338|4039144|FG001|Ongoing|Overall Study||65
3305461|NCT02990338|4039143|FG000|COMPLETED|Overall Study||35
3305462|NCT02990338|4039144|FG001|COMPLETED|Overall Study||65
3305463|NCT02990338|4039143|FG000|NOT COMPLETED|Overall Study||118
3305464|NCT02990338|4039144|FG001|NOT COMPLETED|Overall Study||89
3305465|NCT02990910|4039153|FG000|STARTED|Overall Study||140
3305466|NCT02990910|4039154|FG001|STARTED|Overall Study||140
3305467|NCT02990910|4039153|FG000|COMPLETED|Overall Study||134
3305468|NCT02990910|4039154|FG001|COMPLETED|Overall Study||130
3305469|NCT02990910|4039153|FG000|NOT COMPLETED|Overall Study||6
3305470|NCT02990910|4039154|FG001|NOT COMPLETED|Overall Study||10
3305471|NCT02991040|4039160|FG000|STARTED|Overall Study||100
3305472|NCT02991040|4039160|FG000|COMPLETED|Overall Study||96
3305473|NCT02991040|4039160|FG000|NOT COMPLETED|Overall Study||4
3305474|NCT02991118|4039168|FG000|STARTED|Overall Study||257
3305475|NCT02991118|4039169|FG001|STARTED|Overall Study||522
3305476|NCT02991118|4039168|FG000|COMPLETED|Overall Study||250
3305477|NCT02991118|4039169|FG001|COMPLETED|Overall Study||490
3305478|NCT02991118|4039168|FG000|NOT COMPLETED|Overall Study||7
2996821|NCT00939770|3713714|FG007|NOT COMPLETED|Overall Study||10
2996822|NCT00939783|3713745|FG000|STARTED|Overall Study||649
2996823|NCT00939783|3713745|FG000|Treated|Overall Study||648
2996824|NCT00939783|3713745|FG000|COMPLETED|Overall Study||0
2996825|NCT00939783|3713745|FG000|NOT COMPLETED|Overall Study||649
2996826|NCT00939796|3713749|FG000|STARTED|Overall Study||16
3305479|NCT02991118|4039169|FG001|NOT COMPLETED|Overall Study||32
3305480|NCT02991729|4039177|FG000|STARTED|Overall Study||105
3305481|NCT02991729|4039178|FG001|STARTED|Overall Study||92
3305482|NCT02991729|4039177|FG000|COMPLETED|Overall Study||105
3305483|NCT02991729|4039178|FG001|COMPLETED|Overall Study||92
3305484|NCT02991729|4039177|FG000|NOT COMPLETED|Overall Study||0
3305485|NCT02991729|4039178|FG001|NOT COMPLETED|Overall Study||0
3305486|NCT02991820|4039188|FG000|STARTED|Overall Study||12
3305487|NCT02991820|4039189|FG001|STARTED|Overall Study||31
2996827|NCT00939796|3713749|FG000|COMPLETED|Overall Study||16
2996828|NCT00939796|3713749|FG000|NOT COMPLETED|Overall Study||0
2996829|NCT00939809|3713753|FG000|STARTED|Overall Study||31
2996830|NCT00939809|3713753|FG000|COMPLETED|Overall Study|Patients treated until disease progression; completed defined as off treatment due to progression.|28
2996831|NCT00939809|3713753|FG000|NOT COMPLETED|Overall Study||3
2996832|NCT00939822|3713759|FG000|STARTED|Overall Study||44
2996833|NCT00939822|3713760|FG001|STARTED|Overall Study||44
2996834|NCT00939822|3713759|FG000|COMPLETED|Overall Study||42
2996835|NCT00939822|3713760|FG001|COMPLETED|Overall Study||41
2996836|NCT00939822|3713759|FG000|NOT COMPLETED|Overall Study||2
2996837|NCT00939822|3713760|FG001|NOT COMPLETED|Overall Study||3
2996838|NCT00939874|3713766|FG000|STARTED|Overall Study||52
2996839|NCT00939874|3713766|FG000|Completed Week 48|Overall Study||37
2996840|NCT00939874|3713766|FG000|COMPLETED|Overall Study||32
2996841|NCT00939874|3713766|FG000|NOT COMPLETED|Overall Study||20
2996842|NCT00939900|3713772|FG000|STARTED|Overall Study||55
2996843|NCT00939900|3713773|FG001|STARTED|Overall Study||55
2996844|NCT00939900|3713772|FG000|COMPLETED|Overall Study||53
2996845|NCT00939900|3713773|FG001|COMPLETED|Overall Study||48
2996846|NCT00939900|3713772|FG000|NOT COMPLETED|Overall Study||2
2996847|NCT00939900|3713773|FG001|NOT COMPLETED|Overall Study||7
2996848|NCT00939952|3713779|FG000|STARTED|Overall Study||7
2996849|NCT00939952|3713779|FG000|COMPLETED|Overall Study||7
2996850|NCT00939952|3713779|FG000|NOT COMPLETED|Overall Study||0
2996851|NCT00939991|3713785|FG000|STARTED|Overall Study||9
2996852|NCT00939991|3713786|FG001|STARTED|Overall Study||39
2996853|NCT00939991|3713785|FG000|COMPLETED|Overall Study||9
2996854|NCT00939991|3713786|FG001|COMPLETED|Overall Study||39
2996855|NCT00939991|3713785|FG000|NOT COMPLETED|Overall Study||0
2996856|NCT00939991|3713786|FG001|NOT COMPLETED|Overall Study||0
2996857|NCT00940017|3713792|FG000|STARTED|Overall Study||24
2996858|NCT00940017|3713792|FG000|Subjects Treated|Overall Study||21
2996859|NCT00940017|3713792|FG000|COMPLETED|Overall Study||20
2996860|NCT00940017|3713792|FG000|NOT COMPLETED|Overall Study||4
2996861|NCT00940108|3713800|FG000|STARTED|Overall Study||82
2996862|NCT00940108|3713801|FG001|STARTED|Overall Study||80
2996863|NCT00940108|3713802|FG002|STARTED|Overall Study||103
2996864|NCT00940108|3713803|FG003|STARTED|Overall Study||104
2996865|NCT00940108|3713800|FG000|COMPLETED|Overall Study||77
2996866|NCT00940108|3713801|FG001|COMPLETED|Overall Study||71
3305488|NCT02991820|4039188|FG000|COMPLETED|Overall Study||12
3305489|NCT02991820|4039189|FG001|COMPLETED|Overall Study||31
3305490|NCT02991820|4039188|FG000|NOT COMPLETED|Overall Study||0
3305491|NCT02991820|4039189|FG001|NOT COMPLETED|Overall Study||0
3305492|NCT02991859|4039214|FG000|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2
3305493|NCT02991859|4039215|FG001|STARTED|Period 1,Escalation Phase 1,Upto Day 7||3
3305494|NCT02991859|4039216|FG002|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2
3305495|NCT02991859|4039217|FG003|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2
3305496|NCT02991859|4039218|FG004|STARTED|Period 1,Escalation Phase 1,Upto Day 7||3
3305497|NCT02991859|4039219|FG005|STARTED|Period 1,Escalation Phase 1,Upto Day 7||3
3305498|NCT02991859|4039220|FG006|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2
3305499|NCT02991859|4039221|FG007|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2
3305500|NCT02991859|4039222|FG008|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2
3305501|NCT02991859|4039223|FG009|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2
3305502|NCT02991859|4039224|FG010|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2
3305503|NCT02991859|4039225|FG011|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2
3305504|NCT02991859|4039226|FG012|STARTED|Period 1,Escalation Phase 1,Upto Day 7||7
3305505|NCT02991859|4039227|FG013|STARTED|Period 1,Escalation Phase 1,Upto Day 7||7
3305506|NCT02991859|4039228|FG014|STARTED|Period 1,Escalation Phase 1,Upto Day 7||6
3305507|NCT02991859|4039229|FG015|STARTED|Period 1,Escalation Phase 1,Upto Day 7||3
3305508|NCT02991859|4039230|FG016|STARTED|Period 1,Escalation Phase 1,Upto Day 7||3
3305509|NCT02991859|4039214|FG000|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
3305510|NCT02991859|4039215|FG001|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
2996867|NCT00940108|3713802|FG002|COMPLETED|Overall Study||100
2996868|NCT00940108|3713803|FG003|COMPLETED|Overall Study||99
2996869|NCT00940108|3713800|FG000|NOT COMPLETED|Overall Study||5
2996870|NCT00940108|3713801|FG001|NOT COMPLETED|Overall Study||9
2996871|NCT00940108|3713802|FG002|NOT COMPLETED|Overall Study||3
2996872|NCT00940108|3713803|FG003|NOT COMPLETED|Overall Study||5
2996873|NCT00940290|3713817|FG000|STARTED|Overall Study||54
2996874|NCT00940290|3713818|FG001|STARTED|Overall Study||53
2996875|NCT00940290|3713819|FG002|STARTED|Overall Study||55
2996876|NCT00940290|3713820|FG003|STARTED|Overall Study||54
2996877|NCT00940290|3713817|FG000|COMPLETED|Overall Study||54
2996878|NCT00940290|3713818|FG001|COMPLETED|Overall Study||53
2996879|NCT00940290|3713819|FG002|COMPLETED|Overall Study||55
2996880|NCT00940290|3713820|FG003|COMPLETED|Overall Study||54
2996881|NCT00940290|3713817|FG000|NOT COMPLETED|Overall Study||0
2996882|NCT00940290|3713818|FG001|NOT COMPLETED|Overall Study||0
2996883|NCT00940290|3713819|FG002|NOT COMPLETED|Overall Study||0
2996884|NCT00940290|3713820|FG003|NOT COMPLETED|Overall Study||0
2996885|NCT00940316|3713833|FG000|STARTED|Reached First Response at 8 Weeks||13
2996886|NCT00940316|3713834|FG001|STARTED|Reached First Response at 8 Weeks||13
2996887|NCT00940316|3713835|FG002|STARTED|Reached First Response at 8 Weeks||2
2996888|NCT00940316|3713833|FG000|COMPLETED|Reached First Response at 8 Weeks||10
2996889|NCT00940316|3713834|FG001|COMPLETED|Reached First Response at 8 Weeks||9
2996890|NCT00940316|3713835|FG002|COMPLETED|Reached First Response at 8 Weeks||2
2996891|NCT00940316|3713833|FG000|NOT COMPLETED|Reached First Response at 8 Weeks||3
2996892|NCT00940316|3713834|FG001|NOT COMPLETED|Reached First Response at 8 Weeks||4
2996893|NCT00940316|3713835|FG002|NOT COMPLETED|Reached First Response at 8 Weeks||0
2996894|NCT00940316|3713833|FG000|STARTED|Moved on to be Treated Cycle 5||10
2996895|NCT00940316|3713834|FG001|STARTED|Moved on to be Treated Cycle 5||9
2996896|NCT00940316|3713835|FG002|STARTED|Moved on to be Treated Cycle 5||2
2996897|NCT00940316|3713833|FG000|COMPLETED|Moved on to be Treated Cycle 5||8
2996898|NCT00940316|3713834|FG001|COMPLETED|Moved on to be Treated Cycle 5||9
2996899|NCT00940316|3713835|FG002|COMPLETED|Moved on to be Treated Cycle 5||2
2996900|NCT00940316|3713833|FG000|NOT COMPLETED|Moved on to be Treated Cycle 5||2
2996901|NCT00940316|3713834|FG001|NOT COMPLETED|Moved on to be Treated Cycle 5||0
2996902|NCT00940316|3713835|FG002|NOT COMPLETED|Moved on to be Treated Cycle 5||0
2996903|NCT00940316|3713833|FG000|STARTED|Treated After Cycle 5||8
2996904|NCT00940316|3713834|FG001|STARTED|Treated After Cycle 5||9
2996905|NCT00940316|3713835|FG002|STARTED|Treated After Cycle 5||2
2996906|NCT00940316|3713833|FG000|COMPLETED|Treated After Cycle 5||8
2996907|NCT00940316|3713834|FG001|COMPLETED|Treated After Cycle 5||8
2996908|NCT00940316|3713835|FG002|COMPLETED|Treated After Cycle 5||1
2996909|NCT00940316|3713833|FG000|NOT COMPLETED|Treated After Cycle 5||0
2996910|NCT00940316|3713834|FG001|NOT COMPLETED|Treated After Cycle 5||1
2996911|NCT00940316|3713835|FG002|NOT COMPLETED|Treated After Cycle 5||1
2996912|NCT00940316|3713833|FG000|STARTED|Crossed Over to Arm A After Progression||0
2996913|NCT00940316|3713834|FG001|STARTED|Crossed Over to Arm A After Progression||3
2996914|NCT00940316|3713835|FG002|STARTED|Crossed Over to Arm A After Progression||0
2996915|NCT00940316|3713833|FG000|Treated for Cycle One|Crossed Over to Arm A After Progression||0
2996916|NCT00940316|3713834|FG001|Treated for Cycle One|Crossed Over to Arm A After Progression||3
2996917|NCT00940316|3713835|FG002|Treated for Cycle One|Crossed Over to Arm A After Progression||0
2996918|NCT00940316|3713833|FG000|COMPLETED|Crossed Over to Arm A After Progression||0
2996919|NCT00940316|3713834|FG001|COMPLETED|Crossed Over to Arm A After Progression||3
2996920|NCT00940316|3713835|FG002|COMPLETED|Crossed Over to Arm A After Progression||0
2996921|NCT00940316|3713833|FG000|NOT COMPLETED|Crossed Over to Arm A After Progression||0
2996922|NCT00940316|3713834|FG001|NOT COMPLETED|Crossed Over to Arm A After Progression||0
2996923|NCT00940316|3713835|FG002|NOT COMPLETED|Crossed Over to Arm A After Progression||0
2996924|NCT00940316|3713833|FG000|STARTED|Follow up Every 3 Months||13
2996925|NCT00940316|3713834|FG001|STARTED|Follow up Every 3 Months||13
2996926|NCT00940316|3713835|FG002|STARTED|Follow up Every 3 Months||2
2996927|NCT00940316|3713833|FG000|COMPLETED|Follow up Every 3 Months||13
2996928|NCT00940316|3713834|FG001|COMPLETED|Follow up Every 3 Months||13
2996929|NCT00940316|3713835|FG002|COMPLETED|Follow up Every 3 Months||2
2996930|NCT00940316|3713833|FG000|NOT COMPLETED|Follow up Every 3 Months||0
2996931|NCT00940316|3713834|FG001|NOT COMPLETED|Follow up Every 3 Months||0
2996932|NCT00940316|3713835|FG002|NOT COMPLETED|Follow up Every 3 Months||0
2996933|NCT00940342|3713854|FG000|STARTED|Overall Study||50
2996934|NCT00940342|3713855|FG001|STARTED|Overall Study||40
2996935|NCT00940342|3713856|FG002|STARTED|Overall Study||40
2996936|NCT00940342|3713854|FG000|COMPLETED|Overall Study||50
3164683|NCT01894516|3892107|FG002|COMPLETED|Period 2 (Week 13 to Week 24)||142
3164684|NCT01894516|3892108|FG003|COMPLETED|Period 2 (Week 13 to Week 24)||65
3164685|NCT01894516|3892105|FG000|NOT COMPLETED|Period 2 (Week 13 to Week 24)||0
3164686|NCT01894516|3892106|FG001|NOT COMPLETED|Period 2 (Week 13 to Week 24)||2
3164687|NCT01894516|3892107|FG002|NOT COMPLETED|Period 2 (Week 13 to Week 24)||5
3164688|NCT01894516|3892108|FG003|NOT COMPLETED|Period 2 (Week 13 to Week 24)||1
3164689|NCT01894555|3892122|FG000|STARTED|Overall Study||33
3164690|NCT01894555|3892122|FG000|COMPLETED|Overall Study||33
3164691|NCT01894555|3892122|FG000|NOT COMPLETED|Overall Study||0
3164692|NCT01894568|3892128|FG000|STARTED|Overall Study||192
3164693|NCT01894568|3892129|FG001|STARTED|Overall Study||196
3164694|NCT01894568|3892128|FG000|Received at Least 1 Dose of Study Drug|Overall Study||192
3164695|NCT01894568|3892129|FG001|Received at Least 1 Dose of Study Drug|Overall Study||196
3164696|NCT01894568|3892128|FG000|COMPLETED|Overall Study||182
3164697|NCT01894568|3892129|FG001|COMPLETED|Overall Study||186
3164698|NCT01894568|3892128|FG000|NOT COMPLETED|Overall Study||10
3164699|NCT01894568|3892129|FG001|NOT COMPLETED|Overall Study||10
3164700|NCT01894581|3892138|FG000|STARTED|Overall Study||20
3164701|NCT01894581|3892139|FG001|STARTED|Overall Study||19
3164702|NCT01894581|3892138|FG000|COMPLETED|Overall Study||15
2996937|NCT00940342|3713855|FG001|COMPLETED|Overall Study||38
3164703|NCT01894581|3892139|FG001|COMPLETED|Overall Study||12
3164704|NCT01894581|3892138|FG000|NOT COMPLETED|Overall Study||5
3164705|NCT01894581|3892139|FG001|NOT COMPLETED|Overall Study||7
3164706|NCT01894607|3892145|FG000|STARTED|Overall Study||11
3164707|NCT01894607|3892145|FG000|COMPLETED|Overall Study||10
3164708|NCT01894607|3892145|FG000|NOT COMPLETED|Overall Study||1
3164709|NCT01894620|3892151|FG000|STARTED|Overall Study||6
3164710|NCT01894620|3892152|FG001|STARTED|Overall Study||5
3164711|NCT01894620|3892151|FG000|COMPLETED|Overall Study||6
3164712|NCT01894620|3892152|FG001|COMPLETED|Overall Study||4
3164713|NCT01894620|3892151|FG000|NOT COMPLETED|Overall Study||0
3164714|NCT01894620|3892152|FG001|NOT COMPLETED|Overall Study||1
3164715|NCT01894672|3892160|FG000|STARTED|Overall Study||7
3164716|NCT01894672|3892160|FG000|COMPLETED|Overall Study||7
3164717|NCT01894672|3892160|FG000|NOT COMPLETED|Overall Study||0
3164718|NCT01894776|3892165|FG000|STARTED|Overall Study||15
3164719|NCT01894776|3892165|FG000|COMPLETED|Overall Study||14
3164720|NCT01894776|3892165|FG000|NOT COMPLETED|Overall Study||1
3164721|NCT01894841|3892171|FG000|STARTED|Overall Study||52
3164722|NCT01894841|3892172|FG001|STARTED|Overall Study||53
3164723|NCT01894841|3892171|FG000|COMPLETED|Overall Study||34
3164724|NCT01894841|3892172|FG001|COMPLETED|Overall Study||44
3164725|NCT01894841|3892171|FG000|NOT COMPLETED|Overall Study||18
3164726|NCT01894841|3892172|FG001|NOT COMPLETED|Overall Study||9
3164727|NCT01894906|3892184|FG000|STARTED|Overall Study||6
3305511|NCT02991859|4039216|FG002|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
3305512|NCT02991859|4039217|FG003|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
3305513|NCT02991859|4039218|FG004|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
3305514|NCT02991859|4039219|FG005|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||3
3305515|NCT02991859|4039220|FG006|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
3305516|NCT02991859|4039221|FG007|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
3305517|NCT02991859|4039222|FG008|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
3305518|NCT02991859|4039223|FG009|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
3305519|NCT02991859|4039224|FG010|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
3305520|NCT02991859|4039225|FG011|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
3305521|NCT02991859|4039226|FG012|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||7
3305522|NCT02991859|4039227|FG013|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||7
3305523|NCT02991859|4039228|FG014|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||6
3305524|NCT02991859|4039229|FG015|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||3
3305525|NCT02991859|4039230|FG016|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||3
3305526|NCT02991859|4039214|FG000|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
3305527|NCT02991859|4039215|FG001|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||1
3305528|NCT02991859|4039216|FG002|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
3305529|NCT02991859|4039217|FG003|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
3305530|NCT02991859|4039218|FG004|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||1
3305531|NCT02991859|4039219|FG005|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
3305532|NCT02991859|4039220|FG006|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
3305533|NCT02991859|4039221|FG007|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
3305534|NCT02991859|4039222|FG008|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
3305535|NCT02991859|4039223|FG009|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
3305536|NCT02991859|4039224|FG010|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
3305537|NCT02991859|4039225|FG011|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
3305538|NCT02991859|4039226|FG012|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
3305539|NCT02991859|4039227|FG013|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
3305540|NCT02991859|4039228|FG014|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
3305541|NCT02991859|4039229|FG015|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
3305542|NCT02991859|4039230|FG016|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
3305543|NCT02991859|4039214|FG000|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
3305544|NCT02991859|4039215|FG001|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
3305545|NCT02991859|4039216|FG002|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
3305546|NCT02991859|4039217|FG003|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
3305547|NCT02991859|4039218|FG004|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
3305548|NCT02991859|4039219|FG005|STARTED|Period 1,Escalation Phase2,Upto Day 14||3
3305549|NCT02991859|4039220|FG006|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
3305550|NCT02991859|4039221|FG007|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
3305551|NCT02991859|4039222|FG008|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
3305552|NCT02991859|4039223|FG009|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
3305553|NCT02991859|4039224|FG010|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
3305554|NCT02991859|4039225|FG011|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
3305555|NCT02991859|4039226|FG012|STARTED|Period 1,Escalation Phase2,Upto Day 14||7
3305556|NCT02991859|4039227|FG013|STARTED|Period 1,Escalation Phase2,Upto Day 14||7
3305557|NCT02991859|4039228|FG014|STARTED|Period 1,Escalation Phase2,Upto Day 14||6
3305558|NCT02991859|4039229|FG015|STARTED|Period 1,Escalation Phase2,Upto Day 14||3
3305559|NCT02991859|4039230|FG016|STARTED|Period 1,Escalation Phase2,Upto Day 14||3
3305560|NCT02991859|4039214|FG000|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
3305561|NCT02991859|4039215|FG001|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
3305562|NCT02991859|4039216|FG002|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
3305563|NCT02991859|4039217|FG003|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
3164728|NCT01894906|3892185|FG001|STARTED|Overall Study||6
3164729|NCT01894906|3892184|FG000|Treatment A|Overall Study||6
3164730|NCT01894906|3892185|FG001|Treatment A|Overall Study||6
3164731|NCT01894906|3892184|FG000|Treatment B|Overall Study||6
3164732|NCT01894906|3892185|FG001|Treatment B|Overall Study||6
3164733|NCT01894906|3892184|FG000|Treatment C|Overall Study||6
3164734|NCT01894906|3892185|FG001|Treatment C|Overall Study||6
3305564|NCT02991859|4039218|FG004|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
3305565|NCT02991859|4039219|FG005|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||3
2996938|NCT00940342|3713856|FG002|COMPLETED|Overall Study||39
2996939|NCT00940342|3713854|FG000|NOT COMPLETED|Overall Study||0
2996940|NCT00940342|3713855|FG001|NOT COMPLETED|Overall Study||2
2996941|NCT00940342|3713856|FG002|NOT COMPLETED|Overall Study||1
2996942|NCT00940446|3713866|FG000|STARTED|Overall Study||30
2996943|NCT00940446|3713867|FG001|STARTED|Overall Study||30
2996944|NCT00940446|3713866|FG000|COMPLETED|Overall Study||30
2996945|NCT00940446|3713867|FG001|COMPLETED|Overall Study||30
2996946|NCT00940446|3713866|FG000|NOT COMPLETED|Overall Study||0
2996947|NCT00940446|3713867|FG001|NOT COMPLETED|Overall Study||0
2996948|NCT00940485|3713877|FG000|STARTED|Overall Study||97
2996949|NCT00940485|3713878|FG001|STARTED|Overall Study||100
2996950|NCT00940485|3713877|FG000|COMPLETED|Overall Study||82
2996951|NCT00940485|3713878|FG001|COMPLETED|Overall Study||93
2996952|NCT00940485|3713877|FG000|NOT COMPLETED|Overall Study||15
2996953|NCT00940485|3713878|FG001|NOT COMPLETED|Overall Study||7
2996954|NCT00940537|3713886|FG000|STARTED|Overall Study||5
2996955|NCT00940537|3713887|FG001|STARTED|Overall Study||9
2996956|NCT00940537|3713886|FG000|COMPLETED|Overall Study||5
2996957|NCT00940537|3713887|FG001|COMPLETED|Overall Study||9
2996958|NCT00940537|3713886|FG000|NOT COMPLETED|Overall Study||0
2996959|NCT00940537|3713887|FG001|NOT COMPLETED|Overall Study||0
2996960|NCT00940576|3713894|FG000|STARTED|Overall Study||8
2996961|NCT00940576|3713895|FG001|STARTED|Overall Study||9
2996962|NCT00940576|3713894|FG000|COMPLETED|Overall Study||8
2996963|NCT00940576|3713895|FG001|COMPLETED|Overall Study||9
2996964|NCT00940576|3713894|FG000|NOT COMPLETED|Overall Study||0
2996965|NCT00940576|3713895|FG001|NOT COMPLETED|Overall Study||0
2996966|NCT00940589|3713904|FG000|STARTED|Overall Study||39
2996967|NCT00940589|3713905|FG001|STARTED|Overall Study||34
2996968|NCT00940589|3713904|FG000|COMPLETED|Overall Study||31
2996969|NCT00940589|3713905|FG001|COMPLETED|Overall Study||29
2996970|NCT00940589|3713904|FG000|NOT COMPLETED|Overall Study||8
2996971|NCT00940589|3713905|FG001|NOT COMPLETED|Overall Study||5
2996972|NCT00940602|3713913|FG000|STARTED|Overall Study||149
2996973|NCT00940602|3713914|FG001|STARTED|Overall Study||76
2996974|NCT00940602|3713913|FG000|Safety Analysis Set|Overall Study||148
2996975|NCT00940602|3713914|FG001|Safety Analysis Set|Overall Study||76
2996976|NCT00940602|3713913|FG000|Full Analysis Set|Overall Study||149
2996977|NCT00940602|3713914|FG001|Full Analysis Set|Overall Study||76
2996978|NCT00940602|3713913|FG000|Treated|Overall Study||148
2996979|NCT00940602|3713914|FG001|Treated|Overall Study||76
2996980|NCT00940602|3713913|FG000|Untreated|Overall Study||1
2996981|NCT00940602|3713914|FG001|Untreated|Overall Study||0
2996982|NCT00940602|3713913|FG000|COMPLETED|Overall Study||0
2996983|NCT00940602|3713914|FG001|COMPLETED|Overall Study||0
2996984|NCT00940602|3713913|FG000|NOT COMPLETED|Overall Study||149
2996985|NCT00940602|3713914|FG001|NOT COMPLETED|Overall Study||76
3036946|NCT01146054|3756232|FG000|STARTED|Overall Study||59
3036947|NCT01146054|3756232|FG000|COMPLETED|Overall Study||49
3305566|NCT02991859|4039220|FG006|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
3305567|NCT02991859|4039221|FG007|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
3305568|NCT02991859|4039222|FG008|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
3305569|NCT02991859|4039223|FG009|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
3305570|NCT02991859|4039224|FG010|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
3305571|NCT02991859|4039225|FG011|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
3305572|NCT02991859|4039226|FG012|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||7
3305573|NCT02991859|4039227|FG013|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||7
3305574|NCT02991859|4039228|FG014|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||6
3305575|NCT02991859|4039229|FG015|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||3
3305576|NCT02991859|4039230|FG016|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||3
3305577|NCT02991859|4039214|FG000|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
3305578|NCT02991859|4039215|FG001|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
3305579|NCT02991859|4039216|FG002|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
3305580|NCT02991859|4039217|FG003|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
3305581|NCT02991859|4039218|FG004|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
3305582|NCT02991859|4039219|FG005|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
3305583|NCT02991859|4039220|FG006|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
3305584|NCT02991859|4039221|FG007|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
3305585|NCT02991859|4039222|FG008|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
3305586|NCT02991859|4039223|FG009|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
3036948|NCT01146054|3756232|FG000|NOT COMPLETED|Overall Study||10
3036949|NCT01146275|3756236|FG000|STARTED|Overall Study||6
3164735|NCT01894906|3892184|FG000|Treatment D|Overall Study||6
3164736|NCT01894906|3892185|FG001|Treatment D|Overall Study||6
3164737|NCT01894906|3892184|FG000|Treatment E|Overall Study||6
3036950|NCT01146275|3756236|FG000|COMPLETED|Overall Study||6
3036951|NCT01146275|3756236|FG000|NOT COMPLETED|Overall Study||0
3164738|NCT01894906|3892185|FG001|Treatment E|Overall Study||6
3164739|NCT01894906|3892184|FG000|Treatment F|Overall Study||6
3164740|NCT01894906|3892185|FG001|Treatment F|Overall Study||6
2996986|NCT00940771|3713921|FG000|STARTED|Pre-Entry||10
2996987|NCT00940771|3713921|FG000|COMPLETED|Pre-Entry||10
2996988|NCT00940771|3713921|FG000|NOT COMPLETED|Pre-Entry||0
2996989|NCT00940771|3713921|FG000|STARTED|4 Weeks||10
2996990|NCT00940771|3713921|FG000|COMPLETED|4 Weeks||10
2996991|NCT00940771|3713921|FG000|NOT COMPLETED|4 Weeks||0
2996992|NCT00940771|3713921|FG000|STARTED|12 Weeks||10
2996993|NCT00940771|3713921|FG000|COMPLETED|12 Weeks||10
2996994|NCT00940771|3713921|FG000|NOT COMPLETED|12 Weeks||0
2996995|NCT00940771|3713921|FG000|STARTED|24 Weeks||10
2996996|NCT00940771|3713921|FG000|COMPLETED|24 Weeks||10
2996997|NCT00940771|3713921|FG000|NOT COMPLETED|24 Weeks||0
2996998|NCT00940823|3713927|FG000|STARTED|Overall Study||124
2996999|NCT00940823|3713928|FG001|STARTED|Overall Study||114
2997000|NCT00940823|3713927|FG000|COMPLETED|Overall Study||89
2997001|NCT00940823|3713928|FG001|COMPLETED|Overall Study||82
2997002|NCT00940823|3713927|FG000|NOT COMPLETED|Overall Study||35
2997003|NCT00940823|3713928|FG001|NOT COMPLETED|Overall Study||32
2997004|NCT00940875|3713938|FG000|STARTED|Treatment Phase|Disposition analysis includes 3 participants randomized to G+E but received only gemcitabine|31
2997005|NCT00940875|3713939|FG001|STARTED|Treatment Phase|3 participants randomized to G+E arm received only gemcitabine and were analyzed in Gemcitabine arm|23
2997006|NCT00940875|3713938|FG000|COMPLETED|Treatment Phase||5
2997007|NCT00940875|3713939|FG001|COMPLETED|Treatment Phase||4
2997008|NCT00940875|3713938|FG000|NOT COMPLETED|Treatment Phase||26
2997009|NCT00940875|3713939|FG001|NOT COMPLETED|Treatment Phase||19
2997010|NCT00940875|3713938|FG000|STARTED|Post-Study Treatment||0
2997011|NCT00940875|3713939|FG001|STARTED|Post-Study Treatment||4
3305587|NCT02991859|4039224|FG010|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
3305588|NCT02991859|4039225|FG011|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
3305589|NCT02991859|4039226|FG012|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
3305590|NCT02991859|4039227|FG013|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
3305591|NCT02991859|4039228|FG014|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
3305592|NCT02991859|4039229|FG015|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
3305593|NCT02991859|4039230|FG016|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
3305594|NCT02991859|4039214|FG000|STARTED|Period1, Escalation Phase3, Upto Day21||2
3305595|NCT02991859|4039215|FG001|STARTED|Period1, Escalation Phase3, Upto Day21||2
3305596|NCT02991859|4039216|FG002|STARTED|Period1, Escalation Phase3, Upto Day21||2
3305597|NCT02991859|4039217|FG003|STARTED|Period1, Escalation Phase3, Upto Day21||2
3305598|NCT02991859|4039218|FG004|STARTED|Period1, Escalation Phase3, Upto Day21||2
3305599|NCT02991859|4039219|FG005|STARTED|Period1, Escalation Phase3, Upto Day21||3
3305600|NCT02991859|4039220|FG006|STARTED|Period1, Escalation Phase3, Upto Day21||2
3305601|NCT02991859|4039221|FG007|STARTED|Period1, Escalation Phase3, Upto Day21||2
3305602|NCT02991859|4039222|FG008|STARTED|Period1, Escalation Phase3, Upto Day21||2
3305603|NCT02991859|4039223|FG009|STARTED|Period1, Escalation Phase3, Upto Day21||2
3305604|NCT02991859|4039224|FG010|STARTED|Period1, Escalation Phase3, Upto Day21||2
3305605|NCT02991859|4039225|FG011|STARTED|Period1, Escalation Phase3, Upto Day21||2
3305606|NCT02991859|4039226|FG012|STARTED|Period1, Escalation Phase3, Upto Day21||7
3305607|NCT02991859|4039227|FG013|STARTED|Period1, Escalation Phase3, Upto Day21||7
3305608|NCT02991859|4039228|FG014|STARTED|Period1, Escalation Phase3, Upto Day21||6
3305609|NCT02991859|4039229|FG015|STARTED|Period1, Escalation Phase3, Upto Day21||3
3305610|NCT02991859|4039230|FG016|STARTED|Period1, Escalation Phase3, Upto Day21||3
3305611|NCT02991859|4039214|FG000|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
3305612|NCT02991859|4039215|FG001|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
3305613|NCT02991859|4039216|FG002|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
3305614|NCT02991859|4039217|FG003|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
3305615|NCT02991859|4039218|FG004|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
3305616|NCT02991859|4039219|FG005|COMPLETED|Period1, Escalation Phase3, Upto Day21||3
3305617|NCT02991859|4039220|FG006|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
3305618|NCT02991859|4039221|FG007|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
3305619|NCT02991859|4039222|FG008|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
3305620|NCT02991859|4039223|FG009|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
3305621|NCT02991859|4039224|FG010|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
3305622|NCT02991859|4039225|FG011|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
3305623|NCT02991859|4039226|FG012|COMPLETED|Period1, Escalation Phase3, Upto Day21||6
3305624|NCT02991859|4039227|FG013|COMPLETED|Period1, Escalation Phase3, Upto Day21||6
3305625|NCT02991859|4039228|FG014|COMPLETED|Period1, Escalation Phase3, Upto Day21||6
3305626|NCT02991859|4039229|FG015|COMPLETED|Period1, Escalation Phase3, Upto Day21||3
3305627|NCT02991859|4039230|FG016|COMPLETED|Period1, Escalation Phase3, Upto Day21||3
3305628|NCT02991859|4039214|FG000|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
3305629|NCT02991859|4039215|FG001|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
3305630|NCT02991859|4039216|FG002|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
3305631|NCT02991859|4039217|FG003|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
3305632|NCT02991859|4039218|FG004|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
2997012|NCT00940875|3713938|FG000|COMPLETED|Post-Study Treatment||0
2997013|NCT00940875|3713939|FG001|COMPLETED|Post-Study Treatment||1
2997014|NCT00940875|3713938|FG000|NOT COMPLETED|Post-Study Treatment||0
2997015|NCT00940875|3713939|FG001|NOT COMPLETED|Post-Study Treatment||3
2997016|NCT00940888|3713946|FG000|STARTED|Overall Study|Total number of subjects consented|1701
2997017|NCT00940888|3713946|FG000|COMPLETED|Overall Study|Subjects that completed the 60 month follow up visit|866
2997018|NCT00940888|3713946|FG000|NOT COMPLETED|Overall Study||835
2997019|NCT00940901|3713952|FG000|STARTED|Weeks 1-8 (Phase 1)||6
2997020|NCT00940901|3713953|FG001|STARTED|Weeks 1-8 (Phase 1)||7
2997021|NCT00940901|3713952|FG000|COMPLETED|Weeks 1-8 (Phase 1)||6
2997022|NCT00940901|3713953|FG001|COMPLETED|Weeks 1-8 (Phase 1)||7
2997023|NCT00940901|3713952|FG000|NOT COMPLETED|Weeks 1-8 (Phase 1)||0
2997024|NCT00940901|3713953|FG001|NOT COMPLETED|Weeks 1-8 (Phase 1)||0
2997025|NCT00940901|3713952|FG000|STARTED|Week 9-16 (Phase 2)||6
2997026|NCT00940901|3713953|FG001|STARTED|Week 9-16 (Phase 2)||7
2997027|NCT00940901|3713952|FG000|COMPLETED|Week 9-16 (Phase 2)||4
2997028|NCT00940901|3713953|FG001|COMPLETED|Week 9-16 (Phase 2)||4
2997029|NCT00940901|3713952|FG000|NOT COMPLETED|Week 9-16 (Phase 2)||2
2997030|NCT00940901|3713953|FG001|NOT COMPLETED|Week 9-16 (Phase 2)||3
2997031|NCT00940927|3713961|FG000|STARTED|Overall Study||81
2997032|NCT00940927|3713961|FG000|COMPLETED|Overall Study||81
2997033|NCT00940927|3713961|FG000|NOT COMPLETED|Overall Study||0
2997034|NCT00940992|3713968|FG000|STARTED|Overall Study||32
2997035|NCT00940992|3713969|FG001|STARTED|Overall Study||30
2997036|NCT00940992|3713970|FG002|STARTED|Overall Study||30
2997037|NCT00940992|3713968|FG000|COMPLETED|Overall Study||28
2997038|NCT00940992|3713969|FG001|COMPLETED|Overall Study||28
2997039|NCT00940992|3713970|FG002|COMPLETED|Overall Study||28
2997040|NCT00940992|3713968|FG000|NOT COMPLETED|Overall Study||4
2997041|NCT00940992|3713969|FG001|NOT COMPLETED|Overall Study||2
2997042|NCT00940992|3713970|FG002|NOT COMPLETED|Overall Study||2
2997043|NCT00941005|3713980|FG000|STARTED|Overall Study||61
2997044|NCT00941005|3713981|FG001|STARTED|Overall Study||61
2997045|NCT00941005|3713980|FG000|COMPLETED|Overall Study||61
2997046|NCT00941005|3713981|FG001|COMPLETED|Overall Study||61
2997047|NCT00941005|3713980|FG000|NOT COMPLETED|Overall Study||0
2997048|NCT00941005|3713981|FG001|NOT COMPLETED|Overall Study||0
2997049|NCT00941031|3713993|FG000|STARTED|Induction Period||66
2997050|NCT00941031|3713994|FG001|STARTED|Induction Period||138
2997051|NCT00941031|3713995|FG002|STARTED|Induction Period||133
2997052|NCT00941031|3713996|FG003|STARTED|Induction Period||67
2997053|NCT00941031|3713997|FG004|STARTED|Induction Period||0
2997054|NCT00941031|3713998|FG005|STARTED|Induction Period||0
2997055|NCT00941031|3713999|FG006|STARTED|Induction Period||0
2997056|NCT00941031|3713993|FG000|COMPLETED|Induction Period||61
2997057|NCT00941031|3713994|FG001|COMPLETED|Induction Period||134
2997058|NCT00941031|3713995|FG002|COMPLETED|Induction Period||127
2997059|NCT00941031|3713996|FG003|COMPLETED|Induction Period||58
2997060|NCT00941031|3713997|FG004|COMPLETED|Induction Period||0
2997061|NCT00941031|3713998|FG005|COMPLETED|Induction Period||0
2997062|NCT00941031|3713999|FG006|COMPLETED|Induction Period||0
2997063|NCT00941031|3713993|FG000|NOT COMPLETED|Induction Period||5
2997064|NCT00941031|3713994|FG001|NOT COMPLETED|Induction Period||4
2997065|NCT00941031|3713995|FG002|NOT COMPLETED|Induction Period||6
2997066|NCT00941031|3713996|FG003|NOT COMPLETED|Induction Period||9
2997067|NCT00941031|3713997|FG004|NOT COMPLETED|Induction Period||0
2997068|NCT00941031|3713998|FG005|NOT COMPLETED|Induction Period||0
2997069|NCT00941031|3713999|FG006|NOT COMPLETED|Induction Period||0
2997070|NCT00941031|3713993|FG000|STARTED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
2997071|NCT00941031|3713994|FG001|STARTED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
2997072|NCT00941031|3713995|FG002|STARTED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
2997073|NCT00941031|3713996|FG003|STARTED|Maintenance Period|Non Responders treated with an open label regimen.|0
2997074|NCT00941031|3713997|FG004|STARTED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|65
2997075|NCT00941031|3713998|FG005|STARTED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|67
2997076|NCT00941031|3713999|FG006|STARTED|Maintenance Period|Non Responders treated with an open label regimen.|247
2997077|NCT00941031|3713993|FG000|COMPLETED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
2997078|NCT00941031|3713994|FG001|COMPLETED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
2997079|NCT00941031|3713995|FG002|COMPLETED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
2997080|NCT00941031|3713996|FG003|COMPLETED|Maintenance Period|Non Responders treated with an open label regimen.|0
2997081|NCT00941031|3713997|FG004|COMPLETED|Maintenance Period||56
2997082|NCT00941031|3713998|FG005|COMPLETED|Maintenance Period||61
2997083|NCT00941031|3713999|FG006|COMPLETED|Maintenance Period||204
2997084|NCT00941031|3713993|FG000|NOT COMPLETED|Maintenance Period||0
2997085|NCT00941031|3713994|FG001|NOT COMPLETED|Maintenance Period||0
2997086|NCT00941031|3713995|FG002|NOT COMPLETED|Maintenance Period||0
2997087|NCT00941031|3713996|FG003|NOT COMPLETED|Maintenance Period||0
2997088|NCT00941031|3713997|FG004|NOT COMPLETED|Maintenance Period||9
3164741|NCT01894906|3892184|FG000|COMPLETED|Overall Study||6
3164742|NCT01894906|3892185|FG001|COMPLETED|Overall Study||6
3164743|NCT01894906|3892184|FG000|NOT COMPLETED|Overall Study||0
3164744|NCT01894906|3892185|FG001|NOT COMPLETED|Overall Study||0
3164745|NCT01894919|3892216|FG000|STARTED|Overall Study||98
3164746|NCT01894919|3892217|FG001|STARTED|Overall Study||47
3164747|NCT01894919|3892218|FG002|STARTED|Overall Study||89
3164748|NCT01894919|3892219|FG003|STARTED|Overall Study||43
3164749|NCT01894919|3892220|FG004|STARTED|Overall Study||81
3164750|NCT01894919|3892221|FG005|STARTED|Overall Study||39
2997089|NCT00941031|3713998|FG005|NOT COMPLETED|Maintenance Period||6
2997090|NCT00941031|3713999|FG006|NOT COMPLETED|Maintenance Period||43
2997091|NCT00941070|3714018|FG000|STARTED|Overall Study||26
2997092|NCT00941070|3714018|FG000|COMPLETED|Overall Study||25
2997093|NCT00941070|3714018|FG000|NOT COMPLETED|Overall Study||1
2997094|NCT00941304|3714029|FG000|STARTED|Overall Study||31
2997095|NCT00941304|3714030|FG001|STARTED|Overall Study||30
2997096|NCT00941304|3714031|FG002|STARTED|Overall Study||31
2997097|NCT00941304|3714032|FG003|STARTED|Overall Study||30
2997098|NCT00941304|3714033|FG004|STARTED|Overall Study||31
2997099|NCT00941304|3714029|FG000|COMPLETED|Overall Study||30
2997100|NCT00941304|3714030|FG001|COMPLETED|Overall Study||30
2997101|NCT00941304|3714031|FG002|COMPLETED|Overall Study||31
2997102|NCT00941304|3714032|FG003|COMPLETED|Overall Study||30
2997103|NCT00941304|3714033|FG004|COMPLETED|Overall Study||31
2997104|NCT00941304|3714029|FG000|NOT COMPLETED|Overall Study||1
2997105|NCT00941304|3714030|FG001|NOT COMPLETED|Overall Study||0
2997106|NCT00941304|3714031|FG002|NOT COMPLETED|Overall Study||0
2997107|NCT00941304|3714032|FG003|NOT COMPLETED|Overall Study||0
2997108|NCT00941304|3714033|FG004|NOT COMPLETED|Overall Study||0
2997109|NCT00941330|3714047|FG000|STARTED|Overall Study||15
2997110|NCT00941330|3714048|FG001|STARTED|Overall Study||11
2997111|NCT00941330|3714047|FG000|COMPLETED|Overall Study||14
2997112|NCT00941330|3714048|FG001|COMPLETED|Overall Study||9
2997113|NCT00941330|3714047|FG000|NOT COMPLETED|Overall Study||1
2997114|NCT00941330|3714048|FG001|NOT COMPLETED|Overall Study||2
2997115|NCT00941603|3714060|FG000|STARTED|Overall Study||104
2997116|NCT00941603|3714061|FG001|STARTED|Overall Study||105
2997117|NCT00941603|3714062|FG002|STARTED|Overall Study||104
2997118|NCT00941603|3714063|FG003|STARTED|Overall Study||104
2997119|NCT00941603|3714064|FG004|STARTED|Overall Study||105
2997120|NCT00941603|3714065|FG005|STARTED|Overall Study||97
2997121|NCT00941603|3714060|FG000|COMPLETED|Overall Study||93
2997122|NCT00941603|3714061|FG001|COMPLETED|Overall Study||89
2997123|NCT00941603|3714062|FG002|COMPLETED|Overall Study||99
2997124|NCT00941603|3714063|FG003|COMPLETED|Overall Study||100
2997125|NCT00941603|3714064|FG004|COMPLETED|Overall Study||101
2997126|NCT00941603|3714065|FG005|COMPLETED|Overall Study||94
2997127|NCT00941603|3714060|FG000|NOT COMPLETED|Overall Study||11
2997128|NCT00941603|3714061|FG001|NOT COMPLETED|Overall Study||16
2997129|NCT00941603|3714062|FG002|NOT COMPLETED|Overall Study||5
2997130|NCT00941603|3714063|FG003|NOT COMPLETED|Overall Study||4
2997131|NCT00941603|3714064|FG004|NOT COMPLETED|Overall Study||4
2997132|NCT00941603|3714065|FG005|NOT COMPLETED|Overall Study||3
2997133|NCT00941655|3714081|FG000|STARTED|Overall Study||8
2997134|NCT00941655|3714082|FG001|STARTED|Overall Study||7
2997135|NCT00941655|3714081|FG000|COMPLETED|Overall Study||3
2997136|NCT00941655|3714082|FG001|COMPLETED|Overall Study||2
2997137|NCT00941655|3714081|FG000|NOT COMPLETED|Overall Study||5
2997138|NCT00941655|3714082|FG001|NOT COMPLETED|Overall Study||5
2997139|NCT00941668|3714091|FG000|STARTED|Overall Study||24
2997140|NCT00941668|3714092|FG001|STARTED|Overall Study||25
2997141|NCT00941668|3714091|FG000|COMPLETED|Overall Study||0
2997142|NCT00941668|3714092|FG001|COMPLETED|Overall Study||0
2997143|NCT00941668|3714091|FG000|NOT COMPLETED|Overall Study||24
2997144|NCT00941668|3714092|FG001|NOT COMPLETED|Overall Study||25
2997145|NCT00941681|3714101|FG000|STARTED|Overall Study||12
2997146|NCT00941681|3714102|FG001|STARTED|Overall Study||11
2997147|NCT00941681|3714103|FG002|STARTED|Overall Study||12
2997148|NCT00941681|3714101|FG000|COMPLETED|Overall Study||12
2997149|NCT00941681|3714102|FG001|COMPLETED|Overall Study||10
2997150|NCT00941681|3714103|FG002|COMPLETED|Overall Study||12
2997151|NCT00941681|3714101|FG000|NOT COMPLETED|Overall Study||0
2997152|NCT00941681|3714102|FG001|NOT COMPLETED|Overall Study||1
2997153|NCT00941681|3714103|FG002|NOT COMPLETED|Overall Study||0
2997154|NCT00941720|3714111|FG000|STARTED|Overall Study||71
2997155|NCT00941720|3714111|FG000|COMPLETED|Overall Study||57
2997156|NCT00941720|3714111|FG000|NOT COMPLETED|Overall Study||14
2997157|NCT00941733|3714117|FG000|STARTED|Overall Study||239
2997158|NCT00941733|3714118|FG001|STARTED|Overall Study||119
2997159|NCT00941733|3714117|FG000|COMPLETED|Overall Study|1 year follow-up|165
2997160|NCT00941733|3714118|FG001|COMPLETED|Overall Study|1 year follow-up|91
2997161|NCT00941733|3714117|FG000|NOT COMPLETED|Overall Study||74
2997162|NCT00941733|3714118|FG001|NOT COMPLETED|Overall Study||28
2997163|NCT00941798|3714126|FG000|STARTED|Overall Study||755
2997164|NCT00941798|3714127|FG001|STARTED|Overall Study||763
2997165|NCT00941798|3714126|FG000|Full Analysis Set|Overall Study||749
2997166|NCT00941798|3714127|FG001|Full Analysis Set|Overall Study||759
2997167|NCT00941798|3714126|FG000|COMPLETED|Overall Study||561
2997168|NCT00941798|3714127|FG001|COMPLETED|Overall Study||578
2997169|NCT00941798|3714126|FG000|NOT COMPLETED|Overall Study||194
2997170|NCT00941798|3714127|FG001|NOT COMPLETED|Overall Study||185
2997171|NCT00941863|3714138|FG000|STARTED|Until Primary Completion Date (PCD)||7
2997172|NCT00941863|3714139|FG001|STARTED|Until Primary Completion Date (PCD)||3
2997173|NCT00941863|3714140|FG002|STARTED|Until Primary Completion Date (PCD)||12
2997174|NCT00941863|3714141|FG003|STARTED|Until Primary Completion Date (PCD)||17
2997175|NCT00941863|3714142|FG004|STARTED|Until Primary Completion Date (PCD)||119
2997176|NCT00941863|3714138|FG000|Maximum Tolerated Dose|Until Primary Completion Date (PCD)||7
2997177|NCT00941863|3714139|FG001|Maximum Tolerated Dose|Until Primary Completion Date (PCD)||3
2997178|NCT00941863|3714140|FG002|Maximum Tolerated Dose|Until Primary Completion Date (PCD)||12
2997179|NCT00941863|3714141|FG003|Maximum Tolerated Dose|Until Primary Completion Date (PCD)||17
2997180|NCT00941863|3714142|FG004|Maximum Tolerated Dose|Until Primary Completion Date (PCD)||94
2997181|NCT00941863|3714138|FG000|COMPLETED|Until Primary Completion Date (PCD)||0
2997182|NCT00941863|3714139|FG001|COMPLETED|Until Primary Completion Date (PCD)||0
2997183|NCT00941863|3714140|FG002|COMPLETED|Until Primary Completion Date (PCD)||0
2997184|NCT00941863|3714141|FG003|COMPLETED|Until Primary Completion Date (PCD)||0
2997185|NCT00941863|3714142|FG004|COMPLETED|Until Primary Completion Date (PCD)||25
2997186|NCT00941863|3714138|FG000|NOT COMPLETED|Until Primary Completion Date (PCD)||7
2997187|NCT00941863|3714139|FG001|NOT COMPLETED|Until Primary Completion Date (PCD)||3
2997188|NCT00941863|3714140|FG002|NOT COMPLETED|Until Primary Completion Date (PCD)||12
2997189|NCT00941863|3714141|FG003|NOT COMPLETED|Until Primary Completion Date (PCD)||17
2997190|NCT00941863|3714142|FG004|NOT COMPLETED|Until Primary Completion Date (PCD)||94
2997191|NCT00941863|3714138|FG000|STARTED|Continued After PCD||0
2997192|NCT00941863|3714139|FG001|STARTED|Continued After PCD||0
2997193|NCT00941863|3714140|FG002|STARTED|Continued After PCD||0
2997194|NCT00941863|3714141|FG003|STARTED|Continued After PCD||0
2997195|NCT00941863|3714142|FG004|STARTED|Continued After PCD|25 of 119 participants from the Expansion Phase, were still on the treatment as of 31 May 2005.|25
2997196|NCT00941863|3714138|FG000|COMPLETED|Continued After PCD||0
2997197|NCT00941863|3714139|FG001|COMPLETED|Continued After PCD||0
2997198|NCT00941863|3714140|FG002|COMPLETED|Continued After PCD||0
2997199|NCT00941863|3714141|FG003|COMPLETED|Continued After PCD||0
2997200|NCT00941863|3714142|FG004|COMPLETED|Continued After PCD||6
2997201|NCT00941863|3714138|FG000|NOT COMPLETED|Continued After PCD||0
2997202|NCT00941863|3714139|FG001|NOT COMPLETED|Continued After PCD||0
2997203|NCT00941863|3714140|FG002|NOT COMPLETED|Continued After PCD||0
2997204|NCT00941863|3714141|FG003|NOT COMPLETED|Continued After PCD||0
2997205|NCT00941863|3714142|FG004|NOT COMPLETED|Continued After PCD||19
2997206|NCT00941889|3714160|FG000|STARTED|Overall Study||17
2997207|NCT00941889|3714161|FG001|STARTED|Overall Study||15
2997208|NCT00941889|3714160|FG000|COMPLETED|Overall Study||5
2997209|NCT00941889|3714161|FG001|COMPLETED|Overall Study||3
2997210|NCT00941889|3714160|FG000|NOT COMPLETED|Overall Study||12
2997211|NCT00941889|3714161|FG001|NOT COMPLETED|Overall Study||12
2997212|NCT00941993|3714167|FG000|STARTED|Overall Study||109
2997213|NCT00941993|3714167|FG000|COMPLETED|Overall Study||109
2997214|NCT00941993|3714167|FG000|NOT COMPLETED|Overall Study||0
2997215|NCT00942084|3714172|FG000|STARTED|Overall Study||32
2997216|NCT00942084|3714172|FG000|COMPLETED|Overall Study|There were 2 infant deaths. None determined to be related to study drug.|30
2997217|NCT00942084|3714172|FG000|NOT COMPLETED|Overall Study||2
2997218|NCT00942149|3714176|FG000|STARTED|Overall Study||20
2997219|NCT00942149|3714176|FG000|COMPLETED|Overall Study||20
2997220|NCT00942149|3714176|FG000|NOT COMPLETED|Overall Study||0
2997221|NCT00942162|3714183|FG000|STARTED|Overall Study||71
2997222|NCT00942162|3714184|FG001|STARTED|Overall Study||50
2997223|NCT00942162|3714185|FG002|STARTED|Overall Study||2
2997224|NCT00942162|3714183|FG000|COMPLETED|Overall Study||1
3305633|NCT02991859|4039219|FG005|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
3305634|NCT02991859|4039220|FG006|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
3305635|NCT02991859|4039221|FG007|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
3305636|NCT02991859|4039222|FG008|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
3305637|NCT02991859|4039223|FG009|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
3305638|NCT02991859|4039224|FG010|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
3305639|NCT02991859|4039225|FG011|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
3305640|NCT02991859|4039226|FG012|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||1
3305641|NCT02991859|4039227|FG013|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||1
3305642|NCT02991859|4039228|FG014|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
3305643|NCT02991859|4039229|FG015|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
3305644|NCT02991859|4039230|FG016|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
3305645|NCT02991859|4039214|FG000|STARTED|Period1, Escalation Phase4, Upto Day28||2
3305646|NCT02991859|4039215|FG001|STARTED|Period1, Escalation Phase4, Upto Day28||2
3305647|NCT02991859|4039216|FG002|STARTED|Period1, Escalation Phase4, Upto Day28||2
3305648|NCT02991859|4039217|FG003|STARTED|Period1, Escalation Phase4, Upto Day28||2
3305649|NCT02991859|4039218|FG004|STARTED|Period1, Escalation Phase4, Upto Day28||2
3305650|NCT02991859|4039219|FG005|STARTED|Period1, Escalation Phase4, Upto Day28|1 Par completed Phase 3 did not enter Phase 4|2
3305651|NCT02991859|4039220|FG006|STARTED|Period1, Escalation Phase4, Upto Day28||2
3305652|NCT02991859|4039221|FG007|STARTED|Period1, Escalation Phase4, Upto Day28||2
3305653|NCT02991859|4039222|FG008|STARTED|Period1, Escalation Phase4, Upto Day28||2
3305654|NCT02991859|4039223|FG009|STARTED|Period1, Escalation Phase4, Upto Day28||2
3305655|NCT02991859|4039224|FG010|STARTED|Period1, Escalation Phase4, Upto Day28||2
3305656|NCT02991859|4039225|FG011|STARTED|Period1, Escalation Phase4, Upto Day28||2
3305657|NCT02991859|4039226|FG012|STARTED|Period1, Escalation Phase4, Upto Day28||6
3305658|NCT02991859|4039227|FG013|STARTED|Period1, Escalation Phase4, Upto Day28||6
3305659|NCT02991859|4039228|FG014|STARTED|Period1, Escalation Phase4, Upto Day28||6
3305660|NCT02991859|4039229|FG015|STARTED|Period1, Escalation Phase4, Upto Day28||3
3305661|NCT02991859|4039230|FG016|STARTED|Period1, Escalation Phase4, Upto Day28||3
2997225|NCT00942162|3714184|FG001|COMPLETED|Overall Study||0
2997226|NCT00942162|3714185|FG002|COMPLETED|Overall Study||0
2997227|NCT00942162|3714183|FG000|NOT COMPLETED|Overall Study||70
2997228|NCT00942162|3714184|FG001|NOT COMPLETED|Overall Study||50
2997229|NCT00942162|3714185|FG002|NOT COMPLETED|Overall Study||2
2997230|NCT00942175|3714199|FG000|STARTED|Overall Study||40
2997231|NCT00942175|3714200|FG001|STARTED|Overall Study||40
2997232|NCT00942175|3714201|FG002|STARTED|Overall Study||40
2997233|NCT00942175|3714202|FG003|STARTED|Overall Study||40
2997234|NCT00942175|3714199|FG000|COMPLETED|Overall Study||38
2997235|NCT00942175|3714200|FG001|COMPLETED|Overall Study||36
2997236|NCT00942175|3714201|FG002|COMPLETED|Overall Study||38
2997237|NCT00942175|3714202|FG003|COMPLETED|Overall Study||38
2997238|NCT00942175|3714199|FG000|NOT COMPLETED|Overall Study||2
2997239|NCT00942175|3714200|FG001|NOT COMPLETED|Overall Study||4
2997240|NCT00942175|3714201|FG002|NOT COMPLETED|Overall Study||2
2997241|NCT00942175|3714202|FG003|NOT COMPLETED|Overall Study||2
2997242|NCT00942188|3714224|FG000|STARTED|Overall Study||26
2997243|NCT00942188|3714225|FG001|STARTED|Overall Study||26
2997244|NCT00942188|3714226|FG002|STARTED|Overall Study||27
2997245|NCT00942188|3714227|FG003|STARTED|Overall Study||27
2997246|NCT00942188|3714224|FG000|COMPLETED|Overall Study||22
2997247|NCT00942188|3714225|FG001|COMPLETED|Overall Study||16
2997248|NCT00942188|3714226|FG002|COMPLETED|Overall Study||18
2997249|NCT00942188|3714227|FG003|COMPLETED|Overall Study||23
2997250|NCT00942188|3714224|FG000|NOT COMPLETED|Overall Study||4
2997251|NCT00942188|3714225|FG001|NOT COMPLETED|Overall Study||10
2997252|NCT00942188|3714226|FG002|NOT COMPLETED|Overall Study||9
2997253|NCT00942188|3714227|FG003|NOT COMPLETED|Overall Study||4
2997254|NCT00942266|3714239|FG000|STARTED|Overall Study||43
2997255|NCT00942266|3714240|FG001|STARTED|Overall Study||15
2997256|NCT00942266|3714239|FG000|COMPLETED|Overall Study||0
2997257|NCT00942266|3714240|FG001|COMPLETED|Overall Study||0
2997258|NCT00942266|3714239|FG000|NOT COMPLETED|Overall Study||43
2997259|NCT00942266|3714240|FG001|NOT COMPLETED|Overall Study||15
2997260|NCT00942305|3714256|FG000|STARTED|Overall Study||30
2997261|NCT00942305|3714257|FG001|STARTED|Overall Study||10
2997262|NCT00942305|3714258|FG002|STARTED|Overall Study||29
2997263|NCT00942305|3714259|FG003|STARTED|Overall Study||10
2997264|NCT00942305|3714260|FG004|STARTED|Overall Study||39
2997265|NCT00942305|3714261|FG005|STARTED|Overall Study||14
2997266|NCT00942305|3714262|FG006|STARTED|Overall Study||30
2997267|NCT00942305|3714263|FG007|STARTED|Overall Study||10
2997268|NCT00942305|3714264|FG008|STARTED|Overall Study||50
2997269|NCT00942305|3714265|FG009|STARTED|Overall Study||17
2997270|NCT00942305|3714256|FG000|COMPLETED|Overall Study||7
2997271|NCT00942305|3714257|FG001|COMPLETED|Overall Study||5
2997272|NCT00942305|3714258|FG002|COMPLETED|Overall Study||14
2997273|NCT00942305|3714259|FG003|COMPLETED|Overall Study||4
2997274|NCT00942305|3714260|FG004|COMPLETED|Overall Study||14
2997275|NCT00942305|3714261|FG005|COMPLETED|Overall Study||9
2997276|NCT00942305|3714262|FG006|COMPLETED|Overall Study||6
2997277|NCT00942305|3714263|FG007|COMPLETED|Overall Study||5
2997278|NCT00942305|3714264|FG008|COMPLETED|Overall Study||25
2997279|NCT00942305|3714265|FG009|COMPLETED|Overall Study||7
2997280|NCT00942305|3714256|FG000|NOT COMPLETED|Overall Study||23
2997281|NCT00942305|3714257|FG001|NOT COMPLETED|Overall Study||5
2997282|NCT00942305|3714258|FG002|NOT COMPLETED|Overall Study||15
2997283|NCT00942305|3714259|FG003|NOT COMPLETED|Overall Study||6
2997284|NCT00942305|3714260|FG004|NOT COMPLETED|Overall Study||25
2997285|NCT00942305|3714261|FG005|NOT COMPLETED|Overall Study||5
2997286|NCT00942305|3714262|FG006|NOT COMPLETED|Overall Study||24
2997287|NCT00942305|3714263|FG007|NOT COMPLETED|Overall Study||5
2997288|NCT00942305|3714264|FG008|NOT COMPLETED|Overall Study||25
2997289|NCT00942305|3714265|FG009|NOT COMPLETED|Overall Study||10
2997290|NCT00942357|3714289|FG000|STARTED|Overall Study||407
2997291|NCT00942357|3714290|FG001|STARTED|Overall Study||406
2997292|NCT00942357|3714289|FG000|COMPLETED|Overall Study||370
2997293|NCT00942357|3714290|FG001|COMPLETED|Overall Study||366
2997294|NCT00942357|3714289|FG000|NOT COMPLETED|Overall Study||37
2997295|NCT00942357|3714290|FG001|NOT COMPLETED|Overall Study||40
2997296|NCT00942422|3714296|FG000|STARTED|Overall Study||8
2997297|NCT00942422|3714296|FG000|COMPLETED|Overall Study||5
2997298|NCT00942422|3714296|FG000|NOT COMPLETED|Overall Study||3
2997299|NCT00942448|3714304|FG000|STARTED|Overall Study||77
2997300|NCT00942448|3714305|FG001|STARTED|Overall Study||76
2997301|NCT00942448|3714306|FG002|STARTED|Overall Study||78
2997302|NCT00942448|3714307|FG003|STARTED|Overall Study||75
2997303|NCT00942448|3714304|FG000|COMPLETED|Overall Study||77
2997304|NCT00942448|3714305|FG001|COMPLETED|Overall Study||76
2997305|NCT00942448|3714306|FG002|COMPLETED|Overall Study||78
2997306|NCT00942448|3714307|FG003|COMPLETED|Overall Study||75
2997307|NCT00942448|3714304|FG000|NOT COMPLETED|Overall Study||0
2997308|NCT00942448|3714305|FG001|NOT COMPLETED|Overall Study||0
2997309|NCT00942448|3714306|FG002|NOT COMPLETED|Overall Study||0
2997310|NCT00942448|3714307|FG003|NOT COMPLETED|Overall Study||0
2997311|NCT00942578|3714324|FG000|STARTED|Dose Escalation Phase||3
2997312|NCT00942578|3714325|FG001|STARTED|Dose Escalation Phase||3
2997313|NCT00942578|3714326|FG002|STARTED|Dose Escalation Phase||3
2997314|NCT00942578|3714324|FG000|COMPLETED|Dose Escalation Phase||3
2997315|NCT00942578|3714325|FG001|COMPLETED|Dose Escalation Phase||3
2997316|NCT00942578|3714326|FG002|COMPLETED|Dose Escalation Phase||3
2997317|NCT00942578|3714324|FG000|NOT COMPLETED|Dose Escalation Phase||0
2997318|NCT00942578|3714325|FG001|NOT COMPLETED|Dose Escalation Phase||0
2997319|NCT00942578|3714326|FG002|NOT COMPLETED|Dose Escalation Phase||0
2997320|NCT00942578|3714324|FG000|STARTED|Expansion Phase||11
2997321|NCT00942578|3714325|FG001|STARTED|Expansion Phase||0
2997322|NCT00942578|3714326|FG002|STARTED|Expansion Phase||43
2997323|NCT00942578|3714324|FG000|COMPLETED|Expansion Phase||11
2997324|NCT00942578|3714325|FG001|COMPLETED|Expansion Phase||0
2997325|NCT00942578|3714326|FG002|COMPLETED|Expansion Phase||43
2997326|NCT00942578|3714324|FG000|NOT COMPLETED|Expansion Phase||0
2997327|NCT00942578|3714325|FG001|NOT COMPLETED|Expansion Phase||0
2997328|NCT00942578|3714326|FG002|NOT COMPLETED|Expansion Phase||0
2997329|NCT00942604|3714341|FG000|STARTED|Overall Study||100
2997330|NCT00942604|3714342|FG001|STARTED|Overall Study||103
2997331|NCT00942604|3714341|FG000|COMPLETED|Overall Study||98
2997332|NCT00942604|3714342|FG001|COMPLETED|Overall Study||99
2997333|NCT00942604|3714341|FG000|NOT COMPLETED|Overall Study||2
2997334|NCT00942604|3714342|FG001|NOT COMPLETED|Overall Study||4
2997335|NCT00942708|3714348|FG000|STARTED|Overall Study||6
2997336|NCT00942708|3714348|FG000|COMPLETED|Overall Study||5
2997337|NCT00942708|3714348|FG000|NOT COMPLETED|Overall Study||1
2997338|NCT00942734|3714353|FG000|STARTED|Overall Study||43
2997339|NCT00942734|3714353|FG000|COMPLETED|Overall Study||35
2997340|NCT00942734|3714353|FG000|NOT COMPLETED|Overall Study||8
2997341|NCT00942786|3714357|FG000|STARTED|Overall Study||297
2997342|NCT00942786|3714357|FG000|COMPLETED|Overall Study|date of last follow-up|297
2997343|NCT00942786|3714357|FG000|NOT COMPLETED|Overall Study||0
2997344|NCT00942825|3714366|FG000|STARTED|Overall Study||97
2997345|NCT00942825|3714367|FG001|STARTED|Overall Study||98
2997346|NCT00942825|3714366|FG000|COMPLETED|Overall Study||97
2997347|NCT00942825|3714367|FG001|COMPLETED|Overall Study||98
2997348|NCT00942825|3714366|FG000|NOT COMPLETED|Overall Study||0
2997349|NCT00942825|3714367|FG001|NOT COMPLETED|Overall Study||0
2997350|NCT00942851|3714375|FG000|STARTED|Overall Study||12
2997351|NCT00942851|3714376|FG001|STARTED|Overall Study||12
2997352|NCT00942851|3714375|FG000|COMPLETED|Overall Study||12
2997353|NCT00942851|3714376|FG001|COMPLETED|Overall Study||11
2997354|NCT00942851|3714375|FG000|NOT COMPLETED|Overall Study||0
2997355|NCT00942851|3714376|FG001|NOT COMPLETED|Overall Study||1
2997356|NCT00942877|3714388|FG000|STARTED|Overall Study||46
3305662|NCT02991859|4039214|FG000|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
3305663|NCT02991859|4039215|FG001|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
3305664|NCT02991859|4039216|FG002|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
3305665|NCT02991859|4039217|FG003|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
3305666|NCT02991859|4039218|FG004|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
3305667|NCT02991859|4039219|FG005|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
3305668|NCT02991859|4039220|FG006|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
3305669|NCT02991859|4039221|FG007|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
3305670|NCT02991859|4039222|FG008|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
3305671|NCT02991859|4039223|FG009|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
3305672|NCT02991859|4039224|FG010|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
3305673|NCT02991859|4039225|FG011|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
3305674|NCT02991859|4039226|FG012|COMPLETED|Period1, Escalation Phase4, Upto Day28||6
3305675|NCT02991859|4039227|FG013|COMPLETED|Period1, Escalation Phase4, Upto Day28||6
2997357|NCT00942877|3714389|FG001|STARTED|Overall Study||7
2997358|NCT00942877|3714388|FG000|COMPLETED|Overall Study||1
2997359|NCT00942877|3714389|FG001|COMPLETED|Overall Study||3
2997360|NCT00942877|3714388|FG000|NOT COMPLETED|Overall Study||45
2997361|NCT00942877|3714389|FG001|NOT COMPLETED|Overall Study||4
2997362|NCT00942890|3714398|FG000|STARTED|Overall Study||21
2997363|NCT00942890|3714399|FG001|STARTED|Overall Study||23
2997364|NCT00942890|3714398|FG000|COMPLETED|Overall Study||21
2997365|NCT00942890|3714399|FG001|COMPLETED|Overall Study||23
2997366|NCT00942890|3714398|FG000|NOT COMPLETED|Overall Study||0
2997367|NCT00942890|3714399|FG001|NOT COMPLETED|Overall Study||0
2997368|NCT00942903|3714406|FG000|STARTED|Overall Study||20
2997369|NCT00942903|3714406|FG000|COMPLETED|Overall Study||20
2997370|NCT00942903|3714406|FG000|NOT COMPLETED|Overall Study||0
3305676|NCT02991859|4039228|FG014|COMPLETED|Period1, Escalation Phase4, Upto Day28||6
3305677|NCT02991859|4039229|FG015|COMPLETED|Period1, Escalation Phase4, Upto Day28||3
3305678|NCT02991859|4039230|FG016|COMPLETED|Period1, Escalation Phase4, Upto Day28||3
3305679|NCT02991859|4039214|FG000|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
3305680|NCT02991859|4039215|FG001|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
3305681|NCT02991859|4039216|FG002|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
3305682|NCT02991859|4039217|FG003|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
3305683|NCT02991859|4039218|FG004|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
3305684|NCT02991859|4039219|FG005|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
3305685|NCT02991859|4039220|FG006|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
3305686|NCT02991859|4039221|FG007|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
3305687|NCT02991859|4039222|FG008|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
3305688|NCT02991859|4039223|FG009|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
3305689|NCT02991859|4039224|FG010|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
3317082|NCT03123848|4050592|FG000|NOT COMPLETED|Overall Study||0
2997371|NCT00942968|3714410|FG000|STARTED|Overall Study||338
2997372|NCT00942968|3714410|FG000|Treated|Overall Study||334
2997373|NCT00942968|3714410|FG000|COMPLETED|Overall Study||109
2997374|NCT00942968|3714410|FG000|NOT COMPLETED|Overall Study||229
2997375|NCT00942994|3714416|FG000|STARTED|Overall Study||203
2997376|NCT00942994|3714417|FG001|STARTED|Overall Study||209
2997377|NCT00942994|3714416|FG000|COMPLETED|Overall Study||187
2997378|NCT00942994|3714417|FG001|COMPLETED|Overall Study||190
2997379|NCT00942994|3714416|FG000|NOT COMPLETED|Overall Study||16
2997380|NCT00942994|3714417|FG001|NOT COMPLETED|Overall Study||19
2997381|NCT00943072|3714425|FG000|STARTED|Overall Study||115
2997382|NCT00943072|3714426|FG001|STARTED|Overall Study||74
2997383|NCT00943072|3714425|FG000|Participants Received Treatment|Overall Study|Safety population (SAF)|114
2997384|NCT00943072|3714426|FG001|Participants Received Treatment|Overall Study||74
2997385|NCT00943072|3714425|FG000|Full Analysis Set (FAS) Population|Overall Study|FAS population used for analysis of Primary and Secondary Outcome Measures|114
2997386|NCT00943072|3714426|FG001|Full Analysis Set (FAS) Population|Overall Study||73
2997387|NCT00943072|3714425|FG000|COMPLETED|Overall Study|110 Participants completed Week 24, From FAS; 102 Participants completed up to Week 100, From SAF|110
2997388|NCT00943072|3714426|FG001|COMPLETED|Overall Study|60 Participants completed Week 24, From FAS; 50 Participants completed up to Week 100, From SAF|60
2997389|NCT00943072|3714425|FG000|NOT COMPLETED|Overall Study||5
2997390|NCT00943072|3714426|FG001|NOT COMPLETED|Overall Study||14
2997391|NCT00943098|3714436|FG000|STARTED|Overall Study||70
2997392|NCT00943098|3714437|FG001|STARTED|Overall Study|1 patient was excluded from the ITT and therefore the baseline population is 71|72
2997393|NCT00943098|3714436|FG000|COMPLETED|Overall Study||70
2997394|NCT00943098|3714437|FG001|COMPLETED|Overall Study||72
2997395|NCT00943098|3714436|FG000|NOT COMPLETED|Overall Study||0
2997396|NCT00943098|3714437|FG001|NOT COMPLETED|Overall Study||0
2997397|NCT00943111|3714445|FG000|STARTED|52-Weeks Primary Analysis Period||106
2997398|NCT00943111|3714446|FG001|STARTED|52-Weeks Primary Analysis Period||54
2997399|NCT00943111|3714447|FG002|STARTED|52-Weeks Primary Analysis Period||0
2997400|NCT00943111|3714445|FG000|Treated|52-Weeks Primary Analysis Period||106
2997401|NCT00943111|3714446|FG001|Treated|52-Weeks Primary Analysis Period||53
2997402|NCT00943111|3714447|FG002|Treated|52-Weeks Primary Analysis Period||0
2997403|NCT00943111|3714445|FG000|COMPLETED|52-Weeks Primary Analysis Period||104
2997404|NCT00943111|3714446|FG001|COMPLETED|52-Weeks Primary Analysis Period||52
2997405|NCT00943111|3714447|FG002|COMPLETED|52-Weeks Primary Analysis Period||0
2997406|NCT00943111|3714445|FG000|NOT COMPLETED|52-Weeks Primary Analysis Period||2
2997407|NCT00943111|3714446|FG001|NOT COMPLETED|52-Weeks Primary Analysis Period||2
2997408|NCT00943111|3714447|FG002|NOT COMPLETED|52-Weeks Primary Analysis Period||0
2997409|NCT00943111|3714445|FG000|STARTED|5 Years Long-term Treatment Period||0
2997410|NCT00943111|3714446|FG001|STARTED|5 Years Long-term Treatment Period||0
2997411|NCT00943111|3714447|FG002|STARTED|5 Years Long-term Treatment Period|Participants from both the arms of PAP who completed PAP and remained on-study|152
2997412|NCT00943111|3714445|FG000|COMPLETED|5 Years Long-term Treatment Period||0
2997413|NCT00943111|3714446|FG001|COMPLETED|5 Years Long-term Treatment Period||0
2997414|NCT00943111|3714447|FG002|COMPLETED|5 Years Long-term Treatment Period||77
2997415|NCT00943111|3714445|FG000|NOT COMPLETED|5 Years Long-term Treatment Period||0
2997416|NCT00943111|3714446|FG001|NOT COMPLETED|5 Years Long-term Treatment Period||0
2997417|NCT00943111|3714447|FG002|NOT COMPLETED|5 Years Long-term Treatment Period||75
2997418|NCT00943124|3714454|FG000|STARTED|Period 1||110
2997419|NCT00943124|3714455|FG001|STARTED|Period 1||110
2997420|NCT00943124|3714454|FG000|COMPLETED|Period 1||108
2997421|NCT00943124|3714455|FG001|COMPLETED|Period 1||108
2997422|NCT00943124|3714454|FG000|NOT COMPLETED|Period 1||2
2997423|NCT00943124|3714455|FG001|NOT COMPLETED|Period 1||2
2997424|NCT00943124|3714454|FG000|STARTED|Period 2||108
2997425|NCT00943124|3714455|FG001|STARTED|Period 2||108
2997426|NCT00943124|3714454|FG000|COMPLETED|Period 2||108
2997427|NCT00943124|3714455|FG001|COMPLETED|Period 2||108
2997428|NCT00943124|3714454|FG000|NOT COMPLETED|Period 2||0
2997429|NCT00943124|3714455|FG001|NOT COMPLETED|Period 2||0
2997430|NCT00943150|3714463|FG000|STARTED|Overall Study||10
2997431|NCT00943150|3714464|FG001|STARTED|Overall Study||10
2997432|NCT00943150|3714463|FG000|COMPLETED|Overall Study||10
2997433|NCT00943150|3714464|FG001|COMPLETED|Overall Study||10
2997434|NCT00943150|3714463|FG000|NOT COMPLETED|Overall Study||0
2997435|NCT00943150|3714464|FG001|NOT COMPLETED|Overall Study||0
2997436|NCT00943202|3714478|FG000|STARTED|Overall Study||133
2997437|NCT00943202|3714479|FG001|STARTED|Overall Study||133
2997438|NCT00943202|3714480|FG002|STARTED|Overall Study||133
2997439|NCT00943202|3714481|FG003|STARTED|Overall Study||132
2997440|NCT00943202|3714478|FG000|COMPLETED|Overall Study||132
2997441|NCT00943202|3714479|FG001|COMPLETED|Overall Study||131
2997442|NCT00943202|3714480|FG002|COMPLETED|Overall Study||133
2997443|NCT00943202|3714481|FG003|COMPLETED|Overall Study||131
2997444|NCT00943202|3714478|FG000|NOT COMPLETED|Overall Study||1
2997445|NCT00943202|3714479|FG001|NOT COMPLETED|Overall Study||2
2997446|NCT00943202|3714480|FG002|NOT COMPLETED|Overall Study||0
2997447|NCT00943202|3714481|FG003|NOT COMPLETED|Overall Study||1
2997448|NCT00943306|3714492|FG000|STARTED|Overall Study||19
2997449|NCT00943306|3714492|FG000|COMPLETED|Overall Study||16
2997450|NCT00943306|3714492|FG000|NOT COMPLETED|Overall Study||3
2997451|NCT00943319|3714496|FG000|STARTED|Overall Study||50
2997452|NCT00943319|3714496|FG000|COMPLETED|Overall Study||49
2997453|NCT00943319|3714496|FG000|NOT COMPLETED|Overall Study||1
2997454|NCT00943384|3714500|FG000|STARTED|Overall Study|104 subjects consented and underwent additional screening to determine eligibility to participate|104
3036952|NCT01146288|3756243|FG000|STARTED|First Intervention(1 Day)||7
2997455|NCT00943384|3714500|FG000|Treated|Overall Study|81 subjects were eligible and willing to participate in the study and were treated|81
2997456|NCT00943384|3714500|FG000|Treated on Protocol|Overall Study|5 subjects were treated off protocol due to intraoperative decisions made by the surgeon|76
2997457|NCT00943384|3714500|FG000|COMPLETED|Overall Study|evaluated at the Month 24 visit with complete or partial data|55
2997458|NCT00943384|3714500|FG000|NOT COMPLETED|Overall Study||49
2997459|NCT00943436|3714506|FG000|STARTED|Exercise Session: 45 Minutes of Activity||10
2997460|NCT00943436|3714507|FG001|STARTED|Exercise Session: 45 Minutes of Activity||10
2997461|NCT00943436|3714506|FG000|COMPLETED|Exercise Session: 45 Minutes of Activity||10
2997462|NCT00943436|3714507|FG001|COMPLETED|Exercise Session: 45 Minutes of Activity||10
2997463|NCT00943436|3714506|FG000|NOT COMPLETED|Exercise Session: 45 Minutes of Activity||0
2997464|NCT00943436|3714507|FG001|NOT COMPLETED|Exercise Session: 45 Minutes of Activity||0
2997465|NCT00943436|3714506|FG000|STARTED|Rest Session: 45 Minutes of Reading||10
2997466|NCT00943436|3714507|FG001|STARTED|Rest Session: 45 Minutes of Reading||10
2997467|NCT00943436|3714506|FG000|COMPLETED|Rest Session: 45 Minutes of Reading||10
2997468|NCT00943436|3714507|FG001|COMPLETED|Rest Session: 45 Minutes of Reading||10
2997469|NCT00943436|3714506|FG000|NOT COMPLETED|Rest Session: 45 Minutes of Reading||0
2997470|NCT00943436|3714507|FG001|NOT COMPLETED|Rest Session: 45 Minutes of Reading||0
2997471|NCT00943488|3714515|FG000|STARTED|Overall Study||204
2997472|NCT00943488|3714516|FG001|STARTED|Overall Study||204
2997473|NCT00943488|3714515|FG000|COMPLETED|Overall Study||203
2997474|NCT00943488|3714516|FG001|COMPLETED|Overall Study||202
2997475|NCT00943488|3714515|FG000|NOT COMPLETED|Overall Study||1
2997476|NCT00943488|3714516|FG001|NOT COMPLETED|Overall Study||2
2997477|NCT00943579|3714524|FG000|STARTED|Overall Study||21
2997478|NCT00943579|3714525|FG001|STARTED|Overall Study||20
2997479|NCT00943579|3714524|FG000|COMPLETED|Overall Study||15
2997480|NCT00943579|3714525|FG001|COMPLETED|Overall Study||15
2997481|NCT00943579|3714524|FG000|NOT COMPLETED|Overall Study||6
2997482|NCT00943579|3714525|FG001|NOT COMPLETED|Overall Study||5
2997483|NCT00943592|3714534|FG000|STARTED|Overall Study||82
2997484|NCT00943592|3714534|FG000|Maximum Tolerated Dose|Overall Study|74 patients received the Maximum Tolerated Dose|74
2997485|NCT00943592|3714534|FG000|COMPLETED|Overall Study|None of the three deaths were attributed to the conditioning regimen|79
2997486|NCT00943592|3714534|FG000|NOT COMPLETED|Overall Study||3
2997487|NCT00943631|3714540|FG000|STARTED|Overall Study||202
2997488|NCT00943631|3714541|FG001|STARTED|Overall Study||204
2997489|NCT00943631|3714540|FG000|COMPLETED|Overall Study||198
2997490|NCT00943631|3714541|FG001|COMPLETED|Overall Study||202
2997491|NCT00943631|3714540|FG000|NOT COMPLETED|Overall Study||4
2997492|NCT00943631|3714541|FG001|NOT COMPLETED|Overall Study||2
2997493|NCT00943670|3714547|FG000|STARTED|Single-agent Trastuzumab Emtansine||51
2997494|NCT00943670|3714547|FG000|Treated|Single-agent Trastuzumab Emtansine||51
2997495|NCT00943670|3714547|FG000|COMPLETED|Single-agent Trastuzumab Emtansine|Completed single-agent treatment defined as receiving 17 cycles of trastuzumab emtansine therapy.|9
2997496|NCT00943670|3714547|FG000|NOT COMPLETED|Single-agent Trastuzumab Emtansine||42
2997497|NCT00943670|3714547|FG000|STARTED|Trastuzumab Emtansine + Pertuzumab|Patients with early progressive disease who elected to receive T-DM1 and pertuzumab.|20
2997498|NCT00943670|3714547|FG000|COMPLETED|Trastuzumab Emtansine + Pertuzumab|Completed treatment defined as receiving a total of 17 cycles of therapy in both treatment periods.|2
2997499|NCT00943670|3714547|FG000|NOT COMPLETED|Trastuzumab Emtansine + Pertuzumab||18
2997500|NCT00943722|3714567|FG000|STARTED|Overall Study||648
2997501|NCT00943722|3714568|FG001|STARTED|Overall Study||643
2997502|NCT00943722|3714569|FG002|STARTED|Overall Study||644
2997503|NCT00943722|3714570|FG003|STARTED|Overall Study||669
2997504|NCT00943722|3714571|FG004|STARTED|Overall Study||470
2997505|NCT00943722|3714567|FG000|Vaccination 1|Overall Study||646
2997506|NCT00943722|3714568|FG001|Vaccination 1|Overall Study||642
2997507|NCT00943722|3714569|FG002|Vaccination 1|Overall Study||644
2997508|NCT00943722|3714570|FG003|Vaccination 1|Overall Study||666
2997509|NCT00943722|3714571|FG004|Vaccination 1|Overall Study||468
2997510|NCT00943722|3714567|FG000|Vaccination 2|Overall Study||637
2997511|NCT00943722|3714568|FG001|Vaccination 2|Overall Study||633
2997512|NCT00943722|3714569|FG002|Vaccination 2|Overall Study||638
2997513|NCT00943722|3714570|FG003|Vaccination 2|Overall Study||658
2997514|NCT00943722|3714571|FG004|Vaccination 2|Overall Study||462
2997515|NCT00943722|3714567|FG000|Vaccination 3|Overall Study||635
2997516|NCT00943722|3714568|FG001|Vaccination 3|Overall Study||627
2997517|NCT00943722|3714569|FG002|Vaccination 3|Overall Study||637
2997518|NCT00943722|3714570|FG003|Vaccination 3|Overall Study||653
2997519|NCT00943722|3714571|FG004|Vaccination 3|Overall Study||455
2997520|NCT00943722|3714567|FG000|COMPLETED|Overall Study||623
2997521|NCT00943722|3714568|FG001|COMPLETED|Overall Study||621
2997522|NCT00943722|3714569|FG002|COMPLETED|Overall Study||631
2997523|NCT00943722|3714570|FG003|COMPLETED|Overall Study||647
2997524|NCT00943722|3714571|FG004|COMPLETED|Overall Study|Includes 4 participants for whom completion status is unknown|448
2997525|NCT00943722|3714567|FG000|NOT COMPLETED|Overall Study||25
2997526|NCT00943722|3714568|FG001|NOT COMPLETED|Overall Study||22
2997527|NCT00943722|3714569|FG002|NOT COMPLETED|Overall Study||13
2997528|NCT00943722|3714570|FG003|NOT COMPLETED|Overall Study||22
2997529|NCT00943722|3714571|FG004|NOT COMPLETED|Overall Study||22
2997530|NCT00943735|3714585|FG000|STARTED|Overall Study||774
2997531|NCT00943735|3714585|FG000|Per Protocol Population|Overall Study||500
2997532|NCT00943735|3714585|FG000|COMPLETED|Overall Study||742
2997533|NCT00943735|3714585|FG000|NOT COMPLETED|Overall Study||32
2997534|NCT00943761|3714591|FG000|STARTED|Overall Study||21
2997535|NCT00943761|3714592|FG001|STARTED|Overall Study||24
2997536|NCT00943761|3714591|FG000|COMPLETED|Overall Study||17
2997537|NCT00943761|3714592|FG001|COMPLETED|Overall Study||23
2997538|NCT00943761|3714591|FG000|NOT COMPLETED|Overall Study||4
2997539|NCT00943761|3714592|FG001|NOT COMPLETED|Overall Study||1
2997540|NCT00943787|3714598|FG000|STARTED|Overall Study||41
2997541|NCT00943787|3714598|FG000|COMPLETED|Overall Study||34
2997542|NCT00943787|3714598|FG000|NOT COMPLETED|Overall Study||7
2997543|NCT00943800|3714602|FG000|STARTED|Overall Study||87
2997544|NCT00943800|3714602|FG000|COMPLETED|Overall Study||87
2997545|NCT00943800|3714602|FG000|NOT COMPLETED|Overall Study||0
2997546|NCT00943826|3714608|FG000|STARTED|Concurrent Phase||458
2997547|NCT00943826|3714609|FG001|STARTED|Concurrent Phase||463
2997548|NCT00943826|3714608|FG000|Treated|Concurrent Phase||452
2997549|NCT00943826|3714609|FG001|Treated|Concurrent Phase||459
2997550|NCT00943826|3714608|FG000|COMPLETED|Concurrent Phase||397
2997551|NCT00943826|3714609|FG001|COMPLETED|Concurrent Phase||421
2997552|NCT00943826|3714608|FG000|NOT COMPLETED|Concurrent Phase||61
2997553|NCT00943826|3714609|FG001|NOT COMPLETED|Concurrent Phase||42
2997554|NCT00943826|3714608|FG000|STARTED|Maintenance Phase|Some who completed previous period had discontinued, progressed, or died prior to this period.|396
2997555|NCT00943826|3714609|FG001|STARTED|Maintenance Phase|Some who completed previous period had discontinued, progressed, or died prior to this period.|370
2997556|NCT00943826|3714608|FG000|COMPLETED|Maintenance Phase||353
2997557|NCT00943826|3714609|FG001|COMPLETED|Maintenance Phase||331
2997558|NCT00943826|3714608|FG000|NOT COMPLETED|Maintenance Phase||43
2997559|NCT00943826|3714609|FG001|NOT COMPLETED|Maintenance Phase||39
3305690|NCT02991859|4039225|FG011|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
3305691|NCT02991859|4039226|FG012|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
3305692|NCT02991859|4039227|FG013|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
3305693|NCT02991859|4039228|FG014|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
3305694|NCT02991859|4039229|FG015|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
3305695|NCT02991859|4039230|FG016|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
3305696|NCT02991859|4039214|FG000|STARTED|Period1, Escalation Phase5, Upto Day35||2
3305697|NCT02991859|4039215|FG001|STARTED|Period1, Escalation Phase5, Upto Day35||2
3305698|NCT02991859|4039216|FG002|STARTED|Period1, Escalation Phase5, Upto Day35||2
3305699|NCT02991859|4039217|FG003|STARTED|Period1, Escalation Phase5, Upto Day35||2
3305700|NCT02991859|4039218|FG004|STARTED|Period1, Escalation Phase5, Upto Day35||2
3305701|NCT02991859|4039219|FG005|STARTED|Period1, Escalation Phase5, Upto Day35||2
3305702|NCT02991859|4039220|FG006|STARTED|Period1, Escalation Phase5, Upto Day35||2
3305703|NCT02991859|4039221|FG007|STARTED|Period1, Escalation Phase5, Upto Day35||2
3305704|NCT02991859|4039222|FG008|STARTED|Period1, Escalation Phase5, Upto Day35||2
3305705|NCT02991859|4039223|FG009|STARTED|Period1, Escalation Phase5, Upto Day35||2
3305706|NCT02991859|4039224|FG010|STARTED|Period1, Escalation Phase5, Upto Day35|1 participant did not enter Esc Phase 5, and was not withdrawn|1
3305707|NCT02991859|4039225|FG011|STARTED|Period1, Escalation Phase5, Upto Day35||2
3305708|NCT02991859|4039226|FG012|STARTED|Period1, Escalation Phase5, Upto Day35||6
3305709|NCT02991859|4039227|FG013|STARTED|Period1, Escalation Phase5, Upto Day35||6
3305710|NCT02991859|4039228|FG014|STARTED|Period1, Escalation Phase5, Upto Day35||6
3305711|NCT02991859|4039229|FG015|STARTED|Period1, Escalation Phase5, Upto Day35||3
3305712|NCT02991859|4039230|FG016|STARTED|Period1, Escalation Phase5, Upto Day35||3
3305713|NCT02991859|4039214|FG000|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
3305714|NCT02991859|4039215|FG001|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
3305715|NCT02991859|4039216|FG002|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
3305716|NCT02991859|4039217|FG003|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
3305717|NCT02991859|4039218|FG004|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
3305718|NCT02991859|4039219|FG005|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
3305719|NCT02991859|4039220|FG006|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
3305720|NCT02991859|4039221|FG007|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
3305721|NCT02991859|4039222|FG008|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
3305722|NCT02991859|4039223|FG009|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
3305723|NCT02991859|4039224|FG010|COMPLETED|Period1, Escalation Phase5, Upto Day35||1
3305724|NCT02991859|4039225|FG011|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
3305725|NCT02991859|4039226|FG012|COMPLETED|Period1, Escalation Phase5, Upto Day35||6
3305726|NCT02991859|4039227|FG013|COMPLETED|Period1, Escalation Phase5, Upto Day35||6
3305727|NCT02991859|4039228|FG014|COMPLETED|Period1, Escalation Phase5, Upto Day35||6
3305728|NCT02991859|4039229|FG015|COMPLETED|Period1, Escalation Phase5, Upto Day35||3
3305729|NCT02991859|4039230|FG016|COMPLETED|Period1, Escalation Phase5, Upto Day35||3
3305730|NCT02991859|4039214|FG000|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
3305731|NCT02991859|4039215|FG001|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
3305732|NCT02991859|4039216|FG002|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
3305733|NCT02991859|4039217|FG003|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
3305734|NCT02991859|4039218|FG004|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
3305735|NCT02991859|4039219|FG005|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
3305736|NCT02991859|4039220|FG006|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
3305737|NCT02991859|4039221|FG007|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
3305738|NCT02991859|4039222|FG008|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
2997560|NCT00943826|3714608|FG000|STARTED|Monotherapy Phase|Some who completed previous period had discontinued, progressed, or died prior to this period.|269
2997561|NCT00943826|3714609|FG001|STARTED|Monotherapy Phase|Some who completed previous period had discontinued, progressed, or died prior to this period.|159
2997562|NCT00943826|3714608|FG000|COMPLETED|Monotherapy Phase||204
2997563|NCT00943826|3714609|FG001|COMPLETED|Monotherapy Phase||143
2997564|NCT00943826|3714608|FG000|NOT COMPLETED|Monotherapy Phase||65
2997565|NCT00943826|3714609|FG001|NOT COMPLETED|Monotherapy Phase||16
2997566|NCT00943826|3714608|FG000|STARTED|After Primary Overall Survival Analysis|Some who completed previous period had discontinued, progressed, or died prior to this period.|27
2997567|NCT00943826|3714609|FG001|STARTED|After Primary Overall Survival Analysis|Some who completed previous period had discontinued, progressed, or died prior to this period.|20
2997568|NCT00943826|3714608|FG000|COMPLETED|After Primary Overall Survival Analysis||0
2997569|NCT00943826|3714609|FG001|COMPLETED|After Primary Overall Survival Analysis||0
3305739|NCT02991859|4039223|FG009|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
3305740|NCT02991859|4039224|FG010|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
3305741|NCT02991859|4039225|FG011|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
3305742|NCT02991859|4039226|FG012|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
3305743|NCT02991859|4039227|FG013|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
3305744|NCT02991859|4039228|FG014|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
3305745|NCT02991859|4039229|FG015|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
3305746|NCT02991859|4039230|FG016|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
3305747|NCT02991859|4039214|FG000|STARTED|Wash Out, Up to Day 77||2
3305748|NCT02991859|4039215|FG001|STARTED|Wash Out, Up to Day 77||2
3305749|NCT02991859|4039216|FG002|STARTED|Wash Out, Up to Day 77||2
3305750|NCT02991859|4039217|FG003|STARTED|Wash Out, Up to Day 77||2
3305751|NCT02991859|4039218|FG004|STARTED|Wash Out, Up to Day 77||2
3305752|NCT02991859|4039219|FG005|STARTED|Wash Out, Up to Day 77||2
3305753|NCT02991859|4039220|FG006|STARTED|Wash Out, Up to Day 77||2
3305754|NCT02991859|4039221|FG007|STARTED|Wash Out, Up to Day 77||2
3305755|NCT02991859|4039222|FG008|STARTED|Wash Out, Up to Day 77||2
3305756|NCT02991859|4039223|FG009|STARTED|Wash Out, Up to Day 77||2
3305757|NCT02991859|4039224|FG010|STARTED|Wash Out, Up to Day 77||1
3305758|NCT02991859|4039225|FG011|STARTED|Wash Out, Up to Day 77||2
3305759|NCT02991859|4039226|FG012|STARTED|Wash Out, Up to Day 77|Participants did not enter washout and Period 2|0
3305760|NCT02991859|4039227|FG013|STARTED|Wash Out, Up to Day 77|Participants did not enter washout and Period 2|0
3305761|NCT02991859|4039228|FG014|STARTED|Wash Out, Up to Day 77|Participants did not enter washout and Period 2|0
3305762|NCT02991859|4039229|FG015|STARTED|Wash Out, Up to Day 77|Participants did not enter washout and Period 2|0
3305763|NCT02991859|4039230|FG016|STARTED|Wash Out, Up to Day 77|Participants did not enter washout and Period 2|0
3305764|NCT02991859|4039214|FG000|COMPLETED|Wash Out, Up to Day 77||2
3305765|NCT02991859|4039215|FG001|COMPLETED|Wash Out, Up to Day 77||2
3305766|NCT02991859|4039216|FG002|COMPLETED|Wash Out, Up to Day 77||2
3305767|NCT02991859|4039217|FG003|COMPLETED|Wash Out, Up to Day 77||2
3305768|NCT02991859|4039218|FG004|COMPLETED|Wash Out, Up to Day 77||2
3305769|NCT02991859|4039219|FG005|COMPLETED|Wash Out, Up to Day 77||1
3305770|NCT02991859|4039220|FG006|COMPLETED|Wash Out, Up to Day 77||2
3305771|NCT02991859|4039221|FG007|COMPLETED|Wash Out, Up to Day 77||2
3305772|NCT02991859|4039222|FG008|COMPLETED|Wash Out, Up to Day 77||2
3305773|NCT02991859|4039223|FG009|COMPLETED|Wash Out, Up to Day 77||1
3305774|NCT02991859|4039224|FG010|COMPLETED|Wash Out, Up to Day 77||1
3305775|NCT02991859|4039225|FG011|COMPLETED|Wash Out, Up to Day 77||2
3305776|NCT02991859|4039226|FG012|COMPLETED|Wash Out, Up to Day 77||0
3305777|NCT02991859|4039227|FG013|COMPLETED|Wash Out, Up to Day 77||0
3305778|NCT02991859|4039228|FG014|COMPLETED|Wash Out, Up to Day 77||0
3305779|NCT02991859|4039229|FG015|COMPLETED|Wash Out, Up to Day 77||0
3305780|NCT02991859|4039230|FG016|COMPLETED|Wash Out, Up to Day 77||0
3305781|NCT02991859|4039214|FG000|NOT COMPLETED|Wash Out, Up to Day 77||0
3305782|NCT02991859|4039215|FG001|NOT COMPLETED|Wash Out, Up to Day 77||0
3305783|NCT02991859|4039216|FG002|NOT COMPLETED|Wash Out, Up to Day 77||0
3305784|NCT02991859|4039217|FG003|NOT COMPLETED|Wash Out, Up to Day 77||0
3305785|NCT02991859|4039218|FG004|NOT COMPLETED|Wash Out, Up to Day 77||0
3305786|NCT02991859|4039219|FG005|NOT COMPLETED|Wash Out, Up to Day 77||1
3305787|NCT02991859|4039220|FG006|NOT COMPLETED|Wash Out, Up to Day 77||0
3305788|NCT02991859|4039221|FG007|NOT COMPLETED|Wash Out, Up to Day 77||0
3305789|NCT02991859|4039222|FG008|NOT COMPLETED|Wash Out, Up to Day 77||0
3305790|NCT02991859|4039223|FG009|NOT COMPLETED|Wash Out, Up to Day 77||1
3305791|NCT02991859|4039224|FG010|NOT COMPLETED|Wash Out, Up to Day 77||0
3305792|NCT02991859|4039225|FG011|NOT COMPLETED|Wash Out, Up to Day 77||0
3305793|NCT02991859|4039226|FG012|NOT COMPLETED|Wash Out, Up to Day 77||0
3305794|NCT02991859|4039227|FG013|NOT COMPLETED|Wash Out, Up to Day 77||0
3305795|NCT02991859|4039228|FG014|NOT COMPLETED|Wash Out, Up to Day 77||0
3305796|NCT02991859|4039229|FG015|NOT COMPLETED|Wash Out, Up to Day 77||0
3305797|NCT02991859|4039230|FG016|NOT COMPLETED|Wash Out, Up to Day 77||0
3305798|NCT02991859|4039214|FG000|STARTED|Period2, Escalation Phase1, Upto Day 84||2
3305799|NCT02991859|4039215|FG001|STARTED|Period2, Escalation Phase1, Upto Day 84||2
3305800|NCT02991859|4039216|FG002|STARTED|Period2, Escalation Phase1, Upto Day 84||2
3305801|NCT02991859|4039217|FG003|STARTED|Period2, Escalation Phase1, Upto Day 84||2
3305802|NCT02991859|4039218|FG004|STARTED|Period2, Escalation Phase1, Upto Day 84||2
3305803|NCT02991859|4039219|FG005|STARTED|Period2, Escalation Phase1, Upto Day 84||1
2997570|NCT00943826|3714608|FG000|NOT COMPLETED|After Primary Overall Survival Analysis||27
2997571|NCT00943826|3714609|FG001|NOT COMPLETED|After Primary Overall Survival Analysis||20
2997572|NCT00943878|3714620|FG000|STARTED|Overall Study||202
2997573|NCT00943878|3714621|FG001|STARTED|Overall Study||200
2997574|NCT00943878|3714622|FG002|STARTED|Overall Study||203
2997575|NCT00943878|3714623|FG003|STARTED|Overall Study||200
2997576|NCT00943878|3714620|FG000|COMPLETED|Overall Study||200
2997577|NCT00943878|3714621|FG001|COMPLETED|Overall Study||198
2997578|NCT00943878|3714622|FG002|COMPLETED|Overall Study||197
2997579|NCT00943878|3714623|FG003|COMPLETED|Overall Study||198
2997580|NCT00943878|3714620|FG000|NOT COMPLETED|Overall Study||2
2997581|NCT00943878|3714621|FG001|NOT COMPLETED|Overall Study||2
2997582|NCT00943878|3714622|FG002|NOT COMPLETED|Overall Study||6
2997583|NCT00943878|3714623|FG003|NOT COMPLETED|Overall Study||2
2997584|NCT00943904|3714633|FG000|STARTED|Overall Study||31
2997585|NCT00943904|3714633|FG000|COMPLETED|Overall Study||31
2997586|NCT00943904|3714633|FG000|NOT COMPLETED|Overall Study||0
2997587|NCT00943917|3714652|FG000|STARTED|Stage I||51
2997588|NCT00943917|3714653|FG001|STARTED|Stage I||51
2997589|NCT00943917|3714654|FG002|STARTED|Stage I||53
2997590|NCT00943917|3714655|FG003|STARTED|Stage I||0
2997591|NCT00943917|3714656|FG004|STARTED|Stage I||0
2997592|NCT00943917|3714657|FG005|STARTED|Stage I||0
2997593|NCT00943917|3714658|FG006|STARTED|Stage I||0
2997594|NCT00943917|3714659|FG007|STARTED|Stage I||0
2997595|NCT00943917|3714660|FG008|STARTED|Stage I||0
2997596|NCT00943917|3714661|FG009|STARTED|Stage I||0
2997597|NCT00943917|3714662|FG010|STARTED|Stage I||0
2997598|NCT00943917|3714663|FG011|STARTED|Stage I||0
2997599|NCT00943917|3714664|FG012|STARTED|Stage I||0
2997600|NCT00943917|3714665|FG013|STARTED|Stage I||0
2997601|NCT00943917|3714666|FG014|STARTED|Stage I||0
2997602|NCT00943917|3714652|FG000|COMPLETED|Stage I||47
2997603|NCT00943917|3714653|FG001|COMPLETED|Stage I||48
2997604|NCT00943917|3714654|FG002|COMPLETED|Stage I||47
2997605|NCT00943917|3714655|FG003|COMPLETED|Stage I||0
2997606|NCT00943917|3714656|FG004|COMPLETED|Stage I||0
2997607|NCT00943917|3714657|FG005|COMPLETED|Stage I||0
2997608|NCT00943917|3714658|FG006|COMPLETED|Stage I||0
2997609|NCT00943917|3714659|FG007|COMPLETED|Stage I||0
2997610|NCT00943917|3714660|FG008|COMPLETED|Stage I||0
2997611|NCT00943917|3714661|FG009|COMPLETED|Stage I||0
2997612|NCT00943917|3714662|FG010|COMPLETED|Stage I||0
2997613|NCT00943917|3714663|FG011|COMPLETED|Stage I||0
2997614|NCT00943917|3714664|FG012|COMPLETED|Stage I||0
2997615|NCT00943917|3714665|FG013|COMPLETED|Stage I||0
2997616|NCT00943917|3714666|FG014|COMPLETED|Stage I||0
2997617|NCT00943917|3714652|FG000|NOT COMPLETED|Stage I||4
2997618|NCT00943917|3714653|FG001|NOT COMPLETED|Stage I||3
2997619|NCT00943917|3714654|FG002|NOT COMPLETED|Stage I||6
2997620|NCT00943917|3714655|FG003|NOT COMPLETED|Stage I||0
2997621|NCT00943917|3714656|FG004|NOT COMPLETED|Stage I||0
2997622|NCT00943917|3714657|FG005|NOT COMPLETED|Stage I||0
2997623|NCT00943917|3714658|FG006|NOT COMPLETED|Stage I||0
2997624|NCT00943917|3714659|FG007|NOT COMPLETED|Stage I||0
2997625|NCT00943917|3714660|FG008|NOT COMPLETED|Stage I||0
2997626|NCT00943917|3714661|FG009|NOT COMPLETED|Stage I||0
2997627|NCT00943917|3714662|FG010|NOT COMPLETED|Stage I||0
2997628|NCT00943917|3714663|FG011|NOT COMPLETED|Stage I||0
2997629|NCT00943917|3714664|FG012|NOT COMPLETED|Stage I||0
2997630|NCT00943917|3714665|FG013|NOT COMPLETED|Stage I||0
2997631|NCT00943917|3714666|FG014|NOT COMPLETED|Stage I||0
2997632|NCT00943917|3714652|FG000|STARTED|Stage II||0
2997633|NCT00943917|3714653|FG001|STARTED|Stage II||0
2997634|NCT00943917|3714654|FG002|STARTED|Stage II||0
2997635|NCT00943917|3714655|FG003|STARTED|Stage II||20
2997636|NCT00943917|3714656|FG004|STARTED|Stage II||21
2997637|NCT00943917|3714657|FG005|STARTED|Stage II||23
2997638|NCT00943917|3714658|FG006|STARTED|Stage II||23
2997639|NCT00943917|3714659|FG007|STARTED|Stage II||23
2997640|NCT00943917|3714660|FG008|STARTED|Stage II||21
2997641|NCT00943917|3714661|FG009|STARTED|Stage II||0
2997642|NCT00943917|3714662|FG010|STARTED|Stage II||0
2997643|NCT00943917|3714663|FG011|STARTED|Stage II||0
2997644|NCT00943917|3714664|FG012|STARTED|Stage II||0
2997645|NCT00943917|3714665|FG013|STARTED|Stage II||0
2997646|NCT00943917|3714666|FG014|STARTED|Stage II||0
2997647|NCT00943917|3714652|FG000|COMPLETED|Stage II||0
2997648|NCT00943917|3714653|FG001|COMPLETED|Stage II||0
2997649|NCT00943917|3714654|FG002|COMPLETED|Stage II||0
2997650|NCT00943917|3714655|FG003|COMPLETED|Stage II||20
2997651|NCT00943917|3714656|FG004|COMPLETED|Stage II||21
2997652|NCT00943917|3714657|FG005|COMPLETED|Stage II||20
2997653|NCT00943917|3714658|FG006|COMPLETED|Stage II||20
2997654|NCT00943917|3714659|FG007|COMPLETED|Stage II||23
2997655|NCT00943917|3714660|FG008|COMPLETED|Stage II||20
2997656|NCT00943917|3714661|FG009|COMPLETED|Stage II||0
2997657|NCT00943917|3714662|FG010|COMPLETED|Stage II||0
2997658|NCT00943917|3714663|FG011|COMPLETED|Stage II||0
2997659|NCT00943917|3714664|FG012|COMPLETED|Stage II||0
2997660|NCT00943917|3714665|FG013|COMPLETED|Stage II||0
2997661|NCT00943917|3714666|FG014|COMPLETED|Stage II||0
2997662|NCT00943917|3714652|FG000|NOT COMPLETED|Stage II||0
2997663|NCT00943917|3714653|FG001|NOT COMPLETED|Stage II||0
2997664|NCT00943917|3714654|FG002|NOT COMPLETED|Stage II||0
2997665|NCT00943917|3714655|FG003|NOT COMPLETED|Stage II||0
2997666|NCT00943917|3714656|FG004|NOT COMPLETED|Stage II||0
2997667|NCT00943917|3714657|FG005|NOT COMPLETED|Stage II||3
2997668|NCT00943917|3714658|FG006|NOT COMPLETED|Stage II||3
2997669|NCT00943917|3714659|FG007|NOT COMPLETED|Stage II||0
2997670|NCT00943917|3714660|FG008|NOT COMPLETED|Stage II||1
2997671|NCT00943917|3714661|FG009|NOT COMPLETED|Stage II||0
2997672|NCT00943917|3714662|FG010|NOT COMPLETED|Stage II||0
2997673|NCT00943917|3714663|FG011|NOT COMPLETED|Stage II||0
2997674|NCT00943917|3714664|FG012|NOT COMPLETED|Stage II||0
2997675|NCT00943917|3714665|FG013|NOT COMPLETED|Stage II||0
2997676|NCT00943917|3714666|FG014|NOT COMPLETED|Stage II||0
2997677|NCT00943917|3714652|FG000|STARTED|Stage II Continuation||0
2997678|NCT00943917|3714653|FG001|STARTED|Stage II Continuation||0
2997679|NCT00943917|3714654|FG002|STARTED|Stage II Continuation||0
2997680|NCT00943917|3714655|FG003|STARTED|Stage II Continuation||0
2997681|NCT00943917|3714656|FG004|STARTED|Stage II Continuation||0
2997682|NCT00943917|3714657|FG005|STARTED|Stage II Continuation||0
2997683|NCT00943917|3714658|FG006|STARTED|Stage II Continuation||0
2997684|NCT00943917|3714659|FG007|STARTED|Stage II Continuation||0
2997685|NCT00943917|3714660|FG008|STARTED|Stage II Continuation||0
2997686|NCT00943917|3714661|FG009|STARTED|Stage II Continuation||15
2997687|NCT00943917|3714662|FG010|STARTED|Stage II Continuation||15
2997688|NCT00943917|3714663|FG011|STARTED|Stage II Continuation||13
2997689|NCT00943917|3714664|FG012|STARTED|Stage II Continuation||16
3305804|NCT02991859|4039220|FG006|STARTED|Period2, Escalation Phase1, Upto Day 84||2
3305805|NCT02991859|4039221|FG007|STARTED|Period2, Escalation Phase1, Upto Day 84||2
3305806|NCT02991859|4039222|FG008|STARTED|Period2, Escalation Phase1, Upto Day 84||2
3305807|NCT02991859|4039223|FG009|STARTED|Period2, Escalation Phase1, Upto Day 84|1 Par directly entered into Period 2, Esc 1|2
3305808|NCT02991859|4039224|FG010|STARTED|Period2, Escalation Phase1, Upto Day 84|1 Par cont in P2 Esc 1 insteadP1 Esc 5, was not withdrawn|2
3305809|NCT02991859|4039225|FG011|STARTED|Period2, Escalation Phase1, Upto Day 84||2
3305810|NCT02991859|4039226|FG012|STARTED|Period2, Escalation Phase1, Upto Day 84||0
3305811|NCT02991859|4039227|FG013|STARTED|Period2, Escalation Phase1, Upto Day 84||0
3305812|NCT02991859|4039228|FG014|STARTED|Period2, Escalation Phase1, Upto Day 84||0
3305813|NCT02991859|4039229|FG015|STARTED|Period2, Escalation Phase1, Upto Day 84||0
3305814|NCT02991859|4039230|FG016|STARTED|Period2, Escalation Phase1, Upto Day 84||0
3305815|NCT02991859|4039214|FG000|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
3305816|NCT02991859|4039215|FG001|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
3305817|NCT02991859|4039216|FG002|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
3305818|NCT02991859|4039217|FG003|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
3305819|NCT02991859|4039218|FG004|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
3305820|NCT02991859|4039219|FG005|COMPLETED|Period2, Escalation Phase1, Upto Day 84||1
3305821|NCT02991859|4039220|FG006|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
3305822|NCT02991859|4039221|FG007|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
3305823|NCT02991859|4039222|FG008|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
3305824|NCT02991859|4039223|FG009|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
3305825|NCT02991859|4039224|FG010|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
3305826|NCT02991859|4039225|FG011|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
3305827|NCT02991859|4039226|FG012|COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
3305828|NCT02991859|4039227|FG013|COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
3305829|NCT02991859|4039228|FG014|COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
3305830|NCT02991859|4039229|FG015|COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
3305831|NCT02991859|4039230|FG016|COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
3305832|NCT02991859|4039214|FG000|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
3305833|NCT02991859|4039215|FG001|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
3305834|NCT02991859|4039216|FG002|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
3305835|NCT02991859|4039217|FG003|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
3305836|NCT02991859|4039218|FG004|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
3305837|NCT02991859|4039219|FG005|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
3305838|NCT02991859|4039220|FG006|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
3305839|NCT02991859|4039221|FG007|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
3305840|NCT02991859|4039222|FG008|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
3305841|NCT02991859|4039223|FG009|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
3305842|NCT02991859|4039224|FG010|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
3305843|NCT02991859|4039225|FG011|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
3305844|NCT02991859|4039226|FG012|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
3305845|NCT02991859|4039227|FG013|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
3305846|NCT02991859|4039228|FG014|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
3305847|NCT02991859|4039229|FG015|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
3305848|NCT02991859|4039230|FG016|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
3305849|NCT02991859|4039214|FG000|STARTED|Period2, Escalation Phase2, Upto Day 91||2
3305850|NCT02991859|4039215|FG001|STARTED|Period2, Escalation Phase2, Upto Day 91||2
3305851|NCT02991859|4039216|FG002|STARTED|Period2, Escalation Phase2, Upto Day 91||2
3305852|NCT02991859|4039217|FG003|STARTED|Period2, Escalation Phase2, Upto Day 91||2
3305853|NCT02991859|4039218|FG004|STARTED|Period2, Escalation Phase2, Upto Day 91||2
3305854|NCT02991859|4039219|FG005|STARTED|Period2, Escalation Phase2, Upto Day 91||1
3305855|NCT02991859|4039220|FG006|STARTED|Period2, Escalation Phase2, Upto Day 91||2
3305856|NCT02991859|4039221|FG007|STARTED|Period2, Escalation Phase2, Upto Day 91||2
2997690|NCT00943917|3714665|FG013|STARTED|Stage II Continuation||15
2997691|NCT00943917|3714666|FG014|STARTED|Stage II Continuation||12
2997692|NCT00943917|3714652|FG000|COMPLETED|Stage II Continuation||0
2997693|NCT00943917|3714653|FG001|COMPLETED|Stage II Continuation||0
2997694|NCT00943917|3714654|FG002|COMPLETED|Stage II Continuation||0
2997695|NCT00943917|3714655|FG003|COMPLETED|Stage II Continuation||0
2997696|NCT00943917|3714656|FG004|COMPLETED|Stage II Continuation||0
2997697|NCT00943917|3714657|FG005|COMPLETED|Stage II Continuation||0
2997698|NCT00943917|3714658|FG006|COMPLETED|Stage II Continuation||0
2997699|NCT00943917|3714659|FG007|COMPLETED|Stage II Continuation||0
2997700|NCT00943917|3714660|FG008|COMPLETED|Stage II Continuation||0
2997701|NCT00943917|3714661|FG009|COMPLETED|Stage II Continuation||14
2997702|NCT00943917|3714662|FG010|COMPLETED|Stage II Continuation||15
2997703|NCT00943917|3714663|FG011|COMPLETED|Stage II Continuation||11
2997704|NCT00943917|3714664|FG012|COMPLETED|Stage II Continuation||13
3305857|NCT02991859|4039222|FG008|STARTED|Period2, Escalation Phase2, Upto Day 91||2
3305858|NCT02991859|4039223|FG009|STARTED|Period2, Escalation Phase2, Upto Day 91||2
3305859|NCT02991859|4039224|FG010|STARTED|Period2, Escalation Phase2, Upto Day 91||2
3305860|NCT02991859|4039225|FG011|STARTED|Period2, Escalation Phase2, Upto Day 91||2
3305861|NCT02991859|4039226|FG012|STARTED|Period2, Escalation Phase2, Upto Day 91||0
3305862|NCT02991859|4039227|FG013|STARTED|Period2, Escalation Phase2, Upto Day 91||0
3305863|NCT02991859|4039228|FG014|STARTED|Period2, Escalation Phase2, Upto Day 91||0
3305864|NCT02991859|4039229|FG015|STARTED|Period2, Escalation Phase2, Upto Day 91||0
3305865|NCT02991859|4039230|FG016|STARTED|Period2, Escalation Phase2, Upto Day 91||0
3305866|NCT02991859|4039214|FG000|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
3305867|NCT02991859|4039215|FG001|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
3305868|NCT02991859|4039216|FG002|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
3305869|NCT02991859|4039217|FG003|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
3305870|NCT02991859|4039218|FG004|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
3305871|NCT02991859|4039219|FG005|COMPLETED|Period2, Escalation Phase2, Upto Day 91||1
3305872|NCT02991859|4039220|FG006|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
3305873|NCT02991859|4039221|FG007|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
3305874|NCT02991859|4039222|FG008|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
3305875|NCT02991859|4039223|FG009|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
3305876|NCT02991859|4039224|FG010|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
3305877|NCT02991859|4039225|FG011|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
3305878|NCT02991859|4039226|FG012|COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
3305879|NCT02991859|4039227|FG013|COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
3305880|NCT02991859|4039228|FG014|COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
3305881|NCT02991859|4039229|FG015|COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
3305882|NCT02991859|4039230|FG016|COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
3305883|NCT02991859|4039214|FG000|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
3305884|NCT02991859|4039215|FG001|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
3305885|NCT02991859|4039216|FG002|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
3305886|NCT02991859|4039217|FG003|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
3305887|NCT02991859|4039218|FG004|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
3305888|NCT02991859|4039219|FG005|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
3305889|NCT02991859|4039220|FG006|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
3305890|NCT02991859|4039221|FG007|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
3305891|NCT02991859|4039222|FG008|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
3305892|NCT02991859|4039223|FG009|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
3305893|NCT02991859|4039224|FG010|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
3305894|NCT02991859|4039225|FG011|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
3305895|NCT02991859|4039226|FG012|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
3305896|NCT02991859|4039227|FG013|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
3305897|NCT02991859|4039228|FG014|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
3305898|NCT02991859|4039229|FG015|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
3305899|NCT02991859|4039230|FG016|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
3305900|NCT02991859|4039214|FG000|STARTED|Period2, Escalation Phase3, Upto Day 98||2
3305901|NCT02991859|4039215|FG001|STARTED|Period2, Escalation Phase3, Upto Day 98||2
3305902|NCT02991859|4039216|FG002|STARTED|Period2, Escalation Phase3, Upto Day 98||2
3305903|NCT02991859|4039217|FG003|STARTED|Period2, Escalation Phase3, Upto Day 98||2
3305904|NCT02991859|4039218|FG004|STARTED|Period2, Escalation Phase3, Upto Day 98||2
3305905|NCT02991859|4039219|FG005|STARTED|Period2, Escalation Phase3, Upto Day 98||1
3305906|NCT02991859|4039220|FG006|STARTED|Period2, Escalation Phase3, Upto Day 98||2
3305907|NCT02991859|4039221|FG007|STARTED|Period2, Escalation Phase3, Upto Day 98||2
3305908|NCT02991859|4039222|FG008|STARTED|Period2, Escalation Phase3, Upto Day 98||2
3305909|NCT02991859|4039223|FG009|STARTED|Period2, Escalation Phase3, Upto Day 98||2
3305910|NCT02991859|4039224|FG010|STARTED|Period2, Escalation Phase3, Upto Day 98||2
3305911|NCT02991859|4039225|FG011|STARTED|Period2, Escalation Phase3, Upto Day 98||2
3305912|NCT02991859|4039226|FG012|STARTED|Period2, Escalation Phase3, Upto Day 98||0
3305913|NCT02991859|4039227|FG013|STARTED|Period2, Escalation Phase3, Upto Day 98||0
3305914|NCT02991859|4039228|FG014|STARTED|Period2, Escalation Phase3, Upto Day 98||0
3305915|NCT02991859|4039229|FG015|STARTED|Period2, Escalation Phase3, Upto Day 98||0
3305916|NCT02991859|4039230|FG016|STARTED|Period2, Escalation Phase3, Upto Day 98||0
3305917|NCT02991859|4039214|FG000|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
3305918|NCT02991859|4039215|FG001|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
3305919|NCT02991859|4039216|FG002|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
2997705|NCT00943917|3714665|FG013|COMPLETED|Stage II Continuation||12
2997706|NCT00943917|3714666|FG014|COMPLETED|Stage II Continuation||8
2997707|NCT00943917|3714652|FG000|NOT COMPLETED|Stage II Continuation||0
2997708|NCT00943917|3714653|FG001|NOT COMPLETED|Stage II Continuation||0
2997709|NCT00943917|3714654|FG002|NOT COMPLETED|Stage II Continuation||0
2997710|NCT00943917|3714655|FG003|NOT COMPLETED|Stage II Continuation||0
2997711|NCT00943917|3714656|FG004|NOT COMPLETED|Stage II Continuation||0
2997712|NCT00943917|3714657|FG005|NOT COMPLETED|Stage II Continuation||0
2997713|NCT00943917|3714658|FG006|NOT COMPLETED|Stage II Continuation||0
2997714|NCT00943917|3714659|FG007|NOT COMPLETED|Stage II Continuation||0
2997715|NCT00943917|3714660|FG008|NOT COMPLETED|Stage II Continuation||0
2997716|NCT00943917|3714661|FG009|NOT COMPLETED|Stage II Continuation||1
2997717|NCT00943917|3714662|FG010|NOT COMPLETED|Stage II Continuation||0
2997718|NCT00943917|3714663|FG011|NOT COMPLETED|Stage II Continuation||2
2997719|NCT00943917|3714664|FG012|NOT COMPLETED|Stage II Continuation||3
2997720|NCT00943917|3714665|FG013|NOT COMPLETED|Stage II Continuation||3
2997721|NCT00943917|3714666|FG014|NOT COMPLETED|Stage II Continuation||4
2997722|NCT00944021|3714704|FG000|STARTED|Overall Study||15
2997723|NCT00944021|3714705|FG001|STARTED|Overall Study||15
2997724|NCT00944021|3714706|FG002|STARTED|Overall Study||15
2997725|NCT00944021|3714707|FG003|STARTED|Overall Study||16
2997726|NCT00944021|3714708|FG004|STARTED|Overall Study||8
2997727|NCT00944021|3714704|FG000|COMPLETED|Overall Study||14
2997728|NCT00944021|3714705|FG001|COMPLETED|Overall Study||15
2997729|NCT00944021|3714706|FG002|COMPLETED|Overall Study||15
2997730|NCT00944021|3714707|FG003|COMPLETED|Overall Study||16
3305920|NCT02991859|4039217|FG003|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
3305921|NCT02991859|4039218|FG004|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
3305922|NCT02991859|4039219|FG005|COMPLETED|Period2, Escalation Phase3, Upto Day 98||1
3305923|NCT02991859|4039220|FG006|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
3305924|NCT02991859|4039221|FG007|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
3305925|NCT02991859|4039222|FG008|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
3305926|NCT02991859|4039223|FG009|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
3305927|NCT02991859|4039224|FG010|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
3305928|NCT02991859|4039225|FG011|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
3305929|NCT02991859|4039226|FG012|COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
3305930|NCT02991859|4039227|FG013|COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
3305931|NCT02991859|4039228|FG014|COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
3305932|NCT02991859|4039229|FG015|COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
3305933|NCT02991859|4039230|FG016|COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
3305934|NCT02991859|4039214|FG000|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
3305935|NCT02991859|4039215|FG001|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
3305936|NCT02991859|4039216|FG002|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
3305937|NCT02991859|4039217|FG003|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
3305938|NCT02991859|4039218|FG004|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
3305939|NCT02991859|4039219|FG005|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
3305940|NCT02991859|4039220|FG006|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
3305941|NCT02991859|4039221|FG007|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
3305942|NCT02991859|4039222|FG008|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
3305943|NCT02991859|4039223|FG009|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
3305944|NCT02991859|4039224|FG010|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
3305945|NCT02991859|4039225|FG011|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
3305946|NCT02991859|4039226|FG012|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
3305947|NCT02991859|4039227|FG013|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
3305948|NCT02991859|4039228|FG014|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
3305949|NCT02991859|4039229|FG015|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
3305950|NCT02991859|4039230|FG016|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
3305951|NCT02991859|4039214|FG000|STARTED|Period2, Escalation Phase4, Upto Day 105||2
3305952|NCT02991859|4039215|FG001|STARTED|Period2, Escalation Phase4, Upto Day 105||2
3305953|NCT02991859|4039216|FG002|STARTED|Period2, Escalation Phase4, Upto Day 105||2
3305954|NCT02991859|4039217|FG003|STARTED|Period2, Escalation Phase4, Upto Day 105||2
3305955|NCT02991859|4039218|FG004|STARTED|Period2, Escalation Phase4, Upto Day 105||2
3305956|NCT02991859|4039219|FG005|STARTED|Period2, Escalation Phase4, Upto Day 105||1
3305957|NCT02991859|4039220|FG006|STARTED|Period2, Escalation Phase4, Upto Day 105||2
3305958|NCT02991859|4039221|FG007|STARTED|Period2, Escalation Phase4, Upto Day 105||2
3305959|NCT02991859|4039222|FG008|STARTED|Period2, Escalation Phase4, Upto Day 105||2
3305960|NCT02991859|4039223|FG009|STARTED|Period2, Escalation Phase4, Upto Day 105||2
3305961|NCT02991859|4039224|FG010|STARTED|Period2, Escalation Phase4, Upto Day 105||2
3305962|NCT02991859|4039225|FG011|STARTED|Period2, Escalation Phase4, Upto Day 105||2
3305963|NCT02991859|4039226|FG012|STARTED|Period2, Escalation Phase4, Upto Day 105||0
3305964|NCT02991859|4039227|FG013|STARTED|Period2, Escalation Phase4, Upto Day 105||0
3305965|NCT02991859|4039228|FG014|STARTED|Period2, Escalation Phase4, Upto Day 105||0
3305966|NCT02991859|4039229|FG015|STARTED|Period2, Escalation Phase4, Upto Day 105||0
2997731|NCT00944021|3714708|FG004|COMPLETED|Overall Study||8
2997732|NCT00944021|3714704|FG000|NOT COMPLETED|Overall Study||1
2997733|NCT00944021|3714705|FG001|NOT COMPLETED|Overall Study||0
2997734|NCT00944021|3714706|FG002|NOT COMPLETED|Overall Study||0
2997735|NCT00944021|3714707|FG003|NOT COMPLETED|Overall Study||0
2997736|NCT00944021|3714708|FG004|NOT COMPLETED|Overall Study||0
2997737|NCT00944034|3714732|FG000|STARTED|Overall Study||188
2997738|NCT00944034|3714733|FG001|STARTED|Overall Study||157
2997739|NCT00944034|3714734|FG002|STARTED|Overall Study||152
2997740|NCT00944034|3714735|FG003|STARTED|Overall Study||174
2997741|NCT00944034|3714736|FG004|STARTED|Overall Study||164
2997742|NCT00944034|3714737|FG005|STARTED|Overall Study||143
2997743|NCT00944034|3714738|FG006|STARTED|Overall Study||106
2997744|NCT00944034|3714739|FG007|STARTED|Overall Study||78
2997745|NCT00944034|3714740|FG008|STARTED|Overall Study||73
2997746|NCT00944034|3714741|FG009|STARTED|Overall Study||246
2997747|NCT00944034|3714742|FG010|STARTED|Overall Study||51
2997748|NCT00944034|3714743|FG011|STARTED|Overall Study||56
2997749|NCT00944034|3714732|FG000|COMPLETED|Overall Study||183
2997750|NCT00944034|3714733|FG001|COMPLETED|Overall Study||150
2997751|NCT00944034|3714734|FG002|COMPLETED|Overall Study||143
2997752|NCT00944034|3714735|FG003|COMPLETED|Overall Study||170
2997753|NCT00944034|3714736|FG004|COMPLETED|Overall Study||150
2997754|NCT00944034|3714737|FG005|COMPLETED|Overall Study||123
2997755|NCT00944034|3714738|FG006|COMPLETED|Overall Study||102
2997756|NCT00944034|3714739|FG007|COMPLETED|Overall Study||73
2997757|NCT00944034|3714740|FG008|COMPLETED|Overall Study||63
2997758|NCT00944034|3714741|FG009|COMPLETED|Overall Study||236
2997759|NCT00944034|3714742|FG010|COMPLETED|Overall Study||50
2997760|NCT00944034|3714743|FG011|COMPLETED|Overall Study||52
2997761|NCT00944034|3714732|FG000|NOT COMPLETED|Overall Study||5
2997762|NCT00944034|3714733|FG001|NOT COMPLETED|Overall Study||7
2997763|NCT00944034|3714734|FG002|NOT COMPLETED|Overall Study||9
2997764|NCT00944034|3714735|FG003|NOT COMPLETED|Overall Study||4
2997765|NCT00944034|3714736|FG004|NOT COMPLETED|Overall Study||14
2997766|NCT00944034|3714737|FG005|NOT COMPLETED|Overall Study||20
2997767|NCT00944034|3714738|FG006|NOT COMPLETED|Overall Study||4
3305967|NCT02991859|4039230|FG016|STARTED|Period2, Escalation Phase4, Upto Day 105||0
3305968|NCT02991859|4039214|FG000|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2
3305969|NCT02991859|4039215|FG001|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2
3305970|NCT02991859|4039216|FG002|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2
3305971|NCT02991859|4039217|FG003|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2
3305972|NCT02991859|4039218|FG004|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2
3305973|NCT02991859|4039219|FG005|COMPLETED|Period2, Escalation Phase4, Upto Day 105||1
3305974|NCT02991859|4039220|FG006|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2
3305975|NCT02991859|4039221|FG007|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2
3305976|NCT02991859|4039222|FG008|COMPLETED|Period2, Escalation Phase4, Upto Day 105||1
3305977|NCT02991859|4039223|FG009|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2
3305978|NCT02991859|4039224|FG010|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2
3305979|NCT02991859|4039225|FG011|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2
3305980|NCT02991859|4039226|FG012|COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
3305981|NCT02991859|4039227|FG013|COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
3305982|NCT02991859|4039228|FG014|COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
3305983|NCT02991859|4039229|FG015|COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
3305984|NCT02991859|4039230|FG016|COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
3305985|NCT02991859|4039214|FG000|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
3305986|NCT02991859|4039215|FG001|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
3305987|NCT02991859|4039216|FG002|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
3305988|NCT02991859|4039217|FG003|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
3305989|NCT02991859|4039218|FG004|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
3305990|NCT02991859|4039219|FG005|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
3305991|NCT02991859|4039220|FG006|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
3305992|NCT02991859|4039221|FG007|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
3305993|NCT02991859|4039222|FG008|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||1
3305994|NCT02991859|4039223|FG009|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
3305995|NCT02991859|4039224|FG010|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
3305996|NCT02991859|4039225|FG011|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
3305997|NCT02991859|4039226|FG012|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
3305998|NCT02991859|4039227|FG013|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
3305999|NCT02991859|4039228|FG014|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
3306000|NCT02991859|4039229|FG015|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
3306001|NCT02991859|4039230|FG016|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
3306002|NCT02991859|4039214|FG000|STARTED|Period2,Escalation Phase5,Upto Day 112||2
3306003|NCT02991859|4039215|FG001|STARTED|Period2,Escalation Phase5,Upto Day 112||2
3306004|NCT02991859|4039216|FG002|STARTED|Period2,Escalation Phase5,Upto Day 112||2
2997768|NCT00944034|3714739|FG007|NOT COMPLETED|Overall Study||5
2997769|NCT00944034|3714740|FG008|NOT COMPLETED|Overall Study||10
2997770|NCT00944034|3714741|FG009|NOT COMPLETED|Overall Study||10
2997771|NCT00944034|3714742|FG010|NOT COMPLETED|Overall Study||1
3306005|NCT02991859|4039217|FG003|STARTED|Period2,Escalation Phase5,Upto Day 112||2
3306006|NCT02991859|4039218|FG004|STARTED|Period2,Escalation Phase5,Upto Day 112||2
3306007|NCT02991859|4039219|FG005|STARTED|Period2,Escalation Phase5,Upto Day 112||1
2997772|NCT00944034|3714743|FG011|NOT COMPLETED|Overall Study||4
2997773|NCT00944047|3714786|FG000|STARTED|Overall Study||32
2997774|NCT00944047|3714786|FG000|COMPLETED|Overall Study||27
2997775|NCT00944047|3714786|FG000|NOT COMPLETED|Overall Study||5
2997776|NCT00944073|3714792|FG000|STARTED|Overall Study||292
2997777|NCT00944073|3714793|FG001|STARTED|Overall Study||291
2997778|NCT00944073|3714792|FG000|COMPLETED|Overall Study||287
2997779|NCT00944073|3714793|FG001|COMPLETED|Overall Study||287
2997780|NCT00944073|3714792|FG000|NOT COMPLETED|Overall Study||5
2997781|NCT00944073|3714793|FG001|NOT COMPLETED|Overall Study||4
2997782|NCT00944125|3714799|FG000|STARTED|Baseline to 3 Months||19
2997783|NCT00944125|3714800|FG001|STARTED|Baseline to 3 Months||22
2997784|NCT00944125|3714799|FG000|COMPLETED|Baseline to 3 Months||19
2997785|NCT00944125|3714800|FG001|COMPLETED|Baseline to 3 Months||22
2997786|NCT00944125|3714799|FG000|NOT COMPLETED|Baseline to 3 Months||0
2997787|NCT00944125|3714800|FG001|NOT COMPLETED|Baseline to 3 Months||0
2997788|NCT00944125|3714799|FG000|STARTED|3 to 6 Months||19
2997789|NCT00944125|3714800|FG001|STARTED|3 to 6 Months||22
2997790|NCT00944125|3714799|FG000|COMPLETED|3 to 6 Months||19
2997791|NCT00944125|3714800|FG001|COMPLETED|3 to 6 Months||20
2997792|NCT00944125|3714799|FG000|NOT COMPLETED|3 to 6 Months||0
2997793|NCT00944125|3714800|FG001|NOT COMPLETED|3 to 6 Months||2
2997794|NCT00944125|3714799|FG000|STARTED|6 Months to Study Completion||19
2997795|NCT00944125|3714800|FG001|STARTED|6 Months to Study Completion||20
2997796|NCT00944125|3714799|FG000|COMPLETED|6 Months to Study Completion||19
2997797|NCT00944125|3714800|FG001|COMPLETED|6 Months to Study Completion||18
2997798|NCT00944125|3714799|FG000|NOT COMPLETED|6 Months to Study Completion||0
3306008|NCT02991859|4039220|FG006|STARTED|Period2,Escalation Phase5,Upto Day 112||2
3306009|NCT02991859|4039221|FG007|STARTED|Period2,Escalation Phase5,Upto Day 112||2
3306010|NCT02991859|4039222|FG008|STARTED|Period2,Escalation Phase5,Upto Day 112||1
3306011|NCT02991859|4039223|FG009|STARTED|Period2,Escalation Phase5,Upto Day 112||2
3306012|NCT02991859|4039224|FG010|STARTED|Period2,Escalation Phase5,Upto Day 112||2
3306013|NCT02991859|4039225|FG011|STARTED|Period2,Escalation Phase5,Upto Day 112||2
3306014|NCT02991859|4039226|FG012|STARTED|Period2,Escalation Phase5,Upto Day 112||0
3306015|NCT02991859|4039227|FG013|STARTED|Period2,Escalation Phase5,Upto Day 112||0
3306016|NCT02991859|4039228|FG014|STARTED|Period2,Escalation Phase5,Upto Day 112||0
3306017|NCT02991859|4039229|FG015|STARTED|Period2,Escalation Phase5,Upto Day 112||0
3306018|NCT02991859|4039230|FG016|STARTED|Period2,Escalation Phase5,Upto Day 112||0
3306019|NCT02991859|4039214|FG000|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2
3306020|NCT02991859|4039215|FG001|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2
3306021|NCT02991859|4039216|FG002|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2
3306022|NCT02991859|4039217|FG003|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2
3306023|NCT02991859|4039218|FG004|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2
3306024|NCT02991859|4039219|FG005|COMPLETED|Period2,Escalation Phase5,Upto Day 112||1
3306025|NCT02991859|4039220|FG006|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2
3306026|NCT02991859|4039221|FG007|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2
3306027|NCT02991859|4039222|FG008|COMPLETED|Period2,Escalation Phase5,Upto Day 112||1
3306028|NCT02991859|4039223|FG009|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2
3306029|NCT02991859|4039224|FG010|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2
3306030|NCT02991859|4039225|FG011|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2
3306031|NCT02991859|4039226|FG012|COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
3306032|NCT02991859|4039227|FG013|COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
3306033|NCT02991859|4039228|FG014|COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
3306034|NCT02991859|4039229|FG015|COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
3306035|NCT02991859|4039230|FG016|COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
3306036|NCT02991859|4039214|FG000|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
3306037|NCT02991859|4039215|FG001|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
3306038|NCT02991859|4039216|FG002|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
3306039|NCT02991859|4039217|FG003|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
3306040|NCT02991859|4039218|FG004|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
3306041|NCT02991859|4039219|FG005|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
3306042|NCT02991859|4039220|FG006|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
3306043|NCT02991859|4039221|FG007|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
3306044|NCT02991859|4039222|FG008|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
3306045|NCT02991859|4039223|FG009|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
3306046|NCT02991859|4039224|FG010|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
3306047|NCT02991859|4039225|FG011|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
3306048|NCT02991859|4039226|FG012|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
3306049|NCT02991859|4039227|FG013|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
3306050|NCT02991859|4039228|FG014|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
3306051|NCT02991859|4039229|FG015|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
3306052|NCT02991859|4039230|FG016|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
3306053|NCT02991898|4039305|FG000|STARTED|Overall Study||3
3306054|NCT02991898|4039305|FG000|COMPLETED|Overall Study||3
3306055|NCT02991898|4039305|FG000|NOT COMPLETED|Overall Study||0
3306056|NCT02992067|4039309|FG000|STARTED|Overall Study||359
3306057|NCT02992067|4039309|FG000|COMPLETED|Overall Study||359
3306058|NCT02992067|4039309|FG000|NOT COMPLETED|Overall Study||0
3306059|NCT02992119|4039320|FG000|STARTED|Overall Study||21
2997799|NCT00944125|3714800|FG001|NOT COMPLETED|6 Months to Study Completion||2
2997800|NCT00944450|3714806|FG000|STARTED|Period 1||6
2997801|NCT00944450|3714807|FG001|STARTED|Period 1||6
2997802|NCT00944450|3714806|FG000|COMPLETED|Period 1||6
2997803|NCT00944450|3714807|FG001|COMPLETED|Period 1||6
2997804|NCT00944450|3714806|FG000|NOT COMPLETED|Period 1||0
2997805|NCT00944450|3714807|FG001|NOT COMPLETED|Period 1||0
2997806|NCT00944450|3714806|FG000|STARTED|Period 2||6
2997807|NCT00944450|3714807|FG001|STARTED|Period 2||6
2997808|NCT00944450|3714806|FG000|COMPLETED|Period 2||6
2997809|NCT00944450|3714807|FG001|COMPLETED|Period 2||6
2997810|NCT00944450|3714806|FG000|NOT COMPLETED|Period 2||0
2997811|NCT00944450|3714807|FG001|NOT COMPLETED|Period 2||0
2997812|NCT00944554|3714815|FG000|STARTED|Overall Study||50
2997813|NCT00944554|3714816|FG001|STARTED|Overall Study||54
2997814|NCT00944554|3714815|FG000|COMPLETED|Overall Study||22
2997815|NCT00944554|3714816|FG001|COMPLETED|Overall Study||25
2997816|NCT00944554|3714815|FG000|NOT COMPLETED|Overall Study||28
2997817|NCT00944554|3714816|FG001|NOT COMPLETED|Overall Study||29
2997818|NCT00944645|3714822|FG000|STARTED|Period 1||94
2997819|NCT00944645|3714823|FG001|STARTED|Period 1||94
2997820|NCT00944645|3714822|FG000|COMPLETED|Period 1||94
2997821|NCT00944645|3714823|FG001|COMPLETED|Period 1||94
2997822|NCT00944645|3714822|FG000|NOT COMPLETED|Period 1||0
2997823|NCT00944645|3714823|FG001|NOT COMPLETED|Period 1||0
2997824|NCT00944645|3714822|FG000|STARTED|Period 2||94
2997825|NCT00944645|3714823|FG001|STARTED|Period 2||94
2997826|NCT00944645|3714822|FG000|COMPLETED|Period 2||86
2997827|NCT00944645|3714823|FG001|COMPLETED|Period 2||85
2997828|NCT00944645|3714822|FG000|NOT COMPLETED|Period 2||8
3306060|NCT02992119|4039321|FG001|STARTED|Overall Study||21
3306061|NCT02992119|4039322|FG002|STARTED|Overall Study||30
3306062|NCT02992119|4039323|FG003|STARTED|Overall Study||30
3306063|NCT02992119|4039324|FG004|STARTED|Overall Study||30
3306064|NCT02992119|4039325|FG005|STARTED|Overall Study||30
3306065|NCT02992119|4039326|FG006|STARTED|Overall Study||31
3306066|NCT02992119|4039320|FG000|COMPLETED|Overall Study||19
3306067|NCT02992119|4039321|FG001|COMPLETED|Overall Study||20
3306068|NCT02992119|4039322|FG002|COMPLETED|Overall Study||29
3306069|NCT02992119|4039323|FG003|COMPLETED|Overall Study||30
3306070|NCT02992119|4039324|FG004|COMPLETED|Overall Study||30
3306071|NCT02992119|4039325|FG005|COMPLETED|Overall Study||30
3306072|NCT02992119|4039326|FG006|COMPLETED|Overall Study||28
3306073|NCT02992119|4039320|FG000|NOT COMPLETED|Overall Study||2
3306074|NCT02992119|4039321|FG001|NOT COMPLETED|Overall Study||1
3306075|NCT02992119|4039322|FG002|NOT COMPLETED|Overall Study||1
3306076|NCT02992119|4039323|FG003|NOT COMPLETED|Overall Study||0
3306077|NCT02992119|4039324|FG004|NOT COMPLETED|Overall Study||0
3306078|NCT02992119|4039325|FG005|NOT COMPLETED|Overall Study||0
3306079|NCT02992119|4039326|FG006|NOT COMPLETED|Overall Study||3
3306080|NCT02992132|4039346|FG000|STARTED|Overall Study||40
3306081|NCT02992132|4039347|FG001|STARTED|Overall Study||35
3306082|NCT02992132|4039348|FG002|STARTED|Overall Study||36
3306083|NCT02992132|4039346|FG000|COMPLETED|Overall Study||27
3306084|NCT02992132|4039347|FG001|COMPLETED|Overall Study||27
3306085|NCT02992132|4039348|FG002|COMPLETED|Overall Study||29
3306086|NCT02992132|4039346|FG000|NOT COMPLETED|Overall Study||13
3306087|NCT02992132|4039347|FG001|NOT COMPLETED|Overall Study||8
3306088|NCT02992132|4039348|FG002|NOT COMPLETED|Overall Study||7
3306089|NCT02992197|4039358|FG000|STARTED|Overall Study||110
3306090|NCT02992197|4039359|FG001|STARTED|Overall Study||110
3306091|NCT02992197|4039358|FG000|COMPLETED|Overall Study||99
3306092|NCT02992197|4039359|FG001|COMPLETED|Overall Study||103
3306093|NCT02992197|4039358|FG000|NOT COMPLETED|Overall Study||11
3306094|NCT02992197|4039359|FG001|NOT COMPLETED|Overall Study||7
3306095|NCT02992236|4039367|FG000|STARTED|Overall Study||8
3306096|NCT02992236|4039368|FG001|STARTED|Overall Study||8
3306097|NCT02992236|4039367|FG000|COMPLETED|Overall Study||8
3306098|NCT02992236|4039368|FG001|COMPLETED|Overall Study||8
3306099|NCT02992236|4039367|FG000|NOT COMPLETED|Overall Study||0
3306100|NCT02992236|4039368|FG001|NOT COMPLETED|Overall Study||0
3306101|NCT02992288|4039382|FG000|STARTED|Overall Study||106
3306102|NCT02992288|4039383|FG001|STARTED|Overall Study||37
3306103|NCT02992288|4039384|FG002|STARTED|Overall Study||70
3306104|NCT02992288|4039385|FG003|STARTED|Overall Study||73
3306105|NCT02992288|4039386|FG004|STARTED|Overall Study||69
3306106|NCT02992288|4039387|FG005|STARTED|Overall Study||72
3306107|NCT02992288|4039382|FG000|Treated|Overall Study||106
3306108|NCT02992288|4039383|FG001|Treated|Overall Study||37
3306109|NCT02992288|4039384|FG002|Treated|Overall Study||70
3306110|NCT02992288|4039385|FG003|Treated|Overall Study||72
3306111|NCT02992288|4039386|FG004|Treated|Overall Study||69
3306112|NCT02992288|4039387|FG005|Treated|Overall Study||72
3306113|NCT02992288|4039382|FG000|COMPLETED|Overall Study||89
3306114|NCT02992288|4039383|FG001|COMPLETED|Overall Study||32
3306115|NCT02992288|4039384|FG002|COMPLETED|Overall Study||63
3306116|NCT02992288|4039385|FG003|COMPLETED|Overall Study||64
3306117|NCT02992288|4039386|FG004|COMPLETED|Overall Study||61
3306118|NCT02992288|4039387|FG005|COMPLETED|Overall Study||59
2997829|NCT00944645|3714823|FG001|NOT COMPLETED|Period 2||9
2997830|NCT00944658|3714831|FG000|STARTED|Treatment 12 Weeks||19
2997831|NCT00944658|3714832|FG001|STARTED|Treatment 12 Weeks||19
2997832|NCT00944658|3714831|FG000|COMPLETED|Treatment 12 Weeks||19
2997833|NCT00944658|3714832|FG001|COMPLETED|Treatment 12 Weeks||17
2997834|NCT00944658|3714831|FG000|NOT COMPLETED|Treatment 12 Weeks||0
2997835|NCT00944658|3714832|FG001|NOT COMPLETED|Treatment 12 Weeks||2
2997836|NCT00944658|3714831|FG000|STARTED|Follow up 4 Weeks||19
2997837|NCT00944658|3714832|FG001|STARTED|Follow up 4 Weeks||17
3306119|NCT02992288|4039382|FG000|NOT COMPLETED|Overall Study||17
3306120|NCT02992288|4039383|FG001|NOT COMPLETED|Overall Study||5
3306121|NCT02992288|4039384|FG002|NOT COMPLETED|Overall Study||7
3306122|NCT02992288|4039385|FG003|NOT COMPLETED|Overall Study||9
3306123|NCT02992288|4039386|FG004|NOT COMPLETED|Overall Study||8
3306124|NCT02992288|4039387|FG005|NOT COMPLETED|Overall Study||13
3306125|NCT02992418|4039403|FG000|STARTED|Overall Study||346
3306126|NCT02992418|4039404|FG001|STARTED|Overall Study||342
3306127|NCT02992418|4039403|FG000|Safety Analysis Set (SafAS)|Overall Study||338
3306128|NCT02992418|4039404|FG001|Safety Analysis Set (SafAS)|Overall Study||342
3306129|NCT02992418|4039403|FG000|COMPLETED|Overall Study||0
3306130|NCT02992418|4039404|FG001|COMPLETED|Overall Study||0
3306131|NCT02992418|4039403|FG000|NOT COMPLETED|Overall Study||346
3306132|NCT02992418|4039404|FG001|NOT COMPLETED|Overall Study||342
3306133|NCT02992691|4039410|FG000|STARTED|Overall Study||56
3306134|NCT02992691|4039410|FG000|Received Test Product 1|Overall Study||55
3306135|NCT02992691|4039410|FG000|Received Test Product 2|Overall Study||55
3306136|NCT02992691|4039410|FG000|Received Test Product 3|Overall Study||52
3306137|NCT02992691|4039410|FG000|Received Positive Control|Overall Study||55
3306138|NCT02992691|4039410|FG000|Received Negative Control|Overall Study||55
3306139|NCT02992691|4039410|FG000|COMPLETED|Overall Study||53
3306140|NCT02992691|4039410|FG000|NOT COMPLETED|Overall Study||3
3306141|NCT02992899|4039427|FG000|STARTED|Overall Study||27
3306142|NCT02992899|4039428|FG001|STARTED|Overall Study||29
3306143|NCT02992899|4039427|FG000|COMPLETED|Overall Study||25
3306144|NCT02992899|4039428|FG001|COMPLETED|Overall Study||26
3306145|NCT02992899|4039427|FG000|NOT COMPLETED|Overall Study||2
3306146|NCT02992899|4039428|FG001|NOT COMPLETED|Overall Study||3
3306147|NCT02993224|4039434|FG000|STARTED|Core Phase - Period 1||148
3306148|NCT02993224|4039434|FG000|COMPLETED|Core Phase - Period 1||140
3306149|NCT02993224|4039434|FG000|NOT COMPLETED|Core Phase - Period 1||8
3306150|NCT02993224|4039434|FG000|STARTED|Core Phase- Period 2||140
3306151|NCT02993224|4039434|FG000|COMPLETED|Core Phase- Period 2||136
3306152|NCT02993224|4039434|FG000|NOT COMPLETED|Core Phase- Period 2||4
3306153|NCT02993224|4039434|FG000|STARTED|Extension Phase||116
3306154|NCT02993224|4039434|FG000|COMPLETED|Extension Phase||80
3306155|NCT02993224|4039434|FG000|NOT COMPLETED|Extension Phase||36
3306156|NCT02993250|4039442|FG000|STARTED|Overall Study||22
3306157|NCT02993250|4039443|FG001|STARTED|Overall Study||11
3306158|NCT02993250|4039442|FG000|COMPLETED|Overall Study||22
3306159|NCT02993250|4039443|FG001|COMPLETED|Overall Study||10
3306160|NCT02993250|4039442|FG000|NOT COMPLETED|Overall Study||0
3306161|NCT02993250|4039443|FG001|NOT COMPLETED|Overall Study||1
3306162|NCT02993302|4039451|FG000|STARTED|Overall Study||13
3306163|NCT02993302|4039452|FG001|STARTED|Overall Study||12
3306164|NCT02993302|4039451|FG000|COMPLETED|Overall Study||13
3306165|NCT02993302|4039452|FG001|COMPLETED|Overall Study||12
3306166|NCT02993302|4039451|FG000|NOT COMPLETED|Overall Study||0
3306167|NCT02993302|4039452|FG001|NOT COMPLETED|Overall Study||0
3306168|NCT02993445|4039460|FG000|STARTED|First Intervention (5 Minutes)||6
3306169|NCT02993445|4039461|FG001|STARTED|First Intervention (5 Minutes)||5
3306170|NCT02993445|4039460|FG000|COMPLETED|First Intervention (5 Minutes)||6
3306171|NCT02993445|4039461|FG001|COMPLETED|First Intervention (5 Minutes)||5
3306172|NCT02993445|4039460|FG000|NOT COMPLETED|First Intervention (5 Minutes)||0
3306173|NCT02993445|4039461|FG001|NOT COMPLETED|First Intervention (5 Minutes)||0
3306174|NCT02993445|4039460|FG000|STARTED|Washout (2 Weeks)||6
3306175|NCT02993445|4039461|FG001|STARTED|Washout (2 Weeks)||5
3306176|NCT02993445|4039460|FG000|COMPLETED|Washout (2 Weeks)||6
3306177|NCT02993445|4039461|FG001|COMPLETED|Washout (2 Weeks)||5
3306178|NCT02993445|4039460|FG000|NOT COMPLETED|Washout (2 Weeks)||0
3306179|NCT02993445|4039461|FG001|NOT COMPLETED|Washout (2 Weeks)||0
3306180|NCT02993445|4039460|FG000|STARTED|Second Intervention (5 Mins)||6
3306181|NCT02993445|4039461|FG001|STARTED|Second Intervention (5 Mins)||5
3306182|NCT02993445|4039460|FG000|COMPLETED|Second Intervention (5 Mins)||6
3306183|NCT02993445|4039461|FG001|COMPLETED|Second Intervention (5 Mins)||5
3306184|NCT02993445|4039460|FG000|NOT COMPLETED|Second Intervention (5 Mins)||0
3306185|NCT02993445|4039461|FG001|NOT COMPLETED|Second Intervention (5 Mins)||0
3306186|NCT02993471|4039467|FG000|STARTED|Period 1 (Drug Cocktail)||28
3306187|NCT02993471|4039467|FG000|Received at Least 1 Dose of Study Drug|Period 1 (Drug Cocktail)||28
3306188|NCT02993471|4039467|FG000|COMPLETED|Period 1 (Drug Cocktail)||28
3306189|NCT02993471|4039467|FG000|NOT COMPLETED|Period 1 (Drug Cocktail)||0
3306190|NCT02993471|4039467|FG000|STARTED|Period 2 (Drug Cocktail + Ixekizumab)||28
3306191|NCT02993471|4039467|FG000|Received at Least 1 Dose of Study Drug|Period 2 (Drug Cocktail + Ixekizumab)||27
3306192|NCT02993471|4039467|FG000|COMPLETED|Period 2 (Drug Cocktail + Ixekizumab)||26
3306193|NCT02993471|4039467|FG000|NOT COMPLETED|Period 2 (Drug Cocktail + Ixekizumab)||2
3306194|NCT02993731|4039491|FG000|STARTED|Overall Study||565
3306195|NCT02993731|4039492|FG001|STARTED|Overall Study||569
3306196|NCT02993731|4039491|FG000|COMPLETED|Overall Study||464
3306197|NCT02993731|4039492|FG001|COMPLETED|Overall Study||464
3306198|NCT02993731|4039491|FG000|NOT COMPLETED|Overall Study||101
3306199|NCT02993731|4039492|FG001|NOT COMPLETED|Overall Study||105
3306200|NCT02993757|4039510|FG000|STARTED|Overall Study||266
3306201|NCT02993757|4039511|FG001|STARTED|Overall Study||262
3306202|NCT02993757|4039510|FG000|Safety Analysis Set (SafAS)|Overall Study||263
3306203|NCT02993757|4039511|FG001|Safety Analysis Set (SafAS)|Overall Study||260
3306204|NCT02993757|4039510|FG000|COMPLETED|Overall Study||102
2997838|NCT00944658|3714831|FG000|COMPLETED|Follow up 4 Weeks||19
2997839|NCT00944658|3714832|FG001|COMPLETED|Follow up 4 Weeks||17
2997840|NCT00944658|3714831|FG000|NOT COMPLETED|Follow up 4 Weeks||0
2997841|NCT00944658|3714832|FG001|NOT COMPLETED|Follow up 4 Weeks||0
2997842|NCT00944671|3714844|FG000|STARTED|Period I||4
2997843|NCT00944671|3714845|FG001|STARTED|Period I||4
2997844|NCT00944671|3714846|FG002|STARTED|Period I||4
2997845|NCT00944671|3714847|FG003|STARTED|Period I||4
2997846|NCT00944671|3714848|FG004|STARTED|Period I||4
2997847|NCT00944671|3714849|FG005|STARTED|Period I||4
2997848|NCT00944671|3714844|FG000|COMPLETED|Period I||4
2997849|NCT00944671|3714845|FG001|COMPLETED|Period I||4
3306205|NCT02993757|4039511|FG001|COMPLETED|Overall Study||84
3306206|NCT02993757|4039510|FG000|NOT COMPLETED|Overall Study||164
3306207|NCT02993757|4039511|FG001|NOT COMPLETED|Overall Study||178
3306208|NCT02993783|4039519|FG000|STARTED|Overall Study||8
3306209|NCT02993783|4039520|FG001|STARTED|Overall Study||9
3306210|NCT02993783|4039519|FG000|COMPLETED|Overall Study||2
3306211|NCT02993783|4039520|FG001|COMPLETED|Overall Study||0
3306212|NCT02993783|4039519|FG000|NOT COMPLETED|Overall Study||6
3306213|NCT02993783|4039520|FG001|NOT COMPLETED|Overall Study||9
3306214|NCT02993926|4039526|FG000|STARTED|Enantone Treatment Phase||108
3306215|NCT02993926|4039527|FG001|STARTED|Enantone Treatment Phase||0
3306216|NCT02993926|4039528|FG002|STARTED|Enantone Treatment Phase||0
3306217|NCT02993926|4039526|FG000|COMPLETED|Enantone Treatment Phase||76
3306218|NCT02993926|4039527|FG001|COMPLETED|Enantone Treatment Phase||0
3306219|NCT02993926|4039528|FG002|COMPLETED|Enantone Treatment Phase||0
3306220|NCT02993926|4039526|FG000|NOT COMPLETED|Enantone Treatment Phase||32
3306221|NCT02993926|4039527|FG001|NOT COMPLETED|Enantone Treatment Phase||0
3306222|NCT02993926|4039528|FG002|NOT COMPLETED|Enantone Treatment Phase||0
3306223|NCT02993926|4039526|FG000|STARTED|Follow-Up Phase||0
3306224|NCT02993926|4039527|FG001|STARTED|Follow-Up Phase||44
3306225|NCT02993926|4039528|FG002|STARTED|Follow-Up Phase||26
3306226|NCT02993926|4039526|FG000|COMPLETED|Follow-Up Phase||0
3306227|NCT02993926|4039527|FG001|COMPLETED|Follow-Up Phase||44
3306228|NCT02993926|4039528|FG002|COMPLETED|Follow-Up Phase||26
3306229|NCT02993926|4039526|FG000|NOT COMPLETED|Follow-Up Phase||0
3306230|NCT02993926|4039527|FG001|NOT COMPLETED|Follow-Up Phase||0
3306231|NCT02993926|4039528|FG002|NOT COMPLETED|Follow-Up Phase||0
3306232|NCT02994056|4039538|FG000|STARTED|Overall Study||32
3306233|NCT02994056|4039538|FG000|COMPLETED|Overall Study||23
3306234|NCT02994056|4039538|FG000|NOT COMPLETED|Overall Study||9
3306235|NCT02994108|4039553|FG000|STARTED|Intervention Messages||74
3306236|NCT02994108|4039554|FG001|STARTED|Intervention Messages||76
3306237|NCT02994108|4039553|FG000|COMPLETED|Intervention Messages||72
3306238|NCT02994108|4039554|FG001|COMPLETED|Intervention Messages||76
3306239|NCT02994108|4039553|FG000|NOT COMPLETED|Intervention Messages||2
3306240|NCT02994108|4039554|FG001|NOT COMPLETED|Intervention Messages||0
3306241|NCT02994108|4039553|FG000|STARTED|Phase 1 Assessment||72
3306242|NCT02994108|4039554|FG001|STARTED|Phase 1 Assessment||76
3306243|NCT02994108|4039553|FG000|COMPLETED|Phase 1 Assessment||67
3306244|NCT02994108|4039554|FG001|COMPLETED|Phase 1 Assessment||73
3306245|NCT02994108|4039553|FG000|NOT COMPLETED|Phase 1 Assessment||5
3306246|NCT02994108|4039554|FG001|NOT COMPLETED|Phase 1 Assessment||3
3306247|NCT02994108|4039553|FG000|STARTED|Phase 2 Assessment||72
3306248|NCT02994108|4039554|FG001|STARTED|Phase 2 Assessment||76
3306249|NCT02994108|4039553|FG000|COMPLETED|Phase 2 Assessment||63
3306250|NCT02994108|4039554|FG001|COMPLETED|Phase 2 Assessment||69
3306251|NCT02994108|4039553|FG000|NOT COMPLETED|Phase 2 Assessment||9
3306252|NCT02994108|4039554|FG001|NOT COMPLETED|Phase 2 Assessment||7
3306253|NCT02994238|4039563|FG000|STARTED|Overall Study||125
3306254|NCT02994238|4039564|FG001|STARTED|Overall Study||127
3306255|NCT02994238|4039563|FG000|COMPLETED|Overall Study||125
3306256|NCT02994238|4039564|FG001|COMPLETED|Overall Study||127
3306257|NCT02994238|4039563|FG000|NOT COMPLETED|Overall Study||0
3306258|NCT02994238|4039564|FG001|NOT COMPLETED|Overall Study||0
3306259|NCT02994394|4039572|FG000|STARTED|Period 1 (Days 1 to 3)||14
3306260|NCT02994394|4039573|FG001|STARTED|Period 1 (Days 1 to 3)||14
3306261|NCT02994394|4039574|FG002|STARTED|Period 1 (Days 1 to 3)||14
3306262|NCT02994394|4039575|FG003|STARTED|Period 1 (Days 1 to 3)||14
3306263|NCT02994394|4039576|FG004|STARTED|Period 1 (Days 1 to 3)||14
3306264|NCT02994394|4039577|FG005|STARTED|Period 1 (Days 1 to 3)||14
3306265|NCT02994394|4039572|FG000|COMPLETED|Period 1 (Days 1 to 3)||14
3306266|NCT02994394|4039573|FG001|COMPLETED|Period 1 (Days 1 to 3)||14
3306267|NCT02994394|4039574|FG002|COMPLETED|Period 1 (Days 1 to 3)||13
3306268|NCT02994394|4039575|FG003|COMPLETED|Period 1 (Days 1 to 3)||14
3306269|NCT02994394|4039576|FG004|COMPLETED|Period 1 (Days 1 to 3)||14
3306270|NCT02994394|4039577|FG005|COMPLETED|Period 1 (Days 1 to 3)||14
3306271|NCT02994394|4039572|FG000|NOT COMPLETED|Period 1 (Days 1 to 3)||0
3306272|NCT02994394|4039573|FG001|NOT COMPLETED|Period 1 (Days 1 to 3)||0
3306273|NCT02994394|4039574|FG002|NOT COMPLETED|Period 1 (Days 1 to 3)||1
3306274|NCT02994394|4039575|FG003|NOT COMPLETED|Period 1 (Days 1 to 3)||0
3306275|NCT02994394|4039576|FG004|NOT COMPLETED|Period 1 (Days 1 to 3)||0
3306276|NCT02994394|4039577|FG005|NOT COMPLETED|Period 1 (Days 1 to 3)||0
3306277|NCT02994394|4039572|FG000|STARTED|Period 2 (Days 4 to 6)||14
2997850|NCT00944671|3714846|FG002|COMPLETED|Period I||4
3306278|NCT02994394|4039573|FG001|STARTED|Period 2 (Days 4 to 6)||14
3306279|NCT02994394|4039574|FG002|STARTED|Period 2 (Days 4 to 6)||13
3306280|NCT02994394|4039575|FG003|STARTED|Period 2 (Days 4 to 6)||14
2997851|NCT00944671|3714847|FG003|COMPLETED|Period I||4
2997852|NCT00944671|3714848|FG004|COMPLETED|Period I||4
2997853|NCT00944671|3714849|FG005|COMPLETED|Period I||4
2997854|NCT00944671|3714844|FG000|NOT COMPLETED|Period I||0
2997855|NCT00944671|3714845|FG001|NOT COMPLETED|Period I||0
2997856|NCT00944671|3714846|FG002|NOT COMPLETED|Period I||0
2997857|NCT00944671|3714847|FG003|NOT COMPLETED|Period I||0
2997858|NCT00944671|3714848|FG004|NOT COMPLETED|Period I||0
2997859|NCT00944671|3714849|FG005|NOT COMPLETED|Period I||0
2997860|NCT00944671|3714844|FG000|STARTED|Period II||4
2997861|NCT00944671|3714845|FG001|STARTED|Period II||4
2997862|NCT00944671|3714846|FG002|STARTED|Period II||4
2997863|NCT00944671|3714847|FG003|STARTED|Period II||4
2997864|NCT00944671|3714848|FG004|STARTED|Period II||4
2997865|NCT00944671|3714849|FG005|STARTED|Period II||4
3306281|NCT02994394|4039576|FG004|STARTED|Period 2 (Days 4 to 6)||14
3306282|NCT02994394|4039577|FG005|STARTED|Period 2 (Days 4 to 6)||14
3306283|NCT02994394|4039572|FG000|COMPLETED|Period 2 (Days 4 to 6)||14
3306284|NCT02994394|4039573|FG001|COMPLETED|Period 2 (Days 4 to 6)||13
3306285|NCT02994394|4039574|FG002|COMPLETED|Period 2 (Days 4 to 6)||13
3306286|NCT02994394|4039575|FG003|COMPLETED|Period 2 (Days 4 to 6)||14
3306287|NCT02994394|4039576|FG004|COMPLETED|Period 2 (Days 4 to 6)||13
3306288|NCT02994394|4039577|FG005|COMPLETED|Period 2 (Days 4 to 6)||14
3306289|NCT02994394|4039572|FG000|NOT COMPLETED|Period 2 (Days 4 to 6)||0
3306290|NCT02994394|4039573|FG001|NOT COMPLETED|Period 2 (Days 4 to 6)||1
3306291|NCT02994394|4039574|FG002|NOT COMPLETED|Period 2 (Days 4 to 6)||0
3306292|NCT02994394|4039575|FG003|NOT COMPLETED|Period 2 (Days 4 to 6)||0
3306293|NCT02994394|4039576|FG004|NOT COMPLETED|Period 2 (Days 4 to 6)||1
3306294|NCT02994394|4039577|FG005|NOT COMPLETED|Period 2 (Days 4 to 6)||0
3306295|NCT02994394|4039572|FG000|STARTED|Period 3 (Days 7 and 8)||14
3306296|NCT02994394|4039573|FG001|STARTED|Period 3 (Days 7 and 8)||13
3306297|NCT02994394|4039574|FG002|STARTED|Period 3 (Days 7 and 8)||13
3306298|NCT02994394|4039575|FG003|STARTED|Period 3 (Days 7 and 8)||14
3306299|NCT02994394|4039576|FG004|STARTED|Period 3 (Days 7 and 8)||13
3306300|NCT02994394|4039577|FG005|STARTED|Period 3 (Days 7 and 8)||14
3306301|NCT02994394|4039572|FG000|COMPLETED|Period 3 (Days 7 and 8)||14
3306302|NCT02994394|4039573|FG001|COMPLETED|Period 3 (Days 7 and 8)||13
3306303|NCT02994394|4039574|FG002|COMPLETED|Period 3 (Days 7 and 8)||13
3306304|NCT02994394|4039575|FG003|COMPLETED|Period 3 (Days 7 and 8)||14
3306305|NCT02994394|4039576|FG004|COMPLETED|Period 3 (Days 7 and 8)||13
3306306|NCT02994394|4039577|FG005|COMPLETED|Period 3 (Days 7 and 8)||14
3306307|NCT02994394|4039572|FG000|NOT COMPLETED|Period 3 (Days 7 and 8)||0
3306308|NCT02994394|4039573|FG001|NOT COMPLETED|Period 3 (Days 7 and 8)||0
3306309|NCT02994394|4039574|FG002|NOT COMPLETED|Period 3 (Days 7 and 8)||0
3306310|NCT02994394|4039575|FG003|NOT COMPLETED|Period 3 (Days 7 and 8)||0
3306311|NCT02994394|4039576|FG004|NOT COMPLETED|Period 3 (Days 7 and 8)||0
3306312|NCT02994394|4039577|FG005|NOT COMPLETED|Period 3 (Days 7 and 8)||0
3306313|NCT02994654|4039591|FG000|STARTED|Overall Study||12
3306314|NCT02994654|4039591|FG000|COMPLETED|Overall Study||11
3306315|NCT02994654|4039591|FG000|NOT COMPLETED|Overall Study||1
3306316|NCT02994732|4039596|FG000|STARTED|Overall Study|All subjects entered clinic on January 11, 2017|6
3306317|NCT02994732|4039596|FG000|COMPLETED|Overall Study|All subjects were discharged from the clinic by Jan 24, 2017|6
3306318|NCT02994732|4039596|FG000|NOT COMPLETED|Overall Study||0
3306319|NCT02994940|4039603|FG000|STARTED|Overall Study||37
3306320|NCT02994940|4039604|FG001|STARTED|Overall Study||37
3306321|NCT02994940|4039603|FG000|COMPLETED|Overall Study||30
3306322|NCT02994940|4039604|FG001|COMPLETED|Overall Study||36
3306323|NCT02994940|4039603|FG000|NOT COMPLETED|Overall Study||7
3306324|NCT02994940|4039604|FG001|NOT COMPLETED|Overall Study||1
3306325|NCT02994979|4039612|FG000|STARTED|Overall Study||114
3306326|NCT02994979|4039613|FG001|STARTED|Overall Study||105
3306327|NCT02994979|4039612|FG000|COMPLETED|Overall Study||114
3306328|NCT02994979|4039613|FG001|COMPLETED|Overall Study||105
3306329|NCT02994979|4039612|FG000|NOT COMPLETED|Overall Study||0
3306330|NCT02994979|4039613|FG001|NOT COMPLETED|Overall Study||0
3306331|NCT02995915|4039621|FG000|STARTED|Overall Study||30
3306332|NCT02995915|4039622|FG001|STARTED|Overall Study||15
3306333|NCT02995915|4039621|FG000|COMPLETED|Overall Study||30
3306334|NCT02995915|4039622|FG001|COMPLETED|Overall Study||15
3306335|NCT02995915|4039621|FG000|NOT COMPLETED|Overall Study||0
3306336|NCT02995915|4039622|FG001|NOT COMPLETED|Overall Study||0
3306337|NCT02995980|4039628|FG000|STARTED|Overall Study||128
3306338|NCT02995980|4039628|FG000|COMPLETED|Overall Study||114
3306339|NCT02995980|4039628|FG000|NOT COMPLETED|Overall Study||14
3306340|NCT02996097|4039633|FG000|STARTED|Overall Study||30
3306341|NCT02996097|4039634|FG001|STARTED|Overall Study||30
3306342|NCT02996097|4039633|FG000|Per Protocol Population|Overall Study||22
3306343|NCT02996097|4039634|FG001|Per Protocol Population|Overall Study||22
3306344|NCT02996097|4039633|FG000|COMPLETED|Overall Study||19
3306345|NCT02996097|4039634|FG001|COMPLETED|Overall Study||19
3306346|NCT02996097|4039633|FG000|NOT COMPLETED|Overall Study||11
3306347|NCT02996097|4039634|FG001|NOT COMPLETED|Overall Study||11
2997866|NCT00944671|3714844|FG000|COMPLETED|Period II||4
3306348|NCT02996448|4039639|FG000|STARTED|Overall Study||3
3306349|NCT02996448|4039639|FG000|COMPLETED|Overall Study||0
3306350|NCT02996448|4039639|FG000|NOT COMPLETED|Overall Study||3
3306351|NCT02996474|4039644|FG000|STARTED|Overall Study||10
3306352|NCT02996474|4039644|FG000|COMPLETED|Overall Study||5
2997867|NCT00944671|3714845|FG001|COMPLETED|Period II||4
2997868|NCT00944671|3714846|FG002|COMPLETED|Period II||4
2997869|NCT00944671|3714847|FG003|COMPLETED|Period II||4
2997870|NCT00944671|3714848|FG004|COMPLETED|Period II||4
2997871|NCT00944671|3714849|FG005|COMPLETED|Period II||4
2997872|NCT00944671|3714844|FG000|NOT COMPLETED|Period II||0
2997873|NCT00944671|3714845|FG001|NOT COMPLETED|Period II||0
2997874|NCT00944671|3714846|FG002|NOT COMPLETED|Period II||0
2997875|NCT00944671|3714847|FG003|NOT COMPLETED|Period II||0
2997876|NCT00944671|3714848|FG004|NOT COMPLETED|Period II||0
2997877|NCT00944671|3714849|FG005|NOT COMPLETED|Period II||0
2997878|NCT00944671|3714844|FG000|STARTED|Period III||4
2997879|NCT00944671|3714845|FG001|STARTED|Period III||4
2997880|NCT00944671|3714846|FG002|STARTED|Period III||4
3306353|NCT02996474|4039644|FG000|NOT COMPLETED|Overall Study||5
3306354|NCT02996500|4039654|FG000|STARTED|Overall Study||39
3306355|NCT02996500|4039655|FG001|STARTED|Overall Study||43
3306356|NCT02996500|4039656|FG002|STARTED|Overall Study||39
3306357|NCT02996500|4039657|FG003|STARTED|Overall Study||50
3306358|NCT02996500|4039658|FG004|STARTED|Overall Study||50
3306359|NCT02996500|4039659|FG005|STARTED|Overall Study||48
3306360|NCT02996500|4039654|FG000|COMPLETED|Overall Study||31
3306361|NCT02996500|4039655|FG001|COMPLETED|Overall Study||42
3306362|NCT02996500|4039656|FG002|COMPLETED|Overall Study||29
3306363|NCT02996500|4039657|FG003|COMPLETED|Overall Study||46
3306364|NCT02996500|4039658|FG004|COMPLETED|Overall Study||45
3306365|NCT02996500|4039659|FG005|COMPLETED|Overall Study||44
3306366|NCT02996500|4039654|FG000|NOT COMPLETED|Overall Study||8
3306367|NCT02996500|4039655|FG001|NOT COMPLETED|Overall Study||1
3306368|NCT02996500|4039656|FG002|NOT COMPLETED|Overall Study||10
3306369|NCT02996500|4039657|FG003|NOT COMPLETED|Overall Study||4
3306370|NCT02996500|4039658|FG004|NOT COMPLETED|Overall Study||5
3306371|NCT02996500|4039659|FG005|NOT COMPLETED|Overall Study||4
3306372|NCT02996591|4039679|FG000|STARTED|Overall Study||18
3306373|NCT02996591|4039680|FG001|STARTED|Overall Study||18
3306374|NCT02996591|4039679|FG000|COMPLETED|Overall Study||18
3306375|NCT02996591|4039680|FG001|COMPLETED|Overall Study||18
3306376|NCT02996591|4039679|FG000|NOT COMPLETED|Overall Study||0
3306377|NCT02996591|4039680|FG001|NOT COMPLETED|Overall Study||0
3306378|NCT02996682|4039688|FG000|STARTED|Overall Study||51
3306379|NCT02996682|4039689|FG001|STARTED|Overall Study||51
3306380|NCT02996682|4039688|FG000|COMPLETED|Overall Study||51
3306381|NCT02996682|4039689|FG001|COMPLETED|Overall Study||48
3306382|NCT02996682|4039688|FG000|NOT COMPLETED|Overall Study||0
3306383|NCT02996682|4039689|FG001|NOT COMPLETED|Overall Study||3
3306384|NCT02996864|4039697|FG000|STARTED|Overall Study||150
3306385|NCT02996864|4039698|FG001|STARTED|Overall Study||150
3306386|NCT02996864|4039697|FG000|COMPLETED|Overall Study||142
3306387|NCT02996864|4039698|FG001|COMPLETED|Overall Study||136
3306388|NCT02996864|4039697|FG000|NOT COMPLETED|Overall Study||8
3306389|NCT02996864|4039698|FG001|NOT COMPLETED|Overall Study||14
3306390|NCT02996968|4039706|FG000|STARTED|Overall Study||79
3306391|NCT02996968|4039707|FG001|STARTED|Overall Study||79
3306392|NCT02996968|4039706|FG000|COMPLETED|Overall Study||78
3306393|NCT02996968|4039707|FG001|COMPLETED|Overall Study||79
3306394|NCT02996968|4039706|FG000|NOT COMPLETED|Overall Study||1
3306395|NCT02996968|4039707|FG001|NOT COMPLETED|Overall Study||0
3306396|NCT02997085|4039716|FG000|STARTED|Overall Study||34
3306397|NCT02997085|4039717|FG001|STARTED|Overall Study||35
3306398|NCT02997085|4039718|FG002|STARTED|Overall Study||34
3306399|NCT02997085|4039716|FG000|COMPLETED|Overall Study||34
3306400|NCT02997085|4039717|FG001|COMPLETED|Overall Study||35
3306401|NCT02997085|4039718|FG002|COMPLETED|Overall Study||34
3306402|NCT02997085|4039716|FG000|NOT COMPLETED|Overall Study||0
3306403|NCT02997085|4039717|FG001|NOT COMPLETED|Overall Study||0
3306404|NCT02997085|4039718|FG002|NOT COMPLETED|Overall Study||0
3306405|NCT02997163|4039729|FG000|STARTED|Overall Study||9
3306406|NCT02997163|4039730|FG001|STARTED|Overall Study||9
3306407|NCT02997163|4039731|FG002|STARTED|Overall Study||8
3306408|NCT02997163|4039732|FG003|STARTED|Overall Study||8
3306409|NCT02997163|4039729|FG000|COMPLETED|Overall Study||8
3306410|NCT02997163|4039730|FG001|COMPLETED|Overall Study||9
3306411|NCT02997163|4039731|FG002|COMPLETED|Overall Study||8
3306412|NCT02997163|4039732|FG003|COMPLETED|Overall Study||7
3306413|NCT02997163|4039729|FG000|NOT COMPLETED|Overall Study||1
3306414|NCT02997163|4039730|FG001|NOT COMPLETED|Overall Study||0
3306415|NCT02997163|4039731|FG002|NOT COMPLETED|Overall Study||0
3306416|NCT02997163|4039732|FG003|NOT COMPLETED|Overall Study||1
3306417|NCT02997176|4039746|FG000|STARTED|Overall Study||7
3306418|NCT02997176|4039747|FG001|STARTED|Overall Study||10
3306419|NCT02997176|4039748|FG002|STARTED|Overall Study||5
3306420|NCT02997176|4039749|FG003|STARTED|Overall Study||16
3306421|NCT02997176|4039746|FG000|COMPLETED|Overall Study||6
3306422|NCT02997176|4039747|FG001|COMPLETED|Overall Study||8
3306423|NCT02997176|4039748|FG002|COMPLETED|Overall Study||3
3306424|NCT02997176|4039749|FG003|COMPLETED|Overall Study||5
3306425|NCT02997176|4039746|FG000|NOT COMPLETED|Overall Study||1
3306426|NCT02997176|4039747|FG001|NOT COMPLETED|Overall Study||2
3306427|NCT02997176|4039748|FG002|NOT COMPLETED|Overall Study||2
2997881|NCT00944671|3714847|FG003|STARTED|Period III||4
3306428|NCT02997176|4039749|FG003|NOT COMPLETED|Overall Study||11
2997882|NCT00944671|3714848|FG004|STARTED|Period III||4
3306429|NCT02997722|4039761|FG000|STARTED|Overall Study||3
3306430|NCT02997722|4039762|FG001|STARTED|Overall Study||1
3306431|NCT02997722|4039761|FG000|COMPLETED|Overall Study||3
3306432|NCT02997722|4039762|FG001|COMPLETED|Overall Study||1
3306433|NCT02997722|4039761|FG000|NOT COMPLETED|Overall Study||0
2997883|NCT00944671|3714849|FG005|STARTED|Period III||4
2997884|NCT00944671|3714844|FG000|COMPLETED|Period III||4
2997885|NCT00944671|3714845|FG001|COMPLETED|Period III||4
2997886|NCT00944671|3714846|FG002|COMPLETED|Period III||4
2997887|NCT00944671|3714847|FG003|COMPLETED|Period III||4
2997888|NCT00944671|3714848|FG004|COMPLETED|Period III||4
2997889|NCT00944671|3714849|FG005|COMPLETED|Period III||4
3306434|NCT02997722|4039762|FG001|NOT COMPLETED|Overall Study||0
3306435|NCT02997735|4039770|FG000|STARTED|Overall Study||233
3306436|NCT02997735|4039771|FG001|STARTED|Overall Study||251
3306437|NCT02997735|4039770|FG000|COMPLETED|Overall Study||233
3306438|NCT02997735|4039771|FG001|COMPLETED|Overall Study||251
3306439|NCT02997735|4039770|FG000|NOT COMPLETED|Overall Study||0
3306440|NCT02997735|4039771|FG001|NOT COMPLETED|Overall Study||0
3306441|NCT02997904|4039779|FG000|STARTED|Overall Study||51
3306442|NCT02997904|4039780|FG001|STARTED|Overall Study||49
3306443|NCT02997904|4039779|FG000|COMPLETED|Overall Study||51
3306444|NCT02997904|4039780|FG001|COMPLETED|Overall Study||49
3306445|NCT02997904|4039779|FG000|NOT COMPLETED|Overall Study||0
3306446|NCT02997904|4039780|FG001|NOT COMPLETED|Overall Study||0
3306447|NCT02998021|4039792|FG000|STARTED|Overall Study||8
3306448|NCT02998021|4039793|FG001|STARTED|Overall Study||2
3306449|NCT02998021|4039792|FG000|COMPLETED|Overall Study||5
3306450|NCT02998021|4039793|FG001|COMPLETED|Overall Study||0
3306451|NCT02998021|4039792|FG000|NOT COMPLETED|Overall Study||3
3306452|NCT02998021|4039793|FG001|NOT COMPLETED|Overall Study||2
3306453|NCT02998151|4039799|FG000|STARTED|Overall Study||29
3306454|NCT02998151|4039799|FG000|Placebo|Overall Study|Two participants withdrew from the study before receiving placebo.|27
3306455|NCT02998151|4039799|FG000|Acamprosate|Overall Study|Every participant received acamprosate prior to acamprosate's discontinuance.|16
3306456|NCT02998151|4039799|FG000|Lovastatin|Overall Study|All participants received lovastatin.|29
3306457|NCT02998151|4039799|FG000|Minocycline|Overall Study|Two participants withdrew from the study before receiving minocycline.|27
3306458|NCT02998151|4039799|FG000|Baclofen|Overall Study|All 13 remaining participants received baclofen after acamprosate was discontinued. Five participants were re-enrolled to receive baclofen.|18
3306459|NCT02998151|4039799|FG000|COMPLETED|Overall Study|Acamprosate was discontinued mid-study due to undetectable serum levels and replaced with baclofen. Participants who already completed acamprosate were given the option to re-enroll and receive baclofen. Five participants received all 5 interventions; 26 received 4+ interventions.|5
3306460|NCT02998151|4039799|FG000|NOT COMPLETED|Overall Study||24
3306461|NCT02998476|4039813|FG000|STARTED|Overall Study||55
3306462|NCT02998476|4039814|FG001|STARTED|Overall Study||5
3306463|NCT02998476|4039813|FG000|COMPLETED|Overall Study||0
3306464|NCT02998476|4039814|FG001|COMPLETED|Overall Study||0
3306465|NCT02998476|4039813|FG000|NOT COMPLETED|Overall Study||55
3306466|NCT02998476|4039814|FG001|NOT COMPLETED|Overall Study||5
3306467|NCT02998541|4039822|FG000|STARTED|Overall Study||86
3306468|NCT02998541|4039823|FG001|STARTED|Overall Study||90
3306469|NCT02998541|4039824|FG002|STARTED|Overall Study||43
3306470|NCT02998541|4039822|FG000|COMPLETED|Overall Study||78
3306471|NCT02998541|4039823|FG001|COMPLETED|Overall Study||81
3306472|NCT02998541|4039824|FG002|COMPLETED|Overall Study||37
3306473|NCT02998541|4039822|FG000|NOT COMPLETED|Overall Study||8
3306474|NCT02998541|4039823|FG001|NOT COMPLETED|Overall Study||9
3306475|NCT02998541|4039824|FG002|NOT COMPLETED|Overall Study||6
3306476|NCT02998554|4039834|FG000|STARTED|Overall Study||79
3306477|NCT02998554|4039835|FG001|STARTED|Overall Study||77
3306478|NCT02998554|4039834|FG000|COMPLETED|Overall Study||68
3306479|NCT02998554|4039835|FG001|COMPLETED|Overall Study||66
3306480|NCT02998554|4039834|FG000|NOT COMPLETED|Overall Study||11
3306481|NCT02998554|4039835|FG001|NOT COMPLETED|Overall Study||11
3306482|NCT02998671|4039848|FG000|STARTED|Period 1||21
3306483|NCT02998671|4039849|FG001|STARTED|Period 1||13
3306484|NCT02998671|4039850|FG002|STARTED|Period 1||6
3306485|NCT02998671|4039851|FG003|STARTED|Period 1||8
3306486|NCT02998671|4039852|FG004|STARTED|Period 1||4
3306487|NCT02998671|4039848|FG000|COMPLETED|Period 1||17
3306488|NCT02998671|4039849|FG001|COMPLETED|Period 1||10
3306489|NCT02998671|4039850|FG002|COMPLETED|Period 1||6
3306490|NCT02998671|4039851|FG003|COMPLETED|Period 1||8
3306491|NCT02998671|4039852|FG004|COMPLETED|Period 1||0
3306492|NCT02998671|4039848|FG000|NOT COMPLETED|Period 1||4
3306493|NCT02998671|4039849|FG001|NOT COMPLETED|Period 1||3
3306494|NCT02998671|4039850|FG002|NOT COMPLETED|Period 1||0
3306495|NCT02998671|4039851|FG003|NOT COMPLETED|Period 1||0
3306496|NCT02998671|4039852|FG004|NOT COMPLETED|Period 1||4
3306497|NCT02998671|4039848|FG000|STARTED|Period 2||17
3306498|NCT02998671|4039849|FG001|STARTED|Period 2||10
3306499|NCT02998671|4039850|FG002|STARTED|Period 2||6
3306500|NCT02998671|4039851|FG003|STARTED|Period 2||8
3306501|NCT02998671|4039852|FG004|STARTED|Period 2||0
3306502|NCT02998671|4039848|FG000|COMPLETED|Period 2||14
3306503|NCT02998671|4039849|FG001|COMPLETED|Period 2||3
3306504|NCT02998671|4039850|FG002|COMPLETED|Period 2||5
3306505|NCT02998671|4039851|FG003|COMPLETED|Period 2||4
3306506|NCT02998671|4039852|FG004|COMPLETED|Period 2||0
3306507|NCT02998671|4039848|FG000|NOT COMPLETED|Period 2||3
3306508|NCT02998671|4039849|FG001|NOT COMPLETED|Period 2||7
3306509|NCT02998671|4039850|FG002|NOT COMPLETED|Period 2||1
3306510|NCT02998671|4039851|FG003|NOT COMPLETED|Period 2||4
3306511|NCT02998671|4039852|FG004|NOT COMPLETED|Period 2||0
3306512|NCT02998684|4039874|FG000|STARTED|Overall Study||7
3306513|NCT02998684|4039875|FG001|STARTED|Overall Study||7
2997890|NCT00944671|3714844|FG000|NOT COMPLETED|Period III||0
2997891|NCT00944671|3714845|FG001|NOT COMPLETED|Period III||0
2997892|NCT00944671|3714846|FG002|NOT COMPLETED|Period III||0
2997893|NCT00944671|3714847|FG003|NOT COMPLETED|Period III||0
2997894|NCT00944671|3714848|FG004|NOT COMPLETED|Period III||0
2997895|NCT00944671|3714849|FG005|NOT COMPLETED|Period III||0
2997896|NCT00944697|3714859|FG000|STARTED|Overall Study||50
2997897|NCT00944697|3714860|FG001|STARTED|Overall Study||48
2997898|NCT00944697|3714859|FG000|COMPLETED|Overall Study||48
2997899|NCT00944697|3714860|FG001|COMPLETED|Overall Study||43
2997900|NCT00944697|3714859|FG000|NOT COMPLETED|Overall Study||2
2997901|NCT00944697|3714860|FG001|NOT COMPLETED|Overall Study||5
2997902|NCT00944710|3714868|FG000|STARTED|10-week Primary Outcome||40
2997903|NCT00944710|3714869|FG001|STARTED|10-week Primary Outcome||33
2997904|NCT00944710|3714868|FG000|COMPLETED|10-week Primary Outcome||40
2997905|NCT00944710|3714869|FG001|COMPLETED|10-week Primary Outcome||33
2997906|NCT00944710|3714868|FG000|NOT COMPLETED|10-week Primary Outcome||0
2997907|NCT00944710|3714869|FG001|NOT COMPLETED|10-week Primary Outcome||0
2997908|NCT00944710|3714868|FG000|STARTED|12-week Visit (Off-treatment)||40
2997909|NCT00944710|3714869|FG001|STARTED|12-week Visit (Off-treatment)||33
2997910|NCT00944710|3714868|FG000|COMPLETED|12-week Visit (Off-treatment)||40
2997911|NCT00944710|3714869|FG001|COMPLETED|12-week Visit (Off-treatment)||33
2997912|NCT00944710|3714868|FG000|NOT COMPLETED|12-week Visit (Off-treatment)||0
2997913|NCT00944710|3714869|FG001|NOT COMPLETED|12-week Visit (Off-treatment)||0
2997914|NCT00944710|3714868|FG000|STARTED|Additional Post 10-week Primary Outcome||40
2997915|NCT00944710|3714869|FG001|STARTED|Additional Post 10-week Primary Outcome||33
2997916|NCT00944710|3714868|FG000|Eligible to Enter Post 10-week Phase|Additional Post 10-week Primary Outcome||24
2997917|NCT00944710|3714869|FG001|Eligible to Enter Post 10-week Phase|Additional Post 10-week Primary Outcome||26
2997918|NCT00944710|3714868|FG000|COMPLETED|Additional Post 10-week Primary Outcome||23
2997919|NCT00944710|3714869|FG001|COMPLETED|Additional Post 10-week Primary Outcome||22
2997920|NCT00944710|3714868|FG000|NOT COMPLETED|Additional Post 10-week Primary Outcome||17
2997921|NCT00944710|3714869|FG001|NOT COMPLETED|Additional Post 10-week Primary Outcome||11
2997922|NCT00944749|3714875|FG000|STARTED|Overall Study||23
2997923|NCT00944749|3714875|FG000|COMPLETED|Overall Study||22
2997924|NCT00944749|3714875|FG000|NOT COMPLETED|Overall Study||1
2997925|NCT00945009|3714882|FG000|STARTED|Overall Study||201
2997926|NCT00945009|3714883|FG001|STARTED|Overall Study||39
2997927|NCT00945009|3714884|FG002|STARTED|Overall Study||9
2997928|NCT00945009|3714882|FG000|COMPLETED|Overall Study||156
2997929|NCT00945009|3714883|FG001|COMPLETED|Overall Study||32
2997930|NCT00945009|3714884|FG002|COMPLETED|Overall Study||6
2997931|NCT00945009|3714882|FG000|NOT COMPLETED|Overall Study||45
2997932|NCT00945009|3714883|FG001|NOT COMPLETED|Overall Study||7
2997933|NCT00945009|3714884|FG002|NOT COMPLETED|Overall Study||3
2997934|NCT00945061|3714894|FG000|STARTED|Overall Study||12
2997935|NCT00945061|3714895|FG001|STARTED|Overall Study||1
2997936|NCT00945061|3714894|FG000|COMPLETED|Overall Study||12
2997937|NCT00945061|3714895|FG001|COMPLETED|Overall Study||1
2997938|NCT00945061|3714894|FG000|NOT COMPLETED|Overall Study||0
2997939|NCT00945061|3714895|FG001|NOT COMPLETED|Overall Study||0
2997940|NCT00945100|3714912|FG000|STARTED|10-week Primary Outcome||83
2997941|NCT00945100|3714913|FG001|STARTED|10-week Primary Outcome||86
2997942|NCT00945100|3714912|FG000|Completed, Eligible|10-week Primary Outcome|Eligible for Post-10 week phase|55
2997943|NCT00945100|3714913|FG001|Completed, Eligible|10-week Primary Outcome|Eligible for Post-10 week phase|63
2997944|NCT00945100|3714912|FG000|Completed, Not Eligible|10-week Primary Outcome|Not Eligible for Post-10 week phase|27
2997945|NCT00945100|3714913|FG001|Completed, Not Eligible|10-week Primary Outcome|Not Eligible for Post-10 week phase|20
2997946|NCT00945100|3714912|FG000|COMPLETED|10-week Primary Outcome||82
2997947|NCT00945100|3714913|FG001|COMPLETED|10-week Primary Outcome||83
2997948|NCT00945100|3714912|FG000|NOT COMPLETED|10-week Primary Outcome||1
2997949|NCT00945100|3714913|FG001|NOT COMPLETED|10-week Primary Outcome||3
2997950|NCT00945100|3714912|FG000|STARTED|Post-10 Week Primary Outcome|27 participants were not eligible for Post 10 week Primary Outcome phase|55
2997951|NCT00945100|3714913|FG001|STARTED|Post-10 Week Primary Outcome|20 participants were not eligible for Post 10 week Primary Outcome phase|63
2997952|NCT00945100|3714912|FG000|COMPLETED|Post-10 Week Primary Outcome||51
2997953|NCT00945100|3714913|FG001|COMPLETED|Post-10 Week Primary Outcome||56
2997954|NCT00945100|3714912|FG000|NOT COMPLETED|Post-10 Week Primary Outcome||4
2997955|NCT00945100|3714913|FG001|NOT COMPLETED|Post-10 Week Primary Outcome||7
2997956|NCT00945139|3714919|FG000|STARTED|Overall Study||46
2997957|NCT00945139|3714919|FG000|COMPLETED|Overall Study||46
2997958|NCT00945139|3714919|FG000|NOT COMPLETED|Overall Study||0
2997959|NCT00945191|3714924|FG000|STARTED|Overall Study||24
2997960|NCT00945191|3714924|FG000|COMPLETED|Overall Study||0
2997961|NCT00945191|3714924|FG000|NOT COMPLETED|Overall Study||24
2997962|NCT00945243|3714928|FG000|STARTED|Overall Study|Enrolled and Treated Per Protocol|11
2997963|NCT00945243|3714928|FG000|COMPLETED|Overall Study||8
2997964|NCT00945243|3714928|FG000|NOT COMPLETED|Overall Study||3
2997965|NCT00945256|3714937|FG000|STARTED|Overall Study||13
2997966|NCT00945256|3714938|FG001|STARTED|Overall Study||10
2997967|NCT00945256|3714939|FG002|STARTED|Overall Study||15
2997968|NCT00945256|3714940|FG003|STARTED|Overall Study||16
2997969|NCT00945256|3714941|FG004|STARTED|Overall Study||8
2997970|NCT00945256|3714937|FG000|COMPLETED|Overall Study||9
2997971|NCT00945256|3714938|FG001|COMPLETED|Overall Study||8
2997972|NCT00945256|3714939|FG002|COMPLETED|Overall Study||7
2997973|NCT00945256|3714940|FG003|COMPLETED|Overall Study||7
2997974|NCT00945256|3714941|FG004|COMPLETED|Overall Study||7
2997975|NCT00945256|3714937|FG000|NOT COMPLETED|Overall Study||4
2997976|NCT00945256|3714938|FG001|NOT COMPLETED|Overall Study||2
2997977|NCT00945256|3714939|FG002|NOT COMPLETED|Overall Study||8
2997978|NCT00945256|3714940|FG003|NOT COMPLETED|Overall Study||9
2997979|NCT00945256|3714941|FG004|NOT COMPLETED|Overall Study||1
2997980|NCT00945282|3714955|FG000|STARTED|Overall Study||6
2997981|NCT00945282|3714956|FG001|STARTED|Overall Study||2
2997982|NCT00945282|3714955|FG000|COMPLETED|Overall Study||6
2997983|NCT00945282|3714956|FG001|COMPLETED|Overall Study||2
2997984|NCT00945282|3714955|FG000|NOT COMPLETED|Overall Study||0
2997985|NCT00945282|3714956|FG001|NOT COMPLETED|Overall Study||0
2997986|NCT00945295|3714972|FG000|STARTED|Overall Study||15
2997987|NCT00945295|3714973|FG001|STARTED|Overall Study||16
2997988|NCT00945295|3714972|FG000|COMPLETED|Overall Study||15
2997989|NCT00945295|3714973|FG001|COMPLETED|Overall Study||14
2997990|NCT00945295|3714972|FG000|NOT COMPLETED|Overall Study||0
2997991|NCT00945295|3714973|FG001|NOT COMPLETED|Overall Study||2
2997992|NCT00945321|3714979|FG000|STARTED|Period 1||7
2997993|NCT00945321|3714980|FG001|STARTED|Period 1||7
2997994|NCT00945321|3714981|FG002|STARTED|Period 1||7
3164751|NCT01894919|3892222|FG006|STARTED|Overall Study||32
3164752|NCT01894919|3892223|FG007|STARTED|Overall Study||36
3164753|NCT01894919|3892224|FG008|STARTED|Overall Study||91
3164754|NCT01894919|3892225|FG009|STARTED|Overall Study||90
3164755|NCT01894919|3892226|FG010|STARTED|Overall Study||100
3164756|NCT01894919|3892227|FG011|STARTED|Overall Study||55
3164757|NCT01894919|3892228|FG012|STARTED|Overall Study||50
3164758|NCT01894919|3892216|FG000|COMPLETED|Overall Study||96
3164759|NCT01894919|3892217|FG001|COMPLETED|Overall Study||47
3164760|NCT01894919|3892218|FG002|COMPLETED|Overall Study||89
2997995|NCT00945321|3714982|FG003|STARTED|Period 1||7
2997996|NCT00945321|3714983|FG004|STARTED|Period 1||7
2997997|NCT00945321|3714984|FG005|STARTED|Period 1||7
2997998|NCT00945321|3714979|FG000|COMPLETED|Period 1||7
2997999|NCT00945321|3714980|FG001|COMPLETED|Period 1||7
2998000|NCT00945321|3714981|FG002|COMPLETED|Period 1||7
2998001|NCT00945321|3714982|FG003|COMPLETED|Period 1||7
2998002|NCT00945321|3714983|FG004|COMPLETED|Period 1||6
2998003|NCT00945321|3714984|FG005|COMPLETED|Period 1||7
2998004|NCT00945321|3714979|FG000|NOT COMPLETED|Period 1||0
2998005|NCT00945321|3714980|FG001|NOT COMPLETED|Period 1||0
2998006|NCT00945321|3714981|FG002|NOT COMPLETED|Period 1||0
2998007|NCT00945321|3714982|FG003|NOT COMPLETED|Period 1||0
2998008|NCT00945321|3714983|FG004|NOT COMPLETED|Period 1||1
2998009|NCT00945321|3714984|FG005|NOT COMPLETED|Period 1||0
2998010|NCT00945321|3714979|FG000|STARTED|Period 2||7
2998011|NCT00945321|3714980|FG001|STARTED|Period 2||7
2998012|NCT00945321|3714981|FG002|STARTED|Period 2||7
2998013|NCT00945321|3714982|FG003|STARTED|Period 2||7
2998014|NCT00945321|3714983|FG004|STARTED|Period 2||6
2998015|NCT00945321|3714984|FG005|STARTED|Period 2||7
2998016|NCT00945321|3714979|FG000|COMPLETED|Period 2||7
2998017|NCT00945321|3714980|FG001|COMPLETED|Period 2||7
2998018|NCT00945321|3714981|FG002|COMPLETED|Period 2||7
2998019|NCT00945321|3714982|FG003|COMPLETED|Period 2||7
2998020|NCT00945321|3714983|FG004|COMPLETED|Period 2||6
2998021|NCT00945321|3714984|FG005|COMPLETED|Period 2||7
2998022|NCT00945321|3714979|FG000|NOT COMPLETED|Period 2||0
2998023|NCT00945321|3714980|FG001|NOT COMPLETED|Period 2||0
2998024|NCT00945321|3714981|FG002|NOT COMPLETED|Period 2||0
2998025|NCT00945321|3714982|FG003|NOT COMPLETED|Period 2||0
2998026|NCT00945321|3714983|FG004|NOT COMPLETED|Period 2||0
2998027|NCT00945321|3714984|FG005|NOT COMPLETED|Period 2||0
2998028|NCT00945321|3714979|FG000|STARTED|Period 3||7
2998029|NCT00945321|3714980|FG001|STARTED|Period 3||7
2998030|NCT00945321|3714981|FG002|STARTED|Period 3||7
2998031|NCT00945321|3714982|FG003|STARTED|Period 3||7
2998032|NCT00945321|3714983|FG004|STARTED|Period 3||6
2998033|NCT00945321|3714984|FG005|STARTED|Period 3||7
2998034|NCT00945321|3714979|FG000|COMPLETED|Period 3||7
2998035|NCT00945321|3714980|FG001|COMPLETED|Period 3||7
2998036|NCT00945321|3714981|FG002|COMPLETED|Period 3||7
2998037|NCT00945321|3714982|FG003|COMPLETED|Period 3||7
2998038|NCT00945321|3714983|FG004|COMPLETED|Period 3||6
2998039|NCT00945321|3714984|FG005|COMPLETED|Period 3||7
2998040|NCT00945321|3714979|FG000|NOT COMPLETED|Period 3||0
2998041|NCT00945321|3714980|FG001|NOT COMPLETED|Period 3||0
2998042|NCT00945321|3714981|FG002|NOT COMPLETED|Period 3||0
2998043|NCT00945321|3714982|FG003|NOT COMPLETED|Period 3||0
2998044|NCT00945321|3714983|FG004|NOT COMPLETED|Period 3||0
2998045|NCT00945321|3714984|FG005|NOT COMPLETED|Period 3||0
2998046|NCT00945321|3714979|FG000|STARTED|Period 4||7
2998047|NCT00945321|3714980|FG001|STARTED|Period 4||7
2998048|NCT00945321|3714981|FG002|STARTED|Period 4||7
2998049|NCT00945321|3714982|FG003|STARTED|Period 4||7
2998050|NCT00945321|3714983|FG004|STARTED|Period 4||6
2998051|NCT00945321|3714984|FG005|STARTED|Period 4||7
2998052|NCT00945321|3714979|FG000|COMPLETED|Period 4||7
2998053|NCT00945321|3714980|FG001|COMPLETED|Period 4||7
2998054|NCT00945321|3714981|FG002|COMPLETED|Period 4||7
2998055|NCT00945321|3714982|FG003|COMPLETED|Period 4||7
3164761|NCT01894919|3892219|FG003|COMPLETED|Overall Study||43
2998056|NCT00945321|3714983|FG004|COMPLETED|Period 4||6
2998057|NCT00945321|3714984|FG005|COMPLETED|Period 4||6
2998058|NCT00945321|3714979|FG000|NOT COMPLETED|Period 4||0
2998059|NCT00945321|3714980|FG001|NOT COMPLETED|Period 4||0
2998060|NCT00945321|3714981|FG002|NOT COMPLETED|Period 4||0
2998061|NCT00945321|3714982|FG003|NOT COMPLETED|Period 4||0
2998062|NCT00945321|3714983|FG004|NOT COMPLETED|Period 4||0
2998063|NCT00945321|3714984|FG005|NOT COMPLETED|Period 4||1
2998064|NCT00945334|3715004|FG000|STARTED|Overall Study||19
2998065|NCT00945334|3715005|FG001|STARTED|Overall Study||18
2998066|NCT00945334|3715004|FG000|COMPLETED|Overall Study||16
2998067|NCT00945334|3715005|FG001|COMPLETED|Overall Study||15
2998068|NCT00945334|3715004|FG000|NOT COMPLETED|Overall Study||3
2998069|NCT00945334|3715005|FG001|NOT COMPLETED|Overall Study||3
2998070|NCT00945477|3715011|FG000|STARTED|Overall Study||11
2998071|NCT00945477|3715011|FG000|COMPLETED|Overall Study||5
2998072|NCT00945477|3715011|FG000|NOT COMPLETED|Overall Study||6
2998073|NCT00945555|3715016|FG000|STARTED|Overall Study||264
2998074|NCT00945555|3715016|FG000|COMPLETED|Overall Study||236
2998075|NCT00945555|3715016|FG000|NOT COMPLETED|Overall Study||28
2998076|NCT00945594|3715022|FG000|STARTED|Overall Study||50
2998077|NCT00945594|3715023|FG001|STARTED|Overall Study||50
2998078|NCT00945594|3715022|FG000|COMPLETED|Overall Study||50
2998079|NCT00945594|3715023|FG001|COMPLETED|Overall Study||50
2998080|NCT00945594|3715022|FG000|NOT COMPLETED|Overall Study||0
2998081|NCT00945594|3715023|FG001|NOT COMPLETED|Overall Study||0
2998082|NCT00945659|3715034|FG000|STARTED|Overall Study||39
2998083|NCT00945659|3715035|FG001|STARTED|Overall Study||40
2998084|NCT00945659|3715036|FG002|STARTED|Overall Study||37
2998085|NCT00945659|3715034|FG000|Baseline|Overall Study||39
2998086|NCT00945659|3715035|FG001|Baseline|Overall Study||40
2998087|NCT00945659|3715036|FG002|Baseline|Overall Study||37
2998088|NCT00945659|3715034|FG000|3-Months|Overall Study||38
2998089|NCT00945659|3715035|FG001|3-Months|Overall Study||39
2998090|NCT00945659|3715036|FG002|3-Months|Overall Study||35
2998091|NCT00945659|3715034|FG000|6-Months|Overall Study||31
2998092|NCT00945659|3715035|FG001|6-Months|Overall Study||29
2998093|NCT00945659|3715036|FG002|6-Months|Overall Study||25
2998094|NCT00945659|3715034|FG000|9-Months|Overall Study||32
2998095|NCT00945659|3715035|FG001|9-Months|Overall Study||20
2998096|NCT00945659|3715036|FG002|9-Months|Overall Study||20
2998097|NCT00945659|3715034|FG000|12-Months|Overall Study||32
2998098|NCT00945659|3715035|FG001|12-Months|Overall Study||20
2998099|NCT00945659|3715036|FG002|12-Months|Overall Study||20
2998100|NCT00945659|3715034|FG000|COMPLETED|Overall Study||32
2998101|NCT00945659|3715035|FG001|COMPLETED|Overall Study||20
2998102|NCT00945659|3715036|FG002|COMPLETED|Overall Study||20
2998103|NCT00945659|3715034|FG000|NOT COMPLETED|Overall Study||7
2998104|NCT00945659|3715035|FG001|NOT COMPLETED|Overall Study||20
2998105|NCT00945659|3715036|FG002|NOT COMPLETED|Overall Study||17
2998106|NCT00945750|3715050|FG000|STARTED|Period I||5
2998107|NCT00945750|3715051|FG001|STARTED|Period I||5
2998108|NCT00945750|3715052|FG002|STARTED|Period I||5
2998109|NCT00945750|3715053|FG003|STARTED|Period I||5
2998110|NCT00945750|3715054|FG004|STARTED|Period I||5
2998111|NCT00945750|3715055|FG005|STARTED|Period I||5
2998112|NCT00945750|3715050|FG000|COMPLETED|Period I||5
2998113|NCT00945750|3715051|FG001|COMPLETED|Period I||5
2998114|NCT00945750|3715052|FG002|COMPLETED|Period I||5
2998115|NCT00945750|3715053|FG003|COMPLETED|Period I||5
2998116|NCT00945750|3715054|FG004|COMPLETED|Period I||5
2998117|NCT00945750|3715055|FG005|COMPLETED|Period I||5
2998118|NCT00945750|3715050|FG000|NOT COMPLETED|Period I||0
2998119|NCT00945750|3715051|FG001|NOT COMPLETED|Period I||0
2998120|NCT00945750|3715052|FG002|NOT COMPLETED|Period I||0
2998121|NCT00945750|3715053|FG003|NOT COMPLETED|Period I||0
2998122|NCT00945750|3715054|FG004|NOT COMPLETED|Period I||0
2998123|NCT00945750|3715055|FG005|NOT COMPLETED|Period I||0
2998124|NCT00945750|3715050|FG000|STARTED|Period II||5
2998125|NCT00945750|3715051|FG001|STARTED|Period II||5
2998126|NCT00945750|3715052|FG002|STARTED|Period II||5
2998127|NCT00945750|3715053|FG003|STARTED|Period II||5
2998128|NCT00945750|3715054|FG004|STARTED|Period II||5
2998129|NCT00945750|3715055|FG005|STARTED|Period II||5
2998130|NCT00945750|3715050|FG000|COMPLETED|Period II||5
2998131|NCT00945750|3715051|FG001|COMPLETED|Period II||5
3306514|NCT02998684|4039874|FG000|COMPLETED|Overall Study||4
3306515|NCT02998684|4039875|FG001|COMPLETED|Overall Study||6
3306516|NCT02998684|4039874|FG000|NOT COMPLETED|Overall Study||3
3306517|NCT02998684|4039875|FG001|NOT COMPLETED|Overall Study||1
3306518|NCT02998996|4039887|FG000|STARTED|Overall Study||36
2998132|NCT00945750|3715052|FG002|COMPLETED|Period II||5
2998133|NCT00945750|3715053|FG003|COMPLETED|Period II||5
2998134|NCT00945750|3715054|FG004|COMPLETED|Period II||5
3306519|NCT02998996|4039888|FG001|STARTED|Overall Study||35
2998135|NCT00945750|3715055|FG005|COMPLETED|Period II||5
2998136|NCT00945750|3715050|FG000|NOT COMPLETED|Period II||0
2998137|NCT00945750|3715051|FG001|NOT COMPLETED|Period II||0
2998138|NCT00945750|3715052|FG002|NOT COMPLETED|Period II||0
2998139|NCT00945750|3715053|FG003|NOT COMPLETED|Period II||0
2998140|NCT00945750|3715054|FG004|NOT COMPLETED|Period II||0
2998141|NCT00945750|3715055|FG005|NOT COMPLETED|Period II||0
2998142|NCT00945750|3715050|FG000|STARTED|Period III||5
2998143|NCT00945750|3715051|FG001|STARTED|Period III||5
2998144|NCT00945750|3715052|FG002|STARTED|Period III||5
2998145|NCT00945750|3715053|FG003|STARTED|Period III||5
2998146|NCT00945750|3715054|FG004|STARTED|Period III||5
2998147|NCT00945750|3715055|FG005|STARTED|Period III||5
2998148|NCT00945750|3715050|FG000|COMPLETED|Period III||5
2998149|NCT00945750|3715051|FG001|COMPLETED|Period III||5
2998150|NCT00945750|3715052|FG002|COMPLETED|Period III||5
2998151|NCT00945750|3715053|FG003|COMPLETED|Period III||5
3164762|NCT01894919|3892220|FG004|COMPLETED|Overall Study||78
3164763|NCT01894919|3892221|FG005|COMPLETED|Overall Study||39
3164764|NCT01894919|3892222|FG006|COMPLETED|Overall Study||32
2998152|NCT00945750|3715054|FG004|COMPLETED|Period III||5
2998153|NCT00945750|3715055|FG005|COMPLETED|Period III||5
2998154|NCT00945750|3715050|FG000|NOT COMPLETED|Period III||0
2998155|NCT00945750|3715051|FG001|NOT COMPLETED|Period III||0
2998156|NCT00945750|3715052|FG002|NOT COMPLETED|Period III||0
2998157|NCT00945750|3715053|FG003|NOT COMPLETED|Period III||0
2998158|NCT00945750|3715054|FG004|NOT COMPLETED|Period III||0
2998159|NCT00945750|3715055|FG005|NOT COMPLETED|Period III||0
2998160|NCT00945815|3715063|FG000|STARTED|Overall Study||35
2998161|NCT00945815|3715063|FG000|Eligible|Overall Study||32
2998162|NCT00945815|3715063|FG000|Eligible and Began Protocol Therapy|Overall Study||31
2998163|NCT00945815|3715063|FG000|COMPLETED|Overall Study||27
2998164|NCT00945815|3715063|FG000|NOT COMPLETED|Overall Study||8
2998165|NCT00945854|3715069|FG000|STARTED|Overall Study||30
2998166|NCT00945854|3715070|FG001|STARTED|Overall Study||30
2998167|NCT00945854|3715069|FG000|COMPLETED|Overall Study||28
2998168|NCT00945854|3715070|FG001|COMPLETED|Overall Study||26
2998169|NCT00945854|3715069|FG000|NOT COMPLETED|Overall Study||2
2998170|NCT00945854|3715070|FG001|NOT COMPLETED|Overall Study||4
2998171|NCT00945893|3715078|FG000|STARTED|Overall Study||60
2998172|NCT00945893|3715079|FG001|STARTED|Overall Study||240
3164765|NCT01894919|3892223|FG007|COMPLETED|Overall Study||36
3164766|NCT01894919|3892224|FG008|COMPLETED|Overall Study||91
3164767|NCT01894919|3892225|FG009|COMPLETED|Overall Study||89
3164768|NCT01894919|3892226|FG010|COMPLETED|Overall Study||98
3164769|NCT01894919|3892227|FG011|COMPLETED|Overall Study||55
3164770|NCT01894919|3892228|FG012|COMPLETED|Overall Study||50
3164771|NCT01894919|3892216|FG000|NOT COMPLETED|Overall Study||2
3164772|NCT01894919|3892217|FG001|NOT COMPLETED|Overall Study||0
3164773|NCT01894919|3892218|FG002|NOT COMPLETED|Overall Study||0
3164774|NCT01894919|3892219|FG003|NOT COMPLETED|Overall Study||0
3164775|NCT01894919|3892220|FG004|NOT COMPLETED|Overall Study||3
3164776|NCT01894919|3892221|FG005|NOT COMPLETED|Overall Study||0
3164777|NCT01894919|3892222|FG006|NOT COMPLETED|Overall Study||0
3164778|NCT01894919|3892223|FG007|NOT COMPLETED|Overall Study||0
3164779|NCT01894919|3892224|FG008|NOT COMPLETED|Overall Study||0
3164780|NCT01894919|3892225|FG009|NOT COMPLETED|Overall Study||1
3164781|NCT01894919|3892226|FG010|NOT COMPLETED|Overall Study||2
3164782|NCT01894919|3892227|FG011|NOT COMPLETED|Overall Study||0
3164783|NCT01894919|3892228|FG012|NOT COMPLETED|Overall Study||0
3164784|NCT01894984|3892272|FG000|STARTED|Overall Study||396
3164785|NCT01894984|3892273|FG001|STARTED|Overall Study||244
3164786|NCT01894984|3892272|FG000|COMPLETED|Overall Study||82
3164787|NCT01894984|3892273|FG001|COMPLETED|Overall Study||69
3164788|NCT01894984|3892272|FG000|NOT COMPLETED|Overall Study||314
3164789|NCT01894984|3892273|FG001|NOT COMPLETED|Overall Study||175
3164790|NCT01895036|3892279|FG000|STARTED|Overall Study||6
3164791|NCT01895036|3892279|FG000|COMPLETED|Overall Study||6
3164792|NCT01895036|3892279|FG000|NOT COMPLETED|Overall Study||0
3164793|NCT01895062|3892285|FG000|STARTED|Overall Study||30
3164794|NCT01895062|3892286|FG001|STARTED|Overall Study||24
2998173|NCT00945893|3715078|FG000|Day 15 Post Dose 1|Overall Study||60
2998174|NCT00945893|3715079|FG001|Day 15 Post Dose 1|Overall Study||238
2998175|NCT00945893|3715078|FG000|Day 15 Post Dose 2|Overall Study||54
2998176|NCT00945893|3715079|FG001|Day 15 Post Dose 2|Overall Study||226
2998177|NCT00945893|3715078|FG000|COMPLETED|Overall Study||57
2998178|NCT00945893|3715079|FG001|COMPLETED|Overall Study||230
2998179|NCT00945893|3715078|FG000|NOT COMPLETED|Overall Study||3
2998180|NCT00945893|3715079|FG001|NOT COMPLETED|Overall Study||10
3164795|NCT01895062|3892285|FG000|COMPLETED|Overall Study||30
3164796|NCT01895062|3892286|FG001|COMPLETED|Overall Study||24
3164797|NCT01895062|3892285|FG000|NOT COMPLETED|Overall Study||0
3036953|NCT01146288|3756244|FG001|STARTED|First Intervention(1 Day)||6
3036954|NCT01146288|3756243|FG000|COMPLETED|First Intervention(1 Day)||7
3036955|NCT01146288|3756244|FG001|COMPLETED|First Intervention(1 Day)||5
3306520|NCT02998996|4039889|FG002|STARTED|Overall Study||36
3306521|NCT02998996|4039890|FG003|STARTED|Overall Study||18
3036956|NCT01146288|3756243|FG000|NOT COMPLETED|First Intervention(1 Day)||0
3036957|NCT01146288|3756244|FG001|NOT COMPLETED|First Intervention(1 Day)||1
3036958|NCT01146288|3756243|FG000|STARTED|Second Intervention (1 Day)||7
3036959|NCT01146288|3756244|FG001|STARTED|Second Intervention (1 Day)||5
3036960|NCT01146288|3756243|FG000|COMPLETED|Second Intervention (1 Day)||7
3036961|NCT01146288|3756244|FG001|COMPLETED|Second Intervention (1 Day)||5
3036962|NCT01146288|3756243|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
3036963|NCT01146288|3756244|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
3036964|NCT01146379|3756255|FG000|STARTED|Overall Study||21
3036965|NCT01146379|3756256|FG001|STARTED|Overall Study||22
3036966|NCT01146379|3756257|FG002|STARTED|Overall Study||21
3036967|NCT01146379|3756258|FG003|STARTED|Overall Study||21
3036968|NCT01146379|3756255|FG000|COMPLETED|Overall Study||20
3036969|NCT01146379|3756256|FG001|COMPLETED|Overall Study||21
3036970|NCT01146379|3756257|FG002|COMPLETED|Overall Study||21
3164798|NCT01895062|3892286|FG001|NOT COMPLETED|Overall Study||0
3164799|NCT01895088|3892292|FG000|STARTED|Overall Study|1 subject consented for monitoring after device removal (not included in cohort), per FDA request.|271
3036971|NCT01146379|3756258|FG003|COMPLETED|Overall Study||20
3036972|NCT01146379|3756255|FG000|NOT COMPLETED|Overall Study||1
3036973|NCT01146379|3756256|FG001|NOT COMPLETED|Overall Study||1
2998181|NCT00945906|3715089|FG000|STARTED|Overall Study||61
2998182|NCT00945906|3715089|FG000|COMPLETED|Overall Study||54
2998183|NCT00945906|3715089|FG000|NOT COMPLETED|Overall Study||7
2998184|NCT00945945|3715095|FG000|STARTED|Overall Study||207
2998185|NCT00945945|3715096|FG001|STARTED|Overall Study||217
2998186|NCT00945945|3715095|FG000|COMPLETED|Overall Study||171
2998187|NCT00945945|3715096|FG001|COMPLETED|Overall Study||162
2998188|NCT00945945|3715095|FG000|NOT COMPLETED|Overall Study||36
2998189|NCT00945945|3715096|FG001|NOT COMPLETED|Overall Study||55
2998190|NCT00945958|3715102|FG000|STARTED|Overall Study||161
2998191|NCT00945958|3715102|FG000|COMPLETED|Overall Study||149
2998192|NCT00945958|3715102|FG000|NOT COMPLETED|Overall Study||12
2998193|NCT00946023|3715107|FG000|STARTED|Overall Study||83
2998194|NCT00946023|3715107|FG000|COMPLETED|Overall Study||83
2998195|NCT00946023|3715107|FG000|NOT COMPLETED|Overall Study||0
2998196|NCT00946088|3715113|FG000|STARTED|Overall Study||4
2998197|NCT00946088|3715114|FG001|STARTED|Overall Study||3
2998198|NCT00946088|3715113|FG000|COMPLETED|Overall Study|At least one dose administered and pre-term birth status known.|4
2998199|NCT00946088|3715114|FG001|COMPLETED|Overall Study|At least one dose administered and pre-term birth status known.|2
2998200|NCT00946088|3715113|FG000|NOT COMPLETED|Overall Study||0
2998201|NCT00946088|3715114|FG001|NOT COMPLETED|Overall Study||1
2998202|NCT00946101|3715124|FG000|STARTED|Overall Study|Intent to Treat population, enrolled and randomized|261
2998203|NCT00946101|3715125|FG001|STARTED|Overall Study||65
2998204|NCT00946101|3715124|FG000|Day 15 Post Dose 1|Overall Study||260
2998205|NCT00946101|3715125|FG001|Day 15 Post Dose 1|Overall Study||64
2998206|NCT00946101|3715124|FG000|Day 15 Post Dose 2|Overall Study||254
2998207|NCT00946101|3715125|FG001|Day 15 Post Dose 2|Overall Study||63
2998208|NCT00946101|3715124|FG000|COMPLETED|Overall Study||257
2998209|NCT00946101|3715125|FG001|COMPLETED|Overall Study||63
2998210|NCT00946101|3715124|FG000|NOT COMPLETED|Overall Study||4
2998211|NCT00946101|3715125|FG001|NOT COMPLETED|Overall Study||2
2998212|NCT00946114|3715137|FG000|STARTED|Overall Study||20
2998213|NCT00946114|3715138|FG001|STARTED|Overall Study||12
2998214|NCT00946114|3715137|FG000|COMPLETED|Overall Study||12
2998215|NCT00946114|3715138|FG001|COMPLETED|Overall Study||10
2998216|NCT00946114|3715137|FG000|NOT COMPLETED|Overall Study||8
2998217|NCT00946114|3715138|FG001|NOT COMPLETED|Overall Study||2
2998218|NCT00946153|3715149|FG000|STARTED|Phase 1||6
2998219|NCT00946153|3715150|FG001|STARTED|Phase 1||3
2998220|NCT00946153|3715151|FG002|STARTED|Phase 1||6
2998221|NCT00946153|3715152|FG003|STARTED|Phase 1||5
2998222|NCT00946153|3715153|FG004|STARTED|Phase 1||0
2998223|NCT00946153|3715149|FG000|COMPLETED|Phase 1||6
2998224|NCT00946153|3715150|FG001|COMPLETED|Phase 1||3
2998225|NCT00946153|3715151|FG002|COMPLETED|Phase 1||6
2998226|NCT00946153|3715152|FG003|COMPLETED|Phase 1||5
2998227|NCT00946153|3715153|FG004|COMPLETED|Phase 1||0
2998228|NCT00946153|3715149|FG000|NOT COMPLETED|Phase 1||0
2998229|NCT00946153|3715150|FG001|NOT COMPLETED|Phase 1||0
2998230|NCT00946153|3715151|FG002|NOT COMPLETED|Phase 1||0
2998231|NCT00946153|3715152|FG003|NOT COMPLETED|Phase 1||0
2998232|NCT00946153|3715153|FG004|NOT COMPLETED|Phase 1||0
2998233|NCT00946153|3715149|FG000|STARTED|Phase 2||0
2998234|NCT00946153|3715150|FG001|STARTED|Phase 2||0
2998235|NCT00946153|3715151|FG002|STARTED|Phase 2||0
2998236|NCT00946153|3715152|FG003|STARTED|Phase 2||0
2998237|NCT00946153|3715153|FG004|STARTED|Phase 2||46
2998238|NCT00946153|3715149|FG000|COMPLETED|Phase 2||0
2998239|NCT00946153|3715150|FG001|COMPLETED|Phase 2||0
2998240|NCT00946153|3715151|FG002|COMPLETED|Phase 2||0
2998241|NCT00946153|3715152|FG003|COMPLETED|Phase 2||0
2998242|NCT00946153|3715153|FG004|COMPLETED|Phase 2||33
2998243|NCT00946153|3715149|FG000|NOT COMPLETED|Phase 2||0
2998244|NCT00946153|3715150|FG001|NOT COMPLETED|Phase 2||0
2998245|NCT00946153|3715151|FG002|NOT COMPLETED|Phase 2||0
2998246|NCT00946153|3715152|FG003|NOT COMPLETED|Phase 2||0
2998247|NCT00946153|3715153|FG004|NOT COMPLETED|Phase 2||13
2998248|NCT00946192|3715173|FG000|STARTED|Overall Study||43
2998249|NCT00946192|3715174|FG001|STARTED|Overall Study||40
2998250|NCT00946192|3715175|FG002|STARTED|Overall Study||38
2998251|NCT00946192|3715173|FG000|COMPLETED|Overall Study||25
2998252|NCT00946192|3715174|FG001|COMPLETED|Overall Study||22
2998253|NCT00946192|3715175|FG002|COMPLETED|Overall Study||26
2998254|NCT00946192|3715173|FG000|NOT COMPLETED|Overall Study||18
2998255|NCT00946192|3715174|FG001|NOT COMPLETED|Overall Study||18
2998256|NCT00946192|3715175|FG002|NOT COMPLETED|Overall Study||12
2998257|NCT00946270|3715186|FG000|STARTED|Overall Study||21
2998258|NCT00946270|3715187|FG001|STARTED|Overall Study||20
2998259|NCT00946270|3715188|FG002|STARTED|Overall Study||29
2998260|NCT00946270|3715186|FG000|COMPLETED|Overall Study||21
2998261|NCT00946270|3715187|FG001|COMPLETED|Overall Study||20
2998262|NCT00946270|3715188|FG002|COMPLETED|Overall Study||29
2998263|NCT00946270|3715186|FG000|NOT COMPLETED|Overall Study||0
2998264|NCT00946270|3715187|FG001|NOT COMPLETED|Overall Study||0
2998265|NCT00946270|3715188|FG002|NOT COMPLETED|Overall Study||0
2998266|NCT00946296|3715198|FG000|STARTED|Overall Study||21
2998267|NCT00946296|3715199|FG001|STARTED|Overall Study||15
2998268|NCT00946296|3715198|FG000|COMPLETED|Overall Study||18
2998269|NCT00946296|3715199|FG001|COMPLETED|Overall Study||15
2998270|NCT00946296|3715198|FG000|NOT COMPLETED|Overall Study||3
2998271|NCT00946296|3715199|FG001|NOT COMPLETED|Overall Study||0
2998272|NCT00946309|3715207|FG000|STARTED|Overall Study||22
2998273|NCT00946309|3715208|FG001|STARTED|Overall Study||23
2998274|NCT00946309|3715207|FG000|COMPLETED|Overall Study||21
2998275|NCT00946309|3715208|FG001|COMPLETED|Overall Study||19
2998276|NCT00946309|3715207|FG000|NOT COMPLETED|Overall Study||1
2998277|NCT00946309|3715208|FG001|NOT COMPLETED|Overall Study||4
2998278|NCT00946322|3715215|FG000|STARTED|Pre-treatment||12
2998279|NCT00946322|3715215|FG000|COMPLETED|Pre-treatment||11
2998280|NCT00946322|3715215|FG000|NOT COMPLETED|Pre-treatment||1
2998281|NCT00946322|3715215|FG000|STARTED|Post-treatment||11
2998282|NCT00946322|3715215|FG000|COMPLETED|Post-treatment||9
2998283|NCT00946322|3715215|FG000|NOT COMPLETED|Post-treatment||2
2998284|NCT00946348|3715221|FG000|STARTED|Overall Study||6
2998285|NCT00946348|3715222|FG001|STARTED|Overall Study||6
2998286|NCT00946348|3715221|FG000|COMPLETED|Overall Study||6
2998287|NCT00946348|3715222|FG001|COMPLETED|Overall Study||6
2998288|NCT00946348|3715221|FG000|NOT COMPLETED|Overall Study||0
2998289|NCT00946348|3715222|FG001|NOT COMPLETED|Overall Study||0
2998290|NCT00946478|3715230|FG000|STARTED|Overall Study||20
2998291|NCT00946478|3715231|FG001|STARTED|Overall Study||20
2998292|NCT00946478|3715230|FG000|COMPLETED|Overall Study||20
2998293|NCT00946478|3715231|FG001|COMPLETED|Overall Study||20
2998294|NCT00946478|3715230|FG000|NOT COMPLETED|Overall Study||0
2998295|NCT00946478|3715231|FG001|NOT COMPLETED|Overall Study||0
2998296|NCT00946530|3715241|FG000|STARTED|Overall Study|32 dyads consisting of 1 AD patient and 1 caregiver were assigned the Bright Light Arm|32
2998297|NCT00946530|3715242|FG001|STARTED|Overall Study|27 dyads consisting of 1 AD patient and 1 caregiver were assigned to the Dim Light (Control) arm|27
2998298|NCT00946530|3715243|FG002|STARTED|Overall Study|32 dyads consisting of 1 AD patient and 1 caregiver were assigned the Bright Light Arm|32
2998299|NCT00946530|3715244|FG003|STARTED|Overall Study|27 dyads consisting of 1 AD patient and 1 caregiver were assigned to the Dim Light (Control) arm|27
2998300|NCT00946530|3715241|FG000|COMPLETED|Overall Study|31 dyads consisting of 1 AD patient and 1 caregiver completed the Bright Light Arm|31
2998301|NCT00946530|3715242|FG001|COMPLETED|Overall Study|23 dyads consisting of 1 AD patient and 1 caregiver completed to the Dim Light (Control) arm|23
2998302|NCT00946530|3715243|FG002|COMPLETED|Overall Study|31 dyads consisting of 1 AD patient and 1 caregiver completed the Bright Light Arm|31
2998303|NCT00946530|3715244|FG003|COMPLETED|Overall Study|23 dyads consisting of 1 AD patient and 1 caregiver were assigned to the Dim Light (Control) arm|23
2998304|NCT00946530|3715241|FG000|NOT COMPLETED|Overall Study||1
2998305|NCT00946530|3715242|FG001|NOT COMPLETED|Overall Study||4
2998306|NCT00946530|3715243|FG002|NOT COMPLETED|Overall Study||1
2998307|NCT00946530|3715244|FG003|NOT COMPLETED|Overall Study||4
2998308|NCT00946647|3715263|FG000|STARTED|Phase 1 Part||6
2998309|NCT00946647|3715264|FG001|STARTED|Phase 1 Part||18
2998310|NCT00946647|3715265|FG002|STARTED|Phase 1 Part||7
2998311|NCT00946647|3715266|FG003|STARTED|Phase 1 Part||0
2998312|NCT00946647|3715267|FG004|STARTED|Phase 1 Part||0
2998313|NCT00946647|3715263|FG000|COMPLETED|Phase 1 Part||0
2998314|NCT00946647|3715264|FG001|COMPLETED|Phase 1 Part||0
2998315|NCT00946647|3715265|FG002|COMPLETED|Phase 1 Part||0
2998316|NCT00946647|3715266|FG003|COMPLETED|Phase 1 Part||0
2998317|NCT00946647|3715267|FG004|COMPLETED|Phase 1 Part||0
2998318|NCT00946647|3715263|FG000|NOT COMPLETED|Phase 1 Part||6
2998319|NCT00946647|3715264|FG001|NOT COMPLETED|Phase 1 Part||18
2998320|NCT00946647|3715265|FG002|NOT COMPLETED|Phase 1 Part||7
2998321|NCT00946647|3715266|FG003|NOT COMPLETED|Phase 1 Part||0
2998322|NCT00946647|3715267|FG004|NOT COMPLETED|Phase 1 Part||0
2998323|NCT00946647|3715263|FG000|STARTED|Phase ll Part||0
2998324|NCT00946647|3715264|FG001|STARTED|Phase ll Part||0
2998325|NCT00946647|3715265|FG002|STARTED|Phase ll Part||0
2998326|NCT00946647|3715266|FG003|STARTED|Phase ll Part||40
2998327|NCT00946647|3715267|FG004|STARTED|Phase ll Part||42
2998328|NCT00946647|3715263|FG000|Safety Set|Phase ll Part||0
2998329|NCT00946647|3715264|FG001|Safety Set|Phase ll Part||0
2998330|NCT00946647|3715265|FG002|Safety Set|Phase ll Part||0
2998331|NCT00946647|3715266|FG003|Safety Set|Phase ll Part|2 pts rand. to this grp did not receive PAN|38
2998332|NCT00946647|3715267|FG004|Safety Set|Phase ll Part|2 pts rand. to PAN+5AZA, did not receive PAN but received 5AZA|42
2998333|NCT00946647|3715263|FG000|COMPLETED|Phase ll Part||0
2998334|NCT00946647|3715264|FG001|COMPLETED|Phase ll Part||0
2998335|NCT00946647|3715265|FG002|COMPLETED|Phase ll Part||0
2998336|NCT00946647|3715266|FG003|COMPLETED|Phase ll Part||0
2998337|NCT00946647|3715267|FG004|COMPLETED|Phase ll Part||0
2998338|NCT00946647|3715263|FG000|NOT COMPLETED|Phase ll Part||0
2998339|NCT00946647|3715264|FG001|NOT COMPLETED|Phase ll Part||0
2998340|NCT00946647|3715265|FG002|NOT COMPLETED|Phase ll Part||0
2998341|NCT00946647|3715266|FG003|NOT COMPLETED|Phase ll Part||40
2998342|NCT00946647|3715267|FG004|NOT COMPLETED|Phase ll Part||42
2998343|NCT00946712|3715282|FG000|STARTED|Overall Study||671
2998344|NCT00946712|3715283|FG001|STARTED|Overall Study||662
2998345|NCT00946712|3715282|FG000|COMPLETED|Overall Study||124
2998346|NCT00946712|3715283|FG001|COMPLETED|Overall Study||0
2998347|NCT00946712|3715282|FG000|NOT COMPLETED|Overall Study||547
2998348|NCT00946712|3715283|FG001|NOT COMPLETED|Overall Study||662
2998349|NCT00946881|3715290|FG000|STARTED|First Treatment||30
2998350|NCT00946881|3715290|FG000|COMPLETED|First Treatment||28
2998351|NCT00946881|3715290|FG000|NOT COMPLETED|First Treatment||2
2998352|NCT00946881|3715290|FG000|STARTED|Retreatment||8
2998353|NCT00946881|3715290|FG000|COMPLETED|Retreatment||7
2998354|NCT00946881|3715290|FG000|NOT COMPLETED|Retreatment||1
2998355|NCT00946920|3715317|FG000|STARTED|Overall Study|Received at least one dose of degarelix.|565
2998356|NCT00946920|3715318|FG001|STARTED|Overall Study|Received at least one dose of goserelin acetate.|283
2998357|NCT00946920|3715317|FG000|Full Analysis Set (FAS)|Overall Study|Received at least one dose of degarelix and had at least one post-dosing efficacy assessment.|565
2998358|NCT00946920|3715318|FG001|Full Analysis Set (FAS)|Overall Study|Received at least one dose of goserelin and had at least one post-dosing efficacy assessment.|282
2998359|NCT00946920|3715317|FG000|COMPLETED|Overall Study||455
2998360|NCT00946920|3715318|FG001|COMPLETED|Overall Study||239
2998361|NCT00946920|3715317|FG000|NOT COMPLETED|Overall Study||110
2998362|NCT00946920|3715318|FG001|NOT COMPLETED|Overall Study||44
2998363|NCT00946998|3715326|FG000|STARTED|Overall Study||102
2998364|NCT00946998|3715327|FG001|STARTED|Overall Study||99
2998365|NCT00946998|3715326|FG000|Received Treatment as Randomized|Overall Study||102
2998366|NCT00946998|3715327|FG001|Received Treatment as Randomized|Overall Study||99
2998367|NCT00946998|3715326|FG000|COMPLETED|Overall Study||97
2998368|NCT00946998|3715327|FG001|COMPLETED|Overall Study||96
2998369|NCT00946998|3715326|FG000|NOT COMPLETED|Overall Study||5
2998370|NCT00946998|3715327|FG001|NOT COMPLETED|Overall Study||3
2998371|NCT00947115|3715336|FG000|STARTED|Overall Study||159
2998372|NCT00947115|3715337|FG001|STARTED|Overall Study||194
2998373|NCT00947115|3715338|FG002|STARTED|Overall Study||171
2998374|NCT00947115|3715336|FG000|COMPLETED|Overall Study||142
2998375|NCT00947115|3715337|FG001|COMPLETED|Overall Study||172
2998376|NCT00947115|3715338|FG002|COMPLETED|Overall Study||156
2998377|NCT00947115|3715336|FG000|NOT COMPLETED|Overall Study||17
2998378|NCT00947115|3715337|FG001|NOT COMPLETED|Overall Study||22
2998379|NCT00947115|3715338|FG002|NOT COMPLETED|Overall Study||15
2998380|NCT00947154|3715346|FG000|STARTED|Overall Study||12
2998381|NCT00947154|3715346|FG000|COMPLETED|Overall Study||11
2998382|NCT00947154|3715346|FG000|NOT COMPLETED|Overall Study||1
2998383|NCT00947167|3715351|FG000|STARTED|Pertuzumab Alone||4
2998384|NCT00947167|3715351|FG000|COMPLETED|Pertuzumab Alone||4
2998385|NCT00947167|3715351|FG000|NOT COMPLETED|Pertuzumab Alone||0
2998386|NCT00947167|3715351|FG000|STARTED|Erlotinib Added to Pertuzumab||3
2998387|NCT00947167|3715351|FG000|COMPLETED|Erlotinib Added to Pertuzumab||3
2998388|NCT00947167|3715351|FG000|NOT COMPLETED|Erlotinib Added to Pertuzumab||0
2998389|NCT00947193|3715355|FG000|STARTED|Overall Study||3
2998390|NCT00947193|3715356|FG001|STARTED|Overall Study||10
2998391|NCT00947193|3715355|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
2998392|NCT00947193|3715356|FG001|Received at Least 1 Dose of Study Drug|Overall Study||10
2998393|NCT00947193|3715355|FG000|COMPLETED|Overall Study||0
2998394|NCT00947193|3715356|FG001|COMPLETED|Overall Study||10
2998395|NCT00947193|3715355|FG000|NOT COMPLETED|Overall Study||3
2998396|NCT00947193|3715356|FG001|NOT COMPLETED|Overall Study||0
2998397|NCT00947219|3715364|FG000|STARTED|Overall Study||28
2998398|NCT00947219|3715365|FG001|STARTED|Overall Study||25
2998399|NCT00947219|3715366|FG002|STARTED|Overall Study||26
2998400|NCT00947219|3715364|FG000|COMPLETED|Overall Study||22
2998401|NCT00947219|3715365|FG001|COMPLETED|Overall Study||21
2998402|NCT00947219|3715366|FG002|COMPLETED|Overall Study||22
2998403|NCT00947219|3715364|FG000|NOT COMPLETED|Overall Study||6
2998404|NCT00947219|3715365|FG001|NOT COMPLETED|Overall Study||4
2998405|NCT00947219|3715366|FG002|NOT COMPLETED|Overall Study||4
2998406|NCT00947271|3715378|FG000|STARTED|3 Months Post Intervention||254
2998407|NCT00947271|3715379|FG001|STARTED|3 Months Post Intervention||252
2998408|NCT00947271|3715380|FG002|STARTED|3 Months Post Intervention||254
2998409|NCT00947271|3715381|FG003|STARTED|3 Months Post Intervention||250
2998410|NCT00947271|3715378|FG000|COMPLETED|3 Months Post Intervention||202
2998411|NCT00947271|3715379|FG001|COMPLETED|3 Months Post Intervention||204
2998412|NCT00947271|3715380|FG002|COMPLETED|3 Months Post Intervention||218
2998413|NCT00947271|3715381|FG003|COMPLETED|3 Months Post Intervention||206
2998414|NCT00947271|3715378|FG000|NOT COMPLETED|3 Months Post Intervention||52
2998415|NCT00947271|3715379|FG001|NOT COMPLETED|3 Months Post Intervention||48
2998416|NCT00947271|3715380|FG002|NOT COMPLETED|3 Months Post Intervention||36
2998417|NCT00947271|3715381|FG003|NOT COMPLETED|3 Months Post Intervention||44
2998418|NCT00947271|3715378|FG000|STARTED|6 Months Post Intervention||254
2998419|NCT00947271|3715379|FG001|STARTED|6 Months Post Intervention||252
2998420|NCT00947271|3715380|FG002|STARTED|6 Months Post Intervention||254
2998421|NCT00947271|3715381|FG003|STARTED|6 Months Post Intervention||250
2998422|NCT00947271|3715378|FG000|COMPLETED|6 Months Post Intervention||199
2998423|NCT00947271|3715379|FG001|COMPLETED|6 Months Post Intervention||199
2998424|NCT00947271|3715380|FG002|COMPLETED|6 Months Post Intervention||196
2998425|NCT00947271|3715381|FG003|COMPLETED|6 Months Post Intervention||196
2998426|NCT00947271|3715378|FG000|NOT COMPLETED|6 Months Post Intervention||55
2998427|NCT00947271|3715379|FG001|NOT COMPLETED|6 Months Post Intervention||53
2998428|NCT00947271|3715380|FG002|NOT COMPLETED|6 Months Post Intervention||58
2998429|NCT00947271|3715381|FG003|NOT COMPLETED|6 Months Post Intervention||54
2998430|NCT00947271|3715378|FG000|STARTED|9 Months Post Intervention||254
2998431|NCT00947271|3715379|FG001|STARTED|9 Months Post Intervention||252
2998432|NCT00947271|3715380|FG002|STARTED|9 Months Post Intervention||254
2998433|NCT00947271|3715381|FG003|STARTED|9 Months Post Intervention||250
2998434|NCT00947271|3715378|FG000|COMPLETED|9 Months Post Intervention||184
2998435|NCT00947271|3715379|FG001|COMPLETED|9 Months Post Intervention||192
2998436|NCT00947271|3715380|FG002|COMPLETED|9 Months Post Intervention||193
2998437|NCT00947271|3715381|FG003|COMPLETED|9 Months Post Intervention||191
2998438|NCT00947271|3715378|FG000|NOT COMPLETED|9 Months Post Intervention||70
2998439|NCT00947271|3715379|FG001|NOT COMPLETED|9 Months Post Intervention||60
2998440|NCT00947271|3715380|FG002|NOT COMPLETED|9 Months Post Intervention||61
2998441|NCT00947271|3715381|FG003|NOT COMPLETED|9 Months Post Intervention||59
2998442|NCT00947271|3715378|FG000|STARTED|12 Months Post Intervention||254
2998443|NCT00947271|3715379|FG001|STARTED|12 Months Post Intervention||252
2998444|NCT00947271|3715380|FG002|STARTED|12 Months Post Intervention||254
2998445|NCT00947271|3715381|FG003|STARTED|12 Months Post Intervention||250
2998446|NCT00947271|3715378|FG000|COMPLETED|12 Months Post Intervention||183
2998447|NCT00947271|3715379|FG001|COMPLETED|12 Months Post Intervention||192
2998448|NCT00947271|3715380|FG002|COMPLETED|12 Months Post Intervention||195
2998449|NCT00947271|3715381|FG003|COMPLETED|12 Months Post Intervention||188
2998450|NCT00947271|3715378|FG000|NOT COMPLETED|12 Months Post Intervention||71
2998451|NCT00947271|3715379|FG001|NOT COMPLETED|12 Months Post Intervention||60
2998452|NCT00947271|3715380|FG002|NOT COMPLETED|12 Months Post Intervention||59
2998453|NCT00947271|3715381|FG003|NOT COMPLETED|12 Months Post Intervention||62
2998454|NCT00947297|3715391|FG000|STARTED|Overall Study||60
2998455|NCT00947297|3715391|FG000|COMPLETED|Overall Study||53
2998456|NCT00947297|3715391|FG000|NOT COMPLETED|Overall Study||7
2998457|NCT00947310|3715399|FG000|STARTED|Overall Study||514
2998458|NCT00947310|3715400|FG001|STARTED|Overall Study||500
2998459|NCT00947310|3715401|FG002|STARTED|Overall Study||486
2998460|NCT00947310|3715399|FG000|COMPLETED|Overall Study||514
2998461|NCT00947310|3715400|FG001|COMPLETED|Overall Study||500
2998462|NCT00947310|3715401|FG002|COMPLETED|Overall Study||486
2998463|NCT00947310|3715399|FG000|NOT COMPLETED|Overall Study||0
2998464|NCT00947310|3715400|FG001|NOT COMPLETED|Overall Study||0
2998465|NCT00947310|3715401|FG002|NOT COMPLETED|Overall Study||0
2998466|NCT00947349|3715413|FG000|STARTED|Triple Treatment Combination Period||4
2998467|NCT00947349|3715414|FG001|STARTED|Triple Treatment Combination Period||6
2998468|NCT00947349|3715415|FG002|STARTED|Triple Treatment Combination Period||6
2998469|NCT00947349|3715416|FG003|STARTED|Triple Treatment Combination Period||6
3164800|NCT01895088|3892292|FG000|COMPLETED|Overall Study||253
3164801|NCT01895088|3892292|FG000|NOT COMPLETED|Overall Study||18
3164802|NCT01895101|3892299|FG000|STARTED|Overall Study||250
3164803|NCT01895101|3892300|FG001|STARTED|Overall Study||250
3164804|NCT01895101|3892301|FG002|STARTED|Overall Study||250
3164805|NCT01895101|3892299|FG000|COMPLETED|Overall Study||249
2998470|NCT00947349|3715413|FG000|COMPLETED|Triple Treatment Combination Period||4
2998471|NCT00947349|3715414|FG001|COMPLETED|Triple Treatment Combination Period||5
2998472|NCT00947349|3715415|FG002|COMPLETED|Triple Treatment Combination Period||6
2998473|NCT00947349|3715416|FG003|COMPLETED|Triple Treatment Combination Period||6
2998474|NCT00947349|3715413|FG000|NOT COMPLETED|Triple Treatment Combination Period||0
2998475|NCT00947349|3715414|FG001|NOT COMPLETED|Triple Treatment Combination Period||1
2998476|NCT00947349|3715415|FG002|NOT COMPLETED|Triple Treatment Combination Period||0
2998477|NCT00947349|3715416|FG003|NOT COMPLETED|Triple Treatment Combination Period||0
3164806|NCT01895101|3892300|FG001|COMPLETED|Overall Study||245
3164807|NCT01895101|3892301|FG002|COMPLETED|Overall Study||245
3164808|NCT01895101|3892299|FG000|NOT COMPLETED|Overall Study||1
3164809|NCT01895101|3892300|FG001|NOT COMPLETED|Overall Study||5
3164810|NCT01895101|3892301|FG002|NOT COMPLETED|Overall Study||5
3164811|NCT01895127|3892311|FG000|STARTED|Screening||4
3164812|NCT01895127|3892312|FG001|STARTED|Screening||7
3164813|NCT01895127|3892311|FG000|COMPLETED|Screening|One subject was found to be pregnant at screening so was withdrawn from the study prior to treatment|4
3164814|NCT01895127|3892312|FG001|COMPLETED|Screening||7
3164815|NCT01895127|3892311|FG000|NOT COMPLETED|Screening||0
2998478|NCT00947349|3715413|FG000|STARTED|Overall Study Standard of Care||4
2998479|NCT00947349|3715414|FG001|STARTED|Overall Study Standard of Care||5
2998480|NCT00947349|3715415|FG002|STARTED|Overall Study Standard of Care||6
2998481|NCT00947349|3715416|FG003|STARTED|Overall Study Standard of Care||6
2998482|NCT00947349|3715413|FG000|COMPLETED|Overall Study Standard of Care||4
2998483|NCT00947349|3715414|FG001|COMPLETED|Overall Study Standard of Care||5
2998484|NCT00947349|3715415|FG002|COMPLETED|Overall Study Standard of Care||4
2998485|NCT00947349|3715416|FG003|COMPLETED|Overall Study Standard of Care||4
2998486|NCT00947349|3715413|FG000|NOT COMPLETED|Overall Study Standard of Care||0
2998487|NCT00947349|3715414|FG001|NOT COMPLETED|Overall Study Standard of Care||0
2998488|NCT00947349|3715415|FG002|NOT COMPLETED|Overall Study Standard of Care||2
2998489|NCT00947349|3715416|FG003|NOT COMPLETED|Overall Study Standard of Care||2
2998490|NCT00947427|3715446|FG000|STARTED|Overall Study||22
2998491|NCT00947427|3715447|FG001|STARTED|Overall Study|2 participants discontinued prior to any study drug administration|49
2998492|NCT00947427|3715446|FG000|COMPLETED|Overall Study||21
2998493|NCT00947427|3715447|FG001|COMPLETED|Overall Study||45
2998494|NCT00947427|3715446|FG000|NOT COMPLETED|Overall Study||1
2998495|NCT00947427|3715447|FG001|NOT COMPLETED|Overall Study||4
2998496|NCT00947505|3715455|FG000|STARTED|Overall Study||33
2998497|NCT00947505|3715456|FG001|STARTED|Overall Study||16
2998498|NCT00947505|3715455|FG000|COMPLETED|Overall Study||24
2998499|NCT00947505|3715456|FG001|COMPLETED|Overall Study||14
2998500|NCT00947505|3715455|FG000|NOT COMPLETED|Overall Study||9
2998501|NCT00947505|3715456|FG001|NOT COMPLETED|Overall Study||2
2998502|NCT00947531|3715464|FG000|STARTED|Overall Study||121
2998503|NCT00947531|3715465|FG001|STARTED|Overall Study||121
2998504|NCT00947531|3715464|FG000|COMPLETED|Overall Study||107
2998505|NCT00947531|3715465|FG001|COMPLETED|Overall Study||110
2998506|NCT00947531|3715464|FG000|NOT COMPLETED|Overall Study||14
2998507|NCT00947531|3715465|FG001|NOT COMPLETED|Overall Study||11
2998508|NCT00947544|3715471|FG000|STARTED|Switch-Over Period (2 Weeks)||11
2998509|NCT00947544|3715472|FG001|STARTED|Switch-Over Period (2 Weeks)||0
2998510|NCT00947544|3715471|FG000|COMPLETED|Switch-Over Period (2 Weeks)||11
2998511|NCT00947544|3715472|FG001|COMPLETED|Switch-Over Period (2 Weeks)||0
2998512|NCT00947544|3715471|FG000|NOT COMPLETED|Switch-Over Period (2 Weeks)||0
2998513|NCT00947544|3715472|FG001|NOT COMPLETED|Switch-Over Period (2 Weeks)||0
2998514|NCT00947544|3715471|FG000|STARTED|Safety-Extension Period (12 Months)||11
2998515|NCT00947544|3715472|FG001|STARTED|Safety-Extension Period (12 Months)|New participants were enrolled due to DSMB approval.|6
2998516|NCT00947544|3715471|FG000|COMPLETED|Safety-Extension Period (12 Months)||10
2998517|NCT00947544|3715472|FG001|COMPLETED|Safety-Extension Period (12 Months)||6
2998518|NCT00947544|3715471|FG000|NOT COMPLETED|Safety-Extension Period (12 Months)||1
2998519|NCT00947544|3715472|FG001|NOT COMPLETED|Safety-Extension Period (12 Months)||0
2998520|NCT00947661|3715484|FG000|STARTED|Overall Study||289
2998521|NCT00947661|3715485|FG001|STARTED|Overall Study||289
2998522|NCT00947661|3715484|FG000|COMPLETED|Overall Study||276
2998523|NCT00947661|3715485|FG001|COMPLETED|Overall Study||274
2998524|NCT00947661|3715484|FG000|NOT COMPLETED|Overall Study||13
2998525|NCT00947661|3715485|FG001|NOT COMPLETED|Overall Study||15
2998526|NCT00947752|3715493|FG000|STARTED|7-Day Run-in Treatment Period|All subjects started with a daily does of F1 for 7 days|147
2998527|NCT00947752|3715494|FG001|STARTED|7-Day Run-in Treatment Period||0
2998528|NCT00947752|3715493|FG000|COMPLETED|7-Day Run-in Treatment Period||147
2998529|NCT00947752|3715494|FG001|COMPLETED|7-Day Run-in Treatment Period||0
2998530|NCT00947752|3715493|FG000|NOT COMPLETED|7-Day Run-in Treatment Period||0
2998531|NCT00947752|3715494|FG001|NOT COMPLETED|7-Day Run-in Treatment Period||0
2998532|NCT00947752|3715493|FG000|STARTED|1st 14-day Treatment Period||76
2998533|NCT00947752|3715494|FG001|STARTED|1st 14-day Treatment Period||71
2998534|NCT00947752|3715493|FG000|COMPLETED|1st 14-day Treatment Period||76
2998535|NCT00947752|3715494|FG001|COMPLETED|1st 14-day Treatment Period||71
2998536|NCT00947752|3715493|FG000|NOT COMPLETED|1st 14-day Treatment Period||0
2998537|NCT00947752|3715494|FG001|NOT COMPLETED|1st 14-day Treatment Period||0
2998538|NCT00947752|3715493|FG000|STARTED|Crossover to 2nd 14-day Treatment Period||71
2998539|NCT00947752|3715494|FG001|STARTED|Crossover to 2nd 14-day Treatment Period||76
2998540|NCT00947752|3715493|FG000|COMPLETED|Crossover to 2nd 14-day Treatment Period||71
2998541|NCT00947752|3715494|FG001|COMPLETED|Crossover to 2nd 14-day Treatment Period||76
2998542|NCT00947752|3715493|FG000|NOT COMPLETED|Crossover to 2nd 14-day Treatment Period||0
2998543|NCT00947752|3715494|FG001|NOT COMPLETED|Crossover to 2nd 14-day Treatment Period||0
2998544|NCT00947765|3715502|FG000|STARTED|Overall Study||30
2998545|NCT00947765|3715503|FG001|STARTED|Overall Study||30
2998546|NCT00947765|3715502|FG000|COMPLETED|Overall Study||30
2998547|NCT00947765|3715503|FG001|COMPLETED|Overall Study||30
2998548|NCT00947765|3715502|FG000|NOT COMPLETED|Overall Study||0
2998549|NCT00947765|3715503|FG001|NOT COMPLETED|Overall Study||0
2998550|NCT00947856|3715511|FG000|STARTED|Treatment Period||78
2998551|NCT00947856|3715512|FG001|STARTED|Treatment Period|Two patients in extension arm re-enrolled in retreatment arm and are represented in both arms|32
2998552|NCT00947856|3715511|FG000|COMPLETED|Treatment Period||0
2998553|NCT00947856|3715512|FG001|COMPLETED|Treatment Period|Patients treated until disease progression, unacceptable toxicity or study closure|0
2998554|NCT00947856|3715511|FG000|NOT COMPLETED|Treatment Period||78
2998555|NCT00947856|3715512|FG001|NOT COMPLETED|Treatment Period||32
2998556|NCT00947856|3715511|FG000|STARTED|Follow-up Period||78
2998557|NCT00947856|3715512|FG001|STARTED|Follow-up Period|All participants were followed after treatment; thus, number started will not match number completed|32
2998558|NCT00947856|3715511|FG000|COMPLETED|Follow-up Period||27
2998559|NCT00947856|3715512|FG001|COMPLETED|Follow-up Period|Completed survival follow-up due to death|9
2998560|NCT00947856|3715511|FG000|NOT COMPLETED|Follow-up Period||51
2998561|NCT00947856|3715512|FG001|NOT COMPLETED|Follow-up Period||23
2998562|NCT00947882|3715531|FG000|STARTED|Overall Study|Started: Randomised.|100
2998563|NCT00947882|3715532|FG001|STARTED|Overall Study||101
2998564|NCT00947882|3715533|FG002|STARTED|Overall Study||101
2998565|NCT00947882|3715534|FG003|STARTED|Overall Study||102
2998566|NCT00947882|3715531|FG000|Full Analysis Set (FAS)|Overall Study|FAS: Received a dose of IMP and completed at least one post-baseline IPSS questionnaire.|100
2998567|NCT00947882|3715532|FG001|Full Analysis Set (FAS)|Overall Study||101
2998568|NCT00947882|3715533|FG002|Full Analysis Set (FAS)|Overall Study|1 patient received 20 mg degarelix but had no post-baseline IPSS value and was excluded from the FAS|100
2998569|NCT00947882|3715534|FG003|Full Analysis Set (FAS)|Overall Study||102
2998570|NCT00947882|3715531|FG000|Actual Treatment|Overall Study|2 placebo patients received 30 mg degarelix|98
2998571|NCT00947882|3715532|FG001|Actual Treatment|Overall Study||101
2998572|NCT00947882|3715533|FG002|Actual Treatment|Overall Study|1 patient randomised to 20 mg degarelix received 30 mg degarelix|100
2998573|NCT00947882|3715534|FG003|Actual Treatment|Overall Study||105
2998574|NCT00947882|3715531|FG000|Safety Analysis Set|Overall Study|Safety Analysis Set: Received a dose of Investigational Medicinal Product (IMP).|98
2998575|NCT00947882|3715532|FG001|Safety Analysis Set|Overall Study||101
2998576|NCT00947882|3715533|FG002|Safety Analysis Set|Overall Study||100
2998577|NCT00947882|3715534|FG003|Safety Analysis Set|Overall Study||105
2998578|NCT00947882|3715531|FG000|Visit 12, Month 6|Overall Study|The trial was stopped when all patients had completed Visit 12, scheduled 6 months after the dosing.|93
2998579|NCT00947882|3715532|FG001|Visit 12, Month 6|Overall Study||91
2998580|NCT00947882|3715533|FG002|Visit 12, Month 6|Overall Study||90
2998581|NCT00947882|3715534|FG003|Visit 12, Month 6|Overall Study||95
3036974|NCT01146379|3756257|FG002|NOT COMPLETED|Overall Study||0
2998582|NCT00947882|3715531|FG000|COMPLETED|Overall Study|End of Trial, Month 12: Patients who had completed the 12-month period when the trial was stopped.|26
2998583|NCT00947882|3715532|FG001|COMPLETED|Overall Study||24
2998584|NCT00947882|3715533|FG002|COMPLETED|Overall Study||22
2998585|NCT00947882|3715534|FG003|COMPLETED|Overall Study||20
2998586|NCT00947882|3715531|FG000|NOT COMPLETED|Overall Study||74
2998587|NCT00947882|3715532|FG001|NOT COMPLETED|Overall Study||77
2998588|NCT00947882|3715533|FG002|NOT COMPLETED|Overall Study||79
2998589|NCT00947882|3715534|FG003|NOT COMPLETED|Overall Study||82
2998590|NCT00948025|3715547|FG000|STARTED|Phase 1 (Pilot Phase)||14
2998591|NCT00948025|3715548|FG001|STARTED|Phase 1 (Pilot Phase)||9
2998592|NCT00948025|3715547|FG000|COMPLETED|Phase 1 (Pilot Phase)||5
2998593|NCT00948025|3715548|FG001|COMPLETED|Phase 1 (Pilot Phase)||6
2998594|NCT00948025|3715547|FG000|NOT COMPLETED|Phase 1 (Pilot Phase)||9
2998595|NCT00948025|3715548|FG001|NOT COMPLETED|Phase 1 (Pilot Phase)||3
2998596|NCT00948025|3715547|FG000|STARTED|Phase 2 (Comparative Phase)||0
2998597|NCT00948025|3715548|FG001|STARTED|Phase 2 (Comparative Phase)||0
2998598|NCT00948025|3715547|FG000|COMPLETED|Phase 2 (Comparative Phase)||0
2998599|NCT00948025|3715548|FG001|COMPLETED|Phase 2 (Comparative Phase)||0
2998600|NCT00948025|3715547|FG000|NOT COMPLETED|Phase 2 (Comparative Phase)||0
2998601|NCT00948025|3715548|FG001|NOT COMPLETED|Phase 2 (Comparative Phase)||0
2998602|NCT00948064|3715558|FG000|STARTED|Phase I||31
2998603|NCT00948064|3715559|FG001|STARTED|Phase I||0
2998604|NCT00948064|3715560|FG002|STARTED|Phase I||0
2998605|NCT00948064|3715558|FG000|COMPLETED|Phase I||30
2998606|NCT00948064|3715559|FG001|COMPLETED|Phase I||0
2998607|NCT00948064|3715560|FG002|COMPLETED|Phase I||0
2998608|NCT00948064|3715558|FG000|NOT COMPLETED|Phase I||1
2998609|NCT00948064|3715559|FG001|NOT COMPLETED|Phase I||0
2998610|NCT00948064|3715560|FG002|NOT COMPLETED|Phase I||0
2998611|NCT00948064|3715558|FG000|STARTED|Phase II||0
2998612|NCT00948064|3715559|FG001|STARTED|Phase II||52
2998613|NCT00948064|3715560|FG002|STARTED|Phase II||27
2998614|NCT00948064|3715558|FG000|COMPLETED|Phase II||0
2998615|NCT00948064|3715559|FG001|COMPLETED|Phase II||51
2998616|NCT00948064|3715560|FG002|COMPLETED|Phase II||26
2998617|NCT00948064|3715558|FG000|NOT COMPLETED|Phase II||0
2998618|NCT00948064|3715559|FG001|NOT COMPLETED|Phase II||1
3164816|NCT01895127|3892312|FG001|NOT COMPLETED|Screening||0
3164817|NCT01895127|3892311|FG000|STARTED|Treatment Period (Week 0-Month 3)||3
3164818|NCT01895127|3892312|FG001|STARTED|Treatment Period (Week 0-Month 3)||7
2998619|NCT00948064|3715560|FG002|NOT COMPLETED|Phase II||1
2998620|NCT00948090|3715572|FG000|STARTED|Overall Study||65
2998621|NCT00948090|3715573|FG001|STARTED|Overall Study||1
2998622|NCT00948090|3715574|FG002|STARTED|Overall Study||123
2998623|NCT00948090|3715575|FG003|STARTED|Overall Study||18
2998624|NCT00948090|3715572|FG000|COMPLETED|Overall Study||22
2998625|NCT00948090|3715573|FG001|COMPLETED|Overall Study||0
2998626|NCT00948090|3715574|FG002|COMPLETED|Overall Study||67
2998627|NCT00948090|3715575|FG003|COMPLETED|Overall Study||7
2998628|NCT00948090|3715572|FG000|NOT COMPLETED|Overall Study||43
2998629|NCT00948090|3715573|FG001|NOT COMPLETED|Overall Study||1
2998630|NCT00948090|3715574|FG002|NOT COMPLETED|Overall Study||56
2998631|NCT00948090|3715575|FG003|NOT COMPLETED|Overall Study||11
2998632|NCT00948155|3715584|FG000|STARTED|First Intervention 21 Days||14
2998633|NCT00948155|3715585|FG001|STARTED|First Intervention 21 Days||15
2998634|NCT00948155|3715584|FG000|COMPLETED|First Intervention 21 Days||12
2998635|NCT00948155|3715585|FG001|COMPLETED|First Intervention 21 Days||13
2998636|NCT00948155|3715584|FG000|NOT COMPLETED|First Intervention 21 Days||2
2998637|NCT00948155|3715585|FG001|NOT COMPLETED|First Intervention 21 Days||2
2998638|NCT00948155|3715584|FG000|STARTED|Washout 14 Days||12
2998639|NCT00948155|3715585|FG001|STARTED|Washout 14 Days||13
2998640|NCT00948155|3715584|FG000|COMPLETED|Washout 14 Days||11
2998641|NCT00948155|3715585|FG001|COMPLETED|Washout 14 Days||11
2998642|NCT00948155|3715584|FG000|NOT COMPLETED|Washout 14 Days||1
2998643|NCT00948155|3715585|FG001|NOT COMPLETED|Washout 14 Days||2
2998644|NCT00948155|3715584|FG000|STARTED|Second Intervention 21 Days||11
2998645|NCT00948155|3715585|FG001|STARTED|Second Intervention 21 Days||11
2998646|NCT00948155|3715584|FG000|COMPLETED|Second Intervention 21 Days||9
2998647|NCT00948155|3715585|FG001|COMPLETED|Second Intervention 21 Days||8
2998648|NCT00948155|3715584|FG000|NOT COMPLETED|Second Intervention 21 Days||2
2998649|NCT00948155|3715585|FG001|NOT COMPLETED|Second Intervention 21 Days||3
2998650|NCT00948246|3715593|FG000|STARTED|Overall Study||110
2998651|NCT00948246|3715593|FG000|COMPLETED|Overall Study||86
2998652|NCT00948246|3715593|FG000|NOT COMPLETED|Overall Study||24
2998653|NCT00948298|3715599|FG000|STARTED|Overall Study||65
2998654|NCT00948298|3715600|FG001|STARTED|Overall Study||65
2998655|NCT00948298|3715599|FG000|COMPLETED|Overall Study||55
2998656|NCT00948298|3715600|FG001|COMPLETED|Overall Study||60
2998657|NCT00948298|3715599|FG000|NOT COMPLETED|Overall Study||10
2998658|NCT00948298|3715600|FG001|NOT COMPLETED|Overall Study||5
2998659|NCT00948389|3715611|FG000|STARTED|Overall Study||6
2998660|NCT00948389|3715612|FG001|STARTED|Overall Study||3
2998661|NCT00948389|3715613|FG002|STARTED|Overall Study||7
2998662|NCT00948389|3715614|FG003|STARTED|Overall Study||9
2998663|NCT00948389|3715615|FG004|STARTED|Overall Study||1
2998664|NCT00948389|3715611|FG000|COMPLETED|Overall Study||0
2998665|NCT00948389|3715612|FG001|COMPLETED|Overall Study||0
2998666|NCT00948389|3715613|FG002|COMPLETED|Overall Study||0
2998667|NCT00948389|3715614|FG003|COMPLETED|Overall Study||0
2998668|NCT00948389|3715615|FG004|COMPLETED|Overall Study||0
2998669|NCT00948389|3715611|FG000|NOT COMPLETED|Overall Study||6
2998670|NCT00948389|3715612|FG001|NOT COMPLETED|Overall Study||3
2998671|NCT00948389|3715613|FG002|NOT COMPLETED|Overall Study||7
3164819|NCT01895127|3892311|FG000|COMPLETED|Treatment Period (Week 0-Month 3)||3
3164820|NCT01895127|3892312|FG001|COMPLETED|Treatment Period (Week 0-Month 3)||7
3164821|NCT01895127|3892311|FG000|NOT COMPLETED|Treatment Period (Week 0-Month 3)||0
3164822|NCT01895127|3892312|FG001|NOT COMPLETED|Treatment Period (Week 0-Month 3)||0
3164823|NCT01895127|3892311|FG000|STARTED|Month 3 Follow-up & Biopsy||3
3164824|NCT01895127|3892312|FG001|STARTED|Month 3 Follow-up & Biopsy||7
3164825|NCT01895127|3892311|FG000|COMPLETED|Month 3 Follow-up & Biopsy||3
3164826|NCT01895127|3892312|FG001|COMPLETED|Month 3 Follow-up & Biopsy||7
2998672|NCT00948389|3715614|FG003|NOT COMPLETED|Overall Study||9
2998673|NCT00948389|3715615|FG004|NOT COMPLETED|Overall Study||1
2998674|NCT00948428|3715632|FG000|STARTED|Overall Study||185
2998675|NCT00948428|3715633|FG001|STARTED|Overall Study||185
2998676|NCT00948428|3715634|FG002|STARTED|Overall Study||92
2998677|NCT00948428|3715632|FG000|COMPLETED|Overall Study||167
2998678|NCT00948428|3715633|FG001|COMPLETED|Overall Study||167
2998679|NCT00948428|3715634|FG002|COMPLETED|Overall Study||84
2998680|NCT00948428|3715632|FG000|NOT COMPLETED|Overall Study||18
2998681|NCT00948428|3715633|FG001|NOT COMPLETED|Overall Study||18
2998682|NCT00948428|3715634|FG002|NOT COMPLETED|Overall Study||8
2998683|NCT00948441|3715644|FG000|STARTED|Overall Study||8
2998684|NCT00948441|3715645|FG001|STARTED|Overall Study||8
3164827|NCT01895127|3892311|FG000|NOT COMPLETED|Month 3 Follow-up & Biopsy||0
3164828|NCT01895127|3892312|FG001|NOT COMPLETED|Month 3 Follow-up & Biopsy||0
2998685|NCT00948441|3715644|FG000|COMPLETED|Overall Study||7
2998686|NCT00948441|3715645|FG001|COMPLETED|Overall Study||4
2998687|NCT00948441|3715644|FG000|NOT COMPLETED|Overall Study||1
2998688|NCT00948441|3715645|FG001|NOT COMPLETED|Overall Study||4
2998689|NCT00948506|3715655|FG000|STARTED|Overall Study||11
2998690|NCT00948506|3715656|FG001|STARTED|Overall Study||9
2998691|NCT00948506|3715655|FG000|COMPLETED|Overall Study||8
2998692|NCT00948506|3715656|FG001|COMPLETED|Overall Study||8
2998693|NCT00948506|3715655|FG000|NOT COMPLETED|Overall Study||3
2998694|NCT00948506|3715656|FG001|NOT COMPLETED|Overall Study||1
2998695|NCT00948610|3715667|FG000|STARTED|Overall Study||10
2998696|NCT00948610|3715668|FG001|STARTED|Overall Study||10
2998697|NCT00948610|3715667|FG000|COMPLETED|Overall Study||9
2998698|NCT00948610|3715668|FG001|COMPLETED|Overall Study||9
2998699|NCT00948610|3715667|FG000|NOT COMPLETED|Overall Study||1
2998700|NCT00948610|3715668|FG001|NOT COMPLETED|Overall Study||1
2998701|NCT00948675|3715676|FG000|STARTED|Overall Study||182
2998702|NCT00948675|3715677|FG001|STARTED|Overall Study||179
2998703|NCT00948675|3715676|FG000|Received Any Amount of Study Drug|Overall Study||171
2998704|NCT00948675|3715677|FG001|Received Any Amount of Study Drug|Overall Study||166
2998705|NCT00948675|3715676|FG000|COMPLETED|Overall Study||181
2998706|NCT00948675|3715677|FG001|COMPLETED|Overall Study||179
2998707|NCT00948675|3715676|FG000|NOT COMPLETED|Overall Study||1
2998708|NCT00948675|3715677|FG001|NOT COMPLETED|Overall Study||0
2998709|NCT00948688|3715683|FG000|STARTED|Period 1: 200 mg Vorinostat||4
2998710|NCT00948688|3715684|FG001|STARTED|Period 1: 200 mg Vorinostat||0
2998711|NCT00948688|3715683|FG000|COMPLETED|Period 1: 200 mg Vorinostat||2
2998712|NCT00948688|3715684|FG001|COMPLETED|Period 1: 200 mg Vorinostat||0
2998713|NCT00948688|3715683|FG000|NOT COMPLETED|Period 1: 200 mg Vorinostat||2
2998714|NCT00948688|3715684|FG001|NOT COMPLETED|Period 1: 200 mg Vorinostat||0
2998715|NCT00948688|3715683|FG000|STARTED|Period 2: 100 mg Vorinostat||0
2998716|NCT00948688|3715684|FG001|STARTED|Period 2: 100 mg Vorinostat||6
2998717|NCT00948688|3715683|FG000|COMPLETED|Period 2: 100 mg Vorinostat||0
2998718|NCT00948688|3715684|FG001|COMPLETED|Period 2: 100 mg Vorinostat||5
2998719|NCT00948688|3715683|FG000|NOT COMPLETED|Period 2: 100 mg Vorinostat||0
2998720|NCT00948688|3715684|FG001|NOT COMPLETED|Period 2: 100 mg Vorinostat||1
2998721|NCT00948766|3715693|FG000|STARTED|Core Study||356
2998722|NCT00948766|3715694|FG001|STARTED|Core Study||360
2998723|NCT00948766|3715693|FG000|Exposed to Study Medication|Core Study||355
2998724|NCT00948766|3715694|FG001|Exposed to Study Medication|Core Study||359
2998725|NCT00948766|3715693|FG000|COMPLETED|Core Study||229
2998726|NCT00948766|3715694|FG001|COMPLETED|Core Study||234
2998727|NCT00948766|3715693|FG000|NOT COMPLETED|Core Study||127
2998728|NCT00948766|3715694|FG001|NOT COMPLETED|Core Study||126
2998729|NCT00948766|3715693|FG000|STARTED|Extension Study|397 of the 463 patients who completed the core study entered the extension study.|397
2998730|NCT00948766|3715694|FG001|STARTED|Extension Study|No patients received this treatment in the extension study.|0
2998731|NCT00948766|3715693|FG000|Exposed to Study Medication|Extension Study||396
2998732|NCT00948766|3715694|FG001|Exposed to Study Medication|Extension Study||0
2998733|NCT00948766|3715693|FG000|COMPLETED|Extension Study||306
2998734|NCT00948766|3715694|FG001|COMPLETED|Extension Study||0
2998735|NCT00948766|3715693|FG000|NOT COMPLETED|Extension Study||91
2998736|NCT00948766|3715694|FG001|NOT COMPLETED|Extension Study||0
2998737|NCT00948792|3715701|FG000|STARTED|Overall Study||21
2998738|NCT00948792|3715701|FG000|COMPLETED|Overall Study||21
2998739|NCT00948792|3715701|FG000|NOT COMPLETED|Overall Study||0
2998740|NCT00948818|3715709|FG000|STARTED|Overall Study||397
2998741|NCT00948818|3715710|FG001|STARTED|Overall Study||406
2998742|NCT00948818|3715709|FG000|COMPLETED|Overall Study||335
2998743|NCT00948818|3715710|FG001|COMPLETED|Overall Study||312
2998744|NCT00948818|3715709|FG000|NOT COMPLETED|Overall Study||62
2998745|NCT00948818|3715710|FG001|NOT COMPLETED|Overall Study||94
2998746|NCT00948857|3715721|FG000|STARTED|Overall Study||3
2998747|NCT00948857|3715722|FG001|STARTED|Overall Study||2
2998748|NCT00948857|3715721|FG000|COMPLETED|Overall Study|3 completed and 1 dropped out.|2
2998749|NCT00948857|3715722|FG001|COMPLETED|Overall Study||2
2998750|NCT00948857|3715721|FG000|NOT COMPLETED|Overall Study||1
2998751|NCT00948857|3715722|FG001|NOT COMPLETED|Overall Study||0
2998752|NCT00948896|3715736|FG000|STARTED|Randomization to 24 Months of Age||98
2998753|NCT00948896|3715737|FG001|STARTED|Randomization to 24 Months of Age||98
2998754|NCT00948896|3715738|FG002|STARTED|Randomization to 24 Months of Age||99
2998755|NCT00948896|3715739|FG003|STARTED|Randomization to 24 Months of Age||98
2998756|NCT00948896|3715740|FG004|STARTED|Randomization to 24 Months of Age||46
2998757|NCT00948896|3715741|FG005|STARTED|Randomization to 24 Months of Age||46
2998758|NCT00948896|3715742|FG006|STARTED|Randomization to 24 Months of Age||47
2998759|NCT00948896|3715743|FG007|STARTED|Randomization to 24 Months of Age||47
2998760|NCT00948896|3715736|FG000|COMPLETED|Randomization to 24 Months of Age||90
2998761|NCT00948896|3715737|FG001|COMPLETED|Randomization to 24 Months of Age||85
2998762|NCT00948896|3715738|FG002|COMPLETED|Randomization to 24 Months of Age||90
2998763|NCT00948896|3715739|FG003|COMPLETED|Randomization to 24 Months of Age||87
2998764|NCT00948896|3715740|FG004|COMPLETED|Randomization to 24 Months of Age||44
2998765|NCT00948896|3715741|FG005|COMPLETED|Randomization to 24 Months of Age||42
2998766|NCT00948896|3715742|FG006|COMPLETED|Randomization to 24 Months of Age||43
2998767|NCT00948896|3715743|FG007|COMPLETED|Randomization to 24 Months of Age||45
2998768|NCT00948896|3715736|FG000|NOT COMPLETED|Randomization to 24 Months of Age||8
3164829|NCT01895127|3892311|FG000|STARTED|Long Term Follow-up (Month 3-12)||3
3164830|NCT01895127|3892312|FG001|STARTED|Long Term Follow-up (Month 3-12)||7
3164831|NCT01895127|3892311|FG000|COMPLETED|Long Term Follow-up (Month 3-12)||1
3164832|NCT01895127|3892312|FG001|COMPLETED|Long Term Follow-up (Month 3-12)||4
3164833|NCT01895127|3892311|FG000|NOT COMPLETED|Long Term Follow-up (Month 3-12)||2
3164834|NCT01895127|3892312|FG001|NOT COMPLETED|Long Term Follow-up (Month 3-12)||3
2998769|NCT00948896|3715737|FG001|NOT COMPLETED|Randomization to 24 Months of Age||13
2998770|NCT00948896|3715738|FG002|NOT COMPLETED|Randomization to 24 Months of Age||9
2998771|NCT00948896|3715739|FG003|NOT COMPLETED|Randomization to 24 Months of Age||11
2998772|NCT00948896|3715740|FG004|NOT COMPLETED|Randomization to 24 Months of Age||2
2998773|NCT00948896|3715741|FG005|NOT COMPLETED|Randomization to 24 Months of Age||4
2998774|NCT00948896|3715742|FG006|NOT COMPLETED|Randomization to 24 Months of Age||4
2998775|NCT00948896|3715743|FG007|NOT COMPLETED|Randomization to 24 Months of Age||2
2998776|NCT00948896|3715736|FG000|STARTED|24 Months of Age to 36 Months of Age||90
2998777|NCT00948896|3715737|FG001|STARTED|24 Months of Age to 36 Months of Age||85
2998778|NCT00948896|3715738|FG002|STARTED|24 Months of Age to 36 Months of Age||90
2998779|NCT00948896|3715739|FG003|STARTED|24 Months of Age to 36 Months of Age||87
2998780|NCT00948896|3715740|FG004|STARTED|24 Months of Age to 36 Months of Age||44
2998781|NCT00948896|3715741|FG005|STARTED|24 Months of Age to 36 Months of Age||42
2998782|NCT00948896|3715742|FG006|STARTED|24 Months of Age to 36 Months of Age||43
2998783|NCT00948896|3715743|FG007|STARTED|24 Months of Age to 36 Months of Age||45
2998784|NCT00948896|3715736|FG000|COMPLETED|24 Months of Age to 36 Months of Age||87
2998785|NCT00948896|3715737|FG001|COMPLETED|24 Months of Age to 36 Months of Age||83
2998786|NCT00948896|3715738|FG002|COMPLETED|24 Months of Age to 36 Months of Age||85
2998787|NCT00948896|3715739|FG003|COMPLETED|24 Months of Age to 36 Months of Age||85
2998788|NCT00948896|3715740|FG004|COMPLETED|24 Months of Age to 36 Months of Age||43
2998789|NCT00948896|3715741|FG005|COMPLETED|24 Months of Age to 36 Months of Age||40
2998790|NCT00948896|3715742|FG006|COMPLETED|24 Months of Age to 36 Months of Age||43
2998791|NCT00948896|3715743|FG007|COMPLETED|24 Months of Age to 36 Months of Age||45
2998792|NCT00948896|3715736|FG000|NOT COMPLETED|24 Months of Age to 36 Months of Age||3
2998793|NCT00948896|3715737|FG001|NOT COMPLETED|24 Months of Age to 36 Months of Age||2
2998794|NCT00948896|3715738|FG002|NOT COMPLETED|24 Months of Age to 36 Months of Age||5
2998795|NCT00948896|3715739|FG003|NOT COMPLETED|24 Months of Age to 36 Months of Age||2
2998796|NCT00948896|3715740|FG004|NOT COMPLETED|24 Months of Age to 36 Months of Age||1
2998797|NCT00948896|3715741|FG005|NOT COMPLETED|24 Months of Age to 36 Months of Age||2
2998798|NCT00948896|3715742|FG006|NOT COMPLETED|24 Months of Age to 36 Months of Age||0
2998799|NCT00948896|3715743|FG007|NOT COMPLETED|24 Months of Age to 36 Months of Age||0
2998800|NCT00948922|3715768|FG000|STARTED|Overall Study||34
2998801|NCT00948922|3715769|FG001|STARTED|Overall Study||51
2998802|NCT00948922|3715770|FG002|STARTED|Overall Study||39
2998803|NCT00948922|3715768|FG000|COMPLETED|Overall Study||26
2998804|NCT00948922|3715769|FG001|COMPLETED|Overall Study||37
2998805|NCT00948922|3715770|FG002|COMPLETED|Overall Study||38
2998806|NCT00948922|3715768|FG000|NOT COMPLETED|Overall Study||8
2998807|NCT00948922|3715769|FG001|NOT COMPLETED|Overall Study||14
2998808|NCT00948922|3715770|FG002|NOT COMPLETED|Overall Study||1
2998809|NCT00948935|3715782|FG000|STARTED|Overall Study||35
2998810|NCT00948935|3715782|FG000|COMPLETED|Overall Study||35
2998811|NCT00948935|3715782|FG000|NOT COMPLETED|Overall Study||0
2998812|NCT00948974|3715788|FG000|STARTED|Overall Study||40
2998813|NCT00948974|3715789|FG001|STARTED|Overall Study||48
2998814|NCT00948974|3715788|FG000|COMPLETED|Overall Study||17
2998815|NCT00948974|3715789|FG001|COMPLETED|Overall Study||28
2998816|NCT00948974|3715788|FG000|NOT COMPLETED|Overall Study||23
2998817|NCT00948974|3715789|FG001|NOT COMPLETED|Overall Study||20
2998818|NCT00949078|3715797|FG000|STARTED|Overall Study||5
2998819|NCT00949078|3715798|FG001|STARTED|Overall Study||9
2998820|NCT00949078|3715797|FG000|COMPLETED|Overall Study||5
2998821|NCT00949078|3715798|FG001|COMPLETED|Overall Study||9
2998822|NCT00949078|3715797|FG000|NOT COMPLETED|Overall Study||0
2998823|NCT00949078|3715798|FG001|NOT COMPLETED|Overall Study||0
2998824|NCT00949117|3715806|FG000|STARTED|Overall Study||4
2998825|NCT00949117|3715807|FG001|STARTED|Overall Study||5
2998826|NCT00949117|3715806|FG000|COMPLETED|Overall Study||1
2998827|NCT00949117|3715807|FG001|COMPLETED|Overall Study||0
2998828|NCT00949117|3715806|FG000|NOT COMPLETED|Overall Study||3
2998829|NCT00949117|3715807|FG001|NOT COMPLETED|Overall Study||5
2998830|NCT00949234|3715815|FG000|STARTED|Overall Study||267
2998831|NCT00949234|3715815|FG000|COMPLETED|Overall Study||225
2998832|NCT00949234|3715815|FG000|NOT COMPLETED|Overall Study||42
2998833|NCT00949325|3715819|FG000|STARTED|Overall Study||3
2998834|NCT00949325|3715820|FG001|STARTED|Overall Study||18
2998835|NCT00949325|3715821|FG002|STARTED|Overall Study||3
2998836|NCT00949325|3715819|FG000|COMPLETED|Overall Study||3
2998837|NCT00949325|3715820|FG001|COMPLETED|Overall Study||16
2998838|NCT00949325|3715821|FG002|COMPLETED|Overall Study||3
2998839|NCT00949325|3715819|FG000|NOT COMPLETED|Overall Study||0
2998840|NCT00949325|3715820|FG001|NOT COMPLETED|Overall Study||2
2998841|NCT00949325|3715821|FG002|NOT COMPLETED|Overall Study||0
2998842|NCT00949533|3715839|FG000|STARTED|Overall Study||19
2998843|NCT00949533|3715840|FG001|STARTED|Overall Study||18
2998844|NCT00949533|3715839|FG000|COMPLETED|Overall Study||19
2998845|NCT00949533|3715840|FG001|COMPLETED|Overall Study||17
2998846|NCT00949533|3715839|FG000|NOT COMPLETED|Overall Study||0
2998847|NCT00949533|3715840|FG001|NOT COMPLETED|Overall Study||1
2998848|NCT00949650|3715848|FG000|STARTED|Overall Study|Treated patients.|230
2998849|NCT00949650|3715849|FG001|STARTED|Overall Study|Treated patients.|115
2998850|NCT00949650|3715848|FG000|COMPLETED|Overall Study|On treatment at the cut-off date 17MAR2017.|0
2998851|NCT00949650|3715849|FG001|COMPLETED|Overall Study||0
2998852|NCT00949650|3715848|FG000|NOT COMPLETED|Overall Study||230
2998853|NCT00949650|3715849|FG001|NOT COMPLETED|Overall Study||115
2998854|NCT00949702|3715859|FG000|STARTED|Overall Study||132
2998855|NCT00949702|3715859|FG000|COMPLETED|Overall Study||84
2998856|NCT00949702|3715859|FG000|NOT COMPLETED|Overall Study||48
2998857|NCT00949715|3715865|FG000|STARTED|Overall Study||32
2998858|NCT00949715|3715866|FG001|STARTED|Overall Study||33
2998859|NCT00949715|3715865|FG000|COMPLETED|Overall Study||28
2998860|NCT00949715|3715866|FG001|COMPLETED|Overall Study||33
2998861|NCT00949715|3715865|FG000|NOT COMPLETED|Overall Study||4
2998862|NCT00949715|3715866|FG001|NOT COMPLETED|Overall Study||0
2998863|NCT00949884|3715874|FG000|STARTED|Overall Study||420
2998864|NCT00949884|3715875|FG001|STARTED|Overall Study||52
2998865|NCT00949884|3715876|FG002|STARTED|Overall Study||469
2998866|NCT00949884|3715874|FG000|COMPLETED|Overall Study||370
2998867|NCT00949884|3715875|FG001|COMPLETED|Overall Study||37
2998868|NCT00949884|3715876|FG002|COMPLETED|Overall Study||411
2998869|NCT00949884|3715874|FG000|NOT COMPLETED|Overall Study||50
2998870|NCT00949884|3715875|FG001|NOT COMPLETED|Overall Study||15
2998871|NCT00949884|3715876|FG002|NOT COMPLETED|Overall Study||58
2998872|NCT00949910|3715885|FG000|STARTED|Overall Study||6586
2998873|NCT00949910|3715885|FG000|COMPLETED|Overall Study||10
2998874|NCT00949910|3715885|FG000|NOT COMPLETED|Overall Study||6576
2998875|NCT00949975|3715893|FG000|STARTED|Overall Study||212
2998876|NCT00949975|3715894|FG001|STARTED|Overall Study||206
2998877|NCT00949975|3715895|FG002|STARTED|Overall Study||202
2998878|NCT00949975|3715896|FG003|STARTED|Overall Study||218
2998879|NCT00949975|3715893|FG000|COMPLETED|Overall Study||185
2998880|NCT00949975|3715894|FG001|COMPLETED|Overall Study||177
2998881|NCT00949975|3715895|FG002|COMPLETED|Overall Study||183
2998882|NCT00949975|3715896|FG003|COMPLETED|Overall Study||190
2998883|NCT00949975|3715893|FG000|NOT COMPLETED|Overall Study||27
2998884|NCT00949975|3715894|FG001|NOT COMPLETED|Overall Study||29
2998885|NCT00949975|3715895|FG002|NOT COMPLETED|Overall Study||19
2998886|NCT00949975|3715896|FG003|NOT COMPLETED|Overall Study||28
2998887|NCT00950170|3715906|FG000|STARTED|Overall Study||23
2998888|NCT00950170|3715906|FG000|COMPLETED|Overall Study||19
2998889|NCT00950170|3715906|FG000|NOT COMPLETED|Overall Study||4
2998890|NCT00950235|3715930|FG000|STARTED|Overall Study||60
2998891|NCT00950235|3715931|FG001|STARTED|Overall Study||58
2998892|NCT00950235|3715930|FG000|COMPLETED|Overall Study||58
2998893|NCT00950235|3715931|FG001|COMPLETED|Overall Study||54
2998894|NCT00950235|3715930|FG000|NOT COMPLETED|Overall Study||2
2998895|NCT00950235|3715931|FG001|NOT COMPLETED|Overall Study||4
2998896|NCT00950248|3715939|FG000|STARTED|Year 1: Baseline||85
2998897|NCT00950248|3715940|FG001|STARTED|Year 1: Baseline||0
2998898|NCT00950248|3715941|FG002|STARTED|Year 1: Baseline||0
2998899|NCT00950248|3715939|FG000|COMPLETED|Year 1: Baseline||77
2998900|NCT00950248|3715940|FG001|COMPLETED|Year 1: Baseline||0
2998901|NCT00950248|3715941|FG002|COMPLETED|Year 1: Baseline||0
2998902|NCT00950248|3715939|FG000|NOT COMPLETED|Year 1: Baseline||8
2998903|NCT00950248|3715940|FG001|NOT COMPLETED|Year 1: Baseline||0
2998904|NCT00950248|3715941|FG002|NOT COMPLETED|Year 1: Baseline||0
2998905|NCT00950248|3715939|FG000|STARTED|Year 2&3 Treatment Randomization||0
2998906|NCT00950248|3715940|FG001|STARTED|Year 2&3 Treatment Randomization||39
2998907|NCT00950248|3715941|FG002|STARTED|Year 2&3 Treatment Randomization||38
2998908|NCT00950248|3715939|FG000|COMPLETED|Year 2&3 Treatment Randomization||0
2998909|NCT00950248|3715940|FG001|COMPLETED|Year 2&3 Treatment Randomization||33
2998910|NCT00950248|3715941|FG002|COMPLETED|Year 2&3 Treatment Randomization||33
2998911|NCT00950248|3715939|FG000|NOT COMPLETED|Year 2&3 Treatment Randomization||0
2998912|NCT00950248|3715940|FG001|NOT COMPLETED|Year 2&3 Treatment Randomization||6
2998913|NCT00950248|3715941|FG002|NOT COMPLETED|Year 2&3 Treatment Randomization||5
2998914|NCT00950300|3715950|FG000|STARTED|Neoadjuvant/Adjuvant Treatment Periods||299
2998915|NCT00950300|3715951|FG001|STARTED|Neoadjuvant/Adjuvant Treatment Periods||297
2998916|NCT00950300|3715950|FG000|Received Neoadjuvant Treatment|Neoadjuvant/Adjuvant Treatment Periods||298
2998917|NCT00950300|3715951|FG001|Received Neoadjuvant Treatment|Neoadjuvant/Adjuvant Treatment Periods||297
2998918|NCT00950300|3715950|FG000|Underwent Surgery|Neoadjuvant/Adjuvant Treatment Periods||277
2998919|NCT00950300|3715951|FG001|Underwent Surgery|Neoadjuvant/Adjuvant Treatment Periods||273
2998920|NCT00950300|3715950|FG000|Entered Adjuvant Treatment|Neoadjuvant/Adjuvant Treatment Periods||277
2998921|NCT00950300|3715951|FG001|Entered Adjuvant Treatment|Neoadjuvant/Adjuvant Treatment Periods||274
2998922|NCT00950300|3715950|FG000|COMPLETED|Neoadjuvant/Adjuvant Treatment Periods||257
2998923|NCT00950300|3715951|FG001|COMPLETED|Neoadjuvant/Adjuvant Treatment Periods||255
2998924|NCT00950300|3715950|FG000|NOT COMPLETED|Neoadjuvant/Adjuvant Treatment Periods||42
2998925|NCT00950300|3715951|FG001|NOT COMPLETED|Neoadjuvant/Adjuvant Treatment Periods||42
2998926|NCT00950300|3715950|FG000|STARTED|TFFU Period|Participants could withdraw from the study entirely or advance directly to the TFFU or SFU Period.|265
2998927|NCT00950300|3715951|FG001|STARTED|TFFU Period|Participants could withdraw from the study entirely or advance directly to the TFFU or SFU Period.|268
2998928|NCT00950300|3715950|FG000|COMPLETED|TFFU Period|Includes participants who completed either 2 years of follow-up or 5 years of follow-up.|165
2998929|NCT00950300|3715951|FG001|COMPLETED|TFFU Period|Includes participants who completed either 2 years of follow-up or 5 years of follow-up.|161
2998930|NCT00950300|3715950|FG000|NOT COMPLETED|TFFU Period||100
2998931|NCT00950300|3715951|FG001|NOT COMPLETED|TFFU Period||107
2998932|NCT00950300|3715950|FG000|STARTED|SFU Period|Participants could withdraw from the study entirely or advance directly to the SFU Period.|118
2998933|NCT00950300|3715951|FG001|STARTED|SFU Period|Participants could withdraw from the study entirely or advance directly to the SFU Period.|123
2998934|NCT00950300|3715950|FG000|COMPLETED|SFU Period|Includes participants who completed either 2 years of follow-up or 5 years of follow-up.|40
2998935|NCT00950300|3715951|FG001|COMPLETED|SFU Period|Includes participants who completed either 2 years of follow-up or 5 years of follow-up.|45
2998936|NCT00950300|3715950|FG000|NOT COMPLETED|SFU Period||78
2998937|NCT00950300|3715951|FG001|NOT COMPLETED|SFU Period||78
2998938|NCT00950352|3715960|FG000|STARTED|Overall Study||72
2998939|NCT00950352|3715961|FG001|STARTED|Overall Study||32
2998940|NCT00950352|3715960|FG000|COMPLETED|Overall Study||30
2998941|NCT00950352|3715961|FG001|COMPLETED|Overall Study||21
2998942|NCT00950352|3715960|FG000|NOT COMPLETED|Overall Study||42
2998943|NCT00950352|3715961|FG001|NOT COMPLETED|Overall Study||11
2998944|NCT00950365|3715969|FG000|STARTED|Overall Study||27
2998945|NCT00950365|3715970|FG001|STARTED|Overall Study||52
2998946|NCT00950365|3715969|FG000|COMPLETED|Overall Study||25
2998947|NCT00950365|3715970|FG001|COMPLETED|Overall Study||50
2998948|NCT00950365|3715969|FG000|NOT COMPLETED|Overall Study||2
2998949|NCT00950365|3715970|FG001|NOT COMPLETED|Overall Study||2
2998950|NCT00950599|3715984|FG000|STARTED|Double-Blind Treatment Period||55
2998951|NCT00950599|3715985|FG001|STARTED|Double-Blind Treatment Period||47
2998952|NCT00950599|3715986|FG002|STARTED|Double-Blind Treatment Period||63
2998953|NCT00950599|3715987|FG003|STARTED|Double-Blind Treatment Period||54
2998954|NCT00950599|3715988|FG004|STARTED|Double-Blind Treatment Period||52
2998955|NCT00950599|3715989|FG005|STARTED|Double-Blind Treatment Period||67
2998956|NCT00950599|3715990|FG006|STARTED|Double-Blind Treatment Period||44
2998957|NCT00950599|3715991|FG007|STARTED|Double-Blind Treatment Period||41
2998958|NCT00950599|3715992|FG008|STARTED|Double-Blind Treatment Period||0
2998959|NCT00950599|3715993|FG009|STARTED|Double-Blind Treatment Period||0
2998960|NCT00950599|3715984|FG000|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|48
2998961|NCT00950599|3715985|FG001|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|37
2998962|NCT00950599|3715986|FG002|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|54
2998963|NCT00950599|3715987|FG003|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|43
2998964|NCT00950599|3715988|FG004|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|45
2998965|NCT00950599|3715989|FG005|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|55
2998966|NCT00950599|3715990|FG006|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|44
2998967|NCT00950599|3715991|FG007|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|35
2998968|NCT00950599|3715992|FG008|COMPLETED|Double-Blind Treatment Period||0
2998969|NCT00950599|3715993|FG009|COMPLETED|Double-Blind Treatment Period||0
2998970|NCT00950599|3715984|FG000|NOT COMPLETED|Double-Blind Treatment Period||7
2998971|NCT00950599|3715985|FG001|NOT COMPLETED|Double-Blind Treatment Period||10
2998972|NCT00950599|3715986|FG002|NOT COMPLETED|Double-Blind Treatment Period||9
2998973|NCT00950599|3715987|FG003|NOT COMPLETED|Double-Blind Treatment Period||11
2998974|NCT00950599|3715988|FG004|NOT COMPLETED|Double-Blind Treatment Period||7
2998975|NCT00950599|3715989|FG005|NOT COMPLETED|Double-Blind Treatment Period||12
2998976|NCT00950599|3715990|FG006|NOT COMPLETED|Double-Blind Treatment Period||0
2998977|NCT00950599|3715991|FG007|NOT COMPLETED|Double-Blind Treatment Period||6
2998978|NCT00950599|3715992|FG008|NOT COMPLETED|Double-Blind Treatment Period||0
2998979|NCT00950599|3715993|FG009|NOT COMPLETED|Double-Blind Treatment Period||0
2998980|NCT00950599|3715984|FG000|STARTED|Follow-Up Period||0
2998981|NCT00950599|3715985|FG001|STARTED|Follow-Up Period||0
2998982|NCT00950599|3715986|FG002|STARTED|Follow-Up Period||0
2998983|NCT00950599|3715987|FG003|STARTED|Follow-Up Period||0
2998984|NCT00950599|3715988|FG004|STARTED|Follow-Up Period||0
2998985|NCT00950599|3715989|FG005|STARTED|Follow-Up Period||0
2998986|NCT00950599|3715990|FG006|STARTED|Follow-Up Period||0
2998987|NCT00950599|3715991|FG007|STARTED|Follow-Up Period||0
2998988|NCT00950599|3715992|FG008|STARTED|Follow-Up Period|those completing double blind period (DB) + those rescued/discontinued from DB due to hyperglycemia|309
2998989|NCT00950599|3715993|FG009|STARTED|Follow-Up Period|those completing double blind period (DB) + those rescued/discontinued from DB due to hyperglycemia|80
2998990|NCT00950599|3715984|FG000|COMPLETED|Follow-Up Period||0
2998991|NCT00950599|3715985|FG001|COMPLETED|Follow-Up Period||0
2998992|NCT00950599|3715986|FG002|COMPLETED|Follow-Up Period||0
2998993|NCT00950599|3715987|FG003|COMPLETED|Follow-Up Period||0
2998994|NCT00950599|3715988|FG004|COMPLETED|Follow-Up Period||0
2998995|NCT00950599|3715989|FG005|COMPLETED|Follow-Up Period||0
2998996|NCT00950599|3715990|FG006|COMPLETED|Follow-Up Period||0
2998997|NCT00950599|3715991|FG007|COMPLETED|Follow-Up Period||0
2998998|NCT00950599|3715992|FG008|COMPLETED|Follow-Up Period||296
2998999|NCT00950599|3715993|FG009|COMPLETED|Follow-Up Period||78
2999000|NCT00950599|3715984|FG000|NOT COMPLETED|Follow-Up Period||0
2999001|NCT00950599|3715985|FG001|NOT COMPLETED|Follow-Up Period||0
2999002|NCT00950599|3715986|FG002|NOT COMPLETED|Follow-Up Period||0
2999003|NCT00950599|3715987|FG003|NOT COMPLETED|Follow-Up Period||0
2999004|NCT00950599|3715988|FG004|NOT COMPLETED|Follow-Up Period||0
2999005|NCT00950599|3715989|FG005|NOT COMPLETED|Follow-Up Period||0
2999006|NCT00950599|3715990|FG006|NOT COMPLETED|Follow-Up Period||0
2999007|NCT00950599|3715991|FG007|NOT COMPLETED|Follow-Up Period||0
2999008|NCT00950599|3715992|FG008|NOT COMPLETED|Follow-Up Period||13
2999009|NCT00950599|3715993|FG009|NOT COMPLETED|Follow-Up Period||2
2999010|NCT00950612|3716018|FG000|STARTED|Overall Study||40
2999011|NCT00950612|3716019|FG001|STARTED|Overall Study||20
2999012|NCT00950612|3716018|FG000|COMPLETED|Overall Study||40
2999013|NCT00950612|3716019|FG001|COMPLETED|Overall Study||20
2999014|NCT00950612|3716018|FG000|NOT COMPLETED|Overall Study||0
2999015|NCT00950612|3716019|FG001|NOT COMPLETED|Overall Study||0
2999016|NCT00950651|3716027|FG000|STARTED|Overall Study||215
2999017|NCT00950651|3716028|FG001|STARTED|Overall Study|216 patients randomized but one never took study medication|216
2999018|NCT00950651|3716027|FG000|COMPLETED|Overall Study||184
2999019|NCT00950651|3716028|FG001|COMPLETED|Overall Study||181
2999020|NCT00950651|3716027|FG000|NOT COMPLETED|Overall Study||31
2999021|NCT00950651|3716028|FG001|NOT COMPLETED|Overall Study||35
2999022|NCT00950664|3716036|FG000|STARTED|First Intervention||49
2999023|NCT00950664|3716037|FG001|STARTED|First Intervention||53
2999024|NCT00950664|3716036|FG000|COMPLETED|First Intervention||46
2999025|NCT00950664|3716037|FG001|COMPLETED|First Intervention||48
2999026|NCT00950664|3716036|FG000|NOT COMPLETED|First Intervention||3
2999027|NCT00950664|3716037|FG001|NOT COMPLETED|First Intervention||5
2999028|NCT00950664|3716036|FG000|STARTED|Washout Period of 4 Weeks||46
2999029|NCT00950664|3716037|FG001|STARTED|Washout Period of 4 Weeks||48
2999030|NCT00950664|3716036|FG000|COMPLETED|Washout Period of 4 Weeks||46
2999031|NCT00950664|3716037|FG001|COMPLETED|Washout Period of 4 Weeks||48
2999032|NCT00950664|3716036|FG000|NOT COMPLETED|Washout Period of 4 Weeks||0
2999033|NCT00950664|3716037|FG001|NOT COMPLETED|Washout Period of 4 Weeks||0
2999034|NCT00950664|3716036|FG000|STARTED|Second Intervention||46
2999035|NCT00950664|3716037|FG001|STARTED|Second Intervention||48
2999036|NCT00950664|3716036|FG000|COMPLETED|Second Intervention||0
2999037|NCT00950664|3716037|FG001|COMPLETED|Second Intervention||0
2999038|NCT00950664|3716036|FG000|NOT COMPLETED|Second Intervention||46
2999039|NCT00950664|3716037|FG001|NOT COMPLETED|Second Intervention||48
2999040|NCT00950729|3716043|FG000|STARTED|Driving With Running Shoes|March 2007|48
2999041|NCT00950729|3716043|FG000|COMPLETED|Driving With Running Shoes|June 2007|48
2999042|NCT00950729|3716043|FG000|NOT COMPLETED|Driving With Running Shoes||0
2999043|NCT00950729|3716043|FG000|STARTED|Driving With Plaster Cast||48
2999044|NCT00950729|3716043|FG000|COMPLETED|Driving With Plaster Cast||48
2999045|NCT00950729|3716043|FG000|NOT COMPLETED|Driving With Plaster Cast||0
2999046|NCT00950729|3716043|FG000|STARTED|Driving With Aircast||48
2999047|NCT00950729|3716043|FG000|COMPLETED|Driving With Aircast||48
2999048|NCT00950729|3716043|FG000|NOT COMPLETED|Driving With Aircast||0
2999049|NCT00950742|3716049|FG000|STARTED|Overall Study|entered and treated|16
2999050|NCT00950742|3716050|FG001|STARTED|Overall Study|entered and treated|2
2999051|NCT00950742|3716049|FG000|COMPLETED|Overall Study||0
2999052|NCT00950742|3716050|FG001|COMPLETED|Overall Study||0
2999053|NCT00950742|3716049|FG000|NOT COMPLETED|Overall Study||16
2999054|NCT00950742|3716050|FG001|NOT COMPLETED|Overall Study||2
2999055|NCT00950755|3716060|FG000|STARTED|Dosimetric and Therapeutic Treatment||41
2999056|NCT00950755|3716060|FG000|COMPLETED|Dosimetric and Therapeutic Treatment||0
2999057|NCT00950755|3716060|FG000|NOT COMPLETED|Dosimetric and Therapeutic Treatment||41
2999058|NCT00950755|3716060|FG000|STARTED|Long-Term Follow-Up|18 of the 41 participants withdrawing from Study BEX104505 enrolled in the LTFU study.|18
2999059|NCT00950755|3716060|FG000|COMPLETED|Long-Term Follow-Up||9
2999060|NCT00950755|3716060|FG000|NOT COMPLETED|Long-Term Follow-Up||9
2999061|NCT00950807|3716064|FG000|STARTED|Treatment Period 1||59
2999062|NCT00950807|3716065|FG001|STARTED|Treatment Period 1||13
2999063|NCT00950807|3716066|FG002|STARTED|Treatment Period 1||14
2999064|NCT00950807|3716067|FG003|STARTED|Treatment Period 1||12
2999065|NCT00950807|3716068|FG004|STARTED|Treatment Period 1||13
2999066|NCT00950807|3716069|FG005|STARTED|Treatment Period 1||13
2999067|NCT00950807|3716070|FG006|STARTED|Treatment Period 1||12
2999068|NCT00950807|3716071|FG007|STARTED|Treatment Period 1||14
2999069|NCT00950807|3716072|FG008|STARTED|Treatment Period 1||13
2999070|NCT00950807|3716073|FG009|STARTED|Treatment Period 1||13
2999071|NCT00950807|3716064|FG000|COMPLETED|Treatment Period 1||56
2999072|NCT00950807|3716065|FG001|COMPLETED|Treatment Period 1||13
2999073|NCT00950807|3716066|FG002|COMPLETED|Treatment Period 1||13
2999074|NCT00950807|3716067|FG003|COMPLETED|Treatment Period 1||12
2999075|NCT00950807|3716068|FG004|COMPLETED|Treatment Period 1||12
2999076|NCT00950807|3716069|FG005|COMPLETED|Treatment Period 1||11
2999077|NCT00950807|3716070|FG006|COMPLETED|Treatment Period 1||12
2999078|NCT00950807|3716071|FG007|COMPLETED|Treatment Period 1||14
2999079|NCT00950807|3716072|FG008|COMPLETED|Treatment Period 1||12
2999080|NCT00950807|3716073|FG009|COMPLETED|Treatment Period 1||13
2999081|NCT00950807|3716064|FG000|NOT COMPLETED|Treatment Period 1||3
2999082|NCT00950807|3716065|FG001|NOT COMPLETED|Treatment Period 1||0
2999083|NCT00950807|3716066|FG002|NOT COMPLETED|Treatment Period 1||1
2999084|NCT00950807|3716067|FG003|NOT COMPLETED|Treatment Period 1||0
2999085|NCT00950807|3716068|FG004|NOT COMPLETED|Treatment Period 1||1
2999086|NCT00950807|3716069|FG005|NOT COMPLETED|Treatment Period 1||2
2999087|NCT00950807|3716070|FG006|NOT COMPLETED|Treatment Period 1||0
2999088|NCT00950807|3716071|FG007|NOT COMPLETED|Treatment Period 1||0
2999089|NCT00950807|3716072|FG008|NOT COMPLETED|Treatment Period 1||1
2999090|NCT00950807|3716073|FG009|NOT COMPLETED|Treatment Period 1||0
2999091|NCT00950807|3716064|FG000|STARTED|Washout Period 1||56
2999092|NCT00950807|3716065|FG001|STARTED|Washout Period 1||13
2999093|NCT00950807|3716066|FG002|STARTED|Washout Period 1||13
2999094|NCT00950807|3716067|FG003|STARTED|Washout Period 1||12
2999095|NCT00950807|3716068|FG004|STARTED|Washout Period 1||12
2999096|NCT00950807|3716069|FG005|STARTED|Washout Period 1||11
2999097|NCT00950807|3716070|FG006|STARTED|Washout Period 1||12
2999098|NCT00950807|3716071|FG007|STARTED|Washout Period 1||14
2999099|NCT00950807|3716072|FG008|STARTED|Washout Period 1||12
2999100|NCT00950807|3716073|FG009|STARTED|Washout Period 1||13
2999101|NCT00950807|3716064|FG000|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|51
2999102|NCT00950807|3716065|FG001|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|13
2999103|NCT00950807|3716066|FG002|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|13
2999104|NCT00950807|3716067|FG003|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|11
2999105|NCT00950807|3716068|FG004|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|11
2999106|NCT00950807|3716069|FG005|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|11
2999107|NCT00950807|3716070|FG006|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|10
2999108|NCT00950807|3716071|FG007|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|13
2999109|NCT00950807|3716072|FG008|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|11
2999110|NCT00950807|3716073|FG009|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|13
2999111|NCT00950807|3716064|FG000|NOT COMPLETED|Washout Period 1||5
2999112|NCT00950807|3716065|FG001|NOT COMPLETED|Washout Period 1||0
2999113|NCT00950807|3716066|FG002|NOT COMPLETED|Washout Period 1||0
2999114|NCT00950807|3716067|FG003|NOT COMPLETED|Washout Period 1||1
2999115|NCT00950807|3716068|FG004|NOT COMPLETED|Washout Period 1||1
2999116|NCT00950807|3716069|FG005|NOT COMPLETED|Washout Period 1||0
2999117|NCT00950807|3716070|FG006|NOT COMPLETED|Washout Period 1||2
2999118|NCT00950807|3716071|FG007|NOT COMPLETED|Washout Period 1||1
2999119|NCT00950807|3716072|FG008|NOT COMPLETED|Washout Period 1||1
2999120|NCT00950807|3716073|FG009|NOT COMPLETED|Washout Period 1||0
2999121|NCT00950807|3716064|FG000|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|53
2999122|NCT00950807|3716065|FG001|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|13
2999123|NCT00950807|3716066|FG002|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|10
2999124|NCT00950807|3716067|FG003|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|13
2999125|NCT00950807|3716068|FG004|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|13
2999126|NCT00950807|3716069|FG005|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|10
2999127|NCT00950807|3716070|FG006|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|10
2999128|NCT00950807|3716071|FG007|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|13
2999129|NCT00950807|3716072|FG008|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|11
2999130|NCT00950807|3716073|FG009|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|11
2999131|NCT00950807|3716064|FG000|COMPLETED|Treatment Period 2||51
2999132|NCT00950807|3716065|FG001|COMPLETED|Treatment Period 2||12
2999133|NCT00950807|3716066|FG002|COMPLETED|Treatment Period 2||10
2999134|NCT00950807|3716067|FG003|COMPLETED|Treatment Period 2||12
2999135|NCT00950807|3716068|FG004|COMPLETED|Treatment Period 2||13
2999136|NCT00950807|3716069|FG005|COMPLETED|Treatment Period 2||9
2999137|NCT00950807|3716070|FG006|COMPLETED|Treatment Period 2||9
2999138|NCT00950807|3716071|FG007|COMPLETED|Treatment Period 2||10
2999139|NCT00950807|3716072|FG008|COMPLETED|Treatment Period 2||11
2999140|NCT00950807|3716073|FG009|COMPLETED|Treatment Period 2||11
2999141|NCT00950807|3716064|FG000|NOT COMPLETED|Treatment Period 2||2
2999142|NCT00950807|3716065|FG001|NOT COMPLETED|Treatment Period 2||1
2999143|NCT00950807|3716066|FG002|NOT COMPLETED|Treatment Period 2||0
2999144|NCT00950807|3716067|FG003|NOT COMPLETED|Treatment Period 2||1
2999145|NCT00950807|3716068|FG004|NOT COMPLETED|Treatment Period 2||0
2999146|NCT00950807|3716069|FG005|NOT COMPLETED|Treatment Period 2||1
2999147|NCT00950807|3716070|FG006|NOT COMPLETED|Treatment Period 2||1
2999148|NCT00950807|3716071|FG007|NOT COMPLETED|Treatment Period 2||3
2999149|NCT00950807|3716072|FG008|NOT COMPLETED|Treatment Period 2||0
2999150|NCT00950807|3716073|FG009|NOT COMPLETED|Treatment Period 2||0
2999151|NCT00950807|3716064|FG000|STARTED|Washout Period 2||51
2999152|NCT00950807|3716065|FG001|STARTED|Washout Period 2||12
2999153|NCT00950807|3716066|FG002|STARTED|Washout Period 2||10
2999154|NCT00950807|3716067|FG003|STARTED|Washout Period 2||12
2999155|NCT00950807|3716068|FG004|STARTED|Washout Period 2||13
2999156|NCT00950807|3716069|FG005|STARTED|Washout Period 2||9
2999157|NCT00950807|3716070|FG006|STARTED|Washout Period 2||9
2999158|NCT00950807|3716071|FG007|STARTED|Washout Period 2||10
2999159|NCT00950807|3716072|FG008|STARTED|Washout Period 2||11
2999160|NCT00950807|3716073|FG009|STARTED|Washout Period 2||11
2999161|NCT00950807|3716064|FG000|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|47
2999162|NCT00950807|3716065|FG001|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|11
2999163|NCT00950807|3716066|FG002|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|10
2999164|NCT00950807|3716067|FG003|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|11
2999165|NCT00950807|3716068|FG004|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|12
2999166|NCT00950807|3716069|FG005|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|9
2999167|NCT00950807|3716070|FG006|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|8
2999168|NCT00950807|3716071|FG007|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|9
2999169|NCT00950807|3716072|FG008|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|11
2999170|NCT00950807|3716073|FG009|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|11
2999171|NCT00950807|3716064|FG000|NOT COMPLETED|Washout Period 2||4
2999172|NCT00950807|3716065|FG001|NOT COMPLETED|Washout Period 2||1
2999173|NCT00950807|3716066|FG002|NOT COMPLETED|Washout Period 2||0
2999174|NCT00950807|3716067|FG003|NOT COMPLETED|Washout Period 2||1
2999175|NCT00950807|3716068|FG004|NOT COMPLETED|Washout Period 2||1
2999176|NCT00950807|3716069|FG005|NOT COMPLETED|Washout Period 2||0
2999177|NCT00950807|3716070|FG006|NOT COMPLETED|Washout Period 2||1
2999178|NCT00950807|3716071|FG007|NOT COMPLETED|Washout Period 2||1
2999179|NCT00950807|3716072|FG008|NOT COMPLETED|Washout Period 2||0
2999180|NCT00950807|3716073|FG009|NOT COMPLETED|Washout Period 2||0
2999181|NCT00950807|3716064|FG000|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|46
2999182|NCT00950807|3716065|FG001|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|9
2999183|NCT00950807|3716066|FG002|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|10
2999184|NCT00950807|3716067|FG003|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|11
2999185|NCT00950807|3716068|FG004|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|12
2999186|NCT00950807|3716069|FG005|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|9
2999187|NCT00950807|3716070|FG006|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|12
2999188|NCT00950807|3716071|FG007|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|10
2999189|NCT00950807|3716072|FG008|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|9
2999190|NCT00950807|3716073|FG009|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|11
2999191|NCT00950807|3716064|FG000|COMPLETED|Treatment Period 3||45
2999192|NCT00950807|3716065|FG001|COMPLETED|Treatment Period 3||9
2999193|NCT00950807|3716066|FG002|COMPLETED|Treatment Period 3||10
2999194|NCT00950807|3716067|FG003|COMPLETED|Treatment Period 3||11
2999195|NCT00950807|3716068|FG004|COMPLETED|Treatment Period 3||12
2999196|NCT00950807|3716069|FG005|COMPLETED|Treatment Period 3||9
2999197|NCT00950807|3716070|FG006|COMPLETED|Treatment Period 3||11
2999198|NCT00950807|3716071|FG007|COMPLETED|Treatment Period 3||9
2999199|NCT00950807|3716072|FG008|COMPLETED|Treatment Period 3||9
2999200|NCT00950807|3716073|FG009|COMPLETED|Treatment Period 3||10
2999201|NCT00950807|3716064|FG000|NOT COMPLETED|Treatment Period 3||1
2999202|NCT00950807|3716065|FG001|NOT COMPLETED|Treatment Period 3||0
2999203|NCT00950807|3716066|FG002|NOT COMPLETED|Treatment Period 3||0
2999204|NCT00950807|3716067|FG003|NOT COMPLETED|Treatment Period 3||0
2999205|NCT00950807|3716068|FG004|NOT COMPLETED|Treatment Period 3||0
2999206|NCT00950807|3716069|FG005|NOT COMPLETED|Treatment Period 3||0
2999207|NCT00950807|3716070|FG006|NOT COMPLETED|Treatment Period 3||1
2999208|NCT00950807|3716071|FG007|NOT COMPLETED|Treatment Period 3||1
2999209|NCT00950807|3716072|FG008|NOT COMPLETED|Treatment Period 3||0
2999210|NCT00950807|3716073|FG009|NOT COMPLETED|Treatment Period 3||1
2999211|NCT00950833|3716098|FG000|STARTED|Overall Study||112
2999212|NCT00950833|3716099|FG001|STARTED|Overall Study||108
2999213|NCT00950833|3716100|FG002|STARTED|Overall Study||223
2999214|NCT00950833|3716098|FG000|COMPLETED|Overall Study||112
2999215|NCT00950833|3716099|FG001|COMPLETED|Overall Study||108
2999216|NCT00950833|3716100|FG002|COMPLETED|Overall Study||223
2999217|NCT00950833|3716098|FG000|NOT COMPLETED|Overall Study||0
2999218|NCT00950833|3716099|FG001|NOT COMPLETED|Overall Study||0
2999219|NCT00950833|3716100|FG002|NOT COMPLETED|Overall Study||0
2999220|NCT00950859|3716112|FG000|STARTED|Overall Study||27
2999221|NCT00950859|3716113|FG001|STARTED|Overall Study||24
2999222|NCT00950859|3716112|FG000|COMPLETED|Overall Study||11
2999223|NCT00950859|3716113|FG001|COMPLETED|Overall Study||14
2999224|NCT00950859|3716112|FG000|NOT COMPLETED|Overall Study||16
2999225|NCT00950859|3716113|FG001|NOT COMPLETED|Overall Study||10
2999226|NCT00950872|3716119|FG000|STARTED|Overall Study||29
2999227|NCT00950872|3716119|FG000|COMPLETED|Overall Study||26
2999228|NCT00950872|3716119|FG000|NOT COMPLETED|Overall Study||3
2999229|NCT00950911|3716125|FG000|STARTED|Overall Study||17
2999230|NCT00950911|3716126|FG001|STARTED|Overall Study||18
2999231|NCT00950911|3716125|FG000|COMPLETED|Overall Study||5
2999232|NCT00950911|3716126|FG001|COMPLETED|Overall Study||3
2999233|NCT00950911|3716125|FG000|NOT COMPLETED|Overall Study||12
2999234|NCT00950911|3716126|FG001|NOT COMPLETED|Overall Study||15
2999235|NCT00950950|3716134|FG000|STARTED|Overall Study||12
2999236|NCT00950950|3716135|FG001|STARTED|Overall Study||12
2999237|NCT00950950|3716134|FG000|COMPLETED|Overall Study||11
2999238|NCT00950950|3716135|FG001|COMPLETED|Overall Study||11
2999239|NCT00950950|3716134|FG000|NOT COMPLETED|Overall Study||1
2999240|NCT00950950|3716135|FG001|NOT COMPLETED|Overall Study||1
2999241|NCT00950963|3716144|FG000|STARTED|Overall Study|Patients were randomized from a diabetes registry and were followed as intent to treat|381
2999242|NCT00950963|3716145|FG001|STARTED|Overall Study|Patients were randomized from a diabetes registry and were followed as intent to treat|381
2999243|NCT00950963|3716144|FG000|COMPLETED|Overall Study||352
2999244|NCT00950963|3716145|FG001|COMPLETED|Overall Study||357
2999245|NCT00950963|3716144|FG000|NOT COMPLETED|Overall Study||29
2999246|NCT00950963|3716145|FG001|NOT COMPLETED|Overall Study||24
2999247|NCT00951015|3716155|FG000|STARTED|Randomization Phase 96 Week||53
2999248|NCT00951015|3716156|FG001|STARTED|Randomization Phase 96 Week||51
2999249|NCT00951015|3716157|FG002|STARTED|Randomization Phase 96 Week||51
2999250|NCT00951015|3716158|FG003|STARTED|Randomization Phase 96 Week||50
2999251|NCT00951015|3716159|FG004|STARTED|Randomization Phase 96 Week||0
2999252|NCT00951015|3716155|FG000|COMPLETED|Randomization Phase 96 Week||48
2999253|NCT00951015|3716156|FG001|COMPLETED|Randomization Phase 96 Week||44
2999254|NCT00951015|3716157|FG002|COMPLETED|Randomization Phase 96 Week||46
2999255|NCT00951015|3716158|FG003|COMPLETED|Randomization Phase 96 Week||40
2999256|NCT00951015|3716159|FG004|COMPLETED|Randomization Phase 96 Week||0
2999257|NCT00951015|3716155|FG000|NOT COMPLETED|Randomization Phase 96 Week||5
2999258|NCT00951015|3716156|FG001|NOT COMPLETED|Randomization Phase 96 Week||7
2999259|NCT00951015|3716157|FG002|NOT COMPLETED|Randomization Phase 96 Week||5
2999260|NCT00951015|3716158|FG003|NOT COMPLETED|Randomization Phase 96 Week||10
2999261|NCT00951015|3716159|FG004|NOT COMPLETED|Randomization Phase 96 Week||0
2999262|NCT00951015|3716155|FG000|STARTED|Open-label Phase||0
2999263|NCT00951015|3716156|FG001|STARTED|Open-label Phase||0
2999264|NCT00951015|3716157|FG002|STARTED|Open-label Phase||0
2999265|NCT00951015|3716158|FG003|STARTED|Open-label Phase||0
2999266|NCT00951015|3716159|FG004|STARTED|Open-label Phase||138
2999267|NCT00951015|3716155|FG000|COMPLETED|Open-label Phase||0
2999268|NCT00951015|3716156|FG001|COMPLETED|Open-label Phase||0
2999269|NCT00951015|3716157|FG002|COMPLETED|Open-label Phase||0
2999270|NCT00951015|3716158|FG003|COMPLETED|Open-label Phase||0
2999271|NCT00951015|3716159|FG004|COMPLETED|Open-label Phase||88
2999272|NCT00951015|3716155|FG000|NOT COMPLETED|Open-label Phase||0
2999273|NCT00951015|3716156|FG001|NOT COMPLETED|Open-label Phase||0
2999274|NCT00951015|3716157|FG002|NOT COMPLETED|Open-label Phase||0
2999275|NCT00951015|3716158|FG003|NOT COMPLETED|Open-label Phase||0
2999276|NCT00951015|3716159|FG004|NOT COMPLETED|Open-label Phase||50
2999277|NCT00951041|3716184|FG000|STARTED|Overall Study||64
2999278|NCT00951041|3716185|FG001|STARTED|Overall Study||66
2999279|NCT00951041|3716184|FG000|COMPLETED|Overall Study||59
2999280|NCT00951041|3716185|FG001|COMPLETED|Overall Study||65
2999281|NCT00951041|3716184|FG000|NOT COMPLETED|Overall Study||5
2999282|NCT00951041|3716185|FG001|NOT COMPLETED|Overall Study||1
2999283|NCT00951080|3716194|FG000|STARTED|Overall Study||64
2999284|NCT00951080|3716195|FG001|STARTED|Overall Study||68
2999285|NCT00951080|3716194|FG000|COMPLETED|Overall Study||38
2999286|NCT00951080|3716195|FG001|COMPLETED|Overall Study||41
2999287|NCT00951080|3716194|FG000|NOT COMPLETED|Overall Study||26
2999288|NCT00951080|3716195|FG001|NOT COMPLETED|Overall Study||27
2999289|NCT00951093|3716201|FG000|STARTED|Before GBP||53
2999290|NCT00951093|3716201|FG000|COMPLETED|Before GBP||53
2999291|NCT00951093|3716201|FG000|NOT COMPLETED|Before GBP||0
2999292|NCT00951093|3716201|FG000|STARTED|6 Months After GBP||53
2999293|NCT00951093|3716201|FG000|COMPLETED|6 Months After GBP||53
2999294|NCT00951093|3716201|FG000|NOT COMPLETED|6 Months After GBP||0
2999295|NCT00951171|3716209|FG000|STARTED|Overall Study||40
2999296|NCT00951171|3716210|FG001|STARTED|Overall Study||55
2999297|NCT00951171|3716209|FG000|Pregnancy|Overall Study||1
2999298|NCT00951171|3716210|FG001|Pregnancy|Overall Study||7
2999299|NCT00951171|3716209|FG000|COMPLETED|Overall Study||38
2999300|NCT00951171|3716210|FG001|COMPLETED|Overall Study|2 of the cervical occlusion group transferred to standard group because of pain during attempted IUI|55
2999301|NCT00951171|3716209|FG000|NOT COMPLETED|Overall Study||2
2999302|NCT00951171|3716210|FG001|NOT COMPLETED|Overall Study||0
2999303|NCT00951275|3716216|FG000|STARTED|Overall Study||105
2999304|NCT00951275|3716216|FG000|COMPLETED|Overall Study||92
2999305|NCT00951275|3716216|FG000|NOT COMPLETED|Overall Study||13
2999306|NCT00951379|3716222|FG000|STARTED|Overall Study||27
2999307|NCT00951379|3716223|FG001|STARTED|Overall Study||25
2999308|NCT00951379|3716222|FG000|COMPLETED|Overall Study||21
2999309|NCT00951379|3716223|FG001|COMPLETED|Overall Study||23
2999310|NCT00951379|3716222|FG000|NOT COMPLETED|Overall Study||6
2999311|NCT00951379|3716223|FG001|NOT COMPLETED|Overall Study||2
2999312|NCT00951483|3716239|FG000|STARTED|Overall Study||47
2999313|NCT00951483|3716240|FG001|STARTED|Overall Study||44
2999314|NCT00951483|3716239|FG000|COMPLETED|Overall Study||28
3306522|NCT02998996|4039891|FG004|STARTED|Overall Study||18
3306523|NCT02998996|4039892|FG005|STARTED|Overall Study||19
3306524|NCT02998996|4039887|FG000|COMPLETED|Overall Study||36
3306525|NCT02998996|4039888|FG001|COMPLETED|Overall Study||34
3306526|NCT02998996|4039889|FG002|COMPLETED|Overall Study||35
2999315|NCT00951483|3716240|FG001|COMPLETED|Overall Study||44
2999316|NCT00951483|3716239|FG000|NOT COMPLETED|Overall Study||19
2999317|NCT00951483|3716240|FG001|NOT COMPLETED|Overall Study||0
2999318|NCT00951496|3716251|FG000|STARTED|Overall Study||521
2999319|NCT00951496|3716252|FG001|STARTED|Overall Study||518
2999320|NCT00951496|3716253|FG002|STARTED|Overall Study||521
2999321|NCT00951496|3716251|FG000|COMPLETED|Overall Study||511
2999322|NCT00951496|3716252|FG001|COMPLETED|Overall Study||510
2999323|NCT00951496|3716253|FG002|COMPLETED|Overall Study||508
2999324|NCT00951496|3716251|FG000|NOT COMPLETED|Overall Study||10
2999325|NCT00951496|3716252|FG001|NOT COMPLETED|Overall Study||8
2999326|NCT00951496|3716253|FG002|NOT COMPLETED|Overall Study||13
3036975|NCT01146379|3756258|FG003|NOT COMPLETED|Overall Study||1
3036976|NCT01146457|3756273|FG000|STARTED|Overall Study||19
3036977|NCT01146457|3756274|FG001|STARTED|Overall Study||17
3036978|NCT01146457|3756275|FG002|STARTED|Overall Study||21
3036979|NCT01146457|3756276|FG003|STARTED|Overall Study||13
3036980|NCT01146457|3756277|FG004|STARTED|Overall Study||13
3036981|NCT01146457|3756273|FG000|COMPLETED|Overall Study||19
3036982|NCT01146457|3756274|FG001|COMPLETED|Overall Study||17
3036983|NCT01146457|3756275|FG002|COMPLETED|Overall Study||20
3036984|NCT01146457|3756276|FG003|COMPLETED|Overall Study||13
3036985|NCT01146457|3756277|FG004|COMPLETED|Overall Study||13
3036986|NCT01146457|3756273|FG000|NOT COMPLETED|Overall Study||0
3036987|NCT01146457|3756274|FG001|NOT COMPLETED|Overall Study||0
3036988|NCT01146457|3756275|FG002|NOT COMPLETED|Overall Study||1
3036989|NCT01146457|3756276|FG003|NOT COMPLETED|Overall Study||0
3036990|NCT01146457|3756277|FG004|NOT COMPLETED|Overall Study||0
3036991|NCT01146496|3756291|FG000|STARTED|Overall Study||114168
3036992|NCT01146496|3756292|FG001|STARTED|Overall Study||109693
3036993|NCT01146496|3756291|FG000|COMPLETED|Overall Study||114168
3036994|NCT01146496|3756292|FG001|COMPLETED|Overall Study||109693
3036995|NCT01146496|3756291|FG000|NOT COMPLETED|Overall Study||0
3036996|NCT01146496|3756292|FG001|NOT COMPLETED|Overall Study||0
3036997|NCT01146561|3756299|FG000|STARTED|Overall Study||2
3036998|NCT01146561|3756299|FG000|COMPLETED|Overall Study||0
3036999|NCT01146561|3756299|FG000|NOT COMPLETED|Overall Study||2
3037000|NCT01146600|3756305|FG000|STARTED|Period 1 (Weeks 1 & 2)||13
3037001|NCT01146600|3756306|FG001|STARTED|Period 1 (Weeks 1 & 2)||10
3037002|NCT01146600|3756305|FG000|COMPLETED|Period 1 (Weeks 1 & 2)||10
3037003|NCT01146600|3756306|FG001|COMPLETED|Period 1 (Weeks 1 & 2)||10
3037004|NCT01146600|3756305|FG000|NOT COMPLETED|Period 1 (Weeks 1 & 2)||3
3037005|NCT01146600|3756306|FG001|NOT COMPLETED|Period 1 (Weeks 1 & 2)||0
3037006|NCT01146600|3756305|FG000|STARTED|Washout (Week 3)||10
3037007|NCT01146600|3756306|FG001|STARTED|Washout (Week 3)||10
3037008|NCT01146600|3756305|FG000|COMPLETED|Washout (Week 3)||10
3037009|NCT01146600|3756306|FG001|COMPLETED|Washout (Week 3)||10
3037010|NCT01146600|3756305|FG000|NOT COMPLETED|Washout (Week 3)||0
3037011|NCT01146600|3756306|FG001|NOT COMPLETED|Washout (Week 3)||0
3037012|NCT01146600|3756305|FG000|STARTED|Period 2 (Weeks 4 & 5)||10
3037013|NCT01146600|3756306|FG001|STARTED|Period 2 (Weeks 4 & 5)||10
3037014|NCT01146600|3756305|FG000|COMPLETED|Period 2 (Weeks 4 & 5)||10
3037015|NCT01146600|3756306|FG001|COMPLETED|Period 2 (Weeks 4 & 5)||10
3037016|NCT01146600|3756305|FG000|NOT COMPLETED|Period 2 (Weeks 4 & 5)||0
3037017|NCT01146600|3756306|FG001|NOT COMPLETED|Period 2 (Weeks 4 & 5)||0
3037018|NCT01146613|3756315|FG000|STARTED|Overall Study||99
3037019|NCT01146613|3756316|FG001|STARTED|Overall Study||101
3037020|NCT01146613|3756315|FG000|COMPLETED|Overall Study||92
3037021|NCT01146613|3756316|FG001|COMPLETED|Overall Study||89
3037022|NCT01146613|3756315|FG000|NOT COMPLETED|Overall Study||7
3037023|NCT01146613|3756316|FG001|NOT COMPLETED|Overall Study||12
3037024|NCT01146665|3756324|FG000|STARTED|Overall Study||18
3306527|NCT02998996|4039890|FG003|COMPLETED|Overall Study||18
2999327|NCT00951509|3716264|FG000|STARTED|Overall Study||31
2999328|NCT00951509|3716264|FG000|Driving Condition 1|Overall Study||29
2999329|NCT00951509|3716264|FG000|Driving Condition 2|Overall Study||29
2999330|NCT00951509|3716264|FG000|Driving Condition 3|Overall Study||25
2999331|NCT00951509|3716264|FG000|Driving Condition 4|Overall Study||28
2999332|NCT00951509|3716264|FG000|Driving Condition 5|Overall Study||30
2999333|NCT00951509|3716264|FG000|COMPLETED|Overall Study||29
2999334|NCT00951509|3716264|FG000|NOT COMPLETED|Overall Study||2
2999335|NCT00951561|3716272|FG000|STARTED|Overall Study|Randomized Vipon or Ibuprofen period 1, crossover period 2, randomized period 3, crossover period 4|25
2999336|NCT00951561|3716273|FG001|STARTED|Overall Study||29
2999337|NCT00951561|3716274|FG002|STARTED|Overall Study|1 subject used Vipon periods 1 & 2 instead of Ibuprofen period 2.|21
2999338|NCT00951561|3716275|FG003|STARTED|Overall Study||27
2999339|NCT00951561|3716272|FG000|COMPLETED|Overall Study||25
2999340|NCT00951561|3716273|FG001|COMPLETED|Overall Study||29
2999341|NCT00951561|3716274|FG002|COMPLETED|Overall Study|3 subjects dropped after period 2|18
2999342|NCT00951561|3716275|FG003|COMPLETED|Overall Study|1 subject dropped after period 2|26
2999343|NCT00951561|3716272|FG000|NOT COMPLETED|Overall Study||0
2999344|NCT00951561|3716273|FG001|NOT COMPLETED|Overall Study||0
2999345|NCT00951561|3716274|FG002|NOT COMPLETED|Overall Study||3
2999346|NCT00951561|3716275|FG003|NOT COMPLETED|Overall Study||1
2999347|NCT00951665|3716286|FG000|STARTED|Phase 1b||29
2999348|NCT00951665|3716287|FG001|STARTED|Phase 1b||10
2999349|NCT00951665|3716288|FG002|STARTED|Phase 1b||21
2999350|NCT00951665|3716289|FG003|STARTED|Phase 1b||3
2999351|NCT00951665|3716290|FG004|STARTED|Phase 1b||0
2999352|NCT00951665|3716291|FG005|STARTED|Phase 1b||0
2999353|NCT00951665|3716286|FG000|Started Treatment|Phase 1b||26
2999354|NCT00951665|3716287|FG001|Started Treatment|Phase 1b||10
2999355|NCT00951665|3716288|FG002|Started Treatment|Phase 1b||21
2999356|NCT00951665|3716289|FG003|Started Treatment|Phase 1b||3
2999357|NCT00951665|3716290|FG004|Started Treatment|Phase 1b||0
2999358|NCT00951665|3716291|FG005|Started Treatment|Phase 1b||0
2999359|NCT00951665|3716286|FG000|COMPLETED|Phase 1b||7
2999360|NCT00951665|3716287|FG001|COMPLETED|Phase 1b||6
2999361|NCT00951665|3716288|FG002|COMPLETED|Phase 1b||4
2999362|NCT00951665|3716289|FG003|COMPLETED|Phase 1b||2
2999363|NCT00951665|3716290|FG004|COMPLETED|Phase 1b||0
2999364|NCT00951665|3716291|FG005|COMPLETED|Phase 1b||0
2999365|NCT00951665|3716286|FG000|NOT COMPLETED|Phase 1b||22
2999366|NCT00951665|3716287|FG001|NOT COMPLETED|Phase 1b||4
2999367|NCT00951665|3716288|FG002|NOT COMPLETED|Phase 1b||17
2999368|NCT00951665|3716289|FG003|NOT COMPLETED|Phase 1b||1
2999369|NCT00951665|3716290|FG004|NOT COMPLETED|Phase 1b||0
2999370|NCT00951665|3716291|FG005|NOT COMPLETED|Phase 1b||0
2999371|NCT00951665|3716286|FG000|STARTED|Phase 2a||0
2999372|NCT00951665|3716287|FG001|STARTED|Phase 2a||0
2999373|NCT00951665|3716288|FG002|STARTED|Phase 2a||0
2999374|NCT00951665|3716289|FG003|STARTED|Phase 2a||0
2999375|NCT00951665|3716290|FG004|STARTED|Phase 2a||22
2999376|NCT00951665|3716291|FG005|STARTED|Phase 2a||22
2999377|NCT00951665|3716286|FG000|COMPLETED|Phase 2a||0
2999378|NCT00951665|3716287|FG001|COMPLETED|Phase 2a||0
2999379|NCT00951665|3716288|FG002|COMPLETED|Phase 2a||0
2999380|NCT00951665|3716289|FG003|COMPLETED|Phase 2a||0
2999381|NCT00951665|3716290|FG004|COMPLETED|Phase 2a||10
2999382|NCT00951665|3716291|FG005|COMPLETED|Phase 2a||15
2999383|NCT00951665|3716286|FG000|NOT COMPLETED|Phase 2a||0
2999384|NCT00951665|3716287|FG001|NOT COMPLETED|Phase 2a||0
2999385|NCT00951665|3716288|FG002|NOT COMPLETED|Phase 2a||0
2999386|NCT00951665|3716289|FG003|NOT COMPLETED|Phase 2a||0
2999387|NCT00951665|3716290|FG004|NOT COMPLETED|Phase 2a||12
2999388|NCT00951665|3716291|FG005|NOT COMPLETED|Phase 2a||7
2999389|NCT00951808|3716325|FG000|STARTED|Overall Study||4
2999390|NCT00951808|3716326|FG001|STARTED|Overall Study||6
2999391|NCT00951808|3716327|FG002|STARTED|Overall Study||227
2999392|NCT00951808|3716325|FG000|COMPLETED|Overall Study||4
2999393|NCT00951808|3716326|FG001|COMPLETED|Overall Study||6
2999394|NCT00951808|3716327|FG002|COMPLETED|Overall Study|Four subjects withdrew from the study.|223
2999395|NCT00951808|3716325|FG000|NOT COMPLETED|Overall Study||0
2999396|NCT00951808|3716326|FG001|NOT COMPLETED|Overall Study||0
2999397|NCT00951808|3716327|FG002|NOT COMPLETED|Overall Study||4
2999398|NCT00951821|3716335|FG000|STARTED|Overall Study||16
2999399|NCT00951821|3716336|FG001|STARTED|Overall Study||8
2999400|NCT00951821|3716335|FG000|COMPLETED|Overall Study||16
2999401|NCT00951821|3716336|FG001|COMPLETED|Overall Study||8
2999402|NCT00951821|3716335|FG000|NOT COMPLETED|Overall Study||0
2999403|NCT00951821|3716336|FG001|NOT COMPLETED|Overall Study||0
2999404|NCT00951899|3716344|FG000|STARTED|Overall Study||19
2999405|NCT00951899|3716345|FG001|STARTED|Overall Study||19
2999406|NCT00951899|3716344|FG000|COMPLETED|Overall Study||19
2999407|NCT00951899|3716345|FG001|COMPLETED|Overall Study||19
2999408|NCT00951899|3716344|FG000|NOT COMPLETED|Overall Study||0
2999409|NCT00951899|3716345|FG001|NOT COMPLETED|Overall Study||0
2999410|NCT00951912|3716354|FG000|STARTED|Overall Study||54
2999411|NCT00951912|3716355|FG001|STARTED|Overall Study||55
2999412|NCT00951912|3716356|FG002|STARTED|Overall Study||56
2999413|NCT00951912|3716354|FG000|COMPLETED|Overall Study||47
2999414|NCT00951912|3716355|FG001|COMPLETED|Overall Study||50
2999415|NCT00951912|3716356|FG002|COMPLETED|Overall Study||54
2999416|NCT00951912|3716354|FG000|NOT COMPLETED|Overall Study||7
2999417|NCT00951912|3716355|FG001|NOT COMPLETED|Overall Study||5
2999418|NCT00951912|3716356|FG002|NOT COMPLETED|Overall Study||2
2999419|NCT00952068|3716364|FG000|STARTED|Overall Study||47
2999420|NCT00952068|3716364|FG000|COMPLETED|Overall Study||40
2999421|NCT00952068|3716364|FG000|NOT COMPLETED|Overall Study||7
2999422|NCT00952081|3716368|FG000|STARTED|Overall Study||22
2999423|NCT00952081|3716368|FG000|COMPLETED|Overall Study||22
2999424|NCT00952081|3716368|FG000|NOT COMPLETED|Overall Study||0
2999425|NCT00952120|3716375|FG000|STARTED|Overall Study||52
2999426|NCT00952120|3716376|FG001|STARTED|Overall Study||47
2999427|NCT00952120|3716377|FG002|STARTED|Overall Study||5
2999428|NCT00952120|3716375|FG000|COMPLETED|Overall Study||52
2999429|NCT00952120|3716376|FG001|COMPLETED|Overall Study||47
2999430|NCT00952120|3716377|FG002|COMPLETED|Overall Study||5
2999431|NCT00952120|3716375|FG000|NOT COMPLETED|Overall Study||0
2999432|NCT00952120|3716376|FG001|NOT COMPLETED|Overall Study||0
2999433|NCT00952120|3716377|FG002|NOT COMPLETED|Overall Study||0
2999434|NCT00952133|3716385|FG000|STARTED|Overall Study||59
2999435|NCT00952133|3716386|FG001|STARTED|Overall Study||59
2999436|NCT00952133|3716385|FG000|COMPLETED|Overall Study||59
2999437|NCT00952133|3716386|FG001|COMPLETED|Overall Study||59
2999438|NCT00952133|3716385|FG000|NOT COMPLETED|Overall Study||0
2999439|NCT00952133|3716386|FG001|NOT COMPLETED|Overall Study||0
2999440|NCT00952211|3716396|FG000|STARTED|Overall Study||3
2999441|NCT00952211|3716397|FG001|STARTED|Overall Study||0
2999442|NCT00952211|3716396|FG000|COMPLETED|Overall Study||3
2999443|NCT00952211|3716397|FG001|COMPLETED|Overall Study||0
2999444|NCT00952211|3716396|FG000|NOT COMPLETED|Overall Study||0
2999445|NCT00952211|3716397|FG001|NOT COMPLETED|Overall Study||0
2999446|NCT00952276|3716408|FG000|STARTED|Overall Study||127
2999447|NCT00952276|3716409|FG001|STARTED|Overall Study||115
2999448|NCT00952276|3716410|FG002|STARTED|Overall Study||122
2999449|NCT00952276|3716411|FG003|STARTED|Overall Study||121
2999450|NCT00952276|3716412|FG004|STARTED|Overall Study||63
2999451|NCT00952276|3716408|FG000|COMPLETED|Overall Study||126
2999452|NCT00952276|3716409|FG001|COMPLETED|Overall Study||115
2999453|NCT00952276|3716410|FG002|COMPLETED|Overall Study||122
2999454|NCT00952276|3716411|FG003|COMPLETED|Overall Study||120
2999455|NCT00952276|3716412|FG004|COMPLETED|Overall Study||63
2999456|NCT00952276|3716408|FG000|NOT COMPLETED|Overall Study||1
2999457|NCT00952276|3716409|FG001|NOT COMPLETED|Overall Study||0
2999458|NCT00952276|3716410|FG002|NOT COMPLETED|Overall Study||0
2999459|NCT00952276|3716411|FG003|NOT COMPLETED|Overall Study||1
2999460|NCT00952276|3716412|FG004|NOT COMPLETED|Overall Study||0
2999461|NCT00952289|3716426|FG000|STARTED|All Participants||155
2999462|NCT00952289|3716427|FG001|STARTED|All Participants||154
2999463|NCT00952289|3716426|FG000|Safety Population|All Participants||155
2999464|NCT00952289|3716427|FG001|Safety Population|All Participants|Randomized patients who are documented to have received at least 1 dose of study medication.|151
2999465|NCT00952289|3716426|FG000|COMPLETED|All Participants|Represents the number of patients who were still in the study as of 02 November 2010|134
2999466|NCT00952289|3716427|FG001|COMPLETED|All Participants|Includes patients in the study as of 2 November 2010 (78) + those who crossed over to Ruxolitinib.|114
2999467|NCT00952289|3716426|FG000|NOT COMPLETED|All Participants||21
2999468|NCT00952289|3716427|FG001|NOT COMPLETED|All Participants||40
2999469|NCT00952289|3716426|FG000|STARTED|Patients Who Crossed Over to Ruxolitinib||0
2999470|NCT00952289|3716427|FG001|STARTED|Patients Who Crossed Over to Ruxolitinib||111
2999471|NCT00952289|3716426|FG000|COMPLETED|Patients Who Crossed Over to Ruxolitinib||0
2999472|NCT00952289|3716427|FG001|COMPLETED|Patients Who Crossed Over to Ruxolitinib|Number of cross over subjects who were still in the study as of 25 JAN 2013|57
2999473|NCT00952289|3716426|FG000|NOT COMPLETED|Patients Who Crossed Over to Ruxolitinib||0
2999474|NCT00952289|3716427|FG001|NOT COMPLETED|Patients Who Crossed Over to Ruxolitinib||54
2999475|NCT00952315|3716436|FG000|STARTED|Overall Study||90
2999476|NCT00952315|3716437|FG001|STARTED|Overall Study||90
2999477|NCT00952315|3716438|FG002|STARTED|Overall Study||90
2999478|NCT00952315|3716436|FG000|COMPLETED|Overall Study||64
2999479|NCT00952315|3716437|FG001|COMPLETED|Overall Study||66
2999480|NCT00952315|3716438|FG002|COMPLETED|Overall Study||71
2999481|NCT00952315|3716436|FG000|NOT COMPLETED|Overall Study||26
2999482|NCT00952315|3716437|FG001|NOT COMPLETED|Overall Study||24
2999483|NCT00952315|3716438|FG002|NOT COMPLETED|Overall Study||19
2999484|NCT00952341|3716451|FG000|STARTED|Cycle 1||209
2999485|NCT00952341|3716452|FG001|STARTED|Cycle 1||212
2999486|NCT00952341|3716451|FG000|COMPLETED|Cycle 1||189
2999487|NCT00952341|3716452|FG001|COMPLETED|Cycle 1||199
2999488|NCT00952341|3716451|FG000|NOT COMPLETED|Cycle 1||20
2999489|NCT00952341|3716452|FG001|NOT COMPLETED|Cycle 1||13
2999490|NCT00952341|3716451|FG000|STARTED|Cycle 2||110
2999491|NCT00952341|3716452|FG001|STARTED|Cycle 2||130
2999492|NCT00952341|3716451|FG000|COMPLETED|Cycle 2||101
2999493|NCT00952341|3716452|FG001|COMPLETED|Cycle 2||118
2999494|NCT00952341|3716451|FG000|NOT COMPLETED|Cycle 2||9
2999495|NCT00952341|3716452|FG001|NOT COMPLETED|Cycle 2||12
2999496|NCT00952367|3716458|FG000|STARTED|Overall Study||3641
2999497|NCT00952367|3716458|FG000|COMPLETED|Overall Study||3635
2999498|NCT00952367|3716458|FG000|NOT COMPLETED|Overall Study||6
2999499|NCT00952380|3716467|FG000|STARTED|Overall Study||1
2999500|NCT00952380|3716468|FG001|STARTED|Overall Study||2
2999501|NCT00952380|3716469|FG002|STARTED|Overall Study||8
2999502|NCT00952380|3716470|FG003|STARTED|Overall Study||7
2999503|NCT00952380|3716471|FG004|STARTED|Overall Study||20
2999504|NCT00952380|3716467|FG000|COMPLETED|Overall Study||1
2999505|NCT00952380|3716468|FG001|COMPLETED|Overall Study||1
2999506|NCT00952380|3716469|FG002|COMPLETED|Overall Study||6
2999507|NCT00952380|3716470|FG003|COMPLETED|Overall Study||4
2999508|NCT00952380|3716471|FG004|COMPLETED|Overall Study||14
2999509|NCT00952380|3716467|FG000|NOT COMPLETED|Overall Study||0
2999510|NCT00952380|3716468|FG001|NOT COMPLETED|Overall Study||1
2999511|NCT00952380|3716469|FG002|NOT COMPLETED|Overall Study||2
2999512|NCT00952380|3716470|FG003|NOT COMPLETED|Overall Study||3
2999513|NCT00952380|3716471|FG004|NOT COMPLETED|Overall Study||6
2999514|NCT00952393|3716488|FG000|STARTED|Overall Study|10|10
2999515|NCT00952393|3716488|FG000|COMPLETED|Overall Study||10
2999516|NCT00952393|3716488|FG000|NOT COMPLETED|Overall Study||0
2999517|NCT00952419|3716495|FG000|STARTED|Overall Study||215
2999518|NCT00952419|3716496|FG001|STARTED|Overall Study||208
2999519|NCT00952419|3716497|FG002|STARTED|Overall Study||51
2999520|NCT00952419|3716495|FG000|COMPLETED|Overall Study||209
2999521|NCT00952419|3716496|FG001|COMPLETED|Overall Study||198
2999522|NCT00952419|3716497|FG002|COMPLETED|Overall Study||51
2999523|NCT00952419|3716495|FG000|NOT COMPLETED|Overall Study||6
2999524|NCT00952419|3716496|FG001|NOT COMPLETED|Overall Study||10
2999525|NCT00952419|3716497|FG002|NOT COMPLETED|Overall Study||0
2999526|NCT00952484|3716508|FG000|STARTED|Overall Study||6
2999527|NCT00952484|3716509|FG001|STARTED|Overall Study||7
2999528|NCT00952484|3716510|FG002|STARTED|Overall Study||16
2999529|NCT00952484|3716508|FG000|COMPLETED|Overall Study||6
2999530|NCT00952484|3716509|FG001|COMPLETED|Overall Study||6
2999531|NCT00952484|3716510|FG002|COMPLETED|Overall Study||16
2999532|NCT00952484|3716508|FG000|NOT COMPLETED|Overall Study||0
2999533|NCT00952484|3716509|FG001|NOT COMPLETED|Overall Study||1
2999534|NCT00952484|3716510|FG002|NOT COMPLETED|Overall Study||0
2999535|NCT00952523|3716519|FG000|STARTED|Overall Study||162
2999536|NCT00952523|3716519|FG000|COMPLETED|Overall Study||155
2999537|NCT00952523|3716519|FG000|NOT COMPLETED|Overall Study||7
2999538|NCT00952588|3716527|FG000|STARTED|Overall Study||48
2999539|NCT00952588|3716528|FG001|STARTED|Overall Study||26
2999540|NCT00952588|3716527|FG000|COMPLETED|Overall Study||12
2999541|NCT00952588|3716528|FG001|COMPLETED|Overall Study||2
2999542|NCT00952588|3716527|FG000|NOT COMPLETED|Overall Study||36
2999543|NCT00952588|3716528|FG001|NOT COMPLETED|Overall Study||24
2999544|NCT00952614|3716534|FG000|STARTED|Overall Study||30
2999545|NCT00952614|3716534|FG000|Participants Started Treatment|Overall Study|29 subjects signed consent; 1 agreed for both eyes to enroll. 30 eyes rec'd drug delivery implant|30
2999546|NCT00952614|3716534|FG000|COMPLETED|Overall Study|3 subjects died from unrelated causes, 3 were lost to follow-up & 1 had both eyes included in study.|23
2999547|NCT00952614|3716534|FG000|NOT COMPLETED|Overall Study||7
2999548|NCT00952653|3716539|FG000|STARTED|Period 1: MDZ Alone||28
2999549|NCT00952653|3716539|FG000|COMPLETED|Period 1: MDZ Alone||28
2999550|NCT00952653|3716539|FG000|NOT COMPLETED|Period 1: MDZ Alone||0
2999551|NCT00952653|3716539|FG000|STARTED|Period 2: Coadministration DVS SR, MDZ||28
2999552|NCT00952653|3716539|FG000|COMPLETED|Period 2: Coadministration DVS SR, MDZ||28
2999553|NCT00952653|3716539|FG000|NOT COMPLETED|Period 2: Coadministration DVS SR, MDZ||0
2999554|NCT00952705|3716549|FG000|STARTED|Overall Study|Three not treated with Q/LAIV-BFS (1 treated with FluMist/B/Yamagata; 2 withdrew prior to dosing).|1202
2999555|NCT00952705|3716550|FG001|STARTED|Overall Study||300
2999556|NCT00952705|3716551|FG002|STARTED|Overall Study||298
2999557|NCT00952705|3716549|FG000|COMPLETED|Overall Study||1169
2999558|NCT00952705|3716550|FG001|COMPLETED|Overall Study||290
2999559|NCT00952705|3716551|FG002|COMPLETED|Overall Study||288
2999560|NCT00952705|3716549|FG000|NOT COMPLETED|Overall Study||33
2999561|NCT00952705|3716550|FG001|NOT COMPLETED|Overall Study||10
2999562|NCT00952705|3716551|FG002|NOT COMPLETED|Overall Study||10
2999563|NCT00952718|3716565|FG000|STARTED|Overall Study||19
2999564|NCT00952718|3716566|FG001|STARTED|Overall Study||19
2999565|NCT00952718|3716565|FG000|COMPLETED|Overall Study||13
2999566|NCT00952718|3716566|FG001|COMPLETED|Overall Study||13
2999567|NCT00952718|3716565|FG000|NOT COMPLETED|Overall Study||6
2999568|NCT00952718|3716566|FG001|NOT COMPLETED|Overall Study||6
2999569|NCT00952731|3716576|FG000|STARTED|Overall Study||13
2999570|NCT00952731|3716577|FG001|STARTED|Overall Study||14
2999571|NCT00952731|3716576|FG000|Randomization|Overall Study||13
2999572|NCT00952731|3716577|FG001|Randomization|Overall Study||14
2999573|NCT00952731|3716576|FG000|Treatment & Pre-Surgery|Overall Study||12
2999574|NCT00952731|3716577|FG001|Treatment & Pre-Surgery|Overall Study||14
2999575|NCT00952731|3716576|FG000|Surgery|Overall Study||12
2999576|NCT00952731|3716577|FG001|Surgery|Overall Study||14
2999577|NCT00952731|3716576|FG000|Follow-up|Overall Study||12
2999578|NCT00952731|3716577|FG001|Follow-up|Overall Study||14
2999579|NCT00952731|3716576|FG000|COMPLETED|Overall Study||12
2999580|NCT00952731|3716577|FG001|COMPLETED|Overall Study||14
2999581|NCT00952731|3716576|FG000|NOT COMPLETED|Overall Study||1
2999582|NCT00952731|3716577|FG001|NOT COMPLETED|Overall Study||0
2999583|NCT00952822|3716583|FG000|STARTED|1st Pharmacokinetic Evaluation||9
2999584|NCT00952822|3716584|FG001|STARTED|1st Pharmacokinetic Evaluation||18
2999585|NCT00952822|3716585|FG002|STARTED|1st Pharmacokinetic Evaluation||11
2999586|NCT00952822|3716586|FG003|STARTED|1st Pharmacokinetic Evaluation||4
2999587|NCT00952822|3716583|FG000|COMPLETED|1st Pharmacokinetic Evaluation||9
2999588|NCT00952822|3716584|FG001|COMPLETED|1st Pharmacokinetic Evaluation||17
2999589|NCT00952822|3716585|FG002|COMPLETED|1st Pharmacokinetic Evaluation||11
2999590|NCT00952822|3716586|FG003|COMPLETED|1st Pharmacokinetic Evaluation||4
2999591|NCT00952822|3716583|FG000|NOT COMPLETED|1st Pharmacokinetic Evaluation||0
2999592|NCT00952822|3716584|FG001|NOT COMPLETED|1st Pharmacokinetic Evaluation||1
2999593|NCT00952822|3716585|FG002|NOT COMPLETED|1st Pharmacokinetic Evaluation||0
2999594|NCT00952822|3716586|FG003|NOT COMPLETED|1st Pharmacokinetic Evaluation||0
2999595|NCT00952822|3716583|FG000|STARTED|2nd Pharmacokinetic Evaluation||9
2999596|NCT00952822|3716584|FG001|STARTED|2nd Pharmacokinetic Evaluation||17
2999597|NCT00952822|3716585|FG002|STARTED|2nd Pharmacokinetic Evaluation||11
2999598|NCT00952822|3716586|FG003|STARTED|2nd Pharmacokinetic Evaluation||4
2999599|NCT00952822|3716583|FG000|COMPLETED|2nd Pharmacokinetic Evaluation||9
2999600|NCT00952822|3716584|FG001|COMPLETED|2nd Pharmacokinetic Evaluation||17
2999601|NCT00952822|3716585|FG002|COMPLETED|2nd Pharmacokinetic Evaluation||10
2999602|NCT00952822|3716586|FG003|COMPLETED|2nd Pharmacokinetic Evaluation||4
2999603|NCT00952822|3716583|FG000|NOT COMPLETED|2nd Pharmacokinetic Evaluation||0
2999604|NCT00952822|3716584|FG001|NOT COMPLETED|2nd Pharmacokinetic Evaluation||0
3164835|NCT01895270|3892321|FG000|STARTED|Study Medications Induction (W1-4)||11
3164836|NCT01895270|3892322|FG001|STARTED|Study Medications Induction (W1-4)||14
3164837|NCT01895270|3892321|FG000|COMPLETED|Study Medications Induction (W1-4)||5
3164838|NCT01895270|3892322|FG001|COMPLETED|Study Medications Induction (W1-4)||8
3164839|NCT01895270|3892321|FG000|NOT COMPLETED|Study Medications Induction (W1-4)||6
3164840|NCT01895270|3892322|FG001|NOT COMPLETED|Study Medications Induction (W1-4)||6
3164841|NCT01895270|3892321|FG000|STARTED|Buprenorphine Taper (W5 to W6D3)||5
3164842|NCT01895270|3892322|FG001|STARTED|Buprenorphine Taper (W5 to W6D3)|1 subject missed meds prior to bup taper so did not start this phase|7
3164843|NCT01895270|3892321|FG000|COMPLETED|Buprenorphine Taper (W5 to W6D3)||2
3164844|NCT01895270|3892322|FG001|COMPLETED|Buprenorphine Taper (W5 to W6D3)||2
3164845|NCT01895270|3892321|FG000|NOT COMPLETED|Buprenorphine Taper (W5 to W6D3)||3
3164846|NCT01895270|3892322|FG001|NOT COMPLETED|Buprenorphine Taper (W5 to W6D3)||5
2999605|NCT00952822|3716585|FG002|NOT COMPLETED|2nd Pharmacokinetic Evaluation||1
2999606|NCT00952822|3716586|FG003|NOT COMPLETED|2nd Pharmacokinetic Evaluation||0
2999607|NCT00952848|3716597|FG000|STARTED|Overall Study||18
2999608|NCT00952848|3716597|FG000|COMPLETED|Overall Study||14
2999609|NCT00952848|3716597|FG000|NOT COMPLETED|Overall Study||4
2999610|NCT00953017|3716605|FG000|STARTED|Overall Study||106
2999611|NCT00953017|3716606|FG001|STARTED|Overall Study||107
2999612|NCT00953017|3716607|FG002|STARTED|Overall Study||106
2999613|NCT00953017|3716608|FG003|STARTED|Overall Study||106
2999614|NCT00953017|3716605|FG000|COMPLETED|Overall Study||101
2999615|NCT00953017|3716606|FG001|COMPLETED|Overall Study||101
2999616|NCT00953017|3716607|FG002|COMPLETED|Overall Study||100
2999617|NCT00953017|3716608|FG003|COMPLETED|Overall Study||101
2999618|NCT00953017|3716605|FG000|NOT COMPLETED|Overall Study||5
2999619|NCT00953017|3716606|FG001|NOT COMPLETED|Overall Study||6
2999620|NCT00953017|3716607|FG002|NOT COMPLETED|Overall Study||6
2999621|NCT00953017|3716608|FG003|NOT COMPLETED|Overall Study||5
2999622|NCT00953043|3716620|FG000|STARTED|Overall Study||30
2999623|NCT00953043|3716621|FG001|STARTED|Overall Study||30
2999624|NCT00953043|3716620|FG000|COMPLETED|Overall Study||26
3164847|NCT01895270|3892321|FG000|STARTED|Isradipine Taper (W7-8)||2
3164848|NCT01895270|3892322|FG001|STARTED|Isradipine Taper (W7-8)||2
2999625|NCT00953043|3716621|FG001|COMPLETED|Overall Study||28
2999626|NCT00953043|3716620|FG000|NOT COMPLETED|Overall Study||4
2999627|NCT00953043|3716621|FG001|NOT COMPLETED|Overall Study||2
2999628|NCT00953056|3716633|FG000|STARTED|Overall Study||24
2999629|NCT00953056|3716634|FG001|STARTED|Overall Study||24
2999630|NCT00953056|3716635|FG002|STARTED|Overall Study||24
2999631|NCT00953056|3716636|FG003|STARTED|Overall Study||24
2999632|NCT00953056|3716637|FG004|STARTED|Overall Study||24
2999633|NCT00953056|3716638|FG005|STARTED|Overall Study||24
2999634|NCT00953056|3716633|FG000|COMPLETED|Overall Study||24
2999635|NCT00953056|3716634|FG001|COMPLETED|Overall Study||24
2999636|NCT00953056|3716635|FG002|COMPLETED|Overall Study||24
2999637|NCT00953056|3716636|FG003|COMPLETED|Overall Study||24
2999638|NCT00953056|3716637|FG004|COMPLETED|Overall Study|One participant received placebo at the second dose in error, but completed the study.|22
2999639|NCT00953056|3716638|FG005|COMPLETED|Overall Study||20
2999640|NCT00953056|3716633|FG000|NOT COMPLETED|Overall Study||0
2999641|NCT00953056|3716634|FG001|NOT COMPLETED|Overall Study||0
2999642|NCT00953056|3716635|FG002|NOT COMPLETED|Overall Study||0
2999643|NCT00953056|3716636|FG003|NOT COMPLETED|Overall Study||0
2999644|NCT00953056|3716637|FG004|NOT COMPLETED|Overall Study||2
2999645|NCT00953056|3716638|FG005|NOT COMPLETED|Overall Study||4
2999646|NCT00953121|3716657|FG000|STARTED|Overall Study||40
2999647|NCT00953121|3716658|FG001|STARTED|Overall Study||39
2999648|NCT00953121|3716659|FG002|STARTED|Overall Study||25
2999649|NCT00953121|3716657|FG000|COMPLETED|Overall Study||40
2999650|NCT00953121|3716658|FG001|COMPLETED|Overall Study||39
2999651|NCT00953121|3716659|FG002|COMPLETED|Overall Study||25
2999652|NCT00953121|3716657|FG000|NOT COMPLETED|Overall Study||0
2999653|NCT00953121|3716658|FG001|NOT COMPLETED|Overall Study||0
2999654|NCT00953121|3716659|FG002|NOT COMPLETED|Overall Study||0
2999655|NCT00953147|3716670|FG000|STARTED|Overall Study||298
2999656|NCT00953147|3716671|FG001|STARTED|Overall Study||505
2999657|NCT00953147|3716672|FG002|STARTED|Overall Study||307
2999658|NCT00953147|3716670|FG000|COMPLETED|Overall Study||261
2999659|NCT00953147|3716671|FG001|COMPLETED|Overall Study||439
2999660|NCT00953147|3716672|FG002|COMPLETED|Overall Study||265
2999661|NCT00953147|3716670|FG000|NOT COMPLETED|Overall Study||37
2999662|NCT00953147|3716671|FG001|NOT COMPLETED|Overall Study||66
2999663|NCT00953147|3716672|FG002|NOT COMPLETED|Overall Study||42
2999664|NCT00953160|3716680|FG000|STARTED|Overall Study||76
2999665|NCT00953160|3716680|FG000|COMPLETED|Overall Study||49
2999666|NCT00953160|3716680|FG000|NOT COMPLETED|Overall Study||27
2999667|NCT00953173|3716684|FG000|STARTED|Overall Study||671
2999668|NCT00953173|3716684|FG000|COMPLETED|Overall Study||389
2999669|NCT00953173|3716684|FG000|NOT COMPLETED|Overall Study||282
2999670|NCT00953199|3716690|FG000|STARTED|Overall Study||254
2999671|NCT00953199|3716691|FG001|STARTED|Overall Study||252
2999672|NCT00953199|3716690|FG000|COMPLETED|Overall Study||254
2999673|NCT00953199|3716691|FG001|COMPLETED|Overall Study||252
2999674|NCT00953199|3716690|FG000|NOT COMPLETED|Overall Study||0
2999675|NCT00953199|3716691|FG001|NOT COMPLETED|Overall Study||0
2999676|NCT00953212|3716703|FG000|STARTED|Overall Study||76
2999677|NCT00953212|3716704|FG001|STARTED|Overall Study||74
2999678|NCT00953212|3716705|FG002|STARTED|Overall Study||78
3164849|NCT01895270|3892321|FG000|COMPLETED|Isradipine Taper (W7-8)||2
3164850|NCT01895270|3892322|FG001|COMPLETED|Isradipine Taper (W7-8)||0
3164851|NCT01895270|3892321|FG000|NOT COMPLETED|Isradipine Taper (W7-8)||0
2999679|NCT00953212|3716706|FG003|STARTED|Overall Study||76
2999680|NCT00953212|3716703|FG000|COMPLETED|Overall Study||76
2999681|NCT00953212|3716704|FG001|COMPLETED|Overall Study||74
2999682|NCT00953212|3716705|FG002|COMPLETED|Overall Study||78
2999683|NCT00953212|3716706|FG003|COMPLETED|Overall Study||76
2999684|NCT00953212|3716703|FG000|NOT COMPLETED|Overall Study||0
2999685|NCT00953212|3716704|FG001|NOT COMPLETED|Overall Study||0
2999686|NCT00953212|3716705|FG002|NOT COMPLETED|Overall Study||0
2999687|NCT00953212|3716706|FG003|NOT COMPLETED|Overall Study||0
2999688|NCT00953225|3716722|FG000|STARTED|Overall Study||46
2999689|NCT00953225|3716723|FG001|STARTED|Overall Study||37
2999690|NCT00953225|3716722|FG000|COMPLETED|Overall Study||44
2999691|NCT00953225|3716723|FG001|COMPLETED|Overall Study||37
2999692|NCT00953225|3716722|FG000|NOT COMPLETED|Overall Study||2
2999693|NCT00953225|3716723|FG001|NOT COMPLETED|Overall Study||0
2999694|NCT00953290|3716729|FG000|STARTED|Overall Study||4
2999695|NCT00953290|3716729|FG000|COMPLETED|Overall Study||4
2999696|NCT00953290|3716729|FG000|NOT COMPLETED|Overall Study||0
2999697|NCT00953407|3716741|FG000|STARTED|Overall Study||26
2999698|NCT00953407|3716742|FG001|STARTED|Overall Study||25
2999699|NCT00953407|3716743|FG002|STARTED|Overall Study||26
2999700|NCT00953407|3716744|FG003|STARTED|Overall Study||25
2999701|NCT00953407|3716745|FG004|STARTED|Overall Study||24
2999702|NCT00953407|3716741|FG000|COMPLETED|Overall Study||25
2999703|NCT00953407|3716742|FG001|COMPLETED|Overall Study||24
2999704|NCT00953407|3716743|FG002|COMPLETED|Overall Study||25
2999705|NCT00953407|3716744|FG003|COMPLETED|Overall Study||23
2999706|NCT00953407|3716745|FG004|COMPLETED|Overall Study||23
2999707|NCT00953407|3716741|FG000|NOT COMPLETED|Overall Study||1
2999708|NCT00953407|3716742|FG001|NOT COMPLETED|Overall Study||1
2999709|NCT00953407|3716743|FG002|NOT COMPLETED|Overall Study||1
2999710|NCT00953407|3716744|FG003|NOT COMPLETED|Overall Study||2
2999711|NCT00953407|3716745|FG004|NOT COMPLETED|Overall Study||1
2999712|NCT00953524|3716761|FG000|STARTED|Overall Study||249
2999713|NCT00953524|3716762|FG001|STARTED|Overall Study||254
2999714|NCT00953524|3716763|FG002|STARTED|Overall Study||247
2999715|NCT00953524|3716764|FG003|STARTED|Overall Study||99
2999716|NCT00953524|3716761|FG000|COMPLETED|Overall Study||227
2999717|NCT00953524|3716762|FG001|COMPLETED|Overall Study||239
2999718|NCT00953524|3716763|FG002|COMPLETED|Overall Study||233
2999719|NCT00953524|3716764|FG003|COMPLETED|Overall Study||91
2999720|NCT00953524|3716761|FG000|NOT COMPLETED|Overall Study||22
2999721|NCT00953524|3716762|FG001|NOT COMPLETED|Overall Study||15
2999722|NCT00953524|3716763|FG002|NOT COMPLETED|Overall Study||14
2999723|NCT00953524|3716764|FG003|NOT COMPLETED|Overall Study||8
2999724|NCT00953576|3716776|FG000|STARTED|Overall Study||6
2999725|NCT00953576|3716777|FG001|STARTED|Overall Study||5
2999726|NCT00953576|3716776|FG000|DLT Evaluable|Overall Study||3
2999727|NCT00953576|3716777|FG001|DLT Evaluable|Overall Study||5
2999728|NCT00953576|3716776|FG000|Treated|Overall Study||4
2999729|NCT00953576|3716777|FG001|Treated|Overall Study||5
2999730|NCT00953576|3716776|FG000|Pharmacokinetic (PK) Evaluable|Overall Study||4
2999731|NCT00953576|3716777|FG001|Pharmacokinetic (PK) Evaluable|Overall Study||3
2999732|NCT00953576|3716776|FG000|COMPLETED|Overall Study|One participant enrolled on dose level 1 did not receive full dose ketoconazole and was replaced.|4
2999733|NCT00953576|3716777|FG001|COMPLETED|Overall Study||4
2999734|NCT00953576|3716776|FG000|NOT COMPLETED|Overall Study||2
2999735|NCT00953576|3716777|FG001|NOT COMPLETED|Overall Study||1
2999736|NCT00953654|3716789|FG000|STARTED|Overall Study||10
2999737|NCT00953654|3716790|FG001|STARTED|Overall Study||10
2999738|NCT00953654|3716791|FG002|STARTED|Overall Study||10
2999739|NCT00953654|3716789|FG000|COMPLETED|Overall Study||10
2999740|NCT00953654|3716790|FG001|COMPLETED|Overall Study||10
2999741|NCT00953654|3716791|FG002|COMPLETED|Overall Study||10
2999742|NCT00953654|3716789|FG000|NOT COMPLETED|Overall Study||0
2999743|NCT00953654|3716790|FG001|NOT COMPLETED|Overall Study||0
2999744|NCT00953654|3716791|FG002|NOT COMPLETED|Overall Study||0
2999745|NCT00953667|3716799|FG000|STARTED|Overall Study||400
2999746|NCT00953667|3716799|FG000|COMPLETED|Overall Study||277
2999747|NCT00953667|3716799|FG000|NOT COMPLETED|Overall Study||123
2999748|NCT00953706|3716805|FG000|STARTED|Part A (16-Week Double-Blind Treatment)|All subjects who received at least 1 dose of study drug (placebo)|28
2999749|NCT00953706|3716806|FG001|STARTED|Part A (16-Week Double-Blind Treatment)|All subjects who received at least 1 dose of study drug (ivacaftor)|112
2999750|NCT00953706|3716807|FG002|STARTED|Part A (16-Week Double-Blind Treatment)||0
3164852|NCT01895270|3892322|FG001|NOT COMPLETED|Isradipine Taper (W7-8)||2
2999751|NCT00953706|3716808|FG003|STARTED|Part A (16-Week Double-Blind Treatment)||0
2999752|NCT00953706|3716805|FG000|COMPLETED|Part A (16-Week Double-Blind Treatment)|Only 5 participants continued in Part B.|26
2999753|NCT00953706|3716806|FG001|COMPLETED|Part A (16-Week Double-Blind Treatment)|Only 33 participants continued in Part B.|104
2999754|NCT00953706|3716807|FG002|COMPLETED|Part A (16-Week Double-Blind Treatment)||0
2999755|NCT00953706|3716808|FG003|COMPLETED|Part A (16-Week Double-Blind Treatment)||0
2999756|NCT00953706|3716805|FG000|NOT COMPLETED|Part A (16-Week Double-Blind Treatment)||2
2999757|NCT00953706|3716806|FG001|NOT COMPLETED|Part A (16-Week Double-Blind Treatment)||8
2999758|NCT00953706|3716807|FG002|NOT COMPLETED|Part A (16-Week Double-Blind Treatment)||0
2999759|NCT00953706|3716808|FG003|NOT COMPLETED|Part A (16-Week Double-Blind Treatment)||0
2999760|NCT00953706|3716805|FG000|STARTED|Part B (96-Week Open-Label Extension)||0
2999761|NCT00953706|3716806|FG001|STARTED|Part B (96-Week Open-Label Extension)||0
2999762|NCT00953706|3716807|FG002|STARTED|Part B (96-Week Open-Label Extension)||5
2999763|NCT00953706|3716808|FG003|STARTED|Part B (96-Week Open-Label Extension)||33
2999764|NCT00953706|3716805|FG000|COMPLETED|Part B (96-Week Open-Label Extension)||0
2999765|NCT00953706|3716806|FG001|COMPLETED|Part B (96-Week Open-Label Extension)||0
2999766|NCT00953706|3716807|FG002|COMPLETED|Part B (96-Week Open-Label Extension)||0
2999767|NCT00953706|3716808|FG003|COMPLETED|Part B (96-Week Open-Label Extension)||0
2999768|NCT00953706|3716805|FG000|NOT COMPLETED|Part B (96-Week Open-Label Extension)||0
2999769|NCT00953706|3716806|FG001|NOT COMPLETED|Part B (96-Week Open-Label Extension)||0
2999770|NCT00953706|3716807|FG002|NOT COMPLETED|Part B (96-Week Open-Label Extension)||5
2999771|NCT00953706|3716808|FG003|NOT COMPLETED|Part B (96-Week Open-Label Extension)||33
2999772|NCT00953719|3716820|FG000|STARTED|Overall Study||169
2999773|NCT00953719|3716821|FG001|STARTED|Overall Study||74
2999774|NCT00953719|3716820|FG000|COMPLETED|Overall Study||150
2999775|NCT00953719|3716821|FG001|COMPLETED|Overall Study||69
2999776|NCT00953719|3716820|FG000|NOT COMPLETED|Overall Study||19
2999777|NCT00953719|3716821|FG001|NOT COMPLETED|Overall Study||5
2999778|NCT00953745|3716829|FG000|STARTED|Phase 1: 8 Weeks Escitalopram + Placebo||37
2999779|NCT00953745|3716830|FG001|STARTED|Phase 1: 8 Weeks Escitalopram + Placebo||6
2999780|NCT00953745|3716829|FG000|COMPLETED|Phase 1: 8 Weeks Escitalopram + Placebo||24
2999781|NCT00953745|3716830|FG001|COMPLETED|Phase 1: 8 Weeks Escitalopram + Placebo||6
2999782|NCT00953745|3716829|FG000|NOT COMPLETED|Phase 1: 8 Weeks Escitalopram + Placebo||13
2999783|NCT00953745|3716830|FG001|NOT COMPLETED|Phase 1: 8 Weeks Escitalopram + Placebo||0
2999784|NCT00953745|3716829|FG000|STARTED|Phase 2: 2 Weeks Escitalopram + Placebo||18
2999785|NCT00953745|3716830|FG001|STARTED|Phase 2: 2 Weeks Escitalopram + Placebo||0
2999786|NCT00953745|3716829|FG000|COMPLETED|Phase 2: 2 Weeks Escitalopram + Placebo||17
2999787|NCT00953745|3716830|FG001|COMPLETED|Phase 2: 2 Weeks Escitalopram + Placebo||0
2999788|NCT00953745|3716829|FG000|NOT COMPLETED|Phase 2: 2 Weeks Escitalopram + Placebo||1
2999789|NCT00953745|3716830|FG001|NOT COMPLETED|Phase 2: 2 Weeks Escitalopram + Placebo||0
2999790|NCT00953745|3716829|FG000|STARTED|ARP Phase: 6 Weeks Escitalopram + ARP||17
2999791|NCT00953745|3716830|FG001|STARTED|ARP Phase: 6 Weeks Escitalopram + ARP||0
2999792|NCT00953745|3716829|FG000|COMPLETED|ARP Phase: 6 Weeks Escitalopram + ARP||17
2999793|NCT00953745|3716830|FG001|COMPLETED|ARP Phase: 6 Weeks Escitalopram + ARP||0
2999794|NCT00953745|3716829|FG000|NOT COMPLETED|ARP Phase: 6 Weeks Escitalopram + ARP||0
2999795|NCT00953745|3716830|FG001|NOT COMPLETED|ARP Phase: 6 Weeks Escitalopram + ARP||0
2999796|NCT00953849|3716842|FG000|STARTED|Overall Study||6
2999797|NCT00953849|3716843|FG001|STARTED|Overall Study||6
2999798|NCT00953849|3716844|FG002|STARTED|Overall Study||4
2999799|NCT00953849|3716845|FG003|STARTED|Overall Study||5
2999800|NCT00953849|3716842|FG000|COMPLETED|Overall Study||6
2999801|NCT00953849|3716843|FG001|COMPLETED|Overall Study||6
2999802|NCT00953849|3716844|FG002|COMPLETED|Overall Study||4
2999803|NCT00953849|3716845|FG003|COMPLETED|Overall Study||5
2999804|NCT00953849|3716842|FG000|NOT COMPLETED|Overall Study||0
2999805|NCT00953849|3716843|FG001|NOT COMPLETED|Overall Study||0
2999806|NCT00953849|3716844|FG002|NOT COMPLETED|Overall Study||0
2999807|NCT00953849|3716845|FG003|NOT COMPLETED|Overall Study||0
2999808|NCT00953862|3716859|FG000|STARTED|Overall Study||18
2999809|NCT00953862|3716859|FG000|COMPLETED|Overall Study||12
2999810|NCT00953862|3716859|FG000|NOT COMPLETED|Overall Study||6
2999811|NCT00953927|3716867|FG000|STARTED|Overall Study||1399
2999812|NCT00953927|3716868|FG001|STARTED|Overall Study||1398
2999813|NCT00953927|3716867|FG000|COMPLETED|Overall Study||1294
2999814|NCT00953927|3716868|FG001|COMPLETED|Overall Study||1303
2999815|NCT00953927|3716867|FG000|NOT COMPLETED|Overall Study||105
2999816|NCT00953927|3716868|FG001|NOT COMPLETED|Overall Study||95
2999817|NCT00954109|3716874|FG000|STARTED|Overall Study||11
2999818|NCT00954109|3716874|FG000|COMPLETED|Overall Study||11
2999819|NCT00954109|3716874|FG000|NOT COMPLETED|Overall Study||0
2999820|NCT00954122|3716878|FG000|STARTED|Overall Study||35
2999821|NCT00954122|3716878|FG000|COMPLETED|Overall Study||28
2999822|NCT00954122|3716878|FG000|NOT COMPLETED|Overall Study||7
2999823|NCT00954174|3716887|FG000|STARTED|Overall Study||268
2999824|NCT00954174|3716888|FG001|STARTED|Overall Study||268
2999825|NCT00954174|3716889|FG002|STARTED|Overall Study||51
2999826|NCT00954174|3716890|FG003|STARTED|Overall Study||50
2999827|NCT00954174|3716887|FG000|COMPLETED|Overall Study||142
2999828|NCT00954174|3716888|FG001|COMPLETED|Overall Study||145
2999829|NCT00954174|3716889|FG002|COMPLETED|Overall Study||27
2999830|NCT00954174|3716890|FG003|COMPLETED|Overall Study||25
2999831|NCT00954174|3716887|FG000|NOT COMPLETED|Overall Study||126
2999832|NCT00954174|3716888|FG001|NOT COMPLETED|Overall Study||123
2999833|NCT00954174|3716889|FG002|NOT COMPLETED|Overall Study||24
2999834|NCT00954174|3716890|FG003|NOT COMPLETED|Overall Study||25
2999835|NCT00954356|3716905|FG000|STARTED|Overall Study||41
2999836|NCT00954356|3716906|FG001|STARTED|Overall Study||20
2999837|NCT00954356|3716905|FG000|COMPLETED|Overall Study||41
2999838|NCT00954356|3716906|FG001|COMPLETED|Overall Study||20
2999839|NCT00954356|3716905|FG000|NOT COMPLETED|Overall Study||0
2999840|NCT00954356|3716906|FG001|NOT COMPLETED|Overall Study||0
2999841|NCT00954421|3716912|FG000|STARTED|Screening||16
2999842|NCT00954421|3716912|FG000|COMPLETED|Screening||13
2999843|NCT00954421|3716912|FG000|NOT COMPLETED|Screening||3
2999844|NCT00954421|3716912|FG000|STARTED|Baseline||13
2999845|NCT00954421|3716912|FG000|COMPLETED|Baseline||13
2999846|NCT00954421|3716912|FG000|NOT COMPLETED|Baseline||0
2999847|NCT00954421|3716912|FG000|STARTED|6 Months of DBS||13
2999848|NCT00954421|3716912|FG000|COMPLETED|6 Months of DBS||12
2999849|NCT00954421|3716912|FG000|NOT COMPLETED|6 Months of DBS||1
2999850|NCT00954421|3716912|FG000|STARTED|VIM=ON VO=ON at 6 Months|This is the point of evaluation: Order of assessment was random for periods 4-7|12
2999851|NCT00954421|3716912|FG000|COMPLETED|VIM=ON VO=ON at 6 Months||12
2999852|NCT00954421|3716912|FG000|NOT COMPLETED|VIM=ON VO=ON at 6 Months||0
2999853|NCT00954421|3716912|FG000|STARTED|VIM=OFF VO=OFF at 6 Months||12
2999854|NCT00954421|3716912|FG000|COMPLETED|VIM=OFF VO=OFF at 6 Months||12
2999855|NCT00954421|3716912|FG000|NOT COMPLETED|VIM=OFF VO=OFF at 6 Months||0
2999856|NCT00954421|3716912|FG000|STARTED|VIM=OFF VO=ON at 6 Months||12
2999857|NCT00954421|3716912|FG000|COMPLETED|VIM=OFF VO=ON at 6 Months||12
2999858|NCT00954421|3716912|FG000|NOT COMPLETED|VIM=OFF VO=ON at 6 Months||0
2999859|NCT00954421|3716912|FG000|STARTED|VIM=ON VO=OFF at 6 Months||12
2999860|NCT00954421|3716912|FG000|COMPLETED|VIM=ON VO=OFF at 6 Months||11
2999861|NCT00954421|3716912|FG000|NOT COMPLETED|VIM=ON VO=OFF at 6 Months||1
2999862|NCT00954447|3716920|FG000|STARTED|Overall Study||630
2999863|NCT00954447|3716921|FG001|STARTED|Overall Study||631
2999864|NCT00954447|3716920|FG000|COMPLETED|Overall Study||520
2999865|NCT00954447|3716921|FG001|COMPLETED|Overall Study||543
2999866|NCT00954447|3716920|FG000|NOT COMPLETED|Overall Study||110
2999867|NCT00954447|3716921|FG001|NOT COMPLETED|Overall Study||88
2999868|NCT00954512|3716933|FG000|STARTED|Overall Study||2
2999869|NCT00954512|3716934|FG001|STARTED|Overall Study||3
2999870|NCT00954512|3716935|FG002|STARTED|Overall Study||0
2999871|NCT00954512|3716936|FG003|STARTED|Overall Study||2
2999872|NCT00954512|3716937|FG004|STARTED|Overall Study||4
2999873|NCT00954512|3716938|FG005|STARTED|Overall Study||4
2999874|NCT00954512|3716933|FG000|COMPLETED|Overall Study||0
2999875|NCT00954512|3716934|FG001|COMPLETED|Overall Study||0
2999876|NCT00954512|3716935|FG002|COMPLETED|Overall Study||0
2999877|NCT00954512|3716936|FG003|COMPLETED|Overall Study||0
2999878|NCT00954512|3716937|FG004|COMPLETED|Overall Study||0
2999879|NCT00954512|3716938|FG005|COMPLETED|Overall Study||0
2999880|NCT00954512|3716933|FG000|NOT COMPLETED|Overall Study||2
2999881|NCT00954512|3716934|FG001|NOT COMPLETED|Overall Study||3
2999882|NCT00954512|3716935|FG002|NOT COMPLETED|Overall Study||0
2999883|NCT00954512|3716936|FG003|NOT COMPLETED|Overall Study||2
2999884|NCT00954512|3716937|FG004|NOT COMPLETED|Overall Study||4
2999885|NCT00954512|3716938|FG005|NOT COMPLETED|Overall Study||4
2999886|NCT00954538|3716953|FG000|STARTED|Part I|These subjects did not participate in Part II or III|3
2999887|NCT00954538|3716954|FG001|STARTED|Part I||0
2999888|NCT00954538|3716955|FG002|STARTED|Part I||0
2999889|NCT00954538|3716956|FG003|STARTED|Part I||0
2999890|NCT00954538|3716957|FG004|STARTED|Part I||0
2999891|NCT00954538|3716958|FG005|STARTED|Part I||0
3164853|NCT01895309|3892330|FG000|STARTED|Overall Study||299
3164854|NCT01895309|3892331|FG001|STARTED|Overall Study||297
3164855|NCT01895309|3892330|FG000|COMPLETED|Overall Study||259
2999892|NCT00954538|3716953|FG000|COMPLETED|Part I||3
2999893|NCT00954538|3716954|FG001|COMPLETED|Part I||0
2999894|NCT00954538|3716955|FG002|COMPLETED|Part I||0
2999895|NCT00954538|3716956|FG003|COMPLETED|Part I||0
2999896|NCT00954538|3716957|FG004|COMPLETED|Part I||0
2999897|NCT00954538|3716958|FG005|COMPLETED|Part I||0
2999898|NCT00954538|3716953|FG000|NOT COMPLETED|Part I||0
2999899|NCT00954538|3716954|FG001|NOT COMPLETED|Part I||0
2999900|NCT00954538|3716955|FG002|NOT COMPLETED|Part I||0
2999901|NCT00954538|3716956|FG003|NOT COMPLETED|Part I||0
2999902|NCT00954538|3716957|FG004|NOT COMPLETED|Part I||0
2999903|NCT00954538|3716958|FG005|NOT COMPLETED|Part I||0
2999904|NCT00954538|3716953|FG000|STARTED|Part II||0
2999905|NCT00954538|3716954|FG001|STARTED|Part II|This subject did not participate in Part I or III|1
2999906|NCT00954538|3716955|FG002|STARTED|Part II|These subjects did not participate in Part I or III|3
2999907|NCT00954538|3716956|FG003|STARTED|Part II||0
2999908|NCT00954538|3716957|FG004|STARTED|Part II||0
2999909|NCT00954538|3716958|FG005|STARTED|Part II|These subjects did not participate in Part I and did participate in Part II and III|2
2999910|NCT00954538|3716953|FG000|COMPLETED|Part II||0
2999911|NCT00954538|3716954|FG001|COMPLETED|Part II||1
2999912|NCT00954538|3716955|FG002|COMPLETED|Part II||3
2999913|NCT00954538|3716956|FG003|COMPLETED|Part II||0
2999914|NCT00954538|3716957|FG004|COMPLETED|Part II||0
2999915|NCT00954538|3716958|FG005|COMPLETED|Part II||2
2999916|NCT00954538|3716953|FG000|NOT COMPLETED|Part II||0
3164856|NCT01895309|3892331|FG001|COMPLETED|Overall Study||246
2999917|NCT00954538|3716954|FG001|NOT COMPLETED|Part II||0
2999918|NCT00954538|3716955|FG002|NOT COMPLETED|Part II||0
2999919|NCT00954538|3716956|FG003|NOT COMPLETED|Part II||0
2999920|NCT00954538|3716957|FG004|NOT COMPLETED|Part II||0
2999921|NCT00954538|3716958|FG005|NOT COMPLETED|Part II||0
2999922|NCT00954538|3716953|FG000|STARTED|Part III||0
2999923|NCT00954538|3716954|FG001|STARTED|Part III||0
2999924|NCT00954538|3716955|FG002|STARTED|Part III||0
2999925|NCT00954538|3716956|FG003|STARTED|Part III|These subjects did not participate in Part I or II|4
2999926|NCT00954538|3716957|FG004|STARTED|Part III|These subjects did not participate in Part I or II|6
2999927|NCT00954538|3716958|FG005|STARTED|Part III|These subjects did not participate in Part I and did participate in Part II and III|2
2999928|NCT00954538|3716953|FG000|COMPLETED|Part III||0
2999929|NCT00954538|3716954|FG001|COMPLETED|Part III||0
2999930|NCT00954538|3716955|FG002|COMPLETED|Part III||0
2999931|NCT00954538|3716956|FG003|COMPLETED|Part III||4
2999932|NCT00954538|3716957|FG004|COMPLETED|Part III|The subject who did not complete received 1 dose of study drug|5
2999933|NCT00954538|3716958|FG005|COMPLETED|Part III||2
2999934|NCT00954538|3716953|FG000|NOT COMPLETED|Part III||0
2999935|NCT00954538|3716954|FG001|NOT COMPLETED|Part III||0
2999936|NCT00954538|3716955|FG002|NOT COMPLETED|Part III||0
2999937|NCT00954538|3716956|FG003|NOT COMPLETED|Part III||0
2999938|NCT00954538|3716957|FG004|NOT COMPLETED|Part III||1
2999939|NCT00954538|3716958|FG005|NOT COMPLETED|Part III||0
2999940|NCT00954681|3716967|FG000|STARTED|Overall Study||15
2999941|NCT00954681|3716967|FG000|COMPLETED|Overall Study||10
2999942|NCT00954681|3716967|FG000|NOT COMPLETED|Overall Study||5
2999943|NCT00954707|3716971|FG000|STARTED|Overall Study||2509
2999944|NCT00954707|3716971|FG000|COMPLETED|Overall Study|2342 Subjects completed 12-month Phase 1 follow-up; 167 subjects didn't complete the Phase 1.|2342
2999945|NCT00954707|3716971|FG000|NOT COMPLETED|Overall Study||167
2999946|NCT00954733|3716975|FG000|STARTED|Overall Study||40
2999947|NCT00954733|3716975|FG000|COMPLETED|Overall Study||39
2999948|NCT00954733|3716975|FG000|NOT COMPLETED|Overall Study||1
2999949|NCT00954824|3716979|FG000|STARTED|Overall Study||100
2999950|NCT00954824|3716979|FG000|COMPLETED|Overall Study||50
2999951|NCT00954824|3716979|FG000|NOT COMPLETED|Overall Study||50
2999952|NCT00954941|3716985|FG000|STARTED|Overall Study||50
2999953|NCT00954941|3716986|FG001|STARTED|Overall Study||48
2999954|NCT00954941|3716985|FG000|COMPLETED|Overall Study||42
2999955|NCT00954941|3716986|FG001|COMPLETED|Overall Study||41
2999956|NCT00954941|3716985|FG000|NOT COMPLETED|Overall Study||8
2999957|NCT00954941|3716986|FG001|NOT COMPLETED|Overall Study||7
2999958|NCT00954993|3716992|FG000|STARTED|Period 1||3
2999959|NCT00954993|3716992|FG000|COMPLETED|Period 1||3
2999960|NCT00954993|3716992|FG000|NOT COMPLETED|Period 1||0
2999961|NCT00954993|3716992|FG000|STARTED|Washout||3
2999962|NCT00954993|3716992|FG000|COMPLETED|Washout||3
2999963|NCT00954993|3716992|FG000|NOT COMPLETED|Washout||0
2999964|NCT00954993|3716992|FG000|STARTED|Period 2||3
2999965|NCT00954993|3716992|FG000|COMPLETED|Period 2||3
2999966|NCT00954993|3716992|FG000|NOT COMPLETED|Period 2||0
2999967|NCT00955032|3717000|FG000|STARTED|Overall Study||16
2999968|NCT00955032|3717001|FG001|STARTED|Overall Study||8
2999969|NCT00955032|3717000|FG000|COMPLETED|Overall Study||16
2999970|NCT00955032|3717001|FG001|COMPLETED|Overall Study||8
2999971|NCT00955032|3717000|FG000|NOT COMPLETED|Overall Study||0
2999972|NCT00955032|3717001|FG001|NOT COMPLETED|Overall Study||0
2999973|NCT00955110|3717016|FG000|STARTED|Qualification Phase||78
2999974|NCT00955110|3717016|FG000|COMPLETED|Qualification Phase||54
2999975|NCT00955110|3717016|FG000|NOT COMPLETED|Qualification Phase||24
2999976|NCT00955110|3717016|FG000|STARTED|Treatment Phase||41
2999977|NCT00955110|3717016|FG000|Placebo|Treatment Phase||38
2999978|NCT00955110|3717016|FG000|Oxymorphone ER 15 mg|Treatment Phase||37
2999979|NCT00955110|3717016|FG000|Oxymorphone ER 30 mg|Treatment Phase||38
2999980|NCT00955110|3717016|FG000|Oxycodone CR 30 mg|Treatment Phase||40
2999981|NCT00955110|3717016|FG000|Oxycodone CR 60 mg|Treatment Phase||40
2999982|NCT00955110|3717016|FG000|COMPLETED|Treatment Phase||35
2999983|NCT00955110|3717016|FG000|NOT COMPLETED|Treatment Phase||6
2999984|NCT00955201|3717032|FG000|STARTED|Overall Study||12
2999985|NCT00955201|3717033|FG001|STARTED|Overall Study||11
2999986|NCT00955201|3717034|FG002|STARTED|Overall Study||11
2999987|NCT00955201|3717035|FG003|STARTED|Overall Study||11
2999988|NCT00955201|3717032|FG000|COMPLETED|Overall Study||8
2999989|NCT00955201|3717033|FG001|COMPLETED|Overall Study||11
2999990|NCT00955201|3717034|FG002|COMPLETED|Overall Study||10
2999991|NCT00955201|3717035|FG003|COMPLETED|Overall Study||7
2999992|NCT00955201|3717032|FG000|NOT COMPLETED|Overall Study||4
2999993|NCT00955201|3717033|FG001|NOT COMPLETED|Overall Study||0
2999994|NCT00955201|3717034|FG002|NOT COMPLETED|Overall Study||1
2999995|NCT00955201|3717035|FG003|NOT COMPLETED|Overall Study||4
2999996|NCT00955253|3717054|FG000|STARTED|First Intervention (Day 2)||7
2999997|NCT00955253|3717055|FG001|STARTED|First Intervention (Day 2)||6
2999998|NCT00955253|3717054|FG000|COMPLETED|First Intervention (Day 2)||7
2999999|NCT00955253|3717055|FG001|COMPLETED|First Intervention (Day 2)||6
3000000|NCT00955253|3717054|FG000|NOT COMPLETED|First Intervention (Day 2)||0
3000001|NCT00955253|3717055|FG001|NOT COMPLETED|First Intervention (Day 2)||0
3000002|NCT00955253|3717054|FG000|STARTED|Second Intervention (Day 4)||7
3000003|NCT00955253|3717055|FG001|STARTED|Second Intervention (Day 4)||6
3000004|NCT00955253|3717054|FG000|COMPLETED|Second Intervention (Day 4)||7
3000005|NCT00955253|3717055|FG001|COMPLETED|Second Intervention (Day 4)||6
3000006|NCT00955253|3717054|FG000|NOT COMPLETED|Second Intervention (Day 4)||0
3000007|NCT00955253|3717055|FG001|NOT COMPLETED|Second Intervention (Day 4)||0
3000008|NCT00955266|3717062|FG000|STARTED|Overall Study||4
3000009|NCT00955266|3717063|FG001|STARTED|Overall Study||4
3000010|NCT00955266|3717062|FG000|COMPLETED|Overall Study||4
3000011|NCT00955266|3717063|FG001|COMPLETED|Overall Study||4
3000012|NCT00955266|3717062|FG000|NOT COMPLETED|Overall Study||0
3000013|NCT00955266|3717063|FG001|NOT COMPLETED|Overall Study||0
3000014|NCT00955279|3717072|FG000|STARTED|Overall Study||58
3164857|NCT01895309|3892330|FG000|NOT COMPLETED|Overall Study||40
3164858|NCT01895309|3892331|FG001|NOT COMPLETED|Overall Study||51
3164859|NCT01895322|3892341|FG000|STARTED|Overall Study||20
3164860|NCT01895322|3892341|FG000|COMPLETED|Overall Study||7
3164861|NCT01895322|3892341|FG000|NOT COMPLETED|Overall Study||13
3164862|NCT01895335|3892346|FG000|STARTED|Overall Study||1001
3164863|NCT01895335|3892346|FG000|Treated|Overall Study||1000
3000015|NCT00955279|3717073|FG001|STARTED|Overall Study||55
3000016|NCT00955279|3717074|FG002|STARTED|Overall Study||60
3000017|NCT00955279|3717072|FG000|COMPLETED|Overall Study||55
3000018|NCT00955279|3717073|FG001|COMPLETED|Overall Study||51
3000019|NCT00955279|3717074|FG002|COMPLETED|Overall Study||52
3000020|NCT00955279|3717072|FG000|NOT COMPLETED|Overall Study||3
3000021|NCT00955279|3717073|FG001|NOT COMPLETED|Overall Study||4
3000022|NCT00955279|3717074|FG002|NOT COMPLETED|Overall Study||8
3000023|NCT00955305|3717084|FG000|STARTED|Overall Study||88
3000024|NCT00955305|3717085|FG001|STARTED|Overall Study||87
3000025|NCT00955305|3717084|FG000|Treated|Overall Study||83
3000026|NCT00955305|3717085|FG001|Treated|Overall Study||82
3000027|NCT00955305|3717084|FG000|Eligible and Treated|Overall Study||78
3000028|NCT00955305|3717085|FG001|Eligible and Treated|Overall Study||75
3000029|NCT00955305|3717084|FG000|COMPLETED|Overall Study|Treatment continued until disease progression or unacceptable toxicities.|0
3000030|NCT00955305|3717085|FG001|COMPLETED|Overall Study|Treatment continued until disease progression or unacceptable toxicities.|0
3000031|NCT00955305|3717084|FG000|NOT COMPLETED|Overall Study||88
3000032|NCT00955305|3717085|FG001|NOT COMPLETED|Overall Study||87
3000033|NCT00955357|3717093|FG000|STARTED|Titration Phase||96
3000034|NCT00955357|3717094|FG001|STARTED|Titration Phase||360
3000035|NCT00955357|3717093|FG000|COMPLETED|Titration Phase||80
3000036|NCT00955357|3717094|FG001|COMPLETED|Titration Phase||294
3000037|NCT00955357|3717093|FG000|NOT COMPLETED|Titration Phase||16
3000038|NCT00955357|3717094|FG001|NOT COMPLETED|Titration Phase||66
3000039|NCT00955357|3717093|FG000|STARTED|Maintenance Phase||80
3000040|NCT00955357|3717094|FG001|STARTED|Maintenance Phase||294
3000041|NCT00955357|3717093|FG000|COMPLETED|Maintenance Phase||68
3000042|NCT00955357|3717094|FG001|COMPLETED|Maintenance Phase||249
3000043|NCT00955357|3717093|FG000|NOT COMPLETED|Maintenance Phase||12
3000044|NCT00955357|3717094|FG001|NOT COMPLETED|Maintenance Phase||45
3000045|NCT00955409|3717110|FG000|STARTED|Overall Study|Started=Randomized|21
3000046|NCT00955409|3717111|FG001|STARTED|Overall Study|Started=Randomized|6
3000047|NCT00955409|3717112|FG002|STARTED|Overall Study|Started=Randomized|41
3000048|NCT00955409|3717113|FG003|STARTED|Overall Study|Started=Randomized.|25
3000049|NCT00955409|3717114|FG004|STARTED|Overall Study|Started=Randomized|5
3000050|NCT00955409|3717115|FG005|STARTED|Overall Study|Started=Randomized|9
3000051|NCT00955409|3717116|FG006|STARTED|Overall Study|Started=Randomized|27
3000052|NCT00955409|3717117|FG007|STARTED|Overall Study|Started=Randomized|6
3000053|NCT00955409|3717118|FG008|STARTED|Overall Study|Started=Randomized|16
3000054|NCT00955409|3717119|FG009|STARTED|Overall Study|Started=Randomized|4
3000055|NCT00955409|3717110|FG000|Treated|Overall Study||21
3000056|NCT00955409|3717111|FG001|Treated|Overall Study||6
3000057|NCT00955409|3717112|FG002|Treated|Overall Study||41
3000058|NCT00955409|3717113|FG003|Treated|Overall Study||24
3000059|NCT00955409|3717114|FG004|Treated|Overall Study||5
3000060|NCT00955409|3717115|FG005|Treated|Overall Study||9
3000061|NCT00955409|3717116|FG006|Treated|Overall Study||27
3000062|NCT00955409|3717117|FG007|Treated|Overall Study||6
3000063|NCT00955409|3717118|FG008|Treated|Overall Study||16
3000064|NCT00955409|3717119|FG009|Treated|Overall Study||4
3000065|NCT00955409|3717110|FG000|Completed Treatment|Overall Study||12
3000066|NCT00955409|3717111|FG001|Completed Treatment|Overall Study||5
3000067|NCT00955409|3717112|FG002|Completed Treatment|Overall Study||15
3000068|NCT00955409|3717113|FG003|Completed Treatment|Overall Study||17
3000069|NCT00955409|3717114|FG004|Completed Treatment|Overall Study||3
3000070|NCT00955409|3717115|FG005|Completed Treatment|Overall Study||7
3000071|NCT00955409|3717116|FG006|Completed Treatment|Overall Study||4
3000072|NCT00955409|3717117|FG007|Completed Treatment|Overall Study||3
3000073|NCT00955409|3717118|FG008|Completed Treatment|Overall Study||2
3000074|NCT00955409|3717119|FG009|Completed Treatment|Overall Study||4
3000075|NCT00955409|3717110|FG000|COMPLETED|Overall Study|Completed study|11
3000076|NCT00955409|3717111|FG001|COMPLETED|Overall Study|Completed study|5
3000077|NCT00955409|3717112|FG002|COMPLETED|Overall Study|Completed study|15
3000078|NCT00955409|3717113|FG003|COMPLETED|Overall Study|Completed study|17
3000079|NCT00955409|3717114|FG004|COMPLETED|Overall Study|Completed study|3
3000080|NCT00955409|3717115|FG005|COMPLETED|Overall Study|Completed study|6
3000081|NCT00955409|3717116|FG006|COMPLETED|Overall Study|Completed study|3
3000082|NCT00955409|3717117|FG007|COMPLETED|Overall Study|Completed study|2
3000083|NCT00955409|3717118|FG008|COMPLETED|Overall Study|Completed study|2
3000084|NCT00955409|3717119|FG009|COMPLETED|Overall Study|Completed study|3
3000085|NCT00955409|3717110|FG000|NOT COMPLETED|Overall Study||10
3000086|NCT00955409|3717111|FG001|NOT COMPLETED|Overall Study||1
3000087|NCT00955409|3717112|FG002|NOT COMPLETED|Overall Study||26
3000088|NCT00955409|3717113|FG003|NOT COMPLETED|Overall Study||8
3000089|NCT00955409|3717114|FG004|NOT COMPLETED|Overall Study||2
3000090|NCT00955409|3717115|FG005|NOT COMPLETED|Overall Study||3
3000091|NCT00955409|3717116|FG006|NOT COMPLETED|Overall Study||24
3000092|NCT00955409|3717117|FG007|NOT COMPLETED|Overall Study||4
3000093|NCT00955409|3717118|FG008|NOT COMPLETED|Overall Study||14
3000094|NCT00955409|3717119|FG009|NOT COMPLETED|Overall Study||1
3000095|NCT00955474|3717147|FG000|STARTED|Overall Study||12
3000096|NCT00955474|3717148|FG001|STARTED|Overall Study||13
3000097|NCT00955474|3717147|FG000|COMPLETED|Overall Study||5
3000098|NCT00955474|3717148|FG001|COMPLETED|Overall Study||8
3000099|NCT00955474|3717147|FG000|NOT COMPLETED|Overall Study||7
3000100|NCT00955474|3717148|FG001|NOT COMPLETED|Overall Study||5
3000101|NCT00955487|3717158|FG000|STARTED|Overall Study||10
3000102|NCT00955487|3717159|FG001|STARTED|Overall Study||9
3000103|NCT00955487|3717160|FG002|STARTED|Overall Study||17
3000104|NCT00955487|3717161|FG003|STARTED|Overall Study||21
3000105|NCT00955487|3717162|FG004|STARTED|Overall Study||32
3000106|NCT00955487|3717163|FG005|STARTED|Overall Study||35
3000107|NCT00955487|3717158|FG000|COMPLETED|Overall Study||10
3000108|NCT00955487|3717159|FG001|COMPLETED|Overall Study||9
3000109|NCT00955487|3717160|FG002|COMPLETED|Overall Study||17
3000110|NCT00955487|3717161|FG003|COMPLETED|Overall Study||21
3000111|NCT00955487|3717162|FG004|COMPLETED|Overall Study||32
3000112|NCT00955487|3717163|FG005|COMPLETED|Overall Study||35
3000113|NCT00955487|3717158|FG000|NOT COMPLETED|Overall Study||0
3000114|NCT00955487|3717159|FG001|NOT COMPLETED|Overall Study||0
3000115|NCT00955487|3717160|FG002|NOT COMPLETED|Overall Study||0
3000116|NCT00955487|3717161|FG003|NOT COMPLETED|Overall Study||0
3000117|NCT00955487|3717162|FG004|NOT COMPLETED|Overall Study||0
3000118|NCT00955487|3717163|FG005|NOT COMPLETED|Overall Study||0
3000119|NCT00955513|3717178|FG000|STARTED|Overall Study||80
3000120|NCT00955513|3717179|FG001|STARTED|Overall Study||80
3000121|NCT00955513|3717180|FG002|STARTED|Overall Study||82
3000122|NCT00955513|3717178|FG000|COMPLETED|Overall Study||79
3000123|NCT00955513|3717179|FG001|COMPLETED|Overall Study||78
3000124|NCT00955513|3717180|FG002|COMPLETED|Overall Study||79
3000125|NCT00955513|3717178|FG000|NOT COMPLETED|Overall Study||1
3000126|NCT00955513|3717179|FG001|NOT COMPLETED|Overall Study||2
3000127|NCT00955513|3717180|FG002|NOT COMPLETED|Overall Study||3
3000128|NCT00955617|3717188|FG000|STARTED|First MRA (Between Day0 and Day21)||10
3000129|NCT00955617|3717189|FG001|STARTED|First MRA (Between Day0 and Day21)||10
3000130|NCT00955617|3717188|FG000|COMPLETED|First MRA (Between Day0 and Day21)||10
3000131|NCT00955617|3717189|FG001|COMPLETED|First MRA (Between Day0 and Day21)||10
3000132|NCT00955617|3717188|FG000|NOT COMPLETED|First MRA (Between Day0 and Day21)||0
3000133|NCT00955617|3717189|FG001|NOT COMPLETED|First MRA (Between Day0 and Day21)||0
3000134|NCT00955617|3717188|FG000|STARTED|Second MRA (Between Day 1 and Day 51)||10
3000135|NCT00955617|3717189|FG001|STARTED|Second MRA (Between Day 1 and Day 51)||10
3000136|NCT00955617|3717188|FG000|COMPLETED|Second MRA (Between Day 1 and Day 51)||7
3000137|NCT00955617|3717189|FG001|COMPLETED|Second MRA (Between Day 1 and Day 51)||7
3000138|NCT00955617|3717188|FG000|NOT COMPLETED|Second MRA (Between Day 1 and Day 51)||3
3000139|NCT00955617|3717189|FG001|NOT COMPLETED|Second MRA (Between Day 1 and Day 51)||3
3000140|NCT00955682|3717197|FG000|STARTED|Year 2 Period||253
3000141|NCT00955682|3717198|FG001|STARTED|Year 2 Period||42
3000142|NCT00955682|3717197|FG000|COMPLETED|Year 2 Period||253
3000143|NCT00955682|3717198|FG001|COMPLETED|Year 2 Period||42
3000144|NCT00955682|3717197|FG000|NOT COMPLETED|Year 2 Period||0
3000145|NCT00955682|3717198|FG001|NOT COMPLETED|Year 2 Period||0
3000146|NCT00955682|3717197|FG000|STARTED|Year 3 Period||273
3000147|NCT00955682|3717198|FG001|STARTED|Year 3 Period||47
3000148|NCT00955682|3717197|FG000|COMPLETED|Year 3 Period||273
3000149|NCT00955682|3717198|FG001|COMPLETED|Year 3 Period||47
3000150|NCT00955682|3717197|FG000|NOT COMPLETED|Year 3 Period||0
3000151|NCT00955682|3717198|FG001|NOT COMPLETED|Year 3 Period||0
3000152|NCT00955682|3717197|FG000|STARTED|Year 4 Period||246
3000153|NCT00955682|3717198|FG001|STARTED|Year 4 Period||48
3000154|NCT00955682|3717197|FG000|COMPLETED|Year 4 Period||246
3000155|NCT00955682|3717198|FG001|COMPLETED|Year 4 Period||48
3000156|NCT00955682|3717197|FG000|NOT COMPLETED|Year 4 Period||0
3000157|NCT00955682|3717198|FG001|NOT COMPLETED|Year 4 Period||0
3000158|NCT00955682|3717197|FG000|STARTED|Booster Period (Month 48- 49)||245
3000159|NCT00955682|3717198|FG001|STARTED|Booster Period (Month 48- 49)||48
3000160|NCT00955682|3717197|FG000|COMPLETED|Booster Period (Month 48- 49)||244
3000161|NCT00955682|3717198|FG001|COMPLETED|Booster Period (Month 48- 49)||47
3000162|NCT00955682|3717197|FG000|NOT COMPLETED|Booster Period (Month 48- 49)||1
3000163|NCT00955682|3717198|FG001|NOT COMPLETED|Booster Period (Month 48- 49)||1
3000164|NCT00955682|3717197|FG000|STARTED|Year 5 Period||239
3000165|NCT00955682|3717198|FG001|STARTED|Year 5 Period||47
3000166|NCT00955682|3717197|FG000|COMPLETED|Year 5 Period||239
3000167|NCT00955682|3717198|FG001|COMPLETED|Year 5 Period||47
3000168|NCT00955682|3717197|FG000|NOT COMPLETED|Year 5 Period||0
3000169|NCT00955682|3717198|FG001|NOT COMPLETED|Year 5 Period||0
3000170|NCT00955708|3717212|FG000|STARTED|Overall Study||1308
3000171|NCT00955708|3717212|FG000|COMPLETED|Overall Study||250
3000172|NCT00955708|3717212|FG000|NOT COMPLETED|Overall Study||1058
3000173|NCT00955721|3717218|FG000|STARTED|Overall Study||9
3000174|NCT00955721|3717219|FG001|STARTED|Overall Study||0
3000175|NCT00955721|3717218|FG000|COMPLETED|Overall Study||6
3000176|NCT00955721|3717219|FG001|COMPLETED|Overall Study||0
3000177|NCT00955721|3717218|FG000|NOT COMPLETED|Overall Study||3
3000178|NCT00955721|3717219|FG001|NOT COMPLETED|Overall Study||0
3000179|NCT00955747|3717228|FG000|STARTED|Overall Study||253
3000180|NCT00955747|3717229|FG001|STARTED|Overall Study||241
3000181|NCT00955747|3717228|FG000|COMPLETED|Overall Study||184
3000182|NCT00955747|3717229|FG001|COMPLETED|Overall Study||172
3000183|NCT00955747|3717228|FG000|NOT COMPLETED|Overall Study||69
3000184|NCT00955747|3717229|FG001|NOT COMPLETED|Overall Study||69
3000185|NCT00955825|3717237|FG000|STARTED|Overall Study||233
3000186|NCT00955825|3717238|FG001|STARTED|Overall Study||240
3000187|NCT00955825|3717237|FG000|COMPLETED|Overall Study||207
3000188|NCT00955825|3717238|FG001|COMPLETED|Overall Study||223
3000189|NCT00955825|3717237|FG000|NOT COMPLETED|Overall Study||26
3000190|NCT00955825|3717238|FG001|NOT COMPLETED|Overall Study||17
3000191|NCT00955877|3717247|FG000|STARTED|Overall Study|Drug manufacturer ceased producing the drug prior to completion of 10 enrolled in this arm.|6
3000192|NCT00955877|3717248|FG001|STARTED|Overall Study|No patients were enrolled because analysis of previous arm wasn't completed.|0
3000193|NCT00955877|3717249|FG002|STARTED|Overall Study||7
3000194|NCT00955877|3717247|FG000|COMPLETED|Overall Study||6
3000195|NCT00955877|3717248|FG001|COMPLETED|Overall Study||0
3000196|NCT00955877|3717249|FG002|COMPLETED|Overall Study||7
3000197|NCT00955877|3717247|FG000|NOT COMPLETED|Overall Study||0
3000198|NCT00955877|3717248|FG001|NOT COMPLETED|Overall Study||0
3000199|NCT00955877|3717249|FG002|NOT COMPLETED|Overall Study||0
3000200|NCT00955903|3717260|FG000|STARTED|Overall Study||55
3000201|NCT00955903|3717261|FG001|STARTED|Overall Study||54
3000202|NCT00955903|3717262|FG002|STARTED|Overall Study||55
3000203|NCT00955903|3717260|FG000|COMPLETED|Overall Study||49
3000204|NCT00955903|3717261|FG001|COMPLETED|Overall Study||51
3000205|NCT00955903|3717262|FG002|COMPLETED|Overall Study||48
3000206|NCT00955903|3717260|FG000|NOT COMPLETED|Overall Study||6
3000207|NCT00955903|3717261|FG001|NOT COMPLETED|Overall Study||3
3000208|NCT00955903|3717262|FG002|NOT COMPLETED|Overall Study||7
3000209|NCT00955916|3717270|FG000|STARTED|Overall Study||38
3000210|NCT00955916|3717270|FG000|COMPLETED|Overall Study||38
3000211|NCT00955916|3717270|FG000|NOT COMPLETED|Overall Study||0
3000212|NCT00955955|3717277|FG000|STARTED|Overall Study||19
3000213|NCT00955955|3717278|FG001|STARTED|Overall Study||28
3000214|NCT00955955|3717279|FG002|STARTED|Overall Study||28
3000215|NCT00955955|3717277|FG000|COMPLETED|Overall Study||17
3000216|NCT00955955|3717278|FG001|COMPLETED|Overall Study||28
3000217|NCT00955955|3717279|FG002|COMPLETED|Overall Study||28
3000218|NCT00955955|3717277|FG000|NOT COMPLETED|Overall Study||2
3000219|NCT00955955|3717278|FG001|NOT COMPLETED|Overall Study||0
3000220|NCT00955955|3717279|FG002|NOT COMPLETED|Overall Study||0
3000221|NCT00955968|3717295|FG000|STARTED|Overall Study||828
3000222|NCT00955968|3717296|FG001|STARTED|Overall Study||825
3000223|NCT00955968|3717295|FG000|COMPLETED|Overall Study||691
3000224|NCT00955968|3717296|FG001|COMPLETED|Overall Study||699
3000225|NCT00955968|3717295|FG000|NOT COMPLETED|Overall Study||137
3000226|NCT00955968|3717296|FG001|NOT COMPLETED|Overall Study||126
3000227|NCT00956020|3717305|FG000|STARTED|Overall Study||4
3000228|NCT00956020|3717305|FG000|COMPLETED|Overall Study||4
3000229|NCT00956020|3717305|FG000|NOT COMPLETED|Overall Study||0
3000230|NCT00956085|3717318|FG000|STARTED|Overall Study||12
3000231|NCT00956085|3717318|FG000|COMPLETED|Overall Study||12
3000232|NCT00956085|3717318|FG000|NOT COMPLETED|Overall Study||0
3000233|NCT00956254|3717322|FG000|STARTED|Overall Study||18
3000234|NCT00956254|3717322|FG000|COMPLETED|Overall Study||18
3000235|NCT00956254|3717322|FG000|NOT COMPLETED|Overall Study||0
3000236|NCT00956293|3717330|FG000|STARTED|Main Period (Pre-randomization)||0
3306528|NCT02998996|4039891|FG004|COMPLETED|Overall Study||17
3306529|NCT02998996|4039892|FG005|COMPLETED|Overall Study||19
3000237|NCT00956293|3717331|FG001|STARTED|Main Period (Pre-randomization)||0
3000238|NCT00956293|3717332|FG002|STARTED|Main Period (Pre-randomization)||207
3000239|NCT00956293|3717330|FG000|Enrolled Safety Set|Main Period (Pre-randomization)||0
3000240|NCT00956293|3717331|FG001|Enrolled Safety Set|Main Period (Pre-randomization)||0
3000241|NCT00956293|3717332|FG002|Enrolled Safety Set|Main Period (Pre-randomization)||203
3000242|NCT00956293|3717330|FG000|COMPLETED|Main Period (Pre-randomization)||0
3000243|NCT00956293|3717331|FG001|COMPLETED|Main Period (Pre-randomization)||0
3000244|NCT00956293|3717332|FG002|COMPLETED|Main Period (Pre-randomization)||77
3000245|NCT00956293|3717330|FG000|NOT COMPLETED|Main Period (Pre-randomization)||0
3000246|NCT00956293|3717331|FG001|NOT COMPLETED|Main Period (Pre-randomization)||0
3000247|NCT00956293|3717332|FG002|NOT COMPLETED|Main Period (Pre-randomization)||130
3000248|NCT00956293|3717330|FG000|STARTED|Main Period (Randomization)||24
3000249|NCT00956293|3717331|FG001|STARTED|Main Period (Randomization)||53
3000250|NCT00956293|3717332|FG002|STARTED|Main Period (Randomization)||0
3000251|NCT00956293|3717330|FG000|Full Analysis Set|Main Period (Randomization)||24
3000252|NCT00956293|3717331|FG001|Full Analysis Set|Main Period (Randomization)|Two participants, randomized to this arm, did not receive everolimus.|51
3000253|NCT00956293|3717332|FG002|Full Analysis Set|Main Period (Randomization)||0
3000254|NCT00956293|3717330|FG000|Randomized Safety Set|Main Period (Randomization)||24
3000255|NCT00956293|3717331|FG001|Randomized Safety Set|Main Period (Randomization)||51
3000256|NCT00956293|3717332|FG002|Randomized Safety Set|Main Period (Randomization)||0
3000257|NCT00956293|3717330|FG000|COMPLETED|Main Period (Randomization)||23
3000258|NCT00956293|3717331|FG001|COMPLETED|Main Period (Randomization)||26
3000259|NCT00956293|3717332|FG002|COMPLETED|Main Period (Randomization)||0
3000260|NCT00956293|3717330|FG000|NOT COMPLETED|Main Period (Randomization)||1
3000261|NCT00956293|3717331|FG001|NOT COMPLETED|Main Period (Randomization)||27
3000262|NCT00956293|3717332|FG002|NOT COMPLETED|Main Period (Randomization)||0
3000263|NCT00956293|3717330|FG000|STARTED|Follow-up Period||20
3000264|NCT00956293|3717331|FG001|STARTED|Follow-up Period||32
3000265|NCT00956293|3717332|FG002|STARTED|Follow-up Period||0
3000266|NCT00956293|3717330|FG000|COMPLETED|Follow-up Period||0
3000267|NCT00956293|3717331|FG001|COMPLETED|Follow-up Period||0
3000268|NCT00956293|3717332|FG002|COMPLETED|Follow-up Period||0
3000269|NCT00956293|3717330|FG000|NOT COMPLETED|Follow-up Period||20
3000270|NCT00956293|3717331|FG001|NOT COMPLETED|Follow-up Period||32
3000271|NCT00956293|3717332|FG002|NOT COMPLETED|Follow-up Period||0
3000272|NCT00956540|3717342|FG000|STARTED|Overall Study||54
3000273|NCT00956540|3717343|FG001|STARTED|Overall Study||50
3000274|NCT00956540|3717344|FG002|STARTED|Overall Study||46
3000275|NCT00956540|3717345|FG003|STARTED|Overall Study||45
3000276|NCT00956540|3717342|FG000|COMPLETED|Overall Study||51
3000277|NCT00956540|3717343|FG001|COMPLETED|Overall Study||46
3000278|NCT00956540|3717344|FG002|COMPLETED|Overall Study||43
3000279|NCT00956540|3717345|FG003|COMPLETED|Overall Study||41
3000280|NCT00956540|3717342|FG000|NOT COMPLETED|Overall Study||3
3000281|NCT00956540|3717343|FG001|NOT COMPLETED|Overall Study||4
3000282|NCT00956540|3717344|FG002|NOT COMPLETED|Overall Study||3
3000283|NCT00956540|3717345|FG003|NOT COMPLETED|Overall Study||4
3000284|NCT00956592|3717357|FG000|STARTED|Overall Study||150
3000285|NCT00956592|3717358|FG001|STARTED|Overall Study||150
3000286|NCT00956592|3717357|FG000|COMPLETED|Overall Study||149
3000287|NCT00956592|3717358|FG001|COMPLETED|Overall Study||147
3000288|NCT00956592|3717357|FG000|NOT COMPLETED|Overall Study||1
3000289|NCT00956592|3717358|FG001|NOT COMPLETED|Overall Study||3
3000290|NCT00956631|3717366|FG000|STARTED|Overall Study||78
3000291|NCT00956631|3717366|FG000|COMPLETED|Overall Study||62
3000292|NCT00956631|3717366|FG000|NOT COMPLETED|Overall Study||16
3000293|NCT00956657|3717374|FG000|STARTED|Overall Study||18
3000294|NCT00956657|3717375|FG001|STARTED|Overall Study||13
3000295|NCT00956657|3717374|FG000|COMPLETED|Overall Study||18
3000296|NCT00956657|3717375|FG001|COMPLETED|Overall Study||13
3000297|NCT00956657|3717374|FG000|NOT COMPLETED|Overall Study||0
3000298|NCT00956657|3717375|FG001|NOT COMPLETED|Overall Study||0
3000299|NCT00956709|3717383|FG000|STARTED|Overall Study||16
3000300|NCT00956709|3717384|FG001|STARTED|Overall Study||19
3000301|NCT00956709|3717383|FG000|COMPLETED|Overall Study||16
3000302|NCT00956709|3717384|FG001|COMPLETED|Overall Study||19
3000303|NCT00956709|3717383|FG000|NOT COMPLETED|Overall Study||0
3000304|NCT00956709|3717384|FG001|NOT COMPLETED|Overall Study||0
3000305|NCT00956761|3717390|FG000|STARTED|Overall Study||63
3000306|NCT00956761|3717390|FG000|COMPLETED|Overall Study||63
3000307|NCT00956761|3717390|FG000|NOT COMPLETED|Overall Study||0
3000308|NCT00956813|3717397|FG000|STARTED|Flaxseed and Placebo||105
3000309|NCT00956813|3717398|FG001|STARTED|Flaxseed and Placebo||105
3000310|NCT00956813|3717397|FG000|COMPLETED|Flaxseed and Placebo||97
3000311|NCT00956813|3717398|FG001|COMPLETED|Flaxseed and Placebo||100
3000312|NCT00956813|3717397|FG000|NOT COMPLETED|Flaxseed and Placebo||8
3000313|NCT00956813|3717398|FG001|NOT COMPLETED|Flaxseed and Placebo||5
3000314|NCT00956813|3717397|FG000|STARTED|Continuation Phase||80
3000315|NCT00956813|3717398|FG001|STARTED|Continuation Phase||0
3000316|NCT00956813|3717397|FG000|COMPLETED|Continuation Phase||80
3000317|NCT00956813|3717398|FG001|COMPLETED|Continuation Phase||0
3000318|NCT00956813|3717397|FG000|NOT COMPLETED|Continuation Phase||0
3000319|NCT00956813|3717398|FG001|NOT COMPLETED|Continuation Phase||0
3037025|NCT01146665|3756325|FG001|STARTED|Overall Study||26
3037026|NCT01146665|3756324|FG000|1-month Post-ED Discharge (Follow-up)|Overall Study||9
3037027|NCT01146665|3756325|FG001|1-month Post-ED Discharge (Follow-up)|Overall Study||12
3037028|NCT01146665|3756324|FG000|3-month Post-ED Discharge (Follow-up)|Overall Study||8
3037029|NCT01146665|3756325|FG001|3-month Post-ED Discharge (Follow-up)|Overall Study||10
3037030|NCT01146665|3756324|FG000|COMPLETED|Overall Study||8
3037031|NCT01146665|3756325|FG001|COMPLETED|Overall Study||10
3037032|NCT01146665|3756324|FG000|NOT COMPLETED|Overall Study||10
3037033|NCT01146665|3756325|FG001|NOT COMPLETED|Overall Study||16
3037034|NCT01146704|3756342|FG000|STARTED|Overall Study||16
3037035|NCT01146704|3756343|FG001|STARTED|Overall Study||15
3037036|NCT01146704|3756342|FG000|COMPLETED|Overall Study||16
3037037|NCT01146704|3756343|FG001|COMPLETED|Overall Study||15
3037038|NCT01146704|3756342|FG000|NOT COMPLETED|Overall Study||0
3037039|NCT01146704|3756343|FG001|NOT COMPLETED|Overall Study||0
3037040|NCT01146782|3756349|FG000|STARTED|Screening Cohort||367
3037041|NCT01146782|3756349|FG000|COMPLETED|Screening Cohort||146
3037042|NCT01146782|3756349|FG000|NOT COMPLETED|Screening Cohort||221
3037043|NCT01146782|3756349|FG000|STARTED|Safety Cohort||146
3037044|NCT01146782|3756349|FG000|COMPLETED|Safety Cohort||63
3037045|NCT01146782|3756349|FG000|NOT COMPLETED|Safety Cohort||83
3037046|NCT01146782|3756349|FG000|STARTED|Primary Endpoint Cohort|63 Subjects in the Primary Endpoint Cohort|63
3037047|NCT01146782|3756349|FG000|COMPLETED|Primary Endpoint Cohort|57 Subjects in the Primary Endpoint Cohort completed the 28 day study|57
3037048|NCT01146782|3756349|FG000|NOT COMPLETED|Primary Endpoint Cohort||6
3037049|NCT01146795|3756354|FG000|STARTED|Overall Study||32
3037050|NCT01146795|3756354|FG000|COMPLETED|Overall Study||12
3037051|NCT01146795|3756354|FG000|NOT COMPLETED|Overall Study||20
3037052|NCT01146808|3756358|FG000|STARTED|Overall Study||16
3037053|NCT01146808|3756358|FG000|COMPLETED|Overall Study||16
3037054|NCT01146808|3756358|FG000|NOT COMPLETED|Overall Study||0
3037055|NCT01146834|3756367|FG000|STARTED|Overall Study||20
3000320|NCT00956839|3717408|FG000|STARTED|Overall Study||14
3000321|NCT00956839|3717409|FG001|STARTED|Overall Study||13
3000322|NCT00956839|3717410|FG002|STARTED|Overall Study||13
3000323|NCT00956839|3717408|FG000|COMPLETED|Overall Study||11
3000324|NCT00956839|3717409|FG001|COMPLETED|Overall Study||13
3000325|NCT00956839|3717410|FG002|COMPLETED|Overall Study||10
3000326|NCT00956839|3717408|FG000|NOT COMPLETED|Overall Study||3
3000327|NCT00956839|3717409|FG001|NOT COMPLETED|Overall Study||0
3000328|NCT00956839|3717410|FG002|NOT COMPLETED|Overall Study||3
3000329|NCT00956930|3717420|FG000|STARTED|Overall Study||24
3000330|NCT00956930|3717421|FG001|STARTED|Overall Study||21
3000331|NCT00956930|3717420|FG000|COMPLETED|Overall Study||24
3000332|NCT00956930|3717421|FG001|COMPLETED|Overall Study||21
3000333|NCT00956930|3717420|FG000|NOT COMPLETED|Overall Study||0
3000334|NCT00956930|3717421|FG001|NOT COMPLETED|Overall Study||0
3164864|NCT01895335|3892346|FG000|COMPLETED|Overall Study||786
3164865|NCT01895335|3892346|FG000|NOT COMPLETED|Overall Study||215
3164866|NCT01895361|3892353|FG000|STARTED|Overall Study||67
3164867|NCT01895361|3892354|FG001|STARTED|Overall Study||66
3164868|NCT01895361|3892355|FG002|STARTED|Overall Study||65
3000335|NCT00956943|3717431|FG000|STARTED|Overall Study||43
3000336|NCT00956943|3717432|FG001|STARTED|Overall Study||44
3000337|NCT00956943|3717431|FG000|Baseline|Overall Study||43
3000338|NCT00956943|3717432|FG001|Baseline|Overall Study||44
3000339|NCT00956943|3717431|FG000|COMPLETED|Overall Study||34
3000340|NCT00956943|3717432|FG001|COMPLETED|Overall Study||34
3000341|NCT00956943|3717431|FG000|NOT COMPLETED|Overall Study||9
3000342|NCT00956943|3717432|FG001|NOT COMPLETED|Overall Study||10
3000343|NCT00957008|3717442|FG000|STARTED|Overall Study||49
3000344|NCT00957008|3717443|FG001|STARTED|Overall Study||49
3000345|NCT00957008|3717444|FG002|STARTED|Overall Study||49
3000346|NCT00957008|3717445|FG003|STARTED|Overall Study||50
3000347|NCT00957008|3717442|FG000|COMPLETED|Overall Study||28
3000348|NCT00957008|3717443|FG001|COMPLETED|Overall Study||37
3000349|NCT00957008|3717444|FG002|COMPLETED|Overall Study||32
3000350|NCT00957008|3717445|FG003|COMPLETED|Overall Study||26
3000351|NCT00957008|3717442|FG000|NOT COMPLETED|Overall Study||21
3000352|NCT00957008|3717443|FG001|NOT COMPLETED|Overall Study||12
3000353|NCT00957008|3717444|FG002|NOT COMPLETED|Overall Study||17
3000354|NCT00957008|3717445|FG003|NOT COMPLETED|Overall Study||24
3000355|NCT00957021|3717459|FG000|STARTED|Overall Study||354
3000356|NCT00957021|3717459|FG000|COMPLETED|Overall Study|Completed/Not completed counts are based on participant status at the 2 yr primary outcome interval.|237
3000357|NCT00957021|3717459|FG000|NOT COMPLETED|Overall Study||117
3000358|NCT00957047|3717468|FG000|STARTED|PART I||100
3000359|NCT00957047|3717469|FG001|STARTED|PART I||96
3000360|NCT00957047|3717470|FG002|STARTED|PART I||101
3000361|NCT00957047|3717471|FG003|STARTED|PART I||98
3000362|NCT00957047|3717472|FG004|STARTED|PART I||0
3000363|NCT00957047|3717468|FG000|Randomized/Safety Population|PART I||100
3000364|NCT00957047|3717469|FG001|Randomized/Safety Population|PART I||96
3000365|NCT00957047|3717470|FG002|Randomized/Safety Population|PART I||101
3000366|NCT00957047|3717471|FG003|Randomized/Safety Population|PART I||98
3000367|NCT00957047|3717472|FG004|Randomized/Safety Population|PART I||0
3000368|NCT00957047|3717468|FG000|Intention-to-treat (ITT) Population|PART I||100
3000369|NCT00957047|3717469|FG001|Intention-to-treat (ITT) Population|PART I||96
3000370|NCT00957047|3717470|FG002|Intention-to-treat (ITT) Population|PART I||100
3000371|NCT00957047|3717471|FG003|Intention-to-treat (ITT) Population|PART I||97
3000372|NCT00957047|3717472|FG004|Intention-to-treat (ITT) Population|PART I||0
3000373|NCT00957047|3717468|FG000|Per-Protocol Population|PART I||81
3000374|NCT00957047|3717469|FG001|Per-Protocol Population|PART I||70
3000375|NCT00957047|3717470|FG002|Per-Protocol Population|PART I||75
3000376|NCT00957047|3717471|FG003|Per-Protocol Population|PART I||54
3000377|NCT00957047|3717472|FG004|Per-Protocol Population|PART I||0
3000378|NCT00957047|3717468|FG000|COMPLETED|PART I||94
3000379|NCT00957047|3717469|FG001|COMPLETED|PART I||83
3000380|NCT00957047|3717470|FG002|COMPLETED|PART I||80
3000381|NCT00957047|3717471|FG003|COMPLETED|PART I||68
3000382|NCT00957047|3717472|FG004|COMPLETED|PART I||0
3000383|NCT00957047|3717468|FG000|NOT COMPLETED|PART I||6
3000384|NCT00957047|3717469|FG001|NOT COMPLETED|PART I||13
3000385|NCT00957047|3717470|FG002|NOT COMPLETED|PART I||21
3000386|NCT00957047|3717471|FG003|NOT COMPLETED|PART I||30
3000387|NCT00957047|3717472|FG004|NOT COMPLETED|PART I||0
3000388|NCT00957047|3717468|FG000|STARTED|PART II||0
3000389|NCT00957047|3717469|FG001|STARTED|PART II||0
3000390|NCT00957047|3717470|FG002|STARTED|PART II||0
3000391|NCT00957047|3717471|FG003|STARTED|PART II||0
3000392|NCT00957047|3717472|FG004|STARTED|PART II|325 patients who completed Part I were enrolled in Part II.|325
3000393|NCT00957047|3717468|FG000|Terminated Prematurely|PART II||0
3000394|NCT00957047|3717469|FG001|Terminated Prematurely|PART II||0
3000395|NCT00957047|3717470|FG002|Terminated Prematurely|PART II||0
3000396|NCT00957047|3717471|FG003|Terminated Prematurely|PART II||0
3000397|NCT00957047|3717472|FG004|Terminated Prematurely|PART II|Terminated Prematurely during 1-year Open-Label Period|102
3000398|NCT00957047|3717468|FG000|COMPLETED|PART II||0
3000399|NCT00957047|3717469|FG001|COMPLETED|PART II||0
3000400|NCT00957047|3717470|FG002|COMPLETED|PART II||0
3000401|NCT00957047|3717471|FG003|COMPLETED|PART II||0
3000402|NCT00957047|3717472|FG004|COMPLETED|PART II||223
3000403|NCT00957047|3717468|FG000|NOT COMPLETED|PART II||0
3000404|NCT00957047|3717469|FG001|NOT COMPLETED|PART II||0
3000405|NCT00957047|3717470|FG002|NOT COMPLETED|PART II||0
3000406|NCT00957047|3717471|FG003|NOT COMPLETED|PART II||0
3000407|NCT00957047|3717472|FG004|NOT COMPLETED|PART II||102
3000408|NCT00957229|3717492|FG000|STARTED|Study Start||15
3000409|NCT00957229|3717493|FG001|STARTED|Study Start||26
3000410|NCT00957229|3717492|FG000|COMPLETED|Study Start||14
3000411|NCT00957229|3717493|FG001|COMPLETED|Study Start||23
3164869|NCT01895361|3892353|FG000|COMPLETED|Overall Study||43
3164870|NCT01895361|3892354|FG001|COMPLETED|Overall Study||45
3164871|NCT01895361|3892355|FG002|COMPLETED|Overall Study||41
3164872|NCT01895361|3892353|FG000|NOT COMPLETED|Overall Study||24
3164873|NCT01895361|3892354|FG001|NOT COMPLETED|Overall Study||21
3164874|NCT01895361|3892355|FG002|NOT COMPLETED|Overall Study||24
3000412|NCT00957229|3717492|FG000|NOT COMPLETED|Study Start||1
3000413|NCT00957229|3717493|FG001|NOT COMPLETED|Study Start||3
3000414|NCT00957229|3717492|FG000|STARTED|Reallocated to or Continued Vismodegib||14
3000415|NCT00957229|3717493|FG001|STARTED|Reallocated to or Continued Vismodegib||23
3000416|NCT00957229|3717492|FG000|COMPLETED|Reallocated to or Continued Vismodegib||11
3000417|NCT00957229|3717493|FG001|COMPLETED|Reallocated to or Continued Vismodegib||21
3000418|NCT00957229|3717492|FG000|NOT COMPLETED|Reallocated to or Continued Vismodegib||3
3000419|NCT00957229|3717493|FG001|NOT COMPLETED|Reallocated to or Continued Vismodegib||2
3000420|NCT00957242|3717501|FG000|STARTED|Overall Study||73
3000421|NCT00957242|3717502|FG001|STARTED|Overall Study||72
3000422|NCT00957242|3717501|FG000|COMPLETED|Overall Study||73
3000423|NCT00957242|3717502|FG001|COMPLETED|Overall Study||72
3000424|NCT00957242|3717501|FG000|NOT COMPLETED|Overall Study||0
3000425|NCT00957242|3717502|FG001|NOT COMPLETED|Overall Study||0
3000426|NCT00957268|3717515|FG000|STARTED|Overall Study||5
3000427|NCT00957268|3717516|FG001|STARTED|Overall Study||4
3000428|NCT00957268|3717517|FG002|STARTED|Overall Study||8
3000429|NCT00957268|3717518|FG003|STARTED|Overall Study||7
3000430|NCT00957268|3717519|FG004|STARTED|Overall Study||22
3000431|NCT00957268|3717515|FG000|COMPLETED|Overall Study||5
3000432|NCT00957268|3717516|FG001|COMPLETED|Overall Study||4
3000433|NCT00957268|3717517|FG002|COMPLETED|Overall Study||7
3000434|NCT00957268|3717518|FG003|COMPLETED|Overall Study||7
3000435|NCT00957268|3717519|FG004|COMPLETED|Overall Study||22
3000436|NCT00957268|3717515|FG000|NOT COMPLETED|Overall Study||0
3000437|NCT00957268|3717516|FG001|NOT COMPLETED|Overall Study||0
3000438|NCT00957268|3717517|FG002|NOT COMPLETED|Overall Study||1
3000439|NCT00957268|3717518|FG003|NOT COMPLETED|Overall Study||0
3000440|NCT00957268|3717519|FG004|NOT COMPLETED|Overall Study||0
3000441|NCT00957333|3717531|FG000|STARTED|Overall Study||44
3000442|NCT00957333|3717531|FG000|COMPLETED|Overall Study||44
3000443|NCT00957333|3717531|FG000|NOT COMPLETED|Overall Study||0
3000444|NCT00957359|3717537|FG000|STARTED|Overall Study||14
3000445|NCT00957359|3717538|FG001|STARTED|Overall Study||15
3000446|NCT00957359|3717537|FG000|COMPLETED|Overall Study||14
3000447|NCT00957359|3717538|FG001|COMPLETED|Overall Study||15
3000448|NCT00957359|3717537|FG000|NOT COMPLETED|Overall Study||0
3000449|NCT00957359|3717538|FG001|NOT COMPLETED|Overall Study||0
3000450|NCT00957372|3717547|FG000|STARTED|PART I||80
3000451|NCT00957372|3717548|FG001|STARTED|PART I||85
3000452|NCT00957372|3717549|FG002|STARTED|PART I||88
3000453|NCT00957372|3717550|FG003|STARTED|PART I||0
3000454|NCT00957372|3717547|FG000|Safety Population|PART I||80
3000455|NCT00957372|3717548|FG001|Safety Population|PART I||85
3000456|NCT00957372|3717549|FG002|Safety Population|PART I||87
3000457|NCT00957372|3717550|FG003|Safety Population|PART I||0
3000458|NCT00957372|3717547|FG000|Intention-to-Treat Population|PART I||77
3000459|NCT00957372|3717548|FG001|Intention-to-Treat Population|PART I||84
3000460|NCT00957372|3717549|FG002|Intention-to-Treat Population|PART I||84
3000461|NCT00957372|3717550|FG003|Intention-to-Treat Population|PART I||0
3000462|NCT00957372|3717547|FG000|Per-Protocol Population|PART I||35
3000463|NCT00957372|3717548|FG001|Per-Protocol Population|PART I||47
3000464|NCT00957372|3717549|FG002|Per-Protocol Population|PART I||51
3000465|NCT00957372|3717550|FG003|Per-Protocol Population|PART I||0
3000466|NCT00957372|3717547|FG000|Randomized But Not Treated|PART I||0
3000467|NCT00957372|3717548|FG001|Randomized But Not Treated|PART I||0
3000468|NCT00957372|3717549|FG002|Randomized But Not Treated|PART I||1
3000469|NCT00957372|3717550|FG003|Randomized But Not Treated|PART I||0
3000470|NCT00957372|3717547|FG000|COMPLETED|PART I||80
3000471|NCT00957372|3717548|FG001|COMPLETED|PART I||85
3000472|NCT00957372|3717549|FG002|COMPLETED|PART I||87
3000473|NCT00957372|3717550|FG003|COMPLETED|PART I||0
3000474|NCT00957372|3717547|FG000|NOT COMPLETED|PART I||0
3000475|NCT00957372|3717548|FG001|NOT COMPLETED|PART I||0
3000476|NCT00957372|3717549|FG002|NOT COMPLETED|PART I||1
3000477|NCT00957372|3717550|FG003|NOT COMPLETED|PART I||0
3000478|NCT00957372|3717547|FG000|STARTED|PART II||0
3000479|NCT00957372|3717548|FG001|STARTED|PART II||0
3000480|NCT00957372|3717549|FG002|STARTED|PART II||0
3000481|NCT00957372|3717550|FG003|STARTED|PART II||194
3000482|NCT00957372|3717547|FG000|Safety Population|PART II||0
3000483|NCT00957372|3717548|FG001|Safety Population|PART II||0
3000484|NCT00957372|3717549|FG002|Safety Population|PART II||0
3000485|NCT00957372|3717550|FG003|Safety Population|PART II||194
3000486|NCT00957372|3717547|FG000|Intention-to-treat (ITT) Population|PART II||0
3000487|NCT00957372|3717548|FG001|Intention-to-treat (ITT) Population|PART II||0
3000488|NCT00957372|3717549|FG002|Intention-to-treat (ITT) Population|PART II||0
3000489|NCT00957372|3717550|FG003|Intention-to-treat (ITT) Population|PART II||191
3000490|NCT00957372|3717547|FG000|Per-Protocol Population|PART II||0
3164875|NCT01895452|3892365|FG000|STARTED|Overall Study||65
3000491|NCT00957372|3717548|FG001|Per-Protocol Population|PART II||0
3000492|NCT00957372|3717549|FG002|Per-Protocol Population|PART II||0
3000493|NCT00957372|3717550|FG003|Per-Protocol Population|PART II||108
3000494|NCT00957372|3717547|FG000|COMPLETED|PART II||0
3000495|NCT00957372|3717548|FG001|COMPLETED|PART II||0
3000496|NCT00957372|3717549|FG002|COMPLETED|PART II||0
3000497|NCT00957372|3717550|FG003|COMPLETED|PART II||150
3000498|NCT00957372|3717547|FG000|NOT COMPLETED|PART II||0
3000499|NCT00957372|3717548|FG001|NOT COMPLETED|PART II||0
3000500|NCT00957372|3717549|FG002|NOT COMPLETED|PART II||0
3000501|NCT00957372|3717550|FG003|NOT COMPLETED|PART II||44
3000502|NCT00957424|3717566|FG000|STARTED|Overall Study||67
3000503|NCT00957424|3717566|FG000|Follow-up #1|Overall Study||59
3000504|NCT00957424|3717566|FG000|Follow-up #2|Overall Study||50
3000505|NCT00957424|3717566|FG000|COMPLETED|Overall Study||44
3000506|NCT00957424|3717566|FG000|NOT COMPLETED|Overall Study||23
3000507|NCT00957528|3717573|FG000|STARTED|Overall Study||8
3000508|NCT00957528|3717574|FG001|STARTED|Overall Study||9
3000509|NCT00957528|3717575|FG002|STARTED|Overall Study||9
3000510|NCT00957528|3717573|FG000|COMPLETED|Overall Study||8
3000511|NCT00957528|3717574|FG001|COMPLETED|Overall Study||8
3000512|NCT00957528|3717575|FG002|COMPLETED|Overall Study||8
3000513|NCT00957528|3717573|FG000|NOT COMPLETED|Overall Study||0
3000514|NCT00957528|3717574|FG001|NOT COMPLETED|Overall Study||1
3000515|NCT00957528|3717575|FG002|NOT COMPLETED|Overall Study||1
3000516|NCT00957580|3717586|FG000|STARTED|Overall Study||33
3000517|NCT00957580|3717587|FG001|STARTED|Overall Study||33
3000518|NCT00957580|3717588|FG002|STARTED|Overall Study||15
3000519|NCT00957580|3717586|FG000|Treated|Overall Study||33
3000520|NCT00957580|3717587|FG001|Treated|Overall Study||32
3000521|NCT00957580|3717588|FG002|Treated|Overall Study||15
3000522|NCT00957580|3717586|FG000|COMPLETED|Overall Study||33
3000523|NCT00957580|3717587|FG001|COMPLETED|Overall Study||31
3000524|NCT00957580|3717588|FG002|COMPLETED|Overall Study||15
3000525|NCT00957580|3717586|FG000|NOT COMPLETED|Overall Study||0
3000526|NCT00957580|3717587|FG001|NOT COMPLETED|Overall Study||2
3000527|NCT00957580|3717588|FG002|NOT COMPLETED|Overall Study||0
3000528|NCT00957593|3717611|FG000|STARTED|Overall Study||127
3000529|NCT00957593|3717612|FG001|STARTED|Overall Study||125
3000530|NCT00957593|3717611|FG000|COMPLETED|Overall Study||127
3000531|NCT00957593|3717612|FG001|COMPLETED|Overall Study||125
3000532|NCT00957593|3717611|FG000|NOT COMPLETED|Overall Study||0
3000533|NCT00957593|3717612|FG001|NOT COMPLETED|Overall Study||0
3000534|NCT00957658|3717620|FG000|STARTED|Overall Study||234
3000535|NCT00957658|3717620|FG000|COMPLETED|Overall Study|Completed/Not completed counts are based on participant status at the 2yr primary outcome interval.|169
3000536|NCT00957658|3717620|FG000|NOT COMPLETED|Overall Study||65
3000537|NCT00957671|3717626|FG000|STARTED|Overall Study|15 subjects began the treatment phase.|15
3000538|NCT00957671|3717626|FG000|COMPLETED|Overall Study|15 subjects completed the treatment phase of the study.|15
3000539|NCT00957671|3717626|FG000|NOT COMPLETED|Overall Study||0
3000540|NCT00957684|3717635|FG000|STARTED|PART I||102
3000541|NCT00957684|3717636|FG001|STARTED|PART I||98
3000542|NCT00957684|3717637|FG002|STARTED|PART I||100
3000543|NCT00957684|3717638|FG003|STARTED|PART I||102
3000544|NCT00957684|3717639|FG004|STARTED|PART I||0
3000545|NCT00957684|3717635|FG000|Randomised (Safety Population)|PART I||102
3000546|NCT00957684|3717636|FG001|Randomised (Safety Population)|PART I||98
3000547|NCT00957684|3717637|FG002|Randomised (Safety Population)|PART I||100
3000548|NCT00957684|3717638|FG003|Randomised (Safety Population)|PART I||102
3000549|NCT00957684|3717639|FG004|Randomised (Safety Population)|PART I||0
3000550|NCT00957684|3717635|FG000|Intention-to-treat (ITT) Population|PART I||98
3000551|NCT00957684|3717636|FG001|Intention-to-treat (ITT) Population|PART I||98
3000552|NCT00957684|3717637|FG002|Intention-to-treat (ITT) Population|PART I||99
3000553|NCT00957684|3717638|FG003|Intention-to-treat (ITT) Population|PART I||102
3000554|NCT00957684|3717639|FG004|Intention-to-treat (ITT) Population|PART I||0
3000555|NCT00957684|3717635|FG000|Per-protocol (PP)Population|PART I||72
3000556|NCT00957684|3717636|FG001|Per-protocol (PP)Population|PART I||86
3000557|NCT00957684|3717637|FG002|Per-protocol (PP)Population|PART I||94
3000558|NCT00957684|3717638|FG003|Per-protocol (PP)Population|PART I||91
3000559|NCT00957684|3717639|FG004|Per-protocol (PP)Population|PART I||0
3000560|NCT00957684|3717635|FG000|COMPLETED|PART I||71
3000561|NCT00957684|3717636|FG001|COMPLETED|PART I||85
3000562|NCT00957684|3717637|FG002|COMPLETED|PART I||90
3000563|NCT00957684|3717638|FG003|COMPLETED|PART I||84
3000564|NCT00957684|3717639|FG004|COMPLETED|PART I||0
3000565|NCT00957684|3717635|FG000|NOT COMPLETED|PART I||31
3000566|NCT00957684|3717636|FG001|NOT COMPLETED|PART I||13
3000567|NCT00957684|3717637|FG002|NOT COMPLETED|PART I||10
3000568|NCT00957684|3717638|FG003|NOT COMPLETED|PART I||18
3000569|NCT00957684|3717639|FG004|NOT COMPLETED|PART I||0
3000570|NCT00957684|3717635|FG000|STARTED|PART II||0
3000571|NCT00957684|3717636|FG001|STARTED|PART II||0
3000572|NCT00957684|3717637|FG002|STARTED|PART II||0
3000573|NCT00957684|3717638|FG003|STARTED|PART II||0
3000574|NCT00957684|3717639|FG004|STARTED|PART II||314
3000575|NCT00957684|3717635|FG000|Patients Entered Part II|PART II||0
3000576|NCT00957684|3717636|FG001|Patients Entered Part II|PART II||0
3000577|NCT00957684|3717637|FG002|Patients Entered Part II|PART II||0
3000578|NCT00957684|3717638|FG003|Patients Entered Part II|PART II||0
3000579|NCT00957684|3717639|FG004|Patients Entered Part II|PART II||314
3000580|NCT00957684|3717635|FG000|COMPLETED|PART II||0
3000581|NCT00957684|3717636|FG001|COMPLETED|PART II||0
3000582|NCT00957684|3717637|FG002|COMPLETED|PART II||0
3000583|NCT00957684|3717638|FG003|COMPLETED|PART II||0
3000584|NCT00957684|3717639|FG004|COMPLETED|PART II||239
3000585|NCT00957684|3717635|FG000|NOT COMPLETED|PART II||0
3000586|NCT00957684|3717636|FG001|NOT COMPLETED|PART II||0
3000587|NCT00957684|3717637|FG002|NOT COMPLETED|PART II||0
3000588|NCT00957684|3717638|FG003|NOT COMPLETED|PART II||0
3000589|NCT00957684|3717639|FG004|NOT COMPLETED|PART II||75
3000590|NCT00957723|3717649|FG000|STARTED|Overall Study||411
3000591|NCT00957723|3717649|FG000|COMPLETED|Overall Study|Completed/Not completed counts are based on participant status at the 2yr primary outcome interval.|298
3000592|NCT00957723|3717649|FG000|NOT COMPLETED|Overall Study||113
3000593|NCT00957801|3717659|FG000|STARTED|Overall Study||7
3000594|NCT00957801|3717660|FG001|STARTED|Overall Study||7
3000595|NCT00957801|3717661|FG002|STARTED|Overall Study||7
3000596|NCT00957801|3717662|FG003|STARTED|Overall Study||8
3000597|NCT00957801|3717659|FG000|COMPLETED|Overall Study||7
3000598|NCT00957801|3717660|FG001|COMPLETED|Overall Study||7
3000599|NCT00957801|3717661|FG002|COMPLETED|Overall Study||7
3000600|NCT00957801|3717662|FG003|COMPLETED|Overall Study||7
3000601|NCT00957801|3717659|FG000|NOT COMPLETED|Overall Study||0
3000602|NCT00957801|3717660|FG001|NOT COMPLETED|Overall Study||0
3000603|NCT00957801|3717661|FG002|NOT COMPLETED|Overall Study||0
3000604|NCT00957801|3717662|FG003|NOT COMPLETED|Overall Study||1
3000605|NCT00957853|3717675|FG000|STARTED|Overall Study||4
3000606|NCT00957853|3717676|FG001|STARTED|Overall Study||6
3000607|NCT00957853|3717677|FG002|STARTED|Overall Study||5
3000608|NCT00957853|3717675|FG000|Randomization|Overall Study||4
3000609|NCT00957853|3717676|FG001|Randomization|Overall Study||6
3000610|NCT00957853|3717677|FG002|Randomization|Overall Study||5
3000611|NCT00957853|3717675|FG000|Neoadjuvant Tx Completion|Overall Study||3
3000612|NCT00957853|3717676|FG001|Neoadjuvant Tx Completion|Overall Study||6
3000613|NCT00957853|3717677|FG002|Neoadjuvant Tx Completion|Overall Study||5
3000614|NCT00957853|3717675|FG000|COMPLETED|Overall Study||3
3000615|NCT00957853|3717676|FG001|COMPLETED|Overall Study||6
3000616|NCT00957853|3717677|FG002|COMPLETED|Overall Study||5
3000617|NCT00957853|3717675|FG000|NOT COMPLETED|Overall Study||1
3000618|NCT00957853|3717676|FG001|NOT COMPLETED|Overall Study||0
3000619|NCT00957853|3717677|FG002|NOT COMPLETED|Overall Study||0
3000620|NCT00957905|3717687|FG000|STARTED|Part A||7
3000621|NCT00957905|3717688|FG001|STARTED|Part A||0
3000622|NCT00957905|3717687|FG000|COMPLETED|Part A||7
3000623|NCT00957905|3717688|FG001|COMPLETED|Part A||0
3000624|NCT00957905|3717687|FG000|NOT COMPLETED|Part A||0
3000625|NCT00957905|3717688|FG001|NOT COMPLETED|Part A||0
3000626|NCT00957905|3717687|FG000|STARTED|Part B||0
3000627|NCT00957905|3717688|FG001|STARTED|Part B||29
3000628|NCT00957905|3717687|FG000|COMPLETED|Part B||0
3000629|NCT00957905|3717688|FG001|COMPLETED|Part B||25
3000630|NCT00957905|3717687|FG000|NOT COMPLETED|Part B||0
3000631|NCT00957905|3717688|FG001|NOT COMPLETED|Part B||4
3000632|NCT00957931|3717694|FG000|STARTED|Overall Study||6
3000633|NCT00957931|3717694|FG000|COMPLETED|Overall Study||2
3000634|NCT00957931|3717694|FG000|NOT COMPLETED|Overall Study||4
3000635|NCT00957944|3717700|FG000|STARTED|First Intervention- 24 Hours||20
3000636|NCT00957944|3717701|FG001|STARTED|First Intervention- 24 Hours||20
3000637|NCT00957944|3717700|FG000|COMPLETED|First Intervention- 24 Hours||20
3000638|NCT00957944|3717701|FG001|COMPLETED|First Intervention- 24 Hours||19
3000639|NCT00957944|3717700|FG000|NOT COMPLETED|First Intervention- 24 Hours||0
3000640|NCT00957944|3717701|FG001|NOT COMPLETED|First Intervention- 24 Hours||1
3000641|NCT00957944|3717700|FG000|STARTED|Washout Period of at Least 5 Days||20
3000642|NCT00957944|3717701|FG001|STARTED|Washout Period of at Least 5 Days||19
3000643|NCT00957944|3717700|FG000|COMPLETED|Washout Period of at Least 5 Days||20
3000644|NCT00957944|3717701|FG001|COMPLETED|Washout Period of at Least 5 Days||19
3000645|NCT00957944|3717700|FG000|NOT COMPLETED|Washout Period of at Least 5 Days||0
3000646|NCT00957944|3717701|FG001|NOT COMPLETED|Washout Period of at Least 5 Days||0
3000647|NCT00957944|3717700|FG000|STARTED|Second Intervention- 24 Hours||20
3000648|NCT00957944|3717701|FG001|STARTED|Second Intervention- 24 Hours||19
3000649|NCT00957944|3717700|FG000|Pharmacokinetic Set (PKS)|Second Intervention- 24 Hours||20
3000650|NCT00957944|3717701|FG001|Pharmacokinetic Set (PKS)|Second Intervention- 24 Hours|One subject that fullfilled predefined criteria for patch adhesiveness was excluded from the PKS|18
3000651|NCT00957944|3717700|FG000|COMPLETED|Second Intervention- 24 Hours||20
3000652|NCT00957944|3717701|FG001|COMPLETED|Second Intervention- 24 Hours||19
3000653|NCT00957944|3717700|FG000|NOT COMPLETED|Second Intervention- 24 Hours||0
3000654|NCT00957944|3717701|FG001|NOT COMPLETED|Second Intervention- 24 Hours||0
3000655|NCT00957996|3717709|FG000|STARTED|Overall Study||117
3000656|NCT00957996|3717710|FG001|STARTED|Overall Study||117
3000657|NCT00957996|3717709|FG000|COMPLETED|Overall Study||91
3000658|NCT00957996|3717710|FG001|COMPLETED|Overall Study||89
3000659|NCT00957996|3717709|FG000|NOT COMPLETED|Overall Study||26
3000660|NCT00957996|3717710|FG001|NOT COMPLETED|Overall Study||28
3000661|NCT00958009|3717718|FG000|STARTED|Overall Study||109
3000662|NCT00958009|3717718|FG000|COMPLETED|Overall Study||107
3000663|NCT00958009|3717718|FG000|NOT COMPLETED|Overall Study||2
3000664|NCT00958035|3717724|FG000|STARTED|Overall Study||46
3000665|NCT00958035|3717725|FG001|STARTED|Overall Study||43
3000666|NCT00958035|3717724|FG000|COMPLETED|Overall Study||43
3000667|NCT00958035|3717725|FG001|COMPLETED|Overall Study||39
3000668|NCT00958035|3717724|FG000|NOT COMPLETED|Overall Study||3
3000669|NCT00958035|3717725|FG001|NOT COMPLETED|Overall Study||4
3000670|NCT00958074|3717733|FG000|STARTED|Overall Study||4
3000671|NCT00958074|3717734|FG001|STARTED|Overall Study||7
3000672|NCT00958074|3717733|FG000|COMPLETED|Overall Study||4
3000673|NCT00958074|3717734|FG001|COMPLETED|Overall Study||6
3000674|NCT00958074|3717733|FG000|NOT COMPLETED|Overall Study||0
3000675|NCT00958074|3717734|FG001|NOT COMPLETED|Overall Study||1
3000676|NCT00958126|3717748|FG000|STARTED|Overall Study||49
3000677|NCT00958126|3717749|FG001|STARTED|Overall Study||205
3000678|NCT00958126|3717750|FG002|STARTED|Overall Study||201
3000679|NCT00958126|3717751|FG003|STARTED|Overall Study||203
3000680|NCT00958126|3717752|FG004|STARTED|Overall Study||50
3000681|NCT00958126|3717753|FG005|STARTED|Overall Study||203
3000682|NCT00958126|3717754|FG006|STARTED|Overall Study||200
3000683|NCT00958126|3717755|FG007|STARTED|Overall Study||202
3000684|NCT00958126|3717748|FG000|COMPLETED|Overall Study||48
3000685|NCT00958126|3717749|FG001|COMPLETED|Overall Study||196
3000686|NCT00958126|3717750|FG002|COMPLETED|Overall Study||191
3000687|NCT00958126|3717751|FG003|COMPLETED|Overall Study||192
3000688|NCT00958126|3717752|FG004|COMPLETED|Overall Study||50
3000689|NCT00958126|3717753|FG005|COMPLETED|Overall Study||202
3000690|NCT00958126|3717754|FG006|COMPLETED|Overall Study||199
3000691|NCT00958126|3717755|FG007|COMPLETED|Overall Study||202
3000692|NCT00958126|3717748|FG000|NOT COMPLETED|Overall Study||1
3000693|NCT00958126|3717749|FG001|NOT COMPLETED|Overall Study||9
3000694|NCT00958126|3717750|FG002|NOT COMPLETED|Overall Study||10
3000695|NCT00958126|3717751|FG003|NOT COMPLETED|Overall Study||11
3000696|NCT00958126|3717752|FG004|NOT COMPLETED|Overall Study||0
3000697|NCT00958126|3717753|FG005|NOT COMPLETED|Overall Study||1
3000698|NCT00958126|3717754|FG006|NOT COMPLETED|Overall Study||1
3000699|NCT00958126|3717755|FG007|NOT COMPLETED|Overall Study||0
3000700|NCT00958165|3717777|FG000|STARTED|Overall Study|81 enrolled participants resulted in 72 eligible participants that were treated.|81
3000701|NCT00958165|3717777|FG000|Treated|Overall Study||72
3000702|NCT00958165|3717777|FG000|COMPLETED|Overall Study|Of the 72 treated participants, 67 completed follow-up and were evaluable for effectiveness.|67
3000703|NCT00958165|3717777|FG000|NOT COMPLETED|Overall Study||14
3000704|NCT00958191|3717781|FG000|STARTED|Overall Study||221
3000705|NCT00958191|3717781|FG000|COMPLETED|Overall Study||110
3000706|NCT00958191|3717781|FG000|NOT COMPLETED|Overall Study||111
3000707|NCT00958217|3717789|FG000|STARTED|Overall Study||61
3000708|NCT00958217|3717790|FG001|STARTED|Overall Study||62
3000709|NCT00958217|3717789|FG000|End of Treatment|Overall Study|Participants had a maximum of 16 weeks to complete 12 individual psychotherapy sessions|56
3000710|NCT00958217|3717790|FG001|End of Treatment|Overall Study|Participants had a maximum of 16 weeks to complete 12 individual psychotherapy sessions|57
3000711|NCT00958217|3717789|FG000|COMPLETED|Overall Study|Participants were assessed quarterly for one year following end of treatment|37
3000712|NCT00958217|3717790|FG001|COMPLETED|Overall Study|Participants were assessed quarterly for one year following end of treatment|37
3000713|NCT00958217|3717789|FG000|NOT COMPLETED|Overall Study||24
3000714|NCT00958217|3717790|FG001|NOT COMPLETED|Overall Study||25
3000715|NCT00958243|3717803|FG000|STARTED|Overall Study||26
3000716|NCT00958243|3717804|FG001|STARTED|Overall Study||105
3000717|NCT00958243|3717805|FG002|STARTED|Overall Study||96
3000718|NCT00958243|3717806|FG003|STARTED|Overall Study||28
3000719|NCT00958243|3717807|FG004|STARTED|Overall Study||109
3000720|NCT00958243|3717808|FG005|STARTED|Overall Study||109
3000721|NCT00958243|3717803|FG000|COMPLETED|Overall Study||24
3000722|NCT00958243|3717804|FG001|COMPLETED|Overall Study||99
3000723|NCT00958243|3717805|FG002|COMPLETED|Overall Study||82
3000724|NCT00958243|3717806|FG003|COMPLETED|Overall Study||25
3000725|NCT00958243|3717807|FG004|COMPLETED|Overall Study||100
3000726|NCT00958243|3717808|FG005|COMPLETED|Overall Study||99
3000727|NCT00958243|3717803|FG000|NOT COMPLETED|Overall Study||2
3000728|NCT00958243|3717804|FG001|NOT COMPLETED|Overall Study||6
3000729|NCT00958243|3717805|FG002|NOT COMPLETED|Overall Study||14
3000730|NCT00958243|3717806|FG003|NOT COMPLETED|Overall Study||3
3000731|NCT00958243|3717807|FG004|NOT COMPLETED|Overall Study||9
3000732|NCT00958243|3717808|FG005|NOT COMPLETED|Overall Study||10
3000733|NCT00958256|3717828|FG000|STARTED|Overall Study||21
3000734|NCT00958256|3717828|FG000|COMPLETED|Overall Study||18
3000735|NCT00958256|3717828|FG000|NOT COMPLETED|Overall Study||3
3000736|NCT00958282|3717834|FG000|STARTED|Overall Study||22
3000737|NCT00958282|3717835|FG001|STARTED|Overall Study||21
3000738|NCT00958282|3717834|FG000|COMPLETED|Overall Study||12
3000739|NCT00958282|3717835|FG001|COMPLETED|Overall Study||15
3000740|NCT00958282|3717834|FG000|NOT COMPLETED|Overall Study||10
3000741|NCT00958282|3717835|FG001|NOT COMPLETED|Overall Study||6
3000742|NCT00958308|3717844|FG000|STARTED|Overall Study||84
3000743|NCT00958308|3717845|FG001|STARTED|Overall Study||85
3000744|NCT00958308|3717846|FG002|STARTED|Overall Study||86
3000745|NCT00958308|3717844|FG000|COMPLETED|Overall Study||84
3000746|NCT00958308|3717845|FG001|COMPLETED|Overall Study||85
3000747|NCT00958308|3717846|FG002|COMPLETED|Overall Study||86
3000748|NCT00958308|3717844|FG000|NOT COMPLETED|Overall Study||0
3000749|NCT00958308|3717845|FG001|NOT COMPLETED|Overall Study||0
3000750|NCT00958308|3717846|FG002|NOT COMPLETED|Overall Study||0
3000751|NCT00958334|3717857|FG000|STARTED|Overall Study||22
3000752|NCT00958334|3717858|FG001|STARTED|Overall Study||22
3000753|NCT00958334|3717859|FG002|STARTED|Overall Study||21
3000754|NCT00958334|3717857|FG000|COMPLETED|Overall Study||8
3000755|NCT00958334|3717858|FG001|COMPLETED|Overall Study||5
3000756|NCT00958334|3717859|FG002|COMPLETED|Overall Study||8
3000757|NCT00958334|3717857|FG000|NOT COMPLETED|Overall Study||14
3000758|NCT00958334|3717858|FG001|NOT COMPLETED|Overall Study||17
3000759|NCT00958334|3717859|FG002|NOT COMPLETED|Overall Study||13
3000760|NCT00958360|3717869|FG000|STARTED|Overall Study||163
3000761|NCT00958360|3717870|FG001|STARTED|Overall Study||160
3000762|NCT00958360|3717869|FG000|COMPLETED|Overall Study||152
3000763|NCT00958360|3717870|FG001|COMPLETED|Overall Study||150
3000764|NCT00958360|3717869|FG000|NOT COMPLETED|Overall Study||11
3000765|NCT00958360|3717870|FG001|NOT COMPLETED|Overall Study||10
3000766|NCT00958412|3717876|FG000|STARTED|Overall Study||18
3000767|NCT00958412|3717876|FG000|COMPLETED|Overall Study||0
3000768|NCT00958412|3717876|FG000|NOT COMPLETED|Overall Study||18
3000769|NCT00958438|3717883|FG000|STARTED|Overall Study||82
3000770|NCT00958438|3717884|FG001|STARTED|Overall Study||82
3000771|NCT00958438|3717885|FG002|STARTED|Overall Study||84
3000772|NCT00958438|3717883|FG000|COMPLETED|Overall Study||72
3000773|NCT00958438|3717884|FG001|COMPLETED|Overall Study||72
3000774|NCT00958438|3717885|FG002|COMPLETED|Overall Study||78
3000775|NCT00958438|3717883|FG000|NOT COMPLETED|Overall Study||10
3000776|NCT00958438|3717884|FG001|NOT COMPLETED|Overall Study||10
3000777|NCT00958438|3717885|FG002|NOT COMPLETED|Overall Study||6
3000778|NCT00958477|3717897|FG000|STARTED|Overall Study||8
3000779|NCT00958477|3717898|FG001|STARTED|Overall Study||6
3000780|NCT00958477|3717899|FG002|STARTED|Overall Study||6
3000781|NCT00958477|3717900|FG003|STARTED|Overall Study||6
3000782|NCT00958477|3717897|FG000|COMPLETED|Overall Study||8
3000783|NCT00958477|3717898|FG001|COMPLETED|Overall Study||6
3000784|NCT00958477|3717899|FG002|COMPLETED|Overall Study||6
3000785|NCT00958477|3717900|FG003|COMPLETED|Overall Study||6
3000786|NCT00958477|3717897|FG000|NOT COMPLETED|Overall Study||0
3000787|NCT00958477|3717898|FG001|NOT COMPLETED|Overall Study||0
3000788|NCT00958477|3717899|FG002|NOT COMPLETED|Overall Study||0
3000789|NCT00958477|3717900|FG003|NOT COMPLETED|Overall Study||0
3000790|NCT00958568|3717916|FG000|STARTED|SPII (Wk 0-8, Acute Open-label)||892
3000791|NCT00958568|3717917|FG001|STARTED|SPII (Wk 0-8, Acute Open-label)||0
3000792|NCT00958568|3717918|FG002|STARTED|SPII (Wk 0-8, Acute Open-label)||0
3000793|NCT00958568|3717919|FG003|STARTED|SPII (Wk 0-8, Acute Open-label)||0
3000794|NCT00958568|3717916|FG000|COMPLETED|SPII (Wk 0-8, Acute Open-label)||655
3000795|NCT00958568|3717917|FG001|COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
3000796|NCT00958568|3717918|FG002|COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
3000797|NCT00958568|3717919|FG003|COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
3000798|NCT00958568|3717916|FG000|NOT COMPLETED|SPII (Wk 0-8, Acute Open-label)||237
3000799|NCT00958568|3717917|FG001|NOT COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
3000800|NCT00958568|3717918|FG002|NOT COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
3000801|NCT00958568|3717919|FG003|NOT COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
3000802|NCT00958568|3717916|FG000|STARTED|SPIII (Wk 9-20,Open-label Stabilization)||0
3000803|NCT00958568|3717917|FG001|STARTED|SPIII (Wk 9-20,Open-label Stabilization)||655
3000804|NCT00958568|3717918|FG002|STARTED|SPIII (Wk 9-20,Open-label Stabilization)||0
3000805|NCT00958568|3717919|FG003|STARTED|SPIII (Wk 9-20,Open-label Stabilization)||0
3000806|NCT00958568|3717916|FG000|COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
3000807|NCT00958568|3717917|FG001|COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||444
3000808|NCT00958568|3717918|FG002|COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
3000809|NCT00958568|3717919|FG003|COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
3000810|NCT00958568|3717916|FG000|NOT COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
3000811|NCT00958568|3717917|FG001|NOT COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||211
3000812|NCT00958568|3717918|FG002|NOT COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
3000813|NCT00958568|3717919|FG003|NOT COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
3000814|NCT00958568|3717916|FG000|STARTED|SPIV (Wk 21-47, DB Relapse Prevention)||0
3000815|NCT00958568|3717917|FG001|STARTED|SPIV (Wk 21-47, DB Relapse Prevention)||0
3000816|NCT00958568|3717918|FG002|STARTED|SPIV (Wk 21-47, DB Relapse Prevention)||221
3000817|NCT00958568|3717919|FG003|STARTED|SPIV (Wk 21-47, DB Relapse Prevention)||223
3000818|NCT00958568|3717916|FG000|COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||0
3000819|NCT00958568|3717917|FG001|COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||0
3000820|NCT00958568|3717918|FG002|COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||139
3000821|NCT00958568|3717919|FG003|COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||117
3000822|NCT00958568|3717916|FG000|NOT COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||0
3000823|NCT00958568|3717917|FG001|NOT COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||0
3000824|NCT00958568|3717918|FG002|NOT COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||82
3000825|NCT00958568|3717919|FG003|NOT COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||106
3000826|NCT00958581|3717933|FG000|STARTED|Overall Study||61
3000827|NCT00958581|3717934|FG001|STARTED|Overall Study||61
3000828|NCT00958581|3717935|FG002|STARTED|Overall Study||55
3000829|NCT00958581|3717933|FG000|COMPLETED|Overall Study||61
3000830|NCT00958581|3717934|FG001|COMPLETED|Overall Study||61
3000831|NCT00958581|3717935|FG002|COMPLETED|Overall Study||55
3164876|NCT01895452|3892366|FG001|STARTED|Overall Study||226
3164877|NCT01895452|3892365|FG000|COMPLETED|Overall Study||61
3164878|NCT01895452|3892366|FG001|COMPLETED|Overall Study||198
3164879|NCT01895452|3892365|FG000|NOT COMPLETED|Overall Study||4
3164880|NCT01895452|3892366|FG001|NOT COMPLETED|Overall Study||28
3000832|NCT00958581|3717933|FG000|NOT COMPLETED|Overall Study||0
3000833|NCT00958581|3717934|FG001|NOT COMPLETED|Overall Study||0
3000834|NCT00958581|3717935|FG002|NOT COMPLETED|Overall Study||0
3000835|NCT00958711|3717948|FG000|STARTED|Overall Study||42
3000836|NCT00958711|3717949|FG001|STARTED|Overall Study||48
3000837|NCT00958711|3717948|FG000|COMPLETED|Overall Study||29
3000838|NCT00958711|3717949|FG001|COMPLETED|Overall Study||27
3000839|NCT00958711|3717948|FG000|NOT COMPLETED|Overall Study||13
3000840|NCT00958711|3717949|FG001|NOT COMPLETED|Overall Study||21
3000841|NCT00958724|3717955|FG000|STARTED|Overall Study||6
3000842|NCT00958724|3717955|FG000|COMPLETED|Overall Study||0
3000843|NCT00958724|3717955|FG000|NOT COMPLETED|Overall Study||6
3000844|NCT00958776|3717961|FG000|STARTED|Overall Study||137
3000845|NCT00958776|3717962|FG001|STARTED|Overall Study||268
3000846|NCT00958776|3717961|FG000|COMPLETED|Overall Study||121
3000847|NCT00958776|3717962|FG001|COMPLETED|Overall Study||239
3000848|NCT00958776|3717961|FG000|NOT COMPLETED|Overall Study||16
3000849|NCT00958776|3717962|FG001|NOT COMPLETED|Overall Study||29
3000850|NCT00958789|3717969|FG000|STARTED|Overall Study||180
3000851|NCT00958789|3717969|FG000|COMPLETED|Overall Study|Participant status at the 2 year primary outcome interval determined Completed/Not Completed counts.|130
3000852|NCT00958789|3717969|FG000|NOT COMPLETED|Overall Study||50
3000853|NCT00958828|3717978|FG000|STARTED|Period 1, 1 Week of Wear||89
3000854|NCT00958828|3717979|FG001|STARTED|Period 1, 1 Week of Wear||89
3000855|NCT00958828|3717978|FG000|COMPLETED|Period 1, 1 Week of Wear||89
3000856|NCT00958828|3717979|FG001|COMPLETED|Period 1, 1 Week of Wear||88
3000857|NCT00958828|3717978|FG000|NOT COMPLETED|Period 1, 1 Week of Wear||0
3000858|NCT00958828|3717979|FG001|NOT COMPLETED|Period 1, 1 Week of Wear||1
3000859|NCT00958828|3717978|FG000|STARTED|Period 2, 1 Week of Wear||89
3000860|NCT00958828|3717979|FG001|STARTED|Period 2, 1 Week of Wear||88
3000861|NCT00958828|3717978|FG000|COMPLETED|Period 2, 1 Week of Wear||89
3000862|NCT00958828|3717979|FG001|COMPLETED|Period 2, 1 Week of Wear||87
3000863|NCT00958828|3717978|FG000|NOT COMPLETED|Period 2, 1 Week of Wear||0
3000864|NCT00958828|3717979|FG001|NOT COMPLETED|Period 2, 1 Week of Wear||1
3000865|NCT00958841|3717985|FG000|STARTED|Overall Study||118
3000866|NCT00958841|3717985|FG000|Completed Month 6 (M6)|Overall Study||90
3000867|NCT00958841|3717985|FG000|Entered in Extension|Overall Study||63
3000868|NCT00958841|3717985|FG000|COMPLETED|Overall Study|Completed = Completed extension|22
3000869|NCT00958841|3717985|FG000|NOT COMPLETED|Overall Study||96
3000870|NCT00958880|3718001|FG000|STARTED|Overall Study||20
3000871|NCT00958880|3718002|FG001|STARTED|Overall Study||20
3000872|NCT00958880|3718001|FG000|COMPLETED|Overall Study||18
3000873|NCT00958880|3718002|FG001|COMPLETED|Overall Study||18
3000874|NCT00958880|3718001|FG000|NOT COMPLETED|Overall Study||2
3000875|NCT00958880|3718002|FG001|NOT COMPLETED|Overall Study||2
3000876|NCT00958919|3718008|FG000|STARTED|First Intervention||7
3000877|NCT00958919|3718009|FG001|STARTED|First Intervention||7
3000878|NCT00958919|3718008|FG000|COMPLETED|First Intervention||7
3000879|NCT00958919|3718009|FG001|COMPLETED|First Intervention||7
3000880|NCT00958919|3718008|FG000|NOT COMPLETED|First Intervention||0
3000881|NCT00958919|3718009|FG001|NOT COMPLETED|First Intervention||0
3000882|NCT00958919|3718008|FG000|STARTED|Second Intervention||7
3000883|NCT00958919|3718009|FG001|STARTED|Second Intervention||7
3000884|NCT00958919|3718008|FG000|COMPLETED|Second Intervention||7
3000885|NCT00958919|3718009|FG001|COMPLETED|Second Intervention||7
3000886|NCT00958919|3718008|FG000|NOT COMPLETED|Second Intervention||0
3000887|NCT00958919|3718009|FG001|NOT COMPLETED|Second Intervention||0
3000888|NCT00959049|3718028|FG000|STARTED|Overall Study||231
3000889|NCT00959049|3718029|FG001|STARTED|Overall Study||254
3000890|NCT00959049|3718030|FG002|STARTED|Overall Study||254
3000891|NCT00959049|3718031|FG003|STARTED|Overall Study||228
3000892|NCT00959049|3718032|FG004|STARTED|Overall Study||257
3000893|NCT00959049|3718033|FG005|STARTED|Overall Study||250
3000894|NCT00959049|3718028|FG000|COMPLETED|Overall Study||213
3000895|NCT00959049|3718029|FG001|COMPLETED|Overall Study||247
3000896|NCT00959049|3718030|FG002|COMPLETED|Overall Study||253
3000897|NCT00959049|3718031|FG003|COMPLETED|Overall Study||217
3000898|NCT00959049|3718032|FG004|COMPLETED|Overall Study||248
3000899|NCT00959049|3718033|FG005|COMPLETED|Overall Study||249
3000900|NCT00959049|3718028|FG000|NOT COMPLETED|Overall Study||18
3000901|NCT00959049|3718029|FG001|NOT COMPLETED|Overall Study||7
3000902|NCT00959049|3718030|FG002|NOT COMPLETED|Overall Study||1
3000903|NCT00959049|3718031|FG003|NOT COMPLETED|Overall Study||11
3000904|NCT00959049|3718032|FG004|NOT COMPLETED|Overall Study||9
3000905|NCT00959049|3718033|FG005|NOT COMPLETED|Overall Study||1
3000906|NCT00959166|3718060|FG000|STARTED|Overall Study||24
3000907|NCT00959166|3718061|FG001|STARTED|Overall Study||57
3000908|NCT00959166|3718060|FG000|COMPLETED|Overall Study||24
3000909|NCT00959166|3718061|FG001|COMPLETED|Overall Study||57
3000910|NCT00959166|3718060|FG000|NOT COMPLETED|Overall Study||0
3000911|NCT00959166|3718061|FG001|NOT COMPLETED|Overall Study||0
3000912|NCT00959192|3718071|FG000|STARTED|Overall Study||6
3000913|NCT00959192|3718072|FG001|STARTED|Overall Study||9
3000914|NCT00959192|3718073|FG002|STARTED|Overall Study||9
3000915|NCT00959192|3718074|FG003|STARTED|Overall Study||8
3000916|NCT00959192|3718071|FG000|COMPLETED|Overall Study||4
3000917|NCT00959192|3718072|FG001|COMPLETED|Overall Study||8
3000918|NCT00959192|3718073|FG002|COMPLETED|Overall Study||6
3000919|NCT00959192|3718074|FG003|COMPLETED|Overall Study||7
3000920|NCT00959192|3718071|FG000|NOT COMPLETED|Overall Study||2
3000921|NCT00959192|3718072|FG001|NOT COMPLETED|Overall Study||1
3000922|NCT00959192|3718073|FG002|NOT COMPLETED|Overall Study||3
3000923|NCT00959192|3718074|FG003|NOT COMPLETED|Overall Study||1
3000924|NCT00959374|3718085|FG000|STARTED|Overall Study|Of the 241 enrolled subjects, 229 were randomized and treated|241
3000925|NCT00959374|3718085|FG000|COMPLETED|Overall Study||218
3000926|NCT00959374|3718085|FG000|NOT COMPLETED|Overall Study||23
3000927|NCT00959647|3718093|FG000|STARTED|Overall Study||19
3000928|NCT00959647|3718093|FG000|COMPLETED|Overall Study||0
3000929|NCT00959647|3718093|FG000|NOT COMPLETED|Overall Study||19
3000930|NCT00959660|3718101|FG000|STARTED|Overall Study||26
3000931|NCT00959660|3718102|FG001|STARTED|Overall Study||24
3000932|NCT00959660|3718103|FG002|STARTED|Overall Study||25
3000933|NCT00959660|3718104|FG003|STARTED|Overall Study||25
3000934|NCT00959660|3718101|FG000|COMPLETED|Overall Study||24
3000935|NCT00959660|3718102|FG001|COMPLETED|Overall Study||24
3000936|NCT00959660|3718103|FG002|COMPLETED|Overall Study||22
3000937|NCT00959660|3718104|FG003|COMPLETED|Overall Study||22
3000938|NCT00959660|3718101|FG000|NOT COMPLETED|Overall Study||2
3000939|NCT00959660|3718102|FG001|NOT COMPLETED|Overall Study||0
3000940|NCT00959660|3718103|FG002|NOT COMPLETED|Overall Study||3
3000941|NCT00959660|3718104|FG003|NOT COMPLETED|Overall Study||3
3000942|NCT00959699|3718116|FG000|STARTED|Treatment Period||34
3000943|NCT00959699|3718117|FG001|STARTED|Treatment Period||65
3000944|NCT00959699|3718116|FG000|Treated|Treatment Period||34
3000945|NCT00959699|3718117|FG001|Treated|Treatment Period||64
3000946|NCT00959699|3718116|FG000|COMPLETED|Treatment Period|At TW24, 4 participants not achieving undetectable HCV-RNA crossed-over and received boceprevir.|11
3000947|NCT00959699|3718117|FG001|COMPLETED|Treatment Period||40
3000948|NCT00959699|3718116|FG000|NOT COMPLETED|Treatment Period||23
3000949|NCT00959699|3718117|FG001|NOT COMPLETED|Treatment Period||25
3000950|NCT00959699|3718116|FG000|STARTED|Follow-up Period|1 participant didn't enter Follow-up; participants discontinuing treatment could enter Follow-up.|33
3000951|NCT00959699|3718117|FG001|STARTED|Follow-up Period|2 participants didn't enter Follow-up; participants discontinuing treatment could enter Follow-up.|62
3000952|NCT00959699|3718116|FG000|COMPLETED|Follow-up Period||27
3000953|NCT00959699|3718117|FG001|COMPLETED|Follow-up Period||56
3000954|NCT00959699|3718116|FG000|NOT COMPLETED|Follow-up Period||6
3000955|NCT00959699|3718117|FG001|NOT COMPLETED|Follow-up Period||6
3000956|NCT00959751|3718126|FG000|STARTED|Overall Study||97
3000957|NCT00959751|3718127|FG001|STARTED|Overall Study||98
3000958|NCT00959751|3718126|FG000|COMPLETED|Overall Study||88
3000959|NCT00959751|3718127|FG001|COMPLETED|Overall Study||86
3000960|NCT00959751|3718126|FG000|NOT COMPLETED|Overall Study||9
3000961|NCT00959751|3718127|FG001|NOT COMPLETED|Overall Study||12
3000962|NCT00959764|3718136|FG000|STARTED|Overall Study||271
3000963|NCT00959764|3718137|FG001|STARTED|Overall Study||185
3000964|NCT00959764|3718138|FG002|STARTED|Overall Study||109
3000965|NCT00959764|3718136|FG000|COMPLETED|Overall Study||176
3000966|NCT00959764|3718137|FG001|COMPLETED|Overall Study||128
3000967|NCT00959764|3718138|FG002|COMPLETED|Overall Study||73
3000968|NCT00959764|3718136|FG000|NOT COMPLETED|Overall Study||95
3000969|NCT00959764|3718137|FG001|NOT COMPLETED|Overall Study||57
3000970|NCT00959764|3718138|FG002|NOT COMPLETED|Overall Study||36
3000971|NCT00959842|3718149|FG000|STARTED|Overall Study|17 were recruited and at baseline. 2 dropped out before starting the study drug. 15 finished|15
3000972|NCT00959842|3718149|FG000|COMPLETED|Overall Study||15
3000973|NCT00959842|3718149|FG000|NOT COMPLETED|Overall Study||0
3000974|NCT00959894|3718153|FG000|STARTED|Overall Study|One (1) additional subject became ineligible on the day of entry and never started study medication.|79
3000975|NCT00959894|3718153|FG000|COMPLETED|Overall Study||63
3000976|NCT00959894|3718153|FG000|NOT COMPLETED|Overall Study||16
3000977|NCT00959907|3718160|FG000|STARTED|Overall Study||30
3000978|NCT00959907|3718161|FG001|STARTED|Overall Study||29
3000979|NCT00959907|3718160|FG000|COMPLETED|Overall Study||27
3000980|NCT00959907|3718161|FG001|COMPLETED|Overall Study||28
3000981|NCT00959907|3718160|FG000|NOT COMPLETED|Overall Study||3
3000982|NCT00959907|3718161|FG001|NOT COMPLETED|Overall Study||1
3000983|NCT00959920|3718169|FG000|STARTED|Overall Study||72
3000984|NCT00959920|3718170|FG001|STARTED|Overall Study||67
3000985|NCT00959920|3718169|FG000|COMPLETED|Overall Study||72
3000986|NCT00959920|3718170|FG001|COMPLETED|Overall Study||66
3000987|NCT00959920|3718169|FG000|NOT COMPLETED|Overall Study||0
3000988|NCT00959920|3718170|FG001|NOT COMPLETED|Overall Study||1
3000989|NCT00959946|3718186|FG000|STARTED|Overall Study||2
3000990|NCT00959946|3718187|FG001|STARTED|Overall Study||4
3000991|NCT00959946|3718188|FG002|STARTED|Overall Study||4
3000992|NCT00959946|3718189|FG003|STARTED|Overall Study||5
3000993|NCT00959946|3718190|FG004|STARTED|Overall Study||4
3000994|NCT00959946|3718191|FG005|STARTED|Overall Study||9
3000995|NCT00959946|3718192|FG006|STARTED|Overall Study||2
3164881|NCT01895543|3892372|FG000|STARTED|Overall Study||411
3171771|NCT01937026|3898964|FG000|NOT COMPLETED|Period 1 (Day 1 Through Predose Day 3)||0
3000996|NCT00959946|3718193|FG007|STARTED|Overall Study||2
3000997|NCT00959946|3718186|FG000|COMPLETED|Overall Study||0
3000998|NCT00959946|3718187|FG001|COMPLETED|Overall Study||0
3000999|NCT00959946|3718188|FG002|COMPLETED|Overall Study||0
3001000|NCT00959946|3718189|FG003|COMPLETED|Overall Study||0
3001001|NCT00959946|3718190|FG004|COMPLETED|Overall Study||0
3001002|NCT00959946|3718191|FG005|COMPLETED|Overall Study||0
3001003|NCT00959946|3718192|FG006|COMPLETED|Overall Study||0
3001004|NCT00959946|3718193|FG007|COMPLETED|Overall Study||0
3001005|NCT00959946|3718186|FG000|NOT COMPLETED|Overall Study||2
3001006|NCT00959946|3718187|FG001|NOT COMPLETED|Overall Study||4
3001007|NCT00959946|3718188|FG002|NOT COMPLETED|Overall Study||4
3001008|NCT00959946|3718189|FG003|NOT COMPLETED|Overall Study||5
3001009|NCT00959946|3718190|FG004|NOT COMPLETED|Overall Study||4
3001010|NCT00959946|3718191|FG005|NOT COMPLETED|Overall Study||9
3001011|NCT00959946|3718192|FG006|NOT COMPLETED|Overall Study||2
3001012|NCT00959946|3718193|FG007|NOT COMPLETED|Overall Study||2
3001013|NCT00959985|3718220|FG000|STARTED|Overall Study||8
3001014|NCT00959985|3718221|FG001|STARTED|Overall Study||7
3001015|NCT00959985|3718222|FG002|STARTED|Overall Study||4
3001016|NCT00959985|3718223|FG003|STARTED|Overall Study||4
3001017|NCT00959985|3718220|FG000|COMPLETED|Overall Study||8
3001018|NCT00959985|3718221|FG001|COMPLETED|Overall Study||7
3001019|NCT00959985|3718222|FG002|COMPLETED|Overall Study||4
3001020|NCT00959985|3718223|FG003|COMPLETED|Overall Study||4
3001021|NCT00959985|3718220|FG000|NOT COMPLETED|Overall Study||0
3001022|NCT00959985|3718221|FG001|NOT COMPLETED|Overall Study||0
3001023|NCT00959985|3718222|FG002|NOT COMPLETED|Overall Study||0
3001024|NCT00959985|3718223|FG003|NOT COMPLETED|Overall Study||0
3001025|NCT00960011|3718235|FG000|STARTED|Overall Study||33
3001026|NCT00960011|3718236|FG001|STARTED|Overall Study||25
3001027|NCT00960011|3718235|FG000|COMPLETED|Overall Study||22
3001028|NCT00960011|3718236|FG001|COMPLETED|Overall Study||23
3001029|NCT00960011|3718235|FG000|NOT COMPLETED|Overall Study||11
3001030|NCT00960011|3718236|FG001|NOT COMPLETED|Overall Study||2
3001031|NCT00960063|3718279|FG000|STARTED|Overall Study||1
3001032|NCT00960063|3718280|FG001|STARTED|Overall Study||0
3001033|NCT00960063|3718281|FG002|STARTED|Overall Study||3
3001034|NCT00960063|3718279|FG000|COMPLETED|Overall Study||0
3001035|NCT00960063|3718280|FG001|COMPLETED|Overall Study||0
3001036|NCT00960063|3718281|FG002|COMPLETED|Overall Study||0
3001037|NCT00960063|3718279|FG000|NOT COMPLETED|Overall Study||1
3001038|NCT00960063|3718280|FG001|NOT COMPLETED|Overall Study||0
3001039|NCT00960063|3718281|FG002|NOT COMPLETED|Overall Study||3
3001040|NCT00960076|3718291|FG000|STARTED|Overall Study|Randomized and treated|138
3001041|NCT00960076|3718292|FG001|STARTED|Overall Study|Randomized and treated|144
3001042|NCT00960076|3718291|FG000|COMPLETED|Overall Study|Completing 18 weeks of treatment|130
3001043|NCT00960076|3718292|FG001|COMPLETED|Overall Study|Completing 18 weeks of treatment|119
3001044|NCT00960076|3718291|FG000|NOT COMPLETED|Overall Study||8
3001045|NCT00960076|3718292|FG001|NOT COMPLETED|Overall Study||25
3001046|NCT00960115|3718300|FG000|STARTED|Overall Study||114
3001047|NCT00960115|3718301|FG001|STARTED|Overall Study||58
3001048|NCT00960115|3718300|FG000|COMPLETED|Overall Study||95
3001049|NCT00960115|3718301|FG001|COMPLETED|Overall Study||43
3001050|NCT00960115|3718300|FG000|NOT COMPLETED|Overall Study||19
3001051|NCT00960115|3718301|FG001|NOT COMPLETED|Overall Study||15
3001052|NCT00960193|3718307|FG000|STARTED|Colchicine Alone||24
3001053|NCT00960193|3718307|FG000|COMPLETED|Colchicine Alone||24
3001054|NCT00960193|3718307|FG000|NOT COMPLETED|Colchicine Alone||0
3001055|NCT00960193|3718307|FG000|STARTED|14 Day Washout Period||24
3001056|NCT00960193|3718307|FG000|COMPLETED|14 Day Washout Period||23
3001057|NCT00960193|3718307|FG000|NOT COMPLETED|14 Day Washout Period||1
3001058|NCT00960193|3718307|FG000|STARTED|Seville Orange Juice Alone||23
3001059|NCT00960193|3718307|FG000|COMPLETED|Seville Orange Juice Alone||23
3001060|NCT00960193|3718307|FG000|NOT COMPLETED|Seville Orange Juice Alone||0
3001061|NCT00960193|3718307|FG000|STARTED|Colchicine With Seville Orange Juice||23
3001062|NCT00960193|3718307|FG000|COMPLETED|Colchicine With Seville Orange Juice||23
3001063|NCT00960193|3718307|FG000|NOT COMPLETED|Colchicine With Seville Orange Juice||0
3001064|NCT00960206|3718317|FG000|STARTED|Overall Study||190
3001065|NCT00960206|3718318|FG001|STARTED|Overall Study||185
3001066|NCT00960206|3718319|FG002|STARTED|Overall Study||89
3001067|NCT00960206|3718317|FG000|COMPLETED|Overall Study||150
3001068|NCT00960206|3718318|FG001|COMPLETED|Overall Study||158
3001069|NCT00960206|3718319|FG002|COMPLETED|Overall Study||77
3001070|NCT00960206|3718317|FG000|NOT COMPLETED|Overall Study||40
3001071|NCT00960206|3718318|FG001|NOT COMPLETED|Overall Study||27
3001072|NCT00960206|3718319|FG002|NOT COMPLETED|Overall Study||12
3001073|NCT00960323|3718328|FG000|STARTED|Colchicine Alone||24
3001074|NCT00960323|3718328|FG000|COMPLETED|Colchicine Alone||24
3001075|NCT00960323|3718328|FG000|NOT COMPLETED|Colchicine Alone||0
3001076|NCT00960323|3718328|FG000|STARTED|14 Day Washout Period||24
3001077|NCT00960323|3718328|FG000|COMPLETED|14 Day Washout Period||24
3001078|NCT00960323|3718328|FG000|NOT COMPLETED|14 Day Washout Period||0
3001079|NCT00960323|3718328|FG000|STARTED|Atorvastatin Alone||24
3001080|NCT00960323|3718328|FG000|COMPLETED|Atorvastatin Alone||23
3001081|NCT00960323|3718328|FG000|NOT COMPLETED|Atorvastatin Alone||1
3001082|NCT00960323|3718328|FG000|STARTED|Colchicine and Atorvastatin||23
3001083|NCT00960323|3718328|FG000|COMPLETED|Colchicine and Atorvastatin||23
3001084|NCT00960323|3718328|FG000|NOT COMPLETED|Colchicine and Atorvastatin||0
3001085|NCT00960375|3718338|FG000|STARTED|Overall Study||92
3001086|NCT00960375|3718339|FG001|STARTED|Overall Study||87
3001087|NCT00960375|3718338|FG000|COMPLETED|Overall Study||72
3001088|NCT00960375|3718339|FG001|COMPLETED|Overall Study||65
3001089|NCT00960375|3718338|FG000|NOT COMPLETED|Overall Study||20
3001090|NCT00960375|3718339|FG001|NOT COMPLETED|Overall Study||22
3001091|NCT00960440|3718349|FG000|STARTED|Overall Study||133
3001092|NCT00960440|3718350|FG001|STARTED|Overall Study||134
3001093|NCT00960440|3718351|FG002|STARTED|Overall Study||66
3001094|NCT00960440|3718352|FG003|STARTED|Overall Study||66
3001095|NCT00960440|3718349|FG000|COMPLETED|Overall Study||107
3001096|NCT00960440|3718350|FG001|COMPLETED|Overall Study||103
3001097|NCT00960440|3718351|FG002|COMPLETED|Overall Study||53
3001098|NCT00960440|3718352|FG003|COMPLETED|Overall Study||48
3001099|NCT00960440|3718349|FG000|NOT COMPLETED|Overall Study||26
3001100|NCT00960440|3718350|FG001|NOT COMPLETED|Overall Study||31
3001101|NCT00960440|3718351|FG002|NOT COMPLETED|Overall Study||13
3001102|NCT00960440|3718352|FG003|NOT COMPLETED|Overall Study||18
3001103|NCT00960505|3718367|FG000|STARTED|Overall Study||34
3001104|NCT00960505|3718368|FG001|STARTED|Overall Study||35
3001105|NCT00960505|3718369|FG002|STARTED|Overall Study||31
3001106|NCT00960505|3718367|FG000|COMPLETED|Overall Study||21
3001107|NCT00960505|3718368|FG001|COMPLETED|Overall Study||25
3001108|NCT00960505|3718369|FG002|COMPLETED|Overall Study||23
3001109|NCT00960505|3718367|FG000|NOT COMPLETED|Overall Study||13
3001110|NCT00960505|3718368|FG001|NOT COMPLETED|Overall Study||10
3001111|NCT00960505|3718369|FG002|NOT COMPLETED|Overall Study||8
3001112|NCT00960531|3718387|FG000|STARTED|Overall Study|Started=Randomized|21
3001113|NCT00960531|3718388|FG001|STARTED|Overall Study|Started=Randomized|6
3001114|NCT00960531|3718389|FG002|STARTED|Overall Study|Started=Randomized|41
3001115|NCT00960531|3718390|FG003|STARTED|Overall Study|Started=Randomized.|25
3001116|NCT00960531|3718391|FG004|STARTED|Overall Study|Started=Randomized|5
3001117|NCT00960531|3718392|FG005|STARTED|Overall Study|Started=Randomized|9
3001118|NCT00960531|3718393|FG006|STARTED|Overall Study|Started=Randomized|27
3001119|NCT00960531|3718394|FG007|STARTED|Overall Study|Started=Randomized|6
3001120|NCT00960531|3718395|FG008|STARTED|Overall Study|Started=Randomized|16
3001121|NCT00960531|3718396|FG009|STARTED|Overall Study|Started=Randomized|4
3001122|NCT00960531|3718387|FG000|Treated|Overall Study||21
3001123|NCT00960531|3718388|FG001|Treated|Overall Study||6
3001124|NCT00960531|3718389|FG002|Treated|Overall Study||41
3001125|NCT00960531|3718390|FG003|Treated|Overall Study||24
3001126|NCT00960531|3718391|FG004|Treated|Overall Study||5
3001127|NCT00960531|3718392|FG005|Treated|Overall Study||9
3001128|NCT00960531|3718393|FG006|Treated|Overall Study||27
3001129|NCT00960531|3718394|FG007|Treated|Overall Study||6
3001130|NCT00960531|3718395|FG008|Treated|Overall Study||16
3001131|NCT00960531|3718396|FG009|Treated|Overall Study||4
3001132|NCT00960531|3718387|FG000|Completed Treatment|Overall Study||12
3001133|NCT00960531|3718388|FG001|Completed Treatment|Overall Study||5
3001134|NCT00960531|3718389|FG002|Completed Treatment|Overall Study||15
3001135|NCT00960531|3718390|FG003|Completed Treatment|Overall Study||17
3001136|NCT00960531|3718391|FG004|Completed Treatment|Overall Study||3
3001137|NCT00960531|3718392|FG005|Completed Treatment|Overall Study||7
3001138|NCT00960531|3718393|FG006|Completed Treatment|Overall Study||4
3001139|NCT00960531|3718394|FG007|Completed Treatment|Overall Study||3
3001140|NCT00960531|3718395|FG008|Completed Treatment|Overall Study||2
3001141|NCT00960531|3718396|FG009|Completed Treatment|Overall Study||4
3001142|NCT00960531|3718387|FG000|COMPLETED|Overall Study|Completed study|11
3001143|NCT00960531|3718388|FG001|COMPLETED|Overall Study|Completed study|5
3001144|NCT00960531|3718389|FG002|COMPLETED|Overall Study|Completed study|15
3001145|NCT00960531|3718390|FG003|COMPLETED|Overall Study|Completed study|17
3001146|NCT00960531|3718391|FG004|COMPLETED|Overall Study|Completed study|3
3001147|NCT00960531|3718392|FG005|COMPLETED|Overall Study|Completed study|6
3001148|NCT00960531|3718393|FG006|COMPLETED|Overall Study|Completed study|3
3001149|NCT00960531|3718394|FG007|COMPLETED|Overall Study|Completed study|2
3001150|NCT00960531|3718395|FG008|COMPLETED|Overall Study|Completed study|2
3001151|NCT00960531|3718396|FG009|COMPLETED|Overall Study|Completed study|3
3001152|NCT00960531|3718387|FG000|NOT COMPLETED|Overall Study||10
3001153|NCT00960531|3718388|FG001|NOT COMPLETED|Overall Study||1
3001154|NCT00960531|3718389|FG002|NOT COMPLETED|Overall Study||26
3001155|NCT00960531|3718390|FG003|NOT COMPLETED|Overall Study||8
3001156|NCT00960531|3718391|FG004|NOT COMPLETED|Overall Study||2
3001157|NCT00960531|3718392|FG005|NOT COMPLETED|Overall Study||3
3001158|NCT00960531|3718393|FG006|NOT COMPLETED|Overall Study||24
3001159|NCT00960531|3718394|FG007|NOT COMPLETED|Overall Study||4
3001160|NCT00960531|3718395|FG008|NOT COMPLETED|Overall Study||14
3001161|NCT00960531|3718396|FG009|NOT COMPLETED|Overall Study||1
3001162|NCT00960570|3718422|FG000|STARTED|Efavirenz Alone||30
3001163|NCT00960570|3718422|FG000|COMPLETED|Efavirenz Alone||30
3001164|NCT00960570|3718422|FG000|NOT COMPLETED|Efavirenz Alone||0
3001165|NCT00960570|3718422|FG000|STARTED|21 Day Washout Period||30
3001166|NCT00960570|3718422|FG000|COMPLETED|21 Day Washout Period||28
3001167|NCT00960570|3718422|FG000|NOT COMPLETED|21 Day Washout Period||2
3001168|NCT00960570|3718422|FG000|STARTED|Fenofibric Acid Alone||28
3001169|NCT00960570|3718422|FG000|COMPLETED|Fenofibric Acid Alone||28
3001170|NCT00960570|3718422|FG000|NOT COMPLETED|Fenofibric Acid Alone||0
3001171|NCT00960570|3718422|FG000|STARTED|1 Day Period Between Dosing||28
3001172|NCT00960570|3718422|FG000|COMPLETED|1 Day Period Between Dosing||25
3001173|NCT00960570|3718422|FG000|NOT COMPLETED|1 Day Period Between Dosing||3
3001174|NCT00960570|3718422|FG000|STARTED|Efavirenz and Fenofibric Acid||25
3001175|NCT00960570|3718422|FG000|COMPLETED|Efavirenz and Fenofibric Acid||25
3001176|NCT00960570|3718422|FG000|NOT COMPLETED|Efavirenz and Fenofibric Acid||0
3001177|NCT00960622|3718431|FG000|STARTED|Overall Study||10
3001178|NCT00960622|3718432|FG001|STARTED|Overall Study||10
3001179|NCT00960622|3718431|FG000|COMPLETED|Overall Study||10
3001180|NCT00960622|3718432|FG001|COMPLETED|Overall Study||7
3001181|NCT00960622|3718431|FG000|NOT COMPLETED|Overall Study||0
3001182|NCT00960622|3718432|FG001|NOT COMPLETED|Overall Study||3
3001183|NCT00960661|3718440|FG000|STARTED|Basal Insulin Optimization Phase (BIO)||1036
3001184|NCT00960661|3718441|FG001|STARTED|Basal Insulin Optimization Phase (BIO)||0
3001185|NCT00960661|3718442|FG002|STARTED|Basal Insulin Optimization Phase (BIO)||0
3001186|NCT00960661|3718440|FG000|COMPLETED|Basal Insulin Optimization Phase (BIO)||637
3001187|NCT00960661|3718441|FG001|COMPLETED|Basal Insulin Optimization Phase (BIO)||0
3001188|NCT00960661|3718442|FG002|COMPLETED|Basal Insulin Optimization Phase (BIO)||0
3001189|NCT00960661|3718440|FG000|NOT COMPLETED|Basal Insulin Optimization Phase (BIO)||399
3001190|NCT00960661|3718441|FG001|NOT COMPLETED|Basal Insulin Optimization Phase (BIO)||0
3001191|NCT00960661|3718442|FG002|NOT COMPLETED|Basal Insulin Optimization Phase (BIO)||0
3001192|NCT00960661|3718440|FG000|STARTED|Interventional Phase||0
3001193|NCT00960661|3718441|FG001|STARTED|Interventional Phase||316
3001194|NCT00960661|3718442|FG002|STARTED|Interventional Phase||321
3001195|NCT00960661|3718440|FG000|Intent to Treat Population|Interventional Phase||0
3001196|NCT00960661|3718441|FG001|Intent to Treat Population|Interventional Phase|all randomized participants who took at least one dose of study drug|315
3001197|NCT00960661|3718442|FG002|Intent to Treat Population|Interventional Phase|all randomized participants who took at least one dose of study drug|312
3001198|NCT00960661|3718440|FG000|Per Protocol Population|Interventional Phase||0
3001199|NCT00960661|3718441|FG001|Per Protocol Population|Interventional Phase|all randomized participants who completed study and had no violations|247
3001200|NCT00960661|3718442|FG002|Per Protocol Population|Interventional Phase|all randomized participants who completed study and had no violations|263
3001201|NCT00960661|3718440|FG000|COMPLETED|Interventional Phase||0
3001202|NCT00960661|3718441|FG001|COMPLETED|Interventional Phase||264
3001203|NCT00960661|3718442|FG002|COMPLETED|Interventional Phase||275
3001204|NCT00960661|3718440|FG000|NOT COMPLETED|Interventional Phase||0
3001205|NCT00960661|3718441|FG001|NOT COMPLETED|Interventional Phase||52
3001206|NCT00960661|3718442|FG002|NOT COMPLETED|Interventional Phase||46
3001207|NCT00960687|3718448|FG000|STARTED|First Intervention||27
3001208|NCT00960687|3718449|FG001|STARTED|First Intervention||27
3001209|NCT00960687|3718448|FG000|COMPLETED|First Intervention||27
3001210|NCT00960687|3718449|FG001|COMPLETED|First Intervention||27
3001211|NCT00960687|3718448|FG000|NOT COMPLETED|First Intervention||0
3001212|NCT00960687|3718449|FG001|NOT COMPLETED|First Intervention||0
3001213|NCT00960687|3718448|FG000|STARTED|Washout Period of 7 Days||27
3001214|NCT00960687|3718449|FG001|STARTED|Washout Period of 7 Days||27
3001215|NCT00960687|3718448|FG000|COMPLETED|Washout Period of 7 Days|three subjects withdrew due to adverse events and one subject withdrew for personal reasons.|23
3001216|NCT00960687|3718449|FG001|COMPLETED|Washout Period of 7 Days|two subjects withdrew due to adverse events and one subject withdrew for personal reasons.|24
3001217|NCT00960687|3718448|FG000|NOT COMPLETED|Washout Period of 7 Days||4
3001218|NCT00960687|3718449|FG001|NOT COMPLETED|Washout Period of 7 Days||3
3001219|NCT00960687|3718448|FG000|STARTED|Second Intervention||23
3001220|NCT00960687|3718449|FG001|STARTED|Second Intervention||24
3001221|NCT00960687|3718448|FG000|COMPLETED|Second Intervention||23
3001222|NCT00960687|3718449|FG001|COMPLETED|Second Intervention||24
3001223|NCT00960687|3718448|FG000|NOT COMPLETED|Second Intervention||0
3001224|NCT00960687|3718449|FG001|NOT COMPLETED|Second Intervention||0
3001225|NCT00960778|3718457|FG000|STARTED|Overall Study||17
3001226|NCT00960778|3718458|FG001|STARTED|Overall Study||16
3001227|NCT00960778|3718457|FG000|COMPLETED|Overall Study||8
3001228|NCT00960778|3718458|FG001|COMPLETED|Overall Study||13
3001229|NCT00960778|3718457|FG000|NOT COMPLETED|Overall Study||9
3001230|NCT00960778|3718458|FG001|NOT COMPLETED|Overall Study||3
3001231|NCT00960804|3718467|FG000|STARTED|Overall Study||7
3001232|NCT00960804|3718468|FG001|STARTED|Overall Study||4
3001233|NCT00960804|3718469|FG002|STARTED|Overall Study||10
3001234|NCT00960804|3718467|FG000|COMPLETED|Overall Study||0
3001235|NCT00960804|3718468|FG001|COMPLETED|Overall Study||0
3001236|NCT00960804|3718469|FG002|COMPLETED|Overall Study||0
3001237|NCT00960804|3718467|FG000|NOT COMPLETED|Overall Study||7
3001238|NCT00960804|3718468|FG001|NOT COMPLETED|Overall Study||4
3001239|NCT00960804|3718469|FG002|NOT COMPLETED|Overall Study||10
3001240|NCT00960843|3718479|FG000|STARTED|Overall Study||25
3001241|NCT00960843|3718480|FG001|STARTED|Overall Study||26
3001242|NCT00960843|3718479|FG000|COMPLETED|Overall Study||23
3001243|NCT00960843|3718480|FG001|COMPLETED|Overall Study||21
3001244|NCT00960843|3718479|FG000|NOT COMPLETED|Overall Study||2
3001245|NCT00960843|3718480|FG001|NOT COMPLETED|Overall Study||5
3001246|NCT00960856|3718486|FG000|STARTED|Period I||10
3001247|NCT00960856|3718487|FG001|STARTED|Period I||9
3001248|NCT00960856|3718488|FG002|STARTED|Period I||9
3001249|NCT00960856|3718489|FG003|STARTED|Period I||9
3001250|NCT00960856|3718486|FG000|COMPLETED|Period I||10
3001251|NCT00960856|3718487|FG001|COMPLETED|Period I||9
3001252|NCT00960856|3718488|FG002|COMPLETED|Period I||9
3001253|NCT00960856|3718489|FG003|COMPLETED|Period I||9
3001254|NCT00960856|3718486|FG000|NOT COMPLETED|Period I||0
3001255|NCT00960856|3718487|FG001|NOT COMPLETED|Period I||0
3001256|NCT00960856|3718488|FG002|NOT COMPLETED|Period I||0
3001257|NCT00960856|3718489|FG003|NOT COMPLETED|Period I||0
3001258|NCT00960856|3718486|FG000|STARTED|Washout Period of 7 Days||10
3001259|NCT00960856|3718487|FG001|STARTED|Washout Period of 7 Days||9
3001260|NCT00960856|3718488|FG002|STARTED|Washout Period of 7 Days||9
3001261|NCT00960856|3718489|FG003|STARTED|Washout Period of 7 Days||9
3001262|NCT00960856|3718486|FG000|COMPLETED|Washout Period of 7 Days||10
3001263|NCT00960856|3718487|FG001|COMPLETED|Washout Period of 7 Days|personal reasons|7
3001264|NCT00960856|3718488|FG002|COMPLETED|Washout Period of 7 Days||9
3001265|NCT00960856|3718489|FG003|COMPLETED|Washout Period of 7 Days||9
3001266|NCT00960856|3718486|FG000|NOT COMPLETED|Washout Period of 7 Days||0
3001267|NCT00960856|3718487|FG001|NOT COMPLETED|Washout Period of 7 Days||2
3001268|NCT00960856|3718488|FG002|NOT COMPLETED|Washout Period of 7 Days||0
3001269|NCT00960856|3718489|FG003|NOT COMPLETED|Washout Period of 7 Days||0
3001270|NCT00960856|3718486|FG000|STARTED|Period II||10
3001271|NCT00960856|3718487|FG001|STARTED|Period II||7
3001272|NCT00960856|3718488|FG002|STARTED|Period II||9
3001273|NCT00960856|3718489|FG003|STARTED|Period II||9
3001274|NCT00960856|3718486|FG000|COMPLETED|Period II||10
3001275|NCT00960856|3718487|FG001|COMPLETED|Period II||7
3001276|NCT00960856|3718488|FG002|COMPLETED|Period II||9
3001277|NCT00960856|3718489|FG003|COMPLETED|Period II||9
3001278|NCT00960856|3718486|FG000|NOT COMPLETED|Period II||0
3001279|NCT00960856|3718487|FG001|NOT COMPLETED|Period II||0
3001280|NCT00960856|3718488|FG002|NOT COMPLETED|Period II||0
3001281|NCT00960856|3718489|FG003|NOT COMPLETED|Period II||0
3001282|NCT00960856|3718486|FG000|STARTED|Washout Period of 7 Days||10
3001283|NCT00960856|3718487|FG001|STARTED|Washout Period of 7 Days||7
3001284|NCT00960856|3718488|FG002|STARTED|Washout Period of 7 Days||9
3001285|NCT00960856|3718489|FG003|STARTED|Washout Period of 7 Days||9
3001286|NCT00960856|3718486|FG000|COMPLETED|Washout Period of 7 Days||10
3001287|NCT00960856|3718487|FG001|COMPLETED|Washout Period of 7 Days||7
3001288|NCT00960856|3718488|FG002|COMPLETED|Washout Period of 7 Days||9
3001289|NCT00960856|3718489|FG003|COMPLETED|Washout Period of 7 Days||9
3001290|NCT00960856|3718486|FG000|NOT COMPLETED|Washout Period of 7 Days||0
3001291|NCT00960856|3718487|FG001|NOT COMPLETED|Washout Period of 7 Days||0
3001292|NCT00960856|3718488|FG002|NOT COMPLETED|Washout Period of 7 Days||0
3001293|NCT00960856|3718489|FG003|NOT COMPLETED|Washout Period of 7 Days||0
3001294|NCT00960856|3718486|FG000|STARTED|Period III||10
3001295|NCT00960856|3718487|FG001|STARTED|Period III||7
3001296|NCT00960856|3718488|FG002|STARTED|Period III||9
3001297|NCT00960856|3718489|FG003|STARTED|Period III||9
3001298|NCT00960856|3718486|FG000|COMPLETED|Period III||10
3001299|NCT00960856|3718487|FG001|COMPLETED|Period III||7
3001300|NCT00960856|3718488|FG002|COMPLETED|Period III||9
3001301|NCT00960856|3718489|FG003|COMPLETED|Period III||9
3001302|NCT00960856|3718486|FG000|NOT COMPLETED|Period III||0
3001303|NCT00960856|3718487|FG001|NOT COMPLETED|Period III||0
3001304|NCT00960856|3718488|FG002|NOT COMPLETED|Period III||0
3001305|NCT00960856|3718489|FG003|NOT COMPLETED|Period III||0
3001306|NCT00960856|3718486|FG000|STARTED|Washout Period of 7 Days||10
3001307|NCT00960856|3718487|FG001|STARTED|Washout Period of 7 Days||7
3001308|NCT00960856|3718488|FG002|STARTED|Washout Period of 7 Days||9
3001309|NCT00960856|3718489|FG003|STARTED|Washout Period of 7 Days||9
3001310|NCT00960856|3718486|FG000|COMPLETED|Washout Period of 7 Days||10
3001311|NCT00960856|3718487|FG001|COMPLETED|Washout Period of 7 Days||7
3001312|NCT00960856|3718488|FG002|COMPLETED|Washout Period of 7 Days||8
3001313|NCT00960856|3718489|FG003|COMPLETED|Washout Period of 7 Days||9
3001314|NCT00960856|3718486|FG000|NOT COMPLETED|Washout Period of 7 Days||0
3001315|NCT00960856|3718487|FG001|NOT COMPLETED|Washout Period of 7 Days||0
3001316|NCT00960856|3718488|FG002|NOT COMPLETED|Washout Period of 7 Days||1
3001317|NCT00960856|3718489|FG003|NOT COMPLETED|Washout Period of 7 Days||0
3001318|NCT00960856|3718486|FG000|STARTED|Period IV||10
3001319|NCT00960856|3718487|FG001|STARTED|Period IV||7
3001320|NCT00960856|3718488|FG002|STARTED|Period IV||8
3001321|NCT00960856|3718489|FG003|STARTED|Period IV||9
3001322|NCT00960856|3718486|FG000|COMPLETED|Period IV||10
3001323|NCT00960856|3718487|FG001|COMPLETED|Period IV||7
3001324|NCT00960856|3718488|FG002|COMPLETED|Period IV||8
3001325|NCT00960856|3718489|FG003|COMPLETED|Period IV||9
3001326|NCT00960856|3718486|FG000|NOT COMPLETED|Period IV||0
3001327|NCT00960856|3718487|FG001|NOT COMPLETED|Period IV||0
3001328|NCT00960856|3718488|FG002|NOT COMPLETED|Period IV||0
3001329|NCT00960856|3718489|FG003|NOT COMPLETED|Period IV||0
3001330|NCT00960869|3718501|FG000|STARTED|Overall Study||259
3001331|NCT00960869|3718502|FG001|STARTED|Overall Study||260
3001332|NCT00960869|3718501|FG000|Intent-to-Treat Population (ITT)|Overall Study||259
3001333|NCT00960869|3718502|FG001|Intent-to-Treat Population (ITT)|Overall Study||260
3001334|NCT00960869|3718501|FG000|Safety Popluation|Overall Study|3 rand to PA32540 took EC-ASA 325mg/3 rand to EC-ASA 325mg took PA32540 counted by actual treatment.|257
3001335|NCT00960869|3718502|FG001|Safety Popluation|Overall Study|3 rand to PA32540 took EC-ASA 325mg/3 rand to EC-ASA 325mg took PA32540 counted by actual treatment.|259
3001336|NCT00960869|3718501|FG000|COMPLETED|Overall Study||206
3001337|NCT00960869|3718502|FG001|COMPLETED|Overall Study||198
3001338|NCT00960869|3718501|FG000|NOT COMPLETED|Overall Study||53
3001339|NCT00960869|3718502|FG001|NOT COMPLETED|Overall Study||62
3001340|NCT00960934|3718514|FG000|STARTED|Overall Study||64
3001341|NCT00960934|3718515|FG001|STARTED|Overall Study||63
3001342|NCT00960934|3718516|FG002|STARTED|Overall Study||64
3001343|NCT00960934|3718517|FG003|STARTED|Overall Study||64
3001344|NCT00960934|3718518|FG004|STARTED|Overall Study||64
3001345|NCT00960934|3718519|FG005|STARTED|Overall Study||64
3001346|NCT00960934|3718514|FG000|Number Treated|Overall Study||64
3001347|NCT00960934|3718515|FG001|Number Treated|Overall Study|1 participant was randomized but not treated|62
3001348|NCT00960934|3718516|FG002|Number Treated|Overall Study||64
3001349|NCT00960934|3718517|FG003|Number Treated|Overall Study||64
3001350|NCT00960934|3718518|FG004|Number Treated|Overall Study|1 participant was randomized but not treated|63
3001351|NCT00960934|3718519|FG005|Number Treated|Overall Study|1 participant was randomized but not treated|63
3001352|NCT00960934|3718514|FG000|COMPLETED|Overall Study||0
3001353|NCT00960934|3718515|FG001|COMPLETED|Overall Study||0
3001354|NCT00960934|3718516|FG002|COMPLETED|Overall Study||0
3001355|NCT00960934|3718517|FG003|COMPLETED|Overall Study||0
3001356|NCT00960934|3718518|FG004|COMPLETED|Overall Study||0
3001357|NCT00960934|3718519|FG005|COMPLETED|Overall Study||0
3001358|NCT00960934|3718514|FG000|NOT COMPLETED|Overall Study||64
3001359|NCT00960934|3718515|FG001|NOT COMPLETED|Overall Study||63
3001360|NCT00960934|3718516|FG002|NOT COMPLETED|Overall Study||64
3001361|NCT00960934|3718517|FG003|NOT COMPLETED|Overall Study||64
3001362|NCT00960934|3718518|FG004|NOT COMPLETED|Overall Study||64
3001363|NCT00960934|3718519|FG005|NOT COMPLETED|Overall Study||64
3001364|NCT00960986|3718537|FG000|STARTED|Period 1 (Screening and Washout)||59
3001365|NCT00960986|3718538|FG001|STARTED|Period 1 (Screening and Washout)||63
3001366|NCT00960986|3718539|FG002|STARTED|Period 1 (Screening and Washout)||63
3001367|NCT00960986|3718540|FG003|STARTED|Period 1 (Screening and Washout)||64
3001368|NCT00960986|3718537|FG000|COMPLETED|Period 1 (Screening and Washout)||56
3001369|NCT00960986|3718538|FG001|COMPLETED|Period 1 (Screening and Washout)||59
3001370|NCT00960986|3718539|FG002|COMPLETED|Period 1 (Screening and Washout)||59
3001371|NCT00960986|3718540|FG003|COMPLETED|Period 1 (Screening and Washout)||61
3001372|NCT00960986|3718537|FG000|NOT COMPLETED|Period 1 (Screening and Washout)||3
3001373|NCT00960986|3718538|FG001|NOT COMPLETED|Period 1 (Screening and Washout)||4
3001374|NCT00960986|3718539|FG002|NOT COMPLETED|Period 1 (Screening and Washout)||4
3001375|NCT00960986|3718540|FG003|NOT COMPLETED|Period 1 (Screening and Washout)||3
3001376|NCT00960986|3718537|FG000|STARTED|Period 2 (1-week Initial Dosing Period)||56
3001377|NCT00960986|3718538|FG001|STARTED|Period 2 (1-week Initial Dosing Period)||59
3001378|NCT00960986|3718539|FG002|STARTED|Period 2 (1-week Initial Dosing Period)||59
3001379|NCT00960986|3718540|FG003|STARTED|Period 2 (1-week Initial Dosing Period)||61
3001380|NCT00960986|3718537|FG000|COMPLETED|Period 2 (1-week Initial Dosing Period)||56
3001381|NCT00960986|3718538|FG001|COMPLETED|Period 2 (1-week Initial Dosing Period)||59
3001382|NCT00960986|3718539|FG002|COMPLETED|Period 2 (1-week Initial Dosing Period)||59
3001383|NCT00960986|3718540|FG003|COMPLETED|Period 2 (1-week Initial Dosing Period)||61
3001384|NCT00960986|3718537|FG000|NOT COMPLETED|Period 2 (1-week Initial Dosing Period)||0
3001385|NCT00960986|3718538|FG001|NOT COMPLETED|Period 2 (1-week Initial Dosing Period)||0
3001386|NCT00960986|3718539|FG002|NOT COMPLETED|Period 2 (1-week Initial Dosing Period)||0
3001387|NCT00960986|3718540|FG003|NOT COMPLETED|Period 2 (1-week Initial Dosing Period)||0
3001388|NCT00960986|3718537|FG000|STARTED|Period 3 (7-week Therapy Period)||56
3001389|NCT00960986|3718538|FG001|STARTED|Period 3 (7-week Therapy Period)||59
3001390|NCT00960986|3718539|FG002|STARTED|Period 3 (7-week Therapy Period)||59
3001391|NCT00960986|3718540|FG003|STARTED|Period 3 (7-week Therapy Period)||61
3001392|NCT00960986|3718537|FG000|COMPLETED|Period 3 (7-week Therapy Period)||26
3001393|NCT00960986|3718538|FG001|COMPLETED|Period 3 (7-week Therapy Period)||36
3001394|NCT00960986|3718539|FG002|COMPLETED|Period 3 (7-week Therapy Period)||39
3001395|NCT00960986|3718540|FG003|COMPLETED|Period 3 (7-week Therapy Period)||36
3001396|NCT00960986|3718537|FG000|NOT COMPLETED|Period 3 (7-week Therapy Period)||30
3001397|NCT00960986|3718538|FG001|NOT COMPLETED|Period 3 (7-week Therapy Period)||23
3001398|NCT00960986|3718539|FG002|NOT COMPLETED|Period 3 (7-week Therapy Period)||20
3001399|NCT00960986|3718540|FG003|NOT COMPLETED|Period 3 (7-week Therapy Period)||25
3001400|NCT00960999|3718552|FG000|STARTED|Overall Study||47
3001401|NCT00960999|3718553|FG001|STARTED|Overall Study||47
3001402|NCT00960999|3718552|FG000|Eligible|Overall Study||39
3001403|NCT00960999|3718553|FG001|Eligible|Overall Study||45
3001404|NCT00960999|3718552|FG000|Started Protocol Treatment|Overall Study||39
3001405|NCT00960999|3718553|FG001|Started Protocol Treatment|Overall Study||45
3001406|NCT00960999|3718552|FG000|Primary Endpoint Population|Overall Study||38
3001407|NCT00960999|3718553|FG001|Primary Endpoint Population|Overall Study||38
3001408|NCT00960999|3718552|FG000|Peak SUV at 8 Weeks|Overall Study||3
3001409|NCT00960999|3718553|FG001|Peak SUV at 8 Weeks|Overall Study||11
3001410|NCT00960999|3718552|FG000|Peak SUV at 1 Year|Overall Study||4
3001411|NCT00960999|3718553|FG001|Peak SUV at 1 Year|Overall Study||7
3001412|NCT00960999|3718552|FG000|Normalized SUV at 8 Weeks|Overall Study||3
3001413|NCT00960999|3718553|FG001|Normalized SUV at 8 Weeks|Overall Study||9
3001414|NCT00960999|3718552|FG000|Normalized SUV at 1 Year|Overall Study||4
3001415|NCT00960999|3718553|FG001|Normalized SUV at 1 Year|Overall Study||7
3001416|NCT00960999|3718552|FG000|FEV1 by Best Response|Overall Study||26
3001417|NCT00960999|3718553|FG001|FEV1 by Best Response|Overall Study||33
3001418|NCT00960999|3718552|FG000|DLCO by Best Response|Overall Study||23
3001419|NCT00960999|3718553|FG001|DLCO by Best Response|Overall Study||28
3001420|NCT00960999|3718552|FG000|COMPLETED|Overall Study||39
3001421|NCT00960999|3718553|FG001|COMPLETED|Overall Study||45
3001422|NCT00960999|3718552|FG000|NOT COMPLETED|Overall Study||8
3001423|NCT00960999|3718553|FG001|NOT COMPLETED|Overall Study||2
3001424|NCT00961051|3718561|FG000|STARTED|Overall Study||177
3001425|NCT00961051|3718562|FG001|STARTED|Overall Study||93
3001426|NCT00961051|3718561|FG000|COMPLETED|Overall Study||165
3001427|NCT00961051|3718562|FG001|COMPLETED|Overall Study||79
3001428|NCT00961051|3718561|FG000|NOT COMPLETED|Overall Study||12
3001429|NCT00961051|3718562|FG001|NOT COMPLETED|Overall Study||14
3001430|NCT00961064|3718568|FG000|STARTED|Overall Study||30
3001431|NCT00961064|3718568|FG000|COMPLETED|Overall Study||30
3001432|NCT00961064|3718568|FG000|NOT COMPLETED|Overall Study||0
3001433|NCT00961116|3718572|FG000|STARTED|First Intervention||27
3001434|NCT00961116|3718573|FG001|STARTED|First Intervention||27
3001435|NCT00961116|3718572|FG000|COMPLETED|First Intervention||27
3001436|NCT00961116|3718573|FG001|COMPLETED|First Intervention||27
3001437|NCT00961116|3718572|FG000|NOT COMPLETED|First Intervention||0
3001438|NCT00961116|3718573|FG001|NOT COMPLETED|First Intervention||0
3001439|NCT00961116|3718572|FG000|STARTED|Washout Period of 7 Days||27
3001440|NCT00961116|3718573|FG001|STARTED|Washout Period of 7 Days||27
3001441|NCT00961116|3718572|FG000|COMPLETED|Washout Period of 7 Days||25
3001442|NCT00961116|3718573|FG001|COMPLETED|Washout Period of 7 Days||24
3001443|NCT00961116|3718572|FG000|NOT COMPLETED|Washout Period of 7 Days||2
3001444|NCT00961116|3718573|FG001|NOT COMPLETED|Washout Period of 7 Days||3
3001445|NCT00961116|3718572|FG000|STARTED|Second Intervention||25
3001446|NCT00961116|3718573|FG001|STARTED|Second Intervention||24
3001447|NCT00961116|3718572|FG000|COMPLETED|Second Intervention||25
3001448|NCT00961116|3718573|FG001|COMPLETED|Second Intervention||24
3001449|NCT00961116|3718572|FG000|NOT COMPLETED|Second Intervention||0
3001450|NCT00961116|3718573|FG001|NOT COMPLETED|Second Intervention||0
3001451|NCT00961181|3718580|FG000|STARTED|Overall Study||81
3001452|NCT00961181|3718580|FG000|COMPLETED|Overall Study||76
3001453|NCT00961181|3718580|FG000|NOT COMPLETED|Overall Study||5
3001454|NCT00961220|3718584|FG000|STARTED|Overall Study||17
3001455|NCT00961220|3718584|FG000|COMPLETED|Overall Study||10
3001456|NCT00961220|3718584|FG000|NOT COMPLETED|Overall Study||7
3001457|NCT00961233|3718592|FG000|STARTED|Overall Study||13
3001458|NCT00961233|3718593|FG001|STARTED|Overall Study||12
3001459|NCT00961233|3718592|FG000|COMPLETED|Overall Study||11
3001460|NCT00961233|3718593|FG001|COMPLETED|Overall Study||11
3001461|NCT00961233|3718592|FG000|NOT COMPLETED|Overall Study||2
3001462|NCT00961233|3718593|FG001|NOT COMPLETED|Overall Study||1
3001463|NCT00961259|3718601|FG000|STARTED|First Intervention||18
3001464|NCT00961259|3718602|FG001|STARTED|First Intervention||18
3001465|NCT00961259|3718603|FG002|STARTED|First Intervention||18
3001466|NCT00961259|3718601|FG000|COMPLETED|First Intervention||18
3001467|NCT00961259|3718602|FG001|COMPLETED|First Intervention||18
3001468|NCT00961259|3718603|FG002|COMPLETED|First Intervention||18
3001469|NCT00961259|3718601|FG000|NOT COMPLETED|First Intervention||0
3001470|NCT00961259|3718602|FG001|NOT COMPLETED|First Intervention||0
3001471|NCT00961259|3718603|FG002|NOT COMPLETED|First Intervention||0
3001472|NCT00961259|3718601|FG000|STARTED|Washout Period of 7 Days||18
3001473|NCT00961259|3718602|FG001|STARTED|Washout Period of 7 Days||18
3001474|NCT00961259|3718603|FG002|STARTED|Washout Period of 7 Days||18
3001475|NCT00961259|3718601|FG000|COMPLETED|Washout Period of 7 Days||18
3001476|NCT00961259|3718602|FG001|COMPLETED|Washout Period of 7 Days|dropped due to concomitant medication used prior to admission.|17
3001477|NCT00961259|3718603|FG002|COMPLETED|Washout Period of 7 Days||18
3001478|NCT00961259|3718601|FG000|NOT COMPLETED|Washout Period of 7 Days||0
3001479|NCT00961259|3718602|FG001|NOT COMPLETED|Washout Period of 7 Days||1
3001480|NCT00961259|3718603|FG002|NOT COMPLETED|Washout Period of 7 Days||0
3001481|NCT00961259|3718601|FG000|STARTED|Second Intervention||18
3001482|NCT00961259|3718602|FG001|STARTED|Second Intervention||17
3001483|NCT00961259|3718603|FG002|STARTED|Second Intervention||18
3001484|NCT00961259|3718601|FG000|COMPLETED|Second Intervention||18
3001485|NCT00961259|3718602|FG001|COMPLETED|Second Intervention||17
3001486|NCT00961259|3718603|FG002|COMPLETED|Second Intervention||18
3001487|NCT00961259|3718601|FG000|NOT COMPLETED|Second Intervention||0
3001488|NCT00961259|3718602|FG001|NOT COMPLETED|Second Intervention||0
3001489|NCT00961259|3718603|FG002|NOT COMPLETED|Second Intervention||0
3001490|NCT00961259|3718601|FG000|STARTED|Washout Period of 7 Days||18
3001491|NCT00961259|3718602|FG001|STARTED|Washout Period of 7 Days||17
3001492|NCT00961259|3718603|FG002|STARTED|Washout Period of 7 Days||18
3001493|NCT00961259|3718601|FG000|COMPLETED|Washout Period of 7 Days||18
3001494|NCT00961259|3718602|FG001|COMPLETED|Washout Period of 7 Days||17
3001495|NCT00961259|3718603|FG002|COMPLETED|Washout Period of 7 Days||18
3001496|NCT00961259|3718601|FG000|NOT COMPLETED|Washout Period of 7 Days||0
3001497|NCT00961259|3718602|FG001|NOT COMPLETED|Washout Period of 7 Days||0
3001498|NCT00961259|3718603|FG002|NOT COMPLETED|Washout Period of 7 Days||0
3001499|NCT00961259|3718601|FG000|STARTED|Third Intervention||18
3001500|NCT00961259|3718602|FG001|STARTED|Third Intervention||17
3001501|NCT00961259|3718603|FG002|STARTED|Third Intervention||18
3001502|NCT00961259|3718601|FG000|COMPLETED|Third Intervention||18
3001503|NCT00961259|3718602|FG001|COMPLETED|Third Intervention||17
3001504|NCT00961259|3718603|FG002|COMPLETED|Third Intervention||18
3001505|NCT00961259|3718601|FG000|NOT COMPLETED|Third Intervention||0
3001506|NCT00961259|3718602|FG001|NOT COMPLETED|Third Intervention||0
3001507|NCT00961259|3718603|FG002|NOT COMPLETED|Third Intervention||0
3001508|NCT00961298|3718612|FG000|STARTED|Two Week Placebo Run in||15
3001509|NCT00961298|3718612|FG000|COMPLETED|Two Week Placebo Run in||14
3001510|NCT00961298|3718612|FG000|NOT COMPLETED|Two Week Placebo Run in||1
3001511|NCT00961298|3718612|FG000|STARTED|12 Weeks Duloxetine Treatment Phase||14
3001512|NCT00961298|3718612|FG000|COMPLETED|12 Weeks Duloxetine Treatment Phase||11
3001513|NCT00961298|3718612|FG000|NOT COMPLETED|12 Weeks Duloxetine Treatment Phase||3
3001514|NCT00961311|3718616|FG000|STARTED|Overall Study||51
3001515|NCT00961311|3718616|FG000|COMPLETED|Overall Study||51
3001516|NCT00961311|3718616|FG000|NOT COMPLETED|Overall Study||0
3001517|NCT00961350|3718622|FG000|STARTED|Overall Study||265
3001518|NCT00961350|3718623|FG001|STARTED|Overall Study||265
3001519|NCT00961350|3718622|FG000|Intent-to-Treat Population (ITT)|Overall Study||265
3001520|NCT00961350|3718623|FG001|Intent-to-Treat Population (ITT)|Overall Study||265
3001521|NCT00961350|3718622|FG000|Safety Population|Overall Study|1. One sub rand to PA32540 took EC-Aspirin|264
3001522|NCT00961350|3718623|FG001|Safety Population|Overall Study||265
3001523|NCT00961350|3718622|FG000|COMPLETED|Overall Study||218
3001524|NCT00961350|3718623|FG001|COMPLETED|Overall Study||198
3001525|NCT00961350|3718622|FG000|NOT COMPLETED|Overall Study||47
3001526|NCT00961350|3718623|FG001|NOT COMPLETED|Overall Study||67
3037056|NCT01146834|3756368|FG001|STARTED|Overall Study||4
3037057|NCT01146834|3756369|FG002|STARTED|Overall Study||23
3037058|NCT01146834|3756370|FG003|STARTED|Overall Study||0
3037059|NCT01146834|3756371|FG004|STARTED|Overall Study||0
3037060|NCT01146834|3756367|FG000|COMPLETED|Overall Study||17
3037061|NCT01146834|3756368|FG001|COMPLETED|Overall Study||4
3037062|NCT01146834|3756369|FG002|COMPLETED|Overall Study||21
3037063|NCT01146834|3756370|FG003|COMPLETED|Overall Study||0
3037064|NCT01146834|3756371|FG004|COMPLETED|Overall Study||0
3037065|NCT01146834|3756367|FG000|NOT COMPLETED|Overall Study||3
3037066|NCT01146834|3756368|FG001|NOT COMPLETED|Overall Study||0
3037067|NCT01146834|3756369|FG002|NOT COMPLETED|Overall Study||2
3037068|NCT01146834|3756370|FG003|NOT COMPLETED|Overall Study||0
3037069|NCT01146834|3756371|FG004|NOT COMPLETED|Overall Study||0
3037070|NCT01146860|3756385|FG000|STARTED|Overall Study||194
3037071|NCT01146860|3756386|FG001|STARTED|Overall Study||192
3037072|NCT01146860|3756385|FG000|COMPLETED|Overall Study||194
3037073|NCT01146860|3756386|FG001|COMPLETED|Overall Study||191
3164882|NCT01895543|3892372|FG000|Safety Analysis Set|Overall Study|Set included all enrolled patients who took at least one dose of Investigational Medicinal Product.|409
3164883|NCT01895543|3892372|FG000|Per Protocol Analysis Set|Overall Study|Set included all enrolled patients who had no major protocol deviations.|380
3164884|NCT01895543|3892372|FG000|COMPLETED|Overall Study||282
3037074|NCT01146860|3756385|FG000|NOT COMPLETED|Overall Study||0
3037075|NCT01146860|3756386|FG001|NOT COMPLETED|Overall Study||1
3037076|NCT01146873|3756394|FG000|STARTED|Overall Study||148
3037077|NCT01146873|3756395|FG001|STARTED|Overall Study||150
3037078|NCT01146873|3756394|FG000|COMPLETED|Overall Study||148
3037079|NCT01146873|3756395|FG001|COMPLETED|Overall Study||144
3037080|NCT01146873|3756394|FG000|NOT COMPLETED|Overall Study||0
3037081|NCT01146873|3756395|FG001|NOT COMPLETED|Overall Study||6
3037082|NCT01146912|3756408|FG000|STARTED|Overall Study||4607
3037083|NCT01146912|3756409|FG001|STARTED|Overall Study||4606
3037084|NCT01146912|3756410|FG002|STARTED|Overall Study||593
3037085|NCT01146912|3756411|FG003|STARTED|Overall Study||594
3037086|NCT01146912|3756412|FG004|STARTED|Overall Study||1821
3037087|NCT01146912|3756413|FG005|STARTED|Overall Study||1821
3037088|NCT01146912|3756414|FG006|STARTED|Overall Study||1820
3037089|NCT01146912|3756415|FG007|STARTED|Overall Study||14675
3037090|NCT01146912|3756408|FG000|COMPLETED|Overall Study||3790
3037091|NCT01146912|3756409|FG001|COMPLETED|Overall Study||3784
3037092|NCT01146912|3756410|FG002|COMPLETED|Overall Study||576
3037093|NCT01146912|3756411|FG003|COMPLETED|Overall Study||577
3037094|NCT01146912|3756412|FG004|COMPLETED|Overall Study||1780
3037095|NCT01146912|3756413|FG005|COMPLETED|Overall Study||1760
3037096|NCT01146912|3756414|FG006|COMPLETED|Overall Study||1764
3037097|NCT01146912|3756415|FG007|COMPLETED|Overall Study|Parents are considered subjects but outcomes are on child level|14675
3037098|NCT01146912|3756408|FG000|NOT COMPLETED|Overall Study||817
3037099|NCT01146912|3756409|FG001|NOT COMPLETED|Overall Study||822
3037100|NCT01146912|3756410|FG002|NOT COMPLETED|Overall Study||17
3037101|NCT01146912|3756411|FG003|NOT COMPLETED|Overall Study||17
3037102|NCT01146912|3756412|FG004|NOT COMPLETED|Overall Study||41
3037103|NCT01146912|3756413|FG005|NOT COMPLETED|Overall Study||61
3037104|NCT01146912|3756414|FG006|NOT COMPLETED|Overall Study||56
3037105|NCT01146912|3756415|FG007|NOT COMPLETED|Overall Study||0
3037106|NCT01146951|3756436|FG000|STARTED|Overall Study||29
3037107|NCT01146951|3756437|FG001|STARTED|Overall Study||30
3037108|NCT01146951|3756436|FG000|COMPLETED|Overall Study||25
3037109|NCT01146951|3756437|FG001|COMPLETED|Overall Study||29
3037110|NCT01146951|3756436|FG000|NOT COMPLETED|Overall Study||4
3037111|NCT01146951|3756437|FG001|NOT COMPLETED|Overall Study||1
3037112|NCT01147055|3756443|FG000|STARTED|First Intervention Period||15
3037113|NCT01147055|3756444|FG001|STARTED|First Intervention Period||0
3037114|NCT01147055|3756443|FG000|COMPLETED|First Intervention Period||14
3037115|NCT01147055|3756444|FG001|COMPLETED|First Intervention Period||0
3037116|NCT01147055|3756443|FG000|NOT COMPLETED|First Intervention Period||1
3037117|NCT01147055|3756444|FG001|NOT COMPLETED|First Intervention Period||0
3037118|NCT01147055|3756443|FG000|STARTED|Washout Period (at Least 14 Days)||14
3037119|NCT01147055|3756444|FG001|STARTED|Washout Period (at Least 14 Days)||0
3037120|NCT01147055|3756443|FG000|COMPLETED|Washout Period (at Least 14 Days)||14
3037121|NCT01147055|3756444|FG001|COMPLETED|Washout Period (at Least 14 Days)||0
3037122|NCT01147055|3756443|FG000|NOT COMPLETED|Washout Period (at Least 14 Days)||0
3037123|NCT01147055|3756444|FG001|NOT COMPLETED|Washout Period (at Least 14 Days)||0
3037124|NCT01147055|3756443|FG000|STARTED|Second Intervention Period||0
3037125|NCT01147055|3756444|FG001|STARTED|Second Intervention Period||14
3037126|NCT01147055|3756443|FG000|COMPLETED|Second Intervention Period||0
3037127|NCT01147055|3756444|FG001|COMPLETED|Second Intervention Period||14
3037128|NCT01147055|3756443|FG000|NOT COMPLETED|Second Intervention Period||0
3037129|NCT01147055|3756444|FG001|NOT COMPLETED|Second Intervention Period||0
3037130|NCT01147068|3756457|FG000|STARTED|Subjects That Received 1st Dose||60
3037131|NCT01147068|3756458|FG001|STARTED|Subjects That Received 1st Dose||57
3037132|NCT01147068|3756459|FG002|STARTED|Subjects That Received 1st Dose||55
3037133|NCT01147068|3756460|FG003|STARTED|Subjects That Received 1st Dose||56
3037134|NCT01147068|3756461|FG004|STARTED|Subjects That Received 1st Dose||56
3037135|NCT01147068|3756462|FG005|STARTED|Subjects That Received 1st Dose||53
3037136|NCT01147068|3756463|FG006|STARTED|Subjects That Received 1st Dose||55
3037137|NCT01147068|3756457|FG000|COMPLETED|Subjects That Received 1st Dose||60
3001527|NCT00961402|3718631|FG000|STARTED|Overall Study||64
3001528|NCT00961402|3718632|FG001|STARTED|Overall Study||66
3001529|NCT00961402|3718631|FG000|Randomized|Overall Study||64
3001530|NCT00961402|3718632|FG001|Randomized|Overall Study||66
3001531|NCT00961402|3718631|FG000|COMPLETED|Overall Study||63
3001532|NCT00961402|3718632|FG001|COMPLETED|Overall Study||61
3001533|NCT00961402|3718631|FG000|NOT COMPLETED|Overall Study||1
3001534|NCT00961402|3718632|FG001|NOT COMPLETED|Overall Study||5
3001535|NCT00961415|3718640|FG000|STARTED|Induction Treatment Phase||376
3001536|NCT00961415|3718641|FG001|STARTED|Induction Treatment Phase||0
3001537|NCT00961415|3718642|FG002|STARTED|Induction Treatment Phase||0
3001538|NCT00961415|3718640|FG000|COMPLETED|Induction Treatment Phase||253
3001539|NCT00961415|3718641|FG001|COMPLETED|Induction Treatment Phase||0
3001540|NCT00961415|3718642|FG002|COMPLETED|Induction Treatment Phase||0
3001541|NCT00961415|3718640|FG000|NOT COMPLETED|Induction Treatment Phase||123
3001542|NCT00961415|3718641|FG001|NOT COMPLETED|Induction Treatment Phase||0
3001543|NCT00961415|3718642|FG002|NOT COMPLETED|Induction Treatment Phase||0
3001544|NCT00961415|3718640|FG000|STARTED|Maintenance Treatment Phase||0
3001545|NCT00961415|3718641|FG001|STARTED|Maintenance Treatment Phase||125
3001546|NCT00961415|3718642|FG002|STARTED|Maintenance Treatment Phase||128
3164885|NCT01895543|3892372|FG000|NOT COMPLETED|Overall Study||129
3164886|NCT01895608|3892380|FG000|STARTED|Overall Study||10
3164887|NCT01895608|3892381|FG001|STARTED|Overall Study||7
3164888|NCT01895608|3892382|FG002|STARTED|Overall Study||11
3164889|NCT01895608|3892383|FG003|STARTED|Overall Study||6
3306530|NCT02998996|4039887|FG000|NOT COMPLETED|Overall Study||0
3001547|NCT00961415|3718640|FG000|COMPLETED|Maintenance Treatment Phase||0
3001548|NCT00961415|3718641|FG001|COMPLETED|Maintenance Treatment Phase||77
3001549|NCT00961415|3718642|FG002|COMPLETED|Maintenance Treatment Phase||83
3001550|NCT00961415|3718640|FG000|NOT COMPLETED|Maintenance Treatment Phase||0
3001551|NCT00961415|3718641|FG001|NOT COMPLETED|Maintenance Treatment Phase||48
3001552|NCT00961415|3718642|FG002|NOT COMPLETED|Maintenance Treatment Phase||45
3306531|NCT02998996|4039888|FG001|NOT COMPLETED|Overall Study||1
3306532|NCT02998996|4039889|FG002|NOT COMPLETED|Overall Study||1
3306533|NCT02998996|4039890|FG003|NOT COMPLETED|Overall Study||0
3306534|NCT02998996|4039891|FG004|NOT COMPLETED|Overall Study||1
3306535|NCT02998996|4039892|FG005|NOT COMPLETED|Overall Study||0
3306536|NCT02999100|4039912|FG000|STARTED|Part 1 (up to 15 Days)||9
3306537|NCT02999100|4039913|FG001|STARTED|Part 1 (up to 15 Days)||8
3306538|NCT02999100|4039914|FG002|STARTED|Part 1 (up to 15 Days)||0
3306539|NCT02999100|4039915|FG003|STARTED|Part 1 (up to 15 Days)||0
3306540|NCT02999100|4039916|FG004|STARTED|Part 1 (up to 15 Days)||0
3306541|NCT02999100|4039917|FG005|STARTED|Part 1 (up to 15 Days)||0
3306542|NCT02999100|4039912|FG000|COMPLETED|Part 1 (up to 15 Days)||9
3001553|NCT00961441|3718658|FG000|STARTED|Overall Study||12
3001554|NCT00961441|3718659|FG001|STARTED|Overall Study||13
3001555|NCT00961441|3718658|FG000|Pharmacokinetic (PK-PP) Population|Overall Study||12
3001556|NCT00961441|3718659|FG001|Pharmacokinetic (PK-PP) Population|Overall Study|Two subjects were excluded due to study medication noncompliance, one due to wrong dosing regimen.|10
3001557|NCT00961441|3718658|FG000|COMPLETED|Overall Study||12
3001558|NCT00961441|3718659|FG001|COMPLETED|Overall Study||13
3001559|NCT00961441|3718658|FG000|NOT COMPLETED|Overall Study||0
3001560|NCT00961441|3718659|FG001|NOT COMPLETED|Overall Study||0
3001561|NCT00961532|3718665|FG000|STARTED|Overall Study||14
3001562|NCT00961532|3718665|FG000|COMPLETED|Overall Study||14
3001563|NCT00961532|3718665|FG000|NOT COMPLETED|Overall Study||0
3001564|NCT00961571|3718669|FG000|STARTED|Overall Study||50
3001565|NCT00961571|3718669|FG000|COMPLETED|Overall Study|high percentage of patient drop-off study prior cancer progression|11
3001566|NCT00961571|3718669|FG000|NOT COMPLETED|Overall Study||39
3001567|NCT00961636|3718676|FG000|STARTED|Overall Study||463
3001568|NCT00961636|3718677|FG001|STARTED|Overall Study||456
3001569|NCT00961636|3718678|FG002|STARTED|Overall Study||233
3001570|NCT00961636|3718676|FG000|COMPLETED|Overall Study||356
3001571|NCT00961636|3718677|FG001|COMPLETED|Overall Study||325
3001572|NCT00961636|3718678|FG002|COMPLETED|Overall Study||201
3001573|NCT00961636|3718676|FG000|NOT COMPLETED|Overall Study||107
3001574|NCT00961636|3718677|FG001|NOT COMPLETED|Overall Study||131
3001575|NCT00961636|3718678|FG002|NOT COMPLETED|Overall Study||32
3001576|NCT00961649|3718690|FG000|STARTED|Overall Study||41
3001577|NCT00961649|3718691|FG001|STARTED|Overall Study||44
3001578|NCT00961649|3718692|FG002|STARTED|Overall Study||44
3001579|NCT00961649|3718693|FG003|STARTED|Overall Study||41
3001580|NCT00961649|3718690|FG000|COMPLETED|Overall Study||32
3001581|NCT00961649|3718691|FG001|COMPLETED|Overall Study||40
3001582|NCT00961649|3718692|FG002|COMPLETED|Overall Study||39
3001583|NCT00961649|3718693|FG003|COMPLETED|Overall Study||37
3001584|NCT00961649|3718690|FG000|NOT COMPLETED|Overall Study||9
3001585|NCT00961649|3718691|FG001|NOT COMPLETED|Overall Study||4
3001586|NCT00961649|3718692|FG002|NOT COMPLETED|Overall Study||5
3001587|NCT00961649|3718693|FG003|NOT COMPLETED|Overall Study||4
3001588|NCT00961662|3718706|FG000|STARTED|Overall Study||57
3001589|NCT00961662|3718707|FG001|STARTED|Overall Study||51
3001590|NCT00961662|3718708|FG002|STARTED|Overall Study||53
3001591|NCT00961662|3718706|FG000|COMPLETED|Overall Study||35
3001592|NCT00961662|3718707|FG001|COMPLETED|Overall Study||32
3001593|NCT00961662|3718708|FG002|COMPLETED|Overall Study||34
3001594|NCT00961662|3718706|FG000|NOT COMPLETED|Overall Study||22
3001595|NCT00961662|3718707|FG001|NOT COMPLETED|Overall Study||19
3001596|NCT00961662|3718708|FG002|NOT COMPLETED|Overall Study||19
3001597|NCT00961896|3718719|FG000|STARTED|Overall Study||8
3001598|NCT00961896|3718720|FG001|STARTED|Overall Study||3
3001599|NCT00961896|3718721|FG002|STARTED|Overall Study||7
3001600|NCT00961896|3718719|FG000|COMPLETED|Overall Study||8
3001601|NCT00961896|3718720|FG001|COMPLETED|Overall Study||3
3001602|NCT00961896|3718721|FG002|COMPLETED|Overall Study||6
3001603|NCT00961896|3718719|FG000|NOT COMPLETED|Overall Study||0
3001604|NCT00961896|3718720|FG001|NOT COMPLETED|Overall Study||0
3001605|NCT00961896|3718721|FG002|NOT COMPLETED|Overall Study||1
3001606|NCT00961961|3718736|FG000|STARTED|Phase I||177
3001607|NCT00961961|3718737|FG001|STARTED|Phase I||0
3001608|NCT00961961|3718738|FG002|STARTED|Phase I||0
3001609|NCT00961961|3718739|FG003|STARTED|Phase I||0
3001610|NCT00961961|3718736|FG000|COMPLETED|Phase I||51
3001611|NCT00961961|3718737|FG001|COMPLETED|Phase I||0
3001612|NCT00961961|3718738|FG002|COMPLETED|Phase I||0
3001613|NCT00961961|3718739|FG003|COMPLETED|Phase I||0
3001614|NCT00961961|3718736|FG000|NOT COMPLETED|Phase I||126
3001615|NCT00961961|3718737|FG001|NOT COMPLETED|Phase I||0
3001616|NCT00961961|3718738|FG002|NOT COMPLETED|Phase I||0
3001617|NCT00961961|3718739|FG003|NOT COMPLETED|Phase I||0
3001618|NCT00961961|3718736|FG000|STARTED|Phase II|This is a Phase I category. Not relevant in Phase II.|0
3001619|NCT00961961|3718737|FG001|STARTED|Phase II|This is a Phase I category. Not relevant in Phase II.|0
3001620|NCT00961961|3718738|FG002|STARTED|Phase II||29
3001621|NCT00961961|3718739|FG003|STARTED|Phase II||22
3001622|NCT00961961|3718736|FG000|COMPLETED|Phase II||0
3001623|NCT00961961|3718737|FG001|COMPLETED|Phase II||0
3001624|NCT00961961|3718738|FG002|COMPLETED|Phase II||17
3001625|NCT00961961|3718739|FG003|COMPLETED|Phase II||14
3001626|NCT00961961|3718736|FG000|NOT COMPLETED|Phase II||0
3001627|NCT00961961|3718737|FG001|NOT COMPLETED|Phase II||0
3001628|NCT00961961|3718738|FG002|NOT COMPLETED|Phase II||12
3001629|NCT00961961|3718739|FG003|NOT COMPLETED|Phase II||8
3001630|NCT00962000|3718759|FG000|STARTED|Period 1 - 1 Week||21
3001631|NCT00962000|3718760|FG001|STARTED|Period 1 - 1 Week||21
3001632|NCT00962000|3718759|FG000|COMPLETED|Period 1 - 1 Week||21
3001633|NCT00962000|3718760|FG001|COMPLETED|Period 1 - 1 Week||21
3001634|NCT00962000|3718759|FG000|NOT COMPLETED|Period 1 - 1 Week||0
3001635|NCT00962000|3718760|FG001|NOT COMPLETED|Period 1 - 1 Week||0
3001636|NCT00962000|3718759|FG000|STARTED|Period 2 - 1 Week||21
3001637|NCT00962000|3718760|FG001|STARTED|Period 2 - 1 Week||21
3001638|NCT00962000|3718759|FG000|COMPLETED|Period 2 - 1 Week||21
3001639|NCT00962000|3718760|FG001|COMPLETED|Period 2 - 1 Week||21
3001640|NCT00962000|3718759|FG000|NOT COMPLETED|Period 2 - 1 Week||0
3001641|NCT00962000|3718760|FG001|NOT COMPLETED|Period 2 - 1 Week||0
3001642|NCT00962000|3718759|FG000|STARTED|Period 3 - 1 Week||21
3001643|NCT00962000|3718760|FG001|STARTED|Period 3 - 1 Week||21
3001644|NCT00962000|3718759|FG000|COMPLETED|Period 3 - 1 Week||21
3001645|NCT00962000|3718760|FG001|COMPLETED|Period 3 - 1 Week||21
3001646|NCT00962000|3718759|FG000|NOT COMPLETED|Period 3 - 1 Week||0
3001647|NCT00962000|3718760|FG001|NOT COMPLETED|Period 3 - 1 Week||0
3001648|NCT00962000|3718759|FG000|STARTED|Period 4 - 1 Week||21
3001649|NCT00962000|3718760|FG001|STARTED|Period 4 - 1 Week||21
3001650|NCT00962000|3718759|FG000|COMPLETED|Period 4 - 1 Week||21
3001651|NCT00962000|3718760|FG001|COMPLETED|Period 4 - 1 Week||21
3001652|NCT00962000|3718759|FG000|NOT COMPLETED|Period 4 - 1 Week||0
3001653|NCT00962000|3718760|FG001|NOT COMPLETED|Period 4 - 1 Week||0
3001654|NCT00962013|3718766|FG000|STARTED|Overall Study||120
3001655|NCT00962013|3718766|FG000|COMPLETED|Overall Study|Number of participants with 5 year primary endpoint data|52
3001656|NCT00962013|3718766|FG000|NOT COMPLETED|Overall Study||68
3001657|NCT00962039|3718772|FG000|STARTED|Overall Study||40
3001658|NCT00962039|3718773|FG001|STARTED|Overall Study||41
3001659|NCT00962039|3718772|FG000|COMPLETED|Overall Study||35
3001660|NCT00962039|3718773|FG001|COMPLETED|Overall Study||37
3001661|NCT00962039|3718772|FG000|NOT COMPLETED|Overall Study||5
3001662|NCT00962039|3718773|FG001|NOT COMPLETED|Overall Study||4
3001663|NCT00962065|3718782|FG000|STARTED|Overall Study||12
3001664|NCT00962065|3718783|FG001|STARTED|Overall Study||12
3001665|NCT00962065|3718784|FG002|STARTED|Overall Study||12
3001666|NCT00962065|3718782|FG000|COMPLETED|Overall Study||12
3001667|NCT00962065|3718783|FG001|COMPLETED|Overall Study||12
3001668|NCT00962065|3718784|FG002|COMPLETED|Overall Study||12
3001669|NCT00962065|3718782|FG000|NOT COMPLETED|Overall Study||0
3001670|NCT00962065|3718783|FG001|NOT COMPLETED|Overall Study||0
3001671|NCT00962065|3718784|FG002|NOT COMPLETED|Overall Study||0
3001672|NCT00962078|3718794|FG000|STARTED|Overall Study||35
3001673|NCT00962078|3718795|FG001|STARTED|Overall Study||36
3001674|NCT00962078|3718794|FG000|COMPLETED|Overall Study||30
3001675|NCT00962078|3718795|FG001|COMPLETED|Overall Study||30
3001676|NCT00962078|3718794|FG000|NOT COMPLETED|Overall Study||5
3001677|NCT00962078|3718795|FG001|NOT COMPLETED|Overall Study||6
3001678|NCT00962091|3718808|FG000|STARTED|Overall Study||4
3001679|NCT00962091|3718809|FG001|STARTED|Overall Study||9
3001680|NCT00962091|3718810|FG002|STARTED|Overall Study||10
3001681|NCT00962091|3718811|FG003|STARTED|Overall Study||3
3001682|NCT00962091|3718812|FG004|STARTED|Overall Study||3
3001683|NCT00962091|3718813|FG005|STARTED|Overall Study||12
3001684|NCT00962091|3718814|FG006|STARTED|Overall Study||12
3001685|NCT00962091|3718808|FG000|COMPLETED|Overall Study||3
3001686|NCT00962091|3718809|FG001|COMPLETED|Overall Study||7
3001687|NCT00962091|3718810|FG002|COMPLETED|Overall Study||9
3001688|NCT00962091|3718811|FG003|COMPLETED|Overall Study||2
3001689|NCT00962091|3718812|FG004|COMPLETED|Overall Study||3
3001690|NCT00962091|3718813|FG005|COMPLETED|Overall Study||11
3001691|NCT00962091|3718814|FG006|COMPLETED|Overall Study||11
3001692|NCT00962091|3718808|FG000|NOT COMPLETED|Overall Study||1
3001693|NCT00962091|3718809|FG001|NOT COMPLETED|Overall Study||2
3001694|NCT00962091|3718810|FG002|NOT COMPLETED|Overall Study||1
3001695|NCT00962091|3718811|FG003|NOT COMPLETED|Overall Study||1
3001696|NCT00962091|3718812|FG004|NOT COMPLETED|Overall Study||0
3001697|NCT00962091|3718813|FG005|NOT COMPLETED|Overall Study||1
3001698|NCT00962091|3718814|FG006|NOT COMPLETED|Overall Study||1
3001699|NCT00962104|3718840|FG000|STARTED|Overall Study||195
3001700|NCT00962104|3718841|FG001|STARTED|Overall Study||196
3001701|NCT00962104|3718840|FG000|Full Analysis Set|Overall Study|2 participants were excluded because they failed to take the assigned study medication.|193
3001702|NCT00962104|3718841|FG001|Full Analysis Set|Overall Study|1 participant was excluded because that participant failed to take the assigned study medication.|195
3001703|NCT00962104|3718840|FG000|COMPLETED|Overall Study||155
3001704|NCT00962104|3718841|FG001|COMPLETED|Overall Study||171
3001705|NCT00962104|3718840|FG000|NOT COMPLETED|Overall Study||40
3001706|NCT00962104|3718841|FG001|NOT COMPLETED|Overall Study||25
3001707|NCT00962208|3718849|FG000|STARTED|Overall Study||51
3001708|NCT00962208|3718850|FG001|STARTED|Overall Study||51
3001709|NCT00962208|3718849|FG000|COMPLETED|Overall Study||37
3001710|NCT00962208|3718850|FG001|COMPLETED|Overall Study||41
3001711|NCT00962208|3718849|FG000|NOT COMPLETED|Overall Study||14
3001712|NCT00962208|3718850|FG001|NOT COMPLETED|Overall Study||10
3001713|NCT00962247|3718856|FG000|STARTED|Usual Sedentary||61
3001714|NCT00962247|3718856|FG000|COMPLETED|Usual Sedentary||61
3001715|NCT00962247|3718856|FG000|NOT COMPLETED|Usual Sedentary||0
3001716|NCT00962247|3718856|FG000|STARTED|25% Reduction of Sedentary Activity||61
3001717|NCT00962247|3718856|FG000|COMPLETED|25% Reduction of Sedentary Activity||56
3001718|NCT00962247|3718856|FG000|NOT COMPLETED|25% Reduction of Sedentary Activity||5
3001719|NCT00962247|3718856|FG000|STARTED|50% Reduction of Sedentary Activity||56
3001720|NCT00962247|3718856|FG000|COMPLETED|50% Reduction of Sedentary Activity||56
3001721|NCT00962247|3718856|FG000|NOT COMPLETED|50% Reduction of Sedentary Activity||0
3001722|NCT00962390|3718866|FG000|STARTED|Overall Study||29
3001723|NCT00962390|3718867|FG001|STARTED|Overall Study||29
3001724|NCT00962390|3718868|FG002|STARTED|Overall Study||29
3001725|NCT00962390|3718869|FG003|STARTED|Overall Study||29
3001726|NCT00962390|3718866|FG000|COMPLETED|Overall Study||25
3001727|NCT00962390|3718867|FG001|COMPLETED|Overall Study||26
3001728|NCT00962390|3718868|FG002|COMPLETED|Overall Study||25
3001729|NCT00962390|3718869|FG003|COMPLETED|Overall Study||28
3001730|NCT00962390|3718866|FG000|NOT COMPLETED|Overall Study||4
3001731|NCT00962390|3718867|FG001|NOT COMPLETED|Overall Study||3
3001732|NCT00962390|3718868|FG002|NOT COMPLETED|Overall Study||4
3001733|NCT00962390|3718869|FG003|NOT COMPLETED|Overall Study||1
3001734|NCT00962585|3718883|FG000|STARTED|Overall Study||43
3001735|NCT00962585|3718884|FG001|STARTED|Overall Study||42
3001736|NCT00962585|3718885|FG002|STARTED|Overall Study||42
3001737|NCT00962585|3718886|FG003|STARTED|Overall Study||42
3001738|NCT00962585|3718883|FG000|COMPLETED|Overall Study||37
3001739|NCT00962585|3718884|FG001|COMPLETED|Overall Study||40
3001740|NCT00962585|3718885|FG002|COMPLETED|Overall Study||39
3001741|NCT00962585|3718886|FG003|COMPLETED|Overall Study||42
3001742|NCT00962585|3718883|FG000|NOT COMPLETED|Overall Study||6
3001743|NCT00962585|3718884|FG001|NOT COMPLETED|Overall Study||2
3001744|NCT00962585|3718885|FG002|NOT COMPLETED|Overall Study||3
3001745|NCT00962585|3718886|FG003|NOT COMPLETED|Overall Study||0
3001746|NCT00962598|3718900|FG000|STARTED|Overall Study||7
3001747|NCT00962598|3718901|FG001|STARTED|Overall Study||9
3001748|NCT00962598|3718900|FG000|COMPLETED|Overall Study||7
3001749|NCT00962598|3718901|FG001|COMPLETED|Overall Study||9
3001750|NCT00962598|3718900|FG000|NOT COMPLETED|Overall Study||0
3001751|NCT00962598|3718901|FG001|NOT COMPLETED|Overall Study||0
3001752|NCT00962650|3718907|FG000|STARTED|Overall Study||10
3001753|NCT00962650|3718907|FG000|COMPLETED|Overall Study||8
3001754|NCT00962650|3718907|FG000|NOT COMPLETED|Overall Study||2
3001755|NCT00962741|3718911|FG000|STARTED|Overall Study||127
3001756|NCT00962741|3718911|FG000|COMPLETED|Overall Study||119
3001757|NCT00962741|3718911|FG000|NOT COMPLETED|Overall Study||8
3001758|NCT00962754|3718917|FG000|STARTED|Overall Study||86
3001759|NCT00962754|3718918|FG001|STARTED|Overall Study||84
3001760|NCT00962754|3718917|FG000|COMPLETED|Overall Study||86
3001761|NCT00962754|3718918|FG001|COMPLETED|Overall Study||84
3001762|NCT00962754|3718917|FG000|NOT COMPLETED|Overall Study||0
3001763|NCT00962754|3718918|FG001|NOT COMPLETED|Overall Study||0
3001764|NCT00962780|3718930|FG000|STARTED|Overall Study||151
3001765|NCT00962780|3718931|FG001|STARTED|Overall Study||152
3001766|NCT00962780|3718930|FG000|Vaccinated 13vPnC Dose 1|Overall Study||150
3001767|NCT00962780|3718931|FG001|Vaccinated 13vPnC Dose 1|Overall Study||151
3001768|NCT00962780|3718930|FG000|Vaccinated 13vPnC Dose 2|Overall Study||145
3001769|NCT00962780|3718931|FG001|Vaccinated 13vPnC Dose 2|Overall Study||145
3001770|NCT00962780|3718930|FG000|Vaccinated 13vPnC Dose 3|Overall Study||144
3001771|NCT00962780|3718931|FG001|Vaccinated 13vPnC Dose 3|Overall Study||142
3001772|NCT00962780|3718930|FG000|Vaccinated 23vPS Dose|Overall Study||143
3001773|NCT00962780|3718931|FG001|Vaccinated 23vPS Dose|Overall Study||139
3001774|NCT00962780|3718930|FG000|COMPLETED|Overall Study||141
3001775|NCT00962780|3718931|FG001|COMPLETED|Overall Study||138
3001776|NCT00962780|3718930|FG000|NOT COMPLETED|Overall Study||10
3001777|NCT00962780|3718931|FG001|NOT COMPLETED|Overall Study||14
3001778|NCT00962871|3718947|FG000|STARTED|Overall Study||6
3001779|NCT00962871|3718948|FG001|STARTED|Overall Study||6
3001780|NCT00962871|3718949|FG002|STARTED|Overall Study||12
3001781|NCT00962871|3718950|FG003|STARTED|Overall Study||6
3001782|NCT00962871|3718947|FG000|COMPLETED|Overall Study||6
3001783|NCT00962871|3718948|FG001|COMPLETED|Overall Study||6
3001784|NCT00962871|3718949|FG002|COMPLETED|Overall Study||12
3001785|NCT00962871|3718950|FG003|COMPLETED|Overall Study||6
3001786|NCT00962871|3718947|FG000|NOT COMPLETED|Overall Study||0
3001787|NCT00962871|3718948|FG001|NOT COMPLETED|Overall Study||0
3001788|NCT00962871|3718949|FG002|NOT COMPLETED|Overall Study||0
3001789|NCT00962871|3718950|FG003|NOT COMPLETED|Overall Study||0
3001790|NCT00962949|3718962|FG000|STARTED|Overall Study||13
3001791|NCT00962949|3718963|FG001|STARTED|Overall Study||15
3001792|NCT00962949|3718962|FG000|COMPLETED|Overall Study||13
3001793|NCT00962949|3718963|FG001|COMPLETED|Overall Study||15
3001794|NCT00962949|3718962|FG000|NOT COMPLETED|Overall Study||0
3001795|NCT00962949|3718963|FG001|NOT COMPLETED|Overall Study||0
3001796|NCT00963105|3718972|FG000|STARTED|Overall Study||34
3001797|NCT00963105|3718973|FG001|STARTED|Overall Study||35
3001798|NCT00963105|3718974|FG002|STARTED|Overall Study||35
3001799|NCT00963105|3718972|FG000|Received Treatment|Overall Study||34
3001800|NCT00963105|3718973|FG001|Received Treatment|Overall Study||34
3001801|NCT00963105|3718974|FG002|Received Treatment|Overall Study||35
3001802|NCT00963105|3718972|FG000|COMPLETED|Overall Study||34
3001803|NCT00963105|3718973|FG001|COMPLETED|Overall Study||35
3001804|NCT00963105|3718974|FG002|COMPLETED|Overall Study||35
3001805|NCT00963105|3718972|FG000|NOT COMPLETED|Overall Study||0
3001806|NCT00963105|3718973|FG001|NOT COMPLETED|Overall Study||0
3001807|NCT00963105|3718974|FG002|NOT COMPLETED|Overall Study||0
3001808|NCT00963157|3718987|FG000|STARTED|Overall Study||156
3001809|NCT00963157|3718988|FG001|STARTED|Overall Study||163
3001810|NCT00963157|3718989|FG002|STARTED|Overall Study||160
3001811|NCT00963157|3718990|FG003|STARTED|Overall Study||157
3001812|NCT00963157|3718991|FG004|STARTED|Overall Study||153
3001813|NCT00963157|3718987|FG000|COMPLETED|Overall Study||151
3001814|NCT00963157|3718988|FG001|COMPLETED|Overall Study||159
3001815|NCT00963157|3718989|FG002|COMPLETED|Overall Study||155
3001816|NCT00963157|3718990|FG003|COMPLETED|Overall Study||150
3001817|NCT00963157|3718991|FG004|COMPLETED|Overall Study||151
3001818|NCT00963157|3718987|FG000|NOT COMPLETED|Overall Study||5
3001819|NCT00963157|3718988|FG001|NOT COMPLETED|Overall Study||4
3001820|NCT00963157|3718989|FG002|NOT COMPLETED|Overall Study||5
3001821|NCT00963157|3718990|FG003|NOT COMPLETED|Overall Study||7
3001822|NCT00963157|3718991|FG004|NOT COMPLETED|Overall Study||2
3001823|NCT00963235|3719003|FG000|STARTED|Overall Study||331
3001824|NCT00963235|3719003|FG000|Vaccinated Dose 1|Overall Study||329
3001825|NCT00963235|3719003|FG000|Vaccinated Dose 2|Overall Study||300
3001826|NCT00963235|3719003|FG000|Vaccinated Dose 3|Overall Study||279
3001827|NCT00963235|3719003|FG000|Completed Dose 3 1-month Blood Draw|Overall Study||277
3001828|NCT00963235|3719003|FG000|COMPLETED|Overall Study||271
3001829|NCT00963235|3719003|FG000|NOT COMPLETED|Overall Study||60
3001830|NCT00963430|3719012|FG000|STARTED|Overall Study||60
3001831|NCT00963430|3719013|FG001|STARTED|Overall Study||60
3001832|NCT00963430|3719012|FG000|COMPLETED|Overall Study||59
3001833|NCT00963430|3719013|FG001|COMPLETED|Overall Study||57
3001834|NCT00963430|3719012|FG000|NOT COMPLETED|Overall Study||1
3001835|NCT00963430|3719013|FG001|NOT COMPLETED|Overall Study||3
3001836|NCT00963482|3719021|FG000|STARTED|Overall Study||53
3001837|NCT00963482|3719022|FG001|STARTED|Overall Study||50
3001838|NCT00963482|3719021|FG000|COMPLETED|Overall Study||25
3001839|NCT00963482|3719022|FG001|COMPLETED|Overall Study||33
3001840|NCT00963482|3719021|FG000|NOT COMPLETED|Overall Study||28
3001841|NCT00963482|3719022|FG001|NOT COMPLETED|Overall Study||17
3001842|NCT00963508|3719030|FG000|STARTED|Overall Study||206
3001843|NCT00963508|3719031|FG001|STARTED|Overall Study||197
3001844|NCT00963508|3719030|FG000|COMPLETED|Overall Study||196
3001845|NCT00963508|3719031|FG001|COMPLETED|Overall Study||169
3001846|NCT00963508|3719030|FG000|NOT COMPLETED|Overall Study||10
3001847|NCT00963508|3719031|FG001|NOT COMPLETED|Overall Study||28
3001848|NCT00963547|3719041|FG000|STARTED|Overall Study||4
3001849|NCT00963547|3719042|FG001|STARTED|Overall Study||11
3001850|NCT00963547|3719043|FG002|STARTED|Overall Study||12
3001851|NCT00963547|3719044|FG003|STARTED|Overall Study||6
3001852|NCT00963547|3719045|FG004|STARTED|Overall Study|Study terminated before Part 2 enrollment.|0
3001853|NCT00963547|3719046|FG005|STARTED|Overall Study|Study terminated before Part 2 enrollment.|0
3001854|NCT00963547|3719047|FG006|STARTED|Overall Study|Study terminated before Part 2 enrollment.|0
3001855|NCT00963547|3719041|FG000|Treated|Overall Study||3
3001856|NCT00963547|3719042|FG001|Treated|Overall Study||11
3001857|NCT00963547|3719043|FG002|Treated|Overall Study||11
3001858|NCT00963547|3719044|FG003|Treated|Overall Study||6
3001859|NCT00963547|3719045|FG004|Treated|Overall Study|Study terminated before Part 2 enrollment.|0
3001860|NCT00963547|3719046|FG005|Treated|Overall Study|Study terminated before Part 2 enrollment.|0
3001861|NCT00963547|3719047|FG006|Treated|Overall Study|Study terminated before Part 2 enrollment.|0
3001862|NCT00963547|3719041|FG000|COMPLETED|Overall Study||0
3001863|NCT00963547|3719042|FG001|COMPLETED|Overall Study||0
3001864|NCT00963547|3719043|FG002|COMPLETED|Overall Study||0
3001865|NCT00963547|3719044|FG003|COMPLETED|Overall Study||0
3001866|NCT00963547|3719045|FG004|COMPLETED|Overall Study|Study terminated before Part 2 enrollment.|0
3001867|NCT00963547|3719046|FG005|COMPLETED|Overall Study|Study terminated before Part 2 enrollment.|0
3001868|NCT00963547|3719047|FG006|COMPLETED|Overall Study|Study terminated before Part 2 enrollment.|0
3001869|NCT00963547|3719041|FG000|NOT COMPLETED|Overall Study||4
3001870|NCT00963547|3719042|FG001|NOT COMPLETED|Overall Study||11
3001871|NCT00963547|3719043|FG002|NOT COMPLETED|Overall Study||12
3001872|NCT00963547|3719044|FG003|NOT COMPLETED|Overall Study||6
3001873|NCT00963547|3719045|FG004|NOT COMPLETED|Overall Study||0
3001874|NCT00963547|3719046|FG005|NOT COMPLETED|Overall Study||0
3001875|NCT00963547|3719047|FG006|NOT COMPLETED|Overall Study||0
3001876|NCT00963560|3719063|FG000|STARTED|Overall Study||47
3001877|NCT00963560|3719064|FG001|STARTED|Overall Study||44
3001878|NCT00963560|3719065|FG002|STARTED|Overall Study||41
3001879|NCT00963560|3719063|FG000|COMPLETED|Overall Study||44
3001880|NCT00963560|3719064|FG001|COMPLETED|Overall Study||41
3001881|NCT00963560|3719065|FG002|COMPLETED|Overall Study||41
3001882|NCT00963560|3719063|FG000|NOT COMPLETED|Overall Study||3
3001883|NCT00963560|3719064|FG001|NOT COMPLETED|Overall Study||3
3001884|NCT00963560|3719065|FG002|NOT COMPLETED|Overall Study||0
3001885|NCT00963638|3719075|FG000|STARTED|Overall Study||20
3001886|NCT00963638|3719076|FG001|STARTED|Overall Study||20
3001887|NCT00963638|3719075|FG000|COMPLETED|Overall Study||20
3001888|NCT00963638|3719076|FG001|COMPLETED|Overall Study||20
3001889|NCT00963638|3719075|FG000|NOT COMPLETED|Overall Study||0
3001890|NCT00963638|3719076|FG001|NOT COMPLETED|Overall Study||0
3001891|NCT00963677|3719084|FG000|STARTED|Overall Study|Patients without predicted difficult intubation|35
3001892|NCT00963677|3719085|FG001|STARTED|Overall Study|Patients with predicted difficult intubation but not ventilation|20
3001893|NCT00963677|3719084|FG000|COMPLETED|Overall Study||35
3001894|NCT00963677|3719085|FG001|COMPLETED|Overall Study|Two patients were excluded from the study due to the difficult ventilation with facemask ventilation|18
3001895|NCT00963677|3719084|FG000|NOT COMPLETED|Overall Study||0
3001896|NCT00963677|3719085|FG001|NOT COMPLETED|Overall Study||2
3001897|NCT00963807|3719091|FG000|STARTED|Overall Study||26
3001898|NCT00963807|3719091|FG000|Completed Baseline Imaging|Overall Study||11
3001899|NCT00963807|3719091|FG000|Completed Post-Cycle 1 Imaging|Overall Study||9
3001900|NCT00963807|3719091|FG000|Completed Post-Cycle 2 FLT Imaging|Overall Study||9
3001901|NCT00963807|3719091|FG000|Completed Post-Cycle 2 FDG Imaging|Overall Study||8
3001902|NCT00963807|3719091|FG000|COMPLETED|Overall Study||8
3001903|NCT00963807|3719091|FG000|NOT COMPLETED|Overall Study||18
3001904|NCT00963820|3719097|FG000|STARTED|Dose Escalation Phase||3
3001905|NCT00963820|3719098|FG001|STARTED|Dose Escalation Phase||3
3001906|NCT00963820|3719099|FG002|STARTED|Dose Escalation Phase||3
3001907|NCT00963820|3719100|FG003|STARTED|Dose Escalation Phase||3
3001908|NCT00963820|3719101|FG004|STARTED|Dose Escalation Phase||4
3001909|NCT00963820|3719102|FG005|STARTED|Dose Escalation Phase||3
3001910|NCT00963820|3719103|FG006|STARTED|Dose Escalation Phase||8
3001911|NCT00963820|3719104|FG007|STARTED|Dose Escalation Phase||5
3001912|NCT00963820|3719105|FG008|STARTED|Dose Escalation Phase|Expansion cohorts were not part of Dose Escalation except as noted in comments.|0
3001913|NCT00963820|3719106|FG009|STARTED|Dose Escalation Phase||0
3001914|NCT00963820|3719107|FG010|STARTED|Dose Escalation Phase||0
3001915|NCT00963820|3719108|FG011|STARTED|Dose Escalation Phase||0
3001916|NCT00963820|3719097|FG000|COMPLETED|Dose Escalation Phase||0
3001917|NCT00963820|3719098|FG001|COMPLETED|Dose Escalation Phase||0
3001918|NCT00963820|3719099|FG002|COMPLETED|Dose Escalation Phase||0
3001919|NCT00963820|3719100|FG003|COMPLETED|Dose Escalation Phase||0
3001920|NCT00963820|3719101|FG004|COMPLETED|Dose Escalation Phase||0
3001921|NCT00963820|3719102|FG005|COMPLETED|Dose Escalation Phase||0
3001922|NCT00963820|3719103|FG006|COMPLETED|Dose Escalation Phase||0
3001923|NCT00963820|3719104|FG007|COMPLETED|Dose Escalation Phase||0
3001924|NCT00963820|3719105|FG008|COMPLETED|Dose Escalation Phase||0
3001925|NCT00963820|3719106|FG009|COMPLETED|Dose Escalation Phase||0
3001926|NCT00963820|3719107|FG010|COMPLETED|Dose Escalation Phase||0
3001927|NCT00963820|3719108|FG011|COMPLETED|Dose Escalation Phase||0
3001928|NCT00963820|3719097|FG000|NOT COMPLETED|Dose Escalation Phase||3
3001929|NCT00963820|3719098|FG001|NOT COMPLETED|Dose Escalation Phase||3
3001930|NCT00963820|3719099|FG002|NOT COMPLETED|Dose Escalation Phase||3
3001931|NCT00963820|3719100|FG003|NOT COMPLETED|Dose Escalation Phase||3
3001932|NCT00963820|3719101|FG004|NOT COMPLETED|Dose Escalation Phase||4
3001933|NCT00963820|3719102|FG005|NOT COMPLETED|Dose Escalation Phase||3
3001934|NCT00963820|3719103|FG006|NOT COMPLETED|Dose Escalation Phase||8
3001935|NCT00963820|3719104|FG007|NOT COMPLETED|Dose Escalation Phase||5
3001936|NCT00963820|3719105|FG008|NOT COMPLETED|Dose Escalation Phase||0
3001937|NCT00963820|3719106|FG009|NOT COMPLETED|Dose Escalation Phase||0
3001938|NCT00963820|3719107|FG010|NOT COMPLETED|Dose Escalation Phase||0
3001939|NCT00963820|3719108|FG011|NOT COMPLETED|Dose Escalation Phase||0
3001940|NCT00963820|3719097|FG000|STARTED|Expansion Phase|Dose escalation cohorts were not part of the Expansion Phase except as noted in comments.|0
3001941|NCT00963820|3719098|FG001|STARTED|Expansion Phase||0
3001942|NCT00963820|3719099|FG002|STARTED|Expansion Phase||0
3001943|NCT00963820|3719100|FG003|STARTED|Expansion Phase||0
3001944|NCT00963820|3719101|FG004|STARTED|Expansion Phase||0
3001945|NCT00963820|3719102|FG005|STARTED|Expansion Phase||0
3001946|NCT00963820|3719103|FG006|STARTED|Expansion Phase||0
3001947|NCT00963820|3719104|FG007|STARTED|Expansion Phase||0
3001948|NCT00963820|3719105|FG008|STARTED|Expansion Phase|Includes 2 participants from the dose escalation cohort 2.97 mg/m^2.|11
3001949|NCT00963820|3719106|FG009|STARTED|Expansion Phase|Includes 1 participant from the dose escalation cohort 2.97 mg/m^2.|10
3001950|NCT00963820|3719107|FG010|STARTED|Expansion Phase|Includes only participants who are proteasome inhibitor (PI)-naïve.|6
3001951|NCT00963820|3719108|FG011|STARTED|Expansion Phase|Includes participants with last dose of carfilzomib 21 to 60 days before 1st ixazomib citrate dose.|4
3001952|NCT00963820|3719097|FG000|COMPLETED|Expansion Phase||0
3001953|NCT00963820|3719098|FG001|COMPLETED|Expansion Phase||0
3001954|NCT00963820|3719099|FG002|COMPLETED|Expansion Phase||0
3001955|NCT00963820|3719100|FG003|COMPLETED|Expansion Phase||0
3001956|NCT00963820|3719101|FG004|COMPLETED|Expansion Phase||0
3001957|NCT00963820|3719102|FG005|COMPLETED|Expansion Phase||0
3001958|NCT00963820|3719103|FG006|COMPLETED|Expansion Phase||0
3001959|NCT00963820|3719104|FG007|COMPLETED|Expansion Phase||0
3001960|NCT00963820|3719105|FG008|COMPLETED|Expansion Phase|Participant was ongoing at the time of data cut off for analysis|1
3001961|NCT00963820|3719106|FG009|COMPLETED|Expansion Phase|Participant was ongoing at the time of data cut off for analysis|1
3001962|NCT00963820|3719107|FG010|COMPLETED|Expansion Phase|Participant was ongoing at the time of data cut off for analysis|1
3001963|NCT00963820|3719108|FG011|COMPLETED|Expansion Phase||0
3001964|NCT00963820|3719097|FG000|NOT COMPLETED|Expansion Phase||0
3001965|NCT00963820|3719098|FG001|NOT COMPLETED|Expansion Phase||0
3001966|NCT00963820|3719099|FG002|NOT COMPLETED|Expansion Phase||0
3001967|NCT00963820|3719100|FG003|NOT COMPLETED|Expansion Phase||0
3001968|NCT00963820|3719101|FG004|NOT COMPLETED|Expansion Phase||0
3001969|NCT00963820|3719102|FG005|NOT COMPLETED|Expansion Phase||0
3001970|NCT00963820|3719103|FG006|NOT COMPLETED|Expansion Phase||0
3001971|NCT00963820|3719104|FG007|NOT COMPLETED|Expansion Phase||0
3001972|NCT00963820|3719105|FG008|NOT COMPLETED|Expansion Phase||10
3001973|NCT00963820|3719106|FG009|NOT COMPLETED|Expansion Phase||9
3001974|NCT00963820|3719107|FG010|NOT COMPLETED|Expansion Phase||5
3001975|NCT00963820|3719108|FG011|NOT COMPLETED|Expansion Phase||4
3001976|NCT00963859|3719125|FG000|STARTED|Overall Study||11
3001977|NCT00963859|3719125|FG000|COMPLETED|Overall Study||11
3001978|NCT00963859|3719125|FG000|NOT COMPLETED|Overall Study||0
3001979|NCT00963872|3719131|FG000|STARTED|Overall Study||25
3001980|NCT00963872|3719132|FG001|STARTED|Overall Study||6
3001981|NCT00963872|3719131|FG000|COMPLETED|Overall Study||24
3001982|NCT00963872|3719132|FG001|COMPLETED|Overall Study||5
3001983|NCT00963872|3719131|FG000|NOT COMPLETED|Overall Study||1
3001984|NCT00963872|3719132|FG001|NOT COMPLETED|Overall Study||1
3001985|NCT00963911|3719138|FG000|STARTED|Overall Study||1674
3001986|NCT00963911|3719138|FG000|COMPLETED|Overall Study||1674
3001987|NCT00963911|3719138|FG000|NOT COMPLETED|Overall Study||0
3001988|NCT00963924|3719144|FG000|STARTED|Overall Study||18
3001989|NCT00963924|3719145|FG001|STARTED|Overall Study||18
3001990|NCT00963924|3719144|FG000|COMPLETED|Overall Study||17
3001991|NCT00963924|3719145|FG001|COMPLETED|Overall Study||15
3001992|NCT00963924|3719144|FG000|NOT COMPLETED|Overall Study||1
3001993|NCT00963924|3719145|FG001|NOT COMPLETED|Overall Study||3
3001994|NCT00963937|3719156|FG000|STARTED|Overall Study||89
3001995|NCT00963937|3719157|FG001|STARTED|Overall Study||44
3001996|NCT00963937|3719158|FG002|STARTED|Overall Study||45
3001997|NCT00963937|3719156|FG000|COMPLETED|Overall Study||70
3001998|NCT00963937|3719157|FG001|COMPLETED|Overall Study||33
3001999|NCT00963937|3719158|FG002|COMPLETED|Overall Study||41
3002000|NCT00963937|3719156|FG000|NOT COMPLETED|Overall Study||19
3002001|NCT00963937|3719157|FG001|NOT COMPLETED|Overall Study||11
3002002|NCT00963937|3719158|FG002|NOT COMPLETED|Overall Study||4
3002003|NCT00963989|3719169|FG000|STARTED|Overall Study||146
3002004|NCT00963989|3719169|FG000|COMPLETED|Overall Study||127
3002005|NCT00963989|3719169|FG000|NOT COMPLETED|Overall Study||19
3002006|NCT00964028|3719175|FG000|STARTED|Overall Study||25
3002007|NCT00964028|3719176|FG001|STARTED|Overall Study||25
3002008|NCT00964028|3719175|FG000|COMPLETED|Overall Study||25
3002009|NCT00964028|3719176|FG001|COMPLETED|Overall Study||24
3002010|NCT00964028|3719175|FG000|NOT COMPLETED|Overall Study||0
3002011|NCT00964028|3719176|FG001|NOT COMPLETED|Overall Study||1
3002012|NCT00964119|3719182|FG000|STARTED|Overall Study||15
3002013|NCT00964119|3719182|FG000|COMPLETED|Overall Study||15
3002014|NCT00964119|3719182|FG000|NOT COMPLETED|Overall Study||0
3002015|NCT00964158|3719189|FG000|STARTED|Overall Study||53
3002016|NCT00964158|3719190|FG001|STARTED|Overall Study||57
3002017|NCT00964158|3719191|FG002|STARTED|Overall Study||100
3002018|NCT00964158|3719189|FG000|COMPLETED|Overall Study||53
3002019|NCT00964158|3719190|FG001|COMPLETED|Overall Study||56
3002020|NCT00964158|3719191|FG002|COMPLETED|Overall Study||92
3002021|NCT00964158|3719189|FG000|NOT COMPLETED|Overall Study||0
3002022|NCT00964158|3719190|FG001|NOT COMPLETED|Overall Study||1
3002023|NCT00964158|3719191|FG002|NOT COMPLETED|Overall Study||8
3002024|NCT00964223|3719202|FG000|STARTED|Split Face Treatment (Weeks 1 and 2)||28
3002025|NCT00964223|3719202|FG000|COMPLETED|Split Face Treatment (Weeks 1 and 2)||28
3002026|NCT00964223|3719202|FG000|NOT COMPLETED|Split Face Treatment (Weeks 1 and 2)||0
3002027|NCT00964223|3719202|FG000|STARTED|Full Face Treatment (Weeks 5 and 8)||28
3002028|NCT00964223|3719202|FG000|COMPLETED|Full Face Treatment (Weeks 5 and 8)||27
3002029|NCT00964223|3719202|FG000|NOT COMPLETED|Full Face Treatment (Weeks 5 and 8)||1
3002030|NCT00964353|3719209|FG000|STARTED|Overall Study||181
3002031|NCT00964353|3719210|FG001|STARTED|Overall Study||178
3002032|NCT00964353|3719209|FG000|COMPLETED|Overall Study||181
3002033|NCT00964353|3719210|FG001|COMPLETED|Overall Study||178
3002034|NCT00964353|3719209|FG000|NOT COMPLETED|Overall Study||0
3002035|NCT00964353|3719210|FG001|NOT COMPLETED|Overall Study||0
3002036|NCT00964366|3719218|FG000|STARTED|Overall Study|27 of the 28 enrolled were eligible after screening.|28
3002037|NCT00964366|3719219|FG001|STARTED|Overall Study||25
3002038|NCT00964366|3719218|FG000|COMPLETED|Overall Study||27
3002039|NCT00964366|3719219|FG001|COMPLETED|Overall Study||24
3002040|NCT00964366|3719218|FG000|NOT COMPLETED|Overall Study||1
3002041|NCT00964366|3719219|FG001|NOT COMPLETED|Overall Study||1
3002042|NCT00964392|3719227|FG000|STARTED|Overall Study|Both safety and efficacy cohort: Total 128 (3 MEP Excluded)|125
3002043|NCT00964392|3719228|FG001|STARTED|Overall Study|Both safety and efficacy cohort: Total 292 (10 LEP Excluded)|282
3002044|NCT00964392|3719227|FG000|COMPLETED|Overall Study||72
3002045|NCT00964392|3719228|FG001|COMPLETED|Overall Study||92
3002046|NCT00964392|3719227|FG000|NOT COMPLETED|Overall Study||53
3002047|NCT00964392|3719228|FG001|NOT COMPLETED|Overall Study||190
3002048|NCT00964431|3719238|FG000|STARTED|Overall Study||50
3002049|NCT00964431|3719239|FG001|STARTED|Overall Study||51
3002050|NCT00964431|3719240|FG002|STARTED|Overall Study||51
3002051|NCT00964431|3719241|FG003|STARTED|Overall Study||51
3002052|NCT00964431|3719238|FG000|COMPLETED|Overall Study||50
3002053|NCT00964431|3719239|FG001|COMPLETED|Overall Study||51
3164890|NCT01895608|3892380|FG000|COMPLETED|Overall Study||10
3164891|NCT01895608|3892381|FG001|COMPLETED|Overall Study||6
3164892|NCT01895608|3892382|FG002|COMPLETED|Overall Study||8
3164893|NCT01895608|3892383|FG003|COMPLETED|Overall Study||6
3164894|NCT01895608|3892380|FG000|NOT COMPLETED|Overall Study||0
3164895|NCT01895608|3892381|FG001|NOT COMPLETED|Overall Study||1
3002054|NCT00964431|3719240|FG002|COMPLETED|Overall Study||51
3002055|NCT00964431|3719241|FG003|COMPLETED|Overall Study||51
3002056|NCT00964431|3719238|FG000|NOT COMPLETED|Overall Study||0
3002057|NCT00964431|3719239|FG001|NOT COMPLETED|Overall Study||0
3002058|NCT00964431|3719240|FG002|NOT COMPLETED|Overall Study||0
3002059|NCT00964431|3719241|FG003|NOT COMPLETED|Overall Study||0
3002060|NCT00964444|3719251|FG000|STARTED|Overall Study||10
3002061|NCT00964444|3719251|FG000|COMPLETED|Overall Study||10
3002062|NCT00964444|3719251|FG000|NOT COMPLETED|Overall Study||0
3002063|NCT00964496|3719257|FG000|STARTED|Overall Study||28
3002064|NCT00964496|3719258|FG001|STARTED|Overall Study||27
3002065|NCT00964496|3719257|FG000|COMPLETED|Overall Study||26
3002066|NCT00964496|3719258|FG001|COMPLETED|Overall Study||26
3002067|NCT00964496|3719257|FG000|NOT COMPLETED|Overall Study||2
3002068|NCT00964496|3719258|FG001|NOT COMPLETED|Overall Study||1
3002069|NCT00964548|3719266|FG000|STARTED|Overall Study||5
3002070|NCT00964548|3719267|FG001|STARTED|Overall Study||5
3002071|NCT00964548|3719266|FG000|COMPLETED|Overall Study||5
3002072|NCT00964548|3719267|FG001|COMPLETED|Overall Study||5
3002073|NCT00964548|3719266|FG000|NOT COMPLETED|Overall Study||0
3002074|NCT00964548|3719267|FG001|NOT COMPLETED|Overall Study||0
3002075|NCT00964678|3719273|FG000|STARTED|Overall Study||10
3002076|NCT00964678|3719273|FG000|COMPLETED|Overall Study||6
3002077|NCT00964678|3719273|FG000|NOT COMPLETED|Overall Study||4
3002078|NCT00964743|3719278|FG000|STARTED|Overall Study||2
3002079|NCT00964743|3719278|FG000|COMPLETED|Overall Study||0
3002080|NCT00964743|3719278|FG000|NOT COMPLETED|Overall Study||2
3002081|NCT00964782|3719284|FG000|STARTED|Overall Study||8
3002082|NCT00964782|3719285|FG001|STARTED|Overall Study||8
3002083|NCT00964782|3719284|FG000|COMPLETED|Overall Study||7
3002084|NCT00964782|3719285|FG001|COMPLETED|Overall Study||8
3002085|NCT00964782|3719284|FG000|NOT COMPLETED|Overall Study||1
3002086|NCT00964782|3719285|FG001|NOT COMPLETED|Overall Study||0
3002087|NCT00964795|3719293|FG000|STARTED|Overall Study|randomized|323
3002088|NCT00964795|3719293|FG000|Number of Participants Treated|Overall Study||320
3164896|NCT01895608|3892382|FG002|NOT COMPLETED|Overall Study||3
3164897|NCT01895608|3892383|FG003|NOT COMPLETED|Overall Study||0
3164898|NCT01895634|3892393|FG000|STARTED|Overall Study||49
3164899|NCT01895634|3892393|FG000|COMPLETED|Overall Study||46
3164900|NCT01895634|3892393|FG000|NOT COMPLETED|Overall Study||3
3002089|NCT00964795|3719293|FG000|COMPLETED|Overall Study|Prior to amendment 4, 16 participants completed up to Week 120. No participants completed Week 180.|16
3002090|NCT00964795|3719293|FG000|NOT COMPLETED|Overall Study||307
3002091|NCT00964860|3719300|FG000|STARTED|Overall Study||30
3002092|NCT00964860|3719301|FG001|STARTED|Overall Study||30
3002093|NCT00964860|3719300|FG000|COMPLETED|Overall Study||30
3002094|NCT00964860|3719301|FG001|COMPLETED|Overall Study||29
3002095|NCT00964860|3719300|FG000|NOT COMPLETED|Overall Study||0
3002096|NCT00964860|3719301|FG001|NOT COMPLETED|Overall Study||1
3002097|NCT00964886|3719311|FG000|STARTED|Overall Study||38
3002098|NCT00964886|3719312|FG001|STARTED|Overall Study||34
3002099|NCT00964886|3719313|FG002|STARTED|Overall Study||37
3002100|NCT00964886|3719314|FG003|STARTED|Overall Study||33
3002101|NCT00964886|3719311|FG000|COMPLETED|Overall Study||27
3002102|NCT00964886|3719312|FG001|COMPLETED|Overall Study||27
3002103|NCT00964886|3719313|FG002|COMPLETED|Overall Study||21
3002104|NCT00964886|3719314|FG003|COMPLETED|Overall Study||24
3002105|NCT00964886|3719311|FG000|NOT COMPLETED|Overall Study||11
3002106|NCT00964886|3719312|FG001|NOT COMPLETED|Overall Study||7
3002107|NCT00964886|3719313|FG002|NOT COMPLETED|Overall Study||16
3002108|NCT00964886|3719314|FG003|NOT COMPLETED|Overall Study||9
3002109|NCT00965081|3719330|FG000|STARTED|Overall Study|2 randomized participants had no post-baseline measures and are not included in outcome measures.|155
3002110|NCT00965081|3719331|FG001|STARTED|Overall Study||153
3002111|NCT00965081|3719330|FG000|COMPLETED|Overall Study|In addition, 16/17 rescue participants completed study on protocol-specified study medication.|121
3002112|NCT00965081|3719331|FG001|COMPLETED|Overall Study||110
3164901|NCT01895647|3892400|FG000|STARTED|Overall Study||8
3002113|NCT00965081|3719330|FG000|NOT COMPLETED|Overall Study||34
3002114|NCT00965081|3719331|FG001|NOT COMPLETED|Overall Study||43
3002115|NCT00965094|3719340|FG000|STARTED|Overall Study||19
3002116|NCT00965094|3719341|FG001|STARTED|Overall Study||17
3002117|NCT00965094|3719340|FG000|COMPLETED|Overall Study||14
3002118|NCT00965094|3719341|FG001|COMPLETED|Overall Study||16
3002119|NCT00965094|3719340|FG000|NOT COMPLETED|Overall Study||5
3002120|NCT00965094|3719341|FG001|NOT COMPLETED|Overall Study||1
3002121|NCT00965185|3719350|FG000|STARTED|Overall Study||19
3002122|NCT00965185|3719351|FG001|STARTED|Overall Study||21
3002123|NCT00965185|3719350|FG000|1 Month Visit|Overall Study||18
3002124|NCT00965185|3719351|FG001|1 Month Visit|Overall Study||21
3002125|NCT00965185|3719350|FG000|3 Month Visit|Overall Study||18
3002126|NCT00965185|3719351|FG001|3 Month Visit|Overall Study||21
3002127|NCT00965185|3719350|FG000|6 Month Visit|Overall Study||18
3002128|NCT00965185|3719351|FG001|6 Month Visit|Overall Study||21
3002129|NCT00965185|3719350|FG000|9 Month Visit|Overall Study||18
3002130|NCT00965185|3719351|FG001|9 Month Visit|Overall Study||21
3002131|NCT00965185|3719350|FG000|COMPLETED|Overall Study||17
3002132|NCT00965185|3719351|FG001|COMPLETED|Overall Study||20
3002133|NCT00965185|3719350|FG000|NOT COMPLETED|Overall Study||2
3002134|NCT00965185|3719351|FG001|NOT COMPLETED|Overall Study||1
3002135|NCT00965237|3719359|FG000|STARTED|Period 1, One Week of Wear||8
3002136|NCT00965237|3719360|FG001|STARTED|Period 1, One Week of Wear||8
3002137|NCT00965237|3719359|FG000|COMPLETED|Period 1, One Week of Wear||8
3002138|NCT00965237|3719360|FG001|COMPLETED|Period 1, One Week of Wear||8
3002139|NCT00965237|3719359|FG000|NOT COMPLETED|Period 1, One Week of Wear||0
3002140|NCT00965237|3719360|FG001|NOT COMPLETED|Period 1, One Week of Wear||0
3002141|NCT00965237|3719359|FG000|STARTED|Period 2, One Week of Wear||8
3002142|NCT00965237|3719360|FG001|STARTED|Period 2, One Week of Wear||8
3002143|NCT00965237|3719359|FG000|COMPLETED|Period 2, One Week of Wear||8
3002144|NCT00965237|3719360|FG001|COMPLETED|Period 2, One Week of Wear||8
3002145|NCT00965237|3719359|FG000|NOT COMPLETED|Period 2, One Week of Wear||0
3002146|NCT00965237|3719360|FG001|NOT COMPLETED|Period 2, One Week of Wear||0
3002147|NCT00965250|3719368|FG000|STARTED|Overall Study||37
3002148|NCT00965250|3719369|FG001|STARTED|Overall Study||12
3002149|NCT00965250|3719368|FG000|COMPLETED|Overall Study||37
3002150|NCT00965250|3719369|FG001|COMPLETED|Overall Study||12
3002151|NCT00965250|3719368|FG000|NOT COMPLETED|Overall Study||0
3002152|NCT00965250|3719369|FG001|NOT COMPLETED|Overall Study||0
3002153|NCT00965263|3719377|FG000|STARTED|Overall Study||6
3002154|NCT00965263|3719378|FG001|STARTED|Overall Study||9
3002155|NCT00965263|3719377|FG000|COMPLETED|Overall Study||4
3002156|NCT00965263|3719378|FG001|COMPLETED|Overall Study||6
3002157|NCT00965263|3719377|FG000|NOT COMPLETED|Overall Study||2
3002158|NCT00965263|3719378|FG001|NOT COMPLETED|Overall Study||3
3002159|NCT00965341|3719404|FG000|STARTED|Overall Study||19
3002160|NCT00965341|3719405|FG001|STARTED|Overall Study||24
3002161|NCT00965341|3719404|FG000|COMPLETED|Overall Study||13
3002162|NCT00965341|3719405|FG001|COMPLETED|Overall Study||16
3002163|NCT00965341|3719404|FG000|NOT COMPLETED|Overall Study||6
3002164|NCT00965341|3719405|FG001|NOT COMPLETED|Overall Study||8
3002165|NCT00965419|3719411|FG000|STARTED|Open Label Treatment for Responders||267
3002166|NCT00965419|3719411|FG000|Not Lost to f/u at First Post-baseline|Open Label Treatment for Responders||264
3002167|NCT00965419|3719411|FG000|COMPLETED|Open Label Treatment for Responders||20
3002168|NCT00965419|3719411|FG000|NOT COMPLETED|Open Label Treatment for Responders||247
3002169|NCT00965419|3719411|FG000|STARTED|Follow-up Phase||80
3002170|NCT00965419|3719411|FG000|COMPLETED|Follow-up Phase||18
3002171|NCT00965419|3719411|FG000|NOT COMPLETED|Follow-up Phase||62
3002172|NCT00965458|3719418|FG000|STARTED|Overall Study||33
3002173|NCT00965458|3719419|FG001|STARTED|Overall Study||16
3002174|NCT00965458|3719418|FG000|COMPLETED|Overall Study||31
3002175|NCT00965458|3719419|FG001|COMPLETED|Overall Study||12
3002176|NCT00965458|3719418|FG000|NOT COMPLETED|Overall Study||2
3002177|NCT00965458|3719419|FG001|NOT COMPLETED|Overall Study||4
3002178|NCT00965484|3719427|FG000|STARTED|Overall Study||136
3002179|NCT00965484|3719427|FG000|COMPLETED|Overall Study||134
3002180|NCT00965484|3719427|FG000|NOT COMPLETED|Overall Study||2
3306543|NCT02999100|4039913|FG001|COMPLETED|Part 1 (up to 15 Days)||7
3306544|NCT02999100|4039914|FG002|COMPLETED|Part 1 (up to 15 Days)||0
3002181|NCT00965497|3719431|FG000|STARTED|Overall Study||14
3002182|NCT00965497|3719431|FG000|COMPLETED|Overall Study||13
3002183|NCT00965497|3719431|FG000|NOT COMPLETED|Overall Study||1
3002184|NCT00965523|3719435|FG000|STARTED|Study 221|Study 221 (Safety Analysis Set).|81
3002185|NCT00965523|3719435|FG000|COMPLETED|Study 221||74
3002186|NCT00965523|3719435|FG000|NOT COMPLETED|Study 221||7
3002187|NCT00965523|3719435|FG000|STARTED|Study 224|Six subjects continued into Study 224 from Study 221.|6
3002188|NCT00965523|3719435|FG000|COMPLETED|Study 224||0
3002189|NCT00965523|3719435|FG000|NOT COMPLETED|Study 224||6
3002190|NCT00965562|3719442|FG000|STARTED|Overall Study||16
3002191|NCT00965562|3719443|FG001|STARTED|Overall Study||17
3002192|NCT00965562|3719444|FG002|STARTED|Overall Study||16
3002193|NCT00965562|3719442|FG000|Women With at Least 2 Follow up Visits|Overall Study|3 patients with no follow up visits: 1 out of contact, 2 patient requests|13
3002194|NCT00965562|3719443|FG001|Women With at Least 2 Follow up Visits|Overall Study|4 patients with no follow up visits: 2 out of contact, 2 patient requests|13
3002195|NCT00965562|3719444|FG002|Women With at Least 2 Follow up Visits|Overall Study|3 patients with no follow up visits: 3 out of contact|13
3002196|NCT00965562|3719442|FG000|Women Who Participated Full Follow up|Overall Study|7 patients discontinued intervention: 2 out of contact, 4 patient requests, 1 suspended by IRB|6
3002197|NCT00965562|3719443|FG001|Women Who Participated Full Follow up|Overall Study|3 patients discontinued intervention: 1 out of contact, 2 patient requests|10
3164902|NCT01895647|3892401|FG001|STARTED|Overall Study||10
3164903|NCT01895647|3892402|FG002|STARTED|Overall Study||7
3164904|NCT01895647|3892400|FG000|COMPLETED|Overall Study||8
3164905|NCT01895647|3892401|FG001|COMPLETED|Overall Study||10
3164906|NCT01895647|3892402|FG002|COMPLETED|Overall Study||7
3164907|NCT01895647|3892400|FG000|NOT COMPLETED|Overall Study||0
3164908|NCT01895647|3892401|FG001|NOT COMPLETED|Overall Study||0
3164909|NCT01895647|3892402|FG002|NOT COMPLETED|Overall Study||0
3164910|NCT01895777|3892412|FG000|STARTED|Overall Study||177
3002198|NCT00965562|3719444|FG002|Women Who Participated Full Follow up|Overall Study|2 patients discontinued intervention: 2 patient requests|11
3002199|NCT00965562|3719442|FG000|COMPLETED|Overall Study|Participants who completed at least 2 visits were analyzed.|13
3002200|NCT00965562|3719443|FG001|COMPLETED|Overall Study|Participants who completed at least 2 visits were analyzed.|13
3002201|NCT00965562|3719444|FG002|COMPLETED|Overall Study|Participants who completed at least 2 visits were analyzed.|13
3002202|NCT00965562|3719442|FG000|NOT COMPLETED|Overall Study||3
3002203|NCT00965562|3719443|FG001|NOT COMPLETED|Overall Study||4
3164911|NCT01895777|3892413|FG001|STARTED|Overall Study||90
3164912|NCT01895777|3892412|FG000|Treated|Overall Study||176
3164913|NCT01895777|3892413|FG001|Treated|Overall Study||90
3164914|NCT01895777|3892412|FG000|COMPLETED|Overall Study||168
3164915|NCT01895777|3892413|FG001|COMPLETED|Overall Study||85
3002204|NCT00965562|3719444|FG002|NOT COMPLETED|Overall Study||3
3002205|NCT00965575|3719455|FG000|STARTED|Overall Study|cross over, total enrolled 11|6
3002206|NCT00965575|3719456|FG001|STARTED|Overall Study|cross over, total enrolled 11|5
3002207|NCT00965575|3719455|FG000|COMPLETED|Overall Study||5
3002208|NCT00965575|3719456|FG001|COMPLETED|Overall Study||5
3002209|NCT00965575|3719455|FG000|NOT COMPLETED|Overall Study||1
3002210|NCT00965575|3719456|FG001|NOT COMPLETED|Overall Study||0
3002211|NCT00965718|3719464|FG000|STARTED|Overall Study||20
3002212|NCT00965718|3719464|FG000|COMPLETED|Overall Study||16
3002213|NCT00965718|3719464|FG000|NOT COMPLETED|Overall Study||4
3002214|NCT00965731|3719470|FG000|STARTED|Overall Study||7
3002215|NCT00965731|3719471|FG001|STARTED|Overall Study|Dose level given only after lower dose was successfully administered|20
3002216|NCT00965731|3719470|FG000|COMPLETED|Overall Study||0
3002217|NCT00965731|3719471|FG001|COMPLETED|Overall Study||0
3002218|NCT00965731|3719470|FG000|NOT COMPLETED|Overall Study||7
3002219|NCT00965731|3719471|FG001|NOT COMPLETED|Overall Study||20
3002220|NCT00965848|3719482|FG000|STARTED|Overall Study||107
3002221|NCT00965848|3719483|FG001|STARTED|Overall Study||34
3002222|NCT00965848|3719484|FG002|STARTED|Overall Study||127
3002223|NCT00965848|3719482|FG000|COMPLETED|Overall Study||78
3002224|NCT00965848|3719483|FG001|COMPLETED|Overall Study||32
3002225|NCT00965848|3719484|FG002|COMPLETED|Overall Study||117
3002226|NCT00965848|3719482|FG000|NOT COMPLETED|Overall Study||29
3002227|NCT00965848|3719483|FG001|NOT COMPLETED|Overall Study||2
3002228|NCT00965848|3719484|FG002|NOT COMPLETED|Overall Study||10
3002229|NCT00966186|3719494|FG000|STARTED|Overall Study||60
3002230|NCT00966186|3719495|FG001|STARTED|Overall Study||60
3002231|NCT00966186|3719494|FG000|COMPLETED|Overall Study||60
3002232|NCT00966186|3719495|FG001|COMPLETED|Overall Study||60
3002233|NCT00966186|3719494|FG000|NOT COMPLETED|Overall Study||0
3002234|NCT00966186|3719495|FG001|NOT COMPLETED|Overall Study||0
3002235|NCT00966238|3719507|FG000|STARTED|Overall Study||20
3002236|NCT00966238|3719508|FG001|STARTED|Overall Study||20
3002237|NCT00966238|3719509|FG002|STARTED|Overall Study||20
3002238|NCT00966238|3719510|FG003|STARTED|Overall Study||20
3002239|NCT00966238|3719511|FG004|STARTED|Overall Study||20
3002240|NCT00966238|3719512|FG005|STARTED|Overall Study||20
3002241|NCT00966238|3719507|FG000|COMPLETED|Overall Study||20
3002242|NCT00966238|3719508|FG001|COMPLETED|Overall Study||20
3002243|NCT00966238|3719509|FG002|COMPLETED|Overall Study||20
3002244|NCT00966238|3719510|FG003|COMPLETED|Overall Study||20
3002245|NCT00966238|3719511|FG004|COMPLETED|Overall Study||20
3002246|NCT00966238|3719512|FG005|COMPLETED|Overall Study||20
3002247|NCT00966238|3719507|FG000|NOT COMPLETED|Overall Study||0
3002248|NCT00966238|3719508|FG001|NOT COMPLETED|Overall Study||0
3002249|NCT00966238|3719509|FG002|NOT COMPLETED|Overall Study||0
3002250|NCT00966238|3719510|FG003|NOT COMPLETED|Overall Study||0
3002251|NCT00966238|3719511|FG004|NOT COMPLETED|Overall Study||0
3002252|NCT00966238|3719512|FG005|NOT COMPLETED|Overall Study||0
3002253|NCT00966264|3719528|FG000|STARTED|Overall Study||119
3002254|NCT00966264|3719529|FG001|STARTED|Overall Study||117
3002255|NCT00966264|3719528|FG000|COMPLETED|Overall Study|5 years results|115
3002256|NCT00966264|3719529|FG001|COMPLETED|Overall Study|5 years results|114
3002257|NCT00966264|3719528|FG000|NOT COMPLETED|Overall Study||4
3002258|NCT00966264|3719529|FG001|NOT COMPLETED|Overall Study||3
3002259|NCT00966277|3719537|FG000|STARTED|Overall Study||38
3002260|NCT00966277|3719538|FG001|STARTED|Overall Study||37
3002261|NCT00966277|3719537|FG000|COMPLETED|Overall Study|Four participants did not receive study treatment, see 'Reasons Not Completed.'|34
3037138|NCT01147068|3756458|FG001|COMPLETED|Subjects That Received 1st Dose||57
3164916|NCT01895777|3892412|FG000|NOT COMPLETED|Overall Study||9
3164917|NCT01895777|3892413|FG001|NOT COMPLETED|Overall Study||5
3164918|NCT01895855|3892424|FG000|STARTED|Overall Study||95
3164919|NCT01895855|3892425|FG001|STARTED|Overall Study||102
3002262|NCT00966277|3719538|FG001|COMPLETED|Overall Study|Four participants did not receive study treatment, see 'Reasons Not Completed.'|33
3002263|NCT00966277|3719537|FG000|NOT COMPLETED|Overall Study||4
3002264|NCT00966277|3719538|FG001|NOT COMPLETED|Overall Study||4
3306545|NCT02999100|4039915|FG003|COMPLETED|Part 1 (up to 15 Days)||0
3306546|NCT02999100|4039916|FG004|COMPLETED|Part 1 (up to 15 Days)||0
3002265|NCT00966355|3719547|FG000|STARTED|Overall Study||344
3002266|NCT00966355|3719548|FG001|STARTED|Overall Study||345
3002267|NCT00966355|3719549|FG002|STARTED|Overall Study||345
3002268|NCT00966355|3719547|FG000|COMPLETED|Overall Study||260
3002269|NCT00966355|3719548|FG001|COMPLETED|Overall Study||259
3002270|NCT00966355|3719549|FG002|COMPLETED|Overall Study||261
3002271|NCT00966355|3719547|FG000|NOT COMPLETED|Overall Study||84
3002272|NCT00966355|3719548|FG001|NOT COMPLETED|Overall Study||86
3002273|NCT00966355|3719549|FG002|NOT COMPLETED|Overall Study||84
3002274|NCT00966433|3719560|FG000|STARTED|Overall Study||11
3002275|NCT00966433|3719561|FG001|STARTED|Overall Study||11
3002276|NCT00966433|3719562|FG002|STARTED|Overall Study||11
3002277|NCT00966433|3719560|FG000|COMPLETED|Overall Study||10
3002278|NCT00966433|3719561|FG001|COMPLETED|Overall Study||10
3002279|NCT00966433|3719562|FG002|COMPLETED|Overall Study||11
3002280|NCT00966433|3719560|FG000|NOT COMPLETED|Overall Study||1
3002281|NCT00966433|3719561|FG001|NOT COMPLETED|Overall Study||1
3002282|NCT00966433|3719562|FG002|NOT COMPLETED|Overall Study||0
3002283|NCT00966446|3719575|FG000|STARTED|Overall Study||76
3002284|NCT00966446|3719576|FG001|STARTED|Overall Study||74
3002285|NCT00966446|3719577|FG002|STARTED|Overall Study||73
3002286|NCT00966446|3719575|FG000|COMPLETED|Overall Study||48
3002287|NCT00966446|3719576|FG001|COMPLETED|Overall Study||49
3002288|NCT00966446|3719577|FG002|COMPLETED|Overall Study||52
3002289|NCT00966446|3719575|FG000|NOT COMPLETED|Overall Study||28
3002290|NCT00966446|3719576|FG001|NOT COMPLETED|Overall Study||25
3002291|NCT00966446|3719577|FG002|NOT COMPLETED|Overall Study||21
3002292|NCT00966550|3719587|FG000|STARTED|Overall Study||13
3002293|NCT00966550|3719588|FG001|STARTED|Overall Study||12
3002294|NCT00966550|3719587|FG000|COMPLETED|Overall Study||13
3002295|NCT00966550|3719588|FG001|COMPLETED|Overall Study||12
3002296|NCT00966550|3719587|FG000|NOT COMPLETED|Overall Study||0
3002297|NCT00966550|3719588|FG001|NOT COMPLETED|Overall Study||0
3002298|NCT00966641|3719594|FG000|STARTED|First Intervention||17
3002299|NCT00966641|3719595|FG001|STARTED|First Intervention||17
3002300|NCT00966641|3719594|FG000|COMPLETED|First Intervention||17
3002301|NCT00966641|3719595|FG001|COMPLETED|First Intervention||17
3002302|NCT00966641|3719594|FG000|NOT COMPLETED|First Intervention||0
3002303|NCT00966641|3719595|FG001|NOT COMPLETED|First Intervention||0
3002304|NCT00966641|3719594|FG000|STARTED|Second Intervention||17
3002305|NCT00966641|3719595|FG001|STARTED|Second Intervention||17
3002306|NCT00966641|3719594|FG000|COMPLETED|Second Intervention||17
3002307|NCT00966641|3719595|FG001|COMPLETED|Second Intervention||17
3002308|NCT00966641|3719594|FG000|NOT COMPLETED|Second Intervention||0
3002309|NCT00966641|3719595|FG001|NOT COMPLETED|Second Intervention||0
3002310|NCT00966693|3719605|FG000|STARTED|Overall Study||3
3002311|NCT00966693|3719606|FG001|STARTED|Overall Study||3
3002312|NCT00966693|3719607|FG002|STARTED|Overall Study||9
3002313|NCT00966693|3719608|FG003|STARTED|Overall Study||49
3002314|NCT00966693|3719605|FG000|Phase 1 Completed|Overall Study||2
3002315|NCT00966693|3719606|FG001|Phase 1 Completed|Overall Study||3
3002316|NCT00966693|3719607|FG002|Phase 1 Completed|Overall Study||6
3002317|NCT00966693|3719608|FG003|Phase 1 Completed|Overall Study||0
3002318|NCT00966693|3719605|FG000|Phase 2 Completed|Overall Study||0
3002319|NCT00966693|3719606|FG001|Phase 2 Completed|Overall Study||0
3002320|NCT00966693|3719607|FG002|Phase 2 Completed|Overall Study||0
3002321|NCT00966693|3719608|FG003|Phase 2 Completed|Overall Study||46
3002322|NCT00966693|3719605|FG000|COMPLETED|Overall Study||2
3002323|NCT00966693|3719606|FG001|COMPLETED|Overall Study||3
3002324|NCT00966693|3719607|FG002|COMPLETED|Overall Study||6
3002325|NCT00966693|3719608|FG003|COMPLETED|Overall Study||26
3002326|NCT00966693|3719605|FG000|NOT COMPLETED|Overall Study||1
3002327|NCT00966693|3719606|FG001|NOT COMPLETED|Overall Study||0
3002328|NCT00966693|3719607|FG002|NOT COMPLETED|Overall Study||3
3002329|NCT00966693|3719608|FG003|NOT COMPLETED|Overall Study||23
3002330|NCT00966719|3719620|FG000|STARTED|Overall Study||50
3002331|NCT00966719|3719621|FG001|STARTED|Overall Study||49
3002332|NCT00966719|3719620|FG000|COMPLETED|Overall Study||44
3002333|NCT00966719|3719621|FG001|COMPLETED|Overall Study||38
3002334|NCT00966719|3719620|FG000|NOT COMPLETED|Overall Study||6
3002335|NCT00966719|3719621|FG001|NOT COMPLETED|Overall Study||11
3002336|NCT00966823|3719627|FG000|STARTED|Overall Study||3
3002337|NCT00966823|3719627|FG000|COMPLETED|Overall Study||2
3002338|NCT00966823|3719627|FG000|NOT COMPLETED|Overall Study||1
3002339|NCT00966849|3719634|FG000|STARTED|Overall Study||3660
3002340|NCT00966849|3719635|FG001|STARTED|Overall Study||3976
3002341|NCT00966849|3719636|FG002|STARTED|Overall Study||3169
3002342|NCT00966849|3719634|FG000|COMPLETED|Overall Study||2119
3002343|NCT00966849|3719635|FG001|COMPLETED|Overall Study||2498
3002344|NCT00966849|3719636|FG002|COMPLETED|Overall Study||1876
3002345|NCT00966849|3719634|FG000|NOT COMPLETED|Overall Study||1541
3002346|NCT00966849|3719635|FG001|NOT COMPLETED|Overall Study||1478
3002347|NCT00966849|3719636|FG002|NOT COMPLETED|Overall Study||1293
3002348|NCT00966875|3719653|FG000|STARTED|Part A||54
3002349|NCT00966875|3719654|FG001|STARTED|Part A||40
3002350|NCT00966875|3719655|FG002|STARTED|Part A||35
3002351|NCT00966875|3719656|FG003|STARTED|Part A||37
3002352|NCT00966875|3719657|FG004|STARTED|Part A||57
3002353|NCT00966875|3719658|FG005|STARTED|Part A||37
3002354|NCT00966875|3719659|FG006|STARTED|Part A||64
3002355|NCT00966875|3719660|FG007|STARTED|Part A||65
3002356|NCT00966875|3719661|FG008|STARTED|Part A||59
3002357|NCT00966875|3719653|FG000|Received ≥1 Doses of Study Drug|Part A||54
3002358|NCT00966875|3719654|FG001|Received ≥1 Doses of Study Drug|Part A||40
3002359|NCT00966875|3719655|FG002|Received ≥1 Doses of Study Drug|Part A||35
3002360|NCT00966875|3719656|FG003|Received ≥1 Doses of Study Drug|Part A||37
3002361|NCT00966875|3719657|FG004|Received ≥1 Doses of Study Drug|Part A||57
3002362|NCT00966875|3719658|FG005|Received ≥1 Doses of Study Drug|Part A||37
3002363|NCT00966875|3719659|FG006|Received ≥1 Doses of Study Drug|Part A||64
3002364|NCT00966875|3719660|FG007|Received ≥1 Doses of Study Drug|Part A||65
3002365|NCT00966875|3719661|FG008|Received ≥1 Doses of Study Drug|Part A||59
3002366|NCT00966875|3719653|FG000|COMPLETED|Part A||48
3002367|NCT00966875|3719654|FG001|COMPLETED|Part A||36
3002368|NCT00966875|3719655|FG002|COMPLETED|Part A||33
3002369|NCT00966875|3719656|FG003|COMPLETED|Part A||34
3002370|NCT00966875|3719657|FG004|COMPLETED|Part A||52
3002371|NCT00966875|3719658|FG005|COMPLETED|Part A||33
3002372|NCT00966875|3719659|FG006|COMPLETED|Part A||52
3002373|NCT00966875|3719660|FG007|COMPLETED|Part A||58
3002374|NCT00966875|3719661|FG008|COMPLETED|Part A||51
3002375|NCT00966875|3719653|FG000|NOT COMPLETED|Part A||6
3002376|NCT00966875|3719654|FG001|NOT COMPLETED|Part A||4
3002377|NCT00966875|3719655|FG002|NOT COMPLETED|Part A||2
3002378|NCT00966875|3719656|FG003|NOT COMPLETED|Part A||3
3002379|NCT00966875|3719657|FG004|NOT COMPLETED|Part A||5
3002380|NCT00966875|3719658|FG005|NOT COMPLETED|Part A||4
3002381|NCT00966875|3719659|FG006|NOT COMPLETED|Part A||12
3002382|NCT00966875|3719660|FG007|NOT COMPLETED|Part A||7
3002383|NCT00966875|3719661|FG008|NOT COMPLETED|Part A||8
3002384|NCT00966875|3719653|FG000|STARTED|Part B|Two (2) participants who completed Part A did not enter Part B.|46
3002385|NCT00966875|3719654|FG001|STARTED|Part B||36
3002386|NCT00966875|3719655|FG002|STARTED|Part B||33
3002387|NCT00966875|3719656|FG003|STARTED|Part B||34
3002388|NCT00966875|3719657|FG004|STARTED|Part B|One (1) participant who completed Part A did not enter Part B.|51
3002389|NCT00966875|3719658|FG005|STARTED|Part B|One (1) participant who completed Part A did not enter Part B.|32
3002390|NCT00966875|3719659|FG006|STARTED|Part B|One (1) participant who completed Part A did not enter Part B.|51
3002391|NCT00966875|3719660|FG007|STARTED|Part B|One (1) participant who completed Part A did not enter Part B.|57
3002392|NCT00966875|3719661|FG008|STARTED|Part B|One (1) participant who completed Part A did not enter Part B.|50
3002393|NCT00966875|3719653|FG000|COMPLETED|Part B||41
3002394|NCT00966875|3719654|FG001|COMPLETED|Part B||33
3002395|NCT00966875|3719655|FG002|COMPLETED|Part B||27
3002396|NCT00966875|3719656|FG003|COMPLETED|Part B||31
3002397|NCT00966875|3719657|FG004|COMPLETED|Part B||44
3002398|NCT00966875|3719658|FG005|COMPLETED|Part B||26
3002399|NCT00966875|3719659|FG006|COMPLETED|Part B||29
3002400|NCT00966875|3719660|FG007|COMPLETED|Part B||38
3002401|NCT00966875|3719661|FG008|COMPLETED|Part B||32
3002402|NCT00966875|3719653|FG000|NOT COMPLETED|Part B||5
3002403|NCT00966875|3719654|FG001|NOT COMPLETED|Part B||3
3002404|NCT00966875|3719655|FG002|NOT COMPLETED|Part B||6
3002405|NCT00966875|3719656|FG003|NOT COMPLETED|Part B||3
3002406|NCT00966875|3719657|FG004|NOT COMPLETED|Part B||7
3002407|NCT00966875|3719658|FG005|NOT COMPLETED|Part B||6
3002408|NCT00966875|3719659|FG006|NOT COMPLETED|Part B||22
3002409|NCT00966875|3719660|FG007|NOT COMPLETED|Part B||19
3002410|NCT00966875|3719661|FG008|NOT COMPLETED|Part B||18
3002411|NCT00966940|3719736|FG000|STARTED|Period 1, First 6 Weeks||28
3002412|NCT00966940|3719737|FG001|STARTED|Period 1, First 6 Weeks||23
3002413|NCT00966940|3719736|FG000|COMPLETED|Period 1, First 6 Weeks||25
3002414|NCT00966940|3719737|FG001|COMPLETED|Period 1, First 6 Weeks||23
3002415|NCT00966940|3719736|FG000|NOT COMPLETED|Period 1, First 6 Weeks||3
3002416|NCT00966940|3719737|FG001|NOT COMPLETED|Period 1, First 6 Weeks||0
3002417|NCT00966940|3719736|FG000|STARTED|Period 2, Second 6 Weeks||25
3002418|NCT00966940|3719737|FG001|STARTED|Period 2, Second 6 Weeks||23
3002419|NCT00966940|3719736|FG000|COMPLETED|Period 2, Second 6 Weeks||25
3002420|NCT00966940|3719737|FG001|COMPLETED|Period 2, Second 6 Weeks||23
3002421|NCT00966940|3719736|FG000|NOT COMPLETED|Period 2, Second 6 Weeks||0
3002422|NCT00966940|3719737|FG001|NOT COMPLETED|Period 2, Second 6 Weeks||0
3002423|NCT00967005|3719745|FG000|STARTED|Overall Study||13
3002424|NCT00967005|3719746|FG001|STARTED|Overall Study||15
3002425|NCT00967005|3719745|FG000|Treatment Completion|Overall Study||10
3002426|NCT00967005|3719746|FG001|Treatment Completion|Overall Study||10
3002427|NCT00967005|3719745|FG000|COMPLETED|Overall Study||6
3002428|NCT00967005|3719746|FG001|COMPLETED|Overall Study||5
3002429|NCT00967005|3719745|FG000|NOT COMPLETED|Overall Study||7
3002430|NCT00967005|3719746|FG001|NOT COMPLETED|Overall Study||10
3002431|NCT00967018|3719752|FG000|STARTED|Overall Study||77
3002432|NCT00967018|3719752|FG000|COMPLETED|Overall Study||56
3002433|NCT00967018|3719752|FG000|NOT COMPLETED|Overall Study||21
3002434|NCT00967044|3719756|FG000|STARTED|Overall Study||30
3002435|NCT00967044|3719756|FG000|COMPLETED|Overall Study||30
3002436|NCT00967044|3719756|FG000|NOT COMPLETED|Overall Study||0
3002437|NCT00967226|3719762|FG000|STARTED|Overall Study||11
3002438|NCT00967226|3719763|FG001|STARTED|Overall Study||8
3002439|NCT00967226|3719762|FG000|COMPLETED|Overall Study||9
3002440|NCT00967226|3719763|FG001|COMPLETED|Overall Study||2
3002441|NCT00967226|3719762|FG000|NOT COMPLETED|Overall Study||2
3002442|NCT00967226|3719763|FG001|NOT COMPLETED|Overall Study||6
3002443|NCT00967330|3719795|FG000|STARTED|Overall Study||122
3002444|NCT00967330|3719796|FG001|STARTED|Overall Study||60
3002445|NCT00967330|3719795|FG000|COMPLETED|Overall Study||0
3002446|NCT00967330|3719796|FG001|COMPLETED|Overall Study||0
3002447|NCT00967330|3719795|FG000|NOT COMPLETED|Overall Study||122
3002448|NCT00967330|3719796|FG001|NOT COMPLETED|Overall Study||60
3037139|NCT01147068|3756459|FG002|COMPLETED|Subjects That Received 1st Dose||55
3037140|NCT01147068|3756460|FG003|COMPLETED|Subjects That Received 1st Dose||56
3037141|NCT01147068|3756461|FG004|COMPLETED|Subjects That Received 1st Dose||56
3037142|NCT01147068|3756462|FG005|COMPLETED|Subjects That Received 1st Dose||53
3037143|NCT01147068|3756463|FG006|COMPLETED|Subjects That Received 1st Dose||55
3037144|NCT01147068|3756457|FG000|NOT COMPLETED|Subjects That Received 1st Dose||0
3037145|NCT01147068|3756458|FG001|NOT COMPLETED|Subjects That Received 1st Dose||0
3037146|NCT01147068|3756459|FG002|NOT COMPLETED|Subjects That Received 1st Dose||0
3037147|NCT01147068|3756460|FG003|NOT COMPLETED|Subjects That Received 1st Dose||0
3037148|NCT01147068|3756461|FG004|NOT COMPLETED|Subjects That Received 1st Dose||0
3037149|NCT01147068|3756462|FG005|NOT COMPLETED|Subjects That Received 1st Dose||0
3037150|NCT01147068|3756463|FG006|NOT COMPLETED|Subjects That Received 1st Dose||0
3037151|NCT01147068|3756457|FG000|STARTED|Subjects That Received 2nd Dose||60
3037152|NCT01147068|3756458|FG001|STARTED|Subjects That Received 2nd Dose||57
3037153|NCT01147068|3756459|FG002|STARTED|Subjects That Received 2nd Dose||55
3037154|NCT01147068|3756460|FG003|STARTED|Subjects That Received 2nd Dose||56
3037155|NCT01147068|3756461|FG004|STARTED|Subjects That Received 2nd Dose||56
3037156|NCT01147068|3756462|FG005|STARTED|Subjects That Received 2nd Dose||53
3037157|NCT01147068|3756463|FG006|STARTED|Subjects That Received 2nd Dose||55
3037158|NCT01147068|3756457|FG000|COMPLETED|Subjects That Received 2nd Dose||59
3037159|NCT01147068|3756458|FG001|COMPLETED|Subjects That Received 2nd Dose||52
3037160|NCT01147068|3756459|FG002|COMPLETED|Subjects That Received 2nd Dose||52
3037161|NCT01147068|3756460|FG003|COMPLETED|Subjects That Received 2nd Dose||56
3037162|NCT01147068|3756461|FG004|COMPLETED|Subjects That Received 2nd Dose||55
3037163|NCT01147068|3756462|FG005|COMPLETED|Subjects That Received 2nd Dose||51
3037164|NCT01147068|3756463|FG006|COMPLETED|Subjects That Received 2nd Dose||55
3037165|NCT01147068|3756457|FG000|NOT COMPLETED|Subjects That Received 2nd Dose||1
3037166|NCT01147068|3756458|FG001|NOT COMPLETED|Subjects That Received 2nd Dose||5
3037167|NCT01147068|3756459|FG002|NOT COMPLETED|Subjects That Received 2nd Dose||3
3037168|NCT01147068|3756460|FG003|NOT COMPLETED|Subjects That Received 2nd Dose||0
3037169|NCT01147068|3756461|FG004|NOT COMPLETED|Subjects That Received 2nd Dose||1
3037170|NCT01147068|3756462|FG005|NOT COMPLETED|Subjects That Received 2nd Dose||2
3037171|NCT01147068|3756463|FG006|NOT COMPLETED|Subjects That Received 2nd Dose||0
3037172|NCT01147068|3756457|FG000|STARTED|Subjects That Completed Safety Follow-up|Participants were eligible for follow-up regardless of number of doses received.|60
3037173|NCT01147068|3756458|FG001|STARTED|Subjects That Completed Safety Follow-up|One subject was ineligible, one subject did not complete the study, and the other data is unknown.|57
3037174|NCT01147068|3756459|FG002|STARTED|Subjects That Completed Safety Follow-up|Data on three subjects is unknown.|55
3037175|NCT01147068|3756460|FG003|STARTED|Subjects That Completed Safety Follow-up||56
3037176|NCT01147068|3756461|FG004|STARTED|Subjects That Completed Safety Follow-up|Data for one subject is unknown.|56
3037177|NCT01147068|3756462|FG005|STARTED|Subjects That Completed Safety Follow-up|One subject was lost to follow up and one subject did not complete the study.|53
3037178|NCT01147068|3756463|FG006|STARTED|Subjects That Completed Safety Follow-up||55
3037179|NCT01147068|3756457|FG000|COMPLETED|Subjects That Completed Safety Follow-up||59
3037180|NCT01147068|3756458|FG001|COMPLETED|Subjects That Completed Safety Follow-up||56
3037181|NCT01147068|3756459|FG002|COMPLETED|Subjects That Completed Safety Follow-up||55
3037182|NCT01147068|3756460|FG003|COMPLETED|Subjects That Completed Safety Follow-up||54
3037183|NCT01147068|3756461|FG004|COMPLETED|Subjects That Completed Safety Follow-up||56
3037184|NCT01147068|3756462|FG005|COMPLETED|Subjects That Completed Safety Follow-up||52
3037185|NCT01147068|3756463|FG006|COMPLETED|Subjects That Completed Safety Follow-up||54
3037186|NCT01147068|3756457|FG000|NOT COMPLETED|Subjects That Completed Safety Follow-up||1
3037187|NCT01147068|3756458|FG001|NOT COMPLETED|Subjects That Completed Safety Follow-up||1
3037188|NCT01147068|3756459|FG002|NOT COMPLETED|Subjects That Completed Safety Follow-up||0
3037189|NCT01147068|3756460|FG003|NOT COMPLETED|Subjects That Completed Safety Follow-up||2
3037190|NCT01147068|3756461|FG004|NOT COMPLETED|Subjects That Completed Safety Follow-up||0
3037191|NCT01147068|3756462|FG005|NOT COMPLETED|Subjects That Completed Safety Follow-up||1
3037192|NCT01147068|3756463|FG006|NOT COMPLETED|Subjects That Completed Safety Follow-up||1
3037193|NCT01147107|3756481|FG000|STARTED|Overall Study||39
3037194|NCT01147107|3756482|FG001|STARTED|Overall Study||41
3037195|NCT01147107|3756481|FG000|COMPLETED|Overall Study||33
3037196|NCT01147107|3756482|FG001|COMPLETED|Overall Study||40
3037197|NCT01147107|3756481|FG000|NOT COMPLETED|Overall Study||6
3037198|NCT01147107|3756482|FG001|NOT COMPLETED|Overall Study||1
3037199|NCT01147172|3756488|FG000|STARTED|Overall Study||100
3037200|NCT01147172|3756488|FG000|COMPLETED|Overall Study||96
3037201|NCT01147172|3756488|FG000|NOT COMPLETED|Overall Study||4
3037202|NCT01147250|3756496|FG000|STARTED|Overall Study||3034
3037203|NCT01147250|3756497|FG001|STARTED|Overall Study||3034
3037204|NCT01147250|3756496|FG000|Treated|Overall Study||3032
3037205|NCT01147250|3756497|FG001|Treated|Overall Study||3031
3037206|NCT01147250|3756496|FG000|COMPLETED|Overall Study||2924
3037207|NCT01147250|3756497|FG001|COMPLETED|Overall Study||2929
3002449|NCT00967343|3719802|FG000|STARTED|Overall Study||40
3002450|NCT00967343|3719802|FG000|COMPLETED|Overall Study||2
3002451|NCT00967343|3719802|FG000|NOT COMPLETED|Overall Study||38
3002452|NCT00967369|3719808|FG000|STARTED|Overall Study||10
3002453|NCT00967369|3719809|FG001|STARTED|Overall Study||10
3002454|NCT00967369|3719808|FG000|Relapsed|Overall Study||4
3002455|NCT00967369|3719809|FG001|Relapsed|Overall Study||7
3002456|NCT00967369|3719808|FG000|Refractory|Overall Study||6
3002457|NCT00967369|3719809|FG001|Refractory|Overall Study||3
3002458|NCT00967369|3719808|FG000|COMPLETED|Overall Study||10
3002459|NCT00967369|3719809|FG001|COMPLETED|Overall Study||10
3002460|NCT00967369|3719808|FG000|NOT COMPLETED|Overall Study||0
3002461|NCT00967369|3719809|FG001|NOT COMPLETED|Overall Study||0
3002462|NCT00967473|3719815|FG000|STARTED|Overall Study||15
3002463|NCT00967473|3719815|FG000|COMPLETED|Overall Study||15
3002464|NCT00967473|3719815|FG000|NOT COMPLETED|Overall Study||0
3002465|NCT00967486|3719821|FG000|STARTED|Overall Study||98
3002466|NCT00967486|3719822|FG001|STARTED|Overall Study||102
3002467|NCT00967486|3719821|FG000|COMPLETED|Overall Study||98
3002468|NCT00967486|3719822|FG001|COMPLETED|Overall Study||102
3002469|NCT00967486|3719821|FG000|NOT COMPLETED|Overall Study||0
3002470|NCT00967486|3719822|FG001|NOT COMPLETED|Overall Study||0
3002471|NCT00967499|3719830|FG000|STARTED|Overall Study||111
3002472|NCT00967499|3719831|FG001|STARTED|Overall Study||109
3002473|NCT00967499|3719830|FG000|Treated (Full Analysis Set)|Overall Study||48
3002474|NCT00967499|3719831|FG001|Treated (Full Analysis Set)|Overall Study||50
3002475|NCT00967499|3719830|FG000|COMPLETED|Overall Study||46
3002476|NCT00967499|3719831|FG001|COMPLETED|Overall Study||49
3002477|NCT00967499|3719830|FG000|NOT COMPLETED|Overall Study||65
3002478|NCT00967499|3719831|FG001|NOT COMPLETED|Overall Study||60
3002479|NCT00967551|3719839|FG000|STARTED|Overall Study||68
3002480|NCT00967551|3719840|FG001|STARTED|Overall Study||75
3002481|NCT00967551|3719839|FG000|COMPLETED|Overall Study||68
3002482|NCT00967551|3719840|FG001|COMPLETED|Overall Study||75
3002483|NCT00967551|3719839|FG000|NOT COMPLETED|Overall Study||0
3002484|NCT00967551|3719840|FG001|NOT COMPLETED|Overall Study||0
3002485|NCT00967616|3719848|FG000|STARTED|Overall Study||50
3002486|NCT00967616|3719849|FG001|STARTED|Overall Study||50
3002487|NCT00967616|3719848|FG000|COMPLETED|Overall Study||0
3002488|NCT00967616|3719849|FG001|COMPLETED|Overall Study||0
3002489|NCT00967616|3719848|FG000|NOT COMPLETED|Overall Study||50
3002490|NCT00967616|3719849|FG001|NOT COMPLETED|Overall Study||50
3002491|NCT00967668|3719858|FG000|STARTED|Overall Study||162
3002492|NCT00967668|3719859|FG001|STARTED|Overall Study||160
3002493|NCT00967668|3719860|FG002|STARTED|Overall Study||159
3002494|NCT00967668|3719858|FG000|3-mo Assessment|Overall Study||131
3002495|NCT00967668|3719859|FG001|3-mo Assessment|Overall Study||127
3002496|NCT00967668|3719860|FG002|3-mo Assessment|Overall Study||115
3002497|NCT00967668|3719858|FG000|Completed Year 1 - 12-mo Assessment|Overall Study||120
3002498|NCT00967668|3719859|FG001|Completed Year 1 - 12-mo Assessment|Overall Study||122
3002499|NCT00967668|3719860|FG002|Completed Year 1 - 12-mo Assessment|Overall Study||119
3002500|NCT00967668|3719858|FG000|18-mo Assessment|Overall Study||95
3002501|NCT00967668|3719859|FG001|18-mo Assessment|Overall Study||102
3002502|NCT00967668|3719860|FG002|18-mo Assessment|Overall Study||92
3002503|NCT00967668|3719858|FG000|COMPLETED|Overall Study||91
3002504|NCT00967668|3719859|FG001|COMPLETED|Overall Study||104
3002505|NCT00967668|3719860|FG002|COMPLETED|Overall Study||90
3002506|NCT00967668|3719858|FG000|NOT COMPLETED|Overall Study||71
3002507|NCT00967668|3719859|FG001|NOT COMPLETED|Overall Study||56
3002508|NCT00967668|3719860|FG002|NOT COMPLETED|Overall Study||69
3002509|NCT00967694|3719871|FG000|STARTED|Overall Study||26
3002510|NCT00967694|3719871|FG000|COMPLETED|Overall Study|5 discontinued during N2O administration due to agitation ⁄ dysphoria, one due to nausea⁄vomiting.|20
3002511|NCT00967694|3719871|FG000|NOT COMPLETED|Overall Study||6
3002512|NCT00967798|3719877|FG000|STARTED|Overall Study||17
3002513|NCT00967798|3719878|FG001|STARTED|Overall Study||16
3002514|NCT00967798|3719877|FG000|COMPLETED|Overall Study||8
3002515|NCT00967798|3719878|FG001|COMPLETED|Overall Study||13
3002516|NCT00967798|3719877|FG000|NOT COMPLETED|Overall Study||9
3002517|NCT00967798|3719878|FG001|NOT COMPLETED|Overall Study||3
3002518|NCT00967941|3719887|FG000|STARTED|Overall Study||67
3002519|NCT00967941|3719888|FG001|STARTED|Overall Study||54
3002520|NCT00967941|3719889|FG002|STARTED|Overall Study||60
3002521|NCT00967941|3719887|FG000|COMPLETED|Overall Study||62
3002522|NCT00967941|3719888|FG001|COMPLETED|Overall Study||51
3002523|NCT00967941|3719889|FG002|COMPLETED|Overall Study||56
3002524|NCT00967941|3719887|FG000|NOT COMPLETED|Overall Study||5
3002525|NCT00967941|3719888|FG001|NOT COMPLETED|Overall Study||3
3002526|NCT00967941|3719889|FG002|NOT COMPLETED|Overall Study||4
3002527|NCT00967993|3719897|FG000|STARTED|Overall Study||22
3002528|NCT00967993|3719897|FG000|COMPLETED|Overall Study||18
3002529|NCT00967993|3719897|FG000|NOT COMPLETED|Overall Study||4
3002530|NCT00968019|3719901|FG000|STARTED|Overall Study||318
3002531|NCT00968019|3719901|FG000|COMPLETED|Overall Study||303
3002532|NCT00968019|3719901|FG000|NOT COMPLETED|Overall Study||15
3002533|NCT00968032|3719905|FG000|STARTED|Overall Study||63
3002534|NCT00968032|3719905|FG000|COMPLETED|Overall Study|"1 patient not receiving investigational device due to failure in usage~1 patient denied latest FU"|61
3002535|NCT00968032|3719905|FG000|NOT COMPLETED|Overall Study||2
3002536|NCT00968071|3719909|FG000|STARTED|Overall Study||71
3002537|NCT00968071|3719909|FG000|COMPLETED|Overall Study||71
3002538|NCT00968071|3719909|FG000|NOT COMPLETED|Overall Study||0
3002539|NCT00968227|3719913|FG000|STARTED|Overall Study||56
3002540|NCT00968227|3719913|FG000|COMPLETED|Overall Study||56
3002541|NCT00968227|3719913|FG000|NOT COMPLETED|Overall Study||0
3002542|NCT00968253|3719920|FG000|STARTED|Overall Study||3
3002543|NCT00968253|3719921|FG001|STARTED|Overall Study||9
3002544|NCT00968253|3719922|FG002|STARTED|Overall Study||12
3002545|NCT00968253|3719920|FG000|COMPLETED|Overall Study||3
3002546|NCT00968253|3719921|FG001|COMPLETED|Overall Study||6
3002547|NCT00968253|3719922|FG002|COMPLETED|Overall Study||5
3002548|NCT00968253|3719920|FG000|NOT COMPLETED|Overall Study||0
3002549|NCT00968253|3719921|FG001|NOT COMPLETED|Overall Study||3
3002550|NCT00968253|3719922|FG002|NOT COMPLETED|Overall Study||7
3002551|NCT00968344|3719933|FG000|STARTED|Overall Study|Includes screen fails|20
3002552|NCT00968344|3719934|FG001|STARTED|Overall Study|Includes screen fails|20
3002553|NCT00968344|3719933|FG000|COMPLETED|Overall Study||10
3002554|NCT00968344|3719934|FG001|COMPLETED|Overall Study||9
3002555|NCT00968344|3719933|FG000|NOT COMPLETED|Overall Study||10
3002556|NCT00968344|3719934|FG001|NOT COMPLETED|Overall Study||11
3002557|NCT00968526|3719942|FG000|STARTED|Overall Study||138
3002558|NCT00968526|3719943|FG001|STARTED|Overall Study||102
3002559|NCT00968526|3719942|FG000|COMPLETED|Overall Study||135
3002560|NCT00968526|3719943|FG001|COMPLETED|Overall Study||102
3002561|NCT00968526|3719942|FG000|NOT COMPLETED|Overall Study||3
3002562|NCT00968526|3719943|FG001|NOT COMPLETED|Overall Study||0
3002563|NCT00968539|3719960|FG000|STARTED|Overall Study||64
3002564|NCT00968539|3719961|FG001|STARTED|Overall Study||66
3002565|NCT00968539|3719960|FG000|COMPLETED|Overall Study||63
3002566|NCT00968539|3719961|FG001|COMPLETED|Overall Study||66
3002567|NCT00968539|3719960|FG000|NOT COMPLETED|Overall Study||1
3002568|NCT00968539|3719961|FG001|NOT COMPLETED|Overall Study||0
3002569|NCT00968617|3719968|FG000|STARTED|Overall Study||7
3002570|NCT00968617|3719968|FG000|COMPLETED|Overall Study||1
3002571|NCT00968617|3719968|FG000|NOT COMPLETED|Overall Study||6
3002572|NCT00968669|3719976|FG000|STARTED|Overall Study||82
3002573|NCT00968669|3719977|FG001|STARTED|Overall Study||81
3002574|NCT00968669|3719978|FG002|STARTED|Overall Study||83
3002575|NCT00968669|3719979|FG003|STARTED|Overall Study||81
3002576|NCT00968669|3719976|FG000|COMPLETED|Overall Study||64
3002577|NCT00968669|3719977|FG001|COMPLETED|Overall Study||63
3002578|NCT00968669|3719978|FG002|COMPLETED|Overall Study||72
3002579|NCT00968669|3719979|FG003|COMPLETED|Overall Study||72
3002580|NCT00968669|3719976|FG000|NOT COMPLETED|Overall Study||18
3002581|NCT00968669|3719977|FG001|NOT COMPLETED|Overall Study||18
3002582|NCT00968669|3719978|FG002|NOT COMPLETED|Overall Study||11
3002583|NCT00968669|3719979|FG003|NOT COMPLETED|Overall Study||9
3002584|NCT00968708|3719991|FG000|STARTED|Overall Study||2679
3002585|NCT00968708|3719992|FG001|STARTED|Overall Study||2701
3002586|NCT00968708|3719991|FG000|Treated|Overall Study||2676
3002587|NCT00968708|3719992|FG001|Treated|Overall Study||2698
3002588|NCT00968708|3719991|FG000|COMPLETED|Overall Study||2361
3002589|NCT00968708|3719992|FG001|COMPLETED|Overall Study||2403
3002590|NCT00968708|3719991|FG000|NOT COMPLETED|Overall Study||318
3002591|NCT00968708|3719992|FG001|NOT COMPLETED|Overall Study||298
3002592|NCT00968799|3719998|FG000|STARTED|Overall Study||6
3002593|NCT00968799|3719998|FG000|COMPLETED|Overall Study||4
3002594|NCT00968799|3719998|FG000|NOT COMPLETED|Overall Study||2
3002595|NCT00968812|3720005|FG000|STARTED|Overall Study||483
3002596|NCT00968812|3720006|FG001|STARTED|Overall Study||485
3002597|NCT00968812|3720007|FG002|STARTED|Overall Study||482
3002598|NCT00968812|3720005|FG000|COMPLETED|Overall Study||343
3002599|NCT00968812|3720006|FG001|COMPLETED|Overall Study||323
3002600|NCT00968812|3720007|FG002|COMPLETED|Overall Study||314
3002601|NCT00968812|3720005|FG000|NOT COMPLETED|Overall Study||140
3002602|NCT00968812|3720006|FG001|NOT COMPLETED|Overall Study||162
3002603|NCT00968812|3720007|FG002|NOT COMPLETED|Overall Study||168
3002604|NCT00968838|3720020|FG000|STARTED|Overall Study||50
3002605|NCT00968838|3720021|FG001|STARTED|Overall Study||58
3002606|NCT00968838|3720020|FG000|COMPLETED|Overall Study||50
3002607|NCT00968838|3720021|FG001|COMPLETED|Overall Study||58
3002608|NCT00968838|3720020|FG000|NOT COMPLETED|Overall Study||0
3002609|NCT00968838|3720021|FG001|NOT COMPLETED|Overall Study||0
3002610|NCT00968864|3720027|FG000|STARTED|Overall Study|One patient, FDA and IRB approved to enroll as an exception, was not evaluable for study endpoints.|53
3002611|NCT00968864|3720027|FG000|COMPLETED|Overall Study||52
3002612|NCT00968864|3720027|FG000|NOT COMPLETED|Overall Study||1
3002613|NCT00968890|3720038|FG000|STARTED|Overall Study||84
3002614|NCT00968890|3720039|FG001|STARTED|Overall Study||84
3002615|NCT00968890|3720038|FG000|COMPLETED|Overall Study||84
3002616|NCT00968890|3720039|FG001|COMPLETED|Overall Study||84
3002617|NCT00968890|3720038|FG000|NOT COMPLETED|Overall Study||0
3002618|NCT00968890|3720039|FG001|NOT COMPLETED|Overall Study||0
3002619|NCT00968968|3720047|FG000|STARTED|Overall Study||20
3002620|NCT00968968|3720048|FG001|STARTED|Overall Study||17
3002621|NCT00968968|3720047|FG000|COMPLETED|Overall Study||4
3002622|NCT00968968|3720048|FG001|COMPLETED|Overall Study||3
3002623|NCT00968968|3720047|FG000|NOT COMPLETED|Overall Study||16
3002624|NCT00968968|3720048|FG001|NOT COMPLETED|Overall Study||14
3002625|NCT00968981|3720058|FG000|STARTED|Overall Study||23
3002626|NCT00968981|3720059|FG001|STARTED|Overall Study||22
3002627|NCT00968981|3720060|FG002|STARTED|Overall Study||22
3002628|NCT00968981|3720058|FG000|Pharmacokinetic(PK) Evaluable Population|Overall Study|Participants with sufficient data to ensure reliable estimation of PK for at least Day 1 PK profile.|20
3002629|NCT00968981|3720059|FG001|Pharmacokinetic(PK) Evaluable Population|Overall Study|Participants with sufficient data to ensure reliable estimation of PK for at least Day 1 PK profile.|21
3002630|NCT00968981|3720060|FG002|Pharmacokinetic(PK) Evaluable Population|Overall Study|Participants with sufficient data to ensure reliable estimation of PK for at least Day 1 PK profile.|22
3002631|NCT00968981|3720058|FG000|COMPLETED|Overall Study||1
3002632|NCT00968981|3720059|FG001|COMPLETED|Overall Study||0
3002633|NCT00968981|3720060|FG002|COMPLETED|Overall Study||0
3002634|NCT00968981|3720058|FG000|NOT COMPLETED|Overall Study||22
3002635|NCT00968981|3720059|FG001|NOT COMPLETED|Overall Study||22
3002636|NCT00968981|3720060|FG002|NOT COMPLETED|Overall Study||22
3002637|NCT00969124|3720069|FG000|STARTED|Overall Study||328
3002638|NCT00969124|3720069|FG000|COMPLETED|Overall Study||298
3002639|NCT00969124|3720069|FG000|NOT COMPLETED|Overall Study||30
3002640|NCT00969150|3720076|FG000|STARTED|Overall Study||182
3002641|NCT00969150|3720077|FG001|STARTED|Overall Study||175
3002642|NCT00969150|3720076|FG000|COMPLETED|Overall Study||149
3002643|NCT00969150|3720077|FG001|COMPLETED|Overall Study||135
3002644|NCT00969150|3720076|FG000|NOT COMPLETED|Overall Study||33
3002645|NCT00969150|3720077|FG001|NOT COMPLETED|Overall Study||40
3002646|NCT00969228|3720085|FG000|STARTED|Overall Study||508
3002647|NCT00969228|3720086|FG001|STARTED|Overall Study||176
3002648|NCT00969228|3720085|FG000|COMPLETED|Overall Study||465
3002649|NCT00969228|3720086|FG001|COMPLETED|Overall Study||162
3002650|NCT00969228|3720085|FG000|NOT COMPLETED|Overall Study||43
3002651|NCT00969228|3720086|FG001|NOT COMPLETED|Overall Study||14
3002652|NCT00969280|3720094|FG000|STARTED|Overall Study||21
3002653|NCT00969280|3720095|FG001|STARTED|Overall Study||21
3002654|NCT00969280|3720094|FG000|COMPLETED|Overall Study||19
3002655|NCT00969280|3720095|FG001|COMPLETED|Overall Study||18
3002656|NCT00969280|3720094|FG000|NOT COMPLETED|Overall Study||2
3002657|NCT00969280|3720095|FG001|NOT COMPLETED|Overall Study||3
3002658|NCT00969332|3720101|FG000|STARTED|Overall Study||62
3002659|NCT00969332|3720101|FG000|COMPLETED|Overall Study||51
3002660|NCT00969332|3720101|FG000|NOT COMPLETED|Overall Study||11
3002661|NCT00969436|3720109|FG000|STARTED|Overall Study||180
3002662|NCT00969436|3720110|FG001|STARTED|Overall Study||180
3002663|NCT00969436|3720111|FG002|STARTED|Overall Study||90
3002664|NCT00969436|3720109|FG000|COMPLETED|Overall Study||155
3002665|NCT00969436|3720110|FG001|COMPLETED|Overall Study||159
3002666|NCT00969436|3720111|FG002|COMPLETED|Overall Study||79
3002667|NCT00969436|3720109|FG000|NOT COMPLETED|Overall Study||25
3002668|NCT00969436|3720110|FG001|NOT COMPLETED|Overall Study||21
3002669|NCT00969436|3720111|FG002|NOT COMPLETED|Overall Study||11
3002670|NCT00969501|3720119|FG000|STARTED|Overall Study||32
3002671|NCT00969501|3720119|FG000|COMPLETED|Overall Study||27
3002672|NCT00969501|3720119|FG000|NOT COMPLETED|Overall Study||5
3002673|NCT00969540|3720125|FG000|STARTED|Overall Study||4
3002674|NCT00969540|3720126|FG001|STARTED|Overall Study||4
3002675|NCT00969540|3720125|FG000|COMPLETED|Overall Study||3
3002676|NCT00969540|3720126|FG001|COMPLETED|Overall Study||3
3002677|NCT00969540|3720125|FG000|NOT COMPLETED|Overall Study||1
3002678|NCT00969540|3720126|FG001|NOT COMPLETED|Overall Study||1
3002679|NCT00969553|3720153|FG000|STARTED|Overall Study||3
3002680|NCT00969553|3720154|FG001|STARTED|Overall Study||3
3002681|NCT00969553|3720155|FG002|STARTED|Overall Study||6
3002682|NCT00969553|3720156|FG003|STARTED|Overall Study||17
3002683|NCT00969553|3720157|FG004|STARTED|Overall Study||3
3002684|NCT00969553|3720158|FG005|STARTED|Overall Study||4
3002685|NCT00969553|3720159|FG006|STARTED|Overall Study||4
3002686|NCT00969553|3720160|FG007|STARTED|Overall Study||16
3002687|NCT00969553|3720161|FG008|STARTED|Overall Study||3
3002688|NCT00969553|3720153|FG000|COMPLETED|Overall Study||0
3002689|NCT00969553|3720154|FG001|COMPLETED|Overall Study||0
3002690|NCT00969553|3720155|FG002|COMPLETED|Overall Study||0
3002691|NCT00969553|3720156|FG003|COMPLETED|Overall Study|on-treatment at analysis data base lock date (27-Oct-2011)|1
3002692|NCT00969553|3720157|FG004|COMPLETED|Overall Study||0
3002693|NCT00969553|3720158|FG005|COMPLETED|Overall Study||0
3002694|NCT00969553|3720159|FG006|COMPLETED|Overall Study||0
3002695|NCT00969553|3720160|FG007|COMPLETED|Overall Study|on-treatment at analysis data base lock date (27-Oct-2011)|2
3002696|NCT00969553|3720161|FG008|COMPLETED|Overall Study||0
3002697|NCT00969553|3720153|FG000|NOT COMPLETED|Overall Study||3
3002698|NCT00969553|3720154|FG001|NOT COMPLETED|Overall Study||3
3002699|NCT00969553|3720155|FG002|NOT COMPLETED|Overall Study||6
3002700|NCT00969553|3720156|FG003|NOT COMPLETED|Overall Study||16
3002701|NCT00969553|3720157|FG004|NOT COMPLETED|Overall Study||3
3002702|NCT00969553|3720158|FG005|NOT COMPLETED|Overall Study||4
3002703|NCT00969553|3720159|FG006|NOT COMPLETED|Overall Study||4
3002704|NCT00969553|3720160|FG007|NOT COMPLETED|Overall Study||14
3002705|NCT00969553|3720161|FG008|NOT COMPLETED|Overall Study||3
3002706|NCT00969618|3720189|FG000|STARTED|Overall Study||211
3002707|NCT00969618|3720189|FG000|COMPLETED|Overall Study||133
3002708|NCT00969618|3720189|FG000|NOT COMPLETED|Overall Study||78
3002709|NCT00969709|3720197|FG000|STARTED|Overall Study||176
3002710|NCT00969709|3720198|FG001|STARTED|Overall Study||178
3002711|NCT00969709|3720199|FG002|STARTED|Overall Study||179
3002712|NCT00969709|3720200|FG003|STARTED|Overall Study||180
3002713|NCT00969709|3720197|FG000|COMPLETED|Overall Study||138
3002714|NCT00969709|3720198|FG001|COMPLETED|Overall Study||130
3002715|NCT00969709|3720199|FG002|COMPLETED|Overall Study||121
3002716|NCT00969709|3720200|FG003|COMPLETED|Overall Study||117
3002717|NCT00969709|3720197|FG000|NOT COMPLETED|Overall Study||38
3002718|NCT00969709|3720198|FG001|NOT COMPLETED|Overall Study||48
3002719|NCT00969709|3720199|FG002|NOT COMPLETED|Overall Study||58
3002720|NCT00969709|3720200|FG003|NOT COMPLETED|Overall Study||63
3002721|NCT00969761|3720226|FG000|STARTED|Discont. Before Start of Treat. Cycle 2||3
3002722|NCT00969761|3720227|FG001|STARTED|Discont. Before Start of Treat. Cycle 2||3
3002723|NCT00969761|3720228|FG002|STARTED|Discont. Before Start of Treat. Cycle 2||12
3002724|NCT00969761|3720229|FG003|STARTED|Discont. Before Start of Treat. Cycle 2||6
3002725|NCT00969761|3720230|FG004|STARTED|Discont. Before Start of Treat. Cycle 2||3
3002726|NCT00969761|3720231|FG005|STARTED|Discont. Before Start of Treat. Cycle 2||3
3002727|NCT00969761|3720232|FG006|STARTED|Discont. Before Start of Treat. Cycle 2||3
3002728|NCT00969761|3720233|FG007|STARTED|Discont. Before Start of Treat. Cycle 2||6
3002729|NCT00969761|3720234|FG008|STARTED|Discont. Before Start of Treat. Cycle 2||13
3002730|NCT00969761|3720235|FG009|STARTED|Discont. Before Start of Treat. Cycle 2||3
3002731|NCT00969761|3720236|FG010|STARTED|Discont. Before Start of Treat. Cycle 2||3
3002732|NCT00969761|3720237|FG011|STARTED|Discont. Before Start of Treat. Cycle 2||3
3002733|NCT00969761|3720226|FG000|COMPLETED|Discont. Before Start of Treat. Cycle 2||2
3002734|NCT00969761|3720227|FG001|COMPLETED|Discont. Before Start of Treat. Cycle 2||3
3002735|NCT00969761|3720228|FG002|COMPLETED|Discont. Before Start of Treat. Cycle 2||10
3002736|NCT00969761|3720229|FG003|COMPLETED|Discont. Before Start of Treat. Cycle 2||5
3002737|NCT00969761|3720230|FG004|COMPLETED|Discont. Before Start of Treat. Cycle 2||3
3002738|NCT00969761|3720231|FG005|COMPLETED|Discont. Before Start of Treat. Cycle 2||3
3002739|NCT00969761|3720232|FG006|COMPLETED|Discont. Before Start of Treat. Cycle 2||3
3002740|NCT00969761|3720233|FG007|COMPLETED|Discont. Before Start of Treat. Cycle 2||6
3002741|NCT00969761|3720234|FG008|COMPLETED|Discont. Before Start of Treat. Cycle 2||11
3002742|NCT00969761|3720235|FG009|COMPLETED|Discont. Before Start of Treat. Cycle 2||2
3002743|NCT00969761|3720236|FG010|COMPLETED|Discont. Before Start of Treat. Cycle 2||3
3002744|NCT00969761|3720237|FG011|COMPLETED|Discont. Before Start of Treat. Cycle 2||3
3002745|NCT00969761|3720226|FG000|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||1
3002746|NCT00969761|3720227|FG001|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||0
3002747|NCT00969761|3720228|FG002|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||2
3002748|NCT00969761|3720229|FG003|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||1
3002749|NCT00969761|3720230|FG004|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||0
3002750|NCT00969761|3720231|FG005|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||0
3002751|NCT00969761|3720232|FG006|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||0
3002752|NCT00969761|3720233|FG007|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||0
3002753|NCT00969761|3720234|FG008|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||2
3002754|NCT00969761|3720235|FG009|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||1
3002755|NCT00969761|3720236|FG010|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||0
3002756|NCT00969761|3720237|FG011|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||0
3002757|NCT00969761|3720226|FG000|STARTED|Treated in and Beyond Treat. Cycle 2||2
3002758|NCT00969761|3720227|FG001|STARTED|Treated in and Beyond Treat. Cycle 2||3
3002759|NCT00969761|3720228|FG002|STARTED|Treated in and Beyond Treat. Cycle 2||10
3002760|NCT00969761|3720229|FG003|STARTED|Treated in and Beyond Treat. Cycle 2||5
3002761|NCT00969761|3720230|FG004|STARTED|Treated in and Beyond Treat. Cycle 2||3
3002762|NCT00969761|3720231|FG005|STARTED|Treated in and Beyond Treat. Cycle 2||3
3002763|NCT00969761|3720232|FG006|STARTED|Treated in and Beyond Treat. Cycle 2||3
3002764|NCT00969761|3720233|FG007|STARTED|Treated in and Beyond Treat. Cycle 2||6
3002765|NCT00969761|3720234|FG008|STARTED|Treated in and Beyond Treat. Cycle 2||11
3002766|NCT00969761|3720235|FG009|STARTED|Treated in and Beyond Treat. Cycle 2||2
3002767|NCT00969761|3720236|FG010|STARTED|Treated in and Beyond Treat. Cycle 2||3
3002768|NCT00969761|3720237|FG011|STARTED|Treated in and Beyond Treat. Cycle 2||3
3002769|NCT00969761|3720226|FG000|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
3002770|NCT00969761|3720227|FG001|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
3002771|NCT00969761|3720228|FG002|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
3002772|NCT00969761|3720229|FG003|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
3002773|NCT00969761|3720230|FG004|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
3002774|NCT00969761|3720231|FG005|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
3002775|NCT00969761|3720232|FG006|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
3002776|NCT00969761|3720233|FG007|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
3002777|NCT00969761|3720234|FG008|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
3002778|NCT00969761|3720235|FG009|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
3002779|NCT00969761|3720236|FG010|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
3002780|NCT00969761|3720237|FG011|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
3002781|NCT00969761|3720226|FG000|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||2
3002782|NCT00969761|3720227|FG001|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||3
3002783|NCT00969761|3720228|FG002|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||10
3002784|NCT00969761|3720229|FG003|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||5
3002785|NCT00969761|3720230|FG004|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||3
3002786|NCT00969761|3720231|FG005|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||3
3002787|NCT00969761|3720232|FG006|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||3
3002788|NCT00969761|3720233|FG007|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||6
3002789|NCT00969761|3720234|FG008|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||11
3002790|NCT00969761|3720235|FG009|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||2
3002791|NCT00969761|3720236|FG010|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||3
3002792|NCT00969761|3720237|FG011|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||3
3002793|NCT00969878|3720265|FG000|STARTED|Overall Study||148
3002794|NCT00969878|3720266|FG001|STARTED|Overall Study||152
3002795|NCT00969878|3720265|FG000|COMPLETED|Overall Study||118
3002796|NCT00969878|3720266|FG001|COMPLETED|Overall Study||126
3002797|NCT00969878|3720265|FG000|NOT COMPLETED|Overall Study||30
3002798|NCT00969878|3720266|FG001|NOT COMPLETED|Overall Study||26
3002799|NCT00970073|3720277|FG000|STARTED|Overall Study||10
3002800|NCT00970073|3720278|FG001|STARTED|Overall Study||10
3002801|NCT00970073|3720279|FG002|STARTED|Overall Study||10
3002802|NCT00970073|3720277|FG000|COMPLETED|Overall Study||10
3002803|NCT00970073|3720278|FG001|COMPLETED|Overall Study||10
3002804|NCT00970073|3720279|FG002|COMPLETED|Overall Study||10
3002805|NCT00970073|3720277|FG000|NOT COMPLETED|Overall Study||0
3002806|NCT00970073|3720278|FG001|NOT COMPLETED|Overall Study||0
3002807|NCT00970073|3720279|FG002|NOT COMPLETED|Overall Study||0
3002808|NCT00970203|3720289|FG000|STARTED|Overall Study||7
3002809|NCT00970203|3720290|FG001|STARTED|Overall Study||6
3002810|NCT00970203|3720289|FG000|COMPLETED|Overall Study||7
3002811|NCT00970203|3720290|FG001|COMPLETED|Overall Study||6
3002812|NCT00970203|3720289|FG000|NOT COMPLETED|Overall Study||0
3002813|NCT00970203|3720290|FG001|NOT COMPLETED|Overall Study||0
3002814|NCT00970216|3720296|FG000|STARTED|Overall Study||160
3002815|NCT00970216|3720296|FG000|COMPLETED|Overall Study||80
3002816|NCT00970216|3720296|FG000|NOT COMPLETED|Overall Study||80
3002817|NCT00970268|3720302|FG000|STARTED|Overall Study||139
3002818|NCT00970268|3720303|FG001|STARTED|Overall Study||152
3002819|NCT00970268|3720302|FG000|COMPLETED|Overall Study||96
3002820|NCT00970268|3720303|FG001|COMPLETED|Overall Study||103
3002821|NCT00970268|3720302|FG000|NOT COMPLETED|Overall Study||43
3002822|NCT00970268|3720303|FG001|NOT COMPLETED|Overall Study||49
3002823|NCT00970281|3720317|FG000|STARTED|Overall Study||46
3002824|NCT00970281|3720318|FG001|STARTED|Overall Study||45
3002825|NCT00970281|3720317|FG000|Full Analysis Set|Overall Study|1 participant in the olanzapine arm discontinued before the first intramuscular (IM) injection.|45
3002826|NCT00970281|3720318|FG001|Full Analysis Set|Overall Study||45
3002827|NCT00970281|3720317|FG000|COMPLETED|Overall Study||44
3002828|NCT00970281|3720318|FG001|COMPLETED|Overall Study||29
3002829|NCT00970281|3720317|FG000|NOT COMPLETED|Overall Study||2
3002830|NCT00970281|3720318|FG001|NOT COMPLETED|Overall Study||16
3002831|NCT00970294|3720324|FG000|STARTED|Overall Study||11
3002832|NCT00970294|3720324|FG000|COMPLETED|Overall Study||6
3002833|NCT00970294|3720324|FG000|NOT COMPLETED|Overall Study||5
3002834|NCT00970307|3720331|FG000|STARTED|Overall Study||141
3002835|NCT00970307|3720332|FG001|STARTED|Overall Study||139
3002836|NCT00970307|3720333|FG002|STARTED|Overall Study||141
3002837|NCT00970307|3720331|FG000|COMPLETED|Overall Study||138
3002838|NCT00970307|3720332|FG001|COMPLETED|Overall Study||136
3002839|NCT00970307|3720333|FG002|COMPLETED|Overall Study||139
3002840|NCT00970307|3720331|FG000|NOT COMPLETED|Overall Study||3
3002841|NCT00970307|3720332|FG001|NOT COMPLETED|Overall Study||3
3002842|NCT00970307|3720333|FG002|NOT COMPLETED|Overall Study||2
3002843|NCT00970320|3720346|FG000|STARTED|Overall Study||25
3002844|NCT00970320|3720347|FG001|STARTED|Overall Study||24
3002845|NCT00970320|3720348|FG002|STARTED|Overall Study||48
3002846|NCT00970320|3720349|FG003|STARTED|Overall Study||50
3002847|NCT00970320|3720350|FG004|STARTED|Overall Study||1571
3002848|NCT00970320|3720346|FG000|COMPLETED|Overall Study||25
3002849|NCT00970320|3720347|FG001|COMPLETED|Overall Study||13
3002850|NCT00970320|3720348|FG002|COMPLETED|Overall Study||35
3002851|NCT00970320|3720349|FG003|COMPLETED|Overall Study||36
3002852|NCT00970320|3720350|FG004|COMPLETED|Overall Study||1031
3002853|NCT00970320|3720346|FG000|NOT COMPLETED|Overall Study||0
3002854|NCT00970320|3720347|FG001|NOT COMPLETED|Overall Study||11
3002855|NCT00970320|3720348|FG002|NOT COMPLETED|Overall Study||13
3002856|NCT00970320|3720349|FG003|NOT COMPLETED|Overall Study||14
3002857|NCT00970320|3720350|FG004|NOT COMPLETED|Overall Study||540
3002858|NCT00970359|3720362|FG000|STARTED|Overall Study||24
3002859|NCT00970359|3720362|FG000|COMPLETED|Overall Study||20
3002860|NCT00970359|3720362|FG000|NOT COMPLETED|Overall Study||4
3002861|NCT00970489|3720368|FG000|STARTED|Overall Study||758
3002862|NCT00970489|3720369|FG001|STARTED|Overall Study||758
3002863|NCT00970489|3720368|FG000|COMPLETED|Overall Study||704
3002864|NCT00970489|3720369|FG001|COMPLETED|Overall Study||717
3002865|NCT00970489|3720368|FG000|NOT COMPLETED|Overall Study||54
3164920|NCT01895855|3892424|FG000|COMPLETED|Overall Study||95
3164921|NCT01895855|3892425|FG001|COMPLETED|Overall Study||102
3002866|NCT00970489|3720369|FG001|NOT COMPLETED|Overall Study||41
3002867|NCT00970502|3720375|FG000|STARTED|Overall Study||15
3002868|NCT00970502|3720375|FG000|COMPLETED|Overall Study||14
3002869|NCT00970502|3720375|FG000|NOT COMPLETED|Overall Study||1
3002870|NCT00970593|3720390|FG000|STARTED|Overall Study||11
3002871|NCT00970593|3720391|FG001|STARTED|Overall Study||15
3002872|NCT00970593|3720392|FG002|STARTED|Overall Study||13
3002873|NCT00970593|3720393|FG003|STARTED|Overall Study||12
3002874|NCT00970593|3720394|FG004|STARTED|Overall Study||20
3002875|NCT00970593|3720395|FG005|STARTED|Overall Study||5
3002876|NCT00970593|3720396|FG006|STARTED|Overall Study||16
3002877|NCT00970593|3720390|FG000|COMPLETED|Overall Study||10
3002878|NCT00970593|3720391|FG001|COMPLETED|Overall Study||14
3002879|NCT00970593|3720392|FG002|COMPLETED|Overall Study||7
3002880|NCT00970593|3720393|FG003|COMPLETED|Overall Study||12
3002881|NCT00970593|3720394|FG004|COMPLETED|Overall Study||20
3002882|NCT00970593|3720395|FG005|COMPLETED|Overall Study||5
3002883|NCT00970593|3720396|FG006|COMPLETED|Overall Study||14
3002884|NCT00970593|3720390|FG000|NOT COMPLETED|Overall Study||1
3002885|NCT00970593|3720391|FG001|NOT COMPLETED|Overall Study||1
3002886|NCT00970593|3720392|FG002|NOT COMPLETED|Overall Study||6
3002887|NCT00970593|3720393|FG003|NOT COMPLETED|Overall Study||0
3002888|NCT00970593|3720394|FG004|NOT COMPLETED|Overall Study||0
3306547|NCT02999100|4039917|FG005|COMPLETED|Part 1 (up to 15 Days)||0
3306548|NCT02999100|4039912|FG000|NOT COMPLETED|Part 1 (up to 15 Days)||0
3002889|NCT00970593|3720395|FG005|NOT COMPLETED|Overall Study||0
3002890|NCT00970593|3720396|FG006|NOT COMPLETED|Overall Study||2
3002891|NCT00970632|3720419|FG000|STARTED|Overall Study||172
3002892|NCT00970632|3720420|FG001|STARTED|Overall Study||171
3002893|NCT00970632|3720421|FG002|STARTED|Overall Study||168
3002894|NCT00970632|3720419|FG000|COMPLETED|Overall Study||148
3002895|NCT00970632|3720420|FG001|COMPLETED|Overall Study||156
3002896|NCT00970632|3720421|FG002|COMPLETED|Overall Study||150
3002897|NCT00970632|3720419|FG000|NOT COMPLETED|Overall Study||24
3002898|NCT00970632|3720420|FG001|NOT COMPLETED|Overall Study||15
3002899|NCT00970632|3720421|FG002|NOT COMPLETED|Overall Study||18
3002900|NCT00970684|3720429|FG000|STARTED|Overall Study||13
3002901|NCT00970684|3720429|FG000|COMPLETED|Overall Study||3
3002902|NCT00970684|3720429|FG000|NOT COMPLETED|Overall Study||10
3002903|NCT00970814|3720435|FG000|STARTED|Overall Study||66
3002904|NCT00970814|3720436|FG001|STARTED|Overall Study||64
3002905|NCT00970814|3720435|FG000|COMPLETED|Overall Study||58
3002906|NCT00970814|3720436|FG001|COMPLETED|Overall Study||50
3002907|NCT00970814|3720435|FG000|NOT COMPLETED|Overall Study||8
3002908|NCT00970814|3720436|FG001|NOT COMPLETED|Overall Study||14
3002909|NCT00970853|3720444|FG000|STARTED|Overall Study||89
3002910|NCT00970853|3720445|FG001|STARTED|Overall Study||98
3002911|NCT00970853|3720444|FG000|COMPLETED|Overall Study||89
3002912|NCT00970853|3720445|FG001|COMPLETED|Overall Study||98
3002913|NCT00970853|3720444|FG000|NOT COMPLETED|Overall Study||0
3002914|NCT00970853|3720445|FG001|NOT COMPLETED|Overall Study||0
3002915|NCT00970944|3720453|FG000|STARTED|Overall Study||87
3002916|NCT00970944|3720454|FG001|STARTED|Overall Study||97
3002917|NCT00970944|3720453|FG000|COMPLETED|Overall Study||86
3002918|NCT00970944|3720454|FG001|COMPLETED|Overall Study||95
3002919|NCT00970944|3720453|FG000|NOT COMPLETED|Overall Study||1
3002920|NCT00970944|3720454|FG001|NOT COMPLETED|Overall Study||2
3002921|NCT00971048|3720465|FG000|STARTED|Overall Study||30
3002922|NCT00971048|3720466|FG001|STARTED|Overall Study||33
3002923|NCT00971048|3720467|FG002|STARTED|Overall Study||12
3002924|NCT00971048|3720468|FG003|STARTED|Overall Study||13
3002925|NCT00971048|3720465|FG000|COMPLETED|Overall Study||29
3002926|NCT00971048|3720466|FG001|COMPLETED|Overall Study||31
3002927|NCT00971048|3720467|FG002|COMPLETED|Overall Study||11
3002928|NCT00971048|3720468|FG003|COMPLETED|Overall Study||11
3002929|NCT00971048|3720465|FG000|NOT COMPLETED|Overall Study||1
3002930|NCT00971048|3720466|FG001|NOT COMPLETED|Overall Study||2
3002931|NCT00971048|3720467|FG002|NOT COMPLETED|Overall Study||1
3002932|NCT00971048|3720468|FG003|NOT COMPLETED|Overall Study||2
3002933|NCT00971178|3720483|FG000|STARTED|Overall Study||35
3002934|NCT00971178|3720484|FG001|STARTED|Overall Study||35
3002935|NCT00971178|3720485|FG002|STARTED|Overall Study||35
3002936|NCT00971178|3720483|FG000|COMPLETED|Overall Study||33
3002937|NCT00971178|3720484|FG001|COMPLETED|Overall Study||33
3002938|NCT00971178|3720485|FG002|COMPLETED|Overall Study||33
3002939|NCT00971178|3720483|FG000|NOT COMPLETED|Overall Study||2
3002940|NCT00971178|3720484|FG001|NOT COMPLETED|Overall Study||2
3002941|NCT00971178|3720485|FG002|NOT COMPLETED|Overall Study||2
3002942|NCT00971204|3720493|FG000|STARTED|Overall Study|100 enrolled participants|100
3002943|NCT00971204|3720493|FG000|Treated|Overall Study||86
3002944|NCT00971204|3720493|FG000|COMPLETED|Overall Study|86 participants were treated and of these 86, 76 completed the study.|76
3002945|NCT00971204|3720493|FG000|NOT COMPLETED|Overall Study||24
3002946|NCT00971243|3720502|FG000|STARTED|Double Blind Period||87
3002947|NCT00971243|3720503|FG001|STARTED|Double Blind Period||93
3002948|NCT00971243|3720504|FG002|STARTED|Double Blind Period||91
3002949|NCT00971243|3720505|FG003|STARTED|Double Blind Period|One subject who did not receive any study drug was excluded from the ITT|88
3002950|NCT00971243|3720506|FG004|STARTED|Double Blind Period||88
3002951|NCT00971243|3720502|FG000|COMPLETED|Double Blind Period||68
3002952|NCT00971243|3720503|FG001|COMPLETED|Double Blind Period||82
3002953|NCT00971243|3720504|FG002|COMPLETED|Double Blind Period||72
3002954|NCT00971243|3720505|FG003|COMPLETED|Double Blind Period||74
3002955|NCT00971243|3720506|FG004|COMPLETED|Double Blind Period||70
3002956|NCT00971243|3720502|FG000|NOT COMPLETED|Double Blind Period||19
3002957|NCT00971243|3720503|FG001|NOT COMPLETED|Double Blind Period||11
3002958|NCT00971243|3720504|FG002|NOT COMPLETED|Double Blind Period||19
3002959|NCT00971243|3720505|FG003|NOT COMPLETED|Double Blind Period||14
3002960|NCT00971243|3720506|FG004|NOT COMPLETED|Double Blind Period||18
3002961|NCT00971243|3720502|FG000|STARTED|Open-label Period||68
3002962|NCT00971243|3720503|FG001|STARTED|Open-label Period|One Subject did not entered because of the failure of inclusion/exclusion criteria.|81
3002963|NCT00971243|3720504|FG002|STARTED|Open-label Period|One Subject did not entered the Open-label Period because of the withdrawal of consent.|71
3002964|NCT00971243|3720505|FG003|STARTED|Open-label Period||74
3002965|NCT00971243|3720506|FG004|STARTED|Open-label Period||70
3002966|NCT00971243|3720502|FG000|COMPLETED|Open-label Period||60
3002967|NCT00971243|3720503|FG001|COMPLETED|Open-label Period||71
3002968|NCT00971243|3720504|FG002|COMPLETED|Open-label Period||66
3002969|NCT00971243|3720505|FG003|COMPLETED|Open-label Period||64
3002970|NCT00971243|3720506|FG004|COMPLETED|Open-label Period||64
3002971|NCT00971243|3720502|FG000|NOT COMPLETED|Open-label Period||8
3002972|NCT00971243|3720503|FG001|NOT COMPLETED|Open-label Period||10
3002973|NCT00971243|3720504|FG002|NOT COMPLETED|Open-label Period||5
3002974|NCT00971243|3720505|FG003|NOT COMPLETED|Open-label Period||10
3002975|NCT00971243|3720506|FG004|NOT COMPLETED|Open-label Period||6
3002976|NCT00971282|3720518|FG000|STARTED|Overall Study||30
3002977|NCT00971282|3720518|FG000|COMPLETED|Overall Study||30
3002978|NCT00971282|3720518|FG000|NOT COMPLETED|Overall Study||0
3002979|NCT00971295|3720524|FG000|STARTED|Overall Study||10
3002980|NCT00971295|3720525|FG001|STARTED|Overall Study||10
3002981|NCT00971295|3720524|FG000|COMPLETED|Overall Study||10
3002982|NCT00971295|3720525|FG001|COMPLETED|Overall Study||9
3002983|NCT00971295|3720524|FG000|NOT COMPLETED|Overall Study||0
3002984|NCT00971295|3720525|FG001|NOT COMPLETED|Overall Study||1
3002985|NCT00971321|3720533|FG000|STARTED|Up to Day 42||104
3002986|NCT00971321|3720534|FG001|STARTED|Up to Day 42||53
3002987|NCT00971321|3720533|FG000|COMPLETED|Up to Day 42||104
3002988|NCT00971321|3720534|FG001|COMPLETED|Up to Day 42||53
3002989|NCT00971321|3720533|FG000|NOT COMPLETED|Up to Day 42||0
3002990|NCT00971321|3720534|FG001|NOT COMPLETED|Up to Day 42||0
3002991|NCT00971321|3720533|FG000|STARTED|Up to Month 7||104
3002992|NCT00971321|3720534|FG001|STARTED|Up to Month 7||53
3002993|NCT00971321|3720533|FG000|COMPLETED|Up to Month 7||100
3002994|NCT00971321|3720534|FG001|COMPLETED|Up to Month 7||51
3002995|NCT00971321|3720533|FG000|NOT COMPLETED|Up to Month 7||4
3002996|NCT00971321|3720534|FG001|NOT COMPLETED|Up to Month 7||2
3002997|NCT00971321|3720533|FG000|STARTED|Up to Month 11-12||104
3002998|NCT00971321|3720534|FG001|STARTED|Up to Month 11-12||53
3002999|NCT00971321|3720533|FG000|COMPLETED|Up to Month 11-12||99
3003000|NCT00971321|3720534|FG001|COMPLETED|Up to Month 11-12||50
3003001|NCT00971321|3720533|FG000|NOT COMPLETED|Up to Month 11-12||5
3003002|NCT00971321|3720534|FG001|NOT COMPLETED|Up to Month 11-12||3
3003003|NCT00971425|3720542|FG000|STARTED|Overall Study||72
3003004|NCT00971425|3720543|FG001|STARTED|Overall Study||73
3003005|NCT00971425|3720542|FG000|COMPLETED|Overall Study||71
3003006|NCT00971425|3720543|FG001|COMPLETED|Overall Study||71
3164922|NCT01895855|3892424|FG000|NOT COMPLETED|Overall Study||0
3164923|NCT01895855|3892425|FG001|NOT COMPLETED|Overall Study||0
3164924|NCT01895946|3892437|FG000|STARTED|Overall Study||18
3164925|NCT01895946|3892438|FG001|STARTED|Overall Study||12
3164926|NCT01895946|3892437|FG000|COMPLETED|Overall Study||18
3164927|NCT01895946|3892438|FG001|COMPLETED|Overall Study||12
3164928|NCT01895946|3892437|FG000|NOT COMPLETED|Overall Study||0
3164929|NCT01895946|3892438|FG001|NOT COMPLETED|Overall Study||0
3164930|NCT01895972|3892444|FG000|STARTED|Overall Study||130
3164931|NCT01895972|3892444|FG000|COMPLETED|Overall Study||121
3164932|NCT01895972|3892444|FG000|NOT COMPLETED|Overall Study||9
3164933|NCT01896050|3892450|FG000|STARTED|Overall Study||93
3164934|NCT01896050|3892451|FG001|STARTED|Overall Study||22
3164935|NCT01896050|3892450|FG000|COMPLETED|Overall Study|This includes only patients who remained on the same aromatase inhibitor medication for 12 months|55
3164936|NCT01896050|3892451|FG001|COMPLETED|Overall Study||20
3164937|NCT01896050|3892450|FG000|NOT COMPLETED|Overall Study||38
3164938|NCT01896050|3892451|FG001|NOT COMPLETED|Overall Study||2
3164939|NCT01896115|3892461|FG000|STARTED|Overall Study||16
3003007|NCT00971425|3720542|FG000|NOT COMPLETED|Overall Study||1
3003008|NCT00971425|3720543|FG001|NOT COMPLETED|Overall Study||2
3003009|NCT00971620|3720551|FG000|STARTED|Overall Study||9
3003010|NCT00971620|3720552|FG001|STARTED|Overall Study||9
3164940|NCT01896115|3892462|FG001|STARTED|Overall Study||24
3164941|NCT01896115|3892461|FG000|Phase 1 Short PW|Overall Study||15
3164942|NCT01896115|3892462|FG001|Phase 1 Short PW|Overall Study||0
3164943|NCT01896115|3892461|FG000|Phase 1 Conventional PW|Overall Study||15
3164944|NCT01896115|3892462|FG001|Phase 1 Conventional PW|Overall Study||0
3164945|NCT01896115|3892461|FG000|Phase 1 Dorsal Steering|Overall Study||15
3164946|NCT01896115|3892462|FG001|Phase 1 Dorsal Steering|Overall Study||0
3164947|NCT01896115|3892461|FG000|Phase 1 Ventral Steering|Overall Study||15
3164948|NCT01896115|3892462|FG001|Phase 1 Ventral Steering|Overall Study||0
3164949|NCT01896115|3892461|FG000|Phase 2 Single Contact|Overall Study||0
3164950|NCT01896115|3892462|FG001|Phase 2 Single Contact|Overall Study||24
3003011|NCT00971620|3720551|FG000|COMPLETED|Overall Study||9
3003012|NCT00971620|3720552|FG001|COMPLETED|Overall Study||9
3003013|NCT00971620|3720551|FG000|NOT COMPLETED|Overall Study||0
3003014|NCT00971620|3720552|FG001|NOT COMPLETED|Overall Study||0
3003015|NCT00971633|3720558|FG000|STARTED|Period 1||2
3003016|NCT00971633|3720559|FG001|STARTED|Period 1||2
3003017|NCT00971633|3720560|FG002|STARTED|Period 1||2
3003018|NCT00971633|3720561|FG003|STARTED|Period 1||2
3003019|NCT00971633|3720562|FG004|STARTED|Period 1||2
3003020|NCT00971633|3720563|FG005|STARTED|Period 1||2
3003021|NCT00971633|3720558|FG000|COMPLETED|Period 1||2
3003022|NCT00971633|3720559|FG001|COMPLETED|Period 1||2
3003023|NCT00971633|3720560|FG002|COMPLETED|Period 1||2
3003024|NCT00971633|3720561|FG003|COMPLETED|Period 1||2
3003025|NCT00971633|3720562|FG004|COMPLETED|Period 1||2
3003026|NCT00971633|3720563|FG005|COMPLETED|Period 1||2
3003027|NCT00971633|3720558|FG000|NOT COMPLETED|Period 1||0
3003028|NCT00971633|3720559|FG001|NOT COMPLETED|Period 1||0
3003029|NCT00971633|3720560|FG002|NOT COMPLETED|Period 1||0
3003030|NCT00971633|3720561|FG003|NOT COMPLETED|Period 1||0
3003031|NCT00971633|3720562|FG004|NOT COMPLETED|Period 1||0
3003032|NCT00971633|3720563|FG005|NOT COMPLETED|Period 1||0
3003033|NCT00971633|3720558|FG000|STARTED|Period 2||2
3003034|NCT00971633|3720559|FG001|STARTED|Period 2||2
3003035|NCT00971633|3720560|FG002|STARTED|Period 2||2
3003036|NCT00971633|3720561|FG003|STARTED|Period 2||2
3003037|NCT00971633|3720562|FG004|STARTED|Period 2||2
3003038|NCT00971633|3720563|FG005|STARTED|Period 2||2
3003039|NCT00971633|3720558|FG000|COMPLETED|Period 2||2
3003040|NCT00971633|3720559|FG001|COMPLETED|Period 2||2
3003041|NCT00971633|3720560|FG002|COMPLETED|Period 2||2
3003042|NCT00971633|3720561|FG003|COMPLETED|Period 2||2
3003043|NCT00971633|3720562|FG004|COMPLETED|Period 2||2
3003044|NCT00971633|3720563|FG005|COMPLETED|Period 2||2
3003045|NCT00971633|3720558|FG000|NOT COMPLETED|Period 2||0
3003046|NCT00971633|3720559|FG001|NOT COMPLETED|Period 2||0
3003047|NCT00971633|3720560|FG002|NOT COMPLETED|Period 2||0
3003048|NCT00971633|3720561|FG003|NOT COMPLETED|Period 2||0
3003049|NCT00971633|3720562|FG004|NOT COMPLETED|Period 2||0
3003050|NCT00971633|3720563|FG005|NOT COMPLETED|Period 2||0
3003051|NCT00971633|3720558|FG000|STARTED|Period 3||2
3003052|NCT00971633|3720559|FG001|STARTED|Period 3||2
3003053|NCT00971633|3720560|FG002|STARTED|Period 3||2
3003054|NCT00971633|3720561|FG003|STARTED|Period 3||2
3003055|NCT00971633|3720562|FG004|STARTED|Period 3||2
3003056|NCT00971633|3720563|FG005|STARTED|Period 3||2
3306549|NCT02999100|4039913|FG001|NOT COMPLETED|Part 1 (up to 15 Days)||1
3306550|NCT02999100|4039914|FG002|NOT COMPLETED|Part 1 (up to 15 Days)||0
3306551|NCT02999100|4039915|FG003|NOT COMPLETED|Part 1 (up to 15 Days)||0
3306552|NCT02999100|4039916|FG004|NOT COMPLETED|Part 1 (up to 15 Days)||0
3306553|NCT02999100|4039917|FG005|NOT COMPLETED|Part 1 (up to 15 Days)||0
3306554|NCT02999100|4039912|FG000|STARTED|Part 2 (Day 1): Dosing Session 1|Participants from Part 1 did not enter Part 2|0
3003057|NCT00971633|3720558|FG000|COMPLETED|Period 3||2
3003058|NCT00971633|3720559|FG001|COMPLETED|Period 3||2
3003059|NCT00971633|3720560|FG002|COMPLETED|Period 3||2
3164951|NCT01896115|3892461|FG000|Phase 2 Steering|Overall Study||0
3164952|NCT01896115|3892462|FG001|Phase 2 Steering|Overall Study||24
3164953|NCT01896115|3892461|FG000|COMPLETED|Overall Study||15
3164954|NCT01896115|3892462|FG001|COMPLETED|Overall Study||24
3164955|NCT01896115|3892461|FG000|NOT COMPLETED|Overall Study||1
3164956|NCT01896115|3892462|FG001|NOT COMPLETED|Overall Study||0
3164957|NCT01896128|3892475|FG000|STARTED|Overall Study||8
3164958|NCT01896128|3892476|FG001|STARTED|Overall Study||11
3164959|NCT01896128|3892475|FG000|COMPLETED|Overall Study||5
3164960|NCT01896128|3892476|FG001|COMPLETED|Overall Study||8
3164961|NCT01896128|3892475|FG000|NOT COMPLETED|Overall Study||3
3164962|NCT01896128|3892476|FG001|NOT COMPLETED|Overall Study||3
3003060|NCT00971633|3720561|FG003|COMPLETED|Period 3||2
3003061|NCT00971633|3720562|FG004|COMPLETED|Period 3||2
3003062|NCT00971633|3720563|FG005|COMPLETED|Period 3||2
3003063|NCT00971633|3720558|FG000|NOT COMPLETED|Period 3||0
3003064|NCT00971633|3720559|FG001|NOT COMPLETED|Period 3||0
3003065|NCT00971633|3720560|FG002|NOT COMPLETED|Period 3||0
3003066|NCT00971633|3720561|FG003|NOT COMPLETED|Period 3||0
3003067|NCT00971633|3720562|FG004|NOT COMPLETED|Period 3||0
3003068|NCT00971633|3720563|FG005|NOT COMPLETED|Period 3||0
3003069|NCT00971737|3720573|FG000|STARTED|Overall Study||30
3003070|NCT00971737|3720574|FG001|STARTED|Overall Study||30
3003071|NCT00971737|3720573|FG000|COMPLETED|Overall Study||30
3003072|NCT00971737|3720574|FG001|COMPLETED|Overall Study||30
3003073|NCT00971737|3720573|FG000|NOT COMPLETED|Overall Study||0
3003074|NCT00971737|3720574|FG001|NOT COMPLETED|Overall Study||0
3003075|NCT00971750|3720580|FG000|STARTED|Overall Study||253
3003076|NCT00971750|3720580|FG000|COMPLETED|Overall Study||253
3003077|NCT00971750|3720580|FG000|NOT COMPLETED|Overall Study||0
3003078|NCT00971789|3720586|FG000|STARTED|Overall Study||18
3003079|NCT00971789|3720586|FG000|COMPLETED|Overall Study||18
3003080|NCT00971789|3720586|FG000|NOT COMPLETED|Overall Study||0
3003081|NCT00971841|3720590|FG000|STARTED|Overall Study||1
3003082|NCT00971841|3720590|FG000|COMPLETED|Overall Study||1
3003083|NCT00971841|3720590|FG000|NOT COMPLETED|Overall Study||0
3003084|NCT00971932|3720594|FG000|STARTED|Overall Study|Number of participants treated.|33
3003085|NCT00971932|3720594|FG000|COMPLETED|Overall Study||26
3003086|NCT00971932|3720594|FG000|NOT COMPLETED|Overall Study||7
3003087|NCT00971945|3720598|FG000|STARTED|Overall Study||6
3003088|NCT00971945|3720598|FG000|COMPLETED|Overall Study||0
3003089|NCT00971945|3720598|FG000|NOT COMPLETED|Overall Study||6
3003090|NCT00971997|3720602|FG000|STARTED|Overall Study||135
3003091|NCT00971997|3720602|FG000|COMPLETED|Overall Study||116
3003092|NCT00971997|3720602|FG000|NOT COMPLETED|Overall Study||19
3003093|NCT00972088|3720609|FG000|STARTED|Overall Study||26
3003094|NCT00972088|3720609|FG000|COMPLETED|Overall Study||26
3003095|NCT00972088|3720609|FG000|NOT COMPLETED|Overall Study||0
3003096|NCT00972153|3720616|FG000|STARTED|Overall Study||12
3003097|NCT00972153|3720617|FG001|STARTED|Overall Study||12
3003098|NCT00972153|3720618|FG002|STARTED|Overall Study||12
3164963|NCT01896193|3892486|FG000|STARTED|Overall Study||62
3003099|NCT00972153|3720616|FG000|COMPLETED|Overall Study||12
3003100|NCT00972153|3720617|FG001|COMPLETED|Overall Study|One case excluded due to technical problem with measuring equipment.|11
3003101|NCT00972153|3720618|FG002|COMPLETED|Overall Study||12
3003102|NCT00972153|3720616|FG000|NOT COMPLETED|Overall Study||0
3003103|NCT00972153|3720617|FG001|NOT COMPLETED|Overall Study||1
3003104|NCT00972153|3720618|FG002|NOT COMPLETED|Overall Study||0
3003105|NCT00972205|3720626|FG000|STARTED|Overall Study||12
3003106|NCT00972205|3720626|FG000|COMPLETED|Overall Study||12
3003107|NCT00972205|3720626|FG000|NOT COMPLETED|Overall Study||0
3003108|NCT00972244|3720635|FG000|STARTED|Overall Study||59
3003109|NCT00972244|3720636|FG001|STARTED|Overall Study||56
3003110|NCT00972244|3720637|FG002|STARTED|Overall Study||58
3003111|NCT00972244|3720638|FG003|STARTED|Overall Study||52
3003112|NCT00972244|3720639|FG004|STARTED|Overall Study||54
3003113|NCT00972244|3720635|FG000|COMPLETED|Overall Study||54
3003114|NCT00972244|3720636|FG001|COMPLETED|Overall Study||51
3003115|NCT00972244|3720637|FG002|COMPLETED|Overall Study||56
3003116|NCT00972244|3720638|FG003|COMPLETED|Overall Study||52
3003117|NCT00972244|3720639|FG004|COMPLETED|Overall Study||45
3003118|NCT00972244|3720635|FG000|NOT COMPLETED|Overall Study||5
3003119|NCT00972244|3720636|FG001|NOT COMPLETED|Overall Study||5
3003120|NCT00972244|3720637|FG002|NOT COMPLETED|Overall Study||2
3003121|NCT00972244|3720638|FG003|NOT COMPLETED|Overall Study||0
3003122|NCT00972244|3720639|FG004|NOT COMPLETED|Overall Study||9
3003123|NCT00972283|3720653|FG000|STARTED|Main: Week 0 to 52 (NN1250-3582)||755
3003124|NCT00972283|3720654|FG001|STARTED|Main: Week 0 to 52 (NN1250-3582)||251
3003125|NCT00972283|3720653|FG000|Full Analysis Set|Main: Week 0 to 52 (NN1250-3582)|11 subjects were excluded due to closure of a site|744
3003126|NCT00972283|3720654|FG001|Full Analysis Set|Main: Week 0 to 52 (NN1250-3582)|3 subjects were excluded due to closure of a site|248
3003127|NCT00972283|3720653|FG000|Exposed|Main: Week 0 to 52 (NN1250-3582)|2 subjects were withdrawn prior to exposure to trial products|753
3003128|NCT00972283|3720654|FG001|Exposed|Main: Week 0 to 52 (NN1250-3582)||251
3003129|NCT00972283|3720653|FG000|COMPLETED|Main: Week 0 to 52 (NN1250-3582)||618
3003130|NCT00972283|3720654|FG001|COMPLETED|Main: Week 0 to 52 (NN1250-3582)||211
3003131|NCT00972283|3720653|FG000|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3582)||137
3003132|NCT00972283|3720654|FG001|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3582)||40
3003133|NCT00972283|3720653|FG000|STARTED|Extension: Week 53 to 78 (NN1250-3667)|52 subjects did not continue into the extension from main trial|566
3003134|NCT00972283|3720654|FG001|STARTED|Extension: Week 53 to 78 (NN1250-3667)|20 subjects did not continue into the extension from main trial|191
3003135|NCT00972283|3720653|FG000|COMPLETED|Extension: Week 53 to 78 (NN1250-3667)||539
3003136|NCT00972283|3720654|FG001|COMPLETED|Extension: Week 53 to 78 (NN1250-3667)||183
3003137|NCT00972283|3720653|FG000|NOT COMPLETED|Extension: Week 53 to 78 (NN1250-3667)||27
3003138|NCT00972283|3720654|FG001|NOT COMPLETED|Extension: Week 53 to 78 (NN1250-3667)||8
3003139|NCT00972322|3720662|FG000|STARTED|Overall Study||28
3003140|NCT00972322|3720663|FG001|STARTED|Overall Study||28
3003141|NCT00972322|3720662|FG000|COMPLETED|Overall Study||25
3003142|NCT00972322|3720663|FG001|COMPLETED|Overall Study||25
3003143|NCT00972322|3720662|FG000|NOT COMPLETED|Overall Study||3
3003144|NCT00972322|3720663|FG001|NOT COMPLETED|Overall Study||3
3003145|NCT00972335|3720669|FG000|STARTED|Overall Study|One patient was enrolled but showed no evidence of disease at study entry and was not treated|17
3003146|NCT00972335|3720669|FG000|COMPLETED|Overall Study|Patients were on study until an event or condition occured which required them to come off study|0
3003147|NCT00972335|3720669|FG000|NOT COMPLETED|Overall Study||17
3003148|NCT00972374|3720676|FG000|STARTED|Overall Study||15
3003149|NCT00972374|3720677|FG001|STARTED|Overall Study||15
3003150|NCT00972374|3720678|FG002|STARTED|Overall Study||14
3003151|NCT00972374|3720676|FG000|COMPLETED|Overall Study||13
3003152|NCT00972374|3720677|FG001|COMPLETED|Overall Study||15
3003153|NCT00972374|3720678|FG002|COMPLETED|Overall Study||13
3003154|NCT00972374|3720676|FG000|NOT COMPLETED|Overall Study||2
3003155|NCT00972374|3720677|FG001|NOT COMPLETED|Overall Study||0
3003156|NCT00972374|3720678|FG002|NOT COMPLETED|Overall Study||1
3003157|NCT00972439|3720688|FG000|STARTED|Overall Study||17
3003158|NCT00972439|3720689|FG001|STARTED|Overall Study||16
3003159|NCT00972439|3720688|FG000|COMPLETED|Overall Study||17
3003160|NCT00972439|3720689|FG001|COMPLETED|Overall Study||16
3003161|NCT00972439|3720688|FG000|NOT COMPLETED|Overall Study||0
3003162|NCT00972439|3720689|FG001|NOT COMPLETED|Overall Study||0
3003163|NCT00972478|3720697|FG000|STARTED|Overall Study||11
3003164|NCT00972478|3720698|FG001|STARTED|Overall Study||72
3003165|NCT00972478|3720697|FG000|Eligible and Began Protocol Therapy|Overall Study||9
3003166|NCT00972478|3720698|FG001|Eligible and Began Protocol Therapy|Overall Study||63
3003167|NCT00972478|3720697|FG000|COMPLETED|Overall Study||4
3003168|NCT00972478|3720698|FG001|COMPLETED|Overall Study||34
3003169|NCT00972478|3720697|FG000|NOT COMPLETED|Overall Study||7
3003170|NCT00972478|3720698|FG001|NOT COMPLETED|Overall Study||38
3003171|NCT00972504|3720705|FG000|STARTED|Overall Study||54
3003172|NCT00972504|3720705|FG000|COMPLETED|Overall Study||51
3003173|NCT00972504|3720705|FG000|NOT COMPLETED|Overall Study||3
3003174|NCT00972517|3720715|FG000|STARTED|Overall Study||31
3003175|NCT00972517|3720716|FG001|STARTED|Overall Study||31
3003176|NCT00972517|3720717|FG002|STARTED|Overall Study||60
3003177|NCT00972517|3720718|FG003|STARTED|Overall Study||30
3003178|NCT00972517|3720719|FG004|STARTED|Overall Study||34
3003179|NCT00972517|3720720|FG005|STARTED|Overall Study||58
3003180|NCT00972517|3720715|FG000|COMPLETED|Overall Study||31
3003181|NCT00972517|3720716|FG001|COMPLETED|Overall Study||30
3003182|NCT00972517|3720717|FG002|COMPLETED|Overall Study||60
3003183|NCT00972517|3720718|FG003|COMPLETED|Overall Study||27
3003184|NCT00972517|3720719|FG004|COMPLETED|Overall Study||33
3003185|NCT00972517|3720720|FG005|COMPLETED|Overall Study||58
3003186|NCT00972517|3720715|FG000|NOT COMPLETED|Overall Study||0
3003187|NCT00972517|3720716|FG001|NOT COMPLETED|Overall Study||1
3003188|NCT00972517|3720717|FG002|NOT COMPLETED|Overall Study||0
3003189|NCT00972517|3720718|FG003|NOT COMPLETED|Overall Study||3
3003190|NCT00972517|3720719|FG004|NOT COMPLETED|Overall Study||1
3003191|NCT00972517|3720720|FG005|NOT COMPLETED|Overall Study||0
3003192|NCT00972530|3720742|FG000|STARTED|Overall Study||44
3003193|NCT00972530|3720743|FG001|STARTED|Overall Study||46
3003194|NCT00972530|3720742|FG000|COMPLETED|Overall Study||44
3003195|NCT00972530|3720743|FG001|COMPLETED|Overall Study||46
3003196|NCT00972530|3720742|FG000|NOT COMPLETED|Overall Study||0
3003197|NCT00972530|3720743|FG001|NOT COMPLETED|Overall Study||0
3003198|NCT00972543|3720751|FG000|STARTED|Overall Study||5
3003199|NCT00972543|3720752|FG001|STARTED|Overall Study||1
3003200|NCT00972543|3720751|FG000|COMPLETED|Overall Study||0
3003201|NCT00972543|3720752|FG001|COMPLETED|Overall Study||0
3003202|NCT00972543|3720751|FG000|NOT COMPLETED|Overall Study||5
3003203|NCT00972543|3720752|FG001|NOT COMPLETED|Overall Study||1
3003204|NCT00972595|3720758|FG000|STARTED|Period 1||23
3003205|NCT00972595|3720759|FG001|STARTED|Period 1||22
3003206|NCT00972595|3720758|FG000|COMPLETED|Period 1||22
3003207|NCT00972595|3720759|FG001|COMPLETED|Period 1||22
3003208|NCT00972595|3720758|FG000|NOT COMPLETED|Period 1||1
3003209|NCT00972595|3720759|FG001|NOT COMPLETED|Period 1||0
3003210|NCT00972595|3720758|FG000|STARTED|Period 2||22
3003211|NCT00972595|3720759|FG001|STARTED|Period 2||22
3003212|NCT00972595|3720758|FG000|COMPLETED|Period 2||22
3003213|NCT00972595|3720759|FG001|COMPLETED|Period 2||22
3003214|NCT00972595|3720758|FG000|NOT COMPLETED|Period 2||0
3003215|NCT00972595|3720759|FG001|NOT COMPLETED|Period 2||0
3003216|NCT00972621|3720767|FG000|STARTED|Overall Study||200
3003217|NCT00972621|3720768|FG001|STARTED|Overall Study||200
3003218|NCT00972621|3720767|FG000|COMPLETED|Overall Study||200
3003219|NCT00972621|3720768|FG001|COMPLETED|Overall Study|One subject discontinued due to lens exchange.|199
3003220|NCT00972621|3720767|FG000|NOT COMPLETED|Overall Study||0
3003221|NCT00972621|3720768|FG001|NOT COMPLETED|Overall Study||1
3003222|NCT00972725|3720776|FG000|STARTED|Overall Study||13
3003223|NCT00972725|3720777|FG001|STARTED|Overall Study||15
3003224|NCT00972725|3720776|FG000|COMPLETED|Overall Study||13
3003225|NCT00972725|3720777|FG001|COMPLETED|Overall Study||15
3003226|NCT00972725|3720776|FG000|NOT COMPLETED|Overall Study||0
3003227|NCT00972725|3720777|FG001|NOT COMPLETED|Overall Study||0
3003228|NCT00972777|3720785|FG000|STARTED|Overall Study||231
3003229|NCT00972777|3720786|FG001|STARTED|Overall Study||243
3003230|NCT00972777|3720785|FG000|COMPLETED|Overall Study||217
3003231|NCT00972777|3720786|FG001|COMPLETED|Overall Study||229
3003232|NCT00972777|3720785|FG000|NOT COMPLETED|Overall Study||14
3003233|NCT00972777|3720786|FG001|NOT COMPLETED|Overall Study||14
3003234|NCT00972816|3720800|FG000|STARTED|Overall Study||173
3003235|NCT00972816|3720801|FG001|STARTED|Overall Study||169
3003236|NCT00972816|3720802|FG002|STARTED|Overall Study||169
3003237|NCT00972816|3720803|FG003|STARTED|Overall Study||169
3003238|NCT00972816|3720804|FG004|STARTED|Overall Study||169
3003239|NCT00972816|3720805|FG005|STARTED|Overall Study||169
3003240|NCT00972816|3720806|FG006|STARTED|Overall Study||169
3003241|NCT00972816|3720807|FG007|STARTED|Overall Study||170
3003242|NCT00972816|3720800|FG000|COMPLETED|Overall Study||156
3003243|NCT00972816|3720801|FG001|COMPLETED|Overall Study||158
3003244|NCT00972816|3720802|FG002|COMPLETED|Overall Study||160
3003245|NCT00972816|3720803|FG003|COMPLETED|Overall Study||161
3003246|NCT00972816|3720804|FG004|COMPLETED|Overall Study||157
3003247|NCT00972816|3720805|FG005|COMPLETED|Overall Study||158
3003248|NCT00972816|3720806|FG006|COMPLETED|Overall Study||159
3003249|NCT00972816|3720807|FG007|COMPLETED|Overall Study||161
3003250|NCT00972816|3720800|FG000|NOT COMPLETED|Overall Study||17
3003251|NCT00972816|3720801|FG001|NOT COMPLETED|Overall Study||11
3003252|NCT00972816|3720802|FG002|NOT COMPLETED|Overall Study||9
3003253|NCT00972816|3720803|FG003|NOT COMPLETED|Overall Study||8
3003254|NCT00972816|3720804|FG004|NOT COMPLETED|Overall Study||12
3003255|NCT00972816|3720805|FG005|NOT COMPLETED|Overall Study||11
3003256|NCT00972816|3720806|FG006|NOT COMPLETED|Overall Study||10
3003257|NCT00972816|3720807|FG007|NOT COMPLETED|Overall Study||9
3003258|NCT00972959|3720825|FG000|STARTED|Overall Study||17
3003259|NCT00972959|3720825|FG000|COMPLETED|Overall Study||17
3003260|NCT00972959|3720825|FG000|NOT COMPLETED|Overall Study||0
3003261|NCT00973102|3720831|FG000|STARTED|Overall Study||24
3003262|NCT00973102|3720832|FG001|STARTED|Overall Study||26
3003263|NCT00973102|3720831|FG000|COMPLETED|Overall Study||23
3003264|NCT00973102|3720832|FG001|COMPLETED|Overall Study||25
3003265|NCT00973102|3720831|FG000|NOT COMPLETED|Overall Study||1
3164964|NCT01896193|3892487|FG001|STARTED|Overall Study||65
3164965|NCT01896193|3892486|FG000|COMPLETED|Overall Study||41
3164966|NCT01896193|3892487|FG001|COMPLETED|Overall Study||53
3164967|NCT01896193|3892486|FG000|NOT COMPLETED|Overall Study||21
3164968|NCT01896193|3892487|FG001|NOT COMPLETED|Overall Study||12
3003266|NCT00973102|3720832|FG001|NOT COMPLETED|Overall Study||1
3003267|NCT00973349|3720854|FG000|STARTED|Overall Study||170
3003268|NCT00973349|3720855|FG001|STARTED|Overall Study||168
3003269|NCT00973349|3720856|FG002|STARTED|Overall Study||171
3003270|NCT00973349|3720857|FG003|STARTED|Overall Study||168
3003271|NCT00973349|3720858|FG004|STARTED|Overall Study||170
3003272|NCT00973349|3720859|FG005|STARTED|Overall Study||169
3003273|NCT00973349|3720860|FG006|STARTED|Overall Study||174
3003274|NCT00973349|3720861|FG007|STARTED|Overall Study||169
3003275|NCT00973349|3720862|FG008|STARTED|Overall Study||171
3003276|NCT00973349|3720863|FG009|STARTED|Overall Study||169
3003277|NCT00973349|3720864|FG010|STARTED|Overall Study||174
3003278|NCT00973349|3720865|FG011|STARTED|Overall Study||169
3003279|NCT00973349|3720866|FG012|STARTED|Overall Study||169
3003280|NCT00973349|3720867|FG013|STARTED|Overall Study||171
3003281|NCT00973349|3720868|FG014|STARTED|Overall Study||170
3003282|NCT00973349|3720869|FG015|STARTED|Overall Study||167
3003283|NCT00973349|3720854|FG000|COMPLETED|Overall Study||166
3003284|NCT00973349|3720855|FG001|COMPLETED|Overall Study||165
3003285|NCT00973349|3720856|FG002|COMPLETED|Overall Study||166
3003286|NCT00973349|3720857|FG003|COMPLETED|Overall Study||163
3003287|NCT00973349|3720858|FG004|COMPLETED|Overall Study||165
3003288|NCT00973349|3720859|FG005|COMPLETED|Overall Study||165
3003289|NCT00973349|3720860|FG006|COMPLETED|Overall Study||172
3003290|NCT00973349|3720861|FG007|COMPLETED|Overall Study||166
3003291|NCT00973349|3720862|FG008|COMPLETED|Overall Study||167
3003292|NCT00973349|3720863|FG009|COMPLETED|Overall Study||163
3003293|NCT00973349|3720864|FG010|COMPLETED|Overall Study||174
3003294|NCT00973349|3720865|FG011|COMPLETED|Overall Study||167
3003295|NCT00973349|3720866|FG012|COMPLETED|Overall Study||168
3003296|NCT00973349|3720867|FG013|COMPLETED|Overall Study||171
3003297|NCT00973349|3720868|FG014|COMPLETED|Overall Study||168
3003298|NCT00973349|3720869|FG015|COMPLETED|Overall Study||165
3003299|NCT00973349|3720854|FG000|NOT COMPLETED|Overall Study||4
3003300|NCT00973349|3720855|FG001|NOT COMPLETED|Overall Study||3
3003301|NCT00973349|3720856|FG002|NOT COMPLETED|Overall Study||5
3003302|NCT00973349|3720857|FG003|NOT COMPLETED|Overall Study||5
3003303|NCT00973349|3720858|FG004|NOT COMPLETED|Overall Study||5
3003304|NCT00973349|3720859|FG005|NOT COMPLETED|Overall Study||4
3003305|NCT00973349|3720860|FG006|NOT COMPLETED|Overall Study||2
3003306|NCT00973349|3720861|FG007|NOT COMPLETED|Overall Study||3
3003307|NCT00973349|3720862|FG008|NOT COMPLETED|Overall Study||4
3003308|NCT00973349|3720863|FG009|NOT COMPLETED|Overall Study||6
3003309|NCT00973349|3720864|FG010|NOT COMPLETED|Overall Study||0
3003310|NCT00973349|3720865|FG011|NOT COMPLETED|Overall Study||2
3003311|NCT00973349|3720866|FG012|NOT COMPLETED|Overall Study||1
3003312|NCT00973349|3720867|FG013|NOT COMPLETED|Overall Study||0
3003313|NCT00973349|3720868|FG014|NOT COMPLETED|Overall Study||2
3003314|NCT00973349|3720869|FG015|NOT COMPLETED|Overall Study||2
3003315|NCT00973362|3720897|FG000|STARTED|Baseline Evaluation||11644
3003316|NCT00973362|3720898|FG001|STARTED|Baseline Evaluation||1252
3003317|NCT00973362|3720897|FG000|Evaluable for Analysis|Baseline Evaluation||10871
3003318|NCT00973362|3720898|FG001|Evaluable for Analysis|Baseline Evaluation||958
3003319|NCT00973362|3720897|FG000|Conclusive Disease Status|Baseline Evaluation||819
3003320|NCT00973362|3720898|FG001|Conclusive Disease Status|Baseline Evaluation||939
3003321|NCT00973362|3720897|FG000|COMPLETED|Baseline Evaluation||10871
3003322|NCT00973362|3720898|FG001|COMPLETED|Baseline Evaluation||1029
3003323|NCT00973362|3720897|FG000|NOT COMPLETED|Baseline Evaluation||773
3003324|NCT00973362|3720898|FG001|NOT COMPLETED|Baseline Evaluation||223
3003325|NCT00973362|3720897|FG000|STARTED|3-Year Follow-up||10871
3003326|NCT00973362|3720898|FG001|STARTED|3-Year Follow-up|ASC-US study arm did not have a follow-up period|0
3003327|NCT00973362|3720897|FG000|COMPLETED|3-Year Follow-up||10854
3003328|NCT00973362|3720898|FG001|COMPLETED|3-Year Follow-up||0
3003329|NCT00973362|3720897|FG000|NOT COMPLETED|3-Year Follow-up||17
3003330|NCT00973362|3720898|FG001|NOT COMPLETED|3-Year Follow-up||0
3037208|NCT01147250|3756496|FG000|NOT COMPLETED|Overall Study||110
3306555|NCT02999100|4039913|FG001|STARTED|Part 2 (Day 1): Dosing Session 1|Participants from Part 1 did not enter Part 2|0
3306556|NCT02999100|4039914|FG002|STARTED|Part 2 (Day 1): Dosing Session 1|New participants were enrolled in Part 2 of study|5
3306557|NCT02999100|4039915|FG003|STARTED|Part 2 (Day 1): Dosing Session 1|New participants were enrolled in Part 2 of study|3
3306558|NCT02999100|4039916|FG004|STARTED|Part 2 (Day 1): Dosing Session 1|New participants were enrolled in Part 2 of study|3
3037209|NCT01147250|3756497|FG001|NOT COMPLETED|Overall Study||105
3037210|NCT01147302|3756505|FG000|STARTED|Overall Study||9
3037211|NCT01147302|3756506|FG001|STARTED|Overall Study||9
3037212|NCT01147302|3756505|FG000|COMPLETED|Overall Study||9
3037213|NCT01147302|3756506|FG001|COMPLETED|Overall Study||9
3037214|NCT01147302|3756505|FG000|NOT COMPLETED|Overall Study||0
3037215|NCT01147302|3756506|FG001|NOT COMPLETED|Overall Study||0
3037216|NCT01147341|3756514|FG000|STARTED|Double Blind Period||27
3037217|NCT01147341|3756515|FG001|STARTED|Double Blind Period||10
3037218|NCT01147341|3756514|FG000|COMPLETED|Double Blind Period||26
3037219|NCT01147341|3756515|FG001|COMPLETED|Double Blind Period||8
3037220|NCT01147341|3756514|FG000|NOT COMPLETED|Double Blind Period||1
3037221|NCT01147341|3756515|FG001|NOT COMPLETED|Double Blind Period||2
3037222|NCT01147341|3756514|FG000|STARTED|Open Label Period||26
3037223|NCT01147341|3756515|FG001|STARTED|Open Label Period||8
3037224|NCT01147341|3756514|FG000|COMPLETED|Open Label Period||22
3037225|NCT01147341|3756515|FG001|COMPLETED|Open Label Period||8
3037226|NCT01147341|3756514|FG000|NOT COMPLETED|Open Label Period||4
3037227|NCT01147341|3756515|FG001|NOT COMPLETED|Open Label Period||0
3037228|NCT01147380|3756523|FG000|STARTED|Overall Study||6
3037229|NCT01147380|3756524|FG001|STARTED|Overall Study||12
3037230|NCT01147380|3756523|FG000|COMPLETED|Overall Study||6
3037231|NCT01147380|3756524|FG001|COMPLETED|Overall Study||12
3037232|NCT01147380|3756523|FG000|NOT COMPLETED|Overall Study||0
3037233|NCT01147380|3756524|FG001|NOT COMPLETED|Overall Study||0
3037234|NCT01147406|3756538|FG000|STARTED|Overall Study||6
3003331|NCT00973479|3720909|FG000|STARTED|Overall Study||197
3003332|NCT00973479|3720910|FG001|STARTED|Overall Study||395
3003333|NCT00973479|3720909|FG000|COMPLETED|Overall Study||160
3003334|NCT00973479|3720910|FG001|COMPLETED|Overall Study||326
3003335|NCT00973479|3720909|FG000|NOT COMPLETED|Overall Study||37
3003336|NCT00973479|3720910|FG001|NOT COMPLETED|Overall Study||69
3003337|NCT00973622|3720920|FG000|STARTED|Overall Study|75 passed telephone interview; 28 passed in-person interview, were enrolled, and sent for MRI.|47
3003338|NCT00973622|3720921|FG001|STARTED|Overall Study|21 passed telephone interview; 19 passed the in-person interview, were enrolled, and sent for MRI.|19
3003339|NCT00973622|3720920|FG000|COMPLETED|Overall Study|Completed three sessions of rTMS|16
3003340|NCT00973622|3720921|FG001|COMPLETED|Overall Study|Completed three sessions of rTMS|14
3003341|NCT00973622|3720920|FG000|NOT COMPLETED|Overall Study||31
3003342|NCT00973622|3720921|FG001|NOT COMPLETED|Overall Study||5
3003343|NCT00973674|3720929|FG000|STARTED|Overall Study||24
3003344|NCT00973674|3720930|FG001|STARTED|Overall Study||26
3003345|NCT00973674|3720929|FG000|COMPLETED|Overall Study||22
3003346|NCT00973674|3720930|FG001|COMPLETED|Overall Study||26
3003347|NCT00973674|3720929|FG000|NOT COMPLETED|Overall Study||2
3003348|NCT00973674|3720930|FG001|NOT COMPLETED|Overall Study||0
3003349|NCT00973700|3720942|FG000|STARTED|Overall Study||56
3003350|NCT00973700|3720943|FG001|STARTED|Overall Study||56
3003351|NCT00973700|3720944|FG002|STARTED|Overall Study||168
3003352|NCT00973700|3720945|FG003|STARTED|Overall Study||336
3003353|NCT00973700|3720946|FG004|STARTED|Overall Study||168
3003354|NCT00973700|3720942|FG000|COMPLETED|Overall Study||49
3003355|NCT00973700|3720943|FG001|COMPLETED|Overall Study||54
3003356|NCT00973700|3720944|FG002|COMPLETED|Overall Study||158
3003357|NCT00973700|3720945|FG003|COMPLETED|Overall Study||318
3003358|NCT00973700|3720946|FG004|COMPLETED|Overall Study||158
3003359|NCT00973700|3720942|FG000|NOT COMPLETED|Overall Study||7
3003360|NCT00973700|3720943|FG001|NOT COMPLETED|Overall Study||2
3003361|NCT00973700|3720944|FG002|NOT COMPLETED|Overall Study||10
3003362|NCT00973700|3720945|FG003|NOT COMPLETED|Overall Study||18
3003363|NCT00973700|3720946|FG004|NOT COMPLETED|Overall Study||10
3003364|NCT00973739|3720973|FG000|STARTED|Overall Study||21
3003365|NCT00973739|3720973|FG000|COMPLETED|Overall Study||17
3003366|NCT00973739|3720973|FG000|NOT COMPLETED|Overall Study||4
3003367|NCT00973752|3720977|FG000|STARTED|Overall Study||30
3003368|NCT00973752|3720977|FG000|COMPLETED|Overall Study||30
3003369|NCT00973752|3720977|FG000|NOT COMPLETED|Overall Study||0
3003370|NCT00973765|3720983|FG000|STARTED|Overall Study|96|96
3003371|NCT00973765|3720984|FG001|STARTED|Overall Study|116|116
3003372|NCT00973765|3720983|FG000|COMPLETED|Overall Study|88|88
3003373|NCT00973765|3720984|FG001|COMPLETED|Overall Study|102|102
3003374|NCT00973765|3720983|FG000|NOT COMPLETED|Overall Study||8
3003375|NCT00973765|3720984|FG001|NOT COMPLETED|Overall Study||14
3003376|NCT00973921|3720990|FG000|STARTED|Overall Study||40
3003377|NCT00973921|3720990|FG000|COMPLETED|Overall Study||31
3003378|NCT00973921|3720990|FG000|NOT COMPLETED|Overall Study||9
3003379|NCT00973973|3720996|FG000|STARTED|Double-blind Treatment Phase (Weeks 1-8)||69
3003380|NCT00973973|3720997|FG001|STARTED|Double-blind Treatment Phase (Weeks 1-8)||68
3003381|NCT00973973|3720996|FG000|Received Study Drug|Double-blind Treatment Phase (Weeks 1-8)||69
3003382|NCT00973973|3720997|FG001|Received Study Drug|Double-blind Treatment Phase (Weeks 1-8)||68
3003383|NCT00973973|3720996|FG000|COMPLETED|Double-blind Treatment Phase (Weeks 1-8)||63
3003384|NCT00973973|3720997|FG001|COMPLETED|Double-blind Treatment Phase (Weeks 1-8)||60
3003385|NCT00973973|3720996|FG000|NOT COMPLETED|Double-blind Treatment Phase (Weeks 1-8)||6
3003386|NCT00973973|3720997|FG001|NOT COMPLETED|Double-blind Treatment Phase (Weeks 1-8)||8
3003387|NCT00973973|3720996|FG000|STARTED|Open-label Treatment Phase (Weeks 8-24)||63
3003388|NCT00973973|3720997|FG001|STARTED|Open-label Treatment Phase (Weeks 8-24)||60
3003389|NCT00973973|3720996|FG000|COMPLETED|Open-label Treatment Phase (Weeks 8-24)||57
3003390|NCT00973973|3720997|FG001|COMPLETED|Open-label Treatment Phase (Weeks 8-24)||55
3003391|NCT00973973|3720996|FG000|NOT COMPLETED|Open-label Treatment Phase (Weeks 8-24)||6
3003392|NCT00973973|3720997|FG001|NOT COMPLETED|Open-label Treatment Phase (Weeks 8-24)||5
3003393|NCT00974051|3721003|FG000|STARTED|Overall Study||6
3003394|NCT00974051|3721004|FG001|STARTED|Overall Study||4
3003395|NCT00974051|3721005|FG002|STARTED|Overall Study||6
3003396|NCT00974051|3721003|FG000|COMPLETED|Overall Study||6
3003397|NCT00974051|3721004|FG001|COMPLETED|Overall Study||4
3003398|NCT00974051|3721005|FG002|COMPLETED|Overall Study||6
3003399|NCT00974051|3721003|FG000|NOT COMPLETED|Overall Study||0
3003400|NCT00974051|3721004|FG001|NOT COMPLETED|Overall Study||0
3003401|NCT00974051|3721005|FG002|NOT COMPLETED|Overall Study||0
3003402|NCT00974090|3721016|FG000|STARTED|Period 1: Double Blind Period||98
3003403|NCT00974090|3721017|FG001|STARTED|Period 1: Double Blind Period||96
3003404|NCT00974090|3721016|FG000|COMPLETED|Period 1: Double Blind Period||95
3003405|NCT00974090|3721017|FG001|COMPLETED|Period 1: Double Blind Period||95
3003406|NCT00974090|3721016|FG000|NOT COMPLETED|Period 1: Double Blind Period||3
3003407|NCT00974090|3721017|FG001|NOT COMPLETED|Period 1: Double Blind Period||1
3003408|NCT00974090|3721016|FG000|STARTED|Period 2: Open-label Period||95
3003409|NCT00974090|3721017|FG001|STARTED|Period 2: Open-label Period||95
3003410|NCT00974090|3721016|FG000|COMPLETED|Period 2: Open-label Period||87
3003411|NCT00974090|3721017|FG001|COMPLETED|Period 2: Open-label Period||85
3003412|NCT00974090|3721016|FG000|NOT COMPLETED|Period 2: Open-label Period||8
3003413|NCT00974090|3721017|FG001|NOT COMPLETED|Period 2: Open-label Period||10
3003414|NCT00974142|3721027|FG000|STARTED|Overall Study||8
3003415|NCT00974142|3721028|FG001|STARTED|Overall Study||9
3003416|NCT00974142|3721027|FG000|COMPLETED|Overall Study||8
3003417|NCT00974142|3721028|FG001|COMPLETED|Overall Study||9
3003418|NCT00974142|3721027|FG000|NOT COMPLETED|Overall Study||0
3003419|NCT00974142|3721028|FG001|NOT COMPLETED|Overall Study||0
3003420|NCT00974220|3721036|FG000|STARTED|Treatment Period 1||9
3003421|NCT00974220|3721037|FG001|STARTED|Treatment Period 1||7
3003422|NCT00974220|3721036|FG000|COMPLETED|Treatment Period 1||7
3003423|NCT00974220|3721037|FG001|COMPLETED|Treatment Period 1||5
3003424|NCT00974220|3721036|FG000|NOT COMPLETED|Treatment Period 1||2
3003425|NCT00974220|3721037|FG001|NOT COMPLETED|Treatment Period 1||2
3003426|NCT00974220|3721036|FG000|STARTED|Treatment Period 2||7
3003427|NCT00974220|3721037|FG001|STARTED|Treatment Period 2||5
3003428|NCT00974220|3721036|FG000|COMPLETED|Treatment Period 2||7
3003429|NCT00974220|3721037|FG001|COMPLETED|Treatment Period 2||5
3003430|NCT00974220|3721036|FG000|NOT COMPLETED|Treatment Period 2||0
3003431|NCT00974220|3721037|FG001|NOT COMPLETED|Treatment Period 2||0
3003432|NCT00974233|3721043|FG000|STARTED|Induction Chemoimmunotherapy||34
3003433|NCT00974233|3721043|FG000|COMPLETED|Induction Chemoimmunotherapy||19
3003434|NCT00974233|3721043|FG000|NOT COMPLETED|Induction Chemoimmunotherapy||15
3003435|NCT00974233|3721043|FG000|STARTED|Maintenance Lenalidomide||19
3003436|NCT00974233|3721043|FG000|COMPLETED|Maintenance Lenalidomide||6
3003437|NCT00974233|3721043|FG000|NOT COMPLETED|Maintenance Lenalidomide||13
3003438|NCT00974246|3721055|FG000|STARTED|Overall Study||27
3003439|NCT00974246|3721055|FG000|COMPLETED|Overall Study||27
3003440|NCT00974246|3721055|FG000|NOT COMPLETED|Overall Study||0
3003441|NCT00974259|3721062|FG000|STARTED|Overall Study||59
3003442|NCT00974259|3721063|FG001|STARTED|Overall Study||63
3003443|NCT00974259|3721062|FG000|COMPLETED|Overall Study||57
3003444|NCT00974259|3721063|FG001|COMPLETED|Overall Study||62
3003445|NCT00974259|3721062|FG000|NOT COMPLETED|Overall Study||2
3003446|NCT00974259|3721063|FG001|NOT COMPLETED|Overall Study||1
3003447|NCT00974311|3721071|FG000|STARTED|DB Phase (up to 24 Months)||800
3003448|NCT00974311|3721072|FG001|STARTED|DB Phase (up to 24 Months)||399
3003449|NCT00974311|3721071|FG000|COMPLETED|DB Phase (up to 24 Months)||109
3003450|NCT00974311|3721072|FG001|COMPLETED|DB Phase (up to 24 Months)||50
3003451|NCT00974311|3721071|FG000|NOT COMPLETED|DB Phase (up to 24 Months)||691
3306559|NCT02999100|4039917|FG005|STARTED|Part 2 (Day 1): Dosing Session 1|New participants were enrolled in Part 2 of study|3
3306560|NCT02999100|4039912|FG000|COMPLETED|Part 2 (Day 1): Dosing Session 1||0
3306561|NCT02999100|4039913|FG001|COMPLETED|Part 2 (Day 1): Dosing Session 1||0
3306562|NCT02999100|4039914|FG002|COMPLETED|Part 2 (Day 1): Dosing Session 1||4
3306563|NCT02999100|4039915|FG003|COMPLETED|Part 2 (Day 1): Dosing Session 1||3
3306564|NCT02999100|4039916|FG004|COMPLETED|Part 2 (Day 1): Dosing Session 1||3
3306565|NCT02999100|4039917|FG005|COMPLETED|Part 2 (Day 1): Dosing Session 1||2
3306566|NCT02999100|4039912|FG000|NOT COMPLETED|Part 2 (Day 1): Dosing Session 1||0
3306567|NCT02999100|4039913|FG001|NOT COMPLETED|Part 2 (Day 1): Dosing Session 1||0
3306568|NCT02999100|4039914|FG002|NOT COMPLETED|Part 2 (Day 1): Dosing Session 1||1
3306569|NCT02999100|4039915|FG003|NOT COMPLETED|Part 2 (Day 1): Dosing Session 1||0
3306570|NCT02999100|4039916|FG004|NOT COMPLETED|Part 2 (Day 1): Dosing Session 1||0
3306571|NCT02999100|4039917|FG005|NOT COMPLETED|Part 2 (Day 1): Dosing Session 1||1
3003452|NCT00974311|3721072|FG001|NOT COMPLETED|DB Phase (up to 24 Months)||349
3003453|NCT00974311|3721071|FG000|STARTED|OLE Phase (up to 77 Months)||109
3003454|NCT00974311|3721072|FG001|STARTED|OLE Phase (up to 77 Months)||50
3003455|NCT00974311|3721071|FG000|COMPLETED|OLE Phase (up to 77 Months)||0
3003456|NCT00974311|3721072|FG001|COMPLETED|OLE Phase (up to 77 Months)||0
3003457|NCT00974311|3721071|FG000|NOT COMPLETED|OLE Phase (up to 77 Months)||109
3003458|NCT00974311|3721072|FG001|NOT COMPLETED|OLE Phase (up to 77 Months)||50
3003459|NCT00974350|3721084|FG000|STARTED|Overall Study||45
3003460|NCT00974350|3721085|FG001|STARTED|Overall Study||47
3003461|NCT00974350|3721086|FG002|STARTED|Overall Study||32
3003462|NCT00974350|3721084|FG000|COMPLETED|Overall Study||42
3003463|NCT00974350|3721085|FG001|COMPLETED|Overall Study||47
3003464|NCT00974350|3721086|FG002|COMPLETED|Overall Study||31
3003465|NCT00974350|3721084|FG000|NOT COMPLETED|Overall Study||3
3003466|NCT00974350|3721085|FG001|NOT COMPLETED|Overall Study||0
3003467|NCT00974350|3721086|FG002|NOT COMPLETED|Overall Study||1
3003468|NCT00974363|3721097|FG000|STARTED|Overall Study||521
3003469|NCT00974363|3721098|FG001|STARTED|Overall Study||168
3003470|NCT00974363|3721097|FG000|COMPLETED|Overall Study||521
3003471|NCT00974363|3721098|FG001|COMPLETED|Overall Study||168
3003472|NCT00974363|3721097|FG000|NOT COMPLETED|Overall Study||0
3003473|NCT00974363|3721098|FG001|NOT COMPLETED|Overall Study||0
3003474|NCT00974376|3721106|FG000|STARTED|Overall Study||75
3003475|NCT00974376|3721107|FG001|STARTED|Overall Study||75
3003476|NCT00974376|3721106|FG000|COMPLETED|Overall Study||41
3003477|NCT00974376|3721107|FG001|COMPLETED|Overall Study||42
3003478|NCT00974376|3721106|FG000|NOT COMPLETED|Overall Study||34
3003479|NCT00974376|3721107|FG001|NOT COMPLETED|Overall Study||33
3003480|NCT00974480|3721116|FG000|STARTED|Overall Study||40
3003481|NCT00974480|3721117|FG001|STARTED|Overall Study||40
3003482|NCT00974480|3721118|FG002|STARTED|Overall Study||40
3306572|NCT02999100|4039912|FG000|STARTED|Part 2 (Day 14): Dosing Session 2||0
3003483|NCT00974480|3721116|FG000|COMPLETED|Overall Study||29
3003484|NCT00974480|3721117|FG001|COMPLETED|Overall Study||33
3003485|NCT00974480|3721118|FG002|COMPLETED|Overall Study||30
3003486|NCT00974480|3721116|FG000|NOT COMPLETED|Overall Study||11
3003487|NCT00974480|3721117|FG001|NOT COMPLETED|Overall Study||7
3003488|NCT00974480|3721118|FG002|NOT COMPLETED|Overall Study||10
3003489|NCT00974493|3721134|FG000|STARTED|Overall Study||527
3003490|NCT00974493|3721135|FG001|STARTED|Overall Study||527
3003491|NCT00974493|3721134|FG000|COMPLETED|Overall Study||509
3003492|NCT00974493|3721135|FG001|COMPLETED|Overall Study||506
3003493|NCT00974493|3721134|FG000|NOT COMPLETED|Overall Study||18
3003494|NCT00974493|3721135|FG001|NOT COMPLETED|Overall Study||21
3003495|NCT00974675|3721145|FG000|STARTED|Overall Study||8
3003496|NCT00974675|3721146|FG001|STARTED|Overall Study||8
3003497|NCT00974675|3721147|FG002|STARTED|Overall Study||3
3003498|NCT00974675|3721148|FG003|STARTED|Overall Study||4
3003499|NCT00974675|3721145|FG000|COMPLETED|Overall Study||6
3003500|NCT00974675|3721146|FG001|COMPLETED|Overall Study||7
3003501|NCT00974675|3721147|FG002|COMPLETED|Overall Study||1
3003502|NCT00974675|3721148|FG003|COMPLETED|Overall Study||2
3003503|NCT00974675|3721145|FG000|NOT COMPLETED|Overall Study||2
3003504|NCT00974675|3721146|FG001|NOT COMPLETED|Overall Study||1
3003505|NCT00974675|3721147|FG002|NOT COMPLETED|Overall Study||2
3003506|NCT00974675|3721148|FG003|NOT COMPLETED|Overall Study||2
3003507|NCT00974818|3721160|FG000|STARTED|Overall Study||25
3003508|NCT00974818|3721161|FG001|STARTED|Overall Study||25
3003509|NCT00974818|3721160|FG000|COMPLETED|Overall Study||25
3306573|NCT02999100|4039913|FG001|STARTED|Part 2 (Day 14): Dosing Session 2||0
3306574|NCT02999100|4039914|FG002|STARTED|Part 2 (Day 14): Dosing Session 2||4
3306575|NCT02999100|4039915|FG003|STARTED|Part 2 (Day 14): Dosing Session 2||3
3306576|NCT02999100|4039916|FG004|STARTED|Part 2 (Day 14): Dosing Session 2||3
3306577|NCT02999100|4039917|FG005|STARTED|Part 2 (Day 14): Dosing Session 2||2
3306578|NCT02999100|4039912|FG000|COMPLETED|Part 2 (Day 14): Dosing Session 2||0
3306579|NCT02999100|4039913|FG001|COMPLETED|Part 2 (Day 14): Dosing Session 2||0
3306580|NCT02999100|4039914|FG002|COMPLETED|Part 2 (Day 14): Dosing Session 2||4
3306581|NCT02999100|4039915|FG003|COMPLETED|Part 2 (Day 14): Dosing Session 2||3
3306582|NCT02999100|4039916|FG004|COMPLETED|Part 2 (Day 14): Dosing Session 2||3
3306583|NCT02999100|4039917|FG005|COMPLETED|Part 2 (Day 14): Dosing Session 2||2
3003510|NCT00974818|3721161|FG001|COMPLETED|Overall Study||25
3003511|NCT00974818|3721160|FG000|NOT COMPLETED|Overall Study||0
3003512|NCT00974818|3721161|FG001|NOT COMPLETED|Overall Study||0
3003513|NCT00974974|3721169|FG000|STARTED|IR CD-LD Dose Adjustment||0
3003514|NCT00974974|3721170|FG001|STARTED|IR CD-LD Dose Adjustment||471
3003515|NCT00974974|3721169|FG000|COMPLETED|IR CD-LD Dose Adjustment||0
3003516|NCT00974974|3721170|FG001|COMPLETED|IR CD-LD Dose Adjustment||450
3003517|NCT00974974|3721169|FG000|NOT COMPLETED|IR CD-LD Dose Adjustment||0
3003518|NCT00974974|3721170|FG001|NOT COMPLETED|IR CD-LD Dose Adjustment||21
3003519|NCT00974974|3721169|FG000|STARTED|IPX066 Dose Conversion|All subjects who completed IR Dose adjustment entered into IPX066 dose conversion.|450
3003520|NCT00974974|3721170|FG001|STARTED|IPX066 Dose Conversion|IR is not applicable in IPX066 dose conversion.|0
3003521|NCT00974974|3721169|FG000|COMPLETED|IPX066 Dose Conversion||393
3003522|NCT00974974|3721170|FG001|COMPLETED|IPX066 Dose Conversion||0
3003523|NCT00974974|3721169|FG000|NOT COMPLETED|IPX066 Dose Conversion||57
3003524|NCT00974974|3721170|FG001|NOT COMPLETED|IPX066 Dose Conversion||0
3003525|NCT00974974|3721169|FG000|STARTED|Maintenance - Double Blind Treatment|All subjects who completed IPX066 Dose Conversion were randomized to either IPX066 or IR.|201
3003526|NCT00974974|3721170|FG001|STARTED|Maintenance - Double Blind Treatment|All subjects who completed IPX066 Dose Conversion were randomized to either IPX066 or IR.|192
3003527|NCT00974974|3721169|FG000|COMPLETED|Maintenance - Double Blind Treatment||186
3003528|NCT00974974|3721170|FG001|COMPLETED|Maintenance - Double Blind Treatment||182
3003529|NCT00974974|3721169|FG000|NOT COMPLETED|Maintenance - Double Blind Treatment||15
3003530|NCT00974974|3721170|FG001|NOT COMPLETED|Maintenance - Double Blind Treatment||10
3003531|NCT00975000|3721178|FG000|STARTED|Overall Study||57
3003532|NCT00975000|3721179|FG001|STARTED|Overall Study||57
3003533|NCT00975000|3721178|FG000|Completed Titration Phase|Overall Study||54
3003534|NCT00975000|3721179|FG001|Completed Titration Phase|Overall Study||55
3003535|NCT00975000|3721178|FG000|Completed Efficacy Assessment Phase|Overall Study||54
3003536|NCT00975000|3721179|FG001|Completed Efficacy Assessment Phase|Overall Study||54
3003537|NCT00975000|3721178|FG000|Completed Maintenance Phase|Overall Study||52
3003538|NCT00975000|3721179|FG001|Completed Maintenance Phase|Overall Study||52
3003539|NCT00975000|3721178|FG000|COMPLETED|Overall Study|Completed post-treatment follow-up phase|52
3003540|NCT00975000|3721179|FG001|COMPLETED|Overall Study|Completed post-treatment follow-up phase|52
3003541|NCT00975000|3721178|FG000|NOT COMPLETED|Overall Study||5
3003542|NCT00975000|3721179|FG001|NOT COMPLETED|Overall Study||5
3003543|NCT00975130|3721185|FG000|STARTED|Study Part 1||3366
3003544|NCT00975130|3721186|FG001|STARTED|Study Part 1||0
3003545|NCT00975130|3721187|FG002|STARTED|Study Part 1||0
3003546|NCT00975130|3721185|FG000|COMPLETED|Study Part 1||3086
3003547|NCT00975130|3721186|FG001|COMPLETED|Study Part 1||0
3003548|NCT00975130|3721187|FG002|COMPLETED|Study Part 1||0
3003549|NCT00975130|3721185|FG000|NOT COMPLETED|Study Part 1||280
3003550|NCT00975130|3721186|FG001|NOT COMPLETED|Study Part 1||0
3003551|NCT00975130|3721187|FG002|NOT COMPLETED|Study Part 1||0
3003552|NCT00975130|3721185|FG000|STARTED|Study Part 2||0
3037235|NCT01147406|3756539|FG001|STARTED|Overall Study||12
3306584|NCT02999100|4039912|FG000|NOT COMPLETED|Part 2 (Day 14): Dosing Session 2||0
3306585|NCT02999100|4039913|FG001|NOT COMPLETED|Part 2 (Day 14): Dosing Session 2||0
3306586|NCT02999100|4039914|FG002|NOT COMPLETED|Part 2 (Day 14): Dosing Session 2||0
3317083|NCT03123861|4050600|FG000|STARTED|Overall Study||22
3003553|NCT00975130|3721186|FG001|STARTED|Study Part 2|Good/moderate responders without remission at the end of Part 1 were invited to enroll in Part 2.|250
3003554|NCT00975130|3721187|FG002|STARTED|Study Part 2|Good/moderate responders without remission at the end of Part 1 were invited to enroll in Part 2.|255
3003555|NCT00975130|3721185|FG000|COMPLETED|Study Part 2||0
3003556|NCT00975130|3721186|FG001|COMPLETED|Study Part 2||212
3003557|NCT00975130|3721187|FG002|COMPLETED|Study Part 2||238
3003558|NCT00975130|3721185|FG000|NOT COMPLETED|Study Part 2||0
3003559|NCT00975130|3721186|FG001|NOT COMPLETED|Study Part 2||38
3003560|NCT00975130|3721187|FG002|NOT COMPLETED|Study Part 2||17
3003561|NCT00975143|3721202|FG000|STARTED|Overall Study||464
3003562|NCT00975143|3721203|FG001|STARTED|Overall Study||461
3003563|NCT00975143|3721202|FG000|Completed Treatment (Week 20)|Overall Study||403
3003564|NCT00975143|3721203|FG001|Completed Treatment (Week 20)|Overall Study||410
3003565|NCT00975143|3721202|FG000|COMPLETED|Overall Study||394
3003566|NCT00975143|3721203|FG001|COMPLETED|Overall Study||401
3003567|NCT00975143|3721202|FG000|NOT COMPLETED|Overall Study||70
3003568|NCT00975143|3721203|FG001|NOT COMPLETED|Overall Study||60
3003569|NCT00975156|3721211|FG000|STARTED|Overall Study||11
3003570|NCT00975156|3721212|FG001|STARTED|Overall Study||10
3003571|NCT00975156|3721211|FG000|COMPLETED|Overall Study||11
3003572|NCT00975156|3721212|FG001|COMPLETED|Overall Study||9
3003573|NCT00975156|3721211|FG000|NOT COMPLETED|Overall Study||0
3003574|NCT00975156|3721212|FG001|NOT COMPLETED|Overall Study||1
3003575|NCT00975195|3721224|FG000|STARTED|Overall Study||1244
3003576|NCT00975195|3721225|FG001|STARTED|Overall Study||1244
3003577|NCT00975195|3721224|FG000|COMPLETED|Overall Study|Includes open-label treatment if appropriate|1016
3003578|NCT00975195|3721225|FG001|COMPLETED|Overall Study|Includes open-label treatment if appropriate|1011
3003579|NCT00975195|3721224|FG000|NOT COMPLETED|Overall Study||228
3003580|NCT00975195|3721225|FG001|NOT COMPLETED|Overall Study||233
3003581|NCT00975221|3721233|FG000|STARTED|Titration Phase (Weeks 1-12)||34
3003582|NCT00975221|3721234|FG001|STARTED|Titration Phase (Weeks 1-12)||33
3003583|NCT00975221|3721233|FG000|Received Study Drug|Titration Phase (Weeks 1-12)||34
3003584|NCT00975221|3721234|FG001|Received Study Drug|Titration Phase (Weeks 1-12)||33
3003585|NCT00975221|3721233|FG000|COMPLETED|Titration Phase (Weeks 1-12)||31
3003586|NCT00975221|3721234|FG001|COMPLETED|Titration Phase (Weeks 1-12)||29
3003587|NCT00975221|3721233|FG000|NOT COMPLETED|Titration Phase (Weeks 1-12)||3
3003588|NCT00975221|3721234|FG001|NOT COMPLETED|Titration Phase (Weeks 1-12)||4
3003589|NCT00975221|3721233|FG000|STARTED|Efficacy Assessment Phase (Weeks 13-28)|1 participant who completed the Titration Phase did not enter the EAP|30
3003590|NCT00975221|3721234|FG001|STARTED|Efficacy Assessment Phase (Weeks 13-28)||29
3003591|NCT00975221|3721233|FG000|COMPLETED|Efficacy Assessment Phase (Weeks 13-28)||30
3003592|NCT00975221|3721234|FG001|COMPLETED|Efficacy Assessment Phase (Weeks 13-28)||28
3003593|NCT00975221|3721233|FG000|NOT COMPLETED|Efficacy Assessment Phase (Weeks 13-28)||0
3003594|NCT00975221|3721234|FG001|NOT COMPLETED|Efficacy Assessment Phase (Weeks 13-28)||1
3003595|NCT00975221|3721233|FG000|STARTED|Open-label Extension Phase (Weeks 29-52)|1 participant who completed the EAP did not enter the open-label phase|29
3003596|NCT00975221|3721234|FG001|STARTED|Open-label Extension Phase (Weeks 29-52)||28
3003597|NCT00975221|3721233|FG000|COMPLETED|Open-label Extension Phase (Weeks 29-52)||27
3003598|NCT00975221|3721234|FG001|COMPLETED|Open-label Extension Phase (Weeks 29-52)||27
3003599|NCT00975221|3721233|FG000|NOT COMPLETED|Open-label Extension Phase (Weeks 29-52)||2
3003600|NCT00975221|3721234|FG001|NOT COMPLETED|Open-label Extension Phase (Weeks 29-52)||1
3003601|NCT00975286|3721244|FG000|STARTED|Overall Study|Randomized.|223
3003602|NCT00975286|3721245|FG001|STARTED|Overall Study||223
3003603|NCT00975286|3721244|FG000|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|223
3003604|NCT00975286|3721245|FG001|Safety Population|Overall Study||223
3003605|NCT00975286|3721244|FG000|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|223
3003606|NCT00975286|3721245|FG001|Modified Intent-to-Treat(mITT)Population|Overall Study||223
3003607|NCT00975286|3721244|FG000|COMPLETED|Overall Study||211
3003608|NCT00975286|3721245|FG001|COMPLETED|Overall Study||194
3003609|NCT00975286|3721244|FG000|NOT COMPLETED|Overall Study||12
3003610|NCT00975286|3721245|FG001|NOT COMPLETED|Overall Study||29
3003611|NCT00975416|3721253|FG000|STARTED|Overall Study||14
3003612|NCT00975416|3721254|FG001|STARTED|Overall Study||16
3003613|NCT00975416|3721253|FG000|COMPLETED|Overall Study||11
3003614|NCT00975416|3721254|FG001|COMPLETED|Overall Study||11
3003615|NCT00975416|3721253|FG000|NOT COMPLETED|Overall Study||3
3003616|NCT00975416|3721254|FG001|NOT COMPLETED|Overall Study||5
3003617|NCT00975481|3721261|FG000|STARTED|First Intervention Period||6
3003618|NCT00975481|3721262|FG001|STARTED|First Intervention Period||6
3003619|NCT00975481|3721263|FG002|STARTED|First Intervention Period||6
3003620|NCT00975481|3721264|FG003|STARTED|First Intervention Period||6
3003621|NCT00975481|3721265|FG004|STARTED|First Intervention Period||6
3003622|NCT00975481|3721266|FG005|STARTED|First Intervention Period||6
3003623|NCT00975481|3721261|FG000|COMPLETED|First Intervention Period||6
3003624|NCT00975481|3721262|FG001|COMPLETED|First Intervention Period||6
3003625|NCT00975481|3721263|FG002|COMPLETED|First Intervention Period||6
3003626|NCT00975481|3721264|FG003|COMPLETED|First Intervention Period||6
3003627|NCT00975481|3721265|FG004|COMPLETED|First Intervention Period||6
3164969|NCT01896206|3892495|FG000|STARTED|Overall Study||21
3164970|NCT01896206|3892495|FG000|COMPLETED|Overall Study||21
3164971|NCT01896206|3892495|FG000|NOT COMPLETED|Overall Study||0
3164972|NCT01896232|3892501|FG000|STARTED|Overall Study||343
3164973|NCT01896232|3892502|FG001|STARTED|Overall Study||340
3164974|NCT01896232|3892501|FG000|Received Treatment|Overall Study||341
3164975|NCT01896232|3892502|FG001|Received Treatment|Overall Study||338
3164976|NCT01896232|3892501|FG000|COMPLETED|Overall Study||294
3164977|NCT01896232|3892502|FG001|COMPLETED|Overall Study||287
3003628|NCT00975481|3721266|FG005|COMPLETED|First Intervention Period||6
3003629|NCT00975481|3721261|FG000|NOT COMPLETED|First Intervention Period||0
3003630|NCT00975481|3721262|FG001|NOT COMPLETED|First Intervention Period||0
3003631|NCT00975481|3721263|FG002|NOT COMPLETED|First Intervention Period||0
3003632|NCT00975481|3721264|FG003|NOT COMPLETED|First Intervention Period||0
3003633|NCT00975481|3721265|FG004|NOT COMPLETED|First Intervention Period||0
3003634|NCT00975481|3721266|FG005|NOT COMPLETED|First Intervention Period||0
3003635|NCT00975481|3721261|FG000|STARTED|Washout Period (at Least 7 Days)||6
3003636|NCT00975481|3721262|FG001|STARTED|Washout Period (at Least 7 Days)||6
3003637|NCT00975481|3721263|FG002|STARTED|Washout Period (at Least 7 Days)||6
3003638|NCT00975481|3721264|FG003|STARTED|Washout Period (at Least 7 Days)||6
3003639|NCT00975481|3721265|FG004|STARTED|Washout Period (at Least 7 Days)||6
3003640|NCT00975481|3721266|FG005|STARTED|Washout Period (at Least 7 Days)||6
3003641|NCT00975481|3721261|FG000|COMPLETED|Washout Period (at Least 7 Days)||6
3003642|NCT00975481|3721262|FG001|COMPLETED|Washout Period (at Least 7 Days)||6
3003643|NCT00975481|3721263|FG002|COMPLETED|Washout Period (at Least 7 Days)||6
3003644|NCT00975481|3721264|FG003|COMPLETED|Washout Period (at Least 7 Days)||6
3003645|NCT00975481|3721265|FG004|COMPLETED|Washout Period (at Least 7 Days)||6
3003646|NCT00975481|3721266|FG005|COMPLETED|Washout Period (at Least 7 Days)||6
3003647|NCT00975481|3721261|FG000|NOT COMPLETED|Washout Period (at Least 7 Days)||0
3003648|NCT00975481|3721262|FG001|NOT COMPLETED|Washout Period (at Least 7 Days)||0
3003649|NCT00975481|3721263|FG002|NOT COMPLETED|Washout Period (at Least 7 Days)||0
3003650|NCT00975481|3721264|FG003|NOT COMPLETED|Washout Period (at Least 7 Days)||0
3003651|NCT00975481|3721265|FG004|NOT COMPLETED|Washout Period (at Least 7 Days)||0
3003652|NCT00975481|3721266|FG005|NOT COMPLETED|Washout Period (at Least 7 Days)||0
3003653|NCT00975481|3721261|FG000|STARTED|Second Intervention Period||6
3003654|NCT00975481|3721262|FG001|STARTED|Second Intervention Period||6
3003655|NCT00975481|3721263|FG002|STARTED|Second Intervention Period||6
3003656|NCT00975481|3721264|FG003|STARTED|Second Intervention Period||6
3003657|NCT00975481|3721265|FG004|STARTED|Second Intervention Period||6
3003658|NCT00975481|3721266|FG005|STARTED|Second Intervention Period||6
3003659|NCT00975481|3721261|FG000|COMPLETED|Second Intervention Period||4
3003660|NCT00975481|3721262|FG001|COMPLETED|Second Intervention Period||5
3003661|NCT00975481|3721263|FG002|COMPLETED|Second Intervention Period||5
3003662|NCT00975481|3721264|FG003|COMPLETED|Second Intervention Period||6
3003663|NCT00975481|3721265|FG004|COMPLETED|Second Intervention Period||6
3003664|NCT00975481|3721266|FG005|COMPLETED|Second Intervention Period||6
3003665|NCT00975481|3721261|FG000|NOT COMPLETED|Second Intervention Period||2
3003666|NCT00975481|3721262|FG001|NOT COMPLETED|Second Intervention Period||1
3003667|NCT00975481|3721263|FG002|NOT COMPLETED|Second Intervention Period||1
3003668|NCT00975481|3721264|FG003|NOT COMPLETED|Second Intervention Period||0
3003669|NCT00975481|3721265|FG004|NOT COMPLETED|Second Intervention Period||0
3003670|NCT00975481|3721266|FG005|NOT COMPLETED|Second Intervention Period||0
3003671|NCT00975481|3721261|FG000|STARTED|Washout Period (at Least 7 Days)||4
3003672|NCT00975481|3721262|FG001|STARTED|Washout Period (at Least 7 Days)||5
3003673|NCT00975481|3721263|FG002|STARTED|Washout Period (at Least 7 Days)||5
3003674|NCT00975481|3721264|FG003|STARTED|Washout Period (at Least 7 Days)||6
3003675|NCT00975481|3721265|FG004|STARTED|Washout Period (at Least 7 Days)||6
3003676|NCT00975481|3721266|FG005|STARTED|Washout Period (at Least 7 Days)||6
3003677|NCT00975481|3721261|FG000|COMPLETED|Washout Period (at Least 7 Days)||4
3003678|NCT00975481|3721262|FG001|COMPLETED|Washout Period (at Least 7 Days)||5
3003679|NCT00975481|3721263|FG002|COMPLETED|Washout Period (at Least 7 Days)||5
3003680|NCT00975481|3721264|FG003|COMPLETED|Washout Period (at Least 7 Days)||6
3003681|NCT00975481|3721265|FG004|COMPLETED|Washout Period (at Least 7 Days)||6
3003682|NCT00975481|3721266|FG005|COMPLETED|Washout Period (at Least 7 Days)||6
3003683|NCT00975481|3721261|FG000|NOT COMPLETED|Washout Period (at Least 7 Days)||0
3003684|NCT00975481|3721262|FG001|NOT COMPLETED|Washout Period (at Least 7 Days)||0
3003685|NCT00975481|3721263|FG002|NOT COMPLETED|Washout Period (at Least 7 Days)||0
3003686|NCT00975481|3721264|FG003|NOT COMPLETED|Washout Period (at Least 7 Days)||0
3003687|NCT00975481|3721265|FG004|NOT COMPLETED|Washout Period (at Least 7 Days)||0
3003688|NCT00975481|3721266|FG005|NOT COMPLETED|Washout Period (at Least 7 Days)||0
3003689|NCT00975481|3721261|FG000|STARTED|Third Intervention Period||4
3003690|NCT00975481|3721262|FG001|STARTED|Third Intervention Period||5
3003691|NCT00975481|3721263|FG002|STARTED|Third Intervention Period||5
3003692|NCT00975481|3721264|FG003|STARTED|Third Intervention Period||6
3003693|NCT00975481|3721265|FG004|STARTED|Third Intervention Period||6
3003694|NCT00975481|3721266|FG005|STARTED|Third Intervention Period||6
3003695|NCT00975481|3721261|FG000|COMPLETED|Third Intervention Period||4
3003696|NCT00975481|3721262|FG001|COMPLETED|Third Intervention Period||5
3003697|NCT00975481|3721263|FG002|COMPLETED|Third Intervention Period||5
3003698|NCT00975481|3721264|FG003|COMPLETED|Third Intervention Period||6
3003699|NCT00975481|3721265|FG004|COMPLETED|Third Intervention Period||6
3003700|NCT00975481|3721266|FG005|COMPLETED|Third Intervention Period||6
3164978|NCT01896232|3892501|FG000|NOT COMPLETED|Overall Study||49
3003701|NCT00975481|3721261|FG000|NOT COMPLETED|Third Intervention Period||0
3003702|NCT00975481|3721262|FG001|NOT COMPLETED|Third Intervention Period||0
3003703|NCT00975481|3721263|FG002|NOT COMPLETED|Third Intervention Period||0
3003704|NCT00975481|3721264|FG003|NOT COMPLETED|Third Intervention Period||0
3003705|NCT00975481|3721265|FG004|NOT COMPLETED|Third Intervention Period||0
3003706|NCT00975481|3721266|FG005|NOT COMPLETED|Third Intervention Period||0
3003707|NCT00975481|3721261|FG000|STARTED|Washout Period (at Least 7 Days)||4
3003708|NCT00975481|3721262|FG001|STARTED|Washout Period (at Least 7 Days)||5
3003709|NCT00975481|3721263|FG002|STARTED|Washout Period (at Least 7 Days)||5
3003710|NCT00975481|3721264|FG003|STARTED|Washout Period (at Least 7 Days)||6
3003711|NCT00975481|3721265|FG004|STARTED|Washout Period (at Least 7 Days)||6
3003712|NCT00975481|3721266|FG005|STARTED|Washout Period (at Least 7 Days)||6
3003713|NCT00975481|3721261|FG000|COMPLETED|Washout Period (at Least 7 Days)||4
3003714|NCT00975481|3721262|FG001|COMPLETED|Washout Period (at Least 7 Days)||5
3003715|NCT00975481|3721263|FG002|COMPLETED|Washout Period (at Least 7 Days)||5
3003716|NCT00975481|3721264|FG003|COMPLETED|Washout Period (at Least 7 Days)||6
3003717|NCT00975481|3721265|FG004|COMPLETED|Washout Period (at Least 7 Days)||6
3003718|NCT00975481|3721266|FG005|COMPLETED|Washout Period (at Least 7 Days)||6
3003719|NCT00975481|3721261|FG000|NOT COMPLETED|Washout Period (at Least 7 Days)||0
3003720|NCT00975481|3721262|FG001|NOT COMPLETED|Washout Period (at Least 7 Days)||0
3003721|NCT00975481|3721263|FG002|NOT COMPLETED|Washout Period (at Least 7 Days)||0
3003722|NCT00975481|3721264|FG003|NOT COMPLETED|Washout Period (at Least 7 Days)||0
3003723|NCT00975481|3721265|FG004|NOT COMPLETED|Washout Period (at Least 7 Days)||0
3003724|NCT00975481|3721266|FG005|NOT COMPLETED|Washout Period (at Least 7 Days)||0
3003725|NCT00975481|3721261|FG000|STARTED|Fourth Intervention Period||4
3003726|NCT00975481|3721262|FG001|STARTED|Fourth Intervention Period||5
3003727|NCT00975481|3721263|FG002|STARTED|Fourth Intervention Period||5
3003728|NCT00975481|3721264|FG003|STARTED|Fourth Intervention Period||6
3003729|NCT00975481|3721265|FG004|STARTED|Fourth Intervention Period||6
3003730|NCT00975481|3721266|FG005|STARTED|Fourth Intervention Period||6
3003731|NCT00975481|3721261|FG000|COMPLETED|Fourth Intervention Period||4
3003732|NCT00975481|3721262|FG001|COMPLETED|Fourth Intervention Period||5
3003733|NCT00975481|3721263|FG002|COMPLETED|Fourth Intervention Period||4
3003734|NCT00975481|3721264|FG003|COMPLETED|Fourth Intervention Period||5
3003735|NCT00975481|3721265|FG004|COMPLETED|Fourth Intervention Period||6
3003736|NCT00975481|3721266|FG005|COMPLETED|Fourth Intervention Period||6
3003737|NCT00975481|3721261|FG000|NOT COMPLETED|Fourth Intervention Period||0
3003738|NCT00975481|3721262|FG001|NOT COMPLETED|Fourth Intervention Period||0
3003739|NCT00975481|3721263|FG002|NOT COMPLETED|Fourth Intervention Period||1
3003740|NCT00975481|3721264|FG003|NOT COMPLETED|Fourth Intervention Period||1
3003741|NCT00975481|3721265|FG004|NOT COMPLETED|Fourth Intervention Period||0
3003742|NCT00975481|3721266|FG005|NOT COMPLETED|Fourth Intervention Period||0
3003743|NCT00975481|3721261|FG000|STARTED|Washout Period (at Least 7 Days)||4
3003744|NCT00975481|3721262|FG001|STARTED|Washout Period (at Least 7 Days)||5
3003745|NCT00975481|3721263|FG002|STARTED|Washout Period (at Least 7 Days)||4
3003746|NCT00975481|3721264|FG003|STARTED|Washout Period (at Least 7 Days)||5
3003747|NCT00975481|3721265|FG004|STARTED|Washout Period (at Least 7 Days)||6
3003748|NCT00975481|3721266|FG005|STARTED|Washout Period (at Least 7 Days)||6
3003749|NCT00975481|3721261|FG000|COMPLETED|Washout Period (at Least 7 Days)||4
3003750|NCT00975481|3721262|FG001|COMPLETED|Washout Period (at Least 7 Days)||5
3003751|NCT00975481|3721263|FG002|COMPLETED|Washout Period (at Least 7 Days)||4
3003752|NCT00975481|3721264|FG003|COMPLETED|Washout Period (at Least 7 Days)||5
3003753|NCT00975481|3721265|FG004|COMPLETED|Washout Period (at Least 7 Days)||6
3003754|NCT00975481|3721266|FG005|COMPLETED|Washout Period (at Least 7 Days)||6
3003755|NCT00975481|3721261|FG000|NOT COMPLETED|Washout Period (at Least 7 Days)||0
3003756|NCT00975481|3721262|FG001|NOT COMPLETED|Washout Period (at Least 7 Days)||0
3003757|NCT00975481|3721263|FG002|NOT COMPLETED|Washout Period (at Least 7 Days)||0
3003758|NCT00975481|3721264|FG003|NOT COMPLETED|Washout Period (at Least 7 Days)||0
3003759|NCT00975481|3721265|FG004|NOT COMPLETED|Washout Period (at Least 7 Days)||0
3003760|NCT00975481|3721266|FG005|NOT COMPLETED|Washout Period (at Least 7 Days)||0
3003761|NCT00975481|3721261|FG000|STARTED|Fifth Intervention Period||4
3003762|NCT00975481|3721262|FG001|STARTED|Fifth Intervention Period||5
3003763|NCT00975481|3721263|FG002|STARTED|Fifth Intervention Period||4
3003764|NCT00975481|3721264|FG003|STARTED|Fifth Intervention Period||5
3003765|NCT00975481|3721265|FG004|STARTED|Fifth Intervention Period||6
3003766|NCT00975481|3721266|FG005|STARTED|Fifth Intervention Period||6
3003767|NCT00975481|3721261|FG000|COMPLETED|Fifth Intervention Period||4
3003768|NCT00975481|3721262|FG001|COMPLETED|Fifth Intervention Period||5
3003769|NCT00975481|3721263|FG002|COMPLETED|Fifth Intervention Period||4
3003770|NCT00975481|3721264|FG003|COMPLETED|Fifth Intervention Period||5
3003771|NCT00975481|3721265|FG004|COMPLETED|Fifth Intervention Period||5
3003772|NCT00975481|3721266|FG005|COMPLETED|Fifth Intervention Period||6
3003773|NCT00975481|3721261|FG000|NOT COMPLETED|Fifth Intervention Period||0
3003774|NCT00975481|3721262|FG001|NOT COMPLETED|Fifth Intervention Period||0
3003775|NCT00975481|3721263|FG002|NOT COMPLETED|Fifth Intervention Period||0
3003776|NCT00975481|3721264|FG003|NOT COMPLETED|Fifth Intervention Period||0
3003777|NCT00975481|3721265|FG004|NOT COMPLETED|Fifth Intervention Period||1
3003778|NCT00975481|3721266|FG005|NOT COMPLETED|Fifth Intervention Period||0
3003779|NCT00975481|3721261|FG000|STARTED|Washout Period (at Least 7 Days)||4
3003780|NCT00975481|3721262|FG001|STARTED|Washout Period (at Least 7 Days)||5
3003781|NCT00975481|3721263|FG002|STARTED|Washout Period (at Least 7 Days)||4
3003782|NCT00975481|3721264|FG003|STARTED|Washout Period (at Least 7 Days)||5
3003783|NCT00975481|3721265|FG004|STARTED|Washout Period (at Least 7 Days)||5
3003784|NCT00975481|3721266|FG005|STARTED|Washout Period (at Least 7 Days)||6
3003785|NCT00975481|3721261|FG000|COMPLETED|Washout Period (at Least 7 Days)||4
3003786|NCT00975481|3721262|FG001|COMPLETED|Washout Period (at Least 7 Days)||5
3003787|NCT00975481|3721263|FG002|COMPLETED|Washout Period (at Least 7 Days)||4
3003788|NCT00975481|3721264|FG003|COMPLETED|Washout Period (at Least 7 Days)||5
3003789|NCT00975481|3721265|FG004|COMPLETED|Washout Period (at Least 7 Days)||5
3003790|NCT00975481|3721266|FG005|COMPLETED|Washout Period (at Least 7 Days)||6
3003791|NCT00975481|3721261|FG000|NOT COMPLETED|Washout Period (at Least 7 Days)||0
3003792|NCT00975481|3721262|FG001|NOT COMPLETED|Washout Period (at Least 7 Days)||0
3003793|NCT00975481|3721263|FG002|NOT COMPLETED|Washout Period (at Least 7 Days)||0
3003794|NCT00975481|3721264|FG003|NOT COMPLETED|Washout Period (at Least 7 Days)||0
3003795|NCT00975481|3721265|FG004|NOT COMPLETED|Washout Period (at Least 7 Days)||0
3003796|NCT00975481|3721266|FG005|NOT COMPLETED|Washout Period (at Least 7 Days)||0
3003797|NCT00975481|3721261|FG000|STARTED|Sixth Intervention Period||4
3003798|NCT00975481|3721262|FG001|STARTED|Sixth Intervention Period||5
3003799|NCT00975481|3721263|FG002|STARTED|Sixth Intervention Period||4
3003800|NCT00975481|3721264|FG003|STARTED|Sixth Intervention Period||5
3003801|NCT00975481|3721265|FG004|STARTED|Sixth Intervention Period||5
3003802|NCT00975481|3721266|FG005|STARTED|Sixth Intervention Period||6
3003803|NCT00975481|3721261|FG000|COMPLETED|Sixth Intervention Period||4
3003804|NCT00975481|3721262|FG001|COMPLETED|Sixth Intervention Period||5
3003805|NCT00975481|3721263|FG002|COMPLETED|Sixth Intervention Period||4
3003806|NCT00975481|3721264|FG003|COMPLETED|Sixth Intervention Period||5
3003807|NCT00975481|3721265|FG004|COMPLETED|Sixth Intervention Period||5
3003808|NCT00975481|3721266|FG005|COMPLETED|Sixth Intervention Period||6
3003809|NCT00975481|3721261|FG000|NOT COMPLETED|Sixth Intervention Period||0
3003810|NCT00975481|3721262|FG001|NOT COMPLETED|Sixth Intervention Period||0
3003811|NCT00975481|3721263|FG002|NOT COMPLETED|Sixth Intervention Period||0
3003812|NCT00975481|3721264|FG003|NOT COMPLETED|Sixth Intervention Period||0
3003813|NCT00975481|3721265|FG004|NOT COMPLETED|Sixth Intervention Period||0
3003814|NCT00975481|3721266|FG005|NOT COMPLETED|Sixth Intervention Period||0
3003815|NCT00975507|3721286|FG000|STARTED|Overall Study||323
3003816|NCT00975507|3721287|FG001|STARTED|Overall Study||157
3003817|NCT00975507|3721286|FG000|Vaccinated at Visit 1|Overall Study||323
3003818|NCT00975507|3721287|FG001|Vaccinated at Visit 1|Overall Study||157
3003819|NCT00975507|3721286|FG000|Vaccinated at Visit 2|Overall Study||310
3003820|NCT00975507|3721287|FG001|Vaccinated at Visit 2|Overall Study|Per-protocol, subjects receiving M-M-R™ II + VARIVAX™ at Visit 1 were not vaccinated at Visit 2|0
3003821|NCT00975507|3721286|FG000|COMPLETED|Overall Study||303
3003822|NCT00975507|3721287|FG001|COMPLETED|Overall Study||153
3003823|NCT00975507|3721286|FG000|NOT COMPLETED|Overall Study||20
3003824|NCT00975507|3721287|FG001|NOT COMPLETED|Overall Study||4
3003825|NCT00975585|3721297|FG000|STARTED|Overall Study||184
3003826|NCT00975585|3721298|FG001|STARTED|Overall Study||195
3003827|NCT00975585|3721297|FG000|COMPLETED|Overall Study||177
3003828|NCT00975585|3721298|FG001|COMPLETED|Overall Study||183
3003829|NCT00975585|3721297|FG000|NOT COMPLETED|Overall Study||7
3003830|NCT00975585|3721298|FG001|NOT COMPLETED|Overall Study||12
3003831|NCT00975637|3721311|FG000|STARTED|Overall Study||40
3003832|NCT00975637|3721312|FG001|STARTED|Overall Study||39
3003833|NCT00975637|3721313|FG002|STARTED|Overall Study||42
3003834|NCT00975637|3721314|FG003|STARTED|Overall Study||38
3003835|NCT00975637|3721315|FG004|STARTED|Overall Study||39
3164979|NCT01896232|3892502|FG001|NOT COMPLETED|Overall Study||53
3164980|NCT01896271|3892508|FG000|STARTED|Overall Study||30
3164981|NCT01896271|3892508|FG000|COMPLETED|Overall Study||20
3164982|NCT01896271|3892508|FG000|NOT COMPLETED|Overall Study||10
3164983|NCT01896297|3892512|FG000|STARTED|Overall Study||60
3164984|NCT01896297|3892512|FG000|COMPLETED|Overall Study||59
3164985|NCT01896297|3892512|FG000|NOT COMPLETED|Overall Study||1
3164986|NCT01896544|3892519|FG000|STARTED|Overall Study||10
3003836|NCT00975637|3721311|FG000|COMPLETED|Overall Study||37
3003837|NCT00975637|3721312|FG001|COMPLETED|Overall Study||38
3003838|NCT00975637|3721313|FG002|COMPLETED|Overall Study||40
3003839|NCT00975637|3721314|FG003|COMPLETED|Overall Study||32
3003840|NCT00975637|3721315|FG004|COMPLETED|Overall Study||37
3003841|NCT00975637|3721311|FG000|NOT COMPLETED|Overall Study||3
3003842|NCT00975637|3721312|FG001|NOT COMPLETED|Overall Study||1
3003843|NCT00975637|3721313|FG002|NOT COMPLETED|Overall Study||2
3003844|NCT00975637|3721314|FG003|NOT COMPLETED|Overall Study||6
3003845|NCT00975637|3721315|FG004|NOT COMPLETED|Overall Study||2
3003846|NCT00975650|3721327|FG000|STARTED|Period 1||13
3003847|NCT00975650|3721328|FG001|STARTED|Period 1||16
3003848|NCT00975650|3721329|FG002|STARTED|Period 1||14
3003849|NCT00975650|3721330|FG003|STARTED|Period 1||14
3003850|NCT00975650|3721327|FG000|COMPLETED|Period 1||13
3003851|NCT00975650|3721328|FG001|COMPLETED|Period 1||16
3003852|NCT00975650|3721329|FG002|COMPLETED|Period 1||14
3003853|NCT00975650|3721330|FG003|COMPLETED|Period 1||14
3003854|NCT00975650|3721327|FG000|NOT COMPLETED|Period 1||0
3003855|NCT00975650|3721328|FG001|NOT COMPLETED|Period 1||0
3003856|NCT00975650|3721329|FG002|NOT COMPLETED|Period 1||0
3003857|NCT00975650|3721330|FG003|NOT COMPLETED|Period 1||0
3003858|NCT00975650|3721327|FG000|STARTED|Period 2||13
3003859|NCT00975650|3721328|FG001|STARTED|Period 2||16
3003860|NCT00975650|3721329|FG002|STARTED|Period 2||14
3003861|NCT00975650|3721330|FG003|STARTED|Period 2||14
3003862|NCT00975650|3721327|FG000|COMPLETED|Period 2||12
3003863|NCT00975650|3721328|FG001|COMPLETED|Period 2||14
3003864|NCT00975650|3721329|FG002|COMPLETED|Period 2||14
3003865|NCT00975650|3721330|FG003|COMPLETED|Period 2||14
3003866|NCT00975650|3721327|FG000|NOT COMPLETED|Period 2||1
3003867|NCT00975650|3721328|FG001|NOT COMPLETED|Period 2||2
3003868|NCT00975650|3721329|FG002|NOT COMPLETED|Period 2||0
3003869|NCT00975650|3721330|FG003|NOT COMPLETED|Period 2||0
3003870|NCT00975650|3721327|FG000|STARTED|Period 3||12
3003871|NCT00975650|3721328|FG001|STARTED|Period 3||14
3003872|NCT00975650|3721329|FG002|STARTED|Period 3||14
3003873|NCT00975650|3721330|FG003|STARTED|Period 3||14
3003874|NCT00975650|3721327|FG000|COMPLETED|Period 3||12
3003875|NCT00975650|3721328|FG001|COMPLETED|Period 3||14
3003876|NCT00975650|3721329|FG002|COMPLETED|Period 3||14
3003877|NCT00975650|3721330|FG003|COMPLETED|Period 3||14
3003878|NCT00975650|3721327|FG000|NOT COMPLETED|Period 3||0
3003879|NCT00975650|3721328|FG001|NOT COMPLETED|Period 3||0
3003880|NCT00975650|3721329|FG002|NOT COMPLETED|Period 3||0
3003881|NCT00975650|3721330|FG003|NOT COMPLETED|Period 3||0
3003882|NCT00975650|3721327|FG000|STARTED|Period 4||12
3003883|NCT00975650|3721328|FG001|STARTED|Period 4||14
3003884|NCT00975650|3721329|FG002|STARTED|Period 4||14
3003885|NCT00975650|3721330|FG003|STARTED|Period 4||14
3003886|NCT00975650|3721327|FG000|COMPLETED|Period 4||12
3003887|NCT00975650|3721328|FG001|COMPLETED|Period 4||14
3003888|NCT00975650|3721329|FG002|COMPLETED|Period 4||14
3003889|NCT00975650|3721330|FG003|COMPLETED|Period 4||14
3003890|NCT00975650|3721327|FG000|NOT COMPLETED|Period 4||0
3003891|NCT00975650|3721328|FG001|NOT COMPLETED|Period 4||0
3003892|NCT00975650|3721329|FG002|NOT COMPLETED|Period 4||0
3003893|NCT00975650|3721330|FG003|NOT COMPLETED|Period 4||0
3003894|NCT00975676|3721342|FG000|STARTED|Overall Study||32
3003895|NCT00975676|3721343|FG001|STARTED|Overall Study||91
3003896|NCT00975676|3721342|FG000|COMPLETED|Overall Study||26
3003897|NCT00975676|3721343|FG001|COMPLETED|Overall Study||83
3003898|NCT00975676|3721342|FG000|NOT COMPLETED|Overall Study||6
3003899|NCT00975676|3721343|FG001|NOT COMPLETED|Overall Study||8
3003900|NCT00975689|3721356|FG000|STARTED|Overall Study||17
3003901|NCT00975689|3721357|FG001|STARTED|Overall Study||18
3003902|NCT00975689|3721356|FG000|COMPLETED|Overall Study||15
3003903|NCT00975689|3721357|FG001|COMPLETED|Overall Study||15
3003904|NCT00975689|3721356|FG000|NOT COMPLETED|Overall Study||2
3003905|NCT00975689|3721357|FG001|NOT COMPLETED|Overall Study||3
3003906|NCT00975715|3721365|FG000|STARTED|Titration Period||48
3003907|NCT00975715|3721366|FG001|STARTED|Titration Period||51
3003908|NCT00975715|3721365|FG000|COMPLETED|Titration Period||41
3003909|NCT00975715|3721366|FG001|COMPLETED|Titration Period||51
3003910|NCT00975715|3721365|FG000|NOT COMPLETED|Titration Period||7
3003911|NCT00975715|3721366|FG001|NOT COMPLETED|Titration Period||0
3003912|NCT00975715|3721365|FG000|STARTED|Maintenance Period||41
3003913|NCT00975715|3721366|FG001|STARTED|Maintenance Period||51
3003914|NCT00975715|3721365|FG000|COMPLETED|Maintenance Period||39
3003915|NCT00975715|3721366|FG001|COMPLETED|Maintenance Period||50
3003916|NCT00975715|3721365|FG000|NOT COMPLETED|Maintenance Period||2
3003917|NCT00975715|3721366|FG001|NOT COMPLETED|Maintenance Period||1
3003918|NCT00975780|3721374|FG000|STARTED|Allocation||400
3003919|NCT00975780|3721375|FG001|STARTED|Allocation||434
3003920|NCT00975780|3721374|FG000|COMPLETED|Allocation||400
3003921|NCT00975780|3721375|FG001|COMPLETED|Allocation||434
3003922|NCT00975780|3721374|FG000|NOT COMPLETED|Allocation||0
3003923|NCT00975780|3721375|FG001|NOT COMPLETED|Allocation||0
3003924|NCT00975780|3721374|FG000|STARTED|Follow Up||400
3003925|NCT00975780|3721375|FG001|STARTED|Follow Up||434
3003926|NCT00975780|3721374|FG000|COMPLETED|Follow Up||298
3003927|NCT00975780|3721375|FG001|COMPLETED|Follow Up||277
3003928|NCT00975780|3721374|FG000|NOT COMPLETED|Follow Up||102
3003929|NCT00975780|3721375|FG001|NOT COMPLETED|Follow Up||157
3003930|NCT00975806|3721384|FG000|STARTED|Overall Study||5
3003931|NCT00975806|3721385|FG001|STARTED|Overall Study||7
3003932|NCT00975806|3721386|FG002|STARTED|Overall Study||4
3003933|NCT00975806|3721384|FG000|COMPLETED|Overall Study|Participants were prematurely discontinued|0
3003934|NCT00975806|3721385|FG001|COMPLETED|Overall Study|Participants were prematurely discontinued|0
3003935|NCT00975806|3721386|FG002|COMPLETED|Overall Study|Participants were prematurely discontinued|0
3003936|NCT00975806|3721384|FG000|NOT COMPLETED|Overall Study||5
3003937|NCT00975806|3721385|FG001|NOT COMPLETED|Overall Study||7
3003938|NCT00975806|3721386|FG002|NOT COMPLETED|Overall Study||4
3003939|NCT00975884|3721398|FG000|STARTED|Overall Study||184
3003940|NCT00975884|3721399|FG001|STARTED|Overall Study||122
3003941|NCT00975884|3721398|FG000|COMPLETED|Overall Study||168
3003942|NCT00975884|3721399|FG001|COMPLETED|Overall Study||107
3003943|NCT00975884|3721398|FG000|NOT COMPLETED|Overall Study||16
3003944|NCT00975884|3721399|FG001|NOT COMPLETED|Overall Study||15
3003945|NCT00975923|3721417|FG000|STARTED|Overall Study||30
3003946|NCT00975923|3721418|FG001|STARTED|Overall Study||30
3003947|NCT00975923|3721417|FG000|COMPLETED|Overall Study||30
3003948|NCT00975923|3721418|FG001|COMPLETED|Overall Study|1 hospital was sold, yielding 29 hospitals in the Tool Kit Group|29
3003949|NCT00975923|3721417|FG000|NOT COMPLETED|Overall Study||0
3003950|NCT00975923|3721418|FG001|NOT COMPLETED|Overall Study||1
3003951|NCT00975975|3721425|FG000|STARTED|Overall Study||17
3003952|NCT00975975|3721425|FG000|COMPLETED|Overall Study||11
3003953|NCT00975975|3721425|FG000|NOT COMPLETED|Overall Study||6
3003954|NCT00976027|3721431|FG000|STARTED|Overall Study||6108
3003955|NCT00976027|3721432|FG001|STARTED|Overall Study||3050
3003956|NCT00976027|3721431|FG000|COMPLETED|Overall Study||5697
3003957|NCT00976027|3721432|FG001|COMPLETED|Overall Study||2835
3003958|NCT00976027|3721431|FG000|NOT COMPLETED|Overall Study||411
3003959|NCT00976027|3721432|FG001|NOT COMPLETED|Overall Study||215
3003960|NCT00976183|3721438|FG000|STARTED|Overall Study||18
3003961|NCT00976183|3721438|FG000|COMPLETED|Overall Study|The study was closed on 05/30/12 due to adverse events. We did not complete enrollment|18
3003962|NCT00976183|3721438|FG000|NOT COMPLETED|Overall Study||0
3003963|NCT00976209|3721444|FG000|STARTED|Treatment Period 1||165
3003964|NCT00976209|3721445|FG001|STARTED|Treatment Period 1||166
3003965|NCT00976209|3721444|FG000|COMPLETED|Treatment Period 1||162
3003966|NCT00976209|3721445|FG001|COMPLETED|Treatment Period 1||165
3003967|NCT00976209|3721444|FG000|NOT COMPLETED|Treatment Period 1||3
3003968|NCT00976209|3721445|FG001|NOT COMPLETED|Treatment Period 1||1
3003969|NCT00976209|3721444|FG000|STARTED|Wash-out Period||162
3003970|NCT00976209|3721445|FG001|STARTED|Wash-out Period||165
3003971|NCT00976209|3721444|FG000|COMPLETED|Wash-out Period||158
3003972|NCT00976209|3721445|FG001|COMPLETED|Wash-out Period||163
3003973|NCT00976209|3721444|FG000|NOT COMPLETED|Wash-out Period||4
3003974|NCT00976209|3721445|FG001|NOT COMPLETED|Wash-out Period||2
3003975|NCT00976209|3721444|FG000|STARTED|Treatment Period 2||158
3003976|NCT00976209|3721445|FG001|STARTED|Treatment Period 2||163
3003977|NCT00976209|3721444|FG000|COMPLETED|Treatment Period 2||158
3306587|NCT02999100|4039915|FG003|NOT COMPLETED|Part 2 (Day 14): Dosing Session 2||0
3003978|NCT00976209|3721445|FG001|COMPLETED|Treatment Period 2||161
3003979|NCT00976209|3721444|FG000|NOT COMPLETED|Treatment Period 2||0
3003980|NCT00976209|3721445|FG001|NOT COMPLETED|Treatment Period 2||2
3003981|NCT00976248|3721450|FG000|STARTED|Overall Study||33
3003982|NCT00976248|3721450|FG000|COMPLETED|Overall Study||33
3003983|NCT00976248|3721450|FG000|NOT COMPLETED|Overall Study||0
3003984|NCT00976274|3721457|FG000|STARTED|Overall Study||31
3003985|NCT00976274|3721458|FG001|STARTED|Overall Study||29
3003986|NCT00976274|3721457|FG000|COMPLETED|Overall Study||24
3003987|NCT00976274|3721458|FG001|COMPLETED|Overall Study||21
3003988|NCT00976274|3721457|FG000|NOT COMPLETED|Overall Study||7
3003989|NCT00976274|3721458|FG001|NOT COMPLETED|Overall Study||8
3003990|NCT00976352|3721466|FG000|STARTED|Overall Study||3
3003991|NCT00976352|3721467|FG001|STARTED|Overall Study||10
3003992|NCT00976352|3721466|FG000|COMPLETED|Overall Study||3
3003993|NCT00976352|3721467|FG001|COMPLETED|Overall Study|Last evaluation of last subject in cohort.|6
3003994|NCT00976352|3721466|FG000|NOT COMPLETED|Overall Study||0
3003995|NCT00976352|3721467|FG001|NOT COMPLETED|Overall Study||4
3003996|NCT00976391|3721479|FG000|STARTED|Treatment Period (52 Weeks)||285
3003997|NCT00976391|3721480|FG001|STARTED|Treatment Period (52 Weeks)||281
3003998|NCT00976391|3721479|FG000|COMPLETED|Treatment Period (52 Weeks)||243
3003999|NCT00976391|3721480|FG001|COMPLETED|Treatment Period (52 Weeks)||242
3004000|NCT00976391|3721479|FG000|NOT COMPLETED|Treatment Period (52 Weeks)||42
3004001|NCT00976391|3721480|FG001|NOT COMPLETED|Treatment Period (52 Weeks)||39
3004002|NCT00976391|3721479|FG000|STARTED|Follow-up Period (8 Weeks)||285
3004003|NCT00976391|3721480|FG001|STARTED|Follow-up Period (8 Weeks)||281
3004004|NCT00976391|3721479|FG000|COMPLETED|Follow-up Period (8 Weeks)||256
3004005|NCT00976391|3721480|FG001|COMPLETED|Follow-up Period (8 Weeks)||247
3004006|NCT00976391|3721479|FG000|NOT COMPLETED|Follow-up Period (8 Weeks)||29
3004007|NCT00976391|3721480|FG001|NOT COMPLETED|Follow-up Period (8 Weeks)||34
3004008|NCT00976404|3721488|FG000|STARTED|Overall Study||14
3004009|NCT00976404|3721489|FG001|STARTED|Overall Study||14
3004010|NCT00976404|3721488|FG000|COMPLETED|Overall Study||14
3004011|NCT00976404|3721489|FG001|COMPLETED|Overall Study||14
3004012|NCT00976404|3721488|FG000|NOT COMPLETED|Overall Study||0
3004013|NCT00976404|3721489|FG001|NOT COMPLETED|Overall Study||0
3004014|NCT00976456|3721499|FG000|STARTED|Overall Study||135
3004015|NCT00976456|3721500|FG001|STARTED|Overall Study||136
3004016|NCT00976456|3721499|FG000|COMPLETED|Overall Study||92
3004017|NCT00976456|3721500|FG001|COMPLETED|Overall Study||98
3004018|NCT00976456|3721499|FG000|NOT COMPLETED|Overall Study||43
3004019|NCT00976456|3721500|FG001|NOT COMPLETED|Overall Study||38
3004020|NCT00976482|3721506|FG000|STARTED|Overall Study||1745
3004021|NCT00976482|3721506|FG000|Eligible for Last Follow up|Overall Study||1487
3004022|NCT00976482|3721506|FG000|COMPLETED|Overall Study||1486
3004023|NCT00976482|3721506|FG000|NOT COMPLETED|Overall Study||259
3004024|NCT00976495|3721513|FG000|STARTED|Overall Study||25
3004025|NCT00976495|3721514|FG001|STARTED|Overall Study||24
3004026|NCT00976495|3721515|FG002|STARTED|Overall Study||26
3004027|NCT00976495|3721513|FG000|COMPLETED|Overall Study||25
3004028|NCT00976495|3721514|FG001|COMPLETED|Overall Study||23
3004029|NCT00976495|3721515|FG002|COMPLETED|Overall Study||26
3004030|NCT00976495|3721513|FG000|NOT COMPLETED|Overall Study||0
3004031|NCT00976495|3721514|FG001|NOT COMPLETED|Overall Study||1
3004032|NCT00976495|3721515|FG002|NOT COMPLETED|Overall Study||0
3004033|NCT00976508|3721525|FG000|STARTED|Overall Study|18 subjects were enrolled; 17 subjects were treated; 1 subject was not eligible.|17
3004034|NCT00976508|3721526|FG001|STARTED|Overall Study||6
3004035|NCT00976508|3721525|FG000|COMPLETED|Overall Study|These subjects withdrew from last study treatment due to progressive disease.|3
3004036|NCT00976508|3721526|FG001|COMPLETED|Overall Study||0
3306588|NCT02999100|4039916|FG004|NOT COMPLETED|Part 2 (Day 14): Dosing Session 2||0
3004037|NCT00976508|3721525|FG000|NOT COMPLETED|Overall Study||14
3004038|NCT00976508|3721526|FG001|NOT COMPLETED|Overall Study||6
3004039|NCT00976521|3721539|FG000|STARTED|Overall Study||118
3004040|NCT00976521|3721540|FG001|STARTED|Overall Study||111
3004041|NCT00976521|3721541|FG002|STARTED|Overall Study||111
3004042|NCT00976521|3721542|FG003|STARTED|Overall Study||112
3004043|NCT00976521|3721539|FG000|COMPLETED|Overall Study||109
3004044|NCT00976521|3721540|FG001|COMPLETED|Overall Study||99
3004045|NCT00976521|3721541|FG002|COMPLETED|Overall Study||102
3004046|NCT00976521|3721542|FG003|COMPLETED|Overall Study||93
3004047|NCT00976521|3721539|FG000|NOT COMPLETED|Overall Study||9
3004048|NCT00976521|3721540|FG001|NOT COMPLETED|Overall Study||12
3004049|NCT00976521|3721541|FG002|NOT COMPLETED|Overall Study||9
3004050|NCT00976521|3721542|FG003|NOT COMPLETED|Overall Study||19
3004051|NCT00976560|3721555|FG000|STARTED|Overall Study||64
3004052|NCT00976560|3721556|FG001|STARTED|Overall Study||64
3004053|NCT00976560|3721555|FG000|COMPLETED|Overall Study||50
3004054|NCT00976560|3721556|FG001|COMPLETED|Overall Study||51
3004055|NCT00976560|3721555|FG000|NOT COMPLETED|Overall Study||14
3004056|NCT00976560|3721556|FG001|NOT COMPLETED|Overall Study||13
3004057|NCT00976573|3721564|FG000|STARTED|Overall Study||75
3004058|NCT00976573|3721565|FG001|STARTED|Overall Study||74
3004059|NCT00976573|3721564|FG000|COMPLETED|Overall Study||71
3004060|NCT00976573|3721565|FG001|COMPLETED|Overall Study||71
3004061|NCT00976573|3721564|FG000|NOT COMPLETED|Overall Study||4
3004062|NCT00976573|3721565|FG001|NOT COMPLETED|Overall Study||3
3004063|NCT00976599|3721573|FG000|STARTED|Overall Study||15
3004064|NCT00976599|3721574|FG001|STARTED|Overall Study||14
3004065|NCT00976599|3721573|FG000|COMPLETED|Overall Study||15
3004066|NCT00976599|3721574|FG001|COMPLETED|Overall Study||14
3004067|NCT00976599|3721573|FG000|NOT COMPLETED|Overall Study||0
3004068|NCT00976599|3721574|FG001|NOT COMPLETED|Overall Study||0
3004069|NCT00976664|3721582|FG000|STARTED|Overall Study||25
3004070|NCT00976664|3721583|FG001|STARTED|Overall Study||25
3004071|NCT00976664|3721582|FG000|COMPLETED|Overall Study||22
3004072|NCT00976664|3721583|FG001|COMPLETED|Overall Study||24
3004073|NCT00976664|3721582|FG000|NOT COMPLETED|Overall Study||3
3004074|NCT00976664|3721583|FG001|NOT COMPLETED|Overall Study||1
3004075|NCT00976677|3721591|FG000|STARTED|Overall Study||5
3004076|NCT00976677|3721592|FG001|STARTED|Overall Study||5
3004077|NCT00976677|3721591|FG000|COMPLETED|Overall Study||0
3004078|NCT00976677|3721592|FG001|COMPLETED|Overall Study||0
3004079|NCT00976677|3721591|FG000|NOT COMPLETED|Overall Study||5
3004080|NCT00976677|3721592|FG001|NOT COMPLETED|Overall Study||5
3004081|NCT00976703|3721600|FG000|STARTED|Overall Study||99
3004082|NCT00976703|3721601|FG001|STARTED|Overall Study||98
3004083|NCT00976703|3721600|FG000|COMPLETED|Overall Study||96
3004084|NCT00976703|3721601|FG001|COMPLETED|Overall Study||95
3004085|NCT00976703|3721600|FG000|NOT COMPLETED|Overall Study||3
3004086|NCT00976703|3721601|FG001|NOT COMPLETED|Overall Study||3
3004087|NCT00976716|3721607|FG000|STARTED|Overall Study||80
3004088|NCT00976716|3721607|FG000|COMPLETED|Overall Study||79
3004089|NCT00976716|3721607|FG000|NOT COMPLETED|Overall Study||1
3004090|NCT00976820|3721616|FG000|STARTED|Overall Study||67
3004091|NCT00976820|3721617|FG001|STARTED|Overall Study||128
3004092|NCT00976820|3721618|FG002|STARTED|Overall Study||64
3004093|NCT00976820|3721619|FG003|STARTED|Overall Study||63
3004094|NCT00976820|3721616|FG000|COMPLETED|Overall Study||59
3004095|NCT00976820|3721617|FG001|COMPLETED|Overall Study||108
3004096|NCT00976820|3721618|FG002|COMPLETED|Overall Study||60
3004097|NCT00976820|3721619|FG003|COMPLETED|Overall Study||56
3004098|NCT00976820|3721616|FG000|NOT COMPLETED|Overall Study||8
3004099|NCT00976820|3721617|FG001|NOT COMPLETED|Overall Study||20
3004100|NCT00976820|3721618|FG002|NOT COMPLETED|Overall Study||4
3004101|NCT00976820|3721619|FG003|NOT COMPLETED|Overall Study||7
3004102|NCT00976898|3721670|FG000|STARTED|Overall Study||83
3004103|NCT00976898|3721670|FG000|COMPLETED|Overall Study||78
3004104|NCT00976898|3721670|FG000|NOT COMPLETED|Overall Study||5
3004105|NCT00976911|3721676|FG000|STARTED|Overall Study||182
3004106|NCT00976911|3721677|FG001|STARTED|Overall Study||179
3004107|NCT00976911|3721676|FG000|COMPLETED|Overall Study|At time of clinical cutoff for overall survival and safety (25 January 2013)|0
3004108|NCT00976911|3721677|FG001|COMPLETED|Overall Study|At time of clinical cutoff for overall survival and safety (25 January 2013)|0
3004109|NCT00976911|3721676|FG000|NOT COMPLETED|Overall Study||182
3004110|NCT00976911|3721677|FG001|NOT COMPLETED|Overall Study||179
3004111|NCT00976937|3721685|FG000|STARTED|Overall Study|Randomized|158
3004112|NCT00976937|3721686|FG001|STARTED|Overall Study||161
3004113|NCT00976937|3721685|FG000|Treated/Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|158
3004114|NCT00976937|3721686|FG001|Treated/Safety Population|Overall Study||161
3004115|NCT00976937|3721685|FG000|Modified Intent-to-Treat(mITT)Population|Overall Study|All randomized patients who received at least 1 dose of study drug.|158
3004116|NCT00976937|3721686|FG001|Modified Intent-to-Treat(mITT)Population|Overall Study||161
3004117|NCT00976937|3721685|FG000|COMPLETED|Overall Study||142
3004118|NCT00976937|3721686|FG001|COMPLETED|Overall Study||150
3004119|NCT00976937|3721685|FG000|NOT COMPLETED|Overall Study||16
3164987|NCT01896544|3892520|FG001|STARTED|Overall Study||10
3164988|NCT01896544|3892521|FG002|STARTED|Overall Study||10
3004120|NCT00976937|3721686|FG001|NOT COMPLETED|Overall Study||11
3004121|NCT00976950|3721692|FG000|STARTED|Overall Study||42
3004122|NCT00976950|3721692|FG000|COMPLETED|Overall Study||36
3164989|NCT01896544|3892519|FG000|COMPLETED|Overall Study||10
3004123|NCT00976950|3721692|FG000|NOT COMPLETED|Overall Study||6
3004124|NCT00976989|3721699|FG000|STARTED|Overall Study||73
3004125|NCT00976989|3721700|FG001|STARTED|Overall Study||75
3004126|NCT00976989|3721701|FG002|STARTED|Overall Study||77
3004127|NCT00976989|3721699|FG000|COMPLETED|Overall Study||60
3004128|NCT00976989|3721700|FG001|COMPLETED|Overall Study||63
3004129|NCT00976989|3721701|FG002|COMPLETED|Overall Study||60
3004130|NCT00976989|3721699|FG000|NOT COMPLETED|Overall Study||13
3004131|NCT00976989|3721700|FG001|NOT COMPLETED|Overall Study||12
3004132|NCT00976989|3721701|FG002|NOT COMPLETED|Overall Study||17
3004133|NCT00977080|3721713|FG000|STARTED|Overall Study||62
3004134|NCT00977080|3721714|FG001|STARTED|Overall Study||64
3004135|NCT00977080|3721715|FG002|STARTED|Overall Study||72
3004136|NCT00977080|3721716|FG003|STARTED|Overall Study||70
3004137|NCT00977080|3721713|FG000|COMPLETED|Overall Study||50
3004138|NCT00977080|3721714|FG001|COMPLETED|Overall Study||44
3004139|NCT00977080|3721715|FG002|COMPLETED|Overall Study||56
3004140|NCT00977080|3721716|FG003|COMPLETED|Overall Study||53
3004141|NCT00977080|3721713|FG000|NOT COMPLETED|Overall Study||12
3004142|NCT00977080|3721714|FG001|NOT COMPLETED|Overall Study||20
3164990|NCT01896544|3892520|FG001|COMPLETED|Overall Study||10
3164991|NCT01896544|3892521|FG002|COMPLETED|Overall Study||10
3164992|NCT01896544|3892519|FG000|NOT COMPLETED|Overall Study||0
3164993|NCT01896544|3892520|FG001|NOT COMPLETED|Overall Study||0
3164994|NCT01896544|3892521|FG002|NOT COMPLETED|Overall Study||0
3164995|NCT01896557|3892534|FG000|STARTED|Clopidogrel Alone||44
3004143|NCT00977080|3721715|FG002|NOT COMPLETED|Overall Study||16
3004144|NCT00977080|3721716|FG003|NOT COMPLETED|Overall Study||17
3004145|NCT00977106|3721728|FG000|STARTED|Overall Study||47
3004146|NCT00977106|3721729|FG001|STARTED|Overall Study|Includes 3 participants who were randomized to placebo, but received tocilizumab.|56
3004147|NCT00977106|3721728|FG000|COMPLETED|Overall Study||37
3004148|NCT00977106|3721729|FG001|COMPLETED|Overall Study||45
3004149|NCT00977106|3721728|FG000|NOT COMPLETED|Overall Study||10
3004150|NCT00977106|3721729|FG001|NOT COMPLETED|Overall Study||11
3004151|NCT00977171|3721737|FG000|STARTED|Overall Study||3
3004152|NCT00977171|3721737|FG000|COMPLETED|Overall Study||3
3004153|NCT00977171|3721737|FG000|NOT COMPLETED|Overall Study||0
3004154|NCT00977184|3721743|FG000|STARTED|Overall Study||13
3004155|NCT00977184|3721744|FG001|STARTED|Overall Study||13
3004156|NCT00977184|3721743|FG000|COMPLETED|Overall Study||13
3004157|NCT00977184|3721744|FG001|COMPLETED|Overall Study||13
3004158|NCT00977184|3721743|FG000|NOT COMPLETED|Overall Study||0
3004159|NCT00977184|3721744|FG001|NOT COMPLETED|Overall Study||0
3004160|NCT00977197|3721759|FG000|STARTED|Overall Study||41
3004161|NCT00977197|3721760|FG001|STARTED|Overall Study||44
3004162|NCT00977197|3721759|FG000|COMPLETED|Overall Study||32
3004163|NCT00977197|3721760|FG001|COMPLETED|Overall Study||35
3004164|NCT00977197|3721759|FG000|NOT COMPLETED|Overall Study||9
3004165|NCT00977197|3721760|FG001|NOT COMPLETED|Overall Study||9
3004166|NCT00977314|3721768|FG000|STARTED|Overall Study||30
3004167|NCT00977314|3721769|FG001|STARTED|Overall Study|First 5 subjects enrolled were pilot subjects and not included in analysis.|5
3004168|NCT00977314|3721768|FG000|COMPLETED|Overall Study||28
3004169|NCT00977314|3721769|FG001|COMPLETED|Overall Study|First 5 subjects enrolled were pilot subjects and not included in analysis.|5
3004170|NCT00977314|3721768|FG000|NOT COMPLETED|Overall Study||2
3004171|NCT00977314|3721769|FG001|NOT COMPLETED|Overall Study||0
3004172|NCT00977379|3721777|FG000|STARTED|Overall Study|Randomized|12
3004173|NCT00977379|3721778|FG001|STARTED|Overall Study|Randomized|12
3004174|NCT00977379|3721777|FG000|Treated|Overall Study||12
3004175|NCT00977379|3721778|FG001|Treated|Overall Study||11
3004176|NCT00977379|3721777|FG000|COMPLETED|Overall Study||0
3004177|NCT00977379|3721778|FG001|COMPLETED|Overall Study||0
3004178|NCT00977379|3721777|FG000|NOT COMPLETED|Overall Study||12
3004179|NCT00977379|3721778|FG001|NOT COMPLETED|Overall Study||12
3004180|NCT00977431|3721789|FG000|STARTED|Overall Study||7
3004181|NCT00977431|3721790|FG001|STARTED|Overall Study||6
3004182|NCT00977431|3721791|FG002|STARTED|Overall Study||7
3004183|NCT00977431|3721792|FG003|STARTED|Overall Study||3
3004184|NCT00977431|3721793|FG004|STARTED|Overall Study||13
3004185|NCT00977431|3721789|FG000|Discontinued Afatinib Before/on Day 42|Overall Study||1
3004186|NCT00977431|3721790|FG001|Discontinued Afatinib Before/on Day 42|Overall Study||0
3004187|NCT00977431|3721791|FG002|Discontinued Afatinib Before/on Day 42|Overall Study||4
3004188|NCT00977431|3721792|FG003|Discontinued Afatinib Before/on Day 42|Overall Study||0
3004189|NCT00977431|3721793|FG004|Discontinued Afatinib Before/on Day 42|Overall Study||3
3004190|NCT00977431|3721789|FG000|COMPLETED|Overall Study||0
3004191|NCT00977431|3721790|FG001|COMPLETED|Overall Study||0
3004192|NCT00977431|3721791|FG002|COMPLETED|Overall Study||0
3004193|NCT00977431|3721792|FG003|COMPLETED|Overall Study||0
3004194|NCT00977431|3721793|FG004|COMPLETED|Overall Study||0
3004195|NCT00977431|3721789|FG000|NOT COMPLETED|Overall Study||7
3004196|NCT00977431|3721790|FG001|NOT COMPLETED|Overall Study||6
3004197|NCT00977431|3721791|FG002|NOT COMPLETED|Overall Study||7
3004198|NCT00977431|3721792|FG003|NOT COMPLETED|Overall Study||3
3004199|NCT00977431|3721793|FG004|NOT COMPLETED|Overall Study||13
3004200|NCT00977470|3721811|FG000|STARTED|Overall Study||38
3004201|NCT00977470|3721812|FG001|STARTED|Overall Study||38
3004202|NCT00977470|3721811|FG000|COMPLETED|Overall Study||0
3004203|NCT00977470|3721812|FG001|COMPLETED|Overall Study||0
3004204|NCT00977470|3721811|FG000|NOT COMPLETED|Overall Study||38
3004205|NCT00977470|3721812|FG001|NOT COMPLETED|Overall Study||38
3004206|NCT00977548|3721818|FG000|STARTED|Overall Study||39
3004207|NCT00977548|3721818|FG000|COMPLETED|Overall Study||26
3004208|NCT00977548|3721818|FG000|NOT COMPLETED|Overall Study||13
3004209|NCT00977561|3721824|FG000|STARTED|Overall Study||5
3004210|NCT00977561|3721825|FG001|STARTED|Overall Study||4
3004211|NCT00977561|3721824|FG000|COMPLETED|Overall Study||0
3004212|NCT00977561|3721825|FG001|COMPLETED|Overall Study||0
3004213|NCT00977561|3721824|FG000|NOT COMPLETED|Overall Study||5
3004214|NCT00977561|3721825|FG001|NOT COMPLETED|Overall Study||4
3004215|NCT00977613|3721833|FG000|STARTED|Overall Study||50
3004216|NCT00977613|3721833|FG000|COMPLETED|Overall Study||34
3004217|NCT00977613|3721833|FG000|NOT COMPLETED|Overall Study||16
3004218|NCT00977665|3721839|FG000|STARTED|Overall Study||84
3004219|NCT00977665|3721840|FG001|STARTED|Overall Study||90
3004220|NCT00977665|3721839|FG000|COMPLETED|Overall Study||63
3004221|NCT00977665|3721840|FG001|COMPLETED|Overall Study||75
3004222|NCT00977665|3721839|FG000|NOT COMPLETED|Overall Study||21
3004223|NCT00977665|3721840|FG001|NOT COMPLETED|Overall Study||15
3004224|NCT00977691|3721849|FG000|STARTED|Overall Study||3
3004225|NCT00977691|3721850|FG001|STARTED|Overall Study||8
3004226|NCT00977691|3721851|FG002|STARTED|Overall Study||12
3004227|NCT00977691|3721849|FG000|COMPLETED|Overall Study||3
3004228|NCT00977691|3721850|FG001|COMPLETED|Overall Study||7
3004229|NCT00977691|3721851|FG002|COMPLETED|Overall Study||12
3004230|NCT00977691|3721849|FG000|NOT COMPLETED|Overall Study||0
3004231|NCT00977691|3721850|FG001|NOT COMPLETED|Overall Study||1
3004232|NCT00977691|3721851|FG002|NOT COMPLETED|Overall Study||0
3004233|NCT00977704|3721859|FG000|STARTED|Overall Study||20
3004234|NCT00977704|3721859|FG000|COMPLETED|Overall Study||20
3004235|NCT00977704|3721859|FG000|NOT COMPLETED|Overall Study||0
3004236|NCT00977769|3721866|FG000|STARTED|Overall Study||25
3004237|NCT00977769|3721867|FG001|STARTED|Overall Study||26
3004238|NCT00977769|3721868|FG002|STARTED|Overall Study||25
3004239|NCT00977769|3721866|FG000|COMPLETED|Overall Study||25
3004240|NCT00977769|3721867|FG001|COMPLETED|Overall Study||26
3004241|NCT00977769|3721868|FG002|COMPLETED|Overall Study||25
3004242|NCT00977769|3721866|FG000|NOT COMPLETED|Overall Study||0
3004243|NCT00977769|3721867|FG001|NOT COMPLETED|Overall Study||0
3004244|NCT00977769|3721868|FG002|NOT COMPLETED|Overall Study||0
3004245|NCT00977808|3721876|FG000|STARTED|Overall Study||12
3004246|NCT00977808|3721876|FG000|Completion of Open-Loop Admission|Overall Study||12
3004247|NCT00977808|3721876|FG000|Completion of Closed-Loop Admission|Overall Study||11
3004248|NCT00977808|3721876|FG000|COMPLETED|Overall Study||11
3004249|NCT00977808|3721876|FG000|NOT COMPLETED|Overall Study||1
3004250|NCT00977938|3721885|FG000|STARTED|Treatment (12-30 mo. Post Procedure)||5020
3004251|NCT00977938|3721886|FG001|STARTED|Treatment (12-30 mo. Post Procedure)||4941
3004252|NCT00977938|3721887|FG002|STARTED|Treatment (12-30 mo. Post Procedure)||842
3004253|NCT00977938|3721888|FG003|STARTED|Treatment (12-30 mo. Post Procedure)||845
3004254|NCT00977938|3721885|FG000|COMPLETED|Treatment (12-30 mo. Post Procedure)||4783
3004255|NCT00977938|3721886|FG001|COMPLETED|Treatment (12-30 mo. Post Procedure)||4716
3004256|NCT00977938|3721887|FG002|COMPLETED|Treatment (12-30 mo. Post Procedure)||796
3004257|NCT00977938|3721888|FG003|COMPLETED|Treatment (12-30 mo. Post Procedure)||784
3004258|NCT00977938|3721885|FG000|NOT COMPLETED|Treatment (12-30 mo. Post Procedure)||237
3004259|NCT00977938|3721886|FG001|NOT COMPLETED|Treatment (12-30 mo. Post Procedure)||225
3004260|NCT00977938|3721887|FG002|NOT COMPLETED|Treatment (12-30 mo. Post Procedure)||46
3004261|NCT00977938|3721888|FG003|NOT COMPLETED|Treatment (12-30 mo. Post Procedure)||61
3004262|NCT00977938|3721885|FG000|STARTED|Observation (30-33 mo. Post Procedure)||4783
3004263|NCT00977938|3721886|FG001|STARTED|Observation (30-33 mo. Post Procedure)||4716
3004264|NCT00977938|3721887|FG002|STARTED|Observation (30-33 mo. Post Procedure)||796
3004265|NCT00977938|3721888|FG003|STARTED|Observation (30-33 mo. Post Procedure)||784
3004266|NCT00977938|3721885|FG000|COMPLETED|Observation (30-33 mo. Post Procedure)||4732
3004267|NCT00977938|3721886|FG001|COMPLETED|Observation (30-33 mo. Post Procedure)||4658
3004268|NCT00977938|3721887|FG002|COMPLETED|Observation (30-33 mo. Post Procedure)||784
3004269|NCT00977938|3721888|FG003|COMPLETED|Observation (30-33 mo. Post Procedure)||781
3004270|NCT00977938|3721885|FG000|NOT COMPLETED|Observation (30-33 mo. Post Procedure)||51
3004271|NCT00977938|3721886|FG001|NOT COMPLETED|Observation (30-33 mo. Post Procedure)||58
3004272|NCT00977938|3721887|FG002|NOT COMPLETED|Observation (30-33 mo. Post Procedure)||12
3004273|NCT00977938|3721888|FG003|NOT COMPLETED|Observation (30-33 mo. Post Procedure)||3
3004274|NCT00978029|3721903|FG000|STARTED|Overall Study||65
3004275|NCT00978029|3721904|FG001|STARTED|Overall Study||66
3004276|NCT00978029|3721905|FG002|STARTED|Overall Study||65
3004277|NCT00978029|3721903|FG000|COMPLETED|Overall Study||64
3004278|NCT00978029|3721904|FG001|COMPLETED|Overall Study||63
3004279|NCT00978029|3721905|FG002|COMPLETED|Overall Study||59
3004280|NCT00978029|3721903|FG000|NOT COMPLETED|Overall Study||1
3004281|NCT00978029|3721904|FG001|NOT COMPLETED|Overall Study||3
3004282|NCT00978029|3721905|FG002|NOT COMPLETED|Overall Study||6
3004283|NCT00978042|3721915|FG000|STARTED|Initial Treatment Period||235
3004284|NCT00978042|3721916|FG001|STARTED|Initial Treatment Period||47
3004285|NCT00978042|3721915|FG000|MITT_treated With VOLUMA XC|Initial Treatment Period||235
3004286|NCT00978042|3721916|FG001|MITT_treated With VOLUMA XC|Initial Treatment Period||35
3004287|NCT00978042|3721915|FG000|COMPLETED|Initial Treatment Period|Completed 24-month Follow-Up|174
3004288|NCT00978042|3721916|FG001|COMPLETED|Initial Treatment Period||32
3004289|NCT00978042|3721915|FG000|NOT COMPLETED|Initial Treatment Period||61
3004290|NCT00978042|3721916|FG001|NOT COMPLETED|Initial Treatment Period||15
3004291|NCT00978042|3721915|FG000|STARTED|Received Repeat Treatment|Participants who were deemed eligible for re-treatment.|141
3004292|NCT00978042|3721916|FG001|STARTED|Received Repeat Treatment|Participants who were deemed eligible for re-treatment.|26
3004293|NCT00978042|3721915|FG000|COMPLETED|Received Repeat Treatment|Completed=Completed Repeat Treatment Follow-up|98
3004294|NCT00978042|3721916|FG001|COMPLETED|Received Repeat Treatment||23
3004295|NCT00978042|3721915|FG000|NOT COMPLETED|Received Repeat Treatment||43
3004296|NCT00978042|3721916|FG001|NOT COMPLETED|Received Repeat Treatment||3
3004297|NCT00978068|3721924|FG000|STARTED|Overall Study||87
3004298|NCT00978068|3721925|FG001|STARTED|Overall Study||89
3004299|NCT00978068|3721924|FG000|Initiated Study Drugs|Overall Study||84
3004300|NCT00978068|3721925|FG001|Initiated Study Drugs|Overall Study||86
3004301|NCT00978068|3721924|FG000|COMPLETED|Overall Study||83
3004302|NCT00978068|3721925|FG001|COMPLETED|Overall Study||80
3004303|NCT00978068|3721924|FG000|NOT COMPLETED|Overall Study||4
3004304|NCT00978068|3721925|FG001|NOT COMPLETED|Overall Study||9
3004305|NCT00978120|3721939|FG000|STARTED|Overall Study||110
3004306|NCT00978120|3721940|FG001|STARTED|Overall Study||107
3004307|NCT00978120|3721941|FG002|STARTED|Overall Study||87
3004308|NCT00978120|3721942|FG003|STARTED|Overall Study||86
3004309|NCT00978120|3721939|FG000|COMPLETED|Overall Study||108
3004310|NCT00978120|3721940|FG001|COMPLETED|Overall Study||107
3004311|NCT00978120|3721941|FG002|COMPLETED|Overall Study||84
3004312|NCT00978120|3721942|FG003|COMPLETED|Overall Study||84
3004313|NCT00978120|3721939|FG000|NOT COMPLETED|Overall Study||2
3004314|NCT00978120|3721940|FG001|NOT COMPLETED|Overall Study||0
3004315|NCT00978120|3721941|FG002|NOT COMPLETED|Overall Study||3
3004316|NCT00978120|3721942|FG003|NOT COMPLETED|Overall Study||2
3004317|NCT00978250|3721960|FG000|STARTED|Overall Study||25
3004318|NCT00978250|3721961|FG001|STARTED|Overall Study||30
3004319|NCT00978250|3721962|FG002|STARTED|Overall Study||18
3004320|NCT00978250|3721963|FG003|STARTED|Overall Study||22
3004321|NCT00978250|3721960|FG000|COMPLETED|Overall Study||25
3004322|NCT00978250|3721961|FG001|COMPLETED|Overall Study||29
3004323|NCT00978250|3721962|FG002|COMPLETED|Overall Study||18
3004324|NCT00978250|3721963|FG003|COMPLETED|Overall Study||21
3004325|NCT00978250|3721960|FG000|NOT COMPLETED|Overall Study||0
3004326|NCT00978250|3721961|FG001|NOT COMPLETED|Overall Study||1
3004327|NCT00978250|3721962|FG002|NOT COMPLETED|Overall Study||0
3004328|NCT00978250|3721963|FG003|NOT COMPLETED|Overall Study||1
3004329|NCT00978341|3721975|FG000|STARTED|First Intervention||8
3004330|NCT00978341|3721976|FG001|STARTED|First Intervention||7
3004331|NCT00978341|3721975|FG000|COMPLETED|First Intervention||8
3004332|NCT00978341|3721976|FG001|COMPLETED|First Intervention||7
3004333|NCT00978341|3721975|FG000|NOT COMPLETED|First Intervention||0
3004334|NCT00978341|3721976|FG001|NOT COMPLETED|First Intervention||0
3004335|NCT00978341|3721975|FG000|STARTED|Washout Period of 2 Weeks||8
3004336|NCT00978341|3721976|FG001|STARTED|Washout Period of 2 Weeks||7
3004337|NCT00978341|3721975|FG000|COMPLETED|Washout Period of 2 Weeks||7
3004338|NCT00978341|3721976|FG001|COMPLETED|Washout Period of 2 Weeks||7
3004339|NCT00978341|3721975|FG000|NOT COMPLETED|Washout Period of 2 Weeks||1
3004340|NCT00978341|3721976|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0
3004341|NCT00978341|3721975|FG000|STARTED|Second Intervention||7
3004342|NCT00978341|3721976|FG001|STARTED|Second Intervention||7
3004343|NCT00978341|3721975|FG000|COMPLETED|Second Intervention||7
3004344|NCT00978341|3721976|FG001|COMPLETED|Second Intervention||7
3004345|NCT00978341|3721975|FG000|NOT COMPLETED|Second Intervention||0
3004346|NCT00978341|3721976|FG001|NOT COMPLETED|Second Intervention||0
3004347|NCT00978380|3721983|FG000|STARTED|Overall Study||63
3004348|NCT00978380|3721983|FG000|COMPLETED|Overall Study||44
3004349|NCT00978380|3721983|FG000|NOT COMPLETED|Overall Study||19
3004350|NCT00978432|3721991|FG000|STARTED|Overall Study||10
3004351|NCT00978432|3721992|FG001|STARTED|Overall Study||5
3004352|NCT00978432|3721993|FG002|STARTED|Overall Study||18
3004353|NCT00978432|3721991|FG000|COMPLETED|Overall Study||7
3004354|NCT00978432|3721992|FG001|COMPLETED|Overall Study||4
3004355|NCT00978432|3721993|FG002|COMPLETED|Overall Study||13
3004356|NCT00978432|3721991|FG000|NOT COMPLETED|Overall Study||3
3004357|NCT00978432|3721992|FG001|NOT COMPLETED|Overall Study||1
3004358|NCT00978432|3721993|FG002|NOT COMPLETED|Overall Study||5
3004359|NCT00978445|3722001|FG000|STARTED|Overall Study||12
3004360|NCT00978445|3722002|FG001|STARTED|Overall Study||13
3004361|NCT00978445|3722001|FG000|COMPLETED|Overall Study||10
3004362|NCT00978445|3722002|FG001|COMPLETED|Overall Study||12
3004363|NCT00978445|3722001|FG000|NOT COMPLETED|Overall Study||2
3004364|NCT00978445|3722002|FG001|NOT COMPLETED|Overall Study||1
3004365|NCT00978562|3722009|FG000|STARTED|Overall Study||7
3004366|NCT00978562|3722009|FG000|COMPLETED|Overall Study||7
3004367|NCT00978562|3722009|FG000|NOT COMPLETED|Overall Study||0
3037236|NCT01147406|3756540|FG002|STARTED|Overall Study||1
3037237|NCT01147406|3756541|FG003|STARTED|Overall Study||6
3037238|NCT01147406|3756542|FG004|STARTED|Overall Study||6
3037239|NCT01147406|3756543|FG005|STARTED|Overall Study||10
3037240|NCT01147406|3756538|FG000|COMPLETED|Overall Study||6
3037241|NCT01147406|3756539|FG001|COMPLETED|Overall Study||12
3037242|NCT01147406|3756540|FG002|COMPLETED|Overall Study||1
3037243|NCT01147406|3756541|FG003|COMPLETED|Overall Study||6
3037244|NCT01147406|3756542|FG004|COMPLETED|Overall Study||6
3037245|NCT01147406|3756543|FG005|COMPLETED|Overall Study||10
3037246|NCT01147406|3756538|FG000|NOT COMPLETED|Overall Study||0
3004368|NCT00978627|3722016|FG000|STARTED|Main: Week 0 to 26 (NN5401-3594)||366
3004369|NCT00978627|3722017|FG001|STARTED|Main: Week 0 to 26 (NN5401-3594)||182
3004370|NCT00978627|3722016|FG000|Exposed|Main: Week 0 to 26 (NN5401-3594)|Four subjects withdrew prior to exposure to trial products|362
3004371|NCT00978627|3722017|FG001|Exposed|Main: Week 0 to 26 (NN5401-3594)|Two subjects withdrew prior to exposure to trial products|180
3004372|NCT00978627|3722016|FG000|COMPLETED|Main: Week 0 to 26 (NN5401-3594)||320
3004373|NCT00978627|3722017|FG001|COMPLETED|Main: Week 0 to 26 (NN5401-3594)||156
3004374|NCT00978627|3722016|FG000|NOT COMPLETED|Main: Week 0 to 26 (NN5401-3594)||46
3004375|NCT00978627|3722017|FG001|NOT COMPLETED|Main: Week 0 to 26 (NN5401-3594)||26
3004376|NCT00978627|3722016|FG000|STARTED|Extension: Week 27 to 52 (NN5401-3645)|Sixty six subjects from main trial did not continue into extension trial|254
3004377|NCT00978627|3722017|FG001|STARTED|Extension: Week 27 to 52 (NN5401-3645)|Thirty four subjects from main trial did not continue into extension trial|122
3004378|NCT00978627|3722016|FG000|COMPLETED|Extension: Week 27 to 52 (NN5401-3645)||233
3004379|NCT00978627|3722017|FG001|COMPLETED|Extension: Week 27 to 52 (NN5401-3645)||113
3004380|NCT00978627|3722016|FG000|NOT COMPLETED|Extension: Week 27 to 52 (NN5401-3645)||21
3004381|NCT00978627|3722017|FG001|NOT COMPLETED|Extension: Week 27 to 52 (NN5401-3645)||9
3004382|NCT00978731|3722027|FG000|STARTED|Overall Study||22
3004383|NCT00978731|3722028|FG001|STARTED|Overall Study||15
3004384|NCT00978731|3722029|FG002|STARTED|Overall Study||5
3004385|NCT00978731|3722030|FG003|STARTED|Overall Study||4
3004386|NCT00978731|3722027|FG000|COMPLETED|Overall Study||0
3004387|NCT00978731|3722028|FG001|COMPLETED|Overall Study||0
3004388|NCT00978731|3722029|FG002|COMPLETED|Overall Study||0
3004389|NCT00978731|3722030|FG003|COMPLETED|Overall Study||0
3004390|NCT00978731|3722027|FG000|NOT COMPLETED|Overall Study||22
3004391|NCT00978731|3722028|FG001|NOT COMPLETED|Overall Study||15
3004392|NCT00978731|3722029|FG002|NOT COMPLETED|Overall Study||5
3004393|NCT00978731|3722030|FG003|NOT COMPLETED|Overall Study||4
3004394|NCT00978757|3722046|FG000|STARTED|Overall Study|June 2001|22
3004395|NCT00978757|3722047|FG001|STARTED|Overall Study|June 2001|20
3004396|NCT00978757|3722046|FG000|COMPLETED|Overall Study|June 2008|21
3004397|NCT00978757|3722047|FG001|COMPLETED|Overall Study|June 2008|17
3004398|NCT00978757|3722046|FG000|NOT COMPLETED|Overall Study||1
3004399|NCT00978757|3722047|FG001|NOT COMPLETED|Overall Study||3
3004400|NCT00979017|3722053|FG000|STARTED|Overall Study||41
3004401|NCT00979017|3722053|FG000|COMPLETED|Overall Study||41
3004402|NCT00979017|3722053|FG000|NOT COMPLETED|Overall Study||0
3004403|NCT00979069|3722059|FG000|STARTED|Overall Study||10
3004404|NCT00979069|3722060|FG001|STARTED|Overall Study||10
3004405|NCT00979069|3722059|FG000|COMPLETED|Overall Study||10
3004406|NCT00979069|3722060|FG001|COMPLETED|Overall Study||8
3004407|NCT00979069|3722059|FG000|NOT COMPLETED|Overall Study||0
3004408|NCT00979069|3722060|FG001|NOT COMPLETED|Overall Study||2
3004409|NCT00979121|3722068|FG000|STARTED|Overall Study||379
3004410|NCT00979121|3722069|FG001|STARTED|Overall Study||366
3004411|NCT00979121|3722068|FG000|COMPLETED|Overall Study||379
3004412|NCT00979121|3722069|FG001|COMPLETED|Overall Study||366
3004413|NCT00979121|3722068|FG000|NOT COMPLETED|Overall Study||0
3004414|NCT00979121|3722069|FG001|NOT COMPLETED|Overall Study||0
3004415|NCT00979134|3722084|FG000|STARTED|Overall Study||43
3004416|NCT00979134|3722085|FG001|STARTED|Overall Study||6
3004417|NCT00979134|3722086|FG002|STARTED|Overall Study||45
3004418|NCT00979134|3722084|FG000|COMPLETED|Overall Study|At DCO|10
3004419|NCT00979134|3722085|FG001|COMPLETED|Overall Study|At DCO|0
3004420|NCT00979134|3722086|FG002|COMPLETED|Overall Study|At DCO|5
3004421|NCT00979134|3722084|FG000|NOT COMPLETED|Overall Study||33
3004422|NCT00979134|3722085|FG001|NOT COMPLETED|Overall Study||6
3004423|NCT00979134|3722086|FG002|NOT COMPLETED|Overall Study||40
3004424|NCT00979199|3722099|FG000|STARTED|Overall Study||697
3004425|NCT00979199|3722099|FG000|COMPLETED|Overall Study||475
3004426|NCT00979199|3722099|FG000|NOT COMPLETED|Overall Study||222
3004427|NCT00979212|3722105|FG000|STARTED|Overall Study||24
3004428|NCT00979212|3722106|FG001|STARTED|Overall Study||47
3004429|NCT00979212|3722105|FG000|COMPLETED|Overall Study|Subjects with data available for primary analysis are considered to have completed the study.|22
3004430|NCT00979212|3722106|FG001|COMPLETED|Overall Study|Subjects with data available for primary analysis are considered to have completed the study.|39
3004431|NCT00979212|3722105|FG000|NOT COMPLETED|Overall Study||2
3004432|NCT00979212|3722106|FG001|NOT COMPLETED|Overall Study||8
3004433|NCT00979303|3722114|FG000|STARTED|Overall Study||37
3004434|NCT00979303|3722115|FG001|STARTED|Overall Study||37
3004435|NCT00979303|3722114|FG000|COMPLETED|Overall Study||37
3004436|NCT00979303|3722115|FG001|COMPLETED|Overall Study||37
3004437|NCT00979303|3722114|FG000|NOT COMPLETED|Overall Study||0
3004438|NCT00979303|3722115|FG001|NOT COMPLETED|Overall Study||0
3004439|NCT00979407|3722123|FG000|STARTED|Overall Study||167
3004440|NCT00979407|3722124|FG001|STARTED|Overall Study||167
3004441|NCT00979407|3722123|FG000|COMPLETED|Overall Study||161
3004442|NCT00979407|3722124|FG001|COMPLETED|Overall Study||160
3004443|NCT00979407|3722123|FG000|NOT COMPLETED|Overall Study||6
3004444|NCT00979407|3722124|FG001|NOT COMPLETED|Overall Study||7
3004445|NCT00979420|3722136|FG000|STARTED|Overall Study||178
3004446|NCT00979420|3722137|FG001|STARTED|Overall Study||57
3004447|NCT00979420|3722138|FG002|STARTED|Overall Study||60
3004448|NCT00979420|3722139|FG003|STARTED|Overall Study||61
3004449|NCT00979420|3722136|FG000|COMPLETED|Overall Study||171
3004450|NCT00979420|3722137|FG001|COMPLETED|Overall Study||57
3004451|NCT00979420|3722138|FG002|COMPLETED|Overall Study||59
3004452|NCT00979420|3722139|FG003|COMPLETED|Overall Study||59
3004453|NCT00979420|3722136|FG000|NOT COMPLETED|Overall Study||7
3004454|NCT00979420|3722137|FG001|NOT COMPLETED|Overall Study||0
3004455|NCT00979420|3722138|FG002|NOT COMPLETED|Overall Study||1
3004456|NCT00979420|3722139|FG003|NOT COMPLETED|Overall Study||2
3004457|NCT00979459|3722147|FG000|STARTED|First Intervention||6
3004458|NCT00979459|3722148|FG001|STARTED|First Intervention||6
3004459|NCT00979459|3722147|FG000|COMPLETED|First Intervention||6
3004460|NCT00979459|3722148|FG001|COMPLETED|First Intervention||6
3004461|NCT00979459|3722147|FG000|NOT COMPLETED|First Intervention||0
3004462|NCT00979459|3722148|FG001|NOT COMPLETED|First Intervention||0
3004463|NCT00979459|3722147|FG000|STARTED|7-day Washout Period||6
3004464|NCT00979459|3722148|FG001|STARTED|7-day Washout Period||6
3004465|NCT00979459|3722147|FG000|COMPLETED|7-day Washout Period||6
3004466|NCT00979459|3722148|FG001|COMPLETED|7-day Washout Period||6
3004467|NCT00979459|3722147|FG000|NOT COMPLETED|7-day Washout Period||0
3004468|NCT00979459|3722148|FG001|NOT COMPLETED|7-day Washout Period||0
3004469|NCT00979459|3722147|FG000|STARTED|Second Intervention||6
3004470|NCT00979459|3722148|FG001|STARTED|Second Intervention||6
3004471|NCT00979459|3722147|FG000|COMPLETED|Second Intervention||6
3004472|NCT00979459|3722148|FG001|COMPLETED|Second Intervention||6
3004473|NCT00979459|3722147|FG000|NOT COMPLETED|Second Intervention||0
3004474|NCT00979459|3722148|FG001|NOT COMPLETED|Second Intervention||0
3004475|NCT00979576|3722159|FG000|STARTED|Combination Treatment Phase||3
3004476|NCT00979576|3722160|FG001|STARTED|Combination Treatment Phase||6
3004477|NCT00979576|3722161|FG002|STARTED|Combination Treatment Phase||9
3004478|NCT00979576|3722159|FG000|COMPLETED|Combination Treatment Phase||0
3004479|NCT00979576|3722160|FG001|COMPLETED|Combination Treatment Phase||0
3004480|NCT00979576|3722161|FG002|COMPLETED|Combination Treatment Phase||0
3004481|NCT00979576|3722159|FG000|NOT COMPLETED|Combination Treatment Phase||3
3004482|NCT00979576|3722160|FG001|NOT COMPLETED|Combination Treatment Phase||6
3004483|NCT00979576|3722161|FG002|NOT COMPLETED|Combination Treatment Phase||9
3004484|NCT00979576|3722159|FG000|STARTED|Combination Followed by Monotherapy||0
3004485|NCT00979576|3722160|FG001|STARTED|Combination Followed by Monotherapy||2
3004486|NCT00979576|3722161|FG002|STARTED|Combination Followed by Monotherapy||1
3004487|NCT00979576|3722159|FG000|COMPLETED|Combination Followed by Monotherapy||0
3004488|NCT00979576|3722160|FG001|COMPLETED|Combination Followed by Monotherapy||0
3004489|NCT00979576|3722161|FG002|COMPLETED|Combination Followed by Monotherapy||0
3004490|NCT00979576|3722159|FG000|NOT COMPLETED|Combination Followed by Monotherapy||0
3004491|NCT00979576|3722160|FG001|NOT COMPLETED|Combination Followed by Monotherapy||2
3004492|NCT00979576|3722161|FG002|NOT COMPLETED|Combination Followed by Monotherapy||1
3004493|NCT00979602|3722172|FG000|STARTED|Overall Study||2025
3004494|NCT00979602|3722173|FG001|STARTED|Overall Study||2023
3004495|NCT00979602|3722172|FG000|COMPLETED|Overall Study||1880
3004496|NCT00979602|3722173|FG001|COMPLETED|Overall Study||1890
3004497|NCT00979602|3722172|FG000|NOT COMPLETED|Overall Study||145
3004498|NCT00979602|3722173|FG001|NOT COMPLETED|Overall Study||133
3004499|NCT00979615|3722193|FG000|STARTED|Overall Study||63
3004500|NCT00979615|3722194|FG001|STARTED|Overall Study||66
3004501|NCT00979615|3722193|FG000|COMPLETED|Overall Study||57
3004502|NCT00979615|3722194|FG001|COMPLETED|Overall Study||58
3004503|NCT00979615|3722193|FG000|NOT COMPLETED|Overall Study||6
3004504|NCT00979615|3722194|FG001|NOT COMPLETED|Overall Study||8
3004505|NCT00979628|3722203|FG000|STARTED|Overall Study||153
3004506|NCT00979628|3722204|FG001|STARTED|Overall Study||142
3004507|NCT00979628|3722205|FG002|STARTED|Overall Study||80
3004508|NCT00979628|3722203|FG000|COMPLETED|Overall Study||144
3004509|NCT00979628|3722204|FG001|COMPLETED|Overall Study||133
3004510|NCT00979628|3722205|FG002|COMPLETED|Overall Study||74
3004511|NCT00979628|3722203|FG000|NOT COMPLETED|Overall Study||9
3004512|NCT00979628|3722204|FG001|NOT COMPLETED|Overall Study||9
3004513|NCT00979628|3722205|FG002|NOT COMPLETED|Overall Study||6
3004514|NCT00979654|3722216|FG000|STARTED|Overall Study||103
3004515|NCT00979654|3722216|FG000|COMPLETED|Overall Study||67
3004516|NCT00979654|3722216|FG000|NOT COMPLETED|Overall Study||36
3004517|NCT00979732|3722222|FG000|STARTED|Overall Study||15
3004518|NCT00979732|3722223|FG001|STARTED|Overall Study||18
3004519|NCT00979732|3722222|FG000|COMPLETED|Overall Study||12
3004520|NCT00979732|3722223|FG001|COMPLETED|Overall Study||17
3004521|NCT00979732|3722222|FG000|NOT COMPLETED|Overall Study||3
3004522|NCT00979732|3722223|FG001|NOT COMPLETED|Overall Study||1
3004523|NCT00979745|3722231|FG000|STARTED|Overall Study||38
3004524|NCT00979745|3722232|FG001|STARTED|Overall Study||36
3004525|NCT00979745|3722231|FG000|COMPLETED|Overall Study||34
3004526|NCT00979745|3722232|FG001|COMPLETED|Overall Study||34
3004527|NCT00979745|3722231|FG000|NOT COMPLETED|Overall Study||4
3004528|NCT00979745|3722232|FG001|NOT COMPLETED|Overall Study||2
3004529|NCT00979875|3722238|FG000|STARTED|Intervention 1||2
3004530|NCT00979875|3722239|FG001|STARTED|Intervention 1||2
3004531|NCT00979875|3722240|FG002|STARTED|Intervention 1||3
3004532|NCT00979875|3722241|FG003|STARTED|Intervention 1||2
3004533|NCT00979875|3722242|FG004|STARTED|Intervention 1||3
3004534|NCT00979875|3722243|FG005|STARTED|Intervention 1||2
3004535|NCT00979875|3722238|FG000|Received at Least 1 Dose of Study Drug|Intervention 1||2
3004536|NCT00979875|3722239|FG001|Received at Least 1 Dose of Study Drug|Intervention 1||2
3004537|NCT00979875|3722240|FG002|Received at Least 1 Dose of Study Drug|Intervention 1||3
3004538|NCT00979875|3722241|FG003|Received at Least 1 Dose of Study Drug|Intervention 1||2
3004539|NCT00979875|3722242|FG004|Received at Least 1 Dose of Study Drug|Intervention 1||3
3004540|NCT00979875|3722243|FG005|Received at Least 1 Dose of Study Drug|Intervention 1||2
3004541|NCT00979875|3722238|FG000|COMPLETED|Intervention 1||2
3004542|NCT00979875|3722239|FG001|COMPLETED|Intervention 1||2
3004543|NCT00979875|3722240|FG002|COMPLETED|Intervention 1||3
3004544|NCT00979875|3722241|FG003|COMPLETED|Intervention 1||2
3004545|NCT00979875|3722242|FG004|COMPLETED|Intervention 1||3
3004546|NCT00979875|3722243|FG005|COMPLETED|Intervention 1||2
3004547|NCT00979875|3722238|FG000|NOT COMPLETED|Intervention 1||0
3004548|NCT00979875|3722239|FG001|NOT COMPLETED|Intervention 1||0
3004549|NCT00979875|3722240|FG002|NOT COMPLETED|Intervention 1||0
3004550|NCT00979875|3722241|FG003|NOT COMPLETED|Intervention 1||0
3004551|NCT00979875|3722242|FG004|NOT COMPLETED|Intervention 1||0
3004552|NCT00979875|3722243|FG005|NOT COMPLETED|Intervention 1||0
3004553|NCT00979875|3722238|FG000|STARTED|Washout 1 (3 to 14 Days)||2
3004554|NCT00979875|3722239|FG001|STARTED|Washout 1 (3 to 14 Days)||2
3004555|NCT00979875|3722240|FG002|STARTED|Washout 1 (3 to 14 Days)||3
3004556|NCT00979875|3722241|FG003|STARTED|Washout 1 (3 to 14 Days)||2
3004557|NCT00979875|3722242|FG004|STARTED|Washout 1 (3 to 14 Days)||3
3004558|NCT00979875|3722243|FG005|STARTED|Washout 1 (3 to 14 Days)||2
3004559|NCT00979875|3722238|FG000|COMPLETED|Washout 1 (3 to 14 Days)||2
3004560|NCT00979875|3722239|FG001|COMPLETED|Washout 1 (3 to 14 Days)||2
3004561|NCT00979875|3722240|FG002|COMPLETED|Washout 1 (3 to 14 Days)||3
3004562|NCT00979875|3722241|FG003|COMPLETED|Washout 1 (3 to 14 Days)||2
3004563|NCT00979875|3722242|FG004|COMPLETED|Washout 1 (3 to 14 Days)||3
3004564|NCT00979875|3722243|FG005|COMPLETED|Washout 1 (3 to 14 Days)||2
3004565|NCT00979875|3722238|FG000|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
3004566|NCT00979875|3722239|FG001|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
3004567|NCT00979875|3722240|FG002|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
3004568|NCT00979875|3722241|FG003|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
3004569|NCT00979875|3722242|FG004|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
3004570|NCT00979875|3722243|FG005|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
3004571|NCT00979875|3722238|FG000|STARTED|Intervention 2||2
3004572|NCT00979875|3722239|FG001|STARTED|Intervention 2||2
3004573|NCT00979875|3722240|FG002|STARTED|Intervention 2||3
3004574|NCT00979875|3722241|FG003|STARTED|Intervention 2||2
3004575|NCT00979875|3722242|FG004|STARTED|Intervention 2||3
3004576|NCT00979875|3722243|FG005|STARTED|Intervention 2||2
3004577|NCT00979875|3722238|FG000|COMPLETED|Intervention 2||2
3004578|NCT00979875|3722239|FG001|COMPLETED|Intervention 2||2
3004579|NCT00979875|3722240|FG002|COMPLETED|Intervention 2||3
3004580|NCT00979875|3722241|FG003|COMPLETED|Intervention 2||2
3004581|NCT00979875|3722242|FG004|COMPLETED|Intervention 2||3
3004582|NCT00979875|3722243|FG005|COMPLETED|Intervention 2||2
3004583|NCT00979875|3722238|FG000|NOT COMPLETED|Intervention 2||0
3004584|NCT00979875|3722239|FG001|NOT COMPLETED|Intervention 2||0
3004585|NCT00979875|3722240|FG002|NOT COMPLETED|Intervention 2||0
3004586|NCT00979875|3722241|FG003|NOT COMPLETED|Intervention 2||0
3004587|NCT00979875|3722242|FG004|NOT COMPLETED|Intervention 2||0
3004588|NCT00979875|3722243|FG005|NOT COMPLETED|Intervention 2||0
3004589|NCT00979875|3722238|FG000|STARTED|Washout 2 (3 to 14 Days)||2
3004590|NCT00979875|3722239|FG001|STARTED|Washout 2 (3 to 14 Days)||2
3004591|NCT00979875|3722240|FG002|STARTED|Washout 2 (3 to 14 Days)||3
3004592|NCT00979875|3722241|FG003|STARTED|Washout 2 (3 to 14 Days)||2
3004593|NCT00979875|3722242|FG004|STARTED|Washout 2 (3 to 14 Days)||3
3004594|NCT00979875|3722243|FG005|STARTED|Washout 2 (3 to 14 Days)||2
3004595|NCT00979875|3722238|FG000|COMPLETED|Washout 2 (3 to 14 Days)||2
3004596|NCT00979875|3722239|FG001|COMPLETED|Washout 2 (3 to 14 Days)||2
3004597|NCT00979875|3722240|FG002|COMPLETED|Washout 2 (3 to 14 Days)||3
3004598|NCT00979875|3722241|FG003|COMPLETED|Washout 2 (3 to 14 Days)||2
3004599|NCT00979875|3722242|FG004|COMPLETED|Washout 2 (3 to 14 Days)||3
3004600|NCT00979875|3722243|FG005|COMPLETED|Washout 2 (3 to 14 Days)||2
3004601|NCT00979875|3722238|FG000|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
3004602|NCT00979875|3722239|FG001|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
3004603|NCT00979875|3722240|FG002|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
3004604|NCT00979875|3722241|FG003|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
3004605|NCT00979875|3722242|FG004|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
3004606|NCT00979875|3722243|FG005|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
3004607|NCT00979875|3722238|FG000|STARTED|Intervention 3||2
3004608|NCT00979875|3722239|FG001|STARTED|Intervention 3||2
3004609|NCT00979875|3722240|FG002|STARTED|Intervention 3||3
3004610|NCT00979875|3722241|FG003|STARTED|Intervention 3||2
3004611|NCT00979875|3722242|FG004|STARTED|Intervention 3||3
3004612|NCT00979875|3722243|FG005|STARTED|Intervention 3||2
3004613|NCT00979875|3722238|FG000|COMPLETED|Intervention 3||2
3004614|NCT00979875|3722239|FG001|COMPLETED|Intervention 3||2
3004615|NCT00979875|3722240|FG002|COMPLETED|Intervention 3||3
3004616|NCT00979875|3722241|FG003|COMPLETED|Intervention 3||2
3004617|NCT00979875|3722242|FG004|COMPLETED|Intervention 3||3
3004618|NCT00979875|3722243|FG005|COMPLETED|Intervention 3||2
3004619|NCT00979875|3722238|FG000|NOT COMPLETED|Intervention 3||0
3004620|NCT00979875|3722239|FG001|NOT COMPLETED|Intervention 3||0
3004621|NCT00979875|3722240|FG002|NOT COMPLETED|Intervention 3||0
3004622|NCT00979875|3722241|FG003|NOT COMPLETED|Intervention 3||0
3004623|NCT00979875|3722242|FG004|NOT COMPLETED|Intervention 3||0
3004624|NCT00979875|3722243|FG005|NOT COMPLETED|Intervention 3||0
3004625|NCT00979940|3722259|FG000|STARTED|Overall Study||32
3004626|NCT00979940|3722260|FG001|STARTED|Overall Study||28
3004627|NCT00979940|3722259|FG000|COMPLETED|Overall Study||32
3004628|NCT00979940|3722260|FG001|COMPLETED|Overall Study||28
3004629|NCT00979940|3722259|FG000|NOT COMPLETED|Overall Study||0
3004630|NCT00979940|3722260|FG001|NOT COMPLETED|Overall Study||0
3004631|NCT00979953|3722270|FG000|STARTED|Overall Study||101
3004632|NCT00979953|3722271|FG001|STARTED|Overall Study||99
3004633|NCT00979953|3722272|FG002|STARTED|Overall Study||104
3004634|NCT00979953|3722273|FG003|STARTED|Overall Study||104
3004635|NCT00979953|3722270|FG000|Received at Least 1 Dose of Study Drug|Overall Study||101
3004636|NCT00979953|3722271|FG001|Received at Least 1 Dose of Study Drug|Overall Study||99
3004637|NCT00979953|3722272|FG002|Received at Least 1 Dose of Study Drug|Overall Study||104
3004638|NCT00979953|3722273|FG003|Received at Least 1 Dose of Study Drug|Overall Study||104
3004639|NCT00979953|3722270|FG000|COMPLETED|Overall Study||93
3004640|NCT00979953|3722271|FG001|COMPLETED|Overall Study||94
3004641|NCT00979953|3722272|FG002|COMPLETED|Overall Study||82
3004642|NCT00979953|3722273|FG003|COMPLETED|Overall Study||97
3004643|NCT00979953|3722270|FG000|NOT COMPLETED|Overall Study||8
3004644|NCT00979953|3722271|FG001|NOT COMPLETED|Overall Study||5
3004645|NCT00979953|3722272|FG002|NOT COMPLETED|Overall Study||22
3004646|NCT00979953|3722273|FG003|NOT COMPLETED|Overall Study||7
3004647|NCT00979992|3722283|FG000|STARTED|Overall Study||35
3004648|NCT00979992|3722283|FG000|COMPLETED|Overall Study||30
3004649|NCT00979992|3722283|FG000|NOT COMPLETED|Overall Study||5
3004650|NCT00980005|3722289|FG000|STARTED|Overall Study||1055
3004651|NCT00980005|3722290|FG001|STARTED|Overall Study||1061
3004652|NCT00980005|3722289|FG000|COMPLETED|Overall Study||1008
3004653|NCT00980005|3722290|FG001|COMPLETED|Overall Study||998
3004654|NCT00980005|3722289|FG000|NOT COMPLETED|Overall Study||47
3004655|NCT00980005|3722290|FG001|NOT COMPLETED|Overall Study||63
3004656|NCT00980018|3722300|FG000|STARTED|Overall Study||52
3004657|NCT00980018|3722300|FG000|COMPLETED|Overall Study||40
3004658|NCT00980018|3722300|FG000|NOT COMPLETED|Overall Study||12
3004659|NCT00980044|3722307|FG000|STARTED|Overall Study||17
3004660|NCT00980044|3722308|FG001|STARTED|Overall Study||19
3004661|NCT00980044|3722309|FG002|STARTED|Overall Study||17
3004662|NCT00980044|3722307|FG000|COMPLETED|Overall Study||12
3004663|NCT00980044|3722308|FG001|COMPLETED|Overall Study||12
3004664|NCT00980044|3722309|FG002|COMPLETED|Overall Study||12
3004665|NCT00980044|3722307|FG000|NOT COMPLETED|Overall Study||5
3004666|NCT00980044|3722308|FG001|NOT COMPLETED|Overall Study||7
3004667|NCT00980044|3722309|FG002|NOT COMPLETED|Overall Study||5
3004668|NCT00980057|3722322|FG000|STARTED|Overall Study||318
3004669|NCT00980057|3722323|FG001|STARTED|Overall Study||160
3004670|NCT00980057|3722322|FG000|COMPLETED|Overall Study||299
3004671|NCT00980057|3722323|FG001|COMPLETED|Overall Study||155
3004672|NCT00980057|3722322|FG000|NOT COMPLETED|Overall Study||19
3004673|NCT00980057|3722323|FG001|NOT COMPLETED|Overall Study||5
3004674|NCT00980148|3722332|FG000|STARTED|Overall Study||284
3004675|NCT00980148|3722333|FG001|STARTED|Overall Study||283
3004676|NCT00980148|3722332|FG000|COMPLETED|Overall Study|Completed primary evaluation at study visit # 2 (day 28 after therapy started)|155
3004677|NCT00980148|3722333|FG001|COMPLETED|Overall Study|Completed primary evaluation at study visit # 2 (day 28 after therapy started)|155
3004678|NCT00980148|3722332|FG000|NOT COMPLETED|Overall Study||129
3004679|NCT00980148|3722333|FG001|NOT COMPLETED|Overall Study||128
3004680|NCT00980174|3722341|FG000|STARTED|Overall Study||121
3004681|NCT00980174|3722342|FG001|STARTED|Overall Study||121
3004682|NCT00980174|3722341|FG000|COMPLETED|Overall Study||117
3004683|NCT00980174|3722342|FG001|COMPLETED|Overall Study||111
3004684|NCT00980174|3722341|FG000|NOT COMPLETED|Overall Study||4
3004685|NCT00980174|3722342|FG001|NOT COMPLETED|Overall Study||10
3004686|NCT00980200|3722348|FG000|STARTED|7-day Treatment Period 1||15
3004687|NCT00980200|3722349|FG001|STARTED|7-day Treatment Period 1||14
3004688|NCT00980200|3722350|FG002|STARTED|7-day Treatment Period 1||15
3004689|NCT00980200|3722351|FG003|STARTED|7-day Treatment Period 1||16
3004690|NCT00980200|3722352|FG004|STARTED|7-day Treatment Period 1||15
3004691|NCT00980200|3722348|FG000|COMPLETED|7-day Treatment Period 1||15
3004692|NCT00980200|3722349|FG001|COMPLETED|7-day Treatment Period 1||13
3004693|NCT00980200|3722350|FG002|COMPLETED|7-day Treatment Period 1||15
3004694|NCT00980200|3722351|FG003|COMPLETED|7-day Treatment Period 1||16
3004695|NCT00980200|3722352|FG004|COMPLETED|7-day Treatment Period 1||15
3004696|NCT00980200|3722348|FG000|NOT COMPLETED|7-day Treatment Period 1||0
3004697|NCT00980200|3722349|FG001|NOT COMPLETED|7-day Treatment Period 1||1
3004698|NCT00980200|3722350|FG002|NOT COMPLETED|7-day Treatment Period 1||0
3004699|NCT00980200|3722351|FG003|NOT COMPLETED|7-day Treatment Period 1||0
3004700|NCT00980200|3722352|FG004|NOT COMPLETED|7-day Treatment Period 1||0
3004701|NCT00980200|3722348|FG000|STARTED|7-day Washout Period 1||15
3004702|NCT00980200|3722349|FG001|STARTED|7-day Washout Period 1||13
3004703|NCT00980200|3722350|FG002|STARTED|7-day Washout Period 1||15
3004704|NCT00980200|3722351|FG003|STARTED|7-day Washout Period 1||16
3004705|NCT00980200|3722352|FG004|STARTED|7-day Washout Period 1||15
3004706|NCT00980200|3722348|FG000|COMPLETED|7-day Washout Period 1||15
3004707|NCT00980200|3722349|FG001|COMPLETED|7-day Washout Period 1||13
3004708|NCT00980200|3722350|FG002|COMPLETED|7-day Washout Period 1||15
3004709|NCT00980200|3722351|FG003|COMPLETED|7-day Washout Period 1||16
3004710|NCT00980200|3722352|FG004|COMPLETED|7-day Washout Period 1||15
3004711|NCT00980200|3722348|FG000|NOT COMPLETED|7-day Washout Period 1||0
3004712|NCT00980200|3722349|FG001|NOT COMPLETED|7-day Washout Period 1||0
3004713|NCT00980200|3722350|FG002|NOT COMPLETED|7-day Washout Period 1||0
3004714|NCT00980200|3722351|FG003|NOT COMPLETED|7-day Washout Period 1||0
3004715|NCT00980200|3722352|FG004|NOT COMPLETED|7-day Washout Period 1||0
3004716|NCT00980200|3722348|FG000|STARTED|7-day Treatment Period 2||15
3004717|NCT00980200|3722349|FG001|STARTED|7-day Treatment Period 2||13
3004718|NCT00980200|3722350|FG002|STARTED|7-day Treatment Period 2||15
3004719|NCT00980200|3722351|FG003|STARTED|7-day Treatment Period 2||16
3004720|NCT00980200|3722352|FG004|STARTED|7-day Treatment Period 2||15
3004721|NCT00980200|3722348|FG000|COMPLETED|7-day Treatment Period 2||15
3004722|NCT00980200|3722349|FG001|COMPLETED|7-day Treatment Period 2||13
3004723|NCT00980200|3722350|FG002|COMPLETED|7-day Treatment Period 2||15
3004724|NCT00980200|3722351|FG003|COMPLETED|7-day Treatment Period 2||16
3004725|NCT00980200|3722352|FG004|COMPLETED|7-day Treatment Period 2||15
3004726|NCT00980200|3722348|FG000|NOT COMPLETED|7-day Treatment Period 2||0
3004727|NCT00980200|3722349|FG001|NOT COMPLETED|7-day Treatment Period 2||0
3004728|NCT00980200|3722350|FG002|NOT COMPLETED|7-day Treatment Period 2||0
3004729|NCT00980200|3722351|FG003|NOT COMPLETED|7-day Treatment Period 2||0
3004730|NCT00980200|3722352|FG004|NOT COMPLETED|7-day Treatment Period 2||0
3004731|NCT00980200|3722348|FG000|STARTED|7-day Washout Period 2||15
3004732|NCT00980200|3722349|FG001|STARTED|7-day Washout Period 2||13
3004733|NCT00980200|3722350|FG002|STARTED|7-day Washout Period 2||15
3004734|NCT00980200|3722351|FG003|STARTED|7-day Washout Period 2||16
3004735|NCT00980200|3722352|FG004|STARTED|7-day Washout Period 2||15
3004736|NCT00980200|3722348|FG000|COMPLETED|7-day Washout Period 2||15
3004737|NCT00980200|3722349|FG001|COMPLETED|7-day Washout Period 2||13
3004738|NCT00980200|3722350|FG002|COMPLETED|7-day Washout Period 2||15
3004739|NCT00980200|3722351|FG003|COMPLETED|7-day Washout Period 2||16
3004740|NCT00980200|3722352|FG004|COMPLETED|7-day Washout Period 2||15
3004741|NCT00980200|3722348|FG000|NOT COMPLETED|7-day Washout Period 2||0
3004742|NCT00980200|3722349|FG001|NOT COMPLETED|7-day Washout Period 2||0
3004743|NCT00980200|3722350|FG002|NOT COMPLETED|7-day Washout Period 2||0
3004744|NCT00980200|3722351|FG003|NOT COMPLETED|7-day Washout Period 2||0
3004745|NCT00980200|3722352|FG004|NOT COMPLETED|7-day Washout Period 2||0
3004746|NCT00980200|3722348|FG000|STARTED|7-day Treatment Period 3||15
3004747|NCT00980200|3722349|FG001|STARTED|7-day Treatment Period 3||13
3004748|NCT00980200|3722350|FG002|STARTED|7-day Treatment Period 3||15
3004749|NCT00980200|3722351|FG003|STARTED|7-day Treatment Period 3||16
3004750|NCT00980200|3722352|FG004|STARTED|7-day Treatment Period 3||15
3004751|NCT00980200|3722348|FG000|COMPLETED|7-day Treatment Period 3||15
3004752|NCT00980200|3722349|FG001|COMPLETED|7-day Treatment Period 3||12
3004753|NCT00980200|3722350|FG002|COMPLETED|7-day Treatment Period 3||15
3004754|NCT00980200|3722351|FG003|COMPLETED|7-day Treatment Period 3||16
3004755|NCT00980200|3722352|FG004|COMPLETED|7-day Treatment Period 3||14
3004756|NCT00980200|3722348|FG000|NOT COMPLETED|7-day Treatment Period 3||0
3004757|NCT00980200|3722349|FG001|NOT COMPLETED|7-day Treatment Period 3||1
3004758|NCT00980200|3722350|FG002|NOT COMPLETED|7-day Treatment Period 3||0
3004759|NCT00980200|3722351|FG003|NOT COMPLETED|7-day Treatment Period 3||0
3004760|NCT00980200|3722352|FG004|NOT COMPLETED|7-day Treatment Period 3||1
3004761|NCT00980200|3722348|FG000|STARTED|7-day Washout Period 3||15
3004762|NCT00980200|3722349|FG001|STARTED|7-day Washout Period 3||12
3004763|NCT00980200|3722350|FG002|STARTED|7-day Washout Period 3||15
3004764|NCT00980200|3722351|FG003|STARTED|7-day Washout Period 3||16
3004765|NCT00980200|3722352|FG004|STARTED|7-day Washout Period 3||14
3004766|NCT00980200|3722348|FG000|COMPLETED|7-day Washout Period 3||15
3004767|NCT00980200|3722349|FG001|COMPLETED|7-day Washout Period 3||12
3004768|NCT00980200|3722350|FG002|COMPLETED|7-day Washout Period 3||15
3004769|NCT00980200|3722351|FG003|COMPLETED|7-day Washout Period 3||16
3004770|NCT00980200|3722352|FG004|COMPLETED|7-day Washout Period 3||14
3004771|NCT00980200|3722348|FG000|NOT COMPLETED|7-day Washout Period 3||0
3004772|NCT00980200|3722349|FG001|NOT COMPLETED|7-day Washout Period 3||0
3004773|NCT00980200|3722350|FG002|NOT COMPLETED|7-day Washout Period 3||0
3004774|NCT00980200|3722351|FG003|NOT COMPLETED|7-day Washout Period 3||0
3004775|NCT00980200|3722352|FG004|NOT COMPLETED|7-day Washout Period 3||0
3004776|NCT00980200|3722348|FG000|STARTED|7-day Treatment Period 4||15
3004777|NCT00980200|3722349|FG001|STARTED|7-day Treatment Period 4||12
3004778|NCT00980200|3722350|FG002|STARTED|7-day Treatment Period 4||15
3004779|NCT00980200|3722351|FG003|STARTED|7-day Treatment Period 4||16
3004780|NCT00980200|3722352|FG004|STARTED|7-day Treatment Period 4||14
3004781|NCT00980200|3722348|FG000|COMPLETED|7-day Treatment Period 4||15
3004782|NCT00980200|3722349|FG001|COMPLETED|7-day Treatment Period 4||12
3004783|NCT00980200|3722350|FG002|COMPLETED|7-day Treatment Period 4||15
3004784|NCT00980200|3722351|FG003|COMPLETED|7-day Treatment Period 4||16
3004785|NCT00980200|3722352|FG004|COMPLETED|7-day Treatment Period 4||14
3004786|NCT00980200|3722348|FG000|NOT COMPLETED|7-day Treatment Period 4||0
3004787|NCT00980200|3722349|FG001|NOT COMPLETED|7-day Treatment Period 4||0
3004788|NCT00980200|3722350|FG002|NOT COMPLETED|7-day Treatment Period 4||0
3004789|NCT00980200|3722351|FG003|NOT COMPLETED|7-day Treatment Period 4||0
3004790|NCT00980200|3722352|FG004|NOT COMPLETED|7-day Treatment Period 4||0
3004791|NCT00980200|3722348|FG000|STARTED|7-day Washout Period 4||15
3004792|NCT00980200|3722349|FG001|STARTED|7-day Washout Period 4||12
3004793|NCT00980200|3722350|FG002|STARTED|7-day Washout Period 4||15
3004794|NCT00980200|3722351|FG003|STARTED|7-day Washout Period 4||16
3004795|NCT00980200|3722352|FG004|STARTED|7-day Washout Period 4||14
3004796|NCT00980200|3722348|FG000|COMPLETED|7-day Washout Period 4||15
3004797|NCT00980200|3722349|FG001|COMPLETED|7-day Washout Period 4||12
3004798|NCT00980200|3722350|FG002|COMPLETED|7-day Washout Period 4||15
3004799|NCT00980200|3722351|FG003|COMPLETED|7-day Washout Period 4||16
3004800|NCT00980200|3722352|FG004|COMPLETED|7-day Washout Period 4||14
3004801|NCT00980200|3722348|FG000|NOT COMPLETED|7-day Washout Period 4||0
3004802|NCT00980200|3722349|FG001|NOT COMPLETED|7-day Washout Period 4||0
3004803|NCT00980200|3722350|FG002|NOT COMPLETED|7-day Washout Period 4||0
3004804|NCT00980200|3722351|FG003|NOT COMPLETED|7-day Washout Period 4||0
3004805|NCT00980200|3722352|FG004|NOT COMPLETED|7-day Washout Period 4||0
3004806|NCT00980200|3722348|FG000|STARTED|7-day Treatment Period 5||15
3004807|NCT00980200|3722349|FG001|STARTED|7-day Treatment Period 5||12
3004808|NCT00980200|3722350|FG002|STARTED|7-day Treatment Period 5||15
3004809|NCT00980200|3722351|FG003|STARTED|7-day Treatment Period 5||16
3004810|NCT00980200|3722352|FG004|STARTED|7-day Treatment Period 5||14
3004811|NCT00980200|3722348|FG000|COMPLETED|7-day Treatment Period 5||15
3004812|NCT00980200|3722349|FG001|COMPLETED|7-day Treatment Period 5||12
3004813|NCT00980200|3722350|FG002|COMPLETED|7-day Treatment Period 5||15
3004814|NCT00980200|3722351|FG003|COMPLETED|7-day Treatment Period 5||16
3004815|NCT00980200|3722352|FG004|COMPLETED|7-day Treatment Period 5||14
3004816|NCT00980200|3722348|FG000|NOT COMPLETED|7-day Treatment Period 5||0
3004817|NCT00980200|3722349|FG001|NOT COMPLETED|7-day Treatment Period 5||0
3004818|NCT00980200|3722350|FG002|NOT COMPLETED|7-day Treatment Period 5||0
3004819|NCT00980200|3722351|FG003|NOT COMPLETED|7-day Treatment Period 5||0
3004820|NCT00980200|3722352|FG004|NOT COMPLETED|7-day Treatment Period 5||0
3004821|NCT00980278|3722366|FG000|STARTED|Overall Study||13
3004822|NCT00980278|3722367|FG001|STARTED|Overall Study||13
3004823|NCT00980278|3722366|FG000|COMPLETED|Overall Study||11
3004824|NCT00980278|3722367|FG001|COMPLETED|Overall Study||13
3004825|NCT00980278|3722366|FG000|NOT COMPLETED|Overall Study||2
3004826|NCT00980278|3722367|FG001|NOT COMPLETED|Overall Study||0
3004827|NCT00980330|3722380|FG000|STARTED|Overall Study||66
3004828|NCT00980330|3722381|FG001|STARTED|Overall Study||65
3004829|NCT00980330|3722382|FG002|STARTED|Overall Study||66
3004830|NCT00980330|3722383|FG003|STARTED|Overall Study||66
3004831|NCT00980330|3722384|FG004|STARTED|Overall Study||68
3004832|NCT00980330|3722385|FG005|STARTED|Overall Study||65
3004833|NCT00980330|3722386|FG006|STARTED|Overall Study||66
3004834|NCT00980330|3722380|FG000|COMPLETED|Overall Study||61
3004835|NCT00980330|3722381|FG001|COMPLETED|Overall Study||60
3004836|NCT00980330|3722382|FG002|COMPLETED|Overall Study||58
3004837|NCT00980330|3722383|FG003|COMPLETED|Overall Study||61
3004838|NCT00980330|3722384|FG004|COMPLETED|Overall Study||63
3004839|NCT00980330|3722385|FG005|COMPLETED|Overall Study||61
3004840|NCT00980330|3722386|FG006|COMPLETED|Overall Study||59
3004841|NCT00980330|3722380|FG000|NOT COMPLETED|Overall Study||5
3004842|NCT00980330|3722381|FG001|NOT COMPLETED|Overall Study||5
3004843|NCT00980330|3722382|FG002|NOT COMPLETED|Overall Study||8
3004844|NCT00980330|3722383|FG003|NOT COMPLETED|Overall Study||5
3004845|NCT00980330|3722384|FG004|NOT COMPLETED|Overall Study||5
3004846|NCT00980330|3722385|FG005|NOT COMPLETED|Overall Study||4
3004847|NCT00980330|3722386|FG006|NOT COMPLETED|Overall Study||7
3004848|NCT00980343|3722405|FG000|STARTED|Overall Study||21
3004849|NCT00980343|3722406|FG001|STARTED|Overall Study||23
3004850|NCT00980343|3722405|FG000|COMPLETED|Overall Study||20
3004851|NCT00980343|3722406|FG001|COMPLETED|Overall Study||20
3004852|NCT00980343|3722405|FG000|NOT COMPLETED|Overall Study||1
3004853|NCT00980343|3722406|FG001|NOT COMPLETED|Overall Study||3
3004854|NCT00980395|3722413|FG000|STARTED|Overall Study||24
3004855|NCT00980395|3722413|FG000|COMPLETED|Overall Study||24
3004856|NCT00980395|3722413|FG000|NOT COMPLETED|Overall Study||0
3004857|NCT00980590|3722419|FG000|STARTED|Overall Study||50
3004858|NCT00980590|3722420|FG001|STARTED|Overall Study||50
3004859|NCT00980590|3722419|FG000|COMPLETED|Overall Study||50
3004860|NCT00980590|3722420|FG001|COMPLETED|Overall Study||50
3004861|NCT00980590|3722419|FG000|NOT COMPLETED|Overall Study||0
3004862|NCT00980590|3722420|FG001|NOT COMPLETED|Overall Study||0
3004863|NCT00980642|3722428|FG000|STARTED|Overall Study||36
3004864|NCT00980642|3722429|FG001|STARTED|Overall Study||20
3004865|NCT00980642|3722428|FG000|COMPLETED|Overall Study||36
3004866|NCT00980642|3722429|FG001|COMPLETED|Overall Study||20
3004867|NCT00980642|3722428|FG000|NOT COMPLETED|Overall Study||0
3004868|NCT00980642|3722429|FG001|NOT COMPLETED|Overall Study||0
3004869|NCT00980655|3722438|FG000|STARTED|Overall Study||61
3004870|NCT00980655|3722439|FG001|STARTED|Overall Study||190
3004871|NCT00980655|3722438|FG000|Vaccinated 13vPnC Dose 1|Overall Study||59
3004872|NCT00980655|3722439|FG001|Vaccinated 13vPnC Dose 1|Overall Study||188
3004873|NCT00980655|3722438|FG000|Vaccinated 13vPnC Dose 2|Overall Study||55
3004874|NCT00980655|3722439|FG001|Vaccinated 13vPnC Dose 2|Overall Study||176
3004875|NCT00980655|3722438|FG000|Vaccinated 13vPnC Dose 3|Overall Study||54
3004876|NCT00980655|3722439|FG001|Vaccinated 13vPnC Dose 3|Overall Study||167
3004877|NCT00980655|3722438|FG000|Vaccinated 13vPnC Dose 4|Overall Study||46
3004878|NCT00980655|3722439|FG001|Vaccinated 13vPnC Dose 4|Overall Study||146
3004879|NCT00980655|3722438|FG000|Vaccinated 23vPS Dose|Overall Study||45
3004880|NCT00980655|3722439|FG001|Vaccinated 23vPS Dose|Overall Study||140
3004881|NCT00980655|3722438|FG000|COMPLETED|Overall Study||45
3004882|NCT00980655|3722439|FG001|COMPLETED|Overall Study||139
3004883|NCT00980655|3722438|FG000|NOT COMPLETED|Overall Study||16
3004884|NCT00980655|3722439|FG001|NOT COMPLETED|Overall Study||51
3004885|NCT00980681|3722450|FG000|STARTED|TOF MRA|Out of the 13 enrolled patients, three did not receive treatment|10
3004886|NCT00980681|3722450|FG000|COMPLETED|TOF MRA||10
3004887|NCT00980681|3722450|FG000|NOT COMPLETED|TOF MRA||0
3004888|NCT00980681|3722450|FG000|STARTED|Dotarem MRA|Out of the 13 enrolled patients, three did not receive treatment|10
3004889|NCT00980681|3722450|FG000|COMPLETED|Dotarem MRA||10
3004890|NCT00980681|3722450|FG000|NOT COMPLETED|Dotarem MRA||0
3004891|NCT00980746|3722462|FG000|STARTED|Overall Study||85
3004892|NCT00980746|3722463|FG001|STARTED|Overall Study||89
3004893|NCT00980746|3722464|FG002|STARTED|Overall Study||95
3004894|NCT00980746|3722465|FG003|STARTED|Overall Study||100
3004895|NCT00980746|3722466|FG004|STARTED|Overall Study||92
3004896|NCT00980746|3722467|FG005|STARTED|Overall Study||96
3004897|NCT00980746|3722462|FG000|Randomized|Overall Study||85
3004898|NCT00980746|3722463|FG001|Randomized|Overall Study||89
3004899|NCT00980746|3722464|FG002|Randomized|Overall Study||95
3004900|NCT00980746|3722465|FG003|Randomized|Overall Study||100
3004901|NCT00980746|3722466|FG004|Randomized|Overall Study||92
3004902|NCT00980746|3722467|FG005|Randomized|Overall Study||96
3004903|NCT00980746|3722462|FG000|Safety Population|Overall Study||85
3004904|NCT00980746|3722463|FG001|Safety Population|Overall Study||89
3004905|NCT00980746|3722464|FG002|Safety Population|Overall Study||95
3004906|NCT00980746|3722465|FG003|Safety Population|Overall Study||100
3004907|NCT00980746|3722466|FG004|Safety Population|Overall Study||92
3004908|NCT00980746|3722467|FG005|Safety Population|Overall Study||96
3004909|NCT00980746|3722462|FG000|Per-protocol|Overall Study||55
3004910|NCT00980746|3722463|FG001|Per-protocol|Overall Study||66
3004911|NCT00980746|3722464|FG002|Per-protocol|Overall Study||73
3004912|NCT00980746|3722465|FG003|Per-protocol|Overall Study||62
3004913|NCT00980746|3722466|FG004|Per-protocol|Overall Study||73
3004914|NCT00980746|3722467|FG005|Per-protocol|Overall Study||74
3004915|NCT00980746|3722462|FG000|COMPLETED|Overall Study||58
3004916|NCT00980746|3722463|FG001|COMPLETED|Overall Study||67
3004917|NCT00980746|3722464|FG002|COMPLETED|Overall Study||75
3004918|NCT00980746|3722465|FG003|COMPLETED|Overall Study||64
3004919|NCT00980746|3722466|FG004|COMPLETED|Overall Study||75
3004920|NCT00980746|3722467|FG005|COMPLETED|Overall Study||78
3004921|NCT00980746|3722462|FG000|NOT COMPLETED|Overall Study||27
3004922|NCT00980746|3722463|FG001|NOT COMPLETED|Overall Study||22
3004923|NCT00980746|3722464|FG002|NOT COMPLETED|Overall Study||20
3004924|NCT00980746|3722465|FG003|NOT COMPLETED|Overall Study||36
3004925|NCT00980746|3722466|FG004|NOT COMPLETED|Overall Study||17
3004926|NCT00980746|3722467|FG005|NOT COMPLETED|Overall Study||18
3004927|NCT00980785|3722483|FG000|STARTED|Overall Study||6
3004928|NCT00980785|3722484|FG001|STARTED|Overall Study||8
3004929|NCT00980785|3722483|FG000|COMPLETED|Overall Study||6
3004930|NCT00980785|3722484|FG001|COMPLETED|Overall Study||8
3004931|NCT00980785|3722483|FG000|NOT COMPLETED|Overall Study||0
3004932|NCT00980785|3722484|FG001|NOT COMPLETED|Overall Study||0
3004933|NCT00980798|3722492|FG000|STARTED|Overall Study||149
3004934|NCT00980798|3722493|FG001|STARTED|Overall Study||139
3004935|NCT00980798|3722492|FG000|COMPLETED|Overall Study||116
3004936|NCT00980798|3722493|FG001|COMPLETED|Overall Study||84
3004937|NCT00980798|3722492|FG000|NOT COMPLETED|Overall Study||33
3004938|NCT00980798|3722493|FG001|NOT COMPLETED|Overall Study||55
3004939|NCT00980980|3722502|FG000|STARTED|Overall Study||16
3004940|NCT00980980|3722503|FG001|STARTED|Overall Study||14
3004941|NCT00980980|3722504|FG002|STARTED|Overall Study||13
3004942|NCT00980980|3722502|FG000|COMPLETED|Overall Study||16
3004943|NCT00980980|3722503|FG001|COMPLETED|Overall Study||13
3004944|NCT00980980|3722504|FG002|COMPLETED|Overall Study||13
3004945|NCT00980980|3722502|FG000|NOT COMPLETED|Overall Study||0
3004946|NCT00980980|3722503|FG001|NOT COMPLETED|Overall Study||1
3004947|NCT00980980|3722504|FG002|NOT COMPLETED|Overall Study||0
3004948|NCT00981019|3722515|FG000|STARTED|Overall Study||778
3004949|NCT00981019|3722515|FG000|COMPLETED|Overall Study||301
3004950|NCT00981019|3722515|FG000|NOT COMPLETED|Overall Study||477
3004951|NCT00981045|3722521|FG000|STARTED|Overall Study||1290
3004952|NCT00981045|3722522|FG001|STARTED|Overall Study||1294
3004953|NCT00981045|3722521|FG000|COMPLETED|Overall Study||1276
3004954|NCT00981045|3722522|FG001|COMPLETED|Overall Study||1285
3004955|NCT00981045|3722521|FG000|NOT COMPLETED|Overall Study||14
3004956|NCT00981045|3722522|FG001|NOT COMPLETED|Overall Study||9
3004957|NCT00981084|3722530|FG000|STARTED|First Intervention (One Day)||16
3004958|NCT00981084|3722531|FG001|STARTED|First Intervention (One Day)||17
3004959|NCT00981084|3722530|FG000|COMPLETED|First Intervention (One Day)||16
3004960|NCT00981084|3722531|FG001|COMPLETED|First Intervention (One Day)||17
3004961|NCT00981084|3722530|FG000|NOT COMPLETED|First Intervention (One Day)||0
3004962|NCT00981084|3722531|FG001|NOT COMPLETED|First Intervention (One Day)||0
3004963|NCT00981084|3722530|FG000|STARTED|Washout Period (7 Days)||16
3004964|NCT00981084|3722531|FG001|STARTED|Washout Period (7 Days)||17
3004965|NCT00981084|3722530|FG000|COMPLETED|Washout Period (7 Days)||16
3004966|NCT00981084|3722531|FG001|COMPLETED|Washout Period (7 Days)||17
3004967|NCT00981084|3722530|FG000|NOT COMPLETED|Washout Period (7 Days)||0
3004968|NCT00981084|3722531|FG001|NOT COMPLETED|Washout Period (7 Days)||0
3004969|NCT00981084|3722530|FG000|STARTED|Second Intervention (One Day)||16
3004970|NCT00981084|3722531|FG001|STARTED|Second Intervention (One Day)||17
3004971|NCT00981084|3722530|FG000|COMPLETED|Second Intervention (One Day)||16
3004972|NCT00981084|3722531|FG001|COMPLETED|Second Intervention (One Day)||17
3004973|NCT00981084|3722530|FG000|NOT COMPLETED|Second Intervention (One Day)||0
3004974|NCT00981084|3722531|FG001|NOT COMPLETED|Second Intervention (One Day)||0
3004975|NCT00981084|3722530|FG000|STARTED|Post Intervention (Data Analysis)||16
3004976|NCT00981084|3722531|FG001|STARTED|Post Intervention (Data Analysis)||17
3004977|NCT00981084|3722530|FG000|COMPLETED|Post Intervention (Data Analysis)||14
3004978|NCT00981084|3722531|FG001|COMPLETED|Post Intervention (Data Analysis)||16
3004979|NCT00981084|3722530|FG000|NOT COMPLETED|Post Intervention (Data Analysis)||2
3004980|NCT00981084|3722531|FG001|NOT COMPLETED|Post Intervention (Data Analysis)||1
3004981|NCT00981149|3722541|FG000|STARTED|Overall Study||12
3004982|NCT00981149|3722542|FG001|STARTED|Overall Study||12
3004983|NCT00981149|3722541|FG000|COMPLETED|Overall Study||10
3004984|NCT00981149|3722542|FG001|COMPLETED|Overall Study||9
3004985|NCT00981149|3722541|FG000|NOT COMPLETED|Overall Study||2
3004986|NCT00981149|3722542|FG001|NOT COMPLETED|Overall Study||3
3004987|NCT00981175|3722551|FG000|STARTED|Primary Dose Vaccination||101
3004988|NCT00981175|3722552|FG001|STARTED|Primary Dose Vaccination||101
3004989|NCT00981175|3722551|FG000|COMPLETED|Primary Dose Vaccination||98
3004990|NCT00981175|3722552|FG001|COMPLETED|Primary Dose Vaccination||99
3004991|NCT00981175|3722551|FG000|NOT COMPLETED|Primary Dose Vaccination||3
3004992|NCT00981175|3722552|FG001|NOT COMPLETED|Primary Dose Vaccination||2
3004993|NCT00981175|3722551|FG000|STARTED|Booster Dose Vaccination|A sub-set of participants in the group received the booster ChimeriVax™-JE vaccine.|55
3004994|NCT00981175|3722552|FG001|STARTED|Booster Dose Vaccination|A sub-set of participants in the group received the booster ChimeriVax™-JE vaccine.|43
3004995|NCT00981175|3722551|FG000|COMPLETED|Booster Dose Vaccination||53
3004996|NCT00981175|3722552|FG001|COMPLETED|Booster Dose Vaccination||40
3004997|NCT00981175|3722551|FG000|NOT COMPLETED|Booster Dose Vaccination||2
3004998|NCT00981175|3722552|FG001|NOT COMPLETED|Booster Dose Vaccination||3
3004999|NCT00981214|3722565|FG000|STARTED|Overall Study||19
3005000|NCT00981214|3722565|FG000|COMPLETED|Overall Study||19
3005001|NCT00981214|3722565|FG000|NOT COMPLETED|Overall Study||0
3005002|NCT00981227|3722575|FG000|STARTED|Overall Study||102
3005003|NCT00981227|3722576|FG001|STARTED|Overall Study||94
3005004|NCT00981227|3722577|FG002|STARTED|Overall Study||94
3005005|NCT00981227|3722578|FG003|STARTED|Overall Study||94
3005006|NCT00981227|3722579|FG004|STARTED|Overall Study||90
3005007|NCT00981227|3722580|FG005|STARTED|Overall Study||93
3005008|NCT00981227|3722575|FG000|Randomized|Overall Study||102
3005009|NCT00981227|3722576|FG001|Randomized|Overall Study||94
3005010|NCT00981227|3722577|FG002|Randomized|Overall Study||94
3005011|NCT00981227|3722578|FG003|Randomized|Overall Study||94
3005012|NCT00981227|3722579|FG004|Randomized|Overall Study||90
3005013|NCT00981227|3722580|FG005|Randomized|Overall Study||93
3005014|NCT00981227|3722575|FG000|Safety Population|Overall Study||102
3005015|NCT00981227|3722576|FG001|Safety Population|Overall Study||94
3005016|NCT00981227|3722577|FG002|Safety Population|Overall Study||94
3005017|NCT00981227|3722578|FG003|Safety Population|Overall Study||94
3005018|NCT00981227|3722579|FG004|Safety Population|Overall Study||90
3005019|NCT00981227|3722580|FG005|Safety Population|Overall Study||93
3005020|NCT00981227|3722575|FG000|Per-Protocol|Overall Study||69
3005021|NCT00981227|3722576|FG001|Per-Protocol|Overall Study||72
3005022|NCT00981227|3722577|FG002|Per-Protocol|Overall Study||67
3005023|NCT00981227|3722578|FG003|Per-Protocol|Overall Study||68
3005024|NCT00981227|3722579|FG004|Per-Protocol|Overall Study||50
3005025|NCT00981227|3722580|FG005|Per-Protocol|Overall Study||70
3005026|NCT00981227|3722575|FG000|COMPLETED|Overall Study||80
3005027|NCT00981227|3722576|FG001|COMPLETED|Overall Study||75
3005028|NCT00981227|3722577|FG002|COMPLETED|Overall Study||73
3005029|NCT00981227|3722578|FG003|COMPLETED|Overall Study||73
3005030|NCT00981227|3722579|FG004|COMPLETED|Overall Study||60
3005031|NCT00981227|3722580|FG005|COMPLETED|Overall Study||75
3005032|NCT00981227|3722575|FG000|NOT COMPLETED|Overall Study||22
3005033|NCT00981227|3722576|FG001|NOT COMPLETED|Overall Study||19
3005034|NCT00981227|3722577|FG002|NOT COMPLETED|Overall Study||21
3005035|NCT00981227|3722578|FG003|NOT COMPLETED|Overall Study||21
3005036|NCT00981227|3722579|FG004|NOT COMPLETED|Overall Study||30
3005037|NCT00981227|3722580|FG005|NOT COMPLETED|Overall Study||18
3005038|NCT00981253|3722600|FG000|STARTED|Overall Study||76
3005039|NCT00981253|3722601|FG001|STARTED|Overall Study||75
3005040|NCT00981253|3722600|FG000|COMPLETED|Overall Study||73
3005041|NCT00981253|3722601|FG001|COMPLETED|Overall Study||72
3005042|NCT00981253|3722600|FG000|NOT COMPLETED|Overall Study||3
3005043|NCT00981253|3722601|FG001|NOT COMPLETED|Overall Study||3
3005044|NCT00981292|3722614|FG000|STARTED|Day 1||7
3005045|NCT00981292|3722615|FG001|STARTED|Day 1||4
3005046|NCT00981292|3722616|FG002|STARTED|Day 1||6
3005047|NCT00981292|3722617|FG003|STARTED|Day 1||4
3005048|NCT00981292|3722618|FG004|STARTED|Day 1||4
3005049|NCT00981292|3722619|FG005|STARTED|Day 1||7
3005050|NCT00981292|3722614|FG000|COMPLETED|Day 1||6
3005051|NCT00981292|3722615|FG001|COMPLETED|Day 1||4
3005052|NCT00981292|3722616|FG002|COMPLETED|Day 1||6
3005053|NCT00981292|3722617|FG003|COMPLETED|Day 1||4
3005054|NCT00981292|3722618|FG004|COMPLETED|Day 1||4
3005055|NCT00981292|3722619|FG005|COMPLETED|Day 1||5
3005056|NCT00981292|3722614|FG000|NOT COMPLETED|Day 1||1
3005057|NCT00981292|3722615|FG001|NOT COMPLETED|Day 1||0
3005058|NCT00981292|3722616|FG002|NOT COMPLETED|Day 1||0
3005059|NCT00981292|3722617|FG003|NOT COMPLETED|Day 1||0
3005060|NCT00981292|3722618|FG004|NOT COMPLETED|Day 1||0
3005061|NCT00981292|3722619|FG005|NOT COMPLETED|Day 1||2
3005062|NCT00981292|3722614|FG000|STARTED|Day 2||6
3005063|NCT00981292|3722615|FG001|STARTED|Day 2||4
3005064|NCT00981292|3722616|FG002|STARTED|Day 2||6
3005065|NCT00981292|3722617|FG003|STARTED|Day 2||4
3005066|NCT00981292|3722618|FG004|STARTED|Day 2||4
3005067|NCT00981292|3722619|FG005|STARTED|Day 2||5
3005068|NCT00981292|3722614|FG000|COMPLETED|Day 2||4
3005069|NCT00981292|3722615|FG001|COMPLETED|Day 2||4
3005070|NCT00981292|3722616|FG002|COMPLETED|Day 2||6
3005071|NCT00981292|3722617|FG003|COMPLETED|Day 2||4
3005072|NCT00981292|3722618|FG004|COMPLETED|Day 2||4
3005073|NCT00981292|3722619|FG005|COMPLETED|Day 2||5
3005074|NCT00981292|3722614|FG000|NOT COMPLETED|Day 2||2
3005075|NCT00981292|3722615|FG001|NOT COMPLETED|Day 2||0
3005076|NCT00981292|3722616|FG002|NOT COMPLETED|Day 2||0
3005077|NCT00981292|3722617|FG003|NOT COMPLETED|Day 2||0
3005078|NCT00981292|3722618|FG004|NOT COMPLETED|Day 2||0
3005079|NCT00981292|3722619|FG005|NOT COMPLETED|Day 2||0
3005080|NCT00981292|3722614|FG000|STARTED|Day 3||4
3005081|NCT00981292|3722615|FG001|STARTED|Day 3||4
3005082|NCT00981292|3722616|FG002|STARTED|Day 3||6
3005083|NCT00981292|3722617|FG003|STARTED|Day 3||4
3005084|NCT00981292|3722618|FG004|STARTED|Day 3||4
3005085|NCT00981292|3722619|FG005|STARTED|Day 3||5
3005086|NCT00981292|3722614|FG000|COMPLETED|Day 3||4
3005087|NCT00981292|3722615|FG001|COMPLETED|Day 3||4
3005088|NCT00981292|3722616|FG002|COMPLETED|Day 3||6
3005089|NCT00981292|3722617|FG003|COMPLETED|Day 3||4
3005090|NCT00981292|3722618|FG004|COMPLETED|Day 3||4
3005091|NCT00981292|3722619|FG005|COMPLETED|Day 3||4
3005092|NCT00981292|3722614|FG000|NOT COMPLETED|Day 3||0
3005093|NCT00981292|3722615|FG001|NOT COMPLETED|Day 3||0
3005094|NCT00981292|3722616|FG002|NOT COMPLETED|Day 3||0
3005095|NCT00981292|3722617|FG003|NOT COMPLETED|Day 3||0
3005096|NCT00981292|3722618|FG004|NOT COMPLETED|Day 3||0
3005097|NCT00981292|3722619|FG005|NOT COMPLETED|Day 3||1
3005098|NCT00981305|3722633|FG000|STARTED|Overall Study||69
3005099|NCT00981305|3722634|FG001|STARTED|Overall Study||67
3005100|NCT00981305|3722633|FG000|COMPLETED|Overall Study||50
3005101|NCT00981305|3722634|FG001|COMPLETED|Overall Study||57
3005102|NCT00981305|3722633|FG000|NOT COMPLETED|Overall Study||19
3005103|NCT00981305|3722634|FG001|NOT COMPLETED|Overall Study||10
3005104|NCT00981409|3722642|FG000|STARTED|Overall Study||30
3005105|NCT00981409|3722643|FG001|STARTED|Overall Study||11
3005106|NCT00981409|3722642|FG000|COMPLETED|Overall Study||24
3005107|NCT00981409|3722643|FG001|COMPLETED|Overall Study||10
3005108|NCT00981409|3722642|FG000|NOT COMPLETED|Overall Study||6
3005109|NCT00981409|3722643|FG001|NOT COMPLETED|Overall Study||1
3005110|NCT00981435|3722652|FG000|STARTED|Overall Study||31
3005111|NCT00981435|3722653|FG001|STARTED|Overall Study||29
3005112|NCT00981435|3722654|FG002|STARTED|Overall Study||37
3005113|NCT00981435|3722652|FG000|COMPLETED|Overall Study||31
3005114|NCT00981435|3722653|FG001|COMPLETED|Overall Study||29
3005115|NCT00981435|3722654|FG002|COMPLETED|Overall Study||37
3005116|NCT00981435|3722652|FG000|NOT COMPLETED|Overall Study||0
3005117|NCT00981435|3722653|FG001|NOT COMPLETED|Overall Study||0
3005118|NCT00981435|3722654|FG002|NOT COMPLETED|Overall Study||0
3005119|NCT00981461|3722664|FG000|STARTED|Overall Study||48
3005120|NCT00981461|3722665|FG001|STARTED|Overall Study||24
3005121|NCT00981461|3722664|FG000|COMPLETED|Overall Study||43
3005122|NCT00981461|3722665|FG001|COMPLETED|Overall Study||22
3005123|NCT00981461|3722664|FG000|NOT COMPLETED|Overall Study||5
3005124|NCT00981461|3722665|FG001|NOT COMPLETED|Overall Study||2
3005125|NCT00981474|3722673|FG000|STARTED|Overall Study||228
3005126|NCT00981474|3722674|FG001|STARTED|Overall Study||232
3005127|NCT00981474|3722673|FG000|COMPLETED|Overall Study||228
3005128|NCT00981474|3722674|FG001|COMPLETED|Overall Study||232
3005129|NCT00981474|3722673|FG000|NOT COMPLETED|Overall Study||0
3005130|NCT00981474|3722674|FG001|NOT COMPLETED|Overall Study||0
3005131|NCT00981526|3722684|FG000|STARTED|Overall Study||26
3005132|NCT00981526|3722685|FG001|STARTED|Overall Study||28
3005133|NCT00981526|3722684|FG000|COMPLETED|Overall Study||22
3005134|NCT00981526|3722685|FG001|COMPLETED|Overall Study||22
3005135|NCT00981526|3722684|FG000|NOT COMPLETED|Overall Study||4
3005136|NCT00981526|3722685|FG001|NOT COMPLETED|Overall Study||6
3005137|NCT00981578|3722693|FG000|STARTED|Overall Study||17
3005138|NCT00981578|3722693|FG000|COMPLETED|Overall Study||14
3005139|NCT00981578|3722693|FG000|NOT COMPLETED|Overall Study||3
3005140|NCT00981630|3722701|FG000|STARTED|Overall Study||32
3005141|NCT00981630|3722702|FG001|STARTED|Overall Study||32
3005142|NCT00981630|3722703|FG002|STARTED|Overall Study||32
3005143|NCT00981630|3722704|FG003|STARTED|Overall Study||32
3005144|NCT00981630|3722701|FG000|COMPLETED|Overall Study||32
3005145|NCT00981630|3722702|FG001|COMPLETED|Overall Study||32
3005146|NCT00981630|3722703|FG002|COMPLETED|Overall Study||32
3005147|NCT00981630|3722704|FG003|COMPLETED|Overall Study||32
3005148|NCT00981630|3722701|FG000|NOT COMPLETED|Overall Study||0
3005149|NCT00981630|3722702|FG001|NOT COMPLETED|Overall Study||0
3005150|NCT00981630|3722703|FG002|NOT COMPLETED|Overall Study||0
3005151|NCT00981630|3722704|FG003|NOT COMPLETED|Overall Study||0
3005152|NCT00981669|3722716|FG000|STARTED|Overall Study||40
3005153|NCT00981669|3722717|FG001|STARTED|Overall Study||40
3005154|NCT00981669|3722716|FG000|COMPLETED|Overall Study||39
3005155|NCT00981669|3722717|FG001|COMPLETED|Overall Study||40
3005156|NCT00981669|3722716|FG000|NOT COMPLETED|Overall Study||1
3005157|NCT00981669|3722717|FG001|NOT COMPLETED|Overall Study||0
3005158|NCT00981682|3722723|FG000|STARTED|Overall Study||376
3005159|NCT00981682|3722723|FG000|COMPLETED|Overall Study||234
3005160|NCT00981682|3722723|FG000|NOT COMPLETED|Overall Study||142
3005161|NCT00981747|3722727|FG000|STARTED|Losartan||12
3005162|NCT00981747|3722727|FG000|Started Losartan|Losartan||12
3164996|NCT01896557|3892535|FG001|STARTED|Clopidogrel Alone||48
3164997|NCT01896557|3892534|FG000|COMPLETED|Clopidogrel Alone||43
3164998|NCT01896557|3892535|FG001|COMPLETED|Clopidogrel Alone||48
3164999|NCT01896557|3892534|FG000|NOT COMPLETED|Clopidogrel Alone||1
3165000|NCT01896557|3892535|FG001|NOT COMPLETED|Clopidogrel Alone||0
3165001|NCT01896557|3892534|FG000|STARTED|Clopidogrel + GI Protector||43
3165002|NCT01896557|3892535|FG001|STARTED|Clopidogrel + GI Protector||48
3165003|NCT01896557|3892534|FG000|COMPLETED|Clopidogrel + GI Protector||41
3165004|NCT01896557|3892535|FG001|COMPLETED|Clopidogrel + GI Protector||44
3005163|NCT00981747|3722727|FG000|Completed Losartan|Losartan|Only 9 were analyzed because only 9 completed all four interventions.|10
3005164|NCT00981747|3722727|FG000|COMPLETED|Losartan|Only 9 were analyzed because only 9 completed all four interventions.|10
3005165|NCT00981747|3722727|FG000|NOT COMPLETED|Losartan||2
3005166|NCT00981747|3722727|FG000|STARTED|Placebo Oral Tablet||10
3005167|NCT00981747|3722727|FG000|Started Placebo Oral Tablet|Placebo Oral Tablet||10
3005168|NCT00981747|3722727|FG000|Completed Placebo Oral Tablet|Placebo Oral Tablet||9
3005169|NCT00981747|3722727|FG000|COMPLETED|Placebo Oral Tablet||9
3005170|NCT00981747|3722727|FG000|NOT COMPLETED|Placebo Oral Tablet||1
3005171|NCT00981747|3722727|FG000|STARTED|Sildenafil||9
3005172|NCT00981747|3722727|FG000|Started Sildenafil|Sildenafil||9
3005173|NCT00981747|3722727|FG000|Completed Sildenafil|Sildenafil||9
3005174|NCT00981747|3722727|FG000|COMPLETED|Sildenafil||9
3005175|NCT00981747|3722727|FG000|NOT COMPLETED|Sildenafil||0
3005176|NCT00981747|3722727|FG000|STARTED|Sildenafil and Losartan||9
3005177|NCT00981747|3722727|FG000|Started Sildenafil and Losartan|Sildenafil and Losartan||9
3005178|NCT00981747|3722727|FG000|Completed Sildenafil and Losartan|Sildenafil and Losartan||9
3005179|NCT00981747|3722727|FG000|COMPLETED|Sildenafil and Losartan||9
3005180|NCT00981747|3722727|FG000|NOT COMPLETED|Sildenafil and Losartan||0
3005181|NCT00981799|3722741|FG000|STARTED|Overall Study||6
3005182|NCT00981799|3722742|FG001|STARTED|Overall Study||7
3005183|NCT00981799|3722743|FG002|STARTED|Overall Study||10
3005184|NCT00981799|3722744|FG003|STARTED|Overall Study||0
3005185|NCT00981799|3722741|FG000|COMPLETED|Overall Study||5
3005186|NCT00981799|3722742|FG001|COMPLETED|Overall Study||6
3005187|NCT00981799|3722743|FG002|COMPLETED|Overall Study||10
3005188|NCT00981799|3722744|FG003|COMPLETED|Overall Study||0
3005189|NCT00981799|3722741|FG000|NOT COMPLETED|Overall Study||1
3005190|NCT00981799|3722742|FG001|NOT COMPLETED|Overall Study||1
3005191|NCT00981799|3722743|FG002|NOT COMPLETED|Overall Study||0
3005192|NCT00981799|3722744|FG003|NOT COMPLETED|Overall Study||0
3005193|NCT00981812|3722755|FG000|STARTED|Overall Study||20
3005194|NCT00981812|3722755|FG000|COMPLETED|Overall Study||20
3005195|NCT00981812|3722755|FG000|NOT COMPLETED|Overall Study||0
3005196|NCT00981825|3722761|FG000|STARTED|First Intervention||11
3005197|NCT00981825|3722762|FG001|STARTED|First Intervention||11
3005198|NCT00981825|3722761|FG000|COMPLETED|First Intervention||11
3005199|NCT00981825|3722762|FG001|COMPLETED|First Intervention||11
3005200|NCT00981825|3722761|FG000|NOT COMPLETED|First Intervention||0
3005201|NCT00981825|3722762|FG001|NOT COMPLETED|First Intervention||0
3005202|NCT00981825|3722761|FG000|STARTED|Washout After 1st Intervention||11
3005203|NCT00981825|3722762|FG001|STARTED|Washout After 1st Intervention||11
3005204|NCT00981825|3722761|FG000|COMPLETED|Washout After 1st Intervention||11
3005205|NCT00981825|3722762|FG001|COMPLETED|Washout After 1st Intervention||11
3005206|NCT00981825|3722761|FG000|NOT COMPLETED|Washout After 1st Intervention||0
3005207|NCT00981825|3722762|FG001|NOT COMPLETED|Washout After 1st Intervention||0
3005208|NCT00981825|3722761|FG000|STARTED|Second Intervention||11
3005209|NCT00981825|3722762|FG001|STARTED|Second Intervention||11
3005210|NCT00981825|3722761|FG000|COMPLETED|Second Intervention||11
3005211|NCT00981825|3722762|FG001|COMPLETED|Second Intervention||11
3005212|NCT00981825|3722761|FG000|NOT COMPLETED|Second Intervention||0
3005213|NCT00981825|3722762|FG001|NOT COMPLETED|Second Intervention||0
3005214|NCT00982007|3722772|FG000|STARTED|Overall Study||250
3005215|NCT00982007|3722773|FG001|STARTED|Overall Study||257
3005216|NCT00982007|3722774|FG002|STARTED|Overall Study||253
3005217|NCT00982007|3722775|FG003|STARTED|Overall Study||251
3005218|NCT00982007|3722772|FG000|COMPLETED|Overall Study||246
3005219|NCT00982007|3722773|FG001|COMPLETED|Overall Study||253
3005220|NCT00982007|3722774|FG002|COMPLETED|Overall Study||253
3005221|NCT00982007|3722775|FG003|COMPLETED|Overall Study||245
3005222|NCT00982007|3722772|FG000|NOT COMPLETED|Overall Study||4
3005223|NCT00982007|3722773|FG001|NOT COMPLETED|Overall Study||4
3005224|NCT00982007|3722774|FG002|NOT COMPLETED|Overall Study||0
3005225|NCT00982007|3722775|FG003|NOT COMPLETED|Overall Study||6
3005226|NCT00982020|3722787|FG000|STARTED|Overall Study||102
3005227|NCT00982020|3722788|FG001|STARTED|Overall Study||101
3005228|NCT00982020|3722787|FG000|Received at Least 1 Dose of Study Drug|Overall Study||102
3005229|NCT00982020|3722788|FG001|Received at Least 1 Dose of Study Drug|Overall Study||101
3005230|NCT00982020|3722787|FG000|COMPLETED|Overall Study||45
3005231|NCT00982020|3722788|FG001|COMPLETED|Overall Study||37
3005232|NCT00982020|3722787|FG000|NOT COMPLETED|Overall Study||57
3005233|NCT00982020|3722788|FG001|NOT COMPLETED|Overall Study||64
3005234|NCT00982033|3722801|FG000|STARTED|Overall Study||25
3005235|NCT00982033|3722802|FG001|STARTED|Overall Study||27
3005236|NCT00982033|3722801|FG000|COMPLETED|Overall Study||25
3005237|NCT00982033|3722802|FG001|COMPLETED|Overall Study||27
3005238|NCT00982033|3722801|FG000|NOT COMPLETED|Overall Study||0
3005239|NCT00982033|3722802|FG001|NOT COMPLETED|Overall Study||0
3005240|NCT00982072|3722810|FG000|STARTED|Overall Study||25
3005241|NCT00982072|3722811|FG001|STARTED|Overall Study||27
3005242|NCT00982072|3722810|FG000|COMPLETED|Overall Study||25
3005243|NCT00982072|3722811|FG001|COMPLETED|Overall Study||25
3005244|NCT00982072|3722810|FG000|NOT COMPLETED|Overall Study||0
3005245|NCT00982072|3722811|FG001|NOT COMPLETED|Overall Study||2
3005246|NCT00982137|3722821|FG000|STARTED|Overall Study||36
3005247|NCT00982137|3722822|FG001|STARTED|Overall Study||36
3005248|NCT00982137|3722823|FG002|STARTED|Overall Study||18
3005249|NCT00982137|3722824|FG003|STARTED|Overall Study||18
3005250|NCT00982137|3722821|FG000|COMPLETED|Overall Study||36
3005251|NCT00982137|3722822|FG001|COMPLETED|Overall Study||35
3005252|NCT00982137|3722823|FG002|COMPLETED|Overall Study||18
3005253|NCT00982137|3722824|FG003|COMPLETED|Overall Study||17
3005254|NCT00982137|3722821|FG000|NOT COMPLETED|Overall Study||0
3005255|NCT00982137|3722822|FG001|NOT COMPLETED|Overall Study||1
3005256|NCT00982137|3722823|FG002|NOT COMPLETED|Overall Study||0
3005257|NCT00982137|3722824|FG003|NOT COMPLETED|Overall Study||1
3005258|NCT00982189|3722845|FG000|STARTED|Overall Study||10
3005259|NCT00982189|3722846|FG001|STARTED|Overall Study||9
3005260|NCT00982189|3722847|FG002|STARTED|Overall Study||9
3005261|NCT00982189|3722848|FG003|STARTED|Overall Study||9
3005262|NCT00982189|3722845|FG000|COMPLETED|Overall Study||10
3005263|NCT00982189|3722846|FG001|COMPLETED|Overall Study||9
3005264|NCT00982189|3722847|FG002|COMPLETED|Overall Study||9
3005265|NCT00982189|3722848|FG003|COMPLETED|Overall Study||9
3005266|NCT00982189|3722845|FG000|NOT COMPLETED|Overall Study||0
3005267|NCT00982189|3722846|FG001|NOT COMPLETED|Overall Study||0
3005268|NCT00982189|3722847|FG002|NOT COMPLETED|Overall Study||0
3005269|NCT00982189|3722848|FG003|NOT COMPLETED|Overall Study||0
3005270|NCT00982228|3722862|FG000|STARTED|Main: Week 0 to 52 (NN1250-3583)||472
3005271|NCT00982228|3722863|FG001|STARTED|Main: Week 0 to 52 (NN1250-3583)||157
3005272|NCT00982228|3722862|FG000|Full Analysis Set|Main: Week 0 to 52 (NN1250-3583)||472
3005273|NCT00982228|3722863|FG001|Full Analysis Set|Main: Week 0 to 52 (NN1250-3583)||157
3005274|NCT00982228|3722862|FG000|Exposed|Main: Week 0 to 52 (NN1250-3583)||472
3005275|NCT00982228|3722863|FG001|Exposed|Main: Week 0 to 52 (NN1250-3583)|Three subjects withdrew prior to exposure to trial drug|154
3005276|NCT00982228|3722862|FG000|COMPLETED|Main: Week 0 to 52 (NN1250-3583)||404
3005277|NCT00982228|3722863|FG001|COMPLETED|Main: Week 0 to 52 (NN1250-3583)||137
3005278|NCT00982228|3722862|FG000|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3583)||68
3005279|NCT00982228|3722863|FG001|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3583)||20
3005280|NCT00982228|3722862|FG000|STARTED|Extension: Week 53 to 104 (NN1250-3644)|Fifty-three subjects from the main trial did not continue into the extension|351
3005281|NCT00982228|3722863|FG001|STARTED|Extension: Week 53 to 104 (NN1250-3644)|Nineteen subjects from the main trial did not continue into the extension|118
3005282|NCT00982228|3722862|FG000|COMPLETED|Extension: Week 53 to 104 (NN1250-3644)||330
3005283|NCT00982228|3722863|FG001|COMPLETED|Extension: Week 53 to 104 (NN1250-3644)||113
3005284|NCT00982228|3722862|FG000|NOT COMPLETED|Extension: Week 53 to 104 (NN1250-3644)||21
3005285|NCT00982228|3722863|FG001|NOT COMPLETED|Extension: Week 53 to 104 (NN1250-3644)||5
3005286|NCT00982280|3722869|FG000|STARTED|Observation Period||82
3005287|NCT00982280|3722869|FG000|COMPLETED|Observation Period||63
3005288|NCT00982280|3722869|FG000|NOT COMPLETED|Observation Period||19
3005289|NCT00982280|3722869|FG000|STARTED|Titration and Optimal Dose Period||63
3005290|NCT00982280|3722869|FG000|COMPLETED|Titration and Optimal Dose Period||55
3005291|NCT00982280|3722869|FG000|NOT COMPLETED|Titration and Optimal Dose Period||8
3005292|NCT00982280|3722869|FG000|STARTED|Maintenance Period||55
3005293|NCT00982280|3722869|FG000|COMPLETED|Maintenance Period||54
3005294|NCT00982280|3722869|FG000|NOT COMPLETED|Maintenance Period||1
3005295|NCT00982319|3722876|FG000|STARTED|Overall Study||17
3005296|NCT00982319|3722877|FG001|STARTED|Overall Study||17
3005297|NCT00982319|3722876|FG000|COMPLETED|Overall Study||15
3005298|NCT00982319|3722877|FG001|COMPLETED|Overall Study||15
3005299|NCT00982319|3722876|FG000|NOT COMPLETED|Overall Study||2
3005300|NCT00982319|3722877|FG001|NOT COMPLETED|Overall Study||2
3005301|NCT00982345|3722883|FG000|STARTED|Overall Study||20
3005302|NCT00982345|3722883|FG000|COMPLETED|Overall Study||18
3005303|NCT00982345|3722883|FG000|NOT COMPLETED|Overall Study||2
3005304|NCT00982397|3722889|FG000|STARTED|Phase I||236
3005305|NCT00982397|3722890|FG001|STARTED|Phase I||0
3005306|NCT00982397|3722889|FG000|COMPLETED|Phase I||236
3005307|NCT00982397|3722890|FG001|COMPLETED|Phase I||0
3005308|NCT00982397|3722889|FG000|NOT COMPLETED|Phase I||0
3005309|NCT00982397|3722890|FG001|NOT COMPLETED|Phase I||0
3005310|NCT00982397|3722889|FG000|STARTED|Phase II/Overall Study||2019
3005311|NCT00982397|3722890|FG001|STARTED|Phase II/Overall Study||751
3005312|NCT00982397|3722889|FG000|Secondary Prevention Randomized 18/24NID|Phase II/Overall Study||231
3165005|NCT01896557|3892534|FG000|NOT COMPLETED|Clopidogrel + GI Protector||2
3165006|NCT01896557|3892535|FG001|NOT COMPLETED|Clopidogrel + GI Protector||4
3005313|NCT00982397|3722890|FG001|Secondary Prevention Randomized 18/24NID|Phase II/Overall Study||122
3005314|NCT00982397|3722889|FG000|Secondary Prevention Randomized 30/40NID|Phase II/Overall Study||221
3005315|NCT00982397|3722890|FG001|Secondary Prevention Randomized 30/40NID|Phase II/Overall Study||131
3005316|NCT00982397|3722889|FG000|COMPLETED|Phase II/Overall Study||2019
3005317|NCT00982397|3722890|FG001|COMPLETED|Phase II/Overall Study||751
3005318|NCT00982397|3722889|FG000|NOT COMPLETED|Phase II/Overall Study||0
3005319|NCT00982397|3722890|FG001|NOT COMPLETED|Phase II/Overall Study||0
3005320|NCT00982410|3722901|FG000|STARTED|3-month Follow-up Assessment||65
3165007|NCT01896687|3892543|FG000|STARTED|Overall Study||15
3005321|NCT00982410|3722902|FG001|STARTED|3-month Follow-up Assessment||66
3005322|NCT00982410|3722901|FG000|COMPLETED|3-month Follow-up Assessment||56
3005323|NCT00982410|3722902|FG001|COMPLETED|3-month Follow-up Assessment||53
3005324|NCT00982410|3722901|FG000|NOT COMPLETED|3-month Follow-up Assessment||9
3005325|NCT00982410|3722902|FG001|NOT COMPLETED|3-month Follow-up Assessment||13
3005326|NCT00982410|3722901|FG000|STARTED|6-month Follow-up Assessment|n=65 : intent to treat. Some persons missed follow-up assessment without withdrawing from study.|65
3165008|NCT01896687|3892544|FG001|STARTED|Overall Study||15
3165009|NCT01896687|3892543|FG000|COMPLETED|Overall Study||15
3165010|NCT01896687|3892544|FG001|COMPLETED|Overall Study||15
3165011|NCT01896687|3892543|FG000|NOT COMPLETED|Overall Study||0
3165012|NCT01896687|3892544|FG001|NOT COMPLETED|Overall Study||0
3165013|NCT01896700|3892552|FG000|STARTED|Overall Study||12
3165014|NCT01896700|3892553|FG001|STARTED|Overall Study||12
3165015|NCT01896700|3892552|FG000|COMPLETED|Overall Study||8
3165016|NCT01896700|3892553|FG001|COMPLETED|Overall Study||6
3165017|NCT01896700|3892552|FG000|NOT COMPLETED|Overall Study||4
3165018|NCT01896700|3892553|FG001|NOT COMPLETED|Overall Study||6
3165019|NCT01896726|3892559|FG000|STARTED|Treatment Period 1 (Days 1-22)||20
3165020|NCT01896726|3892559|FG000|Received Microgynon|Treatment Period 1 (Days 1-22)||20
3165021|NCT01896726|3892559|FG000|COMPLETED|Treatment Period 1 (Days 1-22)||20
3165022|NCT01896726|3892559|FG000|NOT COMPLETED|Treatment Period 1 (Days 1-22)||0
3165023|NCT01896726|3892559|FG000|STARTED|Treatment Period 2 (Days 23-31)||20
3165024|NCT01896726|3892559|FG000|Received at Least 1 Dose of Baricitinib|Treatment Period 2 (Days 23-31)||20
3165025|NCT01896726|3892559|FG000|Received Microgynon|Treatment Period 2 (Days 23-31)||18
3165026|NCT01896726|3892559|FG000|COMPLETED|Treatment Period 2 (Days 23-31)||18
3165027|NCT01896726|3892559|FG000|NOT COMPLETED|Treatment Period 2 (Days 23-31)||2
3165028|NCT01896856|3892572|FG000|STARTED|Overall Study||6
3165029|NCT01896856|3892573|FG001|STARTED|Overall Study||3
3165030|NCT01896856|3892574|FG002|STARTED|Overall Study||7
3165031|NCT01896856|3892575|FG003|STARTED|Overall Study||6
3005327|NCT00982410|3722902|FG001|STARTED|6-month Follow-up Assessment|n=2 persons withdrew before 3-mo. f/u, reducing pool of participants to N=64 with intent to treat.|64
3005328|NCT00982410|3722901|FG000|COMPLETED|6-month Follow-up Assessment||59
3005329|NCT00982410|3722902|FG001|COMPLETED|6-month Follow-up Assessment||53
3005330|NCT00982410|3722901|FG000|NOT COMPLETED|6-month Follow-up Assessment||6
3005331|NCT00982410|3722902|FG001|NOT COMPLETED|6-month Follow-up Assessment||11
3005332|NCT00982410|3722901|FG000|STARTED|12-month Follow-up Assessment|n=65 : intent to treat. Some persons missed follow-up assessment without withdrawing from study.|65
3005333|NCT00982410|3722902|FG001|STARTED|12-month Follow-up Assessment|n=2 persons withdrew before 3-mo. f/u, reducing pool of participants to N=64 with intent to treat.|64
3005334|NCT00982410|3722901|FG000|COMPLETED|12-month Follow-up Assessment||56
3005335|NCT00982410|3722902|FG001|COMPLETED|12-month Follow-up Assessment||55
3005336|NCT00982410|3722901|FG000|NOT COMPLETED|12-month Follow-up Assessment||9
3005337|NCT00982410|3722902|FG001|NOT COMPLETED|12-month Follow-up Assessment||9
3005338|NCT00982423|3722911|FG000|STARTED|Overall Study||13
3005339|NCT00982423|3722912|FG001|STARTED|Overall Study||19
3005340|NCT00982423|3722911|FG000|COMPLETED|Overall Study||13
3005341|NCT00982423|3722912|FG001|COMPLETED|Overall Study||19
3005342|NCT00982423|3722911|FG000|NOT COMPLETED|Overall Study||0
3005343|NCT00982423|3722912|FG001|NOT COMPLETED|Overall Study||0
3005344|NCT00982488|3722924|FG000|STARTED|Overall Study|Received treatment|185
3005345|NCT00982488|3722925|FG001|STARTED|Overall Study|Received treatment|14
3005346|NCT00982488|3722926|FG002|STARTED|Overall Study|Received treatment|34
3005347|NCT00982488|3722927|FG003|STARTED|Overall Study|Received treatment|3
3005348|NCT00982488|3722928|FG004|STARTED|Overall Study|Received treatment|1
3005349|NCT00982488|3722924|FG000|COMPLETED|Overall Study|Still receiving treatment|0
3005350|NCT00982488|3722925|FG001|COMPLETED|Overall Study|Still receiving treatment|0
3005351|NCT00982488|3722926|FG002|COMPLETED|Overall Study|Still receiving treatment|0
3005352|NCT00982488|3722927|FG003|COMPLETED|Overall Study|Still receiving treatment|0
3005353|NCT00982488|3722928|FG004|COMPLETED|Overall Study|Still receiving treatment|0
3005354|NCT00982488|3722924|FG000|NOT COMPLETED|Overall Study||185
3005355|NCT00982488|3722925|FG001|NOT COMPLETED|Overall Study||14
3005356|NCT00982488|3722926|FG002|NOT COMPLETED|Overall Study||34
3005357|NCT00982488|3722927|FG003|NOT COMPLETED|Overall Study||3
3005358|NCT00982488|3722928|FG004|NOT COMPLETED|Overall Study||1
3005359|NCT00982553|3722940|FG000|STARTED|Phase1||14
3005360|NCT00982553|3722940|FG000|COMPLETED|Phase1||14
3005361|NCT00982553|3722940|FG000|NOT COMPLETED|Phase1||0
3005362|NCT00982553|3722940|FG000|STARTED|Phase2||14
3005363|NCT00982553|3722940|FG000|COMPLETED|Phase2||14
3005364|NCT00982553|3722940|FG000|NOT COMPLETED|Phase2||0
3005365|NCT00982553|3722940|FG000|STARTED|Phase3||14
3005366|NCT00982553|3722940|FG000|COMPLETED|Phase3||14
3005367|NCT00982553|3722940|FG000|NOT COMPLETED|Phase3||0
3005368|NCT00982592|3722951|FG000|STARTED|Overall Study||64
3005369|NCT00982592|3722952|FG001|STARTED|Overall Study||60
3005370|NCT00982592|3722951|FG000|Treatment Received|Overall Study||63
3165032|NCT01896856|3892576|FG004|STARTED|Overall Study||62
3005371|NCT00982592|3722952|FG001|Treatment Received|Overall Study||52
3005372|NCT00982592|3722951|FG000|COMPLETED|Overall Study|patients who were off treatment due to disease progression|33
3005373|NCT00982592|3722952|FG001|COMPLETED|Overall Study|patients who were off treatment due to disease progression|27
3005374|NCT00982592|3722951|FG000|NOT COMPLETED|Overall Study||31
3005375|NCT00982592|3722952|FG001|NOT COMPLETED|Overall Study||33
3005376|NCT00982644|3722960|FG000|STARTED|Main: Week 0 to 52 (NN1250-3579)||773
3005377|NCT00982644|3722961|FG001|STARTED|Main: Week 0 to 52 (NN1250-3579)||257
3005378|NCT00982644|3722960|FG000|Full Analysis Set|Main: Week 0 to 52 (NN1250-3579)||773
3005379|NCT00982644|3722961|FG001|Full Analysis Set|Main: Week 0 to 52 (NN1250-3579)||257
3005380|NCT00982644|3722960|FG000|Exposed|Main: Week 0 to 52 (NN1250-3579)|7 subjects were withdrawn prior to exposure to trial products|766
3005381|NCT00982644|3722961|FG001|Exposed|Main: Week 0 to 52 (NN1250-3579)||257
3005382|NCT00982644|3722960|FG000|COMPLETED|Main: Week 0 to 52 (NN1250-3579)||607
3005383|NCT00982644|3722961|FG001|COMPLETED|Main: Week 0 to 52 (NN1250-3579)||197
3005384|NCT00982644|3722960|FG000|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3579)||166
3005385|NCT00982644|3722961|FG001|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3579)||60
3005386|NCT00982644|3722960|FG000|STARTED|Extension: Week 53 to 104 (NN1250-3643)|Fifty-six subjects did not continue into extension trial|551
3005387|NCT00982644|3722961|FG001|STARTED|Extension: Week 53 to 104 (NN1250-3643)|Twenty-three subjects did not continue into extension trial|174
3005388|NCT00982644|3722960|FG000|COMPLETED|Extension: Week 53 to 104 (NN1250-3643)||505
3005389|NCT00982644|3722961|FG001|COMPLETED|Extension: Week 53 to 104 (NN1250-3643)||154
3005390|NCT00982644|3722960|FG000|NOT COMPLETED|Extension: Week 53 to 104 (NN1250-3643)||46
3005391|NCT00982644|3722961|FG001|NOT COMPLETED|Extension: Week 53 to 104 (NN1250-3643)||20
3005392|NCT00982657|3722971|FG000|STARTED|Overall Study||12
3005393|NCT00982657|3722972|FG001|STARTED|Overall Study||3
3005394|NCT00982657|3722973|FG002|STARTED|Overall Study||3
3005395|NCT00982657|3722974|FG003|STARTED|Overall Study||16
3005396|NCT00982657|3722971|FG000|COMPLETED|Overall Study||11
3005397|NCT00982657|3722972|FG001|COMPLETED|Overall Study||3
3005398|NCT00982657|3722973|FG002|COMPLETED|Overall Study||1
3005399|NCT00982657|3722974|FG003|COMPLETED|Overall Study||7
3005400|NCT00982657|3722971|FG000|NOT COMPLETED|Overall Study||1
3005401|NCT00982657|3722972|FG001|NOT COMPLETED|Overall Study||0
3005402|NCT00982657|3722973|FG002|NOT COMPLETED|Overall Study||2
3005403|NCT00982657|3722974|FG003|NOT COMPLETED|Overall Study||9
3005404|NCT00982735|3722994|FG000|STARTED|Overall Study||987
3005405|NCT00982735|3722994|FG000|COMPLETED|Overall Study||757
3005406|NCT00982735|3722994|FG000|NOT COMPLETED|Overall Study||230
3005407|NCT00982865|3723002|FG000|STARTED|Overall Study||49
3005408|NCT00982865|3723003|FG001|STARTED|Overall Study||82
3005409|NCT00982865|3723004|FG002|STARTED|Overall Study||15
3005410|NCT00982865|3723005|FG003|STARTED|Overall Study||34
3005411|NCT00982865|3723002|FG000|COMPLETED|Overall Study||49
3005412|NCT00982865|3723003|FG001|COMPLETED|Overall Study||82
3005413|NCT00982865|3723004|FG002|COMPLETED|Overall Study||15
3005414|NCT00982865|3723005|FG003|COMPLETED|Overall Study||34
3005415|NCT00982865|3723002|FG000|NOT COMPLETED|Overall Study||0
3005416|NCT00982865|3723003|FG001|NOT COMPLETED|Overall Study||0
3005417|NCT00982865|3723004|FG002|NOT COMPLETED|Overall Study||0
3005418|NCT00982865|3723005|FG003|NOT COMPLETED|Overall Study||0
3005419|NCT00982878|3723052|FG000|STARTED|Overall Study||13
3005420|NCT00982878|3723052|FG000|COMPLETED|Overall Study||12
3005421|NCT00982878|3723052|FG000|NOT COMPLETED|Overall Study||1
3005422|NCT00982930|3723056|FG000|STARTED|Overall Study||55
3005423|NCT00982930|3723056|FG000|COMPLETED|Overall Study||51
3005424|NCT00982930|3723056|FG000|NOT COMPLETED|Overall Study||4
3005425|NCT00983073|3723060|FG000|STARTED|Observation Period||224
3005426|NCT00983073|3723060|FG000|COMPLETED|Observation Period|24 participants not eligible to be dosed.|200
3005427|NCT00983073|3723060|FG000|NOT COMPLETED|Observation Period||24
3005428|NCT00983073|3723060|FG000|STARTED|Titration and Optimal Dose Period||200
3005429|NCT00983073|3723060|FG000|COMPLETED|Titration and Optimal Dose Period||160
3005430|NCT00983073|3723060|FG000|NOT COMPLETED|Titration and Optimal Dose Period||40
3005431|NCT00983073|3723060|FG000|STARTED|Maintenance Period||160
3005432|NCT00983073|3723060|FG000|COMPLETED|Maintenance Period||144
3005433|NCT00983073|3723060|FG000|NOT COMPLETED|Maintenance Period||16
3005434|NCT00983216|3723065|FG000|STARTED|Colchicine Alone||24
3005435|NCT00983216|3723065|FG000|COMPLETED|Colchicine Alone||24
3005436|NCT00983216|3723065|FG000|NOT COMPLETED|Colchicine Alone||0
3005437|NCT00983216|3723065|FG000|STARTED|14 Day Washout Period||24
3005438|NCT00983216|3723065|FG000|COMPLETED|14 Day Washout Period||24
3005439|NCT00983216|3723065|FG000|NOT COMPLETED|14 Day Washout Period||0
3005440|NCT00983216|3723065|FG000|STARTED|Ketoconazole Alone||24
3005441|NCT00983216|3723065|FG000|COMPLETED|Ketoconazole Alone||24
3005442|NCT00983216|3723065|FG000|NOT COMPLETED|Ketoconazole Alone||0
3005443|NCT00983216|3723065|FG000|STARTED|Colchicine With Ketoconazole||24
3005444|NCT00983216|3723065|FG000|COMPLETED|Colchicine With Ketoconazole||24
3005445|NCT00983216|3723065|FG000|NOT COMPLETED|Colchicine With Ketoconazole||0
3005446|NCT00983242|3723072|FG000|STARTED|Colchicine Alone||24
3005447|NCT00983242|3723072|FG000|COMPLETED|Colchicine Alone||24
3005448|NCT00983242|3723072|FG000|NOT COMPLETED|Colchicine Alone||0
3005449|NCT00983242|3723072|FG000|STARTED|14 Day Washout Period||24
3005450|NCT00983242|3723072|FG000|COMPLETED|14 Day Washout Period||24
3005451|NCT00983242|3723072|FG000|NOT COMPLETED|14 Day Washout Period||0
3165033|NCT01896856|3892577|FG005|STARTED|Overall Study||34
3165034|NCT01896856|3892572|FG000|COMPLETED|Overall Study||6
3165035|NCT01896856|3892573|FG001|COMPLETED|Overall Study||3
3005452|NCT00983242|3723072|FG000|STARTED|Verapamil HCl ER Alone||24
3005453|NCT00983242|3723072|FG000|COMPLETED|Verapamil HCl ER Alone||24
3005454|NCT00983242|3723072|FG000|NOT COMPLETED|Verapamil HCl ER Alone||0
3005455|NCT00983242|3723072|FG000|STARTED|Colchicine With Verapamil HCl ER||24
3165036|NCT01896856|3892574|FG002|COMPLETED|Overall Study||6
3005456|NCT00983242|3723072|FG000|COMPLETED|Colchicine With Verapamil HCl ER||24
3005457|NCT00983242|3723072|FG000|NOT COMPLETED|Colchicine With Verapamil HCl ER||0
3005458|NCT00983281|3723081|FG000|STARTED|Overall Study||805
3005459|NCT00983281|3723082|FG001|STARTED|Overall Study||909
3005460|NCT00983281|3723081|FG000|COMPLETED|Overall Study||805
3005461|NCT00983281|3723082|FG001|COMPLETED|Overall Study||909
3005462|NCT00983281|3723081|FG000|NOT COMPLETED|Overall Study||0
3005463|NCT00983281|3723082|FG001|NOT COMPLETED|Overall Study||0
3005464|NCT00983294|3723088|FG000|STARTED|Colchicine Alone||24
3005465|NCT00983294|3723088|FG000|COMPLETED|Colchicine Alone||24
3005466|NCT00983294|3723088|FG000|NOT COMPLETED|Colchicine Alone||0
3005467|NCT00983294|3723088|FG000|STARTED|14 Day Washout Period||24
3005468|NCT00983294|3723088|FG000|COMPLETED|14 Day Washout Period|two subjects withdrew consent due to personal reasons|22
3005469|NCT00983294|3723088|FG000|NOT COMPLETED|14 Day Washout Period||2
3005470|NCT00983294|3723088|FG000|STARTED|Azithromycin Alone||22
3005471|NCT00983294|3723088|FG000|COMPLETED|Azithromycin Alone||22
3005472|NCT00983294|3723088|FG000|NOT COMPLETED|Azithromycin Alone||0
3005473|NCT00983294|3723088|FG000|STARTED|Colchicine With Azithromycin||22
3005474|NCT00983294|3723088|FG000|COMPLETED|Colchicine With Azithromycin|withdrawn by sponsor on Day 21 due to vomiting on Day 15, prior to azithromycin dosing(1)|21
3005475|NCT00983294|3723088|FG000|NOT COMPLETED|Colchicine With Azithromycin||1
3165037|NCT01896856|3892575|FG003|COMPLETED|Overall Study||6
3165038|NCT01896856|3892576|FG004|COMPLETED|Overall Study||62
3165039|NCT01896856|3892577|FG005|COMPLETED|Overall Study||34
3165040|NCT01896856|3892572|FG000|NOT COMPLETED|Overall Study||0
3165041|NCT01896856|3892573|FG001|NOT COMPLETED|Overall Study||0
3005476|NCT00983307|3723095|FG000|STARTED|Overall Study||17
3005477|NCT00983307|3723095|FG000|COMPLETED|Overall Study||17
3005478|NCT00983307|3723095|FG000|NOT COMPLETED|Overall Study||0
3005479|NCT00983346|3723099|FG000|STARTED|Overall Study||17
3005480|NCT00983346|3723099|FG000|COMPLETED|Overall Study||17
3005481|NCT00983346|3723099|FG000|NOT COMPLETED|Overall Study||0
3005482|NCT00983359|3723103|FG000|STARTED|Overall Study||40
3005483|NCT00983359|3723103|FG000|Not Eligible for Analysis|Overall Study||1
3005484|NCT00983359|3723103|FG000|COMPLETED|Overall Study||39
3005485|NCT00983359|3723103|FG000|NOT COMPLETED|Overall Study||1
3005486|NCT00983372|3723107|FG000|STARTED|Colchicine Alone||24
3005487|NCT00983372|3723107|FG000|COMPLETED|Colchicine Alone||24
3005488|NCT00983372|3723107|FG000|NOT COMPLETED|Colchicine Alone||0
3005489|NCT00983372|3723107|FG000|STARTED|14 Day Washout Period||24
3005490|NCT00983372|3723107|FG000|COMPLETED|14 Day Washout Period|subject withdrew consent due to schedule conflict - during washout period or diltiazem alone|23
3005491|NCT00983372|3723107|FG000|NOT COMPLETED|14 Day Washout Period||1
3005492|NCT00983372|3723107|FG000|STARTED|Diltiazem ER Alone||23
3005493|NCT00983372|3723107|FG000|COMPLETED|Diltiazem ER Alone|two subjects dropped due to missed diltiazem ER dose; one subject dropped due to vomitting|20
3005494|NCT00983372|3723107|FG000|NOT COMPLETED|Diltiazem ER Alone||3
3005495|NCT00983372|3723107|FG000|STARTED|Colchicine With Diltiazem ER||20
3005496|NCT00983372|3723107|FG000|COMPLETED|Colchicine With Diltiazem ER||20
3005497|NCT00983372|3723107|FG000|NOT COMPLETED|Colchicine With Diltiazem ER||0
3005498|NCT00983385|3723114|FG000|STARTED|Observation Period||208
3005499|NCT00983385|3723114|FG000|COMPLETED|Observation Period||176
3005500|NCT00983385|3723114|FG000|NOT COMPLETED|Observation Period||32
3005501|NCT00983385|3723114|FG000|STARTED|Titration and Optimal Dose Period||176
3005502|NCT00983385|3723114|FG000|COMPLETED|Titration and Optimal Dose Period||140
3005503|NCT00983385|3723114|FG000|NOT COMPLETED|Titration and Optimal Dose Period||36
3005504|NCT00983385|3723114|FG000|STARTED|Maintenance Period||140
3005505|NCT00983385|3723114|FG000|COMPLETED|Maintenance Period||117
3005506|NCT00983385|3723114|FG000|NOT COMPLETED|Maintenance Period||23
3005507|NCT00983476|3723136|FG000|STARTED|Overall Study||95
3005508|NCT00983476|3723137|FG001|STARTED|Overall Study||93
3005509|NCT00983476|3723138|FG002|STARTED|Overall Study||88
3005510|NCT00983476|3723136|FG000|6 Month Follow up Assessment|Overall Study||71
3005511|NCT00983476|3723137|FG001|6 Month Follow up Assessment|Overall Study||62
3005512|NCT00983476|3723138|FG002|6 Month Follow up Assessment|Overall Study||74
3005513|NCT00983476|3723136|FG000|COMPLETED|Overall Study||78
3005514|NCT00983476|3723137|FG001|COMPLETED|Overall Study||71
3005515|NCT00983476|3723138|FG002|COMPLETED|Overall Study||88
3005516|NCT00983476|3723136|FG000|NOT COMPLETED|Overall Study||17
3005517|NCT00983476|3723137|FG001|NOT COMPLETED|Overall Study||22
3005518|NCT00983476|3723138|FG002|NOT COMPLETED|Overall Study||0
3005519|NCT00983489|3723155|FG000|STARTED|Overall Study||511
3005520|NCT00983489|3723156|FG001|STARTED|Overall Study||453
3005521|NCT00983489|3723157|FG002|STARTED|Overall Study||447
3005522|NCT00983489|3723155|FG000|COMPLETED|Overall Study||326
3005523|NCT00983489|3723156|FG001|COMPLETED|Overall Study||168
3005524|NCT00983489|3723157|FG002|COMPLETED|Overall Study||135
3005525|NCT00983489|3723155|FG000|NOT COMPLETED|Overall Study||185
3005526|NCT00983489|3723156|FG001|NOT COMPLETED|Overall Study||285
3005527|NCT00983489|3723157|FG002|NOT COMPLETED|Overall Study||312
3037247|NCT01147406|3756539|FG001|NOT COMPLETED|Overall Study||0
3037248|NCT01147406|3756540|FG002|NOT COMPLETED|Overall Study||0
3037249|NCT01147406|3756541|FG003|NOT COMPLETED|Overall Study||0
3037250|NCT01147406|3756542|FG004|NOT COMPLETED|Overall Study||0
3037251|NCT01147406|3756543|FG005|NOT COMPLETED|Overall Study||0
3037252|NCT01147458|3756558|FG000|STARTED|First Intervention||48
3037253|NCT01147458|3756559|FG001|STARTED|First Intervention||47
3005528|NCT00983515|3723165|FG000|STARTED|Colchicine Alone||24
3005529|NCT00983515|3723165|FG000|COMPLETED|Colchicine Alone||24
3005530|NCT00983515|3723165|FG000|NOT COMPLETED|Colchicine Alone||0
3005531|NCT00983515|3723165|FG000|STARTED|14 Day Washout Period||24
3005532|NCT00983515|3723165|FG000|COMPLETED|14 Day Washout Period||24
3005533|NCT00983515|3723165|FG000|NOT COMPLETED|14 Day Washout Period||0
3005534|NCT00983515|3723165|FG000|STARTED|Ritonavir Alone||24
3005535|NCT00983515|3723165|FG000|COMPLETED|Ritonavir Alone||18
3005536|NCT00983515|3723165|FG000|NOT COMPLETED|Ritonavir Alone||6
3005537|NCT00983515|3723165|FG000|STARTED|Colchicine With Ritonavir||18
3005538|NCT00983515|3723165|FG000|COMPLETED|Colchicine With Ritonavir|pharmacokinetic data included since parameters could be estimated for both dosing conditions|17
3005539|NCT00983515|3723165|FG000|NOT COMPLETED|Colchicine With Ritonavir||1
3005540|NCT00983528|3723172|FG000|STARTED|Overall Study||6
3005541|NCT00983528|3723172|FG000|COMPLETED|Overall Study||0
3005542|NCT00983528|3723172|FG000|NOT COMPLETED|Overall Study||6
3005543|NCT00983541|3723176|FG000|STARTED|Overall Study||1
3005544|NCT00983541|3723176|FG000|COMPLETED|Overall Study||1
3005545|NCT00983541|3723176|FG000|NOT COMPLETED|Overall Study||0
3005546|NCT00983580|3723182|FG000|STARTED|Overall Study||54
3005547|NCT00983580|3723183|FG001|STARTED|Overall Study||53
3005548|NCT00983580|3723182|FG000|COMPLETED|Overall Study||49
3005549|NCT00983580|3723183|FG001|COMPLETED|Overall Study||49
3005550|NCT00983580|3723182|FG000|NOT COMPLETED|Overall Study||5
3005551|NCT00983580|3723183|FG001|NOT COMPLETED|Overall Study||4
3005552|NCT00983619|3723202|FG000|STARTED|Overall Study||3
3005553|NCT00983619|3723203|FG001|STARTED|Overall Study||4
3005554|NCT00983619|3723204|FG002|STARTED|Overall Study||3
3005555|NCT00983619|3723205|FG003|STARTED|Overall Study||6
3005556|NCT00983619|3723206|FG004|STARTED|Overall Study||3
3005557|NCT00983619|3723207|FG005|STARTED|Overall Study||76
3005558|NCT00983619|3723208|FG006|STARTED|Overall Study||3
3005559|NCT00983619|3723209|FG007|STARTED|Overall Study||3
3005560|NCT00983619|3723210|FG008|STARTED|Overall Study||1
3005561|NCT00983619|3723211|FG009|STARTED|Overall Study||3
3005562|NCT00983619|3723212|FG010|STARTED|Overall Study||17
3005563|NCT00983619|3723213|FG011|STARTED|Overall Study||14
3005564|NCT00983619|3723202|FG000|COMPLETED|Overall Study||0
3005565|NCT00983619|3723203|FG001|COMPLETED|Overall Study||0
3005566|NCT00983619|3723204|FG002|COMPLETED|Overall Study||0
3005567|NCT00983619|3723205|FG003|COMPLETED|Overall Study||1
3005568|NCT00983619|3723206|FG004|COMPLETED|Overall Study||0
3005569|NCT00983619|3723207|FG005|COMPLETED|Overall Study||9
3005570|NCT00983619|3723208|FG006|COMPLETED|Overall Study||0
3005571|NCT00983619|3723209|FG007|COMPLETED|Overall Study||1
3005572|NCT00983619|3723210|FG008|COMPLETED|Overall Study||0
3005573|NCT00983619|3723211|FG009|COMPLETED|Overall Study||0
3005574|NCT00983619|3723212|FG010|COMPLETED|Overall Study||6
3005575|NCT00983619|3723213|FG011|COMPLETED|Overall Study||3
3005576|NCT00983619|3723202|FG000|NOT COMPLETED|Overall Study||3
3005577|NCT00983619|3723203|FG001|NOT COMPLETED|Overall Study||4
3005578|NCT00983619|3723204|FG002|NOT COMPLETED|Overall Study||3
3005579|NCT00983619|3723205|FG003|NOT COMPLETED|Overall Study||5
3005580|NCT00983619|3723206|FG004|NOT COMPLETED|Overall Study||3
3005581|NCT00983619|3723207|FG005|NOT COMPLETED|Overall Study||67
3005582|NCT00983619|3723208|FG006|NOT COMPLETED|Overall Study||3
3005583|NCT00983619|3723209|FG007|NOT COMPLETED|Overall Study||2
3005584|NCT00983619|3723210|FG008|NOT COMPLETED|Overall Study||1
3005585|NCT00983619|3723211|FG009|NOT COMPLETED|Overall Study||3
3005586|NCT00983619|3723212|FG010|NOT COMPLETED|Overall Study||11
3005587|NCT00983619|3723213|FG011|NOT COMPLETED|Overall Study||11
3005588|NCT00983749|3723261|FG000|STARTED|Acute Phase (Enrollment to Hospital DC)||13
3005589|NCT00983749|3723262|FG001|STARTED|Acute Phase (Enrollment to Hospital DC)||10
3005590|NCT00983749|3723261|FG000|COMPLETED|Acute Phase (Enrollment to Hospital DC)||13
3005591|NCT00983749|3723262|FG001|COMPLETED|Acute Phase (Enrollment to Hospital DC)||10
3005592|NCT00983749|3723261|FG000|NOT COMPLETED|Acute Phase (Enrollment to Hospital DC)||0
3005593|NCT00983749|3723262|FG001|NOT COMPLETED|Acute Phase (Enrollment to Hospital DC)||0
3005594|NCT00983749|3723261|FG000|STARTED|Follow-up Phase (Hospital DC to 30 Days)||13
3005595|NCT00983749|3723262|FG001|STARTED|Follow-up Phase (Hospital DC to 30 Days)||10
3005596|NCT00983749|3723261|FG000|COMPLETED|Follow-up Phase (Hospital DC to 30 Days)||12
3165042|NCT01896856|3892574|FG002|NOT COMPLETED|Overall Study||1
3005597|NCT00983749|3723262|FG001|COMPLETED|Follow-up Phase (Hospital DC to 30 Days)||7
3005598|NCT00983749|3723261|FG000|NOT COMPLETED|Follow-up Phase (Hospital DC to 30 Days)||1
3005599|NCT00983749|3723262|FG001|NOT COMPLETED|Follow-up Phase (Hospital DC to 30 Days)||3
3005600|NCT00983801|3723268|FG000|STARTED|Overall Study|Participants who received treatment.|52
3005601|NCT00983801|3723268|FG000|COMPLETED|Overall Study|Participants who were taken off treatment.|52
3005602|NCT00983801|3723268|FG000|NOT COMPLETED|Overall Study||0
3005603|NCT00983827|3723272|FG000|STARTED|Overall Study||8
3005604|NCT00983827|3723272|FG000|COMPLETED|Overall Study||7
3005605|NCT00983827|3723272|FG000|NOT COMPLETED|Overall Study||1
3005606|NCT00983853|3723282|FG000|STARTED|Overall Study||7
3005607|NCT00983853|3723283|FG001|STARTED|Overall Study|1 subject was randomized but not dosed|7
3005608|NCT00983853|3723284|FG002|STARTED|Overall Study|1 subject was randomized but not dosed|17
3005609|NCT00983853|3723285|FG003|STARTED|Overall Study||8
3005610|NCT00983853|3723286|FG004|STARTED|Overall Study||15
3005611|NCT00983853|3723287|FG005|STARTED|Overall Study||8
3005612|NCT00983853|3723282|FG000|COMPLETED|Overall Study||6
3005613|NCT00983853|3723283|FG001|COMPLETED|Overall Study||5
3005614|NCT00983853|3723284|FG002|COMPLETED|Overall Study||14
3005615|NCT00983853|3723285|FG003|COMPLETED|Overall Study||6
3005616|NCT00983853|3723286|FG004|COMPLETED|Overall Study||12
3005617|NCT00983853|3723287|FG005|COMPLETED|Overall Study||7
3005618|NCT00983853|3723282|FG000|NOT COMPLETED|Overall Study||1
3005619|NCT00983853|3723283|FG001|NOT COMPLETED|Overall Study||2
3005620|NCT00983853|3723284|FG002|NOT COMPLETED|Overall Study||3
3005621|NCT00983853|3723285|FG003|NOT COMPLETED|Overall Study||2
3005622|NCT00983853|3723286|FG004|NOT COMPLETED|Overall Study||3
3165043|NCT01896856|3892575|FG003|NOT COMPLETED|Overall Study||0
3165044|NCT01896856|3892576|FG004|NOT COMPLETED|Overall Study||0
3165045|NCT01896856|3892577|FG005|NOT COMPLETED|Overall Study||0
3165046|NCT01896869|3892594|FG000|STARTED|Overall Study||41
3165047|NCT01896869|3892595|FG001|STARTED|Overall Study||42
3165048|NCT01896869|3892594|FG000|COMPLETED|Overall Study||40
3165049|NCT01896869|3892595|FG001|COMPLETED|Overall Study||36
3165050|NCT01896869|3892594|FG000|NOT COMPLETED|Overall Study||1
3165051|NCT01896869|3892595|FG001|NOT COMPLETED|Overall Study||6
3165052|NCT01896895|3892606|FG000|STARTED|Double-blind MP||20
3165053|NCT01896895|3892607|FG001|STARTED|Double-blind MP||22
3165054|NCT01896895|3892608|FG002|STARTED|Double-blind MP||19
3165055|NCT01896895|3892609|FG003|STARTED|Double-blind MP||0
3165056|NCT01896895|3892606|FG000|COMPLETED|Double-blind MP||19
3165057|NCT01896895|3892607|FG001|COMPLETED|Double-blind MP||20
3165058|NCT01896895|3892608|FG002|COMPLETED|Double-blind MP||16
3165059|NCT01896895|3892609|FG003|COMPLETED|Double-blind MP||0
3165060|NCT01896895|3892606|FG000|NOT COMPLETED|Double-blind MP||1
3005623|NCT00983853|3723287|FG005|NOT COMPLETED|Overall Study||1
3005624|NCT00983892|3723305|FG000|STARTED|Overall Study||66
3005625|NCT00983892|3723306|FG001|STARTED|Overall Study||68
3005626|NCT00983892|3723305|FG000|COMPLETED|Overall Study||56
3005627|NCT00983892|3723306|FG001|COMPLETED|Overall Study||56
3005628|NCT00983892|3723305|FG000|NOT COMPLETED|Overall Study||10
3005629|NCT00983892|3723306|FG001|NOT COMPLETED|Overall Study||12
3005630|NCT00983905|3723312|FG000|STARTED|Theophylline Alone||30
3005631|NCT00983905|3723312|FG000|COMPLETED|Theophylline Alone|withdrawn by sponsor due to vomiting(1)|29
3005632|NCT00983905|3723312|FG000|NOT COMPLETED|Theophylline Alone||1
3005633|NCT00983905|3723312|FG000|STARTED|4 Day Washout Period||29
3005634|NCT00983905|3723312|FG000|COMPLETED|4 Day Washout Period||29
3005635|NCT00983905|3723312|FG000|NOT COMPLETED|4 Day Washout Period||0
3005636|NCT00983905|3723312|FG000|STARTED|Colchicine Alone||29
3005637|NCT00983905|3723312|FG000|COMPLETED|Colchicine Alone|withdrawn by sponsor due to: diarrhea(1); vomiting and diarrhea(1)|27
3005638|NCT00983905|3723312|FG000|NOT COMPLETED|Colchicine Alone||2
3005639|NCT00983905|3723312|FG000|STARTED|Theophylline With Colchicine||27
3005640|NCT00983905|3723312|FG000|COMPLETED|Theophylline With Colchicine||27
3005641|NCT00983905|3723312|FG000|NOT COMPLETED|Theophylline With Colchicine||0
3005642|NCT00983918|3723323|FG000|STARTED|Overall Study||20
3005643|NCT00983918|3723324|FG001|STARTED|Overall Study||20
3005644|NCT00983918|3723325|FG002|STARTED|Overall Study||20
3005645|NCT00983918|3723326|FG003|STARTED|Overall Study||20
3005646|NCT00983918|3723323|FG000|COMPLETED|Overall Study||20
3005647|NCT00983918|3723324|FG001|COMPLETED|Overall Study||18
3005648|NCT00983918|3723325|FG002|COMPLETED|Overall Study||18
3005649|NCT00983918|3723326|FG003|COMPLETED|Overall Study||18
3005650|NCT00983918|3723323|FG000|NOT COMPLETED|Overall Study||0
3005651|NCT00983918|3723324|FG001|NOT COMPLETED|Overall Study||2
3005652|NCT00983918|3723325|FG002|NOT COMPLETED|Overall Study||2
3005653|NCT00983918|3723326|FG003|NOT COMPLETED|Overall Study||2
3005654|NCT00983931|3723336|FG000|STARTED|Colchicine Alone||24
3005655|NCT00983931|3723336|FG000|COMPLETED|Colchicine Alone||24
3005656|NCT00983931|3723336|FG000|NOT COMPLETED|Colchicine Alone||0
3005657|NCT00983931|3723336|FG000|STARTED|14 Day Washout Period||24
3005658|NCT00983931|3723336|FG000|COMPLETED|14 Day Washout Period|one subject withdrawn due to creatine kinase out of range|23
3005659|NCT00983931|3723336|FG000|NOT COMPLETED|14 Day Washout Period||1
3005660|NCT00983931|3723336|FG000|STARTED|Colchicine With Cyclosporine||23
3005661|NCT00983931|3723336|FG000|COMPLETED|Colchicine With Cyclosporine||23
3005662|NCT00983931|3723336|FG000|NOT COMPLETED|Colchicine With Cyclosporine||0
3005663|NCT00983957|3723342|FG000|STARTED|Overall Study||20
3005664|NCT00983957|3723342|FG000|Treatment A|Overall Study||20
3005665|NCT00983957|3723342|FG000|Treatment B|Overall Study||20
3005666|NCT00983957|3723342|FG000|Treatment C|Overall Study||18
3005667|NCT00983957|3723342|FG000|COMPLETED|Overall Study||18
3005668|NCT00983957|3723342|FG000|NOT COMPLETED|Overall Study||2
3005669|NCT00983983|3723355|FG000|STARTED|Overall Study||8
3005670|NCT00983983|3723356|FG001|STARTED|Overall Study||9
3005671|NCT00983983|3723357|FG002|STARTED|Overall Study||7
3005672|NCT00983983|3723355|FG000|COMPLETED|Overall Study||6
3005673|NCT00983983|3723356|FG001|COMPLETED|Overall Study||8
3005674|NCT00983983|3723357|FG002|COMPLETED|Overall Study||6
3005675|NCT00983983|3723355|FG000|NOT COMPLETED|Overall Study||2
3005676|NCT00983983|3723356|FG001|NOT COMPLETED|Overall Study||1
3005677|NCT00983983|3723357|FG002|NOT COMPLETED|Overall Study||1
3005678|NCT00984009|3723366|FG000|STARTED|Colchicine Alone||22
3005679|NCT00984009|3723366|FG000|COMPLETED|Colchicine Alone||22
3005680|NCT00984009|3723366|FG000|NOT COMPLETED|Colchicine Alone||0
3005681|NCT00984009|3723366|FG000|STARTED|14 Day Washout Period||22
3005682|NCT00984009|3723366|FG000|COMPLETED|14 Day Washout Period||22
3005683|NCT00984009|3723366|FG000|NOT COMPLETED|14 Day Washout Period||0
3005684|NCT00984009|3723366|FG000|STARTED|Grapefruit Juice Alone||22
3005685|NCT00984009|3723366|FG000|COMPLETED|Grapefruit Juice Alone|one subject dropped due to missed a.m. serving of grapefruit juice on Day 16|21
3005686|NCT00984009|3723366|FG000|NOT COMPLETED|Grapefruit Juice Alone||1
3005687|NCT00984009|3723366|FG000|STARTED|Colchicine With Grapefruit Juice||21
3005688|NCT00984009|3723366|FG000|COMPLETED|Colchicine With Grapefruit Juice||21
3005689|NCT00984009|3723366|FG000|NOT COMPLETED|Colchicine With Grapefruit Juice||0
3005690|NCT00984022|3723375|FG000|STARTED|Overall Study||43
3005691|NCT00984022|3723376|FG001|STARTED|Overall Study||49
3005692|NCT00984022|3723375|FG000|COMPLETED|Overall Study||33
3005693|NCT00984022|3723376|FG001|COMPLETED|Overall Study||35
3005694|NCT00984022|3723375|FG000|NOT COMPLETED|Overall Study||10
3005695|NCT00984022|3723376|FG001|NOT COMPLETED|Overall Study||14
3005696|NCT00984061|3723382|FG000|STARTED|Colchicine Alone||24
3005697|NCT00984061|3723382|FG000|COMPLETED|Colchicine Alone||24
3005698|NCT00984061|3723382|FG000|NOT COMPLETED|Colchicine Alone||0
3005699|NCT00984061|3723382|FG000|STARTED|21 Day Washout Period||24
3005700|NCT00984061|3723382|FG000|COMPLETED|21 Day Washout Period||24
3005701|NCT00984061|3723382|FG000|NOT COMPLETED|21 Day Washout Period||0
3005702|NCT00984061|3723382|FG000|STARTED|Clarithromycin Alone||24
3005703|NCT00984061|3723382|FG000|COMPLETED|Clarithromycin Alone|One subject was dropped due to noncompliance with outpatient clarithromycin regimen.|23
3005704|NCT00984061|3723382|FG000|NOT COMPLETED|Clarithromycin Alone||1
3005705|NCT00984061|3723382|FG000|STARTED|Colchicine With Clarithromycin||23
3005706|NCT00984061|3723382|FG000|COMPLETED|Colchicine With Clarithromycin||23
3005707|NCT00984061|3723382|FG000|NOT COMPLETED|Colchicine With Clarithromycin||0
3005708|NCT00984126|3723393|FG000|STARTED|Overall Study||27
3005709|NCT00984126|3723394|FG001|STARTED|Overall Study||28
3005710|NCT00984126|3723395|FG002|STARTED|Overall Study||23
3005711|NCT00984126|3723396|FG003|STARTED|Overall Study||135
3005712|NCT00984126|3723393|FG000|COMPLETED|Overall Study||20
3005713|NCT00984126|3723394|FG001|COMPLETED|Overall Study||20
3005714|NCT00984126|3723395|FG002|COMPLETED|Overall Study||16
3005715|NCT00984126|3723396|FG003|COMPLETED|Overall Study||76
3005716|NCT00984126|3723393|FG000|NOT COMPLETED|Overall Study||7
3005717|NCT00984126|3723394|FG001|NOT COMPLETED|Overall Study||8
3005718|NCT00984126|3723395|FG002|NOT COMPLETED|Overall Study||7
3005719|NCT00984126|3723396|FG003|NOT COMPLETED|Overall Study||59
3005720|NCT00984139|3723415|FG000|STARTED|Overall Study||306
3005721|NCT00984139|3723415|FG000|COMPLETED|Overall Study||306
3005722|NCT00984139|3723415|FG000|NOT COMPLETED|Overall Study||0
3005723|NCT00984165|3723423|FG000|STARTED|Overall Study||9
3005724|NCT00984165|3723424|FG001|STARTED|Overall Study||1
3005725|NCT00984165|3723425|FG002|STARTED|Overall Study||4
3005726|NCT00984165|3723426|FG003|STARTED|Overall Study||4
3005727|NCT00984165|3723423|FG000|COMPLETED|Overall Study||2
3005728|NCT00984165|3723424|FG001|COMPLETED|Overall Study||0
3005729|NCT00984165|3723425|FG002|COMPLETED|Overall Study||4
3005730|NCT00984165|3723426|FG003|COMPLETED|Overall Study||0
3005731|NCT00984165|3723423|FG000|NOT COMPLETED|Overall Study||7
3005732|NCT00984165|3723424|FG001|NOT COMPLETED|Overall Study||1
3005733|NCT00984165|3723425|FG002|NOT COMPLETED|Overall Study||0
3005734|NCT00984165|3723426|FG003|NOT COMPLETED|Overall Study||4
3005735|NCT00984204|3723437|FG000|STARTED|Overall Study||188
3005736|NCT00984204|3723437|FG000|COMPLETED|Overall Study|"Seven subjects of the ten Lack of efficacy were acute failures that had no block after 30 min"|173
3005737|NCT00984204|3723437|FG000|NOT COMPLETED|Overall Study||15
3005738|NCT00984256|3723443|FG000|STARTED|Overall Study||6
3005739|NCT00984256|3723444|FG001|STARTED|Overall Study||30
3005740|NCT00984256|3723443|FG000|COMPLETED|Overall Study||6
3005741|NCT00984256|3723444|FG001|COMPLETED|Overall Study||29
3005742|NCT00984256|3723443|FG000|NOT COMPLETED|Overall Study||0
3005743|NCT00984256|3723444|FG001|NOT COMPLETED|Overall Study||1
3005744|NCT00984282|3723461|FG000|STARTED|Double Blind Treatment||207
3005745|NCT00984282|3723462|FG001|STARTED|Double Blind Treatment||210
3005746|NCT00984282|3723461|FG000|Received Treatment|Double Blind Treatment|Subjects at Risk/Safety Population - in RG1 (RG= Reporting Group for Safety Data)|207
3005747|NCT00984282|3723462|FG001|Received Treatment|Double Blind Treatment|Subjects at Risk/Safety Population - in RG2 (RG= Reporting Group for Safety Data)|209
3005748|NCT00984282|3723461|FG000|COMPLETED|Double Blind Treatment||103
3005749|NCT00984282|3723462|FG001|COMPLETED|Double Blind Treatment||172
3005750|NCT00984282|3723461|FG000|NOT COMPLETED|Double Blind Treatment||104
3005751|NCT00984282|3723462|FG001|NOT COMPLETED|Double Blind Treatment||38
3005752|NCT00984282|3723461|FG000|STARTED|Open-label Treatment||86
3005753|NCT00984282|3723462|FG001|STARTED|Open-label Treatment||161
3005754|NCT00984282|3723461|FG000|Received Treatment|Open-label Treatment|Subjects at Risk/Safety Population - in RG3 (RG= Reporting Group for Safety Data)|86
3005755|NCT00984282|3723462|FG001|Received Treatment|Open-label Treatment|Subjects at Risk/Safety Population - in RG4 (RG= Reporting Group for Safety Data)|161
3005756|NCT00984282|3723461|FG000|COMPLETED|Open-label Treatment||0
3005757|NCT00984282|3723462|FG001|COMPLETED|Open-label Treatment||0
3005758|NCT00984282|3723461|FG000|NOT COMPLETED|Open-label Treatment||86
3005759|NCT00984282|3723462|FG001|NOT COMPLETED|Open-label Treatment||161
3005760|NCT00984282|3723461|FG000|STARTED|Long Term Follow-up|Participants entered long-term follow-up if terminated double-blind or open-label periods|72
3005761|NCT00984282|3723462|FG001|STARTED|Long Term Follow-up|Participants entered long-term follow-up if terminated double-blind or open-label periods|124
3165061|NCT01896895|3892607|FG001|NOT COMPLETED|Double-blind MP||2
3165062|NCT01896895|3892608|FG002|NOT COMPLETED|Double-blind MP||3
3165063|NCT01896895|3892609|FG003|NOT COMPLETED|Double-blind MP||0
3165064|NCT01896895|3892606|FG000|STARTED|OLEX Period||0
3165065|NCT01896895|3892607|FG001|STARTED|OLEX Period||0
3165066|NCT01896895|3892608|FG002|STARTED|OLEX Period||0
3005762|NCT00984282|3723461|FG000|COMPLETED|Long Term Follow-up||3
3005763|NCT00984282|3723462|FG001|COMPLETED|Long Term Follow-up||4
3005764|NCT00984282|3723461|FG000|NOT COMPLETED|Long Term Follow-up||69
3005765|NCT00984282|3723462|FG001|NOT COMPLETED|Long Term Follow-up||120
3005766|NCT00984295|3723473|FG000|STARTED|Overall Study|2 patients were incorrectly vaccinated and are excluded from this table.|949
3005767|NCT00984295|3723474|FG001|STARTED|Overall Study||485
3005768|NCT00984295|3723475|FG002|STARTED|Overall Study||479
3005769|NCT00984295|3723473|FG000|Visit 1|Overall Study||949
3005770|NCT00984295|3723474|FG001|Visit 1|Overall Study||485
3005771|NCT00984295|3723475|FG002|Visit 1|Overall Study||479
3005772|NCT00984295|3723473|FG000|Visit 2|Overall Study||909
3005773|NCT00984295|3723474|FG001|Visit 2|Overall Study||468
3005774|NCT00984295|3723475|FG002|Visit 2|Overall Study||453
3005775|NCT00984295|3723473|FG000|COMPLETED|Overall Study||884
3005776|NCT00984295|3723474|FG001|COMPLETED|Overall Study||453
3005777|NCT00984295|3723475|FG002|COMPLETED|Overall Study||442
3005778|NCT00984295|3723473|FG000|NOT COMPLETED|Overall Study||65
3005779|NCT00984295|3723474|FG001|NOT COMPLETED|Overall Study||32
3005780|NCT00984295|3723475|FG002|NOT COMPLETED|Overall Study||37
3005781|NCT00984308|3723485|FG000|STARTED|Overall Study||110
3005782|NCT00984308|3723486|FG001|STARTED|Overall Study||115
3005783|NCT00984308|3723485|FG000|COMPLETED|Overall Study||92
3005784|NCT00984308|3723486|FG001|COMPLETED|Overall Study||109
3005785|NCT00984308|3723485|FG000|NOT COMPLETED|Overall Study||18
3005786|NCT00984308|3723486|FG001|NOT COMPLETED|Overall Study||6
3005787|NCT00984334|3723497|FG000|STARTED|Overall Study||8
3005788|NCT00984334|3723498|FG001|STARTED|Overall Study||8
3005789|NCT00984334|3723499|FG002|STARTED|Overall Study||8
3005790|NCT00984334|3723500|FG003|STARTED|Overall Study||8
3005791|NCT00984334|3723501|FG004|STARTED|Overall Study||8
3005792|NCT00984334|3723497|FG000|COMPLETED|Overall Study||7
3165067|NCT01896895|3892609|FG003|STARTED|OLEX Period|Not all participants who completed double-blind MP fulfilled the inclusion criteria for OLEX period.|39
3165068|NCT01896895|3892606|FG000|COMPLETED|OLEX Period||0
3165069|NCT01896895|3892607|FG001|COMPLETED|OLEX Period||0
3165070|NCT01896895|3892608|FG002|COMPLETED|OLEX Period||0
3165071|NCT01896895|3892609|FG003|COMPLETED|OLEX Period||39
3005793|NCT00984334|3723498|FG001|COMPLETED|Overall Study||7
3005794|NCT00984334|3723499|FG002|COMPLETED|Overall Study||8
3005795|NCT00984334|3723500|FG003|COMPLETED|Overall Study||7
3005796|NCT00984334|3723501|FG004|COMPLETED|Overall Study||7
3005797|NCT00984334|3723497|FG000|NOT COMPLETED|Overall Study||1
3005798|NCT00984334|3723498|FG001|NOT COMPLETED|Overall Study||1
3005799|NCT00984334|3723499|FG002|NOT COMPLETED|Overall Study||0
3005800|NCT00984334|3723500|FG003|NOT COMPLETED|Overall Study||1
3005801|NCT00984334|3723501|FG004|NOT COMPLETED|Overall Study||1
3005802|NCT00984542|3723513|FG000|STARTED|Overall Study||50
3005803|NCT00984542|3723513|FG000|COMPLETED|Overall Study||9
3005804|NCT00984542|3723513|FG000|NOT COMPLETED|Overall Study||41
3005805|NCT00984568|3723520|FG000|STARTED|Overall Study||15
3005806|NCT00984568|3723521|FG001|STARTED|Overall Study||13
3005807|NCT00984568|3723520|FG000|COMPLETED|Overall Study||7
3005808|NCT00984568|3723521|FG001|COMPLETED|Overall Study||7
3005809|NCT00984568|3723520|FG000|NOT COMPLETED|Overall Study||8
3005810|NCT00984568|3723521|FG001|NOT COMPLETED|Overall Study||6
3005811|NCT00984594|3723529|FG000|STARTED|Overall Study||2
3005812|NCT00984594|3723530|FG001|STARTED|Overall Study|One patient withdrew consent and left the study before treatment.|2
3005813|NCT00984594|3723529|FG000|COMPLETED|Overall Study||1
3005814|NCT00984594|3723530|FG001|COMPLETED|Overall Study||1
3005815|NCT00984594|3723529|FG000|NOT COMPLETED|Overall Study||1
3005816|NCT00984594|3723530|FG001|NOT COMPLETED|Overall Study||1
3005817|NCT00984620|3723540|FG000|STARTED|Overall Study||81
3005818|NCT00984620|3723541|FG001|STARTED|Overall Study||79
3005819|NCT00984620|3723540|FG000|COMPLETED|Overall Study||75
3005820|NCT00984620|3723541|FG001|COMPLETED|Overall Study||67
3005821|NCT00984620|3723540|FG000|NOT COMPLETED|Overall Study||6
3005822|NCT00984620|3723541|FG001|NOT COMPLETED|Overall Study||12
3005823|NCT00984659|3723553|FG000|STARTED|2-week Run-in Period||418
3005824|NCT00984659|3723554|FG001|STARTED|2-week Run-in Period||0
3005825|NCT00984659|3723555|FG002|STARTED|2-week Run-in Period||0
3005826|NCT00984659|3723556|FG003|STARTED|2-week Run-in Period||0
3005827|NCT00984659|3723553|FG000|COMPLETED|2-week Run-in Period||366
3005828|NCT00984659|3723554|FG001|COMPLETED|2-week Run-in Period||0
3005829|NCT00984659|3723555|FG002|COMPLETED|2-week Run-in Period||0
3005830|NCT00984659|3723556|FG003|COMPLETED|2-week Run-in Period||0
3005831|NCT00984659|3723553|FG000|NOT COMPLETED|2-week Run-in Period||52
3005832|NCT00984659|3723554|FG001|NOT COMPLETED|2-week Run-in Period||0
3005833|NCT00984659|3723555|FG002|NOT COMPLETED|2-week Run-in Period||0
3005834|NCT00984659|3723556|FG003|NOT COMPLETED|2-week Run-in Period||0
3005835|NCT00984659|3723553|FG000|STARTED|6-week Double-blind Treatment Period||0
3005836|NCT00984659|3723554|FG001|STARTED|6-week Double-blind Treatment Period||75
3005837|NCT00984659|3723555|FG002|STARTED|6-week Double-blind Treatment Period||152
3005838|NCT00984659|3723556|FG003|STARTED|6-week Double-blind Treatment Period||139
3005839|NCT00984659|3723553|FG000|COMPLETED|6-week Double-blind Treatment Period||0
3005840|NCT00984659|3723554|FG001|COMPLETED|6-week Double-blind Treatment Period||69
3005841|NCT00984659|3723555|FG002|COMPLETED|6-week Double-blind Treatment Period||141
3005842|NCT00984659|3723556|FG003|COMPLETED|6-week Double-blind Treatment Period||126
3005843|NCT00984659|3723553|FG000|NOT COMPLETED|6-week Double-blind Treatment Period||0
3005844|NCT00984659|3723554|FG001|NOT COMPLETED|6-week Double-blind Treatment Period||6
3005845|NCT00984659|3723555|FG002|NOT COMPLETED|6-week Double-blind Treatment Period||11
3005846|NCT00984659|3723556|FG003|NOT COMPLETED|6-week Double-blind Treatment Period||13
3005847|NCT00984698|3723565|FG000|STARTED|Overall Study||21
3005848|NCT00984698|3723566|FG001|STARTED|Overall Study||22
3005849|NCT00984698|3723565|FG000|COMPLETED|Overall Study||18
3005850|NCT00984698|3723566|FG001|COMPLETED|Overall Study||14
3005851|NCT00984698|3723565|FG000|NOT COMPLETED|Overall Study||3
3005852|NCT00984698|3723566|FG001|NOT COMPLETED|Overall Study||8
3005853|NCT00984815|3723572|FG000|STARTED|Overall Study||86
3005854|NCT00984815|3723572|FG000|COMPLETED|Overall Study||56
3005855|NCT00984815|3723572|FG000|NOT COMPLETED|Overall Study||30
3005856|NCT00984867|3723578|FG000|STARTED|Overall Study|Of the 226 randomized and treated participants only 224 were included in the full analysis set.|226
3005857|NCT00984867|3723579|FG001|STARTED|Overall Study|Of the 225 randomized and treated participants only 223 were included in the full analysis set.|225
3005858|NCT00984867|3723578|FG000|COMPLETED|Overall Study||203
3005859|NCT00984867|3723579|FG001|COMPLETED|Overall Study||208
3005860|NCT00984867|3723578|FG000|NOT COMPLETED|Overall Study||23
3005861|NCT00984867|3723579|FG001|NOT COMPLETED|Overall Study||17
3005862|NCT00985010|3723589|FG000|STARTED|Overall Study||4
3005863|NCT00985010|3723590|FG001|STARTED|Overall Study||5
3005864|NCT00985010|3723589|FG000|COMPLETED|Overall Study||4
3005865|NCT00985010|3723590|FG001|COMPLETED|Overall Study||5
3005866|NCT00985010|3723589|FG000|NOT COMPLETED|Overall Study||0
3005867|NCT00985010|3723590|FG001|NOT COMPLETED|Overall Study||0
3005868|NCT00985088|3723604|FG000|STARTED|Overall Study||222
3005869|NCT00985088|3723605|FG001|STARTED|Overall Study||114
3005870|NCT00985088|3723606|FG002|STARTED|Overall Study||112
3005871|NCT00985088|3723607|FG003|STARTED|Overall Study||221
3005872|NCT00985088|3723608|FG004|STARTED|Overall Study||223
3005873|NCT00985088|3723609|FG005|STARTED|Overall Study||115
3005874|NCT00985088|3723610|FG006|STARTED|Overall Study||111
3005875|NCT00985088|3723611|FG007|STARTED|Overall Study||222
3005876|NCT00985088|3723604|FG000|COMPLETED|Overall Study||211
3005877|NCT00985088|3723605|FG001|COMPLETED|Overall Study||112
3005878|NCT00985088|3723606|FG002|COMPLETED|Overall Study||108
3005879|NCT00985088|3723607|FG003|COMPLETED|Overall Study||214
3005880|NCT00985088|3723608|FG004|COMPLETED|Overall Study||214
3005881|NCT00985088|3723609|FG005|COMPLETED|Overall Study||108
3005882|NCT00985088|3723610|FG006|COMPLETED|Overall Study||107
3005883|NCT00985088|3723611|FG007|COMPLETED|Overall Study||216
3005884|NCT00985088|3723604|FG000|NOT COMPLETED|Overall Study||11
3005885|NCT00985088|3723605|FG001|NOT COMPLETED|Overall Study||2
3005886|NCT00985088|3723606|FG002|NOT COMPLETED|Overall Study||4
3005887|NCT00985088|3723607|FG003|NOT COMPLETED|Overall Study||7
3005888|NCT00985088|3723608|FG004|NOT COMPLETED|Overall Study||9
3005889|NCT00985088|3723609|FG005|NOT COMPLETED|Overall Study||7
3005890|NCT00985088|3723610|FG006|NOT COMPLETED|Overall Study||4
3005891|NCT00985088|3723611|FG007|NOT COMPLETED|Overall Study||6
3005892|NCT00985114|3723641|FG000|STARTED|Overall Study|38 randomized, 34 received the device|34
3005893|NCT00985114|3723642|FG001|STARTED|Overall Study||39
3005894|NCT00985114|3723641|FG000|Diet + Lifestyle Counseling Cross-over|Overall Study||0
3005895|NCT00985114|3723642|FG001|Diet + Lifestyle Counseling Cross-over|Overall Study|Received device for intended period of 12 months with 6 months follow up|28
3005896|NCT00985114|3723641|FG000|COMPLETED|Overall Study||33
3005897|NCT00985114|3723642|FG001|COMPLETED|Overall Study||37
3005898|NCT00985114|3723641|FG000|NOT COMPLETED|Overall Study||1
3005899|NCT00985114|3723642|FG001|NOT COMPLETED|Overall Study||2
3005900|NCT00985140|3723648|FG000|STARTED|Overall Study||15
3005901|NCT00985140|3723648|FG000|COMPLETED|Overall Study||15
3005902|NCT00985140|3723648|FG000|NOT COMPLETED|Overall Study||0
3005903|NCT00985153|3723656|FG000|STARTED|Overall Study||985
3005904|NCT00985153|3723657|FG001|STARTED|Overall Study||968
3005905|NCT00985153|3723658|FG002|STARTED|Overall Study||962
3005906|NCT00985153|3723659|FG003|STARTED|Overall Study||1012
3005907|NCT00985153|3723656|FG000|Vaccinated at Visit 1|Overall Study||985
3005908|NCT00985153|3723657|FG001|Vaccinated at Visit 1|Overall Study||968
3005909|NCT00985153|3723658|FG002|Vaccinated at Visit 1|Overall Study||962
3005910|NCT00985153|3723659|FG003|Vaccinated at Visit 1|Overall Study||1012
3005911|NCT00985153|3723656|FG000|COMPLETED|Overall Study||950
3005912|NCT00985153|3723657|FG001|COMPLETED|Overall Study||924
3005913|NCT00985153|3723658|FG002|COMPLETED|Overall Study||918
3005914|NCT00985153|3723659|FG003|COMPLETED|Overall Study||965
3005915|NCT00985153|3723656|FG000|NOT COMPLETED|Overall Study||35
3005916|NCT00985153|3723657|FG001|NOT COMPLETED|Overall Study||44
3005917|NCT00985153|3723658|FG002|NOT COMPLETED|Overall Study||44
3005918|NCT00985153|3723659|FG003|NOT COMPLETED|Overall Study||47
3005919|NCT00985166|3723672|FG000|STARTED|Overall Study|Two randomized subjects withdrew consent before vaccination: no demographic information available.|401
3005920|NCT00985166|3723673|FG001|STARTED|Overall Study||205
3005921|NCT00985166|3723674|FG002|STARTED|Overall Study||195
3005922|NCT00985166|3723672|FG000|Vaccinated at Visit 1|Overall Study||399
3005923|NCT00985166|3723673|FG001|Vaccinated at Visit 1|Overall Study||205
3005924|NCT00985166|3723674|FG002|Vaccinated at Visit 1|Overall Study||195
3005925|NCT00985166|3723672|FG000|COMPLETED|Overall Study||392
3005926|NCT00985166|3723673|FG001|COMPLETED|Overall Study||201
3005927|NCT00985166|3723674|FG002|COMPLETED|Overall Study||188
3005928|NCT00985166|3723672|FG000|NOT COMPLETED|Overall Study||9
3005929|NCT00985166|3723673|FG001|NOT COMPLETED|Overall Study||4
3005930|NCT00985166|3723674|FG002|NOT COMPLETED|Overall Study||7
3005931|NCT00985192|3723684|FG000|STARTED|Overall Study||49
3005932|NCT00985192|3723684|FG000|COMPLETED|Overall Study||45
3005933|NCT00985192|3723684|FG000|NOT COMPLETED|Overall Study||4
3005934|NCT00985231|3723690|FG000|STARTED|Overall Study||133
3005935|NCT00985231|3723691|FG001|STARTED|Overall Study||132
3005936|NCT00985231|3723690|FG000|COMPLETED|Overall Study||130
3005937|NCT00985231|3723691|FG001|COMPLETED|Overall Study||129
3005938|NCT00985231|3723690|FG000|NOT COMPLETED|Overall Study||3
3005939|NCT00985231|3723691|FG001|NOT COMPLETED|Overall Study||3
3005940|NCT00985257|3723697|FG000|STARTED|Overall Study||123
3005941|NCT00985257|3723697|FG000|COMPLETED|Overall Study||123
3005942|NCT00985257|3723697|FG000|NOT COMPLETED|Overall Study||0
3005943|NCT00985426|3723703|FG000|STARTED|Overall Study||258
3005944|NCT00985426|3723704|FG001|STARTED|Overall Study||263
3005945|NCT00985426|3723703|FG000|COMPLETED|Overall Study||215
3005946|NCT00985426|3723704|FG001|COMPLETED|Overall Study||219
3005947|NCT00985426|3723703|FG000|NOT COMPLETED|Overall Study||43
3005948|NCT00985426|3723704|FG001|NOT COMPLETED|Overall Study||44
3005949|NCT00985439|3723714|FG000|STARTED|Overall Study||49
3005950|NCT00985439|3723715|FG001|STARTED|Overall Study||51
3005951|NCT00985439|3723716|FG002|STARTED|Overall Study||51
3005952|NCT00985439|3723717|FG003|STARTED|Overall Study||51
3005953|NCT00985439|3723714|FG000|COMPLETED|Overall Study||49
3005954|NCT00985439|3723715|FG001|COMPLETED|Overall Study||51
3005955|NCT00985439|3723716|FG002|COMPLETED|Overall Study||50
3005956|NCT00985439|3723717|FG003|COMPLETED|Overall Study||51
3005957|NCT00985439|3723714|FG000|NOT COMPLETED|Overall Study||0
3005958|NCT00985439|3723715|FG001|NOT COMPLETED|Overall Study||0
3005959|NCT00985439|3723716|FG002|NOT COMPLETED|Overall Study||1
3005960|NCT00985439|3723717|FG003|NOT COMPLETED|Overall Study||0
3005961|NCT00985465|3723729|FG000|STARTED|Overall Study||141
3005962|NCT00985465|3723730|FG001|STARTED|Overall Study||69
3005963|NCT00985465|3723729|FG000|COMPLETED|Overall Study||140
3005964|NCT00985465|3723730|FG001|COMPLETED|Overall Study||66
3005965|NCT00985465|3723729|FG000|NOT COMPLETED|Overall Study||1
3005966|NCT00985465|3723730|FG001|NOT COMPLETED|Overall Study||3
3005967|NCT00985491|3723737|FG000|STARTED|Overall Study|46 subjects underwent an attempted implantation procedure|46
3005968|NCT00985491|3723737|FG000|Received Device|Overall Study||43
3005969|NCT00985491|3723737|FG000|COMPLETED|Overall Study|43 subjects received a device, 27 subjects completed 12 month implant period|27
3005970|NCT00985491|3723737|FG000|NOT COMPLETED|Overall Study||19
3005971|NCT00985504|3723744|FG000|STARTED|Acute Treatment Period||244
3005972|NCT00985504|3723745|FG001|STARTED|Acute Treatment Period||239
3005973|NCT00985504|3723744|FG000|COMPLETED|Acute Treatment Period||229
3005974|NCT00985504|3723745|FG001|COMPLETED|Acute Treatment Period||227
3005975|NCT00985504|3723744|FG000|NOT COMPLETED|Acute Treatment Period||15
3005976|NCT00985504|3723745|FG001|NOT COMPLETED|Acute Treatment Period||12
3005977|NCT00985504|3723744|FG000|STARTED|Optimization Period||229
3005978|NCT00985504|3723745|FG001|STARTED|Optimization Period||227
3005979|NCT00985504|3723744|FG000|COMPLETED|Optimization Period||203
3005980|NCT00985504|3723745|FG001|COMPLETED|Optimization Period||204
3005981|NCT00985504|3723744|FG000|NOT COMPLETED|Optimization Period||26
3005982|NCT00985504|3723745|FG001|NOT COMPLETED|Optimization Period||23
3005983|NCT00985517|3723755|FG000|STARTED|Overall Study||3
3005984|NCT00985517|3723756|FG001|STARTED|Overall Study||3
3005985|NCT00985517|3723757|FG002|STARTED|Overall Study||24
3005986|NCT00985517|3723758|FG003|STARTED|Overall Study||27
3005987|NCT00985517|3723755|FG000|COMPLETED|Overall Study||3
3005988|NCT00985517|3723756|FG001|COMPLETED|Overall Study||3
3005989|NCT00985517|3723757|FG002|COMPLETED|Overall Study||23
3005990|NCT00985517|3723758|FG003|COMPLETED|Overall Study||24
3005991|NCT00985517|3723755|FG000|NOT COMPLETED|Overall Study||0
3005992|NCT00985517|3723756|FG001|NOT COMPLETED|Overall Study||0
3005993|NCT00985517|3723757|FG002|NOT COMPLETED|Overall Study||1
3005994|NCT00985517|3723758|FG003|NOT COMPLETED|Overall Study||3
3133647|NCT01696760|3858565|FG000|NOT COMPLETED|Overall Study||0
3005995|NCT00985543|3723769|FG000|STARTED|Overall Study||22
3005996|NCT00985543|3723769|FG000|COMPLETED|Overall Study||22
3005997|NCT00985543|3723769|FG000|NOT COMPLETED|Overall Study||0
3005998|NCT00985621|3723779|FG000|STARTED|Overall Study||142
3005999|NCT00985621|3723780|FG001|STARTED|Overall Study||161
3006000|NCT00985621|3723781|FG002|STARTED|Overall Study||152
3006001|NCT00985621|3723782|FG003|STARTED|Overall Study||159
3006002|NCT00985621|3723779|FG000|Treated|Overall Study||141
3006003|NCT00985621|3723780|FG001|Treated|Overall Study||161
3006004|NCT00985621|3723781|FG002|Treated|Overall Study||150
3006005|NCT00985621|3723782|FG003|Treated|Overall Study||158
3006006|NCT00985621|3723779|FG000|COMPLETED|Overall Study||28
3006007|NCT00985621|3723780|FG001|COMPLETED|Overall Study||30
3006008|NCT00985621|3723781|FG002|COMPLETED|Overall Study||29
3006009|NCT00985621|3723782|FG003|COMPLETED|Overall Study||22
3006010|NCT00985621|3723779|FG000|NOT COMPLETED|Overall Study||114
3006011|NCT00985621|3723780|FG001|NOT COMPLETED|Overall Study||131
3006012|NCT00985621|3723781|FG002|NOT COMPLETED|Overall Study||123
3006013|NCT00985621|3723782|FG003|NOT COMPLETED|Overall Study||137
3006014|NCT00985673|3723800|FG000|STARTED|Overall Study||102
3006015|NCT00985673|3723801|FG001|STARTED|Overall Study||104
3006016|NCT00985673|3723802|FG002|STARTED|Overall Study||102
3006017|NCT00985673|3723803|FG003|STARTED|Overall Study||100
3006018|NCT00985673|3723804|FG004|STARTED|Overall Study||101
3006019|NCT00985673|3723805|FG005|STARTED|Overall Study||102
3006020|NCT00985673|3723800|FG000|COMPLETED|Overall Study||95
3006021|NCT00985673|3723801|FG001|COMPLETED|Overall Study||93
3006022|NCT00985673|3723802|FG002|COMPLETED|Overall Study||90
3006023|NCT00985673|3723803|FG003|COMPLETED|Overall Study||88
3006024|NCT00985673|3723804|FG004|COMPLETED|Overall Study||93
3006025|NCT00985673|3723805|FG005|COMPLETED|Overall Study||96
3006026|NCT00985673|3723800|FG000|NOT COMPLETED|Overall Study||7
3006027|NCT00985673|3723801|FG001|NOT COMPLETED|Overall Study||11
3006028|NCT00985673|3723802|FG002|NOT COMPLETED|Overall Study||12
3006029|NCT00985673|3723803|FG003|NOT COMPLETED|Overall Study||12
3006030|NCT00985673|3723804|FG004|NOT COMPLETED|Overall Study||8
3006031|NCT00985673|3723805|FG005|NOT COMPLETED|Overall Study||6
3006032|NCT00985686|3723824|FG000|STARTED|Overall Study||18
3006033|NCT00985686|3723825|FG001|STARTED|Overall Study||16
3006034|NCT00985686|3723826|FG002|STARTED|Overall Study||13
3006035|NCT00985686|3723827|FG003|STARTED|Overall Study||16
3006036|NCT00985686|3723824|FG000|Visit 1: Baseline Data Collection|Overall Study||18
3006037|NCT00985686|3723825|FG001|Visit 1: Baseline Data Collection|Overall Study||15
3006038|NCT00985686|3723826|FG002|Visit 1: Baseline Data Collection|Overall Study||13
3006039|NCT00985686|3723827|FG003|Visit 1: Baseline Data Collection|Overall Study||16
3006040|NCT00985686|3723824|FG000|Visit 2: Data Collection at 8 Weeks|Overall Study||18
3006041|NCT00985686|3723825|FG001|Visit 2: Data Collection at 8 Weeks|Overall Study||15
3006042|NCT00985686|3723826|FG002|Visit 2: Data Collection at 8 Weeks|Overall Study||13
3006043|NCT00985686|3723827|FG003|Visit 2: Data Collection at 8 Weeks|Overall Study||16
3006044|NCT00985686|3723824|FG000|Visit 3: Data Collection at 16 Weeks|Overall Study||17
3006045|NCT00985686|3723825|FG001|Visit 3: Data Collection at 16 Weeks|Overall Study||15
3006046|NCT00985686|3723826|FG002|Visit 3: Data Collection at 16 Weeks|Overall Study||13
3006047|NCT00985686|3723827|FG003|Visit 3: Data Collection at 16 Weeks|Overall Study||16
3006048|NCT00985686|3723824|FG000|Visit 4: Data Collection at 24 Weeks|Overall Study||17
3006049|NCT00985686|3723825|FG001|Visit 4: Data Collection at 24 Weeks|Overall Study||15
3006050|NCT00985686|3723826|FG002|Visit 4: Data Collection at 24 Weeks|Overall Study||13
3006051|NCT00985686|3723827|FG003|Visit 4: Data Collection at 24 Weeks|Overall Study||14
3006052|NCT00985686|3723824|FG000|COMPLETED|Overall Study||17
3006053|NCT00985686|3723825|FG001|COMPLETED|Overall Study||15
3006054|NCT00985686|3723826|FG002|COMPLETED|Overall Study||13
3006055|NCT00985686|3723827|FG003|COMPLETED|Overall Study||14
3006056|NCT00985686|3723824|FG000|NOT COMPLETED|Overall Study||1
3006057|NCT00985686|3723825|FG001|NOT COMPLETED|Overall Study||1
3006058|NCT00985686|3723826|FG002|NOT COMPLETED|Overall Study||0
3006059|NCT00985686|3723827|FG003|NOT COMPLETED|Overall Study||2
3006060|NCT00985712|3723837|FG000|STARTED|Overall Study||133
3006061|NCT00985712|3723838|FG001|STARTED|Overall Study||130
3006062|NCT00985712|3723837|FG000|Received at Least One Dose of Study Drug|Overall Study||131
3006063|NCT00985712|3723838|FG001|Received at Least One Dose of Study Drug|Overall Study||130
3006064|NCT00985712|3723837|FG000|Full Analysis Set (FAS)|Overall Study|Participants completed baseline and had at least 1 post-baseline measurement for efficacy analysis.|128
3006065|NCT00985712|3723838|FG001|Full Analysis Set (FAS)|Overall Study|Participants completed baseline and had at least 1 post-baseline measurement for efficacy analysis.|129
3006066|NCT00985712|3723837|FG000|COMPLETED|Overall Study||127
3006067|NCT00985712|3723838|FG001|COMPLETED|Overall Study||123
3006068|NCT00985712|3723837|FG000|NOT COMPLETED|Overall Study||6
3006069|NCT00985712|3723838|FG001|NOT COMPLETED|Overall Study||7
3006070|NCT00985725|3723846|FG000|STARTED|Overall Study||71
3006071|NCT00985725|3723847|FG001|STARTED|Overall Study||72
3006072|NCT00985725|3723846|FG000|COMPLETED|Overall Study||60
3006073|NCT00985725|3723847|FG001|COMPLETED|Overall Study||59
3006074|NCT00985725|3723846|FG000|NOT COMPLETED|Overall Study||11
3006075|NCT00985725|3723847|FG001|NOT COMPLETED|Overall Study||13
3006076|NCT00985751|3723858|FG000|STARTED|Overall Study||51
3006077|NCT00985751|3723859|FG001|STARTED|Overall Study||52
3006078|NCT00985751|3723860|FG002|STARTED|Overall Study||52
3006079|NCT00985751|3723861|FG003|STARTED|Overall Study||51
3006080|NCT00985751|3723862|FG004|STARTED|Overall Study||51
3006081|NCT00985751|3723858|FG000|COMPLETED|Overall Study||51
3006082|NCT00985751|3723859|FG001|COMPLETED|Overall Study||52
3006083|NCT00985751|3723860|FG002|COMPLETED|Overall Study||52
3006084|NCT00985751|3723861|FG003|COMPLETED|Overall Study||51
3006085|NCT00985751|3723862|FG004|COMPLETED|Overall Study||50
3006086|NCT00985751|3723858|FG000|NOT COMPLETED|Overall Study||0
3006087|NCT00985751|3723859|FG001|NOT COMPLETED|Overall Study||0
3006088|NCT00985751|3723860|FG002|NOT COMPLETED|Overall Study||0
3006089|NCT00985751|3723861|FG003|NOT COMPLETED|Overall Study||0
3006090|NCT00985751|3723862|FG004|NOT COMPLETED|Overall Study||1
3006091|NCT00985790|3723879|FG000|STARTED|Overall Study|95 were primed and 203 were unprimed subjects.|298
3006092|NCT00985790|3723880|FG001|STARTED|Overall Study|97 were primed and 204 were unprimed subjects.|301
3006093|NCT00985790|3723879|FG000|COMPLETED|Overall Study||291
3006094|NCT00985790|3723880|FG001|COMPLETED|Overall Study||293
3006095|NCT00985790|3723879|FG000|NOT COMPLETED|Overall Study||7
3006096|NCT00985790|3723880|FG001|NOT COMPLETED|Overall Study||8
3006097|NCT00985829|3723891|FG000|STARTED|Overall Study||28
3006098|NCT00985829|3723891|FG000|COMPLETED|Overall Study||28
3006099|NCT00985829|3723891|FG000|NOT COMPLETED|Overall Study||0
3006100|NCT00985907|3723896|FG000|STARTED|Overall Study||13
3006101|NCT00985907|3723896|FG000|COMPLETED|Overall Study||0
3006102|NCT00985907|3723896|FG000|NOT COMPLETED|Overall Study||13
3006103|NCT00985946|3723900|FG000|STARTED|Overall Study|Eighty-seven percent (n=13) were evaluable for response.|15
3006104|NCT00985946|3723900|FG000|COMPLETED|Overall Study||8
3006105|NCT00985946|3723900|FG000|NOT COMPLETED|Overall Study||7
3006106|NCT00985959|3723907|FG000|STARTED|Overall Study|Number of participants treated|6
3006107|NCT00985959|3723908|FG001|STARTED|Overall Study|Number of participants treated|6
3006108|NCT00985959|3723909|FG002|STARTED|Overall Study|Number of participants treated|87
3006109|NCT00985959|3723907|FG000|COMPLETED|Overall Study|Completed all 9 cycles|3
3006110|NCT00985959|3723908|FG001|COMPLETED|Overall Study|Completed all 9 cycles|3
3006111|NCT00985959|3723909|FG002|COMPLETED|Overall Study||28
3006112|NCT00985959|3723907|FG000|NOT COMPLETED|Overall Study||3
3006113|NCT00985959|3723908|FG001|NOT COMPLETED|Overall Study||3
3006114|NCT00985959|3723909|FG002|NOT COMPLETED|Overall Study||59
3006115|NCT00985985|3723927|FG000|STARTED|Overall Study||241
3006116|NCT00985985|3723928|FG001|STARTED|Overall Study||242
3006117|NCT00985985|3723929|FG002|STARTED|Overall Study||120
3006118|NCT00985985|3723930|FG003|STARTED|Overall Study||120
3006119|NCT00985985|3723927|FG000|Safety Population|Overall Study||241
3006120|NCT00985985|3723928|FG001|Safety Population|Overall Study||242
3006121|NCT00985985|3723929|FG002|Safety Population|Overall Study||119
3006122|NCT00985985|3723930|FG003|Safety Population|Overall Study||118
3006123|NCT00985985|3723927|FG000|Full Analysis Set (FAS) Population|Overall Study||241
3006124|NCT00985985|3723928|FG001|Full Analysis Set (FAS) Population|Overall Study||242
3006125|NCT00985985|3723929|FG002|Full Analysis Set (FAS) Population|Overall Study||120
3006126|NCT00985985|3723930|FG003|Full Analysis Set (FAS) Population|Overall Study|One participant withdrew consent and was not included as the FAS population.|119
3006127|NCT00985985|3723927|FG000|COMPLETED|Overall Study||217
3006128|NCT00985985|3723928|FG001|COMPLETED|Overall Study||218
3006129|NCT00985985|3723929|FG002|COMPLETED|Overall Study||109
3006130|NCT00985985|3723930|FG003|COMPLETED|Overall Study||107
3006131|NCT00985985|3723927|FG000|NOT COMPLETED|Overall Study||24
3006132|NCT00985985|3723928|FG001|NOT COMPLETED|Overall Study||24
3006133|NCT00985985|3723929|FG002|NOT COMPLETED|Overall Study||11
3006134|NCT00985985|3723930|FG003|NOT COMPLETED|Overall Study||13
3006135|NCT00986102|3723949|FG000|STARTED|Overall Study|Number of participants who received study medication|53
3006136|NCT00986102|3723950|FG001|STARTED|Overall Study|Number of participants who received study medication|77
3006137|NCT00986102|3723951|FG002|STARTED|Overall Study|Number of participants who received study medication|19
3006138|NCT00986102|3723952|FG003|STARTED|Overall Study|Number of participants who received study medication|67
3006139|NCT00986102|3723949|FG000|COMPLETED|Overall Study||52
3006140|NCT00986102|3723950|FG001|COMPLETED|Overall Study||75
3006141|NCT00986102|3723951|FG002|COMPLETED|Overall Study||19
3006142|NCT00986102|3723952|FG003|COMPLETED|Overall Study||66
3006143|NCT00986102|3723949|FG000|NOT COMPLETED|Overall Study||1
3006144|NCT00986102|3723950|FG001|NOT COMPLETED|Overall Study||2
3006145|NCT00986102|3723951|FG002|NOT COMPLETED|Overall Study||0
3006146|NCT00986102|3723952|FG003|NOT COMPLETED|Overall Study||1
3006147|NCT00986154|3723964|FG000|STARTED|Overall Study||4143
3006148|NCT00986154|3723965|FG001|STARTED|Overall Study||4149
3006149|NCT00986154|3723964|FG000|Safety Analysis Set (Received Drug)|Overall Study||4118
3006150|NCT00986154|3723965|FG001|Safety Analysis Set (Received Drug)|Overall Study||4122
3006151|NCT00986154|3723964|FG000|COMPLETED|Overall Study||3937
3006152|NCT00986154|3723965|FG001|COMPLETED|Overall Study||3955
3006153|NCT00986154|3723964|FG000|NOT COMPLETED|Overall Study||206
3006154|NCT00986154|3723965|FG001|NOT COMPLETED|Overall Study||194
3006155|NCT00986180|3723973|FG000|STARTED|Overall Study||321
3006156|NCT00986180|3723974|FG001|STARTED|Overall Study||324
3006157|NCT00986180|3723973|FG000|COMPLETED|Overall Study||277
3006158|NCT00986180|3723974|FG001|COMPLETED|Overall Study||268
3006159|NCT00986180|3723973|FG000|NOT COMPLETED|Overall Study||44
3006160|NCT00986180|3723974|FG001|NOT COMPLETED|Overall Study||56
3006161|NCT00986232|3723984|FG000|STARTED|Overall Study||387
3006162|NCT00986232|3723985|FG001|STARTED|Overall Study|Excludes 1 patient who was randomized to receive ProQuad (Middle Dose), but was not vaccinated.|393
3006163|NCT00986232|3723986|FG002|STARTED|Overall Study||381
3006164|NCT00986232|3723987|FG003|STARTED|Overall Study|Excludes 1 patient who was randomized to receive M-M-R™ II + PUVV, but was not vaccinated.|390
3006165|NCT00986232|3723984|FG000|Vaccination Visit 1|Overall Study||387
3006166|NCT00986232|3723985|FG001|Vaccination Visit 1|Overall Study||393
3006167|NCT00986232|3723986|FG002|Vaccination Visit 1|Overall Study||381
3006168|NCT00986232|3723987|FG003|Vaccination Visit 1|Overall Study||390
3006169|NCT00986232|3723984|FG000|Vaccination Visit 2|Overall Study||360
3006170|NCT00986232|3723985|FG001|Vaccination Visit 2|Overall Study||365
3006171|NCT00986232|3723986|FG002|Vaccination Visit 2|Overall Study||360
3006172|NCT00986232|3723987|FG003|Vaccination Visit 2|Overall Study||0
3006173|NCT00986232|3723984|FG000|COMPLETED|Overall Study||336
3006174|NCT00986232|3723985|FG001|COMPLETED|Overall Study||343
3006175|NCT00986232|3723986|FG002|COMPLETED|Overall Study||346
3006176|NCT00986232|3723987|FG003|COMPLETED|Overall Study||370
3006177|NCT00986232|3723984|FG000|NOT COMPLETED|Overall Study||51
3006178|NCT00986232|3723985|FG001|NOT COMPLETED|Overall Study||50
3006179|NCT00986232|3723986|FG002|NOT COMPLETED|Overall Study||35
3006180|NCT00986232|3723987|FG003|NOT COMPLETED|Overall Study||20
3006181|NCT00986245|3724003|FG000|STARTED|First Intervention||41
3006182|NCT00986245|3724004|FG001|STARTED|First Intervention||41
3006183|NCT00986245|3724003|FG000|COMPLETED|First Intervention||31
3006184|NCT00986245|3724004|FG001|COMPLETED|First Intervention||33
3006185|NCT00986245|3724003|FG000|NOT COMPLETED|First Intervention||10
3006186|NCT00986245|3724004|FG001|NOT COMPLETED|First Intervention||8
3006187|NCT00986245|3724003|FG000|STARTED|Second Intervention||31
3006188|NCT00986245|3724004|FG001|STARTED|Second Intervention||33
3006189|NCT00986245|3724003|FG000|COMPLETED|Second Intervention||29
3006190|NCT00986245|3724004|FG001|COMPLETED|Second Intervention||32
3006191|NCT00986245|3724003|FG000|NOT COMPLETED|Second Intervention||2
3006192|NCT00986245|3724004|FG001|NOT COMPLETED|Second Intervention||1
3006193|NCT00986258|3724015|FG000|STARTED|Observation Period||136
3006194|NCT00986258|3724015|FG000|COMPLETED|Observation Period||125
3006195|NCT00986258|3724015|FG000|NOT COMPLETED|Observation Period||11
3006196|NCT00986258|3724015|FG000|STARTED|Titration and Optimal Dose Period||125
3006197|NCT00986258|3724015|FG000|COMPLETED|Titration and Optimal Dose Period||102
3006198|NCT00986258|3724015|FG000|NOT COMPLETED|Titration and Optimal Dose Period||23
3006199|NCT00986258|3724015|FG000|STARTED|Maintenance Period||102
3006200|NCT00986258|3724015|FG000|COMPLETED|Maintenance Period||93
3006201|NCT00986258|3724015|FG000|NOT COMPLETED|Maintenance Period||9
3006202|NCT00986349|3724029|FG000|STARTED|Overall Study|attempted implant procedures|23
3006203|NCT00986349|3724029|FG000|Successful Implant Procedure|Overall Study|successful device implant procedure|20
3006204|NCT00986349|3724029|FG000|Early Explant|Overall Study||4
3006205|NCT00986349|3724029|FG000|COMPLETED|Overall Study||16
3006206|NCT00986349|3724029|FG000|NOT COMPLETED|Overall Study||7
3006207|NCT00986362|3724044|FG000|STARTED|Overall Study|16 eyes randomized and treated (in 15 subjects).|16
3165072|NCT01896895|3892606|FG000|NOT COMPLETED|OLEX Period||0
3165073|NCT01896895|3892607|FG001|NOT COMPLETED|OLEX Period||0
3165074|NCT01896895|3892608|FG002|NOT COMPLETED|OLEX Period||0
3165075|NCT01896895|3892609|FG003|NOT COMPLETED|OLEX Period||0
3165076|NCT01896921|3892618|FG000|STARTED|Overall Study||7
3165077|NCT01896921|3892618|FG000|COMPLETED|Overall Study||5
3006208|NCT00986362|3724045|FG001|STARTED|Overall Study|8 eyes randomized and treated (in 8 subjects).|8
3006209|NCT00986362|3724044|FG000|COMPLETED|Overall Study|14 eyes completed the study (in 14 subjects).|14
3006210|NCT00986362|3724045|FG001|COMPLETED|Overall Study|7 eyes completed the study (in 7 subjects).|7
3006211|NCT00986362|3724044|FG000|NOT COMPLETED|Overall Study||2
3006212|NCT00986362|3724045|FG001|NOT COMPLETED|Overall Study||1
3006213|NCT00986401|3724053|FG000|STARTED|Period 1||22
3006214|NCT00986401|3724054|FG001|STARTED|Period 1||22
3006215|NCT00986401|3724053|FG000|COMPLETED|Period 1||22
3006216|NCT00986401|3724054|FG001|COMPLETED|Period 1||21
3006217|NCT00986401|3724053|FG000|NOT COMPLETED|Period 1||0
3006218|NCT00986401|3724054|FG001|NOT COMPLETED|Period 1||1
3006219|NCT00986401|3724053|FG000|STARTED|Period 2||22
3006220|NCT00986401|3724054|FG001|STARTED|Period 2||21
3006221|NCT00986401|3724053|FG000|COMPLETED|Period 2||22
3006222|NCT00986401|3724054|FG001|COMPLETED|Period 2||21
3006223|NCT00986401|3724053|FG000|NOT COMPLETED|Period 2||0
3006224|NCT00986401|3724054|FG001|NOT COMPLETED|Period 2||0
3006225|NCT00986427|3724065|FG000|STARTED|Overall Study||12
3006226|NCT00986427|3724066|FG001|STARTED|Overall Study||12
3006227|NCT00986427|3724065|FG000|COMPLETED|Overall Study||8
3006228|NCT00986427|3724066|FG001|COMPLETED|Overall Study||12
3006229|NCT00986427|3724065|FG000|NOT COMPLETED|Overall Study||4
3006230|NCT00986427|3724066|FG001|NOT COMPLETED|Overall Study||0
3006231|NCT00986440|3724078|FG000|STARTED|Overall Study||41
3006232|NCT00986440|3724079|FG001|STARTED|Overall Study||43
3006233|NCT00986440|3724078|FG000|Randomized, But Not Dosed|Overall Study||0
3006234|NCT00986440|3724079|FG001|Randomized, But Not Dosed|Overall Study||1
3006235|NCT00986440|3724078|FG000|COMPLETED|Overall Study||0
3006236|NCT00986440|3724079|FG001|COMPLETED|Overall Study||0
3006237|NCT00986440|3724078|FG000|NOT COMPLETED|Overall Study||41
3006238|NCT00986440|3724079|FG001|NOT COMPLETED|Overall Study||43
3006239|NCT00986453|3724085|FG000|STARTED|Overall Study||45
3006240|NCT00986453|3724085|FG000|COMPLETED|Overall Study||43
3006241|NCT00986453|3724085|FG000|NOT COMPLETED|Overall Study||2
3006242|NCT00986479|3724093|FG000|STARTED|Period 1||12
3006243|NCT00986479|3724094|FG001|STARTED|Period 1||10
3006244|NCT00986479|3724093|FG000|COMPLETED|Period 1||10
3006245|NCT00986479|3724094|FG001|COMPLETED|Period 1||10
3006246|NCT00986479|3724093|FG000|NOT COMPLETED|Period 1||2
3165078|NCT01896921|3892618|FG000|NOT COMPLETED|Overall Study||2
3165079|NCT01896934|3892622|FG000|STARTED|Overall Study||21
3165080|NCT01896934|3892622|FG000|COMPLETED|Overall Study||19
3165081|NCT01896934|3892622|FG000|NOT COMPLETED|Overall Study||2
3165082|NCT01896986|3892628|FG000|STARTED|Overall Study||14
3165083|NCT01896986|3892629|FG001|STARTED|Overall Study||23
3165084|NCT01896986|3892628|FG000|COMPLETED|Overall Study||0
3165085|NCT01896986|3892629|FG001|COMPLETED|Overall Study||0
3165086|NCT01896986|3892628|FG000|NOT COMPLETED|Overall Study||14
3006247|NCT00986479|3724094|FG001|NOT COMPLETED|Period 1||0
3006248|NCT00986479|3724093|FG000|STARTED|Period 2||10
3006249|NCT00986479|3724094|FG001|STARTED|Period 2||10
3006250|NCT00986479|3724093|FG000|COMPLETED|Period 2||10
3006251|NCT00986479|3724094|FG001|COMPLETED|Period 2||10
3006252|NCT00986479|3724093|FG000|NOT COMPLETED|Period 2||0
3006253|NCT00986479|3724094|FG001|NOT COMPLETED|Period 2||0
3006254|NCT00986544|3724102|FG000|STARTED|Overall Study||53
3006255|NCT00986544|3724103|FG001|STARTED|Overall Study||53
3006256|NCT00986544|3724102|FG000|COMPLETED|Overall Study||53
3165087|NCT01896986|3892629|FG001|NOT COMPLETED|Overall Study||23
3006257|NCT00986544|3724103|FG001|COMPLETED|Overall Study||53
3006258|NCT00986544|3724102|FG000|NOT COMPLETED|Overall Study||0
3006259|NCT00986544|3724103|FG001|NOT COMPLETED|Overall Study||0
3006260|NCT00986570|3724110|FG000|STARTED|Overall Study||121
3006261|NCT00986570|3724110|FG000|COMPLETED|Overall Study||114
3006262|NCT00986570|3724110|FG000|NOT COMPLETED|Overall Study||7
3006263|NCT00986583|3724116|FG000|STARTED|Overall Study||38
3006264|NCT00986583|3724117|FG001|STARTED|Overall Study||32
3006265|NCT00986583|3724116|FG000|COMPLETED|Overall Study||38
3006266|NCT00986583|3724117|FG001|COMPLETED|Overall Study||32
3006267|NCT00986583|3724116|FG000|NOT COMPLETED|Overall Study||0
3006268|NCT00986583|3724117|FG001|NOT COMPLETED|Overall Study||0
3006269|NCT00986674|3724127|FG000|STARTED|Overall Study||47
3006270|NCT00986674|3724128|FG001|STARTED|Overall Study||45
3006271|NCT00986674|3724129|FG002|STARTED|Overall Study||48
3006272|NCT00986674|3724127|FG000|Treated|Overall Study||43
3006273|NCT00986674|3724128|FG001|Treated|Overall Study||42
3006274|NCT00986674|3724129|FG002|Treated|Overall Study||47
3006275|NCT00986674|3724127|FG000|Eligible and Treated|Overall Study||39
3006276|NCT00986674|3724128|FG001|Eligible and Treated|Overall Study||41
3006277|NCT00986674|3724129|FG002|Eligible and Treated|Overall Study||47
3006278|NCT00986674|3724127|FG000|COMPLETED|Overall Study||0
3006279|NCT00986674|3724128|FG001|COMPLETED|Overall Study||0
3006280|NCT00986674|3724129|FG002|COMPLETED|Overall Study||0
3006281|NCT00986674|3724127|FG000|NOT COMPLETED|Overall Study||47
3006282|NCT00986674|3724128|FG001|NOT COMPLETED|Overall Study||45
3006283|NCT00986674|3724129|FG002|NOT COMPLETED|Overall Study||48
3006284|NCT00986830|3724137|FG000|STARTED|Overall Study||74
3006285|NCT00986830|3724137|FG000|Treated|Overall Study||69
3006286|NCT00986830|3724137|FG000|COMPLETED|Overall Study||66
3006287|NCT00986830|3724137|FG000|NOT COMPLETED|Overall Study||8
3006288|NCT00986856|3724143|FG000|STARTED|Overall Study||42
3006289|NCT00986856|3724144|FG001|STARTED|Overall Study||16
3006290|NCT00986856|3724143|FG000|COMPLETED|Overall Study||42
3006291|NCT00986856|3724144|FG001|COMPLETED|Overall Study||16
3006292|NCT00986856|3724143|FG000|NOT COMPLETED|Overall Study||0
3006293|NCT00986856|3724144|FG001|NOT COMPLETED|Overall Study||0
3006294|NCT00986921|3724152|FG000|STARTED|Overall Study||25
3006295|NCT00986921|3724153|FG001|STARTED|Overall Study||25
3006296|NCT00986921|3724152|FG000|COMPLETED|Overall Study||24
3006297|NCT00986921|3724153|FG001|COMPLETED|Overall Study||25
3006298|NCT00986921|3724152|FG000|NOT COMPLETED|Overall Study||1
3006299|NCT00986921|3724153|FG001|NOT COMPLETED|Overall Study||0
3006300|NCT00986973|3724162|FG000|STARTED|Overall Study||6
3006301|NCT00986973|3724162|FG000|COMPLETED|Overall Study|One subject was withdrawn from the study due to poor compliance with KUVAN therapy.|5
3006302|NCT00986973|3724162|FG000|NOT COMPLETED|Overall Study||1
3006303|NCT00986986|3724169|FG000|STARTED|Overall Study||10
3006304|NCT00986986|3724170|FG001|STARTED|Overall Study||10
3006305|NCT00986986|3724169|FG000|COMPLETED|Overall Study||10
3006306|NCT00986986|3724170|FG001|COMPLETED|Overall Study||9
3006307|NCT00986986|3724169|FG000|NOT COMPLETED|Overall Study||0
3006308|NCT00986986|3724170|FG001|NOT COMPLETED|Overall Study||1
3006309|NCT00987337|3724180|FG000|STARTED|Overall Study||96
3006310|NCT00987337|3724181|FG001|STARTED|Overall Study||96
3006311|NCT00987337|3724182|FG002|STARTED|Overall Study||96
3006312|NCT00987337|3724180|FG000|COMPLETED|Overall Study||39
3006313|NCT00987337|3724181|FG001|COMPLETED|Overall Study||41
3006314|NCT00987337|3724182|FG002|COMPLETED|Overall Study||45
3006315|NCT00987337|3724180|FG000|NOT COMPLETED|Overall Study||57
3006316|NCT00987337|3724181|FG001|NOT COMPLETED|Overall Study||55
3006317|NCT00987337|3724182|FG002|NOT COMPLETED|Overall Study||51
3006318|NCT00987389|3724194|FG000|STARTED|Overall Study||176
3006319|NCT00987389|3724195|FG001|STARTED|Overall Study||176
3006320|NCT00987389|3724196|FG002|STARTED|Overall Study||175
3006321|NCT00987389|3724197|FG003|STARTED|Overall Study||177
3006322|NCT00987389|3724194|FG000|COMPLETED|Overall Study||167
3006323|NCT00987389|3724195|FG001|COMPLETED|Overall Study||168
3006324|NCT00987389|3724196|FG002|COMPLETED|Overall Study||167
3006325|NCT00987389|3724197|FG003|COMPLETED|Overall Study||174
3006326|NCT00987389|3724194|FG000|NOT COMPLETED|Overall Study||9
3006327|NCT00987389|3724195|FG001|NOT COMPLETED|Overall Study||8
3006328|NCT00987389|3724196|FG002|NOT COMPLETED|Overall Study||8
3006329|NCT00987389|3724197|FG003|NOT COMPLETED|Overall Study||3
3006330|NCT00987402|3724207|FG000|STARTED|Overall Study|January 2007, with crossover every 2 months|1682
3006331|NCT00987402|3724208|FG001|STARTED|Overall Study|January 2007 with crossover every 2 months|1635
3006332|NCT00987402|3724207|FG000|COMPLETED|Overall Study|86 patients did not have some data, and could not be evaluated|1596
3006333|NCT00987402|3724208|FG001|COMPLETED|Overall Study|98 patients did not have sufficient data|1537
3006334|NCT00987402|3724207|FG000|NOT COMPLETED|Overall Study||86
3006335|NCT00987402|3724208|FG001|NOT COMPLETED|Overall Study||98
3006336|NCT00987415|3724216|FG000|STARTED|Overall Study||128
3006337|NCT00987415|3724217|FG001|STARTED|Overall Study||125
3006338|NCT00987415|3724216|FG000|COMPLETED|Overall Study||119
3006339|NCT00987415|3724217|FG001|COMPLETED|Overall Study||116
3006340|NCT00987415|3724216|FG000|NOT COMPLETED|Overall Study||9
3006341|NCT00987415|3724217|FG001|NOT COMPLETED|Overall Study||9
3006342|NCT00987467|3724223|FG000|STARTED|Overall Study||12
3006343|NCT00987467|3724223|FG000|COMPLETED|Overall Study||10
3006344|NCT00987467|3724223|FG000|NOT COMPLETED|Overall Study||2
3006345|NCT00987480|3724228|FG000|STARTED|Overall Study||45
3006346|NCT00987480|3724228|FG000|COMPLETED|Overall Study||45
3006347|NCT00987480|3724228|FG000|NOT COMPLETED|Overall Study||0
3006348|NCT00987558|3724232|FG000|STARTED|Overall Study||13
3006349|NCT00987558|3724233|FG001|STARTED|Overall Study||17
3006350|NCT00987558|3724232|FG000|Simvastatin|Overall Study||13
3006351|NCT00987558|3724233|FG001|Simvastatin|Overall Study||12
3006352|NCT00987558|3724232|FG000|Washout|Overall Study||13
3006353|NCT00987558|3724233|FG001|Washout|Overall Study||12
3006354|NCT00987558|3724232|FG000|Eslicarbazepine Acetate + Simvastatin|Overall Study||13
3006355|NCT00987558|3724233|FG001|Eslicarbazepine Acetate + Simvastatin|Overall Study||17
3006356|NCT00987558|3724232|FG000|COMPLETED|Overall Study||12
3006357|NCT00987558|3724233|FG001|COMPLETED|Overall Study||12
3006358|NCT00987558|3724232|FG000|NOT COMPLETED|Overall Study||1
3006359|NCT00987558|3724233|FG001|NOT COMPLETED|Overall Study||5
3006360|NCT00987623|3724242|FG000|STARTED|Overall Study||145
3006361|NCT00987623|3724243|FG001|STARTED|Overall Study||154
3006362|NCT00987623|3724242|FG000|COMPLETED|Overall Study||140
3006363|NCT00987623|3724243|FG001|COMPLETED|Overall Study||151
3006364|NCT00987623|3724242|FG000|NOT COMPLETED|Overall Study||5
3006365|NCT00987623|3724243|FG001|NOT COMPLETED|Overall Study||3
3006366|NCT00987727|3724251|FG000|STARTED|Overall Study||41
3006367|NCT00987727|3724252|FG001|STARTED|Overall Study||41
3006368|NCT00987727|3724251|FG000|COMPLETED|Overall Study||36
3006369|NCT00987727|3724252|FG001|COMPLETED|Overall Study||34
3006370|NCT00987727|3724251|FG000|NOT COMPLETED|Overall Study||5
3006371|NCT00987727|3724252|FG001|NOT COMPLETED|Overall Study||7
3006372|NCT00987831|3724261|FG000|STARTED|Overall Study|41 patients improved after depomedrol, if not improved, treated and moved to Group B|41
3006373|NCT00987831|3724262|FG001|STARTED|Overall Study|52 healthy controls donated biomarkers on two occasions in order to verify biomarkers ranges|55
3006374|NCT00987831|3724263|FG002|STARTED|Overall Study|Anyone who entered this arm completed it the same day|62
3006375|NCT00987831|3724261|FG000|COMPLETED|Overall Study|40 patients completed in 6 months. 1 patient did not meet completion definition in 12 months.|40
3006376|NCT00987831|3724262|FG001|COMPLETED|Overall Study|all controls returned for two visits|52
3006377|NCT00987831|3724263|FG002|COMPLETED|Overall Study|Anyone who entered this arm completed it the same day|62
3006378|NCT00987831|3724261|FG000|NOT COMPLETED|Overall Study||1
3006379|NCT00987831|3724262|FG001|NOT COMPLETED|Overall Study||3
3006380|NCT00987831|3724263|FG002|NOT COMPLETED|Overall Study||0
3006381|NCT00987935|3724281|FG000|STARTED|Overall Study||4
3006382|NCT00987935|3724282|FG001|STARTED|Overall Study||3
3006383|NCT00987935|3724283|FG002|STARTED|Overall Study||3
3006384|NCT00987935|3724284|FG003|STARTED|Overall Study||3
3006385|NCT00987935|3724285|FG004|STARTED|Overall Study||7
3006386|NCT00987935|3724286|FG005|STARTED|Overall Study||3
3006387|NCT00987935|3724287|FG006|STARTED|Overall Study||16
3006388|NCT00987935|3724288|FG007|STARTED|Overall Study||63
3006389|NCT00987935|3724289|FG008|STARTED|Overall Study||32
3006390|NCT00987935|3724281|FG000|COMPLETED|Overall Study||0
3006391|NCT00987935|3724282|FG001|COMPLETED|Overall Study||0
3006392|NCT00987935|3724283|FG002|COMPLETED|Overall Study||0
3006393|NCT00987935|3724284|FG003|COMPLETED|Overall Study||0
3006394|NCT00987935|3724285|FG004|COMPLETED|Overall Study||0
3006395|NCT00987935|3724286|FG005|COMPLETED|Overall Study||0
3006396|NCT00987935|3724287|FG006|COMPLETED|Overall Study|On-treatment at analysis cut-off date (16 July 2014).|1
3006397|NCT00987935|3724288|FG007|COMPLETED|Overall Study|On-treatment at analysis cut-off date (16 July 2014).|1
3006398|NCT00987935|3724289|FG008|COMPLETED|Overall Study||0
3006399|NCT00987935|3724281|FG000|NOT COMPLETED|Overall Study||4
3006400|NCT00987935|3724282|FG001|NOT COMPLETED|Overall Study||3
3006401|NCT00987935|3724283|FG002|NOT COMPLETED|Overall Study||3
3006402|NCT00987935|3724284|FG003|NOT COMPLETED|Overall Study||3
3006403|NCT00987935|3724285|FG004|NOT COMPLETED|Overall Study||7
3006404|NCT00987935|3724286|FG005|NOT COMPLETED|Overall Study||3
3006405|NCT00987935|3724287|FG006|NOT COMPLETED|Overall Study||15
3006406|NCT00987935|3724288|FG007|NOT COMPLETED|Overall Study||62
3006407|NCT00987935|3724289|FG008|NOT COMPLETED|Overall Study||32
3006408|NCT00987948|3724315|FG000|STARTED|Overall Study||15
3006409|NCT00987948|3724315|FG000|COMPLETED|Overall Study||12
3165088|NCT01897025|3892637|FG000|STARTED|Overall Study||10
3165089|NCT01897025|3892638|FG001|STARTED|Overall Study||9
3165090|NCT01897025|3892637|FG000|COMPLETED|Overall Study||10
3006410|NCT00987948|3724315|FG000|NOT COMPLETED|Overall Study||3
3006411|NCT00988000|3724322|FG000|STARTED|Overall Study||49
3006412|NCT00988000|3724323|FG001|STARTED|Overall Study||51
3006413|NCT00988000|3724324|FG002|STARTED|Overall Study||57
3006414|NCT00988000|3724322|FG000|COMPLETED|Overall Study||49
3006415|NCT00988000|3724323|FG001|COMPLETED|Overall Study||51
3006416|NCT00988000|3724324|FG002|COMPLETED|Overall Study||57
3006417|NCT00988000|3724322|FG000|NOT COMPLETED|Overall Study||0
3006418|NCT00988000|3724323|FG001|NOT COMPLETED|Overall Study||0
3006419|NCT00988000|3724324|FG002|NOT COMPLETED|Overall Study||0
3006420|NCT00988013|3724338|FG000|STARTED|Overall Study||3
3006421|NCT00988013|3724339|FG001|STARTED|Overall Study||3
3006422|NCT00988013|3724340|FG002|STARTED|Overall Study||6
3006423|NCT00988013|3724341|FG003|STARTED|Overall Study||2
3006424|NCT00988013|3724338|FG000|COMPLETED|Overall Study||3
3006425|NCT00988013|3724339|FG001|COMPLETED|Overall Study||3
3006426|NCT00988013|3724340|FG002|COMPLETED|Overall Study||6
3006427|NCT00988013|3724341|FG003|COMPLETED|Overall Study||2
3006428|NCT00988013|3724338|FG000|NOT COMPLETED|Overall Study||0
3006429|NCT00988013|3724339|FG001|NOT COMPLETED|Overall Study||0
3165091|NCT01897025|3892638|FG001|COMPLETED|Overall Study||9
3006430|NCT00988013|3724340|FG002|NOT COMPLETED|Overall Study||0
3006431|NCT00988013|3724341|FG003|NOT COMPLETED|Overall Study||0
3006432|NCT00988065|3724356|FG000|STARTED|Overall Study|Randomized to double-blind treatment|148
3006433|NCT00988065|3724357|FG001|STARTED|Overall Study|Randomized to double-blind treatment|150
3006434|NCT00988065|3724358|FG002|STARTED|Overall Study|Randomized to double-blind treatment|150
3006435|NCT00988065|3724356|FG000|Received First Randomized Dose|Overall Study||148
3006436|NCT00988065|3724357|FG001|Received First Randomized Dose|Overall Study||150
3006437|NCT00988065|3724358|FG002|Received First Randomized Dose|Overall Study||150
3006438|NCT00988065|3724356|FG000|Received Second Randomized Dose|Overall Study||139
3006439|NCT00988065|3724357|FG001|Received Second Randomized Dose|Overall Study||135
3006440|NCT00988065|3724358|FG002|Received Second Randomized Dose|Overall Study||145
3006441|NCT00988065|3724356|FG000|Received Third Randomized Dose|Overall Study||135
3006442|NCT00988065|3724357|FG001|Received Third Randomized Dose|Overall Study||127
3006443|NCT00988065|3724358|FG002|Received Third Randomized Dose|Overall Study||135
3006444|NCT00988065|3724356|FG000|COMPLETED|Overall Study||135
3006445|NCT00988065|3724357|FG001|COMPLETED|Overall Study||127
3006446|NCT00988065|3724358|FG002|COMPLETED|Overall Study||135
3006447|NCT00988065|3724356|FG000|NOT COMPLETED|Overall Study||13
3006448|NCT00988065|3724357|FG001|NOT COMPLETED|Overall Study||23
3006449|NCT00988065|3724358|FG002|NOT COMPLETED|Overall Study||15
3037254|NCT01147458|3756560|FG002|STARTED|First Intervention||47
3037255|NCT01147458|3756561|FG003|STARTED|First Intervention||48
3037256|NCT01147458|3756558|FG000|COMPLETED|First Intervention||34
3037257|NCT01147458|3756559|FG001|COMPLETED|First Intervention||31
3037258|NCT01147458|3756560|FG002|COMPLETED|First Intervention||35
3037259|NCT01147458|3756561|FG003|COMPLETED|First Intervention||34
3037260|NCT01147458|3756558|FG000|NOT COMPLETED|First Intervention||14
3037261|NCT01147458|3756559|FG001|NOT COMPLETED|First Intervention||16
3037262|NCT01147458|3756560|FG002|NOT COMPLETED|First Intervention||12
3037263|NCT01147458|3756561|FG003|NOT COMPLETED|First Intervention||14
3037264|NCT01147458|3756558|FG000|STARTED|Washout Period of 2 Weeks||34
3037265|NCT01147458|3756559|FG001|STARTED|Washout Period of 2 Weeks||31
3037266|NCT01147458|3756560|FG002|STARTED|Washout Period of 2 Weeks||35
3037267|NCT01147458|3756561|FG003|STARTED|Washout Period of 2 Weeks||34
3037268|NCT01147458|3756558|FG000|COMPLETED|Washout Period of 2 Weeks||34
3037269|NCT01147458|3756559|FG001|COMPLETED|Washout Period of 2 Weeks||31
3037270|NCT01147458|3756560|FG002|COMPLETED|Washout Period of 2 Weeks||35
3037271|NCT01147458|3756561|FG003|COMPLETED|Washout Period of 2 Weeks||34
3037272|NCT01147458|3756558|FG000|NOT COMPLETED|Washout Period of 2 Weeks||0
3037273|NCT01147458|3756559|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0
3037274|NCT01147458|3756560|FG002|NOT COMPLETED|Washout Period of 2 Weeks||0
3037275|NCT01147458|3756561|FG003|NOT COMPLETED|Washout Period of 2 Weeks||0
3037276|NCT01147458|3756558|FG000|STARTED|Second Intervention||34
3037277|NCT01147458|3756559|FG001|STARTED|Second Intervention||31
3037278|NCT01147458|3756560|FG002|STARTED|Second Intervention||35
3037279|NCT01147458|3756561|FG003|STARTED|Second Intervention||34
3037280|NCT01147458|3756558|FG000|COMPLETED|Second Intervention||25
3037281|NCT01147458|3756559|FG001|COMPLETED|Second Intervention||24
3037282|NCT01147458|3756560|FG002|COMPLETED|Second Intervention||27
3037283|NCT01147458|3756561|FG003|COMPLETED|Second Intervention||30
3037284|NCT01147458|3756558|FG000|NOT COMPLETED|Second Intervention||9
3037285|NCT01147458|3756559|FG001|NOT COMPLETED|Second Intervention||7
3037286|NCT01147458|3756560|FG002|NOT COMPLETED|Second Intervention||8
3037287|NCT01147458|3756561|FG003|NOT COMPLETED|Second Intervention||4
3037288|NCT01147471|3756575|FG000|STARTED|Through Initial Hospital Discharge||13
3037289|NCT01147471|3756576|FG001|STARTED|Through Initial Hospital Discharge||11
3037290|NCT01147471|3756575|FG000|COMPLETED|Through Initial Hospital Discharge||13
3037291|NCT01147471|3756576|FG001|COMPLETED|Through Initial Hospital Discharge||11
3037292|NCT01147471|3756575|FG000|NOT COMPLETED|Through Initial Hospital Discharge||0
3037293|NCT01147471|3756576|FG001|NOT COMPLETED|Through Initial Hospital Discharge||0
3037294|NCT01147471|3756575|FG000|STARTED|Post-discharge Follow Up (Approx 2 Wks)||13
3037295|NCT01147471|3756576|FG001|STARTED|Post-discharge Follow Up (Approx 2 Wks)||11
3037296|NCT01147471|3756575|FG000|COMPLETED|Post-discharge Follow Up (Approx 2 Wks)||13
3037297|NCT01147471|3756576|FG001|COMPLETED|Post-discharge Follow Up (Approx 2 Wks)||8
3037298|NCT01147471|3756575|FG000|NOT COMPLETED|Post-discharge Follow Up (Approx 2 Wks)||0
3037299|NCT01147471|3756576|FG001|NOT COMPLETED|Post-discharge Follow Up (Approx 2 Wks)||3
3037300|NCT01147471|3756575|FG000|STARTED|3 Month Follow Up||13
3037301|NCT01147471|3756576|FG001|STARTED|3 Month Follow Up||8
3037302|NCT01147471|3756575|FG000|COMPLETED|3 Month Follow Up||12
3037303|NCT01147471|3756576|FG001|COMPLETED|3 Month Follow Up||6
3037304|NCT01147471|3756575|FG000|NOT COMPLETED|3 Month Follow Up||1
3037305|NCT01147471|3756576|FG001|NOT COMPLETED|3 Month Follow Up||2
3037306|NCT01147471|3756575|FG000|STARTED|6 Month Follow Up||12
3037307|NCT01147471|3756576|FG001|STARTED|6 Month Follow Up||6
3037308|NCT01147471|3756575|FG000|COMPLETED|6 Month Follow Up||8
3037309|NCT01147471|3756576|FG001|COMPLETED|6 Month Follow Up||4
3037310|NCT01147471|3756575|FG000|NOT COMPLETED|6 Month Follow Up||4
3037311|NCT01147471|3756576|FG001|NOT COMPLETED|6 Month Follow Up||2
3037312|NCT01147497|3756584|FG000|STARTED|Overall Study||37
3037313|NCT01147497|3756585|FG001|STARTED|Overall Study||36
3037314|NCT01147497|3756584|FG000|COMPLETED|Overall Study||35
3037315|NCT01147497|3756585|FG001|COMPLETED|Overall Study||36
3037316|NCT01147497|3756584|FG000|NOT COMPLETED|Overall Study||2
3037317|NCT01147497|3756585|FG001|NOT COMPLETED|Overall Study||0
3006450|NCT00988091|3724368|FG000|STARTED|Double-blind Period||298
3006451|NCT00988091|3724369|FG001|STARTED|Double-blind Period||298
3006452|NCT00988091|3724368|FG000|Intent to Treat Population|Double-blind Period|ITT population excludes participants from one site which was closed for non-compliance.|294
3006453|NCT00988091|3724369|FG001|Intent to Treat Population|Double-blind Period|ITT population excludes participants from one site which was closed for non-compliance.|295
3006454|NCT00988091|3724368|FG000|COMPLETED|Double-blind Period||255
3006455|NCT00988091|3724369|FG001|COMPLETED|Double-blind Period||251
3006456|NCT00988091|3724368|FG000|NOT COMPLETED|Double-blind Period||43
3006457|NCT00988091|3724369|FG001|NOT COMPLETED|Double-blind Period||47
3006458|NCT00988091|3724368|FG000|STARTED|Open-label Period|Participation in the Open-label period was optional.|229
3006459|NCT00988091|3724369|FG001|STARTED|Open-label Period|Participation in the Open-label period was optional.|225
3006460|NCT00988091|3724368|FG000|COMPLETED|Open-label Period||208
3006461|NCT00988091|3724369|FG001|COMPLETED|Open-label Period||192
3006462|NCT00988091|3724368|FG000|NOT COMPLETED|Open-label Period||21
3006463|NCT00988091|3724369|FG001|NOT COMPLETED|Open-label Period||33
3006464|NCT00988117|3724376|FG000|STARTED|4.6 mg/24 Hours From Baseline to Week 4||15
3006465|NCT00988117|3724376|FG000|COMPLETED|4.6 mg/24 Hours From Baseline to Week 4||14
3006466|NCT00988117|3724376|FG000|NOT COMPLETED|4.6 mg/24 Hours From Baseline to Week 4||1
3006467|NCT00988117|3724376|FG000|STARTED|9.5 mg/24 Hours From Week 4 to 12||14
3006468|NCT00988117|3724376|FG000|COMPLETED|9.5 mg/24 Hours From Week 4 to 12||12
3006469|NCT00988117|3724376|FG000|NOT COMPLETED|9.5 mg/24 Hours From Week 4 to 12||2
3006470|NCT00988143|3724384|FG000|STARTED|Overall Study||220
3006471|NCT00988143|3724385|FG001|STARTED|Overall Study||190
3006472|NCT00988143|3724386|FG002|STARTED|Overall Study||190
3006473|NCT00988143|3724384|FG000|COMPLETED|Overall Study||220
3006474|NCT00988143|3724385|FG001|COMPLETED|Overall Study||190
3006475|NCT00988143|3724386|FG002|COMPLETED|Overall Study||190
3006476|NCT00988143|3724384|FG000|NOT COMPLETED|Overall Study||0
3006477|NCT00988143|3724385|FG001|NOT COMPLETED|Overall Study||0
3006478|NCT00988143|3724386|FG002|NOT COMPLETED|Overall Study||0
3006479|NCT00988156|3724396|FG000|STARTED|Overall Study||149
3006480|NCT00988156|3724397|FG001|STARTED|Overall Study||155
3006481|NCT00988156|3724396|FG000|Intention-to-Treat Set (ITT)|Overall Study||129
3006482|NCT00988156|3724397|FG001|Intention-to-Treat Set (ITT)|Overall Study||134
3006483|NCT00988156|3724396|FG000|Per Protocol Set (PP)|Overall Study||101
3006484|NCT00988156|3724397|FG001|Per Protocol Set (PP)|Overall Study||97
3006485|NCT00988156|3724396|FG000|Safety Set|Overall Study||129
3006486|NCT00988156|3724397|FG001|Safety Set|Overall Study||134
3006487|NCT00988156|3724396|FG000|COMPLETED|Overall Study||132
3006488|NCT00988156|3724397|FG001|COMPLETED|Overall Study||135
3006489|NCT00988156|3724396|FG000|NOT COMPLETED|Overall Study||17
3006490|NCT00988156|3724397|FG001|NOT COMPLETED|Overall Study||20
3006491|NCT00988169|3724403|FG000|STARTED|Overall Study||6
3006492|NCT00988169|3724403|FG000|COMPLETED|Overall Study||5
3006493|NCT00988169|3724403|FG000|NOT COMPLETED|Overall Study||1
3006494|NCT00988208|3724409|FG000|STARTED|Overall Study||526
3006495|NCT00988208|3724410|FG001|STARTED|Overall Study||533
3006496|NCT00988208|3724409|FG000|Treated|Overall Study||521
3006497|NCT00988208|3724410|FG001|Treated|Overall Study||525
3006498|NCT00988208|3724409|FG000|COMPLETED|Overall Study|DP Completed = kept on treatment with docetaxel/prednisone; Placebo was discontinued in DP arm|95
3006499|NCT00988208|3724410|FG001|COMPLETED|Overall Study|DPL Completed = kept on treatment with docetaxel/prednisone; Lenalidomide discontinued in DPL arm|95
3006500|NCT00988208|3724409|FG000|NOT COMPLETED|Overall Study||431
3006501|NCT00988208|3724410|FG001|NOT COMPLETED|Overall Study||438
3006502|NCT00988221|3724419|FG000|STARTED|Part I||35
3006503|NCT00988221|3724420|FG001|STARTED|Part I||34
3006504|NCT00988221|3724421|FG002|STARTED|Part I||119
3006505|NCT00988221|3724422|FG003|STARTED|Part I|No patients received placebo in Part I of this study.|0
3006506|NCT00988221|3724419|FG000|COMPLETED|Part I||31
3006507|NCT00988221|3724420|FG001|COMPLETED|Part I||24
3006508|NCT00988221|3724421|FG002|COMPLETED|Part I||111
3006509|NCT00988221|3724422|FG003|COMPLETED|Part I||0
3006510|NCT00988221|3724419|FG000|NOT COMPLETED|Part I||4
3006511|NCT00988221|3724420|FG001|NOT COMPLETED|Part I||10
3006512|NCT00988221|3724421|FG002|NOT COMPLETED|Part I||8
3006513|NCT00988221|3724422|FG003|NOT COMPLETED|Part I||0
3006514|NCT00988221|3724419|FG000|STARTED|Part II|Some of the patients in this group in Part I were randomized to receive placebo in Part II.|16
3006515|NCT00988221|3724420|FG001|STARTED|Part II|Some of the patients in this group in Part I were randomized to receive placebo in Part II.|11
3006516|NCT00988221|3724421|FG002|STARTED|Part II|Some of the patients in this group in Part I were randomized to receive placebo in Part II.|55
3006517|NCT00988221|3724422|FG003|STARTED|Part II||84
3006518|NCT00988221|3724419|FG000|COMPLETED|Part II||15
3006519|NCT00988221|3724420|FG001|COMPLETED|Part II||11
3006520|NCT00988221|3724421|FG002|COMPLETED|Part II|One participant who did not complete Part II was available to continue in the study and did.|52
3006521|NCT00988221|3724422|FG003|COMPLETED|Part II||81
3006522|NCT00988221|3724419|FG000|NOT COMPLETED|Part II||1
3006523|NCT00988221|3724420|FG001|NOT COMPLETED|Part II||0
3006524|NCT00988221|3724421|FG002|NOT COMPLETED|Part II||3
3006525|NCT00988221|3724422|FG003|NOT COMPLETED|Part II||3
3006526|NCT00988221|3724419|FG000|STARTED|Part III||30
3006527|NCT00988221|3724420|FG001|STARTED|Part III||24
3006528|NCT00988221|3724421|FG002|STARTED|Part III||106
3006529|NCT00988221|3724422|FG003|STARTED|Part III|No patients received placebo in Part III of this study.|0
3006530|NCT00988221|3724419|FG000|COMPLETED|Part III||29
3006531|NCT00988221|3724420|FG001|COMPLETED|Part III||23
3006532|NCT00988221|3724421|FG002|COMPLETED|Part III||103
3006533|NCT00988221|3724422|FG003|COMPLETED|Part III||0
3006534|NCT00988221|3724419|FG000|NOT COMPLETED|Part III||1
3006535|NCT00988221|3724420|FG001|NOT COMPLETED|Part III||1
3006536|NCT00988221|3724421|FG002|NOT COMPLETED|Part III||3
3006537|NCT00988221|3724422|FG003|NOT COMPLETED|Part III||0
3006538|NCT00988325|3724444|FG000|STARTED|Overall Study||40
3006539|NCT00988325|3724445|FG001|STARTED|Overall Study||20
3006540|NCT00988325|3724446|FG002|STARTED|Overall Study||5
3006541|NCT00988325|3724444|FG000|COMPLETED|Overall Study||40
3006542|NCT00988325|3724445|FG001|COMPLETED|Overall Study||20
3006543|NCT00988325|3724446|FG002|COMPLETED|Overall Study||5
3006544|NCT00988325|3724444|FG000|NOT COMPLETED|Overall Study||0
3006545|NCT00988325|3724445|FG001|NOT COMPLETED|Overall Study||0
3006546|NCT00988325|3724446|FG002|NOT COMPLETED|Overall Study||0
3006547|NCT00988351|3724460|FG000|STARTED|Overall Study||78
3006548|NCT00988351|3724461|FG001|STARTED|Overall Study||78
3006549|NCT00988351|3724460|FG000|CPAP Titration|Overall Study|8 declined CPAP treatment|78
3006550|NCT00988351|3724461|FG001|CPAP Titration|Overall Study|no titration needed|78
3006551|NCT00988351|3724460|FG000|PAP Setup|Overall Study|CPAP treatment started|70
3006552|NCT00988351|3724461|FG001|PAP Setup|Overall Study|APAP treatment started|78
3006553|NCT00988351|3724460|FG000|Clinic Visit|Overall Study|6 lost to follow-up or no show for clinic|64
3006554|NCT00988351|3724461|FG001|Clinic Visit|Overall Study|9 lost to follow-up or no show for clinic|69
3006555|NCT00988351|3724460|FG000|Using CPAP or APAP|Overall Study|5 not using CPAP (use < 1/2 hour per night)|59
3006556|NCT00988351|3724461|FG001|Using CPAP or APAP|Overall Study|3 not using APAP (less than 1/2 hour per night)|66
3006557|NCT00988351|3724460|FG000|COMPLETED|Overall Study||59
3006558|NCT00988351|3724461|FG001|COMPLETED|Overall Study||66
3006559|NCT00988351|3724460|FG000|NOT COMPLETED|Overall Study||19
3006560|NCT00988351|3724461|FG001|NOT COMPLETED|Overall Study||12
3006561|NCT00988429|3724470|FG000|STARTED|Overall Study||226
3006562|NCT00988429|3724471|FG001|STARTED|Overall Study||216
3006563|NCT00988429|3724472|FG002|STARTED|Overall Study||211
3006564|NCT00988429|3724470|FG000|Safety Population|Overall Study||224
3006565|NCT00988429|3724471|FG001|Safety Population|Overall Study||216
3006566|NCT00988429|3724472|FG002|Safety Population|Overall Study||210
3006567|NCT00988429|3724470|FG000|Intention-to-treat (ITT) Population|Overall Study||220
3006568|NCT00988429|3724471|FG001|Intention-to-treat (ITT) Population|Overall Study||215
3006569|NCT00988429|3724472|FG002|Intention-to-treat (ITT) Population|Overall Study||205
3006570|NCT00988429|3724470|FG000|COMPLETED|Overall Study||189
3006571|NCT00988429|3724471|FG001|COMPLETED|Overall Study||173
3006572|NCT00988429|3724472|FG002|COMPLETED|Overall Study||142
3006573|NCT00988429|3724470|FG000|NOT COMPLETED|Overall Study||37
3006574|NCT00988429|3724471|FG001|NOT COMPLETED|Overall Study||43
3006575|NCT00988429|3724472|FG002|NOT COMPLETED|Overall Study||69
3006576|NCT00988442|3724483|FG000|STARTED|Overall Study||30
3006577|NCT00988442|3724484|FG001|STARTED|Overall Study||29
3006578|NCT00988442|3724483|FG000|COMPLETED|Overall Study||0
3006579|NCT00988442|3724484|FG001|COMPLETED|Overall Study||1
3006580|NCT00988442|3724483|FG000|NOT COMPLETED|Overall Study||30
3006581|NCT00988442|3724484|FG001|NOT COMPLETED|Overall Study||28
3006582|NCT00988533|3724493|FG000|STARTED|Overall Study||30
3006583|NCT00988533|3724493|FG000|COMPLETED|Overall Study||27
3006584|NCT00988533|3724493|FG000|NOT COMPLETED|Overall Study||3
3006585|NCT00988559|3724501|FG000|STARTED|Overall Study||10
3006586|NCT00988559|3724502|FG001|STARTED|Overall Study||11
3006587|NCT00988559|3724503|FG002|STARTED|Overall Study||11
3006588|NCT00988559|3724504|FG003|STARTED|Overall Study||7
3006589|NCT00988559|3724501|FG000|COMPLETED|Overall Study||9
3006590|NCT00988559|3724502|FG001|COMPLETED|Overall Study||9
3006591|NCT00988559|3724503|FG002|COMPLETED|Overall Study||9
3006592|NCT00988559|3724504|FG003|COMPLETED|Overall Study||6
3006593|NCT00988559|3724501|FG000|NOT COMPLETED|Overall Study||1
3006594|NCT00988559|3724502|FG001|NOT COMPLETED|Overall Study||2
3006595|NCT00988559|3724503|FG002|NOT COMPLETED|Overall Study||2
3006596|NCT00988559|3724504|FG003|NOT COMPLETED|Overall Study||1
3006597|NCT00988598|3724516|FG000|STARTED|Overall Study||10
3006598|NCT00988598|3724517|FG001|STARTED|Overall Study||5
3006599|NCT00988598|3724516|FG000|COMPLETED|Overall Study||8
3006600|NCT00988598|3724517|FG001|COMPLETED|Overall Study||5
3006601|NCT00988598|3724516|FG000|NOT COMPLETED|Overall Study||2
3006602|NCT00988598|3724517|FG001|NOT COMPLETED|Overall Study||0
3006603|NCT00988637|3724525|FG000|STARTED|Overall Study||70
3006604|NCT00988637|3724526|FG001|STARTED|Overall Study||68
3006605|NCT00988637|3724525|FG000|COMPLETED|Overall Study||67
3006606|NCT00988637|3724526|FG001|COMPLETED|Overall Study||65
3006607|NCT00988637|3724525|FG000|NOT COMPLETED|Overall Study||3
3006608|NCT00988637|3724526|FG001|NOT COMPLETED|Overall Study||3
3006609|NCT00988832|3724532|FG000|STARTED|Overall Study||380
3006610|NCT00988832|3724532|FG000|COMPLETED|Overall Study||380
3006611|NCT00988832|3724532|FG000|NOT COMPLETED|Overall Study||0
3006612|NCT00988858|3724539|FG000|STARTED|Overall Study||55
3006613|NCT00988858|3724539|FG000|COMPLETED|Overall Study||45
3006614|NCT00988858|3724539|FG000|NOT COMPLETED|Overall Study||10
3006615|NCT00988884|3724545|FG000|STARTED|Overall Study||621
3006616|NCT00988884|3724546|FG001|STARTED|Overall Study||620
3006617|NCT00988884|3724545|FG000|COMPLETED|Overall Study||586
3006618|NCT00988884|3724546|FG001|COMPLETED|Overall Study||584
3006619|NCT00988884|3724545|FG000|NOT COMPLETED|Overall Study||35
3006620|NCT00988884|3724546|FG001|NOT COMPLETED|Overall Study||36
3006621|NCT00989014|3724556|FG000|STARTED|Overall Study||31
3006622|NCT00989014|3724557|FG001|STARTED|Overall Study||31
3006623|NCT00989014|3724558|FG002|STARTED|Overall Study||28
3006624|NCT00989014|3724559|FG003|STARTED|Overall Study||32
3006625|NCT00989014|3724556|FG000|COMPLETED|Overall Study||31
3006626|NCT00989014|3724557|FG001|COMPLETED|Overall Study||31
3006627|NCT00989014|3724558|FG002|COMPLETED|Overall Study||28
3006628|NCT00989014|3724559|FG003|COMPLETED|Overall Study||32
3006629|NCT00989014|3724556|FG000|NOT COMPLETED|Overall Study||0
3006630|NCT00989014|3724557|FG001|NOT COMPLETED|Overall Study||0
3006631|NCT00989014|3724558|FG002|NOT COMPLETED|Overall Study||0
3006632|NCT00989014|3724559|FG003|NOT COMPLETED|Overall Study||0
3006633|NCT00989092|3724571|FG000|STARTED|Overall Study||228
3006634|NCT00989092|3724572|FG001|STARTED|Overall Study||59
3006635|NCT00989092|3724571|FG000|Treated With Darbepoetin Alfa|Overall Study||226
3006636|NCT00989092|3724572|FG001|Treated With Darbepoetin Alfa|Overall Study||33
3006637|NCT00989092|3724571|FG000|COMPLETED|Overall Study||138
3006638|NCT00989092|3724572|FG001|COMPLETED|Overall Study||31
3006639|NCT00989092|3724571|FG000|NOT COMPLETED|Overall Study||90
3006640|NCT00989092|3724572|FG001|NOT COMPLETED|Overall Study||28
3006641|NCT00989157|3724581|FG000|STARTED|Overall Study||10
3006642|NCT00989157|3724582|FG001|STARTED|Overall Study||10
3006643|NCT00989157|3724581|FG000|COMPLETED|Overall Study||10
3006644|NCT00989157|3724582|FG001|COMPLETED|Overall Study||10
3006645|NCT00989157|3724581|FG000|NOT COMPLETED|Overall Study||0
3006646|NCT00989157|3724582|FG001|NOT COMPLETED|Overall Study||0
3006647|NCT00989196|3724590|FG000|STARTED|PK Crossover Period||10
3006648|NCT00989196|3724591|FG001|STARTED|PK Crossover Period||12
3006649|NCT00989196|3724590|FG000|COMPLETED|PK Crossover Period||10
3006650|NCT00989196|3724591|FG001|COMPLETED|PK Crossover Period||12
3006651|NCT00989196|3724590|FG000|NOT COMPLETED|PK Crossover Period||0
3006652|NCT00989196|3724591|FG001|NOT COMPLETED|PK Crossover Period||0
3006653|NCT00989196|3724590|FG000|STARTED|Treatment Period||10
3006654|NCT00989196|3724591|FG001|STARTED|Treatment Period||12
3006655|NCT00989196|3724590|FG000|COMPLETED|Treatment Period||9
3006656|NCT00989196|3724591|FG001|COMPLETED|Treatment Period||12
3006657|NCT00989196|3724590|FG000|NOT COMPLETED|Treatment Period||1
3006658|NCT00989196|3724591|FG001|NOT COMPLETED|Treatment Period||0
3006659|NCT00989235|3724599|FG000|STARTED|Overall Study||58
3006660|NCT00989235|3724600|FG001|STARTED|Overall Study||50
3006661|NCT00989235|3724599|FG000|Number Rescued to Open-Label Treatment|Overall Study||4
3006662|NCT00989235|3724600|FG001|Number Rescued to Open-Label Treatment|Overall Study|Of these, 1 was discontinued from open-label treatment (lost to follow-up).|4
3006663|NCT00989235|3724599|FG000|Number Completing Double-Blind Treatment|Overall Study||51
3006664|NCT00989235|3724600|FG001|Number Completing Double-Blind Treatment|Overall Study||41
3006665|NCT00989235|3724599|FG000|COMPLETED|Overall Study||55
3006666|NCT00989235|3724600|FG001|COMPLETED|Overall Study||44
3006667|NCT00989235|3724599|FG000|NOT COMPLETED|Overall Study||3
3006668|NCT00989235|3724600|FG001|NOT COMPLETED|Overall Study||6
3006669|NCT00989261|3724611|FG000|STARTED|Overall Study||157
3006670|NCT00989261|3724612|FG001|STARTED|Overall Study||176
3006671|NCT00989261|3724611|FG000|COMPLETED|Overall Study||142
3006672|NCT00989261|3724612|FG001|COMPLETED|Overall Study||154
3006673|NCT00989261|3724611|FG000|NOT COMPLETED|Overall Study||15
3006674|NCT00989261|3724612|FG001|NOT COMPLETED|Overall Study||22
3006675|NCT00989287|3724620|FG000|STARTED|Overall Study||65
3006676|NCT00989287|3724621|FG001|STARTED|Overall Study||66
3006677|NCT00989287|3724620|FG000|COMPLETED|Overall Study||64
3006678|NCT00989287|3724621|FG001|COMPLETED|Overall Study||65
3006679|NCT00989287|3724620|FG000|NOT COMPLETED|Overall Study||1
3006680|NCT00989287|3724621|FG001|NOT COMPLETED|Overall Study||1
3006681|NCT00989573|3724643|FG000|STARTED|Overall Study||65
3006682|NCT00989573|3724644|FG001|STARTED|Overall Study||63
3006683|NCT00989573|3724645|FG002|STARTED|Overall Study||63
3006684|NCT00989573|3724643|FG000|COMPLETED|Overall Study||52
3006685|NCT00989573|3724644|FG001|COMPLETED|Overall Study||41
3006686|NCT00989573|3724645|FG002|COMPLETED|Overall Study||55
3006687|NCT00989573|3724643|FG000|NOT COMPLETED|Overall Study||13
3006688|NCT00989573|3724644|FG001|NOT COMPLETED|Overall Study||22
3006689|NCT00989573|3724645|FG002|NOT COMPLETED|Overall Study||8
3006690|NCT00989586|3724655|FG000|STARTED|Overall Study||18
3006691|NCT00989586|3724656|FG001|STARTED|Overall Study||17
3006692|NCT00989586|3724655|FG000|COMPLETED|Overall Study||18
3006693|NCT00989586|3724656|FG001|COMPLETED|Overall Study||17
3006694|NCT00989586|3724655|FG000|NOT COMPLETED|Overall Study||0
3006695|NCT00989586|3724656|FG001|NOT COMPLETED|Overall Study||0
3006696|NCT00989612|3724663|FG000|STARTED|Overall Study||100
3006697|NCT00989612|3724663|FG000|COMPLETED|Overall Study||100
3006698|NCT00989612|3724663|FG000|NOT COMPLETED|Overall Study||0
3006699|NCT00989664|3724669|FG000|STARTED|Dosimetric and Therapeutic Treatment||61
3006700|NCT00989664|3724669|FG000|COMPLETED|Dosimetric and Therapeutic Treatment||0
3006701|NCT00989664|3724669|FG000|NOT COMPLETED|Dosimetric and Therapeutic Treatment||61
3006702|NCT00989664|3724669|FG000|STARTED|Long-Term Follow-Up|14 of the 61 participants withdrawing from Study BEX104504 enrolled in the LTFU study.|14
3006703|NCT00989664|3724669|FG000|COMPLETED|Long-Term Follow-Up||11
3006704|NCT00989664|3724669|FG000|NOT COMPLETED|Long-Term Follow-Up||3
3006705|NCT00989768|3724675|FG000|STARTED|Overall Study|All patients received both treatments. They are their own controls|29
3006706|NCT00989768|3724675|FG000|COMPLETED|Overall Study||28
3006707|NCT00989768|3724675|FG000|NOT COMPLETED|Overall Study||1
3006708|NCT00989781|3724685|FG000|STARTED|Ovarian Response to hCG||21
3006709|NCT00989781|3724686|FG001|STARTED|Ovarian Response to hCG||20
3006710|NCT00989781|3724685|FG000|COMPLETED|Ovarian Response to hCG||18
3006711|NCT00989781|3724686|FG001|COMPLETED|Ovarian Response to hCG||18
3006712|NCT00989781|3724685|FG000|NOT COMPLETED|Ovarian Response to hCG||3
3006713|NCT00989781|3724686|FG001|NOT COMPLETED|Ovarian Response to hCG||2
3006714|NCT00989781|3724685|FG000|STARTED|Adrenal Response ot ACTH|15 subjects that completed part 1 elected to participate in Part 2|18
3006715|NCT00989781|3724686|FG001|STARTED|Adrenal Response ot ACTH|15 subjects that completed part 1 elected to participate in Part 2|18
3006716|NCT00989781|3724685|FG000|COMPLETED|Adrenal Response ot ACTH|Of 18 eligible, 15 consented. 2 dropped out and 13 completed study|13
3006717|NCT00989781|3724686|FG001|COMPLETED|Adrenal Response ot ACTH|Of 18 eligible, 15 consented and completed study|15
3006718|NCT00989781|3724685|FG000|NOT COMPLETED|Adrenal Response ot ACTH||5
3006719|NCT00989781|3724686|FG001|NOT COMPLETED|Adrenal Response ot ACTH||3
3006720|NCT00989833|3724696|FG000|STARTED|Overall Study||21
3006721|NCT00989833|3724697|FG001|STARTED|Overall Study||22
3006722|NCT00989833|3724698|FG002|STARTED|Overall Study||23
3006723|NCT00989833|3724696|FG000|COMPLETED|Overall Study||19
3006724|NCT00989833|3724697|FG001|COMPLETED|Overall Study||19
3006725|NCT00989833|3724698|FG002|COMPLETED|Overall Study||21
3006726|NCT00989833|3724696|FG000|NOT COMPLETED|Overall Study||2
3006727|NCT00989833|3724697|FG001|NOT COMPLETED|Overall Study||3
3006728|NCT00989833|3724698|FG002|NOT COMPLETED|Overall Study||2
3006729|NCT00989911|3724706|FG000|STARTED|Overall Study||10
3006730|NCT00989911|3724706|FG000|COMPLETED|Overall Study||7
3006731|NCT00989911|3724706|FG000|NOT COMPLETED|Overall Study||3
3006732|NCT00989950|3724714|FG000|STARTED|Open Label Dose Optimization||6
3006733|NCT00989950|3724715|FG001|STARTED|Open Label Dose Optimization||9
3006734|NCT00989950|3724716|FG002|STARTED|Open Label Dose Optimization||4
3006735|NCT00989950|3724717|FG003|STARTED|Open Label Dose Optimization||7
3006736|NCT00989950|3724714|FG000|COMPLETED|Open Label Dose Optimization||6
3006737|NCT00989950|3724715|FG001|COMPLETED|Open Label Dose Optimization||9
3006738|NCT00989950|3724716|FG002|COMPLETED|Open Label Dose Optimization||4
3006739|NCT00989950|3724717|FG003|COMPLETED|Open Label Dose Optimization||7
3006740|NCT00989950|3724714|FG000|NOT COMPLETED|Open Label Dose Optimization||0
3006741|NCT00989950|3724715|FG001|NOT COMPLETED|Open Label Dose Optimization||0
3006742|NCT00989950|3724716|FG002|NOT COMPLETED|Open Label Dose Optimization||0
3006743|NCT00989950|3724717|FG003|NOT COMPLETED|Open Label Dose Optimization||0
3006744|NCT00989950|3724714|FG000|STARTED|Randomized Phase||6
3006745|NCT00989950|3724715|FG001|STARTED|Randomized Phase||9
3006746|NCT00989950|3724716|FG002|STARTED|Randomized Phase||4
3006747|NCT00989950|3724717|FG003|STARTED|Randomized Phase||7
3006748|NCT00989950|3724714|FG000|COMPLETED|Randomized Phase||5
3006749|NCT00989950|3724715|FG001|COMPLETED|Randomized Phase||8
3006750|NCT00989950|3724716|FG002|COMPLETED|Randomized Phase||4
3006751|NCT00989950|3724717|FG003|COMPLETED|Randomized Phase||7
3006752|NCT00989950|3724714|FG000|NOT COMPLETED|Randomized Phase||1
3006753|NCT00989950|3724715|FG001|NOT COMPLETED|Randomized Phase||1
3006754|NCT00989950|3724716|FG002|NOT COMPLETED|Randomized Phase||0
3006755|NCT00989950|3724717|FG003|NOT COMPLETED|Randomized Phase||0
3006756|NCT00989963|3724730|FG000|STARTED|Overall Study||12
3006757|NCT00989963|3724731|FG001|STARTED|Overall Study||12
3006758|NCT00989963|3724732|FG002|STARTED|Overall Study||12
3006759|NCT00989963|3724730|FG000|Safety Population|Overall Study|1 participant randomized to MTD received FD 60 ug; was included in FD 60 ug arm for this population|13
3006760|NCT00989963|3724731|FG001|Safety Population|Overall Study||12
3006761|NCT00989963|3724732|FG002|Safety Population|Overall Study|1 participant randomized to MTD received FD 60 ug; was included in FD 60 ug arm for this population|11
3006762|NCT00989963|3724730|FG000|Per-Protocol Population|Overall Study|1 participant randomized to MTD received FD 60 ug; was included in FD 60 ug arm for this population|12
3006763|NCT00989963|3724731|FG001|Per-Protocol Population|Overall Study||11
3006764|NCT00989963|3724732|FG002|Per-Protocol Population|Overall Study|1 participant randomized to MTD received FD 60 ug; was included in FD 60 ug arm for this population|10
3006765|NCT00989963|3724730|FG000|COMPLETED|Overall Study||11
3006766|NCT00989963|3724731|FG001|COMPLETED|Overall Study||11
3006767|NCT00989963|3724732|FG002|COMPLETED|Overall Study||11
3006768|NCT00989963|3724730|FG000|NOT COMPLETED|Overall Study||1
3006769|NCT00989963|3724731|FG001|NOT COMPLETED|Overall Study||1
3006770|NCT00989963|3724732|FG002|NOT COMPLETED|Overall Study||1
3006771|NCT00989989|3724743|FG000|STARTED|Overall Study||132
3006772|NCT00989989|3724744|FG001|STARTED|Overall Study||133
3006773|NCT00989989|3724745|FG002|STARTED|Overall Study||131
3006774|NCT00989989|3724743|FG000|COMPLETED|Overall Study||114
3006775|NCT00989989|3724744|FG001|COMPLETED|Overall Study||123
3006776|NCT00989989|3724745|FG002|COMPLETED|Overall Study||108
3006777|NCT00989989|3724743|FG000|NOT COMPLETED|Overall Study||18
3006778|NCT00989989|3724744|FG001|NOT COMPLETED|Overall Study||10
3006779|NCT00989989|3724745|FG002|NOT COMPLETED|Overall Study||23
3006780|NCT00990093|3724753|FG000|STARTED|Test Period 1 (1-14 Days)||19
3006781|NCT00990093|3724754|FG001|STARTED|Test Period 1 (1-14 Days)||17
3006782|NCT00990093|3724753|FG000|COMPLETED|Test Period 1 (1-14 Days)||15
3006783|NCT00990093|3724754|FG001|COMPLETED|Test Period 1 (1-14 Days)||15
3006784|NCT00990093|3724753|FG000|NOT COMPLETED|Test Period 1 (1-14 Days)||4
3006785|NCT00990093|3724754|FG001|NOT COMPLETED|Test Period 1 (1-14 Days)||2
3133648|NCT01696760|3858566|FG001|NOT COMPLETED|Overall Study||0
3133649|NCT01696773|3858574|FG000|STARTED|Days 1-13, Washout||6
3133650|NCT01696773|3858575|FG001|STARTED|Days 1-13, Washout||6
3133651|NCT01696773|3858574|FG000|COMPLETED|Days 1-13, Washout||6
3006786|NCT00990093|3724753|FG000|STARTED|Test Period 2 (15-28 Days)||15
3006787|NCT00990093|3724754|FG001|STARTED|Test Period 2 (15-28 Days)||15
3006788|NCT00990093|3724753|FG000|COMPLETED|Test Period 2 (15-28 Days)||13
3006789|NCT00990093|3724754|FG001|COMPLETED|Test Period 2 (15-28 Days)||14
3006790|NCT00990093|3724753|FG000|NOT COMPLETED|Test Period 2 (15-28 Days)||2
3006791|NCT00990093|3724754|FG001|NOT COMPLETED|Test Period 2 (15-28 Days)||1
3006792|NCT00990106|3724762|FG000|STARTED|Overall Study||32
3006793|NCT00990106|3724763|FG001|STARTED|Overall Study||35
3006794|NCT00990106|3724762|FG000|COMPLETED|Overall Study||23
3006795|NCT00990106|3724763|FG001|COMPLETED|Overall Study||23
3006796|NCT00990106|3724762|FG000|NOT COMPLETED|Overall Study||9
3006797|NCT00990106|3724763|FG001|NOT COMPLETED|Overall Study||12
3006798|NCT00990184|3724769|FG000|STARTED|Overall Study||21
3006799|NCT00990184|3724769|FG000|COMPLETED|Overall Study||20
3006800|NCT00990184|3724769|FG000|NOT COMPLETED|Overall Study||1
3006801|NCT00990236|3724777|FG000|STARTED|Overall Study||89
3006802|NCT00990236|3724778|FG001|STARTED|Overall Study||96
3006803|NCT00990236|3724777|FG000|COMPLETED|Overall Study||89
3006804|NCT00990236|3724778|FG001|COMPLETED|Overall Study||96
3006805|NCT00990236|3724777|FG000|NOT COMPLETED|Overall Study||0
3006806|NCT00990236|3724778|FG001|NOT COMPLETED|Overall Study||0
3006807|NCT00990249|3724784|FG000|STARTED|Overall Study||120
3006808|NCT00990249|3724784|FG000|COMPLETED|Overall Study||107
3006809|NCT00990249|3724784|FG000|NOT COMPLETED|Overall Study||13
3006810|NCT00990288|3724790|FG000|STARTED|Overall Study||97
3006811|NCT00990288|3724791|FG001|STARTED|Overall Study||99
3006812|NCT00990288|3724790|FG000|COMPLETED|Overall Study||97
3006813|NCT00990288|3724791|FG001|COMPLETED|Overall Study||99
3006814|NCT00990288|3724790|FG000|NOT COMPLETED|Overall Study||0
3006815|NCT00990288|3724791|FG001|NOT COMPLETED|Overall Study||0
3006816|NCT00990314|3724797|FG000|STARTED|Overall Study||31
3006817|NCT00990314|3724797|FG000|COMPLETED|Overall Study||19
3006818|NCT00990314|3724797|FG000|NOT COMPLETED|Overall Study||12
3006819|NCT00990340|3724803|FG000|STARTED|First 14-day Treatment||27
3006820|NCT00990340|3724804|FG001|STARTED|First 14-day Treatment||25
3006821|NCT00990340|3724803|FG000|COMPLETED|First 14-day Treatment||21
3006822|NCT00990340|3724804|FG001|COMPLETED|First 14-day Treatment||21
3006823|NCT00990340|3724803|FG000|NOT COMPLETED|First 14-day Treatment||6
3006824|NCT00990340|3724804|FG001|NOT COMPLETED|First 14-day Treatment||4
3006825|NCT00990340|3724803|FG000|STARTED|Second 14-day Treatment||21
3006826|NCT00990340|3724804|FG001|STARTED|Second 14-day Treatment||21
3006827|NCT00990340|3724803|FG000|COMPLETED|Second 14-day Treatment||21
3006828|NCT00990340|3724804|FG001|COMPLETED|Second 14-day Treatment||21
3006829|NCT00990340|3724803|FG000|NOT COMPLETED|Second 14-day Treatment||0
3006830|NCT00990340|3724804|FG001|NOT COMPLETED|Second 14-day Treatment||0
3006831|NCT00990509|3724814|FG000|STARTED|Overall Study||5
3006832|NCT00990509|3724815|FG001|STARTED|Overall Study||9
3006833|NCT00990509|3724814|FG000|COMPLETED|Overall Study||5
3006834|NCT00990509|3724815|FG001|COMPLETED|Overall Study||8
3006835|NCT00990509|3724814|FG000|NOT COMPLETED|Overall Study||0
3006836|NCT00990509|3724815|FG001|NOT COMPLETED|Overall Study||1
3006837|NCT00990561|3724823|FG000|STARTED|Period 1||20
3006838|NCT00990561|3724824|FG001|STARTED|Period 1||20
3006839|NCT00990561|3724825|FG002|STARTED|Period 1||0
3006840|NCT00990561|3724826|FG003|STARTED|Period 1||0
3006841|NCT00990561|3724823|FG000|COMPLETED|Period 1||20
3006842|NCT00990561|3724824|FG001|COMPLETED|Period 1||19
3006843|NCT00990561|3724825|FG002|COMPLETED|Period 1||0
3006844|NCT00990561|3724826|FG003|COMPLETED|Period 1||0
3006845|NCT00990561|3724823|FG000|NOT COMPLETED|Period 1||0
3006846|NCT00990561|3724824|FG001|NOT COMPLETED|Period 1||1
3006847|NCT00990561|3724825|FG002|NOT COMPLETED|Period 1||0
3006848|NCT00990561|3724826|FG003|NOT COMPLETED|Period 1||0
3006849|NCT00990561|3724823|FG000|STARTED|Period 2||0
3006850|NCT00990561|3724824|FG001|STARTED|Period 2||0
3006851|NCT00990561|3724825|FG002|STARTED|Period 2||20
3006852|NCT00990561|3724826|FG003|STARTED|Period 2||19
3006853|NCT00990561|3724823|FG000|COMPLETED|Period 2||0
3006854|NCT00990561|3724824|FG001|COMPLETED|Period 2||0
3006855|NCT00990561|3724825|FG002|COMPLETED|Period 2||20
3006856|NCT00990561|3724826|FG003|COMPLETED|Period 2||17
3006857|NCT00990561|3724823|FG000|NOT COMPLETED|Period 2||0
3006858|NCT00990561|3724824|FG001|NOT COMPLETED|Period 2||0
3006859|NCT00990561|3724825|FG002|NOT COMPLETED|Period 2||0
3006860|NCT00990561|3724826|FG003|NOT COMPLETED|Period 2||2
3006861|NCT00990652|3724832|FG000|STARTED|Pre-surgical Bortezomib||10
3006862|NCT00990652|3724832|FG000|COMPLETED|Pre-surgical Bortezomib||9
3006863|NCT00990652|3724832|FG000|NOT COMPLETED|Pre-surgical Bortezomib||1
3006864|NCT00990652|3724832|FG000|STARTED|Surgical Resection||9
3006865|NCT00990652|3724832|FG000|COMPLETED|Surgical Resection||9
3006866|NCT00990652|3724832|FG000|NOT COMPLETED|Surgical Resection||0
3006867|NCT00990652|3724832|FG000|STARTED|Post-sugery Bortezomib + Temozolomide||9
3006868|NCT00990652|3724832|FG000|COMPLETED|Post-sugery Bortezomib + Temozolomide||8
3006869|NCT00990652|3724832|FG000|NOT COMPLETED|Post-sugery Bortezomib + Temozolomide||1
3006870|NCT00990665|3724837|FG000|STARTED|Overall Study||178
3006871|NCT00990665|3724837|FG000|COMPLETED|Overall Study||130
3006872|NCT00990665|3724837|FG000|NOT COMPLETED|Overall Study||48
3006873|NCT00990704|3724845|FG000|STARTED|Overall Study||14
3006874|NCT00990704|3724846|FG001|STARTED|Overall Study||33
3006875|NCT00990704|3724845|FG000|COMPLETED|Overall Study||13
3006876|NCT00990704|3724846|FG001|COMPLETED|Overall Study||31
3006877|NCT00990704|3724845|FG000|NOT COMPLETED|Overall Study||1
3006878|NCT00990704|3724846|FG001|NOT COMPLETED|Overall Study||2
3006879|NCT00990769|3724854|FG000|STARTED|Overall Study|Signed consent and assigned to High-normal BIS|22
3006880|NCT00990769|3724855|FG001|STARTED|Overall Study|Signed consent and assigned to Low-normal BIS|18
3006881|NCT00990769|3724854|FG000|COMPLETED|Overall Study||22
3006882|NCT00990769|3724855|FG001|COMPLETED|Overall Study||18
3006883|NCT00990769|3724854|FG000|NOT COMPLETED|Overall Study||0
3006884|NCT00990769|3724855|FG001|NOT COMPLETED|Overall Study||0
3006885|NCT00990782|3724861|FG000|STARTED|Overall Study||93
3006886|NCT00990782|3724861|FG000|COMPLETED|Overall Study||88
3006887|NCT00990782|3724861|FG000|NOT COMPLETED|Overall Study||5
3006888|NCT00990821|3724879|FG000|STARTED|Overall Study||14
3006889|NCT00990821|3724880|FG001|STARTED|Overall Study||16
3006890|NCT00990821|3724881|FG002|STARTED|Overall Study||14
3006891|NCT00990821|3724882|FG003|STARTED|Overall Study||8
3006892|NCT00990821|3724883|FG004|STARTED|Overall Study||17
3006893|NCT00990821|3724884|FG005|STARTED|Overall Study||17
3006894|NCT00990821|3724885|FG006|STARTED|Overall Study||12
3006895|NCT00990821|3724886|FG007|STARTED|Overall Study||14
3006896|NCT00990821|3724887|FG008|STARTED|Overall Study||12
3006897|NCT00990821|3724888|FG009|STARTED|Overall Study||14
3006898|NCT00990821|3724889|FG010|STARTED|Overall Study||12
3006899|NCT00990821|3724890|FG011|STARTED|Overall Study||14
3006900|NCT00990821|3724891|FG012|STARTED|Overall Study||12
3006901|NCT00990821|3724892|FG013|STARTED|Overall Study||12
3006902|NCT00990821|3724879|FG000|COMPLETED|Overall Study||14
3006903|NCT00990821|3724880|FG001|COMPLETED|Overall Study||14
3006904|NCT00990821|3724881|FG002|COMPLETED|Overall Study||14
3006905|NCT00990821|3724882|FG003|COMPLETED|Overall Study||8
3006906|NCT00990821|3724883|FG004|COMPLETED|Overall Study||14
3006907|NCT00990821|3724884|FG005|COMPLETED|Overall Study||14
3006908|NCT00990821|3724885|FG006|COMPLETED|Overall Study||11
3006909|NCT00990821|3724886|FG007|COMPLETED|Overall Study||14
3006910|NCT00990821|3724887|FG008|COMPLETED|Overall Study||12
3006911|NCT00990821|3724888|FG009|COMPLETED|Overall Study||13
3006912|NCT00990821|3724889|FG010|COMPLETED|Overall Study||9
3006913|NCT00990821|3724890|FG011|COMPLETED|Overall Study||9
3006914|NCT00990821|3724891|FG012|COMPLETED|Overall Study||10
3006915|NCT00990821|3724892|FG013|COMPLETED|Overall Study||11
3006916|NCT00990821|3724879|FG000|NOT COMPLETED|Overall Study||0
3006917|NCT00990821|3724880|FG001|NOT COMPLETED|Overall Study||2
3006918|NCT00990821|3724881|FG002|NOT COMPLETED|Overall Study||0
3006919|NCT00990821|3724882|FG003|NOT COMPLETED|Overall Study||0
3006920|NCT00990821|3724883|FG004|NOT COMPLETED|Overall Study||3
3006921|NCT00990821|3724884|FG005|NOT COMPLETED|Overall Study||3
3006922|NCT00990821|3724885|FG006|NOT COMPLETED|Overall Study||1
3006923|NCT00990821|3724886|FG007|NOT COMPLETED|Overall Study||0
3006924|NCT00990821|3724887|FG008|NOT COMPLETED|Overall Study||0
3006925|NCT00990821|3724888|FG009|NOT COMPLETED|Overall Study||1
3006926|NCT00990821|3724889|FG010|NOT COMPLETED|Overall Study||3
3006927|NCT00990821|3724890|FG011|NOT COMPLETED|Overall Study||5
3006928|NCT00990821|3724891|FG012|NOT COMPLETED|Overall Study||2
3006929|NCT00990821|3724892|FG013|NOT COMPLETED|Overall Study||1
3006930|NCT00990938|3724915|FG000|STARTED|Overall Study||3
3006931|NCT00990938|3724916|FG001|STARTED|Overall Study||12
3006932|NCT00990938|3724917|FG002|STARTED|Overall Study||12
3006933|NCT00990938|3724918|FG003|STARTED|Overall Study||12
3006934|NCT00990938|3724919|FG004|STARTED|Overall Study||12
3006935|NCT00990938|3724920|FG005|STARTED|Overall Study||12
3006936|NCT00990938|3724915|FG000|COMPLETED|Overall Study||3
3006937|NCT00990938|3724916|FG001|COMPLETED|Overall Study||12
3006938|NCT00990938|3724917|FG002|COMPLETED|Overall Study||12
3006939|NCT00990938|3724918|FG003|COMPLETED|Overall Study||12
3006940|NCT00990938|3724919|FG004|COMPLETED|Overall Study||12
3006941|NCT00990938|3724920|FG005|COMPLETED|Overall Study||12
3006942|NCT00990938|3724915|FG000|NOT COMPLETED|Overall Study||0
3006943|NCT00990938|3724916|FG001|NOT COMPLETED|Overall Study||0
3006944|NCT00990938|3724917|FG002|NOT COMPLETED|Overall Study||0
3006945|NCT00990938|3724918|FG003|NOT COMPLETED|Overall Study||0
3006946|NCT00990938|3724919|FG004|NOT COMPLETED|Overall Study||0
3006947|NCT00990938|3724920|FG005|NOT COMPLETED|Overall Study||0
3006948|NCT00990964|3724934|FG000|STARTED|Overall Study|Total number of subjects enrolled|2014
3006949|NCT00990964|3724934|FG000|Attain Family Study System Attempt|Overall Study|Total number of subjects with an Attain Family lead attempt after an Attain Family catheter attempt|1917
3006950|NCT00990964|3724934|FG000|COMPLETED|Overall Study|Total number of subjects with successful Attain Family lead using Attain Family catheter|1802
3006951|NCT00990964|3724934|FG000|NOT COMPLETED|Overall Study||212
3006952|NCT00991029|3724941|FG000|STARTED|Overall Study||2432
3006953|NCT00991029|3724942|FG001|STARTED|Overall Study||2449
3006954|NCT00991029|3724941|FG000|COMPLETED|Overall Study||2276
3006955|NCT00991029|3724942|FG001|COMPLETED|Overall Study||2281
3006956|NCT00991029|3724941|FG000|NOT COMPLETED|Overall Study||156
3006957|NCT00991029|3724942|FG001|NOT COMPLETED|Overall Study||168
3006958|NCT00991081|3724950|FG000|STARTED|Phase I, Formative Research||20
3006959|NCT00991081|3724951|FG001|STARTED|Phase I, Formative Research||0
3006960|NCT00991081|3724952|FG002|STARTED|Phase I, Formative Research||0
3006961|NCT00991081|3724950|FG000|COMPLETED|Phase I, Formative Research|The 10 smokers interviewed were not enrolled in the Phase II RCT.|20
3006962|NCT00991081|3724951|FG001|COMPLETED|Phase I, Formative Research||0
3006963|NCT00991081|3724952|FG002|COMPLETED|Phase I, Formative Research||0
3006964|NCT00991081|3724950|FG000|NOT COMPLETED|Phase I, Formative Research||0
3006965|NCT00991081|3724951|FG001|NOT COMPLETED|Phase I, Formative Research||0
3006966|NCT00991081|3724952|FG002|NOT COMPLETED|Phase I, Formative Research||0
3006967|NCT00991081|3724950|FG000|STARTED|Phase II, Randomized Control Trial||0
3006968|NCT00991081|3724951|FG001|STARTED|Phase II, Randomized Control Trial|Phase I interview participants were not enrolled in the Phase II RCT.|17
3006969|NCT00991081|3724952|FG002|STARTED|Phase II, Randomized Control Trial|Phase I interview participants were not enrolled in the Phase II RCT.|19
3006970|NCT00991081|3724950|FG000|Received First Clinical Call|Phase II, Randomized Control Trial||0
3006971|NCT00991081|3724951|FG001|Received First Clinical Call|Phase II, Randomized Control Trial||16
3006972|NCT00991081|3724952|FG002|Received First Clinical Call|Phase II, Randomized Control Trial||17
3006973|NCT00991081|3724950|FG000|COMPLETED|Phase II, Randomized Control Trial||0
3006974|NCT00991081|3724951|FG001|COMPLETED|Phase II, Randomized Control Trial||15
3006975|NCT00991081|3724952|FG002|COMPLETED|Phase II, Randomized Control Trial||15
3006976|NCT00991081|3724950|FG000|NOT COMPLETED|Phase II, Randomized Control Trial||0
3006977|NCT00991081|3724951|FG001|NOT COMPLETED|Phase II, Randomized Control Trial||2
3006978|NCT00991081|3724952|FG002|NOT COMPLETED|Phase II, Randomized Control Trial||4
3006979|NCT00991185|3724958|FG000|STARTED|Overall Study||8
3006980|NCT00991185|3724958|FG000|COMPLETED|Overall Study||8
3006981|NCT00991185|3724958|FG000|NOT COMPLETED|Overall Study||0
3006982|NCT00991276|3724968|FG000|STARTED|First Intervention Period||15
3006983|NCT00991276|3724969|FG001|STARTED|First Intervention Period||13
3006984|NCT00991276|3724970|FG002|STARTED|First Intervention Period||14
3006985|NCT00991276|3724971|FG003|STARTED|First Intervention Period||15
3006986|NCT00991276|3724972|FG004|STARTED|First Intervention Period||15
3006987|NCT00991276|3724973|FG005|STARTED|First Intervention Period||13
3006988|NCT00991276|3724968|FG000|COMPLETED|First Intervention Period||15
3006989|NCT00991276|3724969|FG001|COMPLETED|First Intervention Period||10
3006990|NCT00991276|3724970|FG002|COMPLETED|First Intervention Period||14
3006991|NCT00991276|3724971|FG003|COMPLETED|First Intervention Period||11
3006992|NCT00991276|3724972|FG004|COMPLETED|First Intervention Period||11
3006993|NCT00991276|3724973|FG005|COMPLETED|First Intervention Period||12
3006994|NCT00991276|3724968|FG000|NOT COMPLETED|First Intervention Period||0
3006995|NCT00991276|3724969|FG001|NOT COMPLETED|First Intervention Period||3
3006996|NCT00991276|3724970|FG002|NOT COMPLETED|First Intervention Period||0
3006997|NCT00991276|3724971|FG003|NOT COMPLETED|First Intervention Period||4
3006998|NCT00991276|3724972|FG004|NOT COMPLETED|First Intervention Period||4
3006999|NCT00991276|3724973|FG005|NOT COMPLETED|First Intervention Period||1
3007000|NCT00991276|3724968|FG000|STARTED|Placebo Wash-out Period (7 Days)||15
3007001|NCT00991276|3724969|FG001|STARTED|Placebo Wash-out Period (7 Days)||10
3007002|NCT00991276|3724970|FG002|STARTED|Placebo Wash-out Period (7 Days)||14
3007003|NCT00991276|3724971|FG003|STARTED|Placebo Wash-out Period (7 Days)||11
3007004|NCT00991276|3724972|FG004|STARTED|Placebo Wash-out Period (7 Days)||11
3007005|NCT00991276|3724973|FG005|STARTED|Placebo Wash-out Period (7 Days)||12
3007006|NCT00991276|3724968|FG000|COMPLETED|Placebo Wash-out Period (7 Days)||15
3007007|NCT00991276|3724969|FG001|COMPLETED|Placebo Wash-out Period (7 Days)||10
3007008|NCT00991276|3724970|FG002|COMPLETED|Placebo Wash-out Period (7 Days)||14
3007009|NCT00991276|3724971|FG003|COMPLETED|Placebo Wash-out Period (7 Days)||11
3007010|NCT00991276|3724972|FG004|COMPLETED|Placebo Wash-out Period (7 Days)||11
3007011|NCT00991276|3724973|FG005|COMPLETED|Placebo Wash-out Period (7 Days)||12
3007012|NCT00991276|3724968|FG000|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
3007013|NCT00991276|3724969|FG001|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
3007014|NCT00991276|3724970|FG002|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
3007015|NCT00991276|3724971|FG003|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
3007016|NCT00991276|3724972|FG004|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
3007017|NCT00991276|3724973|FG005|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
3007018|NCT00991276|3724968|FG000|STARTED|Second Intervention Period||15
3007019|NCT00991276|3724969|FG001|STARTED|Second Intervention Period||10
3007020|NCT00991276|3724970|FG002|STARTED|Second Intervention Period||14
3007021|NCT00991276|3724971|FG003|STARTED|Second Intervention Period||11
3007022|NCT00991276|3724972|FG004|STARTED|Second Intervention Period||11
3007023|NCT00991276|3724973|FG005|STARTED|Second Intervention Period||12
3007024|NCT00991276|3724968|FG000|COMPLETED|Second Intervention Period||14
3007025|NCT00991276|3724969|FG001|COMPLETED|Second Intervention Period||8
3007026|NCT00991276|3724970|FG002|COMPLETED|Second Intervention Period||14
3007027|NCT00991276|3724971|FG003|COMPLETED|Second Intervention Period||9
3007028|NCT00991276|3724972|FG004|COMPLETED|Second Intervention Period||10
3007029|NCT00991276|3724973|FG005|COMPLETED|Second Intervention Period||11
3007030|NCT00991276|3724968|FG000|NOT COMPLETED|Second Intervention Period||1
3007031|NCT00991276|3724969|FG001|NOT COMPLETED|Second Intervention Period||2
3007032|NCT00991276|3724970|FG002|NOT COMPLETED|Second Intervention Period||0
3007033|NCT00991276|3724971|FG003|NOT COMPLETED|Second Intervention Period||2
3007034|NCT00991276|3724972|FG004|NOT COMPLETED|Second Intervention Period||1
3007035|NCT00991276|3724973|FG005|NOT COMPLETED|Second Intervention Period||1
3007036|NCT00991276|3724968|FG000|STARTED|Placebo Wash-out Period (7 Days)||14
3007037|NCT00991276|3724969|FG001|STARTED|Placebo Wash-out Period (7 Days)||8
3165092|NCT01897025|3892637|FG000|NOT COMPLETED|Overall Study||0
3165093|NCT01897025|3892638|FG001|NOT COMPLETED|Overall Study||0
3165094|NCT01897077|3892646|FG000|STARTED|Overall Study||0
3165095|NCT01897077|3892647|FG001|STARTED|Overall Study||5
3165096|NCT01897077|3892646|FG000|COMPLETED|Overall Study||0
3007038|NCT00991276|3724970|FG002|STARTED|Placebo Wash-out Period (7 Days)||14
3007039|NCT00991276|3724971|FG003|STARTED|Placebo Wash-out Period (7 Days)||9
3007040|NCT00991276|3724972|FG004|STARTED|Placebo Wash-out Period (7 Days)||10
3007041|NCT00991276|3724973|FG005|STARTED|Placebo Wash-out Period (7 Days)||11
3007042|NCT00991276|3724968|FG000|COMPLETED|Placebo Wash-out Period (7 Days)||14
3007043|NCT00991276|3724969|FG001|COMPLETED|Placebo Wash-out Period (7 Days)||8
3007044|NCT00991276|3724970|FG002|COMPLETED|Placebo Wash-out Period (7 Days)||14
3007045|NCT00991276|3724971|FG003|COMPLETED|Placebo Wash-out Period (7 Days)||9
3007046|NCT00991276|3724972|FG004|COMPLETED|Placebo Wash-out Period (7 Days)||10
3007047|NCT00991276|3724973|FG005|COMPLETED|Placebo Wash-out Period (7 Days)||11
3007048|NCT00991276|3724968|FG000|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
3007049|NCT00991276|3724969|FG001|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
3007050|NCT00991276|3724970|FG002|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
3007051|NCT00991276|3724971|FG003|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
3007052|NCT00991276|3724972|FG004|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
3007053|NCT00991276|3724973|FG005|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
3007054|NCT00991276|3724968|FG000|STARTED|Third Intervention Period||14
3007055|NCT00991276|3724969|FG001|STARTED|Third Intervention Period||8
3007056|NCT00991276|3724970|FG002|STARTED|Third Intervention Period||14
3007057|NCT00991276|3724971|FG003|STARTED|Third Intervention Period||9
3007058|NCT00991276|3724972|FG004|STARTED|Third Intervention Period||10
3165097|NCT01897077|3892647|FG001|COMPLETED|Overall Study||5
3165098|NCT01897077|3892646|FG000|NOT COMPLETED|Overall Study||0
3165099|NCT01897077|3892647|FG001|NOT COMPLETED|Overall Study||0
3165100|NCT01897233|3892653|FG000|STARTED|Part A (14 Days)||10
3165101|NCT01897233|3892653|FG000|Part A Cohort 1 (6 to 8 Years)|Part A (14 Days)||5
3007059|NCT00991276|3724973|FG005|STARTED|Third Intervention Period||11
3007060|NCT00991276|3724968|FG000|COMPLETED|Third Intervention Period||13
3007061|NCT00991276|3724969|FG001|COMPLETED|Third Intervention Period||8
3007062|NCT00991276|3724970|FG002|COMPLETED|Third Intervention Period||13
3007063|NCT00991276|3724971|FG003|COMPLETED|Third Intervention Period||8
3007064|NCT00991276|3724972|FG004|COMPLETED|Third Intervention Period||10
3007065|NCT00991276|3724973|FG005|COMPLETED|Third Intervention Period||10
3007066|NCT00991276|3724968|FG000|NOT COMPLETED|Third Intervention Period||1
3007067|NCT00991276|3724969|FG001|NOT COMPLETED|Third Intervention Period||0
3007068|NCT00991276|3724970|FG002|NOT COMPLETED|Third Intervention Period||1
3007069|NCT00991276|3724971|FG003|NOT COMPLETED|Third Intervention Period||1
3007070|NCT00991276|3724972|FG004|NOT COMPLETED|Third Intervention Period||0
3007071|NCT00991276|3724973|FG005|NOT COMPLETED|Third Intervention Period||1
3007072|NCT00991289|3724982|FG000|STARTED|Overall Study|68 participants enrolled, one was found to have been ineligible and was excluded.|67
3007073|NCT00991289|3724982|FG000|COMPLETED Week 16|Overall Study|Completed 16 weeks of the study (the primary endpoint time point). The study continued to Week 76.|61
3007074|NCT00991289|3724982|FG000|COMPLETED|Overall Study|Completed study.|55
3007075|NCT00991289|3724982|FG000|NOT COMPLETED|Overall Study||12
3007076|NCT00991302|3724988|FG000|STARTED|Overall Study||86
3007077|NCT00991302|3724989|FG001|STARTED|Overall Study||86
3007078|NCT00991302|3724988|FG000|COMPLETED|Overall Study||72
3007079|NCT00991302|3724989|FG001|COMPLETED|Overall Study||73
3007080|NCT00991302|3724988|FG000|NOT COMPLETED|Overall Study||14
3007081|NCT00991302|3724989|FG001|NOT COMPLETED|Overall Study||13
3007082|NCT00991341|3724997|FG000|STARTED|Overall Study||742
3007083|NCT00991341|3724998|FG001|STARTED|Overall Study||739
3007084|NCT00991341|3724997|FG000|COMPLETED|Overall Study||538
3007085|NCT00991341|3724998|FG001|COMPLETED|Overall Study||560
3007086|NCT00991341|3724997|FG000|NOT COMPLETED|Overall Study||204
3007087|NCT00991341|3724998|FG001|NOT COMPLETED|Overall Study||179
3007088|NCT00991406|3725004|FG000|STARTED|Overall Study||9
3007089|NCT00991406|3725004|FG000|COMPLETED|Overall Study|One participant did not respond to FES due to tone.|8
3007090|NCT00991406|3725004|FG000|NOT COMPLETED|Overall Study||1
3007091|NCT00991458|3725011|FG000|STARTED|Overall Study||207
3007092|NCT00991458|3725012|FG001|STARTED|Overall Study||209
3007093|NCT00991458|3725013|FG002|STARTED|Overall Study||205
3007094|NCT00991458|3725011|FG000|COMPLETED|Overall Study||187
3007095|NCT00991458|3725012|FG001|COMPLETED|Overall Study||181
3007096|NCT00991458|3725013|FG002|COMPLETED|Overall Study||180
3007097|NCT00991458|3725011|FG000|NOT COMPLETED|Overall Study||20
3007098|NCT00991458|3725012|FG001|NOT COMPLETED|Overall Study||28
3007099|NCT00991458|3725013|FG002|NOT COMPLETED|Overall Study||25
3007100|NCT00991510|3725023|FG000|STARTED|Period I (Days 1-14)||22
3007101|NCT00991510|3725024|FG001|STARTED|Period I (Days 1-14)||21
3007102|NCT00991510|3725023|FG000|COMPLETED|Period I (Days 1-14)||21
3007103|NCT00991510|3725024|FG001|COMPLETED|Period I (Days 1-14)||21
3007104|NCT00991510|3725023|FG000|NOT COMPLETED|Period I (Days 1-14)||1
3007105|NCT00991510|3725024|FG001|NOT COMPLETED|Period I (Days 1-14)||0
3007106|NCT00991510|3725023|FG000|STARTED|Period II (Days 15-28)||21
3007107|NCT00991510|3725024|FG001|STARTED|Period II (Days 15-28)||21
3007108|NCT00991510|3725023|FG000|COMPLETED|Period II (Days 15-28)||21
3007109|NCT00991510|3725024|FG001|COMPLETED|Period II (Days 15-28)||21
3007110|NCT00991510|3725023|FG000|NOT COMPLETED|Period II (Days 15-28)||0
3007111|NCT00991510|3725024|FG001|NOT COMPLETED|Period II (Days 15-28)||0
3007112|NCT00991510|3725023|FG000|STARTED|Period III (Days 29-112)||21
3007113|NCT00991510|3725024|FG001|STARTED|Period III (Days 29-112)||21
3165102|NCT01897233|3892653|FG000|Part A Cohort 2 (9 to 11 Years)|Part A (14 Days)||5
3007114|NCT00991510|3725023|FG000|COMPLETED|Period III (Days 29-112)||20
3007115|NCT00991510|3725024|FG001|COMPLETED|Period III (Days 29-112)||20
3007116|NCT00991510|3725023|FG000|NOT COMPLETED|Period III (Days 29-112)||1
3007117|NCT00991510|3725024|FG001|NOT COMPLETED|Period III (Days 29-112)||1
3007118|NCT00991809|3725036|FG000|STARTED|Overall Study||12
3165103|NCT01897233|3892653|FG000|COMPLETED|Part A (14 Days)||10
3165104|NCT01897233|3892653|FG000|NOT COMPLETED|Part A (14 Days)||0
3165105|NCT01897233|3892653|FG000|STARTED|Part B (24 Weeks)|6 participants from Part A also participated in Part B of the study.|58
3007119|NCT00991809|3725037|FG001|STARTED|Overall Study||10
3007120|NCT00991809|3725036|FG000|COMPLETED|Overall Study||8
3007121|NCT00991809|3725037|FG001|COMPLETED|Overall Study||4
3007122|NCT00991809|3725036|FG000|NOT COMPLETED|Overall Study||4
3007123|NCT00991809|3725037|FG001|NOT COMPLETED|Overall Study||6
3007124|NCT00991887|3725047|FG000|STARTED|Overall Study||26
3007125|NCT00991887|3725048|FG001|STARTED|Overall Study||22
3007126|NCT00991887|3725047|FG000|COMPLETED|Overall Study||24
3007127|NCT00991887|3725048|FG001|COMPLETED|Overall Study||21
3007128|NCT00991887|3725047|FG000|NOT COMPLETED|Overall Study||2
3007129|NCT00991887|3725048|FG001|NOT COMPLETED|Overall Study||1
3007130|NCT00991939|3725056|FG000|STARTED|Overall Study||5
3007131|NCT00991939|3725057|FG001|STARTED|Overall Study||3
3007132|NCT00991939|3725056|FG000|COMPLETED|Overall Study||0
3007133|NCT00991939|3725057|FG001|COMPLETED|Overall Study||1
3007134|NCT00991939|3725056|FG000|NOT COMPLETED|Overall Study||5
3007135|NCT00991939|3725057|FG001|NOT COMPLETED|Overall Study||2
3165106|NCT01897233|3892653|FG000|COMPLETED|Part B (24 Weeks)||54
3165107|NCT01897233|3892653|FG000|NOT COMPLETED|Part B (24 Weeks)||4
3165108|NCT01897285|3892661|FG000|STARTED|Overall Study|All 20 participants received original AND test adhesive dressings on upper arms and lower back.|20
3165109|NCT01897285|3892661|FG000|COMPLETED|Overall Study||20
3165110|NCT01897285|3892661|FG000|NOT COMPLETED|Overall Study||0
3165111|NCT01897402|3892669|FG000|STARTED|Overall Study||265
3165112|NCT01897402|3892670|FG001|STARTED|Overall Study||260
3165113|NCT01897402|3892669|FG000|COMPLETED|Overall Study||246
3165114|NCT01897402|3892670|FG001|COMPLETED|Overall Study||244
3306589|NCT02999100|4039917|FG005|NOT COMPLETED|Part 2 (Day 14): Dosing Session 2||0
3306590|NCT02999178|4039941|FG000|STARTED|Overall Study||332
3306591|NCT02999178|4039942|FG001|STARTED|Overall Study||331
3007136|NCT00991952|3725067|FG000|STARTED|Overall Study||13
3007137|NCT00991952|3725068|FG001|STARTED|Overall Study||6
3007138|NCT00991952|3725067|FG000|COMPLETED|Overall Study||13
3007139|NCT00991952|3725068|FG001|COMPLETED|Overall Study||5
3007140|NCT00991952|3725067|FG000|NOT COMPLETED|Overall Study||0
3007141|NCT00991952|3725068|FG001|NOT COMPLETED|Overall Study||1
3007142|NCT00992017|3725074|FG000|STARTED|Overall Study|Two additional women were enrolled but left the clinic before vaccine was administered.|128
3007143|NCT00992017|3725074|FG000|Received Both Study Vaccinations|Overall Study||124
3007144|NCT00992017|3725074|FG000|Received Only One Study Vaccination|Overall Study|Reasons: delivered and LFU; moved; no transportation; ineligible - blood transfusion at delivery|4
3007145|NCT00992017|3725074|FG000|COMPLETED|Overall Study||118
3007146|NCT00992017|3725074|FG000|NOT COMPLETED|Overall Study||10
3007147|NCT00992056|3725085|FG000|STARTED|Treatment Period 1 (6 Weeks)||12
3007148|NCT00992056|3725086|FG001|STARTED|Treatment Period 1 (6 Weeks)||12
3007149|NCT00992056|3725085|FG000|COMPLETED|Treatment Period 1 (6 Weeks)|February 2012|11
3007150|NCT00992056|3725086|FG001|COMPLETED|Treatment Period 1 (6 Weeks)||10
3007151|NCT00992056|3725085|FG000|NOT COMPLETED|Treatment Period 1 (6 Weeks)||1
3007152|NCT00992056|3725086|FG001|NOT COMPLETED|Treatment Period 1 (6 Weeks)||2
3007153|NCT00992056|3725085|FG000|STARTED|Washout Period (2 Weeks)||11
3007154|NCT00992056|3725086|FG001|STARTED|Washout Period (2 Weeks)||10
3007155|NCT00992056|3725085|FG000|COMPLETED|Washout Period (2 Weeks)||10
3007156|NCT00992056|3725086|FG001|COMPLETED|Washout Period (2 Weeks)||10
3007157|NCT00992056|3725085|FG000|NOT COMPLETED|Washout Period (2 Weeks)||1
3007158|NCT00992056|3725086|FG001|NOT COMPLETED|Washout Period (2 Weeks)||0
3007159|NCT00992056|3725085|FG000|STARTED|Treatment Period 2 (6 Weeks)||10
3007160|NCT00992056|3725086|FG001|STARTED|Treatment Period 2 (6 Weeks)||10
3007161|NCT00992056|3725085|FG000|COMPLETED|Treatment Period 2 (6 Weeks)||10
3007162|NCT00992056|3725086|FG001|COMPLETED|Treatment Period 2 (6 Weeks)||10
3007163|NCT00992056|3725085|FG000|NOT COMPLETED|Treatment Period 2 (6 Weeks)||0
3007164|NCT00992056|3725086|FG001|NOT COMPLETED|Treatment Period 2 (6 Weeks)||0
3007165|NCT00992108|3725094|FG000|STARTED|Overall Study||7
3007166|NCT00992108|3725095|FG001|STARTED|Overall Study||10
3007167|NCT00992108|3725094|FG000|COMPLETED|Overall Study||7
3007168|NCT00992108|3725095|FG001|COMPLETED|Overall Study||9
3007169|NCT00992108|3725094|FG000|NOT COMPLETED|Overall Study||0
3007170|NCT00992108|3725095|FG001|NOT COMPLETED|Overall Study||1
3007171|NCT00992186|3725101|FG000|STARTED|Overall Study||46
3007172|NCT00992186|3725101|FG000|COMPLETED|Overall Study||0
3007173|NCT00992186|3725101|FG000|NOT COMPLETED|Overall Study||46
3007174|NCT00992225|3725106|FG000|STARTED|Overall Study||43
3007175|NCT00992225|3725106|FG000|Received at Least One Dose of Study Drug|Overall Study||33
3317084|NCT03123861|4050601|FG001|STARTED|Overall Study||23
3007176|NCT00992225|3725106|FG000|COMPLETED|Overall Study||33
3007177|NCT00992225|3725106|FG000|NOT COMPLETED|Overall Study||10
3007178|NCT00992264|3725126|FG000|STARTED|Overall Study||116
3007179|NCT00992264|3725127|FG001|STARTED|Overall Study||116
3007180|NCT00992264|3725128|FG002|STARTED|Overall Study||117
3007181|NCT00992264|3725129|FG003|STARTED|Overall Study||117
3007182|NCT00992264|3725130|FG004|STARTED|Overall Study||117
3007183|NCT00992264|3725131|FG005|STARTED|Overall Study||117
3007184|NCT00992264|3725132|FG006|STARTED|Overall Study||116
3007185|NCT00992264|3725133|FG007|STARTED|Overall Study||117
3007186|NCT00992264|3725134|FG008|STARTED|Overall Study||116
3007187|NCT00992264|3725135|FG009|STARTED|Overall Study||116
3007188|NCT00992264|3725136|FG010|STARTED|Overall Study||117
3007189|NCT00992264|3725137|FG011|STARTED|Overall Study||117
3007190|NCT00992264|3725138|FG012|STARTED|Overall Study||116
3007191|NCT00992264|3725139|FG013|STARTED|Overall Study||117
3007192|NCT00992264|3725140|FG014|STARTED|Overall Study||117
3007193|NCT00992264|3725141|FG015|STARTED|Overall Study||116
3007194|NCT00992264|3725126|FG000|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
3007195|NCT00992264|3725127|FG001|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
3007196|NCT00992264|3725128|FG002|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
3007197|NCT00992264|3725129|FG003|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
3007198|NCT00992264|3725130|FG004|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
3007199|NCT00992264|3725131|FG005|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
3007200|NCT00992264|3725132|FG006|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
3007201|NCT00992264|3725133|FG007|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
3007202|NCT00992264|3725134|FG008|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
3007203|NCT00992264|3725135|FG009|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
3007204|NCT00992264|3725136|FG010|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
3007205|NCT00992264|3725137|FG011|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
3007206|NCT00992264|3725138|FG012|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
3007207|NCT00992264|3725139|FG013|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
3007208|NCT00992264|3725140|FG014|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
3007209|NCT00992264|3725141|FG015|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
3007210|NCT00992264|3725126|FG000|NOT COMPLETED|Overall Study||0
3007211|NCT00992264|3725127|FG001|NOT COMPLETED|Overall Study||0
3007212|NCT00992264|3725128|FG002|NOT COMPLETED|Overall Study||0
3007213|NCT00992264|3725129|FG003|NOT COMPLETED|Overall Study||0
3007214|NCT00992264|3725130|FG004|NOT COMPLETED|Overall Study||0
3007215|NCT00992264|3725131|FG005|NOT COMPLETED|Overall Study||0
3007216|NCT00992264|3725132|FG006|NOT COMPLETED|Overall Study||0
3007217|NCT00992264|3725133|FG007|NOT COMPLETED|Overall Study||0
3007218|NCT00992264|3725134|FG008|NOT COMPLETED|Overall Study||0
3007219|NCT00992264|3725135|FG009|NOT COMPLETED|Overall Study||0
3007220|NCT00992264|3725136|FG010|NOT COMPLETED|Overall Study||0
3007221|NCT00992264|3725137|FG011|NOT COMPLETED|Overall Study||0
3007222|NCT00992264|3725138|FG012|NOT COMPLETED|Overall Study||0
3007223|NCT00992264|3725139|FG013|NOT COMPLETED|Overall Study||0
3007224|NCT00992264|3725140|FG014|NOT COMPLETED|Overall Study||0
3007225|NCT00992264|3725141|FG015|NOT COMPLETED|Overall Study||0
3007226|NCT00992394|3725154|FG000|STARTED|Overall Study||88
3007227|NCT00992394|3725155|FG001|STARTED|Overall Study||86
3007228|NCT00992394|3725154|FG000|Safety Population|Overall Study||87
3007229|NCT00992394|3725155|FG001|Safety Population|Overall Study||84
3007230|NCT00992394|3725154|FG000|mITT Population|Overall Study||86
3007231|NCT00992394|3725155|FG001|mITT Population|Overall Study||84
3007232|NCT00992394|3725154|FG000|COMPLETED|Overall Study||64
3007233|NCT00992394|3725155|FG001|COMPLETED|Overall Study||72
3007234|NCT00992394|3725154|FG000|NOT COMPLETED|Overall Study||24
3007235|NCT00992394|3725155|FG001|NOT COMPLETED|Overall Study||14
3007236|NCT00992407|3725163|FG000|STARTED|Overall Study||37
3007237|NCT00992407|3725164|FG001|STARTED|Overall Study||38
3007238|NCT00992407|3725163|FG000|Treated|Overall Study||20
3007239|NCT00992407|3725164|FG001|Treated|Overall Study||25
3007240|NCT00992407|3725163|FG000|COMPLETED|Overall Study||6
3007241|NCT00992407|3725164|FG001|COMPLETED|Overall Study||14
3007242|NCT00992407|3725163|FG000|NOT COMPLETED|Overall Study||31
3007243|NCT00992407|3725164|FG001|NOT COMPLETED|Overall Study||24
3007244|NCT00992433|3725175|FG000|STARTED|Overall Study||95
3007245|NCT00992433|3725176|FG001|STARTED|Overall Study||97
3007246|NCT00992433|3725175|FG000|COMPLETED|Overall Study||91
3007247|NCT00992433|3725176|FG001|COMPLETED|Overall Study||90
3007248|NCT00992433|3725175|FG000|NOT COMPLETED|Overall Study||4
3007249|NCT00992433|3725176|FG001|NOT COMPLETED|Overall Study||7
3007250|NCT00992446|3725182|FG000|STARTED|Overall Study||27
3007251|NCT00992446|3725182|FG000|COMPLETED|Overall Study||19
3007252|NCT00992446|3725182|FG000|NOT COMPLETED|Overall Study||8
3007253|NCT00992459|3725188|FG000|STARTED|Overall Study|All patients received HPN 100 placebo in Arm A (+ concomitant active NaPBA)|22
3007254|NCT00992459|3725189|FG001|STARTED|Overall Study|All patients received NaPBA placebo in Arm B (+ concomitant active HPN 100)|24
3007255|NCT00992459|3725188|FG000|COMPLETED|Overall Study|Totals enrolled and completed in Arm A NaPBA treatment + HPN 100 Placebo are not mutually exclusive.|21
3007256|NCT00992459|3725189|FG001|COMPLETED|Overall Study|Totals enrolled and completed in Arm B HPN 100 treatment + NaPBA Placebo are not mutually exclusive.|23
3007257|NCT00992459|3725188|FG000|NOT COMPLETED|Overall Study||1
3007258|NCT00992459|3725189|FG001|NOT COMPLETED|Overall Study||1
3007259|NCT00992511|3725199|FG000|STARTED|Overall Study||76
3007260|NCT00992511|3725200|FG001|STARTED|Overall Study||73
3007261|NCT00992511|3725201|FG002|STARTED|Overall Study||76
3007262|NCT00992511|3725202|FG003|STARTED|Overall Study||75
3007263|NCT00992511|3725199|FG000|COMPLETED|Overall Study||74
3007264|NCT00992511|3725200|FG001|COMPLETED|Overall Study||73
3007265|NCT00992511|3725201|FG002|COMPLETED|Overall Study||74
3007266|NCT00992511|3725202|FG003|COMPLETED|Overall Study||70
3007267|NCT00992511|3725199|FG000|NOT COMPLETED|Overall Study||2
3007268|NCT00992511|3725200|FG001|NOT COMPLETED|Overall Study||0
3007269|NCT00992511|3725201|FG002|NOT COMPLETED|Overall Study||2
3007270|NCT00992511|3725202|FG003|NOT COMPLETED|Overall Study||5
3007271|NCT00992589|3725212|FG000|STARTED|Open-Label Phase||344
3007272|NCT00992589|3725213|FG001|STARTED|Open-Label Phase||0
3007273|NCT00992589|3725214|FG002|STARTED|Open-Label Phase||0
3007274|NCT00992589|3725215|FG003|STARTED|Open-Label Phase||0
3007275|NCT00992589|3725212|FG000|COMPLETED|Open-Label Phase||267
3007276|NCT00992589|3725213|FG001|COMPLETED|Open-Label Phase||0
3007277|NCT00992589|3725214|FG002|COMPLETED|Open-Label Phase||0
3007278|NCT00992589|3725215|FG003|COMPLETED|Open-Label Phase||0
3007279|NCT00992589|3725212|FG000|NOT COMPLETED|Open-Label Phase||77
3007280|NCT00992589|3725213|FG001|NOT COMPLETED|Open-Label Phase||0
3007281|NCT00992589|3725214|FG002|NOT COMPLETED|Open-Label Phase||0
3007282|NCT00992589|3725215|FG003|NOT COMPLETED|Open-Label Phase||0
3007283|NCT00992589|3725212|FG000|STARTED|Double-Blind Phase||0
3007284|NCT00992589|3725213|FG001|STARTED|Double-Blind Phase||89
3007285|NCT00992589|3725214|FG002|STARTED|Double-Blind Phase||90
3007286|NCT00992589|3725215|FG003|STARTED|Double-Blind Phase||88
3007287|NCT00992589|3725212|FG000|COMPLETED|Double-Blind Phase||0
3007288|NCT00992589|3725213|FG001|COMPLETED|Double-Blind Phase||76
3007289|NCT00992589|3725214|FG002|COMPLETED|Double-Blind Phase||77
3007290|NCT00992589|3725215|FG003|COMPLETED|Double-Blind Phase||78
3007291|NCT00992589|3725212|FG000|NOT COMPLETED|Double-Blind Phase||0
3007292|NCT00992589|3725213|FG001|NOT COMPLETED|Double-Blind Phase||13
3007293|NCT00992589|3725214|FG002|NOT COMPLETED|Double-Blind Phase||13
3007294|NCT00992589|3725215|FG003|NOT COMPLETED|Double-Blind Phase||10
3007295|NCT00992602|3725233|FG000|STARTED|Overall Study||3
3007296|NCT00992602|3725233|FG000|COMPLETED|Overall Study||0
3007297|NCT00992602|3725233|FG000|NOT COMPLETED|Overall Study||3
3007298|NCT00992719|3725240|FG000|STARTED|Overall Study||28
3007299|NCT00992719|3725241|FG001|STARTED|Overall Study||28
3007300|NCT00992719|3725242|FG002|STARTED|Overall Study||28
3007301|NCT00992719|3725240|FG000|COMPLETED|Overall Study||27
3007302|NCT00992719|3725241|FG001|COMPLETED|Overall Study||27
3007303|NCT00992719|3725242|FG002|COMPLETED|Overall Study||28
3007304|NCT00992719|3725240|FG000|NOT COMPLETED|Overall Study||1
3007305|NCT00992719|3725241|FG001|NOT COMPLETED|Overall Study||1
3007306|NCT00992719|3725242|FG002|NOT COMPLETED|Overall Study||0
3007307|NCT00992784|3725253|FG000|STARTED|Overall Study||180
3007308|NCT00992784|3725254|FG001|STARTED|Overall Study||104
3007309|NCT00992784|3725255|FG002|STARTED|Overall Study||86
3007310|NCT00992784|3725253|FG000|COMPLETED|Overall Study||177
3007311|NCT00992784|3725254|FG001|COMPLETED|Overall Study||102
3007312|NCT00992784|3725255|FG002|COMPLETED|Overall Study||85
3007313|NCT00992784|3725253|FG000|NOT COMPLETED|Overall Study||3
3007314|NCT00992784|3725254|FG001|NOT COMPLETED|Overall Study||2
3165115|NCT01897402|3892669|FG000|NOT COMPLETED|Overall Study||19
3165116|NCT01897402|3892670|FG001|NOT COMPLETED|Overall Study||16
3165117|NCT01897493|3892682|FG000|STARTED|Period 1 (Day 1 Through Day 6 Predose)||16
3007315|NCT00992784|3725255|FG002|NOT COMPLETED|Overall Study||1
3007316|NCT00992836|3725263|FG000|STARTED|Overall Study||155
3007317|NCT00992836|3725263|FG000|Received Both Study Vaccinations|Overall Study||150
3007318|NCT00992836|3725263|FG000|COMPLETED|Overall Study||150
3007319|NCT00992836|3725263|FG000|NOT COMPLETED|Overall Study||5
3007320|NCT00992927|3725275|FG000|STARTED|Overall Study||32
3165118|NCT01897493|3892682|FG000|Received at Least 1 Dose of Study Drug|Period 1 (Day 1 Through Day 6 Predose)||16
3165119|NCT01897493|3892682|FG000|COMPLETED|Period 1 (Day 1 Through Day 6 Predose)||15
3165120|NCT01897493|3892682|FG000|NOT COMPLETED|Period 1 (Day 1 Through Day 6 Predose)||1
3165121|NCT01897493|3892682|FG000|STARTED|Period 2 (Day 6 Postdose Through Day 20)||15
3171816|NCT01937351|3899028|FG001|STARTED|Overall Study||28
3007321|NCT00992927|3725276|FG001|STARTED|Overall Study||22
3007322|NCT00992927|3725275|FG000|COMPLETED|Overall Study||32
3007323|NCT00992927|3725276|FG001|COMPLETED|Overall Study||22
3007324|NCT00992927|3725275|FG000|NOT COMPLETED|Overall Study||0
3007325|NCT00992927|3725276|FG001|NOT COMPLETED|Overall Study||0
3007326|NCT00992992|3725282|FG000|STARTED|Overall Study||25
3007327|NCT00992992|3725282|FG000|COMPLETED|Overall Study||0
3007328|NCT00992992|3725282|FG000|NOT COMPLETED|Overall Study||25
3007329|NCT00993031|3725288|FG000|STARTED|Overall Study||195
3007330|NCT00993031|3725289|FG001|STARTED|Overall Study||194
3007331|NCT00993031|3725288|FG000|Delivered|Overall Study||187
3007332|NCT00993031|3725289|FG001|Delivered|Overall Study||190
3007333|NCT00993031|3725288|FG000|COMPLETED|Overall Study||173
3007334|NCT00993031|3725289|FG001|COMPLETED|Overall Study||175
3007335|NCT00993031|3725288|FG000|NOT COMPLETED|Overall Study||22
3007336|NCT00993031|3725289|FG001|NOT COMPLETED|Overall Study||19
3165122|NCT01897493|3892682|FG000|Received at Least 1 Dose of Study Drug|Period 2 (Day 6 Postdose Through Day 20)||15
3165123|NCT01897493|3892682|FG000|COMPLETED|Period 2 (Day 6 Postdose Through Day 20)||15
3165124|NCT01897493|3892682|FG000|NOT COMPLETED|Period 2 (Day 6 Postdose Through Day 20)||0
3165125|NCT01897532|3892691|FG000|STARTED|Discontinuation From Treatment||3492
3007337|NCT00993044|3725299|FG000|STARTED|Irinotecan 30 mg||6
3007338|NCT00993044|3725299|FG000|COMPLETED|Irinotecan 30 mg||6
3007339|NCT00993044|3725299|FG000|NOT COMPLETED|Irinotecan 30 mg||0
3007340|NCT00993044|3725299|FG000|STARTED|Irinotecan 50 mg||7
3007341|NCT00993044|3725299|FG000|COMPLETED|Irinotecan 50 mg||6
3007342|NCT00993044|3725299|FG000|NOT COMPLETED|Irinotecan 50 mg||1
3007343|NCT00993148|3725304|FG000|STARTED|Overall Study||25
3007344|NCT00993148|3725304|FG000|COMPLETED|Overall Study||22
3007345|NCT00993148|3725304|FG000|NOT COMPLETED|Overall Study||3
3007346|NCT00993187|3725310|FG000|STARTED|Overall Study||147
3007347|NCT00993187|3725311|FG001|STARTED|Overall Study||145
3007348|NCT00993187|3725310|FG000|Received at Least 1 Dose of Study Drug|Overall Study||146
3007349|NCT00993187|3725311|FG001|Received at Least 1 Dose of Study Drug|Overall Study||144
3007350|NCT00993187|3725310|FG000|COMPLETED|Overall Study||121
3007351|NCT00993187|3725311|FG001|COMPLETED|Overall Study||108
3007352|NCT00993187|3725310|FG000|NOT COMPLETED|Overall Study||26
3007353|NCT00993187|3725311|FG001|NOT COMPLETED|Overall Study||37
3007354|NCT00993200|3725319|FG000|STARTED|Overall Study||13
3007355|NCT00993200|3725320|FG001|STARTED|Overall Study||13
3007356|NCT00993200|3725319|FG000|COMPLETED|Overall Study||13
3007357|NCT00993200|3725320|FG001|COMPLETED|Overall Study||13
3007358|NCT00993200|3725319|FG000|NOT COMPLETED|Overall Study||0
3007359|NCT00993200|3725320|FG001|NOT COMPLETED|Overall Study||0
3007360|NCT00993226|3725331|FG000|STARTED|Overall Study||61
3007361|NCT00993226|3725332|FG001|STARTED|Overall Study||27
3007362|NCT00993226|3725333|FG002|STARTED|Overall Study||27
3007363|NCT00993226|3725331|FG000|COMPLETED|Overall Study||60
3007364|NCT00993226|3725332|FG001|COMPLETED|Overall Study||26
3007365|NCT00993226|3725333|FG002|COMPLETED|Overall Study||27
3007366|NCT00993226|3725331|FG000|NOT COMPLETED|Overall Study||1
3007367|NCT00993226|3725332|FG001|NOT COMPLETED|Overall Study||1
3007368|NCT00993226|3725333|FG002|NOT COMPLETED|Overall Study||0
3007369|NCT00993265|3725343|FG000|STARTED|Overall Study||20
3007370|NCT00993265|3725344|FG001|STARTED|Overall Study||19
3007371|NCT00993265|3725343|FG000|COMPLETED|Overall Study||16
3007372|NCT00993265|3725344|FG001|COMPLETED|Overall Study||19
3007373|NCT00993265|3725343|FG000|NOT COMPLETED|Overall Study||4
3007374|NCT00993265|3725344|FG001|NOT COMPLETED|Overall Study||0
3007375|NCT00993291|3725350|FG000|STARTED|Overall Study||20
3007376|NCT00993291|3725350|FG000|COMPLETED|Overall Study||19
3007377|NCT00993291|3725350|FG000|NOT COMPLETED|Overall Study||1
3007378|NCT00993317|3725356|FG000|STARTED|Overall Study||42
3007379|NCT00993317|3725357|FG001|STARTED|Overall Study||85
3007380|NCT00993317|3725356|FG000|COMPLETED|Overall Study||21
3007381|NCT00993317|3725357|FG001|COMPLETED|Overall Study||60
3007382|NCT00993317|3725356|FG000|NOT COMPLETED|Overall Study||21
3007383|NCT00993317|3725357|FG001|NOT COMPLETED|Overall Study||25
3007384|NCT00993421|3725370|FG000|STARTED|Overall Study||49
3007385|NCT00993421|3725371|FG001|STARTED|Overall Study||49
3007386|NCT00993421|3725372|FG002|STARTED|Overall Study||48
3007387|NCT00993421|3725373|FG003|STARTED|Overall Study||49
3007388|NCT00993421|3725374|FG004|STARTED|Overall Study||52
3007389|NCT00993421|3725375|FG005|STARTED|Overall Study||50
3007390|NCT00993421|3725376|FG006|STARTED|Overall Study||46
3007391|NCT00993421|3725370|FG000|COMPLETED|Overall Study||5
3007392|NCT00993421|3725371|FG001|COMPLETED|Overall Study||4
3007393|NCT00993421|3725372|FG002|COMPLETED|Overall Study||5
3007394|NCT00993421|3725373|FG003|COMPLETED|Overall Study||4
3007395|NCT00993421|3725374|FG004|COMPLETED|Overall Study||6
3007396|NCT00993421|3725375|FG005|COMPLETED|Overall Study||4
3007397|NCT00993421|3725376|FG006|COMPLETED|Overall Study||4
3007398|NCT00993421|3725370|FG000|NOT COMPLETED|Overall Study||44
3007399|NCT00993421|3725371|FG001|NOT COMPLETED|Overall Study||45
3007400|NCT00993421|3725372|FG002|NOT COMPLETED|Overall Study||43
3007401|NCT00993421|3725373|FG003|NOT COMPLETED|Overall Study||45
3007402|NCT00993421|3725374|FG004|NOT COMPLETED|Overall Study||46
3007403|NCT00993421|3725375|FG005|NOT COMPLETED|Overall Study||46
3007404|NCT00993421|3725376|FG006|NOT COMPLETED|Overall Study||42
3007405|NCT00993447|3725394|FG000|STARTED|Overall Study||401
3007406|NCT00993447|3725395|FG001|STARTED|Overall Study||199
3007407|NCT00993447|3725394|FG000|COMPLETED|Overall Study||364
3007408|NCT00993447|3725395|FG001|COMPLETED|Overall Study||180
3007409|NCT00993447|3725394|FG000|NOT COMPLETED|Overall Study||37
3007410|NCT00993447|3725395|FG001|NOT COMPLETED|Overall Study||19
3007411|NCT00993473|3725403|FG000|STARTED|Overall Study|61 patients randomized to Lantus but 62 patients treated with Lantus due to a dispensation's error|61
3007412|NCT00993473|3725404|FG001|STARTED|Overall Study|64 patients randomized to NPH but only 63 patients treated with NPH due to a dispensation's error|64
3007413|NCT00993473|3725403|FG000|COMPLETED|Overall Study||57
3007414|NCT00993473|3725404|FG001|COMPLETED|Overall Study||54
3007415|NCT00993473|3725403|FG000|NOT COMPLETED|Overall Study||4
3007416|NCT00993473|3725404|FG001|NOT COMPLETED|Overall Study||10
3007417|NCT00993499|3725416|FG000|STARTED|Run-in Period (8 Days)||13
3007418|NCT00993499|3725417|FG001|STARTED|Run-in Period (8 Days)||12
3007419|NCT00993499|3725418|FG002|STARTED|Run-in Period (8 Days)||10
3007420|NCT00993499|3725419|FG003|STARTED|Run-in Period (8 Days)||3
3007421|NCT00993499|3725420|FG004|STARTED|Run-in Period (8 Days)||3
3007422|NCT00993499|3725421|FG005|STARTED|Run-in Period (8 Days)||3
3007423|NCT00993499|3725416|FG000|COMPLETED|Run-in Period (8 Days)||12
3007424|NCT00993499|3725417|FG001|COMPLETED|Run-in Period (8 Days)||9
3007425|NCT00993499|3725418|FG002|COMPLETED|Run-in Period (8 Days)||9
3007426|NCT00993499|3725419|FG003|COMPLETED|Run-in Period (8 Days)||3
3007427|NCT00993499|3725420|FG004|COMPLETED|Run-in Period (8 Days)||3
3007428|NCT00993499|3725421|FG005|COMPLETED|Run-in Period (8 Days)||3
3007429|NCT00993499|3725416|FG000|NOT COMPLETED|Run-in Period (8 Days)||1
3007430|NCT00993499|3725417|FG001|NOT COMPLETED|Run-in Period (8 Days)||3
3007431|NCT00993499|3725418|FG002|NOT COMPLETED|Run-in Period (8 Days)||1
3007432|NCT00993499|3725419|FG003|NOT COMPLETED|Run-in Period (8 Days)||0
3007433|NCT00993499|3725420|FG004|NOT COMPLETED|Run-in Period (8 Days)||0
3007434|NCT00993499|3725421|FG005|NOT COMPLETED|Run-in Period (8 Days)||0
3007435|NCT00993499|3725416|FG000|STARTED|Discontinued Before Starting Course 3||12
3007436|NCT00993499|3725417|FG001|STARTED|Discontinued Before Starting Course 3||9
3007437|NCT00993499|3725418|FG002|STARTED|Discontinued Before Starting Course 3||9
3007438|NCT00993499|3725419|FG003|STARTED|Discontinued Before Starting Course 3||3
3007439|NCT00993499|3725420|FG004|STARTED|Discontinued Before Starting Course 3||3
3007440|NCT00993499|3725421|FG005|STARTED|Discontinued Before Starting Course 3||3
3007441|NCT00993499|3725416|FG000|COMPLETED|Discontinued Before Starting Course 3||8
3007442|NCT00993499|3725417|FG001|COMPLETED|Discontinued Before Starting Course 3||5
3007443|NCT00993499|3725418|FG002|COMPLETED|Discontinued Before Starting Course 3||6
3007444|NCT00993499|3725419|FG003|COMPLETED|Discontinued Before Starting Course 3||2
3007445|NCT00993499|3725420|FG004|COMPLETED|Discontinued Before Starting Course 3||3
3007446|NCT00993499|3725421|FG005|COMPLETED|Discontinued Before Starting Course 3||3
3007447|NCT00993499|3725416|FG000|NOT COMPLETED|Discontinued Before Starting Course 3||4
3007448|NCT00993499|3725417|FG001|NOT COMPLETED|Discontinued Before Starting Course 3||4
3007449|NCT00993499|3725418|FG002|NOT COMPLETED|Discontinued Before Starting Course 3||3
3007450|NCT00993499|3725419|FG003|NOT COMPLETED|Discontinued Before Starting Course 3||1
3007451|NCT00993499|3725420|FG004|NOT COMPLETED|Discontinued Before Starting Course 3||0
3007452|NCT00993499|3725421|FG005|NOT COMPLETED|Discontinued Before Starting Course 3||0
3007453|NCT00993499|3725416|FG000|STARTED|Discontinued After Starting Course 3||12
3007454|NCT00993499|3725417|FG001|STARTED|Discontinued After Starting Course 3||9
3007455|NCT00993499|3725418|FG002|STARTED|Discontinued After Starting Course 3||9
3007456|NCT00993499|3725419|FG003|STARTED|Discontinued After Starting Course 3||3
3007457|NCT00993499|3725420|FG004|STARTED|Discontinued After Starting Course 3||3
3007458|NCT00993499|3725421|FG005|STARTED|Discontinued After Starting Course 3||3
3007459|NCT00993499|3725416|FG000|COMPLETED|Discontinued After Starting Course 3||4
3007460|NCT00993499|3725417|FG001|COMPLETED|Discontinued After Starting Course 3||4
3007461|NCT00993499|3725418|FG002|COMPLETED|Discontinued After Starting Course 3||3
3007462|NCT00993499|3725419|FG003|COMPLETED|Discontinued After Starting Course 3||1
3007463|NCT00993499|3725420|FG004|COMPLETED|Discontinued After Starting Course 3||0
3007464|NCT00993499|3725421|FG005|COMPLETED|Discontinued After Starting Course 3||0
3007465|NCT00993499|3725416|FG000|NOT COMPLETED|Discontinued After Starting Course 3||8
3007466|NCT00993499|3725417|FG001|NOT COMPLETED|Discontinued After Starting Course 3||5
3007467|NCT00993499|3725418|FG002|NOT COMPLETED|Discontinued After Starting Course 3||6
3007468|NCT00993499|3725419|FG003|NOT COMPLETED|Discontinued After Starting Course 3||2
3007469|NCT00993499|3725420|FG004|NOT COMPLETED|Discontinued After Starting Course 3||3
3007470|NCT00993499|3725421|FG005|NOT COMPLETED|Discontinued After Starting Course 3||3
3037318|NCT01147601|3756593|FG000|STARTED|Overall Study||5
3037319|NCT01147601|3756594|FG001|STARTED|Overall Study||1
3037320|NCT01147601|3756593|FG000|COMPLETED|Overall Study||2
3037321|NCT01147601|3756594|FG001|COMPLETED|Overall Study||1
3037322|NCT01147601|3756593|FG000|NOT COMPLETED|Overall Study||3
3037323|NCT01147601|3756594|FG001|NOT COMPLETED|Overall Study||0
3037324|NCT01147627|3756603|FG000|STARTED|Overall Study||142
3037325|NCT01147627|3756604|FG001|STARTED|Overall Study||138
3037326|NCT01147627|3756605|FG002|STARTED|Overall Study||136
3037327|NCT01147627|3756603|FG000|COMPLETED|Overall Study||110
3037328|NCT01147627|3756604|FG001|COMPLETED|Overall Study||114
3037329|NCT01147627|3756605|FG002|COMPLETED|Overall Study||118
3037330|NCT01147627|3756603|FG000|NOT COMPLETED|Overall Study||32
3037331|NCT01147627|3756604|FG001|NOT COMPLETED|Overall Study||24
3037332|NCT01147627|3756605|FG002|NOT COMPLETED|Overall Study||18
3037333|NCT01147640|3756615|FG000|STARTED|Overall Study||83
3037334|NCT01147640|3756616|FG001|STARTED|Overall Study||39
3037335|NCT01147640|3756615|FG000|COMPLETED|Overall Study||78
3037336|NCT01147640|3756616|FG001|COMPLETED|Overall Study||38
3037337|NCT01147640|3756615|FG000|NOT COMPLETED|Overall Study||5
3037338|NCT01147640|3756616|FG001|NOT COMPLETED|Overall Study||1
3037339|NCT01147744|3756629|FG000|STARTED|Overall Study||100
3037340|NCT01147744|3756630|FG001|STARTED|Overall Study||99
3037341|NCT01147744|3756631|FG002|STARTED|Overall Study||100
3037342|NCT01147744|3756632|FG003|STARTED|Overall Study||100
3037343|NCT01147744|3756633|FG004|STARTED|Overall Study||101
3037344|NCT01147744|3756634|FG005|STARTED|Overall Study||103
3037345|NCT01147744|3756635|FG006|STARTED|Overall Study||97
3037346|NCT01147744|3756629|FG000|COMPLETED|Overall Study||71
3037347|NCT01147744|3756630|FG001|COMPLETED|Overall Study||76
3037348|NCT01147744|3756631|FG002|COMPLETED|Overall Study||82
3037349|NCT01147744|3756632|FG003|COMPLETED|Overall Study||82
3037350|NCT01147744|3756633|FG004|COMPLETED|Overall Study||76
3007471|NCT00993616|3725435|FG000|STARTED|Overall Study||29
3007472|NCT00993616|3725435|FG000|COMPLETED|Overall Study|Number of eligible and evaluable participants|27
3007473|NCT00993616|3725435|FG000|NOT COMPLETED|Overall Study||2
3007474|NCT00993655|3725448|FG000|STARTED|Overall Study||101
3007475|NCT00993655|3725449|FG001|STARTED|Overall Study||72
3007476|NCT00993655|3725450|FG002|STARTED|Overall Study||102
3007477|NCT00993655|3725448|FG000|COMPLETED|Overall Study||101
3007478|NCT00993655|3725449|FG001|COMPLETED|Overall Study||72
3007479|NCT00993655|3725450|FG002|COMPLETED|Overall Study||102
3007480|NCT00993655|3725448|FG000|NOT COMPLETED|Overall Study||0
3007481|NCT00993655|3725449|FG001|NOT COMPLETED|Overall Study||0
3007482|NCT00993655|3725450|FG002|NOT COMPLETED|Overall Study||0
3007483|NCT00993668|3725463|FG000|STARTED|Single-Blind Period||114
3007484|NCT00993668|3725464|FG001|STARTED|Single-Blind Period||110
3007485|NCT00993668|3725463|FG000|COMPLETED|Single-Blind Period||110
3007486|NCT00993668|3725464|FG001|COMPLETED|Single-Blind Period||107
3007487|NCT00993668|3725463|FG000|NOT COMPLETED|Single-Blind Period||4
3007488|NCT00993668|3725464|FG001|NOT COMPLETED|Single-Blind Period||3
3007489|NCT00993668|3725463|FG000|STARTED|Open-Label Period|1 subject chose not to enter the optional open-label period|109
3007490|NCT00993668|3725464|FG001|STARTED|Open-Label Period|1 subject chose not to enter the optional open-label period|106
3007491|NCT00993668|3725463|FG000|COMPLETED|Open-Label Period||86
3007492|NCT00993668|3725464|FG001|COMPLETED|Open-Label Period||91
3007493|NCT00993668|3725463|FG000|NOT COMPLETED|Open-Label Period||23
3007494|NCT00993668|3725464|FG001|NOT COMPLETED|Open-Label Period||15
3007495|NCT00993798|3725474|FG000|STARTED|Overall Study||53
3007496|NCT00993798|3725475|FG001|STARTED|Overall Study||25
3007497|NCT00993798|3725476|FG002|STARTED|Overall Study||29
3007498|NCT00993798|3725477|FG003|STARTED|Overall Study||0
3007499|NCT00993798|3725478|FG004|STARTED|Overall Study||0
3007500|NCT00993798|3725474|FG000|COMPLETED|Overall Study||53
3007501|NCT00993798|3725475|FG001|COMPLETED|Overall Study||25
3007502|NCT00993798|3725476|FG002|COMPLETED|Overall Study||29
3007503|NCT00993798|3725477|FG003|COMPLETED|Overall Study||0
3007504|NCT00993798|3725478|FG004|COMPLETED|Overall Study||0
3007505|NCT00993798|3725474|FG000|NOT COMPLETED|Overall Study||0
3007506|NCT00993798|3725475|FG001|NOT COMPLETED|Overall Study||0
3007507|NCT00993798|3725476|FG002|NOT COMPLETED|Overall Study||0
3007508|NCT00993798|3725477|FG003|NOT COMPLETED|Overall Study||0
3007509|NCT00993798|3725478|FG004|NOT COMPLETED|Overall Study||0
3007510|NCT00993824|3725488|FG000|STARTED|Overall Study||11
3007511|NCT00993824|3725489|FG001|STARTED|Overall Study||10
3007512|NCT00993824|3725488|FG000|COMPLETED|Overall Study||11
3007513|NCT00993824|3725489|FG001|COMPLETED|Overall Study||10
3007514|NCT00993824|3725488|FG000|NOT COMPLETED|Overall Study||0
3007515|NCT00993824|3725489|FG001|NOT COMPLETED|Overall Study||0
3007516|NCT00993915|3725497|FG000|STARTED|Overall Study||687
3007517|NCT00993915|3725497|FG000|COMPLETED|Overall Study||678
3007518|NCT00993915|3725497|FG000|NOT COMPLETED|Overall Study||9
3007519|NCT00993928|3725503|FG000|STARTED|Overall Study||48
3007520|NCT00993928|3725504|FG001|STARTED|Overall Study||45
3007521|NCT00993928|3725503|FG000|COMPLETED|Overall Study||43
3007522|NCT00993928|3725504|FG001|COMPLETED|Overall Study||38
3007523|NCT00993928|3725503|FG000|NOT COMPLETED|Overall Study||5
3007524|NCT00993928|3725504|FG001|NOT COMPLETED|Overall Study||7
3007525|NCT00993954|3725516|FG000|STARTED|Overall Study||145
3007526|NCT00993954|3725517|FG001|STARTED|Overall Study||123
3007527|NCT00993954|3725516|FG000|COMPLETED|Overall Study||124
3007528|NCT00993954|3725517|FG001|COMPLETED|Overall Study||121
3007529|NCT00993954|3725516|FG000|NOT COMPLETED|Overall Study||21
3007530|NCT00993954|3725517|FG001|NOT COMPLETED|Overall Study||2
3007531|NCT00993967|3725523|FG000|STARTED|Overall Study||200
3007532|NCT00993967|3725523|FG000|COMPLETED|Overall Study||139
3007533|NCT00993967|3725523|FG000|NOT COMPLETED|Overall Study||61
3007534|NCT00994110|3725529|FG000|STARTED|Overall Study||217
3007535|NCT00994110|3725530|FG001|STARTED|Overall Study||222
3007536|NCT00994110|3725529|FG000|COMPLETED|Overall Study||152
3165126|NCT01897532|3892692|FG001|STARTED|Discontinuation From Treatment||3499
3165127|NCT01897532|3892691|FG000|Treated|Discontinuation From Treatment||3485
3165128|NCT01897532|3892692|FG001|Treated|Discontinuation From Treatment||3494
3165129|NCT01897532|3892691|FG000|COMPLETED|Discontinuation From Treatment||2530
3165130|NCT01897532|3892692|FG001|COMPLETED|Discontinuation From Treatment||2660
3007537|NCT00994110|3725530|FG001|COMPLETED|Overall Study||148
3007538|NCT00994110|3725529|FG000|NOT COMPLETED|Overall Study||65
3007539|NCT00994110|3725530|FG001|NOT COMPLETED|Overall Study||74
3007540|NCT00994123|3725539|FG000|STARTED|Overall Study||33
3007541|NCT00994123|3725540|FG001|STARTED|Overall Study||85
3007542|NCT00994123|3725541|FG002|STARTED|Overall Study||44
3007543|NCT00994123|3725539|FG000|COMPLETED|Overall Study||33
3007544|NCT00994123|3725540|FG001|COMPLETED|Overall Study||85
3007545|NCT00994123|3725541|FG002|COMPLETED|Overall Study||44
3007546|NCT00994123|3725539|FG000|NOT COMPLETED|Overall Study||0
3007547|NCT00994123|3725540|FG001|NOT COMPLETED|Overall Study||0
3007548|NCT00994123|3725541|FG002|NOT COMPLETED|Overall Study||0
3007549|NCT00994175|3725560|FG000|STARTED|First Intervention||6
3007550|NCT00994175|3725561|FG001|STARTED|First Intervention||9
3007551|NCT00994175|3725560|FG000|COMPLETED|First Intervention||4
3007552|NCT00994175|3725561|FG001|COMPLETED|First Intervention||8
3007553|NCT00994175|3725560|FG000|NOT COMPLETED|First Intervention||2
3007554|NCT00994175|3725561|FG001|NOT COMPLETED|First Intervention||1
3007555|NCT00994175|3725560|FG000|STARTED|Second Intervention||4
3007556|NCT00994175|3725561|FG001|STARTED|Second Intervention||8
3007557|NCT00994175|3725560|FG000|COMPLETED|Second Intervention||4
3007558|NCT00994175|3725561|FG001|COMPLETED|Second Intervention||8
3007559|NCT00994175|3725560|FG000|NOT COMPLETED|Second Intervention||0
3007560|NCT00994175|3725561|FG001|NOT COMPLETED|Second Intervention||0
3007561|NCT00994214|3725571|FG000|STARTED|ITT (Intention-to-Treat) - Part A||19
3007562|NCT00994214|3725572|FG001|STARTED|ITT (Intention-to-Treat) - Part A||19
3007563|NCT00994214|3725573|FG002|STARTED|ITT (Intention-to-Treat) - Part A||18
3007564|NCT00994214|3725574|FG003|STARTED|ITT (Intention-to-Treat) - Part A||20
3007565|NCT00994214|3725571|FG000|COMPLETED|ITT (Intention-to-Treat) - Part A||5
3007566|NCT00994214|3725572|FG001|COMPLETED|ITT (Intention-to-Treat) - Part A||6
3007567|NCT00994214|3725573|FG002|COMPLETED|ITT (Intention-to-Treat) - Part A||5
3007568|NCT00994214|3725574|FG003|COMPLETED|ITT (Intention-to-Treat) - Part A||5
3007569|NCT00994214|3725571|FG000|NOT COMPLETED|ITT (Intention-to-Treat) - Part A||14
3007570|NCT00994214|3725572|FG001|NOT COMPLETED|ITT (Intention-to-Treat) - Part A||13
3007571|NCT00994214|3725573|FG002|NOT COMPLETED|ITT (Intention-to-Treat) - Part A||13
3007572|NCT00994214|3725574|FG003|NOT COMPLETED|ITT (Intention-to-Treat) - Part A||15
3007573|NCT00994214|3725571|FG000|STARTED|ITT (Intention-to-Treat) - Part B|1 subject did not enter Part B Arm A|4
3007574|NCT00994214|3725572|FG001|STARTED|ITT (Intention-to-Treat) - Part B|3 subjects did not enter Part B Arm B|3
3007575|NCT00994214|3725573|FG002|STARTED|ITT (Intention-to-Treat) - Part B|3 subjects did not enter Part B Arm C|2
3007576|NCT00994214|3725574|FG003|STARTED|ITT (Intention-to-Treat) - Part B|2 subjects did not enter Part B Arm D|3
3007577|NCT00994214|3725571|FG000|Received Maximum Dose of 1mg|ITT (Intention-to-Treat) - Part B||0
3007578|NCT00994214|3725572|FG001|Received Maximum Dose of 1mg|ITT (Intention-to-Treat) - Part B||0
3007579|NCT00994214|3725573|FG002|Received Maximum Dose of 1mg|ITT (Intention-to-Treat) - Part B||0
3007580|NCT00994214|3725574|FG003|Received Maximum Dose of 1mg|ITT (Intention-to-Treat) - Part B||0
3007581|NCT00994214|3725571|FG000|Received Maximum Dose of 2mg|ITT (Intention-to-Treat) - Part B||3
3007582|NCT00994214|3725572|FG001|Received Maximum Dose of 2mg|ITT (Intention-to-Treat) - Part B||0
3007583|NCT00994214|3725573|FG002|Received Maximum Dose of 2mg|ITT (Intention-to-Treat) - Part B||0
3007584|NCT00994214|3725574|FG003|Received Maximum Dose of 2mg|ITT (Intention-to-Treat) - Part B||0
3007585|NCT00994214|3725571|FG000|Received Maximum Dose of 4mg|ITT (Intention-to-Treat) - Part B||1
3007586|NCT00994214|3725572|FG001|Received Maximum Dose of 4mg|ITT (Intention-to-Treat) - Part B||3
3007587|NCT00994214|3725573|FG002|Received Maximum Dose of 4mg|ITT (Intention-to-Treat) - Part B||0
3007588|NCT00994214|3725574|FG003|Received Maximum Dose of 4mg|ITT (Intention-to-Treat) - Part B||0
3007589|NCT00994214|3725571|FG000|Received Maximum Dose of 6mg|ITT (Intention-to-Treat) - Part B||0
3007590|NCT00994214|3725572|FG001|Received Maximum Dose of 6mg|ITT (Intention-to-Treat) - Part B||0
3007591|NCT00994214|3725573|FG002|Received Maximum Dose of 6mg|ITT (Intention-to-Treat) - Part B||2
3007592|NCT00994214|3725574|FG003|Received Maximum Dose of 6mg|ITT (Intention-to-Treat) - Part B||3
3007593|NCT00994214|3725571|FG000|COMPLETED|ITT (Intention-to-Treat) - Part B||0
3007594|NCT00994214|3725572|FG001|COMPLETED|ITT (Intention-to-Treat) - Part B||0
3007595|NCT00994214|3725573|FG002|COMPLETED|ITT (Intention-to-Treat) - Part B||0
3007596|NCT00994214|3725574|FG003|COMPLETED|ITT (Intention-to-Treat) - Part B||0
3007597|NCT00994214|3725571|FG000|NOT COMPLETED|ITT (Intention-to-Treat) - Part B||4
3007598|NCT00994214|3725572|FG001|NOT COMPLETED|ITT (Intention-to-Treat) - Part B||3
3007599|NCT00994214|3725573|FG002|NOT COMPLETED|ITT (Intention-to-Treat) - Part B||2
3007600|NCT00994214|3725574|FG003|NOT COMPLETED|ITT (Intention-to-Treat) - Part B||3
3007601|NCT00994240|3725604|FG000|STARTED|Overall Study||41
3007602|NCT00994240|3725605|FG001|STARTED|Overall Study||44
3007603|NCT00994240|3725604|FG000|COMPLETED|Overall Study||35
3007604|NCT00994240|3725605|FG001|COMPLETED|Overall Study||39
3007605|NCT00994240|3725604|FG000|NOT COMPLETED|Overall Study||6
3007606|NCT00994240|3725605|FG001|NOT COMPLETED|Overall Study||5
3007607|NCT00994279|3725613|FG000|STARTED|Overall Study||22
3007608|NCT00994279|3725614|FG001|STARTED|Overall Study||18
3007609|NCT00994279|3725613|FG000|COMPLETED|Overall Study||18
3007610|NCT00994279|3725614|FG001|COMPLETED|Overall Study||13
3007611|NCT00994279|3725613|FG000|NOT COMPLETED|Overall Study||4
3007612|NCT00994279|3725614|FG001|NOT COMPLETED|Overall Study||5
3007613|NCT00994318|3725623|FG000|STARTED|Overall Study||155
3007614|NCT00994318|3725624|FG001|STARTED|Overall Study||154
3007615|NCT00994318|3725625|FG002|STARTED|Overall Study||317
3007616|NCT00994318|3725623|FG000|COMPLETED|Overall Study||133
3007617|NCT00994318|3725624|FG001|COMPLETED|Overall Study||136
3007618|NCT00994318|3725625|FG002|COMPLETED|Overall Study||250
3007619|NCT00994318|3725623|FG000|NOT COMPLETED|Overall Study||22
3007620|NCT00994318|3725624|FG001|NOT COMPLETED|Overall Study||18
3007621|NCT00994318|3725625|FG002|NOT COMPLETED|Overall Study||67
3007622|NCT00994422|3725635|FG000|STARTED|Overall Study||192
3007623|NCT00994422|3725636|FG001|STARTED|Overall Study||55
3007624|NCT00994422|3725635|FG000|COMPLETED|Overall Study||185
3007625|NCT00994422|3725636|FG001|COMPLETED|Overall Study||54
3007626|NCT00994422|3725635|FG000|NOT COMPLETED|Overall Study||7
3007627|NCT00994422|3725636|FG001|NOT COMPLETED|Overall Study||1
3007628|NCT00994448|3725646|FG000|STARTED|Overall Study||12
3007629|NCT00994448|3725647|FG001|STARTED|Overall Study||7
3007630|NCT00994448|3725646|FG000|COMPLETED|Overall Study||4
3007631|NCT00994448|3725647|FG001|COMPLETED|Overall Study||5
3007632|NCT00994448|3725646|FG000|NOT COMPLETED|Overall Study||8
3007633|NCT00994448|3725647|FG001|NOT COMPLETED|Overall Study||2
3007634|NCT00994461|3725656|FG000|STARTED|Overall Study||76
3007635|NCT00994461|3725657|FG001|STARTED|Overall Study||76
3007636|NCT00994461|3725658|FG002|STARTED|Overall Study|One subject was randomized but did not receive study drug.|37
3007637|NCT00994461|3725656|FG000|COMPLETED|Overall Study||74
3007638|NCT00994461|3725657|FG001|COMPLETED|Overall Study||75
3007639|NCT00994461|3725658|FG002|COMPLETED|Overall Study||37
3007640|NCT00994461|3725656|FG000|NOT COMPLETED|Overall Study||2
3007641|NCT00994461|3725657|FG001|NOT COMPLETED|Overall Study||1
3007642|NCT00994461|3725658|FG002|NOT COMPLETED|Overall Study||0
3007643|NCT00994604|3725666|FG000|STARTED|Overall Study||51
3007644|NCT00994604|3725666|FG000|COMPLETED|Overall Study||45
3007645|NCT00994604|3725666|FG000|NOT COMPLETED|Overall Study||6
3007646|NCT00994643|3725673|FG000|STARTED|Overall Study||11
3007647|NCT00994643|3725673|FG000|COMPLETED|Overall Study||10
3007648|NCT00994643|3725673|FG000|NOT COMPLETED|Overall Study||1
3007649|NCT00994682|3725679|FG000|STARTED|Double Bilnd||51
3007650|NCT00994682|3725680|FG001|STARTED|Double Bilnd||50
3007651|NCT00994682|3725679|FG000|COMPLETED|Double Bilnd||42
3007652|NCT00994682|3725680|FG001|COMPLETED|Double Bilnd||41
3007653|NCT00994682|3725679|FG000|NOT COMPLETED|Double Bilnd||9
3007654|NCT00994682|3725680|FG001|NOT COMPLETED|Double Bilnd||9
3007655|NCT00994682|3725679|FG000|STARTED|Pioglitazone Open Label||42
3007656|NCT00994682|3725680|FG001|STARTED|Pioglitazone Open Label||41
3007657|NCT00994682|3725679|FG000|COMPLETED|Pioglitazone Open Label||29
3007658|NCT00994682|3725680|FG001|COMPLETED|Pioglitazone Open Label||34
3007659|NCT00994682|3725679|FG000|NOT COMPLETED|Pioglitazone Open Label||13
3007660|NCT00994682|3725680|FG001|NOT COMPLETED|Pioglitazone Open Label||7
3007661|NCT00994760|3725690|FG000|STARTED|Overall Study||131
3007662|NCT00994760|3725690|FG000|COMPLETED|Overall Study||107
3007663|NCT00994760|3725690|FG000|NOT COMPLETED|Overall Study||24
3007664|NCT00994890|3725711|FG000|STARTED|Overall Study||231
3007665|NCT00994890|3725712|FG001|STARTED|Overall Study||222
3007666|NCT00994890|3725713|FG002|STARTED|Overall Study||226
3007667|NCT00994890|3725711|FG000|Treated|Overall Study||230
3007668|NCT00994890|3725712|FG001|Treated|Overall Study||222
3007669|NCT00994890|3725713|FG002|Treated|Overall Study||226
3007670|NCT00994890|3725711|FG000|COMPLETED|Overall Study||0
3007671|NCT00994890|3725712|FG001|COMPLETED|Overall Study||0
3007672|NCT00994890|3725713|FG002|COMPLETED|Overall Study||0
3007673|NCT00994890|3725711|FG000|NOT COMPLETED|Overall Study||231
3007674|NCT00994890|3725712|FG001|NOT COMPLETED|Overall Study||222
3007675|NCT00994890|3725713|FG002|NOT COMPLETED|Overall Study||226
3007676|NCT00994929|3725721|FG000|STARTED|Overall Study||9
3007677|NCT00994929|3725721|FG000|COMPLETED|Overall Study||9
3007678|NCT00994929|3725721|FG000|NOT COMPLETED|Overall Study||0
3007679|NCT00995007|3725728|FG000|STARTED|Overall Study||56
3007680|NCT00995007|3725729|FG001|STARTED|Overall Study||56
3007681|NCT00995007|3725728|FG000|Crossover to Vandetanib|Overall Study||42
3007682|NCT00995007|3725729|FG001|Crossover to Vandetanib|Overall Study||0
3007683|NCT00995007|3725728|FG000|COMPLETED|Overall Study||39
3007684|NCT00995007|3725729|FG001|COMPLETED|Overall Study||54
3007685|NCT00995007|3725728|FG000|NOT COMPLETED|Overall Study||17
3007686|NCT00995007|3725729|FG001|NOT COMPLETED|Overall Study||2
3007687|NCT00995020|3725746|FG000|STARTED|Overall Study||51
3007688|NCT00995020|3725747|FG001|STARTED|Overall Study||52
3007689|NCT00995020|3725746|FG000|COMPLETED|Overall Study|"Reasons for not completed:~margin analysis not performed specimen fragmentation thermal damage"|48
3007690|NCT00995020|3725747|FG001|COMPLETED|Overall Study|"Reasons for not completed:~margin analysis not performed specimen fragmentation thermal damage"|45
3007691|NCT00995020|3725746|FG000|NOT COMPLETED|Overall Study||3
3007692|NCT00995020|3725747|FG001|NOT COMPLETED|Overall Study||7
3007693|NCT00995072|3725757|FG000|STARTED|Overall Study||10
3007694|NCT00995072|3725758|FG001|STARTED|Overall Study||15
3007695|NCT00995072|3725757|FG000|COMPLETED|Overall Study||9
3007696|NCT00995072|3725758|FG001|COMPLETED|Overall Study||12
3007697|NCT00995072|3725757|FG000|NOT COMPLETED|Overall Study||1
3007698|NCT00995072|3725758|FG001|NOT COMPLETED|Overall Study||3
3007699|NCT00995085|3725764|FG000|STARTED|Overall Study||43
3007700|NCT00995085|3725764|FG000|COMPLETED|Overall Study||38
3007701|NCT00995085|3725764|FG000|NOT COMPLETED|Overall Study||5
3007702|NCT00995215|3725768|FG000|STARTED|Overall Study||6
3007703|NCT00995215|3725768|FG000|COMPLETED|Overall Study||6
3007704|NCT00995215|3725768|FG000|NOT COMPLETED|Overall Study||0
3007705|NCT00995345|3725778|FG000|STARTED|Overall Study||81
3007706|NCT00995345|3725779|FG001|STARTED|Overall Study||81
3007707|NCT00995345|3725780|FG002|STARTED|Overall Study||80
3007708|NCT00995345|3725781|FG003|STARTED|Overall Study||81
3007709|NCT00995345|3725782|FG004|STARTED|Overall Study||80
3007710|NCT00995345|3725778|FG000|COMPLETED|Overall Study||70
3007711|NCT00995345|3725779|FG001|COMPLETED|Overall Study||74
3007712|NCT00995345|3725780|FG002|COMPLETED|Overall Study||73
3007713|NCT00995345|3725781|FG003|COMPLETED|Overall Study||76
3007714|NCT00995345|3725782|FG004|COMPLETED|Overall Study||75
3007715|NCT00995345|3725778|FG000|NOT COMPLETED|Overall Study||11
3007716|NCT00995345|3725779|FG001|NOT COMPLETED|Overall Study||7
3007717|NCT00995345|3725780|FG002|NOT COMPLETED|Overall Study||7
3007718|NCT00995345|3725781|FG003|NOT COMPLETED|Overall Study||5
3007719|NCT00995345|3725782|FG004|NOT COMPLETED|Overall Study||5
3007720|NCT00995371|3725796|FG000|STARTED|Prior to ESI Cross-over, 6 Weeks||21
3007721|NCT00995371|3725797|FG001|STARTED|Prior to ESI Cross-over, 6 Weeks||17
3007722|NCT00995371|3725796|FG000|COMPLETED|Prior to ESI Cross-over, 6 Weeks||21
3007723|NCT00995371|3725797|FG001|COMPLETED|Prior to ESI Cross-over, 6 Weeks||17
3007724|NCT00995371|3725796|FG000|NOT COMPLETED|Prior to ESI Cross-over, 6 Weeks||0
3007725|NCT00995371|3725797|FG001|NOT COMPLETED|Prior to ESI Cross-over, 6 Weeks||0
3007726|NCT00995371|3725796|FG000|STARTED|After ESI Cross-over to Mild, 26 Weeks||21
3007727|NCT00995371|3725797|FG001|STARTED|After ESI Cross-over to Mild, 26 Weeks||17
3007728|NCT00995371|3725796|FG000|COMPLETED|After ESI Cross-over to Mild, 26 Weeks|All 21 completed Wk 6 Intent to Treat analysis. Sixteen reported Week 26 outcomes.|16
3007729|NCT00995371|3725797|FG001|COMPLETED|After ESI Cross-over to Mild, 26 Weeks|All 17 completed Wk 6 Intent to Treat analysis prior to x-over. After x-over 12 reported Wk 26|12
3007730|NCT00995371|3725796|FG000|NOT COMPLETED|After ESI Cross-over to Mild, 26 Weeks||5
3007731|NCT00995371|3725797|FG001|NOT COMPLETED|After ESI Cross-over to Mild, 26 Weeks||5
3007732|NCT00995410|3725805|FG000|STARTED|Overall Study||380
3007733|NCT00995410|3725805|FG000|Treated|Overall Study||379
3007734|NCT00995410|3725805|FG000|COMPLETED|Overall Study||292
3007735|NCT00995410|3725805|FG000|NOT COMPLETED|Overall Study||88
3007736|NCT00995436|3725812|FG000|STARTED|Overall Study|25|25
3007737|NCT00995436|3725813|FG001|STARTED|Overall Study||27
3007738|NCT00995436|3725814|FG002|STARTED|Overall Study||26
3007739|NCT00995436|3725812|FG000|COMPLETED|Overall Study||23
3007740|NCT00995436|3725813|FG001|COMPLETED|Overall Study||22
3007741|NCT00995436|3725814|FG002|COMPLETED|Overall Study||26
3007742|NCT00995436|3725812|FG000|NOT COMPLETED|Overall Study||2
3007743|NCT00995436|3725813|FG001|NOT COMPLETED|Overall Study||5
3007744|NCT00995436|3725814|FG002|NOT COMPLETED|Overall Study||0
3007745|NCT00995449|3725826|FG000|STARTED|Overall Study||0
3007746|NCT00995449|3725827|FG001|STARTED|Overall Study||0
3007747|NCT00995449|3725828|FG002|STARTED|Overall Study||7
3007748|NCT00995449|3725829|FG003|STARTED|Overall Study||2
3007749|NCT00995449|3725826|FG000|COMPLETED|Overall Study||0
3007750|NCT00995449|3725827|FG001|COMPLETED|Overall Study||0
3007751|NCT00995449|3725828|FG002|COMPLETED|Overall Study||5
3007752|NCT00995449|3725829|FG003|COMPLETED|Overall Study||2
3007753|NCT00995449|3725826|FG000|NOT COMPLETED|Overall Study||0
3007754|NCT00995449|3725827|FG001|NOT COMPLETED|Overall Study||0
3007755|NCT00995449|3725828|FG002|NOT COMPLETED|Overall Study||2
3007756|NCT00995449|3725829|FG003|NOT COMPLETED|Overall Study||0
3007757|NCT00995475|3725837|FG000|STARTED|First Intervention||9
3007758|NCT00995475|3725838|FG001|STARTED|First Intervention||9
3007759|NCT00995475|3725837|FG000|COMPLETED|First Intervention||9
3007760|NCT00995475|3725838|FG001|COMPLETED|First Intervention||9
3007761|NCT00995475|3725837|FG000|NOT COMPLETED|First Intervention||0
3007762|NCT00995475|3725838|FG001|NOT COMPLETED|First Intervention||0
3007763|NCT00995475|3725837|FG000|STARTED|Wash-out Two Week||9
3007764|NCT00995475|3725838|FG001|STARTED|Wash-out Two Week||9
3007765|NCT00995475|3725837|FG000|COMPLETED|Wash-out Two Week||9
3007766|NCT00995475|3725838|FG001|COMPLETED|Wash-out Two Week||9
3007767|NCT00995475|3725837|FG000|NOT COMPLETED|Wash-out Two Week||0
3007768|NCT00995475|3725838|FG001|NOT COMPLETED|Wash-out Two Week||0
3007769|NCT00995475|3725837|FG000|STARTED|Second Intervention||9
3007770|NCT00995475|3725838|FG001|STARTED|Second Intervention||9
3007771|NCT00995475|3725837|FG000|COMPLETED|Second Intervention||9
3007772|NCT00995475|3725838|FG001|COMPLETED|Second Intervention||9
3007773|NCT00995475|3725837|FG000|NOT COMPLETED|Second Intervention||0
3007774|NCT00995475|3725838|FG001|NOT COMPLETED|Second Intervention||0
3007775|NCT00995488|3725844|FG000|STARTED|Overall Study||16
3007776|NCT00995488|3725844|FG000|COMPLETED|Overall Study||15
3007777|NCT00995488|3725844|FG000|NOT COMPLETED|Overall Study||1
3007778|NCT00995501|3725856|FG000|STARTED|Overall Study||52
3007779|NCT00995501|3725857|FG001|STARTED|Overall Study||51
3007780|NCT00995501|3725858|FG002|STARTED|Overall Study||47
3007781|NCT00995501|3725859|FG003|STARTED|Overall Study||46
3007782|NCT00995501|3725860|FG004|STARTED|Overall Study||46
3007783|NCT00995501|3725861|FG005|STARTED|Overall Study||44
3007784|NCT00995501|3725862|FG006|STARTED|Overall Study||49
3007785|NCT00995501|3725863|FG007|STARTED|Overall Study||46
3007786|NCT00995501|3725856|FG000|COMPLETED|Overall Study||52
3007787|NCT00995501|3725857|FG001|COMPLETED|Overall Study||51
3007788|NCT00995501|3725858|FG002|COMPLETED|Overall Study||47
3007789|NCT00995501|3725859|FG003|COMPLETED|Overall Study||46
3007790|NCT00995501|3725860|FG004|COMPLETED|Overall Study||46
3007791|NCT00995501|3725861|FG005|COMPLETED|Overall Study||44
3007792|NCT00995501|3725862|FG006|COMPLETED|Overall Study||49
3007793|NCT00995501|3725863|FG007|COMPLETED|Overall Study||46
3007794|NCT00995501|3725856|FG000|NOT COMPLETED|Overall Study||0
3007795|NCT00995501|3725857|FG001|NOT COMPLETED|Overall Study||0
3007796|NCT00995501|3725858|FG002|NOT COMPLETED|Overall Study||0
3007797|NCT00995501|3725859|FG003|NOT COMPLETED|Overall Study||0
3007798|NCT00995501|3725860|FG004|NOT COMPLETED|Overall Study||0
3007799|NCT00995501|3725861|FG005|NOT COMPLETED|Overall Study||0
3007800|NCT00995501|3725862|FG006|NOT COMPLETED|Overall Study||0
3007801|NCT00995501|3725863|FG007|NOT COMPLETED|Overall Study||0
3007802|NCT00995553|3725883|FG000|STARTED|Overall Study||40
3007803|NCT00995553|3725884|FG001|STARTED|Overall Study||41
3007804|NCT00995553|3725883|FG000|COMPLETED|Overall Study||38
3007805|NCT00995553|3725884|FG001|COMPLETED|Overall Study||35
3007806|NCT00995553|3725883|FG000|NOT COMPLETED|Overall Study||2
3007807|NCT00995553|3725884|FG001|NOT COMPLETED|Overall Study||6
3007808|NCT00995566|3725890|FG000|STARTED|Overall Study||54
3007809|NCT00995566|3725890|FG000|COMPLETED|Overall Study||0
3007810|NCT00995566|3725890|FG000|NOT COMPLETED|Overall Study||54
3007811|NCT00995670|3725897|FG000|STARTED|Overall Study||26
3007812|NCT00995670|3725898|FG001|STARTED|Overall Study||16
3007813|NCT00995670|3725899|FG002|STARTED|Overall Study||17
3007814|NCT00995670|3725897|FG000|COMPLETED|Overall Study|These 26 subjects underwent a total of 58 studies to determine the effect of dose of glucose on I/R.|25
3007815|NCT00995670|3725898|FG001|COMPLETED|Overall Study|These 16 subjects underwent a total of 25 studies on the effect of Vitamin C.|16
3007816|NCT00995670|3725899|FG002|COMPLETED|Overall Study|These 17 volunteers underwent 33 studies on the effect of statins, glucose, and glucose & statins.|14
3007817|NCT00995670|3725897|FG000|NOT COMPLETED|Overall Study||1
3007818|NCT00995670|3725898|FG001|NOT COMPLETED|Overall Study||0
3007819|NCT00995670|3725899|FG002|NOT COMPLETED|Overall Study||3
3007820|NCT00995709|3725910|FG000|STARTED|Overall Study||39
3007821|NCT00995709|3725911|FG001|STARTED|Overall Study||40
3007822|NCT00995709|3725912|FG002|STARTED|Overall Study||39
3007823|NCT00995709|3725910|FG000|COMPLETED|Overall Study||32
3007824|NCT00995709|3725911|FG001|COMPLETED|Overall Study|patient in the 300 mg monthly group was randomized,was not eligible,never received study medication|31
3007825|NCT00995709|3725912|FG002|COMPLETED|Overall Study||34
3007826|NCT00995709|3725910|FG000|NOT COMPLETED|Overall Study||7
3007827|NCT00995709|3725911|FG001|NOT COMPLETED|Overall Study||9
3007828|NCT00995709|3725912|FG002|NOT COMPLETED|Overall Study||5
3007829|NCT00995722|3725922|FG000|STARTED|Double Blinded: 16 Weeks||6
3007830|NCT00995722|3725923|FG001|STARTED|Double Blinded: 16 Weeks||5
3007831|NCT00995722|3725922|FG000|COMPLETED|Double Blinded: 16 Weeks||5
3007832|NCT00995722|3725923|FG001|COMPLETED|Double Blinded: 16 Weeks||4
3007833|NCT00995722|3725922|FG000|NOT COMPLETED|Double Blinded: 16 Weeks||1
3007834|NCT00995722|3725923|FG001|NOT COMPLETED|Double Blinded: 16 Weeks||1
3007835|NCT00995722|3725922|FG000|STARTED|Overall Study: 36 Weeks||5
3007836|NCT00995722|3725923|FG001|STARTED|Overall Study: 36 Weeks||4
3007837|NCT00995722|3725922|FG000|COMPLETED|Overall Study: 36 Weeks||3
3007838|NCT00995722|3725923|FG001|COMPLETED|Overall Study: 36 Weeks||2
3007839|NCT00995722|3725922|FG000|NOT COMPLETED|Overall Study: 36 Weeks||2
3007840|NCT00995722|3725923|FG001|NOT COMPLETED|Overall Study: 36 Weeks||2
3007841|NCT00995761|3725929|FG000|STARTED|Overall Study||48
3007842|NCT00995761|3725929|FG000|COMPLETED|Overall Study||48
3007843|NCT00995761|3725929|FG000|NOT COMPLETED|Overall Study||0
3007844|NCT00995774|3725935|FG000|STARTED|Training Period 1||7
3007845|NCT00995774|3725936|FG001|STARTED|Training Period 1||5
3007846|NCT00995774|3725935|FG000|COMPLETED|Training Period 1||7
3007847|NCT00995774|3725936|FG001|COMPLETED|Training Period 1||5
3007848|NCT00995774|3725935|FG000|NOT COMPLETED|Training Period 1||0
3007849|NCT00995774|3725936|FG001|NOT COMPLETED|Training Period 1||0
3007850|NCT00995774|3725935|FG000|STARTED|Washout Period||7
3007851|NCT00995774|3725936|FG001|STARTED|Washout Period||5
3007852|NCT00995774|3725935|FG000|COMPLETED|Washout Period||7
3007853|NCT00995774|3725936|FG001|COMPLETED|Washout Period||5
3007854|NCT00995774|3725935|FG000|NOT COMPLETED|Washout Period||0
3007855|NCT00995774|3725936|FG001|NOT COMPLETED|Washout Period||0
3007856|NCT00995774|3725935|FG000|STARTED|Training Period 2||7
3007857|NCT00995774|3725936|FG001|STARTED|Training Period 2||5
3007858|NCT00995774|3725935|FG000|COMPLETED|Training Period 2||5
3007859|NCT00995774|3725936|FG001|COMPLETED|Training Period 2||5
3007860|NCT00995774|3725935|FG000|NOT COMPLETED|Training Period 2||2
3007861|NCT00995774|3725936|FG001|NOT COMPLETED|Training Period 2||0
3007862|NCT00995865|3725945|FG000|STARTED|Overall Study||24
3007863|NCT00995865|3725946|FG001|STARTED|Overall Study||24
3007864|NCT00995865|3725947|FG002|STARTED|Overall Study||12
3007865|NCT00995865|3725945|FG000|COMPLETED|Overall Study||22
3007866|NCT00995865|3725946|FG001|COMPLETED|Overall Study||24
3007867|NCT00995865|3725947|FG002|COMPLETED|Overall Study||11
3007868|NCT00995865|3725945|FG000|NOT COMPLETED|Overall Study||2
3007869|NCT00995865|3725946|FG001|NOT COMPLETED|Overall Study||0
3007870|NCT00995865|3725947|FG002|NOT COMPLETED|Overall Study||1
3007871|NCT00995904|3725960|FG000|STARTED|Visit 2 (Randomization)||4
3007872|NCT00995904|3725961|FG001|STARTED|Visit 2 (Randomization)||3
3007873|NCT00995904|3725962|FG002|STARTED|Visit 2 (Randomization)||4
3007874|NCT00995904|3725963|FG003|STARTED|Visit 2 (Randomization)||5
3007875|NCT00995904|3725964|FG004|STARTED|Visit 2 (Randomization)||5
3007876|NCT00995904|3725965|FG005|STARTED|Visit 2 (Randomization)||4
3007877|NCT00995904|3725960|FG000|COMPLETED|Visit 2 (Randomization)||4
3007878|NCT00995904|3725961|FG001|COMPLETED|Visit 2 (Randomization)||3
3007879|NCT00995904|3725962|FG002|COMPLETED|Visit 2 (Randomization)||4
3007880|NCT00995904|3725963|FG003|COMPLETED|Visit 2 (Randomization)||5
3007881|NCT00995904|3725964|FG004|COMPLETED|Visit 2 (Randomization)||5
3007882|NCT00995904|3725965|FG005|COMPLETED|Visit 2 (Randomization)||4
3007883|NCT00995904|3725960|FG000|NOT COMPLETED|Visit 2 (Randomization)||0
3007884|NCT00995904|3725961|FG001|NOT COMPLETED|Visit 2 (Randomization)||0
3007885|NCT00995904|3725962|FG002|NOT COMPLETED|Visit 2 (Randomization)||0
3007886|NCT00995904|3725963|FG003|NOT COMPLETED|Visit 2 (Randomization)||0
3007887|NCT00995904|3725964|FG004|NOT COMPLETED|Visit 2 (Randomization)||0
3007888|NCT00995904|3725965|FG005|NOT COMPLETED|Visit 2 (Randomization)||0
3007889|NCT00995904|3725960|FG000|STARTED|Visit 3||4
3007890|NCT00995904|3725961|FG001|STARTED|Visit 3||3
3007891|NCT00995904|3725962|FG002|STARTED|Visit 3||4
3007892|NCT00995904|3725963|FG003|STARTED|Visit 3||5
3007893|NCT00995904|3725964|FG004|STARTED|Visit 3||5
3007894|NCT00995904|3725965|FG005|STARTED|Visit 3|One subject was withdrawn from the study after completion of Visit 2 but prior to Visit 3.|3
3007895|NCT00995904|3725960|FG000|COMPLETED|Visit 3||4
3007896|NCT00995904|3725961|FG001|COMPLETED|Visit 3||3
3007897|NCT00995904|3725962|FG002|COMPLETED|Visit 3||4
3007898|NCT00995904|3725963|FG003|COMPLETED|Visit 3||5
3007899|NCT00995904|3725964|FG004|COMPLETED|Visit 3||5
3007900|NCT00995904|3725965|FG005|COMPLETED|Visit 3||3
3007901|NCT00995904|3725960|FG000|NOT COMPLETED|Visit 3||0
3007902|NCT00995904|3725961|FG001|NOT COMPLETED|Visit 3||0
3007903|NCT00995904|3725962|FG002|NOT COMPLETED|Visit 3||0
3007904|NCT00995904|3725963|FG003|NOT COMPLETED|Visit 3||0
3007905|NCT00995904|3725964|FG004|NOT COMPLETED|Visit 3||0
3007906|NCT00995904|3725965|FG005|NOT COMPLETED|Visit 3||0
3007907|NCT00995904|3725960|FG000|STARTED|Visit 4||4
3007908|NCT00995904|3725961|FG001|STARTED|Visit 4||3
3007909|NCT00995904|3725962|FG002|STARTED|Visit 4||4
3007910|NCT00995904|3725963|FG003|STARTED|Visit 4||5
3007911|NCT00995904|3725964|FG004|STARTED|Visit 4||5
3007912|NCT00995904|3725965|FG005|STARTED|Visit 4||3
3007913|NCT00995904|3725960|FG000|COMPLETED|Visit 4||4
3007914|NCT00995904|3725961|FG001|COMPLETED|Visit 4||3
3007915|NCT00995904|3725962|FG002|COMPLETED|Visit 4||4
3007916|NCT00995904|3725963|FG003|COMPLETED|Visit 4||5
3007917|NCT00995904|3725964|FG004|COMPLETED|Visit 4||5
3007918|NCT00995904|3725965|FG005|COMPLETED|Visit 4||3
3007919|NCT00995904|3725960|FG000|NOT COMPLETED|Visit 4||0
3007920|NCT00995904|3725961|FG001|NOT COMPLETED|Visit 4||0
3007921|NCT00995904|3725962|FG002|NOT COMPLETED|Visit 4||0
3007922|NCT00995904|3725963|FG003|NOT COMPLETED|Visit 4||0
3007923|NCT00995904|3725964|FG004|NOT COMPLETED|Visit 4||0
3007924|NCT00995904|3725965|FG005|NOT COMPLETED|Visit 4||0
3007925|NCT00995904|3725960|FG000|STARTED|Follow-up Visit (Final Visit)||4
3007926|NCT00995904|3725961|FG001|STARTED|Follow-up Visit (Final Visit)||3
3007927|NCT00995904|3725962|FG002|STARTED|Follow-up Visit (Final Visit)||4
3007928|NCT00995904|3725963|FG003|STARTED|Follow-up Visit (Final Visit)||5
3007929|NCT00995904|3725964|FG004|STARTED|Follow-up Visit (Final Visit)||5
3007930|NCT00995904|3725965|FG005|STARTED|Follow-up Visit (Final Visit)||3
3007931|NCT00995904|3725960|FG000|COMPLETED|Follow-up Visit (Final Visit)||4
3007932|NCT00995904|3725961|FG001|COMPLETED|Follow-up Visit (Final Visit)||3
3007933|NCT00995904|3725962|FG002|COMPLETED|Follow-up Visit (Final Visit)||4
3007934|NCT00995904|3725963|FG003|COMPLETED|Follow-up Visit (Final Visit)||5
3007935|NCT00995904|3725964|FG004|COMPLETED|Follow-up Visit (Final Visit)||5
3007936|NCT00995904|3725965|FG005|COMPLETED|Follow-up Visit (Final Visit)||3
3007937|NCT00995904|3725960|FG000|NOT COMPLETED|Follow-up Visit (Final Visit)||0
3007938|NCT00995904|3725961|FG001|NOT COMPLETED|Follow-up Visit (Final Visit)||0
3007939|NCT00995904|3725962|FG002|NOT COMPLETED|Follow-up Visit (Final Visit)||0
3007940|NCT00995904|3725963|FG003|NOT COMPLETED|Follow-up Visit (Final Visit)||0
3007941|NCT00995904|3725964|FG004|NOT COMPLETED|Follow-up Visit (Final Visit)||0
3007942|NCT00995904|3725965|FG005|NOT COMPLETED|Follow-up Visit (Final Visit)||0
3007943|NCT00995930|3725978|FG000|STARTED|Overall Study||94
3007944|NCT00995930|3725979|FG001|STARTED|Overall Study||95
3007945|NCT00995930|3725978|FG000|Safety Analysis Set|Overall Study||94
3007946|NCT00995930|3725979|FG001|Safety Analysis Set|Overall Study||95
3007947|NCT00995930|3725978|FG000|Pharmacokinetic (PK) Analysis Set|Overall Study||0
3007948|NCT00995930|3725979|FG001|Pharmacokinetic (PK) Analysis Set|Overall Study||95
3007949|NCT00995930|3725978|FG000|Pharmacodynamic (PD) Analysis Set|Overall Study||92
3007950|NCT00995930|3725979|FG001|Pharmacodynamic (PD) Analysis Set|Overall Study||92
3007951|NCT00995930|3725978|FG000|Imaging Analysis Set|Overall Study||92
3007952|NCT00995930|3725979|FG001|Imaging Analysis Set|Overall Study||92
3007953|NCT00995930|3725978|FG000|COMPLETED|Overall Study||73
3007954|NCT00995930|3725979|FG001|COMPLETED|Overall Study||67
3007955|NCT00995930|3725978|FG000|NOT COMPLETED|Overall Study||21
3007956|NCT00995930|3725979|FG001|NOT COMPLETED|Overall Study||28
3007957|NCT00996034|3725986|FG000|STARTED|Overall Study||14
3007958|NCT00996034|3725986|FG000|COMPLETED|Overall Study||11
3007959|NCT00996034|3725986|FG000|NOT COMPLETED|Overall Study||3
3007960|NCT00996125|3725992|FG000|STARTED|Overall Study||374
3007961|NCT00996125|3725993|FG001|STARTED|Overall Study||376
3007962|NCT00996125|3725992|FG000|COMPLETED|Overall Study||369
3007963|NCT00996125|3725993|FG001|COMPLETED|Overall Study||365
3007964|NCT00996125|3725992|FG000|NOT COMPLETED|Overall Study||5
3007965|NCT00996125|3725993|FG001|NOT COMPLETED|Overall Study||11
3007966|NCT00996164|3726001|FG000|STARTED|Overall Study||543
3007967|NCT00996164|3726002|FG001|STARTED|Overall Study||547
3007968|NCT00996164|3726001|FG000|COMPLETED|Overall Study||408
3007969|NCT00996164|3726002|FG001|COMPLETED|Overall Study||446
3007970|NCT00996164|3726001|FG000|NOT COMPLETED|Overall Study||135
3007971|NCT00996164|3726002|FG001|NOT COMPLETED|Overall Study||101
3007972|NCT00996203|3726008|FG000|STARTED|Overall Study||201
3007973|NCT00996203|3726008|FG000|COMPLETED|Overall Study||194
3007974|NCT00996203|3726008|FG000|NOT COMPLETED|Overall Study||7
3007975|NCT00996216|3726013|FG000|STARTED|Part 1 (Pre-Antiviral Treatment Phase)||27
3007976|NCT00996216|3726013|FG000|COMPLETED|Part 1 (Pre-Antiviral Treatment Phase)||26
3007977|NCT00996216|3726013|FG000|NOT COMPLETED|Part 1 (Pre-Antiviral Treatment Phase)||1
3007978|NCT00996216|3726013|FG000|STARTED|Part 2 (Antiviral Treatment Phase)|One participant who completed Part 1 didn't qualify to begin antiviral treatment in Part 2.|25
3007979|NCT00996216|3726013|FG000|COMPLETED|Part 2 (Antiviral Treatment Phase)||21
3007980|NCT00996216|3726013|FG000|NOT COMPLETED|Part 2 (Antiviral Treatment Phase)||4
3007981|NCT00996281|3726020|FG000|STARTED|Overall Study||418
3007982|NCT00996281|3726021|FG001|STARTED|Overall Study||419
3007983|NCT00996281|3726020|FG000|COMPLETED|Overall Study||287
3007984|NCT00996281|3726021|FG001|COMPLETED|Overall Study||330
3007985|NCT00996281|3726020|FG000|NOT COMPLETED|Overall Study||131
3007986|NCT00996281|3726021|FG001|NOT COMPLETED|Overall Study||89
3007987|NCT00996307|3726031|FG000|STARTED|Overall Study||164
3007988|NCT00996307|3726032|FG001|STARTED|Overall Study||165
3007989|NCT00996307|3726033|FG002|STARTED|Overall Study||160
3007990|NCT00996307|3726034|FG003|STARTED|Overall Study||165
3007991|NCT00996307|3726031|FG000|COMPLETED|Overall Study||144
3007992|NCT00996307|3726032|FG001|COMPLETED|Overall Study||148
3007993|NCT00996307|3726033|FG002|COMPLETED|Overall Study||146
3007994|NCT00996307|3726034|FG003|COMPLETED|Overall Study||144
3007995|NCT00996307|3726031|FG000|NOT COMPLETED|Overall Study||20
3007996|NCT00996307|3726032|FG001|NOT COMPLETED|Overall Study||17
3007997|NCT00996307|3726033|FG002|NOT COMPLETED|Overall Study||14
3007998|NCT00996307|3726034|FG003|NOT COMPLETED|Overall Study||21
3007999|NCT00996346|3726065|FG000|STARTED|Overall Study||6
3008000|NCT00996346|3726066|FG001|STARTED|Overall Study||8
3008001|NCT00996346|3726067|FG002|STARTED|Overall Study||3
3008002|NCT00996346|3726065|FG000|COMPLETED|Overall Study||6
3008003|NCT00996346|3726066|FG001|COMPLETED|Overall Study||8
3008004|NCT00996346|3726067|FG002|COMPLETED|Overall Study||3
3008005|NCT00996346|3726065|FG000|NOT COMPLETED|Overall Study||0
3008006|NCT00996346|3726066|FG001|NOT COMPLETED|Overall Study||0
3008007|NCT00996346|3726067|FG002|NOT COMPLETED|Overall Study||0
3008008|NCT00996372|3726075|FG000|STARTED|Overall Study||468
3008009|NCT00996372|3726076|FG001|STARTED|Overall Study||481
3008010|NCT00996372|3726075|FG000|COMPLETED|Overall Study||365
3008011|NCT00996372|3726076|FG001|COMPLETED|Overall Study||397
3008012|NCT00996372|3726075|FG000|NOT COMPLETED|Overall Study||103
3008013|NCT00996372|3726076|FG001|NOT COMPLETED|Overall Study||84
3008014|NCT00996437|3726086|FG000|STARTED|Overall Study||125
3008015|NCT00996437|3726087|FG001|STARTED|Overall Study||136
3306592|NCT02999178|4039941|FG000|COMPLETED|Overall Study|On treatment at analysis cut-off date, 12-August-2019|218
3306593|NCT02999178|4039942|FG001|COMPLETED|Overall Study|On treatment at analysis cut-off date, 12-August-2019|231
3306594|NCT02999178|4039941|FG000|NOT COMPLETED|Overall Study||114
3306595|NCT02999178|4039942|FG001|NOT COMPLETED|Overall Study||100
3306596|NCT02999191|4039951|FG000|STARTED|Treatment Period 1 [1 Day]||6
3306597|NCT02999191|4039952|FG001|STARTED|Treatment Period 1 [1 Day]||6
3306598|NCT02999191|4039953|FG002|STARTED|Treatment Period 1 [1 Day]||6
3306599|NCT02999191|4039951|FG000|COMPLETED|Treatment Period 1 [1 Day]||6
3306600|NCT02999191|4039952|FG001|COMPLETED|Treatment Period 1 [1 Day]||6
3008016|NCT00996437|3726086|FG000|COMPLETED|Overall Study||120
3008017|NCT00996437|3726087|FG001|COMPLETED|Overall Study||129
3008018|NCT00996437|3726086|FG000|NOT COMPLETED|Overall Study||5
3008019|NCT00996437|3726087|FG001|NOT COMPLETED|Overall Study||7
3008020|NCT00996476|3726098|FG000|STARTED|Overall Study||27
3008021|NCT00996476|3726099|FG001|STARTED|Overall Study||26
3008022|NCT00996476|3726100|FG002|STARTED|Overall Study||13
3008023|NCT00996476|3726101|FG003|STARTED|Overall Study||13
3008024|NCT00996476|3726102|FG004|STARTED|Overall Study||13
3008025|NCT00996476|3726098|FG000|COMPLETED|Overall Study||26
3008026|NCT00996476|3726099|FG001|COMPLETED|Overall Study||23
3008027|NCT00996476|3726100|FG002|COMPLETED|Overall Study||12
3008028|NCT00996476|3726101|FG003|COMPLETED|Overall Study||13
3008029|NCT00996476|3726102|FG004|COMPLETED|Overall Study||11
3008030|NCT00996476|3726098|FG000|NOT COMPLETED|Overall Study||1
3008031|NCT00996476|3726099|FG001|NOT COMPLETED|Overall Study||3
3008032|NCT00996476|3726100|FG002|NOT COMPLETED|Overall Study||1
3008033|NCT00996476|3726101|FG003|NOT COMPLETED|Overall Study||0
3008034|NCT00996476|3726102|FG004|NOT COMPLETED|Overall Study||2
3008035|NCT00996489|3726119|FG000|STARTED|Overall Study||459
3008036|NCT00996489|3726119|FG000|COMPLETED|Overall Study||298
3008037|NCT00996489|3726119|FG000|NOT COMPLETED|Overall Study||161
3008038|NCT00996580|3726123|FG000|STARTED|Overall Study||3597
3008039|NCT00996580|3726123|FG000|Pregnancy Intent-to-Treat Population|Overall Study||3019
3008040|NCT00996580|3726123|FG000|COMPLETED|Overall Study||2144
3008041|NCT00996580|3726123|FG000|NOT COMPLETED|Overall Study||1453
3008042|NCT00996593|3726130|FG000|STARTED|Dosimetric and Therapeutic Treatment||43
3008043|NCT00996593|3726130|FG000|COMPLETED|Dosimetric and Therapeutic Treatment||0
3008044|NCT00996593|3726130|FG000|NOT COMPLETED|Dosimetric and Therapeutic Treatment||43
3008045|NCT00996593|3726130|FG000|STARTED|Long-Term Follow-Up|9 of the 40 participants withdrawing from Study BEX104507 enrolled in long-term follow-up study.|9
3008046|NCT00996593|3726130|FG000|COMPLETED|Long-Term Follow-Up||6
3008047|NCT00996593|3726130|FG000|NOT COMPLETED|Long-Term Follow-Up||3
3008048|NCT00996606|3726134|FG000|STARTED|Overall Study||58
3008049|NCT00996606|3726134|FG000|COMPLETED|Overall Study||50
3008050|NCT00996606|3726134|FG000|NOT COMPLETED|Overall Study||8
3008051|NCT00996632|3726140|FG000|STARTED|Overall Study||38
3008052|NCT00996632|3726141|FG001|STARTED|Overall Study||56
3008053|NCT00996632|3726140|FG000|COMPLETED|Overall Study||38
3008054|NCT00996632|3726141|FG001|COMPLETED|Overall Study||56
3008055|NCT00996632|3726140|FG000|NOT COMPLETED|Overall Study||0
3008056|NCT00996632|3726141|FG001|NOT COMPLETED|Overall Study||0
3008057|NCT00996658|3726149|FG000|STARTED|Overall Study||92
3008058|NCT00996658|3726150|FG001|STARTED|Overall Study||186
3008059|NCT00996658|3726149|FG000|COMPLETED|Overall Study||76
3008060|NCT00996658|3726150|FG001|COMPLETED|Overall Study||165
3008061|NCT00996658|3726149|FG000|NOT COMPLETED|Overall Study||16
3008062|NCT00996658|3726150|FG001|NOT COMPLETED|Overall Study||21
3008063|NCT00996736|3726158|FG000|STARTED|Overall Study||162
3008064|NCT00996736|3726159|FG001|STARTED|Overall Study||161
3008065|NCT00996736|3726158|FG000|3-week Visit|Overall Study|149 visited within pre-specified 3-week window (2.5-5 weeks); 6 had a second visit not within window|155
3008066|NCT00996736|3726159|FG001|3-week Visit|Overall Study|144 visited within pre-specified 3-week window (2.5-5 weeks); 7 had a second visit not within window|151
3008067|NCT00996736|3726158|FG000|3-month Visit|Overall Study||146
3008068|NCT00996736|3726159|FG001|3-month Visit|Overall Study||146
3008069|NCT00996736|3726158|FG000|COMPLETED|Overall Study||141
3008070|NCT00996736|3726159|FG001|COMPLETED|Overall Study||143
3008071|NCT00996736|3726158|FG000|NOT COMPLETED|Overall Study||21
3008072|NCT00996736|3726159|FG001|NOT COMPLETED|Overall Study||18
3008073|NCT00996775|3726167|FG000|STARTED|Overall Study||78
3008074|NCT00996775|3726168|FG001|STARTED|Overall Study||89
3008075|NCT00996775|3726167|FG000|COMPLETED|Overall Study||67
3008076|NCT00996775|3726168|FG001|COMPLETED|Overall Study||75
3008077|NCT00996775|3726167|FG000|NOT COMPLETED|Overall Study||11
3008078|NCT00996775|3726168|FG001|NOT COMPLETED|Overall Study||14
3008079|NCT00996801|3726180|FG000|STARTED|Overall Study||88
3008080|NCT00996801|3726181|FG001|STARTED|Overall Study||88
3008081|NCT00996801|3726182|FG002|STARTED|Overall Study||88
3008082|NCT00996801|3726183|FG003|STARTED|Overall Study||87
3008083|NCT00996801|3726184|FG004|STARTED|Overall Study|15-mg arm was discontinued as a result of Protocol Amendment 1.|88
3008084|NCT00996801|3726185|FG005|STARTED|Overall Study||87
3008085|NCT00996801|3726180|FG000|COMPLETED|Overall Study||68
3008086|NCT00996801|3726181|FG001|COMPLETED|Overall Study||72
3008087|NCT00996801|3726182|FG002|COMPLETED|Overall Study||65
3008088|NCT00996801|3726183|FG003|COMPLETED|Overall Study||56
3008089|NCT00996801|3726184|FG004|COMPLETED|Overall Study||0
3008090|NCT00996801|3726185|FG005|COMPLETED|Overall Study||68
3008091|NCT00996801|3726180|FG000|NOT COMPLETED|Overall Study||20
3008092|NCT00996801|3726181|FG001|NOT COMPLETED|Overall Study||16
3008093|NCT00996801|3726182|FG002|NOT COMPLETED|Overall Study||23
3008094|NCT00996801|3726183|FG003|NOT COMPLETED|Overall Study||31
3008095|NCT00996801|3726184|FG004|NOT COMPLETED|Overall Study||88
3008096|NCT00996801|3726185|FG005|NOT COMPLETED|Overall Study||19
3008097|NCT00996840|3726206|FG000|STARTED|Overall Study||20
3008098|NCT00996840|3726207|FG001|STARTED|Overall Study||9
3008099|NCT00996840|3726208|FG002|STARTED|Overall Study||12
3008100|NCT00996840|3726209|FG003|STARTED|Overall Study||18
3008101|NCT00996840|3726210|FG004|STARTED|Overall Study||18
3008102|NCT00996840|3726206|FG000|COMPLETED|Overall Study||19
3008103|NCT00996840|3726207|FG001|COMPLETED|Overall Study||7
3008104|NCT00996840|3726208|FG002|COMPLETED|Overall Study||11
3008105|NCT00996840|3726209|FG003|COMPLETED|Overall Study||17
3008106|NCT00996840|3726210|FG004|COMPLETED|Overall Study||16
3008107|NCT00996840|3726206|FG000|NOT COMPLETED|Overall Study||1
3008108|NCT00996840|3726207|FG001|NOT COMPLETED|Overall Study||2
3008109|NCT00996840|3726208|FG002|NOT COMPLETED|Overall Study||1
3008110|NCT00996840|3726209|FG003|NOT COMPLETED|Overall Study||1
3008111|NCT00996840|3726210|FG004|NOT COMPLETED|Overall Study||2
3008112|NCT00996892|3726226|FG000|STARTED|Dose-Escalation Stage 1||4
3008113|NCT00996892|3726227|FG001|STARTED|Dose-Escalation Stage 1||3
3008114|NCT00996892|3726228|FG002|STARTED|Dose-Escalation Stage 1||3
3008115|NCT00996892|3726229|FG003|STARTED|Dose-Escalation Stage 1||9
3008116|NCT00996892|3726230|FG004|STARTED|Dose-Escalation Stage 1||11
3008117|NCT00996892|3726231|FG005|STARTED|Dose-Escalation Stage 1||10
3008118|NCT00996892|3726232|FG006|STARTED|Dose-Escalation Stage 1||4
3008119|NCT00996892|3726233|FG007|STARTED|Dose-Escalation Stage 1||0
3008120|NCT00996892|3726234|FG008|STARTED|Dose-Escalation Stage 1||0
3008121|NCT00996892|3726235|FG009|STARTED|Dose-Escalation Stage 1||0
3008122|NCT00996892|3726236|FG010|STARTED|Dose-Escalation Stage 1||0
3008123|NCT00996892|3726237|FG011|STARTED|Dose-Escalation Stage 1||0
3008124|NCT00996892|3726238|FG012|STARTED|Dose-Escalation Stage 1||0
3008125|NCT00996892|3726239|FG013|STARTED|Dose-Escalation Stage 1||0
3008126|NCT00996892|3726240|FG014|STARTED|Dose-Escalation Stage 1||0
3008127|NCT00996892|3726241|FG015|STARTED|Dose-Escalation Stage 1||0
3008128|NCT00996892|3726242|FG016|STARTED|Dose-Escalation Stage 1||0
3008129|NCT00996892|3726243|FG017|STARTED|Dose-Escalation Stage 1||0
3008130|NCT00996892|3726244|FG018|STARTED|Dose-Escalation Stage 1||0
3008131|NCT00996892|3726245|FG019|STARTED|Dose-Escalation Stage 1||0
3008132|NCT00996892|3726226|FG000|COMPLETED|Dose-Escalation Stage 1||0
3008133|NCT00996892|3726227|FG001|COMPLETED|Dose-Escalation Stage 1||0
3008134|NCT00996892|3726228|FG002|COMPLETED|Dose-Escalation Stage 1||0
3008135|NCT00996892|3726229|FG003|COMPLETED|Dose-Escalation Stage 1||0
3008136|NCT00996892|3726230|FG004|COMPLETED|Dose-Escalation Stage 1||0
3008137|NCT00996892|3726231|FG005|COMPLETED|Dose-Escalation Stage 1||0
3008138|NCT00996892|3726232|FG006|COMPLETED|Dose-Escalation Stage 1||0
3008139|NCT00996892|3726233|FG007|COMPLETED|Dose-Escalation Stage 1||0
3008140|NCT00996892|3726234|FG008|COMPLETED|Dose-Escalation Stage 1||0
3008141|NCT00996892|3726235|FG009|COMPLETED|Dose-Escalation Stage 1||0
3008142|NCT00996892|3726236|FG010|COMPLETED|Dose-Escalation Stage 1||0
3008143|NCT00996892|3726237|FG011|COMPLETED|Dose-Escalation Stage 1||0
3008144|NCT00996892|3726238|FG012|COMPLETED|Dose-Escalation Stage 1||0
3008145|NCT00996892|3726239|FG013|COMPLETED|Dose-Escalation Stage 1||0
3008146|NCT00996892|3726240|FG014|COMPLETED|Dose-Escalation Stage 1||0
3008147|NCT00996892|3726241|FG015|COMPLETED|Dose-Escalation Stage 1||0
3008148|NCT00996892|3726242|FG016|COMPLETED|Dose-Escalation Stage 1||0
3008149|NCT00996892|3726243|FG017|COMPLETED|Dose-Escalation Stage 1||0
3008150|NCT00996892|3726244|FG018|COMPLETED|Dose-Escalation Stage 1||0
3008151|NCT00996892|3726245|FG019|COMPLETED|Dose-Escalation Stage 1||0
3008152|NCT00996892|3726226|FG000|NOT COMPLETED|Dose-Escalation Stage 1||4
3008153|NCT00996892|3726227|FG001|NOT COMPLETED|Dose-Escalation Stage 1||3
3008154|NCT00996892|3726228|FG002|NOT COMPLETED|Dose-Escalation Stage 1||3
3008155|NCT00996892|3726229|FG003|NOT COMPLETED|Dose-Escalation Stage 1||9
3008156|NCT00996892|3726230|FG004|NOT COMPLETED|Dose-Escalation Stage 1||11
3008157|NCT00996892|3726231|FG005|NOT COMPLETED|Dose-Escalation Stage 1||10
3008158|NCT00996892|3726232|FG006|NOT COMPLETED|Dose-Escalation Stage 1||4
3008159|NCT00996892|3726233|FG007|NOT COMPLETED|Dose-Escalation Stage 1||0
3008160|NCT00996892|3726234|FG008|NOT COMPLETED|Dose-Escalation Stage 1||0
3008161|NCT00996892|3726235|FG009|NOT COMPLETED|Dose-Escalation Stage 1||0
3008162|NCT00996892|3726236|FG010|NOT COMPLETED|Dose-Escalation Stage 1||0
3008163|NCT00996892|3726237|FG011|NOT COMPLETED|Dose-Escalation Stage 1||0
3008164|NCT00996892|3726238|FG012|NOT COMPLETED|Dose-Escalation Stage 1||0
3008165|NCT00996892|3726239|FG013|NOT COMPLETED|Dose-Escalation Stage 1||0
3008166|NCT00996892|3726240|FG014|NOT COMPLETED|Dose-Escalation Stage 1||0
3008167|NCT00996892|3726241|FG015|NOT COMPLETED|Dose-Escalation Stage 1||0
3306601|NCT02999191|4039953|FG002|COMPLETED|Treatment Period 1 [1 Day]||6
3306602|NCT02999191|4039951|FG000|NOT COMPLETED|Treatment Period 1 [1 Day]||0
3306603|NCT02999191|4039952|FG001|NOT COMPLETED|Treatment Period 1 [1 Day]||0
3306604|NCT02999191|4039953|FG002|NOT COMPLETED|Treatment Period 1 [1 Day]||0
3306605|NCT02999191|4039951|FG000|STARTED|Wash-out Period 1 [21 Days]||6
3306606|NCT02999191|4039952|FG001|STARTED|Wash-out Period 1 [21 Days]||6
3306607|NCT02999191|4039953|FG002|STARTED|Wash-out Period 1 [21 Days]||6
3306608|NCT02999191|4039951|FG000|COMPLETED|Wash-out Period 1 [21 Days]||6
3008168|NCT00996892|3726242|FG016|NOT COMPLETED|Dose-Escalation Stage 1||0
3008169|NCT00996892|3726243|FG017|NOT COMPLETED|Dose-Escalation Stage 1||0
3008170|NCT00996892|3726244|FG018|NOT COMPLETED|Dose-Escalation Stage 1||0
3008171|NCT00996892|3726245|FG019|NOT COMPLETED|Dose-Escalation Stage 1||0
3008172|NCT00996892|3726226|FG000|STARTED|Dose-Escalation Stage 1A||0
3008173|NCT00996892|3726227|FG001|STARTED|Dose-Escalation Stage 1A||0
3008174|NCT00996892|3726228|FG002|STARTED|Dose-Escalation Stage 1A||0
3008175|NCT00996892|3726229|FG003|STARTED|Dose-Escalation Stage 1A||0
3008176|NCT00996892|3726230|FG004|STARTED|Dose-Escalation Stage 1A||0
3008177|NCT00996892|3726231|FG005|STARTED|Dose-Escalation Stage 1A||0
3008178|NCT00996892|3726232|FG006|STARTED|Dose-Escalation Stage 1A||0
3008179|NCT00996892|3726233|FG007|STARTED|Dose-Escalation Stage 1A||3
3008180|NCT00996892|3726234|FG008|STARTED|Dose-Escalation Stage 1A||3
3008181|NCT00996892|3726235|FG009|STARTED|Dose-Escalation Stage 1A||4
3008182|NCT00996892|3726236|FG010|STARTED|Dose-Escalation Stage 1A||7
3008183|NCT00996892|3726237|FG011|STARTED|Dose-Escalation Stage 1A||9
3008184|NCT00996892|3726238|FG012|STARTED|Dose-Escalation Stage 1A||8
3008185|NCT00996892|3726239|FG013|STARTED|Dose-Escalation Stage 1A||5
3008186|NCT00996892|3726240|FG014|STARTED|Dose-Escalation Stage 1A||0
3008187|NCT00996892|3726241|FG015|STARTED|Dose-Escalation Stage 1A||0
3008188|NCT00996892|3726242|FG016|STARTED|Dose-Escalation Stage 1A||0
3008189|NCT00996892|3726243|FG017|STARTED|Dose-Escalation Stage 1A||0
3008190|NCT00996892|3726244|FG018|STARTED|Dose-Escalation Stage 1A||0
3008191|NCT00996892|3726245|FG019|STARTED|Dose-Escalation Stage 1A||0
3008192|NCT00996892|3726226|FG000|COMPLETED|Dose-Escalation Stage 1A||0
3008193|NCT00996892|3726227|FG001|COMPLETED|Dose-Escalation Stage 1A||0
3008194|NCT00996892|3726228|FG002|COMPLETED|Dose-Escalation Stage 1A||0
3008195|NCT00996892|3726229|FG003|COMPLETED|Dose-Escalation Stage 1A||0
3008196|NCT00996892|3726230|FG004|COMPLETED|Dose-Escalation Stage 1A||0
3008197|NCT00996892|3726231|FG005|COMPLETED|Dose-Escalation Stage 1A||0
3008198|NCT00996892|3726232|FG006|COMPLETED|Dose-Escalation Stage 1A||0
3008199|NCT00996892|3726233|FG007|COMPLETED|Dose-Escalation Stage 1A||0
3008200|NCT00996892|3726234|FG008|COMPLETED|Dose-Escalation Stage 1A||0
3008201|NCT00996892|3726235|FG009|COMPLETED|Dose-Escalation Stage 1A||0
3008202|NCT00996892|3726236|FG010|COMPLETED|Dose-Escalation Stage 1A||0
3008203|NCT00996892|3726237|FG011|COMPLETED|Dose-Escalation Stage 1A||0
3306609|NCT02999191|4039952|FG001|COMPLETED|Wash-out Period 1 [21 Days]||5
3306610|NCT02999191|4039953|FG002|COMPLETED|Wash-out Period 1 [21 Days]||6
3008204|NCT00996892|3726238|FG012|COMPLETED|Dose-Escalation Stage 1A||0
3008205|NCT00996892|3726239|FG013|COMPLETED|Dose-Escalation Stage 1A||0
3008206|NCT00996892|3726240|FG014|COMPLETED|Dose-Escalation Stage 1A||0
3008207|NCT00996892|3726241|FG015|COMPLETED|Dose-Escalation Stage 1A||0
3008208|NCT00996892|3726242|FG016|COMPLETED|Dose-Escalation Stage 1A||0
3008209|NCT00996892|3726243|FG017|COMPLETED|Dose-Escalation Stage 1A||0
3008210|NCT00996892|3726244|FG018|COMPLETED|Dose-Escalation Stage 1A||0
3008211|NCT00996892|3726245|FG019|COMPLETED|Dose-Escalation Stage 1A||0
3008212|NCT00996892|3726226|FG000|NOT COMPLETED|Dose-Escalation Stage 1A||0
3008213|NCT00996892|3726227|FG001|NOT COMPLETED|Dose-Escalation Stage 1A||0
3008214|NCT00996892|3726228|FG002|NOT COMPLETED|Dose-Escalation Stage 1A||0
3008215|NCT00996892|3726229|FG003|NOT COMPLETED|Dose-Escalation Stage 1A||0
3008216|NCT00996892|3726230|FG004|NOT COMPLETED|Dose-Escalation Stage 1A||0
3008217|NCT00996892|3726231|FG005|NOT COMPLETED|Dose-Escalation Stage 1A||0
3008218|NCT00996892|3726232|FG006|NOT COMPLETED|Dose-Escalation Stage 1A||0
3008219|NCT00996892|3726233|FG007|NOT COMPLETED|Dose-Escalation Stage 1A||3
3008220|NCT00996892|3726234|FG008|NOT COMPLETED|Dose-Escalation Stage 1A||3
3008221|NCT00996892|3726235|FG009|NOT COMPLETED|Dose-Escalation Stage 1A||4
3008222|NCT00996892|3726236|FG010|NOT COMPLETED|Dose-Escalation Stage 1A||7
3008223|NCT00996892|3726237|FG011|NOT COMPLETED|Dose-Escalation Stage 1A||9
3306611|NCT02999191|4039951|FG000|NOT COMPLETED|Wash-out Period 1 [21 Days]||0
3008224|NCT00996892|3726238|FG012|NOT COMPLETED|Dose-Escalation Stage 1A||8
3008225|NCT00996892|3726239|FG013|NOT COMPLETED|Dose-Escalation Stage 1A||5
3008226|NCT00996892|3726240|FG014|NOT COMPLETED|Dose-Escalation Stage 1A||0
3008227|NCT00996892|3726241|FG015|NOT COMPLETED|Dose-Escalation Stage 1A||0
3008228|NCT00996892|3726242|FG016|NOT COMPLETED|Dose-Escalation Stage 1A||0
3008229|NCT00996892|3726243|FG017|NOT COMPLETED|Dose-Escalation Stage 1A||0
3008230|NCT00996892|3726244|FG018|NOT COMPLETED|Dose-Escalation Stage 1A||0
3008231|NCT00996892|3726245|FG019|NOT COMPLETED|Dose-Escalation Stage 1A||0
3008232|NCT00996892|3726226|FG000|STARTED|Dose-Escalation Stage 1B||0
3008233|NCT00996892|3726227|FG001|STARTED|Dose-Escalation Stage 1B||0
3008234|NCT00996892|3726228|FG002|STARTED|Dose-Escalation Stage 1B||0
3008235|NCT00996892|3726229|FG003|STARTED|Dose-Escalation Stage 1B||0
3008236|NCT00996892|3726230|FG004|STARTED|Dose-Escalation Stage 1B||0
3008237|NCT00996892|3726231|FG005|STARTED|Dose-Escalation Stage 1B||0
3008238|NCT00996892|3726232|FG006|STARTED|Dose-Escalation Stage 1B||0
3008239|NCT00996892|3726233|FG007|STARTED|Dose-Escalation Stage 1B||0
3008240|NCT00996892|3726234|FG008|STARTED|Dose-Escalation Stage 1B||0
3008241|NCT00996892|3726235|FG009|STARTED|Dose-Escalation Stage 1B||0
3008242|NCT00996892|3726236|FG010|STARTED|Dose-Escalation Stage 1B||0
3008243|NCT00996892|3726237|FG011|STARTED|Dose-Escalation Stage 1B||0
3008244|NCT00996892|3726238|FG012|STARTED|Dose-Escalation Stage 1B||0
3008245|NCT00996892|3726239|FG013|STARTED|Dose-Escalation Stage 1B||0
3008246|NCT00996892|3726240|FG014|STARTED|Dose-Escalation Stage 1B||4
3008247|NCT00996892|3726241|FG015|STARTED|Dose-Escalation Stage 1B||3
3008248|NCT00996892|3726242|FG016|STARTED|Dose-Escalation Stage 1B||3
3008249|NCT00996892|3726243|FG017|STARTED|Dose-Escalation Stage 1B||5
3008250|NCT00996892|3726244|FG018|STARTED|Dose-Escalation Stage 1B||0
3008251|NCT00996892|3726245|FG019|STARTED|Dose-Escalation Stage 1B||0
3008252|NCT00996892|3726226|FG000|COMPLETED|Dose-Escalation Stage 1B||0
3008253|NCT00996892|3726227|FG001|COMPLETED|Dose-Escalation Stage 1B||0
3008254|NCT00996892|3726228|FG002|COMPLETED|Dose-Escalation Stage 1B||0
3008255|NCT00996892|3726229|FG003|COMPLETED|Dose-Escalation Stage 1B||0
3008256|NCT00996892|3726230|FG004|COMPLETED|Dose-Escalation Stage 1B||0
3008257|NCT00996892|3726231|FG005|COMPLETED|Dose-Escalation Stage 1B||0
3008258|NCT00996892|3726232|FG006|COMPLETED|Dose-Escalation Stage 1B||0
3008259|NCT00996892|3726233|FG007|COMPLETED|Dose-Escalation Stage 1B||0
3008260|NCT00996892|3726234|FG008|COMPLETED|Dose-Escalation Stage 1B||0
3008261|NCT00996892|3726235|FG009|COMPLETED|Dose-Escalation Stage 1B||0
3008262|NCT00996892|3726236|FG010|COMPLETED|Dose-Escalation Stage 1B||0
3008263|NCT00996892|3726237|FG011|COMPLETED|Dose-Escalation Stage 1B||0
3008264|NCT00996892|3726238|FG012|COMPLETED|Dose-Escalation Stage 1B||0
3008265|NCT00996892|3726239|FG013|COMPLETED|Dose-Escalation Stage 1B||0
3008266|NCT00996892|3726240|FG014|COMPLETED|Dose-Escalation Stage 1B||0
3008267|NCT00996892|3726241|FG015|COMPLETED|Dose-Escalation Stage 1B||0
3008268|NCT00996892|3726242|FG016|COMPLETED|Dose-Escalation Stage 1B||0
3008269|NCT00996892|3726243|FG017|COMPLETED|Dose-Escalation Stage 1B||0
3165131|NCT01897532|3892691|FG000|NOT COMPLETED|Discontinuation From Treatment||962
3165132|NCT01897532|3892692|FG001|NOT COMPLETED|Discontinuation From Treatment||839
3008270|NCT00996892|3726244|FG018|COMPLETED|Dose-Escalation Stage 1B||0
3008271|NCT00996892|3726245|FG019|COMPLETED|Dose-Escalation Stage 1B||0
3008272|NCT00996892|3726226|FG000|NOT COMPLETED|Dose-Escalation Stage 1B||0
3008273|NCT00996892|3726227|FG001|NOT COMPLETED|Dose-Escalation Stage 1B||0
3008274|NCT00996892|3726228|FG002|NOT COMPLETED|Dose-Escalation Stage 1B||0
3008275|NCT00996892|3726229|FG003|NOT COMPLETED|Dose-Escalation Stage 1B||0
3008276|NCT00996892|3726230|FG004|NOT COMPLETED|Dose-Escalation Stage 1B||0
3008277|NCT00996892|3726231|FG005|NOT COMPLETED|Dose-Escalation Stage 1B||0
3008278|NCT00996892|3726232|FG006|NOT COMPLETED|Dose-Escalation Stage 1B||0
3008279|NCT00996892|3726233|FG007|NOT COMPLETED|Dose-Escalation Stage 1B||0
3008280|NCT00996892|3726234|FG008|NOT COMPLETED|Dose-Escalation Stage 1B||0
3008281|NCT00996892|3726235|FG009|NOT COMPLETED|Dose-Escalation Stage 1B||0
3008282|NCT00996892|3726236|FG010|NOT COMPLETED|Dose-Escalation Stage 1B||0
3008283|NCT00996892|3726237|FG011|NOT COMPLETED|Dose-Escalation Stage 1B||0
3008284|NCT00996892|3726238|FG012|NOT COMPLETED|Dose-Escalation Stage 1B||0
3008285|NCT00996892|3726239|FG013|NOT COMPLETED|Dose-Escalation Stage 1B||0
3008286|NCT00996892|3726240|FG014|NOT COMPLETED|Dose-Escalation Stage 1B||4
3008287|NCT00996892|3726241|FG015|NOT COMPLETED|Dose-Escalation Stage 1B||3
3008288|NCT00996892|3726242|FG016|NOT COMPLETED|Dose-Escalation Stage 1B||3
3008289|NCT00996892|3726243|FG017|NOT COMPLETED|Dose-Escalation Stage 1B||5
3008290|NCT00996892|3726244|FG018|NOT COMPLETED|Dose-Escalation Stage 1B||0
3008291|NCT00996892|3726245|FG019|NOT COMPLETED|Dose-Escalation Stage 1B||0
3008292|NCT00996892|3726226|FG000|STARTED|Expansion Stage 2||0
3008293|NCT00996892|3726227|FG001|STARTED|Expansion Stage 2||0
3008294|NCT00996892|3726228|FG002|STARTED|Expansion Stage 2||0
3008295|NCT00996892|3726229|FG003|STARTED|Expansion Stage 2||0
3008296|NCT00996892|3726230|FG004|STARTED|Expansion Stage 2||0
3008297|NCT00996892|3726231|FG005|STARTED|Expansion Stage 2||0
3008298|NCT00996892|3726232|FG006|STARTED|Expansion Stage 2||0
3008299|NCT00996892|3726233|FG007|STARTED|Expansion Stage 2||0
3008300|NCT00996892|3726234|FG008|STARTED|Expansion Stage 2||0
3008301|NCT00996892|3726235|FG009|STARTED|Expansion Stage 2||0
3008302|NCT00996892|3726236|FG010|STARTED|Expansion Stage 2||0
3008303|NCT00996892|3726237|FG011|STARTED|Expansion Stage 2||0
3008304|NCT00996892|3726238|FG012|STARTED|Expansion Stage 2||0
3008305|NCT00996892|3726239|FG013|STARTED|Expansion Stage 2||0
3008306|NCT00996892|3726240|FG014|STARTED|Expansion Stage 2||0
3008307|NCT00996892|3726241|FG015|STARTED|Expansion Stage 2||0
3008308|NCT00996892|3726242|FG016|STARTED|Expansion Stage 2||0
3008309|NCT00996892|3726243|FG017|STARTED|Expansion Stage 2||0
3008310|NCT00996892|3726244|FG018|STARTED|Expansion Stage 2||35
3008311|NCT00996892|3726245|FG019|STARTED|Expansion Stage 2||0
3008312|NCT00996892|3726226|FG000|COMPLETED|Expansion Stage 2||0
3008313|NCT00996892|3726227|FG001|COMPLETED|Expansion Stage 2||0
3008314|NCT00996892|3726228|FG002|COMPLETED|Expansion Stage 2||0
3008315|NCT00996892|3726229|FG003|COMPLETED|Expansion Stage 2||0
3008316|NCT00996892|3726230|FG004|COMPLETED|Expansion Stage 2||0
3008317|NCT00996892|3726231|FG005|COMPLETED|Expansion Stage 2||0
3008318|NCT00996892|3726232|FG006|COMPLETED|Expansion Stage 2||0
3008319|NCT00996892|3726233|FG007|COMPLETED|Expansion Stage 2||0
3008320|NCT00996892|3726234|FG008|COMPLETED|Expansion Stage 2||0
3008321|NCT00996892|3726235|FG009|COMPLETED|Expansion Stage 2||0
3008322|NCT00996892|3726236|FG010|COMPLETED|Expansion Stage 2||0
3008323|NCT00996892|3726237|FG011|COMPLETED|Expansion Stage 2||0
3008324|NCT00996892|3726238|FG012|COMPLETED|Expansion Stage 2||0
3008325|NCT00996892|3726239|FG013|COMPLETED|Expansion Stage 2||0
3008326|NCT00996892|3726240|FG014|COMPLETED|Expansion Stage 2||0
3008327|NCT00996892|3726241|FG015|COMPLETED|Expansion Stage 2||0
3008328|NCT00996892|3726242|FG016|COMPLETED|Expansion Stage 2||0
3008329|NCT00996892|3726243|FG017|COMPLETED|Expansion Stage 2||0
3008330|NCT00996892|3726244|FG018|COMPLETED|Expansion Stage 2||0
3008331|NCT00996892|3726245|FG019|COMPLETED|Expansion Stage 2||0
3008332|NCT00996892|3726226|FG000|NOT COMPLETED|Expansion Stage 2||0
3008333|NCT00996892|3726227|FG001|NOT COMPLETED|Expansion Stage 2||0
3008334|NCT00996892|3726228|FG002|NOT COMPLETED|Expansion Stage 2||0
3008335|NCT00996892|3726229|FG003|NOT COMPLETED|Expansion Stage 2||0
3008336|NCT00996892|3726230|FG004|NOT COMPLETED|Expansion Stage 2||0
3008337|NCT00996892|3726231|FG005|NOT COMPLETED|Expansion Stage 2||0
3008338|NCT00996892|3726232|FG006|NOT COMPLETED|Expansion Stage 2||0
3008339|NCT00996892|3726233|FG007|NOT COMPLETED|Expansion Stage 2||0
3008340|NCT00996892|3726234|FG008|NOT COMPLETED|Expansion Stage 2||0
3008341|NCT00996892|3726235|FG009|NOT COMPLETED|Expansion Stage 2||0
3008342|NCT00996892|3726236|FG010|NOT COMPLETED|Expansion Stage 2||0
3008343|NCT00996892|3726237|FG011|NOT COMPLETED|Expansion Stage 2||0
3008344|NCT00996892|3726238|FG012|NOT COMPLETED|Expansion Stage 2||0
3008345|NCT00996892|3726239|FG013|NOT COMPLETED|Expansion Stage 2||0
3008346|NCT00996892|3726240|FG014|NOT COMPLETED|Expansion Stage 2||0
3008347|NCT00996892|3726241|FG015|NOT COMPLETED|Expansion Stage 2||0
3008348|NCT00996892|3726242|FG016|NOT COMPLETED|Expansion Stage 2||0
3008349|NCT00996892|3726243|FG017|NOT COMPLETED|Expansion Stage 2||0
3008350|NCT00996892|3726244|FG018|NOT COMPLETED|Expansion Stage 2||35
3008351|NCT00996892|3726245|FG019|NOT COMPLETED|Expansion Stage 2||0
3008352|NCT00996892|3726226|FG000|STARTED|Expansion Stage 2A||0
3008353|NCT00996892|3726227|FG001|STARTED|Expansion Stage 2A||0
3008354|NCT00996892|3726228|FG002|STARTED|Expansion Stage 2A||0
3008355|NCT00996892|3726229|FG003|STARTED|Expansion Stage 2A||0
3008356|NCT00996892|3726230|FG004|STARTED|Expansion Stage 2A||0
3008357|NCT00996892|3726231|FG005|STARTED|Expansion Stage 2A||0
3008358|NCT00996892|3726232|FG006|STARTED|Expansion Stage 2A||0
3008359|NCT00996892|3726233|FG007|STARTED|Expansion Stage 2A||0
3008360|NCT00996892|3726234|FG008|STARTED|Expansion Stage 2A||0
3008361|NCT00996892|3726235|FG009|STARTED|Expansion Stage 2A||0
3008362|NCT00996892|3726236|FG010|STARTED|Expansion Stage 2A||0
3008363|NCT00996892|3726237|FG011|STARTED|Expansion Stage 2A||0
3008364|NCT00996892|3726238|FG012|STARTED|Expansion Stage 2A||0
3008365|NCT00996892|3726239|FG013|STARTED|Expansion Stage 2A||0
3008366|NCT00996892|3726240|FG014|STARTED|Expansion Stage 2A||0
3008367|NCT00996892|3726241|FG015|STARTED|Expansion Stage 2A||0
3008368|NCT00996892|3726242|FG016|STARTED|Expansion Stage 2A||0
3008369|NCT00996892|3726243|FG017|STARTED|Expansion Stage 2A||0
3008370|NCT00996892|3726244|FG018|STARTED|Expansion Stage 2A||0
3008371|NCT00996892|3726245|FG019|STARTED|Expansion Stage 2A||45
3008372|NCT00996892|3726226|FG000|COMPLETED|Expansion Stage 2A||0
3008373|NCT00996892|3726227|FG001|COMPLETED|Expansion Stage 2A||0
3008374|NCT00996892|3726228|FG002|COMPLETED|Expansion Stage 2A||0
3008375|NCT00996892|3726229|FG003|COMPLETED|Expansion Stage 2A||0
3008376|NCT00996892|3726230|FG004|COMPLETED|Expansion Stage 2A||0
3008377|NCT00996892|3726231|FG005|COMPLETED|Expansion Stage 2A||0
3008378|NCT00996892|3726232|FG006|COMPLETED|Expansion Stage 2A||0
3008379|NCT00996892|3726233|FG007|COMPLETED|Expansion Stage 2A||0
3008380|NCT00996892|3726234|FG008|COMPLETED|Expansion Stage 2A||0
3008381|NCT00996892|3726235|FG009|COMPLETED|Expansion Stage 2A||0
3008382|NCT00996892|3726236|FG010|COMPLETED|Expansion Stage 2A||0
3008383|NCT00996892|3726237|FG011|COMPLETED|Expansion Stage 2A||0
3008384|NCT00996892|3726238|FG012|COMPLETED|Expansion Stage 2A||0
3008385|NCT00996892|3726239|FG013|COMPLETED|Expansion Stage 2A||0
3008386|NCT00996892|3726240|FG014|COMPLETED|Expansion Stage 2A||0
3008387|NCT00996892|3726241|FG015|COMPLETED|Expansion Stage 2A||0
3008388|NCT00996892|3726242|FG016|COMPLETED|Expansion Stage 2A||0
3008389|NCT00996892|3726243|FG017|COMPLETED|Expansion Stage 2A||0
3008390|NCT00996892|3726244|FG018|COMPLETED|Expansion Stage 2A||0
3008391|NCT00996892|3726245|FG019|COMPLETED|Expansion Stage 2A||0
3008392|NCT00996892|3726226|FG000|NOT COMPLETED|Expansion Stage 2A||0
3008393|NCT00996892|3726227|FG001|NOT COMPLETED|Expansion Stage 2A||0
3008394|NCT00996892|3726228|FG002|NOT COMPLETED|Expansion Stage 2A||0
3008395|NCT00996892|3726229|FG003|NOT COMPLETED|Expansion Stage 2A||0
3008396|NCT00996892|3726230|FG004|NOT COMPLETED|Expansion Stage 2A||0
3165133|NCT01897532|3892691|FG000|STARTED|Discontinuation From Trial||3492
3165134|NCT01897532|3892692|FG001|STARTED|Discontinuation From Trial||3499
3165135|NCT01897532|3892691|FG000|Treated|Discontinuation From Trial||3485
3008397|NCT00996892|3726231|FG005|NOT COMPLETED|Expansion Stage 2A||0
3008398|NCT00996892|3726232|FG006|NOT COMPLETED|Expansion Stage 2A||0
3008399|NCT00996892|3726233|FG007|NOT COMPLETED|Expansion Stage 2A||0
3008400|NCT00996892|3726234|FG008|NOT COMPLETED|Expansion Stage 2A||0
3008401|NCT00996892|3726235|FG009|NOT COMPLETED|Expansion Stage 2A||0
3008402|NCT00996892|3726236|FG010|NOT COMPLETED|Expansion Stage 2A||0
3306612|NCT02999191|4039952|FG001|NOT COMPLETED|Wash-out Period 1 [21 Days]||1
3306613|NCT02999191|4039953|FG002|NOT COMPLETED|Wash-out Period 1 [21 Days]||0
3306614|NCT02999191|4039951|FG000|STARTED|Treatment Period 2 [1 Day]||6
3306615|NCT02999191|4039952|FG001|STARTED|Treatment Period 2 [1 Day]||5
3306616|NCT02999191|4039953|FG002|STARTED|Treatment Period 2 [1 Day]||6
3306617|NCT02999191|4039951|FG000|COMPLETED|Treatment Period 2 [1 Day]||6
3306618|NCT02999191|4039952|FG001|COMPLETED|Treatment Period 2 [1 Day]||5
3306619|NCT02999191|4039953|FG002|COMPLETED|Treatment Period 2 [1 Day]||6
3306620|NCT02999191|4039951|FG000|NOT COMPLETED|Treatment Period 2 [1 Day]||0
3306621|NCT02999191|4039952|FG001|NOT COMPLETED|Treatment Period 2 [1 Day]||0
3306622|NCT02999191|4039953|FG002|NOT COMPLETED|Treatment Period 2 [1 Day]||0
3306623|NCT02999191|4039951|FG000|STARTED|Wash-out Period 2 [21 Days]||6
3008403|NCT00996892|3726237|FG011|NOT COMPLETED|Expansion Stage 2A||0
3008404|NCT00996892|3726238|FG012|NOT COMPLETED|Expansion Stage 2A||0
3008405|NCT00996892|3726239|FG013|NOT COMPLETED|Expansion Stage 2A||0
3008406|NCT00996892|3726240|FG014|NOT COMPLETED|Expansion Stage 2A||0
3008407|NCT00996892|3726241|FG015|NOT COMPLETED|Expansion Stage 2A||0
3008408|NCT00996892|3726242|FG016|NOT COMPLETED|Expansion Stage 2A||0
3008409|NCT00996892|3726243|FG017|NOT COMPLETED|Expansion Stage 2A||0
3008410|NCT00996892|3726244|FG018|NOT COMPLETED|Expansion Stage 2A||0
3008411|NCT00996892|3726245|FG019|NOT COMPLETED|Expansion Stage 2A||45
3165136|NCT01897532|3892692|FG001|Treated|Discontinuation From Trial||3494
3165137|NCT01897532|3892691|FG000|COMPLETED|Discontinuation From Trial||3430
3165138|NCT01897532|3892692|FG001|COMPLETED|Discontinuation From Trial||3458
3165139|NCT01897532|3892691|FG000|NOT COMPLETED|Discontinuation From Trial||62
3165140|NCT01897532|3892692|FG001|NOT COMPLETED|Discontinuation From Trial||41
3165141|NCT01897714|3892704|FG000|STARTED|Phase I (Dose Escalation)||4
3165142|NCT01897714|3892705|FG001|STARTED|Phase I (Dose Escalation)||7
3165143|NCT01897714|3892706|FG002|STARTED|Phase I (Dose Escalation)||6
3165144|NCT01897714|3892707|FG003|STARTED|Phase I (Dose Escalation)||6
3165145|NCT01897714|3892708|FG004|STARTED|Phase I (Dose Escalation)||0
3165146|NCT01897714|3892709|FG005|STARTED|Phase I (Dose Escalation)||0
3165147|NCT01897714|3892704|FG000|COMPLETED|Phase I (Dose Escalation)||1
3165148|NCT01897714|3892705|FG001|COMPLETED|Phase I (Dose Escalation)||0
3165149|NCT01897714|3892706|FG002|COMPLETED|Phase I (Dose Escalation)||1
3165150|NCT01897714|3892707|FG003|COMPLETED|Phase I (Dose Escalation)||0
3165151|NCT01897714|3892708|FG004|COMPLETED|Phase I (Dose Escalation)||0
3165152|NCT01897714|3892709|FG005|COMPLETED|Phase I (Dose Escalation)||0
3165153|NCT01897714|3892704|FG000|NOT COMPLETED|Phase I (Dose Escalation)||3
3165154|NCT01897714|3892705|FG001|NOT COMPLETED|Phase I (Dose Escalation)||7
3165155|NCT01897714|3892706|FG002|NOT COMPLETED|Phase I (Dose Escalation)||5
3165156|NCT01897714|3892707|FG003|NOT COMPLETED|Phase I (Dose Escalation)||6
3165157|NCT01897714|3892708|FG004|NOT COMPLETED|Phase I (Dose Escalation)||0
3165158|NCT01897714|3892709|FG005|NOT COMPLETED|Phase I (Dose Escalation)||0
3165159|NCT01897714|3892704|FG000|STARTED|Phase II (MTD)||0
3165160|NCT01897714|3892705|FG001|STARTED|Phase II (MTD)||0
3165161|NCT01897714|3892706|FG002|STARTED|Phase II (MTD)||0
3165162|NCT01897714|3892707|FG003|STARTED|Phase II (MTD)||0
3165163|NCT01897714|3892708|FG004|STARTED|Phase II (MTD)|6 patients were entered from the Phase I: Melflufen 40 mg + Dexamethasone arm.|45
3165164|NCT01897714|3892709|FG005|STARTED|Phase II (MTD)||13
3165165|NCT01897714|3892704|FG000|COMPLETED|Phase II (MTD)||0
3165166|NCT01897714|3892705|FG001|COMPLETED|Phase II (MTD)||0
3165167|NCT01897714|3892706|FG002|COMPLETED|Phase II (MTD)||0
3165168|NCT01897714|3892707|FG003|COMPLETED|Phase II (MTD)||0
3165169|NCT01897714|3892708|FG004|COMPLETED|Phase II (MTD)||15
3165170|NCT01897714|3892709|FG005|COMPLETED|Phase II (MTD)||2
3165171|NCT01897714|3892704|FG000|NOT COMPLETED|Phase II (MTD)||0
3165172|NCT01897714|3892705|FG001|NOT COMPLETED|Phase II (MTD)||0
3165173|NCT01897714|3892706|FG002|NOT COMPLETED|Phase II (MTD)||0
3165174|NCT01897714|3892707|FG003|NOT COMPLETED|Phase II (MTD)||0
3165175|NCT01897714|3892708|FG004|NOT COMPLETED|Phase II (MTD)||30
3165176|NCT01897714|3892709|FG005|NOT COMPLETED|Phase II (MTD)||11
3165177|NCT01897727|3892727|FG000|STARTED|Overall Study||8
3165178|NCT01897727|3892728|FG001|STARTED|Overall Study||9
3165179|NCT01897727|3892727|FG000|COMPLETED|Overall Study||8
3165180|NCT01897727|3892728|FG001|COMPLETED|Overall Study||8
3165181|NCT01897727|3892727|FG000|NOT COMPLETED|Overall Study||0
3008412|NCT00996918|3726311|FG000|STARTED|Overall Study||39
3008413|NCT00996918|3726312|FG001|STARTED|Overall Study||66
3008414|NCT00996918|3726313|FG002|STARTED|Overall Study||37
3008415|NCT00996918|3726314|FG003|STARTED|Overall Study||56
3008416|NCT00996918|3726315|FG004|STARTED|Overall Study||4
3165182|NCT01897727|3892728|FG001|NOT COMPLETED|Overall Study||1
3165183|NCT01897766|3892734|FG000|STARTED|Overall Study||482
3165184|NCT01897766|3892734|FG000|COMPLETED|Overall Study||482
3165185|NCT01897766|3892734|FG000|NOT COMPLETED|Overall Study||0
3008417|NCT00996918|3726311|FG000|Treated|Overall Study||39
3008418|NCT00996918|3726312|FG001|Treated|Overall Study||66
3008419|NCT00996918|3726313|FG002|Treated|Overall Study||37
3008420|NCT00996918|3726314|FG003|Treated|Overall Study||56
3008421|NCT00996918|3726315|FG004|Treated|Overall Study||4
3008422|NCT00996918|3726311|FG000|COMPLETED|Overall Study||0
3008423|NCT00996918|3726312|FG001|COMPLETED|Overall Study||0
3008424|NCT00996918|3726313|FG002|COMPLETED|Overall Study||0
3008425|NCT00996918|3726314|FG003|COMPLETED|Overall Study||0
3008426|NCT00996918|3726315|FG004|COMPLETED|Overall Study||0
3008427|NCT00996918|3726311|FG000|NOT COMPLETED|Overall Study||39
3008428|NCT00996918|3726312|FG001|NOT COMPLETED|Overall Study||66
3008429|NCT00996918|3726313|FG002|NOT COMPLETED|Overall Study||37
3008430|NCT00996918|3726314|FG003|NOT COMPLETED|Overall Study||56
3008431|NCT00996918|3726315|FG004|NOT COMPLETED|Overall Study||4
3008432|NCT00996931|3726327|FG000|STARTED|Overall Study||6
3008433|NCT00996931|3726327|FG000|COMPLETED|Overall Study||6
3008434|NCT00996931|3726327|FG000|NOT COMPLETED|Overall Study||0
3008435|NCT00996944|3726334|FG000|STARTED|Double-blind Treatment Period||22
3008436|NCT00996944|3726335|FG001|STARTED|Double-blind Treatment Period||12
3008437|NCT00996944|3726334|FG000|COMPLETED|Double-blind Treatment Period||12
3008438|NCT00996944|3726335|FG001|COMPLETED|Double-blind Treatment Period||5
3008439|NCT00996944|3726334|FG000|NOT COMPLETED|Double-blind Treatment Period||10
3008440|NCT00996944|3726335|FG001|NOT COMPLETED|Double-blind Treatment Period||7
3306624|NCT02999191|4039952|FG001|STARTED|Wash-out Period 2 [21 Days]||5
3306625|NCT02999191|4039953|FG002|STARTED|Wash-out Period 2 [21 Days]||6
3306626|NCT02999191|4039951|FG000|COMPLETED|Wash-out Period 2 [21 Days]||6
3306627|NCT02999191|4039952|FG001|COMPLETED|Wash-out Period 2 [21 Days]||5
3306628|NCT02999191|4039953|FG002|COMPLETED|Wash-out Period 2 [21 Days]||6
3306629|NCT02999191|4039951|FG000|NOT COMPLETED|Wash-out Period 2 [21 Days]||0
3008441|NCT00996944|3726334|FG000|STARTED|Long-term Treatment Period||12
3008442|NCT00996944|3726335|FG001|STARTED|Long-term Treatment Period||5
3008443|NCT00996944|3726334|FG000|COMPLETED|Long-term Treatment Period||0
3008444|NCT00996944|3726335|FG001|COMPLETED|Long-term Treatment Period||0
3008445|NCT00996944|3726334|FG000|NOT COMPLETED|Long-term Treatment Period||12
3008446|NCT00996944|3726335|FG001|NOT COMPLETED|Long-term Treatment Period||5
3008447|NCT00996996|3726343|FG000|STARTED|Overall Study||77
3008448|NCT00996996|3726343|FG000|COMPLETED|Overall Study|These participants completed 12 years of follow-up.|44
3008449|NCT00996996|3726343|FG000|NOT COMPLETED|Overall Study||33
3008450|NCT00997035|3726349|FG000|STARTED|3-week Followup Visit||121
3008451|NCT00997035|3726350|FG001|STARTED|3-week Followup Visit||119
3008452|NCT00997035|3726349|FG000|COMPLETED|3-week Followup Visit||112
3008453|NCT00997035|3726350|FG001|COMPLETED|3-week Followup Visit||113
3008454|NCT00997035|3726349|FG000|NOT COMPLETED|3-week Followup Visit||9
3008455|NCT00997035|3726350|FG001|NOT COMPLETED|3-week Followup Visit||6
3008456|NCT00997035|3726349|FG000|STARTED|3-month Follow-up Visit||112
3008457|NCT00997035|3726350|FG001|STARTED|3-month Follow-up Visit||113
3008458|NCT00997035|3726349|FG000|COMPLETED|3-month Follow-up Visit||100
3008459|NCT00997035|3726350|FG001|COMPLETED|3-month Follow-up Visit||107
3008460|NCT00997035|3726349|FG000|NOT COMPLETED|3-month Follow-up Visit||12
3008461|NCT00997035|3726350|FG001|NOT COMPLETED|3-month Follow-up Visit||6
3008462|NCT00997113|3726368|FG000|STARTED|Overall Study||10
3008463|NCT00997113|3726369|FG001|STARTED|Overall Study||10
3008464|NCT00997113|3726368|FG000|COMPLETED|Overall Study||10
3008465|NCT00997113|3726369|FG001|COMPLETED|Overall Study||10
3008466|NCT00997113|3726368|FG000|NOT COMPLETED|Overall Study||0
3008467|NCT00997113|3726369|FG001|NOT COMPLETED|Overall Study||0
3008468|NCT00997126|3726377|FG000|STARTED|Overall Study||63
3008469|NCT00997126|3726378|FG001|STARTED|Overall Study||63
3008470|NCT00997126|3726377|FG000|COMPLETED|Overall Study||56
3008471|NCT00997126|3726378|FG001|COMPLETED|Overall Study||52
3008472|NCT00997126|3726377|FG000|NOT COMPLETED|Overall Study||7
3008473|NCT00997126|3726378|FG001|NOT COMPLETED|Overall Study||11
3008474|NCT00997139|3726384|FG000|STARTED|Overall Study||216
3008475|NCT00997139|3726384|FG000|Treated for Positive Baseline Culture|Overall Study||30
3008476|NCT00997139|3726384|FG000|COMPLETED|Overall Study||30
3008477|NCT00997139|3726384|FG000|NOT COMPLETED|Overall Study||186
3008478|NCT00997204|3726392|FG000|STARTED|Naive Treatment Phase||25
3008479|NCT00997204|3726393|FG001|STARTED|Naive Treatment Phase|Non-naive patients participated in the study but they were not treated in the naive treatment phase|79
3008480|NCT00997204|3726392|FG000|COMPLETED|Naive Treatment Phase||19
3008481|NCT00997204|3726393|FG001|COMPLETED|Naive Treatment Phase||0
3008482|NCT00997204|3726392|FG000|NOT COMPLETED|Naive Treatment Phase||6
3008483|NCT00997204|3726393|FG001|NOT COMPLETED|Naive Treatment Phase||79
3008484|NCT00997204|3726392|FG000|STARTED|Self-administration Phase||19
3008485|NCT00997204|3726393|FG001|STARTED|Self-administration Phase|1 subject did not self-administered icatibant but had a HCP to perform. the data were not included.|78
3008486|NCT00997204|3726392|FG000|COMPLETED|Self-administration Phase||19
3008487|NCT00997204|3726393|FG001|COMPLETED|Self-administration Phase||77
3008488|NCT00997204|3726392|FG000|NOT COMPLETED|Self-administration Phase||0
3008489|NCT00997204|3726393|FG001|NOT COMPLETED|Self-administration Phase||1
3306630|NCT02999191|4039952|FG001|NOT COMPLETED|Wash-out Period 2 [21 Days]||0
3008490|NCT00997243|3726403|FG000|STARTED|Overall Study||7
3008491|NCT00997243|3726403|FG000|COMPLETED|Overall Study||0
3008492|NCT00997243|3726403|FG000|NOT COMPLETED|Overall Study||7
3008493|NCT00997321|3726409|FG000|STARTED|Overall Study||50
3008494|NCT00997321|3726410|FG001|STARTED|Overall Study||50
3008495|NCT00997321|3726409|FG000|COMPLETED|Overall Study||50
3008496|NCT00997321|3726410|FG001|COMPLETED|Overall Study||47
3008497|NCT00997321|3726409|FG000|NOT COMPLETED|Overall Study||0
3008498|NCT00997321|3726410|FG001|NOT COMPLETED|Overall Study||3
3008499|NCT00997334|3726422|FG000|STARTED|Overall Study||60
3008500|NCT00997334|3726422|FG000|Eligible for Repeat Biopsy|Overall Study|Patients who experience disease progression on treatment were eligible for repeat biopsy|44
3008501|NCT00997334|3726422|FG000|Evaluable|Overall Study|Patients with tissue available for re-biopsy at time of progression|35
3008502|NCT00997334|3726422|FG000|COMPLETED|Overall Study||35
3008503|NCT00997334|3726422|FG000|NOT COMPLETED|Overall Study||25
3008504|NCT00997373|3726428|FG000|STARTED|Overall Study||28
3008505|NCT00997373|3726429|FG001|STARTED|Overall Study||15
3008506|NCT00997373|3726428|FG000|Received Letrozole|Overall Study||23
3008507|NCT00997373|3726429|FG001|Received Letrozole|Overall Study||0
3008508|NCT00997373|3726428|FG000|Completed Hysterectomy|Overall Study||17
3008509|NCT00997373|3726429|FG001|Completed Hysterectomy|Overall Study||15
3008510|NCT00997373|3726428|FG000|COMPLETED|Overall Study||13
3008511|NCT00997373|3726429|FG001|COMPLETED|Overall Study||15
3008512|NCT00997373|3726428|FG000|NOT COMPLETED|Overall Study||15
3008513|NCT00997373|3726429|FG001|NOT COMPLETED|Overall Study||0
3008514|NCT00997425|3726435|FG000|STARTED|Overall Study||19
3008515|NCT00997425|3726435|FG000|COMPLETED|Overall Study||19
3008516|NCT00997425|3726435|FG000|NOT COMPLETED|Overall Study||0
3008517|NCT00997438|3726443|FG000|STARTED|Overall Study||21
3008518|NCT00997438|3726444|FG001|STARTED|Overall Study||24
3008519|NCT00997438|3726445|FG002|STARTED|Overall Study||24
3008520|NCT00997438|3726443|FG000|COMPLETED|Overall Study||16
3008521|NCT00997438|3726444|FG001|COMPLETED|Overall Study||21
3008522|NCT00997438|3726445|FG002|COMPLETED|Overall Study||20
3008523|NCT00997438|3726443|FG000|NOT COMPLETED|Overall Study||5
3008524|NCT00997438|3726444|FG001|NOT COMPLETED|Overall Study||3
3008525|NCT00997438|3726445|FG002|NOT COMPLETED|Overall Study||4
3008526|NCT00997503|3726454|FG000|STARTED|Overall Study||4199
3008527|NCT00997503|3726454|FG000|12 Months|Overall Study|4059 subjects evaluable at 12-months (cardiac death/MI within 365 days or completed follow-up)|4059
3008528|NCT00997503|3726454|FG000|COMPLETED|Overall Study||3926
3008529|NCT00997503|3726454|FG000|NOT COMPLETED|Overall Study||273
3008530|NCT00997516|3726463|FG000|STARTED|Short-term Follow-up (Post Operative)||37
3008531|NCT00997516|3726464|FG001|STARTED|Short-term Follow-up (Post Operative)||38
3008532|NCT00997516|3726463|FG000|COMPLETED|Short-term Follow-up (Post Operative)||37
3008533|NCT00997516|3726464|FG001|COMPLETED|Short-term Follow-up (Post Operative)||38
3008534|NCT00997516|3726463|FG000|NOT COMPLETED|Short-term Follow-up (Post Operative)||0
3008535|NCT00997516|3726464|FG001|NOT COMPLETED|Short-term Follow-up (Post Operative)||0
3008536|NCT00997516|3726463|FG000|STARTED|Long-term Follow-up (After 6 Months)||37
3008537|NCT00997516|3726464|FG001|STARTED|Long-term Follow-up (After 6 Months)||38
3008538|NCT00997516|3726463|FG000|COMPLETED|Long-term Follow-up (After 6 Months)||31
3008539|NCT00997516|3726464|FG001|COMPLETED|Long-term Follow-up (After 6 Months)||36
3008540|NCT00997516|3726463|FG000|NOT COMPLETED|Long-term Follow-up (After 6 Months)||6
3008541|NCT00997516|3726464|FG001|NOT COMPLETED|Long-term Follow-up (After 6 Months)||2
3008542|NCT00997555|3726472|FG000|STARTED|Overall Study||13
3008543|NCT00997555|3726473|FG001|STARTED|Overall Study||15
3008544|NCT00997555|3726472|FG000|COMPLETED|Overall Study||13
3008545|NCT00997555|3726473|FG001|COMPLETED|Overall Study||15
3008546|NCT00997555|3726472|FG000|NOT COMPLETED|Overall Study||0
3008547|NCT00997555|3726473|FG001|NOT COMPLETED|Overall Study||0
3008548|NCT00997594|3726481|FG000|STARTED|Overall Study||9
3008549|NCT00997594|3726482|FG001|STARTED|Overall Study||9
3008550|NCT00997594|3726481|FG000|Completion of Ablation Procedure|Overall Study||9
3008551|NCT00997594|3726482|FG001|Completion of Ablation Procedure|Overall Study||9
3008552|NCT00997594|3726481|FG000|COMPLETED|Overall Study||9
3008553|NCT00997594|3726482|FG001|COMPLETED|Overall Study||9
3008554|NCT00997594|3726481|FG000|NOT COMPLETED|Overall Study||0
3008555|NCT00997594|3726482|FG001|NOT COMPLETED|Overall Study||0
3008556|NCT00997620|3726490|FG000|STARTED|Overall Study||19
3008557|NCT00997620|3726491|FG001|STARTED|Overall Study||21
3008558|NCT00997620|3726490|FG000|COMPLETED|Overall Study||19
3008559|NCT00997620|3726491|FG001|COMPLETED|Overall Study||21
3008560|NCT00997620|3726490|FG000|NOT COMPLETED|Overall Study||0
3008561|NCT00997620|3726491|FG001|NOT COMPLETED|Overall Study||0
3008562|NCT00997672|3726502|FG000|STARTED|Overall Study||4
3008563|NCT00997672|3726503|FG001|STARTED|Overall Study||5
3008564|NCT00997672|3726502|FG000|COMPLETED|Overall Study||0
3008565|NCT00997672|3726503|FG001|COMPLETED|Overall Study||1
3008566|NCT00997672|3726502|FG000|NOT COMPLETED|Overall Study||4
3008567|NCT00997672|3726503|FG001|NOT COMPLETED|Overall Study||4
3008568|NCT00997893|3726512|FG000|STARTED|Overall Study||14
3008569|NCT00997893|3726513|FG001|STARTED|Overall Study||13
3008570|NCT00997893|3726514|FG002|STARTED|Overall Study||13
3008571|NCT00997893|3726512|FG000|COMPLETED|Overall Study||12
3008572|NCT00997893|3726513|FG001|COMPLETED|Overall Study||12
3008573|NCT00997893|3726514|FG002|COMPLETED|Overall Study||13
3008574|NCT00997893|3726512|FG000|NOT COMPLETED|Overall Study||2
3008575|NCT00997893|3726513|FG001|NOT COMPLETED|Overall Study||1
3008576|NCT00997893|3726514|FG002|NOT COMPLETED|Overall Study||0
3008577|NCT00997932|3726522|FG000|STARTED|Overall Study||29
3008578|NCT00997932|3726522|FG000|COMPLETED|Overall Study||27
3008579|NCT00997932|3726522|FG000|NOT COMPLETED|Overall Study||2
3008580|NCT00997984|3726530|FG000|STARTED|Overall Study||113
3008581|NCT00997984|3726531|FG001|STARTED|Overall Study||113
3008582|NCT00997984|3726532|FG002|STARTED|Overall Study||114
3008583|NCT00997984|3726530|FG000|COMPLETED|Overall Study||76
3008584|NCT00997984|3726531|FG001|COMPLETED|Overall Study||79
3008585|NCT00997984|3726532|FG002|COMPLETED|Overall Study||88
3008586|NCT00997984|3726530|FG000|NOT COMPLETED|Overall Study||37
3008587|NCT00997984|3726531|FG001|NOT COMPLETED|Overall Study||34
3008588|NCT00997984|3726532|FG002|NOT COMPLETED|Overall Study||26
3008589|NCT00998010|3726542|FG000|STARTED|Overall Study||24
3008590|NCT00998010|3726542|FG000|COMPLETED|Overall Study||24
3008591|NCT00998010|3726542|FG000|NOT COMPLETED|Overall Study||0
3008592|NCT00998023|3726548|FG000|STARTED|Overall Study||32
3008593|NCT00998023|3726549|FG001|STARTED|Overall Study||32
3008594|NCT00998023|3726548|FG000|COMPLETED|Overall Study||32
3008595|NCT00998023|3726549|FG001|COMPLETED|Overall Study||32
3008596|NCT00998023|3726548|FG000|NOT COMPLETED|Overall Study||0
3008597|NCT00998023|3726549|FG001|NOT COMPLETED|Overall Study||0
3008598|NCT00998049|3726555|FG000|STARTED|Overall Study||39
3008599|NCT00998049|3726555|FG000|COMPLETED|Overall Study||39
3008600|NCT00998049|3726555|FG000|NOT COMPLETED|Overall Study||0
3008601|NCT00998205|3726559|FG000|STARTED|Overall Study||16
3008602|NCT00998205|3726559|FG000|COMPLETED|Overall Study||16
3008603|NCT00998205|3726559|FG000|NOT COMPLETED|Overall Study||0
3008604|NCT00998296|3726575|FG000|STARTED|Overall Study||6
3008605|NCT00998296|3726576|FG001|STARTED|Overall Study||3
3008606|NCT00998296|3726577|FG002|STARTED|Overall Study||3
3008607|NCT00998296|3726578|FG003|STARTED|Overall Study||3
3008608|NCT00998296|3726579|FG004|STARTED|Overall Study||8
3008609|NCT00998296|3726580|FG005|STARTED|Overall Study||3
3008610|NCT00998296|3726581|FG006|STARTED|Overall Study||7
3008611|NCT00998296|3726582|FG007|STARTED|Overall Study||6
3008612|NCT00998296|3726583|FG008|STARTED|Overall Study||6
3008613|NCT00998296|3726584|FG009|STARTED|Overall Study||18
3008614|NCT00998296|3726585|FG010|STARTED|Overall Study||7
3008615|NCT00998296|3726575|FG000|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|6
3008616|NCT00998296|3726576|FG001|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|2
3008617|NCT00998296|3726577|FG002|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|3
3008618|NCT00998296|3726578|FG003|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|3
3008619|NCT00998296|3726579|FG004|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|6
3008620|NCT00998296|3726580|FG005|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|3
3008621|NCT00998296|3726581|FG006|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|6
3008622|NCT00998296|3726582|FG007|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|4
3008623|NCT00998296|3726583|FG008|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|4
3008624|NCT00998296|3726584|FG009|COMPLETED|Overall Study||0
3008625|NCT00998296|3726585|FG010|COMPLETED|Overall Study||0
3008626|NCT00998296|3726575|FG000|NOT COMPLETED|Overall Study||0
3008627|NCT00998296|3726576|FG001|NOT COMPLETED|Overall Study||1
3008628|NCT00998296|3726577|FG002|NOT COMPLETED|Overall Study||0
3008629|NCT00998296|3726578|FG003|NOT COMPLETED|Overall Study||0
3008630|NCT00998296|3726579|FG004|NOT COMPLETED|Overall Study||2
3008631|NCT00998296|3726580|FG005|NOT COMPLETED|Overall Study||0
3008632|NCT00998296|3726581|FG006|NOT COMPLETED|Overall Study||1
3008633|NCT00998296|3726582|FG007|NOT COMPLETED|Overall Study||2
3008634|NCT00998296|3726583|FG008|NOT COMPLETED|Overall Study||2
3008635|NCT00998296|3726584|FG009|NOT COMPLETED|Overall Study||18
3008636|NCT00998296|3726585|FG010|NOT COMPLETED|Overall Study||7
3008637|NCT00998309|3726614|FG000|STARTED|Overall Study||502
3008638|NCT00998309|3726614|FG000|COMPLETED|Overall Study||498
3008639|NCT00998309|3726614|FG000|NOT COMPLETED|Overall Study||4
3037351|NCT01147744|3756634|FG005|COMPLETED|Overall Study||83
3037352|NCT01147744|3756635|FG006|COMPLETED|Overall Study||78
3037353|NCT01147744|3756629|FG000|NOT COMPLETED|Overall Study||29
3037354|NCT01147744|3756630|FG001|NOT COMPLETED|Overall Study||23
3037355|NCT01147744|3756631|FG002|NOT COMPLETED|Overall Study||18
3037356|NCT01147744|3756632|FG003|NOT COMPLETED|Overall Study||18
3037357|NCT01147744|3756633|FG004|NOT COMPLETED|Overall Study||25
3037358|NCT01147744|3756634|FG005|NOT COMPLETED|Overall Study||20
3037359|NCT01147744|3756635|FG006|NOT COMPLETED|Overall Study||19
3037360|NCT01147809|3756663|FG000|STARTED|Phase I (168 Days)||3
3037361|NCT01147809|3756664|FG001|STARTED|Phase I (168 Days)||9
3037362|NCT01147809|3756665|FG002|STARTED|Phase I (168 Days)||4
3037363|NCT01147809|3756666|FG003|STARTED|Phase I (168 Days)||10
3037364|NCT01147809|3756667|FG004|STARTED|Phase I (168 Days)||0
3037365|NCT01147809|3756668|FG005|STARTED|Phase I (168 Days)||0
3037366|NCT01147809|3756663|FG000|COMPLETED|Phase I (168 Days)||2
3037367|NCT01147809|3756664|FG001|COMPLETED|Phase I (168 Days)||8
3037368|NCT01147809|3756665|FG002|COMPLETED|Phase I (168 Days)||2
3037369|NCT01147809|3756666|FG003|COMPLETED|Phase I (168 Days)||5
3037370|NCT01147809|3756667|FG004|COMPLETED|Phase I (168 Days)||0
3037371|NCT01147809|3756668|FG005|COMPLETED|Phase I (168 Days)||0
3037372|NCT01147809|3756663|FG000|NOT COMPLETED|Phase I (168 Days)||1
3037373|NCT01147809|3756664|FG001|NOT COMPLETED|Phase I (168 Days)||1
3037374|NCT01147809|3756665|FG002|NOT COMPLETED|Phase I (168 Days)||2
3037375|NCT01147809|3756666|FG003|NOT COMPLETED|Phase I (168 Days)||5
3037376|NCT01147809|3756667|FG004|NOT COMPLETED|Phase I (168 Days)||0
3037377|NCT01147809|3756668|FG005|NOT COMPLETED|Phase I (168 Days)||0
3037378|NCT01147809|3756663|FG000|STARTED|Phase II (168 Days)||0
3008640|NCT00998335|3726668|FG000|STARTED|Initial Treatment (Months 0 - 3)||30
3008641|NCT00998335|3726669|FG001|STARTED|Initial Treatment (Months 0 - 3)||0
3008642|NCT00998335|3726668|FG000|COMPLETED|Initial Treatment (Months 0 - 3)||30
3008643|NCT00998335|3726669|FG001|COMPLETED|Initial Treatment (Months 0 - 3)||0
3008644|NCT00998335|3726668|FG000|NOT COMPLETED|Initial Treatment (Months 0 - 3)||0
3008645|NCT00998335|3726669|FG001|NOT COMPLETED|Initial Treatment (Months 0 - 3)||0
3008646|NCT00998335|3726668|FG000|STARTED|Randomized Period (Months 3 to 6)|"All participants started in the Insulin detemir only arm. At month 3 subjects were randomized 2:1."|8
3008647|NCT00998335|3726669|FG001|STARTED|Randomized Period (Months 3 to 6)|"All participants started in the Insulin detemir only arm. At month 3 subjects were randomized 2:1."|22
3008648|NCT00998335|3726668|FG000|COMPLETED|Randomized Period (Months 3 to 6)||8
3008649|NCT00998335|3726669|FG001|COMPLETED|Randomized Period (Months 3 to 6)||20
3008650|NCT00998335|3726668|FG000|NOT COMPLETED|Randomized Period (Months 3 to 6)||0
3008651|NCT00998335|3726669|FG001|NOT COMPLETED|Randomized Period (Months 3 to 6)||2
3008652|NCT00998374|3726683|FG000|STARTED|Overall Study||39
3008653|NCT00998374|3726684|FG001|STARTED|Overall Study||23
3008654|NCT00998374|3726683|FG000|COMPLETED|Overall Study||27
3008655|NCT00998374|3726684|FG001|COMPLETED|Overall Study||12
3008656|NCT00998374|3726683|FG000|NOT COMPLETED|Overall Study||12
3008657|NCT00998374|3726684|FG001|NOT COMPLETED|Overall Study||11
3008658|NCT00998400|3726694|FG000|STARTED|Overall Study||50
3008659|NCT00998400|3726695|FG001|STARTED|Overall Study||50
3008660|NCT00998400|3726694|FG000|COMPLETED|Overall Study||48
3008661|NCT00998400|3726695|FG001|COMPLETED|Overall Study||48
3008662|NCT00998400|3726694|FG000|NOT COMPLETED|Overall Study||2
3008663|NCT00998400|3726695|FG001|NOT COMPLETED|Overall Study||2
3008664|NCT00998426|3726702|FG000|STARTED|Overall Study||5
3008665|NCT00998426|3726702|FG000|Blood Glucose Monitoring|Overall Study||5
3008666|NCT00998426|3726702|FG000|COMPLETED|Overall Study||5
3008667|NCT00998426|3726702|FG000|NOT COMPLETED|Overall Study||0
3008668|NCT00998517|3726710|FG000|STARTED|Overall Study||888
3008669|NCT00998517|3726711|FG001|STARTED|Overall Study||906
3008670|NCT00998517|3726712|FG002|STARTED|Overall Study||918
3008671|NCT00998517|3726710|FG000|COMPLETED|Overall Study||888
3008672|NCT00998517|3726711|FG001|COMPLETED|Overall Study||906
3008673|NCT00998517|3726712|FG002|COMPLETED|Overall Study||918
3008674|NCT00998517|3726710|FG000|NOT COMPLETED|Overall Study||0
3008675|NCT00998517|3726711|FG001|NOT COMPLETED|Overall Study||0
3306631|NCT02999191|4039953|FG002|NOT COMPLETED|Wash-out Period 2 [21 Days]||0
3306632|NCT02999191|4039951|FG000|STARTED|Treatment Period 3 [1 Day]||6
3306633|NCT02999191|4039952|FG001|STARTED|Treatment Period 3 [1 Day]||6
3306634|NCT02999191|4039953|FG002|STARTED|Treatment Period 3 [1 Day]||6
3306635|NCT02999191|4039951|FG000|COMPLETED|Treatment Period 3 [1 Day]||6
3306636|NCT02999191|4039952|FG001|COMPLETED|Treatment Period 3 [1 Day]||6
3306637|NCT02999191|4039953|FG002|COMPLETED|Treatment Period 3 [1 Day]||6
3306638|NCT02999191|4039951|FG000|NOT COMPLETED|Treatment Period 3 [1 Day]||0
3306639|NCT02999191|4039952|FG001|NOT COMPLETED|Treatment Period 3 [1 Day]||0
3306640|NCT02999191|4039953|FG002|NOT COMPLETED|Treatment Period 3 [1 Day]||0
3306641|NCT02999633|4039961|FG000|STARTED|Overall Study||14
3306642|NCT02999633|4039961|FG000|COMPLETED|Overall Study||0
3306643|NCT02999633|4039961|FG000|NOT COMPLETED|Overall Study||14
3306644|NCT02999672|4039967|FG000|STARTED|Overall Study||13
3306645|NCT02999672|4039968|FG001|STARTED|Overall Study||7
3306646|NCT02999672|4039967|FG000|COMPLETED|Overall Study||0
3306647|NCT02999672|4039968|FG001|COMPLETED|Overall Study||0
3306648|NCT02999672|4039967|FG000|NOT COMPLETED|Overall Study||13
3306649|NCT02999672|4039968|FG001|NOT COMPLETED|Overall Study||7
3306650|NCT02999763|4039974|FG000|STARTED|Overall Study||70
3306651|NCT02999763|4039974|FG000|COMPLETED|Overall Study||58
3306652|NCT02999763|4039974|FG000|NOT COMPLETED|Overall Study||12
3306653|NCT03000010|4039980|FG000|STARTED|Overall Study||21
3306654|NCT03000010|4039981|FG001|STARTED|Overall Study||20
3306655|NCT03000010|4039980|FG000|COMPLETED|Overall Study||21
3306656|NCT03000010|4039981|FG001|COMPLETED|Overall Study||20
3306657|NCT03000010|4039980|FG000|NOT COMPLETED|Overall Study||0
3306658|NCT03000010|4039981|FG001|NOT COMPLETED|Overall Study||0
3306659|NCT03000075|4039990|FG000|STARTED|Part A||58
3306660|NCT03000075|4039991|FG001|STARTED|Part A||58
3306661|NCT03000075|4039992|FG002|STARTED|Part A||55
3306662|NCT03000075|4039993|FG003|STARTED|Part A||0
3306663|NCT03000075|4039994|FG004|STARTED|Part A||0
3306664|NCT03000075|4039995|FG005|STARTED|Part A||0
3306665|NCT03000075|4039996|FG006|STARTED|Part A||0
3306666|NCT03000075|4039990|FG000|COMPLETED|Part A||54
3306667|NCT03000075|4039991|FG001|COMPLETED|Part A||58
3306668|NCT03000075|4039992|FG002|COMPLETED|Part A||55
3306669|NCT03000075|4039993|FG003|COMPLETED|Part A||0
3306670|NCT03000075|4039994|FG004|COMPLETED|Part A||0
3306671|NCT03000075|4039995|FG005|COMPLETED|Part A||0
3306672|NCT03000075|4039996|FG006|COMPLETED|Part A||0
3306673|NCT03000075|4039990|FG000|NOT COMPLETED|Part A||4
3306674|NCT03000075|4039991|FG001|NOT COMPLETED|Part A||0
3306675|NCT03000075|4039992|FG002|NOT COMPLETED|Part A||0
3306676|NCT03000075|4039993|FG003|NOT COMPLETED|Part A||0
3306677|NCT03000075|4039994|FG004|NOT COMPLETED|Part A||0
3306678|NCT03000075|4039995|FG005|NOT COMPLETED|Part A||0
3306679|NCT03000075|4039996|FG006|NOT COMPLETED|Part A||0
3306680|NCT03000075|4039990|FG000|STARTED|Part B||0
3306681|NCT03000075|4039991|FG001|STARTED|Part B||0
3306682|NCT03000075|4039992|FG002|STARTED|Part B||0
3317085|NCT03123861|4050600|FG000|Received Intervention|Overall Study||21
3008676|NCT00998517|3726712|FG002|NOT COMPLETED|Overall Study||0
3008677|NCT00998582|3726722|FG000|STARTED|Overall Study||13
3008678|NCT00998582|3726723|FG001|STARTED|Overall Study||14
3008679|NCT00998582|3726722|FG000|COMPLETED|Overall Study||13
3008680|NCT00998582|3726723|FG001|COMPLETED|Overall Study||14
3008681|NCT00998582|3726722|FG000|NOT COMPLETED|Overall Study||0
3008682|NCT00998582|3726723|FG001|NOT COMPLETED|Overall Study||0
3008683|NCT00998660|3726732|FG000|STARTED|Overall Study||100
3008684|NCT00998660|3726732|FG000|Implanted|Overall Study||93
3008685|NCT00998660|3726732|FG000|Month 3 Visit|Overall Study||87
3008686|NCT00998660|3726732|FG000|COMPLETED|Overall Study|87 subjects reached the final study visit at Month 6.|87
3008687|NCT00998660|3726732|FG000|NOT COMPLETED|Overall Study||13
3008688|NCT00998764|3726738|FG000|STARTED|Overall Study||216
3008689|NCT00998764|3726739|FG001|STARTED|Overall Study||276
3008690|NCT00998764|3726738|FG000|Treated|Overall Study||215
3008691|NCT00998764|3726739|FG001|Treated|Overall Study||275
3008692|NCT00998764|3726738|FG000|COMPLETED|Overall Study||0
3008693|NCT00998764|3726739|FG001|COMPLETED|Overall Study||2
3008694|NCT00998764|3726738|FG000|NOT COMPLETED|Overall Study||216
3008695|NCT00998764|3726739|FG001|NOT COMPLETED|Overall Study||274
3008696|NCT00998790|3726747|FG000|STARTED|Overall Study||114
3008697|NCT00998790|3726747|FG000|Participants Who Were Treated|Overall Study||113
3008698|NCT00998790|3726747|FG000|COMPLETED|Overall Study||93
3008699|NCT00998790|3726747|FG000|NOT COMPLETED|Overall Study||21
3165186|NCT01897792|3892740|FG000|STARTED|Overall Study||6
3165187|NCT01897792|3892741|FG001|STARTED|Overall Study||5
3165188|NCT01897792|3892740|FG000|COMPLETED|Overall Study||6
3165189|NCT01897792|3892741|FG001|COMPLETED|Overall Study||5
3165190|NCT01897792|3892740|FG000|NOT COMPLETED|Overall Study||0
3165191|NCT01897792|3892741|FG001|NOT COMPLETED|Overall Study||0
3165192|NCT01897896|3892753|FG000|STARTED|Overall Study||82
3165193|NCT01897896|3892754|FG001|STARTED|Overall Study||37
3008700|NCT00998868|3726751|FG000|STARTED|Overall Study|>=10 for each muscle strength per MRC scale, after excluding the cases following exclusion criteria|51
3008701|NCT00998868|3726751|FG000|COMPLETED|Overall Study||51
3008702|NCT00998868|3726751|FG000|NOT COMPLETED|Overall Study||0
3008703|NCT00998881|3726757|FG000|STARTED|Overall Study||104
3008704|NCT00998881|3726758|FG001|STARTED|Overall Study||99
3008705|NCT00998881|3726757|FG000|COMPLETED|Overall Study||96
3008706|NCT00998881|3726758|FG001|COMPLETED|Overall Study||97
3008707|NCT00998881|3726757|FG000|NOT COMPLETED|Overall Study||8
3008708|NCT00998881|3726758|FG001|NOT COMPLETED|Overall Study||2
3008709|NCT00998946|3726764|FG000|STARTED|Overall Study||29
3008710|NCT00998946|3726764|FG000|Safety Population|Overall Study|Safety population included all participants who received at least 1 dose of the study drug.|27
3008711|NCT00998946|3726764|FG000|COMPLETED|Overall Study||20
3008712|NCT00998946|3726764|FG000|NOT COMPLETED|Overall Study||9
3008713|NCT00998985|3726782|FG000|STARTED|Overall Study||5
3008714|NCT00998985|3726783|FG001|STARTED|Overall Study||5
3008715|NCT00998985|3726784|FG002|STARTED|Overall Study||15
3008716|NCT00998985|3726785|FG003|STARTED|Overall Study||5
3008717|NCT00998985|3726786|FG004|STARTED|Overall Study||5
3008718|NCT00998985|3726787|FG005|STARTED|Overall Study||5
3008719|NCT00998985|3726788|FG006|STARTED|Overall Study||5
3008720|NCT00998985|3726789|FG007|STARTED|Overall Study||5
3008721|NCT00998985|3726790|FG008|STARTED|Overall Study||6
3008722|NCT00998985|3726791|FG009|STARTED|Overall Study||5
3008723|NCT00998985|3726792|FG010|STARTED|Overall Study||5
3008724|NCT00998985|3726793|FG011|STARTED|Overall Study||5
3008725|NCT00998985|3726794|FG012|STARTED|Overall Study||5
3008726|NCT00998985|3726795|FG013|STARTED|Overall Study||15
3008727|NCT00998985|3726782|FG000|COMPLETED|Overall Study||5
3008728|NCT00998985|3726783|FG001|COMPLETED|Overall Study||5
3008729|NCT00998985|3726784|FG002|COMPLETED|Overall Study||15
3008730|NCT00998985|3726785|FG003|COMPLETED|Overall Study||5
3008731|NCT00998985|3726786|FG004|COMPLETED|Overall Study||5
3008732|NCT00998985|3726787|FG005|COMPLETED|Overall Study||4
3008733|NCT00998985|3726788|FG006|COMPLETED|Overall Study||5
3008734|NCT00998985|3726789|FG007|COMPLETED|Overall Study||5
3008735|NCT00998985|3726790|FG008|COMPLETED|Overall Study||5
3008736|NCT00998985|3726791|FG009|COMPLETED|Overall Study||5
3008737|NCT00998985|3726792|FG010|COMPLETED|Overall Study||5
3008738|NCT00998985|3726793|FG011|COMPLETED|Overall Study||5
3008739|NCT00998985|3726794|FG012|COMPLETED|Overall Study||5
3008740|NCT00998985|3726795|FG013|COMPLETED|Overall Study||15
3008741|NCT00998985|3726782|FG000|NOT COMPLETED|Overall Study||0
3008742|NCT00998985|3726783|FG001|NOT COMPLETED|Overall Study||0
3008743|NCT00998985|3726784|FG002|NOT COMPLETED|Overall Study||0
3008744|NCT00998985|3726785|FG003|NOT COMPLETED|Overall Study||0
3008745|NCT00998985|3726786|FG004|NOT COMPLETED|Overall Study||0
3008746|NCT00998985|3726787|FG005|NOT COMPLETED|Overall Study||1
3008747|NCT00998985|3726788|FG006|NOT COMPLETED|Overall Study||0
3008748|NCT00998985|3726789|FG007|NOT COMPLETED|Overall Study||0
3008749|NCT00998985|3726790|FG008|NOT COMPLETED|Overall Study||1
3008750|NCT00998985|3726791|FG009|NOT COMPLETED|Overall Study||0
3008751|NCT00998985|3726792|FG010|NOT COMPLETED|Overall Study||0
3008752|NCT00998985|3726793|FG011|NOT COMPLETED|Overall Study||0
3008753|NCT00998985|3726794|FG012|NOT COMPLETED|Overall Study||0
3008754|NCT00998985|3726795|FG013|NOT COMPLETED|Overall Study||0
3165194|NCT01897896|3892753|FG000|COMPLETED|Overall Study||56
3165195|NCT01897896|3892754|FG001|COMPLETED|Overall Study||25
3165196|NCT01897896|3892753|FG000|NOT COMPLETED|Overall Study||26
3008755|NCT00999037|3726842|FG000|STARTED|Overall Study||9
3008756|NCT00999037|3726843|FG001|STARTED|Overall Study|20|9
3008757|NCT00999037|3726842|FG000|COMPLETED|Overall Study||9
3008758|NCT00999037|3726843|FG001|COMPLETED|Overall Study||9
3008759|NCT00999037|3726842|FG000|NOT COMPLETED|Overall Study||0
3008760|NCT00999037|3726843|FG001|NOT COMPLETED|Overall Study||0
3008761|NCT00999102|3726851|FG000|STARTED|4 Weeks at Lower Dose of First Drug||16
3008762|NCT00999102|3726852|FG001|STARTED|4 Weeks at Lower Dose of First Drug||17
3008763|NCT00999102|3726851|FG000|COMPLETED|4 Weeks at Lower Dose of First Drug||15
3008764|NCT00999102|3726852|FG001|COMPLETED|4 Weeks at Lower Dose of First Drug||16
3008765|NCT00999102|3726851|FG000|NOT COMPLETED|4 Weeks at Lower Dose of First Drug||1
3008766|NCT00999102|3726852|FG001|NOT COMPLETED|4 Weeks at Lower Dose of First Drug||1
3008767|NCT00999102|3726851|FG000|STARTED|4 Weeks at Higher Dose of First Drug||15
3008768|NCT00999102|3726852|FG001|STARTED|4 Weeks at Higher Dose of First Drug||16
3008769|NCT00999102|3726851|FG000|COMPLETED|4 Weeks at Higher Dose of First Drug||15
3008770|NCT00999102|3726852|FG001|COMPLETED|4 Weeks at Higher Dose of First Drug||16
3008771|NCT00999102|3726851|FG000|NOT COMPLETED|4 Weeks at Higher Dose of First Drug||0
3008772|NCT00999102|3726852|FG001|NOT COMPLETED|4 Weeks at Higher Dose of First Drug||0
3008773|NCT00999102|3726851|FG000|STARTED|4 Weeks at Lower Dose of Second Drug||15
3008774|NCT00999102|3726852|FG001|STARTED|4 Weeks at Lower Dose of Second Drug||16
3008775|NCT00999102|3726851|FG000|COMPLETED|4 Weeks at Lower Dose of Second Drug||15
3008776|NCT00999102|3726852|FG001|COMPLETED|4 Weeks at Lower Dose of Second Drug||16
3008777|NCT00999102|3726851|FG000|NOT COMPLETED|4 Weeks at Lower Dose of Second Drug||0
3008778|NCT00999102|3726852|FG001|NOT COMPLETED|4 Weeks at Lower Dose of Second Drug||0
3008779|NCT00999102|3726851|FG000|STARTED|4 Weeks at Higher Dose of Second Drug||15
3008780|NCT00999102|3726852|FG001|STARTED|4 Weeks at Higher Dose of Second Drug||16
3008781|NCT00999102|3726851|FG000|COMPLETED|4 Weeks at Higher Dose of Second Drug||15
3008782|NCT00999102|3726852|FG001|COMPLETED|4 Weeks at Higher Dose of Second Drug||16
3008783|NCT00999102|3726851|FG000|NOT COMPLETED|4 Weeks at Higher Dose of Second Drug||0
3008784|NCT00999102|3726852|FG001|NOT COMPLETED|4 Weeks at Higher Dose of Second Drug||0
3008785|NCT00999141|3726862|FG000|STARTED|Overall Study|Randomized and treated|75
3008786|NCT00999141|3726862|FG000|COMPLETED|Overall Study||75
3008787|NCT00999141|3726862|FG000|NOT COMPLETED|Overall Study||0
3008788|NCT00999167|3726920|FG000|STARTED|Part A: Open Label Safety run-in||15
3008789|NCT00999167|3726921|FG001|STARTED|Part A: Open Label Safety run-in||0
3008790|NCT00999167|3726922|FG002|STARTED|Part A: Open Label Safety run-in||0
3008791|NCT00999167|3726920|FG000|Received 9 mL BID|Part A: Open Label Safety run-in||15
3008792|NCT00999167|3726921|FG001|Received 9 mL BID|Part A: Open Label Safety run-in||0
3008793|NCT00999167|3726922|FG002|Received 9 mL BID|Part A: Open Label Safety run-in||0
3008794|NCT00999167|3726920|FG000|COMPLETED|Part A: Open Label Safety run-in||8
3008795|NCT00999167|3726921|FG001|COMPLETED|Part A: Open Label Safety run-in||0
3008796|NCT00999167|3726922|FG002|COMPLETED|Part A: Open Label Safety run-in||0
3008797|NCT00999167|3726920|FG000|NOT COMPLETED|Part A: Open Label Safety run-in||7
3008798|NCT00999167|3726921|FG001|NOT COMPLETED|Part A: Open Label Safety run-in||0
3008799|NCT00999167|3726922|FG002|NOT COMPLETED|Part A: Open Label Safety run-in||0
3008800|NCT00999167|3726920|FG000|STARTED|Part B: Randomized, Placebo Controlled||0
3008801|NCT00999167|3726921|FG001|STARTED|Part B: Randomized, Placebo Controlled|4 subjects who participated in Part A enrolled in Part B and remainder were newly enrolled|90
3008802|NCT00999167|3726922|FG002|STARTED|Part B: Randomized, Placebo Controlled||88
3008803|NCT00999167|3726920|FG000|COMPLETED|Part B: Randomized, Placebo Controlled||0
3008804|NCT00999167|3726921|FG001|COMPLETED|Part B: Randomized, Placebo Controlled||55
3008805|NCT00999167|3726922|FG002|COMPLETED|Part B: Randomized, Placebo Controlled||67
3008806|NCT00999167|3726920|FG000|NOT COMPLETED|Part B: Randomized, Placebo Controlled||0
3008807|NCT00999167|3726921|FG001|NOT COMPLETED|Part B: Randomized, Placebo Controlled||35
3008808|NCT00999167|3726922|FG002|NOT COMPLETED|Part B: Randomized, Placebo Controlled||21
3008809|NCT00999466|3726935|FG000|STARTED|Pilot Part||6
3008810|NCT00999466|3726936|FG001|STARTED|Pilot Part|AZD8848 nasal spray 60 μg group was not participated in the Pilot part|0
3008811|NCT00999466|3726937|FG002|STARTED|Pilot Part||3
3008812|NCT00999466|3726935|FG000|COMPLETED|Pilot Part||6
3008813|NCT00999466|3726936|FG001|COMPLETED|Pilot Part||0
3008814|NCT00999466|3726937|FG002|COMPLETED|Pilot Part||3
3008815|NCT00999466|3726935|FG000|NOT COMPLETED|Pilot Part||0
3008816|NCT00999466|3726936|FG001|NOT COMPLETED|Pilot Part||0
3008817|NCT00999466|3726937|FG002|NOT COMPLETED|Pilot Part||0
3008818|NCT00999466|3726935|FG000|STARTED|Main Part|AZD8848 nasal spray 30 μg group was not participated in the Main part|0
3008819|NCT00999466|3726936|FG001|STARTED|Main Part||26
3008820|NCT00999466|3726937|FG002|STARTED|Main Part||25
3008821|NCT00999466|3726935|FG000|COMPLETED|Main Part||0
3008822|NCT00999466|3726936|FG001|COMPLETED|Main Part||22
3008823|NCT00999466|3726937|FG002|COMPLETED|Main Part||21
3008824|NCT00999466|3726935|FG000|NOT COMPLETED|Main Part||0
3008825|NCT00999466|3726936|FG001|NOT COMPLETED|Main Part||4
3008826|NCT00999466|3726937|FG002|NOT COMPLETED|Main Part||4
3008827|NCT00999518|3726950|FG000|STARTED|Overall Study||43
3165197|NCT01897896|3892754|FG001|NOT COMPLETED|Overall Study||12
3165198|NCT01898013|3892764|FG000|STARTED|Visit 3 (Randomization Visit)||45
3165199|NCT01898013|3892765|FG001|STARTED|Visit 3 (Randomization Visit)||49
3165200|NCT01898013|3892764|FG000|COMPLETED|Visit 3 (Randomization Visit)||45
3165201|NCT01898013|3892765|FG001|COMPLETED|Visit 3 (Randomization Visit)||49
3008828|NCT00999518|3726951|FG001|STARTED|Overall Study||42
3008829|NCT00999518|3726952|FG002|STARTED|Overall Study||39
3008830|NCT00999518|3726953|FG003|STARTED|Overall Study||40
3008831|NCT00999518|3726954|FG004|STARTED|Overall Study||41
3008832|NCT00999518|3726950|FG000|Treated|Overall Study||42
3008833|NCT00999518|3726951|FG001|Treated|Overall Study||41
3008834|NCT00999518|3726952|FG002|Treated|Overall Study||37
3008835|NCT00999518|3726953|FG003|Treated|Overall Study||40
3008836|NCT00999518|3726954|FG004|Treated|Overall Study||40
3008837|NCT00999518|3726950|FG000|COMPLETED|Overall Study||19
3008838|NCT00999518|3726951|FG001|COMPLETED|Overall Study||17
3008839|NCT00999518|3726952|FG002|COMPLETED|Overall Study||17
3008840|NCT00999518|3726953|FG003|COMPLETED|Overall Study||18
3008841|NCT00999518|3726954|FG004|COMPLETED|Overall Study||17
3008842|NCT00999518|3726950|FG000|NOT COMPLETED|Overall Study||24
3008843|NCT00999518|3726951|FG001|NOT COMPLETED|Overall Study||25
3008844|NCT00999518|3726952|FG002|NOT COMPLETED|Overall Study||22
3008845|NCT00999518|3726953|FG003|NOT COMPLETED|Overall Study||22
3008846|NCT00999518|3726954|FG004|NOT COMPLETED|Overall Study||24
3008847|NCT00999544|3726970|FG000|STARTED|Overall Study||9
3008848|NCT00999544|3726970|FG000|COMPLETED|Overall Study||8
3008849|NCT00999544|3726970|FG000|NOT COMPLETED|Overall Study||1
3008850|NCT00999596|3727003|FG000|STARTED|Overall Study||107
3008851|NCT00999596|3727003|FG000|New FDA Guideline Released|Overall Study|FDA Guidance: Class II Special Controls Guidance Document: Full-Field Digital Mammography System|6
3008852|NCT00999596|3727003|FG000|COMPLETED|Overall Study|Not all patient images were used for the reader evaluation based on new FDA Guidelines|6
3008853|NCT00999596|3727003|FG000|NOT COMPLETED|Overall Study||101
3008854|NCT00999661|3727008|FG000|STARTED|Overall Study||231
3008855|NCT00999661|3727008|FG000|COMPLETED|Overall Study||161
3008856|NCT00999661|3727008|FG000|NOT COMPLETED|Overall Study||70
3008857|NCT00999687|3727012|FG000|STARTED|First Intervention|16 used the INOE on the right hand,15 used the INOE on the left hand.|31
3008858|NCT00999687|3727012|FG000|COMPLETED|First Intervention||30
3008859|NCT00999687|3727012|FG000|NOT COMPLETED|First Intervention||1
3008860|NCT00999687|3727012|FG000|STARTED|Second Intervention|From week 13 to 24, all participants applied INOE to both hands twice daily.|30
3008861|NCT00999687|3727012|FG000|COMPLETED|Second Intervention||27
3008862|NCT00999687|3727012|FG000|NOT COMPLETED|Second Intervention||3
3008863|NCT00999713|3727020|FG000|STARTED|Overall Study||26
3008864|NCT00999713|3727021|FG001|STARTED|Overall Study||17
3008865|NCT00999713|3727020|FG000|COMPLETED|Overall Study||24
3008866|NCT00999713|3727021|FG001|COMPLETED|Overall Study||17
3008867|NCT00999713|3727020|FG000|NOT COMPLETED|Overall Study||2
3008868|NCT00999713|3727021|FG001|NOT COMPLETED|Overall Study||0
3008869|NCT00999804|3727029|FG000|STARTED|Overall Study||85
3008870|NCT00999804|3727030|FG001|STARTED|Overall Study||43
3008871|NCT00999804|3727029|FG000|COMPLETED|Overall Study||64
3008872|NCT00999804|3727030|FG001|COMPLETED|Overall Study||38
3008873|NCT00999804|3727029|FG000|NOT COMPLETED|Overall Study||21
3008874|NCT00999804|3727030|FG001|NOT COMPLETED|Overall Study||5
3008875|NCT00999830|3727038|FG000|STARTED|Overall Study||14
3008876|NCT00999830|3727039|FG001|STARTED|Overall Study||13
3008877|NCT00999830|3727038|FG000|COMPLETED|Overall Study||14
3008878|NCT00999830|3727039|FG001|COMPLETED|Overall Study||13
3008879|NCT00999830|3727038|FG000|NOT COMPLETED|Overall Study||0
3008880|NCT00999830|3727039|FG001|NOT COMPLETED|Overall Study||0
3008881|NCT00999908|3727045|FG000|STARTED|Treatment Period 1||19
3008882|NCT00999908|3727046|FG001|STARTED|Treatment Period 1||16
3008883|NCT00999908|3727047|FG002|STARTED|Treatment Period 1||19
3008884|NCT00999908|3727045|FG000|COMPLETED|Treatment Period 1||17
3008885|NCT00999908|3727046|FG001|COMPLETED|Treatment Period 1||16
3008886|NCT00999908|3727047|FG002|COMPLETED|Treatment Period 1||19
3008887|NCT00999908|3727045|FG000|NOT COMPLETED|Treatment Period 1||2
3008888|NCT00999908|3727046|FG001|NOT COMPLETED|Treatment Period 1||0
3008889|NCT00999908|3727047|FG002|NOT COMPLETED|Treatment Period 1||0
3008890|NCT00999908|3727045|FG000|STARTED|Treatment Period 2||17
3008891|NCT00999908|3727046|FG001|STARTED|Treatment Period 2||16
3008892|NCT00999908|3727047|FG002|STARTED|Treatment Period 2||19
3008893|NCT00999908|3727045|FG000|COMPLETED|Treatment Period 2||16
3008894|NCT00999908|3727046|FG001|COMPLETED|Treatment Period 2||16
3008895|NCT00999908|3727047|FG002|COMPLETED|Treatment Period 2||19
3008896|NCT00999908|3727045|FG000|NOT COMPLETED|Treatment Period 2||1
3008897|NCT00999908|3727046|FG001|NOT COMPLETED|Treatment Period 2||0
3008898|NCT00999908|3727047|FG002|NOT COMPLETED|Treatment Period 2||0
3008899|NCT00999908|3727045|FG000|STARTED|Treatment Period 3||16
3008900|NCT00999908|3727046|FG001|STARTED|Treatment Period 3||16
3008901|NCT00999908|3727047|FG002|STARTED|Treatment Period 3||19
3008902|NCT00999908|3727045|FG000|COMPLETED|Treatment Period 3||16
3008903|NCT00999908|3727046|FG001|COMPLETED|Treatment Period 3||16
3008904|NCT00999908|3727047|FG002|COMPLETED|Treatment Period 3||19
3008905|NCT00999908|3727045|FG000|NOT COMPLETED|Treatment Period 3||0
3008906|NCT00999908|3727046|FG001|NOT COMPLETED|Treatment Period 3||0
3008907|NCT00999908|3727047|FG002|NOT COMPLETED|Treatment Period 3||0
3008908|NCT00999921|3727057|FG000|STARTED|Overall Study||127
3008909|NCT00999921|3727058|FG001|STARTED|Overall Study||129
3008910|NCT00999921|3727057|FG000|COMPLETED|Overall Study||117
3008911|NCT00999921|3727058|FG001|COMPLETED|Overall Study||110
3008912|NCT00999921|3727057|FG000|NOT COMPLETED|Overall Study||10
3008913|NCT00999921|3727058|FG001|NOT COMPLETED|Overall Study||19
3008914|NCT01000025|3727069|FG000|STARTED|Overall Study||480
3008915|NCT01000025|3727070|FG001|STARTED|Overall Study||240
3306683|NCT03000075|4039993|FG003|STARTED|Part B|Participants who received placebo in Part A received risankizumab 75 mg in Part B|27
3306684|NCT03000075|4039994|FG004|STARTED|Part B|Participants who received placebo in Part A received risankizumab 150 mg in Part B|27
3306685|NCT03000075|4039995|FG005|STARTED|Part B|Participants who received risankizumab 75 mg in Part A received risankizumab 75 mg in Part B|58
3306686|NCT03000075|4039996|FG006|STARTED|Part B|Participants who received risankizumab 150 mg in Part A received risankizumab 150 mg in Part B|55
3306687|NCT03000075|4039990|FG000|COMPLETED|Part B||0
3165202|NCT01898013|3892764|FG000|NOT COMPLETED|Visit 3 (Randomization Visit)||0
3165203|NCT01898013|3892765|FG001|NOT COMPLETED|Visit 3 (Randomization Visit)||0
3165204|NCT01898013|3892764|FG000|STARTED|Visit 4||45
3306688|NCT03000075|4039991|FG001|COMPLETED|Part B||0
3306689|NCT03000075|4039992|FG002|COMPLETED|Part B||0
3008916|NCT01000025|3727069|FG000|COMPLETED|Overall Study||12
3008917|NCT01000025|3727070|FG001|COMPLETED|Overall Study||2
3008918|NCT01000025|3727069|FG000|NOT COMPLETED|Overall Study||468
3008919|NCT01000025|3727070|FG001|NOT COMPLETED|Overall Study||238
3008920|NCT01000051|3727078|FG000|STARTED|Overall Study||42
3008921|NCT01000051|3727079|FG001|STARTED|Overall Study||18
3008922|NCT01000051|3727078|FG000|COMPLETED|Overall Study||39
3008923|NCT01000051|3727079|FG001|COMPLETED|Overall Study||17
3008924|NCT01000051|3727078|FG000|NOT COMPLETED|Overall Study||3
3008925|NCT01000051|3727079|FG001|NOT COMPLETED|Overall Study||1
3008926|NCT01000064|3727085|FG000|STARTED|Overall Study||7
3008927|NCT01000064|3727086|FG001|STARTED|Overall Study||6
3008928|NCT01000064|3727085|FG000|COMPLETED|Overall Study||6
3008929|NCT01000064|3727086|FG001|COMPLETED|Overall Study||5
3008930|NCT01000064|3727085|FG000|NOT COMPLETED|Overall Study||1
3008931|NCT01000064|3727086|FG001|NOT COMPLETED|Overall Study||1
3008932|NCT01000155|3727095|FG000|STARTED|Overall Study||5
3008933|NCT01000155|3727095|FG000|COMPLETED|Overall Study||3
3008934|NCT01000155|3727095|FG000|NOT COMPLETED|Overall Study||2
3008935|NCT01000285|3727101|FG000|STARTED|Overall Study||18
3008936|NCT01000285|3727101|FG000|COMPLETED|Overall Study||18
3008937|NCT01000285|3727101|FG000|NOT COMPLETED|Overall Study||0
3008938|NCT01000311|3727117|FG000|STARTED|Overall Study||258
3008939|NCT01000311|3727118|FG001|STARTED|Overall Study||271
3008940|NCT01000311|3727117|FG000|COMPLETED|Overall Study||213
3008941|NCT01000311|3727118|FG001|COMPLETED|Overall Study||201
3008942|NCT01000311|3727117|FG000|NOT COMPLETED|Overall Study||45
3008943|NCT01000311|3727118|FG001|NOT COMPLETED|Overall Study||70
3008944|NCT01000324|3727124|FG000|STARTED|Year 16||40
3008945|NCT01000324|3727124|FG000|COMPLETED|Year 16||40
3165205|NCT01898013|3892765|FG001|STARTED|Visit 4||49
3165206|NCT01898013|3892764|FG000|COMPLETED|Visit 4||45
3165207|NCT01898013|3892765|FG001|COMPLETED|Visit 4||48
3165208|NCT01898013|3892764|FG000|NOT COMPLETED|Visit 4||0
3165209|NCT01898013|3892765|FG001|NOT COMPLETED|Visit 4||1
3165210|NCT01898013|3892764|FG000|STARTED|Visit 5||45
3008946|NCT01000324|3727124|FG000|NOT COMPLETED|Year 16||0
3008947|NCT01000324|3727124|FG000|STARTED|Year 17||32
3008948|NCT01000324|3727124|FG000|COMPLETED|Year 17||32
3008949|NCT01000324|3727124|FG000|NOT COMPLETED|Year 17||0
3008950|NCT01000324|3727124|FG000|STARTED|Year 18||29
3008951|NCT01000324|3727124|FG000|COMPLETED|Year 18||29
3008952|NCT01000324|3727124|FG000|NOT COMPLETED|Year 18||0
3008953|NCT01000324|3727124|FG000|STARTED|Year 19||28
3008954|NCT01000324|3727124|FG000|COMPLETED|Year 19||28
3008955|NCT01000324|3727124|FG000|NOT COMPLETED|Year 19||0
3008956|NCT01000324|3727124|FG000|STARTED|Year 20||28
3008957|NCT01000324|3727124|FG000|COMPLETED|Year 20||28
3008958|NCT01000324|3727124|FG000|NOT COMPLETED|Year 20||0
3008959|NCT01000337|3727131|FG000|STARTED|Overall Study||34
3008960|NCT01000337|3727132|FG001|STARTED|Overall Study||33
3008961|NCT01000337|3727131|FG000|COMPLETED|Overall Study||30
3008962|NCT01000337|3727132|FG001|COMPLETED|Overall Study||30
3008963|NCT01000337|3727131|FG000|NOT COMPLETED|Overall Study||4
3008964|NCT01000337|3727132|FG001|NOT COMPLETED|Overall Study||3
3008965|NCT01000376|3727140|FG000|STARTED|Cycle 1 Day 1||6
3008966|NCT01000376|3727141|FG001|STARTED|Cycle 1 Day 1||6
3008967|NCT01000376|3727140|FG000|COMPLETED|Cycle 1 Day 1||4
3008968|NCT01000376|3727141|FG001|COMPLETED|Cycle 1 Day 1||6
3008969|NCT01000376|3727140|FG000|NOT COMPLETED|Cycle 1 Day 1||2
3008970|NCT01000376|3727141|FG001|NOT COMPLETED|Cycle 1 Day 1||0
3008971|NCT01000376|3727140|FG000|STARTED|Cycle 1 Day 15||4
3008972|NCT01000376|3727141|FG001|STARTED|Cycle 1 Day 15||6
3008973|NCT01000376|3727140|FG000|COMPLETED|Cycle 1 Day 15||4
3008974|NCT01000376|3727141|FG001|COMPLETED|Cycle 1 Day 15||6
3008975|NCT01000376|3727140|FG000|NOT COMPLETED|Cycle 1 Day 15||0
3165211|NCT01898013|3892765|FG001|STARTED|Visit 5||48
3165212|NCT01898013|3892764|FG000|COMPLETED|Visit 5||44
3165213|NCT01898013|3892765|FG001|COMPLETED|Visit 5||47
3165214|NCT01898013|3892764|FG000|NOT COMPLETED|Visit 5||1
3165215|NCT01898013|3892765|FG001|NOT COMPLETED|Visit 5||1
3165216|NCT01898013|3892764|FG000|STARTED|Visit 6||44
3008976|NCT01000376|3727141|FG001|NOT COMPLETED|Cycle 1 Day 15||0
3008977|NCT01000480|3727147|FG000|STARTED|Induction Phase||90
3008978|NCT01000480|3727147|FG000|Received at Least 1 Dose of Either Drug|Induction Phase||90
3008979|NCT01000480|3727147|FG000|Death (Any Cause) or Disease Progression|Induction Phase|Participants who died (any cause) or had disease progression considered to have completed phase.|8
3008980|NCT01000480|3727147|FG000|COMPLETED|Induction Phase||83
3008981|NCT01000480|3727147|FG000|NOT COMPLETED|Induction Phase||7
3037379|NCT01147809|3756664|FG001|STARTED|Phase II (168 Days)||0
3165217|NCT01898013|3892765|FG001|STARTED|Visit 6||47
3165218|NCT01898013|3892764|FG000|COMPLETED|Visit 6||41
3008982|NCT01000480|3727147|FG000|STARTED|Concurrent Therapy Phase|Eight participants (pts) who completed Induction Phase, not eligible for Concurrent Therapy Phase.|75
3008983|NCT01000480|3727147|FG000|Death (Any Cause) or Disease Progression|Concurrent Therapy Phase|Pts who died (any cause) or had disease progression considered to have completed the phase.|1
3008984|NCT01000480|3727147|FG000|COMPLETED|Concurrent Therapy Phase||65
3008985|NCT01000480|3727147|FG000|NOT COMPLETED|Concurrent Therapy Phase||10
3008986|NCT01000480|3727147|FG000|STARTED|Follow-Up Period|One pt lost to follow-up during induction, 1 pt died in concurrent therapy, both not enter follow-up|88
3008987|NCT01000480|3727147|FG000|COMPLETED|Follow-Up Period||88
3008988|NCT01000480|3727147|FG000|NOT COMPLETED|Follow-Up Period||0
3008989|NCT01000493|3727153|FG000|STARTED|Overall Study||60
3008990|NCT01000493|3727154|FG001|STARTED|Overall Study||69
3008991|NCT01000493|3727153|FG000|COMPLETED|Overall Study||21
3008992|NCT01000493|3727154|FG001|COMPLETED|Overall Study||14
3008993|NCT01000493|3727153|FG000|NOT COMPLETED|Overall Study||39
3008994|NCT01000493|3727154|FG001|NOT COMPLETED|Overall Study||55
3008995|NCT01000506|3727164|FG000|STARTED|Overall Study||155
3008996|NCT01000506|3727165|FG001|STARTED|Overall Study||153
3008997|NCT01000506|3727166|FG002|STARTED|Overall Study||152
3008998|NCT01000506|3727167|FG003|STARTED|Overall Study||156
3008999|NCT01000506|3727164|FG000|COMPLETED|Overall Study||127
3009000|NCT01000506|3727165|FG001|COMPLETED|Overall Study||129
3009001|NCT01000506|3727166|FG002|COMPLETED|Overall Study||131
3009002|NCT01000506|3727167|FG003|COMPLETED|Overall Study||133
3009003|NCT01000506|3727164|FG000|NOT COMPLETED|Overall Study||28
3009004|NCT01000506|3727165|FG001|NOT COMPLETED|Overall Study||24
3009005|NCT01000506|3727166|FG002|NOT COMPLETED|Overall Study||21
3009006|NCT01000506|3727167|FG003|NOT COMPLETED|Overall Study||23
3009007|NCT01000610|3727177|FG000|STARTED|Overall Study||18
3009008|NCT01000610|3727177|FG000|COMPLETED|Overall Study||12
3009009|NCT01000610|3727177|FG000|NOT COMPLETED|Overall Study||6
3009010|NCT01000636|3727181|FG000|STARTED|Overall Study||9
3009011|NCT01000636|3727181|FG000|COMPLETED|Overall Study||7
3009012|NCT01000636|3727181|FG000|NOT COMPLETED|Overall Study||2
3009013|NCT01000649|3727189|FG000|STARTED|Overall Study|This represents Full Analysis Set population, which comprised of all dosed patients.|10
3009014|NCT01000649|3727190|FG001|STARTED|Overall Study|This represents Full Analysis Set population, which comprised of all dosed patients.|19
3009015|NCT01000649|3727191|FG002|STARTED|Overall Study|This represents Full Analysis Set population, which comprised of all dosed patients.|2
3009016|NCT01000649|3727192|FG003|STARTED|Overall Study|This represents Full Analysis Set population, which comprised of all dosed patients.|21
3009017|NCT01000649|3727189|FG000|Intention-to-Treat (ITT) Analysis Set|Overall Study|ITT population comprised of all randomized patients.|10
3009018|NCT01000649|3727190|FG001|Intention-to-Treat (ITT) Analysis Set|Overall Study|ITT population comprised of all randomized patients.|20
3165219|NCT01898013|3892765|FG001|COMPLETED|Visit 6||42
3165220|NCT01898013|3892764|FG000|NOT COMPLETED|Visit 6||3
3165221|NCT01898013|3892765|FG001|NOT COMPLETED|Visit 6||5
3165222|NCT01898078|3892773|FG000|STARTED|Overall Study||13
3165223|NCT01898078|3892774|FG001|STARTED|Overall Study||13
3165224|NCT01898078|3892773|FG000|COMPLETED|Overall Study|Completed treatment|7
3009019|NCT01000649|3727191|FG002|Intention-to-Treat (ITT) Analysis Set|Overall Study|ITT population comprised of all randomized patients.|2
3009020|NCT01000649|3727192|FG003|Intention-to-Treat (ITT) Analysis Set|Overall Study|ITT population comprised of all randomized patients.|21
3009021|NCT01000649|3727189|FG000|COMPLETED|Overall Study||5
3009022|NCT01000649|3727190|FG001|COMPLETED|Overall Study||16
3009023|NCT01000649|3727191|FG002|COMPLETED|Overall Study||0
3009024|NCT01000649|3727192|FG003|COMPLETED|Overall Study||15
3009025|NCT01000649|3727189|FG000|NOT COMPLETED|Overall Study||5
3009026|NCT01000649|3727190|FG001|NOT COMPLETED|Overall Study||3
3009027|NCT01000649|3727191|FG002|NOT COMPLETED|Overall Study||2
3009028|NCT01000649|3727192|FG003|NOT COMPLETED|Overall Study||6
3009029|NCT01000662|3727203|FG000|STARTED|Overall Study||206
3009030|NCT01000662|3727204|FG001|STARTED|Overall Study||206
3009031|NCT01000662|3727203|FG000|COMPLETED|Overall Study||202
3009032|NCT01000662|3727204|FG001|COMPLETED|Overall Study||198
3009033|NCT01000662|3727203|FG000|NOT COMPLETED|Overall Study||4
3009034|NCT01000662|3727204|FG001|NOT COMPLETED|Overall Study||8
3009035|NCT01000727|3727214|FG000|STARTED|Overall Study||6522
3009036|NCT01000727|3727215|FG001|STARTED|Overall Study||6504
3009037|NCT01000727|3727214|FG000|COMPLETED|Overall Study||6347
3009038|NCT01000727|3727215|FG001|COMPLETED|Overall Study||6328
3009039|NCT01000727|3727214|FG000|NOT COMPLETED|Overall Study||175
3009040|NCT01000727|3727215|FG001|NOT COMPLETED|Overall Study||176
3009041|NCT01000805|3727225|FG000|STARTED|Overall Study||262
3009042|NCT01000805|3727226|FG001|STARTED|Overall Study||266
3009043|NCT01000805|3727225|FG000|COMPLETED|Overall Study||192
3009044|NCT01000805|3727226|FG001|COMPLETED|Overall Study||204
3009045|NCT01000805|3727225|FG000|NOT COMPLETED|Overall Study||70
3009046|NCT01000805|3727226|FG001|NOT COMPLETED|Overall Study||62
3009047|NCT01000818|3727233|FG000|STARTED|Raltegravir||18
3009048|NCT01000818|3727233|FG000|COMPLETED|Raltegravir||18
3009049|NCT01000818|3727233|FG000|NOT COMPLETED|Raltegravir||0
3009050|NCT01000818|3727233|FG000|STARTED|Famotidine + Raltegravir||18
3165225|NCT01898078|3892774|FG001|COMPLETED|Overall Study|Completed treatment|5
3165226|NCT01898078|3892773|FG000|NOT COMPLETED|Overall Study||6
3165227|NCT01898078|3892774|FG001|NOT COMPLETED|Overall Study||8
3171817|NCT01937351|3899027|FG000|Treated w Study Device|Overall Study||130
3009051|NCT01000818|3727233|FG000|COMPLETED|Famotidine + Raltegravir||18
3009052|NCT01000818|3727233|FG000|NOT COMPLETED|Famotidine + Raltegravir||0
3165228|NCT01898091|3892784|FG000|STARTED|Overall Study|Allocated to intervention. All allocated received intervention.|25
3165229|NCT01898091|3892785|FG001|STARTED|Overall Study|Allocated to intervention. All allocated received intervention.|25
3165230|NCT01898091|3892784|FG000|COMPLETED|Overall Study||23
3165231|NCT01898091|3892785|FG001|COMPLETED|Overall Study||19
3165232|NCT01898091|3892784|FG000|NOT COMPLETED|Overall Study||2
3165233|NCT01898091|3892785|FG001|NOT COMPLETED|Overall Study||6
3165234|NCT01898130|3892791|FG000|STARTED|Treatment||27
3165235|NCT01898130|3892791|FG000|Reached 1st Response/2 Cycles|Treatment||24
3009053|NCT01000818|3727233|FG000|STARTED|Omeprazole + Raltegravir||18
3009054|NCT01000818|3727233|FG000|COMPLETED|Omeprazole + Raltegravir||18
3009055|NCT01000818|3727233|FG000|NOT COMPLETED|Omeprazole + Raltegravir||0
3009056|NCT01000961|3727242|FG000|STARTED|Run-in Period of 2-3 Weeks on Cystagon|Part of the Safety analysis set|21
3009057|NCT01000961|3727243|FG001|STARTED|Run-in Period of 2-3 Weeks on Cystagon|Part of the Safety analysis set|22
3009058|NCT01000961|3727242|FG000|COMPLETED|Run-in Period of 2-3 Weeks on Cystagon||21
3009059|NCT01000961|3727243|FG001|COMPLETED|Run-in Period of 2-3 Weeks on Cystagon||22
3009060|NCT01000961|3727242|FG000|NOT COMPLETED|Run-in Period of 2-3 Weeks on Cystagon||0
3009061|NCT01000961|3727243|FG001|NOT COMPLETED|Run-in Period of 2-3 Weeks on Cystagon||0
3009062|NCT01000961|3727242|FG000|STARTED|First Intervention (3 Weeks)||21
3009063|NCT01000961|3727243|FG001|STARTED|First Intervention (3 Weeks)||22
3009064|NCT01000961|3727242|FG000|COMPLETED|First Intervention (3 Weeks)||21
3009065|NCT01000961|3727243|FG001|COMPLETED|First Intervention (3 Weeks)||20
3009066|NCT01000961|3727242|FG000|NOT COMPLETED|First Intervention (3 Weeks)||0
3009067|NCT01000961|3727243|FG001|NOT COMPLETED|First Intervention (3 Weeks)||2
3009068|NCT01000961|3727242|FG000|STARTED|Second Intervention (3 Weeks)||21
3009069|NCT01000961|3727243|FG001|STARTED|Second Intervention (3 Weeks)||20
3009070|NCT01000961|3727242|FG000|COMPLETED|Second Intervention (3 Weeks)|Part of Efficacy analysis set|21
3009071|NCT01000961|3727243|FG001|COMPLETED|Second Intervention (3 Weeks)|Part of Efficacy analysis set|20
3009072|NCT01000961|3727242|FG000|NOT COMPLETED|Second Intervention (3 Weeks)||0
3009073|NCT01000961|3727243|FG001|NOT COMPLETED|Second Intervention (3 Weeks)||0
3009074|NCT01000974|3727254|FG000|STARTED|Primary Vaccination Phase||2963
3009075|NCT01000974|3727255|FG001|STARTED|Primary Vaccination Phase||520
3009076|NCT01000974|3727256|FG002|STARTED|Primary Vaccination Phase||520
3009077|NCT01000974|3727254|FG000|COMPLETED|Primary Vaccination Phase||2625
3009078|NCT01000974|3727255|FG001|COMPLETED|Primary Vaccination Phase||470
3009079|NCT01000974|3727256|FG002|COMPLETED|Primary Vaccination Phase||457
3009080|NCT01000974|3727254|FG000|NOT COMPLETED|Primary Vaccination Phase||338
3009081|NCT01000974|3727255|FG001|NOT COMPLETED|Primary Vaccination Phase||50
3009082|NCT01000974|3727256|FG002|NOT COMPLETED|Primary Vaccination Phase||63
3009083|NCT01000974|3727254|FG000|STARTED|Booster Vaccination Phase||2337
3009084|NCT01000974|3727255|FG001|STARTED|Booster Vaccination Phase||435
3009085|NCT01000974|3727256|FG002|STARTED|Booster Vaccination Phase||400
3009086|NCT01000974|3727254|FG000|COMPLETED|Booster Vaccination Phase||2270
3009087|NCT01000974|3727255|FG001|COMPLETED|Booster Vaccination Phase||423
3009088|NCT01000974|3727256|FG002|COMPLETED|Booster Vaccination Phase||386
3009089|NCT01000974|3727254|FG000|NOT COMPLETED|Booster Vaccination Phase||67
3009090|NCT01000974|3727255|FG001|NOT COMPLETED|Booster Vaccination Phase||12
3009091|NCT01000974|3727256|FG002|NOT COMPLETED|Booster Vaccination Phase||14
3009092|NCT01000987|3727270|FG000|STARTED|Overall Study||12
3009093|NCT01000987|3727271|FG001|STARTED|Overall Study||15
3009094|NCT01000987|3727272|FG002|STARTED|Overall Study||17
3009095|NCT01000987|3727270|FG000|COMPLETED|Overall Study||12
3009096|NCT01000987|3727271|FG001|COMPLETED|Overall Study||15
3009097|NCT01000987|3727272|FG002|COMPLETED|Overall Study||17
3009098|NCT01000987|3727270|FG000|NOT COMPLETED|Overall Study||0
3009099|NCT01000987|3727271|FG001|NOT COMPLETED|Overall Study||0
3009100|NCT01000987|3727272|FG002|NOT COMPLETED|Overall Study||0
3009101|NCT01001052|3727280|FG000|STARTED|Overall Study||20
3009102|NCT01001052|3727281|FG001|STARTED|Overall Study||18
3009103|NCT01001052|3727280|FG000|COMPLETED|Overall Study||20
3009104|NCT01001052|3727281|FG001|COMPLETED|Overall Study||18
3009105|NCT01001052|3727280|FG000|NOT COMPLETED|Overall Study||0
3009106|NCT01001052|3727281|FG001|NOT COMPLETED|Overall Study||0
3009107|NCT01001078|3727289|FG000|STARTED|Overall Study||50
3009108|NCT01001078|3727290|FG001|STARTED|Overall Study||50
3009109|NCT01001078|3727289|FG000|Received Allocated Intervention|Overall Study||46
3009110|NCT01001078|3727290|FG001|Received Allocated Intervention|Overall Study||46
3009111|NCT01001078|3727289|FG000|Received Crossover|Overall Study||2
3009112|NCT01001078|3727290|FG001|Received Crossover|Overall Study||3
3009113|NCT01001078|3727289|FG000|Intubated|Overall Study||2
3009114|NCT01001078|3727290|FG001|Intubated|Overall Study||1
3009115|NCT01001078|3727289|FG000|Lost to Followup Interview|Overall Study|Could not be interviewed.|5
3009116|NCT01001078|3727290|FG001|Lost to Followup Interview|Overall Study|Could not be interviewed.|2
3009117|NCT01001078|3727289|FG000|COMPLETED|Overall Study|Analyzed: 46, excluded from interview analysis: 5|50
3009118|NCT01001078|3727290|FG001|COMPLETED|Overall Study|Analyzed: 46, excluded from interview analysis: 2|50
3009119|NCT01001078|3727289|FG000|NOT COMPLETED|Overall Study||0
3009120|NCT01001078|3727290|FG001|NOT COMPLETED|Overall Study||0
3009121|NCT01001104|3727302|FG000|STARTED|Overall Study||35
3009122|NCT01001104|3727303|FG001|STARTED|Overall Study||37
3009123|NCT01001104|3727304|FG002|STARTED|Overall Study||36
3009124|NCT01001104|3727305|FG003|STARTED|Overall Study||37
3009125|NCT01001104|3727302|FG000|COMPLETED|Overall Study||33
3009126|NCT01001104|3727303|FG001|COMPLETED|Overall Study||36
3009127|NCT01001104|3727304|FG002|COMPLETED|Overall Study||35
3009128|NCT01001104|3727305|FG003|COMPLETED|Overall Study||34
3009129|NCT01001104|3727302|FG000|NOT COMPLETED|Overall Study||2
3009130|NCT01001104|3727303|FG001|NOT COMPLETED|Overall Study||1
3009131|NCT01001104|3727304|FG002|NOT COMPLETED|Overall Study||1
3009132|NCT01001104|3727305|FG003|NOT COMPLETED|Overall Study||3
3009133|NCT01001169|3727320|FG000|STARTED|Overall Study||30
3009134|NCT01001169|3727321|FG001|STARTED|Overall Study||30
3009135|NCT01001169|3727320|FG000|COMPLETED|Overall Study||28
3009136|NCT01001169|3727321|FG001|COMPLETED|Overall Study||29
3009137|NCT01001169|3727320|FG000|NOT COMPLETED|Overall Study||2
3009138|NCT01001169|3727321|FG001|NOT COMPLETED|Overall Study||1
3009139|NCT01001195|3727339|FG000|STARTED|Overall Study||39
3009140|NCT01001195|3727340|FG001|STARTED|Overall Study||41
3009141|NCT01001195|3727341|FG002|STARTED|Overall Study||44
3009142|NCT01001195|3727342|FG003|STARTED|Overall Study||41
3009143|NCT01001195|3727339|FG000|COMPLETED|Overall Study||37
3009144|NCT01001195|3727340|FG001|COMPLETED|Overall Study||39
3009145|NCT01001195|3727341|FG002|COMPLETED|Overall Study||44
3009146|NCT01001195|3727342|FG003|COMPLETED|Overall Study||41
3009147|NCT01001195|3727339|FG000|NOT COMPLETED|Overall Study||2
3009148|NCT01001195|3727340|FG001|NOT COMPLETED|Overall Study||2
3009149|NCT01001195|3727341|FG002|NOT COMPLETED|Overall Study||0
3009150|NCT01001195|3727342|FG003|NOT COMPLETED|Overall Study||0
3009151|NCT01001208|3727354|FG000|STARTED|Overall Study||239
3009152|NCT01001208|3727355|FG001|STARTED|Overall Study||239
3009153|NCT01001208|3727354|FG000|COMPLETED|Overall Study||211
3009154|NCT01001208|3727355|FG001|COMPLETED|Overall Study||206
3009155|NCT01001208|3727354|FG000|NOT COMPLETED|Overall Study||28
3009156|NCT01001208|3727355|FG001|NOT COMPLETED|Overall Study||33
3009157|NCT01001221|3727365|FG000|STARTED|Overall Study||5
3009158|NCT01001221|3727366|FG001|STARTED|Overall Study||5
3009159|NCT01001221|3727367|FG002|STARTED|Overall Study||3
3009160|NCT01001221|3727368|FG003|STARTED|Overall Study||6
3009161|NCT01001221|3727369|FG004|STARTED|Overall Study|Inability to determine the MTD during study part 1|0
3009162|NCT01001221|3727365|FG000|Treated|Overall Study||5
3009163|NCT01001221|3727366|FG001|Treated|Overall Study||5
3009164|NCT01001221|3727367|FG002|Treated|Overall Study||2
3009165|NCT01001221|3727368|FG003|Treated|Overall Study||6
3009166|NCT01001221|3727369|FG004|Treated|Overall Study||0
3009167|NCT01001221|3727365|FG000|Completed 1st Treatment Cycle|Overall Study||5
3009168|NCT01001221|3727366|FG001|Completed 1st Treatment Cycle|Overall Study||5
3009169|NCT01001221|3727367|FG002|Completed 1st Treatment Cycle|Overall Study||2
3009170|NCT01001221|3727368|FG003|Completed 1st Treatment Cycle|Overall Study||6
3009171|NCT01001221|3727369|FG004|Completed 1st Treatment Cycle|Overall Study||0
3009172|NCT01001221|3727365|FG000|COMPLETED|Overall Study|Participants treated until disease progression or unacceptable toxicity.|0
3009173|NCT01001221|3727366|FG001|COMPLETED|Overall Study|Participants treated until disease progression or unacceptable toxicity.|0
3009174|NCT01001221|3727367|FG002|COMPLETED|Overall Study|Participants treated until disease progression or unacceptable toxicity.|0
3009175|NCT01001221|3727368|FG003|COMPLETED|Overall Study|Participants treated until disease progression or unacceptable toxicity.|0
3009176|NCT01001221|3727369|FG004|COMPLETED|Overall Study||0
3009177|NCT01001221|3727365|FG000|NOT COMPLETED|Overall Study||5
3009178|NCT01001221|3727366|FG001|NOT COMPLETED|Overall Study||5
3009179|NCT01001221|3727367|FG002|NOT COMPLETED|Overall Study||3
3009180|NCT01001221|3727368|FG003|NOT COMPLETED|Overall Study||6
3009181|NCT01001221|3727369|FG004|NOT COMPLETED|Overall Study||0
3009182|NCT01001299|3727380|FG000|STARTED|Overall Study||25
3009183|NCT01001299|3727380|FG000|COMPLETED|Overall Study||0
3009184|NCT01001299|3727380|FG000|NOT COMPLETED|Overall Study||25
3009185|NCT01001325|3727386|FG000|STARTED|Overall Study||234
3009186|NCT01001325|3727387|FG001|STARTED|Overall Study||234
3009187|NCT01001325|3727386|FG000|COMPLETED|Overall Study||216
3009188|NCT01001325|3727387|FG001|COMPLETED|Overall Study||224
3009189|NCT01001325|3727386|FG000|NOT COMPLETED|Overall Study||18
3009190|NCT01001325|3727387|FG001|NOT COMPLETED|Overall Study||10
3009191|NCT01001377|3727395|FG000|STARTED|Overall Study||504
3009192|NCT01001377|3727396|FG001|STARTED|Overall Study||506
3009193|NCT01001377|3727395|FG000|Received Treatment|Overall Study||500
3009194|NCT01001377|3727396|FG001|Received Treatment|Overall Study||499
3009195|NCT01001377|3727395|FG000|COMPLETED|Overall Study|Indicates participants continuing in study|78
3009196|NCT01001377|3727396|FG001|COMPLETED|Overall Study|Indicates participants continuing in study|85
3009197|NCT01001377|3727395|FG000|NOT COMPLETED|Overall Study||426
3009198|NCT01001377|3727396|FG001|NOT COMPLETED|Overall Study||421
3009199|NCT01001403|3727404|FG000|STARTED|Overall Study||31
3009200|NCT01001403|3727405|FG001|STARTED|Overall Study||31
3009201|NCT01001403|3727404|FG000|COMPLETED|Overall Study||31
3009202|NCT01001403|3727405|FG001|COMPLETED|Overall Study||31
3009203|NCT01001403|3727404|FG000|NOT COMPLETED|Overall Study||0
3009204|NCT01001403|3727405|FG001|NOT COMPLETED|Overall Study||0
3009205|NCT01001429|3727413|FG000|STARTED|Overall Study||39
3009206|NCT01001429|3727414|FG001|STARTED|Overall Study||38
3009207|NCT01001429|3727413|FG000|COMPLETED|Overall Study||39
3009208|NCT01001429|3727414|FG001|COMPLETED|Overall Study||37
3009209|NCT01001429|3727413|FG000|NOT COMPLETED|Overall Study||0
3009210|NCT01001429|3727414|FG001|NOT COMPLETED|Overall Study||1
3009211|NCT01001442|3727452|FG000|STARTED|Overall Study||4
3009212|NCT01001442|3727453|FG001|STARTED|Overall Study||3
3009213|NCT01001442|3727454|FG002|STARTED|Overall Study||4
3009214|NCT01001442|3727455|FG003|STARTED|Overall Study||3
3009215|NCT01001442|3727456|FG004|STARTED|Overall Study||4
3009216|NCT01001442|3727457|FG005|STARTED|Overall Study||3
3009217|NCT01001442|3727458|FG006|STARTED|Overall Study||10
3009218|NCT01001442|3727459|FG007|STARTED|Overall Study||4
3009219|NCT01001442|3727452|FG000|COMPLETED|Overall Study||4
3009220|NCT01001442|3727453|FG001|COMPLETED|Overall Study||3
3009221|NCT01001442|3727454|FG002|COMPLETED|Overall Study||4
3009222|NCT01001442|3727455|FG003|COMPLETED|Overall Study||3
3009223|NCT01001442|3727456|FG004|COMPLETED|Overall Study||2
3009224|NCT01001442|3727457|FG005|COMPLETED|Overall Study||3
3009225|NCT01001442|3727458|FG006|COMPLETED|Overall Study||6
3009226|NCT01001442|3727459|FG007|COMPLETED|Overall Study||2
3009227|NCT01001442|3727452|FG000|NOT COMPLETED|Overall Study||0
3009228|NCT01001442|3727453|FG001|NOT COMPLETED|Overall Study||0
3009229|NCT01001442|3727454|FG002|NOT COMPLETED|Overall Study||0
3009230|NCT01001442|3727455|FG003|NOT COMPLETED|Overall Study||0
3009231|NCT01001442|3727456|FG004|NOT COMPLETED|Overall Study||2
3009232|NCT01001442|3727457|FG005|NOT COMPLETED|Overall Study||0
3009233|NCT01001442|3727458|FG006|NOT COMPLETED|Overall Study||4
3009234|NCT01001442|3727459|FG007|NOT COMPLETED|Overall Study||2
3009235|NCT01001494|3727484|FG000|STARTED|Overall Study|280 patients were randomized, but baseline data was missing from 3 patients in one center|277
3009236|NCT01001494|3727485|FG001|STARTED|Overall Study|272 patients were randomized, but baseline data was missing from 3 patients in one center|269
3009237|NCT01001494|3727486|FG002|STARTED|Overall Study|276 patients were randomized, but baseline data was missing from 3 patients in one center|273
3009238|NCT01001494|3727484|FG000|COMPLETED|Overall Study||253
3009239|NCT01001494|3727485|FG001|COMPLETED|Overall Study||252
3009240|NCT01001494|3727486|FG002|COMPLETED|Overall Study||232
3009241|NCT01001494|3727484|FG000|NOT COMPLETED|Overall Study||24
3009242|NCT01001494|3727485|FG001|NOT COMPLETED|Overall Study||17
3009243|NCT01001494|3727486|FG002|NOT COMPLETED|Overall Study||41
3009244|NCT01001520|3727494|FG000|STARTED|Medication Period 1||22
3009245|NCT01001520|3727495|FG001|STARTED|Medication Period 1||24
3009246|NCT01001520|3727494|FG000|COMPLETED|Medication Period 1||18
3009247|NCT01001520|3727495|FG001|COMPLETED|Medication Period 1||17
3009248|NCT01001520|3727494|FG000|NOT COMPLETED|Medication Period 1||4
3009249|NCT01001520|3727495|FG001|NOT COMPLETED|Medication Period 1||7
3009250|NCT01001520|3727494|FG000|STARTED|Washout Period||18
3009251|NCT01001520|3727495|FG001|STARTED|Washout Period||17
3009252|NCT01001520|3727494|FG000|COMPLETED|Washout Period||16
3009253|NCT01001520|3727495|FG001|COMPLETED|Washout Period||16
3009254|NCT01001520|3727494|FG000|NOT COMPLETED|Washout Period||2
3009255|NCT01001520|3727495|FG001|NOT COMPLETED|Washout Period||1
3009256|NCT01001520|3727494|FG000|STARTED|Medication Period 2||16
3009257|NCT01001520|3727495|FG001|STARTED|Medication Period 2||16
3009258|NCT01001520|3727494|FG000|COMPLETED|Medication Period 2||16
3009259|NCT01001520|3727495|FG001|COMPLETED|Medication Period 2||13
3009260|NCT01001520|3727494|FG000|NOT COMPLETED|Medication Period 2||0
3009261|NCT01001520|3727495|FG001|NOT COMPLETED|Medication Period 2||3
3009262|NCT01001546|3727506|FG000|STARTED|Overall Study||206
3009263|NCT01001546|3727507|FG001|STARTED|Overall Study||207
3009264|NCT01001546|3727506|FG000|COMPLETED|Overall Study||206
3009265|NCT01001546|3727507|FG001|COMPLETED|Overall Study||207
3009266|NCT01001546|3727506|FG000|NOT COMPLETED|Overall Study||0
3009267|NCT01001546|3727507|FG001|NOT COMPLETED|Overall Study||0
3009268|NCT01001559|3727515|FG000|STARTED|Overall Study||95
3009269|NCT01001559|3727516|FG001|STARTED|Overall Study||147
3009270|NCT01001559|3727515|FG000|COMPLETED|Overall Study||95
3009271|NCT01001559|3727516|FG001|COMPLETED|Overall Study||147
3009272|NCT01001559|3727515|FG000|NOT COMPLETED|Overall Study||0
3009273|NCT01001559|3727516|FG001|NOT COMPLETED|Overall Study||0
3009274|NCT01001572|3727524|FG000|STARTED|Single-Blind Valsartan 160 mg||932
3009275|NCT01001572|3727525|FG001|STARTED|Single-Blind Valsartan 160 mg|Participants did not enroll into this arm during single blind period.|0
3009276|NCT01001572|3727526|FG002|STARTED|Single-Blind Valsartan 160 mg|Participants did not enroll into this arm during single blind period.|0
3009277|NCT01001572|3727524|FG000|COMPLETED|Single-Blind Valsartan 160 mg||654
3009278|NCT01001572|3727525|FG001|COMPLETED|Single-Blind Valsartan 160 mg||0
3009279|NCT01001572|3727526|FG002|COMPLETED|Single-Blind Valsartan 160 mg||0
3009280|NCT01001572|3727524|FG000|NOT COMPLETED|Single-Blind Valsartan 160 mg||278
3009281|NCT01001572|3727525|FG001|NOT COMPLETED|Single-Blind Valsartan 160 mg||0
3009282|NCT01001572|3727526|FG002|NOT COMPLETED|Single-Blind Valsartan 160 mg||0
3009283|NCT01001572|3727524|FG000|STARTED|Double-Blind Treatment Phase|This arm is only used for single blind period. So, no enrollment during double blind period.|0
3009284|NCT01001572|3727525|FG001|STARTED|Double-Blind Treatment Phase||329
3009285|NCT01001572|3727526|FG002|STARTED|Double-Blind Treatment Phase||325
3009286|NCT01001572|3727524|FG000|Full Analysis Set (FAS)|Double-Blind Treatment Phase||0
3009287|NCT01001572|3727525|FG001|Full Analysis Set (FAS)|Double-Blind Treatment Phase|One patient was excluded from full analysis set for having no post-baseline efficacy assessment.|328
3009288|NCT01001572|3727526|FG002|Full Analysis Set (FAS)|Double-Blind Treatment Phase|Two patients were excluded from full analysis set for having no post-baseline efficacy assessment.|323
3009289|NCT01001572|3727524|FG000|COMPLETED|Double-Blind Treatment Phase||0
3009290|NCT01001572|3727525|FG001|COMPLETED|Double-Blind Treatment Phase||319
3009291|NCT01001572|3727526|FG002|COMPLETED|Double-Blind Treatment Phase||306
3009292|NCT01001572|3727524|FG000|NOT COMPLETED|Double-Blind Treatment Phase||0
3009293|NCT01001572|3727525|FG001|NOT COMPLETED|Double-Blind Treatment Phase||10
3009294|NCT01001572|3727526|FG002|NOT COMPLETED|Double-Blind Treatment Phase||19
3009295|NCT01001598|3727532|FG000|STARTED|Overall Study||5
3009296|NCT01001598|3727532|FG000|COMPLETED|Overall Study|3 completed study (2 FA and 1 DC) in 2011|3
3009297|NCT01001598|3727532|FG000|NOT COMPLETED|Overall Study||2
3009298|NCT01001702|3727536|FG000|STARTED|Overall Study||85
3009299|NCT01001702|3727536|FG000|COMPLETED|Overall Study||13
3009300|NCT01001702|3727536|FG000|NOT COMPLETED|Overall Study||72
3009301|NCT01001767|3727542|FG000|STARTED|Overall Study||18
3009302|NCT01001767|3727543|FG001|STARTED|Overall Study||17
3009303|NCT01001767|3727542|FG000|COMPLETED|Overall Study||14
3009304|NCT01001767|3727543|FG001|COMPLETED|Overall Study||17
3009305|NCT01001767|3727542|FG000|NOT COMPLETED|Overall Study||4
3009306|NCT01001767|3727543|FG001|NOT COMPLETED|Overall Study||0
3009307|NCT01001806|3727552|FG000|STARTED|Overall Study||42
3009308|NCT01001806|3727553|FG001|STARTED|Overall Study||42
3009309|NCT01001806|3727554|FG002|STARTED|Overall Study||42
3009310|NCT01001806|3727552|FG000|COMPLETED|Overall Study||42
3009311|NCT01001806|3727553|FG001|COMPLETED|Overall Study||41
3009312|NCT01001806|3727554|FG002|COMPLETED|Overall Study||38
3009313|NCT01001806|3727552|FG000|NOT COMPLETED|Overall Study||0
3009314|NCT01001806|3727553|FG001|NOT COMPLETED|Overall Study||1
3009315|NCT01001806|3727554|FG002|NOT COMPLETED|Overall Study||4
3009316|NCT01001832|3727564|FG000|STARTED|Short-term Period||59
3009317|NCT01001832|3727565|FG001|STARTED|Short-term Period||59
3009318|NCT01001832|3727564|FG000|COMPLETED|Short-term Period||57
3009319|NCT01001832|3727565|FG001|COMPLETED|Short-term Period||56
3009320|NCT01001832|3727564|FG000|NOT COMPLETED|Short-term Period||2
3009321|NCT01001832|3727565|FG001|NOT COMPLETED|Short-term Period||3
3009322|NCT01001832|3727564|FG000|STARTED|Long-term Period|1 participant completed the short term period but discontinued before start of the Long-term Period.|56
3009323|NCT01001832|3727565|FG001|STARTED|Long-term Period||56
3009324|NCT01001832|3727564|FG000|COMPLETED|Long-term Period||52
3009325|NCT01001832|3727565|FG001|COMPLETED|Long-term Period||51
3009326|NCT01001832|3727564|FG000|NOT COMPLETED|Long-term Period||4
3009327|NCT01001832|3727565|FG001|NOT COMPLETED|Long-term Period||5
3009328|NCT01001832|3727564|FG000|STARTED|Follow-up Period||52
3009329|NCT01001832|3727565|FG001|STARTED|Follow-up Period||51
3009330|NCT01001832|3727564|FG000|COMPLETED|Follow-up Period||34
3009331|NCT01001832|3727565|FG001|COMPLETED|Follow-up Period||30
3009332|NCT01001832|3727564|FG000|NOT COMPLETED|Follow-up Period||18
3009333|NCT01001832|3727565|FG001|NOT COMPLETED|Follow-up Period||21
3009334|NCT01001910|3727574|FG000|STARTED|Overall Study|We screened and started 28 patients in the study. However only 22 patients were evaluable for outcome, because 6 patients did not receive adequate number of cycles of treatment for analysis. While we could not evaluate these 6 patients for their outcome, their treatment-cycles were included in the safe analysis.|28
3009335|NCT01001910|3727574|FG000|COMPLETED|Overall Study|6 patients did not receive 3 cycles required for evaluation of response as per protocol s7.1.1|22
3009336|NCT01001910|3727574|FG000|NOT COMPLETED|Overall Study||6
3009337|NCT01001975|3727580|FG000|STARTED|Overall Study||5
3009338|NCT01001975|3727581|FG001|STARTED|Overall Study||5
3009339|NCT01001975|3727580|FG000|COMPLETED|Overall Study||5
3009340|NCT01001975|3727581|FG001|COMPLETED|Overall Study||5
3009341|NCT01001975|3727580|FG000|NOT COMPLETED|Overall Study||0
3009342|NCT01001975|3727581|FG001|NOT COMPLETED|Overall Study||0
3009343|NCT01001988|3727587|FG000|STARTED|Overall Study||596
3009344|NCT01001988|3727587|FG000|COMPLETED|Overall Study||479
3009345|NCT01001988|3727587|FG000|NOT COMPLETED|Overall Study||117
3009346|NCT01002105|3727593|FG000|STARTED|Overall Study||32
3009347|NCT01002105|3727594|FG001|STARTED|Overall Study||32
3009348|NCT01002105|3727593|FG000|COMPLETED|Overall Study||13
3009349|NCT01002105|3727594|FG001|COMPLETED|Overall Study||11
3009350|NCT01002105|3727593|FG000|NOT COMPLETED|Overall Study||19
3009351|NCT01002105|3727594|FG001|NOT COMPLETED|Overall Study||21
3009352|NCT01002118|3727603|FG000|STARTED|Overall Study||1
3009353|NCT01002118|3727603|FG000|Randomized Only Patient|Overall Study||1
3009354|NCT01002118|3727603|FG000|COMPLETED|Overall Study||1
3009355|NCT01002118|3727603|FG000|NOT COMPLETED|Overall Study||0
3009356|NCT01002287|3727609|FG000|STARTED|Overall Study||8
3009357|NCT01002287|3727610|FG001|STARTED|Overall Study||3
3009358|NCT01002287|3727609|FG000|COMPLETED|Overall Study||8
3009359|NCT01002287|3727610|FG001|COMPLETED|Overall Study||3
3009360|NCT01002287|3727609|FG000|NOT COMPLETED|Overall Study||0
3009361|NCT01002287|3727610|FG001|NOT COMPLETED|Overall Study||0
3009362|NCT01002339|3727619|FG000|STARTED|Overall Study||44
3009363|NCT01002339|3727620|FG001|STARTED|Overall Study||43
3009364|NCT01002339|3727621|FG002|STARTED|Overall Study||47
3009365|NCT01002339|3727619|FG000|COMPLETED|Overall Study||44
3009366|NCT01002339|3727620|FG001|COMPLETED|Overall Study||42
3009367|NCT01002339|3727621|FG002|COMPLETED|Overall Study||42
3009368|NCT01002339|3727619|FG000|NOT COMPLETED|Overall Study||0
3009369|NCT01002339|3727620|FG001|NOT COMPLETED|Overall Study||1
3009370|NCT01002339|3727621|FG002|NOT COMPLETED|Overall Study||5
3009371|NCT01002456|3727631|FG000|STARTED|Overall Study||98
3009372|NCT01002456|3727632|FG001|STARTED|Overall Study||122
3009373|NCT01002456|3727631|FG000|COMPLETED|Overall Study||98
3009374|NCT01002456|3727632|FG001|COMPLETED|Overall Study||122
3009375|NCT01002456|3727631|FG000|NOT COMPLETED|Overall Study||0
3009376|NCT01002456|3727632|FG001|NOT COMPLETED|Overall Study||0
3009377|NCT01002482|3727642|FG000|STARTED|Overall Study||1351
3009378|NCT01002482|3727643|FG001|STARTED|Overall Study||1333
3009379|NCT01002482|3727642|FG000|COMPLETED|Overall Study||1336
3009380|NCT01002482|3727643|FG001|COMPLETED|Overall Study||1312
3009381|NCT01002482|3727642|FG000|NOT COMPLETED|Overall Study||15
3009382|NCT01002482|3727643|FG001|NOT COMPLETED|Overall Study||21
3009383|NCT01002547|3727652|FG000|STARTED|Overall Study||32
3009384|NCT01002547|3727653|FG001|STARTED|Overall Study||36
3009385|NCT01002547|3727654|FG002|STARTED|Overall Study||37
3009386|NCT01002547|3727652|FG000|COMPLETED|Overall Study||24
3009387|NCT01002547|3727653|FG001|COMPLETED|Overall Study||33
3009388|NCT01002547|3727654|FG002|COMPLETED|Overall Study||29
3009389|NCT01002547|3727652|FG000|NOT COMPLETED|Overall Study||8
3009390|NCT01002547|3727653|FG001|NOT COMPLETED|Overall Study||3
3009391|NCT01002547|3727654|FG002|NOT COMPLETED|Overall Study||8
3009392|NCT01002573|3727664|FG000|STARTED|Overall Study||58
3009393|NCT01002573|3727665|FG001|STARTED|Overall Study||60
3009394|NCT01002573|3727664|FG000|COMPLETED|Overall Study||47
3009395|NCT01002573|3727665|FG001|COMPLETED|Overall Study||53
3009396|NCT01002573|3727664|FG000|NOT COMPLETED|Overall Study||11
3009397|NCT01002573|3727665|FG001|NOT COMPLETED|Overall Study||7
3009398|NCT01002742|3727673|FG000|STARTED|Overall Study||119
3009399|NCT01002742|3727674|FG001|STARTED|Overall Study||117
3009400|NCT01002742|3727673|FG000|COMPLETED|Overall Study||119
3009401|NCT01002742|3727674|FG001|COMPLETED|Overall Study||116
3009402|NCT01002742|3727673|FG000|NOT COMPLETED|Overall Study||0
3009403|NCT01002742|3727674|FG001|NOT COMPLETED|Overall Study||1
3009404|NCT01002755|3727680|FG000|STARTED|Overall Study||36
3009405|NCT01002755|3727680|FG000|COMPLETED|Overall Study||36
3009406|NCT01002755|3727680|FG000|NOT COMPLETED|Overall Study||0
3009407|NCT01002989|3727684|FG000|STARTED|Overall Study||98
3009408|NCT01002989|3727684|FG000|COMPLETED|Overall Study||93
3009409|NCT01002989|3727684|FG000|NOT COMPLETED|Overall Study||5
3009410|NCT01003067|3727690|FG000|STARTED|Overall Study||136
3009411|NCT01003067|3727691|FG001|STARTED|Overall Study||131
3009412|NCT01003067|3727690|FG000|COMPLETED|Overall Study||103
3009413|NCT01003067|3727691|FG001|COMPLETED|Overall Study||107
3009414|NCT01003067|3727690|FG000|NOT COMPLETED|Overall Study||33
3009415|NCT01003067|3727691|FG001|NOT COMPLETED|Overall Study||24
3009416|NCT01003080|3727699|FG000|STARTED|Overall Study||50
3009417|NCT01003080|3727700|FG001|STARTED|Overall Study||61
3009418|NCT01003080|3727699|FG000|COMPLETED|Overall Study||50
3009419|NCT01003080|3727700|FG001|COMPLETED|Overall Study||61
3009420|NCT01003080|3727699|FG000|NOT COMPLETED|Overall Study||0
3009421|NCT01003080|3727700|FG001|NOT COMPLETED|Overall Study||0
3009422|NCT01003106|3727710|FG000|STARTED|Baseline to Month 6||22
3009423|NCT01003106|3727711|FG001|STARTED|Baseline to Month 6||20
3009424|NCT01003106|3727712|FG002|STARTED|Baseline to Month 6||0
3009425|NCT01003106|3727713|FG003|STARTED|Baseline to Month 6||0
3009426|NCT01003106|3727714|FG004|STARTED|Baseline to Month 6||19
3009427|NCT01003106|3727715|FG005|STARTED|Baseline to Month 6||20
3009428|NCT01003106|3727716|FG006|STARTED|Baseline to Month 6||0
3009429|NCT01003106|3727717|FG007|STARTED|Baseline to Month 6||0
3009430|NCT01003106|3727710|FG000|COMPLETED|Baseline to Month 6||22
3009431|NCT01003106|3727711|FG001|COMPLETED|Baseline to Month 6||20
3009432|NCT01003106|3727712|FG002|COMPLETED|Baseline to Month 6||0
3009433|NCT01003106|3727713|FG003|COMPLETED|Baseline to Month 6||0
3009434|NCT01003106|3727714|FG004|COMPLETED|Baseline to Month 6||19
3009435|NCT01003106|3727715|FG005|COMPLETED|Baseline to Month 6||20
3009436|NCT01003106|3727716|FG006|COMPLETED|Baseline to Month 6||0
3009437|NCT01003106|3727717|FG007|COMPLETED|Baseline to Month 6||0
3009438|NCT01003106|3727710|FG000|NOT COMPLETED|Baseline to Month 6||0
3009439|NCT01003106|3727711|FG001|NOT COMPLETED|Baseline to Month 6||0
3009440|NCT01003106|3727712|FG002|NOT COMPLETED|Baseline to Month 6||0
3009441|NCT01003106|3727713|FG003|NOT COMPLETED|Baseline to Month 6||0
3009442|NCT01003106|3727714|FG004|NOT COMPLETED|Baseline to Month 6||0
3009443|NCT01003106|3727715|FG005|NOT COMPLETED|Baseline to Month 6||0
3009444|NCT01003106|3727716|FG006|NOT COMPLETED|Baseline to Month 6||0
3009445|NCT01003106|3727717|FG007|NOT COMPLETED|Baseline to Month 6||0
3009446|NCT01003106|3727710|FG000|STARTED|Month 6-Month 36||0
3009447|NCT01003106|3727711|FG001|STARTED|Month 6-Month 36||0
3009448|NCT01003106|3727712|FG002|STARTED|Month 6-Month 36||19
3009449|NCT01003106|3727713|FG003|STARTED|Month 6-Month 36||20
3009450|NCT01003106|3727714|FG004|STARTED|Month 6-Month 36||0
3009451|NCT01003106|3727715|FG005|STARTED|Month 6-Month 36||0
3009452|NCT01003106|3727716|FG006|STARTED|Month 6-Month 36||20
3009453|NCT01003106|3727717|FG007|STARTED|Month 6-Month 36||18
3009454|NCT01003106|3727710|FG000|COMPLETED|Month 6-Month 36||0
3009455|NCT01003106|3727711|FG001|COMPLETED|Month 6-Month 36||0
3009456|NCT01003106|3727712|FG002|COMPLETED|Month 6-Month 36||18
3009457|NCT01003106|3727713|FG003|COMPLETED|Month 6-Month 36||20
3009458|NCT01003106|3727714|FG004|COMPLETED|Month 6-Month 36||0
3009459|NCT01003106|3727715|FG005|COMPLETED|Month 6-Month 36||0
3009460|NCT01003106|3727716|FG006|COMPLETED|Month 6-Month 36||19
3009461|NCT01003106|3727717|FG007|COMPLETED|Month 6-Month 36||18
3009462|NCT01003106|3727710|FG000|NOT COMPLETED|Month 6-Month 36||0
3009463|NCT01003106|3727711|FG001|NOT COMPLETED|Month 6-Month 36||0
3009464|NCT01003106|3727712|FG002|NOT COMPLETED|Month 6-Month 36||1
3009465|NCT01003106|3727713|FG003|NOT COMPLETED|Month 6-Month 36||0
3009466|NCT01003106|3727714|FG004|NOT COMPLETED|Month 6-Month 36||0
3009467|NCT01003106|3727715|FG005|NOT COMPLETED|Month 6-Month 36||0
3009468|NCT01003106|3727716|FG006|NOT COMPLETED|Month 6-Month 36||1
3009469|NCT01003106|3727717|FG007|NOT COMPLETED|Month 6-Month 36||0
3009470|NCT01003184|3727733|FG000|STARTED|Overall Study||111
3009471|NCT01003184|3727734|FG001|STARTED|Overall Study||111
3009472|NCT01003184|3727733|FG000|Full Analysis Set (FAS)|Overall Study||111
3009473|NCT01003184|3727734|FG001|Full Analysis Set (FAS)|Overall Study||105
3009474|NCT01003184|3727733|FG000|COMPLETED|Overall Study||92
3009475|NCT01003184|3727734|FG001|COMPLETED|Overall Study||99
3009476|NCT01003184|3727733|FG000|NOT COMPLETED|Overall Study||19
3009477|NCT01003184|3727734|FG001|NOT COMPLETED|Overall Study||12
3009478|NCT01003210|3727742|FG000|STARTED|Overall Study||105
3009479|NCT01003210|3727743|FG001|STARTED|Overall Study||105
3009480|NCT01003210|3727742|FG000|COMPLETED|Overall Study||104
3009481|NCT01003210|3727743|FG001|COMPLETED|Overall Study||102
3009482|NCT01003210|3727742|FG000|NOT COMPLETED|Overall Study||1
3009483|NCT01003210|3727743|FG001|NOT COMPLETED|Overall Study||3
3009484|NCT01003249|3727749|FG000|STARTED|First Intervention (4 Weeks)||7
3009485|NCT01003249|3727750|FG001|STARTED|First Intervention (4 Weeks)||5
3009486|NCT01003249|3727749|FG000|Received Intervention|First Intervention (4 Weeks)||7
3009487|NCT01003249|3727750|FG001|Received Intervention|First Intervention (4 Weeks)||5
3009488|NCT01003249|3727749|FG000|COMPLETED|First Intervention (4 Weeks)||5
3009489|NCT01003249|3727750|FG001|COMPLETED|First Intervention (4 Weeks)||3
3009490|NCT01003249|3727749|FG000|NOT COMPLETED|First Intervention (4 Weeks)||2
3009491|NCT01003249|3727750|FG001|NOT COMPLETED|First Intervention (4 Weeks)||2
3009492|NCT01003249|3727749|FG000|STARTED|Washout (3 Weeks)||4
3009493|NCT01003249|3727750|FG001|STARTED|Washout (3 Weeks)||3
3009494|NCT01003249|3727749|FG000|COMPLETED|Washout (3 Weeks)||4
3009495|NCT01003249|3727750|FG001|COMPLETED|Washout (3 Weeks)||3
3009496|NCT01003249|3727749|FG000|NOT COMPLETED|Washout (3 Weeks)||0
3009497|NCT01003249|3727750|FG001|NOT COMPLETED|Washout (3 Weeks)||0
3009498|NCT01003249|3727749|FG000|STARTED|Second Intervention (4 Weeks)||4
3009499|NCT01003249|3727750|FG001|STARTED|Second Intervention (4 Weeks)||3
3009500|NCT01003249|3727749|FG000|COMPLETED|Second Intervention (4 Weeks)||3
3009501|NCT01003249|3727750|FG001|COMPLETED|Second Intervention (4 Weeks)||2
3009502|NCT01003249|3727749|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||1
3009503|NCT01003249|3727750|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||1
3009504|NCT01003275|3727762|FG000|STARTED|Overall Study||11
3009505|NCT01003275|3727763|FG001|STARTED|Overall Study||11
3009506|NCT01003275|3727762|FG000|COMPLETED|Overall Study||10
3009507|NCT01003275|3727763|FG001|COMPLETED|Overall Study||11
3009508|NCT01003275|3727762|FG000|NOT COMPLETED|Overall Study||1
3009509|NCT01003275|3727763|FG001|NOT COMPLETED|Overall Study||0
3009510|NCT01003288|3727771|FG000|STARTED|Overall Study||255
3009511|NCT01003288|3727771|FG000|COMPLETED|Overall Study||255
3009512|NCT01003288|3727771|FG000|NOT COMPLETED|Overall Study||0
3009513|NCT01003301|3727778|FG000|STARTED|Overall Study||10
3009514|NCT01003301|3727779|FG001|STARTED|Overall Study||9
3009515|NCT01003301|3727778|FG000|COMPLETED|Overall Study||10
3009516|NCT01003301|3727779|FG001|COMPLETED|Overall Study||9
3009517|NCT01003301|3727778|FG000|NOT COMPLETED|Overall Study||0
3009518|NCT01003301|3727779|FG001|NOT COMPLETED|Overall Study||0
3009519|NCT01003418|3727787|FG000|STARTED|Overall Study||5
3009520|NCT01003418|3727788|FG001|STARTED|Overall Study||3
3009521|NCT01003418|3727787|FG000|COMPLETED|Overall Study||5
3009522|NCT01003418|3727788|FG001|COMPLETED|Overall Study||3
3009523|NCT01003418|3727787|FG000|NOT COMPLETED|Overall Study||0
3009524|NCT01003418|3727788|FG001|NOT COMPLETED|Overall Study||0
3009525|NCT01003639|3727796|FG000|STARTED|Overall Study||86
3009526|NCT01003639|3727797|FG001|STARTED|Overall Study||79
3009527|NCT01003639|3727796|FG000|COMPLETED|Overall Study||69
3009528|NCT01003639|3727797|FG001|COMPLETED|Overall Study||57
3009529|NCT01003639|3727796|FG000|NOT COMPLETED|Overall Study||17
3009530|NCT01003639|3727797|FG001|NOT COMPLETED|Overall Study||22
3009531|NCT01003769|3727803|FG000|STARTED|Overall Study||5
3009532|NCT01003769|3727803|FG000|COMPLETED|Overall Study||5
3009533|NCT01003769|3727803|FG000|NOT COMPLETED|Overall Study||0
3009534|NCT01003886|3727807|FG000|STARTED|Overall Study||989
3009535|NCT01003886|3727807|FG000|COMPLETED|Overall Study||759
3009536|NCT01003886|3727807|FG000|NOT COMPLETED|Overall Study||230
3037380|NCT01147809|3756665|FG002|STARTED|Phase II (168 Days)||0
3037381|NCT01147809|3756666|FG003|STARTED|Phase II (168 Days)||0
3037382|NCT01147809|3756667|FG004|STARTED|Phase II (168 Days)||23
3037383|NCT01147809|3756668|FG005|STARTED|Phase II (168 Days)||52
3037384|NCT01147809|3756663|FG000|Ongoing|Phase II (168 Days)||0
3037385|NCT01147809|3756664|FG001|Ongoing|Phase II (168 Days)||0
3037386|NCT01147809|3756665|FG002|Ongoing|Phase II (168 Days)||0
3037387|NCT01147809|3756666|FG003|Ongoing|Phase II (168 Days)||0
3037388|NCT01147809|3756667|FG004|Ongoing|Phase II (168 Days)||1
3037389|NCT01147809|3756668|FG005|Ongoing|Phase II (168 Days)||0
3037390|NCT01147809|3756663|FG000|COMPLETED|Phase II (168 Days)||0
3037391|NCT01147809|3756664|FG001|COMPLETED|Phase II (168 Days)||0
3037392|NCT01147809|3756665|FG002|COMPLETED|Phase II (168 Days)||0
3037393|NCT01147809|3756666|FG003|COMPLETED|Phase II (168 Days)||0
3037394|NCT01147809|3756667|FG004|COMPLETED|Phase II (168 Days)||7
3037395|NCT01147809|3756668|FG005|COMPLETED|Phase II (168 Days)||19
3037396|NCT01147809|3756663|FG000|NOT COMPLETED|Phase II (168 Days)||0
3037397|NCT01147809|3756664|FG001|NOT COMPLETED|Phase II (168 Days)||0
3037398|NCT01147809|3756665|FG002|NOT COMPLETED|Phase II (168 Days)||0
3037399|NCT01147809|3756666|FG003|NOT COMPLETED|Phase II (168 Days)||0
3037400|NCT01147809|3756667|FG004|NOT COMPLETED|Phase II (168 Days)||16
3037401|NCT01147809|3756668|FG005|NOT COMPLETED|Phase II (168 Days)||33
3009537|NCT01003899|3727811|FG000|STARTED|Overall Study|enrolled|47
3009538|NCT01003899|3727811|FG000|COMPLETED|Overall Study||0
3009539|NCT01003899|3727811|FG000|NOT COMPLETED|Overall Study||47
3009540|NCT01003938|3727815|FG000|STARTED|Overall Study||6
3009541|NCT01003938|3727815|FG000|COMPLETED|Overall Study||6
3009542|NCT01003938|3727815|FG000|NOT COMPLETED|Overall Study||0
3009543|NCT01003990|3727822|FG000|STARTED|Overall Study||459
3009544|NCT01003990|3727823|FG001|STARTED|Overall Study||154
3009545|NCT01003990|3727824|FG002|STARTED|Overall Study||96
3009546|NCT01003990|3727822|FG000|COMPLETED|Overall Study||367
3009547|NCT01003990|3727823|FG001|COMPLETED|Overall Study||103
3009548|NCT01003990|3727824|FG002|COMPLETED|Overall Study||53
3009549|NCT01003990|3727822|FG000|NOT COMPLETED|Overall Study||92
3009550|NCT01003990|3727823|FG001|NOT COMPLETED|Overall Study||51
3009551|NCT01003990|3727824|FG002|NOT COMPLETED|Overall Study||43
3009552|NCT01004003|3727841|FG000|STARTED|Overall Study||6
3009553|NCT01004003|3727842|FG001|STARTED|Overall Study||3
3009554|NCT01004003|3727843|FG002|STARTED|Overall Study||4
3009555|NCT01004003|3727844|FG003|STARTED|Overall Study||3
3009556|NCT01004003|3727845|FG004|STARTED|Overall Study||4
3009557|NCT01004003|3727846|FG005|STARTED|Overall Study||4
3009558|NCT01004003|3727847|FG006|STARTED|Overall Study||8
3009559|NCT01004003|3727848|FG007|STARTED|Overall Study||62
3009560|NCT01004003|3727849|FG008|STARTED|Overall Study||31
3009561|NCT01004003|3727841|FG000|COMPLETED|Overall Study||0
3009562|NCT01004003|3727842|FG001|COMPLETED|Overall Study||0
3009563|NCT01004003|3727843|FG002|COMPLETED|Overall Study||0
3009564|NCT01004003|3727844|FG003|COMPLETED|Overall Study||0
3009565|NCT01004003|3727845|FG004|COMPLETED|Overall Study||0
3009566|NCT01004003|3727846|FG005|COMPLETED|Overall Study||0
3009567|NCT01004003|3727847|FG006|COMPLETED|Overall Study||0
3009568|NCT01004003|3727848|FG007|COMPLETED|Overall Study|On-treatment at analysis cut-off date (15 July 2014).|2
3009569|NCT01004003|3727849|FG008|COMPLETED|Overall Study|On-treatment at analysis cut-off date (15 July 2014).|1
3009570|NCT01004003|3727841|FG000|NOT COMPLETED|Overall Study||6
3009571|NCT01004003|3727842|FG001|NOT COMPLETED|Overall Study||3
3009572|NCT01004003|3727843|FG002|NOT COMPLETED|Overall Study||4
3009573|NCT01004003|3727844|FG003|NOT COMPLETED|Overall Study||3
3009574|NCT01004003|3727845|FG004|NOT COMPLETED|Overall Study||4
3009575|NCT01004003|3727846|FG005|NOT COMPLETED|Overall Study||4
3009576|NCT01004003|3727847|FG006|NOT COMPLETED|Overall Study||8
3009577|NCT01004003|3727848|FG007|NOT COMPLETED|Overall Study||60
3009578|NCT01004003|3727849|FG008|NOT COMPLETED|Overall Study||30
3009579|NCT01004029|3727873|FG000|STARTED|Overall Study||578
3009580|NCT01004029|3727874|FG001|STARTED|Overall Study||1130
3009581|NCT01004029|3727873|FG000|Safety Population|Overall Study||578
3009582|NCT01004029|3727874|FG001|Safety Population|Overall Study||1128
3009583|NCT01004029|3727873|FG000|COMPLETED|Overall Study||530
3009584|NCT01004029|3727874|FG001|COMPLETED|Overall Study||1057
3009585|NCT01004029|3727873|FG000|NOT COMPLETED|Overall Study||48
3009586|NCT01004029|3727874|FG001|NOT COMPLETED|Overall Study||73
3009587|NCT01004042|3727883|FG000|STARTED|Overall Study||25
3009588|NCT01004042|3727884|FG001|STARTED|Overall Study||25
3009589|NCT01004042|3727883|FG000|COMPLETED|Overall Study||21
3009590|NCT01004042|3727884|FG001|COMPLETED|Overall Study||25
3009591|NCT01004042|3727883|FG000|NOT COMPLETED|Overall Study||4
3009592|NCT01004042|3727884|FG001|NOT COMPLETED|Overall Study||0
3009593|NCT01004107|3727892|FG000|STARTED|Overall Study||76
3009594|NCT01004107|3727893|FG001|STARTED|Overall Study||25
3009595|NCT01004107|3727892|FG000|COMPLETED|Overall Study||75
3009596|NCT01004107|3727893|FG001|COMPLETED|Overall Study||23
3009597|NCT01004107|3727892|FG000|NOT COMPLETED|Overall Study||1
3009598|NCT01004107|3727893|FG001|NOT COMPLETED|Overall Study||2
3009599|NCT01004146|3727920|FG000|STARTED|Overall Study||25
3009600|NCT01004146|3727921|FG001|STARTED|Overall Study||25
3009601|NCT01004146|3727920|FG000|Have Incentive Spirometry Data|Overall Study||21
3009602|NCT01004146|3727921|FG001|Have Incentive Spirometry Data|Overall Study||20
3009603|NCT01004146|3727920|FG000|COMPLETED|Overall Study||21
3009604|NCT01004146|3727921|FG001|COMPLETED|Overall Study||20
3009605|NCT01004146|3727920|FG000|NOT COMPLETED|Overall Study||4
3009606|NCT01004146|3727921|FG001|NOT COMPLETED|Overall Study||5
3009607|NCT01004159|3727927|FG000|STARTED|Overall Study||20
3009608|NCT01004159|3727927|FG000|COMPLETED|Overall Study||0
3009609|NCT01004159|3727927|FG000|NOT COMPLETED|Overall Study||20
3009610|NCT01004172|3727931|FG000|STARTED|Overall Study||38
3009611|NCT01004172|3727931|FG000|COMPLETED|Overall Study||0
3009612|NCT01004172|3727931|FG000|NOT COMPLETED|Overall Study||38
3009613|NCT01004185|3727938|FG000|STARTED|Overall Study||19
3009614|NCT01004185|3727939|FG001|STARTED|Overall Study||20
3009615|NCT01004185|3727938|FG000|COMPLETED|Overall Study||10
3009616|NCT01004185|3727939|FG001|COMPLETED|Overall Study||11
3009617|NCT01004185|3727938|FG000|NOT COMPLETED|Overall Study||9
3009618|NCT01004185|3727939|FG001|NOT COMPLETED|Overall Study||9
3009619|NCT01004250|3727945|FG000|STARTED|Induction Therapy Period||109
3009620|NCT01004250|3727945|FG000|Received at Least One Dose of Study Drug|Induction Therapy Period||109
3009621|NCT01004250|3727945|FG000|Death (Any Cause) or Disease Progression|Induction Therapy Period|Participants (pts) with death or disease progression considered to have completed phase.|21
3009622|NCT01004250|3727945|FG000|COMPLETED|Induction Therapy Period||94
3009623|NCT01004250|3727945|FG000|NOT COMPLETED|Induction Therapy Period||15
3009624|NCT01004250|3727945|FG000|STARTED|Maintenance Therapy Period|Did not enter Maint: 21 pts due to death or disease progression; 1 pts had performance status 2.|72
3009625|NCT01004250|3727945|FG000|Death (Any Cause) or Disease Progression|Maintenance Therapy Period|Pts with death or disease progression considered to have completed phase.|46
3009626|NCT01004250|3727945|FG000|COMPLETED|Maintenance Therapy Period||46
3009627|NCT01004250|3727945|FG000|NOT COMPLETED|Maintenance Therapy Period||26
3009628|NCT01004250|3727945|FG000|STARTED|Follow-Up (FU) Period|Did not enter FU:Death-4pts Ind,1pts Maint; Pt Withdrew-1 pts Ind,1pts Maint; Lost to FU-1 pts Maint|101
3009629|NCT01004250|3727945|FG000|COMPLETED|Follow-Up (FU) Period||100
3009630|NCT01004250|3727945|FG000|NOT COMPLETED|Follow-Up (FU) Period||1
3009631|NCT01004354|3727953|FG000|STARTED|Overall Study||12
3009632|NCT01004354|3727953|FG000|COMPLETED|Overall Study||12
3009633|NCT01004354|3727953|FG000|NOT COMPLETED|Overall Study||0
3009634|NCT01004393|3727957|FG000|STARTED|Overall Study||12
3009635|NCT01004393|3727957|FG000|COMPLETED|Overall Study||12
3009636|NCT01004393|3727957|FG000|NOT COMPLETED|Overall Study||0
3009637|NCT01004406|3727963|FG000|STARTED|Overall Study||21
3009638|NCT01004406|3727964|FG001|STARTED|Overall Study||10
3009639|NCT01004406|3727963|FG000|COMPLETED|Overall Study||18
3009640|NCT01004406|3727964|FG001|COMPLETED|Overall Study||10
3009641|NCT01004406|3727963|FG000|NOT COMPLETED|Overall Study||3
3009642|NCT01004406|3727964|FG001|NOT COMPLETED|Overall Study||0
3009643|NCT01004432|3727970|FG000|STARTED|Open-label (OL) Period (Week 0 - 16)||433
3009644|NCT01004432|3727971|FG001|STARTED|Open-label (OL) Period (Week 0 - 16)||0
3009645|NCT01004432|3727972|FG002|STARTED|Open-label (OL) Period (Week 0 - 16)||0
3009646|NCT01004432|3727973|FG003|STARTED|Open-label (OL) Period (Week 0 - 16)||0
3009647|NCT01004432|3727974|FG004|STARTED|Open-label (OL) Period (Week 0 - 16)||0
3009648|NCT01004432|3727970|FG000|COMPLETED|Open-label (OL) Period (Week 0 - 16)|1 Participant died after completing open-label period. Discontinuation was noted as adverse event.|350
3009649|NCT01004432|3727971|FG001|COMPLETED|Open-label (OL) Period (Week 0 - 16)||0
3009650|NCT01004432|3727972|FG002|COMPLETED|Open-label (OL) Period (Week 0 - 16)||0
3009651|NCT01004432|3727973|FG003|COMPLETED|Open-label (OL) Period (Week 0 - 16)||0
3165236|NCT01898130|3892791|FG000|Went on to Start Cycle 3|Treatment||21
3165237|NCT01898130|3892791|FG000|COMPLETED|Treatment||21
3165238|NCT01898130|3892791|FG000|NOT COMPLETED|Treatment||6
3306690|NCT03000075|4039993|FG003|COMPLETED|Part B||27
3009652|NCT01004432|3727974|FG004|COMPLETED|Open-label (OL) Period (Week 0 - 16)||0
3009653|NCT01004432|3727970|FG000|NOT COMPLETED|Open-label (OL) Period (Week 0 - 16)||83
3009654|NCT01004432|3727971|FG001|NOT COMPLETED|Open-label (OL) Period (Week 0 - 16)||0
3009655|NCT01004432|3727972|FG002|NOT COMPLETED|Open-label (OL) Period (Week 0 - 16)||0
3009656|NCT01004432|3727973|FG003|NOT COMPLETED|Open-label (OL) Period (Week 0 - 16)||0
3009657|NCT01004432|3727974|FG004|NOT COMPLETED|Open-label (OL) Period (Week 0 - 16)||0
3009658|NCT01004432|3727970|FG000|STARTED|OL/Double-Blind (DB) Period (Week 16-52)||0
3009659|NCT01004432|3727971|FG001|STARTED|OL/Double-Blind (DB) Period (Week 16-52)||75
3009660|NCT01004432|3727972|FG002|STARTED|OL/Double-Blind (DB) Period (Week 16-52)||91
3009661|NCT01004432|3727973|FG003|STARTED|OL/Double-Blind (DB) Period (Week 16-52)||184
3009662|NCT01004432|3727974|FG004|STARTED|OL/Double-Blind (DB) Period (Week 16-52)||0
3009663|NCT01004432|3727970|FG000|COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||0
3009664|NCT01004432|3727971|FG001|COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||65
3009665|NCT01004432|3727972|FG002|COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||54
3009666|NCT01004432|3727973|FG003|COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||126
3009667|NCT01004432|3727974|FG004|COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||0
3009668|NCT01004432|3727970|FG000|NOT COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||0
3306691|NCT03000075|4039994|FG004|COMPLETED|Part B||26
3306692|NCT03000075|4039995|FG005|COMPLETED|Part B||56
3306693|NCT03000075|4039996|FG006|COMPLETED|Part B||54
3306694|NCT03000075|4039990|FG000|NOT COMPLETED|Part B||0
3306695|NCT03000075|4039991|FG001|NOT COMPLETED|Part B||0
3306696|NCT03000075|4039992|FG002|NOT COMPLETED|Part B||0
3306697|NCT03000075|4039993|FG003|NOT COMPLETED|Part B||0
3306698|NCT03000075|4039994|FG004|NOT COMPLETED|Part B||1
3306699|NCT03000075|4039995|FG005|NOT COMPLETED|Part B||2
3306700|NCT03000075|4039996|FG006|NOT COMPLETED|Part B||1
3306701|NCT03000088|4040014|FG000|STARTED|Overall Study||70
3306702|NCT03000088|4040015|FG001|STARTED|Overall Study||70
3306703|NCT03000088|4040014|FG000|COMPLETED|Overall Study||70
3306704|NCT03000088|4040015|FG001|COMPLETED|Overall Study||70
3306705|NCT03000088|4040014|FG000|NOT COMPLETED|Overall Study||0
3306706|NCT03000088|4040015|FG001|NOT COMPLETED|Overall Study||0
3306707|NCT03000166|4040023|FG000|STARTED|Overall Study||25
3306708|NCT03000166|4040024|FG001|STARTED|Overall Study||22
3306709|NCT03000166|4040023|FG000|COMPLETED|Overall Study||25
3306710|NCT03000166|4040024|FG001|COMPLETED|Overall Study||19
3306711|NCT03000166|4040023|FG000|NOT COMPLETED|Overall Study||0
3306712|NCT03000166|4040024|FG001|NOT COMPLETED|Overall Study||3
3306713|NCT03000283|4040031|FG000|STARTED|Overall Study||7
3306714|NCT03000283|4040031|FG000|COMPLETED|Overall Study||7
3306715|NCT03000283|4040031|FG000|NOT COMPLETED|Overall Study||0
3306716|NCT03000309|4040035|FG000|STARTED|Overall Study||20
3306717|NCT03000309|4040035|FG000|COMPLETED|Overall Study||19
3306718|NCT03000309|4040035|FG000|NOT COMPLETED|Overall Study||1
3306719|NCT03000348|4040045|FG000|STARTED|Overall Study||17
3306720|NCT03000348|4040046|FG001|STARTED|Overall Study||11
3306721|NCT03000348|4040047|FG002|STARTED|Overall Study||15
3306722|NCT03000348|4040048|FG003|STARTED|Overall Study||15
3306723|NCT03000348|4040049|FG004|STARTED|Overall Study||16
3306724|NCT03000348|4040050|FG005|STARTED|Overall Study||15
3009669|NCT01004432|3727971|FG001|NOT COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||10
3009670|NCT01004432|3727972|FG002|NOT COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||37
3009671|NCT01004432|3727973|FG003|NOT COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||58
3009672|NCT01004432|3727974|FG004|NOT COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||0
3009673|NCT01004432|3727970|FG000|STARTED|OL Study Extension (Week 52 - 76)||0
3009674|NCT01004432|3727971|FG001|STARTED|OL Study Extension (Week 52 - 76)||0
3009675|NCT01004432|3727972|FG002|STARTED|OL Study Extension (Week 52 - 76)||0
3009676|NCT01004432|3727973|FG003|STARTED|OL Study Extension (Week 52 - 76)||0
3009677|NCT01004432|3727974|FG004|STARTED|OL Study Extension (Week 52 - 76)||212
3009678|NCT01004432|3727970|FG000|COMPLETED|OL Study Extension (Week 52 - 76)||0
3009679|NCT01004432|3727971|FG001|COMPLETED|OL Study Extension (Week 52 - 76)||0
3009680|NCT01004432|3727972|FG002|COMPLETED|OL Study Extension (Week 52 - 76)||0
3009681|NCT01004432|3727973|FG003|COMPLETED|OL Study Extension (Week 52 - 76)||0
3009682|NCT01004432|3727974|FG004|COMPLETED|OL Study Extension (Week 52 - 76)||194
3009683|NCT01004432|3727970|FG000|NOT COMPLETED|OL Study Extension (Week 52 - 76)||0
3009684|NCT01004432|3727971|FG001|NOT COMPLETED|OL Study Extension (Week 52 - 76)||0
3009685|NCT01004432|3727972|FG002|NOT COMPLETED|OL Study Extension (Week 52 - 76)||0
3009686|NCT01004432|3727973|FG003|NOT COMPLETED|OL Study Extension (Week 52 - 76)||0
3009687|NCT01004432|3727974|FG004|NOT COMPLETED|OL Study Extension (Week 52 - 76)||18
3009688|NCT01004614|3727992|FG000|STARTED|First Intervention||12
3009689|NCT01004614|3727993|FG001|STARTED|First Intervention||12
3009690|NCT01004614|3727994|FG002|STARTED|First Intervention||12
3009691|NCT01004614|3727995|FG003|STARTED|First Intervention||12
3009692|NCT01004614|3727992|FG000|COMPLETED|First Intervention||12
3009693|NCT01004614|3727993|FG001|COMPLETED|First Intervention||12
3009694|NCT01004614|3727994|FG002|COMPLETED|First Intervention||12
3009695|NCT01004614|3727995|FG003|COMPLETED|First Intervention||12
3009696|NCT01004614|3727992|FG000|NOT COMPLETED|First Intervention||0
3009697|NCT01004614|3727993|FG001|NOT COMPLETED|First Intervention||0
3009698|NCT01004614|3727994|FG002|NOT COMPLETED|First Intervention||0
3009699|NCT01004614|3727995|FG003|NOT COMPLETED|First Intervention||0
3009700|NCT01004614|3727992|FG000|STARTED|Washout||12
3009701|NCT01004614|3727993|FG001|STARTED|Washout||12
3009702|NCT01004614|3727994|FG002|STARTED|Washout||12
3009703|NCT01004614|3727995|FG003|STARTED|Washout||12
3009704|NCT01004614|3727992|FG000|COMPLETED|Washout||12
3009705|NCT01004614|3727993|FG001|COMPLETED|Washout||11
3009706|NCT01004614|3727994|FG002|COMPLETED|Washout||12
3009707|NCT01004614|3727995|FG003|COMPLETED|Washout||12
3009708|NCT01004614|3727992|FG000|NOT COMPLETED|Washout||0
3009709|NCT01004614|3727993|FG001|NOT COMPLETED|Washout||1
3009710|NCT01004614|3727994|FG002|NOT COMPLETED|Washout||0
3009711|NCT01004614|3727995|FG003|NOT COMPLETED|Washout||0
3009712|NCT01004614|3727992|FG000|STARTED|Second Intervention||12
3009713|NCT01004614|3727993|FG001|STARTED|Second Intervention||11
3009714|NCT01004614|3727994|FG002|STARTED|Second Intervention||12
3009715|NCT01004614|3727995|FG003|STARTED|Second Intervention||12
3009716|NCT01004614|3727992|FG000|COMPLETED|Second Intervention||12
3009717|NCT01004614|3727993|FG001|COMPLETED|Second Intervention||11
3009718|NCT01004614|3727994|FG002|COMPLETED|Second Intervention||12
3009719|NCT01004614|3727995|FG003|COMPLETED|Second Intervention||12
3009720|NCT01004614|3727992|FG000|NOT COMPLETED|Second Intervention||0
3009721|NCT01004614|3727993|FG001|NOT COMPLETED|Second Intervention||0
3009722|NCT01004614|3727994|FG002|NOT COMPLETED|Second Intervention||0
3009723|NCT01004614|3727995|FG003|NOT COMPLETED|Second Intervention||0
3009724|NCT01004705|3728005|FG000|STARTED|Run-In||44
3009725|NCT01004705|3728006|FG001|STARTED|Run-In||0
3009726|NCT01004705|3728007|FG002|STARTED|Run-In||0
3009727|NCT01004705|3728005|FG000|COMPLETED|Run-In||36
3009728|NCT01004705|3728006|FG001|COMPLETED|Run-In||0
3009729|NCT01004705|3728007|FG002|COMPLETED|Run-In||0
3009730|NCT01004705|3728005|FG000|NOT COMPLETED|Run-In||8
3009731|NCT01004705|3728006|FG001|NOT COMPLETED|Run-In||0
3009732|NCT01004705|3728007|FG002|NOT COMPLETED|Run-In||0
3009733|NCT01004705|3728005|FG000|STARTED|Period 1 (12 Weeks)||0
3009734|NCT01004705|3728006|FG001|STARTED|Period 1 (12 Weeks)||18
3009735|NCT01004705|3728007|FG002|STARTED|Period 1 (12 Weeks)||18
3009736|NCT01004705|3728005|FG000|COMPLETED|Period 1 (12 Weeks)||0
3009737|NCT01004705|3728006|FG001|COMPLETED|Period 1 (12 Weeks)||13
3009738|NCT01004705|3728007|FG002|COMPLETED|Period 1 (12 Weeks)||13
3009739|NCT01004705|3728005|FG000|NOT COMPLETED|Period 1 (12 Weeks)||0
3009740|NCT01004705|3728006|FG001|NOT COMPLETED|Period 1 (12 Weeks)||5
3009741|NCT01004705|3728007|FG002|NOT COMPLETED|Period 1 (12 Weeks)||5
3009742|NCT01004705|3728005|FG000|STARTED|Washout Period (6 Weeks)||0
3009743|NCT01004705|3728006|FG001|STARTED|Washout Period (6 Weeks)||13
3009744|NCT01004705|3728007|FG002|STARTED|Washout Period (6 Weeks)||13
3009745|NCT01004705|3728005|FG000|COMPLETED|Washout Period (6 Weeks)||0
3009746|NCT01004705|3728006|FG001|COMPLETED|Washout Period (6 Weeks)||13
3009747|NCT01004705|3728007|FG002|COMPLETED|Washout Period (6 Weeks)||13
3009748|NCT01004705|3728005|FG000|NOT COMPLETED|Washout Period (6 Weeks)||0
3009749|NCT01004705|3728006|FG001|NOT COMPLETED|Washout Period (6 Weeks)||0
3009750|NCT01004705|3728007|FG002|NOT COMPLETED|Washout Period (6 Weeks)||0
3009751|NCT01004705|3728005|FG000|STARTED|Period 2 (12 Weeks)||0
3009752|NCT01004705|3728006|FG001|STARTED|Period 2 (12 Weeks)||13
3009753|NCT01004705|3728007|FG002|STARTED|Period 2 (12 Weeks)||13
3009754|NCT01004705|3728005|FG000|COMPLETED|Period 2 (12 Weeks)||0
3009755|NCT01004705|3728006|FG001|COMPLETED|Period 2 (12 Weeks)||13
3009756|NCT01004705|3728007|FG002|COMPLETED|Period 2 (12 Weeks)||9
3009757|NCT01004705|3728005|FG000|NOT COMPLETED|Period 2 (12 Weeks)||0
3009758|NCT01004705|3728006|FG001|NOT COMPLETED|Period 2 (12 Weeks)||0
3009759|NCT01004705|3728007|FG002|NOT COMPLETED|Period 2 (12 Weeks)||4
3009760|NCT01004718|3728014|FG000|STARTED|Overall Study||10
3009761|NCT01004718|3728014|FG000|COMPLETED|Overall Study||10
3009762|NCT01004718|3728014|FG000|NOT COMPLETED|Overall Study||0
3009763|NCT01004744|3728019|FG000|STARTED|Overall Study||10
3009764|NCT01004744|3728019|FG000|COMPLETED|Overall Study||10
3009765|NCT01004744|3728019|FG000|NOT COMPLETED|Overall Study||0
3009766|NCT01004770|3728028|FG000|STARTED|Overall Study||10
3009767|NCT01004770|3728029|FG001|STARTED|Overall Study||10
3009768|NCT01004770|3728030|FG002|STARTED|Overall Study||10
3009769|NCT01004770|3728031|FG003|STARTED|Overall Study||10
3009770|NCT01004770|3728032|FG004|STARTED|Overall Study||10
3009771|NCT01004770|3728028|FG000|COMPLETED|Overall Study||10
3009772|NCT01004770|3728029|FG001|COMPLETED|Overall Study||10
3009773|NCT01004770|3728030|FG002|COMPLETED|Overall Study||10
3009774|NCT01004770|3728031|FG003|COMPLETED|Overall Study||10
3009775|NCT01004770|3728032|FG004|COMPLETED|Overall Study||10
3009776|NCT01004770|3728028|FG000|NOT COMPLETED|Overall Study||0
3009777|NCT01004770|3728029|FG001|NOT COMPLETED|Overall Study||0
3009778|NCT01004770|3728030|FG002|NOT COMPLETED|Overall Study||0
3009779|NCT01004770|3728031|FG003|NOT COMPLETED|Overall Study||0
3009780|NCT01004770|3728032|FG004|NOT COMPLETED|Overall Study||0
3009781|NCT01004822|3728052|FG000|STARTED|Overall Study||3
3009782|NCT01004822|3728053|FG001|STARTED|Overall Study||3
3009783|NCT01004822|3728054|FG002|STARTED|Overall Study||4
3009784|NCT01004822|3728055|FG003|STARTED|Overall Study||4
3009785|NCT01004822|3728056|FG004|STARTED|Overall Study||4
3009786|NCT01004822|3728057|FG005|STARTED|Overall Study||4
3009787|NCT01004822|3728058|FG006|STARTED|Overall Study||4
3009788|NCT01004822|3728059|FG007|STARTED|Overall Study||5
3009789|NCT01004822|3728052|FG000|Treated|Overall Study||3
3009790|NCT01004822|3728053|FG001|Treated|Overall Study||3
3009791|NCT01004822|3728054|FG002|Treated|Overall Study||3
3009792|NCT01004822|3728055|FG003|Treated|Overall Study||4
3009793|NCT01004822|3728056|FG004|Treated|Overall Study||4
3009794|NCT01004822|3728057|FG005|Treated|Overall Study||4
3009795|NCT01004822|3728058|FG006|Treated|Overall Study||4
3009796|NCT01004822|3728059|FG007|Treated|Overall Study||5
3009797|NCT01004822|3728052|FG000|COMPLETED|Overall Study||0
3009798|NCT01004822|3728053|FG001|COMPLETED|Overall Study||0
3009799|NCT01004822|3728054|FG002|COMPLETED|Overall Study||0
3009800|NCT01004822|3728055|FG003|COMPLETED|Overall Study||0
3009801|NCT01004822|3728056|FG004|COMPLETED|Overall Study||0
3009802|NCT01004822|3728057|FG005|COMPLETED|Overall Study||0
3009803|NCT01004822|3728058|FG006|COMPLETED|Overall Study||0
3009804|NCT01004822|3728059|FG007|COMPLETED|Overall Study||0
3009805|NCT01004822|3728052|FG000|NOT COMPLETED|Overall Study||3
3009806|NCT01004822|3728053|FG001|NOT COMPLETED|Overall Study||3
3009807|NCT01004822|3728054|FG002|NOT COMPLETED|Overall Study||4
3009808|NCT01004822|3728055|FG003|NOT COMPLETED|Overall Study||4
3009809|NCT01004822|3728056|FG004|NOT COMPLETED|Overall Study||4
3009810|NCT01004822|3728057|FG005|NOT COMPLETED|Overall Study||4
3009811|NCT01004822|3728058|FG006|NOT COMPLETED|Overall Study||4
3009812|NCT01004822|3728059|FG007|NOT COMPLETED|Overall Study||5
3009813|NCT01004848|3728081|FG000|STARTED|Overall Study||210
3009814|NCT01004848|3728082|FG001|STARTED|Overall Study||192
3009815|NCT01004848|3728081|FG000|COMPLETED|Overall Study||155
3009816|NCT01004848|3728082|FG001|COMPLETED|Overall Study||147
3009817|NCT01004848|3728081|FG000|NOT COMPLETED|Overall Study||55
3009818|NCT01004848|3728082|FG001|NOT COMPLETED|Overall Study||45
3009819|NCT01004874|3728090|FG000|STARTED|Overall Study||80
3009820|NCT01004874|3728090|FG000|COMPLETED|Overall Study||80
3009821|NCT01004874|3728090|FG000|NOT COMPLETED|Overall Study||0
3009822|NCT01004939|3728094|FG000|STARTED|Overall Study||120
3009823|NCT01004939|3728094|FG000|COMPLETED|Overall Study||120
3009824|NCT01004939|3728094|FG000|NOT COMPLETED|Overall Study||0
3009825|NCT01004991|3728100|FG000|STARTED|Overall Study||12
3009826|NCT01004991|3728100|FG000|COMPLETED|Overall Study||12
3009827|NCT01004991|3728100|FG000|NOT COMPLETED|Overall Study||0
3009828|NCT01005251|3728109|FG000|STARTED|Overall Study||134
3009829|NCT01005251|3728110|FG001|STARTED|Overall Study||125
3009830|NCT01005251|3728111|FG002|STARTED|Overall Study||136
3009831|NCT01005251|3728112|FG003|STARTED|Overall Study||126
3009832|NCT01005251|3728113|FG004|STARTED|Overall Study||140
3009833|NCT01005251|3728109|FG000|COMPLETED|Overall Study||121
3009834|NCT01005251|3728110|FG001|COMPLETED|Overall Study||109
3009835|NCT01005251|3728111|FG002|COMPLETED|Overall Study||114
3009836|NCT01005251|3728112|FG003|COMPLETED|Overall Study||114
3009837|NCT01005251|3728113|FG004|COMPLETED|Overall Study||122
3009838|NCT01005251|3728109|FG000|NOT COMPLETED|Overall Study||13
3009839|NCT01005251|3728110|FG001|NOT COMPLETED|Overall Study||16
3009840|NCT01005251|3728111|FG002|NOT COMPLETED|Overall Study||22
3009841|NCT01005251|3728112|FG003|NOT COMPLETED|Overall Study||12
3009842|NCT01005251|3728113|FG004|NOT COMPLETED|Overall Study||18
3009843|NCT01005290|3728125|FG000|STARTED|Run-In||52
3009844|NCT01005290|3728126|FG001|STARTED|Run-In||0
3009845|NCT01005290|3728127|FG002|STARTED|Run-In||0
3009846|NCT01005290|3728125|FG000|COMPLETED|Run-In||38
3009847|NCT01005290|3728126|FG001|COMPLETED|Run-In||0
3009848|NCT01005290|3728127|FG002|COMPLETED|Run-In||0
3009849|NCT01005290|3728125|FG000|NOT COMPLETED|Run-In||14
3009850|NCT01005290|3728126|FG001|NOT COMPLETED|Run-In||0
3009851|NCT01005290|3728127|FG002|NOT COMPLETED|Run-In||0
3009852|NCT01005290|3728125|FG000|STARTED|Period 1 (5 Weeks)||0
3009853|NCT01005290|3728126|FG001|STARTED|Period 1 (5 Weeks)||20
3009854|NCT01005290|3728127|FG002|STARTED|Period 1 (5 Weeks)||18
3009855|NCT01005290|3728125|FG000|COMPLETED|Period 1 (5 Weeks)||0
3009856|NCT01005290|3728126|FG001|COMPLETED|Period 1 (5 Weeks)||13
3009857|NCT01005290|3728127|FG002|COMPLETED|Period 1 (5 Weeks)||9
3009858|NCT01005290|3728125|FG000|NOT COMPLETED|Period 1 (5 Weeks)||0
3009859|NCT01005290|3728126|FG001|NOT COMPLETED|Period 1 (5 Weeks)||7
3009860|NCT01005290|3728127|FG002|NOT COMPLETED|Period 1 (5 Weeks)||9
3009861|NCT01005290|3728125|FG000|STARTED|Washout Period (2 Weeks)||0
3009862|NCT01005290|3728126|FG001|STARTED|Washout Period (2 Weeks)||13
3009863|NCT01005290|3728127|FG002|STARTED|Washout Period (2 Weeks)||9
3009864|NCT01005290|3728125|FG000|COMPLETED|Washout Period (2 Weeks)||0
3009865|NCT01005290|3728126|FG001|COMPLETED|Washout Period (2 Weeks)||13
3009866|NCT01005290|3728127|FG002|COMPLETED|Washout Period (2 Weeks)||9
3009867|NCT01005290|3728125|FG000|NOT COMPLETED|Washout Period (2 Weeks)||0
3009868|NCT01005290|3728126|FG001|NOT COMPLETED|Washout Period (2 Weeks)||0
3009869|NCT01005290|3728127|FG002|NOT COMPLETED|Washout Period (2 Weeks)||0
3009870|NCT01005290|3728125|FG000|STARTED|Period 2 (5 Weeks)||0
3009871|NCT01005290|3728126|FG001|STARTED|Period 2 (5 Weeks)||13
3009872|NCT01005290|3728127|FG002|STARTED|Period 2 (5 Weeks)||9
3009873|NCT01005290|3728125|FG000|COMPLETED|Period 2 (5 Weeks)||0
3009874|NCT01005290|3728126|FG001|COMPLETED|Period 2 (5 Weeks)||13
3009875|NCT01005290|3728127|FG002|COMPLETED|Period 2 (5 Weeks)||7
3009876|NCT01005290|3728125|FG000|NOT COMPLETED|Period 2 (5 Weeks)||0
3009877|NCT01005290|3728126|FG001|NOT COMPLETED|Period 2 (5 Weeks)||0
3009878|NCT01005290|3728127|FG002|NOT COMPLETED|Period 2 (5 Weeks)||2
3009879|NCT01005316|3728137|FG000|STARTED|Overall Study||50
3009880|NCT01005316|3728138|FG001|STARTED|Overall Study||97
3009881|NCT01005316|3728139|FG002|STARTED|Overall Study||16
3009882|NCT01005316|3728140|FG003|STARTED|Overall Study||127
3009883|NCT01005316|3728137|FG000|COMPLETED|Overall Study||0
3009884|NCT01005316|3728138|FG001|COMPLETED|Overall Study||21
3009885|NCT01005316|3728139|FG002|COMPLETED|Overall Study||5
3009886|NCT01005316|3728140|FG003|COMPLETED|Overall Study||19
3009887|NCT01005316|3728137|FG000|NOT COMPLETED|Overall Study||50
3009888|NCT01005316|3728138|FG001|NOT COMPLETED|Overall Study||76
3009889|NCT01005316|3728139|FG002|NOT COMPLETED|Overall Study||11
3009890|NCT01005316|3728140|FG003|NOT COMPLETED|Overall Study||108
3009891|NCT01005329|3728151|FG000|STARTED|Overall Study||34
3009892|NCT01005329|3728151|FG000|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|30
3009893|NCT01005329|3728151|FG000|NOT COMPLETED|Overall Study||4
3009894|NCT01005355|3728159|FG000|STARTED|Overall Study||3
3009895|NCT01005355|3728160|FG001|STARTED|Overall Study||6
3009896|NCT01005355|3728161|FG002|STARTED|Overall Study||6
3009897|NCT01005355|3728159|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
3009898|NCT01005355|3728160|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6
3009899|NCT01005355|3728161|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
3009900|NCT01005355|3728159|FG000|COMPLETED|Overall Study||3
3009901|NCT01005355|3728160|FG001|COMPLETED|Overall Study||6
3009902|NCT01005355|3728161|FG002|COMPLETED|Overall Study||6
3009903|NCT01005355|3728159|FG000|NOT COMPLETED|Overall Study||0
3009904|NCT01005355|3728160|FG001|NOT COMPLETED|Overall Study||0
3009905|NCT01005355|3728161|FG002|NOT COMPLETED|Overall Study||0
3009906|NCT01005407|3728174|FG000|STARTED|Overall Study||1969
3009907|NCT01005407|3728175|FG001|STARTED|Overall Study||483
3009908|NCT01005407|3728174|FG000|COMPLETED|Overall Study||1818
3009909|NCT01005407|3728175|FG001|COMPLETED|Overall Study||451
3009910|NCT01005407|3728174|FG000|NOT COMPLETED|Overall Study||151
3009911|NCT01005407|3728175|FG001|NOT COMPLETED|Overall Study||32
3009912|NCT01005459|3728183|FG000|STARTED|Overall Study||23
3009913|NCT01005459|3728184|FG001|STARTED|Overall Study||23
3009914|NCT01005459|3728183|FG000|COMPLETED|Overall Study||23
3009915|NCT01005459|3728184|FG001|COMPLETED|Overall Study||23
3009916|NCT01005459|3728183|FG000|NOT COMPLETED|Overall Study||0
3009917|NCT01005459|3728184|FG001|NOT COMPLETED|Overall Study||0
3009918|NCT01005576|3728190|FG000|STARTED|Overall Study||21
3009919|NCT01005576|3728190|FG000|COMPLETED|Overall Study|All participants completed the conditioning regimen and received their stem cell transplant|21
3009920|NCT01005576|3728190|FG000|NOT COMPLETED|Overall Study||0
3009921|NCT01005602|3728196|FG000|STARTED|Overall Study||66
3009922|NCT01005602|3728197|FG001|STARTED|Overall Study||66
3009923|NCT01005602|3728196|FG000|COMPLETED|Overall Study|One patient completed the trial but was excluded from data analyses due to unreliable clinical data.|65
3009924|NCT01005602|3728197|FG001|COMPLETED|Overall Study||66
3009925|NCT01005602|3728196|FG000|NOT COMPLETED|Overall Study||1
3009926|NCT01005602|3728197|FG001|NOT COMPLETED|Overall Study||0
3009927|NCT01005680|3728212|FG000|STARTED|Overall Study||126
3009928|NCT01005680|3728213|FG001|STARTED|Overall Study||130
3009929|NCT01005680|3728212|FG000|Received at Least 1 Dose of Study Drug|Overall Study||125
3009930|NCT01005680|3728213|FG001|Received at Least 1 Dose of Study Drug|Overall Study||127
3009931|NCT01005680|3728212|FG000|COMPLETED|Overall Study||120
3009932|NCT01005680|3728213|FG001|COMPLETED|Overall Study||119
3009933|NCT01005680|3728212|FG000|NOT COMPLETED|Overall Study||6
3009934|NCT01005680|3728213|FG001|NOT COMPLETED|Overall Study||11
3009935|NCT01005706|3728222|FG000|STARTED|Overall Study||23
3009936|NCT01005706|3728223|FG001|STARTED|Overall Study||17
3009937|NCT01005706|3728222|FG000|COMPLETED|Overall Study||23
3009938|NCT01005706|3728223|FG001|COMPLETED|Overall Study||17
3009939|NCT01005706|3728222|FG000|NOT COMPLETED|Overall Study||0
3009940|NCT01005706|3728223|FG001|NOT COMPLETED|Overall Study||0
3009941|NCT01005719|3728229|FG000|STARTED|Period 1||10
3009942|NCT01005719|3728230|FG001|STARTED|Period 1||10
3009943|NCT01005719|3728231|FG002|STARTED|Period 1||10
3009944|NCT01005719|3728232|FG003|STARTED|Period 1||11
3009945|NCT01005719|3728233|FG004|STARTED|Period 1||11
3009946|NCT01005719|3728234|FG005|STARTED|Period 1||11
3009947|NCT01005719|3728229|FG000|COMPLETED|Period 1||10
3009948|NCT01005719|3728230|FG001|COMPLETED|Period 1||10
3009949|NCT01005719|3728231|FG002|COMPLETED|Period 1||10
3009950|NCT01005719|3728232|FG003|COMPLETED|Period 1||10
3009951|NCT01005719|3728233|FG004|COMPLETED|Period 1||11
3009952|NCT01005719|3728234|FG005|COMPLETED|Period 1||10
3009953|NCT01005719|3728229|FG000|NOT COMPLETED|Period 1||0
3009954|NCT01005719|3728230|FG001|NOT COMPLETED|Period 1||0
3009955|NCT01005719|3728231|FG002|NOT COMPLETED|Period 1||0
3009956|NCT01005719|3728232|FG003|NOT COMPLETED|Period 1||1
3009957|NCT01005719|3728233|FG004|NOT COMPLETED|Period 1||0
3009958|NCT01005719|3728234|FG005|NOT COMPLETED|Period 1||1
3009959|NCT01005719|3728229|FG000|STARTED|Period 2||10
3009960|NCT01005719|3728230|FG001|STARTED|Period 2||10
3009961|NCT01005719|3728231|FG002|STARTED|Period 2||10
3009962|NCT01005719|3728232|FG003|STARTED|Period 2||10
3009963|NCT01005719|3728233|FG004|STARTED|Period 2||11
3009964|NCT01005719|3728234|FG005|STARTED|Period 2||10
3009965|NCT01005719|3728229|FG000|COMPLETED|Period 2||10
3009966|NCT01005719|3728230|FG001|COMPLETED|Period 2||10
3009967|NCT01005719|3728231|FG002|COMPLETED|Period 2||10
3009968|NCT01005719|3728232|FG003|COMPLETED|Period 2||10
3009969|NCT01005719|3728233|FG004|COMPLETED|Period 2||10
3009970|NCT01005719|3728234|FG005|COMPLETED|Period 2||9
3009971|NCT01005719|3728229|FG000|NOT COMPLETED|Period 2||0
3009972|NCT01005719|3728230|FG001|NOT COMPLETED|Period 2||0
3009973|NCT01005719|3728231|FG002|NOT COMPLETED|Period 2||0
3009974|NCT01005719|3728232|FG003|NOT COMPLETED|Period 2||0
3009975|NCT01005719|3728233|FG004|NOT COMPLETED|Period 2||1
3009976|NCT01005719|3728234|FG005|NOT COMPLETED|Period 2||1
3009977|NCT01005719|3728229|FG000|STARTED|Period 3||10
3009978|NCT01005719|3728230|FG001|STARTED|Period 3||10
3009979|NCT01005719|3728231|FG002|STARTED|Period 3||10
3009980|NCT01005719|3728232|FG003|STARTED|Period 3||10
3009981|NCT01005719|3728233|FG004|STARTED|Period 3||10
3009982|NCT01005719|3728234|FG005|STARTED|Period 3||9
3009983|NCT01005719|3728229|FG000|COMPLETED|Period 3||10
3009984|NCT01005719|3728230|FG001|COMPLETED|Period 3||10
3009985|NCT01005719|3728231|FG002|COMPLETED|Period 3||10
3009986|NCT01005719|3728232|FG003|COMPLETED|Period 3||10
3009987|NCT01005719|3728233|FG004|COMPLETED|Period 3||10
3009988|NCT01005719|3728234|FG005|COMPLETED|Period 3||9
3009989|NCT01005719|3728229|FG000|NOT COMPLETED|Period 3||0
3009990|NCT01005719|3728230|FG001|NOT COMPLETED|Period 3||0
3009991|NCT01005719|3728231|FG002|NOT COMPLETED|Period 3||0
3009992|NCT01005719|3728232|FG003|NOT COMPLETED|Period 3||0
3009993|NCT01005719|3728233|FG004|NOT COMPLETED|Period 3||0
3009994|NCT01005719|3728234|FG005|NOT COMPLETED|Period 3||0
3009995|NCT01005732|3728243|FG000|STARTED|Overall Study||54
3009996|NCT01005732|3728243|FG000|COMPLETED|Overall Study||43
3009997|NCT01005732|3728243|FG000|NOT COMPLETED|Overall Study||11
3009998|NCT01005745|3728251|FG000|STARTED|Overall Study||19
3009999|NCT01005745|3728251|FG000|COMPLETED|Overall Study||13
3010000|NCT01005745|3728251|FG000|NOT COMPLETED|Overall Study||6
3010001|NCT01005810|3728257|FG000|STARTED|Overall Study||58
3010002|NCT01005810|3728258|FG001|STARTED|Overall Study||58
3010003|NCT01005810|3728257|FG000|COMPLETED|Overall Study||37
3010004|NCT01005810|3728258|FG001|COMPLETED|Overall Study||33
3010005|NCT01005810|3728257|FG000|NOT COMPLETED|Overall Study||21
3010006|NCT01005810|3728258|FG001|NOT COMPLETED|Overall Study||25
3010007|NCT01005875|3728264|FG000|STARTED|Overall Study||5
3010008|NCT01005875|3728264|FG000|COMPLETED|Overall Study||2
3010009|NCT01005875|3728264|FG000|NOT COMPLETED|Overall Study||3
3010010|NCT01005888|3728272|FG000|STARTED|First Intervention||12
3010011|NCT01005888|3728273|FG001|STARTED|First Intervention||12
3010012|NCT01005888|3728272|FG000|COMPLETED|First Intervention||11
3010013|NCT01005888|3728273|FG001|COMPLETED|First Intervention||11
3010014|NCT01005888|3728272|FG000|NOT COMPLETED|First Intervention||1
3010015|NCT01005888|3728273|FG001|NOT COMPLETED|First Intervention||1
3010016|NCT01005888|3728272|FG000|STARTED|Second Intervention||11
3010017|NCT01005888|3728273|FG001|STARTED|Second Intervention||11
3010018|NCT01005888|3728272|FG000|COMPLETED|Second Intervention||10
3010019|NCT01005888|3728273|FG001|COMPLETED|Second Intervention||10
3010020|NCT01005888|3728272|FG000|NOT COMPLETED|Second Intervention||1
3010021|NCT01005888|3728273|FG001|NOT COMPLETED|Second Intervention||1
3010022|NCT01005901|3728281|FG000|STARTED|Overall Study||552
3010023|NCT01005901|3728282|FG001|STARTED|Overall Study||270
3010024|NCT01005901|3728281|FG000|Safety Population|Overall Study||550
3010025|NCT01005901|3728282|FG001|Safety Population|Overall Study||267
3010026|NCT01005901|3728281|FG000|Full Analysis Set|Overall Study||534
3010027|NCT01005901|3728282|FG001|Full Analysis Set|Overall Study||260
3010028|NCT01005901|3728281|FG000|COMPLETED|Overall Study||450
3010029|NCT01005901|3728282|FG001|COMPLETED|Overall Study||212
3010030|NCT01005901|3728281|FG000|NOT COMPLETED|Overall Study||102
3010031|NCT01005901|3728282|FG001|NOT COMPLETED|Overall Study||58
3010032|NCT01005966|3728288|FG000|STARTED|Treatment Period 1 (14 Days)||13
3010033|NCT01005966|3728289|FG001|STARTED|Treatment Period 1 (14 Days)||13
3010034|NCT01005966|3728290|FG002|STARTED|Treatment Period 1 (14 Days)||13
3010035|NCT01005966|3728291|FG003|STARTED|Treatment Period 1 (14 Days)||13
3010036|NCT01005966|3728292|FG004|STARTED|Treatment Period 1 (14 Days)||13
3010037|NCT01005966|3728288|FG000|COMPLETED|Treatment Period 1 (14 Days)||11
3010038|NCT01005966|3728289|FG001|COMPLETED|Treatment Period 1 (14 Days)||13
3010039|NCT01005966|3728290|FG002|COMPLETED|Treatment Period 1 (14 Days)||12
3010040|NCT01005966|3728291|FG003|COMPLETED|Treatment Period 1 (14 Days)||13
3010041|NCT01005966|3728292|FG004|COMPLETED|Treatment Period 1 (14 Days)||13
3010042|NCT01005966|3728288|FG000|NOT COMPLETED|Treatment Period 1 (14 Days)||2
3010043|NCT01005966|3728289|FG001|NOT COMPLETED|Treatment Period 1 (14 Days)||0
3010044|NCT01005966|3728290|FG002|NOT COMPLETED|Treatment Period 1 (14 Days)||1
3010045|NCT01005966|3728291|FG003|NOT COMPLETED|Treatment Period 1 (14 Days)||0
3010046|NCT01005966|3728292|FG004|NOT COMPLETED|Treatment Period 1 (14 Days)||0
3010047|NCT01005966|3728288|FG000|STARTED|Washout Period 1 (4 Days)||11
3010048|NCT01005966|3728289|FG001|STARTED|Washout Period 1 (4 Days)||13
3010049|NCT01005966|3728290|FG002|STARTED|Washout Period 1 (4 Days)||12
3010050|NCT01005966|3728291|FG003|STARTED|Washout Period 1 (4 Days)||13
3010051|NCT01005966|3728292|FG004|STARTED|Washout Period 1 (4 Days)||13
3010052|NCT01005966|3728288|FG000|COMPLETED|Washout Period 1 (4 Days)||11
3010053|NCT01005966|3728289|FG001|COMPLETED|Washout Period 1 (4 Days)||13
3010054|NCT01005966|3728290|FG002|COMPLETED|Washout Period 1 (4 Days)||12
3010055|NCT01005966|3728291|FG003|COMPLETED|Washout Period 1 (4 Days)||12
3010056|NCT01005966|3728292|FG004|COMPLETED|Washout Period 1 (4 Days)||13
3010057|NCT01005966|3728288|FG000|NOT COMPLETED|Washout Period 1 (4 Days)||0
3010058|NCT01005966|3728289|FG001|NOT COMPLETED|Washout Period 1 (4 Days)||0
3010059|NCT01005966|3728290|FG002|NOT COMPLETED|Washout Period 1 (4 Days)||0
3010060|NCT01005966|3728291|FG003|NOT COMPLETED|Washout Period 1 (4 Days)||1
3010061|NCT01005966|3728292|FG004|NOT COMPLETED|Washout Period 1 (4 Days)||0
3010062|NCT01005966|3728288|FG000|STARTED|Treatment Period 2 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 1|13
3010063|NCT01005966|3728289|FG001|STARTED|Treatment Period 2 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 1|13
3010064|NCT01005966|3728290|FG002|STARTED|Treatment Period 2 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 1|12
3010065|NCT01005966|3728291|FG003|STARTED|Treatment Period 2 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 1|12
3010066|NCT01005966|3728292|FG004|STARTED|Treatment Period 2 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 1|11
3010067|NCT01005966|3728288|FG000|COMPLETED|Treatment Period 2 (14 Days)||13
3010068|NCT01005966|3728289|FG001|COMPLETED|Treatment Period 2 (14 Days)||12
3010069|NCT01005966|3728290|FG002|COMPLETED|Treatment Period 2 (14 Days)||10
3010070|NCT01005966|3728291|FG003|COMPLETED|Treatment Period 2 (14 Days)||11
3010071|NCT01005966|3728292|FG004|COMPLETED|Treatment Period 2 (14 Days)||11
3010072|NCT01005966|3728288|FG000|NOT COMPLETED|Treatment Period 2 (14 Days)||0
3010073|NCT01005966|3728289|FG001|NOT COMPLETED|Treatment Period 2 (14 Days)||1
3010074|NCT01005966|3728290|FG002|NOT COMPLETED|Treatment Period 2 (14 Days)||2
3010075|NCT01005966|3728291|FG003|NOT COMPLETED|Treatment Period 2 (14 Days)||1
3010076|NCT01005966|3728292|FG004|NOT COMPLETED|Treatment Period 2 (14 Days)||0
3010077|NCT01005966|3728288|FG000|STARTED|Washout Period 2 (4 Days)||13
3010078|NCT01005966|3728289|FG001|STARTED|Washout Period 2 (4 Days)||12
3010079|NCT01005966|3728290|FG002|STARTED|Washout Period 2 (4 Days)||10
3010080|NCT01005966|3728291|FG003|STARTED|Washout Period 2 (4 Days)||11
3010081|NCT01005966|3728292|FG004|STARTED|Washout Period 2 (4 Days)||11
3010082|NCT01005966|3728288|FG000|COMPLETED|Washout Period 2 (4 Days)||13
3010083|NCT01005966|3728289|FG001|COMPLETED|Washout Period 2 (4 Days)||12
3010084|NCT01005966|3728290|FG002|COMPLETED|Washout Period 2 (4 Days)||10
3010085|NCT01005966|3728291|FG003|COMPLETED|Washout Period 2 (4 Days)||11
3010086|NCT01005966|3728292|FG004|COMPLETED|Washout Period 2 (4 Days)||11
3010087|NCT01005966|3728288|FG000|NOT COMPLETED|Washout Period 2 (4 Days)||0
3010088|NCT01005966|3728289|FG001|NOT COMPLETED|Washout Period 2 (4 Days)||0
3010089|NCT01005966|3728290|FG002|NOT COMPLETED|Washout Period 2 (4 Days)||0
3010090|NCT01005966|3728291|FG003|NOT COMPLETED|Washout Period 2 (4 Days)||0
3010091|NCT01005966|3728292|FG004|NOT COMPLETED|Washout Period 2 (4 Days)||0
3010092|NCT01005966|3728288|FG000|STARTED|Treatment Period 3 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 2|12
3010093|NCT01005966|3728289|FG001|STARTED|Treatment Period 3 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 2|8
3010094|NCT01005966|3728290|FG002|STARTED|Treatment Period 3 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 2|12
3010095|NCT01005966|3728291|FG003|STARTED|Treatment Period 3 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 2|13
3010096|NCT01005966|3728292|FG004|STARTED|Treatment Period 3 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 2|12
3010097|NCT01005966|3728288|FG000|COMPLETED|Treatment Period 3 (14 Days)||12
3010098|NCT01005966|3728289|FG001|COMPLETED|Treatment Period 3 (14 Days)||7
3010099|NCT01005966|3728290|FG002|COMPLETED|Treatment Period 3 (14 Days)||12
3010100|NCT01005966|3728291|FG003|COMPLETED|Treatment Period 3 (14 Days)||13
3010101|NCT01005966|3728292|FG004|COMPLETED|Treatment Period 3 (14 Days)||11
3010102|NCT01005966|3728288|FG000|NOT COMPLETED|Treatment Period 3 (14 Days)||0
3010103|NCT01005966|3728289|FG001|NOT COMPLETED|Treatment Period 3 (14 Days)||1
3010104|NCT01005966|3728290|FG002|NOT COMPLETED|Treatment Period 3 (14 Days)||0
3010105|NCT01005966|3728291|FG003|NOT COMPLETED|Treatment Period 3 (14 Days)||0
3010106|NCT01005966|3728292|FG004|NOT COMPLETED|Treatment Period 3 (14 Days)||1
3010107|NCT01005966|3728288|FG000|STARTED|Washout Period 3 ( 4 Days)||12
3010108|NCT01005966|3728289|FG001|STARTED|Washout Period 3 ( 4 Days)||7
3010109|NCT01005966|3728290|FG002|STARTED|Washout Period 3 ( 4 Days)||12
3010110|NCT01005966|3728291|FG003|STARTED|Washout Period 3 ( 4 Days)||13
3010111|NCT01005966|3728292|FG004|STARTED|Washout Period 3 ( 4 Days)||11
3010112|NCT01005966|3728288|FG000|COMPLETED|Washout Period 3 ( 4 Days)||12
3010113|NCT01005966|3728289|FG001|COMPLETED|Washout Period 3 ( 4 Days)||7
3010114|NCT01005966|3728290|FG002|COMPLETED|Washout Period 3 ( 4 Days)||12
3010115|NCT01005966|3728291|FG003|COMPLETED|Washout Period 3 ( 4 Days)||13
3010116|NCT01005966|3728292|FG004|COMPLETED|Washout Period 3 ( 4 Days)||11
3010117|NCT01005966|3728288|FG000|NOT COMPLETED|Washout Period 3 ( 4 Days)||0
3010118|NCT01005966|3728289|FG001|NOT COMPLETED|Washout Period 3 ( 4 Days)||0
3010119|NCT01005966|3728290|FG002|NOT COMPLETED|Washout Period 3 ( 4 Days)||0
3010120|NCT01005966|3728291|FG003|NOT COMPLETED|Washout Period 3 ( 4 Days)||0
3010121|NCT01005966|3728292|FG004|NOT COMPLETED|Washout Period 3 ( 4 Days)||0
3010122|NCT01005966|3728288|FG000|STARTED|Treatment Period 4 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 3|10
3010123|NCT01005966|3728289|FG001|STARTED|Treatment Period 4 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 3|11
3010124|NCT01005966|3728290|FG002|STARTED|Treatment Period 4 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 3|11
3010125|NCT01005966|3728291|FG003|STARTED|Treatment Period 4 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 3|10
3010126|NCT01005966|3728292|FG004|STARTED|Treatment Period 4 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 3|13
3010127|NCT01005966|3728288|FG000|COMPLETED|Treatment Period 4 (14 Days)||10
3010128|NCT01005966|3728289|FG001|COMPLETED|Treatment Period 4 (14 Days)||10
3010129|NCT01005966|3728290|FG002|COMPLETED|Treatment Period 4 (14 Days)||11
3010130|NCT01005966|3728291|FG003|COMPLETED|Treatment Period 4 (14 Days)||10
3010131|NCT01005966|3728292|FG004|COMPLETED|Treatment Period 4 (14 Days)||12
3010132|NCT01005966|3728288|FG000|NOT COMPLETED|Treatment Period 4 (14 Days)||0
3010133|NCT01005966|3728289|FG001|NOT COMPLETED|Treatment Period 4 (14 Days)||1
3010134|NCT01005966|3728290|FG002|NOT COMPLETED|Treatment Period 4 (14 Days)||0
3010135|NCT01005966|3728291|FG003|NOT COMPLETED|Treatment Period 4 (14 Days)||0
3010136|NCT01005966|3728292|FG004|NOT COMPLETED|Treatment Period 4 (14 Days)||1
3010137|NCT01005966|3728288|FG000|STARTED|Washout Period 4 (4 Days)||10
3010138|NCT01005966|3728289|FG001|STARTED|Washout Period 4 (4 Days)||10
3010139|NCT01005966|3728290|FG002|STARTED|Washout Period 4 (4 Days)||11
3010140|NCT01005966|3728291|FG003|STARTED|Washout Period 4 (4 Days)||10
3010141|NCT01005966|3728292|FG004|STARTED|Washout Period 4 (4 Days)||12
3010142|NCT01005966|3728288|FG000|COMPLETED|Washout Period 4 (4 Days)||10
3010143|NCT01005966|3728289|FG001|COMPLETED|Washout Period 4 (4 Days)||10
3010144|NCT01005966|3728290|FG002|COMPLETED|Washout Period 4 (4 Days)||11
3010145|NCT01005966|3728291|FG003|COMPLETED|Washout Period 4 (4 Days)||10
3010146|NCT01005966|3728292|FG004|COMPLETED|Washout Period 4 (4 Days)||12
3010147|NCT01005966|3728288|FG000|NOT COMPLETED|Washout Period 4 (4 Days)||0
3010148|NCT01005966|3728289|FG001|NOT COMPLETED|Washout Period 4 (4 Days)||0
3010149|NCT01005966|3728290|FG002|NOT COMPLETED|Washout Period 4 (4 Days)||0
3010150|NCT01005966|3728291|FG003|NOT COMPLETED|Washout Period 4 (4 Days)||0
3010151|NCT01005966|3728292|FG004|NOT COMPLETED|Washout Period 4 (4 Days)||0
3010152|NCT01005966|3728288|FG000|STARTED|Treatment Period 5 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 4|9
3010153|NCT01005966|3728289|FG001|STARTED|Treatment Period 5 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 4|12
3010154|NCT01005966|3728290|FG002|STARTED|Treatment Period 5 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 4|11
3010155|NCT01005966|3728291|FG003|STARTED|Treatment Period 5 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 4|11
3010156|NCT01005966|3728292|FG004|STARTED|Treatment Period 5 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 4|10
3010157|NCT01005966|3728288|FG000|COMPLETED|Treatment Period 5 (14 Days)||9
3010158|NCT01005966|3728289|FG001|COMPLETED|Treatment Period 5 (14 Days)||12
3010159|NCT01005966|3728290|FG002|COMPLETED|Treatment Period 5 (14 Days)||11
3010160|NCT01005966|3728291|FG003|COMPLETED|Treatment Period 5 (14 Days)||11
3010161|NCT01005966|3728292|FG004|COMPLETED|Treatment Period 5 (14 Days)||10
3010162|NCT01005966|3728288|FG000|NOT COMPLETED|Treatment Period 5 (14 Days)||0
3010163|NCT01005966|3728289|FG001|NOT COMPLETED|Treatment Period 5 (14 Days)||0
3010164|NCT01005966|3728290|FG002|NOT COMPLETED|Treatment Period 5 (14 Days)||0
3010165|NCT01005966|3728291|FG003|NOT COMPLETED|Treatment Period 5 (14 Days)||0
3010166|NCT01005966|3728292|FG004|NOT COMPLETED|Treatment Period 5 (14 Days)||0
3010167|NCT01006122|3728309|FG000|STARTED|First Double-blind Intervention Period||47
3010168|NCT01006122|3728310|FG001|STARTED|First Double-blind Intervention Period||48
3010169|NCT01006122|3728309|FG000|COMPLETED|First Double-blind Intervention Period||31
3010170|NCT01006122|3728310|FG001|COMPLETED|First Double-blind Intervention Period||31
3010171|NCT01006122|3728309|FG000|NOT COMPLETED|First Double-blind Intervention Period||16
3010172|NCT01006122|3728310|FG001|NOT COMPLETED|First Double-blind Intervention Period||17
3010173|NCT01006122|3728309|FG000|STARTED|Wash-out Period (at Least 7 Days)||31
3010174|NCT01006122|3728310|FG001|STARTED|Wash-out Period (at Least 7 Days)||31
3010175|NCT01006122|3728309|FG000|COMPLETED|Wash-out Period (at Least 7 Days)||31
3010176|NCT01006122|3728310|FG001|COMPLETED|Wash-out Period (at Least 7 Days)||31
3010177|NCT01006122|3728309|FG000|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
3010178|NCT01006122|3728310|FG001|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
3010179|NCT01006122|3728309|FG000|STARTED|Second Double-blind Intervention Period||31
3010180|NCT01006122|3728310|FG001|STARTED|Second Double-blind Intervention Period||31
3010181|NCT01006122|3728309|FG000|COMPLETED|Second Double-blind Intervention Period||29
3010182|NCT01006122|3728310|FG001|COMPLETED|Second Double-blind Intervention Period||24
3010183|NCT01006122|3728309|FG000|NOT COMPLETED|Second Double-blind Intervention Period||2
3010184|NCT01006122|3728310|FG001|NOT COMPLETED|Second Double-blind Intervention Period||7
3010185|NCT01006135|3728316|FG000|STARTED|Overall Study||4852
3010186|NCT01006135|3728316|FG000|COMPLETED|Overall Study||4712
3010187|NCT01006135|3728316|FG000|NOT COMPLETED|Overall Study||140
3010188|NCT01006252|3728322|FG000|STARTED|Overall Study||168
3010189|NCT01006252|3728323|FG001|STARTED|Overall Study||168
3010190|NCT01006252|3728322|FG000|Received Treatment|Overall Study||164
3010191|NCT01006252|3728323|FG001|Received Treatment|Overall Study||161
3010192|NCT01006252|3728322|FG000|COMPLETED|Overall Study||168
3010193|NCT01006252|3728323|FG001|COMPLETED|Overall Study||168
3010194|NCT01006252|3728322|FG000|NOT COMPLETED|Overall Study||0
3010195|NCT01006252|3728323|FG001|NOT COMPLETED|Overall Study||0
3010196|NCT01006291|3728336|FG000|STARTED|Overall Study||229
3010197|NCT01006291|3728337|FG001|STARTED|Overall Study||228
3010198|NCT01006291|3728338|FG002|STARTED|Overall Study||230
3010199|NCT01006291|3728336|FG000|Exposed|Overall Study|1 subject withdrew before exposure to drug. 2 subjects randomised to IDeg OD received IDeg OD FF|230
3010200|NCT01006291|3728337|FG001|Exposed|Overall Study|2 subjects received IDeg OD FF|226
3010201|NCT01006291|3728338|FG002|Exposed|Overall Study|1 subject withdrew prior to exposure to trial drug|229
3010202|NCT01006291|3728336|FG000|COMPLETED|Overall Study||203
3010203|NCT01006291|3728337|FG001|COMPLETED|Overall Study||204
3010204|NCT01006291|3728338|FG002|COMPLETED|Overall Study||203
3010205|NCT01006291|3728336|FG000|NOT COMPLETED|Overall Study||26
3010206|NCT01006291|3728337|FG001|NOT COMPLETED|Overall Study||24
3010207|NCT01006291|3728338|FG002|NOT COMPLETED|Overall Study||27
3010208|NCT01006356|3728346|FG000|STARTED|Overall Study||141
3010209|NCT01006356|3728346|FG000|COMPLETED|Overall Study||99
3010210|NCT01006356|3728346|FG000|NOT COMPLETED|Overall Study||42
3010211|NCT01006369|3728352|FG000|STARTED|Overall Study||13
3010212|NCT01006369|3728353|FG001|STARTED|Overall Study||25
3010213|NCT01006369|3728352|FG000|COMPLETED|Overall Study||1
3010214|NCT01006369|3728353|FG001|COMPLETED|Overall Study||0
3010215|NCT01006369|3728352|FG000|NOT COMPLETED|Overall Study||12
3010216|NCT01006369|3728353|FG001|NOT COMPLETED|Overall Study||25
3010217|NCT01006538|3728360|FG000|STARTED|Overall Study||244
3010218|NCT01006538|3728361|FG001|STARTED|Overall Study||119
3010219|NCT01006538|3728360|FG000|COMPLETED|Overall Study||233
3010220|NCT01006538|3728361|FG001|COMPLETED|Overall Study||115
3010221|NCT01006538|3728360|FG000|NOT COMPLETED|Overall Study||11
3010222|NCT01006538|3728361|FG001|NOT COMPLETED|Overall Study||4
3010223|NCT01006590|3728369|FG000|STARTED|Overall Study|Randomised and treated|147
3010224|NCT01006590|3728370|FG001|STARTED|Overall Study|Randomised and treated|139
3010225|NCT01006590|3728369|FG000|COMPLETED|Overall Study|Completed 24 weeks of treatment|119
3010226|NCT01006590|3728370|FG001|COMPLETED|Overall Study|Completed 24 weeks of treatment|107
3010227|NCT01006590|3728369|FG000|NOT COMPLETED|Overall Study||28
3010228|NCT01006590|3728370|FG001|NOT COMPLETED|Overall Study||32
3010229|NCT01006603|3728378|FG000|STARTED|Overall Study|Completed lead-in period and were randomised|360
3010230|NCT01006603|3728379|FG001|STARTED|Overall Study|Completed lead-in period and were randomised|360
3010231|NCT01006603|3728378|FG000|COMPLETED|Overall Study||289
3010232|NCT01006603|3728379|FG001|COMPLETED|Overall Study||285
3010233|NCT01006603|3728378|FG000|NOT COMPLETED|Overall Study||71
3010234|NCT01006603|3728379|FG001|NOT COMPLETED|Overall Study||75
3010235|NCT01006616|3728389|FG000|STARTED|Period 1 (6 Months)||152
3010236|NCT01006616|3728390|FG001|STARTED|Period 1 (6 Months)||156
3010237|NCT01006616|3728391|FG002|STARTED|Period 1 (6 Months)||153
3010238|NCT01006616|3728392|FG003|STARTED|Period 1 (6 Months)||155
3010239|NCT01006616|3728389|FG000|Treated|Period 1 (6 Months)||152
3010240|NCT01006616|3728390|FG001|Treated|Period 1 (6 Months)||156
3010241|NCT01006616|3728391|FG002|Treated|Period 1 (6 Months)||152
3010242|NCT01006616|3728392|FG003|Treated|Period 1 (6 Months)||154
3010243|NCT01006616|3728389|FG000|COMPLETED|Period 1 (6 Months)||126
3010244|NCT01006616|3728390|FG001|COMPLETED|Period 1 (6 Months)||102
3010245|NCT01006616|3728391|FG002|COMPLETED|Period 1 (6 Months)||102
3133652|NCT01696773|3858575|FG001|COMPLETED|Days 1-13, Washout||6
3010246|NCT01006616|3728392|FG003|COMPLETED|Period 1 (6 Months)||128
3010247|NCT01006616|3728389|FG000|NOT COMPLETED|Period 1 (6 Months)||26
3010248|NCT01006616|3728390|FG001|NOT COMPLETED|Period 1 (6 Months)||54
3010249|NCT01006616|3728391|FG002|NOT COMPLETED|Period 1 (6 Months)||51
3010250|NCT01006616|3728392|FG003|NOT COMPLETED|Period 1 (6 Months)||27
3010251|NCT01006616|3728389|FG000|STARTED|Period 2 (18 Months)|Period 2 was optional. Not all participants completing Period 1 continued into Period 2.|75
3010252|NCT01006616|3728390|FG001|STARTED|Period 2 (18 Months)|Period 2 was optional. Not all participants completing Period 1 continued into Period 2.|63
3010253|NCT01006616|3728391|FG002|STARTED|Period 2 (18 Months)|Period 2 was optional. Not all participants completing Period 1 continued into Period 2.|55
3010254|NCT01006616|3728392|FG003|STARTED|Period 2 (18 Months)|Period 2 was optional. Not all participants completing Period 1 continued into Period 2.|82
3010255|NCT01006616|3728389|FG000|Treated|Period 2 (18 Months)||75
3010256|NCT01006616|3728390|FG001|Treated|Period 2 (18 Months)||63
3010257|NCT01006616|3728391|FG002|Treated|Period 2 (18 Months)||55
3010258|NCT01006616|3728392|FG003|Treated|Period 2 (18 Months)||82
3010259|NCT01006616|3728389|FG000|COMPLETED|Period 2 (18 Months)||0
3010260|NCT01006616|3728390|FG001|COMPLETED|Period 2 (18 Months)||0
3010261|NCT01006616|3728391|FG002|COMPLETED|Period 2 (18 Months)||0
3010262|NCT01006616|3728392|FG003|COMPLETED|Period 2 (18 Months)||0
3010263|NCT01006616|3728389|FG000|NOT COMPLETED|Period 2 (18 Months)||75
3010264|NCT01006616|3728390|FG001|NOT COMPLETED|Period 2 (18 Months)||63
3010265|NCT01006616|3728391|FG002|NOT COMPLETED|Period 2 (18 Months)||55
3010266|NCT01006616|3728392|FG003|NOT COMPLETED|Period 2 (18 Months)||82
3010267|NCT01006629|3728402|FG000|STARTED|Overall Study||100
3010268|NCT01006629|3728402|FG000|COMPLETED|Overall Study||94
3010269|NCT01006629|3728402|FG000|NOT COMPLETED|Overall Study||6
3010270|NCT01006655|3728408|FG000|STARTED|First Intervention||11
3010271|NCT01006655|3728409|FG001|STARTED|First Intervention||10
3010272|NCT01006655|3728408|FG000|COMPLETED|First Intervention||11
3010273|NCT01006655|3728409|FG001|COMPLETED|First Intervention||10
3010274|NCT01006655|3728408|FG000|NOT COMPLETED|First Intervention||0
3010275|NCT01006655|3728409|FG001|NOT COMPLETED|First Intervention||0
3010276|NCT01006655|3728408|FG000|STARTED|Washout Period of 2 Weeks||11
3010277|NCT01006655|3728409|FG001|STARTED|Washout Period of 2 Weeks||10
3010278|NCT01006655|3728408|FG000|COMPLETED|Washout Period of 2 Weeks||11
3010279|NCT01006655|3728409|FG001|COMPLETED|Washout Period of 2 Weeks||10
3010280|NCT01006655|3728408|FG000|NOT COMPLETED|Washout Period of 2 Weeks||0
3010281|NCT01006655|3728409|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0
3010282|NCT01006655|3728408|FG000|STARTED|Second Intervention||11
3010283|NCT01006655|3728409|FG001|STARTED|Second Intervention||10
3010284|NCT01006655|3728408|FG000|COMPLETED|Second Intervention||11
3010285|NCT01006655|3728409|FG001|COMPLETED|Second Intervention||10
3010286|NCT01006655|3728408|FG000|NOT COMPLETED|Second Intervention||0
3010287|NCT01006655|3728409|FG001|NOT COMPLETED|Second Intervention||0
3010288|NCT01006707|3728415|FG000|STARTED|Study Session 1||15
3010289|NCT01006707|3728416|FG001|STARTED|Study Session 1||0
3010290|NCT01006707|3728417|FG002|STARTED|Study Session 1||0
3010291|NCT01006707|3728415|FG000|COMPLETED|Study Session 1||10
3010292|NCT01006707|3728416|FG001|COMPLETED|Study Session 1||0
3010293|NCT01006707|3728417|FG002|COMPLETED|Study Session 1||0
3010294|NCT01006707|3728415|FG000|NOT COMPLETED|Study Session 1||5
3010295|NCT01006707|3728416|FG001|NOT COMPLETED|Study Session 1||0
3010296|NCT01006707|3728417|FG002|NOT COMPLETED|Study Session 1||0
3010297|NCT01006707|3728415|FG000|STARTED|Study Session 2||0
3010298|NCT01006707|3728416|FG001|STARTED|Study Session 2||4
3010299|NCT01006707|3728417|FG002|STARTED|Study Session 2||6
3010300|NCT01006707|3728415|FG000|COMPLETED|Study Session 2||0
3010301|NCT01006707|3728416|FG001|COMPLETED|Study Session 2||4
3010302|NCT01006707|3728417|FG002|COMPLETED|Study Session 2||6
3010303|NCT01006707|3728415|FG000|NOT COMPLETED|Study Session 2||0
3010304|NCT01006707|3728416|FG001|NOT COMPLETED|Study Session 2||0
3010305|NCT01006707|3728417|FG002|NOT COMPLETED|Study Session 2||0
3010306|NCT01006707|3728415|FG000|STARTED|Study Session 3||0
3010307|NCT01006707|3728416|FG001|STARTED|Study Session 3||4
3010308|NCT01006707|3728417|FG002|STARTED|Study Session 3||6
3010309|NCT01006707|3728415|FG000|COMPLETED|Study Session 3||0
3010310|NCT01006707|3728416|FG001|COMPLETED|Study Session 3||4
3010311|NCT01006707|3728417|FG002|COMPLETED|Study Session 3||6
3010312|NCT01006707|3728415|FG000|NOT COMPLETED|Study Session 3||0
3010313|NCT01006707|3728416|FG001|NOT COMPLETED|Study Session 3||0
3010314|NCT01006707|3728417|FG002|NOT COMPLETED|Study Session 3||0
3010315|NCT01006889|3728425|FG000|STARTED|Overall Study||20
3010316|NCT01006889|3728425|FG000|COMPLETED|Overall Study||17
3010317|NCT01006889|3728425|FG000|NOT COMPLETED|Overall Study||3
3010318|NCT01006967|3728432|FG000|STARTED|Overall Study||253
3010319|NCT01006967|3728433|FG001|STARTED|Overall Study||253
3010320|NCT01006967|3728432|FG000|Received Treatment|Overall Study||245
3010321|NCT01006967|3728433|FG001|Received Treatment|Overall Study||245
3010322|NCT01006967|3728432|FG000|3 Month Follow-up|Overall Study||212
3010323|NCT01006967|3728433|FG001|3 Month Follow-up|Overall Study||210
3010324|NCT01006967|3728432|FG000|COMPLETED|Overall Study||187
3010325|NCT01006967|3728433|FG001|COMPLETED|Overall Study||190
3010326|NCT01006967|3728432|FG000|NOT COMPLETED|Overall Study||66
3010327|NCT01006967|3728433|FG001|NOT COMPLETED|Overall Study||63
3010328|NCT01006980|3728443|FG000|STARTED|Vemurafenib and Dacarbazine||337
3010329|NCT01006980|3728444|FG001|STARTED|Vemurafenib and Dacarbazine||338
3010330|NCT01006980|3728443|FG000|Treated|Vemurafenib and Dacarbazine||336
3010331|NCT01006980|3728444|FG001|Treated|Vemurafenib and Dacarbazine||293
3010332|NCT01006980|3728443|FG000|COMPLETED|Vemurafenib and Dacarbazine||0
3010333|NCT01006980|3728444|FG001|COMPLETED|Vemurafenib and Dacarbazine||0
3010334|NCT01006980|3728443|FG000|NOT COMPLETED|Vemurafenib and Dacarbazine||337
3010335|NCT01006980|3728444|FG001|NOT COMPLETED|Vemurafenib and Dacarbazine||338
3010336|NCT01006980|3728443|FG000|STARTED|Crossover: Dacarbazine to Vemurafenib||0
3010337|NCT01006980|3728444|FG001|STARTED|Crossover: Dacarbazine to Vemurafenib|Participants who crossed over from dacarbazine to vemurafenib treatment.|84
3010338|NCT01006980|3728443|FG000|COMPLETED|Crossover: Dacarbazine to Vemurafenib||0
3010339|NCT01006980|3728444|FG001|COMPLETED|Crossover: Dacarbazine to Vemurafenib||0
3010340|NCT01006980|3728443|FG000|NOT COMPLETED|Crossover: Dacarbazine to Vemurafenib||0
3010341|NCT01006980|3728444|FG001|NOT COMPLETED|Crossover: Dacarbazine to Vemurafenib||84
3010342|NCT01007032|3728455|FG000|STARTED|Overall Study||4
3010343|NCT01007032|3728456|FG001|STARTED|Overall Study||7
3010344|NCT01007032|3728457|FG002|STARTED|Overall Study||3
3010345|NCT01007032|3728458|FG003|STARTED|Overall Study||7
3010346|NCT01007032|3728455|FG000|Received at Least 1 Dose of Study Drug|Overall Study||4
3010347|NCT01007032|3728456|FG001|Received at Least 1 Dose of Study Drug|Overall Study||7
3010348|NCT01007032|3728457|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3
3010349|NCT01007032|3728458|FG003|Received at Least 1 Dose of Study Drug|Overall Study||7
3010350|NCT01007032|3728455|FG000|COMPLETED|Overall Study||4
3010351|NCT01007032|3728456|FG001|COMPLETED|Overall Study||6
3010352|NCT01007032|3728457|FG002|COMPLETED|Overall Study||2
3010353|NCT01007032|3728458|FG003|COMPLETED|Overall Study||6
3010354|NCT01007032|3728455|FG000|NOT COMPLETED|Overall Study||0
3010355|NCT01007032|3728456|FG001|NOT COMPLETED|Overall Study||1
3010356|NCT01007032|3728457|FG002|NOT COMPLETED|Overall Study||1
3010357|NCT01007032|3728458|FG003|NOT COMPLETED|Overall Study||1
3010358|NCT01007071|3728475|FG000|STARTED|Overall Study||6
3010359|NCT01007071|3728476|FG001|STARTED|Overall Study||5
3010360|NCT01007071|3728475|FG000|COMPLETED|Overall Study||6
3010361|NCT01007071|3728476|FG001|COMPLETED|Overall Study||5
3010362|NCT01007071|3728475|FG000|NOT COMPLETED|Overall Study||0
3010363|NCT01007071|3728476|FG001|NOT COMPLETED|Overall Study||0
3010364|NCT01007110|3728485|FG000|STARTED|Allocation||32
3010365|NCT01007110|3728486|FG001|STARTED|Allocation||35
3010366|NCT01007110|3728485|FG000|COMPLETED|Allocation||25
3010367|NCT01007110|3728486|FG001|COMPLETED|Allocation||27
3010368|NCT01007110|3728485|FG000|NOT COMPLETED|Allocation||7
3010369|NCT01007110|3728486|FG001|NOT COMPLETED|Allocation||8
3010370|NCT01007110|3728485|FG000|STARTED|Follow-Up at 24 Weeks||25
3010371|NCT01007110|3728486|FG001|STARTED|Follow-Up at 24 Weeks||27
3010372|NCT01007110|3728485|FG000|COMPLETED|Follow-Up at 24 Weeks||25
3010373|NCT01007110|3728486|FG001|COMPLETED|Follow-Up at 24 Weeks||23
3010374|NCT01007110|3728485|FG000|NOT COMPLETED|Follow-Up at 24 Weeks||0
3010375|NCT01007110|3728486|FG001|NOT COMPLETED|Follow-Up at 24 Weeks||4
3010376|NCT01007110|3728485|FG000|STARTED|Follow-Up at 32 Weeks||25
3010377|NCT01007110|3728486|FG001|STARTED|Follow-Up at 32 Weeks||23
3010378|NCT01007110|3728485|FG000|COMPLETED|Follow-Up at 32 Weeks||24
3010379|NCT01007110|3728486|FG001|COMPLETED|Follow-Up at 32 Weeks||22
3010380|NCT01007110|3728485|FG000|NOT COMPLETED|Follow-Up at 32 Weeks||1
3010381|NCT01007110|3728486|FG001|NOT COMPLETED|Follow-Up at 32 Weeks||1
3010382|NCT01007110|3728485|FG000|STARTED|Follow-Up at 36 Weeks||24
3010383|NCT01007110|3728486|FG001|STARTED|Follow-Up at 36 Weeks||22
3010384|NCT01007110|3728485|FG000|COMPLETED|Follow-Up at 36 Weeks||24
3010385|NCT01007110|3728486|FG001|COMPLETED|Follow-Up at 36 Weeks||20
3010386|NCT01007110|3728485|FG000|NOT COMPLETED|Follow-Up at 36 Weeks||0
3010387|NCT01007110|3728486|FG001|NOT COMPLETED|Follow-Up at 36 Weeks||2
3010388|NCT01007110|3728485|FG000|STARTED|Neonatal Behavioral Assessment Scale (NB||24
3010389|NCT01007110|3728486|FG001|STARTED|Neonatal Behavioral Assessment Scale (NB||20
3010390|NCT01007110|3728485|FG000|COMPLETED|Neonatal Behavioral Assessment Scale (NB||12
3010391|NCT01007110|3728486|FG001|COMPLETED|Neonatal Behavioral Assessment Scale (NB||15
3010392|NCT01007110|3728485|FG000|NOT COMPLETED|Neonatal Behavioral Assessment Scale (NB||12
3010393|NCT01007110|3728486|FG001|NOT COMPLETED|Neonatal Behavioral Assessment Scale (NB||5
3165239|NCT01898130|3892791|FG000|STARTED|Follow up Until PD or Death|All patients treated on study go into follow up period for survival data.|27
3165240|NCT01898130|3892791|FG000|COMPLETED|Follow up Until PD or Death||26
3165241|NCT01898130|3892791|FG000|NOT COMPLETED|Follow up Until PD or Death||1
3010394|NCT01007123|3728497|FG000|STARTED|Overall Study||48
3010395|NCT01007123|3728498|FG001|STARTED|Overall Study||47
3010396|NCT01007123|3728499|FG002|STARTED|Overall Study||48
3010397|NCT01007123|3728500|FG003|STARTED|Overall Study||47
3010398|NCT01007123|3728497|FG000|COMPLETED|Overall Study||42
3010399|NCT01007123|3728498|FG001|COMPLETED|Overall Study||41
3010400|NCT01007123|3728499|FG002|COMPLETED|Overall Study||37
3010401|NCT01007123|3728500|FG003|COMPLETED|Overall Study||41
3010402|NCT01007123|3728497|FG000|NOT COMPLETED|Overall Study||6
3010403|NCT01007123|3728498|FG001|NOT COMPLETED|Overall Study||6
3010404|NCT01007123|3728499|FG002|NOT COMPLETED|Overall Study||11
3010405|NCT01007123|3728500|FG003|NOT COMPLETED|Overall Study||6
3010406|NCT01007136|3728516|FG000|STARTED|Overall Study||19
3010407|NCT01007136|3728517|FG001|STARTED|Overall Study|One additional subject was excluded prior to randomization due to illicit drug use.|17
3010408|NCT01007136|3728518|FG002|STARTED|Overall Study||15
3165242|NCT01898195|3892798|FG000|STARTED|Varenicline Adherence||53
3165243|NCT01898195|3892799|FG001|STARTED|Varenicline Adherence||54
3165244|NCT01898195|3892800|FG002|STARTED|Varenicline Adherence||51
3165245|NCT01898195|3892798|FG000|COMPLETED|Varenicline Adherence||18
3165246|NCT01898195|3892799|FG001|COMPLETED|Varenicline Adherence||16
3010409|NCT01007136|3728519|FG003|STARTED|Overall Study||6
3010410|NCT01007136|3728520|FG004|STARTED|Overall Study||4
3010411|NCT01007136|3728516|FG000|COMPLETED|Overall Study||15
3010412|NCT01007136|3728517|FG001|COMPLETED|Overall Study||13
3010413|NCT01007136|3728518|FG002|COMPLETED|Overall Study||15
3010414|NCT01007136|3728519|FG003|COMPLETED|Overall Study||6
3010415|NCT01007136|3728520|FG004|COMPLETED|Overall Study||4
3010416|NCT01007136|3728516|FG000|NOT COMPLETED|Overall Study||4
3010417|NCT01007136|3728517|FG001|NOT COMPLETED|Overall Study||4
3010418|NCT01007136|3728518|FG002|NOT COMPLETED|Overall Study||0
3010419|NCT01007136|3728519|FG003|NOT COMPLETED|Overall Study||0
3010420|NCT01007136|3728520|FG004|NOT COMPLETED|Overall Study||0
3010421|NCT01007149|3728533|FG000|STARTED|Overall Study||20
3010422|NCT01007149|3728534|FG001|STARTED|Overall Study||21
3010423|NCT01007149|3728533|FG000|COMPLETED|Overall Study||20
3010424|NCT01007149|3728534|FG001|COMPLETED|Overall Study||20
3010425|NCT01007149|3728533|FG000|NOT COMPLETED|Overall Study||0
3010426|NCT01007149|3728534|FG001|NOT COMPLETED|Overall Study||1
3010427|NCT01007253|3728540|FG000|STARTED|First Intervention||6
3010428|NCT01007253|3728541|FG001|STARTED|First Intervention||5
3010429|NCT01007253|3728542|FG002|STARTED|First Intervention||5
3010430|NCT01007253|3728543|FG003|STARTED|First Intervention||5
3010431|NCT01007253|3728540|FG000|COMPLETED|First Intervention||6
3010432|NCT01007253|3728541|FG001|COMPLETED|First Intervention||5
3010433|NCT01007253|3728542|FG002|COMPLETED|First Intervention||5
3010434|NCT01007253|3728543|FG003|COMPLETED|First Intervention||5
3010435|NCT01007253|3728540|FG000|NOT COMPLETED|First Intervention||0
3010436|NCT01007253|3728541|FG001|NOT COMPLETED|First Intervention||0
3010437|NCT01007253|3728542|FG002|NOT COMPLETED|First Intervention||0
3010438|NCT01007253|3728543|FG003|NOT COMPLETED|First Intervention||0
3010439|NCT01007253|3728540|FG000|STARTED|Washout Period (2 Weeks) # 1||6
3010440|NCT01007253|3728541|FG001|STARTED|Washout Period (2 Weeks) # 1||5
3010441|NCT01007253|3728542|FG002|STARTED|Washout Period (2 Weeks) # 1||5
3010442|NCT01007253|3728543|FG003|STARTED|Washout Period (2 Weeks) # 1||5
3010443|NCT01007253|3728540|FG000|COMPLETED|Washout Period (2 Weeks) # 1||6
3010444|NCT01007253|3728541|FG001|COMPLETED|Washout Period (2 Weeks) # 1||5
3010445|NCT01007253|3728542|FG002|COMPLETED|Washout Period (2 Weeks) # 1||5
3010446|NCT01007253|3728543|FG003|COMPLETED|Washout Period (2 Weeks) # 1||5
3010447|NCT01007253|3728540|FG000|NOT COMPLETED|Washout Period (2 Weeks) # 1||0
3010448|NCT01007253|3728541|FG001|NOT COMPLETED|Washout Period (2 Weeks) # 1||0
3010449|NCT01007253|3728542|FG002|NOT COMPLETED|Washout Period (2 Weeks) # 1||0
3010450|NCT01007253|3728543|FG003|NOT COMPLETED|Washout Period (2 Weeks) # 1||0
3010451|NCT01007253|3728540|FG000|STARTED|Second Intervention||6
3010452|NCT01007253|3728541|FG001|STARTED|Second Intervention||5
3010453|NCT01007253|3728542|FG002|STARTED|Second Intervention||5
3010454|NCT01007253|3728543|FG003|STARTED|Second Intervention||5
3010455|NCT01007253|3728540|FG000|COMPLETED|Second Intervention||6
3010456|NCT01007253|3728541|FG001|COMPLETED|Second Intervention||5
3010457|NCT01007253|3728542|FG002|COMPLETED|Second Intervention||5
3010458|NCT01007253|3728543|FG003|COMPLETED|Second Intervention||5
3010459|NCT01007253|3728540|FG000|NOT COMPLETED|Second Intervention||0
3010460|NCT01007253|3728541|FG001|NOT COMPLETED|Second Intervention||0
3010461|NCT01007253|3728542|FG002|NOT COMPLETED|Second Intervention||0
3010462|NCT01007253|3728543|FG003|NOT COMPLETED|Second Intervention||0
3010463|NCT01007253|3728540|FG000|STARTED|Washout Period (2 Weeks) # 2||6
3010464|NCT01007253|3728541|FG001|STARTED|Washout Period (2 Weeks) # 2||5
3010465|NCT01007253|3728542|FG002|STARTED|Washout Period (2 Weeks) # 2||5
3010466|NCT01007253|3728543|FG003|STARTED|Washout Period (2 Weeks) # 2||5
3010467|NCT01007253|3728540|FG000|COMPLETED|Washout Period (2 Weeks) # 2||6
3010468|NCT01007253|3728541|FG001|COMPLETED|Washout Period (2 Weeks) # 2||5
3010469|NCT01007253|3728542|FG002|COMPLETED|Washout Period (2 Weeks) # 2||5
3010470|NCT01007253|3728543|FG003|COMPLETED|Washout Period (2 Weeks) # 2||5
3010471|NCT01007253|3728540|FG000|NOT COMPLETED|Washout Period (2 Weeks) # 2||0
3010472|NCT01007253|3728541|FG001|NOT COMPLETED|Washout Period (2 Weeks) # 2||0
3010473|NCT01007253|3728542|FG002|NOT COMPLETED|Washout Period (2 Weeks) # 2||0
3010474|NCT01007253|3728543|FG003|NOT COMPLETED|Washout Period (2 Weeks) # 2||0
3010475|NCT01007253|3728540|FG000|STARTED|Third Intervention||6
3010476|NCT01007253|3728541|FG001|STARTED|Third Intervention||5
3010477|NCT01007253|3728542|FG002|STARTED|Third Intervention||5
3010478|NCT01007253|3728543|FG003|STARTED|Third Intervention||5
3010479|NCT01007253|3728540|FG000|COMPLETED|Third Intervention||6
3010480|NCT01007253|3728541|FG001|COMPLETED|Third Intervention||5
3010481|NCT01007253|3728542|FG002|COMPLETED|Third Intervention||5
3010482|NCT01007253|3728543|FG003|COMPLETED|Third Intervention||5
3010483|NCT01007253|3728540|FG000|NOT COMPLETED|Third Intervention||0
3010484|NCT01007253|3728541|FG001|NOT COMPLETED|Third Intervention||0
3010485|NCT01007253|3728542|FG002|NOT COMPLETED|Third Intervention||0
3010486|NCT01007253|3728543|FG003|NOT COMPLETED|Third Intervention||0
3010487|NCT01007253|3728540|FG000|STARTED|Washout Period (2 Weeks) # 3||6
3010488|NCT01007253|3728541|FG001|STARTED|Washout Period (2 Weeks) # 3||5
3010489|NCT01007253|3728542|FG002|STARTED|Washout Period (2 Weeks) # 3||5
3010490|NCT01007253|3728543|FG003|STARTED|Washout Period (2 Weeks) # 3||5
3010491|NCT01007253|3728540|FG000|COMPLETED|Washout Period (2 Weeks) # 3||5
3010492|NCT01007253|3728541|FG001|COMPLETED|Washout Period (2 Weeks) # 3||5
3010493|NCT01007253|3728542|FG002|COMPLETED|Washout Period (2 Weeks) # 3||5
3010494|NCT01007253|3728543|FG003|COMPLETED|Washout Period (2 Weeks) # 3||5
3010495|NCT01007253|3728540|FG000|NOT COMPLETED|Washout Period (2 Weeks) # 3||1
3010496|NCT01007253|3728541|FG001|NOT COMPLETED|Washout Period (2 Weeks) # 3||0
3010497|NCT01007253|3728542|FG002|NOT COMPLETED|Washout Period (2 Weeks) # 3||0
3010498|NCT01007253|3728543|FG003|NOT COMPLETED|Washout Period (2 Weeks) # 3||0
3010499|NCT01007253|3728540|FG000|STARTED|Fourth Intervention||5
3010500|NCT01007253|3728541|FG001|STARTED|Fourth Intervention||5
3010501|NCT01007253|3728542|FG002|STARTED|Fourth Intervention||5
3010502|NCT01007253|3728543|FG003|STARTED|Fourth Intervention||5
3010503|NCT01007253|3728540|FG000|COMPLETED|Fourth Intervention||5
3010504|NCT01007253|3728541|FG001|COMPLETED|Fourth Intervention||5
3010505|NCT01007253|3728542|FG002|COMPLETED|Fourth Intervention||5
3010506|NCT01007253|3728543|FG003|COMPLETED|Fourth Intervention||5
3010507|NCT01007253|3728540|FG000|NOT COMPLETED|Fourth Intervention||0
3010508|NCT01007253|3728541|FG001|NOT COMPLETED|Fourth Intervention||0
3010509|NCT01007253|3728542|FG002|NOT COMPLETED|Fourth Intervention||0
3010510|NCT01007253|3728543|FG003|NOT COMPLETED|Fourth Intervention||0
3010511|NCT01007396|3728553|FG000|STARTED|Overall Study||322
3010512|NCT01007396|3728553|FG000|COMPLETED|Overall Study||275
3010513|NCT01007396|3728553|FG000|NOT COMPLETED|Overall Study||47
3010514|NCT01007435|3728561|FG000|STARTED|Overall Study||289
3010515|NCT01007435|3728562|FG001|STARTED|Overall Study||290
3010516|NCT01007435|3728563|FG002|STARTED|Overall Study||291
3010517|NCT01007435|3728564|FG003|STARTED|Overall Study||292
3010518|NCT01007435|3728561|FG000|COMPLETED|Overall Study||226
3010519|NCT01007435|3728562|FG001|COMPLETED|Overall Study||231
3010520|NCT01007435|3728563|FG002|COMPLETED|Overall Study||227
3010521|NCT01007435|3728564|FG003|COMPLETED|Overall Study||236
3010522|NCT01007435|3728561|FG000|NOT COMPLETED|Overall Study||63
3010523|NCT01007435|3728562|FG001|NOT COMPLETED|Overall Study||59
3010524|NCT01007435|3728563|FG002|NOT COMPLETED|Overall Study||64
3010525|NCT01007435|3728564|FG003|NOT COMPLETED|Overall Study||56
3010526|NCT01007448|3728576|FG000|STARTED|Overall Study||30
3010527|NCT01007448|3728577|FG001|STARTED|Overall Study||29
3010528|NCT01007448|3728576|FG000|Full Analysis Population|Overall Study||30
3010529|NCT01007448|3728577|FG001|Full Analysis Population|Overall Study||29
3010530|NCT01007448|3728576|FG000|Safety Population|Overall Study||30
3010531|NCT01007448|3728577|FG001|Safety Population|Overall Study||29
3010532|NCT01007448|3728576|FG000|COMPLETED|Overall Study||20
3010533|NCT01007448|3728577|FG001|COMPLETED|Overall Study||20
3010534|NCT01007448|3728576|FG000|NOT COMPLETED|Overall Study||10
3010535|NCT01007448|3728577|FG001|NOT COMPLETED|Overall Study||9
3010536|NCT01007526|3728583|FG000|STARTED|Overall Study||31
3010537|NCT01007526|3728583|FG000|COMPLETED|Overall Study||31
3010538|NCT01007526|3728583|FG000|NOT COMPLETED|Overall Study||0
3010539|NCT01007552|3728587|FG000|STARTED|Overall Study||50
3010540|NCT01007552|3728587|FG000|COMPLETED|Overall Study||49
3010541|NCT01007552|3728587|FG000|NOT COMPLETED|Overall Study||1
3010542|NCT01007591|3728593|FG000|STARTED|Overall Study||27
3010543|NCT01007591|3728594|FG001|STARTED|Overall Study||13
3010544|NCT01007591|3728593|FG000|COMPLETED|Overall Study||26
3010545|NCT01007591|3728594|FG001|COMPLETED|Overall Study||12
3010546|NCT01007591|3728593|FG000|NOT COMPLETED|Overall Study||1
3010547|NCT01007591|3728594|FG001|NOT COMPLETED|Overall Study||1
3010548|NCT01007643|3728602|FG000|STARTED|Overall Study||8
3010549|NCT01007643|3728603|FG001|STARTED|Overall Study||14
3010550|NCT01007643|3728602|FG000|COMPLETED|Overall Study||8
3010551|NCT01007643|3728603|FG001|COMPLETED|Overall Study||14
3010552|NCT01007643|3728602|FG000|NOT COMPLETED|Overall Study||0
3010553|NCT01007643|3728603|FG001|NOT COMPLETED|Overall Study||0
3010554|NCT01007656|3728609|FG000|STARTED|Overall Study||31
3010555|NCT01007656|3728609|FG000|COMPLETED|Overall Study||31
3010556|NCT01007656|3728609|FG000|NOT COMPLETED|Overall Study||0
3010557|NCT01007812|3728613|FG000|STARTED|Period 1, One Week||25
3010558|NCT01007812|3728614|FG001|STARTED|Period 1, One Week||25
3010559|NCT01007812|3728613|FG000|COMPLETED|Period 1, One Week||24
3010560|NCT01007812|3728614|FG001|COMPLETED|Period 1, One Week||24
3010561|NCT01007812|3728613|FG000|NOT COMPLETED|Period 1, One Week||1
3010562|NCT01007812|3728614|FG001|NOT COMPLETED|Period 1, One Week||1
3010563|NCT01007812|3728613|FG000|STARTED|Period 2, One Week||24
3010564|NCT01007812|3728614|FG001|STARTED|Period 2, One Week||24
3010565|NCT01007812|3728613|FG000|COMPLETED|Period 2, One Week||24
3010566|NCT01007812|3728614|FG001|COMPLETED|Period 2, One Week||24
3010567|NCT01007812|3728613|FG000|NOT COMPLETED|Period 2, One Week||0
3010568|NCT01007812|3728614|FG001|NOT COMPLETED|Period 2, One Week||0
3010569|NCT01007838|3728624|FG000|STARTED|Overall Study||12
3010570|NCT01007838|3728625|FG001|STARTED|Overall Study||11
3010571|NCT01007838|3728626|FG002|STARTED|Overall Study||5
3010572|NCT01007838|3728627|FG003|STARTED|Overall Study||4
3010573|NCT01007838|3728624|FG000|COMPLETED|Overall Study||9
3010574|NCT01007838|3728625|FG001|COMPLETED|Overall Study||11
3010575|NCT01007838|3728626|FG002|COMPLETED|Overall Study||5
3010576|NCT01007838|3728627|FG003|COMPLETED|Overall Study||4
3010577|NCT01007838|3728624|FG000|NOT COMPLETED|Overall Study||3
3010578|NCT01007838|3728625|FG001|NOT COMPLETED|Overall Study||0
3010579|NCT01007838|3728626|FG002|NOT COMPLETED|Overall Study||0
3010580|NCT01007838|3728627|FG003|NOT COMPLETED|Overall Study||0
3010581|NCT01007916|3728637|FG000|STARTED|Period 1, 4 Weeks of Wear||23
3010582|NCT01007916|3728638|FG001|STARTED|Period 1, 4 Weeks of Wear||26
3010583|NCT01007916|3728637|FG000|COMPLETED|Period 1, 4 Weeks of Wear||22
3010584|NCT01007916|3728638|FG001|COMPLETED|Period 1, 4 Weeks of Wear||26
3010585|NCT01007916|3728637|FG000|NOT COMPLETED|Period 1, 4 Weeks of Wear||1
3010586|NCT01007916|3728638|FG001|NOT COMPLETED|Period 1, 4 Weeks of Wear||0
3010587|NCT01007916|3728637|FG000|STARTED|Period 2, 4 Weeks of Wear||22
3010588|NCT01007916|3728638|FG001|STARTED|Period 2, 4 Weeks of Wear|One participant completed Period 1 but did not start Period 2 due to failing inclusion criteria.|25
3010589|NCT01007916|3728637|FG000|COMPLETED|Period 2, 4 Weeks of Wear||21
3010590|NCT01007916|3728638|FG001|COMPLETED|Period 2, 4 Weeks of Wear||25
3010591|NCT01007916|3728637|FG000|NOT COMPLETED|Period 2, 4 Weeks of Wear||1
3306725|NCT03000348|4040045|FG000|Day 14 Treatment Period|Overall Study||17
3306726|NCT03000348|4040046|FG001|Day 14 Treatment Period|Overall Study||10
3306727|NCT03000348|4040047|FG002|Day 14 Treatment Period|Overall Study||13
3306728|NCT03000348|4040048|FG003|Day 14 Treatment Period|Overall Study||14
3306729|NCT03000348|4040049|FG004|Day 14 Treatment Period|Overall Study||13
3010592|NCT01007916|3728638|FG001|NOT COMPLETED|Period 2, 4 Weeks of Wear||0
3010593|NCT01007942|3728646|FG000|STARTED|Overall Study||284
3010594|NCT01007942|3728647|FG001|STARTED|Overall Study||285
3010595|NCT01007942|3728646|FG000|COMPLETED|Overall Study|Pts completed= on treatment at time of DCO. Not Completed = ended treatment as per protocol.|3
3010596|NCT01007942|3728647|FG001|COMPLETED|Overall Study|Pts completed= on treatment at time of DCO. Not Completed = ended treatment as per protocol.|7
3010597|NCT01007942|3728646|FG000|NOT COMPLETED|Overall Study||281
3010598|NCT01007942|3728647|FG001|NOT COMPLETED|Overall Study||278
3010599|NCT01007994|3728659|FG000|STARTED|Overall Study||17
3010600|NCT01007994|3728660|FG001|STARTED|Overall Study||16
3010601|NCT01007994|3728659|FG000|COMPLETED|Overall Study||15
3010602|NCT01007994|3728660|FG001|COMPLETED|Overall Study||14
3010603|NCT01007994|3728659|FG000|NOT COMPLETED|Overall Study||2
3010604|NCT01007994|3728660|FG001|NOT COMPLETED|Overall Study||2
3010605|NCT01008059|3728666|FG000|STARTED|Control Sequential Alfentanil||6
3010606|NCT01008059|3728667|FG001|STARTED|Control Sequential Alfentanil||0
3010607|NCT01008059|3728668|FG002|STARTED|Control Sequential Alfentanil||0
3010608|NCT01008059|3728669|FG003|STARTED|Control Sequential Alfentanil||0
3010609|NCT01008059|3728670|FG004|STARTED|Control Sequential Alfentanil||0
3010610|NCT01008059|3728671|FG005|STARTED|Control Sequential Alfentanil||0
3010611|NCT01008059|3728672|FG006|STARTED|Control Sequential Alfentanil||0
3010612|NCT01008059|3728673|FG007|STARTED|Control Sequential Alfentanil||0
3010613|NCT01008059|3728666|FG000|COMPLETED|Control Sequential Alfentanil||6
3010614|NCT01008059|3728667|FG001|COMPLETED|Control Sequential Alfentanil||0
3010615|NCT01008059|3728668|FG002|COMPLETED|Control Sequential Alfentanil||0
3010616|NCT01008059|3728669|FG003|COMPLETED|Control Sequential Alfentanil||0
3010617|NCT01008059|3728670|FG004|COMPLETED|Control Sequential Alfentanil||0
3010618|NCT01008059|3728671|FG005|COMPLETED|Control Sequential Alfentanil||0
3010619|NCT01008059|3728672|FG006|COMPLETED|Control Sequential Alfentanil||0
3010620|NCT01008059|3728673|FG007|COMPLETED|Control Sequential Alfentanil||0
3010621|NCT01008059|3728666|FG000|NOT COMPLETED|Control Sequential Alfentanil||0
3010622|NCT01008059|3728667|FG001|NOT COMPLETED|Control Sequential Alfentanil||0
3010623|NCT01008059|3728668|FG002|NOT COMPLETED|Control Sequential Alfentanil||0
3010624|NCT01008059|3728669|FG003|NOT COMPLETED|Control Sequential Alfentanil||0
3010625|NCT01008059|3728670|FG004|NOT COMPLETED|Control Sequential Alfentanil||0
3010626|NCT01008059|3728671|FG005|NOT COMPLETED|Control Sequential Alfentanil||0
3010627|NCT01008059|3728672|FG006|NOT COMPLETED|Control Sequential Alfentanil||0
3010628|NCT01008059|3728673|FG007|NOT COMPLETED|Control Sequential Alfentanil||0
3010629|NCT01008059|3728666|FG000|STARTED|Rifampin Sequential Alfentanil||0
3010630|NCT01008059|3728667|FG001|STARTED|Rifampin Sequential Alfentanil||6
3010631|NCT01008059|3728668|FG002|STARTED|Rifampin Sequential Alfentanil||0
3010632|NCT01008059|3728669|FG003|STARTED|Rifampin Sequential Alfentanil||0
3010633|NCT01008059|3728670|FG004|STARTED|Rifampin Sequential Alfentanil||0
3010634|NCT01008059|3728671|FG005|STARTED|Rifampin Sequential Alfentanil||0
3010635|NCT01008059|3728672|FG006|STARTED|Rifampin Sequential Alfentanil||0
3010636|NCT01008059|3728673|FG007|STARTED|Rifampin Sequential Alfentanil||0
3010637|NCT01008059|3728666|FG000|COMPLETED|Rifampin Sequential Alfentanil||0
3010638|NCT01008059|3728667|FG001|COMPLETED|Rifampin Sequential Alfentanil||6
3010639|NCT01008059|3728668|FG002|COMPLETED|Rifampin Sequential Alfentanil||0
3010640|NCT01008059|3728669|FG003|COMPLETED|Rifampin Sequential Alfentanil||0
3010641|NCT01008059|3728670|FG004|COMPLETED|Rifampin Sequential Alfentanil||0
3010642|NCT01008059|3728671|FG005|COMPLETED|Rifampin Sequential Alfentanil||0
3010643|NCT01008059|3728672|FG006|COMPLETED|Rifampin Sequential Alfentanil||0
3010644|NCT01008059|3728673|FG007|COMPLETED|Rifampin Sequential Alfentanil||0
3010645|NCT01008059|3728666|FG000|NOT COMPLETED|Rifampin Sequential Alfentanil||0
3010646|NCT01008059|3728667|FG001|NOT COMPLETED|Rifampin Sequential Alfentanil||0
3010647|NCT01008059|3728668|FG002|NOT COMPLETED|Rifampin Sequential Alfentanil||0
3010648|NCT01008059|3728669|FG003|NOT COMPLETED|Rifampin Sequential Alfentanil||0
3010649|NCT01008059|3728670|FG004|NOT COMPLETED|Rifampin Sequential Alfentanil||0
3010650|NCT01008059|3728671|FG005|NOT COMPLETED|Rifampin Sequential Alfentanil||0
3010651|NCT01008059|3728672|FG006|NOT COMPLETED|Rifampin Sequential Alfentanil||0
3010652|NCT01008059|3728673|FG007|NOT COMPLETED|Rifampin Sequential Alfentanil||0
3010653|NCT01008059|3728666|FG000|STARTED|Grapefruit Juice Sequential Alfentanil||0
3010654|NCT01008059|3728667|FG001|STARTED|Grapefruit Juice Sequential Alfentanil||0
3010655|NCT01008059|3728668|FG002|STARTED|Grapefruit Juice Sequential Alfentanil||6
3010656|NCT01008059|3728669|FG003|STARTED|Grapefruit Juice Sequential Alfentanil||0
3165247|NCT01898195|3892800|FG002|COMPLETED|Varenicline Adherence||15
3165248|NCT01898195|3892798|FG000|NOT COMPLETED|Varenicline Adherence||35
3165249|NCT01898195|3892799|FG001|NOT COMPLETED|Varenicline Adherence||38
3165250|NCT01898195|3892800|FG002|NOT COMPLETED|Varenicline Adherence||36
3165251|NCT01898195|3892798|FG000|STARTED|Smoking Abstinence||53
3165252|NCT01898195|3892799|FG001|STARTED|Smoking Abstinence||54
3010657|NCT01008059|3728670|FG004|STARTED|Grapefruit Juice Sequential Alfentanil||0
3010658|NCT01008059|3728671|FG005|STARTED|Grapefruit Juice Sequential Alfentanil||0
3010659|NCT01008059|3728672|FG006|STARTED|Grapefruit Juice Sequential Alfentanil||0
3010660|NCT01008059|3728673|FG007|STARTED|Grapefruit Juice Sequential Alfentanil||0
3010661|NCT01008059|3728666|FG000|COMPLETED|Grapefruit Juice Sequential Alfentanil||0
3010662|NCT01008059|3728667|FG001|COMPLETED|Grapefruit Juice Sequential Alfentanil||0
3010663|NCT01008059|3728668|FG002|COMPLETED|Grapefruit Juice Sequential Alfentanil||6
3010664|NCT01008059|3728669|FG003|COMPLETED|Grapefruit Juice Sequential Alfentanil||0
3010665|NCT01008059|3728670|FG004|COMPLETED|Grapefruit Juice Sequential Alfentanil||0
3010666|NCT01008059|3728671|FG005|COMPLETED|Grapefruit Juice Sequential Alfentanil||0
3010667|NCT01008059|3728672|FG006|COMPLETED|Grapefruit Juice Sequential Alfentanil||0
3010668|NCT01008059|3728673|FG007|COMPLETED|Grapefruit Juice Sequential Alfentanil||0
3010669|NCT01008059|3728666|FG000|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0
3010670|NCT01008059|3728667|FG001|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0
3010671|NCT01008059|3728668|FG002|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0
3010672|NCT01008059|3728669|FG003|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0
3010673|NCT01008059|3728670|FG004|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0
3010674|NCT01008059|3728671|FG005|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0
3010675|NCT01008059|3728672|FG006|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0
3010676|NCT01008059|3728673|FG007|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0
3010677|NCT01008059|3728666|FG000|STARTED|Ketoconazole Sequential Alfentanil||0
3010678|NCT01008059|3728667|FG001|STARTED|Ketoconazole Sequential Alfentanil||0
3010679|NCT01008059|3728668|FG002|STARTED|Ketoconazole Sequential Alfentanil||0
3010680|NCT01008059|3728669|FG003|STARTED|Ketoconazole Sequential Alfentanil||6
3165253|NCT01898195|3892800|FG002|STARTED|Smoking Abstinence||51
3165254|NCT01898195|3892798|FG000|COMPLETED|Smoking Abstinence||18
3165255|NCT01898195|3892799|FG001|COMPLETED|Smoking Abstinence||16
3165256|NCT01898195|3892800|FG002|COMPLETED|Smoking Abstinence||15
3306730|NCT03000348|4040050|FG005|Day 14 Treatment Period|Overall Study||14
3306731|NCT03000348|4040045|FG000|COMPLETED|Overall Study||14
3306732|NCT03000348|4040046|FG001|COMPLETED|Overall Study||7
3306733|NCT03000348|4040047|FG002|COMPLETED|Overall Study||11
3306734|NCT03000348|4040048|FG003|COMPLETED|Overall Study||12
3306735|NCT03000348|4040049|FG004|COMPLETED|Overall Study||11
3306736|NCT03000348|4040050|FG005|COMPLETED|Overall Study||13
3306737|NCT03000348|4040045|FG000|NOT COMPLETED|Overall Study||3
3306738|NCT03000348|4040046|FG001|NOT COMPLETED|Overall Study||4
3306739|NCT03000348|4040047|FG002|NOT COMPLETED|Overall Study||4
3306740|NCT03000348|4040048|FG003|NOT COMPLETED|Overall Study||3
3306741|NCT03000348|4040049|FG004|NOT COMPLETED|Overall Study||5
3306742|NCT03000348|4040050|FG005|NOT COMPLETED|Overall Study||2
3306743|NCT03000452|4040067|FG000|STARTED|Treatment Period||18
3306744|NCT03000452|4040067|FG000|COMPLETED|Treatment Period||0
3306745|NCT03000452|4040067|FG000|NOT COMPLETED|Treatment Period||18
3306746|NCT03000452|4040067|FG000|STARTED|Follow-Up Period|1 participant died in Cycle 1 due to PD prior to evaluation.|17
3306747|NCT03000452|4040067|FG000|COMPLETED|Follow-Up Period||10
3306748|NCT03000452|4040067|FG000|NOT COMPLETED|Follow-Up Period||7
3306749|NCT03000608|4040073|FG000|STARTED|Overall Study||46
3306750|NCT03000608|4040074|FG001|STARTED|Overall Study||23
3306751|NCT03000608|4040073|FG000|COMPLETED|Overall Study||40
3306752|NCT03000608|4040074|FG001|COMPLETED|Overall Study||19
3306753|NCT03000608|4040073|FG000|NOT COMPLETED|Overall Study||6
3306754|NCT03000608|4040074|FG001|NOT COMPLETED|Overall Study||4
3306755|NCT03000673|4040084|FG000|STARTED|Overall Study||7
3306756|NCT03000673|4040085|FG001|STARTED|Overall Study||9
3306757|NCT03000673|4040086|FG002|STARTED|Overall Study||7
3306758|NCT03000673|4040087|FG003|STARTED|Overall Study||9
3306759|NCT03000673|4040084|FG000|COMPLETED|Overall Study||6
3306760|NCT03000673|4040085|FG001|COMPLETED|Overall Study||9
3306761|NCT03000673|4040086|FG002|COMPLETED|Overall Study||7
3306762|NCT03000673|4040087|FG003|COMPLETED|Overall Study||9
3306763|NCT03000673|4040084|FG000|NOT COMPLETED|Overall Study||1
3306764|NCT03000673|4040085|FG001|NOT COMPLETED|Overall Study||0
3306765|NCT03000673|4040086|FG002|NOT COMPLETED|Overall Study||0
3306766|NCT03000673|4040087|FG003|NOT COMPLETED|Overall Study||0
3306767|NCT03000686|4040100|FG000|STARTED|Part 1, Period 1 (1 Day)||5
3306768|NCT03000686|4040101|FG001|STARTED|Part 1, Period 1 (1 Day)||6
3306769|NCT03000686|4040102|FG002|STARTED|Part 1, Period 1 (1 Day)||0
3306770|NCT03000686|4040103|FG003|STARTED|Part 1, Period 1 (1 Day)||0
3306771|NCT03000686|4040100|FG000|COMPLETED|Part 1, Period 1 (1 Day)||5
3306772|NCT03000686|4040101|FG001|COMPLETED|Part 1, Period 1 (1 Day)||5
3306773|NCT03000686|4040102|FG002|COMPLETED|Part 1, Period 1 (1 Day)||0
3306774|NCT03000686|4040103|FG003|COMPLETED|Part 1, Period 1 (1 Day)||0
3306775|NCT03000686|4040100|FG000|NOT COMPLETED|Part 1, Period 1 (1 Day)||0
3306776|NCT03000686|4040101|FG001|NOT COMPLETED|Part 1, Period 1 (1 Day)||1
3306777|NCT03000686|4040102|FG002|NOT COMPLETED|Part 1, Period 1 (1 Day)||0
3010681|NCT01008059|3728670|FG004|STARTED|Ketoconazole Sequential Alfentanil||0
3010682|NCT01008059|3728671|FG005|STARTED|Ketoconazole Sequential Alfentanil||0
3010683|NCT01008059|3728672|FG006|STARTED|Ketoconazole Sequential Alfentanil||0
3165257|NCT01898195|3892798|FG000|NOT COMPLETED|Smoking Abstinence||35
3306778|NCT03000686|4040103|FG003|NOT COMPLETED|Part 1, Period 1 (1 Day)||0
3306779|NCT03000686|4040100|FG000|STARTED|Part 1, Wash-out (Up to 14 Days)||5
3306780|NCT03000686|4040101|FG001|STARTED|Part 1, Wash-out (Up to 14 Days)||5
3306781|NCT03000686|4040102|FG002|STARTED|Part 1, Wash-out (Up to 14 Days)||0
3306782|NCT03000686|4040103|FG003|STARTED|Part 1, Wash-out (Up to 14 Days)||0
3306783|NCT03000686|4040100|FG000|COMPLETED|Part 1, Wash-out (Up to 14 Days)||5
3010684|NCT01008059|3728673|FG007|STARTED|Ketoconazole Sequential Alfentanil||0
3010685|NCT01008059|3728666|FG000|COMPLETED|Ketoconazole Sequential Alfentanil||0
3010686|NCT01008059|3728667|FG001|COMPLETED|Ketoconazole Sequential Alfentanil||0
3010687|NCT01008059|3728668|FG002|COMPLETED|Ketoconazole Sequential Alfentanil||0
3010688|NCT01008059|3728669|FG003|COMPLETED|Ketoconazole Sequential Alfentanil||6
3010689|NCT01008059|3728670|FG004|COMPLETED|Ketoconazole Sequential Alfentanil||0
3010690|NCT01008059|3728671|FG005|COMPLETED|Ketoconazole Sequential Alfentanil||0
3010691|NCT01008059|3728672|FG006|COMPLETED|Ketoconazole Sequential Alfentanil||0
3010692|NCT01008059|3728673|FG007|COMPLETED|Ketoconazole Sequential Alfentanil||0
3010693|NCT01008059|3728666|FG000|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0
3010694|NCT01008059|3728667|FG001|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0
3010695|NCT01008059|3728668|FG002|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0
3010696|NCT01008059|3728669|FG003|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0
3010697|NCT01008059|3728670|FG004|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0
3010698|NCT01008059|3728671|FG005|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0
3010699|NCT01008059|3728672|FG006|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0
3010700|NCT01008059|3728673|FG007|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0
3010701|NCT01008059|3728666|FG000|STARTED|Control Simultaneous Alfentanil||0
3010702|NCT01008059|3728667|FG001|STARTED|Control Simultaneous Alfentanil||0
3010703|NCT01008059|3728668|FG002|STARTED|Control Simultaneous Alfentanil||0
3010704|NCT01008059|3728669|FG003|STARTED|Control Simultaneous Alfentanil||0
3010705|NCT01008059|3728670|FG004|STARTED|Control Simultaneous Alfentanil||6
3010706|NCT01008059|3728671|FG005|STARTED|Control Simultaneous Alfentanil||0
3010707|NCT01008059|3728672|FG006|STARTED|Control Simultaneous Alfentanil||0
3010708|NCT01008059|3728673|FG007|STARTED|Control Simultaneous Alfentanil||0
3010709|NCT01008059|3728666|FG000|COMPLETED|Control Simultaneous Alfentanil||0
3010710|NCT01008059|3728667|FG001|COMPLETED|Control Simultaneous Alfentanil||0
3010711|NCT01008059|3728668|FG002|COMPLETED|Control Simultaneous Alfentanil||0
3010712|NCT01008059|3728669|FG003|COMPLETED|Control Simultaneous Alfentanil||0
3010713|NCT01008059|3728670|FG004|COMPLETED|Control Simultaneous Alfentanil||6
3010714|NCT01008059|3728671|FG005|COMPLETED|Control Simultaneous Alfentanil||0
3010715|NCT01008059|3728672|FG006|COMPLETED|Control Simultaneous Alfentanil||0
3010716|NCT01008059|3728673|FG007|COMPLETED|Control Simultaneous Alfentanil||0
3010717|NCT01008059|3728666|FG000|NOT COMPLETED|Control Simultaneous Alfentanil||0
3010718|NCT01008059|3728667|FG001|NOT COMPLETED|Control Simultaneous Alfentanil||0
3010719|NCT01008059|3728668|FG002|NOT COMPLETED|Control Simultaneous Alfentanil||0
3010720|NCT01008059|3728669|FG003|NOT COMPLETED|Control Simultaneous Alfentanil||0
3010721|NCT01008059|3728670|FG004|NOT COMPLETED|Control Simultaneous Alfentanil||0
3010722|NCT01008059|3728671|FG005|NOT COMPLETED|Control Simultaneous Alfentanil||0
3010723|NCT01008059|3728672|FG006|NOT COMPLETED|Control Simultaneous Alfentanil||0
3010724|NCT01008059|3728673|FG007|NOT COMPLETED|Control Simultaneous Alfentanil||0
3010725|NCT01008059|3728666|FG000|STARTED|Rifampin Simultaneous Alfentanil||0
3010726|NCT01008059|3728667|FG001|STARTED|Rifampin Simultaneous Alfentanil||0
3010727|NCT01008059|3728668|FG002|STARTED|Rifampin Simultaneous Alfentanil||0
3010728|NCT01008059|3728669|FG003|STARTED|Rifampin Simultaneous Alfentanil||0
3010729|NCT01008059|3728670|FG004|STARTED|Rifampin Simultaneous Alfentanil||0
3010730|NCT01008059|3728671|FG005|STARTED|Rifampin Simultaneous Alfentanil||6
3010731|NCT01008059|3728672|FG006|STARTED|Rifampin Simultaneous Alfentanil||0
3010732|NCT01008059|3728673|FG007|STARTED|Rifampin Simultaneous Alfentanil||0
3010733|NCT01008059|3728666|FG000|COMPLETED|Rifampin Simultaneous Alfentanil||0
3010734|NCT01008059|3728667|FG001|COMPLETED|Rifampin Simultaneous Alfentanil||0
3010735|NCT01008059|3728668|FG002|COMPLETED|Rifampin Simultaneous Alfentanil||0
3010736|NCT01008059|3728669|FG003|COMPLETED|Rifampin Simultaneous Alfentanil||0
3010737|NCT01008059|3728670|FG004|COMPLETED|Rifampin Simultaneous Alfentanil||0
3010738|NCT01008059|3728671|FG005|COMPLETED|Rifampin Simultaneous Alfentanil||6
3010739|NCT01008059|3728672|FG006|COMPLETED|Rifampin Simultaneous Alfentanil||0
3010740|NCT01008059|3728673|FG007|COMPLETED|Rifampin Simultaneous Alfentanil||0
3010741|NCT01008059|3728666|FG000|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0
3165258|NCT01898195|3892799|FG001|NOT COMPLETED|Smoking Abstinence||38
3165259|NCT01898195|3892800|FG002|NOT COMPLETED|Smoking Abstinence||36
3165260|NCT01898208|3892811|FG000|STARTED|Overall Study||247
3165261|NCT01898208|3892812|FG001|STARTED|Overall Study||247
3165262|NCT01898208|3892813|FG002|STARTED|Overall Study||249
3010742|NCT01008059|3728667|FG001|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0
3010743|NCT01008059|3728668|FG002|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0
3010744|NCT01008059|3728669|FG003|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0
3010745|NCT01008059|3728670|FG004|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0
3010746|NCT01008059|3728671|FG005|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0
3010747|NCT01008059|3728672|FG006|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0
3010748|NCT01008059|3728673|FG007|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0
3010749|NCT01008059|3728666|FG000|STARTED|Grapefruit Juice Simultaneous Alfentanil||0
3010750|NCT01008059|3728667|FG001|STARTED|Grapefruit Juice Simultaneous Alfentanil||0
3010751|NCT01008059|3728668|FG002|STARTED|Grapefruit Juice Simultaneous Alfentanil||0
3010752|NCT01008059|3728669|FG003|STARTED|Grapefruit Juice Simultaneous Alfentanil||0
3010753|NCT01008059|3728670|FG004|STARTED|Grapefruit Juice Simultaneous Alfentanil||0
3010754|NCT01008059|3728671|FG005|STARTED|Grapefruit Juice Simultaneous Alfentanil||0
3165263|NCT01898208|3892811|FG000|COMPLETED|Overall Study||207
3165264|NCT01898208|3892812|FG001|COMPLETED|Overall Study||198
3010755|NCT01008059|3728672|FG006|STARTED|Grapefruit Juice Simultaneous Alfentanil||6
3010756|NCT01008059|3728673|FG007|STARTED|Grapefruit Juice Simultaneous Alfentanil||0
3010757|NCT01008059|3728666|FG000|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
3010758|NCT01008059|3728667|FG001|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
3010759|NCT01008059|3728668|FG002|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
3010760|NCT01008059|3728669|FG003|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
3010761|NCT01008059|3728670|FG004|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
3010762|NCT01008059|3728671|FG005|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
3010763|NCT01008059|3728672|FG006|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||6
3010764|NCT01008059|3728673|FG007|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
3010765|NCT01008059|3728666|FG000|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
3010766|NCT01008059|3728667|FG001|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
3010767|NCT01008059|3728668|FG002|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
3010768|NCT01008059|3728669|FG003|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
3010769|NCT01008059|3728670|FG004|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
3010770|NCT01008059|3728671|FG005|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
3010771|NCT01008059|3728672|FG006|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
3010772|NCT01008059|3728673|FG007|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
3010773|NCT01008059|3728666|FG000|STARTED|Ketoconazole Simultaneous Alfentanil||0
3010774|NCT01008059|3728667|FG001|STARTED|Ketoconazole Simultaneous Alfentanil||0
3010775|NCT01008059|3728668|FG002|STARTED|Ketoconazole Simultaneous Alfentanil||0
3010776|NCT01008059|3728669|FG003|STARTED|Ketoconazole Simultaneous Alfentanil||0
3010777|NCT01008059|3728670|FG004|STARTED|Ketoconazole Simultaneous Alfentanil||0
3010778|NCT01008059|3728671|FG005|STARTED|Ketoconazole Simultaneous Alfentanil||0
3010779|NCT01008059|3728672|FG006|STARTED|Ketoconazole Simultaneous Alfentanil||0
3010780|NCT01008059|3728673|FG007|STARTED|Ketoconazole Simultaneous Alfentanil||6
3010781|NCT01008059|3728666|FG000|COMPLETED|Ketoconazole Simultaneous Alfentanil||0
3010782|NCT01008059|3728667|FG001|COMPLETED|Ketoconazole Simultaneous Alfentanil||0
3010783|NCT01008059|3728668|FG002|COMPLETED|Ketoconazole Simultaneous Alfentanil||0
3010784|NCT01008059|3728669|FG003|COMPLETED|Ketoconazole Simultaneous Alfentanil||0
3010785|NCT01008059|3728670|FG004|COMPLETED|Ketoconazole Simultaneous Alfentanil||0
3010786|NCT01008059|3728671|FG005|COMPLETED|Ketoconazole Simultaneous Alfentanil||0
3010787|NCT01008059|3728672|FG006|COMPLETED|Ketoconazole Simultaneous Alfentanil||0
3010788|NCT01008059|3728673|FG007|COMPLETED|Ketoconazole Simultaneous Alfentanil||6
3010789|NCT01008059|3728666|FG000|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0
3010790|NCT01008059|3728667|FG001|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0
3010791|NCT01008059|3728668|FG002|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0
3010792|NCT01008059|3728669|FG003|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0
3010793|NCT01008059|3728670|FG004|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0
3010794|NCT01008059|3728671|FG005|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0
3010795|NCT01008059|3728672|FG006|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0
3010796|NCT01008059|3728673|FG007|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0
3010797|NCT01008150|3728688|FG000|STARTED|Overall Study||43
3010798|NCT01008150|3728689|FG001|STARTED|Overall Study||43
3010799|NCT01008150|3728690|FG002|STARTED|Overall Study||43
3010800|NCT01008150|3728691|FG003|STARTED|Overall Study||12
3010801|NCT01008150|3728688|FG000|COMPLETED|Overall Study||42
3010802|NCT01008150|3728689|FG001|COMPLETED|Overall Study||42
3010803|NCT01008150|3728690|FG002|COMPLETED|Overall Study||42
3010804|NCT01008150|3728691|FG003|COMPLETED|Overall Study||12
3010805|NCT01008150|3728688|FG000|NOT COMPLETED|Overall Study||1
3010806|NCT01008150|3728689|FG001|NOT COMPLETED|Overall Study||1
3010807|NCT01008150|3728690|FG002|NOT COMPLETED|Overall Study||1
3010808|NCT01008150|3728691|FG003|NOT COMPLETED|Overall Study||0
3010809|NCT01008280|3728704|FG000|STARTED|Overall Study||88
3010810|NCT01008280|3728705|FG001|STARTED|Overall Study||92
3010811|NCT01008280|3728704|FG000|COMPLETED|Overall Study||67
3010812|NCT01008280|3728705|FG001|COMPLETED|Overall Study||73
3010813|NCT01008280|3728704|FG000|NOT COMPLETED|Overall Study||21
3010814|NCT01008280|3728705|FG001|NOT COMPLETED|Overall Study||19
3010815|NCT01008319|3728713|FG000|STARTED|Overall Study||60
3010816|NCT01008319|3728714|FG001|STARTED|Overall Study||60
3010817|NCT01008319|3728713|FG000|COMPLETED|Overall Study||60
3010818|NCT01008319|3728714|FG001|COMPLETED|Overall Study||60
3010819|NCT01008319|3728713|FG000|NOT COMPLETED|Overall Study||0
3010820|NCT01008319|3728714|FG001|NOT COMPLETED|Overall Study||0
3010821|NCT01008410|3728726|FG000|STARTED|Overall Study||133
3010822|NCT01008410|3728727|FG001|STARTED|Overall Study||132
3010823|NCT01008410|3728726|FG000|Received at Least 1 Dose of Study Drug|Overall Study||133
3010824|NCT01008410|3728727|FG001|Received at Least 1 Dose of Study Drug|Overall Study||132
3010825|NCT01008410|3728726|FG000|COMPLETED|Overall Study||108
3010826|NCT01008410|3728727|FG001|COMPLETED|Overall Study||116
3010827|NCT01008410|3728726|FG000|NOT COMPLETED|Overall Study||25
3010828|NCT01008410|3728727|FG001|NOT COMPLETED|Overall Study||16
3010829|NCT01008423|3728735|FG000|STARTED|Overall Study||134
3010830|NCT01008423|3728736|FG001|STARTED|Overall Study||147
3010831|NCT01008423|3728735|FG000|Received at Least 1 Dose of Study Drug|Overall Study||134
3010832|NCT01008423|3728736|FG001|Received at Least 1 Dose of Study Drug|Overall Study||147
3010833|NCT01008423|3728735|FG000|COMPLETED|Overall Study||115
3010834|NCT01008423|3728736|FG001|COMPLETED|Overall Study||125
3306784|NCT03000686|4040101|FG001|COMPLETED|Part 1, Wash-out (Up to 14 Days)||5
3306785|NCT03000686|4040102|FG002|COMPLETED|Part 1, Wash-out (Up to 14 Days)||0
3306786|NCT03000686|4040103|FG003|COMPLETED|Part 1, Wash-out (Up to 14 Days)||0
3306787|NCT03000686|4040100|FG000|NOT COMPLETED|Part 1, Wash-out (Up to 14 Days)||0
3306788|NCT03000686|4040101|FG001|NOT COMPLETED|Part 1, Wash-out (Up to 14 Days)||0
3306789|NCT03000686|4040102|FG002|NOT COMPLETED|Part 1, Wash-out (Up to 14 Days)||0
3306790|NCT03000686|4040103|FG003|NOT COMPLETED|Part 1, Wash-out (Up to 14 Days)||0
3306791|NCT03000686|4040100|FG000|STARTED|Part 1, Period 2 (1 Day)||5
3306792|NCT03000686|4040101|FG001|STARTED|Part 1, Period 2 (1 Day)||5
3306793|NCT03000686|4040102|FG002|STARTED|Part 1, Period 2 (1 Day)||0
3306794|NCT03000686|4040103|FG003|STARTED|Part 1, Period 2 (1 Day)||0
3306795|NCT03000686|4040100|FG000|COMPLETED|Part 1, Period 2 (1 Day)||5
3306796|NCT03000686|4040101|FG001|COMPLETED|Part 1, Period 2 (1 Day)||5
3306797|NCT03000686|4040102|FG002|COMPLETED|Part 1, Period 2 (1 Day)||0
3306798|NCT03000686|4040103|FG003|COMPLETED|Part 1, Period 2 (1 Day)||0
3306799|NCT03000686|4040100|FG000|NOT COMPLETED|Part 1, Period 2 (1 Day)||0
3306800|NCT03000686|4040101|FG001|NOT COMPLETED|Part 1, Period 2 (1 Day)||0
3306801|NCT03000686|4040102|FG002|NOT COMPLETED|Part 1, Period 2 (1 Day)||0
3306802|NCT03000686|4040103|FG003|NOT COMPLETED|Part 1, Period 2 (1 Day)||0
3306803|NCT03000686|4040100|FG000|STARTED|Part 2, Period 1 (1 Day)||0
3306804|NCT03000686|4040101|FG001|STARTED|Part 2, Period 1 (1 Day)||0
3306805|NCT03000686|4040102|FG002|STARTED|Part 2, Period 1 (1 Day)||3
3306806|NCT03000686|4040103|FG003|STARTED|Part 2, Period 1 (1 Day)||3
3306807|NCT03000686|4040100|FG000|COMPLETED|Part 2, Period 1 (1 Day)||0
3306808|NCT03000686|4040101|FG001|COMPLETED|Part 2, Period 1 (1 Day)||0
3306809|NCT03000686|4040102|FG002|COMPLETED|Part 2, Period 1 (1 Day)||3
3306810|NCT03000686|4040103|FG003|COMPLETED|Part 2, Period 1 (1 Day)||3
3306811|NCT03000686|4040100|FG000|NOT COMPLETED|Part 2, Period 1 (1 Day)||0
3306812|NCT03000686|4040101|FG001|NOT COMPLETED|Part 2, Period 1 (1 Day)||0
3306813|NCT03000686|4040102|FG002|NOT COMPLETED|Part 2, Period 1 (1 Day)||0
3306814|NCT03000686|4040103|FG003|NOT COMPLETED|Part 2, Period 1 (1 Day)||0
3306815|NCT03000686|4040100|FG000|STARTED|Part 2, Wash-out (Up to 14 Days)||0
3306816|NCT03000686|4040101|FG001|STARTED|Part 2, Wash-out (Up to 14 Days)||0
3306817|NCT03000686|4040102|FG002|STARTED|Part 2, Wash-out (Up to 14 Days)||3
3306818|NCT03000686|4040103|FG003|STARTED|Part 2, Wash-out (Up to 14 Days)||3
3306819|NCT03000686|4040100|FG000|COMPLETED|Part 2, Wash-out (Up to 14 Days)||0
3306820|NCT03000686|4040101|FG001|COMPLETED|Part 2, Wash-out (Up to 14 Days)||0
3306821|NCT03000686|4040102|FG002|COMPLETED|Part 2, Wash-out (Up to 14 Days)||3
3306822|NCT03000686|4040103|FG003|COMPLETED|Part 2, Wash-out (Up to 14 Days)||3
3306823|NCT03000686|4040100|FG000|NOT COMPLETED|Part 2, Wash-out (Up to 14 Days)||0
3306824|NCT03000686|4040101|FG001|NOT COMPLETED|Part 2, Wash-out (Up to 14 Days)||0
3306825|NCT03000686|4040102|FG002|NOT COMPLETED|Part 2, Wash-out (Up to 14 Days)||0
3306826|NCT03000686|4040103|FG003|NOT COMPLETED|Part 2, Wash-out (Up to 14 Days)||0
3306827|NCT03000686|4040100|FG000|STARTED|Part 2, Period 2 (1 Day)||0
3306828|NCT03000686|4040101|FG001|STARTED|Part 2, Period 2 (1 Day)||0
3306829|NCT03000686|4040102|FG002|STARTED|Part 2, Period 2 (1 Day)||3
3306830|NCT03000686|4040103|FG003|STARTED|Part 2, Period 2 (1 Day)||3
3306831|NCT03000686|4040100|FG000|COMPLETED|Part 2, Period 2 (1 Day)||0
3306832|NCT03000686|4040101|FG001|COMPLETED|Part 2, Period 2 (1 Day)||0
3306833|NCT03000686|4040102|FG002|COMPLETED|Part 2, Period 2 (1 Day)||3
3306834|NCT03000686|4040103|FG003|COMPLETED|Part 2, Period 2 (1 Day)||3
3306835|NCT03000686|4040100|FG000|NOT COMPLETED|Part 2, Period 2 (1 Day)||0
3010835|NCT01008423|3728735|FG000|NOT COMPLETED|Overall Study||19
3010836|NCT01008423|3728736|FG001|NOT COMPLETED|Overall Study||22
3010837|NCT01008449|3728744|FG000|STARTED|Overall Study||200
3010838|NCT01008449|3728745|FG001|STARTED|Overall Study||198
3010839|NCT01008449|3728744|FG000|COMPLETED|Overall Study||171
3010840|NCT01008449|3728745|FG001|COMPLETED|Overall Study||179
3010841|NCT01008449|3728744|FG000|NOT COMPLETED|Overall Study||29
3010842|NCT01008449|3728745|FG001|NOT COMPLETED|Overall Study||19
3010843|NCT01008462|3728751|FG000|STARTED|Overall Study||16
3010844|NCT01008462|3728751|FG000|COMPLETED|Overall Study||16
3010845|NCT01008462|3728751|FG000|NOT COMPLETED|Overall Study||0
3010846|NCT01008475|3728762|FG000|STARTED|Overall Study||3
3010847|NCT01008475|3728763|FG001|STARTED|Overall Study||3
3010848|NCT01008475|3728764|FG002|STARTED|Overall Study||7
3010849|NCT01008475|3728765|FG003|STARTED|Overall Study||3
3010850|NCT01008475|3728766|FG004|STARTED|Overall Study||72
3010851|NCT01008475|3728767|FG005|STARTED|Overall Study||73
3010852|NCT01008475|3728768|FG006|STARTED|Overall Study||71
3010853|NCT01008475|3728762|FG000|Safety Analysis Set|Overall Study||3
3010854|NCT01008475|3728763|FG001|Safety Analysis Set|Overall Study||3
3010855|NCT01008475|3728764|FG002|Safety Analysis Set|Overall Study||7
3010856|NCT01008475|3728765|FG003|Safety Analysis Set|Overall Study||3
3010857|NCT01008475|3728766|FG004|Safety Analysis Set|Overall Study|1 subject randomized to EMD525797 1000 mg group received only SoC. Hence, reported under SOC group.|73
3010858|NCT01008475|3728767|FG005|Safety Analysis Set|Overall Study||72
3010859|NCT01008475|3728768|FG006|Safety Analysis Set|Overall Study||69
3010860|NCT01008475|3728762|FG000|COMPLETED|Overall Study||3
3010861|NCT01008475|3728763|FG001|COMPLETED|Overall Study||3
3010862|NCT01008475|3728764|FG002|COMPLETED|Overall Study||7
3010863|NCT01008475|3728765|FG003|COMPLETED|Overall Study||3
3010864|NCT01008475|3728766|FG004|COMPLETED|Overall Study||67
3010865|NCT01008475|3728767|FG005|COMPLETED|Overall Study||67
3010866|NCT01008475|3728768|FG006|COMPLETED|Overall Study||67
3010867|NCT01008475|3728762|FG000|NOT COMPLETED|Overall Study||0
3010868|NCT01008475|3728763|FG001|NOT COMPLETED|Overall Study||0
3010869|NCT01008475|3728764|FG002|NOT COMPLETED|Overall Study||0
3010870|NCT01008475|3728765|FG003|NOT COMPLETED|Overall Study||0
3010871|NCT01008475|3728766|FG004|NOT COMPLETED|Overall Study||5
3010872|NCT01008475|3728767|FG005|NOT COMPLETED|Overall Study||6
3010873|NCT01008475|3728768|FG006|NOT COMPLETED|Overall Study||4
3010874|NCT01008553|3728784|FG000|STARTED|Period 1 (Titration Period)||258
3010875|NCT01008553|3728785|FG001|STARTED|Period 1 (Titration Period)||0
3010876|NCT01008553|3728786|FG002|STARTED|Period 1 (Titration Period)||0
3010877|NCT01008553|3728784|FG000|COMPLETED|Period 1 (Titration Period)||163
3010878|NCT01008553|3728785|FG001|COMPLETED|Period 1 (Titration Period)||0
3010879|NCT01008553|3728786|FG002|COMPLETED|Period 1 (Titration Period)||0
3010880|NCT01008553|3728784|FG000|NOT COMPLETED|Period 1 (Titration Period)||95
3010881|NCT01008553|3728785|FG001|NOT COMPLETED|Period 1 (Titration Period)||0
3010882|NCT01008553|3728786|FG002|NOT COMPLETED|Period 1 (Titration Period)||0
3010883|NCT01008553|3728784|FG000|STARTED|Period 2 (Double-Blind Period)||0
3010884|NCT01008553|3728785|FG001|STARTED|Period 2 (Double-Blind Period)||84
3010885|NCT01008553|3728786|FG002|STARTED|Period 2 (Double-Blind Period)||79
3010886|NCT01008553|3728784|FG000|COMPLETED|Period 2 (Double-Blind Period)||0
3010887|NCT01008553|3728785|FG001|COMPLETED|Period 2 (Double-Blind Period)||47
3010888|NCT01008553|3728786|FG002|COMPLETED|Period 2 (Double-Blind Period)||28
3010889|NCT01008553|3728784|FG000|NOT COMPLETED|Period 2 (Double-Blind Period)||0
3010890|NCT01008553|3728785|FG001|NOT COMPLETED|Period 2 (Double-Blind Period)||37
3010891|NCT01008553|3728786|FG002|NOT COMPLETED|Period 2 (Double-Blind Period)||51
3010892|NCT01008605|3728795|FG000|STARTED|Overall Study||48
3010893|NCT01008605|3728795|FG000|COMPLETED|Overall Study||48
3010894|NCT01008605|3728795|FG000|NOT COMPLETED|Overall Study||0
3010895|NCT01008618|3728807|FG000|STARTED|Period 1 (Titration Period)||218
3010896|NCT01008618|3728808|FG001|STARTED|Period 1 (Titration Period)||0
3010897|NCT01008618|3728809|FG002|STARTED|Period 1 (Titration Period)||0
3010898|NCT01008618|3728807|FG000|COMPLETED|Period 1 (Titration Period)||150
3010899|NCT01008618|3728808|FG001|COMPLETED|Period 1 (Titration Period)||0
3010900|NCT01008618|3728809|FG002|COMPLETED|Period 1 (Titration Period)||0
3010901|NCT01008618|3728807|FG000|NOT COMPLETED|Period 1 (Titration Period)||68
3010902|NCT01008618|3728808|FG001|NOT COMPLETED|Period 1 (Titration Period)||0
3165265|NCT01898208|3892813|FG002|COMPLETED|Overall Study||212
3165266|NCT01898208|3892811|FG000|NOT COMPLETED|Overall Study||40
3306836|NCT03000686|4040101|FG001|NOT COMPLETED|Part 2, Period 2 (1 Day)||0
3306837|NCT03000686|4040102|FG002|NOT COMPLETED|Part 2, Period 2 (1 Day)||0
3306838|NCT03000686|4040103|FG003|NOT COMPLETED|Part 2, Period 2 (1 Day)||0
3306839|NCT03001011|4040117|FG000|STARTED|Overall Study||101
3306840|NCT03001011|4040118|FG001|STARTED|Overall Study||101
3306841|NCT03001011|4040117|FG000|COMPLETED|Overall Study||74
3306842|NCT03001011|4040118|FG001|COMPLETED|Overall Study||80
3306843|NCT03001011|4040117|FG000|NOT COMPLETED|Overall Study||27
3306844|NCT03001011|4040118|FG001|NOT COMPLETED|Overall Study||21
3306845|NCT03001076|4040127|FG000|STARTED|Overall Study||88
3306846|NCT03001076|4040128|FG001|STARTED|Overall Study||181
3306847|NCT03001076|4040127|FG000|COMPLETED|Overall Study||81
3306848|NCT03001076|4040128|FG001|COMPLETED|Overall Study||176
3306849|NCT03001076|4040127|FG000|NOT COMPLETED|Overall Study||7
3306850|NCT03001076|4040128|FG001|NOT COMPLETED|Overall Study||5
3306851|NCT03001219|4040136|FG000|STARTED|Proof of Concept||37
3306852|NCT03001219|4040137|FG001|STARTED|Proof of Concept||72
3306853|NCT03001219|4040136|FG000|COMPLETED|Proof of Concept||35
3306854|NCT03001219|4040137|FG001|COMPLETED|Proof of Concept||65
3306855|NCT03001219|4040136|FG000|NOT COMPLETED|Proof of Concept||2
3306856|NCT03001219|4040137|FG001|NOT COMPLETED|Proof of Concept||7
3306857|NCT03001219|4040136|FG000|STARTED|Extension Period Analysis||9
3306858|NCT03001219|4040137|FG001|STARTED|Extension Period Analysis||97
3306859|NCT03001219|4040136|FG000|COMPLETED|Extension Period Analysis||4
3306860|NCT03001219|4040137|FG001|COMPLETED|Extension Period Analysis||52
3306861|NCT03001219|4040136|FG000|NOT COMPLETED|Extension Period Analysis||5
3306862|NCT03001219|4040137|FG001|NOT COMPLETED|Extension Period Analysis||45
3306863|NCT03001258|4040151|FG000|STARTED|Overall Study||765
3306864|NCT03001258|4040152|FG001|STARTED|Overall Study||751
3306865|NCT03001258|4040153|FG002|STARTED|Overall Study||485
3306866|NCT03001258|4040151|FG000|COMPLETED|Overall Study||765
3306867|NCT03001258|4040152|FG001|COMPLETED|Overall Study||751
3306868|NCT03001258|4040153|FG002|COMPLETED|Overall Study||485
3306869|NCT03001258|4040151|FG000|NOT COMPLETED|Overall Study||0
3306870|NCT03001258|4040152|FG001|NOT COMPLETED|Overall Study||0
3306871|NCT03001258|4040153|FG002|NOT COMPLETED|Overall Study||0
3306872|NCT03001453|4040163|FG000|STARTED|Overall Study||50
3306873|NCT03001453|4040164|FG001|STARTED|Overall Study||57
3306874|NCT03001453|4040163|FG000|COMPLETED|Overall Study||50
3306875|NCT03001453|4040164|FG001|COMPLETED|Overall Study||57
3010903|NCT01008618|3728809|FG002|NOT COMPLETED|Period 1 (Titration Period)||0
3010904|NCT01008618|3728807|FG000|STARTED|Period 2 (Double-Blind Period)||0
3010905|NCT01008618|3728808|FG001|STARTED|Period 2 (Double-Blind Period)||73
3010906|NCT01008618|3728809|FG002|STARTED|Period 2 (Double-Blind Period)||77
3010907|NCT01008618|3728807|FG000|COMPLETED|Period 2 (Double-Blind Period)||0
3010908|NCT01008618|3728808|FG001|COMPLETED|Period 2 (Double-Blind Period)||37
3010909|NCT01008618|3728809|FG002|COMPLETED|Period 2 (Double-Blind Period)||39
3306876|NCT03001453|4040163|FG000|NOT COMPLETED|Overall Study||0
3306877|NCT03001453|4040164|FG001|NOT COMPLETED|Overall Study||0
3010910|NCT01008618|3728807|FG000|NOT COMPLETED|Period 2 (Double-Blind Period)||0
3010911|NCT01008618|3728808|FG001|NOT COMPLETED|Period 2 (Double-Blind Period)||36
3010912|NCT01008618|3728809|FG002|NOT COMPLETED|Period 2 (Double-Blind Period)||38
3010913|NCT01008696|3728820|FG000|STARTED|Overall Study||108
3010914|NCT01008696|3728821|FG001|STARTED|Overall Study||109
3010915|NCT01008696|3728820|FG000|COMPLETED|Overall Study||91
3010916|NCT01008696|3728821|FG001|COMPLETED|Overall Study||92
3010917|NCT01008696|3728820|FG000|NOT COMPLETED|Overall Study||17
3010918|NCT01008696|3728821|FG001|NOT COMPLETED|Overall Study||17
3010919|NCT01008722|3728830|FG000|STARTED|Overall Study|Based on Power Calculations to see 20% outcome improvement by adding FIRM-guided ablation to PVI|36
3010920|NCT01008722|3728831|FG001|STARTED|Overall Study|Based on Power Calculations to see 20% outcome improvement by adding FIRM-guided ablation to PVI|71
3010921|NCT01008722|3728830|FG000|COMPLETED|Overall Study||36
3010922|NCT01008722|3728831|FG001|COMPLETED|Overall Study||71
3010923|NCT01008722|3728830|FG000|NOT COMPLETED|Overall Study||0
3010924|NCT01008722|3728831|FG001|NOT COMPLETED|Overall Study||0
3010925|NCT01008748|3728837|FG000|STARTED|Overall Study||200
3010926|NCT01008748|3728837|FG000|Baseline|Overall Study||188
3010927|NCT01008748|3728837|FG000|Week 0|Overall Study||182
3010928|NCT01008748|3728837|FG000|Week 3|Overall Study||168
3010929|NCT01008748|3728837|FG000|Week 26|Overall Study||119
3010930|NCT01008748|3728837|FG000|COMPLETED|Overall Study||119
3010931|NCT01008748|3728837|FG000|NOT COMPLETED|Overall Study||81
3010932|NCT01008904|3728841|FG000|STARTED|Overall Study||29
3010933|NCT01008904|3728841|FG000|COMPLETED|Overall Study||25
3010934|NCT01008904|3728841|FG000|NOT COMPLETED|Overall Study||4
3010935|NCT01008943|3728845|FG000|STARTED|Overall Study||16
3010936|NCT01008943|3728845|FG000|COMPLETED|Overall Study||15
3010937|NCT01008943|3728845|FG000|NOT COMPLETED|Overall Study||1
3010938|NCT01008969|3728849|FG000|STARTED|Overall Study||10
3010939|NCT01008969|3728849|FG000|COMPLETED|Overall Study||10
3010940|NCT01008969|3728849|FG000|NOT COMPLETED|Overall Study||0
3010941|NCT01008995|3728855|FG000|STARTED|Controlled Period||162
3010942|NCT01008995|3728856|FG001|STARTED|Controlled Period||160
3010943|NCT01008995|3728857|FG002|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
3010944|NCT01008995|3728858|FG003|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
3010945|NCT01008995|3728855|FG000|COMPLETED|Controlled Period||159
3010946|NCT01008995|3728856|FG001|COMPLETED|Controlled Period||157
3010947|NCT01008995|3728857|FG002|COMPLETED|Controlled Period||0
3010948|NCT01008995|3728858|FG003|COMPLETED|Controlled Period||0
3010949|NCT01008995|3728855|FG000|NOT COMPLETED|Controlled Period||3
3010950|NCT01008995|3728856|FG001|NOT COMPLETED|Controlled Period||3
3010951|NCT01008995|3728857|FG002|NOT COMPLETED|Controlled Period||0
3010952|NCT01008995|3728858|FG003|NOT COMPLETED|Controlled Period||0
3010953|NCT01008995|3728855|FG000|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
3010954|NCT01008995|3728856|FG001|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
3010955|NCT01008995|3728857|FG002|STARTED|After Controlled Period|1 placebo participant discontinued after completing the CP and did not receive ustekinumab 45 mg.|158
3010956|NCT01008995|3728858|FG003|STARTED|After Controlled Period|2 participants discontinued in CP, had follow-up, and are among frequent and serious adverse events.|157
3010957|NCT01008995|3728855|FG000|COMPLETED|After Controlled Period||0
3010958|NCT01008995|3728856|FG001|COMPLETED|After Controlled Period||0
3010959|NCT01008995|3728857|FG002|COMPLETED|After Controlled Period||156
3010960|NCT01008995|3728858|FG003|COMPLETED|After Controlled Period||156
3010961|NCT01008995|3728855|FG000|NOT COMPLETED|After Controlled Period||0
3010962|NCT01008995|3728856|FG001|NOT COMPLETED|After Controlled Period||0
3010963|NCT01008995|3728857|FG002|NOT COMPLETED|After Controlled Period||2
3010964|NCT01008995|3728858|FG003|NOT COMPLETED|After Controlled Period||1
3037402|NCT01147848|3756685|FG000|STARTED|Run-in Period||1564
3037403|NCT01147848|3756686|FG001|STARTED|Run-in Period||0
3037404|NCT01147848|3756687|FG002|STARTED|Run-in Period||0
3037405|NCT01147848|3756685|FG000|COMPLETED|Run-in Period||806
3037406|NCT01147848|3756686|FG001|COMPLETED|Run-in Period||0
3037407|NCT01147848|3756687|FG002|COMPLETED|Run-in Period||0
3037408|NCT01147848|3756685|FG000|NOT COMPLETED|Run-in Period||758
3037409|NCT01147848|3756686|FG001|NOT COMPLETED|Run-in Period||0
3037410|NCT01147848|3756687|FG002|NOT COMPLETED|Run-in Period||0
3037411|NCT01147848|3756685|FG000|STARTED|Randomized Phase||0
3037412|NCT01147848|3756686|FG001|STARTED|Randomized Phase||403
3037413|NCT01147848|3756687|FG002|STARTED|Randomized Phase||403
3037414|NCT01147848|3756685|FG000|COMPLETED|Randomized Phase||0
3037415|NCT01147848|3756686|FG001|COMPLETED|Randomized Phase||358
3037416|NCT01147848|3756687|FG002|COMPLETED|Randomized Phase||357
3037417|NCT01147848|3756685|FG000|NOT COMPLETED|Randomized Phase||0
3037418|NCT01147848|3756686|FG001|NOT COMPLETED|Randomized Phase||45
3037419|NCT01147848|3756687|FG002|NOT COMPLETED|Randomized Phase||46
3037420|NCT01147874|3756694|FG000|STARTED|Overall Study||1013
3037421|NCT01147874|3756694|FG000|COMPLETED|Overall Study||946
3037422|NCT01147874|3756694|FG000|NOT COMPLETED|Overall Study||67
3037423|NCT01147900|3756701|FG000|STARTED|At Year 8.5||54
3037424|NCT01147900|3756702|FG001|STARTED|At Year 8.5||60
3037425|NCT01147900|3756703|FG002|STARTED|At Year 8.5||66
3037426|NCT01147900|3756701|FG000|COMPLETED|At Year 8.5||54
3037427|NCT01147900|3756702|FG001|COMPLETED|At Year 8.5||60
3037428|NCT01147900|3756703|FG002|COMPLETED|At Year 8.5||66
3037429|NCT01147900|3756701|FG000|NOT COMPLETED|At Year 8.5||0
3010965|NCT01009034|3728866|FG000|STARTED|Overall Study||14
3010966|NCT01009034|3728866|FG000|COMPLETED|Overall Study||10
3010967|NCT01009034|3728866|FG000|NOT COMPLETED|Overall Study||4
3010968|NCT01009047|3728872|FG000|STARTED|Overall Study||113
3010969|NCT01009047|3728873|FG001|STARTED|Overall Study||115
3010970|NCT01009047|3728872|FG000|COMPLETED|Overall Study||85
3010971|NCT01009047|3728873|FG001|COMPLETED|Overall Study||89
3010972|NCT01009047|3728872|FG000|NOT COMPLETED|Overall Study||28
3010973|NCT01009047|3728873|FG001|NOT COMPLETED|Overall Study||26
3010974|NCT01009060|3728881|FG000|STARTED|Overall Study||25
3010975|NCT01009060|3728882|FG001|STARTED|Overall Study||25
3010976|NCT01009060|3728881|FG000|COMPLETED|Overall Study||21
3010977|NCT01009060|3728882|FG001|COMPLETED|Overall Study||20
3010978|NCT01009060|3728881|FG000|NOT COMPLETED|Overall Study||4
3010979|NCT01009060|3728882|FG001|NOT COMPLETED|Overall Study||5
3010980|NCT01009086|3728895|FG000|STARTED|Overall Study||206
3010981|NCT01009086|3728896|FG001|STARTED|Overall Study||205
3010982|NCT01009086|3728897|FG002|STARTED|Overall Study||204
3010983|NCT01009086|3728895|FG000|COMPLETED|Overall Study||162
3010984|NCT01009086|3728896|FG001|COMPLETED|Overall Study||158
3010985|NCT01009086|3728897|FG002|COMPLETED|Overall Study||170
3010986|NCT01009086|3728895|FG000|NOT COMPLETED|Overall Study||44
3010987|NCT01009086|3728896|FG001|NOT COMPLETED|Overall Study||47
3010988|NCT01009086|3728897|FG002|NOT COMPLETED|Overall Study||34
3010989|NCT01009099|3728912|FG000|STARTED|Overall Study||58
3010990|NCT01009099|3728913|FG001|STARTED|Overall Study||61
3010991|NCT01009099|3728912|FG000|COMPLETED|Overall Study||53
3010992|NCT01009099|3728913|FG001|COMPLETED|Overall Study||57
3010993|NCT01009099|3728912|FG000|NOT COMPLETED|Overall Study||5
3010994|NCT01009099|3728913|FG001|NOT COMPLETED|Overall Study||4
3010995|NCT01009138|3728921|FG000|STARTED|Overall Study||106
3010996|NCT01009138|3728922|FG001|STARTED|Overall Study||108
3010997|NCT01009138|3728921|FG000|COMPLETED|Overall Study||93
3010998|NCT01009138|3728922|FG001|COMPLETED|Overall Study||88
3010999|NCT01009138|3728921|FG000|NOT COMPLETED|Overall Study||13
3011000|NCT01009138|3728922|FG001|NOT COMPLETED|Overall Study||20
3011001|NCT01009203|3728928|FG000|STARTED|Overall Study||13
3011002|NCT01009203|3728928|FG000|Received Treatment|Overall Study|One patient withdrew consent before treatment started.|12
3011003|NCT01009203|3728928|FG000|COMPLETED|Overall Study||6
3011004|NCT01009203|3728928|FG000|NOT COMPLETED|Overall Study||7
3011005|NCT01009281|3728932|FG000|STARTED|Overall Study||7
3011006|NCT01009281|3728932|FG000|COMPLETED|Overall Study||0
3011007|NCT01009281|3728932|FG000|NOT COMPLETED|Overall Study||7
3011008|NCT01009333|3728936|FG000|STARTED|Week 1||2
3011009|NCT01009333|3728937|FG001|STARTED|Week 1||3
3011010|NCT01009333|3728938|FG002|STARTED|Week 1||2
3011011|NCT01009333|3728939|FG003|STARTED|Week 1||2
3011012|NCT01009333|3728940|FG004|STARTED|Week 1||2
3011013|NCT01009333|3728941|FG005|STARTED|Week 1||2
3011014|NCT01009333|3728936|FG000|COMPLETED|Week 1||2
3011015|NCT01009333|3728937|FG001|COMPLETED|Week 1|1 participant did not progress to the second period due to a protocol violation.|3
3011016|NCT01009333|3728938|FG002|COMPLETED|Week 1||2
3011017|NCT01009333|3728939|FG003|COMPLETED|Week 1||2
3011018|NCT01009333|3728940|FG004|COMPLETED|Week 1||2
3011019|NCT01009333|3728941|FG005|COMPLETED|Week 1||2
3011020|NCT01009333|3728936|FG000|NOT COMPLETED|Week 1||0
3011021|NCT01009333|3728937|FG001|NOT COMPLETED|Week 1||0
3011022|NCT01009333|3728938|FG002|NOT COMPLETED|Week 1||0
3011023|NCT01009333|3728939|FG003|NOT COMPLETED|Week 1||0
3011024|NCT01009333|3728940|FG004|NOT COMPLETED|Week 1||0
3011025|NCT01009333|3728941|FG005|NOT COMPLETED|Week 1||0
3011026|NCT01009333|3728936|FG000|STARTED|Week 2||2
3011027|NCT01009333|3728937|FG001|STARTED|Week 2||2
3011028|NCT01009333|3728938|FG002|STARTED|Week 2||2
3011029|NCT01009333|3728939|FG003|STARTED|Week 2||2
3011030|NCT01009333|3728940|FG004|STARTED|Week 2||2
3011031|NCT01009333|3728941|FG005|STARTED|Week 2||2
3011032|NCT01009333|3728936|FG000|COMPLETED|Week 2||2
3011033|NCT01009333|3728937|FG001|COMPLETED|Week 2||2
3011034|NCT01009333|3728938|FG002|COMPLETED|Week 2||2
3011035|NCT01009333|3728939|FG003|COMPLETED|Week 2||2
3011036|NCT01009333|3728940|FG004|COMPLETED|Week 2||2
3011037|NCT01009333|3728941|FG005|COMPLETED|Week 2||2
3011038|NCT01009333|3728936|FG000|NOT COMPLETED|Week 2||0
3011039|NCT01009333|3728937|FG001|NOT COMPLETED|Week 2||0
3011040|NCT01009333|3728938|FG002|NOT COMPLETED|Week 2||0
3011041|NCT01009333|3728939|FG003|NOT COMPLETED|Week 2||0
3011042|NCT01009333|3728940|FG004|NOT COMPLETED|Week 2||0
3011043|NCT01009333|3728941|FG005|NOT COMPLETED|Week 2||0
3011044|NCT01009333|3728936|FG000|STARTED|Week 3||2
3011045|NCT01009333|3728937|FG001|STARTED|Week 3||2
3011046|NCT01009333|3728938|FG002|STARTED|Week 3||2
3011047|NCT01009333|3728939|FG003|STARTED|Week 3||2
3011048|NCT01009333|3728940|FG004|STARTED|Week 3||2
3011049|NCT01009333|3728941|FG005|STARTED|Week 3||2
3011050|NCT01009333|3728936|FG000|COMPLETED|Week 3||2
3011051|NCT01009333|3728937|FG001|COMPLETED|Week 3||2
3011052|NCT01009333|3728938|FG002|COMPLETED|Week 3||2
3011053|NCT01009333|3728939|FG003|COMPLETED|Week 3||2
3011054|NCT01009333|3728940|FG004|COMPLETED|Week 3||2
3011055|NCT01009333|3728941|FG005|COMPLETED|Week 3||2
3011056|NCT01009333|3728936|FG000|NOT COMPLETED|Week 3||0
3011057|NCT01009333|3728937|FG001|NOT COMPLETED|Week 3||0
3011058|NCT01009333|3728938|FG002|NOT COMPLETED|Week 3||0
3011059|NCT01009333|3728939|FG003|NOT COMPLETED|Week 3||0
3011060|NCT01009333|3728940|FG004|NOT COMPLETED|Week 3||0
3011061|NCT01009333|3728941|FG005|NOT COMPLETED|Week 3||0
3011062|NCT01009346|3728949|FG000|STARTED|Overall Study||9
3011063|NCT01009346|3728949|FG000|COMPLETED|Overall Study||5
3011064|NCT01009346|3728949|FG000|NOT COMPLETED|Overall Study||4
3011065|NCT01009463|3728958|FG000|STARTED|4-week, Open-label Run-In Period||2071
3011066|NCT01009463|3728959|FG001|STARTED|4-week, Open-label Run-In Period||0
3011067|NCT01009463|3728960|FG002|STARTED|4-week, Open-label Run-In Period||0
3011068|NCT01009463|3728961|FG003|STARTED|4-week, Open-label Run-In Period||0
3011069|NCT01009463|3728962|FG004|STARTED|4-week, Open-label Run-In Period||0
3011070|NCT01009463|3728958|FG000|COMPLETED|4-week, Open-label Run-In Period||1622
3011071|NCT01009463|3728959|FG001|COMPLETED|4-week, Open-label Run-In Period||0
3011072|NCT01009463|3728960|FG002|COMPLETED|4-week, Open-label Run-In Period||0
3011073|NCT01009463|3728961|FG003|COMPLETED|4-week, Open-label Run-In Period||0
3011074|NCT01009463|3728962|FG004|COMPLETED|4-week, Open-label Run-In Period||0
3011075|NCT01009463|3728958|FG000|NOT COMPLETED|4-week, Open-label Run-In Period||449
3011076|NCT01009463|3728959|FG001|NOT COMPLETED|4-week, Open-label Run-In Period||0
3011077|NCT01009463|3728960|FG002|NOT COMPLETED|4-week, Open-label Run-In Period||0
3011078|NCT01009463|3728961|FG003|NOT COMPLETED|4-week, Open-label Run-In Period||0
3011079|NCT01009463|3728962|FG004|NOT COMPLETED|4-week, Open-label Run-In Period||0
3011080|NCT01009463|3728958|FG000|STARTED|52-week, Double-blind Treatment Period||0
3011081|NCT01009463|3728959|FG001|STARTED|52-week, Double-blind Treatment Period||409
3011082|NCT01009463|3728960|FG002|STARTED|52-week, Double-blind Treatment Period||408
3011083|NCT01009463|3728961|FG003|STARTED|52-week, Double-blind Treatment Period||403
3011084|NCT01009463|3728962|FG004|STARTED|52-week, Double-blind Treatment Period||402
3011085|NCT01009463|3728958|FG000|Completed the Treatment Period|52-week, Double-blind Treatment Period||0
3011086|NCT01009463|3728959|FG001|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|295
3011087|NCT01009463|3728960|FG002|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|318
3011088|NCT01009463|3728961|FG003|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|314
3011089|NCT01009463|3728962|FG004|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|303
3011090|NCT01009463|3728958|FG000|COMPLETED|52-week, Double-blind Treatment Period||0
3011091|NCT01009463|3728959|FG001|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|294
3011092|NCT01009463|3728960|FG002|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|315
3011093|NCT01009463|3728961|FG003|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|312
3011094|NCT01009463|3728962|FG004|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|301
3011095|NCT01009463|3728958|FG000|NOT COMPLETED|52-week, Double-blind Treatment Period||0
3011096|NCT01009463|3728959|FG001|NOT COMPLETED|52-week, Double-blind Treatment Period||115
3011097|NCT01009463|3728960|FG002|NOT COMPLETED|52-week, Double-blind Treatment Period||93
3011098|NCT01009463|3728961|FG003|NOT COMPLETED|52-week, Double-blind Treatment Period||91
3011099|NCT01009463|3728962|FG004|NOT COMPLETED|52-week, Double-blind Treatment Period||101
3011100|NCT01009515|3728973|FG000|STARTED|Overall Study||19
3011101|NCT01009515|3728973|FG000|COMPLETED|Overall Study||16
3011102|NCT01009515|3728973|FG000|NOT COMPLETED|Overall Study||3
3011103|NCT01009554|3728979|FG000|STARTED|Overall Study||48
3011104|NCT01009554|3728980|FG001|STARTED|Overall Study||48
3011105|NCT01009554|3728979|FG000|COMPLETED|Overall Study||46
3011106|NCT01009554|3728980|FG001|COMPLETED|Overall Study||41
3011107|NCT01009554|3728979|FG000|NOT COMPLETED|Overall Study||2
3011108|NCT01009554|3728980|FG001|NOT COMPLETED|Overall Study||7
3011109|NCT01009580|3728988|FG000|STARTED|Overall Study||224
3011110|NCT01009580|3728989|FG001|STARTED|Overall Study||223
3011111|NCT01009580|3728988|FG000|Exposed|Overall Study||224
3011112|NCT01009580|3728989|FG001|Exposed|Overall Study|One subject was randomised in error and withdrew prior to exposure to drug|222
3011113|NCT01009580|3728988|FG000|COMPLETED|Overall Study||197
3011114|NCT01009580|3728989|FG001|COMPLETED|Overall Study||188
3011115|NCT01009580|3728988|FG000|NOT COMPLETED|Overall Study||27
3011116|NCT01009580|3728989|FG001|NOT COMPLETED|Overall Study||35
3011117|NCT01009619|3728997|FG000|STARTED|Overall Study||40
3011118|NCT01009619|3728998|FG001|STARTED|Overall Study||43
3011119|NCT01009619|3728997|FG000|COMPLETED|Overall Study||40
3011120|NCT01009619|3728998|FG001|COMPLETED|Overall Study||43
3011121|NCT01009619|3728997|FG000|NOT COMPLETED|Overall Study||0
3011122|NCT01009619|3728998|FG001|NOT COMPLETED|Overall Study||0
3011123|NCT01009645|3729008|FG000|STARTED|Overall Study||31
3011124|NCT01009645|3729009|FG001|STARTED|Overall Study||31
3011125|NCT01009645|3729010|FG002|STARTED|Overall Study||32
3011126|NCT01009645|3729011|FG003|STARTED|Overall Study||31
3011127|NCT01009645|3729008|FG000|COMPLETED|Overall Study||29
3011128|NCT01009645|3729009|FG001|COMPLETED|Overall Study||23
3011129|NCT01009645|3729010|FG002|COMPLETED|Overall Study||28
3011130|NCT01009645|3729011|FG003|COMPLETED|Overall Study||26
3011131|NCT01009645|3729008|FG000|NOT COMPLETED|Overall Study||2
3011132|NCT01009645|3729009|FG001|NOT COMPLETED|Overall Study||8
3011133|NCT01009645|3729010|FG002|NOT COMPLETED|Overall Study||4
3011134|NCT01009645|3729011|FG003|NOT COMPLETED|Overall Study||5
3011135|NCT01009762|3729023|FG000|STARTED|Overall Study||1
3011136|NCT01009762|3729024|FG001|STARTED|Overall Study||10
3011137|NCT01009762|3729023|FG000|Primary Outcome|Overall Study|no Serious Adverse Events (SAE), no treatment related side effects DLT grade 3 or more|0
3011138|NCT01009762|3729024|FG001|Primary Outcome|Overall Study|no SAE, no treatment related side effects DLT grade 3 or more|0
3011139|NCT01009762|3729023|FG000|COMPLETED|Overall Study|according to randomization this one participant received placebo|1
3011140|NCT01009762|3729024|FG001|COMPLETED|Overall Study|10 participants received vaccine|10
3011141|NCT01009762|3729023|FG000|NOT COMPLETED|Overall Study||0
3011142|NCT01009762|3729024|FG001|NOT COMPLETED|Overall Study||0
3011143|NCT01009814|3729037|FG000|STARTED|Overall Study||10
3011144|NCT01009814|3729038|FG001|STARTED|Overall Study||10
3011145|NCT01009814|3729039|FG002|STARTED|Overall Study||10
3011146|NCT01009814|3729040|FG003|STARTED|Overall Study||10
3011147|NCT01009814|3729041|FG004|STARTED|Overall Study||10
3011148|NCT01009814|3729037|FG000|COMPLETED|Overall Study||9
3011149|NCT01009814|3729038|FG001|COMPLETED|Overall Study||9
3011150|NCT01009814|3729039|FG002|COMPLETED|Overall Study||10
3011151|NCT01009814|3729040|FG003|COMPLETED|Overall Study||10
3011152|NCT01009814|3729041|FG004|COMPLETED|Overall Study||10
3011153|NCT01009814|3729037|FG000|NOT COMPLETED|Overall Study||1
3011154|NCT01009814|3729038|FG001|NOT COMPLETED|Overall Study||1
3011155|NCT01009814|3729039|FG002|NOT COMPLETED|Overall Study||0
3011156|NCT01009814|3729040|FG003|NOT COMPLETED|Overall Study||0
3011157|NCT01009814|3729041|FG004|NOT COMPLETED|Overall Study||0
3011158|NCT01009840|3729057|FG000|STARTED|Overall Study||30
3011159|NCT01009840|3729057|FG000|COMPLETED|Overall Study||16
3011160|NCT01009840|3729057|FG000|NOT COMPLETED|Overall Study||14
3011161|NCT01009918|3729064|FG000|STARTED|Overall Study||158
3011162|NCT01009918|3729065|FG001|STARTED|Overall Study||156
3011163|NCT01009918|3729066|FG002|STARTED|Overall Study||154
3011164|NCT01009918|3729064|FG000|COMPLETED|Overall Study||134
3011165|NCT01009918|3729065|FG001|COMPLETED|Overall Study||132
3011166|NCT01009918|3729066|FG002|COMPLETED|Overall Study||124
3011167|NCT01009918|3729064|FG000|NOT COMPLETED|Overall Study||24
3011168|NCT01009918|3729065|FG001|NOT COMPLETED|Overall Study||24
3011169|NCT01009918|3729066|FG002|NOT COMPLETED|Overall Study||30
3011170|NCT01009983|3729074|FG000|STARTED|Overall Study||14
3011171|NCT01009983|3729074|FG000|COMPLETED|Overall Study||13
3011172|NCT01009983|3729074|FG000|NOT COMPLETED|Overall Study||1
3011173|NCT01010009|3729081|FG000|STARTED|Overall Study||8
3011174|NCT01010009|3729082|FG001|STARTED|Overall Study||8
3011175|NCT01010009|3729083|FG002|STARTED|Overall Study||8
3306878|NCT03001557|4040175|FG000|STARTED|Core Phase||12
3306879|NCT03001557|4040176|FG001|STARTED|Core Phase||12
3306880|NCT03001557|4040177|FG002|STARTED|Core Phase||14
3306881|NCT03001557|4040178|FG003|STARTED|Core Phase||13
3306882|NCT03001557|4040179|FG004|STARTED|Core Phase||12
3306883|NCT03001557|4040180|FG005|STARTED|Core Phase||0
3306884|NCT03001557|4040181|FG006|STARTED|Core Phase||0
3306885|NCT03001557|4040182|FG007|STARTED|Core Phase||0
3306886|NCT03001557|4040175|FG000|Treated|Core Phase||12
3306887|NCT03001557|4040176|FG001|Treated|Core Phase||12
3306888|NCT03001557|4040177|FG002|Treated|Core Phase||13
3306889|NCT03001557|4040178|FG003|Treated|Core Phase||13
3306890|NCT03001557|4040179|FG004|Treated|Core Phase||12
3306891|NCT03001557|4040180|FG005|Treated|Core Phase||0
3306892|NCT03001557|4040181|FG006|Treated|Core Phase||0
3306893|NCT03001557|4040182|FG007|Treated|Core Phase||0
3306894|NCT03001557|4040175|FG000|COMPLETED|Core Phase||12
3306895|NCT03001557|4040176|FG001|COMPLETED|Core Phase||12
3306896|NCT03001557|4040177|FG002|COMPLETED|Core Phase||13
3306897|NCT03001557|4040178|FG003|COMPLETED|Core Phase||13
3306898|NCT03001557|4040179|FG004|COMPLETED|Core Phase||12
3306899|NCT03001557|4040180|FG005|COMPLETED|Core Phase||0
3306900|NCT03001557|4040181|FG006|COMPLETED|Core Phase||0
3306901|NCT03001557|4040182|FG007|COMPLETED|Core Phase||0
3306902|NCT03001557|4040175|FG000|NOT COMPLETED|Core Phase||0
3306903|NCT03001557|4040176|FG001|NOT COMPLETED|Core Phase||0
3306904|NCT03001557|4040177|FG002|NOT COMPLETED|Core Phase||1
3306905|NCT03001557|4040178|FG003|NOT COMPLETED|Core Phase||0
3306906|NCT03001557|4040179|FG004|NOT COMPLETED|Core Phase||0
3306907|NCT03001557|4040180|FG005|NOT COMPLETED|Core Phase||0
3306908|NCT03001557|4040181|FG006|NOT COMPLETED|Core Phase||0
3306909|NCT03001557|4040182|FG007|NOT COMPLETED|Core Phase||0
3306910|NCT03001557|4040175|FG000|STARTED|Extension Phase||0
3306911|NCT03001557|4040176|FG001|STARTED|Extension Phase||0
3306912|NCT03001557|4040177|FG002|STARTED|Extension Phase||0
3306913|NCT03001557|4040178|FG003|STARTED|Extension Phase||0
3306914|NCT03001557|4040179|FG004|STARTED|Extension Phase||0
3306915|NCT03001557|4040180|FG005|STARTED|Extension Phase||5
3306916|NCT03001557|4040181|FG006|STARTED|Extension Phase||14
3306917|NCT03001557|4040182|FG007|STARTED|Extension Phase||6
3306918|NCT03001557|4040175|FG000|COMPLETED|Extension Phase||0
3306919|NCT03001557|4040176|FG001|COMPLETED|Extension Phase||0
3306920|NCT03001557|4040177|FG002|COMPLETED|Extension Phase||0
3306921|NCT03001557|4040178|FG003|COMPLETED|Extension Phase||0
3306922|NCT03001557|4040179|FG004|COMPLETED|Extension Phase||0
3306923|NCT03001557|4040180|FG005|COMPLETED|Extension Phase||0
3306924|NCT03001557|4040181|FG006|COMPLETED|Extension Phase||0
3306925|NCT03001557|4040182|FG007|COMPLETED|Extension Phase||0
3306926|NCT03001557|4040175|FG000|NOT COMPLETED|Extension Phase||0
3306927|NCT03001557|4040176|FG001|NOT COMPLETED|Extension Phase||0
3306928|NCT03001557|4040177|FG002|NOT COMPLETED|Extension Phase||0
3011176|NCT01010009|3729081|FG000|COMPLETED|Overall Study||8
3011177|NCT01010009|3729082|FG001|COMPLETED|Overall Study||8
3011178|NCT01010009|3729083|FG002|COMPLETED|Overall Study||8
3011179|NCT01010009|3729081|FG000|NOT COMPLETED|Overall Study||0
3011180|NCT01010009|3729082|FG001|NOT COMPLETED|Overall Study||0
3011181|NCT01010009|3729083|FG002|NOT COMPLETED|Overall Study||0
3011182|NCT01010061|3729093|FG000|STARTED|Overall Study||238
3011183|NCT01010061|3729094|FG001|STARTED|Overall Study||118
3011184|NCT01010061|3729093|FG000|Received Study Drug|Overall Study||236
3011185|NCT01010061|3729094|FG001|Received Study Drug|Overall Study||116
3011186|NCT01010061|3729093|FG000|COMPLETED|Overall Study|Completed=Completed treatment.|190
3011187|NCT01010061|3729094|FG001|COMPLETED|Overall Study||78
3011188|NCT01010061|3729093|FG000|NOT COMPLETED|Overall Study||48
3011189|NCT01010061|3729094|FG001|NOT COMPLETED|Overall Study||40
3011190|NCT01010126|3729108|FG000|STARTED|Overall Study||27
3011191|NCT01010126|3729109|FG001|STARTED|Overall Study||58
3011192|NCT01010126|3729110|FG002|STARTED|Overall Study||28
3011193|NCT01010126|3729111|FG003|STARTED|Overall Study||57
3011194|NCT01010126|3729112|FG004|STARTED|Overall Study||58
3011195|NCT01010126|3729113|FG005|STARTED|Overall Study||24
3011196|NCT01010126|3729108|FG000|COMPLETED|Overall Study||26
3011197|NCT01010126|3729109|FG001|COMPLETED|Overall Study||58
3011198|NCT01010126|3729110|FG002|COMPLETED|Overall Study||27
3011199|NCT01010126|3729111|FG003|COMPLETED|Overall Study||57
3011200|NCT01010126|3729112|FG004|COMPLETED|Overall Study||55
3011201|NCT01010126|3729113|FG005|COMPLETED|Overall Study||24
3011202|NCT01010126|3729108|FG000|NOT COMPLETED|Overall Study||1
3011203|NCT01010126|3729109|FG001|NOT COMPLETED|Overall Study||0
3011204|NCT01010126|3729110|FG002|NOT COMPLETED|Overall Study||1
3011205|NCT01010126|3729111|FG003|NOT COMPLETED|Overall Study||0
3011206|NCT01010126|3729112|FG004|NOT COMPLETED|Overall Study||3
3011207|NCT01010126|3729113|FG005|NOT COMPLETED|Overall Study||0
3011208|NCT01010204|3729129|FG000|STARTED|Overall Study||31
3011209|NCT01010204|3729130|FG001|STARTED|Overall Study||29
3011210|NCT01010204|3729129|FG000|COMPLETED|Overall Study||24
3011211|NCT01010204|3729130|FG001|COMPLETED|Overall Study||20
3011212|NCT01010204|3729129|FG000|NOT COMPLETED|Overall Study||7
3011213|NCT01010204|3729130|FG001|NOT COMPLETED|Overall Study||9
3011214|NCT01010217|3729141|FG000|STARTED|Overall Study||89
3011215|NCT01010217|3729142|FG001|STARTED|Overall Study||56
3011216|NCT01010217|3729143|FG002|STARTED|Overall Study||22
3165267|NCT01898208|3892812|FG001|NOT COMPLETED|Overall Study||49
3165268|NCT01898208|3892813|FG002|NOT COMPLETED|Overall Study||37
3165269|NCT01898286|3892821|FG000|STARTED|Overall Study||38
3165270|NCT01898286|3892821|FG000|COMPLETED|Overall Study|"For this study completed is defined as completing the Early Termination visit"|35
3011217|NCT01010217|3729144|FG003|STARTED|Overall Study||6
3011218|NCT01010217|3729145|FG004|STARTED|Overall Study||3
3011219|NCT01010217|3729141|FG000|COMPLETED|Overall Study||84
3011220|NCT01010217|3729142|FG001|COMPLETED|Overall Study||51
3011221|NCT01010217|3729143|FG002|COMPLETED|Overall Study||21
3011222|NCT01010217|3729144|FG003|COMPLETED|Overall Study||0
3011223|NCT01010217|3729145|FG004|COMPLETED|Overall Study||0
3011224|NCT01010217|3729141|FG000|NOT COMPLETED|Overall Study||5
3011225|NCT01010217|3729142|FG001|NOT COMPLETED|Overall Study||5
3011226|NCT01010217|3729143|FG002|NOT COMPLETED|Overall Study||1
3011227|NCT01010217|3729144|FG003|NOT COMPLETED|Overall Study||6
3011228|NCT01010217|3729145|FG004|NOT COMPLETED|Overall Study||3
3011229|NCT01010230|3729159|FG000|STARTED|Overall Study||32
3011230|NCT01010230|3729160|FG001|STARTED|Overall Study||33
3011231|NCT01010230|3729159|FG000|COMPLETED|Overall Study||22
3011232|NCT01010230|3729160|FG001|COMPLETED|Overall Study||26
3011233|NCT01010230|3729159|FG000|NOT COMPLETED|Overall Study||10
3011234|NCT01010230|3729160|FG001|NOT COMPLETED|Overall Study||7
3011235|NCT01010282|3729169|FG000|STARTED|Overall Study||97
3011236|NCT01010282|3729170|FG001|STARTED|Overall Study||95
3011237|NCT01010282|3729171|FG002|STARTED|Overall Study||96
3011238|NCT01010282|3729169|FG000|COMPLETED|Overall Study||91
3011239|NCT01010282|3729170|FG001|COMPLETED|Overall Study||88
3011240|NCT01010282|3729171|FG002|COMPLETED|Overall Study||77
3011241|NCT01010282|3729169|FG000|NOT COMPLETED|Overall Study||6
3011242|NCT01010282|3729170|FG001|NOT COMPLETED|Overall Study||7
3011243|NCT01010282|3729171|FG002|NOT COMPLETED|Overall Study||19
3011244|NCT01010399|3729179|FG000|STARTED|Overall Study||36
3011245|NCT01010399|3729179|FG000|COMPLETED|Overall Study||31
3011246|NCT01010399|3729179|FG000|NOT COMPLETED|Overall Study||5
3011247|NCT01010477|3729185|FG000|STARTED|Overall Study||27
3011248|NCT01010477|3729186|FG001|STARTED|Overall Study||25
3011249|NCT01010477|3729185|FG000|COMPLETED|Overall Study||21
3011250|NCT01010477|3729186|FG001|COMPLETED|Overall Study||22
3011251|NCT01010477|3729185|FG000|NOT COMPLETED|Overall Study||6
3011252|NCT01010477|3729186|FG001|NOT COMPLETED|Overall Study||3
3011253|NCT01010503|3729192|FG000|STARTED|Overall Study||32
3011254|NCT01010503|3729192|FG000|COMPLETED|Overall Study||30
3011255|NCT01010503|3729192|FG000|NOT COMPLETED|Overall Study||2
3011256|NCT01010555|3729196|FG000|STARTED|First Four Weeks of Wear||11
3011257|NCT01010555|3729197|FG001|STARTED|First Four Weeks of Wear||10
3011258|NCT01010555|3729196|FG000|COMPLETED|First Four Weeks of Wear|One participant who completed Period 1 did not start Period 2. Relocation.|11
3011259|NCT01010555|3729197|FG001|COMPLETED|First Four Weeks of Wear|One participant who completed Period 1 did not start Period 2. Non-compliance with visit schedule.|10
3011260|NCT01010555|3729196|FG000|NOT COMPLETED|First Four Weeks of Wear||0
3011261|NCT01010555|3729197|FG001|NOT COMPLETED|First Four Weeks of Wear||0
3011262|NCT01010555|3729196|FG000|STARTED|Second Four Weeks of Wear||10
3011263|NCT01010555|3729197|FG001|STARTED|Second Four Weeks of Wear||9
3011264|NCT01010555|3729196|FG000|COMPLETED|Second Four Weeks of Wear||10
3011265|NCT01010555|3729197|FG001|COMPLETED|Second Four Weeks of Wear||9
3011266|NCT01010555|3729196|FG000|NOT COMPLETED|Second Four Weeks of Wear||0
3011267|NCT01010555|3729197|FG001|NOT COMPLETED|Second Four Weeks of Wear||0
3011268|NCT01010568|3729207|FG000|STARTED|Overall Study||10
3011269|NCT01010568|3729207|FG000|COMPLETED|Overall Study||5
3011270|NCT01010568|3729207|FG000|NOT COMPLETED|Overall Study||5
3011271|NCT01010633|3729214|FG000|STARTED|Overall Study||203
3011272|NCT01010633|3729215|FG001|STARTED|Overall Study||203
3011273|NCT01010633|3729214|FG000|COMPLETED|Overall Study||199
3011274|NCT01010633|3729215|FG001|COMPLETED|Overall Study||198
3011275|NCT01010633|3729214|FG000|NOT COMPLETED|Overall Study||4
3011276|NCT01010633|3729215|FG001|NOT COMPLETED|Overall Study||5
3011277|NCT01010750|3729227|FG000|STARTED|First Intervention||3
3011278|NCT01010750|3729228|FG001|STARTED|First Intervention||4
3011279|NCT01010750|3729229|FG002|STARTED|First Intervention||3
3011280|NCT01010750|3729230|FG003|STARTED|First Intervention||3
3011281|NCT01010750|3729231|FG004|STARTED|First Intervention||2
3011282|NCT01010750|3729232|FG005|STARTED|First Intervention||3
3011283|NCT01010750|3729227|FG000|COMPLETED|First Intervention||3
3011284|NCT01010750|3729228|FG001|COMPLETED|First Intervention||4
3011285|NCT01010750|3729229|FG002|COMPLETED|First Intervention||3
3011286|NCT01010750|3729230|FG003|COMPLETED|First Intervention||3
3011287|NCT01010750|3729231|FG004|COMPLETED|First Intervention||2
3011288|NCT01010750|3729232|FG005|COMPLETED|First Intervention||3
3011289|NCT01010750|3729227|FG000|NOT COMPLETED|First Intervention||0
3011290|NCT01010750|3729228|FG001|NOT COMPLETED|First Intervention||0
3011291|NCT01010750|3729229|FG002|NOT COMPLETED|First Intervention||0
3011292|NCT01010750|3729230|FG003|NOT COMPLETED|First Intervention||0
3011293|NCT01010750|3729231|FG004|NOT COMPLETED|First Intervention||0
3011294|NCT01010750|3729232|FG005|NOT COMPLETED|First Intervention||0
3011295|NCT01010750|3729227|FG000|STARTED|Second Intervention||3
3011296|NCT01010750|3729228|FG001|STARTED|Second Intervention||4
3011297|NCT01010750|3729229|FG002|STARTED|Second Intervention||3
3011298|NCT01010750|3729230|FG003|STARTED|Second Intervention||3
3011299|NCT01010750|3729231|FG004|STARTED|Second Intervention||2
3011300|NCT01010750|3729232|FG005|STARTED|Second Intervention||3
3011301|NCT01010750|3729227|FG000|COMPLETED|Second Intervention||3
3011302|NCT01010750|3729228|FG001|COMPLETED|Second Intervention||3
3011303|NCT01010750|3729229|FG002|COMPLETED|Second Intervention||3
3011304|NCT01010750|3729230|FG003|COMPLETED|Second Intervention||3
3011305|NCT01010750|3729231|FG004|COMPLETED|Second Intervention||2
3011306|NCT01010750|3729232|FG005|COMPLETED|Second Intervention||3
3011307|NCT01010750|3729227|FG000|NOT COMPLETED|Second Intervention||0
3011308|NCT01010750|3729228|FG001|NOT COMPLETED|Second Intervention||1
3011309|NCT01010750|3729229|FG002|NOT COMPLETED|Second Intervention||0
3011310|NCT01010750|3729230|FG003|NOT COMPLETED|Second Intervention||0
3011311|NCT01010750|3729231|FG004|NOT COMPLETED|Second Intervention||0
3011312|NCT01010750|3729232|FG005|NOT COMPLETED|Second Intervention||0
3011313|NCT01010750|3729227|FG000|STARTED|Third Intervention||3
3011314|NCT01010750|3729228|FG001|STARTED|Third Intervention||3
3011315|NCT01010750|3729229|FG002|STARTED|Third Intervention||3
3011316|NCT01010750|3729230|FG003|STARTED|Third Intervention||3
3011317|NCT01010750|3729231|FG004|STARTED|Third Intervention||2
3011318|NCT01010750|3729232|FG005|STARTED|Third Intervention||3
3011319|NCT01010750|3729227|FG000|COMPLETED|Third Intervention||3
3011320|NCT01010750|3729228|FG001|COMPLETED|Third Intervention||3
3011321|NCT01010750|3729229|FG002|COMPLETED|Third Intervention||3
3011322|NCT01010750|3729230|FG003|COMPLETED|Third Intervention||3
3011323|NCT01010750|3729231|FG004|COMPLETED|Third Intervention||2
3011324|NCT01010750|3729232|FG005|COMPLETED|Third Intervention||3
3011325|NCT01010750|3729227|FG000|NOT COMPLETED|Third Intervention||0
3011326|NCT01010750|3729228|FG001|NOT COMPLETED|Third Intervention||0
3011327|NCT01010750|3729229|FG002|NOT COMPLETED|Third Intervention||0
3011328|NCT01010750|3729230|FG003|NOT COMPLETED|Third Intervention||0
3011329|NCT01010750|3729231|FG004|NOT COMPLETED|Third Intervention||0
3011330|NCT01010750|3729232|FG005|NOT COMPLETED|Third Intervention||0
3011331|NCT01010763|3729242|FG000|STARTED|Overall Study||96
3011332|NCT01010763|3729243|FG001|STARTED|Overall Study||84
3011333|NCT01010763|3729242|FG000|COMPLETED|Overall Study||61
3011334|NCT01010763|3729243|FG001|COMPLETED|Overall Study||54
3011335|NCT01010763|3729242|FG000|NOT COMPLETED|Overall Study||35
3011336|NCT01010763|3729243|FG001|NOT COMPLETED|Overall Study||30
3165271|NCT01898286|3892821|FG000|NOT COMPLETED|Overall Study||3
3165272|NCT01898299|3892827|FG000|STARTED|Post Treatment (One Week)||47
3011337|NCT01010776|3729249|FG000|STARTED|Main Phase||223
3011338|NCT01010776|3729249|FG000|Treated|Main Phase||218
3011339|NCT01010776|3729249|FG000|COMPLETED|Main Phase||174
3011340|NCT01010776|3729249|FG000|NOT COMPLETED|Main Phase||49
3011341|NCT01010776|3729249|FG000|STARTED|In-Between Main Phase & Extension Phase||174
3011342|NCT01010776|3729249|FG000|COMPLETED|In-Between Main Phase & Extension Phase||159
3011343|NCT01010776|3729249|FG000|NOT COMPLETED|In-Between Main Phase & Extension Phase||15
3011344|NCT01010776|3729249|FG000|STARTED|Extension Phase||159
3011345|NCT01010776|3729249|FG000|COMPLETED|Extension Phase||156
3011346|NCT01010776|3729249|FG000|NOT COMPLETED|Extension Phase||3
3011347|NCT01010854|3729264|FG000|STARTED|Overall Study||6
3165273|NCT01898299|3892828|FG001|STARTED|Post Treatment (One Week)||42
3165274|NCT01898299|3892827|FG000|COMPLETED|Post Treatment (One Week)||47
3165275|NCT01898299|3892828|FG001|COMPLETED|Post Treatment (One Week)||42
3165276|NCT01898299|3892827|FG000|NOT COMPLETED|Post Treatment (One Week)||0
3165277|NCT01898299|3892828|FG001|NOT COMPLETED|Post Treatment (One Week)||0
3165278|NCT01898299|3892827|FG000|STARTED|Post Treatment (One Month)||47
3165279|NCT01898299|3892828|FG001|STARTED|Post Treatment (One Month)||42
3165280|NCT01898299|3892827|FG000|COMPLETED|Post Treatment (One Month)||44
3165281|NCT01898299|3892828|FG001|COMPLETED|Post Treatment (One Month)||38
3165282|NCT01898299|3892827|FG000|NOT COMPLETED|Post Treatment (One Month)||3
3165283|NCT01898299|3892828|FG001|NOT COMPLETED|Post Treatment (One Month)||4
3165284|NCT01898403|3892834|FG000|STARTED|Overall Study||50
3165285|NCT01898403|3892834|FG000|COMPLETED|Overall Study||50
3165286|NCT01898403|3892834|FG000|NOT COMPLETED|Overall Study||0
3165287|NCT01898429|3892840|FG000|STARTED|Phase 1||5
3165288|NCT01898429|3892841|FG001|STARTED|Phase 1||0
3165289|NCT01898429|3892842|FG002|STARTED|Phase 1||0
3165290|NCT01898429|3892840|FG000|COMPLETED|Phase 1||5
3165291|NCT01898429|3892841|FG001|COMPLETED|Phase 1||0
3165292|NCT01898429|3892842|FG002|COMPLETED|Phase 1||0
3306929|NCT03001557|4040178|FG003|NOT COMPLETED|Extension Phase||0
3011348|NCT01010854|3729264|FG000|COMPLETED|Overall Study||6
3011349|NCT01010854|3729264|FG000|NOT COMPLETED|Overall Study||0
3011350|NCT01010867|3729268|FG000|STARTED|Overall Study||31
3011351|NCT01010867|3729268|FG000|COMPLETED|Overall Study||30
3011352|NCT01010867|3729268|FG000|NOT COMPLETED|Overall Study||1
3011353|NCT01010906|3729278|FG000|STARTED|Overall Study||10
3011354|NCT01010906|3729279|FG001|STARTED|Overall Study||10
3011355|NCT01010906|3729280|FG002|STARTED|Overall Study||10
3011356|NCT01010906|3729281|FG003|STARTED|Overall Study||10
3011357|NCT01010906|3729282|FG004|STARTED|Overall Study||10
3011358|NCT01010906|3729283|FG005|STARTED|Overall Study||10
3011359|NCT01010906|3729278|FG000|COMPLETED|Overall Study||10
3011360|NCT01010906|3729279|FG001|COMPLETED|Overall Study||10
3011361|NCT01010906|3729280|FG002|COMPLETED|Overall Study||10
3011362|NCT01010906|3729281|FG003|COMPLETED|Overall Study||10
3011363|NCT01010906|3729282|FG004|COMPLETED|Overall Study||10
3011364|NCT01010906|3729283|FG005|COMPLETED|Overall Study||10
3011365|NCT01010906|3729278|FG000|NOT COMPLETED|Overall Study||0
3011366|NCT01010906|3729279|FG001|NOT COMPLETED|Overall Study||0
3011367|NCT01010906|3729280|FG002|NOT COMPLETED|Overall Study||0
3011368|NCT01010906|3729281|FG003|NOT COMPLETED|Overall Study||0
3011369|NCT01010906|3729282|FG004|NOT COMPLETED|Overall Study||0
3011370|NCT01010906|3729283|FG005|NOT COMPLETED|Overall Study||0
3011371|NCT01010932|3729297|FG000|STARTED|Overall Study||222
3011372|NCT01010932|3729297|FG000|COMPLETED|Overall Study||200
3011373|NCT01010932|3729297|FG000|NOT COMPLETED|Overall Study||22
3011374|NCT01010971|3729308|FG000|STARTED|Overall Study||225
3011375|NCT01010971|3729309|FG001|STARTED|Overall Study||226
3011376|NCT01010971|3729310|FG002|STARTED|Overall Study||220
3011377|NCT01010971|3729308|FG000|COMPLETED|Overall Study||222
3011378|NCT01010971|3729309|FG001|COMPLETED|Overall Study||218
3011379|NCT01010971|3729310|FG002|COMPLETED|Overall Study||207
3011380|NCT01010971|3729308|FG000|NOT COMPLETED|Overall Study||3
3011381|NCT01010971|3729309|FG001|NOT COMPLETED|Overall Study||8
3011382|NCT01010971|3729310|FG002|NOT COMPLETED|Overall Study||13
3011383|NCT01010984|3729318|FG000|STARTED|Overall Study||20
3011384|NCT01010984|3729318|FG000|COMPLETED|Overall Study||20
3011385|NCT01010984|3729318|FG000|NOT COMPLETED|Overall Study||0
3011386|NCT01011049|3729327|FG000|STARTED|Overall Study||507
3306930|NCT03001557|4040179|FG004|NOT COMPLETED|Extension Phase||0
3306931|NCT03001557|4040180|FG005|NOT COMPLETED|Extension Phase||5
3306932|NCT03001557|4040181|FG006|NOT COMPLETED|Extension Phase||14
3306933|NCT03001557|4040182|FG007|NOT COMPLETED|Extension Phase||6
3306934|NCT03001674|4040206|FG000|STARTED|Overall Study||10
3306935|NCT03001674|4040207|FG001|STARTED|Overall Study||5
3306936|NCT03001674|4040206|FG000|COMPLETED|Overall Study||10
3306937|NCT03001674|4040207|FG001|COMPLETED|Overall Study||5
3306938|NCT03001674|4040206|FG000|NOT COMPLETED|Overall Study||0
3306939|NCT03001674|4040207|FG001|NOT COMPLETED|Overall Study||0
3306940|NCT03001778|4040215|FG000|STARTED|Overall Study||21
3306941|NCT03001778|4040216|FG001|STARTED|Overall Study||46
3306942|NCT03001778|4040215|FG000|COMPLETED|Overall Study||21
3306943|NCT03001778|4040216|FG001|COMPLETED|Overall Study||46
3306944|NCT03001778|4040215|FG000|NOT COMPLETED|Overall Study||0
3306945|NCT03001778|4040216|FG001|NOT COMPLETED|Overall Study||0
3306946|NCT03001843|4040224|FG000|STARTED|Overall Study||27
3306947|NCT03001843|4040225|FG001|STARTED|Overall Study||27
3306948|NCT03001843|4040224|FG000|COMPLETED|Overall Study||27
3306949|NCT03001843|4040225|FG001|COMPLETED|Overall Study||27
3306950|NCT03001843|4040224|FG000|NOT COMPLETED|Overall Study||0
3011387|NCT01011049|3729328|FG001|STARTED|Overall Study||252
3011388|NCT01011049|3729329|FG002|STARTED|Overall Study||243
3011389|NCT01011049|3729330|FG003|STARTED|Overall Study||246
3011390|NCT01011049|3729327|FG000|COMPLETED|Overall Study||506
3011391|NCT01011049|3729328|FG001|COMPLETED|Overall Study||250
3165293|NCT01898429|3892840|FG000|NOT COMPLETED|Phase 1||0
3165294|NCT01898429|3892841|FG001|NOT COMPLETED|Phase 1||0
3165295|NCT01898429|3892842|FG002|NOT COMPLETED|Phase 1||0
3165296|NCT01898429|3892840|FG000|STARTED|Phase 2||0
3306951|NCT03001843|4040225|FG001|NOT COMPLETED|Overall Study||0
3306952|NCT03002012|4040233|FG000|STARTED|Overall Study||11
3306953|NCT03002012|4040234|FG001|STARTED|Overall Study||11
3011392|NCT01011049|3729329|FG002|COMPLETED|Overall Study||239
3011393|NCT01011049|3729330|FG003|COMPLETED|Overall Study||246
3011394|NCT01011049|3729327|FG000|NOT COMPLETED|Overall Study||1
3011395|NCT01011049|3729328|FG001|NOT COMPLETED|Overall Study||2
3011396|NCT01011049|3729329|FG002|NOT COMPLETED|Overall Study||4
3011397|NCT01011049|3729330|FG003|NOT COMPLETED|Overall Study||0
3011398|NCT01011075|3729340|FG000|STARTED|Overall Study||34
3011399|NCT01011075|3729340|FG000|COMPLETED|Overall Study||34
3011400|NCT01011075|3729340|FG000|NOT COMPLETED|Overall Study||0
3011401|NCT01011153|3729347|FG000|STARTED|Overall Study||54
3011402|NCT01011153|3729348|FG001|STARTED|Overall Study||75
3011403|NCT01011153|3729349|FG002|STARTED|Overall Study||54
3011404|NCT01011153|3729347|FG000|COMPLETED|Overall Study||46
3011405|NCT01011153|3729348|FG001|COMPLETED|Overall Study||64
3011406|NCT01011153|3729349|FG002|COMPLETED|Overall Study||45
3011407|NCT01011153|3729347|FG000|NOT COMPLETED|Overall Study||8
3011408|NCT01011153|3729348|FG001|NOT COMPLETED|Overall Study||11
3011409|NCT01011153|3729349|FG002|NOT COMPLETED|Overall Study||9
3011410|NCT01011179|3729367|FG000|STARTED|Overall Study||24
3011411|NCT01011179|3729368|FG001|STARTED|Overall Study||22
3011412|NCT01011179|3729367|FG000|COMPLETED|Overall Study||20
3011413|NCT01011179|3729368|FG001|COMPLETED|Overall Study||20
3011414|NCT01011179|3729367|FG000|NOT COMPLETED|Overall Study||4
3011415|NCT01011179|3729368|FG001|NOT COMPLETED|Overall Study||2
3011416|NCT01011218|3729380|FG000|STARTED|Overall Study||9
3011417|NCT01011218|3729381|FG001|STARTED|Overall Study||9
3011418|NCT01011218|3729382|FG002|STARTED|Overall Study||26
3011419|NCT01011218|3729383|FG003|STARTED|Overall Study||26
3011420|NCT01011218|3729380|FG000|COMPLETED|Overall Study||9
3011421|NCT01011218|3729381|FG001|COMPLETED|Overall Study||9
3011422|NCT01011218|3729382|FG002|COMPLETED|Overall Study||26
3011423|NCT01011218|3729383|FG003|COMPLETED|Overall Study||26
3011424|NCT01011218|3729380|FG000|NOT COMPLETED|Overall Study||0
3011425|NCT01011218|3729381|FG001|NOT COMPLETED|Overall Study||0
3011426|NCT01011218|3729382|FG002|NOT COMPLETED|Overall Study||0
3011427|NCT01011218|3729383|FG003|NOT COMPLETED|Overall Study||0
3011428|NCT01011283|3729395|FG000|STARTED|Overall Study||13
3011429|NCT01011283|3729396|FG001|STARTED|Overall Study||13
3011430|NCT01011283|3729395|FG000|COMPLETED|Overall Study||2
3011431|NCT01011283|3729396|FG001|COMPLETED|Overall Study||2
3306954|NCT03002012|4040233|FG000|COMPLETED|Overall Study||11
3306955|NCT03002012|4040234|FG001|COMPLETED|Overall Study||11
3306956|NCT03002012|4040233|FG000|NOT COMPLETED|Overall Study||0
3306957|NCT03002012|4040234|FG001|NOT COMPLETED|Overall Study||0
3306958|NCT03002038|4040242|FG000|STARTED|Overall Study||46
3306959|NCT03002038|4040243|FG001|STARTED|Overall Study||40
3306960|NCT03002038|4040242|FG000|COMPLETED|Overall Study||35
3306961|NCT03002038|4040243|FG001|COMPLETED|Overall Study||33
3306962|NCT03002038|4040242|FG000|NOT COMPLETED|Overall Study||11
3306963|NCT03002038|4040243|FG001|NOT COMPLETED|Overall Study||7
3306964|NCT03002077|4040249|FG000|STARTED|Overall Study||617
3306965|NCT03002077|4040249|FG000|COMPLETED|Overall Study||179
3306966|NCT03002077|4040249|FG000|NOT COMPLETED|Overall Study||438
3306967|NCT03002194|4040253|FG000|STARTED|Overall Study||48
3306968|NCT03002194|4040253|FG000|COMPLETED|Overall Study||38
3306969|NCT03002194|4040253|FG000|NOT COMPLETED|Overall Study||10
3306970|NCT03002311|4040259|FG000|STARTED|Overall Study||147
3306971|NCT03002311|4040260|FG001|STARTED|Overall Study||180
3306972|NCT03002311|4040259|FG000|COMPLETED|Overall Study||128
3306973|NCT03002311|4040260|FG001|COMPLETED|Overall Study||150
3306974|NCT03002311|4040259|FG000|NOT COMPLETED|Overall Study||19
3306975|NCT03002311|4040260|FG001|NOT COMPLETED|Overall Study||30
3306976|NCT03002454|4040266|FG000|STARTED|Overall Study||4
3306977|NCT03002454|4040266|FG000|COMPLETED|Overall Study||4
3306978|NCT03002454|4040266|FG000|NOT COMPLETED|Overall Study||0
3306979|NCT03002506|4040271|FG000|STARTED|Overall Study||6
3306980|NCT03002506|4040271|FG000|COMPLETED|Overall Study||6
3306981|NCT03002506|4040271|FG000|NOT COMPLETED|Overall Study||0
3306982|NCT03002610|4040278|FG000|STARTED|Overall Study||24
3306983|NCT03002610|4040279|FG001|STARTED|Overall Study||50
3306984|NCT03002610|4040280|FG002|STARTED|Overall Study||34
3306985|NCT03002610|4040278|FG000|COMPLETED|Overall Study||18
3306986|NCT03002610|4040279|FG001|COMPLETED|Overall Study||25
3306987|NCT03002610|4040280|FG002|COMPLETED|Overall Study||21
3306988|NCT03002610|4040278|FG000|NOT COMPLETED|Overall Study||6
3306989|NCT03002610|4040279|FG001|NOT COMPLETED|Overall Study||25
3306990|NCT03002610|4040280|FG002|NOT COMPLETED|Overall Study||13
3306991|NCT03002623|4040290|FG000|STARTED|Overall Study||4
3306992|NCT03002623|4040291|FG001|STARTED|Overall Study||3
3306993|NCT03002623|4040290|FG000|COMPLETED|Overall Study||2
3306994|NCT03002623|4040291|FG001|COMPLETED|Overall Study||2
3306995|NCT03002623|4040290|FG000|NOT COMPLETED|Overall Study||2
3011432|NCT01011283|3729395|FG000|NOT COMPLETED|Overall Study||11
3011433|NCT01011283|3729396|FG001|NOT COMPLETED|Overall Study||11
3011434|NCT01011309|3729405|FG000|STARTED|Overall Study||14
3011435|NCT01011309|3729406|FG001|STARTED|Overall Study||10
3011436|NCT01011309|3729407|FG002|STARTED|Overall Study||21
3011437|NCT01011309|3729405|FG000|COMPLETED|Overall Study||12
3011438|NCT01011309|3729406|FG001|COMPLETED|Overall Study||7
3011439|NCT01011309|3729407|FG002|COMPLETED|Overall Study||16
3306996|NCT03002623|4040291|FG001|NOT COMPLETED|Overall Study||1
3306997|NCT03002753|4040301|FG000|STARTED|First Randomization||10
3306998|NCT03002753|4040302|FG001|STARTED|First Randomization||12
3306999|NCT03002753|4040303|FG002|STARTED|First Randomization||21
3011440|NCT01011309|3729405|FG000|NOT COMPLETED|Overall Study||2
3011441|NCT01011309|3729406|FG001|NOT COMPLETED|Overall Study||3
3011442|NCT01011309|3729407|FG002|NOT COMPLETED|Overall Study||5
3011443|NCT01011335|3729419|FG000|STARTED|Overall Study||11
3011444|NCT01011335|3729420|FG001|STARTED|Overall Study||12
3011445|NCT01011335|3729421|FG002|STARTED|Overall Study||12
3011446|NCT01011335|3729422|FG003|STARTED|Overall Study||12
3011447|NCT01011335|3729423|FG004|STARTED|Overall Study||13
3011448|NCT01011335|3729424|FG005|STARTED|Overall Study||12
3011449|NCT01011335|3729425|FG006|STARTED|Overall Study||12
3011450|NCT01011335|3729426|FG007|STARTED|Overall Study||12
3011451|NCT01011335|3729427|FG008|STARTED|Overall Study||12
3011452|NCT01011335|3729428|FG009|STARTED|Overall Study||12
3011453|NCT01011335|3729429|FG010|STARTED|Overall Study||12
3011454|NCT01011335|3729430|FG011|STARTED|Overall Study||22
3011455|NCT01011335|3729431|FG012|STARTED|Overall Study||22
3011456|NCT01011335|3729419|FG000|COMPLETED|Overall Study||10
3011457|NCT01011335|3729420|FG001|COMPLETED|Overall Study||11
3011458|NCT01011335|3729421|FG002|COMPLETED|Overall Study||11
3011459|NCT01011335|3729422|FG003|COMPLETED|Overall Study||10
3011460|NCT01011335|3729423|FG004|COMPLETED|Overall Study||12
3011461|NCT01011335|3729424|FG005|COMPLETED|Overall Study||11
3011462|NCT01011335|3729425|FG006|COMPLETED|Overall Study||9
3011463|NCT01011335|3729426|FG007|COMPLETED|Overall Study||10
3011464|NCT01011335|3729427|FG008|COMPLETED|Overall Study||10
3011465|NCT01011335|3729428|FG009|COMPLETED|Overall Study||12
3011466|NCT01011335|3729429|FG010|COMPLETED|Overall Study||6
3011467|NCT01011335|3729430|FG011|COMPLETED|Overall Study||21
3011468|NCT01011335|3729431|FG012|COMPLETED|Overall Study||19
3011469|NCT01011335|3729419|FG000|NOT COMPLETED|Overall Study||1
3011470|NCT01011335|3729420|FG001|NOT COMPLETED|Overall Study||1
3011471|NCT01011335|3729421|FG002|NOT COMPLETED|Overall Study||1
3011472|NCT01011335|3729422|FG003|NOT COMPLETED|Overall Study||2
3011473|NCT01011335|3729423|FG004|NOT COMPLETED|Overall Study||1
3011474|NCT01011335|3729424|FG005|NOT COMPLETED|Overall Study||1
3011475|NCT01011335|3729425|FG006|NOT COMPLETED|Overall Study||3
3011476|NCT01011335|3729426|FG007|NOT COMPLETED|Overall Study||2
3011477|NCT01011335|3729427|FG008|NOT COMPLETED|Overall Study||2
3011478|NCT01011335|3729428|FG009|NOT COMPLETED|Overall Study||0
3011479|NCT01011335|3729429|FG010|NOT COMPLETED|Overall Study||6
3011480|NCT01011335|3729430|FG011|NOT COMPLETED|Overall Study||1
3011481|NCT01011335|3729431|FG012|NOT COMPLETED|Overall Study||3
3011482|NCT01011387|3729468|FG000|STARTED|Overall Study||16
3011483|NCT01011387|3729468|FG000|COMPLETED|Overall Study||10
3011484|NCT01011387|3729468|FG000|NOT COMPLETED|Overall Study||6
3011485|NCT01011413|3729474|FG000|STARTED|Overall Study|312 randomised|312
3011486|NCT01011413|3729475|FG001|STARTED|Overall Study|324 randomised|324
3011487|NCT01011413|3729474|FG000|Did Not Start Study Drug|Overall Study||3
3011488|NCT01011413|3729475|FG001|Did Not Start Study Drug|Overall Study||3
3011489|NCT01011413|3729474|FG000|In Modified ITT|Overall Study||309
3011490|NCT01011413|3729475|FG001|In Modified ITT|Overall Study||321
3011491|NCT01011413|3729474|FG000|Died Before Week 48|Overall Study||3
3011492|NCT01011413|3729475|FG001|Died Before Week 48|Overall Study||2
3011493|NCT01011413|3729474|FG000|Lost to Follow up Before w48|Overall Study||3
3011494|NCT01011413|3729475|FG001|Lost to Follow up Before w48|Overall Study||4
3011495|NCT01011413|3729474|FG000|Withdrew Consent Before w48|Overall Study||3
3011496|NCT01011413|3729475|FG001|Withdrew Consent Before w48|Overall Study||3
3011497|NCT01011413|3729474|FG000|Attended w48 Visit|Overall Study||295
3011498|NCT01011413|3729475|FG001|Attended w48 Visit|Overall Study||311
3011499|NCT01011413|3729474|FG000|Died Between Week 48 and 96|Overall Study||2
3011500|NCT01011413|3729475|FG001|Died Between Week 48 and 96|Overall Study||3
3011501|NCT01011413|3729474|FG000|Withdrew Consent Between Week 48 and 96|Overall Study||2
3011502|NCT01011413|3729475|FG001|Withdrew Consent Between Week 48 and 96|Overall Study||6
3011503|NCT01011413|3729474|FG000|Lost to Follow-up Between Week 48 and 96|Overall Study||10
3011504|NCT01011413|3729475|FG001|Lost to Follow-up Between Week 48 and 96|Overall Study||4
3011505|NCT01011413|3729474|FG000|COMPLETED|Overall Study||286
3011506|NCT01011413|3729475|FG001|COMPLETED|Overall Study||299
3011507|NCT01011413|3729474|FG000|NOT COMPLETED|Overall Study||26
3011508|NCT01011413|3729475|FG001|NOT COMPLETED|Overall Study||25
3011509|NCT01011439|3729488|FG000|STARTED|Overall Study||72
3011510|NCT01011439|3729488|FG000|COMPLETED|Overall Study||15
3011511|NCT01011439|3729488|FG000|NOT COMPLETED|Overall Study||57
3011512|NCT01011465|3729501|FG000|STARTED|Overall Study||36
3011513|NCT01011465|3729502|FG001|STARTED|Overall Study||20
3011514|NCT01011465|3729503|FG002|STARTED|Overall Study||36
3011515|NCT01011465|3729504|FG003|STARTED|Overall Study||18
3011516|NCT01011465|3729505|FG004|STARTED|Overall Study||47
3011517|NCT01011465|3729506|FG005|STARTED|Overall Study||29
3011518|NCT01011465|3729507|FG006|STARTED|Overall Study||52
3011519|NCT01011465|3729508|FG007|STARTED|Overall Study||32
3011520|NCT01011465|3729501|FG000|COMPLETED|Overall Study||34
3011521|NCT01011465|3729502|FG001|COMPLETED|Overall Study||19
3011522|NCT01011465|3729503|FG002|COMPLETED|Overall Study||36
3011523|NCT01011465|3729504|FG003|COMPLETED|Overall Study||18
3011524|NCT01011465|3729505|FG004|COMPLETED|Overall Study||46
3011525|NCT01011465|3729506|FG005|COMPLETED|Overall Study||29
3011526|NCT01011465|3729507|FG006|COMPLETED|Overall Study||51
3011527|NCT01011465|3729508|FG007|COMPLETED|Overall Study||32
3011528|NCT01011465|3729501|FG000|NOT COMPLETED|Overall Study||2
3011529|NCT01011465|3729502|FG001|NOT COMPLETED|Overall Study||1
3011530|NCT01011465|3729503|FG002|NOT COMPLETED|Overall Study||0
3011531|NCT01011465|3729504|FG003|NOT COMPLETED|Overall Study||0
3011532|NCT01011465|3729505|FG004|NOT COMPLETED|Overall Study||1
3011533|NCT01011465|3729506|FG005|NOT COMPLETED|Overall Study||0
3011534|NCT01011465|3729507|FG006|NOT COMPLETED|Overall Study||1
3011535|NCT01011465|3729508|FG007|NOT COMPLETED|Overall Study||0
3011536|NCT01011556|3729528|FG000|STARTED|Overall Study||58
3011537|NCT01011556|3729529|FG001|STARTED|Overall Study||56
3307000|NCT03002753|4040301|FG000|COMPLETED|First Randomization||9
3307001|NCT03002753|4040302|FG001|COMPLETED|First Randomization||11
3307002|NCT03002753|4040303|FG002|COMPLETED|First Randomization||21
3011538|NCT01011556|3729530|FG002|STARTED|Overall Study||55
3011539|NCT01011556|3729531|FG003|STARTED|Overall Study||64
3011540|NCT01011556|3729528|FG000|Received at Least 1 Dose of Study Drug|Overall Study||57
3011541|NCT01011556|3729529|FG001|Received at Least 1 Dose of Study Drug|Overall Study||56
3011542|NCT01011556|3729530|FG002|Received at Least 1 Dose of Study Drug|Overall Study||54
3011543|NCT01011556|3729531|FG003|Received at Least 1 Dose of Study Drug|Overall Study||64
3011544|NCT01011556|3729528|FG000|COMPLETED|Overall Study||52
3011545|NCT01011556|3729529|FG001|COMPLETED|Overall Study||48
3011546|NCT01011556|3729530|FG002|COMPLETED|Overall Study||45
3165297|NCT01898429|3892841|FG001|STARTED|Phase 2||5
3165298|NCT01898429|3892842|FG002|STARTED|Phase 2||0
3165299|NCT01898429|3892840|FG000|COMPLETED|Phase 2||0
3165300|NCT01898429|3892841|FG001|COMPLETED|Phase 2||5
3165301|NCT01898429|3892842|FG002|COMPLETED|Phase 2||0
3165302|NCT01898429|3892840|FG000|NOT COMPLETED|Phase 2||0
3165303|NCT01898429|3892841|FG001|NOT COMPLETED|Phase 2||0
3307003|NCT03002753|4040301|FG000|NOT COMPLETED|First Randomization||1
3307004|NCT03002753|4040302|FG001|NOT COMPLETED|First Randomization||1
3011547|NCT01011556|3729531|FG003|COMPLETED|Overall Study||51
3011548|NCT01011556|3729528|FG000|NOT COMPLETED|Overall Study||6
3011549|NCT01011556|3729529|FG001|NOT COMPLETED|Overall Study||8
3011550|NCT01011556|3729530|FG002|NOT COMPLETED|Overall Study||10
3011551|NCT01011556|3729531|FG003|NOT COMPLETED|Overall Study||13
3011552|NCT01011673|3729546|FG000|STARTED|Randomized||62
3011553|NCT01011673|3729547|FG001|STARTED|Randomized||61
3011554|NCT01011673|3729546|FG000|COMPLETED|Randomized|2 patients were randomized but not included in analyses bc they did not truly meet study criteria.|60
3011555|NCT01011673|3729547|FG001|COMPLETED|Randomized|1 patient was randomized but not included in analyses bc they did not truly meet study criteria.|60
3011556|NCT01011673|3729546|FG000|NOT COMPLETED|Randomized||2
3011557|NCT01011673|3729547|FG001|NOT COMPLETED|Randomized||1
3011558|NCT01011673|3729546|FG000|STARTED|Emergency Department Portion||60
3011559|NCT01011673|3729547|FG001|STARTED|Emergency Department Portion||60
3011560|NCT01011673|3729546|FG000|COMPLETED|Emergency Department Portion||60
3011561|NCT01011673|3729547|FG001|COMPLETED|Emergency Department Portion||60
3011562|NCT01011673|3729546|FG000|NOT COMPLETED|Emergency Department Portion||0
3011563|NCT01011673|3729547|FG001|NOT COMPLETED|Emergency Department Portion||0
3011564|NCT01011673|3729546|FG000|STARTED|24 Hour Follow-up||60
3011565|NCT01011673|3729547|FG001|STARTED|24 Hour Follow-up||60
3011566|NCT01011673|3729546|FG000|COMPLETED|24 Hour Follow-up||57
3011567|NCT01011673|3729547|FG001|COMPLETED|24 Hour Follow-up||57
3011568|NCT01011673|3729546|FG000|NOT COMPLETED|24 Hour Follow-up||3
3011569|NCT01011673|3729547|FG001|NOT COMPLETED|24 Hour Follow-up||3
3011570|NCT01011738|3729556|FG000|STARTED|Overall Study||877
3011571|NCT01011738|3729557|FG001|STARTED|Overall Study||912
3011572|NCT01011738|3729558|FG002|STARTED|Overall Study||53
3011573|NCT01011738|3729556|FG000|COMPLETED|Overall Study||553
3011574|NCT01011738|3729557|FG001|COMPLETED|Overall Study||618
3011575|NCT01011738|3729558|FG002|COMPLETED|Overall Study||36
3011576|NCT01011738|3729556|FG000|NOT COMPLETED|Overall Study||324
3011577|NCT01011738|3729557|FG001|NOT COMPLETED|Overall Study||294
3011578|NCT01011738|3729558|FG002|NOT COMPLETED|Overall Study||17
3011579|NCT01011816|3729569|FG000|STARTED|26-Week Primary Endpoint||164
3011580|NCT01011816|3729570|FG001|STARTED|26-Week Primary Endpoint||56
3011581|NCT01011816|3729569|FG000|COMPLETED|26-Week Primary Endpoint||157
3165304|NCT01898429|3892842|FG002|NOT COMPLETED|Phase 2||0
3307005|NCT03002753|4040303|FG002|NOT COMPLETED|First Randomization||0
3307006|NCT03002753|4040301|FG000|STARTED|Second Randomization (Re-randomization)||11
3307007|NCT03002753|4040302|FG001|STARTED|Second Randomization (Re-randomization)||10
3307008|NCT03002753|4040303|FG002|STARTED|Second Randomization (Re-randomization)||0
3307009|NCT03002753|4040301|FG000|COMPLETED|Second Randomization (Re-randomization)||11
3307010|NCT03002753|4040302|FG001|COMPLETED|Second Randomization (Re-randomization)||9
3307011|NCT03002753|4040303|FG002|COMPLETED|Second Randomization (Re-randomization)||0
3307012|NCT03002753|4040301|FG000|NOT COMPLETED|Second Randomization (Re-randomization)||0
3307013|NCT03002753|4040302|FG001|NOT COMPLETED|Second Randomization (Re-randomization)||1
3307014|NCT03002753|4040303|FG002|NOT COMPLETED|Second Randomization (Re-randomization)||0
3307015|NCT03002818|4040311|FG000|STARTED|Overall Study||41
3307016|NCT03002818|4040311|FG000|COMPLETED|Overall Study||40
3307017|NCT03002818|4040311|FG000|NOT COMPLETED|Overall Study||1
3307018|NCT03002974|4040318|FG000|STARTED|Overall Study||55
3307019|NCT03002974|4040319|FG001|STARTED|Overall Study||56
3307020|NCT03002974|4040320|FG002|STARTED|Overall Study||54
3307021|NCT03002974|4040318|FG000|Intention To Treat Populatio|Overall Study||55
3307022|NCT03002974|4040319|FG001|Intention To Treat Populatio|Overall Study||56
3307023|NCT03002974|4040320|FG002|Intention To Treat Populatio|Overall Study||54
3307024|NCT03002974|4040318|FG000|Safety Population|Overall Study||54
3011582|NCT01011816|3729570|FG001|COMPLETED|26-Week Primary Endpoint||54
3011583|NCT01011816|3729569|FG000|NOT COMPLETED|26-Week Primary Endpoint||7
3011584|NCT01011816|3729570|FG001|NOT COMPLETED|26-Week Primary Endpoint||2
3011585|NCT01011816|3729569|FG000|STARTED|78-Week Extended Follow-up||157
3011586|NCT01011816|3729570|FG001|STARTED|78-Week Extended Follow-up||54
3011587|NCT01011816|3729569|FG000|COMPLETED|78-Week Extended Follow-up||85
3011588|NCT01011816|3729570|FG001|COMPLETED|78-Week Extended Follow-up||26
3011589|NCT01011816|3729569|FG000|NOT COMPLETED|78-Week Extended Follow-up||72
3011590|NCT01011816|3729570|FG001|NOT COMPLETED|78-Week Extended Follow-up||28
3011591|NCT01011829|3729580|FG000|STARTED|Overall Study||10
3011592|NCT01011829|3729581|FG001|STARTED|Overall Study||10
3011593|NCT01011829|3729580|FG000|COMPLETED|Overall Study||6
3011594|NCT01011829|3729581|FG001|COMPLETED|Overall Study||1
3011595|NCT01011829|3729580|FG000|NOT COMPLETED|Overall Study||4
3011596|NCT01011829|3729581|FG001|NOT COMPLETED|Overall Study||9
3011597|NCT01011868|3729590|FG000|STARTED|After Week 18 Follow-up||170
3011598|NCT01011868|3729591|FG001|STARTED|After Week 18 Follow-up||169
3011599|NCT01011868|3729592|FG002|STARTED|After Week 18 Follow-up||155
3011600|NCT01011868|3729590|FG000|COMPLETED|After Week 18 Follow-up||147
3011601|NCT01011868|3729591|FG001|COMPLETED|After Week 18 Follow-up||153
3011602|NCT01011868|3729592|FG002|COMPLETED|After Week 18 Follow-up||129
3011603|NCT01011868|3729590|FG000|NOT COMPLETED|After Week 18 Follow-up||23
3011604|NCT01011868|3729591|FG001|NOT COMPLETED|After Week 18 Follow-up||16
3011605|NCT01011868|3729592|FG002|NOT COMPLETED|After Week 18 Follow-up||26
3011606|NCT01011868|3729590|FG000|STARTED|After Week 78 Follow-up||170
3011607|NCT01011868|3729591|FG001|STARTED|After Week 78 Follow-up||169
3011608|NCT01011868|3729592|FG002|STARTED|After Week 78 Follow-up||155
3011609|NCT01011868|3729590|FG000|COMPLETED|After Week 78 Follow-up||118
3011610|NCT01011868|3729591|FG001|COMPLETED|After Week 78 Follow-up||131
3011611|NCT01011868|3729592|FG002|COMPLETED|After Week 78 Follow-up||111
3011612|NCT01011868|3729590|FG000|NOT COMPLETED|After Week 78 Follow-up||52
3011613|NCT01011868|3729591|FG001|NOT COMPLETED|After Week 78 Follow-up||38
3011614|NCT01011868|3729592|FG002|NOT COMPLETED|After Week 78 Follow-up||44
3011615|NCT01011894|3729600|FG000|STARTED|Overall Study||26
3011616|NCT01011894|3729600|FG000|COMPLETED|Overall Study||26
3011617|NCT01011894|3729600|FG000|NOT COMPLETED|Overall Study||0
3011618|NCT01011907|3729606|FG000|STARTED|Overall Study||31
3011619|NCT01011907|3729607|FG001|STARTED|Overall Study||33
3011620|NCT01011907|3729606|FG000|COMPLETED|Overall Study||17
3011621|NCT01011907|3729607|FG001|COMPLETED|Overall Study||18
3011622|NCT01011907|3729606|FG000|NOT COMPLETED|Overall Study||14
3011623|NCT01011907|3729607|FG001|NOT COMPLETED|Overall Study||15
3011624|NCT01011933|3729613|FG000|STARTED|Overall Study|total enrolled|54
3011625|NCT01011933|3729613|FG000|COMPLETED|Overall Study|total eligible and evaluable|50
3011626|NCT01011933|3729613|FG000|NOT COMPLETED|Overall Study||4
3011627|NCT01011946|3729623|FG000|STARTED|Overall Study||36
3011628|NCT01011946|3729623|FG000|COMPLETED|Overall Study||33
3011629|NCT01011946|3729623|FG000|NOT COMPLETED|Overall Study||3
3011630|NCT01012037|3729630|FG000|STARTED|Overall Study||44
3011631|NCT01012037|3729631|FG001|STARTED|Overall Study||223
3011632|NCT01012037|3729632|FG002|STARTED|Overall Study||224
3011633|NCT01012037|3729630|FG000|COMPLETED|Overall Study||43
3011634|NCT01012037|3729631|FG001|COMPLETED|Overall Study||207
3011635|NCT01012037|3729632|FG002|COMPLETED|Overall Study||214
3011636|NCT01012037|3729630|FG000|NOT COMPLETED|Overall Study||1
3011637|NCT01012037|3729631|FG001|NOT COMPLETED|Overall Study||16
3011638|NCT01012037|3729632|FG002|NOT COMPLETED|Overall Study||10
3011639|NCT01012089|3729642|FG000|STARTED|Overall Study||6
3011640|NCT01012089|3729642|FG000|COMPLETED|Overall Study||6
3011641|NCT01012089|3729642|FG000|NOT COMPLETED|Overall Study||0
3011642|NCT01012219|3729648|FG000|STARTED|Period 1|Number randomized|36
3165305|NCT01898429|3892840|FG000|STARTED|Phase 3||0
3165306|NCT01898429|3892841|FG001|STARTED|Phase 3||0
3165307|NCT01898429|3892842|FG002|STARTED|Phase 3||5
3165308|NCT01898429|3892840|FG000|COMPLETED|Phase 3||0
3165309|NCT01898429|3892841|FG001|COMPLETED|Phase 3||0
3165310|NCT01898429|3892842|FG002|COMPLETED|Phase 3||5
3011643|NCT01012219|3729648|FG000|COMPLETED|Period 1||35
3011644|NCT01012219|3729648|FG000|NOT COMPLETED|Period 1||1
3011645|NCT01012219|3729648|FG000|STARTED|Period 2|Number who completed Period 1|35
3165311|NCT01898429|3892840|FG000|NOT COMPLETED|Phase 3||0
3307025|NCT03002974|4040319|FG001|Safety Population|Overall Study||55
3307026|NCT03002974|4040320|FG002|Safety Population|Overall Study||52
3011646|NCT01012219|3729648|FG000|COMPLETED|Period 2||34
3011647|NCT01012219|3729648|FG000|NOT COMPLETED|Period 2||1
3011648|NCT01012219|3729648|FG000|STARTED|Period 3|of the 36 who started Period 1|20
3011649|NCT01012219|3729648|FG000|COMPLETED|Period 3||20
3011650|NCT01012219|3729648|FG000|NOT COMPLETED|Period 3||0
3011651|NCT01012245|3729659|FG000|STARTED|Overall Study||28812
3011652|NCT01012245|3729659|FG000|COMPLETED|Overall Study|More than 1 discontinuation (DC) reason possible per subject. See outcome measure Reasons for DC.|26385
3011653|NCT01012245|3729659|FG000|NOT COMPLETED|Overall Study||2427
3011654|NCT01012258|3729670|FG000|STARTED|Overall Study||66
3011655|NCT01012258|3729670|FG000|COMPLETED|Overall Study||0
3011656|NCT01012258|3729670|FG000|NOT COMPLETED|Overall Study||66
3011657|NCT01012297|3729677|FG000|STARTED|Overall Study||54
3011658|NCT01012297|3729678|FG001|STARTED|Overall Study||53
3011659|NCT01012297|3729677|FG000|COMPLETED|Overall Study||54
3011660|NCT01012297|3729678|FG001|COMPLETED|Overall Study||53
3165312|NCT01898429|3892841|FG001|NOT COMPLETED|Phase 3||0
3011661|NCT01012297|3729677|FG000|NOT COMPLETED|Overall Study||0
3011662|NCT01012297|3729678|FG001|NOT COMPLETED|Overall Study||0
3011663|NCT01012323|3729684|FG000|STARTED|Overall Study||51
3011664|NCT01012323|3729684|FG000|COMPLETED|Overall Study||50
3011665|NCT01012323|3729684|FG000|NOT COMPLETED|Overall Study||1
3011666|NCT01012336|3729688|FG000|STARTED|Overall Study||85
3011667|NCT01012336|3729688|FG000|COMPLETED|Overall Study||85
3011668|NCT01012336|3729688|FG000|NOT COMPLETED|Overall Study||0
3011669|NCT01012362|3729697|FG000|STARTED|Overall Study||9
3011670|NCT01012362|3729698|FG001|STARTED|Overall Study||6
3011671|NCT01012362|3729699|FG002|STARTED|Overall Study||3
3011672|NCT01012362|3729700|FG003|STARTED|Overall Study||4
3011673|NCT01012362|3729701|FG004|STARTED|Overall Study||9
3011674|NCT01012362|3729697|FG000|COMPLETED|Overall Study||9
3011675|NCT01012362|3729698|FG001|COMPLETED|Overall Study||6
3011676|NCT01012362|3729699|FG002|COMPLETED|Overall Study||3
3011677|NCT01012362|3729700|FG003|COMPLETED|Overall Study||4
3011678|NCT01012362|3729701|FG004|COMPLETED|Overall Study||9
3011679|NCT01012362|3729697|FG000|NOT COMPLETED|Overall Study||0
3011680|NCT01012362|3729698|FG001|NOT COMPLETED|Overall Study||0
3011681|NCT01012362|3729699|FG002|NOT COMPLETED|Overall Study||0
3011682|NCT01012362|3729700|FG003|NOT COMPLETED|Overall Study||0
3011683|NCT01012362|3729701|FG004|NOT COMPLETED|Overall Study||0
3011684|NCT01012388|3729717|FG000|STARTED|Overall Study||100
3011685|NCT01012388|3729717|FG000|COMPLETED|Overall Study||100
3011686|NCT01012388|3729717|FG000|NOT COMPLETED|Overall Study||0
3011687|NCT01012440|3729721|FG000|STARTED|Overall Study||5
3011688|NCT01012440|3729721|FG000|COMPLETED|Overall Study||3
3011689|NCT01012440|3729721|FG000|NOT COMPLETED|Overall Study||2
3011690|NCT01012492|3729725|FG000|STARTED|Overall Study||10
3011691|NCT01012492|3729725|FG000|COMPLETED|Overall Study||10
3011692|NCT01012492|3729725|FG000|NOT COMPLETED|Overall Study||0
3011693|NCT01012609|3729731|FG000|STARTED|Overall Study||21
3011694|NCT01012609|3729732|FG001|STARTED|Overall Study||26
3011695|NCT01012609|3729731|FG000|COMPLETED|Overall Study||20
3011696|NCT01012609|3729732|FG001|COMPLETED|Overall Study||25
3011697|NCT01012609|3729731|FG000|NOT COMPLETED|Overall Study||1
3011698|NCT01012609|3729732|FG001|NOT COMPLETED|Overall Study||1
3011699|NCT01012622|3729739|FG000|STARTED|Overall Study||142
3011700|NCT01012622|3729739|FG000|COMPLETED|Overall Study||111
3011701|NCT01012622|3729739|FG000|NOT COMPLETED|Overall Study||31
3011702|NCT01012661|3729743|FG000|STARTED|Overall Study||50
3011703|NCT01012661|3729743|FG000|COMPLETED|Overall Study||50
3011704|NCT01012661|3729743|FG000|NOT COMPLETED|Overall Study||0
3011705|NCT01012674|3729749|FG000|STARTED|Overall Study||211
3011706|NCT01012674|3729749|FG000|COMPLETED|Overall Study||187
3011707|NCT01012674|3729749|FG000|NOT COMPLETED|Overall Study||24
3011708|NCT01012713|3729757|FG000|STARTED|Overall Study||30
3011709|NCT01012713|3729757|FG000|COMPLETED|Overall Study||27
3011710|NCT01012713|3729757|FG000|NOT COMPLETED|Overall Study||3
3307027|NCT03002974|4040318|FG000|COMPLETED|Overall Study||35
3307028|NCT03002974|4040319|FG001|COMPLETED|Overall Study||40
3307029|NCT03002974|4040320|FG002|COMPLETED|Overall Study||36
3307030|NCT03002974|4040318|FG000|NOT COMPLETED|Overall Study||20
3307031|NCT03002974|4040319|FG001|NOT COMPLETED|Overall Study||16
3307032|NCT03002974|4040320|FG002|NOT COMPLETED|Overall Study||18
3317086|NCT03123861|4050601|FG001|Received Intervention|Overall Study||22
3317087|NCT03123861|4050600|FG000|COMPLETED|Overall Study||19
3317088|NCT03123861|4050601|FG001|COMPLETED|Overall Study||20
3317089|NCT03123861|4050600|FG000|NOT COMPLETED|Overall Study||3
3317090|NCT03123861|4050601|FG001|NOT COMPLETED|Overall Study||3
3317091|NCT03123874|4050609|FG000|STARTED|Overall Study||27
3317092|NCT03123874|4050610|FG001|STARTED|Overall Study||25
3317093|NCT03123874|4050609|FG000|COMPLETED|Overall Study||27
3317094|NCT03123874|4050610|FG001|COMPLETED|Overall Study||25
3317095|NCT03123874|4050609|FG000|NOT COMPLETED|Overall Study||0
3317096|NCT03123874|4050610|FG001|NOT COMPLETED|Overall Study||0
3317097|NCT03123939|4050620|FG000|STARTED|Overall Study||74
3317098|NCT03123939|4050620|FG000|CTL019 Infused|Overall Study||69
3317099|NCT03123939|4050620|FG000|Full Analysis Set (FAS)|Overall Study||69
3317100|NCT03123939|4050620|FG000|Cellular Kinetic Analysis Set (CKAS)|Overall Study||69
3317101|NCT03123939|4050620|FG000|Safety Set (SAF)|Overall Study||69
3317102|NCT03123939|4050620|FG000|COMPLETED|Overall Study||33
3317103|NCT03123939|4050620|FG000|NOT COMPLETED|Overall Study||41
3317104|NCT03124069|4050624|FG000|STARTED|Overall Study||37
3317105|NCT03124069|4050624|FG000|COMPLETED|Overall Study||37
3317106|NCT03124069|4050624|FG000|NOT COMPLETED|Overall Study||0
3317107|NCT03124108|4050633|FG000|STARTED|Overall Study||15
3317108|NCT03124108|4050634|FG001|STARTED|Overall Study||15
3317109|NCT03124108|4050635|FG002|STARTED|Overall Study||15
3317110|NCT03124108|4050633|FG000|COMPLETED|Overall Study||15
3317111|NCT03124108|4050634|FG001|COMPLETED|Overall Study||14
3317112|NCT03124108|4050635|FG002|COMPLETED|Overall Study||15
3317113|NCT03124108|4050633|FG000|NOT COMPLETED|Overall Study||0
3317114|NCT03124108|4050634|FG001|NOT COMPLETED|Overall Study||1
3317115|NCT03124108|4050635|FG002|NOT COMPLETED|Overall Study||0
3011711|NCT01012739|3729762|FG000|STARTED|Treatment Period 1||9
3011712|NCT01012739|3729763|FG001|STARTED|Treatment Period 1||8
3011713|NCT01012739|3729764|FG002|STARTED|Treatment Period 1||9
3011714|NCT01012739|3729765|FG003|STARTED|Treatment Period 1||9
3011715|NCT01012739|3729762|FG000|COMPLETED|Treatment Period 1||9
3011716|NCT01012739|3729763|FG001|COMPLETED|Treatment Period 1||8
3011717|NCT01012739|3729764|FG002|COMPLETED|Treatment Period 1||9
3011718|NCT01012739|3729765|FG003|COMPLETED|Treatment Period 1||8
3011719|NCT01012739|3729762|FG000|NOT COMPLETED|Treatment Period 1||0
3011720|NCT01012739|3729763|FG001|NOT COMPLETED|Treatment Period 1||0
3011721|NCT01012739|3729764|FG002|NOT COMPLETED|Treatment Period 1||0
3011722|NCT01012739|3729765|FG003|NOT COMPLETED|Treatment Period 1||1
3011723|NCT01012739|3729762|FG000|STARTED|Treatment Period 2||9
3011724|NCT01012739|3729763|FG001|STARTED|Treatment Period 2||8
3011725|NCT01012739|3729764|FG002|STARTED|Treatment Period 2||9
3011726|NCT01012739|3729765|FG003|STARTED|Treatment Period 2||8
3011727|NCT01012739|3729762|FG000|COMPLETED|Treatment Period 2||9
3011728|NCT01012739|3729763|FG001|COMPLETED|Treatment Period 2||8
3011729|NCT01012739|3729764|FG002|COMPLETED|Treatment Period 2||9
3011730|NCT01012739|3729765|FG003|COMPLETED|Treatment Period 2||7
3011731|NCT01012739|3729762|FG000|NOT COMPLETED|Treatment Period 2||0
3011732|NCT01012739|3729763|FG001|NOT COMPLETED|Treatment Period 2||0
3011733|NCT01012739|3729764|FG002|NOT COMPLETED|Treatment Period 2||0
3011734|NCT01012739|3729765|FG003|NOT COMPLETED|Treatment Period 2||1
3011735|NCT01012739|3729762|FG000|STARTED|Treatment Period 3||9
3011736|NCT01012739|3729763|FG001|STARTED|Treatment Period 3||8
3011737|NCT01012739|3729764|FG002|STARTED|Treatment Period 3||9
3011738|NCT01012739|3729765|FG003|STARTED|Treatment Period 3||7
3011739|NCT01012739|3729762|FG000|COMPLETED|Treatment Period 3||9
3011740|NCT01012739|3729763|FG001|COMPLETED|Treatment Period 3||8
3011741|NCT01012739|3729764|FG002|COMPLETED|Treatment Period 3||9
3011742|NCT01012739|3729765|FG003|COMPLETED|Treatment Period 3||7
3011743|NCT01012739|3729762|FG000|NOT COMPLETED|Treatment Period 3||0
3011744|NCT01012739|3729763|FG001|NOT COMPLETED|Treatment Period 3||0
3011745|NCT01012739|3729764|FG002|NOT COMPLETED|Treatment Period 3||0
3011746|NCT01012739|3729765|FG003|NOT COMPLETED|Treatment Period 3||0
3011747|NCT01012739|3729762|FG000|STARTED|Treatment Period 4||9
3011748|NCT01012739|3729763|FG001|STARTED|Treatment Period 4||8
3011749|NCT01012739|3729764|FG002|STARTED|Treatment Period 4||9
3011750|NCT01012739|3729765|FG003|STARTED|Treatment Period 4||7
3011751|NCT01012739|3729762|FG000|COMPLETED|Treatment Period 4||9
3011752|NCT01012739|3729763|FG001|COMPLETED|Treatment Period 4||8
3011753|NCT01012739|3729764|FG002|COMPLETED|Treatment Period 4||9
3011754|NCT01012739|3729765|FG003|COMPLETED|Treatment Period 4||7
3011755|NCT01012739|3729762|FG000|NOT COMPLETED|Treatment Period 4||0
3011756|NCT01012739|3729763|FG001|NOT COMPLETED|Treatment Period 4||0
3011757|NCT01012739|3729764|FG002|NOT COMPLETED|Treatment Period 4||0
3011758|NCT01012739|3729765|FG003|NOT COMPLETED|Treatment Period 4||0
3011759|NCT01012765|3729776|FG000|STARTED|Treatment Period 1||20
3011760|NCT01012765|3729777|FG001|STARTED|Treatment Period 1||21
3011761|NCT01012765|3729778|FG002|STARTED|Treatment Period 1||23
3011762|NCT01012765|3729779|FG003|STARTED|Treatment Period 1||18
3011763|NCT01012765|3729780|FG004|STARTED|Treatment Period 1||22
3011764|NCT01012765|3729781|FG005|STARTED|Treatment Period 1||25
3307033|NCT03003000|4040331|FG000|STARTED|Overall Study||126
3307034|NCT03003000|4040332|FG001|STARTED|Overall Study||253
3307035|NCT03003000|4040333|FG002|STARTED|Overall Study||256
3307036|NCT03003000|4040331|FG000|COMPLETED|Overall Study||121
3307037|NCT03003000|4040332|FG001|COMPLETED|Overall Study||249
3307038|NCT03003000|4040333|FG002|COMPLETED|Overall Study||251
3307039|NCT03003000|4040331|FG000|NOT COMPLETED|Overall Study||5
3307040|NCT03003000|4040332|FG001|NOT COMPLETED|Overall Study||4
3307041|NCT03003000|4040333|FG002|NOT COMPLETED|Overall Study||5
3307042|NCT03003130|4040343|FG000|STARTED|Overall Study||88
3307043|NCT03003130|4040344|FG001|STARTED|Overall Study||87
3307044|NCT03003130|4040343|FG000|COMPLETED|Overall Study||80
3307045|NCT03003130|4040344|FG001|COMPLETED|Overall Study||80
3307046|NCT03003130|4040343|FG000|NOT COMPLETED|Overall Study||8
3307047|NCT03003130|4040344|FG001|NOT COMPLETED|Overall Study||7
3307048|NCT03003390|4040352|FG000|STARTED|Overall Study||27
3307049|NCT03003390|4040353|FG001|STARTED|Overall Study||24
3307050|NCT03003390|4040352|FG000|COMPLETED|Overall Study||23
3307051|NCT03003390|4040353|FG001|COMPLETED|Overall Study||24
3307052|NCT03003390|4040352|FG000|NOT COMPLETED|Overall Study||4
3307053|NCT03003390|4040353|FG001|NOT COMPLETED|Overall Study||0
3307054|NCT03003494|4040364|FG000|STARTED|Overall Study||306
3307055|NCT03003494|4040364|FG000|COMPLETED|Overall Study||278
3307056|NCT03003494|4040364|FG000|NOT COMPLETED|Overall Study||28
3307057|NCT03003676|4040370|FG000|STARTED|Overall Study||9
3307058|NCT03003676|4040371|FG001|STARTED|Overall Study||12
3307059|NCT03003676|4040370|FG000|COMPLETED|Overall Study||3
3307060|NCT03003676|4040371|FG001|COMPLETED|Overall Study||4
3307061|NCT03003676|4040370|FG000|NOT COMPLETED|Overall Study||6
3307062|NCT03003676|4040371|FG001|NOT COMPLETED|Overall Study||8
3307063|NCT03003793|4040381|FG000|STARTED|Overall Study||16
3307064|NCT03003793|4040382|FG001|STARTED|Overall Study||16
3307065|NCT03003793|4040381|FG000|COMPLETED|Overall Study||16
3307066|NCT03003793|4040382|FG001|COMPLETED|Overall Study||16
3307067|NCT03003793|4040381|FG000|NOT COMPLETED|Overall Study||0
3307068|NCT03003793|4040382|FG001|NOT COMPLETED|Overall Study||0
3307069|NCT03003949|4040390|FG000|STARTED|Overall Study||40
3307070|NCT03003949|4040391|FG001|STARTED|Overall Study||42
3307071|NCT03003949|4040390|FG000|Week 8|Overall Study||40
3307072|NCT03003949|4040391|FG001|Week 8|Overall Study||42
3307073|NCT03003949|4040390|FG000|Week 16|Overall Study||38
3307074|NCT03003949|4040391|FG001|Week 16|Overall Study||35
3307075|NCT03003949|4040390|FG000|Week 20|Overall Study||35
3011765|NCT01012765|3729776|FG000|COMPLETED|Treatment Period 1||17
3011766|NCT01012765|3729777|FG001|COMPLETED|Treatment Period 1||21
3011767|NCT01012765|3729778|FG002|COMPLETED|Treatment Period 1||21
3011768|NCT01012765|3729779|FG003|COMPLETED|Treatment Period 1||15
3011769|NCT01012765|3729780|FG004|COMPLETED|Treatment Period 1||19
3011770|NCT01012765|3729781|FG005|COMPLETED|Treatment Period 1||25
3011771|NCT01012765|3729776|FG000|NOT COMPLETED|Treatment Period 1||3
3011772|NCT01012765|3729777|FG001|NOT COMPLETED|Treatment Period 1||0
3011773|NCT01012765|3729778|FG002|NOT COMPLETED|Treatment Period 1||2
3011774|NCT01012765|3729779|FG003|NOT COMPLETED|Treatment Period 1||3
3011775|NCT01012765|3729780|FG004|NOT COMPLETED|Treatment Period 1||3
3011776|NCT01012765|3729781|FG005|NOT COMPLETED|Treatment Period 1||0
3011777|NCT01012765|3729776|FG000|STARTED|Treatment Period 2||17
3011778|NCT01012765|3729777|FG001|STARTED|Treatment Period 2||21
3011779|NCT01012765|3729778|FG002|STARTED|Treatment Period 2||21
3011780|NCT01012765|3729779|FG003|STARTED|Treatment Period 2||15
3011781|NCT01012765|3729780|FG004|STARTED|Treatment Period 2||19
3011782|NCT01012765|3729781|FG005|STARTED|Treatment Period 2||25
3011783|NCT01012765|3729776|FG000|COMPLETED|Treatment Period 2||16
3011784|NCT01012765|3729777|FG001|COMPLETED|Treatment Period 2||19
3011785|NCT01012765|3729778|FG002|COMPLETED|Treatment Period 2||18
3011786|NCT01012765|3729779|FG003|COMPLETED|Treatment Period 2||15
3011787|NCT01012765|3729780|FG004|COMPLETED|Treatment Period 2||18
3011788|NCT01012765|3729781|FG005|COMPLETED|Treatment Period 2||24
3011789|NCT01012765|3729776|FG000|NOT COMPLETED|Treatment Period 2||1
3011790|NCT01012765|3729777|FG001|NOT COMPLETED|Treatment Period 2||2
3011791|NCT01012765|3729778|FG002|NOT COMPLETED|Treatment Period 2||3
3011792|NCT01012765|3729779|FG003|NOT COMPLETED|Treatment Period 2||0
3011793|NCT01012765|3729780|FG004|NOT COMPLETED|Treatment Period 2||1
3011794|NCT01012765|3729781|FG005|NOT COMPLETED|Treatment Period 2||1
3011795|NCT01012765|3729776|FG000|STARTED|Treatment Period 3||16
3011796|NCT01012765|3729777|FG001|STARTED|Treatment Period 3||19
3011797|NCT01012765|3729778|FG002|STARTED|Treatment Period 3||18
3011798|NCT01012765|3729779|FG003|STARTED|Treatment Period 3||15
3011799|NCT01012765|3729780|FG004|STARTED|Treatment Period 3||18
3011800|NCT01012765|3729781|FG005|STARTED|Treatment Period 3||24
3011801|NCT01012765|3729776|FG000|COMPLETED|Treatment Period 3||16
3011802|NCT01012765|3729777|FG001|COMPLETED|Treatment Period 3||19
3011803|NCT01012765|3729778|FG002|COMPLETED|Treatment Period 3||18
3011804|NCT01012765|3729779|FG003|COMPLETED|Treatment Period 3||15
3011805|NCT01012765|3729780|FG004|COMPLETED|Treatment Period 3||18
3011806|NCT01012765|3729781|FG005|COMPLETED|Treatment Period 3||24
3011807|NCT01012765|3729776|FG000|NOT COMPLETED|Treatment Period 3||0
3011808|NCT01012765|3729777|FG001|NOT COMPLETED|Treatment Period 3||0
3011809|NCT01012765|3729778|FG002|NOT COMPLETED|Treatment Period 3||0
3011810|NCT01012765|3729779|FG003|NOT COMPLETED|Treatment Period 3||0
3011811|NCT01012765|3729780|FG004|NOT COMPLETED|Treatment Period 3||0
3011812|NCT01012765|3729781|FG005|NOT COMPLETED|Treatment Period 3||0
3011813|NCT01012921|3729791|FG000|STARTED|Overall Study||57
3011814|NCT01012921|3729792|FG001|STARTED|Overall Study||60
3011815|NCT01012921|3729791|FG000|COMPLETED|Overall Study||47
3011816|NCT01012921|3729792|FG001|COMPLETED|Overall Study||47
3011817|NCT01012921|3729791|FG000|NOT COMPLETED|Overall Study||10
3011818|NCT01012921|3729792|FG001|NOT COMPLETED|Overall Study||13
3011819|NCT01012947|3729803|FG000|STARTED|Overall Study||212
3011820|NCT01012947|3729804|FG001|STARTED|Overall Study||215
3011821|NCT01012947|3729805|FG002|STARTED|Overall Study||241
3011822|NCT01012947|3729806|FG003|STARTED|Overall Study||211
3011823|NCT01012947|3729807|FG004|STARTED|Overall Study||236
3011824|NCT01012947|3729803|FG000|COMPLETED|Overall Study||81
3011825|NCT01012947|3729804|FG001|COMPLETED|Overall Study||80
3011826|NCT01012947|3729805|FG002|COMPLETED|Overall Study||111
3011827|NCT01012947|3729806|FG003|COMPLETED|Overall Study||93
3011828|NCT01012947|3729807|FG004|COMPLETED|Overall Study||94
3011829|NCT01012947|3729803|FG000|NOT COMPLETED|Overall Study||131
3011830|NCT01012947|3729804|FG001|NOT COMPLETED|Overall Study||135
3011831|NCT01012947|3729805|FG002|NOT COMPLETED|Overall Study||130
3011832|NCT01012947|3729806|FG003|NOT COMPLETED|Overall Study||118
3011833|NCT01012947|3729807|FG004|NOT COMPLETED|Overall Study||142
3011834|NCT01012973|3729821|FG000|STARTED|Overall Study||106
3011835|NCT01012973|3729822|FG001|STARTED|Overall Study||71
3011836|NCT01012973|3729821|FG000|Participants Received Treatment|Overall Study|Safety Population: Participants received treatment|104
3011837|NCT01012973|3729822|FG001|Participants Received Treatment|Overall Study|Safety Population: Participants received treatment|68
3011838|NCT01012973|3729821|FG000|Fulfilled Requirements of FAS Population|Overall Study|Full Analysis Set (FAS) Population: Participants received treatment with post baseline measurements|103
3011839|NCT01012973|3729822|FG001|Fulfilled Requirements of FAS Population|Overall Study|Full Analysis Set (FAS) Population: Participants received treatment with post baseline measurements|68
3011840|NCT01012973|3729821|FG000|Completed Week 24, From FAS|Overall Study||97
3011841|NCT01012973|3729822|FG001|Completed Week 24, From FAS|Overall Study||57
3011842|NCT01012973|3729821|FG000|Completed Week 52, From FAS|Overall Study||91
3011843|NCT01012973|3729822|FG001|Completed Week 52, From FAS|Overall Study||52
3011844|NCT01012973|3729821|FG000|COMPLETED|Overall Study||90
3011845|NCT01012973|3729822|FG001|COMPLETED|Overall Study||52
3011846|NCT01012973|3729821|FG000|NOT COMPLETED|Overall Study||16
3011847|NCT01012973|3729822|FG001|NOT COMPLETED|Overall Study||19
3011848|NCT01012999|3729832|FG000|STARTED|Overall Study||16
3011849|NCT01012999|3729832|FG000|COMPLETED|Overall Study||15
3011850|NCT01012999|3729832|FG000|NOT COMPLETED|Overall Study||1
3011851|NCT01013194|3729838|FG000|STARTED|Overall Study||9
3011852|NCT01013194|3729839|FG001|STARTED|Overall Study||16
3011853|NCT01013194|3729838|FG000|COMPLETED|Overall Study|Consecutive patients|9
3011854|NCT01013194|3729839|FG001|COMPLETED|Overall Study|Retrospectively contemporary matched-pair group|16
3011855|NCT01013194|3729838|FG000|NOT COMPLETED|Overall Study||0
3011856|NCT01013194|3729839|FG001|NOT COMPLETED|Overall Study||0
3011857|NCT01013207|3729849|FG000|STARTED|CPAP Pre Nexus (S9)||50
3011858|NCT01013207|3729849|FG000|COMPLETED|CPAP Pre Nexus (S9)||50
3011859|NCT01013207|3729849|FG000|NOT COMPLETED|CPAP Pre Nexus (S9)||0
3011860|NCT01013207|3729849|FG000|STARTED|Nexus (S9)||50
3011861|NCT01013207|3729849|FG000|COMPLETED|Nexus (S9)||50
3011862|NCT01013207|3729849|FG000|NOT COMPLETED|Nexus (S9)||0
3011863|NCT01013207|3729849|FG000|STARTED|CPAP Post Nexus (S9)||50
3011864|NCT01013207|3729849|FG000|COMPLETED|CPAP Post Nexus (S9)||44
3011865|NCT01013207|3729849|FG000|NOT COMPLETED|CPAP Post Nexus (S9)||6
3011866|NCT01013285|3729855|FG000|STARTED|Overall Study||70
3011867|NCT01013285|3729856|FG001|STARTED|Overall Study||110
3011868|NCT01013285|3729855|FG000|COMPLETED|Overall Study||22
3011869|NCT01013285|3729856|FG001|COMPLETED|Overall Study||21
3011870|NCT01013285|3729855|FG000|NOT COMPLETED|Overall Study||48
3011871|NCT01013285|3729856|FG001|NOT COMPLETED|Overall Study||89
3011872|NCT01013350|3729863|FG000|STARTED|Overall Study||198
3011873|NCT01013350|3729864|FG001|STARTED|Overall Study||963
3011874|NCT01013350|3729863|FG000|Safety Analysis Set|Overall Study||198
3011875|NCT01013350|3729864|FG001|Safety Analysis Set|Overall Study||950
3011876|NCT01013350|3729863|FG000|COMPLETED|Overall Study||160
3011877|NCT01013350|3729864|FG001|COMPLETED|Overall Study||771
3011878|NCT01013350|3729863|FG000|NOT COMPLETED|Overall Study||38
3011879|NCT01013350|3729864|FG001|NOT COMPLETED|Overall Study||192
3011880|NCT01013597|3729871|FG000|STARTED|Overall Study||13
3011881|NCT01013597|3729871|FG000|COMPLETED|Overall Study||12
3011882|NCT01013597|3729871|FG000|NOT COMPLETED|Overall Study||1
3011883|NCT01013740|3729877|FG000|STARTED|Overall Study|13 participants (par.) experiencing PD in the RP elected to enroll in the optional CP.|37
3011884|NCT01013740|3729878|FG001|STARTED|Overall Study|29 participants experiencing PD in the RP elected to enroll in the optional CP.|75
3011885|NCT01013740|3729877|FG000|Ongoing|Overall Study||0
3011886|NCT01013740|3729878|FG001|Ongoing|Overall Study||0
3011887|NCT01013740|3729877|FG000|COMPLETED|Overall Study|Completion also = 18 mos.of a new anti-cancer therapy initiation +/or progression of disease|26
3011888|NCT01013740|3729878|FG001|COMPLETED|Overall Study|Completion also = 18 mos.of a new anti-cancer therapy initiation +/or progression of disease|56
3011889|NCT01013740|3729877|FG000|NOT COMPLETED|Overall Study||11
3011890|NCT01013740|3729878|FG001|NOT COMPLETED|Overall Study||19
3011891|NCT01013753|3729886|FG000|STARTED|Overall Study|Entered and treated|198
3011892|NCT01013753|3729886|FG000|Received Placebo|Overall Study||125
3011893|NCT01013753|3729886|FG000|Received Olo 2 mcg qd|Overall Study||121
3011894|NCT01013753|3729886|FG000|Received Olo 5 mcg qd|Overall Study||130
3011895|NCT01013753|3729886|FG000|Received Olo 10 mcg qd|Overall Study||127
3011896|NCT01013753|3729886|FG000|Received Olo 20 mcg qd|Overall Study||124
3011897|NCT01013753|3729886|FG000|Received Form 12 mcg Bid|Overall Study||125
3011898|NCT01013753|3729886|FG000|COMPLETED|Overall Study||182
3011899|NCT01013753|3729886|FG000|NOT COMPLETED|Overall Study||16
3011900|NCT01013792|3729902|FG000|STARTED|Overall Study||14
3011901|NCT01013792|3729903|FG001|STARTED|Overall Study||16
3011902|NCT01013792|3729902|FG000|COMPLETED|Overall Study||12
3011903|NCT01013792|3729903|FG001|COMPLETED|Overall Study||11
3011904|NCT01013792|3729902|FG000|NOT COMPLETED|Overall Study||2
3011905|NCT01013792|3729903|FG001|NOT COMPLETED|Overall Study||5
3011906|NCT01013844|3729911|FG000|STARTED|Overall Study||65
3011907|NCT01013844|3729912|FG001|STARTED|Overall Study||65
3011908|NCT01013844|3729911|FG000|COMPLETED|Overall Study||65
3011909|NCT01013844|3729912|FG001|COMPLETED|Overall Study||65
3011910|NCT01013844|3729911|FG000|NOT COMPLETED|Overall Study||0
3011911|NCT01013844|3729912|FG001|NOT COMPLETED|Overall Study||0
3011912|NCT01013870|3729924|FG000|STARTED|Overall Study||28
3011913|NCT01013870|3729925|FG001|STARTED|Overall Study||24
3011914|NCT01013870|3729924|FG000|COMPLETED|Overall Study||27
3011915|NCT01013870|3729925|FG001|COMPLETED|Overall Study||21
3011916|NCT01013870|3729924|FG000|NOT COMPLETED|Overall Study||1
3011917|NCT01013870|3729925|FG001|NOT COMPLETED|Overall Study||3
3011918|NCT01013883|3729933|FG000|STARTED|Overall Study||270
3011919|NCT01013883|3729934|FG001|STARTED|Overall Study||243
3011920|NCT01013883|3729933|FG000|COMPLETED|Overall Study||268
3011921|NCT01013883|3729934|FG001|COMPLETED|Overall Study||241
3011922|NCT01013883|3729933|FG000|NOT COMPLETED|Overall Study||2
3011923|NCT01013883|3729934|FG001|NOT COMPLETED|Overall Study||2
3011924|NCT01013961|3729942|FG000|STARTED|Overall Study||16
3011925|NCT01013961|3729943|FG001|STARTED|Overall Study||15
3011926|NCT01013961|3729942|FG000|COMPLETED|Overall Study||13
3011927|NCT01013961|3729943|FG001|COMPLETED|Overall Study||12
3011928|NCT01013961|3729942|FG000|NOT COMPLETED|Overall Study||3
3011929|NCT01013961|3729943|FG001|NOT COMPLETED|Overall Study||3
3037430|NCT01147900|3756702|FG001|NOT COMPLETED|At Year 8.5||0
3037431|NCT01147900|3756703|FG002|NOT COMPLETED|At Year 8.5||0
3037432|NCT01147900|3756701|FG000|STARTED|At Year 10|At Year 10, a total of 177 subjects (out of the 180 planned) were enrolled|55
3037433|NCT01147900|3756702|FG001|STARTED|At Year 10||60
3037434|NCT01147900|3756703|FG002|STARTED|At Year 10|At Year 10, a total of 177 subjects (out of the 180 planned) were enrolled.|62
3037435|NCT01147900|3756701|FG000|COMPLETED|At Year 10||55
3011930|NCT01014013|3729951|FG000|STARTED|Overall Study||135
3011931|NCT01014013|3729952|FG001|STARTED|Overall Study||136
3011932|NCT01014013|3729951|FG000|Adverse Event Reporting|Overall Study|Patients who received at least 1 dose of MK0826 parenteral therapy|132
3011933|NCT01014013|3729952|FG001|Adverse Event Reporting|Overall Study|Patients who received at least 1 dose of Ceftriaxone parenteral therapy|135
3011934|NCT01014013|3729951|FG000|Completed Parenteral Therapy|Overall Study|"Patients completing MK0826 as a single daily dose of 1.0g intravenous~infusion at least 3 days"|87
3011935|NCT01014013|3729952|FG001|Completed Parenteral Therapy|Overall Study|Patients completing Ceftriaxone as a single daily dose of 2.0g intravenous infusion at least 3 days|88
3011936|NCT01014013|3729951|FG000|COMPLETED|Overall Study|Patients who completed 7 days therapy including minimum 3 days of MK0826 parentheral therapy|84
3011937|NCT01014013|3729952|FG001|COMPLETED|Overall Study|Patients who completed 7 days therapy including minimum 3 days of Ceftriaxone parentheral therapy|80
3011938|NCT01014013|3729951|FG000|NOT COMPLETED|Overall Study||51
3011939|NCT01014013|3729952|FG001|NOT COMPLETED|Overall Study||56
3011940|NCT01014091|3729966|FG000|STARTED|Overall Study||7
3011941|NCT01014091|3729967|FG001|STARTED|Overall Study||13
3011942|NCT01014091|3729968|FG002|STARTED|Overall Study||5
3011943|NCT01014091|3729969|FG003|STARTED|Overall Study||15
3011944|NCT01014091|3729970|FG004|STARTED|Overall Study||6
3011945|NCT01014091|3729971|FG005|STARTED|Overall Study||12
3011946|NCT01014091|3729966|FG000|COMPLETED|Overall Study||7
3011947|NCT01014091|3729967|FG001|COMPLETED|Overall Study||13
3011948|NCT01014091|3729968|FG002|COMPLETED|Overall Study||5
3011949|NCT01014091|3729969|FG003|COMPLETED|Overall Study||15
3011950|NCT01014091|3729970|FG004|COMPLETED|Overall Study||6
3011951|NCT01014091|3729971|FG005|COMPLETED|Overall Study||12
3011952|NCT01014091|3729966|FG000|NOT COMPLETED|Overall Study||0
3011953|NCT01014091|3729967|FG001|NOT COMPLETED|Overall Study||0
3011954|NCT01014091|3729968|FG002|NOT COMPLETED|Overall Study||0
3011955|NCT01014091|3729969|FG003|NOT COMPLETED|Overall Study||0
3011956|NCT01014091|3729970|FG004|NOT COMPLETED|Overall Study||0
3011957|NCT01014091|3729971|FG005|NOT COMPLETED|Overall Study||0
3011958|NCT01014143|3729997|FG000|STARTED|First Intervention||10
3011959|NCT01014143|3729998|FG001|STARTED|First Intervention||9
3011960|NCT01014143|3729999|FG002|STARTED|First Intervention||9
3011961|NCT01014143|3729997|FG000|COMPLETED|First Intervention||10
3011962|NCT01014143|3729998|FG001|COMPLETED|First Intervention||9
3011963|NCT01014143|3729999|FG002|COMPLETED|First Intervention||9
3011964|NCT01014143|3729997|FG000|NOT COMPLETED|First Intervention||0
3011965|NCT01014143|3729998|FG001|NOT COMPLETED|First Intervention||0
3011966|NCT01014143|3729999|FG002|NOT COMPLETED|First Intervention||0
3011967|NCT01014143|3729997|FG000|STARTED|Washout Period After 1st Intervention||10
3011968|NCT01014143|3729998|FG001|STARTED|Washout Period After 1st Intervention||9
3011969|NCT01014143|3729999|FG002|STARTED|Washout Period After 1st Intervention||9
3011970|NCT01014143|3729997|FG000|COMPLETED|Washout Period After 1st Intervention||10
3011971|NCT01014143|3729998|FG001|COMPLETED|Washout Period After 1st Intervention||9
3011972|NCT01014143|3729999|FG002|COMPLETED|Washout Period After 1st Intervention||9
3011973|NCT01014143|3729997|FG000|NOT COMPLETED|Washout Period After 1st Intervention||0
3011974|NCT01014143|3729998|FG001|NOT COMPLETED|Washout Period After 1st Intervention||0
3011975|NCT01014143|3729999|FG002|NOT COMPLETED|Washout Period After 1st Intervention||0
3011976|NCT01014143|3729997|FG000|STARTED|Second Intervention||10
3011977|NCT01014143|3729998|FG001|STARTED|Second Intervention||9
3011978|NCT01014143|3729999|FG002|STARTED|Second Intervention||9
3011979|NCT01014143|3729997|FG000|COMPLETED|Second Intervention||8
3011980|NCT01014143|3729998|FG001|COMPLETED|Second Intervention||9
3011981|NCT01014143|3729999|FG002|COMPLETED|Second Intervention||9
3011982|NCT01014143|3729997|FG000|NOT COMPLETED|Second Intervention||2
3011983|NCT01014143|3729998|FG001|NOT COMPLETED|Second Intervention||0
3011984|NCT01014143|3729999|FG002|NOT COMPLETED|Second Intervention||0
3011985|NCT01014143|3729997|FG000|STARTED|Washout After 2nd Intervention||8
3011986|NCT01014143|3729998|FG001|STARTED|Washout After 2nd Intervention||9
3011987|NCT01014143|3729999|FG002|STARTED|Washout After 2nd Intervention||9
3011988|NCT01014143|3729997|FG000|COMPLETED|Washout After 2nd Intervention||8
3011989|NCT01014143|3729998|FG001|COMPLETED|Washout After 2nd Intervention||9
3011990|NCT01014143|3729999|FG002|COMPLETED|Washout After 2nd Intervention||9
3011991|NCT01014143|3729997|FG000|NOT COMPLETED|Washout After 2nd Intervention||0
3011992|NCT01014143|3729998|FG001|NOT COMPLETED|Washout After 2nd Intervention||0
3011993|NCT01014143|3729999|FG002|NOT COMPLETED|Washout After 2nd Intervention||0
3011994|NCT01014143|3729997|FG000|STARTED|Third Intervention||8
3011995|NCT01014143|3729998|FG001|STARTED|Third Intervention||9
3011996|NCT01014143|3729999|FG002|STARTED|Third Intervention||9
3011997|NCT01014143|3729997|FG000|COMPLETED|Third Intervention||8
3011998|NCT01014143|3729998|FG001|COMPLETED|Third Intervention||9
3011999|NCT01014143|3729999|FG002|COMPLETED|Third Intervention||9
3012000|NCT01014143|3729997|FG000|NOT COMPLETED|Third Intervention||0
3012001|NCT01014143|3729998|FG001|NOT COMPLETED|Third Intervention||0
3012002|NCT01014143|3729999|FG002|NOT COMPLETED|Third Intervention||0
3012003|NCT01014169|3730009|FG000|STARTED|Overall Study||65
3012004|NCT01014169|3730010|FG001|STARTED|Overall Study||61
3012005|NCT01014169|3730009|FG000|COMPLETED|Overall Study||58
3012006|NCT01014169|3730010|FG001|COMPLETED|Overall Study||48
3012007|NCT01014169|3730009|FG000|NOT COMPLETED|Overall Study||7
3012008|NCT01014169|3730010|FG001|NOT COMPLETED|Overall Study||13
3012009|NCT01014208|3730018|FG000|STARTED|Overall Study||225
3012010|NCT01014208|3730019|FG001|STARTED|Overall Study||222
3012011|NCT01014208|3730018|FG000|Intent-to-Treat Population|Overall Study||223
3012012|NCT01014208|3730019|FG001|Intent-to-Treat Population|Overall Study||222
3012013|NCT01014208|3730018|FG000|COMPLETED|Overall Study||131
3012014|NCT01014208|3730019|FG001|COMPLETED|Overall Study||122
3012015|NCT01014208|3730018|FG000|NOT COMPLETED|Overall Study||94
3012016|NCT01014208|3730019|FG001|NOT COMPLETED|Overall Study||100
3012017|NCT01014351|3730025|FG000|STARTED|Overall Study||70
3012018|NCT01014351|3730025|FG000|COMPLETED|Overall Study||33
3012019|NCT01014351|3730025|FG000|NOT COMPLETED|Overall Study||37
3012020|NCT01014390|3730029|FG000|STARTED|Overall Study||187
3012021|NCT01014390|3730029|FG000|COMPLETED|Overall Study||177
3012022|NCT01014390|3730029|FG000|NOT COMPLETED|Overall Study||10
3012023|NCT01014403|3730035|FG000|STARTED|Overall Study||34
3012024|NCT01014403|3730036|FG001|STARTED|Overall Study||28
3012025|NCT01014403|3730035|FG000|COMPLETED|Overall Study||34
3012026|NCT01014403|3730036|FG001|COMPLETED|Overall Study||28
3012027|NCT01014403|3730035|FG000|NOT COMPLETED|Overall Study||0
3012028|NCT01014403|3730036|FG001|NOT COMPLETED|Overall Study||0
3012029|NCT01014442|3730044|FG000|STARTED|Overall Study||33
3012030|NCT01014442|3730045|FG001|STARTED|Overall Study||35
3012031|NCT01014442|3730044|FG000|COMPLETED|Overall Study||26
3012032|NCT01014442|3730045|FG001|COMPLETED|Overall Study||16
3012033|NCT01014442|3730044|FG000|NOT COMPLETED|Overall Study||7
3012034|NCT01014442|3730045|FG001|NOT COMPLETED|Overall Study||19
3012035|NCT01014455|3730057|FG000|STARTED|Overall Study||82
3012036|NCT01014455|3730058|FG001|STARTED|Overall Study||87
3012037|NCT01014455|3730057|FG000|COMPLETED|Overall Study||82
3012038|NCT01014455|3730058|FG001|COMPLETED|Overall Study||87
3012039|NCT01014455|3730057|FG000|NOT COMPLETED|Overall Study||0
3012040|NCT01014455|3730058|FG001|NOT COMPLETED|Overall Study||0
3012041|NCT01014533|3730066|FG000|STARTED|Overall Study||29
3012042|NCT01014533|3730067|FG001|STARTED|Overall Study||30
3012043|NCT01014533|3730066|FG000|COMPLETED|Overall Study||24
3012044|NCT01014533|3730067|FG001|COMPLETED|Overall Study||25
3012045|NCT01014533|3730066|FG000|NOT COMPLETED|Overall Study||5
3012046|NCT01014533|3730067|FG001|NOT COMPLETED|Overall Study||5
3012047|NCT01014585|3730078|FG000|STARTED|Overall Study||51
3012048|NCT01014585|3730079|FG001|STARTED|Overall Study||100
3012049|NCT01014585|3730080|FG002|STARTED|Overall Study||60
3012050|NCT01014585|3730081|FG003|STARTED|Overall Study||129
3012051|NCT01014585|3730078|FG000|COMPLETED|Overall Study||31
3012052|NCT01014585|3730079|FG001|COMPLETED|Overall Study||75
3012053|NCT01014585|3730080|FG002|COMPLETED|Overall Study||37
3012054|NCT01014585|3730081|FG003|COMPLETED|Overall Study||99
3012055|NCT01014585|3730078|FG000|NOT COMPLETED|Overall Study||20
3012056|NCT01014585|3730079|FG001|NOT COMPLETED|Overall Study||25
3012057|NCT01014585|3730080|FG002|NOT COMPLETED|Overall Study||23
3012058|NCT01014585|3730081|FG003|NOT COMPLETED|Overall Study||30
3012059|NCT01014624|3730093|FG000|STARTED|Overall Study||29
3012060|NCT01014624|3730094|FG001|STARTED|Overall Study||27
3012061|NCT01014624|3730093|FG000|COMPLETED|Overall Study||27
3012062|NCT01014624|3730094|FG001|COMPLETED|Overall Study||26
3012063|NCT01014624|3730093|FG000|NOT COMPLETED|Overall Study||2
3012064|NCT01014624|3730094|FG001|NOT COMPLETED|Overall Study||1
3012065|NCT01014689|3730104|FG000|STARTED|Overall Study||191
3012066|NCT01014689|3730105|FG001|STARTED|Overall Study||187
3012067|NCT01014689|3730104|FG000|COMPLETED|Overall Study||178
3012068|NCT01014689|3730105|FG001|COMPLETED|Overall Study||174
3012069|NCT01014689|3730104|FG000|NOT COMPLETED|Overall Study||13
3012070|NCT01014689|3730105|FG001|NOT COMPLETED|Overall Study||13
3012071|NCT01014728|3730113|FG000|STARTED|Overall Study||18
3012072|NCT01014728|3730114|FG001|STARTED|Overall Study||15
3012073|NCT01014728|3730113|FG000|COMPLETED|Overall Study||18
3012074|NCT01014728|3730114|FG001|COMPLETED|Overall Study||15
3012075|NCT01014728|3730113|FG000|NOT COMPLETED|Overall Study||0
3012076|NCT01014728|3730114|FG001|NOT COMPLETED|Overall Study||0
3012077|NCT01014741|3730122|FG000|STARTED|Overall Study||105
3012078|NCT01014741|3730123|FG001|STARTED|Overall Study||95
3012079|NCT01014741|3730122|FG000|COMPLETED|Overall Study||94
3012080|NCT01014741|3730123|FG001|COMPLETED|Overall Study||90
3012081|NCT01014741|3730122|FG000|NOT COMPLETED|Overall Study||11
3012082|NCT01014741|3730123|FG001|NOT COMPLETED|Overall Study||5
3012083|NCT01014871|3730129|FG000|STARTED|Overall Study||30
3012084|NCT01014871|3730129|FG000|COMPLETED|Overall Study||30
3012085|NCT01014871|3730129|FG000|NOT COMPLETED|Overall Study||0
3012086|NCT01014910|3730137|FG000|STARTED|Overall Study||80
3012087|NCT01014910|3730138|FG001|STARTED|Overall Study||81
3012088|NCT01014910|3730137|FG000|COMPLETED|Overall Study||80
3012089|NCT01014910|3730138|FG001|COMPLETED|Overall Study||79
3012090|NCT01014910|3730137|FG000|NOT COMPLETED|Overall Study||0
3012091|NCT01014910|3730138|FG001|NOT COMPLETED|Overall Study||2
3012092|NCT01014936|3730147|FG000|STARTED|Overall Study||42
3012093|NCT01014936|3730148|FG001|STARTED|Overall Study||45
3012094|NCT01014936|3730149|FG002|STARTED|Overall Study||62
3012095|NCT01014936|3730147|FG000|COMPLETED|Overall Study||42
3012096|NCT01014936|3730148|FG001|COMPLETED|Overall Study||45
3012097|NCT01014936|3730149|FG002|COMPLETED|Overall Study||62
3012098|NCT01014936|3730147|FG000|NOT COMPLETED|Overall Study||0
3012099|NCT01014936|3730148|FG001|NOT COMPLETED|Overall Study||0
3012100|NCT01014936|3730149|FG002|NOT COMPLETED|Overall Study||0
3012101|NCT01014975|3730215|FG000|STARTED|Overall Study||8
3012102|NCT01014975|3730216|FG001|STARTED|Overall Study||16
3012103|NCT01014975|3730217|FG002|STARTED|Overall Study||16
3012104|NCT01014975|3730215|FG000|COMPLETED|Overall Study||4
3012105|NCT01014975|3730216|FG001|COMPLETED|Overall Study||13
3012106|NCT01014975|3730217|FG002|COMPLETED|Overall Study||10
3012107|NCT01014975|3730215|FG000|NOT COMPLETED|Overall Study||4
3012108|NCT01014975|3730216|FG001|NOT COMPLETED|Overall Study||3
3012109|NCT01014975|3730217|FG002|NOT COMPLETED|Overall Study||6
3012110|NCT01014988|3730231|FG000|STARTED|Overall Study||130
3012111|NCT01014988|3730232|FG001|STARTED|Overall Study||7
3012112|NCT01014988|3730233|FG002|STARTED|Overall Study||11
3012113|NCT01014988|3730234|FG003|STARTED|Overall Study||12
3012114|NCT01014988|3730235|FG004|STARTED|Overall Study||27
3012115|NCT01014988|3730236|FG005|STARTED|Overall Study||14
3012116|NCT01014988|3730231|FG000|COMPLETED|Overall Study||107
3012117|NCT01014988|3730232|FG001|COMPLETED|Overall Study||7
3012118|NCT01014988|3730233|FG002|COMPLETED|Overall Study||9
3012119|NCT01014988|3730234|FG003|COMPLETED|Overall Study||12
3012120|NCT01014988|3730235|FG004|COMPLETED|Overall Study||26
3012121|NCT01014988|3730236|FG005|COMPLETED|Overall Study||11
3012122|NCT01014988|3730231|FG000|NOT COMPLETED|Overall Study||23
3012123|NCT01014988|3730232|FG001|NOT COMPLETED|Overall Study||0
3012124|NCT01014988|3730233|FG002|NOT COMPLETED|Overall Study||2
3012125|NCT01014988|3730234|FG003|NOT COMPLETED|Overall Study||0
3012126|NCT01014988|3730235|FG004|NOT COMPLETED|Overall Study||1
3012127|NCT01014988|3730236|FG005|NOT COMPLETED|Overall Study||3
3012128|NCT01015118|3730260|FG000|STARTED|Overall Study||911
3012129|NCT01015118|3730261|FG001|STARTED|Overall Study||455
3012130|NCT01015118|3730260|FG000|COMPLETED|Overall Study|Patients who completed max trial therapy duration.|242
3012131|NCT01015118|3730261|FG001|COMPLETED|Overall Study|Patients who completed max trial therapy duration.|128
3012132|NCT01015118|3730260|FG000|NOT COMPLETED|Overall Study||669
3012133|NCT01015118|3730261|FG001|NOT COMPLETED|Overall Study||327
3012134|NCT01015131|3730267|FG000|STARTED|Overall Study||44
3012135|NCT01015131|3730267|FG000|COMPLETED|Overall Study||36
3012136|NCT01015131|3730267|FG000|NOT COMPLETED|Overall Study||8
3012137|NCT01015170|3730271|FG000|STARTED|Overall Study||454
3012138|NCT01015170|3730271|FG000|COMPLETED|Overall Study||215
3012139|NCT01015170|3730271|FG000|NOT COMPLETED|Overall Study||239
3012140|NCT01015287|3730279|FG000|STARTED|Overall Study||1996
3012141|NCT01015287|3730280|FG001|STARTED|Overall Study||2037
3012142|NCT01015287|3730279|FG000|Received at Least 1 Dose of Study Drug|Overall Study||1996
3012143|NCT01015287|3730280|FG001|Received at Least 1 Dose of Study Drug|Overall Study||2037
3012144|NCT01015287|3730279|FG000|COMPLETED|Overall Study||1924
3012145|NCT01015287|3730280|FG001|COMPLETED|Overall Study||1958
3012146|NCT01015287|3730279|FG000|NOT COMPLETED|Overall Study||72
3012147|NCT01015287|3730280|FG001|NOT COMPLETED|Overall Study||79
3012148|NCT01015326|3730290|FG000|STARTED|Overall Study||12
3012149|NCT01015326|3730291|FG001|STARTED|Overall Study||20
3012150|NCT01015326|3730290|FG000|COMPLETED|Overall Study||11
3012151|NCT01015326|3730291|FG001|COMPLETED|Overall Study||18
3012152|NCT01015326|3730290|FG000|NOT COMPLETED|Overall Study||1
3012153|NCT01015326|3730291|FG001|NOT COMPLETED|Overall Study||2
3012154|NCT01015443|3730299|FG000|STARTED|Overall Study||191
3012155|NCT01015443|3730300|FG001|STARTED|Overall Study||94
3012156|NCT01015443|3730299|FG000|Treated|Overall Study||191
3012157|NCT01015443|3730300|FG001|Treated|Overall Study||93
3012158|NCT01015443|3730299|FG000|COMPLETED|Overall Study||191
3012159|NCT01015443|3730300|FG001|COMPLETED|Overall Study||94
3012160|NCT01015443|3730299|FG000|NOT COMPLETED|Overall Study||0
3012161|NCT01015443|3730300|FG001|NOT COMPLETED|Overall Study||0
3012162|NCT01015534|3730308|FG000|STARTED|Overall Study||28
3012163|NCT01015534|3730309|FG001|STARTED|Overall Study||27
3012164|NCT01015534|3730308|FG000|COMPLETED|Overall Study||27
3012165|NCT01015534|3730309|FG001|COMPLETED|Overall Study||27
3012166|NCT01015534|3730308|FG000|NOT COMPLETED|Overall Study||1
3012167|NCT01015534|3730309|FG001|NOT COMPLETED|Overall Study||0
3012168|NCT01015560|3730318|FG000|STARTED|Overall Study||44
3012169|NCT01015560|3730318|FG000|Eligible and Analyzable|Overall Study||43
3012170|NCT01015560|3730318|FG000|COMPLETED|Overall Study||41
3012171|NCT01015560|3730318|FG000|NOT COMPLETED|Overall Study||3
3012172|NCT01015586|3730324|FG000|STARTED|Overall Study||21
3012173|NCT01015586|3730325|FG001|STARTED|Overall Study||22
3012174|NCT01015586|3730324|FG000|COMPLETED|Overall Study||14
3012175|NCT01015586|3730325|FG001|COMPLETED|Overall Study||11
3012176|NCT01015586|3730324|FG000|NOT COMPLETED|Overall Study||7
3012177|NCT01015586|3730325|FG001|NOT COMPLETED|Overall Study||11
3012178|NCT01015612|3730331|FG000|STARTED|Overall Study||634
3012179|NCT01015612|3730331|FG000|COMPLETED|Overall Study||481
3012180|NCT01015612|3730331|FG000|NOT COMPLETED|Overall Study||153
3012181|NCT01015638|3730337|FG000|STARTED|Overall Study||17
3012182|NCT01015638|3730338|FG001|STARTED|Overall Study||19
3012183|NCT01015638|3730337|FG000|COMPLETED|Overall Study||16
3012184|NCT01015638|3730338|FG001|COMPLETED|Overall Study||19
3012185|NCT01015638|3730337|FG000|NOT COMPLETED|Overall Study||1
3012186|NCT01015638|3730338|FG001|NOT COMPLETED|Overall Study||0
3012187|NCT01015677|3730347|FG000|STARTED|Overall Study||34
3012188|NCT01015677|3730348|FG001|STARTED|Overall Study||32
3012189|NCT01015677|3730349|FG002|STARTED|Overall Study||33
3012190|NCT01015677|3730347|FG000|COMPLETED|Overall Study||33
3012191|NCT01015677|3730348|FG001|COMPLETED|Overall Study||28
3012192|NCT01015677|3730349|FG002|COMPLETED|Overall Study||33
3012193|NCT01015677|3730347|FG000|NOT COMPLETED|Overall Study||1
3012194|NCT01015677|3730348|FG001|NOT COMPLETED|Overall Study||4
3012195|NCT01015677|3730349|FG002|NOT COMPLETED|Overall Study||0
3012196|NCT01015703|3730362|FG000|STARTED|Overall Study||10
3012197|NCT01015703|3730363|FG001|STARTED|Overall Study||10
3012198|NCT01015703|3730364|FG002|STARTED|Overall Study||10
3012199|NCT01015703|3730365|FG003|STARTED|Overall Study||10
3012200|NCT01015703|3730366|FG004|STARTED|Overall Study||10
3012201|NCT01015703|3730362|FG000|COMPLETED|Overall Study||8
3012202|NCT01015703|3730363|FG001|COMPLETED|Overall Study||9
3012203|NCT01015703|3730364|FG002|COMPLETED|Overall Study||10
3012204|NCT01015703|3730365|FG003|COMPLETED|Overall Study||10
3012205|NCT01015703|3730366|FG004|COMPLETED|Overall Study||10
3012206|NCT01015703|3730362|FG000|NOT COMPLETED|Overall Study||2
3012207|NCT01015703|3730363|FG001|NOT COMPLETED|Overall Study||1
3012208|NCT01015703|3730364|FG002|NOT COMPLETED|Overall Study||0
3012209|NCT01015703|3730365|FG003|NOT COMPLETED|Overall Study||0
3012210|NCT01015703|3730366|FG004|NOT COMPLETED|Overall Study||0
3012211|NCT01015768|3730378|FG000|STARTED|Overall Study||30
3012212|NCT01015768|3730379|FG001|STARTED|Overall Study||30
3012213|NCT01015768|3730378|FG000|COMPLETED|Overall Study||26
3012214|NCT01015768|3730379|FG001|COMPLETED|Overall Study||26
3012215|NCT01015768|3730378|FG000|NOT COMPLETED|Overall Study||4
3012216|NCT01015768|3730379|FG001|NOT COMPLETED|Overall Study||4
3012217|NCT01015781|3730389|FG000|STARTED|Overall Study||150
3012218|NCT01015781|3730390|FG001|STARTED|Overall Study||150
3012219|NCT01015781|3730389|FG000|COMPLETED|Overall Study||113
3012220|NCT01015781|3730390|FG001|COMPLETED|Overall Study||121
3012221|NCT01015781|3730389|FG000|NOT COMPLETED|Overall Study||37
3012222|NCT01015781|3730390|FG001|NOT COMPLETED|Overall Study||29
3012223|NCT01015807|3730399|FG000|STARTED|Overall Study||30
3012224|NCT01015807|3730400|FG001|STARTED|Overall Study||30
3012225|NCT01015807|3730401|FG002|STARTED|Overall Study||30
3012226|NCT01015807|3730399|FG000|COMPLETED|Overall Study||30
3012227|NCT01015807|3730400|FG001|COMPLETED|Overall Study||30
3012228|NCT01015807|3730401|FG002|COMPLETED|Overall Study||30
3012229|NCT01015807|3730399|FG000|NOT COMPLETED|Overall Study||0
3012230|NCT01015807|3730400|FG001|NOT COMPLETED|Overall Study||0
3012231|NCT01015807|3730401|FG002|NOT COMPLETED|Overall Study||0
3012232|NCT01015820|3730411|FG000|STARTED|Overall Study||15
3012233|NCT01015820|3730412|FG001|STARTED|Overall Study||15
3012234|NCT01015820|3730411|FG000|COMPLETED|Overall Study||14
3012235|NCT01015820|3730412|FG001|COMPLETED|Overall Study||15
3012236|NCT01015820|3730411|FG000|NOT COMPLETED|Overall Study||1
3012237|NCT01015820|3730412|FG001|NOT COMPLETED|Overall Study||0
3012238|NCT01015976|3730418|FG000|STARTED|Overall Study||5
3012239|NCT01015976|3730419|FG001|STARTED|Overall Study||5
3012240|NCT01015976|3730418|FG000|COMPLETED|Overall Study||5
3012241|NCT01015976|3730419|FG001|COMPLETED|Overall Study||5
3012242|NCT01015976|3730418|FG000|NOT COMPLETED|Overall Study||0
3012243|NCT01015976|3730419|FG001|NOT COMPLETED|Overall Study||0
3012244|NCT01016015|3730423|FG000|STARTED|Overall Study||178
3012245|NCT01016015|3730423|FG000|COMPLETED|Overall Study||159
3012246|NCT01016015|3730423|FG000|NOT COMPLETED|Overall Study||19
3012247|NCT01016067|3730429|FG000|STARTED|Overall Study||11
3012248|NCT01016067|3730430|FG001|STARTED|Overall Study||12
3012249|NCT01016067|3730429|FG000|COMPLETED|Overall Study||9
3012250|NCT01016067|3730430|FG001|COMPLETED|Overall Study||8
3012251|NCT01016067|3730429|FG000|NOT COMPLETED|Overall Study||2
3012252|NCT01016067|3730430|FG001|NOT COMPLETED|Overall Study||4
3012253|NCT01016106|3730438|FG000|STARTED|Overall Study||17
3012254|NCT01016106|3730439|FG001|STARTED|Overall Study||18
3012255|NCT01016106|3730438|FG000|COMPLETED|Overall Study||17
3012256|NCT01016106|3730439|FG001|COMPLETED|Overall Study||18
3012257|NCT01016106|3730438|FG000|NOT COMPLETED|Overall Study||0
3012258|NCT01016106|3730439|FG001|NOT COMPLETED|Overall Study||0
3012259|NCT01016132|3730445|FG000|STARTED|Overall Study||152
3012260|NCT01016132|3730445|FG000|COMPLETED|Overall Study||151
3012261|NCT01016132|3730445|FG000|NOT COMPLETED|Overall Study||1
3012262|NCT01016262|3730452|FG000|STARTED|Double-blind Phase||41
3012263|NCT01016262|3730453|FG001|STARTED|Double-blind Phase||39
3012264|NCT01016262|3730454|FG002|STARTED|Double-blind Phase||39
3012265|NCT01016262|3730455|FG003|STARTED|Double-blind Phase||0
3012266|NCT01016262|3730456|FG004|STARTED|Double-blind Phase||0
3012267|NCT01016262|3730457|FG005|STARTED|Double-blind Phase||0
3012268|NCT01016262|3730452|FG000|COMPLETED|Double-blind Phase||40
3012269|NCT01016262|3730453|FG001|COMPLETED|Double-blind Phase||38
3012270|NCT01016262|3730454|FG002|COMPLETED|Double-blind Phase||30
3012271|NCT01016262|3730455|FG003|COMPLETED|Double-blind Phase||0
3012272|NCT01016262|3730456|FG004|COMPLETED|Double-blind Phase||0
3012273|NCT01016262|3730457|FG005|COMPLETED|Double-blind Phase||0
3012274|NCT01016262|3730452|FG000|NOT COMPLETED|Double-blind Phase||1
3012275|NCT01016262|3730453|FG001|NOT COMPLETED|Double-blind Phase||1
3012276|NCT01016262|3730454|FG002|NOT COMPLETED|Double-blind Phase||9
3012277|NCT01016262|3730455|FG003|NOT COMPLETED|Double-blind Phase||0
3012278|NCT01016262|3730456|FG004|NOT COMPLETED|Double-blind Phase||0
3012279|NCT01016262|3730457|FG005|NOT COMPLETED|Double-blind Phase||0
3012280|NCT01016262|3730452|FG000|STARTED|Open-Label Phase||0
3307076|NCT03003949|4040391|FG001|Week 20|Overall Study||33
3307077|NCT03003949|4040390|FG000|Week 24|Overall Study||35
3012281|NCT01016262|3730453|FG001|STARTED|Open-Label Phase||0
3012282|NCT01016262|3730454|FG002|STARTED|Open-Label Phase||0
3012283|NCT01016262|3730455|FG003|STARTED|Open-Label Phase||44
3012284|NCT01016262|3730456|FG004|STARTED|Open-Label Phase||52
3012285|NCT01016262|3730457|FG005|STARTED|Open-Label Phase||20
3012286|NCT01016262|3730452|FG000|COMPLETED|Open-Label Phase||0
3307078|NCT03003949|4040391|FG001|Week 24|Overall Study||32
3012287|NCT01016262|3730453|FG001|COMPLETED|Open-Label Phase||0
3012288|NCT01016262|3730454|FG002|COMPLETED|Open-Label Phase||0
3012289|NCT01016262|3730455|FG003|COMPLETED|Open-Label Phase||42
3012290|NCT01016262|3730456|FG004|COMPLETED|Open-Label Phase||50
3012291|NCT01016262|3730457|FG005|COMPLETED|Open-Label Phase||20
3012292|NCT01016262|3730452|FG000|NOT COMPLETED|Open-Label Phase||0
3012293|NCT01016262|3730453|FG001|NOT COMPLETED|Open-Label Phase||0
3012294|NCT01016262|3730454|FG002|NOT COMPLETED|Open-Label Phase||0
3012295|NCT01016262|3730455|FG003|NOT COMPLETED|Open-Label Phase||2
3012296|NCT01016262|3730456|FG004|NOT COMPLETED|Open-Label Phase||2
3012297|NCT01016262|3730457|FG005|NOT COMPLETED|Open-Label Phase||0
3012298|NCT01016353|3730470|FG000|STARTED|Overall Study||180
3012299|NCT01016353|3730471|FG001|STARTED|Overall Study||103
3012300|NCT01016353|3730470|FG000|COMPLETED|Overall Study||178
3012301|NCT01016353|3730471|FG001|COMPLETED|Overall Study||102
3012302|NCT01016353|3730470|FG000|NOT COMPLETED|Overall Study||2
3012303|NCT01016353|3730471|FG001|NOT COMPLETED|Overall Study||1
3307079|NCT03003949|4040390|FG000|COMPLETED|Overall Study||35
3307080|NCT03003949|4040391|FG001|COMPLETED|Overall Study||32
3307081|NCT03003949|4040390|FG000|NOT COMPLETED|Overall Study||5
3307082|NCT03003949|4040391|FG001|NOT COMPLETED|Overall Study||10
3307083|NCT03004469|4040400|FG000|STARTED|Overall Study||189
3307084|NCT03004469|4040401|FG001|STARTED|Overall Study||184
3307085|NCT03004469|4040402|FG002|STARTED|Overall Study||85
3307086|NCT03004469|4040400|FG000|COMPLETED|Overall Study||128
3307087|NCT03004469|4040401|FG001|COMPLETED|Overall Study||135
3307088|NCT03004469|4040402|FG002|COMPLETED|Overall Study||60
3307089|NCT03004469|4040400|FG000|NOT COMPLETED|Overall Study||61
3307090|NCT03004469|4040401|FG001|NOT COMPLETED|Overall Study||49
3307091|NCT03004469|4040402|FG002|NOT COMPLETED|Overall Study||25
3307092|NCT03004534|4040411|FG000|STARTED|Overall Study||36
3307093|NCT03004534|4040411|FG000|COMPLETED|Overall Study||36
3307094|NCT03004534|4040411|FG000|NOT COMPLETED|Overall Study||0
3307095|NCT03004638|4040421|FG000|STARTED|Overall Study||6
3307096|NCT03004638|4040422|FG001|STARTED|Overall Study||6
3307097|NCT03004638|4040423|FG002|STARTED|Overall Study||6
3307098|NCT03004638|4040424|FG003|STARTED|Overall Study||6
3307099|NCT03004638|4040425|FG004|STARTED|Overall Study||1
3307100|NCT03004638|4040426|FG005|STARTED|Overall Study||7
3307101|NCT03004638|4040421|FG000|COMPLETED|Overall Study||6
3307102|NCT03004638|4040422|FG001|COMPLETED|Overall Study||6
3307103|NCT03004638|4040423|FG002|COMPLETED|Overall Study||6
3307104|NCT03004638|4040424|FG003|COMPLETED|Overall Study||6
3307105|NCT03004638|4040425|FG004|COMPLETED|Overall Study||1
3307106|NCT03004638|4040426|FG005|COMPLETED|Overall Study||7
3307107|NCT03004638|4040421|FG000|NOT COMPLETED|Overall Study||0
3307108|NCT03004638|4040422|FG001|NOT COMPLETED|Overall Study||0
3307109|NCT03004638|4040423|FG002|NOT COMPLETED|Overall Study||0
3307110|NCT03004638|4040424|FG003|NOT COMPLETED|Overall Study||0
3307111|NCT03004638|4040425|FG004|NOT COMPLETED|Overall Study||0
3307112|NCT03004638|4040426|FG005|NOT COMPLETED|Overall Study||0
3307113|NCT03004846|4040447|FG000|STARTED|Part A (Up to 14 Weeks)||8
3307114|NCT03004846|4040448|FG001|STARTED|Part A (Up to 14 Weeks)||0
3307115|NCT03004846|4040449|FG002|STARTED|Part A (Up to 14 Weeks)||0
3307116|NCT03004846|4040447|FG000|COMPLETED|Part A (Up to 14 Weeks)||8
3307117|NCT03004846|4040448|FG001|COMPLETED|Part A (Up to 14 Weeks)||0
3307118|NCT03004846|4040449|FG002|COMPLETED|Part A (Up to 14 Weeks)||0
3307119|NCT03004846|4040447|FG000|NOT COMPLETED|Part A (Up to 14 Weeks)||0
3307120|NCT03004846|4040448|FG001|NOT COMPLETED|Part A (Up to 14 Weeks)||0
3307121|NCT03004846|4040449|FG002|NOT COMPLETED|Part A (Up to 14 Weeks)||0
3307122|NCT03004846|4040447|FG000|STARTED|Part B (Up to 14 Weeks)||0
3307123|NCT03004846|4040448|FG001|STARTED|Part B (Up to 14 Weeks)||0
3307124|NCT03004846|4040449|FG002|STARTED|Part B (Up to 14 Weeks)||0
3307125|NCT03004846|4040447|FG000|COMPLETED|Part B (Up to 14 Weeks)||0
3307126|NCT03004846|4040448|FG001|COMPLETED|Part B (Up to 14 Weeks)||0
3307127|NCT03004846|4040449|FG002|COMPLETED|Part B (Up to 14 Weeks)||0
3307128|NCT03004846|4040447|FG000|NOT COMPLETED|Part B (Up to 14 Weeks)||0
3307129|NCT03004846|4040448|FG001|NOT COMPLETED|Part B (Up to 14 Weeks)||0
3307130|NCT03004846|4040449|FG002|NOT COMPLETED|Part B (Up to 14 Weeks)||0
3307131|NCT03004911|4040460|FG000|STARTED|Overall Study||20
3307132|NCT03004911|4040461|FG001|STARTED|Overall Study||20
3307133|NCT03004911|4040460|FG000|COMPLETED|Overall Study||19
3307134|NCT03004911|4040461|FG001|COMPLETED|Overall Study||17
3307135|NCT03004911|4040460|FG000|NOT COMPLETED|Overall Study||1
3307136|NCT03004911|4040461|FG001|NOT COMPLETED|Overall Study||3
3307137|NCT03004924|4040470|FG000|STARTED|Overall Study||324
3307138|NCT03004924|4040471|FG001|STARTED|Overall Study||108
3307139|NCT03004924|4040472|FG002|STARTED|Overall Study||321
3307140|NCT03004924|4040470|FG000|COMPLETED|Overall Study||297
3307141|NCT03004924|4040471|FG001|COMPLETED|Overall Study||94
3307142|NCT03004924|4040472|FG002|COMPLETED|Overall Study||293
3307143|NCT03004924|4040470|FG000|NOT COMPLETED|Overall Study||27
3307144|NCT03004924|4040471|FG001|NOT COMPLETED|Overall Study||14
3307145|NCT03004924|4040472|FG002|NOT COMPLETED|Overall Study||28
3307146|NCT03005041|4040481|FG000|STARTED|Period 1||28
3307147|NCT03005041|4040482|FG001|STARTED|Period 1||27
3307148|NCT03005041|4040481|FG000|COMPLETED|Period 1||28
3307149|NCT03005041|4040482|FG001|COMPLETED|Period 1||27
3307150|NCT03005041|4040481|FG000|NOT COMPLETED|Period 1||0
3012304|NCT01016483|3730481|FG000|STARTED|Safety Run-in Part||27
3012305|NCT01016483|3730482|FG001|STARTED|Safety Run-in Part||26
3307151|NCT03005041|4040482|FG001|NOT COMPLETED|Period 1||0
3012306|NCT01016483|3730483|FG002|STARTED|Safety Run-in Part||0
3012307|NCT01016483|3730484|FG003|STARTED|Safety Run-in Part||0
3012308|NCT01016483|3730481|FG000|COMPLETED|Safety Run-in Part||27
3012309|NCT01016483|3730482|FG001|COMPLETED|Safety Run-in Part||26
3012310|NCT01016483|3730483|FG002|COMPLETED|Safety Run-in Part||0
3012311|NCT01016483|3730484|FG003|COMPLETED|Safety Run-in Part||0
3012312|NCT01016483|3730481|FG000|NOT COMPLETED|Safety Run-in Part||0
3012313|NCT01016483|3730482|FG001|NOT COMPLETED|Safety Run-in Part||0
3012314|NCT01016483|3730483|FG002|NOT COMPLETED|Safety Run-in Part||0
3012315|NCT01016483|3730484|FG003|NOT COMPLETED|Safety Run-in Part||0
3012316|NCT01016483|3730481|FG000|STARTED|Phase II||0
3012317|NCT01016483|3730482|FG001|STARTED|Phase II||0
3012318|NCT01016483|3730483|FG002|STARTED|Phase II|Subjects presented as randomized (Intention-to-Treat [ITT] Analysis Set).|44
3012319|NCT01016483|3730484|FG003|STARTED|Phase II|Subjects presented as randomized (ITT Analysis Set).|44
3307152|NCT03005041|4040481|FG000|STARTED|Washout Period 1||28
3307153|NCT03005041|4040482|FG001|STARTED|Washout Period 1||27
3307154|NCT03005041|4040481|FG000|COMPLETED|Washout Period 1||28
3307155|NCT03005041|4040482|FG001|COMPLETED|Washout Period 1||27
3307156|NCT03005041|4040481|FG000|NOT COMPLETED|Washout Period 1||0
3307157|NCT03005041|4040482|FG001|NOT COMPLETED|Washout Period 1||0
3307158|NCT03005041|4040481|FG000|STARTED|Period 2||28
3307159|NCT03005041|4040482|FG001|STARTED|Period 2||27
3307160|NCT03005041|4040481|FG000|COMPLETED|Period 2||28
3012320|NCT01016483|3730481|FG000|Treated (Safety Analysis Set [SAF])|Phase II||0
3012321|NCT01016483|3730482|FG001|Treated (Safety Analysis Set [SAF])|Phase II||0
3012322|NCT01016483|3730483|FG002|Treated (Safety Analysis Set [SAF])|Phase II|Subjects presented as treated (SAF).|42
3012323|NCT01016483|3730484|FG003|Treated (Safety Analysis Set [SAF])|Phase II|Subjects presented as treated (SAF).|45
3012324|NCT01016483|3730481|FG000|COMPLETED|Phase II||0
3012325|NCT01016483|3730482|FG001|COMPLETED|Phase II||0
3012326|NCT01016483|3730483|FG002|COMPLETED|Phase II||44
3012327|NCT01016483|3730484|FG003|COMPLETED|Phase II||44
3012328|NCT01016483|3730481|FG000|NOT COMPLETED|Phase II||0
3012329|NCT01016483|3730482|FG001|NOT COMPLETED|Phase II||0
3012330|NCT01016483|3730483|FG002|NOT COMPLETED|Phase II||0
3012331|NCT01016483|3730484|FG003|NOT COMPLETED|Phase II||0
3012332|NCT01016600|3730526|FG000|STARTED|Overall Study||9
3012333|NCT01016600|3730527|FG001|STARTED|Overall Study||4
3012334|NCT01016600|3730528|FG002|STARTED|Overall Study||6
3012335|NCT01016600|3730529|FG003|STARTED|Overall Study||12
3012336|NCT01016600|3730526|FG000|COMPLETED|Overall Study||8
3012337|NCT01016600|3730527|FG001|COMPLETED|Overall Study||4
3012338|NCT01016600|3730528|FG002|COMPLETED|Overall Study||6
3012339|NCT01016600|3730529|FG003|COMPLETED|Overall Study||12
3012340|NCT01016600|3730526|FG000|NOT COMPLETED|Overall Study||1
3012341|NCT01016600|3730527|FG001|NOT COMPLETED|Overall Study||0
3012342|NCT01016600|3730528|FG002|NOT COMPLETED|Overall Study||0
3012343|NCT01016600|3730529|FG003|NOT COMPLETED|Overall Study||0
3012344|NCT01016652|3730542|FG000|STARTED|Period 1||25
3012345|NCT01016652|3730543|FG001|STARTED|Period 1||24
3012346|NCT01016652|3730542|FG000|COMPLETED|Period 1||25
3012347|NCT01016652|3730543|FG001|COMPLETED|Period 1||24
3012348|NCT01016652|3730542|FG000|NOT COMPLETED|Period 1||0
3012349|NCT01016652|3730543|FG001|NOT COMPLETED|Period 1||0
3012350|NCT01016652|3730542|FG000|STARTED|Period 2|Crossover study: the completed from period 1 will crossover in period 2 to the opposite arm.|25
3012351|NCT01016652|3730543|FG001|STARTED|Period 2|Crossover study: the completed from period 1 will crossover in period 2 to the opposite arm.|24
3012352|NCT01016652|3730542|FG000|COMPLETED|Period 2||25
3012353|NCT01016652|3730543|FG001|COMPLETED|Period 2||24
3012354|NCT01016652|3730542|FG000|NOT COMPLETED|Period 2||0
3012355|NCT01016652|3730543|FG001|NOT COMPLETED|Period 2||0
3012356|NCT01016678|3730551|FG000|STARTED|Overall Study||20
3012357|NCT01016678|3730552|FG001|STARTED|Overall Study||17
3012358|NCT01016678|3730553|FG002|STARTED|Overall Study||19
3012359|NCT01016678|3730554|FG003|STARTED|Overall Study||19
3012360|NCT01016678|3730555|FG004|STARTED|Overall Study||19
3012361|NCT01016678|3730551|FG000|COMPLETED|Overall Study||18
3012362|NCT01016678|3730552|FG001|COMPLETED|Overall Study||14
3012363|NCT01016678|3730553|FG002|COMPLETED|Overall Study||15
3012364|NCT01016678|3730554|FG003|COMPLETED|Overall Study||19
3012365|NCT01016678|3730555|FG004|COMPLETED|Overall Study||13
3012366|NCT01016678|3730551|FG000|NOT COMPLETED|Overall Study||2
3012367|NCT01016678|3730552|FG001|NOT COMPLETED|Overall Study||3
3012368|NCT01016678|3730553|FG002|NOT COMPLETED|Overall Study||4
3012369|NCT01016678|3730554|FG003|NOT COMPLETED|Overall Study||0
3012370|NCT01016678|3730555|FG004|NOT COMPLETED|Overall Study||6
3012371|NCT01016691|3730576|FG000|STARTED|Overall Study||17
3012372|NCT01016691|3730577|FG001|STARTED|Overall Study||12
3012373|NCT01016691|3730578|FG002|STARTED|Overall Study||18
3012374|NCT01016691|3730576|FG000|COMPLETED|Overall Study||17
3012375|NCT01016691|3730577|FG001|COMPLETED|Overall Study||12
3012376|NCT01016691|3730578|FG002|COMPLETED|Overall Study||18
3012377|NCT01016691|3730576|FG000|NOT COMPLETED|Overall Study||0
3012378|NCT01016691|3730577|FG001|NOT COMPLETED|Overall Study||0
3012379|NCT01016691|3730578|FG002|NOT COMPLETED|Overall Study||0
3012380|NCT01016769|3730590|FG000|STARTED|Overall Study||4
3012381|NCT01016769|3730591|FG001|STARTED|Overall Study||7
3012382|NCT01016769|3730592|FG002|STARTED|Overall Study||7
3307161|NCT03005041|4040482|FG001|COMPLETED|Period 2||27
3307162|NCT03005041|4040481|FG000|NOT COMPLETED|Period 2||0
3307163|NCT03005041|4040482|FG001|NOT COMPLETED|Period 2||0
3012383|NCT01016769|3730593|FG003|STARTED|Overall Study||30
3012384|NCT01016769|3730590|FG000|COMPLETED|Overall Study||3
3012385|NCT01016769|3730591|FG001|COMPLETED|Overall Study||6
3012386|NCT01016769|3730592|FG002|COMPLETED|Overall Study||6
3012387|NCT01016769|3730593|FG003|COMPLETED|Overall Study||30
3012388|NCT01016769|3730590|FG000|NOT COMPLETED|Overall Study||1
3012389|NCT01016769|3730591|FG001|NOT COMPLETED|Overall Study||1
3012390|NCT01016769|3730592|FG002|NOT COMPLETED|Overall Study||1
3012391|NCT01016769|3730593|FG003|NOT COMPLETED|Overall Study||0
3012392|NCT01016834|3730602|FG000|STARTED|Overall Study||242
3012393|NCT01016834|3730602|FG000|COMPLETED|Overall Study||220
3012394|NCT01016834|3730602|FG000|NOT COMPLETED|Overall Study||22
3012395|NCT01016873|3730609|FG000|STARTED|12 Months||75
3012396|NCT01016873|3730610|FG001|STARTED|12 Months||75
3012397|NCT01016873|3730611|FG002|STARTED|12 Months||80
3012398|NCT01016873|3730609|FG000|COMPLETED|12 Months||74
3012399|NCT01016873|3730610|FG001|COMPLETED|12 Months||72
3012400|NCT01016873|3730611|FG002|COMPLETED|12 Months||79
3012401|NCT01016873|3730609|FG000|NOT COMPLETED|12 Months||1
3012402|NCT01016873|3730610|FG001|NOT COMPLETED|12 Months||3
3012403|NCT01016873|3730611|FG002|NOT COMPLETED|12 Months||1
3012404|NCT01016873|3730609|FG000|STARTED|24 Months||74
3012405|NCT01016873|3730610|FG001|STARTED|24 Months||72
3012406|NCT01016873|3730611|FG002|STARTED|24 Months||79
3012407|NCT01016873|3730609|FG000|COMPLETED|24 Months||69
3012408|NCT01016873|3730610|FG001|COMPLETED|24 Months||68
3012409|NCT01016873|3730611|FG002|COMPLETED|24 Months||73
3012410|NCT01016873|3730609|FG000|NOT COMPLETED|24 Months||5
3012411|NCT01016873|3730610|FG001|NOT COMPLETED|24 Months||4
3012412|NCT01016873|3730611|FG002|NOT COMPLETED|24 Months||6
3012413|NCT01016873|3730609|FG000|STARTED|36 Months||69
3012414|NCT01016873|3730610|FG001|STARTED|36 Months||68
3012415|NCT01016873|3730611|FG002|STARTED|36 Months||73
3012416|NCT01016873|3730609|FG000|COMPLETED|36 Months||58
3012417|NCT01016873|3730610|FG001|COMPLETED|36 Months||64
3012418|NCT01016873|3730611|FG002|COMPLETED|36 Months||67
3012419|NCT01016873|3730609|FG000|NOT COMPLETED|36 Months||11
3012420|NCT01016873|3730610|FG001|NOT COMPLETED|36 Months||4
3012421|NCT01016873|3730611|FG002|NOT COMPLETED|36 Months||6
3012422|NCT01016912|3730624|FG000|STARTED|End of Treatment Period||8
3012423|NCT01016912|3730625|FG001|STARTED|End of Treatment Period||9
3012424|NCT01016912|3730626|FG002|STARTED|End of Treatment Period||10
3012425|NCT01016912|3730627|FG003|STARTED|End of Treatment Period||9
3012426|NCT01016912|3730628|FG004|STARTED|End of Treatment Period||9
3012427|NCT01016912|3730624|FG000|Received Treatment|End of Treatment Period||8
3012428|NCT01016912|3730625|FG001|Received Treatment|End of Treatment Period||9
3012429|NCT01016912|3730626|FG002|Received Treatment|End of Treatment Period||10
3012430|NCT01016912|3730627|FG003|Received Treatment|End of Treatment Period||9
3012431|NCT01016912|3730628|FG004|Received Treatment|End of Treatment Period||9
3012432|NCT01016912|3730624|FG000|COMPLETED|End of Treatment Period||8
3012433|NCT01016912|3730625|FG001|COMPLETED|End of Treatment Period||6
3012434|NCT01016912|3730626|FG002|COMPLETED|End of Treatment Period||9
3012435|NCT01016912|3730627|FG003|COMPLETED|End of Treatment Period||5
3012436|NCT01016912|3730628|FG004|COMPLETED|End of Treatment Period||5
3012437|NCT01016912|3730624|FG000|NOT COMPLETED|End of Treatment Period||0
3012438|NCT01016912|3730625|FG001|NOT COMPLETED|End of Treatment Period||3
3012439|NCT01016912|3730626|FG002|NOT COMPLETED|End of Treatment Period||1
3012440|NCT01016912|3730627|FG003|NOT COMPLETED|End of Treatment Period||4
3012441|NCT01016912|3730628|FG004|NOT COMPLETED|End of Treatment Period||4
3012442|NCT01016912|3730624|FG000|STARTED|Follow-up Period||8
3012443|NCT01016912|3730625|FG001|STARTED|Follow-up Period|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment|9
3012444|NCT01016912|3730626|FG002|STARTED|Follow-up Period|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment|10
3012445|NCT01016912|3730627|FG003|STARTED|Follow-up Period|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment|9
3012446|NCT01016912|3730628|FG004|STARTED|Follow-up Period|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment|9
3012447|NCT01016912|3730624|FG000|COMPLETED|Follow-up Period||8
3012448|NCT01016912|3730625|FG001|COMPLETED|Follow-up Period||9
3012449|NCT01016912|3730626|FG002|COMPLETED|Follow-up Period||9
3012450|NCT01016912|3730627|FG003|COMPLETED|Follow-up Period||8
3012451|NCT01016912|3730628|FG004|COMPLETED|Follow-up Period||9
3012452|NCT01016912|3730624|FG000|NOT COMPLETED|Follow-up Period||0
3012453|NCT01016912|3730625|FG001|NOT COMPLETED|Follow-up Period||0
3012454|NCT01016912|3730626|FG002|NOT COMPLETED|Follow-up Period||1
3012455|NCT01016912|3730627|FG003|NOT COMPLETED|Follow-up Period||1
3012456|NCT01016912|3730628|FG004|NOT COMPLETED|Follow-up Period||0
3012457|NCT01016938|3730660|FG000|STARTED|Overall Study||16
3012458|NCT01016938|3730660|FG000|COMPLETED|Overall Study||7
3012459|NCT01016938|3730660|FG000|NOT COMPLETED|Overall Study||9
3012460|NCT01016964|3730667|FG000|STARTED|Overall Study||21
3012461|NCT01016964|3730668|FG001|STARTED|Overall Study||42
3012462|NCT01016964|3730667|FG000|COMPLETED|Overall Study||18
3012463|NCT01016964|3730668|FG001|COMPLETED|Overall Study||39
3012464|NCT01016964|3730667|FG000|NOT COMPLETED|Overall Study||3
3012465|NCT01016964|3730668|FG001|NOT COMPLETED|Overall Study||3
3012466|NCT01016977|3730676|FG000|STARTED|Overall Study||20
3012467|NCT01016977|3730677|FG001|STARTED|Overall Study||20
3012468|NCT01016977|3730676|FG000|COMPLETED|Overall Study||17
3012469|NCT01016977|3730677|FG001|COMPLETED|Overall Study||18
3012470|NCT01016977|3730676|FG000|NOT COMPLETED|Overall Study||3
3012471|NCT01016977|3730677|FG001|NOT COMPLETED|Overall Study||2
3012472|NCT01017003|3730686|FG000|STARTED|Single Dose Colchicine 0.6 mg, Day 1||13
3012473|NCT01017003|3730686|FG000|COMPLETED|Single Dose Colchicine 0.6 mg, Day 1||13
3012474|NCT01017003|3730686|FG000|NOT COMPLETED|Single Dose Colchicine 0.6 mg, Day 1||0
3012475|NCT01017003|3730686|FG000|STARTED|14 Day Washout Period||13
3012476|NCT01017003|3730686|FG000|COMPLETED|14 Day Washout Period||13
3012477|NCT01017003|3730686|FG000|NOT COMPLETED|14 Day Washout Period||0
3165313|NCT01898429|3892842|FG002|NOT COMPLETED|Phase 3||0
3165314|NCT01898442|3892849|FG000|STARTED|Overall Study||17
3165315|NCT01898442|3892850|FG001|STARTED|Overall Study||17
3165316|NCT01898442|3892851|FG002|STARTED|Overall Study||18
3165317|NCT01898442|3892849|FG000|COMPLETED|Overall Study||16
3165318|NCT01898442|3892850|FG001|COMPLETED|Overall Study||15
3165319|NCT01898442|3892851|FG002|COMPLETED|Overall Study||15
3165320|NCT01898442|3892849|FG000|NOT COMPLETED|Overall Study||1
3165321|NCT01898442|3892850|FG001|NOT COMPLETED|Overall Study||2
3165322|NCT01898442|3892851|FG002|NOT COMPLETED|Overall Study||3
3165323|NCT01898598|3892861|FG000|STARTED|Overall Study||12
3012478|NCT01017003|3730686|FG000|STARTED|Colchicine 0.6 mg Twice Daily x 10 Days||13
3012479|NCT01017003|3730686|FG000|COMPLETED|Colchicine 0.6 mg Twice Daily x 10 Days||13
3012480|NCT01017003|3730686|FG000|NOT COMPLETED|Colchicine 0.6 mg Twice Daily x 10 Days||0
3012481|NCT01017003|3730686|FG000|STARTED|Colchicine 0.6 mg Final Dose||13
3012482|NCT01017003|3730686|FG000|COMPLETED|Colchicine 0.6 mg Final Dose||13
3012483|NCT01017003|3730686|FG000|NOT COMPLETED|Colchicine 0.6 mg Final Dose||0
3012484|NCT01017029|3730694|FG000|STARTED|Overall Study||89
3012485|NCT01017029|3730695|FG001|STARTED|Overall Study||92
3012486|NCT01017029|3730694|FG000|COMPLETED|Overall Study||85
3012487|NCT01017029|3730695|FG001|COMPLETED|Overall Study||90
3012488|NCT01017029|3730694|FG000|NOT COMPLETED|Overall Study||4
3012489|NCT01017029|3730695|FG001|NOT COMPLETED|Overall Study||2
3012490|NCT01017042|3730701|FG000|STARTED|Overall Study||13
3012491|NCT01017042|3730701|FG000|COMPLETED|Overall Study||13
3012492|NCT01017042|3730701|FG000|NOT COMPLETED|Overall Study||0
3012493|NCT01017120|3730712|FG000|STARTED|Overall Study||373
3012494|NCT01017120|3730713|FG001|STARTED|Overall Study||369
3012495|NCT01017120|3730712|FG000|COMPLETED|Overall Study||307
3012496|NCT01017120|3730713|FG001|COMPLETED|Overall Study||334
3012497|NCT01017120|3730712|FG000|NOT COMPLETED|Overall Study||66
3012498|NCT01017120|3730713|FG001|NOT COMPLETED|Overall Study||35
3012499|NCT01017146|3730721|FG000|STARTED|Overall Study||372
3012500|NCT01017146|3730722|FG001|STARTED|Overall Study||372
3012501|NCT01017146|3730721|FG000|COMPLETED|Overall Study||306
3012502|NCT01017146|3730722|FG001|COMPLETED|Overall Study||333
3012503|NCT01017146|3730721|FG000|NOT COMPLETED|Overall Study||66
3012504|NCT01017146|3730722|FG001|NOT COMPLETED|Overall Study||39
3012505|NCT01017237|3730730|FG000|STARTED|Overall Study||10
3012506|NCT01017237|3730731|FG001|STARTED|Overall Study||8
3012507|NCT01017237|3730730|FG000|COMPLETED|Overall Study||5
3012508|NCT01017237|3730731|FG001|COMPLETED|Overall Study||6
3012509|NCT01017237|3730730|FG000|NOT COMPLETED|Overall Study||5
3012510|NCT01017237|3730731|FG001|NOT COMPLETED|Overall Study||2
3012511|NCT01017250|3730740|FG000|STARTED|Overall Study||15
3012512|NCT01017250|3730740|FG000|2-month MRI|Overall Study|1 participant did not return for the 2 month MRI at treating facility. Resides out of state.|14
3012513|NCT01017250|3730740|FG000|COMPLETED|Overall Study||15
3012514|NCT01017250|3730740|FG000|NOT COMPLETED|Overall Study||0
3012515|NCT01017497|3730745|FG000|STARTED|Overall Study||49
3012516|NCT01017497|3730745|FG000|COMPLETED|Overall Study||49
3012517|NCT01017497|3730745|FG000|NOT COMPLETED|Overall Study||0
3012518|NCT01017536|3730753|FG000|STARTED|Overall Study||13
3012519|NCT01017536|3730754|FG001|STARTED|Overall Study||13
3012520|NCT01017536|3730753|FG000|COMPLETED|Overall Study||13
3012521|NCT01017536|3730754|FG001|COMPLETED|Overall Study||13
3012522|NCT01017536|3730753|FG000|NOT COMPLETED|Overall Study||0
3012523|NCT01017536|3730754|FG001|NOT COMPLETED|Overall Study||0
3012524|NCT01017549|3730760|FG000|STARTED|Eligibility Through 6 Month Follow-up||44
3012525|NCT01017549|3730760|FG000|COMPLETED|Eligibility Through 6 Month Follow-up|6 month follow-up complete Oct 2008; data through 6 months and 1 year are published.|43
3012526|NCT01017549|3730760|FG000|NOT COMPLETED|Eligibility Through 6 Month Follow-up||1
3012527|NCT01017549|3730760|FG000|STARTED|One-year Follow-up||43
3012528|NCT01017549|3730760|FG000|COMPLETED|One-year Follow-up||36
3012529|NCT01017549|3730760|FG000|NOT COMPLETED|One-year Follow-up||7
3012530|NCT01017549|3730760|FG000|STARTED|5 Year Follow-up||36
3012531|NCT01017549|3730760|FG000|COMPLETED|5 Year Follow-up||24
3012532|NCT01017549|3730760|FG000|NOT COMPLETED|5 Year Follow-up||12
3012533|NCT01017575|3730769|FG000|STARTED|Overall Study||8
3012534|NCT01017575|3730770|FG001|STARTED|Overall Study||9
3012535|NCT01017575|3730771|FG002|STARTED|Overall Study||8
3012536|NCT01017575|3730772|FG003|STARTED|Overall Study||8
3012537|NCT01017575|3730773|FG004|STARTED|Overall Study||9
3012538|NCT01017575|3730769|FG000|COMPLETED|Overall Study||7
3012539|NCT01017575|3730770|FG001|COMPLETED|Overall Study||7
3012540|NCT01017575|3730771|FG002|COMPLETED|Overall Study||8
3012541|NCT01017575|3730772|FG003|COMPLETED|Overall Study||7
3012542|NCT01017575|3730773|FG004|COMPLETED|Overall Study||6
3012543|NCT01017575|3730769|FG000|NOT COMPLETED|Overall Study||1
3012544|NCT01017575|3730770|FG001|NOT COMPLETED|Overall Study||2
3012545|NCT01017575|3730771|FG002|NOT COMPLETED|Overall Study||0
3165324|NCT01898598|3892862|FG001|STARTED|Overall Study||6
3012546|NCT01017575|3730772|FG003|NOT COMPLETED|Overall Study||1
3012547|NCT01017575|3730773|FG004|NOT COMPLETED|Overall Study||3
3012548|NCT01017601|3730787|FG000|STARTED|Overall Study||26
3012549|NCT01017601|3730788|FG001|STARTED|Overall Study||24
3012550|NCT01017601|3730787|FG000|COMPLETED|Overall Study||14
3012551|NCT01017601|3730788|FG001|COMPLETED|Overall Study||11
3012552|NCT01017601|3730787|FG000|NOT COMPLETED|Overall Study||12
3012553|NCT01017601|3730788|FG001|NOT COMPLETED|Overall Study||13
3012554|NCT01017653|3730794|FG000|STARTED|Overall Study||16
3012555|NCT01017653|3730794|FG000|COMPLETED|Overall Study||16
3012556|NCT01017653|3730794|FG000|NOT COMPLETED|Overall Study||0
3012557|NCT01017731|3730798|FG000|STARTED|Overall Study||68
3012558|NCT01017731|3730798|FG000|Received at Least 1 Dose of Study Drug|Overall Study||66
3012559|NCT01017731|3730798|FG000|COMPLETED|Overall Study||60
3012560|NCT01017731|3730798|FG000|NOT COMPLETED|Overall Study||8
3012561|NCT01017874|3730805|FG000|STARTED|Overall Study||118
3012562|NCT01017874|3730806|FG001|STARTED|Overall Study||118
3012563|NCT01017874|3730805|FG000|Received at Least 1 Dose of Study Drug|Overall Study||114
3012564|NCT01017874|3730806|FG001|Received at Least 1 Dose of Study Drug|Overall Study||118
3012565|NCT01017874|3730805|FG000|COMPLETED|Overall Study||88
3012566|NCT01017874|3730806|FG001|COMPLETED|Overall Study||92
3012567|NCT01017874|3730805|FG000|NOT COMPLETED|Overall Study||30
3012568|NCT01017874|3730806|FG001|NOT COMPLETED|Overall Study||26
3012569|NCT01017952|3730816|FG000|STARTED|4-week, Open-label Run-In Period||2092
3012570|NCT01017952|3730817|FG001|STARTED|4-week, Open-label Run-In Period||0
3012571|NCT01017952|3730818|FG002|STARTED|4-week, Open-label Run-In Period||0
3012572|NCT01017952|3730819|FG003|STARTED|4-week, Open-label Run-In Period||0
3012573|NCT01017952|3730820|FG004|STARTED|4-week, Open-label Run-In Period||0
3012574|NCT01017952|3730816|FG000|COMPLETED|4-week, Open-label Run-In Period||1633
3012575|NCT01017952|3730817|FG001|COMPLETED|4-week, Open-label Run-In Period||0
3012576|NCT01017952|3730818|FG002|COMPLETED|4-week, Open-label Run-In Period||0
3012577|NCT01017952|3730819|FG003|COMPLETED|4-week, Open-label Run-In Period||0
3012578|NCT01017952|3730820|FG004|COMPLETED|4-week, Open-label Run-In Period||0
3012579|NCT01017952|3730816|FG000|NOT COMPLETED|4-week, Open-label Run-In Period||459
3012580|NCT01017952|3730817|FG001|NOT COMPLETED|4-week, Open-label Run-In Period||0
3012581|NCT01017952|3730818|FG002|NOT COMPLETED|4-week, Open-label Run-In Period||0
3012582|NCT01017952|3730819|FG003|NOT COMPLETED|4-week, Open-label Run-In Period||0
3012583|NCT01017952|3730820|FG004|NOT COMPLETED|4-week, Open-label Run-In Period||0
3012584|NCT01017952|3730816|FG000|STARTED|52-week, Double-blind Treatment Period||0
3012585|NCT01017952|3730817|FG001|STARTED|52-week, Double-blind Treatment Period||409
3012586|NCT01017952|3730818|FG002|STARTED|52-week, Double-blind Treatment Period||412
3012587|NCT01017952|3730819|FG003|STARTED|52-week, Double-blind Treatment Period||403
3307164|NCT03005054|4040488|FG000|STARTED|Overall Study||3
3307165|NCT03005054|4040488|FG000|COMPLETED|Overall Study||3
3307166|NCT03005054|4040488|FG000|NOT COMPLETED|Overall Study||0
3307167|NCT03005067|4040494|FG000|STARTED|Overall Study||90
3307168|NCT03005067|4040495|FG001|STARTED|Overall Study||81
3307169|NCT03005067|4040494|FG000|COMPLETED|Overall Study||80
3307170|NCT03005067|4040495|FG001|COMPLETED|Overall Study||74
3307171|NCT03005067|4040494|FG000|NOT COMPLETED|Overall Study||10
3307172|NCT03005067|4040495|FG001|NOT COMPLETED|Overall Study||7
3307173|NCT03005106|4040501|FG000|STARTED|Overall Study||71
3307174|NCT03005106|4040501|FG000|Completed Month 3 Visit|Overall Study||64
3307175|NCT03005106|4040501|FG000|Completed Month 12 Visit|Overall Study||51
3307176|NCT03005106|4040501|FG000|COMPLETED|Overall Study||51
3307177|NCT03005106|4040501|FG000|NOT COMPLETED|Overall Study||20
3307178|NCT03005288|4040507|FG000|STARTED|Overall Study||39
3307179|NCT03005288|4040508|FG001|STARTED|Overall Study||39
3307180|NCT03005288|4040507|FG000|Safety Analysis Set|Overall Study||37
3307181|NCT03005288|4040508|FG001|Safety Analysis Set|Overall Study||38
3307182|NCT03005288|4040507|FG000|Pharmacokinetics (PK) Analysis Set|Overall Study|One subject was excluded due to a protocol deviation.|36
3307183|NCT03005288|4040508|FG001|Pharmacokinetics (PK) Analysis Set|Overall Study|PK samples were only obtained and evaluated for subjects treated with BYM338.|0
3307184|NCT03005288|4040507|FG000|Pharmacodynamics (PD) Analysis Set|Overall Study|One subject was excluded due to a protocol deviation.|36
3307185|NCT03005288|4040508|FG001|Pharmacodynamics (PD) Analysis Set|Overall Study|Two subjects were excluded due to protocol deviations.|36
3307186|NCT03005288|4040507|FG000|COMPLETED|Overall Study||27
3307187|NCT03005288|4040508|FG001|COMPLETED|Overall Study||31
3307188|NCT03005288|4040507|FG000|NOT COMPLETED|Overall Study||12
3307189|NCT03005288|4040508|FG001|NOT COMPLETED|Overall Study||8
3307190|NCT03006341|4040518|FG000|STARTED|Overall Study||26199
3307191|NCT03006341|4040519|FG001|STARTED|Overall Study||70071
3307192|NCT03006341|4040520|FG002|STARTED|Overall Study||32595
3307193|NCT03006341|4040521|FG003|STARTED|Overall Study||11322
3307194|NCT03006341|4040518|FG000|COMPLETED|Overall Study||1130
3307195|NCT03006341|4040519|FG001|COMPLETED|Overall Study||2566
3307196|NCT03006341|4040520|FG002|COMPLETED|Overall Study||1602
3307197|NCT03006341|4040521|FG003|COMPLETED|Overall Study||637
3307198|NCT03006341|4040518|FG000|NOT COMPLETED|Overall Study||25069
3307199|NCT03006341|4040519|FG001|NOT COMPLETED|Overall Study||67505
3307200|NCT03006341|4040520|FG002|NOT COMPLETED|Overall Study||30993
3307201|NCT03006341|4040521|FG003|NOT COMPLETED|Overall Study||10685
3307202|NCT03006393|4040531|FG000|STARTED|Overall Study||21
3307203|NCT03006393|4040532|FG001|STARTED|Overall Study||21
3307204|NCT03006393|4040531|FG000|COMPLETED|Overall Study||20
3307205|NCT03006393|4040532|FG001|COMPLETED|Overall Study||18
3012588|NCT01017952|3730820|FG004|STARTED|52-week, Double-blind Treatment Period||409
3012589|NCT01017952|3730816|FG000|Completed the Treatment Period|52-week, Double-blind Treatment Period||0
3012590|NCT01017952|3730817|FG001|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|285
3012591|NCT01017952|3730818|FG002|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|305
3012592|NCT01017952|3730819|FG003|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|293
3012593|NCT01017952|3730820|FG004|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|307
3012594|NCT01017952|3730816|FG000|COMPLETED|52-week, Double-blind Treatment Period||0
3012595|NCT01017952|3730817|FG001|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|284
3012596|NCT01017952|3730818|FG002|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|303
3012597|NCT01017952|3730819|FG003|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|291
3012598|NCT01017952|3730820|FG004|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|306
3012599|NCT01017952|3730816|FG000|NOT COMPLETED|52-week, Double-blind Treatment Period||0
3012600|NCT01017952|3730817|FG001|NOT COMPLETED|52-week, Double-blind Treatment Period||125
3012601|NCT01017952|3730818|FG002|NOT COMPLETED|52-week, Double-blind Treatment Period||109
3012602|NCT01017952|3730819|FG003|NOT COMPLETED|52-week, Double-blind Treatment Period||112
3012603|NCT01017952|3730820|FG004|NOT COMPLETED|52-week, Double-blind Treatment Period||103
3012604|NCT01018030|3730833|FG000|STARTED|Overall Study||246
3012605|NCT01018030|3730834|FG001|STARTED|Overall Study||243
3012606|NCT01018030|3730835|FG002|STARTED|Overall Study||252
3012607|NCT01018030|3730833|FG000|COMPLETED|Overall Study||227
3012608|NCT01018030|3730834|FG001|COMPLETED|Overall Study||232
3012609|NCT01018030|3730835|FG002|COMPLETED|Overall Study||239
3012610|NCT01018030|3730833|FG000|NOT COMPLETED|Overall Study||19
3012611|NCT01018030|3730834|FG001|NOT COMPLETED|Overall Study||11
3012612|NCT01018030|3730835|FG002|NOT COMPLETED|Overall Study||13
3012613|NCT01018056|3730848|FG000|STARTED|Overall Study||12
3012614|NCT01018056|3730849|FG001|STARTED|Overall Study||12
3012615|NCT01018056|3730850|FG002|STARTED|Overall Study||6
3012616|NCT01018056|3730848|FG000|COMPLETED|Overall Study||9
3012617|NCT01018056|3730849|FG001|COMPLETED|Overall Study||10
3012618|NCT01018056|3730850|FG002|COMPLETED|Overall Study||5
3012619|NCT01018056|3730848|FG000|NOT COMPLETED|Overall Study||3
3012620|NCT01018056|3730849|FG001|NOT COMPLETED|Overall Study||2
3012621|NCT01018056|3730850|FG002|NOT COMPLETED|Overall Study||1
3012622|NCT01018095|3730863|FG000|STARTED|Overall Study||135
3012623|NCT01018095|3730864|FG001|STARTED|Overall Study||135
3012624|NCT01018095|3730863|FG000|COMPLETED|Overall Study||79
3012625|NCT01018095|3730864|FG001|COMPLETED|Overall Study||73
3012626|NCT01018095|3730863|FG000|NOT COMPLETED|Overall Study||56
3012627|NCT01018095|3730864|FG001|NOT COMPLETED|Overall Study||62
3012628|NCT01018134|3730876|FG000|STARTED|Overall Study||30
3012629|NCT01018134|3730877|FG001|STARTED|Overall Study||31
3012630|NCT01018134|3730878|FG002|STARTED|Overall Study||30
3012631|NCT01018134|3730879|FG003|STARTED|Overall Study|30 enrolled patients, one who did not use the study medication was excluded from all analyses|29
3012632|NCT01018134|3730880|FG004|STARTED|Overall Study||15
3012633|NCT01018134|3730881|FG005|STARTED|Overall Study||15
3012634|NCT01018134|3730876|FG000|COMPLETED|Overall Study||30
3012635|NCT01018134|3730877|FG001|COMPLETED|Overall Study||30
3012636|NCT01018134|3730878|FG002|COMPLETED|Overall Study||29
3307206|NCT03006393|4040531|FG000|NOT COMPLETED|Overall Study||1
3307207|NCT03006393|4040532|FG001|NOT COMPLETED|Overall Study||3
3307208|NCT03006458|4040538|FG000|STARTED|First Intervention||14
3307209|NCT03006458|4040539|FG001|STARTED|First Intervention||10
3307210|NCT03006458|4040538|FG000|COMPLETED|First Intervention||14
3307211|NCT03006458|4040539|FG001|COMPLETED|First Intervention||7
3307212|NCT03006458|4040538|FG000|NOT COMPLETED|First Intervention||0
3307213|NCT03006458|4040539|FG001|NOT COMPLETED|First Intervention||3
3307214|NCT03006458|4040538|FG000|STARTED|Second Intervention||14
3307215|NCT03006458|4040539|FG001|STARTED|Second Intervention||10
3307216|NCT03006458|4040538|FG000|COMPLETED|Second Intervention||14
3307217|NCT03006458|4040539|FG001|COMPLETED|Second Intervention||10
3307218|NCT03006458|4040538|FG000|NOT COMPLETED|Second Intervention||0
3307219|NCT03006458|4040539|FG001|NOT COMPLETED|Second Intervention||0
3307220|NCT03006471|4040547|FG000|STARTED|Overall Study||15
3307221|NCT03006471|4040548|FG001|STARTED|Overall Study||15
3307222|NCT03006471|4040547|FG000|COMPLETED|Overall Study|Two patients did not complete the study due to early withdrawal|13
3307223|NCT03006471|4040548|FG001|COMPLETED|Overall Study|Two patients did not complete the study due to early withdrawal|13
3307224|NCT03006471|4040547|FG000|NOT COMPLETED|Overall Study||2
3307225|NCT03006471|4040548|FG001|NOT COMPLETED|Overall Study||2
3307226|NCT03006562|4040556|FG000|STARTED|Overall Study||251
3307227|NCT03006562|4040557|FG001|STARTED|Overall Study||250
3307228|NCT03006562|4040556|FG000|Voluntary Ultrasound at 30 Days|Overall Study||141
3012637|NCT01018134|3730879|FG003|COMPLETED|Overall Study||29
3012638|NCT01018134|3730880|FG004|COMPLETED|Overall Study||15
3012639|NCT01018134|3730881|FG005|COMPLETED|Overall Study||15
3012640|NCT01018134|3730876|FG000|NOT COMPLETED|Overall Study||0
3012641|NCT01018134|3730877|FG001|NOT COMPLETED|Overall Study||1
3012642|NCT01018134|3730878|FG002|NOT COMPLETED|Overall Study||1
3012643|NCT01018134|3730879|FG003|NOT COMPLETED|Overall Study||0
3012644|NCT01018134|3730880|FG004|NOT COMPLETED|Overall Study||0
3012645|NCT01018134|3730881|FG005|NOT COMPLETED|Overall Study||0
3012646|NCT01018186|3730898|FG000|STARTED|2-week Run-in Period||617
3012647|NCT01018186|3730899|FG001|STARTED|2-week Run-in Period||0
3012648|NCT01018186|3730900|FG002|STARTED|2-week Run-in Period||0
3012649|NCT01018186|3730901|FG003|STARTED|2-week Run-in Period||0
3012650|NCT01018186|3730898|FG000|COMPLETED|2-week Run-in Period||503
3012651|NCT01018186|3730899|FG001|COMPLETED|2-week Run-in Period||0
3012652|NCT01018186|3730900|FG002|COMPLETED|2-week Run-in Period||0
3012653|NCT01018186|3730901|FG003|COMPLETED|2-week Run-in Period||0
3012654|NCT01018186|3730898|FG000|NOT COMPLETED|2-week Run-in Period||114
3012655|NCT01018186|3730899|FG001|NOT COMPLETED|2-week Run-in Period||0
3012656|NCT01018186|3730900|FG002|NOT COMPLETED|2-week Run-in Period||0
3012657|NCT01018186|3730901|FG003|NOT COMPLETED|2-week Run-in Period||0
3012658|NCT01018186|3730898|FG000|STARTED|52-week Double-blind Treatment Period||0
3012659|NCT01018186|3730899|FG001|STARTED|52-week Double-blind Treatment Period||201
3012660|NCT01018186|3730900|FG002|STARTED|52-week Double-blind Treatment Period||202
3012661|NCT01018186|3730901|FG003|STARTED|52-week Double-blind Treatment Period||100
3012662|NCT01018186|3730898|FG000|COMPLETED|52-week Double-blind Treatment Period||0
3012663|NCT01018186|3730899|FG001|COMPLETED|52-week Double-blind Treatment Period||161
3012664|NCT01018186|3730900|FG002|COMPLETED|52-week Double-blind Treatment Period||161
3012665|NCT01018186|3730901|FG003|COMPLETED|52-week Double-blind Treatment Period||71
3012666|NCT01018186|3730898|FG000|NOT COMPLETED|52-week Double-blind Treatment Period||0
3012667|NCT01018186|3730899|FG001|NOT COMPLETED|52-week Double-blind Treatment Period||40
3012668|NCT01018186|3730900|FG002|NOT COMPLETED|52-week Double-blind Treatment Period||41
3012669|NCT01018186|3730901|FG003|NOT COMPLETED|52-week Double-blind Treatment Period||29
3012670|NCT01018264|3730915|FG000|STARTED|Overall Study||10
3012671|NCT01018264|3730916|FG001|STARTED|Overall Study||13
3012672|NCT01018264|3730915|FG000|COMPLETED|Overall Study||9
3012673|NCT01018264|3730916|FG001|COMPLETED|Overall Study||12
3012674|NCT01018264|3730915|FG000|NOT COMPLETED|Overall Study||1
3012675|NCT01018264|3730916|FG001|NOT COMPLETED|Overall Study||1
3012676|NCT01018394|3730924|FG000|STARTED|Overall Study||40
3012677|NCT01018394|3730925|FG001|STARTED|Overall Study||41
3012678|NCT01018394|3730924|FG000|COMPLETED|Overall Study||31
3012679|NCT01018394|3730925|FG001|COMPLETED|Overall Study||33
3012680|NCT01018394|3730924|FG000|NOT COMPLETED|Overall Study||9
3012681|NCT01018394|3730925|FG001|NOT COMPLETED|Overall Study||8
3012682|NCT01018420|3730933|FG000|STARTED|Overall Study||15
3012683|NCT01018420|3730934|FG001|STARTED|Overall Study||3
3012684|NCT01018420|3730933|FG000|COMPLETED|Overall Study||15
3012685|NCT01018420|3730934|FG001|COMPLETED|Overall Study||3
3012686|NCT01018420|3730933|FG000|NOT COMPLETED|Overall Study||0
3012687|NCT01018420|3730934|FG001|NOT COMPLETED|Overall Study||0
3012688|NCT01018511|3730961|FG000|STARTED|Overall Study||341
3307229|NCT03006562|4040557|FG001|Voluntary Ultrasound at 30 Days|Overall Study||137
3307230|NCT03006562|4040556|FG000|COMPLETED|Overall Study||251
3307231|NCT03006562|4040557|FG001|COMPLETED|Overall Study||249
3307232|NCT03006562|4040556|FG000|NOT COMPLETED|Overall Study||0
3307233|NCT03006562|4040557|FG001|NOT COMPLETED|Overall Study||1
3307234|NCT03006848|4040563|FG000|STARTED|Overall Study||18
3307235|NCT03006848|4040563|FG000|COMPLETED|Overall Study||0
3307236|NCT03006848|4040563|FG000|NOT COMPLETED|Overall Study||18
3307237|NCT03006887|4040574|FG000|STARTED|Overall Study||6
3307238|NCT03006887|4040574|FG000|COMPLETED|Overall Study||5
3307239|NCT03006887|4040574|FG000|NOT COMPLETED|Overall Study||1
3307240|NCT03006926|4040580|FG000|STARTED|Overall Study||6
3307241|NCT03006926|4040581|FG001|STARTED|Overall Study||98
3307242|NCT03006926|4040580|FG000|COMPLETED|Overall Study||6
3307243|NCT03006926|4040581|FG001|COMPLETED|Overall Study||0
3307244|NCT03006926|4040580|FG000|NOT COMPLETED|Overall Study||0
3307245|NCT03006926|4040581|FG001|NOT COMPLETED|Overall Study||98
3307246|NCT03007225|4040591|FG000|STARTED|Overall Study|Followed up for at least 6 months after DEB TACE|25
3307247|NCT03007225|4040592|FG001|STARTED|Overall Study|followed up for at least 6 months after TACE|25
3307248|NCT03007225|4040591|FG000|COMPLETED|Overall Study||25
3307249|NCT03007225|4040592|FG001|COMPLETED|Overall Study||25
3307250|NCT03007225|4040591|FG000|NOT COMPLETED|Overall Study||0
3012689|NCT01018511|3730962|FG001|STARTED|Overall Study||327
3012690|NCT01018511|3730963|FG002|STARTED|Overall Study||339
3012691|NCT01018511|3730964|FG003|STARTED|Overall Study||327
3012692|NCT01018511|3730961|FG000|Randomized and Treated|Overall Study||341
3012693|NCT01018511|3730962|FG001|Randomized and Treated|Overall Study||326
3012694|NCT01018511|3730963|FG002|Randomized and Treated|Overall Study||338
3012695|NCT01018511|3730964|FG003|Randomized and Treated|Overall Study||324
3012696|NCT01018511|3730961|FG000|COMPLETED|Overall Study||315
3012697|NCT01018511|3730962|FG001|COMPLETED|Overall Study||295
3012698|NCT01018511|3730963|FG002|COMPLETED|Overall Study||299
3012699|NCT01018511|3730964|FG003|COMPLETED|Overall Study||294
3012700|NCT01018511|3730961|FG000|NOT COMPLETED|Overall Study||26
3012701|NCT01018511|3730962|FG001|NOT COMPLETED|Overall Study||32
3012702|NCT01018511|3730963|FG002|NOT COMPLETED|Overall Study||40
3012703|NCT01018511|3730964|FG003|NOT COMPLETED|Overall Study||33
3012704|NCT01018680|3730982|FG000|STARTED|Overall Study||260
3012705|NCT01018680|3730983|FG001|STARTED|Overall Study||264
3012706|NCT01018680|3730982|FG000|COMPLETED|Overall Study||199
3012707|NCT01018680|3730983|FG001|COMPLETED|Overall Study||189
3012708|NCT01018680|3730982|FG000|NOT COMPLETED|Overall Study||61
3012709|NCT01018680|3730983|FG001|NOT COMPLETED|Overall Study||75
3012710|NCT01018732|3730992|FG000|STARTED|Overall Study||50
3012711|NCT01018732|3730993|FG001|STARTED|Overall Study||51
3012712|NCT01018732|3730994|FG002|STARTED|Overall Study||54
3012713|NCT01018732|3730992|FG000|COMPLETED|Overall Study||49
3012714|NCT01018732|3730993|FG001|COMPLETED|Overall Study||49
3012715|NCT01018732|3730994|FG002|COMPLETED|Overall Study||50
3012716|NCT01018732|3730992|FG000|NOT COMPLETED|Overall Study||1
3012717|NCT01018732|3730993|FG001|NOT COMPLETED|Overall Study||2
3012718|NCT01018732|3730994|FG002|NOT COMPLETED|Overall Study||4
3012719|NCT01018862|3731005|FG000|STARTED|Overall Study||161
3012720|NCT01018862|3731006|FG001|STARTED|Overall Study||166
3012721|NCT01018862|3731007|FG002|STARTED|Overall Study||162
3307251|NCT03007225|4040592|FG001|NOT COMPLETED|Overall Study||0
3307252|NCT03007394|4040600|FG000|STARTED|Overall Study||118
3307253|NCT03007394|4040601|FG001|STARTED|Overall Study||154
3307254|NCT03007394|4040600|FG000|COMPLETED|Overall Study||91
3307255|NCT03007394|4040601|FG001|COMPLETED|Overall Study||91
3307256|NCT03007394|4040600|FG000|NOT COMPLETED|Overall Study||27
3307257|NCT03007394|4040601|FG001|NOT COMPLETED|Overall Study||63
3307258|NCT03007472|4040607|FG000|STARTED|Overall Study||96
3307259|NCT03007472|4040607|FG000|COMPLETED|Overall Study||91
3307260|NCT03007472|4040607|FG000|NOT COMPLETED|Overall Study||5
3307261|NCT03007953|4040613|FG000|STARTED|Overall Study||73
3307262|NCT03007953|4040614|FG001|STARTED|Overall Study||78
3307263|NCT03007953|4040613|FG000|COMPLETED|Overall Study||57
3307264|NCT03007953|4040614|FG001|COMPLETED|Overall Study||65
3307265|NCT03007953|4040613|FG000|NOT COMPLETED|Overall Study||16
3307266|NCT03007953|4040614|FG001|NOT COMPLETED|Overall Study||13
3307267|NCT03007966|4040622|FG000|STARTED|Overall Study||30
3307268|NCT03007966|4040623|FG001|STARTED|Overall Study||30
3307269|NCT03007966|4040622|FG000|COMPLETED|Overall Study||29
3307270|NCT03007966|4040623|FG001|COMPLETED|Overall Study||30
3307271|NCT03007966|4040622|FG000|NOT COMPLETED|Overall Study||1
3307272|NCT03007966|4040623|FG001|NOT COMPLETED|Overall Study||0
3307273|NCT03007979|4040630|FG000|STARTED|Overall Study||55
3307274|NCT03007979|4040630|FG000|COMPLETED|Overall Study||54
3307275|NCT03007979|4040630|FG000|NOT COMPLETED|Overall Study||1
3307276|NCT03008070|4040637|FG000|STARTED|Overall Study||83
3307277|NCT03008070|4040638|FG001|STARTED|Overall Study||83
3307278|NCT03008070|4040639|FG002|STARTED|Overall Study||81
3307279|NCT03008070|4040637|FG000|COMPLETED|Overall Study||77
3307280|NCT03008070|4040638|FG001|COMPLETED|Overall Study||77
3307281|NCT03008070|4040639|FG002|COMPLETED|Overall Study||74
3307282|NCT03008070|4040637|FG000|NOT COMPLETED|Overall Study||6
3307283|NCT03008070|4040638|FG001|NOT COMPLETED|Overall Study||6
3307284|NCT03008070|4040639|FG002|NOT COMPLETED|Overall Study||7
3307285|NCT03008174|4040651|FG000|STARTED|Overall Study||10
3307286|NCT03008174|4040652|FG001|STARTED|Overall Study||10
3307287|NCT03008174|4040651|FG000|COMPLETED|Overall Study||7
3307288|NCT03008174|4040652|FG001|COMPLETED|Overall Study||6
3307289|NCT03008174|4040651|FG000|NOT COMPLETED|Overall Study||3
3307290|NCT03008174|4040652|FG001|NOT COMPLETED|Overall Study||4
3307291|NCT03008213|4040658|FG000|STARTED|Overall Study||1
3307292|NCT03008213|4040658|FG000|COMPLETED|Overall Study||1
3307293|NCT03008213|4040658|FG000|NOT COMPLETED|Overall Study||0
3307294|NCT03008460|4040664|FG000|STARTED|Overall Study||126
3307295|NCT03008460|4040665|FG001|STARTED|Overall Study||124
3307296|NCT03008460|4040664|FG000|COMPLETED|Overall Study||119
3307297|NCT03008460|4040665|FG001|COMPLETED|Overall Study||110
3307298|NCT03008460|4040664|FG000|NOT COMPLETED|Overall Study||7
3307299|NCT03008460|4040665|FG001|NOT COMPLETED|Overall Study||14
3307300|NCT03008590|4040673|FG000|STARTED|Overall Study||14
3307301|NCT03008590|4040674|FG001|STARTED|Overall Study||15
3307302|NCT03008590|4040673|FG000|COMPLETED|Overall Study||11
3307303|NCT03008590|4040674|FG001|COMPLETED|Overall Study||12
3307304|NCT03008590|4040673|FG000|NOT COMPLETED|Overall Study||3
3307305|NCT03008590|4040674|FG001|NOT COMPLETED|Overall Study||3
3307306|NCT03008707|4040682|FG000|STARTED|Overall Study||28
3307307|NCT03008707|4040683|FG001|STARTED|Overall Study||38
3307308|NCT03008707|4040682|FG000|COMPLETED|Overall Study||28
3307309|NCT03008707|4040683|FG001|COMPLETED|Overall Study||38
3012722|NCT01018862|3731005|FG000|COMPLETED|Overall Study||148
3012723|NCT01018862|3731006|FG001|COMPLETED|Overall Study||156
3012724|NCT01018862|3731007|FG002|COMPLETED|Overall Study||146
3012725|NCT01018862|3731005|FG000|NOT COMPLETED|Overall Study||13
3307310|NCT03008707|4040682|FG000|NOT COMPLETED|Overall Study||0
3307311|NCT03008707|4040683|FG001|NOT COMPLETED|Overall Study||0
3307312|NCT03008837|4040691|FG000|STARTED|Overall Study||12
3307313|NCT03008837|4040692|FG001|STARTED|Overall Study||9
3307314|NCT03008837|4040691|FG000|COMPLETED|Overall Study||9
3307315|NCT03008837|4040692|FG001|COMPLETED|Overall Study||5
3307316|NCT03008837|4040691|FG000|NOT COMPLETED|Overall Study||3
3012726|NCT01018862|3731006|FG001|NOT COMPLETED|Overall Study||10
3012727|NCT01018862|3731007|FG002|NOT COMPLETED|Overall Study||16
3307317|NCT03008837|4040692|FG001|NOT COMPLETED|Overall Study||4
3307318|NCT03008889|4040703|FG000|STARTED|Overall Study||1
3307319|NCT03008889|4040704|FG001|STARTED|Overall Study||1
3307320|NCT03008889|4040703|FG000|COMPLETED|Overall Study||1
3012728|NCT01018953|3731015|FG000|STARTED|Overall Study||8
3012729|NCT01018953|3731015|FG000|BIM 23A760 1 mg|Overall Study||3
3012730|NCT01018953|3731015|FG000|BIM 23A760 2 mg|Overall Study||2
3012731|NCT01018953|3731015|FG000|BIM 23A760 4 mg|Overall Study||3
3012732|NCT01018953|3731015|FG000|COMPLETED|Overall Study||0
3012733|NCT01018953|3731015|FG000|NOT COMPLETED|Overall Study||8
3012734|NCT01018979|3731022|FG000|STARTED|Overall Study||7
3012735|NCT01018979|3731023|FG001|STARTED|Overall Study|A total of 20 subjects were randomized.|13
3012736|NCT01018979|3731022|FG000|Received at Least One Dose|Overall Study||7
3012737|NCT01018979|3731023|FG001|Received at Least One Dose|Overall Study||12
3012738|NCT01018979|3731022|FG000|COMPLETED|Overall Study||4
3012739|NCT01018979|3731023|FG001|COMPLETED|Overall Study||3
3012740|NCT01018979|3731022|FG000|NOT COMPLETED|Overall Study||3
3012741|NCT01018979|3731023|FG001|NOT COMPLETED|Overall Study||10
3012742|NCT01018992|3731034|FG000|STARTED|Overall Study||63
3012743|NCT01018992|3731035|FG001|STARTED|Overall Study||65
3012744|NCT01018992|3731034|FG000|COMPLETED|Overall Study||47
3012745|NCT01018992|3731035|FG001|COMPLETED|Overall Study||49
3012746|NCT01018992|3731034|FG000|NOT COMPLETED|Overall Study||16
3012747|NCT01018992|3731035|FG001|NOT COMPLETED|Overall Study||16
3012748|NCT01019135|3731044|FG000|STARTED|Overall Study||55
3012749|NCT01019135|3731045|FG001|STARTED|Overall Study||59
3012750|NCT01019135|3731046|FG002|STARTED|Overall Study||55
3012751|NCT01019135|3731044|FG000|COMPLETED|Overall Study||35
3012752|NCT01019135|3731045|FG001|COMPLETED|Overall Study||40
3012753|NCT01019135|3731046|FG002|COMPLETED|Overall Study||24
3012754|NCT01019135|3731044|FG000|NOT COMPLETED|Overall Study||20
3012755|NCT01019135|3731045|FG001|NOT COMPLETED|Overall Study||19
3012756|NCT01019135|3731046|FG002|NOT COMPLETED|Overall Study||31
3012757|NCT01019252|3731056|FG000|STARTED|Initial CBT for ADHD vs. Wait List|Stratified based on biological sex and clinician-rated severity (CGI score)|24
3012758|NCT01019252|3731057|FG001|STARTED|Initial CBT for ADHD vs. Wait List|Stratified based on biological sex and clinician-rated severity (CGI score)|22
3012759|NCT01019252|3731056|FG000|COMPLETED|Initial CBT for ADHD vs. Wait List||21
3012760|NCT01019252|3731057|FG001|COMPLETED|Initial CBT for ADHD vs. Wait List||22
3012761|NCT01019252|3731056|FG000|NOT COMPLETED|Initial CBT for ADHD vs. Wait List||3
3012762|NCT01019252|3731057|FG001|NOT COMPLETED|Initial CBT for ADHD vs. Wait List||0
3012763|NCT01019252|3731056|FG000|STARTED|Wait List Cross-over to CBT for ADHD|Lost to follow up, did not start treatment following wait list completion (n=3)|21
3012764|NCT01019252|3731057|FG001|STARTED|Wait List Cross-over to CBT for ADHD||22
3012765|NCT01019252|3731056|FG000|COMPLETED|Wait List Cross-over to CBT for ADHD||21
3012766|NCT01019252|3731057|FG001|COMPLETED|Wait List Cross-over to CBT for ADHD||15
3012767|NCT01019252|3731056|FG000|NOT COMPLETED|Wait List Cross-over to CBT for ADHD||0
3012768|NCT01019252|3731057|FG001|NOT COMPLETED|Wait List Cross-over to CBT for ADHD||7
3012769|NCT01019317|3731063|FG000|STARTED|Overall Study||151
3012770|NCT01019317|3731063|FG000|COMPLETED|Overall Study||147
3012771|NCT01019317|3731063|FG000|NOT COMPLETED|Overall Study||4
3012772|NCT01019369|3731069|FG000|STARTED|Overall Study||86
3012773|NCT01019369|3731070|FG001|STARTED|Overall Study||46
3012774|NCT01019369|3731069|FG000|COMPLETED|Overall Study||76
3012775|NCT01019369|3731070|FG001|COMPLETED|Overall Study||39
3012776|NCT01019369|3731069|FG000|NOT COMPLETED|Overall Study||10
3012777|NCT01019369|3731070|FG001|NOT COMPLETED|Overall Study||7
3012778|NCT01019486|3731080|FG000|STARTED|Overall Study||5
3012779|NCT01019486|3731081|FG001|STARTED|Overall Study||5
3012780|NCT01019486|3731082|FG002|STARTED|Overall Study||16
3012781|NCT01019486|3731080|FG000|COMPLETED|Overall Study||4
3012782|NCT01019486|3731081|FG001|COMPLETED|Overall Study||4
3012783|NCT01019486|3731082|FG002|COMPLETED|Overall Study||15
3012784|NCT01019486|3731080|FG000|NOT COMPLETED|Overall Study||1
3012785|NCT01019486|3731081|FG001|NOT COMPLETED|Overall Study||1
3012786|NCT01019486|3731082|FG002|NOT COMPLETED|Overall Study||1
3307321|NCT03008889|4040704|FG001|COMPLETED|Overall Study||1
3307322|NCT03008889|4040703|FG000|NOT COMPLETED|Overall Study||0
3307323|NCT03008889|4040704|FG001|NOT COMPLETED|Overall Study||0
3307324|NCT03008915|4040711|FG000|STARTED|Treatment 1||8
3307325|NCT03008915|4040712|FG001|STARTED|Treatment 1||7
3307326|NCT03008915|4040711|FG000|COMPLETED|Treatment 1||8
3307327|NCT03008915|4040712|FG001|COMPLETED|Treatment 1||6
3307328|NCT03008915|4040711|FG000|NOT COMPLETED|Treatment 1||0
3307329|NCT03008915|4040712|FG001|NOT COMPLETED|Treatment 1||1
3307330|NCT03008915|4040711|FG000|STARTED|Treatment 2||8
3307331|NCT03008915|4040712|FG001|STARTED|Treatment 2||6
3307332|NCT03008915|4040711|FG000|COMPLETED|Treatment 2||8
3307333|NCT03008915|4040712|FG001|COMPLETED|Treatment 2||6
3307334|NCT03008915|4040711|FG000|NOT COMPLETED|Treatment 2||0
3307335|NCT03008915|4040712|FG001|NOT COMPLETED|Treatment 2||0
3307336|NCT03009162|4040721|FG000|STARTED|Overall Study||8
3307337|NCT03009162|4040722|FG001|STARTED|Overall Study||8
3307338|NCT03009162|4040721|FG000|Received at Least 1 Dose of Study Drug|Overall Study||8
3307339|NCT03009162|4040722|FG001|Received at Least 1 Dose of Study Drug|Overall Study||8
3307340|NCT03009162|4040721|FG000|COMPLETED|Overall Study||8
3307341|NCT03009162|4040722|FG001|COMPLETED|Overall Study||8
3307342|NCT03009162|4040721|FG000|NOT COMPLETED|Overall Study||0
3307343|NCT03009162|4040722|FG001|NOT COMPLETED|Overall Study||0
3307344|NCT03009396|4040728|FG000|STARTED|Overall Study||16
3307345|NCT03009396|4040729|FG001|STARTED|Overall Study||38
3307346|NCT03009396|4040728|FG000|COMPLETED|Overall Study||9
3307347|NCT03009396|4040729|FG001|COMPLETED|Overall Study||21
3012787|NCT01019694|3731094|FG000|STARTED|Overall Study|2 pats. in Comb. Inh. Aero. and 3 pats. in Atro+Alb not treated and excluded from the Treated Set|157
3012788|NCT01019694|3731095|FG001|STARTED|Overall Study|2 pats. in Comb. Inh. Aero. and 3 pats. in Atro+Alb not treated and excluded from the Treated Set|156
3012789|NCT01019694|3731096|FG002|STARTED|Overall Study|2 pats. in Comb. Inh. Aero. and 3 pats. in Atro+Alb not treated and excluded from the Treated Set|157
3012790|NCT01019694|3731094|FG000|COMPLETED|Overall Study||133
3012791|NCT01019694|3731095|FG001|COMPLETED|Overall Study||118
3012792|NCT01019694|3731096|FG002|COMPLETED|Overall Study||110
3012793|NCT01019694|3731094|FG000|NOT COMPLETED|Overall Study||24
3012794|NCT01019694|3731095|FG001|NOT COMPLETED|Overall Study||38
3012795|NCT01019694|3731096|FG002|NOT COMPLETED|Overall Study||47
3012796|NCT01019707|3731104|FG000|STARTED|First Phase||3
3012797|NCT01019707|3731105|FG001|STARTED|First Phase||3
3012798|NCT01019707|3731104|FG000|COMPLETED|First Phase||3
3012799|NCT01019707|3731105|FG001|COMPLETED|First Phase||3
3012800|NCT01019707|3731104|FG000|NOT COMPLETED|First Phase||0
3012801|NCT01019707|3731105|FG001|NOT COMPLETED|First Phase||0
3012802|NCT01019707|3731104|FG000|STARTED|Washout||3
3012803|NCT01019707|3731105|FG001|STARTED|Washout||3
3012804|NCT01019707|3731104|FG000|COMPLETED|Washout||3
3012805|NCT01019707|3731105|FG001|COMPLETED|Washout||1
3012806|NCT01019707|3731104|FG000|NOT COMPLETED|Washout||0
3012807|NCT01019707|3731105|FG001|NOT COMPLETED|Washout||2
3012808|NCT01019707|3731104|FG000|STARTED|Second Phase||3
3012809|NCT01019707|3731105|FG001|STARTED|Second Phase||1
3012810|NCT01019707|3731104|FG000|COMPLETED|Second Phase||3
3012811|NCT01019707|3731105|FG001|COMPLETED|Second Phase||1
3012812|NCT01019707|3731104|FG000|NOT COMPLETED|Second Phase||0
3012813|NCT01019707|3731105|FG001|NOT COMPLETED|Second Phase||0
3012814|NCT01019928|3731113|FG000|STARTED|Period 1||7
3012815|NCT01019928|3731114|FG001|STARTED|Period 1||7
3012816|NCT01019928|3731113|FG000|COMPLETED|Period 1||7
3012817|NCT01019928|3731114|FG001|COMPLETED|Period 1||7
3012818|NCT01019928|3731113|FG000|NOT COMPLETED|Period 1||0
3012819|NCT01019928|3731114|FG001|NOT COMPLETED|Period 1||0
3307348|NCT03009396|4040728|FG000|NOT COMPLETED|Overall Study||7
3307349|NCT03009396|4040729|FG001|NOT COMPLETED|Overall Study||17
3307350|NCT03010137|4040738|FG000|STARTED|Overall Study||15
3307351|NCT03010137|4040739|FG001|STARTED|Overall Study||15
3307352|NCT03010137|4040738|FG000|COMPLETED|Overall Study||15
3307353|NCT03010137|4040739|FG001|COMPLETED|Overall Study||15
3307354|NCT03010137|4040738|FG000|NOT COMPLETED|Overall Study||0
3307355|NCT03010137|4040739|FG001|NOT COMPLETED|Overall Study||0
3307356|NCT03010254|4040747|FG000|STARTED|Overall Study||159
3307357|NCT03010254|4040748|FG001|STARTED|Overall Study||123
3307358|NCT03010254|4040747|FG000|Attempted Implantation|Overall Study||156
3307359|NCT03010254|4040748|FG001|Attempted Implantation|Overall Study||120
3307360|NCT03010254|4040747|FG000|Successful Implantation|Overall Study||156
3307361|NCT03010254|4040748|FG001|Successful Implantation|Overall Study||120
3307362|NCT03010254|4040747|FG000|COMPLETED|Overall Study||152
3307363|NCT03010254|4040748|FG001|COMPLETED|Overall Study||118
3307364|NCT03010254|4040747|FG000|NOT COMPLETED|Overall Study||7
3307365|NCT03010254|4040748|FG001|NOT COMPLETED|Overall Study||5
3307366|NCT03010462|4040763|FG000|STARTED|Overall Study||31
3307367|NCT03010462|4040764|FG001|STARTED|Overall Study||29
3307368|NCT03010462|4040763|FG000|COMPLETED|Overall Study|1 subject withdrew consent before baseline visit. 2 subjects completed treatment but were lost during follow-up|28
3307369|NCT03010462|4040764|FG001|COMPLETED|Overall Study|1 subject withdrew consent prior to baseline visit|28
3307370|NCT03010462|4040763|FG000|NOT COMPLETED|Overall Study||3
3307371|NCT03010462|4040764|FG001|NOT COMPLETED|Overall Study||1
3307372|NCT03010488|4040772|FG000|STARTED|Overall Study||22
3307373|NCT03010488|4040773|FG001|STARTED|Overall Study||22
3307374|NCT03010488|4040772|FG000|COMPLETED|Overall Study||17
3307375|NCT03010488|4040773|FG001|COMPLETED|Overall Study||15
3307376|NCT03010488|4040772|FG000|NOT COMPLETED|Overall Study||5
3307377|NCT03010488|4040773|FG001|NOT COMPLETED|Overall Study||7
3307378|NCT03010501|4040779|FG000|STARTED|Study Week 1||9
3307379|NCT03010501|4040780|FG001|STARTED|Study Week 1||15
3307380|NCT03010501|4040781|FG002|STARTED|Study Week 1||7
3307381|NCT03010501|4040782|FG003|STARTED|Study Week 1||7
3307382|NCT03010501|4040783|FG004|STARTED|Study Week 1||7
3307383|NCT03010501|4040784|FG005|STARTED|Study Week 1||11
3307384|NCT03010501|4040779|FG000|COMPLETED|Study Week 1||7
3307385|NCT03010501|4040780|FG001|COMPLETED|Study Week 1||14
3307386|NCT03010501|4040781|FG002|COMPLETED|Study Week 1||7
3307387|NCT03010501|4040782|FG003|COMPLETED|Study Week 1||5
3307388|NCT03010501|4040783|FG004|COMPLETED|Study Week 1||7
3307389|NCT03010501|4040784|FG005|COMPLETED|Study Week 1||11
3307390|NCT03010501|4040779|FG000|NOT COMPLETED|Study Week 1||2
3307391|NCT03010501|4040780|FG001|NOT COMPLETED|Study Week 1||1
3307392|NCT03010501|4040781|FG002|NOT COMPLETED|Study Week 1||0
3307393|NCT03010501|4040782|FG003|NOT COMPLETED|Study Week 1||2
3307394|NCT03010501|4040783|FG004|NOT COMPLETED|Study Week 1||0
3307395|NCT03010501|4040784|FG005|NOT COMPLETED|Study Week 1||0
3307396|NCT03010501|4040779|FG000|STARTED|Study Week 2||7
3307397|NCT03010501|4040780|FG001|STARTED|Study Week 2||14
3307398|NCT03010501|4040781|FG002|STARTED|Study Week 2||7
3012820|NCT01019928|3731113|FG000|STARTED|Period 2||7
3012821|NCT01019928|3731114|FG001|STARTED|Period 2||7
3012822|NCT01019928|3731113|FG000|COMPLETED|Period 2||7
3012823|NCT01019928|3731114|FG001|COMPLETED|Period 2|One patient had an SAE, and was withdrawn, prior to receiving AZD1386|6
3012824|NCT01019928|3731113|FG000|NOT COMPLETED|Period 2||0
3012825|NCT01019928|3731114|FG001|NOT COMPLETED|Period 2||1
3165325|NCT01898598|3892861|FG000|Treated|Overall Study||11
3165326|NCT01898598|3892862|FG001|Treated|Overall Study||5
3165327|NCT01898598|3892861|FG000|COMPLETED|Overall Study||8
3165328|NCT01898598|3892862|FG001|COMPLETED|Overall Study||4
3165329|NCT01898598|3892861|FG000|NOT COMPLETED|Overall Study||4
3165330|NCT01898598|3892862|FG001|NOT COMPLETED|Overall Study||2
3307399|NCT03010501|4040782|FG003|STARTED|Study Week 2||5
3307400|NCT03010501|4040783|FG004|STARTED|Study Week 2||7
3307401|NCT03010501|4040784|FG005|STARTED|Study Week 2||11
3307402|NCT03010501|4040779|FG000|COMPLETED|Study Week 2||7
3307403|NCT03010501|4040780|FG001|COMPLETED|Study Week 2||14
3307404|NCT03010501|4040781|FG002|COMPLETED|Study Week 2||7
3307405|NCT03010501|4040782|FG003|COMPLETED|Study Week 2||5
3307406|NCT03010501|4040783|FG004|COMPLETED|Study Week 2||7
3307407|NCT03010501|4040784|FG005|COMPLETED|Study Week 2||11
3307408|NCT03010501|4040779|FG000|NOT COMPLETED|Study Week 2||0
3307409|NCT03010501|4040780|FG001|NOT COMPLETED|Study Week 2||0
3307410|NCT03010501|4040781|FG002|NOT COMPLETED|Study Week 2||0
3307411|NCT03010501|4040782|FG003|NOT COMPLETED|Study Week 2||0
3307412|NCT03010501|4040783|FG004|NOT COMPLETED|Study Week 2||0
3307413|NCT03010501|4040784|FG005|NOT COMPLETED|Study Week 2||0
3307414|NCT03010501|4040779|FG000|STARTED|Study Week 3||7
3307415|NCT03010501|4040780|FG001|STARTED|Study Week 3||14
3307416|NCT03010501|4040781|FG002|STARTED|Study Week 3||7
3307417|NCT03010501|4040782|FG003|STARTED|Study Week 3||5
3307418|NCT03010501|4040783|FG004|STARTED|Study Week 3||7
3307419|NCT03010501|4040784|FG005|STARTED|Study Week 3||11
3307420|NCT03010501|4040779|FG000|COMPLETED|Study Week 3||7
3307421|NCT03010501|4040780|FG001|COMPLETED|Study Week 3||14
3307422|NCT03010501|4040781|FG002|COMPLETED|Study Week 3||7
3307423|NCT03010501|4040782|FG003|COMPLETED|Study Week 3||4
3307424|NCT03010501|4040783|FG004|COMPLETED|Study Week 3||7
3307425|NCT03010501|4040784|FG005|COMPLETED|Study Week 3||11
3307426|NCT03010501|4040779|FG000|NOT COMPLETED|Study Week 3||0
3307427|NCT03010501|4040780|FG001|NOT COMPLETED|Study Week 3||0
3307428|NCT03010501|4040781|FG002|NOT COMPLETED|Study Week 3||0
3307429|NCT03010501|4040782|FG003|NOT COMPLETED|Study Week 3||1
3307430|NCT03010501|4040783|FG004|NOT COMPLETED|Study Week 3||0
3307431|NCT03010501|4040784|FG005|NOT COMPLETED|Study Week 3||0
3307432|NCT03010527|4040795|FG000|STARTED|Overall Study||15
3307433|NCT03010527|4040796|FG001|STARTED|Overall Study||111
3307434|NCT03010527|4040797|FG002|STARTED|Overall Study||91
3307435|NCT03010527|4040795|FG000|COMPLETED|Overall Study||15
3307436|NCT03010527|4040796|FG001|COMPLETED|Overall Study||92
3307437|NCT03010527|4040797|FG002|COMPLETED|Overall Study||75
3307438|NCT03010527|4040795|FG000|NOT COMPLETED|Overall Study||0
3307439|NCT03010527|4040796|FG001|NOT COMPLETED|Overall Study||19
3307440|NCT03010527|4040797|FG002|NOT COMPLETED|Overall Study||16
3307441|NCT03010631|4040818|FG000|STARTED|Cohort 1||18
3307442|NCT03010631|4040819|FG001|STARTED|Cohort 1||17
3307443|NCT03010631|4040820|FG002|STARTED|Cohort 1||0
3307444|NCT03010631|4040821|FG003|STARTED|Cohort 1||0
3307445|NCT03010631|4040818|FG000|COMPLETED|Cohort 1||14
3307446|NCT03010631|4040819|FG001|COMPLETED|Cohort 1||17
3307447|NCT03010631|4040820|FG002|COMPLETED|Cohort 1||0
3307448|NCT03010631|4040821|FG003|COMPLETED|Cohort 1||0
3307449|NCT03010631|4040818|FG000|NOT COMPLETED|Cohort 1||4
3307450|NCT03010631|4040819|FG001|NOT COMPLETED|Cohort 1||0
3307451|NCT03010631|4040820|FG002|NOT COMPLETED|Cohort 1||0
3307452|NCT03010631|4040821|FG003|NOT COMPLETED|Cohort 1||0
3307453|NCT03010631|4040818|FG000|STARTED|Cohort 2||0
3307454|NCT03010631|4040819|FG001|STARTED|Cohort 2||0
3307455|NCT03010631|4040820|FG002|STARTED|Cohort 2|New participants were enrolled for Cohort 2|7
3307456|NCT03010631|4040821|FG003|STARTED|Cohort 2||7
3307457|NCT03010631|4040818|FG000|COMPLETED|Cohort 2||0
3307458|NCT03010631|4040819|FG001|COMPLETED|Cohort 2||0
3307459|NCT03010631|4040820|FG002|COMPLETED|Cohort 2||7
3307460|NCT03010631|4040821|FG003|COMPLETED|Cohort 2||7
3307461|NCT03010631|4040818|FG000|NOT COMPLETED|Cohort 2||0
3307462|NCT03010631|4040819|FG001|NOT COMPLETED|Cohort 2||0
3307463|NCT03010631|4040820|FG002|NOT COMPLETED|Cohort 2||0
3307464|NCT03010631|4040821|FG003|NOT COMPLETED|Cohort 2||0
3307465|NCT03010683|4040837|FG000|STARTED|Overall Study||30
3307466|NCT03010683|4040838|FG001|STARTED|Overall Study||30
3307467|NCT03010683|4040837|FG000|COMPLETED|Overall Study||30
3307468|NCT03010683|4040838|FG001|COMPLETED|Overall Study||30
3307469|NCT03010683|4040837|FG000|NOT COMPLETED|Overall Study||0
3307470|NCT03010683|4040838|FG001|NOT COMPLETED|Overall Study||0
3307471|NCT03010800|4040846|FG000|STARTED|Initial Assignment||4
3307472|NCT03010800|4040847|FG001|STARTED|Initial Assignment||4
3307473|NCT03010800|4040846|FG000|COMPLETED|Initial Assignment||4
3307474|NCT03010800|4040847|FG001|COMPLETED|Initial Assignment||4
3307475|NCT03010800|4040846|FG000|NOT COMPLETED|Initial Assignment||0
3307476|NCT03010800|4040847|FG001|NOT COMPLETED|Initial Assignment||0
3012826|NCT01019928|3731113|FG000|STARTED|Period 3||7
3307477|NCT03010800|4040846|FG000|STARTED|Cross Over||4
3307478|NCT03010800|4040847|FG001|STARTED|Cross Over||4
3307479|NCT03010800|4040846|FG000|COMPLETED|Cross Over||4
3307480|NCT03010800|4040847|FG001|COMPLETED|Cross Over||4
3307481|NCT03010800|4040846|FG000|NOT COMPLETED|Cross Over||0
3307482|NCT03010800|4040847|FG001|NOT COMPLETED|Cross Over||0
3307483|NCT03011099|4040855|FG000|STARTED|Overall Study||6
3307484|NCT03011099|4040856|FG001|STARTED|Overall Study||5
3012827|NCT01019928|3731114|FG001|STARTED|Period 3|One patient had an SAE, and was withdrawn, prior to receiving AZD1386|6
3012828|NCT01019928|3731113|FG000|COMPLETED|Period 3||7
3012829|NCT01019928|3731114|FG001|COMPLETED|Period 3|One patient had an SAE, and was withdrawn, prior to receiving AZD1386|6
3012830|NCT01019928|3731113|FG000|NOT COMPLETED|Period 3||0
3012831|NCT01019928|3731114|FG001|NOT COMPLETED|Period 3||0
3012832|NCT01020006|3731123|FG000|STARTED|Overall Study||8
3012833|NCT01020006|3731124|FG001|STARTED|Overall Study||18
3012834|NCT01020006|3731125|FG002|STARTED|Overall Study||16
3012835|NCT01020006|3731123|FG000|COMPLETED|Overall Study|No subjects reached study completion as defined by protocol.|0
3012836|NCT01020006|3731124|FG001|COMPLETED|Overall Study|No subjects reached study completion as defined by protocol.|0
3012837|NCT01020006|3731125|FG002|COMPLETED|Overall Study|No subjects reached study completion as defined by protocol.|0
3012838|NCT01020006|3731123|FG000|NOT COMPLETED|Overall Study||8
3012839|NCT01020006|3731124|FG001|NOT COMPLETED|Overall Study||18
3012840|NCT01020006|3731125|FG002|NOT COMPLETED|Overall Study||16
3012841|NCT01020019|3731135|FG000|STARTED|Overall Study||61
3012842|NCT01020019|3731136|FG001|STARTED|Overall Study||61
3012843|NCT01020019|3731135|FG000|COMPLETED|Overall Study||35
3012844|NCT01020019|3731136|FG001|COMPLETED|Overall Study||32
3012845|NCT01020019|3731135|FG000|NOT COMPLETED|Overall Study||26
3012846|NCT01020019|3731136|FG001|NOT COMPLETED|Overall Study||29
3012847|NCT01020123|3731149|FG000|STARTED|Main Period||93
3012848|NCT01020123|3731150|FG001|STARTED|Main Period||91
3012849|NCT01020123|3731151|FG002|STARTED|Main Period||52
3012850|NCT01020123|3731152|FG003|STARTED|Main Period||40
3012851|NCT01020123|3731153|FG004|STARTED|Main Period||88
3012852|NCT01020123|3731154|FG005|STARTED|Main Period||94
3012853|NCT01020123|3731155|FG006|STARTED|Main Period||72
3012854|NCT01020123|3731149|FG000|COMPLETED|Main Period||76
3012855|NCT01020123|3731150|FG001|COMPLETED|Main Period||77
3012856|NCT01020123|3731151|FG002|COMPLETED|Main Period||44
3012857|NCT01020123|3731152|FG003|COMPLETED|Main Period||33
3012858|NCT01020123|3731153|FG004|COMPLETED|Main Period||77
3012859|NCT01020123|3731154|FG005|COMPLETED|Main Period||83
3012860|NCT01020123|3731155|FG006|COMPLETED|Main Period||61
3012861|NCT01020123|3731149|FG000|NOT COMPLETED|Main Period||17
3012862|NCT01020123|3731150|FG001|NOT COMPLETED|Main Period||14
3012863|NCT01020123|3731151|FG002|NOT COMPLETED|Main Period||8
3012864|NCT01020123|3731152|FG003|NOT COMPLETED|Main Period||7
3012865|NCT01020123|3731153|FG004|NOT COMPLETED|Main Period||11
3012866|NCT01020123|3731154|FG005|NOT COMPLETED|Main Period||11
3012867|NCT01020123|3731155|FG006|NOT COMPLETED|Main Period||11
3012868|NCT01020123|3731149|FG000|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|40
3012869|NCT01020123|3731150|FG001|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|35
3012870|NCT01020123|3731151|FG002|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|19
3012871|NCT01020123|3731152|FG003|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|13
3012872|NCT01020123|3731153|FG004|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|31
3012873|NCT01020123|3731154|FG005|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|38
3012874|NCT01020123|3731155|FG006|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|19
3012875|NCT01020123|3731149|FG000|COMPLETED|Extention Period||37
3012876|NCT01020123|3731150|FG001|COMPLETED|Extention Period||33
3012877|NCT01020123|3731151|FG002|COMPLETED|Extention Period||17
3012878|NCT01020123|3731152|FG003|COMPLETED|Extention Period||12
3012879|NCT01020123|3731153|FG004|COMPLETED|Extention Period||31
3012880|NCT01020123|3731154|FG005|COMPLETED|Extention Period||36
3012881|NCT01020123|3731155|FG006|COMPLETED|Extention Period||18
3012882|NCT01020123|3731149|FG000|NOT COMPLETED|Extention Period||3
3012883|NCT01020123|3731150|FG001|NOT COMPLETED|Extention Period||2
3012884|NCT01020123|3731151|FG002|NOT COMPLETED|Extention Period||2
3012885|NCT01020123|3731152|FG003|NOT COMPLETED|Extention Period||1
3012886|NCT01020123|3731153|FG004|NOT COMPLETED|Extention Period||0
3012887|NCT01020123|3731154|FG005|NOT COMPLETED|Extention Period||2
3012888|NCT01020123|3731155|FG006|NOT COMPLETED|Extention Period||1
3012889|NCT01020305|3731172|FG000|STARTED|Overall Study||5
3012890|NCT01020305|3731172|FG000|COMPLETED|Overall Study||3
3012891|NCT01020305|3731172|FG000|NOT COMPLETED|Overall Study||2
3037436|NCT01147900|3756702|FG001|COMPLETED|At Year 10||59
3037437|NCT01147900|3756703|FG002|COMPLETED|At Year 10||62
3037438|NCT01147900|3756701|FG000|NOT COMPLETED|At Year 10||0
3037439|NCT01147900|3756702|FG001|NOT COMPLETED|At Year 10||1
3037440|NCT01147900|3756703|FG002|NOT COMPLETED|At Year 10||0
3037441|NCT01147926|3756713|FG000|STARTED|Overall Study||187
3037442|NCT01147926|3756714|FG001|STARTED|Overall Study||187
3037443|NCT01147926|3756713|FG000|COMPLETED|Overall Study||160
3037444|NCT01147926|3756714|FG001|COMPLETED|Overall Study||158
3037445|NCT01147926|3756713|FG000|NOT COMPLETED|Overall Study||27
3037446|NCT01147926|3756714|FG001|NOT COMPLETED|Overall Study||29
3037447|NCT01148017|3756724|FG000|STARTED|Overall Study||214
3037448|NCT01148017|3756725|FG001|STARTED|Overall Study||121
3037449|NCT01148017|3756726|FG002|STARTED|Overall Study||53
3037450|NCT01148017|3756727|FG003|STARTED|Overall Study||45
3037451|NCT01148017|3756724|FG000|COMPLETED|Overall Study||134
3037452|NCT01148017|3756725|FG001|COMPLETED|Overall Study||87
3012892|NCT01020435|3731178|FG000|STARTED|Overall Study||24
3012893|NCT01020435|3731179|FG001|STARTED|Overall Study||27
3012894|NCT01020435|3731178|FG000|COMPLETED|Overall Study||24
3012895|NCT01020435|3731179|FG001|COMPLETED|Overall Study||26
3012896|NCT01020435|3731178|FG000|NOT COMPLETED|Overall Study||0
3012897|NCT01020435|3731179|FG001|NOT COMPLETED|Overall Study||1
3012898|NCT01020448|3731186|FG000|STARTED|Pre-assignment||339
3012899|NCT01020448|3731186|FG000|COMPLETED|Pre-assignment||326
3012900|NCT01020448|3731186|FG000|NOT COMPLETED|Pre-assignment||13
3012901|NCT01020448|3731186|FG000|STARTED|Treatment|One patient was excluded from the safety population as no post-baseline assessment was available|325
3012902|NCT01020448|3731186|FG000|COMPLETED|Treatment||299
3012903|NCT01020448|3731186|FG000|NOT COMPLETED|Treatment||26
3012904|NCT01020474|3731193|FG000|STARTED|Overall Study||54
3012905|NCT01020474|3731194|FG001|STARTED|Overall Study||53
3012906|NCT01020474|3731193|FG000|COMPLETED|Overall Study||44
3012907|NCT01020474|3731194|FG001|COMPLETED|Overall Study||36
3012908|NCT01020474|3731193|FG000|NOT COMPLETED|Overall Study||10
3012909|NCT01020474|3731194|FG001|NOT COMPLETED|Overall Study||17
3012910|NCT01020487|3731203|FG000|STARTED|Part 1||12
3012911|NCT01020487|3731204|FG001|STARTED|Part 1||0
3012912|NCT01020487|3731205|FG002|STARTED|Part 1||0
3012913|NCT01020487|3731203|FG000|COMPLETED|Part 1||12
3012914|NCT01020487|3731204|FG001|COMPLETED|Part 1||0
3012915|NCT01020487|3731205|FG002|COMPLETED|Part 1||0
3012916|NCT01020487|3731203|FG000|NOT COMPLETED|Part 1||0
3012917|NCT01020487|3731204|FG001|NOT COMPLETED|Part 1||0
3012918|NCT01020487|3731205|FG002|NOT COMPLETED|Part 1||0
3012919|NCT01020487|3731203|FG000|STARTED|Part 2 Double-blind Treatment Period||0
3012920|NCT01020487|3731204|FG001|STARTED|Part 2 Double-blind Treatment Period|Includes one participant who enrolled in Part 2 after completing Part 1|18
3012921|NCT01020487|3731205|FG002|STARTED|Part 2 Double-blind Treatment Period|Includes one participant who enrolled in Part 2 after completing Part 1|19
3012922|NCT01020487|3731203|FG000|Received Treatment|Part 2 Double-blind Treatment Period||0
3012923|NCT01020487|3731204|FG001|Received Treatment|Part 2 Double-blind Treatment Period||18
3012924|NCT01020487|3731205|FG002|Received Treatment|Part 2 Double-blind Treatment Period||18
3012925|NCT01020487|3731203|FG000|COMPLETED|Part 2 Double-blind Treatment Period||0
3012926|NCT01020487|3731204|FG001|COMPLETED|Part 2 Double-blind Treatment Period||16
3012927|NCT01020487|3731205|FG002|COMPLETED|Part 2 Double-blind Treatment Period||13
3012928|NCT01020487|3731203|FG000|NOT COMPLETED|Part 2 Double-blind Treatment Period||0
3012929|NCT01020487|3731204|FG001|NOT COMPLETED|Part 2 Double-blind Treatment Period||2
3012930|NCT01020487|3731205|FG002|NOT COMPLETED|Part 2 Double-blind Treatment Period||6
3012931|NCT01020487|3731203|FG000|STARTED|Part 2 Open-label Period||0
3012932|NCT01020487|3731204|FG001|STARTED|Part 2 Open-label Period||16
3012933|NCT01020487|3731205|FG002|STARTED|Part 2 Open-label Period||13
3012934|NCT01020487|3731203|FG000|COMPLETED|Part 2 Open-label Period||0
3012935|NCT01020487|3731204|FG001|COMPLETED|Part 2 Open-label Period||12
3307485|NCT03011099|4040855|FG000|COMPLETED|Overall Study||6
3307486|NCT03011099|4040856|FG001|COMPLETED|Overall Study||3
3307487|NCT03011099|4040855|FG000|NOT COMPLETED|Overall Study||0
3307488|NCT03011099|4040856|FG001|NOT COMPLETED|Overall Study||2
3307489|NCT03011333|4040871|FG000|STARTED|Overall Study||12
3307490|NCT03011333|4040872|FG001|STARTED|Overall Study||27
3307491|NCT03011333|4040873|FG002|STARTED|Overall Study||25
3307492|NCT03011333|4040874|FG003|STARTED|Overall Study||47
3307493|NCT03011333|4040875|FG004|STARTED|Overall Study||50
3307494|NCT03011333|4040876|FG005|STARTED|Overall Study||41
3307495|NCT03011333|4040877|FG006|STARTED|Overall Study||41
3307496|NCT03011333|4040871|FG000|COMPLETED|Overall Study||12
3307497|NCT03011333|4040872|FG001|COMPLETED|Overall Study||26
3307498|NCT03011333|4040873|FG002|COMPLETED|Overall Study||25
3307499|NCT03011333|4040874|FG003|COMPLETED|Overall Study||46
3307500|NCT03011333|4040875|FG004|COMPLETED|Overall Study||46
3307501|NCT03011333|4040876|FG005|COMPLETED|Overall Study||37
3307502|NCT03011333|4040877|FG006|COMPLETED|Overall Study||36
3307503|NCT03011333|4040871|FG000|NOT COMPLETED|Overall Study||0
3307504|NCT03011333|4040872|FG001|NOT COMPLETED|Overall Study||1
3307505|NCT03011333|4040873|FG002|NOT COMPLETED|Overall Study||0
3307506|NCT03011333|4040874|FG003|NOT COMPLETED|Overall Study||1
3307507|NCT03011333|4040875|FG004|NOT COMPLETED|Overall Study||4
3307508|NCT03011333|4040876|FG005|NOT COMPLETED|Overall Study||4
3307509|NCT03011333|4040877|FG006|NOT COMPLETED|Overall Study||5
3307510|NCT03011840|4040895|FG000|STARTED|Overall Study||232
3307511|NCT03011840|4040896|FG001|STARTED|Overall Study||217
3307512|NCT03011840|4040895|FG000|COMPLETED|Overall Study||232
3307513|NCT03011840|4040896|FG001|COMPLETED|Overall Study||196
3307514|NCT03011840|4040895|FG000|NOT COMPLETED|Overall Study||0
3307515|NCT03011840|4040896|FG001|NOT COMPLETED|Overall Study||21
3307516|NCT03011892|4040908|FG000|STARTED|Double Blind (DB) Period||52
3307517|NCT03011892|4040909|FG001|STARTED|Double Blind (DB) Period||51
3307518|NCT03011892|4040910|FG002|STARTED|Double Blind (DB) Period||51
3307519|NCT03011892|4040911|FG003|STARTED|Double Blind (DB) Period||51
3307520|NCT03011892|4040912|FG004|STARTED|Double Blind (DB) Period||52
3307521|NCT03011892|4040913|FG005|STARTED|Double Blind (DB) Period||50
3307522|NCT03011892|4040914|FG006|STARTED|Double Blind (DB) Period||0
3307523|NCT03011892|4040915|FG007|STARTED|Double Blind (DB) Period||0
3307524|NCT03011892|4040916|FG008|STARTED|Double Blind (DB) Period||0
3307525|NCT03011892|4040917|FG009|STARTED|Double Blind (DB) Period||0
3307526|NCT03011892|4040918|FG010|STARTED|Double Blind (DB) Period||0
3307527|NCT03011892|4040919|FG011|STARTED|Double Blind (DB) Period||0
3012936|NCT01020487|3731205|FG002|COMPLETED|Part 2 Open-label Period||12
3012937|NCT01020487|3731203|FG000|NOT COMPLETED|Part 2 Open-label Period||0
3012938|NCT01020487|3731204|FG001|NOT COMPLETED|Part 2 Open-label Period||4
3012939|NCT01020487|3731205|FG002|NOT COMPLETED|Part 2 Open-label Period||1
3012940|NCT01020526|3731215|FG000|STARTED|Overall Study||63
3012941|NCT01020526|3731215|FG000|COMPLETED|Overall Study||49
3012942|NCT01020526|3731215|FG000|NOT COMPLETED|Overall Study||14
3012943|NCT01020591|3731221|FG000|STARTED|Overall Study||15
3012944|NCT01020591|3731222|FG001|STARTED|Overall Study||15
3012945|NCT01020591|3731221|FG000|COMPLETED|Overall Study||15
3012946|NCT01020591|3731222|FG001|COMPLETED|Overall Study||15
3012947|NCT01020591|3731221|FG000|NOT COMPLETED|Overall Study||0
3012948|NCT01020591|3731222|FG001|NOT COMPLETED|Overall Study||0
3012949|NCT01020747|3731230|FG000|STARTED|Overall Study||20
3012950|NCT01020747|3731230|FG000|COMPLETED|Overall Study||19
3012951|NCT01020747|3731230|FG000|NOT COMPLETED|Overall Study||1
3012952|NCT01020773|3731237|FG000|STARTED|Overall Study||35
3012953|NCT01020773|3731238|FG001|STARTED|Overall Study||32
3012954|NCT01020773|3731237|FG000|COMPLETED|Overall Study||31
3012955|NCT01020773|3731238|FG001|COMPLETED|Overall Study||29
3012956|NCT01020773|3731237|FG000|NOT COMPLETED|Overall Study||4
3012957|NCT01020773|3731238|FG001|NOT COMPLETED|Overall Study||3
3012958|NCT01020786|3731244|FG000|STARTED|Induction Period||109
3012959|NCT01020786|3731244|FG000|COMPLETED|Induction Period|Completed induction therapy. Completed=starting the maintenance therapy.|60
3012960|NCT01020786|3731244|FG000|NOT COMPLETED|Induction Period||49
3012961|NCT01020786|3731244|FG000|STARTED|Maintenance Period||60
3012962|NCT01020786|3731244|FG000|COMPLETED|Maintenance Period||0
3012963|NCT01020786|3731244|FG000|NOT COMPLETED|Maintenance Period||60
3012964|NCT01020799|3731252|FG000|STARTED|Overall Study||98
3012965|NCT01020799|3731253|FG001|STARTED|Overall Study||99
3012966|NCT01020799|3731254|FG002|STARTED|Overall Study||50
3012967|NCT01020799|3731252|FG000|Patients Received Treatment|Overall Study||96
3012968|NCT01020799|3731253|FG001|Patients Received Treatment|Overall Study||99
3012969|NCT01020799|3731254|FG002|Patients Received Treatment|Overall Study||50
3012970|NCT01020799|3731252|FG000|Full Analysis Set|Overall Study||91
3012971|NCT01020799|3731253|FG001|Full Analysis Set|Overall Study||94
3012972|NCT01020799|3731254|FG002|Full Analysis Set|Overall Study||49
3012973|NCT01020799|3731252|FG000|COMPLETED|Overall Study||79
3012974|NCT01020799|3731253|FG001|COMPLETED|Overall Study||85
3012975|NCT01020799|3731254|FG002|COMPLETED|Overall Study||43
3012976|NCT01020799|3731252|FG000|NOT COMPLETED|Overall Study||19
3012977|NCT01020799|3731253|FG001|NOT COMPLETED|Overall Study||14
3012978|NCT01020799|3731254|FG002|NOT COMPLETED|Overall Study||7
3012979|NCT01020812|3731262|FG000|STARTED|Overall Study||11
3012980|NCT01020812|3731262|FG000|COMPLETED|Overall Study||8
3012981|NCT01020812|3731262|FG000|NOT COMPLETED|Overall Study||3
3012982|NCT01020838|3731266|FG000|STARTED|Overall Study||218
3012983|NCT01020838|3731266|FG000|Safety Analysis Set|Overall Study|Two patients were excluded from this population because injection of florbetaben was not done.|216
3012984|NCT01020838|3731266|FG000|Interim Analysis Set (Primary Efficacy)|Overall Study|Primary efficacy analysis of initial study period (tissue-scan matched regional analysis)|41
3012985|NCT01020838|3731266|FG000|Final Analysis Set (Whole Brain)|Overall Study|Final analysis set comparing PET scans with different histopathological evaluations.|97
3012986|NCT01020838|3731266|FG000|First Annual Repeat Injection|Overall Study|Patients returning for first follow-up administration and PET-scan.|91
3012987|NCT01020838|3731266|FG000|Second Annual Repeat Injection|Overall Study|Patients returning for second follow-up administration and PET-scan.|34
3012988|NCT01020838|3731266|FG000|COMPLETED|Overall Study||35
3012989|NCT01020838|3731266|FG000|NOT COMPLETED|Overall Study||183
3012990|NCT01020877|3731281|FG000|STARTED|First Intervention||19
3012991|NCT01020877|3731282|FG001|STARTED|First Intervention||19
3012992|NCT01020877|3731281|FG000|COMPLETED|First Intervention||19
3012993|NCT01020877|3731282|FG001|COMPLETED|First Intervention||19
3307528|NCT03011892|4040908|FG000|Treated in DB Period|Double Blind (DB) Period||52
3307529|NCT03011892|4040909|FG001|Treated in DB Period|Double Blind (DB) Period||51
3307530|NCT03011892|4040910|FG002|Treated in DB Period|Double Blind (DB) Period||51
3307531|NCT03011892|4040911|FG003|Treated in DB Period|Double Blind (DB) Period||51
3307532|NCT03011892|4040912|FG004|Treated in DB Period|Double Blind (DB) Period||51
3307533|NCT03011892|4040913|FG005|Treated in DB Period|Double Blind (DB) Period||50
3307534|NCT03011892|4040914|FG006|Treated in DB Period|Double Blind (DB) Period||0
3307535|NCT03011892|4040915|FG007|Treated in DB Period|Double Blind (DB) Period||0
3307536|NCT03011892|4040916|FG008|Treated in DB Period|Double Blind (DB) Period||0
3307537|NCT03011892|4040917|FG009|Treated in DB Period|Double Blind (DB) Period||0
3307538|NCT03011892|4040918|FG010|Treated in DB Period|Double Blind (DB) Period||0
3307539|NCT03011892|4040919|FG011|Treated in DB Period|Double Blind (DB) Period||0
3307540|NCT03011892|4040908|FG000|Completed Treatment Through Week 4|Double Blind (DB) Period||44
3307541|NCT03011892|4040909|FG001|Completed Treatment Through Week 4|Double Blind (DB) Period||46
3307542|NCT03011892|4040910|FG002|Completed Treatment Through Week 4|Double Blind (DB) Period||48
3307543|NCT03011892|4040911|FG003|Completed Treatment Through Week 4|Double Blind (DB) Period||47
3307544|NCT03011892|4040912|FG004|Completed Treatment Through Week 4|Double Blind (DB) Period||49
3307545|NCT03011892|4040913|FG005|Completed Treatment Through Week 4|Double Blind (DB) Period||49
3307546|NCT03011892|4040914|FG006|Completed Treatment Through Week 4|Double Blind (DB) Period||0
3012994|NCT01020877|3731281|FG000|NOT COMPLETED|First Intervention||0
3012995|NCT01020877|3731282|FG001|NOT COMPLETED|First Intervention||0
3012996|NCT01020877|3731281|FG000|STARTED|Washout of 7 Days||19
3012997|NCT01020877|3731282|FG001|STARTED|Washout of 7 Days||19
3012998|NCT01020877|3731281|FG000|COMPLETED|Washout of 7 Days||19
3012999|NCT01020877|3731282|FG001|COMPLETED|Washout of 7 Days||19
3013000|NCT01020877|3731281|FG000|NOT COMPLETED|Washout of 7 Days||0
3013001|NCT01020877|3731282|FG001|NOT COMPLETED|Washout of 7 Days||0
3013002|NCT01020877|3731281|FG000|STARTED|Second Intervention||19
3013003|NCT01020877|3731282|FG001|STARTED|Second Intervention||19
3013004|NCT01020877|3731281|FG000|COMPLETED|Second Intervention||18
3013005|NCT01020877|3731282|FG001|COMPLETED|Second Intervention||19
3013006|NCT01020877|3731281|FG000|NOT COMPLETED|Second Intervention||1
3013007|NCT01020877|3731282|FG001|NOT COMPLETED|Second Intervention||0
3013008|NCT01020981|3731290|FG000|STARTED|Overall Study||150
3013009|NCT01020981|3731291|FG001|STARTED|Overall Study||150
3013010|NCT01020981|3731290|FG000|COMPLETED|Overall Study||66
3307547|NCT03011892|4040915|FG007|Completed Treatment Through Week 4|Double Blind (DB) Period||0
3307548|NCT03011892|4040916|FG008|Completed Treatment Through Week 4|Double Blind (DB) Period||0
3307549|NCT03011892|4040917|FG009|Completed Treatment Through Week 4|Double Blind (DB) Period||0
3307550|NCT03011892|4040918|FG010|Completed Treatment Through Week 4|Double Blind (DB) Period||0
3307551|NCT03011892|4040919|FG011|Completed Treatment Through Week 4|Double Blind (DB) Period||0
3307552|NCT03011892|4040908|FG000|COMPLETED|Double Blind (DB) Period||41
3307553|NCT03011892|4040909|FG001|COMPLETED|Double Blind (DB) Period||41
3307554|NCT03011892|4040910|FG002|COMPLETED|Double Blind (DB) Period||45
3307555|NCT03011892|4040911|FG003|COMPLETED|Double Blind (DB) Period||44
3307556|NCT03011892|4040912|FG004|COMPLETED|Double Blind (DB) Period||45
3307557|NCT03011892|4040913|FG005|COMPLETED|Double Blind (DB) Period||45
3307558|NCT03011892|4040914|FG006|COMPLETED|Double Blind (DB) Period||0
3307559|NCT03011892|4040915|FG007|COMPLETED|Double Blind (DB) Period||0
3307560|NCT03011892|4040916|FG008|COMPLETED|Double Blind (DB) Period||0
3307561|NCT03011892|4040917|FG009|COMPLETED|Double Blind (DB) Period||0
3307562|NCT03011892|4040918|FG010|COMPLETED|Double Blind (DB) Period||0
3307563|NCT03011892|4040919|FG011|COMPLETED|Double Blind (DB) Period||0
3307564|NCT03011892|4040908|FG000|NOT COMPLETED|Double Blind (DB) Period||11
3307565|NCT03011892|4040909|FG001|NOT COMPLETED|Double Blind (DB) Period||10
3307566|NCT03011892|4040910|FG002|NOT COMPLETED|Double Blind (DB) Period||6
3307567|NCT03011892|4040911|FG003|NOT COMPLETED|Double Blind (DB) Period||7
3307568|NCT03011892|4040912|FG004|NOT COMPLETED|Double Blind (DB) Period||7
3307569|NCT03011892|4040913|FG005|NOT COMPLETED|Double Blind (DB) Period||5
3307570|NCT03011892|4040914|FG006|NOT COMPLETED|Double Blind (DB) Period||0
3307571|NCT03011892|4040915|FG007|NOT COMPLETED|Double Blind (DB) Period||0
3307572|NCT03011892|4040916|FG008|NOT COMPLETED|Double Blind (DB) Period||0
3307573|NCT03011892|4040917|FG009|NOT COMPLETED|Double Blind (DB) Period||0
3307574|NCT03011892|4040918|FG010|NOT COMPLETED|Double Blind (DB) Period||0
3307575|NCT03011892|4040919|FG011|NOT COMPLETED|Double Blind (DB) Period||0
3307576|NCT03011892|4040908|FG000|STARTED|Open Label (OL) Period||0
3307577|NCT03011892|4040909|FG001|STARTED|Open Label (OL) Period||0
3307578|NCT03011892|4040910|FG002|STARTED|Open Label (OL) Period||0
3307579|NCT03011892|4040911|FG003|STARTED|Open Label (OL) Period||0
3307580|NCT03011892|4040912|FG004|STARTED|Open Label (OL) Period||0
3307581|NCT03011892|4040913|FG005|STARTED|Open Label (OL) Period||0
3307582|NCT03011892|4040914|FG006|STARTED|Open Label (OL) Period||41
3307583|NCT03011892|4040915|FG007|STARTED|Open Label (OL) Period||40
3307584|NCT03011892|4040916|FG008|STARTED|Open Label (OL) Period||45
3307585|NCT03011892|4040917|FG009|STARTED|Open Label (OL) Period||41
3307586|NCT03011892|4040918|FG010|STARTED|Open Label (OL) Period||42
3307587|NCT03011892|4040919|FG011|STARTED|Open Label (OL) Period||43
3307588|NCT03011892|4040908|FG000|COMPLETED|Open Label (OL) Period||0
3307589|NCT03011892|4040909|FG001|COMPLETED|Open Label (OL) Period||0
3307590|NCT03011892|4040910|FG002|COMPLETED|Open Label (OL) Period||0
3307591|NCT03011892|4040911|FG003|COMPLETED|Open Label (OL) Period||0
3307592|NCT03011892|4040912|FG004|COMPLETED|Open Label (OL) Period||0
3307593|NCT03011892|4040913|FG005|COMPLETED|Open Label (OL) Period||0
3307594|NCT03011892|4040914|FG006|COMPLETED|Open Label (OL) Period||34
3307595|NCT03011892|4040915|FG007|COMPLETED|Open Label (OL) Period||37
3307596|NCT03011892|4040916|FG008|COMPLETED|Open Label (OL) Period||43
3307597|NCT03011892|4040917|FG009|COMPLETED|Open Label (OL) Period||41
3307598|NCT03011892|4040918|FG010|COMPLETED|Open Label (OL) Period||40
3307599|NCT03011892|4040919|FG011|COMPLETED|Open Label (OL) Period||40
3307600|NCT03011892|4040908|FG000|NOT COMPLETED|Open Label (OL) Period||0
3307601|NCT03011892|4040909|FG001|NOT COMPLETED|Open Label (OL) Period||0
3307602|NCT03011892|4040910|FG002|NOT COMPLETED|Open Label (OL) Period||0
3307603|NCT03011892|4040911|FG003|NOT COMPLETED|Open Label (OL) Period||0
3307604|NCT03011892|4040912|FG004|NOT COMPLETED|Open Label (OL) Period||0
3307605|NCT03011892|4040913|FG005|NOT COMPLETED|Open Label (OL) Period||0
3307606|NCT03011892|4040914|FG006|NOT COMPLETED|Open Label (OL) Period||7
3307607|NCT03011892|4040915|FG007|NOT COMPLETED|Open Label (OL) Period||3
3307608|NCT03011892|4040916|FG008|NOT COMPLETED|Open Label (OL) Period||2
3307609|NCT03011892|4040917|FG009|NOT COMPLETED|Open Label (OL) Period||0
3307610|NCT03011892|4040918|FG010|NOT COMPLETED|Open Label (OL) Period||2
3307611|NCT03011892|4040919|FG011|NOT COMPLETED|Open Label (OL) Period||3
3307612|NCT03012061|4040949|FG000|STARTED|Overall Study||143
3307613|NCT03012061|4040950|FG001|STARTED|Overall Study||139
3307614|NCT03012061|4040951|FG002|STARTED|Overall Study||139
3307615|NCT03012061|4040949|FG000|COMPLETED|Overall Study||137
3013011|NCT01020981|3731291|FG001|COMPLETED|Overall Study||60
3013012|NCT01020981|3731290|FG000|NOT COMPLETED|Overall Study||84
3013013|NCT01020981|3731291|FG001|NOT COMPLETED|Overall Study||90
3307616|NCT03012061|4040950|FG001|COMPLETED|Overall Study||130
3307617|NCT03012061|4040951|FG002|COMPLETED|Overall Study||131
3307618|NCT03012061|4040949|FG000|NOT COMPLETED|Overall Study||6
3307619|NCT03012061|4040950|FG001|NOT COMPLETED|Overall Study||9
3307620|NCT03012061|4040951|FG002|NOT COMPLETED|Overall Study||8
3307621|NCT03012191|4040962|FG000|STARTED|Overall Study||2
3307622|NCT03012191|4040963|FG001|STARTED|Overall Study||2
3307623|NCT03012191|4040964|FG002|STARTED|Overall Study||2
3307624|NCT03012191|4040962|FG000|COMPLETED|Overall Study||2
3307625|NCT03012191|4040963|FG001|COMPLETED|Overall Study||2
3307626|NCT03012191|4040964|FG002|COMPLETED|Overall Study||2
3307627|NCT03012191|4040962|FG000|NOT COMPLETED|Overall Study||0
3307628|NCT03012191|4040963|FG001|NOT COMPLETED|Overall Study||0
3307629|NCT03012191|4040964|FG002|NOT COMPLETED|Overall Study||0
3307630|NCT03012334|4040983|FG000|STARTED|Period 1||9
3307631|NCT03012334|4040984|FG001|STARTED|Period 1||9
3307632|NCT03012334|4040985|FG002|STARTED|Period 1||9
3307633|NCT03012334|4040986|FG003|STARTED|Period 1||9
3307634|NCT03012334|4040987|FG004|STARTED|Period 1||9
3307635|NCT03012334|4040988|FG005|STARTED|Period 1||9
3307636|NCT03012334|4040989|FG006|STARTED|Period 1||9
3307637|NCT03012334|4040990|FG007|STARTED|Period 1||9
3307638|NCT03012334|4040991|FG008|STARTED|Period 1||9
3307639|NCT03012334|4040992|FG009|STARTED|Period 1||9
3307640|NCT03012334|4040983|FG000|COMPLETED|Period 1||9
3307641|NCT03012334|4040984|FG001|COMPLETED|Period 1||9
3307642|NCT03012334|4040985|FG002|COMPLETED|Period 1||9
3307643|NCT03012334|4040986|FG003|COMPLETED|Period 1||9
3307644|NCT03012334|4040987|FG004|COMPLETED|Period 1||9
3307645|NCT03012334|4040988|FG005|COMPLETED|Period 1||9
3307646|NCT03012334|4040989|FG006|COMPLETED|Period 1||9
3307647|NCT03012334|4040990|FG007|COMPLETED|Period 1||9
3307648|NCT03012334|4040991|FG008|COMPLETED|Period 1||9
3307649|NCT03012334|4040992|FG009|COMPLETED|Period 1||8
3307650|NCT03012334|4040983|FG000|NOT COMPLETED|Period 1||0
3307651|NCT03012334|4040984|FG001|NOT COMPLETED|Period 1||0
3307652|NCT03012334|4040985|FG002|NOT COMPLETED|Period 1||0
3307653|NCT03012334|4040986|FG003|NOT COMPLETED|Period 1||0
3307654|NCT03012334|4040987|FG004|NOT COMPLETED|Period 1||0
3307655|NCT03012334|4040988|FG005|NOT COMPLETED|Period 1||0
3307656|NCT03012334|4040989|FG006|NOT COMPLETED|Period 1||0
3307657|NCT03012334|4040990|FG007|NOT COMPLETED|Period 1||0
3307658|NCT03012334|4040991|FG008|NOT COMPLETED|Period 1||0
3307659|NCT03012334|4040992|FG009|NOT COMPLETED|Period 1||1
3307660|NCT03012334|4040983|FG000|STARTED|Period 2||9
3307661|NCT03012334|4040984|FG001|STARTED|Period 2||9
3307662|NCT03012334|4040985|FG002|STARTED|Period 2||9
3307663|NCT03012334|4040986|FG003|STARTED|Period 2||9
3307664|NCT03012334|4040987|FG004|STARTED|Period 2||9
3307665|NCT03012334|4040988|FG005|STARTED|Period 2||9
3307666|NCT03012334|4040989|FG006|STARTED|Period 2||9
3307667|NCT03012334|4040990|FG007|STARTED|Period 2||9
3307668|NCT03012334|4040991|FG008|STARTED|Period 2||9
3307669|NCT03012334|4040992|FG009|STARTED|Period 2||8
3307670|NCT03012334|4040983|FG000|COMPLETED|Period 2||9
3307671|NCT03012334|4040984|FG001|COMPLETED|Period 2||8
3307672|NCT03012334|4040985|FG002|COMPLETED|Period 2||8
3307673|NCT03012334|4040986|FG003|COMPLETED|Period 2||9
3307674|NCT03012334|4040987|FG004|COMPLETED|Period 2||9
3307675|NCT03012334|4040988|FG005|COMPLETED|Period 2||9
3307676|NCT03012334|4040989|FG006|COMPLETED|Period 2||9
3307677|NCT03012334|4040990|FG007|COMPLETED|Period 2||8
3307678|NCT03012334|4040991|FG008|COMPLETED|Period 2||9
3307679|NCT03012334|4040992|FG009|COMPLETED|Period 2||8
3307680|NCT03012334|4040983|FG000|NOT COMPLETED|Period 2||0
3307681|NCT03012334|4040984|FG001|NOT COMPLETED|Period 2||1
3307682|NCT03012334|4040985|FG002|NOT COMPLETED|Period 2||1
3307683|NCT03012334|4040986|FG003|NOT COMPLETED|Period 2||0
3307684|NCT03012334|4040987|FG004|NOT COMPLETED|Period 2||0
3307685|NCT03012334|4040988|FG005|NOT COMPLETED|Period 2||0
3307686|NCT03012334|4040989|FG006|NOT COMPLETED|Period 2||0
3307687|NCT03012334|4040990|FG007|NOT COMPLETED|Period 2||1
3307688|NCT03012334|4040991|FG008|NOT COMPLETED|Period 2||0
3307689|NCT03012334|4040992|FG009|NOT COMPLETED|Period 2||0
3307690|NCT03012334|4040983|FG000|STARTED|Period 3||9
3307691|NCT03012334|4040984|FG001|STARTED|Period 3||8
3307692|NCT03012334|4040985|FG002|STARTED|Period 3||8
3307693|NCT03012334|4040986|FG003|STARTED|Period 3||9
3307694|NCT03012334|4040987|FG004|STARTED|Period 3||9
3307695|NCT03012334|4040988|FG005|STARTED|Period 3||9
3307696|NCT03012334|4040989|FG006|STARTED|Period 3||9
3307697|NCT03012334|4040990|FG007|STARTED|Period 3||8
3307698|NCT03012334|4040991|FG008|STARTED|Period 3||9
3013014|NCT01021007|3731301|FG000|STARTED|Overall Study||36
3307699|NCT03012334|4040992|FG009|STARTED|Period 3||8
3307700|NCT03012334|4040983|FG000|COMPLETED|Period 3||9
3307701|NCT03012334|4040984|FG001|COMPLETED|Period 3||8
3307702|NCT03012334|4040985|FG002|COMPLETED|Period 3||8
3307703|NCT03012334|4040986|FG003|COMPLETED|Period 3||9
3307704|NCT03012334|4040987|FG004|COMPLETED|Period 3||9
3307705|NCT03012334|4040988|FG005|COMPLETED|Period 3||9
3307706|NCT03012334|4040989|FG006|COMPLETED|Period 3||9
3307707|NCT03012334|4040990|FG007|COMPLETED|Period 3||8
3307708|NCT03012334|4040991|FG008|COMPLETED|Period 3||9
3307709|NCT03012334|4040992|FG009|COMPLETED|Period 3||8
3307710|NCT03012334|4040983|FG000|NOT COMPLETED|Period 3||0
3013015|NCT01021007|3731302|FG001|STARTED|Overall Study||37
3013016|NCT01021007|3731301|FG000|COMPLETED|Overall Study||34
3013017|NCT01021007|3731302|FG001|COMPLETED|Overall Study||33
3013018|NCT01021007|3731301|FG000|NOT COMPLETED|Overall Study||2
3013019|NCT01021007|3731302|FG001|NOT COMPLETED|Overall Study||4
3013020|NCT01021020|3731308|FG000|STARTED|Period I||28
3013021|NCT01021020|3731308|FG000|COMPLETED|Period I|Colchicine(fasted)-subject took Claritin-D 12hour.Colchicine(fed)arm-subject had schedule conflict.|26
3013022|NCT01021020|3731308|FG000|NOT COMPLETED|Period I||2
3013023|NCT01021020|3731308|FG000|STARTED|14 Day Washout Period A||26
3013024|NCT01021020|3731308|FG000|COMPLETED|14 Day Washout Period A|Colchicine/Probenecid-medical investigator dropped due to abnormal check-in lab results.|25
3013025|NCT01021020|3731308|FG000|NOT COMPLETED|14 Day Washout Period A||1
3013026|NCT01021020|3731308|FG000|STARTED|Period II||25
3013027|NCT01021020|3731308|FG000|COMPLETED|Period II||25
3013028|NCT01021020|3731308|FG000|NOT COMPLETED|Period II||0
3013029|NCT01021020|3731308|FG000|STARTED|14 Day Washout Period B||25
3013030|NCT01021020|3731308|FG000|COMPLETED|14 Day Washout Period B||25
3013031|NCT01021020|3731308|FG000|NOT COMPLETED|14 Day Washout Period B||0
3013032|NCT01021020|3731308|FG000|STARTED|Period III||25
3013033|NCT01021020|3731308|FG000|COMPLETED|Period III||25
3013034|NCT01021020|3731308|FG000|NOT COMPLETED|Period III||0
3013035|NCT01021111|3731320|FG000|STARTED|Overall Study||17
3013036|NCT01021111|3731320|FG000|COMPLETED|Overall Study||17
3013037|NCT01021111|3731320|FG000|NOT COMPLETED|Overall Study||0
3013038|NCT01021137|3731328|FG000|STARTED|Overall Study||62
3013039|NCT01021137|3731329|FG001|STARTED|Overall Study||20
3013040|NCT01021137|3731330|FG002|STARTED|Overall Study||11
3013041|NCT01021137|3731331|FG003|STARTED|Overall Study||41
3013042|NCT01021137|3731328|FG000|COMPLETED|Overall Study||52
3013043|NCT01021137|3731329|FG001|COMPLETED|Overall Study||16
3013044|NCT01021137|3731330|FG002|COMPLETED|Overall Study||9
3013045|NCT01021137|3731331|FG003|COMPLETED|Overall Study||32
3013046|NCT01021137|3731328|FG000|NOT COMPLETED|Overall Study||10
3013047|NCT01021137|3731329|FG001|NOT COMPLETED|Overall Study||4
3013048|NCT01021137|3731330|FG002|NOT COMPLETED|Overall Study||2
3013049|NCT01021137|3731331|FG003|NOT COMPLETED|Overall Study||9
3013050|NCT01021215|3731344|FG000|STARTED|Overall Study||60
3013051|NCT01021215|3731345|FG001|STARTED|Overall Study||20
3307711|NCT03012334|4040984|FG001|NOT COMPLETED|Period 3||0
3307712|NCT03012334|4040985|FG002|NOT COMPLETED|Period 3||0
3307713|NCT03012334|4040986|FG003|NOT COMPLETED|Period 3||0
3307714|NCT03012334|4040987|FG004|NOT COMPLETED|Period 3||0
3307715|NCT03012334|4040988|FG005|NOT COMPLETED|Period 3||0
3307716|NCT03012334|4040989|FG006|NOT COMPLETED|Period 3||0
3307717|NCT03012334|4040990|FG007|NOT COMPLETED|Period 3||0
3307718|NCT03012334|4040991|FG008|NOT COMPLETED|Period 3||0
3307719|NCT03012334|4040992|FG009|NOT COMPLETED|Period 3||0
3307720|NCT03012334|4040983|FG000|STARTED|Period 4||9
3307721|NCT03012334|4040984|FG001|STARTED|Period 4||8
3307722|NCT03012334|4040985|FG002|STARTED|Period 4||8
3307723|NCT03012334|4040986|FG003|STARTED|Period 4||9
3307724|NCT03012334|4040987|FG004|STARTED|Period 4||9
3307725|NCT03012334|4040988|FG005|STARTED|Period 4||9
3307726|NCT03012334|4040989|FG006|STARTED|Period 4||9
3307727|NCT03012334|4040990|FG007|STARTED|Period 4||8
3307728|NCT03012334|4040991|FG008|STARTED|Period 4||9
3307729|NCT03012334|4040992|FG009|STARTED|Period 4||8
3307730|NCT03012334|4040983|FG000|COMPLETED|Period 4||9
3307731|NCT03012334|4040984|FG001|COMPLETED|Period 4||8
3307732|NCT03012334|4040985|FG002|COMPLETED|Period 4||8
3307733|NCT03012334|4040986|FG003|COMPLETED|Period 4||9
3307734|NCT03012334|4040987|FG004|COMPLETED|Period 4||9
3307735|NCT03012334|4040988|FG005|COMPLETED|Period 4||9
3307736|NCT03012334|4040989|FG006|COMPLETED|Period 4||8
3307737|NCT03012334|4040990|FG007|COMPLETED|Period 4||8
3307738|NCT03012334|4040991|FG008|COMPLETED|Period 4||8
3307739|NCT03012334|4040992|FG009|COMPLETED|Period 4||8
3307740|NCT03012334|4040983|FG000|NOT COMPLETED|Period 4||0
3307741|NCT03012334|4040984|FG001|NOT COMPLETED|Period 4||0
3307742|NCT03012334|4040985|FG002|NOT COMPLETED|Period 4||0
3307743|NCT03012334|4040986|FG003|NOT COMPLETED|Period 4||0
3307744|NCT03012334|4040987|FG004|NOT COMPLETED|Period 4||0
3307745|NCT03012334|4040988|FG005|NOT COMPLETED|Period 4||0
3307746|NCT03012334|4040989|FG006|NOT COMPLETED|Period 4||1
3307747|NCT03012334|4040990|FG007|NOT COMPLETED|Period 4||0
3307748|NCT03012334|4040991|FG008|NOT COMPLETED|Period 4||1
3307749|NCT03012334|4040992|FG009|NOT COMPLETED|Period 4||0
3307750|NCT03012334|4040983|FG000|STARTED|Period 5||9
3307751|NCT03012334|4040984|FG001|STARTED|Period 5||8
3307752|NCT03012334|4040985|FG002|STARTED|Period 5||8
3307753|NCT03012334|4040986|FG003|STARTED|Period 5||9
3307754|NCT03012334|4040987|FG004|STARTED|Period 5||9
3307755|NCT03012334|4040988|FG005|STARTED|Period 5||9
3307756|NCT03012334|4040989|FG006|STARTED|Period 5||8
3307757|NCT03012334|4040990|FG007|STARTED|Period 5||8
3307758|NCT03012334|4040991|FG008|STARTED|Period 5||8
3307759|NCT03012334|4040992|FG009|STARTED|Period 5||8
3307760|NCT03012334|4040983|FG000|COMPLETED|Period 5||9
3013052|NCT01021215|3731344|FG000|Received Allocated Intervention|Overall Study||60
3013053|NCT01021215|3731345|FG001|Received Allocated Intervention|Overall Study||20
3013054|NCT01021215|3731344|FG000|COMPLETED|Overall Study||57
3013055|NCT01021215|3731345|FG001|COMPLETED|Overall Study||20
3307761|NCT03012334|4040984|FG001|COMPLETED|Period 5||8
3307762|NCT03012334|4040985|FG002|COMPLETED|Period 5||8
3307763|NCT03012334|4040986|FG003|COMPLETED|Period 5||9
3307764|NCT03012334|4040987|FG004|COMPLETED|Period 5||9
3307765|NCT03012334|4040988|FG005|COMPLETED|Period 5||9
3307766|NCT03012334|4040989|FG006|COMPLETED|Period 5||8
3307767|NCT03012334|4040990|FG007|COMPLETED|Period 5||8
3307768|NCT03012334|4040991|FG008|COMPLETED|Period 5||8
3307769|NCT03012334|4040992|FG009|COMPLETED|Period 5||8
3307770|NCT03012334|4040983|FG000|NOT COMPLETED|Period 5||0
3307771|NCT03012334|4040984|FG001|NOT COMPLETED|Period 5||0
3307772|NCT03012334|4040985|FG002|NOT COMPLETED|Period 5||0
3307773|NCT03012334|4040986|FG003|NOT COMPLETED|Period 5||0
3307774|NCT03012334|4040987|FG004|NOT COMPLETED|Period 5||0
3307775|NCT03012334|4040988|FG005|NOT COMPLETED|Period 5||0
3307776|NCT03012334|4040989|FG006|NOT COMPLETED|Period 5||0
3307777|NCT03012334|4040990|FG007|NOT COMPLETED|Period 5||0
3307778|NCT03012334|4040991|FG008|NOT COMPLETED|Period 5||0
3307779|NCT03012334|4040992|FG009|NOT COMPLETED|Period 5||0
3307780|NCT03012477|4041005|FG000|STARTED|Overall Study||34
3307781|NCT03012477|4041005|FG000|COMPLETED|Overall Study||34
3307782|NCT03012477|4041005|FG000|NOT COMPLETED|Overall Study||0
3307783|NCT03012594|4041009|FG000|STARTED|Overall Study||12
3307784|NCT03012594|4041009|FG000|COMPLETED|Overall Study||9
3307785|NCT03012594|4041009|FG000|NOT COMPLETED|Overall Study||3
3307786|NCT03012672|4041015|FG000|STARTED|Overall Study||20
3307787|NCT03012672|4041016|FG001|STARTED|Overall Study||30
3307788|NCT03012672|4041015|FG000|COMPLETED|Overall Study||20
3307789|NCT03012672|4041016|FG001|COMPLETED|Overall Study||30
3307790|NCT03012672|4041015|FG000|NOT COMPLETED|Overall Study||0
3307791|NCT03012672|4041016|FG001|NOT COMPLETED|Overall Study||0
3307792|NCT03012828|4041027|FG000|STARTED|Overall Study||10
3307793|NCT03012828|4041028|FG001|STARTED|Overall Study||10
3307794|NCT03012828|4041029|FG002|STARTED|Overall Study||10
3307795|NCT03012828|4041030|FG003|STARTED|Overall Study||10
3307796|NCT03012828|4041031|FG004|STARTED|Overall Study||10
3307797|NCT03012828|4041032|FG005|STARTED|Overall Study||10
3307798|NCT03012828|4041027|FG000|COMPLETED|Overall Study||9
3307799|NCT03012828|4041028|FG001|COMPLETED|Overall Study||10
3307800|NCT03012828|4041029|FG002|COMPLETED|Overall Study||8
3307801|NCT03012828|4041030|FG003|COMPLETED|Overall Study||10
3307802|NCT03012828|4041031|FG004|COMPLETED|Overall Study||8
3307803|NCT03012828|4041032|FG005|COMPLETED|Overall Study||8
3307804|NCT03012828|4041027|FG000|NOT COMPLETED|Overall Study||1
3307805|NCT03012828|4041028|FG001|NOT COMPLETED|Overall Study||0
3307806|NCT03012828|4041029|FG002|NOT COMPLETED|Overall Study||2
3307807|NCT03012828|4041030|FG003|NOT COMPLETED|Overall Study||0
3307808|NCT03012828|4041031|FG004|NOT COMPLETED|Overall Study||2
3307809|NCT03012828|4041032|FG005|NOT COMPLETED|Overall Study||2
3307810|NCT03012841|4041048|FG000|STARTED|Overall Study||165
3307811|NCT03012841|4041049|FG001|STARTED|Overall Study||21
3307812|NCT03012841|4041048|FG000|COMPLETED|Overall Study||145
3307813|NCT03012841|4041049|FG001|COMPLETED|Overall Study||0
3307814|NCT03012841|4041048|FG000|NOT COMPLETED|Overall Study||20
3307815|NCT03012841|4041049|FG001|NOT COMPLETED|Overall Study||21
3307816|NCT03013985|4041056|FG000|STARTED|Overall Study||108
3307817|NCT03013985|4041057|FG001|STARTED|Overall Study||103
3307818|NCT03013985|4041056|FG000|COMPLETED|Overall Study||92
3307819|NCT03013985|4041057|FG001|COMPLETED|Overall Study||84
3307820|NCT03013985|4041056|FG000|NOT COMPLETED|Overall Study||16
3307821|NCT03013985|4041057|FG001|NOT COMPLETED|Overall Study||19
3307822|NCT03014011|4041063|FG000|STARTED|First Intervention||14
3307823|NCT03014011|4041064|FG001|STARTED|First Intervention||13
3307824|NCT03014011|4041063|FG000|COMPLETED|First Intervention||13
3307825|NCT03014011|4041064|FG001|COMPLETED|First Intervention||13
3307826|NCT03014011|4041063|FG000|NOT COMPLETED|First Intervention||1
3307827|NCT03014011|4041064|FG001|NOT COMPLETED|First Intervention||0
3307828|NCT03014011|4041063|FG000|STARTED|Washout||13
3307829|NCT03014011|4041064|FG001|STARTED|Washout||13
3307830|NCT03014011|4041063|FG000|COMPLETED|Washout||12
3307831|NCT03014011|4041064|FG001|COMPLETED|Washout||13
3307832|NCT03014011|4041063|FG000|NOT COMPLETED|Washout||1
3307833|NCT03014011|4041064|FG001|NOT COMPLETED|Washout||0
3307834|NCT03014011|4041063|FG000|STARTED|Second Intervention||12
3307835|NCT03014011|4041064|FG001|STARTED|Second Intervention||13
3307836|NCT03014011|4041063|FG000|COMPLETED|Second Intervention||12
3307837|NCT03014011|4041064|FG001|COMPLETED|Second Intervention||13
3307838|NCT03014011|4041063|FG000|NOT COMPLETED|Second Intervention||0
3307839|NCT03014011|4041064|FG001|NOT COMPLETED|Second Intervention||0
3307840|NCT03014180|4041070|FG000|STARTED|Overall Study||60
3307841|NCT03014180|4041070|FG000|COMPLETED|Overall Study||58
3307842|NCT03014180|4041070|FG000|NOT COMPLETED|Overall Study||2
3307843|NCT03014206|4041078|FG000|STARTED|Overall Study||696
3307844|NCT03014206|4041078|FG000|COMPLETED|Overall Study||684
3307845|NCT03014206|4041078|FG000|NOT COMPLETED|Overall Study||12
3307846|NCT03014453|4041082|FG000|STARTED|Overall Study||187
3307847|NCT03014453|4041082|FG000|COMPLETED|Overall Study||116
3307848|NCT03014453|4041082|FG000|NOT COMPLETED|Overall Study||71
3307849|NCT03014479|4041088|FG000|STARTED|Overall Study||110
3307850|NCT03014479|4041089|FG001|STARTED|Overall Study||109
3307851|NCT03014479|4041088|FG000|COMPLETED|Overall Study||110
3307852|NCT03014479|4041089|FG001|COMPLETED|Overall Study||105
3307853|NCT03014479|4041088|FG000|NOT COMPLETED|Overall Study||0
3307854|NCT03014479|4041089|FG001|NOT COMPLETED|Overall Study||4
3307855|NCT03014492|4041097|FG000|STARTED|Overall Study||44
3307856|NCT03014492|4041098|FG001|STARTED|Overall Study||28
3307857|NCT03014492|4041097|FG000|COMPLETED|Overall Study||44
3307858|NCT03014492|4041098|FG001|COMPLETED|Overall Study||28
3013056|NCT01021215|3731344|FG000|NOT COMPLETED|Overall Study||3
3013057|NCT01021215|3731345|FG001|NOT COMPLETED|Overall Study||0
3013058|NCT01021293|3731353|FG000|STARTED|Overall Study||550
3013059|NCT01021293|3731354|FG001|STARTED|Overall Study||550
3013060|NCT01021293|3731353|FG000|COMPLETED|Overall Study||538
3013061|NCT01021293|3731354|FG001|COMPLETED|Overall Study||526
3013062|NCT01021293|3731353|FG000|NOT COMPLETED|Overall Study||12
3013063|NCT01021293|3731354|FG001|NOT COMPLETED|Overall Study||24
3013064|NCT01021306|3731365|FG000|STARTED|2 Month (Primary Outcome)||20
3013065|NCT01021306|3731366|FG001|STARTED|2 Month (Primary Outcome)||20
3013066|NCT01021306|3731367|FG002|STARTED|2 Month (Primary Outcome)||19
3013067|NCT01021306|3731368|FG003|STARTED|2 Month (Primary Outcome)||21
3013068|NCT01021306|3731365|FG000|COMPLETED|2 Month (Primary Outcome)||14
3013069|NCT01021306|3731366|FG001|COMPLETED|2 Month (Primary Outcome)||14
3013070|NCT01021306|3731367|FG002|COMPLETED|2 Month (Primary Outcome)||14
3013071|NCT01021306|3731368|FG003|COMPLETED|2 Month (Primary Outcome)||17
3013072|NCT01021306|3731365|FG000|NOT COMPLETED|2 Month (Primary Outcome)||6
3013073|NCT01021306|3731366|FG001|NOT COMPLETED|2 Month (Primary Outcome)||6
3013074|NCT01021306|3731367|FG002|NOT COMPLETED|2 Month (Primary Outcome)||5
3013075|NCT01021306|3731368|FG003|NOT COMPLETED|2 Month (Primary Outcome)||4
3013076|NCT01021306|3731365|FG000|STARTED|6 Month (Follow-up)||14
3013077|NCT01021306|3731366|FG001|STARTED|6 Month (Follow-up)||14
3013078|NCT01021306|3731367|FG002|STARTED|6 Month (Follow-up)||14
3013079|NCT01021306|3731368|FG003|STARTED|6 Month (Follow-up)||17
3013080|NCT01021306|3731365|FG000|COMPLETED|6 Month (Follow-up)||11
3013081|NCT01021306|3731366|FG001|COMPLETED|6 Month (Follow-up)||13
3013082|NCT01021306|3731367|FG002|COMPLETED|6 Month (Follow-up)||14
3013083|NCT01021306|3731368|FG003|COMPLETED|6 Month (Follow-up)||14
3013084|NCT01021306|3731365|FG000|NOT COMPLETED|6 Month (Follow-up)||3
3013085|NCT01021306|3731366|FG001|NOT COMPLETED|6 Month (Follow-up)||1
3013086|NCT01021306|3731367|FG002|NOT COMPLETED|6 Month (Follow-up)||0
3013087|NCT01021306|3731368|FG003|NOT COMPLETED|6 Month (Follow-up)||3
3013088|NCT01021332|3731378|FG000|STARTED|Overall Study|Took ≥ 1 dose of FDC open-label study drug|1066
3013089|NCT01021332|3731378|FG000|Safety Analysis Set (SAF)|Overall Study||1066
3013090|NCT01021332|3731378|FG000|Full Analysis Set (FAS)|Overall Study||1009
3013091|NCT01021332|3731378|FG000|COMPLETED|Overall Study||960
3013092|NCT01021332|3731378|FG000|NOT COMPLETED|Overall Study||106
3013093|NCT01021423|3731386|FG000|STARTED|Overall Study|One participant discontinued treatment (continued in the study) due to an AE|4
3013094|NCT01021423|3731387|FG001|STARTED|Overall Study|One participant discontinued treatment (continued in the study) due to disease progression|5
3307859|NCT03014492|4041097|FG000|NOT COMPLETED|Overall Study||0
3307860|NCT03014492|4041098|FG001|NOT COMPLETED|Overall Study||0
3307861|NCT03014674|4041107|FG000|STARTED|Overall Study||85
3307862|NCT03014674|4041108|FG001|STARTED|Overall Study||79
3307863|NCT03014674|4041109|FG002|STARTED|Overall Study||80
3307864|NCT03014674|4041107|FG000|COMPLETED|Overall Study||84
3307865|NCT03014674|4041108|FG001|COMPLETED|Overall Study||79
3307866|NCT03014674|4041109|FG002|COMPLETED|Overall Study||80
3307867|NCT03014674|4041107|FG000|NOT COMPLETED|Overall Study||1
3307868|NCT03014674|4041108|FG001|NOT COMPLETED|Overall Study||0
3307869|NCT03014674|4041109|FG002|NOT COMPLETED|Overall Study||0
3307870|NCT03014700|4041119|FG000|STARTED|Overall Study||30
3307871|NCT03014700|4041120|FG001|STARTED|Overall Study||30
3307872|NCT03014700|4041119|FG000|COMPLETED|Overall Study||25
3307873|NCT03014700|4041120|FG001|COMPLETED|Overall Study||29
3307874|NCT03014700|4041119|FG000|NOT COMPLETED|Overall Study||5
3307875|NCT03014700|4041120|FG001|NOT COMPLETED|Overall Study||1
3307876|NCT03015116|4041129|FG000|STARTED|Overall Study||38
3307877|NCT03015116|4041130|FG001|STARTED|Overall Study||38
3307878|NCT03015116|4041131|FG002|STARTED|Overall Study||38
3307879|NCT03015116|4041129|FG000|COMPLETED|Overall Study||31
3307880|NCT03015116|4041130|FG001|COMPLETED|Overall Study||36
3307881|NCT03015116|4041131|FG002|COMPLETED|Overall Study||36
3307882|NCT03015116|4041129|FG000|NOT COMPLETED|Overall Study||7
3307883|NCT03015116|4041130|FG001|NOT COMPLETED|Overall Study||2
3307884|NCT03015116|4041131|FG002|NOT COMPLETED|Overall Study||2
3307885|NCT03015142|4041141|FG000|STARTED|Overall Study||21
3307886|NCT03015142|4041141|FG000|COMPLETED|Overall Study||20
3307887|NCT03015142|4041141|FG000|NOT COMPLETED|Overall Study||1
3307888|NCT03015181|4041154|FG000|STARTED|Overall Study||4
3307889|NCT03015181|4041155|FG001|STARTED|Overall Study||3
3307890|NCT03015181|4041156|FG002|STARTED|Overall Study||3
3307891|NCT03015181|4041157|FG003|STARTED|Overall Study||3
3307892|NCT03015181|4041158|FG004|STARTED|Overall Study||3
3307893|NCT03015181|4041159|FG005|STARTED|Overall Study||5
3307894|NCT03015181|4041160|FG006|STARTED|Overall Study||5
3307895|NCT03015181|4041154|FG000|Received VRC07-523LS Per Protocol|Overall Study||3
3307896|NCT03015181|4041155|FG001|Received VRC07-523LS Per Protocol|Overall Study||3
3307897|NCT03015181|4041156|FG002|Received VRC07-523LS Per Protocol|Overall Study||3
3307898|NCT03015181|4041157|FG003|Received VRC07-523LS Per Protocol|Overall Study||3
3307899|NCT03015181|4041158|FG004|Received VRC07-523LS Per Protocol|Overall Study||3
3307900|NCT03015181|4041159|FG005|Received VRC07-523LS Per Protocol|Overall Study||4
3307901|NCT03015181|4041160|FG006|Received VRC07-523LS Per Protocol|Overall Study||4
3013095|NCT01021423|3731386|FG000|COMPLETED|Overall Study||0
3013096|NCT01021423|3731387|FG001|COMPLETED|Overall Study||0
3013097|NCT01021423|3731386|FG000|NOT COMPLETED|Overall Study||4
3013098|NCT01021423|3731387|FG001|NOT COMPLETED|Overall Study||5
3013099|NCT01021553|3731396|FG000|STARTED|Overall Study||27
3013100|NCT01021553|3731397|FG001|STARTED|Overall Study||22
3013101|NCT01021553|3731398|FG002|STARTED|Overall Study||28
3013102|NCT01021553|3731396|FG000|COMPLETED|Overall Study||23
3013103|NCT01021553|3731397|FG001|COMPLETED|Overall Study||17
3013104|NCT01021553|3731398|FG002|COMPLETED|Overall Study||25
3013105|NCT01021553|3731396|FG000|NOT COMPLETED|Overall Study||4
3013106|NCT01021553|3731397|FG001|NOT COMPLETED|Overall Study||5
3013107|NCT01021553|3731398|FG002|NOT COMPLETED|Overall Study||3
3013108|NCT01021618|3731413|FG000|STARTED|Overall Study||44
3013109|NCT01021618|3731414|FG001|STARTED|Overall Study||96
3307902|NCT03015181|4041154|FG000|Discontinued VRC07-523LS Administrations|Overall Study|One Group 1 subject decided not to receive the VRC07-523LS infusion|1
3307903|NCT03015181|4041155|FG001|Discontinued VRC07-523LS Administrations|Overall Study||0
3307904|NCT03015181|4041156|FG002|Discontinued VRC07-523LS Administrations|Overall Study||0
3307905|NCT03015181|4041157|FG003|Discontinued VRC07-523LS Administrations|Overall Study||0
3307906|NCT03015181|4041158|FG004|Discontinued VRC07-523LS Administrations|Overall Study||0
3307907|NCT03015181|4041159|FG005|Discontinued VRC07-523LS Administrations|Overall Study|One Group 6 subject received only 1 of 3 scheduled doses prior to withdrawing from the study|1
3307908|NCT03015181|4041160|FG006|Discontinued VRC07-523LS Administrations|Overall Study|One Group 7 subject received only 1 of 3 scheduled doses due to an unrelated intercurrent illness|1
3307909|NCT03015181|4041154|FG000|COMPLETED|Overall Study||3
3307910|NCT03015181|4041155|FG001|COMPLETED|Overall Study||3
3307911|NCT03015181|4041156|FG002|COMPLETED|Overall Study||3
3307912|NCT03015181|4041157|FG003|COMPLETED|Overall Study||3
3307913|NCT03015181|4041158|FG004|COMPLETED|Overall Study||3
3307914|NCT03015181|4041159|FG005|COMPLETED|Overall Study|Group 6 subject who received only 1 dose chose to withdraw from study after the first administration|4
3307915|NCT03015181|4041160|FG006|COMPLETED|Overall Study|Group 7 subject who received only 1 dose was withdrawn after unrelated intercurrent illness resolved|4
3307916|NCT03015181|4041154|FG000|NOT COMPLETED|Overall Study||1
3307917|NCT03015181|4041155|FG001|NOT COMPLETED|Overall Study||0
3307918|NCT03015181|4041156|FG002|NOT COMPLETED|Overall Study||0
3307919|NCT03015181|4041157|FG003|NOT COMPLETED|Overall Study||0
3307920|NCT03015181|4041158|FG004|NOT COMPLETED|Overall Study||0
3307921|NCT03015181|4041159|FG005|NOT COMPLETED|Overall Study||1
3307922|NCT03015181|4041160|FG006|NOT COMPLETED|Overall Study||1
3307923|NCT03015194|4041196|FG000|STARTED|Overall Study||30
3307924|NCT03015194|4041196|FG000|COMPLETED|Overall Study||18
3307925|NCT03015194|4041196|FG000|NOT COMPLETED|Overall Study||12
3307926|NCT03015220|4041205|FG000|STARTED|Overall Study||131
3307927|NCT03015220|4041206|FG001|STARTED|Overall Study||132
3307928|NCT03015220|4041207|FG002|STARTED|Overall Study||130
3307929|NCT03015220|4041208|FG003|STARTED|Overall Study||65
3307930|NCT03015220|4041205|FG000|Full Analysis Set (FAS)|Overall Study||131
3307931|NCT03015220|4041206|FG001|Full Analysis Set (FAS)|Overall Study||132
3307932|NCT03015220|4041207|FG002|Full Analysis Set (FAS)|Overall Study||130
3307933|NCT03015220|4041208|FG003|Full Analysis Set (FAS)|Overall Study||65
3307934|NCT03015220|4041205|FG000|Safety Analysis Set (SAS)|Overall Study||131
3307935|NCT03015220|4041206|FG001|Safety Analysis Set (SAS)|Overall Study||132
3307936|NCT03015220|4041207|FG002|Safety Analysis Set (SAS)|Overall Study||130
3307937|NCT03015220|4041208|FG003|Safety Analysis Set (SAS)|Overall Study||65
3307938|NCT03015220|4041205|FG000|COMPLETED|Overall Study||128
3307939|NCT03015220|4041206|FG001|COMPLETED|Overall Study||130
3307940|NCT03015220|4041207|FG002|COMPLETED|Overall Study||127
3307941|NCT03015220|4041208|FG003|COMPLETED|Overall Study||63
3307942|NCT03015220|4041205|FG000|NOT COMPLETED|Overall Study||3
3307943|NCT03015220|4041206|FG001|NOT COMPLETED|Overall Study||2
3307944|NCT03015220|4041207|FG002|NOT COMPLETED|Overall Study||3
3307945|NCT03015220|4041208|FG003|NOT COMPLETED|Overall Study||2
3307946|NCT03015363|4041218|FG000|STARTED|Overall Study||37
3307947|NCT03015363|4041218|FG000|COMPLETED|Overall Study||20
3307948|NCT03015363|4041218|FG000|NOT COMPLETED|Overall Study||17
3307949|NCT03015532|4041230|FG000|STARTED|Overall Study||20
3307950|NCT03015532|4041231|FG001|STARTED|Overall Study||22
3307951|NCT03015532|4041232|FG002|STARTED|Overall Study||11
3307952|NCT03015532|4041233|FG003|STARTED|Overall Study||10
3307953|NCT03015532|4041234|FG004|STARTED|Overall Study||58
3307954|NCT03015532|4041235|FG005|STARTED|Overall Study||56
3307955|NCT03015532|4041236|FG006|STARTED|Overall Study||53
3307956|NCT03015532|4041237|FG007|STARTED|Overall Study||55
3307957|NCT03015532|4041230|FG000|COMPLETED|Overall Study||20
3307958|NCT03015532|4041231|FG001|COMPLETED|Overall Study||22
3307959|NCT03015532|4041232|FG002|COMPLETED|Overall Study||11
3307960|NCT03015532|4041233|FG003|COMPLETED|Overall Study||10
3307961|NCT03015532|4041234|FG004|COMPLETED|Overall Study||58
3307962|NCT03015532|4041235|FG005|COMPLETED|Overall Study||54
3307963|NCT03015532|4041236|FG006|COMPLETED|Overall Study||51
3307964|NCT03015532|4041237|FG007|COMPLETED|Overall Study||55
3307965|NCT03015532|4041230|FG000|NOT COMPLETED|Overall Study||0
3307966|NCT03015532|4041231|FG001|NOT COMPLETED|Overall Study||0
3307967|NCT03015532|4041232|FG002|NOT COMPLETED|Overall Study||0
3307968|NCT03015532|4041233|FG003|NOT COMPLETED|Overall Study||0
3307969|NCT03015532|4041234|FG004|NOT COMPLETED|Overall Study||0
3307970|NCT03015532|4041235|FG005|NOT COMPLETED|Overall Study||2
3307971|NCT03015532|4041236|FG006|NOT COMPLETED|Overall Study||2
3307972|NCT03015532|4041237|FG007|NOT COMPLETED|Overall Study||0
3307973|NCT03015649|4041257|FG000|STARTED|Overall Study||34
3013110|NCT01021618|3731413|FG000|COMPLETED|Overall Study||44
3013111|NCT01021618|3731414|FG001|COMPLETED|Overall Study||96
3013112|NCT01021618|3731413|FG000|NOT COMPLETED|Overall Study||0
3013113|NCT01021618|3731414|FG001|NOT COMPLETED|Overall Study||0
3013114|NCT01021683|3731420|FG000|STARTED|Overall Study||203
3013115|NCT01021683|3731420|FG000|COMPLETED|Overall Study||132
3013116|NCT01021683|3731420|FG000|NOT COMPLETED|Overall Study||71
3013117|NCT01021748|3731433|FG000|STARTED|Overall Study||6
3307974|NCT03015649|4041257|FG000|COMPLETED|Overall Study||34
3307975|NCT03015649|4041257|FG000|NOT COMPLETED|Overall Study||0
3307976|NCT03015961|4041263|FG000|STARTED|Overall Study||18
3307977|NCT03015961|4041264|FG001|STARTED|Overall Study||20
3307978|NCT03015961|4041263|FG000|COMPLETED|Overall Study||18
3307979|NCT03015961|4041264|FG001|COMPLETED|Overall Study||18
3307980|NCT03015961|4041263|FG000|NOT COMPLETED|Overall Study||0
3307981|NCT03015961|4041264|FG001|NOT COMPLETED|Overall Study||2
3307982|NCT03016078|4041270|FG000|STARTED|Overall Study||21
3307983|NCT03016078|4041270|FG000|COMPLETED|Overall Study||19
3307984|NCT03016078|4041270|FG000|NOT COMPLETED|Overall Study||2
3307985|NCT03016325|4041282|FG000|STARTED|Treatment Period||48
3307986|NCT03016325|4041283|FG001|STARTED|Treatment Period||49
3307987|NCT03016325|4041284|FG002|STARTED|Treatment Period||71
3307988|NCT03016325|4041285|FG003|STARTED|Treatment Period||71
3307989|NCT03016325|4041286|FG004|STARTED|Treatment Period||72
3307990|NCT03016325|4041287|FG005|STARTED|Treatment Period||6
3307991|NCT03016325|4041288|FG006|STARTED|Treatment Period||6
3307992|NCT03016325|4041289|FG007|STARTED|Treatment Period||6
3307993|NCT03016325|4041282|FG000|COMPLETED|Treatment Period||48
3307994|NCT03016325|4041283|FG001|COMPLETED|Treatment Period||48
3307995|NCT03016325|4041284|FG002|COMPLETED|Treatment Period||70
3307996|NCT03016325|4041285|FG003|COMPLETED|Treatment Period||71
3307997|NCT03016325|4041286|FG004|COMPLETED|Treatment Period||70
3307998|NCT03016325|4041287|FG005|COMPLETED|Treatment Period||6
3307999|NCT03016325|4041288|FG006|COMPLETED|Treatment Period||6
3308000|NCT03016325|4041289|FG007|COMPLETED|Treatment Period||6
3308001|NCT03016325|4041282|FG000|NOT COMPLETED|Treatment Period||0
3308002|NCT03016325|4041283|FG001|NOT COMPLETED|Treatment Period||1
3308003|NCT03016325|4041284|FG002|NOT COMPLETED|Treatment Period||1
3308004|NCT03016325|4041285|FG003|NOT COMPLETED|Treatment Period||0
3308005|NCT03016325|4041286|FG004|NOT COMPLETED|Treatment Period||2
3308006|NCT03016325|4041287|FG005|NOT COMPLETED|Treatment Period||0
3308007|NCT03016325|4041288|FG006|NOT COMPLETED|Treatment Period||0
3308008|NCT03016325|4041289|FG007|NOT COMPLETED|Treatment Period||0
3308009|NCT03016325|4041282|FG000|STARTED|32-Day Follow-Up Period||48
3308010|NCT03016325|4041283|FG001|STARTED|32-Day Follow-Up Period||49
3308011|NCT03016325|4041284|FG002|STARTED|32-Day Follow-Up Period||71
3308012|NCT03016325|4041285|FG003|STARTED|32-Day Follow-Up Period||71
3308013|NCT03016325|4041286|FG004|STARTED|32-Day Follow-Up Period||72
3308014|NCT03016325|4041287|FG005|STARTED|32-Day Follow-Up Period||6
3308015|NCT03016325|4041288|FG006|STARTED|32-Day Follow-Up Period||6
3308016|NCT03016325|4041289|FG007|STARTED|32-Day Follow-Up Period||6
3308017|NCT03016325|4041282|FG000|COMPLETED|32-Day Follow-Up Period||44
3308018|NCT03016325|4041283|FG001|COMPLETED|32-Day Follow-Up Period||47
3308019|NCT03016325|4041284|FG002|COMPLETED|32-Day Follow-Up Period||62
3308020|NCT03016325|4041285|FG003|COMPLETED|32-Day Follow-Up Period||63
3308021|NCT03016325|4041286|FG004|COMPLETED|32-Day Follow-Up Period||64
3308022|NCT03016325|4041287|FG005|COMPLETED|32-Day Follow-Up Period||6
3308023|NCT03016325|4041288|FG006|COMPLETED|32-Day Follow-Up Period||5
3308024|NCT03016325|4041289|FG007|COMPLETED|32-Day Follow-Up Period||6
3308025|NCT03016325|4041282|FG000|NOT COMPLETED|32-Day Follow-Up Period||4
3308026|NCT03016325|4041283|FG001|NOT COMPLETED|32-Day Follow-Up Period||2
3308027|NCT03016325|4041284|FG002|NOT COMPLETED|32-Day Follow-Up Period||9
3308028|NCT03016325|4041285|FG003|NOT COMPLETED|32-Day Follow-Up Period||8
3308029|NCT03016325|4041286|FG004|NOT COMPLETED|32-Day Follow-Up Period||8
3308030|NCT03016325|4041287|FG005|NOT COMPLETED|32-Day Follow-Up Period||0
3308031|NCT03016325|4041288|FG006|NOT COMPLETED|32-Day Follow-Up Period||1
3308032|NCT03016325|4041289|FG007|NOT COMPLETED|32-Day Follow-Up Period||0
3308033|NCT03016325|4041282|FG000|STARTED|182-Day Follow-Up Period||48
3308034|NCT03016325|4041283|FG001|STARTED|182-Day Follow-Up Period||49
3308035|NCT03016325|4041284|FG002|STARTED|182-Day Follow-Up Period||71
3308036|NCT03016325|4041285|FG003|STARTED|182-Day Follow-Up Period||71
3308037|NCT03016325|4041286|FG004|STARTED|182-Day Follow-Up Period||72
3308038|NCT03016325|4041287|FG005|STARTED|182-Day Follow-Up Period||6
3308039|NCT03016325|4041288|FG006|STARTED|182-Day Follow-Up Period||6
3308040|NCT03016325|4041289|FG007|STARTED|182-Day Follow-Up Period||6
3308041|NCT03016325|4041282|FG000|COMPLETED|182-Day Follow-Up Period||44
3308042|NCT03016325|4041283|FG001|COMPLETED|182-Day Follow-Up Period||45
3308043|NCT03016325|4041284|FG002|COMPLETED|182-Day Follow-Up Period||60
3308044|NCT03016325|4041285|FG003|COMPLETED|182-Day Follow-Up Period||58
3308045|NCT03016325|4041286|FG004|COMPLETED|182-Day Follow-Up Period||60
3308046|NCT03016325|4041287|FG005|COMPLETED|182-Day Follow-Up Period||1
3308047|NCT03016325|4041288|FG006|COMPLETED|182-Day Follow-Up Period||2
3308048|NCT03016325|4041289|FG007|COMPLETED|182-Day Follow-Up Period||1
3308049|NCT03016325|4041282|FG000|NOT COMPLETED|182-Day Follow-Up Period||4
3308050|NCT03016325|4041283|FG001|NOT COMPLETED|182-Day Follow-Up Period||4
3308051|NCT03016325|4041284|FG002|NOT COMPLETED|182-Day Follow-Up Period||11
3308052|NCT03016325|4041285|FG003|NOT COMPLETED|182-Day Follow-Up Period||13
3013118|NCT01021748|3731434|FG001|STARTED|Overall Study||5
3013119|NCT01021748|3731435|FG002|STARTED|Overall Study||7
3308053|NCT03016325|4041286|FG004|NOT COMPLETED|182-Day Follow-Up Period||12
3013120|NCT01021748|3731436|FG003|STARTED|Overall Study||7
3013121|NCT01021748|3731437|FG004|STARTED|Overall Study||9
3013122|NCT01021748|3731438|FG005|STARTED|Overall Study||3
3013123|NCT01021748|3731439|FG006|STARTED|Overall Study||3
3013124|NCT01021748|3731440|FG007|STARTED|Overall Study||6
3013125|NCT01021748|3731441|FG008|STARTED|Overall Study||17
3013126|NCT01021748|3731433|FG000|Treated|Overall Study||6
3013127|NCT01021748|3731434|FG001|Treated|Overall Study|One participant was allocated, but not treated.|4
3013128|NCT01021748|3731435|FG002|Treated|Overall Study||7
3013129|NCT01021748|3731436|FG003|Treated|Overall Study||7
3013130|NCT01021748|3731437|FG004|Treated|Overall Study||9
3013131|NCT01021748|3731438|FG005|Treated|Overall Study||3
3013132|NCT01021748|3731439|FG006|Treated|Overall Study||3
3013133|NCT01021748|3731440|FG007|Treated|Overall Study||6
3013134|NCT01021748|3731441|FG008|Treated|Overall Study||17
3308054|NCT03016325|4041287|FG005|NOT COMPLETED|182-Day Follow-Up Period||5
3308055|NCT03016325|4041288|FG006|NOT COMPLETED|182-Day Follow-Up Period||4
3308056|NCT03016325|4041289|FG007|NOT COMPLETED|182-Day Follow-Up Period||5
3308057|NCT03016403|4041314|FG000|STARTED|Baseline||139
3308058|NCT03016403|4041315|FG001|STARTED|Baseline||147
3308059|NCT03016403|4041316|FG002|STARTED|Baseline||118
3308060|NCT03016403|4041317|FG003|STARTED|Baseline||131
3308061|NCT03016403|4041314|FG000|COMPLETED|Baseline||123
3308062|NCT03016403|4041315|FG001|COMPLETED|Baseline||120
3308063|NCT03016403|4041316|FG002|COMPLETED|Baseline||107
3308064|NCT03016403|4041317|FG003|COMPLETED|Baseline||97
3308065|NCT03016403|4041314|FG000|NOT COMPLETED|Baseline||16
3308066|NCT03016403|4041315|FG001|NOT COMPLETED|Baseline||27
3308067|NCT03016403|4041316|FG002|NOT COMPLETED|Baseline||11
3308068|NCT03016403|4041317|FG003|NOT COMPLETED|Baseline||34
3308069|NCT03016403|4041314|FG000|STARTED|6-week Follow-up|Anyone who had at least 1 follow-up after baseline.|123
3308070|NCT03016403|4041315|FG001|STARTED|6-week Follow-up||120
3308071|NCT03016403|4041316|FG002|STARTED|6-week Follow-up||107
3308072|NCT03016403|4041317|FG003|STARTED|6-week Follow-up||97
3308073|NCT03016403|4041314|FG000|COMPLETED|6-week Follow-up||120
3308074|NCT03016403|4041315|FG001|COMPLETED|6-week Follow-up||107
3308075|NCT03016403|4041316|FG002|COMPLETED|6-week Follow-up||103
3308076|NCT03016403|4041317|FG003|COMPLETED|6-week Follow-up||88
3308077|NCT03016403|4041314|FG000|NOT COMPLETED|6-week Follow-up||3
3308078|NCT03016403|4041315|FG001|NOT COMPLETED|6-week Follow-up||13
3308079|NCT03016403|4041316|FG002|NOT COMPLETED|6-week Follow-up||4
3308080|NCT03016403|4041317|FG003|NOT COMPLETED|6-week Follow-up||9
3308081|NCT03016403|4041314|FG000|STARTED|3-month Follow-up and 6-month Follow-up||120
3308082|NCT03016403|4041315|FG001|STARTED|3-month Follow-up and 6-month Follow-up||107
3308083|NCT03016403|4041316|FG002|STARTED|3-month Follow-up and 6-month Follow-up||103
3308084|NCT03016403|4041317|FG003|STARTED|3-month Follow-up and 6-month Follow-up||88
3308085|NCT03016403|4041314|FG000|COMPLETED|3-month Follow-up and 6-month Follow-up||108
3308086|NCT03016403|4041315|FG001|COMPLETED|3-month Follow-up and 6-month Follow-up||96
3308087|NCT03016403|4041316|FG002|COMPLETED|3-month Follow-up and 6-month Follow-up||95
3308088|NCT03016403|4041317|FG003|COMPLETED|3-month Follow-up and 6-month Follow-up||81
3308089|NCT03016403|4041314|FG000|NOT COMPLETED|3-month Follow-up and 6-month Follow-up||12
3308090|NCT03016403|4041315|FG001|NOT COMPLETED|3-month Follow-up and 6-month Follow-up||11
3308091|NCT03016403|4041316|FG002|NOT COMPLETED|3-month Follow-up and 6-month Follow-up||8
3308092|NCT03016403|4041317|FG003|NOT COMPLETED|3-month Follow-up and 6-month Follow-up||7
3308093|NCT03016598|4041331|FG000|STARTED|Overall Study||18
3308094|NCT03016598|4041332|FG001|STARTED|Overall Study||22
3308095|NCT03016598|4041331|FG000|COMPLETED|Overall Study||18
3308096|NCT03016598|4041332|FG001|COMPLETED|Overall Study||20
3308097|NCT03016598|4041331|FG000|NOT COMPLETED|Overall Study||0
3308098|NCT03016598|4041332|FG001|NOT COMPLETED|Overall Study||2
3308099|NCT03017079|4041340|FG000|STARTED|Overall Study||20
3308100|NCT03017079|4041341|FG001|STARTED|Overall Study||20
3308101|NCT03017079|4041340|FG000|COMPLETED|Overall Study||14
3308102|NCT03017079|4041341|FG001|COMPLETED|Overall Study||14
3308103|NCT03017079|4041340|FG000|NOT COMPLETED|Overall Study||6
3308104|NCT03017079|4041341|FG001|NOT COMPLETED|Overall Study||6
3308105|NCT03017235|4041356|FG000|STARTED|Overall Study||456
3308106|NCT03017235|4041357|FG001|STARTED|Overall Study||461
3308107|NCT03017235|4041356|FG000|COMPLETED|Overall Study||444
3308108|NCT03017235|4041357|FG001|COMPLETED|Overall Study||447
3308109|NCT03017235|4041356|FG000|NOT COMPLETED|Overall Study||12
3308110|NCT03017235|4041357|FG001|NOT COMPLETED|Overall Study||14
3308111|NCT03017261|4041363|FG000|STARTED|6 Week Follow up||115
3308112|NCT03017261|4041363|FG000|COMPLETED|6 Week Follow up||115
3308113|NCT03017261|4041363|FG000|NOT COMPLETED|6 Week Follow up||0
3308114|NCT03017261|4041363|FG000|STARTED|3 Month Follow up||115
3308115|NCT03017261|4041363|FG000|COMPLETED|3 Month Follow up|1 failed to compete 3M imaging so only 114 have 3M data for tibial slope and KSS Objective Score.|115
3308116|NCT03017261|4041363|FG000|NOT COMPLETED|3 Month Follow up||0
3308117|NCT03017261|4041363|FG000|STARTED|6 Month Follow up||115
3308118|NCT03017261|4041363|FG000|COMPLETED|6 Month Follow up||106
3308119|NCT03017261|4041363|FG000|NOT COMPLETED|6 Month Follow up||9
3308120|NCT03017261|4041363|FG000|STARTED|12 Month Follow up||106
3013135|NCT01021748|3731433|FG000|COMPLETED|Overall Study||0
3013136|NCT01021748|3731434|FG001|COMPLETED|Overall Study||0
3013137|NCT01021748|3731435|FG002|COMPLETED|Overall Study||0
3013138|NCT01021748|3731436|FG003|COMPLETED|Overall Study||0
3013139|NCT01021748|3731437|FG004|COMPLETED|Overall Study||0
3013140|NCT01021748|3731438|FG005|COMPLETED|Overall Study||0
3013141|NCT01021748|3731439|FG006|COMPLETED|Overall Study||0
3308121|NCT03017261|4041363|FG000|COMPLETED|12 Month Follow up|1 failed to compete 12M imaging so only 58 have 12M data for KSS Objective Score.|59
3308122|NCT03017261|4041363|FG000|NOT COMPLETED|12 Month Follow up||47
3308123|NCT03017508|4041369|FG000|STARTED|Overall Study||12
3308124|NCT03017508|4041370|FG001|STARTED|Overall Study||10
3308125|NCT03017508|4041369|FG000|First Intervention (1 Day)|Overall Study||12
3308126|NCT03017508|4041370|FG001|First Intervention (1 Day)|Overall Study||10
3308127|NCT03017508|4041369|FG000|Washout (2-10 Days)|Overall Study||12
3308128|NCT03017508|4041370|FG001|Washout (2-10 Days)|Overall Study||10
3308129|NCT03017508|4041369|FG000|Second Intervention (1 Day)|Overall Study||12
3308130|NCT03017508|4041370|FG001|Second Intervention (1 Day)|Overall Study||10
3308131|NCT03017508|4041369|FG000|COMPLETED|Overall Study||12
3308132|NCT03017508|4041370|FG001|COMPLETED|Overall Study||10
3308133|NCT03017508|4041369|FG000|NOT COMPLETED|Overall Study||0
3308134|NCT03017508|4041370|FG001|NOT COMPLETED|Overall Study||0
3308135|NCT03017612|4041376|FG000|STARTED|Overall Study||13
3308136|NCT03017612|4041376|FG000|COMPLETED|Overall Study||11
3308137|NCT03017612|4041376|FG000|NOT COMPLETED|Overall Study||2
3308138|NCT03017846|4041380|FG000|STARTED|Overall Study||30
3308139|NCT03017846|4041380|FG000|COMPLETED|Overall Study||25
3308140|NCT03017846|4041380|FG000|NOT COMPLETED|Overall Study||5
3308141|NCT03017924|4041388|FG000|STARTED|Overall Study||12
3308142|NCT03017924|4041389|FG001|STARTED|Overall Study||11
3308143|NCT03017924|4041388|FG000|COMPLETED|Overall Study||10
3308144|NCT03017924|4041389|FG001|COMPLETED|Overall Study||8
3308145|NCT03017924|4041388|FG000|NOT COMPLETED|Overall Study||2
3308146|NCT03017924|4041389|FG001|NOT COMPLETED|Overall Study||3
3308147|NCT03017937|4041397|FG000|STARTED|Overall Study||155
3308148|NCT03017937|4041397|FG000|COMPLETED|Overall Study||155
3308149|NCT03017937|4041397|FG000|NOT COMPLETED|Overall Study||0
3308150|NCT03018028|4041407|FG000|STARTED|Overall Study||49
3308151|NCT03018028|4041408|FG001|STARTED|Overall Study||49
3308152|NCT03018028|4041409|FG002|STARTED|Overall Study||48
3308153|NCT03018028|4041410|FG003|STARTED|Overall Study||48
3308154|NCT03018028|4041411|FG004|STARTED|Overall Study||49
3308155|NCT03018028|4041407|FG000|Full Analysis Set (FAS)|Overall Study||49
3308156|NCT03018028|4041408|FG001|Full Analysis Set (FAS)|Overall Study||49
3308157|NCT03018028|4041409|FG002|Full Analysis Set (FAS)|Overall Study||48
3308158|NCT03018028|4041410|FG003|Full Analysis Set (FAS)|Overall Study||48
3308159|NCT03018028|4041411|FG004|Full Analysis Set (FAS)|Overall Study||49
3308160|NCT03018028|4041407|FG000|Safety Analysis Set (SAS)|Overall Study||49
3308161|NCT03018028|4041408|FG001|Safety Analysis Set (SAS)|Overall Study||49
3308162|NCT03018028|4041409|FG002|Safety Analysis Set (SAS)|Overall Study||48
3308163|NCT03018028|4041410|FG003|Safety Analysis Set (SAS)|Overall Study||48
3308164|NCT03018028|4041411|FG004|Safety Analysis Set (SAS)|Overall Study||49
3308165|NCT03018028|4041407|FG000|COMPLETED|Overall Study||46
3308166|NCT03018028|4041408|FG001|COMPLETED|Overall Study||49
3308167|NCT03018028|4041409|FG002|COMPLETED|Overall Study||47
3308168|NCT03018028|4041410|FG003|COMPLETED|Overall Study||46
3308169|NCT03018028|4041411|FG004|COMPLETED|Overall Study||49
3308170|NCT03018028|4041407|FG000|NOT COMPLETED|Overall Study||3
3308171|NCT03018028|4041408|FG001|NOT COMPLETED|Overall Study||0
3308172|NCT03018028|4041409|FG002|NOT COMPLETED|Overall Study||1
3308173|NCT03018028|4041410|FG003|NOT COMPLETED|Overall Study||2
3308174|NCT03018028|4041411|FG004|NOT COMPLETED|Overall Study||0
3308175|NCT03018106|4041425|FG000|STARTED|Overall Study||0
3308176|NCT03018106|4041426|FG001|STARTED|Overall Study||1
3308177|NCT03018106|4041425|FG000|COMPLETED|Overall Study||0
3308178|NCT03018106|4041426|FG001|COMPLETED|Overall Study||0
3308179|NCT03018106|4041425|FG000|NOT COMPLETED|Overall Study||0
3308180|NCT03018106|4041426|FG001|NOT COMPLETED|Overall Study||1
3308181|NCT03018223|4041430|FG000|STARTED|Overall Study||32
3308182|NCT03018223|4041430|FG000|COMPLETED|Overall Study||32
3308183|NCT03018223|4041430|FG000|NOT COMPLETED|Overall Study||0
3308184|NCT03018249|4041436|FG000|STARTED|Overall Study||25
3308185|NCT03018249|4041437|FG001|STARTED|Overall Study||25
3308186|NCT03018249|4041436|FG000|COMPLETED|Overall Study||23
3308187|NCT03018249|4041437|FG001|COMPLETED|Overall Study||23
3308188|NCT03018249|4041436|FG000|NOT COMPLETED|Overall Study||2
3308189|NCT03018249|4041437|FG001|NOT COMPLETED|Overall Study||2
3308190|NCT03018340|4041445|FG000|STARTED|Overall Study||52
3308191|NCT03018340|4041446|FG001|STARTED|Overall Study||155
3308192|NCT03018340|4041445|FG000|COMPLETED|Overall Study||44
3308193|NCT03018340|4041446|FG001|COMPLETED|Overall Study||125
3308194|NCT03018340|4041445|FG000|NOT COMPLETED|Overall Study||8
3308195|NCT03018340|4041446|FG001|NOT COMPLETED|Overall Study||30
3308196|NCT03018691|4041459|FG000|STARTED|Overall Study||24
3308197|NCT03018691|4041460|FG001|STARTED|Overall Study||25
3308198|NCT03018691|4041461|FG002|STARTED|Overall Study||24
3308199|NCT03018691|4041459|FG000|COMPLETED|Overall Study||22
3308200|NCT03018691|4041460|FG001|COMPLETED|Overall Study||24
3308201|NCT03018691|4041461|FG002|COMPLETED|Overall Study||17
3308202|NCT03018691|4041459|FG000|NOT COMPLETED|Overall Study||2
3308203|NCT03018691|4041460|FG001|NOT COMPLETED|Overall Study||1
3308204|NCT03018691|4041461|FG002|NOT COMPLETED|Overall Study||7
3317116|NCT03124121|4050647|FG000|STARTED|Overall Study||42
3013142|NCT01021748|3731440|FG007|COMPLETED|Overall Study||0
3317117|NCT03124121|4050648|FG001|STARTED|Overall Study||70
3317118|NCT03124121|4050647|FG000|COMPLETED|Overall Study||39
3317119|NCT03124121|4050648|FG001|COMPLETED|Overall Study||67
3013143|NCT01021748|3731441|FG008|COMPLETED|Overall Study||1
3165331|NCT01898611|3892870|FG000|STARTED|Overall Study||5
3165332|NCT01898611|3892871|FG001|STARTED|Overall Study||11
3013144|NCT01021748|3731433|FG000|NOT COMPLETED|Overall Study||6
3013145|NCT01021748|3731434|FG001|NOT COMPLETED|Overall Study||5
3013146|NCT01021748|3731435|FG002|NOT COMPLETED|Overall Study||7
3013147|NCT01021748|3731436|FG003|NOT COMPLETED|Overall Study||7
3013148|NCT01021748|3731437|FG004|NOT COMPLETED|Overall Study||9
3013149|NCT01021748|3731438|FG005|NOT COMPLETED|Overall Study||3
3013150|NCT01021748|3731439|FG006|NOT COMPLETED|Overall Study||3
3013151|NCT01021748|3731440|FG007|NOT COMPLETED|Overall Study||6
3013152|NCT01021748|3731441|FG008|NOT COMPLETED|Overall Study||16
3013153|NCT01021761|3731464|FG000|STARTED|Overall Study||42
3013154|NCT01021761|3731465|FG001|STARTED|Overall Study||42
3013155|NCT01021761|3731466|FG002|STARTED|Overall Study||42
3013156|NCT01021761|3731464|FG000|COMPLETED|Overall Study||41
3013157|NCT01021761|3731465|FG001|COMPLETED|Overall Study||38
3013158|NCT01021761|3731466|FG002|COMPLETED|Overall Study||42
3013159|NCT01021761|3731464|FG000|NOT COMPLETED|Overall Study||1
3013160|NCT01021761|3731465|FG001|NOT COMPLETED|Overall Study||4
3013161|NCT01021761|3731466|FG002|NOT COMPLETED|Overall Study||0
3013162|NCT01021813|3731476|FG000|STARTED|DB Treatment Phase||522
3013163|NCT01021813|3731477|FG001|STARTED|DB Treatment Phase||259
3013164|NCT01021813|3731478|FG002|STARTED|DB Treatment Phase||0
3013165|NCT01021813|3731479|FG003|STARTED|DB Treatment Phase||0
3013166|NCT01021813|3731480|FG004|STARTED|DB Treatment Phase||0
3013167|NCT01021813|3731476|FG000|Treated|DB Treatment Phase||521
3013168|NCT01021813|3731477|FG001|Treated|DB Treatment Phase||258
3013169|NCT01021813|3731478|FG002|Treated|DB Treatment Phase||0
3013170|NCT01021813|3731479|FG003|Treated|DB Treatment Phase||0
3013171|NCT01021813|3731480|FG004|Treated|DB Treatment Phase||0
3013172|NCT01021813|3731476|FG000|COMPLETED|DB Treatment Phase||322
3013173|NCT01021813|3731477|FG001|COMPLETED|DB Treatment Phase||162
3013174|NCT01021813|3731478|FG002|COMPLETED|DB Treatment Phase||0
3013175|NCT01021813|3731479|FG003|COMPLETED|DB Treatment Phase||0
3013176|NCT01021813|3731480|FG004|COMPLETED|DB Treatment Phase||0
3013177|NCT01021813|3731476|FG000|NOT COMPLETED|DB Treatment Phase||200
3013178|NCT01021813|3731477|FG001|NOT COMPLETED|DB Treatment Phase||97
3013179|NCT01021813|3731478|FG002|NOT COMPLETED|DB Treatment Phase||0
3013180|NCT01021813|3731479|FG003|NOT COMPLETED|DB Treatment Phase||0
3013181|NCT01021813|3731480|FG004|NOT COMPLETED|DB Treatment Phase||0
3013182|NCT01021813|3731476|FG000|STARTED|DB Randomized Discontinuation Phase||0
3013183|NCT01021813|3731477|FG001|STARTED|DB Randomized Discontinuation Phase||0
3013184|NCT01021813|3731478|FG002|STARTED|DB Randomized Discontinuation Phase||156
3013185|NCT01021813|3731479|FG003|STARTED|DB Randomized Discontinuation Phase||166
3013186|NCT01021813|3731480|FG004|STARTED|DB Randomized Discontinuation Phase||162
3013187|NCT01021813|3731476|FG000|COMPLETED|DB Randomized Discontinuation Phase||0
3013188|NCT01021813|3731477|FG001|COMPLETED|DB Randomized Discontinuation Phase||0
3013189|NCT01021813|3731478|FG002|COMPLETED|DB Randomized Discontinuation Phase||152
3013190|NCT01021813|3731479|FG003|COMPLETED|DB Randomized Discontinuation Phase||161
3013191|NCT01021813|3731480|FG004|COMPLETED|DB Randomized Discontinuation Phase||157
3013192|NCT01021813|3731476|FG000|NOT COMPLETED|DB Randomized Discontinuation Phase||0
3013193|NCT01021813|3731477|FG001|NOT COMPLETED|DB Randomized Discontinuation Phase||0
3013194|NCT01021813|3731478|FG002|NOT COMPLETED|DB Randomized Discontinuation Phase||4
3013195|NCT01021813|3731479|FG003|NOT COMPLETED|DB Randomized Discontinuation Phase||5
3013196|NCT01021813|3731480|FG004|NOT COMPLETED|DB Randomized Discontinuation Phase||5
3013197|NCT01021852|3731505|FG000|STARTED|Treatment Period 1||40
3013198|NCT01021852|3731506|FG001|STARTED|Treatment Period 1||40
3013199|NCT01021852|3731507|FG002|STARTED|Treatment Period 1||41
3013200|NCT01021852|3731508|FG003|STARTED|Treatment Period 1||40
3013201|NCT01021852|3731509|FG004|STARTED|Treatment Period 1||42
3013202|NCT01021852|3731510|FG005|STARTED|Treatment Period 1||41
3013203|NCT01021852|3731511|FG006|STARTED|Treatment Period 1||41
3013204|NCT01021852|3731512|FG007|STARTED|Treatment Period 1||41
3013205|NCT01021852|3731505|FG000|Treated|Treatment Period 1||40
3013206|NCT01021852|3731506|FG001|Treated|Treatment Period 1||40
3013207|NCT01021852|3731507|FG002|Treated|Treatment Period 1||41
3013208|NCT01021852|3731508|FG003|Treated|Treatment Period 1||38
3013209|NCT01021852|3731509|FG004|Treated|Treatment Period 1||42
3013210|NCT01021852|3731510|FG005|Treated|Treatment Period 1|1 participant discontinued Treatment Period 1 (AE) but continued in Placebo Washout|41
3013211|NCT01021852|3731511|FG006|Treated|Treatment Period 1||41
3013212|NCT01021852|3731512|FG007|Treated|Treatment Period 1||41
3013213|NCT01021852|3731505|FG000|COMPLETED|Treatment Period 1||37
3013214|NCT01021852|3731506|FG001|COMPLETED|Treatment Period 1||39
3013215|NCT01021852|3731507|FG002|COMPLETED|Treatment Period 1||39
3013216|NCT01021852|3731508|FG003|COMPLETED|Treatment Period 1||38
3013217|NCT01021852|3731509|FG004|COMPLETED|Treatment Period 1||39
3165333|NCT01898611|3892870|FG000|COMPLETED|Overall Study||5
3013218|NCT01021852|3731510|FG005|COMPLETED|Treatment Period 1||39
3013219|NCT01021852|3731511|FG006|COMPLETED|Treatment Period 1||41
3013220|NCT01021852|3731512|FG007|COMPLETED|Treatment Period 1||40
3013221|NCT01021852|3731505|FG000|NOT COMPLETED|Treatment Period 1||3
3013222|NCT01021852|3731506|FG001|NOT COMPLETED|Treatment Period 1||1
3013223|NCT01021852|3731507|FG002|NOT COMPLETED|Treatment Period 1||2
3013224|NCT01021852|3731508|FG003|NOT COMPLETED|Treatment Period 1||2
3013225|NCT01021852|3731509|FG004|NOT COMPLETED|Treatment Period 1||3
3013226|NCT01021852|3731510|FG005|NOT COMPLETED|Treatment Period 1||2
3013227|NCT01021852|3731511|FG006|NOT COMPLETED|Treatment Period 1||0
3013228|NCT01021852|3731512|FG007|NOT COMPLETED|Treatment Period 1||1
3013229|NCT01021852|3731505|FG000|STARTED|Washout Period-Placebo||37
3013230|NCT01021852|3731506|FG001|STARTED|Washout Period-Placebo||39
3013231|NCT01021852|3731507|FG002|STARTED|Washout Period-Placebo||39
3013232|NCT01021852|3731508|FG003|STARTED|Washout Period-Placebo||38
3013233|NCT01021852|3731509|FG004|STARTED|Washout Period-Placebo|Includes 1 participant that discontinued Treatment Period 1 (AE).|40
3013234|NCT01021852|3731510|FG005|STARTED|Washout Period-Placebo|Excludes 1 participant who completed Treatment Period 1 but missed Placebo Washout|39
3013235|NCT01021852|3731511|FG006|STARTED|Washout Period-Placebo||41
3013236|NCT01021852|3731512|FG007|STARTED|Washout Period-Placebo||40
3013237|NCT01021852|3731505|FG000|COMPLETED|Washout Period-Placebo||37
3013238|NCT01021852|3731506|FG001|COMPLETED|Washout Period-Placebo||39
3013239|NCT01021852|3731507|FG002|COMPLETED|Washout Period-Placebo||39
3013240|NCT01021852|3731508|FG003|COMPLETED|Washout Period-Placebo||37
3013241|NCT01021852|3731509|FG004|COMPLETED|Washout Period-Placebo||39
3013242|NCT01021852|3731510|FG005|COMPLETED|Washout Period-Placebo||38
3013243|NCT01021852|3731511|FG006|COMPLETED|Washout Period-Placebo||40
3013244|NCT01021852|3731512|FG007|COMPLETED|Washout Period-Placebo||40
3013245|NCT01021852|3731505|FG000|NOT COMPLETED|Washout Period-Placebo||0
3308205|NCT03018925|4041471|FG000|STARTED|Overall Study||15
3308206|NCT03018925|4041471|FG000|COMPLETED|Overall Study||15
3308207|NCT03018925|4041471|FG000|NOT COMPLETED|Overall Study||0
3308208|NCT03018938|4041498|FG000|STARTED|Overall Study||404
3308209|NCT03018938|4041499|FG001|STARTED|Overall Study||410
3308210|NCT03018938|4041498|FG000|Received at Least 1 Dose of Study Drug|Overall Study||404
3308211|NCT03018938|4041499|FG001|Received at Least 1 Dose of Study Drug|Overall Study||410
3308212|NCT03018938|4041498|FG000|COMPLETED|Overall Study||338
3308213|NCT03018938|4041499|FG001|COMPLETED|Overall Study||325
3308214|NCT03018938|4041498|FG000|NOT COMPLETED|Overall Study||66
3308215|NCT03018938|4041499|FG001|NOT COMPLETED|Overall Study||85
3308216|NCT03019055|4041509|FG000|STARTED|Overall Study||0
3308217|NCT03019055|4041510|FG001|STARTED|Overall Study||3
3308218|NCT03019055|4041511|FG002|STARTED|Overall Study||3
3308219|NCT03019055|4041512|FG003|STARTED|Overall Study||20
3308220|NCT03019055|4041509|FG000|COMPLETED|Overall Study||0
3308221|NCT03019055|4041510|FG001|COMPLETED|Overall Study||3
3308222|NCT03019055|4041511|FG002|COMPLETED|Overall Study||3
3308223|NCT03019055|4041512|FG003|COMPLETED|Overall Study||20
3308224|NCT03019055|4041509|FG000|NOT COMPLETED|Overall Study||0
3308225|NCT03019055|4041510|FG001|NOT COMPLETED|Overall Study||0
3308226|NCT03019055|4041511|FG002|NOT COMPLETED|Overall Study||0
3308227|NCT03019055|4041512|FG003|NOT COMPLETED|Overall Study||0
3308228|NCT03019107|4041524|FG000|STARTED|Overall Study||1
3308229|NCT03019107|4041525|FG001|STARTED|Overall Study||0
3308230|NCT03019107|4041524|FG000|COMPLETED|Overall Study||1
3308231|NCT03019107|4041525|FG001|COMPLETED|Overall Study||0
3308232|NCT03019107|4041524|FG000|NOT COMPLETED|Overall Study||0
3013246|NCT01021852|3731506|FG001|NOT COMPLETED|Washout Period-Placebo||0
3013247|NCT01021852|3731507|FG002|NOT COMPLETED|Washout Period-Placebo||0
3013248|NCT01021852|3731508|FG003|NOT COMPLETED|Washout Period-Placebo||1
3013249|NCT01021852|3731509|FG004|NOT COMPLETED|Washout Period-Placebo||1
3013250|NCT01021852|3731510|FG005|NOT COMPLETED|Washout Period-Placebo||1
3013251|NCT01021852|3731511|FG006|NOT COMPLETED|Washout Period-Placebo||1
3013252|NCT01021852|3731512|FG007|NOT COMPLETED|Washout Period-Placebo||0
3013253|NCT01021852|3731505|FG000|STARTED|Washout Period-No Drug|Includes 1 participant who discontinued Treatment Period 1 (AE) and missed Placebo Washout.|38
3013254|NCT01021852|3731506|FG001|STARTED|Washout Period-No Drug||39
3013255|NCT01021852|3731507|FG002|STARTED|Washout Period-No Drug||39
3013256|NCT01021852|3731508|FG003|STARTED|Washout Period-No Drug||37
3013257|NCT01021852|3731509|FG004|STARTED|Washout Period-No Drug||39
3013258|NCT01021852|3731510|FG005|STARTED|Washout Period-No Drug|Includes 1 participant who completed Treatment Period 1 but missed Placebo Washout.|39
3013259|NCT01021852|3731511|FG006|STARTED|Washout Period-No Drug||40
3013260|NCT01021852|3731512|FG007|STARTED|Washout Period-No Drug||40
3013261|NCT01021852|3731505|FG000|COMPLETED|Washout Period-No Drug||37
3013262|NCT01021852|3731506|FG001|COMPLETED|Washout Period-No Drug||39
3013263|NCT01021852|3731507|FG002|COMPLETED|Washout Period-No Drug||39
3013264|NCT01021852|3731508|FG003|COMPLETED|Washout Period-No Drug||37
3013265|NCT01021852|3731509|FG004|COMPLETED|Washout Period-No Drug||39
3013266|NCT01021852|3731510|FG005|COMPLETED|Washout Period-No Drug||38
3013267|NCT01021852|3731511|FG006|COMPLETED|Washout Period-No Drug||40
3013268|NCT01021852|3731512|FG007|COMPLETED|Washout Period-No Drug||40
3013269|NCT01021852|3731505|FG000|NOT COMPLETED|Washout Period-No Drug||1
3013270|NCT01021852|3731506|FG001|NOT COMPLETED|Washout Period-No Drug||0
3013271|NCT01021852|3731507|FG002|NOT COMPLETED|Washout Period-No Drug||0
3013272|NCT01021852|3731508|FG003|NOT COMPLETED|Washout Period-No Drug||0
3013273|NCT01021852|3731509|FG004|NOT COMPLETED|Washout Period-No Drug||0
3013274|NCT01021852|3731510|FG005|NOT COMPLETED|Washout Period-No Drug||1
3013275|NCT01021852|3731511|FG006|NOT COMPLETED|Washout Period-No Drug||0
3308233|NCT03019107|4041525|FG001|NOT COMPLETED|Overall Study||0
3308234|NCT03019289|4041540|FG000|STARTED|Overall Study||5
3308235|NCT03019289|4041541|FG001|STARTED|Overall Study||1
3308236|NCT03019289|4041542|FG002|STARTED|Overall Study||3
3308237|NCT03019289|4041543|FG003|STARTED|Overall Study||2
3308238|NCT03019289|4041544|FG004|STARTED|Overall Study||1
3165334|NCT01898611|3892871|FG001|COMPLETED|Overall Study||10
3165335|NCT01898611|3892870|FG000|NOT COMPLETED|Overall Study||0
3013276|NCT01021852|3731512|FG007|NOT COMPLETED|Washout Period-No Drug||0
3013277|NCT01021852|3731505|FG000|STARTED|Treatment Period 2||37
3013278|NCT01021852|3731506|FG001|STARTED|Treatment Period 2||39
3013279|NCT01021852|3731507|FG002|STARTED|Treatment Period 2||39
3013280|NCT01021852|3731508|FG003|STARTED|Treatment Period 2||37
3013281|NCT01021852|3731509|FG004|STARTED|Treatment Period 2||39
3013282|NCT01021852|3731510|FG005|STARTED|Treatment Period 2||38
3013283|NCT01021852|3731511|FG006|STARTED|Treatment Period 2||40
3013284|NCT01021852|3731512|FG007|STARTED|Treatment Period 2||40
3013285|NCT01021852|3731505|FG000|COMPLETED|Treatment Period 2||37
3013286|NCT01021852|3731506|FG001|COMPLETED|Treatment Period 2||38
3013287|NCT01021852|3731507|FG002|COMPLETED|Treatment Period 2||38
3013288|NCT01021852|3731508|FG003|COMPLETED|Treatment Period 2||37
3013289|NCT01021852|3731509|FG004|COMPLETED|Treatment Period 2||37
3013290|NCT01021852|3731510|FG005|COMPLETED|Treatment Period 2||37
3013291|NCT01021852|3731511|FG006|COMPLETED|Treatment Period 2||37
3013292|NCT01021852|3731512|FG007|COMPLETED|Treatment Period 2||38
3013293|NCT01021852|3731505|FG000|NOT COMPLETED|Treatment Period 2||0
3013294|NCT01021852|3731506|FG001|NOT COMPLETED|Treatment Period 2||1
3013295|NCT01021852|3731507|FG002|NOT COMPLETED|Treatment Period 2||1
3013296|NCT01021852|3731508|FG003|NOT COMPLETED|Treatment Period 2||0
3013297|NCT01021852|3731509|FG004|NOT COMPLETED|Treatment Period 2||2
3013298|NCT01021852|3731510|FG005|NOT COMPLETED|Treatment Period 2||1
3013299|NCT01021852|3731511|FG006|NOT COMPLETED|Treatment Period 2||3
3013300|NCT01021852|3731512|FG007|NOT COMPLETED|Treatment Period 2||2
3013301|NCT01021878|3731528|FG000|STARTED|Overall Study||33
3013302|NCT01021878|3731529|FG001|STARTED|Overall Study||27
3013303|NCT01021878|3731528|FG000|Completed Follow-up|Overall Study||17
3013304|NCT01021878|3731529|FG001|Completed Follow-up|Overall Study||17
3013305|NCT01021878|3731528|FG000|COMPLETED|Overall Study||17
3013306|NCT01021878|3731529|FG001|COMPLETED|Overall Study||17
3013307|NCT01021878|3731528|FG000|NOT COMPLETED|Overall Study||16
3013308|NCT01021878|3731529|FG001|NOT COMPLETED|Overall Study||10
3013309|NCT01021956|3731542|FG000|STARTED|Overall Study||3
3013310|NCT01021956|3731543|FG001|STARTED|Overall Study||3
3013311|NCT01021956|3731544|FG002|STARTED|Overall Study||3
3013312|NCT01021956|3731545|FG003|STARTED|Overall Study||1
3013313|NCT01021956|3731542|FG000|COMPLETED|Overall Study||3
3013314|NCT01021956|3731543|FG001|COMPLETED|Overall Study||3
3013315|NCT01021956|3731544|FG002|COMPLETED|Overall Study||3
3013316|NCT01021956|3731545|FG003|COMPLETED|Overall Study||1
3013317|NCT01021956|3731542|FG000|NOT COMPLETED|Overall Study||0
3013318|NCT01021956|3731543|FG001|NOT COMPLETED|Overall Study||0
3013319|NCT01021956|3731544|FG002|NOT COMPLETED|Overall Study||0
3013320|NCT01021956|3731545|FG003|NOT COMPLETED|Overall Study||0
3013321|NCT01022073|3731558|FG000|STARTED|Overall Study||86
3013322|NCT01022073|3731559|FG001|STARTED|Overall Study||70
3013323|NCT01022073|3731558|FG000|COMPLETED|Overall Study||67
3013324|NCT01022073|3731559|FG001|COMPLETED|Overall Study||52
3013325|NCT01022073|3731558|FG000|NOT COMPLETED|Overall Study||19
3013326|NCT01022073|3731559|FG001|NOT COMPLETED|Overall Study||18
3013327|NCT01022112|3731570|FG000|STARTED|Overall Study||82
3013328|NCT01022112|3731571|FG001|STARTED|Overall Study||74
3013329|NCT01022112|3731572|FG002|STARTED|Overall Study||77
3013330|NCT01022112|3731573|FG003|STARTED|Overall Study||75
3013331|NCT01022112|3731574|FG004|STARTED|Overall Study||75
3013332|NCT01022112|3731570|FG000|COMPLETED|Overall Study||79
3013333|NCT01022112|3731571|FG001|COMPLETED|Overall Study||71
3013334|NCT01022112|3731572|FG002|COMPLETED|Overall Study||74
3013335|NCT01022112|3731573|FG003|COMPLETED|Overall Study||72
3013336|NCT01022112|3731574|FG004|COMPLETED|Overall Study||65
3013337|NCT01022112|3731570|FG000|NOT COMPLETED|Overall Study||3
3013338|NCT01022112|3731571|FG001|NOT COMPLETED|Overall Study||3
3013339|NCT01022112|3731572|FG002|NOT COMPLETED|Overall Study||3
3013340|NCT01022112|3731573|FG003|NOT COMPLETED|Overall Study||3
3013341|NCT01022112|3731574|FG004|NOT COMPLETED|Overall Study||10
3013342|NCT01022190|3731586|FG000|STARTED|Overall Study||42
3013343|NCT01022190|3731586|FG000|COMPLETED|Overall Study||42
3013344|NCT01022190|3731586|FG000|NOT COMPLETED|Overall Study||0
3013345|NCT01022203|3731592|FG000|STARTED|PreTreatment Assessment||58
3013346|NCT01022203|3731593|FG001|STARTED|PreTreatment Assessment||56
3013347|NCT01022203|3731592|FG000|COMPLETED|PreTreatment Assessment||58
3013348|NCT01022203|3731593|FG001|COMPLETED|PreTreatment Assessment||56
3013349|NCT01022203|3731592|FG000|NOT COMPLETED|PreTreatment Assessment||0
3013350|NCT01022203|3731593|FG001|NOT COMPLETED|PreTreatment Assessment||0
3013351|NCT01022203|3731592|FG000|STARTED|Post Treatment Assessment||58
3013352|NCT01022203|3731593|FG001|STARTED|Post Treatment Assessment||56
3013353|NCT01022203|3731592|FG000|COMPLETED|Post Treatment Assessment||44
3013354|NCT01022203|3731593|FG001|COMPLETED|Post Treatment Assessment||42
3013355|NCT01022203|3731592|FG000|NOT COMPLETED|Post Treatment Assessment||14
3013356|NCT01022203|3731593|FG001|NOT COMPLETED|Post Treatment Assessment||14
3013357|NCT01022203|3731592|FG000|STARTED|Follow-Up Assessment||44
3013358|NCT01022203|3731593|FG001|STARTED|Follow-Up Assessment||42
3013359|NCT01022203|3731592|FG000|COMPLETED|Follow-Up Assessment||42
3013360|NCT01022203|3731593|FG001|COMPLETED|Follow-Up Assessment||40
3013361|NCT01022203|3731592|FG000|NOT COMPLETED|Follow-Up Assessment||2
3013362|NCT01022203|3731593|FG001|NOT COMPLETED|Follow-Up Assessment||2
3165336|NCT01898611|3892871|FG001|NOT COMPLETED|Overall Study||1
3013363|NCT01022242|3731604|FG000|STARTED|Overall Study|71 pat rand to placebo. 1 got incorrect mix of placebo. 70 patients treated with the correct mix.|70
3013364|NCT01022242|3731605|FG001|STARTED|Overall Study|67 pat rand to PXL01. 2 got incorrect mix of PXL01. 65 patients treated with the correct PXL01 mix.|65
3013365|NCT01022242|3731604|FG000|COMPLETED|Overall Study||49
3013366|NCT01022242|3731605|FG001|COMPLETED|Overall Study||46
3013367|NCT01022242|3731604|FG000|NOT COMPLETED|Overall Study||21
3013368|NCT01022242|3731605|FG001|NOT COMPLETED|Overall Study||19
3013369|NCT01022307|3731613|FG000|STARTED|Overall Study||184
3013370|NCT01022307|3731614|FG001|STARTED|Overall Study||28
3013371|NCT01022307|3731613|FG000|COMPLETED|Overall Study||184
3013372|NCT01022307|3731614|FG001|COMPLETED|Overall Study|Some TBI patients could not undergo MR scanning due to contraindications.|24
3013373|NCT01022307|3731613|FG000|NOT COMPLETED|Overall Study||0
3013374|NCT01022307|3731614|FG001|NOT COMPLETED|Overall Study||4
3013375|NCT01022359|3731622|FG000|STARTED|Overall Study||39
3013376|NCT01022359|3731623|FG001|STARTED|Overall Study||41
3013377|NCT01022359|3731622|FG000|COMPLETED|Overall Study||39
3133653|NCT01696773|3858574|FG000|NOT COMPLETED|Days 1-13, Washout||0
3133654|NCT01696773|3858575|FG001|NOT COMPLETED|Days 1-13, Washout||0
3133655|NCT01696773|3858574|FG000|STARTED|Day 14, First Intervention||6
3013378|NCT01022359|3731623|FG001|COMPLETED|Overall Study||41
3013379|NCT01022359|3731622|FG000|NOT COMPLETED|Overall Study||0
3013380|NCT01022359|3731623|FG001|NOT COMPLETED|Overall Study||0
3013381|NCT01022424|3731629|FG000|STARTED|Overall Study||13
3013382|NCT01022424|3731629|FG000|COMPLETED|Overall Study||9
3013383|NCT01022424|3731629|FG000|NOT COMPLETED|Overall Study||4
3013384|NCT01022502|3731637|FG000|STARTED|Overall Study|19 used the refined ointment on the right site, 19 used the crude ointment on the left site.|38
3013385|NCT01022502|3731637|FG000|COMPLETED|Overall Study|3 participants withdrew at week 4,5,6,respectively.|35
3013386|NCT01022502|3731637|FG000|NOT COMPLETED|Overall Study||3
3013387|NCT01022567|3731645|FG000|STARTED|Overall Study||273
3013388|NCT01022567|3731646|FG001|STARTED|Overall Study||257
3013389|NCT01022567|3731645|FG000|COMPLETED|Overall Study||272
3013390|NCT01022567|3731646|FG001|COMPLETED|Overall Study||242
3013391|NCT01022567|3731645|FG000|NOT COMPLETED|Overall Study||1
3013392|NCT01022567|3731646|FG001|NOT COMPLETED|Overall Study||15
3013393|NCT01022580|3731654|FG000|STARTED|Overall Study||252
3013394|NCT01022580|3731655|FG001|STARTED|Overall Study||259
3013395|NCT01022580|3731654|FG000|COMPLETED|Overall Study|Survived to discharge|234
3013396|NCT01022580|3731655|FG001|COMPLETED|Overall Study|Survived to discharge.|237
3013397|NCT01022580|3731654|FG000|NOT COMPLETED|Overall Study||18
3013398|NCT01022580|3731655|FG001|NOT COMPLETED|Overall Study||22
3013399|NCT01022762|3731669|FG000|STARTED|Overall Study||218
3013400|NCT01022762|3731670|FG001|STARTED|Overall Study||222
3013401|NCT01022762|3731669|FG000|Exposed to Trial Drug|Overall Study|One participant was not exposed to the treatment due to fulfillment of exclusion criteria|217
3013402|NCT01022762|3731670|FG001|Exposed to Trial Drug|Overall Study|Four participants were not exposed to the treatment due to non-compliance or lost to follow-up|218
3013403|NCT01022762|3731669|FG000|COMPLETED|Overall Study||196
3013404|NCT01022762|3731670|FG001|COMPLETED|Overall Study||194
3013405|NCT01022762|3731669|FG000|NOT COMPLETED|Overall Study||22
3013406|NCT01022762|3731670|FG001|NOT COMPLETED|Overall Study||28
3013407|NCT01022853|3731681|FG000|STARTED|Overall Study|entered and treated|3
3013408|NCT01022853|3731682|FG001|STARTED|Overall Study|entered and treated|4
3013409|NCT01022853|3731683|FG002|STARTED|Overall Study|entered and treated|13
3013410|NCT01022853|3731684|FG003|STARTED|Overall Study|entered and treated|8
3013411|NCT01022853|3731685|FG004|STARTED|Overall Study|entered and treated|2
3013412|NCT01022853|3731681|FG000|COMPLETED|Overall Study||0
3013413|NCT01022853|3731682|FG001|COMPLETED|Overall Study||0
3013414|NCT01022853|3731683|FG002|COMPLETED|Overall Study||0
3013415|NCT01022853|3731684|FG003|COMPLETED|Overall Study||0
3013416|NCT01022853|3731685|FG004|COMPLETED|Overall Study||0
3013417|NCT01022853|3731681|FG000|NOT COMPLETED|Overall Study||3
3013418|NCT01022853|3731682|FG001|NOT COMPLETED|Overall Study||4
3013419|NCT01022853|3731683|FG002|NOT COMPLETED|Overall Study||13
3013420|NCT01022853|3731684|FG003|NOT COMPLETED|Overall Study||8
3013421|NCT01022853|3731685|FG004|NOT COMPLETED|Overall Study||2
3013422|NCT01022996|3731700|FG000|STARTED|Overall Study||57
3013423|NCT01022996|3731700|FG000|COMPLETED|Overall Study||0
3013424|NCT01022996|3731700|FG000|NOT COMPLETED|Overall Study||57
3013425|NCT01023022|3731704|FG000|STARTED|Overall Study|Previous No.: 178 subjects incl. 2 pts who withdraw their approval for processing personal data|176
3013426|NCT01023022|3731704|FG000|COMPLETED|Overall Study||162
3013427|NCT01023022|3731704|FG000|NOT COMPLETED|Overall Study||14
3013428|NCT01023035|3731711|FG000|STARTED|Treatment Period||249
3133656|NCT01696773|3858575|FG001|STARTED|Day 14, First Intervention||6
3133657|NCT01696773|3858574|FG000|COMPLETED|Day 14, First Intervention||6
3133658|NCT01696773|3858575|FG001|COMPLETED|Day 14, First Intervention||6
3133659|NCT01696773|3858574|FG000|NOT COMPLETED|Day 14, First Intervention||0
3133660|NCT01696773|3858575|FG001|NOT COMPLETED|Day 14, First Intervention||0
3133661|NCT01696773|3858574|FG000|STARTED|Days 15-27, Washout||6
3133662|NCT01696773|3858575|FG001|STARTED|Days 15-27, Washout||6
3133663|NCT01696773|3858574|FG000|COMPLETED|Days 15-27, Washout||5
3133664|NCT01696773|3858575|FG001|COMPLETED|Days 15-27, Washout||6
3133665|NCT01696773|3858574|FG000|NOT COMPLETED|Days 15-27, Washout||1
3133666|NCT01696773|3858575|FG001|NOT COMPLETED|Days 15-27, Washout||0
3133667|NCT01696773|3858574|FG000|STARTED|Day 28, Second Intervention||5
3133668|NCT01696773|3858575|FG001|STARTED|Day 28, Second Intervention||6
3013429|NCT01023035|3731712|FG001|STARTED|Treatment Period||251
3013430|NCT01023035|3731713|FG002|STARTED|Treatment Period||187
3013431|NCT01023035|3731711|FG000|COMPLETED|Treatment Period||177
3013432|NCT01023035|3731712|FG001|COMPLETED|Treatment Period||166
3013433|NCT01023035|3731713|FG002|COMPLETED|Treatment Period||69
3013434|NCT01023035|3731711|FG000|NOT COMPLETED|Treatment Period||72
3013435|NCT01023035|3731712|FG001|NOT COMPLETED|Treatment Period||85
3013436|NCT01023035|3731713|FG002|NOT COMPLETED|Treatment Period||118
3013437|NCT01023035|3731711|FG000|STARTED|Follow-up Period (up to Week 72)||238
3013438|NCT01023035|3731712|FG001|STARTED|Follow-up Period (up to Week 72)||235
3013439|NCT01023035|3731713|FG002|STARTED|Follow-up Period (up to Week 72)||147
3013440|NCT01023035|3731711|FG000|COMPLETED|Follow-up Period (up to Week 72)||210
3013441|NCT01023035|3731712|FG001|COMPLETED|Follow-up Period (up to Week 72)||207
3013442|NCT01023035|3731713|FG002|COMPLETED|Follow-up Period (up to Week 72)||108
3013443|NCT01023035|3731711|FG000|NOT COMPLETED|Follow-up Period (up to Week 72)||28
3013444|NCT01023035|3731712|FG001|NOT COMPLETED|Follow-up Period (up to Week 72)||28
3013445|NCT01023035|3731713|FG002|NOT COMPLETED|Follow-up Period (up to Week 72)||39
3013446|NCT01023061|3731723|FG000|STARTED|Overall Study||24
3013447|NCT01023061|3731723|FG000|COMPLETED|Overall Study||22
3013448|NCT01023061|3731723|FG000|NOT COMPLETED|Overall Study||2
3013449|NCT01023074|3731730|FG000|STARTED|Overall Study||26
3013450|NCT01023074|3731731|FG001|STARTED|Overall Study||13
3013451|NCT01023074|3731732|FG002|STARTED|Overall Study||13
3013452|NCT01023074|3731730|FG000|COMPLETED|Overall Study||26
3013453|NCT01023074|3731731|FG001|COMPLETED|Overall Study||13
3013454|NCT01023074|3731732|FG002|COMPLETED|Overall Study||13
3013455|NCT01023074|3731730|FG000|NOT COMPLETED|Overall Study||0
3013456|NCT01023074|3731731|FG001|NOT COMPLETED|Overall Study||0
3013457|NCT01023074|3731732|FG002|NOT COMPLETED|Overall Study||0
3013458|NCT01023178|3731747|FG000|STARTED|Overall Study||5
3013459|NCT01023178|3731748|FG001|STARTED|Overall Study||8
3013460|NCT01023178|3731749|FG002|STARTED|Overall Study||7
3013461|NCT01023178|3731747|FG000|COMPLETED|Overall Study||3
3013462|NCT01023178|3731748|FG001|COMPLETED|Overall Study||6
3013463|NCT01023178|3731749|FG002|COMPLETED|Overall Study||4
3013464|NCT01023178|3731747|FG000|NOT COMPLETED|Overall Study||2
3013465|NCT01023178|3731748|FG001|NOT COMPLETED|Overall Study||2
3013466|NCT01023178|3731749|FG002|NOT COMPLETED|Overall Study||3
3013467|NCT01023217|3731759|FG000|STARTED|Overall Study||45
3013468|NCT01023217|3731760|FG001|STARTED|Overall Study||45
3013469|NCT01023217|3731759|FG000|COMPLETED|Overall Study||44
3013470|NCT01023217|3731760|FG001|COMPLETED|Overall Study||45
3013471|NCT01023217|3731759|FG000|NOT COMPLETED|Overall Study||1
3013472|NCT01023217|3731760|FG001|NOT COMPLETED|Overall Study||0
3013473|NCT01023256|3731770|FG000|STARTED|Overall Study||25
3013474|NCT01023256|3731771|FG001|STARTED|Overall Study||22
3013475|NCT01023256|3731772|FG002|STARTED|Overall Study||24
3013476|NCT01023256|3731773|FG003|STARTED|Overall Study||27
3013477|NCT01023256|3731770|FG000|COMPLETED|Overall Study||21
3013478|NCT01023256|3731771|FG001|COMPLETED|Overall Study||19
3013479|NCT01023256|3731772|FG002|COMPLETED|Overall Study||23
3013480|NCT01023256|3731773|FG003|COMPLETED|Overall Study||22
3013481|NCT01023256|3731770|FG000|NOT COMPLETED|Overall Study||4
3013482|NCT01023256|3731771|FG001|NOT COMPLETED|Overall Study||3
3013483|NCT01023256|3731772|FG002|NOT COMPLETED|Overall Study||1
3013484|NCT01023256|3731773|FG003|NOT COMPLETED|Overall Study||5
3013485|NCT01023269|3731786|FG000|STARTED|Overall Study||3
3013486|NCT01023269|3731787|FG001|STARTED|Overall Study||2
3013487|NCT01023269|3731786|FG000|COMPLETED|Overall Study||1
3013488|NCT01023269|3731787|FG001|COMPLETED|Overall Study||2
3013489|NCT01023269|3731786|FG000|NOT COMPLETED|Overall Study||2
3013490|NCT01023269|3731787|FG001|NOT COMPLETED|Overall Study||0
3013491|NCT01023308|3731793|FG000|STARTED|Overall Study||387
3013492|NCT01023308|3731794|FG001|STARTED|Overall Study||381
3013493|NCT01023308|3731793|FG000|COMPLETED|Overall Study|completed all planned cycles of study treatment as per protocol|102
3013494|NCT01023308|3731794|FG001|COMPLETED|Overall Study|completed all planned cycles of study treatment as per protocol|102
3013495|NCT01023308|3731793|FG000|NOT COMPLETED|Overall Study||285
3013496|NCT01023308|3731794|FG001|NOT COMPLETED|Overall Study||279
3013497|NCT01023477|3731802|FG000|STARTED|Overall Study||7
3013498|NCT01023477|3731803|FG001|STARTED|Overall Study||5
3013499|NCT01023477|3731802|FG000|COMPLETED|Overall Study||7
3013500|NCT01023477|3731803|FG001|COMPLETED|Overall Study||5
3013501|NCT01023477|3731802|FG000|NOT COMPLETED|Overall Study||0
3013502|NCT01023477|3731803|FG001|NOT COMPLETED|Overall Study||0
3013503|NCT01023516|3731811|FG000|STARTED|Overall Study||313
3013504|NCT01023516|3731812|FG001|STARTED|Overall Study||302
3013505|NCT01023516|3731811|FG000|COMPLETED|Overall Study||289
3013506|NCT01023516|3731812|FG001|COMPLETED|Overall Study||284
3013507|NCT01023516|3731811|FG000|NOT COMPLETED|Overall Study||24
3013508|NCT01023516|3731812|FG001|NOT COMPLETED|Overall Study||18
3013509|NCT01023568|3731821|FG000|STARTED|Overall Study||45
3013510|NCT01023568|3731822|FG001|STARTED|Overall Study||44
3013511|NCT01023568|3731823|FG002|STARTED|Overall Study||45
3013512|NCT01023568|3731821|FG000|COMPLETED|Overall Study||45
3013513|NCT01023568|3731822|FG001|COMPLETED|Overall Study||44
3013514|NCT01023568|3731823|FG002|COMPLETED|Overall Study||45
3013515|NCT01023568|3731821|FG000|NOT COMPLETED|Overall Study||0
3013516|NCT01023568|3731822|FG001|NOT COMPLETED|Overall Study||0
3013517|NCT01023568|3731823|FG002|NOT COMPLETED|Overall Study||0
3013518|NCT01023581|3731838|FG000|STARTED|Overall Study||109
3013519|NCT01023581|3731839|FG001|STARTED|Overall Study||112
3013520|NCT01023581|3731840|FG002|STARTED|Overall Study||113
3013521|NCT01023581|3731841|FG003|STARTED|Overall Study||114
3013522|NCT01023581|3731842|FG004|STARTED|Overall Study||111
3013523|NCT01023581|3731843|FG005|STARTED|Overall Study||111
3013524|NCT01023581|3731844|FG006|STARTED|Overall Study||114
3013525|NCT01023581|3731838|FG000|Received Study Treatment|Overall Study||106
3013526|NCT01023581|3731839|FG001|Received Study Treatment|Overall Study||112
3013527|NCT01023581|3731840|FG002|Received Study Treatment|Overall Study||110
3013528|NCT01023581|3731841|FG003|Received Study Treatment|Overall Study||109
3013529|NCT01023581|3731842|FG004|Received Study Treatment|Overall Study||111
3013530|NCT01023581|3731843|FG005|Received Study Treatment|Overall Study||106
3013531|NCT01023581|3731844|FG006|Received Study Treatment|Overall Study||114
3013532|NCT01023581|3731838|FG000|COMPLETED|Overall Study|The number of completed patients represents those who completed study drug.|74
3013533|NCT01023581|3731839|FG001|COMPLETED|Overall Study||89
3013534|NCT01023581|3731840|FG002|COMPLETED|Overall Study||71
3013535|NCT01023581|3731841|FG003|COMPLETED|Overall Study||94
3013536|NCT01023581|3731842|FG004|COMPLETED|Overall Study||95
3013537|NCT01023581|3731843|FG005|COMPLETED|Overall Study||92
3013538|NCT01023581|3731844|FG006|COMPLETED|Overall Study||94
3013539|NCT01023581|3731838|FG000|NOT COMPLETED|Overall Study||35
3013540|NCT01023581|3731839|FG001|NOT COMPLETED|Overall Study||23
3013541|NCT01023581|3731840|FG002|NOT COMPLETED|Overall Study||42
3013542|NCT01023581|3731841|FG003|NOT COMPLETED|Overall Study||20
3013543|NCT01023581|3731842|FG004|NOT COMPLETED|Overall Study||16
3013544|NCT01023581|3731843|FG005|NOT COMPLETED|Overall Study||19
3013545|NCT01023581|3731844|FG006|NOT COMPLETED|Overall Study||20
3013546|NCT01023659|3731863|FG000|STARTED|Overall Study||258
3013547|NCT01023659|3731864|FG001|STARTED|Overall Study||365
3013548|NCT01023659|3731865|FG002|STARTED|Overall Study||264
3013549|NCT01023659|3731863|FG000|COMPLETED|Overall Study||185
3013550|NCT01023659|3731864|FG001|COMPLETED|Overall Study||137
3013551|NCT01023659|3731865|FG002|COMPLETED|Overall Study||165
3013552|NCT01023659|3731863|FG000|NOT COMPLETED|Overall Study||73
3013553|NCT01023659|3731864|FG001|NOT COMPLETED|Overall Study||228
3013554|NCT01023659|3731865|FG002|NOT COMPLETED|Overall Study||99
3013555|NCT01023672|3731874|FG000|STARTED|Overall Study||20
3013556|NCT01023672|3731874|FG000|COMPLETED|Overall Study||17
3013557|NCT01023672|3731874|FG000|NOT COMPLETED|Overall Study||3
3013558|NCT01023711|3731878|FG000|STARTED|Overall Study||107
3013559|NCT01023711|3731878|FG000|COMPLETED|Overall Study||107
3013560|NCT01023711|3731878|FG000|NOT COMPLETED|Overall Study||0
3013561|NCT01023724|3731885|FG000|STARTED|Overall Study||25
3013562|NCT01023724|3731886|FG001|STARTED|Overall Study||25
3013563|NCT01023724|3731885|FG000|COMPLETED|Overall Study||21
3013564|NCT01023724|3731886|FG001|COMPLETED|Overall Study||22
3013565|NCT01023724|3731885|FG000|NOT COMPLETED|Overall Study||4
3013566|NCT01023724|3731886|FG001|NOT COMPLETED|Overall Study||3
3013567|NCT01023776|3731892|FG000|STARTED|Overall Study|Subjects received 2 dose of vaccine 0.1 ml in each nostril intra nasally 28 days apart|20
3013568|NCT01023776|3731892|FG000|COMPLETED|Overall Study||20
3013569|NCT01023776|3731892|FG000|NOT COMPLETED|Overall Study||0
3013570|NCT01023789|3731896|FG000|STARTED|30-day Follow-up Visit|Intent-to-treat population (ITT).|812
3013571|NCT01023789|3731896|FG000|COMPLETED|30-day Follow-up Visit||812
3013572|NCT01023789|3731896|FG000|NOT COMPLETED|30-day Follow-up Visit||0
3013573|NCT01023789|3731896|FG000|STARTED|180-day Clinical Follow-up||812
3013574|NCT01023789|3731896|FG000|COMPLETED|180-day Clinical Follow-up||812
3013575|NCT01023789|3731896|FG000|NOT COMPLETED|180-day Clinical Follow-up||0
3013576|NCT01023789|3731896|FG000|STARTED|1 - Year Visit||812
3013577|NCT01023789|3731896|FG000|COMPLETED|1 - Year Visit||812
3013578|NCT01023789|3731896|FG000|NOT COMPLETED|1 - Year Visit||0
3013579|NCT01023789|3731896|FG000|STARTED|2 - Year Visit||812
3013580|NCT01023789|3731896|FG000|COMPLETED|2 - Year Visit||812
3013581|NCT01023789|3731896|FG000|NOT COMPLETED|2 - Year Visit||0
3013582|NCT01023789|3731896|FG000|STARTED|3 - Year Visit||812
3013583|NCT01023789|3731896|FG000|COMPLETED|3 - Year Visit||769
3013584|NCT01023789|3731896|FG000|NOT COMPLETED|3 - Year Visit||43
3013585|NCT01023815|3731904|FG000|STARTED|Pre-randomization Period (Day 1 to 90)|Out of 330 enrolled, 2 patients never received everolimus.|328
3013586|NCT01023815|3731905|FG001|STARTED|Pre-randomization Period (Day 1 to 90)||0
3013587|NCT01023815|3731906|FG002|STARTED|Pre-randomization Period (Day 1 to 90)||0
3013588|NCT01023815|3731907|FG003|STARTED|Pre-randomization Period (Day 1 to 90)||0
3013589|NCT01023815|3731904|FG000|COMPLETED|Pre-randomization Period (Day 1 to 90)||184
3013590|NCT01023815|3731905|FG001|COMPLETED|Pre-randomization Period (Day 1 to 90)||0
3013591|NCT01023815|3731906|FG002|COMPLETED|Pre-randomization Period (Day 1 to 90)||0
3013592|NCT01023815|3731907|FG003|COMPLETED|Pre-randomization Period (Day 1 to 90)||0
3013593|NCT01023815|3731904|FG000|NOT COMPLETED|Pre-randomization Period (Day 1 to 90)||144
3013594|NCT01023815|3731905|FG001|NOT COMPLETED|Pre-randomization Period (Day 1 to 90)||0
3013595|NCT01023815|3731906|FG002|NOT COMPLETED|Pre-randomization Period (Day 1 to 90)||0
3013596|NCT01023815|3731907|FG003|NOT COMPLETED|Pre-randomization Period (Day 1 to 90)||0
3013597|NCT01023815|3731904|FG000|STARTED|Randomized Period (Day 90 to Month 12)||0
3013598|NCT01023815|3731905|FG001|STARTED|Randomized Period (Day 90 to Month 12)|Randomized patients to Group A, B and C are also intent to treat population.|45
3013599|NCT01023815|3731906|FG002|STARTED|Randomized Period (Day 90 to Month 12)||68
3013600|NCT01023815|3731907|FG003|STARTED|Randomized Period (Day 90 to Month 12)||71
3013601|NCT01023815|3731904|FG000|COMPLETED|Randomized Period (Day 90 to Month 12)||0
3013602|NCT01023815|3731905|FG001|COMPLETED|Randomized Period (Day 90 to Month 12)||42
3013603|NCT01023815|3731906|FG002|COMPLETED|Randomized Period (Day 90 to Month 12)||60
3013604|NCT01023815|3731907|FG003|COMPLETED|Randomized Period (Day 90 to Month 12)||68
3013605|NCT01023815|3731904|FG000|NOT COMPLETED|Randomized Period (Day 90 to Month 12)||0
3013606|NCT01023815|3731905|FG001|NOT COMPLETED|Randomized Period (Day 90 to Month 12)||3
3013607|NCT01023815|3731906|FG002|NOT COMPLETED|Randomized Period (Day 90 to Month 12)||8
3013608|NCT01023815|3731907|FG003|NOT COMPLETED|Randomized Period (Day 90 to Month 12)||3
3013609|NCT01023841|3731920|FG000|STARTED|Overall Study||48
3013610|NCT01023841|3731921|FG001|STARTED|Overall Study||23
3013611|NCT01023841|3731920|FG000|COMPLETED|Overall Study||47
3013612|NCT01023841|3731921|FG001|COMPLETED|Overall Study||23
3013613|NCT01023841|3731920|FG000|NOT COMPLETED|Overall Study||1
3013614|NCT01023841|3731921|FG001|NOT COMPLETED|Overall Study||0
3013615|NCT01023958|3731927|FG000|STARTED|Overall Study||50
3013616|NCT01023958|3731927|FG000|COMPLETED|Overall Study||0
3013617|NCT01023958|3731927|FG000|NOT COMPLETED|Overall Study||50
3013618|NCT01024010|3731933|FG000|STARTED|Overall Study||48
3013619|NCT01024010|3731934|FG001|STARTED|Overall Study||34
3013620|NCT01024010|3731933|FG000|COMPLETED|Overall Study||48
3013621|NCT01024010|3731934|FG001|COMPLETED|Overall Study||34
3013622|NCT01024010|3731933|FG000|NOT COMPLETED|Overall Study||0
3013623|NCT01024010|3731934|FG001|NOT COMPLETED|Overall Study||0
3013624|NCT01024036|3731942|FG000|STARTED|Blinded Treatment||53
3013625|NCT01024036|3731943|FG001|STARTED|Blinded Treatment||26
3013626|NCT01024036|3731942|FG000|COMPLETED|Blinded Treatment||31
3013627|NCT01024036|3731943|FG001|COMPLETED|Blinded Treatment||6
3013628|NCT01024036|3731942|FG000|NOT COMPLETED|Blinded Treatment||22
3013629|NCT01024036|3731943|FG001|NOT COMPLETED|Blinded Treatment||20
3013630|NCT01024036|3731942|FG000|STARTED|Unblinded Treatment|No participants in this group received treatment during unblinded treatment period|0
3013631|NCT01024036|3731943|FG001|STARTED|Unblinded Treatment|Placebo participants had an option to receive siltuximab in unblinded treatment period|13
3013632|NCT01024036|3731942|FG000|COMPLETED|Unblinded Treatment||0
3013633|NCT01024036|3731943|FG001|COMPLETED|Unblinded Treatment||10
3013634|NCT01024036|3731942|FG000|NOT COMPLETED|Unblinded Treatment||0
3013635|NCT01024036|3731943|FG001|NOT COMPLETED|Unblinded Treatment||3
3013636|NCT01024036|3731942|FG000|STARTED|Follow-Up Period||14
3013637|NCT01024036|3731943|FG001|STARTED|Follow-Up Period||6
3013638|NCT01024036|3731942|FG000|COMPLETED|Follow-Up Period||9
3013639|NCT01024036|3731943|FG001|COMPLETED|Follow-Up Period||3
3013640|NCT01024036|3731942|FG000|NOT COMPLETED|Follow-Up Period||5
3013641|NCT01024036|3731943|FG001|NOT COMPLETED|Follow-Up Period||3
3013642|NCT01024231|3731959|FG000|STARTED|Overall Study||14
3013643|NCT01024231|3731960|FG001|STARTED|Overall Study||17
3013644|NCT01024231|3731961|FG002|STARTED|Overall Study||16
3013645|NCT01024231|3731962|FG003|STARTED|Overall Study||6
3013646|NCT01024231|3731963|FG004|STARTED|Overall Study||17
3013647|NCT01024231|3731964|FG005|STARTED|Overall Study||16
3013648|NCT01024231|3731965|FG006|STARTED|Overall Study||41
3013649|NCT01024231|3731959|FG000|COMPLETED|Overall Study||2
3013650|NCT01024231|3731960|FG001|COMPLETED|Overall Study||2
3013651|NCT01024231|3731961|FG002|COMPLETED|Overall Study||6
3013652|NCT01024231|3731962|FG003|COMPLETED|Overall Study||1
3013653|NCT01024231|3731963|FG004|COMPLETED|Overall Study||0
3013654|NCT01024231|3731964|FG005|COMPLETED|Overall Study||0
3013655|NCT01024231|3731965|FG006|COMPLETED|Overall Study||20
3013656|NCT01024231|3731959|FG000|NOT COMPLETED|Overall Study||12
3013657|NCT01024231|3731960|FG001|NOT COMPLETED|Overall Study||15
3013658|NCT01024231|3731961|FG002|NOT COMPLETED|Overall Study||10
3013659|NCT01024231|3731962|FG003|NOT COMPLETED|Overall Study||5
3013660|NCT01024231|3731963|FG004|NOT COMPLETED|Overall Study||17
3013661|NCT01024231|3731964|FG005|NOT COMPLETED|Overall Study||16
3013662|NCT01024231|3731965|FG006|NOT COMPLETED|Overall Study||21
3013663|NCT01024244|3731991|FG000|STARTED|Overall Study||22
3013664|NCT01024244|3731992|FG001|STARTED|Overall Study||12
3013665|NCT01024244|3731993|FG002|STARTED|Overall Study||15
3013666|NCT01024244|3731994|FG003|STARTED|Overall Study||14
3013667|NCT01024244|3731995|FG004|STARTED|Overall Study||15
3013668|NCT01024244|3731991|FG000|COMPLETED|Overall Study||5
3013669|NCT01024244|3731992|FG001|COMPLETED|Overall Study||1
3013670|NCT01024244|3731993|FG002|COMPLETED|Overall Study||1
3013671|NCT01024244|3731994|FG003|COMPLETED|Overall Study||1
3013672|NCT01024244|3731995|FG004|COMPLETED|Overall Study||1
3133669|NCT01696773|3858574|FG000|COMPLETED|Day 28, Second Intervention||5
3013673|NCT01024244|3731991|FG000|NOT COMPLETED|Overall Study||17
3013674|NCT01024244|3731992|FG001|NOT COMPLETED|Overall Study||11
3013675|NCT01024244|3731993|FG002|NOT COMPLETED|Overall Study||14
3013676|NCT01024244|3731994|FG003|NOT COMPLETED|Overall Study||13
3013677|NCT01024244|3731995|FG004|NOT COMPLETED|Overall Study||14
3013678|NCT01024296|3732007|FG000|STARTED|Overall Study||4
3013679|NCT01024296|3732007|FG000|COMPLETED|Overall Study||4
3013680|NCT01024296|3732007|FG000|NOT COMPLETED|Overall Study||0
3013681|NCT01024309|3732013|FG000|STARTED|Overall Study||35
3013682|NCT01024309|3732014|FG001|STARTED|Overall Study||31
3013683|NCT01024309|3732013|FG000|COMPLETED|Overall Study||27
3013684|NCT01024309|3732014|FG001|COMPLETED|Overall Study||27
3013685|NCT01024309|3732013|FG000|NOT COMPLETED|Overall Study||8
3013686|NCT01024309|3732014|FG001|NOT COMPLETED|Overall Study||4
3013687|NCT01024335|3732022|FG000|STARTED|Overall Study||20
3013688|NCT01024335|3732023|FG001|STARTED|Overall Study||40
3013689|NCT01024335|3732022|FG000|COMPLETED|Overall Study||7
3013690|NCT01024335|3732023|FG001|COMPLETED|Overall Study||14
3013691|NCT01024335|3732022|FG000|NOT COMPLETED|Overall Study||13
3013692|NCT01024335|3732023|FG001|NOT COMPLETED|Overall Study||26
3013693|NCT01024387|3732029|FG000|STARTED|Overall Study||60
3013694|NCT01024387|3732029|FG000|Evaluable for PFS|Overall Study||54
3013695|NCT01024387|3732029|FG000|Evaluable for Response|Overall Study||53
3013696|NCT01024387|3732029|FG000|COMPLETED|Overall Study||0
3013697|NCT01024387|3732029|FG000|NOT COMPLETED|Overall Study||60
3013698|NCT01024465|3732033|FG000|STARTED|Overall Study||26
3013699|NCT01024465|3732033|FG000|COMPLETED|Overall Study||23
3013700|NCT01024465|3732033|FG000|NOT COMPLETED|Overall Study||3
3037453|NCT01148017|3756726|FG002|COMPLETED|Overall Study||53
3037454|NCT01148017|3756727|FG003|COMPLETED|Overall Study||45
3037455|NCT01148017|3756724|FG000|NOT COMPLETED|Overall Study||80
3037456|NCT01148017|3756725|FG001|NOT COMPLETED|Overall Study||34
3037457|NCT01148017|3756726|FG002|NOT COMPLETED|Overall Study||0
3037458|NCT01148017|3756727|FG003|NOT COMPLETED|Overall Study||0
3037459|NCT01148225|3756738|FG000|STARTED|Overall Study||424
3037460|NCT01148225|3756738|FG000|COMPLETED|Overall Study||239
3037461|NCT01148225|3756738|FG000|NOT COMPLETED|Overall Study||185
3037462|NCT01148420|3756745|FG000|STARTED|Overall Study||48
3037463|NCT01148420|3756745|FG000|COMPLETED|Overall Study||48
3037464|NCT01148420|3756745|FG000|NOT COMPLETED|Overall Study||0
3037465|NCT01148459|3756752|FG000|STARTED|Overall Study||99
3037466|NCT01148459|3756753|FG001|STARTED|Overall Study||101
3037467|NCT01148459|3756752|FG000|COMPLETED|Overall Study||87
3037468|NCT01148459|3756753|FG001|COMPLETED|Overall Study||90
3037469|NCT01148459|3756752|FG000|NOT COMPLETED|Overall Study||12
3037470|NCT01148459|3756753|FG001|NOT COMPLETED|Overall Study||11
3037471|NCT01148511|3756761|FG000|STARTED|Exposed to Study Drug||99
3037472|NCT01148511|3756762|FG001|STARTED|Exposed to Study Drug|Patients were not randomized to this group until the Randomized Period.|0
3037473|NCT01148511|3756763|FG002|STARTED|Exposed to Study Drug|Patients were not randomized to this group until the Randomized Period.|0
3037474|NCT01148511|3756761|FG000|COMPLETED|Exposed to Study Drug||93
3037475|NCT01148511|3756762|FG001|COMPLETED|Exposed to Study Drug||0
3037476|NCT01148511|3756763|FG002|COMPLETED|Exposed to Study Drug||0
3037477|NCT01148511|3756761|FG000|NOT COMPLETED|Exposed to Study Drug||6
3037478|NCT01148511|3756762|FG001|NOT COMPLETED|Exposed to Study Drug||0
3037479|NCT01148511|3756763|FG002|NOT COMPLETED|Exposed to Study Drug||0
3037480|NCT01148511|3756761|FG000|STARTED|Randomized|All patients were randomized into the Treat and Extend and the Treat and Observe treatment groups.|0
3037481|NCT01148511|3756762|FG001|STARTED|Randomized||48
3037482|NCT01148511|3756763|FG002|STARTED|Randomized||45
3037483|NCT01148511|3756761|FG000|COMPLETED|Randomized||0
3037484|NCT01148511|3756762|FG001|COMPLETED|Randomized||38
3037485|NCT01148511|3756763|FG002|COMPLETED|Randomized||39
3037486|NCT01148511|3756761|FG000|NOT COMPLETED|Randomized||0
3037487|NCT01148511|3756762|FG001|NOT COMPLETED|Randomized||10
3037488|NCT01148511|3756763|FG002|NOT COMPLETED|Randomized||6
3037489|NCT01148524|3756779|FG000|STARTED|Overall Study||49
3037490|NCT01148524|3756780|FG001|STARTED|Overall Study||95
3037491|NCT01148524|3756781|FG002|STARTED|Overall Study||53
3037492|NCT01148524|3756782|FG003|STARTED|Overall Study||102
3037493|NCT01148524|3756783|FG004|STARTED|Overall Study||57
3037494|NCT01148524|3756784|FG005|STARTED|Overall Study||106
3037495|NCT01148524|3756785|FG006|STARTED|Overall Study||153
3037496|NCT01148524|3756786|FG007|STARTED|Overall Study||51
3037497|NCT01148524|3756787|FG008|STARTED|Overall Study||151
3037498|NCT01148524|3756779|FG000|COMPLETED|Overall Study||49
3037499|NCT01148524|3756780|FG001|COMPLETED|Overall Study||95
3037500|NCT01148524|3756781|FG002|COMPLETED|Overall Study||53
3308239|NCT03019289|4041545|FG005|STARTED|Overall Study||1
3308240|NCT03019289|4041546|FG006|STARTED|Overall Study||3
3308241|NCT03019289|4041547|FG007|STARTED|Overall Study||4
3308242|NCT03019289|4041548|FG008|STARTED|Overall Study||3
3308243|NCT03019289|4041540|FG000|COMPLETED|Overall Study||3
3308244|NCT03019289|4041541|FG001|COMPLETED|Overall Study||1
3308245|NCT03019289|4041542|FG002|COMPLETED|Overall Study||3
3308246|NCT03019289|4041543|FG003|COMPLETED|Overall Study||2
3308247|NCT03019289|4041544|FG004|COMPLETED|Overall Study||1
3037501|NCT01148524|3756782|FG003|COMPLETED|Overall Study||102
3037502|NCT01148524|3756783|FG004|COMPLETED|Overall Study||57
3037503|NCT01148524|3756784|FG005|COMPLETED|Overall Study||106
3037504|NCT01148524|3756785|FG006|COMPLETED|Overall Study||153
3037505|NCT01148524|3756786|FG007|COMPLETED|Overall Study||51
3037506|NCT01148524|3756787|FG008|COMPLETED|Overall Study||151
3037507|NCT01148524|3756779|FG000|NOT COMPLETED|Overall Study||0
3037508|NCT01148524|3756780|FG001|NOT COMPLETED|Overall Study||0
3037509|NCT01148524|3756781|FG002|NOT COMPLETED|Overall Study||0
3037510|NCT01148524|3756782|FG003|NOT COMPLETED|Overall Study||0
3037511|NCT01148524|3756783|FG004|NOT COMPLETED|Overall Study||0
3037512|NCT01148524|3756784|FG005|NOT COMPLETED|Overall Study||0
3037513|NCT01148524|3756785|FG006|NOT COMPLETED|Overall Study||0
3037514|NCT01148524|3756786|FG007|NOT COMPLETED|Overall Study||0
3037515|NCT01148524|3756787|FG008|NOT COMPLETED|Overall Study||0
3037516|NCT01148537|3756810|FG000|STARTED|Overall Study||44
3037517|NCT01148537|3756811|FG001|STARTED|Overall Study||44
3037518|NCT01148537|3756812|FG002|STARTED|Overall Study||44
3037519|NCT01148537|3756810|FG000|COMPLETED|Overall Study||41
3037520|NCT01148537|3756811|FG001|COMPLETED|Overall Study||44
3037521|NCT01148537|3756812|FG002|COMPLETED|Overall Study||41
3037522|NCT01148537|3756810|FG000|NOT COMPLETED|Overall Study||3
3013701|NCT01024569|3732039|FG000|STARTED|Overall Study||276
3013702|NCT01024569|3732040|FG001|STARTED|Overall Study||279
3013703|NCT01024569|3732039|FG000|COMPLETED|Overall Study||251
3013704|NCT01024569|3732040|FG001|COMPLETED|Overall Study||268
3013705|NCT01024569|3732039|FG000|NOT COMPLETED|Overall Study||25
3013706|NCT01024569|3732040|FG001|NOT COMPLETED|Overall Study||11
3013707|NCT01024686|3732051|FG000|STARTED|Overall Study|July 11, 2010: unexpected adverse event, (1) participant|6
3013708|NCT01024686|3732052|FG001|STARTED|Overall Study||0
3013709|NCT01024686|3732053|FG002|STARTED|Overall Study||0
3013710|NCT01024686|3732051|FG000|COMPLETED|Overall Study||6
3013711|NCT01024686|3732052|FG001|COMPLETED|Overall Study|(0) participants because the clinical trial was terminated prior to enrollment.|0
3013712|NCT01024686|3732053|FG002|COMPLETED|Overall Study|(0) participants because the clinical trial was terminated prior to enrollment.|0
3013713|NCT01024686|3732051|FG000|NOT COMPLETED|Overall Study||0
3013714|NCT01024686|3732052|FG001|NOT COMPLETED|Overall Study||0
3013715|NCT01024686|3732053|FG002|NOT COMPLETED|Overall Study||0
3013716|NCT01024738|3732064|FG000|STARTED|First Intervention:||7
3013717|NCT01024738|3732065|FG001|STARTED|First Intervention:||7
3013718|NCT01024738|3732066|FG002|STARTED|First Intervention:||8
3013719|NCT01024738|3732064|FG000|COMPLETED|First Intervention:||7
3013720|NCT01024738|3732065|FG001|COMPLETED|First Intervention:||7
3013721|NCT01024738|3732066|FG002|COMPLETED|First Intervention:||8
3013722|NCT01024738|3732064|FG000|NOT COMPLETED|First Intervention:||0
3013723|NCT01024738|3732065|FG001|NOT COMPLETED|First Intervention:||0
3013724|NCT01024738|3732066|FG002|NOT COMPLETED|First Intervention:||0
3013725|NCT01024738|3732064|FG000|STARTED|Washout After 1st Intervention||7
3013726|NCT01024738|3732065|FG001|STARTED|Washout After 1st Intervention||7
3013727|NCT01024738|3732066|FG002|STARTED|Washout After 1st Intervention||8
3013728|NCT01024738|3732064|FG000|COMPLETED|Washout After 1st Intervention||7
3013729|NCT01024738|3732065|FG001|COMPLETED|Washout After 1st Intervention||7
3013730|NCT01024738|3732066|FG002|COMPLETED|Washout After 1st Intervention||8
3013731|NCT01024738|3732064|FG000|NOT COMPLETED|Washout After 1st Intervention||0
3013732|NCT01024738|3732065|FG001|NOT COMPLETED|Washout After 1st Intervention||0
3013733|NCT01024738|3732066|FG002|NOT COMPLETED|Washout After 1st Intervention||0
3013734|NCT01024738|3732064|FG000|STARTED|Second Intervention:||7
3013735|NCT01024738|3732065|FG001|STARTED|Second Intervention:||7
3013736|NCT01024738|3732066|FG002|STARTED|Second Intervention:||8
3013737|NCT01024738|3732064|FG000|COMPLETED|Second Intervention:||7
3013738|NCT01024738|3732065|FG001|COMPLETED|Second Intervention:||7
3013739|NCT01024738|3732066|FG002|COMPLETED|Second Intervention:||8
3013740|NCT01024738|3732064|FG000|NOT COMPLETED|Second Intervention:||0
3013741|NCT01024738|3732065|FG001|NOT COMPLETED|Second Intervention:||0
3013742|NCT01024738|3732066|FG002|NOT COMPLETED|Second Intervention:||0
3013743|NCT01024738|3732064|FG000|STARTED|Washout After 2nd Intervention||7
3013744|NCT01024738|3732065|FG001|STARTED|Washout After 2nd Intervention||7
3013745|NCT01024738|3732066|FG002|STARTED|Washout After 2nd Intervention||8
3013746|NCT01024738|3732064|FG000|COMPLETED|Washout After 2nd Intervention||7
3013747|NCT01024738|3732065|FG001|COMPLETED|Washout After 2nd Intervention||7
3013748|NCT01024738|3732066|FG002|COMPLETED|Washout After 2nd Intervention||8
3013749|NCT01024738|3732064|FG000|NOT COMPLETED|Washout After 2nd Intervention||0
3013750|NCT01024738|3732065|FG001|NOT COMPLETED|Washout After 2nd Intervention||0
3013751|NCT01024738|3732066|FG002|NOT COMPLETED|Washout After 2nd Intervention||0
3013752|NCT01024738|3732064|FG000|STARTED|Third Intervention:||7
3013753|NCT01024738|3732065|FG001|STARTED|Third Intervention:||7
3013754|NCT01024738|3732066|FG002|STARTED|Third Intervention:||8
3013755|NCT01024738|3732064|FG000|COMPLETED|Third Intervention:||7
3013756|NCT01024738|3732065|FG001|COMPLETED|Third Intervention:||7
3013757|NCT01024738|3732066|FG002|COMPLETED|Third Intervention:||8
3013758|NCT01024738|3732064|FG000|NOT COMPLETED|Third Intervention:||0
3013759|NCT01024738|3732065|FG001|NOT COMPLETED|Third Intervention:||0
3013760|NCT01024738|3732066|FG002|NOT COMPLETED|Third Intervention:||0
3013761|NCT01024751|3732076|FG000|STARTED|Enrolled Participants||156
3013762|NCT01024751|3732077|FG001|STARTED|Enrolled Participants||156
3013763|NCT01024751|3732076|FG000|COMPLETED|Enrolled Participants||153
3013764|NCT01024751|3732077|FG001|COMPLETED|Enrolled Participants||152
3013765|NCT01024751|3732076|FG000|NOT COMPLETED|Enrolled Participants||3
3013766|NCT01024751|3732077|FG001|NOT COMPLETED|Enrolled Participants||4
3013767|NCT01024751|3732076|FG000|STARTED|Eligible Participants||153
3013768|NCT01024751|3732077|FG001|STARTED|Eligible Participants||152
3013769|NCT01024751|3732076|FG000|COMPLETED|Eligible Participants||153
3013770|NCT01024751|3732077|FG001|COMPLETED|Eligible Participants||149
3013771|NCT01024751|3732076|FG000|NOT COMPLETED|Eligible Participants||0
3013772|NCT01024751|3732077|FG001|NOT COMPLETED|Eligible Participants||3
3013773|NCT01024855|3732083|FG000|STARTED|Overall Study|30 subjects enrolled in a paired/split-eye evaluation; each subject used both study treatments|30
3013774|NCT01024855|3732083|FG000|COMPLETED|Overall Study|One subject of the 30 seen for baseline did not meet the inclusion/exclusion criteria|29
3013775|NCT01024855|3732083|FG000|NOT COMPLETED|Overall Study||1
3013776|NCT01024920|3732090|FG000|STARTED|Overall Study||67
3013777|NCT01024920|3732091|FG001|STARTED|Overall Study||32
3013778|NCT01024920|3732090|FG000|Treated|Overall Study||64
3013779|NCT01024920|3732091|FG001|Treated|Overall Study||32
3013780|NCT01024920|3732090|FG000|COMPLETED|Overall Study||0
3013781|NCT01024920|3732091|FG001|COMPLETED|Overall Study||0
3013782|NCT01024920|3732090|FG000|NOT COMPLETED|Overall Study||67
3013783|NCT01024920|3732091|FG001|NOT COMPLETED|Overall Study||32
3013784|NCT01024946|3732097|FG000|STARTED|Overall Study||11
3013785|NCT01024946|3732097|FG000|COMPLETED|Overall Study||6
3013786|NCT01024946|3732097|FG000|NOT COMPLETED|Overall Study||5
3013787|NCT01024959|3732101|FG000|STARTED|Overall Study||507
3013788|NCT01024959|3732101|FG000|COMPLETED|Overall Study||466
3013789|NCT01024959|3732101|FG000|NOT COMPLETED|Overall Study||41
3013790|NCT01024972|3732112|FG000|STARTED|Overall Study||16
3013791|NCT01024972|3732113|FG001|STARTED|Overall Study||15
3013792|NCT01024972|3732112|FG000|COMPLETED|Overall Study||16
3013793|NCT01024972|3732113|FG001|COMPLETED|Overall Study||15
3013794|NCT01024972|3732112|FG000|NOT COMPLETED|Overall Study||0
3013795|NCT01024972|3732113|FG001|NOT COMPLETED|Overall Study||0
3013796|NCT01025037|3732120|FG000|STARTED|Overall Study||61
3013797|NCT01025037|3732120|FG000|COMPLETED|Overall Study||50
3013798|NCT01025037|3732120|FG000|NOT COMPLETED|Overall Study||11
3013799|NCT01025076|3732124|FG000|STARTED|Overall Study||14
3013800|NCT01025076|3732124|FG000|COMPLETED|Overall Study||14
3013801|NCT01025076|3732124|FG000|NOT COMPLETED|Overall Study||0
3013802|NCT01025154|3732128|FG000|STARTED|Overall Study||59
3013803|NCT01025154|3732128|FG000|COMPLETED|Overall Study||57
3013804|NCT01025154|3732128|FG000|NOT COMPLETED|Overall Study||2
3013805|NCT01025193|3732132|FG000|STARTED|Overall Study||8
3013806|NCT01025193|3732132|FG000|COMPLETED|Overall Study|one patient was transplanted 2 weeks after 8 month belimumab dose and did not receive further doses.|4
3013807|NCT01025193|3732132|FG000|NOT COMPLETED|Overall Study||4
3013808|NCT01025232|3732142|FG000|STARTED|Overall Study||46
3013809|NCT01025232|3732143|FG001|STARTED|Overall Study||42
3013810|NCT01025232|3732142|FG000|COMPLETED|Overall Study||43
3013811|NCT01025232|3732143|FG001|COMPLETED|Overall Study||36
3013812|NCT01025232|3732142|FG000|NOT COMPLETED|Overall Study||3
3013813|NCT01025232|3732143|FG001|NOT COMPLETED|Overall Study||6
3013814|NCT01025284|3732152|FG000|STARTED|Overall Study||38
3013815|NCT01025284|3732153|FG001|STARTED|Overall Study||18
3013816|NCT01025284|3732154|FG002|STARTED|Overall Study||8
3013817|NCT01025284|3732152|FG000|Received at Least 1 Dose of Study Drug|Overall Study||38
3013818|NCT01025284|3732153|FG001|Received at Least 1 Dose of Study Drug|Overall Study||18
3013819|NCT01025284|3732154|FG002|Received at Least 1 Dose of Study Drug|Overall Study||8
3013820|NCT01025284|3732152|FG000|COMPLETED|Overall Study||38
3013821|NCT01025284|3732153|FG001|COMPLETED|Overall Study||16
3013822|NCT01025284|3732154|FG002|COMPLETED|Overall Study||8
3013823|NCT01025284|3732152|FG000|NOT COMPLETED|Overall Study||0
3013824|NCT01025284|3732153|FG001|NOT COMPLETED|Overall Study||2
3013825|NCT01025284|3732154|FG002|NOT COMPLETED|Overall Study||0
3013826|NCT01025336|3732169|FG000|STARTED|Overall Study||130
3013827|NCT01025336|3732170|FG001|STARTED|Overall Study||210
3013828|NCT01025336|3732171|FG002|STARTED|Overall Study||179
3013829|NCT01025336|3732172|FG003|STARTED|Overall Study||221
3013830|NCT01025336|3732173|FG004|STARTED|Overall Study||222
3013831|NCT01025336|3732169|FG000|COMPLETED|Overall Study||130
3013832|NCT01025336|3732170|FG001|COMPLETED|Overall Study||210
3013833|NCT01025336|3732171|FG002|COMPLETED|Overall Study||179
3013834|NCT01025336|3732172|FG003|COMPLETED|Overall Study||219
3013835|NCT01025336|3732173|FG004|COMPLETED|Overall Study||222
3013836|NCT01025336|3732169|FG000|NOT COMPLETED|Overall Study||0
3013837|NCT01025336|3732170|FG001|NOT COMPLETED|Overall Study||0
3013838|NCT01025336|3732171|FG002|NOT COMPLETED|Overall Study||0
3013839|NCT01025336|3732172|FG003|NOT COMPLETED|Overall Study||2
3013840|NCT01025336|3732173|FG004|NOT COMPLETED|Overall Study||0
3013841|NCT01025427|3732197|FG000|STARTED|Overall Study||16
3013842|NCT01025427|3732197|FG000|COMPLETED|Overall Study||16
3013843|NCT01025427|3732197|FG000|NOT COMPLETED|Overall Study||0
3013844|NCT01025453|3732201|FG000|STARTED|Overall Study||37
3013845|NCT01025453|3732201|FG000|COMPLETED|Overall Study||37
3013846|NCT01025453|3732201|FG000|NOT COMPLETED|Overall Study||0
3013847|NCT01025635|3732207|FG000|STARTED|Overall Study||198
3013848|NCT01025635|3732208|FG001|STARTED|Overall Study||203
3013849|NCT01025635|3732207|FG000|COMPLETED|Overall Study||175
3013850|NCT01025635|3732208|FG001|COMPLETED|Overall Study||178
3013851|NCT01025635|3732207|FG000|NOT COMPLETED|Overall Study||23
3013852|NCT01025635|3732208|FG001|NOT COMPLETED|Overall Study||25
3013853|NCT01025752|3732216|FG000|STARTED|Overall Study||62
3013854|NCT01025752|3732217|FG001|STARTED|Overall Study||63
3013855|NCT01025752|3732216|FG000|COMPLETED|Overall Study||54
3013856|NCT01025752|3732217|FG001|COMPLETED|Overall Study||50
3013857|NCT01025752|3732216|FG000|NOT COMPLETED|Overall Study||8
3013858|NCT01025752|3732217|FG001|NOT COMPLETED|Overall Study||13
3013859|NCT01025791|3732226|FG000|STARTED|Period 1||2
3013860|NCT01025791|3732227|FG001|STARTED|Period 1||2
3013861|NCT01025791|3732228|FG002|STARTED|Period 1||2
3013862|NCT01025791|3732229|FG003|STARTED|Period 1||2
3013863|NCT01025791|3732230|FG004|STARTED|Period 1||2
3013864|NCT01025791|3732231|FG005|STARTED|Period 1||2
3013865|NCT01025791|3732232|FG006|STARTED|Period 1||2
3013866|NCT01025791|3732233|FG007|STARTED|Period 1||2
3013867|NCT01025791|3732234|FG008|STARTED|Period 1||2
3013868|NCT01025791|3732235|FG009|STARTED|Period 1||1
3013869|NCT01025791|3732236|FG010|STARTED|Period 1||2
3013870|NCT01025791|3732237|FG011|STARTED|Period 1||1
3013871|NCT01025791|3732238|FG012|STARTED|Period 1||2
3013872|NCT01025791|3732239|FG013|STARTED|Period 1||1
3013873|NCT01025791|3732226|FG000|COMPLETED|Period 1||2
3013874|NCT01025791|3732227|FG001|COMPLETED|Period 1||2
3013875|NCT01025791|3732228|FG002|COMPLETED|Period 1||2
3013876|NCT01025791|3732229|FG003|COMPLETED|Period 1||2
3013877|NCT01025791|3732230|FG004|COMPLETED|Period 1||2
3013878|NCT01025791|3732231|FG005|COMPLETED|Period 1||2
3013879|NCT01025791|3732232|FG006|COMPLETED|Period 1||2
3013880|NCT01025791|3732233|FG007|COMPLETED|Period 1||2
3013881|NCT01025791|3732234|FG008|COMPLETED|Period 1||2
3013882|NCT01025791|3732235|FG009|COMPLETED|Period 1||1
3013883|NCT01025791|3732236|FG010|COMPLETED|Period 1||2
3013884|NCT01025791|3732237|FG011|COMPLETED|Period 1||1
3013885|NCT01025791|3732238|FG012|COMPLETED|Period 1||2
3013886|NCT01025791|3732239|FG013|COMPLETED|Period 1||1
3013887|NCT01025791|3732226|FG000|NOT COMPLETED|Period 1||0
3013888|NCT01025791|3732227|FG001|NOT COMPLETED|Period 1||0
3013889|NCT01025791|3732228|FG002|NOT COMPLETED|Period 1||0
3013890|NCT01025791|3732229|FG003|NOT COMPLETED|Period 1||0
3013891|NCT01025791|3732230|FG004|NOT COMPLETED|Period 1||0
3013892|NCT01025791|3732231|FG005|NOT COMPLETED|Period 1||0
3013893|NCT01025791|3732232|FG006|NOT COMPLETED|Period 1||0
3013894|NCT01025791|3732233|FG007|NOT COMPLETED|Period 1||0
3013895|NCT01025791|3732234|FG008|NOT COMPLETED|Period 1||0
3013896|NCT01025791|3732235|FG009|NOT COMPLETED|Period 1||0
3013897|NCT01025791|3732236|FG010|NOT COMPLETED|Period 1||0
3013898|NCT01025791|3732237|FG011|NOT COMPLETED|Period 1||0
3013899|NCT01025791|3732238|FG012|NOT COMPLETED|Period 1||0
3013900|NCT01025791|3732239|FG013|NOT COMPLETED|Period 1||0
3013901|NCT01025791|3732226|FG000|STARTED|Period 2||2
3013902|NCT01025791|3732227|FG001|STARTED|Period 2||2
3013903|NCT01025791|3732228|FG002|STARTED|Period 2||2
3013904|NCT01025791|3732229|FG003|STARTED|Period 2||2
3013905|NCT01025791|3732230|FG004|STARTED|Period 2||2
3013906|NCT01025791|3732231|FG005|STARTED|Period 2||2
3013907|NCT01025791|3732232|FG006|STARTED|Period 2||2
3013908|NCT01025791|3732233|FG007|STARTED|Period 2||2
3013909|NCT01025791|3732234|FG008|STARTED|Period 2||2
3013910|NCT01025791|3732235|FG009|STARTED|Period 2||1
3013911|NCT01025791|3732236|FG010|STARTED|Period 2||2
3013912|NCT01025791|3732237|FG011|STARTED|Period 2||1
3013913|NCT01025791|3732238|FG012|STARTED|Period 2||2
3013914|NCT01025791|3732239|FG013|STARTED|Period 2||1
3013915|NCT01025791|3732226|FG000|COMPLETED|Period 2||2
3013916|NCT01025791|3732227|FG001|COMPLETED|Period 2||2
3013917|NCT01025791|3732228|FG002|COMPLETED|Period 2||2
3013918|NCT01025791|3732229|FG003|COMPLETED|Period 2||2
3013919|NCT01025791|3732230|FG004|COMPLETED|Period 2||2
3013920|NCT01025791|3732231|FG005|COMPLETED|Period 2||2
3013921|NCT01025791|3732232|FG006|COMPLETED|Period 2||2
3013922|NCT01025791|3732233|FG007|COMPLETED|Period 2||2
3013923|NCT01025791|3732234|FG008|COMPLETED|Period 2||2
3013924|NCT01025791|3732235|FG009|COMPLETED|Period 2||1
3013925|NCT01025791|3732236|FG010|COMPLETED|Period 2||2
3013926|NCT01025791|3732237|FG011|COMPLETED|Period 2||1
3013927|NCT01025791|3732238|FG012|COMPLETED|Period 2||2
3013928|NCT01025791|3732239|FG013|COMPLETED|Period 2||1
3013929|NCT01025791|3732226|FG000|NOT COMPLETED|Period 2||0
3013930|NCT01025791|3732227|FG001|NOT COMPLETED|Period 2||0
3013931|NCT01025791|3732228|FG002|NOT COMPLETED|Period 2||0
3013932|NCT01025791|3732229|FG003|NOT COMPLETED|Period 2||0
3013933|NCT01025791|3732230|FG004|NOT COMPLETED|Period 2||0
3013934|NCT01025791|3732231|FG005|NOT COMPLETED|Period 2||0
3013935|NCT01025791|3732232|FG006|NOT COMPLETED|Period 2||0
3013936|NCT01025791|3732233|FG007|NOT COMPLETED|Period 2||0
3013937|NCT01025791|3732234|FG008|NOT COMPLETED|Period 2||0
3013938|NCT01025791|3732235|FG009|NOT COMPLETED|Period 2||0
3013939|NCT01025791|3732236|FG010|NOT COMPLETED|Period 2||0
3013940|NCT01025791|3732237|FG011|NOT COMPLETED|Period 2||0
3013941|NCT01025791|3732238|FG012|NOT COMPLETED|Period 2||0
3013942|NCT01025791|3732239|FG013|NOT COMPLETED|Period 2||0
3013943|NCT01025791|3732226|FG000|STARTED|Period 3||2
3013944|NCT01025791|3732227|FG001|STARTED|Period 3||2
3013945|NCT01025791|3732228|FG002|STARTED|Period 3||2
3013946|NCT01025791|3732229|FG003|STARTED|Period 3||2
3013947|NCT01025791|3732230|FG004|STARTED|Period 3||2
3013948|NCT01025791|3732231|FG005|STARTED|Period 3||2
3013949|NCT01025791|3732232|FG006|STARTED|Period 3||2
3013950|NCT01025791|3732233|FG007|STARTED|Period 3||2
3013951|NCT01025791|3732234|FG008|STARTED|Period 3||2
3013952|NCT01025791|3732235|FG009|STARTED|Period 3||1
3013953|NCT01025791|3732236|FG010|STARTED|Period 3||2
3013954|NCT01025791|3732237|FG011|STARTED|Period 3||1
3013955|NCT01025791|3732238|FG012|STARTED|Period 3||2
3013956|NCT01025791|3732239|FG013|STARTED|Period 3||1
3013957|NCT01025791|3732226|FG000|COMPLETED|Period 3||2
3013958|NCT01025791|3732227|FG001|COMPLETED|Period 3||2
3013959|NCT01025791|3732228|FG002|COMPLETED|Period 3||2
3013960|NCT01025791|3732229|FG003|COMPLETED|Period 3||2
3013961|NCT01025791|3732230|FG004|COMPLETED|Period 3||2
3013962|NCT01025791|3732231|FG005|COMPLETED|Period 3||2
3013963|NCT01025791|3732232|FG006|COMPLETED|Period 3||2
3013964|NCT01025791|3732233|FG007|COMPLETED|Period 3||2
3013965|NCT01025791|3732234|FG008|COMPLETED|Period 3||2
3013966|NCT01025791|3732235|FG009|COMPLETED|Period 3||1
3013967|NCT01025791|3732236|FG010|COMPLETED|Period 3||2
3013968|NCT01025791|3732237|FG011|COMPLETED|Period 3||1
3013969|NCT01025791|3732238|FG012|COMPLETED|Period 3||2
3013970|NCT01025791|3732239|FG013|COMPLETED|Period 3||1
3013971|NCT01025791|3732226|FG000|NOT COMPLETED|Period 3||0
3013972|NCT01025791|3732227|FG001|NOT COMPLETED|Period 3||0
3013973|NCT01025791|3732228|FG002|NOT COMPLETED|Period 3||0
3013974|NCT01025791|3732229|FG003|NOT COMPLETED|Period 3||0
3013975|NCT01025791|3732230|FG004|NOT COMPLETED|Period 3||0
3013976|NCT01025791|3732231|FG005|NOT COMPLETED|Period 3||0
3013977|NCT01025791|3732232|FG006|NOT COMPLETED|Period 3||0
3013978|NCT01025791|3732233|FG007|NOT COMPLETED|Period 3||0
3013979|NCT01025791|3732234|FG008|NOT COMPLETED|Period 3||0
3013980|NCT01025791|3732235|FG009|NOT COMPLETED|Period 3||0
3013981|NCT01025791|3732236|FG010|NOT COMPLETED|Period 3||0
3013982|NCT01025791|3732237|FG011|NOT COMPLETED|Period 3||0
3013983|NCT01025791|3732238|FG012|NOT COMPLETED|Period 3||0
3013984|NCT01025791|3732239|FG013|NOT COMPLETED|Period 3||0
3013985|NCT01025791|3732226|FG000|STARTED|Period 4||2
3013986|NCT01025791|3732227|FG001|STARTED|Period 4||2
3013987|NCT01025791|3732228|FG002|STARTED|Period 4||2
3013988|NCT01025791|3732229|FG003|STARTED|Period 4||2
3013989|NCT01025791|3732230|FG004|STARTED|Period 4||2
3013990|NCT01025791|3732231|FG005|STARTED|Period 4||2
3013991|NCT01025791|3732232|FG006|STARTED|Period 4||2
3013992|NCT01025791|3732233|FG007|STARTED|Period 4||2
3013993|NCT01025791|3732234|FG008|STARTED|Period 4||2
3013994|NCT01025791|3732235|FG009|STARTED|Period 4||1
3013995|NCT01025791|3732236|FG010|STARTED|Period 4||2
3013996|NCT01025791|3732237|FG011|STARTED|Period 4||1
3013997|NCT01025791|3732238|FG012|STARTED|Period 4||2
3013998|NCT01025791|3732239|FG013|STARTED|Period 4||1
3013999|NCT01025791|3732226|FG000|COMPLETED|Period 4||2
3014000|NCT01025791|3732227|FG001|COMPLETED|Period 4||2
3014001|NCT01025791|3732228|FG002|COMPLETED|Period 4||2
3014002|NCT01025791|3732229|FG003|COMPLETED|Period 4||2
3014003|NCT01025791|3732230|FG004|COMPLETED|Period 4||2
3014004|NCT01025791|3732231|FG005|COMPLETED|Period 4||2
3014005|NCT01025791|3732232|FG006|COMPLETED|Period 4||2
3014006|NCT01025791|3732233|FG007|COMPLETED|Period 4||2
3014007|NCT01025791|3732234|FG008|COMPLETED|Period 4||2
3014008|NCT01025791|3732235|FG009|COMPLETED|Period 4||1
3014009|NCT01025791|3732236|FG010|COMPLETED|Period 4||2
3014010|NCT01025791|3732237|FG011|COMPLETED|Period 4||1
3014011|NCT01025791|3732238|FG012|COMPLETED|Period 4||2
3014012|NCT01025791|3732239|FG013|COMPLETED|Period 4||1
3014013|NCT01025791|3732226|FG000|NOT COMPLETED|Period 4||0
3014014|NCT01025791|3732227|FG001|NOT COMPLETED|Period 4||0
3014015|NCT01025791|3732228|FG002|NOT COMPLETED|Period 4||0
3014016|NCT01025791|3732229|FG003|NOT COMPLETED|Period 4||0
3014017|NCT01025791|3732230|FG004|NOT COMPLETED|Period 4||0
3014018|NCT01025791|3732231|FG005|NOT COMPLETED|Period 4||0
3014019|NCT01025791|3732232|FG006|NOT COMPLETED|Period 4||0
3014020|NCT01025791|3732233|FG007|NOT COMPLETED|Period 4||0
3014021|NCT01025791|3732234|FG008|NOT COMPLETED|Period 4||0
3014022|NCT01025791|3732235|FG009|NOT COMPLETED|Period 4||0
3014023|NCT01025791|3732236|FG010|NOT COMPLETED|Period 4||0
3014024|NCT01025791|3732237|FG011|NOT COMPLETED|Period 4||0
3014025|NCT01025791|3732238|FG012|NOT COMPLETED|Period 4||0
3014026|NCT01025791|3732239|FG013|NOT COMPLETED|Period 4||0
3014027|NCT01025791|3732226|FG000|STARTED|Period 5||2
3014028|NCT01025791|3732227|FG001|STARTED|Period 5||2
3014029|NCT01025791|3732228|FG002|STARTED|Period 5||2
3014030|NCT01025791|3732229|FG003|STARTED|Period 5||2
3014031|NCT01025791|3732230|FG004|STARTED|Period 5||0
3014032|NCT01025791|3732231|FG005|STARTED|Period 5||0
3014033|NCT01025791|3732232|FG006|STARTED|Period 5||0
3014034|NCT01025791|3732233|FG007|STARTED|Period 5||0
3014035|NCT01025791|3732234|FG008|STARTED|Period 5||0
3014036|NCT01025791|3732235|FG009|STARTED|Period 5||0
3014037|NCT01025791|3732236|FG010|STARTED|Period 5||0
3014038|NCT01025791|3732237|FG011|STARTED|Period 5||0
3014039|NCT01025791|3732238|FG012|STARTED|Period 5||0
3014040|NCT01025791|3732239|FG013|STARTED|Period 5||0
3014041|NCT01025791|3732226|FG000|COMPLETED|Period 5||2
3014042|NCT01025791|3732227|FG001|COMPLETED|Period 5||2
3014043|NCT01025791|3732228|FG002|COMPLETED|Period 5||2
3014044|NCT01025791|3732229|FG003|COMPLETED|Period 5||2
3014045|NCT01025791|3732230|FG004|COMPLETED|Period 5||0
3014046|NCT01025791|3732231|FG005|COMPLETED|Period 5||0
3014047|NCT01025791|3732232|FG006|COMPLETED|Period 5||0
3014048|NCT01025791|3732233|FG007|COMPLETED|Period 5||0
3014049|NCT01025791|3732234|FG008|COMPLETED|Period 5||0
3014050|NCT01025791|3732235|FG009|COMPLETED|Period 5||0
3014051|NCT01025791|3732236|FG010|COMPLETED|Period 5||0
3014052|NCT01025791|3732237|FG011|COMPLETED|Period 5||0
3014053|NCT01025791|3732238|FG012|COMPLETED|Period 5||0
3014054|NCT01025791|3732239|FG013|COMPLETED|Period 5||0
3014055|NCT01025791|3732226|FG000|NOT COMPLETED|Period 5||0
3014056|NCT01025791|3732227|FG001|NOT COMPLETED|Period 5||0
3014057|NCT01025791|3732228|FG002|NOT COMPLETED|Period 5||0
3014058|NCT01025791|3732229|FG003|NOT COMPLETED|Period 5||0
3014059|NCT01025791|3732230|FG004|NOT COMPLETED|Period 5||0
3014060|NCT01025791|3732231|FG005|NOT COMPLETED|Period 5||0
3014061|NCT01025791|3732232|FG006|NOT COMPLETED|Period 5||0
3014062|NCT01025791|3732233|FG007|NOT COMPLETED|Period 5||0
3014063|NCT01025791|3732234|FG008|NOT COMPLETED|Period 5||0
3014064|NCT01025791|3732235|FG009|NOT COMPLETED|Period 5||0
3014065|NCT01025791|3732236|FG010|NOT COMPLETED|Period 5||0
3014066|NCT01025791|3732237|FG011|NOT COMPLETED|Period 5||0
3014067|NCT01025791|3732238|FG012|NOT COMPLETED|Period 5||0
3014068|NCT01025791|3732239|FG013|NOT COMPLETED|Period 5||0
3014069|NCT01025817|3732292|FG000|STARTED|Completed Study Medication||309
3014070|NCT01025817|3732293|FG001|STARTED|Completed Study Medication||304
3014071|NCT01025817|3732292|FG000|COMPLETED|Completed Study Medication||204
3014072|NCT01025817|3732293|FG001|COMPLETED|Completed Study Medication||232
3014073|NCT01025817|3732292|FG000|NOT COMPLETED|Completed Study Medication||105
3014074|NCT01025817|3732293|FG001|NOT COMPLETED|Completed Study Medication||72
3014075|NCT01025817|3732292|FG000|STARTED|Completed Study||309
3014076|NCT01025817|3732293|FG001|STARTED|Completed Study||304
3014077|NCT01025817|3732292|FG000|COMPLETED|Completed Study|Completed study phase|293
3014078|NCT01025817|3732293|FG001|COMPLETED|Completed Study|Completed study phase|282
3014079|NCT01025817|3732292|FG000|NOT COMPLETED|Completed Study||16
3014080|NCT01025817|3732293|FG001|NOT COMPLETED|Completed Study||22
3014081|NCT01025830|3732299|FG000|STARTED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||8
3014082|NCT01025830|3732300|FG001|STARTED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||12
3014083|NCT01025830|3732299|FG000|COMPLETED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||8
3014084|NCT01025830|3732300|FG001|COMPLETED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||12
3014085|NCT01025830|3732299|FG000|NOT COMPLETED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||0
3014086|NCT01025830|3732300|FG001|NOT COMPLETED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||0
3014087|NCT01025830|3732299|FG000|STARTED|Washout Period of 30 Days||8
3014088|NCT01025830|3732300|FG001|STARTED|Washout Period of 30 Days||12
3014089|NCT01025830|3732299|FG000|COMPLETED|Washout Period of 30 Days||8
3014090|NCT01025830|3732300|FG001|COMPLETED|Washout Period of 30 Days||12
3014091|NCT01025830|3732299|FG000|NOT COMPLETED|Washout Period of 30 Days||0
3014092|NCT01025830|3732300|FG001|NOT COMPLETED|Washout Period of 30 Days||0
3014093|NCT01025830|3732299|FG000|STARTED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||8
3014094|NCT01025830|3732300|FG001|STARTED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||12
3014095|NCT01025830|3732299|FG000|COMPLETED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||8
3014096|NCT01025830|3732300|FG001|COMPLETED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||12
3014097|NCT01025830|3732299|FG000|NOT COMPLETED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||0
3014098|NCT01025830|3732300|FG001|NOT COMPLETED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||0
3037523|NCT01148537|3756811|FG001|NOT COMPLETED|Overall Study||0
3037524|NCT01148537|3756812|FG002|NOT COMPLETED|Overall Study||3
3037525|NCT01148563|3756823|FG000|STARTED|Overall Study||69
3037526|NCT01148563|3756824|FG001|STARTED|Overall Study||67
3037527|NCT01148563|3756823|FG000|COMPLETED|Overall Study||40
3037528|NCT01148563|3756824|FG001|COMPLETED|Overall Study||37
3037529|NCT01148563|3756823|FG000|NOT COMPLETED|Overall Study||29
3037530|NCT01148563|3756824|FG001|NOT COMPLETED|Overall Study||30
3037531|NCT01148693|3756833|FG000|STARTED|Overall Study||70
3037532|NCT01148693|3756834|FG001|STARTED|Overall Study||67
3037533|NCT01148693|3756833|FG000|COMPLETED|Overall Study||57
3037534|NCT01148693|3756834|FG001|COMPLETED|Overall Study||57
3037535|NCT01148693|3756833|FG000|NOT COMPLETED|Overall Study||13
3037536|NCT01148693|3756834|FG001|NOT COMPLETED|Overall Study||10
3037537|NCT01148745|3756840|FG000|STARTED|Overall Study||15
3037538|NCT01148745|3756840|FG000|COMPLETED|Overall Study||15
3037539|NCT01148745|3756840|FG000|NOT COMPLETED|Overall Study||0
3037540|NCT01148771|3756848|FG000|STARTED|First Intervention||6
3037541|NCT01148771|3756849|FG001|STARTED|First Intervention||6
3037542|NCT01148771|3756848|FG000|COMPLETED|First Intervention||6
3037543|NCT01148771|3756849|FG001|COMPLETED|First Intervention||6
3037544|NCT01148771|3756848|FG000|NOT COMPLETED|First Intervention||0
3037545|NCT01148771|3756849|FG001|NOT COMPLETED|First Intervention||0
3037546|NCT01148771|3756848|FG000|STARTED|Washout Period||6
3037547|NCT01148771|3756849|FG001|STARTED|Washout Period||6
3037548|NCT01148771|3756848|FG000|COMPLETED|Washout Period||6
3037549|NCT01148771|3756849|FG001|COMPLETED|Washout Period||5
3037550|NCT01148771|3756848|FG000|NOT COMPLETED|Washout Period||0
3037551|NCT01148771|3756849|FG001|NOT COMPLETED|Washout Period||1
3037552|NCT01148771|3756848|FG000|STARTED|Second Intervention||6
3037553|NCT01148771|3756849|FG001|STARTED|Second Intervention||5
3037554|NCT01148771|3756848|FG000|COMPLETED|Second Intervention||6
3037555|NCT01148771|3756849|FG001|COMPLETED|Second Intervention||5
3037556|NCT01148771|3756848|FG000|NOT COMPLETED|Second Intervention||0
3037557|NCT01148771|3756849|FG001|NOT COMPLETED|Second Intervention||0
3037558|NCT01148810|3756861|FG000|STARTED|Overall Study||8
3037559|NCT01148810|3756862|FG001|STARTED|Overall Study||10
3037560|NCT01148810|3756861|FG000|COMPLETED|Overall Study||7
3037561|NCT01148810|3756862|FG001|COMPLETED|Overall Study||5
3037562|NCT01148810|3756861|FG000|NOT COMPLETED|Overall Study||1
3037563|NCT01148810|3756862|FG001|NOT COMPLETED|Overall Study||5
3037564|NCT01148836|3756871|FG000|STARTED|Overall Study|Enrollment completed|8
3037565|NCT01148836|3756872|FG001|STARTED|Overall Study||10
3037566|NCT01148836|3756871|FG000|COMPLETED|Overall Study|Enrollment completed|7
3037567|NCT01148836|3756872|FG001|COMPLETED|Overall Study||8
3037568|NCT01148836|3756871|FG000|NOT COMPLETED|Overall Study||1
3037569|NCT01148836|3756872|FG001|NOT COMPLETED|Overall Study||2
3037570|NCT01148862|3756878|FG000|STARTED|First Intervention||25
3037571|NCT01148862|3756879|FG001|STARTED|First Intervention||25
3037572|NCT01148862|3756878|FG000|COMPLETED|First Intervention||25
3037573|NCT01148862|3756879|FG001|COMPLETED|First Intervention||25
3037574|NCT01148862|3756878|FG000|NOT COMPLETED|First Intervention||0
3037575|NCT01148862|3756879|FG001|NOT COMPLETED|First Intervention||0
3037576|NCT01148862|3756878|FG000|STARTED|Washout Period of 2 Weeks||25
3037577|NCT01148862|3756879|FG001|STARTED|Washout Period of 2 Weeks||25
3037578|NCT01148862|3756878|FG000|COMPLETED|Washout Period of 2 Weeks||25
3037579|NCT01148862|3756879|FG001|COMPLETED|Washout Period of 2 Weeks||25
3037580|NCT01148862|3756878|FG000|NOT COMPLETED|Washout Period of 2 Weeks||0
3037581|NCT01148862|3756879|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0
3014099|NCT01025843|3732321|FG000|STARTED|Period 1||2
3014100|NCT01025843|3732322|FG001|STARTED|Period 1||2
3014101|NCT01025843|3732323|FG002|STARTED|Period 1||2
3014102|NCT01025843|3732324|FG003|STARTED|Period 1||2
3014103|NCT01025843|3732325|FG004|STARTED|Period 1||2
3014104|NCT01025843|3732326|FG005|STARTED|Period 1||2
3014105|NCT01025843|3732327|FG006|STARTED|Period 1||2
3014106|NCT01025843|3732328|FG007|STARTED|Period 1||2
3014107|NCT01025843|3732329|FG008|STARTED|Period 1||2
3014108|NCT01025843|3732330|FG009|STARTED|Period 1||2
3014109|NCT01025843|3732321|FG000|COMPLETED|Period 1||2
3014110|NCT01025843|3732322|FG001|COMPLETED|Period 1||2
3014111|NCT01025843|3732323|FG002|COMPLETED|Period 1||2
3014112|NCT01025843|3732324|FG003|COMPLETED|Period 1||2
3014113|NCT01025843|3732325|FG004|COMPLETED|Period 1||2
3014114|NCT01025843|3732326|FG005|COMPLETED|Period 1||2
3014115|NCT01025843|3732327|FG006|COMPLETED|Period 1||2
3014116|NCT01025843|3732328|FG007|COMPLETED|Period 1||2
3014117|NCT01025843|3732329|FG008|COMPLETED|Period 1||2
3014118|NCT01025843|3732330|FG009|COMPLETED|Period 1||2
3014119|NCT01025843|3732321|FG000|NOT COMPLETED|Period 1||0
3014120|NCT01025843|3732322|FG001|NOT COMPLETED|Period 1||0
3014121|NCT01025843|3732323|FG002|NOT COMPLETED|Period 1||0
3014122|NCT01025843|3732324|FG003|NOT COMPLETED|Period 1||0
3014123|NCT01025843|3732325|FG004|NOT COMPLETED|Period 1||0
3014124|NCT01025843|3732326|FG005|NOT COMPLETED|Period 1||0
3014125|NCT01025843|3732327|FG006|NOT COMPLETED|Period 1||0
3014126|NCT01025843|3732328|FG007|NOT COMPLETED|Period 1||0
3014127|NCT01025843|3732329|FG008|NOT COMPLETED|Period 1||0
3014128|NCT01025843|3732330|FG009|NOT COMPLETED|Period 1||0
3014129|NCT01025843|3732321|FG000|STARTED|Washout 1||2
3014130|NCT01025843|3732322|FG001|STARTED|Washout 1||2
3014131|NCT01025843|3732323|FG002|STARTED|Washout 1||2
3014132|NCT01025843|3732324|FG003|STARTED|Washout 1||2
3014133|NCT01025843|3732325|FG004|STARTED|Washout 1||2
3014134|NCT01025843|3732326|FG005|STARTED|Washout 1||2
3014135|NCT01025843|3732327|FG006|STARTED|Washout 1||2
3014136|NCT01025843|3732328|FG007|STARTED|Washout 1||2
3014137|NCT01025843|3732329|FG008|STARTED|Washout 1||2
3014138|NCT01025843|3732330|FG009|STARTED|Washout 1||2
3014139|NCT01025843|3732321|FG000|COMPLETED|Washout 1||2
3014140|NCT01025843|3732322|FG001|COMPLETED|Washout 1||2
3014141|NCT01025843|3732323|FG002|COMPLETED|Washout 1||2
3014142|NCT01025843|3732324|FG003|COMPLETED|Washout 1||2
3014143|NCT01025843|3732325|FG004|COMPLETED|Washout 1||2
3014144|NCT01025843|3732326|FG005|COMPLETED|Washout 1||2
3014145|NCT01025843|3732327|FG006|COMPLETED|Washout 1||2
3014146|NCT01025843|3732328|FG007|COMPLETED|Washout 1||2
3014147|NCT01025843|3732329|FG008|COMPLETED|Washout 1||2
3014148|NCT01025843|3732330|FG009|COMPLETED|Washout 1||2
3014149|NCT01025843|3732321|FG000|NOT COMPLETED|Washout 1||0
3014150|NCT01025843|3732322|FG001|NOT COMPLETED|Washout 1||0
3014151|NCT01025843|3732323|FG002|NOT COMPLETED|Washout 1||0
3014152|NCT01025843|3732324|FG003|NOT COMPLETED|Washout 1||0
3014153|NCT01025843|3732325|FG004|NOT COMPLETED|Washout 1||0
3014154|NCT01025843|3732326|FG005|NOT COMPLETED|Washout 1||0
3014155|NCT01025843|3732327|FG006|NOT COMPLETED|Washout 1||0
3014156|NCT01025843|3732328|FG007|NOT COMPLETED|Washout 1||0
3014157|NCT01025843|3732329|FG008|NOT COMPLETED|Washout 1||0
3014158|NCT01025843|3732330|FG009|NOT COMPLETED|Washout 1||0
3014159|NCT01025843|3732321|FG000|STARTED|Period 2||2
3014160|NCT01025843|3732322|FG001|STARTED|Period 2||2
3014161|NCT01025843|3732323|FG002|STARTED|Period 2||2
3014162|NCT01025843|3732324|FG003|STARTED|Period 2||2
3014163|NCT01025843|3732325|FG004|STARTED|Period 2||2
3014164|NCT01025843|3732326|FG005|STARTED|Period 2||2
3014165|NCT01025843|3732327|FG006|STARTED|Period 2||2
3014166|NCT01025843|3732328|FG007|STARTED|Period 2||2
3308248|NCT03019289|4041545|FG005|COMPLETED|Overall Study||1
3308249|NCT03019289|4041546|FG006|COMPLETED|Overall Study||3
3308250|NCT03019289|4041547|FG007|COMPLETED|Overall Study||4
3014167|NCT01025843|3732329|FG008|STARTED|Period 2||2
3014168|NCT01025843|3732330|FG009|STARTED|Period 2||2
3014169|NCT01025843|3732321|FG000|COMPLETED|Period 2||2
3014170|NCT01025843|3732322|FG001|COMPLETED|Period 2||2
3014171|NCT01025843|3732323|FG002|COMPLETED|Period 2||2
3014172|NCT01025843|3732324|FG003|COMPLETED|Period 2||2
3014173|NCT01025843|3732325|FG004|COMPLETED|Period 2||2
3014174|NCT01025843|3732326|FG005|COMPLETED|Period 2||2
3014175|NCT01025843|3732327|FG006|COMPLETED|Period 2||2
3014176|NCT01025843|3732328|FG007|COMPLETED|Period 2||2
3014177|NCT01025843|3732329|FG008|COMPLETED|Period 2||2
3014178|NCT01025843|3732330|FG009|COMPLETED|Period 2||2
3014179|NCT01025843|3732321|FG000|NOT COMPLETED|Period 2||0
3014180|NCT01025843|3732322|FG001|NOT COMPLETED|Period 2||0
3014181|NCT01025843|3732323|FG002|NOT COMPLETED|Period 2||0
3014182|NCT01025843|3732324|FG003|NOT COMPLETED|Period 2||0
3014183|NCT01025843|3732325|FG004|NOT COMPLETED|Period 2||0
3014184|NCT01025843|3732326|FG005|NOT COMPLETED|Period 2||0
3014185|NCT01025843|3732327|FG006|NOT COMPLETED|Period 2||0
3014186|NCT01025843|3732328|FG007|NOT COMPLETED|Period 2||0
3014187|NCT01025843|3732329|FG008|NOT COMPLETED|Period 2||0
3014188|NCT01025843|3732330|FG009|NOT COMPLETED|Period 2||0
3014189|NCT01025843|3732321|FG000|STARTED|Washout 2||2
3014190|NCT01025843|3732322|FG001|STARTED|Washout 2||2
3014191|NCT01025843|3732323|FG002|STARTED|Washout 2||2
3014192|NCT01025843|3732324|FG003|STARTED|Washout 2||2
3014193|NCT01025843|3732325|FG004|STARTED|Washout 2||2
3014194|NCT01025843|3732326|FG005|STARTED|Washout 2||2
3014195|NCT01025843|3732327|FG006|STARTED|Washout 2||2
3014196|NCT01025843|3732328|FG007|STARTED|Washout 2||2
3014197|NCT01025843|3732329|FG008|STARTED|Washout 2||2
3014198|NCT01025843|3732330|FG009|STARTED|Washout 2||2
3014199|NCT01025843|3732321|FG000|COMPLETED|Washout 2||2
3014200|NCT01025843|3732322|FG001|COMPLETED|Washout 2||2
3014201|NCT01025843|3732323|FG002|COMPLETED|Washout 2||2
3014202|NCT01025843|3732324|FG003|COMPLETED|Washout 2||2
3014203|NCT01025843|3732325|FG004|COMPLETED|Washout 2||2
3014204|NCT01025843|3732326|FG005|COMPLETED|Washout 2||2
3014205|NCT01025843|3732327|FG006|COMPLETED|Washout 2||2
3014206|NCT01025843|3732328|FG007|COMPLETED|Washout 2||2
3014207|NCT01025843|3732329|FG008|COMPLETED|Washout 2||2
3014208|NCT01025843|3732330|FG009|COMPLETED|Washout 2||2
3014209|NCT01025843|3732321|FG000|NOT COMPLETED|Washout 2||0
3014210|NCT01025843|3732322|FG001|NOT COMPLETED|Washout 2||0
3014211|NCT01025843|3732323|FG002|NOT COMPLETED|Washout 2||0
3014212|NCT01025843|3732324|FG003|NOT COMPLETED|Washout 2||0
3014213|NCT01025843|3732325|FG004|NOT COMPLETED|Washout 2||0
3014214|NCT01025843|3732326|FG005|NOT COMPLETED|Washout 2||0
3014215|NCT01025843|3732327|FG006|NOT COMPLETED|Washout 2||0
3014216|NCT01025843|3732328|FG007|NOT COMPLETED|Washout 2||0
3014217|NCT01025843|3732329|FG008|NOT COMPLETED|Washout 2||0
3014218|NCT01025843|3732330|FG009|NOT COMPLETED|Washout 2||0
3014219|NCT01025843|3732321|FG000|STARTED|Period 3||2
3014220|NCT01025843|3732322|FG001|STARTED|Period 3||2
3014221|NCT01025843|3732323|FG002|STARTED|Period 3||2
3014222|NCT01025843|3732324|FG003|STARTED|Period 3||2
3014223|NCT01025843|3732325|FG004|STARTED|Period 3||2
3014224|NCT01025843|3732326|FG005|STARTED|Period 3||2
3014225|NCT01025843|3732327|FG006|STARTED|Period 3||2
3014226|NCT01025843|3732328|FG007|STARTED|Period 3||2
3014227|NCT01025843|3732329|FG008|STARTED|Period 3||2
3165337|NCT01898689|3892879|FG000|STARTED|Overall Study||10
3165338|NCT01898689|3892880|FG001|STARTED|Overall Study||14
3165339|NCT01898689|3892879|FG000|COMPLETED|Overall Study||10
3165340|NCT01898689|3892880|FG001|COMPLETED|Overall Study||14
3165341|NCT01898689|3892879|FG000|NOT COMPLETED|Overall Study||0
3165342|NCT01898689|3892880|FG001|NOT COMPLETED|Overall Study||0
3014228|NCT01025843|3732330|FG009|STARTED|Period 3||2
3014229|NCT01025843|3732321|FG000|COMPLETED|Period 3||2
3014230|NCT01025843|3732322|FG001|COMPLETED|Period 3||2
3014231|NCT01025843|3732323|FG002|COMPLETED|Period 3||2
3014232|NCT01025843|3732324|FG003|COMPLETED|Period 3||2
3014233|NCT01025843|3732325|FG004|COMPLETED|Period 3||2
3014234|NCT01025843|3732326|FG005|COMPLETED|Period 3||2
3014235|NCT01025843|3732327|FG006|COMPLETED|Period 3||2
3165343|NCT01898754|3892890|FG000|STARTED|Overall Study||494
3165344|NCT01898754|3892891|FG001|STARTED|Overall Study||497
3165345|NCT01898754|3892890|FG000|COMPLETED|Overall Study||400
3165346|NCT01898754|3892891|FG001|COMPLETED|Overall Study||403
3165347|NCT01898754|3892890|FG000|NOT COMPLETED|Overall Study||94
3165348|NCT01898754|3892891|FG001|NOT COMPLETED|Overall Study||94
3165349|NCT01898806|3892897|FG000|STARTED|Overall Study||11
3165350|NCT01898806|3892897|FG000|COMPLETED|Overall Study||8
3014236|NCT01025843|3732328|FG007|COMPLETED|Period 3||2
3014237|NCT01025843|3732329|FG008|COMPLETED|Period 3||2
3014238|NCT01025843|3732330|FG009|COMPLETED|Period 3||2
3014239|NCT01025843|3732321|FG000|NOT COMPLETED|Period 3||0
3014240|NCT01025843|3732322|FG001|NOT COMPLETED|Period 3||0
3014241|NCT01025843|3732323|FG002|NOT COMPLETED|Period 3||0
3014242|NCT01025843|3732324|FG003|NOT COMPLETED|Period 3||0
3014243|NCT01025843|3732325|FG004|NOT COMPLETED|Period 3||0
3014244|NCT01025843|3732326|FG005|NOT COMPLETED|Period 3||0
3014245|NCT01025843|3732327|FG006|NOT COMPLETED|Period 3||0
3014246|NCT01025843|3732328|FG007|NOT COMPLETED|Period 3||0
3014247|NCT01025843|3732329|FG008|NOT COMPLETED|Period 3||0
3014248|NCT01025843|3732330|FG009|NOT COMPLETED|Period 3||0
3014249|NCT01025843|3732321|FG000|STARTED|Washout 3||2
3014250|NCT01025843|3732322|FG001|STARTED|Washout 3||2
3014251|NCT01025843|3732323|FG002|STARTED|Washout 3||2
3014252|NCT01025843|3732324|FG003|STARTED|Washout 3||2
3014253|NCT01025843|3732325|FG004|STARTED|Washout 3||2
3014254|NCT01025843|3732326|FG005|STARTED|Washout 3||2
3014255|NCT01025843|3732327|FG006|STARTED|Washout 3||2
3014256|NCT01025843|3732328|FG007|STARTED|Washout 3||2
3014257|NCT01025843|3732329|FG008|STARTED|Washout 3||2
3014258|NCT01025843|3732330|FG009|STARTED|Washout 3||2
3014259|NCT01025843|3732321|FG000|COMPLETED|Washout 3||2
3014260|NCT01025843|3732322|FG001|COMPLETED|Washout 3||2
3014261|NCT01025843|3732323|FG002|COMPLETED|Washout 3||2
3014262|NCT01025843|3732324|FG003|COMPLETED|Washout 3||2
3014263|NCT01025843|3732325|FG004|COMPLETED|Washout 3||2
3014264|NCT01025843|3732326|FG005|COMPLETED|Washout 3||2
3014265|NCT01025843|3732327|FG006|COMPLETED|Washout 3||2
3165351|NCT01898806|3892897|FG000|NOT COMPLETED|Overall Study||3
3165352|NCT01898884|3892906|FG000|STARTED|Single Dose Period||8
3165353|NCT01898884|3892907|FG001|STARTED|Single Dose Period||6
3165354|NCT01898884|3892908|FG002|STARTED|Single Dose Period||6
3165355|NCT01898884|3892909|FG003|STARTED|Single Dose Period||6
3165356|NCT01898884|3892910|FG004|STARTED|Single Dose Period||6
3165357|NCT01898884|3892911|FG005|STARTED|Single Dose Period||0
3165358|NCT01898884|3892912|FG006|STARTED|Single Dose Period||0
3014266|NCT01025843|3732328|FG007|COMPLETED|Washout 3||2
3014267|NCT01025843|3732329|FG008|COMPLETED|Washout 3||2
3014268|NCT01025843|3732330|FG009|COMPLETED|Washout 3||2
3014269|NCT01025843|3732321|FG000|NOT COMPLETED|Washout 3||0
3014270|NCT01025843|3732322|FG001|NOT COMPLETED|Washout 3||0
3014271|NCT01025843|3732323|FG002|NOT COMPLETED|Washout 3||0
3014272|NCT01025843|3732324|FG003|NOT COMPLETED|Washout 3||0
3014273|NCT01025843|3732325|FG004|NOT COMPLETED|Washout 3||0
3014274|NCT01025843|3732326|FG005|NOT COMPLETED|Washout 3||0
3014275|NCT01025843|3732327|FG006|NOT COMPLETED|Washout 3||0
3014276|NCT01025843|3732328|FG007|NOT COMPLETED|Washout 3||0
3014277|NCT01025843|3732329|FG008|NOT COMPLETED|Washout 3||0
3014278|NCT01025843|3732330|FG009|NOT COMPLETED|Washout 3||0
3014279|NCT01025843|3732321|FG000|STARTED|Period 4||2
3014280|NCT01025843|3732322|FG001|STARTED|Period 4||2
3014281|NCT01025843|3732323|FG002|STARTED|Period 4||2
3014282|NCT01025843|3732324|FG003|STARTED|Period 4||2
3014283|NCT01025843|3732325|FG004|STARTED|Period 4||2
3014284|NCT01025843|3732326|FG005|STARTED|Period 4||2
3014285|NCT01025843|3732327|FG006|STARTED|Period 4||2
3014286|NCT01025843|3732328|FG007|STARTED|Period 4||2
3014287|NCT01025843|3732329|FG008|STARTED|Period 4||2
3014288|NCT01025843|3732330|FG009|STARTED|Period 4||2
3014289|NCT01025843|3732321|FG000|COMPLETED|Period 4||2
3014290|NCT01025843|3732322|FG001|COMPLETED|Period 4||2
3014291|NCT01025843|3732323|FG002|COMPLETED|Period 4||2
3014292|NCT01025843|3732324|FG003|COMPLETED|Period 4||2
3014293|NCT01025843|3732325|FG004|COMPLETED|Period 4||2
3014294|NCT01025843|3732326|FG005|COMPLETED|Period 4||2
3014295|NCT01025843|3732327|FG006|COMPLETED|Period 4||2
3014296|NCT01025843|3732328|FG007|COMPLETED|Period 4||2
3014297|NCT01025843|3732329|FG008|COMPLETED|Period 4||2
3014298|NCT01025843|3732330|FG009|COMPLETED|Period 4||2
3014299|NCT01025843|3732321|FG000|NOT COMPLETED|Period 4||0
3014300|NCT01025843|3732322|FG001|NOT COMPLETED|Period 4||0
3014301|NCT01025843|3732323|FG002|NOT COMPLETED|Period 4||0
3014302|NCT01025843|3732324|FG003|NOT COMPLETED|Period 4||0
3014303|NCT01025843|3732325|FG004|NOT COMPLETED|Period 4||0
3014304|NCT01025843|3732326|FG005|NOT COMPLETED|Period 4||0
3014305|NCT01025843|3732327|FG006|NOT COMPLETED|Period 4||0
3014306|NCT01025843|3732328|FG007|NOT COMPLETED|Period 4||0
3014307|NCT01025843|3732329|FG008|NOT COMPLETED|Period 4||0
3014308|NCT01025843|3732330|FG009|NOT COMPLETED|Period 4||0
3014309|NCT01025843|3732321|FG000|STARTED|Washout 4||2
3014310|NCT01025843|3732322|FG001|STARTED|Washout 4||2
3014311|NCT01025843|3732323|FG002|STARTED|Washout 4||2
3014312|NCT01025843|3732324|FG003|STARTED|Washout 4||2
3014313|NCT01025843|3732325|FG004|STARTED|Washout 4||2
3014314|NCT01025843|3732326|FG005|STARTED|Washout 4||2
3014315|NCT01025843|3732327|FG006|STARTED|Washout 4||2
3014316|NCT01025843|3732328|FG007|STARTED|Washout 4||2
3014317|NCT01025843|3732329|FG008|STARTED|Washout 4||2
3133670|NCT01696773|3858575|FG001|COMPLETED|Day 28, Second Intervention||6
3133671|NCT01696773|3858574|FG000|NOT COMPLETED|Day 28, Second Intervention||0
3133672|NCT01696773|3858575|FG001|NOT COMPLETED|Day 28, Second Intervention||0
3014318|NCT01025843|3732330|FG009|STARTED|Washout 4||2
3014319|NCT01025843|3732321|FG000|COMPLETED|Washout 4||2
3014320|NCT01025843|3732322|FG001|COMPLETED|Washout 4||2
3014321|NCT01025843|3732323|FG002|COMPLETED|Washout 4||1
3014322|NCT01025843|3732324|FG003|COMPLETED|Washout 4||1
3014323|NCT01025843|3732325|FG004|COMPLETED|Washout 4||2
3014324|NCT01025843|3732326|FG005|COMPLETED|Washout 4||2
3014325|NCT01025843|3732327|FG006|COMPLETED|Washout 4||2
3014326|NCT01025843|3732328|FG007|COMPLETED|Washout 4||2
3014327|NCT01025843|3732329|FG008|COMPLETED|Washout 4||2
3014328|NCT01025843|3732330|FG009|COMPLETED|Washout 4||2
3014329|NCT01025843|3732321|FG000|NOT COMPLETED|Washout 4||0
3014330|NCT01025843|3732322|FG001|NOT COMPLETED|Washout 4||0
3014331|NCT01025843|3732323|FG002|NOT COMPLETED|Washout 4||1
3014332|NCT01025843|3732324|FG003|NOT COMPLETED|Washout 4||1
3014333|NCT01025843|3732325|FG004|NOT COMPLETED|Washout 4||0
3014334|NCT01025843|3732326|FG005|NOT COMPLETED|Washout 4||0
3014335|NCT01025843|3732327|FG006|NOT COMPLETED|Washout 4||0
3014336|NCT01025843|3732328|FG007|NOT COMPLETED|Washout 4||0
3014337|NCT01025843|3732329|FG008|NOT COMPLETED|Washout 4||0
3014338|NCT01025843|3732330|FG009|NOT COMPLETED|Washout 4||0
3014339|NCT01025843|3732321|FG000|STARTED|Period 5||2
3014340|NCT01025843|3732322|FG001|STARTED|Period 5||2
3014341|NCT01025843|3732323|FG002|STARTED|Period 5||1
3014342|NCT01025843|3732324|FG003|STARTED|Period 5||1
3014343|NCT01025843|3732325|FG004|STARTED|Period 5||2
3014344|NCT01025843|3732326|FG005|STARTED|Period 5||2
3014345|NCT01025843|3732327|FG006|STARTED|Period 5||2
3014346|NCT01025843|3732328|FG007|STARTED|Period 5||2
3014347|NCT01025843|3732329|FG008|STARTED|Period 5||2
3014348|NCT01025843|3732330|FG009|STARTED|Period 5||2
3014349|NCT01025843|3732321|FG000|COMPLETED|Period 5||2
3014350|NCT01025843|3732322|FG001|COMPLETED|Period 5||2
3014351|NCT01025843|3732323|FG002|COMPLETED|Period 5||1
3014352|NCT01025843|3732324|FG003|COMPLETED|Period 5||1
3014353|NCT01025843|3732325|FG004|COMPLETED|Period 5||2
3014354|NCT01025843|3732326|FG005|COMPLETED|Period 5||2
3014355|NCT01025843|3732327|FG006|COMPLETED|Period 5||2
3014356|NCT01025843|3732328|FG007|COMPLETED|Period 5||2
3133673|NCT01696877|3858583|FG000|STARTED|Overall Study||15
3133674|NCT01696877|3858584|FG001|STARTED|Overall Study||14
3133675|NCT01696877|3858583|FG000|COMPLETED|Overall Study||15
3133676|NCT01696877|3858584|FG001|COMPLETED|Overall Study||13
3133677|NCT01696877|3858583|FG000|NOT COMPLETED|Overall Study||0
3133678|NCT01696877|3858584|FG001|NOT COMPLETED|Overall Study||1
3133679|NCT01696929|3858592|FG000|STARTED|Overall Study||6
3133680|NCT01696929|3858592|FG000|COMPLETED|Overall Study||5
3133681|NCT01696929|3858592|FG000|NOT COMPLETED|Overall Study||1
3133682|NCT01696942|3858598|FG000|STARTED|Overall Study||5
3133683|NCT01696942|3858599|FG001|STARTED|Overall Study||5
3308251|NCT03019289|4041548|FG008|COMPLETED|Overall Study||2
3308252|NCT03019289|4041540|FG000|NOT COMPLETED|Overall Study||2
3308253|NCT03019289|4041541|FG001|NOT COMPLETED|Overall Study||0
3308254|NCT03019289|4041542|FG002|NOT COMPLETED|Overall Study||0
3308255|NCT03019289|4041543|FG003|NOT COMPLETED|Overall Study||0
3308256|NCT03019289|4041544|FG004|NOT COMPLETED|Overall Study||0
3308257|NCT03019289|4041545|FG005|NOT COMPLETED|Overall Study||0
3308258|NCT03019289|4041546|FG006|NOT COMPLETED|Overall Study||0
3014357|NCT01025843|3732329|FG008|COMPLETED|Period 5||2
3014358|NCT01025843|3732330|FG009|COMPLETED|Period 5||2
3014359|NCT01025843|3732321|FG000|NOT COMPLETED|Period 5||0
3014360|NCT01025843|3732322|FG001|NOT COMPLETED|Period 5||0
3014361|NCT01025843|3732323|FG002|NOT COMPLETED|Period 5||0
3014362|NCT01025843|3732324|FG003|NOT COMPLETED|Period 5||0
3014363|NCT01025843|3732325|FG004|NOT COMPLETED|Period 5||0
3014364|NCT01025843|3732326|FG005|NOT COMPLETED|Period 5||0
3014365|NCT01025843|3732327|FG006|NOT COMPLETED|Period 5||0
3014366|NCT01025843|3732328|FG007|NOT COMPLETED|Period 5||0
3014367|NCT01025843|3732329|FG008|NOT COMPLETED|Period 5||0
3014368|NCT01025843|3732330|FG009|NOT COMPLETED|Period 5||0
3014369|NCT01026012|3732358|FG000|STARTED|Overall Study||40
3014370|NCT01026012|3732358|FG000|COMPLETED|Overall Study||40
3014371|NCT01026012|3732358|FG000|NOT COMPLETED|Overall Study||0
3014372|NCT01026038|3732365|FG000|STARTED|Overall Study||130
3014373|NCT01026038|3732366|FG001|STARTED|Overall Study||65
3014374|NCT01026038|3732367|FG002|STARTED|Overall Study||67
3014375|NCT01026038|3732365|FG000|COMPLETED|Overall Study||129
3014376|NCT01026038|3732366|FG001|COMPLETED|Overall Study||64
3014377|NCT01026038|3732367|FG002|COMPLETED|Overall Study||67
3014378|NCT01026038|3732365|FG000|NOT COMPLETED|Overall Study||1
3014379|NCT01026038|3732366|FG001|NOT COMPLETED|Overall Study||1
3014380|NCT01026038|3732367|FG002|NOT COMPLETED|Overall Study||0
3014381|NCT01026103|3732375|FG000|STARTED|Overall Study||30
3014382|NCT01026103|3732375|FG000|Consented|Overall Study||30
3014383|NCT01026103|3732375|FG000|COMPLETED|Overall Study||28
3014384|NCT01026103|3732375|FG000|NOT COMPLETED|Overall Study||2
3014385|NCT01026142|3732381|FG000|STARTED|Overall Study||224
3014386|NCT01026142|3732382|FG001|STARTED|Overall Study||228
3308259|NCT03019289|4041547|FG007|NOT COMPLETED|Overall Study||0
3308260|NCT03019289|4041548|FG008|NOT COMPLETED|Overall Study||1
3308261|NCT03019406|4041573|FG000|STARTED|PAP: up to 25 Weeks||6
3308262|NCT03019406|4041574|FG001|STARTED|PAP: up to 25 Weeks||5
3308263|NCT03019406|4041575|FG002|STARTED|PAP: up to 25 Weeks||5
3014387|NCT01026142|3732381|FG000|COMPLETED|Overall Study||52
3014388|NCT01026142|3732382|FG001|COMPLETED|Overall Study||65
3014389|NCT01026142|3732381|FG000|NOT COMPLETED|Overall Study||172
3014390|NCT01026142|3732382|FG001|NOT COMPLETED|Overall Study||163
3014391|NCT01026181|3732391|FG000|STARTED|Overall Study||51
3014392|NCT01026181|3732392|FG001|STARTED|Overall Study||51
3014393|NCT01026181|3732393|FG002|STARTED|Overall Study||48
3014394|NCT01026181|3732391|FG000|COMPLETED|Overall Study||51
3014395|NCT01026181|3732392|FG001|COMPLETED|Overall Study||51
3014396|NCT01026181|3732393|FG002|COMPLETED|Overall Study||48
3014397|NCT01026181|3732391|FG000|NOT COMPLETED|Overall Study||0
3014398|NCT01026181|3732392|FG001|NOT COMPLETED|Overall Study||0
3014399|NCT01026181|3732393|FG002|NOT COMPLETED|Overall Study||0
3014400|NCT01026194|3732403|FG000|STARTED|Period 1：Double Blind Period||101
3014401|NCT01026194|3732404|FG001|STARTED|Period 1：Double Blind Period||103
3014402|NCT01026194|3732403|FG000|COMPLETED|Period 1：Double Blind Period||98
3014403|NCT01026194|3732404|FG001|COMPLETED|Period 1：Double Blind Period||98
3014404|NCT01026194|3732403|FG000|NOT COMPLETED|Period 1：Double Blind Period||3
3014405|NCT01026194|3732404|FG001|NOT COMPLETED|Period 1：Double Blind Period||5
3014406|NCT01026194|3732403|FG000|STARTED|Period 2：Open-label Period||98
3014407|NCT01026194|3732404|FG001|STARTED|Period 2：Open-label Period||98
3014408|NCT01026194|3732403|FG000|COMPLETED|Period 2：Open-label Period||91
3014409|NCT01026194|3732404|FG001|COMPLETED|Period 2：Open-label Period||88
3014410|NCT01026194|3732403|FG000|NOT COMPLETED|Period 2：Open-label Period||7
3014411|NCT01026194|3732404|FG001|NOT COMPLETED|Period 2：Open-label Period||10
3014412|NCT01026324|3732415|FG000|STARTED|Treatment Allocation||5
3014413|NCT01026324|3732416|FG001|STARTED|Treatment Allocation||3
3014414|NCT01026324|3732417|FG002|STARTED|Treatment Allocation||4
3014415|NCT01026324|3732415|FG000|Discontinued Intervention (Toxicity)|Treatment Allocation||1
3014416|NCT01026324|3732416|FG001|Discontinued Intervention (Toxicity)|Treatment Allocation||0
3165359|NCT01898884|3892913|FG007|STARTED|Single Dose Period||0
3165360|NCT01898884|3892914|FG008|STARTED|Single Dose Period||0
3165361|NCT01898884|3892906|FG000|COMPLETED|Single Dose Period||8
3165362|NCT01898884|3892907|FG001|COMPLETED|Single Dose Period||6
3165363|NCT01898884|3892908|FG002|COMPLETED|Single Dose Period||6
3165364|NCT01898884|3892909|FG003|COMPLETED|Single Dose Period||6
3165365|NCT01898884|3892910|FG004|COMPLETED|Single Dose Period||6
3165366|NCT01898884|3892911|FG005|COMPLETED|Single Dose Period||0
3165367|NCT01898884|3892912|FG006|COMPLETED|Single Dose Period||0
3165368|NCT01898884|3892913|FG007|COMPLETED|Single Dose Period||0
3165369|NCT01898884|3892914|FG008|COMPLETED|Single Dose Period||0
3165370|NCT01898884|3892906|FG000|NOT COMPLETED|Single Dose Period||0
3165371|NCT01898884|3892907|FG001|NOT COMPLETED|Single Dose Period||0
3165372|NCT01898884|3892908|FG002|NOT COMPLETED|Single Dose Period||0
3014417|NCT01026324|3732417|FG002|Discontinued Intervention (Toxicity)|Treatment Allocation||0
3014418|NCT01026324|3732415|FG000|Discontinuted Intervention (Progression)|Treatment Allocation||3
3165373|NCT01898884|3892909|FG003|NOT COMPLETED|Single Dose Period||0
3165374|NCT01898884|3892910|FG004|NOT COMPLETED|Single Dose Period||0
3014419|NCT01026324|3732416|FG001|Discontinuted Intervention (Progression)|Treatment Allocation||3
3014420|NCT01026324|3732417|FG002|Discontinuted Intervention (Progression)|Treatment Allocation||4
3014421|NCT01026324|3732415|FG000|Discontinued Intervention (Withdrew)|Treatment Allocation||1
3014422|NCT01026324|3732416|FG001|Discontinued Intervention (Withdrew)|Treatment Allocation||0
3014423|NCT01026324|3732417|FG002|Discontinued Intervention (Withdrew)|Treatment Allocation||0
3014424|NCT01026324|3732415|FG000|COMPLETED|Treatment Allocation||5
3014425|NCT01026324|3732416|FG001|COMPLETED|Treatment Allocation||3
3014426|NCT01026324|3732417|FG002|COMPLETED|Treatment Allocation||4
3014427|NCT01026324|3732415|FG000|NOT COMPLETED|Treatment Allocation||0
3014428|NCT01026324|3732416|FG001|NOT COMPLETED|Treatment Allocation||0
3014429|NCT01026324|3732417|FG002|NOT COMPLETED|Treatment Allocation||0
3014430|NCT01026324|3732415|FG000|STARTED|Follow up/Survival||5
3014431|NCT01026324|3732416|FG001|STARTED|Follow up/Survival||3
3014432|NCT01026324|3732417|FG002|STARTED|Follow up/Survival||4
3014433|NCT01026324|3732415|FG000|Follow up Discontinuation (Death)|Follow up/Survival||4
3014434|NCT01026324|3732416|FG001|Follow up Discontinuation (Death)|Follow up/Survival||3
3014435|NCT01026324|3732417|FG002|Follow up Discontinuation (Death)|Follow up/Survival||4
3014436|NCT01026324|3732415|FG000|COMPLETED|Follow up/Survival||4
3014437|NCT01026324|3732416|FG001|COMPLETED|Follow up/Survival||3
3014438|NCT01026324|3732417|FG002|COMPLETED|Follow up/Survival||4
3014439|NCT01026324|3732415|FG000|NOT COMPLETED|Follow up/Survival||1
3014440|NCT01026324|3732416|FG001|NOT COMPLETED|Follow up/Survival||0
3014441|NCT01026324|3732417|FG002|NOT COMPLETED|Follow up/Survival||0
3014442|NCT01026389|3732428|FG000|STARTED|Overall Study||93
3014443|NCT01026389|3732429|FG001|STARTED|Overall Study||93
3014444|NCT01026389|3732428|FG000|COMPLETED|Overall Study||88
3014445|NCT01026389|3732429|FG001|COMPLETED|Overall Study||88
3014446|NCT01026389|3732428|FG000|NOT COMPLETED|Overall Study||5
3014447|NCT01026389|3732429|FG001|NOT COMPLETED|Overall Study||5
3014448|NCT01026402|3732452|FG000|STARTED|Overall Study||6
3014449|NCT01026402|3732453|FG001|STARTED|Overall Study||8
3014450|NCT01026402|3732454|FG002|STARTED|Overall Study||33
3014451|NCT01026402|3732455|FG003|STARTED|Overall Study||18
3014452|NCT01026402|3732456|FG004|STARTED|Overall Study||3
3014453|NCT01026402|3732457|FG005|STARTED|Overall Study||5
3014454|NCT01026402|3732458|FG006|STARTED|Overall Study||8
3014455|NCT01026402|3732459|FG007|STARTED|Overall Study||3
3014456|NCT01026402|3732460|FG008|STARTED|Overall Study||7
3014457|NCT01026402|3732461|FG009|STARTED|Overall Study||3
3014458|NCT01026402|3732462|FG010|STARTED|Overall Study||7
3014459|NCT01026402|3732463|FG011|STARTED|Overall Study||8
3014460|NCT01026402|3732464|FG012|STARTED|Overall Study||8
3014461|NCT01026402|3732465|FG013|STARTED|Overall Study||6
3014462|NCT01026402|3732466|FG014|STARTED|Overall Study||3
3014463|NCT01026402|3732467|FG015|STARTED|Overall Study||5
3014464|NCT01026402|3732468|FG016|STARTED|Overall Study||4
3014465|NCT01026402|3732452|FG000|COMPLETED|Overall Study||6
3014466|NCT01026402|3732453|FG001|COMPLETED|Overall Study||8
3014467|NCT01026402|3732454|FG002|COMPLETED|Overall Study||33
3014468|NCT01026402|3732455|FG003|COMPLETED|Overall Study||18
3014469|NCT01026402|3732456|FG004|COMPLETED|Overall Study||3
3014470|NCT01026402|3732457|FG005|COMPLETED|Overall Study||5
3014471|NCT01026402|3732458|FG006|COMPLETED|Overall Study||8
3014472|NCT01026402|3732459|FG007|COMPLETED|Overall Study||3
3014473|NCT01026402|3732460|FG008|COMPLETED|Overall Study||7
3014474|NCT01026402|3732461|FG009|COMPLETED|Overall Study||3
3014475|NCT01026402|3732462|FG010|COMPLETED|Overall Study||7
3014476|NCT01026402|3732463|FG011|COMPLETED|Overall Study||8
3014477|NCT01026402|3732464|FG012|COMPLETED|Overall Study||8
3014478|NCT01026402|3732465|FG013|COMPLETED|Overall Study||6
3014479|NCT01026402|3732466|FG014|COMPLETED|Overall Study||3
3014480|NCT01026402|3732467|FG015|COMPLETED|Overall Study||5
3014481|NCT01026402|3732468|FG016|COMPLETED|Overall Study||4
3014482|NCT01026402|3732452|FG000|NOT COMPLETED|Overall Study||0
3014483|NCT01026402|3732453|FG001|NOT COMPLETED|Overall Study||0
3014484|NCT01026402|3732454|FG002|NOT COMPLETED|Overall Study||0
3014485|NCT01026402|3732455|FG003|NOT COMPLETED|Overall Study||0
3014486|NCT01026402|3732456|FG004|NOT COMPLETED|Overall Study||0
3014487|NCT01026402|3732457|FG005|NOT COMPLETED|Overall Study||0
3014488|NCT01026402|3732458|FG006|NOT COMPLETED|Overall Study||0
3014489|NCT01026402|3732459|FG007|NOT COMPLETED|Overall Study||0
3014490|NCT01026402|3732460|FG008|NOT COMPLETED|Overall Study||0
3014491|NCT01026402|3732461|FG009|NOT COMPLETED|Overall Study||0
3014492|NCT01026402|3732462|FG010|NOT COMPLETED|Overall Study||0
3014493|NCT01026402|3732463|FG011|NOT COMPLETED|Overall Study||0
3014494|NCT01026402|3732464|FG012|NOT COMPLETED|Overall Study||0
3014495|NCT01026402|3732465|FG013|NOT COMPLETED|Overall Study||0
3014496|NCT01026402|3732466|FG014|NOT COMPLETED|Overall Study||0
3014497|NCT01026402|3732467|FG015|NOT COMPLETED|Overall Study||0
3014498|NCT01026402|3732468|FG016|NOT COMPLETED|Overall Study||0
3014499|NCT01026454|3732509|FG000|STARTED|First Intervention||18
3014500|NCT01026454|3732510|FG001|STARTED|First Intervention||14
3014501|NCT01026454|3732509|FG000|COMPLETED|First Intervention||18
3014502|NCT01026454|3732510|FG001|COMPLETED|First Intervention||14
3014503|NCT01026454|3732509|FG000|NOT COMPLETED|First Intervention||0
3014504|NCT01026454|3732510|FG001|NOT COMPLETED|First Intervention||0
3014505|NCT01026454|3732509|FG000|STARTED|Washout||18
3014506|NCT01026454|3732510|FG001|STARTED|Washout||14
3014507|NCT01026454|3732509|FG000|COMPLETED|Washout||18
3014508|NCT01026454|3732510|FG001|COMPLETED|Washout||14
3014509|NCT01026454|3732509|FG000|NOT COMPLETED|Washout||0
3014510|NCT01026454|3732510|FG001|NOT COMPLETED|Washout||0
3014511|NCT01026454|3732509|FG000|STARTED|Second Intervention||17
3014512|NCT01026454|3732510|FG001|STARTED|Second Intervention||14
3014513|NCT01026454|3732509|FG000|COMPLETED|Second Intervention||16
3014514|NCT01026454|3732510|FG001|COMPLETED|Second Intervention||13
3014515|NCT01026454|3732509|FG000|NOT COMPLETED|Second Intervention||1
3014516|NCT01026454|3732510|FG001|NOT COMPLETED|Second Intervention||1
3014517|NCT01026493|3732524|FG000|STARTED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|8
3014518|NCT01026493|3732525|FG001|STARTED|Overall Study||7
3014519|NCT01026493|3732526|FG002|STARTED|Overall Study||9
3014520|NCT01026493|3732527|FG003|STARTED|Overall Study||8
3014521|NCT01026493|3732528|FG004|STARTED|Overall Study||75
3014522|NCT01026493|3732529|FG005|STARTED|Overall Study||76
3014523|NCT01026493|3732530|FG006|STARTED|Overall Study||36
3014524|NCT01026493|3732531|FG007|STARTED|Overall Study||38
3014525|NCT01026493|3732524|FG000|COMPLETED|Overall Study||8
3014526|NCT01026493|3732525|FG001|COMPLETED|Overall Study||6
3014527|NCT01026493|3732526|FG002|COMPLETED|Overall Study||9
3014528|NCT01026493|3732527|FG003|COMPLETED|Overall Study||8
3014529|NCT01026493|3732528|FG004|COMPLETED|Overall Study||73
3014530|NCT01026493|3732529|FG005|COMPLETED|Overall Study||73
3014531|NCT01026493|3732530|FG006|COMPLETED|Overall Study||32
3014532|NCT01026493|3732531|FG007|COMPLETED|Overall Study||37
3014533|NCT01026493|3732524|FG000|NOT COMPLETED|Overall Study||0
3014534|NCT01026493|3732525|FG001|NOT COMPLETED|Overall Study||1
3014535|NCT01026493|3732526|FG002|NOT COMPLETED|Overall Study||0
3014536|NCT01026493|3732527|FG003|NOT COMPLETED|Overall Study||0
3014537|NCT01026493|3732528|FG004|NOT COMPLETED|Overall Study||2
3014538|NCT01026493|3732529|FG005|NOT COMPLETED|Overall Study||3
3014539|NCT01026493|3732530|FG006|NOT COMPLETED|Overall Study||4
3014540|NCT01026493|3732531|FG007|NOT COMPLETED|Overall Study||1
3014541|NCT01026623|3732552|FG000|STARTED|Overall Study||6
3014542|NCT01026623|3732553|FG001|STARTED|Overall Study||5
3014543|NCT01026623|3732554|FG002|STARTED|Overall Study||5
3014544|NCT01026623|3732552|FG000|COMPLETED|Overall Study||6
3014545|NCT01026623|3732553|FG001|COMPLETED|Overall Study||5
3014546|NCT01026623|3732554|FG002|COMPLETED|Overall Study||5
3014547|NCT01026623|3732552|FG000|NOT COMPLETED|Overall Study||0
3014548|NCT01026623|3732553|FG001|NOT COMPLETED|Overall Study||0
3014549|NCT01026623|3732554|FG002|NOT COMPLETED|Overall Study||0
3014550|NCT01026792|3732563|FG000|STARTED|Overall Study||38
3014551|NCT01026792|3732563|FG000|COMPLETED|Overall Study||37
3014552|NCT01026792|3732563|FG000|NOT COMPLETED|Overall Study||1
3014553|NCT01026805|3732567|FG000|STARTED|Overall Study||11
3014554|NCT01026805|3732567|FG000|COMPLETED|Overall Study||11
3014555|NCT01026805|3732567|FG000|NOT COMPLETED|Overall Study||0
3014556|NCT01026818|3732574|FG000|STARTED|Screening Period||583
3014557|NCT01026818|3732575|FG001|STARTED|Screening Period||0
3014558|NCT01026818|3732576|FG002|STARTED|Screening Period||0
3014559|NCT01026818|3732577|FG003|STARTED|Screening Period||0
3014560|NCT01026818|3732574|FG000|COMPLETED|Screening Period||423
3014561|NCT01026818|3732575|FG001|COMPLETED|Screening Period||0
3014562|NCT01026818|3732576|FG002|COMPLETED|Screening Period||0
3014563|NCT01026818|3732577|FG003|COMPLETED|Screening Period||0
3014564|NCT01026818|3732574|FG000|NOT COMPLETED|Screening Period||160
3014565|NCT01026818|3732575|FG001|NOT COMPLETED|Screening Period||0
3014566|NCT01026818|3732576|FG002|NOT COMPLETED|Screening Period||0
3014567|NCT01026818|3732577|FG003|NOT COMPLETED|Screening Period||0
3014568|NCT01026818|3732574|FG000|STARTED|DB Treatment Period (Month 0 - 9)||0
3014569|NCT01026818|3732575|FG001|STARTED|DB Treatment Period (Month 0 - 9)||139
3014570|NCT01026818|3732576|FG002|STARTED|DB Treatment Period (Month 0 - 9)||143
3014571|NCT01026818|3732577|FG003|STARTED|DB Treatment Period (Month 0 - 9)||141
3014572|NCT01026818|3732574|FG000|Received at Least 1 Dose of Study Drug|DB Treatment Period (Month 0 - 9)||0
3014573|NCT01026818|3732575|FG001|Received at Least 1 Dose of Study Drug|DB Treatment Period (Month 0 - 9)||139
3014574|NCT01026818|3732576|FG002|Received at Least 1 Dose of Study Drug|DB Treatment Period (Month 0 - 9)||143
3014575|NCT01026818|3732577|FG003|Received at Least 1 Dose of Study Drug|DB Treatment Period (Month 0 - 9)||141
3014576|NCT01026818|3732574|FG000|COMPLETED|DB Treatment Period (Month 0 - 9)||0
3014577|NCT01026818|3732575|FG001|COMPLETED|DB Treatment Period (Month 0 - 9)||114
3014578|NCT01026818|3732576|FG002|COMPLETED|DB Treatment Period (Month 0 - 9)||122
3014579|NCT01026818|3732577|FG003|COMPLETED|DB Treatment Period (Month 0 - 9)||115
3014580|NCT01026818|3732574|FG000|NOT COMPLETED|DB Treatment Period (Month 0 - 9)||0
3014581|NCT01026818|3732575|FG001|NOT COMPLETED|DB Treatment Period (Month 0 - 9)||25
3014582|NCT01026818|3732576|FG002|NOT COMPLETED|DB Treatment Period (Month 0 - 9)||21
3014583|NCT01026818|3732577|FG003|NOT COMPLETED|DB Treatment Period (Month 0 - 9)||26
3014584|NCT01026818|3732574|FG000|STARTED|Drug-Free Washout Period (Month 9-10.5)||0
3014585|NCT01026818|3732575|FG001|STARTED|Drug-Free Washout Period (Month 9-10.5)||114
3014586|NCT01026818|3732576|FG002|STARTED|Drug-Free Washout Period (Month 9-10.5)||122
3014587|NCT01026818|3732577|FG003|STARTED|Drug-Free Washout Period (Month 9-10.5)||115
3014588|NCT01026818|3732574|FG000|COMPLETED|Drug-Free Washout Period (Month 9-10.5)||0
3014589|NCT01026818|3732575|FG001|COMPLETED|Drug-Free Washout Period (Month 9-10.5)||105
3014590|NCT01026818|3732576|FG002|COMPLETED|Drug-Free Washout Period (Month 9-10.5)||117
3014591|NCT01026818|3732577|FG003|COMPLETED|Drug-Free Washout Period (Month 9-10.5)||108
3014592|NCT01026818|3732574|FG000|NOT COMPLETED|Drug-Free Washout Period (Month 9-10.5)||0
3014593|NCT01026818|3732575|FG001|NOT COMPLETED|Drug-Free Washout Period (Month 9-10.5)||9
3014594|NCT01026818|3732576|FG002|NOT COMPLETED|Drug-Free Washout Period (Month 9-10.5)||5
3014595|NCT01026818|3732577|FG003|NOT COMPLETED|Drug-Free Washout Period (Month 9-10.5)||7
3014596|NCT01026818|3732574|FG000|STARTED|OL Period (Month 10.5 - 13.5)||0
3014597|NCT01026818|3732575|FG001|STARTED|OL Period (Month 10.5 - 13.5)||105
3014598|NCT01026818|3732576|FG002|STARTED|OL Period (Month 10.5 - 13.5)||117
3014599|NCT01026818|3732577|FG003|STARTED|OL Period (Month 10.5 - 13.5)||108
3014600|NCT01026818|3732574|FG000|COMPLETED|OL Period (Month 10.5 - 13.5)||0
3014601|NCT01026818|3732575|FG001|COMPLETED|OL Period (Month 10.5 - 13.5)||98
3014602|NCT01026818|3732576|FG002|COMPLETED|OL Period (Month 10.5 - 13.5)||112
3014603|NCT01026818|3732577|FG003|COMPLETED|OL Period (Month 10.5 - 13.5)||105
3014604|NCT01026818|3732574|FG000|NOT COMPLETED|OL Period (Month 10.5 - 13.5)||0
3014605|NCT01026818|3732575|FG001|NOT COMPLETED|OL Period (Month 10.5 - 13.5)||7
3014606|NCT01026818|3732576|FG002|NOT COMPLETED|OL Period (Month 10.5 - 13.5)||5
3014607|NCT01026818|3732577|FG003|NOT COMPLETED|OL Period (Month 10.5 - 13.5)||3
3014608|NCT01026831|3732591|FG000|STARTED|Overall Study|randomized|320
3014609|NCT01026831|3732592|FG001|STARTED|Overall Study|randomized|323
3014610|NCT01026831|3732591|FG000|COMPLETED|Overall Study||306
3014611|NCT01026831|3732592|FG001|COMPLETED|Overall Study||312
3014612|NCT01026831|3732591|FG000|NOT COMPLETED|Overall Study||14
3014613|NCT01026831|3732592|FG001|NOT COMPLETED|Overall Study||11
3014614|NCT01026844|3732600|FG000|STARTED|Overall Study||19
3014615|NCT01026844|3732601|FG001|STARTED|Overall Study||8
3014616|NCT01026844|3732600|FG000|COMPLETED|Overall Study||19
3014617|NCT01026844|3732601|FG001|COMPLETED|Overall Study||8
3014618|NCT01026844|3732600|FG000|NOT COMPLETED|Overall Study||0
3014619|NCT01026844|3732601|FG001|NOT COMPLETED|Overall Study||0
3014620|NCT01026909|3732609|FG000|STARTED|Overall Study||1
3014621|NCT01026909|3732610|FG001|STARTED|Overall Study||2
3014622|NCT01026909|3732609|FG000|COMPLETED|Overall Study||1
3014623|NCT01026909|3732610|FG001|COMPLETED|Overall Study||2
3014624|NCT01026909|3732609|FG000|NOT COMPLETED|Overall Study||0
3014625|NCT01026909|3732610|FG001|NOT COMPLETED|Overall Study||0
3014626|NCT01026948|3732616|FG000|STARTED|Overall Study||70
3014627|NCT01026948|3732616|FG000|COMPLETED|Overall Study|8 Women were recalled because of signal loss|62
3014628|NCT01026948|3732616|FG000|NOT COMPLETED|Overall Study||8
3014629|NCT01026974|3732625|FG000|STARTED|Overall Study||16
3014630|NCT01026974|3732626|FG001|STARTED|Overall Study||14
3014631|NCT01026974|3732627|FG002|STARTED|Overall Study||41
3014632|NCT01026974|3732628|FG003|STARTED|Overall Study||49
3014633|NCT01026974|3732625|FG000|COMPLETED|Overall Study||15
3014634|NCT01026974|3732626|FG001|COMPLETED|Overall Study||12
3014635|NCT01026974|3732627|FG002|COMPLETED|Overall Study||29
3014636|NCT01026974|3732628|FG003|COMPLETED|Overall Study||46
3014637|NCT01026974|3732625|FG000|NOT COMPLETED|Overall Study||1
3014638|NCT01026974|3732626|FG001|NOT COMPLETED|Overall Study||2
3014639|NCT01026974|3732627|FG002|NOT COMPLETED|Overall Study||12
3014640|NCT01026974|3732628|FG003|NOT COMPLETED|Overall Study||3
3014641|NCT01027000|3732643|FG000|STARTED|Overall Study||68
3014642|NCT01027000|3732643|FG000|COMPLETED|Overall Study||68
3014643|NCT01027000|3732643|FG000|NOT COMPLETED|Overall Study||0
3014644|NCT01027195|3732649|FG000|STARTED|Overall Study||71
3014645|NCT01027195|3732650|FG001|STARTED|Overall Study||69
3014646|NCT01027195|3732649|FG000|COMPLETED|Overall Study||71
3014647|NCT01027195|3732650|FG001|COMPLETED|Overall Study||69
3014648|NCT01027195|3732649|FG000|NOT COMPLETED|Overall Study||0
3014649|NCT01027195|3732650|FG001|NOT COMPLETED|Overall Study||0
3014650|NCT01027273|3732658|FG000|STARTED|Overall Study||301
3014651|NCT01027273|3732659|FG001|STARTED|Overall Study||299
3014652|NCT01027273|3732658|FG000|COMPLETED|Overall Study||242
3014653|NCT01027273|3732659|FG001|COMPLETED|Overall Study||266
3014654|NCT01027273|3732658|FG000|NOT COMPLETED|Overall Study||59
3014655|NCT01027273|3732659|FG001|NOT COMPLETED|Overall Study||33
3014656|NCT01027286|3732667|FG000|STARTED|Overall Study||50
3014657|NCT01027286|3732668|FG001|STARTED|Overall Study||50
3014658|NCT01027286|3732667|FG000|Preoperative|Overall Study||50
3014659|NCT01027286|3732668|FG001|Preoperative|Overall Study||50
3014660|NCT01027286|3732667|FG000|Day of Surgery|Overall Study||50
3014661|NCT01027286|3732668|FG001|Day of Surgery|Overall Study||50
3014662|NCT01027286|3732667|FG000|4 Week Postoperative|Overall Study||49
3014663|NCT01027286|3732668|FG001|4 Week Postoperative|Overall Study||50
3014664|NCT01027286|3732667|FG000|12 Week Postoperative|Overall Study||49
3014665|NCT01027286|3732668|FG001|12 Week Postoperative|Overall Study||49
3014666|NCT01027286|3732667|FG000|COMPLETED|Overall Study||49
3014667|NCT01027286|3732668|FG001|COMPLETED|Overall Study||49
3014668|NCT01027286|3732667|FG000|NOT COMPLETED|Overall Study||1
3014669|NCT01027286|3732668|FG001|NOT COMPLETED|Overall Study||1
3014670|NCT01027351|3732680|FG000|STARTED|Overall Study||29
3014671|NCT01027351|3732681|FG001|STARTED|Overall Study||19
3014672|NCT01027351|3732682|FG002|STARTED|Overall Study||14
3014673|NCT01027351|3732683|FG003|STARTED|Overall Study||8
3014674|NCT01027351|3732684|FG004|STARTED|Overall Study||43
3014675|NCT01027351|3732685|FG005|STARTED|Overall Study||50
3014676|NCT01027351|3732680|FG000|COMPLETED|Overall Study||26
3014677|NCT01027351|3732681|FG001|COMPLETED|Overall Study||18
3014678|NCT01027351|3732682|FG002|COMPLETED|Overall Study||13
3014679|NCT01027351|3732683|FG003|COMPLETED|Overall Study||6
3014680|NCT01027351|3732684|FG004|COMPLETED|Overall Study||32
3014681|NCT01027351|3732685|FG005|COMPLETED|Overall Study||45
3014682|NCT01027351|3732680|FG000|NOT COMPLETED|Overall Study||3
3014683|NCT01027351|3732681|FG001|NOT COMPLETED|Overall Study||1
3014684|NCT01027351|3732682|FG002|NOT COMPLETED|Overall Study||1
3014685|NCT01027351|3732683|FG003|NOT COMPLETED|Overall Study||2
3014686|NCT01027351|3732684|FG004|NOT COMPLETED|Overall Study||11
3014687|NCT01027351|3732685|FG005|NOT COMPLETED|Overall Study||5
3014688|NCT01027364|3732710|FG000|STARTED|Overall Study||63
3014689|NCT01027364|3732711|FG001|STARTED|Overall Study||29
3014690|NCT01027364|3732712|FG002|STARTED|Overall Study||27
3014691|NCT01027364|3732713|FG003|STARTED|Overall Study|12 total participants in Arm 4 (6 started in Arm 4; 5 joined from Arm 1; 1 joined from Arm 3)|4
3014692|NCT01027364|3732710|FG000|Enrolled in Sequential PK Subgroup|Overall Study||22
3014693|NCT01027364|3732711|FG001|Enrolled in Sequential PK Subgroup|Overall Study||0
3014694|NCT01027364|3732712|FG002|Enrolled in Sequential PK Subgroup|Overall Study||0
3014695|NCT01027364|3732713|FG003|Enrolled in Sequential PK Subgroup|Overall Study||0
3014696|NCT01027364|3732710|FG000|Joined Arm 4 for Surgery Then Returned|Overall Study||5
3014697|NCT01027364|3732711|FG001|Joined Arm 4 for Surgery Then Returned|Overall Study||0
3014698|NCT01027364|3732712|FG002|Joined Arm 4 for Surgery Then Returned|Overall Study||1
3014699|NCT01027364|3732713|FG003|Joined Arm 4 for Surgery Then Returned|Overall Study||0
3014700|NCT01027364|3732710|FG000|Started Arm 4 Then Joined Another Arm|Overall Study||2
3014701|NCT01027364|3732711|FG001|Started Arm 4 Then Joined Another Arm|Overall Study||0
3014702|NCT01027364|3732712|FG002|Started Arm 4 Then Joined Another Arm|Overall Study||0
3014703|NCT01027364|3732713|FG003|Started Arm 4 Then Joined Another Arm|Overall Study||0
3014704|NCT01027364|3732710|FG000|COMPLETED|Overall Study||59
3014705|NCT01027364|3732711|FG001|COMPLETED|Overall Study||27
3014706|NCT01027364|3732712|FG002|COMPLETED|Overall Study||26
3014707|NCT01027364|3732713|FG003|COMPLETED|Overall Study|11 participants total completed Arm 4 (3: compl. Arm 4 only; 7: cont. to Arm 1; 1: cont. to Arm 3)|3
3014708|NCT01027364|3732710|FG000|NOT COMPLETED|Overall Study||4
3014709|NCT01027364|3732711|FG001|NOT COMPLETED|Overall Study||2
3014710|NCT01027364|3732712|FG002|NOT COMPLETED|Overall Study||1
3014711|NCT01027364|3732713|FG003|NOT COMPLETED|Overall Study||1
3014712|NCT01027416|3732741|FG000|STARTED|Overall Study||31
3014713|NCT01027416|3732742|FG001|STARTED|Overall Study||28
3014714|NCT01027416|3732741|FG000|COMPLETED|Overall Study||30
3014715|NCT01027416|3732742|FG001|COMPLETED|Overall Study||23
3014716|NCT01027416|3732741|FG000|NOT COMPLETED|Overall Study||1
3014717|NCT01027416|3732742|FG001|NOT COMPLETED|Overall Study||5
3014718|NCT01027468|3732748|FG000|STARTED|Overall Study||160
3014719|NCT01027468|3732748|FG000|COMPLETED|Overall Study||160
3014720|NCT01027468|3732748|FG000|NOT COMPLETED|Overall Study||0
3014721|NCT01027559|3732755|FG000|STARTED|Overall Study||26
3014722|NCT01027559|3732756|FG001|STARTED|Overall Study||34
3014723|NCT01027559|3732757|FG002|STARTED|Overall Study||31
3014724|NCT01027559|3732755|FG000|COMPLETED|Overall Study||20
3014725|NCT01027559|3732756|FG001|COMPLETED|Overall Study||26
3014726|NCT01027559|3732757|FG002|COMPLETED|Overall Study||22
3014727|NCT01027559|3732755|FG000|NOT COMPLETED|Overall Study||6
3014728|NCT01027559|3732756|FG001|NOT COMPLETED|Overall Study||8
3014729|NCT01027559|3732757|FG002|NOT COMPLETED|Overall Study||9
3014730|NCT01027598|3732768|FG000|STARTED|Overall Study|One patient was enrolled but not treated|134
3014731|NCT01027598|3732769|FG001|STARTED|Overall Study||67
3014732|NCT01027598|3732768|FG000|COMPLETED|Overall Study|Patients remained on treatment until coming off for progression, toxicity or any other reason|0
3014733|NCT01027598|3732769|FG001|COMPLETED|Overall Study|Patients remained on treatment until coming off for progression, toxicity or any other reason|0
3014734|NCT01027598|3732768|FG000|NOT COMPLETED|Overall Study||134
3014735|NCT01027598|3732769|FG001|NOT COMPLETED|Overall Study||67
3014736|NCT01027650|3732783|FG000|STARTED|Overall Study||6
3014737|NCT01027650|3732784|FG001|STARTED|Overall Study||6
3014738|NCT01027650|3732785|FG002|STARTED|Overall Study||6
3014739|NCT01027650|3732786|FG003|STARTED|Overall Study||3
3014740|NCT01027650|3732787|FG004|STARTED|Overall Study||25
3014741|NCT01027650|3732788|FG005|STARTED|Overall Study||26
3014742|NCT01027650|3732789|FG006|STARTED|Overall Study||25
3014743|NCT01027650|3732790|FG007|STARTED|Overall Study||24
3014744|NCT01027650|3732783|FG000|COMPLETED|Overall Study||6
3014745|NCT01027650|3732784|FG001|COMPLETED|Overall Study||6
3014746|NCT01027650|3732785|FG002|COMPLETED|Overall Study||6
3014747|NCT01027650|3732786|FG003|COMPLETED|Overall Study||3
3014748|NCT01027650|3732787|FG004|COMPLETED|Overall Study||23
3014749|NCT01027650|3732788|FG005|COMPLETED|Overall Study||24
3014750|NCT01027650|3732789|FG006|COMPLETED|Overall Study||24
3014751|NCT01027650|3732790|FG007|COMPLETED|Overall Study||24
3014752|NCT01027650|3732783|FG000|NOT COMPLETED|Overall Study||0
3014753|NCT01027650|3732784|FG001|NOT COMPLETED|Overall Study||0
3014754|NCT01027650|3732785|FG002|NOT COMPLETED|Overall Study||0
3014755|NCT01027650|3732786|FG003|NOT COMPLETED|Overall Study||0
3014756|NCT01027650|3732787|FG004|NOT COMPLETED|Overall Study||2
3014757|NCT01027650|3732788|FG005|NOT COMPLETED|Overall Study||2
3014758|NCT01027650|3732789|FG006|NOT COMPLETED|Overall Study||1
3014759|NCT01027650|3732790|FG007|NOT COMPLETED|Overall Study||0
3014760|NCT01027702|3732808|FG000|STARTED|Overall Study||4
3014761|NCT01027702|3732809|FG001|STARTED|Overall Study||4
3014762|NCT01027702|3732810|FG002|STARTED|Overall Study||3
3014763|NCT01027702|3732811|FG003|STARTED|Overall Study||14
3014764|NCT01027702|3732812|FG004|STARTED|Overall Study||10
3014765|NCT01027702|3732813|FG005|STARTED|Overall Study||1
3014766|NCT01027702|3732814|FG006|STARTED|Overall Study||2
3014767|NCT01027702|3732808|FG000|COMPLETED|Overall Study||3
3014768|NCT01027702|3732809|FG001|COMPLETED|Overall Study||2
3014769|NCT01027702|3732810|FG002|COMPLETED|Overall Study||2
3014770|NCT01027702|3732811|FG003|COMPLETED|Overall Study||10
3014771|NCT01027702|3732812|FG004|COMPLETED|Overall Study||9
3014772|NCT01027702|3732813|FG005|COMPLETED|Overall Study||1
3014773|NCT01027702|3732814|FG006|COMPLETED|Overall Study||1
3014774|NCT01027702|3732808|FG000|NOT COMPLETED|Overall Study||1
3014775|NCT01027702|3732809|FG001|NOT COMPLETED|Overall Study||2
3014776|NCT01027702|3732810|FG002|NOT COMPLETED|Overall Study||1
3014777|NCT01027702|3732811|FG003|NOT COMPLETED|Overall Study||4
3014778|NCT01027702|3732812|FG004|NOT COMPLETED|Overall Study||1
3014779|NCT01027702|3732813|FG005|NOT COMPLETED|Overall Study||0
3014780|NCT01027702|3732814|FG006|NOT COMPLETED|Overall Study||1
3014781|NCT01027754|3732827|FG000|STARTED|Overall Study||57
3014782|NCT01027754|3732828|FG001|STARTED|Overall Study||55
3014783|NCT01027754|3732827|FG000|COMPLETED|Overall Study||55
3014784|NCT01027754|3732828|FG001|COMPLETED|Overall Study||47
3014785|NCT01027754|3732827|FG000|NOT COMPLETED|Overall Study||2
3014786|NCT01027754|3732828|FG001|NOT COMPLETED|Overall Study||8
3014787|NCT01027780|3732836|FG000|STARTED|Overall Study||105
3014788|NCT01027780|3732837|FG001|STARTED|Overall Study||103
3014789|NCT01027780|3732836|FG000|COMPLETED|Overall Study||105
3014790|NCT01027780|3732837|FG001|COMPLETED|Overall Study||102
3014791|NCT01027780|3732836|FG000|NOT COMPLETED|Overall Study||0
3014792|NCT01027780|3732837|FG001|NOT COMPLETED|Overall Study||1
3014793|NCT01027793|3732846|FG000|STARTED|Overall Study||17
3014794|NCT01027793|3732847|FG001|STARTED|Overall Study||15
3014795|NCT01027793|3732846|FG000|COMPLETED|Overall Study||10
3014796|NCT01027793|3732847|FG001|COMPLETED|Overall Study||12
3014797|NCT01027793|3732846|FG000|NOT COMPLETED|Overall Study||7
3014798|NCT01027793|3732847|FG001|NOT COMPLETED|Overall Study||3
3014799|NCT01027806|3732855|FG000|STARTED|Overall Study||32
3014800|NCT01027806|3732856|FG001|STARTED|Overall Study||32
3014801|NCT01027806|3732855|FG000|COMPLETED|Overall Study||28
3014802|NCT01027806|3732856|FG001|COMPLETED|Overall Study||29
3014803|NCT01027806|3732855|FG000|NOT COMPLETED|Overall Study||4
3014804|NCT01027806|3732856|FG001|NOT COMPLETED|Overall Study||3
3014805|NCT01027819|3732864|FG000|STARTED|Overall Study||40
3014806|NCT01027819|3732865|FG001|STARTED|Overall Study||40
3014807|NCT01027819|3732864|FG000|COMPLETED|Overall Study||40
3014808|NCT01027819|3732865|FG001|COMPLETED|Overall Study||40
3014809|NCT01027819|3732864|FG000|NOT COMPLETED|Overall Study||0
3014810|NCT01027819|3732865|FG001|NOT COMPLETED|Overall Study||0
3014811|NCT01027845|3732873|FG000|STARTED|Primary Vaccination Phase||237
3014812|NCT01027845|3732874|FG001|STARTED|Primary Vaccination Phase||123
3014813|NCT01027845|3732875|FG002|STARTED|Primary Vaccination Phase|Subjects were not yet assigned to this group at the time of the primary vaccination|0
3014814|NCT01027845|3732876|FG003|STARTED|Primary Vaccination Phase|Subjects were not yet assigned to this group at the time of the primary vaccination|0
3014815|NCT01027845|3732873|FG000|COMPLETED|Primary Vaccination Phase||233
3014816|NCT01027845|3732874|FG001|COMPLETED|Primary Vaccination Phase||122
3014817|NCT01027845|3732875|FG002|COMPLETED|Primary Vaccination Phase||0
3014818|NCT01027845|3732876|FG003|COMPLETED|Primary Vaccination Phase||0
3014819|NCT01027845|3732873|FG000|NOT COMPLETED|Primary Vaccination Phase||4
3014820|NCT01027845|3732874|FG001|NOT COMPLETED|Primary Vaccination Phase||1
3014821|NCT01027845|3732875|FG002|NOT COMPLETED|Primary Vaccination Phase||0
3014822|NCT01027845|3732876|FG003|NOT COMPLETED|Primary Vaccination Phase||0
3014823|NCT01027845|3732873|FG000|STARTED|Booster Vaccination Phase||228
3014824|NCT01027845|3732874|FG001|STARTED|Booster Vaccination Phase|Subjects from this group were assigned to DTPa+Prevenar&DTPa-No Prevenar Groups in the booster phase|0
3014825|NCT01027845|3732875|FG002|STARTED|Booster Vaccination Phase||119
3014826|NCT01027845|3732876|FG003|STARTED|Booster Vaccination Phase||1
3014827|NCT01027845|3732873|FG000|COMPLETED|Booster Vaccination Phase||226
3014828|NCT01027845|3732874|FG001|COMPLETED|Booster Vaccination Phase||0
3014829|NCT01027845|3732875|FG002|COMPLETED|Booster Vaccination Phase||119
3014830|NCT01027845|3732876|FG003|COMPLETED|Booster Vaccination Phase||1
3014831|NCT01027845|3732873|FG000|NOT COMPLETED|Booster Vaccination Phase||2
3014832|NCT01027845|3732874|FG001|NOT COMPLETED|Booster Vaccination Phase||0
3014833|NCT01027845|3732875|FG002|NOT COMPLETED|Booster Vaccination Phase||0
3014834|NCT01027845|3732876|FG003|NOT COMPLETED|Booster Vaccination Phase||0
3014835|NCT01027871|3732888|FG000|STARTED|Overall Study||93
3014836|NCT01027871|3732889|FG001|STARTED|Overall Study||98
3014837|NCT01027871|3732890|FG002|STARTED|Overall Study||98
3014838|NCT01027871|3732888|FG000|Received at Least One Dose of Study Drug|Overall Study||93
3014839|NCT01027871|3732889|FG001|Received at Least One Dose of Study Drug|Overall Study||98
3014840|NCT01027871|3732890|FG002|Received at Least One Dose of Study Drug|Overall Study||97
3014841|NCT01027871|3732888|FG000|COMPLETED|Overall Study||91
3014842|NCT01027871|3732889|FG001|COMPLETED|Overall Study||85
3014843|NCT01027871|3732890|FG002|COMPLETED|Overall Study||91
3014844|NCT01027871|3732888|FG000|NOT COMPLETED|Overall Study||2
3014845|NCT01027871|3732889|FG001|NOT COMPLETED|Overall Study||13
3014846|NCT01027871|3732890|FG002|NOT COMPLETED|Overall Study||7
3014847|NCT01027884|3732905|FG000|STARTED|Overall Study||34
3014848|NCT01027884|3732906|FG001|STARTED|Overall Study||32
3014849|NCT01027884|3732905|FG000|COMPLETED|Overall Study||30
3014850|NCT01027884|3732906|FG001|COMPLETED|Overall Study||25
3014851|NCT01027884|3732905|FG000|NOT COMPLETED|Overall Study||4
3014852|NCT01027884|3732906|FG001|NOT COMPLETED|Overall Study||7
3014853|NCT01027897|3732914|FG000|STARTED|Overall Study||30
3014854|NCT01027897|3732914|FG000|COMPLETED|Overall Study||28
3014855|NCT01027897|3732914|FG000|NOT COMPLETED|Overall Study||2
3014856|NCT01027910|3732920|FG000|STARTED|Overall Study||6
3014857|NCT01027910|3732921|FG001|STARTED|Overall Study||14
3014858|NCT01027910|3732920|FG000|COMPLETED|Overall Study||6
3014859|NCT01027910|3732921|FG001|COMPLETED|Overall Study||14
3165375|NCT01898884|3892911|FG005|NOT COMPLETED|Single Dose Period||0
3165376|NCT01898884|3892912|FG006|NOT COMPLETED|Single Dose Period||0
3165377|NCT01898884|3892913|FG007|NOT COMPLETED|Single Dose Period||0
3014860|NCT01027910|3732920|FG000|NOT COMPLETED|Overall Study||0
3014861|NCT01027910|3732921|FG001|NOT COMPLETED|Overall Study||0
3014862|NCT01027949|3732929|FG000|STARTED|Overall Study||894
3014863|NCT01027949|3732929|FG000|COMPLETED|Overall Study||208
3014864|NCT01027949|3732929|FG000|NOT COMPLETED|Overall Study||686
3014865|NCT01028014|3732939|FG000|STARTED|Overall Study||10
3014866|NCT01028014|3732940|FG001|STARTED|Overall Study||10
3014867|NCT01028014|3732941|FG002|STARTED|Overall Study||10
3014868|NCT01028014|3732942|FG003|STARTED|Overall Study||10
3014869|NCT01028014|3732943|FG004|STARTED|Overall Study||10
3014870|NCT01028014|3732944|FG005|STARTED|Overall Study||6
3014871|NCT01028014|3732939|FG000|COMPLETED|Overall Study||9
3014872|NCT01028014|3732940|FG001|COMPLETED|Overall Study||8
3014873|NCT01028014|3732941|FG002|COMPLETED|Overall Study||10
3014874|NCT01028014|3732942|FG003|COMPLETED|Overall Study||9
3014875|NCT01028014|3732943|FG004|COMPLETED|Overall Study||9
3014876|NCT01028014|3732944|FG005|COMPLETED|Overall Study||4
3014877|NCT01028014|3732939|FG000|NOT COMPLETED|Overall Study||1
3014878|NCT01028014|3732940|FG001|NOT COMPLETED|Overall Study||2
3014879|NCT01028014|3732941|FG002|NOT COMPLETED|Overall Study||0
3014880|NCT01028014|3732942|FG003|NOT COMPLETED|Overall Study||1
3014881|NCT01028014|3732943|FG004|NOT COMPLETED|Overall Study||1
3014882|NCT01028014|3732944|FG005|NOT COMPLETED|Overall Study||2
3014883|NCT01028027|3732960|FG000|STARTED|Overall Study||180
3014884|NCT01028027|3732961|FG001|STARTED|Overall Study||177
3014885|NCT01028027|3732960|FG000|COMPLETED|Overall Study||164
3014886|NCT01028027|3732961|FG001|COMPLETED|Overall Study||164
3014887|NCT01028027|3732960|FG000|NOT COMPLETED|Overall Study||16
3014888|NCT01028027|3732961|FG001|NOT COMPLETED|Overall Study||13
3014889|NCT01028053|3732967|FG000|STARTED|Overall Study||365
3014890|NCT01028053|3732967|FG000|COMPLETED|Overall Study||232
3014891|NCT01028053|3732967|FG000|NOT COMPLETED|Overall Study||133
3014892|NCT01028131|3732977|FG000|STARTED|Overall Study||26
3014893|NCT01028131|3732978|FG001|STARTED|Overall Study||26
3014894|NCT01028131|3732979|FG002|STARTED|Overall Study||28
3014895|NCT01028131|3732980|FG003|STARTED|Overall Study||30
3014896|NCT01028131|3732977|FG000|Completed Intervention/Control Session|Overall Study||26
3014897|NCT01028131|3732978|FG001|Completed Intervention/Control Session|Overall Study||26
3014898|NCT01028131|3732979|FG002|Completed Intervention/Control Session|Overall Study||28
3014899|NCT01028131|3732980|FG003|Completed Intervention/Control Session|Overall Study||30
3014900|NCT01028131|3732977|FG000|COMPLETED|Overall Study||23
3014901|NCT01028131|3732978|FG001|COMPLETED|Overall Study||23
3014902|NCT01028131|3732979|FG002|COMPLETED|Overall Study||22
3014903|NCT01028131|3732980|FG003|COMPLETED|Overall Study||26
3014904|NCT01028131|3732977|FG000|NOT COMPLETED|Overall Study||3
3014905|NCT01028131|3732978|FG001|NOT COMPLETED|Overall Study||3
3014906|NCT01028131|3732979|FG002|NOT COMPLETED|Overall Study||6
3014907|NCT01028131|3732980|FG003|NOT COMPLETED|Overall Study||4
3014908|NCT01028222|3732992|FG000|STARTED|Overall Study||42
3014909|NCT01028222|3732993|FG001|STARTED|Overall Study||13
3014910|NCT01028222|3732992|FG000|Cross Over From DTIC to Nilotinib|Overall Study||0
3014911|NCT01028222|3732993|FG001|Cross Over From DTIC to Nilotinib|Overall Study||10
3014912|NCT01028222|3732992|FG000|COMPLETED|Overall Study||4
3014913|NCT01028222|3732993|FG001|COMPLETED|Overall Study||0
3014914|NCT01028222|3732992|FG000|NOT COMPLETED|Overall Study||38
3014915|NCT01028222|3732993|FG001|NOT COMPLETED|Overall Study||13
3014916|NCT01028352|3733000|FG000|STARTED|Overall Study||35
3014917|NCT01028352|3733000|FG000|COMPLETED|Overall Study||29
3014918|NCT01028352|3733000|FG000|NOT COMPLETED|Overall Study||6
3014919|NCT01028378|3733004|FG000|STARTED|Overall Study|212 participants (249 eyes) with myopia|212
3014920|NCT01028378|3733004|FG000|COMPLETED|Overall Study|195 participants (230 eyes) with myopia|195
3014921|NCT01028378|3733004|FG000|NOT COMPLETED|Overall Study||17
3014922|NCT01028391|3733010|FG000|STARTED|Overall Study||164
3014923|NCT01028391|3733011|FG001|STARTED|Overall Study||153
3014924|NCT01028391|3733010|FG000|COMPLETED|Overall Study||150
3014925|NCT01028391|3733011|FG001|COMPLETED|Overall Study||142
3014926|NCT01028391|3733010|FG000|NOT COMPLETED|Overall Study||14
3014927|NCT01028391|3733011|FG001|NOT COMPLETED|Overall Study||11
3014928|NCT01028560|3733019|FG000|STARTED|Overall Study|4 of 27 withdrew consent immediately after randomization and are excluded from outcome analysis|27
3014929|NCT01028560|3733020|FG001|STARTED|Overall Study|4 of 31 withdrew consent immediately after randomization and are excluded from outcome analysis|31
3014930|NCT01028560|3733019|FG000|Started Study Protocol|Overall Study||23
3014931|NCT01028560|3733020|FG001|Started Study Protocol|Overall Study||27
3014932|NCT01028560|3733019|FG000|COMPLETED|Overall Study||17
3014933|NCT01028560|3733020|FG001|COMPLETED|Overall Study||13
3014934|NCT01028560|3733019|FG000|NOT COMPLETED|Overall Study||10
3165378|NCT01898884|3892914|FG008|NOT COMPLETED|Single Dose Period||0
3014935|NCT01028560|3733020|FG001|NOT COMPLETED|Overall Study||18
3014936|NCT01028651|3733027|FG000|STARTED|Overall Study||13
3014937|NCT01028651|3733027|FG000|COMPLETED|Overall Study||10
3014938|NCT01028651|3733027|FG000|NOT COMPLETED|Overall Study||3
3014939|NCT01028677|3733035|FG000|STARTED|Overall Study||10
3014940|NCT01028677|3733036|FG001|STARTED|Overall Study||7
3014941|NCT01028677|3733035|FG000|COMPLETED|Overall Study||8
3014942|NCT01028677|3733036|FG001|COMPLETED|Overall Study||6
3014943|NCT01028677|3733035|FG000|NOT COMPLETED|Overall Study||2
3014944|NCT01028677|3733036|FG001|NOT COMPLETED|Overall Study||1
3014945|NCT01028820|3733042|FG000|STARTED|Overall Study||13
3014946|NCT01028820|3733042|FG000|COMPLETED|Overall Study||12
3014947|NCT01028820|3733042|FG000|NOT COMPLETED|Overall Study||1
3014948|NCT01028911|3733049|FG000|STARTED|Overall Study||7
3014949|NCT01028911|3733050|FG001|STARTED|Overall Study||2
3014950|NCT01028911|3733049|FG000|COMPLETED|Overall Study||7
3014951|NCT01028911|3733050|FG001|COMPLETED|Overall Study||2
3014952|NCT01028911|3733049|FG000|NOT COMPLETED|Overall Study||0
3014953|NCT01028911|3733050|FG001|NOT COMPLETED|Overall Study||0
3014954|NCT01028937|3733056|FG000|STARTED|Overall Study||6
3014955|NCT01028937|3733056|FG000|COMPLETED|Overall Study||6
3014956|NCT01028937|3733056|FG000|NOT COMPLETED|Overall Study||0
3014957|NCT01029054|3733060|FG000|STARTED|Phase I||4
3014958|NCT01029054|3733061|FG001|STARTED|Phase I||13
3014959|NCT01029054|3733062|FG002|STARTED|Phase I||18
3014960|NCT01029054|3733060|FG000|COMPLETED|Phase I||4
3014961|NCT01029054|3733061|FG001|COMPLETED|Phase I||13
3014962|NCT01029054|3733062|FG002|COMPLETED|Phase I||18
3014963|NCT01029054|3733060|FG000|NOT COMPLETED|Phase I||0
3014964|NCT01029054|3733061|FG001|NOT COMPLETED|Phase I||0
3014965|NCT01029054|3733062|FG002|NOT COMPLETED|Phase I||0
3014966|NCT01029054|3733060|FG000|STARTED|Phase II||0
3014967|NCT01029054|3733061|FG001|STARTED|Phase II||0
3014968|NCT01029054|3733062|FG002|STARTED|Phase II|35 participants were enrolled in Ph I. 18 additional participants were enrolled in Ph II at the MTD.|18
3014969|NCT01029054|3733060|FG000|COMPLETED|Phase II||0
3014970|NCT01029054|3733061|FG001|COMPLETED|Phase II||0
3014971|NCT01029054|3733062|FG002|COMPLETED|Phase II||18
3014972|NCT01029054|3733060|FG000|NOT COMPLETED|Phase II||0
3014973|NCT01029054|3733061|FG001|NOT COMPLETED|Phase II||0
3014974|NCT01029054|3733062|FG002|NOT COMPLETED|Phase II||0
3014975|NCT01029262|3733068|FG000|STARTED|Overall Study||79
3014976|NCT01029262|3733069|FG001|STARTED|Overall Study||160
3014977|NCT01029262|3733068|FG000|COMPLETED|Overall Study||0
3014978|NCT01029262|3733069|FG001|COMPLETED|Overall Study||0
3014979|NCT01029262|3733068|FG000|NOT COMPLETED|Overall Study||79
3014980|NCT01029262|3733069|FG001|NOT COMPLETED|Overall Study||160
3014981|NCT01029340|3733085|FG000|STARTED|Part A Treatment Period||14
3014982|NCT01029340|3733086|FG001|STARTED|Part A Treatment Period||14
3014983|NCT01029340|3733087|FG002|STARTED|Part A Treatment Period||0
3014984|NCT01029340|3733088|FG003|STARTED|Part A Treatment Period||0
3014985|NCT01029340|3733089|FG004|STARTED|Part A Treatment Period||0
3014986|NCT01029340|3733090|FG005|STARTED|Part A Treatment Period||0
3014987|NCT01029340|3733085|FG000|Participants Received Treatment|Part A Treatment Period||14
3014988|NCT01029340|3733086|FG001|Participants Received Treatment|Part A Treatment Period||14
3014989|NCT01029340|3733087|FG002|Participants Received Treatment|Part A Treatment Period||0
3014990|NCT01029340|3733088|FG003|Participants Received Treatment|Part A Treatment Period||0
3014991|NCT01029340|3733089|FG004|Participants Received Treatment|Part A Treatment Period||0
3014992|NCT01029340|3733090|FG005|Participants Received Treatment|Part A Treatment Period||0
3014993|NCT01029340|3733085|FG000|Safety Population|Part A Treatment Period|One excluded because receiving Kogenate FS twice.|13
3014994|NCT01029340|3733086|FG001|Safety Population|Part A Treatment Period||14
3014995|NCT01029340|3733087|FG002|Safety Population|Part A Treatment Period||0
3014996|NCT01029340|3733088|FG003|Safety Population|Part A Treatment Period||0
3014997|NCT01029340|3733089|FG004|Safety Population|Part A Treatment Period||0
3014998|NCT01029340|3733090|FG005|Safety Population|Part A Treatment Period||0
3014999|NCT01029340|3733085|FG000|COMPLETED|Part A Treatment Period||14
3015000|NCT01029340|3733086|FG001|COMPLETED|Part A Treatment Period||14
3015001|NCT01029340|3733087|FG002|COMPLETED|Part A Treatment Period||0
3015002|NCT01029340|3733088|FG003|COMPLETED|Part A Treatment Period||0
3015003|NCT01029340|3733089|FG004|COMPLETED|Part A Treatment Period||0
3015004|NCT01029340|3733090|FG005|COMPLETED|Part A Treatment Period||0
3015005|NCT01029340|3733085|FG000|NOT COMPLETED|Part A Treatment Period||0
3015006|NCT01029340|3733086|FG001|NOT COMPLETED|Part A Treatment Period||0
3015007|NCT01029340|3733087|FG002|NOT COMPLETED|Part A Treatment Period||0
3015008|NCT01029340|3733088|FG003|NOT COMPLETED|Part A Treatment Period||0
3015009|NCT01029340|3733089|FG004|NOT COMPLETED|Part A Treatment Period||0
3015010|NCT01029340|3733090|FG005|NOT COMPLETED|Part A Treatment Period||0
3015011|NCT01029340|3733085|FG000|STARTED|Part A Follow up Period||14
3015012|NCT01029340|3733086|FG001|STARTED|Part A Follow up Period||14
3015013|NCT01029340|3733087|FG002|STARTED|Part A Follow up Period||0
3015014|NCT01029340|3733088|FG003|STARTED|Part A Follow up Period||0
3015015|NCT01029340|3733089|FG004|STARTED|Part A Follow up Period||0
3015016|NCT01029340|3733090|FG005|STARTED|Part A Follow up Period||0
3015017|NCT01029340|3733085|FG000|COMPLETED|Part A Follow up Period||14
3015018|NCT01029340|3733086|FG001|COMPLETED|Part A Follow up Period||14
3015019|NCT01029340|3733087|FG002|COMPLETED|Part A Follow up Period||0
3015020|NCT01029340|3733088|FG003|COMPLETED|Part A Follow up Period||0
3015021|NCT01029340|3733089|FG004|COMPLETED|Part A Follow up Period||0
3015022|NCT01029340|3733090|FG005|COMPLETED|Part A Follow up Period||0
3015023|NCT01029340|3733085|FG000|NOT COMPLETED|Part A Follow up Period||0
3015024|NCT01029340|3733086|FG001|NOT COMPLETED|Part A Follow up Period||0
3015025|NCT01029340|3733087|FG002|NOT COMPLETED|Part A Follow up Period||0
3015026|NCT01029340|3733088|FG003|NOT COMPLETED|Part A Follow up Period||0
3015027|NCT01029340|3733089|FG004|NOT COMPLETED|Part A Follow up Period||0
3015028|NCT01029340|3733090|FG005|NOT COMPLETED|Part A Follow up Period||0
3015029|NCT01029340|3733085|FG000|STARTED|Part B Treatment Period||0
3015030|NCT01029340|3733086|FG001|STARTED|Part B Treatment Period||0
3015031|NCT01029340|3733087|FG002|STARTED|Part B Treatment Period|Enrolled 4 participants from Arm 1 and 7 participants from Arm 2|31
3015032|NCT01029340|3733088|FG003|STARTED|Part B Treatment Period|Enrolled 7 participants from Arm 1 and 4 participants from Arm 2|32
3015033|NCT01029340|3733089|FG004|STARTED|Part B Treatment Period||0
3165379|NCT01898884|3892906|FG000|STARTED|Multiple Dose Period||0
3165380|NCT01898884|3892907|FG001|STARTED|Multiple Dose Period||0
3165381|NCT01898884|3892908|FG002|STARTED|Multiple Dose Period||0
3165382|NCT01898884|3892909|FG003|STARTED|Multiple Dose Period||0
3015034|NCT01029340|3733090|FG005|STARTED|Part B Treatment Period||0
3015035|NCT01029340|3733085|FG000|Participants Received Treatment|Part B Treatment Period||0
3015036|NCT01029340|3733086|FG001|Participants Received Treatment|Part B Treatment Period||0
3015037|NCT01029340|3733087|FG002|Participants Received Treatment|Part B Treatment Period||30
3015038|NCT01029340|3733088|FG003|Participants Received Treatment|Part B Treatment Period||32
3015039|NCT01029340|3733089|FG004|Participants Received Treatment|Part B Treatment Period||0
3015040|NCT01029340|3733090|FG005|Participants Received Treatment|Part B Treatment Period||0
3015041|NCT01029340|3733085|FG000|COMPLETED|Part B Treatment Period||0
3015042|NCT01029340|3733086|FG001|COMPLETED|Part B Treatment Period||0
3015043|NCT01029340|3733087|FG002|COMPLETED|Part B Treatment Period||29
3015044|NCT01029340|3733088|FG003|COMPLETED|Part B Treatment Period||32
3015045|NCT01029340|3733089|FG004|COMPLETED|Part B Treatment Period||0
3015046|NCT01029340|3733090|FG005|COMPLETED|Part B Treatment Period||0
3015047|NCT01029340|3733085|FG000|NOT COMPLETED|Part B Treatment Period||0
3015048|NCT01029340|3733086|FG001|NOT COMPLETED|Part B Treatment Period||0
3015049|NCT01029340|3733087|FG002|NOT COMPLETED|Part B Treatment Period||2
3015050|NCT01029340|3733088|FG003|NOT COMPLETED|Part B Treatment Period||0
3015051|NCT01029340|3733089|FG004|NOT COMPLETED|Part B Treatment Period||0
3015052|NCT01029340|3733090|FG005|NOT COMPLETED|Part B Treatment Period||0
3015053|NCT01029340|3733085|FG000|STARTED|Part B Follow up Period||0
3015054|NCT01029340|3733086|FG001|STARTED|Part B Follow up Period||0
3015055|NCT01029340|3733087|FG002|STARTED|Part B Follow up Period||29
3015056|NCT01029340|3733088|FG003|STARTED|Part B Follow up Period||32
3015057|NCT01029340|3733089|FG004|STARTED|Part B Follow up Period||0
3015058|NCT01029340|3733090|FG005|STARTED|Part B Follow up Period||0
3015059|NCT01029340|3733085|FG000|COMPLETED|Part B Follow up Period||0
3015060|NCT01029340|3733086|FG001|COMPLETED|Part B Follow up Period||0
3015061|NCT01029340|3733087|FG002|COMPLETED|Part B Follow up Period||29
3015062|NCT01029340|3733088|FG003|COMPLETED|Part B Follow up Period||32
3015063|NCT01029340|3733089|FG004|COMPLETED|Part B Follow up Period||0
3015064|NCT01029340|3733090|FG005|COMPLETED|Part B Follow up Period||0
3015065|NCT01029340|3733085|FG000|NOT COMPLETED|Part B Follow up Period||0
3015066|NCT01029340|3733086|FG001|NOT COMPLETED|Part B Follow up Period||0
3015067|NCT01029340|3733087|FG002|NOT COMPLETED|Part B Follow up Period||0
3015068|NCT01029340|3733088|FG003|NOT COMPLETED|Part B Follow up Period||0
3015069|NCT01029340|3733089|FG004|NOT COMPLETED|Part B Follow up Period||0
3015070|NCT01029340|3733090|FG005|NOT COMPLETED|Part B Follow up Period||0
3015071|NCT01029340|3733085|FG000|STARTED|Extension Period||0
3015072|NCT01029340|3733086|FG001|STARTED|Extension Period||0
3015073|NCT01029340|3733087|FG002|STARTED|Extension Period||0
3015074|NCT01029340|3733088|FG003|STARTED|Extension Period||0
3015075|NCT01029340|3733089|FG004|STARTED|Extension Period||0
3015076|NCT01029340|3733090|FG005|STARTED|Extension Period||55
3015077|NCT01029340|3733085|FG000|COMPLETED|Extension Period||0
3015078|NCT01029340|3733086|FG001|COMPLETED|Extension Period||0
3015079|NCT01029340|3733087|FG002|COMPLETED|Extension Period||0
3015080|NCT01029340|3733088|FG003|COMPLETED|Extension Period||0
3015081|NCT01029340|3733089|FG004|COMPLETED|Extension Period||0
3015082|NCT01029340|3733090|FG005|COMPLETED|Extension Period||43
3015083|NCT01029340|3733085|FG000|NOT COMPLETED|Extension Period||0
3015084|NCT01029340|3733086|FG001|NOT COMPLETED|Extension Period||0
3015085|NCT01029340|3733087|FG002|NOT COMPLETED|Extension Period||0
3015086|NCT01029340|3733088|FG003|NOT COMPLETED|Extension Period||0
3015087|NCT01029340|3733089|FG004|NOT COMPLETED|Extension Period||0
3015088|NCT01029340|3733090|FG005|NOT COMPLETED|Extension Period||12
3015089|NCT01029340|3733085|FG000|STARTED|Part C Treatment Period||0
3015090|NCT01029340|3733086|FG001|STARTED|Part C Treatment Period||0
3015091|NCT01029340|3733087|FG002|STARTED|Part C Treatment Period||0
3015092|NCT01029340|3733088|FG003|STARTED|Part C Treatment Period||0
3015093|NCT01029340|3733089|FG004|STARTED|Part C Treatment Period||5
3015094|NCT01029340|3733090|FG005|STARTED|Part C Treatment Period||0
3015095|NCT01029340|3733085|FG000|Participants Received Treatment|Part C Treatment Period||0
3015096|NCT01029340|3733086|FG001|Participants Received Treatment|Part C Treatment Period||0
3015097|NCT01029340|3733087|FG002|Participants Received Treatment|Part C Treatment Period||0
3015098|NCT01029340|3733088|FG003|Participants Received Treatment|Part C Treatment Period||0
3015099|NCT01029340|3733089|FG004|Participants Received Treatment|Part C Treatment Period||5
3165383|NCT01898884|3892910|FG004|STARTED|Multiple Dose Period||0
3015100|NCT01029340|3733090|FG005|Participants Received Treatment|Part C Treatment Period||0
3015101|NCT01029340|3733085|FG000|COMPLETED|Part C Treatment Period||0
3015102|NCT01029340|3733086|FG001|COMPLETED|Part C Treatment Period||0
3015103|NCT01029340|3733087|FG002|COMPLETED|Part C Treatment Period||0
3015104|NCT01029340|3733088|FG003|COMPLETED|Part C Treatment Period||0
3015105|NCT01029340|3733089|FG004|COMPLETED|Part C Treatment Period||5
3015106|NCT01029340|3733090|FG005|COMPLETED|Part C Treatment Period||0
3015107|NCT01029340|3733085|FG000|NOT COMPLETED|Part C Treatment Period||0
3015108|NCT01029340|3733086|FG001|NOT COMPLETED|Part C Treatment Period||0
3015109|NCT01029340|3733087|FG002|NOT COMPLETED|Part C Treatment Period||0
3015110|NCT01029340|3733088|FG003|NOT COMPLETED|Part C Treatment Period||0
3015111|NCT01029340|3733089|FG004|NOT COMPLETED|Part C Treatment Period||0
3015112|NCT01029340|3733090|FG005|NOT COMPLETED|Part C Treatment Period||0
3015113|NCT01029340|3733085|FG000|STARTED|Part C Follow up Period||0
3015114|NCT01029340|3733086|FG001|STARTED|Part C Follow up Period||0
3015115|NCT01029340|3733087|FG002|STARTED|Part C Follow up Period||0
3015116|NCT01029340|3733088|FG003|STARTED|Part C Follow up Period||0
3015117|NCT01029340|3733089|FG004|STARTED|Part C Follow up Period||5
3015118|NCT01029340|3733090|FG005|STARTED|Part C Follow up Period||0
3015119|NCT01029340|3733085|FG000|COMPLETED|Part C Follow up Period||0
3015120|NCT01029340|3733086|FG001|COMPLETED|Part C Follow up Period||0
3015121|NCT01029340|3733087|FG002|COMPLETED|Part C Follow up Period||0
3015122|NCT01029340|3733088|FG003|COMPLETED|Part C Follow up Period||0
3015123|NCT01029340|3733089|FG004|COMPLETED|Part C Follow up Period||5
3015124|NCT01029340|3733090|FG005|COMPLETED|Part C Follow up Period||0
3015125|NCT01029340|3733085|FG000|NOT COMPLETED|Part C Follow up Period||0
3015126|NCT01029340|3733086|FG001|NOT COMPLETED|Part C Follow up Period||0
3015127|NCT01029340|3733087|FG002|NOT COMPLETED|Part C Follow up Period||0
3015128|NCT01029340|3733088|FG003|NOT COMPLETED|Part C Follow up Period||0
3015129|NCT01029340|3733089|FG004|NOT COMPLETED|Part C Follow up Period||0
3015130|NCT01029340|3733090|FG005|NOT COMPLETED|Part C Follow up Period||0
3015131|NCT01029353|3733107|FG000|STARTED|Overall Study||148
3015132|NCT01029353|3733108|FG001|STARTED|Overall Study||162
3015133|NCT01029353|3733109|FG002|STARTED|Overall Study||100
3015134|NCT01029353|3733110|FG003|STARTED|Overall Study||119
3015135|NCT01029353|3733107|FG000|Included in ITT Analysis|Overall Study||146
3015136|NCT01029353|3733108|FG001|Included in ITT Analysis|Overall Study||162
3015137|NCT01029353|3733109|FG002|Included in ITT Analysis|Overall Study||100
3015138|NCT01029353|3733110|FG003|Included in ITT Analysis|Overall Study||119
3015139|NCT01029353|3733107|FG000|Reached Network Status|Overall Study||146
3015140|NCT01029353|3733108|FG001|Reached Network Status|Overall Study||162
3165384|NCT01898884|3892911|FG005|STARTED|Multiple Dose Period|Eligible participants who completed single dose treatment were randomized to multiple dose groups.|6
3308264|NCT03019406|4041576|FG003|STARTED|PAP: up to 25 Weeks||6
3308265|NCT03019406|4041573|FG000|Treated|PAP: up to 25 Weeks||6
3015141|NCT01029353|3733109|FG002|Reached Network Status|Overall Study||100
3015142|NCT01029353|3733110|FG003|Reached Network Status|Overall Study||119
3015143|NCT01029353|3733107|FG000|COMPLETED|Overall Study||141
3015144|NCT01029353|3733108|FG001|COMPLETED|Overall Study||154
3015145|NCT01029353|3733109|FG002|COMPLETED|Overall Study||93
3015146|NCT01029353|3733110|FG003|COMPLETED|Overall Study||115
3015147|NCT01029353|3733107|FG000|NOT COMPLETED|Overall Study||7
3015148|NCT01029353|3733108|FG001|NOT COMPLETED|Overall Study||8
3015149|NCT01029353|3733109|FG002|NOT COMPLETED|Overall Study||7
3015150|NCT01029353|3733110|FG003|NOT COMPLETED|Overall Study||4
3015151|NCT01029366|3733122|FG000|STARTED|Overall Study||18
3015152|NCT01029366|3733123|FG001|STARTED|Overall Study||8
3015153|NCT01029366|3733122|FG000|COMPLETED|Overall Study||14
3015154|NCT01029366|3733123|FG001|COMPLETED|Overall Study||6
3015155|NCT01029366|3733122|FG000|NOT COMPLETED|Overall Study||4
3015156|NCT01029366|3733123|FG001|NOT COMPLETED|Overall Study||2
3015157|NCT01029392|3733132|FG000|STARTED|Overall Study||37
3015158|NCT01029392|3733133|FG001|STARTED|Overall Study||38
3015159|NCT01029392|3733132|FG000|COMPLETED|Overall Study||17
3015160|NCT01029392|3733133|FG001|COMPLETED|Overall Study||27
3015161|NCT01029392|3733132|FG000|NOT COMPLETED|Overall Study||20
3015162|NCT01029392|3733133|FG001|NOT COMPLETED|Overall Study||11
3015163|NCT01029405|3733145|FG000|STARTED|Overall Study||36
3015164|NCT01029405|3733146|FG001|STARTED|Overall Study||37
3015165|NCT01029405|3733147|FG002|STARTED|Overall Study||35
3015166|NCT01029405|3733148|FG003|STARTED|Overall Study||37
3015167|NCT01029405|3733145|FG000|COMPLETED|Overall Study||34
3015168|NCT01029405|3733146|FG001|COMPLETED|Overall Study||34
3015169|NCT01029405|3733147|FG002|COMPLETED|Overall Study||31
3015170|NCT01029405|3733148|FG003|COMPLETED|Overall Study||32
3015171|NCT01029405|3733145|FG000|NOT COMPLETED|Overall Study||2
3015172|NCT01029405|3733146|FG001|NOT COMPLETED|Overall Study||3
3015173|NCT01029405|3733147|FG002|NOT COMPLETED|Overall Study||4
3015174|NCT01029405|3733148|FG003|NOT COMPLETED|Overall Study||5
3015175|NCT01029535|3733158|FG000|STARTED|Overall Study||103
3308266|NCT03019406|4041574|FG001|Treated|PAP: up to 25 Weeks||5
3308267|NCT03019406|4041575|FG002|Treated|PAP: up to 25 Weeks||5
3308268|NCT03019406|4041576|FG003|Treated|PAP: up to 25 Weeks||6
3308269|NCT03019406|4041573|FG000|COMPLETED|PAP: up to 25 Weeks||6
3308270|NCT03019406|4041574|FG001|COMPLETED|PAP: up to 25 Weeks||5
3015176|NCT01029535|3733158|FG000|COMPLETED|Overall Study||72
3015177|NCT01029535|3733158|FG000|NOT COMPLETED|Overall Study||31
3015178|NCT01029587|3733163|FG000|STARTED|Overall Study||1
3015179|NCT01029587|3733163|FG000|COMPLETED|Overall Study||1
3015180|NCT01029587|3733163|FG000|NOT COMPLETED|Overall Study||0
3015181|NCT01029652|3733169|FG000|STARTED|Core Study (0-12 Weeks)||115
3015182|NCT01029652|3733170|FG001|STARTED|Core Study (0-12 Weeks)||115
3015183|NCT01029652|3733169|FG000|Full Analysis Set (FAS), Safety Set|Core Study (0-12 Weeks)||113
3015184|NCT01029652|3733170|FG001|Full Analysis Set (FAS), Safety Set|Core Study (0-12 Weeks)||115
3015185|NCT01029652|3733169|FG000|COMPLETED|Core Study (0-12 Weeks)||109
3015186|NCT01029652|3733170|FG001|COMPLETED|Core Study (0-12 Weeks)||105
3015187|NCT01029652|3733169|FG000|NOT COMPLETED|Core Study (0-12 Weeks)||6
3015188|NCT01029652|3733170|FG001|NOT COMPLETED|Core Study (0-12 Weeks)||10
3015189|NCT01029652|3733169|FG000|STARTED|Extension Study 1 (12-24 Weeks)||90
3015190|NCT01029652|3733170|FG001|STARTED|Extension Study 1 (12-24 Weeks)||85
3015191|NCT01029652|3733169|FG000|COMPLETED|Extension Study 1 (12-24 Weeks)||87
3015192|NCT01029652|3733170|FG001|COMPLETED|Extension Study 1 (12-24 Weeks)||80
3015193|NCT01029652|3733169|FG000|NOT COMPLETED|Extension Study 1 (12-24 Weeks)||3
3015194|NCT01029652|3733170|FG001|NOT COMPLETED|Extension Study 1 (12-24 Weeks)||5
3015195|NCT01029652|3733169|FG000|STARTED|Extension Study 2 (25-72 Weeks)||69
3015196|NCT01029652|3733170|FG001|STARTED|Extension Study 2 (25-72 Weeks)||66
3015197|NCT01029652|3733169|FG000|Re-treated With or Switch to Canakinumab|Extension Study 2 (25-72 Weeks)|Includes patients re-treated with canakinumab over 72 weeks study duration overall|69
3015198|NCT01029652|3733170|FG001|Re-treated With or Switch to Canakinumab|Extension Study 2 (25-72 Weeks)|Includes patients switched to canakinumab from Week 25 - Week 72|39
3015199|NCT01029652|3733169|FG000|COMPLETED|Extension Study 2 (25-72 Weeks)||68
3015200|NCT01029652|3733170|FG001|COMPLETED|Extension Study 2 (25-72 Weeks)||63
3015201|NCT01029652|3733169|FG000|NOT COMPLETED|Extension Study 2 (25-72 Weeks)||1
3015202|NCT01029652|3733170|FG001|NOT COMPLETED|Extension Study 2 (25-72 Weeks)||3
3015203|NCT01029691|3733197|FG000|STARTED|APAP Initiation to Week 1 or Delivery||20
3015204|NCT01029691|3733198|FG001|STARTED|APAP Initiation to Week 1 or Delivery|4 delivered before APAP initiation 7 elected not to have APAP following baseline study|27
3015205|NCT01029691|3733199|FG002|STARTED|APAP Initiation to Week 1 or Delivery||77
3015206|NCT01029691|3733197|FG000|Baseline Sleep Study|APAP Initiation to Week 1 or Delivery||20
3015207|NCT01029691|3733198|FG001|Baseline Sleep Study|APAP Initiation to Week 1 or Delivery||23
3015208|NCT01029691|3733199|FG002|Baseline Sleep Study|APAP Initiation to Week 1 or Delivery||77
3015209|NCT01029691|3733197|FG000|Began Actual APAP Use|APAP Initiation to Week 1 or Delivery||20
3015210|NCT01029691|3733198|FG001|Began Actual APAP Use|APAP Initiation to Week 1 or Delivery||16
3015211|NCT01029691|3733199|FG002|Began Actual APAP Use|APAP Initiation to Week 1 or Delivery||77
3015212|NCT01029691|3733197|FG000|COMPLETED|APAP Initiation to Week 1 or Delivery||20
3015213|NCT01029691|3733198|FG001|COMPLETED|APAP Initiation to Week 1 or Delivery||16
3015214|NCT01029691|3733199|FG002|COMPLETED|APAP Initiation to Week 1 or Delivery||77
3015215|NCT01029691|3733197|FG000|NOT COMPLETED|APAP Initiation to Week 1 or Delivery||0
3015216|NCT01029691|3733198|FG001|NOT COMPLETED|APAP Initiation to Week 1 or Delivery||11
3015217|NCT01029691|3733199|FG002|NOT COMPLETED|APAP Initiation to Week 1 or Delivery||0
3015218|NCT01029691|3733197|FG000|STARTED|Continued APAP to Delivery||20
3015219|NCT01029691|3733198|FG001|STARTED|Continued APAP to Delivery||16
3015220|NCT01029691|3733199|FG002|STARTED|Continued APAP to Delivery||77
3015221|NCT01029691|3733197|FG000|COMPLETED|Continued APAP to Delivery||20
3015222|NCT01029691|3733198|FG001|COMPLETED|Continued APAP to Delivery||16
3015223|NCT01029691|3733199|FG002|COMPLETED|Continued APAP to Delivery||76
3015224|NCT01029691|3733197|FG000|NOT COMPLETED|Continued APAP to Delivery||0
3015225|NCT01029691|3733198|FG001|NOT COMPLETED|Continued APAP to Delivery||0
3015226|NCT01029691|3733199|FG002|NOT COMPLETED|Continued APAP to Delivery||1
3015227|NCT01029704|3733217|FG000|STARTED|Overall Study||5
3015228|NCT01029704|3733218|FG001|STARTED|Overall Study||5
3015229|NCT01029704|3733219|FG002|STARTED|Overall Study||5
3015230|NCT01029704|3733220|FG003|STARTED|Overall Study||5
3015231|NCT01029704|3733221|FG004|STARTED|Overall Study||28
3015232|NCT01029704|3733222|FG005|STARTED|Overall Study||24
3015233|NCT01029704|3733223|FG006|STARTED|Overall Study||23
3015234|NCT01029704|3733224|FG007|STARTED|Overall Study||28
3015235|NCT01029704|3733225|FG008|STARTED|Overall Study||26
3015236|NCT01029704|3733217|FG000|COMPLETED|Overall Study||5
3015237|NCT01029704|3733218|FG001|COMPLETED|Overall Study||5
3015238|NCT01029704|3733219|FG002|COMPLETED|Overall Study||5
3015239|NCT01029704|3733220|FG003|COMPLETED|Overall Study||5
3015240|NCT01029704|3733221|FG004|COMPLETED|Overall Study||23
3015241|NCT01029704|3733222|FG005|COMPLETED|Overall Study||20
3015242|NCT01029704|3733223|FG006|COMPLETED|Overall Study||19
3015243|NCT01029704|3733224|FG007|COMPLETED|Overall Study||22
3015244|NCT01029704|3733225|FG008|COMPLETED|Overall Study||25
3015245|NCT01029704|3733217|FG000|NOT COMPLETED|Overall Study||0
3015246|NCT01029704|3733218|FG001|NOT COMPLETED|Overall Study||0
3015247|NCT01029704|3733219|FG002|NOT COMPLETED|Overall Study||0
3015248|NCT01029704|3733220|FG003|NOT COMPLETED|Overall Study||0
3015249|NCT01029704|3733221|FG004|NOT COMPLETED|Overall Study||5
3015250|NCT01029704|3733222|FG005|NOT COMPLETED|Overall Study||4
3015251|NCT01029704|3733223|FG006|NOT COMPLETED|Overall Study||4
3015252|NCT01029704|3733224|FG007|NOT COMPLETED|Overall Study||6
3015253|NCT01029704|3733225|FG008|NOT COMPLETED|Overall Study||1
3015254|NCT01029730|3733245|FG000|STARTED|Combination Therapy||55
3015255|NCT01029730|3733245|FG000|COMPLETED|Combination Therapy|Patients remained on-study until completing 6 cycles or coming off-treatment for any other reason|39
3015256|NCT01029730|3733245|FG000|NOT COMPLETED|Combination Therapy||16
3015257|NCT01029730|3733245|FG000|STARTED|Maintenance Therapy|Two patients complete study treatment but declined subsequent maintenance therapy|37
3015258|NCT01029730|3733245|FG000|COMPLETED|Maintenance Therapy||14
3015259|NCT01029730|3733245|FG000|NOT COMPLETED|Maintenance Therapy||23
3015260|NCT01029782|3733251|FG000|STARTED|Overall Study||102
3015261|NCT01029782|3733252|FG001|STARTED|Overall Study||104
3015262|NCT01029782|3733251|FG000|COMPLETED|Overall Study||99
3015263|NCT01029782|3733252|FG001|COMPLETED|Overall Study||96
3015264|NCT01029782|3733251|FG000|NOT COMPLETED|Overall Study||3
3015265|NCT01029782|3733252|FG001|NOT COMPLETED|Overall Study||8
3015266|NCT01029795|3733260|FG000|STARTED|Overall Study||16
3015267|NCT01029795|3733261|FG001|STARTED|Overall Study||22
3015268|NCT01029795|3733260|FG000|COMPLETED|Overall Study||0
3015269|NCT01029795|3733261|FG001|COMPLETED|Overall Study||0
3015270|NCT01029795|3733260|FG000|NOT COMPLETED|Overall Study||16
3015271|NCT01029795|3733261|FG001|NOT COMPLETED|Overall Study||22
3015272|NCT01029886|3733269|FG000|STARTED|Overall Study||461
3015273|NCT01029886|3733270|FG001|STARTED|Overall Study||451
3015274|NCT01029886|3733269|FG000|Intent to Treat (ITT)|Overall Study||461
3015275|NCT01029886|3733270|FG001|Intent to Treat (ITT)|Overall Study||450
3015276|NCT01029886|3733269|FG000|COMPLETED|Overall Study||400
3015277|NCT01029886|3733270|FG001|COMPLETED|Overall Study||391
3015278|NCT01029886|3733269|FG000|NOT COMPLETED|Overall Study||61
3015279|NCT01029886|3733270|FG001|NOT COMPLETED|Overall Study||60
3015280|NCT01029912|3733282|FG000|STARTED|Overall Study||14
3015281|NCT01029912|3733283|FG001|STARTED|Overall Study||12
3015282|NCT01029912|3733282|FG000|COMPLETED|Overall Study||12
3015283|NCT01029912|3733283|FG001|COMPLETED|Overall Study||12
3015284|NCT01029912|3733282|FG000|NOT COMPLETED|Overall Study||2
3015285|NCT01029912|3733283|FG001|NOT COMPLETED|Overall Study||0
3015286|NCT01029925|3733289|FG000|STARTED|Completion of Cycle 1 (28 Days)||7
3015287|NCT01029925|3733289|FG000|COMPLETED|Completion of Cycle 1 (28 Days)||3
3015288|NCT01029925|3733289|FG000|NOT COMPLETED|Completion of Cycle 1 (28 Days)||4
3015289|NCT01029925|3733289|FG000|STARTED|Completion of Cycle 2 (56 Days)||3
3015290|NCT01029925|3733289|FG000|COMPLETED|Completion of Cycle 2 (56 Days)||2
3015291|NCT01029925|3733289|FG000|NOT COMPLETED|Completion of Cycle 2 (56 Days)||1
3015292|NCT01030133|3733295|FG000|STARTED|Overall Study||14
3015293|NCT01030133|3733296|FG001|STARTED|Overall Study||14
3015294|NCT01030133|3733295|FG000|COMPLETED|Overall Study||12
3015295|NCT01030133|3733296|FG001|COMPLETED|Overall Study||12
3015296|NCT01030133|3733295|FG000|NOT COMPLETED|Overall Study||2
3015297|NCT01030133|3733296|FG001|NOT COMPLETED|Overall Study||2
3015298|NCT01030289|3733306|FG000|STARTED|Overall Study||9
3015299|NCT01030289|3733307|FG001|STARTED|Overall Study||10
3015300|NCT01030289|3733306|FG000|COMPLETED|Overall Study||9
3015301|NCT01030289|3733307|FG001|COMPLETED|Overall Study||10
3015302|NCT01030289|3733306|FG000|NOT COMPLETED|Overall Study||0
3015303|NCT01030289|3733307|FG001|NOT COMPLETED|Overall Study||0
3015304|NCT01030406|3733319|FG000|STARTED|Overall Study||10
3015305|NCT01030406|3733320|FG001|STARTED|Overall Study||10
3015306|NCT01030406|3733321|FG002|STARTED|Overall Study||10
3015307|NCT01030406|3733322|FG003|STARTED|Overall Study||10
3015308|NCT01030406|3733323|FG004|STARTED|Overall Study||9
3015309|NCT01030406|3733319|FG000|COMPLETED|Overall Study||10
3015310|NCT01030406|3733320|FG001|COMPLETED|Overall Study||10
3015311|NCT01030406|3733321|FG002|COMPLETED|Overall Study||9
3015312|NCT01030406|3733322|FG003|COMPLETED|Overall Study||9
3165385|NCT01898884|3892912|FG006|STARTED|Multiple Dose Period|Eligible participants who completed single dose treatment were randomized to multiple dose groups.|6
3165386|NCT01898884|3892913|FG007|STARTED|Multiple Dose Period|Eligible participants who completed single dose treatment were randomized to multiple dose groups.|6
3171818|NCT01937351|3899028|FG001|Treated w Study Device|Overall Study||28
3015313|NCT01030406|3733323|FG004|COMPLETED|Overall Study||9
3015314|NCT01030406|3733319|FG000|NOT COMPLETED|Overall Study||0
3015315|NCT01030406|3733320|FG001|NOT COMPLETED|Overall Study||0
3015316|NCT01030406|3733321|FG002|NOT COMPLETED|Overall Study||1
3015317|NCT01030406|3733322|FG003|NOT COMPLETED|Overall Study||1
3015318|NCT01030406|3733323|FG004|NOT COMPLETED|Overall Study||0
3015319|NCT01030458|3733337|FG000|STARTED|Overall Study||94
3015320|NCT01030458|3733338|FG001|STARTED|Overall Study||89
3015321|NCT01030458|3733337|FG000|COMPLETED|Overall Study||67
3015322|NCT01030458|3733338|FG001|COMPLETED|Overall Study||57
3015323|NCT01030458|3733337|FG000|NOT COMPLETED|Overall Study||27
3015324|NCT01030458|3733338|FG001|NOT COMPLETED|Overall Study||32
3015325|NCT01030523|3733346|FG000|STARTED|Overall Study||50
3015326|NCT01030523|3733347|FG001|STARTED|Overall Study||51
3015327|NCT01030523|3733346|FG000|COMPLETED|Overall Study||44
3015328|NCT01030523|3733347|FG001|COMPLETED|Overall Study||46
3015329|NCT01030523|3733346|FG000|NOT COMPLETED|Overall Study||6
3015330|NCT01030523|3733347|FG001|NOT COMPLETED|Overall Study||5
3015331|NCT01030536|3733358|FG000|STARTED|Overall Study||7
3015332|NCT01030536|3733359|FG001|STARTED|Overall Study||6
3015333|NCT01030536|3733360|FG002|STARTED|Overall Study||6
3015334|NCT01030536|3733361|FG003|STARTED|Overall Study||3
3015335|NCT01030536|3733362|FG004|STARTED|Overall Study||1
3015336|NCT01030536|3733358|FG000|COMPLETED|Overall Study||0
3015337|NCT01030536|3733359|FG001|COMPLETED|Overall Study||0
3015338|NCT01030536|3733360|FG002|COMPLETED|Overall Study||0
3015339|NCT01030536|3733361|FG003|COMPLETED|Overall Study||0
3015340|NCT01030536|3733362|FG004|COMPLETED|Overall Study||0
3015341|NCT01030536|3733358|FG000|NOT COMPLETED|Overall Study||7
3015342|NCT01030536|3733359|FG001|NOT COMPLETED|Overall Study||6
3015343|NCT01030536|3733360|FG002|NOT COMPLETED|Overall Study||6
3015344|NCT01030536|3733361|FG003|NOT COMPLETED|Overall Study||3
3015345|NCT01030536|3733362|FG004|NOT COMPLETED|Overall Study||1
3015346|NCT01030575|3733382|FG000|STARTED|Overall Study||29
3015347|NCT01030575|3733383|FG001|STARTED|Overall Study||30
3015348|NCT01030575|3733384|FG002|STARTED|Overall Study||28
3015349|NCT01030575|3733385|FG003|STARTED|Overall Study||35
3015350|NCT01030575|3733382|FG000|COMPLETED|Overall Study|1 infant randomized to the placebo arm incorrectly received the low dose. The infant was included in the low dose arm for the pharmacokinetics analyses and as randomized to the placebo arm for all other analyzes.|29
3015351|NCT01030575|3733383|FG001|COMPLETED|Overall Study||30
3015352|NCT01030575|3733384|FG002|COMPLETED|Overall Study||28
3015353|NCT01030575|3733385|FG003|COMPLETED|Overall Study|1 infant randomized to the placebo arm incorrectly received the low dose. The infant was included in the low dose arm for the pharmacokinetics analyses and as randomized to the placebo arm for all other analyzes.|35
3015354|NCT01030575|3733382|FG000|NOT COMPLETED|Overall Study||0
3015355|NCT01030575|3733383|FG001|NOT COMPLETED|Overall Study||0
3015356|NCT01030575|3733384|FG002|NOT COMPLETED|Overall Study||0
3015357|NCT01030575|3733385|FG003|NOT COMPLETED|Overall Study||0
3015358|NCT01030653|3733394|FG000|STARTED|Loading Dose & First Maintenance Regimen||4
3015359|NCT01030653|3733395|FG001|STARTED|Loading Dose & First Maintenance Regimen||4
3015360|NCT01030653|3733394|FG000|COMPLETED|Loading Dose & First Maintenance Regimen||4
3015361|NCT01030653|3733395|FG001|COMPLETED|Loading Dose & First Maintenance Regimen||4
3015362|NCT01030653|3733394|FG000|NOT COMPLETED|Loading Dose & First Maintenance Regimen||0
3015363|NCT01030653|3733395|FG001|NOT COMPLETED|Loading Dose & First Maintenance Regimen||0
3015364|NCT01030653|3733394|FG000|STARTED|7-Day Washout Period||4
3015365|NCT01030653|3733395|FG001|STARTED|7-Day Washout Period||4
3015366|NCT01030653|3733394|FG000|COMPLETED|7-Day Washout Period||4
3015367|NCT01030653|3733395|FG001|COMPLETED|7-Day Washout Period||4
3015368|NCT01030653|3733394|FG000|NOT COMPLETED|7-Day Washout Period||0
3015369|NCT01030653|3733395|FG001|NOT COMPLETED|7-Day Washout Period||0
3015370|NCT01030653|3733394|FG000|STARTED|Loading Dose & 2nd Maintenance Regimen||4
3015371|NCT01030653|3733395|FG001|STARTED|Loading Dose & 2nd Maintenance Regimen||4
3015372|NCT01030653|3733394|FG000|COMPLETED|Loading Dose & 2nd Maintenance Regimen||4
3015373|NCT01030653|3733395|FG001|COMPLETED|Loading Dose & 2nd Maintenance Regimen||4
3015374|NCT01030653|3733394|FG000|NOT COMPLETED|Loading Dose & 2nd Maintenance Regimen||0
3015375|NCT01030653|3733395|FG001|NOT COMPLETED|Loading Dose & 2nd Maintenance Regimen||0
3015376|NCT01030666|3733404|FG000|STARTED|Overall Study||28
3015377|NCT01030666|3733405|FG001|STARTED|Overall Study||33
3015378|NCT01030666|3733404|FG000|COMPLETED|Overall Study||25
3015379|NCT01030666|3733405|FG001|COMPLETED|Overall Study||31
3015380|NCT01030666|3733404|FG000|NOT COMPLETED|Overall Study||3
3015381|NCT01030666|3733405|FG001|NOT COMPLETED|Overall Study||2
3015382|NCT01030718|3733415|FG000|STARTED|Studies CA180-031 and -036 Combined||30
3015383|NCT01030718|3733416|FG001|STARTED|Studies CA180-031 and -036 Combined||11
3015384|NCT01030718|3733417|FG002|STARTED|Studies CA180-031 and -036 Combined||13
3015385|NCT01030718|3733415|FG000|COMPLETED|Studies CA180-031 and -036 Combined||26
3015386|NCT01030718|3733416|FG001|COMPLETED|Studies CA180-031 and -036 Combined||2
3015387|NCT01030718|3733417|FG002|COMPLETED|Studies CA180-031 and -036 Combined||1
3015388|NCT01030718|3733415|FG000|NOT COMPLETED|Studies CA180-031 and -036 Combined||4
3015389|NCT01030718|3733416|FG001|NOT COMPLETED|Studies CA180-031 and -036 Combined||9
3015390|NCT01030718|3733417|FG002|NOT COMPLETED|Studies CA180-031 and -036 Combined||12
3015391|NCT01030718|3733415|FG000|STARTED|Study CA180-036 Only||29
3015392|NCT01030718|3733416|FG001|STARTED|Study CA180-036 Only||9
3015393|NCT01030718|3733417|FG002|STARTED|Study CA180-036 Only||6
3015394|NCT01030718|3733415|FG000|COMPLETED|Study CA180-036 Only||26
3015395|NCT01030718|3733416|FG001|COMPLETED|Study CA180-036 Only||2
3015396|NCT01030718|3733417|FG002|COMPLETED|Study CA180-036 Only||1
3015397|NCT01030718|3733415|FG000|NOT COMPLETED|Study CA180-036 Only||3
3015398|NCT01030718|3733416|FG001|NOT COMPLETED|Study CA180-036 Only||7
3015399|NCT01030718|3733417|FG002|NOT COMPLETED|Study CA180-036 Only||5
3015400|NCT01030783|3733437|FG000|STARTED|Overall Study||260
3015401|NCT01030783|3733438|FG001|STARTED|Overall Study||257
3015402|NCT01030783|3733437|FG000|COMPLETED|Overall Study||211
3015403|NCT01030783|3733438|FG001|COMPLETED|Overall Study||231
3015404|NCT01030783|3733437|FG000|NOT COMPLETED|Overall Study||49
3015405|NCT01030783|3733438|FG001|NOT COMPLETED|Overall Study||26
3015406|NCT01030822|3733447|FG000|STARTED|Overall Study||100
3015407|NCT01030822|3733448|FG001|STARTED|Overall Study||95
3015408|NCT01030822|3733449|FG002|STARTED|Overall Study||87
3015409|NCT01030822|3733447|FG000|COMPLETED|Overall Study||69
3015410|NCT01030822|3733448|FG001|COMPLETED|Overall Study||71
3015411|NCT01030822|3733449|FG002|COMPLETED|Overall Study||61
3015412|NCT01030822|3733447|FG000|NOT COMPLETED|Overall Study||31
3015413|NCT01030822|3733448|FG001|NOT COMPLETED|Overall Study||24
3015414|NCT01030822|3733449|FG002|NOT COMPLETED|Overall Study||26
3015415|NCT01030861|3733460|FG000|STARTED|Overall Study||44
3015416|NCT01030861|3733461|FG001|STARTED|Overall Study||32
3015417|NCT01030861|3733460|FG000|COMPLETED|Overall Study||44
3015418|NCT01030861|3733461|FG001|COMPLETED|Overall Study||32
3015419|NCT01030861|3733460|FG000|NOT COMPLETED|Overall Study||0
3015420|NCT01030861|3733461|FG001|NOT COMPLETED|Overall Study||0
3015421|NCT01030874|3733469|FG000|STARTED|Overall Study|1 with impaired decision making capacity|178
3015422|NCT01030874|3733470|FG001|STARTED|Overall Study|1 with impaired decision making capacity|178
3015423|NCT01030874|3733469|FG000|COMPLETED|Overall Study||160
3015424|NCT01030874|3733470|FG001|COMPLETED|Overall Study||162
3015425|NCT01030874|3733469|FG000|NOT COMPLETED|Overall Study||18
3015426|NCT01030874|3733470|FG001|NOT COMPLETED|Overall Study||16
3015427|NCT01030952|3733478|FG000|STARTED|Overall Study||51
3015428|NCT01030952|3733479|FG001|STARTED|Overall Study||52
3015429|NCT01030952|3733478|FG000|COMPLETED|Overall Study||49
3015430|NCT01030952|3733479|FG001|COMPLETED|Overall Study||49
3015431|NCT01030952|3733478|FG000|NOT COMPLETED|Overall Study||2
3015432|NCT01030952|3733479|FG001|NOT COMPLETED|Overall Study||3
3015433|NCT01030965|3733491|FG000|STARTED|Overall Study||71
3015434|NCT01030965|3733492|FG001|STARTED|Overall Study||71
3015435|NCT01030965|3733493|FG002|STARTED|Overall Study||72
3015436|NCT01030965|3733494|FG003|STARTED|Overall Study||71
3165387|NCT01898884|3892914|FG008|STARTED|Multiple Dose Period|Eligible participants who completed single dose treatment were randomized to multiple dose groups.|6
3015437|NCT01030965|3733491|FG000|COMPLETED|Overall Study||67
3015438|NCT01030965|3733492|FG001|COMPLETED|Overall Study||65
3015439|NCT01030965|3733493|FG002|COMPLETED|Overall Study||68
3015440|NCT01030965|3733494|FG003|COMPLETED|Overall Study||64
3015441|NCT01030965|3733491|FG000|NOT COMPLETED|Overall Study||4
3015442|NCT01030965|3733492|FG001|NOT COMPLETED|Overall Study||6
3015443|NCT01030965|3733493|FG002|NOT COMPLETED|Overall Study||4
3015444|NCT01030965|3733494|FG003|NOT COMPLETED|Overall Study||7
3015445|NCT01031004|3733506|FG000|STARTED|Overall Study||25
3015446|NCT01031004|3733507|FG001|STARTED|Overall Study||25
3015447|NCT01031004|3733506|FG000|COMPLETED|Overall Study||24
3015448|NCT01031004|3733507|FG001|COMPLETED|Overall Study||24
3015449|NCT01031004|3733506|FG000|NOT COMPLETED|Overall Study||1
3015450|NCT01031004|3733507|FG001|NOT COMPLETED|Overall Study||1
3015451|NCT01031043|3733513|FG000|STARTED|Overall Study||5
3015452|NCT01031043|3733513|FG000|COMPLETED|Overall Study||4
3015453|NCT01031043|3733513|FG000|NOT COMPLETED|Overall Study||1
3015454|NCT01031069|3733521|FG000|STARTED|Overall Study||129
3015455|NCT01031069|3733522|FG001|STARTED|Overall Study||128
3015456|NCT01031069|3733523|FG002|STARTED|Overall Study||144
3015457|NCT01031069|3733524|FG003|STARTED|Overall Study||145
3015458|NCT01031069|3733521|FG000|COMPLETED|Overall Study||117
3015459|NCT01031069|3733522|FG001|COMPLETED|Overall Study||117
3015460|NCT01031069|3733523|FG002|COMPLETED|Overall Study||103
3015461|NCT01031069|3733524|FG003|COMPLETED|Overall Study||111
3015462|NCT01031069|3733521|FG000|NOT COMPLETED|Overall Study||12
3015463|NCT01031069|3733522|FG001|NOT COMPLETED|Overall Study||11
3015464|NCT01031069|3733523|FG002|NOT COMPLETED|Overall Study||41
3015465|NCT01031069|3733524|FG003|NOT COMPLETED|Overall Study||34
3015466|NCT01031095|3733538|FG000|STARTED|Overall Study||100
3015467|NCT01031095|3733539|FG001|STARTED|Overall Study||100
3015468|NCT01031095|3733538|FG000|COMPLETED|Overall Study||100
3015469|NCT01031095|3733539|FG001|COMPLETED|Overall Study||100
3015470|NCT01031095|3733538|FG000|NOT COMPLETED|Overall Study||0
3015471|NCT01031095|3733539|FG001|NOT COMPLETED|Overall Study||0
3015472|NCT01031134|3733547|FG000|STARTED|Overall Study||114
3015473|NCT01031134|3733548|FG001|STARTED|Overall Study||88
3015474|NCT01031134|3733547|FG000|COMPLETED|Overall Study||103
3015475|NCT01031134|3733548|FG001|COMPLETED|Overall Study||78
3015476|NCT01031134|3733547|FG000|NOT COMPLETED|Overall Study||11
3015477|NCT01031134|3733548|FG001|NOT COMPLETED|Overall Study||10
3015478|NCT01031381|3733554|FG000|STARTED|Overall Study||59
3015479|NCT01031381|3733554|FG000|COMPLETED|Overall Study||50
3015480|NCT01031381|3733554|FG000|NOT COMPLETED|Overall Study||9
3015481|NCT01031420|3733559|FG000|STARTED|Overall Study||54
3015482|NCT01031420|3733559|FG000|COMPLETED|Overall Study||44
3015483|NCT01031420|3733559|FG000|NOT COMPLETED|Overall Study||10
3015484|NCT01031446|3733563|FG000|STARTED|Overall Study||55
3015485|NCT01031446|3733563|FG000|COMPLETED|Overall Study||0
3015486|NCT01031446|3733563|FG000|NOT COMPLETED|Overall Study||55
3037582|NCT01148862|3756878|FG000|STARTED|Second Intervention||25
3037583|NCT01148862|3756879|FG001|STARTED|Second Intervention||25
3037584|NCT01148862|3756878|FG000|COMPLETED|Second Intervention||25
3037585|NCT01148862|3756879|FG001|COMPLETED|Second Intervention||23
3037586|NCT01148862|3756878|FG000|NOT COMPLETED|Second Intervention||0
3037587|NCT01148862|3756879|FG001|NOT COMPLETED|Second Intervention||2
3037588|NCT01148940|3756887|FG000|STARTED|Overall Study||7
3037589|NCT01148940|3756888|FG001|STARTED|Overall Study||27
3037590|NCT01148940|3756889|FG002|STARTED|Overall Study||0
3037591|NCT01148940|3756887|FG000|COMPLETED|Overall Study||7
3037592|NCT01148940|3756888|FG001|COMPLETED|Overall Study||27
3037593|NCT01148940|3756889|FG002|COMPLETED|Overall Study||0
3037594|NCT01148940|3756887|FG000|NOT COMPLETED|Overall Study||0
3037595|NCT01148940|3756888|FG001|NOT COMPLETED|Overall Study||0
3037596|NCT01148940|3756889|FG002|NOT COMPLETED|Overall Study||0
3037597|NCT01148979|3756899|FG000|STARTED|Overall Study||13
3037598|NCT01148979|3756900|FG001|STARTED|Overall Study||16
3037599|NCT01148979|3756899|FG000|COMPLETED|Overall Study||13
3037600|NCT01148979|3756900|FG001|COMPLETED|Overall Study||15
3037601|NCT01148979|3756899|FG000|NOT COMPLETED|Overall Study||0
3037602|NCT01148979|3756900|FG001|NOT COMPLETED|Overall Study||1
3037603|NCT01149057|3756906|FG000|STARTED|Overall Study||145
3037604|NCT01149057|3756906|FG000|COMPLETED|Overall Study||88
3037605|NCT01149057|3756906|FG000|NOT COMPLETED|Overall Study||57
3037606|NCT01149096|3756912|FG000|STARTED|Overall Study||6
3037607|NCT01149096|3756913|FG001|STARTED|Overall Study||7
3037608|NCT01149096|3756912|FG000|COMPLETED|Overall Study||6
3015487|NCT01031498|3733572|FG000|STARTED|Overall Study|2 patients were not evaluable in arm 1.|49
3015488|NCT01031498|3733573|FG001|STARTED|Overall Study|3 patients were not evaluable in arm 2|51
3015489|NCT01031498|3733574|FG002|STARTED|Overall Study|2 patients were not evaluable in arm 3.|50
3015490|NCT01031498|3733572|FG000|COMPLETED|Overall Study||47
3015491|NCT01031498|3733573|FG001|COMPLETED|Overall Study||48
3015492|NCT01031498|3733574|FG002|COMPLETED|Overall Study||48
3015493|NCT01031498|3733572|FG000|NOT COMPLETED|Overall Study||2
3015494|NCT01031498|3733573|FG001|NOT COMPLETED|Overall Study||3
3015495|NCT01031498|3733574|FG002|NOT COMPLETED|Overall Study||2
3015496|NCT01031537|3733582|FG000|STARTED|Overall Study||66
3015497|NCT01031537|3733582|FG000|COMPLETED|Overall Study||34
3015498|NCT01031537|3733582|FG000|NOT COMPLETED|Overall Study||32
3015499|NCT01031680|3733588|FG000|STARTED|Overall Study|Of the 460 randomized participants only 455 were included in the full analysis set.|460
3015500|NCT01031680|3733589|FG001|STARTED|Overall Study|Of the 462 randomized participants only 459 were included in the full analysis set.|462
3015501|NCT01031680|3733588|FG000|COMPLETED|Overall Study||403
3015502|NCT01031680|3733589|FG001|COMPLETED|Overall Study||404
3015503|NCT01031680|3733588|FG000|NOT COMPLETED|Overall Study||57
3015504|NCT01031680|3733589|FG001|NOT COMPLETED|Overall Study||58
3015505|NCT01031706|3733597|FG000|STARTED|Overall Study||14
3015506|NCT01031706|3733598|FG001|STARTED|Overall Study||9
3015507|NCT01031706|3733597|FG000|COMPLETED|Overall Study||12
3015508|NCT01031706|3733598|FG001|COMPLETED|Overall Study||8
3015509|NCT01031706|3733597|FG000|NOT COMPLETED|Overall Study||2
3015510|NCT01031706|3733598|FG001|NOT COMPLETED|Overall Study||1
3015511|NCT01031810|3733604|FG000|STARTED|Overall Study||13
3015512|NCT01031810|3733604|FG000|COMPLETED|Overall Study||9
3015513|NCT01031810|3733604|FG000|NOT COMPLETED|Overall Study||4
3015514|NCT01031836|3733616|FG000|STARTED|Stage I||5
3015515|NCT01031836|3733617|FG001|STARTED|Stage I||5
3015516|NCT01031836|3733618|FG002|STARTED|Stage I||5
3015517|NCT01031836|3733619|FG003|STARTED|Stage I||5
3015518|NCT01031836|3733620|FG004|STARTED|Stage I||5
3015519|NCT01031836|3733621|FG005|STARTED|Stage I||5
3015520|NCT01031836|3733616|FG000|COMPLETED|Stage I||4
3015521|NCT01031836|3733617|FG001|COMPLETED|Stage I||3
3015522|NCT01031836|3733618|FG002|COMPLETED|Stage I||5
3015523|NCT01031836|3733619|FG003|COMPLETED|Stage I||5
3015524|NCT01031836|3733620|FG004|COMPLETED|Stage I||5
3015525|NCT01031836|3733621|FG005|COMPLETED|Stage I||4
3015526|NCT01031836|3733616|FG000|NOT COMPLETED|Stage I||1
3015527|NCT01031836|3733617|FG001|NOT COMPLETED|Stage I||2
3015528|NCT01031836|3733618|FG002|NOT COMPLETED|Stage I||0
3015529|NCT01031836|3733619|FG003|NOT COMPLETED|Stage I||0
3015530|NCT01031836|3733620|FG004|NOT COMPLETED|Stage I||0
3015531|NCT01031836|3733621|FG005|NOT COMPLETED|Stage I||1
3015532|NCT01031836|3733616|FG000|STARTED|Stage II|1 patient who completed the study treatment in Stage I did not register in Stage II.|3
3015533|NCT01031836|3733617|FG001|STARTED|Stage II|2 patient who completed the study treatment in Stage I did not register in Stage II.|1
3015534|NCT01031836|3733618|FG002|STARTED|Stage II|1 patient who completed the study treatment in Stage I did not register in Stage II.|4
3015535|NCT01031836|3733619|FG003|STARTED|Stage II|1 patient who completed the study treatment in Stage I did not register in Stage II.|4
3015536|NCT01031836|3733620|FG004|STARTED|Stage II||5
3015537|NCT01031836|3733621|FG005|STARTED|Stage II||4
3015538|NCT01031836|3733616|FG000|COMPLETED|Stage II||1
3015539|NCT01031836|3733617|FG001|COMPLETED|Stage II||1
3015540|NCT01031836|3733618|FG002|COMPLETED|Stage II||2
3015541|NCT01031836|3733619|FG003|COMPLETED|Stage II||1
3015542|NCT01031836|3733620|FG004|COMPLETED|Stage II||3
3015543|NCT01031836|3733621|FG005|COMPLETED|Stage II||3
3015544|NCT01031836|3733616|FG000|NOT COMPLETED|Stage II||2
3015545|NCT01031836|3733617|FG001|NOT COMPLETED|Stage II||0
3015546|NCT01031836|3733618|FG002|NOT COMPLETED|Stage II||2
3015547|NCT01031836|3733619|FG003|NOT COMPLETED|Stage II||3
3015548|NCT01031836|3733620|FG004|NOT COMPLETED|Stage II||2
3015549|NCT01031836|3733621|FG005|NOT COMPLETED|Stage II||1
3015550|NCT01031914|3733635|FG000|STARTED|Overall Study||36
3015551|NCT01031914|3733635|FG000|COMPLETED|Overall Study||36
3015552|NCT01031914|3733635|FG000|NOT COMPLETED|Overall Study||0
3015553|NCT01031953|3733639|FG000|STARTED|Overall Study||11
3015554|NCT01031953|3733639|FG000|COMPLETED|Overall Study||11
3015555|NCT01031953|3733639|FG000|NOT COMPLETED|Overall Study||0
3015556|NCT01031979|3733651|FG000|STARTED|Overall Study|To meet eligibility requirements for randomization, subjects had to reach session 3 w/o dropping.|14
3015557|NCT01031979|3733652|FG001|STARTED|Overall Study|To meet eligibility requirements for randomization, subjects had to reach session 3 w/o dropping.|12
3015558|NCT01031979|3733651|FG000|Completed Primary Outcome Measure|Overall Study||12
3015559|NCT01031979|3733652|FG001|Completed Primary Outcome Measure|Overall Study||12
3015560|NCT01031979|3733651|FG000|COMPLETED|Overall Study|These are individuals who completed treatment in the study.|9
3015561|NCT01031979|3733652|FG001|COMPLETED|Overall Study|These are individuals who completed treatment in the study.|8
3015562|NCT01031979|3733651|FG000|NOT COMPLETED|Overall Study||5
3015563|NCT01031979|3733652|FG001|NOT COMPLETED|Overall Study||4
3015564|NCT01032018|3733660|FG000|STARTED|Overall Study||77
3015565|NCT01032018|3733661|FG001|STARTED|Overall Study||73
3015566|NCT01032018|3733660|FG000|COMPLETED|Overall Study||71
3015567|NCT01032018|3733661|FG001|COMPLETED|Overall Study||67
3015568|NCT01032018|3733660|FG000|NOT COMPLETED|Overall Study||6
3015569|NCT01032018|3733661|FG001|NOT COMPLETED|Overall Study||6
3015570|NCT01032044|3733669|FG000|STARTED|Overall Study||82
3015571|NCT01032044|3733670|FG001|STARTED|Overall Study||82
3015572|NCT01032044|3733669|FG000|Procedure|Overall Study||74
3015573|NCT01032044|3733670|FG001|Procedure|Overall Study||75
3015574|NCT01032044|3733669|FG000|COMPLETED|Overall Study||57
3015575|NCT01032044|3733670|FG001|COMPLETED|Overall Study||62
3015576|NCT01032044|3733669|FG000|NOT COMPLETED|Overall Study||25
3015577|NCT01032044|3733670|FG001|NOT COMPLETED|Overall Study||20
3015578|NCT01032070|3733678|FG000|STARTED|Overall Study||13
3015579|NCT01032070|3733679|FG001|STARTED|Overall Study||12
3015580|NCT01032070|3733678|FG000|COMPLETED|Overall Study||0
3015581|NCT01032070|3733679|FG001|COMPLETED|Overall Study||0
3015582|NCT01032070|3733678|FG000|NOT COMPLETED|Overall Study||13
3015583|NCT01032070|3733679|FG001|NOT COMPLETED|Overall Study||12
3015584|NCT01032135|3733690|FG000|STARTED|2 Week Randomization||311
3015585|NCT01032135|3733691|FG001|STARTED|2 Week Randomization||93
3015586|NCT01032135|3733692|FG002|STARTED|2 Week Randomization||96
3015587|NCT01032135|3733693|FG003|STARTED|2 Week Randomization||0
3015588|NCT01032135|3733694|FG004|STARTED|2 Week Randomization||0
3015589|NCT01032135|3733695|FG005|STARTED|2 Week Randomization||0
3015590|NCT01032135|3733696|FG006|STARTED|2 Week Randomization||0
3015591|NCT01032135|3733690|FG000|COMPLETED|2 Week Randomization||311
3015592|NCT01032135|3733691|FG001|COMPLETED|2 Week Randomization||93
3015593|NCT01032135|3733692|FG002|COMPLETED|2 Week Randomization||96
3015594|NCT01032135|3733693|FG003|COMPLETED|2 Week Randomization||0
3015595|NCT01032135|3733694|FG004|COMPLETED|2 Week Randomization||0
3015596|NCT01032135|3733695|FG005|COMPLETED|2 Week Randomization||0
3015597|NCT01032135|3733696|FG006|COMPLETED|2 Week Randomization||0
3015598|NCT01032135|3733690|FG000|NOT COMPLETED|2 Week Randomization||0
3015599|NCT01032135|3733691|FG001|NOT COMPLETED|2 Week Randomization||0
3015600|NCT01032135|3733692|FG002|NOT COMPLETED|2 Week Randomization||0
3015601|NCT01032135|3733693|FG003|NOT COMPLETED|2 Week Randomization||0
3015602|NCT01032135|3733694|FG004|NOT COMPLETED|2 Week Randomization||0
3015603|NCT01032135|3733695|FG005|NOT COMPLETED|2 Week Randomization||0
3015604|NCT01032135|3733696|FG006|NOT COMPLETED|2 Week Randomization||0
3015605|NCT01032135|3733690|FG000|STARTED|8 Week Randomization||227
3015606|NCT01032135|3733691|FG001|STARTED|8 Week Randomization||0
3015607|NCT01032135|3733692|FG002|STARTED|8 Week Randomization||0
3015608|NCT01032135|3733693|FG003|STARTED|8 Week Randomization||41
3015609|NCT01032135|3733694|FG004|STARTED|8 Week Randomization||43
3015610|NCT01032135|3733695|FG005|STARTED|8 Week Randomization||48
3015611|NCT01032135|3733696|FG006|STARTED|8 Week Randomization||54
3015612|NCT01032135|3733690|FG000|12 Week Follow up|8 Week Randomization|These participants were'nt included in analyses as they didn't meet criteria for study intervention.|217
3015613|NCT01032135|3733691|FG001|12 Week Follow up|8 Week Randomization||0
3015614|NCT01032135|3733692|FG002|12 Week Follow up|8 Week Randomization||0
3015615|NCT01032135|3733693|FG003|12 Week Follow up|8 Week Randomization||34
3015616|NCT01032135|3733694|FG004|12 Week Follow up|8 Week Randomization||38
3015617|NCT01032135|3733695|FG005|12 Week Follow up|8 Week Randomization||36
3015618|NCT01032135|3733696|FG006|12 Week Follow up|8 Week Randomization||41
3015619|NCT01032135|3733690|FG000|COMPLETED|8 Week Randomization|These participants were'nt included in analyses as they didn't meet criteria for study intervention.|201
3015620|NCT01032135|3733691|FG001|COMPLETED|8 Week Randomization||0
3015621|NCT01032135|3733692|FG002|COMPLETED|8 Week Randomization||0
3015622|NCT01032135|3733693|FG003|COMPLETED|8 Week Randomization||30
3015623|NCT01032135|3733694|FG004|COMPLETED|8 Week Randomization||34
3015624|NCT01032135|3733695|FG005|COMPLETED|8 Week Randomization||31
3015625|NCT01032135|3733696|FG006|COMPLETED|8 Week Randomization||36
3015626|NCT01032135|3733690|FG000|NOT COMPLETED|8 Week Randomization||26
3015627|NCT01032135|3733691|FG001|NOT COMPLETED|8 Week Randomization||0
3015628|NCT01032135|3733692|FG002|NOT COMPLETED|8 Week Randomization||0
3015629|NCT01032135|3733693|FG003|NOT COMPLETED|8 Week Randomization||11
3015630|NCT01032135|3733694|FG004|NOT COMPLETED|8 Week Randomization||9
3015631|NCT01032135|3733695|FG005|NOT COMPLETED|8 Week Randomization||17
3015632|NCT01032135|3733696|FG006|NOT COMPLETED|8 Week Randomization||18
3015633|NCT01032174|3733712|FG000|STARTED|Overall Study||63
3015634|NCT01032174|3733713|FG001|STARTED|Overall Study||60
3015635|NCT01032174|3733712|FG000|COMPLETED|Overall Study||63
3015636|NCT01032174|3733713|FG001|COMPLETED|Overall Study||59
3015637|NCT01032174|3733712|FG000|NOT COMPLETED|Overall Study||0
3015638|NCT01032174|3733713|FG001|NOT COMPLETED|Overall Study||1
3015639|NCT01032200|3733721|FG000|STARTED|Overall Study||26
3015640|NCT01032200|3733722|FG001|STARTED|Overall Study||28
3015641|NCT01032200|3733721|FG000|COMPLETED|Overall Study||22
3015642|NCT01032200|3733722|FG001|COMPLETED|Overall Study||21
3015643|NCT01032200|3733721|FG000|NOT COMPLETED|Overall Study||4
3015644|NCT01032200|3733722|FG001|NOT COMPLETED|Overall Study||7
3015645|NCT01032239|3733730|FG000|STARTED|Overall Study|randomized to ITB arm|31
3015646|NCT01032239|3733731|FG001|STARTED|Overall Study|randomized to BMT arm|29
3015647|NCT01032239|3733730|FG000|Implant|Overall Study|implanted|25
3015648|NCT01032239|3733731|FG001|Implant|Overall Study||0
3015649|NCT01032239|3733730|FG000|COMPLETED|Overall Study||24
3015650|NCT01032239|3733731|FG001|COMPLETED|Overall Study||24
3015651|NCT01032239|3733730|FG000|NOT COMPLETED|Overall Study||7
3015652|NCT01032239|3733731|FG001|NOT COMPLETED|Overall Study||5
3015653|NCT01032265|3733739|FG000|STARTED|Overall Study||126
3015654|NCT01032265|3733740|FG001|STARTED|Overall Study||124
3015655|NCT01032265|3733739|FG000|COMPLETED|Overall Study||113
3015656|NCT01032265|3733740|FG001|COMPLETED|Overall Study||107
3015657|NCT01032265|3733739|FG000|NOT COMPLETED|Overall Study||13
3015658|NCT01032265|3733740|FG001|NOT COMPLETED|Overall Study||17
3015659|NCT01032291|3733749|FG000|STARTED|Safety Lead-in||8
3015660|NCT01032291|3733750|FG001|STARTED|Safety Lead-in||0
3015661|NCT01032291|3733751|FG002|STARTED|Safety Lead-in||0
3015662|NCT01032291|3733749|FG000|COMPLETED|Safety Lead-in|Participants with disease progression|6
3015663|NCT01032291|3733750|FG001|COMPLETED|Safety Lead-in||0
3015664|NCT01032291|3733751|FG002|COMPLETED|Safety Lead-in||0
3015665|NCT01032291|3733749|FG000|NOT COMPLETED|Safety Lead-in||2
3015666|NCT01032291|3733750|FG001|NOT COMPLETED|Safety Lead-in||0
3015667|NCT01032291|3733751|FG002|NOT COMPLETED|Safety Lead-in||0
3015668|NCT01032291|3733749|FG000|STARTED|Proof of Concept||0
3015669|NCT01032291|3733750|FG001|STARTED|Proof of Concept||22
3015670|NCT01032291|3733751|FG002|STARTED|Proof of Concept||21
3015671|NCT01032291|3733749|FG000|Intent to Treat and Safety Populations|Proof of Concept||0
3015672|NCT01032291|3733750|FG001|Intent to Treat and Safety Populations|Proof of Concept|Participants who took at least one dose of study drug|21
3015673|NCT01032291|3733751|FG002|Intent to Treat and Safety Populations|Proof of Concept|Participants who took at least one dose of study drug|21
3015674|NCT01032291|3733749|FG000|COMPLETED|Proof of Concept||0
3015675|NCT01032291|3733750|FG001|COMPLETED|Proof of Concept|Participants with disease progression|14
3015676|NCT01032291|3733751|FG002|COMPLETED|Proof of Concept|Participants with disease progression|18
3015677|NCT01032291|3733749|FG000|NOT COMPLETED|Proof of Concept||0
3015678|NCT01032291|3733750|FG001|NOT COMPLETED|Proof of Concept||8
3015679|NCT01032291|3733751|FG002|NOT COMPLETED|Proof of Concept||3
3015680|NCT01032330|3733766|FG000|STARTED|Overall Study||183
3015681|NCT01032330|3733767|FG001|STARTED|Overall Study||175
3015682|NCT01032330|3733768|FG002|STARTED|Overall Study||97
3015683|NCT01032330|3733769|FG003|STARTED|Overall Study||104
3015684|NCT01032330|3733766|FG000|COMPLETED|Overall Study||165
3165388|NCT01898884|3892906|FG000|Treated|Multiple Dose Period||0
3165389|NCT01898884|3892907|FG001|Treated|Multiple Dose Period||0
3165390|NCT01898884|3892908|FG002|Treated|Multiple Dose Period||0
3165391|NCT01898884|3892909|FG003|Treated|Multiple Dose Period||0
3165392|NCT01898884|3892910|FG004|Treated|Multiple Dose Period||0
3165393|NCT01898884|3892911|FG005|Treated|Multiple Dose Period||6
3165394|NCT01898884|3892912|FG006|Treated|Multiple Dose Period||6
3165395|NCT01898884|3892913|FG007|Treated|Multiple Dose Period||6
3165396|NCT01898884|3892914|FG008|Treated|Multiple Dose Period||5
3165397|NCT01898884|3892906|FG000|COMPLETED|Multiple Dose Period||0
3165398|NCT01898884|3892907|FG001|COMPLETED|Multiple Dose Period||0
3165399|NCT01898884|3892908|FG002|COMPLETED|Multiple Dose Period||0
3165400|NCT01898884|3892909|FG003|COMPLETED|Multiple Dose Period||0
3165401|NCT01898884|3892910|FG004|COMPLETED|Multiple Dose Period||0
3165402|NCT01898884|3892911|FG005|COMPLETED|Multiple Dose Period||6
3165403|NCT01898884|3892912|FG006|COMPLETED|Multiple Dose Period||5
3165404|NCT01898884|3892913|FG007|COMPLETED|Multiple Dose Period||6
3165405|NCT01898884|3892914|FG008|COMPLETED|Multiple Dose Period||5
3165406|NCT01898884|3892906|FG000|NOT COMPLETED|Multiple Dose Period||0
3165407|NCT01898884|3892907|FG001|NOT COMPLETED|Multiple Dose Period||0
3165408|NCT01898884|3892908|FG002|NOT COMPLETED|Multiple Dose Period||0
3165409|NCT01898884|3892909|FG003|NOT COMPLETED|Multiple Dose Period||0
3015685|NCT01032330|3733767|FG001|COMPLETED|Overall Study||151
3015686|NCT01032330|3733768|FG002|COMPLETED|Overall Study||87
3015687|NCT01032330|3733769|FG003|COMPLETED|Overall Study||90
3015688|NCT01032330|3733766|FG000|NOT COMPLETED|Overall Study||18
3015689|NCT01032330|3733767|FG001|NOT COMPLETED|Overall Study||24
3015690|NCT01032330|3733768|FG002|NOT COMPLETED|Overall Study||10
3015691|NCT01032330|3733769|FG003|NOT COMPLETED|Overall Study||14
3015692|NCT01032382|3733789|FG000|STARTED|Overall Study||16
3015693|NCT01032382|3733790|FG001|STARTED|Overall Study||14
3015694|NCT01032382|3733789|FG000|COMPLETED|Overall Study||11
3015695|NCT01032382|3733790|FG001|COMPLETED|Overall Study||9
3015696|NCT01032382|3733789|FG000|NOT COMPLETED|Overall Study||5
3015697|NCT01032382|3733790|FG001|NOT COMPLETED|Overall Study||5
3015698|NCT01032538|3733796|FG000|STARTED|Overall Study|Knees|99
3015699|NCT01032538|3733796|FG000|COMPLETED|Overall Study|Knees|99
3015700|NCT01032538|3733796|FG000|NOT COMPLETED|Overall Study||0
3015707|NCT01032629|3733814|FG000|STARTED|Overall Study||1442
3015708|NCT01032629|3733815|FG001|STARTED|Overall Study||1445
3015709|NCT01032629|3733816|FG002|STARTED|Overall Study||1443
3015710|NCT01032629|3733814|FG000|Treated|Overall Study||1441
3015711|NCT01032629|3733815|FG001|Treated|Overall Study||1445
3015712|NCT01032629|3733816|FG002|Treated|Overall Study||1441
3037609|NCT01149096|3756913|FG001|COMPLETED|Overall Study||6
3165410|NCT01898884|3892910|FG004|NOT COMPLETED|Multiple Dose Period||0
3165411|NCT01898884|3892911|FG005|NOT COMPLETED|Multiple Dose Period||0
3165412|NCT01898884|3892912|FG006|NOT COMPLETED|Multiple Dose Period||1
3165413|NCT01898884|3892913|FG007|NOT COMPLETED|Multiple Dose Period||0
3165414|NCT01898884|3892914|FG008|NOT COMPLETED|Multiple Dose Period||1
3165415|NCT01898923|3892952|FG000|STARTED|Overall Study||122
3165416|NCT01898923|3892953|FG001|STARTED|Overall Study||114
3165417|NCT01898923|3892952|FG000|COMPLETED|Overall Study||106
3165418|NCT01898923|3892953|FG001|COMPLETED|Overall Study||93
3015713|NCT01032629|3733814|FG000|COMPLETED|Overall Study|Participants who died on trial were considered completed|1297
3015714|NCT01032629|3733815|FG001|COMPLETED|Overall Study|Participants who died on trial were considered completed|1344
3015715|NCT01032629|3733816|FG002|COMPLETED|Overall Study|Participants who died on trial were considered completed|1355
3015716|NCT01032629|3733814|FG000|NOT COMPLETED|Overall Study||145
3015717|NCT01032629|3733815|FG001|NOT COMPLETED|Overall Study||101
3015718|NCT01032629|3733816|FG002|NOT COMPLETED|Overall Study||88
3015719|NCT01032694|3733827|FG000|STARTED|Overall Study||20
3015720|NCT01032694|3733828|FG001|STARTED|Overall Study||10
3015721|NCT01032694|3733827|FG000|COMPLETED|Overall Study||20
3015722|NCT01032694|3733828|FG001|COMPLETED|Overall Study||10
3015723|NCT01032694|3733827|FG000|NOT COMPLETED|Overall Study||0
3015724|NCT01032694|3733828|FG001|NOT COMPLETED|Overall Study||0
3015725|NCT01032733|3733836|FG000|STARTED|Overall Study||17
3015726|NCT01032733|3733837|FG001|STARTED|Overall Study||17
3015727|NCT01032733|3733836|FG000|COMPLETED|Overall Study||16
3015728|NCT01032733|3733837|FG001|COMPLETED|Overall Study||16
3015729|NCT01032733|3733836|FG000|NOT COMPLETED|Overall Study||1
3015730|NCT01032733|3733837|FG001|NOT COMPLETED|Overall Study||1
3015731|NCT01032759|3733846|FG000|STARTED|Overall Study||32
3015732|NCT01032759|3733847|FG001|STARTED|Overall Study||31
3015733|NCT01032759|3733846|FG000|Completed 24 Hour Assessment|Overall Study||32
3015734|NCT01032759|3733847|FG001|Completed 24 Hour Assessment|Overall Study||30
3015735|NCT01032759|3733846|FG000|Completed 48 Hour Assessment|Overall Study||31
3015736|NCT01032759|3733847|FG001|Completed 48 Hour Assessment|Overall Study||28
3015737|NCT01032759|3733846|FG000|COMPLETED|Overall Study||31
3015738|NCT01032759|3733847|FG001|COMPLETED|Overall Study||28
3015739|NCT01032759|3733846|FG000|NOT COMPLETED|Overall Study||1
3015740|NCT01032759|3733847|FG001|NOT COMPLETED|Overall Study||3
3015741|NCT01032837|3733857|FG000|STARTED|Overall Study||26
3015742|NCT01032837|3733858|FG001|STARTED|Overall Study||26
3015743|NCT01032837|3733859|FG002|STARTED|Overall Study||25
3015744|NCT01032837|3733860|FG003|STARTED|Overall Study||25
3015745|NCT01032837|3733857|FG000|Intent-to-Treat|Overall Study|All patients randomized who received at least one dose of study medication.|26
3015746|NCT01032837|3733858|FG001|Intent-to-Treat|Overall Study|All patients randomized who received at least one dose of study medication.|26
3015747|NCT01032837|3733859|FG002|Intent-to-Treat|Overall Study|All patients randomized who received at least one dose of study medication.|25
3015748|NCT01032837|3733860|FG003|Intent-to-Treat|Overall Study|All patients randomized who received at least one dose of study medication.|24
3015749|NCT01032837|3733857|FG000|COMPLETED|Overall Study|Represents patients who completed treatment.|26
3015750|NCT01032837|3733858|FG001|COMPLETED|Overall Study|Represents patients who completed treatment.|23
3015751|NCT01032837|3733859|FG002|COMPLETED|Overall Study|Represents patients who completed treatment.|24
3015752|NCT01032837|3733860|FG003|COMPLETED|Overall Study|Represents patients who completed treatment.|22
3015753|NCT01032837|3733857|FG000|NOT COMPLETED|Overall Study||0
3015754|NCT01032837|3733858|FG001|NOT COMPLETED|Overall Study||3
3015755|NCT01032837|3733859|FG002|NOT COMPLETED|Overall Study||1
3015756|NCT01032837|3733860|FG003|NOT COMPLETED|Overall Study||3
3015757|NCT01032850|3733870|FG000|STARTED|Overall Study||15
3015758|NCT01032850|3733870|FG000|COMPLETED|Overall Study||13
3015759|NCT01032850|3733870|FG000|NOT COMPLETED|Overall Study||2
3015760|NCT01032889|3733877|FG000|STARTED|Overall Study||41
3015761|NCT01032889|3733878|FG001|STARTED|Overall Study||43
3015762|NCT01032889|3733879|FG002|STARTED|Overall Study||45
3015763|NCT01032889|3733877|FG000|Received Treatment|Overall Study||41
3015764|NCT01032889|3733878|FG001|Received Treatment|Overall Study||43
3015765|NCT01032889|3733879|FG002|Received Treatment|Overall Study||45
3015766|NCT01032889|3733877|FG000|COMPLETED|Overall Study||33
3015767|NCT01032889|3733878|FG001|COMPLETED|Overall Study||28
3015768|NCT01032889|3733879|FG002|COMPLETED|Overall Study||42
3015769|NCT01032889|3733877|FG000|NOT COMPLETED|Overall Study||8
3015770|NCT01032889|3733878|FG001|NOT COMPLETED|Overall Study||15
3015771|NCT01032889|3733879|FG002|NOT COMPLETED|Overall Study||3
3015772|NCT01032915|3733891|FG000|STARTED|Overall Study||29
3015773|NCT01032915|3733892|FG001|STARTED|Overall Study||31
3015774|NCT01032915|3733893|FG002|STARTED|Overall Study||31
3015775|NCT01032915|3733894|FG003|STARTED|Overall Study||34
3015776|NCT01032915|3733891|FG000|COMPLETED|Overall Study||21
3015777|NCT01032915|3733892|FG001|COMPLETED|Overall Study||20
3015778|NCT01032915|3733893|FG002|COMPLETED|Overall Study||24
3015779|NCT01032915|3733894|FG003|COMPLETED|Overall Study||27
3015780|NCT01032915|3733891|FG000|NOT COMPLETED|Overall Study||8
3015781|NCT01032915|3733892|FG001|NOT COMPLETED|Overall Study||11
3015782|NCT01032915|3733893|FG002|NOT COMPLETED|Overall Study||7
3015783|NCT01032915|3733894|FG003|NOT COMPLETED|Overall Study||7
3015784|NCT01032928|3733904|FG000|STARTED|Overall Study||30
3015785|NCT01032928|3733904|FG000|COMPLETED|Overall Study||30
3015786|NCT01032928|3733904|FG000|NOT COMPLETED|Overall Study||0
3015787|NCT01032954|3733915|FG000|STARTED|Overall Study||30
3015788|NCT01032954|3733916|FG001|STARTED|Overall Study||30
3015789|NCT01032954|3733917|FG002|STARTED|Overall Study||30
3015790|NCT01032954|3733915|FG000|COMPLETED|Overall Study||26
3015791|NCT01032954|3733916|FG001|COMPLETED|Overall Study||29
3015792|NCT01032954|3733917|FG002|COMPLETED|Overall Study||30
3015793|NCT01032954|3733915|FG000|NOT COMPLETED|Overall Study||4
3015794|NCT01032954|3733916|FG001|NOT COMPLETED|Overall Study||1
3015795|NCT01032954|3733917|FG002|NOT COMPLETED|Overall Study||0
3015796|NCT01032993|3733927|FG000|STARTED|Overall Study||19
3015797|NCT01032993|3733928|FG001|STARTED|Overall Study||20
3015798|NCT01032993|3733927|FG000|COMPLETED|Overall Study||19
3015799|NCT01032993|3733928|FG001|COMPLETED|Overall Study||20
3015800|NCT01032993|3733927|FG000|NOT COMPLETED|Overall Study||0
3015801|NCT01032993|3733928|FG001|NOT COMPLETED|Overall Study||0
3015802|NCT01033019|3733936|FG000|STARTED|Overall Study||16
3015803|NCT01033019|3733937|FG001|STARTED|Overall Study||8
3015804|NCT01033019|3733936|FG000|COMPLETED|Overall Study||15
3015805|NCT01033019|3733937|FG001|COMPLETED|Overall Study||8
3015806|NCT01033019|3733936|FG000|NOT COMPLETED|Overall Study||1
3015807|NCT01033019|3733937|FG001|NOT COMPLETED|Overall Study||0
3015808|NCT01033032|3733944|FG000|STARTED|Phase I||3
3015809|NCT01033032|3733945|FG001|STARTED|Phase I||3
3015810|NCT01033032|3733946|FG002|STARTED|Phase I||3
3015811|NCT01033032|3733947|FG003|STARTED|Phase I||6
3015812|NCT01033032|3733944|FG000|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
3015813|NCT01033032|3733945|FG001|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
3015814|NCT01033032|3733946|FG002|COMPLETED|Phase I||3
3015815|NCT01033032|3733947|FG003|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
3015816|NCT01033032|3733944|FG000|NOT COMPLETED|Phase I||3
3015817|NCT01033032|3733945|FG001|NOT COMPLETED|Phase I||3
3015818|NCT01033032|3733946|FG002|NOT COMPLETED|Phase I||0
3015819|NCT01033032|3733947|FG003|NOT COMPLETED|Phase I||6
3015820|NCT01033032|3733944|FG000|STARTED|Phase II||0
3015821|NCT01033032|3733945|FG001|STARTED|Phase II||0
3015822|NCT01033032|3733946|FG002|STARTED|Phase II|Includes patients treated at MTD during Phase I (3 patients); 63 additional patients enrolled|66
3015823|NCT01033032|3733947|FG003|STARTED|Phase II||0
3015824|NCT01033032|3733944|FG000|COMPLETED|Phase II||0
3015825|NCT01033032|3733945|FG001|COMPLETED|Phase II||0
3015826|NCT01033032|3733946|FG002|COMPLETED|Phase II|Patients continued recieving treatment until disease progression or unacceptable toxicity|0
3015827|NCT01033032|3733947|FG003|COMPLETED|Phase II||0
3015828|NCT01033032|3733944|FG000|NOT COMPLETED|Phase II||0
3015829|NCT01033032|3733945|FG001|NOT COMPLETED|Phase II||0
3015830|NCT01033032|3733946|FG002|NOT COMPLETED|Phase II||66
3015831|NCT01033032|3733947|FG003|NOT COMPLETED|Phase II||0
3015832|NCT01033071|3733954|FG000|STARTED|Overall Study||355
3015833|NCT01033071|3733955|FG001|STARTED|Overall Study||352
3015834|NCT01033071|3733956|FG002|STARTED|Overall Study||364
3015835|NCT01033071|3733954|FG000|COMPLETED|Overall Study||300
3015836|NCT01033071|3733955|FG001|COMPLETED|Overall Study||275
3015837|NCT01033071|3733956|FG002|COMPLETED|Overall Study||317
3015838|NCT01033071|3733954|FG000|NOT COMPLETED|Overall Study||55
3015839|NCT01033071|3733955|FG001|NOT COMPLETED|Overall Study||77
3015840|NCT01033071|3733956|FG002|NOT COMPLETED|Overall Study||47
3015841|NCT01033136|3733966|FG000|STARTED|Baseline Assessment||36
3015842|NCT01033136|3733967|FG001|STARTED|Baseline Assessment||32
3015843|NCT01033136|3733966|FG000|COMPLETED|Baseline Assessment||30
3015844|NCT01033136|3733967|FG001|COMPLETED|Baseline Assessment||26
3015845|NCT01033136|3733966|FG000|NOT COMPLETED|Baseline Assessment||6
3015846|NCT01033136|3733967|FG001|NOT COMPLETED|Baseline Assessment||6
3015847|NCT01033136|3733966|FG000|STARTED|Post-Treatment (1 Week)||30
3015848|NCT01033136|3733967|FG001|STARTED|Post-Treatment (1 Week)||26
3015849|NCT01033136|3733966|FG000|COMPLETED|Post-Treatment (1 Week)||16
3015850|NCT01033136|3733967|FG001|COMPLETED|Post-Treatment (1 Week)||15
3015851|NCT01033136|3733966|FG000|NOT COMPLETED|Post-Treatment (1 Week)||14
3015852|NCT01033136|3733967|FG001|NOT COMPLETED|Post-Treatment (1 Week)||11
3015853|NCT01033136|3733966|FG000|STARTED|Follow-Up (3 Month)||16
3015854|NCT01033136|3733967|FG001|STARTED|Follow-Up (3 Month)||15
3015855|NCT01033136|3733966|FG000|COMPLETED|Follow-Up (3 Month)||14
3015856|NCT01033136|3733967|FG001|COMPLETED|Follow-Up (3 Month)||13
3015857|NCT01033136|3733966|FG000|NOT COMPLETED|Follow-Up (3 Month)||2
3015858|NCT01033136|3733967|FG001|NOT COMPLETED|Follow-Up (3 Month)||2
3015859|NCT01033227|3733977|FG000|STARTED|Overall Study||3
3015860|NCT01033227|3733978|FG001|STARTED|Overall Study||2
3015861|NCT01033227|3733977|FG000|COMPLETED|Overall Study||3
3015862|NCT01033227|3733978|FG001|COMPLETED|Overall Study||2
3015863|NCT01033227|3733977|FG000|NOT COMPLETED|Overall Study||0
3015864|NCT01033227|3733978|FG001|NOT COMPLETED|Overall Study||0
3015865|NCT01033240|3733989|FG000|STARTED|Overall Study||55
3015866|NCT01033240|3733990|FG001|STARTED|Overall Study||53
3015867|NCT01033240|3733991|FG002|STARTED|Overall Study||55
3015868|NCT01033240|3733989|FG000|COMPLETED|Overall Study||6
3015869|NCT01033240|3733990|FG001|COMPLETED|Overall Study||3
3015870|NCT01033240|3733991|FG002|COMPLETED|Overall Study||2
3015871|NCT01033240|3733989|FG000|NOT COMPLETED|Overall Study||49
3015872|NCT01033240|3733990|FG001|NOT COMPLETED|Overall Study||50
3015873|NCT01033240|3733991|FG002|NOT COMPLETED|Overall Study||53
3015874|NCT01033383|3734003|FG000|STARTED|Overall Study||20
3015875|NCT01033383|3734004|FG001|STARTED|Overall Study||20
3015876|NCT01033383|3734005|FG002|STARTED|Overall Study||20
3015877|NCT01033383|3734006|FG003|STARTED|Overall Study||20
3015878|NCT01033383|3734003|FG000|COMPLETED|Overall Study||20
3015879|NCT01033383|3734004|FG001|COMPLETED|Overall Study||20
3015880|NCT01033383|3734005|FG002|COMPLETED|Overall Study||20
3015881|NCT01033383|3734006|FG003|COMPLETED|Overall Study||20
3015882|NCT01033383|3734003|FG000|NOT COMPLETED|Overall Study||0
3015883|NCT01033383|3734004|FG001|NOT COMPLETED|Overall Study||0
3015884|NCT01033383|3734005|FG002|NOT COMPLETED|Overall Study||0
3015885|NCT01033383|3734006|FG003|NOT COMPLETED|Overall Study||0
3015886|NCT01033422|3734019|FG000|STARTED|Overall Study||34
3015887|NCT01033422|3734020|FG001|STARTED|Overall Study||32
3015888|NCT01033422|3734021|FG002|STARTED|Overall Study||23
3015889|NCT01033422|3734019|FG000|COMPLETED|Overall Study||33
3015890|NCT01033422|3734020|FG001|COMPLETED|Overall Study||28
3015891|NCT01033422|3734021|FG002|COMPLETED|Overall Study||22
3015892|NCT01033422|3734019|FG000|NOT COMPLETED|Overall Study||1
3015893|NCT01033422|3734020|FG001|NOT COMPLETED|Overall Study||4
3015894|NCT01033422|3734021|FG002|NOT COMPLETED|Overall Study||1
3015895|NCT01033448|3734029|FG000|STARTED|Overall Study||59
3015896|NCT01033448|3734029|FG000|COMPLETED|Overall Study||47
3015897|NCT01033448|3734029|FG000|NOT COMPLETED|Overall Study||12
3015898|NCT01033487|3734035|FG000|STARTED|First Intervention Period||2
3015899|NCT01033487|3734036|FG001|STARTED|First Intervention Period||3
3015900|NCT01033487|3734037|FG002|STARTED|First Intervention Period||2
3015901|NCT01033487|3734038|FG003|STARTED|First Intervention Period||2
3015902|NCT01033487|3734039|FG004|STARTED|First Intervention Period||2
3015903|NCT01033487|3734040|FG005|STARTED|First Intervention Period||2
3015904|NCT01033487|3734041|FG006|STARTED|First Intervention Period||2
3015905|NCT01033487|3734042|FG007|STARTED|First Intervention Period||3
3015906|NCT01033487|3734043|FG008|STARTED|First Intervention Period||2
3015907|NCT01033487|3734044|FG009|STARTED|First Intervention Period||2
3015908|NCT01033487|3734035|FG000|COMPLETED|First Intervention Period||2
3015909|NCT01033487|3734036|FG001|COMPLETED|First Intervention Period||3
3015910|NCT01033487|3734037|FG002|COMPLETED|First Intervention Period||2
3015911|NCT01033487|3734038|FG003|COMPLETED|First Intervention Period||2
3015912|NCT01033487|3734039|FG004|COMPLETED|First Intervention Period||2
3015913|NCT01033487|3734040|FG005|COMPLETED|First Intervention Period||2
3015914|NCT01033487|3734041|FG006|COMPLETED|First Intervention Period||2
3015915|NCT01033487|3734042|FG007|COMPLETED|First Intervention Period||3
3015916|NCT01033487|3734043|FG008|COMPLETED|First Intervention Period||2
3015917|NCT01033487|3734044|FG009|COMPLETED|First Intervention Period||2
3015918|NCT01033487|3734035|FG000|NOT COMPLETED|First Intervention Period||0
3015919|NCT01033487|3734036|FG001|NOT COMPLETED|First Intervention Period||0
3015920|NCT01033487|3734037|FG002|NOT COMPLETED|First Intervention Period||0
3015921|NCT01033487|3734038|FG003|NOT COMPLETED|First Intervention Period||0
3015922|NCT01033487|3734039|FG004|NOT COMPLETED|First Intervention Period||0
3015923|NCT01033487|3734040|FG005|NOT COMPLETED|First Intervention Period||0
3015924|NCT01033487|3734041|FG006|NOT COMPLETED|First Intervention Period||0
3015925|NCT01033487|3734042|FG007|NOT COMPLETED|First Intervention Period||0
3015926|NCT01033487|3734043|FG008|NOT COMPLETED|First Intervention Period||0
3015927|NCT01033487|3734044|FG009|NOT COMPLETED|First Intervention Period||0
3015928|NCT01033487|3734035|FG000|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
3015929|NCT01033487|3734036|FG001|STARTED|Between Period 1 and 2 (At Least 7 Days)||3
3015930|NCT01033487|3734037|FG002|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
3015931|NCT01033487|3734038|FG003|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
3015932|NCT01033487|3734039|FG004|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
3015933|NCT01033487|3734040|FG005|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
3015934|NCT01033487|3734041|FG006|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
3015935|NCT01033487|3734042|FG007|STARTED|Between Period 1 and 2 (At Least 7 Days)||3
3015936|NCT01033487|3734043|FG008|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
3015937|NCT01033487|3734044|FG009|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
3015938|NCT01033487|3734035|FG000|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
3015939|NCT01033487|3734036|FG001|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||3
3015940|NCT01033487|3734037|FG002|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
3015941|NCT01033487|3734038|FG003|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
3015942|NCT01033487|3734039|FG004|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
3015943|NCT01033487|3734040|FG005|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
3015944|NCT01033487|3734041|FG006|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
3015945|NCT01033487|3734042|FG007|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||3
3015946|NCT01033487|3734043|FG008|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
3015947|NCT01033487|3734044|FG009|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
3015948|NCT01033487|3734035|FG000|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
3015949|NCT01033487|3734036|FG001|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
3015950|NCT01033487|3734037|FG002|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
3015951|NCT01033487|3734038|FG003|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
3165419|NCT01898923|3892952|FG000|NOT COMPLETED|Overall Study||16
3165420|NCT01898923|3892953|FG001|NOT COMPLETED|Overall Study||21
3165421|NCT01899053|3892973|FG000|STARTED|Overall Study||7
3165422|NCT01899053|3892974|FG001|STARTED|Overall Study||3
3165423|NCT01899053|3892975|FG002|STARTED|Overall Study||7
3165424|NCT01899053|3892976|FG003|STARTED|Overall Study||3
3165425|NCT01899053|3892977|FG004|STARTED|Overall Study||6
3015952|NCT01033487|3734039|FG004|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
3015953|NCT01033487|3734040|FG005|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
3015954|NCT01033487|3734041|FG006|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
3015955|NCT01033487|3734042|FG007|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
3015956|NCT01033487|3734043|FG008|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
3015957|NCT01033487|3734044|FG009|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
3015958|NCT01033487|3734035|FG000|STARTED|Second Intervention Period||2
3165426|NCT01899053|3892978|FG005|STARTED|Overall Study||3
3015959|NCT01033487|3734036|FG001|STARTED|Second Intervention Period||3
3015960|NCT01033487|3734037|FG002|STARTED|Second Intervention Period||2
3015961|NCT01033487|3734038|FG003|STARTED|Second Intervention Period||2
3165427|NCT01899053|3892979|FG006|STARTED|Overall Study||3
3165428|NCT01899053|3892980|FG007|STARTED|Overall Study||3
3165429|NCT01899053|3892981|FG008|STARTED|Overall Study||6
3165430|NCT01899053|3892982|FG009|STARTED|Overall Study||3
3165431|NCT01899053|3892983|FG010|STARTED|Overall Study||16
3165432|NCT01899053|3892984|FG011|STARTED|Overall Study||7
3165433|NCT01899053|3892985|FG012|STARTED|Overall Study||14
3165434|NCT01899053|3892986|FG013|STARTED|Overall Study||20
3165435|NCT01899053|3892973|FG000|COMPLETED|Overall Study||0
3165436|NCT01899053|3892974|FG001|COMPLETED|Overall Study||0
3165437|NCT01899053|3892975|FG002|COMPLETED|Overall Study||0
3165438|NCT01899053|3892976|FG003|COMPLETED|Overall Study||0
3165439|NCT01899053|3892977|FG004|COMPLETED|Overall Study||0
3165440|NCT01899053|3892978|FG005|COMPLETED|Overall Study||0
3165441|NCT01899053|3892979|FG006|COMPLETED|Overall Study||0
3165442|NCT01899053|3892980|FG007|COMPLETED|Overall Study||0
3165443|NCT01899053|3892981|FG008|COMPLETED|Overall Study||0
3165444|NCT01899053|3892982|FG009|COMPLETED|Overall Study||0
3015962|NCT01033487|3734039|FG004|STARTED|Second Intervention Period||2
3015963|NCT01033487|3734040|FG005|STARTED|Second Intervention Period||2
3015964|NCT01033487|3734041|FG006|STARTED|Second Intervention Period||2
3015965|NCT01033487|3734042|FG007|STARTED|Second Intervention Period||3
3015966|NCT01033487|3734043|FG008|STARTED|Second Intervention Period||2
3015967|NCT01033487|3734044|FG009|STARTED|Second Intervention Period||2
3015968|NCT01033487|3734035|FG000|COMPLETED|Second Intervention Period||2
3015969|NCT01033487|3734036|FG001|COMPLETED|Second Intervention Period||3
3015970|NCT01033487|3734037|FG002|COMPLETED|Second Intervention Period||2
3015971|NCT01033487|3734038|FG003|COMPLETED|Second Intervention Period||2
3015972|NCT01033487|3734039|FG004|COMPLETED|Second Intervention Period||2
3015973|NCT01033487|3734040|FG005|COMPLETED|Second Intervention Period||2
3015974|NCT01033487|3734041|FG006|COMPLETED|Second Intervention Period||2
3015975|NCT01033487|3734042|FG007|COMPLETED|Second Intervention Period||3
3015976|NCT01033487|3734043|FG008|COMPLETED|Second Intervention Period||2
3015977|NCT01033487|3734044|FG009|COMPLETED|Second Intervention Period||2
3015978|NCT01033487|3734035|FG000|NOT COMPLETED|Second Intervention Period||0
3015979|NCT01033487|3734036|FG001|NOT COMPLETED|Second Intervention Period||0
3015980|NCT01033487|3734037|FG002|NOT COMPLETED|Second Intervention Period||0
3015981|NCT01033487|3734038|FG003|NOT COMPLETED|Second Intervention Period||0
3015982|NCT01033487|3734039|FG004|NOT COMPLETED|Second Intervention Period||0
3015983|NCT01033487|3734040|FG005|NOT COMPLETED|Second Intervention Period||0
3015984|NCT01033487|3734041|FG006|NOT COMPLETED|Second Intervention Period||0
3015985|NCT01033487|3734042|FG007|NOT COMPLETED|Second Intervention Period||0
3015986|NCT01033487|3734043|FG008|NOT COMPLETED|Second Intervention Period||0
3015987|NCT01033487|3734044|FG009|NOT COMPLETED|Second Intervention Period||0
3015988|NCT01033487|3734035|FG000|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
3015989|NCT01033487|3734036|FG001|STARTED|Between Period 2 and 3 (At Least 7 Days)||3
3015990|NCT01033487|3734037|FG002|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
3015991|NCT01033487|3734038|FG003|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
3015992|NCT01033487|3734039|FG004|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
3015993|NCT01033487|3734040|FG005|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
3015994|NCT01033487|3734041|FG006|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
3015995|NCT01033487|3734042|FG007|STARTED|Between Period 2 and 3 (At Least 7 Days)||3
3015996|NCT01033487|3734043|FG008|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
3015997|NCT01033487|3734044|FG009|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
3015998|NCT01033487|3734035|FG000|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
3015999|NCT01033487|3734036|FG001|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||3
3016000|NCT01033487|3734037|FG002|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
3016001|NCT01033487|3734038|FG003|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
3016002|NCT01033487|3734039|FG004|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
3016003|NCT01033487|3734040|FG005|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
3016004|NCT01033487|3734041|FG006|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
3016005|NCT01033487|3734042|FG007|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||3
3016006|NCT01033487|3734043|FG008|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
3016007|NCT01033487|3734044|FG009|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
3016008|NCT01033487|3734035|FG000|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
3016009|NCT01033487|3734036|FG001|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
3016010|NCT01033487|3734037|FG002|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
3016011|NCT01033487|3734038|FG003|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
3016012|NCT01033487|3734039|FG004|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
3016013|NCT01033487|3734040|FG005|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
3016014|NCT01033487|3734041|FG006|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
3016015|NCT01033487|3734042|FG007|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
3165445|NCT01899053|3892983|FG010|COMPLETED|Overall Study||0
3165446|NCT01899053|3892984|FG011|COMPLETED|Overall Study||0
3165447|NCT01899053|3892985|FG012|COMPLETED|Overall Study||0
3165448|NCT01899053|3892986|FG013|COMPLETED|Overall Study||0
3165449|NCT01899053|3892973|FG000|NOT COMPLETED|Overall Study||7
3016016|NCT01033487|3734043|FG008|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
3016017|NCT01033487|3734044|FG009|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
3016018|NCT01033487|3734035|FG000|STARTED|Third Intervention Period||2
3016019|NCT01033487|3734036|FG001|STARTED|Third Intervention Period||3
3016020|NCT01033487|3734037|FG002|STARTED|Third Intervention Period||2
3016021|NCT01033487|3734038|FG003|STARTED|Third Intervention Period||2
3016022|NCT01033487|3734039|FG004|STARTED|Third Intervention Period||2
3016023|NCT01033487|3734040|FG005|STARTED|Third Intervention Period||2
3016024|NCT01033487|3734041|FG006|STARTED|Third Intervention Period||2
3016025|NCT01033487|3734042|FG007|STARTED|Third Intervention Period||3
3016026|NCT01033487|3734043|FG008|STARTED|Third Intervention Period||2
3016027|NCT01033487|3734044|FG009|STARTED|Third Intervention Period||2
3016028|NCT01033487|3734035|FG000|COMPLETED|Third Intervention Period||2
3016029|NCT01033487|3734036|FG001|COMPLETED|Third Intervention Period||3
3016030|NCT01033487|3734037|FG002|COMPLETED|Third Intervention Period||2
3016031|NCT01033487|3734038|FG003|COMPLETED|Third Intervention Period||2
3016032|NCT01033487|3734039|FG004|COMPLETED|Third Intervention Period||2
3016033|NCT01033487|3734040|FG005|COMPLETED|Third Intervention Period||2
3016034|NCT01033487|3734041|FG006|COMPLETED|Third Intervention Period||2
3016035|NCT01033487|3734042|FG007|COMPLETED|Third Intervention Period||3
3016036|NCT01033487|3734043|FG008|COMPLETED|Third Intervention Period||2
3016037|NCT01033487|3734044|FG009|COMPLETED|Third Intervention Period||2
3016038|NCT01033487|3734035|FG000|NOT COMPLETED|Third Intervention Period||0
3016039|NCT01033487|3734036|FG001|NOT COMPLETED|Third Intervention Period||0
3016040|NCT01033487|3734037|FG002|NOT COMPLETED|Third Intervention Period||0
3016041|NCT01033487|3734038|FG003|NOT COMPLETED|Third Intervention Period||0
3016042|NCT01033487|3734039|FG004|NOT COMPLETED|Third Intervention Period||0
3016043|NCT01033487|3734040|FG005|NOT COMPLETED|Third Intervention Period||0
3016044|NCT01033487|3734041|FG006|NOT COMPLETED|Third Intervention Period||0
3016045|NCT01033487|3734042|FG007|NOT COMPLETED|Third Intervention Period||0
3016046|NCT01033487|3734043|FG008|NOT COMPLETED|Third Intervention Period||0
3016047|NCT01033487|3734044|FG009|NOT COMPLETED|Third Intervention Period||0
3016048|NCT01033487|3734035|FG000|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
3016049|NCT01033487|3734036|FG001|STARTED|Between Period 3 and 4 (At Least 7 Days)||3
3016050|NCT01033487|3734037|FG002|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
3016051|NCT01033487|3734038|FG003|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
3016052|NCT01033487|3734039|FG004|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
3016053|NCT01033487|3734040|FG005|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
3016054|NCT01033487|3734041|FG006|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
3016055|NCT01033487|3734042|FG007|STARTED|Between Period 3 and 4 (At Least 7 Days)||3
3016056|NCT01033487|3734043|FG008|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
3016057|NCT01033487|3734044|FG009|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
3016058|NCT01033487|3734035|FG000|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
3016059|NCT01033487|3734036|FG001|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||3
3016060|NCT01033487|3734037|FG002|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
3016061|NCT01033487|3734038|FG003|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
3016062|NCT01033487|3734039|FG004|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
3016063|NCT01033487|3734040|FG005|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
3016064|NCT01033487|3734041|FG006|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
3016065|NCT01033487|3734042|FG007|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||3
3016066|NCT01033487|3734043|FG008|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
3016067|NCT01033487|3734044|FG009|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
3016068|NCT01033487|3734035|FG000|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
3016069|NCT01033487|3734036|FG001|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
3016070|NCT01033487|3734037|FG002|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
3016071|NCT01033487|3734038|FG003|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
3016072|NCT01033487|3734039|FG004|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
3016073|NCT01033487|3734040|FG005|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
3016074|NCT01033487|3734041|FG006|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
3016075|NCT01033487|3734042|FG007|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
3016076|NCT01033487|3734043|FG008|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
3016077|NCT01033487|3734044|FG009|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
3016078|NCT01033487|3734035|FG000|STARTED|Fourth Intervention Period||2
3016079|NCT01033487|3734036|FG001|STARTED|Fourth Intervention Period||3
3016080|NCT01033487|3734037|FG002|STARTED|Fourth Intervention Period||2
3016081|NCT01033487|3734038|FG003|STARTED|Fourth Intervention Period||2
3016082|NCT01033487|3734039|FG004|STARTED|Fourth Intervention Period||2
3016083|NCT01033487|3734040|FG005|STARTED|Fourth Intervention Period||2
3016084|NCT01033487|3734041|FG006|STARTED|Fourth Intervention Period||2
3016085|NCT01033487|3734042|FG007|STARTED|Fourth Intervention Period||3
3016086|NCT01033487|3734043|FG008|STARTED|Fourth Intervention Period||2
3016087|NCT01033487|3734044|FG009|STARTED|Fourth Intervention Period||2
3016088|NCT01033487|3734035|FG000|COMPLETED|Fourth Intervention Period||2
3016089|NCT01033487|3734036|FG001|COMPLETED|Fourth Intervention Period||3
3016090|NCT01033487|3734037|FG002|COMPLETED|Fourth Intervention Period||2
3016091|NCT01033487|3734038|FG003|COMPLETED|Fourth Intervention Period||2
3133684|NCT01696942|3858598|FG000|COMPLETED|Overall Study||3
3016092|NCT01033487|3734039|FG004|COMPLETED|Fourth Intervention Period||2
3016093|NCT01033487|3734040|FG005|COMPLETED|Fourth Intervention Period||2
3016094|NCT01033487|3734041|FG006|COMPLETED|Fourth Intervention Period||2
3016095|NCT01033487|3734042|FG007|COMPLETED|Fourth Intervention Period||3
3016096|NCT01033487|3734043|FG008|COMPLETED|Fourth Intervention Period||1
3016097|NCT01033487|3734044|FG009|COMPLETED|Fourth Intervention Period||2
3016098|NCT01033487|3734035|FG000|NOT COMPLETED|Fourth Intervention Period||0
3016099|NCT01033487|3734036|FG001|NOT COMPLETED|Fourth Intervention Period||0
3016100|NCT01033487|3734037|FG002|NOT COMPLETED|Fourth Intervention Period||0
3016101|NCT01033487|3734038|FG003|NOT COMPLETED|Fourth Intervention Period||0
3016102|NCT01033487|3734039|FG004|NOT COMPLETED|Fourth Intervention Period||0
3016103|NCT01033487|3734040|FG005|NOT COMPLETED|Fourth Intervention Period||0
3016104|NCT01033487|3734041|FG006|NOT COMPLETED|Fourth Intervention Period||0
3016105|NCT01033487|3734042|FG007|NOT COMPLETED|Fourth Intervention Period||0
3016106|NCT01033487|3734043|FG008|NOT COMPLETED|Fourth Intervention Period||1
3016107|NCT01033487|3734044|FG009|NOT COMPLETED|Fourth Intervention Period||0
3016108|NCT01033487|3734035|FG000|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
3016109|NCT01033487|3734036|FG001|STARTED|Between Period 4 and 5 (At Least 7 Days)||3
3016110|NCT01033487|3734037|FG002|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
3016111|NCT01033487|3734038|FG003|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
3016112|NCT01033487|3734039|FG004|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
3016113|NCT01033487|3734040|FG005|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
3016114|NCT01033487|3734041|FG006|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
3016115|NCT01033487|3734042|FG007|STARTED|Between Period 4 and 5 (At Least 7 Days)||3
3016116|NCT01033487|3734043|FG008|STARTED|Between Period 4 and 5 (At Least 7 Days)||1
3016117|NCT01033487|3734044|FG009|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
3016118|NCT01033487|3734035|FG000|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
3016119|NCT01033487|3734036|FG001|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||3
3016120|NCT01033487|3734037|FG002|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
3016121|NCT01033487|3734038|FG003|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
3016122|NCT01033487|3734039|FG004|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
3016123|NCT01033487|3734040|FG005|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
3016124|NCT01033487|3734041|FG006|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
3016125|NCT01033487|3734042|FG007|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||3
3016126|NCT01033487|3734043|FG008|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||1
3016127|NCT01033487|3734044|FG009|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
3016128|NCT01033487|3734035|FG000|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
3016129|NCT01033487|3734036|FG001|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
3016130|NCT01033487|3734037|FG002|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
3016131|NCT01033487|3734038|FG003|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
3016132|NCT01033487|3734039|FG004|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
3016133|NCT01033487|3734040|FG005|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
3016134|NCT01033487|3734041|FG006|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
3016135|NCT01033487|3734042|FG007|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
3016136|NCT01033487|3734043|FG008|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
3016137|NCT01033487|3734044|FG009|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
3016138|NCT01033487|3734035|FG000|STARTED|Fifth Intervention Period||2
3016139|NCT01033487|3734036|FG001|STARTED|Fifth Intervention Period||3
3016140|NCT01033487|3734037|FG002|STARTED|Fifth Intervention Period||2
3016141|NCT01033487|3734038|FG003|STARTED|Fifth Intervention Period||2
3016142|NCT01033487|3734039|FG004|STARTED|Fifth Intervention Period||2
3016143|NCT01033487|3734040|FG005|STARTED|Fifth Intervention Period||2
3016144|NCT01033487|3734041|FG006|STARTED|Fifth Intervention Period||2
3016145|NCT01033487|3734042|FG007|STARTED|Fifth Intervention Period||3
3016146|NCT01033487|3734043|FG008|STARTED|Fifth Intervention Period||1
3016147|NCT01033487|3734044|FG009|STARTED|Fifth Intervention Period||2
3016148|NCT01033487|3734035|FG000|COMPLETED|Fifth Intervention Period||2
3016149|NCT01033487|3734036|FG001|COMPLETED|Fifth Intervention Period||3
3016150|NCT01033487|3734037|FG002|COMPLETED|Fifth Intervention Period||2
3016151|NCT01033487|3734038|FG003|COMPLETED|Fifth Intervention Period||2
3016152|NCT01033487|3734039|FG004|COMPLETED|Fifth Intervention Period||2
3016153|NCT01033487|3734040|FG005|COMPLETED|Fifth Intervention Period||2
3016154|NCT01033487|3734041|FG006|COMPLETED|Fifth Intervention Period||2
3016155|NCT01033487|3734042|FG007|COMPLETED|Fifth Intervention Period||3
3016156|NCT01033487|3734043|FG008|COMPLETED|Fifth Intervention Period||1
3016157|NCT01033487|3734044|FG009|COMPLETED|Fifth Intervention Period||2
3016158|NCT01033487|3734035|FG000|NOT COMPLETED|Fifth Intervention Period||0
3016159|NCT01033487|3734036|FG001|NOT COMPLETED|Fifth Intervention Period||0
3016160|NCT01033487|3734037|FG002|NOT COMPLETED|Fifth Intervention Period||0
3016161|NCT01033487|3734038|FG003|NOT COMPLETED|Fifth Intervention Period||0
3165450|NCT01899053|3892974|FG001|NOT COMPLETED|Overall Study||3
3165451|NCT01899053|3892975|FG002|NOT COMPLETED|Overall Study||7
3165452|NCT01899053|3892976|FG003|NOT COMPLETED|Overall Study||3
3016162|NCT01033487|3734039|FG004|NOT COMPLETED|Fifth Intervention Period||0
3016163|NCT01033487|3734040|FG005|NOT COMPLETED|Fifth Intervention Period||0
3016164|NCT01033487|3734041|FG006|NOT COMPLETED|Fifth Intervention Period||0
3016165|NCT01033487|3734042|FG007|NOT COMPLETED|Fifth Intervention Period||0
3165453|NCT01899053|3892977|FG004|NOT COMPLETED|Overall Study||6
3016166|NCT01033487|3734043|FG008|NOT COMPLETED|Fifth Intervention Period||0
3016167|NCT01033487|3734044|FG009|NOT COMPLETED|Fifth Intervention Period||0
3016168|NCT01033565|3734058|FG000|STARTED|Overall Study||1
3016169|NCT01033565|3734058|FG000|COMPLETED|Overall Study||1
3016170|NCT01033565|3734058|FG000|NOT COMPLETED|Overall Study||0
3016171|NCT01033643|3734067|FG000|STARTED|Overall Study||6
3016172|NCT01033643|3734068|FG001|STARTED|Overall Study||6
3016173|NCT01033643|3734069|FG002|STARTED|Overall Study||6
3016174|NCT01033643|3734070|FG003|STARTED|Overall Study||4
3016175|NCT01033643|3734071|FG004|STARTED|Overall Study||0
3016176|NCT01033643|3734072|FG005|STARTED|Overall Study||8
3016177|NCT01033643|3734067|FG000|COMPLETED|Overall Study||6
3016178|NCT01033643|3734068|FG001|COMPLETED|Overall Study||3
3016179|NCT01033643|3734069|FG002|COMPLETED|Overall Study||6
3016180|NCT01033643|3734070|FG003|COMPLETED|Overall Study||4
3016181|NCT01033643|3734071|FG004|COMPLETED|Overall Study||0
3016182|NCT01033643|3734072|FG005|COMPLETED|Overall Study||7
3016183|NCT01033643|3734067|FG000|NOT COMPLETED|Overall Study||0
3016184|NCT01033643|3734068|FG001|NOT COMPLETED|Overall Study||3
3016185|NCT01033643|3734069|FG002|NOT COMPLETED|Overall Study||0
3016186|NCT01033643|3734070|FG003|NOT COMPLETED|Overall Study||0
3016187|NCT01033643|3734071|FG004|NOT COMPLETED|Overall Study||0
3016188|NCT01033643|3734072|FG005|NOT COMPLETED|Overall Study||1
3016189|NCT01033734|3734086|FG000|STARTED|Overall Study||8
3016190|NCT01033734|3734086|FG000|COMPLETED|Overall Study||7
3016191|NCT01033734|3734086|FG000|NOT COMPLETED|Overall Study||1
3016192|NCT01033747|3734101|FG000|STARTED|Overall Study||51
3016193|NCT01033747|3734102|FG001|STARTED|Overall Study||19
3016194|NCT01033747|3734101|FG000|COMPLETED|Overall Study||14
3016195|NCT01033747|3734102|FG001|COMPLETED|Overall Study||4
3016196|NCT01033747|3734101|FG000|NOT COMPLETED|Overall Study||37
3016197|NCT01033747|3734102|FG001|NOT COMPLETED|Overall Study||15
3016198|NCT01033773|3734108|FG000|STARTED|Overall Study||86
3016199|NCT01033773|3734108|FG000|COMPLETED|Overall Study||51
3016200|NCT01033773|3734108|FG000|NOT COMPLETED|Overall Study||35
3016201|NCT01033825|3734119|FG000|STARTED|Overall Study||51
3016202|NCT01033825|3734120|FG001|STARTED|Overall Study||60
3016203|NCT01033825|3734121|FG002|STARTED|Overall Study||57
3016204|NCT01033825|3734122|FG003|STARTED|Overall Study||48
3016205|NCT01033825|3734123|FG004|STARTED|Overall Study||58
3016206|NCT01033825|3734124|FG005|STARTED|Overall Study||18
3016207|NCT01033825|3734125|FG006|STARTED|Overall Study||18
3016208|NCT01033825|3734119|FG000|COMPLETED|Overall Study||48
3016209|NCT01033825|3734120|FG001|COMPLETED|Overall Study||57
3016210|NCT01033825|3734121|FG002|COMPLETED|Overall Study||55
3016211|NCT01033825|3734122|FG003|COMPLETED|Overall Study||46
3016212|NCT01033825|3734123|FG004|COMPLETED|Overall Study||56
3016213|NCT01033825|3734124|FG005|COMPLETED|Overall Study||18
3016214|NCT01033825|3734125|FG006|COMPLETED|Overall Study||18
3016215|NCT01033825|3734119|FG000|NOT COMPLETED|Overall Study||3
3165454|NCT01899053|3892978|FG005|NOT COMPLETED|Overall Study||3
3165455|NCT01899053|3892979|FG006|NOT COMPLETED|Overall Study||3
3165456|NCT01899053|3892980|FG007|NOT COMPLETED|Overall Study||3
3165457|NCT01899053|3892981|FG008|NOT COMPLETED|Overall Study||6
3165458|NCT01899053|3892982|FG009|NOT COMPLETED|Overall Study||3
3165459|NCT01899053|3892983|FG010|NOT COMPLETED|Overall Study||16
3165460|NCT01899053|3892984|FG011|NOT COMPLETED|Overall Study||7
3016216|NCT01033825|3734120|FG001|NOT COMPLETED|Overall Study||3
3016217|NCT01033825|3734121|FG002|NOT COMPLETED|Overall Study||2
3016218|NCT01033825|3734122|FG003|NOT COMPLETED|Overall Study||2
3016219|NCT01033825|3734123|FG004|NOT COMPLETED|Overall Study||2
3016220|NCT01033825|3734124|FG005|NOT COMPLETED|Overall Study||0
3016221|NCT01033825|3734125|FG006|NOT COMPLETED|Overall Study||0
3016222|NCT01033851|3734145|FG000|STARTED|Overall Study||48
3016223|NCT01033851|3734146|FG001|STARTED|Overall Study||41
3016224|NCT01033851|3734145|FG000|COMPLETED|Overall Study||45
3016225|NCT01033851|3734146|FG001|COMPLETED|Overall Study||34
3016226|NCT01033851|3734145|FG000|NOT COMPLETED|Overall Study||3
3016227|NCT01033851|3734146|FG001|NOT COMPLETED|Overall Study||7
3016228|NCT01033864|3734154|FG000|STARTED|Overall Study||12
3016229|NCT01033864|3734155|FG001|STARTED|Overall Study||11
3016230|NCT01033864|3734154|FG000|COMPLETED|Overall Study||12
3016231|NCT01033864|3734155|FG001|COMPLETED|Overall Study||11
3016232|NCT01033864|3734154|FG000|NOT COMPLETED|Overall Study||0
3016233|NCT01033864|3734155|FG001|NOT COMPLETED|Overall Study||0
3016234|NCT01033942|3734164|FG000|STARTED|Overall Study||20
3016235|NCT01033942|3734165|FG001|STARTED|Overall Study||19
3016236|NCT01033942|3734166|FG002|STARTED|Overall Study||19
3016237|NCT01033942|3734164|FG000|COMPLETED|Overall Study||18
3016238|NCT01033942|3734165|FG001|COMPLETED|Overall Study||15
3016239|NCT01033942|3734166|FG002|COMPLETED|Overall Study||18
3016240|NCT01033942|3734164|FG000|NOT COMPLETED|Overall Study||2
3016241|NCT01033942|3734165|FG001|NOT COMPLETED|Overall Study||4
3016242|NCT01033942|3734166|FG002|NOT COMPLETED|Overall Study||1
3016243|NCT01034111|3734176|FG000|STARTED|Overall Study||30
3016244|NCT01034111|3734176|FG000|COMPLETED|Overall Study||30
3016245|NCT01034111|3734176|FG000|NOT COMPLETED|Overall Study||0
3016246|NCT01034137|3734183|FG000|STARTED|Overall Study||106
3016247|NCT01034137|3734184|FG001|STARTED|Overall Study||103
3016248|NCT01034137|3734185|FG002|STARTED|Overall Study||108
3016249|NCT01034137|3734183|FG000|COMPLETED|Overall Study||78
3016250|NCT01034137|3734184|FG001|COMPLETED|Overall Study||81
3165461|NCT01899053|3892985|FG012|NOT COMPLETED|Overall Study||14
3016251|NCT01034137|3734185|FG002|COMPLETED|Overall Study||78
3016252|NCT01034137|3734183|FG000|NOT COMPLETED|Overall Study||28
3016253|NCT01034137|3734184|FG001|NOT COMPLETED|Overall Study||22
3016254|NCT01034137|3734185|FG002|NOT COMPLETED|Overall Study||30
3016255|NCT01034163|3734196|FG000|STARTED|Overall Study||27
3016256|NCT01034163|3734197|FG001|STARTED|Overall Study||14
3016257|NCT01034163|3734196|FG000|Untreated (Not in Safety Set)|Overall Study||1
3016258|NCT01034163|3734197|FG001|Untreated (Not in Safety Set)|Overall Study||2
3016259|NCT01034163|3734196|FG000|Safety Set|Overall Study||26
3016260|NCT01034163|3734197|FG001|Safety Set|Overall Study||12
3016261|NCT01034163|3734196|FG000|In Open Label Phase After Unblinding|Overall Study||5
3016262|NCT01034163|3734197|FG001|In Open Label Phase After Unblinding|Overall Study||0
3016263|NCT01034163|3734196|FG000|COMPLETED|Overall Study||0
3016264|NCT01034163|3734197|FG001|COMPLETED|Overall Study||0
3016265|NCT01034163|3734196|FG000|NOT COMPLETED|Overall Study||27
3016266|NCT01034163|3734197|FG001|NOT COMPLETED|Overall Study||14
3016267|NCT01034176|3734205|FG000|STARTED|Overall Study||22
3016268|NCT01034176|3734206|FG001|STARTED|Overall Study||21
3016269|NCT01034176|3734205|FG000|COMPLETED|Overall Study||20
3016270|NCT01034176|3734206|FG001|COMPLETED|Overall Study||19
3016271|NCT01034176|3734205|FG000|NOT COMPLETED|Overall Study||2
3016272|NCT01034176|3734206|FG001|NOT COMPLETED|Overall Study||2
3016273|NCT01034306|3734214|FG000|STARTED|Overall Study||42
3016274|NCT01034306|3734215|FG001|STARTED|Overall Study||37
3016275|NCT01034306|3734214|FG000|COMPLETED|Overall Study||37
3016276|NCT01034306|3734215|FG001|COMPLETED|Overall Study||34
3016277|NCT01034306|3734214|FG000|NOT COMPLETED|Overall Study||5
3016278|NCT01034306|3734215|FG001|NOT COMPLETED|Overall Study||3
3016279|NCT01034358|3734221|FG000|STARTED|Overall Study||15
3016280|NCT01034358|3734221|FG000|COMPLETED|Overall Study|One patient was found after enrollment to have already received one prior dose of the HPV vaccine.|13
3016281|NCT01034358|3734221|FG000|NOT COMPLETED|Overall Study||2
3016282|NCT01034397|3734227|FG000|STARTED|Overall Study||35
3016283|NCT01034397|3734228|FG001|STARTED|Overall Study||19
3016284|NCT01034397|3734227|FG000|COMPLETED|Overall Study||28
3016285|NCT01034397|3734228|FG001|COMPLETED|Overall Study||17
3016286|NCT01034397|3734227|FG000|NOT COMPLETED|Overall Study||7
3016287|NCT01034397|3734228|FG001|NOT COMPLETED|Overall Study||2
3016288|NCT01034462|3734245|FG000|STARTED|Overall Study||217
3016289|NCT01034462|3734246|FG001|STARTED|Overall Study||217
3016290|NCT01034462|3734245|FG000|COMPLETED|Overall Study||172
3016291|NCT01034462|3734246|FG001|COMPLETED|Overall Study||163
3016292|NCT01034462|3734245|FG000|NOT COMPLETED|Overall Study||45
3016293|NCT01034462|3734246|FG001|NOT COMPLETED|Overall Study||54
3016294|NCT01034527|3734256|FG000|STARTED|Overall Study||307
3016295|NCT01034527|3734257|FG001|STARTED|Overall Study||216
3016296|NCT01034527|3734256|FG000|COMPLETED|Overall Study||307
3016297|NCT01034527|3734257|FG001|COMPLETED|Overall Study||216
3016298|NCT01034527|3734256|FG000|NOT COMPLETED|Overall Study||0
3016299|NCT01034527|3734257|FG001|NOT COMPLETED|Overall Study||0
3016300|NCT01034540|3734265|FG000|STARTED|Overall Study||11
3016301|NCT01034540|3734266|FG001|STARTED|Overall Study||12
3016302|NCT01034540|3734265|FG000|Completed 1st Treatment Intervention|Overall Study||11
3016303|NCT01034540|3734266|FG001|Completed 1st Treatment Intervention|Overall Study||11
3016304|NCT01034540|3734265|FG000|COMPLETED|Overall Study||11
3016305|NCT01034540|3734266|FG001|COMPLETED|Overall Study||11
3016306|NCT01034540|3734265|FG000|NOT COMPLETED|Overall Study||0
3016307|NCT01034540|3734266|FG001|NOT COMPLETED|Overall Study||1
3016308|NCT01034553|3734274|FG000|STARTED|Overall Study||3
3016309|NCT01034553|3734275|FG001|STARTED|Overall Study||4
3016310|NCT01034553|3734276|FG002|STARTED|Overall Study||3
3016311|NCT01034553|3734277|FG003|STARTED|Overall Study||3
3016312|NCT01034553|3734278|FG004|STARTED|Overall Study||6
3016313|NCT01034553|3734279|FG005|STARTED|Overall Study||7
3016314|NCT01034553|3734274|FG000|COMPLETED|Overall Study||3
3016315|NCT01034553|3734275|FG001|COMPLETED|Overall Study||4
3016316|NCT01034553|3734276|FG002|COMPLETED|Overall Study||3
3016317|NCT01034553|3734277|FG003|COMPLETED|Overall Study||3
3016318|NCT01034553|3734278|FG004|COMPLETED|Overall Study||6
3016319|NCT01034553|3734279|FG005|COMPLETED|Overall Study||7
3016320|NCT01034553|3734274|FG000|NOT COMPLETED|Overall Study||0
3016321|NCT01034553|3734275|FG001|NOT COMPLETED|Overall Study||0
3016322|NCT01034553|3734276|FG002|NOT COMPLETED|Overall Study||0
3016323|NCT01034553|3734277|FG003|NOT COMPLETED|Overall Study||0
3016324|NCT01034553|3734278|FG004|NOT COMPLETED|Overall Study||0
3016325|NCT01034553|3734279|FG005|NOT COMPLETED|Overall Study||0
3016326|NCT01034579|3734295|FG000|STARTED|Overall Study||158
3016327|NCT01034579|3734296|FG001|STARTED|Overall Study||166
3016328|NCT01034579|3734295|FG000|COMPLETED|Overall Study||158
3016329|NCT01034579|3734296|FG001|COMPLETED|Overall Study||166
3016330|NCT01034579|3734295|FG000|NOT COMPLETED|Overall Study||0
3016331|NCT01034579|3734296|FG001|NOT COMPLETED|Overall Study||0
3016332|NCT01034592|3734302|FG000|STARTED|Overall Study||2
3016333|NCT01034592|3734302|FG000|COMPLETED|Overall Study||2
3016334|NCT01034592|3734302|FG000|NOT COMPLETED|Overall Study||0
3016335|NCT01034631|3734310|FG000|STARTED|Phase I||15
3016336|NCT01034631|3734311|FG001|STARTED|Phase I|No Phase II Participants were enrolled during this time period|0
3016337|NCT01034631|3734312|FG002|STARTED|Phase I|No Phase II Participants were enrolled during this time period|0
3016338|NCT01034631|3734310|FG000|COMPLETED|Phase I||12
3016339|NCT01034631|3734311|FG001|COMPLETED|Phase I||0
3016340|NCT01034631|3734312|FG002|COMPLETED|Phase I||0
3016341|NCT01034631|3734310|FG000|NOT COMPLETED|Phase I||3
3016342|NCT01034631|3734311|FG001|NOT COMPLETED|Phase I||0
3016343|NCT01034631|3734312|FG002|NOT COMPLETED|Phase I||0
3016344|NCT01034631|3734310|FG000|STARTED|Phase II|No Phase I Participants were enrolled during this time period.|0
3016345|NCT01034631|3734311|FG001|STARTED|Phase II||70
3016346|NCT01034631|3734312|FG002|STARTED|Phase II||69
3016347|NCT01034631|3734310|FG000|COMPLETED|Phase II||0
3016348|NCT01034631|3734311|FG001|COMPLETED|Phase II||69
3016349|NCT01034631|3734312|FG002|COMPLETED|Phase II||67
3016350|NCT01034631|3734310|FG000|NOT COMPLETED|Phase II||0
3016351|NCT01034631|3734311|FG001|NOT COMPLETED|Phase II||1
3016352|NCT01034631|3734312|FG002|NOT COMPLETED|Phase II||2
3016353|NCT01034657|3734322|FG000|STARTED|Core Phase||34
3016354|NCT01034657|3734323|FG001|STARTED|Core Phase||0
3016355|NCT01034657|3734324|FG002|STARTED|Core Phase||0
3016356|NCT01034657|3734322|FG000|COMPLETED|Core Phase||20
3016357|NCT01034657|3734323|FG001|COMPLETED|Core Phase||0
3016358|NCT01034657|3734324|FG002|COMPLETED|Core Phase||0
3016359|NCT01034657|3734322|FG000|NOT COMPLETED|Core Phase||14
3016360|NCT01034657|3734323|FG001|NOT COMPLETED|Core Phase||0
3016361|NCT01034657|3734324|FG002|NOT COMPLETED|Core Phase||0
3016362|NCT01034657|3734322|FG000|STARTED|Randomized Phase||6
3016363|NCT01034657|3734323|FG001|STARTED|Randomized Phase||6
3016364|NCT01034657|3734324|FG002|STARTED|Randomized Phase||1
3016365|NCT01034657|3734322|FG000|COMPLETED|Randomized Phase||1
3016366|NCT01034657|3734323|FG001|COMPLETED|Randomized Phase||0
3016367|NCT01034657|3734324|FG002|COMPLETED|Randomized Phase||0
3016368|NCT01034657|3734322|FG000|NOT COMPLETED|Randomized Phase||5
3016369|NCT01034657|3734323|FG001|NOT COMPLETED|Randomized Phase||6
3016370|NCT01034657|3734324|FG002|NOT COMPLETED|Randomized Phase||1
3016371|NCT01034709|3734336|FG000|STARTED|Overall Study||53
3016372|NCT01034709|3734337|FG001|STARTED|Overall Study||58
3016373|NCT01034709|3734336|FG000|COMPLETED|Overall Study||44
3016374|NCT01034709|3734337|FG001|COMPLETED|Overall Study||42
3016375|NCT01034709|3734336|FG000|NOT COMPLETED|Overall Study||9
3016376|NCT01034709|3734337|FG001|NOT COMPLETED|Overall Study||16
3016377|NCT01035047|3734345|FG000|STARTED|Overall Study||52
3016378|NCT01035047|3734346|FG001|STARTED|Overall Study||53
3016379|NCT01035047|3734345|FG000|COMPLETED|Overall Study||52
3016380|NCT01035047|3734346|FG001|COMPLETED|Overall Study||53
3016381|NCT01035047|3734345|FG000|NOT COMPLETED|Overall Study||0
3016382|NCT01035047|3734346|FG001|NOT COMPLETED|Overall Study||0
3016383|NCT01035060|3734354|FG000|STARTED|Overall Study||39
3016384|NCT01035060|3734355|FG001|STARTED|Overall Study||29
3016385|NCT01035060|3734354|FG000|COMPLETED|Overall Study||15
3016386|NCT01035060|3734355|FG001|COMPLETED|Overall Study||15
3016387|NCT01035060|3734354|FG000|NOT COMPLETED|Overall Study||24
3016388|NCT01035060|3734355|FG001|NOT COMPLETED|Overall Study||14
3016389|NCT01035099|3734363|FG000|STARTED|Overall Study||18
3016390|NCT01035099|3734364|FG001|STARTED|Overall Study||22
3016391|NCT01035099|3734363|FG000|COMPLETED|Overall Study||18
3016392|NCT01035099|3734364|FG001|COMPLETED|Overall Study||22
3016393|NCT01035099|3734363|FG000|NOT COMPLETED|Overall Study||0
3016394|NCT01035099|3734364|FG001|NOT COMPLETED|Overall Study||0
3308271|NCT03019406|4041575|FG002|COMPLETED|PAP: up to 25 Weeks||5
3308272|NCT03019406|4041576|FG003|COMPLETED|PAP: up to 25 Weeks||6
3308273|NCT03019406|4041573|FG000|NOT COMPLETED|PAP: up to 25 Weeks||0
3308274|NCT03019406|4041574|FG001|NOT COMPLETED|PAP: up to 25 Weeks||0
3308275|NCT03019406|4041575|FG002|NOT COMPLETED|PAP: up to 25 Weeks||0
3308276|NCT03019406|4041576|FG003|NOT COMPLETED|PAP: up to 25 Weeks||0
3308277|NCT03019406|4041573|FG000|STARTED|ETP: Ongoing From Week 26||6
3308278|NCT03019406|4041574|FG001|STARTED|ETP: Ongoing From Week 26||5
3308279|NCT03019406|4041575|FG002|STARTED|ETP: Ongoing From Week 26||5
3308280|NCT03019406|4041576|FG003|STARTED|ETP: Ongoing From Week 26|Participants who completed PAP and accepted to receive avalglucosidase alfa treatment in ETP.|3
3308281|NCT03019406|4041573|FG000|COMPLETED|ETP: Ongoing From Week 26||0
3308282|NCT03019406|4041574|FG001|COMPLETED|ETP: Ongoing From Week 26||0
3308283|NCT03019406|4041575|FG002|COMPLETED|ETP: Ongoing From Week 26||0
3308284|NCT03019406|4041576|FG003|COMPLETED|ETP: Ongoing From Week 26||0
3308285|NCT03019406|4041573|FG000|NOT COMPLETED|ETP: Ongoing From Week 26||6
3308286|NCT03019406|4041574|FG001|NOT COMPLETED|ETP: Ongoing From Week 26||5
3308287|NCT03019406|4041575|FG002|NOT COMPLETED|ETP: Ongoing From Week 26||5
3308288|NCT03019406|4041576|FG003|NOT COMPLETED|ETP: Ongoing From Week 26||3
3308289|NCT03019458|4041591|FG000|STARTED|Overall Study||24
3308290|NCT03019458|4041592|FG001|STARTED|Overall Study||26
3308291|NCT03019458|4041591|FG000|COMPLETED|Overall Study||24
3308292|NCT03019458|4041592|FG001|COMPLETED|Overall Study||25
3308293|NCT03019458|4041591|FG000|NOT COMPLETED|Overall Study||0
3308294|NCT03019458|4041592|FG001|NOT COMPLETED|Overall Study||1
3308295|NCT03019549|4041600|FG000|STARTED|Period 1||42
3308296|NCT03019549|4041600|FG000|Received 1 Dose of Study Drug|Period 1||42
3308297|NCT03019549|4041600|FG000|COMPLETED|Period 1||42
3308298|NCT03019549|4041600|FG000|NOT COMPLETED|Period 1||0
3308299|NCT03019549|4041600|FG000|STARTED|Washout||42
3308300|NCT03019549|4041600|FG000|COMPLETED|Washout||31
3308301|NCT03019549|4041600|FG000|NOT COMPLETED|Washout||11
3308302|NCT03019549|4041600|FG000|STARTED|Period 2||31
3308303|NCT03019549|4041600|FG000|Received at Least 1 Dose of Study Drug|Period 2||29
3308304|NCT03019549|4041600|FG000|COMPLETED|Period 2||26
3016395|NCT01035138|3734374|FG000|STARTED|Overall Study||73
3016396|NCT01035138|3734375|FG001|STARTED|Overall Study||60
3016397|NCT01035138|3734376|FG002|STARTED|Overall Study||47
3016398|NCT01035138|3734374|FG000|COMPLETED|Overall Study||0
3016399|NCT01035138|3734375|FG001|COMPLETED|Overall Study||0
3016400|NCT01035138|3734376|FG002|COMPLETED|Overall Study||0
3016401|NCT01035138|3734374|FG000|NOT COMPLETED|Overall Study||73
3016402|NCT01035138|3734375|FG001|NOT COMPLETED|Overall Study||60
3016403|NCT01035138|3734376|FG002|NOT COMPLETED|Overall Study||47
3016404|NCT01035151|3734388|FG000|STARTED|Overall Study||209
3016405|NCT01035151|3734389|FG001|STARTED|Overall Study||200
3016406|NCT01035151|3734388|FG000|COMPLETED|Overall Study||188
3016407|NCT01035151|3734389|FG001|COMPLETED|Overall Study||185
3016408|NCT01035151|3734388|FG000|NOT COMPLETED|Overall Study||21
3016409|NCT01035151|3734389|FG001|NOT COMPLETED|Overall Study||15
3016410|NCT01035229|3734397|FG000|STARTED|Overall Study||362
3016411|NCT01035229|3734398|FG001|STARTED|Overall Study||184
3016412|NCT01035229|3734397|FG000|COMPLETED|Overall Study||0
3016413|NCT01035229|3734398|FG001|COMPLETED|Overall Study||0
3016414|NCT01035229|3734397|FG000|NOT COMPLETED|Overall Study||362
3016415|NCT01035229|3734398|FG001|NOT COMPLETED|Overall Study||184
3016416|NCT01035255|3734408|FG000|STARTED|Overall Study||4209
3016417|NCT01035255|3734409|FG001|STARTED|Overall Study||4233
3016418|NCT01035255|3734408|FG000|GCP Violations|Overall Study||18
3016419|NCT01035255|3734409|FG001|GCP Violations|Overall Study||19
3016420|NCT01035255|3734408|FG000|Mis-randomized|Overall Study||4
3016421|NCT01035255|3734409|FG001|Mis-randomized|Overall Study||2
3016422|NCT01035255|3734408|FG000|Full Analysis Set (FAS)|Overall Study|patents with GCP violation and mis-randomized are not included in FAS|4187
3016423|NCT01035255|3734409|FG001|Full Analysis Set (FAS)|Overall Study|patents with GCP violation and mis-randomized are not included in FAS|4212
3016424|NCT01035255|3734408|FG000|COMPLETED|Overall Study||3468
3016425|NCT01035255|3734409|FG001|COMPLETED|Overall Study||3371
3016426|NCT01035255|3734408|FG000|NOT COMPLETED|Overall Study||741
3016427|NCT01035255|3734409|FG001|NOT COMPLETED|Overall Study||862
3016428|NCT01035333|3734415|FG000|STARTED|Overall Study||19
3016429|NCT01035333|3734415|FG000|COMPLETED|Overall Study||9
3016430|NCT01035333|3734415|FG000|NOT COMPLETED|Overall Study||10
3016431|NCT01035346|3734421|FG000|STARTED|Overall Study||7
3016432|NCT01035346|3734422|FG001|STARTED|Overall Study||9
3016433|NCT01035346|3734421|FG000|COMPLETED|Overall Study||7
3016434|NCT01035346|3734422|FG001|COMPLETED|Overall Study||9
3016435|NCT01035346|3734421|FG000|NOT COMPLETED|Overall Study||0
3016436|NCT01035346|3734422|FG001|NOT COMPLETED|Overall Study||0
3016437|NCT01035463|3734430|FG000|STARTED|Overall Study||6
3016438|NCT01035463|3734431|FG001|STARTED|Overall Study||3
3016439|NCT01035463|3734432|FG002|STARTED|Overall Study||6
3016440|NCT01035463|3734433|FG003|STARTED|Overall Study||4
3016441|NCT01035463|3734434|FG004|STARTED|Overall Study||7
3016442|NCT01035463|3734435|FG005|STARTED|Overall Study||33
3016443|NCT01035463|3734430|FG000|COMPLETED|Overall Study||6
3016444|NCT01035463|3734431|FG001|COMPLETED|Overall Study||1
3016445|NCT01035463|3734432|FG002|COMPLETED|Overall Study||1
3016446|NCT01035463|3734433|FG003|COMPLETED|Overall Study||2
3016447|NCT01035463|3734434|FG004|COMPLETED|Overall Study||1
3016448|NCT01035463|3734435|FG005|COMPLETED|Overall Study||15
3016449|NCT01035463|3734430|FG000|NOT COMPLETED|Overall Study||0
3016450|NCT01035463|3734431|FG001|NOT COMPLETED|Overall Study||2
3016451|NCT01035463|3734432|FG002|NOT COMPLETED|Overall Study||5
3016452|NCT01035463|3734433|FG003|NOT COMPLETED|Overall Study||2
3016453|NCT01035463|3734434|FG004|NOT COMPLETED|Overall Study||6
3016454|NCT01035463|3734435|FG005|NOT COMPLETED|Overall Study||18
3016455|NCT01035606|3734445|FG000|STARTED|Overall Study||19
3016456|NCT01035606|3734446|FG001|STARTED|Overall Study||19
3016457|NCT01035606|3734447|FG002|STARTED|Overall Study||11
3016458|NCT01035606|3734445|FG000|COMPLETED|Overall Study||16
3016459|NCT01035606|3734446|FG001|COMPLETED|Overall Study||16
3016460|NCT01035606|3734447|FG002|COMPLETED|Overall Study||7
3016461|NCT01035606|3734445|FG000|NOT COMPLETED|Overall Study||3
3016462|NCT01035606|3734446|FG001|NOT COMPLETED|Overall Study||3
3016463|NCT01035606|3734447|FG002|NOT COMPLETED|Overall Study||4
3016464|NCT01035658|3734459|FG000|STARTED|Overall Study||5
3308305|NCT03019549|4041600|FG000|NOT COMPLETED|Period 2||5
3308306|NCT03019627|4041611|FG000|STARTED|Overall Study||100
3308307|NCT03019627|4041612|FG001|STARTED|Overall Study||50
3308308|NCT03019627|4041611|FG000|COMPLETED|Overall Study||85
3016465|NCT01035658|3734460|FG001|STARTED|Overall Study||8
3016466|NCT01035658|3734461|FG002|STARTED|Overall Study||3
3016467|NCT01035658|3734462|FG003|STARTED|Overall Study||6
3016468|NCT01035658|3734459|FG000|COMPLETED|Overall Study||5
3016469|NCT01035658|3734460|FG001|COMPLETED|Overall Study||8
3016470|NCT01035658|3734461|FG002|COMPLETED|Overall Study||3
3016471|NCT01035658|3734462|FG003|COMPLETED|Overall Study||6
3016472|NCT01035658|3734459|FG000|NOT COMPLETED|Overall Study||0
3016473|NCT01035658|3734460|FG001|NOT COMPLETED|Overall Study||0
3016474|NCT01035658|3734461|FG002|NOT COMPLETED|Overall Study||0
3016475|NCT01035658|3734462|FG003|NOT COMPLETED|Overall Study||0
3016476|NCT01035749|3734479|FG000|STARTED|Overall Study||66
3016477|NCT01035749|3734480|FG001|STARTED|Overall Study||66
3016478|NCT01035749|3734481|FG002|STARTED|Overall Study||68
3016479|NCT01035749|3734482|FG003|STARTED|Overall Study||110
3016480|NCT01035749|3734479|FG000|COMPLETED|Overall Study||66
3016481|NCT01035749|3734480|FG001|COMPLETED|Overall Study||66
3016482|NCT01035749|3734481|FG002|COMPLETED|Overall Study||68
3016483|NCT01035749|3734482|FG003|COMPLETED|Overall Study||110
3016484|NCT01035749|3734479|FG000|NOT COMPLETED|Overall Study||0
3016485|NCT01035749|3734480|FG001|NOT COMPLETED|Overall Study||0
3016486|NCT01035749|3734481|FG002|NOT COMPLETED|Overall Study||0
3016487|NCT01035749|3734482|FG003|NOT COMPLETED|Overall Study||0
3016488|NCT01035788|3734494|FG000|STARTED|Overall Study|23 couples = 23 Veterans + 23 partners; only data for Veterans will be included for primary outcome.|23
3016489|NCT01035788|3734495|FG001|STARTED|Overall Study|23 couples = 23 Veterans + 23 partners; only data for Veterans will be included for primary outcome.|23
3016490|NCT01035788|3734494|FG000|COMPLETED|Overall Study||17
3016491|NCT01035788|3734495|FG001|COMPLETED|Overall Study||9
3016492|NCT01035788|3734494|FG000|NOT COMPLETED|Overall Study||6
3016493|NCT01035788|3734495|FG001|NOT COMPLETED|Overall Study||14
3016494|NCT01035905|3734503|FG000|STARTED|Overall Study||32
3016495|NCT01035905|3734504|FG001|STARTED|Overall Study||31
3016496|NCT01035905|3734503|FG000|COMPLETED|Overall Study||31
3016497|NCT01035905|3734504|FG001|COMPLETED|Overall Study||30
3016498|NCT01035905|3734503|FG000|NOT COMPLETED|Overall Study||1
3016499|NCT01035905|3734504|FG001|NOT COMPLETED|Overall Study||1
3016500|NCT01036009|3734512|FG000|STARTED|Overall Study||17
3016501|NCT01036009|3734513|FG001|STARTED|Overall Study||26
3016502|NCT01036009|3734512|FG000|COMPLETED|Overall Study||17
3016503|NCT01036009|3734513|FG001|COMPLETED|Overall Study||26
3016504|NCT01036009|3734512|FG000|NOT COMPLETED|Overall Study||0
3016505|NCT01036009|3734513|FG001|NOT COMPLETED|Overall Study||0
3016506|NCT01036022|3734526|FG000|STARTED|Overall Study||15
3016507|NCT01036022|3734527|FG001|STARTED|Overall Study||11
3016508|NCT01036022|3734528|FG002|STARTED|Overall Study||12
3016509|NCT01036022|3734529|FG003|STARTED|Overall Study||12
3016510|NCT01036022|3734530|FG004|STARTED|Overall Study||12
3016511|NCT01036022|3734531|FG005|STARTED|Overall Study||16
3016512|NCT01036022|3734526|FG000|COMPLETED|Overall Study||13
3016513|NCT01036022|3734527|FG001|COMPLETED|Overall Study||7
3016514|NCT01036022|3734528|FG002|COMPLETED|Overall Study||8
3016515|NCT01036022|3734529|FG003|COMPLETED|Overall Study||10
3016516|NCT01036022|3734530|FG004|COMPLETED|Overall Study||9
3016517|NCT01036022|3734531|FG005|COMPLETED|Overall Study||13
3016518|NCT01036022|3734526|FG000|NOT COMPLETED|Overall Study||2
3016519|NCT01036022|3734527|FG001|NOT COMPLETED|Overall Study||4
3016520|NCT01036022|3734528|FG002|NOT COMPLETED|Overall Study||4
3016521|NCT01036022|3734529|FG003|NOT COMPLETED|Overall Study||2
3016522|NCT01036022|3734530|FG004|NOT COMPLETED|Overall Study||3
3016523|NCT01036022|3734531|FG005|NOT COMPLETED|Overall Study||3
3016524|NCT01036165|3734553|FG000|STARTED|Overall Study||103
3016525|NCT01036165|3734553|FG000|COMPLETED|Overall Study||88
3016526|NCT01036165|3734553|FG000|NOT COMPLETED|Overall Study||15
3016527|NCT01036321|3734559|FG000|STARTED|Overall Study||36
3016528|NCT01036321|3734560|FG001|STARTED|Overall Study||35
3016529|NCT01036321|3734559|FG000|COMPLETED|Overall Study||31
3016530|NCT01036321|3734560|FG001|COMPLETED|Overall Study||31
3016531|NCT01036321|3734559|FG000|NOT COMPLETED|Overall Study||5
3016532|NCT01036321|3734560|FG001|NOT COMPLETED|Overall Study||4
3016533|NCT01036438|3734568|FG000|STARTED|Overall Study||101
3016534|NCT01036438|3734569|FG001|STARTED|Overall Study||100
3016535|NCT01036438|3734568|FG000|COMPLETED|Overall Study||91
3016536|NCT01036438|3734569|FG001|COMPLETED|Overall Study||90
3016537|NCT01036438|3734568|FG000|NOT COMPLETED|Overall Study||10
3016538|NCT01036438|3734569|FG001|NOT COMPLETED|Overall Study||10
3016539|NCT01036490|3734577|FG000|STARTED|Overall Study||18
3016540|NCT01036490|3734578|FG001|STARTED|Overall Study||18
3016541|NCT01036490|3734577|FG000|COMPLETED|Overall Study||14
3016542|NCT01036490|3734578|FG001|COMPLETED|Overall Study||18
3016543|NCT01036490|3734577|FG000|NOT COMPLETED|Overall Study||4
3016544|NCT01036490|3734578|FG001|NOT COMPLETED|Overall Study||0
3016545|NCT01036529|3734586|FG000|STARTED|Overall Study||13
3016546|NCT01036529|3734587|FG001|STARTED|Overall Study||15
3016547|NCT01036529|3734586|FG000|Baseline Visit|Overall Study||10
3016548|NCT01036529|3734587|FG001|Baseline Visit|Overall Study||13
3016549|NCT01036529|3734586|FG000|Index Procedure|Overall Study|Index Procedure: Trial Stimulation|10
3016550|NCT01036529|3734587|FG001|Index Procedure|Overall Study|Index Procedure: Surgery|11
3016551|NCT01036529|3734586|FG000|3 Month Follow-up|Overall Study||7
3016552|NCT01036529|3734587|FG001|3 Month Follow-up|Overall Study||9
3016553|NCT01036529|3734586|FG000|6 Month Follow-up|Overall Study||6
3016554|NCT01036529|3734587|FG001|6 Month Follow-up|Overall Study||7
3016555|NCT01036529|3734586|FG000|12 Month Follow-up|Overall Study||4
3016556|NCT01036529|3734587|FG001|12 Month Follow-up|Overall Study||3
3016557|NCT01036529|3734586|FG000|Requested Crossover|Overall Study||1
3016558|NCT01036529|3734587|FG001|Requested Crossover|Overall Study||2
3016559|NCT01036529|3734586|FG000|Crossover to Other Group|Overall Study||1
3016560|NCT01036529|3734587|FG001|Crossover to Other Group|Overall Study||1
3016561|NCT01036529|3734586|FG000|COMPLETED|Overall Study||0
3016562|NCT01036529|3734587|FG001|COMPLETED|Overall Study||0
3016563|NCT01036529|3734586|FG000|NOT COMPLETED|Overall Study||13
3016564|NCT01036529|3734587|FG001|NOT COMPLETED|Overall Study||15
3308309|NCT03019627|4041612|FG001|COMPLETED|Overall Study||42
3308310|NCT03019627|4041611|FG000|NOT COMPLETED|Overall Study||15
3308311|NCT03019627|4041612|FG001|NOT COMPLETED|Overall Study||8
3308312|NCT03019744|4041620|FG000|STARTED|Overall Study||38
3016565|NCT01036594|3734593|FG000|STARTED|Run-In: Ketoconazole Only (200 mg)||32
3016566|NCT01036594|3734594|FG001|STARTED|Run-In: Ketoconazole Only (200 mg)|Dexamethasone not introduced as treatment option until after Week 12 evaluation|0
3016567|NCT01036594|3734593|FG000|COMPLETED|Run-In: Ketoconazole Only (200 mg)||31
3016568|NCT01036594|3734594|FG001|COMPLETED|Run-In: Ketoconazole Only (200 mg)||0
3016569|NCT01036594|3734593|FG000|NOT COMPLETED|Run-In: Ketoconazole Only (200 mg)||1
3016570|NCT01036594|3734594|FG001|NOT COMPLETED|Run-In: Ketoconazole Only (200 mg)||0
3016571|NCT01036594|3734593|FG000|STARTED|First Treatment Regimen||31
3016572|NCT01036594|3734594|FG001|STARTED|First Treatment Regimen|Dexamethasone not introduced as treatment option until after Week 12 evaluation|0
3016573|NCT01036594|3734593|FG000|COMPLETED|First Treatment Regimen||30
3016574|NCT01036594|3734594|FG001|COMPLETED|First Treatment Regimen||0
3016575|NCT01036594|3734593|FG000|NOT COMPLETED|First Treatment Regimen||1
3016576|NCT01036594|3734594|FG001|NOT COMPLETED|First Treatment Regimen||0
3016577|NCT01036594|3734593|FG000|STARTED|Week 12 Evaluation||30
3016578|NCT01036594|3734594|FG001|STARTED|Week 12 Evaluation|Dexamethasone not introduced as treatment option until after Week 12 evaluation|0
3016579|NCT01036594|3734593|FG000|COMPLETED|Week 12 Evaluation||24
3016580|NCT01036594|3734594|FG001|COMPLETED|Week 12 Evaluation||0
3016581|NCT01036594|3734593|FG000|NOT COMPLETED|Week 12 Evaluation||6
3016582|NCT01036594|3734594|FG001|NOT COMPLETED|Week 12 Evaluation||0
3016583|NCT01036594|3734593|FG000|STARTED|Treatment Regiments Post Week 12||15
3016584|NCT01036594|3734594|FG001|STARTED|Treatment Regiments Post Week 12||9
3016585|NCT01036594|3734593|FG000|COMPLETED|Treatment Regiments Post Week 12||13
3016586|NCT01036594|3734594|FG001|COMPLETED|Treatment Regiments Post Week 12||5
3016587|NCT01036594|3734593|FG000|NOT COMPLETED|Treatment Regiments Post Week 12||2
3016588|NCT01036594|3734594|FG001|NOT COMPLETED|Treatment Regiments Post Week 12||4
3016589|NCT01036724|3734602|FG000|STARTED|Overall Study||52
3016590|NCT01036724|3734603|FG001|STARTED|Overall Study||55
3016591|NCT01036724|3734602|FG000|COMPLETED|Overall Study||46
3016592|NCT01036724|3734603|FG001|COMPLETED|Overall Study||47
3016593|NCT01036724|3734602|FG000|NOT COMPLETED|Overall Study||6
3016594|NCT01036724|3734603|FG001|NOT COMPLETED|Overall Study||8
3016595|NCT01036763|3734609|FG000|STARTED|Overall Study||1264
3016596|NCT01036763|3734609|FG000|COMPLETED|Overall Study||1171
3016597|NCT01036763|3734609|FG000|NOT COMPLETED|Overall Study||93
3016598|NCT01036802|3734615|FG000|STARTED|Overall Study||2
3016599|NCT01036802|3734616|FG001|STARTED|Overall Study||1
3016600|NCT01036802|3734615|FG000|COMPLETED|Overall Study||2
3016601|NCT01036802|3734616|FG001|COMPLETED|Overall Study|Patient was taken off study after 7 months as she required hip replacement surgery.|1
3016602|NCT01036802|3734615|FG000|NOT COMPLETED|Overall Study||0
3016603|NCT01036802|3734616|FG001|NOT COMPLETED|Overall Study||0
3016604|NCT01037088|3734623|FG000|STARTED|Overall Study||39
3016605|NCT01037088|3734623|FG000|Received 3.53% THC|Overall Study||36
3016606|NCT01037088|3734623|FG000|Received 1.29% THC|Overall Study||37
3016607|NCT01037088|3734623|FG000|Received Placebo|Overall Study||38
3016608|NCT01037088|3734623|FG000|COMPLETED|Overall Study||36
3016609|NCT01037088|3734623|FG000|NOT COMPLETED|Overall Study||3
3016610|NCT01037114|3734632|FG000|STARTED|Year 16||49
3016611|NCT01037114|3734632|FG000|COMPLETED|Year 16||49
3016612|NCT01037114|3734632|FG000|NOT COMPLETED|Year 16||0
3016613|NCT01037114|3734632|FG000|STARTED|Year 17||48
3016614|NCT01037114|3734632|FG000|COMPLETED|Year 17||48
3016615|NCT01037114|3734632|FG000|NOT COMPLETED|Year 17||0
3016616|NCT01037114|3734632|FG000|STARTED|Year 18||44
3016617|NCT01037114|3734632|FG000|COMPLETED|Year 18||44
3016618|NCT01037114|3734632|FG000|NOT COMPLETED|Year 18||0
3016619|NCT01037114|3734632|FG000|STARTED|Year 19||45
3016620|NCT01037114|3734632|FG000|COMPLETED|Year 19||45
3016621|NCT01037114|3734632|FG000|NOT COMPLETED|Year 19||0
3016622|NCT01037114|3734632|FG000|STARTED|Year 20||45
3016623|NCT01037114|3734632|FG000|COMPLETED|Year 20|One subject returned at Y20 but did not do lab test because subject met a study exclusion criteria.|44
3016624|NCT01037114|3734632|FG000|NOT COMPLETED|Year 20||1
3016625|NCT01037127|3734638|FG000|STARTED|Overall Study||40
3016626|NCT01037127|3734639|FG001|STARTED|Overall Study||57
3016627|NCT01037127|3734638|FG000|COMPLETED|Overall Study||35
3016628|NCT01037127|3734639|FG001|COMPLETED|Overall Study||36
3016629|NCT01037127|3734638|FG000|NOT COMPLETED|Overall Study||5
3016630|NCT01037127|3734639|FG001|NOT COMPLETED|Overall Study||21
3016631|NCT01037192|3734657|FG000|STARTED|Overall Study||3
3016632|NCT01037192|3734658|FG001|STARTED|Overall Study||1
3016633|NCT01037192|3734657|FG000|COMPLETED|Overall Study||3
3016634|NCT01037192|3734658|FG001|COMPLETED|Overall Study||1
3016635|NCT01037192|3734657|FG000|NOT COMPLETED|Overall Study||0
3016636|NCT01037192|3734658|FG001|NOT COMPLETED|Overall Study||0
3016637|NCT01037218|3734670|FG000|STARTED|Overall Study||147
3016638|NCT01037218|3734671|FG001|STARTED|Overall Study||149
3016639|NCT01037218|3734672|FG002|STARTED|Overall Study||155
3016640|NCT01037218|3734673|FG003|STARTED|Overall Study||150
3016641|NCT01037218|3734670|FG000|Safety Population|Overall Study||147
3016642|NCT01037218|3734671|FG001|Safety Population|Overall Study||148
3016643|NCT01037218|3734672|FG002|Safety Population|Overall Study||154
3016644|NCT01037218|3734673|FG003|Safety Population|Overall Study||150
3016645|NCT01037218|3734670|FG000|mITT Population|Overall Study||141
3016646|NCT01037218|3734671|FG001|mITT Population|Overall Study||140
3016647|NCT01037218|3734672|FG002|mITT Population|Overall Study||147
3016648|NCT01037218|3734673|FG003|mITT Population|Overall Study||141
3016649|NCT01037218|3734670|FG000|COMPLETED|Overall Study||131
3016650|NCT01037218|3734671|FG001|COMPLETED|Overall Study||128
3016651|NCT01037218|3734672|FG002|COMPLETED|Overall Study||134
3016652|NCT01037218|3734673|FG003|COMPLETED|Overall Study||134
3016653|NCT01037218|3734670|FG000|NOT COMPLETED|Overall Study||16
3016654|NCT01037218|3734671|FG001|NOT COMPLETED|Overall Study||21
3016655|NCT01037218|3734672|FG002|NOT COMPLETED|Overall Study||21
3016656|NCT01037218|3734673|FG003|NOT COMPLETED|Overall Study||16
3016657|NCT01037244|3734687|FG000|STARTED|Overall Study||154
3016658|NCT01037244|3734688|FG001|STARTED|Overall Study||152
3016659|NCT01037244|3734689|FG002|STARTED|Overall Study||158
3016660|NCT01037244|3734690|FG003|STARTED|Overall Study||154
3016661|NCT01037244|3734687|FG000|mITT (Modified Intent-to-Treat)|Overall Study||150
3016662|NCT01037244|3734688|FG001|mITT (Modified Intent-to-Treat)|Overall Study||148
3016663|NCT01037244|3734689|FG002|mITT (Modified Intent-to-Treat)|Overall Study||154
3016664|NCT01037244|3734690|FG003|mITT (Modified Intent-to-Treat)|Overall Study||153
3016665|NCT01037244|3734687|FG000|Safety Population|Overall Study|Two subjects randomized to receive placebo inadvertently received udenafil (1 - 50 mg and 1- 150 mg)|155
3016666|NCT01037244|3734688|FG001|Safety Population|Overall Study||150
3016667|NCT01037244|3734689|FG002|Safety Population|Overall Study|Two subjects randomized to receive placebo inadvertently received udenafil (1 - 50 mg and 1- 150 mg)|159
3016668|NCT01037244|3734690|FG003|Safety Population|Overall Study||152
3016669|NCT01037244|3734687|FG000|COMPLETED|Overall Study||141
3016670|NCT01037244|3734688|FG001|COMPLETED|Overall Study||138
3165462|NCT01899053|3892986|FG013|NOT COMPLETED|Overall Study||20
3165463|NCT01899300|3893018|FG000|STARTED|Overall Study||1
3165464|NCT01899300|3893019|FG001|STARTED|Overall Study||0
3016671|NCT01037244|3734689|FG002|COMPLETED|Overall Study||144
3016672|NCT01037244|3734690|FG003|COMPLETED|Overall Study||140
3016673|NCT01037244|3734687|FG000|NOT COMPLETED|Overall Study||13
3016674|NCT01037244|3734688|FG001|NOT COMPLETED|Overall Study||14
3016675|NCT01037244|3734689|FG002|NOT COMPLETED|Overall Study||14
3016676|NCT01037244|3734690|FG003|NOT COMPLETED|Overall Study||14
3037610|NCT01149096|3756912|FG000|NOT COMPLETED|Overall Study||0
3037611|NCT01149096|3756913|FG001|NOT COMPLETED|Overall Study||1
3037612|NCT01149148|3756922|FG000|STARTED|Overall Study||12
3037613|NCT01149148|3756923|FG001|STARTED|Overall Study||13
3037614|NCT01149148|3756922|FG000|COMPLETED|Overall Study||10
3037615|NCT01149148|3756923|FG001|COMPLETED|Overall Study||11
3037616|NCT01149148|3756922|FG000|NOT COMPLETED|Overall Study||2
3037617|NCT01149148|3756923|FG001|NOT COMPLETED|Overall Study||2
3037618|NCT01149343|3756934|FG000|STARTED|Overall Study||20
3037619|NCT01149343|3756935|FG001|STARTED|Overall Study||24
3037620|NCT01149343|3756936|FG002|STARTED|Overall Study||22
3037621|NCT01149343|3756937|FG003|STARTED|Overall Study||40
3037622|NCT01149343|3756934|FG000|COMPLETED|Overall Study||0
3037623|NCT01149343|3756935|FG001|COMPLETED|Overall Study||0
3037624|NCT01149343|3756936|FG002|COMPLETED|Overall Study||0
3037625|NCT01149343|3756937|FG003|COMPLETED|Overall Study||0
3037626|NCT01149343|3756934|FG000|NOT COMPLETED|Overall Study||20
3037627|NCT01149343|3756935|FG001|NOT COMPLETED|Overall Study||24
3037628|NCT01149343|3756936|FG002|NOT COMPLETED|Overall Study||22
3037629|NCT01149343|3756937|FG003|NOT COMPLETED|Overall Study||40
3037630|NCT01149369|3756953|FG000|STARTED|Overall Study||63
3037631|NCT01149369|3756954|FG001|STARTED|Overall Study||63
3037632|NCT01149369|3756953|FG000|COMPLETED|Overall Study||57
3037633|NCT01149369|3756954|FG001|COMPLETED|Overall Study||60
3037634|NCT01149369|3756953|FG000|NOT COMPLETED|Overall Study||6
3037635|NCT01149369|3756954|FG001|NOT COMPLETED|Overall Study||3
3037636|NCT01149421|3756963|FG000|STARTED|Overall Study||251
3037637|NCT01149421|3756964|FG001|STARTED|Overall Study||254
3037638|NCT01149421|3756965|FG002|STARTED|Overall Study||250
3037639|NCT01149421|3756963|FG000|Received at Least One Dose of Study Drug|Overall Study||251
3037640|NCT01149421|3756964|FG001|Received at Least One Dose of Study Drug|Overall Study||254
3037641|NCT01149421|3756965|FG002|Received at Least One Dose of Study Drug|Overall Study||250
3037642|NCT01149421|3756963|FG000|COMPLETED|Overall Study||199
3037643|NCT01149421|3756964|FG001|COMPLETED|Overall Study||225
3037644|NCT01149421|3756965|FG002|COMPLETED|Overall Study||206
3037645|NCT01149421|3756963|FG000|NOT COMPLETED|Overall Study||52
3037646|NCT01149421|3756964|FG001|NOT COMPLETED|Overall Study||29
3037647|NCT01149421|3756965|FG002|NOT COMPLETED|Overall Study||44
3037648|NCT01149434|3756975|FG000|STARTED|Overall Study||4
3037649|NCT01149434|3756976|FG001|STARTED|Overall Study||15
3037650|NCT01149434|3756975|FG000|COMPLETED|Overall Study||4
3165465|NCT01899300|3893018|FG000|COMPLETED|Overall Study||1
3165466|NCT01899300|3893019|FG001|COMPLETED|Overall Study||0
3037651|NCT01149434|3756976|FG001|COMPLETED|Overall Study||10
3037652|NCT01149434|3756975|FG000|NOT COMPLETED|Overall Study||0
3037653|NCT01149434|3756976|FG001|NOT COMPLETED|Overall Study||5
3037654|NCT01149460|3756985|FG000|STARTED|Overall Study||18
3037655|NCT01149460|3756986|FG001|STARTED|Overall Study||18
3037656|NCT01149460|3756985|FG000|COMPLETED|Overall Study||18
3037657|NCT01149460|3756986|FG001|COMPLETED|Overall Study||16
3037658|NCT01149460|3756985|FG000|NOT COMPLETED|Overall Study||0
3037659|NCT01149460|3756986|FG001|NOT COMPLETED|Overall Study||2
3037660|NCT01149473|3756994|FG000|STARTED|First Intervention||40
3037661|NCT01149473|3756995|FG001|STARTED|First Intervention||40
3037662|NCT01149473|3756994|FG000|COMPLETED|First Intervention||39
3037663|NCT01149473|3756995|FG001|COMPLETED|First Intervention||39
3037664|NCT01149473|3756994|FG000|NOT COMPLETED|First Intervention||1
3037665|NCT01149473|3756995|FG001|NOT COMPLETED|First Intervention||1
3037666|NCT01149473|3756994|FG000|STARTED|Washout of 7 Days||39
3037667|NCT01149473|3756995|FG001|STARTED|Washout of 7 Days||39
3037668|NCT01149473|3756994|FG000|COMPLETED|Washout of 7 Days||38
3037669|NCT01149473|3756995|FG001|COMPLETED|Washout of 7 Days||38
3037670|NCT01149473|3756994|FG000|NOT COMPLETED|Washout of 7 Days||1
3016677|NCT01037309|3734706|FG000|STARTED|Subcutaneous Cohort 1 - 6||3
3016678|NCT01037309|3734707|FG001|STARTED|Subcutaneous Cohort 1 - 6||3
3016679|NCT01037309|3734708|FG002|STARTED|Subcutaneous Cohort 1 - 6||3
3016680|NCT01037309|3734709|FG003|STARTED|Subcutaneous Cohort 1 - 6||3
3016681|NCT01037309|3734710|FG004|STARTED|Subcutaneous Cohort 1 - 6||3
3016682|NCT01037309|3734711|FG005|STARTED|Subcutaneous Cohort 1 - 6||3
3016683|NCT01037309|3734712|FG006|STARTED|Subcutaneous Cohort 1 - 6||0
3016684|NCT01037309|3734713|FG007|STARTED|Subcutaneous Cohort 1 - 6||0
3016685|NCT01037309|3734714|FG008|STARTED|Subcutaneous Cohort 1 - 6||0
3016686|NCT01037309|3734706|FG000|COMPLETED|Subcutaneous Cohort 1 - 6||3
3016687|NCT01037309|3734707|FG001|COMPLETED|Subcutaneous Cohort 1 - 6||3
3016688|NCT01037309|3734708|FG002|COMPLETED|Subcutaneous Cohort 1 - 6||3
3016689|NCT01037309|3734709|FG003|COMPLETED|Subcutaneous Cohort 1 - 6||3
3016690|NCT01037309|3734710|FG004|COMPLETED|Subcutaneous Cohort 1 - 6||3
3016691|NCT01037309|3734711|FG005|COMPLETED|Subcutaneous Cohort 1 - 6||3
3016692|NCT01037309|3734712|FG006|COMPLETED|Subcutaneous Cohort 1 - 6||0
3016693|NCT01037309|3734713|FG007|COMPLETED|Subcutaneous Cohort 1 - 6||0
3016694|NCT01037309|3734714|FG008|COMPLETED|Subcutaneous Cohort 1 - 6||0
3016695|NCT01037309|3734706|FG000|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
3016696|NCT01037309|3734707|FG001|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
3016697|NCT01037309|3734708|FG002|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
3016698|NCT01037309|3734709|FG003|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
3016699|NCT01037309|3734710|FG004|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
3016700|NCT01037309|3734711|FG005|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
3016701|NCT01037309|3734712|FG006|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
3016702|NCT01037309|3734713|FG007|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
3016703|NCT01037309|3734714|FG008|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
3016704|NCT01037309|3734706|FG000|STARTED|Intravenous Period 7 - 9||0
3016705|NCT01037309|3734707|FG001|STARTED|Intravenous Period 7 - 9||0
3016706|NCT01037309|3734708|FG002|STARTED|Intravenous Period 7 - 9||0
3016707|NCT01037309|3734709|FG003|STARTED|Intravenous Period 7 - 9||0
3016708|NCT01037309|3734710|FG004|STARTED|Intravenous Period 7 - 9||0
3016709|NCT01037309|3734711|FG005|STARTED|Intravenous Period 7 - 9||0
3016710|NCT01037309|3734712|FG006|STARTED|Intravenous Period 7 - 9||3
3016711|NCT01037309|3734713|FG007|STARTED|Intravenous Period 7 - 9||3
3016712|NCT01037309|3734714|FG008|STARTED|Intravenous Period 7 - 9||3
3016713|NCT01037309|3734706|FG000|COMPLETED|Intravenous Period 7 - 9||0
3016714|NCT01037309|3734707|FG001|COMPLETED|Intravenous Period 7 - 9||0
3016715|NCT01037309|3734708|FG002|COMPLETED|Intravenous Period 7 - 9||0
3016716|NCT01037309|3734709|FG003|COMPLETED|Intravenous Period 7 - 9||0
3016717|NCT01037309|3734710|FG004|COMPLETED|Intravenous Period 7 - 9||0
3016718|NCT01037309|3734711|FG005|COMPLETED|Intravenous Period 7 - 9||0
3016719|NCT01037309|3734712|FG006|COMPLETED|Intravenous Period 7 - 9||3
3016720|NCT01037309|3734713|FG007|COMPLETED|Intravenous Period 7 - 9||3
3016721|NCT01037309|3734714|FG008|COMPLETED|Intravenous Period 7 - 9||3
3016722|NCT01037309|3734706|FG000|NOT COMPLETED|Intravenous Period 7 - 9||0
3016723|NCT01037309|3734707|FG001|NOT COMPLETED|Intravenous Period 7 - 9||0
3016724|NCT01037309|3734708|FG002|NOT COMPLETED|Intravenous Period 7 - 9||0
3016725|NCT01037309|3734709|FG003|NOT COMPLETED|Intravenous Period 7 - 9||0
3016726|NCT01037309|3734710|FG004|NOT COMPLETED|Intravenous Period 7 - 9||0
3016727|NCT01037309|3734711|FG005|NOT COMPLETED|Intravenous Period 7 - 9||0
3016728|NCT01037309|3734712|FG006|NOT COMPLETED|Intravenous Period 7 - 9||0
3016729|NCT01037309|3734713|FG007|NOT COMPLETED|Intravenous Period 7 - 9||0
3016730|NCT01037309|3734714|FG008|NOT COMPLETED|Intravenous Period 7 - 9||0
3016731|NCT01037413|3734737|FG000|STARTED|Part A: Skin Testing||25
3165467|NCT01899300|3893018|FG000|NOT COMPLETED|Overall Study||0
3165468|NCT01899300|3893019|FG001|NOT COMPLETED|Overall Study||0
3165469|NCT01899677|3893027|FG000|STARTED|Overall Study||35
3165470|NCT01899677|3893028|FG001|STARTED|Overall Study||35
3165471|NCT01899677|3893027|FG000|COMPLETED|Overall Study||25
3165472|NCT01899677|3893028|FG001|COMPLETED|Overall Study||28
3165473|NCT01899677|3893027|FG000|NOT COMPLETED|Overall Study||10
3165474|NCT01899677|3893028|FG001|NOT COMPLETED|Overall Study||7
3165475|NCT01899729|3893039|FG000|STARTED|Overall Study||9
3165476|NCT01899729|3893040|FG001|STARTED|Overall Study||9
3165477|NCT01899729|3893041|FG002|STARTED|Overall Study||8
3165478|NCT01899729|3893042|FG003|STARTED|Overall Study||9
3165479|NCT01899729|3893043|FG004|STARTED|Overall Study||11
3165480|NCT01899729|3893039|FG000|COMPLETED|Overall Study||7
3165481|NCT01899729|3893040|FG001|COMPLETED|Overall Study||7
3165482|NCT01899729|3893041|FG002|COMPLETED|Overall Study||6
3165483|NCT01899729|3893042|FG003|COMPLETED|Overall Study||9
3165484|NCT01899729|3893043|FG004|COMPLETED|Overall Study||9
3165485|NCT01899729|3893039|FG000|NOT COMPLETED|Overall Study||2
3016732|NCT01037413|3734738|FG001|STARTED|Part A: Skin Testing||0
3016733|NCT01037413|3734737|FG000|COMPLETED|Part A: Skin Testing||23
3016734|NCT01037413|3734738|FG001|COMPLETED|Part A: Skin Testing||0
3016735|NCT01037413|3734737|FG000|NOT COMPLETED|Part A: Skin Testing||2
3016736|NCT01037413|3734738|FG001|NOT COMPLETED|Part A: Skin Testing||0
3016737|NCT01037413|3734737|FG000|STARTED|Part B: Scar Revision|Participants who tested negative for skin sensitization proceeded to Part B of the study. .|0
3016738|NCT01037413|3734738|FG001|STARTED|Part B: Scar Revision|Participants who completed Part A of the study and were negative for skin sensitization.|23
3016739|NCT01037413|3734737|FG000|Treated|Part B: Scar Revision||0
3016740|NCT01037413|3734738|FG001|Treated|Part B: Scar Revision||22
3165486|NCT01899729|3893040|FG001|NOT COMPLETED|Overall Study||2
3016741|NCT01037413|3734737|FG000|COMPLETED|Part B: Scar Revision||0
3016742|NCT01037413|3734738|FG001|COMPLETED|Part B: Scar Revision||21
3016743|NCT01037413|3734737|FG000|NOT COMPLETED|Part B: Scar Revision||0
3016744|NCT01037413|3734738|FG001|NOT COMPLETED|Part B: Scar Revision||2
3016745|NCT01037452|3734755|FG000|STARTED|Overall Study||30
3016746|NCT01037452|3734756|FG001|STARTED|Overall Study||30
3016747|NCT01037452|3734757|FG002|STARTED|Overall Study||30
3016748|NCT01037452|3734758|FG003|STARTED|Overall Study||30
3016749|NCT01037452|3734755|FG000|COMPLETED|Overall Study||30
3016750|NCT01037452|3734756|FG001|COMPLETED|Overall Study||30
3016751|NCT01037452|3734757|FG002|COMPLETED|Overall Study||30
3016752|NCT01037452|3734758|FG003|COMPLETED|Overall Study||30
3016753|NCT01037452|3734755|FG000|NOT COMPLETED|Overall Study||0
3016754|NCT01037452|3734756|FG001|NOT COMPLETED|Overall Study||0
3016755|NCT01037452|3734757|FG002|NOT COMPLETED|Overall Study||0
3016756|NCT01037452|3734758|FG003|NOT COMPLETED|Overall Study||0
3016757|NCT01037790|3734773|FG000|STARTED|Overall Study||63
3016758|NCT01037790|3734774|FG001|STARTED|Overall Study||18
3016759|NCT01037790|3734775|FG002|STARTED|Overall Study||19
3016760|NCT01037790|3734776|FG003|STARTED|Overall Study||30
3016761|NCT01037790|3734777|FG004|STARTED|Overall Study||11
3016762|NCT01037790|3734773|FG000|COMPLETED|Overall Study||63
3016763|NCT01037790|3734774|FG001|COMPLETED|Overall Study||18
3016764|NCT01037790|3734775|FG002|COMPLETED|Overall Study||19
3016765|NCT01037790|3734776|FG003|COMPLETED|Overall Study||30
3016766|NCT01037790|3734777|FG004|COMPLETED|Overall Study||11
3016767|NCT01037790|3734773|FG000|NOT COMPLETED|Overall Study||0
3016768|NCT01037790|3734774|FG001|NOT COMPLETED|Overall Study||0
3016769|NCT01037790|3734775|FG002|NOT COMPLETED|Overall Study||0
3016770|NCT01037790|3734776|FG003|NOT COMPLETED|Overall Study||0
3016771|NCT01037790|3734777|FG004|NOT COMPLETED|Overall Study||0
3016772|NCT01037881|3734796|FG000|STARTED|Overall Study||25
3016773|NCT01037881|3734797|FG001|STARTED|Overall Study||24
3016774|NCT01037881|3734798|FG002|STARTED|Overall Study||25
3016775|NCT01037881|3734799|FG003|STARTED|Overall Study||25
3016776|NCT01037881|3734800|FG004|STARTED|Overall Study||29
3016777|NCT01037881|3734801|FG005|STARTED|Overall Study||30
3016778|NCT01037881|3734802|FG006|STARTED|Overall Study||25
3016779|NCT01037881|3734796|FG000|COMPLETED|Overall Study||19
3016780|NCT01037881|3734797|FG001|COMPLETED|Overall Study||22
3016781|NCT01037881|3734798|FG002|COMPLETED|Overall Study||22
3016782|NCT01037881|3734799|FG003|COMPLETED|Overall Study||24
3016783|NCT01037881|3734800|FG004|COMPLETED|Overall Study||26
3016784|NCT01037881|3734801|FG005|COMPLETED|Overall Study||27
3016785|NCT01037881|3734802|FG006|COMPLETED|Overall Study||23
3016786|NCT01037881|3734796|FG000|NOT COMPLETED|Overall Study||6
3016787|NCT01037881|3734797|FG001|NOT COMPLETED|Overall Study||2
3016788|NCT01037881|3734798|FG002|NOT COMPLETED|Overall Study||3
3016789|NCT01037881|3734799|FG003|NOT COMPLETED|Overall Study||1
3016790|NCT01037881|3734800|FG004|NOT COMPLETED|Overall Study||3
3016791|NCT01037881|3734801|FG005|NOT COMPLETED|Overall Study||3
3016792|NCT01037881|3734802|FG006|NOT COMPLETED|Overall Study||2
3016793|NCT01037985|3734827|FG000|STARTED|Part A: Skin Testing (50 Days)||41
3016794|NCT01037985|3734828|FG001|STARTED|Part A: Skin Testing (50 Days)||0
3016795|NCT01037985|3734827|FG000|COMPLETED|Part A: Skin Testing (50 Days)||37
3016796|NCT01037985|3734828|FG001|COMPLETED|Part A: Skin Testing (50 Days)||0
3016797|NCT01037985|3734827|FG000|NOT COMPLETED|Part A: Skin Testing (50 Days)||4
3016798|NCT01037985|3734828|FG001|NOT COMPLETED|Part A: Skin Testing (50 Days)||0
3016799|NCT01037985|3734827|FG000|STARTED|Part B:Abdominoplasty Surgery (24 Weeks)|Participants who tested negative for skin sensitization proceeded to Part B of the study. .|0
3016800|NCT01037985|3734828|FG001|STARTED|Part B:Abdominoplasty Surgery (24 Weeks)|Participants who completed Part A of the study and were negative for skin sensitization.|37
3016801|NCT01037985|3734827|FG000|Treated|Part B:Abdominoplasty Surgery (24 Weeks)||0
3016802|NCT01037985|3734828|FG001|Treated|Part B:Abdominoplasty Surgery (24 Weeks)||33
3016803|NCT01037985|3734827|FG000|COMPLETED|Part B:Abdominoplasty Surgery (24 Weeks)||0
3016804|NCT01037985|3734828|FG001|COMPLETED|Part B:Abdominoplasty Surgery (24 Weeks)||32
3016805|NCT01037985|3734827|FG000|NOT COMPLETED|Part B:Abdominoplasty Surgery (24 Weeks)||0
3016806|NCT01037985|3734828|FG001|NOT COMPLETED|Part B:Abdominoplasty Surgery (24 Weeks)||5
3016807|NCT01038128|3734838|FG000|STARTED|Overall Study||5
3016808|NCT01038128|3734838|FG000|Baseline Visit|Overall Study||3
3016809|NCT01038128|3734838|FG000|COMPLETED|Overall Study||1
3016810|NCT01038128|3734838|FG000|NOT COMPLETED|Overall Study||4
3016811|NCT01038297|3734847|FG000|STARTED|Part A: Skin Testing Phase (50 Days)||10
3016812|NCT01038297|3734848|FG001|STARTED|Part A: Skin Testing Phase (50 Days)||10
3016813|NCT01038297|3734849|FG002|STARTED|Part A: Skin Testing Phase (50 Days)||10
3016814|NCT01038297|3734847|FG000|COMPLETED|Part A: Skin Testing Phase (50 Days)||9
3016815|NCT01038297|3734848|FG001|COMPLETED|Part A: Skin Testing Phase (50 Days)||10
3016816|NCT01038297|3734849|FG002|COMPLETED|Part A: Skin Testing Phase (50 Days)||10
3016817|NCT01038297|3734847|FG000|NOT COMPLETED|Part A: Skin Testing Phase (50 Days)||1
3016818|NCT01038297|3734848|FG001|NOT COMPLETED|Part A: Skin Testing Phase (50 Days)||0
3016819|NCT01038297|3734849|FG002|NOT COMPLETED|Part A: Skin Testing Phase (50 Days)||0
3016820|NCT01038297|3734847|FG000|STARTED|Part B: Active Dosing Phase (13 Weeks)||9
3016821|NCT01038297|3734848|FG001|STARTED|Part B: Active Dosing Phase (13 Weeks)||10
3016822|NCT01038297|3734849|FG002|STARTED|Part B: Active Dosing Phase (13 Weeks)||10
3016823|NCT01038297|3734847|FG000|COMPLETED|Part B: Active Dosing Phase (13 Weeks)||9
3016824|NCT01038297|3734848|FG001|COMPLETED|Part B: Active Dosing Phase (13 Weeks)||10
3016825|NCT01038297|3734849|FG002|COMPLETED|Part B: Active Dosing Phase (13 Weeks)||10
3016826|NCT01038297|3734847|FG000|NOT COMPLETED|Part B: Active Dosing Phase (13 Weeks)||0
3016827|NCT01038297|3734848|FG001|NOT COMPLETED|Part B: Active Dosing Phase (13 Weeks)||0
3016828|NCT01038297|3734849|FG002|NOT COMPLETED|Part B: Active Dosing Phase (13 Weeks)||0
3016829|NCT01038323|3734869|FG000|STARTED|Overall Study||20
3016830|NCT01038323|3734870|FG001|STARTED|Overall Study||19
3016831|NCT01038323|3734871|FG002|STARTED|Overall Study||19
3016832|NCT01038323|3734869|FG000|COMPLETED|Overall Study||17
3016833|NCT01038323|3734870|FG001|COMPLETED|Overall Study||17
3016834|NCT01038323|3734871|FG002|COMPLETED|Overall Study||15
3016835|NCT01038323|3734869|FG000|NOT COMPLETED|Overall Study||3
3016836|NCT01038323|3734870|FG001|NOT COMPLETED|Overall Study||2
3016837|NCT01038323|3734871|FG002|NOT COMPLETED|Overall Study||4
3016838|NCT01038336|3734882|FG000|STARTED|Overall Study||43
3016839|NCT01038336|3734883|FG001|STARTED|Overall Study||42
3016840|NCT01038336|3734884|FG002|STARTED|Overall Study||44
3016841|NCT01038336|3734882|FG000|COMPLETED|Overall Study||43
3016842|NCT01038336|3734883|FG001|COMPLETED|Overall Study||42
3016843|NCT01038336|3734884|FG002|COMPLETED|Overall Study||44
3016844|NCT01038336|3734882|FG000|NOT COMPLETED|Overall Study||0
3016845|NCT01038336|3734883|FG001|NOT COMPLETED|Overall Study||0
3016846|NCT01038336|3734884|FG002|NOT COMPLETED|Overall Study||0
3016847|NCT01038427|3734900|FG000|STARTED|Overall Study||317
3016848|NCT01038427|3734901|FG001|STARTED|Overall Study||320
3016849|NCT01038427|3734902|FG002|STARTED|Overall Study||158
3016850|NCT01038427|3734900|FG000|Per-Protocol (PPP) Population|Overall Study||306
3016851|NCT01038427|3734901|FG001|Per-Protocol (PPP) Population|Overall Study||307
3016852|NCT01038427|3734902|FG002|Per-Protocol (PPP) Population|Overall Study||150
3016853|NCT01038427|3734900|FG000|Intent-to-Treat (ITT) Population|Overall Study||314
3016854|NCT01038427|3734901|FG001|Intent-to-Treat (ITT) Population|Overall Study||314
3016855|NCT01038427|3734902|FG002|Intent-to-Treat (ITT) Population|Overall Study||156
3016856|NCT01038427|3734900|FG000|COMPLETED|Overall Study||314
3016857|NCT01038427|3734901|FG001|COMPLETED|Overall Study||314
3016858|NCT01038427|3734902|FG002|COMPLETED|Overall Study||154
3016859|NCT01038427|3734900|FG000|NOT COMPLETED|Overall Study||3
3016860|NCT01038427|3734901|FG001|NOT COMPLETED|Overall Study||6
3016861|NCT01038427|3734902|FG002|NOT COMPLETED|Overall Study||4
3016862|NCT01038557|3734913|FG000|STARTED|Overall Study||82
3016863|NCT01038557|3734914|FG001|STARTED|Overall Study||86
3016864|NCT01038557|3734915|FG002|STARTED|Overall Study||86
3016865|NCT01038557|3734913|FG000|COMPLETED|Overall Study||82
3016866|NCT01038557|3734914|FG001|COMPLETED|Overall Study||86
3016867|NCT01038557|3734915|FG002|COMPLETED|Overall Study||86
3016868|NCT01038557|3734913|FG000|NOT COMPLETED|Overall Study||0
3016869|NCT01038557|3734914|FG001|NOT COMPLETED|Overall Study||0
3016870|NCT01038557|3734915|FG002|NOT COMPLETED|Overall Study||0
3016871|NCT01038609|3734928|FG000|STARTED|Overall Study||50
3016872|NCT01038609|3734929|FG001|STARTED|Overall Study||52
3016873|NCT01038609|3734930|FG002|STARTED|Overall Study||49
3016874|NCT01038609|3734931|FG003|STARTED|Overall Study||48
3016875|NCT01038609|3734932|FG004|STARTED|Overall Study||51
3016876|NCT01038609|3734928|FG000|COMPLETED|Overall Study||49
3016877|NCT01038609|3734929|FG001|COMPLETED|Overall Study||51
3016878|NCT01038609|3734930|FG002|COMPLETED|Overall Study||48
3016879|NCT01038609|3734931|FG003|COMPLETED|Overall Study||47
3016880|NCT01038609|3734932|FG004|COMPLETED|Overall Study||50
3016881|NCT01038609|3734928|FG000|NOT COMPLETED|Overall Study||1
3016882|NCT01038609|3734929|FG001|NOT COMPLETED|Overall Study||1
3016883|NCT01038609|3734930|FG002|NOT COMPLETED|Overall Study||1
3016884|NCT01038609|3734931|FG003|NOT COMPLETED|Overall Study||1
3016885|NCT01038609|3734932|FG004|NOT COMPLETED|Overall Study||1
3016886|NCT01038635|3734953|FG000|STARTED|Overall Study||5
3016887|NCT01038635|3734954|FG001|STARTED|Overall Study||3
3016888|NCT01038635|3734955|FG002|STARTED|Overall Study||3
3016889|NCT01038635|3734956|FG003|STARTED|Overall Study||3
3016890|NCT01038635|3734957|FG004|STARTED|Overall Study||4
3016891|NCT01038635|3734958|FG005|STARTED|Overall Study||3
3016892|NCT01038635|3734959|FG006|STARTED|Overall Study||7
3016893|NCT01038635|3734960|FG007|STARTED|Overall Study||20
3016894|NCT01038635|3734961|FG008|STARTED|Overall Study||40
3016895|NCT01038635|3734953|FG000|COMPLETED|Overall Study||3
3016896|NCT01038635|3734954|FG001|COMPLETED|Overall Study||3
3016897|NCT01038635|3734955|FG002|COMPLETED|Overall Study||3
3016898|NCT01038635|3734956|FG003|COMPLETED|Overall Study||3
3016899|NCT01038635|3734957|FG004|COMPLETED|Overall Study||3
3016900|NCT01038635|3734958|FG005|COMPLETED|Overall Study||3
3016901|NCT01038635|3734959|FG006|COMPLETED|Overall Study||5
3016902|NCT01038635|3734960|FG007|COMPLETED|Overall Study||15
3016903|NCT01038635|3734961|FG008|COMPLETED|Overall Study||38
3016904|NCT01038635|3734953|FG000|NOT COMPLETED|Overall Study||2
3016905|NCT01038635|3734954|FG001|NOT COMPLETED|Overall Study||0
3016906|NCT01038635|3734955|FG002|NOT COMPLETED|Overall Study||0
3016907|NCT01038635|3734956|FG003|NOT COMPLETED|Overall Study||0
3016908|NCT01038635|3734957|FG004|NOT COMPLETED|Overall Study||1
3016909|NCT01038635|3734958|FG005|NOT COMPLETED|Overall Study||0
3016910|NCT01038635|3734959|FG006|NOT COMPLETED|Overall Study||2
3016911|NCT01038635|3734960|FG007|NOT COMPLETED|Overall Study||5
3016912|NCT01038635|3734961|FG008|NOT COMPLETED|Overall Study||2
3016913|NCT01038687|3734985|FG000|STARTED|Overall Study||12
3016914|NCT01038687|3734986|FG001|STARTED|Overall Study||11
3016915|NCT01038687|3734987|FG002|STARTED|Overall Study||13
3016916|NCT01038687|3734985|FG000|COMPLETED|Overall Study||12
3016917|NCT01038687|3734986|FG001|COMPLETED|Overall Study||9
3016918|NCT01038687|3734987|FG002|COMPLETED|Overall Study||12
3016919|NCT01038687|3734985|FG000|NOT COMPLETED|Overall Study||0
3016920|NCT01038687|3734986|FG001|NOT COMPLETED|Overall Study||2
3016921|NCT01038687|3734987|FG002|NOT COMPLETED|Overall Study||1
3016922|NCT01038713|3734998|FG000|STARTED|Overall Study||26
3016923|NCT01038713|3734999|FG001|STARTED|Overall Study||20
3016924|NCT01038713|3735000|FG002|STARTED|Overall Study||17
3016925|NCT01038713|3734998|FG000|COMPLETED|Overall Study||21
3016926|NCT01038713|3734999|FG001|COMPLETED|Overall Study||17
3016927|NCT01038713|3735000|FG002|COMPLETED|Overall Study||16
3016928|NCT01038713|3734998|FG000|NOT COMPLETED|Overall Study||5
3016929|NCT01038713|3734999|FG001|NOT COMPLETED|Overall Study||3
3016930|NCT01038713|3735000|FG002|NOT COMPLETED|Overall Study||1
3016931|NCT01038778|3735010|FG000|STARTED|Overall Study||3
3016932|NCT01038778|3735011|FG001|STARTED|Overall Study||8
3016933|NCT01038778|3735012|FG002|STARTED|Overall Study||36
3016934|NCT01038778|3735010|FG000|COMPLETED|Overall Study||3
3016935|NCT01038778|3735011|FG001|COMPLETED|Overall Study||6
3016936|NCT01038778|3735012|FG002|COMPLETED|Overall Study||33
3016937|NCT01038778|3735010|FG000|NOT COMPLETED|Overall Study||0
3016938|NCT01038778|3735011|FG001|NOT COMPLETED|Overall Study||2
3016939|NCT01038778|3735012|FG002|NOT COMPLETED|Overall Study||3
3016940|NCT01038856|3735019|FG000|STARTED|Overall Study||5
3016941|NCT01038856|3735019|FG000|COMPLETED|Overall Study||3
3016942|NCT01038856|3735019|FG000|NOT COMPLETED|Overall Study||2
3016943|NCT01038869|3735025|FG000|STARTED|Overall Study||20
3016944|NCT01038869|3735025|FG000|COMPLETED|Overall Study||13
3016945|NCT01038869|3735025|FG000|NOT COMPLETED|Overall Study||7
3016946|NCT01038921|3735035|FG000|STARTED|Overall Study|19 subjects received melatonin first(10 weeks), washout (6 weeks), placebo second (10 weeks)|19
3016947|NCT01038921|3735036|FG001|STARTED|Overall Study|20 subjects received placebo first (10 weeks), washout (6 weeks), melatonin second ( 10 weeks)|20
3016948|NCT01038921|3735035|FG000|COMPLETED|Overall Study|2 subjects withdrew|17
3016949|NCT01038921|3735036|FG001|COMPLETED|Overall Study||20
3016950|NCT01038921|3735035|FG000|NOT COMPLETED|Overall Study||2
3016951|NCT01038921|3735036|FG001|NOT COMPLETED|Overall Study||0
3016952|NCT01039207|3735042|FG000|STARTED|Overall Study||31
3016953|NCT01039207|3735042|FG000|COMPLETED|Overall Study||31
3016954|NCT01039207|3735042|FG000|NOT COMPLETED|Overall Study||0
3016955|NCT01039376|3735048|FG000|STARTED|Overall Study||240
3016956|NCT01039376|3735049|FG001|STARTED|Overall Study||240
3016957|NCT01039376|3735048|FG000|COMPLETED|Overall Study||110
3016958|NCT01039376|3735049|FG001|COMPLETED|Overall Study||114
3016959|NCT01039376|3735048|FG000|NOT COMPLETED|Overall Study||130
3016960|NCT01039376|3735049|FG001|NOT COMPLETED|Overall Study||126
3016961|NCT01039428|3735058|FG000|STARTED|Overall Study||35
3016962|NCT01039428|3735059|FG001|STARTED|Overall Study||28
3016963|NCT01039428|3735058|FG000|COMPLETED|Overall Study||33
3016964|NCT01039428|3735059|FG001|COMPLETED|Overall Study||28
3016965|NCT01039428|3735058|FG000|NOT COMPLETED|Overall Study||2
3016966|NCT01039428|3735059|FG001|NOT COMPLETED|Overall Study||0
3016967|NCT01039467|3735067|FG000|STARTED|Overall Study||196
3016968|NCT01039467|3735068|FG001|STARTED|Overall Study||189
3016969|NCT01039467|3735067|FG000|COMPLETED|Overall Study||156
3016970|NCT01039467|3735068|FG001|COMPLETED|Overall Study||140
3016971|NCT01039467|3735067|FG000|NOT COMPLETED|Overall Study||40
3016972|NCT01039467|3735068|FG001|NOT COMPLETED|Overall Study||49
3016973|NCT01039519|3735076|FG000|STARTED|Treatment||27
3016974|NCT01039519|3735076|FG000|COMPLETED|Treatment|Reason not completed represents reason for terminating treatment.|0
3016975|NCT01039519|3735076|FG000|NOT COMPLETED|Treatment||27
3016976|NCT01039519|3735076|FG000|STARTED|Survival Follow-up||27
3016977|NCT01039519|3735076|FG000|COMPLETED|Survival Follow-up||0
3016978|NCT01039519|3735076|FG000|NOT COMPLETED|Survival Follow-up||27
3016979|NCT01039584|3735083|FG000|STARTED|Overall Study||246
3016980|NCT01039584|3735084|FG001|STARTED|Overall Study||243
3016981|NCT01039584|3735085|FG002|STARTED|Overall Study||122
3016982|NCT01039584|3735083|FG000|COMPLETED|Overall Study||143
3016983|NCT01039584|3735084|FG001|COMPLETED|Overall Study||146
3016984|NCT01039584|3735085|FG002|COMPLETED|Overall Study||65
3016985|NCT01039584|3735083|FG000|NOT COMPLETED|Overall Study||103
3016986|NCT01039584|3735084|FG001|NOT COMPLETED|Overall Study||97
3016987|NCT01039584|3735085|FG002|NOT COMPLETED|Overall Study||57
3016988|NCT01039675|3735095|FG000|STARTED|Overall Study||9
3016989|NCT01039675|3735096|FG001|STARTED|Overall Study||42
3016990|NCT01039675|3735095|FG000|COMPLETED|Overall Study||9
3016991|NCT01039675|3735096|FG001|COMPLETED|Overall Study||35
3016992|NCT01039675|3735095|FG000|NOT COMPLETED|Overall Study||0
3016993|NCT01039675|3735096|FG001|NOT COMPLETED|Overall Study||7
3016994|NCT01039688|3735105|FG000|STARTED|Overall Study||373
3016995|NCT01039688|3735106|FG001|STARTED|Overall Study||397
3016996|NCT01039688|3735107|FG002|STARTED|Overall Study||186
3016997|NCT01039688|3735105|FG000|COMPLETED|Overall Study||266
3016998|NCT01039688|3735106|FG001|COMPLETED|Overall Study||286
3016999|NCT01039688|3735107|FG002|COMPLETED|Overall Study||106
3017000|NCT01039688|3735105|FG000|NOT COMPLETED|Overall Study||107
3017001|NCT01039688|3735106|FG001|NOT COMPLETED|Overall Study||111
3017002|NCT01039688|3735107|FG002|NOT COMPLETED|Overall Study||80
3017003|NCT01039792|3735120|FG000|STARTED|Overall Study||29
3017004|NCT01039792|3735121|FG001|STARTED|Overall Study||28
3017005|NCT01039792|3735120|FG000|COMPLETED|Overall Study||23
3017006|NCT01039792|3735121|FG001|COMPLETED|Overall Study||27
3017007|NCT01039792|3735120|FG000|NOT COMPLETED|Overall Study||6
3017008|NCT01039792|3735121|FG001|NOT COMPLETED|Overall Study||1
3017009|NCT01040052|3735127|FG000|STARTED|Overall Study||30
3017010|NCT01040052|3735127|FG000|COMPLETED|Overall Study||30
3017011|NCT01040052|3735127|FG000|NOT COMPLETED|Overall Study||0
3017012|NCT01040130|3735131|FG000|STARTED|Overall Study|Number of patients entered and treated|25
3017013|NCT01040130|3735132|FG001|STARTED|Overall Study||25
3017014|NCT01040130|3735133|FG002|STARTED|Overall Study||25
3017015|NCT01040130|3735134|FG003|STARTED|Overall Study||25
3017016|NCT01040130|3735135|FG004|STARTED|Overall Study||25
3017017|NCT01040130|3735136|FG005|STARTED|Overall Study||26
3017018|NCT01040130|3735131|FG000|COMPLETED|Overall Study|Number of patients who did not discontinue from the trial.|22
3017019|NCT01040130|3735132|FG001|COMPLETED|Overall Study||22
3017020|NCT01040130|3735133|FG002|COMPLETED|Overall Study||23
3017021|NCT01040130|3735134|FG003|COMPLETED|Overall Study||20
3017022|NCT01040130|3735135|FG004|COMPLETED|Overall Study||25
3017023|NCT01040130|3735136|FG005|COMPLETED|Overall Study||22
3017024|NCT01040130|3735131|FG000|NOT COMPLETED|Overall Study||3
3017025|NCT01040130|3735132|FG001|NOT COMPLETED|Overall Study||3
3017026|NCT01040130|3735133|FG002|NOT COMPLETED|Overall Study||2
3017027|NCT01040130|3735134|FG003|NOT COMPLETED|Overall Study||5
3017028|NCT01040130|3735135|FG004|NOT COMPLETED|Overall Study||0
3017029|NCT01040130|3735136|FG005|NOT COMPLETED|Overall Study||4
3017030|NCT01040169|3735148|FG000|STARTED|Overall Study||35
3017031|NCT01040169|3735149|FG001|STARTED|Overall Study||44
3017032|NCT01040169|3735148|FG000|COMPLETED|Overall Study||32
3017033|NCT01040169|3735149|FG001|COMPLETED|Overall Study||36
3017034|NCT01040169|3735148|FG000|NOT COMPLETED|Overall Study||3
3017035|NCT01040169|3735149|FG001|NOT COMPLETED|Overall Study||8
3017036|NCT01040208|3735158|FG000|STARTED|Overall Study||45
3017037|NCT01040208|3735159|FG001|STARTED|Overall Study||28
3017038|NCT01040208|3735160|FG002|STARTED|Overall Study||38
3017039|NCT01040208|3735158|FG000|COMPLETED|Overall Study||39
3017040|NCT01040208|3735159|FG001|COMPLETED|Overall Study||15
3017041|NCT01040208|3735160|FG002|COMPLETED|Overall Study||35
3017042|NCT01040208|3735158|FG000|NOT COMPLETED|Overall Study||6
3017043|NCT01040208|3735159|FG001|NOT COMPLETED|Overall Study||13
3017044|NCT01040208|3735160|FG002|NOT COMPLETED|Overall Study||3
3017045|NCT01040260|3735175|FG000|STARTED|Overall Study||53
3017046|NCT01040260|3735176|FG001|STARTED|Overall Study||50
3017047|NCT01040260|3735175|FG000|COMPLETED|Overall Study||38
3017048|NCT01040260|3735176|FG001|COMPLETED|Overall Study||39
3017049|NCT01040260|3735175|FG000|NOT COMPLETED|Overall Study||15
3017050|NCT01040260|3735176|FG001|NOT COMPLETED|Overall Study||11
3017051|NCT01040351|3735184|FG000|STARTED|Overall Study|October 2006|55
3017052|NCT01040351|3735185|FG001|STARTED|Overall Study|October 2006|55
3017053|NCT01040351|3735184|FG000|COMPLETED|Overall Study|May 2010|54
3017054|NCT01040351|3735185|FG001|COMPLETED|Overall Study|May 2010|53
3017055|NCT01040351|3735184|FG000|NOT COMPLETED|Overall Study||1
3017056|NCT01040351|3735185|FG001|NOT COMPLETED|Overall Study||2
3017057|NCT01040403|3735191|FG000|STARTED|Overall Study||233
3017058|NCT01040403|3735191|FG000|Completed Olo 5|Overall Study||106
3017059|NCT01040403|3735191|FG000|Completed T+O 1.25/5|Overall Study||105
3017060|NCT01040403|3735191|FG000|Completed T+O 2.5/5|Overall Study||111
3017061|NCT01040403|3735191|FG000|Completed T+O 5/5|Overall Study||106
3017062|NCT01040403|3735191|FG000|Completed Olo 10|Overall Study||109
3017063|NCT01040403|3735191|FG000|Completed T+O 1.25/10|Overall Study||106
3017064|NCT01040403|3735191|FG000|Completed T+O 2.5/10|Overall Study||110
3017065|NCT01040403|3735191|FG000|Completed T+O 5/10|Overall Study||107
3017066|NCT01040403|3735191|FG000|COMPLETED|Overall Study|All treatment periods|213
3017067|NCT01040403|3735191|FG000|NOT COMPLETED|Overall Study||20
3017068|NCT01040689|3735210|FG000|STARTED|Overall Study||27
3017069|NCT01040689|3735211|FG001|STARTED|Overall Study||27
3017070|NCT01040689|3735212|FG002|STARTED|Overall Study||27
3017071|NCT01040689|3735213|FG003|STARTED|Overall Study||27
3017072|NCT01040689|3735210|FG000|COMPLETED|Overall Study||24
3017073|NCT01040689|3735211|FG001|COMPLETED|Overall Study||25
3017074|NCT01040689|3735212|FG002|COMPLETED|Overall Study||23
3017075|NCT01040689|3735213|FG003|COMPLETED|Overall Study||23
3017076|NCT01040689|3735210|FG000|NOT COMPLETED|Overall Study||3
3017077|NCT01040689|3735211|FG001|NOT COMPLETED|Overall Study||2
3017078|NCT01040689|3735212|FG002|NOT COMPLETED|Overall Study||4
3017079|NCT01040689|3735213|FG003|NOT COMPLETED|Overall Study||4
3017080|NCT01040728|3735228|FG000|STARTED|Overall Study||31
3017081|NCT01040728|3735229|FG001|STARTED|Overall Study||30
3017082|NCT01040728|3735230|FG002|STARTED|Overall Study||31
3017083|NCT01040728|3735231|FG003|STARTED|Overall Study||30
3017084|NCT01040728|3735228|FG000|COMPLETED|Overall Study||27
3017085|NCT01040728|3735229|FG001|COMPLETED|Overall Study||19
3017086|NCT01040728|3735230|FG002|COMPLETED|Overall Study||30
3017087|NCT01040728|3735231|FG003|COMPLETED|Overall Study||24
3017088|NCT01040728|3735228|FG000|NOT COMPLETED|Overall Study||4
3017089|NCT01040728|3735229|FG001|NOT COMPLETED|Overall Study||11
3017090|NCT01040728|3735230|FG002|NOT COMPLETED|Overall Study||1
3017091|NCT01040728|3735231|FG003|NOT COMPLETED|Overall Study||6
3017092|NCT01040780|3735249|FG000|STARTED|Overall Study||200
3017093|NCT01040780|3735250|FG001|STARTED|Overall Study||199
3017094|NCT01040780|3735249|FG000|COMPLETED|Overall Study||199
3017095|NCT01040780|3735250|FG001|COMPLETED|Overall Study||196
3017096|NCT01040780|3735249|FG000|NOT COMPLETED|Overall Study||1
3017097|NCT01040780|3735250|FG001|NOT COMPLETED|Overall Study||3
3017098|NCT01040793|3735259|FG000|STARTED|Overall Study|Entered and treated|26
3017099|NCT01040793|3735260|FG001|STARTED|Overall Study||26
3017100|NCT01040793|3735261|FG002|STARTED|Overall Study||26
3017101|NCT01040793|3735262|FG003|STARTED|Overall Study||26
3017102|NCT01040793|3735263|FG004|STARTED|Overall Study||26
3017103|NCT01040793|3735264|FG005|STARTED|Overall Study||27
3017104|NCT01040793|3735259|FG000|COMPLETED|Overall Study||20
3017105|NCT01040793|3735260|FG001|COMPLETED|Overall Study||21
3017106|NCT01040793|3735261|FG002|COMPLETED|Overall Study||23
3017107|NCT01040793|3735262|FG003|COMPLETED|Overall Study||22
3017108|NCT01040793|3735263|FG004|COMPLETED|Overall Study||22
3017109|NCT01040793|3735264|FG005|COMPLETED|Overall Study||26
3017110|NCT01040793|3735259|FG000|NOT COMPLETED|Overall Study||6
3017111|NCT01040793|3735260|FG001|NOT COMPLETED|Overall Study||5
3017112|NCT01040793|3735261|FG002|NOT COMPLETED|Overall Study||3
3017113|NCT01040793|3735262|FG003|NOT COMPLETED|Overall Study||4
3017114|NCT01040793|3735263|FG004|NOT COMPLETED|Overall Study||4
3017115|NCT01040793|3735264|FG005|NOT COMPLETED|Overall Study||1
3017116|NCT01040819|3735276|FG000|STARTED|Overall Study||13
3017117|NCT01040819|3735277|FG001|STARTED|Overall Study||12
3017118|NCT01040819|3735276|FG000|COMPLETED|Overall Study||13
3017119|NCT01040819|3735277|FG001|COMPLETED|Overall Study||12
3017120|NCT01040819|3735276|FG000|NOT COMPLETED|Overall Study||0
3017121|NCT01040819|3735277|FG001|NOT COMPLETED|Overall Study||0
3017122|NCT01040832|3735285|FG000|STARTED|Overall Study|One participant was treated with study drug 'Cetuximab Plus EMD 1201081' but was not randomized|54
3017123|NCT01040832|3735286|FG001|STARTED|Overall Study||53
3017124|NCT01040832|3735285|FG000|COMPLETED|Overall Study||8
3017125|NCT01040832|3735286|FG001|COMPLETED|Overall Study||16
3017126|NCT01040832|3735285|FG000|NOT COMPLETED|Overall Study||46
3017127|NCT01040832|3735286|FG001|NOT COMPLETED|Overall Study||37
3017128|NCT01040845|3735294|FG000|STARTED|Overall Study||15
3017129|NCT01040845|3735295|FG001|STARTED|Overall Study||15
3017130|NCT01040845|3735294|FG000|COMPLETED|Overall Study|withdrew consent due to schedule conflict (1); dropped by physician due to positive drug screen (1)|13
3017131|NCT01040845|3735295|FG001|COMPLETED|Overall Study|withdrew consent due to schedule conflict (1)|14
3017132|NCT01040845|3735294|FG000|NOT COMPLETED|Overall Study||2
3017133|NCT01040845|3735295|FG001|NOT COMPLETED|Overall Study||1
3017134|NCT01040858|3735305|FG000|STARTED|Overall Study||59
3017135|NCT01040858|3735306|FG001|STARTED|Overall Study||69
3017136|NCT01040858|3735305|FG000|COMPLETED|Overall Study||50
3017137|NCT01040858|3735306|FG001|COMPLETED|Overall Study||69
3017138|NCT01040858|3735305|FG000|NOT COMPLETED|Overall Study||9
3017139|NCT01040858|3735306|FG001|NOT COMPLETED|Overall Study||0
3017140|NCT01040871|3735317|FG000|STARTED|Overall Study|Intent to Treat, Randomized|84
3017141|NCT01040871|3735318|FG001|STARTED|Overall Study|Intent to Treat, Randomized|80
3017142|NCT01040871|3735317|FG000|COMPLETED|Overall Study||71
3017143|NCT01040871|3735318|FG001|COMPLETED|Overall Study||73
3017144|NCT01040871|3735317|FG000|NOT COMPLETED|Overall Study||13
3017145|NCT01040871|3735318|FG001|NOT COMPLETED|Overall Study||7
3017146|NCT01041209|3735326|FG000|STARTED|Overall Study||60
3017147|NCT01041209|3735327|FG001|STARTED|Overall Study||60
3017148|NCT01041209|3735326|FG000|COMPLETED|Overall Study||60
3017149|NCT01041209|3735327|FG001|COMPLETED|Overall Study||60
3017150|NCT01041209|3735326|FG000|NOT COMPLETED|Overall Study||0
3017151|NCT01041209|3735327|FG001|NOT COMPLETED|Overall Study||0
3017152|NCT01041248|3735334|FG000|STARTED|Overall Study|January 2010|1
3017153|NCT01041248|3735334|FG000|COMPLETED|Overall Study||1
3017154|NCT01041248|3735334|FG000|NOT COMPLETED|Overall Study||0
3017155|NCT01041274|3735341|FG000|STARTED|Overall Study||49
3017156|NCT01041274|3735342|FG001|STARTED|Overall Study||46
3017157|NCT01041274|3735341|FG000|COMPLETED|Overall Study||26
3017158|NCT01041274|3735342|FG001|COMPLETED|Overall Study||25
3017159|NCT01041274|3735341|FG000|NOT COMPLETED|Overall Study||23
3017160|NCT01041274|3735342|FG001|NOT COMPLETED|Overall Study||21
3017161|NCT01041287|3735350|FG000|STARTED|Treatment Period 1 (3 Months)||19
3017162|NCT01041287|3735351|FG001|STARTED|Treatment Period 1 (3 Months)||19
3017163|NCT01041287|3735350|FG000|COMPLETED|Treatment Period 1 (3 Months)||19
3017164|NCT01041287|3735351|FG001|COMPLETED|Treatment Period 1 (3 Months)||19
3017165|NCT01041287|3735350|FG000|NOT COMPLETED|Treatment Period 1 (3 Months)||0
3017166|NCT01041287|3735351|FG001|NOT COMPLETED|Treatment Period 1 (3 Months)||0
3017167|NCT01041287|3735350|FG000|STARTED|Treatment Period 2 (3 Months)||19
3017168|NCT01041287|3735351|FG001|STARTED|Treatment Period 2 (3 Months)||19
3017169|NCT01041287|3735350|FG000|COMPLETED|Treatment Period 2 (3 Months)||16
3017170|NCT01041287|3735351|FG001|COMPLETED|Treatment Period 2 (3 Months)||14
3017171|NCT01041287|3735350|FG000|NOT COMPLETED|Treatment Period 2 (3 Months)||3
3017172|NCT01041287|3735351|FG001|NOT COMPLETED|Treatment Period 2 (3 Months)||5
3017173|NCT01041404|3735359|FG000|STARTED|Overall Study||290
3017174|NCT01041404|3735360|FG001|STARTED|Overall Study||294
3017175|NCT01041404|3735359|FG000|Entered Follow-Up|Overall Study||251
3017176|NCT01041404|3735360|FG001|Entered Follow-Up|Overall Study||251
3017177|NCT01041404|3735359|FG000|Died in Follow-up|Overall Study||199
3017178|NCT01041404|3735360|FG001|Died in Follow-up|Overall Study||200
3017179|NCT01041404|3735359|FG000|Lost to Follow-up|Overall Study||12
3017180|NCT01041404|3735360|FG001|Lost to Follow-up|Overall Study||10
3017181|NCT01041404|3735359|FG000|Alive in Follow-up|Overall Study||40
3017182|NCT01041404|3735360|FG001|Alive in Follow-up|Overall Study||41
3037671|NCT01149473|3756995|FG001|NOT COMPLETED|Washout of 7 Days||1
3017183|NCT01041404|3735359|FG000|COMPLETED|Overall Study|Summary of withdrawals represents withdrawals from treatment, rather than withdrawals from study.|0
3017184|NCT01041404|3735360|FG001|COMPLETED|Overall Study|Summary of withdrawals represents withdrawals from treatment, rather than withdrawals from study.|0
3017185|NCT01041404|3735359|FG000|NOT COMPLETED|Overall Study||290
3017186|NCT01041404|3735360|FG001|NOT COMPLETED|Overall Study||294
3017187|NCT01041417|3735371|FG000|STARTED|Overall Study||80
3017188|NCT01041417|3735372|FG001|STARTED|Overall Study||79
3017189|NCT01041417|3735371|FG000|COMPLETED|Overall Study||73
3017190|NCT01041417|3735372|FG001|COMPLETED|Overall Study||76
3017191|NCT01041417|3735371|FG000|NOT COMPLETED|Overall Study||7
3017192|NCT01041417|3735372|FG001|NOT COMPLETED|Overall Study||3
3017193|NCT01041495|3735382|FG000|STARTED|Overall Study||16
3017194|NCT01041495|3735383|FG001|STARTED|Overall Study||12
3017195|NCT01041495|3735382|FG000|COMPLETED|Overall Study||12
3017196|NCT01041495|3735383|FG001|COMPLETED|Overall Study||5
3017197|NCT01041495|3735382|FG000|NOT COMPLETED|Overall Study||4
3017198|NCT01041495|3735383|FG001|NOT COMPLETED|Overall Study||7
3017199|NCT01041521|3735391|FG000|STARTED|Overall Study||61
3017200|NCT01041521|3735392|FG001|STARTED|Overall Study||56
3017201|NCT01041521|3735391|FG000|COMPLETED|Overall Study||44
3017202|NCT01041521|3735392|FG001|COMPLETED|Overall Study||40
3017203|NCT01041521|3735391|FG000|NOT COMPLETED|Overall Study||17
3017204|NCT01041521|3735392|FG001|NOT COMPLETED|Overall Study||16
3017205|NCT01041573|3735402|FG000|STARTED|Overall Study||540
3017206|NCT01041573|3735403|FG001|STARTED|Overall Study||871
3017207|NCT01041573|3735404|FG002|STARTED|Overall Study||394
3017208|NCT01041573|3735405|FG003|STARTED|Overall Study||64
3165487|NCT01899729|3893041|FG002|NOT COMPLETED|Overall Study||2
3165488|NCT01899729|3893042|FG003|NOT COMPLETED|Overall Study||0
3165489|NCT01899729|3893043|FG004|NOT COMPLETED|Overall Study||2
3017209|NCT01041573|3735402|FG000|COMPLETED|Overall Study||535
3017210|NCT01041573|3735403|FG001|COMPLETED|Overall Study||858
3017211|NCT01041573|3735404|FG002|COMPLETED|Overall Study||387
3017212|NCT01041573|3735405|FG003|COMPLETED|Overall Study||62
3017213|NCT01041573|3735402|FG000|NOT COMPLETED|Overall Study||5
3017214|NCT01041573|3735403|FG001|NOT COMPLETED|Overall Study||13
3017215|NCT01041573|3735404|FG002|NOT COMPLETED|Overall Study||7
3017216|NCT01041573|3735405|FG003|NOT COMPLETED|Overall Study||2
3017217|NCT01041638|3735424|FG000|STARTED|Overall Study||105
3017218|NCT01041638|3735424|FG000|COMPLETED|Overall Study||78
3017219|NCT01041638|3735424|FG000|NOT COMPLETED|Overall Study||27
3017220|NCT01041781|3735430|FG000|STARTED|Overall Study||154
3017221|NCT01041781|3735431|FG001|STARTED|Overall Study||158
3017222|NCT01041781|3735430|FG000|COMPLETED|Overall Study||154
3017223|NCT01041781|3735431|FG001|COMPLETED|Overall Study||158
3017224|NCT01041781|3735430|FG000|NOT COMPLETED|Overall Study||0
3017225|NCT01041781|3735431|FG001|NOT COMPLETED|Overall Study||0
3017226|NCT01041859|3735447|FG000|STARTED|Open-Label Titration|Of 460 total enrollment, one subject enrolled twice; this subject's second enrollment is excluded.|459
3017227|NCT01041859|3735448|FG001|STARTED|Open-Label Titration||0
3017228|NCT01041859|3735449|FG002|STARTED|Open-Label Titration||0
3017229|NCT01041859|3735447|FG000|COMPLETED|Open-Label Titration|Of 358 completed subjects, 320 were randomized to the Double-Blind Maintenance Period.|358
3017230|NCT01041859|3735448|FG001|COMPLETED|Open-Label Titration||0
3165490|NCT01899742|3893057|FG000|STARTED|Overall Study||247
3165491|NCT01899742|3893058|FG001|STARTED|Overall Study||247
3165492|NCT01899742|3893057|FG000|COMPLETED|Overall Study||230
3165493|NCT01899742|3893058|FG001|COMPLETED|Overall Study||231
3165494|NCT01899742|3893057|FG000|NOT COMPLETED|Overall Study||17
3165495|NCT01899742|3893058|FG001|NOT COMPLETED|Overall Study||16
3017231|NCT01041859|3735449|FG002|COMPLETED|Open-Label Titration||0
3017232|NCT01041859|3735447|FG000|NOT COMPLETED|Open-Label Titration||101
3017233|NCT01041859|3735448|FG001|NOT COMPLETED|Open-Label Titration||0
3017234|NCT01041859|3735449|FG002|NOT COMPLETED|Open-Label Titration||0
3017235|NCT01041859|3735447|FG000|STARTED|Double-Blind Maintenance||0
3017236|NCT01041859|3735448|FG001|STARTED|Double-Blind Maintenance|168 were randomized, 2 were not treated (1 randomized in error, 1 withdrew consent).|166
3017237|NCT01041859|3735449|FG002|STARTED|Double-Blind Maintenance|152 randomized, all were treated.|152
3017238|NCT01041859|3735447|FG000|COMPLETED|Double-Blind Maintenance||0
3017239|NCT01041859|3735448|FG001|COMPLETED|Double-Blind Maintenance||120
3017240|NCT01041859|3735449|FG002|COMPLETED|Double-Blind Maintenance||107
3017241|NCT01041859|3735447|FG000|NOT COMPLETED|Double-Blind Maintenance||0
3017242|NCT01041859|3735448|FG001|NOT COMPLETED|Double-Blind Maintenance||46
3017243|NCT01041859|3735449|FG002|NOT COMPLETED|Double-Blind Maintenance||45
3017244|NCT01041976|3735458|FG000|STARTED|Overall Study||42
3017245|NCT01041976|3735459|FG001|STARTED|Overall Study||42
3017246|NCT01041976|3735458|FG000|6 Month Follow-up|Overall Study||39
3017247|NCT01041976|3735459|FG001|6 Month Follow-up|Overall Study||41
3017248|NCT01041976|3735458|FG000|12 Month Follow-up|Overall Study||37
3017249|NCT01041976|3735459|FG001|12 Month Follow-up|Overall Study||38
3017250|NCT01041976|3735458|FG000|18 Month Follow-up|Overall Study||37
3017251|NCT01041976|3735459|FG001|18 Month Follow-up|Overall Study||38
3017252|NCT01041976|3735458|FG000|COMPLETED|Overall Study||37
3017253|NCT01041976|3735459|FG001|COMPLETED|Overall Study||38
3017254|NCT01041976|3735458|FG000|NOT COMPLETED|Overall Study||5
3017255|NCT01041976|3735459|FG001|NOT COMPLETED|Overall Study||4
3017256|NCT01042093|3735469|FG000|STARTED|Overall Study||40
3017257|NCT01042093|3735470|FG001|STARTED|Overall Study||40
3165496|NCT01899768|3893064|FG000|STARTED|Part A||16
3017258|NCT01042093|3735471|FG002|STARTED|Overall Study||40
3017259|NCT01042093|3735472|FG003|STARTED|Overall Study||40
3017260|NCT01042093|3735469|FG000|COMPLETED|Overall Study||38
3017261|NCT01042093|3735470|FG001|COMPLETED|Overall Study||38
3017262|NCT01042093|3735471|FG002|COMPLETED|Overall Study||38
3017263|NCT01042093|3735472|FG003|COMPLETED|Overall Study||36
3017264|NCT01042093|3735469|FG000|NOT COMPLETED|Overall Study||2
3017265|NCT01042093|3735470|FG001|NOT COMPLETED|Overall Study||2
3017266|NCT01042093|3735471|FG002|NOT COMPLETED|Overall Study||2
3017267|NCT01042093|3735472|FG003|NOT COMPLETED|Overall Study||4
3017268|NCT01042145|3735487|FG000|STARTED|Overall Study||41
3017269|NCT01042145|3735488|FG001|STARTED|Overall Study||46
3017270|NCT01042145|3735487|FG000|COMPLETED|Overall Study||40
3017271|NCT01042145|3735488|FG001|COMPLETED|Overall Study||45
3017272|NCT01042145|3735487|FG000|NOT COMPLETED|Overall Study||1
3017273|NCT01042145|3735488|FG001|NOT COMPLETED|Overall Study||1
3017274|NCT01042158|3735494|FG000|STARTED|Overall Study||25
3017275|NCT01042158|3735494|FG000|COMPLETED|Overall Study||24
3017276|NCT01042158|3735494|FG000|NOT COMPLETED|Overall Study||1
3017277|NCT01042236|3735498|FG000|STARTED|Treatment Period 1||3
3017278|NCT01042236|3735499|FG001|STARTED|Treatment Period 1||4
3017279|NCT01042236|3735500|FG002|STARTED|Treatment Period 1||3
3017280|NCT01042236|3735501|FG003|STARTED|Treatment Period 1||5
3017281|NCT01042236|3735502|FG004|STARTED|Treatment Period 1||4
3017282|NCT01042236|3735503|FG005|STARTED|Treatment Period 1||3
3017283|NCT01042236|3735498|FG000|COMPLETED|Treatment Period 1||3
3017284|NCT01042236|3735499|FG001|COMPLETED|Treatment Period 1||3
3017285|NCT01042236|3735500|FG002|COMPLETED|Treatment Period 1||3
3017286|NCT01042236|3735501|FG003|COMPLETED|Treatment Period 1||5
3017287|NCT01042236|3735502|FG004|COMPLETED|Treatment Period 1||3
3017288|NCT01042236|3735503|FG005|COMPLETED|Treatment Period 1||3
3017289|NCT01042236|3735498|FG000|NOT COMPLETED|Treatment Period 1||0
3017290|NCT01042236|3735499|FG001|NOT COMPLETED|Treatment Period 1||1
3017291|NCT01042236|3735500|FG002|NOT COMPLETED|Treatment Period 1||0
3017292|NCT01042236|3735501|FG003|NOT COMPLETED|Treatment Period 1||0
3017293|NCT01042236|3735502|FG004|NOT COMPLETED|Treatment Period 1||1
3017294|NCT01042236|3735503|FG005|NOT COMPLETED|Treatment Period 1||0
3017295|NCT01042236|3735498|FG000|STARTED|Treatment Period 2||3
3017296|NCT01042236|3735499|FG001|STARTED|Treatment Period 2||3
3017297|NCT01042236|3735500|FG002|STARTED|Treatment Period 2||3
3017298|NCT01042236|3735501|FG003|STARTED|Treatment Period 2||5
3017299|NCT01042236|3735502|FG004|STARTED|Treatment Period 2||3
3017300|NCT01042236|3735503|FG005|STARTED|Treatment Period 2||3
3017301|NCT01042236|3735498|FG000|COMPLETED|Treatment Period 2||3
3017302|NCT01042236|3735499|FG001|COMPLETED|Treatment Period 2||3
3017303|NCT01042236|3735500|FG002|COMPLETED|Treatment Period 2||3
3017304|NCT01042236|3735501|FG003|COMPLETED|Treatment Period 2||5
3017305|NCT01042236|3735502|FG004|COMPLETED|Treatment Period 2||3
3017306|NCT01042236|3735503|FG005|COMPLETED|Treatment Period 2||3
3017307|NCT01042236|3735498|FG000|NOT COMPLETED|Treatment Period 2||0
3017308|NCT01042236|3735499|FG001|NOT COMPLETED|Treatment Period 2||0
3017309|NCT01042236|3735500|FG002|NOT COMPLETED|Treatment Period 2||0
3017310|NCT01042236|3735501|FG003|NOT COMPLETED|Treatment Period 2||0
3017311|NCT01042236|3735502|FG004|NOT COMPLETED|Treatment Period 2||0
3017312|NCT01042236|3735503|FG005|NOT COMPLETED|Treatment Period 2||0
3017313|NCT01042236|3735498|FG000|STARTED|Treatment Period 3||3
3017314|NCT01042236|3735499|FG001|STARTED|Treatment Period 3||3
3017315|NCT01042236|3735500|FG002|STARTED|Treatment Period 3||3
3017316|NCT01042236|3735501|FG003|STARTED|Treatment Period 3||5
3017317|NCT01042236|3735502|FG004|STARTED|Treatment Period 3||3
3017318|NCT01042236|3735503|FG005|STARTED|Treatment Period 3||3
3017319|NCT01042236|3735498|FG000|COMPLETED|Treatment Period 3||3
3017320|NCT01042236|3735499|FG001|COMPLETED|Treatment Period 3||3
3017321|NCT01042236|3735500|FG002|COMPLETED|Treatment Period 3||3
3017322|NCT01042236|3735501|FG003|COMPLETED|Treatment Period 3||3
3017323|NCT01042236|3735502|FG004|COMPLETED|Treatment Period 3||3
3017324|NCT01042236|3735503|FG005|COMPLETED|Treatment Period 3||3
3017325|NCT01042236|3735498|FG000|NOT COMPLETED|Treatment Period 3||0
3017326|NCT01042236|3735499|FG001|NOT COMPLETED|Treatment Period 3||0
3017327|NCT01042236|3735500|FG002|NOT COMPLETED|Treatment Period 3||0
3017328|NCT01042236|3735501|FG003|NOT COMPLETED|Treatment Period 3||2
3017329|NCT01042236|3735502|FG004|NOT COMPLETED|Treatment Period 3||0
3017330|NCT01042236|3735503|FG005|NOT COMPLETED|Treatment Period 3||0
3017331|NCT01042288|3735511|FG000|STARTED|Overall Study||69
3017332|NCT01042288|3735511|FG000|Maintenance|Overall Study||27
3017333|NCT01042288|3735511|FG000|COMPLETED|Overall Study|Patients remained on maintenance until disease progression, toxicity or other reason to come off|0
3017334|NCT01042288|3735511|FG000|NOT COMPLETED|Overall Study||69
3017335|NCT01042366|3735518|FG000|STARTED|Overall Study||5
3017336|NCT01042366|3735519|FG001|STARTED|Overall Study||6
3017337|NCT01042366|3735520|FG002|STARTED|Overall Study||4
3017338|NCT01042366|3735518|FG000|COMPLETED|Overall Study||5
3017339|NCT01042366|3735519|FG001|COMPLETED|Overall Study||6
3017340|NCT01042366|3735520|FG002|COMPLETED|Overall Study||4
3017341|NCT01042366|3735518|FG000|NOT COMPLETED|Overall Study||0
3017342|NCT01042366|3735519|FG001|NOT COMPLETED|Overall Study||0
3017343|NCT01042366|3735520|FG002|NOT COMPLETED|Overall Study||0
3017344|NCT01042392|3735528|FG000|STARTED|Period II(Randomized,Double Blinded,8wk)||257
3017345|NCT01042392|3735529|FG001|STARTED|Period II(Randomized,Double Blinded,8wk)|This arm is used only in Period III.|0
3017346|NCT01042392|3735530|FG002|STARTED|Period II(Randomized,Double Blinded,8wk)||249
3017347|NCT01042392|3735531|FG003|STARTED|Period II(Randomized,Double Blinded,8wk)|This arm is used only in Period III.|0
3017348|NCT01042392|3735528|FG000|Intent to Treat (ITT)|Period II(Randomized,Double Blinded,8wk)|ITT excluded patients from centers where 90% of BP measurements were rounded to 5 or 0|222
3017349|NCT01042392|3735529|FG001|Intent to Treat (ITT)|Period II(Randomized,Double Blinded,8wk)||0
3017350|NCT01042392|3735530|FG002|Intent to Treat (ITT)|Period II(Randomized,Double Blinded,8wk)||222
3017351|NCT01042392|3735531|FG003|Intent to Treat (ITT)|Period II(Randomized,Double Blinded,8wk)||0
3017352|NCT01042392|3735528|FG000|COMPLETED|Period II(Randomized,Double Blinded,8wk)||247
3017353|NCT01042392|3735529|FG001|COMPLETED|Period II(Randomized,Double Blinded,8wk)||0
3017354|NCT01042392|3735530|FG002|COMPLETED|Period II(Randomized,Double Blinded,8wk)||241
3017355|NCT01042392|3735531|FG003|COMPLETED|Period II(Randomized,Double Blinded,8wk)||0
3017356|NCT01042392|3735528|FG000|NOT COMPLETED|Period II(Randomized,Double Blinded,8wk)||10
3017357|NCT01042392|3735529|FG001|NOT COMPLETED|Period II(Randomized,Double Blinded,8wk)||0
3017358|NCT01042392|3735530|FG002|NOT COMPLETED|Period II(Randomized,Double Blinded,8wk)||8
3017359|NCT01042392|3735531|FG003|NOT COMPLETED|Period II(Randomized,Double Blinded,8wk)||0
3017360|NCT01042392|3735528|FG000|STARTED|Period III (Unblinded,Controlled, 1 Day)||129
3017361|NCT01042392|3735529|FG001|STARTED|Period III (Unblinded,Controlled, 1 Day)||118
3017362|NCT01042392|3735530|FG002|STARTED|Period III (Unblinded,Controlled, 1 Day)||119
3017363|NCT01042392|3735531|FG003|STARTED|Period III (Unblinded,Controlled, 1 Day)||122
3017364|NCT01042392|3735528|FG000|Per Protocol Missed-dose (PPMD)|Period III (Unblinded,Controlled, 1 Day)|PPMD excluded patients violated protocol instructions for period 3 (duration and treatment intake)|98
3017365|NCT01042392|3735529|FG001|Per Protocol Missed-dose (PPMD)|Period III (Unblinded,Controlled, 1 Day)||73
3017366|NCT01042392|3735530|FG002|Per Protocol Missed-dose (PPMD)|Period III (Unblinded,Controlled, 1 Day)||93
3017367|NCT01042392|3735531|FG003|Per Protocol Missed-dose (PPMD)|Period III (Unblinded,Controlled, 1 Day)||82
3017368|NCT01042392|3735528|FG000|COMPLETED|Period III (Unblinded,Controlled, 1 Day)||127
3017369|NCT01042392|3735529|FG001|COMPLETED|Period III (Unblinded,Controlled, 1 Day)||117
3017370|NCT01042392|3735530|FG002|COMPLETED|Period III (Unblinded,Controlled, 1 Day)||115
3017371|NCT01042392|3735531|FG003|COMPLETED|Period III (Unblinded,Controlled, 1 Day)||121
3017372|NCT01042392|3735528|FG000|NOT COMPLETED|Period III (Unblinded,Controlled, 1 Day)||2
3017373|NCT01042392|3735529|FG001|NOT COMPLETED|Period III (Unblinded,Controlled, 1 Day)||1
3017374|NCT01042392|3735530|FG002|NOT COMPLETED|Period III (Unblinded,Controlled, 1 Day)||4
3017375|NCT01042392|3735531|FG003|NOT COMPLETED|Period III (Unblinded,Controlled, 1 Day)||1
3017376|NCT01042496|3735545|FG000|STARTED|Overall Study||29
3017377|NCT01042496|3735546|FG001|STARTED|Overall Study||33
3017378|NCT01042496|3735545|FG000|COMPLETED|Overall Study||29
3017379|NCT01042496|3735546|FG001|COMPLETED|Overall Study||33
3017380|NCT01042496|3735545|FG000|NOT COMPLETED|Overall Study||0
3017381|NCT01042496|3735546|FG001|NOT COMPLETED|Overall Study||0
3017382|NCT01042509|3735556|FG000|STARTED|Overall Study||15
3017383|NCT01042509|3735556|FG000|COMPLETED|Overall Study||15
3017384|NCT01042509|3735556|FG000|NOT COMPLETED|Overall Study||0
3017385|NCT01042535|3735560|FG000|STARTED|Overall Study||44
3017386|NCT01042535|3735560|FG000|COMPLETED|Overall Study||36
3017387|NCT01042535|3735560|FG000|NOT COMPLETED|Overall Study||8
3017388|NCT01042600|3735566|FG000|STARTED|Overall Study||31
3017389|NCT01042600|3735567|FG001|STARTED|Overall Study||30
3017390|NCT01042600|3735566|FG000|COMPLETED|Overall Study||30
3017391|NCT01042600|3735567|FG001|COMPLETED|Overall Study||30
3017392|NCT01042600|3735566|FG000|NOT COMPLETED|Overall Study||1
3017393|NCT01042600|3735567|FG001|NOT COMPLETED|Overall Study||0
3017394|NCT01042613|3735576|FG000|STARTED|Overall Study||72
3017395|NCT01042613|3735577|FG001|STARTED|Overall Study||74
3017396|NCT01042613|3735576|FG000|COMPLETED|Overall Study||72
3017397|NCT01042613|3735577|FG001|COMPLETED|Overall Study||74
3165497|NCT01899768|3893064|FG000|COMPLETED|Part A||13
3165498|NCT01899768|3893064|FG000|NOT COMPLETED|Part A||3
3165499|NCT01899768|3893064|FG000|STARTED|Part B||13
3165500|NCT01899768|3893064|FG000|COMPLETED|Part B||11
3017398|NCT01042613|3735576|FG000|NOT COMPLETED|Overall Study||0
3017399|NCT01042613|3735577|FG001|NOT COMPLETED|Overall Study||0
3017400|NCT01042678|3735586|FG000|STARTED|Overall Study||6
3017401|NCT01042678|3735587|FG001|STARTED|Overall Study||6
3017402|NCT01042678|3735588|FG002|STARTED|Overall Study||6
3017403|NCT01042678|3735589|FG003|STARTED|Overall Study||0
3017404|NCT01042678|3735590|FG004|STARTED|Overall Study||0
3017405|NCT01042678|3735591|FG005|STARTED|Overall Study||0
3017406|NCT01042678|3735586|FG000|COMPLETED|Overall Study||5
3017407|NCT01042678|3735587|FG001|COMPLETED|Overall Study||6
3017408|NCT01042678|3735588|FG002|COMPLETED|Overall Study||6
3017409|NCT01042678|3735589|FG003|COMPLETED|Overall Study||0
3017410|NCT01042678|3735590|FG004|COMPLETED|Overall Study||0
3017411|NCT01042678|3735591|FG005|COMPLETED|Overall Study||0
3017412|NCT01042678|3735586|FG000|NOT COMPLETED|Overall Study||1
3017413|NCT01042678|3735587|FG001|NOT COMPLETED|Overall Study||0
3017414|NCT01042678|3735588|FG002|NOT COMPLETED|Overall Study||0
3017415|NCT01042678|3735589|FG003|NOT COMPLETED|Overall Study||0
3017416|NCT01042678|3735590|FG004|NOT COMPLETED|Overall Study||0
3017417|NCT01042678|3735591|FG005|NOT COMPLETED|Overall Study||0
3017418|NCT01042795|3735599|FG000|STARTED|Dosing Period - 16 Weeks of Daily Doses||7
3165501|NCT01899768|3893064|FG000|NOT COMPLETED|Part B||2
3165502|NCT01899768|3893064|FG000|STARTED|Part C||11
3165503|NCT01899768|3893064|FG000|COMPLETED|Part C||11
3017419|NCT01042795|3735599|FG000|COMPLETED|Dosing Period - 16 Weeks of Daily Doses||2
3017420|NCT01042795|3735599|FG000|NOT COMPLETED|Dosing Period - 16 Weeks of Daily Doses||5
3017421|NCT01042795|3735599|FG000|STARTED|Follow up - 22 Months After Drug Start||2
3017422|NCT01042795|3735599|FG000|COMPLETED|Follow up - 22 Months After Drug Start||0
3017423|NCT01042795|3735599|FG000|NOT COMPLETED|Follow up - 22 Months After Drug Start||2
3017424|NCT01042938|3735605|FG000|STARTED|Overall Study|1 withdrew before radiation; 1 ineligible due to other clinical trial; 1 non-compliance.|17
3017425|NCT01042938|3735606|FG001|STARTED|Overall Study|1 withdrew before radiation; 1 non-compliance.|18
3017426|NCT01042938|3735605|FG000|COMPLETED|Overall Study||14
3017427|NCT01042938|3735606|FG001|COMPLETED|Overall Study||16
3017428|NCT01042938|3735605|FG000|NOT COMPLETED|Overall Study||3
3017429|NCT01042938|3735606|FG001|NOT COMPLETED|Overall Study||2
3017430|NCT01042977|3735616|FG000|STARTED|Overall Study|Of 482 part. 480 were included in full analysis set. Thereof, 1 part. treated but not randomized.|482
3017431|NCT01042977|3735617|FG001|STARTED|Overall Study|Of the 483 participants only 482 were included in the full analysis set.|483
3017432|NCT01042977|3735616|FG000|COMPLETED|Overall Study||441
3017433|NCT01042977|3735617|FG001|COMPLETED|Overall Study||428
3017434|NCT01042977|3735616|FG000|NOT COMPLETED|Overall Study||41
3017435|NCT01042977|3735617|FG001|NOT COMPLETED|Overall Study||55
3017436|NCT01043094|3735625|FG000|STARTED|Overall Study||8
3017437|NCT01043094|3735626|FG001|STARTED|Overall Study||8
3017438|NCT01043094|3735625|FG000|COMPLETED|Overall Study||8
3017439|NCT01043094|3735626|FG001|COMPLETED|Overall Study||8
3017440|NCT01043094|3735625|FG000|NOT COMPLETED|Overall Study||0
3017441|NCT01043094|3735626|FG001|NOT COMPLETED|Overall Study||0
3017442|NCT01043133|3735634|FG000|STARTED|Overall Study||75
3017443|NCT01043133|3735635|FG001|STARTED|Overall Study||80
3017444|NCT01043133|3735634|FG000|COMPLETED|Overall Study||74
3017445|NCT01043133|3735635|FG001|COMPLETED|Overall Study||78
3017446|NCT01043133|3735634|FG000|NOT COMPLETED|Overall Study||1
3017447|NCT01043133|3735635|FG001|NOT COMPLETED|Overall Study||2
3017448|NCT01043146|3735647|FG000|STARTED|Overall Study||10
3017449|NCT01043146|3735648|FG001|STARTED|Overall Study||8
3017450|NCT01043146|3735649|FG002|STARTED|Overall Study||8
3017451|NCT01043146|3735650|FG003|STARTED|Overall Study||8
3017452|NCT01043146|3735651|FG004|STARTED|Overall Study||8
3017453|NCT01043146|3735652|FG005|STARTED|Overall Study||8
3017454|NCT01043146|3735647|FG000|COMPLETED|Overall Study||10
3017455|NCT01043146|3735648|FG001|COMPLETED|Overall Study||8
3017456|NCT01043146|3735649|FG002|COMPLETED|Overall Study||8
3017457|NCT01043146|3735650|FG003|COMPLETED|Overall Study||8
3017458|NCT01043146|3735651|FG004|COMPLETED|Overall Study||8
3017459|NCT01043146|3735652|FG005|COMPLETED|Overall Study||8
3017460|NCT01043146|3735647|FG000|NOT COMPLETED|Overall Study||0
3017461|NCT01043146|3735648|FG001|NOT COMPLETED|Overall Study||0
3017462|NCT01043146|3735649|FG002|NOT COMPLETED|Overall Study||0
3017463|NCT01043146|3735650|FG003|NOT COMPLETED|Overall Study||0
3017464|NCT01043146|3735651|FG004|NOT COMPLETED|Overall Study||0
3017465|NCT01043146|3735652|FG005|NOT COMPLETED|Overall Study||0
3017466|NCT01043185|3735666|FG000|STARTED|Period 1 - First Intervention||3
3017467|NCT01043185|3735667|FG001|STARTED|Period 1 - First Intervention||2
3017468|NCT01043185|3735668|FG002|STARTED|Period 1 - First Intervention||3
3017469|NCT01043185|3735669|FG003|STARTED|Period 1 - First Intervention||2
3017470|NCT01043185|3735670|FG004|STARTED|Period 1 - First Intervention||2
3017471|NCT01043185|3735671|FG005|STARTED|Period 1 - First Intervention||3
3017472|NCT01043185|3735672|FG006|STARTED|Period 1 - First Intervention||3
3017473|NCT01043185|3735673|FG007|STARTED|Period 1 - First Intervention||3
3017474|NCT01043185|3735674|FG008|STARTED|Period 1 - First Intervention||3
3017475|NCT01043185|3735675|FG009|STARTED|Period 1 - First Intervention||3
3017476|NCT01043185|3735666|FG000|COMPLETED|Period 1 - First Intervention||3
3017477|NCT01043185|3735667|FG001|COMPLETED|Period 1 - First Intervention||2
3017478|NCT01043185|3735668|FG002|COMPLETED|Period 1 - First Intervention||3
3017479|NCT01043185|3735669|FG003|COMPLETED|Period 1 - First Intervention||2
3017480|NCT01043185|3735670|FG004|COMPLETED|Period 1 - First Intervention||2
3017481|NCT01043185|3735671|FG005|COMPLETED|Period 1 - First Intervention||3
3017482|NCT01043185|3735672|FG006|COMPLETED|Period 1 - First Intervention||3
3017483|NCT01043185|3735673|FG007|COMPLETED|Period 1 - First Intervention||3
3017484|NCT01043185|3735674|FG008|COMPLETED|Period 1 - First Intervention||3
3017485|NCT01043185|3735675|FG009|COMPLETED|Period 1 - First Intervention||3
3017486|NCT01043185|3735666|FG000|NOT COMPLETED|Period 1 - First Intervention||0
3017487|NCT01043185|3735667|FG001|NOT COMPLETED|Period 1 - First Intervention||0
3017488|NCT01043185|3735668|FG002|NOT COMPLETED|Period 1 - First Intervention||0
3017489|NCT01043185|3735669|FG003|NOT COMPLETED|Period 1 - First Intervention||0
3017490|NCT01043185|3735670|FG004|NOT COMPLETED|Period 1 - First Intervention||0
3017491|NCT01043185|3735671|FG005|NOT COMPLETED|Period 1 - First Intervention||0
3017492|NCT01043185|3735672|FG006|NOT COMPLETED|Period 1 - First Intervention||0
3017493|NCT01043185|3735673|FG007|NOT COMPLETED|Period 1 - First Intervention||0
3017494|NCT01043185|3735674|FG008|NOT COMPLETED|Period 1 - First Intervention||0
3017495|NCT01043185|3735675|FG009|NOT COMPLETED|Period 1 - First Intervention||0
3017496|NCT01043185|3735666|FG000|STARTED|Period 2 - First Washout Period||3
3017497|NCT01043185|3735667|FG001|STARTED|Period 2 - First Washout Period||2
3017498|NCT01043185|3735668|FG002|STARTED|Period 2 - First Washout Period||3
3017499|NCT01043185|3735669|FG003|STARTED|Period 2 - First Washout Period||2
3017500|NCT01043185|3735670|FG004|STARTED|Period 2 - First Washout Period||2
3017501|NCT01043185|3735671|FG005|STARTED|Period 2 - First Washout Period||3
3017502|NCT01043185|3735672|FG006|STARTED|Period 2 - First Washout Period||3
3017503|NCT01043185|3735673|FG007|STARTED|Period 2 - First Washout Period||3
3017504|NCT01043185|3735674|FG008|STARTED|Period 2 - First Washout Period||3
3017505|NCT01043185|3735675|FG009|STARTED|Period 2 - First Washout Period||3
3017506|NCT01043185|3735666|FG000|COMPLETED|Period 2 - First Washout Period||3
3017507|NCT01043185|3735667|FG001|COMPLETED|Period 2 - First Washout Period||2
3308313|NCT03019744|4041621|FG001|STARTED|Overall Study||44
3308314|NCT03019744|4041620|FG000|COMPLETED|Overall Study||32
3308315|NCT03019744|4041621|FG001|COMPLETED|Overall Study||36
3308316|NCT03019744|4041620|FG000|NOT COMPLETED|Overall Study||6
3308317|NCT03019744|4041621|FG001|NOT COMPLETED|Overall Study||8
3017508|NCT01043185|3735668|FG002|COMPLETED|Period 2 - First Washout Period||3
3017509|NCT01043185|3735669|FG003|COMPLETED|Period 2 - First Washout Period||2
3017510|NCT01043185|3735670|FG004|COMPLETED|Period 2 - First Washout Period||2
3017511|NCT01043185|3735671|FG005|COMPLETED|Period 2 - First Washout Period||3
3017512|NCT01043185|3735672|FG006|COMPLETED|Period 2 - First Washout Period||3
3017513|NCT01043185|3735673|FG007|COMPLETED|Period 2 - First Washout Period||3
3017514|NCT01043185|3735674|FG008|COMPLETED|Period 2 - First Washout Period||3
3017515|NCT01043185|3735675|FG009|COMPLETED|Period 2 - First Washout Period||3
3017516|NCT01043185|3735666|FG000|NOT COMPLETED|Period 2 - First Washout Period||0
3017517|NCT01043185|3735667|FG001|NOT COMPLETED|Period 2 - First Washout Period||0
3017518|NCT01043185|3735668|FG002|NOT COMPLETED|Period 2 - First Washout Period||0
3017519|NCT01043185|3735669|FG003|NOT COMPLETED|Period 2 - First Washout Period||0
3017520|NCT01043185|3735670|FG004|NOT COMPLETED|Period 2 - First Washout Period||0
3017521|NCT01043185|3735671|FG005|NOT COMPLETED|Period 2 - First Washout Period||0
3017522|NCT01043185|3735672|FG006|NOT COMPLETED|Period 2 - First Washout Period||0
3017523|NCT01043185|3735673|FG007|NOT COMPLETED|Period 2 - First Washout Period||0
3017524|NCT01043185|3735674|FG008|NOT COMPLETED|Period 2 - First Washout Period||0
3017525|NCT01043185|3735675|FG009|NOT COMPLETED|Period 2 - First Washout Period||0
3017526|NCT01043185|3735666|FG000|STARTED|Period 3 - Second Intervention||3
3017527|NCT01043185|3735667|FG001|STARTED|Period 3 - Second Intervention||2
3017528|NCT01043185|3735668|FG002|STARTED|Period 3 - Second Intervention||3
3017529|NCT01043185|3735669|FG003|STARTED|Period 3 - Second Intervention||2
3017530|NCT01043185|3735670|FG004|STARTED|Period 3 - Second Intervention||2
3017531|NCT01043185|3735671|FG005|STARTED|Period 3 - Second Intervention||3
3017532|NCT01043185|3735672|FG006|STARTED|Period 3 - Second Intervention||3
3017533|NCT01043185|3735673|FG007|STARTED|Period 3 - Second Intervention||3
3017534|NCT01043185|3735674|FG008|STARTED|Period 3 - Second Intervention||3
3017535|NCT01043185|3735675|FG009|STARTED|Period 3 - Second Intervention||3
3017536|NCT01043185|3735666|FG000|COMPLETED|Period 3 - Second Intervention||3
3017537|NCT01043185|3735667|FG001|COMPLETED|Period 3 - Second Intervention||2
3017538|NCT01043185|3735668|FG002|COMPLETED|Period 3 - Second Intervention||3
3017539|NCT01043185|3735669|FG003|COMPLETED|Period 3 - Second Intervention||2
3017540|NCT01043185|3735670|FG004|COMPLETED|Period 3 - Second Intervention||2
3017541|NCT01043185|3735671|FG005|COMPLETED|Period 3 - Second Intervention||3
3017542|NCT01043185|3735672|FG006|COMPLETED|Period 3 - Second Intervention||3
3017543|NCT01043185|3735673|FG007|COMPLETED|Period 3 - Second Intervention||3
3017544|NCT01043185|3735674|FG008|COMPLETED|Period 3 - Second Intervention||3
3017545|NCT01043185|3735675|FG009|COMPLETED|Period 3 - Second Intervention||3
3017546|NCT01043185|3735666|FG000|NOT COMPLETED|Period 3 - Second Intervention||0
3017547|NCT01043185|3735667|FG001|NOT COMPLETED|Period 3 - Second Intervention||0
3017548|NCT01043185|3735668|FG002|NOT COMPLETED|Period 3 - Second Intervention||0
3017549|NCT01043185|3735669|FG003|NOT COMPLETED|Period 3 - Second Intervention||0
3017550|NCT01043185|3735670|FG004|NOT COMPLETED|Period 3 - Second Intervention||0
3017551|NCT01043185|3735671|FG005|NOT COMPLETED|Period 3 - Second Intervention||0
3017552|NCT01043185|3735672|FG006|NOT COMPLETED|Period 3 - Second Intervention||0
3017553|NCT01043185|3735673|FG007|NOT COMPLETED|Period 3 - Second Intervention||0
3017554|NCT01043185|3735674|FG008|NOT COMPLETED|Period 3 - Second Intervention||0
3017555|NCT01043185|3735675|FG009|NOT COMPLETED|Period 3 - Second Intervention||0
3017556|NCT01043185|3735666|FG000|STARTED|Period 4 - Second Washout Period||3
3017557|NCT01043185|3735667|FG001|STARTED|Period 4 - Second Washout Period||2
3017558|NCT01043185|3735668|FG002|STARTED|Period 4 - Second Washout Period||3
3017559|NCT01043185|3735669|FG003|STARTED|Period 4 - Second Washout Period||2
3017560|NCT01043185|3735670|FG004|STARTED|Period 4 - Second Washout Period||2
3017561|NCT01043185|3735671|FG005|STARTED|Period 4 - Second Washout Period||3
3017562|NCT01043185|3735672|FG006|STARTED|Period 4 - Second Washout Period||3
3017563|NCT01043185|3735673|FG007|STARTED|Period 4 - Second Washout Period||3
3017564|NCT01043185|3735674|FG008|STARTED|Period 4 - Second Washout Period||3
3017565|NCT01043185|3735675|FG009|STARTED|Period 4 - Second Washout Period||3
3017566|NCT01043185|3735666|FG000|COMPLETED|Period 4 - Second Washout Period||3
3017567|NCT01043185|3735667|FG001|COMPLETED|Period 4 - Second Washout Period||2
3017568|NCT01043185|3735668|FG002|COMPLETED|Period 4 - Second Washout Period||3
3017569|NCT01043185|3735669|FG003|COMPLETED|Period 4 - Second Washout Period||2
3017570|NCT01043185|3735670|FG004|COMPLETED|Period 4 - Second Washout Period||2
3017571|NCT01043185|3735671|FG005|COMPLETED|Period 4 - Second Washout Period||3
3017572|NCT01043185|3735672|FG006|COMPLETED|Period 4 - Second Washout Period||3
3017573|NCT01043185|3735673|FG007|COMPLETED|Period 4 - Second Washout Period||3
3308318|NCT03019783|4041629|FG000|STARTED|Overall Study||29
3017574|NCT01043185|3735674|FG008|COMPLETED|Period 4 - Second Washout Period||3
3017575|NCT01043185|3735675|FG009|COMPLETED|Period 4 - Second Washout Period||3
3017576|NCT01043185|3735666|FG000|NOT COMPLETED|Period 4 - Second Washout Period||0
3017577|NCT01043185|3735667|FG001|NOT COMPLETED|Period 4 - Second Washout Period||0
3017578|NCT01043185|3735668|FG002|NOT COMPLETED|Period 4 - Second Washout Period||0
3017579|NCT01043185|3735669|FG003|NOT COMPLETED|Period 4 - Second Washout Period||0
3017580|NCT01043185|3735670|FG004|NOT COMPLETED|Period 4 - Second Washout Period||0
3017581|NCT01043185|3735671|FG005|NOT COMPLETED|Period 4 - Second Washout Period||0
3017582|NCT01043185|3735672|FG006|NOT COMPLETED|Period 4 - Second Washout Period||0
3017583|NCT01043185|3735673|FG007|NOT COMPLETED|Period 4 - Second Washout Period||0
3017584|NCT01043185|3735674|FG008|NOT COMPLETED|Period 4 - Second Washout Period||0
3017585|NCT01043185|3735675|FG009|NOT COMPLETED|Period 4 - Second Washout Period||0
3017586|NCT01043185|3735666|FG000|STARTED|Period 5 - Third Intervention||3
3017587|NCT01043185|3735667|FG001|STARTED|Period 5 - Third Intervention||2
3017588|NCT01043185|3735668|FG002|STARTED|Period 5 - Third Intervention||3
3017589|NCT01043185|3735669|FG003|STARTED|Period 5 - Third Intervention||2
3017590|NCT01043185|3735670|FG004|STARTED|Period 5 - Third Intervention||2
3017591|NCT01043185|3735671|FG005|STARTED|Period 5 - Third Intervention||3
3017592|NCT01043185|3735672|FG006|STARTED|Period 5 - Third Intervention||3
3017593|NCT01043185|3735673|FG007|STARTED|Period 5 - Third Intervention||3
3017594|NCT01043185|3735674|FG008|STARTED|Period 5 - Third Intervention||3
3017595|NCT01043185|3735675|FG009|STARTED|Period 5 - Third Intervention||3
3017596|NCT01043185|3735666|FG000|COMPLETED|Period 5 - Third Intervention||3
3017597|NCT01043185|3735667|FG001|COMPLETED|Period 5 - Third Intervention||2
3017598|NCT01043185|3735668|FG002|COMPLETED|Period 5 - Third Intervention||3
3017599|NCT01043185|3735669|FG003|COMPLETED|Period 5 - Third Intervention||2
3017600|NCT01043185|3735670|FG004|COMPLETED|Period 5 - Third Intervention||2
3017601|NCT01043185|3735671|FG005|COMPLETED|Period 5 - Third Intervention||3
3017602|NCT01043185|3735672|FG006|COMPLETED|Period 5 - Third Intervention||3
3017603|NCT01043185|3735673|FG007|COMPLETED|Period 5 - Third Intervention||3
3017604|NCT01043185|3735674|FG008|COMPLETED|Period 5 - Third Intervention||3
3017605|NCT01043185|3735675|FG009|COMPLETED|Period 5 - Third Intervention||3
3017606|NCT01043185|3735666|FG000|NOT COMPLETED|Period 5 - Third Intervention||0
3017607|NCT01043185|3735667|FG001|NOT COMPLETED|Period 5 - Third Intervention||0
3017608|NCT01043185|3735668|FG002|NOT COMPLETED|Period 5 - Third Intervention||0
3017609|NCT01043185|3735669|FG003|NOT COMPLETED|Period 5 - Third Intervention||0
3017610|NCT01043185|3735670|FG004|NOT COMPLETED|Period 5 - Third Intervention||0
3017611|NCT01043185|3735671|FG005|NOT COMPLETED|Period 5 - Third Intervention||0
3017612|NCT01043185|3735672|FG006|NOT COMPLETED|Period 5 - Third Intervention||0
3017613|NCT01043185|3735673|FG007|NOT COMPLETED|Period 5 - Third Intervention||0
3017614|NCT01043185|3735674|FG008|NOT COMPLETED|Period 5 - Third Intervention||0
3017615|NCT01043185|3735675|FG009|NOT COMPLETED|Period 5 - Third Intervention||0
3017616|NCT01043185|3735666|FG000|STARTED|Period 6 - Third Washout Period||3
3017617|NCT01043185|3735667|FG001|STARTED|Period 6 - Third Washout Period||2
3017618|NCT01043185|3735668|FG002|STARTED|Period 6 - Third Washout Period||3
3017619|NCT01043185|3735669|FG003|STARTED|Period 6 - Third Washout Period||2
3017620|NCT01043185|3735670|FG004|STARTED|Period 6 - Third Washout Period||2
3017621|NCT01043185|3735671|FG005|STARTED|Period 6 - Third Washout Period||3
3017622|NCT01043185|3735672|FG006|STARTED|Period 6 - Third Washout Period||3
3017623|NCT01043185|3735673|FG007|STARTED|Period 6 - Third Washout Period||3
3017624|NCT01043185|3735674|FG008|STARTED|Period 6 - Third Washout Period||3
3017625|NCT01043185|3735675|FG009|STARTED|Period 6 - Third Washout Period||3
3017626|NCT01043185|3735666|FG000|COMPLETED|Period 6 - Third Washout Period||3
3017627|NCT01043185|3735667|FG001|COMPLETED|Period 6 - Third Washout Period||2
3017628|NCT01043185|3735668|FG002|COMPLETED|Period 6 - Third Washout Period||3
3017629|NCT01043185|3735669|FG003|COMPLETED|Period 6 - Third Washout Period||2
3017630|NCT01043185|3735670|FG004|COMPLETED|Period 6 - Third Washout Period||2
3017631|NCT01043185|3735671|FG005|COMPLETED|Period 6 - Third Washout Period||3
3017632|NCT01043185|3735672|FG006|COMPLETED|Period 6 - Third Washout Period||3
3017633|NCT01043185|3735673|FG007|COMPLETED|Period 6 - Third Washout Period||3
3017634|NCT01043185|3735674|FG008|COMPLETED|Period 6 - Third Washout Period||2
3017635|NCT01043185|3735675|FG009|COMPLETED|Period 6 - Third Washout Period||3
3017636|NCT01043185|3735666|FG000|NOT COMPLETED|Period 6 - Third Washout Period||0
3017637|NCT01043185|3735667|FG001|NOT COMPLETED|Period 6 - Third Washout Period||0
3017638|NCT01043185|3735668|FG002|NOT COMPLETED|Period 6 - Third Washout Period||0
3017639|NCT01043185|3735669|FG003|NOT COMPLETED|Period 6 - Third Washout Period||0
3017640|NCT01043185|3735670|FG004|NOT COMPLETED|Period 6 - Third Washout Period||0
3017641|NCT01043185|3735671|FG005|NOT COMPLETED|Period 6 - Third Washout Period||0
3017642|NCT01043185|3735672|FG006|NOT COMPLETED|Period 6 - Third Washout Period||0
3017643|NCT01043185|3735673|FG007|NOT COMPLETED|Period 6 - Third Washout Period||0
3017644|NCT01043185|3735674|FG008|NOT COMPLETED|Period 6 - Third Washout Period||1
3017645|NCT01043185|3735675|FG009|NOT COMPLETED|Period 6 - Third Washout Period||0
3017646|NCT01043185|3735666|FG000|STARTED|Period 7 - Fourth Intervention||3
3017647|NCT01043185|3735667|FG001|STARTED|Period 7 - Fourth Intervention||2
3017648|NCT01043185|3735668|FG002|STARTED|Period 7 - Fourth Intervention||3
3017649|NCT01043185|3735669|FG003|STARTED|Period 7 - Fourth Intervention||2
3017650|NCT01043185|3735670|FG004|STARTED|Period 7 - Fourth Intervention||2
3017651|NCT01043185|3735671|FG005|STARTED|Period 7 - Fourth Intervention||3
3308319|NCT03019783|4041630|FG001|STARTED|Overall Study||31
3308320|NCT03019783|4041629|FG000|COMPLETED|Overall Study||29
3308321|NCT03019783|4041630|FG001|COMPLETED|Overall Study||31
3308322|NCT03019783|4041629|FG000|NOT COMPLETED|Overall Study||0
3308323|NCT03019783|4041630|FG001|NOT COMPLETED|Overall Study||0
3017652|NCT01043185|3735672|FG006|STARTED|Period 7 - Fourth Intervention||3
3017653|NCT01043185|3735673|FG007|STARTED|Period 7 - Fourth Intervention||3
3017654|NCT01043185|3735674|FG008|STARTED|Period 7 - Fourth Intervention||2
3017655|NCT01043185|3735675|FG009|STARTED|Period 7 - Fourth Intervention||3
3017656|NCT01043185|3735666|FG000|COMPLETED|Period 7 - Fourth Intervention||3
3017657|NCT01043185|3735667|FG001|COMPLETED|Period 7 - Fourth Intervention||2
3017658|NCT01043185|3735668|FG002|COMPLETED|Period 7 - Fourth Intervention||3
3017659|NCT01043185|3735669|FG003|COMPLETED|Period 7 - Fourth Intervention||2
3017660|NCT01043185|3735670|FG004|COMPLETED|Period 7 - Fourth Intervention||2
3017661|NCT01043185|3735671|FG005|COMPLETED|Period 7 - Fourth Intervention||3
3017662|NCT01043185|3735672|FG006|COMPLETED|Period 7 - Fourth Intervention||3
3017663|NCT01043185|3735673|FG007|COMPLETED|Period 7 - Fourth Intervention||3
3017664|NCT01043185|3735674|FG008|COMPLETED|Period 7 - Fourth Intervention||2
3017665|NCT01043185|3735675|FG009|COMPLETED|Period 7 - Fourth Intervention||3
3017666|NCT01043185|3735666|FG000|NOT COMPLETED|Period 7 - Fourth Intervention||0
3017667|NCT01043185|3735667|FG001|NOT COMPLETED|Period 7 - Fourth Intervention||0
3017668|NCT01043185|3735668|FG002|NOT COMPLETED|Period 7 - Fourth Intervention||0
3017669|NCT01043185|3735669|FG003|NOT COMPLETED|Period 7 - Fourth Intervention||0
3017670|NCT01043185|3735670|FG004|NOT COMPLETED|Period 7 - Fourth Intervention||0
3017671|NCT01043185|3735671|FG005|NOT COMPLETED|Period 7 - Fourth Intervention||0
3017672|NCT01043185|3735672|FG006|NOT COMPLETED|Period 7 - Fourth Intervention||0
3017673|NCT01043185|3735673|FG007|NOT COMPLETED|Period 7 - Fourth Intervention||0
3017674|NCT01043185|3735674|FG008|NOT COMPLETED|Period 7 - Fourth Intervention||0
3017675|NCT01043185|3735675|FG009|NOT COMPLETED|Period 7 - Fourth Intervention||0
3017676|NCT01043393|3735689|FG000|STARTED|Overall Study||12
3017677|NCT01043393|3735690|FG001|STARTED|Overall Study||12
3017678|NCT01043393|3735689|FG000|COMPLETED|Overall Study||12
3017679|NCT01043393|3735690|FG001|COMPLETED|Overall Study||12
3017680|NCT01043393|3735689|FG000|NOT COMPLETED|Overall Study||0
3017681|NCT01043393|3735690|FG001|NOT COMPLETED|Overall Study||0
3017682|NCT01043432|3735700|FG000|STARTED|Overall Study||22
3017683|NCT01043432|3735701|FG001|STARTED|Overall Study||51
3017684|NCT01043432|3735702|FG002|STARTED|Overall Study||12
3017685|NCT01043432|3735703|FG003|STARTED|Overall Study||48
3017686|NCT01043432|3735700|FG000|COMPLETED|Overall Study||22
3017687|NCT01043432|3735701|FG001|COMPLETED|Overall Study||51
3017688|NCT01043432|3735702|FG002|COMPLETED|Overall Study||12
3017689|NCT01043432|3735703|FG003|COMPLETED|Overall Study||48
3017690|NCT01043432|3735700|FG000|NOT COMPLETED|Overall Study||0
3017691|NCT01043432|3735701|FG001|NOT COMPLETED|Overall Study||0
3017692|NCT01043432|3735702|FG002|NOT COMPLETED|Overall Study||0
3017693|NCT01043432|3735703|FG003|NOT COMPLETED|Overall Study||0
3017694|NCT01043523|3735710|FG000|STARTED|Overall Study||52
3017695|NCT01043523|3735710|FG000|Participants With Unenhanced Images|Overall Study||51
3017696|NCT01043523|3735710|FG000|COMPLETED|Overall Study||52
3017697|NCT01043523|3735710|FG000|NOT COMPLETED|Overall Study||0
3017698|NCT01043562|3735718|FG000|STARTED|Overall Study||20
3017699|NCT01043562|3735718|FG000|COMPLETED|Overall Study||20
3017700|NCT01043562|3735718|FG000|NOT COMPLETED|Overall Study||0
3017701|NCT01043640|3735725|FG000|STARTED|Overall Study||46
3017702|NCT01043640|3735725|FG000|COMPLETED|Overall Study||46
3017703|NCT01043640|3735725|FG000|NOT COMPLETED|Overall Study||0
3017704|NCT01043653|3735729|FG000|STARTED|Overall Study||250
3017705|NCT01043653|3735729|FG000|COMPLETED|Overall Study||186
3017706|NCT01043653|3735729|FG000|NOT COMPLETED|Overall Study||64
3017707|NCT01043705|3735736|FG000|STARTED|Overall Study||459
3017708|NCT01043705|3735737|FG001|STARTED|Overall Study||578
3017709|NCT01043705|3735738|FG002|STARTED|Overall Study||578
3017710|NCT01043705|3735736|FG000|COMPLETED|Overall Study||352
3017711|NCT01043705|3735737|FG001|COMPLETED|Overall Study||447
3017712|NCT01043705|3735738|FG002|COMPLETED|Overall Study||498
3017713|NCT01043705|3735736|FG000|NOT COMPLETED|Overall Study||107
3017714|NCT01043705|3735737|FG001|NOT COMPLETED|Overall Study||131
3017715|NCT01043705|3735738|FG002|NOT COMPLETED|Overall Study||80
3017716|NCT01043874|3735746|FG000|STARTED|Overall Study||45
3017717|NCT01043874|3735746|FG000|COMPLETED|Overall Study||39
3017718|NCT01043874|3735746|FG000|NOT COMPLETED|Overall Study||6
3308324|NCT03019796|4041636|FG000|STARTED|First Intervention Drug Tests||20
3308325|NCT03019796|4041637|FG001|STARTED|First Intervention Drug Tests||20
3308326|NCT03019796|4041636|FG000|COMPLETED|First Intervention Drug Tests||20
3308327|NCT03019796|4041637|FG001|COMPLETED|First Intervention Drug Tests||20
3308328|NCT03019796|4041636|FG000|NOT COMPLETED|First Intervention Drug Tests||0
3308329|NCT03019796|4041637|FG001|NOT COMPLETED|First Intervention Drug Tests||0
3308330|NCT03019796|4041636|FG000|STARTED|Second Intervention Training (4 Months)||20
3308331|NCT03019796|4041637|FG001|STARTED|Second Intervention Training (4 Months)||20
3017719|NCT01043926|3735752|FG000|STARTED|Overall Study||8
3017720|NCT01043926|3735753|FG001|STARTED|Overall Study||8
3017721|NCT01043926|3735754|FG002|STARTED|Overall Study||0
3017722|NCT01043926|3735755|FG003|STARTED|Overall Study||0
3017723|NCT01043926|3735752|FG000|COMPLETED|Overall Study||8
3017724|NCT01043926|3735753|FG001|COMPLETED|Overall Study||8
3017725|NCT01043926|3735754|FG002|COMPLETED|Overall Study||0
3017726|NCT01043926|3735755|FG003|COMPLETED|Overall Study||0
3017727|NCT01043926|3735752|FG000|NOT COMPLETED|Overall Study||0
3017728|NCT01043926|3735753|FG001|NOT COMPLETED|Overall Study||0
3017729|NCT01043926|3735754|FG002|NOT COMPLETED|Overall Study||0
3017730|NCT01043926|3735755|FG003|NOT COMPLETED|Overall Study||0
3017731|NCT01043939|3735763|FG000|STARTED|First Intervention||12
3017732|NCT01043939|3735764|FG001|STARTED|First Intervention||12
3017733|NCT01043939|3735763|FG000|COMPLETED|First Intervention||12
3017734|NCT01043939|3735764|FG001|COMPLETED|First Intervention||12
3017735|NCT01043939|3735763|FG000|NOT COMPLETED|First Intervention||0
3017736|NCT01043939|3735764|FG001|NOT COMPLETED|First Intervention||0
3017737|NCT01043939|3735763|FG000|STARTED|Washout Period||12
3017738|NCT01043939|3735764|FG001|STARTED|Washout Period||12
3017739|NCT01043939|3735763|FG000|COMPLETED|Washout Period||12
3017740|NCT01043939|3735764|FG001|COMPLETED|Washout Period||12
3017741|NCT01043939|3735763|FG000|NOT COMPLETED|Washout Period||0
3017742|NCT01043939|3735764|FG001|NOT COMPLETED|Washout Period||0
3017743|NCT01043939|3735763|FG000|STARTED|Second Intervention||12
3017744|NCT01043939|3735764|FG001|STARTED|Second Intervention||12
3165504|NCT01899768|3893064|FG000|NOT COMPLETED|Part C||0
3165505|NCT01899911|3893072|FG000|STARTED|Overall Study||12
3165506|NCT01899911|3893072|FG000|COMPLETED|Overall Study||12
3165507|NCT01899911|3893072|FG000|NOT COMPLETED|Overall Study||0
3017745|NCT01043939|3735763|FG000|COMPLETED|Second Intervention||12
3017746|NCT01043939|3735764|FG001|COMPLETED|Second Intervention||12
3017747|NCT01043939|3735763|FG000|NOT COMPLETED|Second Intervention||0
3017748|NCT01043939|3735764|FG001|NOT COMPLETED|Second Intervention||0
3017749|NCT01044030|3735773|FG000|STARTED|Overall Study||160
3017750|NCT01044030|3735774|FG001|STARTED|Overall Study||166
3017751|NCT01044030|3735773|FG000|COMPLETED|Overall Study||141
3017752|NCT01044030|3735774|FG001|COMPLETED|Overall Study||146
3017753|NCT01044030|3735773|FG000|NOT COMPLETED|Overall Study||19
3017754|NCT01044030|3735774|FG001|NOT COMPLETED|Overall Study||20
3017755|NCT01044212|3735782|FG000|STARTED|Overall Study||35
3017756|NCT01044212|3735783|FG001|STARTED|Overall Study||37
3017757|NCT01044212|3735782|FG000|COMPLETED|Overall Study||30
3017758|NCT01044212|3735783|FG001|COMPLETED|Overall Study||30
3017759|NCT01044212|3735782|FG000|NOT COMPLETED|Overall Study||5
3017760|NCT01044212|3735783|FG001|NOT COMPLETED|Overall Study||7
3017761|NCT01044264|3735792|FG000|STARTED|Overall Study||200
3017762|NCT01044264|3735793|FG001|STARTED|Overall Study||202
3017763|NCT01044264|3735794|FG002|STARTED|Overall Study||200
3017764|NCT01044264|3735792|FG000|COMPLETED|Overall Study||110
3017765|NCT01044264|3735793|FG001|COMPLETED|Overall Study||108
3017766|NCT01044264|3735794|FG002|COMPLETED|Overall Study||108
3017767|NCT01044264|3735792|FG000|NOT COMPLETED|Overall Study||90
3017768|NCT01044264|3735793|FG001|NOT COMPLETED|Overall Study||94
3017769|NCT01044264|3735794|FG002|NOT COMPLETED|Overall Study||92
3017770|NCT01044290|3735805|FG000|STARTED|Randomization||75
3017771|NCT01044290|3735806|FG001|STARTED|Randomization||74
3017772|NCT01044290|3735807|FG002|STARTED|Randomization||72
3017773|NCT01044290|3735805|FG000|Randomized|Randomization||75
3017774|NCT01044290|3735806|FG001|Randomized|Randomization||74
3017775|NCT01044290|3735807|FG002|Randomized|Randomization||72
3017776|NCT01044290|3735805|FG000|COMPLETED|Randomization||75
3017777|NCT01044290|3735806|FG001|COMPLETED|Randomization||74
3017778|NCT01044290|3735807|FG002|COMPLETED|Randomization||72
3017779|NCT01044290|3735805|FG000|NOT COMPLETED|Randomization||0
3017780|NCT01044290|3735806|FG001|NOT COMPLETED|Randomization||0
3017781|NCT01044290|3735807|FG002|NOT COMPLETED|Randomization||0
3017782|NCT01044290|3735805|FG000|STARTED|Follow-up 1||75
3017783|NCT01044290|3735806|FG001|STARTED|Follow-up 1||74
3017784|NCT01044290|3735807|FG002|STARTED|Follow-up 1||72
3017785|NCT01044290|3735805|FG000|Completed F1 Interview|Follow-up 1||61
3017786|NCT01044290|3735806|FG001|Completed F1 Interview|Follow-up 1||60
3017787|NCT01044290|3735807|FG002|Completed F1 Interview|Follow-up 1||61
3017788|NCT01044290|3735805|FG000|COMPLETED|Follow-up 1||70
3017789|NCT01044290|3735806|FG001|COMPLETED|Follow-up 1||69
3017790|NCT01044290|3735807|FG002|COMPLETED|Follow-up 1||71
3017791|NCT01044290|3735805|FG000|NOT COMPLETED|Follow-up 1||5
3017792|NCT01044290|3735806|FG001|NOT COMPLETED|Follow-up 1||5
3017793|NCT01044290|3735807|FG002|NOT COMPLETED|Follow-up 1||1
3017794|NCT01044290|3735805|FG000|STARTED|Follow-Up 2||70
3017795|NCT01044290|3735806|FG001|STARTED|Follow-Up 2||69
3017796|NCT01044290|3735807|FG002|STARTED|Follow-Up 2||71
3017797|NCT01044290|3735805|FG000|Completed F2 Interview|Follow-Up 2||64
3017798|NCT01044290|3735806|FG001|Completed F2 Interview|Follow-Up 2||57
3017799|NCT01044290|3735807|FG002|Completed F2 Interview|Follow-Up 2||64
3017800|NCT01044290|3735805|FG000|COMPLETED|Follow-Up 2||70
3017801|NCT01044290|3735806|FG001|COMPLETED|Follow-Up 2||67
3017802|NCT01044290|3735807|FG002|COMPLETED|Follow-Up 2||69
3017803|NCT01044290|3735805|FG000|NOT COMPLETED|Follow-Up 2||0
3017804|NCT01044290|3735806|FG001|NOT COMPLETED|Follow-Up 2||2
3017805|NCT01044290|3735807|FG002|NOT COMPLETED|Follow-Up 2||2
3017806|NCT01044303|3735825|FG000|STARTED|Overall Study||32
3017807|NCT01044303|3735825|FG000|COMPLETED|Overall Study||30
3017808|NCT01044303|3735825|FG000|NOT COMPLETED|Overall Study||2
3017809|NCT01044433|3735832|FG000|STARTED|Overall Study||44
3017810|NCT01044433|3735832|FG000|COMPLETED|Overall Study||38
3017811|NCT01044433|3735832|FG000|NOT COMPLETED|Overall Study||6
3017812|NCT01044459|3735839|FG000|STARTED|Overall Study||312
3017813|NCT01044459|3735840|FG001|STARTED|Overall Study||293
3165508|NCT01900054|3893076|FG000|STARTED|Overall Study||58
3017814|NCT01044459|3735839|FG000|COMPLETED|Overall Study||179
3165509|NCT01900054|3893076|FG000|COMPLETED|Overall Study||56
3165510|NCT01900054|3893076|FG000|NOT COMPLETED|Overall Study||2
3165511|NCT01900067|3893082|FG000|STARTED|Overall Study||134
3165512|NCT01900067|3893083|FG001|STARTED|Overall Study||137
3165513|NCT01900067|3893082|FG000|COMPLETED|Overall Study||122
3165514|NCT01900067|3893083|FG001|COMPLETED|Overall Study||124
3165515|NCT01900067|3893082|FG000|NOT COMPLETED|Overall Study||12
3165516|NCT01900067|3893083|FG001|NOT COMPLETED|Overall Study||13
3165517|NCT01900249|3893092|FG000|STARTED|Overall Study||67
3017815|NCT01044459|3735840|FG001|COMPLETED|Overall Study||162
3017816|NCT01044459|3735839|FG000|NOT COMPLETED|Overall Study||133
3017817|NCT01044459|3735840|FG001|NOT COMPLETED|Overall Study||131
3017818|NCT01044498|3735848|FG000|STARTED|Overall Study||23
3017819|NCT01044498|3735849|FG001|STARTED|Overall Study||23
3017820|NCT01044498|3735848|FG000|COMPLETED|Overall Study||20
3017821|NCT01044498|3735849|FG001|COMPLETED|Overall Study||21
3017822|NCT01044498|3735848|FG000|NOT COMPLETED|Overall Study||3
3017823|NCT01044498|3735849|FG001|NOT COMPLETED|Overall Study||2
3017824|NCT01044537|3735862|FG000|STARTED|Overall Study||6
3017825|NCT01044537|3735863|FG001|STARTED|Overall Study||6
3017826|NCT01044537|3735864|FG002|STARTED|Overall Study||6
3017827|NCT01044537|3735865|FG003|STARTED|Overall Study||6
3017828|NCT01044537|3735866|FG004|STARTED|Overall Study||5
3017829|NCT01044537|3735867|FG005|STARTED|Overall Study||5
3017830|NCT01044537|3735868|FG006|STARTED|Overall Study||16
3017831|NCT01044537|3735862|FG000|COMPLETED|Overall Study||6
3017832|NCT01044537|3735863|FG001|COMPLETED|Overall Study||6
3017833|NCT01044537|3735864|FG002|COMPLETED|Overall Study||6
3017834|NCT01044537|3735865|FG003|COMPLETED|Overall Study||6
3017835|NCT01044537|3735866|FG004|COMPLETED|Overall Study||5
3017836|NCT01044537|3735867|FG005|COMPLETED|Overall Study||5
3017837|NCT01044537|3735868|FG006|COMPLETED|Overall Study||16
3165518|NCT01900249|3893093|FG001|STARTED|Overall Study||68
3165519|NCT01900249|3893094|FG002|STARTED|Overall Study||69
3165520|NCT01900249|3893092|FG000|COMPLETED|Overall Study||64
3165521|NCT01900249|3893093|FG001|COMPLETED|Overall Study||63
3165522|NCT01900249|3893094|FG002|COMPLETED|Overall Study||65
3165523|NCT01900249|3893092|FG000|NOT COMPLETED|Overall Study||3
3165524|NCT01900249|3893093|FG001|NOT COMPLETED|Overall Study||5
3165525|NCT01900249|3893094|FG002|NOT COMPLETED|Overall Study||4
3165526|NCT01900314|3893104|FG000|STARTED|Overall Study||20
3165527|NCT01900314|3893105|FG001|STARTED|Overall Study||20
3165528|NCT01900314|3893104|FG000|Completed MRI#1|Overall Study|2 withdrew consent prior to MRI, 1 had MRI technical failure|17
3165529|NCT01900314|3893105|FG001|Completed MRI#1|Overall Study|2 withdrew consent, 1 patient was unable to tolerate MRI|17
3165530|NCT01900314|3893104|FG000|COMPLETED|Overall Study|1 patient had MRI, then moved away after 5 TMS treatments|16
3165531|NCT01900314|3893105|FG001|COMPLETED|Overall Study|1 patient had 4 TMS Tx, but missed too many for protocol requirements,|16
3017838|NCT01044537|3735862|FG000|NOT COMPLETED|Overall Study||0
3017839|NCT01044537|3735863|FG001|NOT COMPLETED|Overall Study||0
3017840|NCT01044537|3735864|FG002|NOT COMPLETED|Overall Study||0
3017841|NCT01044537|3735865|FG003|NOT COMPLETED|Overall Study||0
3017842|NCT01044537|3735866|FG004|NOT COMPLETED|Overall Study||0
3017843|NCT01044537|3735867|FG005|NOT COMPLETED|Overall Study||0
3017844|NCT01044537|3735868|FG006|NOT COMPLETED|Overall Study||0
3017845|NCT01044576|3735884|FG000|STARTED|Overall Study||200
3017846|NCT01044576|3735884|FG000|COMPLETED|Overall Study||200
3017847|NCT01044576|3735884|FG000|NOT COMPLETED|Overall Study||0
3017848|NCT01044589|3735890|FG000|STARTED|Overall Study||6
3017849|NCT01044589|3735891|FG001|STARTED|Overall Study||7
3017850|NCT01044589|3735890|FG000|COMPLETED|Overall Study||3
3017851|NCT01044589|3735891|FG001|COMPLETED|Overall Study||2
3017852|NCT01044589|3735890|FG000|NOT COMPLETED|Overall Study||3
3017853|NCT01044589|3735891|FG001|NOT COMPLETED|Overall Study||5
3017854|NCT01044693|3735897|FG000|STARTED|Overall Study||3
3017855|NCT01044693|3735898|FG001|STARTED|Overall Study||1
3017856|NCT01044693|3735899|FG002|STARTED|Overall Study||1
3017857|NCT01044693|3735900|FG003|STARTED|Overall Study||1
3017858|NCT01044693|3735901|FG004|STARTED|Overall Study||1
3017859|NCT01044693|3735902|FG005|STARTED|Overall Study||2
3017860|NCT01044693|3735903|FG006|STARTED|Overall Study||1
3017861|NCT01044693|3735904|FG007|STARTED|Overall Study||1
3017862|NCT01044693|3735905|FG008|STARTED|Overall Study||1
3017863|NCT01044693|3735906|FG009|STARTED|Overall Study||1
3017864|NCT01044693|3735907|FG010|STARTED|Overall Study||1
3017865|NCT01044693|3735908|FG011|STARTED|Overall Study||1
3017866|NCT01044693|3735909|FG012|STARTED|Overall Study||2
3017867|NCT01044693|3735910|FG013|STARTED|Overall Study||1
3017868|NCT01044693|3735911|FG014|STARTED|Overall Study||1
3017869|NCT01044693|3735912|FG015|STARTED|Overall Study||1
3017870|NCT01044693|3735897|FG000|COMPLETED|Overall Study||3
3017871|NCT01044693|3735898|FG001|COMPLETED|Overall Study||1
3017872|NCT01044693|3735899|FG002|COMPLETED|Overall Study||1
3017873|NCT01044693|3735900|FG003|COMPLETED|Overall Study||1
3017874|NCT01044693|3735901|FG004|COMPLETED|Overall Study||1
3017875|NCT01044693|3735902|FG005|COMPLETED|Overall Study||2
3017876|NCT01044693|3735903|FG006|COMPLETED|Overall Study||1
3017877|NCT01044693|3735904|FG007|COMPLETED|Overall Study||1
3017878|NCT01044693|3735905|FG008|COMPLETED|Overall Study||1
3017879|NCT01044693|3735906|FG009|COMPLETED|Overall Study||1
3165532|NCT01900314|3893104|FG000|NOT COMPLETED|Overall Study||4
3165533|NCT01900314|3893105|FG001|NOT COMPLETED|Overall Study||4
3017880|NCT01044693|3735907|FG010|COMPLETED|Overall Study||1
3017881|NCT01044693|3735908|FG011|COMPLETED|Overall Study||1
3017882|NCT01044693|3735909|FG012|COMPLETED|Overall Study||2
3017883|NCT01044693|3735910|FG013|COMPLETED|Overall Study||1
3017884|NCT01044693|3735911|FG014|COMPLETED|Overall Study||1
3017885|NCT01044693|3735912|FG015|COMPLETED|Overall Study||1
3017886|NCT01044693|3735897|FG000|NOT COMPLETED|Overall Study||0
3017887|NCT01044693|3735898|FG001|NOT COMPLETED|Overall Study||0
3017888|NCT01044693|3735899|FG002|NOT COMPLETED|Overall Study||0
3017889|NCT01044693|3735900|FG003|NOT COMPLETED|Overall Study||0
3017890|NCT01044693|3735901|FG004|NOT COMPLETED|Overall Study||0
3017891|NCT01044693|3735902|FG005|NOT COMPLETED|Overall Study||0
3017892|NCT01044693|3735903|FG006|NOT COMPLETED|Overall Study||0
3017893|NCT01044693|3735904|FG007|NOT COMPLETED|Overall Study||0
3017894|NCT01044693|3735905|FG008|NOT COMPLETED|Overall Study||0
3017895|NCT01044693|3735906|FG009|NOT COMPLETED|Overall Study||0
3017896|NCT01044693|3735907|FG010|NOT COMPLETED|Overall Study||0
3017897|NCT01044693|3735908|FG011|NOT COMPLETED|Overall Study||0
3017898|NCT01044693|3735909|FG012|NOT COMPLETED|Overall Study||0
3017899|NCT01044693|3735910|FG013|NOT COMPLETED|Overall Study||0
3017900|NCT01044693|3735911|FG014|NOT COMPLETED|Overall Study||0
3017901|NCT01044693|3735912|FG015|NOT COMPLETED|Overall Study||0
3037672|NCT01149473|3756994|FG000|STARTED|Second Intervention||38
3037673|NCT01149473|3756995|FG001|STARTED|Second Intervention||38
3037674|NCT01149473|3756994|FG000|COMPLETED|Second Intervention||38
3165534|NCT01900392|3893115|FG000|STARTED|Overall Study||39
3165535|NCT01900392|3893116|FG001|STARTED|Overall Study||75
3165536|NCT01900392|3893117|FG002|STARTED|Overall Study||77
3165537|NCT01900392|3893115|FG000|COMPLETED|Overall Study||38
3037675|NCT01149473|3756995|FG001|COMPLETED|Second Intervention||38
3037676|NCT01149473|3756994|FG000|NOT COMPLETED|Second Intervention||0
3037677|NCT01149473|3756995|FG001|NOT COMPLETED|Second Intervention||0
3037678|NCT01149486|3757003|FG000|STARTED|First Intervention||10
3037679|NCT01149486|3757004|FG001|STARTED|First Intervention||10
3037680|NCT01149486|3757003|FG000|COMPLETED|First Intervention||10
3037681|NCT01149486|3757004|FG001|COMPLETED|First Intervention||9
3037682|NCT01149486|3757003|FG000|NOT COMPLETED|First Intervention||0
3037683|NCT01149486|3757004|FG001|NOT COMPLETED|First Intervention||1
3037684|NCT01149486|3757003|FG000|STARTED|Washout of 7 Days||10
3037685|NCT01149486|3757004|FG001|STARTED|Washout of 7 Days||9
3037686|NCT01149486|3757003|FG000|COMPLETED|Washout of 7 Days||10
3037687|NCT01149486|3757004|FG001|COMPLETED|Washout of 7 Days||9
3037688|NCT01149486|3757003|FG000|NOT COMPLETED|Washout of 7 Days||0
3037689|NCT01149486|3757004|FG001|NOT COMPLETED|Washout of 7 Days||0
3037690|NCT01149486|3757003|FG000|STARTED|Second Intervention||10
3037691|NCT01149486|3757004|FG001|STARTED|Second Intervention||9
3037692|NCT01149486|3757003|FG000|COMPLETED|Second Intervention||10
3037693|NCT01149486|3757004|FG001|COMPLETED|Second Intervention||9
3037694|NCT01149486|3757003|FG000|NOT COMPLETED|Second Intervention||0
3037695|NCT01149486|3757004|FG001|NOT COMPLETED|Second Intervention||0
3037696|NCT01149512|3757010|FG000|STARTED|Overall Study||178
3037697|NCT01149512|3757010|FG000|COMPLETED|Overall Study||178
3037698|NCT01149512|3757010|FG000|NOT COMPLETED|Overall Study||0
3037699|NCT01149538|3757016|FG000|STARTED|Overall Study||31
3037700|NCT01149538|3757017|FG001|STARTED|Overall Study||29
3037701|NCT01149538|3757016|FG000|COMPLETED|Overall Study||26
3037702|NCT01149538|3757017|FG001|COMPLETED|Overall Study||25
3037703|NCT01149538|3757016|FG000|NOT COMPLETED|Overall Study||5
3037704|NCT01149538|3757017|FG001|NOT COMPLETED|Overall Study||4
3037705|NCT01149616|3757025|FG000|STARTED|Overall Study||41
3037706|NCT01149616|3757026|FG001|STARTED|Overall Study||41
3037707|NCT01149616|3757025|FG000|COMPLETED|Overall Study||41
3037708|NCT01149616|3757026|FG001|COMPLETED|Overall Study||41
3037709|NCT01149616|3757025|FG000|NOT COMPLETED|Overall Study||0
3037710|NCT01149616|3757026|FG001|NOT COMPLETED|Overall Study||0
3037711|NCT01149655|3757036|FG000|STARTED|Period 1 - Conversion Phase||186
3037712|NCT01149655|3757037|FG001|STARTED|Period 1 - Conversion Phase||0
3037713|NCT01149655|3757038|FG002|STARTED|Period 1 - Conversion Phase||0
3037714|NCT01149655|3757039|FG003|STARTED|Period 1 - Conversion Phase||0
3037715|NCT01149655|3757036|FG000|COMPLETED|Period 1 - Conversion Phase||168
3037716|NCT01149655|3757037|FG001|COMPLETED|Period 1 - Conversion Phase||0
3037717|NCT01149655|3757038|FG002|COMPLETED|Period 1 - Conversion Phase||0
3037718|NCT01149655|3757039|FG003|COMPLETED|Period 1 - Conversion Phase||0
3037719|NCT01149655|3757036|FG000|NOT COMPLETED|Period 1 - Conversion Phase||18
3037720|NCT01149655|3757037|FG001|NOT COMPLETED|Period 1 - Conversion Phase||0
3037721|NCT01149655|3757038|FG002|NOT COMPLETED|Period 1 - Conversion Phase||0
3037722|NCT01149655|3757039|FG003|NOT COMPLETED|Period 1 - Conversion Phase||0
3037723|NCT01149655|3757036|FG000|STARTED|Period 2-Stabilization Phase||0
3037724|NCT01149655|3757037|FG001|STARTED|Period 2-Stabilization Phase||183
3037725|NCT01149655|3757038|FG002|STARTED|Period 2-Stabilization Phase||0
3037726|NCT01149655|3757039|FG003|STARTED|Period 2-Stabilization Phase||0
3037727|NCT01149655|3757036|FG000|COMPLETED|Period 2-Stabilization Phase||0
3037728|NCT01149655|3757037|FG001|COMPLETED|Period 2-Stabilization Phase||146
3037729|NCT01149655|3757038|FG002|COMPLETED|Period 2-Stabilization Phase||0
3037730|NCT01149655|3757039|FG003|COMPLETED|Period 2-Stabilization Phase||0
3037731|NCT01149655|3757036|FG000|NOT COMPLETED|Period 2-Stabilization Phase||0
3037732|NCT01149655|3757037|FG001|NOT COMPLETED|Period 2-Stabilization Phase||37
3165538|NCT01900392|3893116|FG001|COMPLETED|Overall Study||74
3017902|NCT01044706|3735924|FG000|STARTED|Overall Study||30
3017903|NCT01044706|3735925|FG001|STARTED|Overall Study||30
3017904|NCT01044706|3735924|FG000|COMPLETED|Overall Study||30
3017905|NCT01044706|3735925|FG001|COMPLETED|Overall Study||30
3017906|NCT01044706|3735924|FG000|NOT COMPLETED|Overall Study||0
3017907|NCT01044706|3735925|FG001|NOT COMPLETED|Overall Study||0
3017908|NCT01044732|3735933|FG000|STARTED|Overall Study||222
3017909|NCT01044732|3735934|FG001|STARTED|Overall Study||226
3017910|NCT01044732|3735933|FG000|COMPLETED|Overall Study||173
3017911|NCT01044732|3735934|FG001|COMPLETED|Overall Study||176
3017912|NCT01044732|3735933|FG000|NOT COMPLETED|Overall Study||49
3017913|NCT01044732|3735934|FG001|NOT COMPLETED|Overall Study||50
3017914|NCT01044745|3735942|FG000|STARTED|Overall Study||20
3017915|NCT01044745|3735942|FG000|COMPLETED|Overall Study||18
3017916|NCT01044745|3735942|FG000|NOT COMPLETED|Overall Study||2
3017917|NCT01044758|3735954|FG000|STARTED|Overall Study||12
3017918|NCT01044758|3735955|FG001|STARTED|Overall Study||12
3017919|NCT01044758|3735956|FG002|STARTED|Overall Study||11
3017920|NCT01044758|3735957|FG003|STARTED|Overall Study||12
3017921|NCT01044758|3735958|FG004|STARTED|Overall Study||11
3017922|NCT01044758|3735959|FG005|STARTED|Overall Study||11
3017923|NCT01044758|3735960|FG006|STARTED|Overall Study||27
3017924|NCT01044758|3735954|FG000|COMPLETED|Overall Study||8
3017925|NCT01044758|3735955|FG001|COMPLETED|Overall Study||12
3017926|NCT01044758|3735956|FG002|COMPLETED|Overall Study||7
3308332|NCT03019796|4041636|FG000|COMPLETED|Second Intervention Training (4 Months)||19
3308333|NCT03019796|4041637|FG001|COMPLETED|Second Intervention Training (4 Months)||19
3308334|NCT03019796|4041636|FG000|NOT COMPLETED|Second Intervention Training (4 Months)||1
3308335|NCT03019796|4041637|FG001|NOT COMPLETED|Second Intervention Training (4 Months)||1
3017927|NCT01044758|3735957|FG003|COMPLETED|Overall Study||10
3017928|NCT01044758|3735958|FG004|COMPLETED|Overall Study||9
3017929|NCT01044758|3735959|FG005|COMPLETED|Overall Study||8
3017930|NCT01044758|3735960|FG006|COMPLETED|Overall Study||17
3017931|NCT01044758|3735954|FG000|NOT COMPLETED|Overall Study||4
3017932|NCT01044758|3735955|FG001|NOT COMPLETED|Overall Study||0
3017933|NCT01044758|3735956|FG002|NOT COMPLETED|Overall Study||4
3017934|NCT01044758|3735957|FG003|NOT COMPLETED|Overall Study||2
3017935|NCT01044758|3735958|FG004|NOT COMPLETED|Overall Study||2
3017936|NCT01044758|3735959|FG005|NOT COMPLETED|Overall Study||3
3017937|NCT01044758|3735960|FG006|NOT COMPLETED|Overall Study||10
3017938|NCT01044771|3735979|FG000|STARTED|Overall Study||20
3017939|NCT01044771|3735979|FG000|COMPLETED|Overall Study||20
3017940|NCT01044771|3735979|FG000|NOT COMPLETED|Overall Study||0
3017941|NCT01044862|3735987|FG000|STARTED|Overall Study||299
3017942|NCT01044862|3735988|FG001|STARTED|Overall Study||300
3017943|NCT01044862|3735989|FG002|STARTED|Overall Study||301
3017944|NCT01044862|3735987|FG000|COMPLETED|Overall Study||246
3017945|NCT01044862|3735988|FG001|COMPLETED|Overall Study||251
3017946|NCT01044862|3735989|FG002|COMPLETED|Overall Study||249
3017947|NCT01044862|3735987|FG000|NOT COMPLETED|Overall Study||53
3017948|NCT01044862|3735988|FG001|NOT COMPLETED|Overall Study||49
3017949|NCT01044862|3735989|FG002|NOT COMPLETED|Overall Study||52
3017950|NCT01044966|3735997|FG000|STARTED|Induction Phase||12
3017951|NCT01044966|3735997|FG000|COMPLETED|Induction Phase||12
3017952|NCT01044966|3735997|FG000|NOT COMPLETED|Induction Phase||0
3017953|NCT01044966|3735997|FG000|STARTED|Consolidation Phase||12
3017954|NCT01044966|3735997|FG000|COMPLETED|Consolidation Phase||2
3017955|NCT01044966|3735997|FG000|NOT COMPLETED|Consolidation Phase||10
3017956|NCT01045031|3736004|FG000|STARTED|Overall Study||58
3017957|NCT01045031|3736005|FG001|STARTED|Overall Study||56
3017958|NCT01045031|3736004|FG000|COMPLETED|Overall Study||49
3017959|NCT01045031|3736005|FG001|COMPLETED|Overall Study||50
3017960|NCT01045031|3736004|FG000|NOT COMPLETED|Overall Study||9
3017961|NCT01045031|3736005|FG001|NOT COMPLETED|Overall Study||6
3017962|NCT01045057|3736015|FG000|STARTED|Overall Study||27
3017963|NCT01045057|3736015|FG000|COMPLETED|Overall Study||27
3017964|NCT01045057|3736015|FG000|NOT COMPLETED|Overall Study||0
3017965|NCT01045096|3736024|FG000|STARTED|Overall Study||12
3017966|NCT01045096|3736025|FG001|STARTED|Overall Study||12
3017967|NCT01045096|3736026|FG002|STARTED|Overall Study||12
3017968|NCT01045096|3736024|FG000|Pharmacokinetic Set|Overall Study|All patients with at least one estimable PK parameter for dexlansoprazole on Day 7.|9
3017969|NCT01045096|3736025|FG001|Pharmacokinetic Set|Overall Study||11
3017970|NCT01045096|3736026|FG002|Pharmacokinetic Set|Overall Study||11
3017971|NCT01045096|3736024|FG000|COMPLETED|Overall Study||9
3017972|NCT01045096|3736025|FG001|COMPLETED|Overall Study||12
3017973|NCT01045096|3736026|FG002|COMPLETED|Overall Study||12
3017974|NCT01045096|3736024|FG000|NOT COMPLETED|Overall Study||3
3017975|NCT01045096|3736025|FG001|NOT COMPLETED|Overall Study||0
3017976|NCT01045096|3736026|FG002|NOT COMPLETED|Overall Study||0
3017977|NCT01045122|3736034|FG000|STARTED|Dexmedetomidine Then Propofol||5
3017978|NCT01045122|3736035|FG001|STARTED|Dexmedetomidine Then Propofol||6
3017979|NCT01045122|3736034|FG000|COMPLETED|Dexmedetomidine Then Propofol||5
3017980|NCT01045122|3736035|FG001|COMPLETED|Dexmedetomidine Then Propofol||6
3017981|NCT01045122|3736034|FG000|NOT COMPLETED|Dexmedetomidine Then Propofol||0
3017982|NCT01045122|3736035|FG001|NOT COMPLETED|Dexmedetomidine Then Propofol||0
3017983|NCT01045122|3736034|FG000|STARTED|Propofol Then Dexmedetomidine||5
3017984|NCT01045122|3736035|FG001|STARTED|Propofol Then Dexmedetomidine||6
3017985|NCT01045122|3736034|FG000|COMPLETED|Propofol Then Dexmedetomidine||5
3017986|NCT01045122|3736035|FG001|COMPLETED|Propofol Then Dexmedetomidine||6
3017987|NCT01045122|3736034|FG000|NOT COMPLETED|Propofol Then Dexmedetomidine||0
3017988|NCT01045122|3736035|FG001|NOT COMPLETED|Propofol Then Dexmedetomidine||0
3017989|NCT01045135|3736041|FG000|STARTED|Overall Study||300
3017990|NCT01045135|3736041|FG000|COMPLETED|Overall Study||274
3017991|NCT01045135|3736041|FG000|NOT COMPLETED|Overall Study||26
3017992|NCT01045161|3736050|FG000|STARTED|Part A - 12 Weeks Double Blind Treatment||182
3017993|NCT01045161|3736051|FG001|STARTED|Part A - 12 Weeks Double Blind Treatment||184
3017994|NCT01045161|3736052|FG002|STARTED|Part A - 12 Weeks Double Blind Treatment||178
3017995|NCT01045161|3736050|FG000|COMPLETED|Part A - 12 Weeks Double Blind Treatment||151
3017996|NCT01045161|3736051|FG001|COMPLETED|Part A - 12 Weeks Double Blind Treatment||155
3017997|NCT01045161|3736052|FG002|COMPLETED|Part A - 12 Weeks Double Blind Treatment||148
3017998|NCT01045161|3736050|FG000|NOT COMPLETED|Part A - 12 Weeks Double Blind Treatment||31
3017999|NCT01045161|3736051|FG001|NOT COMPLETED|Part A - 12 Weeks Double Blind Treatment||29
3018000|NCT01045161|3736052|FG002|NOT COMPLETED|Part A - 12 Weeks Double Blind Treatment||30
3165539|NCT01900392|3893117|FG002|COMPLETED|Overall Study||77
3165540|NCT01900392|3893115|FG000|NOT COMPLETED|Overall Study||1
3165541|NCT01900392|3893116|FG001|NOT COMPLETED|Overall Study||1
3165542|NCT01900392|3893117|FG002|NOT COMPLETED|Overall Study||0
3018001|NCT01045161|3736050|FG000|STARTED|Part B - 40 Additional Weeks Open Label||147
3018002|NCT01045161|3736051|FG001|STARTED|Part B - 40 Additional Weeks Open Label||154
3018003|NCT01045161|3736052|FG002|STARTED|Part B - 40 Additional Weeks Open Label||147
3018004|NCT01045161|3736050|FG000|COMPLETED|Part B - 40 Additional Weeks Open Label||111
3018005|NCT01045161|3736051|FG001|COMPLETED|Part B - 40 Additional Weeks Open Label||118
3018006|NCT01045161|3736052|FG002|COMPLETED|Part B - 40 Additional Weeks Open Label||115
3018007|NCT01045161|3736050|FG000|NOT COMPLETED|Part B - 40 Additional Weeks Open Label||36
3018008|NCT01045161|3736051|FG001|NOT COMPLETED|Part B - 40 Additional Weeks Open Label||36
3018009|NCT01045161|3736052|FG002|NOT COMPLETED|Part B - 40 Additional Weeks Open Label||32
3018010|NCT01045174|3736071|FG000|STARTED|Overall Study||90
3018011|NCT01045174|3736072|FG001|STARTED|Overall Study||90
3018012|NCT01045174|3736071|FG000|COMPLETED|Overall Study||90
3018013|NCT01045174|3736072|FG001|COMPLETED|Overall Study||90
3018014|NCT01045174|3736071|FG000|NOT COMPLETED|Overall Study||0
3018015|NCT01045174|3736072|FG001|NOT COMPLETED|Overall Study||0
3018016|NCT01045187|3736078|FG000|STARTED|Overall Study||15
3018017|NCT01045187|3736078|FG000|COMPLETED|Overall Study||15
3018018|NCT01045187|3736078|FG000|NOT COMPLETED|Overall Study||0
3018019|NCT01045265|3736082|FG000|STARTED|Overall Study||16
3018020|NCT01045265|3736082|FG000|COMPLETED|Overall Study||16
3018021|NCT01045265|3736082|FG000|NOT COMPLETED|Overall Study||0
3018022|NCT01045421|3736092|FG000|STARTED|Phase 1||1
3018023|NCT01045421|3736093|FG001|STARTED|Phase 1||3
3018024|NCT01045421|3736094|FG002|STARTED|Phase 1||4
3018025|NCT01045421|3736095|FG003|STARTED|Phase 1||12
3018026|NCT01045421|3736096|FG004|STARTED|Phase 1||3
3018027|NCT01045421|3736097|FG005|STARTED|Phase 1||1
3018028|NCT01045421|3736098|FG006|STARTED|Phase 1||0
3018029|NCT01045421|3736099|FG007|STARTED|Phase 1||0
3018030|NCT01045421|3736100|FG008|STARTED|Phase 1||0
3018031|NCT01045421|3736101|FG009|STARTED|Phase 1||0
3018032|NCT01045421|3736102|FG010|STARTED|Phase 1||0
3018033|NCT01045421|3736092|FG000|COMPLETED|Phase 1||1
3018034|NCT01045421|3736093|FG001|COMPLETED|Phase 1||3
3018035|NCT01045421|3736094|FG002|COMPLETED|Phase 1||4
3018036|NCT01045421|3736095|FG003|COMPLETED|Phase 1||11
3018037|NCT01045421|3736096|FG004|COMPLETED|Phase 1||2
3018038|NCT01045421|3736097|FG005|COMPLETED|Phase 1||1
3018039|NCT01045421|3736098|FG006|COMPLETED|Phase 1||0
3018040|NCT01045421|3736099|FG007|COMPLETED|Phase 1||0
3018041|NCT01045421|3736100|FG008|COMPLETED|Phase 1||0
3018042|NCT01045421|3736101|FG009|COMPLETED|Phase 1||0
3018043|NCT01045421|3736102|FG010|COMPLETED|Phase 1||0
3018044|NCT01045421|3736092|FG000|NOT COMPLETED|Phase 1||0
3018045|NCT01045421|3736093|FG001|NOT COMPLETED|Phase 1||0
3018046|NCT01045421|3736094|FG002|NOT COMPLETED|Phase 1||0
3018047|NCT01045421|3736095|FG003|NOT COMPLETED|Phase 1||1
3018048|NCT01045421|3736096|FG004|NOT COMPLETED|Phase 1||1
3018049|NCT01045421|3736097|FG005|NOT COMPLETED|Phase 1||0
3018050|NCT01045421|3736098|FG006|NOT COMPLETED|Phase 1||0
3018051|NCT01045421|3736099|FG007|NOT COMPLETED|Phase 1||0
3018052|NCT01045421|3736100|FG008|NOT COMPLETED|Phase 1||0
3018053|NCT01045421|3736101|FG009|NOT COMPLETED|Phase 1||0
3018054|NCT01045421|3736102|FG010|NOT COMPLETED|Phase 1||0
3018055|NCT01045421|3736092|FG000|STARTED|Phase 2||0
3018056|NCT01045421|3736093|FG001|STARTED|Phase 2||0
3018057|NCT01045421|3736094|FG002|STARTED|Phase 2||0
3018058|NCT01045421|3736095|FG003|STARTED|Phase 2||0
3018059|NCT01045421|3736096|FG004|STARTED|Phase 2||0
3018060|NCT01045421|3736097|FG005|STARTED|Phase 2||0
3018061|NCT01045421|3736098|FG006|STARTED|Phase 2||53
3018062|NCT01045421|3736099|FG007|STARTED|Phase 2||55
3018063|NCT01045421|3736100|FG008|STARTED|Phase 2||55
3018064|NCT01045421|3736101|FG009|STARTED|Phase 2||26
3018065|NCT01045421|3736102|FG010|STARTED|Phase 2||60
3018066|NCT01045421|3736092|FG000|COMPLETED|Phase 2||0
3018067|NCT01045421|3736093|FG001|COMPLETED|Phase 2||0
3018068|NCT01045421|3736094|FG002|COMPLETED|Phase 2||0
3018069|NCT01045421|3736095|FG003|COMPLETED|Phase 2||0
3018070|NCT01045421|3736096|FG004|COMPLETED|Phase 2||0
3018071|NCT01045421|3736097|FG005|COMPLETED|Phase 2||0
3018072|NCT01045421|3736098|FG006|COMPLETED|Phase 2||53
3018073|NCT01045421|3736099|FG007|COMPLETED|Phase 2||50
3018074|NCT01045421|3736100|FG008|COMPLETED|Phase 2||53
3018075|NCT01045421|3736101|FG009|COMPLETED|Phase 2||23
3018076|NCT01045421|3736102|FG010|COMPLETED|Phase 2||58
3018077|NCT01045421|3736092|FG000|NOT COMPLETED|Phase 2||0
3018078|NCT01045421|3736093|FG001|NOT COMPLETED|Phase 2||0
3018079|NCT01045421|3736094|FG002|NOT COMPLETED|Phase 2||0
3018080|NCT01045421|3736095|FG003|NOT COMPLETED|Phase 2||0
3018081|NCT01045421|3736096|FG004|NOT COMPLETED|Phase 2||0
3018082|NCT01045421|3736097|FG005|NOT COMPLETED|Phase 2||0
3018083|NCT01045421|3736098|FG006|NOT COMPLETED|Phase 2||0
3018084|NCT01045421|3736099|FG007|NOT COMPLETED|Phase 2||5
3018085|NCT01045421|3736100|FG008|NOT COMPLETED|Phase 2||2
3018086|NCT01045421|3736101|FG009|NOT COMPLETED|Phase 2||3
3018087|NCT01045421|3736102|FG010|NOT COMPLETED|Phase 2||2
3018088|NCT01045447|3736125|FG000|STARTED|Overall Study||232
3018089|NCT01045447|3736126|FG001|STARTED|Overall Study||233
3018090|NCT01045447|3736125|FG000|Exposed|Overall Study|Two subjects withdrew prior to exposure to trial drug|230
3018091|NCT01045447|3736126|FG001|Exposed|Overall Study||233
3018092|NCT01045447|3736125|FG000|COMPLETED|Overall Study||196
3018093|NCT01045447|3736126|FG001|COMPLETED|Overall Study||205
3018094|NCT01045447|3736125|FG000|NOT COMPLETED|Overall Study||36
3018095|NCT01045447|3736126|FG001|NOT COMPLETED|Overall Study||28
3018096|NCT01045460|3736134|FG000|STARTED|Overall Study||17
3018097|NCT01045460|3736135|FG001|STARTED|Overall Study||18
3018098|NCT01045460|3736134|FG000|COMPLETED|Overall Study||11
3018099|NCT01045460|3736135|FG001|COMPLETED|Overall Study||15
3018100|NCT01045460|3736134|FG000|NOT COMPLETED|Overall Study||6
3018101|NCT01045460|3736135|FG001|NOT COMPLETED|Overall Study||3
3018102|NCT01045499|3736143|FG000|STARTED|Overall Study||137
3018103|NCT01045499|3736143|FG000|COMPLETED|Overall Study||127
3018104|NCT01045499|3736143|FG000|NOT COMPLETED|Overall Study||10
3018105|NCT01045551|3736147|FG000|STARTED|Overall Study||10
3018106|NCT01045551|3736147|FG000|COMPLETED|Overall Study||10
3018107|NCT01045551|3736147|FG000|NOT COMPLETED|Overall Study||0
3018108|NCT01045707|3736154|FG000|STARTED|Main: Week 0 to 26 (NN5401-3590)||266
3018109|NCT01045707|3736155|FG001|STARTED|Main: Week 0 to 26 (NN5401-3590)||264
3018110|NCT01045707|3736154|FG000|Exposed|Main: Week 0 to 26 (NN5401-3590)|One subject withdrew prior to exposure to trial drug|265
3018111|NCT01045707|3736155|FG001|Exposed|Main: Week 0 to 26 (NN5401-3590)|Three subjects withdrew prior to exposure to trial drug|261
3018112|NCT01045707|3736154|FG000|COMPLETED|Main: Week 0 to 26 (NN5401-3590)||219
3018113|NCT01045707|3736155|FG001|COMPLETED|Main: Week 0 to 26 (NN5401-3590)||232
3018114|NCT01045707|3736154|FG000|NOT COMPLETED|Main: Week 0 to 26 (NN5401-3590)||47
3018115|NCT01045707|3736155|FG001|NOT COMPLETED|Main: Week 0 to 26 (NN5401-3590)||32
3018116|NCT01045707|3736154|FG000|STARTED|Extension: Week 27 to 52 (NN5401-3726)|Twenty seven subjects from main trial did not continue into the extension|192
3018117|NCT01045707|3736155|FG001|STARTED|Extension: Week 27 to 52 (NN5401-3726)|Eleven subjects from main trial did not continue into the extension|221
3018118|NCT01045707|3736154|FG000|COMPLETED|Extension: Week 27 to 52 (NN5401-3726)||179
3018119|NCT01045707|3736155|FG001|COMPLETED|Extension: Week 27 to 52 (NN5401-3726)||209
3018120|NCT01045707|3736154|FG000|NOT COMPLETED|Extension: Week 27 to 52 (NN5401-3726)||13
3018121|NCT01045707|3736155|FG001|NOT COMPLETED|Extension: Week 27 to 52 (NN5401-3726)||12
3018122|NCT01045798|3736163|FG000|STARTED|Overall Study||6
3018123|NCT01045798|3736164|FG001|STARTED|Overall Study||9
3018124|NCT01045798|3736163|FG000|COMPLETED|Overall Study||4
3018125|NCT01045798|3736164|FG001|COMPLETED|Overall Study||5
3018126|NCT01045798|3736163|FG000|NOT COMPLETED|Overall Study||2
3018127|NCT01045798|3736164|FG001|NOT COMPLETED|Overall Study||4
3018128|NCT01045967|3736172|FG000|STARTED|First Intervention||28
3018129|NCT01045967|3736173|FG001|STARTED|First Intervention||28
3018130|NCT01045967|3736172|FG000|COMPLETED|First Intervention||28
3018131|NCT01045967|3736173|FG001|COMPLETED|First Intervention||28
3018132|NCT01045967|3736172|FG000|NOT COMPLETED|First Intervention||0
3018133|NCT01045967|3736173|FG001|NOT COMPLETED|First Intervention||0
3018134|NCT01045967|3736172|FG000|STARTED|Washout of 7 Days||28
3018135|NCT01045967|3736173|FG001|STARTED|Washout of 7 Days||28
3018136|NCT01045967|3736172|FG000|COMPLETED|Washout of 7 Days||28
3018137|NCT01045967|3736173|FG001|COMPLETED|Washout of 7 Days||28
3018138|NCT01045967|3736172|FG000|NOT COMPLETED|Washout of 7 Days||0
3018139|NCT01045967|3736173|FG001|NOT COMPLETED|Washout of 7 Days||0
3018140|NCT01045967|3736172|FG000|STARTED|Second Intervention||28
3018141|NCT01045967|3736173|FG001|STARTED|Second Intervention|Subject was dropped prior to dosing in Period II due to positive drug screen.|28
3018142|NCT01045967|3736172|FG000|COMPLETED|Second Intervention||28
3018143|NCT01045967|3736173|FG001|COMPLETED|Second Intervention||27
3018144|NCT01045967|3736172|FG000|NOT COMPLETED|Second Intervention||0
3018145|NCT01045967|3736173|FG001|NOT COMPLETED|Second Intervention||1
3018146|NCT01045993|3736183|FG000|STARTED|Overall Study||26
3165543|NCT01900431|3893127|FG000|STARTED|Principal Treatment Period (Part A)||20
3165544|NCT01900431|3893128|FG001|STARTED|Principal Treatment Period (Part A)||38
3018147|NCT01045993|3736184|FG001|STARTED|Overall Study||5
3018148|NCT01045993|3736185|FG002|STARTED|Overall Study||5
3018149|NCT01045993|3736186|FG003|STARTED|Overall Study||25
3018150|NCT01045993|3736183|FG000|COMPLETED|Overall Study||26
3018151|NCT01045993|3736184|FG001|COMPLETED|Overall Study||4
3018152|NCT01045993|3736185|FG002|COMPLETED|Overall Study||5
3018153|NCT01045993|3736186|FG003|COMPLETED|Overall Study||25
3018154|NCT01045993|3736183|FG000|NOT COMPLETED|Overall Study||0
3018155|NCT01045993|3736184|FG001|NOT COMPLETED|Overall Study||1
3018156|NCT01045993|3736185|FG002|NOT COMPLETED|Overall Study||0
3018157|NCT01045993|3736186|FG003|NOT COMPLETED|Overall Study||0
3018158|NCT01046084|3736198|FG000|STARTED|First Intervention||25
3018159|NCT01046084|3736199|FG001|STARTED|First Intervention||25
3018160|NCT01046084|3736198|FG000|COMPLETED|First Intervention||25
3018161|NCT01046084|3736199|FG001|COMPLETED|First Intervention||25
3018162|NCT01046084|3736198|FG000|NOT COMPLETED|First Intervention||0
3018163|NCT01046084|3736199|FG001|NOT COMPLETED|First Intervention||0
3165545|NCT01900431|3893129|FG002|STARTED|Principal Treatment Period (Part A)||0
3165546|NCT01900431|3893127|FG000|COMPLETED|Principal Treatment Period (Part A)|8 responders entered Part B and 5 non-responders entered Part C.|13
3165547|NCT01900431|3893128|FG001|COMPLETED|Principal Treatment Period (Part A)|22 responders entered Part B, 5 non-responders entered Part C, 1 discontinued the study.|28
3018164|NCT01046084|3736198|FG000|STARTED|First Washout of 7 Days||25
3018165|NCT01046084|3736199|FG001|STARTED|First Washout of 7 Days||25
3018166|NCT01046084|3736198|FG000|COMPLETED|First Washout of 7 Days||25
3018167|NCT01046084|3736199|FG001|COMPLETED|First Washout of 7 Days||25
3018168|NCT01046084|3736198|FG000|NOT COMPLETED|First Washout of 7 Days||0
3308336|NCT03019796|4041636|FG000|STARTED|Third Intervention Drug Test||19
3308337|NCT03019796|4041637|FG001|STARTED|Third Intervention Drug Test||19
3308338|NCT03019796|4041636|FG000|COMPLETED|Third Intervention Drug Test||19
3308339|NCT03019796|4041637|FG001|COMPLETED|Third Intervention Drug Test||19
3308340|NCT03019796|4041636|FG000|NOT COMPLETED|Third Intervention Drug Test||0
3308341|NCT03019796|4041637|FG001|NOT COMPLETED|Third Intervention Drug Test||0
3308342|NCT03019887|4041644|FG000|STARTED|Overall Study||139
3308343|NCT03019887|4041644|FG000|COMPLETED|Overall Study||130
3018169|NCT01046084|3736199|FG001|NOT COMPLETED|First Washout of 7 Days||0
3018170|NCT01046084|3736198|FG000|STARTED|Second Intervention||25
3018171|NCT01046084|3736199|FG001|STARTED|Second Intervention||25
3018172|NCT01046084|3736198|FG000|COMPLETED|Second Intervention||25
3018173|NCT01046084|3736199|FG001|COMPLETED|Second Intervention||25
3018174|NCT01046084|3736198|FG000|NOT COMPLETED|Second Intervention||0
3018175|NCT01046084|3736199|FG001|NOT COMPLETED|Second Intervention||0
3018176|NCT01046084|3736198|FG000|STARTED|Second Washout of 7 Days||25
3018177|NCT01046084|3736199|FG001|STARTED|Second Washout of 7 Days||25
3018178|NCT01046084|3736198|FG000|COMPLETED|Second Washout of 7 Days||25
3018179|NCT01046084|3736199|FG001|COMPLETED|Second Washout of 7 Days||25
3018180|NCT01046084|3736198|FG000|NOT COMPLETED|Second Washout of 7 Days||0
3018181|NCT01046084|3736199|FG001|NOT COMPLETED|Second Washout of 7 Days||0
3018182|NCT01046084|3736198|FG000|STARTED|Third Intervention||25
3018183|NCT01046084|3736199|FG001|STARTED|Third Intervention||25
3018184|NCT01046084|3736198|FG000|COMPLETED|Third Intervention||25
3018185|NCT01046084|3736199|FG001|COMPLETED|Third Intervention||25
3018186|NCT01046084|3736198|FG000|NOT COMPLETED|Third Intervention||0
3018187|NCT01046084|3736199|FG001|NOT COMPLETED|Third Intervention||0
3018188|NCT01046084|3736198|FG000|STARTED|Third Washout of 7 Days||25
3018189|NCT01046084|3736199|FG001|STARTED|Third Washout of 7 Days||25
3018190|NCT01046084|3736198|FG000|COMPLETED|Third Washout of 7 Days||23
3018191|NCT01046084|3736199|FG001|COMPLETED|Third Washout of 7 Days||25
3018192|NCT01046084|3736198|FG000|NOT COMPLETED|Third Washout of 7 Days||2
3018193|NCT01046084|3736199|FG001|NOT COMPLETED|Third Washout of 7 Days||0
3018194|NCT01046084|3736198|FG000|STARTED|Fourth Intervention||23
3018195|NCT01046084|3736199|FG001|STARTED|Fourth Intervention||25
3018196|NCT01046084|3736198|FG000|COMPLETED|Fourth Intervention||23
3018197|NCT01046084|3736199|FG001|COMPLETED|Fourth Intervention||25
3018198|NCT01046084|3736198|FG000|NOT COMPLETED|Fourth Intervention||0
3018199|NCT01046084|3736199|FG001|NOT COMPLETED|Fourth Intervention||0
3018200|NCT01046110|3736207|FG000|STARTED|Overall Study||229
3018201|NCT01046110|3736208|FG001|STARTED|Overall Study||229
3018202|NCT01046110|3736207|FG000|Exposed|Overall Study|2 subjects were randomised in error and 1 subject did not want to take insulin|226
3018203|NCT01046110|3736208|FG001|Exposed|Overall Study|1 subject was randomised in error|228
3018204|NCT01046110|3736207|FG000|COMPLETED|Overall Study||174
3018205|NCT01046110|3736208|FG001|COMPLETED|Overall Study||174
3018206|NCT01046110|3736207|FG000|NOT COMPLETED|Overall Study||55
3018207|NCT01046110|3736208|FG001|NOT COMPLETED|Overall Study||55
3018208|NCT01046136|3736216|FG000|STARTED|Overall Study||188
3018209|NCT01046136|3736217|FG001|STARTED|Overall Study||190
3018210|NCT01046136|3736216|FG000|COMPLETED|Overall Study||184
3018211|NCT01046136|3736217|FG001|COMPLETED|Overall Study||182
3018212|NCT01046136|3736216|FG000|NOT COMPLETED|Overall Study||4
3018213|NCT01046136|3736217|FG001|NOT COMPLETED|Overall Study||8
3018214|NCT01046253|3736227|FG000|STARTED|First Intervention||25
3018215|NCT01046253|3736228|FG001|STARTED|First Intervention||25
3018216|NCT01046253|3736227|FG000|COMPLETED|First Intervention||25
3018217|NCT01046253|3736228|FG001|COMPLETED|First Intervention||25
3018218|NCT01046253|3736227|FG000|NOT COMPLETED|First Intervention||0
3018219|NCT01046253|3736228|FG001|NOT COMPLETED|First Intervention||0
3018220|NCT01046253|3736227|FG000|STARTED|First Washout of 7 Days||25
3018221|NCT01046253|3736228|FG001|STARTED|First Washout of 7 Days||25
3018222|NCT01046253|3736227|FG000|COMPLETED|First Washout of 7 Days||25
3018223|NCT01046253|3736228|FG001|COMPLETED|First Washout of 7 Days||25
3018224|NCT01046253|3736227|FG000|NOT COMPLETED|First Washout of 7 Days||0
3018225|NCT01046253|3736228|FG001|NOT COMPLETED|First Washout of 7 Days||0
3018226|NCT01046253|3736227|FG000|STARTED|Second Intervention||25
3018227|NCT01046253|3736228|FG001|STARTED|Second Intervention||25
3165548|NCT01900431|3893129|FG002|COMPLETED|Principal Treatment Period (Part A)||0
3308344|NCT03019887|4041644|FG000|NOT COMPLETED|Overall Study||9
3308345|NCT03019939|4041648|FG000|STARTED|Overall Study||65
3018228|NCT01046253|3736227|FG000|COMPLETED|Second Intervention||25
3018229|NCT01046253|3736228|FG001|COMPLETED|Second Intervention||23
3018230|NCT01046253|3736227|FG000|NOT COMPLETED|Second Intervention||0
3018231|NCT01046253|3736228|FG001|NOT COMPLETED|Second Intervention||2
3018232|NCT01046253|3736227|FG000|STARTED|Second Washout of 7 Days||25
3018233|NCT01046253|3736228|FG001|STARTED|Second Washout of 7 Days||23
3018234|NCT01046253|3736227|FG000|COMPLETED|Second Washout of 7 Days||25
3018235|NCT01046253|3736228|FG001|COMPLETED|Second Washout of 7 Days||23
3018236|NCT01046253|3736227|FG000|NOT COMPLETED|Second Washout of 7 Days||0
3018237|NCT01046253|3736228|FG001|NOT COMPLETED|Second Washout of 7 Days||0
3018238|NCT01046253|3736227|FG000|STARTED|Third Intervention||25
3018239|NCT01046253|3736228|FG001|STARTED|Third Intervention||23
3018240|NCT01046253|3736227|FG000|COMPLETED|Third Intervention||25
3018241|NCT01046253|3736228|FG001|COMPLETED|Third Intervention||23
3018242|NCT01046253|3736227|FG000|NOT COMPLETED|Third Intervention||0
3018243|NCT01046253|3736228|FG001|NOT COMPLETED|Third Intervention||0
3018244|NCT01046253|3736227|FG000|STARTED|Third Washout of 7 Days||25
3018245|NCT01046253|3736228|FG001|STARTED|Third Washout of 7 Days||23
3018246|NCT01046253|3736227|FG000|COMPLETED|Third Washout of 7 Days||25
3018247|NCT01046253|3736228|FG001|COMPLETED|Third Washout of 7 Days||23
3018248|NCT01046253|3736227|FG000|NOT COMPLETED|Third Washout of 7 Days||0
3018249|NCT01046253|3736228|FG001|NOT COMPLETED|Third Washout of 7 Days||0
3018250|NCT01046253|3736227|FG000|STARTED|Fourth Intervention||25
3018251|NCT01046253|3736228|FG001|STARTED|Fourth Intervention||23
3018252|NCT01046253|3736227|FG000|COMPLETED|Fourth Intervention||25
3018253|NCT01046253|3736228|FG001|COMPLETED|Fourth Intervention||23
3018254|NCT01046253|3736227|FG000|NOT COMPLETED|Fourth Intervention||0
3018255|NCT01046253|3736228|FG001|NOT COMPLETED|Fourth Intervention||0
3018256|NCT01046396|3736234|FG000|STARTED|Overall Study||69
3018257|NCT01046396|3736234|FG000|COMPLETED|Overall Study||64
3018258|NCT01046396|3736234|FG000|NOT COMPLETED|Overall Study||5
3018259|NCT01046565|3736241|FG000|STARTED|Overall Study||75
3018260|NCT01046565|3736241|FG000|COMPLETED|Overall Study||66
3018261|NCT01046565|3736241|FG000|NOT COMPLETED|Overall Study||9
3018262|NCT01046643|3736252|FG000|STARTED|First Period Treatment or Placebo||9
3018263|NCT01046643|3736253|FG001|STARTED|First Period Treatment or Placebo||7
3018264|NCT01046643|3736254|FG002|STARTED|First Period Treatment or Placebo||7
3018265|NCT01046643|3736255|FG003|STARTED|First Period Treatment or Placebo||7
3018266|NCT01046643|3736252|FG000|COMPLETED|First Period Treatment or Placebo||9
3018267|NCT01046643|3736253|FG001|COMPLETED|First Period Treatment or Placebo||6
3018268|NCT01046643|3736254|FG002|COMPLETED|First Period Treatment or Placebo||7
3018269|NCT01046643|3736255|FG003|COMPLETED|First Period Treatment or Placebo||7
3018270|NCT01046643|3736252|FG000|NOT COMPLETED|First Period Treatment or Placebo||0
3018271|NCT01046643|3736253|FG001|NOT COMPLETED|First Period Treatment or Placebo||1
3018272|NCT01046643|3736254|FG002|NOT COMPLETED|First Period Treatment or Placebo||0
3165549|NCT01900431|3893127|FG000|NOT COMPLETED|Principal Treatment Period (Part A)||7
3165550|NCT01900431|3893128|FG001|NOT COMPLETED|Principal Treatment Period (Part A)||10
3165551|NCT01900431|3893129|FG002|NOT COMPLETED|Principal Treatment Period (Part A)||0
3165552|NCT01900431|3893127|FG000|STARTED|Extended Treatment Period (Part B)||8
3165553|NCT01900431|3893128|FG001|STARTED|Extended Treatment Period (Part B)||22
3165554|NCT01900431|3893129|FG002|STARTED|Extended Treatment Period (Part B)||0
3165555|NCT01900431|3893127|FG000|COMPLETED|Extended Treatment Period (Part B)||7
3165556|NCT01900431|3893128|FG001|COMPLETED|Extended Treatment Period (Part B)||12
3165557|NCT01900431|3893129|FG002|COMPLETED|Extended Treatment Period (Part B)||0
3165558|NCT01900431|3893127|FG000|NOT COMPLETED|Extended Treatment Period (Part B)||1
3165559|NCT01900431|3893128|FG001|NOT COMPLETED|Extended Treatment Period (Part B)||10
3165560|NCT01900431|3893129|FG002|NOT COMPLETED|Extended Treatment Period (Part B)||0
3165561|NCT01900431|3893127|FG000|STARTED|Open-Label Treatment Period (Part C)||0
3165562|NCT01900431|3893128|FG001|STARTED|Open-Label Treatment Period (Part C)||0
3165563|NCT01900431|3893129|FG002|STARTED|Open-Label Treatment Period (Part C)|10 non-responders (5 Placebo, 5 Sarilumab) & 11 non-completers (6 Placebo, 5 Sarilumab) from Part A.|21
3165564|NCT01900431|3893127|FG000|COMPLETED|Open-Label Treatment Period (Part C)||0
3165565|NCT01900431|3893128|FG001|COMPLETED|Open-Label Treatment Period (Part C)||0
3165566|NCT01900431|3893129|FG002|COMPLETED|Open-Label Treatment Period (Part C)||13
3165567|NCT01900431|3893127|FG000|NOT COMPLETED|Open-Label Treatment Period (Part C)||0
3165568|NCT01900431|3893128|FG001|NOT COMPLETED|Open-Label Treatment Period (Part C)||0
3165569|NCT01900431|3893129|FG002|NOT COMPLETED|Open-Label Treatment Period (Part C)||8
3165570|NCT01900444|3893137|FG000|STARTED|Overall Study||119
3165571|NCT01900444|3893137|FG000|COMPLETED|Overall Study||116
3165572|NCT01900444|3893137|FG000|NOT COMPLETED|Overall Study||3
3165573|NCT01900561|3893143|FG000|STARTED|Overall Study||278
3165574|NCT01900561|3893144|FG001|STARTED|Overall Study||278
3165575|NCT01900561|3893143|FG000|COMPLETED|Overall Study||261
3165576|NCT01900561|3893144|FG001|COMPLETED|Overall Study||269
3165577|NCT01900561|3893143|FG000|NOT COMPLETED|Overall Study||17
3165578|NCT01900561|3893144|FG001|NOT COMPLETED|Overall Study||9
3165579|NCT01900652|3893152|FG000|STARTED|Overall Study||83
3165580|NCT01900652|3893153|FG001|STARTED|Overall Study||28
3165581|NCT01900652|3893152|FG000|Post-Erlotinib Progression Tumor Sample|Overall Study||66
3165582|NCT01900652|3893153|FG001|Post-Erlotinib Progression Tumor Sample|Overall Study||23
3018273|NCT01046643|3736255|FG003|NOT COMPLETED|First Period Treatment or Placebo||0
3018274|NCT01046643|3736252|FG000|STARTED|Washout Period||9
3018275|NCT01046643|3736253|FG001|STARTED|Washout Period||6
3165583|NCT01900652|3893152|FG000|COMPLETED|Overall Study||75
3018276|NCT01046643|3736254|FG002|STARTED|Washout Period||7
3018277|NCT01046643|3736255|FG003|STARTED|Washout Period||7
3018278|NCT01046643|3736252|FG000|COMPLETED|Washout Period||9
3018279|NCT01046643|3736253|FG001|COMPLETED|Washout Period||6
3018280|NCT01046643|3736254|FG002|COMPLETED|Washout Period||7
3018281|NCT01046643|3736255|FG003|COMPLETED|Washout Period||7
3018282|NCT01046643|3736252|FG000|NOT COMPLETED|Washout Period||0
3018283|NCT01046643|3736253|FG001|NOT COMPLETED|Washout Period||0
3018284|NCT01046643|3736254|FG002|NOT COMPLETED|Washout Period||0
3018285|NCT01046643|3736255|FG003|NOT COMPLETED|Washout Period||0
3018286|NCT01046643|3736252|FG000|STARTED|Second Period Treatment or Placebo||9
3018287|NCT01046643|3736253|FG001|STARTED|Second Period Treatment or Placebo||6
3018288|NCT01046643|3736254|FG002|STARTED|Second Period Treatment or Placebo||7
3018289|NCT01046643|3736255|FG003|STARTED|Second Period Treatment or Placebo||7
3018290|NCT01046643|3736252|FG000|COMPLETED|Second Period Treatment or Placebo||9
3018291|NCT01046643|3736253|FG001|COMPLETED|Second Period Treatment or Placebo||6
3018292|NCT01046643|3736254|FG002|COMPLETED|Second Period Treatment or Placebo||7
3018293|NCT01046643|3736255|FG003|COMPLETED|Second Period Treatment or Placebo||7
3018294|NCT01046643|3736252|FG000|NOT COMPLETED|Second Period Treatment or Placebo||0
3018295|NCT01046643|3736253|FG001|NOT COMPLETED|Second Period Treatment or Placebo||0
3018296|NCT01046643|3736254|FG002|NOT COMPLETED|Second Period Treatment or Placebo||0
3018297|NCT01046643|3736255|FG003|NOT COMPLETED|Second Period Treatment or Placebo||0
3018298|NCT01046669|3736267|FG000|STARTED|Overall Study||226
3018299|NCT01046669|3736268|FG001|STARTED|Overall Study||224
3018300|NCT01046669|3736267|FG000|COMPLETED|Overall Study||226
3018301|NCT01046669|3736268|FG001|COMPLETED|Overall Study||223
3018302|NCT01046669|3736267|FG000|NOT COMPLETED|Overall Study||0
3018303|NCT01046669|3736268|FG001|NOT COMPLETED|Overall Study||1
3018304|NCT01046682|3736276|FG000|STARTED|Overall Study||20
3018305|NCT01046682|3736277|FG001|STARTED|Overall Study||20
3018306|NCT01046682|3736276|FG000|COMPLETED|Overall Study||18
3018307|NCT01046682|3736277|FG001|COMPLETED|Overall Study||20
3018308|NCT01046682|3736276|FG000|NOT COMPLETED|Overall Study||2
3018309|NCT01046682|3736277|FG001|NOT COMPLETED|Overall Study||0
3018310|NCT01046695|3736285|FG000|STARTED|Overall Study||20
3018311|NCT01046695|3736286|FG001|STARTED|Overall Study||22
3018312|NCT01046695|3736285|FG000|COMPLETED|Overall Study||20
3018313|NCT01046695|3736286|FG001|COMPLETED|Overall Study||20
3018314|NCT01046695|3736285|FG000|NOT COMPLETED|Overall Study||0
3018315|NCT01046695|3736286|FG001|NOT COMPLETED|Overall Study||2
3018316|NCT01046877|3736292|FG000|STARTED|Overall Study||25
3018317|NCT01046877|3736292|FG000|Completed on Schedule|Overall Study|Final visit = the earlier of 24 months post-procedure or 12 months after extrusion.|6
3018318|NCT01046877|3736292|FG000|Completed Study Late|Overall Study|One completed (evidencing extrusions) at 23.5 mos. Missed 9 mo visit. Exam not possible at 12 mo.|1
3018319|NCT01046877|3736292|FG000|COMPLETED|Overall Study||7
3018320|NCT01046877|3736292|FG000|NOT COMPLETED|Overall Study||18
3018321|NCT01046903|3736296|FG000|STARTED|Overall Study||503
3018322|NCT01046903|3736296|FG000|COMPLETED|Overall Study||475
3018323|NCT01046903|3736296|FG000|NOT COMPLETED|Overall Study||28
3018324|NCT01047007|3736304|FG000|STARTED|Overall Study||3
3018325|NCT01047007|3736305|FG001|STARTED|Overall Study||6
3018326|NCT01047007|3736306|FG002|STARTED|Overall Study||2
3018327|NCT01047007|3736307|FG003|STARTED|Overall Study||0
3018328|NCT01047007|3736304|FG000|Treated|Overall Study||3
3018329|NCT01047007|3736305|FG001|Treated|Overall Study||6
3018330|NCT01047007|3736306|FG002|Treated|Overall Study||2
3018331|NCT01047007|3736307|FG003|Treated|Overall Study||0
3018332|NCT01047007|3736304|FG000|COMPLETED|Overall Study||1
3018333|NCT01047007|3736305|FG001|COMPLETED|Overall Study||0
3018334|NCT01047007|3736306|FG002|COMPLETED|Overall Study||0
3018335|NCT01047007|3736307|FG003|COMPLETED|Overall Study||0
3018336|NCT01047007|3736304|FG000|NOT COMPLETED|Overall Study||2
3018337|NCT01047007|3736305|FG001|NOT COMPLETED|Overall Study||6
3018338|NCT01047007|3736306|FG002|NOT COMPLETED|Overall Study||2
3018339|NCT01047007|3736307|FG003|NOT COMPLETED|Overall Study||0
3018340|NCT01047189|3736319|FG000|STARTED|Overall Study||13
3018341|NCT01047189|3736320|FG001|STARTED|Overall Study||13
3018342|NCT01047189|3736319|FG000|COMPLETED|Overall Study||9
3018343|NCT01047189|3736320|FG001|COMPLETED|Overall Study||13
3018344|NCT01047189|3736319|FG000|NOT COMPLETED|Overall Study||4
3018345|NCT01047189|3736320|FG001|NOT COMPLETED|Overall Study||0
3018346|NCT01047241|3736326|FG000|STARTED|Overall Study||50
3018347|NCT01047241|3736326|FG000|COMPLETED|Overall Study||50
3018348|NCT01047241|3736326|FG000|NOT COMPLETED|Overall Study||0
3018349|NCT01047293|3736333|FG000|STARTED|Overall Study||4
3018350|NCT01047293|3736334|FG001|STARTED|Overall Study||8
3018351|NCT01047293|3736335|FG002|STARTED|Overall Study||9
3018352|NCT01047293|3736336|FG003|STARTED|Overall Study||26
3018353|NCT01047293|3736333|FG000|COMPLETED|Overall Study||3
3018354|NCT01047293|3736334|FG001|COMPLETED|Overall Study||7
3018355|NCT01047293|3736335|FG002|COMPLETED|Overall Study||9
3018356|NCT01047293|3736336|FG003|COMPLETED|Overall Study||26
3018357|NCT01047293|3736333|FG000|NOT COMPLETED|Overall Study||1
3018358|NCT01047293|3736334|FG001|NOT COMPLETED|Overall Study||1
3018359|NCT01047293|3736335|FG002|NOT COMPLETED|Overall Study||0
3018360|NCT01047293|3736336|FG003|NOT COMPLETED|Overall Study||0
3018361|NCT01047306|3736345|FG000|STARTED|Overall Study||19
3018362|NCT01047306|3736346|FG001|STARTED|Overall Study||6
3018363|NCT01047306|3736345|FG000|Discontinued From the Study|Overall Study||3
3018364|NCT01047306|3736346|FG001|Discontinued From the Study|Overall Study||0
3018365|NCT01047306|3736345|FG000|COMPLETED|Overall Study||16
3018366|NCT01047306|3736346|FG001|COMPLETED|Overall Study||6
3018367|NCT01047306|3736345|FG000|NOT COMPLETED|Overall Study||3
3018368|NCT01047306|3736346|FG001|NOT COMPLETED|Overall Study||0
3018369|NCT01047332|3736356|FG000|STARTED|Overall Study||61
3018370|NCT01047332|3736357|FG001|STARTED|Overall Study||68
3018371|NCT01047332|3736356|FG000|COMPLETED|Overall Study|Alive at final follow-up|4
3018372|NCT01047332|3736357|FG001|COMPLETED|Overall Study|Alive at final follow-up|4
3018373|NCT01047332|3736356|FG000|NOT COMPLETED|Overall Study||57
3018374|NCT01047332|3736357|FG001|NOT COMPLETED|Overall Study||64
3018375|NCT01047345|3736365|FG000|STARTED|Base Study||618
3018376|NCT01047345|3736366|FG001|STARTED|Base Study||306
3018377|NCT01047345|3736367|FG002|STARTED|Base Study||0
3018378|NCT01047345|3736365|FG000|Vaccination 1|Base Study||615
3018379|NCT01047345|3736366|FG001|Vaccination 1|Base Study||306
3018380|NCT01047345|3736367|FG002|Vaccination 1|Base Study||0
3018381|NCT01047345|3736365|FG000|Vaccination 2|Base Study||604
3018382|NCT01047345|3736366|FG001|Vaccination 2|Base Study||304
3018383|NCT01047345|3736367|FG002|Vaccination 2|Base Study||0
3018384|NCT01047345|3736365|FG000|Vaccination 3|Base Study||597
3018385|NCT01047345|3736366|FG001|Vaccination 3|Base Study||300
3018386|NCT01047345|3736367|FG002|Vaccination 3|Base Study||0
3018387|NCT01047345|3736365|FG000|COMPLETED|Base Study|Includes 1 participant for whom completion status is unknown|596
3018388|NCT01047345|3736366|FG001|COMPLETED|Base Study||300
3018389|NCT01047345|3736367|FG002|COMPLETED|Base Study||0
3018390|NCT01047345|3736365|FG000|NOT COMPLETED|Base Study||22
3018391|NCT01047345|3736366|FG001|NOT COMPLETED|Base Study||6
3018392|NCT01047345|3736367|FG002|NOT COMPLETED|Base Study||0
3018393|NCT01047345|3736365|FG000|STARTED|Extension||0
3018394|NCT01047345|3736366|FG001|STARTED|Extension||0
3018395|NCT01047345|3736367|FG002|STARTED|Extension|Not all eligible participants elected to participate in extension|102
3018396|NCT01047345|3736365|FG000|Vaccination 4|Extension||0
3018397|NCT01047345|3736366|FG001|Vaccination 4|Extension||0
3018398|NCT01047345|3736367|FG002|Vaccination 4|Extension||102
3018399|NCT01047345|3736365|FG000|Vaccination 5|Extension||0
3018400|NCT01047345|3736366|FG001|Vaccination 5|Extension||0
3018401|NCT01047345|3736367|FG002|Vaccination 5|Extension||99
3018402|NCT01047345|3736365|FG000|Vaccination 6|Extension||0
3018403|NCT01047345|3736366|FG001|Vaccination 6|Extension||0
3018404|NCT01047345|3736367|FG002|Vaccination 6|Extension|1 participant received 6th vaccination outside the context of study but completed the study.|95
3018405|NCT01047345|3736365|FG000|COMPLETED|Extension||0
3018406|NCT01047345|3736366|FG001|COMPLETED|Extension||0
3018407|NCT01047345|3736367|FG002|COMPLETED|Extension||96
3018408|NCT01047345|3736365|FG000|NOT COMPLETED|Extension||0
3018409|NCT01047345|3736366|FG001|NOT COMPLETED|Extension||0
3018410|NCT01047345|3736367|FG002|NOT COMPLETED|Extension||6
3018411|NCT01047358|3736375|FG000|STARTED|Overall Study||206
3018412|NCT01047358|3736375|FG000|COMPLETED|Overall Study|At least one safety assessment (Safety Population)|206
3018413|NCT01047358|3736375|FG000|NOT COMPLETED|Overall Study||0
3018414|NCT01047436|3736382|FG000|STARTED|Overall Study||16
3018415|NCT01047436|3736383|FG001|STARTED|Overall Study||15
3018416|NCT01047436|3736382|FG000|COMPLETED|Overall Study||15
3018417|NCT01047436|3736383|FG001|COMPLETED|Overall Study||15
3018418|NCT01047436|3736382|FG000|NOT COMPLETED|Overall Study||1
3018419|NCT01047436|3736383|FG001|NOT COMPLETED|Overall Study||0
3018420|NCT01047475|3736391|FG000|STARTED|Overall Study||34
3018421|NCT01047475|3736392|FG001|STARTED|Overall Study||38
3018422|NCT01047475|3736391|FG000|COMPLETED|Overall Study||29
3018423|NCT01047475|3736392|FG001|COMPLETED|Overall Study||31
3018424|NCT01047475|3736391|FG000|NOT COMPLETED|Overall Study||5
3018425|NCT01047475|3736392|FG001|NOT COMPLETED|Overall Study||7
3018426|NCT01047527|3736401|FG000|STARTED|Overall Study||180
3018427|NCT01047527|3736402|FG001|STARTED|Overall Study||173
3018428|NCT01047527|3736403|FG002|STARTED|Overall Study||172
3018429|NCT01047527|3736401|FG000|8 Weeks|Overall Study||148
3018430|NCT01047527|3736402|FG001|8 Weeks|Overall Study||142
3018431|NCT01047527|3736403|FG002|8 Weeks|Overall Study||138
3018432|NCT01047527|3736401|FG000|24 Weeks|Overall Study||111
3018433|NCT01047527|3736402|FG001|24 Weeks|Overall Study||123
3018434|NCT01047527|3736403|FG002|24 Weeks|Overall Study||119
3018435|NCT01047527|3736401|FG000|COMPLETED|Overall Study||95
3018436|NCT01047527|3736402|FG001|COMPLETED|Overall Study||112
3018437|NCT01047527|3736403|FG002|COMPLETED|Overall Study||107
3018438|NCT01047527|3736401|FG000|NOT COMPLETED|Overall Study||85
3018439|NCT01047527|3736402|FG001|NOT COMPLETED|Overall Study||61
3018440|NCT01047527|3736403|FG002|NOT COMPLETED|Overall Study||65
3018441|NCT01047553|3736414|FG000|STARTED|Overall Study||125
3018442|NCT01047553|3736415|FG001|STARTED|Overall Study||126
3018443|NCT01047553|3736414|FG000|COMPLETED|Overall Study||108
3018444|NCT01047553|3736415|FG001|COMPLETED|Overall Study||117
3018445|NCT01047553|3736414|FG000|NOT COMPLETED|Overall Study||17
3018446|NCT01047553|3736415|FG001|NOT COMPLETED|Overall Study||9
3018447|NCT01047709|3736421|FG000|STARTED|Positional Therapy (1 Night)||9
3018448|NCT01047709|3736422|FG001|STARTED|Positional Therapy (1 Night)||9
3018449|NCT01047709|3736421|FG000|COMPLETED|Positional Therapy (1 Night)||9
3018450|NCT01047709|3736422|FG001|COMPLETED|Positional Therapy (1 Night)||9
3018451|NCT01047709|3736421|FG000|NOT COMPLETED|Positional Therapy (1 Night)||0
3018452|NCT01047709|3736422|FG001|NOT COMPLETED|Positional Therapy (1 Night)||0
3018453|NCT01047709|3736421|FG000|STARTED|Control/Positioning ad Lib (1 Night)||9
3018454|NCT01047709|3736422|FG001|STARTED|Control/Positioning ad Lib (1 Night)||9
3018455|NCT01047709|3736421|FG000|COMPLETED|Control/Positioning ad Lib (1 Night)||9
3018456|NCT01047709|3736422|FG001|COMPLETED|Control/Positioning ad Lib (1 Night)||9
3018457|NCT01047709|3736421|FG000|NOT COMPLETED|Control/Positioning ad Lib (1 Night)||0
3018458|NCT01047709|3736422|FG001|NOT COMPLETED|Control/Positioning ad Lib (1 Night)||0
3018459|NCT01047839|3736431|FG000|STARTED|Overall Study||12
3018460|NCT01047839|3736432|FG001|STARTED|Overall Study||29
3018461|NCT01047839|3736433|FG002|STARTED|Overall Study||59
3018462|NCT01047839|3736431|FG000|COMPLETED|Overall Study||10
3018463|NCT01047839|3736432|FG001|COMPLETED|Overall Study||29
3018464|NCT01047839|3736433|FG002|COMPLETED|Overall Study||53
3018465|NCT01047839|3736431|FG000|NOT COMPLETED|Overall Study||2
3018466|NCT01047839|3736432|FG001|NOT COMPLETED|Overall Study||0
3018467|NCT01047839|3736433|FG002|NOT COMPLETED|Overall Study||6
3165584|NCT01900652|3893153|FG001|COMPLETED|Overall Study||25
3165585|NCT01900652|3893152|FG000|NOT COMPLETED|Overall Study||8
3165586|NCT01900652|3893153|FG001|NOT COMPLETED|Overall Study||3
3018468|NCT01048099|3736448|FG000|STARTED|Patients Enrolled and Blood Collected|Patients enrolled|283
3018469|NCT01048099|3736448|FG000|COMPLETED|Patients Enrolled and Blood Collected|Patients with circulating tumor cells (CTCs)|226
3018470|NCT01048099|3736448|FG000|NOT COMPLETED|Patients Enrolled and Blood Collected||57
3018471|NCT01048099|3736448|FG000|STARTED|Patients Evaluated by PRO Onc Assay|Patients with CTCs who were evaluated by PRO Onc Assay|226
3018472|NCT01048099|3736448|FG000|COMPLETED|Patients Evaluated by PRO Onc Assay|Patients evaluated by PRO Onc Assay with HER2 overexpression/activation detected|24
3018473|NCT01048099|3736448|FG000|NOT COMPLETED|Patients Evaluated by PRO Onc Assay||202
3018474|NCT01048099|3736448|FG000|STARTED|Pts w/ HER2 Overexpression/Activation|Patients with detected HER2 activation and/or overexpression|24
3018475|NCT01048099|3736448|FG000|COMPLETED|Pts w/ HER2 Overexpression/Activation|Patients who proceeded to treatment|14
3018476|NCT01048099|3736448|FG000|NOT COMPLETED|Pts w/ HER2 Overexpression/Activation||10
3018477|NCT01048099|3736448|FG000|STARTED|Treatment Per Protocol||14
3018478|NCT01048099|3736448|FG000|COMPLETED|Treatment Per Protocol|Patients continued treatment until disease progression or coming off-study for any other reason|0
3018479|NCT01048099|3736448|FG000|NOT COMPLETED|Treatment Per Protocol||14
3018480|NCT01048242|3736456|FG000|STARTED|Overall Study||12
3018481|NCT01048242|3736457|FG001|STARTED|Overall Study||15
3018482|NCT01048242|3736456|FG000|COMPLETED|Overall Study||8
3018483|NCT01048242|3736457|FG001|COMPLETED|Overall Study||13
3018484|NCT01048242|3736456|FG000|NOT COMPLETED|Overall Study||4
3018485|NCT01048242|3736457|FG001|NOT COMPLETED|Overall Study||2
3018486|NCT01048333|3736463|FG000|STARTED|Treatment Period 1||21
3018487|NCT01048333|3736464|FG001|STARTED|Treatment Period 1||19
3018488|NCT01048333|3736465|FG002|STARTED|Treatment Period 1||16
3018489|NCT01048333|3736466|FG003|STARTED|Treatment Period 1||18
3018490|NCT01048333|3736467|FG004|STARTED|Treatment Period 1||17
3018491|NCT01048333|3736468|FG005|STARTED|Treatment Period 1||18
3018492|NCT01048333|3736463|FG000|COMPLETED|Treatment Period 1||21
3018493|NCT01048333|3736464|FG001|COMPLETED|Treatment Period 1||19
3018494|NCT01048333|3736465|FG002|COMPLETED|Treatment Period 1||16
3018495|NCT01048333|3736466|FG003|COMPLETED|Treatment Period 1||18
3018496|NCT01048333|3736467|FG004|COMPLETED|Treatment Period 1||17
3018497|NCT01048333|3736468|FG005|COMPLETED|Treatment Period 1||18
3018498|NCT01048333|3736463|FG000|NOT COMPLETED|Treatment Period 1||0
3018499|NCT01048333|3736464|FG001|NOT COMPLETED|Treatment Period 1||0
3018500|NCT01048333|3736465|FG002|NOT COMPLETED|Treatment Period 1||0
3018501|NCT01048333|3736466|FG003|NOT COMPLETED|Treatment Period 1||0
3018502|NCT01048333|3736467|FG004|NOT COMPLETED|Treatment Period 1||0
3018503|NCT01048333|3736468|FG005|NOT COMPLETED|Treatment Period 1||0
3018504|NCT01048333|3736463|FG000|STARTED|Wash-Out Period 1 of 2 - 7 Days||21
3018505|NCT01048333|3736464|FG001|STARTED|Wash-Out Period 1 of 2 - 7 Days||19
3018506|NCT01048333|3736465|FG002|STARTED|Wash-Out Period 1 of 2 - 7 Days||16
3018507|NCT01048333|3736466|FG003|STARTED|Wash-Out Period 1 of 2 - 7 Days||18
3018508|NCT01048333|3736467|FG004|STARTED|Wash-Out Period 1 of 2 - 7 Days||17
3018509|NCT01048333|3736468|FG005|STARTED|Wash-Out Period 1 of 2 - 7 Days||18
3018510|NCT01048333|3736463|FG000|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||21
3018511|NCT01048333|3736464|FG001|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||19
3018512|NCT01048333|3736465|FG002|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||16
3018513|NCT01048333|3736466|FG003|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||18
3018514|NCT01048333|3736467|FG004|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||17
3018515|NCT01048333|3736468|FG005|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||18
3018516|NCT01048333|3736463|FG000|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
3018517|NCT01048333|3736464|FG001|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
3018518|NCT01048333|3736465|FG002|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
3018519|NCT01048333|3736466|FG003|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
3018520|NCT01048333|3736467|FG004|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
3018521|NCT01048333|3736468|FG005|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
3018522|NCT01048333|3736463|FG000|STARTED|Treatment Period 2||21
3018523|NCT01048333|3736464|FG001|STARTED|Treatment Period 2||19
3018524|NCT01048333|3736465|FG002|STARTED|Treatment Period 2||16
3018525|NCT01048333|3736466|FG003|STARTED|Treatment Period 2||18
3018526|NCT01048333|3736467|FG004|STARTED|Treatment Period 2||17
3018527|NCT01048333|3736468|FG005|STARTED|Treatment Period 2||18
3018528|NCT01048333|3736463|FG000|COMPLETED|Treatment Period 2||21
3165587|NCT01900665|3893166|FG000|STARTED|Placebo Controlled Period||1057
3165588|NCT01900665|3893167|FG001|STARTED|Placebo Controlled Period||1072
3165589|NCT01900665|3893166|FG000|Received at Least 1 Dose of Study Drug|Placebo Controlled Period||1054
3165590|NCT01900665|3893167|FG001|Received at Least 1 Dose of Study Drug|Placebo Controlled Period||1067
3165591|NCT01900665|3893166|FG000|COMPLETED|Placebo Controlled Period||914
3165592|NCT01900665|3893167|FG001|COMPLETED|Placebo Controlled Period||908
3165593|NCT01900665|3893166|FG000|NOT COMPLETED|Placebo Controlled Period||143
3165594|NCT01900665|3893167|FG001|NOT COMPLETED|Placebo Controlled Period||164
3165595|NCT01900665|3893166|FG000|STARTED|Open Label Period|Patients from Placebo Controlled Period were not required to enter into Open Label Period.|881
3165596|NCT01900665|3893167|FG001|STARTED|Open Label Period|Patients from Placebo Controlled Period were not required to enter into Open Label Period.|859
3165597|NCT01900665|3893166|FG000|COMPLETED|Open Label Period||0
3165598|NCT01900665|3893167|FG001|COMPLETED|Open Label Period||0
3165599|NCT01900665|3893166|FG000|NOT COMPLETED|Open Label Period||881
3165600|NCT01900665|3893167|FG001|NOT COMPLETED|Open Label Period||859
3165601|NCT01900704|3893179|FG000|STARTED|Overall Study||270
3165602|NCT01900704|3893180|FG001|STARTED|Overall Study||270
3165603|NCT01900704|3893181|FG002|STARTED|Overall Study||270
3165604|NCT01900704|3893179|FG000|COMPLETED|Overall Study||229
3165605|NCT01900704|3893180|FG001|COMPLETED|Overall Study||235
3165606|NCT01900704|3893181|FG002|COMPLETED|Overall Study||237
3165607|NCT01900704|3893179|FG000|NOT COMPLETED|Overall Study||41
3165608|NCT01900704|3893180|FG001|NOT COMPLETED|Overall Study||35
3018529|NCT01048333|3736464|FG001|COMPLETED|Treatment Period 2||19
3018530|NCT01048333|3736465|FG002|COMPLETED|Treatment Period 2||16
3018531|NCT01048333|3736466|FG003|COMPLETED|Treatment Period 2||18
3018532|NCT01048333|3736467|FG004|COMPLETED|Treatment Period 2||17
3018533|NCT01048333|3736468|FG005|COMPLETED|Treatment Period 2||18
3018534|NCT01048333|3736463|FG000|NOT COMPLETED|Treatment Period 2||0
3018535|NCT01048333|3736464|FG001|NOT COMPLETED|Treatment Period 2||0
3018536|NCT01048333|3736465|FG002|NOT COMPLETED|Treatment Period 2||0
3018537|NCT01048333|3736466|FG003|NOT COMPLETED|Treatment Period 2||0
3018538|NCT01048333|3736467|FG004|NOT COMPLETED|Treatment Period 2||0
3018539|NCT01048333|3736468|FG005|NOT COMPLETED|Treatment Period 2||0
3018540|NCT01048333|3736463|FG000|STARTED|Wash-Out Period 2 of 2 - 7 Days||21
3018541|NCT01048333|3736464|FG001|STARTED|Wash-Out Period 2 of 2 - 7 Days||19
3018542|NCT01048333|3736465|FG002|STARTED|Wash-Out Period 2 of 2 - 7 Days||16
3018543|NCT01048333|3736466|FG003|STARTED|Wash-Out Period 2 of 2 - 7 Days||18
3018544|NCT01048333|3736467|FG004|STARTED|Wash-Out Period 2 of 2 - 7 Days||17
3018545|NCT01048333|3736468|FG005|STARTED|Wash-Out Period 2 of 2 - 7 Days||18
3018546|NCT01048333|3736463|FG000|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||21
3018547|NCT01048333|3736464|FG001|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||18
3018548|NCT01048333|3736465|FG002|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||16
3018549|NCT01048333|3736466|FG003|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||18
3018550|NCT01048333|3736467|FG004|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||17
3018551|NCT01048333|3736468|FG005|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||18
3018552|NCT01048333|3736463|FG000|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||0
3018553|NCT01048333|3736464|FG001|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||1
3018554|NCT01048333|3736465|FG002|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||0
3018555|NCT01048333|3736466|FG003|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||0
3018556|NCT01048333|3736467|FG004|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||0
3018557|NCT01048333|3736468|FG005|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||0
3018558|NCT01048333|3736463|FG000|STARTED|Treatment Period 3||21
3018559|NCT01048333|3736464|FG001|STARTED|Treatment Period 3||18
3018560|NCT01048333|3736465|FG002|STARTED|Treatment Period 3||16
3018561|NCT01048333|3736466|FG003|STARTED|Treatment Period 3||18
3018562|NCT01048333|3736467|FG004|STARTED|Treatment Period 3||17
3018563|NCT01048333|3736468|FG005|STARTED|Treatment Period 3||18
3018564|NCT01048333|3736463|FG000|COMPLETED|Treatment Period 3||21
3018565|NCT01048333|3736464|FG001|COMPLETED|Treatment Period 3||18
3018566|NCT01048333|3736465|FG002|COMPLETED|Treatment Period 3||16
3018567|NCT01048333|3736466|FG003|COMPLETED|Treatment Period 3||18
3018568|NCT01048333|3736467|FG004|COMPLETED|Treatment Period 3||17
3018569|NCT01048333|3736468|FG005|COMPLETED|Treatment Period 3||18
3018570|NCT01048333|3736463|FG000|NOT COMPLETED|Treatment Period 3||0
3018571|NCT01048333|3736464|FG001|NOT COMPLETED|Treatment Period 3||0
3018572|NCT01048333|3736465|FG002|NOT COMPLETED|Treatment Period 3||0
3018573|NCT01048333|3736466|FG003|NOT COMPLETED|Treatment Period 3||0
3018574|NCT01048333|3736467|FG004|NOT COMPLETED|Treatment Period 3||0
3018575|NCT01048333|3736468|FG005|NOT COMPLETED|Treatment Period 3||0
3018576|NCT01048424|3736478|FG000|STARTED|Overall Study||10
3018577|NCT01048424|3736479|FG001|STARTED|Overall Study||10
3018578|NCT01048424|3736478|FG000|COMPLETED|Overall Study||8
3018579|NCT01048424|3736479|FG001|COMPLETED|Overall Study||10
3018580|NCT01048424|3736478|FG000|NOT COMPLETED|Overall Study||2
3018581|NCT01048424|3736479|FG001|NOT COMPLETED|Overall Study||0
3018582|NCT01048502|3736490|FG000|STARTED|Overall Study||24
3018583|NCT01048502|3736491|FG001|STARTED|Overall Study||23
3018584|NCT01048502|3736492|FG002|STARTED|Overall Study||28
3018585|NCT01048502|3736493|FG003|STARTED|Overall Study||25
3018586|NCT01048502|3736490|FG000|COMPLETED|Overall Study||20
3018587|NCT01048502|3736491|FG001|COMPLETED|Overall Study||16
3018588|NCT01048502|3736492|FG002|COMPLETED|Overall Study||23
3018589|NCT01048502|3736493|FG003|COMPLETED|Overall Study||21
3018590|NCT01048502|3736490|FG000|NOT COMPLETED|Overall Study||4
3018591|NCT01048502|3736491|FG001|NOT COMPLETED|Overall Study||7
3018592|NCT01048502|3736492|FG002|NOT COMPLETED|Overall Study||5
3018593|NCT01048502|3736493|FG003|NOT COMPLETED|Overall Study||4
3018594|NCT01048541|3736504|FG000|STARTED|Overall Study||18
3018595|NCT01048541|3736505|FG001|STARTED|Overall Study||19
3018596|NCT01048541|3736504|FG000|COMPLETED|Overall Study||17
3018597|NCT01048541|3736505|FG001|COMPLETED|Overall Study||19
3018598|NCT01048541|3736504|FG000|NOT COMPLETED|Overall Study||1
3018599|NCT01048541|3736505|FG001|NOT COMPLETED|Overall Study||0
3018600|NCT01048593|3736514|FG000|STARTED|Overall Study||3
3018601|NCT01048593|3736515|FG001|STARTED|Overall Study||2
3018602|NCT01048593|3736516|FG002|STARTED|Overall Study||1
3018603|NCT01048593|3736514|FG000|COMPLETED|Overall Study||3
3018604|NCT01048593|3736515|FG001|COMPLETED|Overall Study||2
3018605|NCT01048593|3736516|FG002|COMPLETED|Overall Study||1
3018606|NCT01048593|3736514|FG000|NOT COMPLETED|Overall Study||0
3018607|NCT01048593|3736515|FG001|NOT COMPLETED|Overall Study||0
3018608|NCT01048593|3736516|FG002|NOT COMPLETED|Overall Study||0
3018609|NCT01048606|3736528|FG000|STARTED|Overall Study||28
3018610|NCT01048606|3736529|FG001|STARTED|Overall Study||15
3018611|NCT01048606|3736530|FG002|STARTED|Overall Study||26
3018612|NCT01048606|3736531|FG003|STARTED|Overall Study||10
3018613|NCT01048606|3736528|FG000|COMPLETED|Overall Study||16
3018614|NCT01048606|3736529|FG001|COMPLETED|Overall Study||8
3018615|NCT01048606|3736530|FG002|COMPLETED|Overall Study||16
3018616|NCT01048606|3736531|FG003|COMPLETED|Overall Study||5
3018617|NCT01048606|3736528|FG000|NOT COMPLETED|Overall Study||12
3018618|NCT01048606|3736529|FG001|NOT COMPLETED|Overall Study||7
3018619|NCT01048606|3736530|FG002|NOT COMPLETED|Overall Study||10
3018620|NCT01048606|3736531|FG003|NOT COMPLETED|Overall Study||5
3018621|NCT01048658|3736543|FG000|STARTED|Overall Study||80
3018622|NCT01048658|3736544|FG001|STARTED|Overall Study||80
3018623|NCT01048658|3736543|FG000|COMPLETED|Overall Study||80
3018624|NCT01048658|3736544|FG001|COMPLETED|Overall Study||80
3018625|NCT01048658|3736543|FG000|NOT COMPLETED|Overall Study||0
3018626|NCT01048658|3736544|FG001|NOT COMPLETED|Overall Study||0
3018627|NCT01048671|3736553|FG000|STARTED|Overall Study||66
3018628|NCT01048671|3736554|FG001|STARTED|Overall Study||264
3018629|NCT01048671|3736555|FG002|STARTED|Overall Study||152
3018630|NCT01048671|3736553|FG000|COMPLETED|Overall Study||66
3018631|NCT01048671|3736554|FG001|COMPLETED|Overall Study||263
3018632|NCT01048671|3736555|FG002|COMPLETED|Overall Study||151
3018633|NCT01048671|3736553|FG000|NOT COMPLETED|Overall Study||0
3018634|NCT01048671|3736554|FG001|NOT COMPLETED|Overall Study||1
3018635|NCT01048671|3736555|FG002|NOT COMPLETED|Overall Study||1
3018636|NCT01048697|3736563|FG000|STARTED|Overall Study||18
3018637|NCT01048697|3736563|FG000|COMPLETED|Overall Study||18
3018638|NCT01048697|3736563|FG000|NOT COMPLETED|Overall Study||0
3018639|NCT01048788|3736570|FG000|STARTED|Overall Study||8
3018640|NCT01048788|3736571|FG001|STARTED|Overall Study||30
3018641|NCT01048788|3736572|FG002|STARTED|Overall Study||13
3018642|NCT01048788|3736570|FG000|COMPLETED|Overall Study||3
3018643|NCT01048788|3736571|FG001|COMPLETED|Overall Study||28
3018644|NCT01048788|3736572|FG002|COMPLETED|Overall Study||11
3018645|NCT01048788|3736570|FG000|NOT COMPLETED|Overall Study||5
3018646|NCT01048788|3736571|FG001|NOT COMPLETED|Overall Study||2
3018647|NCT01048788|3736572|FG002|NOT COMPLETED|Overall Study||2
3018648|NCT01048866|3736582|FG000|STARTED|Overall Study||101
3018649|NCT01048866|3736583|FG001|STARTED|Overall Study||97
3018650|NCT01048866|3736582|FG000|COMPLETED|Overall Study||97
3018651|NCT01048866|3736583|FG001|COMPLETED|Overall Study||92
3018652|NCT01048866|3736582|FG000|NOT COMPLETED|Overall Study||4
3018653|NCT01048866|3736583|FG001|NOT COMPLETED|Overall Study||5
3018654|NCT01048879|3736592|FG000|STARTED|Overall Study||1
3018655|NCT01048879|3736593|FG001|STARTED|Overall Study||9
3018656|NCT01048879|3736594|FG002|STARTED|Overall Study||5
3018657|NCT01048879|3736592|FG000|COMPLETED|Overall Study||1
3018658|NCT01048879|3736593|FG001|COMPLETED|Overall Study||9
3018659|NCT01048879|3736594|FG002|COMPLETED|Overall Study||5
3018660|NCT01048879|3736592|FG000|NOT COMPLETED|Overall Study||0
3018661|NCT01048879|3736593|FG001|NOT COMPLETED|Overall Study||0
3018662|NCT01048879|3736594|FG002|NOT COMPLETED|Overall Study||0
3018663|NCT01048905|3736602|FG000|STARTED|Overall Study||13
3018664|NCT01048905|3736602|FG000|COMPLETED|Overall Study||12
3018665|NCT01048905|3736602|FG000|NOT COMPLETED|Overall Study||1
3018666|NCT01048944|3736610|FG000|STARTED|Overall Study||32
3018667|NCT01048944|3736611|FG001|STARTED|Overall Study||38
3018668|NCT01048944|3736612|FG002|STARTED|Overall Study||35
3018669|NCT01048944|3736613|FG003|STARTED|Overall Study||21
3018670|NCT01048944|3736610|FG000|COMPLETED|Overall Study||24
3018671|NCT01048944|3736611|FG001|COMPLETED|Overall Study||28
3018672|NCT01048944|3736612|FG002|COMPLETED|Overall Study||25
3018673|NCT01048944|3736613|FG003|COMPLETED|Overall Study||19
3018674|NCT01048944|3736610|FG000|NOT COMPLETED|Overall Study||8
3018675|NCT01048944|3736611|FG001|NOT COMPLETED|Overall Study||10
3018676|NCT01048944|3736612|FG002|NOT COMPLETED|Overall Study||10
3018677|NCT01048944|3736613|FG003|NOT COMPLETED|Overall Study||2
3018678|NCT01049009|3736625|FG000|STARTED|Treatment Period 1 (12 Weeks)||23
3018679|NCT01049009|3736626|FG001|STARTED|Treatment Period 1 (12 Weeks)||21
3018680|NCT01049009|3736625|FG000|COMPLETED|Treatment Period 1 (12 Weeks)||21
3018681|NCT01049009|3736626|FG001|COMPLETED|Treatment Period 1 (12 Weeks)||18
3018682|NCT01049009|3736625|FG000|NOT COMPLETED|Treatment Period 1 (12 Weeks)||2
3018683|NCT01049009|3736626|FG001|NOT COMPLETED|Treatment Period 1 (12 Weeks)||3
3018684|NCT01049009|3736625|FG000|STARTED|Treatment Period 2 (12 Weeks)||21
3018685|NCT01049009|3736626|FG001|STARTED|Treatment Period 2 (12 Weeks)||18
3018686|NCT01049009|3736625|FG000|COMPLETED|Treatment Period 2 (12 Weeks)||11
3018687|NCT01049009|3736626|FG001|COMPLETED|Treatment Period 2 (12 Weeks)||8
3018688|NCT01049009|3736625|FG000|NOT COMPLETED|Treatment Period 2 (12 Weeks)||10
3018689|NCT01049009|3736626|FG001|NOT COMPLETED|Treatment Period 2 (12 Weeks)||10
3018690|NCT01049217|3736634|FG000|STARTED|Overall Study||183
3018691|NCT01049217|3736635|FG001|STARTED|Overall Study||194
3018692|NCT01049217|3736634|FG000|Treated|Overall Study||183
3018693|NCT01049217|3736635|FG001|Treated|Overall Study||192
3018694|NCT01049217|3736634|FG000|COMPLETED|Overall Study||127
3018695|NCT01049217|3736635|FG001|COMPLETED|Overall Study||131
3018696|NCT01049217|3736634|FG000|NOT COMPLETED|Overall Study||56
3018697|NCT01049217|3736635|FG001|NOT COMPLETED|Overall Study||63
3018698|NCT01049243|3736641|FG000|STARTED|Overall Study||20
3018699|NCT01049243|3736641|FG000|COMPLETED|Overall Study||18
3018700|NCT01049243|3736641|FG000|NOT COMPLETED|Overall Study||2
3018701|NCT01049308|3736646|FG000|STARTED|Evaluation of Cognitive Impairment||251
3018702|NCT01049308|3736646|FG000|COMPLETED|Evaluation of Cognitive Impairment||251
3018703|NCT01049308|3736646|FG000|NOT COMPLETED|Evaluation of Cognitive Impairment||0
3018704|NCT01049308|3736646|FG000|STARTED|Pill Counts||251
3018705|NCT01049308|3736646|FG000|COMPLETED|Pill Counts||168
3018706|NCT01049308|3736646|FG000|NOT COMPLETED|Pill Counts||83
3018707|NCT01049334|3736655|FG000|STARTED|Overall Study||102
3018708|NCT01049334|3736656|FG001|STARTED|Overall Study||102
3018709|NCT01049334|3736655|FG000|COMPLETED|Overall Study||93
3018710|NCT01049334|3736656|FG001|COMPLETED|Overall Study||95
3018711|NCT01049334|3736655|FG000|NOT COMPLETED|Overall Study||9
3018712|NCT01049334|3736656|FG001|NOT COMPLETED|Overall Study||7
3018713|NCT01049360|3736662|FG000|STARTED|Period 1||6
3018714|NCT01049360|3736663|FG001|STARTED|Period 1||6
3018715|NCT01049360|3736664|FG002|STARTED|Period 1||7
3018716|NCT01049360|3736665|FG003|STARTED|Period 1||7
3018717|NCT01049360|3736666|FG004|STARTED|Period 1||7
3018718|NCT01049360|3736667|FG005|STARTED|Period 1||6
3018719|NCT01049360|3736668|FG006|STARTED|Period 1||6
3018720|NCT01049360|3736669|FG007|STARTED|Period 1||6
3018721|NCT01049360|3736670|FG008|STARTED|Period 1||7
3018722|NCT01049360|3736671|FG009|STARTED|Period 1||6
3018723|NCT01049360|3736672|FG010|STARTED|Period 1||6
3018724|NCT01049360|3736673|FG011|STARTED|Period 1||6
3018725|NCT01049360|3736674|FG012|STARTED|Period 1||6
3018726|NCT01049360|3736675|FG013|STARTED|Period 1||7
3018727|NCT01049360|3736676|FG014|STARTED|Period 1||7
3018728|NCT01049360|3736677|FG015|STARTED|Period 1||7
3018729|NCT01049360|3736678|FG016|STARTED|Period 1||6
3018730|NCT01049360|3736679|FG017|STARTED|Period 1||6
3018731|NCT01049360|3736680|FG018|STARTED|Period 1||6
3018732|NCT01049360|3736681|FG019|STARTED|Period 1||7
3018733|NCT01049360|3736662|FG000|COMPLETED|Period 1||6
3018734|NCT01049360|3736663|FG001|COMPLETED|Period 1||5
3018735|NCT01049360|3736664|FG002|COMPLETED|Period 1||7
3018736|NCT01049360|3736665|FG003|COMPLETED|Period 1||6
3018737|NCT01049360|3736666|FG004|COMPLETED|Period 1||7
3018738|NCT01049360|3736667|FG005|COMPLETED|Period 1||6
3018739|NCT01049360|3736668|FG006|COMPLETED|Period 1||6
3018740|NCT01049360|3736669|FG007|COMPLETED|Period 1||4
3018741|NCT01049360|3736670|FG008|COMPLETED|Period 1||5
3018742|NCT01049360|3736671|FG009|COMPLETED|Period 1||6
3018743|NCT01049360|3736672|FG010|COMPLETED|Period 1||5
3018744|NCT01049360|3736673|FG011|COMPLETED|Period 1||6
3018745|NCT01049360|3736674|FG012|COMPLETED|Period 1||4
3018746|NCT01049360|3736675|FG013|COMPLETED|Period 1||6
3018747|NCT01049360|3736676|FG014|COMPLETED|Period 1||7
3018748|NCT01049360|3736677|FG015|COMPLETED|Period 1||7
3018749|NCT01049360|3736678|FG016|COMPLETED|Period 1||5
3018750|NCT01049360|3736679|FG017|COMPLETED|Period 1||6
3018751|NCT01049360|3736680|FG018|COMPLETED|Period 1||5
3018752|NCT01049360|3736681|FG019|COMPLETED|Period 1||7
3018753|NCT01049360|3736662|FG000|NOT COMPLETED|Period 1||0
3018754|NCT01049360|3736663|FG001|NOT COMPLETED|Period 1||1
3018755|NCT01049360|3736664|FG002|NOT COMPLETED|Period 1||0
3018756|NCT01049360|3736665|FG003|NOT COMPLETED|Period 1||1
3018757|NCT01049360|3736666|FG004|NOT COMPLETED|Period 1||0
3018758|NCT01049360|3736667|FG005|NOT COMPLETED|Period 1||0
3018759|NCT01049360|3736668|FG006|NOT COMPLETED|Period 1||0
3018760|NCT01049360|3736669|FG007|NOT COMPLETED|Period 1||2
3018761|NCT01049360|3736670|FG008|NOT COMPLETED|Period 1||2
3018762|NCT01049360|3736671|FG009|NOT COMPLETED|Period 1||0
3018763|NCT01049360|3736672|FG010|NOT COMPLETED|Period 1||1
3018764|NCT01049360|3736673|FG011|NOT COMPLETED|Period 1||0
3018765|NCT01049360|3736674|FG012|NOT COMPLETED|Period 1||2
3018766|NCT01049360|3736675|FG013|NOT COMPLETED|Period 1||1
3018767|NCT01049360|3736676|FG014|NOT COMPLETED|Period 1||0
3018768|NCT01049360|3736677|FG015|NOT COMPLETED|Period 1||0
3018769|NCT01049360|3736678|FG016|NOT COMPLETED|Period 1||1
3018770|NCT01049360|3736679|FG017|NOT COMPLETED|Period 1||0
3018771|NCT01049360|3736680|FG018|NOT COMPLETED|Period 1||1
3018772|NCT01049360|3736681|FG019|NOT COMPLETED|Period 1||0
3018773|NCT01049360|3736662|FG000|STARTED|Period 2||6
3018774|NCT01049360|3736663|FG001|STARTED|Period 2||5
3018775|NCT01049360|3736664|FG002|STARTED|Period 2||7
3018776|NCT01049360|3736665|FG003|STARTED|Period 2||6
3018777|NCT01049360|3736666|FG004|STARTED|Period 2||7
3018778|NCT01049360|3736667|FG005|STARTED|Period 2||6
3018779|NCT01049360|3736668|FG006|STARTED|Period 2||6
3018780|NCT01049360|3736669|FG007|STARTED|Period 2||4
3018781|NCT01049360|3736670|FG008|STARTED|Period 2||5
3018782|NCT01049360|3736671|FG009|STARTED|Period 2||6
3018783|NCT01049360|3736672|FG010|STARTED|Period 2||5
3018784|NCT01049360|3736673|FG011|STARTED|Period 2||6
3018785|NCT01049360|3736674|FG012|STARTED|Period 2||4
3018786|NCT01049360|3736675|FG013|STARTED|Period 2||6
3018787|NCT01049360|3736676|FG014|STARTED|Period 2||7
3018788|NCT01049360|3736677|FG015|STARTED|Period 2||7
3018789|NCT01049360|3736678|FG016|STARTED|Period 2||5
3018790|NCT01049360|3736679|FG017|STARTED|Period 2||6
3018791|NCT01049360|3736680|FG018|STARTED|Period 2||5
3018792|NCT01049360|3736681|FG019|STARTED|Period 2||7
3018793|NCT01049360|3736662|FG000|COMPLETED|Period 2||6
3018794|NCT01049360|3736663|FG001|COMPLETED|Period 2||4
3018795|NCT01049360|3736664|FG002|COMPLETED|Period 2||7
3018796|NCT01049360|3736665|FG003|COMPLETED|Period 2||4
3018797|NCT01049360|3736666|FG004|COMPLETED|Period 2||7
3018798|NCT01049360|3736667|FG005|COMPLETED|Period 2||5
3018799|NCT01049360|3736668|FG006|COMPLETED|Period 2||6
3018800|NCT01049360|3736669|FG007|COMPLETED|Period 2||4
3018801|NCT01049360|3736670|FG008|COMPLETED|Period 2||4
3018802|NCT01049360|3736671|FG009|COMPLETED|Period 2||6
3018803|NCT01049360|3736672|FG010|COMPLETED|Period 2||5
3018804|NCT01049360|3736673|FG011|COMPLETED|Period 2||6
3018805|NCT01049360|3736674|FG012|COMPLETED|Period 2||4
3018806|NCT01049360|3736675|FG013|COMPLETED|Period 2||6
3018807|NCT01049360|3736676|FG014|COMPLETED|Period 2||5
3018808|NCT01049360|3736677|FG015|COMPLETED|Period 2||6
3018809|NCT01049360|3736678|FG016|COMPLETED|Period 2||5
3018810|NCT01049360|3736679|FG017|COMPLETED|Period 2||6
3018811|NCT01049360|3736680|FG018|COMPLETED|Period 2||5
3018812|NCT01049360|3736681|FG019|COMPLETED|Period 2||5
3018813|NCT01049360|3736662|FG000|NOT COMPLETED|Period 2||0
3165609|NCT01900704|3893181|FG002|NOT COMPLETED|Overall Study||33
3165610|NCT01900899|3893192|FG000|STARTED|Overall Study||159
3165611|NCT01900899|3893193|FG001|STARTED|Overall Study||25
3018814|NCT01049360|3736663|FG001|NOT COMPLETED|Period 2||1
3018815|NCT01049360|3736664|FG002|NOT COMPLETED|Period 2||0
3018816|NCT01049360|3736665|FG003|NOT COMPLETED|Period 2||2
3018817|NCT01049360|3736666|FG004|NOT COMPLETED|Period 2||0
3018818|NCT01049360|3736667|FG005|NOT COMPLETED|Period 2||1
3018819|NCT01049360|3736668|FG006|NOT COMPLETED|Period 2||0
3018820|NCT01049360|3736669|FG007|NOT COMPLETED|Period 2||0
3018821|NCT01049360|3736670|FG008|NOT COMPLETED|Period 2||1
3018822|NCT01049360|3736671|FG009|NOT COMPLETED|Period 2||0
3018823|NCT01049360|3736672|FG010|NOT COMPLETED|Period 2||0
3018824|NCT01049360|3736673|FG011|NOT COMPLETED|Period 2||0
3018825|NCT01049360|3736674|FG012|NOT COMPLETED|Period 2||0
3018826|NCT01049360|3736675|FG013|NOT COMPLETED|Period 2||0
3018827|NCT01049360|3736676|FG014|NOT COMPLETED|Period 2||2
3018828|NCT01049360|3736677|FG015|NOT COMPLETED|Period 2||1
3018829|NCT01049360|3736678|FG016|NOT COMPLETED|Period 2||0
3018830|NCT01049360|3736679|FG017|NOT COMPLETED|Period 2||0
3018831|NCT01049360|3736680|FG018|NOT COMPLETED|Period 2||0
3018832|NCT01049360|3736681|FG019|NOT COMPLETED|Period 2||2
3018833|NCT01049360|3736662|FG000|STARTED|Period 3||6
3018834|NCT01049360|3736663|FG001|STARTED|Period 3||4
3018835|NCT01049360|3736664|FG002|STARTED|Period 3||7
3018836|NCT01049360|3736665|FG003|STARTED|Period 3||4
3018837|NCT01049360|3736666|FG004|STARTED|Period 3||7
3018838|NCT01049360|3736667|FG005|STARTED|Period 3||5
3018839|NCT01049360|3736668|FG006|STARTED|Period 3||6
3018840|NCT01049360|3736669|FG007|STARTED|Period 3||4
3018841|NCT01049360|3736670|FG008|STARTED|Period 3||4
3018842|NCT01049360|3736671|FG009|STARTED|Period 3||6
3018843|NCT01049360|3736672|FG010|STARTED|Period 3||5
3018844|NCT01049360|3736673|FG011|STARTED|Period 3||6
3018845|NCT01049360|3736674|FG012|STARTED|Period 3||4
3018846|NCT01049360|3736675|FG013|STARTED|Period 3||6
3018847|NCT01049360|3736676|FG014|STARTED|Period 3||5
3018848|NCT01049360|3736677|FG015|STARTED|Period 3||6
3018849|NCT01049360|3736678|FG016|STARTED|Period 3||5
3018850|NCT01049360|3736679|FG017|STARTED|Period 3||6
3018851|NCT01049360|3736680|FG018|STARTED|Period 3||5
3165612|NCT01900899|3893192|FG000|COMPLETED|Overall Study||150
3165613|NCT01900899|3893193|FG001|COMPLETED|Overall Study||24
3018852|NCT01049360|3736681|FG019|STARTED|Period 3||5
3018853|NCT01049360|3736662|FG000|COMPLETED|Period 3||6
3018854|NCT01049360|3736663|FG001|COMPLETED|Period 3||4
3018855|NCT01049360|3736664|FG002|COMPLETED|Period 3||7
3018856|NCT01049360|3736665|FG003|COMPLETED|Period 3||4
3018857|NCT01049360|3736666|FG004|COMPLETED|Period 3||7
3018858|NCT01049360|3736667|FG005|COMPLETED|Period 3||5
3018859|NCT01049360|3736668|FG006|COMPLETED|Period 3||6
3018860|NCT01049360|3736669|FG007|COMPLETED|Period 3||4
3018861|NCT01049360|3736670|FG008|COMPLETED|Period 3||4
3018862|NCT01049360|3736671|FG009|COMPLETED|Period 3||6
3018863|NCT01049360|3736672|FG010|COMPLETED|Period 3||5
3018864|NCT01049360|3736673|FG011|COMPLETED|Period 3||6
3018865|NCT01049360|3736674|FG012|COMPLETED|Period 3||4
3018866|NCT01049360|3736675|FG013|COMPLETED|Period 3||6
3018867|NCT01049360|3736676|FG014|COMPLETED|Period 3||5
3018868|NCT01049360|3736677|FG015|COMPLETED|Period 3||6
3018869|NCT01049360|3736678|FG016|COMPLETED|Period 3||5
3018870|NCT01049360|3736679|FG017|COMPLETED|Period 3||6
3018871|NCT01049360|3736680|FG018|COMPLETED|Period 3||5
3018872|NCT01049360|3736681|FG019|COMPLETED|Period 3||5
3018873|NCT01049360|3736662|FG000|NOT COMPLETED|Period 3||0
3018874|NCT01049360|3736663|FG001|NOT COMPLETED|Period 3||0
3018875|NCT01049360|3736664|FG002|NOT COMPLETED|Period 3||0
3018876|NCT01049360|3736665|FG003|NOT COMPLETED|Period 3||0
3018877|NCT01049360|3736666|FG004|NOT COMPLETED|Period 3||0
3018878|NCT01049360|3736667|FG005|NOT COMPLETED|Period 3||0
3018879|NCT01049360|3736668|FG006|NOT COMPLETED|Period 3||0
3018880|NCT01049360|3736669|FG007|NOT COMPLETED|Period 3||0
3018881|NCT01049360|3736670|FG008|NOT COMPLETED|Period 3||0
3018882|NCT01049360|3736671|FG009|NOT COMPLETED|Period 3||0
3018883|NCT01049360|3736672|FG010|NOT COMPLETED|Period 3||0
3018884|NCT01049360|3736673|FG011|NOT COMPLETED|Period 3||0
3018885|NCT01049360|3736674|FG012|NOT COMPLETED|Period 3||0
3018886|NCT01049360|3736675|FG013|NOT COMPLETED|Period 3||0
3018887|NCT01049360|3736676|FG014|NOT COMPLETED|Period 3||0
3018888|NCT01049360|3736677|FG015|NOT COMPLETED|Period 3||0
3018889|NCT01049360|3736678|FG016|NOT COMPLETED|Period 3||0
3018890|NCT01049360|3736679|FG017|NOT COMPLETED|Period 3||0
3018891|NCT01049360|3736680|FG018|NOT COMPLETED|Period 3||0
3018892|NCT01049360|3736681|FG019|NOT COMPLETED|Period 3||0
3018893|NCT01049360|3736662|FG000|STARTED|Period 4||6
3018894|NCT01049360|3736663|FG001|STARTED|Period 4||4
3018895|NCT01049360|3736664|FG002|STARTED|Period 4||7
3018896|NCT01049360|3736665|FG003|STARTED|Period 4||4
3018897|NCT01049360|3736666|FG004|STARTED|Period 4||7
3018898|NCT01049360|3736667|FG005|STARTED|Period 4||5
3018899|NCT01049360|3736668|FG006|STARTED|Period 4||6
3018900|NCT01049360|3736669|FG007|STARTED|Period 4||4
3018901|NCT01049360|3736670|FG008|STARTED|Period 4||4
3018902|NCT01049360|3736671|FG009|STARTED|Period 4||6
3018903|NCT01049360|3736672|FG010|STARTED|Period 4||5
3018904|NCT01049360|3736673|FG011|STARTED|Period 4||6
3018905|NCT01049360|3736674|FG012|STARTED|Period 4||4
3018906|NCT01049360|3736675|FG013|STARTED|Period 4||6
3018907|NCT01049360|3736676|FG014|STARTED|Period 4||5
3018908|NCT01049360|3736677|FG015|STARTED|Period 4||6
3018909|NCT01049360|3736678|FG016|STARTED|Period 4||5
3018910|NCT01049360|3736679|FG017|STARTED|Period 4||6
3018911|NCT01049360|3736680|FG018|STARTED|Period 4||5
3018912|NCT01049360|3736681|FG019|STARTED|Period 4||5
3018913|NCT01049360|3736662|FG000|COMPLETED|Period 4||6
3018914|NCT01049360|3736663|FG001|COMPLETED|Period 4||4
3018915|NCT01049360|3736664|FG002|COMPLETED|Period 4||7
3018916|NCT01049360|3736665|FG003|COMPLETED|Period 4||3
3018917|NCT01049360|3736666|FG004|COMPLETED|Period 4||7
3018918|NCT01049360|3736667|FG005|COMPLETED|Period 4||5
3018919|NCT01049360|3736668|FG006|COMPLETED|Period 4||6
3018920|NCT01049360|3736669|FG007|COMPLETED|Period 4||4
3018921|NCT01049360|3736670|FG008|COMPLETED|Period 4||4
3018922|NCT01049360|3736671|FG009|COMPLETED|Period 4||6
3018923|NCT01049360|3736672|FG010|COMPLETED|Period 4||5
3018924|NCT01049360|3736673|FG011|COMPLETED|Period 4||6
3018925|NCT01049360|3736674|FG012|COMPLETED|Period 4||4
3018926|NCT01049360|3736675|FG013|COMPLETED|Period 4||6
3018927|NCT01049360|3736676|FG014|COMPLETED|Period 4||5
3018928|NCT01049360|3736677|FG015|COMPLETED|Period 4||6
3018929|NCT01049360|3736678|FG016|COMPLETED|Period 4||5
3018930|NCT01049360|3736679|FG017|COMPLETED|Period 4||5
3018931|NCT01049360|3736680|FG018|COMPLETED|Period 4||5
3018932|NCT01049360|3736681|FG019|COMPLETED|Period 4||5
3018933|NCT01049360|3736662|FG000|NOT COMPLETED|Period 4||0
3018934|NCT01049360|3736663|FG001|NOT COMPLETED|Period 4||0
3018935|NCT01049360|3736664|FG002|NOT COMPLETED|Period 4||0
3018936|NCT01049360|3736665|FG003|NOT COMPLETED|Period 4||1
3018937|NCT01049360|3736666|FG004|NOT COMPLETED|Period 4||0
3018938|NCT01049360|3736667|FG005|NOT COMPLETED|Period 4||0
3018939|NCT01049360|3736668|FG006|NOT COMPLETED|Period 4||0
3018940|NCT01049360|3736669|FG007|NOT COMPLETED|Period 4||0
3018941|NCT01049360|3736670|FG008|NOT COMPLETED|Period 4||0
3018942|NCT01049360|3736671|FG009|NOT COMPLETED|Period 4||0
3018943|NCT01049360|3736672|FG010|NOT COMPLETED|Period 4||0
3018944|NCT01049360|3736673|FG011|NOT COMPLETED|Period 4||0
3018945|NCT01049360|3736674|FG012|NOT COMPLETED|Period 4||0
3018946|NCT01049360|3736675|FG013|NOT COMPLETED|Period 4||0
3018947|NCT01049360|3736676|FG014|NOT COMPLETED|Period 4||0
3018948|NCT01049360|3736677|FG015|NOT COMPLETED|Period 4||0
3018949|NCT01049360|3736678|FG016|NOT COMPLETED|Period 4||0
3018950|NCT01049360|3736679|FG017|NOT COMPLETED|Period 4||1
3018951|NCT01049360|3736680|FG018|NOT COMPLETED|Period 4||0
3018952|NCT01049360|3736681|FG019|NOT COMPLETED|Period 4||0
3018953|NCT01049373|3736695|FG000|STARTED|Overall Study||112
3018954|NCT01049373|3736696|FG001|STARTED|Overall Study||109
3018955|NCT01049373|3736695|FG000|COMPLETED|Overall Study||73
3018956|NCT01049373|3736696|FG001|COMPLETED|Overall Study||65
3018957|NCT01049373|3736695|FG000|NOT COMPLETED|Overall Study||39
3018958|NCT01049373|3736696|FG001|NOT COMPLETED|Overall Study||44
3018959|NCT01049412|3736706|FG000|STARTED|Period I||70
3018960|NCT01049412|3736707|FG001|STARTED|Period I||68
3018961|NCT01049412|3736706|FG000|Took at Least One Dose of Study Drug|Period I||69
3018962|NCT01049412|3736707|FG001|Took at Least One Dose of Study Drug|Period I||68
3018963|NCT01049412|3736706|FG000|COMPLETED|Period I||62
3018964|NCT01049412|3736707|FG001|COMPLETED|Period I||55
3018965|NCT01049412|3736706|FG000|NOT COMPLETED|Period I||8
3018966|NCT01049412|3736707|FG001|NOT COMPLETED|Period I||13
3018967|NCT01049412|3736706|FG000|STARTED|Period II||62
3018968|NCT01049412|3736707|FG001|STARTED|Period II||55
3018969|NCT01049412|3736706|FG000|COMPLETED|Period II||58
3018970|NCT01049412|3736707|FG001|COMPLETED|Period II||52
3018971|NCT01049412|3736706|FG000|NOT COMPLETED|Period II||4
3018972|NCT01049412|3736707|FG001|NOT COMPLETED|Period II||3
3018973|NCT01049503|3736721|FG000|STARTED|Overall Study||52
3018974|NCT01049503|3736722|FG001|STARTED|Overall Study||48
3018975|NCT01049503|3736723|FG002|STARTED|Overall Study||56
3018976|NCT01049503|3736724|FG003|STARTED|Overall Study||55
3018977|NCT01049503|3736725|FG004|STARTED|Overall Study||56
3018978|NCT01049503|3736726|FG005|STARTED|Overall Study||48
3018979|NCT01049503|3736721|FG000|COMPLETED|Overall Study||41
3018980|NCT01049503|3736722|FG001|COMPLETED|Overall Study||36
3018981|NCT01049503|3736723|FG002|COMPLETED|Overall Study||32
3018982|NCT01049503|3736724|FG003|COMPLETED|Overall Study||29
3018983|NCT01049503|3736725|FG004|COMPLETED|Overall Study||29
3018984|NCT01049503|3736726|FG005|COMPLETED|Overall Study||40
3018985|NCT01049503|3736721|FG000|NOT COMPLETED|Overall Study||11
3018986|NCT01049503|3736722|FG001|NOT COMPLETED|Overall Study||12
3018987|NCT01049503|3736723|FG002|NOT COMPLETED|Overall Study||24
3018988|NCT01049503|3736724|FG003|NOT COMPLETED|Overall Study||26
3018989|NCT01049503|3736725|FG004|NOT COMPLETED|Overall Study||27
3018990|NCT01049503|3736726|FG005|NOT COMPLETED|Overall Study||8
3018991|NCT01049581|3736751|FG000|STARTED|Overall Study||13
3018992|NCT01049581|3736752|FG001|STARTED|Overall Study||14
3018993|NCT01049581|3736751|FG000|COMPLETED|Overall Study||11
3018994|NCT01049581|3736752|FG001|COMPLETED|Overall Study||13
3018995|NCT01049581|3736751|FG000|NOT COMPLETED|Overall Study||2
3018996|NCT01049581|3736752|FG001|NOT COMPLETED|Overall Study||1
3018997|NCT01049776|3736761|FG000|STARTED|Overall Study||32
3018998|NCT01049776|3736761|FG000|COMPLETED|Overall Study||12
3018999|NCT01049776|3736761|FG000|NOT COMPLETED|Overall Study||20
3019000|NCT01049802|3736767|FG000|STARTED|Overall Study||20
3019001|NCT01049802|3736768|FG001|STARTED|Overall Study||10
3019002|NCT01049802|3736767|FG000|COMPLETED|Overall Study||20
3019003|NCT01049802|3736768|FG001|COMPLETED|Overall Study||10
3019004|NCT01049802|3736767|FG000|NOT COMPLETED|Overall Study||0
3019005|NCT01049802|3736768|FG001|NOT COMPLETED|Overall Study||0
3019006|NCT01049919|3736776|FG000|STARTED|Overall Study||117
3019007|NCT01049919|3736777|FG001|STARTED|Overall Study|One participant is counted in both treatment groups due to one leg being randomized to each group.|36
3019008|NCT01049919|3736776|FG000|COMPLETED|Overall Study||65
3019009|NCT01049919|3736777|FG001|COMPLETED|Overall Study|Incl. 11 participants that received crossover treatment after completing 52 week primary follow up.|19
3019010|NCT01049919|3736776|FG000|NOT COMPLETED|Overall Study||52
3019011|NCT01049919|3736777|FG001|NOT COMPLETED|Overall Study||17
3019012|NCT01049945|3736785|FG000|STARTED|Overall Study||3
3019013|NCT01049945|3736786|FG001|STARTED|Overall Study||6
3019014|NCT01049945|3736787|FG002|STARTED|Overall Study||3
3019015|NCT01049945|3736788|FG003|STARTED|Overall Study||6
3019016|NCT01049945|3736789|FG004|STARTED|Overall Study||3
3019017|NCT01049945|3736790|FG005|STARTED|Overall Study||49
3019018|NCT01049945|3736785|FG000|COMPLETED|Overall Study||3
3019019|NCT01049945|3736786|FG001|COMPLETED|Overall Study||6
3019020|NCT01049945|3736787|FG002|COMPLETED|Overall Study||3
3019021|NCT01049945|3736788|FG003|COMPLETED|Overall Study||6
3019022|NCT01049945|3736789|FG004|COMPLETED|Overall Study||3
3019023|NCT01049945|3736790|FG005|COMPLETED|Overall Study||49
3019024|NCT01049945|3736785|FG000|NOT COMPLETED|Overall Study||0
3019025|NCT01049945|3736786|FG001|NOT COMPLETED|Overall Study||0
3019026|NCT01049945|3736787|FG002|NOT COMPLETED|Overall Study||0
3019027|NCT01049945|3736788|FG003|NOT COMPLETED|Overall Study||0
3019028|NCT01049945|3736789|FG004|NOT COMPLETED|Overall Study||0
3019029|NCT01049945|3736790|FG005|NOT COMPLETED|Overall Study||0
3019030|NCT01049984|3736806|FG000|STARTED|Overall Study||163
3019031|NCT01049984|3736807|FG001|STARTED|Overall Study||165
3019032|NCT01049984|3736806|FG000|Safety Population|Overall Study|One patient was randomized but not dosed; omitted from safety population|162
3019033|NCT01049984|3736807|FG001|Safety Population|Overall Study|One patient was randomized but not dosed; omitted from safety population|164
3019034|NCT01049984|3736806|FG000|Modified Intent-to-treat Pop|Overall Study|Took >= 1 dose of study drug and had both baseline and at least 1 post-baseline efficacy assessment|159
3019035|NCT01049984|3736807|FG001|Modified Intent-to-treat Pop|Overall Study|Took >= 1 dose of study drug and had both baseline and at least 1 post-baseline efficacy assessment|162
3019036|NCT01049984|3736806|FG000|COMPLETED|Overall Study||144
3019037|NCT01049984|3736807|FG001|COMPLETED|Overall Study||146
3019038|NCT01049984|3736806|FG000|NOT COMPLETED|Overall Study||19
3019039|NCT01049984|3736807|FG001|NOT COMPLETED|Overall Study||19
3019040|NCT01050062|3736815|FG000|STARTED|Overall Study||1070
3019041|NCT01050062|3736816|FG001|STARTED|Overall Study||355
3019042|NCT01050062|3736815|FG000|COMPLETED|Overall Study||799
3019043|NCT01050062|3736816|FG001|COMPLETED|Overall Study||243
3019044|NCT01050062|3736815|FG000|NOT COMPLETED|Overall Study||271
3019045|NCT01050062|3736816|FG001|NOT COMPLETED|Overall Study||112
3019046|NCT01050153|3736826|FG000|STARTED|Overall Study||25
3019047|NCT01050153|3736827|FG001|STARTED|Overall Study||25
3019048|NCT01050153|3736826|FG000|COMPLETED|Overall Study||25
3019049|NCT01050153|3736827|FG001|COMPLETED|Overall Study||25
3019050|NCT01050153|3736826|FG000|NOT COMPLETED|Overall Study||0
3019051|NCT01050153|3736827|FG001|NOT COMPLETED|Overall Study||0
3019052|NCT01050205|3736835|FG000|STARTED|Overall Study||148
3019053|NCT01050205|3736836|FG001|STARTED|Overall Study||75
3019054|NCT01050205|3736835|FG000|COMPLETED|Overall Study||137
3019055|NCT01050205|3736836|FG001|COMPLETED|Overall Study||71
3019056|NCT01050205|3736835|FG000|NOT COMPLETED|Overall Study||11
3019057|NCT01050205|3736836|FG001|NOT COMPLETED|Overall Study||4
3019058|NCT01050231|3736844|FG000|STARTED|Overall Study||10
3019059|NCT01050231|3736845|FG001|STARTED|Overall Study||10
3019060|NCT01050231|3736844|FG000|COMPLETED|Overall Study||10
3019061|NCT01050231|3736845|FG001|COMPLETED|Overall Study||10
3019062|NCT01050231|3736844|FG000|NOT COMPLETED|Overall Study||0
3019063|NCT01050231|3736845|FG001|NOT COMPLETED|Overall Study||0
3019064|NCT01050257|3736854|FG000|STARTED|Overall Study||50
3019065|NCT01050257|3736855|FG001|STARTED|Overall Study||53
3019066|NCT01050257|3736856|FG002|STARTED|Overall Study||15
3019067|NCT01050257|3736854|FG000|Received Treatment|Overall Study||49
3019068|NCT01050257|3736855|FG001|Received Treatment|Overall Study||50
3019069|NCT01050257|3736856|FG002|Received Treatment|Overall Study||14
3019070|NCT01050257|3736854|FG000|Safety Population: Actual Dose Received|Overall Study||48
3019071|NCT01050257|3736855|FG001|Safety Population: Actual Dose Received|Overall Study|One participant randomized to 100 mg actually received the 200 mg doses.|51
3019072|NCT01050257|3736856|FG002|Safety Population: Actual Dose Received|Overall Study||14
3019073|NCT01050257|3736854|FG000|Intent-to-treat Infected Confirmed|Overall Study||30
3019074|NCT01050257|3736855|FG001|Intent-to-treat Infected Confirmed|Overall Study||32
3019075|NCT01050257|3736856|FG002|Intent-to-treat Infected Confirmed|Overall Study||10
3019076|NCT01050257|3736854|FG000|Switched to Oral Treatment|Overall Study||28
3019077|NCT01050257|3736855|FG001|Switched to Oral Treatment|Overall Study||31
3019078|NCT01050257|3736856|FG002|Switched to Oral Treatment|Overall Study||3
3019079|NCT01050257|3736854|FG000|COMPLETED|Overall Study|Completed 5 days of treatment either IV or Oral|39
3019080|NCT01050257|3736855|FG001|COMPLETED|Overall Study||40
3019081|NCT01050257|3736856|FG002|COMPLETED|Overall Study||8
3019082|NCT01050257|3736854|FG000|NOT COMPLETED|Overall Study||11
3019083|NCT01050257|3736855|FG001|NOT COMPLETED|Overall Study||13
3019084|NCT01050257|3736856|FG002|NOT COMPLETED|Overall Study||7
3019085|NCT01050530|3736866|FG000|STARTED|Overall Study||82
3019086|NCT01050530|3736867|FG001|STARTED|Overall Study||80
3165614|NCT01900899|3893192|FG000|NOT COMPLETED|Overall Study||9
3165615|NCT01900899|3893193|FG001|NOT COMPLETED|Overall Study||1
3165616|NCT01901055|3893201|FG000|STARTED|Randomization But Not Titrated||49
3165617|NCT01901055|3893202|FG001|STARTED|Randomization But Not Titrated||49
3165618|NCT01901055|3893201|FG000|COMPLETED|Randomization But Not Titrated||48
3019087|NCT01050530|3736866|FG000|COMPLETED|Overall Study||74
3019088|NCT01050530|3736867|FG001|COMPLETED|Overall Study||70
3019089|NCT01050530|3736866|FG000|NOT COMPLETED|Overall Study||8
3019090|NCT01050530|3736867|FG001|NOT COMPLETED|Overall Study||10
3019091|NCT01050543|3736875|FG000|STARTED|Overall Study|Includes 4 participants who were randomized but discontinued before Treatment Phase.|64
3019092|NCT01050543|3736876|FG001|STARTED|Overall Study|Includes 4 participants who were randomized but discontinued before Treatment Phase.|64
3019093|NCT01050543|3736875|FG000|COMPLETED|Overall Study|Includes 1 participant who started & completed the study but was excluded from Full Analysis Set.|60
3019094|NCT01050543|3736876|FG001|COMPLETED|Overall Study|Includes 1 participant who started & completed the study but was excluded from Full Analysis Set.|60
3019095|NCT01050543|3736875|FG000|NOT COMPLETED|Overall Study||4
3019096|NCT01050543|3736876|FG001|NOT COMPLETED|Overall Study||4
3019097|NCT01050569|3736885|FG000|STARTED|Overall Study||79
3019098|NCT01050569|3736886|FG001|STARTED|Overall Study||76
3019099|NCT01050569|3736887|FG002|STARTED|Overall Study||80
3019100|NCT01050569|3736885|FG000|COMPLETED|Overall Study||41
3019101|NCT01050569|3736886|FG001|COMPLETED|Overall Study||52
3019102|NCT01050569|3736887|FG002|COMPLETED|Overall Study||47
3019103|NCT01050569|3736885|FG000|NOT COMPLETED|Overall Study||38
3019104|NCT01050569|3736886|FG001|NOT COMPLETED|Overall Study||24
3019105|NCT01050569|3736887|FG002|NOT COMPLETED|Overall Study||33
3019106|NCT01050582|3736901|FG000|STARTED|Overall Study||133
3019107|NCT01050582|3736902|FG001|STARTED|Overall Study||51
3019108|NCT01050582|3736901|FG000|COMPLETED|Overall Study||133
3019109|NCT01050582|3736902|FG001|COMPLETED|Overall Study||51
3019110|NCT01050582|3736901|FG000|NOT COMPLETED|Overall Study||0
3019111|NCT01050582|3736902|FG001|NOT COMPLETED|Overall Study||0
3019112|NCT01050634|3736908|FG000|STARTED|Overall Study||980
3019113|NCT01050634|3736908|FG000|Received Treatment|Overall Study||924
3019114|NCT01050634|3736908|FG000|COMPLETED|Overall Study||852
3019115|NCT01050634|3736908|FG000|NOT COMPLETED|Overall Study||128
3019116|NCT01050647|3736914|FG000|STARTED|Overall Study||10
3019117|NCT01050647|3736915|FG001|STARTED|Overall Study||11
3019118|NCT01050647|3736914|FG000|COMPLETED|Overall Study||10
3019119|NCT01050647|3736915|FG001|COMPLETED|Overall Study||11
3019120|NCT01050647|3736914|FG000|NOT COMPLETED|Overall Study||0
3019121|NCT01050647|3736915|FG001|NOT COMPLETED|Overall Study||0
3019122|NCT01050660|3736923|FG000|STARTED|Overall Study||67
3019123|NCT01050660|3736924|FG001|STARTED|Overall Study||69
3019124|NCT01050660|3736923|FG000|COMPLETED|Overall Study||67
3019125|NCT01050660|3736924|FG001|COMPLETED|Overall Study||69
3019126|NCT01050660|3736923|FG000|NOT COMPLETED|Overall Study||0
3019127|NCT01050660|3736924|FG001|NOT COMPLETED|Overall Study||0
3019128|NCT01050673|3736932|FG000|STARTED|Overall Study||21
3019129|NCT01050673|3736933|FG001|STARTED|Overall Study||19
3019130|NCT01050673|3736932|FG000|COMPLETED|Overall Study||17
3019131|NCT01050673|3736933|FG001|COMPLETED|Overall Study||14
3019132|NCT01050673|3736932|FG000|NOT COMPLETED|Overall Study||4
3019133|NCT01050673|3736933|FG001|NOT COMPLETED|Overall Study||5
3019134|NCT01050764|3736939|FG000|STARTED|Overall Study||10
3019135|NCT01050764|3736939|FG000|Received HSCT Graft|Overall Study||8
3019136|NCT01050764|3736939|FG000|Received Infusion of T-reg Cells|Overall Study||7
3019137|NCT01050764|3736939|FG000|Received Infusion of T-con Cells|Overall Study||7
3019138|NCT01050764|3736939|FG000|COMPLETED|Overall Study||7
3019139|NCT01050764|3736939|FG000|NOT COMPLETED|Overall Study||3
3019140|NCT01050790|3736943|FG000|STARTED|Overall Study||17
3019141|NCT01050790|3736943|FG000|COMPLETED|Overall Study||16
3019142|NCT01050790|3736943|FG000|NOT COMPLETED|Overall Study||1
3019143|NCT01050816|3736948|FG000|STARTED|Overall Study||30
3019144|NCT01050816|3736948|FG000|COMPLETED|Overall Study||26
3019145|NCT01050816|3736948|FG000|NOT COMPLETED|Overall Study||4
3019146|NCT01050907|3736952|FG000|STARTED|Overall Study||4
3019147|NCT01050907|3736952|FG000|COMPLETED|Overall Study||4
3019148|NCT01050907|3736952|FG000|NOT COMPLETED|Overall Study||0
3019149|NCT01050946|3736956|FG000|STARTED|Overall Study||1
3019150|NCT01050946|3736956|FG000|COMPLETED|Overall Study|Patient signed consent 2/3/2011. Patient had their transplant 2/15/2011. Patient died 9/2/2011|1
3019151|NCT01050946|3736956|FG000|NOT COMPLETED|Overall Study||0
3037733|NCT01149655|3757038|FG002|NOT COMPLETED|Period 2-Stabilization Phase||0
3037734|NCT01149655|3757039|FG003|NOT COMPLETED|Period 2-Stabilization Phase||0
3037735|NCT01149655|3757036|FG000|STARTED|Period 3-DB Maintenance Phase||0
3037736|NCT01149655|3757037|FG001|STARTED|Period 3-DB Maintenance Phase||0
3037737|NCT01149655|3757038|FG002|STARTED|Period 3-DB Maintenance Phase||98
3037738|NCT01149655|3757039|FG003|STARTED|Period 3-DB Maintenance Phase||48
3037739|NCT01149655|3757036|FG000|COMPLETED|Period 3-DB Maintenance Phase||0
3037740|NCT01149655|3757037|FG001|COMPLETED|Period 3-DB Maintenance Phase||0
3037741|NCT01149655|3757038|FG002|COMPLETED|Period 3-DB Maintenance Phase||15
3037742|NCT01149655|3757039|FG003|COMPLETED|Period 3-DB Maintenance Phase||6
3037743|NCT01149655|3757036|FG000|NOT COMPLETED|Period 3-DB Maintenance Phase||0
3037744|NCT01149655|3757037|FG001|NOT COMPLETED|Period 3-DB Maintenance Phase||0
3037745|NCT01149655|3757038|FG002|NOT COMPLETED|Period 3-DB Maintenance Phase||83
3037746|NCT01149655|3757039|FG003|NOT COMPLETED|Period 3-DB Maintenance Phase||42
3037747|NCT01149681|3757047|FG000|STARTED|Overall Study||12
3037748|NCT01149681|3757047|FG000|COMPLETED|Overall Study||0
3037749|NCT01149681|3757047|FG000|NOT COMPLETED|Overall Study||12
3037750|NCT01149733|3757054|FG000|STARTED|Overall Study||16
3037751|NCT01149733|3757055|FG001|STARTED|Overall Study||16
3037752|NCT01149733|3757054|FG000|COMPLETED|Overall Study||16
3037753|NCT01149733|3757055|FG001|COMPLETED|Overall Study||16
3037754|NCT01149733|3757054|FG000|NOT COMPLETED|Overall Study||0
3037755|NCT01149733|3757055|FG001|NOT COMPLETED|Overall Study||0
3037756|NCT01149759|3757061|FG000|STARTED|Overall Study||9
3037757|NCT01149759|3757061|FG000|COMPLETED|Overall Study||9
3037758|NCT01149759|3757061|FG000|NOT COMPLETED|Overall Study||0
3037759|NCT01149772|3757067|FG000|STARTED|Overall Study||180
3037760|NCT01149772|3757068|FG001|STARTED|Overall Study||122
3037761|NCT01149772|3757067|FG000|COMPLETED|Overall Study||132
3037762|NCT01149772|3757068|FG001|COMPLETED|Overall Study||101
3037763|NCT01149772|3757067|FG000|NOT COMPLETED|Overall Study||48
3037764|NCT01149772|3757068|FG001|NOT COMPLETED|Overall Study||21
3037765|NCT01149785|3757076|FG000|STARTED|First Intervention||15
3037766|NCT01149785|3757077|FG001|STARTED|First Intervention||0
3037767|NCT01149785|3757076|FG000|COMPLETED|First Intervention||15
3037768|NCT01149785|3757077|FG001|COMPLETED|First Intervention||0
3037769|NCT01149785|3757076|FG000|NOT COMPLETED|First Intervention||0
3037770|NCT01149785|3757077|FG001|NOT COMPLETED|First Intervention||0
3037771|NCT01149785|3757076|FG000|STARTED|Washout Period of at Least 14 Days||15
3037772|NCT01149785|3757077|FG001|STARTED|Washout Period of at Least 14 Days||0
3037773|NCT01149785|3757076|FG000|COMPLETED|Washout Period of at Least 14 Days||15
3037774|NCT01149785|3757077|FG001|COMPLETED|Washout Period of at Least 14 Days||0
3037775|NCT01149785|3757076|FG000|NOT COMPLETED|Washout Period of at Least 14 Days||0
3037776|NCT01149785|3757077|FG001|NOT COMPLETED|Washout Period of at Least 14 Days||0
3037777|NCT01149785|3757076|FG000|STARTED|Second Intervention||0
3037778|NCT01149785|3757077|FG001|STARTED|Second Intervention||15
3037779|NCT01149785|3757076|FG000|COMPLETED|Second Intervention||0
3037780|NCT01149785|3757077|FG001|COMPLETED|Second Intervention||15
3037781|NCT01149785|3757076|FG000|NOT COMPLETED|Second Intervention||0
3037782|NCT01149785|3757077|FG001|NOT COMPLETED|Second Intervention||0
3037783|NCT01149863|3757083|FG000|STARTED|Overall Study||34
3037784|NCT01149863|3757083|FG000|COMPLETED|Overall Study||31
3037785|NCT01149863|3757083|FG000|NOT COMPLETED|Overall Study||3
3037786|NCT01149876|3757091|FG000|STARTED|Overall Study||21
3037787|NCT01149876|3757092|FG001|STARTED|Overall Study||20
3037788|NCT01149876|3757093|FG002|STARTED|Overall Study||21
3037789|NCT01149876|3757094|FG003|STARTED|Overall Study||18
3037790|NCT01149876|3757091|FG000|COMPLETED|Overall Study||20
3037791|NCT01149876|3757092|FG001|COMPLETED|Overall Study||20
3037792|NCT01149876|3757093|FG002|COMPLETED|Overall Study||20
3037793|NCT01149876|3757094|FG003|COMPLETED|Overall Study||18
3037794|NCT01149876|3757091|FG000|NOT COMPLETED|Overall Study||1
3037795|NCT01149876|3757092|FG001|NOT COMPLETED|Overall Study||0
3037796|NCT01149876|3757093|FG002|NOT COMPLETED|Overall Study||1
3037797|NCT01149876|3757094|FG003|NOT COMPLETED|Overall Study||0
3037798|NCT01150045|3757109|FG000|STARTED|Overall Study||615
3037799|NCT01150045|3757110|FG001|STARTED|Overall Study||647
3037800|NCT01150045|3757111|FG002|STARTED|Overall Study||646
3037801|NCT01150045|3757112|FG003|STARTED|Overall Study||618
3037802|NCT01150045|3757109|FG000|COMPLETED|Overall Study||615
3037803|NCT01150045|3757110|FG001|COMPLETED|Overall Study||646
3037804|NCT01150045|3757111|FG002|COMPLETED|Overall Study||646
3037805|NCT01150045|3757112|FG003|COMPLETED|Overall Study||617
3037806|NCT01150045|3757109|FG000|NOT COMPLETED|Overall Study||0
3019152|NCT01050998|3736966|FG000|STARTED|Overall Study||48
3019153|NCT01050998|3736967|FG001|STARTED|Overall Study||49
3019154|NCT01050998|3736968|FG002|STARTED|Overall Study||49
3019155|NCT01050998|3736969|FG003|STARTED|Overall Study||48
3019156|NCT01050998|3736970|FG004|STARTED|Overall Study||96
3019157|NCT01050998|3736966|FG000|COMPLETED|Overall Study||44
3165619|NCT01901055|3893202|FG001|COMPLETED|Randomization But Not Titrated||47
3165620|NCT01901055|3893201|FG000|NOT COMPLETED|Randomization But Not Titrated||1
3019158|NCT01050998|3736967|FG001|COMPLETED|Overall Study||47
3019159|NCT01050998|3736968|FG002|COMPLETED|Overall Study||46
3019160|NCT01050998|3736969|FG003|COMPLETED|Overall Study||45
3019161|NCT01050998|3736970|FG004|COMPLETED|Overall Study||82
3019162|NCT01050998|3736966|FG000|NOT COMPLETED|Overall Study||4
3019163|NCT01050998|3736967|FG001|NOT COMPLETED|Overall Study||2
3019164|NCT01050998|3736968|FG002|NOT COMPLETED|Overall Study||3
3019165|NCT01050998|3736969|FG003|NOT COMPLETED|Overall Study||3
3019166|NCT01050998|3736970|FG004|NOT COMPLETED|Overall Study||14
3019167|NCT01051063|3736988|FG000|STARTED|Overall Study||12
3019168|NCT01051063|3736989|FG001|STARTED|Overall Study||5
3019169|NCT01051063|3736988|FG000|COMPLETED|Overall Study||2
3019170|NCT01051063|3736989|FG001|COMPLETED|Overall Study||1
3019171|NCT01051063|3736988|FG000|NOT COMPLETED|Overall Study||10
3019172|NCT01051063|3736989|FG001|NOT COMPLETED|Overall Study||4
3019173|NCT01051310|3736996|FG000|STARTED|Overall Study||18
3019174|NCT01051310|3736996|FG000|COMPLETED|Overall Study||13
3019175|NCT01051310|3736996|FG000|NOT COMPLETED|Overall Study||5
3019176|NCT01051323|3737002|FG000|STARTED|Overall Study||1580
3019177|NCT01051323|3737002|FG000|Received at Least One Dose|Overall Study||1547
3019178|NCT01051323|3737002|FG000|COMPLETED|Overall Study||1041
3019179|NCT01051323|3737002|FG000|NOT COMPLETED|Overall Study||539
3019180|NCT01051349|3737010|FG000|STARTED|Overall Study||410
3019181|NCT01051349|3737010|FG000|COMPLETED|Overall Study||237
3019182|NCT01051349|3737010|FG000|NOT COMPLETED|Overall Study||173
3019183|NCT01051440|3737019|FG000|STARTED|Overall Study||1
3019184|NCT01051440|3737020|FG001|STARTED|Overall Study||1
3019185|NCT01051440|3737019|FG000|COMPLETED|Overall Study||1
3019186|NCT01051440|3737020|FG001|COMPLETED|Overall Study||1
3019187|NCT01051440|3737019|FG000|NOT COMPLETED|Overall Study||0
3019188|NCT01051440|3737020|FG001|NOT COMPLETED|Overall Study||0
3019189|NCT01051466|3737028|FG000|STARTED|Overall Study||32
3019190|NCT01051466|3737029|FG001|STARTED|Overall Study||28
3019191|NCT01051466|3737028|FG000|COMPLETED|Overall Study||24
3019192|NCT01051466|3737029|FG001|COMPLETED|Overall Study||23
3019193|NCT01051466|3737028|FG000|NOT COMPLETED|Overall Study||8
3019194|NCT01051466|3737029|FG001|NOT COMPLETED|Overall Study||5
3019195|NCT01051518|3737039|FG000|STARTED|Overall Study||126
3019196|NCT01051518|3737039|FG000|COMPLETED|Overall Study||53
3019197|NCT01051518|3737039|FG000|NOT COMPLETED|Overall Study||73
3019198|NCT01051557|3737055|FG000|STARTED|Overall Study||4
3019199|NCT01051557|3737056|FG001|STARTED|Overall Study||3
3019200|NCT01051557|3737057|FG002|STARTED|Overall Study||6
3019201|NCT01051557|3737058|FG003|STARTED|Overall Study||3
3019202|NCT01051557|3737059|FG004|STARTED|Overall Study||8
3019203|NCT01051557|3737060|FG005|STARTED|Overall Study||6
3019204|NCT01051557|3737061|FG006|STARTED|Overall Study||6
3019205|NCT01051557|3737055|FG000|COMPLETED|Overall Study||0
3019206|NCT01051557|3737056|FG001|COMPLETED|Overall Study||0
3019207|NCT01051557|3737057|FG002|COMPLETED|Overall Study||0
3019208|NCT01051557|3737058|FG003|COMPLETED|Overall Study||0
3019209|NCT01051557|3737059|FG004|COMPLETED|Overall Study||1
3019210|NCT01051557|3737060|FG005|COMPLETED|Overall Study||0
3019211|NCT01051557|3737061|FG006|COMPLETED|Overall Study||0
3019212|NCT01051557|3737055|FG000|NOT COMPLETED|Overall Study||4
3019213|NCT01051557|3737056|FG001|NOT COMPLETED|Overall Study||3
3019214|NCT01051557|3737057|FG002|NOT COMPLETED|Overall Study||6
3019215|NCT01051557|3737058|FG003|NOT COMPLETED|Overall Study||3
3019216|NCT01051557|3737059|FG004|NOT COMPLETED|Overall Study||7
3019217|NCT01051557|3737060|FG005|NOT COMPLETED|Overall Study||6
3019218|NCT01051557|3737061|FG006|NOT COMPLETED|Overall Study||6
3019219|NCT01051570|3737078|FG000|STARTED|Overall Study||26
3019220|NCT01051570|3737078|FG000|COMPLETED|Overall Study||26
3019221|NCT01051570|3737078|FG000|NOT COMPLETED|Overall Study||0
3019222|NCT01051596|3737082|FG000|STARTED|Overall Study||75
3019223|NCT01051596|3737082|FG000|COMPLETED|Overall Study||75
3019224|NCT01051596|3737082|FG000|NOT COMPLETED|Overall Study||0
3019225|NCT01051661|3737092|FG000|STARTED|Overall Study||610
3019226|NCT01051661|3737093|FG001|STARTED|Overall Study||1438
3019227|NCT01051661|3737094|FG002|STARTED|Overall Study||612
3019228|NCT01051661|3737095|FG003|STARTED|Overall Study||1436
3019229|NCT01051661|3737096|FG004|STARTED|Overall Study||613
3019230|NCT01051661|3737097|FG005|STARTED|Overall Study||1436
3019231|NCT01051661|3737092|FG000|COMPLETED|Overall Study||576
3019232|NCT01051661|3737093|FG001|COMPLETED|Overall Study||1375
3019233|NCT01051661|3737094|FG002|COMPLETED|Overall Study||573
3019234|NCT01051661|3737095|FG003|COMPLETED|Overall Study||1380
3019235|NCT01051661|3737096|FG004|COMPLETED|Overall Study||578
3019236|NCT01051661|3737097|FG005|COMPLETED|Overall Study||1369
3019237|NCT01051661|3737092|FG000|NOT COMPLETED|Overall Study||34
3019238|NCT01051661|3737093|FG001|NOT COMPLETED|Overall Study||63
3019239|NCT01051661|3737094|FG002|NOT COMPLETED|Overall Study||39
3019240|NCT01051661|3737095|FG003|NOT COMPLETED|Overall Study||56
3019241|NCT01051661|3737096|FG004|NOT COMPLETED|Overall Study||35
3019242|NCT01051661|3737097|FG005|NOT COMPLETED|Overall Study||67
3019243|NCT01051739|3737134|FG000|STARTED|Overall Study||120
3019244|NCT01051739|3737135|FG001|STARTED|Overall Study||60
3019245|NCT01051739|3737134|FG000|COMPLETED|Overall Study||92
3019246|NCT01051739|3737135|FG001|COMPLETED|Overall Study||47
3019247|NCT01051739|3737134|FG000|NOT COMPLETED|Overall Study||28
3019248|NCT01051739|3737135|FG001|NOT COMPLETED|Overall Study||13
3019249|NCT01051778|3737143|FG000|STARTED|Overall Study|June 2006|30
3019250|NCT01051778|3737144|FG001|STARTED|Overall Study|June 2006|30
3019251|NCT01051778|3737143|FG000|COMPLETED|Overall Study|November 2009|30
3019252|NCT01051778|3737144|FG001|COMPLETED|Overall Study|November 2009|30
3019253|NCT01051778|3737143|FG000|NOT COMPLETED|Overall Study||0
3019254|NCT01051778|3737144|FG001|NOT COMPLETED|Overall Study||0
3019255|NCT01051791|3737150|FG000|STARTED|Overall Study||13
3019256|NCT01051791|3737150|FG000|COMPLETED|Overall Study||9
3019257|NCT01051791|3737150|FG000|NOT COMPLETED|Overall Study||4
3019258|NCT01051817|3737157|FG000|STARTED|Overall Study||38
3019259|NCT01051817|3737158|FG001|STARTED|Overall Study||35
3019260|NCT01051817|3737157|FG000|COMPLETED|Overall Study||35
3019261|NCT01051817|3737158|FG001|COMPLETED|Overall Study||26
3019262|NCT01051817|3737157|FG000|NOT COMPLETED|Overall Study||3
3165621|NCT01901055|3893202|FG001|NOT COMPLETED|Randomization But Not Titrated||2
3165622|NCT01901055|3893201|FG000|STARTED|Started Protocol to Week 6||48
3165623|NCT01901055|3893202|FG001|STARTED|Started Protocol to Week 6||47
3165624|NCT01901055|3893201|FG000|COMPLETED|Started Protocol to Week 6||45
3165625|NCT01901055|3893202|FG001|COMPLETED|Started Protocol to Week 6||43
3165626|NCT01901055|3893201|FG000|NOT COMPLETED|Started Protocol to Week 6||3
3165627|NCT01901055|3893202|FG001|NOT COMPLETED|Started Protocol to Week 6||4
3165628|NCT01901055|3893201|FG000|STARTED|Week 12 Assessment||45
3165629|NCT01901055|3893202|FG001|STARTED|Week 12 Assessment||43
3019263|NCT01051817|3737158|FG001|NOT COMPLETED|Overall Study||9
3019264|NCT01051856|3737166|FG000|STARTED|Overall Study||33
3019265|NCT01051856|3737167|FG001|STARTED|Overall Study||35
3019266|NCT01051856|3737166|FG000|COMPLETED|Overall Study||32
3019267|NCT01051856|3737167|FG001|COMPLETED|Overall Study||35
3019268|NCT01051856|3737166|FG000|NOT COMPLETED|Overall Study||1
3019269|NCT01051856|3737167|FG001|NOT COMPLETED|Overall Study||0
3019270|NCT01051960|3737173|FG000|STARTED|Overall Study||12
3019271|NCT01051960|3737173|FG000|COMPLETED|Overall Study||11
3019272|NCT01051960|3737173|FG000|NOT COMPLETED|Overall Study||1
3019273|NCT01051986|3737179|FG000|STARTED|Overall Study||112
3019274|NCT01051986|3737180|FG001|STARTED|Overall Study||112
3019275|NCT01051986|3737179|FG000|COMPLETED|Overall Study||107
3019276|NCT01051986|3737180|FG001|COMPLETED|Overall Study||108
3019277|NCT01051986|3737179|FG000|NOT COMPLETED|Overall Study||5
3019278|NCT01051986|3737180|FG001|NOT COMPLETED|Overall Study||4
3019279|NCT01052012|3737192|FG000|STARTED|Overall Study||32
3019280|NCT01052012|3737193|FG001|STARTED|Overall Study||23
3019281|NCT01052012|3737194|FG002|STARTED|Overall Study||30
3019282|NCT01052012|3737195|FG003|STARTED|Overall Study||20
3019283|NCT01052012|3737196|FG004|STARTED|Overall Study||140
3019284|NCT01052012|3737197|FG005|STARTED|Overall Study||86
3019285|NCT01052012|3737192|FG000|COMPLETED|Overall Study||28
3019286|NCT01052012|3737193|FG001|COMPLETED|Overall Study||17
3019287|NCT01052012|3737194|FG002|COMPLETED|Overall Study||30
3019288|NCT01052012|3737195|FG003|COMPLETED|Overall Study||19
3019289|NCT01052012|3737196|FG004|COMPLETED|Overall Study||124
3019290|NCT01052012|3737197|FG005|COMPLETED|Overall Study||76
3019291|NCT01052012|3737192|FG000|NOT COMPLETED|Overall Study||4
3019292|NCT01052012|3737193|FG001|NOT COMPLETED|Overall Study||6
3019293|NCT01052012|3737194|FG002|NOT COMPLETED|Overall Study||0
3019294|NCT01052012|3737195|FG003|NOT COMPLETED|Overall Study||1
3019295|NCT01052012|3737196|FG004|NOT COMPLETED|Overall Study||16
3019296|NCT01052012|3737197|FG005|NOT COMPLETED|Overall Study||10
3019297|NCT01052038|3737214|FG000|STARTED|Overall Study||40
3019298|NCT01052038|3737215|FG001|STARTED|Overall Study||40
3019299|NCT01052038|3737216|FG002|STARTED|Overall Study||40
3019300|NCT01052038|3737214|FG000|COMPLETED|Overall Study||36
3019301|NCT01052038|3737215|FG001|COMPLETED|Overall Study||34
3019302|NCT01052038|3737216|FG002|COMPLETED|Overall Study||36
3019303|NCT01052038|3737214|FG000|NOT COMPLETED|Overall Study||4
3019304|NCT01052038|3737215|FG001|NOT COMPLETED|Overall Study||6
3019305|NCT01052038|3737216|FG002|NOT COMPLETED|Overall Study||4
3019306|NCT01052077|3737226|FG000|STARTED|Phase A||769
3019307|NCT01052077|3737227|FG001|STARTED|Phase A||0
3019308|NCT01052077|3737228|FG002|STARTED|Phase A||0
3019309|NCT01052077|3737229|FG003|STARTED|Phase A||0
3019310|NCT01052077|3737226|FG000|COMPLETED|Phase A||623
3019311|NCT01052077|3737227|FG001|COMPLETED|Phase A||0
3019312|NCT01052077|3737228|FG002|COMPLETED|Phase A||0
3019313|NCT01052077|3737229|FG003|COMPLETED|Phase A||0
3019314|NCT01052077|3737226|FG000|NOT COMPLETED|Phase A||146
3019315|NCT01052077|3737227|FG001|NOT COMPLETED|Phase A||0
3019316|NCT01052077|3737228|FG002|NOT COMPLETED|Phase A||0
3019317|NCT01052077|3737229|FG003|NOT COMPLETED|Phase A||0
3019318|NCT01052077|3737226|FG000|STARTED|Phase B||0
3019319|NCT01052077|3737227|FG001|STARTED|Phase B||185
3019320|NCT01052077|3737228|FG002|STARTED|Phase B||187
3019321|NCT01052077|3737229|FG003|STARTED|Phase B||0
3019322|NCT01052077|3737226|FG000|COMPLETED|Phase B||0
3019323|NCT01052077|3737227|FG001|COMPLETED|Phase B||167
3019324|NCT01052077|3737228|FG002|COMPLETED|Phase B||171
3019325|NCT01052077|3737229|FG003|COMPLETED|Phase B||0
3165630|NCT01901055|3893201|FG000|COMPLETED|Week 12 Assessment||44
3165631|NCT01901055|3893202|FG001|COMPLETED|Week 12 Assessment||39
3019326|NCT01052077|3737226|FG000|NOT COMPLETED|Phase B||0
3019327|NCT01052077|3737227|FG001|NOT COMPLETED|Phase B||18
3019328|NCT01052077|3737228|FG002|NOT COMPLETED|Phase B||16
3019329|NCT01052077|3737229|FG003|NOT COMPLETED|Phase B||0
3019330|NCT01052077|3737226|FG000|STARTED|Phase A+||0
3019331|NCT01052077|3737227|FG001|STARTED|Phase A+||0
3019332|NCT01052077|3737228|FG002|STARTED|Phase A+||0
3019333|NCT01052077|3737229|FG003|STARTED|Phase A+||251
3019334|NCT01052077|3737226|FG000|COMPLETED|Phase A+||0
3019335|NCT01052077|3737227|FG001|COMPLETED|Phase A+||0
3019336|NCT01052077|3737228|FG002|COMPLETED|Phase A+||0
3019337|NCT01052077|3737229|FG003|COMPLETED|Phase A+||230
3019338|NCT01052077|3737226|FG000|NOT COMPLETED|Phase A+||0
3019339|NCT01052077|3737227|FG001|NOT COMPLETED|Phase A+||0
3019340|NCT01052077|3737228|FG002|NOT COMPLETED|Phase A+||0
3019341|NCT01052077|3737229|FG003|NOT COMPLETED|Phase A+||21
3019342|NCT01052103|3737237|FG000|STARTED|Overall Study||84
3019343|NCT01052103|3737238|FG001|STARTED|Overall Study||83
3019344|NCT01052103|3737237|FG000|Received at Least 1 Dose of Study Drug|Overall Study||82
3019345|NCT01052103|3737238|FG001|Received at Least 1 Dose of Study Drug|Overall Study||82
3019346|NCT01052103|3737237|FG000|COMPLETED|Overall Study||50
3019347|NCT01052103|3737238|FG001|COMPLETED|Overall Study||60
3019348|NCT01052103|3737237|FG000|NOT COMPLETED|Overall Study||34
3019349|NCT01052103|3737238|FG001|NOT COMPLETED|Overall Study||23
3019350|NCT01052116|3737247|FG000|STARTED|Overall Study||193
3019351|NCT01052116|3737248|FG001|STARTED|Overall Study||193
3019352|NCT01052116|3737247|FG000|COMPLETED|Overall Study|Completed: defined as having an FEV1 measurement at 24 weeks|179
3308346|NCT03019939|4041648|FG000|COMPLETED|Overall Study||65
3308347|NCT03019939|4041648|FG000|NOT COMPLETED|Overall Study||0
3308348|NCT03019965|4041654|FG000|STARTED|Overall Study||211
3308349|NCT03019965|4041655|FG001|STARTED|Overall Study||215
3308350|NCT03019965|4041654|FG000|COMPLETED|Overall Study||201
3308351|NCT03019965|4041655|FG001|COMPLETED|Overall Study||202
3308352|NCT03019965|4041654|FG000|NOT COMPLETED|Overall Study||10
3308353|NCT03019965|4041655|FG001|NOT COMPLETED|Overall Study||13
3308354|NCT03020004|4041661|FG000|STARTED|Overall Study||70
3308355|NCT03020004|4041661|FG000|COMPLETED|Overall Study||69
3308356|NCT03020004|4041661|FG000|NOT COMPLETED|Overall Study||1
3308357|NCT03020069|4041667|FG000|STARTED|Overall Study||9
3308358|NCT03020069|4041668|FG001|STARTED|Overall Study||4
3308359|NCT03020069|4041667|FG000|COMPLETED|Overall Study||9
3308360|NCT03020069|4041668|FG001|COMPLETED|Overall Study||3
3308361|NCT03020069|4041667|FG000|NOT COMPLETED|Overall Study||0
3308362|NCT03020069|4041668|FG001|NOT COMPLETED|Overall Study||1
3308363|NCT03020082|4041674|FG000|STARTED|Overall Study||141
3308364|NCT03020082|4041674|FG000|COMPLETED|Overall Study||138
3308365|NCT03020082|4041674|FG000|NOT COMPLETED|Overall Study||3
3308366|NCT03020095|4041678|FG000|STARTED|Overall Study||38
3308367|NCT03020095|4041678|FG000|COMPLETED|Overall Study||37
3308368|NCT03020095|4041678|FG000|NOT COMPLETED|Overall Study||1
3308369|NCT03020407|4041684|FG000|STARTED|Overall Study||105
3308370|NCT03020407|4041685|FG001|STARTED|Overall Study||106
3308371|NCT03020407|4041684|FG000|COMPLETED|Overall Study||101
3308372|NCT03020407|4041685|FG001|COMPLETED|Overall Study||101
3308373|NCT03020407|4041684|FG000|NOT COMPLETED|Overall Study||4
3308374|NCT03020407|4041685|FG001|NOT COMPLETED|Overall Study||5
3308375|NCT03020472|4041691|FG000|STARTED|Overall Study||6
3308376|NCT03020472|4041691|FG000|COMPLETED|Overall Study||6
3308377|NCT03020472|4041691|FG000|NOT COMPLETED|Overall Study||0
3308378|NCT03020498|4041698|FG000|STARTED|Overall Study||14
3308379|NCT03020498|4041699|FG001|STARTED|Overall Study||41
3308380|NCT03020498|4041700|FG002|STARTED|Overall Study||36
3308381|NCT03020498|4041698|FG000|COMPLETED|Overall Study||14
3308382|NCT03020498|4041699|FG001|COMPLETED|Overall Study||38
3308383|NCT03020498|4041700|FG002|COMPLETED|Overall Study||36
3308384|NCT03020498|4041698|FG000|NOT COMPLETED|Overall Study||0
3308385|NCT03020498|4041699|FG001|NOT COMPLETED|Overall Study||3
3308386|NCT03020498|4041700|FG002|NOT COMPLETED|Overall Study||0
3308387|NCT03020524|4041711|FG000|STARTED|Overall Study||3
3308388|NCT03020524|4041712|FG001|STARTED|Overall Study||3
3308389|NCT03020524|4041713|FG002|STARTED|Overall Study||3
3308390|NCT03020524|4041711|FG000|COMPLETED|Overall Study||3
3308391|NCT03020524|4041712|FG001|COMPLETED|Overall Study||3
3308392|NCT03020524|4041713|FG002|COMPLETED|Overall Study||3
3308393|NCT03020524|4041711|FG000|NOT COMPLETED|Overall Study||0
3308394|NCT03020524|4041712|FG001|NOT COMPLETED|Overall Study||0
3308395|NCT03020524|4041713|FG002|NOT COMPLETED|Overall Study||0
3308396|NCT03020537|4041723|FG000|STARTED|Overall Study||1
3308397|NCT03020537|4041724|FG001|STARTED|Overall Study||7
3308398|NCT03020537|4041723|FG000|COMPLETED|Overall Study||1
3308399|NCT03020537|4041724|FG001|COMPLETED|Overall Study||7
3308400|NCT03020537|4041723|FG000|NOT COMPLETED|Overall Study||0
3308401|NCT03020537|4041724|FG001|NOT COMPLETED|Overall Study||0
3308402|NCT03020550|4041732|FG000|STARTED|Overall Study||8
3308403|NCT03020550|4041733|FG001|STARTED|Overall Study||16
3308404|NCT03020550|4041732|FG000|COMPLETED|Overall Study||8
3308405|NCT03020550|4041733|FG001|COMPLETED|Overall Study||16
3308406|NCT03020550|4041732|FG000|NOT COMPLETED|Overall Study||0
3019353|NCT01052116|3737248|FG001|COMPLETED|Overall Study|Completed: defined as having an FEV1 measurement at 24 weeks|166
3308407|NCT03020550|4041733|FG001|NOT COMPLETED|Overall Study||0
3308408|NCT03020576|4041741|FG000|STARTED|Overall Study||15
3308409|NCT03020576|4041742|FG001|STARTED|Overall Study||16
3019354|NCT01052116|3737247|FG000|NOT COMPLETED|Overall Study||14
3019355|NCT01052116|3737248|FG001|NOT COMPLETED|Overall Study||27
3019356|NCT01052207|3737256|FG000|STARTED|Overall Study||60
3019357|NCT01052207|3737257|FG001|STARTED|Overall Study||42
3019358|NCT01052207|3737256|FG000|COMPLETED|Overall Study||60
3019359|NCT01052207|3737257|FG001|COMPLETED|Overall Study||42
3019360|NCT01052207|3737256|FG000|NOT COMPLETED|Overall Study||0
3019361|NCT01052207|3737257|FG001|NOT COMPLETED|Overall Study||0
3019362|NCT01052272|3737267|FG000|STARTED|Overall Study||18
3019363|NCT01052272|3737268|FG001|STARTED|Overall Study||18
3019364|NCT01052272|3737269|FG002|STARTED|Overall Study||18
3019365|NCT01052272|3737270|FG003|STARTED|Overall Study||18
3019366|NCT01052272|3737267|FG000|COMPLETED|Overall Study||13
3019367|NCT01052272|3737268|FG001|COMPLETED|Overall Study||11
3019368|NCT01052272|3737269|FG002|COMPLETED|Overall Study||10
3019369|NCT01052272|3737270|FG003|COMPLETED|Overall Study||11
3019370|NCT01052272|3737267|FG000|NOT COMPLETED|Overall Study||5
3019371|NCT01052272|3737268|FG001|NOT COMPLETED|Overall Study||7
3019372|NCT01052272|3737269|FG002|NOT COMPLETED|Overall Study||8
3019373|NCT01052272|3737270|FG003|NOT COMPLETED|Overall Study||7
3019374|NCT01052428|3737282|FG000|STARTED|Overall Study||19
3019375|NCT01052428|3737283|FG001|STARTED|Overall Study||19
3019376|NCT01052428|3737282|FG000|COMPLETED|Overall Study||18
3019377|NCT01052428|3737283|FG001|COMPLETED|Overall Study||18
3019378|NCT01052428|3737282|FG000|NOT COMPLETED|Overall Study||1
3019379|NCT01052428|3737283|FG001|NOT COMPLETED|Overall Study||1
3165632|NCT01901055|3893201|FG000|NOT COMPLETED|Week 12 Assessment||1
3165633|NCT01901055|3893202|FG001|NOT COMPLETED|Week 12 Assessment||4
3165634|NCT01901055|3893201|FG000|STARTED|Week 24||44
3019380|NCT01052480|3737291|FG000|STARTED|Overall Study||49
3019381|NCT01052480|3737292|FG001|STARTED|Overall Study||49
3019382|NCT01052480|3737291|FG000|COMPLETED|Overall Study||41
3019383|NCT01052480|3737292|FG001|COMPLETED|Overall Study||32
3019384|NCT01052480|3737291|FG000|NOT COMPLETED|Overall Study||8
3019385|NCT01052480|3737292|FG001|NOT COMPLETED|Overall Study||17
3019386|NCT01052493|3737298|FG000|STARTED|Intervention 1 (Up to 10 Days)||4
3019387|NCT01052493|3737299|FG001|STARTED|Intervention 1 (Up to 10 Days)||4
3019388|NCT01052493|3737300|FG002|STARTED|Intervention 1 (Up to 10 Days)||4
3019389|NCT01052493|3737298|FG000|COMPLETED|Intervention 1 (Up to 10 Days)||3
3019390|NCT01052493|3737299|FG001|COMPLETED|Intervention 1 (Up to 10 Days)||4
3019391|NCT01052493|3737300|FG002|COMPLETED|Intervention 1 (Up to 10 Days)||4
3019392|NCT01052493|3737298|FG000|NOT COMPLETED|Intervention 1 (Up to 10 Days)||1
3019393|NCT01052493|3737299|FG001|NOT COMPLETED|Intervention 1 (Up to 10 Days)||0
3019394|NCT01052493|3737300|FG002|NOT COMPLETED|Intervention 1 (Up to 10 Days)||0
3019395|NCT01052493|3737298|FG000|STARTED|Washout Period 1 (up to 5 Days)||3
3019396|NCT01052493|3737299|FG001|STARTED|Washout Period 1 (up to 5 Days)||4
3019397|NCT01052493|3737300|FG002|STARTED|Washout Period 1 (up to 5 Days)||4
3019398|NCT01052493|3737298|FG000|COMPLETED|Washout Period 1 (up to 5 Days)||3
3019399|NCT01052493|3737299|FG001|COMPLETED|Washout Period 1 (up to 5 Days)||4
3019400|NCT01052493|3737300|FG002|COMPLETED|Washout Period 1 (up to 5 Days)||4
3019401|NCT01052493|3737298|FG000|NOT COMPLETED|Washout Period 1 (up to 5 Days)||0
3019402|NCT01052493|3737299|FG001|NOT COMPLETED|Washout Period 1 (up to 5 Days)||0
3019403|NCT01052493|3737300|FG002|NOT COMPLETED|Washout Period 1 (up to 5 Days)||0
3019404|NCT01052493|3737298|FG000|STARTED|Intervention 2 (up to 10 Days)|Replacement subject recruited|4
3019405|NCT01052493|3737299|FG001|STARTED|Intervention 2 (up to 10 Days)||4
3019406|NCT01052493|3737300|FG002|STARTED|Intervention 2 (up to 10 Days)||4
3019407|NCT01052493|3737298|FG000|COMPLETED|Intervention 2 (up to 10 Days)||4
3019408|NCT01052493|3737299|FG001|COMPLETED|Intervention 2 (up to 10 Days)||4
3019409|NCT01052493|3737300|FG002|COMPLETED|Intervention 2 (up to 10 Days)||4
3019410|NCT01052493|3737298|FG000|NOT COMPLETED|Intervention 2 (up to 10 Days)||0
3019411|NCT01052493|3737299|FG001|NOT COMPLETED|Intervention 2 (up to 10 Days)||0
3019412|NCT01052493|3737300|FG002|NOT COMPLETED|Intervention 2 (up to 10 Days)||0
3019413|NCT01052493|3737298|FG000|STARTED|Washout Period 2 (up to 5 Days)||4
3019414|NCT01052493|3737299|FG001|STARTED|Washout Period 2 (up to 5 Days)||4
3019415|NCT01052493|3737300|FG002|STARTED|Washout Period 2 (up to 5 Days)||4
3019416|NCT01052493|3737298|FG000|COMPLETED|Washout Period 2 (up to 5 Days)||4
3019417|NCT01052493|3737299|FG001|COMPLETED|Washout Period 2 (up to 5 Days)||4
3019418|NCT01052493|3737300|FG002|COMPLETED|Washout Period 2 (up to 5 Days)||4
3019419|NCT01052493|3737298|FG000|NOT COMPLETED|Washout Period 2 (up to 5 Days)||0
3019420|NCT01052493|3737299|FG001|NOT COMPLETED|Washout Period 2 (up to 5 Days)||0
3019421|NCT01052493|3737300|FG002|NOT COMPLETED|Washout Period 2 (up to 5 Days)||0
3019422|NCT01052493|3737298|FG000|STARTED|Intervention 3 (up to 10 Days)||4
3019423|NCT01052493|3737299|FG001|STARTED|Intervention 3 (up to 10 Days)||4
3019424|NCT01052493|3737300|FG002|STARTED|Intervention 3 (up to 10 Days)||4
3019425|NCT01052493|3737298|FG000|COMPLETED|Intervention 3 (up to 10 Days)||4
3019426|NCT01052493|3737299|FG001|COMPLETED|Intervention 3 (up to 10 Days)||4
3019427|NCT01052493|3737300|FG002|COMPLETED|Intervention 3 (up to 10 Days)||4
3019428|NCT01052493|3737298|FG000|NOT COMPLETED|Intervention 3 (up to 10 Days)||0
3019429|NCT01052493|3737299|FG001|NOT COMPLETED|Intervention 3 (up to 10 Days)||0
3019430|NCT01052493|3737300|FG002|NOT COMPLETED|Intervention 3 (up to 10 Days)||0
3019431|NCT01052545|3737315|FG000|STARTED|Overall Study||867
3019432|NCT01052545|3737316|FG001|STARTED|Overall Study||731
3019433|NCT01052545|3737315|FG000|COMPLETED|Overall Study||867
3165635|NCT01901055|3893202|FG001|STARTED|Week 24||39
3165636|NCT01901055|3893201|FG000|COMPLETED|Week 24||30
3308410|NCT03020576|4041741|FG000|COMPLETED|Overall Study||14
3308411|NCT03020576|4041742|FG001|COMPLETED|Overall Study||14
3308412|NCT03020576|4041741|FG000|NOT COMPLETED|Overall Study||1
3308413|NCT03020576|4041742|FG001|NOT COMPLETED|Overall Study||2
3308414|NCT03020615|4041751|FG000|STARTED|Overall Study||26
3019434|NCT01052545|3737316|FG001|COMPLETED|Overall Study||731
3019435|NCT01052545|3737315|FG000|NOT COMPLETED|Overall Study||0
3019436|NCT01052545|3737316|FG001|NOT COMPLETED|Overall Study||0
3019437|NCT01052662|3737337|FG000|STARTED|Overall Study|1 subject excluded from Intent-to-treat sample for final analysis due to pharmacy issue.|28
3019438|NCT01052662|3737338|FG001|STARTED|Overall Study|3 subjects excluded from Intent-to-treat sample for final analysis due to pharmacy issue|27
3019439|NCT01052662|3737339|FG002|STARTED|Overall Study|3 subjects excluded from Intent-to-treat sample for final analysis due to pharmacy issue|32
3019440|NCT01052662|3737337|FG000|Stabilization Phase|Overall Study||21
3019441|NCT01052662|3737338|FG001|Stabilization Phase|Overall Study||21
3019442|NCT01052662|3737339|FG002|Stabilization Phase|Overall Study||26
3019443|NCT01052662|3737337|FG000|Discontinuation Phase|Overall Study||6
3019444|NCT01052662|3737338|FG001|Discontinuation Phase|Overall Study||5
3019445|NCT01052662|3737339|FG002|Discontinuation Phase|Overall Study||10
3019446|NCT01052662|3737337|FG000|COMPLETED|Overall Study||6
3019447|NCT01052662|3737338|FG001|COMPLETED|Overall Study||5
3019448|NCT01052662|3737339|FG002|COMPLETED|Overall Study||10
3019449|NCT01052662|3737337|FG000|NOT COMPLETED|Overall Study||22
3019450|NCT01052662|3737338|FG001|NOT COMPLETED|Overall Study||22
3019451|NCT01052662|3737339|FG002|NOT COMPLETED|Overall Study||22
3019452|NCT01052701|3737349|FG000|STARTED|Overall Study||14
3019453|NCT01052701|3737350|FG001|STARTED|Overall Study||12
3019454|NCT01052701|3737349|FG000|COMPLETED|Overall Study||14
3019455|NCT01052701|3737350|FG001|COMPLETED|Overall Study||12
3019456|NCT01052701|3737349|FG000|NOT COMPLETED|Overall Study||0
3019457|NCT01052701|3737350|FG001|NOT COMPLETED|Overall Study||0
3019458|NCT01052714|3737358|FG000|STARTED|Overall Study||42
3019459|NCT01052714|3737359|FG001|STARTED|Overall Study||62
3019460|NCT01052714|3737360|FG002|STARTED|Overall Study||17
3019461|NCT01052714|3737358|FG000|COMPLETED|Overall Study||17
3019462|NCT01052714|3737359|FG001|COMPLETED|Overall Study||33
3019463|NCT01052714|3737360|FG002|COMPLETED|Overall Study||15
3019464|NCT01052714|3737358|FG000|NOT COMPLETED|Overall Study||25
3019465|NCT01052714|3737359|FG001|NOT COMPLETED|Overall Study||29
3019466|NCT01052714|3737360|FG002|NOT COMPLETED|Overall Study||2
3019467|NCT01052779|3737368|FG000|STARTED|Overall Study||80
3019468|NCT01052779|3737369|FG001|STARTED|Overall Study||82
3019469|NCT01052779|3737368|FG000|Received at Least 1 Dose of Study Drug|Overall Study||80
3019470|NCT01052779|3737369|FG001|Received at Least 1 Dose of Study Drug|Overall Study||81
3019471|NCT01052779|3737368|FG000|COMPLETED|Overall Study||75
3019472|NCT01052779|3737369|FG001|COMPLETED|Overall Study||73
3019473|NCT01052779|3737368|FG000|NOT COMPLETED|Overall Study||5
3019474|NCT01052779|3737369|FG001|NOT COMPLETED|Overall Study||9
3019475|NCT01052831|3737377|FG000|STARTED|Overall Study||26
3019476|NCT01052831|3737378|FG001|STARTED|Overall Study||24
3019477|NCT01052831|3737377|FG000|COMPLETED|Overall Study||22
3019478|NCT01052831|3737378|FG001|COMPLETED|Overall Study||23
3019479|NCT01052831|3737377|FG000|NOT COMPLETED|Overall Study||4
3019480|NCT01052831|3737378|FG001|NOT COMPLETED|Overall Study||1
3019481|NCT01052844|3737386|FG000|STARTED|Overall Study||40
3019482|NCT01052844|3737387|FG001|STARTED|Overall Study||40
3019483|NCT01052844|3737386|FG000|COMPLETED|Overall Study||40
3019484|NCT01052844|3737387|FG001|COMPLETED|Overall Study||39
3019485|NCT01052844|3737386|FG000|NOT COMPLETED|Overall Study||0
3019486|NCT01052844|3737387|FG001|NOT COMPLETED|Overall Study||1
3019487|NCT01052948|3737397|FG000|STARTED|Overall Study||27812
3019488|NCT01052948|3737398|FG001|STARTED|Overall Study||14669
3019489|NCT01052948|3737399|FG002|STARTED|Overall Study||15147
3019490|NCT01052948|3737400|FG003|STARTED|Overall Study||29311
3019491|NCT01052948|3737397|FG000|COMPLETED|Overall Study||27812
3019492|NCT01052948|3737398|FG001|COMPLETED|Overall Study||14669
3019493|NCT01052948|3737399|FG002|COMPLETED|Overall Study||15147
3019494|NCT01052948|3737400|FG003|COMPLETED|Overall Study||29311
3019495|NCT01052948|3737397|FG000|NOT COMPLETED|Overall Study||0
3308415|NCT03020615|4041752|FG001|STARTED|Overall Study||25
3308416|NCT03020615|4041753|FG002|STARTED|Overall Study||7
3308417|NCT03020615|4041751|FG000|COMPLETED|Overall Study||19
3019496|NCT01052948|3737398|FG001|NOT COMPLETED|Overall Study||0
3019497|NCT01052948|3737399|FG002|NOT COMPLETED|Overall Study||0
3019498|NCT01052948|3737400|FG003|NOT COMPLETED|Overall Study||0
3019499|NCT01053000|3737410|FG000|STARTED|Overall Study||5
3019500|NCT01053000|3737411|FG001|STARTED|Overall Study||5
3019501|NCT01053000|3737410|FG000|COMPLETED|Overall Study||5
3019502|NCT01053000|3737411|FG001|COMPLETED|Overall Study||5
3019503|NCT01053000|3737410|FG000|NOT COMPLETED|Overall Study||0
3019504|NCT01053000|3737411|FG001|NOT COMPLETED|Overall Study||0
3019505|NCT01053013|3737419|FG000|STARTED|Overall Study||24
3019506|NCT01053013|3737420|FG001|STARTED|Overall Study||34
3019507|NCT01053013|3737419|FG000|COMPLETED|Overall Study||24
3019508|NCT01053013|3737420|FG001|COMPLETED|Overall Study||34
3019509|NCT01053013|3737419|FG000|NOT COMPLETED|Overall Study||0
3019510|NCT01053013|3737420|FG001|NOT COMPLETED|Overall Study||0
3019511|NCT01053078|3737524|FG000|STARTED|Overall Study||14
3019512|NCT01053078|3737525|FG001|STARTED|Overall Study||15
3019513|NCT01053078|3737524|FG000|COMPLETED|Overall Study||10
3019514|NCT01053078|3737525|FG001|COMPLETED|Overall Study||12
3019515|NCT01053078|3737524|FG000|NOT COMPLETED|Overall Study||4
3019516|NCT01053078|3737525|FG001|NOT COMPLETED|Overall Study||3
3019517|NCT01053156|3737535|FG000|STARTED|First Intervention (Week 1-12)||33
3019518|NCT01053156|3737536|FG001|STARTED|First Intervention (Week 1-12)||33
3019519|NCT01053156|3737535|FG000|COMPLETED|First Intervention (Week 1-12)||28
3019520|NCT01053156|3737536|FG001|COMPLETED|First Intervention (Week 1-12)||27
3019521|NCT01053156|3737535|FG000|NOT COMPLETED|First Intervention (Week 1-12)||5
3019522|NCT01053156|3737536|FG001|NOT COMPLETED|First Intervention (Week 1-12)||6
3019523|NCT01053156|3737535|FG000|STARTED|Second Intervention (Week 13-24)||28
3019524|NCT01053156|3737536|FG001|STARTED|Second Intervention (Week 13-24)||27
3019525|NCT01053156|3737535|FG000|COMPLETED|Second Intervention (Week 13-24)||26
3019526|NCT01053156|3737536|FG001|COMPLETED|Second Intervention (Week 13-24)||22
3019527|NCT01053156|3737535|FG000|NOT COMPLETED|Second Intervention (Week 13-24)||2
3019528|NCT01053156|3737536|FG001|NOT COMPLETED|Second Intervention (Week 13-24)||5
3019529|NCT01053247|3737548|FG000|STARTED|Overall Study||269
3019530|NCT01053247|3737549|FG001|STARTED|Overall Study||260
3019531|NCT01053247|3737550|FG002|STARTED|Overall Study||264
3019532|NCT01053247|3737548|FG000|COMPLETED|Overall Study||249
3019533|NCT01053247|3737549|FG001|COMPLETED|Overall Study||241
3019534|NCT01053247|3737550|FG002|COMPLETED|Overall Study||236
3308418|NCT03020615|4041752|FG001|COMPLETED|Overall Study||23
3308419|NCT03020615|4041753|FG002|COMPLETED|Overall Study||0
3308420|NCT03020615|4041751|FG000|NOT COMPLETED|Overall Study||7
3308421|NCT03020615|4041752|FG001|NOT COMPLETED|Overall Study||2
3019535|NCT01053247|3737548|FG000|NOT COMPLETED|Overall Study||20
3019536|NCT01053247|3737549|FG001|NOT COMPLETED|Overall Study||19
3019537|NCT01053247|3737550|FG002|NOT COMPLETED|Overall Study||28
3019538|NCT01053312|3737558|FG000|STARTED|Overall Study||7
3019539|NCT01053312|3737558|FG000|COMPLETED|Overall Study||7
3019540|NCT01053312|3737558|FG000|NOT COMPLETED|Overall Study||0
3019541|NCT01053429|3737576|FG000|STARTED|Overall Study||3391
3019542|NCT01053429|3737576|FG000|COMPLETED|Overall Study||3018
3019543|NCT01053429|3737576|FG000|NOT COMPLETED|Overall Study||373
3019544|NCT01053507|3737582|FG000|STARTED|Overall Study||11
3019545|NCT01053507|3737583|FG001|STARTED|Overall Study||12
3019546|NCT01053507|3737582|FG000|COMPLETED|Overall Study||8
3019547|NCT01053507|3737583|FG001|COMPLETED|Overall Study||11
3019548|NCT01053507|3737582|FG000|NOT COMPLETED|Overall Study||3
3019549|NCT01053507|3737583|FG001|NOT COMPLETED|Overall Study||1
3019550|NCT01053663|3737592|FG000|STARTED|Overall Study||9
3019551|NCT01053663|3737592|FG000|COMPLETED|Overall Study||3
3019552|NCT01053663|3737592|FG000|NOT COMPLETED|Overall Study||6
3019553|NCT01053741|3737604|FG000|STARTED|1st Intervention||5
3019554|NCT01053741|3737605|FG001|STARTED|1st Intervention||6
3019555|NCT01053741|3737604|FG000|COMPLETED|1st Intervention||5
3019556|NCT01053741|3737605|FG001|COMPLETED|1st Intervention||6
3019557|NCT01053741|3737604|FG000|NOT COMPLETED|1st Intervention||0
3019558|NCT01053741|3737605|FG001|NOT COMPLETED|1st Intervention||0
3019559|NCT01053741|3737604|FG000|STARTED|14 Day Washout||5
3019560|NCT01053741|3737605|FG001|STARTED|14 Day Washout||6
3019561|NCT01053741|3737604|FG000|COMPLETED|14 Day Washout||5
3019562|NCT01053741|3737605|FG001|COMPLETED|14 Day Washout||6
3019563|NCT01053741|3737604|FG000|NOT COMPLETED|14 Day Washout||0
3019564|NCT01053741|3737605|FG001|NOT COMPLETED|14 Day Washout||0
3019565|NCT01053741|3737604|FG000|STARTED|2nd Study Intervention||5
3019566|NCT01053741|3737605|FG001|STARTED|2nd Study Intervention||6
3019567|NCT01053741|3737604|FG000|COMPLETED|2nd Study Intervention||5
3019568|NCT01053741|3737605|FG001|COMPLETED|2nd Study Intervention||5
3019569|NCT01053741|3737604|FG000|NOT COMPLETED|2nd Study Intervention||0
3019570|NCT01053741|3737605|FG001|NOT COMPLETED|2nd Study Intervention||1
3019571|NCT01053819|3737611|FG000|STARTED|Overall Study||6
3019572|NCT01053819|3737611|FG000|COMPLETED|Overall Study||6
3019573|NCT01053819|3737611|FG000|NOT COMPLETED|Overall Study||0
3019574|NCT01053897|3737616|FG000|STARTED|Overall Study||5
3019575|NCT01053897|3737616|FG000|COMPLETED|Overall Study||5
3019576|NCT01053897|3737616|FG000|NOT COMPLETED|Overall Study||0
3019577|NCT01053962|3737631|FG000|STARTED|Pretreatment Period||14
3019578|NCT01053962|3737632|FG001|STARTED|Pretreatment Period||15
3019579|NCT01053962|3737633|FG002|STARTED|Pretreatment Period||16
3019580|NCT01053962|3737634|FG003|STARTED|Pretreatment Period||17
3019581|NCT01053962|3737635|FG004|STARTED|Pretreatment Period||22
3019582|NCT01053962|3737631|FG000|COMPLETED|Pretreatment Period||14
3019583|NCT01053962|3737632|FG001|COMPLETED|Pretreatment Period||14
3019584|NCT01053962|3737633|FG002|COMPLETED|Pretreatment Period||15
3019585|NCT01053962|3737634|FG003|COMPLETED|Pretreatment Period||15
3019586|NCT01053962|3737635|FG004|COMPLETED|Pretreatment Period||20
3133685|NCT01696942|3858599|FG001|COMPLETED|Overall Study||2
3019587|NCT01053962|3737631|FG000|NOT COMPLETED|Pretreatment Period||0
3019588|NCT01053962|3737632|FG001|NOT COMPLETED|Pretreatment Period||1
3019589|NCT01053962|3737633|FG002|NOT COMPLETED|Pretreatment Period||1
3019590|NCT01053962|3737634|FG003|NOT COMPLETED|Pretreatment Period||2
3019591|NCT01053962|3737635|FG004|NOT COMPLETED|Pretreatment Period||2
3019592|NCT01053962|3737631|FG000|STARTED|Treatment Period||14
3019593|NCT01053962|3737632|FG001|STARTED|Treatment Period||14
3019594|NCT01053962|3737633|FG002|STARTED|Treatment Period||15
3019595|NCT01053962|3737634|FG003|STARTED|Treatment Period||15
3019596|NCT01053962|3737635|FG004|STARTED|Treatment Period||20
3019597|NCT01053962|3737631|FG000|COMPLETED|Treatment Period||13
3019598|NCT01053962|3737632|FG001|COMPLETED|Treatment Period||14
3019599|NCT01053962|3737633|FG002|COMPLETED|Treatment Period||15
3019600|NCT01053962|3737634|FG003|COMPLETED|Treatment Period||15
3019601|NCT01053962|3737635|FG004|COMPLETED|Treatment Period||17
3019602|NCT01053962|3737631|FG000|NOT COMPLETED|Treatment Period||1
3019603|NCT01053962|3737632|FG001|NOT COMPLETED|Treatment Period||0
3019604|NCT01053962|3737633|FG002|NOT COMPLETED|Treatment Period||0
3019605|NCT01053962|3737634|FG003|NOT COMPLETED|Treatment Period||0
3019606|NCT01053962|3737635|FG004|NOT COMPLETED|Treatment Period||3
3019607|NCT01053962|3737631|FG000|STARTED|Follow-up Period||13
3019608|NCT01053962|3737632|FG001|STARTED|Follow-up Period||14
3019609|NCT01053962|3737633|FG002|STARTED|Follow-up Period||15
3019610|NCT01053962|3737634|FG003|STARTED|Follow-up Period||15
3019611|NCT01053962|3737635|FG004|STARTED|Follow-up Period||17
3019612|NCT01053962|3737631|FG000|COMPLETED|Follow-up Period||13
3019613|NCT01053962|3737632|FG001|COMPLETED|Follow-up Period||14
3019614|NCT01053962|3737633|FG002|COMPLETED|Follow-up Period||15
3019615|NCT01053962|3737634|FG003|COMPLETED|Follow-up Period||15
3019616|NCT01053962|3737635|FG004|COMPLETED|Follow-up Period||17
3019617|NCT01053962|3737631|FG000|NOT COMPLETED|Follow-up Period||0
3019618|NCT01053962|3737632|FG001|NOT COMPLETED|Follow-up Period||0
3019619|NCT01053962|3737633|FG002|NOT COMPLETED|Follow-up Period||0
3019620|NCT01053962|3737634|FG003|NOT COMPLETED|Follow-up Period||0
3019621|NCT01053962|3737635|FG004|NOT COMPLETED|Follow-up Period||0
3019622|NCT01053988|3737657|FG000|STARTED|2-week, Single-blind Run-In Period||1390
3019623|NCT01053988|3737658|FG001|STARTED|2-week, Single-blind Run-In Period||0
3019624|NCT01053988|3737659|FG002|STARTED|2-week, Single-blind Run-In Period||0
3019625|NCT01053988|3737660|FG003|STARTED|2-week, Single-blind Run-In Period||0
3019626|NCT01053988|3737661|FG004|STARTED|2-week, Single-blind Run-In Period||0
3019627|NCT01053988|3737662|FG005|STARTED|2-week, Single-blind Run-In Period||0
3019628|NCT01053988|3737657|FG000|COMPLETED|2-week, Single-blind Run-In Period||1030
3019629|NCT01053988|3737658|FG001|COMPLETED|2-week, Single-blind Run-In Period||0
3019630|NCT01053988|3737659|FG002|COMPLETED|2-week, Single-blind Run-In Period||0
3019631|NCT01053988|3737660|FG003|COMPLETED|2-week, Single-blind Run-In Period||0
3019632|NCT01053988|3737661|FG004|COMPLETED|2-week, Single-blind Run-In Period||0
3019633|NCT01053988|3737662|FG005|COMPLETED|2-week, Single-blind Run-In Period||0
3019634|NCT01053988|3737657|FG000|NOT COMPLETED|2-week, Single-blind Run-In Period||360
3019635|NCT01053988|3737658|FG001|NOT COMPLETED|2-week, Single-blind Run-In Period||0
3019636|NCT01053988|3737659|FG002|NOT COMPLETED|2-week, Single-blind Run-In Period||0
3019637|NCT01053988|3737660|FG003|NOT COMPLETED|2-week, Single-blind Run-In Period||0
3019638|NCT01053988|3737661|FG004|NOT COMPLETED|2-week, Single-blind Run-In Period||0
3019639|NCT01053988|3737662|FG005|NOT COMPLETED|2-week, Single-blind Run-In Period||0
3019640|NCT01053988|3737657|FG000|STARTED|24-week, Double-blind Treatment Period||0
3019641|NCT01053988|3737658|FG001|STARTED|24-week, Double-blind Treatment Period||207
3019642|NCT01053988|3737659|FG002|STARTED|24-week, Double-blind Treatment Period||206
3019643|NCT01053988|3737660|FG003|STARTED|24-week, Double-blind Treatment Period||205
3019644|NCT01053988|3737661|FG004|STARTED|24-week, Double-blind Treatment Period||206
3019645|NCT01053988|3737662|FG005|STARTED|24-week, Double-blind Treatment Period||206
3019646|NCT01053988|3737657|FG000|COMPLETED|24-week, Double-blind Treatment Period||0
3019647|NCT01053988|3737658|FG001|COMPLETED|24-week, Double-blind Treatment Period||138
3019648|NCT01053988|3737659|FG002|COMPLETED|24-week, Double-blind Treatment Period||145
3019649|NCT01053988|3737660|FG003|COMPLETED|24-week, Double-blind Treatment Period||142
3019650|NCT01053988|3737661|FG004|COMPLETED|24-week, Double-blind Treatment Period||147
3019651|NCT01053988|3737662|FG005|COMPLETED|24-week, Double-blind Treatment Period||151
3019652|NCT01053988|3737657|FG000|NOT COMPLETED|24-week, Double-blind Treatment Period||0
3019653|NCT01053988|3737658|FG001|NOT COMPLETED|24-week, Double-blind Treatment Period||69
3019654|NCT01053988|3737659|FG002|NOT COMPLETED|24-week, Double-blind Treatment Period||61
3019655|NCT01053988|3737660|FG003|NOT COMPLETED|24-week, Double-blind Treatment Period||63
3019656|NCT01053988|3737661|FG004|NOT COMPLETED|24-week, Double-blind Treatment Period||59
3019657|NCT01053988|3737662|FG005|NOT COMPLETED|24-week, Double-blind Treatment Period||55
3019658|NCT01054079|3737674|FG000|STARTED|Overall Study||20
3019659|NCT01054079|3737674|FG000|# Recieved Proper PSA Testing|Overall Study||10
3019660|NCT01054079|3737674|FG000|COMPLETED|Overall Study|while all 20 patients received at least some of the intervention, some did not get proper PSA tests.|20
3019661|NCT01054079|3737674|FG000|NOT COMPLETED|Overall Study||0
3019662|NCT01054144|3737678|FG000|STARTED|Overall Study||27
3019663|NCT01054144|3737678|FG000|COMPLETED|Overall Study||25
3019664|NCT01054144|3737678|FG000|NOT COMPLETED|Overall Study||2
3019665|NCT01054170|3737687|FG000|STARTED|Overall Study||25
3019666|NCT01054170|3737688|FG001|STARTED|Overall Study||27
3019667|NCT01054170|3737687|FG000|COMPLETED|Overall Study||21
3019668|NCT01054170|3737688|FG001|COMPLETED|Overall Study||21
3019669|NCT01054170|3737687|FG000|NOT COMPLETED|Overall Study||4
3019670|NCT01054170|3737688|FG001|NOT COMPLETED|Overall Study||6
3019671|NCT01054183|3737696|FG000|STARTED|Overall Study||10
3019672|NCT01054183|3737697|FG001|STARTED|Overall Study||12
3019673|NCT01054183|3737696|FG000|COMPLETED|Overall Study||10
3019674|NCT01054183|3737697|FG001|COMPLETED|Overall Study||12
3019675|NCT01054183|3737696|FG000|NOT COMPLETED|Overall Study||0
3019676|NCT01054183|3737697|FG001|NOT COMPLETED|Overall Study||0
3019677|NCT01054209|3737705|FG000|STARTED|Overall Study||58
3019678|NCT01054209|3737706|FG001|STARTED|Overall Study||58
3019679|NCT01054209|3737705|FG000|COMPLETED|Overall Study||58
3019680|NCT01054209|3737706|FG001|COMPLETED|Overall Study||58
3019681|NCT01054209|3737705|FG000|NOT COMPLETED|Overall Study||0
3019682|NCT01054209|3737706|FG001|NOT COMPLETED|Overall Study||0
3019683|NCT01054222|3737712|FG000|STARTED|Overall Study||31
3019684|NCT01054222|3737712|FG000|COMPLETED|Overall Study||20
3019685|NCT01054222|3737712|FG000|NOT COMPLETED|Overall Study||11
3019686|NCT01054300|3737718|FG000|STARTED|Period 1||13
3019687|NCT01054300|3737719|FG001|STARTED|Period 1||13
3019688|NCT01054300|3737720|FG002|STARTED|Period 1||13
3019689|NCT01054300|3737721|FG003|STARTED|Period 1||13
3019690|NCT01054300|3737718|FG000|COMPLETED|Period 1|Discontinuation occurred prior to Period 2 dose.|12
3019691|NCT01054300|3737719|FG001|COMPLETED|Period 1||13
3019692|NCT01054300|3737720|FG002|COMPLETED|Period 1||13
3019693|NCT01054300|3737721|FG003|COMPLETED|Period 1||13
3019694|NCT01054300|3737718|FG000|NOT COMPLETED|Period 1||1
3019695|NCT01054300|3737719|FG001|NOT COMPLETED|Period 1||0
3019696|NCT01054300|3737720|FG002|NOT COMPLETED|Period 1||0
3019697|NCT01054300|3737721|FG003|NOT COMPLETED|Period 1||0
3019698|NCT01054300|3737718|FG000|STARTED|Period 2||12
3019699|NCT01054300|3737719|FG001|STARTED|Period 2||13
3019700|NCT01054300|3737720|FG002|STARTED|Period 2||13
3019701|NCT01054300|3737721|FG003|STARTED|Period 2||13
3019702|NCT01054300|3737718|FG000|COMPLETED|Period 2||12
3019703|NCT01054300|3737719|FG001|COMPLETED|Period 2||13
3019704|NCT01054300|3737720|FG002|COMPLETED|Period 2||12
3019705|NCT01054300|3737721|FG003|COMPLETED|Period 2||13
3019706|NCT01054300|3737718|FG000|NOT COMPLETED|Period 2||0
3019707|NCT01054300|3737719|FG001|NOT COMPLETED|Period 2||0
3019708|NCT01054300|3737720|FG002|NOT COMPLETED|Period 2||1
3019709|NCT01054300|3737721|FG003|NOT COMPLETED|Period 2||0
3019710|NCT01054339|3737734|FG000|STARTED|Overall Study||3
3019711|NCT01054339|3737735|FG001|STARTED|Overall Study||3
3019712|NCT01054339|3737736|FG002|STARTED|Overall Study||3
3019713|NCT01054339|3737734|FG000|COMPLETED|Overall Study||3
3019714|NCT01054339|3737735|FG001|COMPLETED|Overall Study||3
3019715|NCT01054339|3737736|FG002|COMPLETED|Overall Study||3
3019716|NCT01054339|3737734|FG000|NOT COMPLETED|Overall Study||0
3019717|NCT01054339|3737735|FG001|NOT COMPLETED|Overall Study||0
3019718|NCT01054339|3737736|FG002|NOT COMPLETED|Overall Study||0
3019719|NCT01054404|3737748|FG000|STARTED|Overall Study||10
3019720|NCT01054404|3737749|FG001|STARTED|Overall Study||13
3019721|NCT01054404|3737748|FG000|COMPLETED|Overall Study||10
3019722|NCT01054404|3737749|FG001|COMPLETED|Overall Study||13
3019723|NCT01054404|3737748|FG000|NOT COMPLETED|Overall Study||0
3019724|NCT01054404|3737749|FG001|NOT COMPLETED|Overall Study||0
3019725|NCT01054443|3737759|FG000|STARTED|Overall Study||5
3019726|NCT01054443|3737760|FG001|STARTED|Overall Study||5
3019727|NCT01054443|3737761|FG002|STARTED|Overall Study||5
3019728|NCT01054443|3737762|FG003|STARTED|Overall Study||5
3019729|NCT01054443|3737759|FG000|COMPLETED|Overall Study||5
3019730|NCT01054443|3737760|FG001|COMPLETED|Overall Study||5
3019731|NCT01054443|3737761|FG002|COMPLETED|Overall Study||5
3019732|NCT01054443|3737762|FG003|COMPLETED|Overall Study||4
3019733|NCT01054443|3737759|FG000|NOT COMPLETED|Overall Study||0
3019734|NCT01054443|3737760|FG001|NOT COMPLETED|Overall Study||0
3019735|NCT01054443|3737761|FG002|NOT COMPLETED|Overall Study||0
3019736|NCT01054443|3737762|FG003|NOT COMPLETED|Overall Study||1
3019737|NCT01054456|3737775|FG000|STARTED|Overall Study||36
3019738|NCT01054456|3737775|FG000|COMPLETED|Overall Study||35
3019739|NCT01054456|3737775|FG000|NOT COMPLETED|Overall Study||1
3019740|NCT01054560|3737781|FG000|STARTED|Overall Study||58
3019741|NCT01054560|3737782|FG001|STARTED|Overall Study||55
3019742|NCT01054560|3737781|FG000|COMPLETED|Overall Study||45
3019743|NCT01054560|3737782|FG001|COMPLETED|Overall Study||27
3019744|NCT01054560|3737781|FG000|NOT COMPLETED|Overall Study||13
3019745|NCT01054560|3737782|FG001|NOT COMPLETED|Overall Study||28
3019746|NCT01054573|3737794|FG000|STARTED|Overall Study||9
3019747|NCT01054573|3737795|FG001|STARTED|Overall Study||32
3019748|NCT01054573|3737796|FG002|STARTED|Overall Study||22
3019749|NCT01054573|3737797|FG003|STARTED|Overall Study||27
3019750|NCT01054573|3737794|FG000|COMPLETED|Overall Study||8
3019751|NCT01054573|3737795|FG001|COMPLETED|Overall Study||28
3019752|NCT01054573|3737796|FG002|COMPLETED|Overall Study||19
3019753|NCT01054573|3737797|FG003|COMPLETED|Overall Study||25
3019754|NCT01054573|3737794|FG000|NOT COMPLETED|Overall Study||1
3019755|NCT01054573|3737795|FG001|NOT COMPLETED|Overall Study||4
3019756|NCT01054573|3737796|FG002|NOT COMPLETED|Overall Study||3
3019757|NCT01054573|3737797|FG003|NOT COMPLETED|Overall Study||2
3019758|NCT01054586|3737820|FG000|STARTED|Overall Study||43
3019759|NCT01054586|3737821|FG001|STARTED|Overall Study||15
3019760|NCT01054586|3737822|FG002|STARTED|Overall Study||8
3019761|NCT01054586|3737823|FG003|STARTED|Overall Study||101
3019762|NCT01054586|3737820|FG000|COMPLETED|Overall Study||43
3019763|NCT01054586|3737821|FG001|COMPLETED|Overall Study||15
3019764|NCT01054586|3737822|FG002|COMPLETED|Overall Study||8
3019765|NCT01054586|3737823|FG003|COMPLETED|Overall Study||101
3019766|NCT01054586|3737820|FG000|NOT COMPLETED|Overall Study||0
3019767|NCT01054586|3737821|FG001|NOT COMPLETED|Overall Study||0
3019768|NCT01054586|3737822|FG002|NOT COMPLETED|Overall Study||0
3019769|NCT01054586|3737823|FG003|NOT COMPLETED|Overall Study||0
3019770|NCT01054599|3737845|FG000|STARTED|Overall Study||13
3019771|NCT01054599|3737846|FG001|STARTED|Overall Study||16
3019772|NCT01054599|3737845|FG000|COMPLETED|Overall Study||9
3019773|NCT01054599|3737846|FG001|COMPLETED|Overall Study||9
3019774|NCT01054599|3737845|FG000|NOT COMPLETED|Overall Study||4
3019775|NCT01054599|3737846|FG001|NOT COMPLETED|Overall Study||7
3019776|NCT01054625|3737855|FG000|STARTED|Overall Study|A total of 31 patients were enrolled, 1 patient died before receiving any zalutumumab|8
3019777|NCT01054625|3737856|FG001|STARTED|Overall Study||12
3019778|NCT01054625|3737857|FG002|STARTED|Overall Study||10
3019779|NCT01054625|3737855|FG000|COMPLETED|Overall Study||6
3019780|NCT01054625|3737856|FG001|COMPLETED|Overall Study||9
3019781|NCT01054625|3737857|FG002|COMPLETED|Overall Study||9
3019782|NCT01054625|3737855|FG000|NOT COMPLETED|Overall Study||2
3019783|NCT01054625|3737856|FG001|NOT COMPLETED|Overall Study||3
3019784|NCT01054625|3737857|FG002|NOT COMPLETED|Overall Study||1
3019785|NCT01054703|3737865|FG000|STARTED|Overall Study||14
3019786|NCT01054703|3737865|FG000|COMPLETED|Overall Study||14
3019787|NCT01054703|3737865|FG000|NOT COMPLETED|Overall Study||0
3019788|NCT01054729|3737873|FG000|STARTED|Overall Study||16
3019789|NCT01054729|3737874|FG001|STARTED|Overall Study||19
3019790|NCT01054729|3737875|FG002|STARTED|Overall Study||15
3019791|NCT01054729|3737876|FG003|STARTED|Overall Study||14
3019792|NCT01054729|3737873|FG000|Randomized and Treated|Overall Study||16
3019793|NCT01054729|3737874|FG001|Randomized and Treated|Overall Study||18
3019794|NCT01054729|3737875|FG002|Randomized and Treated|Overall Study||15
3019795|NCT01054729|3737876|FG003|Randomized and Treated|Overall Study||14
3019796|NCT01054729|3737873|FG000|COMPLETED|Overall Study||12
3019797|NCT01054729|3737874|FG001|COMPLETED|Overall Study||14
3019798|NCT01054729|3737875|FG002|COMPLETED|Overall Study||9
3019799|NCT01054729|3737876|FG003|COMPLETED|Overall Study||11
3019800|NCT01054729|3737873|FG000|NOT COMPLETED|Overall Study||4
3019801|NCT01054729|3737874|FG001|NOT COMPLETED|Overall Study||5
3019802|NCT01054729|3737875|FG002|NOT COMPLETED|Overall Study||6
3019803|NCT01054729|3737876|FG003|NOT COMPLETED|Overall Study||3
3019804|NCT01054742|3737886|FG000|STARTED|Overall Study||2
3019805|NCT01054742|3737886|FG000|COMPLETED|Overall Study||2
3019806|NCT01054742|3737886|FG000|NOT COMPLETED|Overall Study||0
3019807|NCT01054768|3737892|FG000|STARTED|Overall Study||17
3019808|NCT01054768|3737893|FG001|STARTED|Overall Study||20
3019809|NCT01054768|3737892|FG000|COMPLETED|Overall Study||9
3019810|NCT01054768|3737893|FG001|COMPLETED|Overall Study||17
3019811|NCT01054768|3737892|FG000|NOT COMPLETED|Overall Study||8
3019812|NCT01054768|3737893|FG001|NOT COMPLETED|Overall Study||3
3019813|NCT01054820|3737899|FG000|STARTED|Overall Study||123
3019814|NCT01054820|3737899|FG000|COMPLETED|Overall Study||121
3019815|NCT01054820|3737899|FG000|NOT COMPLETED|Overall Study||2
3019816|NCT01054846|3737905|FG000|STARTED|Overall Study||322
3019817|NCT01054846|3737906|FG001|STARTED|Overall Study||68
3019818|NCT01054846|3737905|FG000|COMPLETED|Overall Study||246
3019819|NCT01054846|3737906|FG001|COMPLETED|Overall Study||51
3019820|NCT01054846|3737905|FG000|NOT COMPLETED|Overall Study||76
3019821|NCT01054846|3737906|FG001|NOT COMPLETED|Overall Study||17
3019822|NCT01054885|3737917|FG000|STARTED|2-week, Single-blind Run-In Period||1577
3019823|NCT01054885|3737918|FG001|STARTED|2-week, Single-blind Run-In Period||0
3019824|NCT01054885|3737919|FG002|STARTED|2-week, Single-blind Run-In Period||0
3019825|NCT01054885|3737920|FG003|STARTED|2-week, Single-blind Run-In Period||0
3019826|NCT01054885|3737921|FG004|STARTED|2-week, Single-blind Run-In Period||0
3019827|NCT01054885|3737922|FG005|STARTED|2-week, Single-blind Run-In Period||0
3019828|NCT01054885|3737923|FG006|STARTED|2-week, Single-blind Run-In Period||0
3019829|NCT01054885|3737917|FG000|COMPLETED|2-week, Single-blind Run-In Period||1226
3019830|NCT01054885|3737918|FG001|COMPLETED|2-week, Single-blind Run-In Period||0
3019831|NCT01054885|3737919|FG002|COMPLETED|2-week, Single-blind Run-In Period||0
3019832|NCT01054885|3737920|FG003|COMPLETED|2-week, Single-blind Run-In Period||0
3019833|NCT01054885|3737921|FG004|COMPLETED|2-week, Single-blind Run-In Period||0
3019834|NCT01054885|3737922|FG005|COMPLETED|2-week, Single-blind Run-In Period||0
3019835|NCT01054885|3737923|FG006|COMPLETED|2-week, Single-blind Run-In Period||0
3019836|NCT01054885|3737917|FG000|NOT COMPLETED|2-week, Single-blind Run-In Period||351
3019837|NCT01054885|3737918|FG001|NOT COMPLETED|2-week, Single-blind Run-In Period||0
3019838|NCT01054885|3737919|FG002|NOT COMPLETED|2-week, Single-blind Run-In Period||0
3019839|NCT01054885|3737920|FG003|NOT COMPLETED|2-week, Single-blind Run-In Period||0
3019840|NCT01054885|3737921|FG004|NOT COMPLETED|2-week, Single-blind Run-In Period||0
3019841|NCT01054885|3737922|FG005|NOT COMPLETED|2-week, Single-blind Run-In Period||0
3019842|NCT01054885|3737923|FG006|NOT COMPLETED|2-week, Single-blind Run-In Period||0
3019843|NCT01054885|3737917|FG000|STARTED|24-week, Double-blind Treatment Period||0
3019844|NCT01054885|3737918|FG001|STARTED|24-week, Double-blind Treatment Period||205
3019845|NCT01054885|3737919|FG002|STARTED|24-week, Double-blind Treatment Period||204
3019846|NCT01054885|3737920|FG003|STARTED|24-week, Double-blind Treatment Period||203
3019847|NCT01054885|3737921|FG004|STARTED|24-week, Double-blind Treatment Period||203
3019848|NCT01054885|3737922|FG005|STARTED|24-week, Double-blind Treatment Period||204
3019849|NCT01054885|3737923|FG006|STARTED|24-week, Double-blind Treatment Period||205
3019850|NCT01054885|3737917|FG000|COMPLETED|24-week, Double-blind Treatment Period||0
3165637|NCT01901055|3893202|FG001|COMPLETED|Week 24||20
3165638|NCT01901055|3893201|FG000|NOT COMPLETED|Week 24||14
3165639|NCT01901055|3893202|FG001|NOT COMPLETED|Week 24||19
3165640|NCT01901055|3893201|FG000|STARTED|Week 36||30
3165641|NCT01901055|3893202|FG001|STARTED|Week 36||20
3165642|NCT01901055|3893201|FG000|COMPLETED|Week 36||30
3165643|NCT01901055|3893202|FG001|COMPLETED|Week 36||15
3165644|NCT01901055|3893201|FG000|NOT COMPLETED|Week 36||0
3165645|NCT01901055|3893202|FG001|NOT COMPLETED|Week 36||5
3165646|NCT01901146|3893213|FG000|STARTED|Neoadjuvant Phase||364
3165647|NCT01901146|3893214|FG001|STARTED|Neoadjuvant Phase||361
3165648|NCT01901146|3893215|FG002|STARTED|Neoadjuvant Phase||0
3165649|NCT01901146|3893216|FG003|STARTED|Neoadjuvant Phase||0
3019851|NCT01054885|3737918|FG001|COMPLETED|24-week, Double-blind Treatment Period||146
3019852|NCT01054885|3737919|FG002|COMPLETED|24-week, Double-blind Treatment Period||155
3019853|NCT01054885|3737920|FG003|COMPLETED|24-week, Double-blind Treatment Period||160
3019854|NCT01054885|3737921|FG004|COMPLETED|24-week, Double-blind Treatment Period||161
3019855|NCT01054885|3737922|FG005|COMPLETED|24-week, Double-blind Treatment Period||144
3019856|NCT01054885|3737923|FG006|COMPLETED|24-week, Double-blind Treatment Period||158
3019857|NCT01054885|3737917|FG000|NOT COMPLETED|24-week, Double-blind Treatment Period||0
3019858|NCT01054885|3737918|FG001|NOT COMPLETED|24-week, Double-blind Treatment Period||59
3019859|NCT01054885|3737919|FG002|NOT COMPLETED|24-week, Double-blind Treatment Period||49
3019860|NCT01054885|3737920|FG003|NOT COMPLETED|24-week, Double-blind Treatment Period||43
3019861|NCT01054885|3737921|FG004|NOT COMPLETED|24-week, Double-blind Treatment Period||42
3019862|NCT01054885|3737922|FG005|NOT COMPLETED|24-week, Double-blind Treatment Period||60
3019863|NCT01054885|3737923|FG006|NOT COMPLETED|24-week, Double-blind Treatment Period||47
3019864|NCT01054911|3737938|FG000|STARTED|Overall Study||5
3019865|NCT01054911|3737938|FG000|COMPLETED|Overall Study||5
3019866|NCT01054911|3737938|FG000|NOT COMPLETED|Overall Study||0
3019867|NCT01054976|3737944|FG000|STARTED|Overall Study||92
3019868|NCT01054976|3737944|FG000|COMPLETED|Overall Study||57
3019869|NCT01054976|3737944|FG000|NOT COMPLETED|Overall Study||35
3019870|NCT01055028|3737950|FG000|STARTED|Screening||9
3019871|NCT01055028|3737951|FG001|STARTED|Screening||9
3019872|NCT01055028|3737950|FG000|COMPLETED|Screening||8
3019873|NCT01055028|3737951|FG001|COMPLETED|Screening||8
3019874|NCT01055028|3737950|FG000|NOT COMPLETED|Screening||1
3019875|NCT01055028|3737951|FG001|NOT COMPLETED|Screening||1
3019876|NCT01055028|3737950|FG000|STARTED|Treatment Cycles 1 to 3||8
3019877|NCT01055028|3737951|FG001|STARTED|Treatment Cycles 1 to 3||8
3019878|NCT01055028|3737950|FG000|COMPLETED|Treatment Cycles 1 to 3||6
3019879|NCT01055028|3737951|FG001|COMPLETED|Treatment Cycles 1 to 3||5
3019880|NCT01055028|3737950|FG000|NOT COMPLETED|Treatment Cycles 1 to 3||2
3019881|NCT01055028|3737951|FG001|NOT COMPLETED|Treatment Cycles 1 to 3||3
3019882|NCT01055028|3737950|FG000|STARTED|Inter-treatment Period||6
3019883|NCT01055028|3737951|FG001|STARTED|Inter-treatment Period||5
3019884|NCT01055028|3737950|FG000|COMPLETED|Inter-treatment Period||6
3019885|NCT01055028|3737951|FG001|COMPLETED|Inter-treatment Period||2
3019886|NCT01055028|3737950|FG000|NOT COMPLETED|Inter-treatment Period||0
3019887|NCT01055028|3737951|FG001|NOT COMPLETED|Inter-treatment Period||3
3019888|NCT01055028|3737950|FG000|STARTED|Treatment Cycles 4 to 6||6
3019889|NCT01055028|3737951|FG001|STARTED|Treatment Cycles 4 to 6||2
3019890|NCT01055028|3737950|FG000|COMPLETED|Treatment Cycles 4 to 6||6
3019891|NCT01055028|3737951|FG001|COMPLETED|Treatment Cycles 4 to 6||2
3019892|NCT01055028|3737950|FG000|NOT COMPLETED|Treatment Cycles 4 to 6||0
3019893|NCT01055028|3737951|FG001|NOT COMPLETED|Treatment Cycles 4 to 6||0
3019894|NCT01055067|3737961|FG000|STARTED|Overall Study||27
3019895|NCT01055067|3737961|FG000|COMPLETED|Overall Study||27
3019896|NCT01055067|3737961|FG000|NOT COMPLETED|Overall Study||0
3019897|NCT01055132|3737967|FG000|STARTED|Period 1 (5-9 Days)||36
3019898|NCT01055132|3737968|FG001|STARTED|Period 1 (5-9 Days)||33
3019899|NCT01055132|3737967|FG000|COMPLETED|Period 1 (5-9 Days)||35
3019900|NCT01055132|3737968|FG001|COMPLETED|Period 1 (5-9 Days)||33
3019901|NCT01055132|3737967|FG000|NOT COMPLETED|Period 1 (5-9 Days)||1
3019902|NCT01055132|3737968|FG001|NOT COMPLETED|Period 1 (5-9 Days)||0
3019903|NCT01055132|3737967|FG000|STARTED|Period 2 (5-9 Days)||35
3019904|NCT01055132|3737968|FG001|STARTED|Period 2 (5-9 Days)||33
3019905|NCT01055132|3737967|FG000|COMPLETED|Period 2 (5-9 Days)||35
3019906|NCT01055132|3737968|FG001|COMPLETED|Period 2 (5-9 Days)||32
3019907|NCT01055132|3737967|FG000|NOT COMPLETED|Period 2 (5-9 Days)||0
3019908|NCT01055132|3737968|FG001|NOT COMPLETED|Period 2 (5-9 Days)||1
3019909|NCT01055171|3737980|FG000|STARTED|Overall Study|Randomized to receive medication.|29
3019910|NCT01055171|3737981|FG001|STARTED|Overall Study|Randomized to receive placebo.|28
3019911|NCT01055171|3737980|FG000|Retrieval Completion|Overall Study|Received the medication and completed the retrieval session.|25
3019912|NCT01055171|3737981|FG001|Retrieval Completion|Overall Study|Received the sugar pill and completed the retrieval session.|24
3019913|NCT01055171|3737980|FG000|Test Procedure Completion|Overall Study|Received the medication and completed the first test session.|21
3019914|NCT01055171|3737981|FG001|Test Procedure Completion|Overall Study|Received the placebo and completed the first test session.|23
3019915|NCT01055171|3737980|FG000|COMPLETED|Overall Study|Received the medication and completed all visits including the one-week follow-up.|18
3019916|NCT01055171|3737981|FG001|COMPLETED|Overall Study|Received the sugar pill and completed all visits including the one-week follow-up.|21
3019917|NCT01055171|3737980|FG000|NOT COMPLETED|Overall Study||11
3019918|NCT01055171|3737981|FG001|NOT COMPLETED|Overall Study||7
3019919|NCT01055184|3737987|FG000|STARTED|Overall Study||34
3019920|NCT01055184|3737987|FG000|COMPLETED|Overall Study||34
3019921|NCT01055184|3737987|FG000|NOT COMPLETED|Overall Study||0
3019922|NCT01055197|3737993|FG000|STARTED|Overall Study||51
3019923|NCT01055197|3737994|FG001|STARTED|Overall Study||46
3019924|NCT01055197|3737993|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|42
3037807|NCT01150045|3757110|FG001|NOT COMPLETED|Overall Study||1
3019925|NCT01055197|3737994|FG001|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|44
3019926|NCT01055197|3737993|FG000|NOT COMPLETED|Overall Study||9
3019927|NCT01055197|3737994|FG001|NOT COMPLETED|Overall Study||2
3019928|NCT01055223|3738000|FG000|STARTED|Overall Study||98483
3019929|NCT01055223|3738000|FG000|COMPLETED|Overall Study||98483
3019930|NCT01055223|3738000|FG000|NOT COMPLETED|Overall Study||0
3019931|NCT01055262|3738013|FG000|STARTED|Overall Study||169
3019932|NCT01055262|3738013|FG000|COMPLETED|Overall Study||160
3019933|NCT01055262|3738013|FG000|NOT COMPLETED|Overall Study||9
3019934|NCT01055314|3738019|FG000|STARTED|Overall Study||100
3019935|NCT01055314|3738020|FG001|STARTED|Overall Study||75
3019936|NCT01055314|3738019|FG000|COMPLETED|Overall Study||55
3019937|NCT01055314|3738020|FG001|COMPLETED|Overall Study||37
3019938|NCT01055314|3738019|FG000|NOT COMPLETED|Overall Study||45
3019939|NCT01055314|3738020|FG001|NOT COMPLETED|Overall Study||38
3019940|NCT01055457|3738037|FG000|STARTED|Overall Study||40
3019941|NCT01055457|3738038|FG001|STARTED|Overall Study||40
3019942|NCT01055457|3738039|FG002|STARTED|Overall Study||38
3019943|NCT01055457|3738040|FG003|STARTED|Overall Study||40
3019944|NCT01055457|3738041|FG004|STARTED|Overall Study||41
3019945|NCT01055457|3738042|FG005|STARTED|Overall Study||18
3019946|NCT01055457|3738043|FG006|STARTED|Overall Study||19
3019947|NCT01055457|3738044|FG007|STARTED|Overall Study||19
3019948|NCT01055457|3738045|FG008|STARTED|Overall Study||20
3019949|NCT01055457|3738046|FG009|STARTED|Overall Study||20
3019950|NCT01055457|3738037|FG000|COMPLETED|Overall Study||39
3019951|NCT01055457|3738038|FG001|COMPLETED|Overall Study||39
3019952|NCT01055457|3738039|FG002|COMPLETED|Overall Study||36
3019953|NCT01055457|3738040|FG003|COMPLETED|Overall Study||37
3019954|NCT01055457|3738041|FG004|COMPLETED|Overall Study||38
3019955|NCT01055457|3738042|FG005|COMPLETED|Overall Study||15
3019956|NCT01055457|3738043|FG006|COMPLETED|Overall Study||18
3019957|NCT01055457|3738044|FG007|COMPLETED|Overall Study||18
3019958|NCT01055457|3738045|FG008|COMPLETED|Overall Study||20
3019959|NCT01055457|3738046|FG009|COMPLETED|Overall Study||19
3019960|NCT01055457|3738037|FG000|NOT COMPLETED|Overall Study||1
3019961|NCT01055457|3738038|FG001|NOT COMPLETED|Overall Study||1
3019962|NCT01055457|3738039|FG002|NOT COMPLETED|Overall Study||2
3019963|NCT01055457|3738040|FG003|NOT COMPLETED|Overall Study||3
3019964|NCT01055457|3738041|FG004|NOT COMPLETED|Overall Study||3
3019965|NCT01055457|3738042|FG005|NOT COMPLETED|Overall Study||3
3019966|NCT01055457|3738043|FG006|NOT COMPLETED|Overall Study||1
3019967|NCT01055457|3738044|FG007|NOT COMPLETED|Overall Study||1
3019968|NCT01055457|3738045|FG008|NOT COMPLETED|Overall Study||0
3019969|NCT01055457|3738046|FG009|NOT COMPLETED|Overall Study||1
3019970|NCT01055496|3738070|FG000|STARTED|Overall Study||48
3019971|NCT01055496|3738071|FG001|STARTED|Overall Study||55
3019972|NCT01055496|3738070|FG000|COMPLETED|Overall Study||33
3019973|NCT01055496|3738071|FG001|COMPLETED|Overall Study||25
3019974|NCT01055496|3738070|FG000|NOT COMPLETED|Overall Study||15
3019975|NCT01055496|3738071|FG001|NOT COMPLETED|Overall Study||30
3019976|NCT01055613|3738100|FG000|STARTED|Overall Study||200
3019977|NCT01055613|3738101|FG001|STARTED|Overall Study||100
3019978|NCT01055613|3738100|FG000|COMPLETED|Overall Study||191
3019979|NCT01055613|3738101|FG001|COMPLETED|Overall Study||96
3019980|NCT01055613|3738100|FG000|NOT COMPLETED|Overall Study||9
3019981|NCT01055613|3738101|FG001|NOT COMPLETED|Overall Study||4
3019982|NCT01055639|3738109|FG000|STARTED|Overall Study||66
3019983|NCT01055639|3738110|FG001|STARTED|Overall Study||60
3019984|NCT01055639|3738109|FG000|COMPLETED|Overall Study||45
3019985|NCT01055639|3738110|FG001|COMPLETED|Overall Study||31
3019986|NCT01055639|3738109|FG000|NOT COMPLETED|Overall Study||21
3019987|NCT01055639|3738110|FG001|NOT COMPLETED|Overall Study||29
3019988|NCT01055704|3738120|FG000|STARTED|Overall Study||16
3019989|NCT01055704|3738121|FG001|STARTED|Overall Study||8
3019990|NCT01055704|3738122|FG002|STARTED|Overall Study||16
3019991|NCT01055704|3738123|FG003|STARTED|Overall Study||8
3019992|NCT01055704|3738120|FG000|COMPLETED|Overall Study||16
3019993|NCT01055704|3738121|FG001|COMPLETED|Overall Study||8
3019994|NCT01055704|3738122|FG002|COMPLETED|Overall Study||16
3019995|NCT01055704|3738123|FG003|COMPLETED|Overall Study||8
3019996|NCT01055704|3738120|FG000|NOT COMPLETED|Overall Study||0
3019997|NCT01055704|3738121|FG001|NOT COMPLETED|Overall Study||0
3019998|NCT01055704|3738122|FG002|NOT COMPLETED|Overall Study||0
3019999|NCT01055704|3738123|FG003|NOT COMPLETED|Overall Study||0
3308422|NCT03020615|4041753|FG002|NOT COMPLETED|Overall Study||7
3308423|NCT03020641|4041766|FG000|STARTED|Overall Study||50
3308424|NCT03020641|4041767|FG001|STARTED|Overall Study||50
3308425|NCT03020641|4041766|FG000|COMPLETED|Overall Study||48
3308426|NCT03020641|4041767|FG001|COMPLETED|Overall Study||47
3020000|NCT01055769|3738133|FG000|STARTED|First Intervention||10
3020001|NCT01055769|3738134|FG001|STARTED|First Intervention||10
3020002|NCT01055769|3738133|FG000|COMPLETED|First Intervention||10
3020003|NCT01055769|3738134|FG001|COMPLETED|First Intervention||10
3020004|NCT01055769|3738133|FG000|NOT COMPLETED|First Intervention||0
3020005|NCT01055769|3738134|FG001|NOT COMPLETED|First Intervention||0
3020006|NCT01055769|3738133|FG000|STARTED|Washout Period of Atleast 4 Days||10
3020007|NCT01055769|3738134|FG001|STARTED|Washout Period of Atleast 4 Days||10
3308427|NCT03020641|4041766|FG000|NOT COMPLETED|Overall Study||2
3020008|NCT01055769|3738133|FG000|COMPLETED|Washout Period of Atleast 4 Days||10
3020009|NCT01055769|3738134|FG001|COMPLETED|Washout Period of Atleast 4 Days||10
3020010|NCT01055769|3738133|FG000|NOT COMPLETED|Washout Period of Atleast 4 Days||0
3020011|NCT01055769|3738134|FG001|NOT COMPLETED|Washout Period of Atleast 4 Days||0
3020012|NCT01055769|3738133|FG000|STARTED|Second Intervention||10
3020013|NCT01055769|3738134|FG001|STARTED|Second Intervention||10
3020014|NCT01055769|3738133|FG000|COMPLETED|Second Intervention||10
3020015|NCT01055769|3738134|FG001|COMPLETED|Second Intervention||10
3020016|NCT01055769|3738133|FG000|NOT COMPLETED|Second Intervention||0
3020017|NCT01055769|3738134|FG001|NOT COMPLETED|Second Intervention||0
3020018|NCT01055782|3738143|FG000|STARTED|Overall Study||555
3020019|NCT01055782|3738144|FG001|STARTED|Overall Study||449
3020020|NCT01055782|3738143|FG000|COMPLETED|Overall Study||555
3020021|NCT01055782|3738144|FG001|COMPLETED|Overall Study||449
3020022|NCT01055782|3738143|FG000|NOT COMPLETED|Overall Study||0
3020023|NCT01055782|3738144|FG001|NOT COMPLETED|Overall Study||0
3020024|NCT01055834|3738154|FG000|STARTED|Treatment Period I||21
3020025|NCT01055834|3738155|FG001|STARTED|Treatment Period I||21
3020026|NCT01055834|3738154|FG000|COMPLETED|Treatment Period I||20
3020027|NCT01055834|3738155|FG001|COMPLETED|Treatment Period I||21
3020028|NCT01055834|3738154|FG000|NOT COMPLETED|Treatment Period I||1
3020029|NCT01055834|3738155|FG001|NOT COMPLETED|Treatment Period I||0
3020030|NCT01055834|3738154|FG000|STARTED|Treatment Period II||20
3020031|NCT01055834|3738155|FG001|STARTED|Treatment Period II||21
3020032|NCT01055834|3738154|FG000|COMPLETED|Treatment Period II||20
3020033|NCT01055834|3738155|FG001|COMPLETED|Treatment Period II||21
3020034|NCT01055834|3738154|FG000|NOT COMPLETED|Treatment Period II||0
3020035|NCT01055834|3738155|FG001|NOT COMPLETED|Treatment Period II||0
3020036|NCT01055834|3738154|FG000|STARTED|Treatment Period III|Participants from Group A did not continue into Period III.|0
3020037|NCT01055834|3738155|FG001|STARTED|Treatment Period III|14 of 21 participants in Group B who were treated in Period II participated in Period III.|14
3020038|NCT01055834|3738154|FG000|COMPLETED|Treatment Period III||0
3020039|NCT01055834|3738155|FG001|COMPLETED|Treatment Period III||14
3020040|NCT01055834|3738154|FG000|NOT COMPLETED|Treatment Period III||0
3020041|NCT01055834|3738155|FG001|NOT COMPLETED|Treatment Period III||0
3020042|NCT01055886|3738166|FG000|STARTED|Overall Study||33
3020043|NCT01055886|3738167|FG001|STARTED|Overall Study||32
3020044|NCT01055886|3738166|FG000|Reached Pre-quit Period|Overall Study|2 withdrawals, 1 lost to contact|30
3020045|NCT01055886|3738167|FG001|Reached Pre-quit Period|Overall Study|1 lost to contact|31
3020046|NCT01055886|3738166|FG000|COMPLETED|Overall Study|This includes those who completed all sessions and those with w/d post quit (missing = smoking).|28
3020047|NCT01055886|3738167|FG001|COMPLETED|Overall Study|This includes those who completed all sessions and those with w/d post quit (missing = smoking).|21
3020048|NCT01055886|3738166|FG000|NOT COMPLETED|Overall Study||5
3020049|NCT01055886|3738167|FG001|NOT COMPLETED|Overall Study||11
3020050|NCT01056016|3738175|FG000|STARTED|Overall Study|22 pediatricians were at 4 practices; practices were unit of randomization|22
3020051|NCT01056016|3738176|FG001|STARTED|Overall Study|27 pediatricians were at 4 practices; practices were unit of randomization|27
3020052|NCT01056016|3738175|FG000|COMPLETED|Overall Study||20
3020053|NCT01056016|3738176|FG001|COMPLETED|Overall Study||26
3020054|NCT01056016|3738175|FG000|NOT COMPLETED|Overall Study||2
3020055|NCT01056016|3738176|FG001|NOT COMPLETED|Overall Study||1
3020056|NCT01056107|3738186|FG000|STARTED|Overall Study||11
3020057|NCT01056107|3738187|FG001|STARTED|Overall Study||11
3020058|NCT01056107|3738188|FG002|STARTED|Overall Study||12
3020059|NCT01056107|3738189|FG003|STARTED|Overall Study||12
3020060|NCT01056107|3738186|FG000|COMPLETED|Overall Study||11
3020061|NCT01056107|3738187|FG001|COMPLETED|Overall Study||10
3020062|NCT01056107|3738188|FG002|COMPLETED|Overall Study||9
3020063|NCT01056107|3738189|FG003|COMPLETED|Overall Study||12
3020064|NCT01056107|3738186|FG000|NOT COMPLETED|Overall Study||0
3020065|NCT01056107|3738187|FG001|NOT COMPLETED|Overall Study||1
3020066|NCT01056107|3738188|FG002|NOT COMPLETED|Overall Study||3
3020067|NCT01056107|3738189|FG003|NOT COMPLETED|Overall Study||0
3020068|NCT01056198|3738201|FG000|STARTED|Overall Study||24
3020069|NCT01056198|3738202|FG001|STARTED|Overall Study||24
3020070|NCT01056198|3738201|FG000|COMPLETED|Overall Study||24
3020071|NCT01056198|3738202|FG001|COMPLETED|Overall Study||24
3020072|NCT01056198|3738201|FG000|NOT COMPLETED|Overall Study||0
3020073|NCT01056198|3738202|FG001|NOT COMPLETED|Overall Study||0
3020074|NCT01056263|3738210|FG000|STARTED|Overall Study||52
3020075|NCT01056263|3738210|FG000|COMPLETED|Overall Study||0
3020076|NCT01056263|3738210|FG000|NOT COMPLETED|Overall Study||52
3020077|NCT01056276|3738216|FG000|STARTED|Treatment Period-Cycles 1-8||18
3020078|NCT01056276|3738217|FG001|STARTED|Treatment Period-Cycles 1-8||41
3020079|NCT01056276|3738216|FG000|COMPLETED|Treatment Period-Cycles 1-8||5
3020080|NCT01056276|3738217|FG001|COMPLETED|Treatment Period-Cycles 1-8||33
3020081|NCT01056276|3738216|FG000|NOT COMPLETED|Treatment Period-Cycles 1-8||13
3020082|NCT01056276|3738217|FG001|NOT COMPLETED|Treatment Period-Cycles 1-8||8
3020083|NCT01056276|3738216|FG000|STARTED|Maintenance Therapy|Original regimen did not include maintenance therapy.|0
3020084|NCT01056276|3738217|FG001|STARTED|Maintenance Therapy|5 patients completed 8 cycles but did not have maintenance therapy.|28
3020085|NCT01056276|3738216|FG000|COMPLETED|Maintenance Therapy||0
3020086|NCT01056276|3738217|FG001|COMPLETED|Maintenance Therapy|14 patients are continuing maintenance therapy.|0
3020087|NCT01056276|3738216|FG000|NOT COMPLETED|Maintenance Therapy||0
3020088|NCT01056276|3738217|FG001|NOT COMPLETED|Maintenance Therapy||28
3020089|NCT01056289|3738228|FG000|STARTED|Open-label Phase||480
3020090|NCT01056289|3738229|FG001|STARTED|Open-label Phase||0
3020091|NCT01056289|3738230|FG002|STARTED|Open-label Phase||0
3020092|NCT01056289|3738231|FG003|STARTED|Open-label Phase||0
3020093|NCT01056289|3738228|FG000|COMPLETED|Open-label Phase|Participants transitioned to Double-blind phase|361
3020094|NCT01056289|3738229|FG001|COMPLETED|Open-label Phase||0
3020095|NCT01056289|3738230|FG002|COMPLETED|Open-label Phase||0
3020096|NCT01056289|3738231|FG003|COMPLETED|Open-label Phase||0
3020097|NCT01056289|3738228|FG000|NOT COMPLETED|Open-label Phase||119
3020098|NCT01056289|3738229|FG001|NOT COMPLETED|Open-label Phase||0
3020099|NCT01056289|3738230|FG002|NOT COMPLETED|Open-label Phase||0
3020100|NCT01056289|3738231|FG003|NOT COMPLETED|Open-label Phase||0
3020101|NCT01056289|3738228|FG000|STARTED|Double-blind Phase||0
3020102|NCT01056289|3738229|FG001|STARTED|Double-blind Phase||73
3020103|NCT01056289|3738230|FG002|STARTED|Double-blind Phase||140
3020104|NCT01056289|3738231|FG003|STARTED|Double-blind Phase||148
3020105|NCT01056289|3738228|FG000|COMPLETED|Double-blind Phase||0
3020106|NCT01056289|3738229|FG001|COMPLETED|Double-blind Phase||69
3020107|NCT01056289|3738230|FG002|COMPLETED|Double-blind Phase||127
3020108|NCT01056289|3738231|FG003|COMPLETED|Double-blind Phase||138
3020109|NCT01056289|3738228|FG000|NOT COMPLETED|Double-blind Phase||0
3020110|NCT01056289|3738229|FG001|NOT COMPLETED|Double-blind Phase||4
3020111|NCT01056289|3738230|FG002|NOT COMPLETED|Double-blind Phase||13
3020112|NCT01056289|3738231|FG003|NOT COMPLETED|Double-blind Phase||10
3037808|NCT01150045|3757111|FG002|NOT COMPLETED|Overall Study||0
3037809|NCT01150045|3757112|FG003|NOT COMPLETED|Overall Study||1
3037810|NCT01150097|3757123|FG000|STARTED|Months 24 to 36 Post-transplantation||106
3037811|NCT01150097|3757124|FG001|STARTED|Months 24 to 36 Post-transplantation||51
3037812|NCT01150097|3757125|FG002|STARTED|Months 24 to 36 Post-transplantation||125
3037813|NCT01150097|3757123|FG000|COMPLETED|Months 24 to 36 Post-transplantation||96
3037814|NCT01150097|3757124|FG001|COMPLETED|Months 24 to 36 Post-transplantation||49
3037815|NCT01150097|3757125|FG002|COMPLETED|Months 24 to 36 Post-transplantation||117
3037816|NCT01150097|3757123|FG000|NOT COMPLETED|Months 24 to 36 Post-transplantation||10
3037817|NCT01150097|3757124|FG001|NOT COMPLETED|Months 24 to 36 Post-transplantation||2
3037818|NCT01150097|3757125|FG002|NOT COMPLETED|Months 24 to 36 Post-transplantation||8
3165650|NCT01901146|3893217|FG004|STARTED|Neoadjuvant Phase||0
3165651|NCT01901146|3893213|FG000|COMPLETED|Neoadjuvant Phase|Indicates participants who completed surgery|358
3037819|NCT01150097|3757123|FG000|STARTED|Months 24 to 48 Post-transplantation||106
3037820|NCT01150097|3757124|FG001|STARTED|Months 24 to 48 Post-transplantation||51
3037821|NCT01150097|3757125|FG002|STARTED|Months 24 to 48 Post-transplantation||0
3037822|NCT01150097|3757123|FG000|COMPLETED|Months 24 to 48 Post-transplantation||95
3037823|NCT01150097|3757124|FG001|COMPLETED|Months 24 to 48 Post-transplantation||47
3037824|NCT01150097|3757125|FG002|COMPLETED|Months 24 to 48 Post-transplantation||0
3037825|NCT01150097|3757123|FG000|NOT COMPLETED|Months 24 to 48 Post-transplantation||11
3037826|NCT01150097|3757124|FG001|NOT COMPLETED|Months 24 to 48 Post-transplantation||4
3037827|NCT01150097|3757125|FG002|NOT COMPLETED|Months 24 to 48 Post-transplantation||0
3037828|NCT01150123|3757153|FG000|STARTED|Overall Study||40
3037829|NCT01150123|3757154|FG001|STARTED|Overall Study||40
3037830|NCT01150123|3757155|FG002|STARTED|Overall Study||39
3037831|NCT01150123|3757156|FG003|STARTED|Overall Study||40
3037832|NCT01150123|3757157|FG004|STARTED|Overall Study||40
3037833|NCT01150123|3757158|FG005|STARTED|Overall Study||40
3037834|NCT01150123|3757159|FG006|STARTED|Overall Study||39
3037835|NCT01150123|3757160|FG007|STARTED|Overall Study||40
3037836|NCT01150123|3757161|FG008|STARTED|Overall Study||20
3037837|NCT01150123|3757162|FG009|STARTED|Overall Study||40
3037838|NCT01150123|3757163|FG010|STARTED|Overall Study||40
3037839|NCT01150123|3757164|FG011|STARTED|Overall Study||40
3037840|NCT01150123|3757165|FG012|STARTED|Overall Study||40
3037841|NCT01150123|3757166|FG013|STARTED|Overall Study||40
3037842|NCT01150123|3757167|FG014|STARTED|Overall Study||40
3037843|NCT01150123|3757168|FG015|STARTED|Overall Study||40
3037844|NCT01150123|3757169|FG016|STARTED|Overall Study||40
3037845|NCT01150123|3757170|FG017|STARTED|Overall Study||20
3037846|NCT01150123|3757153|FG000|COMPLETED|Overall Study||37
3037847|NCT01150123|3757154|FG001|COMPLETED|Overall Study||38
3037848|NCT01150123|3757155|FG002|COMPLETED|Overall Study||35
3037849|NCT01150123|3757156|FG003|COMPLETED|Overall Study||37
3037850|NCT01150123|3757157|FG004|COMPLETED|Overall Study||37
3037851|NCT01150123|3757158|FG005|COMPLETED|Overall Study||34
3037852|NCT01150123|3757159|FG006|COMPLETED|Overall Study||39
3037853|NCT01150123|3757160|FG007|COMPLETED|Overall Study||37
3037854|NCT01150123|3757161|FG008|COMPLETED|Overall Study||15
3037855|NCT01150123|3757162|FG009|COMPLETED|Overall Study||39
3037856|NCT01150123|3757163|FG010|COMPLETED|Overall Study||38
3037857|NCT01150123|3757164|FG011|COMPLETED|Overall Study||39
3037858|NCT01150123|3757165|FG012|COMPLETED|Overall Study||37
3037859|NCT01150123|3757166|FG013|COMPLETED|Overall Study||40
3037860|NCT01150123|3757167|FG014|COMPLETED|Overall Study||40
3037861|NCT01150123|3757168|FG015|COMPLETED|Overall Study||39
3037862|NCT01150123|3757169|FG016|COMPLETED|Overall Study||40
3037863|NCT01150123|3757170|FG017|COMPLETED|Overall Study||19
3037864|NCT01150123|3757153|FG000|NOT COMPLETED|Overall Study||3
3037865|NCT01150123|3757154|FG001|NOT COMPLETED|Overall Study||2
3037866|NCT01150123|3757155|FG002|NOT COMPLETED|Overall Study||4
3037867|NCT01150123|3757156|FG003|NOT COMPLETED|Overall Study||3
3037868|NCT01150123|3757157|FG004|NOT COMPLETED|Overall Study||3
3037869|NCT01150123|3757158|FG005|NOT COMPLETED|Overall Study||6
3037870|NCT01150123|3757159|FG006|NOT COMPLETED|Overall Study||0
3037871|NCT01150123|3757160|FG007|NOT COMPLETED|Overall Study||3
3020113|NCT01056302|3738241|FG000|STARTED|Overall Study||3
3020114|NCT01056302|3738241|FG000|COMPLETED|Overall Study|The study was completed with 3 datasets from patients who had maxillofacial trauma and were treated|3
3020115|NCT01056302|3738241|FG000|NOT COMPLETED|Overall Study||0
3020116|NCT01056328|3738248|FG000|STARTED|Overall Study||164
3020117|NCT01056328|3738249|FG001|STARTED|Overall Study||160
3020118|NCT01056328|3738248|FG000|COMPLETED|Overall Study||147
3020119|NCT01056328|3738249|FG001|COMPLETED|Overall Study||144
3020120|NCT01056328|3738248|FG000|NOT COMPLETED|Overall Study||17
3020121|NCT01056328|3738249|FG001|NOT COMPLETED|Overall Study||16
3020122|NCT01056341|3738263|FG000|STARTED|Overall Study||55
3020123|NCT01056341|3738264|FG001|STARTED|Overall Study||99
3020124|NCT01056341|3738265|FG002|STARTED|Overall Study||103
3020125|NCT01056341|3738266|FG003|STARTED|Overall Study||101
3020126|NCT01056341|3738267|FG004|STARTED|Overall Study||102
3020127|NCT01056341|3738263|FG000|Interim Analysis|Overall Study||25
3020128|NCT01056341|3738264|FG001|Interim Analysis|Overall Study||41
3020129|NCT01056341|3738265|FG002|Interim Analysis|Overall Study||41
3020130|NCT01056341|3738266|FG003|Interim Analysis|Overall Study||40
3020131|NCT01056341|3738267|FG004|Interim Analysis|Overall Study||43
3020132|NCT01056341|3738263|FG000|COMPLETED|Overall Study||19
3020133|NCT01056341|3738264|FG001|COMPLETED|Overall Study||63
3020134|NCT01056341|3738265|FG002|COMPLETED|Overall Study||88
3020135|NCT01056341|3738266|FG003|COMPLETED|Overall Study||65
3020136|NCT01056341|3738267|FG004|COMPLETED|Overall Study||88
3020137|NCT01056341|3738263|FG000|NOT COMPLETED|Overall Study||36
3020138|NCT01056341|3738264|FG001|NOT COMPLETED|Overall Study||36
3020139|NCT01056341|3738265|FG002|NOT COMPLETED|Overall Study||15
3020140|NCT01056341|3738266|FG003|NOT COMPLETED|Overall Study||36
3020141|NCT01056341|3738267|FG004|NOT COMPLETED|Overall Study||14
3020142|NCT01056380|3738287|FG000|STARTED|Overall Study||37
3020143|NCT01056380|3738288|FG001|STARTED|Overall Study||42
3020144|NCT01056380|3738287|FG000|COMPLETED|Overall Study||35
3020145|NCT01056380|3738288|FG001|COMPLETED|Overall Study||39
3020146|NCT01056380|3738287|FG000|NOT COMPLETED|Overall Study||2
3020147|NCT01056380|3738288|FG001|NOT COMPLETED|Overall Study||3
3020148|NCT01056484|3738298|FG000|STARTED|Randomized Controlled Trial||64
3020149|NCT01056484|3738299|FG001|STARTED|Randomized Controlled Trial||59
3020150|NCT01056484|3738298|FG000|COMPLETED|Randomized Controlled Trial||57
3020151|NCT01056484|3738299|FG001|COMPLETED|Randomized Controlled Trial||58
3020152|NCT01056484|3738298|FG000|NOT COMPLETED|Randomized Controlled Trial||7
3020153|NCT01056484|3738299|FG001|NOT COMPLETED|Randomized Controlled Trial||1
3020154|NCT01056484|3738298|FG000|STARTED|Follow up - Non-randomized|Out of the enrolled experimental subjects (N=64), 57 completed Period 1 and entered into Period 2.|57
3020155|NCT01056484|3738299|FG001|STARTED|Follow up - Non-randomized|Out of the enrolled control subjects (N=59), 58 completed Period 1 and entered into Period 2.|58
3020156|NCT01056484|3738298|FG000|COMPLETED|Follow up - Non-randomized||57
3020157|NCT01056484|3738299|FG001|COMPLETED|Follow up - Non-randomized||56
3020158|NCT01056484|3738298|FG000|NOT COMPLETED|Follow up - Non-randomized||0
3020159|NCT01056484|3738299|FG001|NOT COMPLETED|Follow up - Non-randomized||2
3020160|NCT01056510|3738308|FG000|STARTED|Overall Study||178
3020161|NCT01056510|3738309|FG001|STARTED|Overall Study||179
3020162|NCT01056510|3738308|FG000|COMPLETED|Overall Study||124
3020163|NCT01056510|3738309|FG001|COMPLETED|Overall Study||115
3020164|NCT01056510|3738308|FG000|NOT COMPLETED|Overall Study||54
3020165|NCT01056510|3738309|FG001|NOT COMPLETED|Overall Study||64
3020166|NCT01056523|3738315|FG000|STARTED|Overall Study||4
3020167|NCT01056523|3738316|FG001|STARTED|Overall Study||3
3020168|NCT01056523|3738317|FG002|STARTED|Overall Study||5
3020169|NCT01056523|3738318|FG003|STARTED|Overall Study||6
3020170|NCT01056523|3738319|FG004|STARTED|Overall Study||3
3020171|NCT01056523|3738320|FG005|STARTED|Overall Study||3
3020172|NCT01056523|3738321|FG006|STARTED|Overall Study||5
3020173|NCT01056523|3738315|FG000|COMPLETED|Overall Study||3
3020174|NCT01056523|3738316|FG001|COMPLETED|Overall Study||3
3020175|NCT01056523|3738317|FG002|COMPLETED|Overall Study||3
3020176|NCT01056523|3738318|FG003|COMPLETED|Overall Study||3
3020177|NCT01056523|3738319|FG004|COMPLETED|Overall Study||3
3020178|NCT01056523|3738320|FG005|COMPLETED|Overall Study||3
3020179|NCT01056523|3738321|FG006|COMPLETED|Overall Study||4
3020180|NCT01056523|3738315|FG000|NOT COMPLETED|Overall Study||1
3020181|NCT01056523|3738316|FG001|NOT COMPLETED|Overall Study||0
3020182|NCT01056523|3738317|FG002|NOT COMPLETED|Overall Study||2
3020183|NCT01056523|3738318|FG003|NOT COMPLETED|Overall Study||3
3020184|NCT01056523|3738319|FG004|NOT COMPLETED|Overall Study||0
3020185|NCT01056523|3738320|FG005|NOT COMPLETED|Overall Study||0
3020186|NCT01056523|3738321|FG006|NOT COMPLETED|Overall Study||1
3020187|NCT01056536|3738329|FG000|STARTED|Overall Study||596
3020188|NCT01056536|3738330|FG001|STARTED|Overall Study||356
3020189|NCT01056536|3738331|FG002|STARTED|Overall Study||729
3020190|NCT01056536|3738329|FG000|COMPLETED|Overall Study||394
3020191|NCT01056536|3738330|FG001|COMPLETED|Overall Study||240
3020192|NCT01056536|3738331|FG002|COMPLETED|Overall Study||481
3020193|NCT01056536|3738329|FG000|NOT COMPLETED|Overall Study||202
3020194|NCT01056536|3738330|FG001|NOT COMPLETED|Overall Study||116
3020195|NCT01056536|3738331|FG002|NOT COMPLETED|Overall Study||248
3020196|NCT01056601|3738339|FG000|STARTED|Overall Study||7
3020197|NCT01056601|3738339|FG000|COMPLETED|Overall Study||7
3020198|NCT01056601|3738339|FG000|NOT COMPLETED|Overall Study||0
3020199|NCT01056640|3738345|FG000|STARTED|Overall Study||102
3020200|NCT01056640|3738346|FG001|STARTED|Overall Study||103
3020201|NCT01056640|3738345|FG000|COMPLETED|Overall Study||76
3020202|NCT01056640|3738346|FG001|COMPLETED|Overall Study||91
3020203|NCT01056640|3738345|FG000|NOT COMPLETED|Overall Study||26
3020204|NCT01056640|3738346|FG001|NOT COMPLETED|Overall Study||12
3020205|NCT01056653|3738355|FG000|STARTED|Overall Study||46
3020206|NCT01056653|3738356|FG001|STARTED|Overall Study||23
3020207|NCT01056653|3738357|FG002|STARTED|Overall Study||44
3020208|NCT01056653|3738355|FG000|COMPLETED|Overall Study||46
3020209|NCT01056653|3738356|FG001|COMPLETED|Overall Study||23
3020210|NCT01056653|3738357|FG002|COMPLETED|Overall Study|2 were lost to follow-up because one mother left the country and one father was too busy.|42
3020211|NCT01056653|3738355|FG000|NOT COMPLETED|Overall Study||0
3020212|NCT01056653|3738356|FG001|NOT COMPLETED|Overall Study||0
3020213|NCT01056653|3738357|FG002|NOT COMPLETED|Overall Study||2
3020214|NCT01056718|3738366|FG000|STARTED|Overall Study||53
3020215|NCT01056718|3738366|FG000|COMPLETED|Overall Study||50
3020216|NCT01056718|3738366|FG000|NOT COMPLETED|Overall Study||3
3020217|NCT01056822|3738373|FG000|STARTED|Overall Study||47
3020218|NCT01056822|3738374|FG001|STARTED|Overall Study||42
3020219|NCT01056822|3738373|FG000|Intention-to-treat (ITT) Population: YES|Overall Study||43
3020220|NCT01056822|3738374|FG001|Intention-to-treat (ITT) Population: YES|Overall Study||38
3020221|NCT01056822|3738373|FG000|Intention-to-treat (ITT) Population: NO|Overall Study||4
3020222|NCT01056822|3738374|FG001|Intention-to-treat (ITT) Population: NO|Overall Study||4
3020223|NCT01056822|3738373|FG000|Per-protocol (PP) Population: YES|Overall Study||29
3020224|NCT01056822|3738374|FG001|Per-protocol (PP) Population: YES|Overall Study||25
3020225|NCT01056822|3738373|FG000|Per-protocol (PP) Population: NO|Overall Study||18
3165652|NCT01901146|3893214|FG001|COMPLETED|Neoadjuvant Phase|Indicates participants who completed surgery|347
3165653|NCT01901146|3893215|FG002|COMPLETED|Neoadjuvant Phase||0
3165654|NCT01901146|3893216|FG003|COMPLETED|Neoadjuvant Phase||0
3165655|NCT01901146|3893217|FG004|COMPLETED|Neoadjuvant Phase||0
3165656|NCT01901146|3893213|FG000|NOT COMPLETED|Neoadjuvant Phase||6
3020226|NCT01056822|3738374|FG001|Per-protocol (PP) Population: NO|Overall Study||17
3020227|NCT01056822|3738373|FG000|Safety (SAF) Population: YES|Overall Study||46
3020228|NCT01056822|3738374|FG001|Safety (SAF) Population: YES|Overall Study||40
3020229|NCT01056822|3738373|FG000|Safety (SAF) Population: NO|Overall Study||1
3020230|NCT01056822|3738374|FG001|Safety (SAF) Population: NO|Overall Study||2
3020231|NCT01056822|3738373|FG000|COMPLETED|Overall Study||39
3020232|NCT01056822|3738374|FG001|COMPLETED|Overall Study||35
3020233|NCT01056822|3738373|FG000|NOT COMPLETED|Overall Study||8
3020234|NCT01056822|3738374|FG001|NOT COMPLETED|Overall Study||7
3020235|NCT01056913|3738381|FG000|STARTED|Overall Study||62
3020236|NCT01056913|3738381|FG000|COMPLETED|Overall Study||62
3020237|NCT01056913|3738381|FG000|NOT COMPLETED|Overall Study||0
3020238|NCT01057017|3738385|FG000|STARTED|Overall Study||5
3020239|NCT01057017|3738385|FG000|COMPLETED|Overall Study||5
3020240|NCT01057017|3738385|FG000|NOT COMPLETED|Overall Study||0
3020241|NCT01057225|3738389|FG000|STARTED|Overall Study||3
3020242|NCT01057225|3738390|FG001|STARTED|Overall Study||3
3020243|NCT01057225|3738391|FG002|STARTED|Overall Study||6
3020244|NCT01057225|3738392|FG003|STARTED|Overall Study||7
3020245|NCT01057225|3738393|FG004|STARTED|Overall Study||22
3020246|NCT01057225|3738394|FG005|STARTED|Overall Study||23
3020247|NCT01057225|3738389|FG000|COMPLETED|Overall Study||3
3020248|NCT01057225|3738390|FG001|COMPLETED|Overall Study||3
3020249|NCT01057225|3738391|FG002|COMPLETED|Overall Study||6
3020250|NCT01057225|3738392|FG003|COMPLETED|Overall Study||7
3020251|NCT01057225|3738393|FG004|COMPLETED|Overall Study||22
3020252|NCT01057225|3738394|FG005|COMPLETED|Overall Study||23
3020253|NCT01057225|3738389|FG000|NOT COMPLETED|Overall Study||0
3020254|NCT01057225|3738390|FG001|NOT COMPLETED|Overall Study||0
3020255|NCT01057225|3738391|FG002|NOT COMPLETED|Overall Study||0
3020256|NCT01057225|3738392|FG003|NOT COMPLETED|Overall Study||0
3020257|NCT01057225|3738393|FG004|NOT COMPLETED|Overall Study||0
3020258|NCT01057225|3738394|FG005|NOT COMPLETED|Overall Study||0
3020259|NCT01057251|3738409|FG000|STARTED|Overall Study||290
3020260|NCT01057251|3738410|FG001|STARTED|Overall Study|The safety population is 142, as one patient was randomized, but never received study drug.|143
3020261|NCT01057251|3738409|FG000|COMPLETED|Overall Study||262
3020262|NCT01057251|3738410|FG001|COMPLETED|Overall Study||114
3020263|NCT01057251|3738409|FG000|NOT COMPLETED|Overall Study||28
3020264|NCT01057251|3738410|FG001|NOT COMPLETED|Overall Study||29
3020265|NCT01057277|3738416|FG000|STARTED|Overall Study||3
3020266|NCT01057277|3738416|FG000|COMPLETED|Overall Study||3
3020267|NCT01057277|3738416|FG000|NOT COMPLETED|Overall Study||0
3020268|NCT01057381|3738424|FG000|STARTED|Overall Study||26
3020269|NCT01057381|3738425|FG001|STARTED|Overall Study||27
3020270|NCT01057381|3738426|FG002|STARTED|Overall Study||30
3020271|NCT01057381|3738427|FG003|STARTED|Overall Study||26
3020272|NCT01057381|3738424|FG000|COMPLETED|Overall Study||26
3020273|NCT01057381|3738425|FG001|COMPLETED|Overall Study||27
3020274|NCT01057381|3738426|FG002|COMPLETED|Overall Study||30
3020275|NCT01057381|3738427|FG003|COMPLETED|Overall Study||26
3020276|NCT01057381|3738424|FG000|NOT COMPLETED|Overall Study||0
3020277|NCT01057381|3738425|FG001|NOT COMPLETED|Overall Study||0
3020278|NCT01057381|3738426|FG002|NOT COMPLETED|Overall Study||0
3020279|NCT01057381|3738427|FG003|NOT COMPLETED|Overall Study||0
3020280|NCT01057394|3738437|FG000|STARTED|Overall Study||0
3020281|NCT01057394|3738438|FG001|STARTED|Overall Study|21 enrolled participants|21
3020282|NCT01057394|3738437|FG000|COMPLETED|Overall Study||0
3020283|NCT01057394|3738438|FG001|COMPLETED|Overall Study|19 treated participants|19
3020284|NCT01057394|3738437|FG000|NOT COMPLETED|Overall Study||0
3020285|NCT01057394|3738438|FG001|NOT COMPLETED|Overall Study||2
3020286|NCT01057433|3738442|FG000|STARTED|Overall Study||24
3020287|NCT01057433|3738442|FG000|COMPLETED|Overall Study||23
3020288|NCT01057433|3738442|FG000|NOT COMPLETED|Overall Study||1
3020289|NCT01057589|3738446|FG000|STARTED|Overall Study||66
3020290|NCT01057589|3738446|FG000|COMPLETED|Overall Study||0
3020291|NCT01057589|3738446|FG000|NOT COMPLETED|Overall Study||66
3020292|NCT01057693|3738450|FG000|STARTED|Single-Blind Phase (Up to Week 6)||665
3020293|NCT01057693|3738451|FG001|STARTED|Single-Blind Phase (Up to Week 6)||0
3020294|NCT01057693|3738452|FG002|STARTED|Single-Blind Phase (Up to Week 6)||0
3020295|NCT01057693|3738450|FG000|COMPLETED|Single-Blind Phase (Up to Week 6)||566
3020296|NCT01057693|3738451|FG001|COMPLETED|Single-Blind Phase (Up to Week 6)||0
3020297|NCT01057693|3738452|FG002|COMPLETED|Single-Blind Phase (Up to Week 6)||0
3020298|NCT01057693|3738450|FG000|NOT COMPLETED|Single-Blind Phase (Up to Week 6)||99
3020299|NCT01057693|3738451|FG001|NOT COMPLETED|Single-Blind Phase (Up to Week 6)||0
3020300|NCT01057693|3738452|FG002|NOT COMPLETED|Single-Blind Phase (Up to Week 6)||0
3020301|NCT01057693|3738450|FG000|STARTED|Between Single-Blind and Double-Blind||566
3020302|NCT01057693|3738451|FG001|STARTED|Between Single-Blind and Double-Blind||0
3020303|NCT01057693|3738452|FG002|STARTED|Between Single-Blind and Double-Blind||0
3020304|NCT01057693|3738450|FG000|COMPLETED|Between Single-Blind and Double-Blind||296
3020305|NCT01057693|3738451|FG001|COMPLETED|Between Single-Blind and Double-Blind||0
3020306|NCT01057693|3738452|FG002|COMPLETED|Between Single-Blind and Double-Blind||0
3020307|NCT01057693|3738450|FG000|NOT COMPLETED|Between Single-Blind and Double-Blind||270
3020308|NCT01057693|3738451|FG001|NOT COMPLETED|Between Single-Blind and Double-Blind||0
3020309|NCT01057693|3738452|FG002|NOT COMPLETED|Between Single-Blind and Double-Blind||0
3020310|NCT01057693|3738450|FG000|STARTED|Double-Blind Phase (Week 7 to Week 19)||0
3020311|NCT01057693|3738451|FG001|STARTED|Double-Blind Phase (Week 7 to Week 19)||147
3020312|NCT01057693|3738452|FG002|STARTED|Double-Blind Phase (Week 7 to Week 19)||149
3020313|NCT01057693|3738450|FG000|Treated|Double-Blind Phase (Week 7 to Week 19)||0
3020314|NCT01057693|3738451|FG001|Treated|Double-Blind Phase (Week 7 to Week 19)||147
3020315|NCT01057693|3738452|FG002|Treated|Double-Blind Phase (Week 7 to Week 19)||147
3020316|NCT01057693|3738450|FG000|COMPLETED|Double-Blind Phase (Week 7 to Week 19)||0
3020317|NCT01057693|3738451|FG001|COMPLETED|Double-Blind Phase (Week 7 to Week 19)||125
3020318|NCT01057693|3738452|FG002|COMPLETED|Double-Blind Phase (Week 7 to Week 19)||113
3020319|NCT01057693|3738450|FG000|NOT COMPLETED|Double-Blind Phase (Week 7 to Week 19)||0
3020320|NCT01057693|3738451|FG001|NOT COMPLETED|Double-Blind Phase (Week 7 to Week 19)||22
3020321|NCT01057693|3738452|FG002|NOT COMPLETED|Double-Blind Phase (Week 7 to Week 19)||36
3020322|NCT01057810|3738462|FG000|STARTED|Overall Study||199
3020323|NCT01057810|3738463|FG001|STARTED|Overall Study||399
3020324|NCT01057810|3738462|FG000|COMPLETED|Overall Study||1
3020325|NCT01057810|3738463|FG001|COMPLETED|Overall Study||1
3020326|NCT01057810|3738462|FG000|NOT COMPLETED|Overall Study||198
3020327|NCT01057810|3738463|FG001|NOT COMPLETED|Overall Study||398
3020328|NCT01057862|3738471|FG000|STARTED|Overall Study||5
3020329|NCT01057862|3738472|FG001|STARTED|Overall Study||4
3020330|NCT01057862|3738471|FG000|COMPLETED|Overall Study||4
3020331|NCT01057862|3738472|FG001|COMPLETED|Overall Study||2
3020332|NCT01057862|3738471|FG000|NOT COMPLETED|Overall Study||1
3020333|NCT01057862|3738472|FG001|NOT COMPLETED|Overall Study||2
3020334|NCT01057888|3738481|FG000|STARTED|Overall Study||2504
3020335|NCT01057888|3738482|FG001|STARTED|Overall Study||2406
3020336|NCT01057888|3738483|FG002|STARTED|Overall Study||2494
3020337|NCT01057888|3738481|FG000|COMPLETED|Overall Study||2504
3020338|NCT01057888|3738482|FG001|COMPLETED|Overall Study||2406
3020339|NCT01057888|3738483|FG002|COMPLETED|Overall Study||2494
3020340|NCT01057888|3738481|FG000|NOT COMPLETED|Overall Study||0
3020341|NCT01057888|3738482|FG001|NOT COMPLETED|Overall Study||0
3020342|NCT01057888|3738483|FG002|NOT COMPLETED|Overall Study||0
3020343|NCT01057901|3738491|FG000|STARTED|Overall Study||376
3020344|NCT01057901|3738492|FG001|STARTED|Overall Study||372
3020345|NCT01057901|3738491|FG000|COMPLETED|Overall Study||116
3020346|NCT01057901|3738492|FG001|COMPLETED|Overall Study||126
3020347|NCT01057901|3738491|FG000|NOT COMPLETED|Overall Study||260
3020348|NCT01057901|3738492|FG001|NOT COMPLETED|Overall Study||246
3020349|NCT01058005|3738501|FG000|STARTED|Overall Study||38
3020350|NCT01058005|3738502|FG001|STARTED|Overall Study||25
3020351|NCT01058005|3738503|FG002|STARTED|Overall Study||21
3020352|NCT01058005|3738501|FG000|Dosed With Study Treatment|Overall Study||36
3020353|NCT01058005|3738502|FG001|Dosed With Study Treatment|Overall Study||22
3020354|NCT01058005|3738503|FG002|Dosed With Study Treatment|Overall Study||17
3020355|NCT01058005|3738501|FG000|COMPLETED|Overall Study||0
3020356|NCT01058005|3738502|FG001|COMPLETED|Overall Study||0
3020357|NCT01058005|3738503|FG002|COMPLETED|Overall Study||1
3020358|NCT01058005|3738501|FG000|NOT COMPLETED|Overall Study||38
3020359|NCT01058005|3738502|FG001|NOT COMPLETED|Overall Study||25
3020360|NCT01058005|3738503|FG002|NOT COMPLETED|Overall Study||20
3020361|NCT01058070|3738511|FG000|STARTED|Overall Study||44
3020362|NCT01058070|3738511|FG000|COMPLETED|Overall Study||33
3020363|NCT01058070|3738511|FG000|NOT COMPLETED|Overall Study||11
3020364|NCT01058096|3738518|FG000|STARTED|Double-blind Treatment Phase||154
3020365|NCT01058096|3738519|FG001|STARTED|Double-blind Treatment Phase||158
3020366|NCT01058096|3738518|FG000|COMPLETED|Double-blind Treatment Phase||106
3020367|NCT01058096|3738519|FG001|COMPLETED|Double-blind Treatment Phase||108
3020368|NCT01058096|3738518|FG000|NOT COMPLETED|Double-blind Treatment Phase||48
3020369|NCT01058096|3738519|FG001|NOT COMPLETED|Double-blind Treatment Phase||50
3020370|NCT01058096|3738518|FG000|STARTED|Safety Follow-up|Not all participants continued to Safety Follow-up.|133
3020371|NCT01058096|3738519|FG001|STARTED|Safety Follow-up||134
3020372|NCT01058096|3738518|FG000|COMPLETED|Safety Follow-up||129
3020373|NCT01058096|3738519|FG001|COMPLETED|Safety Follow-up||130
3020374|NCT01058096|3738518|FG000|NOT COMPLETED|Safety Follow-up||4
3020375|NCT01058096|3738519|FG001|NOT COMPLETED|Safety Follow-up||4
3020376|NCT01058239|3738525|FG000|STARTED|Overall Study||7
3020377|NCT01058239|3738525|FG000|COMPLETED|Overall Study||7
3020378|NCT01058239|3738525|FG000|NOT COMPLETED|Overall Study||0
3020379|NCT01058265|3738531|FG000|STARTED|Overall Study||22
3020380|NCT01058265|3738532|FG001|STARTED|Overall Study||25
3020381|NCT01058265|3738531|FG000|COMPLETED|Overall Study||11
3020382|NCT01058265|3738532|FG001|COMPLETED|Overall Study||13
3020383|NCT01058265|3738531|FG000|NOT COMPLETED|Overall Study||11
3020384|NCT01058265|3738532|FG001|NOT COMPLETED|Overall Study||12
3020385|NCT01058304|3738540|FG000|STARTED|Overall Study||159
3020386|NCT01058304|3738541|FG001|STARTED|Overall Study||161
3020387|NCT01058304|3738540|FG000|COMPLETED|Overall Study||132
3020388|NCT01058304|3738541|FG001|COMPLETED|Overall Study||128
3020389|NCT01058304|3738540|FG000|NOT COMPLETED|Overall Study||27
3020390|NCT01058304|3738541|FG001|NOT COMPLETED|Overall Study||33
3020391|NCT01058356|3738547|FG000|STARTED|Overall Study||214
3020392|NCT01058356|3738547|FG000|COMPLETED|Overall Study||172
3020393|NCT01058356|3738547|FG000|NOT COMPLETED|Overall Study||42
3020394|NCT01058395|3738553|FG000|STARTED|Overall Study||7
3020395|NCT01058395|3738554|FG001|STARTED|Overall Study||8
3020396|NCT01058395|3738553|FG000|COMPLETED|Overall Study|Two died, and one was lost to followup.|4
3020397|NCT01058395|3738554|FG001|COMPLETED|Overall Study|One died after enrollment. The patient died in the first 48 hours.|7
3020398|NCT01058395|3738553|FG000|NOT COMPLETED|Overall Study||3
3020399|NCT01058395|3738554|FG001|NOT COMPLETED|Overall Study||1
3020400|NCT01058421|3738562|FG000|STARTED|1 Month Outcomes||59
3020401|NCT01058421|3738563|FG001|STARTED|1 Month Outcomes||61
3020402|NCT01058421|3738562|FG000|COMPLETED|1 Month Outcomes||20
3020403|NCT01058421|3738563|FG001|COMPLETED|1 Month Outcomes||19
3020404|NCT01058421|3738562|FG000|NOT COMPLETED|1 Month Outcomes||39
3020405|NCT01058421|3738563|FG001|NOT COMPLETED|1 Month Outcomes||42
3020406|NCT01058421|3738562|FG000|STARTED|3 Month Outcomes|59 (Subjects started Period 1) minus 10 (deceased subjects during Period 1) = 49 started Period 2.|49
3020407|NCT01058421|3738563|FG001|STARTED|3 Month Outcomes|61 (Subjects started Period 1) minus 6 (deceased subjects during Period 1) = 55 started Period 2.|55
3020408|NCT01058421|3738562|FG000|COMPLETED|3 Month Outcomes||29
3020409|NCT01058421|3738563|FG001|COMPLETED|3 Month Outcomes||29
3020410|NCT01058421|3738562|FG000|NOT COMPLETED|3 Month Outcomes||20
3020411|NCT01058421|3738563|FG001|NOT COMPLETED|3 Month Outcomes||26
3020412|NCT01058421|3738562|FG000|STARTED|6 Month Outcomes|55 (subjects started Period 1) minus 13 (deceased subjects in Periods 1 & 2) = 46 started Period 3.|46
3020413|NCT01058421|3738563|FG001|STARTED|6 Month Outcomes|61 (subjects started Period 1) minus 11 (deceased subjects in Periods 1 & 2) = 50 started Period 3.|50
3020414|NCT01058421|3738562|FG000|COMPLETED|6 Month Outcomes||27
3020415|NCT01058421|3738563|FG001|COMPLETED|6 Month Outcomes||24
3020416|NCT01058421|3738562|FG000|NOT COMPLETED|6 Month Outcomes||19
3020417|NCT01058421|3738563|FG001|NOT COMPLETED|6 Month Outcomes||26
3020418|NCT01058655|3738573|FG000|STARTED|Overall Study||3
3020419|NCT01058655|3738574|FG001|STARTED|Overall Study||3
3020420|NCT01058655|3738575|FG002|STARTED|Overall Study||8
3020421|NCT01058655|3738576|FG003|STARTED|Overall Study||42
3020422|NCT01058655|3738573|FG000|Evaluable|Overall Study||3
3020423|NCT01058655|3738574|FG001|Evaluable|Overall Study||3
3165657|NCT01901146|3893214|FG001|NOT COMPLETED|Neoadjuvant Phase||14
3165658|NCT01901146|3893215|FG002|NOT COMPLETED|Neoadjuvant Phase||0
3165659|NCT01901146|3893216|FG003|NOT COMPLETED|Neoadjuvant Phase||0
3020424|NCT01058655|3738575|FG002|Evaluable|Overall Study||6
3020425|NCT01058655|3738576|FG003|Evaluable|Overall Study||40
3020426|NCT01058655|3738573|FG000|COMPLETED|Overall Study||0
3020427|NCT01058655|3738574|FG001|COMPLETED|Overall Study||0
3020428|NCT01058655|3738575|FG002|COMPLETED|Overall Study||0
3020429|NCT01058655|3738576|FG003|COMPLETED|Overall Study||0
3020430|NCT01058655|3738573|FG000|NOT COMPLETED|Overall Study||3
3020431|NCT01058655|3738574|FG001|NOT COMPLETED|Overall Study||3
3020432|NCT01058655|3738575|FG002|NOT COMPLETED|Overall Study||8
3020433|NCT01058655|3738576|FG003|NOT COMPLETED|Overall Study||42
3020434|NCT01058668|3738590|FG000|STARTED|Double-blind Treatment Phase||161
3020435|NCT01058668|3738591|FG001|STARTED|Double-blind Treatment Phase||167
3020436|NCT01058668|3738592|FG002|STARTED|Double-blind Treatment Phase||169
3020437|NCT01058668|3738590|FG000|COMPLETED|Double-blind Treatment Phase||122
3020438|NCT01058668|3738591|FG001|COMPLETED|Double-blind Treatment Phase||129
3020439|NCT01058668|3738592|FG002|COMPLETED|Double-blind Treatment Phase||119
3020440|NCT01058668|3738590|FG000|NOT COMPLETED|Double-blind Treatment Phase||39
3020441|NCT01058668|3738591|FG001|NOT COMPLETED|Double-blind Treatment Phase||38
3020442|NCT01058668|3738592|FG002|NOT COMPLETED|Double-blind Treatment Phase||50
3020443|NCT01058668|3738590|FG000|STARTED|Safety Follow-up|Not all participants entered the Safety-Follow-up|144
3020444|NCT01058668|3738591|FG001|STARTED|Safety Follow-up||146
3020445|NCT01058668|3738592|FG002|STARTED|Safety Follow-up||148
3165660|NCT01901146|3893217|FG004|NOT COMPLETED|Neoadjuvant Phase||0
3020446|NCT01058668|3738590|FG000|COMPLETED|Safety Follow-up||139
3020447|NCT01058668|3738591|FG001|COMPLETED|Safety Follow-up||146
3020448|NCT01058668|3738592|FG002|COMPLETED|Safety Follow-up||141
3020449|NCT01058668|3738590|FG000|NOT COMPLETED|Safety Follow-up||5
3020450|NCT01058668|3738591|FG001|NOT COMPLETED|Safety Follow-up||0
3020451|NCT01058668|3738592|FG002|NOT COMPLETED|Safety Follow-up||7
3020452|NCT01058707|3738607|FG000|STARTED|Overall Study||31
3020453|NCT01058707|3738608|FG001|STARTED|Overall Study||30
3020454|NCT01058707|3738609|FG002|STARTED|Overall Study||33
3020455|NCT01058707|3738610|FG003|STARTED|Overall Study||22
3020456|NCT01058707|3738611|FG004|STARTED|Overall Study||39
3020457|NCT01058707|3738612|FG005|STARTED|Overall Study||17
3020458|NCT01058707|3738613|FG006|STARTED|Overall Study||26
3020459|NCT01058707|3738607|FG000|COMPLETED|Overall Study||0
3020460|NCT01058707|3738608|FG001|COMPLETED|Overall Study||0
3020461|NCT01058707|3738609|FG002|COMPLETED|Overall Study||0
3020462|NCT01058707|3738610|FG003|COMPLETED|Overall Study||0
3020463|NCT01058707|3738611|FG004|COMPLETED|Overall Study||0
3020464|NCT01058707|3738612|FG005|COMPLETED|Overall Study||0
3020465|NCT01058707|3738613|FG006|COMPLETED|Overall Study||0
3020466|NCT01058707|3738607|FG000|NOT COMPLETED|Overall Study||31
3020467|NCT01058707|3738608|FG001|NOT COMPLETED|Overall Study||30
3020468|NCT01058707|3738609|FG002|NOT COMPLETED|Overall Study||33
3020469|NCT01058707|3738610|FG003|NOT COMPLETED|Overall Study||22
3020470|NCT01058707|3738611|FG004|NOT COMPLETED|Overall Study||39
3020471|NCT01058707|3738612|FG005|NOT COMPLETED|Overall Study||17
3020472|NCT01058707|3738613|FG006|NOT COMPLETED|Overall Study||26
3020473|NCT01058863|3738651|FG000|STARTED|Overall Study||72
3020474|NCT01058863|3738651|FG000|Safety and ITT Populations|Overall Study|One patient was randomized in error and never received the study drug.|71
3020475|NCT01058863|3738651|FG000|Treated With Albuterol Spiromax® 90 mcg|Overall Study||68
3020476|NCT01058863|3738651|FG000|Treated With Albuterol Spiromax® 180 mcg|Overall Study||68
3020477|NCT01058863|3738651|FG000|Treated With ProAir® HFA 90 mcg|Overall Study||70
3020478|NCT01058863|3738651|FG000|Treated With ProAir® HFA 180 mcg|Overall Study||68
3020479|NCT01058863|3738651|FG000|Treated With Placebo Inhaler|Overall Study||69
3020480|NCT01058863|3738651|FG000|COMPLETED|Overall Study||68
3020481|NCT01058863|3738651|FG000|NOT COMPLETED|Overall Study||4
3020482|NCT01058941|3738666|FG000|STARTED|Overall Study||34
3020483|NCT01058941|3738667|FG001|STARTED|Overall Study||33
3020484|NCT01058941|3738666|FG000|COMPLETED|Overall Study||25
3020485|NCT01058941|3738667|FG001|COMPLETED|Overall Study||22
3020486|NCT01058941|3738666|FG000|NOT COMPLETED|Overall Study||9
3020487|NCT01058941|3738667|FG001|NOT COMPLETED|Overall Study||11
3020488|NCT01058993|3738673|FG000|STARTED|Overall Study||6
3020489|NCT01058993|3738673|FG000|COMPLETED|Overall Study||6
3020490|NCT01058993|3738673|FG000|NOT COMPLETED|Overall Study||0
3020491|NCT01059071|3738677|FG000|STARTED|Overall Study||4
3020492|NCT01059071|3738678|FG001|STARTED|Overall Study||5
3020493|NCT01059071|3738679|FG002|STARTED|Overall Study||3
3020494|NCT01059071|3738680|FG003|STARTED|Overall Study||9
3020495|NCT01059071|3738677|FG000|COMPLETED|Overall Study||2
3020496|NCT01059071|3738678|FG001|COMPLETED|Overall Study||1
3020497|NCT01059071|3738679|FG002|COMPLETED|Overall Study||1
3020498|NCT01059071|3738680|FG003|COMPLETED|Overall Study||3
3020499|NCT01059071|3738677|FG000|NOT COMPLETED|Overall Study||2
3020500|NCT01059071|3738678|FG001|NOT COMPLETED|Overall Study||4
3020501|NCT01059071|3738679|FG002|NOT COMPLETED|Overall Study||2
3020502|NCT01059071|3738680|FG003|NOT COMPLETED|Overall Study||6
3020503|NCT01059175|3738690|FG000|STARTED|Overall Study||43
3020504|NCT01059175|3738691|FG001|STARTED|Overall Study||41
3020505|NCT01059175|3738690|FG000|COMPLETED|Overall Study|17 patients deceased 4 additional patients were prematurely exited|22
3020506|NCT01059175|3738691|FG001|COMPLETED|Overall Study|17 patients deceased 3 patients were prematurely exited|21
3020507|NCT01059175|3738690|FG000|NOT COMPLETED|Overall Study||21
3020508|NCT01059175|3738691|FG001|NOT COMPLETED|Overall Study||20
3020509|NCT01059305|3738697|FG000|STARTED|Overall Study||10
3020510|NCT01059305|3738697|FG000|COMPLETED|Overall Study||10
3020511|NCT01059305|3738697|FG000|NOT COMPLETED|Overall Study||0
3020512|NCT01059318|3738701|FG000|STARTED|Core Study (26 Week)|This is safety set and Pharmacodynamic set|24
3020513|NCT01059318|3738701|FG000|Everolimus 2.5 mg for 4 Weeks|Core Study (26 Week)||24
3020514|NCT01059318|3738701|FG000|Everolimus 5 mg for 4 Weeks|Core Study (26 Week)||24
3020515|NCT01059318|3738701|FG000|Everolimus 10 mg for 18 Weeks|Core Study (26 Week)||24
3020516|NCT01059318|3738701|FG000|Pharmacokinetics (PK) Analysis Set|Core Study (26 Week)|For 8 patients plasma rather than whole blood sample was collected, hence excluded from PK set.|16
3020517|NCT01059318|3738701|FG000|COMPLETED|Core Study (26 Week)||20
3020518|NCT01059318|3738701|FG000|NOT COMPLETED|Core Study (26 Week)||4
3020519|NCT01059318|3738701|FG000|STARTED|Extension (36 Week)||20
3020520|NCT01059318|3738701|FG000|COMPLETED|Extension (36 Week)||17
3020521|NCT01059318|3738701|FG000|NOT COMPLETED|Extension (36 Week)||3
3020522|NCT01059344|3738710|FG000|STARTED|Overall Study||140
3020523|NCT01059344|3738711|FG001|STARTED|Overall Study||141
3020524|NCT01059344|3738710|FG000|COMPLETED|Overall Study||118
3020525|NCT01059344|3738711|FG001|COMPLETED|Overall Study||95
3020526|NCT01059344|3738710|FG000|NOT COMPLETED|Overall Study||22
3020527|NCT01059344|3738711|FG001|NOT COMPLETED|Overall Study||46
3020528|NCT01059357|3738719|FG000|STARTED|Overall Study||58
3020529|NCT01059357|3738719|FG000|COMPLETED|Overall Study||54
3020530|NCT01059357|3738719|FG000|NOT COMPLETED|Overall Study||4
3020531|NCT01059435|3738733|FG000|STARTED|Overall Study||14
3020532|NCT01059435|3738734|FG001|STARTED|Overall Study||6
3020533|NCT01059435|3738735|FG002|STARTED|Overall Study||8
3020534|NCT01059435|3738736|FG003|STARTED|Overall Study||9
3020535|NCT01059435|3738737|FG004|STARTED|Overall Study||6
3020536|NCT01059435|3738738|FG005|STARTED|Overall Study||9
3020537|NCT01059435|3738739|FG006|STARTED|Overall Study||6
3020538|NCT01059435|3738740|FG007|STARTED|Overall Study||4
3020539|NCT01059435|3738741|FG008|STARTED|Overall Study||6
3020540|NCT01059435|3738742|FG009|STARTED|Overall Study||6
3020541|NCT01059435|3738733|FG000|Received Study Drug|Overall Study||14
3020542|NCT01059435|3738734|FG001|Received Study Drug|Overall Study||6
3020543|NCT01059435|3738735|FG002|Received Study Drug|Overall Study||6
3020544|NCT01059435|3738736|FG003|Received Study Drug|Overall Study||9
3020545|NCT01059435|3738737|FG004|Received Study Drug|Overall Study||6
3020546|NCT01059435|3738738|FG005|Received Study Drug|Overall Study||9
3020547|NCT01059435|3738739|FG006|Received Study Drug|Overall Study||6
3020548|NCT01059435|3738740|FG007|Received Study Drug|Overall Study||4
3020549|NCT01059435|3738741|FG008|Received Study Drug|Overall Study||6
3020550|NCT01059435|3738742|FG009|Received Study Drug|Overall Study||6
3020551|NCT01059435|3738733|FG000|COMPLETED|Overall Study||14
3020552|NCT01059435|3738734|FG001|COMPLETED|Overall Study||6
3020553|NCT01059435|3738735|FG002|COMPLETED|Overall Study||6
3020554|NCT01059435|3738736|FG003|COMPLETED|Overall Study||9
3020555|NCT01059435|3738737|FG004|COMPLETED|Overall Study||6
3020556|NCT01059435|3738738|FG005|COMPLETED|Overall Study||9
3020557|NCT01059435|3738739|FG006|COMPLETED|Overall Study||6
3020558|NCT01059435|3738740|FG007|COMPLETED|Overall Study||4
3020559|NCT01059435|3738741|FG008|COMPLETED|Overall Study||6
3020560|NCT01059435|3738742|FG009|COMPLETED|Overall Study||6
3020561|NCT01059435|3738733|FG000|NOT COMPLETED|Overall Study||0
3020562|NCT01059435|3738734|FG001|NOT COMPLETED|Overall Study||0
3020563|NCT01059435|3738735|FG002|NOT COMPLETED|Overall Study||2
3020564|NCT01059435|3738736|FG003|NOT COMPLETED|Overall Study||0
3020565|NCT01059435|3738737|FG004|NOT COMPLETED|Overall Study||0
3020566|NCT01059435|3738738|FG005|NOT COMPLETED|Overall Study||0
3020567|NCT01059435|3738739|FG006|NOT COMPLETED|Overall Study||0
3020568|NCT01059435|3738740|FG007|NOT COMPLETED|Overall Study||0
3020569|NCT01059435|3738741|FG008|NOT COMPLETED|Overall Study||0
3020570|NCT01059435|3738742|FG009|NOT COMPLETED|Overall Study||0
3020571|NCT01059526|3738776|FG000|STARTED|Overall Study|ITT population; defined as signing informed consent and meeting all inclusion/ exclusion criteria|41
3020572|NCT01059526|3738777|FG001|STARTED|Overall Study|ITT population; defined as signing informed consent and meeting all inclusion/ exclusion criteria|40
3020573|NCT01059526|3738776|FG000|Treated|Overall Study|Safety population; defined as all patients who received at least 1 treatment dose of KALBITOR|21
3020574|NCT01059526|3738777|FG001|Treated|Overall Study|Safety population; defined as all patients who received at least 1 treatment dose of KALBITOR|23
3020575|NCT01059526|3738776|FG000|COMPLETED|Overall Study||11
3020576|NCT01059526|3738777|FG001|COMPLETED|Overall Study||18
3020577|NCT01059526|3738776|FG000|NOT COMPLETED|Overall Study||30
3020578|NCT01059526|3738777|FG001|NOT COMPLETED|Overall Study||22
3020579|NCT01059539|3738783|FG000|STARTED|Overall Study||403
3020580|NCT01059539|3738783|FG000|COMPLETED|Overall Study||132
3020581|NCT01059539|3738783|FG000|NOT COMPLETED|Overall Study||271
3020582|NCT01059565|3738789|FG000|STARTED|24-Week Randomized Phase||49
3020583|NCT01059565|3738790|FG001|STARTED|24-Week Randomized Phase||52
3020584|NCT01059565|3738789|FG000|Randomized and Treated|24-Week Randomized Phase||48
3020585|NCT01059565|3738790|FG001|Randomized and Treated|24-Week Randomized Phase||52
3020586|NCT01059565|3738789|FG000|COMPLETED|24-Week Randomized Phase||39
3020587|NCT01059565|3738790|FG001|COMPLETED|24-Week Randomized Phase||45
3020588|NCT01059565|3738789|FG000|NOT COMPLETED|24-Week Randomized Phase||10
3020589|NCT01059565|3738790|FG001|NOT COMPLETED|24-Week Randomized Phase||7
3020590|NCT01059565|3738789|FG000|STARTED|24-Week Open-Label Phase||39
3020591|NCT01059565|3738790|FG001|STARTED|24-Week Open-Label Phase||45
3020592|NCT01059565|3738789|FG000|COMPLETED|24-Week Open-Label Phase||34
3020593|NCT01059565|3738790|FG001|COMPLETED|24-Week Open-Label Phase||42
3020594|NCT01059565|3738789|FG000|NOT COMPLETED|24-Week Open-Label Phase||5
3020595|NCT01059565|3738790|FG001|NOT COMPLETED|24-Week Open-Label Phase||3
3020596|NCT01059617|3738802|FG000|STARTED|Overall Study||33
3020597|NCT01059617|3738803|FG001|STARTED|Overall Study||34
3020598|NCT01059617|3738804|FG002|STARTED|Overall Study||33
3020599|NCT01059617|3738805|FG003|STARTED|Overall Study||33
3020600|NCT01059617|3738802|FG000|COMPLETED|Overall Study||26
3020601|NCT01059617|3738803|FG001|COMPLETED|Overall Study||33
3020602|NCT01059617|3738804|FG002|COMPLETED|Overall Study||25
3020603|NCT01059617|3738805|FG003|COMPLETED|Overall Study||27
3020604|NCT01059617|3738802|FG000|NOT COMPLETED|Overall Study||7
3020605|NCT01059617|3738803|FG001|NOT COMPLETED|Overall Study||1
3020606|NCT01059617|3738804|FG002|NOT COMPLETED|Overall Study||8
3020607|NCT01059617|3738805|FG003|NOT COMPLETED|Overall Study||6
3020608|NCT01059630|3738825|FG000|STARTED|Overall Study||209
3020609|NCT01059630|3738826|FG001|STARTED|Overall Study||204
3020610|NCT01059630|3738825|FG000|COMPLETED|Overall Study||82
3020611|NCT01059630|3738826|FG001|COMPLETED|Overall Study||101
3020612|NCT01059630|3738825|FG000|NOT COMPLETED|Overall Study||127
3020613|NCT01059630|3738826|FG001|NOT COMPLETED|Overall Study||103
3020614|NCT01059643|3738832|FG000|STARTED|Overall Study||103
3020615|NCT01059643|3738832|FG000|Received at Least 1 Dose of Study Drug|Overall Study||103
3020616|NCT01059643|3738832|FG000|COMPLETED|Overall Study||97
3020617|NCT01059643|3738832|FG000|NOT COMPLETED|Overall Study||6
3020618|NCT01059682|3738841|FG000|STARTED|Overall Study||474
3020619|NCT01059682|3738842|FG001|STARTED|Overall Study||462
3020620|NCT01059682|3738841|FG000|COMPLETED|Overall Study||464
3020621|NCT01059682|3738842|FG001|COMPLETED|Overall Study||444
3020622|NCT01059682|3738841|FG000|NOT COMPLETED|Overall Study||10
3020623|NCT01059682|3738842|FG001|NOT COMPLETED|Overall Study||18
3020624|NCT01059760|3738850|FG000|STARTED|Overall Study||16
3020625|NCT01059760|3738851|FG001|STARTED|Overall Study||14
3020626|NCT01059760|3738850|FG000|COMPLETED|Overall Study||16
3020627|NCT01059760|3738851|FG001|COMPLETED|Overall Study||14
3020628|NCT01059760|3738850|FG000|NOT COMPLETED|Overall Study||0
3020629|NCT01059760|3738851|FG001|NOT COMPLETED|Overall Study||0
3020630|NCT01059773|3738860|FG000|STARTED|Overall Study||244
3020631|NCT01059773|3738861|FG001|STARTED|Overall Study||245
3020632|NCT01059773|3738860|FG000|COMPLETED|Overall Study|Completed is refering to no Discontinuation of Study Agent Through Week 52|224
3020633|NCT01059773|3738861|FG001|COMPLETED|Overall Study|Completed is refering to no Discontinuation of Study Agent Through Week 52|221
3020634|NCT01059773|3738860|FG000|NOT COMPLETED|Overall Study||20
3020635|NCT01059773|3738861|FG001|NOT COMPLETED|Overall Study||24
3020636|NCT01059799|3738874|FG000|STARTED|Overall Study||289
3020637|NCT01059799|3738875|FG001|STARTED|Overall Study||146
3020638|NCT01059799|3738874|FG000|Exposed|Overall Study|Five subjects withdrew before exposure to trial drug|284
3020639|NCT01059799|3738875|FG001|Exposed|Overall Study||146
3020640|NCT01059799|3738874|FG000|COMPLETED|Overall Study||258
3020641|NCT01059799|3738875|FG001|COMPLETED|Overall Study||136
3020642|NCT01059799|3738874|FG000|NOT COMPLETED|Overall Study||31
3020643|NCT01059799|3738875|FG001|NOT COMPLETED|Overall Study||10
3020644|NCT01059812|3738883|FG000|STARTED|Overall Study||282
3020645|NCT01059812|3738884|FG001|STARTED|Overall Study||142
3020646|NCT01059812|3738883|FG000|Exposed|Overall Study|Three subjects withdrew prior to exposure to trial drug|279
3020647|NCT01059812|3738884|FG001|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|141
3020648|NCT01059812|3738883|FG000|COMPLETED|Overall Study||245
3020649|NCT01059812|3738884|FG001|COMPLETED|Overall Study||126
3020650|NCT01059812|3738883|FG000|NOT COMPLETED|Overall Study||37
3020651|NCT01059812|3738884|FG001|NOT COMPLETED|Overall Study||16
3020652|NCT01059825|3738896|FG000|STARTED|Enrolled, Run-in Period||0
3020653|NCT01059825|3738897|FG001|STARTED|Enrolled, Run-in Period||0
3020654|NCT01059825|3738898|FG002|STARTED|Enrolled, Run-in Period||0
3020655|NCT01059825|3738899|FG003|STARTED|Enrolled, Run-in Period||0
3020656|NCT01059825|3738900|FG004|STARTED|Enrolled, Run-in Period||0
3020657|NCT01059825|3738901|FG005|STARTED|Enrolled, Run-in Period||0
3020658|NCT01059825|3738902|FG006|STARTED|Enrolled, Run-in Period||375
3020659|NCT01059825|3738896|FG000|COMPLETED|Enrolled, Run-in Period||0
3020660|NCT01059825|3738897|FG001|COMPLETED|Enrolled, Run-in Period||0
3020661|NCT01059825|3738898|FG002|COMPLETED|Enrolled, Run-in Period||0
3020662|NCT01059825|3738899|FG003|COMPLETED|Enrolled, Run-in Period||0
3020663|NCT01059825|3738900|FG004|COMPLETED|Enrolled, Run-in Period||0
3020664|NCT01059825|3738901|FG005|COMPLETED|Enrolled, Run-in Period||0
3020665|NCT01059825|3738902|FG006|COMPLETED|Enrolled, Run-in Period||328
3020666|NCT01059825|3738896|FG000|NOT COMPLETED|Enrolled, Run-in Period||0
3165661|NCT01901146|3893213|FG000|STARTED|Adjuvant Phase||0
3165662|NCT01901146|3893214|FG001|STARTED|Adjuvant Phase||0
3165663|NCT01901146|3893215|FG002|STARTED|Adjuvant Phase|Nine participants discontinued the study after surgery but before entering adjuvant phase.|349
3165664|NCT01901146|3893216|FG003|STARTED|Adjuvant Phase|Two participants discontinued the study after surgery but before entering adjuvant phase.|171
3171772|NCT01937026|3898964|FG000|STARTED|Period 2 (At Dosing Day 3 Through Day 8)||18
3020667|NCT01059825|3738897|FG001|NOT COMPLETED|Enrolled, Run-in Period||0
3020668|NCT01059825|3738898|FG002|NOT COMPLETED|Enrolled, Run-in Period||0
3020669|NCT01059825|3738899|FG003|NOT COMPLETED|Enrolled, Run-in Period||0
3020670|NCT01059825|3738900|FG004|NOT COMPLETED|Enrolled, Run-in Period||0
3020671|NCT01059825|3738901|FG005|NOT COMPLETED|Enrolled, Run-in Period||0
3020672|NCT01059825|3738902|FG006|NOT COMPLETED|Enrolled, Run-in Period||47
3020673|NCT01059825|3738896|FG000|STARTED|Treatment Period|54 participants who completed the run-in period were randomized to this treatment group.|54
3020674|NCT01059825|3738897|FG001|STARTED|Treatment Period|54 participants who completed the run-in period were randomized to this treatment group.|54
3020675|NCT01059825|3738898|FG002|STARTED|Treatment Period|55 participants who completed the run-in period were randomized to this treatment group.|55
3020676|NCT01059825|3738899|FG003|STARTED|Treatment Period|55 participants who completed the run-in period were randomized to this treatment group.|55
3020677|NCT01059825|3738900|FG004|STARTED|Treatment Period|55 participants who completed the run-in period were randomized to this treatment group.|55
3020678|NCT01059825|3738901|FG005|STARTED|Treatment Period|55 participants who completed the run-in period were randomized to this treatment group.|55
3020679|NCT01059825|3738902|FG006|STARTED|Treatment Period|Participants who completed run-in were randomized to 1 of 6 treatment groups.|0
3020680|NCT01059825|3738896|FG000|COMPLETED|Treatment Period||44
3020681|NCT01059825|3738897|FG001|COMPLETED|Treatment Period||50
3020682|NCT01059825|3738898|FG002|COMPLETED|Treatment Period||49
3020683|NCT01059825|3738899|FG003|COMPLETED|Treatment Period||44
3020684|NCT01059825|3738900|FG004|COMPLETED|Treatment Period||47
3020685|NCT01059825|3738901|FG005|COMPLETED|Treatment Period||52
3020686|NCT01059825|3738902|FG006|COMPLETED|Treatment Period||0
3020687|NCT01059825|3738896|FG000|NOT COMPLETED|Treatment Period||10
3020688|NCT01059825|3738897|FG001|NOT COMPLETED|Treatment Period||4
3020689|NCT01059825|3738898|FG002|NOT COMPLETED|Treatment Period||6
3020690|NCT01059825|3738899|FG003|NOT COMPLETED|Treatment Period||11
3020691|NCT01059825|3738900|FG004|NOT COMPLETED|Treatment Period||8
3020692|NCT01059825|3738901|FG005|NOT COMPLETED|Treatment Period||3
3020693|NCT01059825|3738902|FG006|NOT COMPLETED|Treatment Period||0
3020694|NCT01059851|3738920|FG000|STARTED|Overall Study||8
3020695|NCT01059851|3738921|FG001|STARTED|Overall Study||8
3020696|NCT01059851|3738922|FG002|STARTED|Overall Study||0
3020697|NCT01059851|3738923|FG003|STARTED|Overall Study||0
3020698|NCT01059851|3738924|FG004|STARTED|Overall Study||0
3020699|NCT01059851|3738925|FG005|STARTED|Overall Study||0
3020700|NCT01059851|3738920|FG000|COMPLETED|Overall Study||8
3020701|NCT01059851|3738921|FG001|COMPLETED|Overall Study||8
3020702|NCT01059851|3738922|FG002|COMPLETED|Overall Study||0
3020703|NCT01059851|3738923|FG003|COMPLETED|Overall Study||0
3020704|NCT01059851|3738924|FG004|COMPLETED|Overall Study||0
3020705|NCT01059851|3738925|FG005|COMPLETED|Overall Study||0
3020706|NCT01059851|3738920|FG000|NOT COMPLETED|Overall Study||0
3020707|NCT01059851|3738921|FG001|NOT COMPLETED|Overall Study||0
3020708|NCT01059851|3738922|FG002|NOT COMPLETED|Overall Study||0
3020709|NCT01059851|3738923|FG003|NOT COMPLETED|Overall Study||0
3020710|NCT01059851|3738924|FG004|NOT COMPLETED|Overall Study||0
3020711|NCT01059851|3738925|FG005|NOT COMPLETED|Overall Study||0
3020712|NCT01059864|3738935|FG000|STARTED|Open-Label Run-In Phase||111
3020713|NCT01059864|3738936|FG001|STARTED|Open-Label Run-In Phase||0
3020714|NCT01059864|3738937|FG002|STARTED|Open-Label Run-In Phase||0
3020715|NCT01059864|3738935|FG000|COMPLETED|Open-Label Run-In Phase||98
3020716|NCT01059864|3738936|FG001|COMPLETED|Open-Label Run-In Phase||0
3020717|NCT01059864|3738937|FG002|COMPLETED|Open-Label Run-In Phase||0
3020718|NCT01059864|3738935|FG000|NOT COMPLETED|Open-Label Run-In Phase||13
3020719|NCT01059864|3738936|FG001|NOT COMPLETED|Open-Label Run-In Phase||0
3020720|NCT01059864|3738937|FG002|NOT COMPLETED|Open-Label Run-In Phase||0
3020721|NCT01059864|3738935|FG000|STARTED|Double-Blind Treatment Phase||0
3020722|NCT01059864|3738936|FG001|STARTED|Double-Blind Treatment Phase||50
3020723|NCT01059864|3738937|FG002|STARTED|Double-Blind Treatment Phase||48
3020724|NCT01059864|3738935|FG000|Treated|Double-Blind Treatment Phase||0
3020725|NCT01059864|3738936|FG001|Treated|Double-Blind Treatment Phase||50
3020726|NCT01059864|3738937|FG002|Treated|Double-Blind Treatment Phase||47
3020727|NCT01059864|3738935|FG000|COMPLETED|Double-Blind Treatment Phase||0
3020728|NCT01059864|3738936|FG001|COMPLETED|Double-Blind Treatment Phase||47
3020729|NCT01059864|3738937|FG002|COMPLETED|Double-Blind Treatment Phase||45
3020730|NCT01059864|3738935|FG000|NOT COMPLETED|Double-Blind Treatment Phase||0
3020731|NCT01059864|3738936|FG001|NOT COMPLETED|Double-Blind Treatment Phase||3
3020732|NCT01059864|3738937|FG002|NOT COMPLETED|Double-Blind Treatment Phase||3
3020733|NCT01059877|3738946|FG000|STARTED|Overall Study||6
3020734|NCT01059877|3738947|FG001|STARTED|Overall Study||5
3020735|NCT01059877|3738946|FG000|COMPLETED|Overall Study||6
3020736|NCT01059877|3738947|FG001|COMPLETED|Overall Study||3
3020737|NCT01059877|3738946|FG000|NOT COMPLETED|Overall Study||0
3020738|NCT01059877|3738947|FG001|NOT COMPLETED|Overall Study||2
3020739|NCT01059903|3738955|FG000|STARTED|Period 1: First Intervention- 24 Hours||25
3020740|NCT01059903|3738956|FG001|STARTED|Period 1: First Intervention- 24 Hours||25
3020741|NCT01059903|3738955|FG000|COMPLETED|Period 1: First Intervention- 24 Hours||24
3020742|NCT01059903|3738956|FG001|COMPLETED|Period 1: First Intervention- 24 Hours||24
3020743|NCT01059903|3738955|FG000|NOT COMPLETED|Period 1: First Intervention- 24 Hours||1
3020744|NCT01059903|3738956|FG001|NOT COMPLETED|Period 1: First Intervention- 24 Hours||1
3020745|NCT01059903|3738955|FG000|STARTED|Period 2: Washout Period (>= 5 Days)||24
3020746|NCT01059903|3738956|FG001|STARTED|Period 2: Washout Period (>= 5 Days)||24
3020747|NCT01059903|3738955|FG000|COMPLETED|Period 2: Washout Period (>= 5 Days)||24
3020748|NCT01059903|3738956|FG001|COMPLETED|Period 2: Washout Period (>= 5 Days)||24
3020749|NCT01059903|3738955|FG000|NOT COMPLETED|Period 2: Washout Period (>= 5 Days)||0
3020750|NCT01059903|3738956|FG001|NOT COMPLETED|Period 2: Washout Period (>= 5 Days)||0
3020751|NCT01059903|3738955|FG000|STARTED|Period 3: Second Intervention- 24 Hours||24
3020752|NCT01059903|3738956|FG001|STARTED|Period 3: Second Intervention- 24 Hours||24
3020753|NCT01059903|3738955|FG000|Pharmacokinetic Set (PKS)|Period 3: Second Intervention- 24 Hours|Six subjects who fullfilled predefined criteria for patch adhesiveness were excluded from the PKS|18
3020754|NCT01059903|3738956|FG001|Pharmacokinetic Set (PKS)|Period 3: Second Intervention- 24 Hours|Two subjects who fullfilled predefined criteria for patch adhesiveness were excluded from the PKS|22
3020755|NCT01059903|3738955|FG000|COMPLETED|Period 3: Second Intervention- 24 Hours||24
3020756|NCT01059903|3738956|FG001|COMPLETED|Period 3: Second Intervention- 24 Hours||24
3020757|NCT01059903|3738955|FG000|NOT COMPLETED|Period 3: Second Intervention- 24 Hours||0
3020758|NCT01059903|3738956|FG001|NOT COMPLETED|Period 3: Second Intervention- 24 Hours||0
3020759|NCT01059929|3738964|FG000|STARTED|Overall Study||20
3020760|NCT01059929|3738965|FG001|STARTED|Overall Study||21
3020761|NCT01059929|3738964|FG000|COMPLETED|Overall Study||20
3020762|NCT01059929|3738965|FG001|COMPLETED|Overall Study||21
3020763|NCT01059929|3738964|FG000|NOT COMPLETED|Overall Study||0
3020764|NCT01059929|3738965|FG001|NOT COMPLETED|Overall Study||0
3020765|NCT01059994|3738975|FG000|STARTED|Overall Study||3
3020766|NCT01059994|3738976|FG001|STARTED|Overall Study||2
3020767|NCT01059994|3738977|FG002|STARTED|Overall Study||3
3020768|NCT01059994|3738978|FG003|STARTED|Overall Study||4
3020769|NCT01059994|3738975|FG000|COMPLETED|Overall Study||3
3020770|NCT01059994|3738976|FG001|COMPLETED|Overall Study||2
3020771|NCT01059994|3738977|FG002|COMPLETED|Overall Study||3
3020772|NCT01059994|3738978|FG003|COMPLETED|Overall Study||3
3020773|NCT01059994|3738975|FG000|NOT COMPLETED|Overall Study||0
3165665|NCT01901146|3893217|FG004|STARTED|Adjuvant Phase|Three participants discontinued the study after surgery but before entering adjuvant phase.|171
3165666|NCT01901146|3893213|FG000|COMPLETED|Adjuvant Phase||0
3165667|NCT01901146|3893214|FG001|COMPLETED|Adjuvant Phase||0
3165668|NCT01901146|3893215|FG002|COMPLETED|Adjuvant Phase||323
3165669|NCT01901146|3893216|FG003|COMPLETED|Adjuvant Phase||164
3165670|NCT01901146|3893217|FG004|COMPLETED|Adjuvant Phase||157
3165671|NCT01901146|3893213|FG000|NOT COMPLETED|Adjuvant Phase||0
3165672|NCT01901146|3893214|FG001|NOT COMPLETED|Adjuvant Phase||0
3165673|NCT01901146|3893215|FG002|NOT COMPLETED|Adjuvant Phase||26
3165674|NCT01901146|3893216|FG003|NOT COMPLETED|Adjuvant Phase||7
3020774|NCT01059994|3738976|FG001|NOT COMPLETED|Overall Study||0
3020775|NCT01059994|3738977|FG002|NOT COMPLETED|Overall Study||0
3020776|NCT01059994|3738978|FG003|NOT COMPLETED|Overall Study||1
3020777|NCT01060007|3738988|FG000|STARTED|Overall Study||80
3020778|NCT01060007|3738988|FG000|COMPLETED|Overall Study||76
3020779|NCT01060007|3738988|FG000|NOT COMPLETED|Overall Study||4
3020780|NCT01060020|3738995|FG000|STARTED|Overall Study||20
3020781|NCT01060020|3738995|FG000|COMPLETED|Overall Study||20
3020782|NCT01060020|3738995|FG000|NOT COMPLETED|Overall Study||0
3020783|NCT01060059|3739002|FG000|STARTED|Overall Study||444
3020784|NCT01060059|3739003|FG001|STARTED|Overall Study||438
3020785|NCT01060059|3739002|FG000|COMPLETED|Overall Study||377
3020786|NCT01060059|3739003|FG001|COMPLETED|Overall Study||371
3020787|NCT01060059|3739002|FG000|NOT COMPLETED|Overall Study||67
3020788|NCT01060059|3739003|FG001|NOT COMPLETED|Overall Study||67
3020789|NCT01060072|3739013|FG000|STARTED|Overall Study||206
3020790|NCT01060072|3739014|FG001|STARTED|Overall Study||201
3020791|NCT01060072|3739013|FG000|COMPLETED|Overall Study||204
3020792|NCT01060072|3739014|FG001|COMPLETED|Overall Study||196
3020793|NCT01060072|3739013|FG000|NOT COMPLETED|Overall Study||2
3020794|NCT01060072|3739014|FG001|NOT COMPLETED|Overall Study||5
3020795|NCT01060098|3739023|FG000|STARTED|Overall Study||25
3020796|NCT01060098|3739024|FG001|STARTED|Overall Study||15
3020797|NCT01060098|3739025|FG002|STARTED|Overall Study||8
3020798|NCT01060098|3739023|FG000|COMPLETED|Overall Study||25
3020799|NCT01060098|3739024|FG001|COMPLETED|Overall Study||15
3020800|NCT01060098|3739025|FG002|COMPLETED|Overall Study||8
3020801|NCT01060098|3739023|FG000|NOT COMPLETED|Overall Study||0
3020802|NCT01060098|3739024|FG001|NOT COMPLETED|Overall Study||0
3020803|NCT01060098|3739025|FG002|NOT COMPLETED|Overall Study||0
3020804|NCT01060111|3739036|FG000|STARTED|Overall Study||81
3020805|NCT01060111|3739037|FG001|STARTED|Overall Study||84
3020806|NCT01060111|3739038|FG002|STARTED|Overall Study||80
3020807|NCT01060111|3739036|FG000|Treated|Overall Study||81
3020808|NCT01060111|3739037|FG001|Treated|Overall Study||83
3020809|NCT01060111|3739038|FG002|Treated|Overall Study||79
3020810|NCT01060111|3739036|FG000|COMPLETED|Overall Study||54
3020811|NCT01060111|3739037|FG001|COMPLETED|Overall Study||61
3020812|NCT01060111|3739038|FG002|COMPLETED|Overall Study||45
3020813|NCT01060111|3739036|FG000|NOT COMPLETED|Overall Study||27
3020814|NCT01060111|3739037|FG001|NOT COMPLETED|Overall Study||23
3020815|NCT01060111|3739038|FG002|NOT COMPLETED|Overall Study||35
3020816|NCT01060124|3739049|FG000|STARTED|Overall Study||103
3020817|NCT01060124|3739049|FG000|COMPLETED|Overall Study||66
3020818|NCT01060124|3739049|FG000|NOT COMPLETED|Overall Study||37
3020819|NCT01060150|3739053|FG000|STARTED|Overall Study||115
3020820|NCT01060150|3739053|FG000|Treated|Overall Study||113
3020821|NCT01060150|3739053|FG000|COMPLETED|Overall Study||92
3020822|NCT01060150|3739053|FG000|NOT COMPLETED|Overall Study||23
3020823|NCT01060345|3739057|FG000|STARTED|Overall Study||20
3020824|NCT01060345|3739057|FG000|COMPLETED|Overall Study||20
3020825|NCT01060345|3739057|FG000|NOT COMPLETED|Overall Study||0
3020826|NCT01060384|3739061|FG000|STARTED|Overall Study||6
3020827|NCT01060384|3739062|FG001|STARTED|Overall Study||4
3020828|NCT01060384|3739063|FG002|STARTED|Overall Study||0
3020829|NCT01060384|3739064|FG003|STARTED|Overall Study||0
3020830|NCT01060384|3739065|FG004|STARTED|Overall Study||36
3020831|NCT01060384|3739061|FG000|COMPLETED|Overall Study||6
3020832|NCT01060384|3739062|FG001|COMPLETED|Overall Study||3
3020833|NCT01060384|3739063|FG002|COMPLETED|Overall Study||0
3020834|NCT01060384|3739064|FG003|COMPLETED|Overall Study||0
3020835|NCT01060384|3739065|FG004|COMPLETED|Overall Study||34
3020836|NCT01060384|3739061|FG000|NOT COMPLETED|Overall Study||0
3020837|NCT01060384|3739062|FG001|NOT COMPLETED|Overall Study||1
3020838|NCT01060384|3739063|FG002|NOT COMPLETED|Overall Study||0
3020839|NCT01060384|3739064|FG003|NOT COMPLETED|Overall Study||0
3020840|NCT01060384|3739065|FG004|NOT COMPLETED|Overall Study||2
3020841|NCT01060540|3739076|FG000|STARTED|Overall Study||303
3020842|NCT01060540|3739077|FG001|STARTED|Overall Study||298
3020843|NCT01060540|3739076|FG000|COMPLETED|Overall Study||239
3020844|NCT01060540|3739077|FG001|COMPLETED|Overall Study||233
3020845|NCT01060540|3739076|FG000|NOT COMPLETED|Overall Study||64
3020846|NCT01060540|3739077|FG001|NOT COMPLETED|Overall Study||65
3020847|NCT01060553|3739085|FG000|STARTED|Overall Study||15
3020848|NCT01060553|3739086|FG001|STARTED|Overall Study||15
3020849|NCT01060553|3739085|FG000|COMPLETED|Overall Study|5 subjects completed more than half the sessions and midpoint outcome measures were obtained|6
3020850|NCT01060553|3739086|FG001|COMPLETED|Overall Study||5
3020851|NCT01060553|3739085|FG000|NOT COMPLETED|Overall Study||9
3165675|NCT01901146|3893217|FG004|NOT COMPLETED|Adjuvant Phase||14
3165676|NCT01901185|3893226|FG000|STARTED|Overall Study||77
3020852|NCT01060553|3739086|FG001|NOT COMPLETED|Overall Study||10
3020853|NCT01060592|3739093|FG000|STARTED|4-6w||35
3020854|NCT01060592|3739094|FG001|STARTED|4-6w||49
3308428|NCT03020641|4041767|FG001|NOT COMPLETED|Overall Study||3
3308429|NCT03020719|4041778|FG000|STARTED|Overall Study||30
3308430|NCT03020719|4041779|FG001|STARTED|Overall Study||30
3308431|NCT03020719|4041778|FG000|COMPLETED|Overall Study||30
3308432|NCT03020719|4041779|FG001|COMPLETED|Overall Study||28
3308433|NCT03020719|4041778|FG000|NOT COMPLETED|Overall Study||0
3308434|NCT03020719|4041779|FG001|NOT COMPLETED|Overall Study||2
3308435|NCT03020745|4041793|FG000|STARTED|Part 1 (Up to 60 Days)||3
3308436|NCT03020745|4041794|FG001|STARTED|Part 1 (Up to 60 Days)||3
3308437|NCT03020745|4041795|FG002|STARTED|Part 1 (Up to 60 Days)|No participants were enrolled in this arm as per decision made by the dose escalation committee.|0
3308438|NCT03020745|4041796|FG003|STARTED|Part 1 (Up to 60 Days)||6
3308439|NCT03020745|4041797|FG004|STARTED|Part 1 (Up to 60 Days)|No participants were enrolled in this arm as per decision made by the dose escalation committee.|0
3308440|NCT03020745|4041798|FG005|STARTED|Part 1 (Up to 60 Days)||0
3308441|NCT03020745|4041799|FG006|STARTED|Part 1 (Up to 60 Days)||0
3308442|NCT03020745|4041800|FG007|STARTED|Part 1 (Up to 60 Days)||0
3308443|NCT03020745|4041801|FG008|STARTED|Part 1 (Up to 60 Days)||0
3308444|NCT03020745|4041802|FG009|STARTED|Part 1 (Up to 60 Days)||0
3308445|NCT03020745|4041793|FG000|COMPLETED|Part 1 (Up to 60 Days)||3
3308446|NCT03020745|4041794|FG001|COMPLETED|Part 1 (Up to 60 Days)||3
3308447|NCT03020745|4041795|FG002|COMPLETED|Part 1 (Up to 60 Days)||0
3308448|NCT03020745|4041796|FG003|COMPLETED|Part 1 (Up to 60 Days)||6
3308449|NCT03020745|4041797|FG004|COMPLETED|Part 1 (Up to 60 Days)||0
3308450|NCT03020745|4041798|FG005|COMPLETED|Part 1 (Up to 60 Days)||0
3308451|NCT03020745|4041799|FG006|COMPLETED|Part 1 (Up to 60 Days)||0
3308452|NCT03020745|4041800|FG007|COMPLETED|Part 1 (Up to 60 Days)||0
3308453|NCT03020745|4041801|FG008|COMPLETED|Part 1 (Up to 60 Days)||0
3308454|NCT03020745|4041802|FG009|COMPLETED|Part 1 (Up to 60 Days)||0
3308455|NCT03020745|4041793|FG000|NOT COMPLETED|Part 1 (Up to 60 Days)||0
3308456|NCT03020745|4041794|FG001|NOT COMPLETED|Part 1 (Up to 60 Days)||0
3308457|NCT03020745|4041795|FG002|NOT COMPLETED|Part 1 (Up to 60 Days)||0
3308458|NCT03020745|4041796|FG003|NOT COMPLETED|Part 1 (Up to 60 Days)||0
3308459|NCT03020745|4041797|FG004|NOT COMPLETED|Part 1 (Up to 60 Days)||0
3308460|NCT03020745|4041798|FG005|NOT COMPLETED|Part 1 (Up to 60 Days)||0
3020855|NCT01060592|3739093|FG000|COMPLETED|4-6w||23
3020856|NCT01060592|3739094|FG001|COMPLETED|4-6w||39
3020857|NCT01060592|3739093|FG000|NOT COMPLETED|4-6w||12
3020858|NCT01060592|3739094|FG001|NOT COMPLETED|4-6w||10
3020859|NCT01060592|3739093|FG000|STARTED|12m|For some pts, %EWL were not taken/available in the 4-6w period but were available for the 12m period|35
3020860|NCT01060592|3739094|FG001|STARTED|12m|For some pts, %EWL were not taken/available in the 4-6w period but were available for the 12m period|49
3020861|NCT01060592|3739093|FG000|COMPLETED|12m||35
3020862|NCT01060592|3739094|FG001|COMPLETED|12m|Historic data was not available at 12m for 18 of the historic controls|31
3020863|NCT01060592|3739093|FG000|NOT COMPLETED|12m||0
3020864|NCT01060592|3739094|FG001|NOT COMPLETED|12m||18
3020865|NCT01060670|3739102|FG000|STARTED|Run In||0
3020866|NCT01060670|3739103|FG001|STARTED|Run In||545
3020867|NCT01060670|3739102|FG000|COMPLETED|Run In||0
3020868|NCT01060670|3739103|FG001|COMPLETED|Run In||307
3020869|NCT01060670|3739102|FG000|NOT COMPLETED|Run In||0
3020870|NCT01060670|3739103|FG001|NOT COMPLETED|Run In||238
3020871|NCT01060670|3739102|FG000|STARTED|Treatment Phase||154
3020872|NCT01060670|3739103|FG001|STARTED|Treatment Phase||153
3020873|NCT01060670|3739102|FG000|Healed at End of Treatment Phase|Treatment Phase||79
3020874|NCT01060670|3739103|FG001|Healed at End of Treatment Phase|Treatment Phase||49
3020875|NCT01060670|3739102|FG000|Did Not Heal by Treatment Visit 17|Treatment Phase||49
3020876|NCT01060670|3739103|FG001|Did Not Heal by Treatment Visit 17|Treatment Phase||68
3020877|NCT01060670|3739102|FG000|Withdrew From Treatment|Treatment Phase||26
3020878|NCT01060670|3739103|FG001|Withdrew From Treatment|Treatment Phase||36
3020879|NCT01060670|3739102|FG000|COMPLETED|Treatment Phase||128
3020880|NCT01060670|3739103|FG001|COMPLETED|Treatment Phase||117
3020881|NCT01060670|3739102|FG000|NOT COMPLETED|Treatment Phase||26
3020882|NCT01060670|3739103|FG001|NOT COMPLETED|Treatment Phase||36
3020883|NCT01060670|3739102|FG000|STARTED|Follow up Phase||128
3020884|NCT01060670|3739103|FG001|STARTED|Follow up Phase||117
3020885|NCT01060670|3739102|FG000|Recurrence|Follow up Phase||14
3020886|NCT01060670|3739103|FG001|Recurrence|Follow up Phase||9
3020887|NCT01060670|3739102|FG000|Withdrew From Follow up Phase|Follow up Phase||22
3020888|NCT01060670|3739103|FG001|Withdrew From Follow up Phase|Follow up Phase||35
3020889|NCT01060670|3739102|FG000|COMPLETED|Follow up Phase||106
3020890|NCT01060670|3739103|FG001|COMPLETED|Follow up Phase||82
3020891|NCT01060670|3739102|FG000|NOT COMPLETED|Follow up Phase||22
3020892|NCT01060670|3739103|FG001|NOT COMPLETED|Follow up Phase||35
3020893|NCT01061008|3739113|FG000|STARTED|Overall Study||16
3020894|NCT01061008|3739114|FG001|STARTED|Overall Study||15
3020895|NCT01061008|3739113|FG000|COMPLETED|Overall Study||10
3020896|NCT01061008|3739114|FG001|COMPLETED|Overall Study||9
3020897|NCT01061008|3739113|FG000|NOT COMPLETED|Overall Study||6
3020898|NCT01061008|3739114|FG001|NOT COMPLETED|Overall Study||6
3020899|NCT01061034|3739120|FG000|STARTED|Aspirin||9
3020900|NCT01061034|3739120|FG000|COMPLETED|Aspirin||9
3020901|NCT01061034|3739120|FG000|NOT COMPLETED|Aspirin||0
3020902|NCT01061034|3739120|FG000|STARTED|Aspirin Plus Omeprazole||9
3020903|NCT01061034|3739120|FG000|COMPLETED|Aspirin Plus Omeprazole||9
3020904|NCT01061034|3739120|FG000|NOT COMPLETED|Aspirin Plus Omeprazole||0
3020905|NCT01061177|3739124|FG000|STARTED|Overall Study||1089
3020906|NCT01061177|3739124|FG000|ITT_MR (b2a2 &/or b3a2 +ve Pts Only)|Overall Study||1056
3020907|NCT01061177|3739124|FG000|ITT_CyR (Ph+ Patients Only)|Overall Study||983
3020908|NCT01061177|3739124|FG000|COMPLETED|Overall Study||881
3020909|NCT01061177|3739124|FG000|NOT COMPLETED|Overall Study||208
3020910|NCT01061333|3739128|FG000|STARTED|Period 1: Placebo Run-in||8
3020911|NCT01061333|3739129|FG001|STARTED|Period 1: Placebo Run-in||8
3020912|NCT01061333|3739128|FG000|COMPLETED|Period 1: Placebo Run-in||8
3020913|NCT01061333|3739129|FG001|COMPLETED|Period 1: Placebo Run-in||8
3020914|NCT01061333|3739128|FG000|NOT COMPLETED|Period 1: Placebo Run-in||0
3020915|NCT01061333|3739129|FG001|NOT COMPLETED|Period 1: Placebo Run-in||0
3020916|NCT01061333|3739128|FG000|STARTED|Period 2: 20-day Washout||8
3020917|NCT01061333|3739129|FG001|STARTED|Period 2: 20-day Washout||8
3020918|NCT01061333|3739128|FG000|COMPLETED|Period 2: 20-day Washout||8
3020919|NCT01061333|3739129|FG001|COMPLETED|Period 2: 20-day Washout||8
3020920|NCT01061333|3739128|FG000|NOT COMPLETED|Period 2: 20-day Washout||0
3020921|NCT01061333|3739129|FG001|NOT COMPLETED|Period 2: 20-day Washout||0
3020922|NCT01061333|3739128|FG000|STARTED|Period 3: Nedocromil-Montelukast X-over||8
3020923|NCT01061333|3739129|FG001|STARTED|Period 3: Nedocromil-Montelukast X-over||8
3020924|NCT01061333|3739128|FG000|COMPLETED|Period 3: Nedocromil-Montelukast X-over||8
3020925|NCT01061333|3739129|FG001|COMPLETED|Period 3: Nedocromil-Montelukast X-over||8
3020926|NCT01061333|3739128|FG000|NOT COMPLETED|Period 3: Nedocromil-Montelukast X-over||0
3165677|NCT01901185|3893226|FG000|Received Etanercept With Autoinjector A|Overall Study||75
3165678|NCT01901185|3893226|FG000|COMPLETED|Overall Study||75
3020927|NCT01061333|3739129|FG001|NOT COMPLETED|Period 3: Nedocromil-Montelukast X-over||0
3020928|NCT01061333|3739128|FG000|STARTED|Period 4: 20-day Washout||8
3020929|NCT01061333|3739129|FG001|STARTED|Period 4: 20-day Washout||8
3020930|NCT01061333|3739128|FG000|COMPLETED|Period 4: 20-day Washout||8
3020931|NCT01061333|3739129|FG001|COMPLETED|Period 4: 20-day Washout||7
3020932|NCT01061333|3739128|FG000|NOT COMPLETED|Period 4: 20-day Washout||0
3020933|NCT01061333|3739129|FG001|NOT COMPLETED|Period 4: 20-day Washout||1
3020934|NCT01061333|3739128|FG000|STARTED|Period 5: Nedocromil-Montelukast X-over||8
3020935|NCT01061333|3739129|FG001|STARTED|Period 5: Nedocromil-Montelukast X-over||7
3020936|NCT01061333|3739128|FG000|COMPLETED|Period 5: Nedocromil-Montelukast X-over||8
3020937|NCT01061333|3739129|FG001|COMPLETED|Period 5: Nedocromil-Montelukast X-over||7
3020938|NCT01061333|3739128|FG000|NOT COMPLETED|Period 5: Nedocromil-Montelukast X-over||0
3020939|NCT01061333|3739129|FG001|NOT COMPLETED|Period 5: Nedocromil-Montelukast X-over||0
3020940|NCT01061333|3739128|FG000|STARTED|Period 6: 20-day Washout||8
3020941|NCT01061333|3739129|FG001|STARTED|Period 6: 20-day Washout||7
3020942|NCT01061333|3739128|FG000|COMPLETED|Period 6: 20-day Washout||8
3020943|NCT01061333|3739129|FG001|COMPLETED|Period 6: 20-day Washout||7
3020944|NCT01061333|3739128|FG000|NOT COMPLETED|Period 6: 20-day Washout||0
3020945|NCT01061333|3739129|FG001|NOT COMPLETED|Period 6: 20-day Washout||0
3020946|NCT01061333|3739128|FG000|STARTED|Period 7: Mometasone||8
3020947|NCT01061333|3739129|FG001|STARTED|Period 7: Mometasone||7
3020948|NCT01061333|3739128|FG000|COMPLETED|Period 7: Mometasone||8
3020949|NCT01061333|3739129|FG001|COMPLETED|Period 7: Mometasone||7
3020950|NCT01061333|3739128|FG000|NOT COMPLETED|Period 7: Mometasone||0
3020951|NCT01061333|3739129|FG001|NOT COMPLETED|Period 7: Mometasone||0
3020952|NCT01061359|3739140|FG000|STARTED|Overall Study||1972
3020953|NCT01061359|3739140|FG000|COMPLETED|Overall Study|Completed 5 years of follow-up: 668 Disease free and 2 Relapsed|670
3020954|NCT01061359|3739140|FG000|NOT COMPLETED|Overall Study||1302
3020955|NCT01061385|3739146|FG000|STARTED|Overall Study||21
3020956|NCT01061385|3739147|FG001|STARTED|Overall Study||9
3020957|NCT01061385|3739146|FG000|COMPLETED|Overall Study||20
3020958|NCT01061385|3739147|FG001|COMPLETED|Overall Study||8
3020959|NCT01061385|3739146|FG000|NOT COMPLETED|Overall Study||1
3020960|NCT01061385|3739147|FG001|NOT COMPLETED|Overall Study||1
3020961|NCT01061476|3739154|FG000|STARTED|Overall Study||12
3020962|NCT01061476|3739154|FG000|COMPLETED|Overall Study||12
3020963|NCT01061476|3739154|FG000|NOT COMPLETED|Overall Study||0
3020964|NCT01061528|3739160|FG000|STARTED|Overall Study||62
3020965|NCT01061528|3739161|FG001|STARTED|Overall Study||54
3020966|NCT01061528|3739160|FG000|COMPLETED|Overall Study||59
3020967|NCT01061528|3739161|FG001|COMPLETED|Overall Study||52
3020968|NCT01061528|3739160|FG000|NOT COMPLETED|Overall Study||3
3020969|NCT01061528|3739161|FG001|NOT COMPLETED|Overall Study||2
3020970|NCT01061567|3739167|FG000|STARTED|Overall Study||1814
3020971|NCT01061567|3739167|FG000|COMPLETED|Overall Study||1738
3020972|NCT01061567|3739167|FG000|NOT COMPLETED|Overall Study||76
3020973|NCT01061606|3739171|FG000|STARTED|Overall Study||8
3020974|NCT01061606|3739171|FG000|COMPLETED|Overall Study||0
3020975|NCT01061606|3739171|FG000|NOT COMPLETED|Overall Study||8
3020976|NCT01061671|3739177|FG000|STARTED|Overall Study||433
3020977|NCT01061671|3739178|FG001|STARTED|Overall Study||452
3020978|NCT01061671|3739177|FG000|COMPLETED|Overall Study||386
3020979|NCT01061671|3739178|FG001|COMPLETED|Overall Study||397
3020980|NCT01061671|3739177|FG000|NOT COMPLETED|Overall Study||47
3020981|NCT01061671|3739178|FG001|NOT COMPLETED|Overall Study||55
3020982|NCT01061710|3739184|FG000|STARTED|Overall Study||20
3020983|NCT01061710|3739184|FG000|COMPLETED|Overall Study||6
3020984|NCT01061710|3739184|FG000|NOT COMPLETED|Overall Study||14
3020985|NCT01061723|3739194|FG000|STARTED|Overall Study||50
3020986|NCT01061723|3739195|FG001|STARTED|Overall Study||49
3020987|NCT01061723|3739196|FG002|STARTED|Overall Study||50
3020988|NCT01061723|3739197|FG003|STARTED|Overall Study||52
3020989|NCT01061723|3739198|FG004|STARTED|Overall Study||50
3020990|NCT01061723|3739199|FG005|STARTED|Overall Study||50
3020991|NCT01061723|3739194|FG000|Treated|Overall Study||50
3020992|NCT01061723|3739195|FG001|Treated|Overall Study||49
3020993|NCT01061723|3739196|FG002|Treated|Overall Study||50
3020994|NCT01061723|3739197|FG003|Treated|Overall Study||52
3020995|NCT01061723|3739198|FG004|Treated|Overall Study||50
3020996|NCT01061723|3739199|FG005|Treated|Overall Study||49
3020997|NCT01061723|3739194|FG000|COMPLETED|Overall Study||46
3020998|NCT01061723|3739195|FG001|COMPLETED|Overall Study||43
3020999|NCT01061723|3739196|FG002|COMPLETED|Overall Study||40
3021000|NCT01061723|3739197|FG003|COMPLETED|Overall Study||44
3021001|NCT01061723|3739198|FG004|COMPLETED|Overall Study||47
3021002|NCT01061723|3739199|FG005|COMPLETED|Overall Study||41
3021003|NCT01061723|3739194|FG000|NOT COMPLETED|Overall Study||4
3021004|NCT01061723|3739195|FG001|NOT COMPLETED|Overall Study||6
3021005|NCT01061723|3739196|FG002|NOT COMPLETED|Overall Study||10
3021006|NCT01061723|3739197|FG003|NOT COMPLETED|Overall Study||8
3021007|NCT01061723|3739198|FG004|NOT COMPLETED|Overall Study||3
3021008|NCT01061723|3739199|FG005|NOT COMPLETED|Overall Study||9
3021009|NCT01061736|3739228|FG000|STARTED|Overall Study||50
3021010|NCT01061736|3739229|FG001|STARTED|Overall Study||50
3021011|NCT01061736|3739230|FG002|STARTED|Overall Study||51
3021012|NCT01061736|3739231|FG003|STARTED|Overall Study||51
3021013|NCT01061736|3739232|FG004|STARTED|Overall Study||52
3021014|NCT01061736|3739233|FG005|STARTED|Overall Study||52
3021015|NCT01061736|3739234|FG006|STARTED|Overall Study||84
3021016|NCT01061736|3739235|FG007|STARTED|Overall Study||430
3021017|NCT01061736|3739236|FG008|STARTED|Overall Study||427
3021018|NCT01061736|3739237|FG009|STARTED|Overall Study||428
3021019|NCT01061736|3739228|FG000|Treated|Overall Study||50
3021020|NCT01061736|3739229|FG001|Treated|Overall Study||50
3021021|NCT01061736|3739230|FG002|Treated|Overall Study||51
3021022|NCT01061736|3739231|FG003|Treated|Overall Study||51
3021023|NCT01061736|3739232|FG004|Treated|Overall Study||51
3021024|NCT01061736|3739233|FG005|Treated|Overall Study||52
3021025|NCT01061736|3739234|FG006|Treated|Overall Study||84
3021026|NCT01061736|3739235|FG007|Treated|Overall Study||428
3021027|NCT01061736|3739236|FG008|Treated|Overall Study||426
3021028|NCT01061736|3739237|FG009|Treated|Overall Study||428
3021029|NCT01061736|3739228|FG000|Rescued|Overall Study||0
3021030|NCT01061736|3739229|FG001|Rescued|Overall Study||0
3021031|NCT01061736|3739230|FG002|Rescued|Overall Study||0
3021032|NCT01061736|3739231|FG003|Rescued|Overall Study||0
3021033|NCT01061736|3739232|FG004|Rescued|Overall Study||0
3021034|NCT01061736|3739233|FG005|Rescued|Overall Study||0
3021035|NCT01061736|3739234|FG006|Rescued|Overall Study||0
3021036|NCT01061736|3739235|FG007|Rescued|Overall Study|Included both participants who completed and did not complete the study.|61
3021037|NCT01061736|3739236|FG008|Rescued|Overall Study|Included both participants who completed and did not complete the study.|55
3021038|NCT01061736|3739237|FG009|Rescued|Overall Study|Included both participants who completed and did not complete the study.|168
3021039|NCT01061736|3739228|FG000|COMPLETED|Overall Study||37
3021040|NCT01061736|3739229|FG001|COMPLETED|Overall Study||46
3021041|NCT01061736|3739230|FG002|COMPLETED|Overall Study||45
3021042|NCT01061736|3739231|FG003|COMPLETED|Overall Study||48
3021043|NCT01061736|3739232|FG004|COMPLETED|Overall Study||45
3021044|NCT01061736|3739233|FG005|COMPLETED|Overall Study||49
3021045|NCT01061736|3739234|FG006|COMPLETED|Overall Study||0
3021046|NCT01061736|3739235|FG007|COMPLETED|Overall Study||336
3021047|NCT01061736|3739236|FG008|COMPLETED|Overall Study||330
3021048|NCT01061736|3739237|FG009|COMPLETED|Overall Study||354
3021049|NCT01061736|3739228|FG000|NOT COMPLETED|Overall Study||13
3021050|NCT01061736|3739229|FG001|NOT COMPLETED|Overall Study||4
3021051|NCT01061736|3739230|FG002|NOT COMPLETED|Overall Study||6
3021052|NCT01061736|3739231|FG003|NOT COMPLETED|Overall Study||3
3021053|NCT01061736|3739232|FG004|NOT COMPLETED|Overall Study||7
3021054|NCT01061736|3739233|FG005|NOT COMPLETED|Overall Study||3
3021055|NCT01061736|3739234|FG006|NOT COMPLETED|Overall Study||84
3021056|NCT01061736|3739235|FG007|NOT COMPLETED|Overall Study||94
3021057|NCT01061736|3739236|FG008|NOT COMPLETED|Overall Study||97
3021058|NCT01061736|3739237|FG009|NOT COMPLETED|Overall Study||74
3021059|NCT01061775|3739262|FG000|STARTED|Overall Study||19
3021060|NCT01061775|3739262|FG000|COMPLETED|Overall Study||16
3021061|NCT01061775|3739262|FG000|NOT COMPLETED|Overall Study||3
3021062|NCT01061866|3739267|FG000|STARTED|Overall Study||7
3021063|NCT01061866|3739267|FG000|COMPLETED|Overall Study||5
3021064|NCT01061866|3739267|FG000|NOT COMPLETED|Overall Study||2
3021065|NCT01062009|3739275|FG000|STARTED|Overall Study||7
3021066|NCT01062009|3739276|FG001|STARTED|Overall Study||6
3021067|NCT01062009|3739277|FG002|STARTED|Overall Study||6
3021068|NCT01062009|3739278|FG003|STARTED|Overall Study||6
3021069|NCT01062009|3739275|FG000|COMPLETED|Overall Study||6
3021070|NCT01062009|3739276|FG001|COMPLETED|Overall Study||6
3021071|NCT01062009|3739277|FG002|COMPLETED|Overall Study||6
3021072|NCT01062009|3739278|FG003|COMPLETED|Overall Study||6
3021073|NCT01062009|3739275|FG000|NOT COMPLETED|Overall Study||1
3021074|NCT01062009|3739276|FG001|NOT COMPLETED|Overall Study||0
3021075|NCT01062009|3739277|FG002|NOT COMPLETED|Overall Study||0
3021076|NCT01062009|3739278|FG003|NOT COMPLETED|Overall Study||0
3021077|NCT01062061|3739288|FG000|STARTED|Overall Study||754
3021078|NCT01062061|3739288|FG000|COMPLETED|Overall Study||727
3021079|NCT01062061|3739288|FG000|NOT COMPLETED|Overall Study||27
3021080|NCT01062074|3739296|FG000|STARTED|Overall Study||3605
3021081|NCT01062074|3739296|FG000|COMPLETED|Overall Study||3605
3021082|NCT01062074|3739296|FG000|NOT COMPLETED|Overall Study||0
3037872|NCT01150123|3757161|FG008|NOT COMPLETED|Overall Study||5
3037873|NCT01150123|3757162|FG009|NOT COMPLETED|Overall Study||1
3037874|NCT01150123|3757163|FG010|NOT COMPLETED|Overall Study||2
3037875|NCT01150123|3757164|FG011|NOT COMPLETED|Overall Study||1
3037876|NCT01150123|3757165|FG012|NOT COMPLETED|Overall Study||3
3037877|NCT01150123|3757166|FG013|NOT COMPLETED|Overall Study||0
3037878|NCT01150123|3757167|FG014|NOT COMPLETED|Overall Study||0
3037879|NCT01150123|3757168|FG015|NOT COMPLETED|Overall Study||1
3037880|NCT01150123|3757169|FG016|NOT COMPLETED|Overall Study||0
3037881|NCT01150123|3757170|FG017|NOT COMPLETED|Overall Study||1
3037882|NCT01150357|3757230|FG000|STARTED|Dose Response Phase (Phase 1)||108
3037883|NCT01150357|3757231|FG001|STARTED|Dose Response Phase (Phase 1)||54
3037884|NCT01150357|3757232|FG002|STARTED|Dose Response Phase (Phase 1)||105
3037885|NCT01150357|3757230|FG000|COMPLETED|Dose Response Phase (Phase 1)||107
3037886|NCT01150357|3757231|FG001|COMPLETED|Dose Response Phase (Phase 1)||51
3037887|NCT01150357|3757232|FG002|COMPLETED|Dose Response Phase (Phase 1)||102
3037888|NCT01150357|3757230|FG000|NOT COMPLETED|Dose Response Phase (Phase 1)||1
3037889|NCT01150357|3757231|FG001|NOT COMPLETED|Dose Response Phase (Phase 1)||3
3037890|NCT01150357|3757232|FG002|NOT COMPLETED|Dose Response Phase (Phase 1)||3
3037891|NCT01150357|3757230|FG000|STARTED|Placebo-controlled Withdrawal (Phase 2)||107
3037892|NCT01150357|3757231|FG001|STARTED|Placebo-controlled Withdrawal (Phase 2)||51
3037893|NCT01150357|3757232|FG002|STARTED|Placebo-controlled Withdrawal (Phase 2)||102
3037894|NCT01150357|3757230|FG000|Started Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||50
3037895|NCT01150357|3757231|FG001|Started Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||30
3037896|NCT01150357|3757232|FG002|Started Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||50
3037897|NCT01150357|3757230|FG000|Completed Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||50
3037898|NCT01150357|3757231|FG001|Completed Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||30
3037899|NCT01150357|3757232|FG002|Completed Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||49
3037900|NCT01150357|3757230|FG000|Started Placebo Treatment|Placebo-controlled Withdrawal (Phase 2)||57
3037901|NCT01150357|3757231|FG001|Started Placebo Treatment|Placebo-controlled Withdrawal (Phase 2)||21
3037902|NCT01150357|3757232|FG002|Started Placebo Treatment|Placebo-controlled Withdrawal (Phase 2)||52
3037903|NCT01150357|3757230|FG000|Completed Placebo Treament|Placebo-controlled Withdrawal (Phase 2)||54
3037904|NCT01150357|3757231|FG001|Completed Placebo Treament|Placebo-controlled Withdrawal (Phase 2)||21
3037905|NCT01150357|3757232|FG002|Completed Placebo Treament|Placebo-controlled Withdrawal (Phase 2)||51
3037906|NCT01150357|3757230|FG000|COMPLETED|Placebo-controlled Withdrawal (Phase 2)||104
3037907|NCT01150357|3757231|FG001|COMPLETED|Placebo-controlled Withdrawal (Phase 2)||51
3037908|NCT01150357|3757232|FG002|COMPLETED|Placebo-controlled Withdrawal (Phase 2)||100
3037909|NCT01150357|3757230|FG000|NOT COMPLETED|Placebo-controlled Withdrawal (Phase 2)||3
3037910|NCT01150357|3757231|FG001|NOT COMPLETED|Placebo-controlled Withdrawal (Phase 2)||0
3037911|NCT01150357|3757232|FG002|NOT COMPLETED|Placebo-controlled Withdrawal (Phase 2)||2
3037912|NCT01150461|3757254|FG000|STARTED|Overall Study||11
3037913|NCT01150461|3757255|FG001|STARTED|Overall Study||9
3037914|NCT01150461|3757254|FG000|COMPLETED|Overall Study||11
3037915|NCT01150461|3757255|FG001|COMPLETED|Overall Study||9
3037916|NCT01150461|3757254|FG000|NOT COMPLETED|Overall Study||0
3037917|NCT01150461|3757255|FG001|NOT COMPLETED|Overall Study||0
3037918|NCT01150474|3757263|FG000|STARTED|Overall Study||51
3037919|NCT01150474|3757264|FG001|STARTED|Overall Study||52
3037920|NCT01150474|3757263|FG000|COMPLETED|Overall Study||41
3037921|NCT01150474|3757264|FG001|COMPLETED|Overall Study||49
3037922|NCT01150474|3757263|FG000|NOT COMPLETED|Overall Study||10
3037923|NCT01150474|3757264|FG001|NOT COMPLETED|Overall Study||3
3037924|NCT01150500|3757270|FG000|STARTED|Overall Study||65
3037925|NCT01150500|3757270|FG000|COMPLETED|Overall Study||0
3037926|NCT01150500|3757270|FG000|NOT COMPLETED|Overall Study||65
3037927|NCT01150760|3757276|FG000|STARTED|Overall Study||3525
3037928|NCT01150760|3757277|FG001|STARTED|Overall Study||3525
3037929|NCT01150760|3757276|FG000|COMPLETED|Overall Study||3525
3037930|NCT01150760|3757277|FG001|COMPLETED|Overall Study||3525
3037931|NCT01150760|3757276|FG000|NOT COMPLETED|Overall Study||0
3037932|NCT01150760|3757277|FG001|NOT COMPLETED|Overall Study||0
3037933|NCT01150838|3757288|FG000|STARTED|Overall Study||19
3037934|NCT01150838|3757289|FG001|STARTED|Overall Study||26
3037935|NCT01150838|3757290|FG002|STARTED|Overall Study||24
3037936|NCT01150838|3757291|FG003|STARTED|Overall Study||15
3037937|NCT01150838|3757292|FG004|STARTED|Overall Study||16
3037938|NCT01150838|3757293|FG005|STARTED|Overall Study||2
3037939|NCT01150838|3757288|FG000|COMPLETED|Overall Study||19
3037940|NCT01150838|3757289|FG001|COMPLETED|Overall Study||26
3037941|NCT01150838|3757290|FG002|COMPLETED|Overall Study||24
3037942|NCT01150838|3757291|FG003|COMPLETED|Overall Study||15
3037943|NCT01150838|3757292|FG004|COMPLETED|Overall Study||16
3037944|NCT01150838|3757293|FG005|COMPLETED|Overall Study||2
3037945|NCT01150838|3757288|FG000|NOT COMPLETED|Overall Study||0
3037946|NCT01150838|3757289|FG001|NOT COMPLETED|Overall Study||0
3037947|NCT01150838|3757290|FG002|NOT COMPLETED|Overall Study||0
3037948|NCT01150838|3757291|FG003|NOT COMPLETED|Overall Study||0
3037949|NCT01150838|3757292|FG004|NOT COMPLETED|Overall Study||0
3037950|NCT01150838|3757293|FG005|NOT COMPLETED|Overall Study||0
3021083|NCT01062113|3739303|FG000|STARTED|Overall Study||133
3021084|NCT01062113|3739304|FG001|STARTED|Overall Study||64
3021085|NCT01062113|3739305|FG002|STARTED|Overall Study||58
3021086|NCT01062113|3739303|FG000|COMPLETED|Overall Study||93
3021087|NCT01062113|3739304|FG001|COMPLETED|Overall Study||42
3021088|NCT01062113|3739305|FG002|COMPLETED|Overall Study||27
3021089|NCT01062113|3739303|FG000|NOT COMPLETED|Overall Study||40
3021090|NCT01062113|3739304|FG001|NOT COMPLETED|Overall Study||22
3021091|NCT01062113|3739305|FG002|NOT COMPLETED|Overall Study||31
3021092|NCT01062126|3739313|FG000|STARTED|Overall Study||3389
3021093|NCT01062126|3739313|FG000|COMPLETED|Overall Study||2856
3021094|NCT01062126|3739313|FG000|NOT COMPLETED|Overall Study||533
3021095|NCT01062165|3739317|FG000|STARTED|Overall Study||18
3021096|NCT01062165|3739317|FG000|COMPLETED|Overall Study||18
3021097|NCT01062165|3739317|FG000|NOT COMPLETED|Overall Study||0
3021098|NCT01062230|3739321|FG000|STARTED|Overall Study||6
3021099|NCT01062230|3739321|FG000|COMPLETED|Overall Study||6
3021100|NCT01062230|3739321|FG000|NOT COMPLETED|Overall Study||0
3021101|NCT01062256|3739328|FG000|STARTED|Overall Study||55
3021102|NCT01062256|3739329|FG001|STARTED|Overall Study||103
3021103|NCT01062256|3739330|FG002|STARTED|Overall Study||107
3021104|NCT01062256|3739328|FG000|COMPLETED|Overall Study||52
3021105|NCT01062256|3739329|FG001|COMPLETED|Overall Study||96
3021106|NCT01062256|3739330|FG002|COMPLETED|Overall Study||103
3021107|NCT01062256|3739328|FG000|NOT COMPLETED|Overall Study||3
3021108|NCT01062256|3739329|FG001|NOT COMPLETED|Overall Study||7
3021109|NCT01062256|3739330|FG002|NOT COMPLETED|Overall Study||4
3021110|NCT01062269|3739338|FG000|STARTED|Overall Study||42
3021111|NCT01062269|3739338|FG000|COMPLETED|Overall Study||42
3021112|NCT01062269|3739338|FG000|NOT COMPLETED|Overall Study||0
3021113|NCT01062308|3739348|FG000|STARTED|Overall Study||80
3021114|NCT01062308|3739349|FG001|STARTED|Overall Study||82
3021115|NCT01062308|3739348|FG000|COMPLETED|Overall Study||64
3021116|NCT01062308|3739349|FG001|COMPLETED|Overall Study||72
3021117|NCT01062308|3739348|FG000|NOT COMPLETED|Overall Study||16
3308461|NCT03020745|4041799|FG006|NOT COMPLETED|Part 1 (Up to 60 Days)||0
3308462|NCT03020745|4041800|FG007|NOT COMPLETED|Part 1 (Up to 60 Days)||0
3308463|NCT03020745|4041801|FG008|NOT COMPLETED|Part 1 (Up to 60 Days)||0
3308464|NCT03020745|4041802|FG009|NOT COMPLETED|Part 1 (Up to 60 Days)||0
3308465|NCT03020745|4041793|FG000|STARTED|Part 2 (Up to 169 Days)||0
3308466|NCT03020745|4041794|FG001|STARTED|Part 2 (Up to 169 Days)||0
3308467|NCT03020745|4041795|FG002|STARTED|Part 2 (Up to 169 Days)||0
3021118|NCT01062308|3739349|FG001|NOT COMPLETED|Overall Study||10
3021119|NCT01062399|3739360|FG000|STARTED|Overall Study||8
3021120|NCT01062399|3739361|FG001|STARTED|Overall Study||10
3021121|NCT01062399|3739362|FG002|STARTED|Overall Study||8
3021122|NCT01062399|3739363|FG003|STARTED|Overall Study||89
3021123|NCT01062399|3739364|FG004|STARTED|Overall Study||92
3021124|NCT01062399|3739360|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analyses are considered to have completed the study.|8
3021125|NCT01062399|3739361|FG001|COMPLETED|Overall Study||9
3021126|NCT01062399|3739362|FG002|COMPLETED|Overall Study||8
3021127|NCT01062399|3739363|FG003|COMPLETED|Overall Study||83
3021128|NCT01062399|3739364|FG004|COMPLETED|Overall Study||88
3021129|NCT01062399|3739360|FG000|NOT COMPLETED|Overall Study||0
3021130|NCT01062399|3739361|FG001|NOT COMPLETED|Overall Study||1
3021131|NCT01062399|3739362|FG002|NOT COMPLETED|Overall Study||0
3021132|NCT01062399|3739363|FG003|NOT COMPLETED|Overall Study||6
3021133|NCT01062399|3739364|FG004|NOT COMPLETED|Overall Study||4
3021134|NCT01062555|3739378|FG000|STARTED|Phase 1||266
3021135|NCT01062555|3739379|FG001|STARTED|Phase 1||261
3021136|NCT01062555|3739380|FG002|STARTED|Phase 1||0
3021137|NCT01062555|3739381|FG003|STARTED|Phase 1||0
3021138|NCT01062555|3739378|FG000|COMPLETED|Phase 1||243
3021139|NCT01062555|3739379|FG001|COMPLETED|Phase 1||235
3021140|NCT01062555|3739380|FG002|COMPLETED|Phase 1||0
3021141|NCT01062555|3739381|FG003|COMPLETED|Phase 1||0
3021142|NCT01062555|3739378|FG000|NOT COMPLETED|Phase 1||23
3021143|NCT01062555|3739379|FG001|NOT COMPLETED|Phase 1||26
3021144|NCT01062555|3739380|FG002|NOT COMPLETED|Phase 1||0
3021145|NCT01062555|3739381|FG003|NOT COMPLETED|Phase 1||0
3165679|NCT01901185|3893226|FG000|NOT COMPLETED|Overall Study||2
3165680|NCT01901211|3893232|FG000|STARTED|First Ten-week Period||6
3165681|NCT01901211|3893233|FG001|STARTED|First Ten-week Period||5
3021146|NCT01062555|3739378|FG000|STARTED|Phase 2||0
3021147|NCT01062555|3739379|FG001|STARTED|Phase 2||0
3021148|NCT01062555|3739380|FG002|STARTED|Phase 2||86
3021149|NCT01062555|3739381|FG003|STARTED|Phase 2||87
3021150|NCT01062555|3739378|FG000|COMPLETED|Phase 2||0
3021151|NCT01062555|3739379|FG001|COMPLETED|Phase 2||0
3021152|NCT01062555|3739380|FG002|COMPLETED|Phase 2||71
3021153|NCT01062555|3739381|FG003|COMPLETED|Phase 2||53
3021154|NCT01062555|3739378|FG000|NOT COMPLETED|Phase 2||0
3021155|NCT01062555|3739379|FG001|NOT COMPLETED|Phase 2||0
3021156|NCT01062555|3739380|FG002|NOT COMPLETED|Phase 2||15
3021157|NCT01062555|3739381|FG003|NOT COMPLETED|Phase 2||34
3021158|NCT01062568|3739393|FG000|STARTED|Overall Study||10
3021159|NCT01062568|3739394|FG001|STARTED|Overall Study||40
3021160|NCT01062568|3739393|FG000|COMPLETED|Overall Study||10
3021161|NCT01062568|3739394|FG001|COMPLETED|Overall Study||40
3021162|NCT01062568|3739393|FG000|NOT COMPLETED|Overall Study||0
3021163|NCT01062568|3739394|FG001|NOT COMPLETED|Overall Study||0
3021164|NCT01062763|3739407|FG000|STARTED|Overall Study|119 randomized.|58
3021165|NCT01062763|3739408|FG001|STARTED|Overall Study||61
3021166|NCT01062763|3739407|FG000|COMPLETED|Overall Study||55
3021167|NCT01062763|3739408|FG001|COMPLETED|Overall Study||57
3021168|NCT01062763|3739407|FG000|NOT COMPLETED|Overall Study||3
3021169|NCT01062763|3739408|FG001|NOT COMPLETED|Overall Study||4
3021170|NCT01062841|3739416|FG000|STARTED|Overall Study||203
3021171|NCT01062841|3739417|FG001|STARTED|Overall Study||215
3021172|NCT01062841|3739416|FG000|COMPLETED|Overall Study||154
3021173|NCT01062841|3739417|FG001|COMPLETED|Overall Study||162
3021174|NCT01062841|3739416|FG000|NOT COMPLETED|Overall Study||49
3021175|NCT01062841|3739417|FG001|NOT COMPLETED|Overall Study||53
3021176|NCT01062893|3739425|FG000|STARTED|Overall Study||41
3021177|NCT01062893|3739426|FG001|STARTED|Overall Study||41
3021178|NCT01062893|3739425|FG000|COMPLETED|Overall Study||27
3021179|NCT01062893|3739426|FG001|COMPLETED|Overall Study||28
3021180|NCT01062893|3739425|FG000|NOT COMPLETED|Overall Study||14
3021181|NCT01062893|3739426|FG001|NOT COMPLETED|Overall Study||13
3021182|NCT01062971|3739434|FG000|STARTED|Overall Study||60
3021183|NCT01062971|3739435|FG001|STARTED|Overall Study||63
3021184|NCT01062971|3739434|FG000|COMPLETED|Overall Study||56
3021185|NCT01062971|3739435|FG001|COMPLETED|Overall Study||56
3021186|NCT01062971|3739434|FG000|NOT COMPLETED|Overall Study||4
3021187|NCT01062971|3739435|FG001|NOT COMPLETED|Overall Study||7
3021188|NCT01063036|3739441|FG000|STARTED|Participants Treated With Study Drug||92
3021189|NCT01063036|3739441|FG000|COMPLETED|Participants Treated With Study Drug||86
3021190|NCT01063036|3739441|FG000|NOT COMPLETED|Participants Treated With Study Drug||6
3021191|NCT01063036|3739441|FG000|STARTED|Post Dosing Follow-up Through 24 Weeks|2 included did not complete treatment; 3 completed treatment but not included (lost to follow-up).|85
3021192|NCT01063036|3739441|FG000|COMPLETED|Post Dosing Follow-up Through 24 Weeks||46
3021193|NCT01063036|3739441|FG000|NOT COMPLETED|Post Dosing Follow-up Through 24 Weeks||39
3021194|NCT01063049|3739448|FG000|STARTED|Overall Study||200
3021195|NCT01063049|3739449|FG001|STARTED|Overall Study||200
3021196|NCT01063049|3739450|FG002|STARTED|Overall Study||200
3021197|NCT01063049|3739448|FG000|COMPLETED|Overall Study||200
3021198|NCT01063049|3739449|FG001|COMPLETED|Overall Study||200
3021199|NCT01063049|3739450|FG002|COMPLETED|Overall Study||200
3021200|NCT01063049|3739448|FG000|NOT COMPLETED|Overall Study||0
3021201|NCT01063049|3739449|FG001|NOT COMPLETED|Overall Study||0
3021202|NCT01063049|3739450|FG002|NOT COMPLETED|Overall Study||0
3021203|NCT01063062|3739460|FG000|STARTED|Overall Study||30
3021204|NCT01063062|3739461|FG001|STARTED|Overall Study||77
3021205|NCT01063062|3739460|FG000|Received Study Drug|Overall Study||29
3021206|NCT01063062|3739461|FG001|Received Study Drug|Overall Study||76
3021207|NCT01063062|3739460|FG000|COMPLETED|Overall Study||22
3021208|NCT01063062|3739461|FG001|COMPLETED|Overall Study||65
3021209|NCT01063062|3739460|FG000|NOT COMPLETED|Overall Study||8
3021210|NCT01063062|3739461|FG001|NOT COMPLETED|Overall Study||12
3021211|NCT01063075|3739468|FG000|STARTED|Overall Study||2
3021212|NCT01063075|3739469|FG001|STARTED|Overall Study||3
3021213|NCT01063075|3739470|FG002|STARTED|Overall Study||14
3021214|NCT01063075|3739471|FG003|STARTED|Overall Study||15
3021215|NCT01063075|3739468|FG000|COMPLETED|Overall Study||1
3021216|NCT01063075|3739469|FG001|COMPLETED|Overall Study||1
3021217|NCT01063075|3739470|FG002|COMPLETED|Overall Study||9
3021218|NCT01063075|3739471|FG003|COMPLETED|Overall Study||14
3021219|NCT01063075|3739468|FG000|NOT COMPLETED|Overall Study||1
3021220|NCT01063075|3739469|FG001|NOT COMPLETED|Overall Study||2
3021221|NCT01063075|3739470|FG002|NOT COMPLETED|Overall Study||5
3021222|NCT01063075|3739471|FG003|NOT COMPLETED|Overall Study||1
3021223|NCT01063153|3739483|FG000|STARTED|Overall Study||33
3021224|NCT01063153|3739484|FG001|STARTED|Overall Study||38
3021225|NCT01063153|3739483|FG000|COMPLETED|Overall Study||31
3021226|NCT01063153|3739484|FG001|COMPLETED|Overall Study||26
3021227|NCT01063153|3739483|FG000|NOT COMPLETED|Overall Study||2
3021228|NCT01063153|3739484|FG001|NOT COMPLETED|Overall Study||12
3021229|NCT01063283|3739496|FG000|STARTED|Cycle 1||20
3021230|NCT01063283|3739497|FG001|STARTED|Cycle 1||0
3021231|NCT01063283|3739498|FG002|STARTED|Cycle 1||0
3021232|NCT01063283|3739496|FG000|COMPLETED|Cycle 1||17
3021233|NCT01063283|3739497|FG001|COMPLETED|Cycle 1||0
3021234|NCT01063283|3739498|FG002|COMPLETED|Cycle 1||0
3021235|NCT01063283|3739496|FG000|NOT COMPLETED|Cycle 1||3
3021236|NCT01063283|3739497|FG001|NOT COMPLETED|Cycle 1||0
3021237|NCT01063283|3739498|FG002|NOT COMPLETED|Cycle 1||0
3021238|NCT01063283|3739496|FG000|STARTED|Randomized Phase (Cycle 2 and Beyond)||0
3021239|NCT01063283|3739497|FG001|STARTED|Randomized Phase (Cycle 2 and Beyond)||6
3021240|NCT01063283|3739498|FG002|STARTED|Randomized Phase (Cycle 2 and Beyond)||11
3021241|NCT01063283|3739496|FG000|COMPLETED|Randomized Phase (Cycle 2 and Beyond)||0
3021242|NCT01063283|3739497|FG001|COMPLETED|Randomized Phase (Cycle 2 and Beyond)||6
3021243|NCT01063283|3739498|FG002|COMPLETED|Randomized Phase (Cycle 2 and Beyond)||11
3021244|NCT01063283|3739496|FG000|NOT COMPLETED|Randomized Phase (Cycle 2 and Beyond)||0
3021245|NCT01063283|3739497|FG001|NOT COMPLETED|Randomized Phase (Cycle 2 and Beyond)||0
3021246|NCT01063283|3739498|FG002|NOT COMPLETED|Randomized Phase (Cycle 2 and Beyond)||0
3021247|NCT01063348|3739506|FG000|STARTED|Overall Study||35
3021248|NCT01063348|3739507|FG001|STARTED|Overall Study||31
3021249|NCT01063348|3739506|FG000|COMPLETED|Overall Study||32
3021250|NCT01063348|3739507|FG001|COMPLETED|Overall Study||21
3021251|NCT01063348|3739506|FG000|NOT COMPLETED|Overall Study||3
3021252|NCT01063348|3739507|FG001|NOT COMPLETED|Overall Study||10
3021253|NCT01063595|3739513|FG000|STARTED|Enrolled in Study and Randomized||32
3021254|NCT01063595|3739514|FG001|STARTED|Enrolled in Study and Randomized||31
3037951|NCT01150903|3757303|FG000|STARTED|Overall Study||24708
3021255|NCT01063595|3739513|FG000|Received Treatment|Enrolled in Study and Randomized||31
3021256|NCT01063595|3739514|FG001|Received Treatment|Enrolled in Study and Randomized||29
3021257|NCT01063595|3739513|FG000|COMPLETED|Enrolled in Study and Randomized||31
3021258|NCT01063595|3739514|FG001|COMPLETED|Enrolled in Study and Randomized||29
3021259|NCT01063595|3739513|FG000|NOT COMPLETED|Enrolled in Study and Randomized||1
3021260|NCT01063595|3739514|FG001|NOT COMPLETED|Enrolled in Study and Randomized||2
3021261|NCT01063595|3739513|FG000|STARTED|First Intervention||31
3021262|NCT01063595|3739514|FG001|STARTED|First Intervention||29
3021263|NCT01063595|3739513|FG000|COMPLETED|First Intervention||29
3021264|NCT01063595|3739514|FG001|COMPLETED|First Intervention||24
3021265|NCT01063595|3739513|FG000|NOT COMPLETED|First Intervention||2
3021266|NCT01063595|3739514|FG001|NOT COMPLETED|First Intervention||5
3021267|NCT01063595|3739513|FG000|STARTED|Second Intervention||29
3021268|NCT01063595|3739514|FG001|STARTED|Second Intervention||24
3021269|NCT01063595|3739513|FG000|COMPLETED|Second Intervention||29
3021270|NCT01063595|3739514|FG001|COMPLETED|Second Intervention||24
3021271|NCT01063595|3739513|FG000|NOT COMPLETED|Second Intervention||0
3021272|NCT01063595|3739514|FG001|NOT COMPLETED|Second Intervention||0
3021273|NCT01063712|3739520|FG000|STARTED|Overall Study||29
3021274|NCT01063712|3739520|FG000|COMPLETED|Overall Study||29
3021275|NCT01063712|3739520|FG000|NOT COMPLETED|Overall Study||0
3021276|NCT01063764|3739525|FG000|STARTED|1st Period (From Week 8 to Week 22)||73
3021277|NCT01063764|3739525|FG000|COMPLETED|1st Period (From Week 8 to Week 22)|62 subjects completed the First Period, but 7 of these subjects did not enter the Second Period.|62
3021278|NCT01063764|3739525|FG000|NOT COMPLETED|1st Period (From Week 8 to Week 22)||11
3021279|NCT01063764|3739525|FG000|STARTED|2nd Period (Week 22 to the End of Study)|7 subjects who completed Period 1 did not enter the Second Period.|55
3021280|NCT01063764|3739525|FG000|COMPLETED|2nd Period (Week 22 to the End of Study)||35
3021281|NCT01063764|3739525|FG000|NOT COMPLETED|2nd Period (Week 22 to the End of Study)||20
3021282|NCT01063829|3739533|FG000|STARTED|Overall Study||33
3021283|NCT01063829|3739534|FG001|STARTED|Overall Study||31
3021284|NCT01063829|3739535|FG002|STARTED|Overall Study||34
3308468|NCT03020745|4041796|FG003|STARTED|Part 2 (Up to 169 Days)||0
3308469|NCT03020745|4041797|FG004|STARTED|Part 2 (Up to 169 Days)||0
3308470|NCT03020745|4041798|FG005|STARTED|Part 2 (Up to 169 Days)||10
3308471|NCT03020745|4041799|FG006|STARTED|Part 2 (Up to 169 Days)||6
3308472|NCT03020745|4041800|FG007|STARTED|Part 2 (Up to 169 Days)||20
3021285|NCT01063829|3739536|FG003|STARTED|Overall Study||33
3021286|NCT01063829|3739533|FG000|COMPLETED|Overall Study|Non-completers considered as failure; FAS|17
3021287|NCT01063829|3739534|FG001|COMPLETED|Overall Study|Non-completers considered as failure; FAS|21
3021288|NCT01063829|3739535|FG002|COMPLETED|Overall Study|Non-completers considered as failure; FAS|24
3021289|NCT01063829|3739536|FG003|COMPLETED|Overall Study|Non-completers considered as failure; FAS|12
3021290|NCT01063829|3739533|FG000|NOT COMPLETED|Overall Study||16
3021291|NCT01063829|3739534|FG001|NOT COMPLETED|Overall Study||10
3021292|NCT01063829|3739535|FG002|NOT COMPLETED|Overall Study||10
3021293|NCT01063829|3739536|FG003|NOT COMPLETED|Overall Study||21
3021294|NCT01063855|3739548|FG000|STARTED|Overall Study||245
3021295|NCT01063855|3739549|FG001|STARTED|Overall Study||250
3021296|NCT01063855|3739548|FG000|COMPLETED|Overall Study||208
3021297|NCT01063855|3739549|FG001|COMPLETED|Overall Study||221
3021298|NCT01063855|3739548|FG000|NOT COMPLETED|Overall Study||37
3021299|NCT01063855|3739549|FG001|NOT COMPLETED|Overall Study||29
3021300|NCT01063868|3739561|FG000|STARTED|Overall Study||35
3021301|NCT01063868|3739562|FG001|STARTED|Overall Study||12
3021302|NCT01063868|3739561|FG000|COMPLETED|Overall Study||0
3021303|NCT01063868|3739562|FG001|COMPLETED|Overall Study||0
3021304|NCT01063868|3739561|FG000|NOT COMPLETED|Overall Study||35
3021305|NCT01063868|3739562|FG001|NOT COMPLETED|Overall Study||12
3021306|NCT01063881|3739571|FG000|STARTED|Overall Study||147
3021307|NCT01063881|3739572|FG001|STARTED|Overall Study||125
3021308|NCT01063881|3739573|FG002|STARTED|Overall Study||13
3021309|NCT01063881|3739571|FG000|COMPLETED|Overall Study||92
3021310|NCT01063881|3739572|FG001|COMPLETED|Overall Study||114
3021311|NCT01063881|3739573|FG002|COMPLETED|Overall Study||12
3021312|NCT01063881|3739571|FG000|NOT COMPLETED|Overall Study||55
3021313|NCT01063881|3739572|FG001|NOT COMPLETED|Overall Study||11
3021314|NCT01063881|3739573|FG002|NOT COMPLETED|Overall Study||1
3021315|NCT01063907|3739588|FG000|STARTED|Overall Study||15
3021316|NCT01063907|3739589|FG001|STARTED|Overall Study||80
3021317|NCT01063907|3739588|FG000|COMPLETED|Overall Study||15
3021318|NCT01063907|3739589|FG001|COMPLETED|Overall Study||80
3021319|NCT01063907|3739588|FG000|NOT COMPLETED|Overall Study||0
3021320|NCT01063907|3739589|FG001|NOT COMPLETED|Overall Study||0
3021321|NCT01063972|3739613|FG000|STARTED|Overall Study||310
3021322|NCT01063972|3739614|FG001|STARTED|Overall Study||296
3021323|NCT01063972|3739613|FG000|COMPLETED|Overall Study|Participants who were deceased or incarcerated were excluded.|296
3021324|NCT01063972|3739614|FG001|COMPLETED|Overall Study|Participants who were deceased or incarcerated were excluded.|284
3021325|NCT01063972|3739613|FG000|NOT COMPLETED|Overall Study||14
3021326|NCT01063972|3739614|FG001|NOT COMPLETED|Overall Study||12
3021327|NCT01064076|3739620|FG000|STARTED|Overall Study|321 subjects underwent an implant procedure for the S-ICD System|321
3021328|NCT01064076|3739620|FG000|COMPLETED|Overall Study|303 subjects completed a minimum of 180 days of follow up|303
3021329|NCT01064076|3739620|FG000|NOT COMPLETED|Overall Study||18
3021330|NCT01064167|3739627|FG000|STARTED|Overall Study||130
3308473|NCT03020745|4041801|FG008|STARTED|Part 2 (Up to 169 Days)||15
3021331|NCT01064167|3739628|FG001|STARTED|Overall Study||130
3021332|NCT01064167|3739627|FG000|COMPLETED|Overall Study||116
3021333|NCT01064167|3739628|FG001|COMPLETED|Overall Study||115
3021334|NCT01064167|3739627|FG000|NOT COMPLETED|Overall Study||14
3021335|NCT01064167|3739628|FG001|NOT COMPLETED|Overall Study||15
3021336|NCT01064284|3739636|FG000|STARTED|Overall Study|Taking into account the analyzed patients only|125
3021337|NCT01064284|3739637|FG001|STARTED|Overall Study|Taking into account the analyzed patients only|126
3021338|NCT01064284|3739636|FG000|COMPLETED|Overall Study||107
3021339|NCT01064284|3739637|FG001|COMPLETED|Overall Study||109
3021340|NCT01064284|3739636|FG000|NOT COMPLETED|Overall Study||18
3021341|NCT01064284|3739637|FG001|NOT COMPLETED|Overall Study||17
3021342|NCT01064297|3739647|FG000|STARTED|Overall Study||2567
3021343|NCT01064297|3739648|FG001|STARTED|Overall Study||219
3021344|NCT01064297|3739649|FG002|STARTED|Overall Study||630
3021345|NCT01064297|3739647|FG000|COMPLETED|Overall Study||1776
3021346|NCT01064297|3739648|FG001|COMPLETED|Overall Study||171
3021347|NCT01064297|3739649|FG002|COMPLETED|Overall Study||497
3021348|NCT01064297|3739647|FG000|NOT COMPLETED|Overall Study||791
3021349|NCT01064297|3739648|FG001|NOT COMPLETED|Overall Study||48
3021350|NCT01064297|3739649|FG002|NOT COMPLETED|Overall Study||133
3021351|NCT01064310|3739666|FG000|STARTED|Period 1||82
3021352|NCT01064310|3739667|FG001|STARTED|Period 1||86
3021353|NCT01064310|3739668|FG002|STARTED|Period 1||0
3021354|NCT01064310|3739666|FG000|COMPLETED|Period 1||68
3021355|NCT01064310|3739667|FG001|COMPLETED|Period 1||68
3021356|NCT01064310|3739668|FG002|COMPLETED|Period 1||0
3021357|NCT01064310|3739666|FG000|NOT COMPLETED|Period 1||14
3021358|NCT01064310|3739667|FG001|NOT COMPLETED|Period 1||18
3021359|NCT01064310|3739668|FG002|NOT COMPLETED|Period 1||0
3021360|NCT01064310|3739666|FG000|STARTED|Period 2||68
3021361|NCT01064310|3739667|FG001|STARTED|Period 2||68
3021362|NCT01064310|3739668|FG002|STARTED|Period 2||0
3021363|NCT01064310|3739666|FG000|COMPLETED|Period 2||64
3021364|NCT01064310|3739667|FG001|COMPLETED|Period 2||62
3021365|NCT01064310|3739668|FG002|COMPLETED|Period 2||0
3021366|NCT01064310|3739666|FG000|NOT COMPLETED|Period 2||4
3021367|NCT01064310|3739667|FG001|NOT COMPLETED|Period 2||6
3021368|NCT01064310|3739668|FG002|NOT COMPLETED|Period 2||0
3021369|NCT01064310|3739666|FG000|STARTED|Open Label Pazopinib||0
3021370|NCT01064310|3739667|FG001|STARTED|Open Label Pazopinib||0
3021371|NCT01064310|3739668|FG002|STARTED|Open Label Pazopinib||84
3021372|NCT01064310|3739666|FG000|COMPLETED|Open Label Pazopinib||0
3021373|NCT01064310|3739667|FG001|COMPLETED|Open Label Pazopinib||0
3021374|NCT01064310|3739668|FG002|COMPLETED|Open Label Pazopinib||0
3021375|NCT01064310|3739666|FG000|NOT COMPLETED|Open Label Pazopinib||0
3021376|NCT01064310|3739667|FG001|NOT COMPLETED|Open Label Pazopinib||0
3021377|NCT01064310|3739668|FG002|NOT COMPLETED|Open Label Pazopinib||84
3021378|NCT01064323|3739677|FG000|STARTED|Overall Study||10
3021379|NCT01064323|3739677|FG000|COMPLETED|Overall Study||10
3021380|NCT01064323|3739677|FG000|NOT COMPLETED|Overall Study||0
3021381|NCT01064362|3739683|FG000|STARTED|Overall Study||1559
3021382|NCT01064362|3739684|FG001|STARTED|Overall Study||11883
3021383|NCT01064362|3739683|FG000|COMPLETED|Overall Study||1559
3021384|NCT01064362|3739684|FG001|COMPLETED|Overall Study||11883
3021385|NCT01064362|3739683|FG000|NOT COMPLETED|Overall Study||0
3021386|NCT01064362|3739684|FG001|NOT COMPLETED|Overall Study||0
3021387|NCT01064401|3739692|FG000|STARTED|Overall Study||922
3021388|NCT01064401|3739693|FG001|STARTED|Overall Study||919
3021389|NCT01064401|3739692|FG000|COMPLETED|Overall Study||694
3021390|NCT01064401|3739693|FG001|COMPLETED|Overall Study||724
3021391|NCT01064401|3739692|FG000|NOT COMPLETED|Overall Study||228
3021392|NCT01064401|3739693|FG001|NOT COMPLETED|Overall Study||195
3021393|NCT01064414|3739703|FG000|STARTED|Core Period: Baseline to Week 26||90
3021394|NCT01064414|3739704|FG001|STARTED|Core Period: Baseline to Week 26||90
3021395|NCT01064414|3739705|FG002|STARTED|Core Period: Baseline to Week 26||89
3021396|NCT01064414|3739703|FG000|COMPLETED|Core Period: Baseline to Week 26||77
3021397|NCT01064414|3739704|FG001|COMPLETED|Core Period: Baseline to Week 26||75
3021398|NCT01064414|3739705|FG002|COMPLETED|Core Period: Baseline to Week 26||82
3021399|NCT01064414|3739703|FG000|NOT COMPLETED|Core Period: Baseline to Week 26||13
3021400|NCT01064414|3739704|FG001|NOT COMPLETED|Core Period: Baseline to Week 26||15
3021401|NCT01064414|3739705|FG002|NOT COMPLETED|Core Period: Baseline to Week 26||7
3021402|NCT01064414|3739703|FG000|STARTED|Extension Period: Week 26 to Week 52|1 pt completed core but did not enter ext. Reason: other (not specified).|76
3021403|NCT01064414|3739704|FG001|STARTED|Extension Period: Week 26 to Week 52|3 pts completed core but did not enter ext. Reason: other (not specified) (3).|72
3021404|NCT01064414|3739705|FG002|STARTED|Extension Period: Week 26 to Week 52|1 pt completed core but did not enter ext. Reason: other (not specified).|81
3021405|NCT01064414|3739703|FG000|COMPLETED|Extension Period: Week 26 to Week 52||64
3021406|NCT01064414|3739704|FG001|COMPLETED|Extension Period: Week 26 to Week 52||67
3021407|NCT01064414|3739705|FG002|COMPLETED|Extension Period: Week 26 to Week 52||76
3021408|NCT01064414|3739703|FG000|NOT COMPLETED|Extension Period: Week 26 to Week 52||12
3021409|NCT01064414|3739704|FG001|NOT COMPLETED|Extension Period: Week 26 to Week 52||5
3021410|NCT01064414|3739705|FG002|NOT COMPLETED|Extension Period: Week 26 to Week 52||5
3021411|NCT01064531|3739718|FG000|STARTED|Overall Study||21
3021412|NCT01064531|3739719|FG001|STARTED|Overall Study||20
3021413|NCT01064531|3739718|FG000|COMPLETED|Overall Study||18
3021414|NCT01064531|3739719|FG001|COMPLETED|Overall Study||13
3021415|NCT01064531|3739718|FG000|NOT COMPLETED|Overall Study||3
3021416|NCT01064531|3739719|FG001|NOT COMPLETED|Overall Study||7
3021417|NCT01064622|3739728|FG000|STARTED|Lead-in Phase I||0
3021418|NCT01064622|3739729|FG001|STARTED|Lead-in Phase I||7
3021419|NCT01064622|3739728|FG000|COMPLETED|Lead-in Phase I||0
3021420|NCT01064622|3739729|FG001|COMPLETED|Lead-in Phase I||7
3021421|NCT01064622|3739728|FG000|NOT COMPLETED|Lead-in Phase I||0
3021422|NCT01064622|3739729|FG001|NOT COMPLETED|Lead-in Phase I||0
3021423|NCT01064622|3739728|FG000|STARTED|Randomized Phase II||55
3021424|NCT01064622|3739729|FG001|STARTED|Randomized Phase II||56
3021425|NCT01064622|3739728|FG000|COMPLETED|Randomized Phase II||53
3021426|NCT01064622|3739729|FG001|COMPLETED|Randomized Phase II||53
3021427|NCT01064622|3739728|FG000|NOT COMPLETED|Randomized Phase II||2
3021428|NCT01064622|3739729|FG001|NOT COMPLETED|Randomized Phase II||3
3021429|NCT01064622|3739728|FG000|STARTED|Crossover of Arm I|Among 53 patients, 45 had disease progression; however 23 elected not to crossover to vismodegib.|22
3021430|NCT01064622|3739729|FG001|STARTED|Crossover of Arm I||0
3021431|NCT01064622|3739728|FG000|COMPLETED|Crossover of Arm I||22
3021432|NCT01064622|3739729|FG001|COMPLETED|Crossover of Arm I||0
3021433|NCT01064622|3739728|FG000|NOT COMPLETED|Crossover of Arm I||0
3021434|NCT01064622|3739729|FG001|NOT COMPLETED|Crossover of Arm I||0
3021435|NCT01064687|3739742|FG000|STARTED|Overall Study||279
3021436|NCT01064687|3739743|FG001|STARTED|Overall Study||280
3021437|NCT01064687|3739744|FG002|STARTED|Overall Study|Of 278 participants randomized to Exenatide, 2 chose not to take study drug.|278
3021438|NCT01064687|3739745|FG003|STARTED|Overall Study||141
3021439|NCT01064687|3739742|FG000|Received at Least 1 Dose of Study Drug|Overall Study||279
3021440|NCT01064687|3739743|FG001|Received at Least 1 Dose of Study Drug|Overall Study||280
3021441|NCT01064687|3739744|FG002|Received at Least 1 Dose of Study Drug|Overall Study||276
3021442|NCT01064687|3739745|FG003|Received at Least 1 Dose of Study Drug|Overall Study||141
3021443|NCT01064687|3739742|FG000|Completed 26 Weeks|Overall Study||260
3021444|NCT01064687|3739743|FG001|Completed 26 Weeks|Overall Study||263
3021445|NCT01064687|3739744|FG002|Completed 26 Weeks|Overall Study||252
3021446|NCT01064687|3739745|FG003|Completed 26 Weeks|Overall Study||124
3021447|NCT01064687|3739742|FG000|COMPLETED|Overall Study||245
3021448|NCT01064687|3739743|FG001|COMPLETED|Overall Study||254
3021449|NCT01064687|3739744|FG002|COMPLETED|Overall Study||237
3021450|NCT01064687|3739745|FG003|COMPLETED|Overall Study||124
3021451|NCT01064687|3739742|FG000|NOT COMPLETED|Overall Study||34
3021452|NCT01064687|3739743|FG001|NOT COMPLETED|Overall Study||26
3021453|NCT01064687|3739744|FG002|NOT COMPLETED|Overall Study||41
3021454|NCT01064687|3739745|FG003|NOT COMPLETED|Overall Study||17
3021455|NCT01064713|3739768|FG000|STARTED|Overall Study||13
3021456|NCT01064713|3739769|FG001|STARTED|Overall Study||4
3021457|NCT01064713|3739768|FG000|COMPLETED|Overall Study||13
3021458|NCT01064713|3739769|FG001|COMPLETED|Overall Study||4
3021459|NCT01064713|3739768|FG000|NOT COMPLETED|Overall Study||0
3021460|NCT01064713|3739769|FG001|NOT COMPLETED|Overall Study||0
3021461|NCT01064739|3739775|FG000|STARTED|Fixed Sodium Study Diet|14 participants consumed the fixed-sodium study diet prior to the fava bean supplement study day.|14
3021462|NCT01064739|3739775|FG000|COMPLETED|Fixed Sodium Study Diet||14
3021463|NCT01064739|3739775|FG000|NOT COMPLETED|Fixed Sodium Study Diet||0
3021464|NCT01064739|3739775|FG000|STARTED|Fixed Sodium Diet + Fava Beans||14
3021465|NCT01064739|3739775|FG000|COMPLETED|Fixed Sodium Diet + Fava Beans|1 participant withdrew with blood in his urine on the fava bean study day.|13
3021466|NCT01064739|3739775|FG000|NOT COMPLETED|Fixed Sodium Diet + Fava Beans||1
3021467|NCT01064817|3739787|FG000|STARTED|All Study Treatment Days 1-9||62
3021468|NCT01064817|3739788|FG001|STARTED|All Study Treatment Days 1-9||62
3021469|NCT01064817|3739787|FG000|COMPLETED|All Study Treatment Days 1-9||62
3021470|NCT01064817|3739788|FG001|COMPLETED|All Study Treatment Days 1-9||62
3021471|NCT01064817|3739787|FG000|NOT COMPLETED|All Study Treatment Days 1-9||0
3021472|NCT01064817|3739788|FG001|NOT COMPLETED|All Study Treatment Days 1-9||0
3021473|NCT01064817|3739787|FG000|STARTED|Study Completion||62
3021474|NCT01064817|3739788|FG001|STARTED|Study Completion||62
3021475|NCT01064817|3739787|FG000|COMPLETED|Study Completion||60
3021476|NCT01064817|3739788|FG001|COMPLETED|Study Completion||62
3021477|NCT01064817|3739787|FG000|NOT COMPLETED|Study Completion||2
3021478|NCT01064817|3739788|FG001|NOT COMPLETED|Study Completion||0
3021479|NCT01064830|3739796|FG000|STARTED|Overall Study||10
3021480|NCT01064830|3739797|FG001|STARTED|Overall Study||11
3021481|NCT01064830|3739796|FG000|COMPLETED|Overall Study||8
3021482|NCT01064830|3739797|FG001|COMPLETED|Overall Study||7
3021483|NCT01064830|3739796|FG000|NOT COMPLETED|Overall Study||2
3165682|NCT01901211|3893232|FG000|COMPLETED|First Ten-week Period||6
3165683|NCT01901211|3893233|FG001|COMPLETED|First Ten-week Period||5
3165684|NCT01901211|3893232|FG000|NOT COMPLETED|First Ten-week Period||0
3165685|NCT01901211|3893233|FG001|NOT COMPLETED|First Ten-week Period||0
3021484|NCT01064830|3739797|FG001|NOT COMPLETED|Overall Study||4
3021485|NCT01064856|3739807|FG000|STARTED|Double-blind (DB) Period||84
3021486|NCT01064856|3739808|FG001|STARTED|Double-blind (DB) Period||81
3021487|NCT01064856|3739809|FG002|STARTED|Double-blind (DB) Period|This treatment group is not applicable for this period.|0
3021488|NCT01064856|3739810|FG003|STARTED|Double-blind (DB) Period|This treatment group is not applicable for this period.|0
3021489|NCT01064856|3739807|FG000|COMPLETED|Double-blind (DB) Period||82
3021490|NCT01064856|3739808|FG001|COMPLETED|Double-blind (DB) Period||81
3021491|NCT01064856|3739809|FG002|COMPLETED|Double-blind (DB) Period||0
3021492|NCT01064856|3739810|FG003|COMPLETED|Double-blind (DB) Period||0
3165686|NCT01901211|3893232|FG000|STARTED|Washout (6 Weeks)||6
3021493|NCT01064856|3739807|FG000|NOT COMPLETED|Double-blind (DB) Period||2
3021494|NCT01064856|3739808|FG001|NOT COMPLETED|Double-blind (DB) Period||0
3021495|NCT01064856|3739809|FG002|NOT COMPLETED|Double-blind (DB) Period||0
3021496|NCT01064856|3739810|FG003|NOT COMPLETED|Double-blind (DB) Period||0
3021497|NCT01064856|3739807|FG000|STARTED|Open-label (OL) Period|This treatment group is not applicable for this period.|0
3021498|NCT01064856|3739808|FG001|STARTED|Open-label (OL) Period|This treatment group is not applicable for this period.|0
3021499|NCT01064856|3739809|FG002|STARTED|Open-label (OL) Period||82
3021500|NCT01064856|3739810|FG003|STARTED|Open-label (OL) Period||81
3021501|NCT01064856|3739807|FG000|COMPLETED|Open-label (OL) Period||0
3021502|NCT01064856|3739808|FG001|COMPLETED|Open-label (OL) Period||0
3021503|NCT01064856|3739809|FG002|COMPLETED|Open-label (OL) Period||56
3021504|NCT01064856|3739810|FG003|COMPLETED|Open-label (OL) Period||61
3021505|NCT01064856|3739807|FG000|NOT COMPLETED|Open-label (OL) Period||0
3021506|NCT01064856|3739808|FG001|NOT COMPLETED|Open-label (OL) Period||0
3021507|NCT01064856|3739809|FG002|NOT COMPLETED|Open-label (OL) Period||26
3021508|NCT01064856|3739810|FG003|NOT COMPLETED|Open-label (OL) Period||20
3021509|NCT01064882|3739820|FG000|STARTED|Overall Study||36
3021510|NCT01064882|3739821|FG001|STARTED|Overall Study||34
3021511|NCT01064882|3739822|FG002|STARTED|Overall Study||34
3021512|NCT01064882|3739820|FG000|COMPLETED|Overall Study||34
3021513|NCT01064882|3739821|FG001|COMPLETED|Overall Study||32
3021514|NCT01064882|3739822|FG002|COMPLETED|Overall Study||32
3021515|NCT01064882|3739820|FG000|NOT COMPLETED|Overall Study||2
3021516|NCT01064882|3739821|FG001|NOT COMPLETED|Overall Study||2
3021517|NCT01064882|3739822|FG002|NOT COMPLETED|Overall Study||2
3021518|NCT01064947|3739830|FG000|STARTED|Overall Study||70
3021519|NCT01064947|3739830|FG000|COMPLETED|Overall Study||29
3021520|NCT01064947|3739830|FG000|NOT COMPLETED|Overall Study||41
3021521|NCT01065350|3739840|FG000|STARTED|Overall Study||43
3021522|NCT01065350|3739841|FG001|STARTED|Overall Study||42
3021523|NCT01065350|3739840|FG000|COMPLETED|Overall Study||43
3021524|NCT01065350|3739841|FG001|COMPLETED|Overall Study||41
3021525|NCT01065350|3739840|FG000|NOT COMPLETED|Overall Study||0
3021526|NCT01065350|3739841|FG001|NOT COMPLETED|Overall Study||1
3021527|NCT01065428|3739849|FG000|STARTED|Overall Study||17
3021528|NCT01065428|3739850|FG001|STARTED|Overall Study||35
3021529|NCT01065428|3739849|FG000|COMPLETED|Overall Study||17
3021530|NCT01065428|3739850|FG001|COMPLETED|Overall Study||35
3021531|NCT01065428|3739849|FG000|NOT COMPLETED|Overall Study||0
3021532|NCT01065428|3739850|FG001|NOT COMPLETED|Overall Study||0
3021533|NCT01065480|3739858|FG000|STARTED|Overall Study||48
3021534|NCT01065480|3739859|FG001|STARTED|Overall Study||43
3021535|NCT01065480|3739858|FG000|COMPLETED|Overall Study||48
3021536|NCT01065480|3739859|FG001|COMPLETED|Overall Study||43
3021537|NCT01065480|3739858|FG000|NOT COMPLETED|Overall Study||0
3021538|NCT01065480|3739859|FG001|NOT COMPLETED|Overall Study||0
3021539|NCT01065506|3739867|FG000|STARTED|Overall Study||64
3021540|NCT01065506|3739868|FG001|STARTED|Overall Study||72
3021541|NCT01065506|3739867|FG000|End of Treatment|Overall Study||44
3021542|NCT01065506|3739868|FG001|End of Treatment|Overall Study||37
3021543|NCT01065506|3739867|FG000|4-Month Follow-Up|Overall Study||35
3021544|NCT01065506|3739868|FG001|4-Month Follow-Up|Overall Study||34
3021545|NCT01065506|3739867|FG000|COMPLETED|Overall Study||32
3021546|NCT01065506|3739868|FG001|COMPLETED|Overall Study||34
3021547|NCT01065506|3739867|FG000|NOT COMPLETED|Overall Study||32
3021548|NCT01065506|3739868|FG001|NOT COMPLETED|Overall Study||38
3021549|NCT01065558|3739874|FG000|STARTED|Overall Study||5
3021550|NCT01065558|3739874|FG000|COMPLETED|Overall Study||5
3021551|NCT01065558|3739874|FG000|NOT COMPLETED|Overall Study||0
3021552|NCT01065571|3739880|FG000|STARTED|Overall Study||10
3021553|NCT01065571|3739881|FG001|STARTED|Overall Study||5
3021554|NCT01065571|3739880|FG000|COMPLETED|Overall Study||7
3021555|NCT01065571|3739881|FG001|COMPLETED|Overall Study||5
3021556|NCT01065571|3739880|FG000|NOT COMPLETED|Overall Study||3
3021557|NCT01065571|3739881|FG001|NOT COMPLETED|Overall Study||0
3021558|NCT01065597|3739889|FG000|STARTED|Overall Study||13
3021559|NCT01065597|3739889|FG000|COMPLETED|Overall Study||12
3021560|NCT01065597|3739889|FG000|NOT COMPLETED|Overall Study||1
3021561|NCT01065714|3739893|FG000|STARTED|Overall Study|"This was a split body Study. All participants used both Hydrogel and Eucerin"|20
3021562|NCT01065714|3739893|FG000|COMPLETED|Overall Study||20
3021563|NCT01065714|3739893|FG000|NOT COMPLETED|Overall Study||0
3021564|NCT01065766|3739900|FG000|STARTED|Overall Study||4065
3021565|NCT01065766|3739900|FG000|COMPLETED|Overall Study||4033
3021566|NCT01065766|3739900|FG000|NOT COMPLETED|Overall Study||32
3021567|NCT01065844|3739904|FG000|STARTED|Overall Study||15
3021568|NCT01065844|3739904|FG000|COMPLETED|Overall Study||10
3021569|NCT01065844|3739904|FG000|NOT COMPLETED|Overall Study||5
3021570|NCT01066000|3739908|FG000|STARTED|Overall Study||33
3021571|NCT01066000|3739908|FG000|COMPLETED|Overall Study||24
3021572|NCT01066000|3739908|FG000|NOT COMPLETED|Overall Study||9
3021573|NCT01066026|3739912|FG000|STARTED|Overall Study|Each patient was injected with hyaluronic acid in each nasolabial fold (total: 2 injections)|25
3021574|NCT01066026|3739912|FG000|COMPLETED|Overall Study||23
3021575|NCT01066026|3739912|FG000|NOT COMPLETED|Overall Study||2
3021576|NCT01066039|3739918|FG000|STARTED|Overall Study||202
3021577|NCT01066039|3739918|FG000|Treated|Overall Study||200
3021578|NCT01066039|3739918|FG000|COMPLETED|Overall Study||158
3021579|NCT01066039|3739918|FG000|NOT COMPLETED|Overall Study||44
3021580|NCT01066052|3739924|FG000|STARTED|Overall Study||64
3021581|NCT01066052|3739925|FG001|STARTED|Overall Study||51
3021582|NCT01066052|3739924|FG000|Treated|Overall Study||61
3021583|NCT01066052|3739925|FG001|Treated|Overall Study||0
3021584|NCT01066052|3739924|FG000|COMPLETED|Overall Study||61
3021585|NCT01066052|3739925|FG001|COMPLETED|Overall Study||51
3021586|NCT01066052|3739924|FG000|NOT COMPLETED|Overall Study||3
3021587|NCT01066052|3739925|FG001|NOT COMPLETED|Overall Study||0
3021588|NCT01066104|3739932|FG000|STARTED|Overall Study||14
3021589|NCT01066104|3739933|FG001|STARTED|Overall Study||13
3021590|NCT01066104|3739932|FG000|COMPLETED|Overall Study||12
3021591|NCT01066104|3739933|FG001|COMPLETED|Overall Study||12
3021592|NCT01066104|3739932|FG000|NOT COMPLETED|Overall Study||2
3021593|NCT01066104|3739933|FG001|NOT COMPLETED|Overall Study||1
3021594|NCT01066143|3739939|FG000|STARTED|Overall Study||8
3021595|NCT01066143|3739939|FG000|COMPLETED|Overall Study||0
3021596|NCT01066143|3739939|FG000|NOT COMPLETED|Overall Study||8
3021597|NCT01066156|3739943|FG000|STARTED|Overall Study||34
3021598|NCT01066156|3739943|FG000|COMPLETED|Overall Study||24
3021599|NCT01066156|3739943|FG000|NOT COMPLETED|Overall Study||10
3021600|NCT01066364|3739949|FG000|STARTED|Overall Study||25
3021601|NCT01066364|3739950|FG001|STARTED|Overall Study||25
3021602|NCT01066364|3739949|FG000|COMPLETED|Overall Study||22
3021603|NCT01066364|3739950|FG001|COMPLETED|Overall Study||23
3021604|NCT01066364|3739949|FG000|NOT COMPLETED|Overall Study||3
3021605|NCT01066364|3739950|FG001|NOT COMPLETED|Overall Study||2
3021606|NCT01066520|3739959|FG000|STARTED|Overall Study||143
3021607|NCT01066520|3739960|FG001|STARTED|Overall Study||140
3021608|NCT01066520|3739961|FG002|STARTED|Overall Study||137
3021609|NCT01066520|3739959|FG000|COMPLETED|Overall Study||143
3021610|NCT01066520|3739960|FG001|COMPLETED|Overall Study||140
3021611|NCT01066520|3739961|FG002|COMPLETED|Overall Study||137
3021612|NCT01066520|3739959|FG000|NOT COMPLETED|Overall Study||0
3021613|NCT01066520|3739960|FG001|NOT COMPLETED|Overall Study||0
3021614|NCT01066520|3739961|FG002|NOT COMPLETED|Overall Study||0
3021615|NCT01066546|3739969|FG000|STARTED|Overall Study||5
3021616|NCT01066546|3739969|FG000|COMPLETED|Overall Study||0
3021617|NCT01066546|3739969|FG000|NOT COMPLETED|Overall Study||5
3021618|NCT01066585|3739975|FG000|STARTED|Overall Study||211
3021619|NCT01066585|3739976|FG001|STARTED|Overall Study||199
3021620|NCT01066585|3739975|FG000|COMPLETED|Overall Study||210
3021621|NCT01066585|3739976|FG001|COMPLETED|Overall Study||196
3021622|NCT01066585|3739975|FG000|NOT COMPLETED|Overall Study||1
3021623|NCT01066585|3739976|FG001|NOT COMPLETED|Overall Study||3
3021624|NCT01066624|3739985|FG000|STARTED|Overall Study||38
3021625|NCT01066624|3739986|FG001|STARTED|Overall Study||40
3021626|NCT01066624|3739987|FG002|STARTED|Overall Study||39
3021627|NCT01066624|3739985|FG000|COMPLETED|Overall Study||38
3021628|NCT01066624|3739986|FG001|COMPLETED|Overall Study||40
3021629|NCT01066624|3739987|FG002|COMPLETED|Overall Study||39
3021630|NCT01066624|3739985|FG000|NOT COMPLETED|Overall Study||0
3021631|NCT01066624|3739986|FG001|NOT COMPLETED|Overall Study||0
3021632|NCT01066624|3739987|FG002|NOT COMPLETED|Overall Study||0
3021633|NCT01066780|3739995|FG000|STARTED|Overall Study||24
3021634|NCT01066780|3739996|FG001|STARTED|Overall Study||24
3021635|NCT01066780|3739995|FG000|COMPLETED|Overall Study||23
3021636|NCT01066780|3739996|FG001|COMPLETED|Overall Study||23
3021637|NCT01066780|3739995|FG000|NOT COMPLETED|Overall Study||1
3021638|NCT01066780|3739996|FG001|NOT COMPLETED|Overall Study||1
3021639|NCT01066793|3740006|FG000|STARTED|Overall Study||1128
3021640|NCT01066793|3740007|FG001|STARTED|Overall Study||572
3021641|NCT01066793|3740008|FG002|STARTED|Overall Study||484
3021642|NCT01066793|3740009|FG003|STARTED|Overall Study||143
3021643|NCT01066793|3740010|FG004|STARTED|Overall Study||11
3021644|NCT01066793|3740011|FG005|STARTED|Overall Study||5
3021645|NCT01066793|3740006|FG000|COMPLETED|Overall Study||754
3021646|NCT01066793|3740007|FG001|COMPLETED|Overall Study||495
3021647|NCT01066793|3740008|FG002|COMPLETED|Overall Study||369
3021648|NCT01066793|3740009|FG003|COMPLETED|Overall Study||94
3021649|NCT01066793|3740010|FG004|COMPLETED|Overall Study||11
3021650|NCT01066793|3740011|FG005|COMPLETED|Overall Study||4
3021651|NCT01066793|3740006|FG000|NOT COMPLETED|Overall Study||374
3021652|NCT01066793|3740007|FG001|NOT COMPLETED|Overall Study||77
3308474|NCT03020745|4041802|FG009|STARTED|Part 2 (Up to 169 Days)||15
3308475|NCT03020745|4041793|FG000|COMPLETED|Part 2 (Up to 169 Days)||0
3308476|NCT03020745|4041794|FG001|COMPLETED|Part 2 (Up to 169 Days)||0
3308477|NCT03020745|4041795|FG002|COMPLETED|Part 2 (Up to 169 Days)||0
3308478|NCT03020745|4041796|FG003|COMPLETED|Part 2 (Up to 169 Days)||0
3308479|NCT03020745|4041797|FG004|COMPLETED|Part 2 (Up to 169 Days)||0
3021653|NCT01066793|3740008|FG002|NOT COMPLETED|Overall Study||115
3021654|NCT01066793|3740009|FG003|NOT COMPLETED|Overall Study||49
3021655|NCT01066793|3740010|FG004|NOT COMPLETED|Overall Study||0
3021656|NCT01066793|3740011|FG005|NOT COMPLETED|Overall Study||1
3021657|NCT01066819|3740032|FG000|STARTED|Overall Study||1006
3021658|NCT01066819|3740033|FG001|STARTED|Overall Study||348
3308480|NCT03020745|4041798|FG005|COMPLETED|Part 2 (Up to 169 Days)||10
3021659|NCT01066819|3740034|FG002|STARTED|Overall Study||257
3021660|NCT01066819|3740035|FG003|STARTED|Overall Study||25
3021661|NCT01066819|3740036|FG004|STARTED|Overall Study||7
3021662|NCT01066819|3740037|FG005|STARTED|Overall Study||13
3021663|NCT01066819|3740032|FG000|COMPLETED|Overall Study||317
3021664|NCT01066819|3740033|FG001|COMPLETED|Overall Study||177
3021665|NCT01066819|3740034|FG002|COMPLETED|Overall Study||111
3021666|NCT01066819|3740035|FG003|COMPLETED|Overall Study||8
3021667|NCT01066819|3740036|FG004|COMPLETED|Overall Study||3
3021668|NCT01066819|3740037|FG005|COMPLETED|Overall Study||7
3021669|NCT01066819|3740032|FG000|NOT COMPLETED|Overall Study||689
3021670|NCT01066819|3740033|FG001|NOT COMPLETED|Overall Study||171
3021671|NCT01066819|3740034|FG002|NOT COMPLETED|Overall Study||146
3021672|NCT01066819|3740035|FG003|NOT COMPLETED|Overall Study||17
3021673|NCT01066819|3740036|FG004|NOT COMPLETED|Overall Study||4
3021674|NCT01066819|3740037|FG005|NOT COMPLETED|Overall Study||6
3021675|NCT01066871|3740053|FG000|STARTED|Overall Study||20
3021676|NCT01066871|3740054|FG001|STARTED|Overall Study||18
3021677|NCT01066871|3740055|FG002|STARTED|Overall Study||18
3021678|NCT01066871|3740056|FG003|STARTED|Overall Study||18
3021679|NCT01066871|3740053|FG000|COMPLETED|Overall Study||16
3021680|NCT01066871|3740054|FG001|COMPLETED|Overall Study||13
3021681|NCT01066871|3740055|FG002|COMPLETED|Overall Study||12
3021682|NCT01066871|3740056|FG003|COMPLETED|Overall Study||13
3021683|NCT01066871|3740053|FG000|NOT COMPLETED|Overall Study||4
3021684|NCT01066871|3740054|FG001|NOT COMPLETED|Overall Study||5
3021685|NCT01066871|3740055|FG002|NOT COMPLETED|Overall Study||6
3021686|NCT01066871|3740056|FG003|NOT COMPLETED|Overall Study||5
3021687|NCT01066897|3740073|FG000|STARTED|Overall Study||7
3021688|NCT01066897|3740074|FG001|STARTED|Overall Study||9
3021689|NCT01066897|3740073|FG000|COMPLETED|Overall Study||5
3021690|NCT01066897|3740074|FG001|COMPLETED|Overall Study||9
3021691|NCT01066897|3740073|FG000|NOT COMPLETED|Overall Study||2
3021692|NCT01066897|3740074|FG001|NOT COMPLETED|Overall Study||0
3021693|NCT01066923|3740085|FG000|STARTED|Overall Study||28
3021694|NCT01066923|3740086|FG001|STARTED|Overall Study||32
3021695|NCT01066923|3740087|FG002|STARTED|Overall Study||33
3021696|NCT01066923|3740088|FG003|STARTED|Overall Study||31
3021697|NCT01066923|3740085|FG000|Platelet Closure Time|Overall Study||25
3021698|NCT01066923|3740086|FG001|Platelet Closure Time|Overall Study||29
3021699|NCT01066923|3740087|FG002|Platelet Closure Time|Overall Study||25
3021700|NCT01066923|3740088|FG003|Platelet Closure Time|Overall Study||23
3021701|NCT01066923|3740085|FG000|Vascular Function|Overall Study||13
3021702|NCT01066923|3740086|FG001|Vascular Function|Overall Study||14
3021703|NCT01066923|3740087|FG002|Vascular Function|Overall Study||12
3021704|NCT01066923|3740088|FG003|Vascular Function|Overall Study||13
3021705|NCT01066923|3740085|FG000|Activation of Coagulation|Overall Study||0
3021706|NCT01066923|3740086|FG001|Activation of Coagulation|Overall Study||0
3021707|NCT01066923|3740087|FG002|Activation of Coagulation|Overall Study||0
3021708|NCT01066923|3740088|FG003|Activation of Coagulation|Overall Study||0
3021709|NCT01066923|3740085|FG000|Retinal Imaging|Overall Study||0
3021710|NCT01066923|3740086|FG001|Retinal Imaging|Overall Study||0
3021711|NCT01066923|3740087|FG002|Retinal Imaging|Overall Study||0
3021712|NCT01066923|3740088|FG003|Retinal Imaging|Overall Study||0
3021713|NCT01066923|3740085|FG000|COMPLETED|Overall Study||25
3021714|NCT01066923|3740086|FG001|COMPLETED|Overall Study||29
3021715|NCT01066923|3740087|FG002|COMPLETED|Overall Study||25
3021716|NCT01066923|3740088|FG003|COMPLETED|Overall Study||23
3021717|NCT01066923|3740085|FG000|NOT COMPLETED|Overall Study||3
3021718|NCT01066923|3740086|FG001|NOT COMPLETED|Overall Study||3
3021719|NCT01066923|3740087|FG002|NOT COMPLETED|Overall Study||8
3021720|NCT01066923|3740088|FG003|NOT COMPLETED|Overall Study||8
3021721|NCT01066936|3740098|FG000|STARTED|Overall Study||20
3021722|NCT01066936|3740098|FG000|COMPLETED|Overall Study||10
3021723|NCT01066936|3740098|FG000|NOT COMPLETED|Overall Study||10
3021724|NCT01067105|3740104|FG000|STARTED|Overall Study||824
3021725|NCT01067105|3740104|FG000|COMPLETED|Overall Study||683
3021726|NCT01067105|3740104|FG000|NOT COMPLETED|Overall Study||141
3021727|NCT01067144|3740110|FG000|STARTED|Treatment||207
3021728|NCT01067144|3740111|FG001|STARTED|Treatment||215
3021729|NCT01067144|3740110|FG000|COMPLETED|Treatment||203
3021730|NCT01067144|3740111|FG001|COMPLETED|Treatment||208
3021731|NCT01067144|3740110|FG000|NOT COMPLETED|Treatment||4
3021732|NCT01067144|3740111|FG001|NOT COMPLETED|Treatment||7
3021733|NCT01067144|3740110|FG000|STARTED|Follow-up||203
3021734|NCT01067144|3740111|FG001|STARTED|Follow-up||208
3021735|NCT01067144|3740110|FG000|Intention-to-Treat Analysis Set|Follow-up||202
3021736|NCT01067144|3740111|FG001|Intention-to-Treat Analysis Set|Follow-up||208
3021737|NCT01067144|3740110|FG000|COMPLETED|Follow-up||144
3021738|NCT01067144|3740111|FG001|COMPLETED|Follow-up||152
3021739|NCT01067144|3740110|FG000|NOT COMPLETED|Follow-up||59
3021740|NCT01067144|3740111|FG001|NOT COMPLETED|Follow-up||56
3021741|NCT01067326|3740119|FG000|STARTED|Overall Study||14
3021742|NCT01067326|3740120|FG001|STARTED|Overall Study||8
3021743|NCT01067326|3740119|FG000|COMPLETED|Overall Study||12
3021744|NCT01067326|3740120|FG001|COMPLETED|Overall Study||5
3021745|NCT01067326|3740119|FG000|NOT COMPLETED|Overall Study||2
3021746|NCT01067326|3740120|FG001|NOT COMPLETED|Overall Study||3
3021747|NCT01067339|3740128|FG000|STARTED|Overall Study||31
3021748|NCT01067339|3740129|FG001|STARTED|Overall Study||34
3021749|NCT01067339|3740128|FG000|COMPLETED|Overall Study||25
3021750|NCT01067339|3740129|FG001|COMPLETED|Overall Study||29
3021751|NCT01067339|3740128|FG000|NOT COMPLETED|Overall Study||6
3021752|NCT01067339|3740129|FG001|NOT COMPLETED|Overall Study||5
3021753|NCT01067352|3740138|FG000|STARTED|Overall Study||9
3021754|NCT01067352|3740139|FG001|STARTED|Overall Study||6
3021755|NCT01067352|3740140|FG002|STARTED|Overall Study||10
3021756|NCT01067352|3740138|FG000|COMPLETED|Overall Study||8
3021757|NCT01067352|3740139|FG001|COMPLETED|Overall Study||3
3021758|NCT01067352|3740140|FG002|COMPLETED|Overall Study||9
3021759|NCT01067352|3740138|FG000|NOT COMPLETED|Overall Study||1
3021760|NCT01067352|3740139|FG001|NOT COMPLETED|Overall Study||3
3021761|NCT01067352|3740140|FG002|NOT COMPLETED|Overall Study||1
3021762|NCT01067456|3740150|FG000|STARTED|Overall Study||30
3021763|NCT01067456|3740151|FG001|STARTED|Overall Study||29
3021764|NCT01067456|3740150|FG000|COMPLETED|Overall Study||30
3021765|NCT01067456|3740151|FG001|COMPLETED|Overall Study||29
3021766|NCT01067456|3740150|FG000|NOT COMPLETED|Overall Study||0
3021767|NCT01067456|3740151|FG001|NOT COMPLETED|Overall Study||0
3021768|NCT01067469|3740161|FG000|STARTED|Overall Study||36
3021769|NCT01067469|3740162|FG001|STARTED|Overall Study||35
3021770|NCT01067469|3740161|FG000|90 mg/m^2|Overall Study||0
3021771|NCT01067469|3740162|FG001|90 mg/m^2|Overall Study||12
3021772|NCT01067469|3740161|FG000|75 mg/m^2|Overall Study||0
3021773|NCT01067469|3740162|FG001|75 mg/m^2|Overall Study||21
3021774|NCT01067469|3740161|FG000|COMPLETED|Overall Study||36
3021775|NCT01067469|3740162|FG001|COMPLETED|Overall Study||33
3021776|NCT01067469|3740161|FG000|NOT COMPLETED|Overall Study||0
3021777|NCT01067469|3740162|FG001|NOT COMPLETED|Overall Study||2
3021778|NCT01067508|3740170|FG000|STARTED|Overall Study||10
3021779|NCT01067508|3740171|FG001|STARTED|Overall Study||9
3021780|NCT01067508|3740170|FG000|COMPLETED|Overall Study||10
3021781|NCT01067508|3740171|FG001|COMPLETED|Overall Study||7
3021782|NCT01067508|3740170|FG000|NOT COMPLETED|Overall Study||0
3021783|NCT01067508|3740171|FG001|NOT COMPLETED|Overall Study||2
3021784|NCT01067716|3740180|FG000|STARTED|Overall Study|110 eyes|57
3021785|NCT01067716|3740181|FG001|STARTED|Overall Study|25 eyes|13
3021786|NCT01067716|3740182|FG002|STARTED|Overall Study|15 eyes|9
3021787|NCT01067716|3740180|FG000|COMPLETED|Overall Study|110 eyes|57
3021788|NCT01067716|3740181|FG001|COMPLETED|Overall Study|25 eyes|13
3021789|NCT01067716|3740182|FG002|COMPLETED|Overall Study|15 eyes|9
3021790|NCT01067716|3740180|FG000|NOT COMPLETED|Overall Study||0
3021791|NCT01067716|3740181|FG001|NOT COMPLETED|Overall Study||0
3021792|NCT01067716|3740182|FG002|NOT COMPLETED|Overall Study||0
3021793|NCT01067768|3740192|FG000|STARTED|Overall Study||604
3021794|NCT01067768|3740193|FG001|STARTED|Overall Study||605
3021795|NCT01067768|3740192|FG000|COMPLETED|Overall Study||604
3021796|NCT01067768|3740193|FG001|COMPLETED|Overall Study||605
3021797|NCT01067768|3740192|FG000|NOT COMPLETED|Overall Study||0
3021798|NCT01067768|3740193|FG001|NOT COMPLETED|Overall Study||0
3021799|NCT01067781|3740203|FG000|STARTED|Up to Day 180||203
3021800|NCT01067781|3740204|FG001|STARTED|Up to Day 180||199
3021801|NCT01067781|3740205|FG002|STARTED|Up to Day 180||97
3021802|NCT01067781|3740206|FG003|STARTED|Up to Day 180||101
3021803|NCT01067781|3740203|FG000|COMPLETED|Up to Day 180||173
3021804|NCT01067781|3740204|FG001|COMPLETED|Up to Day 180||168
3021805|NCT01067781|3740205|FG002|COMPLETED|Up to Day 180||89
3021806|NCT01067781|3740206|FG003|COMPLETED|Up to Day 180||89
3021807|NCT01067781|3740203|FG000|NOT COMPLETED|Up to Day 180||30
3021808|NCT01067781|3740204|FG001|NOT COMPLETED|Up to Day 180||31
3021809|NCT01067781|3740205|FG002|NOT COMPLETED|Up to Day 180||8
3021810|NCT01067781|3740206|FG003|NOT COMPLETED|Up to Day 180||12
3021811|NCT01067781|3740203|FG000|STARTED|180 to Day 720||173
3021812|NCT01067781|3740204|FG001|STARTED|180 to Day 720||168
3021813|NCT01067781|3740205|FG002|STARTED|180 to Day 720||89
3021814|NCT01067781|3740206|FG003|STARTED|180 to Day 720||89
3021815|NCT01067781|3740203|FG000|COMPLETED|180 to Day 720|all subjects followed till Day180;if ongoing local AE, FU every 6 mths till AE resolved (max.Day720)|3
3021816|NCT01067781|3740204|FG001|COMPLETED|180 to Day 720|all subjects followed till Day180;if ongoing local AE, FU every 6 mths till AE resolved (max.Day720)|4
3021817|NCT01067781|3740205|FG002|COMPLETED|180 to Day 720|all subjects followed till Day180;if ongoing local AE, FU every 6 mths till AE resolved (max.Day720)|0
3021818|NCT01067781|3740206|FG003|COMPLETED|180 to Day 720|all subjects followed till Day180;if ongoing local AE, FU every 6 mths till AE resolved (max.Day720)|0
3021819|NCT01067781|3740203|FG000|NOT COMPLETED|180 to Day 720||170
3021820|NCT01067781|3740204|FG001|NOT COMPLETED|180 to Day 720||164
3021821|NCT01067781|3740205|FG002|NOT COMPLETED|180 to Day 720||89
3021822|NCT01067781|3740206|FG003|NOT COMPLETED|180 to Day 720||89
3021823|NCT01067846|3740220|FG000|STARTED|Overall Study|Due to exclusion prior to group assignment, Study Enrollment will not equal Total # of Participants.|29
3021824|NCT01067846|3740221|FG001|STARTED|Overall Study|Due to exclusion prior to group assignment, Study Enrollment will not equal Total # of Participants.|30
3021825|NCT01067846|3740220|FG000|Completed 3 Tx Sessions|Overall Study|Our final analysis includes these participants.|15
3021826|NCT01067846|3740221|FG001|Completed 3 Tx Sessions|Overall Study|Our final analysis includes these participants.|15
3021827|NCT01067846|3740220|FG000|COMPLETED|Overall Study|Participants that completed all 4 weeks of treatment.|10
3021828|NCT01067846|3740221|FG001|COMPLETED|Overall Study|Participants that completed all 4 weeks of treatment.|11
3021829|NCT01067846|3740220|FG000|NOT COMPLETED|Overall Study||19
3021830|NCT01067846|3740221|FG001|NOT COMPLETED|Overall Study||19
3021831|NCT01067976|3740227|FG000|STARTED|Overall Study|screened and enrolled|446
3021832|NCT01067976|3740227|FG000|Received Treatment|Overall Study|treatment started|426
3021833|NCT01067976|3740227|FG000|Fulfilled Requirements of FAS Population|Overall Study||390
3021834|NCT01067976|3740227|FG000|COMPLETED|Overall Study|study course completed|424
3021835|NCT01067976|3740227|FG000|NOT COMPLETED|Overall Study||22
3021836|NCT01068158|3740247|FG000|STARTED|Overall Study||169
3021837|NCT01068158|3740248|FG001|STARTED|Overall Study||202
3021838|NCT01068158|3740247|FG000|COMPLETED|Overall Study||161
3021839|NCT01068158|3740248|FG001|COMPLETED|Overall Study||198
3021840|NCT01068158|3740247|FG000|NOT COMPLETED|Overall Study||8
3021841|NCT01068158|3740248|FG001|NOT COMPLETED|Overall Study||4
3021842|NCT01068262|3740258|FG000|STARTED|Overall Study||23
3021843|NCT01068262|3740259|FG001|STARTED|Overall Study||9
3021844|NCT01068262|3740260|FG002|STARTED|Overall Study||10
3021845|NCT01068262|3740261|FG003|STARTED|Overall Study||2
3021846|NCT01068262|3740258|FG000|COMPLETED|Overall Study||20
3021847|NCT01068262|3740259|FG001|COMPLETED|Overall Study||8
3021848|NCT01068262|3740260|FG002|COMPLETED|Overall Study||9
3021849|NCT01068262|3740261|FG003|COMPLETED|Overall Study||2
3021850|NCT01068262|3740258|FG000|NOT COMPLETED|Overall Study||3
3021851|NCT01068262|3740259|FG001|NOT COMPLETED|Overall Study||1
3021852|NCT01068262|3740260|FG002|NOT COMPLETED|Overall Study||1
3021853|NCT01068262|3740261|FG003|NOT COMPLETED|Overall Study||0
3021854|NCT01068418|3740274|FG000|STARTED|Overall Study|26 participants found to be eligible|26
3021855|NCT01068418|3740274|FG000|Medication Washout|Overall Study|9 participants were disempaneled during the medication washout phase due to noncompliance or high BP|17
3021856|NCT01068418|3740274|FG000|COMPLETED|Overall Study|14 participants completed all study procedures.|14
3021857|NCT01068418|3740274|FG000|NOT COMPLETED|Overall Study||12
3021858|NCT01068509|3740281|FG000|STARTED|Overall Study||7
3021859|NCT01068509|3740282|FG001|STARTED|Overall Study||29
3021860|NCT01068509|3740283|FG002|STARTED|Overall Study||27
3021861|NCT01068509|3740281|FG000|COMPLETED|Overall Study||1
3021862|NCT01068509|3740282|FG001|COMPLETED|Overall Study||7
3021863|NCT01068509|3740283|FG002|COMPLETED|Overall Study||6
3021864|NCT01068509|3740281|FG000|NOT COMPLETED|Overall Study||6
3021865|NCT01068509|3740282|FG001|NOT COMPLETED|Overall Study||22
3021866|NCT01068509|3740283|FG002|NOT COMPLETED|Overall Study||21
3021867|NCT01068548|3740292|FG000|STARTED|Overall Study||66
3021868|NCT01068548|3740293|FG001|STARTED|Overall Study||63
3021869|NCT01068548|3740292|FG000|COMPLETED|Overall Study||66
3021870|NCT01068548|3740293|FG001|COMPLETED|Overall Study||63
3021871|NCT01068548|3740292|FG000|NOT COMPLETED|Overall Study||0
3021872|NCT01068548|3740293|FG001|NOT COMPLETED|Overall Study||0
3021873|NCT01068600|3740302|FG000|STARTED|Overall Study||159
3021874|NCT01068600|3740303|FG001|STARTED|Overall Study||159
3021875|NCT01068600|3740302|FG000|COMPLETED|Overall Study||148
3021876|NCT01068600|3740303|FG001|COMPLETED|Overall Study||142
3021877|NCT01068600|3740302|FG000|NOT COMPLETED|Overall Study||11
3021878|NCT01068600|3740303|FG001|NOT COMPLETED|Overall Study||17
3021879|NCT01068626|3740311|FG000|STARTED|Overall Study||30
3021880|NCT01068626|3740312|FG001|STARTED|Overall Study||29
3021881|NCT01068626|3740311|FG000|COMPLETED|Overall Study||27
3021882|NCT01068626|3740312|FG001|COMPLETED|Overall Study||27
3021883|NCT01068626|3740311|FG000|NOT COMPLETED|Overall Study||3
3021884|NCT01068626|3740312|FG001|NOT COMPLETED|Overall Study||2
3021885|NCT01068652|3740320|FG000|STARTED|Overall Study||200
3021886|NCT01068652|3740321|FG001|STARTED|Overall Study||203
3021887|NCT01068652|3740320|FG000|COMPLETED|Overall Study||182
3021888|NCT01068652|3740321|FG001|COMPLETED|Overall Study||188
3021889|NCT01068652|3740320|FG000|NOT COMPLETED|Overall Study||18
3021890|NCT01068652|3740321|FG001|NOT COMPLETED|Overall Study||15
3021891|NCT01068665|3740329|FG000|STARTED|Overall Study||230
3021892|NCT01068665|3740330|FG001|STARTED|Overall Study||230
3021893|NCT01068665|3740329|FG000|Full Analysis Set|Overall Study|Two subjects were withdrawn because the subjects were randomised in error.|228
3021894|NCT01068665|3740330|FG001|Full Analysis Set|Overall Study|One subject was withdrawn because the subject was randomised in error.|229
3021895|NCT01068665|3740329|FG000|Exposed|Overall Study||228
3021896|NCT01068665|3740330|FG001|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug.|228
3021897|NCT01068665|3740329|FG000|COMPLETED|Overall Study||200
3021898|NCT01068665|3740330|FG001|COMPLETED|Overall Study||201
3021899|NCT01068665|3740329|FG000|NOT COMPLETED|Overall Study||30
3021900|NCT01068665|3740330|FG001|NOT COMPLETED|Overall Study||29
3037952|NCT01150903|3757304|FG001|STARTED|Overall Study||74124
3037953|NCT01150903|3757303|FG000|COMPLETED|Overall Study||24708
3037954|NCT01150903|3757304|FG001|COMPLETED|Overall Study||74124
3037955|NCT01150903|3757303|FG000|NOT COMPLETED|Overall Study||0
3037956|NCT01150903|3757304|FG001|NOT COMPLETED|Overall Study||0
3037957|NCT01150981|3757312|FG000|STARTED|Overall Study||20
3037958|NCT01150981|3757313|FG001|STARTED|Overall Study||15
3037959|NCT01150981|3757312|FG000|COMPLETED|Overall Study||16
3037960|NCT01150981|3757313|FG001|COMPLETED|Overall Study||13
3037961|NCT01150981|3757312|FG000|NOT COMPLETED|Overall Study||4
3037962|NCT01150981|3757313|FG001|NOT COMPLETED|Overall Study||2
3037963|NCT01151020|3757319|FG000|STARTED|Overall Study||110
3037964|NCT01151020|3757319|FG000|30-day|Overall Study||110
3037965|NCT01151020|3757319|FG000|COMPLETED|Overall Study||56
3037966|NCT01151020|3757319|FG000|NOT COMPLETED|Overall Study||54
3037967|NCT01151046|3757325|FG000|STARTED|Overall Study||59
3037968|NCT01151046|3757326|FG001|STARTED|Overall Study||59
3037969|NCT01151046|3757325|FG000|COMPLETED|Overall Study||56
3037970|NCT01151046|3757326|FG001|COMPLETED|Overall Study||59
3037971|NCT01151046|3757325|FG000|NOT COMPLETED|Overall Study||3
3037972|NCT01151046|3757326|FG001|NOT COMPLETED|Overall Study||0
3037973|NCT01151085|3757336|FG000|STARTED|Overall Study||1002
3037974|NCT01151085|3757336|FG000|COMPLETED|Overall Study||946
3037975|NCT01151085|3757336|FG000|NOT COMPLETED|Overall Study||56
3037976|NCT01151098|3757347|FG000|STARTED|Overall Study|Extension Safety Population|189
3037977|NCT01151098|3757347|FG000|COMPLETED|Overall Study||72
3037978|NCT01151098|3757347|FG000|NOT COMPLETED|Overall Study||117
3037979|NCT01151137|3757353|FG000|STARTED|Overall Study||1617
3037980|NCT01151137|3757354|FG001|STARTED|Overall Study||1619
3038393|NCT01154088|3757826|FG001|NOT COMPLETED|Overall Study||6
3021901|NCT01068678|3740338|FG000|STARTED|Overall Study||230
3021902|NCT01068678|3740339|FG001|STARTED|Overall Study||230
3021903|NCT01068678|3740338|FG000|Exposed|Overall Study|Three subjects withdrew prior to exposure to trial product.|227
3021904|NCT01068678|3740339|FG001|Exposed|Overall Study|one subject withdrew prior to exposure to trial product|229
3021905|NCT01068678|3740338|FG000|COMPLETED|Overall Study||192
3021906|NCT01068678|3740339|FG001|COMPLETED|Overall Study||206
3021907|NCT01068678|3740338|FG000|NOT COMPLETED|Overall Study||38
3021908|NCT01068678|3740339|FG001|NOT COMPLETED|Overall Study||24
3021909|NCT01068717|3740345|FG000|STARTED|Period 1: Treatment Schedule Phase 1||7
3021910|NCT01068717|3740346|FG001|STARTED|Period 1: Treatment Schedule Phase 1||6
3021911|NCT01068717|3740347|FG002|STARTED|Period 1: Treatment Schedule Phase 1||7
3021912|NCT01068717|3740348|FG003|STARTED|Period 1: Treatment Schedule Phase 1||7
3021913|NCT01068717|3740345|FG000|COMPLETED|Period 1: Treatment Schedule Phase 1|Patient who withdrew returned for Treatment Periods 3 and 4.|6
3021914|NCT01068717|3740346|FG001|COMPLETED|Period 1: Treatment Schedule Phase 1||6
3021915|NCT01068717|3740347|FG002|COMPLETED|Period 1: Treatment Schedule Phase 1||7
3021916|NCT01068717|3740348|FG003|COMPLETED|Period 1: Treatment Schedule Phase 1||7
3021917|NCT01068717|3740345|FG000|NOT COMPLETED|Period 1: Treatment Schedule Phase 1||1
3021918|NCT01068717|3740346|FG001|NOT COMPLETED|Period 1: Treatment Schedule Phase 1||0
3021919|NCT01068717|3740347|FG002|NOT COMPLETED|Period 1: Treatment Schedule Phase 1||0
3021920|NCT01068717|3740348|FG003|NOT COMPLETED|Period 1: Treatment Schedule Phase 1||0
3021921|NCT01068717|3740345|FG000|STARTED|Period 2: Treatment Schedule Phase 2||6
3021922|NCT01068717|3740346|FG001|STARTED|Period 2: Treatment Schedule Phase 2||6
3021923|NCT01068717|3740347|FG002|STARTED|Period 2: Treatment Schedule Phase 2||7
3021924|NCT01068717|3740348|FG003|STARTED|Period 2: Treatment Schedule Phase 2||7
3021925|NCT01068717|3740345|FG000|COMPLETED|Period 2: Treatment Schedule Phase 2||6
3021926|NCT01068717|3740346|FG001|COMPLETED|Period 2: Treatment Schedule Phase 2||6
3021927|NCT01068717|3740347|FG002|COMPLETED|Period 2: Treatment Schedule Phase 2||7
3021928|NCT01068717|3740348|FG003|COMPLETED|Period 2: Treatment Schedule Phase 2||7
3021929|NCT01068717|3740345|FG000|NOT COMPLETED|Period 2: Treatment Schedule Phase 2||0
3021930|NCT01068717|3740346|FG001|NOT COMPLETED|Period 2: Treatment Schedule Phase 2||0
3021931|NCT01068717|3740347|FG002|NOT COMPLETED|Period 2: Treatment Schedule Phase 2||0
3021932|NCT01068717|3740348|FG003|NOT COMPLETED|Period 2: Treatment Schedule Phase 2||0
3021933|NCT01068717|3740345|FG000|STARTED|Period 3: Treatment Schedule Phase 3|Patient who withdrew during Treatment Period 1 returned for Treatment Periods 3 and 4.|7
3021934|NCT01068717|3740346|FG001|STARTED|Period 3: Treatment Schedule Phase 3||6
3021935|NCT01068717|3740347|FG002|STARTED|Period 3: Treatment Schedule Phase 3||7
3021936|NCT01068717|3740348|FG003|STARTED|Period 3: Treatment Schedule Phase 3||7
3021937|NCT01068717|3740345|FG000|COMPLETED|Period 3: Treatment Schedule Phase 3||7
3021938|NCT01068717|3740346|FG001|COMPLETED|Period 3: Treatment Schedule Phase 3||6
3021939|NCT01068717|3740347|FG002|COMPLETED|Period 3: Treatment Schedule Phase 3||7
3021940|NCT01068717|3740348|FG003|COMPLETED|Period 3: Treatment Schedule Phase 3||7
3021941|NCT01068717|3740345|FG000|NOT COMPLETED|Period 3: Treatment Schedule Phase 3||0
3021942|NCT01068717|3740346|FG001|NOT COMPLETED|Period 3: Treatment Schedule Phase 3||0
3021943|NCT01068717|3740347|FG002|NOT COMPLETED|Period 3: Treatment Schedule Phase 3||0
3021944|NCT01068717|3740348|FG003|NOT COMPLETED|Period 3: Treatment Schedule Phase 3||0
3021945|NCT01068717|3740345|FG000|STARTED|Period 4: Treatment Schedule Phase 4|Patient who withdrew during Treatment Period 1 returned for Treatment Periods 3 and 4.|7
3021946|NCT01068717|3740346|FG001|STARTED|Period 4: Treatment Schedule Phase 4||6
3021947|NCT01068717|3740347|FG002|STARTED|Period 4: Treatment Schedule Phase 4||7
3021948|NCT01068717|3740348|FG003|STARTED|Period 4: Treatment Schedule Phase 4||7
3021949|NCT01068717|3740345|FG000|COMPLETED|Period 4: Treatment Schedule Phase 4||7
3021950|NCT01068717|3740346|FG001|COMPLETED|Period 4: Treatment Schedule Phase 4||6
3021951|NCT01068717|3740347|FG002|COMPLETED|Period 4: Treatment Schedule Phase 4||7
3021952|NCT01068717|3740348|FG003|COMPLETED|Period 4: Treatment Schedule Phase 4||7
3021953|NCT01068717|3740345|FG000|NOT COMPLETED|Period 4: Treatment Schedule Phase 4||0
3021954|NCT01068717|3740346|FG001|NOT COMPLETED|Period 4: Treatment Schedule Phase 4||0
3021955|NCT01068717|3740347|FG002|NOT COMPLETED|Period 4: Treatment Schedule Phase 4||0
3021956|NCT01068717|3740348|FG003|NOT COMPLETED|Period 4: Treatment Schedule Phase 4||0
3021957|NCT01068730|3740362|FG000|STARTED|Period 1||7
3021958|NCT01068730|3740363|FG001|STARTED|Period 1||7
3021959|NCT01068730|3740364|FG002|STARTED|Period 1||7
3021960|NCT01068730|3740365|FG003|STARTED|Period 1||7
3021961|NCT01068730|3740362|FG000|COMPLETED|Period 1||7
3021962|NCT01068730|3740363|FG001|COMPLETED|Period 1||7
3021963|NCT01068730|3740364|FG002|COMPLETED|Period 1||7
3021964|NCT01068730|3740365|FG003|COMPLETED|Period 1||7
3021965|NCT01068730|3740362|FG000|NOT COMPLETED|Period 1||0
3021966|NCT01068730|3740363|FG001|NOT COMPLETED|Period 1||0
3021967|NCT01068730|3740364|FG002|NOT COMPLETED|Period 1||0
3021968|NCT01068730|3740365|FG003|NOT COMPLETED|Period 1||0
3021969|NCT01068730|3740362|FG000|STARTED|Period 2||7
3021970|NCT01068730|3740363|FG001|STARTED|Period 2||7
3021971|NCT01068730|3740364|FG002|STARTED|Period 2||7
3021972|NCT01068730|3740365|FG003|STARTED|Period 2||7
3021973|NCT01068730|3740362|FG000|COMPLETED|Period 2||7
3021974|NCT01068730|3740363|FG001|COMPLETED|Period 2||7
3021975|NCT01068730|3740364|FG002|COMPLETED|Period 2||7
3021976|NCT01068730|3740365|FG003|COMPLETED|Period 2||7
3021977|NCT01068730|3740362|FG000|NOT COMPLETED|Period 2||0
3021978|NCT01068730|3740363|FG001|NOT COMPLETED|Period 2||0
3021979|NCT01068730|3740364|FG002|NOT COMPLETED|Period 2||0
3021980|NCT01068730|3740365|FG003|NOT COMPLETED|Period 2||0
3021981|NCT01068730|3740362|FG000|STARTED|Period 3||7
3021982|NCT01068730|3740363|FG001|STARTED|Period 3||7
3021983|NCT01068730|3740364|FG002|STARTED|Period 3||7
3021984|NCT01068730|3740365|FG003|STARTED|Period 3||7
3021985|NCT01068730|3740362|FG000|COMPLETED|Period 3||6
3021986|NCT01068730|3740363|FG001|COMPLETED|Period 3||7
3021987|NCT01068730|3740364|FG002|COMPLETED|Period 3||7
3021988|NCT01068730|3740365|FG003|COMPLETED|Period 3||7
3021989|NCT01068730|3740362|FG000|NOT COMPLETED|Period 3||1
3021990|NCT01068730|3740363|FG001|NOT COMPLETED|Period 3||0
3021991|NCT01068730|3740364|FG002|NOT COMPLETED|Period 3||0
3021992|NCT01068730|3740365|FG003|NOT COMPLETED|Period 3||0
3021993|NCT01068730|3740362|FG000|STARTED|Period 4||6
3021994|NCT01068730|3740363|FG001|STARTED|Period 4||7
3021995|NCT01068730|3740364|FG002|STARTED|Period 4||7
3021996|NCT01068730|3740365|FG003|STARTED|Period 4||7
3021997|NCT01068730|3740362|FG000|COMPLETED|Period 4||6
3021998|NCT01068730|3740363|FG001|COMPLETED|Period 4||6
3021999|NCT01068730|3740364|FG002|COMPLETED|Period 4||7
3022000|NCT01068730|3740365|FG003|COMPLETED|Period 4||7
3022001|NCT01068730|3740362|FG000|NOT COMPLETED|Period 4||0
3022002|NCT01068730|3740363|FG001|NOT COMPLETED|Period 4||1
3022003|NCT01068730|3740364|FG002|NOT COMPLETED|Period 4||0
3022004|NCT01068730|3740365|FG003|NOT COMPLETED|Period 4||0
3022005|NCT01068743|3740382|FG000|STARTED|Period 1||6
3022006|NCT01068743|3740383|FG001|STARTED|Period 1||6
3022007|NCT01068743|3740384|FG002|STARTED|Period 1||6
3022008|NCT01068743|3740385|FG003|STARTED|Period 1||6
3022009|NCT01068743|3740382|FG000|COMPLETED|Period 1||6
3022010|NCT01068743|3740383|FG001|COMPLETED|Period 1||6
3022011|NCT01068743|3740384|FG002|COMPLETED|Period 1||6
3022012|NCT01068743|3740385|FG003|COMPLETED|Period 1||6
3022013|NCT01068743|3740382|FG000|NOT COMPLETED|Period 1||0
3022014|NCT01068743|3740383|FG001|NOT COMPLETED|Period 1||0
3022015|NCT01068743|3740384|FG002|NOT COMPLETED|Period 1||0
3022016|NCT01068743|3740385|FG003|NOT COMPLETED|Period 1||0
3022017|NCT01068743|3740382|FG000|STARTED|Period 2||6
3022018|NCT01068743|3740383|FG001|STARTED|Period 2||6
3022019|NCT01068743|3740384|FG002|STARTED|Period 2||6
3022020|NCT01068743|3740385|FG003|STARTED|Period 2||6
3022021|NCT01068743|3740382|FG000|COMPLETED|Period 2||6
3022022|NCT01068743|3740383|FG001|COMPLETED|Period 2||6
3022023|NCT01068743|3740384|FG002|COMPLETED|Period 2||6
3022024|NCT01068743|3740385|FG003|COMPLETED|Period 2||6
3022025|NCT01068743|3740382|FG000|NOT COMPLETED|Period 2||0
3022026|NCT01068743|3740383|FG001|NOT COMPLETED|Period 2||0
3022027|NCT01068743|3740384|FG002|NOT COMPLETED|Period 2||0
3022028|NCT01068743|3740385|FG003|NOT COMPLETED|Period 2||0
3022029|NCT01068743|3740382|FG000|STARTED|Period 3||6
3022030|NCT01068743|3740383|FG001|STARTED|Period 3||6
3022031|NCT01068743|3740384|FG002|STARTED|Period 3||6
3022032|NCT01068743|3740385|FG003|STARTED|Period 3||6
3022033|NCT01068743|3740382|FG000|COMPLETED|Period 3||6
3022034|NCT01068743|3740383|FG001|COMPLETED|Period 3||5
3022035|NCT01068743|3740384|FG002|COMPLETED|Period 3||6
3022036|NCT01068743|3740385|FG003|COMPLETED|Period 3||6
3022037|NCT01068743|3740382|FG000|NOT COMPLETED|Period 3||0
3022038|NCT01068743|3740383|FG001|NOT COMPLETED|Period 3||1
3022039|NCT01068743|3740384|FG002|NOT COMPLETED|Period 3||0
3022040|NCT01068743|3740385|FG003|NOT COMPLETED|Period 3||0
3022041|NCT01068743|3740382|FG000|STARTED|Period 4||6
3022042|NCT01068743|3740383|FG001|STARTED|Period 4||5
3022043|NCT01068743|3740384|FG002|STARTED|Period 4||6
3022044|NCT01068743|3740385|FG003|STARTED|Period 4||6
3022045|NCT01068743|3740382|FG000|COMPLETED|Period 4||6
3022046|NCT01068743|3740383|FG001|COMPLETED|Period 4||5
3022047|NCT01068743|3740384|FG002|COMPLETED|Period 4||6
3022048|NCT01068743|3740385|FG003|COMPLETED|Period 4||6
3022049|NCT01068743|3740382|FG000|NOT COMPLETED|Period 4||0
3022050|NCT01068743|3740383|FG001|NOT COMPLETED|Period 4||0
3022051|NCT01068743|3740384|FG002|NOT COMPLETED|Period 4||0
3022052|NCT01068743|3740385|FG003|NOT COMPLETED|Period 4||0
3022053|NCT01068769|3740398|FG000|STARTED|Overall Study||34
3022054|NCT01068769|3740398|FG000|COMPLETED|Overall Study||33
3022055|NCT01068769|3740398|FG000|NOT COMPLETED|Overall Study||1
3022056|NCT01068821|3740404|FG000|STARTED|Overall Study||31
3022057|NCT01068821|3740405|FG001|STARTED|Overall Study||29
3022058|NCT01068821|3740404|FG000|COMPLETED|Overall Study|1 patient had slide measured, but her patient ID not listed; couldn't do postoperative followup.|30
3165687|NCT01901211|3893233|FG001|STARTED|Washout (6 Weeks)||5
3165688|NCT01901211|3893232|FG000|COMPLETED|Washout (6 Weeks)||6
3022059|NCT01068821|3740405|FG001|COMPLETED|Overall Study||29
3022060|NCT01068821|3740404|FG000|NOT COMPLETED|Overall Study||1
3022061|NCT01068821|3740405|FG001|NOT COMPLETED|Overall Study||0
3022062|NCT01068860|3740421|FG000|STARTED|Overall Study||33
3022063|NCT01068860|3740422|FG001|STARTED|Overall Study||17
3022064|NCT01068860|3740423|FG002|STARTED|Overall Study||33
3022065|NCT01068860|3740424|FG003|STARTED|Overall Study||17
3022066|NCT01068860|3740425|FG004|STARTED|Overall Study||32
3022067|NCT01068860|3740426|FG005|STARTED|Overall Study||16
3022068|NCT01068860|3740427|FG006|STARTED|Overall Study||28
3022069|NCT01068860|3740428|FG007|STARTED|Overall Study||15
3022070|NCT01068860|3740429|FG008|STARTED|Overall Study||28
3022071|NCT01068860|3740430|FG009|STARTED|Overall Study||27
3022072|NCT01068860|3740421|FG000|COMPLETED|Overall Study||33
3022073|NCT01068860|3740422|FG001|COMPLETED|Overall Study||16
3022074|NCT01068860|3740423|FG002|COMPLETED|Overall Study||33
3022075|NCT01068860|3740424|FG003|COMPLETED|Overall Study||16
3022076|NCT01068860|3740425|FG004|COMPLETED|Overall Study||32
3022077|NCT01068860|3740426|FG005|COMPLETED|Overall Study||14
3022078|NCT01068860|3740427|FG006|COMPLETED|Overall Study||28
3022079|NCT01068860|3740428|FG007|COMPLETED|Overall Study||15
3022080|NCT01068860|3740429|FG008|COMPLETED|Overall Study||28
3022081|NCT01068860|3740430|FG009|COMPLETED|Overall Study||23
3022082|NCT01068860|3740421|FG000|NOT COMPLETED|Overall Study||0
3022083|NCT01068860|3740422|FG001|NOT COMPLETED|Overall Study||1
3022084|NCT01068860|3740423|FG002|NOT COMPLETED|Overall Study||0
3022085|NCT01068860|3740424|FG003|NOT COMPLETED|Overall Study||1
3022086|NCT01068860|3740425|FG004|NOT COMPLETED|Overall Study||0
3022087|NCT01068860|3740426|FG005|NOT COMPLETED|Overall Study||2
3022088|NCT01068860|3740427|FG006|NOT COMPLETED|Overall Study||0
3022089|NCT01068860|3740428|FG007|NOT COMPLETED|Overall Study||0
3022090|NCT01068860|3740429|FG008|NOT COMPLETED|Overall Study||0
3022091|NCT01068860|3740430|FG009|NOT COMPLETED|Overall Study||4
3022092|NCT01068873|3740452|FG000|STARTED|Overall Study||1
3022093|NCT01068873|3740452|FG000|COMPLETED|Overall Study||1
3022094|NCT01068873|3740452|FG000|NOT COMPLETED|Overall Study||0
3022095|NCT01068912|3740459|FG000|STARTED|Overall Study||134
3022096|NCT01068912|3740460|FG001|STARTED|Overall Study||195
3022097|NCT01068912|3740461|FG002|STARTED|Overall Study||201
3022098|NCT01068912|3740459|FG000|COMPLETED|Overall Study||123
3022099|NCT01068912|3740460|FG001|COMPLETED|Overall Study||173
3022100|NCT01068912|3740461|FG002|COMPLETED|Overall Study||186
3022101|NCT01068912|3740459|FG000|NOT COMPLETED|Overall Study||11
3022102|NCT01068912|3740460|FG001|NOT COMPLETED|Overall Study||22
3022103|NCT01068912|3740461|FG002|NOT COMPLETED|Overall Study||15
3022104|NCT01068964|3740471|FG000|STARTED|Overall Study||121
3022105|NCT01068964|3740472|FG001|STARTED|Overall Study||114
3022106|NCT01068964|3740471|FG000|COMPLETED|Overall Study||113
3022107|NCT01068964|3740472|FG001|COMPLETED|Overall Study||104
3022108|NCT01068964|3740471|FG000|NOT COMPLETED|Overall Study||8
3022109|NCT01068964|3740472|FG001|NOT COMPLETED|Overall Study||10
3022110|NCT01069003|3740481|FG000|STARTED|Overall Study||399
3022111|NCT01069003|3740482|FG001|STARTED|Overall Study||412
3022112|NCT01069003|3740483|FG002|STARTED|Overall Study||1451
3022113|NCT01069003|3740481|FG000|COMPLETED|Overall Study||353
3022114|NCT01069003|3740482|FG001|COMPLETED|Overall Study||358
3022115|NCT01069003|3740483|FG002|COMPLETED|Overall Study||976
3022116|NCT01069003|3740481|FG000|NOT COMPLETED|Overall Study||46
3022117|NCT01069003|3740482|FG001|NOT COMPLETED|Overall Study||54
3022118|NCT01069003|3740483|FG002|NOT COMPLETED|Overall Study||475
3022119|NCT01069172|3740493|FG000|STARTED|Overall Study|30 eyes|30
3022120|NCT01069172|3740494|FG001|STARTED|Overall Study|30 eyes|30
3022121|NCT01069172|3740493|FG000|COMPLETED|Overall Study|29 eyes|29
3022122|NCT01069172|3740494|FG001|COMPLETED|Overall Study|30 eyes|30
3022123|NCT01069172|3740493|FG000|NOT COMPLETED|Overall Study||1
3022124|NCT01069172|3740494|FG001|NOT COMPLETED|Overall Study||0
3022125|NCT01069185|3740503|FG000|STARTED|Overall Study||47
3022126|NCT01069185|3740504|FG001|STARTED|Overall Study||45
3165689|NCT01901211|3893233|FG001|COMPLETED|Washout (6 Weeks)||5
3165690|NCT01901211|3893232|FG000|NOT COMPLETED|Washout (6 Weeks)||0
3022127|NCT01069185|3740503|FG000|COMPLETED|Overall Study||47
3022128|NCT01069185|3740504|FG001|COMPLETED|Overall Study||45
3022129|NCT01069185|3740503|FG000|NOT COMPLETED|Overall Study||0
3022130|NCT01069185|3740504|FG001|NOT COMPLETED|Overall Study||0
3022131|NCT01069289|3740512|FG000|STARTED|Overall Study||636
3022132|NCT01069289|3740513|FG001|STARTED|Overall Study||657
3022133|NCT01069289|3740512|FG000|COMPLETED|Overall Study||594
3022134|NCT01069289|3740513|FG001|COMPLETED|Overall Study||601
3022135|NCT01069289|3740512|FG000|NOT COMPLETED|Overall Study||42
3022136|NCT01069289|3740513|FG001|NOT COMPLETED|Overall Study||56
3022137|NCT01069315|3740523|FG000|STARTED|Overall Study||27
3022138|NCT01069315|3740524|FG001|STARTED|Overall Study||30
3022139|NCT01069315|3740525|FG002|STARTED|Overall Study||28
3022140|NCT01069315|3740526|FG003|STARTED|Overall Study||26
3022141|NCT01069315|3740523|FG000|COMPLETED|Overall Study||23
3022142|NCT01069315|3740524|FG001|COMPLETED|Overall Study||24
3022143|NCT01069315|3740525|FG002|COMPLETED|Overall Study||23
3022144|NCT01069315|3740526|FG003|COMPLETED|Overall Study||19
3022145|NCT01069315|3740523|FG000|NOT COMPLETED|Overall Study||4
3022146|NCT01069315|3740524|FG001|NOT COMPLETED|Overall Study||6
3022147|NCT01069315|3740525|FG002|NOT COMPLETED|Overall Study||5
3022148|NCT01069315|3740526|FG003|NOT COMPLETED|Overall Study||7
3022149|NCT01069341|3740540|FG000|STARTED|Overall Study||4
3022150|NCT01069341|3740540|FG000|COMPLETED|Overall Study||3
3022151|NCT01069341|3740540|FG000|NOT COMPLETED|Overall Study||1
3022152|NCT01069354|3740544|FG000|STARTED|Overall Study||102
3022153|NCT01069354|3740544|FG000|COMPLETED|Overall Study|One subject's treatment fold not injected due to adverse event during control fold injection|101
3022154|NCT01069354|3740544|FG000|NOT COMPLETED|Overall Study||1
3022155|NCT01069419|3740552|FG000|STARTED|Overall Study||1117
3022156|NCT01069419|3740552|FG000|Safety Set|Overall Study||1111
3022157|NCT01069419|3740552|FG000|Full Analysis Set|Overall Study||851
3022158|NCT01069419|3740552|FG000|COMPLETED|Overall Study||402
3022159|NCT01069419|3740552|FG000|NOT COMPLETED|Overall Study||715
3022160|NCT01069484|3740558|FG000|STARTED|Overall Study|27 in the stratum with major levator ani muscle defects and 60 in the stratum without such defects.|87
3022161|NCT01069484|3740559|FG001|STARTED|Overall Study|28 in the stratum with major levator ani muscle defects and 60 in the stratum without such defects.|88
3022162|NCT01069484|3740558|FG000|COMPLETED|Overall Study|24 in the stratum with major levator ani muscle defects and 51 in the stratum without such defects.|75
3022163|NCT01069484|3740559|FG001|COMPLETED|Overall Study|27 in the stratum with major levator ani muscle defects and 58 in the stratum without such defects.|85
3022164|NCT01069484|3740558|FG000|NOT COMPLETED|Overall Study||12
3022165|NCT01069484|3740559|FG001|NOT COMPLETED|Overall Study||3
3022166|NCT01069510|3740568|FG000|STARTED|Overall Study||8
3022167|NCT01069510|3740569|FG001|STARTED|Overall Study||7
3022168|NCT01069510|3740568|FG000|COMPLETED|Overall Study||8
3022169|NCT01069510|3740569|FG001|COMPLETED|Overall Study||7
3022170|NCT01069510|3740568|FG000|NOT COMPLETED|Overall Study||0
3022171|NCT01069510|3740569|FG001|NOT COMPLETED|Overall Study||0
3022172|NCT01069523|3740577|FG000|STARTED|Overall Study||13
3022173|NCT01069523|3740578|FG001|STARTED|Overall Study||16
3022174|NCT01069523|3740577|FG000|COMPLETED|Overall Study||9
3022175|NCT01069523|3740578|FG001|COMPLETED|Overall Study||9
3022176|NCT01069523|3740577|FG000|NOT COMPLETED|Overall Study||4
3022177|NCT01069523|3740578|FG001|NOT COMPLETED|Overall Study||7
3022178|NCT01069562|3740588|FG000|STARTED|Overall Study||20
3022179|NCT01069562|3740589|FG001|STARTED|Overall Study||20
3022180|NCT01069562|3740588|FG000|COMPLETED|Overall Study||20
3022181|NCT01069562|3740589|FG001|COMPLETED|Overall Study||20
3022182|NCT01069562|3740588|FG000|NOT COMPLETED|Overall Study||0
3022183|NCT01069562|3740589|FG001|NOT COMPLETED|Overall Study||0
3022184|NCT01069627|3740595|FG000|STARTED|Overall Study||20
3022185|NCT01069627|3740595|FG000|COMPLETED|Overall Study||0
3022186|NCT01069627|3740595|FG000|NOT COMPLETED|Overall Study||20
3022187|NCT01069705|3740599|FG000|STARTED|Overall Study||49
3022188|NCT01069705|3740599|FG000|COMPLETED|Overall Study||46
3022189|NCT01069705|3740599|FG000|NOT COMPLETED|Overall Study||3
3022190|NCT01069900|3740605|FG000|STARTED|Overall Study||305
3022191|NCT01069900|3740606|FG001|STARTED|Overall Study||153
3022192|NCT01069900|3740605|FG000|Treated|Overall Study||301
3022193|NCT01069900|3740606|FG001|Treated|Overall Study||150
3022194|NCT01069900|3740605|FG000|COMPLETED|Overall Study||287
3022195|NCT01069900|3740606|FG001|COMPLETED|Overall Study||149
3022196|NCT01069900|3740605|FG000|NOT COMPLETED|Overall Study||18
3022197|NCT01069900|3740606|FG001|NOT COMPLETED|Overall Study||4
3022198|NCT01069939|3740614|FG000|STARTED|Randomised and Included in the Analyses||213
3022199|NCT01069939|3740615|FG001|STARTED|Randomised and Included in the Analyses||214
3022200|NCT01069939|3740614|FG000|COMPLETED|Randomised and Included in the Analyses||164
3022201|NCT01069939|3740615|FG001|COMPLETED|Randomised and Included in the Analyses||137
3022202|NCT01069939|3740614|FG000|NOT COMPLETED|Randomised and Included in the Analyses||49
3022203|NCT01069939|3740615|FG001|NOT COMPLETED|Randomised and Included in the Analyses||77
3022204|NCT01069939|3740614|FG000|STARTED|At Data Cut Off Date (26 Feb 2011)||213
3022205|NCT01069939|3740615|FG001|STARTED|At Data Cut Off Date (26 Feb 2011)||214
3022206|NCT01069939|3740614|FG000|COMPLETED|At Data Cut Off Date (26 Feb 2011)||182
3022207|NCT01069939|3740615|FG001|COMPLETED|At Data Cut Off Date (26 Feb 2011)||182
3022208|NCT01069939|3740614|FG000|NOT COMPLETED|At Data Cut Off Date (26 Feb 2011)||31
3022209|NCT01069939|3740615|FG001|NOT COMPLETED|At Data Cut Off Date (26 Feb 2011)||32
3022210|NCT01070043|3740623|FG000|STARTED|Run-In Phase||60
3022211|NCT01070043|3740624|FG001|STARTED|Run-In Phase|This combination therapy arm is used only for double-blind phase.|0
3022212|NCT01070043|3740625|FG002|STARTED|Run-In Phase|This monotherapy (Valsartan 160 mg) treatment arm is used only for double-blind phase.|0
3022213|NCT01070043|3740623|FG000|COMPLETED|Run-In Phase||42
3022214|NCT01070043|3740624|FG001|COMPLETED|Run-In Phase||0
3022215|NCT01070043|3740625|FG002|COMPLETED|Run-In Phase||0
3022216|NCT01070043|3740623|FG000|NOT COMPLETED|Run-In Phase||18
3022217|NCT01070043|3740624|FG001|NOT COMPLETED|Run-In Phase||0
3022218|NCT01070043|3740625|FG002|NOT COMPLETED|Run-In Phase||0
3022219|NCT01070043|3740623|FG000|STARTED|Double-Blind Treatment||0
3022220|NCT01070043|3740624|FG001|STARTED|Double-Blind Treatment||21
3022221|NCT01070043|3740625|FG002|STARTED|Double-Blind Treatment||21
3022222|NCT01070043|3740623|FG000|COMPLETED|Double-Blind Treatment||0
3022223|NCT01070043|3740624|FG001|COMPLETED|Double-Blind Treatment||21
3022224|NCT01070043|3740625|FG002|COMPLETED|Double-Blind Treatment||19
3022225|NCT01070043|3740623|FG000|NOT COMPLETED|Double-Blind Treatment||0
3022226|NCT01070043|3740624|FG001|NOT COMPLETED|Double-Blind Treatment||0
3022227|NCT01070043|3740625|FG002|NOT COMPLETED|Double-Blind Treatment||2
3022228|NCT01070095|3740631|FG000|STARTED|Baseline Period||19
3022229|NCT01070095|3740632|FG001|STARTED|Baseline Period||830
3022230|NCT01070095|3740631|FG000|COMPLETED|Baseline Period||18
3022231|NCT01070095|3740632|FG001|COMPLETED|Baseline Period||830
3022232|NCT01070095|3740631|FG000|NOT COMPLETED|Baseline Period||1
3022233|NCT01070095|3740632|FG001|NOT COMPLETED|Baseline Period||0
3022234|NCT01070095|3740631|FG000|STARTED|Intervention Period||18
3022235|NCT01070095|3740632|FG001|STARTED|Intervention Period||890
3022236|NCT01070095|3740631|FG000|COMPLETED|Intervention Period||18
3022237|NCT01070095|3740632|FG001|COMPLETED|Intervention Period||890
3022238|NCT01070095|3740631|FG000|NOT COMPLETED|Intervention Period||0
3022239|NCT01070095|3740632|FG001|NOT COMPLETED|Intervention Period||0
3022240|NCT01070173|3740642|FG000|STARTED|Overall Study||33
3022241|NCT01070173|3740643|FG001|STARTED|Overall Study||8
3022242|NCT01070173|3740644|FG002|STARTED|Overall Study||11
3022243|NCT01070173|3740642|FG000|COMPLETED|Overall Study||33
3022244|NCT01070173|3740643|FG001|COMPLETED|Overall Study||8
3022245|NCT01070173|3740644|FG002|COMPLETED|Overall Study||11
3022246|NCT01070173|3740642|FG000|NOT COMPLETED|Overall Study||0
3022247|NCT01070173|3740643|FG001|NOT COMPLETED|Overall Study||0
3022248|NCT01070173|3740644|FG002|NOT COMPLETED|Overall Study||0
3022249|NCT01070303|3740654|FG000|STARTED|Overall Study||177
3022250|NCT01070303|3740654|FG000|COMPLETED|Overall Study||88
3022251|NCT01070303|3740654|FG000|NOT COMPLETED|Overall Study||89
3022252|NCT01070316|3740664|FG000|STARTED|Main Phase||20
3022253|NCT01070316|3740664|FG000|COMPLETED|Main Phase||20
3022254|NCT01070316|3740664|FG000|NOT COMPLETED|Main Phase||0
3022255|NCT01070316|3740664|FG000|STARTED|Extension Phase|Two participants did not qualify for Extension Phase as defined by protocol|18
3022256|NCT01070316|3740664|FG000|COMPLETED|Extension Phase||14
3022257|NCT01070316|3740664|FG000|NOT COMPLETED|Extension Phase||4
3022258|NCT01070329|3740670|FG000|STARTED|Overall Study||261
3022259|NCT01070329|3740671|FG001|STARTED|Overall Study||266
3022260|NCT01070329|3740670|FG000|COMPLETED|Overall Study||209
3022261|NCT01070329|3740671|FG001|COMPLETED|Overall Study||217
3022262|NCT01070329|3740670|FG000|NOT COMPLETED|Overall Study||52
3022263|NCT01070329|3740671|FG001|NOT COMPLETED|Overall Study||49
3022264|NCT01070381|3740677|FG000|STARTED|Period 1, 1 Week of Wear|One subject could not be dispensed into Period 1 product. Subject started Period 2 wear.|109
3022265|NCT01070381|3740678|FG001|STARTED|Period 1, 1 Week of Wear||107
3022266|NCT01070381|3740677|FG000|COMPLETED|Period 1, 1 Week of Wear|One subject could not continue into Period 2 due to product unavailability.|109
3022267|NCT01070381|3740678|FG001|COMPLETED|Period 1, 1 Week of Wear||107
3022268|NCT01070381|3740677|FG000|NOT COMPLETED|Period 1, 1 Week of Wear||0
3022269|NCT01070381|3740678|FG001|NOT COMPLETED|Period 1, 1 Week of Wear||0
3022270|NCT01070381|3740677|FG000|STARTED|Period 2, 1 Week of Wear||109
3022271|NCT01070381|3740678|FG001|STARTED|Period 2, 1 Week of Wear||107
3022272|NCT01070381|3740677|FG000|COMPLETED|Period 2, 1 Week of Wear||108
3022273|NCT01070381|3740678|FG001|COMPLETED|Period 2, 1 Week of Wear||106
3022274|NCT01070381|3740677|FG000|NOT COMPLETED|Period 2, 1 Week of Wear||1
3165691|NCT01901211|3893233|FG001|NOT COMPLETED|Washout (6 Weeks)||0
3165692|NCT01901211|3893232|FG000|STARTED|Second Ten-week Period||6
3165693|NCT01901211|3893233|FG001|STARTED|Second Ten-week Period||5
3165694|NCT01901211|3893232|FG000|COMPLETED|Second Ten-week Period||6
3022275|NCT01070381|3740678|FG001|NOT COMPLETED|Period 2, 1 Week of Wear||1
3022276|NCT01070394|3740684|FG000|STARTED|Overall Study||40
3022277|NCT01070394|3740684|FG000|COMPLETED|Overall Study||33
3022278|NCT01070394|3740684|FG000|NOT COMPLETED|Overall Study||7
3022279|NCT01070550|3740696|FG000|STARTED|Overall Study||3356
3022280|NCT01070550|3740697|FG001|STARTED|Overall Study||316
3022281|NCT01070550|3740698|FG002|STARTED|Overall Study||744
3022282|NCT01070550|3740699|FG003|STARTED|Overall Study||201
3022283|NCT01070550|3740700|FG004|STARTED|Overall Study||21
3022284|NCT01070550|3740701|FG005|STARTED|Overall Study||42
3022285|NCT01070550|3740696|FG000|COMPLETED|Overall Study||2071
3022286|NCT01070550|3740697|FG001|COMPLETED|Overall Study||254
3022287|NCT01070550|3740698|FG002|COMPLETED|Overall Study||528
3022288|NCT01070550|3740699|FG003|COMPLETED|Overall Study||124
3022289|NCT01070550|3740700|FG004|COMPLETED|Overall Study||20
3022290|NCT01070550|3740701|FG005|COMPLETED|Overall Study||35
3022291|NCT01070550|3740696|FG000|NOT COMPLETED|Overall Study||1285
3022292|NCT01070550|3740697|FG001|NOT COMPLETED|Overall Study||62
3022293|NCT01070550|3740698|FG002|NOT COMPLETED|Overall Study||216
3022294|NCT01070550|3740699|FG003|NOT COMPLETED|Overall Study||77
3022295|NCT01070550|3740700|FG004|NOT COMPLETED|Overall Study||1
3022296|NCT01070550|3740701|FG005|NOT COMPLETED|Overall Study||7
3022297|NCT01070693|3740718|FG000|STARTED|Overall Study||150
3022298|NCT01070693|3740719|FG001|STARTED|Overall Study||149
3022299|NCT01070693|3740718|FG000|COMPLETED|Overall Study||122
3022300|NCT01070693|3740719|FG001|COMPLETED|Overall Study||110
3022301|NCT01070693|3740718|FG000|NOT COMPLETED|Overall Study||28
3022302|NCT01070693|3740719|FG001|NOT COMPLETED|Overall Study||39
3022303|NCT01070771|3740725|FG000|STARTED|Overall Study|September 2008|203
3022304|NCT01070771|3740725|FG000|COMPLETED|Overall Study|August 2012|200
3022305|NCT01070771|3740725|FG000|NOT COMPLETED|Overall Study||3
3022306|NCT01070784|3740732|FG000|STARTED|Overall Study||130
3022307|NCT01070784|3740733|FG001|STARTED|Overall Study||130
3022308|NCT01070784|3740732|FG000|COMPLETED|Overall Study||110
3022309|NCT01070784|3740733|FG001|COMPLETED|Overall Study||112
3022310|NCT01070784|3740732|FG000|NOT COMPLETED|Overall Study||20
3022311|NCT01070784|3740733|FG001|NOT COMPLETED|Overall Study||18
3022312|NCT01070810|3740741|FG000|STARTED|Overall Study||45
3022313|NCT01070810|3740742|FG001|STARTED|Overall Study||43
3022314|NCT01070810|3740741|FG000|COMPLETED|Overall Study||45
3022315|NCT01070810|3740742|FG001|COMPLETED|Overall Study||43
3022316|NCT01070810|3740741|FG000|NOT COMPLETED|Overall Study||0
3022317|NCT01070810|3740742|FG001|NOT COMPLETED|Overall Study||0
3022318|NCT01070888|3740752|FG000|STARTED|First Intervention (14 Days)||2
3022319|NCT01070888|3740753|FG001|STARTED|First Intervention (14 Days)||4
3022320|NCT01070888|3740752|FG000|COMPLETED|First Intervention (14 Days)||2
3022321|NCT01070888|3740753|FG001|COMPLETED|First Intervention (14 Days)||2
3022322|NCT01070888|3740752|FG000|NOT COMPLETED|First Intervention (14 Days)||0
3022323|NCT01070888|3740753|FG001|NOT COMPLETED|First Intervention (14 Days)||2
3022324|NCT01070888|3740752|FG000|STARTED|Washout (14 Days)||2
3022325|NCT01070888|3740753|FG001|STARTED|Washout (14 Days)||2
3022326|NCT01070888|3740752|FG000|COMPLETED|Washout (14 Days)||1
3165695|NCT01901211|3893233|FG001|COMPLETED|Second Ten-week Period||5
3022327|NCT01070888|3740753|FG001|COMPLETED|Washout (14 Days)||2
3022328|NCT01070888|3740752|FG000|NOT COMPLETED|Washout (14 Days)||1
3022329|NCT01070888|3740753|FG001|NOT COMPLETED|Washout (14 Days)||0
3022330|NCT01070888|3740752|FG000|STARTED|Second Intervention (14 Days)||1
3022331|NCT01070888|3740753|FG001|STARTED|Second Intervention (14 Days)||2
3022332|NCT01070888|3740752|FG000|COMPLETED|Second Intervention (14 Days)||1
3022333|NCT01070888|3740753|FG001|COMPLETED|Second Intervention (14 Days)||2
3022334|NCT01070888|3740752|FG000|NOT COMPLETED|Second Intervention (14 Days)||0
3022335|NCT01070888|3740753|FG001|NOT COMPLETED|Second Intervention (14 Days)||0
3022336|NCT01070979|3740762|FG000|STARTED|Overall Study||79
3022337|NCT01070979|3740763|FG001|STARTED|Overall Study||85
3022338|NCT01070979|3740764|FG002|STARTED|Overall Study||85
3022339|NCT01070979|3740762|FG000|COMPLETED|Overall Study||68
3022340|NCT01070979|3740763|FG001|COMPLETED|Overall Study||73
3022341|NCT01070979|3740764|FG002|COMPLETED|Overall Study||72
3022342|NCT01070979|3740762|FG000|NOT COMPLETED|Overall Study||11
3022343|NCT01070979|3740763|FG001|NOT COMPLETED|Overall Study||12
3022344|NCT01070979|3740764|FG002|NOT COMPLETED|Overall Study||13
3022345|NCT01071044|3740774|FG000|STARTED|Overall Study||15
3022346|NCT01071044|3740775|FG001|STARTED|Overall Study||11
3022347|NCT01071044|3740774|FG000|COMPLETED|Overall Study||13
3022348|NCT01071044|3740775|FG001|COMPLETED|Overall Study||11
3022349|NCT01071044|3740774|FG000|NOT COMPLETED|Overall Study||2
3022350|NCT01071044|3740775|FG001|NOT COMPLETED|Overall Study||0
3022351|NCT01071070|3740786|FG000|STARTED|Overall Study||108
3022352|NCT01071070|3740787|FG001|STARTED|Overall Study||108
3022353|NCT01071070|3740786|FG000|COMPLETED|Overall Study||104
3022354|NCT01071070|3740787|FG001|COMPLETED|Overall Study||105
3022355|NCT01071070|3740786|FG000|NOT COMPLETED|Overall Study||4
3022356|NCT01071070|3740787|FG001|NOT COMPLETED|Overall Study||3
3022357|NCT01071083|3740798|FG000|STARTED|Overall Study||42
3022358|NCT01071083|3740799|FG001|STARTED|Overall Study||45
3165696|NCT01901211|3893232|FG000|NOT COMPLETED|Second Ten-week Period||0
3022359|NCT01071083|3740800|FG002|STARTED|Overall Study||17
3022360|NCT01071083|3740801|FG003|STARTED|Overall Study||17
3022361|NCT01071083|3740802|FG004|STARTED|Overall Study||54
3022362|NCT01071083|3740798|FG000|COMPLETED|Overall Study||35
3022363|NCT01071083|3740799|FG001|COMPLETED|Overall Study||43
3022364|NCT01071083|3740800|FG002|COMPLETED|Overall Study||12
3022365|NCT01071083|3740801|FG003|COMPLETED|Overall Study||15
3022366|NCT01071083|3740802|FG004|COMPLETED|Overall Study||46
3022367|NCT01071083|3740798|FG000|NOT COMPLETED|Overall Study||7
3022368|NCT01071083|3740799|FG001|NOT COMPLETED|Overall Study||2
3022369|NCT01071083|3740800|FG002|NOT COMPLETED|Overall Study||5
3022370|NCT01071083|3740801|FG003|NOT COMPLETED|Overall Study||2
3022371|NCT01071083|3740802|FG004|NOT COMPLETED|Overall Study||8
3022372|NCT01071096|3740814|FG000|STARTED|First Intervention (90 Days)||10
3022373|NCT01071096|3740815|FG001|STARTED|First Intervention (90 Days)||10
3022374|NCT01071096|3740814|FG000|COMPLETED|First Intervention (90 Days)||9
3022375|NCT01071096|3740815|FG001|COMPLETED|First Intervention (90 Days)||10
3022376|NCT01071096|3740814|FG000|NOT COMPLETED|First Intervention (90 Days)||1
3022377|NCT01071096|3740815|FG001|NOT COMPLETED|First Intervention (90 Days)||0
3022378|NCT01071096|3740814|FG000|STARTED|Washout Period (30 Days)||9
3022379|NCT01071096|3740815|FG001|STARTED|Washout Period (30 Days)||10
3022380|NCT01071096|3740814|FG000|COMPLETED|Washout Period (30 Days)||9
3022381|NCT01071096|3740815|FG001|COMPLETED|Washout Period (30 Days)||10
3022382|NCT01071096|3740814|FG000|NOT COMPLETED|Washout Period (30 Days)||0
3022383|NCT01071096|3740815|FG001|NOT COMPLETED|Washout Period (30 Days)||0
3022384|NCT01071096|3740814|FG000|STARTED|Second Intervention (90 Days)||9
3022385|NCT01071096|3740815|FG001|STARTED|Second Intervention (90 Days)||10
3022386|NCT01071096|3740814|FG000|COMPLETED|Second Intervention (90 Days)||9
3022387|NCT01071096|3740815|FG001|COMPLETED|Second Intervention (90 Days)||10
3022388|NCT01071096|3740814|FG000|NOT COMPLETED|Second Intervention (90 Days)||0
3022389|NCT01071096|3740815|FG001|NOT COMPLETED|Second Intervention (90 Days)||0
3022390|NCT01071200|3740834|FG000|STARTED|Overall Study||67
3022391|NCT01071200|3740835|FG001|STARTED|Overall Study||66
3022392|NCT01071200|3740834|FG000|COMPLETED|Overall Study||60
3022393|NCT01071200|3740835|FG001|COMPLETED|Overall Study||63
3022394|NCT01071200|3740834|FG000|NOT COMPLETED|Overall Study||7
3022395|NCT01071200|3740835|FG001|NOT COMPLETED|Overall Study||3
3022396|NCT01071252|3740846|FG000|STARTED|Overall Study||29
3165697|NCT01901211|3893233|FG001|NOT COMPLETED|Second Ten-week Period||0
3022397|NCT01071252|3740847|FG001|STARTED|Overall Study||26
3022398|NCT01071252|3740848|FG002|STARTED|Overall Study||21
3022399|NCT01071252|3740849|FG003|STARTED|Overall Study||27
3022400|NCT01071252|3740850|FG004|STARTED|Overall Study||22
3022401|NCT01071252|3740846|FG000|COMPLETED|Overall Study||14
3022402|NCT01071252|3740847|FG001|COMPLETED|Overall Study||16
3022403|NCT01071252|3740848|FG002|COMPLETED|Overall Study||17
3022404|NCT01071252|3740849|FG003|COMPLETED|Overall Study||20
3022405|NCT01071252|3740850|FG004|COMPLETED|Overall Study||11
3022406|NCT01071252|3740846|FG000|NOT COMPLETED|Overall Study||15
3022407|NCT01071252|3740847|FG001|NOT COMPLETED|Overall Study||10
3022408|NCT01071252|3740848|FG002|NOT COMPLETED|Overall Study||4
3022409|NCT01071252|3740849|FG003|NOT COMPLETED|Overall Study||7
3022410|NCT01071252|3740850|FG004|NOT COMPLETED|Overall Study||11
3022411|NCT01071278|3740862|FG000|STARTED|Overall Study||2390
3022412|NCT01071278|3740862|FG000|COMPLETED|Overall Study||1677
3022413|NCT01071278|3740862|FG000|NOT COMPLETED|Overall Study||713
3022414|NCT01071317|3740870|FG000|STARTED|Overall Study||25
3022415|NCT01071317|3740871|FG001|STARTED|Overall Study||25
3022416|NCT01071317|3740870|FG000|COMPLETED|Overall Study||23
3022417|NCT01071317|3740871|FG001|COMPLETED|Overall Study||23
3022418|NCT01071317|3740870|FG000|NOT COMPLETED|Overall Study||2
3022419|NCT01071317|3740871|FG001|NOT COMPLETED|Overall Study||2
3022420|NCT01071356|3740879|FG000|STARTED|Overall Study||111
3022421|NCT01071356|3740880|FG001|STARTED|Overall Study||106
3022422|NCT01071356|3740879|FG000|COMPLETED|Overall Study||104
3022423|NCT01071356|3740880|FG001|COMPLETED|Overall Study||97
3022424|NCT01071356|3740879|FG000|NOT COMPLETED|Overall Study||7
3022425|NCT01071356|3740880|FG001|NOT COMPLETED|Overall Study||9
3022426|NCT01071395|3740888|FG000|STARTED|Overall Study||36
3022427|NCT01071395|3740889|FG001|STARTED|Overall Study||32
3022428|NCT01071395|3740888|FG000|COMPLETED|Overall Study||31
3022429|NCT01071395|3740889|FG001|COMPLETED|Overall Study||30
3022430|NCT01071395|3740888|FG000|NOT COMPLETED|Overall Study||5
3022431|NCT01071395|3740889|FG001|NOT COMPLETED|Overall Study||2
3022432|NCT01071512|3740895|FG000|STARTED|Overall Study||20
3022433|NCT01071512|3740895|FG000|COMPLETED|Overall Study||15
3022434|NCT01071512|3740895|FG000|NOT COMPLETED|Overall Study||5
3022435|NCT01071538|3740899|FG000|STARTED|Overall Study||15
3022436|NCT01071538|3740899|FG000|COMPLETED|Overall Study||13
3022437|NCT01071538|3740899|FG000|NOT COMPLETED|Overall Study||2
3022438|NCT01071798|3740903|FG000|STARTED|Participants Who Received One Cycle||1653
3022439|NCT01071798|3740903|FG000|Baseline and Safety Analysis Set|Participants Who Received One Cycle||1653
3022440|NCT01071798|3740903|FG000|COMPLETED|Participants Who Received One Cycle||1588
3022441|NCT01071798|3740903|FG000|NOT COMPLETED|Participants Who Received One Cycle||65
3022442|NCT01071798|3740903|FG000|STARTED|Subpopulation Who Received Two Cycles||820
3022443|NCT01071798|3740903|FG000|Baseline and Safety Analysis Set|Subpopulation Who Received Two Cycles||820
3022444|NCT01071798|3740903|FG000|COMPLETED|Subpopulation Who Received Two Cycles||805
3022445|NCT01071798|3740903|FG000|NOT COMPLETED|Subpopulation Who Received Two Cycles||15
3022446|NCT01071915|3740917|FG000|STARTED|Overall Study|Intention to Treat Analysis Set|157
3022447|NCT01071915|3740917|FG000|Full Analysis Set (FAS)|Overall Study||155
3022448|NCT01071915|3740917|FG000|Safety Analysis Set|Overall Study||156
3022449|NCT01071915|3740917|FG000|COMPLETED|Overall Study||148
3022450|NCT01071915|3740917|FG000|NOT COMPLETED|Overall Study||9
3022451|NCT01071954|3740921|FG000|STARTED|Overall Study||66
3022452|NCT01071954|3740921|FG000|Received Treatment|Overall Study||65
3022453|NCT01071954|3740921|FG000|COMPLETED|Overall Study||39
3022454|NCT01071954|3740921|FG000|NOT COMPLETED|Overall Study||27
3022455|NCT01072006|3740929|FG000|STARTED|Overall Study||14
3022456|NCT01072006|3740930|FG001|STARTED|Overall Study||5
3022457|NCT01072006|3740931|FG002|STARTED|Overall Study||0
3022458|NCT01072006|3740932|FG003|STARTED|Overall Study||11
3022459|NCT01072006|3740929|FG000|COMPLETED|Overall Study||14
3022460|NCT01072006|3740930|FG001|COMPLETED|Overall Study||5
3022461|NCT01072006|3740931|FG002|COMPLETED|Overall Study||0
3022462|NCT01072006|3740932|FG003|COMPLETED|Overall Study||11
3022463|NCT01072006|3740929|FG000|NOT COMPLETED|Overall Study||0
3022464|NCT01072006|3740930|FG001|NOT COMPLETED|Overall Study||0
3022465|NCT01072006|3740931|FG002|NOT COMPLETED|Overall Study||0
3022466|NCT01072006|3740932|FG003|NOT COMPLETED|Overall Study||0
3022467|NCT01072032|3740945|FG000|STARTED|Overall Study||13
3022468|NCT01072032|3740946|FG001|STARTED|Overall Study||14
3022469|NCT01072032|3740945|FG000|COMPLETED|Overall Study||5
3022470|NCT01072032|3740946|FG001|COMPLETED|Overall Study||5
3022471|NCT01072032|3740945|FG000|NOT COMPLETED|Overall Study||8
3022472|NCT01072032|3740946|FG001|NOT COMPLETED|Overall Study||9
3022473|NCT01072136|3740955|FG000|STARTED|Overall Study||44
3022474|NCT01072136|3740956|FG001|STARTED|Overall Study||43
3022475|NCT01072136|3740955|FG000|Met All Enrollment Criteria|Overall Study|Some eligibility test results were not available until after randomization.|30
3022476|NCT01072136|3740956|FG001|Met All Enrollment Criteria|Overall Study||25
3022477|NCT01072136|3740955|FG000|COMPLETED|Overall Study||21
3022478|NCT01072136|3740956|FG001|COMPLETED|Overall Study||12
3022479|NCT01072136|3740955|FG000|NOT COMPLETED|Overall Study||23
3022480|NCT01072136|3740956|FG001|NOT COMPLETED|Overall Study||31
3022481|NCT01072149|3740965|FG000|STARTED|Treatment Period 1 (28 Days)||3
3022482|NCT01072149|3740966|FG001|STARTED|Treatment Period 1 (28 Days)||3
3022483|NCT01072149|3740967|FG002|STARTED|Treatment Period 1 (28 Days)||3
3022484|NCT01072149|3740968|FG003|STARTED|Treatment Period 1 (28 Days)||3
3022485|NCT01072149|3740969|FG004|STARTED|Treatment Period 1 (28 Days)||3
3022486|NCT01072149|3740970|FG005|STARTED|Treatment Period 1 (28 Days)||3
3022487|NCT01072149|3740971|FG006|STARTED|Treatment Period 1 (28 Days)||3
3022488|NCT01072149|3740972|FG007|STARTED|Treatment Period 1 (28 Days)||3
3022489|NCT01072149|3740973|FG008|STARTED|Treatment Period 1 (28 Days)||3
3022490|NCT01072149|3740974|FG009|STARTED|Treatment Period 1 (28 Days)||3
3022491|NCT01072149|3740975|FG010|STARTED|Treatment Period 1 (28 Days)||3
3022492|NCT01072149|3740976|FG011|STARTED|Treatment Period 1 (28 Days)||3
3022493|NCT01072149|3740977|FG012|STARTED|Treatment Period 1 (28 Days)||3
3022494|NCT01072149|3740978|FG013|STARTED|Treatment Period 1 (28 Days)||3
3022495|NCT01072149|3740979|FG014|STARTED|Treatment Period 1 (28 Days)||3
3022496|NCT01072149|3740980|FG015|STARTED|Treatment Period 1 (28 Days)||3
3022497|NCT01072149|3740981|FG016|STARTED|Treatment Period 1 (28 Days)||3
3022498|NCT01072149|3740982|FG017|STARTED|Treatment Period 1 (28 Days)||3
3022499|NCT01072149|3740965|FG000|COMPLETED|Treatment Period 1 (28 Days)||3
3022500|NCT01072149|3740966|FG001|COMPLETED|Treatment Period 1 (28 Days)||3
3022501|NCT01072149|3740967|FG002|COMPLETED|Treatment Period 1 (28 Days)||2
3022502|NCT01072149|3740968|FG003|COMPLETED|Treatment Period 1 (28 Days)||3
3022503|NCT01072149|3740969|FG004|COMPLETED|Treatment Period 1 (28 Days)||3
3022504|NCT01072149|3740970|FG005|COMPLETED|Treatment Period 1 (28 Days)||3
3022505|NCT01072149|3740971|FG006|COMPLETED|Treatment Period 1 (28 Days)||3
3022506|NCT01072149|3740972|FG007|COMPLETED|Treatment Period 1 (28 Days)||3
3022507|NCT01072149|3740973|FG008|COMPLETED|Treatment Period 1 (28 Days)||3
3022508|NCT01072149|3740974|FG009|COMPLETED|Treatment Period 1 (28 Days)||3
3022509|NCT01072149|3740975|FG010|COMPLETED|Treatment Period 1 (28 Days)||2
3022510|NCT01072149|3740976|FG011|COMPLETED|Treatment Period 1 (28 Days)||3
3022511|NCT01072149|3740977|FG012|COMPLETED|Treatment Period 1 (28 Days)||3
3022512|NCT01072149|3740978|FG013|COMPLETED|Treatment Period 1 (28 Days)||3
3022513|NCT01072149|3740979|FG014|COMPLETED|Treatment Period 1 (28 Days)||3
3022514|NCT01072149|3740980|FG015|COMPLETED|Treatment Period 1 (28 Days)||3
3022515|NCT01072149|3740981|FG016|COMPLETED|Treatment Period 1 (28 Days)||3
3022516|NCT01072149|3740982|FG017|COMPLETED|Treatment Period 1 (28 Days)||2
3022517|NCT01072149|3740965|FG000|NOT COMPLETED|Treatment Period 1 (28 Days)||0
3022518|NCT01072149|3740966|FG001|NOT COMPLETED|Treatment Period 1 (28 Days)||0
3022519|NCT01072149|3740967|FG002|NOT COMPLETED|Treatment Period 1 (28 Days)||1
3022520|NCT01072149|3740968|FG003|NOT COMPLETED|Treatment Period 1 (28 Days)||0
3022521|NCT01072149|3740969|FG004|NOT COMPLETED|Treatment Period 1 (28 Days)||0
3022522|NCT01072149|3740970|FG005|NOT COMPLETED|Treatment Period 1 (28 Days)||0
3022523|NCT01072149|3740971|FG006|NOT COMPLETED|Treatment Period 1 (28 Days)||0
3022524|NCT01072149|3740972|FG007|NOT COMPLETED|Treatment Period 1 (28 Days)||0
3022525|NCT01072149|3740973|FG008|NOT COMPLETED|Treatment Period 1 (28 Days)||0
3022526|NCT01072149|3740974|FG009|NOT COMPLETED|Treatment Period 1 (28 Days)||0
3022527|NCT01072149|3740975|FG010|NOT COMPLETED|Treatment Period 1 (28 Days)||1
3022528|NCT01072149|3740976|FG011|NOT COMPLETED|Treatment Period 1 (28 Days)||0
3022529|NCT01072149|3740977|FG012|NOT COMPLETED|Treatment Period 1 (28 Days)||0
3022530|NCT01072149|3740978|FG013|NOT COMPLETED|Treatment Period 1 (28 Days)||0
3022531|NCT01072149|3740979|FG014|NOT COMPLETED|Treatment Period 1 (28 Days)||0
3022532|NCT01072149|3740980|FG015|NOT COMPLETED|Treatment Period 1 (28 Days)||0
3022533|NCT01072149|3740981|FG016|NOT COMPLETED|Treatment Period 1 (28 Days)||0
3022534|NCT01072149|3740982|FG017|NOT COMPLETED|Treatment Period 1 (28 Days)||1
3022535|NCT01072149|3740965|FG000|STARTED|Washout Period 1 (14 Days)||3
3022536|NCT01072149|3740966|FG001|STARTED|Washout Period 1 (14 Days)||3
3022537|NCT01072149|3740967|FG002|STARTED|Washout Period 1 (14 Days)||2
3022538|NCT01072149|3740968|FG003|STARTED|Washout Period 1 (14 Days)||3
3022539|NCT01072149|3740969|FG004|STARTED|Washout Period 1 (14 Days)||3
3022540|NCT01072149|3740970|FG005|STARTED|Washout Period 1 (14 Days)||3
3022541|NCT01072149|3740971|FG006|STARTED|Washout Period 1 (14 Days)||3
3022542|NCT01072149|3740972|FG007|STARTED|Washout Period 1 (14 Days)||3
3022543|NCT01072149|3740973|FG008|STARTED|Washout Period 1 (14 Days)||3
3022544|NCT01072149|3740974|FG009|STARTED|Washout Period 1 (14 Days)||3
3022545|NCT01072149|3740975|FG010|STARTED|Washout Period 1 (14 Days)||2
3022546|NCT01072149|3740976|FG011|STARTED|Washout Period 1 (14 Days)||3
3022547|NCT01072149|3740977|FG012|STARTED|Washout Period 1 (14 Days)||3
3022548|NCT01072149|3740978|FG013|STARTED|Washout Period 1 (14 Days)||3
3022549|NCT01072149|3740979|FG014|STARTED|Washout Period 1 (14 Days)||3
3022550|NCT01072149|3740980|FG015|STARTED|Washout Period 1 (14 Days)||3
3022551|NCT01072149|3740981|FG016|STARTED|Washout Period 1 (14 Days)||3
3022552|NCT01072149|3740982|FG017|STARTED|Washout Period 1 (14 Days)||2
3022553|NCT01072149|3740965|FG000|COMPLETED|Washout Period 1 (14 Days)||3
3022554|NCT01072149|3740966|FG001|COMPLETED|Washout Period 1 (14 Days)||3
3022555|NCT01072149|3740967|FG002|COMPLETED|Washout Period 1 (14 Days)||2
3022556|NCT01072149|3740968|FG003|COMPLETED|Washout Period 1 (14 Days)||3
3022557|NCT01072149|3740969|FG004|COMPLETED|Washout Period 1 (14 Days)||3
3022558|NCT01072149|3740970|FG005|COMPLETED|Washout Period 1 (14 Days)||3
3022559|NCT01072149|3740971|FG006|COMPLETED|Washout Period 1 (14 Days)||3
3308481|NCT03020745|4041799|FG006|COMPLETED|Part 2 (Up to 169 Days)||6
3308482|NCT03020745|4041800|FG007|COMPLETED|Part 2 (Up to 169 Days)||19
3308483|NCT03020745|4041801|FG008|COMPLETED|Part 2 (Up to 169 Days)||14
3308484|NCT03020745|4041802|FG009|COMPLETED|Part 2 (Up to 169 Days)||15
3308485|NCT03020745|4041793|FG000|NOT COMPLETED|Part 2 (Up to 169 Days)||0
3022560|NCT01072149|3740972|FG007|COMPLETED|Washout Period 1 (14 Days)||3
3022561|NCT01072149|3740973|FG008|COMPLETED|Washout Period 1 (14 Days)||3
3022562|NCT01072149|3740974|FG009|COMPLETED|Washout Period 1 (14 Days)||3
3022563|NCT01072149|3740975|FG010|COMPLETED|Washout Period 1 (14 Days)||2
3022564|NCT01072149|3740976|FG011|COMPLETED|Washout Period 1 (14 Days)||3
3022565|NCT01072149|3740977|FG012|COMPLETED|Washout Period 1 (14 Days)||3
3022566|NCT01072149|3740978|FG013|COMPLETED|Washout Period 1 (14 Days)||3
3022567|NCT01072149|3740979|FG014|COMPLETED|Washout Period 1 (14 Days)||3
3022568|NCT01072149|3740980|FG015|COMPLETED|Washout Period 1 (14 Days)||3
3022569|NCT01072149|3740981|FG016|COMPLETED|Washout Period 1 (14 Days)||3
3022570|NCT01072149|3740982|FG017|COMPLETED|Washout Period 1 (14 Days)||2
3022571|NCT01072149|3740965|FG000|NOT COMPLETED|Washout Period 1 (14 Days)||0
3022572|NCT01072149|3740966|FG001|NOT COMPLETED|Washout Period 1 (14 Days)||0
3022573|NCT01072149|3740967|FG002|NOT COMPLETED|Washout Period 1 (14 Days)||0
3022574|NCT01072149|3740968|FG003|NOT COMPLETED|Washout Period 1 (14 Days)||0
3022575|NCT01072149|3740969|FG004|NOT COMPLETED|Washout Period 1 (14 Days)||0
3022576|NCT01072149|3740970|FG005|NOT COMPLETED|Washout Period 1 (14 Days)||0
3022577|NCT01072149|3740971|FG006|NOT COMPLETED|Washout Period 1 (14 Days)||0
3022578|NCT01072149|3740972|FG007|NOT COMPLETED|Washout Period 1 (14 Days)||0
3022579|NCT01072149|3740973|FG008|NOT COMPLETED|Washout Period 1 (14 Days)||0
3022580|NCT01072149|3740974|FG009|NOT COMPLETED|Washout Period 1 (14 Days)||0
3022581|NCT01072149|3740975|FG010|NOT COMPLETED|Washout Period 1 (14 Days)||0
3022582|NCT01072149|3740976|FG011|NOT COMPLETED|Washout Period 1 (14 Days)||0
3022583|NCT01072149|3740977|FG012|NOT COMPLETED|Washout Period 1 (14 Days)||0
3022584|NCT01072149|3740978|FG013|NOT COMPLETED|Washout Period 1 (14 Days)||0
3022585|NCT01072149|3740979|FG014|NOT COMPLETED|Washout Period 1 (14 Days)||0
3022586|NCT01072149|3740980|FG015|NOT COMPLETED|Washout Period 1 (14 Days)||0
3022587|NCT01072149|3740981|FG016|NOT COMPLETED|Washout Period 1 (14 Days)||0
3022588|NCT01072149|3740982|FG017|NOT COMPLETED|Washout Period 1 (14 Days)||0
3022589|NCT01072149|3740965|FG000|STARTED|Treatment Period 2 (28 Days)||3
3022590|NCT01072149|3740966|FG001|STARTED|Treatment Period 2 (28 Days)||3
3022591|NCT01072149|3740967|FG002|STARTED|Treatment Period 2 (28 Days)||2
3022592|NCT01072149|3740968|FG003|STARTED|Treatment Period 2 (28 Days)||3
3022593|NCT01072149|3740969|FG004|STARTED|Treatment Period 2 (28 Days)||3
3022594|NCT01072149|3740970|FG005|STARTED|Treatment Period 2 (28 Days)||3
3022595|NCT01072149|3740971|FG006|STARTED|Treatment Period 2 (28 Days)||3
3022596|NCT01072149|3740972|FG007|STARTED|Treatment Period 2 (28 Days)||3
3022597|NCT01072149|3740973|FG008|STARTED|Treatment Period 2 (28 Days)||3
3022598|NCT01072149|3740974|FG009|STARTED|Treatment Period 2 (28 Days)||3
3022599|NCT01072149|3740975|FG010|STARTED|Treatment Period 2 (28 Days)||2
3022600|NCT01072149|3740976|FG011|STARTED|Treatment Period 2 (28 Days)||3
3022601|NCT01072149|3740977|FG012|STARTED|Treatment Period 2 (28 Days)||3
3022602|NCT01072149|3740978|FG013|STARTED|Treatment Period 2 (28 Days)||3
3022603|NCT01072149|3740979|FG014|STARTED|Treatment Period 2 (28 Days)||3
3022604|NCT01072149|3740980|FG015|STARTED|Treatment Period 2 (28 Days)||3
3022605|NCT01072149|3740981|FG016|STARTED|Treatment Period 2 (28 Days)||3
3022606|NCT01072149|3740982|FG017|STARTED|Treatment Period 2 (28 Days)||2
3022607|NCT01072149|3740965|FG000|COMPLETED|Treatment Period 2 (28 Days)||3
3022608|NCT01072149|3740966|FG001|COMPLETED|Treatment Period 2 (28 Days)||2
3022609|NCT01072149|3740967|FG002|COMPLETED|Treatment Period 2 (28 Days)||1
3022610|NCT01072149|3740968|FG003|COMPLETED|Treatment Period 2 (28 Days)||3
3022611|NCT01072149|3740969|FG004|COMPLETED|Treatment Period 2 (28 Days)||3
3022612|NCT01072149|3740970|FG005|COMPLETED|Treatment Period 2 (28 Days)||3
3022613|NCT01072149|3740971|FG006|COMPLETED|Treatment Period 2 (28 Days)||3
3022614|NCT01072149|3740972|FG007|COMPLETED|Treatment Period 2 (28 Days)||2
3022615|NCT01072149|3740973|FG008|COMPLETED|Treatment Period 2 (28 Days)||3
3022616|NCT01072149|3740974|FG009|COMPLETED|Treatment Period 2 (28 Days)||3
3022617|NCT01072149|3740975|FG010|COMPLETED|Treatment Period 2 (28 Days)||2
3022618|NCT01072149|3740976|FG011|COMPLETED|Treatment Period 2 (28 Days)||3
3022619|NCT01072149|3740977|FG012|COMPLETED|Treatment Period 2 (28 Days)||3
3022620|NCT01072149|3740978|FG013|COMPLETED|Treatment Period 2 (28 Days)||3
3022621|NCT01072149|3740979|FG014|COMPLETED|Treatment Period 2 (28 Days)||3
3022622|NCT01072149|3740980|FG015|COMPLETED|Treatment Period 2 (28 Days)||3
3022623|NCT01072149|3740981|FG016|COMPLETED|Treatment Period 2 (28 Days)||3
3022624|NCT01072149|3740982|FG017|COMPLETED|Treatment Period 2 (28 Days)||2
3022625|NCT01072149|3740965|FG000|NOT COMPLETED|Treatment Period 2 (28 Days)||0
3022626|NCT01072149|3740966|FG001|NOT COMPLETED|Treatment Period 2 (28 Days)||1
3022627|NCT01072149|3740967|FG002|NOT COMPLETED|Treatment Period 2 (28 Days)||1
3022628|NCT01072149|3740968|FG003|NOT COMPLETED|Treatment Period 2 (28 Days)||0
3022629|NCT01072149|3740969|FG004|NOT COMPLETED|Treatment Period 2 (28 Days)||0
3022630|NCT01072149|3740970|FG005|NOT COMPLETED|Treatment Period 2 (28 Days)||0
3022631|NCT01072149|3740971|FG006|NOT COMPLETED|Treatment Period 2 (28 Days)||0
3022632|NCT01072149|3740972|FG007|NOT COMPLETED|Treatment Period 2 (28 Days)||1
3022633|NCT01072149|3740973|FG008|NOT COMPLETED|Treatment Period 2 (28 Days)||0
3022634|NCT01072149|3740974|FG009|NOT COMPLETED|Treatment Period 2 (28 Days)||0
3022635|NCT01072149|3740975|FG010|NOT COMPLETED|Treatment Period 2 (28 Days)||0
3022636|NCT01072149|3740976|FG011|NOT COMPLETED|Treatment Period 2 (28 Days)||0
3022637|NCT01072149|3740977|FG012|NOT COMPLETED|Treatment Period 2 (28 Days)||0
3022638|NCT01072149|3740978|FG013|NOT COMPLETED|Treatment Period 2 (28 Days)||0
3022639|NCT01072149|3740979|FG014|NOT COMPLETED|Treatment Period 2 (28 Days)||0
3022640|NCT01072149|3740980|FG015|NOT COMPLETED|Treatment Period 2 (28 Days)||0
3022641|NCT01072149|3740981|FG016|NOT COMPLETED|Treatment Period 2 (28 Days)||0
3022642|NCT01072149|3740982|FG017|NOT COMPLETED|Treatment Period 2 (28 Days)||0
3022643|NCT01072149|3740965|FG000|STARTED|Washout Period 2 (14 Days)||3
3022644|NCT01072149|3740966|FG001|STARTED|Washout Period 2 (14 Days)||2
3022645|NCT01072149|3740967|FG002|STARTED|Washout Period 2 (14 Days)||1
3022646|NCT01072149|3740968|FG003|STARTED|Washout Period 2 (14 Days)||3
3022647|NCT01072149|3740969|FG004|STARTED|Washout Period 2 (14 Days)||3
3022648|NCT01072149|3740970|FG005|STARTED|Washout Period 2 (14 Days)||3
3022649|NCT01072149|3740971|FG006|STARTED|Washout Period 2 (14 Days)||3
3022650|NCT01072149|3740972|FG007|STARTED|Washout Period 2 (14 Days)||2
3022651|NCT01072149|3740973|FG008|STARTED|Washout Period 2 (14 Days)||3
3022652|NCT01072149|3740974|FG009|STARTED|Washout Period 2 (14 Days)||3
3022653|NCT01072149|3740975|FG010|STARTED|Washout Period 2 (14 Days)||2
3022654|NCT01072149|3740976|FG011|STARTED|Washout Period 2 (14 Days)||3
3022655|NCT01072149|3740977|FG012|STARTED|Washout Period 2 (14 Days)||3
3022656|NCT01072149|3740978|FG013|STARTED|Washout Period 2 (14 Days)||3
3022657|NCT01072149|3740979|FG014|STARTED|Washout Period 2 (14 Days)||3
3022658|NCT01072149|3740980|FG015|STARTED|Washout Period 2 (14 Days)||3
3022659|NCT01072149|3740981|FG016|STARTED|Washout Period 2 (14 Days)||3
3022660|NCT01072149|3740982|FG017|STARTED|Washout Period 2 (14 Days)||2
3022661|NCT01072149|3740965|FG000|COMPLETED|Washout Period 2 (14 Days)||2
3022662|NCT01072149|3740966|FG001|COMPLETED|Washout Period 2 (14 Days)||2
3022663|NCT01072149|3740967|FG002|COMPLETED|Washout Period 2 (14 Days)||1
3022664|NCT01072149|3740968|FG003|COMPLETED|Washout Period 2 (14 Days)||3
3022665|NCT01072149|3740969|FG004|COMPLETED|Washout Period 2 (14 Days)||3
3022666|NCT01072149|3740970|FG005|COMPLETED|Washout Period 2 (14 Days)||3
3022667|NCT01072149|3740971|FG006|COMPLETED|Washout Period 2 (14 Days)||3
3022668|NCT01072149|3740972|FG007|COMPLETED|Washout Period 2 (14 Days)||2
3022669|NCT01072149|3740973|FG008|COMPLETED|Washout Period 2 (14 Days)||3
3022670|NCT01072149|3740974|FG009|COMPLETED|Washout Period 2 (14 Days)||3
3022671|NCT01072149|3740975|FG010|COMPLETED|Washout Period 2 (14 Days)||2
3022672|NCT01072149|3740976|FG011|COMPLETED|Washout Period 2 (14 Days)||3
3022673|NCT01072149|3740977|FG012|COMPLETED|Washout Period 2 (14 Days)||2
3022674|NCT01072149|3740978|FG013|COMPLETED|Washout Period 2 (14 Days)||3
3022675|NCT01072149|3740979|FG014|COMPLETED|Washout Period 2 (14 Days)||3
3022676|NCT01072149|3740980|FG015|COMPLETED|Washout Period 2 (14 Days)||1
3022677|NCT01072149|3740981|FG016|COMPLETED|Washout Period 2 (14 Days)||3
3022678|NCT01072149|3740982|FG017|COMPLETED|Washout Period 2 (14 Days)||2
3022679|NCT01072149|3740965|FG000|NOT COMPLETED|Washout Period 2 (14 Days)||1
3022680|NCT01072149|3740966|FG001|NOT COMPLETED|Washout Period 2 (14 Days)||0
3022681|NCT01072149|3740967|FG002|NOT COMPLETED|Washout Period 2 (14 Days)||0
3022682|NCT01072149|3740968|FG003|NOT COMPLETED|Washout Period 2 (14 Days)||0
3022683|NCT01072149|3740969|FG004|NOT COMPLETED|Washout Period 2 (14 Days)||0
3022684|NCT01072149|3740970|FG005|NOT COMPLETED|Washout Period 2 (14 Days)||0
3022685|NCT01072149|3740971|FG006|NOT COMPLETED|Washout Period 2 (14 Days)||0
3022686|NCT01072149|3740972|FG007|NOT COMPLETED|Washout Period 2 (14 Days)||0
3022687|NCT01072149|3740973|FG008|NOT COMPLETED|Washout Period 2 (14 Days)||0
3022688|NCT01072149|3740974|FG009|NOT COMPLETED|Washout Period 2 (14 Days)||0
3022689|NCT01072149|3740975|FG010|NOT COMPLETED|Washout Period 2 (14 Days)||0
3022690|NCT01072149|3740976|FG011|NOT COMPLETED|Washout Period 2 (14 Days)||0
3022691|NCT01072149|3740977|FG012|NOT COMPLETED|Washout Period 2 (14 Days)||1
3022692|NCT01072149|3740978|FG013|NOT COMPLETED|Washout Period 2 (14 Days)||0
3022693|NCT01072149|3740979|FG014|NOT COMPLETED|Washout Period 2 (14 Days)||0
3022694|NCT01072149|3740980|FG015|NOT COMPLETED|Washout Period 2 (14 Days)||2
3022695|NCT01072149|3740981|FG016|NOT COMPLETED|Washout Period 2 (14 Days)||0
3022696|NCT01072149|3740982|FG017|NOT COMPLETED|Washout Period 2 (14 Days)||0
3022697|NCT01072149|3740965|FG000|STARTED|Treatment Period 3 (28 Days)||2
3022698|NCT01072149|3740966|FG001|STARTED|Treatment Period 3 (28 Days)||2
3022699|NCT01072149|3740967|FG002|STARTED|Treatment Period 3 (28 Days)||1
3022700|NCT01072149|3740968|FG003|STARTED|Treatment Period 3 (28 Days)||3
3022701|NCT01072149|3740969|FG004|STARTED|Treatment Period 3 (28 Days)||3
3022702|NCT01072149|3740970|FG005|STARTED|Treatment Period 3 (28 Days)||3
3022703|NCT01072149|3740971|FG006|STARTED|Treatment Period 3 (28 Days)||3
3022704|NCT01072149|3740972|FG007|STARTED|Treatment Period 3 (28 Days)||2
3022705|NCT01072149|3740973|FG008|STARTED|Treatment Period 3 (28 Days)||3
3022706|NCT01072149|3740974|FG009|STARTED|Treatment Period 3 (28 Days)||3
3022707|NCT01072149|3740975|FG010|STARTED|Treatment Period 3 (28 Days)||2
3022708|NCT01072149|3740976|FG011|STARTED|Treatment Period 3 (28 Days)||3
3022709|NCT01072149|3740977|FG012|STARTED|Treatment Period 3 (28 Days)||2
3022710|NCT01072149|3740978|FG013|STARTED|Treatment Period 3 (28 Days)||3
3022711|NCT01072149|3740979|FG014|STARTED|Treatment Period 3 (28 Days)||3
3022712|NCT01072149|3740980|FG015|STARTED|Treatment Period 3 (28 Days)||1
3022713|NCT01072149|3740981|FG016|STARTED|Treatment Period 3 (28 Days)||3
3022714|NCT01072149|3740982|FG017|STARTED|Treatment Period 3 (28 Days)||2
3022715|NCT01072149|3740965|FG000|COMPLETED|Treatment Period 3 (28 Days)||2
3022716|NCT01072149|3740966|FG001|COMPLETED|Treatment Period 3 (28 Days)||2
3022717|NCT01072149|3740967|FG002|COMPLETED|Treatment Period 3 (28 Days)||0
3022718|NCT01072149|3740968|FG003|COMPLETED|Treatment Period 3 (28 Days)||3
3022719|NCT01072149|3740969|FG004|COMPLETED|Treatment Period 3 (28 Days)||3
3022720|NCT01072149|3740970|FG005|COMPLETED|Treatment Period 3 (28 Days)||3
3022721|NCT01072149|3740971|FG006|COMPLETED|Treatment Period 3 (28 Days)||3
3022722|NCT01072149|3740972|FG007|COMPLETED|Treatment Period 3 (28 Days)||2
3022723|NCT01072149|3740973|FG008|COMPLETED|Treatment Period 3 (28 Days)||3
3022724|NCT01072149|3740974|FG009|COMPLETED|Treatment Period 3 (28 Days)||3
3022725|NCT01072149|3740975|FG010|COMPLETED|Treatment Period 3 (28 Days)||2
3022726|NCT01072149|3740976|FG011|COMPLETED|Treatment Period 3 (28 Days)||3
3022727|NCT01072149|3740977|FG012|COMPLETED|Treatment Period 3 (28 Days)||2
3022728|NCT01072149|3740978|FG013|COMPLETED|Treatment Period 3 (28 Days)||2
3022729|NCT01072149|3740979|FG014|COMPLETED|Treatment Period 3 (28 Days)||3
3022730|NCT01072149|3740980|FG015|COMPLETED|Treatment Period 3 (28 Days)||1
3022731|NCT01072149|3740981|FG016|COMPLETED|Treatment Period 3 (28 Days)||3
3022732|NCT01072149|3740982|FG017|COMPLETED|Treatment Period 3 (28 Days)||2
3038394|NCT01154088|3757827|FG002|NOT COMPLETED|Overall Study||7
3022733|NCT01072149|3740965|FG000|NOT COMPLETED|Treatment Period 3 (28 Days)||0
3022734|NCT01072149|3740966|FG001|NOT COMPLETED|Treatment Period 3 (28 Days)||0
3022735|NCT01072149|3740967|FG002|NOT COMPLETED|Treatment Period 3 (28 Days)||1
3022736|NCT01072149|3740968|FG003|NOT COMPLETED|Treatment Period 3 (28 Days)||0
3022737|NCT01072149|3740969|FG004|NOT COMPLETED|Treatment Period 3 (28 Days)||0
3022738|NCT01072149|3740970|FG005|NOT COMPLETED|Treatment Period 3 (28 Days)||0
3022739|NCT01072149|3740971|FG006|NOT COMPLETED|Treatment Period 3 (28 Days)||0
3022740|NCT01072149|3740972|FG007|NOT COMPLETED|Treatment Period 3 (28 Days)||0
3022741|NCT01072149|3740973|FG008|NOT COMPLETED|Treatment Period 3 (28 Days)||0
3022742|NCT01072149|3740974|FG009|NOT COMPLETED|Treatment Period 3 (28 Days)||0
3022743|NCT01072149|3740975|FG010|NOT COMPLETED|Treatment Period 3 (28 Days)||0
3022744|NCT01072149|3740976|FG011|NOT COMPLETED|Treatment Period 3 (28 Days)||0
3022745|NCT01072149|3740977|FG012|NOT COMPLETED|Treatment Period 3 (28 Days)||0
3022746|NCT01072149|3740978|FG013|NOT COMPLETED|Treatment Period 3 (28 Days)||1
3022747|NCT01072149|3740979|FG014|NOT COMPLETED|Treatment Period 3 (28 Days)||0
3022748|NCT01072149|3740980|FG015|NOT COMPLETED|Treatment Period 3 (28 Days)||0
3022749|NCT01072149|3740981|FG016|NOT COMPLETED|Treatment Period 3 (28 Days)||0
3022750|NCT01072149|3740982|FG017|NOT COMPLETED|Treatment Period 3 (28 Days)||0
3022751|NCT01072188|3740994|FG000|STARTED|Overall Study||22
3022752|NCT01072188|3740995|FG001|STARTED|Overall Study||23
3022753|NCT01072188|3740994|FG000|COMPLETED|Overall Study||22
3022754|NCT01072188|3740995|FG001|COMPLETED|Overall Study||23
3022755|NCT01072188|3740994|FG000|NOT COMPLETED|Overall Study||0
3022756|NCT01072188|3740995|FG001|NOT COMPLETED|Overall Study||0
3022757|NCT01072201|3741003|FG000|STARTED|Overall Study||30
3022758|NCT01072201|3741004|FG001|STARTED|Overall Study||30
3022759|NCT01072201|3741003|FG000|COMPLETED|Overall Study||30
3022760|NCT01072201|3741004|FG001|COMPLETED|Overall Study||29
3022761|NCT01072201|3741003|FG000|NOT COMPLETED|Overall Study||0
3022762|NCT01072201|3741004|FG001|NOT COMPLETED|Overall Study||1
3022763|NCT01072331|3741013|FG000|STARTED|Overall Study||34
3022764|NCT01072331|3741014|FG001|STARTED|Overall Study||33
3022765|NCT01072331|3741015|FG002|STARTED|Overall Study||32
3022766|NCT01072331|3741013|FG000|COMPLETED|Overall Study||34
3022767|NCT01072331|3741014|FG001|COMPLETED|Overall Study||33
3022768|NCT01072331|3741015|FG002|COMPLETED|Overall Study||32
3022769|NCT01072331|3741013|FG000|NOT COMPLETED|Overall Study||0
3022770|NCT01072331|3741014|FG001|NOT COMPLETED|Overall Study||0
3022771|NCT01072331|3741015|FG002|NOT COMPLETED|Overall Study||0
3022772|NCT01072344|3741025|FG000|STARTED|Overall Study||46
3022773|NCT01072344|3741026|FG001|STARTED|Overall Study||47
3022774|NCT01072344|3741025|FG000|COMPLETED|Overall Study||35
3022775|NCT01072344|3741026|FG001|COMPLETED|Overall Study||29
3022776|NCT01072344|3741025|FG000|NOT COMPLETED|Overall Study||11
3022777|NCT01072344|3741026|FG001|NOT COMPLETED|Overall Study||18
3022778|NCT01072357|3741034|FG000|STARTED|Overall Study||15
3022779|NCT01072357|3741035|FG001|STARTED|Overall Study||15
3022780|NCT01072357|3741034|FG000|COMPLETED|Overall Study||15
3022781|NCT01072357|3741035|FG001|COMPLETED|Overall Study||14
3022782|NCT01072357|3741034|FG000|NOT COMPLETED|Overall Study||0
3022783|NCT01072357|3741035|FG001|NOT COMPLETED|Overall Study||1
3022784|NCT01072396|3741043|FG000|STARTED|Period One||63
3022785|NCT01072396|3741044|FG001|STARTED|Period One||63
3022786|NCT01072396|3741043|FG000|COMPLETED|Period One||58
3022787|NCT01072396|3741044|FG001|COMPLETED|Period One||61
3022788|NCT01072396|3741043|FG000|NOT COMPLETED|Period One||5
3022789|NCT01072396|3741044|FG001|NOT COMPLETED|Period One||2
3022790|NCT01072396|3741043|FG000|STARTED|Washout Period||58
3022791|NCT01072396|3741044|FG001|STARTED|Washout Period||61
3022792|NCT01072396|3741043|FG000|COMPLETED|Washout Period||58
3022793|NCT01072396|3741044|FG001|COMPLETED|Washout Period||60
3022794|NCT01072396|3741043|FG000|NOT COMPLETED|Washout Period||0
3022795|NCT01072396|3741044|FG001|NOT COMPLETED|Washout Period||1
3022796|NCT01072396|3741043|FG000|STARTED|Period Two||58
3022797|NCT01072396|3741044|FG001|STARTED|Period Two||60
3022798|NCT01072396|3741043|FG000|COMPLETED|Period Two||57
3022799|NCT01072396|3741044|FG001|COMPLETED|Period Two||57
3022800|NCT01072396|3741043|FG000|NOT COMPLETED|Period Two||1
3022801|NCT01072396|3741044|FG001|NOT COMPLETED|Period Two||3
3022802|NCT01072409|3741050|FG000|STARTED|Overall Study||45
3022803|NCT01072409|3741050|FG000|COMPLETED|Overall Study||38
3022804|NCT01072409|3741050|FG000|NOT COMPLETED|Overall Study||7
3022805|NCT01072448|3741056|FG000|STARTED|Overall Study||163
3022806|NCT01072448|3741057|FG001|STARTED|Overall Study||160
3022807|NCT01072448|3741056|FG000|COMPLETED|Overall Study||144
3022808|NCT01072448|3741057|FG001|COMPLETED|Overall Study||130
3022809|NCT01072448|3741056|FG000|NOT COMPLETED|Overall Study||19
3022810|NCT01072448|3741057|FG001|NOT COMPLETED|Overall Study||30
3022811|NCT01072500|3741065|FG000|STARTED|Overall Study||818
3022812|NCT01072500|3741066|FG001|STARTED|Overall Study||817
3022813|NCT01072500|3741065|FG000|COMPLETED|Overall Study||794
3022814|NCT01072500|3741066|FG001|COMPLETED|Overall Study||803
3022815|NCT01072500|3741065|FG000|NOT COMPLETED|Overall Study||24
3022816|NCT01072500|3741066|FG001|NOT COMPLETED|Overall Study||14
3022817|NCT01072539|3741074|FG000|STARTED|Overall Study||3172
3022818|NCT01072539|3741074|FG000|COMPLETED|Overall Study|Refer to the Safety Analysis Set. Data for completion were not collected.|3169
3022819|NCT01072539|3741074|FG000|NOT COMPLETED|Overall Study||3
3022820|NCT01072617|3741078|FG000|STARTED|Overall Study||8
3022821|NCT01072617|3741078|FG000|COMPLETED|Overall Study||8
3022822|NCT01072617|3741078|FG000|NOT COMPLETED|Overall Study||0
3022823|NCT01072630|3741086|FG000|STARTED|Overall Study||230
3022824|NCT01072630|3741087|FG001|STARTED|Overall Study||232
3022825|NCT01072630|3741088|FG002|STARTED|Overall Study||30
3022826|NCT01072630|3741086|FG000|Safety Population|Overall Study|Treated participants. One participant was randomized but not treated.|229
3022827|NCT01072630|3741087|FG001|Safety Population|Overall Study|Treated participants. One participant was randomized but not treated.|231
3022828|NCT01072630|3741088|FG002|Safety Population|Overall Study|Treated participants.|30
3022829|NCT01072630|3741086|FG000|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|224
3022830|NCT01072630|3741087|FG001|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|230
3022831|NCT01072630|3741088|FG002|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|28
3022832|NCT01072630|3741086|FG000|COMPLETED|Overall Study||175
3022833|NCT01072630|3741087|FG001|COMPLETED|Overall Study||172
3022834|NCT01072630|3741088|FG002|COMPLETED|Overall Study||17
3022835|NCT01072630|3741086|FG000|NOT COMPLETED|Overall Study||55
3022836|NCT01072630|3741087|FG001|NOT COMPLETED|Overall Study||60
3022837|NCT01072630|3741088|FG002|NOT COMPLETED|Overall Study||13
3022838|NCT01072643|3741097|FG000|STARTED|Overall Study||4
3165698|NCT01901250|3893241|FG000|STARTED|Overall Study||260
3165699|NCT01901250|3893242|FG001|STARTED|Overall Study||265
3165700|NCT01901250|3893241|FG000|End of Kidergarten|Overall Study||215
3165701|NCT01901250|3893242|FG001|End of Kidergarten|Overall Study||212
3165702|NCT01901250|3893241|FG000|Start of 1st Grade|Overall Study||173
3165703|NCT01901250|3893242|FG001|Start of 1st Grade|Overall Study||176
3165704|NCT01901250|3893241|FG000|End of 1st Grade|Overall Study||143
3165705|NCT01901250|3893242|FG001|End of 1st Grade|Overall Study||151
3022839|NCT01072643|3741097|FG000|COMPLETED|Overall Study||4
3022840|NCT01072643|3741097|FG000|NOT COMPLETED|Overall Study||0
3022841|NCT01072656|3741122|FG000|STARTED|First Intervention||5
3022842|NCT01072656|3741123|FG001|STARTED|First Intervention||4
3022843|NCT01072656|3741122|FG000|COMPLETED|First Intervention||5
3022844|NCT01072656|3741123|FG001|COMPLETED|First Intervention||4
3022845|NCT01072656|3741122|FG000|NOT COMPLETED|First Intervention||0
3022846|NCT01072656|3741123|FG001|NOT COMPLETED|First Intervention||0
3022847|NCT01072656|3741122|FG000|STARTED|Second Intervention||5
3022848|NCT01072656|3741123|FG001|STARTED|Second Intervention||4
3022849|NCT01072656|3741122|FG000|COMPLETED|Second Intervention||5
3022850|NCT01072656|3741123|FG001|COMPLETED|Second Intervention||4
3022851|NCT01072656|3741122|FG000|NOT COMPLETED|Second Intervention||0
3022852|NCT01072656|3741123|FG001|NOT COMPLETED|Second Intervention||0
3022853|NCT01072669|3741132|FG000|STARTED|Overall Study||15
3022854|NCT01072669|3741133|FG001|STARTED|Overall Study||5
3022855|NCT01072669|3741132|FG000|COMPLETED|Overall Study||15
3022856|NCT01072669|3741133|FG001|COMPLETED|Overall Study||5
3022857|NCT01072669|3741132|FG000|NOT COMPLETED|Overall Study||0
3022858|NCT01072669|3741133|FG001|NOT COMPLETED|Overall Study||0
3022859|NCT01072773|3741139|FG000|STARTED|Overall Study||2
3022860|NCT01072773|3741139|FG000|COMPLETED|Overall Study||2
3022861|NCT01072773|3741139|FG000|NOT COMPLETED|Overall Study||0
3022862|NCT01072877|3741148|FG000|STARTED|Overall Study||56
3022863|NCT01072877|3741149|FG001|STARTED|Overall Study||57
3022864|NCT01072877|3741150|FG002|STARTED|Overall Study||51
3022865|NCT01072877|3741151|FG003|STARTED|Overall Study||52
3022866|NCT01072877|3741152|FG004|STARTED|Overall Study||63
3022867|NCT01072877|3741148|FG000|COMPLETED|Overall Study||55
3022868|NCT01072877|3741149|FG001|COMPLETED|Overall Study||56
3022869|NCT01072877|3741150|FG002|COMPLETED|Overall Study||51
3022870|NCT01072877|3741151|FG003|COMPLETED|Overall Study||50
3022871|NCT01072877|3741152|FG004|COMPLETED|Overall Study||63
3022872|NCT01072877|3741148|FG000|NOT COMPLETED|Overall Study||1
3022873|NCT01072877|3741149|FG001|NOT COMPLETED|Overall Study||1
3022874|NCT01072877|3741150|FG002|NOT COMPLETED|Overall Study||0
3022875|NCT01072877|3741151|FG003|NOT COMPLETED|Overall Study||2
3022876|NCT01072877|3741152|FG004|NOT COMPLETED|Overall Study||0
3022877|NCT01072929|3741169|FG000|STARTED|Overall Study||199
3022878|NCT01072929|3741170|FG001|STARTED|Overall Study||201
3022879|NCT01072929|3741171|FG002|STARTED|Overall Study||33
3022880|NCT01072929|3741169|FG000|Safety Population|Overall Study|Treated participants|199
3022881|NCT01072929|3741170|FG001|Safety Population|Overall Study|Treated participants. Three participants were randomized but not treated.|198
3022882|NCT01072929|3741171|FG002|Safety Population|Overall Study|Treated participants. One participant was randomized but not treated.|32
3022883|NCT01072929|3741169|FG000|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|196
3022884|NCT01072929|3741170|FG001|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|197
3022885|NCT01072929|3741171|FG002|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|31
3022886|NCT01072929|3741169|FG000|COMPLETED|Overall Study||155
3022887|NCT01072929|3741170|FG001|COMPLETED|Overall Study||150
3022888|NCT01072929|3741171|FG002|COMPLETED|Overall Study||24
3022889|NCT01072929|3741169|FG000|NOT COMPLETED|Overall Study||44
3022890|NCT01072929|3741170|FG001|NOT COMPLETED|Overall Study||51
3022891|NCT01072929|3741171|FG002|NOT COMPLETED|Overall Study||9
3022892|NCT01073020|3741184|FG000|STARTED|Overall Study||23
3165706|NCT01901250|3893241|FG000|COMPLETED|Overall Study||122
3165707|NCT01901250|3893242|FG001|COMPLETED|Overall Study||139
3022893|NCT01073020|3741185|FG001|STARTED|Overall Study||22
3022894|NCT01073020|3741186|FG002|STARTED|Overall Study||22
3022895|NCT01073020|3741187|FG003|STARTED|Overall Study||21
3022896|NCT01073020|3741184|FG000|COMPLETED|Overall Study||16
3022897|NCT01073020|3741185|FG001|COMPLETED|Overall Study||17
3022898|NCT01073020|3741186|FG002|COMPLETED|Overall Study||19
3022899|NCT01073020|3741187|FG003|COMPLETED|Overall Study||19
3022900|NCT01073020|3741184|FG000|NOT COMPLETED|Overall Study||7
3022901|NCT01073020|3741185|FG001|NOT COMPLETED|Overall Study||5
3022902|NCT01073020|3741186|FG002|NOT COMPLETED|Overall Study||3
3022903|NCT01073020|3741187|FG003|NOT COMPLETED|Overall Study||2
3022904|NCT01073163|3741197|FG000|STARTED|Overall Study||54
3022905|NCT01073163|3741197|FG000|Enrolled But Not Treated|Overall Study||1
3022906|NCT01073163|3741197|FG000|Treated With <6 Cycles|Overall Study||4
3022907|NCT01073163|3741197|FG000|Treated With >=6 Cycles|Overall Study||49
3022908|NCT01073163|3741197|FG000|COMPLETED|Overall Study|Patients completed study|51
3022909|NCT01073163|3741197|FG000|NOT COMPLETED|Overall Study||3
3022910|NCT01073267|3741205|FG000|STARTED|Overall Study||4
3022911|NCT01073267|3741205|FG000|COMPLETED|Overall Study||1
3022912|NCT01073267|3741205|FG000|NOT COMPLETED|Overall Study||3
3022913|NCT01073293|3741211|FG000|STARTED|Overall Study||526
3022914|NCT01073293|3741212|FG001|STARTED|Overall Study||528
3022915|NCT01073293|3741211|FG000|COMPLETED|Overall Study||521
3022916|NCT01073293|3741212|FG001|COMPLETED|Overall Study||517
3022917|NCT01073293|3741211|FG000|NOT COMPLETED|Overall Study||5
3022918|NCT01073293|3741212|FG001|NOT COMPLETED|Overall Study||11
3022919|NCT01073449|3741218|FG000|STARTED|Overall Study||3362
3022920|NCT01073449|3741218|FG000|COMPLETED|Overall Study||3362
3022921|NCT01073449|3741218|FG000|NOT COMPLETED|Overall Study||0
3022922|NCT01073462|3741222|FG000|STARTED|Overall Study||67
3022923|NCT01073462|3741222|FG000|COMPLETED|Overall Study||26
3022924|NCT01073462|3741222|FG000|NOT COMPLETED|Overall Study||41
3022925|NCT01073566|3741228|FG000|STARTED|Period 1 (6 Weeks)||19
3022926|NCT01073566|3741229|FG001|STARTED|Period 1 (6 Weeks)||19
3022927|NCT01073566|3741228|FG000|COMPLETED|Period 1 (6 Weeks)||19
3022928|NCT01073566|3741229|FG001|COMPLETED|Period 1 (6 Weeks)||19
3022929|NCT01073566|3741228|FG000|NOT COMPLETED|Period 1 (6 Weeks)||0
3022930|NCT01073566|3741229|FG001|NOT COMPLETED|Period 1 (6 Weeks)||0
3022931|NCT01073566|3741228|FG000|STARTED|Period 2 (6 Weeks)||19
3022932|NCT01073566|3741229|FG001|STARTED|Period 2 (6 Weeks)||19
3022933|NCT01073566|3741228|FG000|COMPLETED|Period 2 (6 Weeks)||18
3022934|NCT01073566|3741229|FG001|COMPLETED|Period 2 (6 Weeks)||19
3022935|NCT01073566|3741228|FG000|NOT COMPLETED|Period 2 (6 Weeks)||1
3022936|NCT01073566|3741229|FG001|NOT COMPLETED|Period 2 (6 Weeks)||0
3022937|NCT01073605|3741238|FG000|STARTED|Overall Study||68
3022938|NCT01073605|3741239|FG001|STARTED|Overall Study||71
3022939|NCT01073605|3741240|FG002|STARTED|Overall Study||69
3022940|NCT01073605|3741238|FG000|Received Treatment|Overall Study||68
3022941|NCT01073605|3741239|FG001|Received Treatment|Overall Study||70
3022942|NCT01073605|3741240|FG002|Received Treatment|Overall Study||68
3022943|NCT01073605|3741238|FG000|COMPLETED|Overall Study|Corresponds to follow-up until final height|6
3022944|NCT01073605|3741239|FG001|COMPLETED|Overall Study|Corresponds to follow-up until final height|4
3022945|NCT01073605|3741240|FG002|COMPLETED|Overall Study|Corresponds to follow-up until final height|8
3022946|NCT01073605|3741238|FG000|NOT COMPLETED|Overall Study||62
3022947|NCT01073605|3741239|FG001|NOT COMPLETED|Overall Study||67
3022948|NCT01073605|3741240|FG002|NOT COMPLETED|Overall Study||61
3022949|NCT01073618|3741248|FG000|STARTED|Overall Study||692
3022950|NCT01073618|3741248|FG000|COMPLETED|Overall Study||385
3022951|NCT01073618|3741248|FG000|NOT COMPLETED|Overall Study||307
3022952|NCT01073631|3741252|FG000|STARTED|Overall Study||543
3022953|NCT01073631|3741252|FG000|COMPLETED|Overall Study||374
3022954|NCT01073631|3741252|FG000|NOT COMPLETED|Overall Study||169
3022955|NCT01073657|3741258|FG000|STARTED|Overall Study||17
3022956|NCT01073657|3741259|FG001|STARTED|Overall Study||16
3022957|NCT01073657|3741258|FG000|COMPLETED|Overall Study||17
3022958|NCT01073657|3741259|FG001|COMPLETED|Overall Study||16
3022959|NCT01073657|3741258|FG000|NOT COMPLETED|Overall Study||0
3022960|NCT01073657|3741259|FG001|NOT COMPLETED|Overall Study||0
3022961|NCT01073865|3741267|FG000|STARTED|Overall Study|Number of patients randomised|109
3022962|NCT01073865|3741268|FG001|STARTED|Overall Study|Number of patients randomised|113
3022963|NCT01073865|3741267|FG000|Received Randomised Treatment|Overall Study|Number of patients received randomised treatment|108
3022964|NCT01073865|3741268|FG001|Received Randomised Treatment|Overall Study|Number of patients received randomised treatment|113
3022965|NCT01073865|3741267|FG000|COMPLETED|Overall Study|Number of patients completed the study|81
3022966|NCT01073865|3741268|FG001|COMPLETED|Overall Study|Number of patients completed the study|74
3022967|NCT01073865|3741267|FG000|NOT COMPLETED|Overall Study||28
3022968|NCT01073865|3741268|FG001|NOT COMPLETED|Overall Study||39
3022969|NCT01073930|3741276|FG000|STARTED|Overall Study||307
3022970|NCT01073930|3741277|FG001|STARTED|Overall Study||301
3022971|NCT01073930|3741276|FG000|Safety Population (Treated)|Overall Study||305
3022972|NCT01073930|3741277|FG001|Safety Population (Treated)|Overall Study||298
3022973|NCT01073930|3741276|FG000|Intent to Treat Population|Overall Study|One treated participant did not have an efficacy assessment performed.|304
3022974|NCT01073930|3741277|FG001|Intent to Treat Population|Overall Study|One treated participant did not have an efficacy assessment performed.|297
3022975|NCT01073930|3741276|FG000|COMPLETED|Overall Study||304
3022976|NCT01073930|3741277|FG001|COMPLETED|Overall Study||295
3022977|NCT01073930|3741276|FG000|NOT COMPLETED|Overall Study||3
3022978|NCT01073930|3741277|FG001|NOT COMPLETED|Overall Study||6
3022979|NCT01073943|3741285|FG000|STARTED|Overall Study||300
3022980|NCT01073943|3741286|FG001|STARTED|Overall Study||303
3022981|NCT01073943|3741285|FG000|Safety Population (Treated)|Overall Study||296
3022982|NCT01073943|3741286|FG001|Safety Population (Treated)|Overall Study||302
3022983|NCT01073943|3741285|FG000|Intent to Treat Population|Overall Study|Two treated participants did not have an efficacy assessment performed.|294
3165708|NCT01901250|3893241|FG000|NOT COMPLETED|Overall Study||138
3165709|NCT01901250|3893242|FG001|NOT COMPLETED|Overall Study||126
3165710|NCT01901289|3893248|FG000|STARTED|Overall Study||200
3165711|NCT01901289|3893248|FG000|12-Month Follow-up|Overall Study||175
3165712|NCT01901289|3893248|FG000|COMPLETED|Overall Study||0
3165713|NCT01901289|3893248|FG000|NOT COMPLETED|Overall Study||200
3165714|NCT01901302|3893254|FG000|STARTED|Overall Study||31
3165715|NCT01901302|3893255|FG001|STARTED|Overall Study||30
3165716|NCT01901302|3893254|FG000|Received at Least 1 Dose of Study Drug|Overall Study||31
3165717|NCT01901302|3893255|FG001|Received at Least 1 Dose of Study Drug|Overall Study||30
3165718|NCT01901302|3893254|FG000|COMPLETED|Overall Study||4
3165719|NCT01901302|3893255|FG001|COMPLETED|Overall Study||7
3022984|NCT01073943|3741286|FG001|Intent to Treat Population|Overall Study|Two treated participants did not have an efficacy assessment performed.|300
3022985|NCT01073943|3741285|FG000|COMPLETED|Overall Study||287
3022986|NCT01073943|3741286|FG001|COMPLETED|Overall Study||295
3022987|NCT01073943|3741285|FG000|NOT COMPLETED|Overall Study||13
3022988|NCT01073943|3741286|FG001|NOT COMPLETED|Overall Study||8
3022989|NCT01074008|3741301|FG000|STARTED|Overall Study||8
3022990|NCT01074008|3741302|FG001|STARTED|Overall Study||8
3022991|NCT01074008|3741303|FG002|STARTED|Overall Study||8
3022992|NCT01074008|3741304|FG003|STARTED|Overall Study||8
3022993|NCT01074008|3741305|FG004|STARTED|Overall Study||8
3022994|NCT01074008|3741306|FG005|STARTED|Overall Study||7
3022995|NCT01074008|3741307|FG006|STARTED|Overall Study||8
3022996|NCT01074008|3741308|FG007|STARTED|Overall Study||8
3022997|NCT01074008|3741309|FG008|STARTED|Overall Study||11
3022998|NCT01074008|3741301|FG000|Completed Direct-acting Antiviral Agent|Overall Study||8
3022999|NCT01074008|3741302|FG001|Completed Direct-acting Antiviral Agent|Overall Study||7
3023000|NCT01074008|3741303|FG002|Completed Direct-acting Antiviral Agent|Overall Study||7
3023001|NCT01074008|3741304|FG003|Completed Direct-acting Antiviral Agent|Overall Study||8
3023002|NCT01074008|3741305|FG004|Completed Direct-acting Antiviral Agent|Overall Study||8
3023003|NCT01074008|3741306|FG005|Completed Direct-acting Antiviral Agent|Overall Study||5
3023004|NCT01074008|3741307|FG006|Completed Direct-acting Antiviral Agent|Overall Study||8
3023005|NCT01074008|3741308|FG007|Completed Direct-acting Antiviral Agent|Overall Study||7
3023006|NCT01074008|3741309|FG008|Completed Direct-acting Antiviral Agent|Overall Study||5
3023007|NCT01074008|3741301|FG000|COMPLETED|Overall Study||7
3023008|NCT01074008|3741302|FG001|COMPLETED|Overall Study||5
3023009|NCT01074008|3741303|FG002|COMPLETED|Overall Study||6
3023010|NCT01074008|3741304|FG003|COMPLETED|Overall Study||7
3023011|NCT01074008|3741305|FG004|COMPLETED|Overall Study||6
3023012|NCT01074008|3741306|FG005|COMPLETED|Overall Study||7
3023013|NCT01074008|3741307|FG006|COMPLETED|Overall Study||7
3023014|NCT01074008|3741308|FG007|COMPLETED|Overall Study||8
3023015|NCT01074008|3741309|FG008|COMPLETED|Overall Study||7
3023016|NCT01074008|3741301|FG000|NOT COMPLETED|Overall Study||1
3023017|NCT01074008|3741302|FG001|NOT COMPLETED|Overall Study||3
3023018|NCT01074008|3741303|FG002|NOT COMPLETED|Overall Study||2
3023019|NCT01074008|3741304|FG003|NOT COMPLETED|Overall Study||1
3023020|NCT01074008|3741305|FG004|NOT COMPLETED|Overall Study||2
3023021|NCT01074008|3741306|FG005|NOT COMPLETED|Overall Study||0
3023022|NCT01074008|3741307|FG006|NOT COMPLETED|Overall Study||1
3023023|NCT01074008|3741308|FG007|NOT COMPLETED|Overall Study||0
3023024|NCT01074008|3741309|FG008|NOT COMPLETED|Overall Study||4
3023025|NCT01074034|3741338|FG000|STARTED|Overall Study||211
3023026|NCT01074034|3741338|FG000|COMPLETED|Overall Study||205
3023027|NCT01074034|3741338|FG000|NOT COMPLETED|Overall Study||6
3023028|NCT01074047|3741345|FG000|STARTED|Treatment Phase||241
3165720|NCT01901302|3893254|FG000|NOT COMPLETED|Overall Study||27
3165721|NCT01901302|3893255|FG001|NOT COMPLETED|Overall Study||23
3165722|NCT01901328|3893263|FG000|STARTED|Overall Study||26
3165723|NCT01901328|3893264|FG001|STARTED|Overall Study||23
3165724|NCT01901328|3893263|FG000|Received at Least 1 Dose of Study Drug|Overall Study||26
3165725|NCT01901328|3893264|FG001|Received at Least 1 Dose of Study Drug|Overall Study||23
3023029|NCT01074047|3741346|FG001|STARTED|Treatment Phase||247
3023030|NCT01074047|3741345|FG000|Treated Population|Treatment Phase|5 patients not treated with any drug regimen|236
3023031|NCT01074047|3741346|FG001|Treated Population|Treatment Phase|7 patients not treated with any drug regimen|240
3023032|NCT01074047|3741345|FG000|Safety Population|Treatment Phase|Received at least one dose of study medication and had at least 1 post dose safety assessment|236
3023033|NCT01074047|3741346|FG001|Safety Population|Treatment Phase|Received at least one dose of study medication and had at least 1 post dose safety assessment|235
3023034|NCT01074047|3741345|FG000|Evaluable Population|Treatment Phase|Did not meet criteria for exclusion, received ≥1 cycle of treatment and had ≥ 1 efficacy assessment|179
3023035|NCT01074047|3741346|FG001|Evaluable Population|Treatment Phase|Did not meet criteria for exclusion, received ≥1 cycle of treatment and had ≥ 1 efficacy assessment|191
3023036|NCT01074047|3741345|FG000|COMPLETED|Treatment Phase|Participants who were continuing study treatment at the time of study closure|24
3023037|NCT01074047|3741346|FG001|COMPLETED|Treatment Phase|Participants who were continuing study treatment at the time of study closure|13
3023038|NCT01074047|3741345|FG000|NOT COMPLETED|Treatment Phase||217
3023039|NCT01074047|3741346|FG001|NOT COMPLETED|Treatment Phase||234
3023040|NCT01074047|3741345|FG000|STARTED|Survival Follow-Up Phase||140
3023041|NCT01074047|3741346|FG001|STARTED|Survival Follow-Up Phase||163
3023042|NCT01074047|3741345|FG000|COMPLETED|Survival Follow-Up Phase||16
3023043|NCT01074047|3741346|FG001|COMPLETED|Survival Follow-Up Phase||27
3023044|NCT01074047|3741345|FG000|NOT COMPLETED|Survival Follow-Up Phase||124
3023045|NCT01074047|3741346|FG001|NOT COMPLETED|Survival Follow-Up Phase||136
3023046|NCT01074047|3741345|FG000|STARTED|Extension Phase|2 participants did not enroll in the extension period.|22
3023047|NCT01074047|3741346|FG001|STARTED|Extension Phase||0
3023048|NCT01074047|3741345|FG000|Safety Population|Extension Phase|Participants who enrolled in the extension phase|22
3023049|NCT01074047|3741346|FG001|Safety Population|Extension Phase||0
3023050|NCT01074047|3741345|FG000|COMPLETED|Extension Phase||0
3023051|NCT01074047|3741346|FG001|COMPLETED|Extension Phase||0
3023052|NCT01074047|3741345|FG000|NOT COMPLETED|Extension Phase||22
3023053|NCT01074047|3741346|FG001|NOT COMPLETED|Extension Phase||0
3023054|NCT01074099|3741361|FG000|STARTED|Overall Study||2
3023055|NCT01074099|3741362|FG001|STARTED|Overall Study||3
3023056|NCT01074099|3741361|FG000|COMPLETED|Overall Study||2
3023057|NCT01074099|3741362|FG001|COMPLETED|Overall Study||3
3023058|NCT01074099|3741361|FG000|NOT COMPLETED|Overall Study||0
3023059|NCT01074099|3741362|FG001|NOT COMPLETED|Overall Study||0
3023060|NCT01074125|3741371|FG000|STARTED|Overall Study||51
3023061|NCT01074125|3741372|FG001|STARTED|Overall Study||52
3023062|NCT01074125|3741373|FG002|STARTED|Overall Study||48
3023063|NCT01074125|3741371|FG000|COMPLETED|Overall Study||39
3023064|NCT01074125|3741372|FG001|COMPLETED|Overall Study||47
3023065|NCT01074125|3741373|FG002|COMPLETED|Overall Study||36
3023066|NCT01074125|3741371|FG000|NOT COMPLETED|Overall Study||12
3023067|NCT01074125|3741372|FG001|NOT COMPLETED|Overall Study||5
3023068|NCT01074125|3741373|FG002|NOT COMPLETED|Overall Study||12
3023069|NCT01074164|3741386|FG000|STARTED|Overall Study||7
3023070|NCT01074164|3741387|FG001|STARTED|Overall Study||8
3023071|NCT01074164|3741386|FG000|COMPLETED|Overall Study||4
3023072|NCT01074164|3741387|FG001|COMPLETED|Overall Study||7
3023073|NCT01074164|3741386|FG000|NOT COMPLETED|Overall Study||3
3023074|NCT01074164|3741387|FG001|NOT COMPLETED|Overall Study||1
3023075|NCT01074177|3741393|FG000|STARTED|Overall Study||24
3023076|NCT01074177|3741393|FG000|COMPLETED|Overall Study||24
3023077|NCT01074177|3741393|FG000|NOT COMPLETED|Overall Study||0
3023078|NCT01074216|3741397|FG000|STARTED|Overall Study||54
3023079|NCT01074216|3741397|FG000|COMPLETED|Overall Study||41
3023080|NCT01074216|3741397|FG000|NOT COMPLETED|Overall Study||13
3037981|NCT01151137|3757353|FG000|Treated|Overall Study|One participant randomized to the placebo group received Dronedarone for 7 days by mistake|1610
3037982|NCT01151137|3757354|FG001|Treated|Overall Study||1613
3037983|NCT01151137|3757353|FG000|Discontinued Treatment|Overall Study||171
3037984|NCT01151137|3757354|FG001|Discontinued Treatment|Overall Study||342
3037985|NCT01151137|3757353|FG000|COMPLETED|Overall Study||1601
3037986|NCT01151137|3757354|FG001|COMPLETED|Overall Study||1591
3037987|NCT01151137|3757353|FG000|NOT COMPLETED|Overall Study||16
3037988|NCT01151137|3757354|FG001|NOT COMPLETED|Overall Study||28
3037989|NCT01151189|3757362|FG000|STARTED|Overall Study||326
3037990|NCT01151189|3757363|FG001|STARTED|Overall Study||324
3037991|NCT01151189|3757362|FG000|Received Vaccine|Overall Study||325
3037992|NCT01151189|3757363|FG001|Received Vaccine|Overall Study||324
3037993|NCT01151189|3757362|FG000|COMPLETED|Overall Study||311
3165726|NCT01901328|3893263|FG000|COMPLETED|Overall Study||4
3165727|NCT01901328|3893264|FG001|COMPLETED|Overall Study||2
3165728|NCT01901328|3893263|FG000|NOT COMPLETED|Overall Study||22
3037994|NCT01151189|3757363|FG001|COMPLETED|Overall Study||314
3037995|NCT01151189|3757362|FG000|NOT COMPLETED|Overall Study||15
3037996|NCT01151189|3757363|FG001|NOT COMPLETED|Overall Study||10
3037997|NCT01151215|3757372|FG000|STARTED|Overall Study||120
3037998|NCT01151215|3757373|FG001|STARTED|Overall Study||118
3037999|NCT01151215|3757374|FG002|STARTED|Overall Study||121
3038000|NCT01151215|3757372|FG000|COMPLETED|Overall Study|This is number of patients who were continuing at cut off (ie not withdrawn)|100
3038001|NCT01151215|3757373|FG001|COMPLETED|Overall Study|This is number of patients who were continuing at cut off (ie not withdrawn)|95
3038002|NCT01151215|3757374|FG002|COMPLETED|Overall Study|This is number of patients who were continuing at cut off (ie not withdrawn)|102
3038003|NCT01151215|3757372|FG000|NOT COMPLETED|Overall Study||20
3038004|NCT01151215|3757373|FG001|NOT COMPLETED|Overall Study||23
3038005|NCT01151215|3757374|FG002|NOT COMPLETED|Overall Study||19
3038006|NCT01151280|3757382|FG000|STARTED|Overall Study||10
3038007|NCT01151280|3757382|FG000|COMPLETED|Overall Study||6
3038008|NCT01151280|3757382|FG000|NOT COMPLETED|Overall Study||4
3038009|NCT01151345|3757386|FG000|STARTED|First Intervention Period||13
3038010|NCT01151345|3757387|FG001|STARTED|First Intervention Period||13
3038011|NCT01151345|3757386|FG000|Treated|First Intervention Period||13
3038012|NCT01151345|3757387|FG001|Treated|First Intervention Period||12
3038013|NCT01151345|3757386|FG000|COMPLETED|First Intervention Period||13
3038014|NCT01151345|3757387|FG001|COMPLETED|First Intervention Period||12
3038015|NCT01151345|3757386|FG000|NOT COMPLETED|First Intervention Period||0
3038016|NCT01151345|3757387|FG001|NOT COMPLETED|First Intervention Period||1
3038017|NCT01151345|3757386|FG000|STARTED|Wash-out Period (7 Days)||13
3308486|NCT03020745|4041794|FG001|NOT COMPLETED|Part 2 (Up to 169 Days)||0
3038018|NCT01151345|3757387|FG001|STARTED|Wash-out Period (7 Days)||12
3038019|NCT01151345|3757386|FG000|COMPLETED|Wash-out Period (7 Days)||13
3023081|NCT01074229|3741404|FG000|STARTED|Overall Study||25
3023082|NCT01074229|3741405|FG001|STARTED|Overall Study||25
3023083|NCT01074229|3741406|FG002|STARTED|Overall Study||25
3023084|NCT01074229|3741404|FG000|COMPLETED|Overall Study||23
3023085|NCT01074229|3741405|FG001|COMPLETED|Overall Study||22
3023086|NCT01074229|3741406|FG002|COMPLETED|Overall Study||21
3023087|NCT01074229|3741404|FG000|NOT COMPLETED|Overall Study||2
3023088|NCT01074229|3741405|FG001|NOT COMPLETED|Overall Study||3
3023089|NCT01074229|3741406|FG002|NOT COMPLETED|Overall Study||4
3023090|NCT01074242|3741416|FG000|STARTED|Overall Study||3798
3023091|NCT01074242|3741416|FG000|Received at Least 1 Dose of Vaccine|Overall Study||3395
3023092|NCT01074242|3741416|FG000|COMPLETED|Overall Study||3395
3023093|NCT01074242|3741416|FG000|NOT COMPLETED|Overall Study||403
3023094|NCT01074255|3741420|FG000|STARTED|Overall Study||3141
3023095|NCT01074255|3741420|FG000|Treated|Overall Study||3139
3023096|NCT01074255|3741420|FG000|COMPLETED|Overall Study||3139
3023097|NCT01074255|3741420|FG000|NOT COMPLETED|Overall Study||2
3023098|NCT01074268|3741426|FG000|STARTED|Main: Week 0 to 26 (NN1250-3585)||303
3023099|NCT01074268|3741427|FG001|STARTED|Main: Week 0 to 26 (NN1250-3585)||153
3023100|NCT01074268|3741426|FG000|Full Analysis Set|Main: Week 0 to 26 (NN1250-3585)|One subject was withdrawn because the subject was randomised in error (screening failure)|302
3023101|NCT01074268|3741427|FG001|Full Analysis Set|Main: Week 0 to 26 (NN1250-3585)||153
3023102|NCT01074268|3741426|FG000|Exposed|Main: Week 0 to 26 (NN1250-3585)|Two subjects withdrew prior to exposure to trial drugs|301
3023103|NCT01074268|3741427|FG001|Exposed|Main: Week 0 to 26 (NN1250-3585)|One subject withdrew prior to exposure to trial drugs|152
3023104|NCT01074268|3741426|FG000|COMPLETED|Main: Week 0 to 26 (NN1250-3585)||283
3023105|NCT01074268|3741427|FG001|COMPLETED|Main: Week 0 to 26 (NN1250-3585)||138
3023106|NCT01074268|3741426|FG000|NOT COMPLETED|Main: Week 0 to 26 (NN1250-3585)||20
3023107|NCT01074268|3741427|FG001|NOT COMPLETED|Main: Week 0 to 26 (NN1250-3585)||15
3023108|NCT01074268|3741426|FG000|STARTED|Extension: Week 27 to 52 (NN1250-3725)|Thirty five subjects from main trial did not continue into the extension|248
3023109|NCT01074268|3741427|FG001|STARTED|Extension: Week 27 to 52 (NN1250-3725)|Sixteen subjects from main trial did not continue into the extension|122
3023110|NCT01074268|3741426|FG000|COMPLETED|Extension: Week 27 to 52 (NN1250-3725)||242
3023111|NCT01074268|3741427|FG001|COMPLETED|Extension: Week 27 to 52 (NN1250-3725)||115
3023112|NCT01074268|3741426|FG000|NOT COMPLETED|Extension: Week 27 to 52 (NN1250-3725)||6
3023113|NCT01074268|3741427|FG001|NOT COMPLETED|Extension: Week 27 to 52 (NN1250-3725)||7
3023114|NCT01074307|3741435|FG000|STARTED|Overall Study||66
3023115|NCT01074307|3741436|FG001|STARTED|Overall Study||114
3023116|NCT01074307|3741435|FG000|COMPLETED|Overall Study||44
3023117|NCT01074307|3741436|FG001|COMPLETED|Overall Study||102
3023118|NCT01074307|3741435|FG000|NOT COMPLETED|Overall Study||22
3023119|NCT01074307|3741436|FG001|NOT COMPLETED|Overall Study||12
3023120|NCT01074450|3741444|FG000|STARTED|First Intervention||12
3023121|NCT01074450|3741445|FG001|STARTED|First Intervention||12
3023122|NCT01074450|3741444|FG000|COMPLETED|First Intervention||12
3023123|NCT01074450|3741445|FG001|COMPLETED|First Intervention||10
3023124|NCT01074450|3741444|FG000|NOT COMPLETED|First Intervention||0
3023125|NCT01074450|3741445|FG001|NOT COMPLETED|First Intervention||2
3023126|NCT01074450|3741444|FG000|STARTED|Washout of 7 Days||12
3023127|NCT01074450|3741445|FG001|STARTED|Washout of 7 Days||10
3023128|NCT01074450|3741444|FG000|COMPLETED|Washout of 7 Days||12
3023129|NCT01074450|3741445|FG001|COMPLETED|Washout of 7 Days||10
3023130|NCT01074450|3741444|FG000|NOT COMPLETED|Washout of 7 Days||0
3023131|NCT01074450|3741445|FG001|NOT COMPLETED|Washout of 7 Days||0
3023132|NCT01074450|3741444|FG000|STARTED|Second Intervention||12
3023133|NCT01074450|3741445|FG001|STARTED|Second Intervention||10
3023134|NCT01074450|3741444|FG000|COMPLETED|Second Intervention|Positive Drug Screen at Check in.|11
3023135|NCT01074450|3741445|FG001|COMPLETED|Second Intervention|Influenze Symptoms Present at Check in.|9
3023136|NCT01074450|3741444|FG000|NOT COMPLETED|Second Intervention||1
3023137|NCT01074450|3741445|FG001|NOT COMPLETED|Second Intervention||1
3023138|NCT01074463|3741453|FG000|STARTED|First Intervention||12
3023139|NCT01074463|3741454|FG001|STARTED|First Intervention||12
3023140|NCT01074463|3741453|FG000|COMPLETED|First Intervention||12
3023141|NCT01074463|3741454|FG001|COMPLETED|First Intervention||12
3023142|NCT01074463|3741453|FG000|NOT COMPLETED|First Intervention||0
3023143|NCT01074463|3741454|FG001|NOT COMPLETED|First Intervention||0
3023144|NCT01074463|3741453|FG000|STARTED|Washout of 7 Days||12
3023145|NCT01074463|3741454|FG001|STARTED|Washout of 7 Days||12
3023146|NCT01074463|3741453|FG000|COMPLETED|Washout of 7 Days||12
3023147|NCT01074463|3741454|FG001|COMPLETED|Washout of 7 Days||12
3023148|NCT01074463|3741453|FG000|NOT COMPLETED|Washout of 7 Days||0
3023149|NCT01074463|3741454|FG001|NOT COMPLETED|Washout of 7 Days||0
3023150|NCT01074463|3741453|FG000|STARTED|Second Intervention||12
3023151|NCT01074463|3741454|FG001|STARTED|Second Intervention||12
3023152|NCT01074463|3741453|FG000|COMPLETED|Second Intervention||12
3023153|NCT01074463|3741454|FG001|COMPLETED|Second Intervention||12
3023154|NCT01074463|3741453|FG000|NOT COMPLETED|Second Intervention||0
3023155|NCT01074463|3741454|FG001|NOT COMPLETED|Second Intervention||0
3023156|NCT01074554|3741462|FG000|STARTED|Overall Study||14
3023157|NCT01074554|3741463|FG001|STARTED|Overall Study||15
3023158|NCT01074554|3741462|FG000|COMPLETED|Overall Study||11
3023159|NCT01074554|3741463|FG001|COMPLETED|Overall Study||11
3023160|NCT01074554|3741462|FG000|NOT COMPLETED|Overall Study||3
3023161|NCT01074554|3741463|FG001|NOT COMPLETED|Overall Study||4
3023162|NCT01074658|3741469|FG000|STARTED|Overall Study||1015
3023163|NCT01074658|3741469|FG000|Attempted Implant|Overall Study||996
3023164|NCT01074658|3741469|FG000|COMPLETED|Overall Study||996
3023165|NCT01074658|3741469|FG000|NOT COMPLETED|Overall Study||19
3023166|NCT01074931|3741473|FG000|STARTED|Overall Study||98
3023167|NCT01074931|3741473|FG000|COMPLETED|Overall Study||92
3023168|NCT01074931|3741473|FG000|NOT COMPLETED|Overall Study||6
3023169|NCT01074944|3741481|FG000|STARTED|Lead-in Period (up to 78 Weeks)|LIP conducted to assess randomization criteria of all participants in single reporting arm.|170
3023170|NCT01074944|3741482|FG001|STARTED|Lead-in Period (up to 78 Weeks)||0
3023171|NCT01074944|3741483|FG002|STARTED|Lead-in Period (up to 78 Weeks)||0
3023172|NCT01074944|3741484|FG003|STARTED|Lead-in Period (up to 78 Weeks)||0
3023173|NCT01074944|3741485|FG004|STARTED|Lead-in Period (up to 78 Weeks)||0
3023174|NCT01074944|3741481|FG000|COMPLETED|Lead-in Period (up to 78 Weeks)||157
3023175|NCT01074944|3741482|FG001|COMPLETED|Lead-in Period (up to 78 Weeks)||0
3023176|NCT01074944|3741483|FG002|COMPLETED|Lead-in Period (up to 78 Weeks)||0
3023177|NCT01074944|3741484|FG003|COMPLETED|Lead-in Period (up to 78 Weeks)||0
3023178|NCT01074944|3741485|FG004|COMPLETED|Lead-in Period (up to 78 Weeks)||0
3023179|NCT01074944|3741481|FG000|NOT COMPLETED|Lead-in Period (up to 78 Weeks)||13
3023180|NCT01074944|3741482|FG001|NOT COMPLETED|Lead-in Period (up to 78 Weeks)||0
3023181|NCT01074944|3741483|FG002|NOT COMPLETED|Lead-in Period (up to 78 Weeks)||0
3023182|NCT01074944|3741484|FG003|NOT COMPLETED|Lead-in Period (up to 78 Weeks)||0
3023183|NCT01074944|3741485|FG004|NOT COMPLETED|Lead-in Period (up to 78 Weeks)||0
3023184|NCT01074944|3741481|FG000|STARTED|Primary Analysis Period (up to 52 Weeks)||0
3023185|NCT01074944|3741482|FG001|STARTED|Primary Analysis Period (up to 52 Weeks)|Participants who were randomized after LIP received treatment in PAP.|65
3023186|NCT01074944|3741483|FG002|STARTED|Primary Analysis Period (up to 52 Weeks)|Participants who were randomized after LIP received treatment in PAP.|66
3023187|NCT01074944|3741484|FG003|STARTED|Primary Analysis Period (up to 52 Weeks)||0
3023188|NCT01074944|3741485|FG004|STARTED|Primary Analysis Period (up to 52 Weeks)||0
3023189|NCT01074944|3741481|FG000|COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
3023190|NCT01074944|3741482|FG001|COMPLETED|Primary Analysis Period (up to 52 Weeks)||54
3023191|NCT01074944|3741483|FG002|COMPLETED|Primary Analysis Period (up to 52 Weeks)||60
3023192|NCT01074944|3741484|FG003|COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
3023193|NCT01074944|3741485|FG004|COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
3023194|NCT01074944|3741481|FG000|NOT COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
3023195|NCT01074944|3741482|FG001|NOT COMPLETED|Primary Analysis Period (up to 52 Weeks)||11
3023196|NCT01074944|3741483|FG002|NOT COMPLETED|Primary Analysis Period (up to 52 Weeks)||6
3023197|NCT01074944|3741484|FG003|NOT COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
3023198|NCT01074944|3741485|FG004|NOT COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
3023199|NCT01074944|3741481|FG000|STARTED|Long Term Treatment||0
3023200|NCT01074944|3741482|FG001|STARTED|Long Term Treatment||0
3023201|NCT01074944|3741483|FG002|STARTED|Long Term Treatment||0
3023202|NCT01074944|3741484|FG003|STARTED|Long Term Treatment|Participants who completed PAP (114) including those who considered as treatment failure in PAP (7).|121
3023203|NCT01074944|3741485|FG004|STARTED|Long Term Treatment||0
3023204|NCT01074944|3741481|FG000|COMPLETED|Long Term Treatment||0
3023205|NCT01074944|3741482|FG001|COMPLETED|Long Term Treatment||0
3023206|NCT01074944|3741483|FG002|COMPLETED|Long Term Treatment||0
3023207|NCT01074944|3741484|FG003|COMPLETED|Long Term Treatment||95
3023208|NCT01074944|3741485|FG004|COMPLETED|Long Term Treatment||0
3023209|NCT01074944|3741481|FG000|NOT COMPLETED|Long Term Treatment||0
3023210|NCT01074944|3741482|FG001|NOT COMPLETED|Long Term Treatment||0
3023211|NCT01074944|3741483|FG002|NOT COMPLETED|Long Term Treatment||0
3023212|NCT01074944|3741484|FG003|NOT COMPLETED|Long Term Treatment||26
3023213|NCT01074944|3741485|FG004|NOT COMPLETED|Long Term Treatment||0
3023214|NCT01074944|3741481|FG000|STARTED|Extended Treatment (up to 42 Months)||0
3023215|NCT01074944|3741482|FG001|STARTED|Extended Treatment (up to 42 Months)||0
3023216|NCT01074944|3741483|FG002|STARTED|Extended Treatment (up to 42 Months)||0
3023217|NCT01074944|3741484|FG003|STARTED|Extended Treatment (up to 42 Months)||0
3023218|NCT01074944|3741485|FG004|STARTED|Extended Treatment (up to 42 Months)|Participants who were failed to meet the randomization criteria during the lead-in period.|25
3023219|NCT01074944|3741481|FG000|COMPLETED|Extended Treatment (up to 42 Months)||0
3023220|NCT01074944|3741482|FG001|COMPLETED|Extended Treatment (up to 42 Months)||0
3023221|NCT01074944|3741483|FG002|COMPLETED|Extended Treatment (up to 42 Months)||0
3023222|NCT01074944|3741484|FG003|COMPLETED|Extended Treatment (up to 42 Months)||0
3023223|NCT01074944|3741485|FG004|COMPLETED|Extended Treatment (up to 42 Months)||20
3023224|NCT01074944|3741481|FG000|NOT COMPLETED|Extended Treatment (up to 42 Months)||0
3023225|NCT01074944|3741482|FG001|NOT COMPLETED|Extended Treatment (up to 42 Months)||0
3023226|NCT01074944|3741483|FG002|NOT COMPLETED|Extended Treatment (up to 42 Months)||0
3023227|NCT01074944|3741484|FG003|NOT COMPLETED|Extended Treatment (up to 42 Months)||0
3023228|NCT01074944|3741485|FG004|NOT COMPLETED|Extended Treatment (up to 42 Months)||5
3023229|NCT01075048|3741496|FG000|STARTED|Overall Study||9
3023230|NCT01075048|3741497|FG001|STARTED|Overall Study||60
3023231|NCT01075048|3741498|FG002|STARTED|Overall Study||62
3023232|NCT01075048|3741496|FG000|Did Not Receive Treatment|Overall Study||0
3023233|NCT01075048|3741497|FG001|Did Not Receive Treatment|Overall Study||1
3023234|NCT01075048|3741498|FG002|Did Not Receive Treatment|Overall Study||0
3023235|NCT01075048|3741496|FG000|COMPLETED|Overall Study||0
3023236|NCT01075048|3741497|FG001|COMPLETED|Overall Study||0
3023237|NCT01075048|3741498|FG002|COMPLETED|Overall Study||0
3023238|NCT01075048|3741496|FG000|NOT COMPLETED|Overall Study||9
3023239|NCT01075048|3741497|FG001|NOT COMPLETED|Overall Study||60
3023240|NCT01075048|3741498|FG002|NOT COMPLETED|Overall Study||62
3023241|NCT01075074|3741512|FG000|STARTED|Overall Study||25
3023242|NCT01075074|3741513|FG001|STARTED|Overall Study||25
3023243|NCT01075074|3741514|FG002|STARTED|Overall Study||25
3023244|NCT01075074|3741512|FG000|COMPLETED|Overall Study||24
3023245|NCT01075074|3741513|FG001|COMPLETED|Overall Study||23
3023246|NCT01075074|3741514|FG002|COMPLETED|Overall Study||23
3023247|NCT01075074|3741512|FG000|NOT COMPLETED|Overall Study||1
3023248|NCT01075074|3741513|FG001|NOT COMPLETED|Overall Study||2
3023249|NCT01075074|3741514|FG002|NOT COMPLETED|Overall Study||2
3023250|NCT01075087|3741528|FG000|STARTED|Overall Study||9
3023251|NCT01075087|3741529|FG001|STARTED|Overall Study||10
3023252|NCT01075087|3741528|FG000|COMPLETED|Overall Study||9
3023253|NCT01075087|3741529|FG001|COMPLETED|Overall Study||10
3023254|NCT01075087|3741528|FG000|NOT COMPLETED|Overall Study||0
3023255|NCT01075087|3741529|FG001|NOT COMPLETED|Overall Study||0
3023256|NCT01075100|3741537|FG000|STARTED|Overall Study||49
3023257|NCT01075100|3741538|FG001|STARTED|Overall Study||54
3023258|NCT01075100|3741537|FG000|COMPLETED|Overall Study||0
3023259|NCT01075100|3741538|FG001|COMPLETED|Overall Study||1
3023260|NCT01075100|3741537|FG000|NOT COMPLETED|Overall Study||49
3023261|NCT01075100|3741538|FG001|NOT COMPLETED|Overall Study||53
3023262|NCT01075152|3741548|FG000|STARTED|Overall Study|randomized|88
3023263|NCT01075152|3741549|FG001|STARTED|Overall Study|randomized|89
3023264|NCT01075152|3741548|FG000|COMPLETED|Overall Study||87
3023265|NCT01075152|3741549|FG001|COMPLETED|Overall Study||89
3023266|NCT01075152|3741548|FG000|NOT COMPLETED|Overall Study||1
3023267|NCT01075152|3741549|FG001|NOT COMPLETED|Overall Study||0
3023268|NCT01075178|3741559|FG000|STARTED|Subject Matching|eligible for matching|1148
3023269|NCT01075178|3741560|FG001|STARTED|Subject Matching|eligible for matching|1421
3023270|NCT01075178|3741559|FG000|COMPLETED|Subject Matching|subjects matched|1018
3023271|NCT01075178|3741560|FG001|COMPLETED|Subject Matching|subjects matched|1018
3023272|NCT01075178|3741559|FG000|NOT COMPLETED|Subject Matching||130
3023273|NCT01075178|3741560|FG001|NOT COMPLETED|Subject Matching||403
3023274|NCT01075178|3741559|FG000|STARTED|Subject Chart Review|subjects matched|1018
3023275|NCT01075178|3741560|FG001|STARTED|Subject Chart Review|subjects matched|1018
3023276|NCT01075178|3741559|FG000|COMPLETED|Subject Chart Review|subjects in full analysis set|1009
3023277|NCT01075178|3741560|FG001|COMPLETED|Subject Chart Review|subjects in full analysis set|1009
3023278|NCT01075178|3741559|FG000|NOT COMPLETED|Subject Chart Review||9
3023279|NCT01075178|3741560|FG001|NOT COMPLETED|Subject Chart Review||9
3023280|NCT01075191|3741566|FG000|STARTED|Overall Study|65 participants were enrolled; 5 protocol violations were excluded from all analyses except safety.|60
3023281|NCT01075191|3741566|FG000|Discontinued Year 1|Overall Study||7
3023282|NCT01075191|3741566|FG000|Discontinued Year 2|Overall Study||6
3023283|NCT01075191|3741566|FG000|Discontinued Year 3|Overall Study||5
3023284|NCT01075191|3741566|FG000|COMPLETED|Overall Study||42
3023285|NCT01075191|3741566|FG000|NOT COMPLETED|Overall Study||18
3023286|NCT01075204|3741570|FG000|STARTED|Overall Study||335
3023287|NCT01075204|3741570|FG000|COMPLETED|Overall Study||335
3023288|NCT01075204|3741570|FG000|NOT COMPLETED|Overall Study||0
3023289|NCT01075217|3741576|FG000|STARTED|Overall Study|88 patients randomized to receive Isovue; 4 of the patients did not meet entry requirements|84
3023290|NCT01075217|3741577|FG001|STARTED|Overall Study|86 patients randomized to receive Visipaque; 1 of the patients did not meet entry requirements|85
3023291|NCT01075217|3741576|FG000|COMPLETED|Overall Study||82
3023292|NCT01075217|3741577|FG001|COMPLETED|Overall Study||84
3308487|NCT03020745|4041795|FG002|NOT COMPLETED|Part 2 (Up to 169 Days)||0
3308488|NCT03020745|4041796|FG003|NOT COMPLETED|Part 2 (Up to 169 Days)||0
3308489|NCT03020745|4041797|FG004|NOT COMPLETED|Part 2 (Up to 169 Days)||0
3308490|NCT03020745|4041798|FG005|NOT COMPLETED|Part 2 (Up to 169 Days)||0
3308491|NCT03020745|4041799|FG006|NOT COMPLETED|Part 2 (Up to 169 Days)||0
3308492|NCT03020745|4041800|FG007|NOT COMPLETED|Part 2 (Up to 169 Days)||1
3308493|NCT03020745|4041801|FG008|NOT COMPLETED|Part 2 (Up to 169 Days)||1
3308494|NCT03020745|4041802|FG009|NOT COMPLETED|Part 2 (Up to 169 Days)||0
3308495|NCT03020745|4041793|FG000|STARTED|Part 2:Optional FU (Up to 450 Days)||0
3308496|NCT03020745|4041794|FG001|STARTED|Part 2:Optional FU (Up to 450 Days)||0
3308497|NCT03020745|4041795|FG002|STARTED|Part 2:Optional FU (Up to 450 Days)||0
3308498|NCT03020745|4041796|FG003|STARTED|Part 2:Optional FU (Up to 450 Days)||0
3308499|NCT03020745|4041797|FG004|STARTED|Part 2:Optional FU (Up to 450 Days)||0
3308500|NCT03020745|4041798|FG005|STARTED|Part 2:Optional FU (Up to 450 Days)||10
3023293|NCT01075217|3741576|FG000|NOT COMPLETED|Overall Study||2
3023294|NCT01075217|3741577|FG001|NOT COMPLETED|Overall Study||1
3023295|NCT01075243|3741594|FG000|STARTED|Overall Study||163
3023296|NCT01075243|3741595|FG001|STARTED|Overall Study||158
3023297|NCT01075243|3741596|FG002|STARTED|Overall Study||80
3023298|NCT01075243|3741594|FG000|COMPLETED|Overall Study||157
3023299|NCT01075243|3741595|FG001|COMPLETED|Overall Study||155
3023300|NCT01075243|3741596|FG002|COMPLETED|Overall Study||80
3023301|NCT01075243|3741594|FG000|NOT COMPLETED|Overall Study||6
3023302|NCT01075243|3741595|FG001|NOT COMPLETED|Overall Study||3
3023303|NCT01075243|3741596|FG002|NOT COMPLETED|Overall Study||0
3023304|NCT01075256|3741609|FG000|STARTED|Overall Study||64
3023305|NCT01075256|3741610|FG001|STARTED|Overall Study||66
3023306|NCT01075256|3741611|FG002|STARTED|Overall Study||65
3023307|NCT01075256|3741609|FG000|COMPLETED|Overall Study||63
3023308|NCT01075256|3741610|FG001|COMPLETED|Overall Study||66
3023309|NCT01075256|3741611|FG002|COMPLETED|Overall Study||65
3023310|NCT01075256|3741609|FG000|NOT COMPLETED|Overall Study||1
3023311|NCT01075256|3741610|FG001|NOT COMPLETED|Overall Study||0
3023312|NCT01075256|3741611|FG002|NOT COMPLETED|Overall Study||0
3023313|NCT01075282|3741627|FG000|STARTED|Overall Study||273
3023314|NCT01075282|3741628|FG001|STARTED|Overall Study||272
3023315|NCT01075282|3741629|FG002|STARTED|Overall Study|Of 265 participants randomized to Insulin Glargine, 3 chose not to take study drug.|265
3023316|NCT01075282|3741627|FG000|Received at Least One Dose of Study Drug|Overall Study||273
3023317|NCT01075282|3741628|FG001|Received at Least One Dose of Study Drug|Overall Study||272
3023318|NCT01075282|3741629|FG002|Received at Least One Dose of Study Drug|Overall Study||262
3023319|NCT01075282|3741627|FG000|COMPLETED|Overall Study||242
3023320|NCT01075282|3741628|FG001|COMPLETED|Overall Study||243
3023321|NCT01075282|3741629|FG002|COMPLETED|Overall Study||238
3023322|NCT01075282|3741627|FG000|NOT COMPLETED|Overall Study||31
3023323|NCT01075282|3741628|FG001|NOT COMPLETED|Overall Study||29
3023324|NCT01075282|3741629|FG002|NOT COMPLETED|Overall Study||27
3023325|NCT01075321|3741638|FG000|STARTED|Overall Study||7
3023326|NCT01075321|3741639|FG001|STARTED|Overall Study||9
3023327|NCT01075321|3741640|FG002|STARTED|Overall Study||9
3023328|NCT01075321|3741641|FG003|STARTED|Overall Study||33
3023329|NCT01075321|3741638|FG000|COMPLETED|Overall Study||6
3023330|NCT01075321|3741639|FG001|COMPLETED|Overall Study||9
3023331|NCT01075321|3741640|FG002|COMPLETED|Overall Study||7
3023332|NCT01075321|3741641|FG003|COMPLETED|Overall Study||31
3023333|NCT01075321|3741638|FG000|NOT COMPLETED|Overall Study||1
3023334|NCT01075321|3741639|FG001|NOT COMPLETED|Overall Study||0
3023335|NCT01075321|3741640|FG002|NOT COMPLETED|Overall Study||2
3023336|NCT01075321|3741641|FG003|NOT COMPLETED|Overall Study||2
3023337|NCT01075347|3741655|FG000|STARTED|Overall Study||82
3023338|NCT01075347|3741656|FG001|STARTED|Overall Study||83
3023339|NCT01075347|3741655|FG000|COMPLETED|Overall Study||82
3023340|NCT01075347|3741656|FG001|COMPLETED|Overall Study||83
3023341|NCT01075347|3741655|FG000|NOT COMPLETED|Overall Study||0
3023342|NCT01075347|3741656|FG001|NOT COMPLETED|Overall Study||0
3023343|NCT01075399|3741662|FG000|STARTED|Overall Study|A total of 50 patients were enrolled into the study.|50
3023344|NCT01075399|3741662|FG000|COMPLETED|Overall Study|42 of 50 patients received at least one dose and 39 of 50 patients completed two pre-treatment scan|42
3023345|NCT01075399|3741662|FG000|NOT COMPLETED|Overall Study||8
3023346|NCT01075412|3741668|FG000|STARTED|Overall Study||4
3023347|NCT01075412|3741669|FG001|STARTED|Overall Study||2
3023348|NCT01075412|3741668|FG000|COMPLETED|Overall Study||4
3023349|NCT01075412|3741669|FG001|COMPLETED|Overall Study||1
3023350|NCT01075412|3741668|FG000|NOT COMPLETED|Overall Study||0
3023351|NCT01075412|3741669|FG001|NOT COMPLETED|Overall Study||1
3023352|NCT01075516|3741676|FG000|STARTED|Overall Study||107
3023353|NCT01075516|3741677|FG001|STARTED|Overall Study||102
3023354|NCT01075516|3741676|FG000|COMPLETED|Overall Study||89
3023355|NCT01075516|3741677|FG001|COMPLETED|Overall Study||86
3023356|NCT01075516|3741676|FG000|NOT COMPLETED|Overall Study||18
3023357|NCT01075516|3741677|FG001|NOT COMPLETED|Overall Study||16
3023358|NCT01075646|3741687|FG000|STARTED|Overall Study||33
3023359|NCT01075646|3741688|FG001|STARTED|Overall Study||34
3023360|NCT01075646|3741689|FG002|STARTED|Overall Study||53
3023361|NCT01075646|3741690|FG003|STARTED|Overall Study||46
3023362|NCT01075646|3741687|FG000|COMPLETED|Overall Study||29
3023363|NCT01075646|3741688|FG001|COMPLETED|Overall Study||31
3023364|NCT01075646|3741689|FG002|COMPLETED|Overall Study||52
3023365|NCT01075646|3741690|FG003|COMPLETED|Overall Study||44
3023366|NCT01075646|3741687|FG000|NOT COMPLETED|Overall Study||4
3023367|NCT01075646|3741688|FG001|NOT COMPLETED|Overall Study||3
3023368|NCT01075646|3741689|FG002|NOT COMPLETED|Overall Study||1
3023369|NCT01075646|3741690|FG003|NOT COMPLETED|Overall Study||2
3023370|NCT01075685|3741702|FG000|STARTED|Overall Study||743
3023371|NCT01075685|3741703|FG001|STARTED|Overall Study||414
3023372|NCT01075685|3741702|FG000|Met Inclusion Criteria|Overall Study||734
3023373|NCT01075685|3741703|FG001|Met Inclusion Criteria|Overall Study||413
3023374|NCT01075685|3741702|FG000|Completed Baseline Measures|Overall Study||225
3023375|NCT01075685|3741703|FG001|Completed Baseline Measures|Overall Study||263
3023376|NCT01075685|3741702|FG000|COMPLETED|Overall Study||151
3023377|NCT01075685|3741703|FG001|COMPLETED|Overall Study||188
3023378|NCT01075685|3741702|FG000|NOT COMPLETED|Overall Study||592
3023379|NCT01075685|3741703|FG001|NOT COMPLETED|Overall Study||226
3023380|NCT01075763|3741711|FG000|STARTED|Overall Study||23
3023381|NCT01075763|3741712|FG001|STARTED|Overall Study||19
3023382|NCT01075763|3741711|FG000|COMPLETED|Overall Study||19
3023383|NCT01075763|3741712|FG001|COMPLETED|Overall Study||15
3023384|NCT01075763|3741711|FG000|NOT COMPLETED|Overall Study||4
3023385|NCT01075763|3741712|FG001|NOT COMPLETED|Overall Study||4
3023386|NCT01075815|3741720|FG000|STARTED|Overall Study|Number of participants treated.|40
3023387|NCT01075815|3741721|FG001|STARTED|Overall Study|Number of participants treated.|35
3023388|NCT01075815|3741720|FG000|COMPLETED|Overall Study||30
3023389|NCT01075815|3741721|FG001|COMPLETED|Overall Study||31
3023390|NCT01075815|3741720|FG000|NOT COMPLETED|Overall Study||10
3023391|NCT01075815|3741721|FG001|NOT COMPLETED|Overall Study||4
3023392|NCT01075958|3741727|FG000|STARTED|Overall Study||283
3023393|NCT01075958|3741727|FG000|COMPLETED|Overall Study||239
3023394|NCT01075958|3741727|FG000|NOT COMPLETED|Overall Study||44
3023395|NCT01075971|3741731|FG000|STARTED|Overall Study||52
3023396|NCT01075971|3741731|FG000|COMPLETED|Overall Study||52
3023397|NCT01075971|3741731|FG000|NOT COMPLETED|Overall Study||0
3023398|NCT01075984|3741740|FG000|STARTED|Treatment Phase||10
3023399|NCT01075984|3741741|FG001|STARTED|Treatment Phase||11
3023400|NCT01075984|3741742|FG002|STARTED|Treatment Phase||21
3023401|NCT01075984|3741743|FG003|STARTED|Treatment Phase||24
3023402|NCT01075984|3741744|FG004|STARTED|Treatment Phase||213
3023403|NCT01075984|3741740|FG000|COMPLETED|Treatment Phase||10
3165729|NCT01901328|3893264|FG001|NOT COMPLETED|Overall Study||21
3165730|NCT01901341|3893273|FG000|STARTED|Overall Study||22
3165731|NCT01901341|3893274|FG001|STARTED|Overall Study||22
3023404|NCT01075984|3741741|FG001|COMPLETED|Treatment Phase||10
3023405|NCT01075984|3741742|FG002|COMPLETED|Treatment Phase||14
3023406|NCT01075984|3741743|FG003|COMPLETED|Treatment Phase||17
3023407|NCT01075984|3741744|FG004|COMPLETED|Treatment Phase||153
3023408|NCT01075984|3741740|FG000|NOT COMPLETED|Treatment Phase||0
3023409|NCT01075984|3741741|FG001|NOT COMPLETED|Treatment Phase||1
3023410|NCT01075984|3741742|FG002|NOT COMPLETED|Treatment Phase||7
3023411|NCT01075984|3741743|FG003|NOT COMPLETED|Treatment Phase||7
3023412|NCT01075984|3741744|FG004|NOT COMPLETED|Treatment Phase||60
3023413|NCT01075984|3741740|FG000|STARTED|Follow-up Phase||10
3023414|NCT01075984|3741741|FG001|STARTED|Follow-up Phase||10
3023415|NCT01075984|3741742|FG002|STARTED|Follow-up Phase|One participant did not start the follow-up phase for reasons unrelated to study procedures.|20
3023416|NCT01075984|3741743|FG003|STARTED|Follow-up Phase|Three participants did not start the follow-up phase: one died and two were lost to follow-up.|21
3023417|NCT01075984|3741744|FG004|STARTED|Follow-up Phase|One participant withdrew consent before the start of the follow-up phase.|212
3023418|NCT01075984|3741740|FG000|COMPLETED|Follow-up Phase||10
3023419|NCT01075984|3741741|FG001|COMPLETED|Follow-up Phase||10
3023420|NCT01075984|3741742|FG002|COMPLETED|Follow-up Phase||19
3023421|NCT01075984|3741743|FG003|COMPLETED|Follow-up Phase||19
3023422|NCT01075984|3741744|FG004|COMPLETED|Follow-up Phase||165
3023423|NCT01075984|3741740|FG000|NOT COMPLETED|Follow-up Phase||0
3023424|NCT01075984|3741741|FG001|NOT COMPLETED|Follow-up Phase||0
3023425|NCT01075984|3741742|FG002|NOT COMPLETED|Follow-up Phase||1
3023426|NCT01075984|3741743|FG003|NOT COMPLETED|Follow-up Phase||2
3023427|NCT01075984|3741744|FG004|NOT COMPLETED|Follow-up Phase||47
3023428|NCT01076010|3741759|FG000|STARTED|Overall Study||161
3023429|NCT01076010|3741760|FG001|STARTED|Overall Study||88
3023430|NCT01076010|3741761|FG002|STARTED|Overall Study||28
3023431|NCT01076010|3741759|FG000|COMPLETED|Overall Study||36
3023432|NCT01076010|3741760|FG001|COMPLETED|Overall Study||49
3023433|NCT01076010|3741761|FG002|COMPLETED|Overall Study||26
3023434|NCT01076010|3741759|FG000|NOT COMPLETED|Overall Study||125
3023435|NCT01076010|3741760|FG001|NOT COMPLETED|Overall Study||39
3023436|NCT01076010|3741761|FG002|NOT COMPLETED|Overall Study||2
3023437|NCT01076036|3741769|FG000|STARTED|Overall Study||10
3023438|NCT01076036|3741769|FG000|# of Procedures|Overall Study||8
3023439|NCT01076036|3741769|FG000|Complete CorPath Procedures|Overall Study||8
3023440|NCT01076036|3741769|FG000|COMPLETED|Overall Study||8
3023441|NCT01076036|3741769|FG000|NOT COMPLETED|Overall Study||2
3023442|NCT01076049|3741776|FG000|STARTED|Overall Study||52
3023443|NCT01076049|3741777|FG001|STARTED|Overall Study||55
3023444|NCT01076049|3741778|FG002|STARTED|Overall Study||1
3023445|NCT01076049|3741776|FG000|COMPLETED|Overall Study||45
3023446|NCT01076049|3741777|FG001|COMPLETED|Overall Study||52
3023447|NCT01076049|3741778|FG002|COMPLETED|Overall Study||1
3023448|NCT01076049|3741776|FG000|NOT COMPLETED|Overall Study||7
3023449|NCT01076049|3741777|FG001|NOT COMPLETED|Overall Study||3
3023450|NCT01076049|3741778|FG002|NOT COMPLETED|Overall Study||0
3023451|NCT01076075|3741790|FG000|STARTED|Overall Study|3 participants were excluded from safety and efficacy analyses due to one site's non-compliance|213
3023452|NCT01076075|3741791|FG001|STARTED|Overall Study|2 participants were excluded from safety and efficacy analyses due to one site's non-compliance|214
3023453|NCT01076075|3741790|FG000|Completed Phase A|Overall Study||199
3023454|NCT01076075|3741791|FG001|Completed Phase A|Overall Study||189
3023455|NCT01076075|3741790|FG000|COMPLETED|Overall Study||172
3023456|NCT01076075|3741791|FG001|COMPLETED|Overall Study||167
3023457|NCT01076075|3741790|FG000|NOT COMPLETED|Overall Study||41
3023458|NCT01076075|3741791|FG001|NOT COMPLETED|Overall Study||47
3023459|NCT01076088|3741806|FG000|STARTED|Overall Study||122
3023460|NCT01076088|3741807|FG001|STARTED|Overall Study||125
3023461|NCT01076088|3741808|FG002|STARTED|Overall Study||126
3023462|NCT01076088|3741809|FG003|STARTED|Overall Study||124
3023463|NCT01076088|3741810|FG004|STARTED|Overall Study||120
3023464|NCT01076088|3741811|FG005|STARTED|Overall Study||127
3023465|NCT01076088|3741806|FG000|COMPLETED|Overall Study||111
3023466|NCT01076088|3741807|FG001|COMPLETED|Overall Study||107
3023467|NCT01076088|3741808|FG002|COMPLETED|Overall Study||109
3023468|NCT01076088|3741809|FG003|COMPLETED|Overall Study||109
3023469|NCT01076088|3741810|FG004|COMPLETED|Overall Study||104
3023470|NCT01076088|3741811|FG005|COMPLETED|Overall Study||104
3023471|NCT01076088|3741806|FG000|NOT COMPLETED|Overall Study||11
3023472|NCT01076088|3741807|FG001|NOT COMPLETED|Overall Study||18
3023473|NCT01076088|3741808|FG002|NOT COMPLETED|Overall Study||17
3023474|NCT01076088|3741809|FG003|NOT COMPLETED|Overall Study||15
3023475|NCT01076088|3741810|FG004|NOT COMPLETED|Overall Study||16
3023476|NCT01076088|3741811|FG005|NOT COMPLETED|Overall Study||23
3023477|NCT01076153|3741826|FG000|STARTED|Overall Study||760
3023478|NCT01076153|3741826|FG000|COMPLETED|Overall Study||749
3023479|NCT01076153|3741826|FG000|NOT COMPLETED|Overall Study||11
3023480|NCT01076166|3741834|FG000|STARTED|Overall Study||337
3023481|NCT01076166|3741834|FG000|COMPLETED|Overall Study||328
3023482|NCT01076166|3741834|FG000|NOT COMPLETED|Overall Study||9
3023483|NCT01076179|3741841|FG000|STARTED|Overall Study||502
3023484|NCT01076179|3741841|FG000|COMPLETED|Overall Study||501
3023485|NCT01076179|3741841|FG000|NOT COMPLETED|Overall Study||1
3023486|NCT01076192|3741846|FG000|STARTED|Overall Study||547
3023487|NCT01076192|3741846|FG000|COMPLETED|Overall Study||350
3023488|NCT01076192|3741846|FG000|NOT COMPLETED|Overall Study||197
3023489|NCT01076205|3741851|FG000|STARTED|Overall Study||7229
3023490|NCT01076205|3741851|FG000|COMPLETED|Overall Study||1210
3023491|NCT01076205|3741851|FG000|NOT COMPLETED|Overall Study||6019
3023492|NCT01076231|3741871|FG000|STARTED|Overall Study||34
3023493|NCT01076231|3741871|FG000|COMPLETED|Overall Study||0
3023494|NCT01076231|3741871|FG000|NOT COMPLETED|Overall Study||34
3023495|NCT01076244|3741875|FG000|STARTED|Overall Study||46
3023496|NCT01076244|3741875|FG000|COMPLETED|Overall Study||42
3023497|NCT01076244|3741875|FG000|NOT COMPLETED|Overall Study||4
3023498|NCT01076270|3741879|FG000|STARTED|Overall Study||1
3023499|NCT01076270|3741879|FG000|COMPLETED|Overall Study||1
3023500|NCT01076270|3741879|FG000|NOT COMPLETED|Overall Study||0
3023501|NCT01076283|3741885|FG000|STARTED|Overall Study||7
3023502|NCT01076283|3741886|FG001|STARTED|Overall Study||7
3023503|NCT01076283|3741885|FG000|COMPLETED|Overall Study||6
3023504|NCT01076283|3741886|FG001|COMPLETED|Overall Study||7
3023505|NCT01076283|3741885|FG000|NOT COMPLETED|Overall Study||1
3023506|NCT01076283|3741886|FG001|NOT COMPLETED|Overall Study||0
3023507|NCT01076296|3741892|FG000|STARTED|Overall Study||54
3023508|NCT01076296|3741893|FG001|STARTED|Overall Study||196
3023509|NCT01076296|3741894|FG002|STARTED|Overall Study||51
3023510|NCT01076296|3741895|FG003|STARTED|Overall Study||199
3023511|NCT01076296|3741896|FG004|STARTED|Overall Study||59
3023512|NCT01076296|3741897|FG005|STARTED|Overall Study||191
3023513|NCT01076296|3741898|FG006|STARTED|Overall Study||51
3023514|NCT01076296|3741899|FG007|STARTED|Overall Study||199
3023515|NCT01076296|3741892|FG000|COMPLETED|Overall Study||54
3023516|NCT01076296|3741893|FG001|COMPLETED|Overall Study||196
3023517|NCT01076296|3741894|FG002|COMPLETED|Overall Study||51
3023518|NCT01076296|3741895|FG003|COMPLETED|Overall Study||199
3023519|NCT01076296|3741896|FG004|COMPLETED|Overall Study||59
3023520|NCT01076296|3741897|FG005|COMPLETED|Overall Study||191
3023521|NCT01076296|3741898|FG006|COMPLETED|Overall Study||51
3023522|NCT01076296|3741899|FG007|COMPLETED|Overall Study||199
3165732|NCT01901341|3893273|FG000|Received at Least 1 Dose of Study Drug|Overall Study||22
3165733|NCT01901341|3893274|FG001|Received at Least 1 Dose of Study Drug|Overall Study||22
3165734|NCT01901341|3893273|FG000|COMPLETED|Overall Study||2
3165735|NCT01901341|3893274|FG001|COMPLETED|Overall Study||1
3165736|NCT01901341|3893273|FG000|NOT COMPLETED|Overall Study||20
3165737|NCT01901341|3893274|FG001|NOT COMPLETED|Overall Study||21
3165738|NCT01901393|3893283|FG000|STARTED|Overall Study||51
3165739|NCT01901393|3893284|FG001|STARTED|Overall Study||49
3165740|NCT01901393|3893283|FG000|COMPLETED|Overall Study||50
3023523|NCT01076296|3741892|FG000|NOT COMPLETED|Overall Study||0
3023524|NCT01076296|3741893|FG001|NOT COMPLETED|Overall Study||0
3023525|NCT01076296|3741894|FG002|NOT COMPLETED|Overall Study||0
3023526|NCT01076296|3741895|FG003|NOT COMPLETED|Overall Study||0
3023527|NCT01076296|3741896|FG004|NOT COMPLETED|Overall Study||0
3023528|NCT01076296|3741897|FG005|NOT COMPLETED|Overall Study||0
3165741|NCT01901393|3893284|FG001|COMPLETED|Overall Study||49
3165742|NCT01901393|3893283|FG000|NOT COMPLETED|Overall Study||1
3165743|NCT01901393|3893284|FG001|NOT COMPLETED|Overall Study||0
3165744|NCT01901419|3893292|FG000|STARTED|Overall Study||40
3165745|NCT01901419|3893293|FG001|STARTED|Overall Study||40
3165746|NCT01901419|3893292|FG000|COMPLETED|Overall Study||32
3165747|NCT01901419|3893293|FG001|COMPLETED|Overall Study||31
3023529|NCT01076296|3741898|FG006|NOT COMPLETED|Overall Study||0
3023530|NCT01076296|3741899|FG007|NOT COMPLETED|Overall Study||0
3023531|NCT01076335|3741917|FG000|STARTED|Overall Study||40
3023532|NCT01076335|3741917|FG000|COMPLETED|Overall Study||36
3023533|NCT01076335|3741917|FG000|NOT COMPLETED|Overall Study||4
3023534|NCT01076348|3741921|FG000|STARTED|Overall Study||73
3023535|NCT01076348|3741921|FG000|COMPLETED|Overall Study||51
3023536|NCT01076348|3741921|FG000|NOT COMPLETED|Overall Study||22
3023537|NCT01076361|3741925|FG000|STARTED|Overall Study|631 leads were implanted in 370 patients. 22 leads in 21 patients were excluded from analysis.|370
3023538|NCT01076361|3741925|FG000|COMPLETED|Overall Study|Follow-up data was not available for 21 participants (22 leads)|349
3023539|NCT01076361|3741925|FG000|NOT COMPLETED|Overall Study||21
3023540|NCT01076400|3741929|FG000|STARTED|Overall Study||7
3023541|NCT01076400|3741930|FG001|STARTED|Overall Study|No participants were enrolled in Part 2 of the study.|0
3023542|NCT01076400|3741931|FG002|STARTED|Overall Study|No participants were enrolled in Part 2 of the study.|0
3023543|NCT01076400|3741929|FG000|COMPLETED|Overall Study||0
3023544|NCT01076400|3741930|FG001|COMPLETED|Overall Study||0
3023545|NCT01076400|3741931|FG002|COMPLETED|Overall Study||0
3023546|NCT01076400|3741929|FG000|NOT COMPLETED|Overall Study||7
3023547|NCT01076400|3741930|FG001|NOT COMPLETED|Overall Study||0
3023548|NCT01076400|3741931|FG002|NOT COMPLETED|Overall Study||0
3023549|NCT01076452|3741937|FG000|STARTED|Overall Study||147
3023550|NCT01076452|3741938|FG001|STARTED|Overall Study||152
3023551|NCT01076452|3741937|FG000|COMPLETED|Overall Study||123
3023552|NCT01076452|3741938|FG001|COMPLETED|Overall Study||138
3165748|NCT01901419|3893292|FG000|NOT COMPLETED|Overall Study||8
3165749|NCT01901419|3893293|FG001|NOT COMPLETED|Overall Study||9
3023553|NCT01076452|3741937|FG000|NOT COMPLETED|Overall Study||24
3023554|NCT01076452|3741938|FG001|NOT COMPLETED|Overall Study||14
3023555|NCT01076504|3741944|FG000|STARTED|Overall Study||80
3023556|NCT01076504|3741944|FG000|COMPLETED|Overall Study|Patients remained on study until disease progression or withdrawal for any other reason|0
3023557|NCT01076504|3741944|FG000|NOT COMPLETED|Overall Study||80
3023558|NCT01076543|3741954|FG000|STARTED|Overall Study||8
3023559|NCT01076543|3741955|FG001|STARTED|Overall Study||3
3023560|NCT01076543|3741956|FG002|STARTED|Overall Study||6
3023561|NCT01076543|3741957|FG003|STARTED|Overall Study||39
3023562|NCT01076543|3741958|FG004|STARTED|Overall Study||15
3023563|NCT01076543|3741959|FG005|STARTED|Overall Study||39
3023564|NCT01076543|3741954|FG000|COMPLETED|Overall Study||6
3023565|NCT01076543|3741955|FG001|COMPLETED|Overall Study||3
3023566|NCT01076543|3741956|FG002|COMPLETED|Overall Study||6
3023567|NCT01076543|3741957|FG003|COMPLETED|Overall Study||39
3023568|NCT01076543|3741958|FG004|COMPLETED|Overall Study||15
3023569|NCT01076543|3741959|FG005|COMPLETED|Overall Study||39
3023570|NCT01076543|3741954|FG000|NOT COMPLETED|Overall Study||2
3023571|NCT01076543|3741955|FG001|NOT COMPLETED|Overall Study||0
3023572|NCT01076543|3741956|FG002|NOT COMPLETED|Overall Study||0
3023573|NCT01076543|3741957|FG003|NOT COMPLETED|Overall Study||0
3023574|NCT01076543|3741958|FG004|NOT COMPLETED|Overall Study||0
3023575|NCT01076543|3741959|FG005|NOT COMPLETED|Overall Study||0
3165750|NCT01901575|3893299|FG000|STARTED|Overall Study|enrolled patients with PVC's present prior to sedation with remifentanil IVPCA|16
3165751|NCT01901575|3893299|FG000|COMPLETED|Overall Study||16
3308501|NCT03020745|4041799|FG006|STARTED|Part 2:Optional FU (Up to 450 Days)|1 participant didn't enter into optional follow-up period.|5
3165752|NCT01901575|3893299|FG000|NOT COMPLETED|Overall Study||0
3165753|NCT01901588|3893306|FG000|STARTED|Overall Study||32
3165754|NCT01901588|3893307|FG001|STARTED|Overall Study||31
3165755|NCT01901588|3893306|FG000|COMPLETED|Overall Study||32
3165756|NCT01901588|3893307|FG001|COMPLETED|Overall Study||31
3165757|NCT01901588|3893306|FG000|NOT COMPLETED|Overall Study||0
3165758|NCT01901588|3893307|FG001|NOT COMPLETED|Overall Study||0
3165759|NCT01901614|3893315|FG000|STARTED|Overall Study||3
3165760|NCT01901614|3893316|FG001|STARTED|Overall Study||2
3165761|NCT01901614|3893315|FG000|COMPLETED|Overall Study||1
3165762|NCT01901614|3893316|FG001|COMPLETED|Overall Study||1
3165763|NCT01901614|3893315|FG000|NOT COMPLETED|Overall Study||2
3165764|NCT01901614|3893316|FG001|NOT COMPLETED|Overall Study||1
3165765|NCT01901653|3893335|FG000|STARTED|Overall Study||3
3023576|NCT01076647|3741976|FG000|STARTED|Overall Study||233
3023577|NCT01076647|3741977|FG001|STARTED|Overall Study||234
3023578|NCT01076647|3741976|FG000|COMPLETED|Overall Study||208
3023579|NCT01076647|3741977|FG001|COMPLETED|Overall Study||209
3023580|NCT01076647|3741976|FG000|NOT COMPLETED|Overall Study||25
3023581|NCT01076647|3741977|FG001|NOT COMPLETED|Overall Study||25
3023582|NCT01076686|3741987|FG000|STARTED|Overall Study||17
3023583|NCT01076686|3741988|FG001|STARTED|Overall Study||14
3023584|NCT01076686|3741989|FG002|STARTED|Overall Study||32
3023585|NCT01076686|3741990|FG003|STARTED|Overall Study||31
3023586|NCT01076686|3741987|FG000|COMPLETED|Overall Study||17
3023587|NCT01076686|3741988|FG001|COMPLETED|Overall Study||14
3023588|NCT01076686|3741989|FG002|COMPLETED|Overall Study||32
3023589|NCT01076686|3741990|FG003|COMPLETED|Overall Study||31
3023590|NCT01076686|3741987|FG000|NOT COMPLETED|Overall Study||0
3023591|NCT01076686|3741988|FG001|NOT COMPLETED|Overall Study||0
3023592|NCT01076686|3741989|FG002|NOT COMPLETED|Overall Study||0
3023593|NCT01076686|3741990|FG003|NOT COMPLETED|Overall Study||0
3023594|NCT01076959|3742000|FG000|STARTED|Overall Study||7740
3023595|NCT01076959|3742000|FG000|COMPLETED|Overall Study||5490
3023596|NCT01076959|3742000|FG000|NOT COMPLETED|Overall Study||2250
3023597|NCT01076972|3742017|FG000|STARTED|Overall Study||1184
3023598|NCT01076972|3742017|FG000|COMPLETED|Overall Study||1184
3023599|NCT01076972|3742017|FG000|NOT COMPLETED|Overall Study||0
3023600|NCT01076985|3742031|FG000|STARTED|Overall Study||24
3023601|NCT01076985|3742031|FG000|COMPLETED|Overall Study||24
3023602|NCT01076985|3742031|FG000|NOT COMPLETED|Overall Study||0
3023603|NCT01077024|3742039|FG000|STARTED|Overall Study||267
3023604|NCT01077024|3742040|FG001|STARTED|Overall Study||271
3023605|NCT01077024|3742039|FG000|COMPLETED|Overall Study||236
3023606|NCT01077024|3742040|FG001|COMPLETED|Overall Study||243
3023607|NCT01077024|3742039|FG000|NOT COMPLETED|Overall Study||31
3023608|NCT01077024|3742040|FG001|NOT COMPLETED|Overall Study||28
3023609|NCT01077050|3742046|FG000|STARTED|Overall Study||1951
3023610|NCT01077050|3742046|FG000|COMPLETED|Overall Study||1942
3023611|NCT01077050|3742046|FG000|NOT COMPLETED|Overall Study||9
3023612|NCT01077063|3742052|FG000|STARTED|Overall Study||4
3023613|NCT01077063|3742053|FG001|STARTED|Overall Study||3
3023614|NCT01077063|3742052|FG000|COMPLETED|Overall Study||0
3023615|NCT01077063|3742053|FG001|COMPLETED|Overall Study||0
3023616|NCT01077063|3742052|FG000|NOT COMPLETED|Overall Study||4
3023617|NCT01077063|3742053|FG001|NOT COMPLETED|Overall Study||3
3023618|NCT01077076|3742059|FG000|STARTED|First Intervention||5
3023619|NCT01077076|3742060|FG001|STARTED|First Intervention||5
3023620|NCT01077076|3742061|FG002|STARTED|First Intervention||5
3023621|NCT01077076|3742062|FG003|STARTED|First Intervention||5
3165766|NCT01901653|3893336|FG001|STARTED|Overall Study||1
3165767|NCT01901653|3893337|FG002|STARTED|Overall Study||11
3165768|NCT01901653|3893338|FG003|STARTED|Overall Study||3
3165769|NCT01901653|3893339|FG004|STARTED|Overall Study||2
3023622|NCT01077076|3742063|FG004|STARTED|First Intervention||5
3165770|NCT01901653|3893340|FG005|STARTED|Overall Study||3
3165771|NCT01901653|3893341|FG006|STARTED|Overall Study||7
3165772|NCT01901653|3893342|FG007|STARTED|Overall Study||10
3165773|NCT01901653|3893343|FG008|STARTED|Overall Study||1
3165774|NCT01901653|3893344|FG009|STARTED|Overall Study||18
3165775|NCT01901653|3893345|FG010|STARTED|Overall Study||2
3165776|NCT01901653|3893346|FG011|STARTED|Overall Study||16
3165777|NCT01901653|3893347|FG012|STARTED|Overall Study||5
3023623|NCT01077076|3742064|FG005|STARTED|First Intervention||5
3023624|NCT01077076|3742059|FG000|COMPLETED|First Intervention||4
3023625|NCT01077076|3742060|FG001|COMPLETED|First Intervention||5
3023626|NCT01077076|3742061|FG002|COMPLETED|First Intervention||5
3023627|NCT01077076|3742062|FG003|COMPLETED|First Intervention||5
3023628|NCT01077076|3742063|FG004|COMPLETED|First Intervention||5
3023629|NCT01077076|3742064|FG005|COMPLETED|First Intervention||5
3023630|NCT01077076|3742059|FG000|NOT COMPLETED|First Intervention||1
3023631|NCT01077076|3742060|FG001|NOT COMPLETED|First Intervention||0
3023632|NCT01077076|3742061|FG002|NOT COMPLETED|First Intervention||0
3023633|NCT01077076|3742062|FG003|NOT COMPLETED|First Intervention||0
3023634|NCT01077076|3742063|FG004|NOT COMPLETED|First Intervention||0
3023635|NCT01077076|3742064|FG005|NOT COMPLETED|First Intervention||0
3023636|NCT01077076|3742059|FG000|STARTED|Washout Period of 2 Weeks||4
3023637|NCT01077076|3742060|FG001|STARTED|Washout Period of 2 Weeks||5
3023638|NCT01077076|3742061|FG002|STARTED|Washout Period of 2 Weeks||5
3023639|NCT01077076|3742062|FG003|STARTED|Washout Period of 2 Weeks||5
3023640|NCT01077076|3742063|FG004|STARTED|Washout Period of 2 Weeks||5
3023641|NCT01077076|3742064|FG005|STARTED|Washout Period of 2 Weeks||5
3023642|NCT01077076|3742059|FG000|COMPLETED|Washout Period of 2 Weeks||4
3023643|NCT01077076|3742060|FG001|COMPLETED|Washout Period of 2 Weeks||5
3023644|NCT01077076|3742061|FG002|COMPLETED|Washout Period of 2 Weeks||5
3023645|NCT01077076|3742062|FG003|COMPLETED|Washout Period of 2 Weeks||5
3023646|NCT01077076|3742063|FG004|COMPLETED|Washout Period of 2 Weeks||5
3023647|NCT01077076|3742064|FG005|COMPLETED|Washout Period of 2 Weeks||5
3023648|NCT01077076|3742059|FG000|NOT COMPLETED|Washout Period of 2 Weeks||0
3023649|NCT01077076|3742060|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0
3023650|NCT01077076|3742061|FG002|NOT COMPLETED|Washout Period of 2 Weeks||0
3023651|NCT01077076|3742062|FG003|NOT COMPLETED|Washout Period of 2 Weeks||0
3023652|NCT01077076|3742063|FG004|NOT COMPLETED|Washout Period of 2 Weeks||0
3023653|NCT01077076|3742064|FG005|NOT COMPLETED|Washout Period of 2 Weeks||0
3023654|NCT01077076|3742059|FG000|STARTED|Second Intervention||4
3023655|NCT01077076|3742060|FG001|STARTED|Second Intervention||5
3023656|NCT01077076|3742061|FG002|STARTED|Second Intervention||5
3023657|NCT01077076|3742062|FG003|STARTED|Second Intervention||5
3023658|NCT01077076|3742063|FG004|STARTED|Second Intervention||5
3023659|NCT01077076|3742064|FG005|STARTED|Second Intervention||5
3023660|NCT01077076|3742059|FG000|COMPLETED|Second Intervention||4
3023661|NCT01077076|3742060|FG001|COMPLETED|Second Intervention||5
3023662|NCT01077076|3742061|FG002|COMPLETED|Second Intervention||5
3023663|NCT01077076|3742062|FG003|COMPLETED|Second Intervention||5
3023664|NCT01077076|3742063|FG004|COMPLETED|Second Intervention||5
3023665|NCT01077076|3742064|FG005|COMPLETED|Second Intervention||5
3023666|NCT01077076|3742059|FG000|NOT COMPLETED|Second Intervention||0
3023667|NCT01077076|3742060|FG001|NOT COMPLETED|Second Intervention||0
3023668|NCT01077076|3742061|FG002|NOT COMPLETED|Second Intervention||0
3023669|NCT01077076|3742062|FG003|NOT COMPLETED|Second Intervention||0
3023670|NCT01077076|3742063|FG004|NOT COMPLETED|Second Intervention||0
3023671|NCT01077076|3742064|FG005|NOT COMPLETED|Second Intervention||0
3023672|NCT01077076|3742059|FG000|STARTED|Washout Period of 2 Weeks||4
3023673|NCT01077076|3742060|FG001|STARTED|Washout Period of 2 Weeks||5
3023674|NCT01077076|3742061|FG002|STARTED|Washout Period of 2 Weeks||5
3023675|NCT01077076|3742062|FG003|STARTED|Washout Period of 2 Weeks||5
3023676|NCT01077076|3742063|FG004|STARTED|Washout Period of 2 Weeks||5
3023677|NCT01077076|3742064|FG005|STARTED|Washout Period of 2 Weeks||5
3023678|NCT01077076|3742059|FG000|COMPLETED|Washout Period of 2 Weeks||4
3023679|NCT01077076|3742060|FG001|COMPLETED|Washout Period of 2 Weeks||5
3023680|NCT01077076|3742061|FG002|COMPLETED|Washout Period of 2 Weeks||5
3023681|NCT01077076|3742062|FG003|COMPLETED|Washout Period of 2 Weeks||5
3023682|NCT01077076|3742063|FG004|COMPLETED|Washout Period of 2 Weeks||5
3023683|NCT01077076|3742064|FG005|COMPLETED|Washout Period of 2 Weeks||5
3023684|NCT01077076|3742059|FG000|NOT COMPLETED|Washout Period of 2 Weeks||0
3023685|NCT01077076|3742060|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0
3023686|NCT01077076|3742061|FG002|NOT COMPLETED|Washout Period of 2 Weeks||0
3023687|NCT01077076|3742062|FG003|NOT COMPLETED|Washout Period of 2 Weeks||0
3023688|NCT01077076|3742063|FG004|NOT COMPLETED|Washout Period of 2 Weeks||0
3023689|NCT01077076|3742064|FG005|NOT COMPLETED|Washout Period of 2 Weeks||0
3165778|NCT01901653|3893335|FG000|COMPLETED|Overall Study||0
3023690|NCT01077076|3742059|FG000|STARTED|Third Intervention||4
3023691|NCT01077076|3742060|FG001|STARTED|Third Intervention||5
3023692|NCT01077076|3742061|FG002|STARTED|Third Intervention||5
3023693|NCT01077076|3742062|FG003|STARTED|Third Intervention||5
3023694|NCT01077076|3742063|FG004|STARTED|Third Intervention||5
3023695|NCT01077076|3742064|FG005|STARTED|Third Intervention||5
3023696|NCT01077076|3742059|FG000|COMPLETED|Third Intervention||4
3165779|NCT01901653|3893336|FG001|COMPLETED|Overall Study||0
3165780|NCT01901653|3893337|FG002|COMPLETED|Overall Study||0
3165781|NCT01901653|3893338|FG003|COMPLETED|Overall Study||0
3023697|NCT01077076|3742060|FG001|COMPLETED|Third Intervention||5
3023698|NCT01077076|3742061|FG002|COMPLETED|Third Intervention||5
3023699|NCT01077076|3742062|FG003|COMPLETED|Third Intervention||5
3023700|NCT01077076|3742063|FG004|COMPLETED|Third Intervention||5
3023701|NCT01077076|3742064|FG005|COMPLETED|Third Intervention||4
3023702|NCT01077076|3742059|FG000|NOT COMPLETED|Third Intervention||0
3023703|NCT01077076|3742060|FG001|NOT COMPLETED|Third Intervention||0
3023704|NCT01077076|3742061|FG002|NOT COMPLETED|Third Intervention||0
3023705|NCT01077076|3742062|FG003|NOT COMPLETED|Third Intervention||0
3023706|NCT01077076|3742063|FG004|NOT COMPLETED|Third Intervention||0
3023707|NCT01077076|3742064|FG005|NOT COMPLETED|Third Intervention||1
3023708|NCT01077128|3742072|FG000|STARTED|Overall Study||500
3023709|NCT01077128|3742072|FG000|COMPLETED|Overall Study||433
3023710|NCT01077128|3742072|FG000|NOT COMPLETED|Overall Study||67
3023711|NCT01077154|3742128|FG000|STARTED|Overall Study||2253
3023712|NCT01077154|3742129|FG001|STARTED|Overall Study||2256
3023713|NCT01077154|3742128|FG000|Received Study Drug|Overall Study||2229
3023714|NCT01077154|3742129|FG001|Received Study Drug|Overall Study||2230
3023715|NCT01077154|3742128|FG000|COMPLETED|Overall Study||27
3023716|NCT01077154|3742129|FG001|COMPLETED|Overall Study||28
3023717|NCT01077154|3742128|FG000|NOT COMPLETED|Overall Study||2226
3023718|NCT01077154|3742129|FG001|NOT COMPLETED|Overall Study||2228
3023719|NCT01077193|3742135|FG000|STARTED|Overall Study||44
3023720|NCT01077193|3742135|FG000|COMPLETED|Overall Study||0
3023721|NCT01077193|3742135|FG000|NOT COMPLETED|Overall Study||44
3023722|NCT01077258|3742139|FG000|STARTED|Overall Study||4208
3023723|NCT01077258|3742139|FG000|COMPLETED|Overall Study||1640
3023724|NCT01077258|3742139|FG000|NOT COMPLETED|Overall Study||2568
3023725|NCT01077271|3742156|FG000|STARTED|Overall Study||124
3023726|NCT01077271|3742156|FG000|Participants Treated With Palivizumab|Overall Study||120
3023727|NCT01077271|3742156|FG000|Number of Participants Analyzed|Overall Study||120
3023728|NCT01077271|3742156|FG000|COMPLETED|Overall Study||102
3023729|NCT01077271|3742156|FG000|NOT COMPLETED|Overall Study||22
3023730|NCT01077284|3742171|FG000|STARTED|Overall Study||33
3023731|NCT01077284|3742172|FG001|STARTED|Overall Study||33
3023732|NCT01077284|3742173|FG002|STARTED|Overall Study||33
3023733|NCT01077284|3742171|FG000|COMPLETED|Overall Study||28
3023734|NCT01077284|3742172|FG001|COMPLETED|Overall Study||28
3023735|NCT01077284|3742173|FG002|COMPLETED|Overall Study||30
3023736|NCT01077284|3742171|FG000|NOT COMPLETED|Overall Study||5
3023737|NCT01077284|3742172|FG001|NOT COMPLETED|Overall Study||5
3023738|NCT01077284|3742173|FG002|NOT COMPLETED|Overall Study||3
3023739|NCT01077310|3742183|FG000|STARTED|Overall Study||67
3023740|NCT01077310|3742184|FG001|STARTED|Overall Study||33
3023741|NCT01077310|3742183|FG000|COMPLETED|Overall Study||67
3023742|NCT01077310|3742184|FG001|COMPLETED|Overall Study||33
3023743|NCT01077310|3742183|FG000|NOT COMPLETED|Overall Study||0
3023744|NCT01077310|3742184|FG001|NOT COMPLETED|Overall Study||0
3023745|NCT01077323|3742198|FG000|STARTED|Overall Study|STARTED = Number of subjects considered for inclusion in this cohort.|37097
3023746|NCT01077323|3742199|FG001|STARTED|Overall Study|STARTED = Number of subjects considered for inclusion in this cohort.|620799
3023747|NCT01077323|3742200|FG002|STARTED|Overall Study|STARTED = Number of subjects considered for inclusion in this cohort.|12015600
3023748|NCT01077323|3742198|FG000|COMPLETED|Overall Study|COMPLETED = Group of subjects for whom data in outcome measures is presented.|25719
3023749|NCT01077323|3742199|FG001|COMPLETED|Overall Study|COMPLETED = Group of subjects for whom data in outcome measures is presented.|234536
3023750|NCT01077323|3742200|FG002|COMPLETED|Overall Study|COMPLETED = Group of subjects for whom data in outcome measures is presented.|103511
3023751|NCT01077323|3742198|FG000|NOT COMPLETED|Overall Study||11378
3023752|NCT01077323|3742199|FG001|NOT COMPLETED|Overall Study||386263
3023753|NCT01077323|3742200|FG002|NOT COMPLETED|Overall Study||11912089
3023754|NCT01077362|3742211|FG000|STARTED|Overall Study||104
3023755|NCT01077362|3742212|FG001|STARTED|Overall Study||103
3023756|NCT01077362|3742213|FG002|STARTED|Overall Study||105
3023757|NCT01077362|3742211|FG000|COMPLETED|Overall Study||73
3023758|NCT01077362|3742212|FG001|COMPLETED|Overall Study||84
3023759|NCT01077362|3742213|FG002|COMPLETED|Overall Study||81
3023760|NCT01077362|3742211|FG000|NOT COMPLETED|Overall Study||31
3023761|NCT01077362|3742212|FG001|NOT COMPLETED|Overall Study||19
3023762|NCT01077362|3742213|FG002|NOT COMPLETED|Overall Study||24
3023763|NCT01077375|3742228|FG000|STARTED|Overall Study||21
3023764|NCT01077375|3742229|FG001|STARTED|Overall Study|One randomized patient not taking study drug was excluded from the Double-blind Safety Population.|86
3023765|NCT01077375|3742228|FG000|COMPLETED|Overall Study||11
3023766|NCT01077375|3742229|FG001|COMPLETED|Overall Study||51
3023767|NCT01077375|3742228|FG000|NOT COMPLETED|Overall Study||10
3023768|NCT01077375|3742229|FG001|NOT COMPLETED|Overall Study||35
3023769|NCT01077401|3742239|FG000|STARTED|Overall Study||77
3023770|NCT01077401|3742240|FG001|STARTED|Overall Study||75
3023771|NCT01077401|3742239|FG000|COMPLETED|Overall Study||59
3023772|NCT01077401|3742240|FG001|COMPLETED|Overall Study||54
3023773|NCT01077401|3742239|FG000|NOT COMPLETED|Overall Study||18
3023774|NCT01077401|3742240|FG001|NOT COMPLETED|Overall Study||21
3023775|NCT01077518|3742248|FG000|STARTED|Treatment Phase - no Optional Ofa||173
3023776|NCT01077518|3742249|FG001|STARTED|Treatment Phase - no Optional Ofa||173
3023777|NCT01077518|3742250|FG002|STARTED|Treatment Phase - no Optional Ofa||0
3023778|NCT01077518|3742248|FG000|Completed 5-year Follow-up|Treatment Phase - no Optional Ofa||64
3023779|NCT01077518|3742249|FG001|Completed 5-year Follow-up|Treatment Phase - no Optional Ofa||64
3023780|NCT01077518|3742250|FG002|Completed 5-year Follow-up|Treatment Phase - no Optional Ofa||0
3023781|NCT01077518|3742248|FG000|Safety Population|Treatment Phase - no Optional Ofa||172
3023782|NCT01077518|3742249|FG001|Safety Population|Treatment Phase - no Optional Ofa||170
3023783|NCT01077518|3742250|FG002|Safety Population|Treatment Phase - no Optional Ofa||0
3023784|NCT01077518|3742248|FG000|COMPLETED|Treatment Phase - no Optional Ofa||95
3023785|NCT01077518|3742249|FG001|COMPLETED|Treatment Phase - no Optional Ofa||108
3023786|NCT01077518|3742250|FG002|COMPLETED|Treatment Phase - no Optional Ofa||0
3023787|NCT01077518|3742248|FG000|NOT COMPLETED|Treatment Phase - no Optional Ofa||78
3023788|NCT01077518|3742249|FG001|NOT COMPLETED|Treatment Phase - no Optional Ofa||65
3023789|NCT01077518|3742250|FG002|NOT COMPLETED|Treatment Phase - no Optional Ofa||0
3023790|NCT01077518|3742248|FG000|STARTED|Optional Ofa Phase||0
3023791|NCT01077518|3742249|FG001|STARTED|Optional Ofa Phase||0
3023792|NCT01077518|3742250|FG002|STARTED|Optional Ofa Phase||32
3023793|NCT01077518|3742248|FG000|Completed 5-year Follow-up|Optional Ofa Phase||0
3023794|NCT01077518|3742249|FG001|Completed 5-year Follow-up|Optional Ofa Phase||0
3023795|NCT01077518|3742250|FG002|Completed 5-year Follow-up|Optional Ofa Phase||12
3023796|NCT01077518|3742248|FG000|COMPLETED|Optional Ofa Phase||0
3023797|NCT01077518|3742249|FG001|COMPLETED|Optional Ofa Phase||0
3023798|NCT01077518|3742250|FG002|COMPLETED|Optional Ofa Phase||16
3023799|NCT01077518|3742248|FG000|NOT COMPLETED|Optional Ofa Phase||0
3023800|NCT01077518|3742249|FG001|NOT COMPLETED|Optional Ofa Phase||0
3023801|NCT01077518|3742250|FG002|NOT COMPLETED|Optional Ofa Phase||16
3023802|NCT01077544|3742261|FG000|STARTED|Overall Study||8
3023803|NCT01077544|3742262|FG001|STARTED|Overall Study||7
3023804|NCT01077544|3742261|FG000|COMPLETED|Overall Study||5
3023805|NCT01077544|3742262|FG001|COMPLETED|Overall Study||2
3023806|NCT01077544|3742261|FG000|NOT COMPLETED|Overall Study||3
3023807|NCT01077544|3742262|FG001|NOT COMPLETED|Overall Study||5
3023808|NCT01077596|3742280|FG000|STARTED|Overall Study||350
3023809|NCT01077596|3742281|FG001|STARTED|Overall Study||1050
3023810|NCT01077596|3742282|FG002|STARTED|Overall Study||457
3023811|NCT01077596|3742283|FG003|STARTED|Overall Study||1370
3023812|NCT01077596|3742284|FG004|STARTED|Overall Study||294
3023813|NCT01077596|3742285|FG005|STARTED|Overall Study||882
3023814|NCT01077596|3742286|FG006|STARTED|Overall Study||308
3023815|NCT01077596|3742287|FG007|STARTED|Overall Study||837
3023816|NCT01077596|3742288|FG008|STARTED|Overall Study||2842
3023817|NCT01077596|3742289|FG009|STARTED|Overall Study||28420
3023818|NCT01077596|3742290|FG010|STARTED|Overall Study||2215
3023819|NCT01077596|3742291|FG011|STARTED|Overall Study||22150
3023820|NCT01077596|3742280|FG000|COMPLETED|Overall Study||350
3023821|NCT01077596|3742281|FG001|COMPLETED|Overall Study||1050
3023822|NCT01077596|3742282|FG002|COMPLETED|Overall Study||457
3023823|NCT01077596|3742283|FG003|COMPLETED|Overall Study||1370
3023824|NCT01077596|3742284|FG004|COMPLETED|Overall Study||294
3023825|NCT01077596|3742285|FG005|COMPLETED|Overall Study||882
3023826|NCT01077596|3742286|FG006|COMPLETED|Overall Study||308
3023827|NCT01077596|3742287|FG007|COMPLETED|Overall Study||837
3023828|NCT01077596|3742288|FG008|COMPLETED|Overall Study||2842
3023829|NCT01077596|3742289|FG009|COMPLETED|Overall Study||28420
3023830|NCT01077596|3742290|FG010|COMPLETED|Overall Study||2215
3023831|NCT01077596|3742291|FG011|COMPLETED|Overall Study||22150
3023832|NCT01077596|3742280|FG000|NOT COMPLETED|Overall Study||0
3023833|NCT01077596|3742281|FG001|NOT COMPLETED|Overall Study||0
3023834|NCT01077596|3742282|FG002|NOT COMPLETED|Overall Study||0
3023835|NCT01077596|3742283|FG003|NOT COMPLETED|Overall Study||0
3023836|NCT01077596|3742284|FG004|NOT COMPLETED|Overall Study||0
3023837|NCT01077596|3742285|FG005|NOT COMPLETED|Overall Study||0
3023838|NCT01077596|3742286|FG006|NOT COMPLETED|Overall Study||0
3023839|NCT01077596|3742287|FG007|NOT COMPLETED|Overall Study||0
3023840|NCT01077596|3742288|FG008|NOT COMPLETED|Overall Study||0
3023841|NCT01077596|3742289|FG009|NOT COMPLETED|Overall Study||0
3023842|NCT01077596|3742290|FG010|NOT COMPLETED|Overall Study||0
3023843|NCT01077596|3742291|FG011|NOT COMPLETED|Overall Study||0
3023844|NCT01077622|3742312|FG000|STARTED|Overall Study||10
3023845|NCT01077622|3742312|FG000|COMPLETED|Overall Study||7
3023846|NCT01077622|3742312|FG000|NOT COMPLETED|Overall Study||3
3023847|NCT01077713|3742318|FG000|STARTED|Overall Study||44
3023848|NCT01077713|3742319|FG001|STARTED|Overall Study||42
3023849|NCT01077713|3742318|FG000|COMPLETED|Overall Study||8
3023850|NCT01077713|3742319|FG001|COMPLETED|Overall Study||6
3023851|NCT01077713|3742318|FG000|NOT COMPLETED|Overall Study||36
3023852|NCT01077713|3742319|FG001|NOT COMPLETED|Overall Study||36
3023853|NCT01077739|3742327|FG000|STARTED|Overall Study||25
3023854|NCT01077739|3742328|FG001|STARTED|Overall Study||50
3023855|NCT01077739|3742327|FG000|COMPLETED|Overall Study||20
3023856|NCT01077739|3742328|FG001|COMPLETED|Overall Study||40
3023857|NCT01077739|3742327|FG000|NOT COMPLETED|Overall Study||5
3023858|NCT01077739|3742328|FG001|NOT COMPLETED|Overall Study||10
3023859|NCT01077804|3742334|FG000|STARTED|Overall Study||7585
3023860|NCT01077804|3742334|FG000|COMPLETED|Overall Study||7386
3023861|NCT01077804|3742334|FG000|NOT COMPLETED|Overall Study||199
3023862|NCT01077856|3742341|FG000|STARTED|Overall Study||22199
3023863|NCT01077856|3742342|FG001|STARTED|Overall Study||16604
3023864|NCT01077856|3742343|FG002|STARTED|Overall Study||15713
3023865|NCT01077856|3742341|FG000|COMPLETED|Overall Study||22199
3023866|NCT01077856|3742342|FG001|COMPLETED|Overall Study||16604
3023867|NCT01077856|3742343|FG002|COMPLETED|Overall Study||15713
3023868|NCT01077856|3742341|FG000|NOT COMPLETED|Overall Study||0
3023869|NCT01077856|3742342|FG001|NOT COMPLETED|Overall Study||0
3023870|NCT01077856|3742343|FG002|NOT COMPLETED|Overall Study||0
3023871|NCT01077921|3742385|FG000|STARTED|First Intervention||14
3023872|NCT01077921|3742386|FG001|STARTED|First Intervention||13
3023873|NCT01077921|3742385|FG000|COMPLETED|First Intervention||13
3023874|NCT01077921|3742386|FG001|COMPLETED|First Intervention||12
3023875|NCT01077921|3742385|FG000|NOT COMPLETED|First Intervention||1
3023876|NCT01077921|3742386|FG001|NOT COMPLETED|First Intervention||1
3023877|NCT01077921|3742385|FG000|STARTED|Washout||13
3023878|NCT01077921|3742386|FG001|STARTED|Washout||12
3023879|NCT01077921|3742385|FG000|COMPLETED|Washout||13
3023880|NCT01077921|3742386|FG001|COMPLETED|Washout||10
3023881|NCT01077921|3742385|FG000|NOT COMPLETED|Washout||0
3023882|NCT01077921|3742386|FG001|NOT COMPLETED|Washout||2
3023883|NCT01077921|3742385|FG000|STARTED|Second Intervention||13
3023884|NCT01077921|3742386|FG001|STARTED|Second Intervention||10
3023885|NCT01077921|3742385|FG000|COMPLETED|Second Intervention||13
3023886|NCT01077921|3742386|FG001|COMPLETED|Second Intervention||9
3023887|NCT01077921|3742385|FG000|NOT COMPLETED|Second Intervention||0
3023888|NCT01077921|3742386|FG001|NOT COMPLETED|Second Intervention||1
3023889|NCT01077960|3742393|FG000|STARTED|Overall Study|130 subjects consented to participate, 129 enrolled in the study, and 126 received study drug|126
3023890|NCT01077960|3742393|FG000|COMPLETED|Overall Study|Modified Intent To Treat (ITT) Population|110
3023891|NCT01077960|3742393|FG000|NOT COMPLETED|Overall Study||16
3023892|NCT01077973|3742400|FG000|STARTED|Overall Study||41
3023893|NCT01077973|3742401|FG001|STARTED|Overall Study||79
3023894|NCT01077973|3742402|FG002|STARTED|Overall Study||80
3023895|NCT01077973|3742400|FG000|COMPLETED|Overall Study||41
3023896|NCT01077973|3742401|FG001|COMPLETED|Overall Study||79
3023897|NCT01077973|3742402|FG002|COMPLETED|Overall Study||80
3023898|NCT01077973|3742400|FG000|NOT COMPLETED|Overall Study||0
3023899|NCT01077973|3742401|FG001|NOT COMPLETED|Overall Study||0
3023900|NCT01077973|3742402|FG002|NOT COMPLETED|Overall Study||0
3023901|NCT01078090|3742412|FG000|STARTED|Overall Study||5745
3023902|NCT01078090|3742412|FG000|COMPLETED|Overall Study||1152
3023903|NCT01078090|3742412|FG000|NOT COMPLETED|Overall Study||4593
3023904|NCT01078116|3742430|FG000|STARTED|Overall Study|121 participants were included in analysis (3 were excluded due to missing case report form data).|124
3023905|NCT01078116|3742430|FG000|COMPLETED|Overall Study||76
3023906|NCT01078116|3742430|FG000|NOT COMPLETED|Overall Study||48
3023907|NCT01078155|3742434|FG000|STARTED|Overall Study||131
3023908|NCT01078155|3742434|FG000|COMPLETED|Overall Study||87
3023909|NCT01078155|3742434|FG000|NOT COMPLETED|Overall Study||44
3023910|NCT01078168|3742440|FG000|STARTED|Overall Study||11
3023911|NCT01078168|3742441|FG001|STARTED|Overall Study||11
3023912|NCT01078168|3742440|FG000|COMPLETED|Overall Study||11
3023913|NCT01078168|3742441|FG001|COMPLETED|Overall Study||10
3023914|NCT01078168|3742440|FG000|NOT COMPLETED|Overall Study||0
3023915|NCT01078168|3742441|FG001|NOT COMPLETED|Overall Study||1
3023916|NCT01078207|3742447|FG000|STARTED|Overall Study||100
3023917|NCT01078207|3742447|FG000|COMPLETED|Overall Study||100
3023918|NCT01078207|3742447|FG000|NOT COMPLETED|Overall Study||0
3023919|NCT01078220|3742451|FG000|STARTED|Overall Study||189629
3023920|NCT01078220|3742451|FG000|COMPLETED|Overall Study||189629
3023921|NCT01078220|3742451|FG000|NOT COMPLETED|Overall Study||0
3023922|NCT01078233|3742464|FG000|STARTED|Overall Study||656
3023923|NCT01078233|3742465|FG001|STARTED|Overall Study||296
3023924|NCT01078233|3742466|FG002|STARTED|Overall Study||1681
3023925|NCT01078233|3742467|FG003|STARTED|Overall Study||631
3023926|NCT01078233|3742468|FG004|STARTED|Overall Study||3199
3023927|NCT01078233|3742469|FG005|STARTED|Overall Study||154
3023928|NCT01078233|3742464|FG000|COMPLETED|Overall Study||656
3023929|NCT01078233|3742465|FG001|COMPLETED|Overall Study||296
3023930|NCT01078233|3742466|FG002|COMPLETED|Overall Study||1681
3023931|NCT01078233|3742467|FG003|COMPLETED|Overall Study||631
3023932|NCT01078233|3742468|FG004|COMPLETED|Overall Study||3199
3023933|NCT01078233|3742469|FG005|COMPLETED|Overall Study||154
3023934|NCT01078233|3742464|FG000|NOT COMPLETED|Overall Study||0
3023935|NCT01078233|3742465|FG001|NOT COMPLETED|Overall Study||0
3023936|NCT01078233|3742466|FG002|NOT COMPLETED|Overall Study||0
3023937|NCT01078233|3742467|FG003|NOT COMPLETED|Overall Study||0
3023938|NCT01078233|3742468|FG004|NOT COMPLETED|Overall Study||0
3023939|NCT01078233|3742469|FG005|NOT COMPLETED|Overall Study||0
3023940|NCT01078246|3742484|FG000|STARTED|Overall Study||1041
3023941|NCT01078246|3742485|FG001|STARTED|Overall Study||405
3023942|NCT01078246|3742486|FG002|STARTED|Overall Study||1963
3023943|NCT01078246|3742487|FG003|STARTED|Overall Study||152
3023944|NCT01078246|3742488|FG004|STARTED|Overall Study||3310
3023945|NCT01078246|3742489|FG005|STARTED|Overall Study||231
3023946|NCT01078246|3742490|FG006|STARTED|Overall Study||22
3023947|NCT01078246|3742484|FG000|COMPLETED|Overall Study||1041
3023948|NCT01078246|3742485|FG001|COMPLETED|Overall Study||405
3023949|NCT01078246|3742486|FG002|COMPLETED|Overall Study||1963
3023950|NCT01078246|3742487|FG003|COMPLETED|Overall Study||152
3023951|NCT01078246|3742488|FG004|COMPLETED|Overall Study||3310
3023952|NCT01078246|3742489|FG005|COMPLETED|Overall Study||231
3023953|NCT01078246|3742490|FG006|COMPLETED|Overall Study||22
3023954|NCT01078246|3742484|FG000|NOT COMPLETED|Overall Study||0
3023955|NCT01078246|3742485|FG001|NOT COMPLETED|Overall Study||0
3023956|NCT01078246|3742486|FG002|NOT COMPLETED|Overall Study||0
3023957|NCT01078246|3742487|FG003|NOT COMPLETED|Overall Study||0
3023958|NCT01078246|3742488|FG004|NOT COMPLETED|Overall Study||0
3023959|NCT01078246|3742489|FG005|NOT COMPLETED|Overall Study||0
3023960|NCT01078246|3742490|FG006|NOT COMPLETED|Overall Study||0
3023961|NCT01078298|3742500|FG000|STARTED|Overall Study||256
3023962|NCT01078298|3742501|FG001|STARTED|Overall Study||269
3023963|NCT01078298|3742500|FG000|COMPLETED|Overall Study||175
3023964|NCT01078298|3742501|FG001|COMPLETED|Overall Study||179
3023965|NCT01078298|3742500|FG000|NOT COMPLETED|Overall Study||81
3023966|NCT01078298|3742501|FG001|NOT COMPLETED|Overall Study||90
3023967|NCT01078363|3742509|FG000|STARTED|Overall Study||47
3023968|NCT01078363|3742510|FG001|STARTED|Overall Study||49
3023969|NCT01078363|3742509|FG000|COMPLETED|Overall Study||47
3023970|NCT01078363|3742510|FG001|COMPLETED|Overall Study||49
3023971|NCT01078363|3742509|FG000|NOT COMPLETED|Overall Study||0
3023972|NCT01078363|3742510|FG001|NOT COMPLETED|Overall Study||0
3023973|NCT01078376|3742522|FG000|STARTED|Overall Study||9
3023974|NCT01078376|3742523|FG001|STARTED|Overall Study||9
3023975|NCT01078376|3742524|FG002|STARTED|Overall Study||8
3023976|NCT01078376|3742525|FG003|STARTED|Overall Study||3
3023977|NCT01078376|3742522|FG000|COMPLETED|Overall Study||9
3023978|NCT01078376|3742523|FG001|COMPLETED|Overall Study||9
3023979|NCT01078376|3742524|FG002|COMPLETED|Overall Study||8
3023980|NCT01078376|3742525|FG003|COMPLETED|Overall Study||3
3165782|NCT01901653|3893339|FG004|COMPLETED|Overall Study||0
3165783|NCT01901653|3893340|FG005|COMPLETED|Overall Study||0
3165784|NCT01901653|3893341|FG006|COMPLETED|Overall Study||0
3165785|NCT01901653|3893342|FG007|COMPLETED|Overall Study||0
3165786|NCT01901653|3893343|FG008|COMPLETED|Overall Study||0
3165787|NCT01901653|3893344|FG009|COMPLETED|Overall Study||0
3165788|NCT01901653|3893345|FG010|COMPLETED|Overall Study||0
3165789|NCT01901653|3893346|FG011|COMPLETED|Overall Study||0
3165790|NCT01901653|3893347|FG012|COMPLETED|Overall Study||0
3165791|NCT01901653|3893335|FG000|NOT COMPLETED|Overall Study||3
3165792|NCT01901653|3893336|FG001|NOT COMPLETED|Overall Study||1
3165793|NCT01901653|3893337|FG002|NOT COMPLETED|Overall Study||11
3023981|NCT01078376|3742522|FG000|NOT COMPLETED|Overall Study||0
3023982|NCT01078376|3742523|FG001|NOT COMPLETED|Overall Study||0
3023983|NCT01078376|3742524|FG002|NOT COMPLETED|Overall Study||0
3023984|NCT01078376|3742525|FG003|NOT COMPLETED|Overall Study||0
3023985|NCT01078389|3742540|FG000|STARTED|Overall Study||157
3023986|NCT01078389|3742541|FG001|STARTED|Overall Study||157
3023987|NCT01078389|3742540|FG000|COMPLETED|Overall Study||93
3023988|NCT01078389|3742541|FG001|COMPLETED|Overall Study||90
3023989|NCT01078389|3742540|FG000|NOT COMPLETED|Overall Study||64
3023990|NCT01078389|3742541|FG001|NOT COMPLETED|Overall Study||67
3038020|NCT01151345|3757387|FG001|COMPLETED|Wash-out Period (7 Days)||12
3038021|NCT01151345|3757386|FG000|NOT COMPLETED|Wash-out Period (7 Days)||0
3038022|NCT01151345|3757387|FG001|NOT COMPLETED|Wash-out Period (7 Days)||0
3038023|NCT01151345|3757386|FG000|STARTED|Second Intervention Period||13
3038024|NCT01151345|3757387|FG001|STARTED|Second Intervention Period||12
3038025|NCT01151345|3757386|FG000|COMPLETED|Second Intervention Period||13
3038026|NCT01151345|3757387|FG001|COMPLETED|Second Intervention Period||12
3038027|NCT01151345|3757386|FG000|NOT COMPLETED|Second Intervention Period||0
3038028|NCT01151345|3757387|FG001|NOT COMPLETED|Second Intervention Period||0
3038029|NCT01151371|3757396|FG000|STARTED|Overall Study||149
3038030|NCT01151371|3757397|FG001|STARTED|Overall Study||150
3038031|NCT01151371|3757398|FG002|STARTED|Overall Study||153
3038032|NCT01151371|3757396|FG000|COMPLETED|Overall Study||144
3038033|NCT01151371|3757397|FG001|COMPLETED|Overall Study||149
3038034|NCT01151371|3757398|FG002|COMPLETED|Overall Study||146
3038035|NCT01151371|3757396|FG000|NOT COMPLETED|Overall Study||5
3038036|NCT01151371|3757397|FG001|NOT COMPLETED|Overall Study||1
3038037|NCT01151371|3757398|FG002|NOT COMPLETED|Overall Study||7
3038038|NCT01151410|3757408|FG000|STARTED|Overall Study||104
3038039|NCT01151410|3757409|FG001|STARTED|Overall Study||104
3038040|NCT01151410|3757408|FG000|Safety Set (SAF)|Overall Study||105
3038041|NCT01151410|3757409|FG001|Safety Set (SAF)|Overall Study|Number of patients in SAF differed due to kit dispensing error in 1 patient at Visit 12|103
3038042|NCT01151410|3757408|FG000|COMPLETED|Overall Study||93
3038043|NCT01151410|3757409|FG001|COMPLETED|Overall Study||89
3038044|NCT01151410|3757408|FG000|NOT COMPLETED|Overall Study||11
3038045|NCT01151410|3757409|FG001|NOT COMPLETED|Overall Study||15
3038046|NCT01151423|3757417|FG000|STARTED|Overall Study||36
3038047|NCT01151423|3757418|FG001|STARTED|Overall Study||39
3038048|NCT01151423|3757417|FG000|Received Study Drug|Overall Study||35
3038049|NCT01151423|3757418|FG001|Received Study Drug|Overall Study||37
3038050|NCT01151423|3757417|FG000|COMPLETED|Overall Study||20
3038051|NCT01151423|3757418|FG001|COMPLETED|Overall Study||21
3038052|NCT01151423|3757417|FG000|NOT COMPLETED|Overall Study||16
3038053|NCT01151423|3757418|FG001|NOT COMPLETED|Overall Study||18
3038395|NCT01154101|3757841|FG000|STARTED|Overall Study||7
3038396|NCT01154101|3757842|FG001|STARTED|Overall Study||9
3038397|NCT01154101|3757843|FG002|STARTED|Overall Study||12
3038398|NCT01154101|3757844|FG003|STARTED|Overall Study||11
3038399|NCT01154101|3757845|FG004|STARTED|Overall Study||1
3038400|NCT01154101|3757841|FG000|COMPLETED|Overall Study||7
3038401|NCT01154101|3757842|FG001|COMPLETED|Overall Study||5
3038402|NCT01154101|3757843|FG002|COMPLETED|Overall Study||9
3038403|NCT01154101|3757844|FG003|COMPLETED|Overall Study||9
3038404|NCT01154101|3757845|FG004|COMPLETED|Overall Study||0
3038405|NCT01154101|3757841|FG000|NOT COMPLETED|Overall Study||0
3038406|NCT01154101|3757842|FG001|NOT COMPLETED|Overall Study||4
3038407|NCT01154101|3757843|FG002|NOT COMPLETED|Overall Study||3
3165794|NCT01901653|3893338|FG003|NOT COMPLETED|Overall Study||3
3165795|NCT01901653|3893339|FG004|NOT COMPLETED|Overall Study||2
3165796|NCT01901653|3893340|FG005|NOT COMPLETED|Overall Study||3
3023991|NCT01078402|3742550|FG000|STARTED|Overall Study||431
3023992|NCT01078402|3742551|FG001|STARTED|Overall Study||124
3023993|NCT01078402|3742552|FG002|STARTED|Overall Study||234
3023994|NCT01078402|3742550|FG000|COMPLETED|Overall Study||324
3023995|NCT01078402|3742551|FG001|COMPLETED|Overall Study||95
3023996|NCT01078402|3742552|FG002|COMPLETED|Overall Study||166
3023997|NCT01078402|3742550|FG000|NOT COMPLETED|Overall Study||107
3023998|NCT01078402|3742551|FG001|NOT COMPLETED|Overall Study||29
3023999|NCT01078402|3742552|FG002|NOT COMPLETED|Overall Study||68
3024000|NCT01078441|3742564|FG000|STARTED|Overall Study||2
3024001|NCT01078441|3742564|FG000|COMPLETED|Overall Study||1
3024002|NCT01078441|3742564|FG000|NOT COMPLETED|Overall Study||1
3024003|NCT01078545|3742568|FG000|STARTED|Overall Study||729
3024004|NCT01078545|3742568|FG000|Intent-to-treat Population|Overall Study||729
3024005|NCT01078545|3742568|FG000|Per Protocol Population|Overall Study||661
3024006|NCT01078545|3742568|FG000|COMPLETED|Overall Study||703
3024007|NCT01078545|3742568|FG000|NOT COMPLETED|Overall Study||26
3024008|NCT01078558|3742575|FG000|STARTED|Overall Study||2836
3165797|NCT01901653|3893341|FG006|NOT COMPLETED|Overall Study||7
3165798|NCT01901653|3893342|FG007|NOT COMPLETED|Overall Study||10
3165799|NCT01901653|3893343|FG008|NOT COMPLETED|Overall Study||1
3165800|NCT01901653|3893344|FG009|NOT COMPLETED|Overall Study||18
3165801|NCT01901653|3893345|FG010|NOT COMPLETED|Overall Study||2
3024009|NCT01078558|3742576|FG001|STARTED|Overall Study||1127
3024010|NCT01078558|3742577|FG002|STARTED|Overall Study||1957
3024011|NCT01078558|3742575|FG000|Oligoarticular PsA|Overall Study||0
3024012|NCT01078558|3742576|FG001|Oligoarticular PsA|Overall Study||197
3024013|NCT01078558|3742577|FG002|Oligoarticular PsA|Overall Study||0
3024014|NCT01078558|3742575|FG000|COMPLETED|Overall Study||818
3024015|NCT01078558|3742576|FG001|COMPLETED|Overall Study||372
3024016|NCT01078558|3742577|FG002|COMPLETED|Overall Study||596
3024017|NCT01078558|3742575|FG000|NOT COMPLETED|Overall Study||2018
3024018|NCT01078558|3742576|FG001|NOT COMPLETED|Overall Study||755
3024019|NCT01078558|3742577|FG002|NOT COMPLETED|Overall Study||1361
3024020|NCT01078571|3742585|FG000|STARTED|Overall Study||705
3024021|NCT01078571|3742585|FG000|Safety Population|Overall Study||675
3024022|NCT01078571|3742585|FG000|Intent-to-treat (ITT) Population|Overall Study||591
3024023|NCT01078571|3742585|FG000|COMPLETED|Overall Study||590
3024024|NCT01078571|3742585|FG000|NOT COMPLETED|Overall Study||115
3024025|NCT01078584|3742594|FG000|STARTED|Overall Study||7993
3024026|NCT01078584|3742594|FG000|Participants Conducted Visit 2 (3-month)|Overall Study||7125
3024027|NCT01078584|3742594|FG000|Participants Conducted Visit 3 (6-month)|Overall Study||5833
3024028|NCT01078584|3742594|FG000|Participants Conducted Visit 4(12-month)|Overall Study||4983
3024029|NCT01078584|3742594|FG000|COMPLETED|Overall Study||4983
3024030|NCT01078584|3742594|FG000|NOT COMPLETED|Overall Study||3010
3024031|NCT01078623|3742611|FG000|STARTED|Treatment Period 1||6
3024032|NCT01078623|3742612|FG001|STARTED|Treatment Period 1||6
3024033|NCT01078623|3742613|FG002|STARTED|Treatment Period 1||7
3024034|NCT01078623|3742614|FG003|STARTED|Treatment Period 1||6
3024035|NCT01078623|3742615|FG004|STARTED|Treatment Period 1||7
3024036|NCT01078623|3742616|FG005|STARTED|Treatment Period 1||6
3024037|NCT01078623|3742617|FG006|STARTED|Treatment Period 1||7
3024038|NCT01078623|3742618|FG007|STARTED|Treatment Period 1||7
3024039|NCT01078623|3742619|FG008|STARTED|Treatment Period 1||6
3024040|NCT01078623|3742620|FG009|STARTED|Treatment Period 1||7
3024041|NCT01078623|3742621|FG010|STARTED|Treatment Period 1||7
3024042|NCT01078623|3742622|FG011|STARTED|Treatment Period 1||7
3024043|NCT01078623|3742623|FG012|STARTED|Treatment Period 1||7
3024044|NCT01078623|3742624|FG013|STARTED|Treatment Period 1||7
3024045|NCT01078623|3742625|FG014|STARTED|Treatment Period 1||7
3024046|NCT01078623|3742626|FG015|STARTED|Treatment Period 1||7
3024047|NCT01078623|3742627|FG016|STARTED|Treatment Period 1||7
3024048|NCT01078623|3742628|FG017|STARTED|Treatment Period 1||7
3024049|NCT01078623|3742629|FG018|STARTED|Treatment Period 1||7
3024050|NCT01078623|3742630|FG019|STARTED|Treatment Period 1||7
3024051|NCT01078623|3742611|FG000|COMPLETED|Treatment Period 1||5
3024052|NCT01078623|3742612|FG001|COMPLETED|Treatment Period 1||5
3024053|NCT01078623|3742613|FG002|COMPLETED|Treatment Period 1||6
3024054|NCT01078623|3742614|FG003|COMPLETED|Treatment Period 1||6
3024055|NCT01078623|3742615|FG004|COMPLETED|Treatment Period 1||7
3024056|NCT01078623|3742616|FG005|COMPLETED|Treatment Period 1||5
3024057|NCT01078623|3742617|FG006|COMPLETED|Treatment Period 1||6
3024058|NCT01078623|3742618|FG007|COMPLETED|Treatment Period 1||6
3024059|NCT01078623|3742619|FG008|COMPLETED|Treatment Period 1||5
3024060|NCT01078623|3742620|FG009|COMPLETED|Treatment Period 1||6
3024061|NCT01078623|3742621|FG010|COMPLETED|Treatment Period 1||6
3024062|NCT01078623|3742622|FG011|COMPLETED|Treatment Period 1||7
3024063|NCT01078623|3742623|FG012|COMPLETED|Treatment Period 1||7
3024064|NCT01078623|3742624|FG013|COMPLETED|Treatment Period 1||7
3024065|NCT01078623|3742625|FG014|COMPLETED|Treatment Period 1||7
3024066|NCT01078623|3742626|FG015|COMPLETED|Treatment Period 1||7
3024067|NCT01078623|3742627|FG016|COMPLETED|Treatment Period 1||7
3024068|NCT01078623|3742628|FG017|COMPLETED|Treatment Period 1||7
3024069|NCT01078623|3742629|FG018|COMPLETED|Treatment Period 1||7
3024070|NCT01078623|3742630|FG019|COMPLETED|Treatment Period 1||7
3024071|NCT01078623|3742611|FG000|NOT COMPLETED|Treatment Period 1||1
3024072|NCT01078623|3742612|FG001|NOT COMPLETED|Treatment Period 1||1
3024073|NCT01078623|3742613|FG002|NOT COMPLETED|Treatment Period 1||1
3024074|NCT01078623|3742614|FG003|NOT COMPLETED|Treatment Period 1||0
3024075|NCT01078623|3742615|FG004|NOT COMPLETED|Treatment Period 1||0
3024076|NCT01078623|3742616|FG005|NOT COMPLETED|Treatment Period 1||1
3024077|NCT01078623|3742617|FG006|NOT COMPLETED|Treatment Period 1||1
3024078|NCT01078623|3742618|FG007|NOT COMPLETED|Treatment Period 1||1
3024079|NCT01078623|3742619|FG008|NOT COMPLETED|Treatment Period 1||1
3024080|NCT01078623|3742620|FG009|NOT COMPLETED|Treatment Period 1||1
3024081|NCT01078623|3742621|FG010|NOT COMPLETED|Treatment Period 1||1
3024082|NCT01078623|3742622|FG011|NOT COMPLETED|Treatment Period 1||0
3024083|NCT01078623|3742623|FG012|NOT COMPLETED|Treatment Period 1||0
3024084|NCT01078623|3742624|FG013|NOT COMPLETED|Treatment Period 1||0
3024085|NCT01078623|3742625|FG014|NOT COMPLETED|Treatment Period 1||0
3024086|NCT01078623|3742626|FG015|NOT COMPLETED|Treatment Period 1||0
3024087|NCT01078623|3742627|FG016|NOT COMPLETED|Treatment Period 1||0
3024088|NCT01078623|3742628|FG017|NOT COMPLETED|Treatment Period 1||0
3024089|NCT01078623|3742629|FG018|NOT COMPLETED|Treatment Period 1||0
3024090|NCT01078623|3742630|FG019|NOT COMPLETED|Treatment Period 1||0
3024091|NCT01078623|3742611|FG000|STARTED|Treatment Period 2||5
3024092|NCT01078623|3742612|FG001|STARTED|Treatment Period 2||5
3024093|NCT01078623|3742613|FG002|STARTED|Treatment Period 2||6
3024094|NCT01078623|3742614|FG003|STARTED|Treatment Period 2||6
3024095|NCT01078623|3742615|FG004|STARTED|Treatment Period 2||7
3024096|NCT01078623|3742616|FG005|STARTED|Treatment Period 2||5
3024097|NCT01078623|3742617|FG006|STARTED|Treatment Period 2||6
3024098|NCT01078623|3742618|FG007|STARTED|Treatment Period 2||6
3024099|NCT01078623|3742619|FG008|STARTED|Treatment Period 2||5
3024100|NCT01078623|3742620|FG009|STARTED|Treatment Period 2||6
3024101|NCT01078623|3742621|FG010|STARTED|Treatment Period 2||6
3024102|NCT01078623|3742622|FG011|STARTED|Treatment Period 2||7
3024103|NCT01078623|3742623|FG012|STARTED|Treatment Period 2||7
3024104|NCT01078623|3742624|FG013|STARTED|Treatment Period 2||7
3024105|NCT01078623|3742625|FG014|STARTED|Treatment Period 2||7
3024106|NCT01078623|3742626|FG015|STARTED|Treatment Period 2||7
3024107|NCT01078623|3742627|FG016|STARTED|Treatment Period 2||7
3024108|NCT01078623|3742628|FG017|STARTED|Treatment Period 2||7
3024109|NCT01078623|3742629|FG018|STARTED|Treatment Period 2||7
3024110|NCT01078623|3742630|FG019|STARTED|Treatment Period 2||7
3024111|NCT01078623|3742611|FG000|COMPLETED|Treatment Period 2||5
3024112|NCT01078623|3742612|FG001|COMPLETED|Treatment Period 2||5
3024113|NCT01078623|3742613|FG002|COMPLETED|Treatment Period 2||6
3024114|NCT01078623|3742614|FG003|COMPLETED|Treatment Period 2||6
3024115|NCT01078623|3742615|FG004|COMPLETED|Treatment Period 2||7
3024116|NCT01078623|3742616|FG005|COMPLETED|Treatment Period 2||4
3024117|NCT01078623|3742617|FG006|COMPLETED|Treatment Period 2||5
3024118|NCT01078623|3742618|FG007|COMPLETED|Treatment Period 2||6
3024119|NCT01078623|3742619|FG008|COMPLETED|Treatment Period 2||5
3024120|NCT01078623|3742620|FG009|COMPLETED|Treatment Period 2||6
3024121|NCT01078623|3742621|FG010|COMPLETED|Treatment Period 2||6
3024122|NCT01078623|3742622|FG011|COMPLETED|Treatment Period 2||7
3024123|NCT01078623|3742623|FG012|COMPLETED|Treatment Period 2||7
3024124|NCT01078623|3742624|FG013|COMPLETED|Treatment Period 2||7
3024125|NCT01078623|3742625|FG014|COMPLETED|Treatment Period 2||7
3024126|NCT01078623|3742626|FG015|COMPLETED|Treatment Period 2||7
3024127|NCT01078623|3742627|FG016|COMPLETED|Treatment Period 2||7
3024128|NCT01078623|3742628|FG017|COMPLETED|Treatment Period 2||7
3024129|NCT01078623|3742629|FG018|COMPLETED|Treatment Period 2||6
3024130|NCT01078623|3742630|FG019|COMPLETED|Treatment Period 2||7
3024131|NCT01078623|3742611|FG000|NOT COMPLETED|Treatment Period 2||0
3024132|NCT01078623|3742612|FG001|NOT COMPLETED|Treatment Period 2||0
3024133|NCT01078623|3742613|FG002|NOT COMPLETED|Treatment Period 2||0
3024134|NCT01078623|3742614|FG003|NOT COMPLETED|Treatment Period 2||0
3024135|NCT01078623|3742615|FG004|NOT COMPLETED|Treatment Period 2||0
3024136|NCT01078623|3742616|FG005|NOT COMPLETED|Treatment Period 2||1
3024137|NCT01078623|3742617|FG006|NOT COMPLETED|Treatment Period 2||1
3024138|NCT01078623|3742618|FG007|NOT COMPLETED|Treatment Period 2||0
3024139|NCT01078623|3742619|FG008|NOT COMPLETED|Treatment Period 2||0
3024140|NCT01078623|3742620|FG009|NOT COMPLETED|Treatment Period 2||0
3024141|NCT01078623|3742621|FG010|NOT COMPLETED|Treatment Period 2||0
3024142|NCT01078623|3742622|FG011|NOT COMPLETED|Treatment Period 2||0
3024143|NCT01078623|3742623|FG012|NOT COMPLETED|Treatment Period 2||0
3024144|NCT01078623|3742624|FG013|NOT COMPLETED|Treatment Period 2||0
3024145|NCT01078623|3742625|FG014|NOT COMPLETED|Treatment Period 2||0
3024146|NCT01078623|3742626|FG015|NOT COMPLETED|Treatment Period 2||0
3024147|NCT01078623|3742627|FG016|NOT COMPLETED|Treatment Period 2||0
3024148|NCT01078623|3742628|FG017|NOT COMPLETED|Treatment Period 2||0
3024149|NCT01078623|3742629|FG018|NOT COMPLETED|Treatment Period 2||1
3024150|NCT01078623|3742630|FG019|NOT COMPLETED|Treatment Period 2||0
3024151|NCT01078623|3742611|FG000|STARTED|Treatment Period 3||5
3024152|NCT01078623|3742612|FG001|STARTED|Treatment Period 3||5
3024153|NCT01078623|3742613|FG002|STARTED|Treatment Period 3||6
3024154|NCT01078623|3742614|FG003|STARTED|Treatment Period 3||6
3024155|NCT01078623|3742615|FG004|STARTED|Treatment Period 3||7
3024156|NCT01078623|3742616|FG005|STARTED|Treatment Period 3||4
3024157|NCT01078623|3742617|FG006|STARTED|Treatment Period 3||5
3024158|NCT01078623|3742618|FG007|STARTED|Treatment Period 3||6
3024159|NCT01078623|3742619|FG008|STARTED|Treatment Period 3||5
3024160|NCT01078623|3742620|FG009|STARTED|Treatment Period 3||6
3024161|NCT01078623|3742621|FG010|STARTED|Treatment Period 3||6
3024162|NCT01078623|3742622|FG011|STARTED|Treatment Period 3||7
3024163|NCT01078623|3742623|FG012|STARTED|Treatment Period 3||7
3024164|NCT01078623|3742624|FG013|STARTED|Treatment Period 3||7
3024165|NCT01078623|3742625|FG014|STARTED|Treatment Period 3||7
3024166|NCT01078623|3742626|FG015|STARTED|Treatment Period 3||7
3024167|NCT01078623|3742627|FG016|STARTED|Treatment Period 3||7
3024168|NCT01078623|3742628|FG017|STARTED|Treatment Period 3||7
3024169|NCT01078623|3742629|FG018|STARTED|Treatment Period 3||6
3024170|NCT01078623|3742630|FG019|STARTED|Treatment Period 3||7
3024171|NCT01078623|3742611|FG000|COMPLETED|Treatment Period 3||5
3024172|NCT01078623|3742612|FG001|COMPLETED|Treatment Period 3||5
3024173|NCT01078623|3742613|FG002|COMPLETED|Treatment Period 3||6
3024174|NCT01078623|3742614|FG003|COMPLETED|Treatment Period 3||6
3024175|NCT01078623|3742615|FG004|COMPLETED|Treatment Period 3||6
3024176|NCT01078623|3742616|FG005|COMPLETED|Treatment Period 3||4
3024177|NCT01078623|3742617|FG006|COMPLETED|Treatment Period 3||5
3024178|NCT01078623|3742618|FG007|COMPLETED|Treatment Period 3||6
3024179|NCT01078623|3742619|FG008|COMPLETED|Treatment Period 3||5
3024180|NCT01078623|3742620|FG009|COMPLETED|Treatment Period 3||6
3024181|NCT01078623|3742621|FG010|COMPLETED|Treatment Period 3||6
3024182|NCT01078623|3742622|FG011|COMPLETED|Treatment Period 3||7
3024183|NCT01078623|3742623|FG012|COMPLETED|Treatment Period 3||7
3024184|NCT01078623|3742624|FG013|COMPLETED|Treatment Period 3||6
3024185|NCT01078623|3742625|FG014|COMPLETED|Treatment Period 3||7
3024186|NCT01078623|3742626|FG015|COMPLETED|Treatment Period 3||7
3024187|NCT01078623|3742627|FG016|COMPLETED|Treatment Period 3||7
3024188|NCT01078623|3742628|FG017|COMPLETED|Treatment Period 3||7
3024189|NCT01078623|3742629|FG018|COMPLETED|Treatment Period 3||6
3024190|NCT01078623|3742630|FG019|COMPLETED|Treatment Period 3||7
3024191|NCT01078623|3742611|FG000|NOT COMPLETED|Treatment Period 3||0
3024192|NCT01078623|3742612|FG001|NOT COMPLETED|Treatment Period 3||0
3024193|NCT01078623|3742613|FG002|NOT COMPLETED|Treatment Period 3||0
3024194|NCT01078623|3742614|FG003|NOT COMPLETED|Treatment Period 3||0
3024195|NCT01078623|3742615|FG004|NOT COMPLETED|Treatment Period 3||1
3024196|NCT01078623|3742616|FG005|NOT COMPLETED|Treatment Period 3||0
3024197|NCT01078623|3742617|FG006|NOT COMPLETED|Treatment Period 3||0
3024198|NCT01078623|3742618|FG007|NOT COMPLETED|Treatment Period 3||0
3024199|NCT01078623|3742619|FG008|NOT COMPLETED|Treatment Period 3||0
3024200|NCT01078623|3742620|FG009|NOT COMPLETED|Treatment Period 3||0
3024201|NCT01078623|3742621|FG010|NOT COMPLETED|Treatment Period 3||0
3024202|NCT01078623|3742622|FG011|NOT COMPLETED|Treatment Period 3||0
3024203|NCT01078623|3742623|FG012|NOT COMPLETED|Treatment Period 3||0
3024204|NCT01078623|3742624|FG013|NOT COMPLETED|Treatment Period 3||1
3024205|NCT01078623|3742625|FG014|NOT COMPLETED|Treatment Period 3||0
3024206|NCT01078623|3742626|FG015|NOT COMPLETED|Treatment Period 3||0
3024207|NCT01078623|3742627|FG016|NOT COMPLETED|Treatment Period 3||0
3024208|NCT01078623|3742628|FG017|NOT COMPLETED|Treatment Period 3||0
3024209|NCT01078623|3742629|FG018|NOT COMPLETED|Treatment Period 3||0
3024210|NCT01078623|3742630|FG019|NOT COMPLETED|Treatment Period 3||0
3024211|NCT01078623|3742611|FG000|STARTED|Treatment Period 4||5
3024212|NCT01078623|3742612|FG001|STARTED|Treatment Period 4||5
3024213|NCT01078623|3742613|FG002|STARTED|Treatment Period 4||6
3024214|NCT01078623|3742614|FG003|STARTED|Treatment Period 4||6
3024215|NCT01078623|3742615|FG004|STARTED|Treatment Period 4||6
3024216|NCT01078623|3742616|FG005|STARTED|Treatment Period 4||4
3024217|NCT01078623|3742617|FG006|STARTED|Treatment Period 4||5
3024218|NCT01078623|3742618|FG007|STARTED|Treatment Period 4||6
3024219|NCT01078623|3742619|FG008|STARTED|Treatment Period 4||5
3024220|NCT01078623|3742620|FG009|STARTED|Treatment Period 4||6
3024221|NCT01078623|3742621|FG010|STARTED|Treatment Period 4||6
3024222|NCT01078623|3742622|FG011|STARTED|Treatment Period 4||7
3024223|NCT01078623|3742623|FG012|STARTED|Treatment Period 4||7
3024224|NCT01078623|3742624|FG013|STARTED|Treatment Period 4||6
3024225|NCT01078623|3742625|FG014|STARTED|Treatment Period 4||7
3024226|NCT01078623|3742626|FG015|STARTED|Treatment Period 4||7
3024227|NCT01078623|3742627|FG016|STARTED|Treatment Period 4||7
3024228|NCT01078623|3742628|FG017|STARTED|Treatment Period 4||7
3024229|NCT01078623|3742629|FG018|STARTED|Treatment Period 4||6
3024230|NCT01078623|3742630|FG019|STARTED|Treatment Period 4||7
3024231|NCT01078623|3742611|FG000|COMPLETED|Treatment Period 4||5
3024232|NCT01078623|3742612|FG001|COMPLETED|Treatment Period 4||5
3024233|NCT01078623|3742613|FG002|COMPLETED|Treatment Period 4||5
3165802|NCT01901653|3893346|FG011|NOT COMPLETED|Overall Study||16
3165803|NCT01901653|3893347|FG012|NOT COMPLETED|Overall Study||5
3165804|NCT01901809|3893377|FG000|STARTED|Overall Study||19
3165805|NCT01901809|3893378|FG001|STARTED|Overall Study||23
3165806|NCT01901809|3893379|FG002|STARTED|Overall Study||24
3024234|NCT01078623|3742614|FG003|COMPLETED|Treatment Period 4||6
3024235|NCT01078623|3742615|FG004|COMPLETED|Treatment Period 4||6
3024236|NCT01078623|3742616|FG005|COMPLETED|Treatment Period 4||4
3024237|NCT01078623|3742617|FG006|COMPLETED|Treatment Period 4||5
3024238|NCT01078623|3742618|FG007|COMPLETED|Treatment Period 4||6
3024239|NCT01078623|3742619|FG008|COMPLETED|Treatment Period 4||5
3024240|NCT01078623|3742620|FG009|COMPLETED|Treatment Period 4||6
3024241|NCT01078623|3742621|FG010|COMPLETED|Treatment Period 4||6
3024242|NCT01078623|3742622|FG011|COMPLETED|Treatment Period 4||7
3024243|NCT01078623|3742623|FG012|COMPLETED|Treatment Period 4||7
3024244|NCT01078623|3742624|FG013|COMPLETED|Treatment Period 4||6
3024245|NCT01078623|3742625|FG014|COMPLETED|Treatment Period 4||7
3024246|NCT01078623|3742626|FG015|COMPLETED|Treatment Period 4||6
3024247|NCT01078623|3742627|FG016|COMPLETED|Treatment Period 4||7
3024248|NCT01078623|3742628|FG017|COMPLETED|Treatment Period 4||7
3024249|NCT01078623|3742629|FG018|COMPLETED|Treatment Period 4||6
3024250|NCT01078623|3742630|FG019|COMPLETED|Treatment Period 4||7
3024251|NCT01078623|3742611|FG000|NOT COMPLETED|Treatment Period 4||0
3024252|NCT01078623|3742612|FG001|NOT COMPLETED|Treatment Period 4||0
3024253|NCT01078623|3742613|FG002|NOT COMPLETED|Treatment Period 4||1
3024254|NCT01078623|3742614|FG003|NOT COMPLETED|Treatment Period 4||0
3024255|NCT01078623|3742615|FG004|NOT COMPLETED|Treatment Period 4||0
3024256|NCT01078623|3742616|FG005|NOT COMPLETED|Treatment Period 4||0
3024257|NCT01078623|3742617|FG006|NOT COMPLETED|Treatment Period 4||0
3024258|NCT01078623|3742618|FG007|NOT COMPLETED|Treatment Period 4||0
3024259|NCT01078623|3742619|FG008|NOT COMPLETED|Treatment Period 4||0
3024260|NCT01078623|3742620|FG009|NOT COMPLETED|Treatment Period 4||0
3024261|NCT01078623|3742621|FG010|NOT COMPLETED|Treatment Period 4||0
3024262|NCT01078623|3742622|FG011|NOT COMPLETED|Treatment Period 4||0
3024263|NCT01078623|3742623|FG012|NOT COMPLETED|Treatment Period 4||0
3024264|NCT01078623|3742624|FG013|NOT COMPLETED|Treatment Period 4||0
3024265|NCT01078623|3742625|FG014|NOT COMPLETED|Treatment Period 4||0
3024266|NCT01078623|3742626|FG015|NOT COMPLETED|Treatment Period 4||1
3024267|NCT01078623|3742627|FG016|NOT COMPLETED|Treatment Period 4||0
3024268|NCT01078623|3742628|FG017|NOT COMPLETED|Treatment Period 4||0
3024269|NCT01078623|3742629|FG018|NOT COMPLETED|Treatment Period 4||0
3024270|NCT01078623|3742630|FG019|NOT COMPLETED|Treatment Period 4||0
3024271|NCT01078662|3742647|FG000|STARTED|Overall Study||62
3024272|NCT01078662|3742648|FG001|STARTED|Overall Study||193
3024273|NCT01078662|3742649|FG002|STARTED|Overall Study||23
3024274|NCT01078662|3742650|FG003|STARTED|Overall Study||8
3024275|NCT01078662|3742651|FG004|STARTED|Overall Study||12
3024276|NCT01078662|3742647|FG000|COMPLETED|Overall Study||4
3024277|NCT01078662|3742648|FG001|COMPLETED|Overall Study||25
3024278|NCT01078662|3742649|FG002|COMPLETED|Overall Study||2
3024279|NCT01078662|3742650|FG003|COMPLETED|Overall Study||1
3024280|NCT01078662|3742651|FG004|COMPLETED|Overall Study||1
3024281|NCT01078662|3742647|FG000|NOT COMPLETED|Overall Study||58
3024282|NCT01078662|3742648|FG001|NOT COMPLETED|Overall Study||168
3024283|NCT01078662|3742649|FG002|NOT COMPLETED|Overall Study||21
3024284|NCT01078662|3742650|FG003|NOT COMPLETED|Overall Study||7
3024285|NCT01078662|3742651|FG004|NOT COMPLETED|Overall Study||11
3024286|NCT01078675|3742662|FG000|STARTED|Overall Study||250
3024287|NCT01078675|3742663|FG001|STARTED|Overall Study||65
3024288|NCT01078675|3742662|FG000|Patients Treated|Overall Study||198
3024289|NCT01078675|3742663|FG001|Patients Treated|Overall Study||0
3024290|NCT01078675|3742662|FG000|COMPLETED|Overall Study||182
3024291|NCT01078675|3742663|FG001|COMPLETED|Overall Study|Healthy siblings did not participate in investigational product administration.|59
3024292|NCT01078675|3742662|FG000|NOT COMPLETED|Overall Study||68
3024293|NCT01078675|3742663|FG001|NOT COMPLETED|Overall Study||6
3024294|NCT01078753|3742671|FG000|STARTED|Treatment Period I||45
3024295|NCT01078753|3742672|FG001|STARTED|Treatment Period I||44
3024296|NCT01078753|3742671|FG000|Full Analysis Set|Treatment Period I|One patient was excluded from the full analysis set due to failure to satisfy the entry criteria.|44
3024297|NCT01078753|3742672|FG001|Full Analysis Set|Treatment Period I||44
3024298|NCT01078753|3742671|FG000|COMPLETED|Treatment Period I||45
3024299|NCT01078753|3742672|FG001|COMPLETED|Treatment Period I||44
3024300|NCT01078753|3742671|FG000|NOT COMPLETED|Treatment Period I||0
3024301|NCT01078753|3742672|FG001|NOT COMPLETED|Treatment Period I||0
3024302|NCT01078753|3742671|FG000|STARTED|Treatment Period II|Desmopressin 120 µg - 4 participants Desmopressin 240 µg - 41 participants|45
3024303|NCT01078753|3742672|FG001|STARTED|Treatment Period II||44
3024304|NCT01078753|3742671|FG000|Full Analysis Set|Treatment Period II|One patient was excluded from the full analysis set due to failure to satisfy the entry criteria.|44
3024305|NCT01078753|3742672|FG001|Full Analysis Set|Treatment Period II||44
3024306|NCT01078753|3742671|FG000|COMPLETED|Treatment Period II||45
3024307|NCT01078753|3742672|FG001|COMPLETED|Treatment Period II||44
3024308|NCT01078753|3742671|FG000|NOT COMPLETED|Treatment Period II||0
3024309|NCT01078753|3742672|FG001|NOT COMPLETED|Treatment Period II||0
3024310|NCT01078805|3742678|FG000|STARTED|Overall Study||4167
3024311|NCT01078805|3742678|FG000|Took at Least 1 Dose of Study Drug|Overall Study||4085
3024312|NCT01078805|3742678|FG000|Modified Intent-To-Treat|Overall Study|≥1 dose of study drug (SD) and didn't discontinue SD more than 3 consecutive months during treatment|3720
3024313|NCT01078805|3742678|FG000|COMPLETED|Overall Study||2117
3024314|NCT01078805|3742678|FG000|NOT COMPLETED|Overall Study||2050
3024315|NCT01078909|3742687|FG000|STARTED|Overall Study||25
3024316|NCT01078909|3742688|FG001|STARTED|Overall Study||25
3024317|NCT01078909|3742689|FG002|STARTED|Overall Study||25
3024318|NCT01078909|3742690|FG003|STARTED|Overall Study||25
3024319|NCT01078909|3742691|FG004|STARTED|Overall Study||25
3024320|NCT01078909|3742687|FG000|COMPLETED|Overall Study||23
3024321|NCT01078909|3742688|FG001|COMPLETED|Overall Study||21
3024322|NCT01078909|3742689|FG002|COMPLETED|Overall Study||24
3024323|NCT01078909|3742690|FG003|COMPLETED|Overall Study||24
3024324|NCT01078909|3742691|FG004|COMPLETED|Overall Study||23
3024325|NCT01078909|3742687|FG000|NOT COMPLETED|Overall Study||2
3024326|NCT01078909|3742688|FG001|NOT COMPLETED|Overall Study||4
3024327|NCT01078909|3742689|FG002|NOT COMPLETED|Overall Study||1
3024328|NCT01078909|3742690|FG003|NOT COMPLETED|Overall Study||1
3024329|NCT01078909|3742691|FG004|NOT COMPLETED|Overall Study||2
3024330|NCT01078922|3742703|FG000|STARTED|Overall Study||11
3024331|NCT01078922|3742703|FG000|COMPLETED|Overall Study||10
3024332|NCT01078922|3742703|FG000|NOT COMPLETED|Overall Study||1
3024333|NCT01078974|3742708|FG000|STARTED|Overall Study||7
3024334|NCT01078974|3742708|FG000|COMPLETED|Overall Study||4
3024335|NCT01078974|3742708|FG000|NOT COMPLETED|Overall Study||3
3024336|NCT01079130|3742718|FG000|STARTED|Overall Study||85
3024337|NCT01079130|3742719|FG001|STARTED|Overall Study||85
3024338|NCT01079130|3742720|FG002|STARTED|Overall Study||84
3024339|NCT01079130|3742721|FG003|STARTED|Overall Study||86
3024340|NCT01079130|3742722|FG004|STARTED|Overall Study||86
3024341|NCT01079130|3742723|FG005|STARTED|Overall Study||85
3024342|NCT01079130|3742718|FG000|Safety Set: Received Study Drug|Overall Study||84
3024343|NCT01079130|3742719|FG001|Safety Set: Received Study Drug|Overall Study||81
3024344|NCT01079130|3742720|FG002|Safety Set: Received Study Drug|Overall Study||84
3024345|NCT01079130|3742721|FG003|Safety Set: Received Study Drug|Overall Study||85
3024346|NCT01079130|3742722|FG004|Safety Set: Received Study Drug|Overall Study||84
3024347|NCT01079130|3742723|FG005|Safety Set: Received Study Drug|Overall Study||84
3024348|NCT01079130|3742718|FG000|Full Analysis Set (FAS)|Overall Study||84
3024349|NCT01079130|3742719|FG001|Full Analysis Set (FAS)|Overall Study|2 patients (1 in 37.5 µg;1 in 75 µg group) randomized more than once and were excluded from the FAS.|80
3024350|NCT01079130|3742720|FG002|Full Analysis Set (FAS)|Overall Study||83
3024351|NCT01079130|3742721|FG003|Full Analysis Set (FAS)|Overall Study||85
3024352|NCT01079130|3742722|FG004|Full Analysis Set (FAS)|Overall Study||84
3024353|NCT01079130|3742723|FG005|Full Analysis Set (FAS)|Overall Study||84
3024354|NCT01079130|3742718|FG000|COMPLETED|Overall Study||83
3024355|NCT01079130|3742719|FG001|COMPLETED|Overall Study||78
3024356|NCT01079130|3742720|FG002|COMPLETED|Overall Study||83
3024357|NCT01079130|3742721|FG003|COMPLETED|Overall Study||81
3024358|NCT01079130|3742722|FG004|COMPLETED|Overall Study||78
3024359|NCT01079130|3742723|FG005|COMPLETED|Overall Study||80
3024360|NCT01079130|3742718|FG000|NOT COMPLETED|Overall Study||2
3024361|NCT01079130|3742719|FG001|NOT COMPLETED|Overall Study||7
3024362|NCT01079130|3742720|FG002|NOT COMPLETED|Overall Study||1
3024363|NCT01079130|3742721|FG003|NOT COMPLETED|Overall Study||5
3024364|NCT01079130|3742722|FG004|NOT COMPLETED|Overall Study||8
3024365|NCT01079130|3742723|FG005|NOT COMPLETED|Overall Study||5
3024366|NCT01079143|3742741|FG000|STARTED|Overall Study||36
3024367|NCT01079143|3742742|FG001|STARTED|Overall Study||60
3024368|NCT01079143|3742743|FG002|STARTED|Overall Study||39
3024369|NCT01079143|3742744|FG003|STARTED|Overall Study||59
3024370|NCT01079143|3742741|FG000|Exposed|Overall Study||36
3024371|NCT01079143|3742742|FG001|Exposed|Overall Study||60
3024372|NCT01079143|3742743|FG002|Exposed|Overall Study||39
3024373|NCT01079143|3742744|FG003|Exposed|Overall Study||59
3024374|NCT01079143|3742741|FG000|Month 3 (M3) Biopsies|Overall Study||36
3024375|NCT01079143|3742742|FG001|Month 3 (M3) Biopsies|Overall Study|1 patient was excluded due to an IF/TA Grade of III at the M3 Biopsy|59
3024376|NCT01079143|3742743|FG002|Month 3 (M3) Biopsies|Overall Study||39
3024377|NCT01079143|3742744|FG003|Month 3 (M3) Biopsies|Overall Study||59
3024378|NCT01079143|3742741|FG000|Month 12 (M12) Biopsies|Overall Study|Only 26 out of 36 participants in this group had graft biopsy that was eligible for analysis.|26
3024379|NCT01079143|3742742|FG001|Month 12 (M12) Biopsies|Overall Study||43
3024380|NCT01079143|3742743|FG002|Month 12 (M12) Biopsies|Overall Study|Only 32 out of 39 participants in this group had graft biopsy that was eligible for analysis.|32
3024381|NCT01079143|3742744|FG003|Month 12 (M12) Biopsies|Overall Study|Only 53 out of 59 participants in this group had graft biopsy that was eligible for analysis.|53
3024382|NCT01079143|3742741|FG000|M3 and M12 Biopsies|Overall Study|Only 26 out of 36 participants in this group had graft biopsy that was eligible for analysis.|26
3024383|NCT01079143|3742742|FG001|M3 and M12 Biopsies|Overall Study||43
3024384|NCT01079143|3742743|FG002|M3 and M12 Biopsies|Overall Study|Only 32 out of 39 participants in this group had graft biopsy that was eligible for analysis.|32
3024385|NCT01079143|3742744|FG003|M3 and M12 Biopsies|Overall Study|Only 53 out of 59 participants in this group had graft biopsy that was eligible for analysis.|53
3024386|NCT01079143|3742741|FG000|COMPLETED|Overall Study||27
3024387|NCT01079143|3742742|FG001|COMPLETED|Overall Study||43
3024388|NCT01079143|3742743|FG002|COMPLETED|Overall Study||34
3024389|NCT01079143|3742744|FG003|COMPLETED|Overall Study||54
3024390|NCT01079143|3742741|FG000|NOT COMPLETED|Overall Study||9
3024391|NCT01079143|3742742|FG001|NOT COMPLETED|Overall Study||17
3024392|NCT01079143|3742743|FG002|NOT COMPLETED|Overall Study||5
3024393|NCT01079143|3742744|FG003|NOT COMPLETED|Overall Study||5
3024394|NCT01079182|3742758|FG000|STARTED|Overall Study||4681
3024395|NCT01079182|3742758|FG000|COMPLETED|Overall Study||1962
3024396|NCT01079182|3742758|FG000|NOT COMPLETED|Overall Study||2719
3024397|NCT01079195|3742762|FG000|STARTED|Overall Study||15873
3024398|NCT01079195|3742762|FG000|COMPLETED|Overall Study||14442
3024399|NCT01079195|3742762|FG000|NOT COMPLETED|Overall Study||1431
3024400|NCT01079234|3742769|FG000|STARTED|Main: Week 0 to 26||164
3024401|NCT01079234|3742770|FG001|STARTED|Main: Week 0 to 26||165
3024402|NCT01079234|3742771|FG002|STARTED|Main: Week 0 to 26||164
3024403|NCT01079234|3742772|FG003|STARTED|Main: Week 0 to 26||0
3024404|NCT01079234|3742769|FG000|Exposed|Main: Week 0 to 26||164
3024405|NCT01079234|3742770|FG001|Exposed|Main: Week 0 to 26||165
3024406|NCT01079234|3742771|FG002|Exposed|Main: Week 0 to 26|Three subjects withdrew prior to exposure to trial drug.|161
3024407|NCT01079234|3742772|FG003|Exposed|Main: Week 0 to 26||0
3024408|NCT01079234|3742769|FG000|COMPLETED|Main: Week 0 to 26||138
3024409|NCT01079234|3742770|FG001|COMPLETED|Main: Week 0 to 26||139
3024410|NCT01079234|3742771|FG002|COMPLETED|Main: Week 0 to 26||152
3024411|NCT01079234|3742772|FG003|COMPLETED|Main: Week 0 to 26||0
3024412|NCT01079234|3742769|FG000|NOT COMPLETED|Main: Week 0 to 26||26
3024413|NCT01079234|3742770|FG001|NOT COMPLETED|Main: Week 0 to 26||26
3024414|NCT01079234|3742771|FG002|NOT COMPLETED|Main: Week 0 to 26||12
3024415|NCT01079234|3742772|FG003|NOT COMPLETED|Main: Week 0 to 26||0
3024416|NCT01079234|3742769|FG000|STARTED|Extension: Week 27 to 52||0
3024417|NCT01079234|3742770|FG001|STARTED|Extension: Week 27 to 52||0
3024418|NCT01079234|3742771|FG002|STARTED|Extension: Week 27 to 52|Nineteen subjects from main trial did not continue into extension trial|133
3024419|NCT01079234|3742772|FG003|STARTED|Extension: Week 27 to 52|Thirty eight subjects did not continue into extension trial.|239
3024420|NCT01079234|3742769|FG000|COMPLETED|Extension: Week 27 to 52||0
3024421|NCT01079234|3742770|FG001|COMPLETED|Extension: Week 27 to 52||0
3024422|NCT01079234|3742771|FG002|COMPLETED|Extension: Week 27 to 52||122
3024423|NCT01079234|3742772|FG003|COMPLETED|Extension: Week 27 to 52||223
3024424|NCT01079234|3742769|FG000|NOT COMPLETED|Extension: Week 27 to 52||0
3024425|NCT01079234|3742770|FG001|NOT COMPLETED|Extension: Week 27 to 52||0
3024426|NCT01079234|3742771|FG002|NOT COMPLETED|Extension: Week 27 to 52||11
3024427|NCT01079234|3742772|FG003|NOT COMPLETED|Extension: Week 27 to 52||16
3024428|NCT01079299|3742783|FG000|STARTED|Overall Study||27
3024429|NCT01079299|3742784|FG001|STARTED|Overall Study||25
3024430|NCT01079299|3742783|FG000|COMPLETED|Overall Study||27
3308502|NCT03020745|4041800|FG007|STARTED|Part 2:Optional FU (Up to 450 Days)|2 participants didn't enter into optional follow-up period.|17
3308503|NCT03020745|4041801|FG008|STARTED|Part 2:Optional FU (Up to 450 Days)|1 participant did not enter into optional follow-up period|13
3308504|NCT03020745|4041802|FG009|STARTED|Part 2:Optional FU (Up to 450 Days)||15
3024431|NCT01079299|3742784|FG001|COMPLETED|Overall Study||25
3024432|NCT01079299|3742783|FG000|NOT COMPLETED|Overall Study||0
3024433|NCT01079299|3742784|FG001|NOT COMPLETED|Overall Study||0
3024434|NCT01079390|3742793|FG000|STARTED|Overall Study||15
3024435|NCT01079390|3742794|FG001|STARTED|Overall Study||15
3024436|NCT01079390|3742795|FG002|STARTED|Overall Study||14
3024437|NCT01079390|3742793|FG000|COMPLETED|Overall Study||10
3024438|NCT01079390|3742794|FG001|COMPLETED|Overall Study||10
3024439|NCT01079390|3742795|FG002|COMPLETED|Overall Study||10
3024440|NCT01079390|3742793|FG000|NOT COMPLETED|Overall Study||5
3024441|NCT01079390|3742794|FG001|NOT COMPLETED|Overall Study||5
3024442|NCT01079390|3742795|FG002|NOT COMPLETED|Overall Study||4
3165807|NCT01901809|3893380|FG003|STARTED|Overall Study||24
3165808|NCT01901809|3893377|FG000|COMPLETED|Overall Study||19
3165809|NCT01901809|3893378|FG001|COMPLETED|Overall Study||23
3165810|NCT01901809|3893379|FG002|COMPLETED|Overall Study||21
3165811|NCT01901809|3893380|FG003|COMPLETED|Overall Study||22
3165812|NCT01901809|3893377|FG000|NOT COMPLETED|Overall Study||0
3165813|NCT01901809|3893378|FG001|NOT COMPLETED|Overall Study||0
3165814|NCT01901809|3893379|FG002|NOT COMPLETED|Overall Study||3
3165815|NCT01901809|3893380|FG003|NOT COMPLETED|Overall Study||2
3165816|NCT01901848|3893396|FG000|STARTED|Randomized and Treated||25
3165817|NCT01901848|3893397|FG001|STARTED|Randomized and Treated||25
3165818|NCT01901848|3893396|FG000|COMPLETED|Randomized and Treated|Ten cases were practice cases used to establish fidelity to CPT, and were removed from analyses.|22
3024443|NCT01079663|3742807|FG000|STARTED|Overall Study||30
3024444|NCT01079663|3742808|FG001|STARTED|Overall Study||30
3024445|NCT01079663|3742807|FG000|COMPLETED|Overall Study||30
3024446|NCT01079663|3742808|FG001|COMPLETED|Overall Study||26
3024447|NCT01079663|3742807|FG000|NOT COMPLETED|Overall Study||0
3024448|NCT01079663|3742808|FG001|NOT COMPLETED|Overall Study||4
3024449|NCT01079741|3742819|FG000|STARTED|Cohort 1: Dose Level 1 (Weeks 1-12)||3
3024450|NCT01079741|3742820|FG001|STARTED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
3024451|NCT01079741|3742821|FG002|STARTED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
3024452|NCT01079741|3742822|FG003|STARTED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
3024453|NCT01079741|3742823|FG004|STARTED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
3024454|NCT01079741|3742819|FG000|COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||3
3024455|NCT01079741|3742820|FG001|COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
3024456|NCT01079741|3742821|FG002|COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
3024457|NCT01079741|3742822|FG003|COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
3024458|NCT01079741|3742823|FG004|COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
3024459|NCT01079741|3742819|FG000|NOT COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
3024460|NCT01079741|3742820|FG001|NOT COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
3024461|NCT01079741|3742821|FG002|NOT COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
3024462|NCT01079741|3742822|FG003|NOT COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
3024463|NCT01079741|3742823|FG004|NOT COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
3024464|NCT01079741|3742819|FG000|STARTED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
3024465|NCT01079741|3742820|FG001|STARTED|Cohort 2: Dose Level 2 (Weeks 13-24)||4
3024466|NCT01079741|3742821|FG002|STARTED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
3165819|NCT01901848|3893397|FG001|COMPLETED|Randomized and Treated||19
3165820|NCT01901848|3893396|FG000|NOT COMPLETED|Randomized and Treated||3
3165821|NCT01901848|3893397|FG001|NOT COMPLETED|Randomized and Treated||6
3024467|NCT01079741|3742822|FG003|STARTED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
3024468|NCT01079741|3742823|FG004|STARTED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
3024469|NCT01079741|3742819|FG000|COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
3024470|NCT01079741|3742820|FG001|COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||3
3024471|NCT01079741|3742821|FG002|COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
3024472|NCT01079741|3742822|FG003|COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
3024473|NCT01079741|3742823|FG004|COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
3024474|NCT01079741|3742819|FG000|NOT COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
3024475|NCT01079741|3742820|FG001|NOT COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||1
3024476|NCT01079741|3742821|FG002|NOT COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
3024477|NCT01079741|3742822|FG003|NOT COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
3024478|NCT01079741|3742823|FG004|NOT COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
3024479|NCT01079741|3742819|FG000|STARTED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
3024480|NCT01079741|3742820|FG001|STARTED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
3024481|NCT01079741|3742821|FG002|STARTED|Cohort 3: Dose Level 3 (Weeks 25-36)||3
3024482|NCT01079741|3742822|FG003|STARTED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
3024483|NCT01079741|3742823|FG004|STARTED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
3024484|NCT01079741|3742819|FG000|COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
3024485|NCT01079741|3742820|FG001|COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
3024486|NCT01079741|3742821|FG002|COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
3024487|NCT01079741|3742822|FG003|COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
3024488|NCT01079741|3742823|FG004|COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
3024489|NCT01079741|3742819|FG000|NOT COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
3024490|NCT01079741|3742820|FG001|NOT COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
3024491|NCT01079741|3742821|FG002|NOT COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||3
3024492|NCT01079741|3742822|FG003|NOT COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
3024493|NCT01079741|3742823|FG004|NOT COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
3024494|NCT01079741|3742819|FG000|STARTED|Phase 2 (Weeks 37-48)||0
3024495|NCT01079741|3742820|FG001|STARTED|Phase 2 (Weeks 37-48)||0
3024496|NCT01079741|3742821|FG002|STARTED|Phase 2 (Weeks 37-48)||0
3024497|NCT01079741|3742822|FG003|STARTED|Phase 2 (Weeks 37-48)||12
3024498|NCT01079741|3742823|FG004|STARTED|Phase 2 (Weeks 37-48)||12
3024499|NCT01079741|3742819|FG000|COMPLETED|Phase 2 (Weeks 37-48)||0
3024500|NCT01079741|3742820|FG001|COMPLETED|Phase 2 (Weeks 37-48)||0
3024501|NCT01079741|3742821|FG002|COMPLETED|Phase 2 (Weeks 37-48)||0
3024502|NCT01079741|3742822|FG003|COMPLETED|Phase 2 (Weeks 37-48)||12
3024503|NCT01079741|3742823|FG004|COMPLETED|Phase 2 (Weeks 37-48)||9
3024504|NCT01079741|3742819|FG000|NOT COMPLETED|Phase 2 (Weeks 37-48)||0
3024505|NCT01079741|3742820|FG001|NOT COMPLETED|Phase 2 (Weeks 37-48)||0
3024506|NCT01079741|3742821|FG002|NOT COMPLETED|Phase 2 (Weeks 37-48)||0
3024507|NCT01079741|3742822|FG003|NOT COMPLETED|Phase 2 (Weeks 37-48)||0
3024508|NCT01079741|3742823|FG004|NOT COMPLETED|Phase 2 (Weeks 37-48)||3
3024509|NCT01079806|3742837|FG000|STARTED|Day 1 to Week 96||120
3024510|NCT01079806|3742838|FG001|STARTED|Day 1 to Week 96||60
3024511|NCT01079806|3742837|FG000|Received Treatment|Day 1 to Week 96||120
3024512|NCT01079806|3742838|FG001|Received Treatment|Day 1 to Week 96||60
3024513|NCT01079806|3742837|FG000|Primary Endpoint Cohort|Day 1 to Week 96||82
3024514|NCT01079806|3742838|FG001|Primary Endpoint Cohort|Day 1 to Week 96||41
3024515|NCT01079806|3742837|FG000|COMPLETED|Day 1 to Week 96||113
3024516|NCT01079806|3742838|FG001|COMPLETED|Day 1 to Week 96||53
3024517|NCT01079806|3742837|FG000|NOT COMPLETED|Day 1 to Week 96||7
3024518|NCT01079806|3742838|FG001|NOT COMPLETED|Day 1 to Week 96||7
3024519|NCT01079806|3742837|FG000|STARTED|Long-term Follow-up: Day 1-End of Study||111
3024520|NCT01079806|3742838|FG001|STARTED|Long-term Follow-up: Day 1-End of Study||58
3024521|NCT01079806|3742837|FG000|COMPLETED|Long-term Follow-up: Day 1-End of Study||92
3024522|NCT01079806|3742838|FG001|COMPLETED|Long-term Follow-up: Day 1-End of Study||43
3024523|NCT01079806|3742837|FG000|NOT COMPLETED|Long-term Follow-up: Day 1-End of Study||19
3024524|NCT01079806|3742838|FG001|NOT COMPLETED|Long-term Follow-up: Day 1-End of Study||15
3024525|NCT01079832|3742846|FG000|STARTED|Overall Study||50
3024526|NCT01079832|3742846|FG000|COMPLETED|Overall Study||49
3024527|NCT01079832|3742846|FG000|NOT COMPLETED|Overall Study||1
3024528|NCT01079936|3742854|FG000|STARTED|Phase I: MTD||16
3024529|NCT01079936|3742855|FG001|STARTED|Phase I: MTD||0
3024530|NCT01079936|3742856|FG002|STARTED|Phase I: MTD||0
3024531|NCT01079936|3742857|FG003|STARTED|Phase I: MTD||0
3024532|NCT01079936|3742858|FG004|STARTED|Phase I: MTD||0
3024533|NCT01079936|3742854|FG000|COMPLETED|Phase I: MTD|The 12 Phase I participants were randomized across 4 dose arms for Phase II.|12
3024534|NCT01079936|3742855|FG001|COMPLETED|Phase I: MTD||0
3024535|NCT01079936|3742856|FG002|COMPLETED|Phase I: MTD||0
3024536|NCT01079936|3742857|FG003|COMPLETED|Phase I: MTD||0
3024537|NCT01079936|3742858|FG004|COMPLETED|Phase I: MTD||0
3024538|NCT01079936|3742854|FG000|NOT COMPLETED|Phase I: MTD||4
3024539|NCT01079936|3742855|FG001|NOT COMPLETED|Phase I: MTD||0
3024540|NCT01079936|3742856|FG002|NOT COMPLETED|Phase I: MTD||0
3024541|NCT01079936|3742857|FG003|NOT COMPLETED|Phase I: MTD||0
3024542|NCT01079936|3742858|FG004|NOT COMPLETED|Phase I: MTD||0
3024543|NCT01079936|3742854|FG000|STARTED|Phase II||0
3024544|NCT01079936|3742855|FG001|STARTED|Phase II||3
3024545|NCT01079936|3742856|FG002|STARTED|Phase II||6
3024546|NCT01079936|3742857|FG003|STARTED|Phase II||24
3024547|NCT01079936|3742858|FG004|STARTED|Phase II||26
3024548|NCT01079936|3742854|FG000|COMPLETED|Phase II||0
3024549|NCT01079936|3742855|FG001|COMPLETED|Phase II||3
3024550|NCT01079936|3742856|FG002|COMPLETED|Phase II||5
3024551|NCT01079936|3742857|FG003|COMPLETED|Phase II||24
3024552|NCT01079936|3742858|FG004|COMPLETED|Phase II||25
3024553|NCT01079936|3742854|FG000|NOT COMPLETED|Phase II||0
3024554|NCT01079936|3742855|FG001|NOT COMPLETED|Phase II||0
3024555|NCT01079936|3742856|FG002|NOT COMPLETED|Phase II||1
3024556|NCT01079936|3742857|FG003|NOT COMPLETED|Phase II||0
3024557|NCT01079936|3742858|FG004|NOT COMPLETED|Phase II||1
3024558|NCT01079949|3742871|FG000|STARTED|Overall Study||46
3024559|NCT01079949|3742872|FG001|STARTED|Overall Study||47
3024560|NCT01079949|3742871|FG000|COMPLETED|Overall Study||31
3024561|NCT01079949|3742872|FG001|COMPLETED|Overall Study||34
3024562|NCT01079949|3742871|FG000|NOT COMPLETED|Overall Study||15
3024563|NCT01079949|3742872|FG001|NOT COMPLETED|Overall Study||13
3024564|NCT01079962|3742880|FG000|STARTED|Overall Study||105
3024565|NCT01079962|3742881|FG001|STARTED|Overall Study||104
3024566|NCT01079962|3742880|FG000|COMPLETED|Overall Study||90
3024567|NCT01079962|3742881|FG001|COMPLETED|Overall Study||89
3024568|NCT01079962|3742880|FG000|NOT COMPLETED|Overall Study||15
3024569|NCT01079962|3742881|FG001|NOT COMPLETED|Overall Study||15
3024570|NCT01079988|3742892|FG000|STARTED|Overall Study||10
3024571|NCT01079988|3742893|FG001|STARTED|Overall Study||1
3024572|NCT01079988|3742894|FG002|STARTED|Overall Study||8
3024573|NCT01079988|3742895|FG003|STARTED|Overall Study||20
3024574|NCT01079988|3742896|FG004|STARTED|Overall Study||2
3024575|NCT01079988|3742892|FG000|COMPLETED|Overall Study||9
3024576|NCT01079988|3742893|FG001|COMPLETED|Overall Study||1
3024577|NCT01079988|3742894|FG002|COMPLETED|Overall Study||8
3024578|NCT01079988|3742895|FG003|COMPLETED|Overall Study||17
3024579|NCT01079988|3742896|FG004|COMPLETED|Overall Study||1
3024580|NCT01079988|3742892|FG000|NOT COMPLETED|Overall Study||1
3024581|NCT01079988|3742893|FG001|NOT COMPLETED|Overall Study||0
3024582|NCT01079988|3742894|FG002|NOT COMPLETED|Overall Study||0
3024583|NCT01079988|3742895|FG003|NOT COMPLETED|Overall Study||3
3024584|NCT01079988|3742896|FG004|NOT COMPLETED|Overall Study||1
3024585|NCT01080118|3742910|FG000|STARTED|Overall Study||15
3024586|NCT01080118|3742911|FG001|STARTED|Overall Study||15
3024587|NCT01080118|3742912|FG002|STARTED|Overall Study||30
3024588|NCT01080118|3742913|FG003|STARTED|Overall Study||30
3024589|NCT01080118|3742910|FG000|COMPLETED|Overall Study||15
3024590|NCT01080118|3742911|FG001|COMPLETED|Overall Study||15
3024591|NCT01080118|3742912|FG002|COMPLETED|Overall Study||30
3024592|NCT01080118|3742913|FG003|COMPLETED|Overall Study||30
3024593|NCT01080118|3742910|FG000|NOT COMPLETED|Overall Study||0
3024594|NCT01080118|3742911|FG001|NOT COMPLETED|Overall Study||0
3024595|NCT01080118|3742912|FG002|NOT COMPLETED|Overall Study||0
3024596|NCT01080118|3742913|FG003|NOT COMPLETED|Overall Study||0
3024597|NCT01080131|3742921|FG000|STARTED|Core Study (0- 12 Weeks)||112
3024598|NCT01080131|3742922|FG001|STARTED|Core Study (0- 12 Weeks)||114
3024599|NCT01080131|3742921|FG000|COMPLETED|Core Study (0- 12 Weeks)||99
3024600|NCT01080131|3742922|FG001|COMPLETED|Core Study (0- 12 Weeks)||103
3024601|NCT01080131|3742921|FG000|NOT COMPLETED|Core Study (0- 12 Weeks)||13
3024602|NCT01080131|3742922|FG001|NOT COMPLETED|Core Study (0- 12 Weeks)||11
3024603|NCT01080131|3742921|FG000|STARTED|Extension Study 1 (12 -24 Weeks)||84
3024604|NCT01080131|3742922|FG001|STARTED|Extension Study 1 (12 -24 Weeks)||76
3024605|NCT01080131|3742921|FG000|COMPLETED|Extension Study 1 (12 -24 Weeks)||78
3024606|NCT01080131|3742922|FG001|COMPLETED|Extension Study 1 (12 -24 Weeks)||72
3024607|NCT01080131|3742921|FG000|NOT COMPLETED|Extension Study 1 (12 -24 Weeks)||6
3024608|NCT01080131|3742922|FG001|NOT COMPLETED|Extension Study 1 (12 -24 Weeks)||4
3024609|NCT01080131|3742921|FG000|STARTED|Extension Study 2 (25-72 Weeks)||72
3024610|NCT01080131|3742922|FG001|STARTED|Extension Study 2 (25-72 Weeks)||65
3024611|NCT01080131|3742921|FG000|Re-treated With or Switch to Canakinumab|Extension Study 2 (25-72 Weeks)|Includes patients re-treated with canakinumab at any time during the 72 weeks|62
3024612|NCT01080131|3742922|FG001|Re-treated With or Switch to Canakinumab|Extension Study 2 (25-72 Weeks)|Includes patients switched to canakinumab from Week 25 - Week 72|41
3024613|NCT01080131|3742921|FG000|COMPLETED|Extension Study 2 (25-72 Weeks)||64
3024614|NCT01080131|3742922|FG001|COMPLETED|Extension Study 2 (25-72 Weeks)||54
3024615|NCT01080131|3742921|FG000|NOT COMPLETED|Extension Study 2 (25-72 Weeks)||8
3024616|NCT01080131|3742922|FG001|NOT COMPLETED|Extension Study 2 (25-72 Weeks)||11
3024617|NCT01080196|3742948|FG000|STARTED|Overall Study||68
3024618|NCT01080196|3742949|FG001|STARTED|Overall Study||66
3024619|NCT01080196|3742948|FG000|COMPLETED|Overall Study||68
3024620|NCT01080196|3742949|FG001|COMPLETED|Overall Study||66
3024621|NCT01080196|3742948|FG000|NOT COMPLETED|Overall Study||0
3024622|NCT01080196|3742949|FG001|NOT COMPLETED|Overall Study||0
3024623|NCT01080209|3742964|FG000|STARTED|Overall Study||28
3024624|NCT01080209|3742965|FG001|STARTED|Overall Study||53
3024625|NCT01080209|3742966|FG002|STARTED|Overall Study||33
3024626|NCT01080209|3742967|FG003|STARTED|Overall Study||42
3024627|NCT01080209|3742968|FG004|STARTED|Overall Study||6
3024628|NCT01080209|3742969|FG005|STARTED|Overall Study||2
3024629|NCT01080209|3742970|FG006|STARTED|Overall Study||51
3024630|NCT01080209|3742964|FG000|COMPLETED|Overall Study||22
3024631|NCT01080209|3742965|FG001|COMPLETED|Overall Study||42
3024632|NCT01080209|3742966|FG002|COMPLETED|Overall Study||28
3024633|NCT01080209|3742967|FG003|COMPLETED|Overall Study||37
3024634|NCT01080209|3742968|FG004|COMPLETED|Overall Study||6
3024635|NCT01080209|3742969|FG005|COMPLETED|Overall Study||2
3024636|NCT01080209|3742970|FG006|COMPLETED|Overall Study||44
3024637|NCT01080209|3742964|FG000|NOT COMPLETED|Overall Study||6
3024638|NCT01080209|3742965|FG001|NOT COMPLETED|Overall Study||11
3024639|NCT01080209|3742966|FG002|NOT COMPLETED|Overall Study||5
3024640|NCT01080209|3742967|FG003|NOT COMPLETED|Overall Study||5
3024641|NCT01080209|3742968|FG004|NOT COMPLETED|Overall Study||0
3024642|NCT01080209|3742969|FG005|NOT COMPLETED|Overall Study||0
3024643|NCT01080209|3742970|FG006|NOT COMPLETED|Overall Study||7
3024644|NCT01080248|3742986|FG000|STARTED|Overall Study||2
3024645|NCT01080248|3742986|FG000|COMPLETED|Overall Study||2
3024646|NCT01080248|3742986|FG000|NOT COMPLETED|Overall Study||0
3165822|NCT01901848|3893396|FG000|STARTED|Removed From Analyses||22
3165823|NCT01901848|3893397|FG001|STARTED|Removed From Analyses||19
3165824|NCT01901848|3893396|FG000|COMPLETED|Removed From Analyses||12
3165825|NCT01901848|3893397|FG001|COMPLETED|Removed From Analyses||19
3165826|NCT01901848|3893396|FG000|NOT COMPLETED|Removed From Analyses||10
3165827|NCT01901848|3893397|FG001|NOT COMPLETED|Removed From Analyses||0
3165828|NCT01901874|3893403|FG000|STARTED|Procedure||312
3165829|NCT01901874|3893403|FG000|COMPLETED|Procedure||312
3165830|NCT01901874|3893403|FG000|NOT COMPLETED|Procedure||0
3165831|NCT01901874|3893403|FG000|STARTED|Screening Committee Retrospective Review||312
3165832|NCT01901874|3893403|FG000|COMPLETED|Screening Committee Retrospective Review||265
3165833|NCT01901874|3893403|FG000|NOT COMPLETED|Screening Committee Retrospective Review||47
3165834|NCT01901874|3893403|FG000|STARTED|30-Day MAE Evaluation||265
3165835|NCT01901874|3893403|FG000|COMPLETED|30-Day MAE Evaluation||264
3165836|NCT01901874|3893403|FG000|NOT COMPLETED|30-Day MAE Evaluation||1
3165837|NCT01901874|3893403|FG000|STARTED|1-Year (365-Day) MAE Evaluation||264
3165838|NCT01901874|3893403|FG000|COMPLETED|1-Year (365-Day) MAE Evaluation||244
3165839|NCT01901874|3893403|FG000|NOT COMPLETED|1-Year (365-Day) MAE Evaluation||20
3024647|NCT01080261|3742990|FG000|STARTED|Overall Study||60
3024648|NCT01080261|3742990|FG000|COMPLETED|Overall Study||60
3024649|NCT01080261|3742990|FG000|NOT COMPLETED|Overall Study||0
3024650|NCT01080300|3742996|FG000|STARTED|Overall Study|302 subjects were randomized, but only 300 received study treatment.|300
3024651|NCT01080300|3742997|FG001|STARTED|Overall Study|298 subjects were randomized, but only 295 received study treatment.|295
3024652|NCT01080300|3742996|FG000|COMPLETED|Overall Study||206
3024653|NCT01080300|3742997|FG001|COMPLETED|Overall Study||191
3024654|NCT01080300|3742996|FG000|NOT COMPLETED|Overall Study||94
3024655|NCT01080300|3742997|FG001|NOT COMPLETED|Overall Study||104
3024656|NCT01080326|3743005|FG000|STARTED|Overall Study||7
3024657|NCT01080326|3743005|FG000|COMPLETED|Overall Study||3
3024658|NCT01080326|3743005|FG000|NOT COMPLETED|Overall Study||4
3024659|NCT01080391|3743011|FG000|STARTED|Overall Study||396
3024660|NCT01080391|3743012|FG001|STARTED|Overall Study||396
3024661|NCT01080391|3743011|FG000|Treated|Overall Study||389
3024662|NCT01080391|3743012|FG001|Treated|Overall Study||392
3024663|NCT01080391|3743011|FG000|COMPLETED|Overall Study||389
3024664|NCT01080391|3743012|FG001|COMPLETED|Overall Study||392
3024665|NCT01080391|3743011|FG000|NOT COMPLETED|Overall Study||7
3024666|NCT01080391|3743012|FG001|NOT COMPLETED|Overall Study||4
3024667|NCT01080625|3743021|FG000|STARTED|Overall Study||31
3024668|NCT01080625|3743022|FG001|STARTED|Overall Study||33
3024669|NCT01080625|3743023|FG002|STARTED|Overall Study||32
3024670|NCT01080625|3743021|FG000|COMPLETED|Overall Study||31
3024671|NCT01080625|3743022|FG001|COMPLETED|Overall Study||31
3024672|NCT01080625|3743023|FG002|COMPLETED|Overall Study||31
3024673|NCT01080625|3743021|FG000|NOT COMPLETED|Overall Study||0
3024674|NCT01080625|3743022|FG001|NOT COMPLETED|Overall Study||2
3024675|NCT01080625|3743023|FG002|NOT COMPLETED|Overall Study||1
3024676|NCT01080677|3743034|FG000|STARTED|Overall Study||20
3024677|NCT01080677|3743035|FG001|STARTED|Overall Study||20
3024678|NCT01080677|3743036|FG002|STARTED|Overall Study||20
3024679|NCT01080677|3743034|FG000|COMPLETED|Overall Study||20
3024680|NCT01080677|3743035|FG001|COMPLETED|Overall Study||20
3024681|NCT01080677|3743036|FG002|COMPLETED|Overall Study||20
3024682|NCT01080677|3743034|FG000|NOT COMPLETED|Overall Study||0
3024683|NCT01080677|3743035|FG001|NOT COMPLETED|Overall Study||0
3024684|NCT01080677|3743036|FG002|NOT COMPLETED|Overall Study||0
3024685|NCT01080716|3743048|FG000|STARTED|Part 1||14
3024686|NCT01080716|3743049|FG001|STARTED|Part 1||6
3024687|NCT01080716|3743050|FG002|STARTED|Part 1||0
3024688|NCT01080716|3743051|FG003|STARTED|Part 1||0
3024689|NCT01080716|3743048|FG000|COMPLETED|Part 1||13
3024690|NCT01080716|3743049|FG001|COMPLETED|Part 1||6
3024691|NCT01080716|3743050|FG002|COMPLETED|Part 1||0
3024692|NCT01080716|3743051|FG003|COMPLETED|Part 1||0
3024693|NCT01080716|3743048|FG000|NOT COMPLETED|Part 1||1
3024694|NCT01080716|3743049|FG001|NOT COMPLETED|Part 1||0
3024695|NCT01080716|3743050|FG002|NOT COMPLETED|Part 1||0
3024696|NCT01080716|3743051|FG003|NOT COMPLETED|Part 1||0
3024697|NCT01080716|3743048|FG000|STARTED|Part 2||0
3024698|NCT01080716|3743049|FG001|STARTED|Part 2||0
3165840|NCT01902004|3893409|FG000|STARTED|Overall Study||48
3024699|NCT01080716|3743050|FG002|STARTED|Part 2||10
3024700|NCT01080716|3743051|FG003|STARTED|Part 2||10
3024701|NCT01080716|3743048|FG000|COMPLETED|Part 2||0
3024702|NCT01080716|3743049|FG001|COMPLETED|Part 2||0
3024703|NCT01080716|3743050|FG002|COMPLETED|Part 2||10
3024704|NCT01080716|3743051|FG003|COMPLETED|Part 2||10
3024705|NCT01080716|3743048|FG000|NOT COMPLETED|Part 2||0
3024706|NCT01080716|3743049|FG001|NOT COMPLETED|Part 2||0
3024707|NCT01080716|3743050|FG002|NOT COMPLETED|Part 2||0
3024708|NCT01080716|3743051|FG003|NOT COMPLETED|Part 2||0
3024709|NCT01080794|3743069|FG000|STARTED|Overall Study||20
3024710|NCT01080794|3743070|FG001|STARTED|Overall Study||14
3024711|NCT01080794|3743071|FG002|STARTED|Overall Study||12
3024712|NCT01080794|3743072|FG003|STARTED|Overall Study||15
3024713|NCT01080794|3743069|FG000|COMPLETED|Overall Study||15
3024714|NCT01080794|3743070|FG001|COMPLETED|Overall Study||12
3024715|NCT01080794|3743071|FG002|COMPLETED|Overall Study||10
3024716|NCT01080794|3743072|FG003|COMPLETED|Overall Study||13
3024717|NCT01080794|3743069|FG000|NOT COMPLETED|Overall Study||5
3024718|NCT01080794|3743070|FG001|NOT COMPLETED|Overall Study||2
3024719|NCT01080794|3743071|FG002|NOT COMPLETED|Overall Study||2
3024720|NCT01080794|3743072|FG003|NOT COMPLETED|Overall Study||2
3024721|NCT01080807|3743084|FG000|STARTED|Overall Study|Nine patients randomly assigned to the armodafinil treatment group did not receive study drug.|193
3024722|NCT01080807|3743085|FG001|STARTED|Overall Study|Three patients randomly assigned to the placebo treatment group did not receive study drug.|190
3024723|NCT01080807|3743084|FG000|COMPLETED|Overall Study||158
3024724|NCT01080807|3743085|FG001|COMPLETED|Overall Study||167
3024725|NCT01080807|3743084|FG000|NOT COMPLETED|Overall Study||35
3024726|NCT01080807|3743085|FG001|NOT COMPLETED|Overall Study||23
3024727|NCT01080976|3743093|FG000|STARTED|Overall Study||5
3024728|NCT01080976|3743094|FG001|STARTED|Overall Study||5
3024729|NCT01080976|3743093|FG000|COMPLETED|Overall Study||5
3024730|NCT01080976|3743094|FG001|COMPLETED|Overall Study||5
3024731|NCT01080976|3743093|FG000|NOT COMPLETED|Overall Study||0
3024732|NCT01080976|3743094|FG001|NOT COMPLETED|Overall Study||0
3024733|NCT01081041|3743103|FG000|STARTED|Overall Study||33
3024734|NCT01081041|3743104|FG001|STARTED|Overall Study||81
3024735|NCT01081041|3743105|FG002|STARTED|Overall Study||73
3024736|NCT01081041|3743103|FG000|Received at Least 1 Dose of Study Drug|Overall Study||33
3024737|NCT01081041|3743104|FG001|Received at Least 1 Dose of Study Drug|Overall Study||77
3024738|NCT01081041|3743105|FG002|Received at Least 1 Dose of Study Drug|Overall Study||71
3024739|NCT01081041|3743103|FG000|COMPLETED|Overall Study||33
3024740|NCT01081041|3743104|FG001|COMPLETED|Overall Study||77
3024741|NCT01081041|3743105|FG002|COMPLETED|Overall Study||71
3024742|NCT01081041|3743103|FG000|NOT COMPLETED|Overall Study||0
3024743|NCT01081041|3743104|FG001|NOT COMPLETED|Overall Study||4
3024744|NCT01081041|3743105|FG002|NOT COMPLETED|Overall Study||2
3024745|NCT01081132|3743120|FG000|STARTED|Overall Study||157
3024746|NCT01081132|3743121|FG001|STARTED|Overall Study||157
3024747|NCT01081132|3743120|FG000|COMPLETED|Overall Study||102
3024748|NCT01081132|3743121|FG001|COMPLETED|Overall Study||105
3024749|NCT01081132|3743120|FG000|NOT COMPLETED|Overall Study||55
3024750|NCT01081132|3743121|FG001|NOT COMPLETED|Overall Study||52
3024751|NCT01081145|3743127|FG000|STARTED|Open-Label Phase||528
3024752|NCT01081145|3743128|FG001|STARTED|Open-Label Phase||0
3024753|NCT01081145|3743127|FG000|COMPLETED|Open-Label Phase||316
3024754|NCT01081145|3743128|FG001|COMPLETED|Open-Label Phase||0
3024755|NCT01081145|3743127|FG000|NOT COMPLETED|Open-Label Phase||212
3024756|NCT01081145|3743128|FG001|NOT COMPLETED|Open-Label Phase||0
3024757|NCT01081145|3743127|FG000|STARTED|Double-Blind Randomized-Withdrawal Phase||157
3024758|NCT01081145|3743128|FG001|STARTED|Double-Blind Randomized-Withdrawal Phase||159
3024759|NCT01081145|3743127|FG000|COMPLETED|Double-Blind Randomized-Withdrawal Phase||76
3024760|NCT01081145|3743128|FG001|COMPLETED|Double-Blind Randomized-Withdrawal Phase||53
3024761|NCT01081145|3743127|FG000|NOT COMPLETED|Double-Blind Randomized-Withdrawal Phase||81
3024762|NCT01081145|3743128|FG001|NOT COMPLETED|Double-Blind Randomized-Withdrawal Phase||106
3024763|NCT01081249|3743136|FG000|STARTED|Overall Study||11
3024764|NCT01081249|3743137|FG001|STARTED|Overall Study||7
3024765|NCT01081249|3743136|FG000|First Psychotherapy Appointment (1 Day)|Overall Study||11
3024766|NCT01081249|3743137|FG001|First Psychotherapy Appointment (1 Day)|Overall Study||6
3024767|NCT01081249|3743136|FG000|Washout (5-10 Days)|Overall Study||11
3024768|NCT01081249|3743137|FG001|Washout (5-10 Days)|Overall Study||6
3024769|NCT01081249|3743136|FG000|Second Psychotherapy Appointment (1 Day)|Overall Study||11
3024770|NCT01081249|3743137|FG001|Second Psychotherapy Appointment (1 Day)|Overall Study||6
3024771|NCT01081249|3743136|FG000|COMPLETED|Overall Study||11
3024772|NCT01081249|3743137|FG001|COMPLETED|Overall Study||6
3024773|NCT01081249|3743136|FG000|NOT COMPLETED|Overall Study||0
3024774|NCT01081249|3743137|FG001|NOT COMPLETED|Overall Study||1
3024775|NCT01081301|3743143|FG000|STARTED|Overall Study||36
3024776|NCT01081301|3743143|FG000|COMPLETED|Overall Study||22
3024777|NCT01081301|3743143|FG000|NOT COMPLETED|Overall Study||14
3024778|NCT01081626|3743166|FG000|STARTED|Overall Study||155
3024779|NCT01081626|3743167|FG001|STARTED|Overall Study||155
3024780|NCT01081626|3743166|FG000|Assessed for Efficacy|Overall Study||122
3024781|NCT01081626|3743167|FG001|Assessed for Efficacy|Overall Study||125
3024782|NCT01081626|3743166|FG000|COMPLETED|Overall Study||95
3024783|NCT01081626|3743167|FG001|COMPLETED|Overall Study||94
3024784|NCT01081626|3743166|FG000|NOT COMPLETED|Overall Study||60
3024785|NCT01081626|3743167|FG001|NOT COMPLETED|Overall Study||61
3024786|NCT01081665|3743173|FG000|STARTED|Overall Study||237
3024787|NCT01081665|3743173|FG000|Full Analysis Set|Overall Study||237
3024788|NCT01081665|3743173|FG000|Evaluable Population|Overall Study|Participants with baseline and at least 2 post-baseline parathormone measurements at 24 months.|212
3024789|NCT01081665|3743173|FG000|COMPLETED|Overall Study||142
3024790|NCT01081665|3743173|FG000|NOT COMPLETED|Overall Study||95
3024791|NCT01081678|3743181|FG000|STARTED|Overall Study||89
3024792|NCT01081678|3743182|FG001|STARTED|Overall Study||60
3024793|NCT01081678|3743183|FG002|STARTED|Overall Study||93
3024794|NCT01081678|3743184|FG003|STARTED|Overall Study||90
3024795|NCT01081678|3743181|FG000|Received Study Drug|Overall Study||87
3024796|NCT01081678|3743182|FG001|Received Study Drug|Overall Study||60
3024797|NCT01081678|3743183|FG002|Received Study Drug|Overall Study||89
3024798|NCT01081678|3743184|FG003|Received Study Drug|Overall Study||89
3024799|NCT01081678|3743181|FG000|Completed 24 Weeks of Study|Overall Study||73
3024800|NCT01081678|3743182|FG001|Completed 24 Weeks of Study|Overall Study||50
3024801|NCT01081678|3743183|FG002|Completed 24 Weeks of Study|Overall Study||72
3024802|NCT01081678|3743184|FG003|Completed 24 Weeks of Study|Overall Study||68
3024803|NCT01081678|3743181|FG000|COMPLETED|Overall Study||62
3024804|NCT01081678|3743182|FG001|COMPLETED|Overall Study||44
3024805|NCT01081678|3743183|FG002|COMPLETED|Overall Study||62
3024806|NCT01081678|3743184|FG003|COMPLETED|Overall Study||61
3024807|NCT01081678|3743181|FG000|NOT COMPLETED|Overall Study||27
3024808|NCT01081678|3743182|FG001|NOT COMPLETED|Overall Study||16
3024809|NCT01081678|3743183|FG002|NOT COMPLETED|Overall Study||31
3308505|NCT03020745|4041793|FG000|COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
3308506|NCT03020745|4041794|FG001|COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
3024810|NCT01081678|3743184|FG003|NOT COMPLETED|Overall Study||29
3024811|NCT01081769|3743196|FG000|STARTED|Whole Intent-to-Treat||376
3024812|NCT01081769|3743197|FG001|STARTED|Whole Intent-to-Treat||388
3024813|NCT01081769|3743196|FG000|COMPLETED|Whole Intent-to-Treat||352
3024814|NCT01081769|3743197|FG001|COMPLETED|Whole Intent-to-Treat||363
3024815|NCT01081769|3743196|FG000|NOT COMPLETED|Whole Intent-to-Treat||24
3024816|NCT01081769|3743197|FG001|NOT COMPLETED|Whole Intent-to-Treat||25
3024817|NCT01081769|3743196|FG000|STARTED|CORE Intent-To-Treat||352
3024818|NCT01081769|3743197|FG001|STARTED|CORE Intent-To-Treat||363
3024819|NCT01081769|3743196|FG000|COMPLETED|CORE Intent-To-Treat||272
3024820|NCT01081769|3743197|FG001|COMPLETED|CORE Intent-To-Treat||266
3024821|NCT01081769|3743196|FG000|NOT COMPLETED|CORE Intent-To-Treat||80
3024822|NCT01081769|3743197|FG001|NOT COMPLETED|CORE Intent-To-Treat||97
3024823|NCT01081795|3743206|FG000|STARTED|Overall Study||130
3024824|NCT01081795|3743207|FG001|STARTED|Overall Study||130
3024825|NCT01081795|3743208|FG002|STARTED|Overall Study||127
3024826|NCT01081795|3743206|FG000|COMPLETED|Overall Study||97
3024827|NCT01081795|3743207|FG001|COMPLETED|Overall Study||95
3024828|NCT01081795|3743208|FG002|COMPLETED|Overall Study||97
3024829|NCT01081795|3743206|FG000|NOT COMPLETED|Overall Study||33
3024830|NCT01081795|3743207|FG001|NOT COMPLETED|Overall Study||35
3024831|NCT01081795|3743208|FG002|NOT COMPLETED|Overall Study||30
3024832|NCT01081834|3743221|FG000|STARTED|Core Period: Baseline to Week 26||192
3024833|NCT01081834|3743222|FG001|STARTED|Core Period: Baseline to Week 26||195
3024834|NCT01081834|3743223|FG002|STARTED|Core Period: Baseline to Week 26||197
3024835|NCT01081834|3743224|FG003|STARTED|Core Period: Baseline to Week 26||47
3024836|NCT01081834|3743225|FG004|STARTED|Core Period: Baseline to Week 26||44
3024837|NCT01081834|3743221|FG000|COMPLETED|Core Period: Baseline to Week 26||160
3024838|NCT01081834|3743222|FG001|COMPLETED|Core Period: Baseline to Week 26||172
3024839|NCT01081834|3743223|FG002|COMPLETED|Core Period: Baseline to Week 26||175
3024840|NCT01081834|3743224|FG003|COMPLETED|Core Period: Baseline to Week 26||40
3024841|NCT01081834|3743225|FG004|COMPLETED|Core Period: Baseline to Week 26||40
3024842|NCT01081834|3743221|FG000|NOT COMPLETED|Core Period: Baseline to Week 26||32
3024843|NCT01081834|3743222|FG001|NOT COMPLETED|Core Period: Baseline to Week 26||23
3024844|NCT01081834|3743223|FG002|NOT COMPLETED|Core Period: Baseline to Week 26||22
3024845|NCT01081834|3743224|FG003|NOT COMPLETED|Core Period: Baseline to Week 26||7
3024846|NCT01081834|3743225|FG004|NOT COMPLETED|Core Period: Baseline to Week 26||4
3024847|NCT01081834|3743221|FG000|STARTED|Extension Period: Week 26 to Week 52|5 pts discontinued on last day of core: lack of efficacy on rescue (2), not specified (NS) (3).|155
3024848|NCT01081834|3743222|FG001|STARTED|Extension Period: Week 26 to Week 52|2 pts discontinued on last day of core: adverse event (AE) (1), protocol violation (PV) (1).|170
3024849|NCT01081834|3743223|FG002|STARTED|Extension Period: Week 26 to Week 52|5 pts discontinued last day of core: AE (1), lost f/u (1), PV (1), NS (1), physician decision (1).|170
3024850|NCT01081834|3743224|FG003|STARTED|Extension Period: Week 26 to Week 52|The treatment duration for the High Glycemic Substudy was 26 weeks only.|0
3024851|NCT01081834|3743225|FG004|STARTED|Extension Period: Week 26 to Week 52|The treatment duration for the High Glycemic Substudy was 26 weeks only.|0
3024852|NCT01081834|3743221|FG000|COMPLETED|Extension Period: Week 26 to Week 52||135
3024853|NCT01081834|3743222|FG001|COMPLETED|Extension Period: Week 26 to Week 52||152
3024854|NCT01081834|3743223|FG002|COMPLETED|Extension Period: Week 26 to Week 52||165
3024855|NCT01081834|3743224|FG003|COMPLETED|Extension Period: Week 26 to Week 52||0
3024856|NCT01081834|3743225|FG004|COMPLETED|Extension Period: Week 26 to Week 52||0
3024857|NCT01081834|3743221|FG000|NOT COMPLETED|Extension Period: Week 26 to Week 52||20
3024858|NCT01081834|3743222|FG001|NOT COMPLETED|Extension Period: Week 26 to Week 52||18
3024859|NCT01081834|3743223|FG002|NOT COMPLETED|Extension Period: Week 26 to Week 52||5
3024860|NCT01081834|3743224|FG003|NOT COMPLETED|Extension Period: Week 26 to Week 52||0
3024861|NCT01081834|3743225|FG004|NOT COMPLETED|Extension Period: Week 26 to Week 52||0
3024862|NCT01081873|3743244|FG000|STARTED|Overall Study|3 patients were excluded from this and all analyses due to no available data from Baseline.|2714
3024863|NCT01081873|3743244|FG000|COMPLETED|Overall Study||2416
3024864|NCT01081873|3743244|FG000|NOT COMPLETED|Overall Study||298
3024865|NCT01081912|3743273|FG000|STARTED|Conversion/Titration||510
3024866|NCT01081912|3743274|FG001|STARTED|Conversion/Titration||0
3024867|NCT01081912|3743275|FG002|STARTED|Conversion/Titration||0
3024868|NCT01081912|3743273|FG000|COMPLETED|Conversion/Titration||302
3024869|NCT01081912|3743274|FG001|COMPLETED|Conversion/Titration||0
3024870|NCT01081912|3743275|FG002|COMPLETED|Conversion/Titration||0
3024871|NCT01081912|3743273|FG000|NOT COMPLETED|Conversion/Titration||208
3024872|NCT01081912|3743274|FG001|NOT COMPLETED|Conversion/Titration||0
3024873|NCT01081912|3743275|FG002|NOT COMPLETED|Conversion/Titration||0
3024874|NCT01081912|3743273|FG000|STARTED|Maintenance Treatment||0
3024875|NCT01081912|3743274|FG001|STARTED|Maintenance Treatment||151
3024876|NCT01081912|3743275|FG002|STARTED|Maintenance Treatment||151
3024877|NCT01081912|3743273|FG000|COMPLETED|Maintenance Treatment||0
3024878|NCT01081912|3743274|FG001|COMPLETED|Maintenance Treatment||124
3024879|NCT01081912|3743275|FG002|COMPLETED|Maintenance Treatment||59
3024880|NCT01081912|3743273|FG000|NOT COMPLETED|Maintenance Treatment||0
3024881|NCT01081912|3743274|FG001|NOT COMPLETED|Maintenance Treatment||27
3024882|NCT01081912|3743275|FG002|NOT COMPLETED|Maintenance Treatment||92
3024883|NCT01081951|3743284|FG000|STARTED|Overall Study||81
3024884|NCT01081951|3743285|FG001|STARTED|Overall Study||81
3024885|NCT01081951|3743284|FG000|Received Study Treatment|Overall Study||81
3024886|NCT01081951|3743285|FG001|Received Study Treatment|Overall Study||75
3024887|NCT01081951|3743284|FG000|Entered Maintenance Phase|Overall Study||66
3024888|NCT01081951|3743285|FG001|Entered Maintenance Phase|Overall Study||55
3024889|NCT01081951|3743284|FG000|Ongoing Study Treatment at Data Cut-off|Overall Study||11
3024890|NCT01081951|3743285|FG001|Ongoing Study Treatment at Data Cut-off|Overall Study||0
3024891|NCT01081951|3743284|FG000|COMPLETED|Overall Study|Completed is ongoing study at DCO (Data cut-off),either on-treatment or in survival follow-up|25
3024892|NCT01081951|3743285|FG001|COMPLETED|Overall Study|Completed is ongoing study at DCO (Data cut-off), either on-treatment or in survival follow-up|26
3024893|NCT01081951|3743284|FG000|NOT COMPLETED|Overall Study||56
3024894|NCT01081951|3743285|FG001|NOT COMPLETED|Overall Study||55
3024895|NCT01082081|3743294|FG000|STARTED|Overall Study||121
3024896|NCT01082081|3743295|FG001|STARTED|Overall Study||119
3024897|NCT01082081|3743296|FG002|STARTED|Overall Study||60
3024898|NCT01082081|3743294|FG000|COMPLETED|Overall Study||121
3024899|NCT01082081|3743295|FG001|COMPLETED|Overall Study||118
3024900|NCT01082081|3743296|FG002|COMPLETED|Overall Study||58
3024901|NCT01082081|3743294|FG000|NOT COMPLETED|Overall Study||0
3024902|NCT01082081|3743295|FG001|NOT COMPLETED|Overall Study||1
3024903|NCT01082081|3743296|FG002|NOT COMPLETED|Overall Study||2
3024904|NCT01082159|3743304|FG000|STARTED|Overall Study||55
3024905|NCT01082159|3743304|FG000|COMPLETED|Overall Study||46
3024906|NCT01082159|3743304|FG000|NOT COMPLETED|Overall Study||9
3024907|NCT01082211|3743309|FG000|STARTED|Overall Study||65
3024908|NCT01082211|3743309|FG000|Has Baseline PT QOL Data|Overall Study||46
3024909|NCT01082211|3743309|FG000|Has Baseline MD QOL Data|Overall Study||44
3024910|NCT01082211|3743309|FG000|Has Baseline/12-month PT QOL Data|Overall Study||36
3024911|NCT01082211|3743309|FG000|Has Baseline/12-Month MD QOL Data|Overall Study||35
3024912|NCT01082211|3743309|FG000|Has Baseline/36-month PT QOL Data|Overall Study||32
3024913|NCT01082211|3743309|FG000|Has Baseline/36-Month MD QOL Data|Overall Study||27
3024914|NCT01082211|3743309|FG000|All Eligible Patients|Overall Study||58
3024915|NCT01082211|3743309|FG000|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|58
3024916|NCT01082211|3743309|FG000|NOT COMPLETED|Overall Study||7
3024917|NCT01082328|3743316|FG000|STARTED|Overall Study||59
3024918|NCT01082328|3743316|FG000|COMPLETED|Overall Study||58
3024919|NCT01082328|3743316|FG000|NOT COMPLETED|Overall Study||1
3024920|NCT01082367|3743322|FG000|STARTED|Double-blind Period||26
3024921|NCT01082367|3743323|FG001|STARTED|Double-blind Period||25
3024922|NCT01082367|3743322|FG000|Stage 1:1st Treatment (tx) Cycle|Double-blind Period||26
3024923|NCT01082367|3743323|FG001|Stage 1:1st Treatment (tx) Cycle|Double-blind Period|1 participant discontinued after cycle 1 due to an SAE|25
3024924|NCT01082367|3743322|FG000|Stage 2:no tx|Double-blind Period||0
3024925|NCT01082367|3743323|FG001|Stage 2:no tx|Double-blind Period||0
3024926|NCT01082367|3743322|FG000|Entered OL TOBI|Double-blind Period||4
3024927|NCT01082367|3743323|FG001|Entered OL TOBI|Double-blind Period||18
3024928|NCT01082367|3743322|FG000|P.A-free,Day 29 w/ no Cross-over|Double-blind Period||9
3024929|NCT01082367|3743323|FG001|P.A-free,Day 29 w/ no Cross-over|Double-blind Period||0
3024930|NCT01082367|3743322|FG000|Stage 3: Cross-over (co) tx|Double-blind Period||13
3024931|NCT01082367|3743323|FG001|Stage 3: Cross-over (co) tx|Double-blind Period||6
3024932|NCT01082367|3743322|FG000|Stage 4:no tx for Patients Not in co|Double-blind Period||0
3024933|NCT01082367|3743323|FG001|Stage 4:no tx for Patients Not in co|Double-blind Period||0
3024934|NCT01082367|3743322|FG000|COMPLETED|Double-blind Period||21
3024935|NCT01082367|3743323|FG001|COMPLETED|Double-blind Period||12
3024936|NCT01082367|3743322|FG000|NOT COMPLETED|Double-blind Period||5
3024937|NCT01082367|3743323|FG001|NOT COMPLETED|Double-blind Period||13
3024938|NCT01082367|3743322|FG000|STARTED|Follow-up (F-U) Period||19
3024939|NCT01082367|3743323|FG001|STARTED|Follow-up (F-U) Period||10
3024940|NCT01082367|3743322|FG000|Treated in F-U|Follow-up (F-U) Period||5
3024941|NCT01082367|3743323|FG001|Treated in F-U|Follow-up (F-U) Period||5
3024942|NCT01082367|3743322|FG000|COMPLETED|Follow-up (F-U) Period||17
3024943|NCT01082367|3743323|FG001|COMPLETED|Follow-up (F-U) Period||9
3024944|NCT01082367|3743322|FG000|NOT COMPLETED|Follow-up (F-U) Period||2
3024945|NCT01082367|3743323|FG001|NOT COMPLETED|Follow-up (F-U) Period||1
3024946|NCT01082380|3743333|FG000|STARTED|Overall Study||6
3024947|NCT01082380|3743333|FG000|COMPLETED|Overall Study||6
3024948|NCT01082380|3743333|FG000|NOT COMPLETED|Overall Study||0
3024949|NCT01082575|3743337|FG000|STARTED|Overall Study||100
3024950|NCT01082575|3743337|FG000|COMPLETED|Overall Study||100
3024951|NCT01082575|3743337|FG000|NOT COMPLETED|Overall Study||0
3024952|NCT01082588|3743343|FG000|STARTED|Overall Study||30
3024953|NCT01082588|3743344|FG001|STARTED|Overall Study||30
3024954|NCT01082588|3743343|FG000|COMPLETED|Overall Study||24
3024955|NCT01082588|3743344|FG001|COMPLETED|Overall Study||25
3024956|NCT01082588|3743343|FG000|NOT COMPLETED|Overall Study||6
3024957|NCT01082588|3743344|FG001|NOT COMPLETED|Overall Study||5
3024958|NCT01082614|3743352|FG000|STARTED|Overall Study||23
3024959|NCT01082614|3743353|FG001|STARTED|Overall Study||23
3024960|NCT01082614|3743352|FG000|COMPLETED|Overall Study||20
3024961|NCT01082614|3743353|FG001|COMPLETED|Overall Study||18
3024962|NCT01082614|3743352|FG000|NOT COMPLETED|Overall Study||3
3024963|NCT01082614|3743353|FG001|NOT COMPLETED|Overall Study||5
3024964|NCT01082640|3743362|FG000|STARTED|Overall Study||32
3024965|NCT01082640|3743363|FG001|STARTED|Overall Study||32
3024966|NCT01082640|3743364|FG002|STARTED|Overall Study||32
3024967|NCT01082640|3743362|FG000|COMPLETED|Overall Study||15
3024968|NCT01082640|3743363|FG001|COMPLETED|Overall Study||17
3024969|NCT01082640|3743364|FG002|COMPLETED|Overall Study||24
3024970|NCT01082640|3743362|FG000|NOT COMPLETED|Overall Study||17
3024971|NCT01082640|3743363|FG001|NOT COMPLETED|Overall Study||15
3024972|NCT01082640|3743364|FG002|NOT COMPLETED|Overall Study||8
3024973|NCT01082874|3743379|FG000|STARTED|Overall Study||2499
3024974|NCT01082874|3743380|FG001|STARTED|Overall Study||2510
3024975|NCT01082874|3743381|FG002|STARTED|Overall Study||2499
3024976|NCT01082874|3743382|FG003|STARTED|Overall Study||2502
3024977|NCT01082874|3743379|FG000|COMPLETED|Overall Study||2488
3024978|NCT01082874|3743380|FG001|COMPLETED|Overall Study||2498
3024979|NCT01082874|3743381|FG002|COMPLETED|Overall Study||2488
3024980|NCT01082874|3743382|FG003|COMPLETED|Overall Study||2489
3024981|NCT01082874|3743379|FG000|NOT COMPLETED|Overall Study||11
3024982|NCT01082874|3743380|FG001|NOT COMPLETED|Overall Study||12
3024983|NCT01082874|3743381|FG002|NOT COMPLETED|Overall Study||11
3024984|NCT01082874|3743382|FG003|NOT COMPLETED|Overall Study||13
3024985|NCT01082939|3743392|FG000|STARTED|Overall Study||80
3024986|NCT01082939|3743392|FG000|COMPLETED|Overall Study||80
3024987|NCT01082939|3743392|FG000|NOT COMPLETED|Overall Study||0
3024988|NCT01082952|3743398|FG000|STARTED|Overall Study||6
3024989|NCT01082952|3743399|FG001|STARTED|Overall Study||6
3024990|NCT01082952|3743398|FG000|COMPLETED|Overall Study||6
3024991|NCT01082952|3743399|FG001|COMPLETED|Overall Study||6
3024992|NCT01082952|3743398|FG000|NOT COMPLETED|Overall Study||0
3024993|NCT01082952|3743399|FG001|NOT COMPLETED|Overall Study||0
3024994|NCT01082965|3743407|FG000|STARTED|Overall Study||10
3024995|NCT01082965|3743408|FG001|STARTED|Overall Study||8
3024996|NCT01082965|3743407|FG000|COMPLETED|Overall Study||9
3024997|NCT01082965|3743408|FG001|COMPLETED|Overall Study||6
3024998|NCT01082965|3743407|FG000|NOT COMPLETED|Overall Study||1
3024999|NCT01082965|3743408|FG001|NOT COMPLETED|Overall Study||2
3025000|NCT01083121|3743414|FG000|STARTED|Overall Study|Participants who were enrolled in the study|1779
3025001|NCT01083121|3743414|FG000|COMPLETED|Overall Study|Participants included in the analysis|1698
3025002|NCT01083121|3743414|FG000|NOT COMPLETED|Overall Study||81
3025003|NCT01083160|3743422|FG000|STARTED|Overall Study||82
3025004|NCT01083160|3743422|FG000|Evaluable Population|Overall Study||71
3025005|NCT01083160|3743422|FG000|COMPLETED|Overall Study||81
3025006|NCT01083160|3743422|FG000|NOT COMPLETED|Overall Study||1
3025007|NCT01083173|3743426|FG000|STARTED|Main Surveillance: Safety Group||595
3025008|NCT01083173|3743427|FG001|STARTED|Main Surveillance: Safety Group||0
3025009|NCT01083173|3743426|FG000|COMPLETED|Main Surveillance: Safety Group||580
3025010|NCT01083173|3743427|FG001|COMPLETED|Main Surveillance: Safety Group||0
3025011|NCT01083173|3743426|FG000|NOT COMPLETED|Main Surveillance: Safety Group||15
3025012|NCT01083173|3743427|FG001|NOT COMPLETED|Main Surveillance: Safety Group||0
3025013|NCT01083173|3743426|FG000|STARTED|Main Surveillance: Effectiveness Group||580
3025014|NCT01083173|3743427|FG001|STARTED|Main Surveillance: Effectiveness Group||0
3025015|NCT01083173|3743426|FG000|COMPLETED|Main Surveillance: Effectiveness Group||198
3025016|NCT01083173|3743427|FG001|COMPLETED|Main Surveillance: Effectiveness Group||0
3025017|NCT01083173|3743426|FG000|NOT COMPLETED|Main Surveillance: Effectiveness Group||382
3025018|NCT01083173|3743427|FG001|NOT COMPLETED|Main Surveillance: Effectiveness Group||0
3025019|NCT01083173|3743426|FG000|STARTED|Long-term Surveillance: Safety Group||0
3025020|NCT01083173|3743427|FG001|STARTED|Long-term Surveillance: Safety Group||595
3025021|NCT01083173|3743426|FG000|COMPLETED|Long-term Surveillance: Safety Group||0
3025022|NCT01083173|3743427|FG001|COMPLETED|Long-term Surveillance: Safety Group||479
3025023|NCT01083173|3743426|FG000|NOT COMPLETED|Long-term Surveillance: Safety Group||0
3025024|NCT01083173|3743427|FG001|NOT COMPLETED|Long-term Surveillance: Safety Group||116
3025025|NCT01083173|3743426|FG000|STARTED|Long-term Surveillance: Effectiveness Gr||0
3025026|NCT01083173|3743427|FG001|STARTED|Long-term Surveillance: Effectiveness Gr||479
3025027|NCT01083173|3743426|FG000|COMPLETED|Long-term Surveillance: Effectiveness Gr||0
3025028|NCT01083173|3743427|FG001|COMPLETED|Long-term Surveillance: Effectiveness Gr||102
3025029|NCT01083173|3743426|FG000|NOT COMPLETED|Long-term Surveillance: Effectiveness Gr||0
3025030|NCT01083173|3743427|FG001|NOT COMPLETED|Long-term Surveillance: Effectiveness Gr||377
3025031|NCT01083186|3743436|FG000|STARTED|Overall Study||500
3025032|NCT01083186|3743436|FG000|COMPLETED|Overall Study||406
3025033|NCT01083186|3743436|FG000|NOT COMPLETED|Overall Study||94
3025034|NCT01083199|3743460|FG000|STARTED|Overall Study||10
3025035|NCT01083199|3743460|FG000|COMPLETED|Overall Study||10
3025036|NCT01083199|3743460|FG000|NOT COMPLETED|Overall Study||0
3025037|NCT01083316|3743465|FG000|STARTED|Overall Study||35
3025038|NCT01083316|3743465|FG000|COMPLETED|Overall Study||32
3025039|NCT01083316|3743465|FG000|NOT COMPLETED|Overall Study||3
3025040|NCT01083368|3743472|FG000|STARTED|Dose Escalation Weeks 1-4||0
3025041|NCT01083368|3743473|FG001|STARTED|Dose Escalation Weeks 1-4||0
3025042|NCT01083368|3743474|FG002|STARTED|Dose Escalation Weeks 1-4||4
3025043|NCT01083368|3743475|FG003|STARTED|Dose Escalation Weeks 1-4||0
3025044|NCT01083368|3743472|FG000|Disease Progression|Dose Escalation Weeks 1-4||0
3025045|NCT01083368|3743473|FG001|Disease Progression|Dose Escalation Weeks 1-4||0
3025046|NCT01083368|3743474|FG002|Disease Progression|Dose Escalation Weeks 1-4||1
3025047|NCT01083368|3743475|FG003|Disease Progression|Dose Escalation Weeks 1-4||0
3025048|NCT01083368|3743472|FG000|COMPLETED|Dose Escalation Weeks 1-4||0
3025049|NCT01083368|3743473|FG001|COMPLETED|Dose Escalation Weeks 1-4||0
3025050|NCT01083368|3743474|FG002|COMPLETED|Dose Escalation Weeks 1-4||4
3025051|NCT01083368|3743475|FG003|COMPLETED|Dose Escalation Weeks 1-4||0
3025052|NCT01083368|3743472|FG000|NOT COMPLETED|Dose Escalation Weeks 1-4||0
3025053|NCT01083368|3743473|FG001|NOT COMPLETED|Dose Escalation Weeks 1-4||0
3025054|NCT01083368|3743474|FG002|NOT COMPLETED|Dose Escalation Weeks 1-4||0
3025055|NCT01083368|3743475|FG003|NOT COMPLETED|Dose Escalation Weeks 1-4||0
3025056|NCT01083368|3743472|FG000|STARTED|Dose Escalation Weeks 5-9||0
3025057|NCT01083368|3743473|FG001|STARTED|Dose Escalation Weeks 5-9||0
3025058|NCT01083368|3743474|FG002|STARTED|Dose Escalation Weeks 5-9|Participant on DL1 did not move to dose level 2 because of disease progression.|1
3025059|NCT01083368|3743475|FG003|STARTED|Dose Escalation Weeks 5-9||6
3025060|NCT01083368|3743472|FG000|COMPLETED|Dose Escalation Weeks 5-9||0
3025061|NCT01083368|3743473|FG001|COMPLETED|Dose Escalation Weeks 5-9||0
3025062|NCT01083368|3743474|FG002|COMPLETED|Dose Escalation Weeks 5-9||1
3025063|NCT01083368|3743475|FG003|COMPLETED|Dose Escalation Weeks 5-9|3 participants on dose level 1 moved to dose level 2, 3 more new participants joined.|6
3025064|NCT01083368|3743472|FG000|NOT COMPLETED|Dose Escalation Weeks 5-9||0
3025065|NCT01083368|3743473|FG001|NOT COMPLETED|Dose Escalation Weeks 5-9||0
3025066|NCT01083368|3743474|FG002|NOT COMPLETED|Dose Escalation Weeks 5-9||0
3025067|NCT01083368|3743475|FG003|NOT COMPLETED|Dose Escalation Weeks 5-9||0
3025068|NCT01083368|3743472|FG000|STARTED|Phase II - Efficacy/Safety||0
3025069|NCT01083368|3743473|FG001|STARTED|Phase II - Efficacy/Safety||0
3025070|NCT01083368|3743474|FG002|STARTED|Phase II - Efficacy/Safety||0
3025071|NCT01083368|3743475|FG003|STARTED|Phase II - Efficacy/Safety||20
3025072|NCT01083368|3743472|FG000|COMPLETED|Phase II - Efficacy/Safety||0
3025073|NCT01083368|3743473|FG001|COMPLETED|Phase II - Efficacy/Safety||0
3025074|NCT01083368|3743474|FG002|COMPLETED|Phase II - Efficacy/Safety||0
3025075|NCT01083368|3743475|FG003|COMPLETED|Phase II - Efficacy/Safety|14 plus 6 participants from previous period|20
3025076|NCT01083368|3743472|FG000|NOT COMPLETED|Phase II - Efficacy/Safety||0
3025077|NCT01083368|3743473|FG001|NOT COMPLETED|Phase II - Efficacy/Safety||0
3025078|NCT01083368|3743474|FG002|NOT COMPLETED|Phase II - Efficacy/Safety||0
3025079|NCT01083368|3743475|FG003|NOT COMPLETED|Phase II - Efficacy/Safety||0
3025080|NCT01083485|3743485|FG000|STARTED|Overall Study||70
3025081|NCT01083485|3743486|FG001|STARTED|Overall Study||67
3025082|NCT01083485|3743485|FG000|COMPLETED|Overall Study||63
3025083|NCT01083485|3743486|FG001|COMPLETED|Overall Study||64
3025084|NCT01083485|3743485|FG000|NOT COMPLETED|Overall Study||7
3025085|NCT01083485|3743486|FG001|NOT COMPLETED|Overall Study||3
3025086|NCT01083576|3743496|FG000|STARTED|Overall Study||15
3025087|NCT01083576|3743497|FG001|STARTED|Overall Study||15
3025088|NCT01083576|3743496|FG000|COMPLETED|Overall Study||9
3025089|NCT01083576|3743497|FG001|COMPLETED|Overall Study||14
3025090|NCT01083576|3743496|FG000|NOT COMPLETED|Overall Study||6
3025091|NCT01083576|3743497|FG001|NOT COMPLETED|Overall Study||1
3025092|NCT01083602|3743504|FG000|STARTED|Overall Study||55
3025093|NCT01083602|3743504|FG000|COMPLETED|Overall Study||0
3025094|NCT01083602|3743504|FG000|NOT COMPLETED|Overall Study||55
3025095|NCT01083628|3743510|FG000|STARTED|Overall Study||45
3025096|NCT01083628|3743511|FG001|STARTED|Overall Study||40
3025097|NCT01083628|3743510|FG000|COMPLETED|Overall Study||45
3025098|NCT01083628|3743511|FG001|COMPLETED|Overall Study||40
3025099|NCT01083628|3743510|FG000|NOT COMPLETED|Overall Study||0
3025100|NCT01083628|3743511|FG001|NOT COMPLETED|Overall Study||0
3025101|NCT01083641|3743517|FG000|STARTED|Overall Study||17
3025102|NCT01083641|3743517|FG000|COMPLETED|Overall Study||15
3025103|NCT01083641|3743517|FG000|NOT COMPLETED|Overall Study||2
3025104|NCT01083654|3743523|FG000|STARTED|Overall Study||53
3025105|NCT01083654|3743524|FG001|STARTED|Overall Study||50
3025106|NCT01083654|3743523|FG000|COMPLETED|Overall Study||53
3025107|NCT01083654|3743524|FG001|COMPLETED|Overall Study||50
3025108|NCT01083654|3743523|FG000|NOT COMPLETED|Overall Study||0
3025109|NCT01083654|3743524|FG001|NOT COMPLETED|Overall Study||0
3025110|NCT01083667|3743530|FG000|STARTED|Overall Study|enrolled|32
3025111|NCT01083667|3743530|FG000|COMPLETED|Overall Study|22 completed to visit 9, the last visit on study.|22
3025112|NCT01083667|3743530|FG000|NOT COMPLETED|Overall Study||10
3025113|NCT01083680|3743534|FG000|STARTED|Overall Study||4107
3025114|NCT01083680|3743534|FG000|Full Analysis Set (FAS), Efficacy|Overall Study||1621
3025115|NCT01083680|3743534|FG000|COMPLETED|Overall Study||263
3025116|NCT01083680|3743534|FG000|NOT COMPLETED|Overall Study||3844
3025117|NCT01083693|3743541|FG000|STARTED|Overall Study||93
3025118|NCT01083693|3743542|FG001|STARTED|Overall Study||28
3025119|NCT01083693|3743543|FG002|STARTED|Overall Study||40
3025120|NCT01083693|3743541|FG000|COMPLETED|Overall Study||73
3025121|NCT01083693|3743542|FG001|COMPLETED|Overall Study||22
3025122|NCT01083693|3743543|FG002|COMPLETED|Overall Study||33
3025123|NCT01083693|3743541|FG000|NOT COMPLETED|Overall Study||20
3025124|NCT01083693|3743542|FG001|NOT COMPLETED|Overall Study||6
3025125|NCT01083693|3743543|FG002|NOT COMPLETED|Overall Study||7
3025126|NCT01083706|3743555|FG000|STARTED|Overall Study||39
3025127|NCT01083706|3743555|FG000|COMPLETED|Overall Study||39
3025128|NCT01083706|3743555|FG000|NOT COMPLETED|Overall Study||0
3025129|NCT01083732|3743562|FG000|STARTED|Overall Study||6
3025130|NCT01083732|3743563|FG001|STARTED|Overall Study||9
3025131|NCT01083732|3743564|FG002|STARTED|Overall Study||3
3025132|NCT01083732|3743562|FG000|COMPLETED|Overall Study||6
3025133|NCT01083732|3743563|FG001|COMPLETED|Overall Study||9
3025134|NCT01083732|3743564|FG002|COMPLETED|Overall Study||3
3025135|NCT01083732|3743562|FG000|NOT COMPLETED|Overall Study||0
3025136|NCT01083732|3743563|FG001|NOT COMPLETED|Overall Study||0
3025137|NCT01083732|3743564|FG002|NOT COMPLETED|Overall Study||0
3025138|NCT01083758|3743575|FG000|STARTED|Overall Study||31
3025139|NCT01083758|3743575|FG000|COMPLETED|Overall Study||29
3025140|NCT01083758|3743575|FG000|NOT COMPLETED|Overall Study||2
3025141|NCT01083771|3743579|FG000|STARTED|Overall Study||21
3025142|NCT01083771|3743579|FG000|COMPLETED|Overall Study||16
3025143|NCT01083771|3743579|FG000|NOT COMPLETED|Overall Study||5
3025144|NCT01083810|3743586|FG000|STARTED|Overall Study||137
3165841|NCT01902004|3893410|FG001|STARTED|Overall Study||47
3165842|NCT01902004|3893409|FG000|COMPLETED|Overall Study||33
3165843|NCT01902004|3893410|FG001|COMPLETED|Overall Study||29
3025145|NCT01083810|3743587|FG001|STARTED|Overall Study||92
3025146|NCT01083810|3743588|FG002|STARTED|Overall Study||55
3025147|NCT01083810|3743586|FG000|COMPLETED|Overall Study||72
3025148|NCT01083810|3743587|FG001|COMPLETED|Overall Study||47
3025149|NCT01083810|3743588|FG002|COMPLETED|Overall Study||35
3025150|NCT01083810|3743586|FG000|NOT COMPLETED|Overall Study||65
3025151|NCT01083810|3743587|FG001|NOT COMPLETED|Overall Study||45
3025152|NCT01083810|3743588|FG002|NOT COMPLETED|Overall Study||20
3025153|NCT01083849|3743596|FG000|STARTED|Overall Study||121
3025154|NCT01083849|3743597|FG001|STARTED|Overall Study||638
3025155|NCT01083849|3743596|FG000|COMPLETED|Overall Study||61
3025156|NCT01083849|3743597|FG001|COMPLETED|Overall Study||527
3025157|NCT01083849|3743596|FG000|NOT COMPLETED|Overall Study||60
3025158|NCT01083849|3743597|FG001|NOT COMPLETED|Overall Study||111
3025159|NCT01083901|3743609|FG000|STARTED|Overall Study||13
3025160|NCT01083901|3743610|FG001|STARTED|Overall Study||8
3025161|NCT01083901|3743611|FG002|STARTED|Overall Study||13
3025162|NCT01083901|3743609|FG000|COMPLETED|Overall Study||12
3025163|NCT01083901|3743610|FG001|COMPLETED|Overall Study||6
3025164|NCT01083901|3743611|FG002|COMPLETED|Overall Study||11
3025165|NCT01083901|3743609|FG000|NOT COMPLETED|Overall Study||1
3025166|NCT01083901|3743610|FG001|NOT COMPLETED|Overall Study||2
3025167|NCT01083901|3743611|FG002|NOT COMPLETED|Overall Study||2
3025168|NCT01083979|3743619|FG000|STARTED|Overall Study||1
3025169|NCT01083979|3743619|FG000|COMPLETED|Overall Study||1
3025170|NCT01083979|3743619|FG000|NOT COMPLETED|Overall Study||0
3025171|NCT01084005|3743625|FG000|STARTED|Overall Study||79
3025172|NCT01084005|3743626|FG001|STARTED|Overall Study||162
3025173|NCT01084005|3743625|FG000|COMPLETED|Overall Study||74
3025174|NCT01084005|3743626|FG001|COMPLETED|Overall Study||146
3025175|NCT01084005|3743625|FG000|NOT COMPLETED|Overall Study||5
3025176|NCT01084005|3743626|FG001|NOT COMPLETED|Overall Study||16
3025177|NCT01084083|3743632|FG000|STARTED|Overall Study||90
3025178|NCT01084083|3743632|FG000|Treated|Overall Study|This is the all treated patients for toxicity analysis|89
3025179|NCT01084083|3743632|FG000|Eligible|Overall Study||81
3025180|NCT01084083|3743632|FG000|Eligible and Treated|Overall Study|This is the eligible and treated patients for secondary efficacy endpoints|80
3025181|NCT01084083|3743632|FG000|CR to Induction Therapy|Overall Study||56
3025182|NCT01084083|3743632|FG000|CR and Treated With 5400 cGy IMRT|Overall Study|This is the primary study population for the primary endpoint (24-month PFS).|44
3025183|NCT01084083|3743632|FG000|COMPLETED|Overall Study||78
3025184|NCT01084083|3743632|FG000|NOT COMPLETED|Overall Study||12
3025185|NCT01084135|3743641|FG000|STARTED|12 Week||4
3025186|NCT01084135|3743642|FG001|STARTED|12 Week||4
3025187|NCT01084135|3743641|FG000|COMPLETED|12 Week||4
3025188|NCT01084135|3743642|FG001|COMPLETED|12 Week||4
3025189|NCT01084135|3743641|FG000|NOT COMPLETED|12 Week||0
3025190|NCT01084135|3743642|FG001|NOT COMPLETED|12 Week||0
3025191|NCT01084135|3743641|FG000|STARTED|20 Week||12
3025192|NCT01084135|3743642|FG001|STARTED|20 Week||11
3025193|NCT01084135|3743641|FG000|COMPLETED|20 Week||12
3025194|NCT01084135|3743642|FG001|COMPLETED|20 Week||10
3025195|NCT01084135|3743641|FG000|NOT COMPLETED|20 Week||0
3025196|NCT01084135|3743642|FG001|NOT COMPLETED|20 Week||1
3025197|NCT01084148|3743652|FG000|STARTED|Overall Study||118
3025198|NCT01084148|3743653|FG001|STARTED|Overall Study|Among those 118 patients randomized into V0034 CR 01B vehicle arm, one patient not treated.|118
3025199|NCT01084148|3743652|FG000|Treated Patients|Overall Study||118
3025200|NCT01084148|3743653|FG001|Treated Patients|Overall Study|Patients who received test product at least once|117
3025201|NCT01084148|3743652|FG000|COMPLETED|Overall Study||88
3025202|NCT01084148|3743653|FG001|COMPLETED|Overall Study||102
3025203|NCT01084148|3743652|FG000|NOT COMPLETED|Overall Study||30
3025204|NCT01084148|3743653|FG001|NOT COMPLETED|Overall Study||16
3038054|NCT01151436|3757424|FG000|STARTED|Overall Study||77
3165844|NCT01902004|3893409|FG000|NOT COMPLETED|Overall Study||15
3165845|NCT01902004|3893410|FG001|NOT COMPLETED|Overall Study||18
3165846|NCT01902134|3893422|FG000|STARTED|Overall Study||159
3165847|NCT01902134|3893423|FG001|STARTED|Overall Study||161
3038055|NCT01151436|3757424|FG000|COMPLETED|Overall Study||76
3038056|NCT01151436|3757424|FG000|NOT COMPLETED|Overall Study||1
3038057|NCT01151449|3757428|FG000|STARTED|Overall Study||6
3038058|NCT01151449|3757428|FG000|COMPLETED|Overall Study||6
3038059|NCT01151449|3757428|FG000|NOT COMPLETED|Overall Study||0
3165848|NCT01902134|3893424|FG002|STARTED|Overall Study||160
3025205|NCT01084174|3743663|FG000|STARTED|Overall Study||10
3025206|NCT01084174|3743664|FG001|STARTED|Overall Study||11
3025207|NCT01084174|3743663|FG000|COMPLETED|Overall Study||9
3025208|NCT01084174|3743664|FG001|COMPLETED|Overall Study||7
3025209|NCT01084174|3743663|FG000|NOT COMPLETED|Overall Study||1
3025210|NCT01084174|3743664|FG001|NOT COMPLETED|Overall Study||4
3025211|NCT01084239|3743672|FG000|STARTED|Randomization - Index Hospitalization||501
3025212|NCT01084239|3743673|FG001|STARTED|Randomization - Index Hospitalization||499
3025213|NCT01084239|3743672|FG000|COMPLETED|Randomization - Index Hospitalization||501
3025214|NCT01084239|3743673|FG001|COMPLETED|Randomization - Index Hospitalization||499
3025215|NCT01084239|3743672|FG000|NOT COMPLETED|Randomization - Index Hospitalization||0
3025216|NCT01084239|3743673|FG001|NOT COMPLETED|Randomization - Index Hospitalization||0
3025217|NCT01084239|3743672|FG000|STARTED|28-Day Follow-up|All 501 patients enrolled were evaluated for follow-up at 28 days.|501
3025218|NCT01084239|3743673|FG001|STARTED|28-Day Follow-up||499
3025219|NCT01084239|3743672|FG000|COMPLETED|28-Day Follow-up||497
3025220|NCT01084239|3743673|FG001|COMPLETED|28-Day Follow-up||490
3025221|NCT01084239|3743672|FG000|NOT COMPLETED|28-Day Follow-up||4
3025222|NCT01084239|3743673|FG001|NOT COMPLETED|28-Day Follow-up||9
3025223|NCT01084252|3743695|FG000|STARTED|Phase 1 (120 Weeks)||16
3025224|NCT01084252|3743696|FG001|STARTED|Phase 1 (120 Weeks)||6
3025225|NCT01084252|3743697|FG002|STARTED|Phase 1 (120 Weeks)||3
3308507|NCT03020745|4041795|FG002|COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
3308508|NCT03020745|4041796|FG003|COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
3308509|NCT03020745|4041797|FG004|COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
3308510|NCT03020745|4041798|FG005|COMPLETED|Part 2:Optional FU (Up to 450 Days)||9
3308511|NCT03020745|4041799|FG006|COMPLETED|Part 2:Optional FU (Up to 450 Days)||5
3308512|NCT03020745|4041800|FG007|COMPLETED|Part 2:Optional FU (Up to 450 Days)||17
3308513|NCT03020745|4041801|FG008|COMPLETED|Part 2:Optional FU (Up to 450 Days)||10
3308514|NCT03020745|4041802|FG009|COMPLETED|Part 2:Optional FU (Up to 450 Days)||15
3308515|NCT03020745|4041793|FG000|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
3308516|NCT03020745|4041794|FG001|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
3308517|NCT03020745|4041795|FG002|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
3308518|NCT03020745|4041796|FG003|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
3308519|NCT03020745|4041797|FG004|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
3308520|NCT03020745|4041798|FG005|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||1
3308521|NCT03020745|4041799|FG006|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
3308522|NCT03020745|4041800|FG007|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
3308523|NCT03020745|4041801|FG008|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||3
3308524|NCT03020745|4041802|FG009|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
3308525|NCT03020888|4041826|FG000|STARTED|Overall Study||120
3308526|NCT03020888|4041826|FG000|COMPLETED|Overall Study||107
3308527|NCT03020888|4041826|FG000|NOT COMPLETED|Overall Study||13
3308528|NCT03020966|4041832|FG000|STARTED|Overall Study||77
3308529|NCT03020966|4041833|FG001|STARTED|Overall Study||77
3308530|NCT03020966|4041832|FG000|COMPLETED|Overall Study||75
3308531|NCT03020966|4041833|FG001|COMPLETED|Overall Study||77
3308532|NCT03020966|4041832|FG000|NOT COMPLETED|Overall Study||2
3308533|NCT03020966|4041833|FG001|NOT COMPLETED|Overall Study||0
3308534|NCT03020992|4041839|FG000|STARTED|Overall Study||89
3308535|NCT03020992|4041839|FG000|COMPLETED|Overall Study||83
3308536|NCT03020992|4041839|FG000|NOT COMPLETED|Overall Study||6
3308537|NCT03021005|4041846|FG000|STARTED|Overall Study||102
3308538|NCT03021005|4041847|FG001|STARTED|Overall Study||98
3308539|NCT03021005|4041846|FG000|COMPLETED|Overall Study||63
3308540|NCT03021005|4041847|FG001|COMPLETED|Overall Study||72
3308541|NCT03021005|4041846|FG000|NOT COMPLETED|Overall Study||39
3308542|NCT03021005|4041847|FG001|NOT COMPLETED|Overall Study||26
3308543|NCT03021018|4041856|FG000|STARTED|Overall Study||16
3308544|NCT03021018|4041857|FG001|STARTED|Overall Study||15
3308545|NCT03021018|4041858|FG002|STARTED|Overall Study||15
3308546|NCT03021018|4041856|FG000|COMPLETED|Overall Study||14
3308547|NCT03021018|4041857|FG001|COMPLETED|Overall Study||15
3308548|NCT03021018|4041858|FG002|COMPLETED|Overall Study||15
3308549|NCT03021018|4041856|FG000|NOT COMPLETED|Overall Study||2
3308550|NCT03021018|4041857|FG001|NOT COMPLETED|Overall Study||0
3308551|NCT03021018|4041858|FG002|NOT COMPLETED|Overall Study||0
3308552|NCT03021187|4041870|FG000|STARTED|Overall Study||184
3308553|NCT03021187|4041871|FG001|STARTED|Overall Study||182
3308554|NCT03021187|4041872|FG002|STARTED|Overall Study||181
3308555|NCT03021187|4041873|FG003|STARTED|Overall Study||184
3308556|NCT03021187|4041870|FG000|Exposed|Overall Study||184
3308557|NCT03021187|4041871|FG001|Exposed|Overall Study||181
3308558|NCT03021187|4041872|FG002|Exposed|Overall Study||181
3308559|NCT03021187|4041873|FG003|Exposed|Overall Study||184
3308560|NCT03021187|4041870|FG000|Full Analysis Set (FAS)|Overall Study||184
3308561|NCT03021187|4041871|FG001|Full Analysis Set (FAS)|Overall Study||182
3308562|NCT03021187|4041872|FG002|Full Analysis Set (FAS)|Overall Study||181
3308563|NCT03021187|4041873|FG003|Full Analysis Set (FAS)|Overall Study||184
3308564|NCT03021187|4041870|FG000|Safety Analysis Set (SAS)|Overall Study||184
3308565|NCT03021187|4041871|FG001|Safety Analysis Set (SAS)|Overall Study||181
3308566|NCT03021187|4041872|FG002|Safety Analysis Set (SAS)|Overall Study||181
3308567|NCT03021187|4041873|FG003|Safety Analysis Set (SAS)|Overall Study||184
3308568|NCT03021187|4041870|FG000|COMPLETED|Overall Study||174
3308569|NCT03021187|4041871|FG001|COMPLETED|Overall Study||173
3308570|NCT03021187|4041872|FG002|COMPLETED|Overall Study||175
3025226|NCT01084252|3743698|FG003|STARTED|Phase 1 (120 Weeks)||26
3025227|NCT01084252|3743699|FG004|STARTED|Phase 1 (120 Weeks)||18
3025228|NCT01084252|3743700|FG005|STARTED|Phase 1 (120 Weeks)||6
3025229|NCT01084252|3743701|FG006|STARTED|Phase 1 (120 Weeks)||7
3165849|NCT01902134|3893425|FG003|STARTED|Overall Study||54
3165850|NCT01902134|3893426|FG004|STARTED|Overall Study||53
3165851|NCT01902134|3893427|FG005|STARTED|Overall Study||54
3165852|NCT01902134|3893422|FG000|Single-dose Phase|Overall Study||159
3165853|NCT01902134|3893423|FG001|Single-dose Phase|Overall Study||161
3165854|NCT01902134|3893424|FG002|Single-dose Phase|Overall Study||160
3025230|NCT01084252|3743702|FG007|STARTED|Phase 1 (120 Weeks)||7
3025231|NCT01084252|3743703|FG008|STARTED|Phase 1 (120 Weeks)||0
3025232|NCT01084252|3743704|FG009|STARTED|Phase 1 (120 Weeks)||0
3025233|NCT01084252|3743705|FG010|STARTED|Phase 1 (120 Weeks)||0
3025234|NCT01084252|3743706|FG011|STARTED|Phase 1 (120 Weeks)||0
3025235|NCT01084252|3743707|FG012|STARTED|Phase 1 (120 Weeks)||0
3165855|NCT01902134|3893425|FG003|Single-dose Phase|Overall Study||54
3165856|NCT01902134|3893426|FG004|Single-dose Phase|Overall Study||53
3165857|NCT01902134|3893427|FG005|Single-dose Phase|Overall Study||54
3165858|NCT01902134|3893422|FG000|Multiple-dose Phase|Overall Study||159
3165859|NCT01902134|3893423|FG001|Multiple-dose Phase|Overall Study||160
3165860|NCT01902134|3893424|FG002|Multiple-dose Phase|Overall Study||160
3025236|NCT01084252|3743708|FG013|STARTED|Phase 1 (120 Weeks)||0
3025237|NCT01084252|3743695|FG000|All Treated (AT) Population|Phase 1 (120 Weeks)||16
3025238|NCT01084252|3743696|FG001|All Treated (AT) Population|Phase 1 (120 Weeks)||6
3025239|NCT01084252|3743697|FG002|All Treated (AT) Population|Phase 1 (120 Weeks)||3
3025240|NCT01084252|3743698|FG003|All Treated (AT) Population|Phase 1 (120 Weeks)||26
3025241|NCT01084252|3743699|FG004|All Treated (AT) Population|Phase 1 (120 Weeks)||18
3025242|NCT01084252|3743700|FG005|All Treated (AT) Population|Phase 1 (120 Weeks)||6
3025243|NCT01084252|3743701|FG006|All Treated (AT) Population|Phase 1 (120 Weeks)||7
3025244|NCT01084252|3743702|FG007|All Treated (AT) Population|Phase 1 (120 Weeks)||7
3025245|NCT01084252|3743703|FG008|All Treated (AT) Population|Phase 1 (120 Weeks)||0
3025246|NCT01084252|3743704|FG009|All Treated (AT) Population|Phase 1 (120 Weeks)||0
3025247|NCT01084252|3743705|FG010|All Treated (AT) Population|Phase 1 (120 Weeks)||0
3025248|NCT01084252|3743706|FG011|All Treated (AT) Population|Phase 1 (120 Weeks)||0
3025249|NCT01084252|3743707|FG012|All Treated (AT) Population|Phase 1 (120 Weeks)||0
3025250|NCT01084252|3743708|FG013|All Treated (AT) Population|Phase 1 (120 Weeks)||0
3025251|NCT01084252|3743695|FG000|COMPLETED|Phase 1 (120 Weeks)||0
3025252|NCT01084252|3743696|FG001|COMPLETED|Phase 1 (120 Weeks)||0
3025253|NCT01084252|3743697|FG002|COMPLETED|Phase 1 (120 Weeks)||0
3025254|NCT01084252|3743698|FG003|COMPLETED|Phase 1 (120 Weeks)||0
3025255|NCT01084252|3743699|FG004|COMPLETED|Phase 1 (120 Weeks)||0
3025256|NCT01084252|3743700|FG005|COMPLETED|Phase 1 (120 Weeks)||0
3025257|NCT01084252|3743701|FG006|COMPLETED|Phase 1 (120 Weeks)||0
3025258|NCT01084252|3743702|FG007|COMPLETED|Phase 1 (120 Weeks)||0
3025259|NCT01084252|3743703|FG008|COMPLETED|Phase 1 (120 Weeks)||0
3025260|NCT01084252|3743704|FG009|COMPLETED|Phase 1 (120 Weeks)||0
3025261|NCT01084252|3743705|FG010|COMPLETED|Phase 1 (120 Weeks)||0
3025262|NCT01084252|3743706|FG011|COMPLETED|Phase 1 (120 Weeks)||0
3025263|NCT01084252|3743707|FG012|COMPLETED|Phase 1 (120 Weeks)||0
3025264|NCT01084252|3743708|FG013|COMPLETED|Phase 1 (120 Weeks)||0
3025265|NCT01084252|3743695|FG000|NOT COMPLETED|Phase 1 (120 Weeks)||16
3025266|NCT01084252|3743696|FG001|NOT COMPLETED|Phase 1 (120 Weeks)||6
3025267|NCT01084252|3743697|FG002|NOT COMPLETED|Phase 1 (120 Weeks)||3
3025268|NCT01084252|3743698|FG003|NOT COMPLETED|Phase 1 (120 Weeks)||26
3025269|NCT01084252|3743699|FG004|NOT COMPLETED|Phase 1 (120 Weeks)||18
3025270|NCT01084252|3743700|FG005|NOT COMPLETED|Phase 1 (120 Weeks)||6
3025271|NCT01084252|3743701|FG006|NOT COMPLETED|Phase 1 (120 Weeks)||7
3165861|NCT01902134|3893425|FG003|Multiple-dose Phase|Overall Study||54
3165862|NCT01902134|3893426|FG004|Multiple-dose Phase|Overall Study||53
3165863|NCT01902134|3893427|FG005|Multiple-dose Phase|Overall Study||52
3165864|NCT01902134|3893422|FG000|COMPLETED|Overall Study||151
3025272|NCT01084252|3743702|FG007|NOT COMPLETED|Phase 1 (120 Weeks)||7
3025273|NCT01084252|3743703|FG008|NOT COMPLETED|Phase 1 (120 Weeks)||0
3025274|NCT01084252|3743704|FG009|NOT COMPLETED|Phase 1 (120 Weeks)||0
3025275|NCT01084252|3743705|FG010|NOT COMPLETED|Phase 1 (120 Weeks)||0
3025276|NCT01084252|3743706|FG011|NOT COMPLETED|Phase 1 (120 Weeks)||0
3025277|NCT01084252|3743707|FG012|NOT COMPLETED|Phase 1 (120 Weeks)||0
3025278|NCT01084252|3743708|FG013|NOT COMPLETED|Phase 1 (120 Weeks)||0
3025279|NCT01084252|3743695|FG000|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
3025280|NCT01084252|3743696|FG001|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
3025281|NCT01084252|3743697|FG002|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
3025282|NCT01084252|3743698|FG003|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
3025283|NCT01084252|3743699|FG004|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
3025284|NCT01084252|3743700|FG005|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
3025285|NCT01084252|3743701|FG006|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
3025286|NCT01084252|3743702|FG007|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
3025287|NCT01084252|3743703|FG008|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Phase 1, Phase 2 Stage 1 and Phase 2 Stage 2 were separate populations.|23
3025288|NCT01084252|3743704|FG009|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Phase 1, Phase 2 Stage 1 and Phase 2 Stage 2 were separate populations.|24
3038060|NCT01151540|3757432|FG000|STARTED|Overall Study||54
3165865|NCT01902134|3893423|FG001|COMPLETED|Overall Study||150
3165866|NCT01902134|3893424|FG002|COMPLETED|Overall Study||145
3165867|NCT01902134|3893425|FG003|COMPLETED|Overall Study||52
3025289|NCT01084252|3743705|FG010|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Phase 1, Phase 2 Stage 1 and Phase 2 Stage 2 were separate populations.|25
3025290|NCT01084252|3743706|FG011|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Phase 1, Phase 2 Stage 1 and Phase 2 Stage 2 were separate populations.|25
3025291|NCT01084252|3743707|FG012|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
3025292|NCT01084252|3743708|FG013|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
3025293|NCT01084252|3743695|FG000|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
3025294|NCT01084252|3743696|FG001|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
3025295|NCT01084252|3743697|FG002|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
3025296|NCT01084252|3743698|FG003|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
3025297|NCT01084252|3743699|FG004|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
3025298|NCT01084252|3743700|FG005|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
3025299|NCT01084252|3743701|FG006|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
3025300|NCT01084252|3743702|FG007|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
3025301|NCT01084252|3743703|FG008|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||23
3025302|NCT01084252|3743704|FG009|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||24
3025303|NCT01084252|3743705|FG010|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||25
3025304|NCT01084252|3743706|FG011|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||25
3025305|NCT01084252|3743707|FG012|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
3025306|NCT01084252|3743708|FG013|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
3025307|NCT01084252|3743695|FG000|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
3025308|NCT01084252|3743696|FG001|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
3025309|NCT01084252|3743697|FG002|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
3025310|NCT01084252|3743698|FG003|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
3025311|NCT01084252|3743699|FG004|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
3025312|NCT01084252|3743700|FG005|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
3025313|NCT01084252|3743701|FG006|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
3025314|NCT01084252|3743702|FG007|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
3025315|NCT01084252|3743703|FG008|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
3025316|NCT01084252|3743704|FG009|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
3025317|NCT01084252|3743705|FG010|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
3025318|NCT01084252|3743706|FG011|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
3025319|NCT01084252|3743707|FG012|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
3025320|NCT01084252|3743708|FG013|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
3025321|NCT01084252|3743695|FG000|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
3025322|NCT01084252|3743696|FG001|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
3025323|NCT01084252|3743697|FG002|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
3025324|NCT01084252|3743698|FG003|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
3025325|NCT01084252|3743699|FG004|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
3025326|NCT01084252|3743700|FG005|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
3025327|NCT01084252|3743701|FG006|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
3025328|NCT01084252|3743702|FG007|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
3025329|NCT01084252|3743703|FG008|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||23
3025330|NCT01084252|3743704|FG009|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||24
3025331|NCT01084252|3743705|FG010|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||25
3025332|NCT01084252|3743706|FG011|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||25
3025333|NCT01084252|3743707|FG012|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
3025334|NCT01084252|3743708|FG013|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
3025335|NCT01084252|3743695|FG000|STARTED|Phase 2 Stage 2 (97 Weeks)||0
3025336|NCT01084252|3743696|FG001|STARTED|Phase 2 Stage 2 (97 Weeks)||0
3025337|NCT01084252|3743697|FG002|STARTED|Phase 2 Stage 2 (97 Weeks)||0
3025338|NCT01084252|3743698|FG003|STARTED|Phase 2 Stage 2 (97 Weeks)||0
3025339|NCT01084252|3743699|FG004|STARTED|Phase 2 Stage 2 (97 Weeks)||0
3025340|NCT01084252|3743700|FG005|STARTED|Phase 2 Stage 2 (97 Weeks)||0
3025341|NCT01084252|3743701|FG006|STARTED|Phase 2 Stage 2 (97 Weeks)||0
3025342|NCT01084252|3743702|FG007|STARTED|Phase 2 Stage 2 (97 Weeks)||0
3025343|NCT01084252|3743703|FG008|STARTED|Phase 2 Stage 2 (97 Weeks)||0
3025344|NCT01084252|3743704|FG009|STARTED|Phase 2 Stage 2 (97 Weeks)||0
3025345|NCT01084252|3743705|FG010|STARTED|Phase 2 Stage 2 (97 Weeks)||0
3025346|NCT01084252|3743706|FG011|STARTED|Phase 2 Stage 2 (97 Weeks)||0
3025347|NCT01084252|3743707|FG012|STARTED|Phase 2 Stage 2 (97 Weeks)|Phase 1, Phase 2 Stage 1 and Phase 2 Stage 2 were separate populations.|110
3025348|NCT01084252|3743708|FG013|STARTED|Phase 2 Stage 2 (97 Weeks)|Phase 1, Phase 2 Stage 1 and Phase 2 Stage 2 were separate populations.|55
3025349|NCT01084252|3743695|FG000|AT Population|Phase 2 Stage 2 (97 Weeks)||0
3025350|NCT01084252|3743696|FG001|AT Population|Phase 2 Stage 2 (97 Weeks)||0
3025351|NCT01084252|3743697|FG002|AT Population|Phase 2 Stage 2 (97 Weeks)||0
3025352|NCT01084252|3743698|FG003|AT Population|Phase 2 Stage 2 (97 Weeks)||0
3025353|NCT01084252|3743699|FG004|AT Population|Phase 2 Stage 2 (97 Weeks)||0
3025354|NCT01084252|3743700|FG005|AT Population|Phase 2 Stage 2 (97 Weeks)||0
3025355|NCT01084252|3743701|FG006|AT Population|Phase 2 Stage 2 (97 Weeks)||0
3025356|NCT01084252|3743702|FG007|AT Population|Phase 2 Stage 2 (97 Weeks)||0
3308571|NCT03021187|4041873|FG003|COMPLETED|Overall Study||175
3308572|NCT03021187|4041870|FG000|NOT COMPLETED|Overall Study||10
3308573|NCT03021187|4041871|FG001|NOT COMPLETED|Overall Study||9
3025357|NCT01084252|3743703|FG008|AT Population|Phase 2 Stage 2 (97 Weeks)||0
3025358|NCT01084252|3743704|FG009|AT Population|Phase 2 Stage 2 (97 Weeks)||0
3025359|NCT01084252|3743705|FG010|AT Population|Phase 2 Stage 2 (97 Weeks)||0
3025360|NCT01084252|3743706|FG011|AT Population|Phase 2 Stage 2 (97 Weeks)||0
3025361|NCT01084252|3743707|FG012|AT Population|Phase 2 Stage 2 (97 Weeks)||109
3025362|NCT01084252|3743708|FG013|AT Population|Phase 2 Stage 2 (97 Weeks)||55
3025363|NCT01084252|3743695|FG000|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
3025364|NCT01084252|3743696|FG001|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
3025365|NCT01084252|3743697|FG002|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
3025366|NCT01084252|3743698|FG003|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
3025367|NCT01084252|3743699|FG004|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
3025368|NCT01084252|3743700|FG005|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
3025369|NCT01084252|3743701|FG006|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
3025370|NCT01084252|3743702|FG007|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
3025371|NCT01084252|3743703|FG008|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
3025372|NCT01084252|3743704|FG009|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
3025373|NCT01084252|3743705|FG010|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
3025374|NCT01084252|3743706|FG011|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
3025375|NCT01084252|3743707|FG012|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
3025376|NCT01084252|3743708|FG013|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
3025377|NCT01084252|3743695|FG000|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
3025378|NCT01084252|3743696|FG001|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
3025379|NCT01084252|3743697|FG002|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
3025380|NCT01084252|3743698|FG003|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
3025381|NCT01084252|3743699|FG004|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
3025382|NCT01084252|3743700|FG005|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
3025383|NCT01084252|3743701|FG006|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
3025384|NCT01084252|3743702|FG007|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
3025385|NCT01084252|3743703|FG008|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
3025386|NCT01084252|3743704|FG009|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
3025387|NCT01084252|3743705|FG010|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
3025388|NCT01084252|3743706|FG011|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
3025389|NCT01084252|3743707|FG012|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||110
3025390|NCT01084252|3743708|FG013|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||55
3025391|NCT01084265|3743772|FG000|STARTED|Overall Study||31
3025392|NCT01084265|3743772|FG000|COMPLETED|Overall Study||31
3025393|NCT01084265|3743772|FG000|NOT COMPLETED|Overall Study||0
3025394|NCT01084278|3743781|FG000|STARTED|Overall Study||8
3025395|NCT01084278|3743782|FG001|STARTED|Overall Study||8
3025396|NCT01084278|3743783|FG002|STARTED|Overall Study||8
3025397|NCT01084278|3743784|FG003|STARTED|Overall Study||8
3025398|NCT01084278|3743785|FG004|STARTED|Overall Study||8
3025399|NCT01084278|3743781|FG000|COMPLETED|Overall Study||8
3025400|NCT01084278|3743782|FG001|COMPLETED|Overall Study||8
3025401|NCT01084278|3743783|FG002|COMPLETED|Overall Study||8
3025402|NCT01084278|3743784|FG003|COMPLETED|Overall Study||8
3025403|NCT01084278|3743785|FG004|COMPLETED|Overall Study||8
3025404|NCT01084278|3743781|FG000|NOT COMPLETED|Overall Study||0
3025405|NCT01084278|3743782|FG001|NOT COMPLETED|Overall Study||0
3025406|NCT01084278|3743783|FG002|NOT COMPLETED|Overall Study||0
3025407|NCT01084278|3743784|FG003|NOT COMPLETED|Overall Study||0
3025408|NCT01084278|3743785|FG004|NOT COMPLETED|Overall Study||0
3025409|NCT01084499|3743801|FG000|STARTED|Overall Study|First Intervention (Sequence 1) : Femara (1 Day)|13
3025410|NCT01084499|3743802|FG001|STARTED|Overall Study|First Intervention (Sequence 2) : Peratra (1 Day)|13
3025411|NCT01084499|3743801|FG000|Washout (5 Weeks)|Overall Study||13
3025412|NCT01084499|3743802|FG001|Washout (5 Weeks)|Overall Study||13
3025413|NCT01084499|3743801|FG000|COMPLETED|Overall Study|Second Intervention (Sequence 1) : Peratra (1 Day)|13
3025414|NCT01084499|3743802|FG001|COMPLETED|Overall Study|Second Intervention (Sequence 2) : Femara (1 Day)|13
3025415|NCT01084499|3743801|FG000|NOT COMPLETED|Overall Study||0
3025416|NCT01084499|3743802|FG001|NOT COMPLETED|Overall Study||0
3025417|NCT01084538|3743808|FG000|STARTED|Overall Study||181
3025418|NCT01084538|3743808|FG000|COMPLETED|Overall Study||113
3025419|NCT01084538|3743808|FG000|NOT COMPLETED|Overall Study||68
3025420|NCT01084551|3743815|FG000|STARTED|Overall Study||95
3025421|NCT01084551|3743816|FG001|STARTED|Overall Study||95
3025422|NCT01084551|3743817|FG002|STARTED|Overall Study||94
3025423|NCT01084551|3743815|FG000|COMPLETED|Overall Study||86
3025424|NCT01084551|3743816|FG001|COMPLETED|Overall Study||81
3025425|NCT01084551|3743817|FG002|COMPLETED|Overall Study||86
3025426|NCT01084551|3743815|FG000|NOT COMPLETED|Overall Study||9
3025427|NCT01084551|3743816|FG001|NOT COMPLETED|Overall Study||14
3025428|NCT01084551|3743817|FG002|NOT COMPLETED|Overall Study||8
3025429|NCT01084603|3743825|FG000|STARTED|Baseline||45
3025430|NCT01084603|3743825|FG000|COMPLETED|Baseline||43
3025431|NCT01084603|3743825|FG000|NOT COMPLETED|Baseline||2
3025432|NCT01084603|3743825|FG000|STARTED|NiQuitinTM Lozenge||43
3025433|NCT01084603|3743825|FG000|COMPLETED|NiQuitinTM Lozenge||42
3025434|NCT01084603|3743825|FG000|NOT COMPLETED|NiQuitinTM Lozenge||1
3025435|NCT01084603|3743825|FG000|STARTED|Washout Period 1||42
3025436|NCT01084603|3743825|FG000|COMPLETED|Washout Period 1||42
3025437|NCT01084603|3743825|FG000|NOT COMPLETED|Washout Period 1||0
3025438|NCT01084603|3743825|FG000|STARTED|Nicorette® Gum||42
3025439|NCT01084603|3743825|FG000|COMPLETED|Nicorette® Gum||41
3025440|NCT01084603|3743825|FG000|NOT COMPLETED|Nicorette® Gum||1
3025441|NCT01084603|3743825|FG000|STARTED|Washout Period 2||41
3025442|NCT01084603|3743825|FG000|COMPLETED|Washout Period 2||41
3025443|NCT01084603|3743825|FG000|NOT COMPLETED|Washout Period 2||0
3025444|NCT01084603|3743825|FG000|STARTED|Oral Nicotine 1||41
3025445|NCT01084603|3743825|FG000|COMPLETED|Oral Nicotine 1||40
3025446|NCT01084603|3743825|FG000|NOT COMPLETED|Oral Nicotine 1||1
3025447|NCT01084603|3743825|FG000|STARTED|Washout Period 3||40
3025448|NCT01084603|3743825|FG000|COMPLETED|Washout Period 3||40
3025449|NCT01084603|3743825|FG000|NOT COMPLETED|Washout Period 3||0
3025450|NCT01084603|3743825|FG000|STARTED|Oral Nicotine 2||40
3025451|NCT01084603|3743825|FG000|COMPLETED|Oral Nicotine 2||40
3025452|NCT01084603|3743825|FG000|NOT COMPLETED|Oral Nicotine 2||0
3025453|NCT01084603|3743825|FG000|STARTED|Washout Period 4||40
3025454|NCT01084603|3743825|FG000|COMPLETED|Washout Period 4||39
3025455|NCT01084603|3743825|FG000|NOT COMPLETED|Washout Period 4||1
3025456|NCT01084603|3743825|FG000|STARTED|Oral Nicotine 4||39
3025457|NCT01084603|3743825|FG000|COMPLETED|Oral Nicotine 4||39
3025458|NCT01084603|3743825|FG000|NOT COMPLETED|Oral Nicotine 4||0
3025459|NCT01084655|3743841|FG000|STARTED|Overall Study||6
3025460|NCT01084655|3743842|FG001|STARTED|Overall Study||8
3025461|NCT01084655|3743843|FG002|STARTED|Overall Study||24
3025462|NCT01084655|3743841|FG000|Treated|Overall Study||6
3025463|NCT01084655|3743842|FG001|Treated|Overall Study||8
3025464|NCT01084655|3743843|FG002|Treated|Overall Study||23
3025465|NCT01084655|3743841|FG000|COMPLETED|Overall Study||0
3025466|NCT01084655|3743842|FG001|COMPLETED|Overall Study||2
3025467|NCT01084655|3743843|FG002|COMPLETED|Overall Study||5
3025468|NCT01084655|3743841|FG000|NOT COMPLETED|Overall Study||6
3025469|NCT01084655|3743842|FG001|NOT COMPLETED|Overall Study||6
3025470|NCT01084655|3743843|FG002|NOT COMPLETED|Overall Study||19
3025471|NCT01084668|3743855|FG000|STARTED|Overall Study|Three participants who took Humira prior to study entry have been excluded from the database.|42
3025472|NCT01084668|3743855|FG000|COMPLETED|Overall Study||33
3025473|NCT01084668|3743855|FG000|NOT COMPLETED|Overall Study||9
3025474|NCT01084694|3743863|FG000|STARTED|Overall Study||50
3025475|NCT01084694|3743864|FG001|STARTED|Overall Study||50
3025476|NCT01084694|3743863|FG000|COMPLETED|Overall Study||44
3025477|NCT01084694|3743864|FG001|COMPLETED|Overall Study||30
3025478|NCT01084694|3743863|FG000|NOT COMPLETED|Overall Study||6
3025479|NCT01084694|3743864|FG001|NOT COMPLETED|Overall Study||20
3025480|NCT01084707|3743878|FG000|STARTED|Overall Study||40
3025481|NCT01084707|3743878|FG000|COMPLETED|Overall Study||34
3025482|NCT01084707|3743878|FG000|NOT COMPLETED|Overall Study||6
3025483|NCT01084759|3743890|FG000|STARTED|Overall Study||16
3025484|NCT01084759|3743890|FG000|COMPLETED|Overall Study||14
3025485|NCT01084759|3743890|FG000|NOT COMPLETED|Overall Study||2
3025486|NCT01084772|3743896|FG000|STARTED|Baseline||68
3025487|NCT01084772|3743897|FG001|STARTED|Baseline||66
3025488|NCT01084772|3743896|FG000|COMPLETED|Baseline||61
3025489|NCT01084772|3743897|FG001|COMPLETED|Baseline||60
3025490|NCT01084772|3743896|FG000|NOT COMPLETED|Baseline||7
3025491|NCT01084772|3743897|FG001|NOT COMPLETED|Baseline||6
3025492|NCT01084772|3743896|FG000|STARTED|3 Months||61
3025493|NCT01084772|3743897|FG001|STARTED|3 Months||60
3025494|NCT01084772|3743896|FG000|COMPLETED|3 Months||58
3025495|NCT01084772|3743897|FG001|COMPLETED|3 Months||58
3025496|NCT01084772|3743896|FG000|NOT COMPLETED|3 Months||3
3025497|NCT01084772|3743897|FG001|NOT COMPLETED|3 Months||2
3025498|NCT01084772|3743896|FG000|STARTED|1 Year||58
3025499|NCT01084772|3743897|FG001|STARTED|1 Year||58
3025500|NCT01084772|3743896|FG000|COMPLETED|1 Year||55
3025501|NCT01084772|3743897|FG001|COMPLETED|1 Year||50
3025502|NCT01084772|3743896|FG000|NOT COMPLETED|1 Year||3
3025503|NCT01084772|3743897|FG001|NOT COMPLETED|1 Year||8
3025504|NCT01084772|3743896|FG000|STARTED|2 Years||55
3025505|NCT01084772|3743897|FG001|STARTED|2 Years||50
3025506|NCT01084772|3743896|FG000|COMPLETED|2 Years||46
3025507|NCT01084772|3743897|FG001|COMPLETED|2 Years||46
3025508|NCT01084772|3743896|FG000|NOT COMPLETED|2 Years||9
3025509|NCT01084772|3743897|FG001|NOT COMPLETED|2 Years||4
3025510|NCT01085006|3743905|FG000|STARTED|Overall Study||50
3025511|NCT01085006|3743906|FG001|STARTED|Overall Study||50
3025512|NCT01085006|3743905|FG000|COMPLETED|Overall Study||50
3025513|NCT01085006|3743906|FG001|COMPLETED|Overall Study||50
3025514|NCT01085006|3743905|FG000|NOT COMPLETED|Overall Study||0
3025515|NCT01085006|3743906|FG001|NOT COMPLETED|Overall Study||0
3025516|NCT01085045|3743912|FG000|STARTED|Part A||122
3025517|NCT01085045|3743912|FG000|GFF MDI 72/9.6mcg|Part A||40
3025518|NCT01085045|3743912|FG000|GFF MDI 36/9.6 µg (PT003)|Part A||42
3025519|NCT01085045|3743912|FG000|GP MDI 36 µg (PT001)|Part A||40
3025520|NCT01085045|3743912|FG000|Spiriva 18 µg|Part A||58
3025521|NCT01085045|3743912|FG000|FF MDI 9.6 µg (PT005)|Part A||20
3025522|NCT01085045|3743912|FG000|FF MDI 7.2 µg (PT005)|Part A||21
3025523|NCT01085045|3743912|FG000|Placebo MDI|Part A||5
3025524|NCT01085045|3743912|FG000|Foradil 12 µg|Part A||14
3025525|NCT01085045|3743912|FG000|COMPLETED|Part A||104
3025526|NCT01085045|3743912|FG000|NOT COMPLETED|Part A||18
3025527|NCT01085045|3743912|FG000|STARTED|Part B||104
3025528|NCT01085045|3743912|FG000|GFF MDI 72/9.6mcg (PT003)|Part B||0
3025529|NCT01085045|3743912|FG000|GFF MDI 36/9.6 µg|Part B||0
3025530|NCT01085045|3743912|FG000|Spiriva 18 µg|Part B||0
3025531|NCT01085045|3743912|FG000|FF MDI 9.6 µg (PT005)|Part B||43
3025532|NCT01085045|3743912|FG000|FF MDI 7.2 µg (PT005)|Part B||43
3025533|NCT01085045|3743912|FG000|Placebo MDI|Part B||47
3025534|NCT01085045|3743912|FG000|Foradil 12 µg|Part B||41
3025535|NCT01085045|3743912|FG000|GP MDI 36 µg (PT001)|Part B||0
3025536|NCT01085045|3743912|FG000|COMPLETED|Part B||89
3025537|NCT01085045|3743912|FG000|NOT COMPLETED|Part B||15
3025538|NCT01085136|3743932|FG000|STARTED|Part A||1154
3025539|NCT01085136|3743933|FG001|STARTED|Part A|Only Afatinib monotherapy administered in Part A|0
3025540|NCT01085136|3743934|FG002|STARTED|Part A||0
3025541|NCT01085136|3743932|FG000|Randomized to Part B|Part A|Discontinued Part A -Randomized to Part B|206
3025542|NCT01085136|3743933|FG001|Randomized to Part B|Part A||0
3025543|NCT01085136|3743934|FG002|Randomized to Part B|Part A||0
3025544|NCT01085136|3743932|FG000|COMPLETED|Part A|Randomized to Part B & completed trial as per protocol, had PD, clinical progression.|831
3025545|NCT01085136|3743933|FG001|COMPLETED|Part A||0
3025546|NCT01085136|3743934|FG002|COMPLETED|Part A||0
3025547|NCT01085136|3743932|FG000|NOT COMPLETED|Part A||323
3025548|NCT01085136|3743933|FG001|NOT COMPLETED|Part A||0
3025549|NCT01085136|3743934|FG002|NOT COMPLETED|Part A||0
3025550|NCT01085136|3743932|FG000|STARTED|Part B|Afatinib monotherapy not administered in Part B|0
3025551|NCT01085136|3743933|FG001|STARTED|Part B||138
3025552|NCT01085136|3743934|FG002|STARTED|Part B||68
3025553|NCT01085136|3743932|FG000|COMPLETED|Part B|Afatinib monotherapy not administered in Part B|0
3025554|NCT01085136|3743933|FG001|COMPLETED|Part B|Completed trial as per protocol, had progressive disease, clinical signs or symptoms of progression|87
3025555|NCT01085136|3743934|FG002|COMPLETED|Part B|Completed trial as per protocol, had progressive disease, clinical signs or symptoms of progression|42
3025556|NCT01085136|3743932|FG000|NOT COMPLETED|Part B||0
3025557|NCT01085136|3743933|FG001|NOT COMPLETED|Part B||51
3025558|NCT01085136|3743934|FG002|NOT COMPLETED|Part B||26
3025559|NCT01085201|3743949|FG000|STARTED|Overall Study||18
3025560|NCT01085201|3743950|FG001|STARTED|Overall Study||7
3025561|NCT01085201|3743951|FG002|STARTED|Overall Study||5
3025562|NCT01085201|3743952|FG003|STARTED|Overall Study||6
3025563|NCT01085201|3743953|FG004|STARTED|Overall Study||3
3025564|NCT01085201|3743949|FG000|COMPLETED|Overall Study||15
3025565|NCT01085201|3743950|FG001|COMPLETED|Overall Study||6
3025566|NCT01085201|3743951|FG002|COMPLETED|Overall Study||3
3025567|NCT01085201|3743952|FG003|COMPLETED|Overall Study||6
3025568|NCT01085201|3743953|FG004|COMPLETED|Overall Study||3
3025569|NCT01085201|3743949|FG000|NOT COMPLETED|Overall Study||3
3025570|NCT01085201|3743950|FG001|NOT COMPLETED|Overall Study||1
3025571|NCT01085201|3743951|FG002|NOT COMPLETED|Overall Study||2
3025572|NCT01085201|3743952|FG003|NOT COMPLETED|Overall Study||0
3025573|NCT01085201|3743953|FG004|NOT COMPLETED|Overall Study||0
3025574|NCT01085214|3743970|FG000|STARTED|Overall Study||37
3025575|NCT01085214|3743970|FG000|COMPLETED|Overall Study||36
3025576|NCT01085214|3743970|FG000|NOT COMPLETED|Overall Study||1
3025577|NCT01085318|3743976|FG000|STARTED|Overall Study||23
3025578|NCT01085318|3743977|FG001|STARTED|Overall Study||15
3025579|NCT01085318|3743976|FG000|COMPLETED|Overall Study||21
3025580|NCT01085318|3743977|FG001|COMPLETED|Overall Study||15
3025581|NCT01085318|3743976|FG000|NOT COMPLETED|Overall Study||2
3025582|NCT01085318|3743977|FG001|NOT COMPLETED|Overall Study||0
3025583|NCT01085331|3743985|FG000|STARTED|Overall Study||10
3025584|NCT01085331|3743986|FG001|STARTED|Overall Study||6
3025585|NCT01085331|3743985|FG000|COMPLETED|Overall Study||10
3025586|NCT01085331|3743986|FG001|COMPLETED|Overall Study||6
3025587|NCT01085331|3743985|FG000|NOT COMPLETED|Overall Study||0
3025588|NCT01085331|3743986|FG001|NOT COMPLETED|Overall Study||0
3025589|NCT01085344|3743996|FG000|STARTED|Overall Study||56
3025590|NCT01085344|3743996|FG000|COMPLETED|Overall Study||50
3025591|NCT01085344|3743996|FG000|NOT COMPLETED|Overall Study||6
3025592|NCT01085357|3744002|FG000|STARTED|Overall Study||374
3025593|NCT01085357|3744003|FG001|STARTED|Overall Study||131
3025594|NCT01085357|3744002|FG000|COMPLETED|Overall Study||355
3025595|NCT01085357|3744003|FG001|COMPLETED|Overall Study||125
3025596|NCT01085357|3744002|FG000|NOT COMPLETED|Overall Study||19
3025597|NCT01085357|3744003|FG001|NOT COMPLETED|Overall Study||6
3025598|NCT01085500|3744011|FG000|STARTED|Overall Study||26
3025599|NCT01085500|3744012|FG001|STARTED|Overall Study||24
3025600|NCT01085500|3744011|FG000|COMPLETED|Overall Study||26
3025601|NCT01085500|3744012|FG001|COMPLETED|Overall Study||24
3025602|NCT01085500|3744011|FG000|NOT COMPLETED|Overall Study||0
3025603|NCT01085500|3744012|FG001|NOT COMPLETED|Overall Study||0
3025604|NCT01085513|3744020|FG000|STARTED|Phase I - Development Phase||54
3025605|NCT01085513|3744021|FG001|STARTED|Phase I - Development Phase||52
3025606|NCT01085513|3744020|FG000|COMPLETED|Phase I - Development Phase|recruitment was premature terminated|54
3025607|NCT01085513|3744021|FG001|COMPLETED|Phase I - Development Phase||52
3025608|NCT01085513|3744020|FG000|NOT COMPLETED|Phase I - Development Phase||0
3025609|NCT01085513|3744021|FG001|NOT COMPLETED|Phase I - Development Phase||0
3025610|NCT01085513|3744020|FG000|STARTED|Phase II - Validation Phase||21
3025611|NCT01085513|3744021|FG001|STARTED|Phase II - Validation Phase||16
3025612|NCT01085513|3744020|FG000|COMPLETED|Phase II - Validation Phase||21
3025613|NCT01085513|3744021|FG001|COMPLETED|Phase II - Validation Phase||16
3025614|NCT01085513|3744020|FG000|NOT COMPLETED|Phase II - Validation Phase||0
3025615|NCT01085513|3744021|FG001|NOT COMPLETED|Phase II - Validation Phase||0
3025616|NCT01085539|3744027|FG000|STARTED|Sat Secs Off--No Alarm Evaluation||50
3025617|NCT01085539|3744027|FG000|COMPLETED|Sat Secs Off--No Alarm Evaluation||50
3025618|NCT01085539|3744027|FG000|NOT COMPLETED|Sat Secs Off--No Alarm Evaluation||0
3025619|NCT01085539|3744027|FG000|STARTED|10 Sat Secs--10 Second Alarm Evaluation||50
3025620|NCT01085539|3744027|FG000|COMPLETED|10 Sat Secs--10 Second Alarm Evaluation||50
3025621|NCT01085539|3744027|FG000|NOT COMPLETED|10 Sat Secs--10 Second Alarm Evaluation||0
3025622|NCT01085539|3744027|FG000|STARTED|25 Sat Secs--25 Second Alarm Evaluation||50
3025623|NCT01085539|3744027|FG000|COMPLETED|25 Sat Secs--25 Second Alarm Evaluation||50
3025624|NCT01085539|3744027|FG000|NOT COMPLETED|25 Sat Secs--25 Second Alarm Evaluation||0
3025625|NCT01085539|3744027|FG000|STARTED|50 Sat Secs--50 Second Alarm Evaluation||50
3025626|NCT01085539|3744027|FG000|COMPLETED|50 Sat Secs--50 Second Alarm Evaluation||50
3025627|NCT01085539|3744027|FG000|NOT COMPLETED|50 Sat Secs--50 Second Alarm Evaluation||0
3025628|NCT01085539|3744027|FG000|STARTED|100Sat Secs-100 Second Alarm Evaluation||50
3025629|NCT01085539|3744027|FG000|COMPLETED|100Sat Secs-100 Second Alarm Evaluation||50
3025630|NCT01085539|3744027|FG000|NOT COMPLETED|100Sat Secs-100 Second Alarm Evaluation||0
3025631|NCT01085591|3744034|FG000|STARTED|Overall Study||69
3025632|NCT01085591|3744035|FG001|STARTED|Overall Study||71
3025633|NCT01085591|3744036|FG002|STARTED|Overall Study||70
3025634|NCT01085591|3744034|FG000|Received at Least 1 Dose of Study Drug|Overall Study||68
3025635|NCT01085591|3744035|FG001|Received at Least 1 Dose of Study Drug|Overall Study||69
3025636|NCT01085591|3744036|FG002|Received at Least 1 Dose of Study Drug|Overall Study||70
3025637|NCT01085591|3744034|FG000|COMPLETED|Overall Study||66
3025638|NCT01085591|3744035|FG001|COMPLETED|Overall Study||65
3025639|NCT01085591|3744036|FG002|COMPLETED|Overall Study||63
3025640|NCT01085591|3744034|FG000|NOT COMPLETED|Overall Study||3
3025641|NCT01085591|3744035|FG001|NOT COMPLETED|Overall Study||6
3025642|NCT01085591|3744036|FG002|NOT COMPLETED|Overall Study||7
3025643|NCT01085630|3744047|FG000|STARTED|Overall Study||26
3025644|NCT01085630|3744048|FG001|STARTED|Overall Study||27
3025645|NCT01085630|3744047|FG000|COMPLETED|Overall Study||22
3025646|NCT01085630|3744048|FG001|COMPLETED|Overall Study||27
3025647|NCT01085630|3744047|FG000|NOT COMPLETED|Overall Study||4
3025648|NCT01085630|3744048|FG001|NOT COMPLETED|Overall Study||0
3025649|NCT01085682|3744056|FG000|STARTED|Overall Study||31
3025650|NCT01085682|3744057|FG001|STARTED|Overall Study||28
3025651|NCT01085682|3744056|FG000|COMPLETED|Overall Study||6
3025652|NCT01085682|3744057|FG001|COMPLETED|Overall Study||3
3025653|NCT01085682|3744056|FG000|NOT COMPLETED|Overall Study||25
3025654|NCT01085682|3744057|FG001|NOT COMPLETED|Overall Study||25
3025655|NCT01085734|3744065|FG000|STARTED|Overall Study||15
3025656|NCT01085734|3744066|FG001|STARTED|Overall Study||15
3025657|NCT01085734|3744065|FG000|COMPLETED|Overall Study||14
3025658|NCT01085734|3744066|FG001|COMPLETED|Overall Study||11
3025659|NCT01085734|3744065|FG000|NOT COMPLETED|Overall Study||1
3025660|NCT01085734|3744066|FG001|NOT COMPLETED|Overall Study||4
3025661|NCT01085760|3744077|FG000|STARTED|Overall Study||8
3025662|NCT01085760|3744078|FG001|STARTED|Overall Study||9
3025663|NCT01085760|3744079|FG002|STARTED|Overall Study||9
3025664|NCT01085760|3744080|FG003|STARTED|Overall Study||9
3025665|NCT01085760|3744077|FG000|COMPLETED|Overall Study||7
3025666|NCT01085760|3744078|FG001|COMPLETED|Overall Study||8
3025667|NCT01085760|3744079|FG002|COMPLETED|Overall Study||7
3025668|NCT01085760|3744080|FG003|COMPLETED|Overall Study||6
3308574|NCT03021187|4041872|FG002|NOT COMPLETED|Overall Study||6
3308575|NCT03021187|4041873|FG003|NOT COMPLETED|Overall Study||9
3308576|NCT03021265|4041883|FG000|STARTED|Overall Study||676
3308577|NCT03021265|4041883|FG000|COMPLETED|Overall Study||554
3308578|NCT03021265|4041883|FG000|NOT COMPLETED|Overall Study||122
3308579|NCT03021304|4041887|FG000|STARTED|Overall Study||56
3308580|NCT03021304|4041887|FG000|COMPLETED|Overall Study||55
3025669|NCT01085760|3744077|FG000|NOT COMPLETED|Overall Study||1
3025670|NCT01085760|3744078|FG001|NOT COMPLETED|Overall Study||1
3025671|NCT01085760|3744079|FG002|NOT COMPLETED|Overall Study||2
3025672|NCT01085760|3744080|FG003|NOT COMPLETED|Overall Study||3
3025673|NCT01085786|3744092|FG000|STARTED|Overall Study||123
3025674|NCT01085786|3744093|FG001|STARTED|Overall Study||117
3025675|NCT01085786|3744092|FG000|COMPLETED|Overall Study||123
3025676|NCT01085786|3744093|FG001|COMPLETED|Overall Study||117
3025677|NCT01085786|3744092|FG000|NOT COMPLETED|Overall Study||0
3025678|NCT01085786|3744093|FG001|NOT COMPLETED|Overall Study||0
3025679|NCT01085812|3744099|FG000|STARTED|Open-Label Period||0
3025680|NCT01085812|3744100|FG001|STARTED|Open-Label Period||734
3025681|NCT01085812|3744099|FG000|COMPLETED|Open-Label Period||0
3025682|NCT01085812|3744100|FG001|COMPLETED|Open-Label Period||494
3025683|NCT01085812|3744099|FG000|NOT COMPLETED|Open-Label Period||0
3025684|NCT01085812|3744100|FG001|NOT COMPLETED|Open-Label Period||240
3025685|NCT01085812|3744099|FG000|STARTED|Double-Blind Period||113
3025686|NCT01085812|3744100|FG001|STARTED|Double-Blind Period||235
3025687|NCT01085812|3744099|FG000|COMPLETED|Double-Blind Period||92
3025688|NCT01085812|3744100|FG001|COMPLETED|Double-Blind Period||177
3025689|NCT01085812|3744099|FG000|NOT COMPLETED|Double-Blind Period||21
3165868|NCT01902134|3893426|FG004|COMPLETED|Overall Study||46
3165869|NCT01902134|3893427|FG005|COMPLETED|Overall Study||45
3308581|NCT03021304|4041887|FG000|NOT COMPLETED|Overall Study||1
3025690|NCT01085812|3744100|FG001|NOT COMPLETED|Double-Blind Period||58
3025691|NCT01085812|3744099|FG000|STARTED|Double-blind Intent-to-treat Population||112
3025692|NCT01085812|3744100|FG001|STARTED|Double-blind Intent-to-treat Population||230
3025693|NCT01085812|3744099|FG000|COMPLETED|Double-blind Intent-to-treat Population||92
3025694|NCT01085812|3744100|FG001|COMPLETED|Double-blind Intent-to-treat Population||174
3308582|NCT03021343|4041893|FG000|STARTED|Overall Study||179
3025695|NCT01085812|3744099|FG000|NOT COMPLETED|Double-blind Intent-to-treat Population||20
3025696|NCT01085812|3744100|FG001|NOT COMPLETED|Double-blind Intent-to-treat Population||56
3165870|NCT01902134|3893422|FG000|NOT COMPLETED|Overall Study||8
3165871|NCT01902134|3893423|FG001|NOT COMPLETED|Overall Study||11
3165872|NCT01902134|3893424|FG002|NOT COMPLETED|Overall Study||15
3025697|NCT01085825|3744109|FG000|STARTED|Overall Study|1st participant enrolled|252
3025698|NCT01085825|3744110|FG001|STARTED|Overall Study||248
3025699|NCT01085825|3744109|FG000|COMPLETED|Overall Study||251
3025700|NCT01085825|3744110|FG001|COMPLETED|Overall Study||247
3025701|NCT01085825|3744109|FG000|NOT COMPLETED|Overall Study||1
3025702|NCT01085825|3744110|FG001|NOT COMPLETED|Overall Study||1
3025703|NCT01085903|3744118|FG000|STARTED|Overall Study||21
3025704|NCT01085903|3744119|FG001|STARTED|Overall Study||4
3025705|NCT01085903|3744120|FG002|STARTED|Overall Study||3
3025706|NCT01085903|3744118|FG000|COMPLETED|Overall Study||21
3025707|NCT01085903|3744119|FG001|COMPLETED|Overall Study||4
3025708|NCT01085903|3744120|FG002|COMPLETED|Overall Study||3
3025709|NCT01085903|3744118|FG000|NOT COMPLETED|Overall Study||0
3025710|NCT01085903|3744119|FG001|NOT COMPLETED|Overall Study||0
3025711|NCT01085903|3744120|FG002|NOT COMPLETED|Overall Study||0
3025712|NCT01085968|3744141|FG000|STARTED|Overall Study||29
3025713|NCT01085968|3744142|FG001|STARTED|Overall Study||25
3025714|NCT01085968|3744141|FG000|COMPLETED|Overall Study||19
3025715|NCT01085968|3744142|FG001|COMPLETED|Overall Study||21
3025716|NCT01085968|3744141|FG000|NOT COMPLETED|Overall Study||10
3025717|NCT01085968|3744142|FG001|NOT COMPLETED|Overall Study||4
3025718|NCT01086033|3744148|FG000|STARTED|Overall Study||566
3025719|NCT01086033|3744148|FG000|COMPLETED|Overall Study||262
3025720|NCT01086033|3744148|FG000|NOT COMPLETED|Overall Study||304
3025721|NCT01086150|3744158|FG000|STARTED|Overall Study||11
3025722|NCT01086150|3744159|FG001|STARTED|Overall Study||27
3025723|NCT01086150|3744160|FG002|STARTED|Overall Study||13
3025724|NCT01086150|3744158|FG000|COMPLETED|Overall Study||11
3025725|NCT01086150|3744159|FG001|COMPLETED|Overall Study||21
3025726|NCT01086150|3744160|FG002|COMPLETED|Overall Study||12
3025727|NCT01086150|3744158|FG000|NOT COMPLETED|Overall Study||0
3025728|NCT01086150|3744159|FG001|NOT COMPLETED|Overall Study||6
3025729|NCT01086150|3744160|FG002|NOT COMPLETED|Overall Study||1
3025730|NCT01086215|3744172|FG000|STARTED|Overall Study||212
3025731|NCT01086215|3744173|FG001|STARTED|Overall Study||201
3025732|NCT01086215|3744174|FG002|STARTED|Overall Study||73
3025733|NCT01086215|3744175|FG003|STARTED|Overall Study||14
3025734|NCT01086215|3744172|FG000|3 Month Follow Up|Overall Study|7 LTF; 4 Deaths|201
3025735|NCT01086215|3744173|FG001|3 Month Follow Up|Overall Study|10 LTF; 4 Deaths|187
3025736|NCT01086215|3744174|FG002|3 Month Follow Up|Overall Study|5 LTF; 4 Deaths|64
3025737|NCT01086215|3744175|FG003|3 Month Follow Up|Overall Study|1 LTF; 0 Deaths|13
3025738|NCT01086215|3744172|FG000|6 Month Follow Up|Overall Study|5 LTF; 4 Deaths|192
3025739|NCT01086215|3744173|FG001|6 Month Follow Up|Overall Study|13 LTF; 2 Deaths|172
3025740|NCT01086215|3744174|FG002|6 Month Follow Up|Overall Study|4 LTF; 0 Deaths|60
3025741|NCT01086215|3744175|FG003|6 Month Follow Up|Overall Study|1 LTF; 0 Deaths|12
3025742|NCT01086215|3744172|FG000|12 Month Follow Up|Overall Study|10 LTF; 6 Deaths|176
3025743|NCT01086215|3744173|FG001|12 Month Follow Up|Overall Study|16 LTF; 2 Deaths|154
3025744|NCT01086215|3744174|FG002|12 Month Follow Up|Overall Study|9 LTF; 4 Deaths|47
3025745|NCT01086215|3744175|FG003|12 Month Follow Up|Overall Study|0 LTF; 1 Death|11
3025746|NCT01086215|3744172|FG000|COMPLETED|Overall Study||176
3025747|NCT01086215|3744173|FG001|COMPLETED|Overall Study||154
3025748|NCT01086215|3744174|FG002|COMPLETED|Overall Study||47
3025749|NCT01086215|3744175|FG003|COMPLETED|Overall Study||11
3025750|NCT01086215|3744172|FG000|NOT COMPLETED|Overall Study||36
3025751|NCT01086215|3744173|FG001|NOT COMPLETED|Overall Study||47
3025752|NCT01086215|3744174|FG002|NOT COMPLETED|Overall Study||26
3025753|NCT01086215|3744175|FG003|NOT COMPLETED|Overall Study||3
3025754|NCT01086228|3744185|FG000|STARTED|8 Month Follow-up|Analysis population|2009
3025755|NCT01086228|3744185|FG000|COMPLETED|8 Month Follow-up||1938
3025756|NCT01086228|3744185|FG000|NOT COMPLETED|8 Month Follow-up||71
3025757|NCT01086228|3744185|FG000|STARTED|1-year Follow-up||1938
3165873|NCT01902134|3893425|FG003|NOT COMPLETED|Overall Study||2
3165874|NCT01902134|3893426|FG004|NOT COMPLETED|Overall Study||7
3165875|NCT01902134|3893427|FG005|NOT COMPLETED|Overall Study||9
3165876|NCT01902173|3893449|FG000|STARTED|Phase 1 Doublet Regimen Cohort 1||3
3165877|NCT01902173|3893450|FG001|STARTED|Phase 1 Doublet Regimen Cohort 1||0
3308583|NCT03021343|4041894|FG001|STARTED|Overall Study||181
3308584|NCT03021343|4041893|FG000|COMPLETED|Overall Study||174
3308585|NCT03021343|4041894|FG001|COMPLETED|Overall Study||174
3308586|NCT03021343|4041893|FG000|NOT COMPLETED|Overall Study||5
3308587|NCT03021343|4041894|FG001|NOT COMPLETED|Overall Study||7
3308588|NCT03021499|4041902|FG000|STARTED|Overall Study||179
3308589|NCT03021499|4041903|FG001|STARTED|Overall Study||178
3308590|NCT03021499|4041902|FG000|Week 24|Overall Study||167
3308591|NCT03021499|4041903|FG001|Week 24|Overall Study||162
3308592|NCT03021499|4041902|FG000|Week 52|Overall Study||162
3308593|NCT03021499|4041903|FG001|Week 52|Overall Study||147
3308594|NCT03021499|4041902|FG000|COMPLETED|Overall Study||163
3308595|NCT03021499|4041903|FG001|COMPLETED|Overall Study||147
3308596|NCT03021499|4041902|FG000|NOT COMPLETED|Overall Study||16
3308597|NCT03021499|4041903|FG001|NOT COMPLETED|Overall Study||31
3308598|NCT03021538|4041913|FG000|STARTED|Overall Study||6
3308599|NCT03021538|4041914|FG001|STARTED|Overall Study||7
3025758|NCT01086228|3744185|FG000|COMPLETED|1-year Follow-up||1894
3025759|NCT01086228|3744185|FG000|NOT COMPLETED|1-year Follow-up||44
3025760|NCT01086228|3744185|FG000|STARTED|2-year Follow-up||1894
3025761|NCT01086228|3744185|FG000|COMPLETED|2-year Follow-up||1834
3025762|NCT01086228|3744185|FG000|NOT COMPLETED|2-year Follow-up||60
3025763|NCT01086228|3744185|FG000|STARTED|3-year Follow-up||1834
3308600|NCT03021538|4041913|FG000|COMPLETED|Overall Study||6
3025764|NCT01086228|3744185|FG000|COMPLETED|3-year Follow-up||1767
3025765|NCT01086228|3744185|FG000|NOT COMPLETED|3-year Follow-up||67
3025766|NCT01086228|3744185|FG000|STARTED|4-year Follow-up||1767
3025767|NCT01086228|3744185|FG000|COMPLETED|4-year Follow-up||1664
3025768|NCT01086228|3744185|FG000|NOT COMPLETED|4-year Follow-up||103
3025769|NCT01086228|3744185|FG000|STARTED|5-year Follow-up||1664
3025770|NCT01086228|3744185|FG000|COMPLETED|5-year Follow-up||1012
3025771|NCT01086228|3744185|FG000|NOT COMPLETED|5-year Follow-up||652
3025772|NCT01086358|3744189|FG000|STARTED|First Intervention|30 subjects enrolled.|30
3025773|NCT01086358|3744190|FG001|STARTED|First Intervention|30 subjects enrolled, 1 withdrew before randomization|29
3025774|NCT01086358|3744189|FG000|COMPLETED|First Intervention||21
3025775|NCT01086358|3744190|FG001|COMPLETED|First Intervention||24
3025776|NCT01086358|3744189|FG000|NOT COMPLETED|First Intervention||9
3025777|NCT01086358|3744190|FG001|NOT COMPLETED|First Intervention||5
3025778|NCT01086358|3744189|FG000|STARTED|Second Intervention||21
3025779|NCT01086358|3744190|FG001|STARTED|Second Intervention||24
3025780|NCT01086358|3744189|FG000|COMPLETED|Second Intervention||17
3025781|NCT01086358|3744190|FG001|COMPLETED|Second Intervention||20
3025782|NCT01086358|3744189|FG000|NOT COMPLETED|Second Intervention||4
3025783|NCT01086358|3744190|FG001|NOT COMPLETED|Second Intervention||4
3025784|NCT01086384|3744198|FG000|STARTED|2-week Run-in Period||2183
3025785|NCT01086384|3744199|FG001|STARTED|2-week Run-in Period||0
3025786|NCT01086384|3744200|FG002|STARTED|2-week Run-in Period||0
3025787|NCT01086384|3744198|FG000|COMPLETED|2-week Run-in Period||2020
3025788|NCT01086384|3744199|FG001|COMPLETED|2-week Run-in Period||0
3025789|NCT01086384|3744200|FG002|COMPLETED|2-week Run-in Period||0
3025790|NCT01086384|3744198|FG000|NOT COMPLETED|2-week Run-in Period||163
3025791|NCT01086384|3744199|FG001|NOT COMPLETED|2-week Run-in Period||0
3025792|NCT01086384|3744200|FG002|NOT COMPLETED|2-week Run-in Period||0
3025793|NCT01086384|3744198|FG000|STARTED|Treatment Period||0
3025794|NCT01086384|3744199|FG001|STARTED|Treatment Period||1011
3025795|NCT01086384|3744200|FG002|STARTED|Treatment Period||1009
3025796|NCT01086384|3744198|FG000|COMPLETED|Treatment Period||0
3025797|NCT01086384|3744199|FG001|COMPLETED|Treatment Period||863
3025798|NCT01086384|3744200|FG002|COMPLETED|Treatment Period||885
3025799|NCT01086384|3744198|FG000|NOT COMPLETED|Treatment Period||0
3025800|NCT01086384|3744199|FG001|NOT COMPLETED|Treatment Period||148
3025801|NCT01086384|3744200|FG002|NOT COMPLETED|Treatment Period||124
3025802|NCT01086410|3744210|FG000|STARTED|Overall Study||58
3025803|NCT01086410|3744211|FG001|STARTED|Overall Study||56
3025804|NCT01086410|3744212|FG002|STARTED|Overall Study||56
3025805|NCT01086410|3744213|FG003|STARTED|Overall Study||15
3025806|NCT01086410|3744210|FG000|COMPLETED|Overall Study||55
3025807|NCT01086410|3744211|FG001|COMPLETED|Overall Study||54
3025808|NCT01086410|3744212|FG002|COMPLETED|Overall Study||55
3025809|NCT01086410|3744213|FG003|COMPLETED|Overall Study||13
3025810|NCT01086410|3744210|FG000|NOT COMPLETED|Overall Study||3
3025811|NCT01086410|3744211|FG001|NOT COMPLETED|Overall Study||2
3025812|NCT01086410|3744212|FG002|NOT COMPLETED|Overall Study||1
3025813|NCT01086410|3744213|FG003|NOT COMPLETED|Overall Study||2
3025814|NCT01086423|3744226|FG000|STARTED|Overall Study||330
3025815|NCT01086423|3744227|FG001|STARTED|Overall Study||324
3025816|NCT01086423|3744228|FG002|STARTED|Overall Study||330
3025817|NCT01086423|3744226|FG000|COMPLETED|Overall Study||320
3025818|NCT01086423|3744227|FG001|COMPLETED|Overall Study||321
3025819|NCT01086423|3744228|FG002|COMPLETED|Overall Study||321
3025820|NCT01086423|3744226|FG000|NOT COMPLETED|Overall Study||10
3025821|NCT01086423|3744227|FG001|NOT COMPLETED|Overall Study||3
3025822|NCT01086423|3744228|FG002|NOT COMPLETED|Overall Study||9
3025823|NCT01086475|3744238|FG000|STARTED|Overall Study||34
3025824|NCT01086475|3744239|FG001|STARTED|Overall Study||33
3025825|NCT01086475|3744238|FG000|COMPLETED|Overall Study||34
3025826|NCT01086475|3744239|FG001|COMPLETED|Overall Study||33
3025827|NCT01086475|3744238|FG000|NOT COMPLETED|Overall Study||0
3025828|NCT01086475|3744239|FG001|NOT COMPLETED|Overall Study||0
3025829|NCT01086540|3744247|FG000|STARTED|Overall Study||29
3025830|NCT01086540|3744248|FG001|STARTED|Overall Study||28
3025831|NCT01086540|3744247|FG000|COMPLETED|Overall Study||23
3025832|NCT01086540|3744248|FG001|COMPLETED|Overall Study||26
3025833|NCT01086540|3744247|FG000|NOT COMPLETED|Overall Study||6
3025834|NCT01086540|3744248|FG001|NOT COMPLETED|Overall Study||2
3025835|NCT01086605|3744256|FG000|STARTED|Overall Study||24
3025836|NCT01086605|3744257|FG001|STARTED|Overall Study||22
3025837|NCT01086605|3744256|FG000|COMPLETED|Overall Study||24
3025838|NCT01086605|3744257|FG001|COMPLETED|Overall Study||22
3025839|NCT01086605|3744256|FG000|NOT COMPLETED|Overall Study||0
3025840|NCT01086605|3744257|FG001|NOT COMPLETED|Overall Study||0
3025841|NCT01086761|3744269|FG000|STARTED|Overall Study||9
3025842|NCT01086761|3744270|FG001|STARTED|Overall Study||7
3025843|NCT01086761|3744271|FG002|STARTED|Overall Study||6
3025844|NCT01086761|3744272|FG003|STARTED|Overall Study||6
3025845|NCT01086761|3744273|FG004|STARTED|Overall Study||4
3025846|NCT01086761|3744274|FG005|STARTED|Overall Study||0
3025847|NCT01086761|3744269|FG000|COMPLETED|Overall Study||9
3025848|NCT01086761|3744270|FG001|COMPLETED|Overall Study||7
3025849|NCT01086761|3744271|FG002|COMPLETED|Overall Study||6
3025850|NCT01086761|3744272|FG003|COMPLETED|Overall Study||6
3025851|NCT01086761|3744273|FG004|COMPLETED|Overall Study||4
3025852|NCT01086761|3744274|FG005|COMPLETED|Overall Study||0
3025853|NCT01086761|3744269|FG000|NOT COMPLETED|Overall Study||0
3025854|NCT01086761|3744270|FG001|NOT COMPLETED|Overall Study||0
3025855|NCT01086761|3744271|FG002|NOT COMPLETED|Overall Study||0
3025856|NCT01086761|3744272|FG003|NOT COMPLETED|Overall Study||0
3025857|NCT01086761|3744273|FG004|NOT COMPLETED|Overall Study||0
3025858|NCT01086761|3744274|FG005|NOT COMPLETED|Overall Study||0
3025859|NCT01086852|3744287|FG000|STARTED|Overall Study||4
3025860|NCT01086852|3744287|FG000|COMPLETED|Overall Study||4
3025861|NCT01086852|3744287|FG000|NOT COMPLETED|Overall Study||0
3025862|NCT01086969|3744295|FG000|STARTED|Overall Study||100
3025863|NCT01086969|3744296|FG001|STARTED|Overall Study||100
3025864|NCT01086969|3744297|FG002|STARTED|Overall Study||100
3025865|NCT01086969|3744295|FG000|COMPLETED|Overall Study||99
3025866|NCT01086969|3744296|FG001|COMPLETED|Overall Study||98
3025867|NCT01086969|3744297|FG002|COMPLETED|Overall Study||100
3025868|NCT01086969|3744295|FG000|NOT COMPLETED|Overall Study||1
3025869|NCT01086969|3744296|FG001|NOT COMPLETED|Overall Study||2
3025870|NCT01086969|3744297|FG002|NOT COMPLETED|Overall Study||0
3025871|NCT01087489|3744305|FG000|STARTED|Overall Study||19
3025872|NCT01087489|3744306|FG001|STARTED|Overall Study||34
3025873|NCT01087489|3744305|FG000|COMPLETED|Overall Study||19
3025874|NCT01087489|3744306|FG001|COMPLETED|Overall Study||31
3025875|NCT01087489|3744305|FG000|NOT COMPLETED|Overall Study||0
3025876|NCT01087489|3744306|FG001|NOT COMPLETED|Overall Study||3
3025877|NCT01087502|3744314|FG000|STARTED|Up to Interim Analysis (Week 12)||123
3025878|NCT01087502|3744315|FG001|STARTED|Up to Interim Analysis (Week 12)||118
3025879|NCT01087502|3744314|FG000|COMPLETED|Up to Interim Analysis (Week 12)||114
3025880|NCT01087502|3744315|FG001|COMPLETED|Up to Interim Analysis (Week 12)||110
3025881|NCT01087502|3744314|FG000|NOT COMPLETED|Up to Interim Analysis (Week 12)||9
3025882|NCT01087502|3744315|FG001|NOT COMPLETED|Up to Interim Analysis (Week 12)||8
3025883|NCT01087502|3744314|FG000|STARTED|Up to Final Analysis (Week 52)||123
3025884|NCT01087502|3744315|FG001|STARTED|Up to Final Analysis (Week 52)||118
3025885|NCT01087502|3744314|FG000|COMPLETED|Up to Final Analysis (Week 52)||90
3025886|NCT01087502|3744315|FG001|COMPLETED|Up to Final Analysis (Week 52)||95
3025887|NCT01087502|3744314|FG000|NOT COMPLETED|Up to Final Analysis (Week 52)||33
3025888|NCT01087502|3744315|FG001|NOT COMPLETED|Up to Final Analysis (Week 52)||23
3025889|NCT01087528|3744323|FG000|STARTED|Overall Study||51
3025890|NCT01087528|3744323|FG000|COMPLETED|Overall Study|withdrawn from the study prior to any procedure|44
3025891|NCT01087528|3744323|FG000|NOT COMPLETED|Overall Study||7
3025892|NCT01087541|3744331|FG000|STARTED|Overall Study||3307
3025893|NCT01087541|3744332|FG001|STARTED|Overall Study||3523
3025894|NCT01087541|3744331|FG000|COMPLETED|Overall Study||3307
3025895|NCT01087541|3744332|FG001|COMPLETED|Overall Study||3523
3025896|NCT01087541|3744331|FG000|NOT COMPLETED|Overall Study||0
3025897|NCT01087541|3744332|FG001|NOT COMPLETED|Overall Study||0
3025898|NCT01087723|3744340|FG000|STARTED|Overall Study|Randomized participants who signed an informed consent form (ICF); Intent-to-treat (ITT) population|1089
3025899|NCT01087723|3744341|FG001|STARTED|Overall Study|Randomized participants who signed an informed consent form (ICF); Intent-to-treat (ITT) population|1109
3025900|NCT01087723|3744340|FG000|Received at Least 1 Dose of Study Drug|Overall Study|Participants who were randomized with signed ICF by treatment actually received; Safety population|1099
3025901|NCT01087723|3744341|FG001|Received at Least 1 Dose of Study Drug|Overall Study|Participants who were randomized with signed ICF by treatment actually received; Safety population|1094
3025902|NCT01087723|3744340|FG000|COMPLETED|Overall Study|Completed 1-year follow-up in the study|1075
3025903|NCT01087723|3744341|FG001|COMPLETED|Overall Study|Completed 1-year follow-up in the study|1089
3025904|NCT01087723|3744340|FG000|NOT COMPLETED|Overall Study||14
3025905|NCT01087723|3744341|FG001|NOT COMPLETED|Overall Study||20
3025906|NCT01087736|3744349|FG000|STARTED|Overall Study||14
3025907|NCT01087736|3744350|FG001|STARTED|Overall Study||16
3025908|NCT01087736|3744349|FG000|COMPLETED|Overall Study||13
3025909|NCT01087736|3744350|FG001|COMPLETED|Overall Study||14
3025910|NCT01087736|3744349|FG000|NOT COMPLETED|Overall Study||1
3025911|NCT01087736|3744350|FG001|NOT COMPLETED|Overall Study||2
3025912|NCT01087762|3744359|FG000|STARTED|Double Blind Period (Weeks 0-24)|Completed 24-weeks Double-blind Period|107
3025913|NCT01087762|3744360|FG001|STARTED|Double Blind Period (Weeks 0-24)|Completed 24-weeks Double-blind Period|111
3025914|NCT01087762|3744361|FG002|STARTED|Double Blind Period (Weeks 0-24)|Completed 24-weeks Double-blind Period|107
3025915|NCT01087762|3744362|FG003|STARTED|Double Blind Period (Weeks 0-24)||0
3025916|NCT01087762|3744363|FG004|STARTED|Double Blind Period (Weeks 0-24)||0
3025917|NCT01087762|3744359|FG000|COMPLETED|Double Blind Period (Weeks 0-24)||95
3025918|NCT01087762|3744360|FG001|COMPLETED|Double Blind Period (Weeks 0-24)||105
3025919|NCT01087762|3744361|FG002|COMPLETED|Double Blind Period (Weeks 0-24)||98
3025920|NCT01087762|3744362|FG003|COMPLETED|Double Blind Period (Weeks 0-24)||0
3025921|NCT01087762|3744363|FG004|COMPLETED|Double Blind Period (Weeks 0-24)||0
3025922|NCT01087762|3744359|FG000|NOT COMPLETED|Double Blind Period (Weeks 0-24)||12
3025923|NCT01087762|3744360|FG001|NOT COMPLETED|Double Blind Period (Weeks 0-24)||6
3025924|NCT01087762|3744361|FG002|NOT COMPLETED|Double Blind Period (Weeks 0-24)||9
3025925|NCT01087762|3744362|FG003|NOT COMPLETED|Double Blind Period (Weeks 0-24)||0
3025926|NCT01087762|3744363|FG004|NOT COMPLETED|Double Blind Period (Weeks 0-24)||0
3025927|NCT01087762|3744359|FG000|STARTED|Open-Label Period (Weeks 48-204)||0
3025928|NCT01087762|3744360|FG001|STARTED|Open-Label Period (Weeks 48-204)||0
3025929|NCT01087762|3744361|FG002|STARTED|Open-Label Period (Weeks 48-204)||0
3025930|NCT01087762|3744362|FG003|STARTED|Open-Label Period (Weeks 48-204)||158
3025931|NCT01087762|3744363|FG004|STARTED|Open-Label Period (Weeks 48-204)||157
3025932|NCT01087762|3744359|FG000|COMPLETED|Open-Label Period (Weeks 48-204)||0
3025933|NCT01087762|3744360|FG001|COMPLETED|Open-Label Period (Weeks 48-204)||0
3025934|NCT01087762|3744361|FG002|COMPLETED|Open-Label Period (Weeks 48-204)||0
3025935|NCT01087762|3744362|FG003|COMPLETED|Open-Label Period (Weeks 48-204)||99
3025936|NCT01087762|3744363|FG004|COMPLETED|Open-Label Period (Weeks 48-204)||100
3025937|NCT01087762|3744359|FG000|NOT COMPLETED|Open-Label Period (Weeks 48-204)||0
3025938|NCT01087762|3744360|FG001|NOT COMPLETED|Open-Label Period (Weeks 48-204)||0
3025939|NCT01087762|3744361|FG002|NOT COMPLETED|Open-Label Period (Weeks 48-204)||0
3025940|NCT01087762|3744362|FG003|NOT COMPLETED|Open-Label Period (Weeks 48-204)||59
3025941|NCT01087762|3744363|FG004|NOT COMPLETED|Open-Label Period (Weeks 48-204)||57
3025942|NCT01087775|3744373|FG000|STARTED|Overall Study||25
3025943|NCT01087775|3744373|FG000|COMPLETED|Overall Study|2 subjects were found to be ineligible for the study|23
3025944|NCT01087775|3744373|FG000|NOT COMPLETED|Overall Study||2
3025945|NCT01087788|3744381|FG000|STARTED|24-weeks Double-blind Period||136
3025946|NCT01087788|3744382|FG001|STARTED|24-weeks Double-blind Period||138
3025947|NCT01087788|3744383|FG002|STARTED|24-weeks Double-blind Period||135
3025948|NCT01087788|3744381|FG000|Received CZP 200 mg Q2W at 16 Weeks|24-weeks Double-blind Period|30 subjects left the Placebo group and were re-randomized to CZP 200 mg Q2W on Week 16.|30
3025949|NCT01087788|3744382|FG001|Received CZP 200 mg Q2W at 16 Weeks|24-weeks Double-blind Period|not applicable for this arm|0
3025950|NCT01087788|3744383|FG002|Received CZP 200 mg Q2W at 16 Weeks|24-weeks Double-blind Period|not applicable for this arm|0
3025951|NCT01087788|3744381|FG000|Received CZP 400 mg Q4W at 16 Weeks|24-weeks Double-blind Period|29 subjects left the Placebo group and were re-randomized to CZP 400 mg Q4W on Week 16.|29
3025952|NCT01087788|3744382|FG001|Received CZP 400 mg Q4W at 16 Weeks|24-weeks Double-blind Period|not applicable for this arm|0
3025953|NCT01087788|3744383|FG002|Received CZP 400 mg Q4W at 16 Weeks|24-weeks Double-blind Period|not applicable for this arm|0
3025954|NCT01087788|3744381|FG000|COMPLETED|24-weeks Double-blind Period||120
3025955|NCT01087788|3744382|FG001|COMPLETED|24-weeks Double-blind Period||128
3025956|NCT01087788|3744383|FG002|COMPLETED|24-weeks Double-blind Period||120
3025957|NCT01087788|3744381|FG000|NOT COMPLETED|24-weeks Double-blind Period||16
3025958|NCT01087788|3744382|FG001|NOT COMPLETED|24-weeks Double-blind Period||10
3025959|NCT01087788|3744383|FG002|NOT COMPLETED|24-weeks Double-blind Period||15
3025960|NCT01087788|3744381|FG000|STARTED|24-weeks Dose-blind Period||120
3025961|NCT01087788|3744382|FG001|STARTED|24-weeks Dose-blind Period||128
3025962|NCT01087788|3744383|FG002|STARTED|24-weeks Dose-blind Period||120
3025963|NCT01087788|3744381|FG000|Received CZP 200 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|Sum of subjects re-randomized to CZP 200mg Q2W at week 16 (30 subjects) and at week 24 (30 subjects)|60
3025964|NCT01087788|3744382|FG001|Received CZP 200 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|not applicable for this arm|0
3025965|NCT01087788|3744383|FG002|Received CZP 200 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|not applicable for this arm|0
3025966|NCT01087788|3744381|FG000|Received CZP 400 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|Sum of subjects re-randomized to CZP 400mg Q2W at week 16 (29 subjects) and at week 24 (31 subjects)|60
3025967|NCT01087788|3744382|FG001|Received CZP 400 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|not applicable for this arm|0
3025968|NCT01087788|3744383|FG002|Received CZP 400 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|not applicable for this arm|0
3025969|NCT01087788|3744381|FG000|COMPLETED|24-weeks Dose-blind Period||113
3025970|NCT01087788|3744382|FG001|COMPLETED|24-weeks Dose-blind Period||123
3025971|NCT01087788|3744383|FG002|COMPLETED|24-weeks Dose-blind Period||114
3025972|NCT01087788|3744381|FG000|NOT COMPLETED|24-weeks Dose-blind Period||7
3025973|NCT01087788|3744382|FG001|NOT COMPLETED|24-weeks Dose-blind Period||5
3025974|NCT01087788|3744383|FG002|NOT COMPLETED|24-weeks Dose-blind Period||6
3025975|NCT01087788|3744381|FG000|STARTED|Open-Label Period (OL-P)|2 subj. completed the Dose-Blind Period, then withdrew from the study rather than entering the OL-P.|111
3025976|NCT01087788|3744382|FG001|STARTED|Open-Label Period (OL-P)|2 subj. completed the Dose-Blind Period, then withdrew from the study rather than entering the OL-P.|121
3025977|NCT01087788|3744383|FG002|STARTED|Open-Label Period (OL-P)||114
3025978|NCT01087788|3744381|FG000|COMPLETED|Open-Label Period (OL-P)||81
3025979|NCT01087788|3744382|FG001|COMPLETED|Open-Label Period (OL-P)||97
3025980|NCT01087788|3744383|FG002|COMPLETED|Open-Label Period (OL-P)||86
3025981|NCT01087788|3744381|FG000|NOT COMPLETED|Open-Label Period (OL-P)||30
3025982|NCT01087788|3744382|FG001|NOT COMPLETED|Open-Label Period (OL-P)||24
3025983|NCT01087788|3744383|FG002|NOT COMPLETED|Open-Label Period (OL-P)||28
3025984|NCT01087801|3744394|FG000|STARTED|Overall Study||30
3025985|NCT01087801|3744395|FG001|STARTED|Overall Study||34
3025986|NCT01087801|3744394|FG000|COMPLETED|Overall Study||26
3025987|NCT01087801|3744395|FG001|COMPLETED|Overall Study||29
3025988|NCT01087801|3744394|FG000|NOT COMPLETED|Overall Study||4
3025989|NCT01087801|3744395|FG001|NOT COMPLETED|Overall Study||5
3025990|NCT01087814|3744403|FG000|STARTED|First Intervention (5 Days)||8
3025991|NCT01087814|3744404|FG001|STARTED|First Intervention (5 Days)||7
3025992|NCT01087814|3744403|FG000|COMPLETED|First Intervention (5 Days)||5
3025993|NCT01087814|3744404|FG001|COMPLETED|First Intervention (5 Days)||6
3025994|NCT01087814|3744403|FG000|NOT COMPLETED|First Intervention (5 Days)||3
3025995|NCT01087814|3744404|FG001|NOT COMPLETED|First Intervention (5 Days)||1
3025996|NCT01087814|3744403|FG000|STARTED|Second Intervention (5 Days)||5
3025997|NCT01087814|3744404|FG001|STARTED|Second Intervention (5 Days)||6
3025998|NCT01087814|3744403|FG000|COMPLETED|Second Intervention (5 Days)||4
3025999|NCT01087814|3744404|FG001|COMPLETED|Second Intervention (5 Days)||6
3026000|NCT01087814|3744403|FG000|NOT COMPLETED|Second Intervention (5 Days)||1
3026001|NCT01087814|3744404|FG001|NOT COMPLETED|Second Intervention (5 Days)||0
3026002|NCT01087905|3744418|FG000|STARTED|Overall Study||119
3026003|NCT01087905|3744419|FG001|STARTED|Overall Study||126
3026004|NCT01087905|3744420|FG002|STARTED|Overall Study||123
3026005|NCT01087905|3744421|FG003|STARTED|Overall Study||122
3026006|NCT01087905|3744422|FG004|STARTED|Overall Study||122
3026007|NCT01087905|3744423|FG005|STARTED|Overall Study||127
3026008|NCT01087905|3744424|FG006|STARTED|Overall Study||121
3026009|NCT01087905|3744425|FG007|STARTED|Overall Study||127
3026010|NCT01087905|3744418|FG000|COMPLETED|Overall Study||90
3026011|NCT01087905|3744419|FG001|COMPLETED|Overall Study||94
3026012|NCT01087905|3744420|FG002|COMPLETED|Overall Study||101
3026013|NCT01087905|3744421|FG003|COMPLETED|Overall Study||86
3026014|NCT01087905|3744422|FG004|COMPLETED|Overall Study||91
3026015|NCT01087905|3744423|FG005|COMPLETED|Overall Study||99
3026016|NCT01087905|3744424|FG006|COMPLETED|Overall Study||98
3026017|NCT01087905|3744425|FG007|COMPLETED|Overall Study||98
3026018|NCT01087905|3744418|FG000|NOT COMPLETED|Overall Study||29
3026019|NCT01087905|3744419|FG001|NOT COMPLETED|Overall Study||32
3026020|NCT01087905|3744420|FG002|NOT COMPLETED|Overall Study||22
3026021|NCT01087905|3744421|FG003|NOT COMPLETED|Overall Study||36
3026022|NCT01087905|3744422|FG004|NOT COMPLETED|Overall Study||31
3026023|NCT01087905|3744423|FG005|NOT COMPLETED|Overall Study||28
3026024|NCT01087905|3744424|FG006|NOT COMPLETED|Overall Study||23
3026025|NCT01087905|3744425|FG007|NOT COMPLETED|Overall Study||29
3026026|NCT01087918|3744443|FG000|STARTED|Overall Study||5
3026027|NCT01087918|3744444|FG001|STARTED|Overall Study||4
3026028|NCT01087918|3744443|FG000|COMPLETED|Overall Study||5
3026029|NCT01087918|3744444|FG001|COMPLETED|Overall Study||4
3026030|NCT01087918|3744443|FG000|NOT COMPLETED|Overall Study||0
3026031|NCT01087918|3744444|FG001|NOT COMPLETED|Overall Study||0
3026032|NCT01087931|3744456|FG000|STARTED|Overall Study||20
3026033|NCT01087931|3744457|FG001|STARTED|Overall Study||20
3026034|NCT01087931|3744456|FG000|1st Follow up|Overall Study||20
3026035|NCT01087931|3744457|FG001|1st Follow up|Overall Study||19
3026036|NCT01087931|3744456|FG000|Final Follow up|Overall Study||19
3026037|NCT01087931|3744457|FG001|Final Follow up|Overall Study||17
3026038|NCT01087931|3744456|FG000|COMPLETED|Overall Study||20
3026039|NCT01087931|3744457|FG001|COMPLETED|Overall Study||20
3026040|NCT01087931|3744456|FG000|NOT COMPLETED|Overall Study||0
3026041|NCT01087931|3744457|FG001|NOT COMPLETED|Overall Study||0
3026042|NCT01087944|3744463|FG000|STARTED|Period 1 (Week 1-3)||30
3026043|NCT01087944|3744464|FG001|STARTED|Period 1 (Week 1-3)||30
3026044|NCT01087944|3744463|FG000|COMPLETED|Period 1 (Week 1-3)||29
3026045|NCT01087944|3744464|FG001|COMPLETED|Period 1 (Week 1-3)||30
3026046|NCT01087944|3744463|FG000|NOT COMPLETED|Period 1 (Week 1-3)||1
3026047|NCT01087944|3744464|FG001|NOT COMPLETED|Period 1 (Week 1-3)||0
3026048|NCT01087944|3744463|FG000|STARTED|Period 2 (Week 4-6)||29
3026049|NCT01087944|3744464|FG001|STARTED|Period 2 (Week 4-6)||30
3026050|NCT01087944|3744463|FG000|COMPLETED|Period 2 (Week 4-6)||29
3026051|NCT01087944|3744464|FG001|COMPLETED|Period 2 (Week 4-6)||28
3026052|NCT01087944|3744463|FG000|NOT COMPLETED|Period 2 (Week 4-6)||0
3026053|NCT01087944|3744464|FG001|NOT COMPLETED|Period 2 (Week 4-6)||2
3026054|NCT01087957|3744472|FG000|STARTED|Overall Study||253
3026055|NCT01087957|3744473|FG001|STARTED|Overall Study||242
3026056|NCT01087957|3744472|FG000|COMPLETED|Overall Study||212
3026057|NCT01087957|3744473|FG001|COMPLETED|Overall Study||187
3026058|NCT01087957|3744472|FG000|NOT COMPLETED|Overall Study||41
3026059|NCT01087957|3744473|FG001|NOT COMPLETED|Overall Study||55
3026060|NCT01087970|3744479|FG000|STARTED|Overall Study||69
3026061|NCT01087970|3744479|FG000|Received ≥1 Dose of Any Study Drug|Overall Study||69
3026062|NCT01087970|3744479|FG000|Completed 6 Cycles|Overall Study||69
3026063|NCT01087970|3744479|FG000|Efficacy Population|Overall Study|All treated participants excluding those from a noncompliant study site.|58
3026064|NCT01087970|3744479|FG000|Received Carboplatin|Overall Study||63
3026065|NCT01087970|3744479|FG000|COMPLETED|Overall Study||67
3026066|NCT01087970|3744479|FG000|NOT COMPLETED|Overall Study||2
3026067|NCT01087996|3744486|FG000|STARTED|Overall Study||15
3026068|NCT01087996|3744487|FG001|STARTED|Overall Study||15
3026069|NCT01087996|3744486|FG000|COMPLETED|Overall Study||15
3026070|NCT01087996|3744487|FG001|COMPLETED|Overall Study||15
3026071|NCT01087996|3744486|FG000|NOT COMPLETED|Overall Study||0
3026072|NCT01087996|3744487|FG001|NOT COMPLETED|Overall Study||0
3026073|NCT01088048|3744503|FG000|STARTED|Overall Study||51
3026074|NCT01088048|3744504|FG001|STARTED|Overall Study||51
3026075|NCT01088048|3744505|FG002|STARTED|Overall Study||18
3026076|NCT01088048|3744506|FG003|STARTED|Overall Study||18
3026077|NCT01088048|3744507|FG004|STARTED|Overall Study||33
3026078|NCT01088048|3744508|FG005|STARTED|Overall Study||21
3026079|NCT01088048|3744509|FG006|STARTED|Overall Study||12
3026080|NCT01088048|3744510|FG007|STARTED|Overall Study||15
3026081|NCT01088048|3744511|FG008|STARTED|Overall Study||15
3026082|NCT01088048|3744512|FG009|STARTED|Overall Study||7
3026083|NCT01088048|3744503|FG000|Participants With CLL|Overall Study||19
3026084|NCT01088048|3744504|FG001|Participants With CLL|Overall Study||18
3026085|NCT01088048|3744505|FG002|Participants With CLL|Overall Study||0
3026086|NCT01088048|3744506|FG003|Participants With CLL|Overall Study||0
3026087|NCT01088048|3744507|FG004|Participants With CLL|Overall Study||15
3026088|NCT01088048|3744508|FG005|Participants With CLL|Overall Study||21
3026089|NCT01088048|3744509|FG006|Participants With CLL|Overall Study||12
3026090|NCT01088048|3744510|FG007|Participants With CLL|Overall Study||15
3026091|NCT01088048|3744511|FG008|Participants With CLL|Overall Study||14
3026092|NCT01088048|3744512|FG009|Participants With CLL|Overall Study||1
3026093|NCT01088048|3744503|FG000|Participants With Indolent NHL|Overall Study||32
3026094|NCT01088048|3744504|FG001|Participants With Indolent NHL|Overall Study||33
3026095|NCT01088048|3744505|FG002|Participants With Indolent NHL|Overall Study||0
3026096|NCT01088048|3744506|FG003|Participants With Indolent NHL|Overall Study||0
3026097|NCT01088048|3744507|FG004|Participants With Indolent NHL|Overall Study||14
3026098|NCT01088048|3744508|FG005|Participants With Indolent NHL|Overall Study||0
3026099|NCT01088048|3744509|FG006|Participants With Indolent NHL|Overall Study||0
3026100|NCT01088048|3744510|FG007|Participants With Indolent NHL|Overall Study||0
3026101|NCT01088048|3744511|FG008|Participants With Indolent NHL|Overall Study||1
3026102|NCT01088048|3744512|FG009|Participants With Indolent NHL|Overall Study||6
3026103|NCT01088048|3744503|FG000|Participants With MCL|Overall Study||0
3026104|NCT01088048|3744504|FG001|Participants With MCL|Overall Study||0
3026105|NCT01088048|3744505|FG002|Participants With MCL|Overall Study||18
3026106|NCT01088048|3744506|FG003|Participants With MCL|Overall Study||18
3026107|NCT01088048|3744507|FG004|Participants With MCL|Overall Study||4
3026108|NCT01088048|3744508|FG005|Participants With MCL|Overall Study||0
3026109|NCT01088048|3744509|FG006|Participants With MCL|Overall Study||0
3026110|NCT01088048|3744510|FG007|Participants With MCL|Overall Study||0
3026111|NCT01088048|3744511|FG008|Participants With MCL|Overall Study||0
3026112|NCT01088048|3744512|FG009|Participants With MCL|Overall Study||0
3026113|NCT01088048|3744503|FG000|COMPLETED|Overall Study||29
3026114|NCT01088048|3744504|FG001|COMPLETED|Overall Study||24
3026115|NCT01088048|3744505|FG002|COMPLETED|Overall Study||4
3026116|NCT01088048|3744506|FG003|COMPLETED|Overall Study||4
3026117|NCT01088048|3744507|FG004|COMPLETED|Overall Study||16
3026118|NCT01088048|3744508|FG005|COMPLETED|Overall Study||10
3026119|NCT01088048|3744509|FG006|COMPLETED|Overall Study||6
3026120|NCT01088048|3744510|FG007|COMPLETED|Overall Study||10
3026121|NCT01088048|3744511|FG008|COMPLETED|Overall Study||8
3026122|NCT01088048|3744512|FG009|COMPLETED|Overall Study||3
3026123|NCT01088048|3744503|FG000|NOT COMPLETED|Overall Study||22
3026124|NCT01088048|3744504|FG001|NOT COMPLETED|Overall Study||27
3026125|NCT01088048|3744505|FG002|NOT COMPLETED|Overall Study||14
3026126|NCT01088048|3744506|FG003|NOT COMPLETED|Overall Study||14
3026127|NCT01088048|3744507|FG004|NOT COMPLETED|Overall Study||17
3026128|NCT01088048|3744508|FG005|NOT COMPLETED|Overall Study||11
3026129|NCT01088048|3744509|FG006|NOT COMPLETED|Overall Study||6
3026130|NCT01088048|3744510|FG007|NOT COMPLETED|Overall Study||5
3026131|NCT01088048|3744511|FG008|NOT COMPLETED|Overall Study||7
3026132|NCT01088048|3744512|FG009|NOT COMPLETED|Overall Study||4
3026133|NCT01088243|3744547|FG000|STARTED|Overall Study||13
3026134|NCT01088243|3744548|FG001|STARTED|Overall Study||5
3026135|NCT01088243|3744547|FG000|COMPLETED|Overall Study||12
3026136|NCT01088243|3744548|FG001|COMPLETED|Overall Study||5
3026137|NCT01088243|3744547|FG000|NOT COMPLETED|Overall Study||1
3026138|NCT01088243|3744548|FG001|NOT COMPLETED|Overall Study||0
3026139|NCT01088295|3744554|FG000|STARTED|Overall Study||36
3026140|NCT01088295|3744554|FG000|COMPLETED|Overall Study||35
3026141|NCT01088295|3744554|FG000|NOT COMPLETED|Overall Study||1
3026142|NCT01088399|3744561|FG000|STARTED|Overall Study||8716
3026143|NCT01088399|3744562|FG001|STARTED|Overall Study||1655
3026144|NCT01088399|3744563|FG002|STARTED|Overall Study||302
3026145|NCT01088399|3744561|FG000|COMPLETED|Overall Study||1595
3026146|NCT01088399|3744562|FG001|COMPLETED|Overall Study||308
3026147|NCT01088399|3744563|FG002|COMPLETED|Overall Study||21
3026148|NCT01088399|3744561|FG000|NOT COMPLETED|Overall Study||7121
3026149|NCT01088399|3744562|FG001|NOT COMPLETED|Overall Study||1347
3026150|NCT01088399|3744563|FG002|NOT COMPLETED|Overall Study||281
3026151|NCT01088412|3744574|FG000|STARTED|Overall Study||22311
3026152|NCT01088412|3744575|FG001|STARTED|Overall Study||457
3026153|NCT01088412|3744576|FG002|STARTED|Overall Study||77
3026154|NCT01088412|3744574|FG000|Safety Modified Evaluable (SME)|Overall Study||22294
3026155|NCT01088412|3744575|FG001|Safety Modified Evaluable (SME)|Overall Study||456
3026156|NCT01088412|3744576|FG002|Safety Modified Evaluable (SME)|Overall Study||0
3026157|NCT01088412|3744574|FG000|SME With at Least 1 Follow Up (FU)|Overall Study||21178
3026158|NCT01088412|3744575|FG001|SME With at Least 1 Follow Up (FU)|Overall Study||306
3026159|NCT01088412|3744576|FG002|SME With at Least 1 Follow Up (FU)|Overall Study||0
3026160|NCT01088412|3744574|FG000|SME+ >= 1 FU and Unknown Arm|Overall Study||21177
3026161|NCT01088412|3744575|FG001|SME+ >= 1 FU and Unknown Arm|Overall Study||306
3026162|NCT01088412|3744576|FG002|SME+ >= 1 FU and Unknown Arm|Overall Study||40
3026163|NCT01088412|3744574|FG000|SME+ >= 1 FU and No Previous Cancer|Overall Study||20556
3026164|NCT01088412|3744575|FG001|SME+ >= 1 FU and No Previous Cancer|Overall Study||192
3026165|NCT01088412|3744576|FG002|SME+ >= 1 FU and No Previous Cancer|Overall Study||0
3026166|NCT01088412|3744574|FG000|SME+ >= 1 FU and Previous Cancer|Overall Study||622
3026167|NCT01088412|3744575|FG001|SME+ >= 1 FU and Previous Cancer|Overall Study||114
3026168|NCT01088412|3744576|FG002|SME+ >= 1 FU and Previous Cancer|Overall Study||0
3026169|NCT01088412|3744574|FG000|COMPLETED|Overall Study||4294
3026170|NCT01088412|3744575|FG001|COMPLETED|Overall Study||21
3026171|NCT01088412|3744576|FG002|COMPLETED|Overall Study||5
3026172|NCT01088412|3744574|FG000|NOT COMPLETED|Overall Study||18017
3026173|NCT01088412|3744575|FG001|NOT COMPLETED|Overall Study||436
3026174|NCT01088412|3744576|FG002|NOT COMPLETED|Overall Study||72
3026175|NCT01088438|3744589|FG000|STARTED|Overall Study||94
3308601|NCT03021538|4041914|FG001|COMPLETED|Overall Study||7
3308602|NCT03021538|4041913|FG000|NOT COMPLETED|Overall Study||0
3308603|NCT03021538|4041914|FG001|NOT COMPLETED|Overall Study||0
3308604|NCT03021564|4041922|FG000|STARTED|Overall Study||120
3308605|NCT03021564|4041923|FG001|STARTED|Overall Study||557
3308606|NCT03021564|4041922|FG000|COMPLETED|Overall Study||36
3308607|NCT03021564|4041923|FG001|COMPLETED|Overall Study||89
3308608|NCT03021564|4041922|FG000|NOT COMPLETED|Overall Study||84
3308609|NCT03021564|4041923|FG001|NOT COMPLETED|Overall Study||468
3308610|NCT03021642|4041933|FG000|STARTED|Treatment Period 1 (Day 1)||12
3308611|NCT03021642|4041934|FG001|STARTED|Treatment Period 1 (Day 1)||12
3308612|NCT03021642|4041933|FG000|COMPLETED|Treatment Period 1 (Day 1)||12
3308613|NCT03021642|4041934|FG001|COMPLETED|Treatment Period 1 (Day 1)||12
3308614|NCT03021642|4041933|FG000|NOT COMPLETED|Treatment Period 1 (Day 1)||0
3308615|NCT03021642|4041934|FG001|NOT COMPLETED|Treatment Period 1 (Day 1)||0
3308616|NCT03021642|4041933|FG000|STARTED|Washout Period (21 Days)||12
3308617|NCT03021642|4041934|FG001|STARTED|Washout Period (21 Days)||12
3308618|NCT03021642|4041933|FG000|COMPLETED|Washout Period (21 Days)||11
3308619|NCT03021642|4041934|FG001|COMPLETED|Washout Period (21 Days)||11
3308620|NCT03021642|4041933|FG000|NOT COMPLETED|Washout Period (21 Days)||1
3308621|NCT03021642|4041934|FG001|NOT COMPLETED|Washout Period (21 Days)||1
3308622|NCT03021642|4041933|FG000|STARTED|Treatment Period 2 (Day 22)||11
3308623|NCT03021642|4041934|FG001|STARTED|Treatment Period 2 (Day 22)||11
3308624|NCT03021642|4041933|FG000|COMPLETED|Treatment Period 2 (Day 22)||11
3308625|NCT03021642|4041934|FG001|COMPLETED|Treatment Period 2 (Day 22)||11
3308626|NCT03021642|4041933|FG000|NOT COMPLETED|Treatment Period 2 (Day 22)||0
3308627|NCT03021642|4041934|FG001|NOT COMPLETED|Treatment Period 2 (Day 22)||0
3308628|NCT03021668|4041942|FG000|STARTED|Overall Study||62
3308629|NCT03021668|4041943|FG001|STARTED|Overall Study||62
3308630|NCT03021668|4041942|FG000|COMPLETED|Overall Study||62
3308631|NCT03021668|4041943|FG001|COMPLETED|Overall Study||61
3308632|NCT03021668|4041942|FG000|NOT COMPLETED|Overall Study||0
3308633|NCT03021668|4041943|FG001|NOT COMPLETED|Overall Study||1
3308634|NCT03021759|4041952|FG000|STARTED|Overall Study||1566
3308635|NCT03021759|4041953|FG001|STARTED|Overall Study||1743
3308636|NCT03021759|4041954|FG002|STARTED|Overall Study||1465
3308637|NCT03021759|4041952|FG000|COMPLETED|Overall Study|32 primary care physicians were randomized to this arm and analyzed.|1566
3308638|NCT03021759|4041953|FG001|COMPLETED|Overall Study|32 primary care physicians were randomized to this arm and analyzed.|1743
3308639|NCT03021759|4041954|FG002|COMPLETED|Overall Study|32 primary care physicians were randomized to this arm and analyzed.|1465
3308640|NCT03021759|4041952|FG000|NOT COMPLETED|Overall Study||0
3308641|NCT03021759|4041953|FG001|NOT COMPLETED|Overall Study||0
3308642|NCT03021759|4041954|FG002|NOT COMPLETED|Overall Study||0
3308643|NCT03022045|4041964|FG000|STARTED|Overall Study||9
3308644|NCT03022045|4041965|FG001|STARTED|Overall Study||8
3308645|NCT03022045|4041964|FG000|COMPLETED|Overall Study||8
3308646|NCT03022045|4041965|FG001|COMPLETED|Overall Study||6
3308647|NCT03022045|4041964|FG000|NOT COMPLETED|Overall Study||1
3308648|NCT03022045|4041965|FG001|NOT COMPLETED|Overall Study||2
3308649|NCT03022084|4041977|FG000|STARTED|Overall Study||29
3308650|NCT03022084|4041978|FG001|STARTED|Overall Study||32
3308651|NCT03022084|4041977|FG000|COMPLETED|Overall Study||27
3308652|NCT03022084|4041978|FG001|COMPLETED|Overall Study||29
3308653|NCT03022084|4041977|FG000|NOT COMPLETED|Overall Study||2
3308654|NCT03022084|4041978|FG001|NOT COMPLETED|Overall Study||3
3308655|NCT03022370|4041988|FG000|STARTED|Overall Study||677
3308656|NCT03022370|4041989|FG001|STARTED|Overall Study||674
3308657|NCT03022370|4041988|FG000|COMPLETED|Overall Study||497
3308658|NCT03022370|4041989|FG001|COMPLETED|Overall Study||553
3308659|NCT03022370|4041988|FG000|NOT COMPLETED|Overall Study||180
3308660|NCT03022370|4041989|FG001|NOT COMPLETED|Overall Study||121
3308661|NCT03022396|4042005|FG000|STARTED|Overall Study||16
3308662|NCT03022396|4042006|FG001|STARTED|Overall Study||14
3308663|NCT03022396|4042007|FG002|STARTED|Overall Study||10
3308664|NCT03022396|4042008|FG003|STARTED|Overall Study||20
3308665|NCT03022396|4042009|FG004|STARTED|Overall Study||14
3308666|NCT03022396|4042010|FG005|STARTED|Overall Study||8
3308667|NCT03022396|4042005|FG000|COMPLETED|Overall Study||16
3308668|NCT03022396|4042006|FG001|COMPLETED|Overall Study||14
3308669|NCT03022396|4042007|FG002|COMPLETED|Overall Study||10
3308670|NCT03022396|4042008|FG003|COMPLETED|Overall Study||20
3308671|NCT03022396|4042009|FG004|COMPLETED|Overall Study||14
3308672|NCT03022396|4042010|FG005|COMPLETED|Overall Study||8
3308673|NCT03022396|4042005|FG000|NOT COMPLETED|Overall Study||0
3308674|NCT03022396|4042006|FG001|NOT COMPLETED|Overall Study||0
3308675|NCT03022396|4042007|FG002|NOT COMPLETED|Overall Study||0
3308676|NCT03022396|4042008|FG003|NOT COMPLETED|Overall Study||0
3308677|NCT03022396|4042009|FG004|NOT COMPLETED|Overall Study||0
3308678|NCT03022396|4042010|FG005|NOT COMPLETED|Overall Study||0
3308679|NCT03022422|4042030|FG000|STARTED|Overall Study||8
3308680|NCT03022422|4042031|FG001|STARTED|Overall Study||10
3308681|NCT03022422|4042032|FG002|STARTED|Overall Study||23
3308682|NCT03022422|4042033|FG003|STARTED|Overall Study||12
3308683|NCT03022422|4042034|FG004|STARTED|Overall Study||5
3308684|NCT03022422|4042035|FG005|STARTED|Overall Study||5
3308685|NCT03022422|4042030|FG000|COMPLETED|Overall Study||8
3308686|NCT03022422|4042031|FG001|COMPLETED|Overall Study||10
3308687|NCT03022422|4042032|FG002|COMPLETED|Overall Study||20
3308688|NCT03022422|4042033|FG003|COMPLETED|Overall Study||12
3308689|NCT03022422|4042034|FG004|COMPLETED|Overall Study||5
3308690|NCT03022422|4042035|FG005|COMPLETED|Overall Study||5
3308691|NCT03022422|4042030|FG000|NOT COMPLETED|Overall Study||0
3308692|NCT03022422|4042031|FG001|NOT COMPLETED|Overall Study||0
3308693|NCT03022422|4042032|FG002|NOT COMPLETED|Overall Study||3
3308694|NCT03022422|4042033|FG003|NOT COMPLETED|Overall Study||0
3308695|NCT03022422|4042034|FG004|NOT COMPLETED|Overall Study||0
3308696|NCT03022422|4042035|FG005|NOT COMPLETED|Overall Study||0
3308697|NCT03022435|4042056|FG000|STARTED|Overall Study||5
3308698|NCT03022435|4042057|FG001|STARTED|Overall Study||5
3308699|NCT03022435|4042058|FG002|STARTED|Overall Study||6
3308700|NCT03022435|4042059|FG003|STARTED|Overall Study||3
3308701|NCT03022435|4042060|FG004|STARTED|Overall Study||3
3308702|NCT03022435|4042056|FG000|COMPLETED|Overall Study||5
3308703|NCT03022435|4042057|FG001|COMPLETED|Overall Study||5
3308704|NCT03022435|4042058|FG002|COMPLETED|Overall Study||6
3308705|NCT03022435|4042059|FG003|COMPLETED|Overall Study||3
3026176|NCT01088438|3744590|FG001|STARTED|Overall Study||95
3026177|NCT01088438|3744589|FG000|COMPLETED|Overall Study||65
3026178|NCT01088438|3744590|FG001|COMPLETED|Overall Study||59
3026179|NCT01088438|3744589|FG000|NOT COMPLETED|Overall Study||29
3026180|NCT01088438|3744590|FG001|NOT COMPLETED|Overall Study||36
3026181|NCT01088464|3744599|FG000|STARTED|Overall Study||3
3026182|NCT01088464|3744600|FG001|STARTED|Overall Study||6
3026183|NCT01088464|3744601|FG002|STARTED|Overall Study||6
3026184|NCT01088464|3744599|FG000|Received Any Quantity of Study Drug|Overall Study||3
3026185|NCT01088464|3744600|FG001|Received Any Quantity of Study Drug|Overall Study||6
3026186|NCT01088464|3744601|FG002|Received Any Quantity of Study Drug|Overall Study||6
3026187|NCT01088464|3744599|FG000|COMPLETED|Overall Study||3
3026188|NCT01088464|3744600|FG001|COMPLETED|Overall Study||6
3026189|NCT01088464|3744601|FG002|COMPLETED|Overall Study||6
3026190|NCT01088464|3744599|FG000|NOT COMPLETED|Overall Study||0
3026191|NCT01088464|3744600|FG001|NOT COMPLETED|Overall Study||0
3026192|NCT01088464|3744601|FG002|NOT COMPLETED|Overall Study||0
3026193|NCT01088503|3744612|FG000|STARTED|Overall Study||3123
3026194|NCT01088503|3744613|FG001|STARTED|Overall Study||8846
3026195|NCT01088503|3744614|FG002|STARTED|Overall Study||258
3026196|NCT01088503|3744612|FG000|COMPLETED|Overall Study||2941
3026197|NCT01088503|3744613|FG001|COMPLETED|Overall Study||8161
3026198|NCT01088503|3744614|FG002|COMPLETED|Overall Study||241
3026199|NCT01088503|3744612|FG000|NOT COMPLETED|Overall Study||182
3026200|NCT01088503|3744613|FG001|NOT COMPLETED|Overall Study||685
3026201|NCT01088503|3744614|FG002|NOT COMPLETED|Overall Study||17
3026202|NCT01088529|3744622|FG000|STARTED|Overall Study||44
3026203|NCT01088529|3744623|FG001|STARTED|Overall Study||22
3026204|NCT01088529|3744622|FG000|Received Treatment|Overall Study||44
3026205|NCT01088529|3744623|FG001|Received Treatment|Overall Study||21
3026206|NCT01088529|3744622|FG000|COMPLETED|Overall Study||44
3026207|NCT01088529|3744623|FG001|COMPLETED|Overall Study||21
3026208|NCT01088529|3744622|FG000|NOT COMPLETED|Overall Study||0
3026209|NCT01088529|3744623|FG001|NOT COMPLETED|Overall Study||1
3026210|NCT01088646|3744629|FG000|STARTED|Overall Study||25
3026211|NCT01088646|3744629|FG000|COMPLETED|Overall Study||25
3026212|NCT01088646|3744629|FG000|NOT COMPLETED|Overall Study||0
3026213|NCT01088672|3744634|FG000|STARTED|Overall Study||60
3026214|NCT01088672|3744634|FG000|COMPLETED|Overall Study||60
3026215|NCT01088672|3744634|FG000|NOT COMPLETED|Overall Study||0
3026216|NCT01088711|3744642|FG000|STARTED|Overall Study||18
3026217|NCT01088711|3744643|FG001|STARTED|Overall Study||6
3026218|NCT01088711|3744644|FG002|STARTED|Overall Study||6
3026219|NCT01088711|3744645|FG003|STARTED|Overall Study||2
3026220|NCT01088711|3744642|FG000|COMPLETED|Overall Study||18
3026221|NCT01088711|3744643|FG001|COMPLETED|Overall Study||6
3026222|NCT01088711|3744644|FG002|COMPLETED|Overall Study||6
3026223|NCT01088711|3744645|FG003|COMPLETED|Overall Study||2
3026224|NCT01088711|3744642|FG000|NOT COMPLETED|Overall Study||0
3026225|NCT01088711|3744643|FG001|NOT COMPLETED|Overall Study||0
3026226|NCT01088711|3744644|FG002|NOT COMPLETED|Overall Study||0
3026227|NCT01088711|3744645|FG003|NOT COMPLETED|Overall Study||0
3026228|NCT01088984|3744659|FG000|STARTED|Phase 1||5
3026229|NCT01088984|3744660|FG001|STARTED|Phase 1||6
3026230|NCT01088984|3744659|FG000|COMPLETED|Phase 1|completed follow-up up to 12 month from last dose of study drug|0
3026231|NCT01088984|3744660|FG001|COMPLETED|Phase 1|completed follow-up up to 12 month from last dose of study drug|0
3026232|NCT01088984|3744659|FG000|NOT COMPLETED|Phase 1||5
3026233|NCT01088984|3744660|FG001|NOT COMPLETED|Phase 1||6
3026234|NCT01088984|3744659|FG000|STARTED|Phase 2||0
3026235|NCT01088984|3744660|FG001|STARTED|Phase 2||32
3026236|NCT01088984|3744659|FG000|COMPLETED|Phase 2|completed follow-up up to 12 month from last dose of study drug|0
3308706|NCT03022435|4042060|FG004|COMPLETED|Overall Study||3
3308707|NCT03022435|4042056|FG000|NOT COMPLETED|Overall Study||0
3308708|NCT03022435|4042057|FG001|NOT COMPLETED|Overall Study||0
3308709|NCT03022435|4042058|FG002|NOT COMPLETED|Overall Study||0
3026237|NCT01088984|3744660|FG001|COMPLETED|Phase 2|completed follow-up up to 12 month from last dose of study drug|0
3026238|NCT01088984|3744659|FG000|NOT COMPLETED|Phase 2||0
3026239|NCT01088984|3744660|FG001|NOT COMPLETED|Phase 2||32
3026240|NCT01088997|3744671|FG000|STARTED|Overall Study||7
3026241|NCT01088997|3744672|FG001|STARTED|Overall Study||5
3026242|NCT01088997|3744671|FG000|COMPLETED|Overall Study||4
3026243|NCT01088997|3744672|FG001|COMPLETED|Overall Study||2
3308710|NCT03022435|4042059|FG003|NOT COMPLETED|Overall Study||0
3308711|NCT03022435|4042060|FG004|NOT COMPLETED|Overall Study||0
3308712|NCT03022526|4042077|FG000|STARTED|Overall Study||31
3026244|NCT01088997|3744671|FG000|NOT COMPLETED|Overall Study||3
3026245|NCT01088997|3744672|FG001|NOT COMPLETED|Overall Study||3
3026246|NCT01089023|3744681|FG000|STARTED|Overall Study||95
3026247|NCT01089023|3744681|FG000|COMPLETED|Overall Study||88
3026248|NCT01089023|3744681|FG000|NOT COMPLETED|Overall Study||7
3026249|NCT01089062|3744691|FG000|STARTED|Visit 2 (Randomization)||4
3026250|NCT01089062|3744692|FG001|STARTED|Visit 2 (Randomization)||4
3026251|NCT01089062|3744693|FG002|STARTED|Visit 2 (Randomization)||4
3026252|NCT01089062|3744694|FG003|STARTED|Visit 2 (Randomization)||4
3026253|NCT01089062|3744695|FG004|STARTED|Visit 2 (Randomization)||4
3026254|NCT01089062|3744696|FG005|STARTED|Visit 2 (Randomization)||4
3026255|NCT01089062|3744691|FG000|COMPLETED|Visit 2 (Randomization)||3
3026256|NCT01089062|3744692|FG001|COMPLETED|Visit 2 (Randomization)||3
3026257|NCT01089062|3744693|FG002|COMPLETED|Visit 2 (Randomization)||3
3026258|NCT01089062|3744694|FG003|COMPLETED|Visit 2 (Randomization)||4
3026259|NCT01089062|3744695|FG004|COMPLETED|Visit 2 (Randomization)||3
3026260|NCT01089062|3744696|FG005|COMPLETED|Visit 2 (Randomization)||3
3026261|NCT01089062|3744691|FG000|NOT COMPLETED|Visit 2 (Randomization)||1
3026262|NCT01089062|3744692|FG001|NOT COMPLETED|Visit 2 (Randomization)||1
3026263|NCT01089062|3744693|FG002|NOT COMPLETED|Visit 2 (Randomization)||1
3026264|NCT01089062|3744694|FG003|NOT COMPLETED|Visit 2 (Randomization)||0
3026265|NCT01089062|3744695|FG004|NOT COMPLETED|Visit 2 (Randomization)||1
3165878|NCT01902173|3893451|FG002|STARTED|Phase 1 Doublet Regimen Cohort 1||0
3165879|NCT01902173|3893452|FG003|STARTED|Phase 1 Doublet Regimen Cohort 1||0
3165880|NCT01902173|3893453|FG004|STARTED|Phase 1 Doublet Regimen Cohort 1||0
3165881|NCT01902173|3893454|FG005|STARTED|Phase 1 Doublet Regimen Cohort 1||0
3165882|NCT01902173|3893449|FG000|COMPLETED|Phase 1 Doublet Regimen Cohort 1||0
3165883|NCT01902173|3893450|FG001|COMPLETED|Phase 1 Doublet Regimen Cohort 1||0
3165884|NCT01902173|3893451|FG002|COMPLETED|Phase 1 Doublet Regimen Cohort 1||0
3165885|NCT01902173|3893452|FG003|COMPLETED|Phase 1 Doublet Regimen Cohort 1||0
3165886|NCT01902173|3893453|FG004|COMPLETED|Phase 1 Doublet Regimen Cohort 1||0
3165887|NCT01902173|3893454|FG005|COMPLETED|Phase 1 Doublet Regimen Cohort 1||0
3165888|NCT01902173|3893449|FG000|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 1||3
3165889|NCT01902173|3893450|FG001|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 1||0
3165890|NCT01902173|3893451|FG002|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 1||0
3165891|NCT01902173|3893452|FG003|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 1||0
3026266|NCT01089062|3744696|FG005|NOT COMPLETED|Visit 2 (Randomization)||1
3026267|NCT01089062|3744691|FG000|STARTED|Visit 3||3
3026268|NCT01089062|3744692|FG001|STARTED|Visit 3||3
3026269|NCT01089062|3744693|FG002|STARTED|Visit 3||3
3026270|NCT01089062|3744694|FG003|STARTED|Visit 3||4
3026271|NCT01089062|3744695|FG004|STARTED|Visit 3||3
3026272|NCT01089062|3744696|FG005|STARTED|Visit 3||3
3026273|NCT01089062|3744691|FG000|COMPLETED|Visit 3||3
3026274|NCT01089062|3744692|FG001|COMPLETED|Visit 3||3
3026275|NCT01089062|3744693|FG002|COMPLETED|Visit 3||3
3026276|NCT01089062|3744694|FG003|COMPLETED|Visit 3||3
3026277|NCT01089062|3744695|FG004|COMPLETED|Visit 3||3
3026278|NCT01089062|3744696|FG005|COMPLETED|Visit 3||3
3026279|NCT01089062|3744691|FG000|NOT COMPLETED|Visit 3||0
3026280|NCT01089062|3744692|FG001|NOT COMPLETED|Visit 3||0
3026281|NCT01089062|3744693|FG002|NOT COMPLETED|Visit 3||0
3026282|NCT01089062|3744694|FG003|NOT COMPLETED|Visit 3||1
3026283|NCT01089062|3744695|FG004|NOT COMPLETED|Visit 3||0
3026284|NCT01089062|3744696|FG005|NOT COMPLETED|Visit 3||0
3026285|NCT01089062|3744691|FG000|STARTED|Visit 4||3
3026286|NCT01089062|3744692|FG001|STARTED|Visit 4||3
3026287|NCT01089062|3744693|FG002|STARTED|Visit 4||3
3026288|NCT01089062|3744694|FG003|STARTED|Visit 4||3
3026289|NCT01089062|3744695|FG004|STARTED|Visit 4||3
3026290|NCT01089062|3744696|FG005|STARTED|Visit 4||3
3026291|NCT01089062|3744691|FG000|COMPLETED|Visit 4||3
3026292|NCT01089062|3744692|FG001|COMPLETED|Visit 4||3
3026293|NCT01089062|3744693|FG002|COMPLETED|Visit 4||3
3026294|NCT01089062|3744694|FG003|COMPLETED|Visit 4||3
3026295|NCT01089062|3744695|FG004|COMPLETED|Visit 4||3
3026296|NCT01089062|3744696|FG005|COMPLETED|Visit 4||3
3026297|NCT01089062|3744691|FG000|NOT COMPLETED|Visit 4||0
3026298|NCT01089062|3744692|FG001|NOT COMPLETED|Visit 4||0
3026299|NCT01089062|3744693|FG002|NOT COMPLETED|Visit 4||0
3026300|NCT01089062|3744694|FG003|NOT COMPLETED|Visit 4||0
3026301|NCT01089062|3744695|FG004|NOT COMPLETED|Visit 4||0
3026302|NCT01089062|3744696|FG005|NOT COMPLETED|Visit 4||0
3026303|NCT01089062|3744691|FG000|STARTED|Follow-up Visit (Final Visit)||3
3026304|NCT01089062|3744692|FG001|STARTED|Follow-up Visit (Final Visit)||3
3026305|NCT01089062|3744693|FG002|STARTED|Follow-up Visit (Final Visit)||3
3165892|NCT01902173|3893453|FG004|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 1||0
3026306|NCT01089062|3744694|FG003|STARTED|Follow-up Visit (Final Visit)||3
3026307|NCT01089062|3744695|FG004|STARTED|Follow-up Visit (Final Visit)||3
3026308|NCT01089062|3744696|FG005|STARTED|Follow-up Visit (Final Visit)||3
3026309|NCT01089062|3744691|FG000|COMPLETED|Follow-up Visit (Final Visit)||3
3026310|NCT01089062|3744692|FG001|COMPLETED|Follow-up Visit (Final Visit)||3
3026311|NCT01089062|3744693|FG002|COMPLETED|Follow-up Visit (Final Visit)||3
3026312|NCT01089062|3744694|FG003|COMPLETED|Follow-up Visit (Final Visit)||3
3026313|NCT01089062|3744695|FG004|COMPLETED|Follow-up Visit (Final Visit)||3
3026314|NCT01089062|3744696|FG005|COMPLETED|Follow-up Visit (Final Visit)||3
3026315|NCT01089062|3744691|FG000|NOT COMPLETED|Follow-up Visit (Final Visit)||0
3165893|NCT01902173|3893454|FG005|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 1||0
3165894|NCT01902173|3893449|FG000|STARTED|Phase 1 Doublet Regimen Cohort 2||0
3026316|NCT01089062|3744692|FG001|NOT COMPLETED|Follow-up Visit (Final Visit)||0
3026317|NCT01089062|3744693|FG002|NOT COMPLETED|Follow-up Visit (Final Visit)||0
3026318|NCT01089062|3744694|FG003|NOT COMPLETED|Follow-up Visit (Final Visit)||0
3026319|NCT01089062|3744695|FG004|NOT COMPLETED|Follow-up Visit (Final Visit)||0
3026320|NCT01089062|3744696|FG005|NOT COMPLETED|Follow-up Visit (Final Visit)||0
3026321|NCT01089127|3744711|FG000|STARTED|Overall Study||92
3026322|NCT01089127|3744712|FG001|STARTED|Overall Study||91
3026323|NCT01089127|3744713|FG002|STARTED|Overall Study||94
3026324|NCT01089127|3744714|FG003|STARTED|Overall Study||92
3026325|NCT01089127|3744715|FG004|STARTED|Overall Study||92
3026326|NCT01089127|3744716|FG005|STARTED|Overall Study||91
3026327|NCT01089127|3744711|FG000|Exposed to Study Drug|Overall Study|3 randomized patients in this group were not exposed to study treatment.|89
3026328|NCT01089127|3744712|FG001|Exposed to Study Drug|Overall Study|1 randomized patient in this group was not exposed to study treatment.|90
3026329|NCT01089127|3744713|FG002|Exposed to Study Drug|Overall Study||94
3026330|NCT01089127|3744714|FG003|Exposed to Study Drug|Overall Study||92
3026331|NCT01089127|3744715|FG004|Exposed to Study Drug|Overall Study|1 randomized patient in this group was not exposed to study treatment.|91
3026332|NCT01089127|3744716|FG005|Exposed to Study Drug|Overall Study||91
3026333|NCT01089127|3744711|FG000|COMPLETED|Overall Study||84
3026334|NCT01089127|3744712|FG001|COMPLETED|Overall Study||86
3026335|NCT01089127|3744713|FG002|COMPLETED|Overall Study||92
3026336|NCT01089127|3744714|FG003|COMPLETED|Overall Study||91
3026337|NCT01089127|3744715|FG004|COMPLETED|Overall Study||90
3026338|NCT01089127|3744716|FG005|COMPLETED|Overall Study||88
3026339|NCT01089127|3744711|FG000|NOT COMPLETED|Overall Study||8
3026340|NCT01089127|3744712|FG001|NOT COMPLETED|Overall Study||5
3026341|NCT01089127|3744713|FG002|NOT COMPLETED|Overall Study||2
3026342|NCT01089127|3744714|FG003|NOT COMPLETED|Overall Study||1
3026343|NCT01089127|3744715|FG004|NOT COMPLETED|Overall Study||2
3026344|NCT01089127|3744716|FG005|NOT COMPLETED|Overall Study||3
3026345|NCT01089231|3744734|FG000|STARTED|Overall Study||10
3026346|NCT01089231|3744735|FG001|STARTED|Overall Study||10
3026347|NCT01089231|3744736|FG002|STARTED|Overall Study||10
3026348|NCT01089231|3744737|FG003|STARTED|Overall Study||10
3026349|NCT01089231|3744734|FG000|COMPLETED|Overall Study|4 subjects excluded (2 alcohol use / TG level changes; 1 use of not allowed drugs; 1 low RNA yield)|6
3026350|NCT01089231|3744735|FG001|COMPLETED|Overall Study|2 subjects excluded (1 highly elevated TG and TC data; 1 elevated inflammation (CRP level))|8
3026351|NCT01089231|3744736|FG002|COMPLETED|Overall Study|2 subject excluded (1 use of not allowed drugs; 1 low RNA yield)|8
3026352|NCT01089231|3744737|FG003|COMPLETED|Overall Study|1 subject excluded (low RNA yield)|9
3026353|NCT01089231|3744734|FG000|NOT COMPLETED|Overall Study||4
3026354|NCT01089231|3744735|FG001|NOT COMPLETED|Overall Study||2
3026355|NCT01089231|3744736|FG002|NOT COMPLETED|Overall Study||2
3026356|NCT01089231|3744737|FG003|NOT COMPLETED|Overall Study||1
3026357|NCT01089361|3744749|FG000|STARTED|Overall Study||9
3026358|NCT01089361|3744750|FG001|STARTED|Overall Study||10
3026359|NCT01089361|3744749|FG000|COMPLETED|Overall Study||8
3026360|NCT01089361|3744750|FG001|COMPLETED|Overall Study||10
3026361|NCT01089361|3744749|FG000|NOT COMPLETED|Overall Study||1
3026362|NCT01089361|3744750|FG001|NOT COMPLETED|Overall Study||0
3026363|NCT01089413|3744761|FG000|STARTED|Overall Study||201
3026364|NCT01089413|3744761|FG000|Received Bevacizumab in First Line|Overall Study||199
3026365|NCT01089413|3744761|FG000|COMPLETED|Overall Study||0
3026366|NCT01089413|3744761|FG000|NOT COMPLETED|Overall Study||201
3026367|NCT01089504|3744773|FG000|STARTED|Overall Study||8
3026368|NCT01089504|3744774|FG001|STARTED|Overall Study||5
3026369|NCT01089504|3744773|FG000|COMPLETED|Overall Study||5
3026370|NCT01089504|3744774|FG001|COMPLETED|Overall Study||4
3026371|NCT01089504|3744773|FG000|NOT COMPLETED|Overall Study||3
3026372|NCT01089504|3744774|FG001|NOT COMPLETED|Overall Study||1
3026373|NCT01089517|3744783|FG000|STARTED|Overall Study||148
3026374|NCT01089517|3744784|FG001|STARTED|Overall Study||149
3026375|NCT01089517|3744785|FG002|STARTED|Overall Study||152
3026376|NCT01089517|3744783|FG000|COMPLETED|Overall Study||144
3026377|NCT01089517|3744784|FG001|COMPLETED|Overall Study||144
3026378|NCT01089517|3744785|FG002|COMPLETED|Overall Study||147
3026379|NCT01089517|3744783|FG000|NOT COMPLETED|Overall Study||4
3026380|NCT01089517|3744784|FG001|NOT COMPLETED|Overall Study||5
3026381|NCT01089517|3744785|FG002|NOT COMPLETED|Overall Study||5
3026382|NCT01089543|3744797|FG000|STARTED|Overall Study||84
3026383|NCT01089543|3744798|FG001|STARTED|Overall Study||85
3026384|NCT01089543|3744799|FG002|STARTED|Overall Study||84
3026385|NCT01089543|3744800|FG003|STARTED|Overall Study||85
3026386|NCT01089543|3744797|FG000|COMPLETED|Overall Study||81
3026387|NCT01089543|3744798|FG001|COMPLETED|Overall Study||81
3026388|NCT01089543|3744799|FG002|COMPLETED|Overall Study||81
3026389|NCT01089543|3744800|FG003|COMPLETED|Overall Study||83
3026390|NCT01089543|3744797|FG000|NOT COMPLETED|Overall Study||3
3026391|NCT01089543|3744798|FG001|NOT COMPLETED|Overall Study||4
3026392|NCT01089543|3744799|FG002|NOT COMPLETED|Overall Study||3
3026393|NCT01089543|3744800|FG003|NOT COMPLETED|Overall Study||2
3026394|NCT01089556|3744812|FG000|STARTED|Study Period II (Weeks 1-8)||404
3026395|NCT01089556|3744813|FG001|STARTED|Study Period II (Weeks 1-8)||407
3026396|NCT01089556|3744814|FG002|STARTED|Study Period II (Weeks 1-8)||0
3026397|NCT01089556|3744815|FG003|STARTED|Study Period II (Weeks 1-8)||0
3026398|NCT01089556|3744816|FG004|STARTED|Study Period II (Weeks 1-8)||0
3026399|NCT01089556|3744817|FG005|STARTED|Study Period II (Weeks 1-8)||0
3308713|NCT03022526|4042078|FG001|STARTED|Overall Study||30
3308714|NCT03022526|4042077|FG000|COMPLETED|Overall Study||21
3308715|NCT03022526|4042078|FG001|COMPLETED|Overall Study||25
3026400|NCT01089556|3744812|FG000|Safety Population|Study Period II (Weeks 1-8)|Received at least 1 dose of study drug.|401
3026401|NCT01089556|3744813|FG001|Safety Population|Study Period II (Weeks 1-8)|Received at least 1 dose of study drug.|403
3026402|NCT01089556|3744814|FG002|Safety Population|Study Period II (Weeks 1-8)||0
3026403|NCT01089556|3744815|FG003|Safety Population|Study Period II (Weeks 1-8)||0
3026404|NCT01089556|3744816|FG004|Safety Population|Study Period II (Weeks 1-8)||0
3026405|NCT01089556|3744817|FG005|Safety Population|Study Period II (Weeks 1-8)||0
3026406|NCT01089556|3744812|FG000|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||158
3026407|NCT01089556|3744813|FG001|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||205
3026408|NCT01089556|3744814|FG002|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||0
3026409|NCT01089556|3744815|FG003|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||0
3026410|NCT01089556|3744816|FG004|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||0
3026411|NCT01089556|3744817|FG005|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||0
3026412|NCT01089556|3744812|FG000|COMPLETED|Study Period II (Weeks 1-8)||333
3026413|NCT01089556|3744813|FG001|COMPLETED|Study Period II (Weeks 1-8)||333
3026414|NCT01089556|3744814|FG002|COMPLETED|Study Period II (Weeks 1-8)||0
3026415|NCT01089556|3744815|FG003|COMPLETED|Study Period II (Weeks 1-8)||0
3026416|NCT01089556|3744816|FG004|COMPLETED|Study Period II (Weeks 1-8)||0
3026417|NCT01089556|3744817|FG005|COMPLETED|Study Period II (Weeks 1-8)||0
3026418|NCT01089556|3744812|FG000|NOT COMPLETED|Study Period II (Weeks 1-8)||71
3026419|NCT01089556|3744813|FG001|NOT COMPLETED|Study Period II (Weeks 1-8)||74
3026420|NCT01089556|3744814|FG002|NOT COMPLETED|Study Period II (Weeks 1-8)||0
3026421|NCT01089556|3744815|FG003|NOT COMPLETED|Study Period II (Weeks 1-8)||0
3026422|NCT01089556|3744816|FG004|NOT COMPLETED|Study Period II (Weeks 1-8)||0
3026423|NCT01089556|3744817|FG005|NOT COMPLETED|Study Period II (Weeks 1-8)||0
3026424|NCT01089556|3744812|FG000|STARTED|Study Period III (Weeks 9-16)||0
3026425|NCT01089556|3744813|FG001|STARTED|Study Period III (Weeks 9-16)||0
3026426|NCT01089556|3744814|FG002|STARTED|Study Period III (Weeks 9-16)|Of those who completed SPII, 10 non-responders did not enter SPIII, while 4 responders entered SPIII|74
3026427|NCT01089556|3744815|FG003|STARTED|Study Period III (Weeks 9-16)|Of those who completed SPII, 6 non-responders did not enter SPIII, while 3 responders entered SPIII|75
3026428|NCT01089556|3744816|FG004|STARTED|Study Period III (Weeks 9-16)|Of those who completed SPII, 10 non-responders did not enter SPIII, while 4 responders entered SPIII|95
3026429|NCT01089556|3744817|FG005|STARTED|Study Period III (Weeks 9-16)|Of those who completed SPII, 6 non-responders did not enter SPIII, while 1 responders entered SPIII|99
3026430|NCT01089556|3744812|FG000|Efficacy and Safety Population|Study Period III (Weeks 9-16)||0
3026431|NCT01089556|3744813|FG001|Efficacy and Safety Population|Study Period III (Weeks 9-16)||0
3026432|NCT01089556|3744814|FG002|Efficacy and Safety Population|Study Period III (Weeks 9-16)|Received ≥1 dose study drug, had Week 8 and at least 1 assessment during Weeks 9-16 (SPIII)|73
3026433|NCT01089556|3744815|FG003|Efficacy and Safety Population|Study Period III (Weeks 9-16)|Received ≥1 dose study drug, had Week 8 and at least 1 assessment during Weeks 9-16 (SPIII)|75
3026434|NCT01089556|3744816|FG004|Efficacy and Safety Population|Study Period III (Weeks 9-16)|Received ≥1 dose study drug, had Week 8 and at least 1 assessment during Weeks 9-16 (SPIII)|94
3026435|NCT01089556|3744817|FG005|Efficacy and Safety Population|Study Period III (Weeks 9-16)|Received ≥1 dose study drug, had Week 8 and at least 1 assessment during Weeks 9-16 (SPIII)|97
3026436|NCT01089556|3744812|FG000|COMPLETED|Study Period III (Weeks 9-16)||0
3026437|NCT01089556|3744813|FG001|COMPLETED|Study Period III (Weeks 9-16)||0
3026438|NCT01089556|3744814|FG002|COMPLETED|Study Period III (Weeks 9-16)||60
3026439|NCT01089556|3744815|FG003|COMPLETED|Study Period III (Weeks 9-16)||66
3026440|NCT01089556|3744816|FG004|COMPLETED|Study Period III (Weeks 9-16)||83
3026441|NCT01089556|3744817|FG005|COMPLETED|Study Period III (Weeks 9-16)||92
3026442|NCT01089556|3744812|FG000|NOT COMPLETED|Study Period III (Weeks 9-16)||0
3026443|NCT01089556|3744813|FG001|NOT COMPLETED|Study Period III (Weeks 9-16)||0
3026444|NCT01089556|3744814|FG002|NOT COMPLETED|Study Period III (Weeks 9-16)||14
3026445|NCT01089556|3744815|FG003|NOT COMPLETED|Study Period III (Weeks 9-16)||9
3026446|NCT01089556|3744816|FG004|NOT COMPLETED|Study Period III (Weeks 9-16)||12
3026447|NCT01089556|3744817|FG005|NOT COMPLETED|Study Period III (Weeks 9-16)||7
3026448|NCT01089569|3744832|FG000|STARTED|Overall Study||20
3026449|NCT01089569|3744833|FG001|STARTED|Overall Study||20
3026450|NCT01089569|3744834|FG002|STARTED|Overall Study||20
3026451|NCT01089569|3744832|FG000|COMPLETED|Overall Study||16
3026452|NCT01089569|3744833|FG001|COMPLETED|Overall Study||17
3026453|NCT01089569|3744834|FG002|COMPLETED|Overall Study||16
3308716|NCT03022526|4042077|FG000|NOT COMPLETED|Overall Study||10
3308717|NCT03022526|4042078|FG001|NOT COMPLETED|Overall Study||5
3308718|NCT03022617|4042084|FG000|STARTED|Overall Study||12
3308719|NCT03022617|4042084|FG000|COMPLETED|Overall Study||6
3308720|NCT03022617|4042084|FG000|NOT COMPLETED|Overall Study||6
3308721|NCT03022630|4042090|FG000|STARTED|Overall Study||31
3308722|NCT03022630|4042091|FG001|STARTED|Overall Study||32
3308723|NCT03022630|4042090|FG000|COMPLETED|Overall Study||22
3308724|NCT03022630|4042091|FG001|COMPLETED|Overall Study||20
3308725|NCT03022630|4042090|FG000|NOT COMPLETED|Overall Study||9
3308726|NCT03022630|4042091|FG001|NOT COMPLETED|Overall Study||12
3308727|NCT03022799|4042115|FG000|STARTED|Overall Study||6
3308728|NCT03022799|4042116|FG001|STARTED|Overall Study||6
3308729|NCT03022799|4042117|FG002|STARTED|Overall Study||6
3026454|NCT01089569|3744832|FG000|NOT COMPLETED|Overall Study||4
3026455|NCT01089569|3744833|FG001|NOT COMPLETED|Overall Study||3
3026456|NCT01089569|3744834|FG002|NOT COMPLETED|Overall Study||4
3026457|NCT01089582|3744842|FG000|STARTED|Overall Study||603
3026458|NCT01089582|3744842|FG000|COMPLETED|Overall Study|1 subject died during the study; 1 subject died following permanent discontinuation from the study.|573
3026459|NCT01089582|3744842|FG000|NOT COMPLETED|Overall Study||30
3026460|NCT01089595|3744848|FG000|STARTED|Overall Study||2
3026461|NCT01089595|3744849|FG001|STARTED|Overall Study||3
3026462|NCT01089595|3744848|FG000|COMPLETED|Overall Study||2
3026463|NCT01089595|3744849|FG001|COMPLETED|Overall Study||3
3026464|NCT01089595|3744848|FG000|NOT COMPLETED|Overall Study||0
3026465|NCT01089595|3744849|FG001|NOT COMPLETED|Overall Study||0
3026466|NCT01089608|3744859|FG000|STARTED|Overall Study||43
3026467|NCT01089608|3744860|FG001|STARTED|Overall Study||50
3026468|NCT01089608|3744859|FG000|COMPLETED|Overall Study||43
3026469|NCT01089608|3744860|FG001|COMPLETED|Overall Study||44
3026470|NCT01089608|3744859|FG000|NOT COMPLETED|Overall Study||0
3026471|NCT01089608|3744860|FG001|NOT COMPLETED|Overall Study||6
3026472|NCT01089647|3744868|FG000|STARTED|Overall Study||17
3026473|NCT01089647|3744869|FG001|STARTED|Overall Study||17
3026474|NCT01089647|3744868|FG000|COMPLETED|Overall Study||13
3026475|NCT01089647|3744869|FG001|COMPLETED|Overall Study||13
3026476|NCT01089647|3744868|FG000|NOT COMPLETED|Overall Study||4
3026477|NCT01089647|3744869|FG001|NOT COMPLETED|Overall Study||4
3026478|NCT01089725|3744880|FG000|STARTED|Overall Study||72
3026479|NCT01089725|3744881|FG001|STARTED|Overall Study||75
3026480|NCT01089725|3744882|FG002|STARTED|Overall Study||65
3026481|NCT01089725|3744883|FG003|STARTED|Overall Study||87
3026482|NCT01089725|3744884|FG004|STARTED|Overall Study||86
3026483|NCT01089725|3744880|FG000|Treated|Overall Study||72
3026484|NCT01089725|3744881|FG001|Treated|Overall Study||74
3026485|NCT01089725|3744882|FG002|Treated|Overall Study||63
3026486|NCT01089725|3744883|FG003|Treated|Overall Study||86
3026487|NCT01089725|3744884|FG004|Treated|Overall Study||84
3026488|NCT01089725|3744880|FG000|COMPLETED|Overall Study||6
3026489|NCT01089725|3744881|FG001|COMPLETED|Overall Study||7
3026490|NCT01089725|3744882|FG002|COMPLETED|Overall Study||4
3026491|NCT01089725|3744883|FG003|COMPLETED|Overall Study||8
3026492|NCT01089725|3744884|FG004|COMPLETED|Overall Study||6
3026493|NCT01089725|3744880|FG000|NOT COMPLETED|Overall Study||66
3026494|NCT01089725|3744881|FG001|NOT COMPLETED|Overall Study||68
3026495|NCT01089725|3744882|FG002|NOT COMPLETED|Overall Study||61
3026496|NCT01089725|3744883|FG003|NOT COMPLETED|Overall Study||79
3026497|NCT01089725|3744884|FG004|NOT COMPLETED|Overall Study||80
3026498|NCT01089751|3744902|FG000|STARTED|Overall Study||163
3026499|NCT01089751|3744903|FG001|STARTED|Overall Study||159
3026500|NCT01089751|3744902|FG000|COMPLETED|Overall Study||129
3026501|NCT01089751|3744903|FG001|COMPLETED|Overall Study||132
3026502|NCT01089751|3744902|FG000|NOT COMPLETED|Overall Study||34
3026503|NCT01089751|3744903|FG001|NOT COMPLETED|Overall Study||27
3038061|NCT01151540|3757432|FG000|COMPLETED|Overall Study||41
3038062|NCT01151540|3757432|FG000|NOT COMPLETED|Overall Study||13
3038063|NCT01151579|3757438|FG000|STARTED|Overall Study||58
3038064|NCT01151579|3757439|FG001|STARTED|Overall Study||31
3038065|NCT01151579|3757438|FG000|COMPLETED|Overall Study||46
3038066|NCT01151579|3757439|FG001|COMPLETED|Overall Study||24
3038067|NCT01151579|3757438|FG000|NOT COMPLETED|Overall Study||12
3038068|NCT01151579|3757439|FG001|NOT COMPLETED|Overall Study||7
3038069|NCT01151618|3757445|FG000|STARTED|Overall Study||22
3038070|NCT01151618|3757445|FG000|COMPLETED|Overall Study||13
3038071|NCT01151618|3757445|FG000|NOT COMPLETED|Overall Study||9
3038072|NCT01151761|3757449|FG000|STARTED|Overall Study||2
3038073|NCT01151761|3757449|FG000|COMPLETED|Overall Study||2
3038074|NCT01151761|3757449|FG000|NOT COMPLETED|Overall Study||0
3038075|NCT01151813|3757453|FG000|STARTED|Period 1||8
3038076|NCT01151813|3757454|FG001|STARTED|Period 1||7
3038077|NCT01151813|3757453|FG000|COMPLETED|Period 1||8
3038078|NCT01151813|3757454|FG001|COMPLETED|Period 1||7
3038079|NCT01151813|3757453|FG000|NOT COMPLETED|Period 1||0
3038080|NCT01151813|3757454|FG001|NOT COMPLETED|Period 1||0
3038081|NCT01151813|3757453|FG000|STARTED|Period 2||8
3038082|NCT01151813|3757454|FG001|STARTED|Period 2||7
3038083|NCT01151813|3757453|FG000|COMPLETED|Period 2||8
3038084|NCT01151813|3757454|FG001|COMPLETED|Period 2||7
3038085|NCT01151813|3757453|FG000|NOT COMPLETED|Period 2||0
3038086|NCT01151813|3757454|FG001|NOT COMPLETED|Period 2||0
3038087|NCT01151852|3757463|FG000|STARTED|Overall Study||41
3038088|NCT01151852|3757464|FG001|STARTED|Overall Study||40
3038089|NCT01151852|3757463|FG000|COMPLETED|Overall Study||41
3038090|NCT01151852|3757464|FG001|COMPLETED|Overall Study||40
3038091|NCT01151852|3757463|FG000|NOT COMPLETED|Overall Study||0
3038092|NCT01151852|3757464|FG001|NOT COMPLETED|Overall Study||0
3038093|NCT01152021|3757472|FG000|STARTED|Overall Study||8
3038094|NCT01152021|3757473|FG001|STARTED|Overall Study||7
3038095|NCT01152021|3757472|FG000|COMPLETED|Overall Study||2
3038096|NCT01152021|3757473|FG001|COMPLETED|Overall Study||1
3038097|NCT01152021|3757472|FG000|NOT COMPLETED|Overall Study||6
3038098|NCT01152021|3757473|FG001|NOT COMPLETED|Overall Study||6
3038099|NCT01152112|3757483|FG000|STARTED|Overall Study||42
3038100|NCT01152112|3757484|FG001|STARTED|Overall Study||32
3038101|NCT01152112|3757483|FG000|COMPLETED|Overall Study||42
3038102|NCT01152112|3757484|FG001|COMPLETED|Overall Study||32
3038103|NCT01152112|3757483|FG000|NOT COMPLETED|Overall Study||0
3026504|NCT01090011|3744909|FG000|STARTED|Overall Study||171
3026505|NCT01090011|3744909|FG000|COMPLETED|Overall Study||0
3026506|NCT01090011|3744909|FG000|NOT COMPLETED|Overall Study||171
3026507|NCT01090050|3744923|FG000|STARTED|Overall Study||16
3026508|NCT01090050|3744924|FG001|STARTED|Overall Study||12
3026509|NCT01090050|3744923|FG000|COMPLETED|Overall Study||15
3026510|NCT01090050|3744924|FG001|COMPLETED|Overall Study||5
3026511|NCT01090050|3744923|FG000|NOT COMPLETED|Overall Study||1
3026512|NCT01090050|3744924|FG001|NOT COMPLETED|Overall Study||7
3026513|NCT01090063|3744934|FG000|STARTED|Screen||28
3026514|NCT01090063|3744934|FG000|COMPLETED|Screen||24
3026515|NCT01090063|3744934|FG000|NOT COMPLETED|Screen||4
3026516|NCT01090063|3744934|FG000|STARTED|Treatment||24
3026517|NCT01090063|3744934|FG000|COMPLETED|Treatment||20
3026518|NCT01090063|3744934|FG000|NOT COMPLETED|Treatment||4
3026519|NCT01090076|3744950|FG000|STARTED|Overall Study||12
3026520|NCT01090076|3744951|FG001|STARTED|Overall Study||14
3026521|NCT01090076|3744950|FG000|COMPLETED|Overall Study||11
3026522|NCT01090076|3744951|FG001|COMPLETED|Overall Study||12
3026523|NCT01090076|3744950|FG000|NOT COMPLETED|Overall Study||1
3026524|NCT01090076|3744951|FG001|NOT COMPLETED|Overall Study||2
3026525|NCT01090102|3744961|FG000|STARTED|First 12 Weeks||15
3026526|NCT01090102|3744962|FG001|STARTED|First 12 Weeks||18
3026527|NCT01090102|3744961|FG000|COMPLETED|First 12 Weeks||11
3026528|NCT01090102|3744962|FG001|COMPLETED|First 12 Weeks||16
3026529|NCT01090102|3744961|FG000|NOT COMPLETED|First 12 Weeks||4
3026530|NCT01090102|3744962|FG001|NOT COMPLETED|First 12 Weeks||2
3026531|NCT01090102|3744961|FG000|STARTED|Second 12 Weeks||11
3026532|NCT01090102|3744962|FG001|STARTED|Second 12 Weeks||16
3026533|NCT01090102|3744961|FG000|COMPLETED|Second 12 Weeks||11
3026534|NCT01090102|3744962|FG001|COMPLETED|Second 12 Weeks||15
3026535|NCT01090102|3744961|FG000|NOT COMPLETED|Second 12 Weeks||0
3026536|NCT01090102|3744962|FG001|NOT COMPLETED|Second 12 Weeks||1
3026537|NCT01090180|3744970|FG000|STARTED|Overall Study||33
3026538|NCT01090180|3744971|FG001|STARTED|Overall Study||29
3026539|NCT01090180|3744970|FG000|COMPLETED|Overall Study||22
3026540|NCT01090180|3744971|FG001|COMPLETED|Overall Study||21
3026541|NCT01090180|3744970|FG000|NOT COMPLETED|Overall Study||11
3026542|NCT01090180|3744971|FG001|NOT COMPLETED|Overall Study||8
3026543|NCT01090310|3744981|FG000|STARTED|Core Study||29
3026544|NCT01090310|3744982|FG001|STARTED|Core Study||31
3026545|NCT01090310|3744983|FG002|STARTED|Core Study||31
3026546|NCT01090310|3744984|FG003|STARTED|Core Study||34
3026547|NCT01090310|3744981|FG000|COMPLETED|Core Study||21
3026548|NCT01090310|3744982|FG001|COMPLETED|Core Study||20
3026549|NCT01090310|3744983|FG002|COMPLETED|Core Study||24
3026550|NCT01090310|3744984|FG003|COMPLETED|Core Study||27
3165895|NCT01902173|3893450|FG001|STARTED|Phase 1 Doublet Regimen Cohort 2||9
3165896|NCT01902173|3893451|FG002|STARTED|Phase 1 Doublet Regimen Cohort 2||0
3165897|NCT01902173|3893452|FG003|STARTED|Phase 1 Doublet Regimen Cohort 2||0
3165898|NCT01902173|3893453|FG004|STARTED|Phase 1 Doublet Regimen Cohort 2||0
3165899|NCT01902173|3893454|FG005|STARTED|Phase 1 Doublet Regimen Cohort 2||0
3165900|NCT01902173|3893449|FG000|COMPLETED|Phase 1 Doublet Regimen Cohort 2||0
3165901|NCT01902173|3893450|FG001|COMPLETED|Phase 1 Doublet Regimen Cohort 2||0
3165902|NCT01902173|3893451|FG002|COMPLETED|Phase 1 Doublet Regimen Cohort 2||0
3165903|NCT01902173|3893452|FG003|COMPLETED|Phase 1 Doublet Regimen Cohort 2||0
3165904|NCT01902173|3893453|FG004|COMPLETED|Phase 1 Doublet Regimen Cohort 2||0
3165905|NCT01902173|3893454|FG005|COMPLETED|Phase 1 Doublet Regimen Cohort 2||0
3165906|NCT01902173|3893449|FG000|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 2||0
3165907|NCT01902173|3893450|FG001|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 2||9
3165908|NCT01902173|3893451|FG002|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 2||0
3308730|NCT03022799|4042118|FG003|STARTED|Overall Study||6
3308731|NCT03022799|4042119|FG004|STARTED|Overall Study||6
3026551|NCT01090310|3744981|FG000|NOT COMPLETED|Core Study||8
3026552|NCT01090310|3744982|FG001|NOT COMPLETED|Core Study||11
3026553|NCT01090310|3744983|FG002|NOT COMPLETED|Core Study||7
3026554|NCT01090310|3744984|FG003|NOT COMPLETED|Core Study||7
3026555|NCT01090310|3744981|FG000|STARTED|Extension Study||17
3026556|NCT01090310|3744982|FG001|STARTED|Extension Study||16
3026557|NCT01090310|3744983|FG002|STARTED|Extension Study||16
3026558|NCT01090310|3744984|FG003|STARTED|Extension Study||21
3026559|NCT01090310|3744981|FG000|COMPLETED|Extension Study||3
3026560|NCT01090310|3744982|FG001|COMPLETED|Extension Study||0
3026561|NCT01090310|3744983|FG002|COMPLETED|Extension Study||1
3026562|NCT01090310|3744984|FG003|COMPLETED|Extension Study||1
3026563|NCT01090310|3744981|FG000|NOT COMPLETED|Extension Study||14
3026564|NCT01090310|3744982|FG001|NOT COMPLETED|Extension Study||16
3026565|NCT01090310|3744983|FG002|NOT COMPLETED|Extension Study||15
3026566|NCT01090310|3744984|FG003|NOT COMPLETED|Extension Study||20
3026567|NCT01090323|3744996|FG000|STARTED|Overall Study||132
3026568|NCT01090323|3744997|FG001|STARTED|Overall Study||53
3308732|NCT03022799|4042120|FG005|STARTED|Overall Study||6
3308733|NCT03022799|4042121|FG006|STARTED|Overall Study||12
3308734|NCT03022799|4042122|FG007|STARTED|Overall Study||6
3308735|NCT03022799|4042123|FG008|STARTED|Overall Study||6
3026569|NCT01090323|3744996|FG000|COMPLETED|Overall Study||43
3026570|NCT01090323|3744997|FG001|COMPLETED|Overall Study||19
3026571|NCT01090323|3744996|FG000|NOT COMPLETED|Overall Study||89
3026572|NCT01090323|3744997|FG001|NOT COMPLETED|Overall Study||34
3026573|NCT01090414|3745007|FG000|STARTED|Parent Studies||191
3026574|NCT01090414|3745008|FG001|STARTED|Parent Studies||241
3026575|NCT01090414|3745009|FG002|STARTED|Parent Studies||64
3026576|NCT01090414|3745010|FG003|STARTED|Parent Studies||18
3026577|NCT01090414|3745007|FG000|COMPLETED|Parent Studies||50
3026578|NCT01090414|3745008|FG001|COMPLETED|Parent Studies||114
3026579|NCT01090414|3745009|FG002|COMPLETED|Parent Studies||43
3026580|NCT01090414|3745010|FG003|COMPLETED|Parent Studies||5
3026581|NCT01090414|3745007|FG000|NOT COMPLETED|Parent Studies||141
3026582|NCT01090414|3745008|FG001|NOT COMPLETED|Parent Studies||127
3026583|NCT01090414|3745009|FG002|NOT COMPLETED|Parent Studies||21
3026584|NCT01090414|3745010|FG003|NOT COMPLETED|Parent Studies||13
3026585|NCT01090414|3745007|FG000|STARTED|Study 101-99|50 participants completed the parent study, but only 48 participants enrolled into Study 101-99.|48
3026586|NCT01090414|3745008|FG001|STARTED|Study 101-99|114 participants completed the parent study, but only 108 participants enrolled into Study 101-99.|108
3026587|NCT01090414|3745009|FG002|STARTED|Study 101-99|43 participants completed the parent study, but only 41 participants enrolled into Study 101-99.|41
3026588|NCT01090414|3745010|FG003|STARTED|Study 101-99||5
3026589|NCT01090414|3745007|FG000|COMPLETED|Study 101-99||0
3026590|NCT01090414|3745008|FG001|COMPLETED|Study 101-99||0
3026591|NCT01090414|3745009|FG002|COMPLETED|Study 101-99||0
3026592|NCT01090414|3745010|FG003|COMPLETED|Study 101-99||0
3026593|NCT01090414|3745007|FG000|NOT COMPLETED|Study 101-99||48
3026594|NCT01090414|3745008|FG001|NOT COMPLETED|Study 101-99||108
3026595|NCT01090414|3745009|FG002|NOT COMPLETED|Study 101-99||41
3026596|NCT01090414|3745010|FG003|NOT COMPLETED|Study 101-99||5
3026597|NCT01090427|3745035|FG000|STARTED|Controlled Period||37
3026598|NCT01090427|3745036|FG001|STARTED|Controlled Period||37
3026599|NCT01090427|3745037|FG002|STARTED|Controlled Period||36
3026600|NCT01090427|3745038|FG003|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
3026601|NCT01090427|3745039|FG004|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
3026602|NCT01090427|3745040|FG005|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
3026603|NCT01090427|3745041|FG006|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
3026604|NCT01090427|3745035|FG000|COMPLETED|Controlled Period||37
3026605|NCT01090427|3745036|FG001|COMPLETED|Controlled Period||37
3026606|NCT01090427|3745037|FG002|COMPLETED|Controlled Period||36
3026607|NCT01090427|3745038|FG003|COMPLETED|Controlled Period||0
3026608|NCT01090427|3745039|FG004|COMPLETED|Controlled Period||0
3026609|NCT01090427|3745040|FG005|COMPLETED|Controlled Period||0
3026610|NCT01090427|3745041|FG006|COMPLETED|Controlled Period||0
3026611|NCT01090427|3745035|FG000|NOT COMPLETED|Controlled Period||0
3026612|NCT01090427|3745036|FG001|NOT COMPLETED|Controlled Period||0
3026613|NCT01090427|3745037|FG002|NOT COMPLETED|Controlled Period||0
3026614|NCT01090427|3745038|FG003|NOT COMPLETED|Controlled Period||0
3026615|NCT01090427|3745039|FG004|NOT COMPLETED|Controlled Period||0
3026616|NCT01090427|3745040|FG005|NOT COMPLETED|Controlled Period||0
3026617|NCT01090427|3745041|FG006|NOT COMPLETED|Controlled Period||0
3026618|NCT01090427|3745035|FG000|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
3026619|NCT01090427|3745036|FG001|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
3026620|NCT01090427|3745037|FG002|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
3026621|NCT01090427|3745038|FG003|STARTED|After Controlled Period||19
3026622|NCT01090427|3745039|FG004|STARTED|After Controlled Period||18
3026623|NCT01090427|3745040|FG005|STARTED|After Controlled Period||37
3026624|NCT01090427|3745041|FG006|STARTED|After Controlled Period||36
3026625|NCT01090427|3745035|FG000|COMPLETED|After Controlled Period||0
3026626|NCT01090427|3745036|FG001|COMPLETED|After Controlled Period||0
3026627|NCT01090427|3745037|FG002|COMPLETED|After Controlled Period||0
3026628|NCT01090427|3745038|FG003|COMPLETED|After Controlled Period||17
3026629|NCT01090427|3745039|FG004|COMPLETED|After Controlled Period||18
3026630|NCT01090427|3745040|FG005|COMPLETED|After Controlled Period||32
3026631|NCT01090427|3745041|FG006|COMPLETED|After Controlled Period||34
3026632|NCT01090427|3745035|FG000|NOT COMPLETED|After Controlled Period||0
3026633|NCT01090427|3745036|FG001|NOT COMPLETED|After Controlled Period||0
3026634|NCT01090427|3745037|FG002|NOT COMPLETED|After Controlled Period||0
3026635|NCT01090427|3745038|FG003|NOT COMPLETED|After Controlled Period||2
3026636|NCT01090427|3745039|FG004|NOT COMPLETED|After Controlled Period||0
3026637|NCT01090427|3745040|FG005|NOT COMPLETED|After Controlled Period||5
3026638|NCT01090427|3745041|FG006|NOT COMPLETED|After Controlled Period||2
3026639|NCT01090453|3745055|FG000|STARTED|Overall Study||238
3026640|NCT01090453|3745056|FG001|STARTED|Overall Study||242
3026641|NCT01090453|3745055|FG000|COMPLETED|Overall Study||225
3026642|NCT01090453|3745056|FG001|COMPLETED|Overall Study||228
3026643|NCT01090453|3745055|FG000|NOT COMPLETED|Overall Study||13
3026644|NCT01090453|3745056|FG001|NOT COMPLETED|Overall Study||14
3026645|NCT01090479|3745064|FG000|STARTED|Overall Study||50
3026646|NCT01090479|3745065|FG001|STARTED|Overall Study||50
3026647|NCT01090479|3745064|FG000|COMPLETED|Overall Study||50
3026648|NCT01090479|3745065|FG001|COMPLETED|Overall Study||50
3026649|NCT01090479|3745064|FG000|NOT COMPLETED|Overall Study||0
3026650|NCT01090479|3745065|FG001|NOT COMPLETED|Overall Study||0
3026651|NCT01090492|3745079|FG000|STARTED|First Intervention Period (4 Weeks)||27
3026652|NCT01090492|3745080|FG001|STARTED|First Intervention Period (4 Weeks)||29
3026653|NCT01090492|3745081|FG002|STARTED|First Intervention Period (4 Weeks)||29
3026654|NCT01090492|3745082|FG003|STARTED|First Intervention Period (4 Weeks)||28
3026655|NCT01090492|3745083|FG004|STARTED|First Intervention Period (4 Weeks)||33
3026656|NCT01090492|3745084|FG005|STARTED|First Intervention Period (4 Weeks)||32
3026657|NCT01090492|3745085|FG006|STARTED|First Intervention Period (4 Weeks)||32
3026658|NCT01090492|3745086|FG007|STARTED|First Intervention Period (4 Weeks)||33
3026659|NCT01090492|3745079|FG000|COMPLETED|First Intervention Period (4 Weeks)||26
3026660|NCT01090492|3745080|FG001|COMPLETED|First Intervention Period (4 Weeks)||24
3026661|NCT01090492|3745081|FG002|COMPLETED|First Intervention Period (4 Weeks)||26
3026662|NCT01090492|3745082|FG003|COMPLETED|First Intervention Period (4 Weeks)||22
3026663|NCT01090492|3745083|FG004|COMPLETED|First Intervention Period (4 Weeks)||29
3026664|NCT01090492|3745084|FG005|COMPLETED|First Intervention Period (4 Weeks)||30
3026665|NCT01090492|3745085|FG006|COMPLETED|First Intervention Period (4 Weeks)||31
3026666|NCT01090492|3745086|FG007|COMPLETED|First Intervention Period (4 Weeks)||27
3026667|NCT01090492|3745079|FG000|NOT COMPLETED|First Intervention Period (4 Weeks)||1
3026668|NCT01090492|3745080|FG001|NOT COMPLETED|First Intervention Period (4 Weeks)||5
3026669|NCT01090492|3745081|FG002|NOT COMPLETED|First Intervention Period (4 Weeks)||3
3026670|NCT01090492|3745082|FG003|NOT COMPLETED|First Intervention Period (4 Weeks)||6
3026671|NCT01090492|3745083|FG004|NOT COMPLETED|First Intervention Period (4 Weeks)||4
3026672|NCT01090492|3745084|FG005|NOT COMPLETED|First Intervention Period (4 Weeks)||2
3165909|NCT01902173|3893452|FG003|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 2||0
3165910|NCT01902173|3893453|FG004|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 2||0
3165911|NCT01902173|3893454|FG005|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 2||0
3165912|NCT01902173|3893449|FG000|STARTED|Phase 1 Triplet Regimen Cohort 1||0
3165913|NCT01902173|3893450|FG001|STARTED|Phase 1 Triplet Regimen Cohort 1||0
3165914|NCT01902173|3893451|FG002|STARTED|Phase 1 Triplet Regimen Cohort 1||4
3165915|NCT01902173|3893452|FG003|STARTED|Phase 1 Triplet Regimen Cohort 1||0
3165916|NCT01902173|3893453|FG004|STARTED|Phase 1 Triplet Regimen Cohort 1||0
3026673|NCT01090492|3745085|FG006|NOT COMPLETED|First Intervention Period (4 Weeks)||1
3026674|NCT01090492|3745086|FG007|NOT COMPLETED|First Intervention Period (4 Weeks)||6
3026675|NCT01090492|3745079|FG000|STARTED|Placebo Washout Period ( 2 Weeks)||26
3026676|NCT01090492|3745080|FG001|STARTED|Placebo Washout Period ( 2 Weeks)||24
3026677|NCT01090492|3745081|FG002|STARTED|Placebo Washout Period ( 2 Weeks)||26
3026678|NCT01090492|3745082|FG003|STARTED|Placebo Washout Period ( 2 Weeks)||22
3026679|NCT01090492|3745083|FG004|STARTED|Placebo Washout Period ( 2 Weeks)||29
3026680|NCT01090492|3745084|FG005|STARTED|Placebo Washout Period ( 2 Weeks)||30
3026681|NCT01090492|3745085|FG006|STARTED|Placebo Washout Period ( 2 Weeks)||31
3026682|NCT01090492|3745086|FG007|STARTED|Placebo Washout Period ( 2 Weeks)||27
3026683|NCT01090492|3745079|FG000|COMPLETED|Placebo Washout Period ( 2 Weeks)||26
3026684|NCT01090492|3745080|FG001|COMPLETED|Placebo Washout Period ( 2 Weeks)||24
3026685|NCT01090492|3745081|FG002|COMPLETED|Placebo Washout Period ( 2 Weeks)||26
3026686|NCT01090492|3745082|FG003|COMPLETED|Placebo Washout Period ( 2 Weeks)||22
3026687|NCT01090492|3745083|FG004|COMPLETED|Placebo Washout Period ( 2 Weeks)||29
3026688|NCT01090492|3745084|FG005|COMPLETED|Placebo Washout Period ( 2 Weeks)||30
3026689|NCT01090492|3745085|FG006|COMPLETED|Placebo Washout Period ( 2 Weeks)||31
3026690|NCT01090492|3745086|FG007|COMPLETED|Placebo Washout Period ( 2 Weeks)||27
3026691|NCT01090492|3745079|FG000|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
3026692|NCT01090492|3745080|FG001|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
3026693|NCT01090492|3745081|FG002|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
3026694|NCT01090492|3745082|FG003|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
3026695|NCT01090492|3745083|FG004|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
3026696|NCT01090492|3745084|FG005|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
3026697|NCT01090492|3745085|FG006|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
3026698|NCT01090492|3745086|FG007|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
3026699|NCT01090492|3745079|FG000|STARTED|Second Intervention Period (4 Weeks)||26
3026700|NCT01090492|3745080|FG001|STARTED|Second Intervention Period (4 Weeks)||24
3026701|NCT01090492|3745081|FG002|STARTED|Second Intervention Period (4 Weeks)||26
3026702|NCT01090492|3745082|FG003|STARTED|Second Intervention Period (4 Weeks)||22
3026703|NCT01090492|3745083|FG004|STARTED|Second Intervention Period (4 Weeks)||29
3026704|NCT01090492|3745084|FG005|STARTED|Second Intervention Period (4 Weeks)||30
3026705|NCT01090492|3745085|FG006|STARTED|Second Intervention Period (4 Weeks)||31
3026706|NCT01090492|3745086|FG007|STARTED|Second Intervention Period (4 Weeks)||27
3026707|NCT01090492|3745079|FG000|COMPLETED|Second Intervention Period (4 Weeks)||25
3026708|NCT01090492|3745080|FG001|COMPLETED|Second Intervention Period (4 Weeks)||22
3026709|NCT01090492|3745081|FG002|COMPLETED|Second Intervention Period (4 Weeks)||24
3026710|NCT01090492|3745082|FG003|COMPLETED|Second Intervention Period (4 Weeks)||22
3026711|NCT01090492|3745083|FG004|COMPLETED|Second Intervention Period (4 Weeks)||27
3026712|NCT01090492|3745084|FG005|COMPLETED|Second Intervention Period (4 Weeks)||29
3026713|NCT01090492|3745085|FG006|COMPLETED|Second Intervention Period (4 Weeks)||22
3026714|NCT01090492|3745086|FG007|COMPLETED|Second Intervention Period (4 Weeks)||25
3026715|NCT01090492|3745079|FG000|NOT COMPLETED|Second Intervention Period (4 Weeks)||1
3026716|NCT01090492|3745080|FG001|NOT COMPLETED|Second Intervention Period (4 Weeks)||2
3026717|NCT01090492|3745081|FG002|NOT COMPLETED|Second Intervention Period (4 Weeks)||2
3026718|NCT01090492|3745082|FG003|NOT COMPLETED|Second Intervention Period (4 Weeks)||0
3026719|NCT01090492|3745083|FG004|NOT COMPLETED|Second Intervention Period (4 Weeks)||2
3026720|NCT01090492|3745084|FG005|NOT COMPLETED|Second Intervention Period (4 Weeks)||1
3026721|NCT01090492|3745085|FG006|NOT COMPLETED|Second Intervention Period (4 Weeks)||9
3026722|NCT01090492|3745086|FG007|NOT COMPLETED|Second Intervention Period (4 Weeks)||2
3026723|NCT01090739|3745105|FG000|STARTED|Enrollment|Subject enrollment = signed informed consent form|207
3026724|NCT01090739|3745105|FG000|COMPLETED|Enrollment||152
3026725|NCT01090739|3745105|FG000|NOT COMPLETED|Enrollment||55
3026726|NCT01090739|3745105|FG000|STARTED|12 Month Follow-up||152
3165917|NCT01902173|3893454|FG005|STARTED|Phase 1 Triplet Regimen Cohort 1||0
3165918|NCT01902173|3893449|FG000|COMPLETED|Phase 1 Triplet Regimen Cohort 1||0
3165919|NCT01902173|3893450|FG001|COMPLETED|Phase 1 Triplet Regimen Cohort 1||0
3165920|NCT01902173|3893451|FG002|COMPLETED|Phase 1 Triplet Regimen Cohort 1||0
3165921|NCT01902173|3893452|FG003|COMPLETED|Phase 1 Triplet Regimen Cohort 1||0
3165922|NCT01902173|3893453|FG004|COMPLETED|Phase 1 Triplet Regimen Cohort 1||0
3165923|NCT01902173|3893454|FG005|COMPLETED|Phase 1 Triplet Regimen Cohort 1||0
3165924|NCT01902173|3893449|FG000|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 1||0
3165925|NCT01902173|3893450|FG001|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 1||0
3165926|NCT01902173|3893451|FG002|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 1||4
3165927|NCT01902173|3893452|FG003|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 1||0
3165928|NCT01902173|3893453|FG004|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 1||0
3165929|NCT01902173|3893454|FG005|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 1||0
3165930|NCT01902173|3893449|FG000|STARTED|Phase 1 Triplet Regimen Cohort 2||0
3165931|NCT01902173|3893450|FG001|STARTED|Phase 1 Triplet Regimen Cohort 2||0
3165932|NCT01902173|3893451|FG002|STARTED|Phase 1 Triplet Regimen Cohort 2||0
3165933|NCT01902173|3893452|FG003|STARTED|Phase 1 Triplet Regimen Cohort 2||3
3026727|NCT01090739|3745105|FG000|COMPLETED|12 Month Follow-up||147
3026728|NCT01090739|3745105|FG000|NOT COMPLETED|12 Month Follow-up||5
3026729|NCT01090739|3745105|FG000|STARTED|24 Month Follow-up||147
3026730|NCT01090739|3745105|FG000|COMPLETED|24 Month Follow-up||138
3026731|NCT01090739|3745105|FG000|NOT COMPLETED|24 Month Follow-up||9
3026732|NCT01090739|3745105|FG000|STARTED|36 Month Follow-up||138
3026733|NCT01090739|3745105|FG000|COMPLETED|36 Month Follow-up||115
3026734|NCT01090739|3745105|FG000|NOT COMPLETED|36 Month Follow-up||23
3026735|NCT01090752|3745112|FG000|STARTED|Overall Study||8
3026736|NCT01090752|3745113|FG001|STARTED|Overall Study||8
3026737|NCT01090752|3745112|FG000|COMPLETED|Overall Study||8
3026738|NCT01090752|3745113|FG001|COMPLETED|Overall Study||8
3026739|NCT01090752|3745112|FG000|NOT COMPLETED|Overall Study||0
3026740|NCT01090752|3745113|FG001|NOT COMPLETED|Overall Study||0
3026741|NCT01090765|3745125|FG000|STARTED|Overall Study||3
3026742|NCT01090765|3745126|FG001|STARTED|Overall Study||3
3026743|NCT01090765|3745127|FG002|STARTED|Overall Study||3
3026744|NCT01090765|3745128|FG003|STARTED|Overall Study||2
3026745|NCT01090765|3745129|FG004|STARTED|Overall Study||6
3026746|NCT01090765|3745130|FG005|STARTED|Overall Study||4
3026747|NCT01090765|3745125|FG000|COMPLETED|Overall Study||3
3026748|NCT01090765|3745126|FG001|COMPLETED|Overall Study||3
3026749|NCT01090765|3745127|FG002|COMPLETED|Overall Study||3
3026750|NCT01090765|3745128|FG003|COMPLETED|Overall Study||1
3026751|NCT01090765|3745129|FG004|COMPLETED|Overall Study||4
3026752|NCT01090765|3745130|FG005|COMPLETED|Overall Study||3
3026753|NCT01090765|3745125|FG000|NOT COMPLETED|Overall Study||0
3026754|NCT01090765|3745126|FG001|NOT COMPLETED|Overall Study||0
3026755|NCT01090765|3745127|FG002|NOT COMPLETED|Overall Study||0
3026756|NCT01090765|3745128|FG003|NOT COMPLETED|Overall Study||1
3026757|NCT01090765|3745129|FG004|NOT COMPLETED|Overall Study||2
3026758|NCT01090765|3745130|FG005|NOT COMPLETED|Overall Study||1
3026759|NCT01090921|3745145|FG000|STARTED|Overall Study||50
3026760|NCT01090921|3745145|FG000|COMPLETED|Overall Study||23
3026761|NCT01090921|3745145|FG000|NOT COMPLETED|Overall Study||27
3026762|NCT01090973|3745149|FG000|STARTED|Overall Study||1
3026763|NCT01090973|3745149|FG000|COMPLETED|Overall Study||0
3026764|NCT01090973|3745149|FG000|NOT COMPLETED|Overall Study||1
3026765|NCT01091103|3745153|FG000|STARTED|Overall Study||60
3026766|NCT01091103|3745153|FG000|COMPLETED|Overall Study|Patients on study drug and completed Week 9 visit assessments.|56
3026767|NCT01091103|3745153|FG000|NOT COMPLETED|Overall Study||4
3026768|NCT01091116|3745164|FG000|STARTED|Overall Study||83
3026769|NCT01091116|3745165|FG001|STARTED|Overall Study||88
3026770|NCT01091116|3745166|FG002|STARTED|Overall Study||84
3026771|NCT01091116|3745167|FG003|STARTED|Overall Study||84
3026772|NCT01091116|3745168|FG004|STARTED|Overall Study||84
3026773|NCT01091116|3745164|FG000|COMPLETED|Overall Study||77
3026774|NCT01091116|3745165|FG001|COMPLETED|Overall Study||80
3026775|NCT01091116|3745166|FG002|COMPLETED|Overall Study||73
3026776|NCT01091116|3745167|FG003|COMPLETED|Overall Study||80
3026777|NCT01091116|3745168|FG004|COMPLETED|Overall Study||73
3026778|NCT01091116|3745164|FG000|NOT COMPLETED|Overall Study||6
3026779|NCT01091116|3745165|FG001|NOT COMPLETED|Overall Study||8
3026780|NCT01091116|3745166|FG002|NOT COMPLETED|Overall Study||11
3026781|NCT01091116|3745167|FG003|NOT COMPLETED|Overall Study||4
3026782|NCT01091116|3745168|FG004|NOT COMPLETED|Overall Study||11
3026783|NCT01091155|3745180|FG000|STARTED|Overall Study||288
3026784|NCT01091155|3745180|FG000|COMPLETED|Overall Study||279
3026785|NCT01091155|3745180|FG000|NOT COMPLETED|Overall Study||9
3026786|NCT01091168|3745186|FG000|STARTED|Overall Study||298
3026787|NCT01091168|3745187|FG001|STARTED|Overall Study||296
3026788|NCT01091168|3745186|FG000|COMPLETED|Overall Study||0
3026789|NCT01091168|3745187|FG001|COMPLETED|Overall Study||0
3026790|NCT01091168|3745186|FG000|NOT COMPLETED|Overall Study||298
3165934|NCT01902173|3893453|FG004|STARTED|Phase 1 Triplet Regimen Cohort 2||0
3165935|NCT01902173|3893454|FG005|STARTED|Phase 1 Triplet Regimen Cohort 2||0
3165936|NCT01902173|3893449|FG000|COMPLETED|Phase 1 Triplet Regimen Cohort 2||0
3026791|NCT01091168|3745187|FG001|NOT COMPLETED|Overall Study||296
3026792|NCT01091246|3745196|FG000|STARTED|Overall Study||1385
3026793|NCT01091246|3745197|FG001|STARTED|Overall Study||464
3026794|NCT01091246|3745198|FG002|STARTED|Overall Study||463
3026795|NCT01091246|3745196|FG000|COMPLETED|Overall Study||1350
3026796|NCT01091246|3745197|FG001|COMPLETED|Overall Study||448
3026797|NCT01091246|3745198|FG002|COMPLETED|Overall Study||450
3026798|NCT01091246|3745196|FG000|NOT COMPLETED|Overall Study||35
3026799|NCT01091246|3745197|FG001|NOT COMPLETED|Overall Study||16
3026800|NCT01091246|3745198|FG002|NOT COMPLETED|Overall Study||13
3026801|NCT01091259|3745208|FG000|STARTED|Overall Study||29
3026802|NCT01091259|3745208|FG000|COMPLETED|Overall Study|Number of patients who had at least 2 cycles of treatments|24
3165937|NCT01902173|3893450|FG001|COMPLETED|Phase 1 Triplet Regimen Cohort 2||0
3165938|NCT01902173|3893451|FG002|COMPLETED|Phase 1 Triplet Regimen Cohort 2||0
3165939|NCT01902173|3893452|FG003|COMPLETED|Phase 1 Triplet Regimen Cohort 2||0
3165940|NCT01902173|3893453|FG004|COMPLETED|Phase 1 Triplet Regimen Cohort 2||0
3026803|NCT01091259|3745208|FG000|NOT COMPLETED|Overall Study||5
3026804|NCT01091363|3745214|FG000|STARTED|Overall Study||55
3026805|NCT01091363|3745215|FG001|STARTED|Overall Study||54
3026806|NCT01091363|3745214|FG000|COMPLETED|Overall Study||42
3026807|NCT01091363|3745215|FG001|COMPLETED|Overall Study||37
3026808|NCT01091363|3745214|FG000|NOT COMPLETED|Overall Study||13
3026809|NCT01091363|3745215|FG001|NOT COMPLETED|Overall Study||17
3026810|NCT01091428|3745225|FG000|STARTED|Phase 1||38
3026811|NCT01091428|3745226|FG001|STARTED|Phase 1||11
3026812|NCT01091428|3745227|FG002|STARTED|Phase 1||0
3026813|NCT01091428|3745228|FG003|STARTED|Phase 1||0
3026814|NCT01091428|3745225|FG000|COMPLETED|Phase 1|Completed = participants who completed the treatment.|0
3026815|NCT01091428|3745226|FG001|COMPLETED|Phase 1||0
3026816|NCT01091428|3745227|FG002|COMPLETED|Phase 1||0
3026817|NCT01091428|3745228|FG003|COMPLETED|Phase 1||0
3026818|NCT01091428|3745225|FG000|NOT COMPLETED|Phase 1||38
3026819|NCT01091428|3745226|FG001|NOT COMPLETED|Phase 1||11
3026820|NCT01091428|3745227|FG002|NOT COMPLETED|Phase 1||0
3026821|NCT01091428|3745228|FG003|NOT COMPLETED|Phase 1||0
3026822|NCT01091428|3745225|FG000|STARTED|Phase 2||0
3026823|NCT01091428|3745226|FG001|STARTED|Phase 2||0
3026824|NCT01091428|3745227|FG002|STARTED|Phase 2||73
3026825|NCT01091428|3745228|FG003|STARTED|Phase 2||69
3026826|NCT01091428|3745225|FG000|COMPLETED|Phase 2||0
3026827|NCT01091428|3745226|FG001|COMPLETED|Phase 2||0
3026828|NCT01091428|3745227|FG002|COMPLETED|Phase 2||0
3026829|NCT01091428|3745228|FG003|COMPLETED|Phase 2||0
3026830|NCT01091428|3745225|FG000|NOT COMPLETED|Phase 2||0
3026831|NCT01091428|3745226|FG001|NOT COMPLETED|Phase 2||0
3026832|NCT01091428|3745227|FG002|NOT COMPLETED|Phase 2||73
3026833|NCT01091428|3745228|FG003|NOT COMPLETED|Phase 2||69
3026834|NCT01091454|3745247|FG000|STARTED|Overall Study||48
3026835|NCT01091454|3745247|FG000|COMPLETED|Overall Study||47
3026836|NCT01091454|3745247|FG000|NOT COMPLETED|Overall Study||1
3026837|NCT01091519|3745253|FG000|STARTED|Overall Study||346
3026838|NCT01091519|3745254|FG001|STARTED|Overall Study||435
3026839|NCT01091519|3745253|FG000|Treated|Overall Study||342
3026840|NCT01091519|3745254|FG001|Treated|Overall Study||431
3026841|NCT01091519|3745253|FG000|COMPLETED|Overall Study||291
3026842|NCT01091519|3745254|FG001|COMPLETED|Overall Study||362
3026843|NCT01091519|3745253|FG000|NOT COMPLETED|Overall Study||55
3026844|NCT01091519|3745254|FG001|NOT COMPLETED|Overall Study||73
3026845|NCT01091662|3745262|FG000|STARTED|Overall Study||58
3026846|NCT01091662|3745263|FG001|STARTED|Overall Study||114
3026847|NCT01091662|3745262|FG000|COMPLETED|Overall Study||41
3026848|NCT01091662|3745263|FG001|COMPLETED|Overall Study||80
3026849|NCT01091662|3745262|FG000|NOT COMPLETED|Overall Study||17
3026850|NCT01091662|3745263|FG001|NOT COMPLETED|Overall Study||34
3026851|NCT01091675|3745274|FG000|STARTED|Overall Study|7 patients leave the study due to hypertension, 27 patients withdrew due to lack of efficacy|57
3026852|NCT01091675|3745274|FG000|COMPLETED|Overall Study||23
3026853|NCT01091675|3745274|FG000|NOT COMPLETED|Overall Study||34
3026854|NCT01091948|3745280|FG000|STARTED|Overall Study||37
3026855|NCT01091948|3745281|FG001|STARTED|Overall Study||38
3026856|NCT01091948|3745280|FG000|COMPLETED|Overall Study||37
3026857|NCT01091948|3745281|FG001|COMPLETED|Overall Study||38
3026858|NCT01091948|3745280|FG000|NOT COMPLETED|Overall Study||0
3026859|NCT01091948|3745281|FG001|NOT COMPLETED|Overall Study||0
3026860|NCT01091974|3745292|FG000|STARTED|Overall Study||24
3026861|NCT01091974|3745293|FG001|STARTED|Overall Study||23
3026862|NCT01091974|3745294|FG002|STARTED|Overall Study||25
3026863|NCT01091974|3745295|FG003|STARTED|Overall Study||24
3026864|NCT01091974|3745292|FG000|COMPLETED|Overall Study||19
3026865|NCT01091974|3745293|FG001|COMPLETED|Overall Study||18
3026866|NCT01091974|3745294|FG002|COMPLETED|Overall Study||19
3026867|NCT01091974|3745295|FG003|COMPLETED|Overall Study||17
3026868|NCT01091974|3745292|FG000|NOT COMPLETED|Overall Study||5
3026869|NCT01091974|3745293|FG001|NOT COMPLETED|Overall Study||5
3026870|NCT01091974|3745294|FG002|NOT COMPLETED|Overall Study||6
3026871|NCT01091974|3745295|FG003|NOT COMPLETED|Overall Study||7
3026872|NCT01092182|3745308|FG000|STARTED|Overall Study||15
3026873|NCT01092182|3745309|FG001|STARTED|Overall Study||98
3026874|NCT01092182|3745310|FG002|STARTED|Overall Study||81
3026875|NCT01092182|3745308|FG000|COMPLETED|Overall Study||14
3026876|NCT01092182|3745309|FG001|COMPLETED|Overall Study||80
3026877|NCT01092182|3745310|FG002|COMPLETED|Overall Study||53
3026878|NCT01092182|3745308|FG000|NOT COMPLETED|Overall Study||1
3026879|NCT01092182|3745309|FG001|NOT COMPLETED|Overall Study||18
3026880|NCT01092182|3745310|FG002|NOT COMPLETED|Overall Study||28
3165941|NCT01902173|3893454|FG005|COMPLETED|Phase 1 Triplet Regimen Cohort 2||0
3165942|NCT01902173|3893449|FG000|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 2||0
3165943|NCT01902173|3893450|FG001|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 2||0
3165944|NCT01902173|3893451|FG002|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 2||0
3165945|NCT01902173|3893452|FG003|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 2||3
3165946|NCT01902173|3893453|FG004|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 2||0
3026881|NCT01092195|3745321|FG000|STARTED|Overall Study||23
3026882|NCT01092195|3745322|FG001|STARTED|Overall Study||21
3026883|NCT01092195|3745323|FG002|STARTED|Overall Study||20
3026884|NCT01092195|3745321|FG000|COMPLETED|Overall Study||23
3026885|NCT01092195|3745322|FG001|COMPLETED|Overall Study||21
3026886|NCT01092195|3745323|FG002|COMPLETED|Overall Study||20
3026887|NCT01092195|3745321|FG000|NOT COMPLETED|Overall Study||0
3026888|NCT01092195|3745322|FG001|NOT COMPLETED|Overall Study||0
3026889|NCT01092195|3745323|FG002|NOT COMPLETED|Overall Study||0
3026890|NCT01092338|3745333|FG000|STARTED|Overall Study||22
3026891|NCT01092338|3745334|FG001|STARTED|Overall Study||22
3026892|NCT01092338|3745333|FG000|COMPLETED|Overall Study||21
3026893|NCT01092338|3745334|FG001|COMPLETED|Overall Study||21
3026894|NCT01092338|3745333|FG000|NOT COMPLETED|Overall Study||1
3026895|NCT01092338|3745334|FG001|NOT COMPLETED|Overall Study||1
3026896|NCT01092364|3745343|FG000|STARTED|Overall Study||122
3026897|NCT01092364|3745344|FG001|STARTED|Overall Study||120
3026898|NCT01092364|3745345|FG002|STARTED|Overall Study||123
3026899|NCT01092364|3745343|FG000|COMPLETED|Overall Study||104
3026900|NCT01092364|3745344|FG001|COMPLETED|Overall Study||104
3026901|NCT01092364|3745345|FG002|COMPLETED|Overall Study||105
3026902|NCT01092364|3745343|FG000|NOT COMPLETED|Overall Study||18
3026903|NCT01092364|3745344|FG001|NOT COMPLETED|Overall Study||16
3026904|NCT01092364|3745345|FG002|NOT COMPLETED|Overall Study||18
3026905|NCT01092416|3745353|FG000|STARTED|Enrollment||443
3026906|NCT01092416|3745353|FG000|COMPLETED|Enrollment||440
3026907|NCT01092416|3745353|FG000|NOT COMPLETED|Enrollment||3
3026908|NCT01092416|3745353|FG000|STARTED|30-Day Follow-up||440
3026909|NCT01092416|3745353|FG000|COMPLETED|30-Day Follow-up||430
3026910|NCT01092416|3745353|FG000|NOT COMPLETED|30-Day Follow-up||10
3026911|NCT01092416|3745353|FG000|STARTED|12-Month Follow-up||438
3026912|NCT01092416|3745353|FG000|COMPLETED|12-Month Follow-up||413
3026913|NCT01092416|3745353|FG000|NOT COMPLETED|12-Month Follow-up||25
3026914|NCT01092442|3745362|FG000|STARTED|Overall Study||80
3026915|NCT01092442|3745363|FG001|STARTED|Overall Study||60
3026916|NCT01092442|3745362|FG000|COMPLETED|Overall Study||80
3026917|NCT01092442|3745363|FG001|COMPLETED|Overall Study||60
3026918|NCT01092442|3745362|FG000|NOT COMPLETED|Overall Study||0
3026919|NCT01092442|3745363|FG001|NOT COMPLETED|Overall Study||0
3026920|NCT01092507|3745376|FG000|STARTED|Overall Study||149
3026921|NCT01092507|3745377|FG001|STARTED|Overall Study||150
3026922|NCT01092507|3745376|FG000|COMPLETED|Overall Study||147
3026923|NCT01092507|3745377|FG001|COMPLETED|Overall Study||150
3026924|NCT01092507|3745376|FG000|NOT COMPLETED|Overall Study||2
3026925|NCT01092507|3745377|FG001|NOT COMPLETED|Overall Study||0
3026926|NCT01092546|3745383|FG000|STARTED|Overall Study||16
3026927|NCT01092546|3745383|FG000|COMPLETED|Overall Study||12
3026928|NCT01092546|3745383|FG000|NOT COMPLETED|Overall Study||4
3026929|NCT01092559|3745387|FG000|STARTED|Overall Study||10
3026930|NCT01092559|3745387|FG000|COMPLETED|Overall Study||10
3026931|NCT01092559|3745387|FG000|NOT COMPLETED|Overall Study||0
3026932|NCT01092637|3745393|FG000|STARTED|Overall Study||145
3026933|NCT01092637|3745394|FG001|STARTED|Overall Study||135
3026934|NCT01092637|3745393|FG000|COMPLETED|Overall Study||98
3026935|NCT01092637|3745394|FG001|COMPLETED|Overall Study||86
3026936|NCT01092637|3745393|FG000|NOT COMPLETED|Overall Study||47
3026937|NCT01092637|3745394|FG001|NOT COMPLETED|Overall Study||49
3026938|NCT01092663|3745403|FG000|STARTED|Overall Study||31
3026939|NCT01092663|3745404|FG001|STARTED|Overall Study||30
3026940|NCT01092663|3745403|FG000|COMPLETED|Overall Study||24
3026941|NCT01092663|3745404|FG001|COMPLETED|Overall Study||26
3026942|NCT01092663|3745403|FG000|NOT COMPLETED|Overall Study||7
3165947|NCT01902173|3893454|FG005|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 2||0
3165948|NCT01902173|3893449|FG000|STARTED|Phase 1 Triplet Regimen Cohort 3||0
3026943|NCT01092663|3745404|FG001|NOT COMPLETED|Overall Study||4
3026944|NCT01092676|3745417|FG000|STARTED|Overall Study||50
3026945|NCT01092676|3745418|FG001|STARTED|Overall Study||49
3026946|NCT01092676|3745417|FG000|COMPLETED|Overall Study||50
3026947|NCT01092676|3745418|FG001|COMPLETED|Overall Study||49
3026948|NCT01092676|3745417|FG000|NOT COMPLETED|Overall Study||0
3026949|NCT01092676|3745418|FG001|NOT COMPLETED|Overall Study||0
3026950|NCT01092702|3745424|FG000|STARTED|Overall Study||32
3026951|NCT01092702|3745424|FG000|COMPLETED|Overall Study||23
3026952|NCT01092702|3745424|FG000|NOT COMPLETED|Overall Study||9
3026953|NCT01092728|3745430|FG000|STARTED|Overall Study||4
3026954|NCT01092728|3745431|FG001|STARTED|Overall Study||14
3026955|NCT01092728|3745430|FG000|COMPLETED|Overall Study||0
3026956|NCT01092728|3745431|FG001|COMPLETED|Overall Study||0
3026957|NCT01092728|3745430|FG000|NOT COMPLETED|Overall Study||4
3026958|NCT01092728|3745431|FG001|NOT COMPLETED|Overall Study||14
3026959|NCT01092767|3745437|FG000|STARTED|Overall Study||50
3026960|NCT01092767|3745437|FG000|COMPLETED|Overall Study||45
3026961|NCT01092767|3745437|FG000|NOT COMPLETED|Overall Study||5
3026962|NCT01092780|3745441|FG000|STARTED|Treatment Period 1||14
3026963|NCT01092780|3745442|FG001|STARTED|Treatment Period 1||15
3026964|NCT01092780|3745443|FG002|STARTED|Treatment Period 1||14
3026965|NCT01092780|3745444|FG003|STARTED|Treatment Period 1||13
3026966|NCT01092780|3745441|FG000|COMPLETED|Treatment Period 1||14
3026967|NCT01092780|3745442|FG001|COMPLETED|Treatment Period 1||15
3026968|NCT01092780|3745443|FG002|COMPLETED|Treatment Period 1||14
3026969|NCT01092780|3745444|FG003|COMPLETED|Treatment Period 1||13
3026970|NCT01092780|3745441|FG000|NOT COMPLETED|Treatment Period 1||0
3026971|NCT01092780|3745442|FG001|NOT COMPLETED|Treatment Period 1||0
3026972|NCT01092780|3745443|FG002|NOT COMPLETED|Treatment Period 1||0
3026973|NCT01092780|3745444|FG003|NOT COMPLETED|Treatment Period 1||0
3165949|NCT01902173|3893450|FG001|STARTED|Phase 1 Triplet Regimen Cohort 3||0
3165950|NCT01902173|3893451|FG002|STARTED|Phase 1 Triplet Regimen Cohort 3||0
3165951|NCT01902173|3893452|FG003|STARTED|Phase 1 Triplet Regimen Cohort 3||0
3165952|NCT01902173|3893453|FG004|STARTED|Phase 1 Triplet Regimen Cohort 3||3
3165953|NCT01902173|3893454|FG005|STARTED|Phase 1 Triplet Regimen Cohort 3||0
3308736|NCT03022799|4042124|FG009|STARTED|Overall Study||6
3026974|NCT01092780|3745441|FG000|STARTED|Washout Period 1||14
3026975|NCT01092780|3745442|FG001|STARTED|Washout Period 1||15
3026976|NCT01092780|3745443|FG002|STARTED|Washout Period 1||14
3026977|NCT01092780|3745444|FG003|STARTED|Washout Period 1||13
3026978|NCT01092780|3745441|FG000|COMPLETED|Washout Period 1||13
3026979|NCT01092780|3745442|FG001|COMPLETED|Washout Period 1||14
3026980|NCT01092780|3745443|FG002|COMPLETED|Washout Period 1||14
3026981|NCT01092780|3745444|FG003|COMPLETED|Washout Period 1||13
3026982|NCT01092780|3745441|FG000|NOT COMPLETED|Washout Period 1||1
3026983|NCT01092780|3745442|FG001|NOT COMPLETED|Washout Period 1||1
3026984|NCT01092780|3745443|FG002|NOT COMPLETED|Washout Period 1||0
3026985|NCT01092780|3745444|FG003|NOT COMPLETED|Washout Period 1||0
3026986|NCT01092780|3745441|FG000|STARTED|Treatment Period 2||13
3026987|NCT01092780|3745442|FG001|STARTED|Treatment Period 2||14
3026988|NCT01092780|3745443|FG002|STARTED|Treatment Period 2||14
3026989|NCT01092780|3745444|FG003|STARTED|Treatment Period 2||13
3026990|NCT01092780|3745441|FG000|COMPLETED|Treatment Period 2||13
3026991|NCT01092780|3745442|FG001|COMPLETED|Treatment Period 2||14
3026992|NCT01092780|3745443|FG002|COMPLETED|Treatment Period 2||14
3026993|NCT01092780|3745444|FG003|COMPLETED|Treatment Period 2||13
3026994|NCT01092780|3745441|FG000|NOT COMPLETED|Treatment Period 2||0
3026995|NCT01092780|3745442|FG001|NOT COMPLETED|Treatment Period 2||0
3026996|NCT01092780|3745443|FG002|NOT COMPLETED|Treatment Period 2||0
3026997|NCT01092780|3745444|FG003|NOT COMPLETED|Treatment Period 2||0
3026998|NCT01092780|3745441|FG000|STARTED|Washout Period 2||13
3026999|NCT01092780|3745442|FG001|STARTED|Washout Period 2||14
3027000|NCT01092780|3745443|FG002|STARTED|Washout Period 2||14
3027001|NCT01092780|3745444|FG003|STARTED|Washout Period 2||13
3027002|NCT01092780|3745441|FG000|COMPLETED|Washout Period 2||13
3027003|NCT01092780|3745442|FG001|COMPLETED|Washout Period 2||13
3027004|NCT01092780|3745443|FG002|COMPLETED|Washout Period 2||13
3027005|NCT01092780|3745444|FG003|COMPLETED|Washout Period 2||13
3027006|NCT01092780|3745441|FG000|NOT COMPLETED|Washout Period 2||0
3027007|NCT01092780|3745442|FG001|NOT COMPLETED|Washout Period 2||1
3027008|NCT01092780|3745443|FG002|NOT COMPLETED|Washout Period 2||1
3027009|NCT01092780|3745444|FG003|NOT COMPLETED|Washout Period 2||0
3027010|NCT01092780|3745441|FG000|STARTED|Treatment Period 3||13
3027011|NCT01092780|3745442|FG001|STARTED|Treatment Period 3||13
3027012|NCT01092780|3745443|FG002|STARTED|Treatment Period 3||13
3027013|NCT01092780|3745444|FG003|STARTED|Treatment Period 3||13
3027014|NCT01092780|3745441|FG000|COMPLETED|Treatment Period 3||13
3027015|NCT01092780|3745442|FG001|COMPLETED|Treatment Period 3||13
3027016|NCT01092780|3745443|FG002|COMPLETED|Treatment Period 3||13
3027017|NCT01092780|3745444|FG003|COMPLETED|Treatment Period 3||13
3027018|NCT01092780|3745441|FG000|NOT COMPLETED|Treatment Period 3||0
3027019|NCT01092780|3745442|FG001|NOT COMPLETED|Treatment Period 3||0
3027020|NCT01092780|3745443|FG002|NOT COMPLETED|Treatment Period 3||0
3027021|NCT01092780|3745444|FG003|NOT COMPLETED|Treatment Period 3||0
3027022|NCT01092780|3745441|FG000|STARTED|Washout Period 3||13
3027023|NCT01092780|3745442|FG001|STARTED|Washout Period 3||13
3027024|NCT01092780|3745443|FG002|STARTED|Washout Period 3||13
3027025|NCT01092780|3745444|FG003|STARTED|Washout Period 3||13
3308737|NCT03022799|4042125|FG010|STARTED|Overall Study||6
3308738|NCT03022799|4042126|FG011|STARTED|Overall Study||6
3308739|NCT03022799|4042127|FG012|STARTED|Overall Study||10
3308740|NCT03022799|4042115|FG000|COMPLETED|Overall Study||6
3308741|NCT03022799|4042116|FG001|COMPLETED|Overall Study||6
3308742|NCT03022799|4042117|FG002|COMPLETED|Overall Study||6
3308743|NCT03022799|4042118|FG003|COMPLETED|Overall Study||6
3308744|NCT03022799|4042119|FG004|COMPLETED|Overall Study||6
3308745|NCT03022799|4042120|FG005|COMPLETED|Overall Study||6
3308746|NCT03022799|4042121|FG006|COMPLETED|Overall Study||12
3308747|NCT03022799|4042122|FG007|COMPLETED|Overall Study||6
3308748|NCT03022799|4042123|FG008|COMPLETED|Overall Study||6
3308749|NCT03022799|4042124|FG009|COMPLETED|Overall Study||5
3027026|NCT01092780|3745441|FG000|COMPLETED|Washout Period 3||13
3027027|NCT01092780|3745442|FG001|COMPLETED|Washout Period 3||13
3027028|NCT01092780|3745443|FG002|COMPLETED|Washout Period 3||13
3165954|NCT01902173|3893449|FG000|COMPLETED|Phase 1 Triplet Regimen Cohort 3||0
3308750|NCT03022799|4042125|FG010|COMPLETED|Overall Study||5
3308751|NCT03022799|4042126|FG011|COMPLETED|Overall Study||6
3027029|NCT01092780|3745444|FG003|COMPLETED|Washout Period 3||13
3027030|NCT01092780|3745441|FG000|NOT COMPLETED|Washout Period 3||0
3027031|NCT01092780|3745442|FG001|NOT COMPLETED|Washout Period 3||0
3027032|NCT01092780|3745443|FG002|NOT COMPLETED|Washout Period 3||0
3027033|NCT01092780|3745444|FG003|NOT COMPLETED|Washout Period 3||0
3027034|NCT01092780|3745441|FG000|STARTED|Treatment Period 4||13
3027035|NCT01092780|3745442|FG001|STARTED|Treatment Period 4||13
3027036|NCT01092780|3745443|FG002|STARTED|Treatment Period 4||13
3027037|NCT01092780|3745444|FG003|STARTED|Treatment Period 4||13
3027038|NCT01092780|3745441|FG000|COMPLETED|Treatment Period 4||13
3165955|NCT01902173|3893450|FG001|COMPLETED|Phase 1 Triplet Regimen Cohort 3||0
3165956|NCT01902173|3893451|FG002|COMPLETED|Phase 1 Triplet Regimen Cohort 3||0
3165957|NCT01902173|3893452|FG003|COMPLETED|Phase 1 Triplet Regimen Cohort 3||0
3165958|NCT01902173|3893453|FG004|COMPLETED|Phase 1 Triplet Regimen Cohort 3||0
3165959|NCT01902173|3893454|FG005|COMPLETED|Phase 1 Triplet Regimen Cohort 3||0
3027039|NCT01092780|3745442|FG001|COMPLETED|Treatment Period 4||13
3027040|NCT01092780|3745443|FG002|COMPLETED|Treatment Period 4||13
3027041|NCT01092780|3745444|FG003|COMPLETED|Treatment Period 4||13
3027042|NCT01092780|3745441|FG000|NOT COMPLETED|Treatment Period 4||0
3027043|NCT01092780|3745442|FG001|NOT COMPLETED|Treatment Period 4||0
3027044|NCT01092780|3745443|FG002|NOT COMPLETED|Treatment Period 4||0
3027045|NCT01092780|3745444|FG003|NOT COMPLETED|Treatment Period 4||0
3027046|NCT01092832|3745456|FG000|STARTED|Overall Study||14
3027047|NCT01092832|3745457|FG001|STARTED|Overall Study||8
3027048|NCT01092832|3745456|FG000|COMPLETED|Overall Study||13
3027049|NCT01092832|3745457|FG001|COMPLETED|Overall Study||8
3027050|NCT01092832|3745456|FG000|NOT COMPLETED|Overall Study||1
3027051|NCT01092832|3745457|FG001|NOT COMPLETED|Overall Study||0
3027052|NCT01092910|3745463|FG000|STARTED|Overall Study||57
3027053|NCT01092910|3745463|FG000|4 Month Follow-up|Overall Study||54
3027054|NCT01092910|3745463|FG000|10 Month Follow-up|Overall Study||52
3027055|NCT01092910|3745463|FG000|COMPLETED|Overall Study||52
3027056|NCT01092910|3745463|FG000|NOT COMPLETED|Overall Study||5
3027057|NCT01092923|3745470|FG000|STARTED|Overall Study||10
3027058|NCT01092923|3745471|FG001|STARTED|Overall Study||10
3027059|NCT01092923|3745470|FG000|COMPLETED|Overall Study||10
3027060|NCT01092923|3745471|FG001|COMPLETED|Overall Study||10
3027061|NCT01092923|3745470|FG000|NOT COMPLETED|Overall Study||0
3027062|NCT01092923|3745471|FG001|NOT COMPLETED|Overall Study||0
3027063|NCT01093014|3745481|FG000|STARTED|Overall Study||12
3027064|NCT01093014|3745482|FG001|STARTED|Overall Study||9
3027065|NCT01093014|3745483|FG002|STARTED|Overall Study||12
3027066|NCT01093014|3745481|FG000|COMPLETED|Overall Study||12
3027067|NCT01093014|3745482|FG001|COMPLETED|Overall Study||9
3027068|NCT01093014|3745483|FG002|COMPLETED|Overall Study||12
3027069|NCT01093014|3745481|FG000|NOT COMPLETED|Overall Study||0
3027070|NCT01093014|3745482|FG001|NOT COMPLETED|Overall Study||0
3027071|NCT01093014|3745483|FG002|NOT COMPLETED|Overall Study||0
3027072|NCT01093027|3745496|FG000|STARTED|Visit 1||10
3027073|NCT01093027|3745497|FG001|STARTED|Visit 1||10
3027074|NCT01093027|3745496|FG000|COMPLETED|Visit 1||10
3027075|NCT01093027|3745497|FG001|COMPLETED|Visit 1||10
3027076|NCT01093027|3745496|FG000|NOT COMPLETED|Visit 1||0
3027077|NCT01093027|3745497|FG001|NOT COMPLETED|Visit 1||0
3027078|NCT01093027|3745496|FG000|STARTED|Visit 2||10
3027079|NCT01093027|3745497|FG001|STARTED|Visit 2||10
3027080|NCT01093027|3745496|FG000|COMPLETED|Visit 2||10
3027081|NCT01093027|3745497|FG001|COMPLETED|Visit 2||10
3027082|NCT01093027|3745496|FG000|NOT COMPLETED|Visit 2||0
3027083|NCT01093027|3745497|FG001|NOT COMPLETED|Visit 2||0
3027084|NCT01093183|3745503|FG000|STARTED|Overall Study||19
3027085|NCT01093183|3745504|FG001|STARTED|Overall Study||6
3027086|NCT01093183|3745503|FG000|COMPLETED|Overall Study||18
3027087|NCT01093183|3745504|FG001|COMPLETED|Overall Study||4
3027088|NCT01093183|3745503|FG000|NOT COMPLETED|Overall Study||1
3027089|NCT01093183|3745504|FG001|NOT COMPLETED|Overall Study||2
3027090|NCT01093222|3745508|FG000|STARTED|Overall Study||40
3027091|NCT01093222|3745508|FG000|Eligible and Began Protocol Therapy|Overall Study||34
3027092|NCT01093222|3745508|FG000|COMPLETED|Overall Study||0
3027093|NCT01093222|3745508|FG000|NOT COMPLETED|Overall Study||40
3027094|NCT01093417|3745514|FG000|STARTED|Overall Study||15
3027095|NCT01093417|3745515|FG001|STARTED|Overall Study||30
3027096|NCT01093417|3745514|FG000|COMPLETED|Overall Study||15
3027097|NCT01093417|3745515|FG001|COMPLETED|Overall Study||29
3027098|NCT01093417|3745514|FG000|NOT COMPLETED|Overall Study||0
3027099|NCT01093417|3745515|FG001|NOT COMPLETED|Overall Study||1
3027100|NCT01093469|3745524|FG000|STARTED|Overall Study||13
3027101|NCT01093469|3745525|FG001|STARTED|Overall Study||13
3027102|NCT01093469|3745526|FG002|STARTED|Overall Study||13
3027103|NCT01093469|3745524|FG000|COMPLETED|Overall Study||13
3027104|NCT01093469|3745525|FG001|COMPLETED|Overall Study||13
3027105|NCT01093469|3745526|FG002|COMPLETED|Overall Study||12
3027106|NCT01093469|3745524|FG000|NOT COMPLETED|Overall Study||0
3027107|NCT01093469|3745525|FG001|NOT COMPLETED|Overall Study||0
3027108|NCT01093469|3745526|FG002|NOT COMPLETED|Overall Study||1
3027109|NCT01093482|3745534|FG000|STARTED|Overall Study||8151
3027110|NCT01093482|3745534|FG000|COMPLETED|Overall Study||8151
3027111|NCT01093482|3745534|FG000|NOT COMPLETED|Overall Study||0
3027112|NCT01093521|3745538|FG000|STARTED|Overall Study||20
3027113|NCT01093521|3745538|FG000|COMPLETED|Overall Study||20
3027114|NCT01093521|3745538|FG000|NOT COMPLETED|Overall Study||0
3027115|NCT01093534|3745547|FG000|STARTED|Overall Study||186
3027116|NCT01093534|3745548|FG001|STARTED|Overall Study||183
3027117|NCT01093534|3745549|FG002|STARTED|Overall Study||178
3027118|NCT01093534|3745547|FG000|Received Study Treatment|Overall Study||186
3027119|NCT01093534|3745548|FG001|Received Study Treatment|Overall Study||182
3027120|NCT01093534|3745549|FG002|Received Study Treatment|Overall Study||175
3027121|NCT01093534|3745547|FG000|COMPLETED|Overall Study||176
3027122|NCT01093534|3745548|FG001|COMPLETED|Overall Study||167
3027123|NCT01093534|3745549|FG002|COMPLETED|Overall Study||169
3027124|NCT01093534|3745547|FG000|NOT COMPLETED|Overall Study||10
3027125|NCT01093534|3745548|FG001|NOT COMPLETED|Overall Study||16
3027126|NCT01093534|3745549|FG002|NOT COMPLETED|Overall Study||9
3027127|NCT01093573|3745561|FG000|STARTED|Overall Study||3
3027128|NCT01093573|3745562|FG001|STARTED|Overall Study||3
3027129|NCT01093573|3745563|FG002|STARTED|Overall Study||28
3027130|NCT01093573|3745561|FG000|COMPLETED|Overall Study||3
3027131|NCT01093573|3745562|FG001|COMPLETED|Overall Study||3
3027132|NCT01093573|3745563|FG002|COMPLETED|Overall Study||26
3027133|NCT01093573|3745561|FG000|NOT COMPLETED|Overall Study||0
3027134|NCT01093573|3745562|FG001|NOT COMPLETED|Overall Study||0
3027135|NCT01093573|3745563|FG002|NOT COMPLETED|Overall Study||2
3027136|NCT01093586|3745574|FG000|STARTED|Overall Study||14
3027137|NCT01093586|3745574|FG000|COMPLETED|Overall Study||11
3027138|NCT01093586|3745574|FG000|NOT COMPLETED|Overall Study||3
3027139|NCT01093599|3745580|FG000|STARTED|Overall Study||91
3027140|NCT01093599|3745581|FG001|STARTED|Overall Study||105
3027141|NCT01093599|3745580|FG000|COMPLETED|Overall Study||59
3027142|NCT01093599|3745581|FG001|COMPLETED|Overall Study||59
3027143|NCT01093599|3745580|FG000|NOT COMPLETED|Overall Study||32
3027144|NCT01093599|3745581|FG001|NOT COMPLETED|Overall Study||46
3027145|NCT01093625|3745589|FG000|STARTED|Baseline and Dispensed||49
3027146|NCT01093625|3745590|FG001|STARTED|Baseline and Dispensed||49
3027147|NCT01093625|3745589|FG000|COMPLETED|Baseline and Dispensed||47
3027148|NCT01093625|3745590|FG001|COMPLETED|Baseline and Dispensed||49
3027149|NCT01093625|3745589|FG000|NOT COMPLETED|Baseline and Dispensed||2
3027150|NCT01093625|3745590|FG001|NOT COMPLETED|Baseline and Dispensed||0
3027151|NCT01093625|3745589|FG000|STARTED|2-Week Visit||47
3027152|NCT01093625|3745590|FG001|STARTED|2-Week Visit||49
3027153|NCT01093625|3745589|FG000|COMPLETED|2-Week Visit||46
3027154|NCT01093625|3745590|FG001|COMPLETED|2-Week Visit||49
3027155|NCT01093625|3745589|FG000|NOT COMPLETED|2-Week Visit||1
3027156|NCT01093625|3745590|FG001|NOT COMPLETED|2-Week Visit||0
3027157|NCT01093625|3745589|FG000|STARTED|1-Month Visit||46
3027158|NCT01093625|3745590|FG001|STARTED|1-Month Visit||49
3027159|NCT01093625|3745589|FG000|COMPLETED|1-Month Visit||44
3027160|NCT01093625|3745590|FG001|COMPLETED|1-Month Visit||49
3027161|NCT01093625|3745589|FG000|NOT COMPLETED|1-Month Visit||2
3027162|NCT01093625|3745590|FG001|NOT COMPLETED|1-Month Visit||0
3027163|NCT01093625|3745589|FG000|STARTED|3-Month Visit||44
3027164|NCT01093625|3745590|FG001|STARTED|3-Month Visit||49
3027165|NCT01093625|3745589|FG000|COMPLETED|3-Month Visit||42
3027166|NCT01093625|3745590|FG001|COMPLETED|3-Month Visit||49
3027167|NCT01093625|3745589|FG000|NOT COMPLETED|3-Month Visit||2
3027168|NCT01093625|3745590|FG001|NOT COMPLETED|3-Month Visit||0
3027169|NCT01093625|3745589|FG000|STARTED|6-Month Visit||42
3027170|NCT01093625|3745590|FG001|STARTED|6-Month Visit||49
3027171|NCT01093625|3745589|FG000|COMPLETED|6-Month Visit||34
3027172|NCT01093625|3745590|FG001|COMPLETED|6-Month Visit||40
3165960|NCT01902173|3893449|FG000|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 3||0
3165961|NCT01902173|3893450|FG001|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 3||0
3165962|NCT01902173|3893451|FG002|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 3||0
3165963|NCT01902173|3893452|FG003|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 3||0
3165964|NCT01902173|3893453|FG004|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 3||3
3165965|NCT01902173|3893454|FG005|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 3||0
3165966|NCT01902173|3893449|FG000|STARTED|Phase 1 Triplet Regimen Cohort 4||0
3165967|NCT01902173|3893450|FG001|STARTED|Phase 1 Triplet Regimen Cohort 4||0
3165968|NCT01902173|3893451|FG002|STARTED|Phase 1 Triplet Regimen Cohort 4||0
3165969|NCT01902173|3893452|FG003|STARTED|Phase 1 Triplet Regimen Cohort 4||0
3165970|NCT01902173|3893453|FG004|STARTED|Phase 1 Triplet Regimen Cohort 4||0
3027173|NCT01093625|3745589|FG000|NOT COMPLETED|6-Month Visit||8
3027174|NCT01093625|3745590|FG001|NOT COMPLETED|6-Month Visit||9
3027175|NCT01093625|3745589|FG000|STARTED|1-Year Visit||34
3027176|NCT01093625|3745590|FG001|STARTED|1-Year Visit||40
3027177|NCT01093625|3745589|FG000|COMPLETED|1-Year Visit||29
3027178|NCT01093625|3745590|FG001|COMPLETED|1-Year Visit||37
3027179|NCT01093625|3745589|FG000|NOT COMPLETED|1-Year Visit||5
3027180|NCT01093625|3745590|FG001|NOT COMPLETED|1-Year Visit||3
3027181|NCT01093651|3745598|FG000|STARTED|Overall Study||10
3027182|NCT01093651|3745599|FG001|STARTED|Overall Study||10
3165971|NCT01902173|3893454|FG005|STARTED|Phase 1 Triplet Regimen Cohort 4||5
3165972|NCT01902173|3893449|FG000|COMPLETED|Phase 1 Triplet Regimen Cohort 4||0
3027183|NCT01093651|3745598|FG000|COMPLETED|Overall Study||10
3027184|NCT01093651|3745599|FG001|COMPLETED|Overall Study||10
3027185|NCT01093651|3745598|FG000|NOT COMPLETED|Overall Study||0
3027186|NCT01093651|3745599|FG001|NOT COMPLETED|Overall Study||0
3027187|NCT01093690|3745607|FG000|STARTED|Overall Study||83
3027188|NCT01093690|3745608|FG001|STARTED|Overall Study||79
3027189|NCT01093690|3745607|FG000|COMPLETED|Overall Study||83
3027190|NCT01093690|3745608|FG001|COMPLETED|Overall Study||79
3027191|NCT01093690|3745607|FG000|NOT COMPLETED|Overall Study||0
3027192|NCT01093690|3745608|FG001|NOT COMPLETED|Overall Study||0
3027193|NCT01093755|3745616|FG000|STARTED|Overall Study||16
3027194|NCT01093755|3745617|FG001|STARTED|Overall Study||14
3027195|NCT01093755|3745616|FG000|COMPLETED|Overall Study||13
3027196|NCT01093755|3745617|FG001|COMPLETED|Overall Study||10
3027197|NCT01093755|3745616|FG000|NOT COMPLETED|Overall Study||3
3027198|NCT01093755|3745617|FG001|NOT COMPLETED|Overall Study||4
3027199|NCT01093794|3745623|FG000|STARTED|Treatment Period 1||7
3027200|NCT01093794|3745624|FG001|STARTED|Treatment Period 1||7
3027201|NCT01093794|3745625|FG002|STARTED|Treatment Period 1||7
3027202|NCT01093794|3745626|FG003|STARTED|Treatment Period 1||7
3027203|NCT01093794|3745623|FG000|COMPLETED|Treatment Period 1||7
3027204|NCT01093794|3745624|FG001|COMPLETED|Treatment Period 1||7
3027205|NCT01093794|3745625|FG002|COMPLETED|Treatment Period 1||7
3027206|NCT01093794|3745626|FG003|COMPLETED|Treatment Period 1||7
3027207|NCT01093794|3745623|FG000|NOT COMPLETED|Treatment Period 1||0
3027208|NCT01093794|3745624|FG001|NOT COMPLETED|Treatment Period 1||0
3027209|NCT01093794|3745625|FG002|NOT COMPLETED|Treatment Period 1||0
3027210|NCT01093794|3745626|FG003|NOT COMPLETED|Treatment Period 1||0
3027211|NCT01093794|3745623|FG000|STARTED|Treatment Period 2||7
3027212|NCT01093794|3745624|FG001|STARTED|Treatment Period 2||7
3027213|NCT01093794|3745625|FG002|STARTED|Treatment Period 2|After period 1, one participant was discontinued by the investigator due to a protocol deviation.|6
3027214|NCT01093794|3745626|FG003|STARTED|Treatment Period 2||7
3027215|NCT01093794|3745623|FG000|COMPLETED|Treatment Period 2||7
3027216|NCT01093794|3745624|FG001|COMPLETED|Treatment Period 2||7
3027217|NCT01093794|3745625|FG002|COMPLETED|Treatment Period 2||6
3027218|NCT01093794|3745626|FG003|COMPLETED|Treatment Period 2||7
3027219|NCT01093794|3745623|FG000|NOT COMPLETED|Treatment Period 2||0
3027220|NCT01093794|3745624|FG001|NOT COMPLETED|Treatment Period 2||0
3027221|NCT01093794|3745625|FG002|NOT COMPLETED|Treatment Period 2||0
3027222|NCT01093794|3745626|FG003|NOT COMPLETED|Treatment Period 2||0
3027223|NCT01093794|3745623|FG000|STARTED|Treatment Period 3||7
3027224|NCT01093794|3745624|FG001|STARTED|Treatment Period 3||7
3027225|NCT01093794|3745625|FG002|STARTED|Treatment Period 3||6
3027226|NCT01093794|3745626|FG003|STARTED|Treatment Period 3||7
3027227|NCT01093794|3745623|FG000|COMPLETED|Treatment Period 3||7
3027228|NCT01093794|3745624|FG001|COMPLETED|Treatment Period 3||7
3027229|NCT01093794|3745625|FG002|COMPLETED|Treatment Period 3||6
3027230|NCT01093794|3745626|FG003|COMPLETED|Treatment Period 3||7
3027231|NCT01093794|3745623|FG000|NOT COMPLETED|Treatment Period 3||0
3027232|NCT01093794|3745624|FG001|NOT COMPLETED|Treatment Period 3||0
3027233|NCT01093794|3745625|FG002|NOT COMPLETED|Treatment Period 3||0
3027234|NCT01093794|3745626|FG003|NOT COMPLETED|Treatment Period 3||0
3027235|NCT01093794|3745623|FG000|STARTED|Treatment Period 4||7
3027236|NCT01093794|3745624|FG001|STARTED|Treatment Period 4||7
3027237|NCT01093794|3745625|FG002|STARTED|Treatment Period 4||6
3027238|NCT01093794|3745626|FG003|STARTED|Treatment Period 4||7
3027239|NCT01093794|3745623|FG000|COMPLETED|Treatment Period 4||7
3027240|NCT01093794|3745624|FG001|COMPLETED|Treatment Period 4||7
3027241|NCT01093794|3745625|FG002|COMPLETED|Treatment Period 4||6
3027242|NCT01093794|3745626|FG003|COMPLETED|Treatment Period 4||7
3027243|NCT01093794|3745623|FG000|NOT COMPLETED|Treatment Period 4||0
3027244|NCT01093794|3745624|FG001|NOT COMPLETED|Treatment Period 4||0
3027245|NCT01093794|3745625|FG002|NOT COMPLETED|Treatment Period 4||0
3027246|NCT01093794|3745626|FG003|NOT COMPLETED|Treatment Period 4||0
3027247|NCT01093885|3745636|FG000|STARTED|Overall Study||15
3027248|NCT01093885|3745636|FG000|COMPLETED|Overall Study||10
3027249|NCT01093885|3745636|FG000|NOT COMPLETED|Overall Study||5
3027250|NCT01093976|3745641|FG000|STARTED|Overall Study||14
3027251|NCT01093976|3745641|FG000|COMPLETED|Overall Study||14
3027252|NCT01093976|3745641|FG000|NOT COMPLETED|Overall Study||0
3027253|NCT01094106|3745647|FG000|STARTED|Overall Study||33
3027254|NCT01094106|3745648|FG001|STARTED|Overall Study||34
3027255|NCT01094106|3745647|FG000|COMPLETED|Overall Study||33
3027256|NCT01094106|3745648|FG001|COMPLETED|Overall Study||34
3027257|NCT01094106|3745647|FG000|NOT COMPLETED|Overall Study||0
3027258|NCT01094106|3745648|FG001|NOT COMPLETED|Overall Study||0
3027259|NCT01094119|3745656|FG000|STARTED|Overall Study||34
3027260|NCT01094119|3745657|FG001|STARTED|Overall Study||36
3027261|NCT01094119|3745656|FG000|COMPLETED|Overall Study||32
3027262|NCT01094119|3745657|FG001|COMPLETED|Overall Study||32
3027263|NCT01094119|3745656|FG000|NOT COMPLETED|Overall Study||2
3027264|NCT01094119|3745657|FG001|NOT COMPLETED|Overall Study||4
3027265|NCT01094171|3745663|FG000|STARTED|Overall Study||400
3027266|NCT01094171|3745663|FG000|COMPLETED|Overall Study||390
3027267|NCT01094171|3745663|FG000|NOT COMPLETED|Overall Study||10
3027268|NCT01094184|3745669|FG000|STARTED|Overall Study||36
3027269|NCT01094184|3745670|FG001|STARTED|Overall Study||13
3027270|NCT01094184|3745669|FG000|COMPLETED|Overall Study||1
3308752|NCT03022799|4042127|FG012|COMPLETED|Overall Study||10
3308753|NCT03022799|4042115|FG000|NOT COMPLETED|Overall Study||0
3027271|NCT01094184|3745670|FG001|COMPLETED|Overall Study||2
3027272|NCT01094184|3745669|FG000|NOT COMPLETED|Overall Study||35
3027273|NCT01094184|3745670|FG001|NOT COMPLETED|Overall Study||11
3027274|NCT01094288|3745684|FG000|STARTED|Overall Study||6
3027275|NCT01094288|3745685|FG001|STARTED|Overall Study||15
3027276|NCT01094288|3745686|FG002|STARTED|Overall Study||5
3027277|NCT01094288|3745687|FG003|STARTED|Overall Study||3
3027278|NCT01094288|3745688|FG004|STARTED|Overall Study||2
3027279|NCT01094288|3745689|FG005|STARTED|Overall Study||4
3308754|NCT03022799|4042116|FG001|NOT COMPLETED|Overall Study||0
3027280|NCT01094288|3745690|FG006|STARTED|Overall Study||2
3027281|NCT01094288|3745691|FG007|STARTED|Overall Study||4
3027282|NCT01094288|3745684|FG000|COMPLETED|Overall Study|Completed=Completed Treatment|4
3027283|NCT01094288|3745685|FG001|COMPLETED|Overall Study||5
3027284|NCT01094288|3745686|FG002|COMPLETED|Overall Study||1
3027285|NCT01094288|3745687|FG003|COMPLETED|Overall Study||1
3027286|NCT01094288|3745688|FG004|COMPLETED|Overall Study||2
3027287|NCT01094288|3745689|FG005|COMPLETED|Overall Study||4
3027288|NCT01094288|3745690|FG006|COMPLETED|Overall Study||2
3027289|NCT01094288|3745691|FG007|COMPLETED|Overall Study||2
3027290|NCT01094288|3745684|FG000|NOT COMPLETED|Overall Study||2
3027291|NCT01094288|3745685|FG001|NOT COMPLETED|Overall Study||10
3027292|NCT01094288|3745686|FG002|NOT COMPLETED|Overall Study||4
3027293|NCT01094288|3745687|FG003|NOT COMPLETED|Overall Study||2
3027294|NCT01094288|3745688|FG004|NOT COMPLETED|Overall Study||0
3027295|NCT01094288|3745689|FG005|NOT COMPLETED|Overall Study||0
3027296|NCT01094288|3745690|FG006|NOT COMPLETED|Overall Study||0
3027297|NCT01094288|3745691|FG007|NOT COMPLETED|Overall Study||2
3165973|NCT01902173|3893450|FG001|COMPLETED|Phase 1 Triplet Regimen Cohort 4||0
3165974|NCT01902173|3893451|FG002|COMPLETED|Phase 1 Triplet Regimen Cohort 4||0
3308755|NCT03022799|4042117|FG002|NOT COMPLETED|Overall Study||0
3027298|NCT01094301|3745713|FG000|STARTED|Trial Stage||28
3027299|NCT01094301|3745713|FG000|Subjects Who Received Smartpatch Lead|Trial Stage||28
3027300|NCT01094301|3745713|FG000|COMPLETED|Trial Stage||27
3027301|NCT01094301|3745713|FG000|NOT COMPLETED|Trial Stage||1
3027302|NCT01094301|3745713|FG000|STARTED|Implant Stage||13
3027303|NCT01094301|3745713|FG000|Met Criteria for Implant Stage|Implant Stage||7
3027304|NCT01094301|3745713|FG000|Subjects Who Received SPR IPG|Implant Stage||5
3027305|NCT01094301|3745713|FG000|COMPLETED|Implant Stage||5
3027306|NCT01094301|3745713|FG000|NOT COMPLETED|Implant Stage||8
3027307|NCT01094522|3745721|FG000|STARTED|Overall Study||20
3027308|NCT01094522|3745722|FG001|STARTED|Overall Study||20
3027309|NCT01094522|3745721|FG000|COMPLETED|Overall Study||20
3027310|NCT01094522|3745722|FG001|COMPLETED|Overall Study||20
3027311|NCT01094522|3745721|FG000|NOT COMPLETED|Overall Study||0
3027312|NCT01094522|3745722|FG001|NOT COMPLETED|Overall Study||0
3027313|NCT01094548|3745731|FG000|STARTED|Overall Study||17
3027314|NCT01094548|3745732|FG001|STARTED|Overall Study||17
3027315|NCT01094548|3745731|FG000|COMPLETED|Overall Study||17
3027316|NCT01094548|3745732|FG001|COMPLETED|Overall Study||17
3027317|NCT01094548|3745731|FG000|NOT COMPLETED|Overall Study||0
3027318|NCT01094548|3745732|FG001|NOT COMPLETED|Overall Study||0
3027319|NCT01094574|3745746|FG000|STARTED|Overall Study||1
3027320|NCT01094574|3745747|FG001|STARTED|Overall Study||1
3027321|NCT01094574|3745748|FG002|STARTED|Overall Study||2
3027322|NCT01094574|3745749|FG003|STARTED|Overall Study||2
3308756|NCT03022799|4042118|FG003|NOT COMPLETED|Overall Study||0
3308757|NCT03022799|4042119|FG004|NOT COMPLETED|Overall Study||0
3308758|NCT03022799|4042120|FG005|NOT COMPLETED|Overall Study||0
3308759|NCT03022799|4042121|FG006|NOT COMPLETED|Overall Study||0
3308760|NCT03022799|4042122|FG007|NOT COMPLETED|Overall Study||0
3308761|NCT03022799|4042123|FG008|NOT COMPLETED|Overall Study||0
3308762|NCT03022799|4042124|FG009|NOT COMPLETED|Overall Study||1
3308763|NCT03022799|4042125|FG010|NOT COMPLETED|Overall Study||1
3308764|NCT03022799|4042126|FG011|NOT COMPLETED|Overall Study||0
3308765|NCT03022799|4042127|FG012|NOT COMPLETED|Overall Study||0
3308766|NCT03022916|4042172|FG000|STARTED|Overall Study||5
3308767|NCT03022916|4042173|FG001|STARTED|Overall Study||5
3308768|NCT03022916|4042174|FG002|STARTED|Overall Study||5
3308769|NCT03022916|4042175|FG003|STARTED|Overall Study||5
3308770|NCT03022916|4042172|FG000|Nail Polish|Overall Study||5
3308771|NCT03022916|4042173|FG001|Nail Polish|Overall Study||5
3308772|NCT03022916|4042174|FG002|Nail Polish|Overall Study||5
3308773|NCT03022916|4042175|FG003|Nail Polish|Overall Study||5
3308774|NCT03022916|4042172|FG000|Nail Polish, Base Coat|Overall Study||5
3308775|NCT03022916|4042173|FG001|Nail Polish, Base Coat|Overall Study||5
3308776|NCT03022916|4042174|FG002|Nail Polish, Base Coat|Overall Study||5
3308777|NCT03022916|4042175|FG003|Nail Polish, Base Coat|Overall Study||5
3308778|NCT03022916|4042172|FG000|Nail Polish, Top Coat|Overall Study||5
3308779|NCT03022916|4042173|FG001|Nail Polish, Top Coat|Overall Study||5
3308780|NCT03022916|4042174|FG002|Nail Polish, Top Coat|Overall Study||5
3308781|NCT03022916|4042175|FG003|Nail Polish, Top Coat|Overall Study||5
3308782|NCT03022916|4042172|FG000|COMPLETED|Overall Study||5
3308783|NCT03022916|4042173|FG001|COMPLETED|Overall Study||5
3308784|NCT03022916|4042174|FG002|COMPLETED|Overall Study||5
3308785|NCT03022916|4042175|FG003|COMPLETED|Overall Study||5
3308786|NCT03022916|4042172|FG000|NOT COMPLETED|Overall Study||0
3308787|NCT03022916|4042173|FG001|NOT COMPLETED|Overall Study||0
3308788|NCT03022916|4042174|FG002|NOT COMPLETED|Overall Study||0
3308789|NCT03022916|4042175|FG003|NOT COMPLETED|Overall Study||0
3308790|NCT03022981|4042185|FG000|STARTED|Overall Study||102
3308791|NCT03022981|4042186|FG001|STARTED|Overall Study||73
3308792|NCT03022981|4042187|FG002|STARTED|Overall Study||41
3308793|NCT03022981|4042185|FG000|Participated in PK Lead-in (PKL) Phase|Overall Study|All 17 participants completed treatment in the PK Lead-in phase and continued into treatment phase.|17
3308794|NCT03022981|4042186|FG001|Participated in PK Lead-in (PKL) Phase|Overall Study|All 20 participants completed treatment in the PK Lead-in phase and continued into treatment phase.|20
3317120|NCT03124121|4050647|FG000|NOT COMPLETED|Overall Study||3
3027323|NCT01094574|3745750|FG004|STARTED|Overall Study||2
3027324|NCT01094574|3745751|FG005|STARTED|Overall Study||2
3027325|NCT01094574|3745746|FG000|COMPLETED|Overall Study||1
3027326|NCT01094574|3745747|FG001|COMPLETED|Overall Study||1
3027327|NCT01094574|3745748|FG002|COMPLETED|Overall Study||2
3027328|NCT01094574|3745749|FG003|COMPLETED|Overall Study||2
3027329|NCT01094574|3745750|FG004|COMPLETED|Overall Study||2
3027330|NCT01094574|3745751|FG005|COMPLETED|Overall Study||2
3027331|NCT01094574|3745746|FG000|NOT COMPLETED|Overall Study||0
3027332|NCT01094574|3745747|FG001|NOT COMPLETED|Overall Study||0
3027333|NCT01094574|3745748|FG002|NOT COMPLETED|Overall Study||0
3027334|NCT01094574|3745749|FG003|NOT COMPLETED|Overall Study||0
3027335|NCT01094574|3745750|FG004|NOT COMPLETED|Overall Study||0
3027336|NCT01094574|3745751|FG005|NOT COMPLETED|Overall Study||0
3027337|NCT01094704|3745764|FG000|STARTED|Overall Study||8
3027338|NCT01094704|3745765|FG001|STARTED|Overall Study||8
3027339|NCT01094704|3745764|FG000|COMPLETED|Overall Study||8
3027340|NCT01094704|3745765|FG001|COMPLETED|Overall Study||8
3027341|NCT01094704|3745764|FG000|NOT COMPLETED|Overall Study||0
3027342|NCT01094704|3745765|FG001|NOT COMPLETED|Overall Study||0
3027343|NCT01094717|3745773|FG000|STARTED|Overall Study||3
3027344|NCT01094717|3745774|FG001|STARTED|Overall Study||10
3027345|NCT01094717|3745773|FG000|COMPLETED|Overall Study||3
3027346|NCT01094717|3745774|FG001|COMPLETED|Overall Study||10
3027347|NCT01094717|3745773|FG000|NOT COMPLETED|Overall Study||0
3027348|NCT01094717|3745774|FG001|NOT COMPLETED|Overall Study||0
3027349|NCT01094730|3745790|FG000|STARTED|Period 1 (14 Days)||92
3027350|NCT01094730|3745791|FG001|STARTED|Period 1 (14 Days)||88
3027351|NCT01094730|3745790|FG000|COMPLETED|Period 1 (14 Days)||90
3027352|NCT01094730|3745791|FG001|COMPLETED|Period 1 (14 Days)||86
3027353|NCT01094730|3745790|FG000|NOT COMPLETED|Period 1 (14 Days)||2
3027354|NCT01094730|3745791|FG001|NOT COMPLETED|Period 1 (14 Days)||2
3027355|NCT01094730|3745790|FG000|STARTED|Period 2 (14 Days)||90
3027356|NCT01094730|3745791|FG001|STARTED|Period 2 (14 Days)||86
3027357|NCT01094730|3745790|FG000|COMPLETED|Period 2 (14 Days)||87
3027358|NCT01094730|3745791|FG001|COMPLETED|Period 2 (14 Days)||84
3027359|NCT01094730|3745790|FG000|NOT COMPLETED|Period 2 (14 Days)||3
3027360|NCT01094730|3745791|FG001|NOT COMPLETED|Period 2 (14 Days)||2
3027361|NCT01094743|3745798|FG000|STARTED|Period 1||52
3027362|NCT01094743|3745798|FG000|COMPLETED|Period 1||50
3027363|NCT01094743|3745798|FG000|NOT COMPLETED|Period 1||2
3027364|NCT01094743|3745798|FG000|STARTED|Period 2||50
3027365|NCT01094743|3745798|FG000|COMPLETED|Period 2||50
3027366|NCT01094743|3745798|FG000|NOT COMPLETED|Period 2||0
3027367|NCT01094782|3745809|FG000|STARTED|Overall Study||39
3027368|NCT01094782|3745810|FG001|STARTED|Overall Study||39
3027369|NCT01094782|3745811|FG002|STARTED|Overall Study||34
3165975|NCT01902173|3893452|FG003|COMPLETED|Phase 1 Triplet Regimen Cohort 4||0
3165976|NCT01902173|3893453|FG004|COMPLETED|Phase 1 Triplet Regimen Cohort 4||0
3165977|NCT01902173|3893454|FG005|COMPLETED|Phase 1 Triplet Regimen Cohort 4||0
3165978|NCT01902173|3893449|FG000|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 4||0
3165979|NCT01902173|3893450|FG001|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 4||0
3027370|NCT01094782|3745812|FG003|STARTED|Overall Study||56
3027371|NCT01094782|3745813|FG004|STARTED|Overall Study||42
3027372|NCT01094782|3745814|FG005|STARTED|Overall Study||38
3027373|NCT01094782|3745809|FG000|COMPLETED|Overall Study||31
3027374|NCT01094782|3745810|FG001|COMPLETED|Overall Study||29
3027375|NCT01094782|3745811|FG002|COMPLETED|Overall Study||31
3027376|NCT01094782|3745812|FG003|COMPLETED|Overall Study||45
3027377|NCT01094782|3745813|FG004|COMPLETED|Overall Study||31
3027378|NCT01094782|3745814|FG005|COMPLETED|Overall Study||30
3027379|NCT01094782|3745809|FG000|NOT COMPLETED|Overall Study||8
3027380|NCT01094782|3745810|FG001|NOT COMPLETED|Overall Study||10
3027381|NCT01094782|3745811|FG002|NOT COMPLETED|Overall Study||3
3027382|NCT01094782|3745812|FG003|NOT COMPLETED|Overall Study||11
3027383|NCT01094782|3745813|FG004|NOT COMPLETED|Overall Study||11
3027384|NCT01094782|3745814|FG005|NOT COMPLETED|Overall Study||8
3027385|NCT01094808|3745831|FG000|STARTED|Overall Study||21
3027386|NCT01094808|3745832|FG001|STARTED|Overall Study||20
3027387|NCT01094808|3745833|FG002|STARTED|Overall Study||21
3027388|NCT01094808|3745831|FG000|COMPLETED|Overall Study||20
3027389|NCT01094808|3745832|FG001|COMPLETED|Overall Study||19
3027390|NCT01094808|3745833|FG002|COMPLETED|Overall Study||21
3027391|NCT01094808|3745831|FG000|NOT COMPLETED|Overall Study||1
3027392|NCT01094808|3745832|FG001|NOT COMPLETED|Overall Study||1
3027393|NCT01094808|3745833|FG002|NOT COMPLETED|Overall Study||0
3027394|NCT01094886|3745841|FG000|STARTED|Overall Study||53
3027395|NCT01094886|3745841|FG000|COMPLETED|Overall Study||46
3027396|NCT01094886|3745841|FG000|NOT COMPLETED|Overall Study||7
3027397|NCT01095003|3745847|FG000|STARTED|Overall Study||384
3027398|NCT01095003|3745848|FG001|STARTED|Overall Study||386
3027399|NCT01095003|3745847|FG000|COMPLETED|Overall Study||0
3027400|NCT01095003|3745848|FG001|COMPLETED|Overall Study||0
3027401|NCT01095003|3745847|FG000|NOT COMPLETED|Overall Study||384
3027402|NCT01095003|3745848|FG001|NOT COMPLETED|Overall Study||386
3027403|NCT01095094|3745856|FG000|STARTED|Overall Study||19
3027404|NCT01095094|3745856|FG000|COMPLETED|Overall Study||16
3027405|NCT01095094|3745856|FG000|NOT COMPLETED|Overall Study||3
3027406|NCT01095497|3745862|FG000|STARTED|Intravenous CINRYZE||14
3027407|NCT01095497|3745863|FG001|STARTED|Intravenous CINRYZE||12
3027408|NCT01095497|3745862|FG000|COMPLETED|Intravenous CINRYZE||13
3027409|NCT01095497|3745863|FG001|COMPLETED|Intravenous CINRYZE||12
3027410|NCT01095497|3745862|FG000|NOT COMPLETED|Intravenous CINRYZE||1
3027411|NCT01095497|3745863|FG001|NOT COMPLETED|Intravenous CINRYZE||0
3027412|NCT01095497|3745862|FG000|STARTED|Subcutaneous CINRYZE||13
3027413|NCT01095497|3745863|FG001|STARTED|Subcutaneous CINRYZE||12
3027414|NCT01095497|3745862|FG000|COMPLETED|Subcutaneous CINRYZE||12
3027415|NCT01095497|3745863|FG001|COMPLETED|Subcutaneous CINRYZE||12
3027416|NCT01095497|3745862|FG000|NOT COMPLETED|Subcutaneous CINRYZE||1
3027417|NCT01095497|3745863|FG001|NOT COMPLETED|Subcutaneous CINRYZE||0
3027418|NCT01095510|3745877|FG000|STARTED|Overall Study||3
3027419|NCT01095510|3745878|FG001|STARTED|Overall Study||0
3027420|NCT01095510|3745879|FG002|STARTED|Overall Study||3
3027421|NCT01095510|3745880|FG003|STARTED|Overall Study||3
3027422|NCT01095510|3745877|FG000|COMPLETED|Overall Study||3
3027423|NCT01095510|3745878|FG001|COMPLETED|Overall Study||0
3027424|NCT01095510|3745879|FG002|COMPLETED|Overall Study||3
3027425|NCT01095510|3745880|FG003|COMPLETED|Overall Study||3
3027426|NCT01095510|3745877|FG000|NOT COMPLETED|Overall Study||0
3027427|NCT01095510|3745878|FG001|NOT COMPLETED|Overall Study||0
3027428|NCT01095510|3745879|FG002|NOT COMPLETED|Overall Study||0
3027429|NCT01095510|3745880|FG003|NOT COMPLETED|Overall Study||0
3027430|NCT01095653|3745891|FG000|STARTED|Overall Study||132
3027431|NCT01095653|3745892|FG001|STARTED|Overall Study||128
3027432|NCT01095653|3745893|FG002|STARTED|Overall Study||133
3027433|NCT01095653|3745891|FG000|COMPLETED|Overall Study||113
3027434|NCT01095653|3745892|FG001|COMPLETED|Overall Study||113
3027435|NCT01095653|3745893|FG002|COMPLETED|Overall Study||117
3027436|NCT01095653|3745891|FG000|NOT COMPLETED|Overall Study||19
3027437|NCT01095653|3745892|FG001|NOT COMPLETED|Overall Study||15
3027438|NCT01095653|3745893|FG002|NOT COMPLETED|Overall Study||16
3027439|NCT01095666|3745904|FG000|STARTED|Overall Study||145
3027440|NCT01095666|3745905|FG001|STARTED|Overall Study||147
3027441|NCT01095666|3745906|FG002|STARTED|Overall Study||152
3027442|NCT01095666|3745904|FG000|COMPLETED|Overall Study||128
3027443|NCT01095666|3745905|FG001|COMPLETED|Overall Study||136
3027444|NCT01095666|3745906|FG002|COMPLETED|Overall Study||145
3027445|NCT01095666|3745904|FG000|NOT COMPLETED|Overall Study||17
3027446|NCT01095666|3745905|FG001|NOT COMPLETED|Overall Study||11
3027447|NCT01095666|3745906|FG002|NOT COMPLETED|Overall Study||7
3027448|NCT01095757|3745914|FG000|STARTED|Overall Study||45
3027449|NCT01095757|3745914|FG000|COMPLETED|Overall Study||45
3027450|NCT01095757|3745914|FG000|NOT COMPLETED|Overall Study||0
3027451|NCT01095796|3745921|FG000|STARTED|Overall Study||353
3027452|NCT01095796|3745922|FG001|STARTED|Overall Study||354
3027453|NCT01095796|3745921|FG000|COMPLETED|Overall Study||58
3027454|NCT01095796|3745922|FG001|COMPLETED|Overall Study||65
3027455|NCT01095796|3745921|FG000|NOT COMPLETED|Overall Study||295
3027456|NCT01095796|3745922|FG001|NOT COMPLETED|Overall Study||289
3027457|NCT01095835|3745931|FG000|STARTED|Overall Study||51
3027458|NCT01095835|3745932|FG001|STARTED|Overall Study||52
3027459|NCT01095835|3745933|FG002|STARTED|Overall Study||25
3027460|NCT01095835|3745931|FG000|COMPLETED|Overall Study||41
3027461|NCT01095835|3745932|FG001|COMPLETED|Overall Study||40
3027462|NCT01095835|3745933|FG002|COMPLETED|Overall Study||17
3027463|NCT01095835|3745931|FG000|NOT COMPLETED|Overall Study||10
3027464|NCT01095835|3745932|FG001|NOT COMPLETED|Overall Study||12
3027465|NCT01095835|3745933|FG002|NOT COMPLETED|Overall Study||8
3027466|NCT01095887|3745942|FG000|STARTED|Overall Study||6
3027467|NCT01095887|3745942|FG000|COMPLETED|Overall Study||6
3027468|NCT01095887|3745942|FG000|NOT COMPLETED|Overall Study||0
3027469|NCT01095978|3745946|FG000|STARTED|Overall Study||2822
3027470|NCT01095978|3745946|FG000|COMPLETED|Overall Study||2819
3027471|NCT01095978|3745946|FG000|NOT COMPLETED|Overall Study||3
3027472|NCT01096017|3745952|FG000|STARTED|Treatment Period 1||12
3027473|NCT01096017|3745953|FG001|STARTED|Treatment Period 1||12
3027474|NCT01096017|3745952|FG000|COMPLETED|Treatment Period 1||12
3027475|NCT01096017|3745953|FG001|COMPLETED|Treatment Period 1||12
3027476|NCT01096017|3745952|FG000|NOT COMPLETED|Treatment Period 1||0
3027477|NCT01096017|3745953|FG001|NOT COMPLETED|Treatment Period 1||0
3027478|NCT01096017|3745952|FG000|STARTED|Washout 1 - 14 Days||12
3027479|NCT01096017|3745953|FG001|STARTED|Washout 1 - 14 Days||12
3027480|NCT01096017|3745952|FG000|COMPLETED|Washout 1 - 14 Days||12
3027481|NCT01096017|3745953|FG001|COMPLETED|Washout 1 - 14 Days||12
3027482|NCT01096017|3745952|FG000|NOT COMPLETED|Washout 1 - 14 Days||0
3027483|NCT01096017|3745953|FG001|NOT COMPLETED|Washout 1 - 14 Days||0
3027484|NCT01096017|3745952|FG000|STARTED|Treatment Period 2||12
3027485|NCT01096017|3745953|FG001|STARTED|Treatment Period 2||12
3027486|NCT01096017|3745952|FG000|COMPLETED|Treatment Period 2||11
3027487|NCT01096017|3745953|FG001|COMPLETED|Treatment Period 2||11
3027488|NCT01096017|3745952|FG000|NOT COMPLETED|Treatment Period 2||1
3027489|NCT01096017|3745953|FG001|NOT COMPLETED|Treatment Period 2||1
3027490|NCT01096056|3745961|FG000|STARTED|Overall Study||20
3027491|NCT01096056|3745962|FG001|STARTED|Overall Study||20
3027492|NCT01096056|3745961|FG000|Completed at Day 42|Overall Study||20
3027493|NCT01096056|3745962|FG001|Completed at Day 42|Overall Study||20
3027494|NCT01096056|3745961|FG000|COMPLETED|Overall Study||20
3027495|NCT01096056|3745962|FG001|COMPLETED|Overall Study||19
3027496|NCT01096056|3745961|FG000|NOT COMPLETED|Overall Study||0
3027497|NCT01096056|3745962|FG001|NOT COMPLETED|Overall Study||1
3027498|NCT01096160|3745978|FG000|STARTED|Overall Study||6
3027499|NCT01096160|3745979|FG001|STARTED|Overall Study||2
3027500|NCT01096160|3745980|FG002|STARTED|Overall Study||6
3027501|NCT01096160|3745981|FG003|STARTED|Overall Study||2
3027502|NCT01096160|3745982|FG004|STARTED|Overall Study||6
3027503|NCT01096160|3745983|FG005|STARTED|Overall Study||2
3027504|NCT01096160|3745984|FG006|STARTED|Overall Study||6
3027505|NCT01096160|3745985|FG007|STARTED|Overall Study||2
3027506|NCT01096160|3745986|FG008|STARTED|Overall Study||6
3027507|NCT01096160|3745987|FG009|STARTED|Overall Study||2
3027508|NCT01096160|3745978|FG000|COMPLETED|Overall Study||6
3027509|NCT01096160|3745979|FG001|COMPLETED|Overall Study||2
3027510|NCT01096160|3745980|FG002|COMPLETED|Overall Study||5
3027511|NCT01096160|3745981|FG003|COMPLETED|Overall Study||2
3027512|NCT01096160|3745982|FG004|COMPLETED|Overall Study||5
3027513|NCT01096160|3745983|FG005|COMPLETED|Overall Study||2
3027514|NCT01096160|3745984|FG006|COMPLETED|Overall Study||4
3027515|NCT01096160|3745985|FG007|COMPLETED|Overall Study||2
3027516|NCT01096160|3745986|FG008|COMPLETED|Overall Study||4
3027517|NCT01096160|3745987|FG009|COMPLETED|Overall Study||1
3027518|NCT01096160|3745978|FG000|NOT COMPLETED|Overall Study||0
3027519|NCT01096160|3745979|FG001|NOT COMPLETED|Overall Study||0
3027520|NCT01096160|3745980|FG002|NOT COMPLETED|Overall Study||1
3027521|NCT01096160|3745981|FG003|NOT COMPLETED|Overall Study||0
3027522|NCT01096160|3745982|FG004|NOT COMPLETED|Overall Study||1
3027523|NCT01096160|3745983|FG005|NOT COMPLETED|Overall Study||0
3027524|NCT01096160|3745984|FG006|NOT COMPLETED|Overall Study||2
3027525|NCT01096160|3745985|FG007|NOT COMPLETED|Overall Study||0
3027526|NCT01096160|3745986|FG008|NOT COMPLETED|Overall Study||2
3027527|NCT01096160|3745987|FG009|NOT COMPLETED|Overall Study||1
3038104|NCT01152112|3757484|FG001|NOT COMPLETED|Overall Study||0
3038105|NCT01152190|3757492|FG000|STARTED|Overall Study||50
3038106|NCT01152190|3757493|FG001|STARTED|Overall Study||47
3038107|NCT01152190|3757492|FG000|Received at Least 1 Dose of Study Drug|Overall Study||50
3038108|NCT01152190|3757493|FG001|Received at Least 1 Dose of Study Drug|Overall Study||47
3038109|NCT01152190|3757492|FG000|COMPLETED|Overall Study||45
3038110|NCT01152190|3757493|FG001|COMPLETED|Overall Study||39
3038111|NCT01152190|3757492|FG000|NOT COMPLETED|Overall Study||5
3038112|NCT01152190|3757493|FG001|NOT COMPLETED|Overall Study||8
3038113|NCT01152294|3757501|FG000|STARTED|Overall Study||213
3038114|NCT01152294|3757502|FG001|STARTED|Overall Study||188
3038115|NCT01152294|3757501|FG000|COMPLETED|Overall Study||213
3038116|NCT01152294|3757502|FG001|COMPLETED|Overall Study||188
3038117|NCT01152294|3757501|FG000|NOT COMPLETED|Overall Study||0
3165980|NCT01902173|3893451|FG002|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 4||0
3165981|NCT01902173|3893452|FG003|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 4||0
3165982|NCT01902173|3893453|FG004|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 4||0
3165983|NCT01902173|3893454|FG005|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 4||5
3165984|NCT01902173|3893449|FG000|STARTED|Phase II||0
3308795|NCT03022981|4042187|FG002|Participated in PK Lead-in (PKL) Phase|Overall Study|All 19 participants completed treatment in the PK Lead-in phase and continued into treatment phase.|19
3038118|NCT01152294|3757502|FG001|NOT COMPLETED|Overall Study||0
3038119|NCT01152307|3757510|FG000|STARTED|Overall Study||191
3038120|NCT01152307|3757511|FG001|STARTED|Overall Study||214
3038121|NCT01152307|3757510|FG000|COMPLETED|Overall Study||191
3038122|NCT01152307|3757511|FG001|COMPLETED|Overall Study||214
3038123|NCT01152307|3757510|FG000|NOT COMPLETED|Overall Study||0
3308796|NCT03022981|4042185|FG000|COMPLETED|Overall Study||96
3308797|NCT03022981|4042186|FG001|COMPLETED|Overall Study||69
3308798|NCT03022981|4042187|FG002|COMPLETED|Overall Study||35
3308799|NCT03022981|4042185|FG000|NOT COMPLETED|Overall Study||6
3308800|NCT03022981|4042186|FG001|NOT COMPLETED|Overall Study||4
3308801|NCT03022981|4042187|FG002|NOT COMPLETED|Overall Study||6
3038124|NCT01152307|3757511|FG001|NOT COMPLETED|Overall Study||0
3038125|NCT01152359|3757519|FG000|STARTED|Overall Study||105
3038126|NCT01152359|3757520|FG001|STARTED|Overall Study||102
3038127|NCT01152359|3757519|FG000|COMPLETED|Overall Study||81
3038128|NCT01152359|3757520|FG001|COMPLETED|Overall Study||80
3038129|NCT01152359|3757519|FG000|NOT COMPLETED|Overall Study||24
3038130|NCT01152359|3757520|FG001|NOT COMPLETED|Overall Study||22
3038131|NCT01152385|3757530|FG000|STARTED|Overall Study||55
3038132|NCT01152385|3757531|FG001|STARTED|Overall Study||58
3038133|NCT01152385|3757532|FG002|STARTED|Overall Study||56
3038134|NCT01152385|3757533|FG003|STARTED|Overall Study||55
3038135|NCT01152385|3757530|FG000|COMPLETED|Overall Study||46
3038136|NCT01152385|3757531|FG001|COMPLETED|Overall Study||52
3308802|NCT03023137|4042207|FG000|STARTED|Overall Study||178
3308803|NCT03023137|4042208|FG001|STARTED|Overall Study||171
3308804|NCT03023137|4042207|FG000|COMPLETED|Overall Study||174
3308805|NCT03023137|4042208|FG001|COMPLETED|Overall Study||162
3308806|NCT03023137|4042207|FG000|NOT COMPLETED|Overall Study||4
3308807|NCT03023137|4042208|FG001|NOT COMPLETED|Overall Study||9
3308808|NCT03023176|4042215|FG000|STARTED|Overall Study||20
3308809|NCT03023176|4042215|FG000|COMPLETED|Overall Study||20
3308810|NCT03023176|4042215|FG000|NOT COMPLETED|Overall Study||0
3308811|NCT03023397|4042222|FG000|STARTED|Run-In||8
3308812|NCT03023397|4042223|FG001|STARTED|Run-In||3
3308813|NCT03023397|4042224|FG002|STARTED|Run-In||1
3308814|NCT03023397|4042222|FG000|COMPLETED|Run-In||6
3308815|NCT03023397|4042223|FG001|COMPLETED|Run-In||3
3308816|NCT03023397|4042224|FG002|COMPLETED|Run-In||1
3308817|NCT03023397|4042222|FG000|NOT COMPLETED|Run-In||2
3308818|NCT03023397|4042223|FG001|NOT COMPLETED|Run-In||0
3038137|NCT01152385|3757532|FG002|COMPLETED|Overall Study||51
3308819|NCT03023397|4042224|FG002|NOT COMPLETED|Run-In||0
3038138|NCT01152385|3757533|FG003|COMPLETED|Overall Study||50
3038139|NCT01152385|3757530|FG000|NOT COMPLETED|Overall Study||9
3027528|NCT01096186|3746022|FG000|STARTED|Overall Study||617
3027529|NCT01096186|3746022|FG000|COMPLETED|Overall Study||567
3027530|NCT01096186|3746022|FG000|NOT COMPLETED|Overall Study||50
3027531|NCT01096290|3746028|FG000|STARTED|Overall Study||9
3027532|NCT01096290|3746029|FG001|STARTED|Overall Study||14
3027533|NCT01096290|3746028|FG000|COMPLETED|Overall Study||9
3027534|NCT01096290|3746029|FG001|COMPLETED|Overall Study||14
3027535|NCT01096290|3746028|FG000|NOT COMPLETED|Overall Study||0
3027536|NCT01096290|3746029|FG001|NOT COMPLETED|Overall Study||0
3027537|NCT01096316|3746037|FG000|STARTED|Overall Study||102
3027538|NCT01096316|3746038|FG001|STARTED|Overall Study||103
3027539|NCT01096316|3746037|FG000|COMPLETED|Overall Study||87
3027540|NCT01096316|3746038|FG001|COMPLETED|Overall Study||94
3027541|NCT01096316|3746037|FG000|NOT COMPLETED|Overall Study||15
3027542|NCT01096316|3746038|FG001|NOT COMPLETED|Overall Study||9
3027543|NCT01096342|3746044|FG000|STARTED|Overall Study||16
3027544|NCT01096342|3746044|FG000|COMPLETED|Overall Study||15
3027545|NCT01096342|3746044|FG000|NOT COMPLETED|Overall Study||1
3027546|NCT01096446|3746050|FG000|STARTED|Overall Study||12
3027547|NCT01096446|3746051|FG001|STARTED|Overall Study||10
3027548|NCT01096446|3746050|FG000|COMPLETED|Overall Study|One infant was SGA; one infant had a congenital anomaly; and one discontinued medical management|9
3027549|NCT01096446|3746051|FG001|COMPLETED|Overall Study||10
3027550|NCT01096446|3746050|FG000|NOT COMPLETED|Overall Study||3
3027551|NCT01096446|3746051|FG001|NOT COMPLETED|Overall Study||0
3027552|NCT01096550|3746058|FG000|STARTED|Overall Study||170
3027553|NCT01096550|3746059|FG001|STARTED|Overall Study||175
3027554|NCT01096550|3746058|FG000|COMPLETED|Overall Study||133
3027555|NCT01096550|3746059|FG001|COMPLETED|Overall Study||146
3027556|NCT01096550|3746058|FG000|NOT COMPLETED|Overall Study||37
3027557|NCT01096550|3746059|FG001|NOT COMPLETED|Overall Study||29
3027558|NCT01096589|3746069|FG000|STARTED|Overall Study||22
3027559|NCT01096589|3746070|FG001|STARTED|Overall Study||20
3027560|NCT01096589|3746071|FG002|STARTED|Overall Study||22
3027561|NCT01096589|3746072|FG003|STARTED|Overall Study||18
3027562|NCT01096589|3746069|FG000|COMPLETED|Overall Study||18
3027563|NCT01096589|3746070|FG001|COMPLETED|Overall Study||18
3027564|NCT01096589|3746071|FG002|COMPLETED|Overall Study||18
3027565|NCT01096589|3746072|FG003|COMPLETED|Overall Study||15
3027566|NCT01096589|3746069|FG000|NOT COMPLETED|Overall Study||4
3027567|NCT01096589|3746070|FG001|NOT COMPLETED|Overall Study||2
3027568|NCT01096589|3746071|FG002|NOT COMPLETED|Overall Study||4
3027569|NCT01096589|3746072|FG003|NOT COMPLETED|Overall Study||3
3027570|NCT01096667|3746091|FG000|STARTED|Overall Study||39
3027571|NCT01096667|3746092|FG001|STARTED|Overall Study||39
3027572|NCT01096667|3746093|FG002|STARTED|Overall Study||38
3027573|NCT01096667|3746094|FG003|STARTED|Overall Study||39
3027574|NCT01096667|3746095|FG004|STARTED|Overall Study||39
3027575|NCT01096667|3746091|FG000|Treated|Overall Study||38
3027576|NCT01096667|3746092|FG001|Treated|Overall Study||39
3027577|NCT01096667|3746093|FG002|Treated|Overall Study||38
3027578|NCT01096667|3746094|FG003|Treated|Overall Study||39
3027579|NCT01096667|3746095|FG004|Treated|Overall Study||39
3027580|NCT01096667|3746091|FG000|COMPLETED|Overall Study||36
3027581|NCT01096667|3746092|FG001|COMPLETED|Overall Study||37
3027582|NCT01096667|3746093|FG002|COMPLETED|Overall Study||36
3027583|NCT01096667|3746094|FG003|COMPLETED|Overall Study||36
3027584|NCT01096667|3746095|FG004|COMPLETED|Overall Study||39
3027585|NCT01096667|3746091|FG000|NOT COMPLETED|Overall Study||3
3027586|NCT01096667|3746092|FG001|NOT COMPLETED|Overall Study||2
3027587|NCT01096667|3746093|FG002|NOT COMPLETED|Overall Study||2
3308820|NCT03023397|4042222|FG000|STARTED|Main Study||6
3308821|NCT03023397|4042223|FG001|STARTED|Main Study||3
3308822|NCT03023397|4042224|FG002|STARTED|Main Study||1
3308823|NCT03023397|4042222|FG000|COMPLETED|Main Study||6
3308824|NCT03023397|4042223|FG001|COMPLETED|Main Study||3
3308825|NCT03023397|4042224|FG002|COMPLETED|Main Study||1
3308826|NCT03023397|4042222|FG000|NOT COMPLETED|Main Study||0
3308827|NCT03023397|4042223|FG001|NOT COMPLETED|Main Study||0
3308828|NCT03023397|4042224|FG002|NOT COMPLETED|Main Study||0
3308829|NCT03023423|4042236|FG000|STARTED|Overall Study||7
3027588|NCT01096667|3746094|FG003|NOT COMPLETED|Overall Study||3
3027589|NCT01096667|3746095|FG004|NOT COMPLETED|Overall Study||0
3027590|NCT01096680|3746113|FG000|STARTED|Overall Study||27
3027591|NCT01096680|3746114|FG001|STARTED|Overall Study||27
3027592|NCT01096680|3746115|FG002|STARTED|Overall Study||27
3027593|NCT01096680|3746116|FG003|STARTED|Overall Study||27
3027594|NCT01096680|3746117|FG004|STARTED|Overall Study||27
3027595|NCT01096680|3746113|FG000|COMPLETED|Overall Study||27
3027596|NCT01096680|3746114|FG001|COMPLETED|Overall Study||27
3027597|NCT01096680|3746115|FG002|COMPLETED|Overall Study||27
3027598|NCT01096680|3746116|FG003|COMPLETED|Overall Study||27
3027599|NCT01096680|3746117|FG004|COMPLETED|Overall Study||27
3308830|NCT03023423|4042237|FG001|STARTED|Overall Study||46
3308831|NCT03023423|4042238|FG002|STARTED|Overall Study||46
3308832|NCT03023423|4042236|FG000|Treated|Overall Study||7
3027600|NCT01096680|3746113|FG000|NOT COMPLETED|Overall Study||0
3027601|NCT01096680|3746114|FG001|NOT COMPLETED|Overall Study||0
3027602|NCT01096680|3746115|FG002|NOT COMPLETED|Overall Study||0
3027603|NCT01096680|3746116|FG003|NOT COMPLETED|Overall Study||0
3027604|NCT01096680|3746117|FG004|NOT COMPLETED|Overall Study||0
3027605|NCT01096771|3746131|FG000|STARTED|Overall Study||7
3027606|NCT01096771|3746132|FG001|STARTED|Overall Study||7
3027607|NCT01096771|3746131|FG000|COMPLETED|Overall Study||7
3027608|NCT01096771|3746132|FG001|COMPLETED|Overall Study||7
3027609|NCT01096771|3746131|FG000|NOT COMPLETED|Overall Study||0
3027610|NCT01096771|3746132|FG001|NOT COMPLETED|Overall Study||0
3027611|NCT01096784|3746140|FG000|STARTED|Overall Study||61
3027612|NCT01096784|3746141|FG001|STARTED|Overall Study||60
3027613|NCT01096784|3746140|FG000|COMPLETED|Overall Study||46
3027614|NCT01096784|3746141|FG001|COMPLETED|Overall Study||46
3027615|NCT01096784|3746140|FG000|NOT COMPLETED|Overall Study||15
3027616|NCT01096784|3746141|FG001|NOT COMPLETED|Overall Study||14
3027617|NCT01096810|3746149|FG000|STARTED|Overall Study||20
3027618|NCT01096810|3746149|FG000|COMPLETED|Overall Study||20
3027619|NCT01096810|3746149|FG000|NOT COMPLETED|Overall Study||0
3027620|NCT01096823|3746155|FG000|STARTED|Overall Study||14
3027621|NCT01096823|3746156|FG001|STARTED|Overall Study||16
3027622|NCT01096823|3746155|FG000|COMPLETED|Overall Study||11
3027623|NCT01096823|3746156|FG001|COMPLETED|Overall Study||15
3027624|NCT01096823|3746155|FG000|NOT COMPLETED|Overall Study||3
3027625|NCT01096823|3746156|FG001|NOT COMPLETED|Overall Study||1
3027626|NCT01096849|3746165|FG000|STARTED|Overall Study||22
3027627|NCT01096849|3746166|FG001|STARTED|Overall Study||76
3027628|NCT01096849|3746167|FG002|STARTED|Overall Study||47
3027629|NCT01096849|3746165|FG000|COMPLETED|Overall Study||20
3027630|NCT01096849|3746166|FG001|COMPLETED|Overall Study||64
3027631|NCT01096849|3746167|FG002|COMPLETED|Overall Study||41
3027632|NCT01096849|3746165|FG000|NOT COMPLETED|Overall Study||2
3027633|NCT01096849|3746166|FG001|NOT COMPLETED|Overall Study||12
3027634|NCT01096849|3746167|FG002|NOT COMPLETED|Overall Study||6
3027635|NCT01096875|3746177|FG000|STARTED|Overall Study||30
3027636|NCT01096875|3746178|FG001|STARTED|Overall Study||30
3027637|NCT01096875|3746177|FG000|COMPLETED|Overall Study||30
3027638|NCT01096875|3746178|FG001|COMPLETED|Overall Study||29
3027639|NCT01096875|3746177|FG000|NOT COMPLETED|Overall Study||0
3027640|NCT01096875|3746178|FG001|NOT COMPLETED|Overall Study||1
3027641|NCT01096992|3746191|FG000|STARTED|Overall Study||6
3027642|NCT01096992|3746192|FG001|STARTED|Overall Study||3
3027643|NCT01096992|3746193|FG002|STARTED|Overall Study||6
3027644|NCT01096992|3746194|FG003|STARTED|Overall Study||6
3027645|NCT01096992|3746195|FG004|STARTED|Overall Study||30
3027646|NCT01096992|3746191|FG000|COMPLETED|Overall Study||6
3027647|NCT01096992|3746192|FG001|COMPLETED|Overall Study||3
3027648|NCT01096992|3746193|FG002|COMPLETED|Overall Study||6
3027649|NCT01096992|3746194|FG003|COMPLETED|Overall Study||6
3027650|NCT01096992|3746195|FG004|COMPLETED|Overall Study||30
3027651|NCT01096992|3746191|FG000|NOT COMPLETED|Overall Study||0
3027652|NCT01096992|3746192|FG001|NOT COMPLETED|Overall Study||0
3027653|NCT01096992|3746193|FG002|NOT COMPLETED|Overall Study||0
3027654|NCT01096992|3746194|FG003|NOT COMPLETED|Overall Study||0
3027655|NCT01096992|3746195|FG004|NOT COMPLETED|Overall Study||0
3027656|NCT01097005|3746208|FG000|STARTED|Overall Study|number of participants who were enrolled for this study.|466
3027657|NCT01097005|3746208|FG000|Analysis of Safety|Overall Study|number of participants who could be measured for Adverse Events|441
3027658|NCT01097005|3746208|FG000|Analysis of NTM Lung Disease|Overall Study|number of participants who contributed to the Baseline data|340
3027659|NCT01097005|3746208|FG000|Analysis of Bacilli Negative Conversion|Overall Study|number of participants who were analysed for bacilli negative conversion|285
3027660|NCT01097005|3746208|FG000|Analysis of CGI|Overall Study|number of participants who were measured for Clinical Global Improvement (CGI)|249
3027661|NCT01097005|3746208|FG000|COMPLETED|Overall Study||101
3027662|NCT01097005|3746208|FG000|NOT COMPLETED|Overall Study||365
3027663|NCT01097044|3746216|FG000|STARTED|Overall Study||39
3027664|NCT01097044|3746217|FG001|STARTED|Overall Study||38
3027665|NCT01097044|3746216|FG000|COMPLETED|Overall Study||34
3027666|NCT01097044|3746217|FG001|COMPLETED|Overall Study||33
3027667|NCT01097044|3746216|FG000|NOT COMPLETED|Overall Study||5
3165985|NCT01902173|3893450|FG001|STARTED|Phase II||0
3165986|NCT01902173|3893451|FG002|STARTED|Phase II||0
3308833|NCT03023423|4042237|FG001|Treated|Overall Study||44
3027668|NCT01097044|3746217|FG001|NOT COMPLETED|Overall Study||5
3027669|NCT01097057|3746225|FG000|STARTED|Overall Study||20
3027670|NCT01097057|3746225|FG000|COMPLETED|Overall Study||17
3165987|NCT01902173|3893452|FG003|STARTED|Phase II||0
3308834|NCT03023423|4042238|FG002|Treated|Overall Study||44
3308835|NCT03023423|4042236|FG000|Crossover From Atezo to Dara + Atezo|Overall Study||0
3308836|NCT03023423|4042237|FG001|Crossover From Atezo to Dara + Atezo|Overall Study|Participants who met crossover eligibility criteria entered to Dara + Atezo arm.|8
3308837|NCT03023423|4042238|FG002|Crossover From Atezo to Dara + Atezo|Overall Study||0
3308838|NCT03023423|4042236|FG000|COMPLETED|Overall Study||0
3308839|NCT03023423|4042237|FG001|COMPLETED|Overall Study||0
3308840|NCT03023423|4042238|FG002|COMPLETED|Overall Study||0
3308841|NCT03023423|4042236|FG000|NOT COMPLETED|Overall Study||7
3308842|NCT03023423|4042237|FG001|NOT COMPLETED|Overall Study||46
3308843|NCT03023423|4042238|FG002|NOT COMPLETED|Overall Study||46
3308844|NCT03023488|4042250|FG000|STARTED|Overall Study||46
3308845|NCT03023488|4042250|FG000|COMPLETED|Overall Study||46
3308846|NCT03023488|4042250|FG000|NOT COMPLETED|Overall Study||0
3308847|NCT03023553|4042262|FG000|STARTED|Overall Study||4
3308848|NCT03023553|4042263|FG001|STARTED|Overall Study||9
3308849|NCT03023553|4042262|FG000|COMPLETED|Overall Study||4
3027671|NCT01097057|3746225|FG000|NOT COMPLETED|Overall Study||3
3027672|NCT01097304|3746229|FG000|STARTED|Overall Study||36
3027673|NCT01097304|3746229|FG000|COMPLETED|Overall Study||29
3027674|NCT01097304|3746229|FG000|NOT COMPLETED|Overall Study||7
3165988|NCT01902173|3893453|FG004|STARTED|Phase II||0
3027675|NCT01097330|3746236|FG000|STARTED|Overall Study||7
3027676|NCT01097330|3746237|FG001|STARTED|Overall Study||5
3027677|NCT01097330|3746236|FG000|COMPLETED|Overall Study||0
3027678|NCT01097330|3746237|FG001|COMPLETED|Overall Study||0
3027679|NCT01097330|3746236|FG000|NOT COMPLETED|Overall Study||7
3027680|NCT01097330|3746237|FG001|NOT COMPLETED|Overall Study||5
3027681|NCT01097343|3746243|FG000|STARTED|First Intervention- 30 Days||25
3027682|NCT01097343|3746244|FG001|STARTED|First Intervention- 30 Days||25
3027683|NCT01097343|3746243|FG000|COMPLETED|First Intervention- 30 Days||25
3027684|NCT01097343|3746244|FG001|COMPLETED|First Intervention- 30 Days||25
3027685|NCT01097343|3746243|FG000|NOT COMPLETED|First Intervention- 30 Days||0
3027686|NCT01097343|3746244|FG001|NOT COMPLETED|First Intervention- 30 Days||0
3027687|NCT01097343|3746243|FG000|STARTED|Second Intervention- 30 Days||25
3027688|NCT01097343|3746244|FG001|STARTED|Second Intervention- 30 Days||25
3027689|NCT01097343|3746243|FG000|COMPLETED|Second Intervention- 30 Days||25
3027690|NCT01097343|3746244|FG001|COMPLETED|Second Intervention- 30 Days||25
3027691|NCT01097343|3746243|FG000|NOT COMPLETED|Second Intervention- 30 Days||0
3027692|NCT01097343|3746244|FG001|NOT COMPLETED|Second Intervention- 30 Days||0
3027693|NCT01097395|3746252|FG000|STARTED|Overall Study||17
3027694|NCT01097395|3746253|FG001|STARTED|Overall Study||18
3027695|NCT01097395|3746252|FG000|COMPLETED|Overall Study||14
3027696|NCT01097395|3746253|FG001|COMPLETED|Overall Study||14
3027697|NCT01097395|3746252|FG000|NOT COMPLETED|Overall Study||3
3027698|NCT01097395|3746253|FG001|NOT COMPLETED|Overall Study||4
3027699|NCT01097421|3746259|FG000|STARTED|Overall Study||328
3027700|NCT01097421|3746259|FG000|COMPLETED|Overall Study||314
3027701|NCT01097421|3746259|FG000|NOT COMPLETED|Overall Study||14
3027702|NCT01097460|3746263|FG000|STARTED|Overall Study||16
3027703|NCT01097460|3746263|FG000|COMPLETED|Overall Study||16
3027704|NCT01097460|3746263|FG000|NOT COMPLETED|Overall Study||0
3027705|NCT01097577|3746269|FG000|STARTED|Overall Study||67
3027706|NCT01097577|3746270|FG001|STARTED|Overall Study||63
3027707|NCT01097577|3746269|FG000|COMPLETED|Overall Study||67
3027708|NCT01097577|3746270|FG001|COMPLETED|Overall Study||62
3027709|NCT01097577|3746269|FG000|NOT COMPLETED|Overall Study||0
3027710|NCT01097577|3746270|FG001|NOT COMPLETED|Overall Study||1
3027711|NCT01097616|3746279|FG000|STARTED|Double-Blind (DB) Treatment (TRT) Phase||254
3027712|NCT01097616|3746280|FG001|STARTED|Double-Blind (DB) Treatment (TRT) Phase||383
3027713|NCT01097616|3746281|FG002|STARTED|Double-Blind (DB) Treatment (TRT) Phase||385
3027714|NCT01097616|3746282|FG003|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
3027715|NCT01097616|3746283|FG004|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
3027716|NCT01097616|3746284|FG005|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
3027717|NCT01097616|3746285|FG006|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
3027718|NCT01097616|3746286|FG007|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
3027719|NCT01097616|3746279|FG000|Treated|Double-Blind (DB) Treatment (TRT) Phase||254
3027720|NCT01097616|3746280|FG001|Treated|Double-Blind (DB) Treatment (TRT) Phase||383
3027721|NCT01097616|3746281|FG002|Treated|Double-Blind (DB) Treatment (TRT) Phase||384
3027722|NCT01097616|3746282|FG003|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
3027723|NCT01097616|3746283|FG004|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
3027724|NCT01097616|3746284|FG005|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
3027725|NCT01097616|3746285|FG006|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
3027726|NCT01097616|3746286|FG007|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
3027727|NCT01097616|3746279|FG000|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase|100 continued into EXT, 128 continued directly into RO, 2 did not continue into either Phase|230
3027728|NCT01097616|3746280|FG001|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase|172 continued into EXT, 172 continued directly into RO, 1 did not continue into either Phase|345
3027729|NCT01097616|3746281|FG002|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase|151 continued into EXT, 186 continued directly into RO, 4 did not continue into either Phase|341
3027730|NCT01097616|3746282|FG003|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
3027731|NCT01097616|3746283|FG004|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
3027732|NCT01097616|3746284|FG005|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
3027733|NCT01097616|3746285|FG006|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
3027734|NCT01097616|3746286|FG007|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
3027735|NCT01097616|3746279|FG000|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||24
3027736|NCT01097616|3746280|FG001|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||38
3027737|NCT01097616|3746281|FG002|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||44
3027738|NCT01097616|3746282|FG003|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
3027739|NCT01097616|3746283|FG004|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
3027740|NCT01097616|3746284|FG005|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
3027741|NCT01097616|3746285|FG006|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
3027742|NCT01097616|3746286|FG007|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
3027743|NCT01097616|3746279|FG000|STARTED|Optional DB EXT Phase||100
3027744|NCT01097616|3746280|FG001|STARTED|Optional DB EXT Phase||172
3027745|NCT01097616|3746281|FG002|STARTED|Optional DB EXT Phase||151
3027746|NCT01097616|3746282|FG003|STARTED|Optional DB EXT Phase||0
3027747|NCT01097616|3746283|FG004|STARTED|Optional DB EXT Phase||0
3027748|NCT01097616|3746284|FG005|STARTED|Optional DB EXT Phase||0
3027749|NCT01097616|3746285|FG006|STARTED|Optional DB EXT Phase||0
3027750|NCT01097616|3746286|FG007|STARTED|Optional DB EXT Phase||0
3027751|NCT01097616|3746279|FG000|COMPLETED|Optional DB EXT Phase|All 85 continued into RO|85
3027752|NCT01097616|3746280|FG001|COMPLETED|Optional DB EXT Phase|All 151 continued into RO|151
3027753|NCT01097616|3746281|FG002|COMPLETED|Optional DB EXT Phase|All 141 continued into RO|141
3027754|NCT01097616|3746282|FG003|COMPLETED|Optional DB EXT Phase||0
3027755|NCT01097616|3746283|FG004|COMPLETED|Optional DB EXT Phase||0
3027756|NCT01097616|3746284|FG005|COMPLETED|Optional DB EXT Phase||0
3027757|NCT01097616|3746285|FG006|COMPLETED|Optional DB EXT Phase||0
3027758|NCT01097616|3746286|FG007|COMPLETED|Optional DB EXT Phase||0
3027759|NCT01097616|3746279|FG000|NOT COMPLETED|Optional DB EXT Phase||15
3027760|NCT01097616|3746280|FG001|NOT COMPLETED|Optional DB EXT Phase||21
3027761|NCT01097616|3746281|FG002|NOT COMPLETED|Optional DB EXT Phase||10
3027762|NCT01097616|3746282|FG003|NOT COMPLETED|Optional DB EXT Phase||0
3027763|NCT01097616|3746283|FG004|NOT COMPLETED|Optional DB EXT Phase||0
3027764|NCT01097616|3746284|FG005|NOT COMPLETED|Optional DB EXT Phase||0
3027765|NCT01097616|3746285|FG006|NOT COMPLETED|Optional DB EXT Phase||0
3027766|NCT01097616|3746286|FG007|NOT COMPLETED|Optional DB EXT Phase||0
3027767|NCT01097616|3746279|FG000|STARTED|DB RO Phase||0
3027768|NCT01097616|3746280|FG001|STARTED|DB RO Phase||0
3027769|NCT01097616|3746281|FG002|STARTED|DB RO Phase||0
3027770|NCT01097616|3746282|FG003|STARTED|DB RO Phase||101
3027771|NCT01097616|3746283|FG004|STARTED|DB RO Phase|1 was randomized to this group but actually received suvorexant LD during RO|112
3027772|NCT01097616|3746284|FG005|STARTED|DB RO Phase|1 entered RO but was not treated during RO|161
3027773|NCT01097616|3746285|FG006|STARTED|DB RO Phase||162
3027774|NCT01097616|3746286|FG007|STARTED|DB RO Phase||327
3027775|NCT01097616|3746279|FG000|COMPLETED|DB RO Phase||0
3027776|NCT01097616|3746280|FG001|COMPLETED|DB RO Phase||0
3027777|NCT01097616|3746281|FG002|COMPLETED|DB RO Phase||0
3027778|NCT01097616|3746282|FG003|COMPLETED|DB RO Phase||100
3027779|NCT01097616|3746283|FG004|COMPLETED|DB RO Phase||111
3027780|NCT01097616|3746284|FG005|COMPLETED|DB RO Phase||159
3027781|NCT01097616|3746285|FG006|COMPLETED|DB RO Phase||161
3027782|NCT01097616|3746286|FG007|COMPLETED|DB RO Phase||326
3027783|NCT01097616|3746279|FG000|NOT COMPLETED|DB RO Phase||0
3027784|NCT01097616|3746280|FG001|NOT COMPLETED|DB RO Phase||0
3027785|NCT01097616|3746281|FG002|NOT COMPLETED|DB RO Phase||0
3027786|NCT01097616|3746282|FG003|NOT COMPLETED|DB RO Phase||1
3027787|NCT01097616|3746283|FG004|NOT COMPLETED|DB RO Phase||1
3027788|NCT01097616|3746284|FG005|NOT COMPLETED|DB RO Phase||2
3027789|NCT01097616|3746285|FG006|NOT COMPLETED|DB RO Phase||1
3027790|NCT01097616|3746286|FG007|NOT COMPLETED|DB RO Phase||1
3027791|NCT01097629|3746315|FG000|STARTED|Double-Blind (DB) Treatment (TRT) Phase||240
3027792|NCT01097629|3746316|FG001|STARTED|Double-Blind (DB) Treatment (TRT) Phase||392
3027793|NCT01097629|3746317|FG002|STARTED|Double-Blind (DB) Treatment (TRT) Phase||387
3027794|NCT01097629|3746318|FG003|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
3027795|NCT01097629|3746319|FG004|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
3027796|NCT01097629|3746320|FG005|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
3027797|NCT01097629|3746321|FG006|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
3027798|NCT01097629|3746322|FG007|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
3027799|NCT01097629|3746315|FG000|Treated|Double-Blind (DB) Treatment (TRT) Phase||239
3027800|NCT01097629|3746316|FG001|Treated|Double-Blind (DB) Treatment (TRT) Phase||387
3027801|NCT01097629|3746317|FG002|Treated|Double-Blind (DB) Treatment (TRT) Phase||383
3027802|NCT01097629|3746318|FG003|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
3027803|NCT01097629|3746319|FG004|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
3027804|NCT01097629|3746320|FG005|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
3027805|NCT01097629|3746321|FG006|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
3027806|NCT01097629|3746322|FG007|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
3027807|NCT01097629|3746315|FG000|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||205
3027808|NCT01097629|3746316|FG001|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase|2 did not continue into RO|346
3165989|NCT01902173|3893454|FG005|STARTED|Phase II||0
3165990|NCT01902173|3893449|FG000|COMPLETED|Phase II||0
3165991|NCT01902173|3893450|FG001|COMPLETED|Phase II||0
3165992|NCT01902173|3893451|FG002|COMPLETED|Phase II||0
3165993|NCT01902173|3893452|FG003|COMPLETED|Phase II||0
3027809|NCT01097629|3746317|FG002|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase|3 did not continue into RO|330
3027810|NCT01097629|3746318|FG003|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
3027811|NCT01097629|3746319|FG004|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
3027812|NCT01097629|3746320|FG005|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
3027813|NCT01097629|3746321|FG006|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
3027814|NCT01097629|3746322|FG007|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
3027815|NCT01097629|3746315|FG000|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||35
3027816|NCT01097629|3746316|FG001|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||46
3027817|NCT01097629|3746317|FG002|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||57
3027818|NCT01097629|3746318|FG003|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
3027819|NCT01097629|3746319|FG004|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
3027820|NCT01097629|3746320|FG005|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
3027821|NCT01097629|3746321|FG006|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
3027822|NCT01097629|3746322|FG007|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
3027823|NCT01097629|3746315|FG000|STARTED|DB RO Phase||0
3027824|NCT01097629|3746316|FG001|STARTED|DB RO Phase||0
3027825|NCT01097629|3746317|FG002|STARTED|DB RO Phase||0
3027826|NCT01097629|3746318|FG003|STARTED|DB RO Phase||97
3027827|NCT01097629|3746319|FG004|STARTED|DB RO Phase||108
3027828|NCT01097629|3746320|FG005|STARTED|DB RO Phase||173
3027829|NCT01097629|3746321|FG006|STARTED|DB RO Phase||171
3027830|NCT01097629|3746322|FG007|STARTED|DB RO Phase||327
3027831|NCT01097629|3746315|FG000|COMPLETED|DB RO Phase||0
3027832|NCT01097629|3746316|FG001|COMPLETED|DB RO Phase||0
3027833|NCT01097629|3746317|FG002|COMPLETED|DB RO Phase||0
3027834|NCT01097629|3746318|FG003|COMPLETED|DB RO Phase||96
3027835|NCT01097629|3746319|FG004|COMPLETED|DB RO Phase||108
3027836|NCT01097629|3746320|FG005|COMPLETED|DB RO Phase||172
3027837|NCT01097629|3746321|FG006|COMPLETED|DB RO Phase||168
3027838|NCT01097629|3746322|FG007|COMPLETED|DB RO Phase||326
3027839|NCT01097629|3746315|FG000|NOT COMPLETED|DB RO Phase||0
3027840|NCT01097629|3746316|FG001|NOT COMPLETED|DB RO Phase||0
3027841|NCT01097629|3746317|FG002|NOT COMPLETED|DB RO Phase||0
3027842|NCT01097629|3746318|FG003|NOT COMPLETED|DB RO Phase||1
3027843|NCT01097629|3746319|FG004|NOT COMPLETED|DB RO Phase||0
3027844|NCT01097629|3746320|FG005|NOT COMPLETED|DB RO Phase||1
3027845|NCT01097629|3746321|FG006|NOT COMPLETED|DB RO Phase||3
3027846|NCT01097629|3746322|FG007|NOT COMPLETED|DB RO Phase||1
3027847|NCT01097642|3746347|FG000|STARTED|Overall Study||15
3027848|NCT01097642|3746348|FG001|STARTED|Overall Study||25
3027849|NCT01097642|3746347|FG000|COMPLETED|Overall Study||15
3027850|NCT01097642|3746348|FG001|COMPLETED|Overall Study||25
3027851|NCT01097642|3746347|FG000|NOT COMPLETED|Overall Study||0
3027852|NCT01097642|3746348|FG001|NOT COMPLETED|Overall Study||0
3027853|NCT01097655|3746354|FG000|STARTED|Overall Study||3049
3027854|NCT01097655|3746354|FG000|COMPLETED|Overall Study|participants included for analysis|3039
3027855|NCT01097655|3746354|FG000|NOT COMPLETED|Overall Study||10
3027856|NCT01097668|3746360|FG000|STARTED|Overall Study||21
3027857|NCT01097668|3746361|FG001|STARTED|Overall Study||22
3027858|NCT01097668|3746360|FG000|Week 20|Overall Study|Patient evaluability time point = week 20|21
3027859|NCT01097668|3746361|FG001|Week 20|Overall Study|Patient evaluability time point = week 20|22
3027860|NCT01097668|3746360|FG000|Week 48|Overall Study||19
3027861|NCT01097668|3746361|FG001|Week 48|Overall Study||20
3027862|NCT01097668|3746360|FG000|COMPLETED|Overall Study||19
3027863|NCT01097668|3746361|FG001|COMPLETED|Overall Study||20
3308850|NCT03023553|4042263|FG001|COMPLETED|Overall Study||8
3308851|NCT03023553|4042262|FG000|NOT COMPLETED|Overall Study||0
3308852|NCT03023553|4042263|FG001|NOT COMPLETED|Overall Study||1
3308853|NCT03023683|4042271|FG000|STARTED|Overall Study||0
3308854|NCT03023683|4042272|FG001|STARTED|Overall Study||18
3308855|NCT03023683|4042271|FG000|COMPLETED|Overall Study||0
3308856|NCT03023683|4042272|FG001|COMPLETED|Overall Study||17
3308857|NCT03023683|4042271|FG000|NOT COMPLETED|Overall Study||0
3308858|NCT03023683|4042272|FG001|NOT COMPLETED|Overall Study||1
3308859|NCT03023709|4042280|FG000|STARTED|Overall Study||3
3308860|NCT03023709|4042281|FG001|STARTED|Overall Study||0
3308861|NCT03023709|4042280|FG000|COMPLETED|Overall Study||3
3308862|NCT03023709|4042281|FG001|COMPLETED|Overall Study||0
3308863|NCT03023709|4042280|FG000|NOT COMPLETED|Overall Study||0
3308864|NCT03023709|4042281|FG001|NOT COMPLETED|Overall Study||0
3308865|NCT03023722|4042289|FG000|STARTED|Overall Study||18
3308866|NCT03023722|4042289|FG000|COMPLETED|Overall Study||14
3308867|NCT03023722|4042289|FG000|NOT COMPLETED|Overall Study||4
3308868|NCT03023813|4042296|FG000|STARTED|Overall Study||39
3308869|NCT03023813|4042297|FG001|STARTED|Overall Study||34
3308870|NCT03023813|4042298|FG002|STARTED|Overall Study||31
3308871|NCT03023813|4042296|FG000|COMPLETED|Overall Study||38
3308872|NCT03023813|4042297|FG001|COMPLETED|Overall Study||32
3308873|NCT03023813|4042298|FG002|COMPLETED|Overall Study||31
3308874|NCT03023813|4042296|FG000|NOT COMPLETED|Overall Study||1
3308875|NCT03023813|4042297|FG001|NOT COMPLETED|Overall Study||2
3308876|NCT03023813|4042298|FG002|NOT COMPLETED|Overall Study||0
3308877|NCT03023826|4042306|FG000|STARTED|Period 1||4
3308878|NCT03023826|4042307|FG001|STARTED|Period 1||4
3308879|NCT03023826|4042308|FG002|STARTED|Period 1||5
3308880|NCT03023826|4042309|FG003|STARTED|Period 1||4
3308881|NCT03023826|4042310|FG004|STARTED|Period 1||4
3308882|NCT03023826|4042311|FG005|STARTED|Period 1||5
3308883|NCT03023826|4042306|FG000|Received at Least One Dose of Study Drug|Period 1||4
3308884|NCT03023826|4042307|FG001|Received at Least One Dose of Study Drug|Period 1||4
3308885|NCT03023826|4042308|FG002|Received at Least One Dose of Study Drug|Period 1||5
3308886|NCT03023826|4042309|FG003|Received at Least One Dose of Study Drug|Period 1||4
3308887|NCT03023826|4042310|FG004|Received at Least One Dose of Study Drug|Period 1||4
3308888|NCT03023826|4042311|FG005|Received at Least One Dose of Study Drug|Period 1||5
3308889|NCT03023826|4042306|FG000|COMPLETED|Period 1||4
3308890|NCT03023826|4042307|FG001|COMPLETED|Period 1||4
3308891|NCT03023826|4042308|FG002|COMPLETED|Period 1||5
3308892|NCT03023826|4042309|FG003|COMPLETED|Period 1||4
3308893|NCT03023826|4042310|FG004|COMPLETED|Period 1||3
3308894|NCT03023826|4042311|FG005|COMPLETED|Period 1||5
3308895|NCT03023826|4042306|FG000|NOT COMPLETED|Period 1||0
3308896|NCT03023826|4042307|FG001|NOT COMPLETED|Period 1||0
3308897|NCT03023826|4042308|FG002|NOT COMPLETED|Period 1||0
3308898|NCT03023826|4042309|FG003|NOT COMPLETED|Period 1||0
3027864|NCT01097668|3746360|FG000|NOT COMPLETED|Overall Study||2
3027865|NCT01097668|3746361|FG001|NOT COMPLETED|Overall Study||2
3027866|NCT01097694|3746373|FG000|STARTED|Overall Study||32
3027867|NCT01097694|3746374|FG001|STARTED|Overall Study||30
3027868|NCT01097694|3746373|FG000|COMPLETED|Overall Study||24
3027869|NCT01097694|3746374|FG001|COMPLETED|Overall Study||26
3027870|NCT01097694|3746373|FG000|NOT COMPLETED|Overall Study||8
3027871|NCT01097694|3746374|FG001|NOT COMPLETED|Overall Study||4
3027872|NCT01097707|3746385|FG000|STARTED|Overall Study||83
3027873|NCT01097707|3746386|FG001|STARTED|Overall Study||80
3027874|NCT01097707|3746387|FG002|STARTED|Overall Study||82
3027875|NCT01097707|3746388|FG003|STARTED|Overall Study||84
3027876|NCT01097707|3746389|FG004|STARTED|Overall Study||85
3027877|NCT01097707|3746385|FG000|COMPLETED|Overall Study||39
3027878|NCT01097707|3746386|FG001|COMPLETED|Overall Study||37
3027879|NCT01097707|3746387|FG002|COMPLETED|Overall Study||37
3027880|NCT01097707|3746388|FG003|COMPLETED|Overall Study||40
3027881|NCT01097707|3746389|FG004|COMPLETED|Overall Study||35
3027882|NCT01097707|3746385|FG000|NOT COMPLETED|Overall Study||44
3027883|NCT01097707|3746386|FG001|NOT COMPLETED|Overall Study||43
3027884|NCT01097707|3746387|FG002|NOT COMPLETED|Overall Study||45
3027885|NCT01097707|3746388|FG003|NOT COMPLETED|Overall Study||44
3027886|NCT01097707|3746389|FG004|NOT COMPLETED|Overall Study||50
3027887|NCT01097785|3746403|FG000|STARTED|Cycle 1 (30 Days)||6
3027888|NCT01097785|3746404|FG001|STARTED|Cycle 1 (30 Days)||6
3027889|NCT01097785|3746403|FG000|COMPLETED|Cycle 1 (30 Days)||6
3027890|NCT01097785|3746404|FG001|COMPLETED|Cycle 1 (30 Days)||6
3027891|NCT01097785|3746403|FG000|NOT COMPLETED|Cycle 1 (30 Days)||0
3027892|NCT01097785|3746404|FG001|NOT COMPLETED|Cycle 1 (30 Days)||0
3027893|NCT01097785|3746403|FG000|STARTED|Washout (2 Weeks)||6
3027894|NCT01097785|3746404|FG001|STARTED|Washout (2 Weeks)||6
3027895|NCT01097785|3746403|FG000|COMPLETED|Washout (2 Weeks)||6
3027896|NCT01097785|3746404|FG001|COMPLETED|Washout (2 Weeks)||6
3027897|NCT01097785|3746403|FG000|NOT COMPLETED|Washout (2 Weeks)||0
3027898|NCT01097785|3746404|FG001|NOT COMPLETED|Washout (2 Weeks)||0
3027899|NCT01097785|3746403|FG000|STARTED|Cycle 3 (30 Days)||6
3027900|NCT01097785|3746404|FG001|STARTED|Cycle 3 (30 Days)||6
3027901|NCT01097785|3746403|FG000|COMPLETED|Cycle 3 (30 Days)||6
3308899|NCT03023826|4042310|FG004|NOT COMPLETED|Period 1||1
3308900|NCT03023826|4042311|FG005|NOT COMPLETED|Period 1||0
3308901|NCT03023826|4042306|FG000|STARTED|Period 2||4
3308902|NCT03023826|4042307|FG001|STARTED|Period 2||4
3308903|NCT03023826|4042308|FG002|STARTED|Period 2||5
3308904|NCT03023826|4042309|FG003|STARTED|Period 2||4
3308905|NCT03023826|4042310|FG004|STARTED|Period 2||3
3308906|NCT03023826|4042311|FG005|STARTED|Period 2||5
3308907|NCT03023826|4042306|FG000|COMPLETED|Period 2||4
3308908|NCT03023826|4042307|FG001|COMPLETED|Period 2||4
3308909|NCT03023826|4042308|FG002|COMPLETED|Period 2||5
3308910|NCT03023826|4042309|FG003|COMPLETED|Period 2||4
3308911|NCT03023826|4042310|FG004|COMPLETED|Period 2||3
3308912|NCT03023826|4042311|FG005|COMPLETED|Period 2||5
3308913|NCT03023826|4042306|FG000|NOT COMPLETED|Period 2||0
3308914|NCT03023826|4042307|FG001|NOT COMPLETED|Period 2||0
3308915|NCT03023826|4042308|FG002|NOT COMPLETED|Period 2||0
3308916|NCT03023826|4042309|FG003|NOT COMPLETED|Period 2||0
3308917|NCT03023826|4042310|FG004|NOT COMPLETED|Period 2||0
3308918|NCT03023826|4042311|FG005|NOT COMPLETED|Period 2||0
3308919|NCT03023826|4042306|FG000|STARTED|Period 3||4
3308920|NCT03023826|4042307|FG001|STARTED|Period 3||4
3308921|NCT03023826|4042308|FG002|STARTED|Period 3||5
3308922|NCT03023826|4042309|FG003|STARTED|Period 3||4
3308923|NCT03023826|4042310|FG004|STARTED|Period 3||3
3308924|NCT03023826|4042311|FG005|STARTED|Period 3||5
3308925|NCT03023826|4042306|FG000|COMPLETED|Period 3||4
3308926|NCT03023826|4042307|FG001|COMPLETED|Period 3||4
3308927|NCT03023826|4042308|FG002|COMPLETED|Period 3||5
3308928|NCT03023826|4042309|FG003|COMPLETED|Period 3||4
3308929|NCT03023826|4042310|FG004|COMPLETED|Period 3||3
3308930|NCT03023826|4042311|FG005|COMPLETED|Period 3||5
3308931|NCT03023826|4042306|FG000|NOT COMPLETED|Period 3||0
3308932|NCT03023826|4042307|FG001|NOT COMPLETED|Period 3||0
3308933|NCT03023826|4042308|FG002|NOT COMPLETED|Period 3||0
3308934|NCT03023826|4042309|FG003|NOT COMPLETED|Period 3||0
3308935|NCT03023826|4042310|FG004|NOT COMPLETED|Period 3||0
3308936|NCT03023826|4042311|FG005|NOT COMPLETED|Period 3||0
3308937|NCT03023878|4042319|FG000|STARTED|Pre-Study Run-In Period||47
3308938|NCT03023878|4042319|FG000|COMPLETED|Pre-Study Run-In Period||30
3308939|NCT03023878|4042319|FG000|NOT COMPLETED|Pre-Study Run-In Period||17
3308940|NCT03023878|4042319|FG000|STARTED|Between Run-In and Treatment Periods||30
3308941|NCT03023878|4042319|FG000|COMPLETED|Between Run-In and Treatment Periods||28
3308942|NCT03023878|4042319|FG000|NOT COMPLETED|Between Run-In and Treatment Periods||2
3308943|NCT03023878|4042319|FG000|STARTED|Treatment Period||28
3308944|NCT03023878|4042319|FG000|Started Cycle 1|Treatment Period||28
3308945|NCT03023878|4042319|FG000|Started Cycle 2|Treatment Period||11
3308946|NCT03023878|4042319|FG000|COMPLETED|Treatment Period||25
3308947|NCT03023878|4042319|FG000|NOT COMPLETED|Treatment Period||3
3308948|NCT03023878|4042319|FG000|STARTED|Long Term Follow-Up Period||28
3308949|NCT03023878|4042319|FG000|COMPLETED|Long Term Follow-Up Period||26
3308950|NCT03023878|4042319|FG000|NOT COMPLETED|Long Term Follow-Up Period||2
3027902|NCT01097785|3746404|FG001|COMPLETED|Cycle 3 (30 Days)||6
3027903|NCT01097785|3746403|FG000|NOT COMPLETED|Cycle 3 (30 Days)||0
3027904|NCT01097785|3746404|FG001|NOT COMPLETED|Cycle 3 (30 Days)||0
3027905|NCT01097863|3746414|FG000|STARTED|Overall Study||90
3027906|NCT01097863|3746415|FG001|STARTED|Overall Study||98
3027907|NCT01097863|3746416|FG002|STARTED|Overall Study||91
3027908|NCT01097863|3746414|FG000|COMPLETED|Overall Study||89
3027909|NCT01097863|3746415|FG001|COMPLETED|Overall Study||98
3308951|NCT03023891|4042323|FG000|STARTED|Overall Study||18
3308952|NCT03023891|4042323|FG000|COMPLETED|Overall Study||18
3308953|NCT03023891|4042323|FG000|NOT COMPLETED|Overall Study||0
3308954|NCT03024112|4042329|FG000|STARTED|Overall Study||25
3308955|NCT03024112|4042330|FG001|STARTED|Overall Study||26
3308956|NCT03024112|4042329|FG000|COMPLETED|Overall Study||18
3027910|NCT01097863|3746416|FG002|COMPLETED|Overall Study||89
3027911|NCT01097863|3746414|FG000|NOT COMPLETED|Overall Study||1
3027912|NCT01097863|3746415|FG001|NOT COMPLETED|Overall Study||0
3027913|NCT01097863|3746416|FG002|NOT COMPLETED|Overall Study||2
3027914|NCT01097915|3746427|FG000|STARTED|Overall Study||50
3027915|NCT01097915|3746428|FG001|STARTED|Overall Study||70
3027916|NCT01097915|3746429|FG002|STARTED|Overall Study||50
3027917|NCT01097915|3746427|FG000|COMPLETED|Overall Study||27
3027918|NCT01097915|3746428|FG001|COMPLETED|Overall Study||28
3027919|NCT01097915|3746429|FG002|COMPLETED|Overall Study||20
3027920|NCT01097915|3746427|FG000|NOT COMPLETED|Overall Study||23
3027921|NCT01097915|3746428|FG001|NOT COMPLETED|Overall Study||42
3027922|NCT01097915|3746429|FG002|NOT COMPLETED|Overall Study||30
3027923|NCT01098006|3746448|FG000|STARTED|Overall Study||7
3027924|NCT01098006|3746449|FG001|STARTED|Overall Study||11
3027925|NCT01098006|3746450|FG002|STARTED|Overall Study||60
3027926|NCT01098006|3746451|FG003|STARTED|Overall Study||21
3027927|NCT01098006|3746448|FG000|COMPLETED|Overall Study||7
3027928|NCT01098006|3746449|FG001|COMPLETED|Overall Study||11
3165994|NCT01902173|3893453|FG004|COMPLETED|Phase II||0
3165995|NCT01902173|3893454|FG005|COMPLETED|Phase II||0
3165996|NCT01902173|3893449|FG000|NOT COMPLETED|Phase II||0
3165997|NCT01902173|3893450|FG001|NOT COMPLETED|Phase II||0
3165998|NCT01902173|3893451|FG002|NOT COMPLETED|Phase II||0
3165999|NCT01902173|3893452|FG003|NOT COMPLETED|Phase II||0
3166000|NCT01902173|3893453|FG004|NOT COMPLETED|Phase II||0
3166001|NCT01902173|3893454|FG005|NOT COMPLETED|Phase II||0
3166002|NCT01902303|3893473|FG000|STARTED|Overall Study|Allocated to placebo|77
3308957|NCT03024112|4042330|FG001|COMPLETED|Overall Study||26
3027929|NCT01098006|3746450|FG002|COMPLETED|Overall Study||60
3308958|NCT03024112|4042329|FG000|NOT COMPLETED|Overall Study||7
3308959|NCT03024112|4042330|FG001|NOT COMPLETED|Overall Study||0
3308960|NCT03024606|4042338|FG000|STARTED|Overall Study||23
3027930|NCT01098006|3746451|FG003|COMPLETED|Overall Study||21
3027931|NCT01098006|3746448|FG000|NOT COMPLETED|Overall Study||0
3027932|NCT01098006|3746449|FG001|NOT COMPLETED|Overall Study||0
3027933|NCT01098006|3746450|FG002|NOT COMPLETED|Overall Study||0
3027934|NCT01098006|3746451|FG003|NOT COMPLETED|Overall Study||0
3027935|NCT01098032|3746463|FG000|STARTED|Overall Study|1 patient di not receive the treatment. Therefore this patient was excluded from the analysis.|147
3027936|NCT01098032|3746464|FG001|STARTED|Overall Study|1 patient di not receive the treatment. Therefore this patient was excluded from the analysis.|147
3027937|NCT01098032|3746463|FG000|COMPLETED|Overall Study||146
3027938|NCT01098032|3746464|FG001|COMPLETED|Overall Study||146
3027939|NCT01098032|3746463|FG000|NOT COMPLETED|Overall Study||1
3027940|NCT01098032|3746464|FG001|NOT COMPLETED|Overall Study||1
3027941|NCT01098097|3746470|FG000|STARTED|Overall Study||963
3027942|NCT01098097|3746470|FG000|COMPLETED|Overall Study|Participants completing the study received at least 12 weeks of treatment|881
3027943|NCT01098097|3746470|FG000|NOT COMPLETED|Overall Study||82
3027944|NCT01098162|3746474|FG000|STARTED|Overall Study||573
3027945|NCT01098162|3746474|FG000|COMPLETED|Overall Study||461
3027946|NCT01098162|3746474|FG000|NOT COMPLETED|Overall Study||112
3027947|NCT01098240|3746478|FG000|STARTED|Open-Label Phase||297
3027948|NCT01098240|3746479|FG001|STARTED|Open-Label Phase||0
3027949|NCT01098240|3746480|FG002|STARTED|Open-Label Phase||0
3027950|NCT01098240|3746478|FG000|COMPLETED|Open-Label Phase||162
3027951|NCT01098240|3746479|FG001|COMPLETED|Open-Label Phase||0
3027952|NCT01098240|3746480|FG002|COMPLETED|Open-Label Phase||0
3027953|NCT01098240|3746478|FG000|NOT COMPLETED|Open-Label Phase||135
3027954|NCT01098240|3746479|FG001|NOT COMPLETED|Open-Label Phase||0
3027955|NCT01098240|3746480|FG002|NOT COMPLETED|Open-Label Phase||0
3027956|NCT01098240|3746478|FG000|STARTED|Double-Blind Phase||0
3027957|NCT01098240|3746479|FG001|STARTED|Double-Blind Phase||77
3027958|NCT01098240|3746480|FG002|STARTED|Double-Blind Phase||85
3027959|NCT01098240|3746478|FG000|COMPLETED|Double-Blind Phase||0
3027960|NCT01098240|3746479|FG001|COMPLETED|Double-Blind Phase||60
3027961|NCT01098240|3746480|FG002|COMPLETED|Double-Blind Phase||63
3027962|NCT01098240|3746478|FG000|NOT COMPLETED|Double-Blind Phase||0
3027963|NCT01098240|3746479|FG001|NOT COMPLETED|Double-Blind Phase||17
3027964|NCT01098240|3746480|FG002|NOT COMPLETED|Double-Blind Phase||22
3027965|NCT01098253|3746489|FG000|STARTED|Overall Study||94
3027966|NCT01098253|3746490|FG001|STARTED|Overall Study||88
3027967|NCT01098253|3746489|FG000|COMPLETED|Overall Study||92
3027968|NCT01098253|3746490|FG001|COMPLETED|Overall Study||88
3027969|NCT01098253|3746489|FG000|NOT COMPLETED|Overall Study||2
3027970|NCT01098253|3746490|FG001|NOT COMPLETED|Overall Study||0
3027971|NCT01098266|3746498|FG000|STARTED|Overall Study||200
3027972|NCT01098266|3746499|FG001|STARTED|Overall Study||200
3027973|NCT01098266|3746498|FG000|COMPLETED|Overall Study||193
3027974|NCT01098266|3746499|FG001|COMPLETED|Overall Study||193
3027975|NCT01098266|3746498|FG000|NOT COMPLETED|Overall Study||7
3027976|NCT01098266|3746499|FG001|NOT COMPLETED|Overall Study||7
3027977|NCT01098305|3746507|FG000|STARTED|Overall Study||119
3027978|NCT01098305|3746508|FG001|STARTED|Overall Study||118
3027979|NCT01098305|3746507|FG000|COMPLETED|Overall Study||88
3027980|NCT01098305|3746508|FG001|COMPLETED|Overall Study||85
3027981|NCT01098305|3746507|FG000|NOT COMPLETED|Overall Study||31
3027982|NCT01098305|3746508|FG001|NOT COMPLETED|Overall Study||33
3027983|NCT01098318|3746517|FG000|STARTED|Overall Study||20
3166003|NCT01902303|3893474|FG001|STARTED|Overall Study|Allocated to active treatment|81
3171773|NCT01937026|3898964|FG000|Received Baricitinib|Period 2 (At Dosing Day 3 Through Day 8)||18
3027984|NCT01098318|3746518|FG001|STARTED|Overall Study||19
3027985|NCT01098318|3746519|FG002|STARTED|Overall Study||18
3027986|NCT01098318|3746517|FG000|COMPLETED|Overall Study||17
3027987|NCT01098318|3746518|FG001|COMPLETED|Overall Study||12
3027988|NCT01098318|3746519|FG002|COMPLETED|Overall Study||15
3027989|NCT01098318|3746517|FG000|NOT COMPLETED|Overall Study||3
3027990|NCT01098318|3746518|FG001|NOT COMPLETED|Overall Study||7
3027991|NCT01098318|3746519|FG002|NOT COMPLETED|Overall Study||3
3027992|NCT01098422|3746527|FG000|STARTED|Overall Study||10
3027993|NCT01098422|3746527|FG000|COMPLETED|Overall Study||9
3027994|NCT01098422|3746527|FG000|NOT COMPLETED|Overall Study||1
3027995|NCT01098461|3746535|FG000|STARTED|Treatment Period (TP) (16 Weeks)||53
3027996|NCT01098461|3746536|FG001|STARTED|Treatment Period (TP) (16 Weeks)||52
3027997|NCT01098461|3746537|FG002|STARTED|Treatment Period (TP) (16 Weeks)||54
3027998|NCT01098461|3746538|FG003|STARTED|Treatment Period (TP) (16 Weeks)||53
3166004|NCT01902303|3893473|FG000|Number of Participants|Overall Study|Number of randomized participants who developed a cold sore and used the assigned treatment.|56
3166005|NCT01902303|3893474|FG001|Number of Participants|Overall Study|Number of randomized participants who developed a cold sore and used the assigned treatment.|62
3166006|NCT01902303|3893473|FG000|COMPLETED|Overall Study|21 not treated - did not use placebo medication as they did not develop cold sore|54
3308961|NCT03024606|4042339|FG001|STARTED|Overall Study||26
3308962|NCT03024606|4042338|FG000|COMPLETED|Overall Study||14
3308963|NCT03024606|4042339|FG001|COMPLETED|Overall Study||16
3027999|NCT01098461|3746535|FG000|COMPLETED|Treatment Period (TP) (16 Weeks)||41
3028000|NCT01098461|3746536|FG001|COMPLETED|Treatment Period (TP) (16 Weeks)||45
3028001|NCT01098461|3746537|FG002|COMPLETED|Treatment Period (TP) (16 Weeks)||53
3028002|NCT01098461|3746538|FG003|COMPLETED|Treatment Period (TP) (16 Weeks)||50
3028003|NCT01098461|3746535|FG000|NOT COMPLETED|Treatment Period (TP) (16 Weeks)||12
3028004|NCT01098461|3746536|FG001|NOT COMPLETED|Treatment Period (TP) (16 Weeks)||7
3028005|NCT01098461|3746537|FG002|NOT COMPLETED|Treatment Period (TP) (16 Weeks)||1
3028006|NCT01098461|3746538|FG003|NOT COMPLETED|Treatment Period (TP) (16 Weeks)||3
3028007|NCT01098461|3746535|FG000|STARTED|Follow-up (FU) Period (8 Weeks)|Par. withdrawing from the TP could enter the FU Period. One par. did not participate in the FU.|52
3028008|NCT01098461|3746536|FG001|STARTED|Follow-up (FU) Period (8 Weeks)||52
3028009|NCT01098461|3746537|FG002|STARTED|Follow-up (FU) Period (8 Weeks)|Par. withdrawing from the TP could enter the FU Period. One par. did not participate in the FU.|53
3028010|NCT01098461|3746538|FG003|STARTED|Follow-up (FU) Period (8 Weeks)|Par. withdrawing from the TP could enter the FU Period. One par. did not participate in the FU.|52
3028011|NCT01098461|3746535|FG000|COMPLETED|Follow-up (FU) Period (8 Weeks)||52
3028012|NCT01098461|3746536|FG001|COMPLETED|Follow-up (FU) Period (8 Weeks)||49
3028013|NCT01098461|3746537|FG002|COMPLETED|Follow-up (FU) Period (8 Weeks)||52
3028014|NCT01098461|3746538|FG003|COMPLETED|Follow-up (FU) Period (8 Weeks)||52
3028015|NCT01098461|3746535|FG000|NOT COMPLETED|Follow-up (FU) Period (8 Weeks)||0
3028016|NCT01098461|3746536|FG001|NOT COMPLETED|Follow-up (FU) Period (8 Weeks)||3
3028017|NCT01098461|3746537|FG002|NOT COMPLETED|Follow-up (FU) Period (8 Weeks)||1
3028018|NCT01098461|3746538|FG003|NOT COMPLETED|Follow-up (FU) Period (8 Weeks)||0
3028019|NCT01098474|3746555|FG000|STARTED|Active Phase||50
3028020|NCT01098474|3746556|FG001|STARTED|Active Phase||50
3028021|NCT01098474|3746557|FG002|STARTED|Active Phase||50
3028022|NCT01098474|3746558|FG003|STARTED|Active Phase||49
3028023|NCT01098474|3746559|FG004|STARTED|Active Phase||52
3028024|NCT01098474|3746560|FG005|STARTED|Active Phase||49
3028025|NCT01098474|3746555|FG000|COMPLETED|Active Phase||48
3028026|NCT01098474|3746556|FG001|COMPLETED|Active Phase||49
3028027|NCT01098474|3746557|FG002|COMPLETED|Active Phase||45
3028028|NCT01098474|3746558|FG003|COMPLETED|Active Phase||49
3028029|NCT01098474|3746559|FG004|COMPLETED|Active Phase||52
3028030|NCT01098474|3746560|FG005|COMPLETED|Active Phase||49
3308964|NCT03024606|4042338|FG000|NOT COMPLETED|Overall Study||9
3308965|NCT03024606|4042339|FG001|NOT COMPLETED|Overall Study||10
3308966|NCT03024970|4042345|FG000|STARTED|First Intervention||34
3308967|NCT03024970|4042346|FG001|STARTED|First Intervention||38
3308968|NCT03024970|4042345|FG000|COMPLETED|First Intervention||33
3308969|NCT03024970|4042346|FG001|COMPLETED|First Intervention||38
3308970|NCT03024970|4042345|FG000|NOT COMPLETED|First Intervention||1
3308971|NCT03024970|4042346|FG001|NOT COMPLETED|First Intervention||0
3308972|NCT03024970|4042345|FG000|STARTED|Second Intervention||33
3308973|NCT03024970|4042346|FG001|STARTED|Second Intervention||38
3308974|NCT03024970|4042345|FG000|COMPLETED|Second Intervention||32
3308975|NCT03024970|4042346|FG001|COMPLETED|Second Intervention||38
3308976|NCT03024970|4042345|FG000|NOT COMPLETED|Second Intervention||1
3308977|NCT03024970|4042346|FG001|NOT COMPLETED|Second Intervention||0
3308978|NCT03025217|4042352|FG000|STARTED|Overall Study||31
3308979|NCT03025217|4042352|FG000|COMPLETED|Overall Study||27
3308980|NCT03025217|4042352|FG000|NOT COMPLETED|Overall Study||4
3308981|NCT03025945|4042358|FG000|STARTED|Overall Study||331
3308982|NCT03025945|4042359|FG001|STARTED|Overall Study||331
3308983|NCT03025945|4042358|FG000|COMPLETED|Overall Study||331
3308984|NCT03025945|4042359|FG001|COMPLETED|Overall Study||331
3308985|NCT03025945|4042358|FG000|NOT COMPLETED|Overall Study||0
3308986|NCT03025945|4042359|FG001|NOT COMPLETED|Overall Study||0
3308987|NCT03026075|4042365|FG000|STARTED|Overall Study||47
3308988|NCT03026075|4042365|FG000|COMPLETED|Overall Study||46
3308989|NCT03026075|4042365|FG000|NOT COMPLETED|Overall Study||1
3308990|NCT03026088|4042369|FG000|STARTED|Overall Study||20
3308991|NCT03026088|4042369|FG000|COMPLETED|Overall Study||0
3028031|NCT01098474|3746555|FG000|NOT COMPLETED|Active Phase||2
3028032|NCT01098474|3746556|FG001|NOT COMPLETED|Active Phase||1
3028033|NCT01098474|3746557|FG002|NOT COMPLETED|Active Phase||5
3028034|NCT01098474|3746558|FG003|NOT COMPLETED|Active Phase||0
3028035|NCT01098474|3746559|FG004|NOT COMPLETED|Active Phase||0
3028036|NCT01098474|3746560|FG005|NOT COMPLETED|Active Phase||0
3028037|NCT01098474|3746555|FG000|STARTED|Follow Up Phase||48
3028038|NCT01098474|3746556|FG001|STARTED|Follow Up Phase||49
3028039|NCT01098474|3746557|FG002|STARTED|Follow Up Phase||45
3028040|NCT01098474|3746558|FG003|STARTED|Follow Up Phase||49
3028041|NCT01098474|3746559|FG004|STARTED|Follow Up Phase||52
3028042|NCT01098474|3746560|FG005|STARTED|Follow Up Phase||49
3028043|NCT01098474|3746555|FG000|COMPLETED|Follow Up Phase||48
3028044|NCT01098474|3746556|FG001|COMPLETED|Follow Up Phase||49
3028045|NCT01098474|3746557|FG002|COMPLETED|Follow Up Phase||45
3028046|NCT01098474|3746558|FG003|COMPLETED|Follow Up Phase||47
3028047|NCT01098474|3746559|FG004|COMPLETED|Follow Up Phase||50
3028048|NCT01098474|3746560|FG005|COMPLETED|Follow Up Phase||44
3028049|NCT01098474|3746555|FG000|NOT COMPLETED|Follow Up Phase||0
3028050|NCT01098474|3746556|FG001|NOT COMPLETED|Follow Up Phase||0
3028051|NCT01098474|3746557|FG002|NOT COMPLETED|Follow Up Phase||0
3028052|NCT01098474|3746558|FG003|NOT COMPLETED|Follow Up Phase||2
3028053|NCT01098474|3746559|FG004|NOT COMPLETED|Follow Up Phase||2
3028054|NCT01098474|3746560|FG005|NOT COMPLETED|Follow Up Phase||5
3028055|NCT01098487|3746584|FG000|STARTED|Overall Study||162
3028056|NCT01098487|3746584|FG000|COMPLETED|Overall Study||118
3028057|NCT01098487|3746584|FG000|NOT COMPLETED|Overall Study||44
3028058|NCT01098500|3746588|FG000|STARTED|Overall Study||3800
3028059|NCT01098500|3746588|FG000|COMPLETED|Overall Study||3800
3028060|NCT01098500|3746588|FG000|NOT COMPLETED|Overall Study||0
3028061|NCT01098539|3746594|FG000|STARTED|Overall Study||249
3028062|NCT01098539|3746595|FG001|STARTED|Overall Study||246
3028063|NCT01098539|3746594|FG000|COMPLETED|Overall Study||198
3028064|NCT01098539|3746595|FG001|COMPLETED|Overall Study||178
3028065|NCT01098539|3746594|FG000|NOT COMPLETED|Overall Study||51
3028066|NCT01098539|3746595|FG001|NOT COMPLETED|Overall Study||68
3028067|NCT01098578|3746601|FG000|STARTED|Overall Study||20
3028068|NCT01098578|3746601|FG000|COMPLETED|Overall Study||20
3028069|NCT01098578|3746601|FG000|NOT COMPLETED|Overall Study||0
3028070|NCT01098747|3746611|FG000|STARTED|Overall Study||48
3028071|NCT01098747|3746612|FG001|STARTED|Overall Study||95
3028072|NCT01098747|3746613|FG002|STARTED|Overall Study||86
3028073|NCT01098747|3746614|FG003|STARTED|Overall Study||87
3028074|NCT01098747|3746611|FG000|COMPLETED|Overall Study||48
3028075|NCT01098747|3746612|FG001|COMPLETED|Overall Study||95
3028076|NCT01098747|3746613|FG002|COMPLETED|Overall Study||86
3028077|NCT01098747|3746614|FG003|COMPLETED|Overall Study||87
3028078|NCT01098747|3746611|FG000|NOT COMPLETED|Overall Study||0
3028079|NCT01098747|3746612|FG001|NOT COMPLETED|Overall Study||0
3028080|NCT01098747|3746613|FG002|NOT COMPLETED|Overall Study||0
3028081|NCT01098747|3746614|FG003|NOT COMPLETED|Overall Study||0
3028082|NCT01098812|3746626|FG000|STARTED|Overall Study||95
3028083|NCT01098812|3746627|FG001|STARTED|Overall Study||102
3028084|NCT01098812|3746628|FG002|STARTED|Overall Study||72
3028085|NCT01098812|3746626|FG000|COMPLETED|Overall Study||93
3028086|NCT01098812|3746627|FG001|COMPLETED|Overall Study||101
3028087|NCT01098812|3746628|FG002|COMPLETED|Overall Study||71
3166007|NCT01902303|3893474|FG001|COMPLETED|Overall Study|19 not treated /did not use medication as they did not develop a cold sore|57
3166008|NCT01902303|3893473|FG000|NOT COMPLETED|Overall Study||23
3166009|NCT01902303|3893474|FG001|NOT COMPLETED|Overall Study||24
3166010|NCT01902459|3893484|FG000|STARTED|Overall Study||75
3308992|NCT03026088|4042369|FG000|NOT COMPLETED|Overall Study||20
3308993|NCT03026166|4042375|FG000|STARTED|Overall Study||30
3308994|NCT03026166|4042376|FG001|STARTED|Overall Study||12
3308995|NCT03026166|4042375|FG000|COMPLETED|Overall Study||0
3308996|NCT03026166|4042376|FG001|COMPLETED|Overall Study||0
3308997|NCT03026166|4042375|FG000|NOT COMPLETED|Overall Study||30
3308998|NCT03026166|4042376|FG001|NOT COMPLETED|Overall Study||12
3308999|NCT03026257|4042388|FG000|STARTED|Overall Study||60
3309000|NCT03026257|4042389|FG001|STARTED|Overall Study||64
3309001|NCT03026257|4042390|FG002|STARTED|Overall Study||34
3309002|NCT03026257|4042391|FG003|STARTED|Overall Study||25
3309003|NCT03026257|4042392|FG004|STARTED|Overall Study||23
3309004|NCT03026257|4042393|FG005|STARTED|Overall Study||46
3309005|NCT03026257|4042388|FG000|Treated|Overall Study||58
3309006|NCT03026257|4042389|FG001|Treated|Overall Study||65
3309007|NCT03026257|4042390|FG002|Treated|Overall Study||35
3309008|NCT03026257|4042391|FG003|Treated|Overall Study||24
3309009|NCT03026257|4042392|FG004|Treated|Overall Study||23
3309010|NCT03026257|4042393|FG005|Treated|Overall Study||47
3309011|NCT03026257|4042388|FG000|COMPLETED|Overall Study||54
3309012|NCT03026257|4042389|FG001|COMPLETED|Overall Study||63
3309013|NCT03026257|4042390|FG002|COMPLETED|Overall Study||34
3309014|NCT03026257|4042391|FG003|COMPLETED|Overall Study||24
3028088|NCT01098812|3746626|FG000|NOT COMPLETED|Overall Study||2
3028089|NCT01098812|3746627|FG001|NOT COMPLETED|Overall Study||1
3028090|NCT01098812|3746628|FG002|NOT COMPLETED|Overall Study||1
3028091|NCT01098851|3746637|FG000|STARTED|Overall Study||11
3028092|NCT01098851|3746638|FG001|STARTED|Overall Study||10
3028093|NCT01098851|3746637|FG000|COMPLETED|Overall Study||10
3028094|NCT01098851|3746638|FG001|COMPLETED|Overall Study||10
3028095|NCT01098851|3746637|FG000|NOT COMPLETED|Overall Study||1
3028096|NCT01098851|3746638|FG001|NOT COMPLETED|Overall Study||0
3309015|NCT03026257|4042392|FG004|COMPLETED|Overall Study||22
3309016|NCT03026257|4042393|FG005|COMPLETED|Overall Study||46
3309017|NCT03026257|4042388|FG000|NOT COMPLETED|Overall Study||6
3309018|NCT03026257|4042389|FG001|NOT COMPLETED|Overall Study||1
3309019|NCT03026257|4042390|FG002|NOT COMPLETED|Overall Study||0
3309020|NCT03026257|4042391|FG003|NOT COMPLETED|Overall Study||1
3309021|NCT03026257|4042392|FG004|NOT COMPLETED|Overall Study||1
3309022|NCT03026257|4042393|FG005|NOT COMPLETED|Overall Study||0
3309023|NCT03026283|4042407|FG000|STARTED|CCTA Diagnosis||586
3028097|NCT01099111|3746649|FG000|STARTED|Overall Study||50
3028098|NCT01099111|3746650|FG001|STARTED|Overall Study||50
3028099|NCT01099111|3746651|FG002|STARTED|Overall Study||46
3028100|NCT01099111|3746652|FG003|STARTED|Overall Study||29
3028101|NCT01099111|3746653|FG004|STARTED|Overall Study||50
3028102|NCT01099111|3746649|FG000|COMPLETED|Overall Study|5 subjects were dropped out because of insufficient DNA extraction and accordingly replaced randomly|50
3028103|NCT01099111|3746650|FG001|COMPLETED|Overall Study|3 subjects were dropped out because of insufficient DNA extraction and accordingly replaced randomly|50
3028104|NCT01099111|3746651|FG002|COMPLETED|Overall Study|2 subjects were dropped out because of insufficient DNA extraction and accordingly replaced randomly|46
3028105|NCT01099111|3746652|FG003|COMPLETED|Overall Study||29
3028106|NCT01099111|3746653|FG004|COMPLETED|Overall Study|6 subjects were dropped out because of insufficient DNA extraction and accordingly replaced randomly|50
3028107|NCT01099111|3746649|FG000|NOT COMPLETED|Overall Study||0
3028108|NCT01099111|3746650|FG001|NOT COMPLETED|Overall Study||0
3028109|NCT01099111|3746651|FG002|NOT COMPLETED|Overall Study||0
3028110|NCT01099111|3746652|FG003|NOT COMPLETED|Overall Study||0
3028111|NCT01099111|3746653|FG004|NOT COMPLETED|Overall Study||0
3028112|NCT01099202|3746667|FG000|STARTED|Overall Study||55
3028113|NCT01099202|3746668|FG001|STARTED|Overall Study||54
3028114|NCT01099202|3746667|FG000|COMPLETED|Overall Study||55
3028115|NCT01099202|3746668|FG001|COMPLETED|Overall Study||54
3028116|NCT01099202|3746667|FG000|NOT COMPLETED|Overall Study||0
3028117|NCT01099202|3746668|FG001|NOT COMPLETED|Overall Study||0
3028118|NCT01099215|3746677|FG000|STARTED|Overall Study||11
3028119|NCT01099215|3746678|FG001|STARTED|Overall Study||10
3028120|NCT01099215|3746677|FG000|COMPLETED|Overall Study||10
3028121|NCT01099215|3746678|FG001|COMPLETED|Overall Study||9
3028122|NCT01099215|3746677|FG000|NOT COMPLETED|Overall Study||1
3028123|NCT01099215|3746678|FG001|NOT COMPLETED|Overall Study||1
3028124|NCT01099267|3746684|FG000|STARTED|MDS-003 Study|This information duplicates results in NCT00065156.|148
3028125|NCT01099267|3746684|FG000|COMPLETED|MDS-003 Study||24
3028126|NCT01099267|3746684|FG000|NOT COMPLETED|MDS-003 Study||124
3028127|NCT01099267|3746684|FG000|STARTED|MDS-009 Extension Follow-up|Participants from MDS-003 (including some who did not complete) at sites participating in MDS-009.|54
3028128|NCT01099267|3746684|FG000|Informed Consent Given|MDS-009 Extension Follow-up||33
3028129|NCT01099267|3746684|FG000|Other Source of Follow-up Info Used|MDS-009 Extension Follow-up|Social Security Death Index, public records, verbal reports from health providers and next of kin.|21
3028130|NCT01099267|3746684|FG000|COMPLETED|MDS-009 Extension Follow-up||54
3028131|NCT01099267|3746684|FG000|NOT COMPLETED|MDS-009 Extension Follow-up||0
3028132|NCT01099358|3746688|FG000|STARTED|Overall Study||4
3028133|NCT01099358|3746689|FG001|STARTED|Overall Study||6
3028134|NCT01099358|3746690|FG002|STARTED|Overall Study||21
3028135|NCT01099358|3746691|FG003|STARTED|Overall Study||16
3028136|NCT01099358|3746688|FG000|Received at Least One Dose of Study Drug|Overall Study||3
3028137|NCT01099358|3746689|FG001|Received at Least One Dose of Study Drug|Overall Study||6
3028138|NCT01099358|3746690|FG002|Received at Least One Dose of Study Drug|Overall Study||20
3028139|NCT01099358|3746691|FG003|Received at Least One Dose of Study Drug|Overall Study||15
3028140|NCT01099358|3746688|FG000|COMPLETED|Overall Study||1
3028141|NCT01099358|3746689|FG001|COMPLETED|Overall Study||5
3028142|NCT01099358|3746690|FG002|COMPLETED|Overall Study||13
3028143|NCT01099358|3746691|FG003|COMPLETED|Overall Study||12
3028144|NCT01099358|3746688|FG000|NOT COMPLETED|Overall Study||3
3028145|NCT01099358|3746689|FG001|NOT COMPLETED|Overall Study||1
3028146|NCT01099358|3746690|FG002|NOT COMPLETED|Overall Study||8
3028147|NCT01099358|3746691|FG003|NOT COMPLETED|Overall Study||4
3028148|NCT01099397|3746702|FG000|STARTED|Overall Study||39
3028149|NCT01099397|3746702|FG000|COMPLETED|Overall Study||26
3028150|NCT01099397|3746702|FG000|NOT COMPLETED|Overall Study||13
3028151|NCT01099449|3746710|FG000|STARTED|Overall Study||118
3028152|NCT01099449|3746711|FG001|STARTED|Overall Study||119
3028153|NCT01099449|3746712|FG002|STARTED|Overall Study||116
3028154|NCT01099449|3746710|FG000|COMPLETED|Overall Study||118
3028155|NCT01099449|3746711|FG001|COMPLETED|Overall Study||119
3028156|NCT01099449|3746712|FG002|COMPLETED|Overall Study||116
3028157|NCT01099449|3746710|FG000|NOT COMPLETED|Overall Study||0
3028158|NCT01099449|3746711|FG001|NOT COMPLETED|Overall Study||0
3028159|NCT01099449|3746712|FG002|NOT COMPLETED|Overall Study||0
3028160|NCT01099475|3746735|FG000|STARTED|Overall Study||10
3028161|NCT01099475|3746736|FG001|STARTED|Overall Study||10
3028162|NCT01099475|3746735|FG000|COMPLETED|Overall Study||10
3028163|NCT01099475|3746736|FG001|COMPLETED|Overall Study||10
3028164|NCT01099475|3746735|FG000|NOT COMPLETED|Overall Study||0
3028165|NCT01099475|3746736|FG001|NOT COMPLETED|Overall Study||0
3028166|NCT01099579|3746745|FG000|STARTED|Stage 1 (ATV Powder Formulation)||21
3028167|NCT01099579|3746746|FG001|STARTED|Stage 1 (ATV Powder Formulation)||19
3028168|NCT01099579|3746747|FG002|STARTED|Stage 1 (ATV Powder Formulation)||16
3038140|NCT01152385|3757531|FG001|NOT COMPLETED|Overall Study||6
3028169|NCT01099579|3746745|FG000|COMPLETED|Stage 1 (ATV Powder Formulation)|Completed Stage 1|17
3028170|NCT01099579|3746746|FG001|COMPLETED|Stage 1 (ATV Powder Formulation)|Completed Stage 1|14
3028171|NCT01099579|3746747|FG002|COMPLETED|Stage 1 (ATV Powder Formulation)|Completed Stage 1|15
3028172|NCT01099579|3746745|FG000|NOT COMPLETED|Stage 1 (ATV Powder Formulation)||4
3028173|NCT01099579|3746746|FG001|NOT COMPLETED|Stage 1 (ATV Powder Formulation)||5
3028174|NCT01099579|3746747|FG002|NOT COMPLETED|Stage 1 (ATV Powder Formulation)||1
3028175|NCT01099579|3746745|FG000|STARTED|Stage 2 (ATV Capsule)||16
3028176|NCT01099579|3746746|FG001|STARTED|Stage 2 (ATV Capsule)||14
3028177|NCT01099579|3746747|FG002|STARTED|Stage 2 (ATV Capsule)||15
3028178|NCT01099579|3746745|FG000|COMPLETED|Stage 2 (ATV Capsule)||10
3028179|NCT01099579|3746746|FG001|COMPLETED|Stage 2 (ATV Capsule)||9
3028180|NCT01099579|3746747|FG002|COMPLETED|Stage 2 (ATV Capsule)||9
3028181|NCT01099579|3746745|FG000|NOT COMPLETED|Stage 2 (ATV Capsule)||6
3028182|NCT01099579|3746746|FG001|NOT COMPLETED|Stage 2 (ATV Capsule)||5
3028183|NCT01099579|3746747|FG002|NOT COMPLETED|Stage 2 (ATV Capsule)||6
3028184|NCT01099618|3746760|FG000|STARTED|Overall Study||17
3028185|NCT01099618|3746761|FG001|STARTED|Overall Study||16
3028186|NCT01099618|3746762|FG002|STARTED|Overall Study||15
3028187|NCT01099618|3746760|FG000|COMPLETED|Overall Study||17
3028188|NCT01099618|3746761|FG001|COMPLETED|Overall Study||16
3028189|NCT01099618|3746762|FG002|COMPLETED|Overall Study||15
3028190|NCT01099618|3746760|FG000|NOT COMPLETED|Overall Study||0
3028191|NCT01099618|3746761|FG001|NOT COMPLETED|Overall Study||0
3028192|NCT01099618|3746762|FG002|NOT COMPLETED|Overall Study||0
3028193|NCT01099631|3746776|FG000|STARTED|Overall Study||6
3028194|NCT01099631|3746777|FG001|STARTED|Overall Study||3
3028195|NCT01099631|3746778|FG002|STARTED|Overall Study||3
3028196|NCT01099631|3746779|FG003|STARTED|Overall Study||3
3028197|NCT01099631|3746780|FG004|STARTED|Overall Study||3
3028198|NCT01099631|3746781|FG005|STARTED|Overall Study||4
3028199|NCT01099631|3746776|FG000|COMPLETED|Overall Study||6
3028200|NCT01099631|3746777|FG001|COMPLETED|Overall Study||3
3028201|NCT01099631|3746778|FG002|COMPLETED|Overall Study||3
3028202|NCT01099631|3746779|FG003|COMPLETED|Overall Study||3
3028203|NCT01099631|3746780|FG004|COMPLETED|Overall Study||3
3028204|NCT01099631|3746781|FG005|COMPLETED|Overall Study||4
3309024|NCT03026283|4042408|FG001|STARTED|CCTA Diagnosis||0
3309025|NCT03026283|4042409|FG002|STARTED|CCTA Diagnosis||0
3309026|NCT03026283|4042410|FG003|STARTED|CCTA Diagnosis||0
3309027|NCT03026283|4042411|FG004|STARTED|CCTA Diagnosis||0
3309028|NCT03026283|4042412|FG005|STARTED|CCTA Diagnosis||0
3309029|NCT03026283|4042413|FG006|STARTED|CCTA Diagnosis||0
3309030|NCT03026283|4042414|FG007|STARTED|CCTA Diagnosis||0
3309031|NCT03026283|4042407|FG000|COMPLETED|CCTA Diagnosis||572
3309032|NCT03026283|4042408|FG001|COMPLETED|CCTA Diagnosis||0
3309033|NCT03026283|4042409|FG002|COMPLETED|CCTA Diagnosis||0
3309034|NCT03026283|4042410|FG003|COMPLETED|CCTA Diagnosis||0
3309035|NCT03026283|4042411|FG004|COMPLETED|CCTA Diagnosis||0
3309036|NCT03026283|4042412|FG005|COMPLETED|CCTA Diagnosis||0
3309037|NCT03026283|4042413|FG006|COMPLETED|CCTA Diagnosis||0
3309038|NCT03026283|4042414|FG007|COMPLETED|CCTA Diagnosis||0
3309039|NCT03026283|4042407|FG000|NOT COMPLETED|CCTA Diagnosis||14
3309040|NCT03026283|4042408|FG001|NOT COMPLETED|CCTA Diagnosis||0
3309041|NCT03026283|4042409|FG002|NOT COMPLETED|CCTA Diagnosis||0
3309042|NCT03026283|4042410|FG003|NOT COMPLETED|CCTA Diagnosis||0
3309043|NCT03026283|4042411|FG004|NOT COMPLETED|CCTA Diagnosis||0
3309044|NCT03026283|4042412|FG005|NOT COMPLETED|CCTA Diagnosis||0
3309045|NCT03026283|4042413|FG006|NOT COMPLETED|CCTA Diagnosis||0
3309046|NCT03026283|4042414|FG007|NOT COMPLETED|CCTA Diagnosis||0
3309047|NCT03026283|4042407|FG000|STARTED|Optimal Medical Care/FFR-CT Diagnosis||0
3309048|NCT03026283|4042408|FG001|STARTED|Optimal Medical Care/FFR-CT Diagnosis||289
3309049|NCT03026283|4042409|FG002|STARTED|Optimal Medical Care/FFR-CT Diagnosis||280
3309050|NCT03026283|4042410|FG003|STARTED|Optimal Medical Care/FFR-CT Diagnosis||0
3309051|NCT03026283|4042411|FG004|STARTED|Optimal Medical Care/FFR-CT Diagnosis||0
3309052|NCT03026283|4042412|FG005|STARTED|Optimal Medical Care/FFR-CT Diagnosis||0
3309053|NCT03026283|4042413|FG006|STARTED|Optimal Medical Care/FFR-CT Diagnosis||0
3309054|NCT03026283|4042414|FG007|STARTED|Optimal Medical Care/FFR-CT Diagnosis||0
3309055|NCT03026283|4042407|FG000|COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
3309056|NCT03026283|4042408|FG001|COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||286
3309057|NCT03026283|4042409|FG002|COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||265
3309058|NCT03026283|4042410|FG003|COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
3309059|NCT03026283|4042411|FG004|COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
3309060|NCT03026283|4042412|FG005|COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
3309061|NCT03026283|4042413|FG006|COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
3309062|NCT03026283|4042414|FG007|COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
3309063|NCT03026283|4042407|FG000|NOT COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
3028205|NCT01099631|3746776|FG000|NOT COMPLETED|Overall Study||0
3028206|NCT01099631|3746777|FG001|NOT COMPLETED|Overall Study||0
3028207|NCT01099631|3746778|FG002|NOT COMPLETED|Overall Study||0
3028208|NCT01099631|3746779|FG003|NOT COMPLETED|Overall Study||0
3309064|NCT03026283|4042408|FG001|NOT COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||3
3309065|NCT03026283|4042409|FG002|NOT COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||15
3309066|NCT03026283|4042410|FG003|NOT COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
3309067|NCT03026283|4042411|FG004|NOT COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
3309068|NCT03026283|4042412|FG005|NOT COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
3028209|NCT01099631|3746780|FG004|NOT COMPLETED|Overall Study||0
3028210|NCT01099631|3746781|FG005|NOT COMPLETED|Overall Study||0
3028211|NCT01099709|3746801|FG000|STARTED|Period 1||42
3028212|NCT01099709|3746802|FG001|STARTED|Period 1||43
3028213|NCT01099709|3746801|FG000|COMPLETED|Period 1||41
3028214|NCT01099709|3746802|FG001|COMPLETED|Period 1||41
3028215|NCT01099709|3746801|FG000|NOT COMPLETED|Period 1||1
3028216|NCT01099709|3746802|FG001|NOT COMPLETED|Period 1||2
3028217|NCT01099709|3746801|FG000|STARTED|Period 2||41
3028218|NCT01099709|3746802|FG001|STARTED|Period 2||41
3028219|NCT01099709|3746801|FG000|COMPLETED|Period 2||41
3028220|NCT01099709|3746802|FG001|COMPLETED|Period 2||41
3028221|NCT01099709|3746801|FG000|NOT COMPLETED|Period 2||0
3028222|NCT01099709|3746802|FG001|NOT COMPLETED|Period 2||0
3028223|NCT01099761|3746813|FG000|STARTED|Overall Study||9
3028224|NCT01099761|3746814|FG001|STARTED|Overall Study||9
3028225|NCT01099761|3746815|FG002|STARTED|Overall Study|Study terminated prior to enrolling cohort 3|0
3028226|NCT01099761|3746816|FG003|STARTED|Overall Study||6
3028227|NCT01099761|3746813|FG000|COMPLETED|Overall Study||9
3028228|NCT01099761|3746814|FG001|COMPLETED|Overall Study||9
3028229|NCT01099761|3746815|FG002|COMPLETED|Overall Study||0
3028230|NCT01099761|3746816|FG003|COMPLETED|Overall Study||6
3028231|NCT01099761|3746813|FG000|NOT COMPLETED|Overall Study||0
3028232|NCT01099761|3746814|FG001|NOT COMPLETED|Overall Study||0
3028233|NCT01099761|3746815|FG002|NOT COMPLETED|Overall Study||0
3028234|NCT01099761|3746816|FG003|NOT COMPLETED|Overall Study||0
3028235|NCT01099774|3746827|FG000|STARTED|Overall Study||302
3028236|NCT01099774|3746828|FG001|STARTED|Overall Study||295
3028237|NCT01099774|3746827|FG000|COMPLETED|Overall Study||296
3028238|NCT01099774|3746828|FG001|COMPLETED|Overall Study||289
3028239|NCT01099774|3746827|FG000|NOT COMPLETED|Overall Study||6
3028240|NCT01099774|3746828|FG001|NOT COMPLETED|Overall Study||6
3028241|NCT01099917|3746834|FG000|STARTED|Overall Study||45
3028242|NCT01099917|3746834|FG000|COMPLETED|Overall Study||18
3028243|NCT01099917|3746834|FG000|NOT COMPLETED|Overall Study||27
3028244|NCT01099969|3746842|FG000|STARTED|Overall Study||15
3028245|NCT01099969|3746843|FG001|STARTED|Overall Study||15
3028246|NCT01099969|3746844|FG002|STARTED|Overall Study||15
3028247|NCT01099969|3746845|FG003|STARTED|Overall Study||15
3028248|NCT01099969|3746842|FG000|COMPLETED|Overall Study||15
3028249|NCT01099969|3746843|FG001|COMPLETED|Overall Study||15
3028250|NCT01099969|3746844|FG002|COMPLETED|Overall Study||15
3028251|NCT01099969|3746845|FG003|COMPLETED|Overall Study||15
3028252|NCT01099969|3746842|FG000|NOT COMPLETED|Overall Study||0
3028253|NCT01099969|3746843|FG001|NOT COMPLETED|Overall Study||0
3028254|NCT01099969|3746844|FG002|NOT COMPLETED|Overall Study||0
3028255|NCT01099969|3746845|FG003|NOT COMPLETED|Overall Study||0
3028256|NCT01100034|3746855|FG000|STARTED|Overall Study||72
3028257|NCT01100034|3746855|FG000|COMPLETED|Overall Study||29
3028258|NCT01100034|3746855|FG000|NOT COMPLETED|Overall Study||43
3028259|NCT01100073|3746859|FG000|STARTED|Overall Study|Baseline (Visit 1)|1699
3309069|NCT03026283|4042413|FG006|NOT COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
3309070|NCT03026283|4042414|FG007|NOT COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
3309071|NCT03026283|4042407|FG000|STARTED|Optimal Care/Stress Test/ICA||0
3309072|NCT03026283|4042408|FG001|STARTED|Optimal Care/Stress Test/ICA||0
3309073|NCT03026283|4042409|FG002|STARTED|Optimal Care/Stress Test/ICA||0
3309074|NCT03026283|4042410|FG003|STARTED|Optimal Care/Stress Test/ICA||128
3309075|NCT03026283|4042411|FG004|STARTED|Optimal Care/Stress Test/ICA||52
3309076|NCT03026283|4042412|FG005|STARTED|Optimal Care/Stress Test/ICA||101
3309077|NCT03026283|4042413|FG006|STARTED|Optimal Care/Stress Test/ICA||0
3309078|NCT03026283|4042414|FG007|STARTED|Optimal Care/Stress Test/ICA||0
3309079|NCT03026283|4042407|FG000|COMPLETED|Optimal Care/Stress Test/ICA||0
3309080|NCT03026283|4042408|FG001|COMPLETED|Optimal Care/Stress Test/ICA||0
3309081|NCT03026283|4042409|FG002|COMPLETED|Optimal Care/Stress Test/ICA||0
3309082|NCT03026283|4042410|FG003|COMPLETED|Optimal Care/Stress Test/ICA||108
3309083|NCT03026283|4042411|FG004|COMPLETED|Optimal Care/Stress Test/ICA||14
3309084|NCT03026283|4042412|FG005|COMPLETED|Optimal Care/Stress Test/ICA||73
3309085|NCT03026283|4042413|FG006|COMPLETED|Optimal Care/Stress Test/ICA||0
3309086|NCT03026283|4042414|FG007|COMPLETED|Optimal Care/Stress Test/ICA||0
3309087|NCT03026283|4042407|FG000|NOT COMPLETED|Optimal Care/Stress Test/ICA||0
3309088|NCT03026283|4042408|FG001|NOT COMPLETED|Optimal Care/Stress Test/ICA||0
3309089|NCT03026283|4042409|FG002|NOT COMPLETED|Optimal Care/Stress Test/ICA||0
3309090|NCT03026283|4042410|FG003|NOT COMPLETED|Optimal Care/Stress Test/ICA||20
3309091|NCT03026283|4042411|FG004|NOT COMPLETED|Optimal Care/Stress Test/ICA||38
3309092|NCT03026283|4042412|FG005|NOT COMPLETED|Optimal Care/Stress Test/ICA||28
3309093|NCT03026283|4042413|FG006|NOT COMPLETED|Optimal Care/Stress Test/ICA||0
3028260|NCT01100073|3746859|FG000|COMPLETED|Overall Study|End of study (Visit 3)|1599
3028261|NCT01100073|3746859|FG000|NOT COMPLETED|Overall Study||100
3028262|NCT01100086|3746863|FG000|STARTED|Period 1||43
3028263|NCT01100086|3746864|FG001|STARTED|Period 1||41
3028264|NCT01100086|3746863|FG000|COMPLETED|Period 1||42
3309094|NCT03026283|4042414|FG007|NOT COMPLETED|Optimal Care/Stress Test/ICA||0
3028265|NCT01100086|3746864|FG001|COMPLETED|Period 1||41
3028266|NCT01100086|3746863|FG000|NOT COMPLETED|Period 1||1
3028267|NCT01100086|3746864|FG001|NOT COMPLETED|Period 1||0
3028268|NCT01100086|3746863|FG000|STARTED|Period 2||42
3309095|NCT03026283|4042407|FG000|STARTED|Optimal Care/ICA Diagnostic Cath||0
3309096|NCT03026283|4042408|FG001|STARTED|Optimal Care/ICA Diagnostic Cath||0
3028269|NCT01100086|3746864|FG001|STARTED|Period 2||41
3028270|NCT01100086|3746863|FG000|COMPLETED|Period 2||42
3028271|NCT01100086|3746864|FG001|COMPLETED|Period 2||41
3028272|NCT01100086|3746863|FG000|NOT COMPLETED|Period 2||0
3028273|NCT01100086|3746864|FG001|NOT COMPLETED|Period 2||0
3028274|NCT01100112|3746870|FG000|STARTED|Overall Study||60
3028275|NCT01100112|3746870|FG000|COMPLETED|Overall Study||52
3028276|NCT01100112|3746870|FG000|NOT COMPLETED|Overall Study||8
3028277|NCT01100242|3746874|FG000|STARTED|Overall Study||17
3028278|NCT01100242|3746874|FG000|COMPLETED|Overall Study||17
3028279|NCT01100242|3746874|FG000|NOT COMPLETED|Overall Study||0
3028280|NCT01100255|3746880|FG000|STARTED|Overall Study||8
3028281|NCT01100255|3746881|FG001|STARTED|Overall Study||7
3028282|NCT01100255|3746880|FG000|COMPLETED|Overall Study||8
3028283|NCT01100255|3746881|FG001|COMPLETED|Overall Study||7
3028284|NCT01100255|3746880|FG000|NOT COMPLETED|Overall Study||0
3028285|NCT01100255|3746881|FG001|NOT COMPLETED|Overall Study||0
3028286|NCT01100268|3746887|FG000|STARTED|Overall Study||4
3028287|NCT01100268|3746887|FG000|COMPLETED|Overall Study||4
3028288|NCT01100268|3746887|FG000|NOT COMPLETED|Overall Study||0
3028289|NCT01100307|3746893|FG000|STARTED|Double Masked Phase (Up to Week 24)||123
3028290|NCT01100307|3746894|FG001|STARTED|Double Masked Phase (Up to Week 24)||120
3028291|NCT01100307|3746893|FG000|COMPLETED|Double Masked Phase (Up to Week 24)||117
3028292|NCT01100307|3746894|FG001|COMPLETED|Double Masked Phase (Up to Week 24)||116
3028293|NCT01100307|3746893|FG000|NOT COMPLETED|Double Masked Phase (Up to Week 24)||6
3028294|NCT01100307|3746894|FG001|NOT COMPLETED|Double Masked Phase (Up to Week 24)||4
3028295|NCT01100307|3746893|FG000|STARTED|Open Phase (Week 24 up to Week 54)|One participant discontinued from the study due to adverse event before study drug administration.|116
3028296|NCT01100307|3746894|FG001|STARTED|Open Phase (Week 24 up to Week 54)|Four participants did not enter to the open phase after completing the double masked phase.|112
3028297|NCT01100307|3746893|FG000|COMPLETED|Open Phase (Week 24 up to Week 54)||110
3028298|NCT01100307|3746894|FG001|COMPLETED|Open Phase (Week 24 up to Week 54)||99
3028299|NCT01100307|3746893|FG000|NOT COMPLETED|Open Phase (Week 24 up to Week 54)||6
3028300|NCT01100307|3746894|FG001|NOT COMPLETED|Open Phase (Week 24 up to Week 54)||13
3028301|NCT01100320|3746902|FG000|STARTED|Period 1||43
3028302|NCT01100320|3746903|FG001|STARTED|Period 1||45
3028303|NCT01100320|3746902|FG000|COMPLETED|Period 1||38
3028304|NCT01100320|3746903|FG001|COMPLETED|Period 1||38
3028305|NCT01100320|3746902|FG000|NOT COMPLETED|Period 1||5
3028306|NCT01100320|3746903|FG001|NOT COMPLETED|Period 1||7
3028307|NCT01100320|3746902|FG000|STARTED|Period 2||38
3028308|NCT01100320|3746903|FG001|STARTED|Period 2||38
3028309|NCT01100320|3746902|FG000|COMPLETED|Period 2||37
3028310|NCT01100320|3746903|FG001|COMPLETED|Period 2||37
3028311|NCT01100320|3746902|FG000|NOT COMPLETED|Period 2||1
3028312|NCT01100320|3746903|FG001|NOT COMPLETED|Period 2||1
3309097|NCT03026283|4042409|FG002|STARTED|Optimal Care/ICA Diagnostic Cath||0
3309098|NCT03026283|4042410|FG003|STARTED|Optimal Care/ICA Diagnostic Cath||0
3309099|NCT03026283|4042411|FG004|STARTED|Optimal Care/ICA Diagnostic Cath||0
3309100|NCT03026283|4042412|FG005|STARTED|Optimal Care/ICA Diagnostic Cath||0
3309101|NCT03026283|4042413|FG006|STARTED|Optimal Care/ICA Diagnostic Cath||21
3309102|NCT03026283|4042414|FG007|STARTED|Optimal Care/ICA Diagnostic Cath||0
3309103|NCT03026283|4042407|FG000|COMPLETED|Optimal Care/ICA Diagnostic Cath||0
3309104|NCT03026283|4042408|FG001|COMPLETED|Optimal Care/ICA Diagnostic Cath||0
3309105|NCT03026283|4042409|FG002|COMPLETED|Optimal Care/ICA Diagnostic Cath||0
3309106|NCT03026283|4042410|FG003|COMPLETED|Optimal Care/ICA Diagnostic Cath||0
3309107|NCT03026283|4042411|FG004|COMPLETED|Optimal Care/ICA Diagnostic Cath||0
3309108|NCT03026283|4042412|FG005|COMPLETED|Optimal Care/ICA Diagnostic Cath||0
3309109|NCT03026283|4042413|FG006|COMPLETED|Optimal Care/ICA Diagnostic Cath||21
3309110|NCT03026283|4042414|FG007|COMPLETED|Optimal Care/ICA Diagnostic Cath||0
3309111|NCT03026283|4042407|FG000|NOT COMPLETED|Optimal Care/ICA Diagnostic Cath||0
3309112|NCT03026283|4042408|FG001|NOT COMPLETED|Optimal Care/ICA Diagnostic Cath||0
3309113|NCT03026283|4042409|FG002|NOT COMPLETED|Optimal Care/ICA Diagnostic Cath||0
3309114|NCT03026283|4042410|FG003|NOT COMPLETED|Optimal Care/ICA Diagnostic Cath||0
3309115|NCT03026283|4042411|FG004|NOT COMPLETED|Optimal Care/ICA Diagnostic Cath||0
3309116|NCT03026283|4042412|FG005|NOT COMPLETED|Optimal Care/ICA Diagnostic Cath||0
3309117|NCT03026283|4042413|FG006|NOT COMPLETED|Optimal Care/ICA Diagnostic Cath||0
3309118|NCT03026283|4042414|FG007|NOT COMPLETED|Optimal Care/ICA Diagnostic Cath||0
3309119|NCT03026530|4042429|FG000|STARTED|Overall Study||100
3309120|NCT03026530|4042430|FG001|STARTED|Overall Study||100
3309121|NCT03026530|4042429|FG000|COMPLETED|Overall Study||79
3309122|NCT03026530|4042430|FG001|COMPLETED|Overall Study||71
3309123|NCT03026530|4042429|FG000|NOT COMPLETED|Overall Study||21
3309124|NCT03026530|4042430|FG001|NOT COMPLETED|Overall Study||29
3309125|NCT03026556|4042439|FG000|STARTED|Overall Study||12763
3309126|NCT03026556|4042440|FG001|STARTED|Overall Study||17177
3309127|NCT03026556|4042441|FG002|STARTED|Overall Study||12594
3309128|NCT03026556|4042439|FG000|COMPLETED|Overall Study||12763
3309129|NCT03026556|4042440|FG001|COMPLETED|Overall Study||17177
3309130|NCT03026556|4042441|FG002|COMPLETED|Overall Study||12594
3309131|NCT03026556|4042439|FG000|NOT COMPLETED|Overall Study||0
3309132|NCT03026556|4042440|FG001|NOT COMPLETED|Overall Study||0
3309133|NCT03026556|4042441|FG002|NOT COMPLETED|Overall Study||0
3309134|NCT03026777|4042452|FG000|STARTED|Overall Study||168
3028313|NCT01100437|3746909|FG000|STARTED|Screening||4
3028314|NCT01100437|3746910|FG001|STARTED|Screening||2
3028315|NCT01100437|3746911|FG002|STARTED|Screening||8
3028316|NCT01100437|3746909|FG000|COMPLETED|Screening||4
3028317|NCT01100437|3746910|FG001|COMPLETED|Screening||2
3028318|NCT01100437|3746911|FG002|COMPLETED|Screening||8
3028319|NCT01100437|3746909|FG000|NOT COMPLETED|Screening||0
3028320|NCT01100437|3746910|FG001|NOT COMPLETED|Screening||0
3028321|NCT01100437|3746911|FG002|NOT COMPLETED|Screening||0
3028322|NCT01100437|3746909|FG000|STARTED|Titration/Stabilization||4
3028323|NCT01100437|3746910|FG001|STARTED|Titration/Stabilization||2
3028324|NCT01100437|3746911|FG002|STARTED|Titration/Stabilization||8
3028325|NCT01100437|3746909|FG000|COMPLETED|Titration/Stabilization||4
3028326|NCT01100437|3746910|FG001|COMPLETED|Titration/Stabilization||2
3028327|NCT01100437|3746911|FG002|COMPLETED|Titration/Stabilization||2
3028328|NCT01100437|3746909|FG000|NOT COMPLETED|Titration/Stabilization||0
3028329|NCT01100437|3746910|FG001|NOT COMPLETED|Titration/Stabilization||0
3166011|NCT01902459|3893485|FG001|STARTED|Overall Study||75
3166012|NCT01902459|3893484|FG000|COMPLETED|Overall Study||75
3166013|NCT01902459|3893485|FG001|COMPLETED|Overall Study||75
3166014|NCT01902459|3893484|FG000|NOT COMPLETED|Overall Study||0
3166015|NCT01902459|3893485|FG001|NOT COMPLETED|Overall Study||0
3309135|NCT03026777|4042453|FG001|STARTED|Overall Study||169
3309136|NCT03026777|4042452|FG000|COMPLETED|Overall Study||168
3309137|NCT03026777|4042453|FG001|COMPLETED|Overall Study||169
3309138|NCT03026777|4042452|FG000|NOT COMPLETED|Overall Study||0
3309139|NCT03026777|4042453|FG001|NOT COMPLETED|Overall Study||0
3309140|NCT03026803|4042459|FG000|STARTED|Overall Study||4
3309141|NCT03026803|4042459|FG000|COMPLETED|Overall Study||4
3309142|NCT03026803|4042459|FG000|NOT COMPLETED|Overall Study||0
3309143|NCT03027466|4042467|FG000|STARTED|Overall Study||2027
3309144|NCT03027466|4042468|FG001|STARTED|Overall Study||1984
3309145|NCT03027466|4042469|FG002|STARTED|Overall Study||1903
3309146|NCT03027466|4042470|FG003|STARTED|Overall Study||1985
3309147|NCT03027466|4042467|FG000|COMPLETED|Overall Study||158
3309148|NCT03027466|4042468|FG001|COMPLETED|Overall Study||165
3309149|NCT03027466|4042469|FG002|COMPLETED|Overall Study||160
3309150|NCT03027466|4042470|FG003|COMPLETED|Overall Study||164
3309151|NCT03027466|4042467|FG000|NOT COMPLETED|Overall Study||1869
3309152|NCT03027466|4042468|FG001|NOT COMPLETED|Overall Study||1819
3309153|NCT03027466|4042469|FG002|NOT COMPLETED|Overall Study||1743
3309154|NCT03027466|4042470|FG003|NOT COMPLETED|Overall Study||1821
3309155|NCT03027557|4042483|FG000|STARTED|Overall Study||15
3309156|NCT03027557|4042484|FG001|STARTED|Overall Study||16
3309157|NCT03027557|4042485|FG002|STARTED|Overall Study||15
3309158|NCT03027557|4042483|FG000|COMPLETED|Overall Study||14
3309159|NCT03027557|4042484|FG001|COMPLETED|Overall Study||16
3309160|NCT03027557|4042485|FG002|COMPLETED|Overall Study||15
3309161|NCT03027557|4042483|FG000|NOT COMPLETED|Overall Study||1
3309162|NCT03027557|4042484|FG001|NOT COMPLETED|Overall Study||0
3309163|NCT03027557|4042485|FG002|NOT COMPLETED|Overall Study||0
3309164|NCT03027661|4042495|FG000|STARTED|Overall Study||20
3309165|NCT03027661|4042496|FG001|STARTED|Overall Study||21
3309166|NCT03027661|4042495|FG000|COMPLETED|Overall Study||20
3309167|NCT03027661|4042496|FG001|COMPLETED|Overall Study||21
3309168|NCT03027661|4042495|FG000|NOT COMPLETED|Overall Study||0
3309169|NCT03027661|4042496|FG001|NOT COMPLETED|Overall Study||0
3309170|NCT03028012|4042505|FG000|STARTED|Overall Study||4
3309171|NCT03028012|4042506|FG001|STARTED|Overall Study||3
3309172|NCT03028012|4042507|FG002|STARTED|Overall Study||3
3309173|NCT03028012|4042505|FG000|COMPLETED|Overall Study||2
3309174|NCT03028012|4042506|FG001|COMPLETED|Overall Study||0
3309175|NCT03028012|4042507|FG002|COMPLETED|Overall Study||0
3309176|NCT03028012|4042505|FG000|NOT COMPLETED|Overall Study||2
3309177|NCT03028012|4042506|FG001|NOT COMPLETED|Overall Study||3
3309178|NCT03028012|4042507|FG002|NOT COMPLETED|Overall Study||3
3309179|NCT03028025|4042518|FG000|STARTED|Overall Study||90
3309180|NCT03028025|4042519|FG001|STARTED|Overall Study||94
3309181|NCT03028025|4042518|FG000|COMPLETED|Overall Study||87
3309182|NCT03028025|4042519|FG001|COMPLETED|Overall Study||93
3309183|NCT03028025|4042518|FG000|NOT COMPLETED|Overall Study||3
3309184|NCT03028025|4042519|FG001|NOT COMPLETED|Overall Study||1
3309185|NCT03028103|4042527|FG000|STARTED|Overall Study||16
3309186|NCT03028103|4042528|FG001|STARTED|Overall Study||16
3309187|NCT03028103|4042527|FG000|COMPLETED|Overall Study||16
3309188|NCT03028103|4042528|FG001|COMPLETED|Overall Study||16
3309189|NCT03028103|4042527|FG000|NOT COMPLETED|Overall Study||0
3309190|NCT03028103|4042528|FG001|NOT COMPLETED|Overall Study||0
3309191|NCT03028129|4042540|FG000|STARTED|Overall Study||258
3028330|NCT01100437|3746911|FG002|NOT COMPLETED|Titration/Stabilization||6
3028331|NCT01100437|3746909|FG000|STARTED|Maintenance||4
3028332|NCT01100437|3746910|FG001|STARTED|Maintenance||2
3028333|NCT01100437|3746911|FG002|STARTED|Maintenance||2
3028334|NCT01100437|3746909|FG000|COMPLETED|Maintenance||4
3028335|NCT01100437|3746910|FG001|COMPLETED|Maintenance||2
3028336|NCT01100437|3746911|FG002|COMPLETED|Maintenance||0
3028337|NCT01100437|3746909|FG000|NOT COMPLETED|Maintenance||0
3028338|NCT01100437|3746910|FG001|NOT COMPLETED|Maintenance||0
3028339|NCT01100437|3746911|FG002|NOT COMPLETED|Maintenance||2
3028340|NCT01100437|3746909|FG000|STARTED|Treatment 1||4
3028341|NCT01100437|3746910|FG001|STARTED|Treatment 1||2
3028342|NCT01100437|3746911|FG002|STARTED|Treatment 1||0
3166016|NCT01902628|3893491|FG000|STARTED|Overall Study||437
3309192|NCT03028129|4042541|FG001|STARTED|Overall Study||209
3309193|NCT03028129|4042540|FG000|COMPLETED|Overall Study||132
3309194|NCT03028129|4042541|FG001|COMPLETED|Overall Study||122
3309195|NCT03028129|4042540|FG000|NOT COMPLETED|Overall Study||126
3028343|NCT01100437|3746909|FG000|COMPLETED|Treatment 1||4
3028344|NCT01100437|3746910|FG001|COMPLETED|Treatment 1||2
3028345|NCT01100437|3746911|FG002|COMPLETED|Treatment 1||0
3028346|NCT01100437|3746909|FG000|NOT COMPLETED|Treatment 1||0
3028347|NCT01100437|3746910|FG001|NOT COMPLETED|Treatment 1||0
3028348|NCT01100437|3746911|FG002|NOT COMPLETED|Treatment 1||0
3028349|NCT01100437|3746909|FG000|STARTED|Washout (4 Days)||4
3028350|NCT01100437|3746910|FG001|STARTED|Washout (4 Days)||2
3028351|NCT01100437|3746911|FG002|STARTED|Washout (4 Days)||0
3028352|NCT01100437|3746909|FG000|COMPLETED|Washout (4 Days)||4
3028353|NCT01100437|3746910|FG001|COMPLETED|Washout (4 Days)||2
3028354|NCT01100437|3746911|FG002|COMPLETED|Washout (4 Days)||0
3028355|NCT01100437|3746909|FG000|NOT COMPLETED|Washout (4 Days)||0
3028356|NCT01100437|3746910|FG001|NOT COMPLETED|Washout (4 Days)||0
3028357|NCT01100437|3746911|FG002|NOT COMPLETED|Washout (4 Days)||0
3028358|NCT01100437|3746909|FG000|STARTED|Treatment 2||4
3028359|NCT01100437|3746910|FG001|STARTED|Treatment 2||2
3028360|NCT01100437|3746911|FG002|STARTED|Treatment 2||0
3028361|NCT01100437|3746909|FG000|COMPLETED|Treatment 2||4
3028362|NCT01100437|3746910|FG001|COMPLETED|Treatment 2||2
3028363|NCT01100437|3746911|FG002|COMPLETED|Treatment 2||0
3028364|NCT01100437|3746909|FG000|NOT COMPLETED|Treatment 2||0
3028365|NCT01100437|3746910|FG001|NOT COMPLETED|Treatment 2||0
3028366|NCT01100437|3746911|FG002|NOT COMPLETED|Treatment 2||0
3028367|NCT01100502|3746922|FG000|STARTED|Overall Study||165
3028368|NCT01100502|3746923|FG001|STARTED|Overall Study||164
3028369|NCT01100502|3746922|FG000|COMPLETED|Overall Study|Completed due to study closure by sponsor|89
3028370|NCT01100502|3746923|FG001|COMPLETED|Overall Study|Completed due to study closure by sponsor|70
3028371|NCT01100502|3746922|FG000|NOT COMPLETED|Overall Study||76
3028372|NCT01100502|3746923|FG001|NOT COMPLETED|Overall Study||94
3028373|NCT01100528|3746929|FG000|STARTED|Overall Study||38
3028374|NCT01100528|3746929|FG000|COMPLETED|Overall Study||35
3028375|NCT01100528|3746929|FG000|NOT COMPLETED|Overall Study||3
3028376|NCT01100567|3746935|FG000|STARTED|Overall Study||50
3028377|NCT01100567|3746936|FG001|STARTED|Overall Study||51
3028378|NCT01100567|3746935|FG000|COMPLETED|Overall Study||38
3028379|NCT01100567|3746936|FG001|COMPLETED|Overall Study||35
3028380|NCT01100567|3746935|FG000|NOT COMPLETED|Overall Study||12
3028381|NCT01100567|3746936|FG001|NOT COMPLETED|Overall Study||16
3028382|NCT01100606|3746942|FG000|STARTED|First Treatment Period||8
3028383|NCT01100606|3746943|FG001|STARTED|First Treatment Period||7
3028384|NCT01100606|3746942|FG000|COMPLETED|First Treatment Period|Due to difficulty with syringe nurser,1 participant completed study with apple sauce,not apple juice|8
3028385|NCT01100606|3746943|FG001|COMPLETED|First Treatment Period||7
3028386|NCT01100606|3746942|FG000|NOT COMPLETED|First Treatment Period||0
3028387|NCT01100606|3746943|FG001|NOT COMPLETED|First Treatment Period||0
3028388|NCT01100606|3746942|FG000|STARTED|Second Treatment Period||8
3028389|NCT01100606|3746943|FG001|STARTED|Second Treatment Period||7
3028390|NCT01100606|3746942|FG000|COMPLETED|Second Treatment Period|Due to intolerance to apple sauce & apple juice,1 participant completed study with banana-based food|8
3028391|NCT01100606|3746943|FG001|COMPLETED|Second Treatment Period|Due to difficulty with syringe nurser, 1 participant completed study using apple sauce|7
3028392|NCT01100606|3746942|FG000|NOT COMPLETED|Second Treatment Period||0
3028393|NCT01100606|3746943|FG001|NOT COMPLETED|Second Treatment Period||0
3028394|NCT01100723|3746953|FG000|STARTED|Overall Study||92
3028395|NCT01100723|3746953|FG000|6 Month Analysis|Overall Study|85 subjects had laboratory data at the 6 month analysis and were compared to their baseline data.|85
3028396|NCT01100723|3746953|FG000|COMPLETED|Overall Study|78 subjects had laboratory data at the 12 month analysis and were compared to their baseline data.|78
3028397|NCT01100723|3746953|FG000|NOT COMPLETED|Overall Study||14
3028398|NCT01100762|3746958|FG000|STARTED|Overall Study||10
3028399|NCT01100762|3746958|FG000|COMPLETED|Overall Study||10
3028400|NCT01100762|3746958|FG000|NOT COMPLETED|Overall Study||0
3028401|NCT01100853|3746966|FG000|STARTED|Overall Study||51
3028402|NCT01100853|3746967|FG001|STARTED|Overall Study||49
3028403|NCT01100853|3746966|FG000|COMPLETED|Overall Study||24
3028404|NCT01100853|3746967|FG001|COMPLETED|Overall Study||26
3028405|NCT01100853|3746966|FG000|NOT COMPLETED|Overall Study||27
3028406|NCT01100853|3746967|FG001|NOT COMPLETED|Overall Study||23
3028407|NCT01100931|3746975|FG000|STARTED|Phase I||22
3028408|NCT01100931|3746976|FG001|STARTED|Phase I||0
3028409|NCT01100931|3746975|FG000|COMPLETED|Phase I||22
3028410|NCT01100931|3746976|FG001|COMPLETED|Phase I||0
3028411|NCT01100931|3746975|FG000|NOT COMPLETED|Phase I||0
3028412|NCT01100931|3746976|FG001|NOT COMPLETED|Phase I||0
3028413|NCT01100931|3746975|FG000|STARTED|Phase II||0
3028414|NCT01100931|3746976|FG001|STARTED|Phase II||19
3028415|NCT01100931|3746975|FG000|COMPLETED|Phase II||0
3028416|NCT01100931|3746976|FG001|COMPLETED|Phase II||19
3028417|NCT01100931|3746975|FG000|NOT COMPLETED|Phase II||0
3028418|NCT01100931|3746976|FG001|NOT COMPLETED|Phase II||0
3028419|NCT01100944|3746983|FG000|STARTED|Dose Escalation Phase 1 Dose Level 1||6
3028420|NCT01100944|3746984|FG001|STARTED|Dose Escalation Phase 1 Dose Level 1||0
3028421|NCT01100944|3746985|FG002|STARTED|Dose Escalation Phase 1 Dose Level 1||0
3028422|NCT01100944|3746983|FG000|COMPLETED|Dose Escalation Phase 1 Dose Level 1||2
3028423|NCT01100944|3746984|FG001|COMPLETED|Dose Escalation Phase 1 Dose Level 1||0
3028424|NCT01100944|3746985|FG002|COMPLETED|Dose Escalation Phase 1 Dose Level 1||0
3028425|NCT01100944|3746983|FG000|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 1||4
3028426|NCT01100944|3746984|FG001|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 1||0
3038141|NCT01152385|3757532|FG002|NOT COMPLETED|Overall Study||5
3028427|NCT01100944|3746985|FG002|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 1||0
3028428|NCT01100944|3746983|FG000|STARTED|Dose Escalation Phase 1 Dose Level 2||0
3028429|NCT01100944|3746984|FG001|STARTED|Dose Escalation Phase 1 Dose Level 2||2
3028430|NCT01100944|3746985|FG002|STARTED|Dose Escalation Phase 1 Dose Level 2||0
3028431|NCT01100944|3746983|FG000|COMPLETED|Dose Escalation Phase 1 Dose Level 2||0
3028432|NCT01100944|3746984|FG001|COMPLETED|Dose Escalation Phase 1 Dose Level 2||0
3028433|NCT01100944|3746985|FG002|COMPLETED|Dose Escalation Phase 1 Dose Level 2||0
3028434|NCT01100944|3746983|FG000|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 2||0
3028435|NCT01100944|3746984|FG001|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 2||2
3028436|NCT01100944|3746985|FG002|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 2||0
3028437|NCT01100944|3746983|FG000|STARTED|Expansion Phase - Phase 2||0
3028438|NCT01100944|3746984|FG001|STARTED|Expansion Phase - Phase 2||0
3028439|NCT01100944|3746985|FG002|STARTED|Expansion Phase - Phase 2||18
3028440|NCT01100944|3746983|FG000|COMPLETED|Expansion Phase - Phase 2||0
3028441|NCT01100944|3746984|FG001|COMPLETED|Expansion Phase - Phase 2||0
3028442|NCT01100944|3746985|FG002|COMPLETED|Expansion Phase - Phase 2||18
3028443|NCT01100944|3746983|FG000|NOT COMPLETED|Expansion Phase - Phase 2||0
3028444|NCT01100944|3746984|FG001|NOT COMPLETED|Expansion Phase - Phase 2||0
3028445|NCT01100944|3746985|FG002|NOT COMPLETED|Expansion Phase - Phase 2||0
3028446|NCT01101022|3747008|FG000|STARTED|Overall Study||79
3028447|NCT01101022|3747009|FG001|STARTED|Overall Study||80
3028448|NCT01101022|3747008|FG000|COMPLETED|Overall Study||62
3028449|NCT01101022|3747009|FG001|COMPLETED|Overall Study||53
3028450|NCT01101022|3747008|FG000|NOT COMPLETED|Overall Study||17
3028451|NCT01101022|3747009|FG001|NOT COMPLETED|Overall Study||27
3028452|NCT01101035|3747017|FG000|STARTED|Overall Study||3101
3028453|NCT01101035|3747018|FG001|STARTED|Overall Study||3097
3028454|NCT01101035|3747017|FG000|COMPLETED|Overall Study||1704
3028455|NCT01101035|3747018|FG001|COMPLETED|Overall Study||1706
3028456|NCT01101035|3747017|FG000|NOT COMPLETED|Overall Study||1397
3028457|NCT01101035|3747018|FG001|NOT COMPLETED|Overall Study||1391
3028458|NCT01101061|3747030|FG000|STARTED|Overall Study||6
3028459|NCT01101061|3747031|FG001|STARTED|Overall Study||6
3028460|NCT01101061|3747032|FG002|STARTED|Overall Study||7
3028461|NCT01101061|3747033|FG003|STARTED|Overall Study||6
3028462|NCT01101061|3747034|FG004|STARTED|Overall Study||2
3028463|NCT01101061|3747035|FG005|STARTED|Overall Study||4
3028464|NCT01101061|3747030|FG000|Received Study Drug|Overall Study||6
3028465|NCT01101061|3747031|FG001|Received Study Drug|Overall Study||6
3028466|NCT01101061|3747032|FG002|Received Study Drug|Overall Study||6
3028467|NCT01101061|3747033|FG003|Received Study Drug|Overall Study||6
3028468|NCT01101061|3747034|FG004|Received Study Drug|Overall Study||2
3028469|NCT01101061|3747035|FG005|Received Study Drug|Overall Study||4
3028470|NCT01101061|3747030|FG000|COMPLETED|Overall Study||6
3028471|NCT01101061|3747031|FG001|COMPLETED|Overall Study||6
3028472|NCT01101061|3747032|FG002|COMPLETED|Overall Study||6
3028473|NCT01101061|3747033|FG003|COMPLETED|Overall Study||6
3028474|NCT01101061|3747034|FG004|COMPLETED|Overall Study||2
3028475|NCT01101061|3747035|FG005|COMPLETED|Overall Study||4
3028476|NCT01101061|3747030|FG000|NOT COMPLETED|Overall Study||0
3028477|NCT01101061|3747031|FG001|NOT COMPLETED|Overall Study||0
3028478|NCT01101061|3747032|FG002|NOT COMPLETED|Overall Study||1
3028479|NCT01101061|3747033|FG003|NOT COMPLETED|Overall Study||0
3028480|NCT01101061|3747034|FG004|NOT COMPLETED|Overall Study||0
3028481|NCT01101061|3747035|FG005|NOT COMPLETED|Overall Study||0
3028482|NCT01101100|3747053|FG000|STARTED|Overall Study||181
3028483|NCT01101100|3747053|FG000|COMPLETED|Overall Study||126
3028484|NCT01101100|3747053|FG000|NOT COMPLETED|Overall Study||55
3028485|NCT01101165|3747058|FG000|STARTED|Period 1||47
3028486|NCT01101165|3747059|FG001|STARTED|Period 1||45
3028487|NCT01101165|3747058|FG000|COMPLETED|Period 1||45
3028488|NCT01101165|3747059|FG001|COMPLETED|Period 1||40
3028489|NCT01101165|3747058|FG000|NOT COMPLETED|Period 1||2
3028490|NCT01101165|3747059|FG001|NOT COMPLETED|Period 1||5
3028491|NCT01101165|3747058|FG000|STARTED|Period 2||45
3028492|NCT01101165|3747059|FG001|STARTED|Period 2||40
3028493|NCT01101165|3747058|FG000|COMPLETED|Period 2||41
3028494|NCT01101165|3747059|FG001|COMPLETED|Period 2||39
3028495|NCT01101165|3747058|FG000|NOT COMPLETED|Period 2||4
3028496|NCT01101165|3747059|FG001|NOT COMPLETED|Period 2||1
3028497|NCT01101178|3747065|FG000|STARTED|Period 1||40
3028498|NCT01101178|3747066|FG001|STARTED|Period 1||39
3028499|NCT01101178|3747065|FG000|COMPLETED|Period 1||36
3028500|NCT01101178|3747066|FG001|COMPLETED|Period 1||35
3028501|NCT01101178|3747065|FG000|NOT COMPLETED|Period 1||4
3028502|NCT01101178|3747066|FG001|NOT COMPLETED|Period 1||4
3028503|NCT01101178|3747065|FG000|STARTED|Period 2||36
3028504|NCT01101178|3747066|FG001|STARTED|Period 2||35
3028505|NCT01101178|3747065|FG000|COMPLETED|Period 2||36
3028506|NCT01101178|3747066|FG001|COMPLETED|Period 2||34
3028507|NCT01101178|3747065|FG000|NOT COMPLETED|Period 2||0
3028508|NCT01101178|3747066|FG001|NOT COMPLETED|Period 2||1
3028509|NCT01101191|3747073|FG000|STARTED|Period 1||42
3028510|NCT01101191|3747074|FG001|STARTED|Period 1||42
3028511|NCT01101191|3747073|FG000|COMPLETED|Period 1||40
3028512|NCT01101191|3747074|FG001|COMPLETED|Period 1||40
3028513|NCT01101191|3747073|FG000|NOT COMPLETED|Period 1||2
3028514|NCT01101191|3747074|FG001|NOT COMPLETED|Period 1||2
3028515|NCT01101191|3747073|FG000|STARTED|Period 2||40
3028516|NCT01101191|3747074|FG001|STARTED|Period 2||40
3028517|NCT01101191|3747073|FG000|COMPLETED|Period 2||40
3028518|NCT01101191|3747074|FG001|COMPLETED|Period 2||40
3028519|NCT01101191|3747073|FG000|NOT COMPLETED|Period 2||0
3028520|NCT01101191|3747074|FG001|NOT COMPLETED|Period 2||0
3028521|NCT01101308|3747081|FG000|STARTED|Period 1||27
3028522|NCT01101308|3747082|FG001|STARTED|Period 1||28
3028523|NCT01101308|3747081|FG000|COMPLETED|Period 1||24
3028524|NCT01101308|3747082|FG001|COMPLETED|Period 1||27
3028525|NCT01101308|3747081|FG000|NOT COMPLETED|Period 1||3
3028526|NCT01101308|3747082|FG001|NOT COMPLETED|Period 1||1
3028527|NCT01101308|3747081|FG000|STARTED|Period 2||24
3028528|NCT01101308|3747082|FG001|STARTED|Period 2||27
3028529|NCT01101308|3747081|FG000|COMPLETED|Period 2||24
3028530|NCT01101308|3747082|FG001|COMPLETED|Period 2||27
3028531|NCT01101308|3747081|FG000|NOT COMPLETED|Period 2||0
3028532|NCT01101308|3747082|FG001|NOT COMPLETED|Period 2||0
3028533|NCT01101321|3747089|FG000|STARTED|Period 1||30
3028534|NCT01101321|3747090|FG001|STARTED|Period 1||28
3028535|NCT01101321|3747089|FG000|COMPLETED|Period 1||26
3028536|NCT01101321|3747090|FG001|COMPLETED|Period 1||24
3028537|NCT01101321|3747089|FG000|NOT COMPLETED|Period 1||4
3028538|NCT01101321|3747090|FG001|NOT COMPLETED|Period 1||4
3028539|NCT01101321|3747089|FG000|STARTED|Period 2||26
3028540|NCT01101321|3747090|FG001|STARTED|Period 2||24
3028541|NCT01101321|3747089|FG000|COMPLETED|Period 2||26
3028542|NCT01101321|3747090|FG001|COMPLETED|Period 2||24
3028543|NCT01101321|3747089|FG000|NOT COMPLETED|Period 2||0
3028544|NCT01101321|3747090|FG001|NOT COMPLETED|Period 2||0
3028545|NCT01101334|3747098|FG000|STARTED|Overall Study||45
3028546|NCT01101334|3747099|FG001|STARTED|Overall Study||45
3028547|NCT01101334|3747098|FG000|Received Study Treatment|Overall Study||44
3028548|NCT01101334|3747099|FG001|Received Study Treatment|Overall Study||45
3028549|NCT01101334|3747098|FG000|COMPLETED|Overall Study||0
3028550|NCT01101334|3747099|FG001|COMPLETED|Overall Study||0
3028551|NCT01101334|3747098|FG000|NOT COMPLETED|Overall Study||45
3028552|NCT01101334|3747099|FG001|NOT COMPLETED|Overall Study||45
3038142|NCT01152385|3757533|FG003|NOT COMPLETED|Overall Study||5
3038143|NCT01152437|3757550|FG000|STARTED|Overall Study|randomised|36
3038144|NCT01152437|3757551|FG001|STARTED|Overall Study|randomised|15
3038145|NCT01152437|3757552|FG002|STARTED|Overall Study|entered|43
3038146|NCT01152437|3757550|FG000|COMPLETED|Overall Study||0
3038147|NCT01152437|3757551|FG001|COMPLETED|Overall Study||0
3038148|NCT01152437|3757552|FG002|COMPLETED|Overall Study||0
3038149|NCT01152437|3757550|FG000|NOT COMPLETED|Overall Study||36
3038150|NCT01152437|3757551|FG001|NOT COMPLETED|Overall Study||15
3038151|NCT01152437|3757552|FG002|NOT COMPLETED|Overall Study||43
3038152|NCT01152450|3757562|FG000|STARTED|Period 1 (4 Weeks)||15
3038153|NCT01152450|3757563|FG001|STARTED|Period 1 (4 Weeks)||16
3038154|NCT01152450|3757564|FG002|STARTED|Period 1 (4 Weeks)||17
3038155|NCT01152450|3757565|FG003|STARTED|Period 1 (4 Weeks)||15
3038156|NCT01152450|3757566|FG004|STARTED|Period 1 (4 Weeks)||18
3038157|NCT01152450|3757567|FG005|STARTED|Period 1 (4 Weeks)||13
3038158|NCT01152450|3757562|FG000|COMPLETED|Period 1 (4 Weeks)||15
3038159|NCT01152450|3757563|FG001|COMPLETED|Period 1 (4 Weeks)||15
3038160|NCT01152450|3757564|FG002|COMPLETED|Period 1 (4 Weeks)||16
3038161|NCT01152450|3757565|FG003|COMPLETED|Period 1 (4 Weeks)||15
3038162|NCT01152450|3757566|FG004|COMPLETED|Period 1 (4 Weeks)||16
3038163|NCT01152450|3757567|FG005|COMPLETED|Period 1 (4 Weeks)||12
3038164|NCT01152450|3757562|FG000|NOT COMPLETED|Period 1 (4 Weeks)||0
3038165|NCT01152450|3757563|FG001|NOT COMPLETED|Period 1 (4 Weeks)||1
3038166|NCT01152450|3757564|FG002|NOT COMPLETED|Period 1 (4 Weeks)||1
3038167|NCT01152450|3757565|FG003|NOT COMPLETED|Period 1 (4 Weeks)||0
3038168|NCT01152450|3757566|FG004|NOT COMPLETED|Period 1 (4 Weeks)||2
3038169|NCT01152450|3757567|FG005|NOT COMPLETED|Period 1 (4 Weeks)||1
3038170|NCT01152450|3757562|FG000|STARTED|Period 2 (4 Weeks)||15
3038171|NCT01152450|3757563|FG001|STARTED|Period 2 (4 Weeks)||15
3038172|NCT01152450|3757564|FG002|STARTED|Period 2 (4 Weeks)||16
3038173|NCT01152450|3757565|FG003|STARTED|Period 2 (4 Weeks)||15
3038174|NCT01152450|3757566|FG004|STARTED|Period 2 (4 Weeks)||16
3038175|NCT01152450|3757567|FG005|STARTED|Period 2 (4 Weeks)||12
3038176|NCT01152450|3757562|FG000|COMPLETED|Period 2 (4 Weeks)||15
3038177|NCT01152450|3757563|FG001|COMPLETED|Period 2 (4 Weeks)||15
3038178|NCT01152450|3757564|FG002|COMPLETED|Period 2 (4 Weeks)||16
3038179|NCT01152450|3757565|FG003|COMPLETED|Period 2 (4 Weeks)||15
3038180|NCT01152450|3757566|FG004|COMPLETED|Period 2 (4 Weeks)||16
3038181|NCT01152450|3757567|FG005|COMPLETED|Period 2 (4 Weeks)||12
3038182|NCT01152450|3757562|FG000|NOT COMPLETED|Period 2 (4 Weeks)||0
3038183|NCT01152450|3757563|FG001|NOT COMPLETED|Period 2 (4 Weeks)||0
3038184|NCT01152450|3757564|FG002|NOT COMPLETED|Period 2 (4 Weeks)||0
3038185|NCT01152450|3757565|FG003|NOT COMPLETED|Period 2 (4 Weeks)||0
3038186|NCT01152450|3757566|FG004|NOT COMPLETED|Period 2 (4 Weeks)||0
3038187|NCT01152450|3757567|FG005|NOT COMPLETED|Period 2 (4 Weeks)||0
3038188|NCT01152450|3757562|FG000|STARTED|Period 3 (4 Weeks)||15
3038189|NCT01152450|3757563|FG001|STARTED|Period 3 (4 Weeks)||15
3038190|NCT01152450|3757564|FG002|STARTED|Period 3 (4 Weeks)||16
3038191|NCT01152450|3757565|FG003|STARTED|Period 3 (4 Weeks)||15
3038192|NCT01152450|3757566|FG004|STARTED|Period 3 (4 Weeks)||16
3038193|NCT01152450|3757567|FG005|STARTED|Period 3 (4 Weeks)||12
3038194|NCT01152450|3757562|FG000|COMPLETED|Period 3 (4 Weeks)||15
3038195|NCT01152450|3757563|FG001|COMPLETED|Period 3 (4 Weeks)||15
3038196|NCT01152450|3757564|FG002|COMPLETED|Period 3 (4 Weeks)||16
3038197|NCT01152450|3757565|FG003|COMPLETED|Period 3 (4 Weeks)||15
3038198|NCT01152450|3757566|FG004|COMPLETED|Period 3 (4 Weeks)||16
3038199|NCT01152450|3757567|FG005|COMPLETED|Period 3 (4 Weeks)||12
3028553|NCT01101477|3747108|FG000|STARTED|Overall Study||49
3028554|NCT01101477|3747109|FG001|STARTED|Overall Study||49
3028555|NCT01101477|3747110|FG002|STARTED|Overall Study||46
3028556|NCT01101477|3747108|FG000|COMPLETED|Overall Study||44
3028557|NCT01101477|3747109|FG001|COMPLETED|Overall Study||46
3028558|NCT01101477|3747110|FG002|COMPLETED|Overall Study||45
3028559|NCT01101477|3747108|FG000|NOT COMPLETED|Overall Study||5
3028560|NCT01101477|3747109|FG001|NOT COMPLETED|Overall Study||3
3028561|NCT01101477|3747110|FG002|NOT COMPLETED|Overall Study||1
3028562|NCT01101542|3747118|FG000|STARTED|Year 3 Surveillance Period||105
3028563|NCT01101542|3747118|FG000|COMPLETED|Year 3 Surveillance Period||94
3028564|NCT01101542|3747118|FG000|NOT COMPLETED|Year 3 Surveillance Period||11
3028565|NCT01101542|3747118|FG000|STARTED|Year 4 Surveillance Period||569
3028566|NCT01101542|3747118|FG000|COMPLETED|Year 4 Surveillance Period||282
3028567|NCT01101542|3747118|FG000|NOT COMPLETED|Year 4 Surveillance Period||287
3028568|NCT01101542|3747118|FG000|STARTED|Year 5 Surveillance Period||809
3028569|NCT01101542|3747118|FG000|COMPLETED|Year 5 Surveillance Period||668
3028570|NCT01101542|3747118|FG000|NOT COMPLETED|Year 5 Surveillance Period||141
3028571|NCT01101542|3747118|FG000|STARTED|Year 6 Surveillance Period||3091
3028572|NCT01101542|3747118|FG000|COMPLETED|Year 6 Surveillance Period||2100
3028573|NCT01101542|3747118|FG000|NOT COMPLETED|Year 6 Surveillance Period||991
3028574|NCT01101750|3747122|FG000|STARTED|Overall Study||25
3028575|NCT01101750|3747122|FG000|COMPLETED|Overall Study||9
3028576|NCT01101750|3747122|FG000|NOT COMPLETED|Overall Study||16
3028577|NCT01101841|3747128|FG000|STARTED|Overall Study||285
3028578|NCT01101841|3747129|FG001|STARTED|Overall Study||285
3028579|NCT01101841|3747128|FG000|COMPLETED|Overall Study||235
3028580|NCT01101841|3747129|FG001|COMPLETED|Overall Study||218
3028581|NCT01101841|3747128|FG000|NOT COMPLETED|Overall Study||50
3028582|NCT01101841|3747129|FG001|NOT COMPLETED|Overall Study||67
3028583|NCT01101867|3747138|FG000|STARTED|Overall Study||63
3028584|NCT01101867|3747139|FG001|STARTED|Overall Study||63
3028585|NCT01101867|3747138|FG000|COMPLETED|Overall Study||62
3166017|NCT01902628|3893491|FG000|COMPLETED|Overall Study||354
3166018|NCT01902628|3893491|FG000|NOT COMPLETED|Overall Study||83
3166019|NCT01902758|3893497|FG000|STARTED|Overall Study||14
3166020|NCT01902758|3893498|FG001|STARTED|Overall Study||14
3166021|NCT01902758|3893497|FG000|COMPLETED|Overall Study||14
3166022|NCT01902758|3893498|FG001|COMPLETED|Overall Study||14
3028586|NCT01101867|3747139|FG001|COMPLETED|Overall Study||59
3028587|NCT01101867|3747138|FG000|NOT COMPLETED|Overall Study||1
3028588|NCT01101867|3747139|FG001|NOT COMPLETED|Overall Study||4
3028589|NCT01101880|3747149|FG000|STARTED|Overall Study||50
3028590|NCT01101880|3747149|FG000|COMPLETED|Overall Study||50
3028591|NCT01101880|3747149|FG000|NOT COMPLETED|Overall Study||0
3028592|NCT01101958|3747155|FG000|STARTED|Overall Study||62
3028593|NCT01101958|3747156|FG001|STARTED|Overall Study||34
3028594|NCT01101958|3747155|FG000|COMPLETED|Overall Study||51
3028595|NCT01101958|3747156|FG001|COMPLETED|Overall Study||29
3028596|NCT01101958|3747155|FG000|NOT COMPLETED|Overall Study||11
3028597|NCT01101958|3747156|FG001|NOT COMPLETED|Overall Study||5
3028598|NCT01101971|3747162|FG000|STARTED|Overall Study||45
3028599|NCT01101971|3747162|FG000|COMPLETED|Overall Study||45
3028600|NCT01101971|3747162|FG000|NOT COMPLETED|Overall Study||0
3028601|NCT01101997|3747166|FG000|STARTED|Overall Study||60
3028602|NCT01101997|3747166|FG000|COMPLETED|Overall Study||58
3028603|NCT01101997|3747166|FG000|NOT COMPLETED|Overall Study||2
3028604|NCT01102218|3747174|FG000|STARTED|Overall Study||24
3028605|NCT01102218|3747175|FG001|STARTED|Overall Study||24
3028606|NCT01102218|3747174|FG000|COMPLETED|Overall Study||13
3028607|NCT01102218|3747175|FG001|COMPLETED|Overall Study||14
3028608|NCT01102218|3747174|FG000|NOT COMPLETED|Overall Study||11
3028609|NCT01102218|3747175|FG001|NOT COMPLETED|Overall Study||10
3166023|NCT01902758|3893497|FG000|NOT COMPLETED|Overall Study||0
3166024|NCT01902758|3893498|FG001|NOT COMPLETED|Overall Study||0
3166025|NCT01902901|3893506|FG000|STARTED|Overall Study||180
3166026|NCT01902901|3893507|FG001|STARTED|Overall Study||203
3166027|NCT01902901|3893506|FG000|COMPLETED|Overall Study||180
3166028|NCT01902901|3893507|FG001|COMPLETED|Overall Study||201
3166029|NCT01902901|3893506|FG000|NOT COMPLETED|Overall Study||0
3166030|NCT01902901|3893507|FG001|NOT COMPLETED|Overall Study||2
3028610|NCT01102231|3747181|FG000|STARTED|Overall Study||106
3028611|NCT01102231|3747181|FG000|COMPLETED|Overall Study||91
3028612|NCT01102231|3747181|FG000|NOT COMPLETED|Overall Study||15
3028613|NCT01102257|3747188|FG000|STARTED|Overall Study||9
3028614|NCT01102257|3747189|FG001|STARTED|Overall Study||9
3028615|NCT01102257|3747188|FG000|COMPLETED|Overall Study|2 withdrew from the study d/t adverse events. 1 had shortness of breath and the other had chest pain|7
3028616|NCT01102257|3747189|FG001|COMPLETED|Overall Study||9
3166031|NCT01902953|3893513|FG000|STARTED|Overall Study||16
3166032|NCT01902953|3893513|FG000|COMPLETED|Overall Study||16
3166033|NCT01902953|3893513|FG000|NOT COMPLETED|Overall Study||0
3166034|NCT01903005|3893519|FG000|STARTED|Overall Study|Primary study OX219-006 (n=475); Primary study OX219-007 (n=190)|665
3166035|NCT01903005|3893519|FG000|COMPLETED|Overall Study|Primary study OX219-006 (n=194); Primary study OX219-007 (n=98)|292
3166036|NCT01903005|3893519|FG000|NOT COMPLETED|Overall Study||373
3166037|NCT01903031|3893527|FG000|STARTED|Overall Study||27
3166038|NCT01903031|3893528|FG001|STARTED|Overall Study||28
3028617|NCT01102257|3747188|FG000|NOT COMPLETED|Overall Study||2
3028618|NCT01102257|3747189|FG001|NOT COMPLETED|Overall Study||0
3028619|NCT01102270|3747195|FG000|STARTED|Overall Study||8
3028620|NCT01102270|3747196|FG001|STARTED|Overall Study||9
3028621|NCT01102270|3747195|FG000|COMPLETED|Overall Study||8
3028622|NCT01102270|3747196|FG001|COMPLETED|Overall Study||9
3028623|NCT01102270|3747195|FG000|NOT COMPLETED|Overall Study||0
3028624|NCT01102270|3747196|FG001|NOT COMPLETED|Overall Study||0
3166039|NCT01903031|3893529|FG002|STARTED|Overall Study||29
3166040|NCT01903031|3893527|FG000|COMPLETED|Overall Study||25
3309196|NCT03028129|4042541|FG001|NOT COMPLETED|Overall Study||87
3309197|NCT03028142|4042547|FG000|STARTED|Overall Study||5
3028625|NCT01102374|3747204|FG000|STARTED|Overall Study||55
3028626|NCT01102374|3747205|FG001|STARTED|Overall Study||52
3028627|NCT01102374|3747204|FG000|COMPLETED|Overall Study||39
3028628|NCT01102374|3747205|FG001|COMPLETED|Overall Study||33
3028629|NCT01102374|3747204|FG000|NOT COMPLETED|Overall Study||16
3028630|NCT01102374|3747205|FG001|NOT COMPLETED|Overall Study||19
3028631|NCT01102413|3747213|FG000|STARTED|Overall Study||233
3028632|NCT01102413|3747214|FG001|STARTED|Overall Study||118
3028633|NCT01102413|3747213|FG000|COMPLETED|Overall Study||208
3028634|NCT01102413|3747214|FG001|COMPLETED|Overall Study||106
3028635|NCT01102413|3747213|FG000|NOT COMPLETED|Overall Study||25
3028636|NCT01102413|3747214|FG001|NOT COMPLETED|Overall Study||12
3028637|NCT01102426|3747222|FG000|STARTED|Overall Study||171
3028638|NCT01102426|3747223|FG001|STARTED|Overall Study||84
3028639|NCT01102426|3747222|FG000|COMPLETED|Overall Study||6
3028640|NCT01102426|3747223|FG001|COMPLETED|Overall Study||3
3028641|NCT01102426|3747222|FG000|NOT COMPLETED|Overall Study||165
3028642|NCT01102426|3747223|FG001|NOT COMPLETED|Overall Study||81
3028643|NCT01102491|3747231|FG000|STARTED|Overall Study||71
3028644|NCT01102491|3747232|FG001|STARTED|Overall Study||71
3028645|NCT01102491|3747231|FG000|COMPLETED|Overall Study|11 patient excluded|60
3028646|NCT01102491|3747232|FG001|COMPLETED|Overall Study|12 patients were excluded|59
3028647|NCT01102491|3747231|FG000|NOT COMPLETED|Overall Study||11
3028648|NCT01102491|3747232|FG001|NOT COMPLETED|Overall Study||12
3028649|NCT01102738|3747238|FG000|STARTED|Overall Study||369
3028650|NCT01102738|3747238|FG000|COMPLETED|Overall Study||369
3028651|NCT01102738|3747238|FG000|NOT COMPLETED|Overall Study||0
3028652|NCT01102764|3747244|FG000|STARTED|Overall Study||64
3028653|NCT01102764|3747245|FG001|STARTED|Overall Study||68
3028654|NCT01102764|3747244|FG000|COMPLETED|Overall Study||43
3028655|NCT01102764|3747245|FG001|COMPLETED|Overall Study||55
3028656|NCT01102764|3747244|FG000|NOT COMPLETED|Overall Study||21
3028657|NCT01102764|3747245|FG001|NOT COMPLETED|Overall Study||13
3028658|NCT01102777|3747253|FG000|STARTED|Overall Study||84
3028659|NCT01102777|3747254|FG001|STARTED|Overall Study||155
3028660|NCT01102777|3747253|FG000|COMPLETED|Overall Study||75
3028661|NCT01102777|3747254|FG001|COMPLETED|Overall Study||139
3028662|NCT01102777|3747253|FG000|NOT COMPLETED|Overall Study||9
3309198|NCT03028142|4042548|FG001|STARTED|Overall Study||5
3309199|NCT03028142|4042549|FG002|STARTED|Overall Study||6
3309200|NCT03028142|4042550|FG003|STARTED|Overall Study||4
3309201|NCT03028142|4042551|FG004|STARTED|Overall Study||6
3309202|NCT03028142|4042552|FG005|STARTED|Overall Study||4
3309203|NCT03028142|4042547|FG000|COMPLETED|Overall Study||4
3309204|NCT03028142|4042548|FG001|COMPLETED|Overall Study||4
3309205|NCT03028142|4042549|FG002|COMPLETED|Overall Study||6
3309206|NCT03028142|4042550|FG003|COMPLETED|Overall Study||4
3309207|NCT03028142|4042551|FG004|COMPLETED|Overall Study||5
3309208|NCT03028142|4042552|FG005|COMPLETED|Overall Study||3
3309209|NCT03028142|4042547|FG000|NOT COMPLETED|Overall Study||1
3309210|NCT03028142|4042548|FG001|NOT COMPLETED|Overall Study||1
3309211|NCT03028142|4042549|FG002|NOT COMPLETED|Overall Study||0
3309212|NCT03028142|4042550|FG003|NOT COMPLETED|Overall Study||0
3309213|NCT03028142|4042551|FG004|NOT COMPLETED|Overall Study||1
3309214|NCT03028142|4042552|FG005|NOT COMPLETED|Overall Study||1
3309215|NCT03028220|4042563|FG000|STARTED|Overall Study||20
3309216|NCT03028220|4042564|FG001|STARTED|Overall Study||20
3309217|NCT03028220|4042563|FG000|COMPLETED|Overall Study||20
3309218|NCT03028220|4042564|FG001|COMPLETED|Overall Study||20
3309219|NCT03028220|4042563|FG000|NOT COMPLETED|Overall Study||0
3309220|NCT03028220|4042564|FG001|NOT COMPLETED|Overall Study||0
3309221|NCT03028324|4042570|FG000|STARTED|Overall Study||4
3309222|NCT03028324|4042570|FG000|COMPLETED|Overall Study||4
3309223|NCT03028324|4042570|FG000|NOT COMPLETED|Overall Study||0
3309224|NCT03028363|4042576|FG000|STARTED|Overall Study||498
3309225|NCT03028363|4042577|FG001|STARTED|Overall Study||261
3309226|NCT03028363|4042576|FG000|COMPLETED|Overall Study||420
3309227|NCT03028363|4042577|FG001|COMPLETED|Overall Study||228
3309228|NCT03028363|4042576|FG000|NOT COMPLETED|Overall Study||78
3309229|NCT03028363|4042577|FG001|NOT COMPLETED|Overall Study||33
3309230|NCT03028415|4042585|FG000|STARTED|Overall Study||39
3309231|NCT03028415|4042586|FG001|STARTED|Overall Study||17
3309232|NCT03028415|4042585|FG000|Modified Intention-to-treat (mITT) Population|Overall Study||39
3309233|NCT03028415|4042586|FG001|Modified Intention-to-treat (mITT) Population|Overall Study||17
3309234|NCT03028415|4042585|FG000|COMPLETED|Overall Study||31
3309235|NCT03028415|4042586|FG001|COMPLETED|Overall Study||14
3309236|NCT03028415|4042585|FG000|NOT COMPLETED|Overall Study||8
3028663|NCT01102777|3747254|FG001|NOT COMPLETED|Overall Study||16
3166041|NCT01903031|3893528|FG001|COMPLETED|Overall Study||25
3166042|NCT01903031|3893529|FG002|COMPLETED|Overall Study||24
3166043|NCT01903031|3893527|FG000|NOT COMPLETED|Overall Study||2
3309237|NCT03028415|4042586|FG001|NOT COMPLETED|Overall Study||3
3309238|NCT03028467|4042597|FG000|STARTED|Overall Study||4
3028664|NCT01102803|3747263|FG000|STARTED|Baseline to Post-Treatment||14
3028665|NCT01102803|3747264|FG001|STARTED|Baseline to Post-Treatment||15
3028666|NCT01102803|3747263|FG000|COMPLETED|Baseline to Post-Treatment||11
3028667|NCT01102803|3747264|FG001|COMPLETED|Baseline to Post-Treatment||15
3028668|NCT01102803|3747263|FG000|NOT COMPLETED|Baseline to Post-Treatment||3
3028669|NCT01102803|3747264|FG001|NOT COMPLETED|Baseline to Post-Treatment||0
3028670|NCT01102803|3747263|FG000|STARTED|Post to Follow-Up||11
3028671|NCT01102803|3747264|FG001|STARTED|Post to Follow-Up||15
3028672|NCT01102803|3747263|FG000|COMPLETED|Post to Follow-Up||10
3028673|NCT01102803|3747264|FG001|COMPLETED|Post to Follow-Up||12
3028674|NCT01102803|3747263|FG000|NOT COMPLETED|Post to Follow-Up||1
3028675|NCT01102803|3747264|FG001|NOT COMPLETED|Post to Follow-Up||3
3028676|NCT01102894|3747272|FG000|STARTED|Overall Study||10
3028677|NCT01102894|3747272|FG000|COMPLETED|Overall Study||10
3028678|NCT01102894|3747272|FG000|NOT COMPLETED|Overall Study||0
3028679|NCT01102972|3747280|FG000|STARTED|Overall Study|"297 PAR enrolled. 1 PAR withdrew before taking investigational product and didn't start the study."|199
3028680|NCT01102972|3747281|FG001|STARTED|Overall Study|"297 PAR enrolled. 1 PAR withdrew before taking investigational product and didn't start the study."|97
3028681|NCT01102972|3747280|FG000|Completed Week 24|Overall Study||180
3028682|NCT01102972|3747281|FG001|Completed Week 24|Overall Study||88
3028683|NCT01102972|3747280|FG000|COMPLETED|Overall Study|These participants completed Study Week 48.|170
3028684|NCT01102972|3747281|FG001|COMPLETED|Overall Study|These participants completed Study Week 48.|83
3028685|NCT01102972|3747280|FG000|NOT COMPLETED|Overall Study||29
3028686|NCT01102972|3747281|FG001|NOT COMPLETED|Overall Study||14
3028687|NCT01103063|3747289|FG000|STARTED|Overall Study||1446
3028688|NCT01103063|3747290|FG001|STARTED|Overall Study||1445
3028689|NCT01103063|3747289|FG000|COMPLETED|Overall Study||969
3028690|NCT01103063|3747290|FG001|COMPLETED|Overall Study||1024
3028691|NCT01103063|3747289|FG000|NOT COMPLETED|Overall Study||477
3028692|NCT01103063|3747290|FG001|NOT COMPLETED|Overall Study||421
3028693|NCT01103141|3747300|FG000|STARTED|Overall Study||67
3028694|NCT01103141|3747301|FG001|STARTED|Overall Study||76
3028695|NCT01103141|3747300|FG000|COMPLETED|Overall Study||65
3028696|NCT01103141|3747301|FG001|COMPLETED|Overall Study||74
3028697|NCT01103141|3747300|FG000|NOT COMPLETED|Overall Study||2
3028698|NCT01103141|3747301|FG001|NOT COMPLETED|Overall Study||2
3028699|NCT01103232|3747309|FG000|STARTED|Overall Study||13
3028700|NCT01103232|3747310|FG001|STARTED|Overall Study||13
3028701|NCT01103232|3747309|FG000|COMPLETED|Overall Study||12
3028702|NCT01103232|3747310|FG001|COMPLETED|Overall Study||11
3028703|NCT01103232|3747309|FG000|NOT COMPLETED|Overall Study||1
3028704|NCT01103232|3747310|FG001|NOT COMPLETED|Overall Study||2
3028705|NCT01103245|3747320|FG000|STARTED|Overall Study||13
3028706|NCT01103245|3747321|FG001|STARTED|Overall Study||7
3028707|NCT01103245|3747322|FG002|STARTED|Overall Study||12
3309239|NCT03028467|4042598|FG001|STARTED|Overall Study||3
3309240|NCT03028467|4042599|FG002|STARTED|Overall Study||4
3309241|NCT03028467|4042600|FG003|STARTED|Overall Study||4
3309242|NCT03028467|4042597|FG000|COMPLETED|Overall Study||4
3309243|NCT03028467|4042598|FG001|COMPLETED|Overall Study||3
3309244|NCT03028467|4042599|FG002|COMPLETED|Overall Study||4
3309245|NCT03028467|4042600|FG003|COMPLETED|Overall Study||4
3309246|NCT03028467|4042597|FG000|NOT COMPLETED|Overall Study||0
3309247|NCT03028467|4042598|FG001|NOT COMPLETED|Overall Study||0
3309248|NCT03028467|4042599|FG002|NOT COMPLETED|Overall Study||0
3309249|NCT03028467|4042600|FG003|NOT COMPLETED|Overall Study||0
3309250|NCT03028636|4042613|FG000|STARTED|Overall Study||17
3309251|NCT03028636|4042613|FG000|COMPLETED|Overall Study||11
3309252|NCT03028636|4042613|FG000|NOT COMPLETED|Overall Study||6
3309253|NCT03028870|4042626|FG000|STARTED|Overall Study||74
3309254|NCT03028870|4042627|FG001|STARTED|Overall Study||67
3309255|NCT03028870|4042628|FG002|STARTED|Overall Study||76
3309256|NCT03028870|4042629|FG003|STARTED|Overall Study||74
3309257|NCT03028870|4042626|FG000|COMPLETED|Overall Study||57
3309258|NCT03028870|4042627|FG001|COMPLETED|Overall Study||57
3309259|NCT03028870|4042628|FG002|COMPLETED|Overall Study||60
3309260|NCT03028870|4042629|FG003|COMPLETED|Overall Study||65
3309261|NCT03028870|4042626|FG000|NOT COMPLETED|Overall Study||17
3309262|NCT03028870|4042627|FG001|NOT COMPLETED|Overall Study||10
3309263|NCT03028870|4042628|FG002|NOT COMPLETED|Overall Study||16
3309264|NCT03028870|4042629|FG003|NOT COMPLETED|Overall Study||9
3309265|NCT03028974|4042644|FG000|STARTED|2014-2015||1
3309266|NCT03028974|4042645|FG001|STARTED|2014-2015||0
3309267|NCT03028974|4042646|FG002|STARTED|2014-2015||0
3309268|NCT03028974|4042647|FG003|STARTED|2014-2015||3
3309269|NCT03028974|4042648|FG004|STARTED|2014-2015||0
3309270|NCT03028974|4042649|FG005|STARTED|2014-2015||11
3309271|NCT03028974|4042650|FG006|STARTED|2014-2015||13
3309272|NCT03028974|4042644|FG000|COMPLETED|2014-2015||1
3309273|NCT03028974|4042645|FG001|COMPLETED|2014-2015||0
3309274|NCT03028974|4042646|FG002|COMPLETED|2014-2015||0
3309275|NCT03028974|4042647|FG003|COMPLETED|2014-2015||3
3309276|NCT03028974|4042648|FG004|COMPLETED|2014-2015||0
3309277|NCT03028974|4042649|FG005|COMPLETED|2014-2015|2 participants did not continue to the next period.|11
3309278|NCT03028974|4042650|FG006|COMPLETED|2014-2015|13 participants did not continue to the next period.|13
3309279|NCT03028974|4042644|FG000|NOT COMPLETED|2014-2015||0
3309280|NCT03028974|4042645|FG001|NOT COMPLETED|2014-2015||0
3309281|NCT03028974|4042646|FG002|NOT COMPLETED|2014-2015||0
3028708|NCT01103245|3747323|FG003|STARTED|Overall Study||6
3309282|NCT03028974|4042647|FG003|NOT COMPLETED|2014-2015||0
3028709|NCT01103245|3747320|FG000|COMPLETED|Overall Study||10
3028710|NCT01103245|3747321|FG001|COMPLETED|Overall Study||5
3028711|NCT01103245|3747322|FG002|COMPLETED|Overall Study||8
3028712|NCT01103245|3747323|FG003|COMPLETED|Overall Study||6
3028713|NCT01103245|3747320|FG000|NOT COMPLETED|Overall Study||3
3028714|NCT01103245|3747321|FG001|NOT COMPLETED|Overall Study||2
3028715|NCT01103245|3747322|FG002|NOT COMPLETED|Overall Study||4
3028716|NCT01103245|3747323|FG003|NOT COMPLETED|Overall Study||0
3028717|NCT01103271|3747335|FG000|STARTED|Overall Study||11
3028718|NCT01103271|3747336|FG001|STARTED|Overall Study||9
3028719|NCT01103271|3747335|FG000|COMPLETED|Overall Study||10
3028720|NCT01103271|3747336|FG001|COMPLETED|Overall Study||5
3028721|NCT01103271|3747335|FG000|NOT COMPLETED|Overall Study||1
3028722|NCT01103271|3747336|FG001|NOT COMPLETED|Overall Study||4
3028723|NCT01103284|3747345|FG000|STARTED|Overall Study||236
3028724|NCT01103284|3747346|FG001|STARTED|Overall Study||239
3028725|NCT01103284|3747345|FG000|Treated|Overall Study||236
3028726|NCT01103284|3747346|FG001|Treated|Overall Study||238
3028727|NCT01103284|3747345|FG000|At Least One Post-baseline Visit (FAS)|Overall Study|Patients reaching this milestone were included in the Full Analysis Set (FAS) population|233
3028728|NCT01103284|3747346|FG001|At Least One Post-baseline Visit (FAS)|Overall Study|Patients reaching this milestone were included in the Full Analysis Set (FAS)|235
3028729|NCT01103284|3747345|FG000|COMPLETED|Overall Study||194
3028730|NCT01103284|3747346|FG001|COMPLETED|Overall Study||195
3028731|NCT01103284|3747345|FG000|NOT COMPLETED|Overall Study||42
3028732|NCT01103284|3747346|FG001|NOT COMPLETED|Overall Study||44
3028733|NCT01103323|3747354|FG000|STARTED|Without/Before Drug Switch||505
3028734|NCT01103323|3747355|FG001|STARTED|Without/Before Drug Switch||255
3028735|NCT01103323|3747354|FG000|Participants Received Treatment|Without/Before Drug Switch||500
3028736|NCT01103323|3747355|FG001|Participants Received Treatment|Without/Before Drug Switch||253
3028737|NCT01103323|3747354|FG000|COMPLETED|Without/Before Drug Switch||429
3028738|NCT01103323|3747355|FG001|COMPLETED|Without/Before Drug Switch||237
3028739|NCT01103323|3747354|FG000|NOT COMPLETED|Without/Before Drug Switch||76
3028740|NCT01103323|3747355|FG001|NOT COMPLETED|Without/Before Drug Switch||18
3028741|NCT01103323|3747354|FG000|STARTED|Switched From Placebo to Regorafenib||0
3028742|NCT01103323|3747355|FG001|STARTED|Switched From Placebo to Regorafenib|Participants in the placebo+BSC group switched to Regorafenib treatment after unblinding.|4
3028743|NCT01103323|3747354|FG000|COMPLETED|Switched From Placebo to Regorafenib||0
3028744|NCT01103323|3747355|FG001|COMPLETED|Switched From Placebo to Regorafenib||3
3028745|NCT01103323|3747354|FG000|NOT COMPLETED|Switched From Placebo to Regorafenib||0
3028746|NCT01103323|3747355|FG001|NOT COMPLETED|Switched From Placebo to Regorafenib||1
3028747|NCT01103362|3747362|FG000|STARTED|Overall Study||596
3028748|NCT01103362|3747362|FG000|COMPLETED|Overall Study||0
3028749|NCT01103362|3747362|FG000|NOT COMPLETED|Overall Study||596
3028750|NCT01103414|3747371|FG000|STARTED|Overall Study||72
3028751|NCT01103414|3747372|FG001|STARTED|Overall Study||71
3028752|NCT01103414|3747373|FG002|STARTED|Overall Study||71
3028753|NCT01103414|3747374|FG003|STARTED|Overall Study||71
3028754|NCT01103414|3747375|FG004|STARTED|Overall Study||71
3028755|NCT01103414|3747371|FG000|COMPLETED|Overall Study||59
3028756|NCT01103414|3747372|FG001|COMPLETED|Overall Study||62
3028757|NCT01103414|3747373|FG002|COMPLETED|Overall Study||56
3028758|NCT01103414|3747374|FG003|COMPLETED|Overall Study||64
3028759|NCT01103414|3747375|FG004|COMPLETED|Overall Study||56
3028760|NCT01103414|3747371|FG000|NOT COMPLETED|Overall Study||13
3028761|NCT01103414|3747372|FG001|NOT COMPLETED|Overall Study||9
3028762|NCT01103414|3747373|FG002|NOT COMPLETED|Overall Study||15
3028763|NCT01103414|3747374|FG003|NOT COMPLETED|Overall Study||7
3028764|NCT01103414|3747375|FG004|NOT COMPLETED|Overall Study||15
3028765|NCT01103440|3747389|FG000|STARTED|Overall Study||18
3028766|NCT01103440|3747390|FG001|STARTED|Overall Study||18
3028767|NCT01103440|3747389|FG000|COMPLETED|Overall Study||18
3028768|NCT01103440|3747390|FG001|COMPLETED|Overall Study||18
3028769|NCT01103440|3747389|FG000|NOT COMPLETED|Overall Study||0
3028770|NCT01103440|3747390|FG001|NOT COMPLETED|Overall Study||0
3028771|NCT01103466|3747396|FG000|STARTED|First Period (14 +/- 3 Days)||12
3028772|NCT01103466|3747397|FG001|STARTED|First Period (14 +/- 3 Days)||12
3028773|NCT01103466|3747398|FG002|STARTED|First Period (14 +/- 3 Days)||13
3028774|NCT01103466|3747396|FG000|COMPLETED|First Period (14 +/- 3 Days)||10
3028775|NCT01103466|3747397|FG001|COMPLETED|First Period (14 +/- 3 Days)||12
3028776|NCT01103466|3747398|FG002|COMPLETED|First Period (14 +/- 3 Days)||13
3028777|NCT01103466|3747396|FG000|NOT COMPLETED|First Period (14 +/- 3 Days)||2
3028778|NCT01103466|3747397|FG001|NOT COMPLETED|First Period (14 +/- 3 Days)||0
3028779|NCT01103466|3747398|FG002|NOT COMPLETED|First Period (14 +/- 3 Days)||0
3028780|NCT01103466|3747396|FG000|STARTED|Second Period (14 +/- 3 Days)||15
3028781|NCT01103466|3747397|FG001|STARTED|Second Period (14 +/- 3 Days)||13
3028782|NCT01103466|3747398|FG002|STARTED|Second Period (14 +/- 3 Days)||7
3028783|NCT01103466|3747396|FG000|COMPLETED|Second Period (14 +/- 3 Days)||13
3028784|NCT01103466|3747397|FG001|COMPLETED|Second Period (14 +/- 3 Days)||11
3028785|NCT01103466|3747398|FG002|COMPLETED|Second Period (14 +/- 3 Days)||6
3028786|NCT01103466|3747396|FG000|NOT COMPLETED|Second Period (14 +/- 3 Days)||2
3028787|NCT01103466|3747397|FG001|NOT COMPLETED|Second Period (14 +/- 3 Days)||2
3028788|NCT01103466|3747398|FG002|NOT COMPLETED|Second Period (14 +/- 3 Days)||1
3028789|NCT01103466|3747396|FG000|STARTED|Third Period (14 +/- 3 Days)||8
3028790|NCT01103466|3747397|FG001|STARTED|Third Period (14 +/- 3 Days)||8
3028791|NCT01103466|3747398|FG002|STARTED|Third Period (14 +/- 3 Days)||14
3028792|NCT01103466|3747396|FG000|COMPLETED|Third Period (14 +/- 3 Days)||6
3028793|NCT01103466|3747397|FG001|COMPLETED|Third Period (14 +/- 3 Days)||8
3028794|NCT01103466|3747398|FG002|COMPLETED|Third Period (14 +/- 3 Days)||13
3028795|NCT01103466|3747396|FG000|NOT COMPLETED|Third Period (14 +/- 3 Days)||2
3028796|NCT01103466|3747397|FG001|NOT COMPLETED|Third Period (14 +/- 3 Days)||0
3028797|NCT01103466|3747398|FG002|NOT COMPLETED|Third Period (14 +/- 3 Days)||1
3028798|NCT01103479|3747409|FG000|STARTED|Overall Study||168
3028799|NCT01103479|3747410|FG001|STARTED|Overall Study||210
3028800|NCT01103479|3747411|FG002|STARTED|Overall Study||188
3028801|NCT01103479|3747409|FG000|COMPLETED|Overall Study||163
3028802|NCT01103479|3747410|FG001|COMPLETED|Overall Study||201
3028803|NCT01103479|3747411|FG002|COMPLETED|Overall Study||174
3028804|NCT01103479|3747409|FG000|NOT COMPLETED|Overall Study||5
3028805|NCT01103479|3747410|FG001|NOT COMPLETED|Overall Study||9
3028806|NCT01103479|3747411|FG002|NOT COMPLETED|Overall Study||14
3028807|NCT01103492|3747420|FG000|STARTED|Overall Study||1
3028808|NCT01103492|3747420|FG000|COMPLETED|Overall Study||1
3028809|NCT01103492|3747420|FG000|NOT COMPLETED|Overall Study||0
3028810|NCT01103505|3747426|FG000|STARTED|Overall Study||763
3028811|NCT01103505|3747427|FG001|STARTED|Overall Study||757
3028812|NCT01103505|3747426|FG000|COMPLETED|Overall Study||739
3028813|NCT01103505|3747427|FG001|COMPLETED|Overall Study||737
3028814|NCT01103505|3747426|FG000|NOT COMPLETED|Overall Study||24
3028815|NCT01103505|3747427|FG001|NOT COMPLETED|Overall Study||20
3028816|NCT01103713|3747441|FG000|STARTED|Overall Study||168
3028817|NCT01103713|3747441|FG000|COMPLETED|Overall Study||155
3028818|NCT01103713|3747441|FG000|NOT COMPLETED|Overall Study||13
3028819|NCT01103778|3747448|FG000|STARTED|Overall Study||11
3028820|NCT01103778|3747448|FG000|COMPLETED|Overall Study||8
3028821|NCT01103778|3747448|FG000|NOT COMPLETED|Overall Study||3
3028822|NCT01103934|3747456|FG000|STARTED|Overall Study||17
3028823|NCT01103934|3747457|FG001|STARTED|Overall Study||18
3028824|NCT01103934|3747456|FG000|COMPLETED|Overall Study||17
3028825|NCT01103934|3747457|FG001|COMPLETED|Overall Study||18
3028826|NCT01103934|3747456|FG000|NOT COMPLETED|Overall Study||0
3028827|NCT01103934|3747457|FG001|NOT COMPLETED|Overall Study||0
3028828|NCT01103960|3747465|FG000|STARTED|Overall Study|Randomised and treated.|164
3028829|NCT01103960|3747466|FG001|STARTED|Overall Study|Randomised and treated.|160
3028830|NCT01103960|3747465|FG000|COMPLETED|Overall Study|Completed study medication.|159
3028831|NCT01103960|3747466|FG001|COMPLETED|Overall Study|Completed study medication.|158
3028832|NCT01103960|3747465|FG000|NOT COMPLETED|Overall Study||5
3028833|NCT01103960|3747466|FG001|NOT COMPLETED|Overall Study||2
3028834|NCT01103973|3747474|FG000|STARTED|Overall Study||51
3028835|NCT01103973|3747475|FG001|STARTED|Overall Study||46
3309283|NCT03028974|4042648|FG004|NOT COMPLETED|2014-2015||0
3309284|NCT03028974|4042649|FG005|NOT COMPLETED|2014-2015||0
3309285|NCT03028974|4042650|FG006|NOT COMPLETED|2014-2015||0
3309286|NCT03028974|4042644|FG000|STARTED|2015-2016||0
3309287|NCT03028974|4042645|FG001|STARTED|2015-2016||0
3309288|NCT03028974|4042646|FG002|STARTED|2015-2016||0
3309289|NCT03028974|4042647|FG003|STARTED|2015-2016|One participant joined from Group A, 2 new were enrolled.|6
3309290|NCT03028974|4042648|FG004|STARTED|2015-2016||0
3309291|NCT03028974|4042649|FG005|STARTED|2015-2016|10 new participants were enrolled; 4 subjects switched from Group G.|14
3309292|NCT03028974|4042650|FG006|STARTED|2015-2016|11 new participants were enrolled; 9 subjects switched from Group F.|20
3309293|NCT03028974|4042644|FG000|COMPLETED|2015-2016||0
3309294|NCT03028974|4042645|FG001|COMPLETED|2015-2016||0
3309295|NCT03028974|4042646|FG002|COMPLETED|2015-2016||0
3309296|NCT03028974|4042647|FG003|COMPLETED|2015-2016|3 participants did not continue to the next period. 1 Participant returned in period 4 (2017-2018).|6
3309297|NCT03028974|4042648|FG004|COMPLETED|2015-2016||0
3309298|NCT03028974|4042649|FG005|COMPLETED|2015-2016|14 participants did not continue to the next period.|14
3309299|NCT03028974|4042650|FG006|COMPLETED|2015-2016|20 participants did not continue to the next period.|20
3309300|NCT03028974|4042644|FG000|NOT COMPLETED|2015-2016||0
3309301|NCT03028974|4042645|FG001|NOT COMPLETED|2015-2016||0
3309302|NCT03028974|4042646|FG002|NOT COMPLETED|2015-2016||0
3309303|NCT03028974|4042647|FG003|NOT COMPLETED|2015-2016||0
3309304|NCT03028974|4042648|FG004|NOT COMPLETED|2015-2016||0
3309305|NCT03028974|4042649|FG005|NOT COMPLETED|2015-2016||0
3309306|NCT03028974|4042650|FG006|NOT COMPLETED|2015-2016||0
3309307|NCT03028974|4042644|FG000|STARTED|2016-2017||0
3309308|NCT03028974|4042645|FG001|STARTED|2016-2017||0
3309309|NCT03028974|4042646|FG002|STARTED|2016-2017||0
3309310|NCT03028974|4042647|FG003|STARTED|2016-2017|1 new participant was enrolled.|4
3309311|NCT03028974|4042648|FG004|STARTED|2016-2017|2 new participants were enrolled.|2
3309312|NCT03028974|4042649|FG005|STARTED|2016-2017||0
3309313|NCT03028974|4042650|FG006|STARTED|2016-2017|18 new participants were enrolled.|18
3309314|NCT03028974|4042644|FG000|COMPLETED|2016-2017||0
3309315|NCT03028974|4042645|FG001|COMPLETED|2016-2017||0
3309316|NCT03028974|4042646|FG002|COMPLETED|2016-2017||0
3309317|NCT03028974|4042647|FG003|COMPLETED|2016-2017||4
3309318|NCT03028974|4042648|FG004|COMPLETED|2016-2017|2 participants did not continue to the next period|2
3309319|NCT03028974|4042649|FG005|COMPLETED|2016-2017||0
3309320|NCT03028974|4042650|FG006|COMPLETED|2016-2017|18 participants did not continue to the next period.|18
3309321|NCT03028974|4042644|FG000|NOT COMPLETED|2016-2017||0
3028836|NCT01103973|3747474|FG000|COMPLETED|Overall Study||51
3028837|NCT01103973|3747475|FG001|COMPLETED|Overall Study||46
3028838|NCT01103973|3747474|FG000|NOT COMPLETED|Overall Study||0
3028839|NCT01103973|3747475|FG001|NOT COMPLETED|Overall Study||0
3028840|NCT01104025|3747481|FG000|STARTED|Treatment Period||31
3028841|NCT01104025|3747481|FG000|COMPLETED|Treatment Period||25
3028842|NCT01104025|3747481|FG000|NOT COMPLETED|Treatment Period||6
3028843|NCT01104025|3747481|FG000|STARTED|Follow up Until BMT OR 6 Months||25
3028844|NCT01104025|3747481|FG000|COMPLETED|Follow up Until BMT OR 6 Months||22
3028845|NCT01104025|3747481|FG000|NOT COMPLETED|Follow up Until BMT OR 6 Months||3
3028846|NCT01104025|3747481|FG000|STARTED|Follow up Until Day 100 Post BMT|only 11 participants proceeded to BMT; 14 did not|11
3028847|NCT01104025|3747481|FG000|COMPLETED|Follow up Until Day 100 Post BMT||9
3028848|NCT01104025|3747481|FG000|NOT COMPLETED|Follow up Until Day 100 Post BMT||2
3028849|NCT01104090|3747487|FG000|STARTED|Overall Study||25
3028850|NCT01104090|3747488|FG001|STARTED|Overall Study||25
3028851|NCT01104090|3747487|FG000|COMPLETED|Overall Study||25
3028852|NCT01104090|3747488|FG001|COMPLETED|Overall Study||25
3028853|NCT01104090|3747487|FG000|NOT COMPLETED|Overall Study||0
3028854|NCT01104090|3747488|FG001|NOT COMPLETED|Overall Study||0
3028855|NCT01104103|3747498|FG000|STARTED|Overall Study||243
3028856|NCT01104103|3747499|FG001|STARTED|Overall Study||224
3028857|NCT01104103|3747498|FG000|COMPLETED|Overall Study||243
3028858|NCT01104103|3747499|FG001|COMPLETED|Overall Study||224
3028859|NCT01104103|3747498|FG000|NOT COMPLETED|Overall Study||0
3028860|NCT01104103|3747499|FG001|NOT COMPLETED|Overall Study||0
3028861|NCT01104155|3747507|FG000|STARTED|Overall Study||63
3028862|NCT01104155|3747508|FG001|STARTED|Overall Study||60
3028863|NCT01104155|3747507|FG000|COMPLETED|Overall Study||38
3028864|NCT01104155|3747508|FG001|COMPLETED|Overall Study||42
3028865|NCT01104155|3747507|FG000|NOT COMPLETED|Overall Study||25
3028866|NCT01104155|3747508|FG001|NOT COMPLETED|Overall Study||18
3028867|NCT01104207|3747516|FG000|STARTED|Overall Study||35
3028868|NCT01104207|3747517|FG001|STARTED|Overall Study||35
3028869|NCT01104207|3747516|FG000|COMPLETED|Overall Study||32
3028870|NCT01104207|3747517|FG001|COMPLETED|Overall Study||32
3028871|NCT01104207|3747516|FG000|NOT COMPLETED|Overall Study||3
3028872|NCT01104207|3747517|FG001|NOT COMPLETED|Overall Study||3
3028873|NCT01104246|3747523|FG000|STARTED|Overall Study||40
3028874|NCT01104246|3747523|FG000|Baseline Characteristics Measured|Overall Study||35
3028875|NCT01104246|3747523|FG000|COMPLETED|Overall Study||35
3028876|NCT01104246|3747523|FG000|NOT COMPLETED|Overall Study||5
3028877|NCT01104285|3747529|FG000|STARTED|Overall Study||112
3028878|NCT01104285|3747530|FG001|STARTED|Overall Study||86
3028879|NCT01104285|3747529|FG000|COMPLETED|Overall Study||112
3028880|NCT01104285|3747530|FG001|COMPLETED|Overall Study||86
3028881|NCT01104285|3747529|FG000|NOT COMPLETED|Overall Study||0
3028882|NCT01104285|3747530|FG001|NOT COMPLETED|Overall Study||0
3028883|NCT01104311|3747538|FG000|STARTED|Overall Study||66
3028884|NCT01104311|3747539|FG001|STARTED|Overall Study||66
3028885|NCT01104311|3747538|FG000|COMPLETED|Overall Study||56
3028886|NCT01104311|3747539|FG001|COMPLETED|Overall Study||54
3028887|NCT01104311|3747538|FG000|NOT COMPLETED|Overall Study||10
3028888|NCT01104311|3747539|FG001|NOT COMPLETED|Overall Study||12
3028889|NCT01104376|3747549|FG000|STARTED|Overall Study||89
3028890|NCT01104376|3747549|FG000|COMPLETED|Overall Study||61
3028891|NCT01104376|3747549|FG000|NOT COMPLETED|Overall Study||28
3028892|NCT01104402|3747555|FG000|STARTED|Overall Study||132
3028893|NCT01104402|3747556|FG001|STARTED|Overall Study||135
3028894|NCT01104402|3747555|FG000|COMPLETED|Overall Study||111
3028895|NCT01104402|3747556|FG001|COMPLETED|Overall Study||102
3028896|NCT01104402|3747555|FG000|NOT COMPLETED|Overall Study||21
3028897|NCT01104402|3747556|FG001|NOT COMPLETED|Overall Study||33
3028898|NCT01104415|3747562|FG000|STARTED|Core Phase||15
3028899|NCT01104415|3747563|FG001|STARTED|Core Phase||0
3309322|NCT03028974|4042645|FG001|NOT COMPLETED|2016-2017||0
3309323|NCT03028974|4042646|FG002|NOT COMPLETED|2016-2017||0
3309324|NCT03028974|4042647|FG003|NOT COMPLETED|2016-2017||0
3309325|NCT03028974|4042648|FG004|NOT COMPLETED|2016-2017||0
3309326|NCT03028974|4042649|FG005|NOT COMPLETED|2016-2017||0
3309327|NCT03028974|4042650|FG006|NOT COMPLETED|2016-2017||0
3309328|NCT03028974|4042644|FG000|STARTED|2017-2018||0
3309329|NCT03028974|4042645|FG001|STARTED|2017-2018||0
3309330|NCT03028974|4042646|FG002|STARTED|2017-2018||0
3309331|NCT03028974|4042647|FG003|STARTED|2017-2018||5
3309332|NCT03028974|4042648|FG004|STARTED|2017-2018||0
3028900|NCT01104415|3747562|FG000|COMPLETED|Core Phase||14
3028901|NCT01104415|3747563|FG001|COMPLETED|Core Phase||0
3028902|NCT01104415|3747562|FG000|NOT COMPLETED|Core Phase||1
3028903|NCT01104415|3747563|FG001|NOT COMPLETED|Core Phase||0
3028904|NCT01104415|3747562|FG000|STARTED|Extension Period||0
3028905|NCT01104415|3747563|FG001|STARTED|Extension Period|Out of 14 participants who completed Core Phase, 3 were not eligible to enter the Extension Period.|11
3028906|NCT01104415|3747562|FG000|COMPLETED|Extension Period||0
3028907|NCT01104415|3747563|FG001|COMPLETED|Extension Period||0
3028908|NCT01104415|3747562|FG000|NOT COMPLETED|Extension Period||0
3028909|NCT01104415|3747563|FG001|NOT COMPLETED|Extension Period||11
3028910|NCT01104493|3747572|FG000|STARTED|Overall Study||240
3028911|NCT01104493|3747573|FG001|STARTED|Overall Study||60
3028912|NCT01104493|3747572|FG000|COMPLETED|Overall Study||240
3028913|NCT01104493|3747573|FG001|COMPLETED|Overall Study||58
3028914|NCT01104493|3747572|FG000|NOT COMPLETED|Overall Study||0
3028915|NCT01104493|3747573|FG001|NOT COMPLETED|Overall Study||2
3028916|NCT01104545|3747582|FG000|STARTED|Overall Study||8
3309333|NCT03028974|4042649|FG005|STARTED|2017-2018||0
3028917|NCT01104545|3747583|FG001|STARTED|Overall Study||8
3028918|NCT01104545|3747584|FG002|STARTED|Overall Study|1 participant received 0.50 mg of MK-3614 or placebo in Periods 3 and 4 instead of planned 0.75 mg|8
3028919|NCT01104545|3747582|FG000|COMPLETED|Overall Study||8
3028920|NCT01104545|3747583|FG001|COMPLETED|Overall Study|Participant discontinued after receiving 0.75 mg MK-3614 in Period 1|7
3028921|NCT01104545|3747584|FG002|COMPLETED|Overall Study|Participants discontinued after receiving MK-3614 0.75 mg (Period 1)and placebo (Period 2)|6
3028922|NCT01104545|3747582|FG000|NOT COMPLETED|Overall Study||0
3028923|NCT01104545|3747583|FG001|NOT COMPLETED|Overall Study||1
3028924|NCT01104545|3747584|FG002|NOT COMPLETED|Overall Study||2
3028925|NCT01104558|3747629|FG000|STARTED|Overall Study||100
3028926|NCT01104558|3747629|FG000|COMPLETED|Overall Study||83
3028927|NCT01104558|3747629|FG000|NOT COMPLETED|Overall Study||17
3028928|NCT01104584|3747633|FG000|STARTED|Overall Study|screened and enrolled|460
3028929|NCT01104584|3747633|FG000|Received Treatment|Overall Study|treatment started|439
3028930|NCT01104584|3747633|FG000|Fulfilled Requirements of FAS Population|Overall Study||397
3028931|NCT01104584|3747633|FG000|COMPLETED|Overall Study|study course completed|437
3028932|NCT01104584|3747633|FG000|NOT COMPLETED|Overall Study||23
3028933|NCT01104636|3747655|FG000|STARTED|Overall Study||1177
3028934|NCT01104636|3747655|FG000|COMPLETED|Overall Study||999
3028935|NCT01104636|3747655|FG000|NOT COMPLETED|Overall Study||178
3028936|NCT01104662|3747667|FG000|STARTED|Overall Study||20
3028937|NCT01104662|3747668|FG001|STARTED|Overall Study||21
3028938|NCT01104662|3747669|FG002|STARTED|Overall Study||5
3028939|NCT01104662|3747670|FG003|STARTED|Overall Study||4
3028940|NCT01104662|3747671|FG004|STARTED|Overall Study||15
3028941|NCT01104662|3747672|FG005|STARTED|Overall Study||16
3028942|NCT01104662|3747673|FG006|STARTED|Overall Study||5
3028943|NCT01104662|3747674|FG007|STARTED|Overall Study||6
3028944|NCT01104662|3747667|FG000|Received at Least 1 Dose of Study Drug|Overall Study||17
3028945|NCT01104662|3747668|FG001|Received at Least 1 Dose of Study Drug|Overall Study||17
3028946|NCT01104662|3747669|FG002|Received at Least 1 Dose of Study Drug|Overall Study||4
3028947|NCT01104662|3747670|FG003|Received at Least 1 Dose of Study Drug|Overall Study||4
3028948|NCT01104662|3747671|FG004|Received at Least 1 Dose of Study Drug|Overall Study||15
3028949|NCT01104662|3747672|FG005|Received at Least 1 Dose of Study Drug|Overall Study||15
3028950|NCT01104662|3747673|FG006|Received at Least 1 Dose of Study Drug|Overall Study||5
3028951|NCT01104662|3747674|FG007|Received at Least 1 Dose of Study Drug|Overall Study||6
3028952|NCT01104662|3747667|FG000|COMPLETED|Overall Study||10
3028953|NCT01104662|3747668|FG001|COMPLETED|Overall Study||11
3028954|NCT01104662|3747669|FG002|COMPLETED|Overall Study||4
3028955|NCT01104662|3747670|FG003|COMPLETED|Overall Study||3
3028956|NCT01104662|3747671|FG004|COMPLETED|Overall Study||14
3028957|NCT01104662|3747672|FG005|COMPLETED|Overall Study||12
3028958|NCT01104662|3747673|FG006|COMPLETED|Overall Study||5
3028959|NCT01104662|3747674|FG007|COMPLETED|Overall Study||6
3028960|NCT01104662|3747667|FG000|NOT COMPLETED|Overall Study||10
3028961|NCT01104662|3747668|FG001|NOT COMPLETED|Overall Study||10
3028962|NCT01104662|3747669|FG002|NOT COMPLETED|Overall Study||1
3028963|NCT01104662|3747670|FG003|NOT COMPLETED|Overall Study||1
3028964|NCT01104662|3747671|FG004|NOT COMPLETED|Overall Study||1
3028965|NCT01104662|3747672|FG005|NOT COMPLETED|Overall Study||4
3028966|NCT01104662|3747673|FG006|NOT COMPLETED|Overall Study||0
3028967|NCT01104662|3747674|FG007|NOT COMPLETED|Overall Study||0
3028968|NCT01104701|3747697|FG000|STARTED|Overall Study||30
3028969|NCT01104701|3747698|FG001|STARTED|Overall Study||30
3028970|NCT01104701|3747699|FG002|STARTED|Overall Study||31
3028971|NCT01104701|3747700|FG003|STARTED|Overall Study||30
3028972|NCT01104701|3747697|FG000|COMPLETED|Overall Study||30
3028973|NCT01104701|3747698|FG001|COMPLETED|Overall Study||27
3028974|NCT01104701|3747699|FG002|COMPLETED|Overall Study||29
3028975|NCT01104701|3747700|FG003|COMPLETED|Overall Study||28
3028976|NCT01104701|3747697|FG000|NOT COMPLETED|Overall Study||0
3028977|NCT01104701|3747698|FG001|NOT COMPLETED|Overall Study||3
3028978|NCT01104701|3747699|FG002|NOT COMPLETED|Overall Study||2
3028979|NCT01104701|3747700|FG003|NOT COMPLETED|Overall Study||2
3028980|NCT01104766|3747714|FG000|STARTED|Overall Study||153
3028981|NCT01104766|3747715|FG001|STARTED|Overall Study||155
3028982|NCT01104766|3747716|FG002|STARTED|Overall Study||157
3028983|NCT01104766|3747717|FG003|STARTED|Overall Study||152
3028984|NCT01104766|3747714|FG000|COMPLETED|Overall Study||95
3028985|NCT01104766|3747715|FG001|COMPLETED|Overall Study||104
3028986|NCT01104766|3747716|FG002|COMPLETED|Overall Study||97
3028987|NCT01104766|3747717|FG003|COMPLETED|Overall Study||114
3028988|NCT01104766|3747714|FG000|NOT COMPLETED|Overall Study||58
3028989|NCT01104766|3747715|FG001|NOT COMPLETED|Overall Study||51
3028990|NCT01104766|3747716|FG002|NOT COMPLETED|Overall Study||60
3028991|NCT01104766|3747717|FG003|NOT COMPLETED|Overall Study||38
3028992|NCT01104779|3747730|FG000|STARTED|Overall Study||147
3028993|NCT01104779|3747731|FG001|STARTED|Overall Study||151
3028994|NCT01104779|3747732|FG002|STARTED|Overall Study||148
3028995|NCT01104779|3747730|FG000|COMPLETED|Overall Study||88
3028996|NCT01104779|3747731|FG001|COMPLETED|Overall Study||96
3028997|NCT01104779|3747732|FG002|COMPLETED|Overall Study||86
3028998|NCT01104779|3747730|FG000|NOT COMPLETED|Overall Study||59
3028999|NCT01104779|3747731|FG001|NOT COMPLETED|Overall Study||55
3029000|NCT01104779|3747732|FG002|NOT COMPLETED|Overall Study||62
3029001|NCT01104792|3747740|FG000|STARTED|Overall Study||752
3029002|NCT01104792|3747740|FG000|COMPLETED|Overall Study||226
3029003|NCT01104792|3747740|FG000|NOT COMPLETED|Overall Study||526
3029004|NCT01104870|3747747|FG000|STARTED|Overall Study||11
3029005|NCT01104870|3747748|FG001|STARTED|Overall Study||19
3029006|NCT01104870|3747749|FG002|STARTED|Overall Study||20
3029007|NCT01104870|3747747|FG000|COMPLETED|Overall Study||10
3029008|NCT01104870|3747748|FG001|COMPLETED|Overall Study||18
3029009|NCT01104870|3747749|FG002|COMPLETED|Overall Study||18
3029010|NCT01104870|3747747|FG000|NOT COMPLETED|Overall Study||1
3029011|NCT01104870|3747748|FG001|NOT COMPLETED|Overall Study||1
3029012|NCT01104870|3747749|FG002|NOT COMPLETED|Overall Study||2
3029013|NCT01105065|3747757|FG000|STARTED|Overall Study||23
3029014|NCT01105065|3747757|FG000|COMPLETED|Overall Study||17
3029015|NCT01105065|3747757|FG000|NOT COMPLETED|Overall Study||6
3029016|NCT01105091|3747765|FG000|STARTED|Overall Study||20
3029017|NCT01105091|3747766|FG001|STARTED|Overall Study||10
3029018|NCT01105091|3747765|FG000|COMPLETED|Overall Study||18
3029019|NCT01105091|3747766|FG001|COMPLETED|Overall Study||10
3029020|NCT01105091|3747765|FG000|NOT COMPLETED|Overall Study||2
3309334|NCT03028974|4042650|FG006|STARTED|2017-2018|5 new participants were enrolled.|5
3309335|NCT03028974|4042644|FG000|COMPLETED|2017-2018||0
3309336|NCT03028974|4042645|FG001|COMPLETED|2017-2018||0
3309337|NCT03028974|4042646|FG002|COMPLETED|2017-2018||0
3309338|NCT03028974|4042647|FG003|COMPLETED|2017-2018||5
3309339|NCT03028974|4042648|FG004|COMPLETED|2017-2018||0
3309340|NCT03028974|4042649|FG005|COMPLETED|2017-2018||0
3309341|NCT03028974|4042650|FG006|COMPLETED|2017-2018||5
3309342|NCT03028974|4042644|FG000|NOT COMPLETED|2017-2018||0
3309343|NCT03028974|4042645|FG001|NOT COMPLETED|2017-2018||0
3309344|NCT03028974|4042646|FG002|NOT COMPLETED|2017-2018||0
3309345|NCT03028974|4042647|FG003|NOT COMPLETED|2017-2018||0
3309346|NCT03028974|4042648|FG004|NOT COMPLETED|2017-2018||0
3309347|NCT03028974|4042649|FG005|NOT COMPLETED|2017-2018||0
3309348|NCT03028974|4042650|FG006|NOT COMPLETED|2017-2018||0
3317121|NCT03124121|4050648|FG001|NOT COMPLETED|Overall Study||3
3317122|NCT03124199|4050656|FG000|STARTED|Overall Study||40
3317123|NCT03124199|4050656|FG000|COMPLETED|Overall Study||36
3317124|NCT03124199|4050656|FG000|NOT COMPLETED|Overall Study||4
3317125|NCT03124342|4050662|FG000|STARTED|Overall Study||111
3317126|NCT03124342|4050663|FG001|STARTED|Overall Study||121
3317127|NCT03124342|4050662|FG000|COMPLETED|Overall Study||111
3317128|NCT03124342|4050663|FG001|COMPLETED|Overall Study||121
3317129|NCT03124342|4050662|FG000|NOT COMPLETED|Overall Study||0
3317130|NCT03124342|4050663|FG001|NOT COMPLETED|Overall Study||0
3317131|NCT03124368|4050672|FG000|STARTED|Overall Study||2
3317132|NCT03124368|4050673|FG001|STARTED|Overall Study||4
3317133|NCT03124368|4050672|FG000|Received at Least 1 Dose of Study Drug|Overall Study||2
3317134|NCT03124368|4050673|FG001|Received at Least 1 Dose of Study Drug|Overall Study||4
3317135|NCT03124368|4050672|FG000|COMPLETED|Overall Study||2
3317136|NCT03124368|4050673|FG001|COMPLETED|Overall Study||4
3317137|NCT03124368|4050672|FG000|NOT COMPLETED|Overall Study||0
3317138|NCT03124368|4050673|FG001|NOT COMPLETED|Overall Study||0
3317139|NCT03124381|4050686|FG000|STARTED|Overall Study||65
3317140|NCT03124381|4050687|FG001|STARTED|Overall Study||61
3317141|NCT03124381|4050686|FG000|COMPLETED|Overall Study||56
3317142|NCT03124381|4050687|FG001|COMPLETED|Overall Study||55
3317143|NCT03124381|4050686|FG000|NOT COMPLETED|Overall Study||9
3317144|NCT03124381|4050687|FG001|NOT COMPLETED|Overall Study||6
3317145|NCT03124407|4050697|FG000|STARTED|Overall Study||40
3317146|NCT03124407|4050698|FG001|STARTED|Overall Study||20
3317147|NCT03124407|4050699|FG002|STARTED|Overall Study||40
3317148|NCT03124407|4050700|FG003|STARTED|Overall Study||20
3317149|NCT03124407|4050697|FG000|COMPLETED|Overall Study||39
3317150|NCT03124407|4050698|FG001|COMPLETED|Overall Study||20
3317151|NCT03124407|4050699|FG002|COMPLETED|Overall Study||39
3317152|NCT03124407|4050700|FG003|COMPLETED|Overall Study||20
3317153|NCT03124407|4050697|FG000|NOT COMPLETED|Overall Study||1
3317154|NCT03124407|4050698|FG001|NOT COMPLETED|Overall Study||0
3317155|NCT03124407|4050699|FG002|NOT COMPLETED|Overall Study||1
3317156|NCT03124407|4050700|FG003|NOT COMPLETED|Overall Study||0
3317157|NCT03124459|4050720|FG000|STARTED|Part 1-Open Label Dose Escalation||6
3317158|NCT03124459|4050721|FG001|STARTED|Part 1-Open Label Dose Escalation||6
3317159|NCT03124459|4050722|FG002|STARTED|Part 1-Open Label Dose Escalation||6
3317160|NCT03124459|4050723|FG003|STARTED|Part 1-Open Label Dose Escalation|Patients in the double-blind placebo controlled study were not the same participants that participated in the Part 1 Open-Label Dose escalation portion of the study.|0
3317161|NCT03124459|4050724|FG004|STARTED|Part 1-Open Label Dose Escalation|Patients in the double-blind placebo controlled study were not the same participants that participated in the Part 1 Open-Label Dose escalation portion of the study.|0
3317162|NCT03124459|4050725|FG005|STARTED|Part 1-Open Label Dose Escalation|Patients in the double-blind placebo controlled study were not the same participants that participated in the Part 1 Open-Label Dose escalation portion of the study. Participants that completed the double-blind portion of the study then moved into this Part 2 open-label portion of the study.|0
3317163|NCT03124459|4050720|FG000|COMPLETED|Part 1-Open Label Dose Escalation||6
3317164|NCT03124459|4050721|FG001|COMPLETED|Part 1-Open Label Dose Escalation||6
3317165|NCT03124459|4050722|FG002|COMPLETED|Part 1-Open Label Dose Escalation||6
3317280|NCT03125200|4050833|FG004|STARTED|Overall Study||4
3317281|NCT03125200|4050834|FG005|STARTED|Overall Study||3
3317282|NCT03125200|4050835|FG006|STARTED|Overall Study||3
3029021|NCT01105091|3747766|FG001|NOT COMPLETED|Overall Study||0
3029022|NCT01105117|3747776|FG000|STARTED|Overall Study||1
3029023|NCT01105117|3747777|FG001|STARTED|Overall Study||1
3029024|NCT01105117|3747776|FG000|COMPLETED|Overall Study||1
3029025|NCT01105117|3747777|FG001|COMPLETED|Overall Study||1
3029026|NCT01105117|3747776|FG000|NOT COMPLETED|Overall Study||0
3029027|NCT01105117|3747777|FG001|NOT COMPLETED|Overall Study||0
3029028|NCT01105130|3747786|FG000|STARTED|Overall Study||48
3029029|NCT01105130|3747787|FG001|STARTED|Overall Study||45
3029030|NCT01105130|3747788|FG002|STARTED|Overall Study||47
3029031|NCT01105130|3747786|FG000|COMPLETED|Overall Study||38
3029032|NCT01105130|3747787|FG001|COMPLETED|Overall Study||34
3029033|NCT01105130|3747788|FG002|COMPLETED|Overall Study||37
3029034|NCT01105130|3747786|FG000|NOT COMPLETED|Overall Study||10
3029035|NCT01105130|3747787|FG001|NOT COMPLETED|Overall Study||11
3029036|NCT01105130|3747788|FG002|NOT COMPLETED|Overall Study||10
3029037|NCT01105247|3747798|FG000|STARTED|Overall Study||116
3029038|NCT01105247|3747799|FG001|STARTED|Overall Study||16
3029039|NCT01105247|3747798|FG000|COMPLETED|Overall Study||79
3029040|NCT01105247|3747799|FG001|COMPLETED|Overall Study||16
3029041|NCT01105247|3747798|FG000|NOT COMPLETED|Overall Study||37
3029042|NCT01105247|3747799|FG001|NOT COMPLETED|Overall Study||0
3029043|NCT01105312|3747813|FG000|STARTED|Overall Study||16
3029044|NCT01105312|3747814|FG001|STARTED|Overall Study||6
3029045|NCT01105312|3747815|FG002|STARTED|Overall Study||6
3029046|NCT01105312|3747813|FG000|COMPLETED|Overall Study||13
3029047|NCT01105312|3747814|FG001|COMPLETED|Overall Study||6
3029048|NCT01105312|3747815|FG002|COMPLETED|Overall Study||6
3029049|NCT01105312|3747813|FG000|NOT COMPLETED|Overall Study||3
3029050|NCT01105312|3747814|FG001|NOT COMPLETED|Overall Study||0
3029051|NCT01105312|3747815|FG002|NOT COMPLETED|Overall Study||0
3029052|NCT01105377|3747825|FG000|STARTED|Overall Study||24
3029053|NCT01105377|3747826|FG001|STARTED|Overall Study||23
3029054|NCT01105377|3747825|FG000|COMPLETED|Overall Study||24
3029055|NCT01105377|3747826|FG001|COMPLETED|Overall Study||22
3029056|NCT01105377|3747825|FG000|NOT COMPLETED|Overall Study||0
3029057|NCT01105377|3747826|FG001|NOT COMPLETED|Overall Study||1
3029058|NCT01105533|3747832|FG000|STARTED|Overall Study||1
3029059|NCT01105533|3747833|FG001|STARTED|Overall Study||1
3029060|NCT01105533|3747834|FG002|STARTED|Overall Study||3
3029061|NCT01105533|3747835|FG003|STARTED|Overall Study||3
3029062|NCT01105533|3747836|FG004|STARTED|Overall Study||7
3029063|NCT01105533|3747837|FG005|STARTED|Overall Study||7
3029064|NCT01105533|3747838|FG006|STARTED|Overall Study||8
3029065|NCT01105533|3747839|FG007|STARTED|Overall Study||4
3029066|NCT01105533|3747840|FG008|STARTED|Overall Study||12
3029067|NCT01105533|3747832|FG000|COMPLETED|Overall Study||0
3029068|NCT01105533|3747833|FG001|COMPLETED|Overall Study||0
3029069|NCT01105533|3747834|FG002|COMPLETED|Overall Study||0
3029070|NCT01105533|3747835|FG003|COMPLETED|Overall Study||0
3029071|NCT01105533|3747836|FG004|COMPLETED|Overall Study||0
3029072|NCT01105533|3747837|FG005|COMPLETED|Overall Study||0
3029073|NCT01105533|3747838|FG006|COMPLETED|Overall Study||0
3029074|NCT01105533|3747839|FG007|COMPLETED|Overall Study||0
3029075|NCT01105533|3747840|FG008|COMPLETED|Overall Study||0
3029076|NCT01105533|3747832|FG000|NOT COMPLETED|Overall Study||1
3029077|NCT01105533|3747833|FG001|NOT COMPLETED|Overall Study||1
3029078|NCT01105533|3747834|FG002|NOT COMPLETED|Overall Study||3
3029079|NCT01105533|3747835|FG003|NOT COMPLETED|Overall Study||3
3029080|NCT01105533|3747836|FG004|NOT COMPLETED|Overall Study||7
3029081|NCT01105533|3747837|FG005|NOT COMPLETED|Overall Study||7
3029082|NCT01105533|3747838|FG006|NOT COMPLETED|Overall Study||8
3029083|NCT01105533|3747839|FG007|NOT COMPLETED|Overall Study||4
3029084|NCT01105533|3747840|FG008|NOT COMPLETED|Overall Study||12
3029085|NCT01105650|3747856|FG000|STARTED|Overall Study||3
3029086|NCT01105650|3747857|FG001|STARTED|Overall Study||3
3029087|NCT01105650|3747858|FG002|STARTED|Overall Study||7
3029088|NCT01105650|3747859|FG003|STARTED|Overall Study|Arm 3 was determined to be successful, thus eliminating the need to test Arm 4.|0
3029089|NCT01105650|3747856|FG000|COMPLETED|Overall Study||3
3029090|NCT01105650|3747857|FG001|COMPLETED|Overall Study||3
3029091|NCT01105650|3747858|FG002|COMPLETED|Overall Study||7
3029092|NCT01105650|3747859|FG003|COMPLETED|Overall Study||0
3029093|NCT01105650|3747856|FG000|NOT COMPLETED|Overall Study||0
3029094|NCT01105650|3747857|FG001|NOT COMPLETED|Overall Study||0
3029095|NCT01105650|3747858|FG002|NOT COMPLETED|Overall Study||0
3029096|NCT01105650|3747859|FG003|NOT COMPLETED|Overall Study||0
3029097|NCT01105702|3747867|FG000|STARTED|Overall Study||28
3029098|NCT01105702|3747867|FG000|COMPLETED|Overall Study||10
3029099|NCT01105702|3747867|FG000|NOT COMPLETED|Overall Study||18
3029100|NCT01105754|3747875|FG000|STARTED|Overall Study||319
3029101|NCT01105754|3747876|FG001|STARTED|Overall Study||319
3029102|NCT01105754|3747875|FG000|COMPLETED|Overall Study||304
3029103|NCT01105754|3747876|FG001|COMPLETED|Overall Study||307
3029104|NCT01105754|3747875|FG000|NOT COMPLETED|Overall Study||15
3029105|NCT01105754|3747876|FG001|NOT COMPLETED|Overall Study||12
3029106|NCT01105767|3747885|FG000|STARTED|Overall Study||9315
3029107|NCT01105767|3747886|FG001|STARTED|Overall Study||10864
3029108|NCT01105767|3747887|FG002|STARTED|Overall Study||10030
3029109|NCT01105767|3747885|FG000|COMPLETED|Overall Study||8155
3029110|NCT01105767|3747886|FG001|COMPLETED|Overall Study||9250
3029111|NCT01105767|3747887|FG002|COMPLETED|Overall Study||8846
3029112|NCT01105767|3747885|FG000|NOT COMPLETED|Overall Study||1160
3029113|NCT01105767|3747886|FG001|NOT COMPLETED|Overall Study||1614
3029114|NCT01105767|3747887|FG002|NOT COMPLETED|Overall Study||1184
3029115|NCT01105936|3747895|FG000|STARTED|Period 1||8
3029116|NCT01105936|3747896|FG001|STARTED|Period 1||8
3029117|NCT01105936|3747897|FG002|STARTED|Period 1||7
3029118|NCT01105936|3747898|FG003|STARTED|Period 1||8
3029119|NCT01105936|3747895|FG000|COMPLETED|Period 1||8
3029120|NCT01105936|3747896|FG001|COMPLETED|Period 1||8
3029121|NCT01105936|3747897|FG002|COMPLETED|Period 1||7
3029122|NCT01105936|3747898|FG003|COMPLETED|Period 1||7
3029123|NCT01105936|3747895|FG000|NOT COMPLETED|Period 1||0
3029124|NCT01105936|3747896|FG001|NOT COMPLETED|Period 1||0
3029125|NCT01105936|3747897|FG002|NOT COMPLETED|Period 1||0
3029126|NCT01105936|3747898|FG003|NOT COMPLETED|Period 1||1
3029127|NCT01105936|3747895|FG000|STARTED|Wash-out Period 1||8
3029128|NCT01105936|3747896|FG001|STARTED|Wash-out Period 1||8
3029129|NCT01105936|3747897|FG002|STARTED|Wash-out Period 1||7
3029130|NCT01105936|3747898|FG003|STARTED|Wash-out Period 1||7
3029131|NCT01105936|3747895|FG000|COMPLETED|Wash-out Period 1||8
3029132|NCT01105936|3747896|FG001|COMPLETED|Wash-out Period 1||8
3029133|NCT01105936|3747897|FG002|COMPLETED|Wash-out Period 1||7
3029134|NCT01105936|3747898|FG003|COMPLETED|Wash-out Period 1||7
3029135|NCT01105936|3747895|FG000|NOT COMPLETED|Wash-out Period 1||0
3029136|NCT01105936|3747896|FG001|NOT COMPLETED|Wash-out Period 1||0
3029137|NCT01105936|3747897|FG002|NOT COMPLETED|Wash-out Period 1||0
3029138|NCT01105936|3747898|FG003|NOT COMPLETED|Wash-out Period 1||0
3309349|NCT03028987|4042665|FG000|STARTED|Overall Study||5
3309350|NCT03028987|4042666|FG001|STARTED|Overall Study||5
3309351|NCT03028987|4042665|FG000|COMPLETED|Overall Study||5
3029139|NCT01105936|3747895|FG000|STARTED|Period 2||8
3029140|NCT01105936|3747896|FG001|STARTED|Period 2||8
3029141|NCT01105936|3747897|FG002|STARTED|Period 2||7
3029142|NCT01105936|3747898|FG003|STARTED|Period 2||7
3029143|NCT01105936|3747895|FG000|COMPLETED|Period 2||7
3029144|NCT01105936|3747896|FG001|COMPLETED|Period 2||8
3029145|NCT01105936|3747897|FG002|COMPLETED|Period 2||7
3029146|NCT01105936|3747898|FG003|COMPLETED|Period 2||7
3029147|NCT01105936|3747895|FG000|NOT COMPLETED|Period 2||1
3029148|NCT01105936|3747896|FG001|NOT COMPLETED|Period 2||0
3029149|NCT01105936|3747897|FG002|NOT COMPLETED|Period 2||0
3029150|NCT01105936|3747898|FG003|NOT COMPLETED|Period 2||0
3029151|NCT01105936|3747895|FG000|STARTED|Wash-out Period 2||7
3029152|NCT01105936|3747896|FG001|STARTED|Wash-out Period 2||8
3029153|NCT01105936|3747897|FG002|STARTED|Wash-out Period 2||7
3029154|NCT01105936|3747898|FG003|STARTED|Wash-out Period 2||7
3029155|NCT01105936|3747895|FG000|COMPLETED|Wash-out Period 2||7
3029156|NCT01105936|3747896|FG001|COMPLETED|Wash-out Period 2||8
3029157|NCT01105936|3747897|FG002|COMPLETED|Wash-out Period 2||7
3029158|NCT01105936|3747898|FG003|COMPLETED|Wash-out Period 2||7
3029159|NCT01105936|3747895|FG000|NOT COMPLETED|Wash-out Period 2||0
3029160|NCT01105936|3747896|FG001|NOT COMPLETED|Wash-out Period 2||0
3029161|NCT01105936|3747897|FG002|NOT COMPLETED|Wash-out Period 2||0
3029162|NCT01105936|3747898|FG003|NOT COMPLETED|Wash-out Period 2||0
3029163|NCT01105936|3747895|FG000|STARTED|Period 3||7
3029164|NCT01105936|3747896|FG001|STARTED|Period 3||8
3309352|NCT03028987|4042666|FG001|COMPLETED|Overall Study||5
3309353|NCT03028987|4042665|FG000|NOT COMPLETED|Overall Study||0
3309354|NCT03028987|4042666|FG001|NOT COMPLETED|Overall Study||0
3309355|NCT03029091|4042674|FG000|STARTED|Overall Study||8
3309356|NCT03029091|4042675|FG001|STARTED|Overall Study||7
3309357|NCT03029091|4042674|FG000|COMPLETED|Overall Study||8
3309358|NCT03029091|4042675|FG001|COMPLETED|Overall Study||7
3309359|NCT03029091|4042674|FG000|NOT COMPLETED|Overall Study||0
3309360|NCT03029091|4042675|FG001|NOT COMPLETED|Overall Study||0
3309361|NCT03029143|4042683|FG000|STARTED|Lead-in Period (6 Weeks)||278
3309362|NCT03029143|4042684|FG001|STARTED|Lead-in Period (6 Weeks)||0
3309363|NCT03029143|4042685|FG002|STARTED|Lead-in Period (6 Weeks)||0
3309364|NCT03029143|4042683|FG000|COMPLETED|Lead-in Period (6 Weeks)||109
3309365|NCT03029143|4042684|FG001|COMPLETED|Lead-in Period (6 Weeks)||0
3309366|NCT03029143|4042685|FG002|COMPLETED|Lead-in Period (6 Weeks)||0
3309367|NCT03029143|4042683|FG000|NOT COMPLETED|Lead-in Period (6 Weeks)||169
3309368|NCT03029143|4042684|FG001|NOT COMPLETED|Lead-in Period (6 Weeks)||0
3309369|NCT03029143|4042685|FG002|NOT COMPLETED|Lead-in Period (6 Weeks)||0
3309370|NCT03029143|4042683|FG000|STARTED|Randomized Treatment Period (24 Weeks)||0
3309371|NCT03029143|4042684|FG001|STARTED|Randomized Treatment Period (24 Weeks)||54
3309372|NCT03029143|4042685|FG002|STARTED|Randomized Treatment Period (24 Weeks)||55
3309373|NCT03029143|4042683|FG000|Not Treated Post Randomization|Randomized Treatment Period (24 Weeks)||0
3309374|NCT03029143|4042684|FG001|Not Treated Post Randomization|Randomized Treatment Period (24 Weeks)|One participant was randomized to Randomized Treatment Period: Standard Treatment Arm, but was not treated and was thus included in the Lead-in failure vedolizumab arm for the Safety Analysis Set (N=170).|1
3309375|NCT03029143|4042685|FG002|Not Treated Post Randomization|Randomized Treatment Period (24 Weeks)||0
3309376|NCT03029143|4042683|FG000|Safety Population|Randomized Treatment Period (24 Weeks)||0
3309377|NCT03029143|4042684|FG001|Safety Population|Randomized Treatment Period (24 Weeks)||53
3309378|NCT03029143|4042685|FG002|Safety Population|Randomized Treatment Period (24 Weeks)|Regimen A = 28 Regimen B = 27|55
3309379|NCT03029143|4042683|FG000|COMPLETED|Randomized Treatment Period (24 Weeks)||0
3309380|NCT03029143|4042684|FG001|COMPLETED|Randomized Treatment Period (24 Weeks)||31
3309381|NCT03029143|4042685|FG002|COMPLETED|Randomized Treatment Period (24 Weeks)||31
3309382|NCT03029143|4042683|FG000|NOT COMPLETED|Randomized Treatment Period (24 Weeks)||0
3309383|NCT03029143|4042684|FG001|NOT COMPLETED|Randomized Treatment Period (24 Weeks)||23
3029165|NCT01105936|3747897|FG002|STARTED|Period 3||7
3029166|NCT01105936|3747898|FG003|STARTED|Period 3||7
3029167|NCT01105936|3747895|FG000|COMPLETED|Period 3||7
3029168|NCT01105936|3747896|FG001|COMPLETED|Period 3||6
3029169|NCT01105936|3747897|FG002|COMPLETED|Period 3||7
3029170|NCT01105936|3747898|FG003|COMPLETED|Period 3||7
3029171|NCT01105936|3747895|FG000|NOT COMPLETED|Period 3||0
3029172|NCT01105936|3747896|FG001|NOT COMPLETED|Period 3||2
3029173|NCT01105936|3747897|FG002|NOT COMPLETED|Period 3||0
3029174|NCT01105936|3747898|FG003|NOT COMPLETED|Period 3||0
3029175|NCT01105975|3747917|FG000|STARTED|Overall Study||40
3029176|NCT01105975|3747918|FG001|STARTED|Overall Study||39
3029177|NCT01105975|3747919|FG002|STARTED|Overall Study||42
3029178|NCT01105975|3747920|FG003|STARTED|Overall Study||38
3029179|NCT01105975|3747921|FG004|STARTED|Overall Study||41
3029180|NCT01105975|3747922|FG005|STARTED|Overall Study||35
3029181|NCT01105975|3747923|FG006|STARTED|Overall Study||42
3029182|NCT01105975|3747924|FG007|STARTED|Overall Study||40
3029183|NCT01105975|3747925|FG008|STARTED|Overall Study||40
3029184|NCT01105975|3747926|FG009|STARTED|Overall Study||41
3029185|NCT01105975|3747917|FG000|Took at Least One Dose of Study Drug|Overall Study||40
3029186|NCT01105975|3747918|FG001|Took at Least One Dose of Study Drug|Overall Study||38
3029187|NCT01105975|3747919|FG002|Took at Least One Dose of Study Drug|Overall Study||40
3029188|NCT01105975|3747920|FG003|Took at Least One Dose of Study Drug|Overall Study||38
3029189|NCT01105975|3747921|FG004|Took at Least One Dose of Study Drug|Overall Study||41
3029190|NCT01105975|3747922|FG005|Took at Least One Dose of Study Drug|Overall Study||35
3029191|NCT01105975|3747923|FG006|Took at Least One Dose of Study Drug|Overall Study||41
3029192|NCT01105975|3747924|FG007|Took at Least One Dose of Study Drug|Overall Study||40
3029193|NCT01105975|3747925|FG008|Took at Least One Dose of Study Drug|Overall Study||39
3029194|NCT01105975|3747926|FG009|Took at Least One Dose of Study Drug|Overall Study||41
3029195|NCT01105975|3747917|FG000|COMPLETED|Overall Study||35
3029196|NCT01105975|3747918|FG001|COMPLETED|Overall Study||34
3029197|NCT01105975|3747919|FG002|COMPLETED|Overall Study||32
3029198|NCT01105975|3747920|FG003|COMPLETED|Overall Study||36
3029199|NCT01105975|3747921|FG004|COMPLETED|Overall Study||35
3029200|NCT01105975|3747922|FG005|COMPLETED|Overall Study||30
3029201|NCT01105975|3747923|FG006|COMPLETED|Overall Study||34
3029202|NCT01105975|3747924|FG007|COMPLETED|Overall Study||33
3029203|NCT01105975|3747925|FG008|COMPLETED|Overall Study||34
3029204|NCT01105975|3747926|FG009|COMPLETED|Overall Study||32
3029205|NCT01105975|3747917|FG000|NOT COMPLETED|Overall Study||5
3029206|NCT01105975|3747918|FG001|NOT COMPLETED|Overall Study||5
3029207|NCT01105975|3747919|FG002|NOT COMPLETED|Overall Study||10
3029208|NCT01105975|3747920|FG003|NOT COMPLETED|Overall Study||2
3029209|NCT01105975|3747921|FG004|NOT COMPLETED|Overall Study||6
3029210|NCT01105975|3747922|FG005|NOT COMPLETED|Overall Study||5
3029211|NCT01105975|3747923|FG006|NOT COMPLETED|Overall Study||8
3029212|NCT01105975|3747924|FG007|NOT COMPLETED|Overall Study||7
3166044|NCT01903031|3893528|FG001|NOT COMPLETED|Overall Study||3
3166045|NCT01903031|3893529|FG002|NOT COMPLETED|Overall Study||5
3166046|NCT01903148|3893542|FG000|STARTED|Overall Study||441
3309384|NCT03029143|4042685|FG002|NOT COMPLETED|Randomized Treatment Period (24 Weeks)||24
3309385|NCT03029208|4042696|FG000|STARTED|Overall Study||157
3309386|NCT03029208|4042697|FG001|STARTED|Overall Study||155
3309387|NCT03029208|4042696|FG000|COMPLETED|Overall Study||155
3309388|NCT03029208|4042697|FG001|COMPLETED|Overall Study||151
3309389|NCT03029208|4042696|FG000|NOT COMPLETED|Overall Study||2
3309390|NCT03029208|4042697|FG001|NOT COMPLETED|Overall Study||4
3309391|NCT03029247|4042714|FG000|STARTED|Acute Challenge 1 (Day 1)||45
3309392|NCT03029247|4042715|FG001|STARTED|Acute Challenge 1 (Day 1)||43
3309393|NCT03029247|4042714|FG000|COMPLETED|Acute Challenge 1 (Day 1)||45
3309394|NCT03029247|4042715|FG001|COMPLETED|Acute Challenge 1 (Day 1)||43
3309395|NCT03029247|4042714|FG000|NOT COMPLETED|Acute Challenge 1 (Day 1)||0
3309396|NCT03029247|4042715|FG001|NOT COMPLETED|Acute Challenge 1 (Day 1)||0
3309397|NCT03029247|4042714|FG000|STARTED|Hgb Maintenance Phase (8 Weeks)||45
3309398|NCT03029247|4042715|FG001|STARTED|Hgb Maintenance Phase (8 Weeks)||43
3309399|NCT03029247|4042714|FG000|COMPLETED|Hgb Maintenance Phase (8 Weeks)||32
3309400|NCT03029247|4042715|FG001|COMPLETED|Hgb Maintenance Phase (8 Weeks)||36
3309401|NCT03029247|4042714|FG000|NOT COMPLETED|Hgb Maintenance Phase (8 Weeks)||13
3309402|NCT03029247|4042715|FG001|NOT COMPLETED|Hgb Maintenance Phase (8 Weeks)||7
3309403|NCT03029247|4042714|FG000|STARTED|Acute Challenge 2 (Day 57)||32
3309404|NCT03029247|4042715|FG001|STARTED|Acute Challenge 2 (Day 57)||36
3309405|NCT03029247|4042714|FG000|COMPLETED|Acute Challenge 2 (Day 57)||32
3309406|NCT03029247|4042715|FG001|COMPLETED|Acute Challenge 2 (Day 57)||36
3309407|NCT03029247|4042714|FG000|NOT COMPLETED|Acute Challenge 2 (Day 57)||0
3309408|NCT03029247|4042715|FG001|NOT COMPLETED|Acute Challenge 2 (Day 57)||0
3309409|NCT03029247|4042714|FG000|STARTED|Follow-up Period (14 Days)||32
3309410|NCT03029247|4042715|FG001|STARTED|Follow-up Period (14 Days)||36
3309411|NCT03029247|4042714|FG000|COMPLETED|Follow-up Period (14 Days)||32
3309412|NCT03029247|4042715|FG001|COMPLETED|Follow-up Period (14 Days)||36
3309413|NCT03029247|4042714|FG000|NOT COMPLETED|Follow-up Period (14 Days)||0
3309414|NCT03029247|4042715|FG001|NOT COMPLETED|Follow-up Period (14 Days)||0
3309415|NCT03029585|4042723|FG000|STARTED|Overall Study||7
3309416|NCT03029585|4042724|FG001|STARTED|Overall Study||3
3309417|NCT03029585|4042723|FG000|COMPLETED|Overall Study||5
3309418|NCT03029585|4042724|FG001|COMPLETED|Overall Study||2
3309419|NCT03029585|4042723|FG000|NOT COMPLETED|Overall Study||2
3309420|NCT03029585|4042724|FG001|NOT COMPLETED|Overall Study||1
3029213|NCT01105975|3747925|FG008|NOT COMPLETED|Overall Study||6
3166047|NCT01903148|3893542|FG000|COMPLETED|Overall Study||441
3166048|NCT01903148|3893542|FG000|NOT COMPLETED|Overall Study||0
3166049|NCT01903187|3893550|FG000|STARTED|Procedure||2
3166050|NCT01903187|3893551|FG001|STARTED|Procedure||2
3166051|NCT01903187|3893550|FG000|COMPLETED|Procedure||2
3166052|NCT01903187|3893551|FG001|COMPLETED|Procedure||2
3166053|NCT01903187|3893550|FG000|NOT COMPLETED|Procedure||0
3166054|NCT01903187|3893551|FG001|NOT COMPLETED|Procedure||0
3166055|NCT01903187|3893550|FG000|STARTED|1 Month||2
3166056|NCT01903187|3893551|FG001|STARTED|1 Month||2
3166057|NCT01903187|3893550|FG000|COMPLETED|1 Month||2
3166058|NCT01903187|3893551|FG001|COMPLETED|1 Month||2
3166059|NCT01903187|3893550|FG000|NOT COMPLETED|1 Month||0
3029214|NCT01105975|3747926|FG009|NOT COMPLETED|Overall Study||9
3029215|NCT01106014|3747969|FG000|STARTED|Overall Study||574
3029216|NCT01106014|3747970|FG001|STARTED|Overall Study||582
3029217|NCT01106014|3747969|FG000|COMPLETED|Overall Study||289
3029218|NCT01106014|3747970|FG001|COMPLETED|Overall Study||252
3029219|NCT01106014|3747969|FG000|NOT COMPLETED|Overall Study||285
3029220|NCT01106014|3747970|FG001|NOT COMPLETED|Overall Study||330
3029221|NCT01106027|3747976|FG000|STARTED|Overall Study||2
3029222|NCT01106027|3747976|FG000|COMPLETED|Overall Study||1
3029223|NCT01106027|3747976|FG000|NOT COMPLETED|Overall Study||1
3029224|NCT01106040|3747980|FG000|STARTED|Overall Study||163
3029225|NCT01106040|3747980|FG000|COMPLETED|Overall Study||152
3029226|NCT01106040|3747980|FG000|NOT COMPLETED|Overall Study||11
3029227|NCT01106092|3747989|FG000|STARTED|Overall Study||78
3029228|NCT01106092|3747990|FG001|STARTED|Overall Study||78
3029229|NCT01106092|3747991|FG002|STARTED|Overall Study||78
3029230|NCT01106092|3747992|FG003|STARTED|Overall Study||78
3029231|NCT01106092|3747989|FG000|COMPLETED|Overall Study||78
3029232|NCT01106092|3747990|FG001|COMPLETED|Overall Study||78
3029233|NCT01106092|3747991|FG002|COMPLETED|Overall Study||78
3029234|NCT01106092|3747992|FG003|COMPLETED|Overall Study||77
3029235|NCT01106092|3747989|FG000|NOT COMPLETED|Overall Study||0
3029236|NCT01106092|3747990|FG001|NOT COMPLETED|Overall Study||0
3029237|NCT01106092|3747991|FG002|NOT COMPLETED|Overall Study||0
3029238|NCT01106092|3747992|FG003|NOT COMPLETED|Overall Study||1
3029239|NCT01106157|3748004|FG000|STARTED|Overall Study||17
3029240|NCT01106157|3748005|FG001|STARTED|Overall Study||8
3029241|NCT01106157|3748004|FG000|COMPLETED|Overall Study||16
3029242|NCT01106157|3748005|FG001|COMPLETED|Overall Study||8
3029243|NCT01106157|3748004|FG000|NOT COMPLETED|Overall Study||1
3309421|NCT03029624|4042730|FG000|STARTED|Overall Study||46
3309422|NCT03029624|4042730|FG000|Primary Endpoint (3 Months)|Overall Study||44
3309423|NCT03029624|4042730|FG000|COMPLETED|Overall Study||41
3309424|NCT03029624|4042730|FG000|NOT COMPLETED|Overall Study||5
3309425|NCT03029650|4042736|FG000|STARTED|First Intervention (3 - 6 Days)|More subjects not enrolled after consent in other group leaving uneven number.|14
3309426|NCT03029650|4042737|FG001|STARTED|First Intervention (3 - 6 Days)||12
3309427|NCT03029650|4042736|FG000|COMPLETED|First Intervention (3 - 6 Days)||14
3309428|NCT03029650|4042737|FG001|COMPLETED|First Intervention (3 - 6 Days)||12
3309429|NCT03029650|4042736|FG000|NOT COMPLETED|First Intervention (3 - 6 Days)||0
3309430|NCT03029650|4042737|FG001|NOT COMPLETED|First Intervention (3 - 6 Days)||0
3309431|NCT03029650|4042736|FG000|STARTED|Washout (1 Week)||14
3309432|NCT03029650|4042737|FG001|STARTED|Washout (1 Week)||12
3309433|NCT03029650|4042736|FG000|COMPLETED|Washout (1 Week)||13
3309434|NCT03029650|4042737|FG001|COMPLETED|Washout (1 Week)||10
3309435|NCT03029650|4042736|FG000|NOT COMPLETED|Washout (1 Week)||1
3309436|NCT03029650|4042737|FG001|NOT COMPLETED|Washout (1 Week)||2
3309437|NCT03029650|4042736|FG000|STARTED|2nd Intervention (3 - 6 Days)||13
3309438|NCT03029650|4042737|FG001|STARTED|2nd Intervention (3 - 6 Days)||10
3309439|NCT03029650|4042736|FG000|COMPLETED|2nd Intervention (3 - 6 Days)||13
3309440|NCT03029650|4042737|FG001|COMPLETED|2nd Intervention (3 - 6 Days)||10
3309441|NCT03029650|4042736|FG000|NOT COMPLETED|2nd Intervention (3 - 6 Days)||0
3309442|NCT03029650|4042737|FG001|NOT COMPLETED|2nd Intervention (3 - 6 Days)||0
3309443|NCT03029715|4042749|FG000|STARTED|Overall Study||50
3309444|NCT03029715|4042750|FG001|STARTED|Overall Study||50
3309445|NCT03029715|4042749|FG000|COMPLETED|Overall Study||50
3309446|NCT03029715|4042750|FG001|COMPLETED|Overall Study||50
3309447|NCT03029715|4042749|FG000|NOT COMPLETED|Overall Study||0
3309448|NCT03029715|4042750|FG001|NOT COMPLETED|Overall Study||0
3309449|NCT03029780|4042758|FG000|STARTED|Overall Study||52
3309450|NCT03029780|4042759|FG001|STARTED|Overall Study||52
3309451|NCT03029780|4042758|FG000|COMPLETED|Overall Study||46
3309452|NCT03029780|4042759|FG001|COMPLETED|Overall Study||41
3309453|NCT03029780|4042758|FG000|NOT COMPLETED|Overall Study||6
3309454|NCT03029780|4042759|FG001|NOT COMPLETED|Overall Study||11
3309455|NCT03029819|4042767|FG000|STARTED|Overall Study||33
3309456|NCT03029819|4042768|FG001|STARTED|Overall Study||39
3309457|NCT03029819|4042767|FG000|COMPLETED|Overall Study||30
3309458|NCT03029819|4042768|FG001|COMPLETED|Overall Study||33
3309459|NCT03029819|4042767|FG000|NOT COMPLETED|Overall Study||3
3309460|NCT03029819|4042768|FG001|NOT COMPLETED|Overall Study||6
3309461|NCT03029988|4042777|FG000|STARTED|Overall Study||3
3029244|NCT01106157|3748005|FG001|NOT COMPLETED|Overall Study||0
3029245|NCT01106248|3748011|FG000|STARTED|Overall Study||26
3029246|NCT01106248|3748011|FG000|COMPLETED|Overall Study||23
3029247|NCT01106248|3748011|FG000|NOT COMPLETED|Overall Study||3
3166060|NCT01903187|3893551|FG001|NOT COMPLETED|1 Month||0
3309462|NCT03029988|4042777|FG000|COMPLETED|Overall Study||3
3309463|NCT03029988|4042777|FG000|NOT COMPLETED|Overall Study||0
3029248|NCT01106287|3748019|FG000|STARTED|Overall Study|One participant that discontinued the study due to a pre-treatment adverse event was replaced.|4
3029249|NCT01106287|3748020|FG001|STARTED|Overall Study||3
3029250|NCT01106287|3748021|FG002|STARTED|Overall Study||3
3029251|NCT01106287|3748022|FG003|STARTED|Overall Study||3
3029252|NCT01106287|3748019|FG000|COMPLETED|Overall Study||3
3029253|NCT01106287|3748020|FG001|COMPLETED|Overall Study||3
3029254|NCT01106287|3748021|FG002|COMPLETED|Overall Study||3
3029255|NCT01106287|3748022|FG003|COMPLETED|Overall Study||3
3029256|NCT01106287|3748019|FG000|NOT COMPLETED|Overall Study||1
3029257|NCT01106287|3748020|FG001|NOT COMPLETED|Overall Study||0
3029258|NCT01106287|3748021|FG002|NOT COMPLETED|Overall Study||0
3029259|NCT01106287|3748022|FG003|NOT COMPLETED|Overall Study||0
3029260|NCT01106326|3748036|FG000|STARTED|Overall Study||30
3029261|NCT01106326|3748036|FG000|COMPLETED|Overall Study||28
3029262|NCT01106326|3748036|FG000|NOT COMPLETED|Overall Study||2
3029263|NCT01106352|3748047|FG000|STARTED|Overall Study||7
3029264|NCT01106352|3748048|FG001|STARTED|Overall Study||3
3029265|NCT01106352|3748049|FG002|STARTED|Overall Study||7
3029266|NCT01106352|3748050|FG003|STARTED|Overall Study||36
3029267|NCT01106352|3748051|FG004|STARTED|Overall Study||17
3029268|NCT01106352|3748047|FG000|Started Dose Escalation|Overall Study|Number of subjects for safety analysis set.|7
3029269|NCT01106352|3748048|FG001|Started Dose Escalation|Overall Study|Number of subjects for safety analysis set.|3
3309464|NCT03030183|4042782|FG000|STARTED|Overall Study||3
3309465|NCT03030183|4042782|FG000|COMPLETED|Overall Study||3
3309466|NCT03030183|4042782|FG000|NOT COMPLETED|Overall Study||0
3309467|NCT03030599|4042786|FG000|STARTED|Open Label Treatment and Titration||201
3309468|NCT03030599|4042787|FG001|STARTED|Open Label Treatment and Titration||0
3309469|NCT03030599|4042788|FG002|STARTED|Open Label Treatment and Titration||0
3309470|NCT03030599|4042786|FG000|COMPLETED|Open Label Treatment and Titration||155
3309471|NCT03030599|4042787|FG001|COMPLETED|Open Label Treatment and Titration||0
3309472|NCT03030599|4042788|FG002|COMPLETED|Open Label Treatment and Titration||0
3309473|NCT03030599|4042786|FG000|NOT COMPLETED|Open Label Treatment and Titration||46
3309474|NCT03030599|4042787|FG001|NOT COMPLETED|Open Label Treatment and Titration||0
3309475|NCT03030599|4042788|FG002|NOT COMPLETED|Open Label Treatment and Titration||0
3309476|NCT03030599|4042786|FG000|STARTED|Stable Dose|149 subjects of the 201 entered the Stable Dose Period. Of those subjects, 136 were randomized.|149
3309477|NCT03030599|4042787|FG001|STARTED|Stable Dose||0
3309478|NCT03030599|4042788|FG002|STARTED|Stable Dose||0
3309479|NCT03030599|4042786|FG000|COMPLETED|Stable Dose||144
3309480|NCT03030599|4042787|FG001|COMPLETED|Stable Dose||0
3309481|NCT03030599|4042788|FG002|COMPLETED|Stable Dose||0
3309482|NCT03030599|4042786|FG000|NOT COMPLETED|Stable Dose||5
3309483|NCT03030599|4042787|FG001|NOT COMPLETED|Stable Dose||0
3309484|NCT03030599|4042788|FG002|NOT COMPLETED|Stable Dose||0
3309485|NCT03030599|4042786|FG000|STARTED|Double Blind Randomized Withdrawal||0
3309486|NCT03030599|4042787|FG001|STARTED|Double Blind Randomized Withdrawal|134 of the 136 subjects randomized received at least 1 dose of study drug in the DB RWP.|69
3309487|NCT03030599|4042788|FG002|STARTED|Double Blind Randomized Withdrawal|134 of the 136 subjects randomized received at least 1 dose of study drug in the DB RWP.|67
3309488|NCT03030599|4042786|FG000|COMPLETED|Double Blind Randomized Withdrawal||0
3309489|NCT03030599|4042787|FG001|COMPLETED|Double Blind Randomized Withdrawal||69
3309490|NCT03030599|4042788|FG002|COMPLETED|Double Blind Randomized Withdrawal||59
3309491|NCT03030599|4042786|FG000|NOT COMPLETED|Double Blind Randomized Withdrawal||0
3309492|NCT03030599|4042787|FG001|NOT COMPLETED|Double Blind Randomized Withdrawal||0
3309493|NCT03030599|4042788|FG002|NOT COMPLETED|Double Blind Randomized Withdrawal||8
3309494|NCT03030599|4042786|FG000|STARTED|Open-label Extension||74
3309495|NCT03030599|4042787|FG001|STARTED|Open-label Extension||0
3309496|NCT03030599|4042788|FG002|STARTED|Open-label Extension||0
3309497|NCT03030599|4042786|FG000|COMPLETED|Open-label Extension||67
3309498|NCT03030599|4042787|FG001|COMPLETED|Open-label Extension||0
3309499|NCT03030599|4042788|FG002|COMPLETED|Open-label Extension||0
3309500|NCT03030599|4042786|FG000|NOT COMPLETED|Open-label Extension||7
3309501|NCT03030599|4042787|FG001|NOT COMPLETED|Open-label Extension||0
3309502|NCT03030599|4042788|FG002|NOT COMPLETED|Open-label Extension||0
3309503|NCT03030638|4042802|FG000|STARTED|Overall Study||1386
3309504|NCT03030638|4042803|FG001|STARTED|Overall Study||1841
3309505|NCT03030638|4042804|FG002|STARTED|Overall Study||1712
3309506|NCT03030638|4042805|FG003|STARTED|Overall Study||6406
3309507|NCT03030638|4042806|FG004|STARTED|Overall Study||696
3309508|NCT03030638|4042807|FG005|STARTED|Overall Study||1592
3309509|NCT03030638|4042808|FG006|STARTED|Overall Study||364
3309510|NCT03030638|4042809|FG007|STARTED|Overall Study||127
3309511|NCT03030638|4042802|FG000|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||372
3309512|NCT03030638|4042803|FG001|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||636
3309513|NCT03030638|4042804|FG002|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||0
3309514|NCT03030638|4042805|FG003|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||0
3309515|NCT03030638|4042806|FG004|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||0
3309516|NCT03030638|4042807|FG005|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||0
3309517|NCT03030638|4042808|FG006|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||0
3309518|NCT03030638|4042809|FG007|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||0
3309519|NCT03030638|4042802|FG000|COMPLETED|Overall Study||1386
3309520|NCT03030638|4042803|FG001|COMPLETED|Overall Study||1841
3309521|NCT03030638|4042804|FG002|COMPLETED|Overall Study||1712
3309522|NCT03030638|4042805|FG003|COMPLETED|Overall Study||6406
3029270|NCT01106352|3748049|FG002|Started Dose Escalation|Overall Study|Number of subjects for safety analysis set.|7
3029271|NCT01106352|3748050|FG003|Started Dose Escalation|Overall Study||0
3029272|NCT01106352|3748051|FG004|Started Dose Escalation|Overall Study||0
3029273|NCT01106352|3748047|FG000|Completed Dose Escalation|Overall Study||6
3029274|NCT01106352|3748048|FG001|Completed Dose Escalation|Overall Study||3
3029275|NCT01106352|3748049|FG002|Completed Dose Escalation|Overall Study||5
3029276|NCT01106352|3748050|FG003|Completed Dose Escalation|Overall Study||0
3029277|NCT01106352|3748051|FG004|Completed Dose Escalation|Overall Study||0
3029278|NCT01106352|3748047|FG000|Started Safety Cohort|Overall Study||0
3029279|NCT01106352|3748048|FG001|Started Safety Cohort|Overall Study||0
3029280|NCT01106352|3748049|FG002|Started Safety Cohort|Overall Study||0
3029281|NCT01106352|3748050|FG003|Started Safety Cohort|Overall Study||36
3029282|NCT01106352|3748051|FG004|Started Safety Cohort|Overall Study||17
3029283|NCT01106352|3748047|FG000|Treated Safety Cohort|Overall Study||0
3029284|NCT01106352|3748048|FG001|Treated Safety Cohort|Overall Study||0
3029285|NCT01106352|3748049|FG002|Treated Safety Cohort|Overall Study||0
3029286|NCT01106352|3748050|FG003|Treated Safety Cohort|Overall Study|Number of subjects for safety analysis set.|33
3029287|NCT01106352|3748051|FG004|Treated Safety Cohort|Overall Study|Number of subjects for safety analysis set.|13
3029288|NCT01106352|3748047|FG000|Completed Safety Cohort|Overall Study||0
3029289|NCT01106352|3748048|FG001|Completed Safety Cohort|Overall Study||0
3029290|NCT01106352|3748049|FG002|Completed Safety Cohort|Overall Study||0
3029291|NCT01106352|3748050|FG003|Completed Safety Cohort|Overall Study||23
3029292|NCT01106352|3748051|FG004|Completed Safety Cohort|Overall Study||9
3029293|NCT01106352|3748047|FG000|COMPLETED|Overall Study||6
3029294|NCT01106352|3748048|FG001|COMPLETED|Overall Study||3
3029295|NCT01106352|3748049|FG002|COMPLETED|Overall Study||5
3029296|NCT01106352|3748050|FG003|COMPLETED|Overall Study|This group is only applicable for Safety cohort period.|23
3029297|NCT01106352|3748051|FG004|COMPLETED|Overall Study|This group is only applicable for Safety cohort period.|9
3029298|NCT01106352|3748047|FG000|NOT COMPLETED|Overall Study||1
3029299|NCT01106352|3748048|FG001|NOT COMPLETED|Overall Study||0
3029300|NCT01106352|3748049|FG002|NOT COMPLETED|Overall Study||2
3029301|NCT01106352|3748050|FG003|NOT COMPLETED|Overall Study||13
3029302|NCT01106352|3748051|FG004|NOT COMPLETED|Overall Study||8
3029303|NCT01106391|3748067|FG000|STARTED|Overall Study||60
3029304|NCT01106391|3748067|FG000|COMPLETED|Overall Study||60
3029305|NCT01106391|3748067|FG000|NOT COMPLETED|Overall Study||0
3029306|NCT01106404|3748073|FG000|STARTED|Period I (First 6 Weeks)||36
3029307|NCT01106404|3748074|FG001|STARTED|Period I (First 6 Weeks)||40
3029308|NCT01106404|3748073|FG000|COMPLETED|Period I (First 6 Weeks)||33
3029309|NCT01106404|3748074|FG001|COMPLETED|Period I (First 6 Weeks)||38
3029310|NCT01106404|3748073|FG000|NOT COMPLETED|Period I (First 6 Weeks)||3
3029311|NCT01106404|3748074|FG001|NOT COMPLETED|Period I (First 6 Weeks)||2
3029312|NCT01106404|3748073|FG000|STARTED|Period II (Second 6 Weeks)||33
3309523|NCT03030638|4042806|FG004|COMPLETED|Overall Study||696
3309524|NCT03030638|4042807|FG005|COMPLETED|Overall Study||1592
3309525|NCT03030638|4042808|FG006|COMPLETED|Overall Study||364
3309526|NCT03030638|4042809|FG007|COMPLETED|Overall Study||127
3309527|NCT03030638|4042802|FG000|NOT COMPLETED|Overall Study||0
3309528|NCT03030638|4042803|FG001|NOT COMPLETED|Overall Study||0
3309529|NCT03030638|4042804|FG002|NOT COMPLETED|Overall Study||0
3309530|NCT03030638|4042805|FG003|NOT COMPLETED|Overall Study||0
3309531|NCT03030638|4042806|FG004|NOT COMPLETED|Overall Study||0
3309532|NCT03030638|4042807|FG005|NOT COMPLETED|Overall Study||0
3309533|NCT03030638|4042808|FG006|NOT COMPLETED|Overall Study||0
3309534|NCT03030638|4042809|FG007|NOT COMPLETED|Overall Study||0
3309535|NCT03030989|4042831|FG000|STARTED|Overall Study||21
3309536|NCT03030989|4042832|FG001|STARTED|Overall Study||29
3309537|NCT03030989|4042831|FG000|COMPLETED|Overall Study||9
3309538|NCT03030989|4042832|FG001|COMPLETED|Overall Study||15
3309539|NCT03030989|4042831|FG000|NOT COMPLETED|Overall Study||12
3309540|NCT03030989|4042832|FG001|NOT COMPLETED|Overall Study||14
3309541|NCT03031431|4042838|FG000|STARTED|Overall Study||130
3309542|NCT03031431|4042838|FG000|COMPLETED|Overall Study||129
3309543|NCT03031431|4042838|FG000|NOT COMPLETED|Overall Study||1
3309544|NCT03031496|4042842|FG000|STARTED|Period 1||21
3309545|NCT03031496|4042843|FG001|STARTED|Period 1||21
3309546|NCT03031496|4042842|FG000|COMPLETED|Period 1||19
3309547|NCT03031496|4042843|FG001|COMPLETED|Period 1||19
3309548|NCT03031496|4042842|FG000|NOT COMPLETED|Period 1||2
3309549|NCT03031496|4042843|FG001|NOT COMPLETED|Period 1||2
3309550|NCT03031496|4042842|FG000|STARTED|Period 2||19
3309551|NCT03031496|4042843|FG001|STARTED|Period 2||19
3309552|NCT03031496|4042842|FG000|COMPLETED|Period 2||19
3309553|NCT03031496|4042843|FG001|COMPLETED|Period 2||19
3309554|NCT03031496|4042842|FG000|NOT COMPLETED|Period 2||0
3309555|NCT03031496|4042843|FG001|NOT COMPLETED|Period 2||0
3309556|NCT03031678|4042849|FG000|STARTED|Overall Study||50
3309557|NCT03031678|4042849|FG000|EAS Test Condition Complete|Overall Study||39
3309558|NCT03031678|4042849|FG000|CI Alone Test Condition Complete|Overall Study||10
3309559|NCT03031678|4042849|FG000|COMPLETED|Overall Study||49
3309560|NCT03031678|4042849|FG000|NOT COMPLETED|Overall Study||1
3309561|NCT03031795|4042859|FG000|STARTED|Overall Study||35
3309562|NCT03031795|4042860|FG001|STARTED|Overall Study||36
3309563|NCT03031795|4042859|FG000|COMPLETED|Overall Study||35
3309564|NCT03031795|4042860|FG001|COMPLETED|Overall Study||35
3309565|NCT03031795|4042859|FG000|NOT COMPLETED|Overall Study||0
3029313|NCT01106404|3748074|FG001|STARTED|Period II (Second 6 Weeks)||38
3029314|NCT01106404|3748073|FG000|COMPLETED|Period II (Second 6 Weeks)||33
3029315|NCT01106404|3748074|FG001|COMPLETED|Period II (Second 6 Weeks)||38
3029316|NCT01106404|3748073|FG000|NOT COMPLETED|Period II (Second 6 Weeks)||0
3029317|NCT01106404|3748074|FG001|NOT COMPLETED|Period II (Second 6 Weeks)||0
3029318|NCT01106430|3748088|FG000|STARTED|Overall Study||133
3029319|NCT01106430|3748089|FG001|STARTED|Overall Study||134
3029320|NCT01106430|3748088|FG000|COMPLETED|Overall Study||100
3029321|NCT01106430|3748089|FG001|COMPLETED|Overall Study||101
3029322|NCT01106430|3748088|FG000|NOT COMPLETED|Overall Study||33
3029323|NCT01106430|3748089|FG001|NOT COMPLETED|Overall Study||33
3029324|NCT01106456|3748097|FG000|STARTED|Overall Study||243
3029325|NCT01106456|3748098|FG001|STARTED|Overall Study||220
3029326|NCT01106456|3748097|FG000|COMPLETED|Overall Study||140
3029327|NCT01106456|3748098|FG001|COMPLETED|Overall Study||96
3029328|NCT01106456|3748097|FG000|NOT COMPLETED|Overall Study||103
3029329|NCT01106456|3748098|FG001|NOT COMPLETED|Overall Study||124
3029330|NCT01106586|3748106|FG000|STARTED|Overall Study||353
3029331|NCT01106586|3748107|FG001|STARTED|Overall Study||355
3029332|NCT01106586|3748106|FG000|COMPLETED|Overall Study||68
3029333|NCT01106586|3748107|FG001|COMPLETED|Overall Study||70
3029334|NCT01106586|3748106|FG000|NOT COMPLETED|Overall Study||285
3029335|NCT01106586|3748107|FG001|NOT COMPLETED|Overall Study||285
3029336|NCT01106625|3748116|FG000|STARTED|Core Period: Baseline to Week 26||156
3029337|NCT01106625|3748117|FG001|STARTED|Core Period: Baseline to Week 26||157
3029338|NCT01106625|3748118|FG002|STARTED|Core Period: Baseline to Week 26||156
3029339|NCT01106625|3748116|FG000|COMPLETED|Core Period: Baseline to Week 26||123
3029340|NCT01106625|3748117|FG001|COMPLETED|Core Period: Baseline to Week 26||129
3309566|NCT03031795|4042860|FG001|NOT COMPLETED|Overall Study||1
3309567|NCT03031899|4042866|FG000|STARTED|Overall Study||27
3309568|NCT03031899|4042866|FG000|COMPLETED|Overall Study||25
3309569|NCT03031899|4042866|FG000|NOT COMPLETED|Overall Study||2
3309570|NCT03031938|4042876|FG000|STARTED|Overall Study||2
3309571|NCT03031938|4042877|FG001|STARTED|Overall Study||2
3309572|NCT03031938|4042876|FG000|COMPLETED|Overall Study||1
3309573|NCT03031938|4042877|FG001|COMPLETED|Overall Study||2
3309574|NCT03031938|4042876|FG000|NOT COMPLETED|Overall Study||1
3309575|NCT03031938|4042877|FG001|NOT COMPLETED|Overall Study||0
3309576|NCT03032263|4042885|FG000|STARTED|Overall Study||6
3309577|NCT03032263|4042886|FG001|STARTED|Overall Study||6
3309578|NCT03032263|4042885|FG000|COMPLETED|Overall Study||6
3309579|NCT03032263|4042886|FG001|COMPLETED|Overall Study||6
3309580|NCT03032263|4042885|FG000|NOT COMPLETED|Overall Study||0
3309581|NCT03032263|4042886|FG001|NOT COMPLETED|Overall Study||0
3309582|NCT03032380|4042894|FG000|STARTED|Overall Study||148
3309583|NCT03032380|4042895|FG001|STARTED|Overall Study||152
3309584|NCT03032380|4042894|FG000|Received Treatment|Overall Study||148
3309585|NCT03032380|4042895|FG001|Received Treatment|Overall Study||150
3309586|NCT03032380|4042894|FG000|COMPLETED|Overall Study||106
3309587|NCT03032380|4042895|FG001|COMPLETED|Overall Study||112
3309588|NCT03032380|4042894|FG000|NOT COMPLETED|Overall Study||42
3309589|NCT03032380|4042895|FG001|NOT COMPLETED|Overall Study||40
3309590|NCT03032393|4042903|FG000|STARTED|Overall Study||15
3309591|NCT03032393|4042904|FG001|STARTED|Overall Study||15
3309592|NCT03032393|4042903|FG000|COMPLETED|Overall Study||15
3309593|NCT03032393|4042904|FG001|COMPLETED|Overall Study||15
3309594|NCT03032393|4042903|FG000|NOT COMPLETED|Overall Study||0
3309595|NCT03032393|4042904|FG001|NOT COMPLETED|Overall Study||0
3309596|NCT03032523|4042912|FG000|STARTED|Overall Study||15
3309597|NCT03032523|4042913|FG001|STARTED|Overall Study||6
3309598|NCT03032523|4042912|FG000|COMPLETED|Overall Study||12
3309599|NCT03032523|4042913|FG001|COMPLETED|Overall Study||4
3309600|NCT03032523|4042912|FG000|NOT COMPLETED|Overall Study||3
3309601|NCT03032523|4042913|FG001|NOT COMPLETED|Overall Study||2
3309602|NCT03032965|4042922|FG000|STARTED|Overall Study||61
3309603|NCT03032965|4042923|FG001|STARTED|Overall Study||68
3309604|NCT03032965|4042922|FG000|COMPLETED|Overall Study||61
3309605|NCT03032965|4042923|FG001|COMPLETED|Overall Study||68
3309606|NCT03032965|4042922|FG000|NOT COMPLETED|Overall Study||0
3309607|NCT03032965|4042923|FG001|NOT COMPLETED|Overall Study||0
3309608|NCT03033108|4042932|FG000|STARTED|Overall Study||7
3309609|NCT03033108|4042933|FG001|STARTED|Overall Study||9
3309610|NCT03033108|4042934|FG002|STARTED|Overall Study||7
3309611|NCT03033108|4042932|FG000|COMPLETED|Overall Study||7
3309612|NCT03033108|4042933|FG001|COMPLETED|Overall Study||8
3309613|NCT03033108|4042934|FG002|COMPLETED|Overall Study||7
3309614|NCT03033108|4042932|FG000|NOT COMPLETED|Overall Study||0
3309615|NCT03033108|4042933|FG001|NOT COMPLETED|Overall Study||1
3309616|NCT03033108|4042934|FG002|NOT COMPLETED|Overall Study||0
3309617|NCT03033134|4042944|FG000|STARTED|Overall Study||42
3309618|NCT03033134|4042945|FG001|STARTED|Overall Study||12
3309619|NCT03033134|4042944|FG000|6-month Primary Endpoints|Overall Study||42
3309620|NCT03033134|4042945|FG001|6-month Primary Endpoints|Overall Study||12
3309621|NCT03033134|4042944|FG000|COMPLETED|Overall Study||0
3309622|NCT03033134|4042945|FG001|COMPLETED|Overall Study||0
3309623|NCT03033134|4042944|FG000|NOT COMPLETED|Overall Study||42
3309624|NCT03033134|4042945|FG001|NOT COMPLETED|Overall Study||12
3309625|NCT03033394|4042953|FG000|STARTED|Completed Sampling||65
3309626|NCT03033394|4042953|FG000|COMPLETED|Completed Sampling||65
3309627|NCT03033394|4042953|FG000|NOT COMPLETED|Completed Sampling||0
3309628|NCT03033394|4042953|FG000|STARTED|Completed Pharmacokinetic Analysis||65
3029341|NCT01106625|3748118|FG002|COMPLETED|Core Period: Baseline to Week 26||129
3029342|NCT01106625|3748116|FG000|NOT COMPLETED|Core Period: Baseline to Week 26||33
3029343|NCT01106625|3748117|FG001|NOT COMPLETED|Core Period: Baseline to Week 26||28
3166061|NCT01903187|3893550|FG000|STARTED|3 Month||2
3166062|NCT01903187|3893551|FG001|STARTED|3 Month||0
3309629|NCT03033394|4042953|FG000|COMPLETED|Completed Pharmacokinetic Analysis||59
3029344|NCT01106625|3748118|FG002|NOT COMPLETED|Core Period: Baseline to Week 26||27
3029345|NCT01106625|3748116|FG000|STARTED|Extension Period: Week 26 to Week 52|4 pts discontinued last day of core: physician decision (1), noncompliance (1), not specified (2).|119
3029346|NCT01106625|3748117|FG001|STARTED|Extension Period: Week 26 to Week 52|2 pts discontinued last day of core: adverse event (1), not specified (1).|127
3029347|NCT01106625|3748118|FG002|STARTED|Extension Period: Week 26 to Week 52|1 pt discontinued last day of core: withdrawal by subject (1).|128
3029348|NCT01106625|3748116|FG000|COMPLETED|Extension Period: Week 26 to Week 52||90
3029349|NCT01106625|3748117|FG001|COMPLETED|Extension Period: Week 26 to Week 52||109
3029350|NCT01106625|3748118|FG002|COMPLETED|Extension Period: Week 26 to Week 52||111
3029351|NCT01106625|3748116|FG000|NOT COMPLETED|Extension Period: Week 26 to Week 52||29
3029352|NCT01106625|3748117|FG001|NOT COMPLETED|Extension Period: Week 26 to Week 52||18
3029353|NCT01106625|3748118|FG002|NOT COMPLETED|Extension Period: Week 26 to Week 52||17
3029354|NCT01106651|3748132|FG000|STARTED|Overall Study||237
3029355|NCT01106651|3748133|FG001|STARTED|Overall Study||241
3029356|NCT01106651|3748134|FG002|STARTED|Overall Study||236
3029357|NCT01106651|3748132|FG000|COMPLETED|Overall Study||158
3029358|NCT01106651|3748133|FG001|COMPLETED|Overall Study||184
3029359|NCT01106651|3748134|FG002|COMPLETED|Overall Study||178
3029360|NCT01106651|3748132|FG000|NOT COMPLETED|Overall Study||79
3029361|NCT01106651|3748133|FG001|NOT COMPLETED|Overall Study||57
3029362|NCT01106651|3748134|FG002|NOT COMPLETED|Overall Study||58
3029363|NCT01106677|3748149|FG000|STARTED|Core Period: Baseline to Week 26||183
3029364|NCT01106677|3748150|FG001|STARTED|Core Period: Baseline to Week 26||368
3029365|NCT01106677|3748151|FG002|STARTED|Core Period: Baseline to Week 26||367
3029366|NCT01106677|3748152|FG003|STARTED|Core Period: Baseline to Week 26||366
3166063|NCT01903187|3893550|FG000|COMPLETED|3 Month||2
3166064|NCT01903187|3893551|FG001|COMPLETED|3 Month||0
3309630|NCT03033394|4042953|FG000|NOT COMPLETED|Completed Pharmacokinetic Analysis||6
3309631|NCT03033394|4042953|FG000|STARTED|Completed Final Analysis||59
3309632|NCT03033394|4042953|FG000|COMPLETED|Completed Final Analysis||58
3309633|NCT03033394|4042953|FG000|NOT COMPLETED|Completed Final Analysis||1
3309634|NCT03033511|4042964|FG000|STARTED|Overall Study||376
3309635|NCT03033511|4042965|FG001|STARTED|Overall Study||372
3309636|NCT03033511|4042964|FG000|COMPLETED|Overall Study||376
3309637|NCT03033511|4042965|FG001|COMPLETED|Overall Study||372
3309638|NCT03033511|4042964|FG000|NOT COMPLETED|Overall Study||0
3309639|NCT03033511|4042965|FG001|NOT COMPLETED|Overall Study||0
3309640|NCT03033745|4042974|FG000|STARTED|Overall Study||15
3309641|NCT03033745|4042975|FG001|STARTED|Overall Study||18
3309642|NCT03033745|4042976|FG002|STARTED|Overall Study||16
3309643|NCT03033745|4042974|FG000|COMPLETED|Overall Study||14
3309644|NCT03033745|4042975|FG001|COMPLETED|Overall Study||17
3309645|NCT03033745|4042976|FG002|COMPLETED|Overall Study||14
3309646|NCT03033745|4042974|FG000|NOT COMPLETED|Overall Study||1
3309647|NCT03033745|4042975|FG001|NOT COMPLETED|Overall Study||1
3309648|NCT03033745|4042976|FG002|NOT COMPLETED|Overall Study||2
3309649|NCT03033784|4042993|FG000|STARTED|Overall Study||9
3309650|NCT03033784|4042994|FG001|STARTED|Overall Study||2
3309651|NCT03033784|4042995|FG002|STARTED|Overall Study||4
3309652|NCT03033784|4042996|FG003|STARTED|Overall Study||4
3309653|NCT03033784|4042997|FG004|STARTED|Overall Study||3
3309654|NCT03033784|4042998|FG005|STARTED|Overall Study||2
3309655|NCT03033784|4042999|FG006|STARTED|Overall Study||2
3309656|NCT03033784|4043000|FG007|STARTED|Overall Study||2
3309657|NCT03033784|4043001|FG008|STARTED|Overall Study||1
3309658|NCT03033784|4043002|FG009|STARTED|Overall Study||1
3309659|NCT03033784|4043003|FG010|STARTED|Overall Study||1
3309660|NCT03033784|4043004|FG011|STARTED|Overall Study||1
3309661|NCT03033784|4043005|FG012|STARTED|Overall Study||19
3309662|NCT03033784|4042993|FG000|Clinical Visit 2|Overall Study||9
3309663|NCT03033784|4042994|FG001|Clinical Visit 2|Overall Study||2
3309664|NCT03033784|4042995|FG002|Clinical Visit 2|Overall Study||4
3309665|NCT03033784|4042996|FG003|Clinical Visit 2|Overall Study||4
3309666|NCT03033784|4042997|FG004|Clinical Visit 2|Overall Study||3
3309667|NCT03033784|4042998|FG005|Clinical Visit 2|Overall Study||2
3309668|NCT03033784|4042999|FG006|Clinical Visit 2|Overall Study||2
3309669|NCT03033784|4043000|FG007|Clinical Visit 2|Overall Study||2
3309670|NCT03033784|4043001|FG008|Clinical Visit 2|Overall Study||1
3309671|NCT03033784|4043002|FG009|Clinical Visit 2|Overall Study||1
3309672|NCT03033784|4043003|FG010|Clinical Visit 2|Overall Study||1
3309673|NCT03033784|4043004|FG011|Clinical Visit 2|Overall Study||1
3309674|NCT03033784|4043005|FG012|Clinical Visit 2|Overall Study||17
3309675|NCT03033784|4042993|FG000|Clinical Visit 3|Overall Study||9
3309676|NCT03033784|4042994|FG001|Clinical Visit 3|Overall Study||1
3309677|NCT03033784|4042995|FG002|Clinical Visit 3|Overall Study||4
3309678|NCT03033784|4042996|FG003|Clinical Visit 3|Overall Study||4
3309679|NCT03033784|4042997|FG004|Clinical Visit 3|Overall Study||3
3309680|NCT03033784|4042998|FG005|Clinical Visit 3|Overall Study||2
3309681|NCT03033784|4042999|FG006|Clinical Visit 3|Overall Study||2
3309682|NCT03033784|4043000|FG007|Clinical Visit 3|Overall Study||2
3309683|NCT03033784|4043001|FG008|Clinical Visit 3|Overall Study||1
3029367|NCT01106677|3748149|FG000|COMPLETED|Core Period: Baseline to Week 26||155
3029368|NCT01106677|3748150|FG001|COMPLETED|Core Period: Baseline to Week 26||322
3029369|NCT01106677|3748151|FG002|COMPLETED|Core Period: Baseline to Week 26||323
3029370|NCT01106677|3748152|FG003|COMPLETED|Core Period: Baseline to Week 26||319
3029371|NCT01106677|3748149|FG000|NOT COMPLETED|Core Period: Baseline to Week 26||28
3029372|NCT01106677|3748150|FG001|NOT COMPLETED|Core Period: Baseline to Week 26||46
3029373|NCT01106677|3748151|FG002|NOT COMPLETED|Core Period: Baseline to Week 26||44
3029374|NCT01106677|3748152|FG003|NOT COMPLETED|Core Period: Baseline to Week 26||47
3029375|NCT01106677|3748149|FG000|STARTED|Extension Period: Week 26 to Week 52|2 pts completed core but did not enter ext: protcol violation(1), lost to f/u(1).|153
3029376|NCT01106677|3748150|FG001|STARTED|Extension Period: Week 26 to Week 52|6 pts completed core but did not enter ext: not specified(5), withdrawal by subject(1).|316
3029377|NCT01106677|3748151|FG002|STARTED|Extension Period: Week 26 to Week 52|2 pts completed core but did not enter ext: not specified(1), withdrawal by subject(1).|321
3029378|NCT01106677|3748152|FG003|STARTED|Extension Period: Week 26 to Week 52|6 pts completed core but did not enter ext: not specified(3), physician decision(2), lost to f/u(1).|313
3029379|NCT01106677|3748149|FG000|COMPLETED|Extension Period: Week 26 to Week 52||138
3029380|NCT01106677|3748150|FG001|COMPLETED|Extension Period: Week 26 to Week 52||298
3029381|NCT01106677|3748151|FG002|COMPLETED|Extension Period: Week 26 to Week 52||299
3029382|NCT01106677|3748152|FG003|COMPLETED|Extension Period: Week 26 to Week 52||285
3029383|NCT01106677|3748149|FG000|NOT COMPLETED|Extension Period: Week 26 to Week 52||15
3029384|NCT01106677|3748150|FG001|NOT COMPLETED|Extension Period: Week 26 to Week 52||18
3029385|NCT01106677|3748151|FG002|NOT COMPLETED|Extension Period: Week 26 to Week 52||22
3029386|NCT01106677|3748152|FG003|NOT COMPLETED|Extension Period: Week 26 to Week 52||28
3029387|NCT01106690|3748172|FG000|STARTED|Core Period: Baseline to Week 26||115
3029388|NCT01106690|3748173|FG001|STARTED|Core Period: Baseline to Week 26||113
3029389|NCT01106690|3748174|FG002|STARTED|Core Period: Baseline to Week 26||114
3029390|NCT01106690|3748172|FG000|COMPLETED|Core Period: Baseline to Week 26||91
3029391|NCT01106690|3748173|FG001|COMPLETED|Core Period: Baseline to Week 26||104
3029392|NCT01106690|3748174|FG002|COMPLETED|Core Period: Baseline to Week 26||101
3029393|NCT01106690|3748172|FG000|NOT COMPLETED|Core Period: Baseline to Week 26||24
3029394|NCT01106690|3748173|FG001|NOT COMPLETED|Core Period: Baseline to Week 26||9
3029395|NCT01106690|3748174|FG002|NOT COMPLETED|Core Period: Baseline to Week 26||13
3029396|NCT01106690|3748172|FG000|STARTED|Extension Period: Week 26 to Week 52|1 pt completed core but did not enter ext: physician decision(1).|90
3029397|NCT01106690|3748173|FG001|STARTED|Extension Period: Week 26 to Week 52|1 pt completed core but did not enter ext: physician decision(1).|103
3029398|NCT01106690|3748174|FG002|STARTED|Extension Period: Week 26 to Week 52|5 pts completed core but did not exter ext: lost to f/u(1), not spec(2), AE(1), eGFR criteria(1).|96
3309684|NCT03033784|4043002|FG009|Clinical Visit 3|Overall Study||1
3309685|NCT03033784|4043003|FG010|Clinical Visit 3|Overall Study||1
3309686|NCT03033784|4043004|FG011|Clinical Visit 3|Overall Study||1
3309687|NCT03033784|4043005|FG012|Clinical Visit 3|Overall Study||0
3309688|NCT03033784|4042993|FG000|Clinical Visit 4|Overall Study||9
3309689|NCT03033784|4042994|FG001|Clinical Visit 4|Overall Study||1
3309690|NCT03033784|4042995|FG002|Clinical Visit 4|Overall Study||4
3309691|NCT03033784|4042996|FG003|Clinical Visit 4|Overall Study||4
3309692|NCT03033784|4042997|FG004|Clinical Visit 4|Overall Study||3
3309693|NCT03033784|4042998|FG005|Clinical Visit 4|Overall Study||2
3309694|NCT03033784|4042999|FG006|Clinical Visit 4|Overall Study||2
3309695|NCT03033784|4043000|FG007|Clinical Visit 4|Overall Study||2
3309696|NCT03033784|4043001|FG008|Clinical Visit 4|Overall Study||1
3309697|NCT03033784|4043002|FG009|Clinical Visit 4|Overall Study||1
3309698|NCT03033784|4043003|FG010|Clinical Visit 4|Overall Study||1
3309699|NCT03033784|4043004|FG011|Clinical Visit 4|Overall Study||1
3309700|NCT03033784|4043005|FG012|Clinical Visit 4|Overall Study||0
3309701|NCT03033784|4042993|FG000|COMPLETED|Overall Study||9
3309702|NCT03033784|4042994|FG001|COMPLETED|Overall Study||1
3309703|NCT03033784|4042995|FG002|COMPLETED|Overall Study||4
3309704|NCT03033784|4042996|FG003|COMPLETED|Overall Study||4
3309705|NCT03033784|4042997|FG004|COMPLETED|Overall Study||3
3309706|NCT03033784|4042998|FG005|COMPLETED|Overall Study||2
3309707|NCT03033784|4042999|FG006|COMPLETED|Overall Study||2
3309708|NCT03033784|4043000|FG007|COMPLETED|Overall Study||2
3309709|NCT03033784|4043001|FG008|COMPLETED|Overall Study||1
3309710|NCT03033784|4043002|FG009|COMPLETED|Overall Study||1
3309711|NCT03033784|4043003|FG010|COMPLETED|Overall Study||1
3309712|NCT03033784|4043004|FG011|COMPLETED|Overall Study||1
3309713|NCT03033784|4043005|FG012|COMPLETED|Overall Study||17
3309714|NCT03033784|4042993|FG000|NOT COMPLETED|Overall Study||0
3309715|NCT03033784|4042994|FG001|NOT COMPLETED|Overall Study||1
3309716|NCT03033784|4042995|FG002|NOT COMPLETED|Overall Study||0
3309717|NCT03033784|4042996|FG003|NOT COMPLETED|Overall Study||0
3309718|NCT03033784|4042997|FG004|NOT COMPLETED|Overall Study||0
3309719|NCT03033784|4042998|FG005|NOT COMPLETED|Overall Study||0
3309720|NCT03033784|4042999|FG006|NOT COMPLETED|Overall Study||0
3309721|NCT03033784|4043000|FG007|NOT COMPLETED|Overall Study||0
3309722|NCT03033784|4043001|FG008|NOT COMPLETED|Overall Study||0
3309723|NCT03033784|4043002|FG009|NOT COMPLETED|Overall Study||0
3309724|NCT03033784|4043003|FG010|NOT COMPLETED|Overall Study||0
3309725|NCT03033784|4043004|FG011|NOT COMPLETED|Overall Study||0
3309726|NCT03033784|4043005|FG012|NOT COMPLETED|Overall Study||2
3309727|NCT03034018|4043018|FG000|STARTED|Overall Study||30
3309728|NCT03034018|4043019|FG001|STARTED|Overall Study||30
3029399|NCT01106690|3748172|FG000|COMPLETED|Extension Period: Week 26 to Week 52||78
3029400|NCT01106690|3748173|FG001|COMPLETED|Extension Period: Week 26 to Week 52||96
3029401|NCT01106690|3748174|FG002|COMPLETED|Extension Period: Week 26 to Week 52||89
3029402|NCT01106690|3748172|FG000|NOT COMPLETED|Extension Period: Week 26 to Week 52||12
3029403|NCT01106690|3748173|FG001|NOT COMPLETED|Extension Period: Week 26 to Week 52||7
3029404|NCT01106690|3748174|FG002|NOT COMPLETED|Extension Period: Week 26 to Week 52||7
3029405|NCT01106833|3748187|FG000|STARTED|Overall Study||74
3029406|NCT01106833|3748188|FG001|STARTED|Overall Study||77
3029407|NCT01106833|3748187|FG000|COMPLETED|Overall Study||74
3309729|NCT03034018|4043018|FG000|Initiated Assigned Treatment|Overall Study||27
3309730|NCT03034018|4043019|FG001|Initiated Assigned Treatment|Overall Study||29
3309731|NCT03034018|4043018|FG000|COMPLETED|Overall Study||25
3309732|NCT03034018|4043019|FG001|COMPLETED|Overall Study||28
3309733|NCT03034018|4043018|FG000|NOT COMPLETED|Overall Study||5
3309734|NCT03034018|4043019|FG001|NOT COMPLETED|Overall Study||2
3309735|NCT03034044|4043025|FG000|STARTED|Overall Study||106
3309736|NCT03034044|4043025|FG000|Received Xyntha|Overall Study||105
3309737|NCT03034044|4043025|FG000|COMPLETED|Overall Study||105
3309738|NCT03034044|4043025|FG000|NOT COMPLETED|Overall Study||1
3309739|NCT03034057|4043029|FG000|STARTED|Overall Study||169
3309740|NCT03034057|4043029|FG000|COMPLETED|Overall Study||114
3309741|NCT03034057|4043029|FG000|NOT COMPLETED|Overall Study||55
3309742|NCT03034135|4043033|FG000|STARTED|Overall Study||23
3309743|NCT03034135|4043033|FG000|COMPLETED|Overall Study||21
3309744|NCT03034135|4043033|FG000|NOT COMPLETED|Overall Study||2
3309745|NCT03034460|4043039|FG000|STARTED|Overall Study||48
3309746|NCT03034460|4043040|FG001|STARTED|Overall Study||22
3309747|NCT03034460|4043039|FG000|COMPLETED|Overall Study||45
3309748|NCT03034460|4043040|FG001|COMPLETED|Overall Study||19
3309749|NCT03034460|4043039|FG000|NOT COMPLETED|Overall Study||3
3309750|NCT03034460|4043040|FG001|NOT COMPLETED|Overall Study||3
3309751|NCT03034577|4043052|FG000|STARTED|Overall Study||175
3309752|NCT03034577|4043053|FG001|STARTED|Overall Study||175
3309753|NCT03034577|4043052|FG000|COMPLETED|Overall Study||144
3309754|NCT03034577|4043053|FG001|COMPLETED|Overall Study||140
3309755|NCT03034577|4043052|FG000|NOT COMPLETED|Overall Study||31
3309756|NCT03034577|4043053|FG001|NOT COMPLETED|Overall Study||35
3309757|NCT03034772|4043063|FG000|STARTED|Overall Study||27
3309758|NCT03034772|4043064|FG001|STARTED|Overall Study||25
3309759|NCT03034772|4043063|FG000|COMPLETED|Overall Study||27
3309760|NCT03034772|4043064|FG001|COMPLETED|Overall Study||23
3309761|NCT03034772|4043063|FG000|NOT COMPLETED|Overall Study||0
3309762|NCT03034772|4043064|FG001|NOT COMPLETED|Overall Study||2
3309763|NCT03034915|4043073|FG000|STARTED|Overall Study||812
3309764|NCT03034915|4043074|FG001|STARTED|Overall Study||804
3309765|NCT03034915|4043075|FG002|STARTED|Overall Study||809
3309766|NCT03034915|4043073|FG000|COMPLETED|Overall Study||717
3309767|NCT03034915|4043074|FG001|COMPLETED|Overall Study||650
3309768|NCT03034915|4043075|FG002|COMPLETED|Overall Study||683
3309769|NCT03034915|4043073|FG000|NOT COMPLETED|Overall Study||95
3309770|NCT03034915|4043074|FG001|NOT COMPLETED|Overall Study||154
3309771|NCT03034915|4043075|FG002|NOT COMPLETED|Overall Study||126
3309772|NCT03034928|4043083|FG000|STARTED|Period 1, First 2 Hours of Wear||8
3309773|NCT03034928|4043084|FG001|STARTED|Period 1, First 2 Hours of Wear||8
3309774|NCT03034928|4043085|FG002|STARTED|Period 1, First 2 Hours of Wear||9
3309775|NCT03034928|4043086|FG003|STARTED|Period 1, First 2 Hours of Wear||8
3309776|NCT03034928|4043083|FG000|COMPLETED|Period 1, First 2 Hours of Wear||8
3309777|NCT03034928|4043084|FG001|COMPLETED|Period 1, First 2 Hours of Wear||8
3309778|NCT03034928|4043085|FG002|COMPLETED|Period 1, First 2 Hours of Wear||9
3309779|NCT03034928|4043086|FG003|COMPLETED|Period 1, First 2 Hours of Wear||8
3309780|NCT03034928|4043083|FG000|NOT COMPLETED|Period 1, First 2 Hours of Wear||0
3309781|NCT03034928|4043084|FG001|NOT COMPLETED|Period 1, First 2 Hours of Wear||0
3309782|NCT03034928|4043085|FG002|NOT COMPLETED|Period 1, First 2 Hours of Wear||0
3309783|NCT03034928|4043086|FG003|NOT COMPLETED|Period 1, First 2 Hours of Wear||0
3309784|NCT03034928|4043083|FG000|STARTED|Washout Period Between Lens Wear||8
3309785|NCT03034928|4043084|FG001|STARTED|Washout Period Between Lens Wear||8
3309786|NCT03034928|4043085|FG002|STARTED|Washout Period Between Lens Wear||9
3309787|NCT03034928|4043086|FG003|STARTED|Washout Period Between Lens Wear||8
3309788|NCT03034928|4043083|FG000|COMPLETED|Washout Period Between Lens Wear||8
3309789|NCT03034928|4043084|FG001|COMPLETED|Washout Period Between Lens Wear||8
3309790|NCT03034928|4043085|FG002|COMPLETED|Washout Period Between Lens Wear||9
3309791|NCT03034928|4043086|FG003|COMPLETED|Washout Period Between Lens Wear||8
3309792|NCT03034928|4043083|FG000|NOT COMPLETED|Washout Period Between Lens Wear||0
3309793|NCT03034928|4043084|FG001|NOT COMPLETED|Washout Period Between Lens Wear||0
3309794|NCT03034928|4043085|FG002|NOT COMPLETED|Washout Period Between Lens Wear||0
3309795|NCT03034928|4043086|FG003|NOT COMPLETED|Washout Period Between Lens Wear||0
3309796|NCT03034928|4043083|FG000|STARTED|Period 2, Second 2 Hours of Wear||8
3309797|NCT03034928|4043084|FG001|STARTED|Period 2, Second 2 Hours of Wear||8
3309798|NCT03034928|4043085|FG002|STARTED|Period 2, Second 2 Hours of Wear||9
3309799|NCT03034928|4043086|FG003|STARTED|Period 2, Second 2 Hours of Wear||8
3309800|NCT03034928|4043083|FG000|COMPLETED|Period 2, Second 2 Hours of Wear||8
3309801|NCT03034928|4043084|FG001|COMPLETED|Period 2, Second 2 Hours of Wear||8
3309802|NCT03034928|4043085|FG002|COMPLETED|Period 2, Second 2 Hours of Wear||9
3309803|NCT03034928|4043086|FG003|COMPLETED|Period 2, Second 2 Hours of Wear||8
3309804|NCT03034928|4043083|FG000|NOT COMPLETED|Period 2, Second 2 Hours of Wear||0
3029408|NCT01106833|3748188|FG001|COMPLETED|Overall Study||77
3029409|NCT01106833|3748187|FG000|NOT COMPLETED|Overall Study||0
3029410|NCT01106833|3748188|FG001|NOT COMPLETED|Overall Study||0
3029411|NCT01106846|3748196|FG000|STARTED|Overall Study||12
3029412|NCT01106846|3748197|FG001|STARTED|Overall Study||10
3029413|NCT01106846|3748196|FG000|COMPLETED|Overall Study||12
3029414|NCT01106846|3748197|FG001|COMPLETED|Overall Study||9
3029415|NCT01106846|3748196|FG000|NOT COMPLETED|Overall Study||0
3309805|NCT03034928|4043084|FG001|NOT COMPLETED|Period 2, Second 2 Hours of Wear||0
3309806|NCT03034928|4043085|FG002|NOT COMPLETED|Period 2, Second 2 Hours of Wear||0
3309807|NCT03034928|4043086|FG003|NOT COMPLETED|Period 2, Second 2 Hours of Wear||0
3309808|NCT03034954|4043097|FG000|STARTED|Overall Study||21
3309809|NCT03034954|4043098|FG001|STARTED|Overall Study||21
3309810|NCT03034954|4043097|FG000|COMPLETED|Overall Study||20
3309811|NCT03034954|4043098|FG001|COMPLETED|Overall Study||21
3309812|NCT03034954|4043097|FG000|NOT COMPLETED|Overall Study||1
3309813|NCT03034954|4043098|FG001|NOT COMPLETED|Overall Study||0
3309814|NCT03034967|4043110|FG000|STARTED|Overall Study||102
3309815|NCT03034967|4043111|FG001|STARTED|Overall Study||102
3309816|NCT03034967|4043112|FG002|STARTED|Overall Study||103
3309817|NCT03034967|4043113|FG003|STARTED|Overall Study||103
3309818|NCT03034967|4043114|FG004|STARTED|Overall Study||102
3309819|NCT03034967|4043115|FG005|STARTED|Overall Study||102
3309820|NCT03034967|4043110|FG000|COMPLETED|Overall Study||88
3309821|NCT03034967|4043111|FG001|COMPLETED|Overall Study||97
3309822|NCT03034967|4043112|FG002|COMPLETED|Overall Study||90
3309823|NCT03034967|4043113|FG003|COMPLETED|Overall Study||92
3309824|NCT03034967|4043114|FG004|COMPLETED|Overall Study||88
3309825|NCT03034967|4043115|FG005|COMPLETED|Overall Study||87
3309826|NCT03034967|4043110|FG000|NOT COMPLETED|Overall Study||14
3309827|NCT03034967|4043111|FG001|NOT COMPLETED|Overall Study||5
3309828|NCT03034967|4043112|FG002|NOT COMPLETED|Overall Study||13
3309829|NCT03034967|4043113|FG003|NOT COMPLETED|Overall Study||11
3309830|NCT03034967|4043114|FG004|NOT COMPLETED|Overall Study||14
3309831|NCT03034967|4043115|FG005|NOT COMPLETED|Overall Study||15
3309832|NCT03035032|4043134|FG000|STARTED|Overall Study||107
3309833|NCT03035032|4043134|FG000|COMPLETED|Overall Study||64
3309834|NCT03035032|4043134|FG000|NOT COMPLETED|Overall Study||43
3309835|NCT03035318|4043143|FG000|STARTED|Overall Study||24
3309836|NCT03035318|4043144|FG001|STARTED|Overall Study||25
3309837|NCT03035318|4043145|FG002|STARTED|Overall Study||25
3309838|NCT03035318|4043146|FG003|STARTED|Overall Study||25
3309839|NCT03035318|4043147|FG004|STARTED|Overall Study||27
3309840|NCT03035318|4043143|FG000|COMPLETED|Overall Study||22
3309841|NCT03035318|4043144|FG001|COMPLETED|Overall Study||21
3309842|NCT03035318|4043145|FG002|COMPLETED|Overall Study||21
3309843|NCT03035318|4043146|FG003|COMPLETED|Overall Study||23
3309844|NCT03035318|4043147|FG004|COMPLETED|Overall Study||20
3309845|NCT03035318|4043143|FG000|NOT COMPLETED|Overall Study||2
3309846|NCT03035318|4043144|FG001|NOT COMPLETED|Overall Study||4
3309847|NCT03035318|4043145|FG002|NOT COMPLETED|Overall Study||4
3309848|NCT03035318|4043146|FG003|NOT COMPLETED|Overall Study||2
3309849|NCT03035318|4043147|FG004|NOT COMPLETED|Overall Study||7
3309850|NCT03035487|4043159|FG000|STARTED|Overall Study||9
3309851|NCT03035487|4043159|FG000|COMPLETED|Overall Study||9
3309852|NCT03035487|4043159|FG000|NOT COMPLETED|Overall Study||0
3309853|NCT03035708|4043165|FG000|STARTED|Overall Study||23
3309854|NCT03035708|4043166|FG001|STARTED|Overall Study||24
3309855|NCT03035708|4043165|FG000|COMPLETED|Overall Study||19
3309856|NCT03035708|4043166|FG001|COMPLETED|Overall Study||13
3309857|NCT03035708|4043165|FG000|NOT COMPLETED|Overall Study||4
3309858|NCT03035708|4043166|FG001|NOT COMPLETED|Overall Study||11
3309859|NCT03035760|4043179|FG000|STARTED|First Intervention - 10/7 Days Follow-up||8
3309860|NCT03035760|4043180|FG001|STARTED|First Intervention - 10/7 Days Follow-up||8
3309861|NCT03035760|4043181|FG002|STARTED|First Intervention - 10/7 Days Follow-up||8
3309862|NCT03035760|4043182|FG003|STARTED|First Intervention - 10/7 Days Follow-up||6
3309863|NCT03035760|4043183|FG004|STARTED|First Intervention - 10/7 Days Follow-up||6
3309864|NCT03035760|4043179|FG000|COMPLETED|First Intervention - 10/7 Days Follow-up||8
3309865|NCT03035760|4043180|FG001|COMPLETED|First Intervention - 10/7 Days Follow-up||8
3309866|NCT03035760|4043181|FG002|COMPLETED|First Intervention - 10/7 Days Follow-up||8
3309867|NCT03035760|4043182|FG003|COMPLETED|First Intervention - 10/7 Days Follow-up||6
3309868|NCT03035760|4043183|FG004|COMPLETED|First Intervention - 10/7 Days Follow-up||6
3309869|NCT03035760|4043179|FG000|NOT COMPLETED|First Intervention - 10/7 Days Follow-up||0
3309870|NCT03035760|4043180|FG001|NOT COMPLETED|First Intervention - 10/7 Days Follow-up||0
3309871|NCT03035760|4043181|FG002|NOT COMPLETED|First Intervention - 10/7 Days Follow-up||0
3309872|NCT03035760|4043182|FG003|NOT COMPLETED|First Intervention - 10/7 Days Follow-up||0
3309873|NCT03035760|4043183|FG004|NOT COMPLETED|First Intervention - 10/7 Days Follow-up||0
3309874|NCT03035760|4043179|FG000|STARTED|Second Intervention - 7 Days Follow-up||0
3309875|NCT03035760|4043180|FG001|STARTED|Second Intervention - 7 Days Follow-up||0
3309876|NCT03035760|4043181|FG002|STARTED|Second Intervention - 7 Days Follow-up||0
3309877|NCT03035760|4043182|FG003|STARTED|Second Intervention - 7 Days Follow-up||6
3309878|NCT03035760|4043183|FG004|STARTED|Second Intervention - 7 Days Follow-up||6
3309879|NCT03035760|4043179|FG000|COMPLETED|Second Intervention - 7 Days Follow-up||0
3309880|NCT03035760|4043180|FG001|COMPLETED|Second Intervention - 7 Days Follow-up||0
3309881|NCT03035760|4043181|FG002|COMPLETED|Second Intervention - 7 Days Follow-up||0
3309882|NCT03035760|4043182|FG003|COMPLETED|Second Intervention - 7 Days Follow-up||6
3029416|NCT01106846|3748197|FG001|NOT COMPLETED|Overall Study||1
3029417|NCT01106859|3748203|FG000|STARTED|Overall Study|Intent to treat population and safety population are the same (40 participants)|40
3029418|NCT01106859|3748203|FG000|COMPLETED|Overall Study||40
3029419|NCT01106859|3748203|FG000|NOT COMPLETED|Overall Study||0
3029420|NCT01106898|3748214|FG000|STARTED|Overall Study||100
3029421|NCT01106898|3748214|FG000|COMPLETED|Overall Study||94
3029422|NCT01106898|3748214|FG000|NOT COMPLETED|Overall Study||6
3038200|NCT01152450|3757562|FG000|NOT COMPLETED|Period 3 (4 Weeks)||0
3309883|NCT03035760|4043183|FG004|COMPLETED|Second Intervention - 7 Days Follow-up||6
3309884|NCT03035760|4043179|FG000|NOT COMPLETED|Second Intervention - 7 Days Follow-up||0
3309885|NCT03035760|4043180|FG001|NOT COMPLETED|Second Intervention - 7 Days Follow-up||0
3309886|NCT03035760|4043181|FG002|NOT COMPLETED|Second Intervention - 7 Days Follow-up||0
3309887|NCT03035760|4043182|FG003|NOT COMPLETED|Second Intervention - 7 Days Follow-up||0
3309888|NCT03035760|4043183|FG004|NOT COMPLETED|Second Intervention - 7 Days Follow-up||0
3309889|NCT03035864|4043198|FG000|STARTED|Treatment Period||120
3309890|NCT03035864|4043199|FG001|STARTED|Treatment Period||60
3309891|NCT03035864|4043198|FG000|COMPLETED|Treatment Period||116
3309892|NCT03035864|4043199|FG001|COMPLETED|Treatment Period||59
3309893|NCT03035864|4043198|FG000|NOT COMPLETED|Treatment Period||4
3309894|NCT03035864|4043199|FG001|NOT COMPLETED|Treatment Period||1
3309895|NCT03035864|4043198|FG000|STARTED|Follow-up Period||116
3309896|NCT03035864|4043199|FG001|STARTED|Follow-up Period||59
3309897|NCT03035864|4043198|FG000|COMPLETED|Follow-up Period||105
3309898|NCT03035864|4043199|FG001|COMPLETED|Follow-up Period||55
3309899|NCT03035864|4043198|FG000|NOT COMPLETED|Follow-up Period||11
3309900|NCT03035864|4043199|FG001|NOT COMPLETED|Follow-up Period||4
3309901|NCT03035916|4043208|FG000|STARTED|Overall Study||30
3309902|NCT03035916|4043209|FG001|STARTED|Overall Study||30
3309903|NCT03035916|4043210|FG002|STARTED|Overall Study||31
3309904|NCT03035916|4043208|FG000|COMPLETED|Overall Study||30
3309905|NCT03035916|4043209|FG001|COMPLETED|Overall Study||28
3309906|NCT03035916|4043210|FG002|COMPLETED|Overall Study||31
3309907|NCT03035916|4043208|FG000|NOT COMPLETED|Overall Study||0
3309908|NCT03035916|4043209|FG001|NOT COMPLETED|Overall Study||2
3309909|NCT03035916|4043210|FG002|NOT COMPLETED|Overall Study||0
3309910|NCT03035929|4043218|FG000|STARTED|Overall Study||10
3309911|NCT03035929|4043218|FG000|COMPLETED|Overall Study||10
3309912|NCT03035929|4043218|FG000|NOT COMPLETED|Overall Study||0
3309913|NCT03035942|4043226|FG000|STARTED|Overall Study||45
3309914|NCT03035942|4043227|FG001|STARTED|Overall Study||45
3309915|NCT03035942|4043228|FG002|STARTED|Overall Study||45
3309916|NCT03035942|4043226|FG000|COMPLETED|Overall Study||37
3309917|NCT03035942|4043227|FG001|COMPLETED|Overall Study||41
3309918|NCT03035942|4043228|FG002|COMPLETED|Overall Study||40
3309919|NCT03035942|4043226|FG000|NOT COMPLETED|Overall Study||8
3309920|NCT03035942|4043227|FG001|NOT COMPLETED|Overall Study||4
3309921|NCT03035942|4043228|FG002|NOT COMPLETED|Overall Study||5
3309922|NCT03035955|4043240|FG000|STARTED|Overall Study||10
3309923|NCT03035955|4043241|FG001|STARTED|Overall Study||10
3309924|NCT03035955|4043240|FG000|COMPLETED|Overall Study||9
3309925|NCT03035955|4043241|FG001|COMPLETED|Overall Study||9
3309926|NCT03035955|4043240|FG000|NOT COMPLETED|Overall Study||1
3309927|NCT03035955|4043241|FG001|NOT COMPLETED|Overall Study||1
3309928|NCT03036072|4043249|FG000|STARTED|Overall Study||12
3309929|NCT03036072|4043250|FG001|STARTED|Overall Study||13
3309930|NCT03036072|4043249|FG000|COMPLETED|Overall Study||12
3309931|NCT03036072|4043250|FG001|COMPLETED|Overall Study||10
3309932|NCT03036072|4043249|FG000|NOT COMPLETED|Overall Study||0
3309933|NCT03036072|4043250|FG001|NOT COMPLETED|Overall Study||3
3309934|NCT03036124|4043258|FG000|STARTED|Overall Study||2373
3309935|NCT03036124|4043259|FG001|STARTED|Overall Study||2371
3309936|NCT03036124|4043258|FG000|COMPLETED|Overall Study||2368
3309937|NCT03036124|4043259|FG001|COMPLETED|Overall Study||2365
3309938|NCT03036124|4043258|FG000|NOT COMPLETED|Overall Study||5
3309939|NCT03036124|4043259|FG001|NOT COMPLETED|Overall Study||6
3309940|NCT03036150|4043267|FG000|STARTED|Overall Study||2152
3309941|NCT03036150|4043268|FG001|STARTED|Overall Study||2152
3309942|NCT03036150|4043267|FG000|COMPLETED|Overall Study||2142
3309943|NCT03036150|4043268|FG001|COMPLETED|Overall Study||2147
3309944|NCT03036150|4043267|FG000|NOT COMPLETED|Overall Study||10
3309945|NCT03036150|4043268|FG001|NOT COMPLETED|Overall Study||5
3309946|NCT03036163|4043281|FG000|STARTED|Overall Study||6
3309947|NCT03036163|4043282|FG001|STARTED|Overall Study||6
3309948|NCT03036163|4043283|FG002|STARTED|Overall Study||6
3309949|NCT03036163|4043284|FG003|STARTED|Overall Study||6
3309950|NCT03036163|4043285|FG004|STARTED|Overall Study||6
3309951|NCT03036163|4043286|FG005|STARTED|Overall Study||5
3309952|NCT03036163|4043287|FG006|STARTED|Overall Study||5
3309953|NCT03036163|4043281|FG000|COMPLETED|Overall Study||6
3309954|NCT03036163|4043282|FG001|COMPLETED|Overall Study||6
3309955|NCT03036163|4043283|FG002|COMPLETED|Overall Study||6
3309956|NCT03036163|4043284|FG003|COMPLETED|Overall Study||6
3309957|NCT03036163|4043285|FG004|COMPLETED|Overall Study||6
3309958|NCT03036163|4043286|FG005|COMPLETED|Overall Study||5
3309959|NCT03036163|4043287|FG006|COMPLETED|Overall Study||5
3309960|NCT03036163|4043281|FG000|NOT COMPLETED|Overall Study||0
3309961|NCT03036163|4043282|FG001|NOT COMPLETED|Overall Study||0
3309962|NCT03036163|4043283|FG002|NOT COMPLETED|Overall Study||0
3309963|NCT03036163|4043284|FG003|NOT COMPLETED|Overall Study||0
3309964|NCT03036163|4043285|FG004|NOT COMPLETED|Overall Study||0
3029423|NCT01106911|3748218|FG000|STARTED|Overall Study||1085
3029424|NCT01106911|3748218|FG000|COMPLETED|Overall Study||1080
3029425|NCT01106911|3748218|FG000|NOT COMPLETED|Overall Study||5
3029426|NCT01106950|3748222|FG000|STARTED|Overall Study||15
3029427|NCT01106950|3748222|FG000|COMPLETED|Overall Study||15
3029428|NCT01106950|3748222|FG000|NOT COMPLETED|Overall Study||0
3029429|NCT01106976|3748228|FG000|STARTED|Overall Study||67
3029430|NCT01106976|3748228|FG000|COMPLETED|Overall Study||59
3029431|NCT01106976|3748228|FG000|NOT COMPLETED|Overall Study||8
3029432|NCT01107015|3748236|FG000|STARTED|Overall Study||62
3029433|NCT01107015|3748237|FG001|STARTED|Overall Study||38
3029434|NCT01107015|3748238|FG002|STARTED|Overall Study||33
3029435|NCT01107015|3748239|FG003|STARTED|Overall Study||80
3029436|NCT01107015|3748236|FG000|COMPLETED|Overall Study||56
3029437|NCT01107015|3748237|FG001|COMPLETED|Overall Study||23
3029438|NCT01107015|3748238|FG002|COMPLETED|Overall Study||22
3029439|NCT01107015|3748239|FG003|COMPLETED|Overall Study||62
3029440|NCT01107015|3748236|FG000|NOT COMPLETED|Overall Study||6
3029441|NCT01107015|3748237|FG001|NOT COMPLETED|Overall Study||15
3029442|NCT01107015|3748238|FG002|NOT COMPLETED|Overall Study||11
3029443|NCT01107015|3748239|FG003|NOT COMPLETED|Overall Study||18
3029444|NCT01107197|3748251|FG000|STARTED|Overall Study||99
3029445|NCT01107197|3748252|FG001|STARTED|Overall Study||101
3309965|NCT03036163|4043286|FG005|NOT COMPLETED|Overall Study||0
3309966|NCT03036163|4043287|FG006|NOT COMPLETED|Overall Study||0
3309967|NCT03036215|4043305|FG000|STARTED|Overall Study||41
3309968|NCT03036215|4043306|FG001|STARTED|Overall Study||39
3309969|NCT03036215|4043305|FG000|COMPLETED|Overall Study||39
3309970|NCT03036215|4043306|FG001|COMPLETED|Overall Study||36
3309971|NCT03036215|4043305|FG000|NOT COMPLETED|Overall Study||2
3309972|NCT03036215|4043306|FG001|NOT COMPLETED|Overall Study||3
3309973|NCT03036293|4043319|FG000|STARTED|Overall Study||127
3309974|NCT03036293|4043320|FG001|STARTED|Overall Study||67
3309975|NCT03036293|4043321|FG002|STARTED|Overall Study||131
3309976|NCT03036293|4043322|FG003|STARTED|Overall Study||65
3309977|NCT03036293|4043319|FG000|COMPLETED|Overall Study||126
3309978|NCT03036293|4043320|FG001|COMPLETED|Overall Study||64
3309979|NCT03036293|4043321|FG002|COMPLETED|Overall Study||130
3309980|NCT03036293|4043322|FG003|COMPLETED|Overall Study||64
3309981|NCT03036293|4043319|FG000|NOT COMPLETED|Overall Study||1
3309982|NCT03036293|4043320|FG001|NOT COMPLETED|Overall Study||3
3309983|NCT03036293|4043321|FG002|NOT COMPLETED|Overall Study||1
3309984|NCT03036293|4043322|FG003|NOT COMPLETED|Overall Study||1
3309985|NCT03036384|4043334|FG000|STARTED|Overall Study||4
3309986|NCT03036384|4043335|FG001|STARTED|Overall Study||4
3309987|NCT03036384|4043336|FG002|STARTED|Overall Study||4
3309988|NCT03036384|4043337|FG003|STARTED|Overall Study||4
3309989|NCT03036384|4043338|FG004|STARTED|Overall Study||4
3309990|NCT03036384|4043339|FG005|STARTED|Overall Study||4
3309991|NCT03036384|4043340|FG006|STARTED|Overall Study||4
3309992|NCT03036384|4043341|FG007|STARTED|Overall Study||4
3309993|NCT03036384|4043342|FG008|STARTED|Overall Study||4
3309994|NCT03036384|4043343|FG009|STARTED|Overall Study||4
3309995|NCT03036384|4043334|FG000|COMPLETED|Overall Study||4
3309996|NCT03036384|4043335|FG001|COMPLETED|Overall Study||4
3309997|NCT03036384|4043336|FG002|COMPLETED|Overall Study||4
3309998|NCT03036384|4043337|FG003|COMPLETED|Overall Study||4
3309999|NCT03036384|4043338|FG004|COMPLETED|Overall Study||4
3310000|NCT03036384|4043339|FG005|COMPLETED|Overall Study||4
3310001|NCT03036384|4043340|FG006|COMPLETED|Overall Study||4
3310002|NCT03036384|4043341|FG007|COMPLETED|Overall Study||4
3310003|NCT03036384|4043342|FG008|COMPLETED|Overall Study||4
3310004|NCT03036384|4043343|FG009|COMPLETED|Overall Study||4
3310005|NCT03036384|4043334|FG000|NOT COMPLETED|Overall Study||0
3310006|NCT03036384|4043335|FG001|NOT COMPLETED|Overall Study||0
3310007|NCT03036384|4043336|FG002|NOT COMPLETED|Overall Study||0
3310008|NCT03036384|4043337|FG003|NOT COMPLETED|Overall Study||0
3310009|NCT03036384|4043338|FG004|NOT COMPLETED|Overall Study||0
3310010|NCT03036384|4043339|FG005|NOT COMPLETED|Overall Study||0
3310011|NCT03036384|4043340|FG006|NOT COMPLETED|Overall Study||0
3310012|NCT03036384|4043341|FG007|NOT COMPLETED|Overall Study||0
3310013|NCT03036384|4043342|FG008|NOT COMPLETED|Overall Study||0
3310014|NCT03036384|4043343|FG009|NOT COMPLETED|Overall Study||0
3310015|NCT03036813|4043364|FG000|STARTED|Overall Study||92
3310016|NCT03036813|4043365|FG001|STARTED|Overall Study||90
3310017|NCT03036813|4043366|FG002|STARTED|Overall Study||92
3310018|NCT03036813|4043364|FG000|COMPLETED|Overall Study||70
3310019|NCT03036813|4043365|FG001|COMPLETED|Overall Study||63
3310020|NCT03036813|4043366|FG002|COMPLETED|Overall Study||66
3310021|NCT03036813|4043364|FG000|NOT COMPLETED|Overall Study||22
3310022|NCT03036813|4043365|FG001|NOT COMPLETED|Overall Study||27
3310023|NCT03036813|4043366|FG002|NOT COMPLETED|Overall Study||26
3310024|NCT03036839|4043380|FG000|STARTED|Overall Study||45
3029446|NCT01107197|3748251|FG000|COMPLETED|Overall Study|Included in intention-to-treat efficacy analyses (per-protocol analyses were based on 67 patients )|79
3310025|NCT03036839|4043381|FG001|STARTED|Overall Study||31
3038201|NCT01152450|3757563|FG001|NOT COMPLETED|Period 3 (4 Weeks)||0
3310026|NCT03036839|4043382|FG002|STARTED|Overall Study||19
3310027|NCT03036839|4043380|FG000|COMPLETED|Overall Study||42
3310028|NCT03036839|4043381|FG001|COMPLETED|Overall Study||31
3310029|NCT03036839|4043382|FG002|COMPLETED|Overall Study||14
3310030|NCT03036839|4043380|FG000|NOT COMPLETED|Overall Study||3
3310031|NCT03036839|4043381|FG001|NOT COMPLETED|Overall Study||0
3029447|NCT01107197|3748252|FG001|COMPLETED|Overall Study|Included in intention-to-treat efficacy analyses (per-protocol analyses were based on 64 patients )|78
3029448|NCT01107197|3748251|FG000|NOT COMPLETED|Overall Study||20
3029449|NCT01107197|3748252|FG001|NOT COMPLETED|Overall Study||23
3029450|NCT01107353|3748260|FG000|STARTED|Overall Study||20
3029451|NCT01107353|3748261|FG001|STARTED|Overall Study||20
3029452|NCT01107353|3748260|FG000|COMPLETED|Overall Study||19
3029453|NCT01107353|3748261|FG001|COMPLETED|Overall Study||20
3029454|NCT01107353|3748260|FG000|NOT COMPLETED|Overall Study||1
3029455|NCT01107353|3748261|FG001|NOT COMPLETED|Overall Study||0
3029456|NCT01107379|3748267|FG000|STARTED|Overall Study||203
3029457|NCT01107379|3748267|FG000|COMPLETED|Overall Study||182
3029458|NCT01107379|3748267|FG000|NOT COMPLETED|Overall Study||21
3029459|NCT01107392|3748273|FG000|STARTED|Overall Study||158
3029460|NCT01107392|3748274|FG001|STARTED|Overall Study||157
3029461|NCT01107392|3748273|FG000|COMPLETED|Overall Study||153
3029462|NCT01107392|3748274|FG001|COMPLETED|Overall Study||154
3029463|NCT01107392|3748273|FG000|NOT COMPLETED|Overall Study||5
3029464|NCT01107392|3748274|FG001|NOT COMPLETED|Overall Study||3
3029465|NCT01107405|3748285|FG000|STARTED|Overall Study||21
3029466|NCT01107405|3748286|FG001|STARTED|Overall Study||20
3029467|NCT01107405|3748287|FG002|STARTED|Overall Study||20
3029468|NCT01107405|3748288|FG003|STARTED|Overall Study||20
3029469|NCT01107405|3748289|FG004|STARTED|Overall Study||20
3029470|NCT01107405|3748285|FG000|COMPLETED|Overall Study||19
3029471|NCT01107405|3748286|FG001|COMPLETED|Overall Study||19
3029472|NCT01107405|3748287|FG002|COMPLETED|Overall Study||18
3029473|NCT01107405|3748288|FG003|COMPLETED|Overall Study||17
3029474|NCT01107405|3748289|FG004|COMPLETED|Overall Study||17
3029475|NCT01107405|3748285|FG000|NOT COMPLETED|Overall Study||2
3029476|NCT01107405|3748286|FG001|NOT COMPLETED|Overall Study||1
3029477|NCT01107405|3748287|FG002|NOT COMPLETED|Overall Study||2
3029478|NCT01107405|3748288|FG003|NOT COMPLETED|Overall Study||3
3029479|NCT01107405|3748289|FG004|NOT COMPLETED|Overall Study||3
3029480|NCT01107418|3748305|FG000|STARTED|Overall Study||52
3029481|NCT01107418|3748305|FG000|COMPLETED|Overall Study||0
3029482|NCT01107418|3748305|FG000|NOT COMPLETED|Overall Study||52
3029483|NCT01107444|3748322|FG000|STARTED|Overall Study||120
3029484|NCT01107444|3748323|FG001|STARTED|Overall Study||60
3029485|NCT01107444|3748322|FG000|Received At Least 1 Dose of Study Drug|Overall Study||114
3029486|NCT01107444|3748323|FG001|Received At Least 1 Dose of Study Drug|Overall Study||48
3029487|NCT01107444|3748322|FG000|COMPLETED|Overall Study||112
3029488|NCT01107444|3748323|FG001|COMPLETED|Overall Study||47
3029489|NCT01107444|3748322|FG000|NOT COMPLETED|Overall Study||8
3029490|NCT01107444|3748323|FG001|NOT COMPLETED|Overall Study||13
3029491|NCT01107457|3748337|FG000|STARTED|Part A||27
3029492|NCT01107457|3748338|FG001|STARTED|Part A||28
3029493|NCT01107457|3748339|FG002|STARTED|Part A||30
3029494|NCT01107457|3748340|FG003|STARTED|Part A||29
3029495|NCT01107457|3748341|FG004|STARTED|Part A||28
3029496|NCT01107457|3748342|FG005|STARTED|Part A|120 mg and 80 mg ixekizumab were administered during Part B and C.|0
3029497|NCT01107457|3748337|FG000|Received at Least 1 Dose of Study Drug|Part A||27
3029498|NCT01107457|3748338|FG001|Received at Least 1 Dose of Study Drug|Part A||28
3029499|NCT01107457|3748339|FG002|Received at Least 1 Dose of Study Drug|Part A||30
3029500|NCT01107457|3748340|FG003|Received at Least 1 Dose of Study Drug|Part A||29
3029501|NCT01107457|3748341|FG004|Received at Least 1 Dose of Study Drug|Part A||28
3029502|NCT01107457|3748342|FG005|Received at Least 1 Dose of Study Drug|Part A|120 mg and 80 mg ixekizumab were administered during Part B and C.|0
3029503|NCT01107457|3748337|FG000|COMPLETED|Part A||22
3029504|NCT01107457|3748338|FG001|COMPLETED|Part A||21
3029505|NCT01107457|3748339|FG002|COMPLETED|Part A||29
3029506|NCT01107457|3748340|FG003|COMPLETED|Part A||26
3029507|NCT01107457|3748341|FG004|COMPLETED|Part A||27
3029508|NCT01107457|3748342|FG005|COMPLETED|Part A|120 mg and 80 mg ixekizumab were administered during Part B and C.|0
3029509|NCT01107457|3748337|FG000|NOT COMPLETED|Part A||5
3029510|NCT01107457|3748338|FG001|NOT COMPLETED|Part A||7
3029511|NCT01107457|3748339|FG002|NOT COMPLETED|Part A||1
3029512|NCT01107457|3748340|FG003|NOT COMPLETED|Part A||3
3029513|NCT01107457|3748341|FG004|NOT COMPLETED|Part A||1
3029514|NCT01107457|3748342|FG005|NOT COMPLETED|Part A||0
3029515|NCT01107457|3748337|FG000|STARTED|Part B and C|Placebo,10mg, 25mg,75mg and 150mg ixekizumab were administered during in Part A.|0
3029516|NCT01107457|3748338|FG001|STARTED|Part B and C|Placebo,10mg, 25mg,75mg and 150mg ixekizumab were administered during in Part A.|0
3029517|NCT01107457|3748339|FG002|STARTED|Part B and C|Placebo,10mg, 25mg,75mg and 150mg ixekizumab were administered during in Part A.|0
3029518|NCT01107457|3748340|FG003|STARTED|Part B and C|Placebo,10mg, 25mg,75mg and 150mg ixekizumab were administered during in Part A.|0
3029519|NCT01107457|3748341|FG004|STARTED|Part B and C|Placebo,10mg, 25mg,75mg and 150mg ixekizumab were administered during in Part A.|0
3029520|NCT01107457|3748342|FG005|STARTED|Part B and C|80 and 120 mg ixekizumab were administered during Part B and C.|120
3029521|NCT01107457|3748337|FG000|Completed Part B (Week 240)|Part B and C||0
3029522|NCT01107457|3748338|FG001|Completed Part B (Week 240)|Part B and C||0
3029523|NCT01107457|3748339|FG002|Completed Part B (Week 240)|Part B and C||0
3029524|NCT01107457|3748340|FG003|Completed Part B (Week 240)|Part B and C||0
3029525|NCT01107457|3748341|FG004|Completed Part B (Week 240)|Part B and C||0
3029526|NCT01107457|3748342|FG005|Completed Part B (Week 240)|Part B and C||74
3029527|NCT01107457|3748337|FG000|Completed Part C|Part B and C||0
3029528|NCT01107457|3748338|FG001|Completed Part C|Part B and C||0
3029529|NCT01107457|3748339|FG002|Completed Part C|Part B and C||0
3029530|NCT01107457|3748340|FG003|Completed Part C|Part B and C||0
3029531|NCT01107457|3748341|FG004|Completed Part C|Part B and C||0
3029532|NCT01107457|3748342|FG005|Completed Part C|Part B and C|Part C was stopped once ixekizumab became available through marketing authorization.|0
3029533|NCT01107457|3748337|FG000|Post Treatment Safety Visits|Part B and C||0
3029534|NCT01107457|3748338|FG001|Post Treatment Safety Visits|Part B and C||0
3029535|NCT01107457|3748339|FG002|Post Treatment Safety Visits|Part B and C||0
3029536|NCT01107457|3748340|FG003|Post Treatment Safety Visits|Part B and C||0
3029537|NCT01107457|3748341|FG004|Post Treatment Safety Visits|Part B and C||0
3029538|NCT01107457|3748342|FG005|Post Treatment Safety Visits|Part B and C|Only participants with neutropenia entered the post treatment safety visits.|6
3029539|NCT01107457|3748337|FG000|COMPLETED|Part B and C||0
3029540|NCT01107457|3748338|FG001|COMPLETED|Part B and C||0
3029541|NCT01107457|3748339|FG002|COMPLETED|Part B and C||0
3029542|NCT01107457|3748340|FG003|COMPLETED|Part B and C||0
3029543|NCT01107457|3748341|FG004|COMPLETED|Part B and C||0
3029544|NCT01107457|3748342|FG005|COMPLETED|Part B and C|No participants completed the study as Part C was stopped.|0
3029545|NCT01107457|3748337|FG000|NOT COMPLETED|Part B and C||0
3029546|NCT01107457|3748338|FG001|NOT COMPLETED|Part B and C||0
3029547|NCT01107457|3748339|FG002|NOT COMPLETED|Part B and C||0
3029548|NCT01107457|3748340|FG003|NOT COMPLETED|Part B and C||0
3029549|NCT01107457|3748341|FG004|NOT COMPLETED|Part B and C||0
3029550|NCT01107457|3748342|FG005|NOT COMPLETED|Part B and C||120
3029551|NCT01107535|3748360|FG000|STARTED|Overall Study||82
3029552|NCT01107535|3748360|FG000|Number of Participants Analyzed|Overall Study||82
3029553|NCT01107535|3748360|FG000|COMPLETED|Overall Study||77
3029554|NCT01107535|3748360|FG000|NOT COMPLETED|Overall Study||5
3166065|NCT01903187|3893550|FG000|NOT COMPLETED|3 Month||0
3166066|NCT01903187|3893551|FG001|NOT COMPLETED|3 Month||0
3166067|NCT01903187|3893550|FG000|STARTED|6 Month||2
3029555|NCT01107626|3748368|FG000|STARTED|Step 1: Induction Therapy||642
3029556|NCT01107626|3748369|FG001|STARTED|Step 1: Induction Therapy||287
3029557|NCT01107626|3748370|FG002|STARTED|Step 1: Induction Therapy||294
3029558|NCT01107626|3748371|FG003|STARTED|Step 1: Induction Therapy||293
3029559|NCT01107626|3748368|FG000|COMPLETED|Step 1: Induction Therapy||65
3029560|NCT01107626|3748369|FG001|COMPLETED|Step 1: Induction Therapy||287
3029561|NCT01107626|3748370|FG002|COMPLETED|Step 1: Induction Therapy||294
3029562|NCT01107626|3748371|FG003|COMPLETED|Step 1: Induction Therapy||293
3029563|NCT01107626|3748368|FG000|NOT COMPLETED|Step 1: Induction Therapy||577
3029564|NCT01107626|3748369|FG001|NOT COMPLETED|Step 1: Induction Therapy||0
3029565|NCT01107626|3748370|FG002|NOT COMPLETED|Step 1: Induction Therapy||0
3029566|NCT01107626|3748371|FG003|NOT COMPLETED|Step 1: Induction Therapy||0
3029567|NCT01107626|3748368|FG000|STARTED|Step 2: Maintenance Therapy|Patients without complete/partial response or stable disease post induction phase weren't randomized|0
3029568|NCT01107626|3748369|FG001|STARTED|Step 2: Maintenance Therapy||287
3029569|NCT01107626|3748370|FG002|STARTED|Step 2: Maintenance Therapy||294
3029570|NCT01107626|3748371|FG003|STARTED|Step 2: Maintenance Therapy||293
3029571|NCT01107626|3748368|FG000|COMPLETED|Step 2: Maintenance Therapy|Patients without complete/partial response or stable disease post induction phase weren't randomized|0
3029572|NCT01107626|3748369|FG001|COMPLETED|Step 2: Maintenance Therapy||1
3029573|NCT01107626|3748370|FG002|COMPLETED|Step 2: Maintenance Therapy||0
3029574|NCT01107626|3748371|FG003|COMPLETED|Step 2: Maintenance Therapy||1
3029575|NCT01107626|3748368|FG000|NOT COMPLETED|Step 2: Maintenance Therapy||0
3029576|NCT01107626|3748369|FG001|NOT COMPLETED|Step 2: Maintenance Therapy||286
3029577|NCT01107626|3748370|FG002|NOT COMPLETED|Step 2: Maintenance Therapy||294
3029578|NCT01107626|3748371|FG003|NOT COMPLETED|Step 2: Maintenance Therapy||292
3029579|NCT01107665|3748380|FG000|STARTED|Overall Study||60
3029580|NCT01107665|3748380|FG000|COMPLETED|Overall Study||11
3029581|NCT01107665|3748380|FG000|NOT COMPLETED|Overall Study||49
3029582|NCT01107730|3748389|FG000|STARTED|Overall Study||11
3029583|NCT01107730|3748390|FG001|STARTED|Overall Study||11
3029584|NCT01107730|3748391|FG002|STARTED|Overall Study||11
3029585|NCT01107730|3748389|FG000|COMPLETED|Overall Study||11
3029586|NCT01107730|3748390|FG001|COMPLETED|Overall Study||11
3166068|NCT01903187|3893551|FG001|STARTED|6 Month||0
3166069|NCT01903187|3893550|FG000|COMPLETED|6 Month||2
3166070|NCT01903187|3893551|FG001|COMPLETED|6 Month||0
3029587|NCT01107730|3748391|FG002|COMPLETED|Overall Study||11
3029588|NCT01107730|3748389|FG000|NOT COMPLETED|Overall Study||0
3029589|NCT01107730|3748390|FG001|NOT COMPLETED|Overall Study||0
3029590|NCT01107730|3748391|FG002|NOT COMPLETED|Overall Study||0
3029591|NCT01107743|3748399|FG000|STARTED|Overall Study||1291
3029592|NCT01107743|3748399|FG000|COMPLETED|Overall Study||1245
3029593|NCT01107743|3748399|FG000|NOT COMPLETED|Overall Study||46
3029594|NCT01107834|3748450|FG000|STARTED|Overall Study||30
3029595|NCT01107834|3748451|FG001|STARTED|Overall Study||30
3029596|NCT01107834|3748450|FG000|COMPLETED|Overall Study||30
3029597|NCT01107834|3748451|FG001|COMPLETED|Overall Study||30
3029598|NCT01107834|3748450|FG000|NOT COMPLETED|Overall Study||0
3029599|NCT01107834|3748451|FG001|NOT COMPLETED|Overall Study||0
3029600|NCT01107886|3748459|FG000|STARTED|Overall Study|Randomized subjects|8280
3029601|NCT01107886|3748460|FG001|STARTED|Overall Study|Randomized subjects|8212
3029602|NCT01107886|3748459|FG000|COMPLETED|Overall Study|Completed subjects|8078
3029603|NCT01107886|3748460|FG001|COMPLETED|Overall Study|Completed subjects|7998
3029604|NCT01107886|3748459|FG000|NOT COMPLETED|Overall Study||202
3029605|NCT01107886|3748460|FG001|NOT COMPLETED|Overall Study||214
3166071|NCT01903187|3893550|FG000|NOT COMPLETED|6 Month||0
3029606|NCT01107899|3748469|FG000|STARTED|Overall Study||10
3029607|NCT01107899|3748470|FG001|STARTED|Overall Study||10
3029608|NCT01107899|3748471|FG002|STARTED|Overall Study||9
3029609|NCT01107899|3748469|FG000|Received at Least One Dose of Study Drug|Overall Study||10
3029610|NCT01107899|3748470|FG001|Received at Least One Dose of Study Drug|Overall Study||10
3029611|NCT01107899|3748471|FG002|Received at Least One Dose of Study Drug|Overall Study||8
3029612|NCT01107899|3748469|FG000|Loading Dose (LD) Intent to Treat (ITT)|Overall Study|Received LD and had evaluable pharmacodynamic (PD) measurements 24-hours post-LD.|5
3029613|NCT01107899|3748470|FG001|Loading Dose (LD) Intent to Treat (ITT)|Overall Study|Received LD and had evaluable pharmacodynamic (PD) measurements 24-hours post-LD.|10
3029614|NCT01107899|3748471|FG002|Loading Dose (LD) Intent to Treat (ITT)|Overall Study|Received LD and had evaluable pharmacodynamic (PD) measurements 24-hours post-LD.|6
3029615|NCT01107899|3748469|FG000|ITT Washout Population|Overall Study|ITT Washout Population (WP): Received LD, had evaluable baseline PD data (pre-LD) and post-LD.|5
3029616|NCT01107899|3748470|FG001|ITT Washout Population|Overall Study|ITT Washout Population (WP): Received LD, had evaluable baseline PD data (pre-LD) and post-LD.|10
3029617|NCT01107899|3748471|FG002|ITT Washout Population|Overall Study|ITT Washout Population (WP): Received LD, had evaluable baseline PD data (pre-LD) and post-LD.|6
3029618|NCT01107899|3748469|FG000|Primary Washout Population|Overall Study|Primary WP: Completed study with no missed visits, had evaluable PD data through Day 11.|5
3029619|NCT01107899|3748470|FG001|Primary Washout Population|Overall Study|Primary WP: Completed study with no missed visits, had evaluable PD data through Day 11.|10
3029620|NCT01107899|3748471|FG002|Primary Washout Population|Overall Study|Primary WP: Completed study with no missed visits, had evaluable PD data through Day 11.|4
3029621|NCT01107899|3748469|FG000|COMPLETED|Overall Study||5
3029622|NCT01107899|3748470|FG001|COMPLETED|Overall Study||10
3029623|NCT01107899|3748471|FG002|COMPLETED|Overall Study||5
3029624|NCT01107899|3748469|FG000|NOT COMPLETED|Overall Study||5
3029625|NCT01107899|3748470|FG001|NOT COMPLETED|Overall Study||0
3029626|NCT01107899|3748471|FG002|NOT COMPLETED|Overall Study||4
3029627|NCT01107912|3748486|FG000|STARTED|Period 1||73
3029628|NCT01107912|3748487|FG001|STARTED|Period 1||0
3029629|NCT01107912|3748488|FG002|STARTED|Period 1||0
3029630|NCT01107912|3748489|FG003|STARTED|Period 1||0
3029631|NCT01107912|3748490|FG004|STARTED|Period 1||82
3029632|NCT01107912|3748491|FG005|STARTED|Period 1||0
3029633|NCT01107912|3748486|FG000|Received at Least 1 Dose of Study Drug|Period 1||73
3029634|NCT01107912|3748487|FG001|Received at Least 1 Dose of Study Drug|Period 1||0
3029635|NCT01107912|3748488|FG002|Received at Least 1 Dose of Study Drug|Period 1||0
3029636|NCT01107912|3748489|FG003|Received at Least 1 Dose of Study Drug|Period 1||0
3029637|NCT01107912|3748490|FG004|Received at Least 1 Dose of Study Drug|Period 1||82
3029638|NCT01107912|3748491|FG005|Received at Least 1 Dose of Study Drug|Period 1||0
3029639|NCT01107912|3748486|FG000|COMPLETED|Period 1||72
3029640|NCT01107912|3748487|FG001|COMPLETED|Period 1||0
3029641|NCT01107912|3748488|FG002|COMPLETED|Period 1||0
3029642|NCT01107912|3748489|FG003|COMPLETED|Period 1||0
3029643|NCT01107912|3748490|FG004|COMPLETED|Period 1||79
3029644|NCT01107912|3748491|FG005|COMPLETED|Period 1||0
3029645|NCT01107912|3748486|FG000|NOT COMPLETED|Period 1||1
3029646|NCT01107912|3748487|FG001|NOT COMPLETED|Period 1||0
3029647|NCT01107912|3748488|FG002|NOT COMPLETED|Period 1||0
3029648|NCT01107912|3748489|FG003|NOT COMPLETED|Period 1||0
3029649|NCT01107912|3748490|FG004|NOT COMPLETED|Period 1||3
3029650|NCT01107912|3748491|FG005|NOT COMPLETED|Period 1||0
3029651|NCT01107912|3748486|FG000|STARTED|Period 2|Participants switched to either 10 mg prasugrel or 75 mg clopidogrel in Period 2.|0
3029652|NCT01107912|3748487|FG001|STARTED|Period 2||36
3029653|NCT01107912|3748488|FG002|STARTED|Period 2||36
3029654|NCT01107912|3748489|FG003|STARTED|Period 2||41
3029655|NCT01107912|3748490|FG004|STARTED|Period 2|Participants switched to either 5 mg prasugrel or 75 mg clopidogrel in Period 2.|0
3029656|NCT01107912|3748491|FG005|STARTED|Period 2||38
3029657|NCT01107912|3748486|FG000|COMPLETED|Period 2||0
3029658|NCT01107912|3748487|FG001|COMPLETED|Period 2||36
3029659|NCT01107912|3748488|FG002|COMPLETED|Period 2||35
3029660|NCT01107912|3748489|FG003|COMPLETED|Period 2||41
3029661|NCT01107912|3748490|FG004|COMPLETED|Period 2||0
3029662|NCT01107912|3748491|FG005|COMPLETED|Period 2||38
3029663|NCT01107912|3748486|FG000|NOT COMPLETED|Period 2||0
3029664|NCT01107912|3748487|FG001|NOT COMPLETED|Period 2||0
3029665|NCT01107912|3748488|FG002|NOT COMPLETED|Period 2||1
3029666|NCT01107912|3748489|FG003|NOT COMPLETED|Period 2||0
3029667|NCT01107912|3748490|FG004|NOT COMPLETED|Period 2||0
3029668|NCT01107912|3748491|FG005|NOT COMPLETED|Period 2||0
3029669|NCT01107912|3748486|FG000|STARTED|Period 3||0
3029670|NCT01107912|3748487|FG001|STARTED|Period 3|Participants who received 75 mg clopidogrel in Period 2 received 10 mg prasugrel in Period 3|35
3029671|NCT01107912|3748488|FG002|STARTED|Period 3|Participants who received 10 mg prasugrel in Period 2 received 75 mg clopidogrel in Period 3|36
3029672|NCT01107912|3748489|FG003|STARTED|Period 3|Participants who received 75 mg clopidogrel in Period 2 received 5 mg prasugrel in Period 3|38
3029673|NCT01107912|3748490|FG004|STARTED|Period 3||0
3029674|NCT01107912|3748491|FG005|STARTED|Period 3|Participants who received 5 mg prasugrel in Period 2 received 75 mg clopidogrel in Period 3|41
3029675|NCT01107912|3748486|FG000|COMPLETED|Period 3||0
3029676|NCT01107912|3748487|FG001|COMPLETED|Period 3||34
3029677|NCT01107912|3748488|FG002|COMPLETED|Period 3||35
3029678|NCT01107912|3748489|FG003|COMPLETED|Period 3||37
3029679|NCT01107912|3748490|FG004|COMPLETED|Period 3||0
3029680|NCT01107912|3748491|FG005|COMPLETED|Period 3||41
3029681|NCT01107912|3748486|FG000|NOT COMPLETED|Period 3||0
3029682|NCT01107912|3748487|FG001|NOT COMPLETED|Period 3||1
3029683|NCT01107912|3748488|FG002|NOT COMPLETED|Period 3||1
3029684|NCT01107912|3748489|FG003|NOT COMPLETED|Period 3||1
3029685|NCT01107912|3748490|FG004|NOT COMPLETED|Period 3||0
3029686|NCT01107912|3748491|FG005|NOT COMPLETED|Period 3||0
3029687|NCT01107925|3748510|FG000|STARTED|Period 1-Randomization up Through Day 12||34
3029688|NCT01107925|3748511|FG001|STARTED|Period 1-Randomization up Through Day 12||0
3029689|NCT01107925|3748512|FG002|STARTED|Period 1-Randomization up Through Day 12||0
3029690|NCT01107925|3748513|FG003|STARTED|Period 1-Randomization up Through Day 12||0
3029691|NCT01107925|3748514|FG004|STARTED|Period 1-Randomization up Through Day 12||38
3029692|NCT01107925|3748515|FG005|STARTED|Period 1-Randomization up Through Day 12||0
3029693|NCT01107925|3748510|FG000|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||34
3029694|NCT01107925|3748511|FG001|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||0
3029695|NCT01107925|3748512|FG002|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||0
3029696|NCT01107925|3748513|FG003|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||0
3029697|NCT01107925|3748514|FG004|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||38
3029698|NCT01107925|3748515|FG005|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||0
3029699|NCT01107925|3748510|FG000|COMPLETED|Period 1-Randomization up Through Day 12||33
3029700|NCT01107925|3748511|FG001|COMPLETED|Period 1-Randomization up Through Day 12||0
3029701|NCT01107925|3748512|FG002|COMPLETED|Period 1-Randomization up Through Day 12||0
3029702|NCT01107925|3748513|FG003|COMPLETED|Period 1-Randomization up Through Day 12||0
3029703|NCT01107925|3748514|FG004|COMPLETED|Period 1-Randomization up Through Day 12||37
3029704|NCT01107925|3748515|FG005|COMPLETED|Period 1-Randomization up Through Day 12||0
3029705|NCT01107925|3748510|FG000|NOT COMPLETED|Period 1-Randomization up Through Day 12||1
3029706|NCT01107925|3748511|FG001|NOT COMPLETED|Period 1-Randomization up Through Day 12||0
3029707|NCT01107925|3748512|FG002|NOT COMPLETED|Period 1-Randomization up Through Day 12||0
3029708|NCT01107925|3748513|FG003|NOT COMPLETED|Period 1-Randomization up Through Day 12||0
3029709|NCT01107925|3748514|FG004|NOT COMPLETED|Period 1-Randomization up Through Day 12||1
3029710|NCT01107925|3748515|FG005|NOT COMPLETED|Period 1-Randomization up Through Day 12||0
3029711|NCT01107925|3748510|FG000|STARTED|Period 2|5 mg prasugrel (Period 1, LBW treatment) switched to 10 mg prasugrel or 75 mg clopidogrel (Period 2)|0
3029712|NCT01107925|3748511|FG001|STARTED|Period 2||16
3029713|NCT01107925|3748512|FG002|STARTED|Period 2||17
3029714|NCT01107925|3748513|FG003|STARTED|Period 2||20
3029715|NCT01107925|3748514|FG004|STARTED|Period 2|10 mg prasugrel (Period 1, HBW treatment) switched to 5 mg prasugrel or 75 mg clopidogrel (Period 2)|0
3029716|NCT01107925|3748515|FG005|STARTED|Period 2||17
3029717|NCT01107925|3748510|FG000|Took at Least 1 Dose of Study Drug|Period 2||0
3029718|NCT01107925|3748511|FG001|Took at Least 1 Dose of Study Drug|Period 2||16
3029719|NCT01107925|3748512|FG002|Took at Least 1 Dose of Study Drug|Period 2||17
3029720|NCT01107925|3748513|FG003|Took at Least 1 Dose of Study Drug|Period 2||20
3029721|NCT01107925|3748514|FG004|Took at Least 1 Dose of Study Drug|Period 2||0
3029722|NCT01107925|3748515|FG005|Took at Least 1 Dose of Study Drug|Period 2||17
3029723|NCT01107925|3748510|FG000|COMPLETED|Period 2||0
3029724|NCT01107925|3748511|FG001|COMPLETED|Period 2||15
3029725|NCT01107925|3748512|FG002|COMPLETED|Period 2||17
3029726|NCT01107925|3748513|FG003|COMPLETED|Period 2||20
3029727|NCT01107925|3748514|FG004|COMPLETED|Period 2||0
3029728|NCT01107925|3748515|FG005|COMPLETED|Period 2||16
3029729|NCT01107925|3748510|FG000|NOT COMPLETED|Period 2||0
3029730|NCT01107925|3748511|FG001|NOT COMPLETED|Period 2||1
3029731|NCT01107925|3748512|FG002|NOT COMPLETED|Period 2||0
3029732|NCT01107925|3748513|FG003|NOT COMPLETED|Period 2||0
3029733|NCT01107925|3748514|FG004|NOT COMPLETED|Period 2||0
3029734|NCT01107925|3748515|FG005|NOT COMPLETED|Period 2||1
3029735|NCT01107925|3748510|FG000|STARTED|Period 3||0
3029736|NCT01107925|3748511|FG001|STARTED|Period 3|75 mg clopidogrel (Period 2, LBW treatment sequence) crossed over to 10 mg prasugrel (Period 3).|17
3029737|NCT01107925|3748512|FG002|STARTED|Period 3|10 mg prasugrel (Period 2, LBW treatment sequence) crossed over to 75 mg clopidogrel (Period 3).|15
3029738|NCT01107925|3748513|FG003|STARTED|Period 3|75 mg clopidogrel (Period 2, HBW treatment sequence) crossed over to 5 mg prasugrel (Period 3).|16
3029739|NCT01107925|3748514|FG004|STARTED|Period 3||0
3029740|NCT01107925|3748515|FG005|STARTED|Period 3|5 mg prasugrel (Period 2, HBW treatment sequence) crossed over to 75 mg clopidogrel (Period 3).|20
3029741|NCT01107925|3748510|FG000|Took at Least 1 Dose of Study Drug|Period 3||0
3029742|NCT01107925|3748511|FG001|Took at Least 1 Dose of Study Drug|Period 3||17
3029743|NCT01107925|3748512|FG002|Took at Least 1 Dose of Study Drug|Period 3||15
3029744|NCT01107925|3748513|FG003|Took at Least 1 Dose of Study Drug|Period 3||16
3029745|NCT01107925|3748514|FG004|Took at Least 1 Dose of Study Drug|Period 3||0
3029746|NCT01107925|3748515|FG005|Took at Least 1 Dose of Study Drug|Period 3||20
3029747|NCT01107925|3748510|FG000|COMPLETED|Period 3||0
3029748|NCT01107925|3748511|FG001|COMPLETED|Period 3||17
3029749|NCT01107925|3748512|FG002|COMPLETED|Period 3||15
3029750|NCT01107925|3748513|FG003|COMPLETED|Period 3||16
3029751|NCT01107925|3748514|FG004|COMPLETED|Period 3||0
3029752|NCT01107925|3748515|FG005|COMPLETED|Period 3||20
3029753|NCT01107925|3748510|FG000|NOT COMPLETED|Period 3||0
3029754|NCT01107925|3748511|FG001|NOT COMPLETED|Period 3||0
3029755|NCT01107925|3748512|FG002|NOT COMPLETED|Period 3||0
3029756|NCT01107925|3748513|FG003|NOT COMPLETED|Period 3||0
3029757|NCT01107925|3748514|FG004|NOT COMPLETED|Period 3||0
3029758|NCT01107925|3748515|FG005|NOT COMPLETED|Period 3||0
3029759|NCT01107964|3748545|FG000|STARTED|Overall Study||13
3029760|NCT01107964|3748546|FG001|STARTED|Overall Study||14
3029761|NCT01107964|3748545|FG000|COMPLETED|Overall Study||12
3029762|NCT01107964|3748546|FG001|COMPLETED|Overall Study||13
3029763|NCT01107964|3748545|FG000|NOT COMPLETED|Overall Study||1
3029764|NCT01107964|3748546|FG001|NOT COMPLETED|Overall Study||1
3029765|NCT01108003|3748554|FG000|STARTED|Overall Study||4
3029766|NCT01108003|3748555|FG001|STARTED|Overall Study||3
3029767|NCT01108003|3748554|FG000|COMPLETED|Overall Study||4
3029768|NCT01108003|3748555|FG001|COMPLETED|Overall Study||3
3029769|NCT01108003|3748554|FG000|NOT COMPLETED|Overall Study||0
3029770|NCT01108003|3748555|FG001|NOT COMPLETED|Overall Study||0
3029771|NCT01108068|3748563|FG000|STARTED|Overall Study||10
3029772|NCT01108068|3748564|FG001|STARTED|Overall Study||16
3029773|NCT01108068|3748563|FG000|COMPLETED|Overall Study|Only 5 individuals were recruited into the Lithium treatment arm|4
3029774|NCT01108068|3748564|FG001|COMPLETED|Overall Study||16
3029775|NCT01108068|3748563|FG000|NOT COMPLETED|Overall Study||6
3029776|NCT01108068|3748564|FG001|NOT COMPLETED|Overall Study||0
3029777|NCT01108081|3748575|FG000|STARTED|Overall Study||46
3029778|NCT01108081|3748576|FG001|STARTED|Overall Study||42
3029779|NCT01108081|3748577|FG002|STARTED|Overall Study||38
3029780|NCT01108081|3748578|FG003|STARTED|Overall Study||43
3029781|NCT01108081|3748575|FG000|COMPLETED|Overall Study||44
3029782|NCT01108081|3748576|FG001|COMPLETED|Overall Study||40
3029783|NCT01108081|3748577|FG002|COMPLETED|Overall Study||38
3029784|NCT01108081|3748578|FG003|COMPLETED|Overall Study||39
3029785|NCT01108081|3748575|FG000|NOT COMPLETED|Overall Study||2
3029786|NCT01108081|3748576|FG001|NOT COMPLETED|Overall Study||2
3029787|NCT01108081|3748577|FG002|NOT COMPLETED|Overall Study||0
3029788|NCT01108081|3748578|FG003|NOT COMPLETED|Overall Study||4
3029789|NCT01108094|3748592|FG000|STARTED|Overall Study||12
3029790|NCT01108094|3748593|FG001|STARTED|Overall Study||3
3029791|NCT01108094|3748594|FG002|STARTED|Overall Study||4
3029792|NCT01108094|3748595|FG003|STARTED|Overall Study||10
3029793|NCT01108094|3748592|FG000|COMPLETED|Overall Study||9
3029794|NCT01108094|3748593|FG001|COMPLETED|Overall Study||3
3029795|NCT01108094|3748594|FG002|COMPLETED|Overall Study||4
3029796|NCT01108094|3748595|FG003|COMPLETED|Overall Study||10
3029797|NCT01108094|3748592|FG000|NOT COMPLETED|Overall Study||3
3029798|NCT01108094|3748593|FG001|NOT COMPLETED|Overall Study||0
3029799|NCT01108094|3748594|FG002|NOT COMPLETED|Overall Study||0
3029800|NCT01108094|3748595|FG003|NOT COMPLETED|Overall Study||0
3029801|NCT01108185|3748608|FG000|STARTED|Overall Study||3181
3029802|NCT01108185|3748608|FG000|Per Protocol Population|Overall Study||3181
3029803|NCT01108185|3748608|FG000|COMPLETED|Overall Study||3154
3029804|NCT01108185|3748608|FG000|NOT COMPLETED|Overall Study||27
3029805|NCT01108237|3748614|FG000|STARTED|Overall Study|78 subjects were consented with intent to treat, however, 73 had surgery.|73
3029806|NCT01108237|3748615|FG001|STARTED|Overall Study||101
3029807|NCT01108237|3748614|FG000|COMPLETED|Overall Study|66 subjects underwent surgery per the protocol, however, only 64 met the primary end point.|64
3029808|NCT01108237|3748615|FG001|COMPLETED|Overall Study||84
3029809|NCT01108237|3748614|FG000|NOT COMPLETED|Overall Study||9
3029810|NCT01108237|3748615|FG001|NOT COMPLETED|Overall Study||17
3029811|NCT01108263|3748623|FG000|STARTED|Overall Study||2
3029812|NCT01108263|3748624|FG001|STARTED|Overall Study||3
3029813|NCT01108263|3748623|FG000|COMPLETED|Overall Study||2
3029814|NCT01108263|3748624|FG001|COMPLETED|Overall Study||2
3029815|NCT01108263|3748623|FG000|NOT COMPLETED|Overall Study||0
3383732|NCT01915498|4118891|FG018|STARTED|Main Analysis (Sept 2013 - Sept 2017)||0
3383733|NCT01915498|4118873|FG000|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
3383734|NCT01915498|4118874|FG001|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
3383735|NCT01915498|4118875|FG002|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
3383736|NCT01915498|4118876|FG003|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
3383737|NCT01915498|4118877|FG004|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
3383738|NCT01915498|4118878|FG005|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
3383739|NCT01915498|4118879|FG006|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
3383740|NCT01915498|4118880|FG007|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||1
3383741|NCT01915498|4118881|FG008|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
3383742|NCT01915498|4118882|FG009|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
3383743|NCT01915498|4118883|FG010|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
2911574|NCT00485264|3621309|FG001|NOT COMPLETED|Overall Study||7
2911575|NCT00485264|3621310|FG002|NOT COMPLETED|Overall Study||6
2911576|NCT00485264|3621311|FG003|NOT COMPLETED|Overall Study||4
2911577|NCT00485264|3621312|FG004|NOT COMPLETED|Overall Study||6
2911578|NCT00485264|3621313|FG005|NOT COMPLETED|Overall Study||7
2911579|NCT00485303|3621332|FG000|STARTED|Overall Study||58
2911580|NCT00485303|3621332|FG000|COMPLETED|Overall Study||2
2911581|NCT00485303|3621332|FG000|NOT COMPLETED|Overall Study||56
2911582|NCT00485433|3621340|FG000|STARTED|Overall Study||24
2911583|NCT00485433|3621341|FG001|STARTED|Overall Study||25
2911584|NCT00485433|3621342|FG002|STARTED|Overall Study||24
2911585|NCT00485433|3621343|FG003|STARTED|Overall Study||25
2911586|NCT00485433|3621340|FG000|COMPLETED|Overall Study||24
2911587|NCT00485433|3621341|FG001|COMPLETED|Overall Study||25
2911588|NCT00485433|3621342|FG002|COMPLETED|Overall Study||24
2911589|NCT00485433|3621343|FG003|COMPLETED|Overall Study||25
2911590|NCT00485433|3621340|FG000|NOT COMPLETED|Overall Study||0
2911591|NCT00485433|3621341|FG001|NOT COMPLETED|Overall Study||0
3029816|NCT01108263|3748624|FG001|NOT COMPLETED|Overall Study||1
3029817|NCT01108341|3748630|FG000|STARTED|Overall Study||50
3029818|NCT01108341|3748630|FG000|Safety Set (Enrolled and Treated)|Overall Study||49
3029819|NCT01108341|3748630|FG000|COMPLETED|Overall Study||45
3029820|NCT01108341|3748630|FG000|NOT COMPLETED|Overall Study||5
3029821|NCT01108406|3748634|FG000|STARTED|Overall Study||22
3029822|NCT01108406|3748634|FG000|COMPLETED|Overall Study||22
3029823|NCT01108406|3748634|FG000|NOT COMPLETED|Overall Study||0
3029824|NCT01108445|3748642|FG000|STARTED|Overall Study||57
3029825|NCT01108445|3748643|FG001|STARTED|Overall Study||51
3029826|NCT01108445|3748642|FG000|COMPLETED|Overall Study||1
3029827|NCT01108445|3748643|FG001|COMPLETED|Overall Study||2
3029828|NCT01108445|3748642|FG000|NOT COMPLETED|Overall Study||56
3029829|NCT01108445|3748643|FG001|NOT COMPLETED|Overall Study||49
3029830|NCT01108458|3748649|FG000|STARTED|Overall Study||1
3029831|NCT01108458|3748649|FG000|COMPLETED|Overall Study||0
3029832|NCT01108458|3748649|FG000|NOT COMPLETED|Overall Study||1
3029833|NCT01108510|3748655|FG000|STARTED|Overall Study||349
3029834|NCT01108510|3748656|FG001|STARTED|Overall Study||349
3029835|NCT01108510|3748655|FG000|COMPLETED|Overall Study||70
3029836|NCT01108510|3748656|FG001|COMPLETED|Overall Study||81
3029837|NCT01108510|3748655|FG000|NOT COMPLETED|Overall Study||279
3029838|NCT01108510|3748656|FG001|NOT COMPLETED|Overall Study||268
3029839|NCT01108718|3748664|FG000|STARTED|Received First Intervention (2 Months)||5
3029840|NCT01108718|3748665|FG001|STARTED|Received First Intervention (2 Months)||7
3029841|NCT01108718|3748664|FG000|COMPLETED|Received First Intervention (2 Months)||5
3029842|NCT01108718|3748665|FG001|COMPLETED|Received First Intervention (2 Months)||7
3029843|NCT01108718|3748664|FG000|NOT COMPLETED|Received First Intervention (2 Months)||0
3029844|NCT01108718|3748665|FG001|NOT COMPLETED|Received First Intervention (2 Months)||0
3029845|NCT01108718|3748664|FG000|STARTED|Received Second Intervention (2 Months)|Used control mattress was delivered to participant at crossover causing her to withdraw.|5
3029846|NCT01108718|3748665|FG001|STARTED|Received Second Intervention (2 Months)||7
3029847|NCT01108718|3748664|FG000|COMPLETED|Received Second Intervention (2 Months)||4
3029848|NCT01108718|3748665|FG001|COMPLETED|Received Second Intervention (2 Months)||7
3029849|NCT01108718|3748664|FG000|NOT COMPLETED|Received Second Intervention (2 Months)||1
3029850|NCT01108718|3748665|FG001|NOT COMPLETED|Received Second Intervention (2 Months)||0
3029851|NCT01108731|3748672|FG000|STARTED|Overall Study||17
3029852|NCT01108731|3748673|FG001|STARTED|Overall Study||17
3029853|NCT01108731|3748672|FG000|COMPLETED|Overall Study||13
3029854|NCT01108731|3748673|FG001|COMPLETED|Overall Study||13
3029855|NCT01108731|3748672|FG000|NOT COMPLETED|Overall Study||4
3029856|NCT01108731|3748673|FG001|NOT COMPLETED|Overall Study||4
3029857|NCT01108757|3748681|FG000|STARTED|Overall Study||26
3029858|NCT01108757|3748682|FG001|STARTED|Overall Study||26
3029859|NCT01108757|3748681|FG000|COMPLETED|Overall Study||26
3029860|NCT01108757|3748682|FG001|COMPLETED|Overall Study||26
3029861|NCT01108757|3748681|FG000|NOT COMPLETED|Overall Study||0
3029862|NCT01108757|3748682|FG001|NOT COMPLETED|Overall Study||0
3029863|NCT01108796|3748692|FG000|STARTED|Overall Study||774
3029864|NCT01108796|3748693|FG001|STARTED|Overall Study||1067
3029865|NCT01108796|3748692|FG000|COMPLETED|Overall Study||767
3029866|NCT01108796|3748693|FG001|COMPLETED|Overall Study||1060
3029867|NCT01108796|3748692|FG000|NOT COMPLETED|Overall Study||7
3029868|NCT01108796|3748693|FG001|NOT COMPLETED|Overall Study||7
3029869|NCT01108809|3748701|FG000|STARTED|Overall Study||295
3029870|NCT01108809|3748701|FG000|COMPLETED|Overall Study||291
3029871|NCT01108809|3748701|FG000|NOT COMPLETED|Overall Study||4
3029872|NCT01108835|3748708|FG000|STARTED|Overall Study||90
3029873|NCT01108835|3748709|FG001|STARTED|Overall Study||90
3029874|NCT01108835|3748708|FG000|COMPLETED|Overall Study||73
3029875|NCT01108835|3748709|FG001|COMPLETED|Overall Study||69
3029876|NCT01108835|3748708|FG000|NOT COMPLETED|Overall Study||17
3029877|NCT01108835|3748709|FG001|NOT COMPLETED|Overall Study||21
3029878|NCT01109056|3748718|FG000|STARTED|Overall Study||57
3029879|NCT01109056|3748719|FG001|STARTED|Overall Study||58
3029880|NCT01109056|3748718|FG000|COMPLETED|Overall Study||50
3029881|NCT01109056|3748719|FG001|COMPLETED|Overall Study||53
3029882|NCT01109056|3748718|FG000|NOT COMPLETED|Overall Study||7
3029883|NCT01109056|3748719|FG001|NOT COMPLETED|Overall Study||5
3029884|NCT01109069|3748725|FG000|STARTED|Overall Study||199
3029885|NCT01109069|3748725|FG000|COMPLETED|Overall Study||106
3029886|NCT01109069|3748725|FG000|NOT COMPLETED|Overall Study||93
3029887|NCT01109108|3748732|FG000|STARTED|Overall Study||4035
3029888|NCT01109108|3748733|FG001|STARTED|Overall Study||4755
3029889|NCT01109108|3748732|FG000|COMPLETED|Overall Study||4035
3029890|NCT01109108|3748733|FG001|COMPLETED|Overall Study||4755
3029891|NCT01109108|3748732|FG000|NOT COMPLETED|Overall Study||0
3029892|NCT01109108|3748733|FG001|NOT COMPLETED|Overall Study||0
3029893|NCT01109147|3748742|FG000|STARTED|Overall Study||17
3029894|NCT01109147|3748743|FG001|STARTED|Overall Study||14
3029895|NCT01109147|3748744|FG002|STARTED|Overall Study||36
3029896|NCT01109147|3748742|FG000|COMPLETED|Overall Study|2 have been excluded of the results|15
3029897|NCT01109147|3748743|FG001|COMPLETED|Overall Study|3 have been excluded of the results|11
3029898|NCT01109147|3748744|FG002|COMPLETED|Overall Study|10 have been excluded of the results|26
3029899|NCT01109147|3748742|FG000|NOT COMPLETED|Overall Study||2
3029900|NCT01109147|3748743|FG001|NOT COMPLETED|Overall Study||3
3029901|NCT01109147|3748744|FG002|NOT COMPLETED|Overall Study||10
3029902|NCT01109173|3748756|FG000|STARTED|Overall Study||851
3029903|NCT01109173|3748757|FG001|STARTED|Overall Study||845
3166072|NCT01903187|3893551|FG001|NOT COMPLETED|6 Month||0
3166073|NCT01903187|3893550|FG000|STARTED|12 Month||2
3166074|NCT01903187|3893551|FG001|STARTED|12 Month||0
3166075|NCT01903187|3893550|FG000|COMPLETED|12 Month||2
3166076|NCT01903187|3893551|FG001|COMPLETED|12 Month||0
3166077|NCT01903187|3893550|FG000|NOT COMPLETED|12 Month||0
3166078|NCT01903187|3893551|FG001|NOT COMPLETED|12 Month||0
3166079|NCT01903252|3893560|FG000|STARTED|Double-Blind Induction||409
3166080|NCT01903252|3893561|FG001|STARTED|Double-Blind Induction||408
3029904|NCT01109173|3748758|FG002|STARTED|Overall Study||211
3029905|NCT01109173|3748759|FG003|STARTED|Overall Study||213
3029906|NCT01109173|3748756|FG000|COMPLETED|Overall Study||763
3029907|NCT01109173|3748757|FG001|COMPLETED|Overall Study||759
3029908|NCT01109173|3748758|FG002|COMPLETED|Overall Study||110
3029909|NCT01109173|3748759|FG003|COMPLETED|Overall Study||120
3029910|NCT01109173|3748756|FG000|NOT COMPLETED|Overall Study||88
3029911|NCT01109173|3748757|FG001|NOT COMPLETED|Overall Study||86
3029912|NCT01109173|3748758|FG002|NOT COMPLETED|Overall Study||101
3310032|NCT03036839|4043382|FG002|NOT COMPLETED|Overall Study||5
3310033|NCT03036852|4043396|FG000|STARTED|Overall Study||59
3310034|NCT03036852|4043396|FG000|COMPLETED|Overall Study||53
3310035|NCT03036852|4043396|FG000|NOT COMPLETED|Overall Study||6
3310036|NCT03037203|4043410|FG000|STARTED|Overall Study||28
3310037|NCT03037203|4043411|FG001|STARTED|Overall Study||28
3310038|NCT03037203|4043412|FG002|STARTED|Overall Study||10
3310039|NCT03037203|4043410|FG000|COMPLETED|Overall Study||27
3029913|NCT01109173|3748759|FG003|NOT COMPLETED|Overall Study||93
3029914|NCT01109316|3748775|FG000|STARTED|Study Period 1||22
3029915|NCT01109316|3748776|FG001|STARTED|Study Period 1||22
3029916|NCT01109316|3748777|FG002|STARTED|Study Period 1||22
3029917|NCT01109316|3748778|FG003|STARTED|Study Period 1||22
3029918|NCT01109316|3748779|FG004|STARTED|Study Period 1||22
3029919|NCT01109316|3748780|FG005|STARTED|Study Period 1||22
3029920|NCT01109316|3748775|FG000|Received at Least One Dose of Study Drug|Study Period 1||22
3029921|NCT01109316|3748776|FG001|Received at Least One Dose of Study Drug|Study Period 1||22
3029922|NCT01109316|3748777|FG002|Received at Least One Dose of Study Drug|Study Period 1||22
3029923|NCT01109316|3748778|FG003|Received at Least One Dose of Study Drug|Study Period 1||22
3029924|NCT01109316|3748779|FG004|Received at Least One Dose of Study Drug|Study Period 1||22
3029925|NCT01109316|3748780|FG005|Received at Least One Dose of Study Drug|Study Period 1||20
3029926|NCT01109316|3748775|FG000|COMPLETED|Study Period 1||22
3029927|NCT01109316|3748776|FG001|COMPLETED|Study Period 1||22
3029928|NCT01109316|3748777|FG002|COMPLETED|Study Period 1||19
3029929|NCT01109316|3748778|FG003|COMPLETED|Study Period 1||21
3029930|NCT01109316|3748779|FG004|COMPLETED|Study Period 1||20
3029931|NCT01109316|3748780|FG005|COMPLETED|Study Period 1||20
3029932|NCT01109316|3748775|FG000|NOT COMPLETED|Study Period 1||0
3029933|NCT01109316|3748776|FG001|NOT COMPLETED|Study Period 1||0
3029934|NCT01109316|3748777|FG002|NOT COMPLETED|Study Period 1||3
3029935|NCT01109316|3748778|FG003|NOT COMPLETED|Study Period 1||1
3029936|NCT01109316|3748779|FG004|NOT COMPLETED|Study Period 1||2
3029937|NCT01109316|3748780|FG005|NOT COMPLETED|Study Period 1||2
3029938|NCT01109316|3748775|FG000|STARTED|Study Period 2||22
3029939|NCT01109316|3748776|FG001|STARTED|Study Period 2||22
3029940|NCT01109316|3748777|FG002|STARTED|Study Period 2||19
3029941|NCT01109316|3748778|FG003|STARTED|Study Period 2||21
3029942|NCT01109316|3748779|FG004|STARTED|Study Period 2||20
3029943|NCT01109316|3748780|FG005|STARTED|Study Period 2||20
3029944|NCT01109316|3748775|FG000|COMPLETED|Study Period 2||21
3029945|NCT01109316|3748776|FG001|COMPLETED|Study Period 2||21
3029946|NCT01109316|3748777|FG002|COMPLETED|Study Period 2||18
3029947|NCT01109316|3748778|FG003|COMPLETED|Study Period 2||20
3029948|NCT01109316|3748779|FG004|COMPLETED|Study Period 2||20
3029949|NCT01109316|3748780|FG005|COMPLETED|Study Period 2||19
3029950|NCT01109316|3748775|FG000|NOT COMPLETED|Study Period 2||1
3029951|NCT01109316|3748776|FG001|NOT COMPLETED|Study Period 2||1
3029952|NCT01109316|3748777|FG002|NOT COMPLETED|Study Period 2||1
3029953|NCT01109316|3748778|FG003|NOT COMPLETED|Study Period 2||1
3166081|NCT01903252|3893562|FG002|STARTED|Double-Blind Induction||0
3166082|NCT01903252|3893563|FG003|STARTED|Double-Blind Induction||0
3166083|NCT01903252|3893564|FG004|STARTED|Double-Blind Induction||0
3029954|NCT01109316|3748779|FG004|NOT COMPLETED|Study Period 2||0
3029955|NCT01109316|3748780|FG005|NOT COMPLETED|Study Period 2||1
3029956|NCT01109316|3748775|FG000|STARTED|Study Period 3||21
3029957|NCT01109316|3748776|FG001|STARTED|Study Period 3||21
3029958|NCT01109316|3748777|FG002|STARTED|Study Period 3||18
3029959|NCT01109316|3748778|FG003|STARTED|Study Period 3||20
3029960|NCT01109316|3748779|FG004|STARTED|Study Period 3||20
3029961|NCT01109316|3748780|FG005|STARTED|Study Period 3||19
3029962|NCT01109316|3748775|FG000|COMPLETED|Study Period 3||20
3029963|NCT01109316|3748776|FG001|COMPLETED|Study Period 3||21
3029964|NCT01109316|3748777|FG002|COMPLETED|Study Period 3||18
3029965|NCT01109316|3748778|FG003|COMPLETED|Study Period 3||20
3029966|NCT01109316|3748779|FG004|COMPLETED|Study Period 3||18
3029967|NCT01109316|3748780|FG005|COMPLETED|Study Period 3||19
3029968|NCT01109316|3748775|FG000|NOT COMPLETED|Study Period 3||1
3029969|NCT01109316|3748776|FG001|NOT COMPLETED|Study Period 3||0
3029970|NCT01109316|3748777|FG002|NOT COMPLETED|Study Period 3||0
3029971|NCT01109316|3748778|FG003|NOT COMPLETED|Study Period 3||0
3029972|NCT01109316|3748779|FG004|NOT COMPLETED|Study Period 3||2
3029973|NCT01109316|3748780|FG005|NOT COMPLETED|Study Period 3||0
3166084|NCT01903252|3893565|FG005|STARTED|Double-Blind Induction||0
3310040|NCT03037203|4043411|FG001|COMPLETED|Overall Study||26
3029974|NCT01109381|3748788|FG000|STARTED|Overall Study||33
3029975|NCT01109381|3748788|FG000|COMPLETED|Overall Study||31
3029976|NCT01109381|3748788|FG000|NOT COMPLETED|Overall Study||2
3029977|NCT01109524|3748794|FG000|STARTED|Overall Study||60
3029978|NCT01109524|3748794|FG000|COMPLETED|Overall Study||3
3029979|NCT01109524|3748794|FG000|NOT COMPLETED|Overall Study||57
3029980|NCT01109576|3748798|FG000|STARTED|Overall Study||13
3029981|NCT01109576|3748798|FG000|COMPLETED|Overall Study||12
3029982|NCT01109576|3748798|FG000|NOT COMPLETED|Overall Study||1
3029983|NCT01109602|3748805|FG000|STARTED|Overall Study||14
3029984|NCT01109602|3748806|FG001|STARTED|Overall Study||23
3029985|NCT01109602|3748807|FG002|STARTED|Overall Study||10
3029986|NCT01109602|3748805|FG000|COMPLETED|Overall Study||13
3029987|NCT01109602|3748806|FG001|COMPLETED|Overall Study||21
3029988|NCT01109602|3748807|FG002|COMPLETED|Overall Study||9
3029989|NCT01109602|3748805|FG000|NOT COMPLETED|Overall Study||1
3029990|NCT01109602|3748806|FG001|NOT COMPLETED|Overall Study||2
3029991|NCT01109602|3748807|FG002|NOT COMPLETED|Overall Study||1
3029992|NCT01109849|3748816|FG000|STARTED|Initial Randomization: ADHD Treatment||50
3029993|NCT01109849|3748817|FG001|STARTED|Initial Randomization: ADHD Treatment||180
3029994|NCT01109849|3748818|FG002|STARTED|Initial Randomization: ADHD Treatment||0
3029995|NCT01109849|3748819|FG003|STARTED|Initial Randomization: ADHD Treatment||0
3029996|NCT01109849|3748820|FG004|STARTED|Initial Randomization: ADHD Treatment||0
3029997|NCT01109849|3748816|FG000|COMPLETED|Initial Randomization: ADHD Treatment||32
3029998|NCT01109849|3748817|FG001|COMPLETED|Initial Randomization: ADHD Treatment||131
3029999|NCT01109849|3748818|FG002|COMPLETED|Initial Randomization: ADHD Treatment||0
3030000|NCT01109849|3748819|FG003|COMPLETED|Initial Randomization: ADHD Treatment||0
3030001|NCT01109849|3748820|FG004|COMPLETED|Initial Randomization: ADHD Treatment||0
3030002|NCT01109849|3748816|FG000|NOT COMPLETED|Initial Randomization: ADHD Treatment||18
3030003|NCT01109849|3748817|FG001|NOT COMPLETED|Initial Randomization: ADHD Treatment||49
3030004|NCT01109849|3748818|FG002|NOT COMPLETED|Initial Randomization: ADHD Treatment||0
3030005|NCT01109849|3748819|FG003|NOT COMPLETED|Initial Randomization: ADHD Treatment||0
3030006|NCT01109849|3748820|FG004|NOT COMPLETED|Initial Randomization: ADHD Treatment||0
3030007|NCT01109849|3748816|FG000|STARTED|Adaptive Randomization: Weight Recovery||0
3030008|NCT01109849|3748817|FG001|STARTED|Adaptive Randomization: Weight Recovery||0
3030009|NCT01109849|3748818|FG002|STARTED|Adaptive Randomization: Weight Recovery||24
3030010|NCT01109849|3748819|FG003|STARTED|Adaptive Randomization: Weight Recovery||23
3030011|NCT01109849|3748820|FG004|STARTED|Adaptive Randomization: Weight Recovery||25
3030012|NCT01109849|3748816|FG000|COMPLETED|Adaptive Randomization: Weight Recovery||0
3030013|NCT01109849|3748817|FG001|COMPLETED|Adaptive Randomization: Weight Recovery||0
3030014|NCT01109849|3748818|FG002|COMPLETED|Adaptive Randomization: Weight Recovery||23
3030015|NCT01109849|3748819|FG003|COMPLETED|Adaptive Randomization: Weight Recovery||20
3030016|NCT01109849|3748820|FG004|COMPLETED|Adaptive Randomization: Weight Recovery||24
3030017|NCT01109849|3748816|FG000|NOT COMPLETED|Adaptive Randomization: Weight Recovery||0
3030018|NCT01109849|3748817|FG001|NOT COMPLETED|Adaptive Randomization: Weight Recovery||0
3030019|NCT01109849|3748818|FG002|NOT COMPLETED|Adaptive Randomization: Weight Recovery||1
3030020|NCT01109849|3748819|FG003|NOT COMPLETED|Adaptive Randomization: Weight Recovery||3
3030021|NCT01109849|3748820|FG004|NOT COMPLETED|Adaptive Randomization: Weight Recovery||1
3030022|NCT01109940|3748844|FG000|STARTED|Overall Study||21
3030023|NCT01109940|3748845|FG001|STARTED|Overall Study||8
3030024|NCT01109940|3748846|FG002|STARTED|Overall Study||7
3030025|NCT01109940|3748847|FG003|STARTED|Overall Study||3
3030026|NCT01109940|3748844|FG000|COMPLETED|Overall Study||13
3030027|NCT01109940|3748845|FG001|COMPLETED|Overall Study||6
3030028|NCT01109940|3748846|FG002|COMPLETED|Overall Study||6
3030029|NCT01109940|3748847|FG003|COMPLETED|Overall Study||3
3030030|NCT01109940|3748844|FG000|NOT COMPLETED|Overall Study||8
3030031|NCT01109940|3748845|FG001|NOT COMPLETED|Overall Study||2
3030032|NCT01109940|3748846|FG002|NOT COMPLETED|Overall Study||1
3030033|NCT01109940|3748847|FG003|NOT COMPLETED|Overall Study||0
3030034|NCT01109979|3748859|FG000|STARTED|Overall Study||12
3030035|NCT01109979|3748860|FG001|STARTED|Overall Study||12
3030036|NCT01109979|3748859|FG000|COMPLETED|Overall Study||10
3030037|NCT01109979|3748860|FG001|COMPLETED|Overall Study||11
3030038|NCT01109979|3748859|FG000|NOT COMPLETED|Overall Study||2
3030039|NCT01109979|3748860|FG001|NOT COMPLETED|Overall Study||1
3030040|NCT01109992|3748868|FG000|STARTED|Overall Study||11
3030041|NCT01109992|3748869|FG001|STARTED|Overall Study||32
3030042|NCT01109992|3748868|FG000|Subjects Enrolled|Overall Study||11
3030043|NCT01109992|3748869|FG001|Subjects Enrolled|Overall Study||32
3030044|NCT01109992|3748868|FG000|COMPLETED|Overall Study||11
3030045|NCT01109992|3748869|FG001|COMPLETED|Overall Study||30
3030046|NCT01109992|3748868|FG000|NOT COMPLETED|Overall Study||0
3030047|NCT01109992|3748869|FG001|NOT COMPLETED|Overall Study||2
3030048|NCT01110005|3748880|FG000|STARTED|Overall Study||157
3030049|NCT01110005|3748881|FG001|STARTED|Overall Study||161
3030050|NCT01110005|3748880|FG000|COMPLETED|Overall Study||153
3030051|NCT01110005|3748881|FG001|COMPLETED|Overall Study||156
3030052|NCT01110005|3748880|FG000|NOT COMPLETED|Overall Study||4
3030053|NCT01110005|3748881|FG001|NOT COMPLETED|Overall Study||5
3030054|NCT01110135|3748887|FG000|STARTED|Overall Study||43
3030055|NCT01110135|3748887|FG000|COMPLETED|Overall Study||34
3030056|NCT01110135|3748887|FG000|NOT COMPLETED|Overall Study||9
3030057|NCT01110187|3748893|FG000|STARTED|Overall Study||7
3030058|NCT01110187|3748894|FG001|STARTED|Overall Study||4
3030059|NCT01110187|3748893|FG000|COMPLETED|Overall Study|completed 7 day treatment|7
3030060|NCT01110187|3748894|FG001|COMPLETED|Overall Study|completed 7 day treatment|4
3030061|NCT01110187|3748893|FG000|NOT COMPLETED|Overall Study||0
3030062|NCT01110187|3748894|FG001|NOT COMPLETED|Overall Study||0
3030063|NCT01110200|3748904|FG000|STARTED|Overall Study||314
3030064|NCT01110200|3748905|FG001|STARTED|Overall Study||325
3030065|NCT01110200|3748904|FG000|COMPLETED|Overall Study||208
3030066|NCT01110200|3748905|FG001|COMPLETED|Overall Study||204
3030067|NCT01110200|3748904|FG000|NOT COMPLETED|Overall Study||106
3030068|NCT01110200|3748905|FG001|NOT COMPLETED|Overall Study||121
3030069|NCT01110239|3748915|FG000|STARTED|Sham Preconditioning||7
3030070|NCT01110239|3748916|FG001|STARTED|Sham Preconditioning||14
3030071|NCT01110239|3748917|FG002|STARTED|Sham Preconditioning||7
3030072|NCT01110239|3748918|FG003|STARTED|Sham Preconditioning||6
3030073|NCT01110239|3748915|FG000|COMPLETED|Sham Preconditioning||7
3030074|NCT01110239|3748916|FG001|COMPLETED|Sham Preconditioning||14
3030075|NCT01110239|3748917|FG002|COMPLETED|Sham Preconditioning||6
3030076|NCT01110239|3748918|FG003|COMPLETED|Sham Preconditioning||6
3030077|NCT01110239|3748915|FG000|NOT COMPLETED|Sham Preconditioning||0
3030078|NCT01110239|3748916|FG001|NOT COMPLETED|Sham Preconditioning||0
3030079|NCT01110239|3748917|FG002|NOT COMPLETED|Sham Preconditioning||1
3030080|NCT01110239|3748918|FG003|NOT COMPLETED|Sham Preconditioning||0
3030081|NCT01110239|3748915|FG000|STARTED|5 Min Ischemia||0
3030082|NCT01110239|3748916|FG001|STARTED|5 Min Ischemia||14
3030083|NCT01110239|3748917|FG002|STARTED|5 Min Ischemia||0
3030084|NCT01110239|3748918|FG003|STARTED|5 Min Ischemia||0
3030085|NCT01110239|3748915|FG000|COMPLETED|5 Min Ischemia||0
3030086|NCT01110239|3748916|FG001|COMPLETED|5 Min Ischemia||0
3030087|NCT01110239|3748917|FG002|COMPLETED|5 Min Ischemia||0
3030088|NCT01110239|3748918|FG003|COMPLETED|5 Min Ischemia||0
3030089|NCT01110239|3748915|FG000|NOT COMPLETED|5 Min Ischemia||0
3030090|NCT01110239|3748916|FG001|NOT COMPLETED|5 Min Ischemia||14
3030091|NCT01110239|3748917|FG002|NOT COMPLETED|5 Min Ischemia||0
3030092|NCT01110239|3748918|FG003|NOT COMPLETED|5 Min Ischemia||0
3030093|NCT01110239|3748915|FG000|STARTED|7.5 Min Ischemia||0
3030094|NCT01110239|3748916|FG001|STARTED|7.5 Min Ischemia||0
3030095|NCT01110239|3748917|FG002|STARTED|7.5 Min Ischemia||7
3030096|NCT01110239|3748918|FG003|STARTED|7.5 Min Ischemia||0
3030097|NCT01110239|3748915|FG000|COMPLETED|7.5 Min Ischemia||0
3030098|NCT01110239|3748916|FG001|COMPLETED|7.5 Min Ischemia||0
3030099|NCT01110239|3748917|FG002|COMPLETED|7.5 Min Ischemia||6
3030100|NCT01110239|3748918|FG003|COMPLETED|7.5 Min Ischemia||0
3030101|NCT01110239|3748915|FG000|NOT COMPLETED|7.5 Min Ischemia||0
3030102|NCT01110239|3748916|FG001|NOT COMPLETED|7.5 Min Ischemia||0
3030103|NCT01110239|3748917|FG002|NOT COMPLETED|7.5 Min Ischemia||1
3030104|NCT01110239|3748918|FG003|NOT COMPLETED|7.5 Min Ischemia||0
3030105|NCT01110239|3748915|FG000|STARTED|10 Min Ischemia||0
3030106|NCT01110239|3748916|FG001|STARTED|10 Min Ischemia||0
3030107|NCT01110239|3748917|FG002|STARTED|10 Min Ischemia||0
3030108|NCT01110239|3748918|FG003|STARTED|10 Min Ischemia||6
3030109|NCT01110239|3748915|FG000|COMPLETED|10 Min Ischemia||0
3030110|NCT01110239|3748916|FG001|COMPLETED|10 Min Ischemia||0
3030111|NCT01110239|3748917|FG002|COMPLETED|10 Min Ischemia||0
3030112|NCT01110239|3748918|FG003|COMPLETED|10 Min Ischemia||6
3030113|NCT01110239|3748915|FG000|NOT COMPLETED|10 Min Ischemia||0
3030114|NCT01110239|3748916|FG001|NOT COMPLETED|10 Min Ischemia||0
3030115|NCT01110239|3748917|FG002|NOT COMPLETED|10 Min Ischemia||0
3030116|NCT01110239|3748918|FG003|NOT COMPLETED|10 Min Ischemia||0
3030117|NCT01110252|3748929|FG000|STARTED|Pre-procedure (Stem Cells Infusion)||4
3030118|NCT01110252|3748929|FG000|COMPLETED|Pre-procedure (Stem Cells Infusion)||4
3030119|NCT01110252|3748929|FG000|NOT COMPLETED|Pre-procedure (Stem Cells Infusion)||0
3030120|NCT01110252|3748929|FG000|STARTED|Post-procedure (Stem Cells Infusion)||4
3030121|NCT01110252|3748929|FG000|COMPLETED|Post-procedure (Stem Cells Infusion)||4
3030122|NCT01110252|3748929|FG000|NOT COMPLETED|Post-procedure (Stem Cells Infusion)||0
3030123|NCT01110330|3748937|FG000|STARTED|Overall Study||119
3030124|NCT01110330|3748938|FG001|STARTED|Overall Study||230
3030125|NCT01110330|3748939|FG002|STARTED|Overall Study||234
3030126|NCT01110330|3748937|FG000|Positive Baseline Culture Set|Overall Study||56
3030127|NCT01110330|3748938|FG001|Positive Baseline Culture Set|Overall Study||111
3030128|NCT01110330|3748939|FG002|Positive Baseline Culture Set|Overall Study||114
3030129|NCT01110330|3748937|FG000|COMPLETED|Overall Study||104
3030130|NCT01110330|3748938|FG001|COMPLETED|Overall Study||207
3030131|NCT01110330|3748939|FG002|COMPLETED|Overall Study||208
3030132|NCT01110330|3748937|FG000|NOT COMPLETED|Overall Study||15
3030133|NCT01110330|3748938|FG001|NOT COMPLETED|Overall Study||23
3030134|NCT01110330|3748939|FG002|NOT COMPLETED|Overall Study||26
3030135|NCT01110382|3748949|FG000|STARTED|Overall Study||31
3030136|NCT01110382|3748950|FG001|STARTED|Overall Study||10
3030137|NCT01110382|3748949|FG000|COMPLETED|Overall Study||31
3030138|NCT01110382|3748950|FG001|COMPLETED|Overall Study||8
3030139|NCT01110382|3748949|FG000|NOT COMPLETED|Overall Study||0
3030140|NCT01110382|3748950|FG001|NOT COMPLETED|Overall Study||2
3030141|NCT01110395|3748956|FG000|STARTED|Overall Study||15
3030142|NCT01110395|3748956|FG000|COMPLETED|Overall Study||15
3030143|NCT01110395|3748956|FG000|NOT COMPLETED|Overall Study||0
3030144|NCT01110408|3748962|FG000|STARTED|Overall Study||31
3030145|NCT01110408|3748963|FG001|STARTED|Overall Study||10
3030146|NCT01110408|3748962|FG000|COMPLETED|Overall Study||30
3030147|NCT01110408|3748963|FG001|COMPLETED|Overall Study||10
3030148|NCT01110408|3748962|FG000|NOT COMPLETED|Overall Study||1
3030149|NCT01110408|3748963|FG001|NOT COMPLETED|Overall Study||0
3030150|NCT01110421|3748971|FG000|STARTED|Overall Study||5
3030151|NCT01110421|3748972|FG001|STARTED|Overall Study||2
3030152|NCT01110421|3748971|FG000|COMPLETED|Overall Study|Includes 1 participant who discontinued study drug due to an adverse event of empyema on Days 9-13.|5
3030153|NCT01110421|3748972|FG001|COMPLETED|Overall Study||2
3030154|NCT01110421|3748971|FG000|NOT COMPLETED|Overall Study||0
3030155|NCT01110421|3748972|FG001|NOT COMPLETED|Overall Study||0
3030156|NCT01110434|3748980|FG000|STARTED|Overall Study||40
3030157|NCT01110434|3748981|FG001|STARTED|Overall Study||26
3030158|NCT01110434|3748980|FG000|COMPLETED|Overall Study||29
3030159|NCT01110434|3748981|FG001|COMPLETED|Overall Study||20
3030160|NCT01110434|3748980|FG000|NOT COMPLETED|Overall Study||11
3030161|NCT01110434|3748981|FG001|NOT COMPLETED|Overall Study||6
3030162|NCT01110499|3748995|FG000|STARTED|Overall Study||14
3030163|NCT01110499|3748996|FG001|STARTED|Overall Study||14
3030164|NCT01110499|3748997|FG002|STARTED|Overall Study||14
3030165|NCT01110499|3748998|FG003|STARTED|Overall Study||14
3030166|NCT01110499|3748999|FG004|STARTED|Overall Study||14
3030167|NCT01110499|3749000|FG005|STARTED|Overall Study||14
3030168|NCT01110499|3749001|FG006|STARTED|Overall Study||39
3030169|NCT01110499|3749002|FG007|STARTED|Overall Study||40
3030170|NCT01110499|3748995|FG000|COMPLETED|Overall Study||14
3030171|NCT01110499|3748996|FG001|COMPLETED|Overall Study||14
3030172|NCT01110499|3748997|FG002|COMPLETED|Overall Study||14
3030173|NCT01110499|3748998|FG003|COMPLETED|Overall Study||14
3030174|NCT01110499|3748999|FG004|COMPLETED|Overall Study||14
3030175|NCT01110499|3749000|FG005|COMPLETED|Overall Study||14
3030176|NCT01110499|3749001|FG006|COMPLETED|Overall Study||39
3030177|NCT01110499|3749002|FG007|COMPLETED|Overall Study||40
3030178|NCT01110499|3748995|FG000|NOT COMPLETED|Overall Study||0
3030179|NCT01110499|3748996|FG001|NOT COMPLETED|Overall Study||0
3030180|NCT01110499|3748997|FG002|NOT COMPLETED|Overall Study||0
3030181|NCT01110499|3748998|FG003|NOT COMPLETED|Overall Study||0
3030182|NCT01110499|3748999|FG004|NOT COMPLETED|Overall Study||0
3030183|NCT01110499|3749000|FG005|NOT COMPLETED|Overall Study||0
3030184|NCT01110499|3749001|FG006|NOT COMPLETED|Overall Study||0
3030185|NCT01110499|3749002|FG007|NOT COMPLETED|Overall Study||0
3030186|NCT01110681|3749022|FG000|STARTED|Overall Study||115
3030187|NCT01110681|3749022|FG000|COMPLETED|Overall Study||83
3030188|NCT01110681|3749022|FG000|NOT COMPLETED|Overall Study||32
3030189|NCT01110707|3749028|FG000|STARTED|Overall Study||63
3030190|NCT01110707|3749029|FG001|STARTED|Overall Study||68
3030191|NCT01110707|3749028|FG000|COMPLETED|Overall Study||63
3030192|NCT01110707|3749029|FG001|COMPLETED|Overall Study||65
3030193|NCT01110707|3749028|FG000|NOT COMPLETED|Overall Study||0
3030194|NCT01110707|3749029|FG001|NOT COMPLETED|Overall Study||3
3030195|NCT01110876|3749038|FG000|STARTED|Overall Study|One received 400 mg Erlotinib dose as result of enzyme inducing anticonvulsants (EIACs)|13
3030196|NCT01110876|3749039|FG001|STARTED|Overall Study||5
3030197|NCT01110876|3749038|FG000|COMPLETED|Overall Study||13
3030198|NCT01110876|3749039|FG001|COMPLETED|Overall Study||5
3030199|NCT01110876|3749038|FG000|NOT COMPLETED|Overall Study||0
3030200|NCT01110876|3749039|FG001|NOT COMPLETED|Overall Study||0
3030201|NCT01110915|3749048|FG000|STARTED|Overall Study|Subjects being randomized to the MRI group.|177
3030202|NCT01110915|3749049|FG001|STARTED|Overall Study|Subjects being randomized to the Control group.|86
3030203|NCT01110915|3749048|FG000|COMPLETED|Overall Study|Subjects completing at least 4 months of follow-up.|167
3030204|NCT01110915|3749049|FG001|COMPLETED|Overall Study|Subjects completing at least 4 months of follow-up.|84
3030205|NCT01110915|3749048|FG000|NOT COMPLETED|Overall Study||10
3030206|NCT01110915|3749049|FG001|NOT COMPLETED|Overall Study||2
3030207|NCT01110967|3749056|FG000|STARTED|Overall Study||40
3030208|NCT01110967|3749056|FG000|Surgery|Overall Study||40
3030209|NCT01110967|3749056|FG000|1 Month Follow up|Overall Study||26
3030210|NCT01110967|3749056|FG000|3 Months Follow up|Overall Study||28
3030211|NCT01110967|3749056|FG000|6 Months Follow up|Overall Study||24
3030212|NCT01110967|3749056|FG000|12 Months Follow up|Overall Study||31
3030213|NCT01110967|3749056|FG000|COMPLETED|Overall Study||31
3030214|NCT01110967|3749056|FG000|NOT COMPLETED|Overall Study||9
3030215|NCT01111058|3749062|FG000|STARTED|Overall Study||28
3030216|NCT01111058|3749063|FG001|STARTED|Overall Study||24
3030217|NCT01111058|3749062|FG000|COMPLETED|Overall Study||28
3030218|NCT01111058|3749063|FG001|COMPLETED|Overall Study||24
3030219|NCT01111058|3749062|FG000|NOT COMPLETED|Overall Study||0
3030220|NCT01111058|3749063|FG001|NOT COMPLETED|Overall Study||0
3030227|NCT01111123|3749080|FG000|STARTED|Open- Label Phase||55
3030228|NCT01111123|3749081|FG001|STARTED|Open- Label Phase||0
3030229|NCT01111123|3749080|FG000|COMPLETED|Open- Label Phase||41
3030230|NCT01111123|3749081|FG001|COMPLETED|Open- Label Phase||0
3030231|NCT01111123|3749080|FG000|NOT COMPLETED|Open- Label Phase||14
3030232|NCT01111123|3749081|FG001|NOT COMPLETED|Open- Label Phase||0
3030233|NCT01111123|3749080|FG000|STARTED|Maintenance Phase||21
3030234|NCT01111123|3749081|FG001|STARTED|Maintenance Phase||20
3030235|NCT01111123|3749080|FG000|COMPLETED|Maintenance Phase||21
3030236|NCT01111123|3749081|FG001|COMPLETED|Maintenance Phase||18
3030237|NCT01111123|3749080|FG000|NOT COMPLETED|Maintenance Phase||0
3030238|NCT01111123|3749081|FG001|NOT COMPLETED|Maintenance Phase||2
3030239|NCT01111149|3749092|FG000|STARTED|Overall Study||9
3030240|NCT01111149|3749093|FG001|STARTED|Overall Study||6
3030241|NCT01111149|3749094|FG002|STARTED|Overall Study||9
3030242|NCT01111149|3749092|FG000|COMPLETED|Overall Study||7
3030243|NCT01111149|3749093|FG001|COMPLETED|Overall Study||5
3030244|NCT01111149|3749094|FG002|COMPLETED|Overall Study||5
3030245|NCT01111149|3749092|FG000|NOT COMPLETED|Overall Study||2
3030246|NCT01111149|3749093|FG001|NOT COMPLETED|Overall Study||1
3030247|NCT01111149|3749094|FG002|NOT COMPLETED|Overall Study||4
3030248|NCT01111162|3749102|FG000|STARTED|Overall Study||120
3030249|NCT01111162|3749102|FG000|COMPLETED|Overall Study||120
3030250|NCT01111162|3749102|FG000|NOT COMPLETED|Overall Study||0
3030251|NCT01111240|3749107|FG000|STARTED|Overall Study||4635
3030252|NCT01111240|3749107|FG000|COMPLETED|Overall Study||3569
3030253|NCT01111240|3749107|FG000|NOT COMPLETED|Overall Study||1066
3030254|NCT01111292|3749113|FG000|STARTED|Randomization||3
3030255|NCT01111292|3749114|FG001|STARTED|Randomization||2
3030256|NCT01111292|3749113|FG000|COMPLETED|Randomization||3
3030257|NCT01111292|3749114|FG001|COMPLETED|Randomization||2
3030258|NCT01111292|3749113|FG000|NOT COMPLETED|Randomization||0
3030259|NCT01111292|3749114|FG001|NOT COMPLETED|Randomization||0
3030260|NCT01111292|3749113|FG000|STARTED|Treatment||3
3030261|NCT01111292|3749114|FG001|STARTED|Treatment||2
3030262|NCT01111292|3749113|FG000|COMPLETED|Treatment||2
3030263|NCT01111292|3749114|FG001|COMPLETED|Treatment||1
3030264|NCT01111292|3749113|FG000|NOT COMPLETED|Treatment||1
3030265|NCT01111292|3749114|FG001|NOT COMPLETED|Treatment||1
3030266|NCT01111292|3749113|FG000|STARTED|Post Treatment Biopsy||2
3166085|NCT01903252|3893560|FG000|COMPLETED|Double-Blind Induction||370
3166086|NCT01903252|3893561|FG001|COMPLETED|Double-Blind Induction||367
3166087|NCT01903252|3893562|FG002|COMPLETED|Double-Blind Induction||0
3030267|NCT01111292|3749114|FG001|STARTED|Post Treatment Biopsy||1
3030268|NCT01111292|3749113|FG000|COMPLETED|Post Treatment Biopsy||2
3030269|NCT01111292|3749114|FG001|COMPLETED|Post Treatment Biopsy||1
3030270|NCT01111292|3749113|FG000|NOT COMPLETED|Post Treatment Biopsy||0
3030271|NCT01111292|3749114|FG001|NOT COMPLETED|Post Treatment Biopsy||0
3030272|NCT01111292|3749113|FG000|STARTED|Follow-Up||2
3030273|NCT01111292|3749114|FG001|STARTED|Follow-Up||1
3030274|NCT01111292|3749113|FG000|COMPLETED|Follow-Up||2
3030275|NCT01111292|3749114|FG001|COMPLETED|Follow-Up||1
3030276|NCT01111292|3749113|FG000|NOT COMPLETED|Follow-Up||0
3030277|NCT01111292|3749114|FG001|NOT COMPLETED|Follow-Up||0
3030278|NCT01111318|3749124|FG000|STARTED|Overall Study||12
3030279|NCT01111318|3749125|FG001|STARTED|Overall Study||8
3030280|NCT01111318|3749126|FG002|STARTED|Overall Study||8
3030281|NCT01111318|3749127|FG003|STARTED|Overall Study||8
3030282|NCT01111318|3749124|FG000|COMPLETED|Overall Study||12
3030283|NCT01111318|3749125|FG001|COMPLETED|Overall Study||8
3030284|NCT01111318|3749126|FG002|COMPLETED|Overall Study||8
3030285|NCT01111318|3749127|FG003|COMPLETED|Overall Study||8
3030286|NCT01111318|3749124|FG000|NOT COMPLETED|Overall Study||0
3030287|NCT01111318|3749125|FG001|NOT COMPLETED|Overall Study||0
3030288|NCT01111318|3749126|FG002|NOT COMPLETED|Overall Study||0
3030289|NCT01111318|3749127|FG003|NOT COMPLETED|Overall Study||0
3030290|NCT01111331|3749137|FG000|STARTED|Overall Study||9
3030291|NCT01111331|3749138|FG001|STARTED|Overall Study||9
3030292|NCT01111331|3749137|FG000|COMPLETED|Overall Study||9
3030293|NCT01111331|3749138|FG001|COMPLETED|Overall Study||9
3030294|NCT01111331|3749137|FG000|NOT COMPLETED|Overall Study||0
3030295|NCT01111331|3749138|FG001|NOT COMPLETED|Overall Study||0
3030296|NCT01111370|3749148|FG000|STARTED|Overall Study||60
3030297|NCT01111370|3749148|FG000|COMPLETED|Overall Study||58
3030298|NCT01111370|3749148|FG000|NOT COMPLETED|Overall Study||2
3030299|NCT01111461|3749152|FG000|STARTED|Overall Study||133
3030300|NCT01111461|3749152|FG000|COMPLETED|Overall Study|On treatment at data cut-off or on treatment until disease progression|82
3030301|NCT01111461|3749152|FG000|NOT COMPLETED|Overall Study||51
3030302|NCT01111474|3749156|FG000|STARTED|Overall Study|593 teeth from 74 participants: 296 teeth treated with cyanoacrylate and 297 teeth with LILT|74
3030303|NCT01111474|3749156|FG000|COMPLETED|Overall Study|434 teeth from 62 participants: 218 teeth teated with cyanoacrylate and 216 teeth with LILT|62
3030304|NCT01111474|3749156|FG000|NOT COMPLETED|Overall Study||12
3030305|NCT01111526|3749162|FG000|STARTED|Overall Study||4
3030306|NCT01111526|3749163|FG001|STARTED|Overall Study||8
3030307|NCT01111526|3749164|FG002|STARTED|Overall Study||10
3030308|NCT01111526|3749162|FG000|COMPLETED|Overall Study||4
3030309|NCT01111526|3749163|FG001|COMPLETED|Overall Study||7
3030310|NCT01111526|3749164|FG002|COMPLETED|Overall Study||8
3030311|NCT01111526|3749162|FG000|NOT COMPLETED|Overall Study||0
3030312|NCT01111526|3749163|FG001|NOT COMPLETED|Overall Study||1
3030313|NCT01111526|3749164|FG002|NOT COMPLETED|Overall Study||2
3030314|NCT01111539|3749168|FG000|STARTED|Phase B (Day 1 to Week 8)||211
3030315|NCT01111539|3749169|FG001|STARTED|Phase B (Day 1 to Week 8)||0
3030316|NCT01111539|3749170|FG002|STARTED|Phase B (Day 1 to Week 8)||0
3030317|NCT01111539|3749171|FG003|STARTED|Phase B (Day 1 to Week 8)||0
3030318|NCT01111539|3749172|FG004|STARTED|Phase B (Day 1 to Week 8)||0
3030319|NCT01111539|3749168|FG000|COMPLETED|Phase B (Day 1 to Week 8)||129
3030320|NCT01111539|3749169|FG001|COMPLETED|Phase B (Day 1 to Week 8)||0
3030321|NCT01111539|3749170|FG002|COMPLETED|Phase B (Day 1 to Week 8)||0
3030322|NCT01111539|3749171|FG003|COMPLETED|Phase B (Day 1 to Week 8)||0
3030323|NCT01111539|3749172|FG004|COMPLETED|Phase B (Day 1 to Week 8)||0
3030324|NCT01111539|3749168|FG000|NOT COMPLETED|Phase B (Day 1 to Week 8)||82
3030325|NCT01111539|3749169|FG001|NOT COMPLETED|Phase B (Day 1 to Week 8)||0
3030326|NCT01111539|3749170|FG002|NOT COMPLETED|Phase B (Day 1 to Week 8)||0
3030327|NCT01111539|3749171|FG003|NOT COMPLETED|Phase B (Day 1 to Week 8)||0
3030328|NCT01111539|3749172|FG004|NOT COMPLETED|Phase B (Day 1 to Week 8)||0
3030329|NCT01111539|3749168|FG000|STARTED|Phase B+ and Phase C (Weeks 9 to 14)||0
3030330|NCT01111539|3749169|FG001|STARTED|Phase B+ and Phase C (Weeks 9 to 14)||45
3030331|NCT01111539|3749170|FG002|STARTED|Phase B+ and Phase C (Weeks 9 to 14)||28
3030332|NCT01111539|3749171|FG003|STARTED|Phase B+ and Phase C (Weeks 9 to 14)||28
3030333|NCT01111539|3749172|FG004|STARTED|Phase B+ and Phase C (Weeks 9 to 14)||28
3030334|NCT01111539|3749168|FG000|Intent-to-treat (ITT) Sample|Phase B+ and Phase C (Weeks 9 to 14)||0
3030335|NCT01111539|3749169|FG001|Intent-to-treat (ITT) Sample|Phase B+ and Phase C (Weeks 9 to 14)||45
3030336|NCT01111539|3749170|FG002|Intent-to-treat (ITT) Sample|Phase B+ and Phase C (Weeks 9 to 14)||28
3030337|NCT01111539|3749171|FG003|Intent-to-treat (ITT) Sample|Phase B+ and Phase C (Weeks 9 to 14)||27
3030338|NCT01111539|3749172|FG004|Intent-to-treat (ITT) Sample|Phase B+ and Phase C (Weeks 9 to 14)||28
3030339|NCT01111539|3749168|FG000|Safety Sample|Phase B+ and Phase C (Weeks 9 to 14)||0
3030340|NCT01111539|3749169|FG001|Safety Sample|Phase B+ and Phase C (Weeks 9 to 14)||45
3030341|NCT01111539|3749170|FG002|Safety Sample|Phase B+ and Phase C (Weeks 9 to 14)||28
3030342|NCT01111539|3749171|FG003|Safety Sample|Phase B+ and Phase C (Weeks 9 to 14)||27
3030343|NCT01111539|3749172|FG004|Safety Sample|Phase B+ and Phase C (Weeks 9 to 14)||28
3030344|NCT01111539|3749168|FG000|COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||0
3030345|NCT01111539|3749169|FG001|COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||38
3030346|NCT01111539|3749170|FG002|COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||22
3030347|NCT01111539|3749171|FG003|COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||20
3030348|NCT01111539|3749172|FG004|COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||18
3030349|NCT01111539|3749168|FG000|NOT COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||0
3030350|NCT01111539|3749169|FG001|NOT COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||7
3030351|NCT01111539|3749170|FG002|NOT COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||6
3030352|NCT01111539|3749171|FG003|NOT COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||8
3310041|NCT03037203|4043412|FG002|COMPLETED|Overall Study||9
3310042|NCT03037203|4043410|FG000|NOT COMPLETED|Overall Study||1
3310043|NCT03037203|4043411|FG001|NOT COMPLETED|Overall Study||2
3310044|NCT03037203|4043412|FG002|NOT COMPLETED|Overall Study||1
3310045|NCT03037281|4043432|FG000|STARTED|Overall Study||6
3310046|NCT03037281|4043433|FG001|STARTED|Overall Study||8
3310047|NCT03037281|4043432|FG000|COMPLETED|Overall Study||6
3310048|NCT03037281|4043433|FG001|COMPLETED|Overall Study||8
3310049|NCT03037281|4043432|FG000|NOT COMPLETED|Overall Study||0
3310050|NCT03037281|4043433|FG001|NOT COMPLETED|Overall Study||0
3310051|NCT03037307|4043444|FG000|STARTED|Period 1||7
3030353|NCT01111539|3749172|FG004|NOT COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||10
3030354|NCT01111552|3749182|FG000|STARTED|Phase B (Day 1 to Week 8)||237
3030355|NCT01111552|3749183|FG001|STARTED|Phase B (Day 1 to Week 8)||0
3030356|NCT01111552|3749184|FG002|STARTED|Phase B (Day 1 to Week 8)||0
3030357|NCT01111552|3749185|FG003|STARTED|Phase B (Day 1 to Week 8)||0
3030358|NCT01111552|3749186|FG004|STARTED|Phase B (Day 1 to Week 8)||0
3030359|NCT01111552|3749182|FG000|COMPLETED|Phase B (Day 1 to Week 8)||120
3030360|NCT01111552|3749183|FG001|COMPLETED|Phase B (Day 1 to Week 8)||0
3030361|NCT01111552|3749184|FG002|COMPLETED|Phase B (Day 1 to Week 8)||0
3030362|NCT01111552|3749185|FG003|COMPLETED|Phase B (Day 1 to Week 8)||0
3030363|NCT01111552|3749186|FG004|COMPLETED|Phase B (Day 1 to Week 8)||0
3030364|NCT01111552|3749182|FG000|NOT COMPLETED|Phase B (Day 1 to Week 8)||117
3030365|NCT01111552|3749183|FG001|NOT COMPLETED|Phase B (Day 1 to Week 8)||0
3030366|NCT01111552|3749184|FG002|NOT COMPLETED|Phase B (Day 1 to Week 8)||0
3030367|NCT01111552|3749185|FG003|NOT COMPLETED|Phase B (Day 1 to Week 8)||0
3030368|NCT01111552|3749186|FG004|NOT COMPLETED|Phase B (Day 1 to Week 8)||0
3030369|NCT01111552|3749182|FG000|STARTED|Phase B+ and Phase C (Weeks 9 to 14)||0
3030370|NCT01111552|3749183|FG001|STARTED|Phase B+ and Phase C (Weeks 9 to 14)||54
3030371|NCT01111552|3749184|FG002|STARTED|Phase B+ and Phase C (Weeks 9 to 14)||22
3030372|NCT01111552|3749185|FG003|STARTED|Phase B+ and Phase C (Weeks 9 to 14)||21
3030373|NCT01111552|3749186|FG004|STARTED|Phase B+ and Phase C (Weeks 9 to 14)||23
3030374|NCT01111552|3749182|FG000|COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||0
3030375|NCT01111552|3749183|FG001|COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||45
3030376|NCT01111552|3749184|FG002|COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||17
3030377|NCT01111552|3749185|FG003|COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||17
3030378|NCT01111552|3749186|FG004|COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||18
3030379|NCT01111552|3749182|FG000|NOT COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||0
3030380|NCT01111552|3749183|FG001|NOT COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||9
3030381|NCT01111552|3749184|FG002|NOT COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||5
3030382|NCT01111552|3749185|FG003|NOT COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||4
3030383|NCT01111552|3749186|FG004|NOT COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||5
3030384|NCT01111604|3749199|FG000|STARTED|Overall Study||54
3030385|NCT01111604|3749200|FG001|STARTED|Overall Study||52
3030386|NCT01111604|3749201|FG002|STARTED|Overall Study||52
3030387|NCT01111604|3749199|FG000|Received at Least One Dose of Study Drug|Overall Study||49
3038202|NCT01152450|3757564|FG002|NOT COMPLETED|Period 3 (4 Weeks)||0
3310052|NCT03037307|4043445|FG001|STARTED|Period 1||7
3030388|NCT01111604|3749200|FG001|Received at Least One Dose of Study Drug|Overall Study||52
3030389|NCT01111604|3749201|FG002|Received at Least One Dose of Study Drug|Overall Study||52
3030390|NCT01111604|3749199|FG000|COMPLETED|Overall Study||46
3030391|NCT01111604|3749200|FG001|COMPLETED|Overall Study||52
3030392|NCT01111604|3749201|FG002|COMPLETED|Overall Study||49
3030393|NCT01111604|3749199|FG000|NOT COMPLETED|Overall Study||8
3030394|NCT01111604|3749200|FG001|NOT COMPLETED|Overall Study||0
3030395|NCT01111604|3749201|FG002|NOT COMPLETED|Overall Study||3
3030396|NCT01111825|3749231|FG000|STARTED|Overall Study||8
3030397|NCT01111825|3749232|FG001|STARTED|Overall Study||6
3030398|NCT01111825|3749233|FG002|STARTED|Overall Study||37
3030399|NCT01111825|3749234|FG003|STARTED|Overall Study||48
3030400|NCT01111825|3749231|FG000|COMPLETED|Overall Study||5
3030401|NCT01111825|3749232|FG001|COMPLETED|Overall Study||5
3030402|NCT01111825|3749233|FG002|COMPLETED|Overall Study||29
3030403|NCT01111825|3749234|FG003|COMPLETED|Overall Study||27
3030404|NCT01111825|3749231|FG000|NOT COMPLETED|Overall Study||3
3030405|NCT01111825|3749232|FG001|NOT COMPLETED|Overall Study||1
3030406|NCT01111825|3749233|FG002|NOT COMPLETED|Overall Study||8
3030407|NCT01111825|3749234|FG003|NOT COMPLETED|Overall Study||21
3030408|NCT01111838|3749244|FG000|STARTED|Overall Study||22
3030409|NCT01111838|3749244|FG000|COMPLETED|Overall Study||15
3030410|NCT01111838|3749244|FG000|NOT COMPLETED|Overall Study||7
3030411|NCT01111851|3749250|FG000|STARTED|Overall Study||8
3030412|NCT01111851|3749251|FG001|STARTED|Overall Study||8
3030413|NCT01111851|3749250|FG000|COMPLETED|Overall Study||6
3030414|NCT01111851|3749251|FG001|COMPLETED|Overall Study||8
3030415|NCT01111851|3749250|FG000|NOT COMPLETED|Overall Study||2
3030416|NCT01111851|3749251|FG001|NOT COMPLETED|Overall Study||0
3030417|NCT01112059|3749259|FG000|STARTED|Overall Study||20
3030418|NCT01112059|3749260|FG001|STARTED|Overall Study||20
3030419|NCT01112059|3749259|FG000|COMPLETED|Overall Study||19
3030420|NCT01112059|3749260|FG001|COMPLETED|Overall Study||20
3030421|NCT01112059|3749259|FG000|NOT COMPLETED|Overall Study||1
3030422|NCT01112059|3749260|FG001|NOT COMPLETED|Overall Study||0
3030423|NCT01112228|3749269|FG000|STARTED|Overall Study||600
3030424|NCT01112228|3749269|FG000|COMPLETED|Overall Study||600
3030425|NCT01112228|3749269|FG000|NOT COMPLETED|Overall Study||0
3030426|NCT01112241|3749275|FG000|STARTED|Overall Study||17
3030427|NCT01112241|3749275|FG000|COMPLETED|Overall Study||17
3030428|NCT01112241|3749275|FG000|NOT COMPLETED|Overall Study||0
3030429|NCT01112267|3749281|FG000|STARTED|Overall Study||126
3030430|NCT01112267|3749282|FG001|STARTED|Overall Study||122
3030431|NCT01112267|3749281|FG000|Treated|Overall Study||125
3030432|NCT01112267|3749282|FG001|Treated|Overall Study||120
3030433|NCT01112267|3749281|FG000|COMPLETED|Overall Study||92
3030434|NCT01112267|3749282|FG001|COMPLETED|Overall Study||104
3030435|NCT01112267|3749281|FG000|NOT COMPLETED|Overall Study||34
3030436|NCT01112267|3749282|FG001|NOT COMPLETED|Overall Study||18
3030437|NCT01112293|3749288|FG000|STARTED|Overall Study||14
3030438|NCT01112293|3749288|FG000|COMPLETED|Overall Study||14
3030439|NCT01112293|3749288|FG000|NOT COMPLETED|Overall Study||0
3030440|NCT01112358|3749294|FG000|STARTED|Overall Study||25
3030441|NCT01112358|3749295|FG001|STARTED|Overall Study||33
3030442|NCT01112358|3749294|FG000|COMPLETED|Overall Study||25
3030443|NCT01112358|3749295|FG001|COMPLETED|Overall Study||33
3030444|NCT01112358|3749294|FG000|NOT COMPLETED|Overall Study||0
3030445|NCT01112358|3749295|FG001|NOT COMPLETED|Overall Study||0
3030446|NCT01112514|3749301|FG000|STARTED|Overall Study||4
3030447|NCT01112514|3749301|FG000|COMPLETED|Overall Study||3
3030448|NCT01112514|3749301|FG000|NOT COMPLETED|Overall Study||1
3030449|NCT01112579|3749307|FG000|STARTED|Overall Study||42
3030450|NCT01112579|3749308|FG001|STARTED|Overall Study||24
3030451|NCT01112579|3749307|FG000|COMPLETED|Overall Study||41
3030452|NCT01112579|3749308|FG001|COMPLETED|Overall Study||21
3030453|NCT01112579|3749307|FG000|NOT COMPLETED|Overall Study||1
3030454|NCT01112579|3749308|FG001|NOT COMPLETED|Overall Study||3
3038203|NCT01152450|3757565|FG003|NOT COMPLETED|Period 3 (4 Weeks)||0
3038204|NCT01152450|3757566|FG004|NOT COMPLETED|Period 3 (4 Weeks)||0
3038205|NCT01152450|3757567|FG005|NOT COMPLETED|Period 3 (4 Weeks)||0
3038206|NCT01152515|3757577|FG000|STARTED|Overall Study||25
3038207|NCT01152515|3757578|FG001|STARTED|Overall Study||25
3038208|NCT01152515|3757577|FG000|COMPLETED|Overall Study||25
3038209|NCT01152515|3757578|FG001|COMPLETED|Overall Study||25
3038210|NCT01152515|3757577|FG000|NOT COMPLETED|Overall Study||0
3038211|NCT01152515|3757578|FG001|NOT COMPLETED|Overall Study||0
3038212|NCT01152554|3757586|FG000|STARTED|Overall Study||610
3038213|NCT01152554|3757587|FG001|STARTED|Overall Study||203
3038214|NCT01152554|3757586|FG000|Received Treatment|Overall Study||607
3038215|NCT01152554|3757587|FG001|Received Treatment|Overall Study||201
3038216|NCT01152554|3757586|FG000|COMPLETED|Overall Study||276
3038217|NCT01152554|3757587|FG001|COMPLETED|Overall Study||92
3038218|NCT01152554|3757586|FG000|NOT COMPLETED|Overall Study||334
3038219|NCT01152554|3757587|FG001|NOT COMPLETED|Overall Study||111
3038220|NCT01152580|3757595|FG000|STARTED|Overall Study||5
3038221|NCT01152580|3757596|FG001|STARTED|Overall Study||14
3038222|NCT01152580|3757595|FG000|COMPLETED|Overall Study||5
3038223|NCT01152580|3757596|FG001|COMPLETED|Overall Study||13
3038224|NCT01152580|3757595|FG000|NOT COMPLETED|Overall Study||0
3038225|NCT01152580|3757596|FG001|NOT COMPLETED|Overall Study||1
3038226|NCT01152697|3757602|FG000|STARTED|Overall Study||30
3038227|NCT01152697|3757602|FG000|COMPLETED|Overall Study||11
3038228|NCT01152697|3757602|FG000|NOT COMPLETED|Overall Study||19
3030455|NCT01112670|3749314|FG000|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||8
3030456|NCT01112670|3749315|FG001|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||0
3030457|NCT01112670|3749316|FG002|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||7
3030458|NCT01112670|3749317|FG003|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||0
3030459|NCT01112670|3749318|FG004|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||6
3030460|NCT01112670|3749319|FG005|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||0
3030461|NCT01112670|3749314|FG000|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||7
3030462|NCT01112670|3749315|FG001|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
3030463|NCT01112670|3749316|FG002|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||6
3030464|NCT01112670|3749317|FG003|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
3030465|NCT01112670|3749318|FG004|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||5
3030466|NCT01112670|3749319|FG005|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
3030467|NCT01112670|3749314|FG000|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||1
3030468|NCT01112670|3749315|FG001|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
3030469|NCT01112670|3749316|FG002|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||1
3030470|NCT01112670|3749317|FG003|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
3030471|NCT01112670|3749318|FG004|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||1
3030472|NCT01112670|3749319|FG005|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
3030473|NCT01112670|3749314|FG000|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||0
3030474|NCT01112670|3749315|FG001|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||3
3030475|NCT01112670|3749316|FG002|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||0
3030476|NCT01112670|3749317|FG003|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||4
3030477|NCT01112670|3749318|FG004|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||0
3030478|NCT01112670|3749319|FG005|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||5
3030479|NCT01112670|3749314|FG000|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
3030480|NCT01112670|3749315|FG001|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||3
3030481|NCT01112670|3749316|FG002|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
3030482|NCT01112670|3749317|FG003|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||4
3030483|NCT01112670|3749318|FG004|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
3030484|NCT01112670|3749319|FG005|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||5
3030485|NCT01112670|3749314|FG000|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
3030486|NCT01112670|3749315|FG001|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
3030487|NCT01112670|3749316|FG002|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
3030488|NCT01112670|3749317|FG003|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
3030489|NCT01112670|3749318|FG004|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
3030490|NCT01112670|3749319|FG005|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
3030491|NCT01112683|3749328|FG000|STARTED|Overall Study||19
3030492|NCT01112683|3749329|FG001|STARTED|Overall Study||20
3030493|NCT01112683|3749328|FG000|COMPLETED|Overall Study||18
3030494|NCT01112683|3749329|FG001|COMPLETED|Overall Study||19
3030495|NCT01112683|3749328|FG000|NOT COMPLETED|Overall Study||1
3030496|NCT01112683|3749329|FG001|NOT COMPLETED|Overall Study||1
3030497|NCT01112696|3749335|FG000|STARTED|Overall Study||100
3030498|NCT01112696|3749335|FG000|COMPLETED|Overall Study||98
3030499|NCT01112696|3749335|FG000|NOT COMPLETED|Overall Study||2
3030500|NCT01112735|3749342|FG000|STARTED|Overall Study||20
3030501|NCT01112735|3749343|FG001|STARTED|Overall Study||20
3030502|NCT01112735|3749342|FG000|COMPLETED|Overall Study||20
3030503|NCT01112735|3749343|FG001|COMPLETED|Overall Study||20
3030504|NCT01112735|3749342|FG000|NOT COMPLETED|Overall Study||0
3030505|NCT01112735|3749343|FG001|NOT COMPLETED|Overall Study||0
3030506|NCT01112865|3749349|FG000|STARTED|First Intervention||59
3030507|NCT01112865|3749350|FG001|STARTED|First Intervention||61
3030508|NCT01112865|3749349|FG000|COMPLETED|First Intervention||59
3030509|NCT01112865|3749350|FG001|COMPLETED|First Intervention||61
3030510|NCT01112865|3749349|FG000|NOT COMPLETED|First Intervention||0
3030511|NCT01112865|3749350|FG001|NOT COMPLETED|First Intervention||0
3030512|NCT01112865|3749349|FG000|STARTED|Second Intervention||59
3030513|NCT01112865|3749350|FG001|STARTED|Second Intervention||61
3030514|NCT01112865|3749349|FG000|COMPLETED|Second Intervention||59
3030515|NCT01112865|3749350|FG001|COMPLETED|Second Intervention||61
3030516|NCT01112865|3749349|FG000|NOT COMPLETED|Second Intervention||0
3030517|NCT01112865|3749350|FG001|NOT COMPLETED|Second Intervention||0
3030518|NCT01112917|3749356|FG000|STARTED|Overall Study||96
3030519|NCT01112917|3749357|FG001|STARTED|Overall Study||53
3030520|NCT01112917|3749356|FG000|COMPLETED|Overall Study||89
3030521|NCT01112917|3749357|FG001|COMPLETED|Overall Study||38
3030522|NCT01112917|3749356|FG000|NOT COMPLETED|Overall Study||7
3030523|NCT01112917|3749357|FG001|NOT COMPLETED|Overall Study||15
3030524|NCT01112982|3749361|FG000|STARTED|Overall Study||74
3030525|NCT01112982|3749361|FG000|COMPLETED|Overall Study||72
3030526|NCT01112982|3749361|FG000|NOT COMPLETED|Overall Study||2
3030527|NCT01113008|3749370|FG000|STARTED|Overall Study||133
3030528|NCT01113008|3749371|FG001|STARTED|Overall Study||133
3030529|NCT01113008|3749370|FG000|COMPLETED|Overall Study||133
3030530|NCT01113008|3749371|FG001|COMPLETED|Overall Study||133
3030531|NCT01113008|3749370|FG000|NOT COMPLETED|Overall Study||0
3030532|NCT01113008|3749371|FG001|NOT COMPLETED|Overall Study||0
3030533|NCT01113385|3749377|FG000|STARTED|Overall Study||7
3030534|NCT01113385|3749377|FG000|COMPLETED|Overall Study||7
3030535|NCT01113385|3749377|FG000|NOT COMPLETED|Overall Study||0
3030536|NCT01113398|3749381|FG000|STARTED|Overall Study||36
3166088|NCT01903252|3893563|FG003|COMPLETED|Double-Blind Induction||0
3166089|NCT01903252|3893564|FG004|COMPLETED|Double-Blind Induction||0
3166090|NCT01903252|3893565|FG005|COMPLETED|Double-Blind Induction||0
3166091|NCT01903252|3893560|FG000|NOT COMPLETED|Double-Blind Induction||39
3166092|NCT01903252|3893561|FG001|NOT COMPLETED|Double-Blind Induction||41
3030537|NCT01113398|3749381|FG000|COMPLETED|Overall Study|Completed= Discontinued study drug due to disease progression, death, toxicity or any other reason|36
3030538|NCT01113398|3749381|FG000|NOT COMPLETED|Overall Study||0
3030539|NCT01113463|3749385|FG000|STARTED|Overall Study||17
3030540|NCT01113463|3749385|FG000|COMPLETED|Overall Study||12
3030541|NCT01113463|3749385|FG000|NOT COMPLETED|Overall Study||5
3030542|NCT01113502|3749394|FG000|STARTED|Overall Study||4
3030543|NCT01113502|3749395|FG001|STARTED|Overall Study||3
3030544|NCT01113502|3749396|FG002|STARTED|Overall Study||7
3030545|NCT01113502|3749397|FG003|STARTED|Overall Study||9
3030546|NCT01113502|3749398|FG004|STARTED|Overall Study||21
3030547|NCT01113502|3749394|FG000|COMPLETED|Overall Study||3
3030548|NCT01113502|3749395|FG001|COMPLETED|Overall Study||3
3030549|NCT01113502|3749396|FG002|COMPLETED|Overall Study||3
3030550|NCT01113502|3749397|FG003|COMPLETED|Overall Study||6
3030551|NCT01113502|3749398|FG004|COMPLETED|Overall Study||21
3030552|NCT01113502|3749394|FG000|NOT COMPLETED|Overall Study||1
3030553|NCT01113502|3749395|FG001|NOT COMPLETED|Overall Study||0
3030554|NCT01113502|3749396|FG002|NOT COMPLETED|Overall Study||4
3030555|NCT01113502|3749397|FG003|NOT COMPLETED|Overall Study||3
3030556|NCT01113502|3749398|FG004|NOT COMPLETED|Overall Study||0
3030557|NCT01113541|3749411|FG000|STARTED|Overall Study||13
3030558|NCT01113541|3749411|FG000|COMPLETED|Overall Study||0
3030559|NCT01113541|3749411|FG000|NOT COMPLETED|Overall Study||13
3030560|NCT01113580|3749417|FG000|STARTED|Overall Study||60
3030561|NCT01113580|3749418|FG001|STARTED|Overall Study||60
3030562|NCT01113580|3749417|FG000|COMPLETED|Overall Study||59
3030563|NCT01113580|3749418|FG001|COMPLETED|Overall Study||60
3030564|NCT01113580|3749417|FG000|NOT COMPLETED|Overall Study||1
3030565|NCT01113580|3749418|FG001|NOT COMPLETED|Overall Study||0
3030566|NCT01113632|3749426|FG000|STARTED|Overall Study||33
3030567|NCT01113632|3749427|FG001|STARTED|Overall Study||44
3030568|NCT01113632|3749426|FG000|COMPLETED|Overall Study||2
3030569|NCT01113632|3749427|FG001|COMPLETED|Overall Study||19
3030570|NCT01113632|3749426|FG000|NOT COMPLETED|Overall Study||31
3030571|NCT01113632|3749427|FG001|NOT COMPLETED|Overall Study||25
3030572|NCT01113710|3749433|FG000|STARTED|Overall Study|See Additional Study Description for further information regarding withdrawal due to Adverse Event.|687
3030573|NCT01113710|3749433|FG000|COMPLETED|Overall Study|"Discontinued reasons for Other are listed in the Participant Flow."|418
3030574|NCT01113710|3749433|FG000|NOT COMPLETED|Overall Study||269
3030575|NCT01113723|3749439|FG000|STARTED|Overall Study||70
3030576|NCT01113723|3749440|FG001|STARTED|Overall Study||70
3030577|NCT01113723|3749439|FG000|COMPLETED|Overall Study||70
3030578|NCT01113723|3749440|FG001|COMPLETED|Overall Study||70
3030579|NCT01113723|3749439|FG000|NOT COMPLETED|Overall Study||0
3030580|NCT01113723|3749440|FG001|NOT COMPLETED|Overall Study||0
3030581|NCT01113749|3749450|FG000|STARTED|Overall Study||127
3030582|NCT01113749|3749451|FG001|STARTED|Overall Study||129
3030583|NCT01113749|3749450|FG000|COMPLETED|Overall Study||126
3030584|NCT01113749|3749451|FG001|COMPLETED|Overall Study||127
3030585|NCT01113749|3749450|FG000|NOT COMPLETED|Overall Study||1
3030586|NCT01113749|3749451|FG001|NOT COMPLETED|Overall Study||2
3030587|NCT01113801|3749461|FG000|STARTED|Overall Study||103
3030588|NCT01113801|3749462|FG001|STARTED|Overall Study||105
3030589|NCT01113801|3749463|FG002|STARTED|Overall Study||103
3030590|NCT01113801|3749464|FG003|STARTED|Overall Study||106
3030591|NCT01113801|3749461|FG000|Received at Least One Dose of Drug|Overall Study||103
3030592|NCT01113801|3749462|FG001|Received at Least One Dose of Drug|Overall Study||105
3030593|NCT01113801|3749463|FG002|Received at Least One Dose of Drug|Overall Study||103
3030594|NCT01113801|3749464|FG003|Received at Least One Dose of Drug|Overall Study||105
3030595|NCT01113801|3749461|FG000|COMPLETED|Overall Study||62
3030596|NCT01113801|3749462|FG001|COMPLETED|Overall Study||65
3030597|NCT01113801|3749463|FG002|COMPLETED|Overall Study||66
3030598|NCT01113801|3749464|FG003|COMPLETED|Overall Study||65
3030599|NCT01113801|3749461|FG000|NOT COMPLETED|Overall Study||41
3030600|NCT01113801|3749462|FG001|NOT COMPLETED|Overall Study||40
3030601|NCT01113801|3749463|FG002|NOT COMPLETED|Overall Study||37
3030602|NCT01113801|3749464|FG003|NOT COMPLETED|Overall Study||41
3030603|NCT01113879|3749476|FG000|STARTED|Period 1: Block 1||7
3030604|NCT01113879|3749477|FG001|STARTED|Period 1: Block 1||2
3030605|NCT01113879|3749476|FG000|COMPLETED|Period 1: Block 1||5
3030606|NCT01113879|3749477|FG001|COMPLETED|Period 1: Block 1||2
3030607|NCT01113879|3749476|FG000|NOT COMPLETED|Period 1: Block 1||2
3030608|NCT01113879|3749477|FG001|NOT COMPLETED|Period 1: Block 1||0
3030609|NCT01113879|3749476|FG000|STARTED|Period 2: Block 2||5
3030610|NCT01113879|3749477|FG001|STARTED|Period 2: Block 2||2
3030611|NCT01113879|3749476|FG000|COMPLETED|Period 2: Block 2||5
3030612|NCT01113879|3749477|FG001|COMPLETED|Period 2: Block 2||2
3030613|NCT01113879|3749476|FG000|NOT COMPLETED|Period 2: Block 2||0
3030614|NCT01113879|3749477|FG001|NOT COMPLETED|Period 2: Block 2||0
3030615|NCT01113892|3749487|FG000|STARTED|Overall Study||101
3030616|NCT01113892|3749488|FG001|STARTED|Overall Study||106
3030617|NCT01113892|3749487|FG000|COMPLETED|Overall Study||87
3030618|NCT01113892|3749488|FG001|COMPLETED|Overall Study||90
3030619|NCT01113892|3749487|FG000|NOT COMPLETED|Overall Study||14
3030620|NCT01113892|3749488|FG001|NOT COMPLETED|Overall Study||16
3030621|NCT01113931|3749496|FG000|STARTED|Overall Study||247
3030622|NCT01113931|3749497|FG001|STARTED|Overall Study||248
3030623|NCT01113931|3749496|FG000|Safety Population|Overall Study|1 subject did not take any study medication|246
3030624|NCT01113931|3749497|FG001|Safety Population|Overall Study||248
3030625|NCT01113931|3749496|FG000|mITT Population|Overall Study||188
3030626|NCT01113931|3749497|FG001|mITT Population|Overall Study||190
3030627|NCT01113931|3749496|FG000|COMPLETED|Overall Study||228
3030628|NCT01113931|3749497|FG001|COMPLETED|Overall Study||231
3030629|NCT01113931|3749496|FG000|NOT COMPLETED|Overall Study||19
3030630|NCT01113931|3749497|FG001|NOT COMPLETED|Overall Study||17
3030631|NCT01113983|3749505|FG000|STARTED|Overall Study||37
3030632|NCT01113983|3749506|FG001|STARTED|Overall Study||27
3030633|NCT01113983|3749505|FG000|COMPLETED|Overall Study||12
3030634|NCT01113983|3749506|FG001|COMPLETED|Overall Study||10
3030635|NCT01113983|3749505|FG000|NOT COMPLETED|Overall Study||25
3030636|NCT01113983|3749506|FG001|NOT COMPLETED|Overall Study||17
3030637|NCT01114139|3749514|FG000|STARTED|Overall Study||609
3030638|NCT01114139|3749515|FG001|STARTED|Overall Study||203
3030639|NCT01114139|3749514|FG000|Received at Least 1 Dose of Study Drug|Overall Study||608
3030640|NCT01114139|3749515|FG001|Received at Least 1 Dose of Study Drug|Overall Study||200
3030641|NCT01114139|3749514|FG000|COMPLETED|Overall Study||569
3030642|NCT01114139|3749515|FG001|COMPLETED|Overall Study||187
3030643|NCT01114139|3749514|FG000|NOT COMPLETED|Overall Study||40
3030644|NCT01114139|3749515|FG001|NOT COMPLETED|Overall Study||16
3030645|NCT01114204|3749523|FG000|STARTED|Overall Study||406
3030646|NCT01114204|3749524|FG001|STARTED|Overall Study||199
3030647|NCT01114204|3749523|FG000|Received at Least 1 Dose of Study Drug|Overall Study||406
3030648|NCT01114204|3749524|FG001|Received at Least 1 Dose of Study Drug|Overall Study||199
3030649|NCT01114204|3749523|FG000|COMPLETED|Overall Study||385
3030650|NCT01114204|3749524|FG001|COMPLETED|Overall Study||191
3030651|NCT01114204|3749523|FG000|NOT COMPLETED|Overall Study||21
3030652|NCT01114204|3749524|FG001|NOT COMPLETED|Overall Study||8
3030653|NCT01114217|3749532|FG000|STARTED|Overall Study||337
3030654|NCT01114217|3749533|FG001|STARTED|Overall Study||297
3030655|NCT01114217|3749532|FG000|Received at Least 1 Dose of Ferumoxytol|Overall Study||337
3030656|NCT01114217|3749533|FG001|Received at Least 1 Dose of Ferumoxytol|Overall Study||0
3030657|NCT01114217|3749532|FG000|COMPLETED|Overall Study|Two participants lacked study completion data: one site stopped communicating during the study.|262
3030658|NCT01114217|3749533|FG001|COMPLETED|Overall Study||199
3030659|NCT01114217|3749532|FG000|NOT COMPLETED|Overall Study||75
3030660|NCT01114217|3749533|FG001|NOT COMPLETED|Overall Study||98
3030661|NCT01114334|3749539|FG000|STARTED|Overall Study||88
3030662|NCT01114334|3749540|FG001|STARTED|Overall Study||80
3030663|NCT01114334|3749539|FG000|COMPLETED|Overall Study||67
3030664|NCT01114334|3749540|FG001|COMPLETED|Overall Study||58
3030665|NCT01114334|3749539|FG000|NOT COMPLETED|Overall Study||21
3030666|NCT01114334|3749540|FG001|NOT COMPLETED|Overall Study||22
3030667|NCT01114360|3749547|FG000|STARTED|Intervention 1 (4 Weeks)||18
3030668|NCT01114360|3749548|FG001|STARTED|Intervention 1 (4 Weeks)||19
3030669|NCT01114360|3749547|FG000|COMPLETED|Intervention 1 (4 Weeks)||18
3030670|NCT01114360|3749548|FG001|COMPLETED|Intervention 1 (4 Weeks)||18
3030671|NCT01114360|3749547|FG000|NOT COMPLETED|Intervention 1 (4 Weeks)||0
3030672|NCT01114360|3749548|FG001|NOT COMPLETED|Intervention 1 (4 Weeks)||1
3166093|NCT01903252|3893562|FG002|NOT COMPLETED|Double-Blind Induction||0
3166094|NCT01903252|3893563|FG003|NOT COMPLETED|Double-Blind Induction||0
3166095|NCT01903252|3893564|FG004|NOT COMPLETED|Double-Blind Induction||0
3166096|NCT01903252|3893565|FG005|NOT COMPLETED|Double-Blind Induction||0
3166097|NCT01903252|3893560|FG000|STARTED|Extended Induction, Open-Label||0
3166098|NCT01903252|3893561|FG001|STARTED|Extended Induction, Open-Label|This treatment arm was only used in Period 1, double-blind induction phase.|0
3030673|NCT01114360|3749547|FG000|STARTED|Intervention 2 (4 Weeks)||18
3030674|NCT01114360|3749548|FG001|STARTED|Intervention 2 (4 Weeks)||18
3030675|NCT01114360|3749547|FG000|COMPLETED|Intervention 2 (4 Weeks)||18
3030676|NCT01114360|3749548|FG001|COMPLETED|Intervention 2 (4 Weeks)||18
3030677|NCT01114360|3749547|FG000|NOT COMPLETED|Intervention 2 (4 Weeks)||0
3030678|NCT01114360|3749548|FG001|NOT COMPLETED|Intervention 2 (4 Weeks)||0
3030679|NCT01114373|3749568|FG000|STARTED|Intervention 1 (4 Weeks)||21
3030680|NCT01114373|3749569|FG001|STARTED|Intervention 1 (4 Weeks)||19
3030681|NCT01114373|3749568|FG000|COMPLETED|Intervention 1 (4 Weeks)||18
3030682|NCT01114373|3749569|FG001|COMPLETED|Intervention 1 (4 Weeks)||19
3030683|NCT01114373|3749568|FG000|NOT COMPLETED|Intervention 1 (4 Weeks)||3
3030684|NCT01114373|3749569|FG001|NOT COMPLETED|Intervention 1 (4 Weeks)||0
3030685|NCT01114373|3749568|FG000|STARTED|Intervention 2 (4 Weeks)||18
3030686|NCT01114373|3749569|FG001|STARTED|Intervention 2 (4 Weeks)||19
3030687|NCT01114373|3749568|FG000|COMPLETED|Intervention 2 (4 Weeks)||18
3030688|NCT01114373|3749569|FG001|COMPLETED|Intervention 2 (4 Weeks)||18
3030689|NCT01114373|3749568|FG000|NOT COMPLETED|Intervention 2 (4 Weeks)||0
3030690|NCT01114373|3749569|FG001|NOT COMPLETED|Intervention 2 (4 Weeks)||1
3030691|NCT01114438|3749579|FG000|STARTED|Overall Study||45
3030692|NCT01114438|3749579|FG000|COMPLETED|Overall Study||31
3030693|NCT01114438|3749579|FG000|NOT COMPLETED|Overall Study||14
3030694|NCT01114503|3749588|FG000|STARTED|Overall Study||2
3030695|NCT01114503|3749588|FG000|COMPLETED|Overall Study||2
3030696|NCT01114503|3749588|FG000|NOT COMPLETED|Overall Study||0
3030697|NCT01114516|3749594|FG000|STARTED|Overall Study||26
3030698|NCT01114516|3749595|FG001|STARTED|Overall Study||27
3030699|NCT01114516|3749594|FG000|COMPLETED|Overall Study||24
3030700|NCT01114516|3749595|FG001|COMPLETED|Overall Study||26
3030701|NCT01114516|3749594|FG000|NOT COMPLETED|Overall Study||2
3030702|NCT01114516|3749595|FG001|NOT COMPLETED|Overall Study||1
3030703|NCT01114529|3749604|FG000|STARTED|Completed Study Medication at Month 24|Randomized set - 360 Full analysis set - 353 Safety analysis set -346*|353
3030704|NCT01114529|3749605|FG001|STARTED|Completed Study Medication at Month 24|Randomized set -231 Full analysis set -231 Safety analysis set -238**|231
3030705|NCT01114529|3749606|FG002|STARTED|Completed Study Medication at Month 24|Randomized set-125 Full analysis set -125 Safety analysis set -121***|125
3030706|NCT01114529|3749604|FG000|COMPLETED|Completed Study Medication at Month 24|completed at month 24|229
3166099|NCT01903252|3893562|FG002|STARTED|Extended Induction, Open-Label|The subjects in this phase were non-responders at week 8 and discontinued the double-blind phase.|243
3166100|NCT01903252|3893563|FG003|STARTED|Extended Induction, Open-Label||0
3310053|NCT03037307|4043446|FG002|STARTED|Period 1||8
3030707|NCT01114529|3749605|FG001|COMPLETED|Completed Study Medication at Month 24|completed at month 24|190
3030708|NCT01114529|3749606|FG002|COMPLETED|Completed Study Medication at Month 24|completed at month 24|93
3030709|NCT01114529|3749604|FG000|NOT COMPLETED|Completed Study Medication at Month 24||124
3030710|NCT01114529|3749605|FG001|NOT COMPLETED|Completed Study Medication at Month 24||41
3030711|NCT01114529|3749606|FG002|NOT COMPLETED|Completed Study Medication at Month 24||32
3030712|NCT01114529|3749604|FG000|STARTED|Completed Study Phase at Month 24|It includes those discontinued treatment|353
3030713|NCT01114529|3749605|FG001|STARTED|Completed Study Phase at Month 24|It includes those discontinued treatment|231
3030714|NCT01114529|3749606|FG002|STARTED|Completed Study Phase at Month 24|It includes those discontinued treatment|125
3030715|NCT01114529|3749604|FG000|COMPLETED|Completed Study Phase at Month 24|at month 24|313
3030716|NCT01114529|3749605|FG001|COMPLETED|Completed Study Phase at Month 24|at month 24|215
3030717|NCT01114529|3749606|FG002|COMPLETED|Completed Study Phase at Month 24|at month 24|111
3030718|NCT01114529|3749604|FG000|NOT COMPLETED|Completed Study Phase at Month 24||40
3030719|NCT01114529|3749605|FG001|NOT COMPLETED|Completed Study Phase at Month 24||16
3030720|NCT01114529|3749606|FG002|NOT COMPLETED|Completed Study Phase at Month 24||14
3030721|NCT01114555|3749616|FG000|STARTED|Overall Study||34
3030722|NCT01114555|3749616|FG000|COMPLETED|Overall Study||34
3030723|NCT01114555|3749616|FG000|NOT COMPLETED|Overall Study||0
3030724|NCT01114581|3749622|FG000|STARTED|Overall Study||19
3030725|NCT01114581|3749623|FG001|STARTED|Overall Study||19
3030726|NCT01114581|3749622|FG000|COMPLETED|Overall Study||19
3030727|NCT01114581|3749623|FG001|COMPLETED|Overall Study||19
3030728|NCT01114581|3749622|FG000|NOT COMPLETED|Overall Study||0
3030729|NCT01114581|3749623|FG001|NOT COMPLETED|Overall Study||0
3030730|NCT01114620|3749629|FG000|STARTED|Overall Study||50
3030731|NCT01114620|3749629|FG000|COMPLETED|Overall Study||50
3030732|NCT01114620|3749629|FG000|NOT COMPLETED|Overall Study||0
3030733|NCT01114646|3749635|FG000|STARTED|Overall Study||66
3030734|NCT01114646|3749636|FG001|STARTED|Overall Study||64
3030735|NCT01114646|3749635|FG000|COMPLETED|Overall Study||63
3030736|NCT01114646|3749636|FG001|COMPLETED|Overall Study||62
3030737|NCT01114646|3749635|FG000|NOT COMPLETED|Overall Study||3
3030738|NCT01114646|3749636|FG001|NOT COMPLETED|Overall Study||2
3030739|NCT01114672|3749644|FG000|STARTED|Overall Study||25
3030740|NCT01114672|3749645|FG001|STARTED|Overall Study||25
3030741|NCT01114672|3749644|FG000|COMPLETED|Overall Study||21
3030742|NCT01114672|3749645|FG001|COMPLETED|Overall Study||23
3030743|NCT01114672|3749644|FG000|NOT COMPLETED|Overall Study||4
3030744|NCT01114672|3749645|FG001|NOT COMPLETED|Overall Study||2
3030745|NCT01114724|3749651|FG000|STARTED|Overall Study||50
3030746|NCT01114724|3749651|FG000|COMPLETED|Overall Study||40
3030747|NCT01114724|3749651|FG000|NOT COMPLETED|Overall Study||10
3030748|NCT01114737|3749658|FG000|STARTED|Randomized Treatment Period||108
3030749|NCT01114737|3749659|FG001|STARTED|Randomized Treatment Period||98
3030750|NCT01114737|3749658|FG000|COMPLETED|Randomized Treatment Period||105
3030751|NCT01114737|3749659|FG001|COMPLETED|Randomized Treatment Period||97
3030752|NCT01114737|3749658|FG000|NOT COMPLETED|Randomized Treatment Period||3
3030753|NCT01114737|3749659|FG001|NOT COMPLETED|Randomized Treatment Period||1
3310054|NCT03037307|4043447|FG003|STARTED|Period 1||7
3310055|NCT03037307|4043448|FG004|STARTED|Period 1||7
3310056|NCT03037307|4043449|FG005|STARTED|Period 1||8
3310057|NCT03037307|4043444|FG000|COMPLETED|Period 1||7
3310058|NCT03037307|4043445|FG001|COMPLETED|Period 1||7
3030754|NCT01114737|3749658|FG000|STARTED|Open-Label Treatment Period|One subject did not receive a single dose of the study drug|105
3030755|NCT01114737|3749659|FG001|STARTED|Open-Label Treatment Period|Two subjects did not receive a single dose of the study drug|97
3030756|NCT01114737|3749658|FG000|COMPLETED|Open-Label Treatment Period||100
3030757|NCT01114737|3749659|FG001|COMPLETED|Open-Label Treatment Period||95
3030758|NCT01114737|3749658|FG000|NOT COMPLETED|Open-Label Treatment Period||5
3030759|NCT01114737|3749659|FG001|NOT COMPLETED|Open-Label Treatment Period||2
3030760|NCT01114828|3749678|FG000|STARTED|Overall Study||19
3030761|NCT01114828|3749679|FG001|STARTED|Overall Study||21
3030762|NCT01114828|3749678|FG000|COMPLETED|Overall Study||16
3030763|NCT01114828|3749679|FG001|COMPLETED|Overall Study||17
3030764|NCT01114828|3749678|FG000|NOT COMPLETED|Overall Study||3
3030765|NCT01114828|3749679|FG001|NOT COMPLETED|Overall Study||4
3030766|NCT01114880|3749687|FG000|STARTED|Period 1 (Week 0 to Week 12)||229
3030767|NCT01114880|3749688|FG001|STARTED|Period 1 (Week 0 to Week 12)||115
3310059|NCT03037307|4043446|FG002|COMPLETED|Period 1||8
3030768|NCT01114880|3749687|FG000|COMPLETED|Period 1 (Week 0 to Week 12)||224
3030769|NCT01114880|3749688|FG001|COMPLETED|Period 1 (Week 0 to Week 12)||113
3030770|NCT01114880|3749687|FG000|NOT COMPLETED|Period 1 (Week 0 to Week 12)||5
3030771|NCT01114880|3749688|FG001|NOT COMPLETED|Period 1 (Week 0 to Week 12)||2
3030772|NCT01114880|3749687|FG000|STARTED|Period 2 (Week 12 to Week 24)||224
3030773|NCT01114880|3749688|FG001|STARTED|Period 2 (Week 12 to Week 24)||113
3030774|NCT01114880|3749687|FG000|COMPLETED|Period 2 (Week 12 to Week 24)||221
3030775|NCT01114880|3749688|FG001|COMPLETED|Period 2 (Week 12 to Week 24)||111
3030776|NCT01114880|3749687|FG000|NOT COMPLETED|Period 2 (Week 12 to Week 24)||3
3030777|NCT01114880|3749688|FG001|NOT COMPLETED|Period 2 (Week 12 to Week 24)||2
3030778|NCT01114893|3749701|FG000|STARTED|Overall Study||14
3030779|NCT01114893|3749702|FG001|STARTED|Overall Study||14
3030780|NCT01114893|3749703|FG002|STARTED|Overall Study||14
3030781|NCT01114893|3749704|FG003|STARTED|Overall Study||13
3030782|NCT01114893|3749705|FG004|STARTED|Overall Study||12
3030783|NCT01114893|3749701|FG000|COMPLETED|Overall Study||14
3030784|NCT01114893|3749702|FG001|COMPLETED|Overall Study||14
3030785|NCT01114893|3749703|FG002|COMPLETED|Overall Study||14
3030786|NCT01114893|3749704|FG003|COMPLETED|Overall Study||13
3030787|NCT01114893|3749705|FG004|COMPLETED|Overall Study||12
3030788|NCT01114893|3749701|FG000|NOT COMPLETED|Overall Study||0
3030789|NCT01114893|3749702|FG001|NOT COMPLETED|Overall Study||0
3030790|NCT01114893|3749703|FG002|NOT COMPLETED|Overall Study||0
3030791|NCT01114893|3749704|FG003|NOT COMPLETED|Overall Study||0
3030792|NCT01114893|3749705|FG004|NOT COMPLETED|Overall Study||0
3030793|NCT01114945|3749721|FG000|STARTED|Overall Study||30
3030794|NCT01114945|3749722|FG001|STARTED|Overall Study||30
3030795|NCT01114945|3749723|FG002|STARTED|Overall Study||30
3030796|NCT01114945|3749724|FG003|STARTED|Overall Study||31
3030797|NCT01114945|3749721|FG000|COMPLETED|Overall Study||30
3030798|NCT01114945|3749722|FG001|COMPLETED|Overall Study||30
3030799|NCT01114945|3749723|FG002|COMPLETED|Overall Study||30
3030800|NCT01114945|3749724|FG003|COMPLETED|Overall Study||31
3030801|NCT01114945|3749721|FG000|NOT COMPLETED|Overall Study||0
3030802|NCT01114945|3749722|FG001|NOT COMPLETED|Overall Study||0
3030803|NCT01114945|3749723|FG002|NOT COMPLETED|Overall Study||0
3030804|NCT01114945|3749724|FG003|NOT COMPLETED|Overall Study||0
3030805|NCT01114971|3749738|FG000|STARTED|Overall Study||25
3030806|NCT01114971|3749739|FG001|STARTED|Overall Study||25
3030807|NCT01114971|3749740|FG002|STARTED|Overall Study||25
3166101|NCT01903252|3893564|FG004|STARTED|Extended Induction, Open-Label||0
3166102|NCT01903252|3893565|FG005|STARTED|Extended Induction, Open-Label||0
3166103|NCT01903252|3893560|FG000|COMPLETED|Extended Induction, Open-Label||0
3166104|NCT01903252|3893561|FG001|COMPLETED|Extended Induction, Open-Label||0
3166105|NCT01903252|3893562|FG002|COMPLETED|Extended Induction, Open-Label||220
3310060|NCT03037307|4043447|FG003|COMPLETED|Period 1||6
3030808|NCT01114971|3749738|FG000|COMPLETED|Overall Study||25
3030809|NCT01114971|3749739|FG001|COMPLETED|Overall Study||25
3310061|NCT03037307|4043448|FG004|COMPLETED|Period 1||7
3310062|NCT03037307|4043449|FG005|COMPLETED|Period 1||8
3310063|NCT03037307|4043444|FG000|NOT COMPLETED|Period 1||0
3310064|NCT03037307|4043445|FG001|NOT COMPLETED|Period 1||0
3310065|NCT03037307|4043446|FG002|NOT COMPLETED|Period 1||0
3310066|NCT03037307|4043447|FG003|NOT COMPLETED|Period 1||1
3310067|NCT03037307|4043448|FG004|NOT COMPLETED|Period 1||0
3310068|NCT03037307|4043449|FG005|NOT COMPLETED|Period 1||0
3030810|NCT01114971|3749740|FG002|COMPLETED|Overall Study||25
3030811|NCT01114971|3749738|FG000|NOT COMPLETED|Overall Study||0
3030812|NCT01114971|3749739|FG001|NOT COMPLETED|Overall Study||0
3030813|NCT01114971|3749740|FG002|NOT COMPLETED|Overall Study||0
3030814|NCT01114997|3749751|FG000|STARTED|Overall Study||11
3030815|NCT01114997|3749752|FG001|STARTED|Overall Study||10
3030816|NCT01114997|3749753|FG002|STARTED|Overall Study||11
3030817|NCT01114997|3749751|FG000|COMPLETED|Overall Study||11
3030818|NCT01114997|3749752|FG001|COMPLETED|Overall Study||10
3030819|NCT01114997|3749753|FG002|COMPLETED|Overall Study||11
3030820|NCT01114997|3749751|FG000|NOT COMPLETED|Overall Study||0
3030821|NCT01114997|3749752|FG001|NOT COMPLETED|Overall Study||0
3030822|NCT01114997|3749753|FG002|NOT COMPLETED|Overall Study||0
3030823|NCT01115101|3749764|FG000|STARTED|Overall Study||113
3030824|NCT01115101|3749765|FG001|STARTED|Overall Study||126
3030825|NCT01115101|3749764|FG000|COMPLETED|Overall Study||113
3030826|NCT01115101|3749765|FG001|COMPLETED|Overall Study||126
3030827|NCT01115101|3749764|FG000|NOT COMPLETED|Overall Study||0
3030828|NCT01115101|3749765|FG001|NOT COMPLETED|Overall Study||0
3030829|NCT01115166|3749771|FG000|STARTED|Overall Study||10
3030830|NCT01115166|3749771|FG000|COMPLETED|Overall Study||10
3030831|NCT01115166|3749771|FG000|NOT COMPLETED|Overall Study||0
3030832|NCT01115231|3749777|FG000|STARTED|Overall Study||133
3030833|NCT01115231|3749778|FG001|STARTED|Overall Study||90
3030834|NCT01115231|3749777|FG000|COMPLETED|Overall Study||133
3030835|NCT01115231|3749778|FG001|COMPLETED|Overall Study||90
3030836|NCT01115231|3749777|FG000|NOT COMPLETED|Overall Study||0
3030837|NCT01115231|3749778|FG001|NOT COMPLETED|Overall Study||0
3030838|NCT01115309|3749785|FG000|STARTED|Procedure Safety (1-Month)||175
3030839|NCT01115309|3749785|FG000|COMPLETED|Procedure Safety (1-Month)||172
3030840|NCT01115309|3749785|FG000|NOT COMPLETED|Procedure Safety (1-Month)||3
3030841|NCT01115309|3749785|FG000|STARTED|Long-term Follow-up||50
3030842|NCT01115309|3749785|FG000|6-Month Follow-up|Long-term Follow-up||46
3030843|NCT01115309|3749785|FG000|12-Month Follow-up|Long-term Follow-up||44
3030844|NCT01115309|3749785|FG000|COMPLETED|Long-term Follow-up||44
3030845|NCT01115309|3749785|FG000|NOT COMPLETED|Long-term Follow-up||6
3030846|NCT01115452|3749790|FG000|STARTED|Overall Study||32
3030847|NCT01115452|3749790|FG000|COMPLETED|Overall Study||32
3030848|NCT01115452|3749790|FG000|NOT COMPLETED|Overall Study||0
3030849|NCT01115491|3749798|FG000|STARTED|Overall Study||32
3030850|NCT01115491|3749798|FG000|COMPLETED|Overall Study||2
3030851|NCT01115491|3749798|FG000|NOT COMPLETED|Overall Study||30
3030852|NCT01115517|3749804|FG000|STARTED|Overall Study||18
3030853|NCT01115517|3749805|FG001|STARTED|Overall Study||21
3030854|NCT01115517|3749804|FG000|COMPLETED|Overall Study||14
3030855|NCT01115517|3749805|FG001|COMPLETED|Overall Study||16
3030856|NCT01115517|3749804|FG000|NOT COMPLETED|Overall Study||4
3030857|NCT01115517|3749805|FG001|NOT COMPLETED|Overall Study||5
3030858|NCT01115556|3749813|FG000|STARTED|Overall Study||7
3030859|NCT01115556|3749814|FG001|STARTED|Overall Study||2
3030860|NCT01115556|3749813|FG000|COMPLETED|Overall Study||7
3030861|NCT01115556|3749814|FG001|COMPLETED|Overall Study||2
3030862|NCT01115556|3749813|FG000|NOT COMPLETED|Overall Study||0
3030863|NCT01115556|3749814|FG001|NOT COMPLETED|Overall Study||0
3030864|NCT01115569|3749822|FG000|STARTED|Conversion/Titration Phase||638
3030865|NCT01115569|3749823|FG001|STARTED|Conversion/Titration Phase||0
3030866|NCT01115569|3749822|FG000|COMPLETED|Conversion/Titration Phase||424
3030867|NCT01115569|3749823|FG001|COMPLETED|Conversion/Titration Phase||0
3030868|NCT01115569|3749822|FG000|NOT COMPLETED|Conversion/Titration Phase||214
3030869|NCT01115569|3749823|FG001|NOT COMPLETED|Conversion/Titration Phase||0
3030870|NCT01115569|3749822|FG000|STARTED|Maintenance Phase||0
3030871|NCT01115569|3749823|FG001|STARTED|Maintenance Phase||424
3030872|NCT01115569|3749822|FG000|COMPLETED|Maintenance Phase||0
3030873|NCT01115569|3749823|FG001|COMPLETED|Maintenance Phase||285
3030874|NCT01115569|3749822|FG000|NOT COMPLETED|Maintenance Phase||0
3030875|NCT01115569|3749823|FG001|NOT COMPLETED|Maintenance Phase||139
3030876|NCT01115582|3749828|FG000|STARTED|Overall Study||16
3030877|NCT01115582|3749828|FG000|COMPLETED|Overall Study||16
3030878|NCT01115582|3749828|FG000|NOT COMPLETED|Overall Study||0
3030879|NCT01115660|3749834|FG000|STARTED|Overall Study||20
3030880|NCT01115660|3749835|FG001|STARTED|Overall Study||10
3030881|NCT01115660|3749834|FG000|COMPLETED|Overall Study||19
3030882|NCT01115660|3749835|FG001|COMPLETED|Overall Study||10
3030883|NCT01115660|3749834|FG000|NOT COMPLETED|Overall Study||1
3030884|NCT01115660|3749835|FG001|NOT COMPLETED|Overall Study||0
3030885|NCT01115673|3749844|FG000|STARTED|Overall Study||239
3030886|NCT01115673|3749845|FG001|STARTED|Overall Study||241
3030887|NCT01115673|3749846|FG002|STARTED|Overall Study||60
3030888|NCT01115673|3749844|FG000|COMPLETED|Overall Study||239
3030889|NCT01115673|3749845|FG001|COMPLETED|Overall Study||241
3030890|NCT01115673|3749846|FG002|COMPLETED|Overall Study||60
3030891|NCT01115673|3749844|FG000|NOT COMPLETED|Overall Study||0
3030892|NCT01115673|3749845|FG001|NOT COMPLETED|Overall Study||0
3030893|NCT01115673|3749846|FG002|NOT COMPLETED|Overall Study||0
3030894|NCT01115738|3749857|FG000|STARTED|Overall Study||110
3030895|NCT01115738|3749858|FG001|STARTED|Overall Study||83
3030896|NCT01115738|3749859|FG002|STARTED|Overall Study||89
3030897|NCT01115738|3749857|FG000|Received Any Treatment|Overall Study||109
3030898|NCT01115738|3749858|FG001|Received Any Treatment|Overall Study||79
3030899|NCT01115738|3749859|FG002|Received Any Treatment|Overall Study||88
3030900|NCT01115738|3749857|FG000|Pharmacodynamic (PD) Population|Overall Study|Received prasugrel LD and had at least one evaluable PD measurement after prasugrel LD.|52
3030901|NCT01115738|3749858|FG001|Pharmacodynamic (PD) Population|Overall Study|Received prasugrel LD and had at least one evaluable PD measurement after prasugrel LD.|47
3030902|NCT01115738|3749859|FG002|Pharmacodynamic (PD) Population|Overall Study|Received prasugrel LD and had at least one evaluable PD measurement after prasugrel LD.|50
3030903|NCT01115738|3749857|FG000|COMPLETED|Overall Study||85
3030904|NCT01115738|3749858|FG001|COMPLETED|Overall Study||62
3030905|NCT01115738|3749859|FG002|COMPLETED|Overall Study||62
3030906|NCT01115738|3749857|FG000|NOT COMPLETED|Overall Study||25
3030907|NCT01115738|3749858|FG001|NOT COMPLETED|Overall Study||21
3030908|NCT01115738|3749859|FG002|NOT COMPLETED|Overall Study||27
3030909|NCT01115803|3749882|FG000|STARTED|Overall Study||4
3030910|NCT01115803|3749883|FG001|STARTED|Overall Study||5
3030911|NCT01115803|3749884|FG002|STARTED|Overall Study||3
3030912|NCT01115803|3749885|FG003|STARTED|Overall Study||5
3030913|NCT01115803|3749886|FG004|STARTED|Overall Study||3
3030914|NCT01115803|3749887|FG005|STARTED|Overall Study||3
3030915|NCT01115803|3749888|FG006|STARTED|Overall Study||6
3030916|NCT01115803|3749882|FG000|Received at Least 1 Dose of Study Drug|Overall Study||4
3030917|NCT01115803|3749883|FG001|Received at Least 1 Dose of Study Drug|Overall Study||5
3030918|NCT01115803|3749884|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3
3030919|NCT01115803|3749885|FG003|Received at Least 1 Dose of Study Drug|Overall Study||5
3310069|NCT03037307|4043444|FG000|STARTED|Wash Out Period 1||7
3310070|NCT03037307|4043445|FG001|STARTED|Wash Out Period 1||7
3030920|NCT01115803|3749886|FG004|Received at Least 1 Dose of Study Drug|Overall Study||3
3030921|NCT01115803|3749887|FG005|Received at Least 1 Dose of Study Drug|Overall Study||3
3030922|NCT01115803|3749888|FG006|Received at Least 1 Dose of Study Drug|Overall Study||6
3030923|NCT01115803|3749882|FG000|COMPLETED|Overall Study||4
3030924|NCT01115803|3749883|FG001|COMPLETED|Overall Study||5
3030925|NCT01115803|3749884|FG002|COMPLETED|Overall Study||2
3030926|NCT01115803|3749885|FG003|COMPLETED|Overall Study||5
3310071|NCT03037307|4043446|FG002|STARTED|Wash Out Period 1||8
3030927|NCT01115803|3749886|FG004|COMPLETED|Overall Study||3
3030928|NCT01115803|3749887|FG005|COMPLETED|Overall Study||3
3030929|NCT01115803|3749888|FG006|COMPLETED|Overall Study||4
3030930|NCT01115803|3749882|FG000|NOT COMPLETED|Overall Study||0
3030931|NCT01115803|3749883|FG001|NOT COMPLETED|Overall Study||0
3030932|NCT01115803|3749884|FG002|NOT COMPLETED|Overall Study||1
3030933|NCT01115803|3749885|FG003|NOT COMPLETED|Overall Study||0
3030934|NCT01115803|3749886|FG004|NOT COMPLETED|Overall Study||0
3030935|NCT01115803|3749887|FG005|NOT COMPLETED|Overall Study||0
3030936|NCT01115803|3749888|FG006|NOT COMPLETED|Overall Study||2
3030937|NCT01115855|3749911|FG000|STARTED|Overall Study||111
3030938|NCT01115855|3749912|FG001|STARTED|Overall Study||110
3030939|NCT01115855|3749911|FG000|COMPLETED|Overall Study||75
3030940|NCT01115855|3749912|FG001|COMPLETED|Overall Study||74
3030941|NCT01115855|3749911|FG000|NOT COMPLETED|Overall Study||36
3030942|NCT01115855|3749912|FG001|NOT COMPLETED|Overall Study||36
3030943|NCT01115933|3749918|FG000|STARTED|Overall Study||65
3030944|NCT01115933|3749918|FG000|COMPLETED|Overall Study||64
3030945|NCT01115933|3749918|FG000|NOT COMPLETED|Overall Study||1
3030946|NCT01115998|3749977|FG000|STARTED|Overall Study||17
3030947|NCT01115998|3749978|FG001|STARTED|Overall Study||17
3030948|NCT01115998|3749977|FG000|COMPLETED|Overall Study||11
3030949|NCT01115998|3749978|FG001|COMPLETED|Overall Study||11
3030950|NCT01115998|3749977|FG000|NOT COMPLETED|Overall Study||6
3030951|NCT01115998|3749978|FG001|NOT COMPLETED|Overall Study||6
3030952|NCT01116024|3749984|FG000|STARTED|Overall Study|148 subjects left operating room with the device implanted and were included in the analysis.|148
3030953|NCT01116024|3749984|FG000|COMPLETED|Overall Study|Patient Enrollment stop date|96
3030954|NCT01116024|3749984|FG000|NOT COMPLETED|Overall Study||52
3030955|NCT01116037|3750010|FG000|STARTED|Overall Study||26
3030956|NCT01116037|3750010|FG000|COMPLETED|Overall Study||1
3030957|NCT01116037|3750010|FG000|NOT COMPLETED|Overall Study||25
3030958|NCT01116102|3750022|FG000|STARTED|Overall Study||2
3030959|NCT01116102|3750023|FG001|STARTED|Overall Study||3
3030960|NCT01116102|3750024|FG002|STARTED|Overall Study||3
3030961|NCT01116102|3750025|FG003|STARTED|Overall Study||3
3030962|NCT01116102|3750026|FG004|STARTED|Overall Study||2
3030963|NCT01116102|3750027|FG005|STARTED|Overall Study||2
3030964|NCT01116102|3750028|FG006|STARTED|Overall Study||2
3030965|NCT01116102|3750029|FG007|STARTED|Overall Study||3
3030966|NCT01116102|3750022|FG000|COMPLETED|Overall Study||2
3030967|NCT01116102|3750023|FG001|COMPLETED|Overall Study||3
3030968|NCT01116102|3750024|FG002|COMPLETED|Overall Study||3
3030969|NCT01116102|3750025|FG003|COMPLETED|Overall Study||3
3030970|NCT01116102|3750026|FG004|COMPLETED|Overall Study||2
3030971|NCT01116102|3750027|FG005|COMPLETED|Overall Study||2
3030972|NCT01116102|3750028|FG006|COMPLETED|Overall Study||2
3030973|NCT01116102|3750029|FG007|COMPLETED|Overall Study||3
3030974|NCT01116102|3750022|FG000|NOT COMPLETED|Overall Study||0
3030975|NCT01116102|3750023|FG001|NOT COMPLETED|Overall Study||0
3030976|NCT01116102|3750024|FG002|NOT COMPLETED|Overall Study||0
3166106|NCT01903252|3893563|FG003|COMPLETED|Extended Induction, Open-Label||0
3166107|NCT01903252|3893564|FG004|COMPLETED|Extended Induction, Open-Label||0
3030977|NCT01116102|3750025|FG003|NOT COMPLETED|Overall Study||0
3030978|NCT01116102|3750026|FG004|NOT COMPLETED|Overall Study||0
3030979|NCT01116102|3750027|FG005|NOT COMPLETED|Overall Study||0
3030980|NCT01116102|3750028|FG006|NOT COMPLETED|Overall Study||0
3030981|NCT01116102|3750029|FG007|NOT COMPLETED|Overall Study||0
3030982|NCT01116401|3750047|FG000|STARTED|Overall Study||29
3030983|NCT01116401|3750047|FG000|COMPLETED|Overall Study||29
3030984|NCT01116401|3750047|FG000|NOT COMPLETED|Overall Study||0
3030985|NCT01116427|3750053|FG000|STARTED|Core Phase||44
3030986|NCT01116427|3750054|FG001|STARTED|Core Phase||21
3030987|NCT01116427|3750053|FG000|COMPLETED|Core Phase||39
3030988|NCT01116427|3750054|FG001|COMPLETED|Core Phase||20
3030989|NCT01116427|3750053|FG000|NOT COMPLETED|Core Phase||5
3030990|NCT01116427|3750054|FG001|NOT COMPLETED|Core Phase||1
3030991|NCT01116427|3750053|FG000|STARTED|Extension Phase|One participant that completed core phase did not meet eligibility for Extension Phase|38
3030992|NCT01116427|3750054|FG001|STARTED|Extension Phase||20
3030993|NCT01116427|3750053|FG000|COMPLETED|Extension Phase||29
3030994|NCT01116427|3750054|FG001|COMPLETED|Extension Phase||18
3030995|NCT01116427|3750053|FG000|NOT COMPLETED|Extension Phase||9
3030996|NCT01116427|3750054|FG001|NOT COMPLETED|Extension Phase||2
3030997|NCT01116440|3750066|FG000|STARTED|Treatment||11
3030998|NCT01116440|3750067|FG001|STARTED|Treatment||16
3030999|NCT01116440|3750066|FG000|COMPLETED|Treatment||8
3031000|NCT01116440|3750067|FG001|COMPLETED|Treatment||9
3031001|NCT01116440|3750066|FG000|NOT COMPLETED|Treatment||3
3031002|NCT01116440|3750067|FG001|NOT COMPLETED|Treatment||7
3031003|NCT01116440|3750066|FG000|STARTED|Withdrawal||8
3031004|NCT01116440|3750067|FG001|STARTED|Withdrawal||9
3031005|NCT01116440|3750066|FG000|COMPLETED|Withdrawal||8
3031006|NCT01116440|3750067|FG001|COMPLETED|Withdrawal||7
3031007|NCT01116440|3750066|FG000|NOT COMPLETED|Withdrawal||0
3031008|NCT01116440|3750067|FG001|NOT COMPLETED|Withdrawal||2
3031009|NCT01116440|3750066|FG000|STARTED|Follow-up||8
3031010|NCT01116440|3750067|FG001|STARTED|Follow-up||7
3031011|NCT01116440|3750066|FG000|COMPLETED|Follow-up||8
3031012|NCT01116440|3750067|FG001|COMPLETED|Follow-up||5
3031013|NCT01116440|3750066|FG000|NOT COMPLETED|Follow-up||0
3031014|NCT01116440|3750067|FG001|NOT COMPLETED|Follow-up||2
3031015|NCT01116466|3750075|FG000|STARTED|Overall Study||5
3031016|NCT01116466|3750075|FG000|COMPLETED|Overall Study||5
3031017|NCT01116466|3750075|FG000|NOT COMPLETED|Overall Study||0
3031018|NCT01116544|3750082|FG000|STARTED|Overall Study||23
3031019|NCT01116544|3750083|FG001|STARTED|Overall Study||23
3031020|NCT01116544|3750082|FG000|COMPLETED|Overall Study||21
3031021|NCT01116544|3750083|FG001|COMPLETED|Overall Study||22
3031022|NCT01116544|3750082|FG000|NOT COMPLETED|Overall Study||2
3031023|NCT01116544|3750083|FG001|NOT COMPLETED|Overall Study||1
3031024|NCT01116661|3750089|FG000|STARTED|Overall Study||199
3031025|NCT01116661|3750089|FG000|COMPLETED|Overall Study||197
3031026|NCT01116661|3750089|FG000|NOT COMPLETED|Overall Study||2
3031027|NCT01116687|3750093|FG000|STARTED|Overall Study||37
3031028|NCT01116687|3750093|FG000|COMPLETED|Overall Study||33
3031029|NCT01116687|3750093|FG000|NOT COMPLETED|Overall Study||4
3031030|NCT01116739|3750099|FG000|STARTED|Overall Study||1056
3031031|NCT01116739|3750100|FG001|STARTED|Overall Study||1004
3031032|NCT01116739|3750099|FG000|COMPLETED|Overall Study||926
3031033|NCT01116739|3750100|FG001|COMPLETED|Overall Study||868
3031034|NCT01116739|3750099|FG000|NOT COMPLETED|Overall Study||130
3031035|NCT01116739|3750100|FG001|NOT COMPLETED|Overall Study||136
3031036|NCT01116882|3750108|FG000|STARTED|30-day||2774
3031037|NCT01116882|3750109|FG001|STARTED|30-day||917
3031038|NCT01116882|3750108|FG000|COMPLETED|30-day||2706
3031039|NCT01116882|3750109|FG001|COMPLETED|30-day||886
3031040|NCT01116882|3750108|FG000|NOT COMPLETED|30-day||68
3031041|NCT01116882|3750109|FG001|NOT COMPLETED|30-day||31
3031042|NCT01116882|3750108|FG000|STARTED|12-month||2706
3031043|NCT01116882|3750109|FG001|STARTED|12-month||886
3031044|NCT01116882|3750108|FG000|COMPLETED|12-month||2439
3031045|NCT01116882|3750109|FG001|COMPLETED|12-month||787
3031046|NCT01116882|3750108|FG000|NOT COMPLETED|12-month||267
3031047|NCT01116882|3750109|FG001|NOT COMPLETED|12-month||99
3031048|NCT01116895|3750122|FG000|STARTED|Overall Study||16
3031049|NCT01116895|3750123|FG001|STARTED|Overall Study||15
3031050|NCT01116895|3750124|FG002|STARTED|Overall Study||18
3031051|NCT01116895|3750125|FG003|STARTED|Overall Study||14
3031052|NCT01116895|3750122|FG000|COMPLETED|Overall Study||12
3031053|NCT01116895|3750123|FG001|COMPLETED|Overall Study||8
3031054|NCT01116895|3750124|FG002|COMPLETED|Overall Study||14
3031055|NCT01116895|3750125|FG003|COMPLETED|Overall Study||11
3031056|NCT01116895|3750122|FG000|NOT COMPLETED|Overall Study||4
3031057|NCT01116895|3750123|FG001|NOT COMPLETED|Overall Study||7
3031058|NCT01116895|3750124|FG002|NOT COMPLETED|Overall Study||4
3031059|NCT01116895|3750125|FG003|NOT COMPLETED|Overall Study||3
3031060|NCT01116921|3750137|FG000|STARTED|Overall Study||53
3031061|NCT01116921|3750138|FG001|STARTED|Overall Study||50
3031062|NCT01116921|3750137|FG000|COMPLETED|Overall Study||53
3031063|NCT01116921|3750138|FG001|COMPLETED|Overall Study||50
3031064|NCT01116921|3750137|FG000|NOT COMPLETED|Overall Study||0
3031065|NCT01116921|3750138|FG001|NOT COMPLETED|Overall Study||0
3031066|NCT01116934|3750146|FG000|STARTED|Overall Study||8
3031067|NCT01116934|3750147|FG001|STARTED|Overall Study||9
3031068|NCT01116934|3750146|FG000|COMPLETED|Overall Study||8
3031069|NCT01116934|3750147|FG001|COMPLETED|Overall Study||9
3031070|NCT01116934|3750146|FG000|NOT COMPLETED|Overall Study||0
3031071|NCT01116934|3750147|FG001|NOT COMPLETED|Overall Study||0
3031072|NCT01116986|3750185|FG000|STARTED|Overall Study||24
3031073|NCT01116986|3750186|FG001|STARTED|Overall Study||19
3031074|NCT01116986|3750187|FG002|STARTED|Overall Study||18
3031075|NCT01116986|3750188|FG003|STARTED|Overall Study||22
3031076|NCT01116986|3750189|FG004|STARTED|Overall Study||24
3031077|NCT01116986|3750190|FG005|STARTED|Overall Study||22
3031078|NCT01116986|3750191|FG006|STARTED|Overall Study||22
3031079|NCT01116986|3750192|FG007|STARTED|Overall Study||22
3031080|NCT01116986|3750193|FG008|STARTED|Overall Study||20
3031081|NCT01116986|3750194|FG009|STARTED|Overall Study||23
3031082|NCT01116986|3750195|FG010|STARTED|Overall Study||19
3031083|NCT01116986|3750196|FG011|STARTED|Overall Study||20
3031084|NCT01116986|3750197|FG012|STARTED|Overall Study||17
3031085|NCT01116986|3750198|FG013|STARTED|Overall Study||19
3031086|NCT01116986|3750199|FG014|STARTED|Overall Study||17
3031087|NCT01116986|3750200|FG015|STARTED|Overall Study||21
3031088|NCT01116986|3750201|FG016|STARTED|Overall Study||16
3031089|NCT01116986|3750202|FG017|STARTED|Overall Study||24
3031090|NCT01116986|3750203|FG018|STARTED|Overall Study||23
3031091|NCT01116986|3750204|FG019|STARTED|Overall Study||15
3031092|NCT01116986|3750205|FG020|STARTED|Overall Study||24
3031093|NCT01116986|3750206|FG021|STARTED|Overall Study||20
3031094|NCT01116986|3750207|FG022|STARTED|Overall Study||23
3031095|NCT01116986|3750208|FG023|STARTED|Overall Study||21
3031096|NCT01116986|3750209|FG024|STARTED|Overall Study||18
3031097|NCT01116986|3750210|FG025|STARTED|Overall Study||19
3031098|NCT01116986|3750211|FG026|STARTED|Overall Study||18
3031099|NCT01116986|3750212|FG027|STARTED|Overall Study||19
3031100|NCT01116986|3750213|FG028|STARTED|Overall Study||17
3031101|NCT01116986|3750214|FG029|STARTED|Overall Study||17
3031102|NCT01116986|3750215|FG030|STARTED|Overall Study||17
3031103|NCT01116986|3750216|FG031|STARTED|Overall Study||17
3031104|NCT01116986|3750185|FG000|COMPLETED|Overall Study||22
3031105|NCT01116986|3750186|FG001|COMPLETED|Overall Study||16
3031106|NCT01116986|3750187|FG002|COMPLETED|Overall Study||16
3031107|NCT01116986|3750188|FG003|COMPLETED|Overall Study||20
3031108|NCT01116986|3750189|FG004|COMPLETED|Overall Study||20
3031109|NCT01116986|3750190|FG005|COMPLETED|Overall Study||20
3031110|NCT01116986|3750191|FG006|COMPLETED|Overall Study||20
3031111|NCT01116986|3750192|FG007|COMPLETED|Overall Study||20
3031112|NCT01116986|3750193|FG008|COMPLETED|Overall Study||19
3031113|NCT01116986|3750194|FG009|COMPLETED|Overall Study||19
3031114|NCT01116986|3750195|FG010|COMPLETED|Overall Study||18
3031115|NCT01116986|3750196|FG011|COMPLETED|Overall Study||20
3031116|NCT01116986|3750197|FG012|COMPLETED|Overall Study||16
3031117|NCT01116986|3750198|FG013|COMPLETED|Overall Study||16
3031118|NCT01116986|3750199|FG014|COMPLETED|Overall Study||17
3031119|NCT01116986|3750200|FG015|COMPLETED|Overall Study||15
3031120|NCT01116986|3750201|FG016|COMPLETED|Overall Study||13
3031121|NCT01116986|3750202|FG017|COMPLETED|Overall Study||19
3031122|NCT01116986|3750203|FG018|COMPLETED|Overall Study||20
3031123|NCT01116986|3750204|FG019|COMPLETED|Overall Study||13
3031124|NCT01116986|3750205|FG020|COMPLETED|Overall Study||22
3031125|NCT01116986|3750206|FG021|COMPLETED|Overall Study||18
3031126|NCT01116986|3750207|FG022|COMPLETED|Overall Study||19
3031127|NCT01116986|3750208|FG023|COMPLETED|Overall Study||19
3031128|NCT01116986|3750209|FG024|COMPLETED|Overall Study||15
3031129|NCT01116986|3750210|FG025|COMPLETED|Overall Study||19
3031130|NCT01116986|3750211|FG026|COMPLETED|Overall Study||14
3031131|NCT01116986|3750212|FG027|COMPLETED|Overall Study||18
3031132|NCT01116986|3750213|FG028|COMPLETED|Overall Study||17
3031133|NCT01116986|3750214|FG029|COMPLETED|Overall Study||17
3031134|NCT01116986|3750215|FG030|COMPLETED|Overall Study||16
3031135|NCT01116986|3750216|FG031|COMPLETED|Overall Study||14
3031136|NCT01116986|3750185|FG000|NOT COMPLETED|Overall Study||2
3031137|NCT01116986|3750186|FG001|NOT COMPLETED|Overall Study||3
3031138|NCT01116986|3750187|FG002|NOT COMPLETED|Overall Study||2
3031139|NCT01116986|3750188|FG003|NOT COMPLETED|Overall Study||2
3031140|NCT01116986|3750189|FG004|NOT COMPLETED|Overall Study||4
3031141|NCT01116986|3750190|FG005|NOT COMPLETED|Overall Study||2
3031142|NCT01116986|3750191|FG006|NOT COMPLETED|Overall Study||2
3031143|NCT01116986|3750192|FG007|NOT COMPLETED|Overall Study||2
3031144|NCT01116986|3750193|FG008|NOT COMPLETED|Overall Study||1
3031145|NCT01116986|3750194|FG009|NOT COMPLETED|Overall Study||4
3031146|NCT01116986|3750195|FG010|NOT COMPLETED|Overall Study||1
3031147|NCT01116986|3750196|FG011|NOT COMPLETED|Overall Study||0
3031148|NCT01116986|3750197|FG012|NOT COMPLETED|Overall Study||1
3031149|NCT01116986|3750198|FG013|NOT COMPLETED|Overall Study||3
3031150|NCT01116986|3750199|FG014|NOT COMPLETED|Overall Study||0
3031151|NCT01116986|3750200|FG015|NOT COMPLETED|Overall Study||6
3031152|NCT01116986|3750201|FG016|NOT COMPLETED|Overall Study||3
3031153|NCT01116986|3750202|FG017|NOT COMPLETED|Overall Study||5
3031154|NCT01116986|3750203|FG018|NOT COMPLETED|Overall Study||3
3031155|NCT01116986|3750204|FG019|NOT COMPLETED|Overall Study||2
3031156|NCT01116986|3750205|FG020|NOT COMPLETED|Overall Study||2
3031157|NCT01116986|3750206|FG021|NOT COMPLETED|Overall Study||2
3031158|NCT01116986|3750207|FG022|NOT COMPLETED|Overall Study||4
3031159|NCT01116986|3750208|FG023|NOT COMPLETED|Overall Study||2
3031160|NCT01116986|3750209|FG024|NOT COMPLETED|Overall Study||3
3031161|NCT01116986|3750210|FG025|NOT COMPLETED|Overall Study||0
3031162|NCT01116986|3750211|FG026|NOT COMPLETED|Overall Study||4
3031163|NCT01116986|3750212|FG027|NOT COMPLETED|Overall Study||1
3031164|NCT01116986|3750213|FG028|NOT COMPLETED|Overall Study||0
3031165|NCT01116986|3750214|FG029|NOT COMPLETED|Overall Study||0
3031166|NCT01116986|3750215|FG030|NOT COMPLETED|Overall Study||1
3031167|NCT01116986|3750216|FG031|NOT COMPLETED|Overall Study||3
3031168|NCT01117012|3750238|FG000|STARTED|Overall Study||89
3031169|NCT01117012|3750239|FG001|STARTED|Overall Study||103
3031170|NCT01117012|3750238|FG000|COMPLETED|Overall Study||81
3031171|NCT01117012|3750239|FG001|COMPLETED|Overall Study||98
3031172|NCT01117012|3750238|FG000|NOT COMPLETED|Overall Study||8
3031173|NCT01117012|3750239|FG001|NOT COMPLETED|Overall Study||5
3031174|NCT01117051|3750247|FG000|STARTED|Overall Study||86
3031175|NCT01117051|3750248|FG001|STARTED|Overall Study||88
3031176|NCT01117051|3750247|FG000|COMPLETED|Overall Study||73
3031177|NCT01117051|3750248|FG001|COMPLETED|Overall Study||77
3031178|NCT01117051|3750247|FG000|NOT COMPLETED|Overall Study||13
3031179|NCT01117051|3750248|FG001|NOT COMPLETED|Overall Study||11
3031180|NCT01117090|3750255|FG000|STARTED|Overall Study||47
3031181|NCT01117090|3750255|FG000|COMPLETED|Overall Study||47
3031182|NCT01117090|3750255|FG000|NOT COMPLETED|Overall Study||0
3031183|NCT01117181|3750268|FG000|STARTED|Overall Study||29
3031184|NCT01117181|3750269|FG001|STARTED|Overall Study||31
3031185|NCT01117181|3750268|FG000|COMPLETED|Overall Study||28
3031186|NCT01117181|3750269|FG001|COMPLETED|Overall Study||29
3031187|NCT01117181|3750268|FG000|NOT COMPLETED|Overall Study||1
3031188|NCT01117181|3750269|FG001|NOT COMPLETED|Overall Study||2
3031189|NCT01117311|3750277|FG000|STARTED|Lead-in Mixed Meal 1||3
3031190|NCT01117311|3750278|FG001|STARTED|Lead-in Mixed Meal 1||4
3031191|NCT01117311|3750277|FG000|COMPLETED|Lead-in Mixed Meal 1||3
3031192|NCT01117311|3750278|FG001|COMPLETED|Lead-in Mixed Meal 1||4
3031193|NCT01117311|3750277|FG000|NOT COMPLETED|Lead-in Mixed Meal 1||0
3031194|NCT01117311|3750278|FG001|NOT COMPLETED|Lead-in Mixed Meal 1||0
3031195|NCT01117311|3750277|FG000|STARTED|First Intervention - Mixed Meal 2||3
3031196|NCT01117311|3750278|FG001|STARTED|First Intervention - Mixed Meal 2||4
3031197|NCT01117311|3750277|FG000|COMPLETED|First Intervention - Mixed Meal 2||3
3031198|NCT01117311|3750278|FG001|COMPLETED|First Intervention - Mixed Meal 2||4
3031199|NCT01117311|3750277|FG000|NOT COMPLETED|First Intervention - Mixed Meal 2||0
3031200|NCT01117311|3750278|FG001|NOT COMPLETED|First Intervention - Mixed Meal 2||0
3031201|NCT01117311|3750277|FG000|STARTED|Second Intervention - Mixed Meal 3||3
3031202|NCT01117311|3750278|FG001|STARTED|Second Intervention - Mixed Meal 3||4
3031203|NCT01117311|3750277|FG000|COMPLETED|Second Intervention - Mixed Meal 3||3
3031204|NCT01117311|3750278|FG001|COMPLETED|Second Intervention - Mixed Meal 3||4
3031205|NCT01117311|3750277|FG000|NOT COMPLETED|Second Intervention - Mixed Meal 3||0
3031206|NCT01117311|3750278|FG001|NOT COMPLETED|Second Intervention - Mixed Meal 3||0
3031207|NCT01117337|3750286|FG000|STARTED|Overall Study|52 pateints on inguinal hernia were randomized to mesh fixation group|52
3031208|NCT01117337|3750287|FG001|STARTED|Overall Study||52
3031209|NCT01117337|3750286|FG000|Underwent Surgery|Overall Study|52 patients underwent surgery|52
3031210|NCT01117337|3750287|FG001|Underwent Surgery|Overall Study||52
3031211|NCT01117337|3750286|FG000|COMPLETED|Overall Study|48 completed one year follow-up. 4 lost to follow-up.|48
3031212|NCT01117337|3750287|FG001|COMPLETED|Overall Study||52
3031213|NCT01117337|3750286|FG000|NOT COMPLETED|Overall Study||4
3031214|NCT01117337|3750287|FG001|NOT COMPLETED|Overall Study||0
3031215|NCT01117350|3750295|FG000|STARTED|Comparative Period|STARTED: randomized|489
3031216|NCT01117350|3750296|FG001|STARTED|Comparative Period||489
3031217|NCT01117350|3750295|FG000|TREATED = Safety Population|Comparative Period|Safety population: all randomized and treated patients (received at least one dose)|484
3031218|NCT01117350|3750296|FG001|TREATED = Safety Population|Comparative Period||481
3031219|NCT01117350|3750295|FG000|mITT Population|Comparative Period|modified Intent-To-Treat population: treated patients with at least one efficacy post-baseline value|474
3031220|NCT01117350|3750296|FG001|mITT Population|Comparative Period||470
3031221|NCT01117350|3750295|FG000|COMPLETED|Comparative Period||447
3031222|NCT01117350|3750296|FG001|COMPLETED|Comparative Period||414
3031223|NCT01117350|3750295|FG000|NOT COMPLETED|Comparative Period||42
3031224|NCT01117350|3750296|FG001|NOT COMPLETED|Comparative Period||75
3031225|NCT01117350|3750295|FG000|STARTED|Extension Period||0
3031226|NCT01117350|3750296|FG001|STARTED|Extension Period|STARTED: patients having completed the comparative period and eligible for the extension period|210
3031227|NCT01117350|3750295|FG000|TREATED = Safety Population (Extension)|Extension Period||0
3031228|NCT01117350|3750296|FG001|TREATED = Safety Population (Extension)|Extension Period|Safety population (extension): treated with insulin glargine during the extension period|160
3031229|NCT01117350|3750295|FG000|mITT Population (Extension)|Extension Period||0
3031230|NCT01117350|3750296|FG001|mITT Population (Extension)|Extension Period|mITT (extension): treated patients with at least 1 efficacy value both at entry and during extension|154
3031231|NCT01117350|3750295|FG000|COMPLETED|Extension Period||0
3031232|NCT01117350|3750296|FG001|COMPLETED|Extension Period||147
3031233|NCT01117350|3750295|FG000|NOT COMPLETED|Extension Period||0
3031234|NCT01117350|3750296|FG001|NOT COMPLETED|Extension Period||63
3031235|NCT01117428|3750311|FG000|STARTED|Overall Study|"0.4 mg/kg=1~0.75 mg/kg=1~1.5 mg/kg=3~3 mg/kg=3~6 mg/kg=3~9 mg/kg=6~12 mg/kg=3"|20
3031236|NCT01117428|3750312|FG001|STARTED|Overall Study||29
3031237|NCT01117428|3750313|FG002|STARTED|Overall Study||13
3031238|NCT01117428|3750314|FG003|STARTED|Overall Study||12
3031239|NCT01117428|3750315|FG004|STARTED|Overall Study||17
3031240|NCT01117428|3750316|FG005|STARTED|Overall Study||20
3031241|NCT01117428|3750311|FG000|COMPLETED|Overall Study||0
3031242|NCT01117428|3750312|FG001|COMPLETED|Overall Study||0
3031243|NCT01117428|3750313|FG002|COMPLETED|Overall Study||0
3031244|NCT01117428|3750314|FG003|COMPLETED|Overall Study||0
3031245|NCT01117428|3750315|FG004|COMPLETED|Overall Study||0
3031246|NCT01117428|3750316|FG005|COMPLETED|Overall Study||0
3031247|NCT01117428|3750311|FG000|NOT COMPLETED|Overall Study||20
3031248|NCT01117428|3750312|FG001|NOT COMPLETED|Overall Study||29
3031249|NCT01117428|3750313|FG002|NOT COMPLETED|Overall Study||13
3031250|NCT01117428|3750314|FG003|NOT COMPLETED|Overall Study||12
3031251|NCT01117428|3750315|FG004|NOT COMPLETED|Overall Study||17
3031252|NCT01117428|3750316|FG005|NOT COMPLETED|Overall Study||20
3031253|NCT01117454|3750334|FG000|STARTED|Overall Study||6
3031254|NCT01117454|3750335|FG001|STARTED|Overall Study||8
3031255|NCT01117454|3750334|FG000|COMPLETED|Overall Study||6
3031256|NCT01117454|3750335|FG001|COMPLETED|Overall Study||7
3031257|NCT01117454|3750334|FG000|NOT COMPLETED|Overall Study||0
3031258|NCT01117454|3750335|FG001|NOT COMPLETED|Overall Study||1
3031259|NCT01117480|3750341|FG000|STARTED|Overall Study||1013
3031260|NCT01117480|3750341|FG000|COMPLETED|Overall Study||985
3031261|NCT01117480|3750341|FG000|NOT COMPLETED|Overall Study||28
3031262|NCT01117623|3750353|FG000|STARTED|Overall Study||3
3031263|NCT01117623|3750354|FG001|STARTED|Overall Study||8
3031264|NCT01117623|3750355|FG002|STARTED|Overall Study||11
3031265|NCT01117623|3750356|FG003|STARTED|Overall Study||6
3031266|NCT01117623|3750357|FG004|STARTED|Overall Study||10
3031267|NCT01117623|3750358|FG005|STARTED|Overall Study||16
3031268|NCT01117623|3750359|FG006|STARTED|Overall Study||6
3031269|NCT01117623|3750360|FG007|STARTED|Overall Study||26
3031270|NCT01117623|3750353|FG000|ITT Efficacy Analysis Population|Overall Study||3
3031271|NCT01117623|3750354|FG001|ITT Efficacy Analysis Population|Overall Study||8
3031272|NCT01117623|3750355|FG002|ITT Efficacy Analysis Population|Overall Study||11
3031273|NCT01117623|3750356|FG003|ITT Efficacy Analysis Population|Overall Study||5
3031274|NCT01117623|3750357|FG004|ITT Efficacy Analysis Population|Overall Study||10
3031275|NCT01117623|3750358|FG005|ITT Efficacy Analysis Population|Overall Study||16
3031276|NCT01117623|3750359|FG006|ITT Efficacy Analysis Population|Overall Study||6
3031277|NCT01117623|3750360|FG007|ITT Efficacy Analysis Population|Overall Study||22
3031278|NCT01117623|3750353|FG000|PK Population|Overall Study||3
3031279|NCT01117623|3750354|FG001|PK Population|Overall Study||8
3031280|NCT01117623|3750355|FG002|PK Population|Overall Study||10
3031281|NCT01117623|3750356|FG003|PK Population|Overall Study||6
3031282|NCT01117623|3750357|FG004|PK Population|Overall Study||10
3031283|NCT01117623|3750358|FG005|PK Population|Overall Study||14
3031284|NCT01117623|3750359|FG006|PK Population|Overall Study||6
3031285|NCT01117623|3750360|FG007|PK Population|Overall Study||24
3031286|NCT01117623|3750353|FG000|COMPLETED|Overall Study||0
3031287|NCT01117623|3750354|FG001|COMPLETED|Overall Study||0
3031288|NCT01117623|3750355|FG002|COMPLETED|Overall Study||0
3031289|NCT01117623|3750356|FG003|COMPLETED|Overall Study||0
3031290|NCT01117623|3750357|FG004|COMPLETED|Overall Study||0
3031291|NCT01117623|3750358|FG005|COMPLETED|Overall Study||0
3031292|NCT01117623|3750359|FG006|COMPLETED|Overall Study||0
3031293|NCT01117623|3750360|FG007|COMPLETED|Overall Study||0
3031294|NCT01117623|3750353|FG000|NOT COMPLETED|Overall Study||3
3031295|NCT01117623|3750354|FG001|NOT COMPLETED|Overall Study||8
3031296|NCT01117623|3750355|FG002|NOT COMPLETED|Overall Study||11
3031297|NCT01117623|3750356|FG003|NOT COMPLETED|Overall Study||6
3031298|NCT01117623|3750357|FG004|NOT COMPLETED|Overall Study||10
3031299|NCT01117623|3750358|FG005|NOT COMPLETED|Overall Study||16
3031300|NCT01117623|3750359|FG006|NOT COMPLETED|Overall Study||6
3031301|NCT01117623|3750360|FG007|NOT COMPLETED|Overall Study||26
3031302|NCT01117727|3750380|FG000|STARTED|Overall Study||1
3031303|NCT01117727|3750380|FG000|COMPLETED|Overall Study||1
3031304|NCT01117727|3750380|FG000|NOT COMPLETED|Overall Study||0
3031305|NCT01117766|3750385|FG000|STARTED|First Intervention||14
3031306|NCT01117766|3750386|FG001|STARTED|First Intervention||17
3031307|NCT01117766|3750385|FG000|Received Treatment|First Intervention||14
3031308|NCT01117766|3750386|FG001|Received Treatment|First Intervention||17
3031309|NCT01117766|3750385|FG000|COMPLETED|First Intervention||13
3031310|NCT01117766|3750386|FG001|COMPLETED|First Intervention||16
3031311|NCT01117766|3750385|FG000|NOT COMPLETED|First Intervention||1
3031312|NCT01117766|3750386|FG001|NOT COMPLETED|First Intervention||1
3031313|NCT01117766|3750385|FG000|STARTED|Washout Period||13
3031314|NCT01117766|3750386|FG001|STARTED|Washout Period||16
3031315|NCT01117766|3750385|FG000|COMPLETED|Washout Period||13
3031316|NCT01117766|3750386|FG001|COMPLETED|Washout Period||14
3031317|NCT01117766|3750385|FG000|NOT COMPLETED|Washout Period||0
3031318|NCT01117766|3750386|FG001|NOT COMPLETED|Washout Period||2
3031319|NCT01117766|3750385|FG000|STARTED|Second Intervention||13
3031320|NCT01117766|3750386|FG001|STARTED|Second Intervention||14
3031321|NCT01117766|3750385|FG000|COMPLETED|Second Intervention||11
3031322|NCT01117766|3750386|FG001|COMPLETED|Second Intervention||9
3031323|NCT01117766|3750385|FG000|NOT COMPLETED|Second Intervention||2
3031324|NCT01117766|3750386|FG001|NOT COMPLETED|Second Intervention||5
3031325|NCT01117792|3750392|FG000|STARTED|Overall Study||55
3031326|NCT01117792|3750392|FG000|COMPLETED|Overall Study||51
3031327|NCT01117792|3750392|FG000|NOT COMPLETED|Overall Study||4
3031328|NCT01117857|3750396|FG000|STARTED|Overall Study||22
3031329|NCT01117857|3750396|FG000|COMPLETED|Overall Study||13
3031330|NCT01117857|3750396|FG000|NOT COMPLETED|Overall Study||9
3031331|NCT01117870|3750402|FG000|STARTED|Overall Study||15
3031332|NCT01117870|3750403|FG001|STARTED|Overall Study||16
3031333|NCT01117870|3750402|FG000|COMPLETED|Overall Study|One did not receive the allocated intervention; (degenerate spine/inability to place needle).|14
3031334|NCT01117870|3750403|FG001|COMPLETED|Overall Study||16
3031335|NCT01117870|3750402|FG000|NOT COMPLETED|Overall Study||1
3031336|NCT01117870|3750403|FG001|NOT COMPLETED|Overall Study||0
3031337|NCT01117948|3750415|FG000|STARTED|Double Blind||111
3031338|NCT01117948|3750416|FG001|STARTED|Double Blind||108
3031339|NCT01117948|3750415|FG000|COMPLETED|Double Blind||93
3031340|NCT01117948|3750416|FG001|COMPLETED|Double Blind||98
3031341|NCT01117948|3750415|FG000|NOT COMPLETED|Double Blind||18
3031342|NCT01117948|3750416|FG001|NOT COMPLETED|Double Blind||10
3031343|NCT01117948|3750415|FG000|STARTED|Open Label||93
3031344|NCT01117948|3750416|FG001|STARTED|Open Label||98
3031345|NCT01117948|3750415|FG000|COMPLETED|Open Label||41
3031346|NCT01117948|3750416|FG001|COMPLETED|Open Label||51
3031347|NCT01117948|3750415|FG000|NOT COMPLETED|Open Label||52
3031348|NCT01117948|3750416|FG001|NOT COMPLETED|Open Label||47
3031349|NCT01117987|3750424|FG000|STARTED|Overall Study||66
3031350|NCT01117987|3750425|FG001|STARTED|Overall Study||78
3031351|NCT01117987|3750424|FG000|COMPLETED|Overall Study||5
3031352|NCT01117987|3750425|FG001|COMPLETED|Overall Study||4
3031353|NCT01117987|3750424|FG000|NOT COMPLETED|Overall Study||61
3031354|NCT01117987|3750425|FG001|NOT COMPLETED|Overall Study||74
3031355|NCT01118052|3750431|FG000|STARTED|Overall Study||22
3031356|NCT01118052|3750431|FG000|COMPLETED|Overall Study||20
3031357|NCT01118052|3750431|FG000|NOT COMPLETED|Overall Study||2
3031358|NCT01118091|3750443|FG000|STARTED|Overall Study|2pts were randomized to Arm 2, were not able to grow cell product, were treated with Arm 1 regimen.|7
3031359|NCT01118091|3750444|FG001|STARTED|Overall Study||5
3031360|NCT01118091|3750443|FG000|COMPLETED|Overall Study|Continued from above: These 2 pts are only represented in Arm 1 (and not Arm 2).|7
3031361|NCT01118091|3750444|FG001|COMPLETED|Overall Study||5
3031362|NCT01118091|3750443|FG000|NOT COMPLETED|Overall Study||0
3031363|NCT01118091|3750444|FG001|NOT COMPLETED|Overall Study||0
3031364|NCT01118117|3750452|FG000|STARTED|Overall Study||261
3031365|NCT01118117|3750453|FG001|STARTED|Overall Study||15
3031366|NCT01118117|3750452|FG000|COMPLETED|Overall Study||240
3031367|NCT01118117|3750453|FG001|COMPLETED|Overall Study||15
3031368|NCT01118117|3750452|FG000|NOT COMPLETED|Overall Study||21
3031369|NCT01118117|3750453|FG001|NOT COMPLETED|Overall Study||0
3038229|NCT01152788|3757608|FG000|STARTED|Overall Study||32
3031370|NCT01118143|3750461|FG000|STARTED|Overall Study||64
3031371|NCT01118143|3750462|FG001|STARTED|Overall Study||69
3031372|NCT01118143|3750461|FG000|COMPLETED|Overall Study||62
3031373|NCT01118143|3750462|FG001|COMPLETED|Overall Study||64
3031374|NCT01118143|3750461|FG000|NOT COMPLETED|Overall Study||2
3031375|NCT01118143|3750462|FG001|NOT COMPLETED|Overall Study||5
3031376|NCT01118221|3750472|FG000|STARTED|Overall Study||14
3031377|NCT01118221|3750473|FG001|STARTED|Overall Study||11
3031378|NCT01118221|3750472|FG000|COMPLETED|Overall Study||11
3031379|NCT01118221|3750473|FG001|COMPLETED|Overall Study||10
3031380|NCT01118221|3750472|FG000|NOT COMPLETED|Overall Study||3
3031381|NCT01118221|3750473|FG001|NOT COMPLETED|Overall Study||1
3031382|NCT01118273|3750489|FG000|STARTED|Overall Study||27
3031383|NCT01118273|3750490|FG001|STARTED|Overall Study||27
3031384|NCT01118273|3750491|FG002|STARTED|Overall Study||27
3031385|NCT01118273|3750492|FG003|STARTED|Overall Study||27
3031386|NCT01118273|3750493|FG004|STARTED|Overall Study||27
3031387|NCT01118273|3750494|FG005|STARTED|Overall Study||27
3310072|NCT03037307|4043447|FG003|STARTED|Wash Out Period 1||6
3310073|NCT03037307|4043448|FG004|STARTED|Wash Out Period 1||7
3310074|NCT03037307|4043449|FG005|STARTED|Wash Out Period 1||8
3031388|NCT01118273|3750489|FG000|COMPLETED|Overall Study||27
3031389|NCT01118273|3750490|FG001|COMPLETED|Overall Study||27
3031390|NCT01118273|3750491|FG002|COMPLETED|Overall Study||27
3031391|NCT01118273|3750492|FG003|COMPLETED|Overall Study||27
3031392|NCT01118273|3750493|FG004|COMPLETED|Overall Study||27
3031393|NCT01118273|3750494|FG005|COMPLETED|Overall Study||27
3031394|NCT01118273|3750489|FG000|NOT COMPLETED|Overall Study||0
3031395|NCT01118273|3750490|FG001|NOT COMPLETED|Overall Study||0
3031396|NCT01118273|3750491|FG002|NOT COMPLETED|Overall Study||0
3031397|NCT01118273|3750492|FG003|NOT COMPLETED|Overall Study||0
3031398|NCT01118273|3750493|FG004|NOT COMPLETED|Overall Study||0
3031399|NCT01118273|3750494|FG005|NOT COMPLETED|Overall Study||0
3031400|NCT01118299|3750510|FG000|STARTED|Overall Study||68
3031401|NCT01118299|3750511|FG001|STARTED|Overall Study||29
3031402|NCT01118299|3750510|FG000|COMPLETED|Overall Study||45
3031403|NCT01118299|3750511|FG001|COMPLETED|Overall Study||0
3031404|NCT01118299|3750510|FG000|NOT COMPLETED|Overall Study||23
3031405|NCT01118299|3750511|FG001|NOT COMPLETED|Overall Study||29
3031406|NCT01118312|3750518|FG000|STARTED|Overall Study||189
3031407|NCT01118312|3750519|FG001|STARTED|Overall Study||199
3031408|NCT01118312|3750518|FG000|COMPLETED|Overall Study||155
3031409|NCT01118312|3750519|FG001|COMPLETED|Overall Study||164
3031410|NCT01118312|3750518|FG000|NOT COMPLETED|Overall Study||34
3031411|NCT01118312|3750519|FG001|NOT COMPLETED|Overall Study||35
3031412|NCT01118325|3750528|FG000|STARTED|Overall Study||50
3031413|NCT01118325|3750529|FG001|STARTED|Overall Study||43
3031414|NCT01118325|3750530|FG002|STARTED|Overall Study||46
3031415|NCT01118325|3750528|FG000|COMPLETED|Overall Study||49
3031416|NCT01118325|3750529|FG001|COMPLETED|Overall Study||43
3031417|NCT01118325|3750530|FG002|COMPLETED|Overall Study||45
3031418|NCT01118325|3750528|FG000|NOT COMPLETED|Overall Study||1
3031419|NCT01118325|3750529|FG001|NOT COMPLETED|Overall Study||0
3031420|NCT01118325|3750530|FG002|NOT COMPLETED|Overall Study||1
3031421|NCT01118338|3750553|FG000|STARTED|Overall Study||185
3031422|NCT01118338|3750554|FG001|STARTED|Overall Study||183
3031423|NCT01118338|3750553|FG000|COMPLETED|Overall Study||182
3031424|NCT01118338|3750554|FG001|COMPLETED|Overall Study||174
3031425|NCT01118338|3750553|FG000|NOT COMPLETED|Overall Study||3
3031426|NCT01118338|3750554|FG001|NOT COMPLETED|Overall Study||9
3031427|NCT01118351|3750560|FG000|STARTED|Overall Study||19
3031428|NCT01118351|3750560|FG000|COMPLETED|Overall Study||15
3031429|NCT01118351|3750560|FG000|NOT COMPLETED|Overall Study||4
3031430|NCT01118377|3750564|FG000|STARTED|Overall Study||45
3031431|NCT01118377|3750564|FG000|COMPLETED|Overall Study||3
3031432|NCT01118377|3750564|FG000|NOT COMPLETED|Overall Study||42
3031433|NCT01118455|3750570|FG000|STARTED|Baseline [Visits 1 & 2]||66
3031434|NCT01118455|3750571|FG001|STARTED|Baseline [Visits 1 & 2]||69
3031435|NCT01118455|3750570|FG000|Actual Patients Treated|Baseline [Visits 1 & 2]||65
3031436|NCT01118455|3750571|FG001|Actual Patients Treated|Baseline [Visits 1 & 2]||69
3031437|NCT01118455|3750570|FG000|COMPLETED|Baseline [Visits 1 & 2]||65
3031438|NCT01118455|3750571|FG001|COMPLETED|Baseline [Visits 1 & 2]||69
3031439|NCT01118455|3750570|FG000|NOT COMPLETED|Baseline [Visits 1 & 2]||1
3031440|NCT01118455|3750571|FG001|NOT COMPLETED|Baseline [Visits 1 & 2]||0
3031441|NCT01118455|3750570|FG000|STARTED|Treatment Phase (VNS/AED) [Visits 3-10]||65
3031442|NCT01118455|3750571|FG001|STARTED|Treatment Phase (VNS/AED) [Visits 3-10]||69
3031443|NCT01118455|3750570|FG000|COMPLETED|Treatment Phase (VNS/AED) [Visits 3-10]||65
3031444|NCT01118455|3750571|FG001|COMPLETED|Treatment Phase (VNS/AED) [Visits 3-10]||69
3031445|NCT01118455|3750570|FG000|NOT COMPLETED|Treatment Phase (VNS/AED) [Visits 3-10]||0
3031446|NCT01118455|3750571|FG001|NOT COMPLETED|Treatment Phase (VNS/AED) [Visits 3-10]||0
3031447|NCT01118520|3750588|FG000|STARTED|Overall Study||73
3031448|NCT01118520|3750589|FG001|STARTED|Overall Study||72
3031449|NCT01118520|3750590|FG002|STARTED|Overall Study||79
3031450|NCT01118520|3750588|FG000|COMPLETED|Overall Study||53
3031451|NCT01118520|3750589|FG001|COMPLETED|Overall Study||49
3031452|NCT01118520|3750590|FG002|COMPLETED|Overall Study||59
3031453|NCT01118520|3750588|FG000|NOT COMPLETED|Overall Study||20
3031454|NCT01118520|3750589|FG001|NOT COMPLETED|Overall Study||23
3031455|NCT01118520|3750590|FG002|NOT COMPLETED|Overall Study||20
3031456|NCT01118624|3750598|FG000|STARTED|Overall Study||22
3031457|NCT01118624|3750598|FG000|COMPLETED|Overall Study||0
3031458|NCT01118624|3750598|FG000|NOT COMPLETED|Overall Study||22
3031459|NCT01118663|3750604|FG000|STARTED|Overall Study||7
3031460|NCT01118663|3750605|FG001|STARTED|Overall Study||10
3031461|NCT01118663|3750604|FG000|COMPLETED|Overall Study||5
3031462|NCT01118663|3750605|FG001|COMPLETED|Overall Study||8
3031463|NCT01118663|3750604|FG000|NOT COMPLETED|Overall Study||2
3031464|NCT01118663|3750605|FG001|NOT COMPLETED|Overall Study||2
3031465|NCT01118715|3750613|FG000|STARTED|Overall Study||68
3031466|NCT01118715|3750614|FG001|STARTED|Overall Study||60
3031467|NCT01118715|3750613|FG000|COMPLETED|Overall Study||68
3031468|NCT01118715|3750614|FG001|COMPLETED|Overall Study||60
3031469|NCT01118715|3750613|FG000|NOT COMPLETED|Overall Study||0
3031470|NCT01118715|3750614|FG001|NOT COMPLETED|Overall Study||0
3031471|NCT01118728|3750641|FG000|STARTED|Overall Study||223
3031472|NCT01118728|3750641|FG000|COMPLETED|Overall Study||0
3031473|NCT01118728|3750641|FG000|NOT COMPLETED|Overall Study||223
3031474|NCT01118741|3750647|FG000|STARTED|Overall Study||9
3031475|NCT01118741|3750648|FG001|STARTED|Overall Study||10
3031476|NCT01118741|3750647|FG000|COMPLETED|Overall Study||9
3031477|NCT01118741|3750648|FG001|COMPLETED|Overall Study||10
3031478|NCT01118741|3750647|FG000|NOT COMPLETED|Overall Study||0
3031479|NCT01118741|3750648|FG001|NOT COMPLETED|Overall Study||0
3031480|NCT01118780|3750658|FG000|STARTED|Overall Study||151
3031481|NCT01118780|3750659|FG001|STARTED|Overall Study||140
3031482|NCT01118780|3750658|FG000|COMPLETED|Overall Study||115
3031483|NCT01118780|3750659|FG001|COMPLETED|Overall Study||105
3031484|NCT01118780|3750658|FG000|NOT COMPLETED|Overall Study||36
3031485|NCT01118780|3750659|FG001|NOT COMPLETED|Overall Study||35
3031486|NCT01118845|3750668|FG000|STARTED|Overall Study||59
3031487|NCT01118845|3750668|FG000|COMPLETED|Overall Study||17
3031488|NCT01118845|3750668|FG000|NOT COMPLETED|Overall Study||42
3031489|NCT01118949|3750672|FG000|STARTED|Overall Study||49
3031490|NCT01118949|3750672|FG000|COMPLETED|Overall Study||40
3031491|NCT01118949|3750672|FG000|NOT COMPLETED|Overall Study||9
3031492|NCT01118962|3750676|FG000|STARTED|Overall Study||39
3031493|NCT01118962|3750676|FG000|COMPLETED|Overall Study||29
3031494|NCT01118962|3750676|FG000|NOT COMPLETED|Overall Study||10
3031495|NCT01118975|3750682|FG000|STARTED|Overall Study||9
3031496|NCT01118975|3750683|FG001|STARTED|Overall Study||3
3031497|NCT01118975|3750682|FG000|COMPLETED|Overall Study||9
3031498|NCT01118975|3750683|FG001|COMPLETED|Overall Study||2
3031499|NCT01118975|3750682|FG000|NOT COMPLETED|Overall Study||0
3031500|NCT01118975|3750683|FG001|NOT COMPLETED|Overall Study||1
3031501|NCT01118988|3750692|FG000|STARTED|Overall Study||16
3031502|NCT01118988|3750693|FG001|STARTED|Overall Study||4
3031503|NCT01118988|3750694|FG002|STARTED|Overall Study||7
3031504|NCT01118988|3750692|FG000|COMPLETED|Overall Study||11
3031505|NCT01118988|3750693|FG001|COMPLETED|Overall Study||3
3031506|NCT01118988|3750694|FG002|COMPLETED|Overall Study||3
3031507|NCT01118988|3750692|FG000|NOT COMPLETED|Overall Study||5
3031508|NCT01118988|3750693|FG001|NOT COMPLETED|Overall Study||1
3031509|NCT01118988|3750694|FG002|NOT COMPLETED|Overall Study||4
3031510|NCT01119001|3750701|FG000|STARTED|Overall Study||13
3031511|NCT01119001|3750701|FG000|COMPLETED|Overall Study||11
3031512|NCT01119001|3750701|FG000|NOT COMPLETED|Overall Study||2
3031513|NCT01119040|3750707|FG000|STARTED|Overall Study||1
3031514|NCT01119040|3750707|FG000|COMPLETED|Overall Study||0
3031515|NCT01119040|3750707|FG000|NOT COMPLETED|Overall Study||1
3031516|NCT01119105|3750714|FG000|STARTED|Overall Study||70
3031517|NCT01119105|3750715|FG001|STARTED|Overall Study||72
3031518|NCT01119105|3750716|FG002|STARTED|Overall Study||68
3031519|NCT01119105|3750714|FG000|COMPLETED|Overall Study||66
3031520|NCT01119105|3750715|FG001|COMPLETED|Overall Study||66
3031521|NCT01119105|3750716|FG002|COMPLETED|Overall Study||60
3031522|NCT01119105|3750714|FG000|NOT COMPLETED|Overall Study||4
3031523|NCT01119105|3750715|FG001|NOT COMPLETED|Overall Study||6
3031524|NCT01119105|3750716|FG002|NOT COMPLETED|Overall Study||8
3031525|NCT01119118|3750724|FG000|STARTED|Overall Study||6
3031526|NCT01119118|3750724|FG000|COMPLETED|Overall Study||5
3031527|NCT01119118|3750724|FG000|NOT COMPLETED|Overall Study||1
3031528|NCT01119131|3750731|FG000|STARTED|Overall Study||10
3031529|NCT01119131|3750732|FG001|STARTED|Overall Study||28
3031530|NCT01119131|3750733|FG002|STARTED|Overall Study||30
3031531|NCT01119131|3750731|FG000|COMPLETED|Overall Study||8
3031532|NCT01119131|3750732|FG001|COMPLETED|Overall Study||27
3031533|NCT01119131|3750733|FG002|COMPLETED|Overall Study||24
3031534|NCT01119131|3750731|FG000|NOT COMPLETED|Overall Study||2
3031535|NCT01119131|3750732|FG001|NOT COMPLETED|Overall Study||1
3031536|NCT01119131|3750733|FG002|NOT COMPLETED|Overall Study||6
3031537|NCT01119222|3750741|FG000|STARTED|Overall Study||5
3031538|NCT01119222|3750742|FG001|STARTED|Overall Study||5
3031539|NCT01119222|3750743|FG002|STARTED|Overall Study||5
3031540|NCT01119222|3750744|FG003|STARTED|Overall Study||4
3031541|NCT01119222|3750741|FG000|COMPLETED|Overall Study||5
3031542|NCT01119222|3750742|FG001|COMPLETED|Overall Study||5
3031543|NCT01119222|3750743|FG002|COMPLETED|Overall Study||5
3031544|NCT01119222|3750744|FG003|COMPLETED|Overall Study||4
3031545|NCT01119222|3750741|FG000|NOT COMPLETED|Overall Study||0
3031546|NCT01119222|3750742|FG001|NOT COMPLETED|Overall Study||0
3031547|NCT01119222|3750743|FG002|NOT COMPLETED|Overall Study||0
3031548|NCT01119222|3750744|FG003|NOT COMPLETED|Overall Study||0
3031549|NCT01119248|3750757|FG000|STARTED|Overall Study||120
3031550|NCT01119248|3750757|FG000|COMPLETED|Overall Study||115
3031551|NCT01119248|3750757|FG000|NOT COMPLETED|Overall Study||5
3031552|NCT01119287|3750768|FG000|STARTED|Overall Study||26
3031553|NCT01119287|3750769|FG001|STARTED|Overall Study||24
3031554|NCT01119287|3750770|FG002|STARTED|Overall Study||26
3031555|NCT01119287|3750771|FG003|STARTED|Overall Study||31
3031556|NCT01119287|3750772|FG004|STARTED|Overall Study||31
3031557|NCT01119287|3750773|FG005|STARTED|Overall Study||32
3031558|NCT01119287|3750768|FG000|COMPLETED|Overall Study||26
3031559|NCT01119287|3750769|FG001|COMPLETED|Overall Study||24
3031560|NCT01119287|3750770|FG002|COMPLETED|Overall Study||24
3031561|NCT01119287|3750771|FG003|COMPLETED|Overall Study||29
3031562|NCT01119287|3750772|FG004|COMPLETED|Overall Study||30
3031563|NCT01119287|3750773|FG005|COMPLETED|Overall Study||32
3031564|NCT01119287|3750768|FG000|NOT COMPLETED|Overall Study||0
3031565|NCT01119287|3750769|FG001|NOT COMPLETED|Overall Study||0
3031566|NCT01119287|3750770|FG002|NOT COMPLETED|Overall Study||2
3031567|NCT01119287|3750771|FG003|NOT COMPLETED|Overall Study||2
3031568|NCT01119287|3750772|FG004|NOT COMPLETED|Overall Study||1
3031569|NCT01119287|3750773|FG005|NOT COMPLETED|Overall Study||0
3031570|NCT01119443|3750787|FG000|STARTED|Up-titration Period (10 Days)||14
3031571|NCT01119443|3750788|FG001|STARTED|Up-titration Period (10 Days)||14
3031572|NCT01119443|3750787|FG000|COMPLETED|Up-titration Period (10 Days)||14
3031573|NCT01119443|3750788|FG001|COMPLETED|Up-titration Period (10 Days)||14
3031574|NCT01119443|3750787|FG000|NOT COMPLETED|Up-titration Period (10 Days)||0
3166108|NCT01903252|3893565|FG005|COMPLETED|Extended Induction, Open-Label||0
3166109|NCT01903252|3893560|FG000|NOT COMPLETED|Extended Induction, Open-Label||0
3166110|NCT01903252|3893561|FG001|NOT COMPLETED|Extended Induction, Open-Label||0
3166111|NCT01903252|3893562|FG002|NOT COMPLETED|Extended Induction, Open-Label||23
3166112|NCT01903252|3893563|FG003|NOT COMPLETED|Extended Induction, Open-Label||0
3166113|NCT01903252|3893564|FG004|NOT COMPLETED|Extended Induction, Open-Label||0
3031575|NCT01119443|3750788|FG001|NOT COMPLETED|Up-titration Period (10 Days)||0
3031576|NCT01119443|3750787|FG000|STARTED|Crossover Period 1 (5 Days)||14
3031577|NCT01119443|3750788|FG001|STARTED|Crossover Period 1 (5 Days)||14
3031578|NCT01119443|3750787|FG000|COMPLETED|Crossover Period 1 (5 Days)||14
3031579|NCT01119443|3750788|FG001|COMPLETED|Crossover Period 1 (5 Days)||13
3031580|NCT01119443|3750787|FG000|NOT COMPLETED|Crossover Period 1 (5 Days)||0
3031581|NCT01119443|3750788|FG001|NOT COMPLETED|Crossover Period 1 (5 Days)||1
3031582|NCT01119443|3750787|FG000|STARTED|Crossover Period 2 (5 Days)||14
3031583|NCT01119443|3750788|FG001|STARTED|Crossover Period 2 (5 Days)||13
3031584|NCT01119443|3750787|FG000|COMPLETED|Crossover Period 2 (5 Days)||14
3031585|NCT01119443|3750788|FG001|COMPLETED|Crossover Period 2 (5 Days)||13
3031586|NCT01119443|3750787|FG000|NOT COMPLETED|Crossover Period 2 (5 Days)||0
3031587|NCT01119443|3750788|FG001|NOT COMPLETED|Crossover Period 2 (5 Days)||0
3031588|NCT01119443|3750787|FG000|STARTED|Crossover Period 3 (5 Days)||14
3031589|NCT01119443|3750788|FG001|STARTED|Crossover Period 3 (5 Days)||13
3031590|NCT01119443|3750787|FG000|COMPLETED|Crossover Period 3 (5 Days)||14
3031591|NCT01119443|3750788|FG001|COMPLETED|Crossover Period 3 (5 Days)||13
3031592|NCT01119443|3750787|FG000|NOT COMPLETED|Crossover Period 3 (5 Days)||0
3031593|NCT01119443|3750788|FG001|NOT COMPLETED|Crossover Period 3 (5 Days)||0
3031594|NCT01119443|3750787|FG000|STARTED|Crossover Period 4 (5 Days)||14
3031595|NCT01119443|3750788|FG001|STARTED|Crossover Period 4 (5 Days)||13
3031596|NCT01119443|3750787|FG000|COMPLETED|Crossover Period 4 (5 Days)||14
3031597|NCT01119443|3750788|FG001|COMPLETED|Crossover Period 4 (5 Days)||13
3031598|NCT01119443|3750787|FG000|NOT COMPLETED|Crossover Period 4 (5 Days)||0
3031599|NCT01119443|3750788|FG001|NOT COMPLETED|Crossover Period 4 (5 Days)||0
3031600|NCT01119443|3750787|FG000|STARTED|Down-titration Period (1 Day)||14
3031601|NCT01119443|3750788|FG001|STARTED|Down-titration Period (1 Day)||13
3031602|NCT01119443|3750787|FG000|COMPLETED|Down-titration Period (1 Day)||14
3031603|NCT01119443|3750788|FG001|COMPLETED|Down-titration Period (1 Day)||13
3031604|NCT01119443|3750787|FG000|NOT COMPLETED|Down-titration Period (1 Day)||0
3031605|NCT01119443|3750788|FG001|NOT COMPLETED|Down-titration Period (1 Day)||0
3031606|NCT01119443|3750787|FG000|STARTED|End of Study (All Patients)||14
3031607|NCT01119443|3750788|FG001|STARTED|End of Study (All Patients)||14
3031608|NCT01119443|3750787|FG000|COMPLETED|End of Study (All Patients)||14
3031609|NCT01119443|3750788|FG001|COMPLETED|End of Study (All Patients)||14
3031610|NCT01119443|3750787|FG000|NOT COMPLETED|End of Study (All Patients)||0
3031611|NCT01119443|3750788|FG001|NOT COMPLETED|End of Study (All Patients)||0
3031612|NCT01119456|3750805|FG000|STARTED|Overall Study||7
3031613|NCT01119456|3750806|FG001|STARTED|Overall Study||3
3031614|NCT01119456|3750807|FG002|STARTED|Overall Study||3
3031615|NCT01119456|3750808|FG003|STARTED|Overall Study||13
3031616|NCT01119456|3750809|FG004|STARTED|Overall Study||4
3031617|NCT01119456|3750810|FG005|STARTED|Overall Study||3
3166114|NCT01903252|3893565|FG005|NOT COMPLETED|Extended Induction, Open-Label||0
3166115|NCT01903252|3893560|FG000|STARTED|Maintenance, Open-Label||0
3166116|NCT01903252|3893561|FG001|STARTED|Maintenance, Open-Label||0
3166117|NCT01903252|3893562|FG002|STARTED|Maintenance, Open-Label|Period 2 (extended induction) is completed, subjects are newly allocated to Period 3, maintenance.|0
3166118|NCT01903252|3893563|FG003|STARTED|Maintenance, Open-Label|This is period 3, Open-Label Maintenance following on from period 1, the double-blind induction.|202
3031618|NCT01119456|3750811|FG006|STARTED|Overall Study||3
3031619|NCT01119456|3750812|FG007|STARTED|Overall Study||3
3031620|NCT01119456|3750805|FG000|Received at Least 1 Dose of Study Drug|Overall Study||7
3031621|NCT01119456|3750806|FG001|Received at Least 1 Dose of Study Drug|Overall Study||3
3031622|NCT01119456|3750807|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3
3031623|NCT01119456|3750808|FG003|Received at Least 1 Dose of Study Drug|Overall Study||13
3031624|NCT01119456|3750809|FG004|Received at Least 1 Dose of Study Drug|Overall Study||4
3031625|NCT01119456|3750810|FG005|Received at Least 1 Dose of Study Drug|Overall Study||3
3031626|NCT01119456|3750811|FG006|Received at Least 1 Dose of Study Drug|Overall Study||3
3031627|NCT01119456|3750812|FG007|Received at Least 1 Dose of Study Drug|Overall Study||3
3031628|NCT01119456|3750805|FG000|COMPLETED|Overall Study||7
3031629|NCT01119456|3750806|FG001|COMPLETED|Overall Study||3
3031630|NCT01119456|3750807|FG002|COMPLETED|Overall Study||3
3031631|NCT01119456|3750808|FG003|COMPLETED|Overall Study||13
3031632|NCT01119456|3750809|FG004|COMPLETED|Overall Study||4
3031633|NCT01119456|3750810|FG005|COMPLETED|Overall Study||3
3031634|NCT01119456|3750811|FG006|COMPLETED|Overall Study||3
3031635|NCT01119456|3750812|FG007|COMPLETED|Overall Study||3
3031636|NCT01119456|3750805|FG000|NOT COMPLETED|Overall Study||0
3031637|NCT01119456|3750806|FG001|NOT COMPLETED|Overall Study||0
3031638|NCT01119456|3750807|FG002|NOT COMPLETED|Overall Study||0
3031639|NCT01119456|3750808|FG003|NOT COMPLETED|Overall Study||0
3031640|NCT01119456|3750809|FG004|NOT COMPLETED|Overall Study||0
3031641|NCT01119456|3750810|FG005|NOT COMPLETED|Overall Study||0
3031642|NCT01119456|3750811|FG006|NOT COMPLETED|Overall Study||0
3031643|NCT01119456|3750812|FG007|NOT COMPLETED|Overall Study||0
3031644|NCT01119508|3750837|FG000|STARTED|Overall Study||64
3031645|NCT01119508|3750837|FG000|Received Four Induction Doses|Overall Study||45
3031646|NCT01119508|3750837|FG000|Received Fifth Consolidation Dose week12|Overall Study||32
3031647|NCT01119508|3750837|FG000|COMPLETED|Overall Study||5
3031648|NCT01119508|3750837|FG000|NOT COMPLETED|Overall Study||59
3031649|NCT01119625|3750843|FG000|STARTED|Overall Study||118
3031650|NCT01119625|3750844|FG001|STARTED|Overall Study||120
3031651|NCT01119625|3750843|FG000|COMPLETED|Overall Study||115
3031652|NCT01119625|3750844|FG001|COMPLETED|Overall Study||116
3031653|NCT01119625|3750843|FG000|NOT COMPLETED|Overall Study||3
3031654|NCT01119625|3750844|FG001|NOT COMPLETED|Overall Study||4
3031655|NCT01119703|3750852|FG000|STARTED|Overall Study||30
3031656|NCT01119703|3750853|FG001|STARTED|Overall Study||144
3031657|NCT01119703|3750852|FG000|COMPLETED|Overall Study||30
3031658|NCT01119703|3750853|FG001|COMPLETED|Overall Study||143
3031659|NCT01119703|3750852|FG000|NOT COMPLETED|Overall Study||0
3031660|NCT01119703|3750853|FG001|NOT COMPLETED|Overall Study||1
3031661|NCT01119716|3750858|FG000|STARTED|Overall Study||4658
3031662|NCT01119716|3750858|FG000|COMPLETED|Overall Study||4658
3031663|NCT01119716|3750858|FG000|NOT COMPLETED|Overall Study||0
3031664|NCT01119755|3750866|FG000|STARTED|Overall Study||80
3031665|NCT01119755|3750866|FG000|COMPLETED|Overall Study||80
3031666|NCT01119755|3750866|FG000|NOT COMPLETED|Overall Study||0
3031667|NCT01119768|3750872|FG000|STARTED|Treatment Period||154
3031668|NCT01119768|3750873|FG001|STARTED|Treatment Period||151
3031669|NCT01119768|3750872|FG000|COMPLETED|Treatment Period||136
3031670|NCT01119768|3750873|FG001|COMPLETED|Treatment Period||126
3031671|NCT01119768|3750872|FG000|NOT COMPLETED|Treatment Period||18
3031672|NCT01119768|3750873|FG001|NOT COMPLETED|Treatment Period||25
3031673|NCT01119768|3750872|FG000|STARTED|Follow-up||136
3031674|NCT01119768|3750873|FG001|STARTED|Follow-up||124
3031675|NCT01119768|3750872|FG000|COMPLETED|Follow-up||135
3031676|NCT01119768|3750873|FG001|COMPLETED|Follow-up||122
3031677|NCT01119768|3750872|FG000|NOT COMPLETED|Follow-up||1
3031678|NCT01119768|3750873|FG001|NOT COMPLETED|Follow-up||2
3031679|NCT01119794|3750879|FG000|STARTED|Overall Study||10
3031680|NCT01119794|3750879|FG000|COMPLETED|Overall Study||10
3031681|NCT01119794|3750879|FG000|NOT COMPLETED|Overall Study||0
3031682|NCT01119846|3750886|FG000|STARTED|Overall Study||13
3031683|NCT01119846|3750887|FG001|STARTED|Overall Study||4
3031684|NCT01119846|3750888|FG002|STARTED|Overall Study||83
3031685|NCT01119846|3750886|FG000|COMPLETED|Overall Study||11
3031686|NCT01119846|3750887|FG001|COMPLETED|Overall Study||4
3031687|NCT01119846|3750888|FG002|COMPLETED|Overall Study||72
3031688|NCT01119846|3750886|FG000|NOT COMPLETED|Overall Study||2
3031689|NCT01119846|3750887|FG001|NOT COMPLETED|Overall Study||0
3031690|NCT01119846|3750888|FG002|NOT COMPLETED|Overall Study||11
3031691|NCT01119859|3750925|FG000|STARTED|Overall Study||163
3031692|NCT01119859|3750926|FG001|STARTED|Overall Study||163
3031693|NCT01119859|3750925|FG000|COMPLETED|Overall Study||139
3031694|NCT01119859|3750926|FG001|COMPLETED|Overall Study||133
3031695|NCT01119859|3750925|FG000|NOT COMPLETED|Overall Study||24
3031696|NCT01119859|3750926|FG001|NOT COMPLETED|Overall Study||30
3031697|NCT01119898|3750934|FG000|STARTED|Overall Study||131
3031698|NCT01119898|3750935|FG001|STARTED|Overall Study||129
3166119|NCT01903252|3893564|FG004|STARTED|Maintenance, Open-Label|This is period 3, Open-Label Maintenance following on from period 1, the double-blind induction.|274
3166120|NCT01903252|3893565|FG005|STARTED|Maintenance, Open-Label|This is period 3, Open-Label Maintenance following on from period 1, the double-blind induction.|199
3166121|NCT01903252|3893560|FG000|COMPLETED|Maintenance, Open-Label||0
3166122|NCT01903252|3893561|FG001|COMPLETED|Maintenance, Open-Label||0
3031699|NCT01119898|3750934|FG000|Received Study Drug (mITT)|Overall Study||130
3031700|NCT01119898|3750935|FG001|Received Study Drug (mITT)|Overall Study||129
3031701|NCT01119898|3750934|FG000|COMPLETED|Overall Study||123
3031702|NCT01119898|3750935|FG001|COMPLETED|Overall Study||117
3031703|NCT01119898|3750934|FG000|NOT COMPLETED|Overall Study||8
3031704|NCT01119898|3750935|FG001|NOT COMPLETED|Overall Study||12
3031705|NCT01119937|3750943|FG000|STARTED|Overall Study||123
3031706|NCT01119937|3750944|FG001|STARTED|Overall Study||40
3031707|NCT01119937|3750943|FG000|COMPLETED|Overall Study||104
3031708|NCT01119937|3750944|FG001|COMPLETED|Overall Study||33
3031709|NCT01119937|3750943|FG000|NOT COMPLETED|Overall Study||19
3031710|NCT01119937|3750944|FG001|NOT COMPLETED|Overall Study||7
3031711|NCT01119950|3750950|FG000|STARTED|Overall Study|These participants were randomized to 2 different treatment sequences during period 1 and 2.|388
3031712|NCT01119950|3750950|FG000|NVA237 12.5 ug q.d.|Overall Study|5 randomized and 2 misrandomized patients did not receive study drug, 80 completed, 9 discontinued.|96
3031713|NCT01119950|3750950|FG000|NVA237 25 ug q.d.|Overall Study|3 randomized participants did not receive study drug, 91 completed treatment, 5 discontinued.|99
3031714|NCT01119950|3750950|FG000|NVA237 12.5 ug b.i.d.|Overall Study|4 randomized participants did not receive study drug, 93 completed treatment, 2 discontinued.|99
3031715|NCT01119950|3750950|FG000|NVA237 50 ug q.d.|Overall Study|4 randomized participants did not receive study drug, 89 completed treatment, 3 discontinued.|96
3031716|NCT01119950|3750950|FG000|NVA237 25 ug b.i.d.|Overall Study|4 randomized participants did not receive study drug, 89 completed treatment, 7 discontinued.|100
3031717|NCT01119950|3750950|FG000|NVA237 100 ug q.d.|Overall Study|2 randomized participants did not receive study drug, 92 completed treatment, 4 discontinued.|98
3031718|NCT01119950|3750950|FG000|NVA237 50 ug b.i.d.|Overall Study|6 randomized and 1 misrandomized patients did not receive study drug, 82 completed, 5 discontinued.|94
3031719|NCT01119950|3750950|FG000|Placebo|Overall Study|3 randomized participants did not receive study drug, 82 completed treatment, 5 discontinued.|94
3031720|NCT01119950|3750950|FG000|COMPLETED|Overall Study|These participants completed both periods 1 and 2|341
3031721|NCT01119950|3750950|FG000|NOT COMPLETED|Overall Study||47
3031722|NCT01119963|3750978|FG000|STARTED|Overall Study||74
3031723|NCT01119963|3750979|FG001|STARTED|Overall Study||78
3031724|NCT01119963|3750978|FG000|COMPLETED|Overall Study||73
3031725|NCT01119963|3750979|FG001|COMPLETED|Overall Study||77
3031726|NCT01119963|3750978|FG000|NOT COMPLETED|Overall Study||1
3031727|NCT01119963|3750979|FG001|NOT COMPLETED|Overall Study||1
3031728|NCT01120028|3750991|FG000|STARTED|Period 1: Alemtuzumab or Basiliximab||426
3166123|NCT01903252|3893562|FG002|COMPLETED|Maintenance, Open-Label||0
3166124|NCT01903252|3893563|FG003|COMPLETED|Maintenance, Open-Label||196
3166125|NCT01903252|3893564|FG004|COMPLETED|Maintenance, Open-Label||253
3031729|NCT01120028|3750992|FG001|STARTED|Period 1: Alemtuzumab or Basiliximab||426
3031730|NCT01120028|3750993|FG002|STARTED|Period 1: Alemtuzumab or Basiliximab||0
3031731|NCT01120028|3750994|FG003|STARTED|Period 1: Alemtuzumab or Basiliximab||0
3031732|NCT01120028|3750991|FG000|COMPLETED|Period 1: Alemtuzumab or Basiliximab||412
3031733|NCT01120028|3750992|FG001|COMPLETED|Period 1: Alemtuzumab or Basiliximab||403
3031734|NCT01120028|3750993|FG002|COMPLETED|Period 1: Alemtuzumab or Basiliximab||0
3031735|NCT01120028|3750994|FG003|COMPLETED|Period 1: Alemtuzumab or Basiliximab||0
3031736|NCT01120028|3750991|FG000|NOT COMPLETED|Period 1: Alemtuzumab or Basiliximab||14
3031737|NCT01120028|3750992|FG001|NOT COMPLETED|Period 1: Alemtuzumab or Basiliximab||23
3031738|NCT01120028|3750993|FG002|NOT COMPLETED|Period 1: Alemtuzumab or Basiliximab||0
3031739|NCT01120028|3750994|FG003|NOT COMPLETED|Period 1: Alemtuzumab or Basiliximab||0
3031740|NCT01120028|3750991|FG000|STARTED|Period 2: Tacrolimus or Sirolimus||0
3031741|NCT01120028|3750992|FG001|STARTED|Period 2: Tacrolimus or Sirolimus||0
3031742|NCT01120028|3750993|FG002|STARTED|Period 2: Tacrolimus or Sirolimus||197
3031743|NCT01120028|3750994|FG003|STARTED|Period 2: Tacrolimus or Sirolimus||197
3031744|NCT01120028|3750991|FG000|COMPLETED|Period 2: Tacrolimus or Sirolimus||0
3031745|NCT01120028|3750992|FG001|COMPLETED|Period 2: Tacrolimus or Sirolimus||0
3031746|NCT01120028|3750993|FG002|COMPLETED|Period 2: Tacrolimus or Sirolimus||197
3031747|NCT01120028|3750994|FG003|COMPLETED|Period 2: Tacrolimus or Sirolimus||197
3031748|NCT01120028|3750991|FG000|NOT COMPLETED|Period 2: Tacrolimus or Sirolimus||0
3031749|NCT01120028|3750992|FG001|NOT COMPLETED|Period 2: Tacrolimus or Sirolimus||0
3031750|NCT01120028|3750993|FG002|NOT COMPLETED|Period 2: Tacrolimus or Sirolimus||0
3031751|NCT01120028|3750994|FG003|NOT COMPLETED|Period 2: Tacrolimus or Sirolimus||0
3031752|NCT01120067|3751007|FG000|STARTED|Overall Study||12
3031753|NCT01120067|3751008|FG001|STARTED|Overall Study||11
3031754|NCT01120067|3751007|FG000|COMPLETED|Overall Study||7
3031755|NCT01120067|3751008|FG001|COMPLETED|Overall Study||10
3031756|NCT01120067|3751007|FG000|NOT COMPLETED|Overall Study||5
3031757|NCT01120067|3751008|FG001|NOT COMPLETED|Overall Study||1
3031758|NCT01120093|3751014|FG000|STARTED|Treatment Period 1||18
3031759|NCT01120093|3751015|FG001|STARTED|Treatment Period 1||14
3031760|NCT01120093|3751016|FG002|STARTED|Treatment Period 1||17
3031761|NCT01120093|3751017|FG003|STARTED|Treatment Period 1||14
3031762|NCT01120093|3751018|FG004|STARTED|Treatment Period 1||16
3031763|NCT01120093|3751014|FG000|COMPLETED|Treatment Period 1||18
3031764|NCT01120093|3751015|FG001|COMPLETED|Treatment Period 1||13
3031765|NCT01120093|3751016|FG002|COMPLETED|Treatment Period 1||16
3031766|NCT01120093|3751017|FG003|COMPLETED|Treatment Period 1||14
3031767|NCT01120093|3751018|FG004|COMPLETED|Treatment Period 1||15
3031768|NCT01120093|3751014|FG000|NOT COMPLETED|Treatment Period 1||0
3031769|NCT01120093|3751015|FG001|NOT COMPLETED|Treatment Period 1||1
3031770|NCT01120093|3751016|FG002|NOT COMPLETED|Treatment Period 1||1
3031771|NCT01120093|3751017|FG003|NOT COMPLETED|Treatment Period 1||0
3031772|NCT01120093|3751018|FG004|NOT COMPLETED|Treatment Period 1||1
3031773|NCT01120093|3751014|FG000|STARTED|Treatment Period 2||18
3031774|NCT01120093|3751015|FG001|STARTED|Treatment Period 2||13
3031775|NCT01120093|3751016|FG002|STARTED|Treatment Period 2||16
3166126|NCT01903252|3893565|FG005|COMPLETED|Maintenance, Open-Label||181
3031776|NCT01120093|3751017|FG003|STARTED|Treatment Period 2||14
3031777|NCT01120093|3751018|FG004|STARTED|Treatment Period 2||15
3031778|NCT01120093|3751014|FG000|COMPLETED|Treatment Period 2||18
3031779|NCT01120093|3751015|FG001|COMPLETED|Treatment Period 2||13
3031780|NCT01120093|3751016|FG002|COMPLETED|Treatment Period 2||16
3031781|NCT01120093|3751017|FG003|COMPLETED|Treatment Period 2||13
3031782|NCT01120093|3751018|FG004|COMPLETED|Treatment Period 2||14
3031783|NCT01120093|3751014|FG000|NOT COMPLETED|Treatment Period 2||0
3031784|NCT01120093|3751015|FG001|NOT COMPLETED|Treatment Period 2||0
3031785|NCT01120093|3751016|FG002|NOT COMPLETED|Treatment Period 2||0
3031786|NCT01120093|3751017|FG003|NOT COMPLETED|Treatment Period 2||1
3031787|NCT01120093|3751018|FG004|NOT COMPLETED|Treatment Period 2||1
3031788|NCT01120093|3751014|FG000|STARTED|Treatment Period 3||18
3031789|NCT01120093|3751015|FG001|STARTED|Treatment Period 3||13
3031790|NCT01120093|3751016|FG002|STARTED|Treatment Period 3||16
3031791|NCT01120093|3751017|FG003|STARTED|Treatment Period 3||13
3031792|NCT01120093|3751018|FG004|STARTED|Treatment Period 3||14
3031793|NCT01120093|3751014|FG000|COMPLETED|Treatment Period 3||18
3031794|NCT01120093|3751015|FG001|COMPLETED|Treatment Period 3||13
3031795|NCT01120093|3751016|FG002|COMPLETED|Treatment Period 3||15
3031796|NCT01120093|3751017|FG003|COMPLETED|Treatment Period 3||12
3031797|NCT01120093|3751018|FG004|COMPLETED|Treatment Period 3||13
3031798|NCT01120093|3751014|FG000|NOT COMPLETED|Treatment Period 3||0
3031799|NCT01120093|3751015|FG001|NOT COMPLETED|Treatment Period 3||0
3031800|NCT01120093|3751016|FG002|NOT COMPLETED|Treatment Period 3||1
3031801|NCT01120093|3751017|FG003|NOT COMPLETED|Treatment Period 3||1
3031802|NCT01120093|3751018|FG004|NOT COMPLETED|Treatment Period 3||1
3031803|NCT01120093|3751014|FG000|STARTED|Treatment Period 4||18
3031804|NCT01120093|3751015|FG001|STARTED|Treatment Period 4||13
3031805|NCT01120093|3751016|FG002|STARTED|Treatment Period 4||15
3031806|NCT01120093|3751017|FG003|STARTED|Treatment Period 4||12
3031807|NCT01120093|3751018|FG004|STARTED|Treatment Period 4||13
3031808|NCT01120093|3751014|FG000|COMPLETED|Treatment Period 4||17
3031809|NCT01120093|3751015|FG001|COMPLETED|Treatment Period 4||13
3031810|NCT01120093|3751016|FG002|COMPLETED|Treatment Period 4||15
3031811|NCT01120093|3751017|FG003|COMPLETED|Treatment Period 4||12
3031812|NCT01120093|3751018|FG004|COMPLETED|Treatment Period 4||13
3031813|NCT01120093|3751014|FG000|NOT COMPLETED|Treatment Period 4||1
3031814|NCT01120093|3751015|FG001|NOT COMPLETED|Treatment Period 4||0
3031815|NCT01120093|3751016|FG002|NOT COMPLETED|Treatment Period 4||0
3031816|NCT01120093|3751017|FG003|NOT COMPLETED|Treatment Period 4||0
3031817|NCT01120093|3751018|FG004|NOT COMPLETED|Treatment Period 4||0
3031818|NCT01120093|3751014|FG000|STARTED|Treatment Period 5||17
3031819|NCT01120093|3751015|FG001|STARTED|Treatment Period 5||13
3031820|NCT01120093|3751016|FG002|STARTED|Treatment Period 5||15
3031821|NCT01120093|3751017|FG003|STARTED|Treatment Period 5||12
3031822|NCT01120093|3751018|FG004|STARTED|Treatment Period 5||13
3031823|NCT01120093|3751014|FG000|COMPLETED|Treatment Period 5||17
3031824|NCT01120093|3751015|FG001|COMPLETED|Treatment Period 5||12
3031825|NCT01120093|3751016|FG002|COMPLETED|Treatment Period 5||15
3031826|NCT01120093|3751017|FG003|COMPLETED|Treatment Period 5||11
3031827|NCT01120093|3751018|FG004|COMPLETED|Treatment Period 5||13
3031828|NCT01120093|3751014|FG000|NOT COMPLETED|Treatment Period 5||0
3031829|NCT01120093|3751015|FG001|NOT COMPLETED|Treatment Period 5||1
3031830|NCT01120093|3751016|FG002|NOT COMPLETED|Treatment Period 5||0
3031831|NCT01120093|3751017|FG003|NOT COMPLETED|Treatment Period 5||1
3031832|NCT01120093|3751018|FG004|NOT COMPLETED|Treatment Period 5||0
3031833|NCT01120184|3751033|FG000|STARTED|Overall Study||365
3031834|NCT01120184|3751034|FG001|STARTED|Overall Study||367
3031835|NCT01120184|3751035|FG002|STARTED|Overall Study||363
3031836|NCT01120184|3751033|FG000|Treated|Overall Study||355
3031837|NCT01120184|3751034|FG001|Treated|Overall Study||365
3031838|NCT01120184|3751035|FG002|Treated|Overall Study||360
3031839|NCT01120184|3751033|FG000|COMPLETED|Overall Study||0
3031840|NCT01120184|3751034|FG001|COMPLETED|Overall Study||0
3031841|NCT01120184|3751035|FG002|COMPLETED|Overall Study||0
3031842|NCT01120184|3751033|FG000|NOT COMPLETED|Overall Study||365
3031843|NCT01120184|3751034|FG001|NOT COMPLETED|Overall Study||367
3031844|NCT01120184|3751035|FG002|NOT COMPLETED|Overall Study||363
3031845|NCT01120197|3751045|FG000|STARTED|Overall Study||47
3031846|NCT01120197|3751046|FG001|STARTED|Overall Study||42
3031847|NCT01120197|3751045|FG000|COMPLETED|Overall Study||38
3166127|NCT01903252|3893560|FG000|NOT COMPLETED|Maintenance, Open-Label||0
3166128|NCT01903252|3893561|FG001|NOT COMPLETED|Maintenance, Open-Label||0
3166129|NCT01903252|3893562|FG002|NOT COMPLETED|Maintenance, Open-Label||0
3166130|NCT01903252|3893563|FG003|NOT COMPLETED|Maintenance, Open-Label||6
3166131|NCT01903252|3893564|FG004|NOT COMPLETED|Maintenance, Open-Label||21
3031848|NCT01120197|3751046|FG001|COMPLETED|Overall Study||32
3031849|NCT01120197|3751045|FG000|NOT COMPLETED|Overall Study||9
3031850|NCT01120197|3751046|FG001|NOT COMPLETED|Overall Study||10
3031851|NCT01120210|3751055|FG000|STARTED|MAIN INFUSION||16
3031852|NCT01120210|3751056|FG001|STARTED|MAIN INFUSION||46
3031853|NCT01120210|3751055|FG000|COMPLETED|MAIN INFUSION||15
3031854|NCT01120210|3751056|FG001|COMPLETED|MAIN INFUSION||45
3031855|NCT01120210|3751055|FG000|NOT COMPLETED|MAIN INFUSION||1
3031856|NCT01120210|3751056|FG001|NOT COMPLETED|MAIN INFUSION||1
3031857|NCT01120210|3751055|FG000|STARTED|18-HOUR EXTENDED INFUSION SUBSTUDY||3
3031858|NCT01120210|3751056|FG001|STARTED|18-HOUR EXTENDED INFUSION SUBSTUDY||7
3038230|NCT01152788|3757609|FG001|STARTED|Overall Study||32
3031859|NCT01120210|3751055|FG000|COMPLETED|18-HOUR EXTENDED INFUSION SUBSTUDY||3
3031860|NCT01120210|3751056|FG001|COMPLETED|18-HOUR EXTENDED INFUSION SUBSTUDY||7
3031861|NCT01120210|3751055|FG000|NOT COMPLETED|18-HOUR EXTENDED INFUSION SUBSTUDY||0
3031862|NCT01120210|3751056|FG001|NOT COMPLETED|18-HOUR EXTENDED INFUSION SUBSTUDY||0
3031863|NCT01120223|3751062|FG000|STARTED|Overall Study||78
3031864|NCT01120223|3751062|FG000|COMPLETED|Overall Study||74
3031865|NCT01120223|3751062|FG000|NOT COMPLETED|Overall Study||4
3031866|NCT01120236|3751068|FG000|STARTED|Overall Study||105
3031867|NCT01120236|3751069|FG001|STARTED|Overall Study||106
3031868|NCT01120236|3751068|FG000|Ineligble|Overall Study||0
3031869|NCT01120236|3751069|FG001|Ineligble|Overall Study|Patient ineligible due to no demonstable radiographic metastasis and is excluded from all analyses.|1
3031870|NCT01120236|3751068|FG000|COMPLETED|Overall Study||105
3031871|NCT01120236|3751069|FG001|COMPLETED|Overall Study||105
3031872|NCT01120236|3751068|FG000|NOT COMPLETED|Overall Study||0
3031873|NCT01120236|3751069|FG001|NOT COMPLETED|Overall Study||1
3031874|NCT01120275|3751083|FG000|STARTED|Overall Study||36
3031875|NCT01120275|3751083|FG000|Eligible and Treated|Overall Study||32
3031876|NCT01120275|3751083|FG000|COMPLETED|Overall Study||0
3031877|NCT01120275|3751083|FG000|NOT COMPLETED|Overall Study||36
3031878|NCT01120379|3751088|FG000|STARTED|One Year Timepoint||5020
3031879|NCT01120379|3751088|FG000|COMPLETED|One Year Timepoint||4742
3031880|NCT01120379|3751088|FG000|NOT COMPLETED|One Year Timepoint||278
3031881|NCT01120379|3751088|FG000|STARTED|Two Year Timepoint||4742
3031882|NCT01120379|3751088|FG000|COMPLETED|Two Year Timepoint||4505
3031883|NCT01120379|3751088|FG000|NOT COMPLETED|Two Year Timepoint||237
3031884|NCT01120379|3751088|FG000|STARTED|Three Year Timepoint||4505
3031885|NCT01120379|3751088|FG000|COMPLETED|Three Year Timepoint||4291
3031886|NCT01120379|3751088|FG000|NOT COMPLETED|Three Year Timepoint||214
3031887|NCT01120379|3751088|FG000|STARTED|Four Year Timepoint||4291
3031888|NCT01120379|3751088|FG000|COMPLETED|Four Year Timepoint||3923
3031889|NCT01120379|3751088|FG000|NOT COMPLETED|Four Year Timepoint||368
3031890|NCT01120405|3751094|FG000|STARTED|Overall Study||298
3031891|NCT01120405|3751095|FG001|STARTED|Overall Study||302
3031892|NCT01120405|3751094|FG000|COMPLETED|Overall Study||271
3031893|NCT01120405|3751095|FG001|COMPLETED|Overall Study||269
3031894|NCT01120405|3751094|FG000|NOT COMPLETED|Overall Study||27
3031895|NCT01120405|3751095|FG001|NOT COMPLETED|Overall Study||33
3031896|NCT01120600|3751105|FG000|STARTED|Overall Study||147
3031897|NCT01120600|3751106|FG001|STARTED|Overall Study||147
3031898|NCT01120600|3751105|FG000|Treated|Overall Study||146
3031899|NCT01120600|3751106|FG001|Treated|Overall Study||146
3031900|NCT01120600|3751105|FG000|COMPLETED|Overall Study||128
3031901|NCT01120600|3751106|FG001|COMPLETED|Overall Study||115
3031902|NCT01120600|3751105|FG000|NOT COMPLETED|Overall Study||19
3031903|NCT01120600|3751106|FG001|NOT COMPLETED|Overall Study||32
3031904|NCT01120626|3751114|FG000|STARTED|Overall Study||20
3031905|NCT01120626|3751115|FG001|STARTED|Overall Study||22
3031906|NCT01120626|3751114|FG000|COMPLETED|Overall Study||19
3031907|NCT01120626|3751115|FG001|COMPLETED|Overall Study||22
3031908|NCT01120626|3751114|FG000|NOT COMPLETED|Overall Study||1
3031909|NCT01120626|3751115|FG001|NOT COMPLETED|Overall Study||0
3031910|NCT01120639|3751125|FG000|STARTED|Overall Study||6
3031911|NCT01120639|3751126|FG001|STARTED|Overall Study||6
3031912|NCT01120639|3751127|FG002|STARTED|Overall Study||6
3031913|NCT01120639|3751128|FG003|STARTED|Overall Study||12
3031914|NCT01120639|3751125|FG000|COMPLETED|Overall Study||6
3031915|NCT01120639|3751126|FG001|COMPLETED|Overall Study||6
3031916|NCT01120639|3751127|FG002|COMPLETED|Overall Study||6
3031917|NCT01120639|3751128|FG003|COMPLETED|Overall Study||12
3031918|NCT01120639|3751125|FG000|NOT COMPLETED|Overall Study||0
3383744|NCT01915498|4118884|FG011|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||1
3383745|NCT01915498|4118885|FG012|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
3383746|NCT01915498|4118886|FG013|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||3
3383747|NCT01915498|4118887|FG014|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
3383748|NCT01915498|4118888|FG015|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||2
3383749|NCT01915498|4118889|FG016|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||3
3383750|NCT01915498|4118890|FG017|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||6
3383751|NCT01915498|4118891|FG018|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
3383752|NCT01915498|4118873|FG000|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||7
3383753|NCT01915498|4118874|FG001|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||7
3383754|NCT01915498|4118875|FG002|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||7
3383755|NCT01915498|4118876|FG003|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||8
3383756|NCT01915498|4118877|FG004|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||5
3383757|NCT01915498|4118878|FG005|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||9
3383758|NCT01915498|4118879|FG006|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||7
3383759|NCT01915498|4118880|FG007|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||21
3383760|NCT01915498|4118881|FG008|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||6
3383761|NCT01915498|4118882|FG009|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||14
3383762|NCT01915498|4118883|FG010|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||9
3383763|NCT01915498|4118884|FG011|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||4
3031919|NCT01120639|3751126|FG001|NOT COMPLETED|Overall Study||0
3031920|NCT01120639|3751127|FG002|NOT COMPLETED|Overall Study||0
3031921|NCT01120639|3751128|FG003|NOT COMPLETED|Overall Study||0
3031922|NCT01120691|3751141|FG000|STARTED|Overall Study||741
3031923|NCT01120691|3751142|FG001|STARTED|Overall Study||741
3031924|NCT01120691|3751143|FG002|STARTED|Overall Study||742
3031925|NCT01120691|3751141|FG000|Full Analysis Set (FAS)|Overall Study||736
3031926|NCT01120691|3751142|FG001|Full Analysis Set (FAS)|Overall Study||739
3031927|NCT01120691|3751143|FG002|Full Analysis Set (FAS)|Overall Study||739
3031928|NCT01120691|3751141|FG000|Safety Set (SAF)|Overall Study||736
3031929|NCT01120691|3751142|FG001|Safety Set (SAF)|Overall Study||740
3031930|NCT01120691|3751143|FG002|Safety Set (SAF)|Overall Study||739
3031931|NCT01120691|3751141|FG000|Modified Safety Set (mSAF)|Overall Study||729
3031932|NCT01120691|3751142|FG001|Modified Safety Set (mSAF)|Overall Study||740
3031933|NCT01120691|3751143|FG002|Modified Safety Set (mSAF)|Overall Study||737
3031934|NCT01120691|3751141|FG000|Modified Full Analysis Set (mFAS)|Overall Study||729
3031935|NCT01120691|3751142|FG001|Modified Full Analysis Set (mFAS)|Overall Study||739
3031936|NCT01120691|3751143|FG002|Modified Full Analysis Set (mFAS)|Overall Study||737
3031937|NCT01120691|3751141|FG000|COMPLETED|Overall Study||570
3031938|NCT01120691|3751142|FG001|COMPLETED|Overall Study||538
3031939|NCT01120691|3751143|FG002|COMPLETED|Overall Study||559
3031940|NCT01120691|3751141|FG000|NOT COMPLETED|Overall Study||171
3031941|NCT01120691|3751142|FG001|NOT COMPLETED|Overall Study||203
3031942|NCT01120691|3751143|FG002|NOT COMPLETED|Overall Study||183
3031943|NCT01120704|3751187|FG000|STARTED|Overall Study||13
3031944|NCT01120704|3751188|FG001|STARTED|Overall Study||17
3031945|NCT01120704|3751189|FG002|STARTED|Overall Study||14
3031946|NCT01120704|3751190|FG003|STARTED|Overall Study||19
3031947|NCT01120704|3751191|FG004|STARTED|Overall Study||16
3031948|NCT01120704|3751192|FG005|STARTED|Overall Study||19
3031949|NCT01120704|3751193|FG006|STARTED|Overall Study||15
3031950|NCT01120704|3751194|FG007|STARTED|Overall Study||15
3031951|NCT01120704|3751195|FG008|STARTED|Overall Study||22
3031952|NCT01120704|3751196|FG009|STARTED|Overall Study||20
3031953|NCT01120704|3751197|FG010|STARTED|Overall Study||17
3031954|NCT01120704|3751198|FG011|STARTED|Overall Study||16
3031955|NCT01120704|3751199|FG012|STARTED|Overall Study||17
3031956|NCT01120704|3751200|FG013|STARTED|Overall Study||19
3031957|NCT01120704|3751201|FG014|STARTED|Overall Study||18
3031958|NCT01120704|3751202|FG015|STARTED|Overall Study||18
3031959|NCT01120704|3751203|FG016|STARTED|Overall Study||14
3031960|NCT01120704|3751204|FG017|STARTED|Overall Study||16
3031961|NCT01120704|3751205|FG018|STARTED|Overall Study||17
3031962|NCT01120704|3751206|FG019|STARTED|Overall Study||18
3031963|NCT01120704|3751207|FG020|STARTED|Overall Study||17
3031964|NCT01120704|3751208|FG021|STARTED|Overall Study||16
3031965|NCT01120704|3751209|FG022|STARTED|Overall Study||21
3031966|NCT01120704|3751210|FG023|STARTED|Overall Study||16
3031967|NCT01120704|3751211|FG024|STARTED|Overall Study||18
3031968|NCT01120704|3751212|FG025|STARTED|Overall Study||14
3031969|NCT01120704|3751213|FG026|STARTED|Overall Study||18
3031970|NCT01120704|3751214|FG027|STARTED|Overall Study||18
3031971|NCT01120704|3751215|FG028|STARTED|Overall Study||19
3031972|NCT01120704|3751216|FG029|STARTED|Overall Study||15
3031973|NCT01120704|3751217|FG030|STARTED|Overall Study||14
3031974|NCT01120704|3751218|FG031|STARTED|Overall Study||18
3031975|NCT01120704|3751187|FG000|COMPLETED|Overall Study||10
3031976|NCT01120704|3751188|FG001|COMPLETED|Overall Study||13
3031977|NCT01120704|3751189|FG002|COMPLETED|Overall Study||13
3031978|NCT01120704|3751190|FG003|COMPLETED|Overall Study||15
3031979|NCT01120704|3751191|FG004|COMPLETED|Overall Study||14
3383764|NCT01915498|4118885|FG012|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||7
3383765|NCT01915498|4118886|FG013|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||46
3383766|NCT01915498|4118887|FG014|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||25
3383767|NCT01915498|4118888|FG015|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||23
3383768|NCT01915498|4118889|FG016|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||24
3383769|NCT01915498|4118890|FG017|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||100
3383770|NCT01915498|4118891|FG018|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
3383771|NCT01915498|4118873|FG000|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
3383772|NCT01915498|4118874|FG001|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
3383773|NCT01915498|4118875|FG002|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
3383774|NCT01915498|4118876|FG003|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
3383775|NCT01915498|4118877|FG004|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
3383776|NCT01915498|4118878|FG005|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
3383777|NCT01915498|4118879|FG006|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
3383778|NCT01915498|4118880|FG007|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
3383779|NCT01915498|4118881|FG008|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
3383780|NCT01915498|4118882|FG009|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
3383781|NCT01915498|4118883|FG010|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
3383782|NCT01915498|4118884|FG011|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
3383783|NCT01915498|4118885|FG012|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
3383784|NCT01915498|4118886|FG013|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
3383785|NCT01915498|4118887|FG014|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
3383786|NCT01915498|4118888|FG015|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
3383787|NCT01915498|4118889|FG016|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
3383788|NCT01915498|4118890|FG017|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
3386740|NCT02021773|4122068|FG000|Intent-to-treat (ITT)|Overall Study||89
2911592|NCT00485433|3621342|FG002|NOT COMPLETED|Overall Study||0
3031980|NCT01120704|3751192|FG005|COMPLETED|Overall Study||18
3031981|NCT01120704|3751193|FG006|COMPLETED|Overall Study||12
3031982|NCT01120704|3751194|FG007|COMPLETED|Overall Study||13
3031983|NCT01120704|3751195|FG008|COMPLETED|Overall Study||19
3031984|NCT01120704|3751196|FG009|COMPLETED|Overall Study||19
3031985|NCT01120704|3751197|FG010|COMPLETED|Overall Study||16
3031986|NCT01120704|3751198|FG011|COMPLETED|Overall Study||14
3031987|NCT01120704|3751199|FG012|COMPLETED|Overall Study||14
3031988|NCT01120704|3751200|FG013|COMPLETED|Overall Study||15
3031989|NCT01120704|3751201|FG014|COMPLETED|Overall Study||17
3031990|NCT01120704|3751202|FG015|COMPLETED|Overall Study||16
3031991|NCT01120704|3751203|FG016|COMPLETED|Overall Study||13
3031992|NCT01120704|3751204|FG017|COMPLETED|Overall Study||16
3031993|NCT01120704|3751205|FG018|COMPLETED|Overall Study||15
3031994|NCT01120704|3751206|FG019|COMPLETED|Overall Study||15
3031995|NCT01120704|3751207|FG020|COMPLETED|Overall Study||14
3031996|NCT01120704|3751208|FG021|COMPLETED|Overall Study||16
3031997|NCT01120704|3751209|FG022|COMPLETED|Overall Study||17
3031998|NCT01120704|3751210|FG023|COMPLETED|Overall Study||13
3031999|NCT01120704|3751211|FG024|COMPLETED|Overall Study||16
3032000|NCT01120704|3751212|FG025|COMPLETED|Overall Study||14
3032001|NCT01120704|3751213|FG026|COMPLETED|Overall Study||15
3032002|NCT01120704|3751214|FG027|COMPLETED|Overall Study||16
3032003|NCT01120704|3751215|FG028|COMPLETED|Overall Study||14
3032004|NCT01120704|3751216|FG029|COMPLETED|Overall Study||12
3032005|NCT01120704|3751217|FG030|COMPLETED|Overall Study||12
3032006|NCT01120704|3751218|FG031|COMPLETED|Overall Study||17
3032007|NCT01120704|3751187|FG000|NOT COMPLETED|Overall Study||3
3032008|NCT01120704|3751188|FG001|NOT COMPLETED|Overall Study||4
3032009|NCT01120704|3751189|FG002|NOT COMPLETED|Overall Study||1
3032010|NCT01120704|3751190|FG003|NOT COMPLETED|Overall Study||4
3032011|NCT01120704|3751191|FG004|NOT COMPLETED|Overall Study||2
3032012|NCT01120704|3751192|FG005|NOT COMPLETED|Overall Study||1
3032013|NCT01120704|3751193|FG006|NOT COMPLETED|Overall Study||3
3032014|NCT01120704|3751194|FG007|NOT COMPLETED|Overall Study||2
3032015|NCT01120704|3751195|FG008|NOT COMPLETED|Overall Study||3
3032016|NCT01120704|3751196|FG009|NOT COMPLETED|Overall Study||1
3032017|NCT01120704|3751197|FG010|NOT COMPLETED|Overall Study||1
3032018|NCT01120704|3751198|FG011|NOT COMPLETED|Overall Study||2
3032019|NCT01120704|3751199|FG012|NOT COMPLETED|Overall Study||3
3032020|NCT01120704|3751200|FG013|NOT COMPLETED|Overall Study||4
3032021|NCT01120704|3751201|FG014|NOT COMPLETED|Overall Study||1
3032022|NCT01120704|3751202|FG015|NOT COMPLETED|Overall Study||2
3032023|NCT01120704|3751203|FG016|NOT COMPLETED|Overall Study||1
3032024|NCT01120704|3751204|FG017|NOT COMPLETED|Overall Study||0
3032025|NCT01120704|3751205|FG018|NOT COMPLETED|Overall Study||2
3032026|NCT01120704|3751206|FG019|NOT COMPLETED|Overall Study||3
3032027|NCT01120704|3751207|FG020|NOT COMPLETED|Overall Study||3
3032028|NCT01120704|3751208|FG021|NOT COMPLETED|Overall Study||0
3032029|NCT01120704|3751209|FG022|NOT COMPLETED|Overall Study||4
3032030|NCT01120704|3751210|FG023|NOT COMPLETED|Overall Study||3
3032031|NCT01120704|3751211|FG024|NOT COMPLETED|Overall Study||2
3032032|NCT01120704|3751212|FG025|NOT COMPLETED|Overall Study||0
3032033|NCT01120704|3751213|FG026|NOT COMPLETED|Overall Study||3
3032034|NCT01120704|3751214|FG027|NOT COMPLETED|Overall Study||2
3032035|NCT01120704|3751215|FG028|NOT COMPLETED|Overall Study||5
3032036|NCT01120704|3751216|FG029|NOT COMPLETED|Overall Study||3
3032037|NCT01120704|3751217|FG030|NOT COMPLETED|Overall Study||2
3032038|NCT01120704|3751218|FG031|NOT COMPLETED|Overall Study||1
3032039|NCT01120717|3751234|FG000|STARTED|Overall Study||226
3032040|NCT01120717|3751235|FG001|STARTED|Overall Study||113
3032041|NCT01120717|3751234|FG000|Safety Population: Received Study Drug|Overall Study||225
3032042|NCT01120717|3751235|FG001|Safety Population: Received Study Drug|Overall Study||113
3032043|NCT01120717|3751234|FG000|COMPLETED|Overall Study||194
3032044|NCT01120717|3751235|FG001|COMPLETED|Overall Study||89
3032045|NCT01120717|3751234|FG000|NOT COMPLETED|Overall Study||32
3032046|NCT01120717|3751235|FG001|NOT COMPLETED|Overall Study||24
3032047|NCT01120756|3751243|FG000|STARTED|Overall Study||21
3032048|NCT01120756|3751244|FG001|STARTED|Overall Study||14
3032049|NCT01120756|3751243|FG000|COMPLETED|Overall Study||20
3032050|NCT01120756|3751244|FG001|COMPLETED|Overall Study||13
3032051|NCT01120756|3751243|FG000|NOT COMPLETED|Overall Study||1
3032052|NCT01120756|3751244|FG001|NOT COMPLETED|Overall Study||1
3032053|NCT01120782|3751250|FG000|STARTED|Overall Study||45
3032054|NCT01120782|3751250|FG000|COMPLETED|Overall Study||34
3032055|NCT01120782|3751250|FG000|NOT COMPLETED|Overall Study||11
3032056|NCT01120808|3751254|FG000|STARTED|Overall Study||136
3032057|NCT01120808|3751254|FG000|COMPLETED|Overall Study||90
3032058|NCT01120808|3751254|FG000|NOT COMPLETED|Overall Study||46
3032059|NCT01120834|3751258|FG000|STARTED|Overall Study||18
3032060|NCT01120834|3751258|FG000|COMPLETED|Overall Study||18
3032061|NCT01120834|3751258|FG000|NOT COMPLETED|Overall Study||0
3032062|NCT01120899|3751262|FG000|STARTED|Overall Study||6
3032063|NCT01120899|3751262|FG000|Month 6|Overall Study||5
3032064|NCT01120899|3751262|FG000|Month 12|Overall Study||3
3032065|NCT01120899|3751262|FG000|Month 18|Overall Study||3
3032066|NCT01120899|3751262|FG000|COMPLETED|Overall Study||3
3032067|NCT01120899|3751262|FG000|NOT COMPLETED|Overall Study||3
3032068|NCT01120990|3751266|FG000|STARTED|Overall Study||51
3032069|NCT01120990|3751266|FG000|COMPLETED|Overall Study||51
3032070|NCT01120990|3751266|FG000|NOT COMPLETED|Overall Study||0
3032071|NCT01121146|3751272|FG000|STARTED|Overall Study||116
3032072|NCT01121146|3751273|FG001|STARTED|Overall Study||114
3038231|NCT01152788|3757608|FG000|COMPLETED|Overall Study||32
3032073|NCT01121146|3751272|FG000|COMPLETED|Overall Study|The 90 hips include those that were not revised and had a minimum 9-year questionnaire or radiograph|90
3032074|NCT01121146|3751273|FG001|COMPLETED|Overall Study|The 72 hips include those that were not revised and had a minimum 9-year questionnaire or radiograph|72
3032075|NCT01121146|3751272|FG000|NOT COMPLETED|Overall Study||26
3032076|NCT01121146|3751273|FG001|NOT COMPLETED|Overall Study||42
3032077|NCT01121172|3751282|FG000|STARTED|Overall Study||90
3032078|NCT01121172|3751283|FG001|STARTED|Overall Study||90
3032079|NCT01121172|3751282|FG000|COMPLETED|Overall Study||90
3032080|NCT01121172|3751283|FG001|COMPLETED|Overall Study||90
3032081|NCT01121172|3751282|FG000|NOT COMPLETED|Overall Study||0
3032082|NCT01121172|3751283|FG001|NOT COMPLETED|Overall Study||0
3032083|NCT01121185|3751292|FG000|STARTED|Overall Study||7
3032084|NCT01121185|3751293|FG001|STARTED|Overall Study||6
3032085|NCT01121185|3751292|FG000|Infused|Overall Study||7
3032086|NCT01121185|3751293|FG001|Infused|Overall Study|Excluded medical condition identified in one subject after randomization but before study infusion.|5
3032087|NCT01121185|3751292|FG000|Transplanted|Overall Study|One subject initiated the first study infusion, but transplant surgery was subsequently cancelled.|6
3032088|NCT01121185|3751293|FG001|Transplanted|Overall Study||5
3032089|NCT01121185|3751292|FG000|COMPLETED|Overall Study||6
3032090|NCT01121185|3751293|FG001|COMPLETED|Overall Study||5
3032091|NCT01121185|3751292|FG000|NOT COMPLETED|Overall Study||1
3032092|NCT01121185|3751293|FG001|NOT COMPLETED|Overall Study||1
3032093|NCT01121211|3751301|FG000|STARTED|Overall Study||43
3032094|NCT01121211|3751302|FG001|STARTED|Overall Study||47
3032095|NCT01121211|3751301|FG000|COMPLETED|Overall Study||32
3032096|NCT01121211|3751302|FG001|COMPLETED|Overall Study||35
3032097|NCT01121211|3751301|FG000|NOT COMPLETED|Overall Study||11
3032098|NCT01121211|3751302|FG001|NOT COMPLETED|Overall Study||12
3032099|NCT01121224|3751310|FG000|STARTED|Overall Study||305
3032100|NCT01121224|3751311|FG001|STARTED|Overall Study||292
3032101|NCT01121224|3751310|FG000|COMPLETED|Overall Study||280
3032102|NCT01121224|3751311|FG001|COMPLETED|Overall Study||275
3032103|NCT01121224|3751310|FG000|NOT COMPLETED|Overall Study||25
3032104|NCT01121224|3751311|FG001|NOT COMPLETED|Overall Study||17
3032105|NCT01121250|3751322|FG000|STARTED|Overall Study||76
3032106|NCT01121250|3751323|FG001|STARTED|Overall Study||76
3032107|NCT01121250|3751324|FG002|STARTED|Overall Study||76
3032108|NCT01121250|3751322|FG000|COMPLETED|Overall Study||76
3032109|NCT01121250|3751323|FG001|COMPLETED|Overall Study||76
3032110|NCT01121250|3751324|FG002|COMPLETED|Overall Study||75
3032111|NCT01121250|3751322|FG000|NOT COMPLETED|Overall Study||0
3032112|NCT01121250|3751323|FG001|NOT COMPLETED|Overall Study||0
3032113|NCT01121250|3751324|FG002|NOT COMPLETED|Overall Study||1
3032114|NCT01121263|3751334|FG000|STARTED|Overall Study||200
3032115|NCT01121263|3751335|FG001|STARTED|Overall Study||98
3032116|NCT01121263|3751334|FG000|COMPLETED|Overall Study||175
3032117|NCT01121263|3751335|FG001|COMPLETED|Overall Study||83
3032118|NCT01121263|3751334|FG000|NOT COMPLETED|Overall Study||25
3032119|NCT01121263|3751335|FG001|NOT COMPLETED|Overall Study||15
3032120|NCT01121393|3751345|FG000|STARTED|Overall Study|Randomised|242
3032121|NCT01121393|3751346|FG001|STARTED|Overall Study|Randomised|122
3032122|NCT01121393|3751345|FG000|Treated|Overall Study|Treated|239
3032123|NCT01121393|3751346|FG001|Treated|Overall Study|Treated|113
3032124|NCT01121393|3751345|FG000|COMPLETED|Overall Study|At the time of data cut-off for last-patient out (07 December 2017)|0
3032125|NCT01121393|3751346|FG001|COMPLETED|Overall Study|Completed 6 courses of chemotherapy|38
3166132|NCT01903252|3893565|FG005|NOT COMPLETED|Maintenance, Open-Label||18
3166133|NCT01903265|3893585|FG000|STARTED|Overall Study||103
3166134|NCT01903265|3893586|FG001|STARTED|Overall Study||102
3166135|NCT01903265|3893585|FG000|COMPLETED|Overall Study||89
3166136|NCT01903265|3893586|FG001|COMPLETED|Overall Study||85
3166137|NCT01903265|3893585|FG000|NOT COMPLETED|Overall Study||14
3166138|NCT01903265|3893586|FG001|NOT COMPLETED|Overall Study||17
3032126|NCT01121393|3751345|FG000|NOT COMPLETED|Overall Study||242
3032127|NCT01121393|3751346|FG001|NOT COMPLETED|Overall Study||84
3032128|NCT01121406|3751360|FG000|STARTED|Overall Study||55
3032129|NCT01121406|3751361|FG001|STARTED|Overall Study|24 patients switched to Volasertib (BI 6727) due to disease progression or occurrence of toxicity|55
3032130|NCT01121406|3751360|FG000|COMPLETED|Overall Study||0
3032131|NCT01121406|3751361|FG001|COMPLETED|Overall Study||0
3032132|NCT01121406|3751360|FG000|NOT COMPLETED|Overall Study||55
3032133|NCT01121406|3751361|FG001|NOT COMPLETED|Overall Study||55
3032134|NCT01121484|3751372|FG000|STARTED|Overall Study||218
3032135|NCT01121484|3751373|FG001|STARTED|Overall Study||221
3032136|NCT01121484|3751372|FG000|Treated|Overall Study||217
3032137|NCT01121484|3751373|FG001|Treated|Overall Study||217
3032138|NCT01121484|3751372|FG000|COMPLETED|Overall Study||185
3032139|NCT01121484|3751373|FG001|COMPLETED|Overall Study||178
3032140|NCT01121484|3751372|FG000|NOT COMPLETED|Overall Study||33
3032141|NCT01121484|3751373|FG001|NOT COMPLETED|Overall Study||43
3032142|NCT01121536|3751379|FG000|STARTED|Overall Study||867
3032143|NCT01121536|3751379|FG000|Safety Population|Overall Study|Participants treated|863
3032144|NCT01121536|3751379|FG000|Full Analysis Population|Overall Study|Treated participants who had at least 1 post-baseline efficacy assessment.|859
3032145|NCT01121536|3751379|FG000|COMPLETED|Overall Study|One participant 'completed' early due to study closeout.|506
3032146|NCT01121536|3751379|FG000|NOT COMPLETED|Overall Study||361
3032147|NCT01121549|3751383|FG000|STARTED|Overall Study||378
3032148|NCT01121549|3751383|FG000|COMPLETED|Overall Study||31
3166139|NCT01903356|3893592|FG000|STARTED|Overall Study||724
3032149|NCT01121549|3751383|FG000|NOT COMPLETED|Overall Study||347
3032150|NCT01121562|3751387|FG000|STARTED|Overall Study||12
3032151|NCT01121562|3751387|FG000|COMPLETED|Overall Study||0
3032152|NCT01121562|3751387|FG000|NOT COMPLETED|Overall Study||12
3032153|NCT01121575|3751397|FG000|STARTED|Overall Study||14
3032154|NCT01121575|3751398|FG001|STARTED|Overall Study||6
3032155|NCT01121575|3751399|FG002|STARTED|Overall Study||7
3032156|NCT01121575|3751400|FG003|STARTED|Overall Study||6
3032157|NCT01121575|3751401|FG004|STARTED|Overall Study||25
3032158|NCT01121575|3751402|FG005|STARTED|Overall Study||12
3032159|NCT01121575|3751397|FG000|Treated|Overall Study||14
3032160|NCT01121575|3751398|FG001|Treated|Overall Study||6
3032161|NCT01121575|3751399|FG002|Treated|Overall Study||7
3032162|NCT01121575|3751400|FG003|Treated|Overall Study||6
3032163|NCT01121575|3751401|FG004|Treated|Overall Study||25
3032164|NCT01121575|3751402|FG005|Treated|Overall Study||12
3032165|NCT01121575|3751397|FG000|COMPLETED|Overall Study||0
3032166|NCT01121575|3751398|FG001|COMPLETED|Overall Study||0
3032167|NCT01121575|3751399|FG002|COMPLETED|Overall Study||0
3032168|NCT01121575|3751400|FG003|COMPLETED|Overall Study||0
3032169|NCT01121575|3751401|FG004|COMPLETED|Overall Study||0
3032170|NCT01121575|3751402|FG005|COMPLETED|Overall Study||0
3032171|NCT01121575|3751397|FG000|NOT COMPLETED|Overall Study||14
3032172|NCT01121575|3751398|FG001|NOT COMPLETED|Overall Study||6
3032173|NCT01121575|3751399|FG002|NOT COMPLETED|Overall Study||7
3032174|NCT01121575|3751400|FG003|NOT COMPLETED|Overall Study||6
3032175|NCT01121575|3751401|FG004|NOT COMPLETED|Overall Study||25
3032176|NCT01121575|3751402|FG005|NOT COMPLETED|Overall Study||12
3032177|NCT01121666|3751423|FG000|STARTED|Overall Study||249
3032178|NCT01121666|3751424|FG001|STARTED|Overall Study||123
3032179|NCT01121666|3751423|FG000|COMPLETED|Overall Study||220
3032180|NCT01121666|3751424|FG001|COMPLETED|Overall Study||113
3032181|NCT01121666|3751423|FG000|NOT COMPLETED|Overall Study||29
3032182|NCT01121666|3751424|FG001|NOT COMPLETED|Overall Study||10
3032183|NCT01121757|3751432|FG000|STARTED|First Drug||6
3032184|NCT01121757|3751433|FG001|STARTED|First Drug||3
3032185|NCT01121757|3751432|FG000|COMPLETED|First Drug|Completed a minimum of 4 cycles of Azacitidine.|5
3032186|NCT01121757|3751433|FG001|COMPLETED|First Drug|Completed a minimum of 4 cycles of Lenalidomide|1
3032187|NCT01121757|3751432|FG000|NOT COMPLETED|First Drug||1
3032188|NCT01121757|3751433|FG001|NOT COMPLETED|First Drug||2
3032189|NCT01121757|3751432|FG000|STARTED|Second Drug|1 subject did not start drug 2 due to disease progression|4
3032190|NCT01121757|3751433|FG001|STARTED|Second Drug||1
3032191|NCT01121757|3751432|FG000|COMPLETED|Second Drug||4
3032192|NCT01121757|3751433|FG001|COMPLETED|Second Drug||1
3032193|NCT01121757|3751432|FG000|NOT COMPLETED|Second Drug||0
3032194|NCT01121757|3751433|FG001|NOT COMPLETED|Second Drug||0
3032195|NCT01121757|3751432|FG000|STARTED|Combination|2 subjects did not start combination drug. 1 elected surgery 1 had a complete response after drug 2.|2
3032196|NCT01121757|3751433|FG001|STARTED|Combination||1
3032197|NCT01121757|3751432|FG000|COMPLETED|Combination||0
3032198|NCT01121757|3751433|FG001|COMPLETED|Combination||0
3032199|NCT01121757|3751432|FG000|NOT COMPLETED|Combination||2
3032200|NCT01121757|3751433|FG001|NOT COMPLETED|Combination||1
3166140|NCT01903356|3893592|FG000|COMPLETED|Overall Study||709
3166141|NCT01903356|3893592|FG000|NOT COMPLETED|Overall Study||15
3383789|NCT01915498|4118891|FG018|STARTED|Safety Follow-up (Sept 2017 to July 2019||16
3032201|NCT01121900|3751441|FG000|STARTED|First Intervention Period||13
3032202|NCT01121900|3751442|FG001|STARTED|First Intervention Period||13
3032203|NCT01121900|3751441|FG000|COMPLETED|First Intervention Period||12
3032204|NCT01121900|3751442|FG001|COMPLETED|First Intervention Period||12
3032205|NCT01121900|3751441|FG000|NOT COMPLETED|First Intervention Period||1
3032206|NCT01121900|3751442|FG001|NOT COMPLETED|First Intervention Period||1
3032207|NCT01121900|3751441|FG000|STARTED|Washout Period of 7 Days||12
3032208|NCT01121900|3751442|FG001|STARTED|Washout Period of 7 Days||12
3032209|NCT01121900|3751441|FG000|COMPLETED|Washout Period of 7 Days||12
3032210|NCT01121900|3751442|FG001|COMPLETED|Washout Period of 7 Days||11
3032211|NCT01121900|3751441|FG000|NOT COMPLETED|Washout Period of 7 Days||0
3032212|NCT01121900|3751442|FG001|NOT COMPLETED|Washout Period of 7 Days||1
3032213|NCT01121900|3751441|FG000|STARTED|Second Intervention Period||12
3032214|NCT01121900|3751442|FG001|STARTED|Second Intervention Period||11
3032215|NCT01121900|3751441|FG000|COMPLETED|Second Intervention Period||12
3032216|NCT01121900|3751442|FG001|COMPLETED|Second Intervention Period||11
3383790|NCT01915498|4118873|FG000|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
3383791|NCT01915498|4118874|FG001|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
3383792|NCT01915498|4118875|FG002|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
3383793|NCT01915498|4118876|FG003|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
3383794|NCT01915498|4118877|FG004|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
3383795|NCT01915498|4118878|FG005|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
3383796|NCT01915498|4118879|FG006|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
3386741|NCT02021773|4122069|FG001|Intent-to-treat (ITT)|Overall Study||87
3032217|NCT01121900|3751441|FG000|NOT COMPLETED|Second Intervention Period||0
3032218|NCT01121900|3751442|FG001|NOT COMPLETED|Second Intervention Period||0
3032219|NCT01121913|3751448|FG000|STARTED|First Intervention Period||6
3032220|NCT01121913|3751449|FG001|STARTED|First Intervention Period||6
3032221|NCT01121913|3751450|FG002|STARTED|First Intervention Period||6
3032222|NCT01121913|3751451|FG003|STARTED|First Intervention Period||6
3166142|NCT01903434|3893596|FG000|STARTED|Treatment Period 1||30
3032223|NCT01121913|3751448|FG000|COMPLETED|First Intervention Period||6
3032224|NCT01121913|3751449|FG001|COMPLETED|First Intervention Period||6
3032225|NCT01121913|3751450|FG002|COMPLETED|First Intervention Period||5
3032226|NCT01121913|3751451|FG003|COMPLETED|First Intervention Period||6
3032227|NCT01121913|3751448|FG000|NOT COMPLETED|First Intervention Period||0
3032228|NCT01121913|3751449|FG001|NOT COMPLETED|First Intervention Period||0
3032229|NCT01121913|3751450|FG002|NOT COMPLETED|First Intervention Period||1
3032230|NCT01121913|3751451|FG003|NOT COMPLETED|First Intervention Period||0
3032231|NCT01121913|3751448|FG000|STARTED|First Washout Period||6
3032232|NCT01121913|3751449|FG001|STARTED|First Washout Period||6
3032233|NCT01121913|3751450|FG002|STARTED|First Washout Period||5
3032234|NCT01121913|3751451|FG003|STARTED|First Washout Period||6
3032235|NCT01121913|3751448|FG000|COMPLETED|First Washout Period||5
3032236|NCT01121913|3751449|FG001|COMPLETED|First Washout Period||6
3032237|NCT01121913|3751450|FG002|COMPLETED|First Washout Period||5
3032238|NCT01121913|3751451|FG003|COMPLETED|First Washout Period||6
3032239|NCT01121913|3751448|FG000|NOT COMPLETED|First Washout Period||1
3032240|NCT01121913|3751449|FG001|NOT COMPLETED|First Washout Period||0
3032241|NCT01121913|3751450|FG002|NOT COMPLETED|First Washout Period||0
3032242|NCT01121913|3751451|FG003|NOT COMPLETED|First Washout Period||0
3032243|NCT01121913|3751448|FG000|STARTED|Second Intervention Period||5
3032244|NCT01121913|3751449|FG001|STARTED|Second Intervention Period||6
3032245|NCT01121913|3751450|FG002|STARTED|Second Intervention Period||5
3166143|NCT01903434|3893597|FG001|STARTED|Treatment Period 1||30
3166144|NCT01903434|3893596|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 1||30
3166145|NCT01903434|3893597|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 1||30
3032246|NCT01121913|3751451|FG003|STARTED|Second Intervention Period||6
3032247|NCT01121913|3751448|FG000|COMPLETED|Second Intervention Period||5
3032248|NCT01121913|3751449|FG001|COMPLETED|Second Intervention Period||6
3032249|NCT01121913|3751450|FG002|COMPLETED|Second Intervention Period||4
3032250|NCT01121913|3751451|FG003|COMPLETED|Second Intervention Period||6
3032251|NCT01121913|3751448|FG000|NOT COMPLETED|Second Intervention Period||0
3032252|NCT01121913|3751449|FG001|NOT COMPLETED|Second Intervention Period||0
3032253|NCT01121913|3751450|FG002|NOT COMPLETED|Second Intervention Period||1
3032254|NCT01121913|3751451|FG003|NOT COMPLETED|Second Intervention Period||0
3032255|NCT01121913|3751448|FG000|STARTED|Second Washout Period||5
3032256|NCT01121913|3751449|FG001|STARTED|Second Washout Period||6
3032257|NCT01121913|3751450|FG002|STARTED|Second Washout Period||4
3032258|NCT01121913|3751451|FG003|STARTED|Second Washout Period||6
3032259|NCT01121913|3751448|FG000|COMPLETED|Second Washout Period||5
3032260|NCT01121913|3751449|FG001|COMPLETED|Second Washout Period||6
3032261|NCT01121913|3751450|FG002|COMPLETED|Second Washout Period||3
3032262|NCT01121913|3751451|FG003|COMPLETED|Second Washout Period||6
3032263|NCT01121913|3751448|FG000|NOT COMPLETED|Second Washout Period||0
3032264|NCT01121913|3751449|FG001|NOT COMPLETED|Second Washout Period||0
3032265|NCT01121913|3751450|FG002|NOT COMPLETED|Second Washout Period||1
3032266|NCT01121913|3751451|FG003|NOT COMPLETED|Second Washout Period||0
3032267|NCT01121913|3751448|FG000|STARTED|Third Intervention Period||5
3032268|NCT01121913|3751449|FG001|STARTED|Third Intervention Period||6
3032269|NCT01121913|3751450|FG002|STARTED|Third Intervention Period||3
3032270|NCT01121913|3751451|FG003|STARTED|Third Intervention Period||6
3032271|NCT01121913|3751448|FG000|COMPLETED|Third Intervention Period||5
3032272|NCT01121913|3751449|FG001|COMPLETED|Third Intervention Period||6
3032273|NCT01121913|3751450|FG002|COMPLETED|Third Intervention Period||3
3032274|NCT01121913|3751451|FG003|COMPLETED|Third Intervention Period||6
3032275|NCT01121913|3751448|FG000|NOT COMPLETED|Third Intervention Period||0
3032276|NCT01121913|3751449|FG001|NOT COMPLETED|Third Intervention Period||0
3032277|NCT01121913|3751450|FG002|NOT COMPLETED|Third Intervention Period||0
3032278|NCT01121913|3751451|FG003|NOT COMPLETED|Third Intervention Period||0
3032279|NCT01121913|3751448|FG000|STARTED|Third Washout Period||5
3032280|NCT01121913|3751449|FG001|STARTED|Third Washout Period||6
3032281|NCT01121913|3751450|FG002|STARTED|Third Washout Period||3
3166146|NCT01903434|3893596|FG000|COMPLETED|Treatment Period 1||30
3032282|NCT01121913|3751451|FG003|STARTED|Third Washout Period||6
3032283|NCT01121913|3751448|FG000|COMPLETED|Third Washout Period||4
3032284|NCT01121913|3751449|FG001|COMPLETED|Third Washout Period||6
3032285|NCT01121913|3751450|FG002|COMPLETED|Third Washout Period||3
3032286|NCT01121913|3751451|FG003|COMPLETED|Third Washout Period||6
3032287|NCT01121913|3751448|FG000|NOT COMPLETED|Third Washout Period||1
3032288|NCT01121913|3751449|FG001|NOT COMPLETED|Third Washout Period||0
3032289|NCT01121913|3751450|FG002|NOT COMPLETED|Third Washout Period||0
3032290|NCT01121913|3751451|FG003|NOT COMPLETED|Third Washout Period||0
3032291|NCT01121913|3751448|FG000|STARTED|Fourth Intervention Period||4
3032292|NCT01121913|3751449|FG001|STARTED|Fourth Intervention Period||6
3032293|NCT01121913|3751450|FG002|STARTED|Fourth Intervention Period||3
3032294|NCT01121913|3751451|FG003|STARTED|Fourth Intervention Period||6
3032295|NCT01121913|3751448|FG000|COMPLETED|Fourth Intervention Period||4
3032296|NCT01121913|3751449|FG001|COMPLETED|Fourth Intervention Period||6
3032297|NCT01121913|3751450|FG002|COMPLETED|Fourth Intervention Period||3
3032298|NCT01121913|3751451|FG003|COMPLETED|Fourth Intervention Period||6
3032299|NCT01121913|3751448|FG000|NOT COMPLETED|Fourth Intervention Period||0
3032300|NCT01121913|3751449|FG001|NOT COMPLETED|Fourth Intervention Period||0
3166147|NCT01903434|3893597|FG001|COMPLETED|Treatment Period 1||30
3032301|NCT01121913|3751450|FG002|NOT COMPLETED|Fourth Intervention Period||0
3032302|NCT01121913|3751451|FG003|NOT COMPLETED|Fourth Intervention Period||0
3032303|NCT01121926|3751461|FG000|STARTED|First Intervention Period||15
3032304|NCT01121926|3751462|FG001|STARTED|First Intervention Period||15
3032305|NCT01121926|3751461|FG000|COMPLETED|First Intervention Period||14
3032306|NCT01121926|3751462|FG001|COMPLETED|First Intervention Period||15
3032307|NCT01121926|3751461|FG000|NOT COMPLETED|First Intervention Period||1
3032308|NCT01121926|3751462|FG001|NOT COMPLETED|First Intervention Period||0
3032309|NCT01121926|3751461|FG000|STARTED|Washout Period||14
3032310|NCT01121926|3751462|FG001|STARTED|Washout Period||15
3032311|NCT01121926|3751461|FG000|COMPLETED|Washout Period||14
3032312|NCT01121926|3751462|FG001|COMPLETED|Washout Period||13
3032313|NCT01121926|3751461|FG000|NOT COMPLETED|Washout Period||0
3032314|NCT01121926|3751462|FG001|NOT COMPLETED|Washout Period||2
3032315|NCT01121926|3751461|FG000|STARTED|Second Intervention Period||14
3032316|NCT01121926|3751462|FG001|STARTED|Second Intervention Period||13
3032317|NCT01121926|3751461|FG000|COMPLETED|Second Intervention Period||14
3032318|NCT01121926|3751462|FG001|COMPLETED|Second Intervention Period||13
3032319|NCT01121926|3751461|FG000|NOT COMPLETED|Second Intervention Period||0
3032320|NCT01121926|3751462|FG001|NOT COMPLETED|Second Intervention Period||0
3032321|NCT01121939|3751468|FG000|STARTED|Overall Study||43
3032322|NCT01121939|3751468|FG000|COMPLETED|Overall Study|Patients remained on-study until disease progression or unacceptable toxicity occurred.|0
3032323|NCT01121939|3751468|FG000|NOT COMPLETED|Overall Study||43
3032324|NCT01121991|3751475|FG000|STARTED|Overall Study|Number of participants treated|52
3032325|NCT01121991|3751475|FG000|COMPLETED|Overall Study||46
3310075|NCT03037307|4043444|FG000|COMPLETED|Wash Out Period 1||7
3310076|NCT03037307|4043445|FG001|COMPLETED|Wash Out Period 1||7
3310077|NCT03037307|4043446|FG002|COMPLETED|Wash Out Period 1||8
3310078|NCT03037307|4043447|FG003|COMPLETED|Wash Out Period 1||6
3310079|NCT03037307|4043448|FG004|COMPLETED|Wash Out Period 1||7
3310080|NCT03037307|4043449|FG005|COMPLETED|Wash Out Period 1||8
3310081|NCT03037307|4043444|FG000|NOT COMPLETED|Wash Out Period 1||0
3310082|NCT03037307|4043445|FG001|NOT COMPLETED|Wash Out Period 1||0
3383797|NCT01915498|4118880|FG007|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
3383798|NCT01915498|4118881|FG008|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
2911593|NCT00485433|3621343|FG003|NOT COMPLETED|Overall Study||0
2911594|NCT00485472|3621353|FG000|STARTED|Overall Study||73
2911595|NCT00485472|3621354|FG001|STARTED|Overall Study||76
2911596|NCT00485472|3621353|FG000|Entered Maintenance Phase|Overall Study||65
2911597|NCT00485472|3621354|FG001|Entered Maintenance Phase|Overall Study||67
2911598|NCT00485472|3621353|FG000|COMPLETED|Overall Study||57
2911599|NCT00485472|3621354|FG001|COMPLETED|Overall Study||64
2911600|NCT00485472|3621353|FG000|NOT COMPLETED|Overall Study||16
2911601|NCT00485472|3621354|FG001|NOT COMPLETED|Overall Study||12
2911602|NCT00485485|3621360|FG000|STARTED|Overall Study||7
2911603|NCT00485485|3621360|FG000|COMPLETED|Overall Study||7
2911604|NCT00485485|3621360|FG000|NOT COMPLETED|Overall Study||0
2911605|NCT00485589|3621367|FG000|STARTED|Overall Study||210
2911606|NCT00485589|3621368|FG001|STARTED|Overall Study||200
2911607|NCT00485589|3621369|FG002|STARTED|Overall Study||203
2911608|NCT00485589|3621367|FG000|COMPLETED|Overall Study||183
2911609|NCT00485589|3621368|FG001|COMPLETED|Overall Study||180
2911610|NCT00485589|3621369|FG002|COMPLETED|Overall Study||185
2911611|NCT00485589|3621367|FG000|NOT COMPLETED|Overall Study||27
2911612|NCT00485589|3621368|FG001|NOT COMPLETED|Overall Study||20
2911613|NCT00485589|3621369|FG002|NOT COMPLETED|Overall Study||18
2911614|NCT00485693|3621388|FG000|STARTED|Overall Study||34
2911615|NCT00485693|3621389|FG001|STARTED|Overall Study||104
2911616|NCT00485693|3621388|FG000|COMPLETED|Overall Study||34
2911617|NCT00485693|3621389|FG001|COMPLETED|Overall Study||104
2911618|NCT00485693|3621388|FG000|NOT COMPLETED|Overall Study||0
2911619|NCT00485693|3621389|FG001|NOT COMPLETED|Overall Study||0
3310083|NCT03037307|4043446|FG002|NOT COMPLETED|Wash Out Period 1||0
2911620|NCT00485732|3621400|FG000|STARTED|Overall Study||149
2911621|NCT00485732|3621401|FG001|STARTED|Overall Study||76
2911622|NCT00485732|3621400|FG000|COMPLETED|Overall Study||141
2911623|NCT00485732|3621401|FG001|COMPLETED|Overall Study||67
2911624|NCT00485732|3621400|FG000|NOT COMPLETED|Overall Study||8
2911625|NCT00485732|3621401|FG001|NOT COMPLETED|Overall Study||9
2911626|NCT00485758|3621409|FG000|STARTED|Overall Study||454
2911627|NCT00485758|3621410|FG001|STARTED|Overall Study||342
2911628|NCT00485758|3621409|FG000|COMPLETED|Overall Study||298
2911629|NCT00485758|3621410|FG001|COMPLETED|Overall Study||277
2911630|NCT00485758|3621409|FG000|NOT COMPLETED|Overall Study||156
2911631|NCT00485758|3621410|FG001|NOT COMPLETED|Overall Study||65
2911632|NCT00485836|3621419|FG000|STARTED|Overall Study||130
2911633|NCT00485836|3621420|FG001|STARTED|Overall Study||132
2911634|NCT00485836|3621421|FG002|STARTED|Overall Study||130
2911635|NCT00485836|3621419|FG000|Received Study Drug (Safety Population)|Overall Study||129
2911636|NCT00485836|3621420|FG001|Received Study Drug (Safety Population)|Overall Study||132
2911637|NCT00485836|3621421|FG002|Received Study Drug (Safety Population)|Overall Study||129
2911638|NCT00485836|3621419|FG000|COMPLETED|Overall Study||115
2911639|NCT00485836|3621420|FG001|COMPLETED|Overall Study||129
2911640|NCT00485836|3621421|FG002|COMPLETED|Overall Study||119
2911641|NCT00485836|3621419|FG000|NOT COMPLETED|Overall Study||15
3310084|NCT03037307|4043447|FG003|NOT COMPLETED|Wash Out Period 1||0
3310085|NCT03037307|4043448|FG004|NOT COMPLETED|Wash Out Period 1||0
3032326|NCT01121991|3751475|FG000|NOT COMPLETED|Overall Study||6
3032327|NCT01122030|3751486|FG000|STARTED|Overall Study||18
3032328|NCT01122030|3751487|FG001|STARTED|Overall Study||9
3032329|NCT01122030|3751488|FG002|STARTED|Overall Study||9
3032330|NCT01122030|3751489|FG003|STARTED|Overall Study||9
3032331|NCT01122030|3751490|FG004|STARTED|Overall Study||9
3032332|NCT01122030|3751491|FG005|STARTED|Overall Study||9
3032333|NCT01122030|3751492|FG006|STARTED|Overall Study||9
3032334|NCT01122030|3751486|FG000|Received Treatment|Overall Study||18
3032335|NCT01122030|3751487|FG001|Received Treatment|Overall Study||9
3032336|NCT01122030|3751488|FG002|Received Treatment|Overall Study||9
3032337|NCT01122030|3751489|FG003|Received Treatment|Overall Study||9
3032338|NCT01122030|3751490|FG004|Received Treatment|Overall Study||9
3032339|NCT01122030|3751491|FG005|Received Treatment|Overall Study||9
3032340|NCT01122030|3751492|FG006|Received Treatment|Overall Study||9
3032341|NCT01122030|3751486|FG000|COMPLETED|Overall Study||18
3032342|NCT01122030|3751487|FG001|COMPLETED|Overall Study||9
3032343|NCT01122030|3751488|FG002|COMPLETED|Overall Study||9
3032344|NCT01122030|3751489|FG003|COMPLETED|Overall Study||9
3032345|NCT01122030|3751490|FG004|COMPLETED|Overall Study||9
3032346|NCT01122030|3751491|FG005|COMPLETED|Overall Study||9
3032347|NCT01122030|3751492|FG006|COMPLETED|Overall Study||9
3032348|NCT01122030|3751486|FG000|NOT COMPLETED|Overall Study||0
3032349|NCT01122030|3751487|FG001|NOT COMPLETED|Overall Study||0
3032350|NCT01122030|3751488|FG002|NOT COMPLETED|Overall Study||0
3032351|NCT01122030|3751489|FG003|NOT COMPLETED|Overall Study||0
3032352|NCT01122030|3751490|FG004|NOT COMPLETED|Overall Study||0
3032353|NCT01122030|3751491|FG005|NOT COMPLETED|Overall Study||0
3032354|NCT01122030|3751492|FG006|NOT COMPLETED|Overall Study||0
3032355|NCT01122108|3751514|FG000|STARTED|Overall Study||21
3032356|NCT01122108|3751515|FG001|STARTED|Overall Study||21
3032357|NCT01122108|3751514|FG000|COMPLETED|Overall Study||21
3032358|NCT01122108|3751515|FG001|COMPLETED|Overall Study||21
3032359|NCT01122108|3751514|FG000|NOT COMPLETED|Overall Study||0
3032360|NCT01122108|3751515|FG001|NOT COMPLETED|Overall Study||0
3032361|NCT01122160|3751523|FG000|STARTED|First Intervention (7 Days)||6
3032362|NCT01122160|3751524|FG001|STARTED|First Intervention (7 Days)||5
3032363|NCT01122160|3751523|FG000|COMPLETED|First Intervention (7 Days)||6
3032364|NCT01122160|3751524|FG001|COMPLETED|First Intervention (7 Days)||5
3032365|NCT01122160|3751523|FG000|NOT COMPLETED|First Intervention (7 Days)||0
3032366|NCT01122160|3751524|FG001|NOT COMPLETED|First Intervention (7 Days)||0
3032367|NCT01122160|3751523|FG000|STARTED|Washout (7-14 Days)||6
3032368|NCT01122160|3751524|FG001|STARTED|Washout (7-14 Days)||5
3032369|NCT01122160|3751523|FG000|COMPLETED|Washout (7-14 Days)||6
3032370|NCT01122160|3751524|FG001|COMPLETED|Washout (7-14 Days)||5
3032371|NCT01122160|3751523|FG000|NOT COMPLETED|Washout (7-14 Days)||0
3032372|NCT01122160|3751524|FG001|NOT COMPLETED|Washout (7-14 Days)||0
3032373|NCT01122160|3751523|FG000|STARTED|Second Intervention (7 Days)||6
3032374|NCT01122160|3751524|FG001|STARTED|Second Intervention (7 Days)||5
3032375|NCT01122160|3751523|FG000|COMPLETED|Second Intervention (7 Days)||6
3032376|NCT01122160|3751524|FG001|COMPLETED|Second Intervention (7 Days)||5
3032377|NCT01122160|3751523|FG000|NOT COMPLETED|Second Intervention (7 Days)||0
3032378|NCT01122160|3751524|FG001|NOT COMPLETED|Second Intervention (7 Days)||0
3032379|NCT01122173|3751530|FG000|STARTED|Overall Study||150
3032380|NCT01122173|3751530|FG000|COMPLETED|Overall Study||141
3032381|NCT01122173|3751530|FG000|NOT COMPLETED|Overall Study||9
3032382|NCT01122238|3751551|FG000|STARTED|Overall Study||30
3032383|NCT01122238|3751552|FG001|STARTED|Overall Study||37
3032384|NCT01122238|3751553|FG002|STARTED|Overall Study||33
3032385|NCT01122238|3751554|FG003|STARTED|Overall Study||33
3032386|NCT01122238|3751555|FG004|STARTED|Overall Study||33
3032387|NCT01122238|3751556|FG005|STARTED|Overall Study||32
3032388|NCT01122238|3751557|FG006|STARTED|Overall Study||35
3032389|NCT01122238|3751558|FG007|STARTED|Overall Study||32
3032390|NCT01122238|3751559|FG008|STARTED|Overall Study||32
3032391|NCT01122238|3751560|FG009|STARTED|Overall Study||34
3032392|NCT01122238|3751561|FG010|STARTED|Overall Study||32
3032393|NCT01122238|3751562|FG011|STARTED|Overall Study||33
3032394|NCT01122238|3751563|FG012|STARTED|Overall Study||30
3032395|NCT01122238|3751564|FG013|STARTED|Overall Study||32
3032396|NCT01122238|3751565|FG014|STARTED|Overall Study||28
3032397|NCT01122238|3751566|FG015|STARTED|Overall Study||31
3032398|NCT01122238|3751551|FG000|COMPLETED|Overall Study||28
3032399|NCT01122238|3751552|FG001|COMPLETED|Overall Study||36
3032400|NCT01122238|3751553|FG002|COMPLETED|Overall Study||28
3032401|NCT01122238|3751554|FG003|COMPLETED|Overall Study||33
3032402|NCT01122238|3751555|FG004|COMPLETED|Overall Study||33
3032403|NCT01122238|3751556|FG005|COMPLETED|Overall Study||31
3032404|NCT01122238|3751557|FG006|COMPLETED|Overall Study||34
3032405|NCT01122238|3751558|FG007|COMPLETED|Overall Study||32
3032406|NCT01122238|3751559|FG008|COMPLETED|Overall Study||31
3032407|NCT01122238|3751560|FG009|COMPLETED|Overall Study||33
3032408|NCT01122238|3751561|FG010|COMPLETED|Overall Study||32
3032409|NCT01122238|3751562|FG011|COMPLETED|Overall Study||31
3032410|NCT01122238|3751563|FG012|COMPLETED|Overall Study||28
3032411|NCT01122238|3751564|FG013|COMPLETED|Overall Study||31
3032412|NCT01122238|3751565|FG014|COMPLETED|Overall Study||28
3032413|NCT01122238|3751566|FG015|COMPLETED|Overall Study||31
3032414|NCT01122238|3751551|FG000|NOT COMPLETED|Overall Study||2
3032415|NCT01122238|3751552|FG001|NOT COMPLETED|Overall Study||1
3032416|NCT01122238|3751553|FG002|NOT COMPLETED|Overall Study||5
3032417|NCT01122238|3751554|FG003|NOT COMPLETED|Overall Study||0
3032418|NCT01122238|3751555|FG004|NOT COMPLETED|Overall Study||0
3032419|NCT01122238|3751556|FG005|NOT COMPLETED|Overall Study||1
3032420|NCT01122238|3751557|FG006|NOT COMPLETED|Overall Study||1
3032421|NCT01122238|3751558|FG007|NOT COMPLETED|Overall Study||0
3032422|NCT01122238|3751559|FG008|NOT COMPLETED|Overall Study||1
3032423|NCT01122238|3751560|FG009|NOT COMPLETED|Overall Study||1
3032424|NCT01122238|3751561|FG010|NOT COMPLETED|Overall Study||0
3032425|NCT01122238|3751562|FG011|NOT COMPLETED|Overall Study||2
3032426|NCT01122238|3751563|FG012|NOT COMPLETED|Overall Study||2
3032427|NCT01122238|3751564|FG013|NOT COMPLETED|Overall Study||1
3032428|NCT01122238|3751565|FG014|NOT COMPLETED|Overall Study||0
3032429|NCT01122238|3751566|FG015|NOT COMPLETED|Overall Study||0
3032430|NCT01122264|3751583|FG000|STARTED|Overall Study||252
3032431|NCT01122264|3751584|FG001|STARTED|Overall Study||257
3032432|NCT01122264|3751585|FG002|STARTED|Overall Study||261
3032433|NCT01122264|3751583|FG000|Received at Least 1 Dose of Study Drug|Overall Study||250
3032434|NCT01122264|3751584|FG001|Received at Least 1 Dose of Study Drug|Overall Study||257
3032435|NCT01122264|3751585|FG002|Received at Least 1 Dose of Study Drug|Overall Study||260
3032436|NCT01122264|3751583|FG000|COMPLETED|Overall Study||220
3166148|NCT01903434|3893596|FG000|NOT COMPLETED|Treatment Period 1||0
3166149|NCT01903434|3893597|FG001|NOT COMPLETED|Treatment Period 1||0
3166150|NCT01903434|3893596|FG000|STARTED|Washout Period 1 (at Least 14 Days)||30
3032437|NCT01122264|3751584|FG001|COMPLETED|Overall Study||228
3032438|NCT01122264|3751585|FG002|COMPLETED|Overall Study||214
3032439|NCT01122264|3751583|FG000|NOT COMPLETED|Overall Study||32
3032440|NCT01122264|3751584|FG001|NOT COMPLETED|Overall Study||29
3032441|NCT01122264|3751585|FG002|NOT COMPLETED|Overall Study||47
3032442|NCT01122316|3751597|FG000|STARTED|Overall Study||10
3032443|NCT01122316|3751597|FG000|COMPLETED|Overall Study||8
3032444|NCT01122316|3751597|FG000|NOT COMPLETED|Overall Study||2
3032445|NCT01122394|3751603|FG000|STARTED|Overall Study||66
3032446|NCT01122394|3751604|FG001|STARTED|Overall Study||74
3032447|NCT01122394|3751603|FG000|COMPLETED|Overall Study||63
3032448|NCT01122394|3751604|FG001|COMPLETED|Overall Study||70
3032449|NCT01122394|3751603|FG000|NOT COMPLETED|Overall Study||3
3032450|NCT01122394|3751604|FG001|NOT COMPLETED|Overall Study||4
3032451|NCT01122446|3751614|FG000|STARTED|Overall Study||25
3032452|NCT01122446|3751615|FG001|STARTED|Overall Study||25
3032453|NCT01122446|3751614|FG000|COMPLETED|Overall Study||25
3032454|NCT01122446|3751615|FG001|COMPLETED|Overall Study||25
3032455|NCT01122446|3751614|FG000|NOT COMPLETED|Overall Study||0
3032456|NCT01122446|3751615|FG001|NOT COMPLETED|Overall Study||0
3032457|NCT01122576|3751624|FG000|STARTED|Pre-Cataract Surgery||26
3032458|NCT01122576|3751625|FG001|STARTED|Pre-Cataract Surgery||26
3032459|NCT01122576|3751626|FG002|STARTED|Pre-Cataract Surgery||26
3032460|NCT01122576|3751624|FG000|COMPLETED|Pre-Cataract Surgery||26
3032461|NCT01122576|3751625|FG001|COMPLETED|Pre-Cataract Surgery||25
3032462|NCT01122576|3751626|FG002|COMPLETED|Pre-Cataract Surgery||24
3032463|NCT01122576|3751624|FG000|NOT COMPLETED|Pre-Cataract Surgery||0
3032464|NCT01122576|3751625|FG001|NOT COMPLETED|Pre-Cataract Surgery||1
3032465|NCT01122576|3751626|FG002|NOT COMPLETED|Pre-Cataract Surgery||2
3032466|NCT01122576|3751624|FG000|STARTED|Post-Cataract Surgery||26
3032467|NCT01122576|3751625|FG001|STARTED|Post-Cataract Surgery||25
3032468|NCT01122576|3751626|FG002|STARTED|Post-Cataract Surgery||24
3032469|NCT01122576|3751624|FG000|COMPLETED|Post-Cataract Surgery||26
3032470|NCT01122576|3751625|FG001|COMPLETED|Post-Cataract Surgery||25
3032471|NCT01122576|3751626|FG002|COMPLETED|Post-Cataract Surgery||22
3032472|NCT01122576|3751624|FG000|NOT COMPLETED|Post-Cataract Surgery||0
3032473|NCT01122576|3751625|FG001|NOT COMPLETED|Post-Cataract Surgery||0
3032474|NCT01122576|3751626|FG002|NOT COMPLETED|Post-Cataract Surgery||2
3032475|NCT01122680|3751637|FG000|STARTED|Period 1 (4 Weeks)|Entered this study period.|29
3032476|NCT01122680|3751638|FG001|STARTED|Period 1 (4 Weeks)|Entered this study period.|26
3032477|NCT01122680|3751639|FG002|STARTED|Period 1 (4 Weeks)|Entered this study period.|26
3032478|NCT01122680|3751640|FG003|STARTED|Period 1 (4 Weeks)|Entered this study period.|24
3032479|NCT01122680|3751637|FG000|COMPLETED|Period 1 (4 Weeks)|Completed treatment in this crossover period.|26
3032480|NCT01122680|3751638|FG001|COMPLETED|Period 1 (4 Weeks)|Completed treatment in this crossover period.|25
3032481|NCT01122680|3751639|FG002|COMPLETED|Period 1 (4 Weeks)|Completed treatment in this crossover period.|26
3032482|NCT01122680|3751640|FG003|COMPLETED|Period 1 (4 Weeks)|Completed treatment in this crossover period.|24
3032483|NCT01122680|3751637|FG000|NOT COMPLETED|Period 1 (4 Weeks)||3
3032484|NCT01122680|3751638|FG001|NOT COMPLETED|Period 1 (4 Weeks)||1
3032485|NCT01122680|3751639|FG002|NOT COMPLETED|Period 1 (4 Weeks)||0
3032486|NCT01122680|3751640|FG003|NOT COMPLETED|Period 1 (4 Weeks)||0
3032487|NCT01122680|3751637|FG000|STARTED|Period 2 (4 Weeks)|Entered this study period.|26
3032488|NCT01122680|3751638|FG001|STARTED|Period 2 (4 Weeks)|Entered this study period.|25
3032489|NCT01122680|3751639|FG002|STARTED|Period 2 (4 Weeks)|Entered this study period.|26
3032490|NCT01122680|3751640|FG003|STARTED|Period 2 (4 Weeks)|Entered this study period.|24
3032491|NCT01122680|3751637|FG000|COMPLETED|Period 2 (4 Weeks)|Completed treatment in this crossover period.|25
3032492|NCT01122680|3751638|FG001|COMPLETED|Period 2 (4 Weeks)|Completed treatment in this crossover period.|25
3166151|NCT01903434|3893597|FG001|STARTED|Washout Period 1 (at Least 14 Days)||30
3166152|NCT01903434|3893596|FG000|COMPLETED|Washout Period 1 (at Least 14 Days)||29
3166153|NCT01903434|3893597|FG001|COMPLETED|Washout Period 1 (at Least 14 Days)||28
3166154|NCT01903434|3893596|FG000|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||1
3032493|NCT01122680|3751639|FG002|COMPLETED|Period 2 (4 Weeks)|Completed treatment in this crossover period.|26
3032494|NCT01122680|3751640|FG003|COMPLETED|Period 2 (4 Weeks)|Completed treatment in this crossover period.|23
3032495|NCT01122680|3751637|FG000|NOT COMPLETED|Period 2 (4 Weeks)||1
3032496|NCT01122680|3751638|FG001|NOT COMPLETED|Period 2 (4 Weeks)||0
3032497|NCT01122680|3751639|FG002|NOT COMPLETED|Period 2 (4 Weeks)||0
3032498|NCT01122680|3751640|FG003|NOT COMPLETED|Period 2 (4 Weeks)||1
3032499|NCT01122680|3751637|FG000|STARTED|Period 3 (4 Weeks)|Entered this study period.|25
3032500|NCT01122680|3751638|FG001|STARTED|Period 3 (4 Weeks)|Entered this study period.|25
3032501|NCT01122680|3751639|FG002|STARTED|Period 3 (4 Weeks)|Entered this study period.|26
3032502|NCT01122680|3751640|FG003|STARTED|Period 3 (4 Weeks)|Entered this study period.|23
3032503|NCT01122680|3751637|FG000|COMPLETED|Period 3 (4 Weeks)|Completed treatment in this crossover period.|24
3032504|NCT01122680|3751638|FG001|COMPLETED|Period 3 (4 Weeks)|Completed treatment in this crossover period.|24
3032505|NCT01122680|3751639|FG002|COMPLETED|Period 3 (4 Weeks)|Completed treatment in this crossover period.|26
3032506|NCT01122680|3751640|FG003|COMPLETED|Period 3 (4 Weeks)|Completed treatment in this crossover period.|23
3032507|NCT01122680|3751637|FG000|NOT COMPLETED|Period 3 (4 Weeks)||1
3032508|NCT01122680|3751638|FG001|NOT COMPLETED|Period 3 (4 Weeks)||1
3032509|NCT01122680|3751639|FG002|NOT COMPLETED|Period 3 (4 Weeks)||0
3032510|NCT01122680|3751640|FG003|NOT COMPLETED|Period 3 (4 Weeks)||0
3038232|NCT01152788|3757609|FG001|COMPLETED|Overall Study||28
3038233|NCT01152788|3757608|FG000|NOT COMPLETED|Overall Study||0
3038234|NCT01152788|3757609|FG001|NOT COMPLETED|Overall Study||4
3038235|NCT01152814|3757615|FG000|STARTED|Overall Study||64
3038236|NCT01152814|3757615|FG000|COMPLETED|Overall Study||62
3038237|NCT01152814|3757615|FG000|NOT COMPLETED|Overall Study||2
3038238|NCT01152996|3757619|FG000|STARTED|Overall Study||1075
3038239|NCT01152996|3757619|FG000|Treated|Overall Study||1073
3038240|NCT01152996|3757619|FG000|COMPLETED|Overall Study||538
3038241|NCT01152996|3757619|FG000|NOT COMPLETED|Overall Study||537
3038242|NCT01153009|3757627|FG000|STARTED|Overall Study||161
3038243|NCT01153009|3757628|FG001|STARTED|Overall Study||147
3038244|NCT01153009|3757629|FG002|STARTED|Overall Study||154
3038245|NCT01153009|3757630|FG003|STARTED|Overall Study||152
3038246|NCT01153009|3757627|FG000|Treated|Overall Study||159
3038247|NCT01153009|3757628|FG001|Treated|Overall Study||147
3038248|NCT01153009|3757629|FG002|Treated|Overall Study||154
3038249|NCT01153009|3757630|FG003|Treated|Overall Study||150
3038250|NCT01153009|3757627|FG000|COMPLETED|Overall Study||129
3038251|NCT01153009|3757628|FG001|COMPLETED|Overall Study||113
3038252|NCT01153009|3757629|FG002|COMPLETED|Overall Study||113
3038253|NCT01153009|3757630|FG003|COMPLETED|Overall Study||115
3038254|NCT01153009|3757627|FG000|NOT COMPLETED|Overall Study||32
3038255|NCT01153009|3757628|FG001|NOT COMPLETED|Overall Study||34
3038256|NCT01153009|3757629|FG002|NOT COMPLETED|Overall Study||41
3038257|NCT01153009|3757630|FG003|NOT COMPLETED|Overall Study||37
3038258|NCT01153269|3757640|FG000|STARTED|Overall Study||33
3038259|NCT01153269|3757640|FG000|Participants Analyzed|Overall Study||33
3038260|NCT01153269|3757640|FG000|COMPLETED|Overall Study||31
3038261|NCT01153269|3757640|FG000|NOT COMPLETED|Overall Study||2
3038262|NCT01153321|3757649|FG000|STARTED|Overall Study||22
3038263|NCT01153321|3757650|FG001|STARTED|Overall Study||22
3166155|NCT01903434|3893597|FG001|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||2
3166156|NCT01903434|3893596|FG000|STARTED|Treatment Period 2||29
3166157|NCT01903434|3893597|FG001|STARTED|Treatment Period 2||28
3166158|NCT01903434|3893596|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 2||29
3038264|NCT01153321|3757649|FG000|COMPLETED|Overall Study||21
3038265|NCT01153321|3757650|FG001|COMPLETED|Overall Study||19
3038266|NCT01153321|3757649|FG000|NOT COMPLETED|Overall Study||1
3038267|NCT01153321|3757650|FG001|NOT COMPLETED|Overall Study||3
3038268|NCT01153347|3757660|FG000|STARTED|Overall Study||160
3038269|NCT01153347|3757661|FG001|STARTED|Overall Study||160
3038270|NCT01153347|3757662|FG002|STARTED|Overall Study||160
3038271|NCT01153347|3757663|FG003|STARTED|Overall Study||161
3038272|NCT01153347|3757660|FG000|Received Treatment|Overall Study||160
3038273|NCT01153347|3757661|FG001|Received Treatment|Overall Study||158
3038274|NCT01153347|3757662|FG002|Received Treatment|Overall Study||158
3038275|NCT01153347|3757663|FG003|Received Treatment|Overall Study||160
3038276|NCT01153347|3757660|FG000|COMPLETED|Overall Study||127
3038277|NCT01153347|3757661|FG001|COMPLETED|Overall Study||116
3038278|NCT01153347|3757662|FG002|COMPLETED|Overall Study||110
3038279|NCT01153347|3757663|FG003|COMPLETED|Overall Study||129
3038280|NCT01153347|3757660|FG000|NOT COMPLETED|Overall Study||33
3038281|NCT01153347|3757661|FG001|NOT COMPLETED|Overall Study||44
3038282|NCT01153347|3757662|FG002|NOT COMPLETED|Overall Study||50
3038283|NCT01153347|3757663|FG003|NOT COMPLETED|Overall Study||32
3038284|NCT01153425|3757675|FG000|STARTED|Overall Study||16
3038285|NCT01153425|3757676|FG001|STARTED|Overall Study||17
3038286|NCT01153425|3757675|FG000|COMPLETED|Overall Study||13
3038287|NCT01153425|3757676|FG001|COMPLETED|Overall Study||14
3038288|NCT01153425|3757675|FG000|NOT COMPLETED|Overall Study||3
3038289|NCT01153425|3757676|FG001|NOT COMPLETED|Overall Study||3
3038290|NCT01153503|3757686|FG000|STARTED|Overall Study||25
3038291|NCT01153503|3757687|FG001|STARTED|Overall Study||25
3038292|NCT01153503|3757688|FG002|STARTED|Overall Study||25
3038293|NCT01153503|3757686|FG000|COMPLETED|Overall Study||25
3038294|NCT01153503|3757687|FG001|COMPLETED|Overall Study||24
3038295|NCT01153503|3757688|FG002|COMPLETED|Overall Study||25
3038296|NCT01153503|3757686|FG000|NOT COMPLETED|Overall Study||0
3032511|NCT01122849|3751653|FG000|STARTED|Overall Study||20
3032512|NCT01122849|3751654|FG001|STARTED|Overall Study||21
3032513|NCT01122849|3751655|FG002|STARTED|Overall Study||20
3032514|NCT01122849|3751653|FG000|COMPLETED|Overall Study||20
3032515|NCT01122849|3751654|FG001|COMPLETED|Overall Study||21
3032516|NCT01122849|3751655|FG002|COMPLETED|Overall Study||20
3032517|NCT01122849|3751653|FG000|NOT COMPLETED|Overall Study||0
3032518|NCT01122849|3751654|FG001|NOT COMPLETED|Overall Study||0
3032519|NCT01122849|3751655|FG002|NOT COMPLETED|Overall Study||0
3032520|NCT01122862|3751673|FG000|STARTED|Period 1||8
3032521|NCT01122862|3751674|FG001|STARTED|Period 1||8
3032522|NCT01122862|3751675|FG002|STARTED|Period 1||7
3032523|NCT01122862|3751673|FG000|COMPLETED|Period 1||8
3032524|NCT01122862|3751674|FG001|COMPLETED|Period 1||7
3032525|NCT01122862|3751675|FG002|COMPLETED|Period 1||7
3166159|NCT01903434|3893597|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 2||28
3166160|NCT01903434|3893596|FG000|COMPLETED|Treatment Period 2||29
3166161|NCT01903434|3893597|FG001|COMPLETED|Treatment Period 2||28
3166162|NCT01903434|3893596|FG000|NOT COMPLETED|Treatment Period 2||0
3166163|NCT01903434|3893597|FG001|NOT COMPLETED|Treatment Period 2||0
3166164|NCT01903434|3893596|FG000|STARTED|Washout Period 1 (at Least 14 Days)||29
3166165|NCT01903434|3893597|FG001|STARTED|Washout Period 1 (at Least 14 Days)||28
3166166|NCT01903434|3893596|FG000|COMPLETED|Washout Period 1 (at Least 14 Days)||29
3166167|NCT01903434|3893597|FG001|COMPLETED|Washout Period 1 (at Least 14 Days)||28
3166168|NCT01903434|3893596|FG000|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0
3166169|NCT01903434|3893597|FG001|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0
3166170|NCT01903434|3893596|FG000|STARTED|Treatment Period 3||29
3166171|NCT01903434|3893597|FG001|STARTED|Treatment Period 3||28
3166172|NCT01903434|3893596|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 3||29
3166173|NCT01903434|3893597|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 3||28
3166174|NCT01903434|3893596|FG000|COMPLETED|Treatment Period 3||29
3032526|NCT01122862|3751673|FG000|NOT COMPLETED|Period 1||0
3032527|NCT01122862|3751674|FG001|NOT COMPLETED|Period 1||1
3032528|NCT01122862|3751675|FG002|NOT COMPLETED|Period 1||0
3032529|NCT01122862|3751673|FG000|STARTED|Period 2|Due to crossover design,a different set of participants received this treatment compared to Period 1|8
3032530|NCT01122862|3751674|FG001|STARTED|Period 2|Due to crossover design,a different set of participants received this treatment compared to Period 1|7
3032531|NCT01122862|3751675|FG002|STARTED|Period 2|Due to crossover design,a different set of participants received this treatment compared to Period 1|7
3032532|NCT01122862|3751673|FG000|COMPLETED|Period 2||8
3032533|NCT01122862|3751674|FG001|COMPLETED|Period 2||7
3032534|NCT01122862|3751675|FG002|COMPLETED|Period 2||6
3032535|NCT01122862|3751673|FG000|NOT COMPLETED|Period 2||0
3032536|NCT01122862|3751674|FG001|NOT COMPLETED|Period 2||0
3032537|NCT01122862|3751675|FG002|NOT COMPLETED|Period 2||1
3032538|NCT01122862|3751673|FG000|STARTED|Period 3|Due to crossover design,a different set of participants received this treatment compared to Period 2|6
3032539|NCT01122862|3751674|FG001|STARTED|Period 3|Due to crossover design,a different set of participants received this treatment compared to Period 2|7
3032540|NCT01122862|3751675|FG002|STARTED|Period 3|Due to crossover design,a different set of participants received this treatment compared to Period 2|8
3032541|NCT01122862|3751673|FG000|COMPLETED|Period 3||6
3032542|NCT01122862|3751674|FG001|COMPLETED|Period 3||7
3032543|NCT01122862|3751675|FG002|COMPLETED|Period 3||8
3032544|NCT01122862|3751673|FG000|NOT COMPLETED|Period 3||0
3032545|NCT01122862|3751674|FG001|NOT COMPLETED|Period 3||0
3032546|NCT01122862|3751675|FG002|NOT COMPLETED|Period 3||0
3032547|NCT01122901|3751686|FG000|STARTED|Overall Study||40
3032548|NCT01122901|3751687|FG001|STARTED|Overall Study||7
3032549|NCT01122901|3751686|FG000|COMPLETED|Overall Study||40
3032550|NCT01122901|3751687|FG001|COMPLETED|Overall Study||7
3032551|NCT01122901|3751686|FG000|NOT COMPLETED|Overall Study||0
3032552|NCT01122901|3751687|FG001|NOT COMPLETED|Overall Study||0
3032553|NCT01122927|3751698|FG000|STARTED|Period 1 - Conversion Phase||297
3032554|NCT01122927|3751699|FG001|STARTED|Period 1 - Conversion Phase||0
3032555|NCT01122927|3751698|FG000|COMPLETED|Period 1 - Conversion Phase||283
3032556|NCT01122927|3751699|FG001|COMPLETED|Period 1 - Conversion Phase||0
3032557|NCT01122927|3751698|FG000|NOT COMPLETED|Period 1 - Conversion Phase||14
3032558|NCT01122927|3751699|FG001|NOT COMPLETED|Period 1 - Conversion Phase||0
3032559|NCT01122927|3751698|FG000|STARTED|Period 2- Open-label Treatment Phase||0
3032560|NCT01122927|3751699|FG001|STARTED|Period 2- Open-label Treatment Phase|362 were de novo participants and 148 had rolled over from study NCT01149655.|510
3032561|NCT01122927|3751698|FG000|COMPLETED|Period 2- Open-label Treatment Phase||0
3032562|NCT01122927|3751699|FG001|COMPLETED|Period 2- Open-label Treatment Phase|De novo participants who completed Month 24 visit or rolled over from study NCT01149655.|198
3032563|NCT01122927|3751698|FG000|NOT COMPLETED|Period 2- Open-label Treatment Phase||0
3032564|NCT01122927|3751699|FG001|NOT COMPLETED|Period 2- Open-label Treatment Phase||312
3032565|NCT01123070|3751713|FG000|STARTED|Part A Cohort 1 Open Label Period||3
3032566|NCT01123070|3751714|FG001|STARTED|Part A Cohort 1 Open Label Period||0
3032567|NCT01123070|3751715|FG002|STARTED|Part A Cohort 1 Open Label Period||0
3032568|NCT01123070|3751716|FG003|STARTED|Part A Cohort 1 Open Label Period||0
3032569|NCT01123070|3751713|FG000|COMPLETED|Part A Cohort 1 Open Label Period||3
3032570|NCT01123070|3751714|FG001|COMPLETED|Part A Cohort 1 Open Label Period||0
3032571|NCT01123070|3751715|FG002|COMPLETED|Part A Cohort 1 Open Label Period||0
3032572|NCT01123070|3751716|FG003|COMPLETED|Part A Cohort 1 Open Label Period||0
3032573|NCT01123070|3751713|FG000|NOT COMPLETED|Part A Cohort 1 Open Label Period||0
3032574|NCT01123070|3751714|FG001|NOT COMPLETED|Part A Cohort 1 Open Label Period||0
3032575|NCT01123070|3751715|FG002|NOT COMPLETED|Part A Cohort 1 Open Label Period||0
3032576|NCT01123070|3751716|FG003|NOT COMPLETED|Part A Cohort 1 Open Label Period||0
3032577|NCT01123070|3751713|FG000|STARTED|Part A Cohort 2 Open Label Period||0
3032578|NCT01123070|3751714|FG001|STARTED|Part A Cohort 2 Open Label Period||3
3032579|NCT01123070|3751715|FG002|STARTED|Part A Cohort 2 Open Label Period||0
3032580|NCT01123070|3751716|FG003|STARTED|Part A Cohort 2 Open Label Period||0
3032581|NCT01123070|3751713|FG000|COMPLETED|Part A Cohort 2 Open Label Period||0
3032582|NCT01123070|3751714|FG001|COMPLETED|Part A Cohort 2 Open Label Period||3
3032583|NCT01123070|3751715|FG002|COMPLETED|Part A Cohort 2 Open Label Period||0
3032584|NCT01123070|3751716|FG003|COMPLETED|Part A Cohort 2 Open Label Period||0
3032585|NCT01123070|3751713|FG000|NOT COMPLETED|Part A Cohort 2 Open Label Period||0
3032586|NCT01123070|3751714|FG001|NOT COMPLETED|Part A Cohort 2 Open Label Period||0
3032587|NCT01123070|3751715|FG002|NOT COMPLETED|Part A Cohort 2 Open Label Period||0
3032588|NCT01123070|3751716|FG003|NOT COMPLETED|Part A Cohort 2 Open Label Period||0
3032589|NCT01123070|3751713|FG000|STARTED|Part B Double Blind Period||0
3032590|NCT01123070|3751714|FG001|STARTED|Part B Double Blind Period||0
3032591|NCT01123070|3751715|FG002|STARTED|Part B Double Blind Period||25
3032592|NCT01123070|3751716|FG003|STARTED|Part B Double Blind Period||23
3032593|NCT01123070|3751713|FG000|COMPLETED|Part B Double Blind Period||0
3032594|NCT01123070|3751714|FG001|COMPLETED|Part B Double Blind Period||0
3032595|NCT01123070|3751715|FG002|COMPLETED|Part B Double Blind Period||21
3032596|NCT01123070|3751716|FG003|COMPLETED|Part B Double Blind Period||20
3032597|NCT01123070|3751713|FG000|NOT COMPLETED|Part B Double Blind Period||0
3032598|NCT01123070|3751714|FG001|NOT COMPLETED|Part B Double Blind Period||0
3032599|NCT01123070|3751715|FG002|NOT COMPLETED|Part B Double Blind Period||4
3032600|NCT01123070|3751716|FG003|NOT COMPLETED|Part B Double Blind Period||3
3032601|NCT01123083|3751729|FG000|STARTED|Overall Study||61
3032602|NCT01123083|3751730|FG001|STARTED|Overall Study||118
3032603|NCT01123083|3751729|FG000|COMPLETED|Overall Study||50
3032604|NCT01123083|3751730|FG001|COMPLETED|Overall Study||103
3032605|NCT01123083|3751729|FG000|NOT COMPLETED|Overall Study||11
3032606|NCT01123083|3751730|FG001|NOT COMPLETED|Overall Study||15
3032607|NCT01123148|3751736|FG000|STARTED|Overall Study||14
3032608|NCT01123148|3751736|FG000|BCI Calibration >50% Accuracy|Overall Study||13
3032609|NCT01123148|3751736|FG000|COMPLETED|Overall Study||12
3032610|NCT01123148|3751736|FG000|NOT COMPLETED|Overall Study||2
3032611|NCT01123161|3751742|FG000|STARTED|Overall Study||57
3032612|NCT01123161|3751743|FG001|STARTED|Overall Study||63
3032613|NCT01123161|3751742|FG000|COMPLETED|Overall Study||55
3032614|NCT01123161|3751743|FG001|COMPLETED|Overall Study||63
3032615|NCT01123161|3751742|FG000|NOT COMPLETED|Overall Study||2
3032616|NCT01123161|3751743|FG001|NOT COMPLETED|Overall Study||0
3032617|NCT01123200|3751752|FG000|STARTED|Overall Study||1
3032618|NCT01123200|3751752|FG000|COMPLETED|Overall Study||0
3032619|NCT01123200|3751752|FG000|NOT COMPLETED|Overall Study||1
3032620|NCT01123356|3751756|FG000|STARTED|Overall Study||21
3032621|NCT01123356|3751756|FG000|COMPLETED|Overall Study||14
3032622|NCT01123356|3751756|FG000|NOT COMPLETED|Overall Study||7
3032623|NCT01123382|3751763|FG000|STARTED|Overall Study||13
3032624|NCT01123382|3751764|FG001|STARTED|Overall Study||12
3032625|NCT01123382|3751763|FG000|Received Intervention|Overall Study||12
3032626|NCT01123382|3751764|FG001|Received Intervention|Overall Study||10
3032627|NCT01123382|3751763|FG000|COMPLETED|Overall Study||11
3032628|NCT01123382|3751764|FG001|COMPLETED|Overall Study||6
3032629|NCT01123382|3751763|FG000|NOT COMPLETED|Overall Study||2
3032630|NCT01123382|3751764|FG001|NOT COMPLETED|Overall Study||6
3032631|NCT01123395|3751770|FG000|STARTED|Period 1||8
3032632|NCT01123395|3751771|FG001|STARTED|Period 1||8
3032633|NCT01123395|3751770|FG000|COMPLETED|Period 1||8
3032634|NCT01123395|3751771|FG001|COMPLETED|Period 1||8
3032635|NCT01123395|3751770|FG000|NOT COMPLETED|Period 1||0
3032636|NCT01123395|3751771|FG001|NOT COMPLETED|Period 1||0
3032637|NCT01123395|3751770|FG000|STARTED|Washout Period of 14 Days||8
3032638|NCT01123395|3751771|FG001|STARTED|Washout Period of 14 Days||8
3032639|NCT01123395|3751770|FG000|COMPLETED|Washout Period of 14 Days||8
3032640|NCT01123395|3751771|FG001|COMPLETED|Washout Period of 14 Days||7
3032641|NCT01123395|3751770|FG000|NOT COMPLETED|Washout Period of 14 Days||0
3032642|NCT01123395|3751771|FG001|NOT COMPLETED|Washout Period of 14 Days||1
3032643|NCT01123395|3751770|FG000|STARTED|Period 2||8
3032644|NCT01123395|3751771|FG001|STARTED|Period 2||7
3032645|NCT01123395|3751770|FG000|COMPLETED|Period 2||8
3032646|NCT01123395|3751771|FG001|COMPLETED|Period 2||7
3032647|NCT01123395|3751770|FG000|NOT COMPLETED|Period 2||0
3032648|NCT01123395|3751771|FG001|NOT COMPLETED|Period 2||0
3032649|NCT01123512|3751779|FG000|STARTED|Overall Study||153
3032650|NCT01123512|3751780|FG001|STARTED|Overall Study||147
3032651|NCT01123512|3751779|FG000|COMPLETED|Overall Study||127
3032652|NCT01123512|3751780|FG001|COMPLETED|Overall Study||126
3032653|NCT01123512|3751779|FG000|NOT COMPLETED|Overall Study||26
3032654|NCT01123512|3751780|FG001|NOT COMPLETED|Overall Study||21
3032655|NCT01123642|3751786|FG000|STARTED|Overall Study||345
3032656|NCT01123642|3751786|FG000|COMPLETED|Overall Study||277
3032657|NCT01123642|3751786|FG000|NOT COMPLETED|Overall Study||68
3032658|NCT01123655|3751793|FG000|STARTED|Overall Study||10
3032659|NCT01123655|3751794|FG001|STARTED|Overall Study||4
3032660|NCT01123655|3751795|FG002|STARTED|Overall Study||8
3032661|NCT01123655|3751793|FG000|COMPLETED|Overall Study||9
3032662|NCT01123655|3751794|FG001|COMPLETED|Overall Study||3
3032663|NCT01123655|3751795|FG002|COMPLETED|Overall Study||7
3032664|NCT01123655|3751793|FG000|NOT COMPLETED|Overall Study||1
3032665|NCT01123655|3751794|FG001|NOT COMPLETED|Overall Study||1
3032666|NCT01123655|3751795|FG002|NOT COMPLETED|Overall Study||1
3032667|NCT01123889|3751803|FG000|STARTED|Overall Study||5
3032668|NCT01123889|3751804|FG001|STARTED|Overall Study||7
3032669|NCT01123889|3751803|FG000|COMPLETED|Overall Study||2
3032670|NCT01123889|3751804|FG001|COMPLETED|Overall Study||6
3032671|NCT01123889|3751803|FG000|NOT COMPLETED|Overall Study||3
3032672|NCT01123889|3751804|FG001|NOT COMPLETED|Overall Study||1
3032673|NCT01123928|3751812|FG000|STARTED|Overall Study||212
3032674|NCT01123928|3751813|FG001|STARTED|Overall Study||222
3032675|NCT01123928|3751812|FG000|COMPLETED|Overall Study||212
3032676|NCT01123928|3751813|FG001|COMPLETED|Overall Study||222
3032677|NCT01123928|3751812|FG000|NOT COMPLETED|Overall Study||0
3032678|NCT01123928|3751813|FG001|NOT COMPLETED|Overall Study||0
3032679|NCT01123941|3751821|FG000|STARTED|Overall Study||25
3032680|NCT01123941|3751822|FG001|STARTED|Overall Study||25
3032681|NCT01123941|3751821|FG000|COMPLETED|Overall Study||23
3032682|NCT01123941|3751822|FG001|COMPLETED|Overall Study||24
3032683|NCT01123941|3751821|FG000|NOT COMPLETED|Overall Study||2
3310086|NCT03037307|4043449|FG005|NOT COMPLETED|Wash Out Period 1||0
3310087|NCT03037307|4043444|FG000|STARTED|Period 2||7
3310088|NCT03037307|4043445|FG001|STARTED|Period 2||7
3310089|NCT03037307|4043446|FG002|STARTED|Period 2||8
3310090|NCT03037307|4043447|FG003|STARTED|Period 2||6
3310091|NCT03037307|4043448|FG004|STARTED|Period 2||7
3310092|NCT03037307|4043449|FG005|STARTED|Period 2||8
3310093|NCT03037307|4043444|FG000|COMPLETED|Period 2||7
3310094|NCT03037307|4043445|FG001|COMPLETED|Period 2||7
3310095|NCT03037307|4043446|FG002|COMPLETED|Period 2||8
3383799|NCT01915498|4118882|FG009|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
3383800|NCT01915498|4118883|FG010|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
3032684|NCT01123941|3751822|FG001|NOT COMPLETED|Overall Study||1
3032685|NCT01123980|3751830|FG000|STARTED|Overall Study||261
3032686|NCT01123980|3751831|FG001|STARTED|Overall Study||260
3032687|NCT01123980|3751830|FG000|COMPLETED|Overall Study||242
3032688|NCT01123980|3751831|FG001|COMPLETED|Overall Study||236
3032689|NCT01123980|3751830|FG000|NOT COMPLETED|Overall Study||19
3032690|NCT01123980|3751831|FG001|NOT COMPLETED|Overall Study||24
3032691|NCT01124006|3751840|FG000|STARTED|Overall Study||10
3032692|NCT01124006|3751841|FG001|STARTED|Overall Study||10
3032693|NCT01124006|3751842|FG002|STARTED|Overall Study||4
3032694|NCT01124006|3751840|FG000|COMPLETED|Overall Study||7
3032695|NCT01124006|3751841|FG001|COMPLETED|Overall Study||8
3032696|NCT01124006|3751842|FG002|COMPLETED|Overall Study||2
3032697|NCT01124006|3751840|FG000|NOT COMPLETED|Overall Study||3
3032698|NCT01124006|3751841|FG001|NOT COMPLETED|Overall Study||2
3032699|NCT01124006|3751842|FG002|NOT COMPLETED|Overall Study||2
3032700|NCT01124045|3751852|FG000|STARTED|Overall Study||39
3032701|NCT01124045|3751853|FG001|STARTED|Overall Study||40
3032702|NCT01124045|3751852|FG000|COMPLETED|Overall Study||39
3032703|NCT01124045|3751853|FG001|COMPLETED|Overall Study||37
3032704|NCT01124045|3751852|FG000|NOT COMPLETED|Overall Study||0
3032705|NCT01124045|3751853|FG001|NOT COMPLETED|Overall Study||3
3032706|NCT01124097|3751863|FG000|STARTED|Overall Study||60
3032707|NCT01124097|3751864|FG001|STARTED|Overall Study||60
3032708|NCT01124097|3751865|FG002|STARTED|Overall Study||60
3032709|NCT01124097|3751866|FG003|STARTED|Overall Study||60
3032710|NCT01124097|3751863|FG000|Safety Population|Overall Study||60
3032711|NCT01124097|3751864|FG001|Safety Population|Overall Study||60
3032712|NCT01124097|3751865|FG002|Safety Population|Overall Study||60
3166175|NCT01903434|3893597|FG001|COMPLETED|Treatment Period 3||28
3166176|NCT01903434|3893596|FG000|NOT COMPLETED|Treatment Period 3||0
3166177|NCT01903434|3893597|FG001|NOT COMPLETED|Treatment Period 3||0
3166178|NCT01903460|3893607|FG000|STARTED|Overall Study||6
3166179|NCT01903460|3893608|FG001|STARTED|Overall Study||8
3166180|NCT01903460|3893609|FG002|STARTED|Overall Study||3
3383801|NCT01915498|4118884|FG011|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
3383802|NCT01915498|4118885|FG012|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
3383803|NCT01915498|4118886|FG013|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
3383804|NCT01915498|4118887|FG014|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
3383805|NCT01915498|4118888|FG015|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
3383806|NCT01915498|4118889|FG016|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
3383807|NCT01915498|4118890|FG017|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
3383808|NCT01915498|4118891|FG018|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||14
3032713|NCT01124097|3751866|FG003|Safety Population|Overall Study||60
3032714|NCT01124097|3751863|FG000|Efficacy Population|Overall Study||52
3032715|NCT01124097|3751864|FG001|Efficacy Population|Overall Study||53
3032716|NCT01124097|3751865|FG002|Efficacy Population|Overall Study||53
3032717|NCT01124097|3751866|FG003|Efficacy Population|Overall Study||51
3032718|NCT01124097|3751863|FG000|COMPLETED|Overall Study||26
3032719|NCT01124097|3751864|FG001|COMPLETED|Overall Study||38
3032720|NCT01124097|3751865|FG002|COMPLETED|Overall Study||40
3032721|NCT01124097|3751866|FG003|COMPLETED|Overall Study||46
3310096|NCT03037307|4043447|FG003|COMPLETED|Period 2||6
3310097|NCT03037307|4043448|FG004|COMPLETED|Period 2||7
3310098|NCT03037307|4043449|FG005|COMPLETED|Period 2||8
3032722|NCT01124097|3751863|FG000|NOT COMPLETED|Overall Study||34
3032723|NCT01124097|3751864|FG001|NOT COMPLETED|Overall Study||22
3032724|NCT01124097|3751865|FG002|NOT COMPLETED|Overall Study||20
3032725|NCT01124097|3751866|FG003|NOT COMPLETED|Overall Study||14
3032726|NCT01124149|3751876|FG000|STARTED|Acute Phase||722
3032727|NCT01124149|3751876|FG000|COMPLETED|Acute Phase||639
3032728|NCT01124149|3751876|FG000|NOT COMPLETED|Acute Phase||83
3032729|NCT01124149|3751876|FG000|STARTED|Maintenance Phase||469
3032730|NCT01124149|3751876|FG000|COMPLETED|Maintenance Phase||373
3032731|NCT01124149|3751876|FG000|NOT COMPLETED|Maintenance Phase||96
3032732|NCT01124162|3751885|FG000|STARTED|First Intervention||40
3032733|NCT01124162|3751886|FG001|STARTED|First Intervention||40
3032734|NCT01124162|3751885|FG000|COMPLETED|First Intervention||38
3032735|NCT01124162|3751886|FG001|COMPLETED|First Intervention||40
3032736|NCT01124162|3751885|FG000|NOT COMPLETED|First Intervention||2
3032737|NCT01124162|3751886|FG001|NOT COMPLETED|First Intervention||0
3032738|NCT01124162|3751885|FG000|STARTED|Washout of 7 Days||38
3032739|NCT01124162|3751886|FG001|STARTED|Washout of 7 Days||40
3032740|NCT01124162|3751885|FG000|COMPLETED|Washout of 7 Days||37
3032741|NCT01124162|3751886|FG001|COMPLETED|Washout of 7 Days||40
3032742|NCT01124162|3751885|FG000|NOT COMPLETED|Washout of 7 Days||1
3032743|NCT01124162|3751886|FG001|NOT COMPLETED|Washout of 7 Days||0
3032744|NCT01124162|3751885|FG000|STARTED|Second Intervention||37
3032745|NCT01124162|3751886|FG001|STARTED|Second Intervention||40
3032746|NCT01124162|3751885|FG000|COMPLETED|Second Intervention||37
3032747|NCT01124162|3751886|FG001|COMPLETED|Second Intervention||40
3032748|NCT01124162|3751885|FG000|NOT COMPLETED|Second Intervention||0
3032749|NCT01124162|3751886|FG001|NOT COMPLETED|Second Intervention||0
3032750|NCT01124175|3751894|FG000|STARTED|First Intervention||40
3032751|NCT01124175|3751895|FG001|STARTED|First Intervention||40
3032752|NCT01124175|3751894|FG000|COMPLETED|First Intervention||40
3032753|NCT01124175|3751895|FG001|COMPLETED|First Intervention||40
3032754|NCT01124175|3751894|FG000|NOT COMPLETED|First Intervention||0
3032755|NCT01124175|3751895|FG001|NOT COMPLETED|First Intervention||0
3032756|NCT01124175|3751894|FG000|STARTED|Washout of 7 Days||40
3032757|NCT01124175|3751895|FG001|STARTED|Washout of 7 Days||40
3032758|NCT01124175|3751894|FG000|COMPLETED|Washout of 7 Days||40
3032759|NCT01124175|3751895|FG001|COMPLETED|Washout of 7 Days||38
3032760|NCT01124175|3751894|FG000|NOT COMPLETED|Washout of 7 Days||0
3032761|NCT01124175|3751895|FG001|NOT COMPLETED|Washout of 7 Days||2
3032762|NCT01124175|3751894|FG000|STARTED|Second Intervention||40
3166181|NCT01903460|3893610|FG003|STARTED|Overall Study||3
3166182|NCT01903460|3893607|FG000|COMPLETED|Overall Study||6
3032763|NCT01124175|3751895|FG001|STARTED|Second Intervention||38
3032764|NCT01124175|3751894|FG000|COMPLETED|Second Intervention||40
3032765|NCT01124175|3751895|FG001|COMPLETED|Second Intervention||38
3032766|NCT01124175|3751894|FG000|NOT COMPLETED|Second Intervention||0
3032767|NCT01124175|3751895|FG001|NOT COMPLETED|Second Intervention||0
3032768|NCT01124188|3751903|FG000|STARTED|Overall Study||68
3032769|NCT01124188|3751904|FG001|STARTED|Overall Study||71
3032770|NCT01124188|3751903|FG000|COMPLETED|Overall Study||60
3032771|NCT01124188|3751904|FG001|COMPLETED|Overall Study||65
3032772|NCT01124188|3751903|FG000|NOT COMPLETED|Overall Study||8
3032773|NCT01124188|3751904|FG001|NOT COMPLETED|Overall Study||6
3032774|NCT01124292|3751913|FG000|STARTED|Overall Study||16
3032775|NCT01124292|3751914|FG001|STARTED|Overall Study||24
3032776|NCT01124292|3751915|FG002|STARTED|Overall Study||21
3032777|NCT01124292|3751913|FG000|COMPLETED|Overall Study||14
3032778|NCT01124292|3751914|FG001|COMPLETED|Overall Study||9
3032779|NCT01124292|3751915|FG002|COMPLETED|Overall Study||11
3032780|NCT01124292|3751913|FG000|NOT COMPLETED|Overall Study||2
3032781|NCT01124292|3751914|FG001|NOT COMPLETED|Overall Study||15
3032782|NCT01124292|3751915|FG002|NOT COMPLETED|Overall Study||10
3032783|NCT01124305|3751928|FG000|STARTED|Overall Study||34
3032784|NCT01124305|3751929|FG001|STARTED|Overall Study||36
3032785|NCT01124305|3751928|FG000|COMPLETED|Overall Study||26
3032786|NCT01124305|3751929|FG001|COMPLETED|Overall Study||26
3032787|NCT01124305|3751928|FG000|NOT COMPLETED|Overall Study||8
3032788|NCT01124305|3751929|FG001|NOT COMPLETED|Overall Study||10
3032789|NCT01124370|3751935|FG000|STARTED|Overall Study|Underwent implant attempt|57
3032790|NCT01124370|3751935|FG000|Successfully Implanted|Overall Study||50
3032791|NCT01124370|3751935|FG000|Therapy Initiated|Overall Study||48
3032792|NCT01124370|3751935|FG000|3 Month Visit|Overall Study|Defines evaluable population|47
3032793|NCT01124370|3751935|FG000|COMPLETED|Overall Study|Completed 2 year post-implant follow-up|37
3032794|NCT01124370|3751935|FG000|NOT COMPLETED|Overall Study||20
3032795|NCT01124422|3751941|FG000|STARTED|4-Week Open-label Run-in Phase||338
3032796|NCT01124422|3751942|FG001|STARTED|4-Week Open-label Run-in Phase||0
3032797|NCT01124422|3751943|FG002|STARTED|4-Week Open-label Run-in Phase||0
3166183|NCT01903460|3893608|FG001|COMPLETED|Overall Study||8
3032798|NCT01124422|3751941|FG000|COMPLETED|4-Week Open-label Run-in Phase||255
3032799|NCT01124422|3751942|FG001|COMPLETED|4-Week Open-label Run-in Phase||0
3032800|NCT01124422|3751943|FG002|COMPLETED|4-Week Open-label Run-in Phase||0
3032801|NCT01124422|3751941|FG000|NOT COMPLETED|4-Week Open-label Run-in Phase||83
3032802|NCT01124422|3751942|FG001|NOT COMPLETED|4-Week Open-label Run-in Phase||0
3032803|NCT01124422|3751943|FG002|NOT COMPLETED|4-Week Open-label Run-in Phase||0
3032804|NCT01124422|3751941|FG000|STARTED|4-Week Double-blind Treatment Phase||0
3032805|NCT01124422|3751942|FG001|STARTED|4-Week Double-blind Treatment Phase||131
3166184|NCT01903460|3893609|FG002|COMPLETED|Overall Study||3
3032806|NCT01124422|3751943|FG002|STARTED|4-Week Double-blind Treatment Phase||124
3032807|NCT01124422|3751941|FG000|COMPLETED|4-Week Double-blind Treatment Phase||0
3032808|NCT01124422|3751942|FG001|COMPLETED|4-Week Double-blind Treatment Phase||120
3032809|NCT01124422|3751943|FG002|COMPLETED|4-Week Double-blind Treatment Phase||115
3032810|NCT01124422|3751941|FG000|NOT COMPLETED|4-Week Double-blind Treatment Phase||0
3032811|NCT01124422|3751942|FG001|NOT COMPLETED|4-Week Double-blind Treatment Phase||11
3032812|NCT01124422|3751943|FG002|NOT COMPLETED|4-Week Double-blind Treatment Phase||9
3032813|NCT01124448|3751952|FG000|STARTED|Overall Study||25
3032814|NCT01124448|3751953|FG001|STARTED|Overall Study||15
3032815|NCT01124448|3751952|FG000|COMPLETED|Overall Study||23
3032816|NCT01124448|3751953|FG001|COMPLETED|Overall Study||12
3032817|NCT01124448|3751952|FG000|NOT COMPLETED|Overall Study||2
3032818|NCT01124448|3751953|FG001|NOT COMPLETED|Overall Study||3
3032819|NCT01124604|3751961|FG000|STARTED|Overall Study||60
3032820|NCT01124604|3751962|FG001|STARTED|Overall Study||31
3032821|NCT01124604|3751961|FG000|COMPLETED|Overall Study||45
3032822|NCT01124604|3751962|FG001|COMPLETED|Overall Study||29
3032823|NCT01124604|3751961|FG000|NOT COMPLETED|Overall Study||15
3032824|NCT01124604|3751962|FG001|NOT COMPLETED|Overall Study||2
3032825|NCT01124617|3751970|FG000|STARTED|Overall Study||60
3032826|NCT01124617|3751971|FG001|STARTED|Overall Study||31
3032827|NCT01124617|3751970|FG000|COMPLETED|Overall Study||41
3032828|NCT01124617|3751971|FG001|COMPLETED|Overall Study||25
3032829|NCT01124617|3751970|FG000|NOT COMPLETED|Overall Study||19
3032830|NCT01124617|3751971|FG001|NOT COMPLETED|Overall Study||6
3032831|NCT01124643|3751977|FG000|STARTED|Overall Study||35
3032832|NCT01124643|3751977|FG000|COMPLETED|Overall Study||34
3032833|NCT01124643|3751977|FG000|NOT COMPLETED|Overall Study||1
3032834|NCT01124734|3751981|FG000|STARTED|Overall Study||17
3032835|NCT01124734|3751981|FG000|Completion of Course 1 Cycle 1|Overall Study|All 17 participants successfully completed Course 1 Cycle 1|17
3032836|NCT01124734|3751981|FG000|Initiation of Course 1 Cycle 2|Overall Study||17
3032837|NCT01124734|3751981|FG000|COMPLETED|Overall Study|Closed to accrual|0
3032838|NCT01124734|3751981|FG000|NOT COMPLETED|Overall Study||17
3032839|NCT01124786|3751992|FG000|STARTED|Overall Study||182
3032840|NCT01124786|3751993|FG001|STARTED|Overall Study||185
3032841|NCT01124786|3751992|FG000|Intent-to-Treat (ITT) Population|Overall Study|All randomized patients (pts)|182
3032842|NCT01124786|3751993|FG001|Intent-to-Treat (ITT) Population|Overall Study||185
3032843|NCT01124786|3751992|FG000|Safety Population|Overall Study|All pts who received at least one dose of study drug|179
3032844|NCT01124786|3751993|FG001|Safety Population|Overall Study||181
3032845|NCT01124786|3751992|FG000|Tumor Evaluable Population|Overall Study|All pts with measurable/evaluable tumor at baseline per RECIST and have received ≥ one dose of drug|178
3032846|NCT01124786|3751993|FG001|Tumor Evaluable Population|Overall Study||180
3032847|NCT01124786|3751992|FG000|COMPLETED|Overall Study||178
3032848|NCT01124786|3751993|FG001|COMPLETED|Overall Study||180
3032849|NCT01124786|3751992|FG000|NOT COMPLETED|Overall Study||4
3032850|NCT01124786|3751993|FG001|NOT COMPLETED|Overall Study||5
3032851|NCT01124838|3752001|FG000|STARTED|Overall Study||130
3032852|NCT01124838|3752002|FG001|STARTED|Overall Study||131
3032853|NCT01124838|3752001|FG000|Enrolled in Main Study|Overall Study||114
3032854|NCT01124838|3752002|FG001|Enrolled in Main Study|Overall Study||115
3032855|NCT01124838|3752001|FG000|Enrolled in Japan Sub-study|Overall Study||16
3032856|NCT01124838|3752002|FG001|Enrolled in Japan Sub-study|Overall Study||16
3032857|NCT01124838|3752001|FG000|COMPLETED|Overall Study||112
3032858|NCT01124838|3752002|FG001|COMPLETED|Overall Study||116
3032859|NCT01124838|3752001|FG000|NOT COMPLETED|Overall Study||18
3032860|NCT01124838|3752002|FG001|NOT COMPLETED|Overall Study||15
3032861|NCT01124864|3752016|FG000|STARTED|Overall Study||28
3032862|NCT01124864|3752017|FG001|STARTED|Overall Study||35
3032863|NCT01124864|3752018|FG002|STARTED|Overall Study||34
3032864|NCT01124864|3752019|FG003|STARTED|Overall Study||22
3032865|NCT01124864|3752020|FG004|STARTED|Overall Study||31
3032866|NCT01124864|3752021|FG005|STARTED|Overall Study||3
3032867|NCT01124864|3752016|FG000|COMPLETED|Overall Study||0
3032868|NCT01124864|3752017|FG001|COMPLETED|Overall Study||0
3032869|NCT01124864|3752018|FG002|COMPLETED|Overall Study||0
3032870|NCT01124864|3752019|FG003|COMPLETED|Overall Study|1 patient ongoing at time of data cut-off 30-Jul-2013|1
3032871|NCT01124864|3752020|FG004|COMPLETED|Overall Study|1 patient ongoing at time of data cut-off 30-Jul-2013|1
3032872|NCT01124864|3752021|FG005|COMPLETED|Overall Study||0
3032873|NCT01124864|3752016|FG000|NOT COMPLETED|Overall Study||28
3032874|NCT01124864|3752017|FG001|NOT COMPLETED|Overall Study||35
3032875|NCT01124864|3752018|FG002|NOT COMPLETED|Overall Study||34
3032876|NCT01124864|3752019|FG003|NOT COMPLETED|Overall Study||21
3032877|NCT01124864|3752020|FG004|NOT COMPLETED|Overall Study||30
3032878|NCT01124864|3752021|FG005|NOT COMPLETED|Overall Study||3
3032879|NCT01124916|3752039|FG000|STARTED|Overall Study||38
3032880|NCT01124916|3752040|FG001|STARTED|Overall Study||40
3032881|NCT01124916|3752039|FG000|COMPLETED|Overall Study||35
3032882|NCT01124916|3752040|FG001|COMPLETED|Overall Study||38
3032883|NCT01124916|3752039|FG000|NOT COMPLETED|Overall Study||3
3032884|NCT01124916|3752040|FG001|NOT COMPLETED|Overall Study||2
3032885|NCT01124955|3752048|FG000|STARTED|Overall Study||40
3032886|NCT01124955|3752049|FG001|STARTED|Overall Study||40
3032887|NCT01124955|3752048|FG000|COMPLETED|Overall Study||40
3032888|NCT01124955|3752049|FG001|COMPLETED|Overall Study||40
3032889|NCT01124955|3752048|FG000|NOT COMPLETED|Overall Study||0
3032890|NCT01124955|3752049|FG001|NOT COMPLETED|Overall Study||0
3032891|NCT01125046|3752055|FG000|STARTED|First 6 Months of Treatment||50
3032892|NCT01125046|3752055|FG000|COMPLETED|First 6 Months of Treatment||36
3032893|NCT01125046|3752055|FG000|NOT COMPLETED|First 6 Months of Treatment||14
3032894|NCT01125046|3752055|FG000|STARTED|Continued Treatment After 6 Months||36
3032895|NCT01125046|3752055|FG000|COMPLETED|Continued Treatment After 6 Months||33
3032896|NCT01125046|3752055|FG000|NOT COMPLETED|Continued Treatment After 6 Months||3
3032897|NCT01125046|3752055|FG000|STARTED|Follow-up/Data Cut Off Point||49
3032898|NCT01125046|3752055|FG000|COMPLETED|Follow-up/Data Cut Off Point||16
3032899|NCT01125046|3752055|FG000|NOT COMPLETED|Follow-up/Data Cut Off Point||33
3032900|NCT01125098|3752061|FG000|STARTED|Overall Study||91
3032901|NCT01125098|3752062|FG001|STARTED|Overall Study||90
3032902|NCT01125098|3752061|FG000|COMPLETED|Overall Study||88
3032903|NCT01125098|3752062|FG001|COMPLETED|Overall Study||90
3032904|NCT01125098|3752061|FG000|NOT COMPLETED|Overall Study||3
3032905|NCT01125098|3752062|FG001|NOT COMPLETED|Overall Study||0
3032906|NCT01125163|3752070|FG000|STARTED|Overall Study||76
3032907|NCT01125163|3752071|FG001|STARTED|Overall Study||74
3032908|NCT01125163|3752070|FG000|COMPLETED|Overall Study||76
3032909|NCT01125163|3752071|FG001|COMPLETED|Overall Study||74
3032910|NCT01125163|3752070|FG000|NOT COMPLETED|Overall Study||0
3032911|NCT01125163|3752071|FG001|NOT COMPLETED|Overall Study||0
3032912|NCT01125189|3752081|FG000|STARTED|Treatment Period||159
3032913|NCT01125189|3752082|FG001|STARTED|Treatment Period||158
3032914|NCT01125189|3752083|FG002|STARTED|Treatment Period||78
3032915|NCT01125189|3752081|FG000|COMPLETED|Treatment Period||128
3032916|NCT01125189|3752082|FG001|COMPLETED|Treatment Period||123
3032917|NCT01125189|3752083|FG002|COMPLETED|Treatment Period||37
3032918|NCT01125189|3752081|FG000|NOT COMPLETED|Treatment Period||31
3032919|NCT01125189|3752082|FG001|NOT COMPLETED|Treatment Period||35
3032920|NCT01125189|3752083|FG002|NOT COMPLETED|Treatment Period||41
3032921|NCT01125189|3752081|FG000|STARTED|Follow up Period|All participants who received treatment continued in the follow-up phase.|152
3032922|NCT01125189|3752082|FG001|STARTED|Follow up Period|All participants who received treatment continued in the follow-up phase.|153
3032923|NCT01125189|3752083|FG002|STARTED|Follow up Period|All participants who received treatment continued in the follow-up phase.|74
3032924|NCT01125189|3752081|FG000|COMPLETED|Follow up Period||132
3032925|NCT01125189|3752082|FG001|COMPLETED|Follow up Period||138
3032926|NCT01125189|3752083|FG002|COMPLETED|Follow up Period||58
3032927|NCT01125189|3752081|FG000|NOT COMPLETED|Follow up Period||20
3032928|NCT01125189|3752082|FG001|NOT COMPLETED|Follow up Period||15
3032929|NCT01125189|3752083|FG002|NOT COMPLETED|Follow up Period||16
3032930|NCT01125202|3752096|FG000|STARTED|Overall Study||93
3032931|NCT01125202|3752097|FG001|STARTED|Overall Study||86
3032932|NCT01125202|3752096|FG000|COMPLETED|Overall Study||81
3032933|NCT01125202|3752097|FG001|COMPLETED|Overall Study||79
3032934|NCT01125202|3752096|FG000|NOT COMPLETED|Overall Study||12
3032935|NCT01125202|3752097|FG001|NOT COMPLETED|Overall Study||7
3032936|NCT01125293|3752109|FG000|STARTED|Overall Study||3
3032937|NCT01125293|3752110|FG001|STARTED|Overall Study||3
3032938|NCT01125293|3752111|FG002|STARTED|Overall Study||4
3032939|NCT01125293|3752112|FG003|STARTED|Overall Study||3
3032940|NCT01125293|3752113|FG004|STARTED|Overall Study|Per protocol, a 10 patient expansion cohort is used to confirm the MTD determined in Stage B .|10
3032941|NCT01125293|3752114|FG005|STARTED|Overall Study||23
3032942|NCT01125293|3752109|FG000|Evaluable for Phase I Dose-Limiting Toxicity|Overall Study||3
3032943|NCT01125293|3752110|FG001|Evaluable for Phase I Dose-Limiting Toxicity|Overall Study||3
3032944|NCT01125293|3752111|FG002|Evaluable for Phase I Dose-Limiting Toxicity|Overall Study||3
3032945|NCT01125293|3752112|FG003|Evaluable for Phase I Dose-Limiting Toxicity|Overall Study||3
3032946|NCT01125293|3752113|FG004|Evaluable for Phase I Dose-Limiting Toxicity|Overall Study|The Phase I dose expansion cohort was not evaluated for cycle 1 dose-limiting toxicity.|0
3032947|NCT01125293|3752114|FG005|Evaluable for Phase I Dose-Limiting Toxicity|Overall Study|The Phase II cohort was not evaluated for cycle 1 dose-limiting toxicity.|0
3032948|NCT01125293|3752109|FG000|COMPLETED|Overall Study||0
3032949|NCT01125293|3752110|FG001|COMPLETED|Overall Study||0
3032950|NCT01125293|3752111|FG002|COMPLETED|Overall Study||0
3032951|NCT01125293|3752112|FG003|COMPLETED|Overall Study||0
3032952|NCT01125293|3752113|FG004|COMPLETED|Overall Study||0
3032953|NCT01125293|3752114|FG005|COMPLETED|Overall Study||0
3032954|NCT01125293|3752109|FG000|NOT COMPLETED|Overall Study||3
3032955|NCT01125293|3752110|FG001|NOT COMPLETED|Overall Study||3
3032956|NCT01125293|3752111|FG002|NOT COMPLETED|Overall Study||4
3032957|NCT01125293|3752112|FG003|NOT COMPLETED|Overall Study||3
3032958|NCT01125293|3752113|FG004|NOT COMPLETED|Overall Study||10
3032959|NCT01125293|3752114|FG005|NOT COMPLETED|Overall Study||23
3032960|NCT01125358|3752135|FG000|STARTED|Overall Study||21
3032961|NCT01125358|3752136|FG001|STARTED|Overall Study||21
3032962|NCT01125358|3752137|FG002|STARTED|Overall Study||20
3032963|NCT01125358|3752138|FG003|STARTED|Overall Study||20
3032964|NCT01125358|3752135|FG000|Received at Least 1 Dose of Study Drug|Overall Study||21
3032965|NCT01125358|3752136|FG001|Received at Least 1 Dose of Study Drug|Overall Study||21
3032966|NCT01125358|3752137|FG002|Received at Least 1 Dose of Study Drug|Overall Study||20
3032967|NCT01125358|3752138|FG003|Received at Least 1 Dose of Study Drug|Overall Study||20
3032968|NCT01125358|3752135|FG000|Placebo Responder|Overall Study||1
3032969|NCT01125358|3752136|FG001|Placebo Responder|Overall Study||0
3032970|NCT01125358|3752137|FG002|Placebo Responder|Overall Study||0
3032971|NCT01125358|3752138|FG003|Placebo Responder|Overall Study||0
3032972|NCT01125358|3752135|FG000|COMPLETED|Overall Study||9
3032973|NCT01125358|3752136|FG001|COMPLETED|Overall Study||17
3032974|NCT01125358|3752137|FG002|COMPLETED|Overall Study||11
3032975|NCT01125358|3752138|FG003|COMPLETED|Overall Study||12
3032976|NCT01125358|3752135|FG000|NOT COMPLETED|Overall Study||12
3032977|NCT01125358|3752136|FG001|NOT COMPLETED|Overall Study||4
3032978|NCT01125358|3752137|FG002|NOT COMPLETED|Overall Study||9
3032979|NCT01125358|3752138|FG003|NOT COMPLETED|Overall Study||8
3032980|NCT01125514|3752148|FG000|STARTED|Treatment Period 1 (Day 1 - Day 7)|Randomized and safety population|37
3032981|NCT01125514|3752148|FG000|COMPLETED|Treatment Period 1 (Day 1 - Day 7)||35
3032982|NCT01125514|3752148|FG000|NOT COMPLETED|Treatment Period 1 (Day 1 - Day 7)||2
3032983|NCT01125514|3752148|FG000|STARTED|Treatment Period 2 (Day 8 - Day 17)||35
3032984|NCT01125514|3752148|FG000|Pharmacokinetic (PK) Analysis Set|Treatment Period 2 (Day 8 - Day 17)||33
3032985|NCT01125514|3752148|FG000|Pharmacodynamics (PD) Analysis Set|Treatment Period 2 (Day 8 - Day 17)||33
3032986|NCT01125514|3752148|FG000|COMPLETED|Treatment Period 2 (Day 8 - Day 17)||32
3032987|NCT01125514|3752148|FG000|NOT COMPLETED|Treatment Period 2 (Day 8 - Day 17)||3
3032988|NCT01125514|3752148|FG000|STARTED|Treatment Period2(Day9-Day27) and Day 28||32
3032989|NCT01125514|3752148|FG000|COMPLETED|Treatment Period2(Day9-Day27) and Day 28||28
3032990|NCT01125514|3752148|FG000|NOT COMPLETED|Treatment Period2(Day9-Day27) and Day 28||4
3032991|NCT01125566|3752164|FG000|STARTED|Patients Before the Switch (26Apr2013)||339
3032992|NCT01125566|3752165|FG001|STARTED|Patients Before the Switch (26Apr2013)||169
3032993|NCT01125566|3752166|FG002|STARTED|Patients Before the Switch (26Apr2013)||0
3032994|NCT01125566|3752164|FG000|Treated|Patients Before the Switch (26Apr2013)||337
3032995|NCT01125566|3752165|FG001|Treated|Patients Before the Switch (26Apr2013)||169
3032996|NCT01125566|3752166|FG002|Treated|Patients Before the Switch (26Apr2013)||0
3032997|NCT01125566|3752164|FG000|COMPLETED|Patients Before the Switch (26Apr2013)||74
3032998|NCT01125566|3752165|FG001|COMPLETED|Patients Before the Switch (26Apr2013)||0
3032999|NCT01125566|3752166|FG002|COMPLETED|Patients Before the Switch (26Apr2013)||0
3033000|NCT01125566|3752164|FG000|NOT COMPLETED|Patients Before the Switch (26Apr2013)||265
3033001|NCT01125566|3752165|FG001|NOT COMPLETED|Patients Before the Switch (26Apr2013)||169
3033002|NCT01125566|3752166|FG002|NOT COMPLETED|Patients Before the Switch (26Apr2013)||0
3033003|NCT01125566|3752164|FG000|STARTED|Patients Who Switched From AV to TV||0
3033004|NCT01125566|3752165|FG001|STARTED|Patients Who Switched From AV to TV||0
3033005|NCT01125566|3752166|FG002|STARTED|Patients Who Switched From AV to TV||75
3033006|NCT01125566|3752164|FG000|COMPLETED|Patients Who Switched From AV to TV||0
3033007|NCT01125566|3752165|FG001|COMPLETED|Patients Who Switched From AV to TV||0
3033008|NCT01125566|3752166|FG002|COMPLETED|Patients Who Switched From AV to TV||2
3033009|NCT01125566|3752164|FG000|NOT COMPLETED|Patients Who Switched From AV to TV||0
3033010|NCT01125566|3752165|FG001|NOT COMPLETED|Patients Who Switched From AV to TV||0
3033011|NCT01125566|3752166|FG002|NOT COMPLETED|Patients Who Switched From AV to TV||73
3033012|NCT01125605|3752173|FG000|STARTED|Overall Study|started = had baseline values|325
3033013|NCT01125605|3752173|FG000|Safety|Overall Study|1 patient was only analysed for safety|326
3033014|NCT01125605|3752173|FG000|COMPLETED|Overall Study||325
3033015|NCT01125605|3752173|FG000|NOT COMPLETED|Overall Study||0
3033016|NCT01125722|3752192|FG000|STARTED|Overall Study||37
3033017|NCT01125722|3752193|FG001|STARTED|Overall Study||37
3033018|NCT01125722|3752192|FG000|COMPLETED|Overall Study||34
3033019|NCT01125722|3752193|FG001|COMPLETED|Overall Study||36
3033020|NCT01125722|3752192|FG000|NOT COMPLETED|Overall Study||3
3033021|NCT01125722|3752193|FG001|NOT COMPLETED|Overall Study||1
3033022|NCT01125748|3752201|FG000|STARTED|Overall Study||88
3033023|NCT01125748|3752202|FG001|STARTED|Overall Study||88
3033024|NCT01125748|3752201|FG000|COMPLETED|Overall Study||78
3033025|NCT01125748|3752202|FG001|COMPLETED|Overall Study||74
3033026|NCT01125748|3752201|FG000|NOT COMPLETED|Overall Study||10
3033027|NCT01125748|3752202|FG001|NOT COMPLETED|Overall Study||14
3033028|NCT01125774|3752210|FG000|STARTED|Overall Study|Randomized|3018
3033029|NCT01125774|3752211|FG001|STARTED|Overall Study|Randomized|1502
3033030|NCT01125774|3752212|FG002|STARTED|Overall Study|Unique participants randomized|22
3033031|NCT01125774|3752213|FG003|STARTED|Overall Study|Unique participants randomized|6
3033032|NCT01125774|3752210|FG000|Treated|Overall Study||2638
3033033|NCT01125774|3752211|FG001|Treated|Overall Study|1 mistakenly took telcagepant and is included with telcagepant group for adverse event analysis|1322
3033034|NCT01125774|3752212|FG002|Treated|Overall Study|Received telcagepant|21
3033035|NCT01125774|3752213|FG003|Treated|Overall Study||5
3033036|NCT01125774|3752210|FG000|COMPLETED|Overall Study||1893
3033037|NCT01125774|3752211|FG001|COMPLETED|Overall Study||948
3033038|NCT01125774|3752212|FG002|COMPLETED|Overall Study|"Completed study at least once while treated with telcagepant (otherwise counted Not Completed)"|13
3033039|NCT01125774|3752213|FG003|COMPLETED|Overall Study|Completed study at least once|3
3033040|NCT01125774|3752210|FG000|NOT COMPLETED|Overall Study||1125
3033041|NCT01125774|3752211|FG001|NOT COMPLETED|Overall Study||554
3033042|NCT01125774|3752212|FG002|NOT COMPLETED|Overall Study||9
3033043|NCT01125774|3752213|FG003|NOT COMPLETED|Overall Study||3
3033044|NCT01125800|3752224|FG000|STARTED|Phase I||11
3033045|NCT01125800|3752225|FG001|STARTED|Phase I||16
3033046|NCT01125800|3752226|FG002|STARTED|Phase I||11
3033047|NCT01125800|3752227|FG003|STARTED|Phase I||21
3033048|NCT01125800|3752228|FG004|STARTED|Phase I|None of participants were enrolled to this treatment in this period.|0
3033049|NCT01125800|3752224|FG000|COMPLETED|Phase I||3
3033050|NCT01125800|3752225|FG001|COMPLETED|Phase I||7
3033051|NCT01125800|3752226|FG002|COMPLETED|Phase I||7
3033052|NCT01125800|3752227|FG003|COMPLETED|Phase I||10
3033053|NCT01125800|3752228|FG004|COMPLETED|Phase I||0
3033054|NCT01125800|3752224|FG000|NOT COMPLETED|Phase I||8
3033055|NCT01125800|3752225|FG001|NOT COMPLETED|Phase I||9
3033056|NCT01125800|3752226|FG002|NOT COMPLETED|Phase I||4
3033057|NCT01125800|3752227|FG003|NOT COMPLETED|Phase I||11
3033058|NCT01125800|3752228|FG004|NOT COMPLETED|Phase I||0
3033059|NCT01125800|3752224|FG000|STARTED|Phase II|None of participants were enrolled to this treatment in this period.|0
3033060|NCT01125800|3752225|FG001|STARTED|Phase II|None of participants were enrolled to this treatment in this period.|0
3033061|NCT01125800|3752226|FG002|STARTED|Phase II|None of participants were enrolled to this treatment in this period.|0
3033062|NCT01125800|3752227|FG003|STARTED|Phase II|None of participants were enrolled to this treatment in this period.|1
3033063|NCT01125800|3752228|FG004|STARTED|Phase II|Additional participants were enrolled to this treatment in this period.|16
3033064|NCT01125800|3752224|FG000|COMPLETED|Phase II||0
3033065|NCT01125800|3752225|FG001|COMPLETED|Phase II||0
3033066|NCT01125800|3752226|FG002|COMPLETED|Phase II||0
3033067|NCT01125800|3752227|FG003|COMPLETED|Phase II||0
3033068|NCT01125800|3752228|FG004|COMPLETED|Phase II||5
3033069|NCT01125800|3752224|FG000|NOT COMPLETED|Phase II||0
3033070|NCT01125800|3752225|FG001|NOT COMPLETED|Phase II||0
3033071|NCT01125800|3752226|FG002|NOT COMPLETED|Phase II||0
3033072|NCT01125800|3752227|FG003|NOT COMPLETED|Phase II||1
3033073|NCT01125800|3752228|FG004|NOT COMPLETED|Phase II||11
3033074|NCT01125813|3752243|FG000|STARTED|Overall Study||36
3033075|NCT01125813|3752243|FG000|COMPLETED|Overall Study||30
3033076|NCT01125813|3752243|FG000|NOT COMPLETED|Overall Study||6
3033077|NCT01125917|3752247|FG000|STARTED|Overall Study||354
3033078|NCT01125917|3752247|FG000|COMPLETED|Overall Study||15
3033079|NCT01125917|3752247|FG000|NOT COMPLETED|Overall Study||339
3033080|NCT01125930|3752253|FG000|STARTED|Overall Study||22
3033081|NCT01125930|3752254|FG001|STARTED|Overall Study||46
3033082|NCT01125930|3752253|FG000|COMPLETED|Overall Study||21
3033083|NCT01125930|3752254|FG001|COMPLETED|Overall Study||36
3033084|NCT01125930|3752253|FG000|NOT COMPLETED|Overall Study||1
3033085|NCT01125930|3752254|FG001|NOT COMPLETED|Overall Study||10
3033086|NCT01126060|3752278|FG000|STARTED|Overall Study||40
3033087|NCT01126060|3752279|FG001|STARTED|Overall Study||40
3033088|NCT01126060|3752278|FG000|COMPLETED|Overall Study||40
3033089|NCT01126060|3752279|FG001|COMPLETED|Overall Study||38
3033090|NCT01126060|3752278|FG000|NOT COMPLETED|Overall Study||0
3033091|NCT01126060|3752279|FG001|NOT COMPLETED|Overall Study||2
3033092|NCT01126099|3752287|FG000|STARTED|Double Blind Phase||11
3033093|NCT01126099|3752288|FG001|STARTED|Double Blind Phase||9
3033094|NCT01126099|3752287|FG000|COMPLETED|Double Blind Phase||7
3033095|NCT01126099|3752288|FG001|COMPLETED|Double Blind Phase||7
3033096|NCT01126099|3752287|FG000|NOT COMPLETED|Double Blind Phase||4
3033097|NCT01126099|3752288|FG001|NOT COMPLETED|Double Blind Phase||2
3033098|NCT01126099|3752287|FG000|STARTED|Open-label Extension|2 in the Prazosin arm of the Double Blind Phase elected not to enter the Open-Label extension|5
3033099|NCT01126099|3752288|FG001|STARTED|Open-label Extension||7
3033100|NCT01126099|3752287|FG000|COMPLETED|Open-label Extension||4
3033101|NCT01126099|3752288|FG001|COMPLETED|Open-label Extension||6
3033102|NCT01126099|3752287|FG000|NOT COMPLETED|Open-label Extension||1
3033103|NCT01126099|3752288|FG001|NOT COMPLETED|Open-label Extension||1
3033104|NCT01126268|3752294|FG000|STARTED|Overall Study||38
3033105|NCT01126268|3752294|FG000|COMPLETED|Overall Study||37
3033106|NCT01126268|3752294|FG000|NOT COMPLETED|Overall Study||1
3033107|NCT01126359|3752298|FG000|STARTED|First Intervention (20-minutes)||5
3033108|NCT01126359|3752299|FG001|STARTED|First Intervention (20-minutes)||6
3033109|NCT01126359|3752298|FG000|COMPLETED|First Intervention (20-minutes)||5
3033110|NCT01126359|3752299|FG001|COMPLETED|First Intervention (20-minutes)||5
3033111|NCT01126359|3752298|FG000|NOT COMPLETED|First Intervention (20-minutes)||0
3033112|NCT01126359|3752299|FG001|NOT COMPLETED|First Intervention (20-minutes)||1
3033113|NCT01126359|3752298|FG000|STARTED|Dressing Replacement/Healing (48-hours)||5
3383809|NCT01915498|4118873|FG000|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
3383810|NCT01915498|4118874|FG001|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
3383811|NCT01915498|4118875|FG002|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
3383812|NCT01915498|4118876|FG003|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
3383813|NCT01915498|4118877|FG004|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
3383814|NCT01915498|4118878|FG005|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
3383815|NCT01915498|4118879|FG006|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
3383816|NCT01915498|4118880|FG007|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
3383817|NCT01915498|4118881|FG008|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
3383818|NCT01915498|4118882|FG009|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
3383819|NCT01915498|4118883|FG010|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
3383820|NCT01915498|4118884|FG011|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
3033114|NCT01126359|3752299|FG001|STARTED|Dressing Replacement/Healing (48-hours)||5
3033115|NCT01126359|3752298|FG000|COMPLETED|Dressing Replacement/Healing (48-hours)||5
3033116|NCT01126359|3752299|FG001|COMPLETED|Dressing Replacement/Healing (48-hours)||5
3033117|NCT01126359|3752298|FG000|NOT COMPLETED|Dressing Replacement/Healing (48-hours)||0
3033118|NCT01126359|3752299|FG001|NOT COMPLETED|Dressing Replacement/Healing (48-hours)||0
3033119|NCT01126359|3752298|FG000|STARTED|Second Intervention (20-minutes)||5
3033120|NCT01126359|3752299|FG001|STARTED|Second Intervention (20-minutes)||5
3033121|NCT01126359|3752298|FG000|COMPLETED|Second Intervention (20-minutes)||5
3033122|NCT01126359|3752299|FG001|COMPLETED|Second Intervention (20-minutes)||5
3033123|NCT01126359|3752298|FG000|NOT COMPLETED|Second Intervention (20-minutes)||0
3033124|NCT01126359|3752299|FG001|NOT COMPLETED|Second Intervention (20-minutes)||0
3033125|NCT01126424|3752315|FG000|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|3
3033126|NCT01126424|3752316|FG001|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|4
3033127|NCT01126424|3752317|FG002|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|5
3033128|NCT01126424|3752318|FG003|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|6
3033129|NCT01126424|3752319|FG004|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|4
3033130|NCT01126424|3752320|FG005|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|4
3033131|NCT01126424|3752315|FG000|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|3
3033132|NCT01126424|3752316|FG001|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|4
3033133|NCT01126424|3752317|FG002|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|4
3033134|NCT01126424|3752318|FG003|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|4
3033135|NCT01126424|3752319|FG004|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|4
3033136|NCT01126424|3752320|FG005|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|4
3033137|NCT01126424|3752315|FG000|COMPLETED|Overall Study||3
3033138|NCT01126424|3752316|FG001|COMPLETED|Overall Study||4
3033139|NCT01126424|3752317|FG002|COMPLETED|Overall Study||4
3033140|NCT01126424|3752318|FG003|COMPLETED|Overall Study||3
3033141|NCT01126424|3752319|FG004|COMPLETED|Overall Study||2
3033142|NCT01126424|3752320|FG005|COMPLETED|Overall Study||4
3033143|NCT01126424|3752315|FG000|NOT COMPLETED|Overall Study||0
3033144|NCT01126424|3752316|FG001|NOT COMPLETED|Overall Study||0
3033145|NCT01126424|3752317|FG002|NOT COMPLETED|Overall Study||1
3033146|NCT01126424|3752318|FG003|NOT COMPLETED|Overall Study||3
3033147|NCT01126424|3752319|FG004|NOT COMPLETED|Overall Study||2
3033148|NCT01126424|3752320|FG005|NOT COMPLETED|Overall Study||0
3033149|NCT01126437|3752331|FG000|STARTED|Overall Study||5741
3033150|NCT01126437|3752332|FG001|STARTED|Overall Study||5729
3033151|NCT01126437|3752333|FG002|STARTED|Overall Study||5713
3033152|NCT01126437|3752331|FG000|COMPLETED|Overall Study|See Pre-Assignment Details above for comments.|4400
3033153|NCT01126437|3752332|FG001|COMPLETED|Overall Study|See Pre-Assignment Details above for comments.|4399
3033154|NCT01126437|3752333|FG002|COMPLETED|Overall Study|See Pre-Assignment Details above for comments.|4400
3033155|NCT01126437|3752331|FG000|NOT COMPLETED|Overall Study||1341
3033156|NCT01126437|3752332|FG001|NOT COMPLETED|Overall Study||1330
3033157|NCT01126437|3752333|FG002|NOT COMPLETED|Overall Study||1313
3033158|NCT01126541|3752344|FG000|STARTED|Overall Study||70
3033159|NCT01126541|3752345|FG001|STARTED|Overall Study||73
3033160|NCT01126541|3752346|FG002|STARTED|Overall Study||81
3033161|NCT01126541|3752344|FG000|COMPLETED|Overall Study||60
3033162|NCT01126541|3752345|FG001|COMPLETED|Overall Study||61
3033163|NCT01126541|3752346|FG002|COMPLETED|Overall Study||55
3033164|NCT01126541|3752344|FG000|NOT COMPLETED|Overall Study||10
3033165|NCT01126541|3752345|FG001|NOT COMPLETED|Overall Study||12
3033166|NCT01126541|3752346|FG002|NOT COMPLETED|Overall Study||26
3033167|NCT01126580|3752359|FG000|STARTED|Overall Study||269
3033168|NCT01126580|3752360|FG001|STARTED|Overall Study||270
3033169|NCT01126580|3752361|FG002|STARTED|Overall Study||268
3033170|NCT01126580|3752359|FG000|Received at Least 1 Dose of Study Drug|Overall Study||269
3033171|NCT01126580|3752360|FG001|Received at Least 1 Dose of Study Drug|Overall Study||270
3033172|NCT01126580|3752361|FG002|Received at Least 1 Dose of Study Drug|Overall Study||268
3033173|NCT01126580|3752359|FG000|Completed 26 Weeks|Overall Study||233
3033174|NCT01126580|3752360|FG001|Completed 26 Weeks|Overall Study||242
3033175|NCT01126580|3752361|FG002|Completed 26 Weeks|Overall Study||226
3383821|NCT01915498|4118885|FG012|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
3383822|NCT01915498|4118886|FG013|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
3383823|NCT01915498|4118887|FG014|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
3383824|NCT01915498|4118888|FG015|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
3383825|NCT01915498|4118889|FG016|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
3383826|NCT01915498|4118890|FG017|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
3383827|NCT01915498|4118891|FG018|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||2
3385839|NCT02740972|4121256|FG001|STARTED|4-week Double-blinded Placebo-controlled||6
3385840|NCT02740972|4121257|FG002|STARTED|4-week Double-blinded Placebo-controlled||5
3385841|NCT02740972|4121258|FG003|STARTED|4-week Double-blinded Placebo-controlled||0
3385842|NCT02740972|4121259|FG004|STARTED|4-week Double-blinded Placebo-controlled||0
3385843|NCT02740972|4121255|FG000|COMPLETED|4-week Double-blinded Placebo-controlled||5
3385844|NCT02740972|4121256|FG001|COMPLETED|4-week Double-blinded Placebo-controlled||6
3385845|NCT02740972|4121257|FG002|COMPLETED|4-week Double-blinded Placebo-controlled||5
3385846|NCT02740972|4121258|FG003|COMPLETED|4-week Double-blinded Placebo-controlled||0
3033176|NCT01126580|3752359|FG000|COMPLETED|Overall Study||220
3033177|NCT01126580|3752360|FG001|COMPLETED|Overall Study||218
3033178|NCT01126580|3752361|FG002|COMPLETED|Overall Study||213
3033179|NCT01126580|3752359|FG000|NOT COMPLETED|Overall Study||49
3033180|NCT01126580|3752360|FG001|NOT COMPLETED|Overall Study||52
3033181|NCT01126580|3752361|FG002|NOT COMPLETED|Overall Study||55
3033182|NCT01126593|3752373|FG000|STARTED|Overall Study||33
3033183|NCT01126593|3752374|FG001|STARTED|Overall Study||29
3033184|NCT01126593|3752375|FG002|STARTED|Overall Study||34
3033185|NCT01126593|3752373|FG000|COMPLETED|Overall Study||29
3033186|NCT01126593|3752374|FG001|COMPLETED|Overall Study||27
3033187|NCT01126593|3752375|FG002|COMPLETED|Overall Study||32
3033188|NCT01126593|3752373|FG000|NOT COMPLETED|Overall Study||4
3033189|NCT01126593|3752374|FG001|NOT COMPLETED|Overall Study||2
3033190|NCT01126593|3752375|FG002|NOT COMPLETED|Overall Study||2
3033191|NCT01126619|3752383|FG000|STARTED|Overall Study||103
3033192|NCT01126619|3752383|FG000|COMPLETED|Overall Study|The completed population was used for all effectiveness analyses.|86
3033193|NCT01126619|3752383|FG000|NOT COMPLETED|Overall Study||17
3033194|NCT01126671|3752391|FG000|STARTED|Overall Study||26
3033195|NCT01126671|3752392|FG001|STARTED|Overall Study||30
3033196|NCT01126671|3752391|FG000|COMPLETED|Overall Study||24
3033197|NCT01126671|3752392|FG001|COMPLETED|Overall Study||29
3033198|NCT01126671|3752391|FG000|NOT COMPLETED|Overall Study||2
3033199|NCT01126671|3752392|FG001|NOT COMPLETED|Overall Study||1
3033200|NCT01126723|3752402|FG000|STARTED|Overall Study||35
3033201|NCT01126723|3752403|FG001|STARTED|Overall Study||31
3033202|NCT01126723|3752402|FG000|COMPLETED|Overall Study||29
3033203|NCT01126723|3752403|FG001|COMPLETED|Overall Study||28
3033204|NCT01126723|3752402|FG000|NOT COMPLETED|Overall Study||6
3033205|NCT01126723|3752403|FG001|NOT COMPLETED|Overall Study||3
3033206|NCT01127061|3752411|FG000|STARTED|Overall Study||67
3033207|NCT01127061|3752412|FG001|STARTED|Overall Study||69
3033208|NCT01127061|3752411|FG000|COMPLETED|Overall Study||57
3033209|NCT01127061|3752412|FG001|COMPLETED|Overall Study||56
3033210|NCT01127061|3752411|FG000|NOT COMPLETED|Overall Study||10
3033211|NCT01127061|3752412|FG001|NOT COMPLETED|Overall Study||13
3033212|NCT01127087|3752420|FG000|STARTED|Overall Study||8
3033213|NCT01127087|3752421|FG001|STARTED|Overall Study||2
3033214|NCT01127087|3752420|FG000|COMPLETED|Overall Study||8
3033215|NCT01127087|3752421|FG001|COMPLETED|Overall Study||2
3033216|NCT01127087|3752420|FG000|NOT COMPLETED|Overall Study||0
3033217|NCT01127087|3752421|FG001|NOT COMPLETED|Overall Study||0
3033218|NCT01127139|3752429|FG000|STARTED|Overall Study||3828
3033219|NCT01127139|3752429|FG000|Number of Participants Analyzed|Overall Study||3828
3033220|NCT01127139|3752429|FG000|COMPLETED|Overall Study||3771
3033221|NCT01127139|3752429|FG000|NOT COMPLETED|Overall Study||57
3033222|NCT01127165|3752438|FG000|STARTED|Overall Study||65
3033223|NCT01127165|3752439|FG001|STARTED|Overall Study||60
3033224|NCT01127165|3752438|FG000|COMPLETED|Overall Study||49
3033225|NCT01127165|3752439|FG001|COMPLETED|Overall Study||41
3033226|NCT01127165|3752438|FG000|NOT COMPLETED|Overall Study||16
3033227|NCT01127165|3752439|FG001|NOT COMPLETED|Overall Study||19
3033228|NCT01127321|3752450|FG000|STARTED|Overall Study||3
3033229|NCT01127321|3752451|FG001|STARTED|Overall Study||1
3033230|NCT01127321|3752452|FG002|STARTED|Overall Study||1
3033231|NCT01127321|3752453|FG003|STARTED|Overall Study||7
3033232|NCT01127321|3752454|FG004|STARTED|Overall Study||5
3033233|NCT01127321|3752450|FG000|COMPLETED|Overall Study||3
3033234|NCT01127321|3752451|FG001|COMPLETED|Overall Study||1
3033235|NCT01127321|3752452|FG002|COMPLETED|Overall Study||1
3033236|NCT01127321|3752453|FG003|COMPLETED|Overall Study||7
3033237|NCT01127321|3752454|FG004|COMPLETED|Overall Study||5
3033238|NCT01127321|3752450|FG000|NOT COMPLETED|Overall Study||0
3033239|NCT01127321|3752451|FG001|NOT COMPLETED|Overall Study||0
3033240|NCT01127321|3752452|FG002|NOT COMPLETED|Overall Study||0
3033241|NCT01127321|3752453|FG003|NOT COMPLETED|Overall Study||0
3033242|NCT01127321|3752454|FG004|NOT COMPLETED|Overall Study||0
3033243|NCT01127373|3752466|FG000|STARTED|Overall Study||116
3033244|NCT01127373|3752466|FG000|COMPLETED|Overall Study||104
3033245|NCT01127373|3752466|FG000|NOT COMPLETED|Overall Study||12
3033246|NCT01127438|3752476|FG000|STARTED|Overall Study||25
3033247|NCT01127438|3752477|FG001|STARTED|Overall Study||25
3033248|NCT01127438|3752478|FG002|STARTED|Overall Study||26
3033249|NCT01127438|3752479|FG003|STARTED|Overall Study||24
3033250|NCT01127438|3752480|FG004|STARTED|Overall Study||28
3033251|NCT01127438|3752481|FG005|STARTED|Overall Study||25
3033252|NCT01127438|3752476|FG000|COMPLETED|Overall Study||25
3033253|NCT01127438|3752477|FG001|COMPLETED|Overall Study||25
3033254|NCT01127438|3752478|FG002|COMPLETED|Overall Study|(n=25) One subject randomized to the approved dose group received a lower dose in error.|26
3033255|NCT01127438|3752479|FG003|COMPLETED|Overall Study|(n=25) One subject randomized to the approved dose group received a lower dose in error.|24
3033256|NCT01127438|3752480|FG004|COMPLETED|Overall Study||28
3033257|NCT01127438|3752481|FG005|COMPLETED|Overall Study||25
3033258|NCT01127438|3752476|FG000|NOT COMPLETED|Overall Study||0
3033259|NCT01127438|3752477|FG001|NOT COMPLETED|Overall Study||0
3033260|NCT01127438|3752478|FG002|NOT COMPLETED|Overall Study||0
3033261|NCT01127438|3752479|FG003|NOT COMPLETED|Overall Study||0
3033262|NCT01127438|3752480|FG004|NOT COMPLETED|Overall Study||0
3033263|NCT01127438|3752481|FG005|NOT COMPLETED|Overall Study||0
3033264|NCT01127581|3752493|FG000|STARTED|Overall Study||678
3033265|NCT01127581|3752494|FG001|STARTED|Overall Study||680
3033266|NCT01127581|3752493|FG000|COMPLETED|Overall Study||678
3033267|NCT01127581|3752494|FG001|COMPLETED|Overall Study||680
3033268|NCT01127581|3752493|FG000|NOT COMPLETED|Overall Study||0
3033269|NCT01127581|3752494|FG001|NOT COMPLETED|Overall Study||0
3033270|NCT01127607|3752502|FG000|STARTED|Phase I (Within Subjects)||14
3033271|NCT01127607|3752503|FG001|STARTED|Phase I (Within Subjects)||13
3033272|NCT01127607|3752502|FG000|COMPLETED|Phase I (Within Subjects)||14
3033273|NCT01127607|3752503|FG001|COMPLETED|Phase I (Within Subjects)||13
3033274|NCT01127607|3752502|FG000|NOT COMPLETED|Phase I (Within Subjects)||0
3033275|NCT01127607|3752503|FG001|NOT COMPLETED|Phase I (Within Subjects)||0
3033276|NCT01127607|3752502|FG000|STARTED|Phase II (Between Subjects)||14
3033277|NCT01127607|3752503|FG001|STARTED|Phase II (Between Subjects)||13
3033278|NCT01127607|3752502|FG000|COMPLETED|Phase II (Between Subjects)||13
3033279|NCT01127607|3752503|FG001|COMPLETED|Phase II (Between Subjects)||11
3033280|NCT01127607|3752502|FG000|NOT COMPLETED|Phase II (Between Subjects)||1
3033281|NCT01127607|3752503|FG001|NOT COMPLETED|Phase II (Between Subjects)||2
3033282|NCT01127633|3752528|FG000|STARTED|Overall Study||723
3033283|NCT01127633|3752529|FG001|STARTED|Overall Study||734
3033284|NCT01127633|3752528|FG000|Received at Least 1 Dose of Study Drug|Overall Study||723
3033285|NCT01127633|3752529|FG001|Received at Least 1 Dose of Study Drug|Overall Study||734
3033286|NCT01127633|3752528|FG000|COMPLETED|Overall Study||70
3033287|NCT01127633|3752529|FG001|COMPLETED|Overall Study||61
3033288|NCT01127633|3752528|FG000|NOT COMPLETED|Overall Study||653
3033289|NCT01127633|3752529|FG001|NOT COMPLETED|Overall Study||673
3033290|NCT01127646|3752537|FG000|STARTED|Overall Study||15
3033291|NCT01127646|3752538|FG001|STARTED|Overall Study||8
3033292|NCT01127646|3752537|FG000|COMPLETED|Overall Study||14
3033293|NCT01127646|3752538|FG001|COMPLETED|Overall Study||7
3033294|NCT01127646|3752537|FG000|NOT COMPLETED|Overall Study||1
3033295|NCT01127646|3752538|FG001|NOT COMPLETED|Overall Study||1
3033296|NCT01127659|3752552|FG000|STARTED|Overall Study||22
3033297|NCT01127659|3752553|FG001|STARTED|Overall Study||22
3033298|NCT01127659|3752554|FG002|STARTED|Overall Study||12
3033299|NCT01127659|3752555|FG003|STARTED|Overall Study||10
3033300|NCT01127659|3752556|FG004|STARTED|Overall Study||50
3033301|NCT01127659|3752557|FG005|STARTED|Overall Study||21
3033302|NCT01127659|3752552|FG000|COMPLETED|Overall Study||20
3033303|NCT01127659|3752553|FG001|COMPLETED|Overall Study||14
3033304|NCT01127659|3752554|FG002|COMPLETED|Overall Study||10
3033305|NCT01127659|3752555|FG003|COMPLETED|Overall Study||6
3033306|NCT01127659|3752556|FG004|COMPLETED|Overall Study||50
3033307|NCT01127659|3752557|FG005|COMPLETED|Overall Study||21
3033308|NCT01127659|3752552|FG000|NOT COMPLETED|Overall Study||2
3033309|NCT01127659|3752553|FG001|NOT COMPLETED|Overall Study||8
3033310|NCT01127659|3752554|FG002|NOT COMPLETED|Overall Study||2
3033311|NCT01127659|3752555|FG003|NOT COMPLETED|Overall Study||4
3033312|NCT01127659|3752556|FG004|NOT COMPLETED|Overall Study||0
3033313|NCT01127659|3752557|FG005|NOT COMPLETED|Overall Study||0
3033314|NCT01127737|3752573|FG000|STARTED|Overall Study||37
3033315|NCT01127737|3752574|FG001|STARTED|Overall Study||38
3033316|NCT01127737|3752573|FG000|COMPLETED|Overall Study||37
3033317|NCT01127737|3752574|FG001|COMPLETED|Overall Study||38
3033318|NCT01127737|3752573|FG000|NOT COMPLETED|Overall Study||0
3033319|NCT01127737|3752574|FG001|NOT COMPLETED|Overall Study||0
3033320|NCT01127763|3752580|FG000|STARTED|Overall Study||25
3033321|NCT01127763|3752580|FG000|COMPLETED|Overall Study|Patients off study due to disease progression were considered to have completed the study.|20
3033322|NCT01127763|3752580|FG000|NOT COMPLETED|Overall Study||5
3033323|NCT01127893|3752588|FG000|STARTED|Overall Study||1
3033324|NCT01127893|3752588|FG000|COMPLETED|Overall Study||0
3033325|NCT01127893|3752588|FG000|NOT COMPLETED|Overall Study||1
3033326|NCT01128049|3752595|FG000|STARTED|Overall Study||5
3033327|NCT01128049|3752596|FG001|STARTED|Overall Study||5
3033328|NCT01128049|3752597|FG002|STARTED|Overall Study||5
3033329|NCT01128049|3752595|FG000|COMPLETED|Overall Study||5
3033330|NCT01128049|3752596|FG001|COMPLETED|Overall Study||5
3033331|NCT01128049|3752597|FG002|COMPLETED|Overall Study||5
3033332|NCT01128049|3752595|FG000|NOT COMPLETED|Overall Study||0
3033333|NCT01128049|3752596|FG001|NOT COMPLETED|Overall Study||0
3033334|NCT01128049|3752597|FG002|NOT COMPLETED|Overall Study||0
3033335|NCT01128153|3752607|FG000|STARTED|Overall Study|Randomised|129
3033336|NCT01128153|3752608|FG001|STARTED|Overall Study|Randomised|128
3033337|NCT01128153|3752607|FG000|Full Analysis Set|Overall Study|Received at least 1 dose of investigational product during 24 week blinded period|127
3033338|NCT01128153|3752608|FG001|Full Analysis Set|Overall Study|Received at least 1 dose of investigational product during 24 week blinded period|128
3033339|NCT01128153|3752607|FG000|COMPLETED|Overall Study|Completed 24 weeks|113
3033340|NCT01128153|3752608|FG001|COMPLETED|Overall Study|Completed 24 weeks|113
3033341|NCT01128153|3752607|FG000|NOT COMPLETED|Overall Study||16
3033342|NCT01128153|3752608|FG001|NOT COMPLETED|Overall Study||15
3033343|NCT01128179|3752616|FG000|STARTED|Overall Study||23
3033344|NCT01128179|3752617|FG001|STARTED|Overall Study||12
3033345|NCT01128179|3752616|FG000|COMPLETED|Overall Study||21
3033346|NCT01128179|3752617|FG001|COMPLETED|Overall Study||12
3033347|NCT01128179|3752616|FG000|NOT COMPLETED|Overall Study||2
3033348|NCT01128179|3752617|FG001|NOT COMPLETED|Overall Study||0
3033349|NCT01128192|3752625|FG000|STARTED|Overall Study||19
3033350|NCT01128192|3752626|FG001|STARTED|Overall Study||19
3033351|NCT01128192|3752627|FG002|STARTED|Overall Study||7
3033352|NCT01128192|3752625|FG000|COMPLETED|Overall Study||19
3033353|NCT01128192|3752626|FG001|COMPLETED|Overall Study||19
3033354|NCT01128192|3752627|FG002|COMPLETED|Overall Study||7
3033355|NCT01128192|3752625|FG000|NOT COMPLETED|Overall Study||0
3033356|NCT01128192|3752626|FG001|NOT COMPLETED|Overall Study||0
3033357|NCT01128192|3752627|FG002|NOT COMPLETED|Overall Study||0
3033358|NCT01128244|3752638|FG000|STARTED|Overall Study||13
3033359|NCT01128244|3752638|FG000|COMPLETED|Overall Study||10
3033360|NCT01128244|3752638|FG000|NOT COMPLETED|Overall Study||3
3033361|NCT01128270|3752646|FG000|STARTED|Environment Chloral Hydrate and DCA (1A)||7
3033362|NCT01128270|3752646|FG000|COMPLETED|Environment Chloral Hydrate and DCA (1A)||7
3033363|NCT01128270|3752646|FG000|NOT COMPLETED|Environment Chloral Hydrate and DCA (1A)||0
3033364|NCT01128270|3752646|FG000|STARTED|Environmental Chloral Hydrate (1B)|Per the suggestion from Heather, periods are not in chronological order, but defined by treatment.|8
3033365|NCT01128270|3752646|FG000|COMPLETED|Environmental Chloral Hydrate (1B)||8
3033366|NCT01128270|3752646|FG000|NOT COMPLETED|Environmental Chloral Hydrate (1B)||0
3033367|NCT01128270|3752646|FG000|STARTED|Therapeutic Chloral Hydrate and DCA (2A)||8
3033368|NCT01128270|3752646|FG000|COMPLETED|Therapeutic Chloral Hydrate and DCA (2A)||8
3033369|NCT01128270|3752646|FG000|NOT COMPLETED|Therapeutic Chloral Hydrate and DCA (2A)||0
3033370|NCT01128270|3752646|FG000|STARTED|Therapeutic Chloral Hydrate (2B)||8
3033371|NCT01128270|3752646|FG000|COMPLETED|Therapeutic Chloral Hydrate (2B)||8
3033372|NCT01128270|3752646|FG000|NOT COMPLETED|Therapeutic Chloral Hydrate (2B)||0
3033373|NCT01128296|3752658|FG000|STARTED|Overall Study||1
3033374|NCT01128296|3752659|FG001|STARTED|Overall Study||1
3033375|NCT01128296|3752660|FG002|STARTED|Overall Study||1
3033376|NCT01128296|3752661|FG003|STARTED|Overall Study||1
3033377|NCT01128296|3752662|FG004|STARTED|Overall Study||1
3033378|NCT01128296|3752663|FG005|STARTED|Overall Study||26
3033379|NCT01128296|3752658|FG000|COMPLETED|Overall Study||1
3033380|NCT01128296|3752659|FG001|COMPLETED|Overall Study||1
3033381|NCT01128296|3752660|FG002|COMPLETED|Overall Study||1
3033382|NCT01128296|3752661|FG003|COMPLETED|Overall Study||1
3033383|NCT01128296|3752662|FG004|COMPLETED|Overall Study||1
3033384|NCT01128296|3752663|FG005|COMPLETED|Overall Study||21
3033385|NCT01128296|3752658|FG000|NOT COMPLETED|Overall Study||0
3033386|NCT01128296|3752659|FG001|NOT COMPLETED|Overall Study||0
3033387|NCT01128296|3752660|FG002|NOT COMPLETED|Overall Study||0
3033388|NCT01128296|3752661|FG003|NOT COMPLETED|Overall Study||0
3033389|NCT01128296|3752662|FG004|NOT COMPLETED|Overall Study||0
3033390|NCT01128296|3752663|FG005|NOT COMPLETED|Overall Study||5
3033391|NCT01128361|3752676|FG000|STARTED|Overall Study||39
3033392|NCT01128361|3752677|FG001|STARTED|Overall Study||37
3033393|NCT01128361|3752676|FG000|COMPLETED|Overall Study||34
3033394|NCT01128361|3752677|FG001|COMPLETED|Overall Study||34
3033395|NCT01128361|3752676|FG000|NOT COMPLETED|Overall Study||5
3033396|NCT01128361|3752677|FG001|NOT COMPLETED|Overall Study||3
3033397|NCT01128387|3752685|FG000|STARTED|Overall Study||5
3033398|NCT01128387|3752686|FG001|STARTED|Overall Study||6
3033399|NCT01128387|3752685|FG000|COMPLETED|Overall Study||5
3033400|NCT01128387|3752686|FG001|COMPLETED|Overall Study||5
3033401|NCT01128387|3752685|FG000|NOT COMPLETED|Overall Study||0
3033402|NCT01128387|3752686|FG001|NOT COMPLETED|Overall Study||1
3033403|NCT01128400|3752695|FG000|STARTED|Overall Study||8
3033404|NCT01128400|3752696|FG001|STARTED|Overall Study||9
3033405|NCT01128400|3752697|FG002|STARTED|Overall Study||23
3033406|NCT01128400|3752695|FG000|COMPLETED|Overall Study||6
3033407|NCT01128400|3752696|FG001|COMPLETED|Overall Study||8
3033408|NCT01128400|3752697|FG002|COMPLETED|Overall Study||7
3033409|NCT01128400|3752695|FG000|NOT COMPLETED|Overall Study||2
3033410|NCT01128400|3752696|FG001|NOT COMPLETED|Overall Study||1
3033411|NCT01128400|3752697|FG002|NOT COMPLETED|Overall Study||16
3033412|NCT01128413|3752707|FG000|STARTED|Overall Study||11
3033413|NCT01128413|3752708|FG001|STARTED|Overall Study||11
3033414|NCT01128413|3752707|FG000|COMPLETED|Overall Study||7
3033415|NCT01128413|3752708|FG001|COMPLETED|Overall Study||10
3033416|NCT01128413|3752707|FG000|NOT COMPLETED|Overall Study||4
3033417|NCT01128413|3752708|FG001|NOT COMPLETED|Overall Study||1
3033418|NCT01128426|3752714|FG000|STARTED|Overall Study||53902
3033419|NCT01128426|3752714|FG000|COMPLETED|Overall Study||53902
3033420|NCT01128426|3752714|FG000|NOT COMPLETED|Overall Study||0
3033421|NCT01128543|3752720|FG000|STARTED|Overall Study||29
3033422|NCT01128543|3752720|FG000|COMPLETED|Overall Study||25
3033423|NCT01128543|3752720|FG000|NOT COMPLETED|Overall Study||4
3033424|NCT01128569|3752724|FG000|STARTED|Treatment Period 1||9
3033425|NCT01128569|3752725|FG001|STARTED|Treatment Period 1||8
3033426|NCT01128569|3752726|FG002|STARTED|Treatment Period 1||9
3033427|NCT01128569|3752727|FG003|STARTED|Treatment Period 1||8
3033428|NCT01128569|3752728|FG004|STARTED|Treatment Period 1||9
3033429|NCT01128569|3752729|FG005|STARTED|Treatment Period 1||9
3383828|NCT01917318|4118981|FG000|STARTED|First Treatment||0
3383829|NCT01917318|4118982|FG001|STARTED|First Treatment||1
3383830|NCT01917318|4118981|FG000|COMPLETED|First Treatment||0
3383831|NCT01917318|4118982|FG001|COMPLETED|First Treatment||0
2911642|NCT00485836|3621420|FG001|NOT COMPLETED|Overall Study||3
2911643|NCT00485836|3621421|FG002|NOT COMPLETED|Overall Study||11
2911644|NCT00485953|3621431|FG000|STARTED|Overall Study||55
2911645|NCT00485953|3621432|FG001|STARTED|Overall Study||54
2911646|NCT00485953|3621431|FG000|COMPLETED|Overall Study||48
2911647|NCT00485953|3621432|FG001|COMPLETED|Overall Study||47
2911648|NCT00485953|3621431|FG000|NOT COMPLETED|Overall Study||7
2911649|NCT00485953|3621432|FG001|NOT COMPLETED|Overall Study||7
3383832|NCT01917318|4118981|FG000|NOT COMPLETED|First Treatment||0
3033430|NCT01128569|3752724|FG000|COMPLETED|Treatment Period 1||9
3033431|NCT01128569|3752725|FG001|COMPLETED|Treatment Period 1||8
3033432|NCT01128569|3752726|FG002|COMPLETED|Treatment Period 1||9
3033433|NCT01128569|3752727|FG003|COMPLETED|Treatment Period 1||8
3033434|NCT01128569|3752728|FG004|COMPLETED|Treatment Period 1||9
3033435|NCT01128569|3752729|FG005|COMPLETED|Treatment Period 1||9
3033436|NCT01128569|3752724|FG000|NOT COMPLETED|Treatment Period 1||0
3033437|NCT01128569|3752725|FG001|NOT COMPLETED|Treatment Period 1||0
3033438|NCT01128569|3752726|FG002|NOT COMPLETED|Treatment Period 1||0
3033439|NCT01128569|3752727|FG003|NOT COMPLETED|Treatment Period 1||0
3033440|NCT01128569|3752728|FG004|NOT COMPLETED|Treatment Period 1||0
3033441|NCT01128569|3752729|FG005|NOT COMPLETED|Treatment Period 1||0
3033442|NCT01128569|3752724|FG000|STARTED|Washout Period 1||9
3033443|NCT01128569|3752725|FG001|STARTED|Washout Period 1||8
3033444|NCT01128569|3752726|FG002|STARTED|Washout Period 1||9
3033445|NCT01128569|3752727|FG003|STARTED|Washout Period 1||8
3033446|NCT01128569|3752728|FG004|STARTED|Washout Period 1||9
3033447|NCT01128569|3752729|FG005|STARTED|Washout Period 1||9
3033448|NCT01128569|3752724|FG000|COMPLETED|Washout Period 1||9
3033449|NCT01128569|3752725|FG001|COMPLETED|Washout Period 1||8
3033450|NCT01128569|3752726|FG002|COMPLETED|Washout Period 1||8
3033451|NCT01128569|3752727|FG003|COMPLETED|Washout Period 1||8
3033452|NCT01128569|3752728|FG004|COMPLETED|Washout Period 1||9
3033453|NCT01128569|3752729|FG005|COMPLETED|Washout Period 1||9
3033454|NCT01128569|3752724|FG000|NOT COMPLETED|Washout Period 1||0
3033455|NCT01128569|3752725|FG001|NOT COMPLETED|Washout Period 1||0
3033456|NCT01128569|3752726|FG002|NOT COMPLETED|Washout Period 1||1
3033457|NCT01128569|3752727|FG003|NOT COMPLETED|Washout Period 1||0
3033458|NCT01128569|3752728|FG004|NOT COMPLETED|Washout Period 1||0
3033459|NCT01128569|3752729|FG005|NOT COMPLETED|Washout Period 1||0
3033460|NCT01128569|3752724|FG000|STARTED|Treatment Period 2||9
3033461|NCT01128569|3752725|FG001|STARTED|Treatment Period 2||8
3033462|NCT01128569|3752726|FG002|STARTED|Treatment Period 2||8
3033463|NCT01128569|3752727|FG003|STARTED|Treatment Period 2||8
3033464|NCT01128569|3752728|FG004|STARTED|Treatment Period 2||9
3033465|NCT01128569|3752729|FG005|STARTED|Treatment Period 2||9
3033466|NCT01128569|3752724|FG000|COMPLETED|Treatment Period 2||9
3033467|NCT01128569|3752725|FG001|COMPLETED|Treatment Period 2||7
3033468|NCT01128569|3752726|FG002|COMPLETED|Treatment Period 2||8
3033469|NCT01128569|3752727|FG003|COMPLETED|Treatment Period 2||8
3033470|NCT01128569|3752728|FG004|COMPLETED|Treatment Period 2||9
3033471|NCT01128569|3752729|FG005|COMPLETED|Treatment Period 2||9
3033472|NCT01128569|3752724|FG000|NOT COMPLETED|Treatment Period 2||0
3033473|NCT01128569|3752725|FG001|NOT COMPLETED|Treatment Period 2||1
3033474|NCT01128569|3752726|FG002|NOT COMPLETED|Treatment Period 2||0
3033475|NCT01128569|3752727|FG003|NOT COMPLETED|Treatment Period 2||0
3033476|NCT01128569|3752728|FG004|NOT COMPLETED|Treatment Period 2||0
3310099|NCT03037307|4043444|FG000|NOT COMPLETED|Period 2||0
3383833|NCT01917318|4118982|FG001|NOT COMPLETED|First Treatment||1
3383834|NCT01917318|4118981|FG000|STARTED|Second Treatment||0
3383835|NCT01917318|4118982|FG001|STARTED|Second Treatment||0
3383836|NCT01917318|4118981|FG000|COMPLETED|Second Treatment||0
3383837|NCT01917318|4118982|FG001|COMPLETED|Second Treatment||0
3383838|NCT01917318|4118981|FG000|NOT COMPLETED|Second Treatment||0
3383839|NCT01917318|4118982|FG001|NOT COMPLETED|Second Treatment||0
3385847|NCT02740972|4121259|FG004|COMPLETED|4-week Double-blinded Placebo-controlled||0
3385848|NCT02740972|4121255|FG000|NOT COMPLETED|4-week Double-blinded Placebo-controlled||0
3385849|NCT02740972|4121256|FG001|NOT COMPLETED|4-week Double-blinded Placebo-controlled||0
3385850|NCT02740972|4121257|FG002|NOT COMPLETED|4-week Double-blinded Placebo-controlled||0
3385851|NCT02740972|4121258|FG003|NOT COMPLETED|4-week Double-blinded Placebo-controlled||0
3385852|NCT02740972|4121259|FG004|NOT COMPLETED|4-week Double-blinded Placebo-controlled||0
3385853|NCT02740972|4121255|FG000|STARTED|20-week Open Label Treatment Period||0
3385854|NCT02740972|4121256|FG001|STARTED|20-week Open Label Treatment Period||0
3385855|NCT02740972|4121257|FG002|STARTED|20-week Open Label Treatment Period||0
3385856|NCT02740972|4121258|FG003|STARTED|20-week Open Label Treatment Period||8
3385857|NCT02740972|4121259|FG004|STARTED|20-week Open Label Treatment Period||8
3385858|NCT02740972|4121255|FG000|COMPLETED|20-week Open Label Treatment Period||0
3385859|NCT02740972|4121256|FG001|COMPLETED|20-week Open Label Treatment Period||0
3385860|NCT02740972|4121257|FG002|COMPLETED|20-week Open Label Treatment Period||0
3385861|NCT02740972|4121258|FG003|COMPLETED|20-week Open Label Treatment Period||8
3385862|NCT02740972|4121259|FG004|COMPLETED|20-week Open Label Treatment Period||8
3385863|NCT02740972|4121255|FG000|NOT COMPLETED|20-week Open Label Treatment Period||0
3385864|NCT02740972|4121256|FG001|NOT COMPLETED|20-week Open Label Treatment Period||0
3385865|NCT02740972|4121257|FG002|NOT COMPLETED|20-week Open Label Treatment Period||0
3310100|NCT03037307|4043445|FG001|NOT COMPLETED|Period 2||0
3310101|NCT03037307|4043446|FG002|NOT COMPLETED|Period 2||0
3310102|NCT03037307|4043447|FG003|NOT COMPLETED|Period 2||0
3310103|NCT03037307|4043448|FG004|NOT COMPLETED|Period 2||0
3310104|NCT03037307|4043449|FG005|NOT COMPLETED|Period 2||0
3310105|NCT03037307|4043444|FG000|STARTED|Wash Out Period 2||7
3385866|NCT02740972|4121258|FG003|NOT COMPLETED|20-week Open Label Treatment Period||0
3385867|NCT02740972|4121259|FG004|NOT COMPLETED|20-week Open Label Treatment Period||0
3385868|NCT02662985|4121278|FG000|STARTED|Treatment Period 1||83
3310106|NCT03037307|4043445|FG001|STARTED|Wash Out Period 2||7
3310107|NCT03037307|4043446|FG002|STARTED|Wash Out Period 2||8
3033477|NCT01128569|3752729|FG005|NOT COMPLETED|Treatment Period 2||0
3033478|NCT01128569|3752724|FG000|STARTED|Washout Period 2||9
3033479|NCT01128569|3752725|FG001|STARTED|Washout Period 2||7
3033480|NCT01128569|3752726|FG002|STARTED|Washout Period 2||8
3033481|NCT01128569|3752727|FG003|STARTED|Washout Period 2||8
3033482|NCT01128569|3752728|FG004|STARTED|Washout Period 2||9
3033483|NCT01128569|3752729|FG005|STARTED|Washout Period 2||9
3033484|NCT01128569|3752724|FG000|COMPLETED|Washout Period 2||9
3033485|NCT01128569|3752725|FG001|COMPLETED|Washout Period 2||7
3033486|NCT01128569|3752726|FG002|COMPLETED|Washout Period 2||8
3310108|NCT03037307|4043447|FG003|STARTED|Wash Out Period 2||6
3310109|NCT03037307|4043448|FG004|STARTED|Wash Out Period 2||7
3310110|NCT03037307|4043449|FG005|STARTED|Wash Out Period 2||8
3310111|NCT03037307|4043444|FG000|COMPLETED|Wash Out Period 2||7
3310112|NCT03037307|4043445|FG001|COMPLETED|Wash Out Period 2||7
3383840|NCT01921218|4118990|FG000|STARTED|Overall Study||6
3166185|NCT01903460|3893610|FG003|COMPLETED|Overall Study||2
3166186|NCT01903460|3893607|FG000|NOT COMPLETED|Overall Study||0
3166187|NCT01903460|3893608|FG001|NOT COMPLETED|Overall Study||0
3166188|NCT01903460|3893609|FG002|NOT COMPLETED|Overall Study||0
3383841|NCT01921218|4118991|FG001|STARTED|Overall Study||7
3383842|NCT01921218|4118990|FG000|COMPLETED|Overall Study||3
3033487|NCT01128569|3752727|FG003|COMPLETED|Washout Period 2||8
3033488|NCT01128569|3752728|FG004|COMPLETED|Washout Period 2||9
3033489|NCT01128569|3752729|FG005|COMPLETED|Washout Period 2||9
3033490|NCT01128569|3752724|FG000|NOT COMPLETED|Washout Period 2||0
3033491|NCT01128569|3752725|FG001|NOT COMPLETED|Washout Period 2||0
3033492|NCT01128569|3752726|FG002|NOT COMPLETED|Washout Period 2||0
3033493|NCT01128569|3752727|FG003|NOT COMPLETED|Washout Period 2||0
3033494|NCT01128569|3752728|FG004|NOT COMPLETED|Washout Period 2||0
3033495|NCT01128569|3752729|FG005|NOT COMPLETED|Washout Period 2||0
3033496|NCT01128569|3752724|FG000|STARTED|Treatment Period 3||9
3033497|NCT01128569|3752725|FG001|STARTED|Treatment Period 3||7
3033498|NCT01128569|3752726|FG002|STARTED|Treatment Period 3||8
3033499|NCT01128569|3752727|FG003|STARTED|Treatment Period 3||8
3033500|NCT01128569|3752728|FG004|STARTED|Treatment Period 3||9
3033501|NCT01128569|3752729|FG005|STARTED|Treatment Period 3||9
3033502|NCT01128569|3752724|FG000|COMPLETED|Treatment Period 3||9
3033503|NCT01128569|3752725|FG001|COMPLETED|Treatment Period 3||7
3033504|NCT01128569|3752726|FG002|COMPLETED|Treatment Period 3||8
3033505|NCT01128569|3752727|FG003|COMPLETED|Treatment Period 3||8
3033506|NCT01128569|3752728|FG004|COMPLETED|Treatment Period 3||9
3033507|NCT01128569|3752729|FG005|COMPLETED|Treatment Period 3||9
3033508|NCT01128569|3752724|FG000|NOT COMPLETED|Treatment Period 3||0
3033509|NCT01128569|3752725|FG001|NOT COMPLETED|Treatment Period 3||0
3033510|NCT01128569|3752726|FG002|NOT COMPLETED|Treatment Period 3||0
3033511|NCT01128569|3752727|FG003|NOT COMPLETED|Treatment Period 3||0
3033512|NCT01128569|3752728|FG004|NOT COMPLETED|Treatment Period 3||0
3033513|NCT01128569|3752729|FG005|NOT COMPLETED|Treatment Period 3||0
3033514|NCT01128595|3752737|FG000|STARTED|Treatment Period 1||7
3033515|NCT01128595|3752738|FG001|STARTED|Treatment Period 1||6
3033516|NCT01128595|3752739|FG002|STARTED|Treatment Period 1||7
3033517|NCT01128595|3752740|FG003|STARTED|Treatment Period 1||7
3033518|NCT01128595|3752737|FG000|COMPLETED|Treatment Period 1||7
3033519|NCT01128595|3752738|FG001|COMPLETED|Treatment Period 1||6
3033520|NCT01128595|3752739|FG002|COMPLETED|Treatment Period 1||7
3383843|NCT01921218|4118991|FG001|COMPLETED|Overall Study||3
3383844|NCT01921218|4118990|FG000|NOT COMPLETED|Overall Study||3
3383845|NCT01921218|4118991|FG001|NOT COMPLETED|Overall Study||4
3385869|NCT02662985|4121279|FG001|STARTED|Treatment Period 1||83
3385870|NCT02662985|4121278|FG000|COMPLETED|Treatment Period 1||82
3385871|NCT02662985|4121279|FG001|COMPLETED|Treatment Period 1||79
3385872|NCT02662985|4121278|FG000|NOT COMPLETED|Treatment Period 1||1
3385873|NCT02662985|4121279|FG001|NOT COMPLETED|Treatment Period 1||4
3385874|NCT02662985|4121278|FG000|STARTED|Treatment Period 2||82
3385875|NCT02662985|4121279|FG001|STARTED|Treatment Period 2||79
3385876|NCT02662985|4121278|FG000|COMPLETED|Treatment Period 2||81
3385877|NCT02662985|4121279|FG001|COMPLETED|Treatment Period 2||78
3385878|NCT02662985|4121278|FG000|NOT COMPLETED|Treatment Period 2||1
3385879|NCT02662985|4121279|FG001|NOT COMPLETED|Treatment Period 2||1
3385880|NCT02662985|4121278|FG000|STARTED|Treatment Period 3 (Extension Period)||81
3385881|NCT02662985|4121279|FG001|STARTED|Treatment Period 3 (Extension Period)||78
3385882|NCT02662985|4121278|FG000|COMPLETED|Treatment Period 3 (Extension Period)||75
3385883|NCT02662985|4121279|FG001|COMPLETED|Treatment Period 3 (Extension Period)||69
3385884|NCT02662985|4121278|FG000|NOT COMPLETED|Treatment Period 3 (Extension Period)||6
3385885|NCT02662985|4121279|FG001|NOT COMPLETED|Treatment Period 3 (Extension Period)||9
3385886|NCT02606461|4121289|FG000|STARTED|Overall Study||27
3385887|NCT02606461|4121290|FG001|STARTED|Overall Study||30
3385888|NCT02606461|4121291|FG002|STARTED|Overall Study||188
3385889|NCT02606461|4121292|FG003|STARTED|Overall Study||97
3385890|NCT02606461|4121289|FG000|Treated|Overall Study||27
3033521|NCT01128595|3752740|FG003|COMPLETED|Treatment Period 1||7
3033522|NCT01128595|3752737|FG000|NOT COMPLETED|Treatment Period 1||0
3033523|NCT01128595|3752738|FG001|NOT COMPLETED|Treatment Period 1||0
3166189|NCT01903460|3893610|FG003|NOT COMPLETED|Overall Study||1
3166190|NCT01903525|3893621|FG000|STARTED|Overall Study||20
3310113|NCT03037307|4043446|FG002|COMPLETED|Wash Out Period 2||8
3385891|NCT02606461|4121290|FG001|Treated|Overall Study||30
3385892|NCT02606461|4121291|FG002|Treated|Overall Study||187
3033524|NCT01128595|3752739|FG002|NOT COMPLETED|Treatment Period 1||0
3033525|NCT01128595|3752740|FG003|NOT COMPLETED|Treatment Period 1||0
3033526|NCT01128595|3752737|FG000|STARTED|Washout Period 1||7
3033527|NCT01128595|3752738|FG001|STARTED|Washout Period 1||6
3033528|NCT01128595|3752739|FG002|STARTED|Washout Period 1||7
3033529|NCT01128595|3752740|FG003|STARTED|Washout Period 1||7
3033530|NCT01128595|3752737|FG000|COMPLETED|Washout Period 1||7
3033531|NCT01128595|3752738|FG001|COMPLETED|Washout Period 1||6
3033532|NCT01128595|3752739|FG002|COMPLETED|Washout Period 1||7
3033533|NCT01128595|3752740|FG003|COMPLETED|Washout Period 1||7
3033534|NCT01128595|3752737|FG000|NOT COMPLETED|Washout Period 1||0
3033535|NCT01128595|3752738|FG001|NOT COMPLETED|Washout Period 1||0
3033536|NCT01128595|3752739|FG002|NOT COMPLETED|Washout Period 1||0
3033537|NCT01128595|3752740|FG003|NOT COMPLETED|Washout Period 1||0
3033538|NCT01128595|3752737|FG000|STARTED|Treatment Period 2||7
3033539|NCT01128595|3752738|FG001|STARTED|Treatment Period 2||6
3033540|NCT01128595|3752739|FG002|STARTED|Treatment Period 2||7
3033541|NCT01128595|3752740|FG003|STARTED|Treatment Period 2||7
3033542|NCT01128595|3752737|FG000|COMPLETED|Treatment Period 2||7
3033543|NCT01128595|3752738|FG001|COMPLETED|Treatment Period 2||6
3033544|NCT01128595|3752739|FG002|COMPLETED|Treatment Period 2||7
3033545|NCT01128595|3752740|FG003|COMPLETED|Treatment Period 2||7
3033546|NCT01128595|3752737|FG000|NOT COMPLETED|Treatment Period 2||0
3033547|NCT01128595|3752738|FG001|NOT COMPLETED|Treatment Period 2||0
3033548|NCT01128595|3752739|FG002|NOT COMPLETED|Treatment Period 2||0
3033549|NCT01128595|3752740|FG003|NOT COMPLETED|Treatment Period 2||0
3033550|NCT01128595|3752737|FG000|STARTED|Washout Period 2||7
3033551|NCT01128595|3752738|FG001|STARTED|Washout Period 2||6
3033552|NCT01128595|3752739|FG002|STARTED|Washout Period 2||7
3033553|NCT01128595|3752740|FG003|STARTED|Washout Period 2||7
3033554|NCT01128595|3752737|FG000|COMPLETED|Washout Period 2||7
3033555|NCT01128595|3752738|FG001|COMPLETED|Washout Period 2||6
3033556|NCT01128595|3752739|FG002|COMPLETED|Washout Period 2||7
3033557|NCT01128595|3752740|FG003|COMPLETED|Washout Period 2||7
3033558|NCT01128595|3752737|FG000|NOT COMPLETED|Washout Period 2||0
3033559|NCT01128595|3752738|FG001|NOT COMPLETED|Washout Period 2||0
3033560|NCT01128595|3752739|FG002|NOT COMPLETED|Washout Period 2||0
3033561|NCT01128595|3752740|FG003|NOT COMPLETED|Washout Period 2||0
3033562|NCT01128595|3752737|FG000|STARTED|Treatment Period 3||7
3033563|NCT01128595|3752738|FG001|STARTED|Treatment Period 3||6
3033564|NCT01128595|3752739|FG002|STARTED|Treatment Period 3||7
3033565|NCT01128595|3752740|FG003|STARTED|Treatment Period 3||7
3033566|NCT01128595|3752737|FG000|COMPLETED|Treatment Period 3||7
3033567|NCT01128595|3752738|FG001|COMPLETED|Treatment Period 3||5
3033568|NCT01128595|3752739|FG002|COMPLETED|Treatment Period 3||7
3310114|NCT03037307|4043447|FG003|COMPLETED|Wash Out Period 2||6
3310115|NCT03037307|4043448|FG004|COMPLETED|Wash Out Period 2||7
3310116|NCT03037307|4043449|FG005|COMPLETED|Wash Out Period 2||8
3310117|NCT03037307|4043444|FG000|NOT COMPLETED|Wash Out Period 2||0
3310118|NCT03037307|4043445|FG001|NOT COMPLETED|Wash Out Period 2||0
3383846|NCT01923168|4119000|FG000|STARTED|Overall Study||131
3383847|NCT01923168|4119001|FG001|STARTED|Overall Study||83
3383848|NCT01923168|4119002|FG002|STARTED|Overall Study||126
3383849|NCT01923168|4119000|FG000|COMPLETED|Overall Study||94
3383850|NCT01923168|4119001|FG001|COMPLETED|Overall Study||44
3383851|NCT01923168|4119002|FG002|COMPLETED|Overall Study||109
3383852|NCT01923168|4119000|FG000|NOT COMPLETED|Overall Study||37
3383853|NCT01923168|4119001|FG001|NOT COMPLETED|Overall Study||39
3383854|NCT01923168|4119002|FG002|NOT COMPLETED|Overall Study||17
3385893|NCT02606461|4121292|FG003|Treated|Overall Study||97
3385894|NCT02606461|4121289|FG000|Open Label|Overall Study||0
3385895|NCT02606461|4121290|FG001|Open Label|Overall Study|Participants in the placebo group who had PD during the Phase 2 double-blinded treatment, switched to open-label selinexor.|24
3385896|NCT02606461|4121291|FG002|Open Label|Overall Study||0
3385897|NCT02606461|4121292|FG003|Open Label|Overall Study|Participants in the placebo group who had PD during the Phase 3 double-blinded treatment, switched to open-label selinexor.|57
3385898|NCT02606461|4121289|FG000|COMPLETED|Overall Study||0
3385899|NCT02606461|4121290|FG001|COMPLETED|Overall Study||0
3385900|NCT02606461|4121291|FG002|COMPLETED|Overall Study||0
3385901|NCT02606461|4121292|FG003|COMPLETED|Overall Study||0
3385902|NCT02606461|4121289|FG000|NOT COMPLETED|Overall Study||27
3385903|NCT02606461|4121290|FG001|NOT COMPLETED|Overall Study||30
3385904|NCT02606461|4121291|FG002|NOT COMPLETED|Overall Study||188
3385905|NCT02606461|4121292|FG003|NOT COMPLETED|Overall Study||97
3385906|NCT02536339|4121305|FG000|STARTED|Overall Study||40
3385907|NCT02536339|4121305|FG000|Received at Least One Dose of Study Drug|Overall Study||39
3385908|NCT02536339|4121305|FG000|Efficacy-Evaluable Population|Overall Study|2 participants did not have post-baseline assessments and were not evaluable for efficacy.|37
3385909|NCT02536339|4121305|FG000|COMPLETED|Overall Study||12
3385910|NCT02536339|4121305|FG000|NOT COMPLETED|Overall Study||28
3385911|NCT02514083|4121309|FG000|STARTED|Overall Study||29
3385912|NCT02514083|4121309|FG000|COMPLETED|Overall Study||28
3033569|NCT01128595|3752740|FG003|COMPLETED|Treatment Period 3||7
3033570|NCT01128595|3752737|FG000|NOT COMPLETED|Treatment Period 3||0
3033571|NCT01128595|3752738|FG001|NOT COMPLETED|Treatment Period 3||1
3033572|NCT01128595|3752739|FG002|NOT COMPLETED|Treatment Period 3||0
3033573|NCT01128595|3752740|FG003|NOT COMPLETED|Treatment Period 3||0
3033574|NCT01128595|3752737|FG000|STARTED|Washout Period 3||7
3033575|NCT01128595|3752738|FG001|STARTED|Washout Period 3||5
3033576|NCT01128595|3752739|FG002|STARTED|Washout Period 3||7
3033577|NCT01128595|3752740|FG003|STARTED|Washout Period 3||7
3033578|NCT01128595|3752737|FG000|COMPLETED|Washout Period 3||7
3033579|NCT01128595|3752738|FG001|COMPLETED|Washout Period 3||5
3033580|NCT01128595|3752739|FG002|COMPLETED|Washout Period 3||7
3033581|NCT01128595|3752740|FG003|COMPLETED|Washout Period 3||7
3033582|NCT01128595|3752737|FG000|NOT COMPLETED|Washout Period 3||0
3033583|NCT01128595|3752738|FG001|NOT COMPLETED|Washout Period 3||0
3033584|NCT01128595|3752739|FG002|NOT COMPLETED|Washout Period 3||0
3033585|NCT01128595|3752740|FG003|NOT COMPLETED|Washout Period 3||0
3033586|NCT01128595|3752737|FG000|STARTED|Treatment Period 4||7
3033587|NCT01128595|3752738|FG001|STARTED|Treatment Period 4||5
3033588|NCT01128595|3752739|FG002|STARTED|Treatment Period 4||7
3033589|NCT01128595|3752740|FG003|STARTED|Treatment Period 4||7
3033590|NCT01128595|3752737|FG000|COMPLETED|Treatment Period 4||7
3033591|NCT01128595|3752738|FG001|COMPLETED|Treatment Period 4||5
3033592|NCT01128595|3752739|FG002|COMPLETED|Treatment Period 4||7
3033593|NCT01128595|3752740|FG003|COMPLETED|Treatment Period 4||7
3033594|NCT01128595|3752737|FG000|NOT COMPLETED|Treatment Period 4||0
3033595|NCT01128595|3752738|FG001|NOT COMPLETED|Treatment Period 4||0
3033596|NCT01128595|3752739|FG002|NOT COMPLETED|Treatment Period 4||0
3033597|NCT01128595|3752740|FG003|NOT COMPLETED|Treatment Period 4||0
3033598|NCT01128621|3752753|FG000|STARTED|Part A: GSK1292263 300 mg||6
3033599|NCT01128621|3752754|FG001|STARTED|Part A: GSK1292263 300 mg||0
3033600|NCT01128621|3752753|FG000|COMPLETED|Part A: GSK1292263 300 mg||6
3033601|NCT01128621|3752754|FG001|COMPLETED|Part A: GSK1292263 300 mg||0
3033602|NCT01128621|3752753|FG000|NOT COMPLETED|Part A: GSK1292263 300 mg||0
3033603|NCT01128621|3752754|FG001|NOT COMPLETED|Part A: GSK1292263 300 mg||0
3033604|NCT01128621|3752753|FG000|STARTED|Part B: GSK1292263 75 mg/300 mg/ 600 mg||0
3033605|NCT01128621|3752754|FG001|STARTED|Part B: GSK1292263 75 mg/300 mg/ 600 mg||67
3033606|NCT01128621|3752753|FG000|COMPLETED|Part B: GSK1292263 75 mg/300 mg/ 600 mg||0
3033607|NCT01128621|3752754|FG001|COMPLETED|Part B: GSK1292263 75 mg/300 mg/ 600 mg||65
3033608|NCT01128621|3752753|FG000|NOT COMPLETED|Part B: GSK1292263 75 mg/300 mg/ 600 mg||0
3033609|NCT01128621|3752754|FG001|NOT COMPLETED|Part B: GSK1292263 75 mg/300 mg/ 600 mg||2
3038297|NCT01153503|3757687|FG001|NOT COMPLETED|Overall Study||1
3038298|NCT01153503|3757688|FG002|NOT COMPLETED|Overall Study||0
3038299|NCT01153516|3757698|FG000|STARTED|Overall Study||12
3038300|NCT01153516|3757699|FG001|STARTED|Overall Study||10
3038301|NCT01153516|3757698|FG000|COMPLETED|Overall Study||10
3038302|NCT01153516|3757699|FG001|COMPLETED|Overall Study||10
3038303|NCT01153516|3757698|FG000|NOT COMPLETED|Overall Study||2
3038304|NCT01153516|3757699|FG001|NOT COMPLETED|Overall Study||0
3038305|NCT01153581|3757705|FG000|STARTED|Overall Study||109
3038306|NCT01153581|3757705|FG000|COMPLETED|Overall Study||109
3038307|NCT01153581|3757705|FG000|NOT COMPLETED|Overall Study||0
3038308|NCT01153620|3757717|FG000|STARTED|Overall Study||30
3038309|NCT01153620|3757718|FG001|STARTED|Overall Study|30 patients (31 wounds)|30
3038310|NCT01153620|3757717|FG000|COMPLETED|Overall Study||30
3038311|NCT01153620|3757718|FG001|COMPLETED|Overall Study|30 patients (31 wounds)|30
3038312|NCT01153620|3757717|FG000|NOT COMPLETED|Overall Study||0
3038313|NCT01153620|3757718|FG001|NOT COMPLETED|Overall Study||0
3038314|NCT01153633|3757726|FG000|STARTED|Overall Study||17
3038315|NCT01153633|3757727|FG001|STARTED|Overall Study||17
3038316|NCT01153633|3757726|FG000|COMPLETED|Overall Study||13
3038317|NCT01153633|3757727|FG001|COMPLETED|Overall Study||13
3038318|NCT01153633|3757726|FG000|NOT COMPLETED|Overall Study||4
3038319|NCT01153633|3757727|FG001|NOT COMPLETED|Overall Study||4
3038320|NCT01153672|3757735|FG000|STARTED|Overall Study||8
3038321|NCT01153672|3757735|FG000|COMPLETED|Overall Study||6
3038322|NCT01153672|3757735|FG000|NOT COMPLETED|Overall Study||2
3038323|NCT01153685|3757741|FG000|STARTED|Overall Study||50
3038324|NCT01153685|3757742|FG001|STARTED|Overall Study||70
3038325|NCT01153685|3757741|FG000|COMPLETED|Overall Study||50
3038326|NCT01153685|3757742|FG001|COMPLETED|Overall Study||70
3038327|NCT01153685|3757741|FG000|NOT COMPLETED|Overall Study||0
3038328|NCT01153685|3757742|FG001|NOT COMPLETED|Overall Study||0
3038329|NCT01153698|3757748|FG000|STARTED|Overall Study|Entered and treated.|168
3166191|NCT01903525|3893622|FG001|STARTED|Overall Study||20
3166192|NCT01903525|3893621|FG000|COMPLETED|Overall Study||15
3166193|NCT01903525|3893622|FG001|COMPLETED|Overall Study||10
3166194|NCT01903525|3893621|FG000|NOT COMPLETED|Overall Study||5
3166195|NCT01903525|3893622|FG001|NOT COMPLETED|Overall Study||10
3383855|NCT01923480|4119013|FG000|STARTED|Period 1 (Hours 1-7)||1
3383856|NCT01923480|4119014|FG001|STARTED|Period 1 (Hours 1-7)||2
3383857|NCT01923480|4119015|FG002|STARTED|Period 1 (Hours 1-7)||2
3383858|NCT01923480|4119016|FG003|STARTED|Period 1 (Hours 1-7)||2
3383859|NCT01923480|4119017|FG004|STARTED|Period 1 (Hours 1-7)||2
3383860|NCT01923480|4119018|FG005|STARTED|Period 1 (Hours 1-7)||2
3383861|NCT01923480|4119013|FG000|COMPLETED|Period 1 (Hours 1-7)||1
3383862|NCT01923480|4119014|FG001|COMPLETED|Period 1 (Hours 1-7)|One subject completed Period 1, but withdrew from the study prior to the start of Period 2.|2
3383863|NCT01923480|4119015|FG002|COMPLETED|Period 1 (Hours 1-7)||2
3383864|NCT01923480|4119016|FG003|COMPLETED|Period 1 (Hours 1-7)||2
3383865|NCT01923480|4119017|FG004|COMPLETED|Period 1 (Hours 1-7)||2
3038330|NCT01153698|3757748|FG000|COMPLETED|Overall Study|Completed Pradaxa treatment.|139
3038331|NCT01153698|3757748|FG000|NOT COMPLETED|Overall Study||29
3038332|NCT01153711|3757753|FG000|STARTED|Overall Study||32
3033610|NCT01128738|3752778|FG000|STARTED|First Treatment Phase (TP)||78
3033611|NCT01128738|3752779|FG001|STARTED|First Treatment Phase (TP)||74
3033612|NCT01128738|3752778|FG000|COMPLETED|First Treatment Phase (TP)||74
3033613|NCT01128738|3752779|FG001|COMPLETED|First Treatment Phase (TP)||73
3033614|NCT01128738|3752778|FG000|NOT COMPLETED|First Treatment Phase (TP)||4
3033615|NCT01128738|3752779|FG001|NOT COMPLETED|First Treatment Phase (TP)||1
3033616|NCT01128738|3752778|FG000|STARTED|Second TP|Only participants who received a second treatment entered this phase.|34
3033617|NCT01128738|3752779|FG001|STARTED|Second TP|Only participants who received a second treatment entered this phase.|66
3033618|NCT01128738|3752778|FG000|COMPLETED|Second TP||34
3033619|NCT01128738|3752779|FG001|COMPLETED|Second TP||63
3033620|NCT01128738|3752778|FG000|NOT COMPLETED|Second TP||0
3033621|NCT01128738|3752779|FG001|NOT COMPLETED|Second TP||3
3033622|NCT01128829|3752786|FG000|STARTED|Overall Study||6
3033623|NCT01128829|3752787|FG001|STARTED|Overall Study||11
3033624|NCT01128829|3752786|FG000|COMPLETED|Overall Study||6
3033625|NCT01128829|3752787|FG001|COMPLETED|Overall Study||11
3033626|NCT01128829|3752786|FG000|NOT COMPLETED|Overall Study||0
3033627|NCT01128829|3752787|FG001|NOT COMPLETED|Overall Study||0
3033628|NCT01128842|3752791|FG000|STARTED|Overall Study||7
3033629|NCT01128842|3752791|FG000|COMPLETED|Overall Study||0
3033630|NCT01128842|3752791|FG000|NOT COMPLETED|Overall Study||7
3033631|NCT01128894|3752798|FG000|STARTED|Overall Study||404
3033632|NCT01128894|3752799|FG001|STARTED|Overall Study||408
3033633|NCT01128894|3752798|FG000|COMPLETED|Overall Study||346
3033634|NCT01128894|3752799|FG001|COMPLETED|Overall Study||340
3033635|NCT01128894|3752798|FG000|NOT COMPLETED|Overall Study||58
3033636|NCT01128894|3752799|FG001|NOT COMPLETED|Overall Study||68
3033637|NCT01128946|3752805|FG000|STARTED|Period I||20
3033638|NCT01128946|3752806|FG001|STARTED|Period I||21
3033639|NCT01128946|3752807|FG002|STARTED|Period I||21
3033640|NCT01128946|3752808|FG003|STARTED|Period I||21
3033641|NCT01128946|3752805|FG000|COMPLETED|Period I||20
3033642|NCT01128946|3752806|FG001|COMPLETED|Period I||20
3033643|NCT01128946|3752807|FG002|COMPLETED|Period I||20
3033644|NCT01128946|3752808|FG003|COMPLETED|Period I||20
3033645|NCT01128946|3752805|FG000|NOT COMPLETED|Period I||0
3033646|NCT01128946|3752806|FG001|NOT COMPLETED|Period I||1
3033647|NCT01128946|3752807|FG002|NOT COMPLETED|Period I||1
3033648|NCT01128946|3752808|FG003|NOT COMPLETED|Period I||1
3033649|NCT01128946|3752805|FG000|STARTED|Period II|Due to crossover design, different set of participants received this treatment compared to Period I|20
3033650|NCT01128946|3752806|FG001|STARTED|Period II|Due to crossover design, different set of participants received this treatment compared to Period I|20
3033651|NCT01128946|3752807|FG002|STARTED|Period II|Due to crossover design, different set of participants received this treatment compared to Period I|20
3033652|NCT01128946|3752808|FG003|STARTED|Period II|Due to crossover design, different set of participants received this treatment compared to Period I|20
3033653|NCT01128946|3752805|FG000|COMPLETED|Period II||20
3033654|NCT01128946|3752806|FG001|COMPLETED|Period II||19
3033655|NCT01128946|3752807|FG002|COMPLETED|Period II||20
3033656|NCT01128946|3752808|FG003|COMPLETED|Period II||19
3033657|NCT01128946|3752805|FG000|NOT COMPLETED|Period II||0
3033658|NCT01128946|3752806|FG001|NOT COMPLETED|Period II||1
3033659|NCT01128946|3752807|FG002|NOT COMPLETED|Period II||0
3033660|NCT01128946|3752808|FG003|NOT COMPLETED|Period II||1
3033661|NCT01128946|3752805|FG000|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|20
3033662|NCT01128946|3752806|FG001|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|19
3033663|NCT01128946|3752807|FG002|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|20
3033664|NCT01128946|3752808|FG003|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|19
3033665|NCT01128946|3752805|FG000|COMPLETED|Period III||19
3033666|NCT01128946|3752806|FG001|COMPLETED|Period III||19
3033667|NCT01128946|3752807|FG002|COMPLETED|Period III||20
3033668|NCT01128946|3752808|FG003|COMPLETED|Period III||19
3033669|NCT01128946|3752805|FG000|NOT COMPLETED|Period III||1
3033670|NCT01128946|3752806|FG001|NOT COMPLETED|Period III||0
3033671|NCT01128946|3752807|FG002|NOT COMPLETED|Period III||0
3033672|NCT01128946|3752808|FG003|NOT COMPLETED|Period III||0
3033673|NCT01128946|3752805|FG000|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|19
3033674|NCT01128946|3752806|FG001|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|20
3033675|NCT01128946|3752807|FG002|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|19
3033676|NCT01128946|3752808|FG003|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|19
3033677|NCT01128946|3752805|FG000|COMPLETED|Period IV||19
3033678|NCT01128946|3752806|FG001|COMPLETED|Period IV||20
3033679|NCT01128946|3752807|FG002|COMPLETED|Period IV||19
3033680|NCT01128946|3752808|FG003|COMPLETED|Period IV||19
3033681|NCT01128946|3752805|FG000|NOT COMPLETED|Period IV||0
3033682|NCT01128946|3752806|FG001|NOT COMPLETED|Period IV||0
3033683|NCT01128946|3752807|FG002|NOT COMPLETED|Period IV||0
3033684|NCT01128946|3752808|FG003|NOT COMPLETED|Period IV||0
3033685|NCT01128959|3752819|FG000|STARTED|Lead in Period||108
3033686|NCT01128959|3752819|FG000|COMPLETED|Lead in Period||105
3033687|NCT01128959|3752819|FG000|NOT COMPLETED|Lead in Period||3
3033688|NCT01128959|3752819|FG000|STARTED|Treatment Period||105
3033689|NCT01128959|3752819|FG000|COMPLETED|Treatment Period||101
3033690|NCT01128959|3752819|FG000|NOT COMPLETED|Treatment Period||4
3033691|NCT01128972|3752825|FG000|STARTED|Period I||7
3033692|NCT01128972|3752826|FG001|STARTED|Period I||7
3033693|NCT01128972|3752827|FG002|STARTED|Period I||7
3033694|NCT01128972|3752828|FG003|STARTED|Period I||7
3033695|NCT01128972|3752829|FG004|STARTED|Period I||8
3033696|NCT01128972|3752825|FG000|COMPLETED|Period I||7
3033697|NCT01128972|3752826|FG001|COMPLETED|Period I||7
3033698|NCT01128972|3752827|FG002|COMPLETED|Period I||7
3033699|NCT01128972|3752828|FG003|COMPLETED|Period I||7
3033700|NCT01128972|3752829|FG004|COMPLETED|Period I||8
3033701|NCT01128972|3752825|FG000|NOT COMPLETED|Period I||0
3033702|NCT01128972|3752826|FG001|NOT COMPLETED|Period I||0
3033703|NCT01128972|3752827|FG002|NOT COMPLETED|Period I||0
3033704|NCT01128972|3752828|FG003|NOT COMPLETED|Period I||0
3033705|NCT01128972|3752829|FG004|NOT COMPLETED|Period I||0
3033706|NCT01128972|3752825|FG000|STARTED|Period II|Due to cross over design, different set of participants received this treatment compared to Period I|7
3033707|NCT01128972|3752826|FG001|STARTED|Period II|Due to cross over design, different set of participants received this treatment compared to Period I|7
3038333|NCT01153711|3757753|FG000|COMPLETED|Overall Study||32
3166196|NCT01903564|3893630|FG000|STARTED|Overall Study||10
3166197|NCT01903564|3893631|FG001|STARTED|Overall Study||29
3166198|NCT01903564|3893630|FG000|COMPLETED|Overall Study||10
3383866|NCT01923480|4119018|FG005|COMPLETED|Period 1 (Hours 1-7)||2
3383867|NCT01923480|4119013|FG000|NOT COMPLETED|Period 1 (Hours 1-7)||0
3383868|NCT01923480|4119014|FG001|NOT COMPLETED|Period 1 (Hours 1-7)||0
3383869|NCT01923480|4119015|FG002|NOT COMPLETED|Period 1 (Hours 1-7)||0
3383870|NCT01923480|4119016|FG003|NOT COMPLETED|Period 1 (Hours 1-7)||0
3383871|NCT01923480|4119017|FG004|NOT COMPLETED|Period 1 (Hours 1-7)||0
3383872|NCT01923480|4119018|FG005|NOT COMPLETED|Period 1 (Hours 1-7)||0
3383873|NCT01923480|4119013|FG000|STARTED|Period 2 (Hours 1-7)||1
3383874|NCT01923480|4119014|FG001|STARTED|Period 2 (Hours 1-7)|One subject completed Period 1, but withdrew from the study prior to the start of Period 2.|1
3383875|NCT01923480|4119015|FG002|STARTED|Period 2 (Hours 1-7)||2
3383876|NCT01923480|4119016|FG003|STARTED|Period 2 (Hours 1-7)||2
3383877|NCT01923480|4119017|FG004|STARTED|Period 2 (Hours 1-7)||2
3383878|NCT01923480|4119018|FG005|STARTED|Period 2 (Hours 1-7)||2
3383879|NCT01923480|4119013|FG000|COMPLETED|Period 2 (Hours 1-7)||1
3383880|NCT01923480|4119014|FG001|COMPLETED|Period 2 (Hours 1-7)||1
3383881|NCT01923480|4119015|FG002|COMPLETED|Period 2 (Hours 1-7)||2
3383882|NCT01923480|4119016|FG003|COMPLETED|Period 2 (Hours 1-7)||2
3383883|NCT01923480|4119017|FG004|COMPLETED|Period 2 (Hours 1-7)||2
3383884|NCT01923480|4119018|FG005|COMPLETED|Period 2 (Hours 1-7)||2
3383885|NCT01923480|4119013|FG000|NOT COMPLETED|Period 2 (Hours 1-7)||0
3383886|NCT01923480|4119014|FG001|NOT COMPLETED|Period 2 (Hours 1-7)||0
3383887|NCT01923480|4119015|FG002|NOT COMPLETED|Period 2 (Hours 1-7)||0
3383888|NCT01923480|4119016|FG003|NOT COMPLETED|Period 2 (Hours 1-7)||0
3383889|NCT01923480|4119017|FG004|NOT COMPLETED|Period 2 (Hours 1-7)||0
3166199|NCT01903564|3893631|FG001|COMPLETED|Overall Study||29
3383890|NCT01923480|4119018|FG005|NOT COMPLETED|Period 2 (Hours 1-7)||0
3385913|NCT02514083|4121309|FG000|NOT COMPLETED|Overall Study||1
3385914|NCT02323295|4121315|FG000|STARTED|Overall Study||2
3385915|NCT02323295|4121316|FG001|STARTED|Overall Study||10
3385916|NCT02323295|4121315|FG000|COMPLETED|Overall Study||2
3385917|NCT02323295|4121316|FG001|COMPLETED|Overall Study||7
3385918|NCT02323295|4121315|FG000|NOT COMPLETED|Overall Study||0
3385919|NCT02323295|4121316|FG001|NOT COMPLETED|Overall Study||3
3385920|NCT02180724|4121324|FG000|STARTED|Overall Study||92
3385921|NCT02180724|4121325|FG001|STARTED|Overall Study||14
3385922|NCT02180724|4121324|FG000|Enrolled|Overall Study||92
3385923|NCT02180724|4121325|FG001|Enrolled|Overall Study||14
3385924|NCT02180724|4121324|FG000|Received Study Medication|Overall Study||92
3385925|NCT02180724|4121325|FG001|Received Study Medication|Overall Study||14
3385926|NCT02180724|4121324|FG000|Discontinued Study|Overall Study||14
3385927|NCT02180724|4121325|FG001|Discontinued Study|Overall Study||3
3385928|NCT02180724|4121324|FG000|Discontinued Treatment|Overall Study||23
3385929|NCT02180724|4121325|FG001|Discontinued Treatment|Overall Study||7
3385930|NCT02180724|4121324|FG000|COMPLETED|Overall Study||0
3385931|NCT02180724|4121325|FG001|COMPLETED|Overall Study||0
3385932|NCT02180724|4121324|FG000|NOT COMPLETED|Overall Study||92
3385933|NCT02180724|4121325|FG001|NOT COMPLETED|Overall Study||14
3385934|NCT02108964|4121339|FG000|STARTED|Overall Study||17
3385935|NCT02108964|4121340|FG001|STARTED|Overall Study||38
3385936|NCT02108964|4121341|FG002|STARTED|Overall Study||73
3385937|NCT02108964|4121342|FG003|STARTED|Overall Study||8
3385938|NCT02108964|4121343|FG004|STARTED|Overall Study||28
3385939|NCT02108964|4121344|FG005|STARTED|Overall Study||5
3385940|NCT02108964|4121345|FG006|STARTED|Overall Study||11
3385941|NCT02108964|4121346|FG007|STARTED|Overall Study||45
3166200|NCT01903564|3893630|FG000|NOT COMPLETED|Overall Study||0
3166201|NCT01903564|3893631|FG001|NOT COMPLETED|Overall Study||0
3385942|NCT02108964|4121339|FG000|COMPLETED|Overall Study||3
3385943|NCT02108964|4121340|FG001|COMPLETED|Overall Study||6
3385944|NCT02108964|4121341|FG002|COMPLETED|Overall Study||8
3385945|NCT02108964|4121342|FG003|COMPLETED|Overall Study||2
3385946|NCT02108964|4121343|FG004|COMPLETED|Overall Study||3
3385947|NCT02108964|4121344|FG005|COMPLETED|Overall Study||0
3385948|NCT02108964|4121345|FG006|COMPLETED|Overall Study||0
3385949|NCT02108964|4121346|FG007|COMPLETED|Overall Study||33
3385950|NCT02108964|4121339|FG000|NOT COMPLETED|Overall Study||14
3033708|NCT01128972|3752827|FG002|STARTED|Period II|Due to cross over design, different set of participants received this treatment compared to Period I|7
3033709|NCT01128972|3752828|FG003|STARTED|Period II|Due to cross over design, different set of participants received this treatment compared to Period I|8
3033710|NCT01128972|3752829|FG004|STARTED|Period II|Due to cross over design, different set of participants received this treatment compared to Period I|7
3033711|NCT01128972|3752825|FG000|COMPLETED|Period II||7
3033712|NCT01128972|3752826|FG001|COMPLETED|Period II||7
3033713|NCT01128972|3752827|FG002|COMPLETED|Period II||7
3033714|NCT01128972|3752828|FG003|COMPLETED|Period II||8
3033715|NCT01128972|3752829|FG004|COMPLETED|Period II||7
3033716|NCT01128972|3752825|FG000|NOT COMPLETED|Period II||0
3033717|NCT01128972|3752826|FG001|NOT COMPLETED|Period II||0
3033718|NCT01128972|3752827|FG002|NOT COMPLETED|Period II||0
3033719|NCT01128972|3752828|FG003|NOT COMPLETED|Period II||0
3033720|NCT01128972|3752829|FG004|NOT COMPLETED|Period II||0
3033721|NCT01128972|3752825|FG000|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|7
3033722|NCT01128972|3752826|FG001|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|7
3033723|NCT01128972|3752827|FG002|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|8
3033724|NCT01128972|3752828|FG003|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|7
3033725|NCT01128972|3752829|FG004|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|7
3033726|NCT01128972|3752825|FG000|COMPLETED|Period III||7
3033727|NCT01128972|3752826|FG001|COMPLETED|Period III||7
3033728|NCT01128972|3752827|FG002|COMPLETED|Period III||8
3033729|NCT01128972|3752828|FG003|COMPLETED|Period III||7
3033730|NCT01128972|3752829|FG004|COMPLETED|Period III||7
3033731|NCT01128972|3752825|FG000|NOT COMPLETED|Period III||0
3383891|NCT01931098|4119032|FG000|STARTED|Overall Study||9
3383892|NCT01931098|4119033|FG001|STARTED|Overall Study||26
3383893|NCT01931098|4119032|FG000|COMPLETED|Overall Study||9
3383894|NCT01931098|4119033|FG001|COMPLETED|Overall Study||22
3383895|NCT01931098|4119032|FG000|NOT COMPLETED|Overall Study||0
3383896|NCT01931098|4119033|FG001|NOT COMPLETED|Overall Study||4
3383897|NCT01945021|4119041|FG000|STARTED|Overall Study||127
3383898|NCT01945021|4119041|FG000|Safety Population|Overall Study|Received at least 1 dose of study medication.|127
3383899|NCT01945021|4119041|FG000|Response Evaluable Population|Overall Study|Received at least 1 dose of study drug and an adequate baseline tumor assessment.|127
3383900|NCT01945021|4119041|FG000|Patient Reported Outcome Evaluable|Overall Study|Received at least 1 dose of study drug, completed baseline with at least 1 post-baseline assessment.|123
3383901|NCT01945021|4119041|FG000|COMPLETED|Overall Study||44
3383902|NCT01945021|4119041|FG000|NOT COMPLETED|Overall Study||83
3383903|NCT01956669|4119052|FG000|STARTED|Overall Study||12
3383904|NCT01956669|4119053|FG001|STARTED|Overall Study||11
3383905|NCT01956669|4119054|FG002|STARTED|Overall Study||10
3383906|NCT01956669|4119055|FG003|STARTED|Overall Study||10
3383907|NCT01956669|4119056|FG004|STARTED|Overall Study||4
3383908|NCT01956669|4119057|FG005|STARTED|Overall Study||4
3383909|NCT01956669|4119058|FG006|STARTED|Overall Study||6
3383910|NCT01956669|4119052|FG000|PK Set|Overall Study||11
3383911|NCT01956669|4119053|FG001|PK Set|Overall Study||11
3383912|NCT01956669|4119054|FG002|PK Set|Overall Study||10
3383913|NCT01956669|4119055|FG003|PK Set|Overall Study||10
2911650|NCT00486018|3621443|FG000|STARTED|Overall Study||132
2911651|NCT00486018|3621444|FG001|STARTED|Overall Study||134
2911652|NCT00486018|3621445|FG002|STARTED|Overall Study||131
2911653|NCT00486018|3621443|FG000|Received Drug (Safety Population)|Overall Study||131
2911654|NCT00486018|3621444|FG001|Received Drug (Safety Population)|Overall Study||134
2911655|NCT00486018|3621445|FG002|Received Drug (Safety Population)|Overall Study||130
2911656|NCT00486018|3621443|FG000|COMPLETED|Overall Study||123
2911657|NCT00486018|3621444|FG001|COMPLETED|Overall Study||128
2911658|NCT00486018|3621445|FG002|COMPLETED|Overall Study||125
2911659|NCT00486018|3621443|FG000|NOT COMPLETED|Overall Study||9
2911660|NCT00486018|3621444|FG001|NOT COMPLETED|Overall Study||6
2911661|NCT00486018|3621445|FG002|NOT COMPLETED|Overall Study||6
2911662|NCT00486031|3621453|FG000|STARTED|Overall Study||443
2911663|NCT00486031|3621453|FG000|COMPLETED|Overall Study||440
2911664|NCT00486031|3621453|FG000|NOT COMPLETED|Overall Study||3
2911665|NCT00486044|3621460|FG000|STARTED|Overall Study|50 received assigned intervention (1 withdrew during baseline) 27 in MRI sub-study|51
2911666|NCT00486044|3621461|FG001|STARTED|Overall Study|23 in MRI sub-study|49
2911667|NCT00486044|3621460|FG000|COMPLETED|Overall Study|27 completed MRI sub-study|49
2911668|NCT00486044|3621461|FG001|COMPLETED|Overall Study|21 completed MRI sub-study|46
2911669|NCT00486044|3621460|FG000|NOT COMPLETED|Overall Study||2
2911670|NCT00486044|3621461|FG001|NOT COMPLETED|Overall Study||3
2911671|NCT00486226|3621467|FG000|STARTED|Overall Study||105
2911672|NCT00486226|3621467|FG000|COMPLETED|Overall Study||92
2911673|NCT00486226|3621467|FG000|NOT COMPLETED|Overall Study||13
2911674|NCT00486252|3621474|FG000|STARTED|Overall Study||996
2911675|NCT00486252|3621474|FG000|COMPLETED|Overall Study||938
2911676|NCT00486252|3621474|FG000|NOT COMPLETED|Overall Study||58
2911677|NCT00486265|3621480|FG000|STARTED|Overall Study|Partipants dosed on day 1.|9
2911678|NCT00486265|3621480|FG000|COMPLETED|Overall Study|Treatment is not for a fixed period and continues until a discontinuation criterion is met|0
2911679|NCT00486265|3621480|FG000|NOT COMPLETED|Overall Study||9
3033732|NCT01128972|3752826|FG001|NOT COMPLETED|Period III||0
3033733|NCT01128972|3752827|FG002|NOT COMPLETED|Period III||0
3033734|NCT01128972|3752828|FG003|NOT COMPLETED|Period III||0
3033735|NCT01128972|3752829|FG004|NOT COMPLETED|Period III||0
3033736|NCT01128972|3752825|FG000|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|7
3033737|NCT01128972|3752826|FG001|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|8
3033738|NCT01128972|3752827|FG002|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|7
3033739|NCT01128972|3752828|FG003|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|7
3033740|NCT01128972|3752829|FG004|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|7
3033741|NCT01128972|3752825|FG000|COMPLETED|Period IV||7
3033742|NCT01128972|3752826|FG001|COMPLETED|Period IV||8
3033743|NCT01128972|3752827|FG002|COMPLETED|Period IV||7
3033744|NCT01128972|3752828|FG003|COMPLETED|Period IV||7
3033745|NCT01128972|3752829|FG004|COMPLETED|Period IV||7
3033746|NCT01128972|3752825|FG000|NOT COMPLETED|Period IV||0
3033747|NCT01128972|3752826|FG001|NOT COMPLETED|Period IV||0
3033748|NCT01128972|3752827|FG002|NOT COMPLETED|Period IV||0
3033749|NCT01128972|3752828|FG003|NOT COMPLETED|Period IV||0
3033750|NCT01128972|3752829|FG004|NOT COMPLETED|Period IV||0
3033751|NCT01128972|3752825|FG000|STARTED|Period V|Due to crossover design, different set of participants received this treatment compared to Period IV|8
3033752|NCT01128972|3752826|FG001|STARTED|Period V|Due to crossover design, different set of participants received this treatment compared to Period IV|7
3033753|NCT01128972|3752827|FG002|STARTED|Period V|Due to crossover design, different set of participants received this treatment compared to Period IV|7
3033754|NCT01128972|3752828|FG003|STARTED|Period V|Due to crossover design, different set of participants received this treatment compared to Period IV|7
3033755|NCT01128972|3752829|FG004|STARTED|Period V|Due to crossover design, different set of participants received this treatment compared to Period IV|7
3033756|NCT01128972|3752825|FG000|COMPLETED|Period V||8
3033757|NCT01128972|3752826|FG001|COMPLETED|Period V||7
3033758|NCT01128972|3752827|FG002|COMPLETED|Period V||7
3033759|NCT01128972|3752828|FG003|COMPLETED|Period V||7
3033760|NCT01128972|3752829|FG004|COMPLETED|Period V||7
3383914|NCT01956669|4119056|FG004|PK Set|Overall Study||4
3383915|NCT01956669|4119057|FG005|PK Set|Overall Study||4
3383916|NCT01956669|4119058|FG006|PK Set|Overall Study||6
3383917|NCT01956669|4119052|FG000|PKES Set|Overall Study||4
3383918|NCT01956669|4119053|FG001|PKES Set|Overall Study||0
3383919|NCT01956669|4119054|FG002|PKES Set|Overall Study||3
3383920|NCT01956669|4119055|FG003|PKES Set|Overall Study||0
3383921|NCT01956669|4119056|FG004|PKES Set|Overall Study||1
3383922|NCT01956669|4119057|FG005|PKES Set|Overall Study||1
3383923|NCT01956669|4119058|FG006|PKES Set|Overall Study||5
3383924|NCT01956669|4119052|FG000|Biomarker Set|Overall Study||12
3383925|NCT01956669|4119053|FG001|Biomarker Set|Overall Study||11
3383926|NCT01956669|4119054|FG002|Biomarker Set|Overall Study||9
3383927|NCT01956669|4119055|FG003|Biomarker Set|Overall Study||9
3383928|NCT01956669|4119056|FG004|Biomarker Set|Overall Study||3
3383929|NCT01956669|4119057|FG005|Biomarker Set|Overall Study||4
3383930|NCT01956669|4119058|FG006|Biomarker Set|Overall Study||3
3383931|NCT01956669|4119052|FG000|Per Protocol Set (PP Set)|Overall Study||9
3383932|NCT01956669|4119053|FG001|Per Protocol Set (PP Set)|Overall Study||10
3383933|NCT01956669|4119054|FG002|Per Protocol Set (PP Set)|Overall Study||6
3383934|NCT01956669|4119055|FG003|Per Protocol Set (PP Set)|Overall Study||9
3383935|NCT01956669|4119056|FG004|Per Protocol Set (PP Set)|Overall Study||4
3383936|NCT01956669|4119057|FG005|Per Protocol Set (PP Set)|Overall Study||4
3383937|NCT01956669|4119058|FG006|Per Protocol Set (PP Set)|Overall Study||5
3383938|NCT01956669|4119052|FG000|COMPLETED|Overall Study||0
3383939|NCT01956669|4119053|FG001|COMPLETED|Overall Study||0
3383940|NCT01956669|4119054|FG002|COMPLETED|Overall Study||0
3383941|NCT01956669|4119055|FG003|COMPLETED|Overall Study||0
3383942|NCT01956669|4119056|FG004|COMPLETED|Overall Study||0
3383943|NCT01956669|4119057|FG005|COMPLETED|Overall Study||0
3383944|NCT01956669|4119058|FG006|COMPLETED|Overall Study||0
3383945|NCT01956669|4119052|FG000|NOT COMPLETED|Overall Study||12
3383946|NCT01956669|4119053|FG001|NOT COMPLETED|Overall Study||11
3383947|NCT01956669|4119054|FG002|NOT COMPLETED|Overall Study||10
3383948|NCT01956669|4119055|FG003|NOT COMPLETED|Overall Study||10
3383949|NCT01956669|4119056|FG004|NOT COMPLETED|Overall Study||4
3383950|NCT01956669|4119057|FG005|NOT COMPLETED|Overall Study||4
3383951|NCT01956669|4119058|FG006|NOT COMPLETED|Overall Study||6
3385951|NCT02108964|4121340|FG001|NOT COMPLETED|Overall Study||32
3385952|NCT02108964|4121341|FG002|NOT COMPLETED|Overall Study||65
3385953|NCT02108964|4121342|FG003|NOT COMPLETED|Overall Study||6
3385954|NCT02108964|4121343|FG004|NOT COMPLETED|Overall Study||25
3385955|NCT02108964|4121344|FG005|NOT COMPLETED|Overall Study||5
3385956|NCT02108964|4121345|FG006|NOT COMPLETED|Overall Study||11
3385957|NCT02108964|4121346|FG007|NOT COMPLETED|Overall Study||12
3385958|NCT02050308|4121367|FG000|STARTED|Overall Study||127
3385959|NCT02050308|4121368|FG001|STARTED|Overall Study||124
3385960|NCT02050308|4121367|FG000|COMPLETED|Overall Study||28
2920591|NCT00537407|3631083|FG001|NOT COMPLETED|Part 2 Weeks 5-48 or 72||8
2920592|NCT00537407|3631084|FG002|NOT COMPLETED|Part 2 Weeks 5-48 or 72||9
2920593|NCT00537407|3631085|FG003|NOT COMPLETED|Part 2 Weeks 5-48 or 72||6
2920594|NCT00537407|3631086|FG004|NOT COMPLETED|Part 2 Weeks 5-48 or 72||7
3033761|NCT01128972|3752825|FG000|NOT COMPLETED|Period V||0
3033762|NCT01128972|3752826|FG001|NOT COMPLETED|Period V||0
3033763|NCT01128972|3752827|FG002|NOT COMPLETED|Period V||0
3033764|NCT01128972|3752828|FG003|NOT COMPLETED|Period V||0
3033765|NCT01128972|3752829|FG004|NOT COMPLETED|Period V||0
3033766|NCT01129011|3752849|FG000|STARTED|Overall Study|Safety, Intent-to-Treat population|210
3033767|NCT01129011|3752850|FG001|STARTED|Overall Study|Safety, Intent-to-Treat population|210
3033768|NCT01129011|3752849|FG000|COMPLETED|Overall Study||151
3033769|NCT01129011|3752850|FG001|COMPLETED|Overall Study||153
3033770|NCT01129011|3752849|FG000|NOT COMPLETED|Overall Study||59
3033771|NCT01129011|3752850|FG001|NOT COMPLETED|Overall Study||57
3033772|NCT01129024|3752856|FG000|STARTED|Overall Study||19
3033773|NCT01129024|3752856|FG000|COMPLETED|Overall Study||0
3033774|NCT01129024|3752856|FG000|NOT COMPLETED|Overall Study||19
3033775|NCT01129102|3752863|FG000|STARTED|Overall Study||110
3033776|NCT01129102|3752864|FG001|STARTED|Overall Study||50
3033777|NCT01129102|3752865|FG002|STARTED|Overall Study||55
3383952|NCT01967823|4119083|FG000|STARTED|Overall Study||11
3383953|NCT01967823|4119083|FG000|COMPLETED|Overall Study||10
3383954|NCT01967823|4119083|FG000|NOT COMPLETED|Overall Study||1
3383955|NCT01989676|4119093|FG000|STARTED|Overall Study||352
3383956|NCT01989676|4119094|FG001|STARTED|Overall Study||355
3383957|NCT01989676|4119093|FG000|Treated|Overall Study||349
3383958|NCT01989676|4119094|FG001|Treated|Overall Study||353
3383959|NCT01989676|4119093|FG000|COMPLETED|Overall Study||234
3383960|NCT01989676|4119094|FG001|COMPLETED|Overall Study||217
3383961|NCT01989676|4119093|FG000|NOT COMPLETED|Overall Study||118
3383962|NCT01989676|4119094|FG001|NOT COMPLETED|Overall Study||138
3383963|NCT01992653|4119109|FG000|STARTED|Overall Study||3
3383964|NCT01992653|4119110|FG001|STARTED|Overall Study||3
2911680|NCT00486278|3621484|FG000|STARTED|Overall Study|96 bleeds by 51 subjects, 77 were treated with vatreptacog alfa and 19 with rFVIIa|51
2911681|NCT00486278|3621484|FG000|COMPLETED|Overall Study||42
2911682|NCT00486278|3621484|FG000|NOT COMPLETED|Overall Study||9
2911683|NCT00486291|3621500|FG000|STARTED|Overall Study|3 subjects discontinued prior to first dose|105
2911684|NCT00486291|3621501|FG001|STARTED|Overall Study|1 subject discontinued prior to first dose|105
2911685|NCT00486291|3621500|FG000|COMPLETED|Overall Study||89
2911686|NCT00486291|3621501|FG001|COMPLETED|Overall Study||76
2911687|NCT00486291|3621500|FG000|NOT COMPLETED|Overall Study||16
2911688|NCT00486291|3621501|FG001|NOT COMPLETED|Overall Study||29
2911689|NCT00486330|3621507|FG000|STARTED|Overall Study|Twelve subjects met inclusion/exclusion criteria|12
2911690|NCT00486330|3621507|FG000|COMPLETED|Overall Study|Of the 12 subjects treated, two developed adverse events leading to study drug discontinuation.|10
2911691|NCT00486330|3621507|FG000|NOT COMPLETED|Overall Study||2
2911692|NCT00486434|3621513|FG000|STARTED|Overall Study||588
2911693|NCT00486434|3621514|FG001|STARTED|Overall Study||588
2911694|NCT00486434|3621513|FG000|COMPLETED|Overall Study||394
2911695|NCT00486434|3621514|FG001|COMPLETED|Overall Study||454
2911696|NCT00486434|3621513|FG000|NOT COMPLETED|Overall Study||194
2911697|NCT00486434|3621514|FG001|NOT COMPLETED|Overall Study||134
2911698|NCT00486447|3621521|FG000|STARTED|Overall Study||249
2911699|NCT00486447|3621521|FG000|COMPLETED|Overall Study||249
2911700|NCT00486447|3621521|FG000|NOT COMPLETED|Overall Study||0
2911701|NCT00486525|3621528|FG000|STARTED|Overall Study||100
2911702|NCT00486525|3621529|FG001|STARTED|Overall Study||100
2911703|NCT00486525|3621528|FG000|COMPLETED|Overall Study||94
2911704|NCT00486525|3621529|FG001|COMPLETED|Overall Study||87
2911705|NCT00486525|3621528|FG000|NOT COMPLETED|Overall Study||6
2911706|NCT00486525|3621529|FG001|NOT COMPLETED|Overall Study||13
2911707|NCT00486603|3621537|FG000|STARTED|Overall Study||3
2911708|NCT00486603|3621538|FG001|STARTED|Overall Study||7
2911709|NCT00486603|3621539|FG002|STARTED|Overall Study||3
2911710|NCT00486603|3621540|FG003|STARTED|Overall Study||3
2911711|NCT00486603|3621541|FG004|STARTED|Overall Study||76
2911712|NCT00486603|3621537|FG000|COMPLETED|Overall Study||2
2911713|NCT00486603|3621538|FG001|COMPLETED|Overall Study||6
2911714|NCT00486603|3621539|FG002|COMPLETED|Overall Study||3
2911715|NCT00486603|3621540|FG003|COMPLETED|Overall Study||3
2911716|NCT00486603|3621541|FG004|COMPLETED|Overall Study||76
2911717|NCT00486603|3621537|FG000|NOT COMPLETED|Overall Study||1
2911718|NCT00486603|3621538|FG001|NOT COMPLETED|Overall Study||1
2911719|NCT00486603|3621539|FG002|NOT COMPLETED|Overall Study||0
2911720|NCT00486603|3621540|FG003|NOT COMPLETED|Overall Study||0
2911721|NCT00486603|3621541|FG004|NOT COMPLETED|Overall Study||0
2911722|NCT00486642|3621558|FG000|STARTED|Overall Study||10
2911723|NCT00486642|3621559|FG001|STARTED|Overall Study||13
2911724|NCT00486642|3621558|FG000|COMPLETED|Overall Study||10
2911725|NCT00486642|3621559|FG001|COMPLETED|Overall Study||13
2911726|NCT00486642|3621558|FG000|NOT COMPLETED|Overall Study||0
2911727|NCT00486642|3621559|FG001|NOT COMPLETED|Overall Study||0
2911728|NCT00486720|3621569|FG000|STARTED|Overall Study|1 randomized patient was discontinued before receiving treatment due to a protocol violation|10
2911729|NCT00486720|3621570|FG001|STARTED|Overall Study||12
3033778|NCT01129102|3752863|FG000|COMPLETED|Overall Study||102
3033779|NCT01129102|3752864|FG001|COMPLETED|Overall Study||44
3033780|NCT01129102|3752865|FG002|COMPLETED|Overall Study||48
3033781|NCT01129102|3752863|FG000|NOT COMPLETED|Overall Study||8
3033782|NCT01129102|3752864|FG001|NOT COMPLETED|Overall Study||6
3033783|NCT01129102|3752865|FG002|NOT COMPLETED|Overall Study||7
3033784|NCT01129115|3752876|FG000|STARTED|Overall Study||25
3383965|NCT01992653|4119111|FG002|STARTED|Overall Study||6
3033785|NCT01129115|3752877|FG001|STARTED|Overall Study||25
3033786|NCT01129115|3752878|FG002|STARTED|Overall Study||27
3033787|NCT01129115|3752879|FG003|STARTED|Overall Study||24
3033788|NCT01129115|3752876|FG000|COMPLETED|Overall Study||23
3033789|NCT01129115|3752877|FG001|COMPLETED|Overall Study||18
3033790|NCT01129115|3752878|FG002|COMPLETED|Overall Study||21
3033791|NCT01129115|3752879|FG003|COMPLETED|Overall Study||15
3033792|NCT01129115|3752876|FG000|NOT COMPLETED|Overall Study||2
3033793|NCT01129115|3752877|FG001|NOT COMPLETED|Overall Study||7
3033794|NCT01129115|3752878|FG002|NOT COMPLETED|Overall Study||6
3033795|NCT01129115|3752879|FG003|NOT COMPLETED|Overall Study||9
3033796|NCT01129128|3752892|FG000|STARTED|Overall Study||22
3033797|NCT01129128|3752893|FG001|STARTED|Overall Study||22
3033798|NCT01129128|3752894|FG002|STARTED|Overall Study||23
3033799|NCT01129128|3752892|FG000|COMPLETED|Overall Study||19
3033800|NCT01129128|3752893|FG001|COMPLETED|Overall Study||18
3033801|NCT01129128|3752894|FG002|COMPLETED|Overall Study||19
3033802|NCT01129128|3752892|FG000|NOT COMPLETED|Overall Study||3
3033803|NCT01129128|3752893|FG001|NOT COMPLETED|Overall Study||4
3033804|NCT01129128|3752894|FG002|NOT COMPLETED|Overall Study||4
3033805|NCT01129141|3752904|FG000|STARTED|Overall Study||101
3166202|NCT01903720|3893637|FG000|STARTED|Overall Study||71
3166203|NCT01903720|3893637|FG000|COMPLETED|Overall Study||59
3166204|NCT01903720|3893637|FG000|NOT COMPLETED|Overall Study||12
3166205|NCT01903733|3893645|FG000|STARTED|Overall Study||250
3166206|NCT01903733|3893646|FG001|STARTED|Overall Study||284
3166207|NCT01903733|3893647|FG002|STARTED|Overall Study||119
3166208|NCT01903733|3893648|FG003|STARTED|Overall Study||167
3166209|NCT01903733|3893645|FG000|Full Analysis Set|Overall Study||250
3166210|NCT01903733|3893646|FG001|Full Analysis Set|Overall Study||284
3166211|NCT01903733|3893647|FG002|Full Analysis Set|Overall Study||119
3166212|NCT01903733|3893648|FG003|Full Analysis Set|Overall Study||167
3383966|NCT01992653|4119112|FG003|STARTED|Overall Study||1
3383967|NCT01992653|4119113|FG004|STARTED|Overall Study||6
3383968|NCT01992653|4119114|FG005|STARTED|Overall Study||6
2911730|NCT00486720|3621569|FG000|COMPLETED|Overall Study||0
2911731|NCT00486720|3621570|FG001|COMPLETED|Overall Study||0
2911732|NCT00486720|3621569|FG000|NOT COMPLETED|Overall Study||10
2911733|NCT00486720|3621570|FG001|NOT COMPLETED|Overall Study||12
2911734|NCT00486759|3621578|FG000|STARTED|Treatment||390
2911735|NCT00486759|3621579|FG001|STARTED|Treatment||397
2911736|NCT00486759|3621578|FG000|COMPLETED|Treatment||203
2911737|NCT00486759|3621579|FG001|COMPLETED|Treatment||260
2911738|NCT00486759|3621578|FG000|NOT COMPLETED|Treatment||187
2911739|NCT00486759|3621579|FG001|NOT COMPLETED|Treatment||137
2911740|NCT00486759|3621578|FG000|STARTED|Safety Follow-up||203
2911741|NCT00486759|3621579|FG001|STARTED|Safety Follow-up||260
2911742|NCT00486759|3621578|FG000|COMPLETED|Safety Follow-up||64
2911743|NCT00486759|3621579|FG001|COMPLETED|Safety Follow-up||142
2911744|NCT00486759|3621578|FG000|NOT COMPLETED|Safety Follow-up||139
2911745|NCT00486759|3621579|FG001|NOT COMPLETED|Safety Follow-up||118
2911746|NCT00486811|3621588|FG000|STARTED|Overall Study||337
2911747|NCT00486811|3621589|FG001|STARTED|Overall Study|One participant was not eligible to be dosed.|320
2911748|NCT00486811|3621590|FG002|STARTED|Overall Study|Two participants were not eligible to be dosed.|333
2911749|NCT00486811|3621588|FG000|COMPLETED|Overall Study||215
2911750|NCT00486811|3621589|FG001|COMPLETED|Overall Study||179
2911751|NCT00486811|3621590|FG002|COMPLETED|Overall Study||119
2911752|NCT00486811|3621588|FG000|NOT COMPLETED|Overall Study||122
2911753|NCT00486811|3621589|FG001|NOT COMPLETED|Overall Study||141
2911754|NCT00486811|3621590|FG002|NOT COMPLETED|Overall Study||214
2911755|NCT00486824|3621600|FG000|STARTED|Overall Study||5
2911756|NCT00486824|3621601|FG001|STARTED|Overall Study||5
2911757|NCT00486824|3621600|FG000|COMPLETED|Overall Study||3
2911758|NCT00486824|3621601|FG001|COMPLETED|Overall Study||3
2911759|NCT00486824|3621600|FG000|NOT COMPLETED|Overall Study||2
2911760|NCT00486824|3621601|FG001|NOT COMPLETED|Overall Study||2
2911761|NCT00486837|3621609|FG000|STARTED|Overall Study||37
2911762|NCT00486837|3621610|FG001|STARTED|Overall Study||35
2911763|NCT00486837|3621609|FG000|COMPLETED|Overall Study||28
2911764|NCT00486837|3621610|FG001|COMPLETED|Overall Study||28
2911765|NCT00486837|3621609|FG000|NOT COMPLETED|Overall Study||9
2911766|NCT00486837|3621610|FG001|NOT COMPLETED|Overall Study||7
2911767|NCT00486863|3621620|FG000|STARTED|Overall Study||184
2911768|NCT00486863|3621621|FG001|STARTED|Overall Study||186
2911769|NCT00486863|3621620|FG000|COMPLETED|Overall Study||183
2911770|NCT00486863|3621621|FG001|COMPLETED|Overall Study||183
2911771|NCT00486863|3621620|FG000|NOT COMPLETED|Overall Study||1
2911772|NCT00486863|3621621|FG001|NOT COMPLETED|Overall Study||3
2911773|NCT00486902|3621630|FG000|STARTED|Overall Study||94
2911774|NCT00486902|3621631|FG001|STARTED|Overall Study||94
2911775|NCT00486902|3621630|FG000|COMPLETED|Overall Study||85
2911776|NCT00486902|3621631|FG001|COMPLETED|Overall Study||89
2911777|NCT00486902|3621630|FG000|NOT COMPLETED|Overall Study||9
2911778|NCT00486902|3621631|FG001|NOT COMPLETED|Overall Study||5
2911779|NCT00486954|3621641|FG000|STARTED|Pilot Part||6
2911780|NCT00486954|3621642|FG001|STARTED|Pilot Part||0
2911781|NCT00486954|3621643|FG002|STARTED|Pilot Part||6
2911782|NCT00486954|3621644|FG003|STARTED|Pilot Part||0
2911783|NCT00486954|3621645|FG004|STARTED|Pilot Part||0
2911784|NCT00486954|3621641|FG000|COMPLETED|Pilot Part||0
2911785|NCT00486954|3621642|FG001|COMPLETED|Pilot Part||0
3033806|NCT01129141|3752905|FG001|STARTED|Overall Study||104
3166213|NCT01903733|3893645|FG000|Safety Analysis Set|Overall Study||248
3033807|NCT01129141|3752904|FG000|COMPLETED|Overall Study||86
3033808|NCT01129141|3752905|FG001|COMPLETED|Overall Study||91
3033809|NCT01129141|3752904|FG000|NOT COMPLETED|Overall Study||15
3033810|NCT01129141|3752905|FG001|NOT COMPLETED|Overall Study||13
3033811|NCT01129206|3752911|FG000|STARTED|Overall Study||6
3033812|NCT01129206|3752911|FG000|COMPLETED|Overall Study||6
3033813|NCT01129206|3752911|FG000|NOT COMPLETED|Overall Study||0
3033814|NCT01129245|3752920|FG000|STARTED|Control Cycle (no Celecoxib or Placebo)||10
3033815|NCT01129245|3752921|FG001|STARTED|Control Cycle (no Celecoxib or Placebo)||10
3033816|NCT01129245|3752920|FG000|COMPLETED|Control Cycle (no Celecoxib or Placebo)||10
3033817|NCT01129245|3752921|FG001|COMPLETED|Control Cycle (no Celecoxib or Placebo)||10
3033818|NCT01129245|3752920|FG000|NOT COMPLETED|Control Cycle (no Celecoxib or Placebo)||0
3033819|NCT01129245|3752921|FG001|NOT COMPLETED|Control Cycle (no Celecoxib or Placebo)||0
3033820|NCT01129245|3752920|FG000|STARTED|Treatment Cycle 1||10
3033821|NCT01129245|3752921|FG001|STARTED|Treatment Cycle 1||10
3033822|NCT01129245|3752920|FG000|COMPLETED|Treatment Cycle 1||10
3033823|NCT01129245|3752921|FG001|COMPLETED|Treatment Cycle 1||10
3033824|NCT01129245|3752920|FG000|NOT COMPLETED|Treatment Cycle 1||0
3033825|NCT01129245|3752921|FG001|NOT COMPLETED|Treatment Cycle 1||0
3033826|NCT01129245|3752920|FG000|STARTED|Washout Cycle||10
3033827|NCT01129245|3752921|FG001|STARTED|Washout Cycle||10
3033828|NCT01129245|3752920|FG000|COMPLETED|Washout Cycle||10
3033829|NCT01129245|3752921|FG001|COMPLETED|Washout Cycle||10
3033830|NCT01129245|3752920|FG000|NOT COMPLETED|Washout Cycle||0
3033831|NCT01129245|3752921|FG001|NOT COMPLETED|Washout Cycle||0
3033832|NCT01129245|3752920|FG000|STARTED|Treatment Cycle 2||10
3033833|NCT01129245|3752921|FG001|STARTED|Treatment Cycle 2||10
3033834|NCT01129245|3752920|FG000|COMPLETED|Treatment Cycle 2||10
3033835|NCT01129245|3752921|FG001|COMPLETED|Treatment Cycle 2||10
3033836|NCT01129245|3752920|FG000|NOT COMPLETED|Treatment Cycle 2||0
3033837|NCT01129245|3752921|FG001|NOT COMPLETED|Treatment Cycle 2||0
3033838|NCT01129284|3752933|FG000|STARTED|Overall Study||5
3033839|NCT01129284|3752934|FG001|STARTED|Overall Study||5
3033840|NCT01129284|3752935|FG002|STARTED|Overall Study||5
3033841|NCT01129284|3752933|FG000|COMPLETED|Overall Study||3
3033842|NCT01129284|3752934|FG001|COMPLETED|Overall Study||5
3033843|NCT01129284|3752935|FG002|COMPLETED|Overall Study||4
3033844|NCT01129284|3752933|FG000|NOT COMPLETED|Overall Study||2
3033845|NCT01129284|3752934|FG001|NOT COMPLETED|Overall Study||0
3033846|NCT01129284|3752935|FG002|NOT COMPLETED|Overall Study||1
3033847|NCT01129336|3752945|FG000|STARTED|Overall Study||15
3033848|NCT01129336|3752946|FG001|STARTED|Overall Study||29
3033849|NCT01129336|3752945|FG000|Completed Treatment|Overall Study||1
3033850|NCT01129336|3752946|FG001|Completed Treatment|Overall Study||3
3033851|NCT01129336|3752945|FG000|COMPLETED|Overall Study|Completed indicates Completed Study as per protocol.|3
3033852|NCT01129336|3752946|FG001|COMPLETED|Overall Study|Completed indicates Completed Study as per protocol.|13
3033853|NCT01129336|3752945|FG000|NOT COMPLETED|Overall Study||12
3033854|NCT01129336|3752946|FG001|NOT COMPLETED|Overall Study||16
3033855|NCT01129440|3752954|FG000|STARTED|Overall Study||297
3033856|NCT01129440|3752955|FG001|STARTED|Overall Study||300
3033857|NCT01129440|3752954|FG000|12 Month Follow-up|Overall Study||249
3033858|NCT01129440|3752955|FG001|12 Month Follow-up|Overall Study||256
3033859|NCT01129440|3752954|FG000|24 Month Follow-up|Overall Study||239
3033860|NCT01129440|3752955|FG001|24 Month Follow-up|Overall Study||258
3033861|NCT01129440|3752954|FG000|COMPLETED|Overall Study||246
3033862|NCT01129440|3752955|FG001|COMPLETED|Overall Study||258
3033863|NCT01129440|3752954|FG000|NOT COMPLETED|Overall Study||51
3033864|NCT01129440|3752955|FG001|NOT COMPLETED|Overall Study||42
3033865|NCT01129531|3752965|FG000|STARTED|Treatment Cycle 1||84
3033866|NCT01129531|3752966|FG001|STARTED|Treatment Cycle 1||84
3033867|NCT01129531|3752967|FG002|STARTED|Treatment Cycle 1||126
3033868|NCT01129531|3752965|FG000|COMPLETED|Treatment Cycle 1||80
3033869|NCT01129531|3752966|FG001|COMPLETED|Treatment Cycle 1||78
3033870|NCT01129531|3752967|FG002|COMPLETED|Treatment Cycle 1||110
3033871|NCT01129531|3752965|FG000|NOT COMPLETED|Treatment Cycle 1||4
3033872|NCT01129531|3752966|FG001|NOT COMPLETED|Treatment Cycle 1||6
3033873|NCT01129531|3752967|FG002|NOT COMPLETED|Treatment Cycle 1||16
3033874|NCT01129531|3752965|FG000|STARTED|Treatment Cycle 2|Participants who completed Treatment Cycle 1 were re-randomized.|94
3033875|NCT01129531|3752966|FG001|STARTED|Treatment Cycle 2|Participants who completed Treatment Cycle 1 were re-randomized.|95
3383969|NCT01992653|4119115|FG006|STARTED|Overall Study||40
3383970|NCT01992653|4119116|FG007|STARTED|Overall Study||17
3383971|NCT01992653|4119109|FG000|COMPLETED|Overall Study||3
3383972|NCT01992653|4119110|FG001|COMPLETED|Overall Study||3
3383973|NCT01992653|4119111|FG002|COMPLETED|Overall Study||5
3383974|NCT01992653|4119112|FG003|COMPLETED|Overall Study||1
3383975|NCT01992653|4119113|FG004|COMPLETED|Overall Study||5
3383976|NCT01992653|4119114|FG005|COMPLETED|Overall Study||6
3383977|NCT01992653|4119115|FG006|COMPLETED|Overall Study||32
3383978|NCT01992653|4119116|FG007|COMPLETED|Overall Study||13
3383979|NCT01992653|4119109|FG000|NOT COMPLETED|Overall Study||0
3383980|NCT01992653|4119110|FG001|NOT COMPLETED|Overall Study||0
3383981|NCT01992653|4119111|FG002|NOT COMPLETED|Overall Study||1
3383982|NCT01992653|4119112|FG003|NOT COMPLETED|Overall Study||0
3383983|NCT01992653|4119113|FG004|NOT COMPLETED|Overall Study||1
3383984|NCT01992653|4119114|FG005|NOT COMPLETED|Overall Study||0
3383985|NCT01992653|4119115|FG006|NOT COMPLETED|Overall Study||8
3383986|NCT01992653|4119116|FG007|NOT COMPLETED|Overall Study||4
3385961|NCT02050308|4121368|FG001|COMPLETED|Overall Study||22
3033876|NCT01129531|3752967|FG002|STARTED|Treatment Cycle 2|Participants who completed Treatment Cycle 1 were re-randomized.|79
3033877|NCT01129531|3752965|FG000|COMPLETED|Treatment Cycle 2||88
3033878|NCT01129531|3752966|FG001|COMPLETED|Treatment Cycle 2||92
3033879|NCT01129531|3752967|FG002|COMPLETED|Treatment Cycle 2||74
3033880|NCT01129531|3752965|FG000|NOT COMPLETED|Treatment Cycle 2||6
3033881|NCT01129531|3752966|FG001|NOT COMPLETED|Treatment Cycle 2||3
3033882|NCT01129531|3752967|FG002|NOT COMPLETED|Treatment Cycle 2||5
3033883|NCT01129557|3752982|FG000|STARTED|Overall Study||15
3033884|NCT01129557|3752983|FG001|STARTED|Overall Study||17
3033885|NCT01129557|3752984|FG002|STARTED|Overall Study||14
3033886|NCT01129557|3752982|FG000|COMPLETED|Overall Study||11
3033887|NCT01129557|3752983|FG001|COMPLETED|Overall Study||12
3033888|NCT01129557|3752984|FG002|COMPLETED|Overall Study||10
3033889|NCT01129557|3752982|FG000|NOT COMPLETED|Overall Study||4
3033890|NCT01129557|3752983|FG001|NOT COMPLETED|Overall Study||5
3033891|NCT01129557|3752984|FG002|NOT COMPLETED|Overall Study||4
3033892|NCT01129583|3753005|FG000|STARTED|Overall Study||9
3033893|NCT01129583|3753006|FG001|STARTED|Overall Study||9
3033894|NCT01129583|3753005|FG000|COMPLETED|Overall Study||6
3033895|NCT01129583|3753006|FG001|COMPLETED|Overall Study||7
3033896|NCT01129583|3753005|FG000|NOT COMPLETED|Overall Study||3
3033897|NCT01129583|3753006|FG001|NOT COMPLETED|Overall Study||2
3033898|NCT01129609|3753012|FG000|STARTED|Overall Study||20
3033899|NCT01129609|3753012|FG000|COMPLETED|Overall Study||18
3033900|NCT01129609|3753012|FG000|NOT COMPLETED|Overall Study||2
3033901|NCT01129622|3753016|FG000|STARTED|Overall Study||16
3033902|NCT01129622|3753016|FG000|COMPLETED|Overall Study||14
3033903|NCT01129622|3753016|FG000|NOT COMPLETED|Overall Study||2
3033904|NCT01129765|3753021|FG000|STARTED|Overall Study||30
3033905|NCT01129765|3753021|FG000|COMPLETED|Overall Study||30
3033906|NCT01129765|3753021|FG000|NOT COMPLETED|Overall Study||0
3033907|NCT01129778|3753025|FG000|STARTED|Overall Study||22
3033908|NCT01129778|3753025|FG000|COMPLETED|Overall Study||15
3033909|NCT01129778|3753025|FG000|NOT COMPLETED|Overall Study||7
3033910|NCT01129804|3753031|FG000|STARTED|Overall Study||96
3033911|NCT01129804|3753032|FG001|STARTED|Overall Study||97
3033912|NCT01129804|3753031|FG000|COMPLETED|Overall Study||64
3033913|NCT01129804|3753032|FG001|COMPLETED|Overall Study||66
3033914|NCT01129804|3753031|FG000|NOT COMPLETED|Overall Study||32
3033915|NCT01129804|3753032|FG001|NOT COMPLETED|Overall Study||31
3033916|NCT01129882|3753038|FG000|STARTED|Overall Study||709
3033917|NCT01129882|3753038|FG000|Received at Least 1 Dose of Study Drug|Overall Study||709
3033918|NCT01129882|3753038|FG000|COMPLETED|Overall Study||431
3033919|NCT01129882|3753038|FG000|NOT COMPLETED|Overall Study||278
3033920|NCT01129921|3753044|FG000|STARTED|Prior to Sham Cross-over, 6-12 Weeks||20
3033921|NCT01129921|3753045|FG001|STARTED|Prior to Sham Cross-over, 6-12 Weeks||20
3033922|NCT01129921|3753044|FG000|COMPLETED|Prior to Sham Cross-over, 6-12 Weeks||20
3033923|NCT01129921|3753045|FG001|COMPLETED|Prior to Sham Cross-over, 6-12 Weeks||20
3033924|NCT01129921|3753044|FG000|NOT COMPLETED|Prior to Sham Cross-over, 6-12 Weeks||0
3033925|NCT01129921|3753045|FG001|NOT COMPLETED|Prior to Sham Cross-over, 6-12 Weeks||0
3033926|NCT01129921|3753044|FG000|STARTED|After Sham Cross-over to Mild, One Year||20
3033927|NCT01129921|3753045|FG001|STARTED|After Sham Cross-over to Mild, One Year||20
3033928|NCT01129921|3753044|FG000|COMPLETED|After Sham Cross-over to Mild, One Year|All 20 completed Wk 6-12 Intent to Treat analysis. Eighteen reported Year 1 outcomes.|18
3166214|NCT01903733|3893646|FG001|Safety Analysis Set|Overall Study||284
3166215|NCT01903733|3893647|FG002|Safety Analysis Set|Overall Study||119
3166216|NCT01903733|3893648|FG003|Safety Analysis Set|Overall Study||167
3166217|NCT01903733|3893645|FG000|Enrolled in B1871040|Overall Study||124
3166218|NCT01903733|3893646|FG001|Enrolled in B1871040|Overall Study||90
3166219|NCT01903733|3893647|FG002|Enrolled in B1871040|Overall Study||28
3383987|NCT02001974|4119137|FG000|STARTED|Run-in Period||4
3383988|NCT02001974|4119138|FG001|STARTED|Run-in Period||3
3383989|NCT02001974|4119139|FG002|STARTED|Run-in Period||26
3383990|NCT02001974|4119137|FG000|COMPLETED|Run-in Period||4
3383991|NCT02001974|4119138|FG001|COMPLETED|Run-in Period||3
3383992|NCT02001974|4119139|FG002|COMPLETED|Run-in Period||26
2911786|NCT00486954|3621643|FG002|COMPLETED|Pilot Part||0
2911787|NCT00486954|3621644|FG003|COMPLETED|Pilot Part||0
2911788|NCT00486954|3621645|FG004|COMPLETED|Pilot Part||0
2911789|NCT00486954|3621641|FG000|NOT COMPLETED|Pilot Part||6
2911790|NCT00486954|3621642|FG001|NOT COMPLETED|Pilot Part||0
2911791|NCT00486954|3621643|FG002|NOT COMPLETED|Pilot Part||6
2911792|NCT00486954|3621644|FG003|NOT COMPLETED|Pilot Part||0
2911793|NCT00486954|3621645|FG004|NOT COMPLETED|Pilot Part||0
2911794|NCT00486954|3621641|FG000|STARTED|Randomized Part||0
2911795|NCT00486954|3621642|FG001|STARTED|Randomized Part||0
2911796|NCT00486954|3621643|FG002|STARTED|Randomized Part||0
2911797|NCT00486954|3621644|FG003|STARTED|Randomized Part||132
2911798|NCT00486954|3621645|FG004|STARTED|Randomized Part||129
2911799|NCT00486954|3621641|FG000|COMPLETED|Randomized Part||0
2911800|NCT00486954|3621642|FG001|COMPLETED|Randomized Part||0
2911801|NCT00486954|3621643|FG002|COMPLETED|Randomized Part||0
2911802|NCT00486954|3621644|FG003|COMPLETED|Randomized Part||112
2911803|NCT00486954|3621645|FG004|COMPLETED|Randomized Part||115
2911804|NCT00486954|3621641|FG000|NOT COMPLETED|Randomized Part||0
2911805|NCT00486954|3621642|FG001|NOT COMPLETED|Randomized Part||0
2911806|NCT00486954|3621643|FG002|NOT COMPLETED|Randomized Part||0
2911807|NCT00486954|3621644|FG003|NOT COMPLETED|Randomized Part||20
2911808|NCT00486954|3621645|FG004|NOT COMPLETED|Randomized Part||14
3033929|NCT01129921|3753045|FG001|COMPLETED|After Sham Cross-over to Mild, One Year|All 20 completed Wk 6-12 Intent to Treat analysis prior to x-over. After x-over 13 reported Year 1.|13
3033930|NCT01129921|3753044|FG000|NOT COMPLETED|After Sham Cross-over to Mild, One Year||2
3033931|NCT01129921|3753045|FG001|NOT COMPLETED|After Sham Cross-over to Mild, One Year||7
3033932|NCT01129960|3753059|FG000|STARTED|Overall Study||84
3033933|NCT01129960|3753060|FG001|STARTED|Overall Study||83
3033934|NCT01129960|3753061|FG002|STARTED|Overall Study||82
3033935|NCT01129960|3753062|FG003|STARTED|Overall Study||83
3033936|NCT01129960|3753059|FG000|Safety|Overall Study||84
3033937|NCT01129960|3753060|FG001|Safety|Overall Study||83
3033938|NCT01129960|3753061|FG002|Safety|Overall Study|One subject was randomized to placebo, but was dispensed in error with an ESL 800 mg kit at DB Visit|83
3033939|NCT01129960|3753062|FG003|Safety|Overall Study||82
3033940|NCT01129960|3753059|FG000|Intent-to-Treat|Overall Study||84
3033941|NCT01129960|3753060|FG001|Intent-to-Treat|Overall Study||83
3033942|NCT01129960|3753061|FG002|Intent-to-Treat|Overall Study||82
3033943|NCT01129960|3753062|FG003|Intent-to-Treat|Overall Study||83
3033944|NCT01129960|3753059|FG000|Per-Protocol|Overall Study||34
3033945|NCT01129960|3753060|FG001|Per-Protocol|Overall Study||52
3033946|NCT01129960|3753061|FG002|Per-Protocol|Overall Study||49
3033947|NCT01129960|3753062|FG003|Per-Protocol|Overall Study||55
3033948|NCT01129960|3753059|FG000|Full Analysis Set (FAS|Overall Study||71
3033949|NCT01129960|3753060|FG001|Full Analysis Set (FAS|Overall Study||67
3033950|NCT01129960|3753061|FG002|Full Analysis Set (FAS|Overall Study||68
3033951|NCT01129960|3753062|FG003|Full Analysis Set (FAS|Overall Study||71
3033952|NCT01129960|3753059|FG000|COMPLETED|Overall Study||54
3033953|NCT01129960|3753060|FG001|COMPLETED|Overall Study||61
3033954|NCT01129960|3753061|FG002|COMPLETED|Overall Study||56
3033955|NCT01129960|3753062|FG003|COMPLETED|Overall Study||70
3033956|NCT01129960|3753059|FG000|NOT COMPLETED|Overall Study||30
3033957|NCT01129960|3753060|FG001|NOT COMPLETED|Overall Study||22
3033958|NCT01129960|3753061|FG002|NOT COMPLETED|Overall Study||26
3033959|NCT01129960|3753062|FG003|NOT COMPLETED|Overall Study||13
3033960|NCT01130051|3753072|FG000|STARTED|Period 1||8
3033961|NCT01130051|3753073|FG001|STARTED|Period 1||8
3033962|NCT01130051|3753072|FG000|COMPLETED|Period 1||8
3033963|NCT01130051|3753073|FG001|COMPLETED|Period 1||8
3033964|NCT01130051|3753072|FG000|NOT COMPLETED|Period 1||0
3033965|NCT01130051|3753073|FG001|NOT COMPLETED|Period 1||0
3033966|NCT01130051|3753072|FG000|STARTED|Washout Period of 14 Days||8
3383993|NCT02001974|4119137|FG000|NOT COMPLETED|Run-in Period||0
3383994|NCT02001974|4119138|FG001|NOT COMPLETED|Run-in Period||0
3383995|NCT02001974|4119139|FG002|NOT COMPLETED|Run-in Period||0
3383996|NCT02001974|4119137|FG000|STARTED|Reparixin + Paclitaxel (28-day Cycles)||4
3383997|NCT02001974|4119138|FG001|STARTED|Reparixin + Paclitaxel (28-day Cycles)||3
3383998|NCT02001974|4119139|FG002|STARTED|Reparixin + Paclitaxel (28-day Cycles)||26
3383999|NCT02001974|4119137|FG000|COMPLETED|Reparixin + Paclitaxel (28-day Cycles)||0
3384000|NCT02001974|4119138|FG001|COMPLETED|Reparixin + Paclitaxel (28-day Cycles)||0
3384001|NCT02001974|4119139|FG002|COMPLETED|Reparixin + Paclitaxel (28-day Cycles)||0
3384002|NCT02001974|4119137|FG000|NOT COMPLETED|Reparixin + Paclitaxel (28-day Cycles)||4
3384003|NCT02001974|4119138|FG001|NOT COMPLETED|Reparixin + Paclitaxel (28-day Cycles)||3
3384004|NCT02001974|4119139|FG002|NOT COMPLETED|Reparixin + Paclitaxel (28-day Cycles)||26
3385962|NCT02050308|4121367|FG000|NOT COMPLETED|Overall Study||99
3385963|NCT02050308|4121368|FG001|NOT COMPLETED|Overall Study||102
3385964|NCT02036970|4121389|FG000|STARTED|Part 1: Day 1 Through Week 16||6
3385965|NCT02036970|4121390|FG001|STARTED|Part 1: Day 1 Through Week 16||12
3385966|NCT02036970|4121391|FG002|STARTED|Part 1: Day 1 Through Week 16||11
3385967|NCT02036970|4121392|FG003|STARTED|Part 1: Day 1 Through Week 16||12
3385968|NCT02036970|4121393|FG004|STARTED|Part 1: Day 1 Through Week 16||2
3385969|NCT02036970|4121394|FG005|STARTED|Part 1: Day 1 Through Week 16||4
3385970|NCT02036970|4121395|FG006|STARTED|Part 1: Day 1 Through Week 16||3
3385971|NCT02036970|4121396|FG007|STARTED|Part 1: Day 1 Through Week 16||4
3385972|NCT02036970|4121397|FG008|STARTED|Part 1: Day 1 Through Week 16||74
3385973|NCT02036970|4121398|FG009|STARTED|Part 1: Day 1 Through Week 16||38
3385974|NCT02036970|4121389|FG000|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 1: Day 1 Through Week 16||6
3385975|NCT02036970|4121390|FG001|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 1: Day 1 Through Week 16||6
3385976|NCT02036970|4121391|FG002|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 1: Day 1 Through Week 16||11
3385977|NCT02036970|4121392|FG003|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 1: Day 1 Through Week 16||6
3385978|NCT02036970|4121393|FG004|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 1: Day 1 Through Week 16||2
3385979|NCT02036970|4121394|FG005|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 1: Day 1 Through Week 16||2
3385980|NCT02036970|4121395|FG006|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 1: Day 1 Through Week 16||3
3385981|NCT02036970|4121396|FG007|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 1: Day 1 Through Week 16||2
3385982|NCT02036970|4121397|FG008|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 1: Day 1 Through Week 16||0
3385983|NCT02036970|4121398|FG009|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 1: Day 1 Through Week 16||0
3385984|NCT02036970|4121389|FG000|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 1: Day 1 Through Week 16||0
3385985|NCT02036970|4121390|FG001|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 1: Day 1 Through Week 16||6
3385986|NCT02036970|4121391|FG002|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 1: Day 1 Through Week 16||0
3385987|NCT02036970|4121392|FG003|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 1: Day 1 Through Week 16||6
3385988|NCT02036970|4121393|FG004|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 1: Day 1 Through Week 16||0
3033967|NCT01130051|3753073|FG001|STARTED|Washout Period of 14 Days||8
3033968|NCT01130051|3753072|FG000|COMPLETED|Washout Period of 14 Days||7
3033969|NCT01130051|3753073|FG001|COMPLETED|Washout Period of 14 Days||6
3033970|NCT01130051|3753072|FG000|NOT COMPLETED|Washout Period of 14 Days||1
3033971|NCT01130051|3753073|FG001|NOT COMPLETED|Washout Period of 14 Days||2
3033972|NCT01130051|3753072|FG000|STARTED|Period 2||7
3033973|NCT01130051|3753073|FG001|STARTED|Period 2||6
3033974|NCT01130051|3753072|FG000|COMPLETED|Period 2||7
3033975|NCT01130051|3753073|FG001|COMPLETED|Period 2||6
3033976|NCT01130051|3753072|FG000|NOT COMPLETED|Period 2||0
3033977|NCT01130051|3753073|FG001|NOT COMPLETED|Period 2||0
3033978|NCT01130103|3753081|FG000|STARTED|Randomized Treatment||19
3033979|NCT01130103|3753082|FG001|STARTED|Randomized Treatment||18
3033980|NCT01130103|3753081|FG000|COMPLETED|Randomized Treatment||13
3033981|NCT01130103|3753082|FG001|COMPLETED|Randomized Treatment||13
3033982|NCT01130103|3753081|FG000|NOT COMPLETED|Randomized Treatment||6
3033983|NCT01130103|3753082|FG001|NOT COMPLETED|Randomized Treatment||5
3033984|NCT01130103|3753081|FG000|STARTED|Maintenance Treatment||13
3033985|NCT01130103|3753082|FG001|STARTED|Maintenance Treatment||13
3033986|NCT01130103|3753081|FG000|COMPLETED|Maintenance Treatment||11
3033987|NCT01130103|3753082|FG001|COMPLETED|Maintenance Treatment||11
3033988|NCT01130103|3753081|FG000|NOT COMPLETED|Maintenance Treatment||2
3033989|NCT01130103|3753082|FG001|NOT COMPLETED|Maintenance Treatment||2
3033990|NCT01130168|3753088|FG000|STARTED|Period 1||6
3033991|NCT01130168|3753089|FG001|STARTED|Period 1||7
3033992|NCT01130168|3753090|FG002|STARTED|Period 1||6
3033993|NCT01130168|3753091|FG003|STARTED|Period 1||8
3033994|NCT01130168|3753092|FG004|STARTED|Period 1||5
3033995|NCT01130168|3753093|FG005|STARTED|Period 1||6
3033996|NCT01130168|3753088|FG000|COMPLETED|Period 1||6
3033997|NCT01130168|3753089|FG001|COMPLETED|Period 1||6
3384005|NCT02014558|4119160|FG000|STARTED|Overall Study||5
3384006|NCT02014558|4119161|FG001|STARTED|Overall Study||3
3384007|NCT02014558|4119162|FG002|STARTED|Overall Study||3
3384008|NCT02014558|4119163|FG003|STARTED|Overall Study||3
3384009|NCT02014558|4119164|FG004|STARTED|Overall Study||4
3384010|NCT02014558|4119165|FG005|STARTED|Overall Study||3
3384011|NCT02014558|4119166|FG006|STARTED|Overall Study||4
3384012|NCT02014558|4119167|FG007|STARTED|Overall Study||11
3384013|NCT02014558|4119168|FG008|STARTED|Overall Study||15
3384014|NCT02014558|4119169|FG009|STARTED|Overall Study||21
3384015|NCT02014558|4119170|FG010|STARTED|Overall Study||69
3384016|NCT02014558|4119171|FG011|STARTED|Overall Study||102
3384017|NCT02014558|4119172|FG012|STARTED|Overall Study||17
3384018|NCT02014558|4119160|FG000|Treated|Overall Study||5
3384019|NCT02014558|4119161|FG001|Treated|Overall Study||3
3384020|NCT02014558|4119162|FG002|Treated|Overall Study||3
3384021|NCT02014558|4119163|FG003|Treated|Overall Study||3
3384022|NCT02014558|4119164|FG004|Treated|Overall Study||3
3384023|NCT02014558|4119165|FG005|Treated|Overall Study||3
3384024|NCT02014558|4119166|FG006|Treated|Overall Study||3
3384025|NCT02014558|4119167|FG007|Treated|Overall Study|A participant randomized to the 120 mg was treated with an initial dose of 20 mg by mistake.|12
3384026|NCT02014558|4119168|FG008|Treated|Overall Study||13
3384027|NCT02014558|4119169|FG009|Treated|Overall Study||21
3384028|NCT02014558|4119170|FG010|Treated|Overall Study|A participant randomized to the 120 mg was treated with an initial dose of 20 mg by mistake.|66
3384029|NCT02014558|4119171|FG011|Treated|Overall Study||100
3384030|NCT02014558|4119172|FG012|Treated|Overall Study||17
3384031|NCT02014558|4119160|FG000|COMPLETED|Overall Study||0
3384032|NCT02014558|4119161|FG001|COMPLETED|Overall Study||0
3384033|NCT02014558|4119162|FG002|COMPLETED|Overall Study||0
3384034|NCT02014558|4119163|FG003|COMPLETED|Overall Study||0
3384035|NCT02014558|4119164|FG004|COMPLETED|Overall Study||0
3384036|NCT02014558|4119165|FG005|COMPLETED|Overall Study||0
3384037|NCT02014558|4119166|FG006|COMPLETED|Overall Study||0
3384038|NCT02014558|4119167|FG007|COMPLETED|Overall Study||0
3384039|NCT02014558|4119168|FG008|COMPLETED|Overall Study||0
3384040|NCT02014558|4119169|FG009|COMPLETED|Overall Study||0
3384041|NCT02014558|4119170|FG010|COMPLETED|Overall Study||0
3384042|NCT02014558|4119171|FG011|COMPLETED|Overall Study||0
3384043|NCT02014558|4119172|FG012|COMPLETED|Overall Study||0
3384044|NCT02014558|4119160|FG000|NOT COMPLETED|Overall Study||5
3384045|NCT02014558|4119161|FG001|NOT COMPLETED|Overall Study||3
3384046|NCT02014558|4119162|FG002|NOT COMPLETED|Overall Study||3
3384047|NCT02014558|4119163|FG003|NOT COMPLETED|Overall Study||3
3384048|NCT02014558|4119164|FG004|NOT COMPLETED|Overall Study||4
3384049|NCT02014558|4119165|FG005|NOT COMPLETED|Overall Study||3
3384050|NCT02014558|4119166|FG006|NOT COMPLETED|Overall Study||4
3384051|NCT02014558|4119167|FG007|NOT COMPLETED|Overall Study||11
3384052|NCT02014558|4119168|FG008|NOT COMPLETED|Overall Study||15
3033998|NCT01130168|3753090|FG002|COMPLETED|Period 1||5
3033999|NCT01130168|3753091|FG003|COMPLETED|Period 1||5
3034000|NCT01130168|3753092|FG004|COMPLETED|Period 1||5
3384053|NCT02014558|4119169|FG009|NOT COMPLETED|Overall Study||21
3384054|NCT02014558|4119170|FG010|NOT COMPLETED|Overall Study||69
3384055|NCT02014558|4119171|FG011|NOT COMPLETED|Overall Study||102
3384056|NCT02014558|4119172|FG012|NOT COMPLETED|Overall Study||17
3385989|NCT02036970|4121394|FG005|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 1: Day 1 Through Week 16||2
3385990|NCT02036970|4121395|FG006|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 1: Day 1 Through Week 16||0
3385991|NCT02036970|4121396|FG007|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 1: Day 1 Through Week 16||2
3386742|NCT02021773|4122070|FG002|Intent-to-treat (ITT)|Overall Study||85
3034001|NCT01130168|3753093|FG005|COMPLETED|Period 1||6
3034002|NCT01130168|3753088|FG000|NOT COMPLETED|Period 1||0
3034003|NCT01130168|3753089|FG001|NOT COMPLETED|Period 1||1
3034004|NCT01130168|3753090|FG002|NOT COMPLETED|Period 1||1
3034005|NCT01130168|3753091|FG003|NOT COMPLETED|Period 1||3
3034006|NCT01130168|3753092|FG004|NOT COMPLETED|Period 1||0
3034007|NCT01130168|3753093|FG005|NOT COMPLETED|Period 1||0
3034008|NCT01130168|3753088|FG000|STARTED|Period 2||6
3034009|NCT01130168|3753089|FG001|STARTED|Period 2||6
3034010|NCT01130168|3753090|FG002|STARTED|Period 2||5
3034011|NCT01130168|3753091|FG003|STARTED|Period 2||5
3034012|NCT01130168|3753092|FG004|STARTED|Period 2||5
3034013|NCT01130168|3753093|FG005|STARTED|Period 2||6
3034014|NCT01130168|3753088|FG000|COMPLETED|Period 2||6
3034015|NCT01130168|3753089|FG001|COMPLETED|Period 2||6
3034016|NCT01130168|3753090|FG002|COMPLETED|Period 2||5
3034017|NCT01130168|3753091|FG003|COMPLETED|Period 2||5
3034018|NCT01130168|3753092|FG004|COMPLETED|Period 2||5
3034019|NCT01130168|3753093|FG005|COMPLETED|Period 2||6
3034020|NCT01130168|3753088|FG000|NOT COMPLETED|Period 2||0
3166220|NCT01903733|3893648|FG003|Enrolled in B1871040|Overall Study||18
3166221|NCT01903733|3893645|FG000|Treated in B1871040|Overall Study||98
3166222|NCT01903733|3893646|FG001|Treated in B1871040|Overall Study||69
3166223|NCT01903733|3893647|FG002|Treated in B1871040|Overall Study||13
3384057|NCT02015455|4119216|FG000|STARTED|Step 0 - Oct 2013 to Mar 2014||48233
3384058|NCT02015455|4119217|FG001|STARTED|Step 0 - Oct 2013 to Mar 2014||0
3384059|NCT02015455|4119216|FG000|Did Not Receive Intended Inclusion/Exclusion of Intervention Report Text|Step 0 - Oct 2013 to Mar 2014||135
3384060|NCT02015455|4119217|FG001|Did Not Receive Intended Inclusion/Exclusion of Intervention Report Text|Step 0 - Oct 2013 to Mar 2014||0
3384061|NCT02015455|4119216|FG000|COMPLETED|Step 0 - Oct 2013 to Mar 2014||48233
3384062|NCT02015455|4119217|FG001|COMPLETED|Step 0 - Oct 2013 to Mar 2014||0
3384063|NCT02015455|4119216|FG000|NOT COMPLETED|Step 0 - Oct 2013 to Mar 2014||0
3384064|NCT02015455|4119217|FG001|NOT COMPLETED|Step 0 - Oct 2013 to Mar 2014||0
3384065|NCT02015455|4119216|FG000|STARTED|Step 1 - Apr 2014 to Sep 2014||24074
3384066|NCT02015455|4119217|FG001|STARTED|Step 1 - Apr 2014 to Sep 2014||6455
3384067|NCT02015455|4119216|FG000|Did Not Receive Intended Inclusion/Exclusion of Intervention Report Text|Step 1 - Apr 2014 to Sep 2014||390
3384068|NCT02015455|4119217|FG001|Did Not Receive Intended Inclusion/Exclusion of Intervention Report Text|Step 1 - Apr 2014 to Sep 2014||2208
3384069|NCT02015455|4119216|FG000|COMPLETED|Step 1 - Apr 2014 to Sep 2014||24074
3384070|NCT02015455|4119217|FG001|COMPLETED|Step 1 - Apr 2014 to Sep 2014||6455
3384071|NCT02015455|4119216|FG000|NOT COMPLETED|Step 1 - Apr 2014 to Sep 2014||0
3384072|NCT02015455|4119217|FG001|NOT COMPLETED|Step 1 - Apr 2014 to Sep 2014||0
3384073|NCT02015455|4119216|FG000|STARTED|Step 2 - Oct 2014 to Mar 2015||23139
3384074|NCT02015455|4119217|FG001|STARTED|Step 2 - Oct 2014 to Mar 2015||16285
3384075|NCT02015455|4119216|FG000|Did Not Receive Intended Inclusion/Exclusion of Intervention Report Text|Step 2 - Oct 2014 to Mar 2015||98
3384076|NCT02015455|4119217|FG001|Did Not Receive Intended Inclusion/Exclusion of Intervention Report Text|Step 2 - Oct 2014 to Mar 2015||1511
3384077|NCT02015455|4119216|FG000|COMPLETED|Step 2 - Oct 2014 to Mar 2015||23139
3384078|NCT02015455|4119217|FG001|COMPLETED|Step 2 - Oct 2014 to Mar 2015||16285
3384079|NCT02015455|4119216|FG000|NOT COMPLETED|Step 2 - Oct 2014 to Mar 2015||0
3384080|NCT02015455|4119217|FG001|NOT COMPLETED|Step 2 - Oct 2014 to Mar 2015||0
3384081|NCT02015455|4119216|FG000|STARTED|Step 3 - Apr 2015 to Sep 2015||14135
3384082|NCT02015455|4119217|FG001|STARTED|Step 3 - Apr 2015 to Sep 2015||27661
3384083|NCT02015455|4119216|FG000|Did Not Receive Intended Inclusion/Exclusion of Intervention Report Text|Step 3 - Apr 2015 to Sep 2015||72
3384084|NCT02015455|4119217|FG001|Did Not Receive Intended Inclusion/Exclusion of Intervention Report Text|Step 3 - Apr 2015 to Sep 2015||4915
3384085|NCT02015455|4119216|FG000|COMPLETED|Step 3 - Apr 2015 to Sep 2015||14135
3384086|NCT02015455|4119217|FG001|COMPLETED|Step 3 - Apr 2015 to Sep 2015||27661
3384087|NCT02015455|4119216|FG000|NOT COMPLETED|Step 3 - Apr 2015 to Sep 2015||0
3384088|NCT02015455|4119217|FG001|NOT COMPLETED|Step 3 - Apr 2015 to Sep 2015||0
3384089|NCT02015455|4119216|FG000|STARTED|Step 4 - Oct 2015 to Mar 2016||7874
3384090|NCT02015455|4119217|FG001|STARTED|Step 4 - Oct 2015 to Mar 2016||31316
3384091|NCT02015455|4119216|FG000|Did Not Receive Intended Inclusion/Exclusion of Intervention Report Text|Step 4 - Oct 2015 to Mar 2016||76
3384092|NCT02015455|4119217|FG001|Did Not Receive Intended Inclusion/Exclusion of Intervention Report Text|Step 4 - Oct 2015 to Mar 2016||3742
3384093|NCT02015455|4119216|FG000|COMPLETED|Step 4 - Oct 2015 to Mar 2016||7874
3384094|NCT02015455|4119217|FG001|COMPLETED|Step 4 - Oct 2015 to Mar 2016||31316
3166224|NCT01903733|3893648|FG003|Treated in B1871040|Overall Study||8
3384095|NCT02015455|4119216|FG000|NOT COMPLETED|Step 4 - Oct 2015 to Mar 2016||0
3384096|NCT02015455|4119217|FG001|NOT COMPLETED|Step 4 - Oct 2015 to Mar 2016||0
3384097|NCT02015455|4119216|FG000|STARTED|Step 5 - Apr 2016 to Sep 2016||0
3384098|NCT02015455|4119217|FG001|STARTED|Step 5 - Apr 2016 to Sep 2016||39714
3384099|NCT02015455|4119216|FG000|Did Not Receive Intended Inclusion/Exclusion of Intervention Report Text|Step 5 - Apr 2016 to Sep 2016||0
3384100|NCT02015455|4119217|FG001|Did Not Receive Intended Inclusion/Exclusion of Intervention Report Text|Step 5 - Apr 2016 to Sep 2016||3512
3384101|NCT02015455|4119216|FG000|COMPLETED|Step 5 - Apr 2016 to Sep 2016||0
3384102|NCT02015455|4119217|FG001|COMPLETED|Step 5 - Apr 2016 to Sep 2016||39714
3384103|NCT02015455|4119216|FG000|NOT COMPLETED|Step 5 - Apr 2016 to Sep 2016||0
3034021|NCT01130168|3753089|FG001|NOT COMPLETED|Period 2||0
3034022|NCT01130168|3753090|FG002|NOT COMPLETED|Period 2||0
3034023|NCT01130168|3753091|FG003|NOT COMPLETED|Period 2||0
3034024|NCT01130168|3753092|FG004|NOT COMPLETED|Period 2||0
3034025|NCT01130168|3753093|FG005|NOT COMPLETED|Period 2||0
3034026|NCT01130168|3753088|FG000|STARTED|Period 3||6
3034027|NCT01130168|3753089|FG001|STARTED|Period 3||6
3034028|NCT01130168|3753090|FG002|STARTED|Period 3||5
3034029|NCT01130168|3753091|FG003|STARTED|Period 3||5
3034030|NCT01130168|3753092|FG004|STARTED|Period 3||5
3034031|NCT01130168|3753093|FG005|STARTED|Period 3||6
3034032|NCT01130168|3753088|FG000|COMPLETED|Period 3||6
3034033|NCT01130168|3753089|FG001|COMPLETED|Period 3||6
3034034|NCT01130168|3753090|FG002|COMPLETED|Period 3||5
3034035|NCT01130168|3753091|FG003|COMPLETED|Period 3||5
3034036|NCT01130168|3753092|FG004|COMPLETED|Period 3||5
3034037|NCT01130168|3753093|FG005|COMPLETED|Period 3||6
3034038|NCT01130168|3753088|FG000|NOT COMPLETED|Period 3||0
3034039|NCT01130168|3753089|FG001|NOT COMPLETED|Period 3||0
3034040|NCT01130168|3753090|FG002|NOT COMPLETED|Period 3||0
3034041|NCT01130168|3753091|FG003|NOT COMPLETED|Period 3||0
3034042|NCT01130168|3753092|FG004|NOT COMPLETED|Period 3||0
3034043|NCT01130168|3753093|FG005|NOT COMPLETED|Period 3||0
3034044|NCT01130272|3753107|FG000|STARTED|Overall Study||107
3166225|NCT01903733|3893645|FG000|COMPLETED|Overall Study||144
3166226|NCT01903733|3893646|FG001|COMPLETED|Overall Study||158
3166227|NCT01903733|3893647|FG002|COMPLETED|Overall Study||58
3034045|NCT01130272|3753108|FG001|STARTED|Overall Study||173
3310119|NCT03037307|4043446|FG002|NOT COMPLETED|Wash Out Period 2||0
3310120|NCT03037307|4043447|FG003|NOT COMPLETED|Wash Out Period 2||0
3310121|NCT03037307|4043448|FG004|NOT COMPLETED|Wash Out Period 2||0
3384104|NCT02015455|4119217|FG001|NOT COMPLETED|Step 5 - Apr 2016 to Sep 2016||0
3385992|NCT02036970|4121397|FG008|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 1: Day 1 Through Week 16||0
3385993|NCT02036970|4121398|FG009|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 1: Day 1 Through Week 16||0
3385994|NCT02036970|4121389|FG000|Cohort 3a: PAH CTD|Part 1: Day 1 Through Week 16||0
3385995|NCT02036970|4121390|FG001|Cohort 3a: PAH CTD|Part 1: Day 1 Through Week 16||0
3385996|NCT02036970|4121391|FG002|Cohort 3a: PAH CTD|Part 1: Day 1 Through Week 16||0
3385997|NCT02036970|4121392|FG003|Cohort 3a: PAH CTD|Part 1: Day 1 Through Week 16||0
3385998|NCT02036970|4121393|FG004|Cohort 3a: PAH CTD|Part 1: Day 1 Through Week 16||0
3385999|NCT02036970|4121394|FG005|Cohort 3a: PAH CTD|Part 1: Day 1 Through Week 16||0
3386000|NCT02036970|4121395|FG006|Cohort 3a: PAH CTD|Part 1: Day 1 Through Week 16||0
3386001|NCT02036970|4121396|FG007|Cohort 3a: PAH CTD|Part 1: Day 1 Through Week 16||0
3386002|NCT02036970|4121397|FG008|Cohort 3a: PAH CTD|Part 1: Day 1 Through Week 16||14
3386003|NCT02036970|4121398|FG009|Cohort 3a: PAH CTD|Part 1: Day 1 Through Week 16||8
3386004|NCT02036970|4121389|FG000|Cohort 3b: PAH Non-CTD|Part 1: Day 1 Through Week 16||0
3386005|NCT02036970|4121390|FG001|Cohort 3b: PAH Non-CTD|Part 1: Day 1 Through Week 16||0
3386006|NCT02036970|4121391|FG002|Cohort 3b: PAH Non-CTD|Part 1: Day 1 Through Week 16||0
3386007|NCT02036970|4121392|FG003|Cohort 3b: PAH Non-CTD|Part 1: Day 1 Through Week 16||0
3386008|NCT02036970|4121393|FG004|Cohort 3b: PAH Non-CTD|Part 1: Day 1 Through Week 16||0
3386009|NCT02036970|4121394|FG005|Cohort 3b: PAH Non-CTD|Part 1: Day 1 Through Week 16||0
3386010|NCT02036970|4121395|FG006|Cohort 3b: PAH Non-CTD|Part 1: Day 1 Through Week 16||0
3386011|NCT02036970|4121396|FG007|Cohort 3b: PAH Non-CTD|Part 1: Day 1 Through Week 16||0
3386012|NCT02036970|4121397|FG008|Cohort 3b: PAH Non-CTD|Part 1: Day 1 Through Week 16||16
3386013|NCT02036970|4121398|FG009|Cohort 3b: PAH Non-CTD|Part 1: Day 1 Through Week 16||9
3386014|NCT02036970|4121389|FG000|Cohort 4a: PH CTD-ILD|Part 1: Day 1 Through Week 16||0
3386015|NCT02036970|4121390|FG001|Cohort 4a: PH CTD-ILD|Part 1: Day 1 Through Week 16||0
3386016|NCT02036970|4121391|FG002|Cohort 4a: PH CTD-ILD|Part 1: Day 1 Through Week 16||0
3386017|NCT02036970|4121392|FG003|Cohort 4a: PH CTD-ILD|Part 1: Day 1 Through Week 16||0
3386018|NCT02036970|4121393|FG004|Cohort 4a: PH CTD-ILD|Part 1: Day 1 Through Week 16||0
3386019|NCT02036970|4121394|FG005|Cohort 4a: PH CTD-ILD|Part 1: Day 1 Through Week 16||0
3386020|NCT02036970|4121395|FG006|Cohort 4a: PH CTD-ILD|Part 1: Day 1 Through Week 16||0
3386021|NCT02036970|4121396|FG007|Cohort 4a: PH CTD-ILD|Part 1: Day 1 Through Week 16||0
3386022|NCT02036970|4121397|FG008|Cohort 4a: PH CTD-ILD|Part 1: Day 1 Through Week 16||17
3386023|NCT02036970|4121398|FG009|Cohort 4a: PH CTD-ILD|Part 1: Day 1 Through Week 16||8
3386024|NCT02036970|4121389|FG000|Cohort 4b: PH CTD-IPF|Part 1: Day 1 Through Week 16||0
3386025|NCT02036970|4121390|FG001|Cohort 4b: PH CTD-IPF|Part 1: Day 1 Through Week 16||0
3386026|NCT02036970|4121391|FG002|Cohort 4b: PH CTD-IPF|Part 1: Day 1 Through Week 16||0
3386027|NCT02036970|4121392|FG003|Cohort 4b: PH CTD-IPF|Part 1: Day 1 Through Week 16||0
3386028|NCT02036970|4121393|FG004|Cohort 4b: PH CTD-IPF|Part 1: Day 1 Through Week 16||0
3386029|NCT02036970|4121394|FG005|Cohort 4b: PH CTD-IPF|Part 1: Day 1 Through Week 16||0
3386030|NCT02036970|4121395|FG006|Cohort 4b: PH CTD-IPF|Part 1: Day 1 Through Week 16||0
3386031|NCT02036970|4121396|FG007|Cohort 4b: PH CTD-IPF|Part 1: Day 1 Through Week 16||0
3386032|NCT02036970|4121397|FG008|Cohort 4b: PH CTD-IPF|Part 1: Day 1 Through Week 16||6
3386033|NCT02036970|4121398|FG009|Cohort 4b: PH CTD-IPF|Part 1: Day 1 Through Week 16||2
3386034|NCT02036970|4121389|FG000|Cohort 4c: PH CTD-IIP|Part 1: Day 1 Through Week 16||0
3386035|NCT02036970|4121390|FG001|Cohort 4c: PH CTD-IIP|Part 1: Day 1 Through Week 16||0
3386036|NCT02036970|4121391|FG002|Cohort 4c: PH CTD-IIP|Part 1: Day 1 Through Week 16||0
3034046|NCT01130272|3753109|FG002|STARTED|Overall Study||169
3034047|NCT01130272|3753110|FG003|STARTED|Overall Study||171
3034048|NCT01130272|3753111|FG004|STARTED|Overall Study||169
3166228|NCT01903733|3893648|FG003|COMPLETED|Overall Study||48
3310122|NCT03037307|4043449|FG005|NOT COMPLETED|Wash Out Period 2||0
3310123|NCT03037307|4043444|FG000|STARTED|Period 3||7
3034049|NCT01130272|3753107|FG000|Safety Analysis Set: as Randomized|Overall Study||105
3034050|NCT01130272|3753108|FG001|Safety Analysis Set: as Randomized|Overall Study||171
3034051|NCT01130272|3753109|FG002|Safety Analysis Set: as Randomized|Overall Study||166
3034052|NCT01130272|3753110|FG003|Safety Analysis Set: as Randomized|Overall Study||167
3034053|NCT01130272|3753111|FG004|Safety Analysis Set: as Randomized|Overall Study||162
3034054|NCT01130272|3753107|FG000|Safety Analysis Set: Highest Dose Level|Overall Study|105 total represents 1 patient in from Placebo arm; 1 patient out to 200 mg arm.|105
3034055|NCT01130272|3753108|FG001|Safety Analysis Set: Highest Dose Level|Overall Study|170 total represents 2 patients in from Placebo arm; 3 patients out to 200 mg arm.|170
3034056|NCT01130272|3753109|FG002|Safety Analysis Set: Highest Dose Level|Overall Study|165 total represents 1 patient out to 200 mg arm.|165
3034057|NCT01130272|3753110|FG003|Safety Analysis Set: Highest Dose Level|Overall Study|172 total represents 1 patient in from 5 mg; 3 patients in from 25 mg;1 patient in from 100 mg arms.|172
3034058|NCT01130272|3753111|FG004|Safety Analysis Set: Highest Dose Level|Overall Study|159 total represents 2 patients out to 25 mg arm; 1 patient out to 5 mg arm.|159
3034059|NCT01130272|3753107|FG000|COMPLETED|Overall Study||48
3034060|NCT01130272|3753108|FG001|COMPLETED|Overall Study||131
3034061|NCT01130272|3753109|FG002|COMPLETED|Overall Study||121
3034062|NCT01130272|3753110|FG003|COMPLETED|Overall Study||103
3034063|NCT01130272|3753111|FG004|COMPLETED|Overall Study||117
3034064|NCT01130272|3753107|FG000|NOT COMPLETED|Overall Study||59
3034065|NCT01130272|3753108|FG001|NOT COMPLETED|Overall Study||42
3034066|NCT01130272|3753109|FG002|NOT COMPLETED|Overall Study||48
3034067|NCT01130272|3753110|FG003|NOT COMPLETED|Overall Study||68
3034068|NCT01130272|3753111|FG004|NOT COMPLETED|Overall Study||52
3034069|NCT01130337|3753123|FG000|STARTED|Overall Study||36
3034070|NCT01130337|3753123|FG000|COMPLETED|Overall Study||22
3034071|NCT01130337|3753123|FG000|NOT COMPLETED|Overall Study||14
3034072|NCT01130493|3753127|FG000|STARTED|Open-label Dose Conversion to IPX066|During the open-label dose conversion to IPX066, all subjects received IPX066|110
3166229|NCT01903733|3893645|FG000|NOT COMPLETED|Overall Study||106
3166230|NCT01903733|3893646|FG001|NOT COMPLETED|Overall Study||126
3166231|NCT01903733|3893647|FG002|NOT COMPLETED|Overall Study||61
3166232|NCT01903733|3893648|FG003|NOT COMPLETED|Overall Study||119
3166233|NCT01903798|3893672|FG000|STARTED|Overall Study||2
3166234|NCT01903798|3893673|FG001|STARTED|Overall Study||0
3166235|NCT01903798|3893674|FG002|STARTED|Overall Study||1
3166236|NCT01903798|3893675|FG003|STARTED|Overall Study||1
3166237|NCT01903798|3893672|FG000|COMPLETED|Overall Study||2
3166238|NCT01903798|3893673|FG001|COMPLETED|Overall Study||0
3166239|NCT01903798|3893674|FG002|COMPLETED|Overall Study||1
3166240|NCT01903798|3893675|FG003|COMPLETED|Overall Study||1
3166241|NCT01903798|3893672|FG000|NOT COMPLETED|Overall Study||0
3166242|NCT01903798|3893673|FG001|NOT COMPLETED|Overall Study||0
3310124|NCT03037307|4043445|FG001|STARTED|Period 3||7
3310125|NCT03037307|4043446|FG002|STARTED|Period 3||8
3310126|NCT03037307|4043447|FG003|STARTED|Period 3||6
3310127|NCT03037307|4043448|FG004|STARTED|Period 3||7
3310128|NCT03037307|4043449|FG005|STARTED|Period 3||8
3310129|NCT03037307|4043444|FG000|COMPLETED|Period 3||7
3310130|NCT03037307|4043445|FG001|COMPLETED|Period 3||7
3310131|NCT03037307|4043446|FG002|COMPLETED|Period 3||8
3310132|NCT03037307|4043447|FG003|COMPLETED|Period 3||6
3310133|NCT03037307|4043448|FG004|COMPLETED|Period 3||7
3310134|NCT03037307|4043449|FG005|COMPLETED|Period 3||8
3310135|NCT03037307|4043444|FG000|NOT COMPLETED|Period 3||0
3310136|NCT03037307|4043445|FG001|NOT COMPLETED|Period 3||0
3310137|NCT03037307|4043446|FG002|NOT COMPLETED|Period 3||0
3310138|NCT03037307|4043447|FG003|NOT COMPLETED|Period 3||0
3310139|NCT03037307|4043448|FG004|NOT COMPLETED|Period 3||0
3310140|NCT03037307|4043449|FG005|NOT COMPLETED|Period 3||0
3310141|NCT03037489|4043460|FG000|STARTED|Overall Study||46
3310142|NCT03037489|4043461|FG001|STARTED|Overall Study||4
3310143|NCT03037489|4043460|FG000|COMPLETED|Overall Study||39
3384105|NCT02024555|4119227|FG000|STARTED|Overall Study||49
3384106|NCT02024555|4119228|FG001|STARTED|Overall Study||48
3384107|NCT02024555|4119227|FG000|COMPLETED|Overall Study||43
3384108|NCT02024555|4119228|FG001|COMPLETED|Overall Study||46
3384109|NCT02024555|4119227|FG000|NOT COMPLETED|Overall Study||6
3384110|NCT02024555|4119228|FG001|NOT COMPLETED|Overall Study||2
3384111|NCT02034123|4119252|FG000|STARTED|Part1(Median of 7.286 Weeks of Exposure)||1
3384112|NCT02034123|4119253|FG001|STARTED|Part1(Median of 7.286 Weeks of Exposure)||1
3384113|NCT02034123|4119254|FG002|STARTED|Part1(Median of 7.286 Weeks of Exposure)||5
3384114|NCT02034123|4119255|FG003|STARTED|Part1(Median of 7.286 Weeks of Exposure)||3
3384115|NCT02034123|4119256|FG004|STARTED|Part1(Median of 7.286 Weeks of Exposure)||7
3384116|NCT02034123|4119257|FG005|STARTED|Part1(Median of 7.286 Weeks of Exposure)||3
3384117|NCT02034123|4119258|FG006|STARTED|Part1(Median of 7.286 Weeks of Exposure)||2
3384118|NCT02034123|4119259|FG007|STARTED|Part1(Median of 7.286 Weeks of Exposure)||5
3384119|NCT02034123|4119260|FG008|STARTED|Part1(Median of 7.286 Weeks of Exposure)||2
3384120|NCT02034123|4119261|FG009|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
3384121|NCT02034123|4119262|FG010|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
3384122|NCT02034123|4119263|FG011|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
3384123|NCT02034123|4119264|FG012|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
3384124|NCT02034123|4119265|FG013|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
3384125|NCT02034123|4119266|FG014|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
3384126|NCT02034123|4119267|FG015|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
3166243|NCT01903798|3893674|FG002|NOT COMPLETED|Overall Study||0
3166244|NCT01903798|3893675|FG003|NOT COMPLETED|Overall Study||0
3166245|NCT01903811|3893687|FG000|STARTED|Overall Study||72
3166246|NCT01903811|3893688|FG001|STARTED|Overall Study||71
3166247|NCT01903811|3893687|FG000|Crossover to Arm II|Overall Study|Following disease progression on Arm I. Note: these patients are also counted in 'Completed'.|16
3166248|NCT01903811|3893688|FG001|Crossover to Arm II|Overall Study||0
3166249|NCT01903811|3893687|FG000|COMPLETED|Overall Study||64
3310144|NCT03037489|4043461|FG001|COMPLETED|Overall Study||4
3310145|NCT03037489|4043460|FG000|NOT COMPLETED|Overall Study||7
3310146|NCT03037489|4043461|FG001|NOT COMPLETED|Overall Study||0
3384127|NCT02034123|4119268|FG016|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
3384128|NCT02034123|4119269|FG017|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
3384129|NCT02034123|4119252|FG000|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||1
3384130|NCT02034123|4119253|FG001|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||1
3384131|NCT02034123|4119254|FG002|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||5
3384132|NCT02034123|4119255|FG003|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||1
3384133|NCT02034123|4119256|FG004|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||5
3384134|NCT02034123|4119257|FG005|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||3
3384135|NCT02034123|4119258|FG006|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||2
3384136|NCT02034123|4119259|FG007|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||4
3386743|NCT02021773|4122068|FG000|COMPLETED|Overall Study||77
2911809|NCT00487084|3621658|FG000|STARTED|Overall Study||33
2911810|NCT00487084|3621659|FG001|STARTED|Overall Study||33
2911811|NCT00487084|3621660|FG002|STARTED|Overall Study||33
2911812|NCT00487084|3621658|FG000|COMPLETED|Overall Study||29
2911813|NCT00487084|3621659|FG001|COMPLETED|Overall Study||30
2911814|NCT00487084|3621660|FG002|COMPLETED|Overall Study||28
2911815|NCT00487084|3621658|FG000|NOT COMPLETED|Overall Study||4
2911816|NCT00487084|3621659|FG001|NOT COMPLETED|Overall Study||3
2911817|NCT00487084|3621660|FG002|NOT COMPLETED|Overall Study||5
2911818|NCT00487188|3621670|FG000|STARTED|Induction Phase||31
2911819|NCT00487188|3621671|FG001|STARTED|Induction Phase||16
2911820|NCT00487188|3621672|FG002|STARTED|Induction Phase|Participants were only randomized to this treatment arm in the Maintenance Phase|0
2911821|NCT00487188|3621670|FG000|Safety Population|Induction Phase||29
2911822|NCT00487188|3621671|FG001|Safety Population|Induction Phase|2 patients randomized to ENF + HARRT only received treatment with HAART|18
2911823|NCT00487188|3621672|FG002|Safety Population|Induction Phase||0
2911824|NCT00487188|3621670|FG000|COMPLETED|Induction Phase||22
2911825|NCT00487188|3621671|FG001|COMPLETED|Induction Phase||9
2911826|NCT00487188|3621672|FG002|COMPLETED|Induction Phase||0
2911827|NCT00487188|3621670|FG000|NOT COMPLETED|Induction Phase||9
2911828|NCT00487188|3621671|FG001|NOT COMPLETED|Induction Phase||7
2911829|NCT00487188|3621672|FG002|NOT COMPLETED|Induction Phase||0
2911830|NCT00487188|3621670|FG000|STARTED|Maintenance Phase||10
2911831|NCT00487188|3621671|FG001|STARTED|Maintenance Phase||8
2911832|NCT00487188|3621672|FG002|STARTED|Maintenance Phase||9
2911833|NCT00487188|3621670|FG000|COMPLETED|Maintenance Phase||7
2911834|NCT00487188|3621671|FG001|COMPLETED|Maintenance Phase||8
2911835|NCT00487188|3621672|FG002|COMPLETED|Maintenance Phase||8
2911836|NCT00487188|3621670|FG000|NOT COMPLETED|Maintenance Phase||3
2911837|NCT00487188|3621671|FG001|NOT COMPLETED|Maintenance Phase||0
2911838|NCT00487188|3621672|FG002|NOT COMPLETED|Maintenance Phase||1
2911839|NCT00487240|3621690|FG000|STARTED|Overall Study||195
2911840|NCT00487240|3621691|FG001|STARTED|Overall Study||192
2911841|NCT00487240|3621690|FG000|Full Analysis Set (ITT Population)|Overall Study||192
2911842|NCT00487240|3621691|FG001|Full Analysis Set (ITT Population)|Overall Study||189
2911843|NCT00487240|3621690|FG000|COMPLETED|Overall Study||164
2911844|NCT00487240|3621691|FG001|COMPLETED|Overall Study||166
2911845|NCT00487240|3621690|FG000|NOT COMPLETED|Overall Study||31
2911846|NCT00487240|3621691|FG001|NOT COMPLETED|Overall Study||26
2911847|NCT00487279|3621699|FG000|STARTED|Overall Study||44
2911848|NCT00487279|3621700|FG001|STARTED|Overall Study||37
2911849|NCT00487279|3621699|FG000|COMPLETED|Overall Study||43
2911850|NCT00487279|3621700|FG001|COMPLETED|Overall Study||35
2911851|NCT00487279|3621699|FG000|NOT COMPLETED|Overall Study||1
2911852|NCT00487279|3621700|FG001|NOT COMPLETED|Overall Study||2
2911853|NCT00487396|3621706|FG000|STARTED|Overall Study||98
2911854|NCT00487396|3621706|FG000|COMPLETED|Overall Study||95
2911855|NCT00487396|3621706|FG000|NOT COMPLETED|Overall Study||3
2911856|NCT00487435|3621715|FG000|STARTED|Overall Study|Patients who received at least one dose of Tapentadol (CG5503) Extended Release (ER)|1154
2911857|NCT00487435|3621715|FG000|COMPLETED|Overall Study||669
2911858|NCT00487435|3621715|FG000|NOT COMPLETED|Overall Study||485
2911859|NCT00487539|3621723|FG000|STARTED|Overall Study||331
2911860|NCT00487539|3621724|FG001|STARTED|Overall Study||72
2911861|NCT00487539|3621725|FG002|STARTED|Overall Study||331
2911862|NCT00487539|3621726|FG003|STARTED|Overall Study||331
2911863|NCT00487539|3621723|FG000|COMPLETED|Overall Study||324
2911864|NCT00487539|3621724|FG001|COMPLETED|Overall Study||69
2911865|NCT00487539|3621725|FG002|COMPLETED|Overall Study||328
2911866|NCT00487539|3621726|FG003|COMPLETED|Overall Study||327
3166250|NCT01903811|3893688|FG001|COMPLETED|Overall Study||57
3166251|NCT01903811|3893687|FG000|NOT COMPLETED|Overall Study||8
3166252|NCT01903811|3893688|FG001|NOT COMPLETED|Overall Study||14
3166253|NCT01903837|3893701|FG000|STARTED|Part A||75
3166254|NCT01903837|3893702|FG001|STARTED|Part A||80
3166255|NCT01903837|3893703|FG002|STARTED|Part A||86
3166256|NCT01903837|3893704|FG003|STARTED|Part A||68
3166257|NCT01903837|3893701|FG000|COMPLETED|Part A||56
3166258|NCT01903837|3893702|FG001|COMPLETED|Part A||52
3166259|NCT01903837|3893703|FG002|COMPLETED|Part A||58
3166260|NCT01903837|3893704|FG003|COMPLETED|Part A||55
3166261|NCT01903837|3893701|FG000|NOT COMPLETED|Part A||19
3166262|NCT01903837|3893702|FG001|NOT COMPLETED|Part A||28
3166263|NCT01903837|3893703|FG002|NOT COMPLETED|Part A||28
3166264|NCT01903837|3893704|FG003|NOT COMPLETED|Part A||13
3166265|NCT01903837|3893701|FG000|STARTED|Part B||54
3166266|NCT01903837|3893702|FG001|STARTED|Part B||52
3166267|NCT01903837|3893703|FG002|STARTED|Part B||57
3166268|NCT01903837|3893704|FG003|STARTED|Part B||55
3166269|NCT01903837|3893701|FG000|COMPLETED|Part B||45
3166270|NCT01903837|3893702|FG001|COMPLETED|Part B||46
3166271|NCT01903837|3893703|FG002|COMPLETED|Part B||52
3166272|NCT01903837|3893704|FG003|COMPLETED|Part B||44
3166273|NCT01903837|3893701|FG000|NOT COMPLETED|Part B||9
3166274|NCT01903837|3893702|FG001|NOT COMPLETED|Part B||6
3166275|NCT01903837|3893703|FG002|NOT COMPLETED|Part B||5
3166276|NCT01903837|3893704|FG003|NOT COMPLETED|Part B||11
3166277|NCT01903863|3893737|FG000|STARTED|Overall Study||15
3166278|NCT01903863|3893738|FG001|STARTED|Overall Study||16
3384137|NCT02034123|4119260|FG008|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
3384138|NCT02034123|4119261|FG009|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
3384139|NCT02034123|4119262|FG010|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
3034073|NCT01130493|3753128|FG001|STARTED|Open-label Dose Conversion to IPX066||0
3034074|NCT01130493|3753129|FG002|STARTED|Open-label Dose Conversion to IPX066||0
3034075|NCT01130493|3753127|FG000|COMPLETED|Open-label Dose Conversion to IPX066||91
3034076|NCT01130493|3753128|FG001|COMPLETED|Open-label Dose Conversion to IPX066||0
3034077|NCT01130493|3753129|FG002|COMPLETED|Open-label Dose Conversion to IPX066||0
3034078|NCT01130493|3753127|FG000|NOT COMPLETED|Open-label Dose Conversion to IPX066||19
3034079|NCT01130493|3753128|FG001|NOT COMPLETED|Open-label Dose Conversion to IPX066||0
3034080|NCT01130493|3753129|FG002|NOT COMPLETED|Open-label Dose Conversion to IPX066||0
3034081|NCT01130493|3753127|FG000|STARTED|Part 1: Double-blind Treatment Period 1|91 subjects completed IPX066 dose conversion and were then randomized to the two treatment sequences|0
3034082|NCT01130493|3753128|FG001|STARTED|Part 1: Double-blind Treatment Period 1|48 were randomized to IPX066-CLE double-blind treatment sequence|48
3034083|NCT01130493|3753129|FG002|STARTED|Part 1: Double-blind Treatment Period 1|43 were randomized to CLE-IPX066 double-blind treatment sequence|43
3034084|NCT01130493|3753127|FG000|COMPLETED|Part 1: Double-blind Treatment Period 1||0
3034085|NCT01130493|3753128|FG001|COMPLETED|Part 1: Double-blind Treatment Period 1||46
3034086|NCT01130493|3753129|FG002|COMPLETED|Part 1: Double-blind Treatment Period 1||43
3034087|NCT01130493|3753127|FG000|NOT COMPLETED|Part 1: Double-blind Treatment Period 1||0
3034088|NCT01130493|3753128|FG001|NOT COMPLETED|Part 1: Double-blind Treatment Period 1||2
3034089|NCT01130493|3753129|FG002|NOT COMPLETED|Part 1: Double-blind Treatment Period 1||0
3034090|NCT01130493|3753127|FG000|STARTED|Part 1: Open-Label IPX066 Washout||0
3034091|NCT01130493|3753128|FG001|STARTED|Part 1: Open-Label IPX066 Washout||46
3034092|NCT01130493|3753129|FG002|STARTED|Part 1: Open-Label IPX066 Washout||43
3384140|NCT02034123|4119263|FG011|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
3384141|NCT02034123|4119264|FG012|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
3384142|NCT02034123|4119265|FG013|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
3384143|NCT02034123|4119266|FG014|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
3384144|NCT02034123|4119267|FG015|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
3384145|NCT02034123|4119268|FG016|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
3384146|NCT02034123|4119269|FG017|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
3384147|NCT02034123|4119252|FG000|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
3384148|NCT02034123|4119253|FG001|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
3384149|NCT02034123|4119254|FG002|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
3384150|NCT02034123|4119255|FG003|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||2
3384151|NCT02034123|4119256|FG004|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||2
3384152|NCT02034123|4119257|FG005|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
3384153|NCT02034123|4119258|FG006|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
3384154|NCT02034123|4119259|FG007|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||1
3384155|NCT02034123|4119260|FG008|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||2
3384156|NCT02034123|4119261|FG009|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
3384157|NCT02034123|4119262|FG010|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
3384158|NCT02034123|4119263|FG011|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
3384159|NCT02034123|4119264|FG012|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
3034093|NCT01130493|3753127|FG000|COMPLETED|Part 1: Open-Label IPX066 Washout||0
3034094|NCT01130493|3753128|FG001|COMPLETED|Part 1: Open-Label IPX066 Washout||45
3034095|NCT01130493|3753129|FG002|COMPLETED|Part 1: Open-Label IPX066 Washout||41
3034096|NCT01130493|3753127|FG000|NOT COMPLETED|Part 1: Open-Label IPX066 Washout||0
3034097|NCT01130493|3753128|FG001|NOT COMPLETED|Part 1: Open-Label IPX066 Washout||1
3034098|NCT01130493|3753129|FG002|NOT COMPLETED|Part 1: Open-Label IPX066 Washout||2
3034099|NCT01130493|3753127|FG000|STARTED|Part 1: Double-blind Treatment Period 2||0
3166279|NCT01903863|3893737|FG000|COMPLETED|Overall Study||13
3166280|NCT01903863|3893738|FG001|COMPLETED|Overall Study||16
3166281|NCT01903863|3893737|FG000|NOT COMPLETED|Overall Study||2
3166282|NCT01903863|3893738|FG001|NOT COMPLETED|Overall Study||0
3166283|NCT01903876|3893746|FG000|STARTED|Baseline to Post-Intervention Period||367
3034100|NCT01130493|3753128|FG001|STARTED|Part 1: Double-blind Treatment Period 2||45
3034101|NCT01130493|3753129|FG002|STARTED|Part 1: Double-blind Treatment Period 2||41
3034102|NCT01130493|3753127|FG000|COMPLETED|Part 1: Double-blind Treatment Period 2||0
3034103|NCT01130493|3753128|FG001|COMPLETED|Part 1: Double-blind Treatment Period 2||45
3166284|NCT01903876|3893747|FG001|STARTED|Baseline to Post-Intervention Period||376
3166285|NCT01903876|3893746|FG000|COMPLETED|Baseline to Post-Intervention Period||183
3166286|NCT01903876|3893747|FG001|COMPLETED|Baseline to Post-Intervention Period||268
3166287|NCT01903876|3893746|FG000|NOT COMPLETED|Baseline to Post-Intervention Period||184
3166288|NCT01903876|3893747|FG001|NOT COMPLETED|Baseline to Post-Intervention Period||108
3166289|NCT01903876|3893746|FG000|STARTED|Six-Month Follow-up Period||183
3166290|NCT01903876|3893747|FG001|STARTED|Six-Month Follow-up Period||268
3384160|NCT02034123|4119265|FG013|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
3384161|NCT02034123|4119266|FG014|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
3384162|NCT02034123|4119267|FG015|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
3384163|NCT02034123|4119268|FG016|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
2911867|NCT00487539|3621723|FG000|NOT COMPLETED|Overall Study||7
2911868|NCT00487539|3621724|FG001|NOT COMPLETED|Overall Study||3
2911869|NCT00487539|3621725|FG002|NOT COMPLETED|Overall Study||3
2911870|NCT00487539|3621726|FG003|NOT COMPLETED|Overall Study||4
2911871|NCT00487552|3621735|FG000|STARTED|Overall Study||18
2911872|NCT00487552|3621735|FG000|COMPLETED|Overall Study||12
2911873|NCT00487552|3621735|FG000|NOT COMPLETED|Overall Study||6
2911874|NCT00487565|3621740|FG000|STARTED|Overall Study||210
2911875|NCT00487565|3621740|FG000|COMPLETED|Overall Study||182
2911876|NCT00487565|3621740|FG000|NOT COMPLETED|Overall Study||28
2911877|NCT00487669|3621744|FG000|STARTED|Overall Study||12
2911878|NCT00487669|3621744|FG000|COMPLETED|Overall Study||12
2911879|NCT00487669|3621744|FG000|NOT COMPLETED|Overall Study||0
2911880|NCT00487695|3621750|FG000|STARTED|First Procedure||23
2911881|NCT00487695|3621751|FG001|STARTED|First Procedure||23
2911882|NCT00487695|3621750|FG000|COMPLETED|First Procedure||20
2911883|NCT00487695|3621751|FG001|COMPLETED|First Procedure||23
2911884|NCT00487695|3621750|FG000|NOT COMPLETED|First Procedure||3
2911885|NCT00487695|3621751|FG001|NOT COMPLETED|First Procedure||0
2911886|NCT00487695|3621750|FG000|STARTED|Second Procedure||20
2911887|NCT00487695|3621751|FG001|STARTED|Second Procedure||23
2911888|NCT00487695|3621750|FG000|COMPLETED|Second Procedure||19
2911889|NCT00487695|3621751|FG001|COMPLETED|Second Procedure||20
2911890|NCT00487695|3621750|FG000|NOT COMPLETED|Second Procedure||1
2911891|NCT00487695|3621751|FG001|NOT COMPLETED|Second Procedure||3
2911892|NCT00487721|3621759|FG000|STARTED|Overall Study||6
2911893|NCT00487721|3621760|FG001|STARTED|Overall Study||6
2911894|NCT00487721|3621759|FG000|COMPLETED|Overall Study||6
2911895|NCT00487721|3621760|FG001|COMPLETED|Overall Study||6
2911896|NCT00487721|3621759|FG000|NOT COMPLETED|Overall Study||0
2911897|NCT00487721|3621760|FG001|NOT COMPLETED|Overall Study||0
2911898|NCT00487747|3621765|FG000|STARTED|Overall Study||18
2911899|NCT00487747|3621765|FG000|COMPLETED|Overall Study||7
2911900|NCT00487747|3621765|FG000|NOT COMPLETED|Overall Study||11
2911901|NCT00487825|3621771|FG000|STARTED|Overall Study|"Started indicates Intent-to-treat population (ITT)"|52
2911902|NCT00487825|3621772|FG001|STARTED|Overall Study||26
2911903|NCT00487825|3621771|FG000|COMPLETED|Overall Study||46
2911904|NCT00487825|3621772|FG001|COMPLETED|Overall Study||21
2911905|NCT00487825|3621771|FG000|NOT COMPLETED|Overall Study||6
2911906|NCT00487825|3621772|FG001|NOT COMPLETED|Overall Study||5
2911907|NCT00487942|3621782|FG000|STARTED|Overall Study||15
2911908|NCT00487942|3621783|FG001|STARTED|Overall Study||15
2911909|NCT00487942|3621784|FG002|STARTED|Overall Study||15
2911910|NCT00487942|3621785|FG003|STARTED|Overall Study|One subject randomized to placebo discontinued prior to receiving any study drug, leaving 14.|15
2911911|NCT00487942|3621782|FG000|COMPLETED|Overall Study||12
2911912|NCT00487942|3621783|FG001|COMPLETED|Overall Study||12
2911913|NCT00487942|3621784|FG002|COMPLETED|Overall Study||12
2911914|NCT00487942|3621785|FG003|COMPLETED|Overall Study||13
2911915|NCT00487942|3621782|FG000|NOT COMPLETED|Overall Study||3
2911916|NCT00487942|3621783|FG001|NOT COMPLETED|Overall Study||3
2911917|NCT00487942|3621784|FG002|NOT COMPLETED|Overall Study||3
2911918|NCT00487942|3621785|FG003|NOT COMPLETED|Overall Study||2
2911919|NCT00488033|3621797|FG000|STARTED|Overall Study||448
2911920|NCT00488033|3621798|FG001|STARTED|Overall Study||452
2911921|NCT00488033|3621797|FG000|COMPLETED|Overall Study||447
2911922|NCT00488033|3621798|FG001|COMPLETED|Overall Study||452
2911923|NCT00488033|3621797|FG000|NOT COMPLETED|Overall Study||1
2911924|NCT00488033|3621798|FG001|NOT COMPLETED|Overall Study||0
2911925|NCT00488059|3621804|FG000|STARTED|Phase I: ENF 90mg SC BID||29
2911926|NCT00488059|3621805|FG001|STARTED|Phase I: ENF 90mg SC BID||0
2911927|NCT00488059|3621806|FG002|STARTED|Phase I: ENF 90mg SC BID||0
2911928|NCT00488059|3621804|FG000|COMPLETED|Phase I: ENF 90mg SC BID||14
2911929|NCT00488059|3621805|FG001|COMPLETED|Phase I: ENF 90mg SC BID||0
2911930|NCT00488059|3621806|FG002|COMPLETED|Phase I: ENF 90mg SC BID||0
2911931|NCT00488059|3621804|FG000|NOT COMPLETED|Phase I: ENF 90mg SC BID||15
2911932|NCT00488059|3621805|FG001|NOT COMPLETED|Phase I: ENF 90mg SC BID||0
2911933|NCT00488059|3621806|FG002|NOT COMPLETED|Phase I: ENF 90mg SC BID||0
2911934|NCT00488059|3621804|FG000|STARTED|Phase II Arm A:Phase I Then ENF 90mg BID||0
2911935|NCT00488059|3621805|FG001|STARTED|Phase II Arm A:Phase I Then ENF 90mg BID||9
2911936|NCT00488059|3621806|FG002|STARTED|Phase II Arm A:Phase I Then ENF 90mg BID||0
3038334|NCT01153711|3757753|FG000|NOT COMPLETED|Overall Study||0
3384164|NCT02034123|4119269|FG017|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
3384165|NCT02034123|4119252|FG000|STARTED|Part2(Up to 2 Years)||0
3384166|NCT02034123|4119253|FG001|STARTED|Part2(Up to 2 Years)||0
3384167|NCT02034123|4119254|FG002|STARTED|Part2(Up to 2 Years)||0
3384168|NCT02034123|4119255|FG003|STARTED|Part2(Up to 2 Years)||0
3384169|NCT02034123|4119256|FG004|STARTED|Part2(Up to 2 Years)||0
3384170|NCT02034123|4119257|FG005|STARTED|Part2(Up to 2 Years)||0
3384171|NCT02034123|4119258|FG006|STARTED|Part2(Up to 2 Years)||0
3384172|NCT02034123|4119259|FG007|STARTED|Part2(Up to 2 Years)||0
3384173|NCT02034123|4119260|FG008|STARTED|Part2(Up to 2 Years)||0
3384174|NCT02034123|4119261|FG009|STARTED|Part2(Up to 2 Years)||0
3384175|NCT02034123|4119262|FG010|STARTED|Part2(Up to 2 Years)||0
3384176|NCT02034123|4119263|FG011|STARTED|Part2(Up to 2 Years)||0
3384177|NCT02034123|4119264|FG012|STARTED|Part2(Up to 2 Years)||0
3384178|NCT02034123|4119265|FG013|STARTED|Part2(Up to 2 Years)||0
3384179|NCT02034123|4119266|FG014|STARTED|Part2(Up to 2 Years)||0
3384180|NCT02034123|4119267|FG015|STARTED|Part2(Up to 2 Years)||0
3384181|NCT02034123|4119268|FG016|STARTED|Part2(Up to 2 Years)||0
3384182|NCT02034123|4119269|FG017|STARTED|Part2(Up to 2 Years)||0
3384183|NCT02034123|4119252|FG000|COMPLETED|Part2(Up to 2 Years)||0
3384184|NCT02034123|4119253|FG001|COMPLETED|Part2(Up to 2 Years)||0
3384185|NCT02034123|4119254|FG002|COMPLETED|Part2(Up to 2 Years)||0
3384186|NCT02034123|4119255|FG003|COMPLETED|Part2(Up to 2 Years)||0
3384187|NCT02034123|4119256|FG004|COMPLETED|Part2(Up to 2 Years)||0
3384188|NCT02034123|4119257|FG005|COMPLETED|Part2(Up to 2 Years)||0
3384189|NCT02034123|4119258|FG006|COMPLETED|Part2(Up to 2 Years)||0
3384190|NCT02034123|4119259|FG007|COMPLETED|Part2(Up to 2 Years)||0
3384191|NCT02034123|4119260|FG008|COMPLETED|Part2(Up to 2 Years)||0
3384192|NCT02034123|4119261|FG009|COMPLETED|Part2(Up to 2 Years)||0
3384193|NCT02034123|4119262|FG010|COMPLETED|Part2(Up to 2 Years)||0
3384194|NCT02034123|4119263|FG011|COMPLETED|Part2(Up to 2 Years)||0
3384195|NCT02034123|4119264|FG012|COMPLETED|Part2(Up to 2 Years)||0
3384196|NCT02034123|4119265|FG013|COMPLETED|Part2(Up to 2 Years)||0
3384197|NCT02034123|4119266|FG014|COMPLETED|Part2(Up to 2 Years)||0
3384198|NCT02034123|4119267|FG015|COMPLETED|Part2(Up to 2 Years)||0
3384199|NCT02034123|4119268|FG016|COMPLETED|Part2(Up to 2 Years)||0
3384200|NCT02034123|4119269|FG017|COMPLETED|Part2(Up to 2 Years)||0
3384201|NCT02034123|4119252|FG000|NOT COMPLETED|Part2(Up to 2 Years)||0
3384202|NCT02034123|4119253|FG001|NOT COMPLETED|Part2(Up to 2 Years)||0
3384203|NCT02034123|4119254|FG002|NOT COMPLETED|Part2(Up to 2 Years)||0
3384204|NCT02034123|4119255|FG003|NOT COMPLETED|Part2(Up to 2 Years)||0
3384205|NCT02034123|4119256|FG004|NOT COMPLETED|Part2(Up to 2 Years)||0
3384206|NCT02034123|4119257|FG005|NOT COMPLETED|Part2(Up to 2 Years)||0
3384207|NCT02034123|4119258|FG006|NOT COMPLETED|Part2(Up to 2 Years)||0
3384208|NCT02034123|4119259|FG007|NOT COMPLETED|Part2(Up to 2 Years)||0
3384209|NCT02034123|4119260|FG008|NOT COMPLETED|Part2(Up to 2 Years)||0
3384210|NCT02034123|4119261|FG009|NOT COMPLETED|Part2(Up to 2 Years)||0
3384211|NCT02034123|4119262|FG010|NOT COMPLETED|Part2(Up to 2 Years)||0
3384212|NCT02034123|4119263|FG011|NOT COMPLETED|Part2(Up to 2 Years)||0
3384213|NCT02034123|4119264|FG012|NOT COMPLETED|Part2(Up to 2 Years)||0
3384214|NCT02034123|4119265|FG013|NOT COMPLETED|Part2(Up to 2 Years)||0
3384215|NCT02034123|4119266|FG014|NOT COMPLETED|Part2(Up to 2 Years)||0
3384216|NCT02034123|4119267|FG015|NOT COMPLETED|Part2(Up to 2 Years)||0
3384217|NCT02034123|4119268|FG016|NOT COMPLETED|Part2(Up to 2 Years)||0
3384218|NCT02034123|4119269|FG017|NOT COMPLETED|Part2(Up to 2 Years)||0
3386037|NCT02036970|4121392|FG003|Cohort 4c: PH CTD-IIP|Part 1: Day 1 Through Week 16||0
3386038|NCT02036970|4121393|FG004|Cohort 4c: PH CTD-IIP|Part 1: Day 1 Through Week 16||0
3386039|NCT02036970|4121394|FG005|Cohort 4c: PH CTD-IIP|Part 1: Day 1 Through Week 16||0
3386040|NCT02036970|4121395|FG006|Cohort 4c: PH CTD-IIP|Part 1: Day 1 Through Week 16||0
3386041|NCT02036970|4121396|FG007|Cohort 4c: PH CTD-IIP|Part 1: Day 1 Through Week 16||0
3386042|NCT02036970|4121397|FG008|Cohort 4c: PH CTD-IIP|Part 1: Day 1 Through Week 16||4
3386043|NCT02036970|4121398|FG009|Cohort 4c: PH CTD-IIP|Part 1: Day 1 Through Week 16||1
3386044|NCT02036970|4121389|FG000|Cohort 4d: PH CTD-Sarcoidosis|Part 1: Day 1 Through Week 16||0
3386045|NCT02036970|4121390|FG001|Cohort 4d: PH CTD-Sarcoidosis|Part 1: Day 1 Through Week 16||0
3386046|NCT02036970|4121391|FG002|Cohort 4d: PH CTD-Sarcoidosis|Part 1: Day 1 Through Week 16||0
3386047|NCT02036970|4121392|FG003|Cohort 4d: PH CTD-Sarcoidosis|Part 1: Day 1 Through Week 16||0
3386048|NCT02036970|4121393|FG004|Cohort 4d: PH CTD-Sarcoidosis|Part 1: Day 1 Through Week 16||0
3386049|NCT02036970|4121394|FG005|Cohort 4d: PH CTD-Sarcoidosis|Part 1: Day 1 Through Week 16||0
3386050|NCT02036970|4121395|FG006|Cohort 4d: PH CTD-Sarcoidosis|Part 1: Day 1 Through Week 16||0
3386051|NCT02036970|4121396|FG007|Cohort 4d: PH CTD-Sarcoidosis|Part 1: Day 1 Through Week 16||0
3386052|NCT02036970|4121397|FG008|Cohort 4d: PH CTD-Sarcoidosis|Part 1: Day 1 Through Week 16||17
3386053|NCT02036970|4121398|FG009|Cohort 4d: PH CTD-Sarcoidosis|Part 1: Day 1 Through Week 16||1
3386054|NCT02036970|4121389|FG000|COMPLETED|Part 1: Day 1 Through Week 16||5
3386055|NCT02036970|4121390|FG001|COMPLETED|Part 1: Day 1 Through Week 16||12
3386056|NCT02036970|4121391|FG002|COMPLETED|Part 1: Day 1 Through Week 16||7
3386057|NCT02036970|4121392|FG003|COMPLETED|Part 1: Day 1 Through Week 16||9
3386058|NCT02036970|4121393|FG004|COMPLETED|Part 1: Day 1 Through Week 16||1
3386059|NCT02036970|4121394|FG005|COMPLETED|Part 1: Day 1 Through Week 16||3
3386060|NCT02036970|4121395|FG006|COMPLETED|Part 1: Day 1 Through Week 16||3
3034104|NCT01130493|3753129|FG002|COMPLETED|Part 1: Double-blind Treatment Period 2||39
3034105|NCT01130493|3753127|FG000|NOT COMPLETED|Part 1: Double-blind Treatment Period 2||0
3034106|NCT01130493|3753128|FG001|NOT COMPLETED|Part 1: Double-blind Treatment Period 2||0
3034107|NCT01130493|3753129|FG002|NOT COMPLETED|Part 1: Double-blind Treatment Period 2||2
3034108|NCT01130493|3753127|FG000|STARTED|Part 2: OLE||0
3384219|NCT02040584|4119314|FG000|STARTED|Overall Study||105
3384220|NCT02040584|4119315|FG001|STARTED|Overall Study||106
3384221|NCT02040584|4119314|FG000|COMPLETED|Overall Study||70
3384222|NCT02040584|4119315|FG001|COMPLETED|Overall Study||74
3384223|NCT02040584|4119314|FG000|NOT COMPLETED|Overall Study||35
3384224|NCT02040584|4119315|FG001|NOT COMPLETED|Overall Study||32
3384225|NCT02045797|4119334|FG000|STARTED|Overall Study||58
3384226|NCT02045797|4119335|FG001|STARTED|Overall Study||39
3384227|NCT02045797|4119336|FG002|STARTED|Overall Study||25
3384228|NCT02045797|4119334|FG000|COMPLETED|Overall Study||51
3384229|NCT02045797|4119335|FG001|COMPLETED|Overall Study||32
3384230|NCT02045797|4119336|FG002|COMPLETED|Overall Study||24
3384231|NCT02045797|4119334|FG000|NOT COMPLETED|Overall Study||7
3384232|NCT02045797|4119335|FG001|NOT COMPLETED|Overall Study||7
3384233|NCT02045797|4119336|FG002|NOT COMPLETED|Overall Study||1
3384234|NCT02049710|4119346|FG000|STARTED|Overall Study||653
3384235|NCT02049710|4119347|FG001|STARTED|Overall Study||664
3384236|NCT02049710|4119346|FG000|COMPLETED|Overall Study||334
3384237|NCT02049710|4119347|FG001|COMPLETED|Overall Study||340
2911937|NCT00488059|3621804|FG000|COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||0
2911938|NCT00488059|3621805|FG001|COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||7
2911939|NCT00488059|3621806|FG002|COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||0
2911940|NCT00488059|3621804|FG000|NOT COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||0
2911941|NCT00488059|3621805|FG001|NOT COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||2
2911942|NCT00488059|3621806|FG002|NOT COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||0
2911943|NCT00488059|3621804|FG000|STARTED|Phase II Arm B:Phase I Then ENF 180mg QD||0
2911944|NCT00488059|3621805|FG001|STARTED|Phase II Arm B:Phase I Then ENF 180mg QD||0
2911945|NCT00488059|3621806|FG002|STARTED|Phase II Arm B:Phase I Then ENF 180mg QD||5
2911946|NCT00488059|3621804|FG000|COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||0
2911947|NCT00488059|3621805|FG001|COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||0
2911948|NCT00488059|3621806|FG002|COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||1
2911949|NCT00488059|3621804|FG000|NOT COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||0
2911950|NCT00488059|3621805|FG001|NOT COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||0
2911951|NCT00488059|3621806|FG002|NOT COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||4
2911952|NCT00488293|3621821|FG000|STARTED|Overall Study||196
2911953|NCT00488293|3621822|FG001|STARTED|Overall Study||196
2911954|NCT00488293|3621821|FG000|COMPLETED|Overall Study||160
2911955|NCT00488293|3621822|FG001|COMPLETED|Overall Study||166
2911956|NCT00488293|3621821|FG000|NOT COMPLETED|Overall Study||36
2911957|NCT00488293|3621822|FG001|NOT COMPLETED|Overall Study||30
2911958|NCT00488319|3621831|FG000|STARTED|Overall Study||39
2911959|NCT00488319|3621832|FG001|STARTED|Overall Study||118
2911960|NCT00488319|3621833|FG002|STARTED|Overall Study||243
2911961|NCT00488319|3621831|FG000|COMPLETED|Overall Study||24
2911962|NCT00488319|3621832|FG001|COMPLETED|Overall Study||75
2911963|NCT00488319|3621833|FG002|COMPLETED|Overall Study||121
2911964|NCT00488319|3621831|FG000|NOT COMPLETED|Overall Study||15
2911965|NCT00488319|3621832|FG001|NOT COMPLETED|Overall Study||43
2911966|NCT00488319|3621833|FG002|NOT COMPLETED|Overall Study||122
2911967|NCT00488345|3621845|FG000|STARTED|Overall Study||17
2911968|NCT00488345|3621846|FG001|STARTED|Overall Study||21
2911969|NCT00488345|3621847|FG002|STARTED|Overall Study||20
2911970|NCT00488345|3621845|FG000|COMPLETED|Overall Study||17
2911971|NCT00488345|3621846|FG001|COMPLETED|Overall Study||17
2911972|NCT00488345|3621847|FG002|COMPLETED|Overall Study||17
2911973|NCT00488345|3621845|FG000|NOT COMPLETED|Overall Study||0
2911974|NCT00488345|3621846|FG001|NOT COMPLETED|Overall Study||4
2911975|NCT00488345|3621847|FG002|NOT COMPLETED|Overall Study||3
2911976|NCT00488475|3621856|FG000|STARTED|Overall Study||4945
2911977|NCT00488475|3621856|FG000|COMPLETED|Overall Study||3191
2911978|NCT00488475|3621856|FG000|NOT COMPLETED|Overall Study||1754
2911979|NCT00488488|3621860|FG000|STARTED|Overall Study||1028
2911980|NCT00488488|3621860|FG000|Analyzed|Overall Study|3 participants were not analyzed due to retrospective documentation.|1025
2911981|NCT00488488|3621860|FG000|COMPLETED|Overall Study|Excludes 4 participants with missing information.|760
2911982|NCT00488488|3621860|FG000|NOT COMPLETED|Overall Study||268
2911983|NCT00488514|3621864|FG000|STARTED|Overall Study||656
2911984|NCT00488514|3621864|FG000|COMPLETED|Overall Study||363
2911985|NCT00488514|3621864|FG000|NOT COMPLETED|Overall Study||293
2911986|NCT00488592|3621885|FG000|STARTED|Overall Study|10 subjects were accrued|10
2911987|NCT00488592|3621885|FG000|COMPLETED|Overall Study|7 completed the initial series of 6 vaccinations|7
2911988|NCT00488592|3621885|FG000|NOT COMPLETED|Overall Study||3
2911989|NCT00488618|3621891|FG000|STARTED|Overall Study||120
2911990|NCT00488618|3621892|FG001|STARTED|Overall Study||118
2911991|NCT00488618|3621891|FG000|Safety Population: Received Study Drug|Overall Study||118
2911992|NCT00488618|3621892|FG001|Safety Population: Received Study Drug|Overall Study||118
2911993|NCT00488618|3621891|FG000|COMPLETED|Overall Study||73
2911994|NCT00488618|3621892|FG001|COMPLETED|Overall Study||75
2911995|NCT00488618|3621891|FG000|NOT COMPLETED|Overall Study||47
2911996|NCT00488618|3621892|FG001|NOT COMPLETED|Overall Study||43
3034109|NCT01130493|3753128|FG001|STARTED|Part 2: OLE|All subjects received IPX066 during OLE|39
3034110|NCT01130493|3753129|FG002|STARTED|Part 2: OLE|No subjects received CLE during OLE|35
3384238|NCT02049710|4119346|FG000|NOT COMPLETED|Overall Study||319
3384239|NCT02049710|4119347|FG001|NOT COMPLETED|Overall Study||324
3386061|NCT02036970|4121396|FG007|COMPLETED|Part 1: Day 1 Through Week 16||3
3386062|NCT02036970|4121397|FG008|COMPLETED|Part 1: Day 1 Through Week 16||66
3386063|NCT02036970|4121398|FG009|COMPLETED|Part 1: Day 1 Through Week 16||33
3386064|NCT02036970|4121389|FG000|NOT COMPLETED|Part 1: Day 1 Through Week 16||1
3386065|NCT02036970|4121390|FG001|NOT COMPLETED|Part 1: Day 1 Through Week 16||0
3386066|NCT02036970|4121391|FG002|NOT COMPLETED|Part 1: Day 1 Through Week 16||4
3386067|NCT02036970|4121392|FG003|NOT COMPLETED|Part 1: Day 1 Through Week 16||3
3386068|NCT02036970|4121393|FG004|NOT COMPLETED|Part 1: Day 1 Through Week 16||1
3386069|NCT02036970|4121394|FG005|NOT COMPLETED|Part 1: Day 1 Through Week 16||1
3386070|NCT02036970|4121395|FG006|NOT COMPLETED|Part 1: Day 1 Through Week 16||0
3386071|NCT02036970|4121396|FG007|NOT COMPLETED|Part 1: Day 1 Through Week 16||1
3386072|NCT02036970|4121397|FG008|NOT COMPLETED|Part 1: Day 1 Through Week 16||8
3386073|NCT02036970|4121398|FG009|NOT COMPLETED|Part 1: Day 1 Through Week 16||5
3386074|NCT02036970|4121389|FG000|STARTED|Part 2: Week 16 Onwards||5
3386075|NCT02036970|4121390|FG001|STARTED|Part 2: Week 16 Onwards|One patient who completed Part 1 elected not to continue to Part 2.|11
3386076|NCT02036970|4121391|FG002|STARTED|Part 2: Week 16 Onwards|One patient who completed Part 1 elected not to continue to Part 2.|6
3386077|NCT02036970|4121392|FG003|STARTED|Part 2: Week 16 Onwards||9
3386078|NCT02036970|4121393|FG004|STARTED|Part 2: Week 16 Onwards||1
3386079|NCT02036970|4121394|FG005|STARTED|Part 2: Week 16 Onwards||3
3386080|NCT02036970|4121395|FG006|STARTED|Part 2: Week 16 Onwards||3
3386081|NCT02036970|4121396|FG007|STARTED|Part 2: Week 16 Onwards||3
3386082|NCT02036970|4121397|FG008|STARTED|Part 2: Week 16 Onwards|Three patients who completed Part 1 elected not to continue to Part 2.|63
3386083|NCT02036970|4121398|FG009|STARTED|Part 2: Week 16 Onwards||33
3386084|NCT02036970|4121389|FG000|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 2: Week 16 Onwards||5
3386085|NCT02036970|4121390|FG001|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 2: Week 16 Onwards||5
3386086|NCT02036970|4121391|FG002|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 2: Week 16 Onwards||6
3386087|NCT02036970|4121392|FG003|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 2: Week 16 Onwards||5
3386088|NCT02036970|4121393|FG004|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 2: Week 16 Onwards||1
3386089|NCT02036970|4121394|FG005|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 2: Week 16 Onwards||1
3386090|NCT02036970|4121395|FG006|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 2: Week 16 Onwards||3
3386091|NCT02036970|4121396|FG007|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 2: Week 16 Onwards||2
3386092|NCT02036970|4121397|FG008|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 2: Week 16 Onwards||0
3386093|NCT02036970|4121398|FG009|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 2: Week 16 Onwards||0
3386094|NCT02036970|4121389|FG000|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 2: Week 16 Onwards||0
3386095|NCT02036970|4121390|FG001|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 2: Week 16 Onwards||6
3386096|NCT02036970|4121391|FG002|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 2: Week 16 Onwards||0
3386097|NCT02036970|4121392|FG003|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 2: Week 16 Onwards||4
3386098|NCT02036970|4121393|FG004|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 2: Week 16 Onwards||0
3386099|NCT02036970|4121394|FG005|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 2: Week 16 Onwards||2
3386100|NCT02036970|4121395|FG006|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 2: Week 16 Onwards||0
3386101|NCT02036970|4121396|FG007|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 2: Week 16 Onwards||1
3386102|NCT02036970|4121397|FG008|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 2: Week 16 Onwards||0
3386103|NCT02036970|4121398|FG009|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 2: Week 16 Onwards||0
3386104|NCT02036970|4121389|FG000|Cohort 3a: PAH CTD|Part 2: Week 16 Onwards||0
3386105|NCT02036970|4121390|FG001|Cohort 3a: PAH CTD|Part 2: Week 16 Onwards||0
3386106|NCT02036970|4121391|FG002|Cohort 3a: PAH CTD|Part 2: Week 16 Onwards||0
3386107|NCT02036970|4121392|FG003|Cohort 3a: PAH CTD|Part 2: Week 16 Onwards||0
3386108|NCT02036970|4121393|FG004|Cohort 3a: PAH CTD|Part 2: Week 16 Onwards||0
3386109|NCT02036970|4121394|FG005|Cohort 3a: PAH CTD|Part 2: Week 16 Onwards||0
3386110|NCT02036970|4121395|FG006|Cohort 3a: PAH CTD|Part 2: Week 16 Onwards||0
3386111|NCT02036970|4121396|FG007|Cohort 3a: PAH CTD|Part 2: Week 16 Onwards||0
3386112|NCT02036970|4121397|FG008|Cohort 3a: PAH CTD|Part 2: Week 16 Onwards||12
3386113|NCT02036970|4121398|FG009|Cohort 3a: PAH CTD|Part 2: Week 16 Onwards||8
3386114|NCT02036970|4121389|FG000|Cohort 3b: PAH Non-CTD|Part 2: Week 16 Onwards||0
3386115|NCT02036970|4121390|FG001|Cohort 3b: PAH Non-CTD|Part 2: Week 16 Onwards||0
3386116|NCT02036970|4121391|FG002|Cohort 3b: PAH Non-CTD|Part 2: Week 16 Onwards||0
3386117|NCT02036970|4121392|FG003|Cohort 3b: PAH Non-CTD|Part 2: Week 16 Onwards||0
3386118|NCT02036970|4121393|FG004|Cohort 3b: PAH Non-CTD|Part 2: Week 16 Onwards||0
3386119|NCT02036970|4121394|FG005|Cohort 3b: PAH Non-CTD|Part 2: Week 16 Onwards||0
3386120|NCT02036970|4121395|FG006|Cohort 3b: PAH Non-CTD|Part 2: Week 16 Onwards||0
3386121|NCT02036970|4121396|FG007|Cohort 3b: PAH Non-CTD|Part 2: Week 16 Onwards||0
3386122|NCT02036970|4121397|FG008|Cohort 3b: PAH Non-CTD|Part 2: Week 16 Onwards||12
3386123|NCT02036970|4121398|FG009|Cohort 3b: PAH Non-CTD|Part 2: Week 16 Onwards||7
3386124|NCT02036970|4121389|FG000|Cohort 4a: PH CTD-ILD|Part 2: Week 16 Onwards||0
3386125|NCT02036970|4121390|FG001|Cohort 4a: PH CTD-ILD|Part 2: Week 16 Onwards||0
3386126|NCT02036970|4121391|FG002|Cohort 4a: PH CTD-ILD|Part 2: Week 16 Onwards||0
3386127|NCT02036970|4121392|FG003|Cohort 4a: PH CTD-ILD|Part 2: Week 16 Onwards||0
3384240|NCT02055547|4119353|FG000|STARTED|Overall Study||2
3384241|NCT02055547|4119354|FG001|STARTED|Overall Study||2
3384242|NCT02055547|4119355|FG002|STARTED|Overall Study||5
3384243|NCT02055547|4119356|FG003|STARTED|Overall Study||2
3384244|NCT02055547|4119357|FG004|STARTED|Overall Study||2
3384245|NCT02055547|4119358|FG005|STARTED|Overall Study||2
3384246|NCT02055547|4119359|FG006|STARTED|Overall Study||2
3384247|NCT02055547|4119360|FG007|STARTED|Overall Study||6
3384248|NCT02055547|4119361|FG008|STARTED|Overall Study||6
3384249|NCT02055547|4119362|FG009|STARTED|Overall Study||6
3384250|NCT02055547|4119363|FG010|STARTED|Overall Study||6
3384251|NCT02055547|4119364|FG011|STARTED|Overall Study||6
3384252|NCT02055547|4119365|FG012|STARTED|Overall Study||2
3384253|NCT02055547|4119366|FG013|STARTED|Overall Study||2
3384254|NCT02055547|4119367|FG014|STARTED|Overall Study||2
3384255|NCT02055547|4119368|FG015|STARTED|Overall Study||2
3384256|NCT02055547|4119369|FG016|STARTED|Overall Study||2
3384257|NCT02055547|4119370|FG017|STARTED|Overall Study||2
3384258|NCT02055547|4119371|FG018|STARTED|Overall Study||2
3384259|NCT02055547|4119353|FG000|COMPLETED|Overall Study||2
3384260|NCT02055547|4119354|FG001|COMPLETED|Overall Study||1
3384261|NCT02055547|4119355|FG002|COMPLETED|Overall Study||2
3384262|NCT02055547|4119356|FG003|COMPLETED|Overall Study||2
3384263|NCT02055547|4119357|FG004|COMPLETED|Overall Study||1
3384264|NCT02055547|4119358|FG005|COMPLETED|Overall Study||1
3384265|NCT02055547|4119359|FG006|COMPLETED|Overall Study||0
3384266|NCT02055547|4119360|FG007|COMPLETED|Overall Study||6
3384267|NCT02055547|4119361|FG008|COMPLETED|Overall Study||4
3384268|NCT02055547|4119362|FG009|COMPLETED|Overall Study||5
3384269|NCT02055547|4119363|FG010|COMPLETED|Overall Study||5
3384270|NCT02055547|4119364|FG011|COMPLETED|Overall Study||6
3384271|NCT02055547|4119365|FG012|COMPLETED|Overall Study||2
3384272|NCT02055547|4119366|FG013|COMPLETED|Overall Study||1
3384273|NCT02055547|4119367|FG014|COMPLETED|Overall Study||2
3384274|NCT02055547|4119368|FG015|COMPLETED|Overall Study||1
3384275|NCT02055547|4119369|FG016|COMPLETED|Overall Study||2
3384276|NCT02055547|4119370|FG017|COMPLETED|Overall Study||2
3384277|NCT02055547|4119371|FG018|COMPLETED|Overall Study||2
3384278|NCT02055547|4119353|FG000|NOT COMPLETED|Overall Study||0
3384279|NCT02055547|4119354|FG001|NOT COMPLETED|Overall Study||1
3384280|NCT02055547|4119355|FG002|NOT COMPLETED|Overall Study||3
3384281|NCT02055547|4119356|FG003|NOT COMPLETED|Overall Study||0
3384282|NCT02055547|4119357|FG004|NOT COMPLETED|Overall Study||1
3384283|NCT02055547|4119358|FG005|NOT COMPLETED|Overall Study||1
3384284|NCT02055547|4119359|FG006|NOT COMPLETED|Overall Study||2
3384285|NCT02055547|4119360|FG007|NOT COMPLETED|Overall Study||0
3384286|NCT02055547|4119361|FG008|NOT COMPLETED|Overall Study||2
3166291|NCT01903876|3893746|FG000|COMPLETED|Six-Month Follow-up Period||92
3166292|NCT01903876|3893747|FG001|COMPLETED|Six-Month Follow-up Period||123
3166293|NCT01903876|3893746|FG000|NOT COMPLETED|Six-Month Follow-up Period||91
3166294|NCT01903876|3893747|FG001|NOT COMPLETED|Six-Month Follow-up Period||145
3166295|NCT01903993|3893755|FG000|STARTED|Overall Study||143
3384287|NCT02055547|4119362|FG009|NOT COMPLETED|Overall Study||1
3384288|NCT02055547|4119363|FG010|NOT COMPLETED|Overall Study||1
3384289|NCT02055547|4119364|FG011|NOT COMPLETED|Overall Study||0
3384290|NCT02055547|4119365|FG012|NOT COMPLETED|Overall Study||0
3384291|NCT02055547|4119366|FG013|NOT COMPLETED|Overall Study||1
3384292|NCT02055547|4119367|FG014|NOT COMPLETED|Overall Study||0
3384293|NCT02055547|4119368|FG015|NOT COMPLETED|Overall Study||1
3384294|NCT02055547|4119369|FG016|NOT COMPLETED|Overall Study||0
3384295|NCT02055547|4119370|FG017|NOT COMPLETED|Overall Study||0
3384296|NCT02055547|4119371|FG018|NOT COMPLETED|Overall Study||0
3384297|NCT02064387|4119417|FG000|STARTED|Part 1 Max 23.5 Months Followup Duration||1
3384298|NCT02064387|4119418|FG001|STARTED|Part 1 Max 23.5 Months Followup Duration||1
3384299|NCT02064387|4119419|FG002|STARTED|Part 1 Max 23.5 Months Followup Duration||4
3384300|NCT02064387|4119420|FG003|STARTED|Part 1 Max 23.5 Months Followup Duration||4
3384301|NCT02064387|4119421|FG004|STARTED|Part 1 Max 23.5 Months Followup Duration||4
3384302|NCT02064387|4119422|FG005|STARTED|Part 1 Max 23.5 Months Followup Duration||3
3384303|NCT02064387|4119423|FG006|STARTED|Part 1 Max 23.5 Months Followup Duration||4
3384304|NCT02064387|4119424|FG007|STARTED|Part 1 Max 23.5 Months Followup Duration||8
3384305|NCT02064387|4119425|FG008|STARTED|Part 1 Max 23.5 Months Followup Duration||3
3384306|NCT02064387|4119426|FG009|STARTED|Part 1 Max 23.5 Months Followup Duration||6
3384307|NCT02064387|4119427|FG010|STARTED|Part 1 Max 23.5 Months Followup Duration||0
3384308|NCT02064387|4119428|FG011|STARTED|Part 1 Max 23.5 Months Followup Duration||0
3384309|NCT02064387|4119417|FG000|COMPLETED|Part 1 Max 23.5 Months Followup Duration||1
3384310|NCT02064387|4119418|FG001|COMPLETED|Part 1 Max 23.5 Months Followup Duration||1
3384311|NCT02064387|4119419|FG002|COMPLETED|Part 1 Max 23.5 Months Followup Duration||4
3384312|NCT02064387|4119420|FG003|COMPLETED|Part 1 Max 23.5 Months Followup Duration||4
3384313|NCT02064387|4119421|FG004|COMPLETED|Part 1 Max 23.5 Months Followup Duration||4
3384314|NCT02064387|4119422|FG005|COMPLETED|Part 1 Max 23.5 Months Followup Duration||3
3384315|NCT02064387|4119423|FG006|COMPLETED|Part 1 Max 23.5 Months Followup Duration||4
3384316|NCT02064387|4119424|FG007|COMPLETED|Part 1 Max 23.5 Months Followup Duration||6
3384317|NCT02064387|4119425|FG008|COMPLETED|Part 1 Max 23.5 Months Followup Duration||2
3384318|NCT02064387|4119426|FG009|COMPLETED|Part 1 Max 23.5 Months Followup Duration||5
3384319|NCT02064387|4119427|FG010|COMPLETED|Part 1 Max 23.5 Months Followup Duration||0
3384320|NCT02064387|4119428|FG011|COMPLETED|Part 1 Max 23.5 Months Followup Duration||0
3384321|NCT02064387|4119417|FG000|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||0
3384322|NCT02064387|4119418|FG001|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||0
3384323|NCT02064387|4119419|FG002|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||0
3384324|NCT02064387|4119420|FG003|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||0
3384325|NCT02064387|4119421|FG004|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||0
3384326|NCT02064387|4119422|FG005|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||0
3384327|NCT02064387|4119423|FG006|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||0
3384328|NCT02064387|4119424|FG007|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||2
3384329|NCT02064387|4119425|FG008|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||1
3384330|NCT02064387|4119426|FG009|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||1
3384331|NCT02064387|4119427|FG010|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||0
3384332|NCT02064387|4119428|FG011|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||0
3384333|NCT02064387|4119417|FG000|STARTED|Part 2 Max 35 Months Followup Duration||0
3384334|NCT02064387|4119418|FG001|STARTED|Part 2 Max 35 Months Followup Duration||0
3384335|NCT02064387|4119419|FG002|STARTED|Part 2 Max 35 Months Followup Duration||0
3384336|NCT02064387|4119420|FG003|STARTED|Part 2 Max 35 Months Followup Duration||0
3384337|NCT02064387|4119421|FG004|STARTED|Part 2 Max 35 Months Followup Duration||0
3384338|NCT02064387|4119422|FG005|STARTED|Part 2 Max 35 Months Followup Duration||0
3384339|NCT02064387|4119423|FG006|STARTED|Part 2 Max 35 Months Followup Duration||0
3384340|NCT02064387|4119424|FG007|STARTED|Part 2 Max 35 Months Followup Duration||0
3384341|NCT02064387|4119425|FG008|STARTED|Part 2 Max 35 Months Followup Duration||0
3384342|NCT02064387|4119426|FG009|STARTED|Part 2 Max 35 Months Followup Duration||0
3384343|NCT02064387|4119427|FG010|STARTED|Part 2 Max 35 Months Followup Duration||35
3384344|NCT02064387|4119428|FG011|STARTED|Part 2 Max 35 Months Followup Duration||6
3384345|NCT02064387|4119417|FG000|COMPLETED|Part 2 Max 35 Months Followup Duration||0
3384346|NCT02064387|4119418|FG001|COMPLETED|Part 2 Max 35 Months Followup Duration||0
3384347|NCT02064387|4119419|FG002|COMPLETED|Part 2 Max 35 Months Followup Duration||0
3384348|NCT02064387|4119420|FG003|COMPLETED|Part 2 Max 35 Months Followup Duration||0
3384349|NCT02064387|4119421|FG004|COMPLETED|Part 2 Max 35 Months Followup Duration||0
3384350|NCT02064387|4119422|FG005|COMPLETED|Part 2 Max 35 Months Followup Duration||0
3384351|NCT02064387|4119423|FG006|COMPLETED|Part 2 Max 35 Months Followup Duration||0
3384352|NCT02064387|4119424|FG007|COMPLETED|Part 2 Max 35 Months Followup Duration||0
3384353|NCT02064387|4119425|FG008|COMPLETED|Part 2 Max 35 Months Followup Duration||0
3384354|NCT02064387|4119426|FG009|COMPLETED|Part 2 Max 35 Months Followup Duration||0
3384355|NCT02064387|4119427|FG010|COMPLETED|Part 2 Max 35 Months Followup Duration||29
3384356|NCT02064387|4119428|FG011|COMPLETED|Part 2 Max 35 Months Followup Duration||3
3384357|NCT02064387|4119417|FG000|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0
3384358|NCT02064387|4119418|FG001|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0
3384359|NCT02064387|4119419|FG002|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0
3384360|NCT02064387|4119420|FG003|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0
3384361|NCT02064387|4119421|FG004|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0
3384362|NCT02064387|4119422|FG005|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0
3384363|NCT02064387|4119423|FG006|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0
3384364|NCT02064387|4119424|FG007|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0
3384365|NCT02064387|4119425|FG008|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0
3384366|NCT02064387|4119426|FG009|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0
3384367|NCT02064387|4119427|FG010|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||6
3384368|NCT02064387|4119428|FG011|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||3
3386128|NCT02036970|4121393|FG004|Cohort 4a: PH CTD-ILD|Part 2: Week 16 Onwards||0
3386129|NCT02036970|4121394|FG005|Cohort 4a: PH CTD-ILD|Part 2: Week 16 Onwards||0
3386130|NCT02036970|4121395|FG006|Cohort 4a: PH CTD-ILD|Part 2: Week 16 Onwards||0
3386131|NCT02036970|4121396|FG007|Cohort 4a: PH CTD-ILD|Part 2: Week 16 Onwards||0
3386132|NCT02036970|4121397|FG008|Cohort 4a: PH CTD-ILD|Part 2: Week 16 Onwards||16
3386133|NCT02036970|4121398|FG009|Cohort 4a: PH CTD-ILD|Part 2: Week 16 Onwards||7
3386134|NCT02036970|4121389|FG000|Cohort 4b: PH CTD-IPF|Part 2: Week 16 Onwards||0
3386135|NCT02036970|4121390|FG001|Cohort 4b: PH CTD-IPF|Part 2: Week 16 Onwards||0
3386136|NCT02036970|4121391|FG002|Cohort 4b: PH CTD-IPF|Part 2: Week 16 Onwards||0
3386137|NCT02036970|4121392|FG003|Cohort 4b: PH CTD-IPF|Part 2: Week 16 Onwards||0
3386138|NCT02036970|4121393|FG004|Cohort 4b: PH CTD-IPF|Part 2: Week 16 Onwards||0
3386139|NCT02036970|4121394|FG005|Cohort 4b: PH CTD-IPF|Part 2: Week 16 Onwards||0
3386140|NCT02036970|4121395|FG006|Cohort 4b: PH CTD-IPF|Part 2: Week 16 Onwards||0
3386141|NCT02036970|4121396|FG007|Cohort 4b: PH CTD-IPF|Part 2: Week 16 Onwards||0
3386142|NCT02036970|4121397|FG008|Cohort 4b: PH CTD-IPF|Part 2: Week 16 Onwards||5
3386143|NCT02036970|4121398|FG009|Cohort 4b: PH CTD-IPF|Part 2: Week 16 Onwards||2
3386144|NCT02036970|4121389|FG000|Cohort 4c: PH CTD-IIP|Part 2: Week 16 Onwards||0
3386145|NCT02036970|4121390|FG001|Cohort 4c: PH CTD-IIP|Part 2: Week 16 Onwards||0
3386146|NCT02036970|4121391|FG002|Cohort 4c: PH CTD-IIP|Part 2: Week 16 Onwards||0
3386147|NCT02036970|4121392|FG003|Cohort 4c: PH CTD-IIP|Part 2: Week 16 Onwards||0
3386148|NCT02036970|4121393|FG004|Cohort 4c: PH CTD-IIP|Part 2: Week 16 Onwards||0
3386149|NCT02036970|4121394|FG005|Cohort 4c: PH CTD-IIP|Part 2: Week 16 Onwards||0
3386150|NCT02036970|4121395|FG006|Cohort 4c: PH CTD-IIP|Part 2: Week 16 Onwards||0
3386151|NCT02036970|4121396|FG007|Cohort 4c: PH CTD-IIP|Part 2: Week 16 Onwards||0
3386152|NCT02036970|4121397|FG008|Cohort 4c: PH CTD-IIP|Part 2: Week 16 Onwards||3
3384369|NCT02076178|4119469|FG000|STARTED|Oral Phase||21
3384370|NCT02076178|4119470|FG001|STARTED|Oral Phase||106
3384371|NCT02076178|4119469|FG000|COMPLETED|Oral Phase||21
3384372|NCT02076178|4119470|FG001|COMPLETED|Oral Phase||94
3384373|NCT02076178|4119469|FG000|NOT COMPLETED|Oral Phase||0
3384374|NCT02076178|4119470|FG001|NOT COMPLETED|Oral Phase||12
3384375|NCT02076178|4119469|FG000|STARTED|Injection Phase||21
3384376|NCT02076178|4119470|FG001|STARTED|Injection Phase||94
3384377|NCT02076178|4119469|FG000|COMPLETED|Injection Phase||20
3384378|NCT02076178|4119470|FG001|COMPLETED|Injection Phase||87
3384379|NCT02076178|4119469|FG000|NOT COMPLETED|Injection Phase||1
3384380|NCT02076178|4119470|FG001|NOT COMPLETED|Injection Phase||7
3384381|NCT02079766|4119480|FG000|STARTED|Overall Study||30
3384382|NCT02079766|4119481|FG001|STARTED|Overall Study||11
3384383|NCT02079766|4119480|FG000|COMPLETED|Overall Study||28
3384384|NCT02079766|4119481|FG001|COMPLETED|Overall Study||11
3384385|NCT02079766|4119480|FG000|NOT COMPLETED|Overall Study||2
3384386|NCT02079766|4119481|FG001|NOT COMPLETED|Overall Study||0
3386153|NCT02036970|4121398|FG009|Cohort 4c: PH CTD-IIP|Part 2: Week 16 Onwards||1
3386154|NCT02036970|4121389|FG000|Cohort 4d: PH CTD-Sarcoidosis|Part 2: Week 16 Onwards||0
3386155|NCT02036970|4121390|FG001|Cohort 4d: PH CTD-Sarcoidosis|Part 2: Week 16 Onwards||0
3386156|NCT02036970|4121391|FG002|Cohort 4d: PH CTD-Sarcoidosis|Part 2: Week 16 Onwards||0
3386157|NCT02036970|4121392|FG003|Cohort 4d: PH CTD-Sarcoidosis|Part 2: Week 16 Onwards||0
3386158|NCT02036970|4121393|FG004|Cohort 4d: PH CTD-Sarcoidosis|Part 2: Week 16 Onwards||0
3386159|NCT02036970|4121394|FG005|Cohort 4d: PH CTD-Sarcoidosis|Part 2: Week 16 Onwards||0
3386160|NCT02036970|4121395|FG006|Cohort 4d: PH CTD-Sarcoidosis|Part 2: Week 16 Onwards||0
3386161|NCT02036970|4121396|FG007|Cohort 4d: PH CTD-Sarcoidosis|Part 2: Week 16 Onwards||0
3386162|NCT02036970|4121397|FG008|Cohort 4d: PH CTD-Sarcoidosis|Part 2: Week 16 Onwards||15
3386163|NCT02036970|4121398|FG009|Cohort 4d: PH CTD-Sarcoidosis|Part 2: Week 16 Onwards||8
3386164|NCT02036970|4121389|FG000|COMPLETED|Part 2: Week 16 Onwards||5
3386165|NCT02036970|4121390|FG001|COMPLETED|Part 2: Week 16 Onwards||6
3386166|NCT02036970|4121391|FG002|COMPLETED|Part 2: Week 16 Onwards||3
3386167|NCT02036970|4121392|FG003|COMPLETED|Part 2: Week 16 Onwards||7
3386168|NCT02036970|4121393|FG004|COMPLETED|Part 2: Week 16 Onwards||0
3386169|NCT02036970|4121394|FG005|COMPLETED|Part 2: Week 16 Onwards||3
3386170|NCT02036970|4121395|FG006|COMPLETED|Part 2: Week 16 Onwards||2
3386171|NCT02036970|4121396|FG007|COMPLETED|Part 2: Week 16 Onwards||2
3386172|NCT02036970|4121397|FG008|COMPLETED|Part 2: Week 16 Onwards||54
3386173|NCT02036970|4121398|FG009|COMPLETED|Part 2: Week 16 Onwards||28
3386174|NCT02036970|4121389|FG000|NOT COMPLETED|Part 2: Week 16 Onwards||0
3386175|NCT02036970|4121390|FG001|NOT COMPLETED|Part 2: Week 16 Onwards||5
3386176|NCT02036970|4121391|FG002|NOT COMPLETED|Part 2: Week 16 Onwards||3
3386177|NCT02036970|4121392|FG003|NOT COMPLETED|Part 2: Week 16 Onwards||2
3386178|NCT02036970|4121393|FG004|NOT COMPLETED|Part 2: Week 16 Onwards||1
3386179|NCT02036970|4121394|FG005|NOT COMPLETED|Part 2: Week 16 Onwards||0
3386180|NCT02036970|4121395|FG006|NOT COMPLETED|Part 2: Week 16 Onwards||1
3386181|NCT02036970|4121396|FG007|NOT COMPLETED|Part 2: Week 16 Onwards||1
3386182|NCT02036970|4121397|FG008|NOT COMPLETED|Part 2: Week 16 Onwards||9
3386183|NCT02036970|4121398|FG009|NOT COMPLETED|Part 2: Week 16 Onwards||5
3386184|NCT01958021|4121432|FG000|STARTED|Overall Study||334
3386185|NCT01958021|4121433|FG001|STARTED|Overall Study||334
3386186|NCT01958021|4121432|FG000|Patients Untreated|Overall Study||0
3386187|NCT01958021|4121433|FG001|Patients Untreated|Overall Study||4
3386188|NCT01958021|4121432|FG000|Patients Treated|Overall Study||334
3386189|NCT01958021|4121433|FG001|Patients Treated|Overall Study||330
3386190|NCT01958021|4121432|FG000|COMPLETED|Overall Study|Completed = Treatment ongoing|195
3386191|NCT01958021|4121433|FG001|COMPLETED|Overall Study|Completed = Treatment ongoing|154
3386192|NCT01958021|4121432|FG000|NOT COMPLETED|Overall Study||139
3386193|NCT01958021|4121433|FG001|NOT COMPLETED|Overall Study||180
3386194|NCT01941719|4121441|FG000|STARTED|Overall Study||48
3386195|NCT01941719|4121442|FG001|STARTED|Overall Study||51
3386196|NCT01941719|4121441|FG000|Month 1|Overall Study||43
3386197|NCT01941719|4121442|FG001|Month 1|Overall Study||48
3386198|NCT01941719|4121441|FG000|Month 3|Overall Study||38
3386199|NCT01941719|4121442|FG001|Month 3|Overall Study||44
3386200|NCT01941719|4121441|FG000|Month 6|Overall Study||34
3386201|NCT01941719|4121442|FG001|Month 6|Overall Study||42
3386202|NCT01941719|4121441|FG000|Month 9|Overall Study||29
3386203|NCT01941719|4121442|FG001|Month 9|Overall Study||37
3386204|NCT01941719|4121441|FG000|Month 12|Overall Study||28
3386205|NCT01941719|4121442|FG001|Month 12|Overall Study||32
3386206|NCT01941719|4121441|FG000|COMPLETED|Overall Study||28
3386207|NCT01941719|4121442|FG001|COMPLETED|Overall Study||32
3386208|NCT01941719|4121441|FG000|NOT COMPLETED|Overall Study||20
3386209|NCT01941719|4121442|FG001|NOT COMPLETED|Overall Study||19
3386210|NCT01828099|4121451|FG000|STARTED|Overall Study||189
3386211|NCT01828099|4121452|FG001|STARTED|Overall Study||187
3386212|NCT01828099|4121451|FG000|Untreated Patients|Overall Study||0
3386213|NCT01828099|4121452|FG001|Untreated Patients|Overall Study||12
3386214|NCT01828099|4121451|FG000|Treated|Overall Study|discontinued from treatment phase = Not completed|189
3386215|NCT01828099|4121452|FG001|Treated|Overall Study||175
3386216|NCT01828099|4121451|FG000|Discontinued From Treatment Phase|Overall Study||94
3386217|NCT01828099|4121452|FG001|Discontinued From Treatment Phase|Overall Study||157
3386218|NCT01828099|4121451|FG000|Entered Extension-treatment Phase|Overall Study||0
3386219|NCT01828099|4121452|FG001|Entered Extension-treatment Phase|Overall Study||81
3034111|NCT01130493|3753127|FG000|COMPLETED|Part 2: OLE||0
3034112|NCT01130493|3753128|FG001|COMPLETED|Part 2: OLE||36
3034113|NCT01130493|3753129|FG002|COMPLETED|Part 2: OLE||30
3034114|NCT01130493|3753127|FG000|NOT COMPLETED|Part 2: OLE||0
3034115|NCT01130493|3753128|FG001|NOT COMPLETED|Part 2: OLE||3
3034116|NCT01130493|3753129|FG002|NOT COMPLETED|Part 2: OLE||5
3034117|NCT01130532|3753143|FG000|STARTED|Period III (Weeks 0-12)||207
3034118|NCT01130532|3753144|FG001|STARTED|Period III (Weeks 0-12)||207
3384387|NCT02081391|4119491|FG000|STARTED|12-hour Treatment||108
3384388|NCT02081391|4119492|FG001|STARTED|12-hour Treatment||52
3384389|NCT02081391|4119493|FG002|STARTED|12-hour Treatment||11
3384390|NCT02081391|4119494|FG003|STARTED|12-hour Treatment||4
3384391|NCT02081391|4119491|FG000|COMPLETED|12-hour Treatment||90
3384392|NCT02081391|4119492|FG001|COMPLETED|12-hour Treatment||46
3384393|NCT02081391|4119493|FG002|COMPLETED|12-hour Treatment||10
3384394|NCT02081391|4119494|FG003|COMPLETED|12-hour Treatment||4
3384395|NCT02081391|4119491|FG000|NOT COMPLETED|12-hour Treatment||18
3384396|NCT02081391|4119492|FG001|NOT COMPLETED|12-hour Treatment||6
3384397|NCT02081391|4119493|FG002|NOT COMPLETED|12-hour Treatment||1
3384398|NCT02081391|4119494|FG003|NOT COMPLETED|12-hour Treatment||0
2911997|NCT00488631|3621904|FG000|STARTED|Double Blind Period (Week 0-54)||156
2911998|NCT00488631|3621905|FG001|STARTED|Double Blind Period (Week 0-54)||154
2911999|NCT00488631|3621906|FG002|STARTED|Double Blind Period (Week 0-54)||154
2912000|NCT00488631|3621907|FG003|STARTED|Double Blind Period (Week 0-54)||129
2912001|NCT00488631|3621908|FG004|STARTED|Double Blind Period (Week 0-54)||230
2912002|NCT00488631|3621909|FG005|STARTED|Double Blind Period (Week 0-54)||405
2912003|NCT00488631|3621910|FG006|STARTED|Double Blind Period (Week 0-54)||0
2912004|NCT00488631|3621911|FG007|STARTED|Double Blind Period (Week 0-54)||0
2912005|NCT00488631|3621912|FG008|STARTED|Double Blind Period (Week 0-54)||0
2912006|NCT00488631|3621913|FG009|STARTED|Double Blind Period (Week 0-54)||0
2912007|NCT00488631|3621904|FG000|COMPLETED|Double Blind Period (Week 0-54)||113
2912008|NCT00488631|3621905|FG001|COMPLETED|Double Blind Period (Week 0-54)||111
2912009|NCT00488631|3621906|FG002|COMPLETED|Double Blind Period (Week 0-54)||109
2912010|NCT00488631|3621907|FG003|COMPLETED|Double Blind Period (Week 0-54)||88
2912011|NCT00488631|3621908|FG004|COMPLETED|Double Blind Period (Week 0-54)||127
2912012|NCT00488631|3621909|FG005|COMPLETED|Double Blind Period (Week 0-54)||189
2912013|NCT00488631|3621910|FG006|COMPLETED|Double Blind Period (Week 0-54)||0
2912014|NCT00488631|3621911|FG007|COMPLETED|Double Blind Period (Week 0-54)||0
2912015|NCT00488631|3621912|FG008|COMPLETED|Double Blind Period (Week 0-54)||0
2912016|NCT00488631|3621913|FG009|COMPLETED|Double Blind Period (Week 0-54)||0
2912017|NCT00488631|3621904|FG000|NOT COMPLETED|Double Blind Period (Week 0-54)||43
2912018|NCT00488631|3621905|FG001|NOT COMPLETED|Double Blind Period (Week 0-54)||43
2912019|NCT00488631|3621906|FG002|NOT COMPLETED|Double Blind Period (Week 0-54)||45
2912020|NCT00488631|3621907|FG003|NOT COMPLETED|Double Blind Period (Week 0-54)||41
2912021|NCT00488631|3621908|FG004|NOT COMPLETED|Double Blind Period (Week 0-54)||103
2912022|NCT00488631|3621909|FG005|NOT COMPLETED|Double Blind Period (Week 0-54)||216
2912023|NCT00488631|3621910|FG006|NOT COMPLETED|Double Blind Period (Week 0-54)||0
2912024|NCT00488631|3621911|FG007|NOT COMPLETED|Double Blind Period (Week 0-54)||0
2912025|NCT00488631|3621912|FG008|NOT COMPLETED|Double Blind Period (Week 0-54)||0
2912026|NCT00488631|3621913|FG009|NOT COMPLETED|Double Blind Period (Week 0-54)||0
2912027|NCT00488631|3621904|FG000|STARTED|Open Label Study Extension (Week 54-228)||0
2912028|NCT00488631|3621905|FG001|STARTED|Open Label Study Extension (Week 54-228)||0
2912029|NCT00488631|3621906|FG002|STARTED|Open Label Study Extension (Week 54-228)||0
2912030|NCT00488631|3621907|FG003|STARTED|Open Label Study Extension (Week 54-228)||0
2912031|NCT00488631|3621908|FG004|STARTED|Open Label Study Extension (Week 54-228)||0
2912032|NCT00488631|3621909|FG005|STARTED|Open Label Study Extension (Week 54-228)||0
2912033|NCT00488631|3621910|FG006|STARTED|Open Label Study Extension (Week 54-228)||96
2912034|NCT00488631|3621911|FG007|STARTED|Open Label Study Extension (Week 54-228)||93
2912035|NCT00488631|3621912|FG008|STARTED|Open Label Study Extension (Week 54-228)||470
2912036|NCT00488631|3621913|FG009|STARTED|Open Label Study Extension (Week 54-228)||7
2912037|NCT00488631|3621904|FG000|COMPLETED|Open Label Study Extension (Week 54-228)||0
2912038|NCT00488631|3621905|FG001|COMPLETED|Open Label Study Extension (Week 54-228)||0
2912039|NCT00488631|3621906|FG002|COMPLETED|Open Label Study Extension (Week 54-228)||0
2912040|NCT00488631|3621907|FG003|COMPLETED|Open Label Study Extension (Week 54-228)||0
2912041|NCT00488631|3621908|FG004|COMPLETED|Open Label Study Extension (Week 54-228)||0
2912042|NCT00488631|3621909|FG005|COMPLETED|Open Label Study Extension (Week 54-228)||0
2912043|NCT00488631|3621910|FG006|COMPLETED|Open Label Study Extension (Week 54-228)||16
2912044|NCT00488631|3621911|FG007|COMPLETED|Open Label Study Extension (Week 54-228)||66
2912045|NCT00488631|3621912|FG008|COMPLETED|Open Label Study Extension (Week 54-228)||288
2912046|NCT00488631|3621913|FG009|COMPLETED|Open Label Study Extension (Week 54-228)||4
2912047|NCT00488631|3621904|FG000|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
2912048|NCT00488631|3621905|FG001|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
2912049|NCT00488631|3621906|FG002|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
2912050|NCT00488631|3621907|FG003|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
2912051|NCT00488631|3621908|FG004|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
2912052|NCT00488631|3621909|FG005|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
2912053|NCT00488631|3621910|FG006|NOT COMPLETED|Open Label Study Extension (Week 54-228)||80
2920595|NCT00537485|3631104|FG000|STARTED|Overall Study||90
3384399|NCT02081391|4119491|FG000|STARTED|24-hour Treatment and Trial Completion||90
3384400|NCT02081391|4119492|FG001|STARTED|24-hour Treatment and Trial Completion||46
3384401|NCT02081391|4119493|FG002|STARTED|24-hour Treatment and Trial Completion||10
3384402|NCT02081391|4119494|FG003|STARTED|24-hour Treatment and Trial Completion||4
3384403|NCT02081391|4119491|FG000|COMPLETED|24-hour Treatment and Trial Completion||63
3384404|NCT02081391|4119492|FG001|COMPLETED|24-hour Treatment and Trial Completion||28
3384405|NCT02081391|4119493|FG002|COMPLETED|24-hour Treatment and Trial Completion||9
3384406|NCT02081391|4119494|FG003|COMPLETED|24-hour Treatment and Trial Completion||4
3384407|NCT02081391|4119491|FG000|NOT COMPLETED|24-hour Treatment and Trial Completion||27
3384408|NCT02081391|4119492|FG001|NOT COMPLETED|24-hour Treatment and Trial Completion||18
3384409|NCT02081391|4119493|FG002|NOT COMPLETED|24-hour Treatment and Trial Completion||1
3384410|NCT02081391|4119494|FG003|NOT COMPLETED|24-hour Treatment and Trial Completion||0
3386220|NCT01828099|4121451|FG000|Entered Post-treatment Follow-up Phase|Overall Study||10
3386221|NCT01828099|4121452|FG001|Entered Post-treatment Follow-up Phase|Overall Study||16
3386222|NCT01828099|4121451|FG000|Entered Survival Follow-up Phase|Overall Study||64
3386223|NCT01828099|4121452|FG001|Entered Survival Follow-up Phase|Overall Study||31
3386224|NCT01828099|4121451|FG000|Discontinued From Study|Overall Study||20
3386225|NCT01828099|4121452|FG001|Discontinued From Study|Overall Study||29
3386226|NCT01828099|4121451|FG000|COMPLETED|Overall Study|Completed = Patients ongoing at the time of data cut-off of 24-Jun-2016|95
3386227|NCT01828099|4121452|FG001|COMPLETED|Overall Study|Completed = Patients ongoing at the time of data cut-off of 24-Jun-2016|30
3386228|NCT01828099|4121451|FG000|NOT COMPLETED|Overall Study||94
3386229|NCT01828099|4121452|FG001|NOT COMPLETED|Overall Study||157
3386230|NCT01593254|4121460|FG000|STARTED|Treatment Period||86
3386231|NCT01593254|4121461|FG001|STARTED|Treatment Period||174
3386232|NCT01593254|4121460|FG000|Crossed Over to Dasatinib|Treatment Period||42
3386233|NCT01593254|4121461|FG001|Crossed Over to Dasatinib|Treatment Period||0
3386234|NCT01593254|4121460|FG000|COMPLETED|Treatment Period||72
3386235|NCT01593254|4121461|FG001|COMPLETED|Treatment Period||143
3386236|NCT01593254|4121460|FG000|NOT COMPLETED|Treatment Period||14
3386237|NCT01593254|4121461|FG001|NOT COMPLETED|Treatment Period||31
3166296|NCT01903993|3893756|FG001|STARTED|Overall Study||144
3166297|NCT01903993|3893755|FG000|Received Treatment|Overall Study||135
3166298|NCT01903993|3893756|FG001|Received Treatment|Overall Study||142
3386238|NCT01593254|4121460|FG000|STARTED|Follow-Up Period||14
3386239|NCT01593254|4121461|FG001|STARTED|Follow-Up Period||28
3386240|NCT01593254|4121460|FG000|COMPLETED|Follow-Up Period||11
3386241|NCT01593254|4121461|FG001|COMPLETED|Follow-Up Period||17
3386242|NCT01593254|4121460|FG000|NOT COMPLETED|Follow-Up Period||3
3386243|NCT01593254|4121461|FG001|NOT COMPLETED|Follow-Up Period||11
3166299|NCT01903993|3893755|FG000|COMPLETED|Overall Study||0
3166300|NCT01903993|3893756|FG001|COMPLETED|Overall Study||0
3166301|NCT01903993|3893755|FG000|NOT COMPLETED|Overall Study||143
3166302|NCT01903993|3893756|FG001|NOT COMPLETED|Overall Study||144
3166303|NCT01904019|3893763|FG000|STARTED|Pre-operative||95
3166304|NCT01904019|3893763|FG000|COMPLETED|Pre-operative||95
3166305|NCT01904019|3893763|FG000|NOT COMPLETED|Pre-operative||0
3166306|NCT01904019|3893763|FG000|STARTED|1 Year Follow-up||95
3166307|NCT01904019|3893763|FG000|COMPLETED|1 Year Follow-up||86
3166308|NCT01904019|3893763|FG000|NOT COMPLETED|1 Year Follow-up||9
3166309|NCT01904019|3893763|FG000|STARTED|3 Year Follow-up||86
3166310|NCT01904019|3893763|FG000|COMPLETED|3 Year Follow-up||71
3166311|NCT01904019|3893763|FG000|NOT COMPLETED|3 Year Follow-up||15
3166312|NCT01904019|3893763|FG000|STARTED|5 Year Follow-up||71
3166313|NCT01904019|3893763|FG000|COMPLETED|5 Year Follow-up||65
3386244|NCT01578967|4121468|FG000|STARTED|Overall Study||41
3386245|NCT01578967|4121468|FG000|COMPLETED|Overall Study||41
3386246|NCT01578967|4121468|FG000|NOT COMPLETED|Overall Study||0
3386247|NCT01186003|4121477|FG000|STARTED|Overall Study||14
3386248|NCT01186003|4121478|FG001|STARTED|Overall Study||16
3386249|NCT01186003|4121477|FG000|COMPLETED|Overall Study||14
3386250|NCT01186003|4121478|FG001|COMPLETED|Overall Study||16
3386251|NCT01186003|4121477|FG000|NOT COMPLETED|Overall Study||0
3386252|NCT01186003|4121478|FG001|NOT COMPLETED|Overall Study||0
3386253|NCT00943618|4121487|FG000|STARTED|Overall Study||163
3386254|NCT00943618|4121488|FG001|STARTED|Overall Study||166
3386255|NCT00943618|4121489|FG002|STARTED|Overall Study||56
3386256|NCT00943618|4121487|FG000|COMPLETED|Overall Study||108
3386257|NCT00943618|4121488|FG001|COMPLETED|Overall Study||89
3386258|NCT00943618|4121489|FG002|COMPLETED|Overall Study||25
3386259|NCT00943618|4121487|FG000|NOT COMPLETED|Overall Study||55
3386260|NCT00943618|4121488|FG001|NOT COMPLETED|Overall Study||77
3386261|NCT00943618|4121489|FG002|NOT COMPLETED|Overall Study||31
3386262|NCT00529763|4121500|FG000|STARTED|Overall Study||25
3386263|NCT00529763|4121501|FG001|STARTED|Overall Study|38 participants were enrolled; 37 were treated in this cohort|37
3386264|NCT00529763|4121502|FG002|STARTED|Overall Study||59
3386265|NCT00529763|4121500|FG000|COMPLETED|Overall Study|15 participants still on treatment; not completed = off treatment (n=10)|15
3386266|NCT00529763|4121501|FG001|COMPLETED|Overall Study|4 participants still on treatment; not completed = off treatment (n=33)|4
3386267|NCT00529763|4121502|FG002|COMPLETED|Overall Study|52 participants still on treatment; not completed = off treatment (n=7)|52
3166314|NCT01904019|3893763|FG000|NOT COMPLETED|5 Year Follow-up||6
3166315|NCT01904058|3893771|FG000|STARTED|Overall Study||21
3386268|NCT00529763|4121500|FG000|NOT COMPLETED|Overall Study||10
3386269|NCT00529763|4121501|FG001|NOT COMPLETED|Overall Study||33
3386270|NCT00529763|4121502|FG002|NOT COMPLETED|Overall Study||7
3166316|NCT01904058|3893772|FG001|STARTED|Overall Study||21
3384411|NCT02087189|4119514|FG000|STARTED|Overall Study||30
3384412|NCT02087189|4119514|FG000|COMPLETED|Overall Study||28
3384413|NCT02087189|4119514|FG000|NOT COMPLETED|Overall Study||2
3384414|NCT02112916|4119522|FG000|STARTED|Overall Study||312
3384415|NCT02112916|4119523|FG001|STARTED|Overall Study||315
3384416|NCT02112916|4119524|FG002|STARTED|Overall Study||111
3384417|NCT02112916|4119525|FG003|STARTED|Overall Study||109
3384418|NCT02112916|4119522|FG000|COMPLETED|Overall Study||108
3384419|NCT02112916|4119523|FG001|COMPLETED|Overall Study||123
3384420|NCT02112916|4119524|FG002|COMPLETED|Overall Study||52
3384421|NCT02112916|4119525|FG003|COMPLETED|Overall Study||62
3384422|NCT02112916|4119522|FG000|NOT COMPLETED|Overall Study||204
3384423|NCT02112916|4119523|FG001|NOT COMPLETED|Overall Study||192
3384424|NCT02112916|4119524|FG002|NOT COMPLETED|Overall Study||59
3384425|NCT02112916|4119525|FG003|NOT COMPLETED|Overall Study||47
3384434|NCT02134717|4119549|FG000|STARTED|Overall Study||3
3384435|NCT02134717|4119549|FG000|COMPLETED|Overall Study||3
3384436|NCT02134717|4119549|FG000|NOT COMPLETED|Overall Study||0
3384437|NCT02135029|4119556|FG000|STARTED|Overall Study||73
3384438|NCT02135029|4119557|FG001|STARTED|Overall Study||74
3384439|NCT02135029|4119558|FG002|STARTED|Overall Study||37
3384440|NCT02135029|4119556|FG000|Treated|Overall Study||73
3384441|NCT02135029|4119557|FG001|Treated|Overall Study||74
3384442|NCT02135029|4119558|FG002|Treated|Overall Study||36
3384443|NCT02135029|4119556|FG000|COMPLETED|Overall Study||69
3384444|NCT02135029|4119557|FG001|COMPLETED|Overall Study||69
3384445|NCT02135029|4119558|FG002|COMPLETED|Overall Study||34
3384446|NCT02135029|4119556|FG000|NOT COMPLETED|Overall Study||4
3384447|NCT02135029|4119557|FG001|NOT COMPLETED|Overall Study||5
3384448|NCT02135029|4119558|FG002|NOT COMPLETED|Overall Study||3
3384449|NCT02137239|4119569|FG000|STARTED|Overall Study||26
3384450|NCT02137239|4119570|FG001|STARTED|Overall Study||32
3384451|NCT02137239|4119569|FG000|COMPLETED|Overall Study||23
3384452|NCT02137239|4119570|FG001|COMPLETED|Overall Study||26
3384453|NCT02137239|4119569|FG000|NOT COMPLETED|Overall Study||3
2912054|NCT00488631|3621911|FG007|NOT COMPLETED|Open Label Study Extension (Week 54-228)||27
2912055|NCT00488631|3621912|FG008|NOT COMPLETED|Open Label Study Extension (Week 54-228)||182
2912056|NCT00488631|3621913|FG009|NOT COMPLETED|Open Label Study Extension (Week 54-228)||3
2912057|NCT00488644|3621936|FG000|STARTED|Overall Study||12
2912058|NCT00488644|3621936|FG000|COMPLETED|Overall Study||10
2912059|NCT00488644|3621936|FG000|NOT COMPLETED|Overall Study||2
2912060|NCT00488683|3621943|FG000|STARTED|Overall Study||108
2912061|NCT00488683|3621944|FG001|STARTED|Overall Study||54
2912062|NCT00488683|3621945|FG002|STARTED|Overall Study||54
2912063|NCT00488683|3621943|FG000|COMPLETED|Overall Study||96
2912064|NCT00488683|3621944|FG001|COMPLETED|Overall Study||48
2912065|NCT00488683|3621945|FG002|COMPLETED|Overall Study||52
2912066|NCT00488683|3621943|FG000|NOT COMPLETED|Overall Study||12
2912067|NCT00488683|3621944|FG001|NOT COMPLETED|Overall Study||6
2912068|NCT00488683|3621945|FG002|NOT COMPLETED|Overall Study||2
2912069|NCT00488774|3621961|FG000|STARTED|Overall Study||77
2912070|NCT00488774|3621962|FG001|STARTED|Overall Study||62
2912071|NCT00488774|3621963|FG002|STARTED|Overall Study||75
2912072|NCT00488774|3621964|FG003|STARTED|Overall Study||77
2912073|NCT00488774|3621961|FG000|COMPLETED|Overall Study||69
2912074|NCT00488774|3621962|FG001|COMPLETED|Overall Study||57
2912075|NCT00488774|3621963|FG002|COMPLETED|Overall Study||70
2912076|NCT00488774|3621964|FG003|COMPLETED|Overall Study||74
2912077|NCT00488774|3621961|FG000|NOT COMPLETED|Overall Study||8
2912078|NCT00488774|3621962|FG001|NOT COMPLETED|Overall Study||5
2912079|NCT00488774|3621963|FG002|NOT COMPLETED|Overall Study||5
2912080|NCT00488774|3621964|FG003|NOT COMPLETED|Overall Study||3
2912081|NCT00488826|3621978|FG000|STARTED|Overall Study||300
2912082|NCT00488826|3621979|FG001|STARTED|Overall Study||296
2912083|NCT00488826|3621980|FG002|STARTED|Overall Study||204
2912084|NCT00488826|3621978|FG000|COMPLETED|Overall Study||244
2912085|NCT00488826|3621979|FG001|COMPLETED|Overall Study||244
2912086|NCT00488826|3621980|FG002|COMPLETED|Overall Study||178
2912087|NCT00488826|3621978|FG000|NOT COMPLETED|Overall Study||56
2912088|NCT00488826|3621979|FG001|NOT COMPLETED|Overall Study||52
2912089|NCT00488826|3621980|FG002|NOT COMPLETED|Overall Study||26
2912090|NCT00488865|3621988|FG000|STARTED|Overall Study||100
2912091|NCT00488865|3621988|FG000|COMPLETED|Overall Study||100
2912092|NCT00488865|3621988|FG000|NOT COMPLETED|Overall Study||0
2912093|NCT00488982|3621992|FG000|STARTED|Induction Chemotherapy||125
2912094|NCT00488982|3621993|FG001|STARTED|Induction Chemotherapy||0
2912095|NCT00488982|3621994|FG002|STARTED|Induction Chemotherapy||0
2912096|NCT00488982|3621992|FG000|6 Cycles Completed|Induction Chemotherapy||94
2912097|NCT00488982|3621993|FG001|6 Cycles Completed|Induction Chemotherapy||0
2912098|NCT00488982|3621994|FG002|6 Cycles Completed|Induction Chemotherapy||0
2912099|NCT00488982|3621992|FG000|≥ 50% Prostate-specific Antigen Decline|Induction Chemotherapy||52
2912100|NCT00488982|3621993|FG001|≥ 50% Prostate-specific Antigen Decline|Induction Chemotherapy||0
2912101|NCT00488982|3621994|FG002|≥ 50% Prostate-specific Antigen Decline|Induction Chemotherapy||0
2912102|NCT00488982|3621992|FG000|COMPLETED|Induction Chemotherapy||52
2912103|NCT00488982|3621993|FG001|COMPLETED|Induction Chemotherapy||0
2912104|NCT00488982|3621994|FG002|COMPLETED|Induction Chemotherapy||0
2912105|NCT00488982|3621992|FG000|NOT COMPLETED|Induction Chemotherapy||73
2912106|NCT00488982|3621993|FG001|NOT COMPLETED|Induction Chemotherapy||0
2912107|NCT00488982|3621994|FG002|NOT COMPLETED|Induction Chemotherapy||0
2912108|NCT00488982|3621992|FG000|STARTED|Course 1||0
3384426|NCT02114697|4119542|FG000|STARTED|Overall Study||5
3384427|NCT02114697|4119543|FG001|STARTED|Overall Study||4
3384428|NCT02114697|4119542|FG000|Completed Month 18 Visit|Overall Study||0
3384429|NCT02114697|4119543|FG001|Completed Month 18 Visit|Overall Study||1
3384430|NCT02114697|4119542|FG000|COMPLETED|Overall Study||0
3384431|NCT02114697|4119543|FG001|COMPLETED|Overall Study||0
3384432|NCT02114697|4119542|FG000|NOT COMPLETED|Overall Study||5
3384433|NCT02114697|4119543|FG001|NOT COMPLETED|Overall Study||4
3384454|NCT02137239|4119570|FG001|NOT COMPLETED|Overall Study||6
3386271|NCT03938272|4121519|FG000|STARTED|Overall Study||11
3386272|NCT03938272|4121520|FG001|STARTED|Overall Study||11
3386273|NCT03938272|4121519|FG000|COMPLETED|Overall Study||0
3386274|NCT03938272|4121520|FG001|COMPLETED|Overall Study||1
3386275|NCT03938272|4121519|FG000|NOT COMPLETED|Overall Study||11
3386276|NCT03938272|4121520|FG001|NOT COMPLETED|Overall Study||10
3386277|NCT03641339|4121532|FG000|STARTED|Overall Study||16
3386278|NCT03641339|4121533|FG001|STARTED|Overall Study||17
3386279|NCT03641339|4121534|FG002|STARTED|Overall Study||15
3386280|NCT03641339|4121535|FG003|STARTED|Overall Study||16
3386281|NCT03641339|4121536|FG004|STARTED|Overall Study||15
3386282|NCT03641339|4121537|FG005|STARTED|Overall Study||16
3386283|NCT03641339|4121532|FG000|COMPLETED|Overall Study||15
3386284|NCT03641339|4121533|FG001|COMPLETED|Overall Study||15
3386285|NCT03641339|4121534|FG002|COMPLETED|Overall Study||15
3386286|NCT03641339|4121535|FG003|COMPLETED|Overall Study||14
3386287|NCT03641339|4121536|FG004|COMPLETED|Overall Study||15
3386288|NCT03641339|4121537|FG005|COMPLETED|Overall Study||15
3386289|NCT03641339|4121532|FG000|NOT COMPLETED|Overall Study||1
3386290|NCT03641339|4121533|FG001|NOT COMPLETED|Overall Study||2
3386291|NCT03641339|4121534|FG002|NOT COMPLETED|Overall Study||0
3386292|NCT03641339|4121535|FG003|NOT COMPLETED|Overall Study||2
3386293|NCT03641339|4121536|FG004|NOT COMPLETED|Overall Study||0
3386294|NCT03641339|4121537|FG005|NOT COMPLETED|Overall Study||1
3386295|NCT03625466|4121553|FG000|STARTED|Overall Study||16
3386296|NCT03625466|4121554|FG001|STARTED|Overall Study||35
3386297|NCT03625466|4121553|FG000|COMPLETED|Overall Study||16
3386298|NCT03625466|4121554|FG001|COMPLETED|Overall Study||33
3386299|NCT03625466|4121553|FG000|NOT COMPLETED|Overall Study||0
3386300|NCT03625466|4121554|FG001|NOT COMPLETED|Overall Study||2
3386301|NCT03476239|4121560|FG000|STARTED|Overall Study||106
3386302|NCT03476239|4121560|FG000|Enrolled Before 21 February 2019|Overall Study||91
3386303|NCT03476239|4121560|FG000|Interim Analysis Set|Overall Study||90
3386304|NCT03476239|4121560|FG000|COMPLETED|Overall Study||0
3386305|NCT03476239|4121560|FG000|NOT COMPLETED|Overall Study||106
3386306|NCT03427411|4121566|FG000|STARTED|Overall Study||30
3386307|NCT03427411|4121567|FG001|STARTED|Overall Study||27
3386308|NCT03427411|4121566|FG000|COMPLETED|Overall Study||30
3386309|NCT03427411|4121567|FG001|COMPLETED|Overall Study||26
3386310|NCT03427411|4121566|FG000|NOT COMPLETED|Overall Study||0
3386311|NCT03427411|4121567|FG001|NOT COMPLETED|Overall Study||1
3386312|NCT03317795|4121575|FG000|STARTED|Overall Study||9
3386313|NCT03317795|4121576|FG001|STARTED|Overall Study||9
3386314|NCT03317795|4121575|FG000|COMPLETED|Overall Study||7
3386315|NCT03317795|4121576|FG001|COMPLETED|Overall Study||2
3386316|NCT03317795|4121575|FG000|NOT COMPLETED|Overall Study||2
3386317|NCT03317795|4121576|FG001|NOT COMPLETED|Overall Study||7
3386318|NCT03287245|4121586|FG000|STARTED|Overall Study||15
3386319|NCT03287245|4121587|FG001|STARTED|Overall Study||5
3386320|NCT03287245|4121588|FG002|STARTED|Overall Study||6
3386321|NCT03287245|4121589|FG003|STARTED|Overall Study||1
3386322|NCT03287245|4121586|FG000|COMPLETED|Overall Study||0
3386323|NCT03287245|4121587|FG001|COMPLETED|Overall Study||0
3386324|NCT03287245|4121588|FG002|COMPLETED|Overall Study||0
3386325|NCT03287245|4121589|FG003|COMPLETED|Overall Study||0
3386326|NCT03287245|4121586|FG000|NOT COMPLETED|Overall Study||15
3386327|NCT03287245|4121587|FG001|NOT COMPLETED|Overall Study||5
3386328|NCT03287245|4121588|FG002|NOT COMPLETED|Overall Study||6
3386329|NCT03287245|4121589|FG003|NOT COMPLETED|Overall Study||1
3386330|NCT03165916|4121621|FG000|STARTED|Overall Study||58
3386331|NCT03165916|4121622|FG001|STARTED|Overall Study||57
3386332|NCT03165916|4121621|FG000|Reconstruction Interventions|Overall Study||59
3386333|NCT03165916|4121622|FG001|Reconstruction Interventions|Overall Study||57
3386334|NCT03165916|4121621|FG000|COMPLETED|Overall Study||58
3386335|NCT03165916|4121622|FG001|COMPLETED|Overall Study||57
3386336|NCT03165916|4121621|FG000|NOT COMPLETED|Overall Study||0
3386337|NCT03165916|4121622|FG001|NOT COMPLETED|Overall Study||0
3166317|NCT01904058|3893773|FG002|STARTED|Overall Study||11
3166318|NCT01904058|3893774|FG003|STARTED|Overall Study||13
3166319|NCT01904058|3893771|FG000|COMPLETED|Overall Study||18
3166320|NCT01904058|3893772|FG001|COMPLETED|Overall Study||21
3166321|NCT01904058|3893773|FG002|COMPLETED|Overall Study||10
3166322|NCT01904058|3893774|FG003|COMPLETED|Overall Study||12
3166323|NCT01904058|3893771|FG000|NOT COMPLETED|Overall Study||3
3166324|NCT01904058|3893772|FG001|NOT COMPLETED|Overall Study||0
3386338|NCT03092219|4121630|FG000|STARTED|Overall Study||150
3386339|NCT03092219|4121631|FG001|STARTED|Overall Study||52
3386340|NCT03092219|4121630|FG000|Baseline / ITT Population|Overall Study||150
3386341|NCT03092219|4121631|FG001|Baseline / ITT Population|Overall Study|Subject randomized to No Treatment group but received treatment at Visit 1.|51
3386342|NCT03092219|4121630|FG000|Primary Analysis Endpoint|Overall Study||150
3386343|NCT03092219|4121631|FG001|Primary Analysis Endpoint|Overall Study||51
3386344|NCT03092219|4121630|FG000|Pooled SAFT Population|Overall Study||150
3384455|NCT02148133|4119576|FG000|STARTED|Overall Study||21
3384456|NCT02148133|4119576|FG000|Safety Set (SS)|Overall Study||21
3384457|NCT02148133|4119576|FG000|Pharmacokinetic Analysis Set (PAS)|Overall Study||21
3384458|NCT02148133|4119576|FG000|COMPLETED|Overall Study||16
3384459|NCT02148133|4119576|FG000|NOT COMPLETED|Overall Study||5
3384460|NCT02151383|4119583|FG000|STARTED|Overall Study||8
3384461|NCT02151383|4119584|FG001|STARTED|Overall Study||3
3384462|NCT02151383|4119585|FG002|STARTED|Overall Study||1
3384463|NCT02151383|4119583|FG000|Low-dose|Overall Study||2
3384464|NCT02151383|4119584|FG001|Low-dose|Overall Study||3
3384465|NCT02151383|4119585|FG002|Low-dose|Overall Study||1
3384466|NCT02151383|4119583|FG000|High-dose|Overall Study||6
3384467|NCT02151383|4119584|FG001|High-dose|Overall Study||0
3384468|NCT02151383|4119585|FG002|High-dose|Overall Study||0
3384469|NCT02151383|4119583|FG000|COMPLETED|Overall Study||8
3384470|NCT02151383|4119584|FG001|COMPLETED|Overall Study||3
3384471|NCT02151383|4119585|FG002|COMPLETED|Overall Study||1
3384472|NCT02151383|4119583|FG000|NOT COMPLETED|Overall Study||0
3384473|NCT02151383|4119584|FG001|NOT COMPLETED|Overall Study||0
3384474|NCT02151383|4119585|FG002|NOT COMPLETED|Overall Study||0
3384475|NCT02165215|4119596|FG000|STARTED|Induction Phase||359
3384476|NCT02165215|4119597|FG001|STARTED|Induction Phase||0
3384477|NCT02165215|4119598|FG002|STARTED|Induction Phase||0
3384478|NCT02165215|4119596|FG000|Dosed|Induction Phase||358
3384479|NCT02165215|4119597|FG001|Dosed|Induction Phase||0
3384480|NCT02165215|4119598|FG002|Dosed|Induction Phase||0
3384481|NCT02165215|4119596|FG000|COMPLETED|Induction Phase||336
3384482|NCT02165215|4119597|FG001|COMPLETED|Induction Phase||0
3384483|NCT02165215|4119598|FG002|COMPLETED|Induction Phase||0
3384484|NCT02165215|4119596|FG000|NOT COMPLETED|Induction Phase||23
3384485|NCT02165215|4119597|FG001|NOT COMPLETED|Induction Phase||0
3384486|NCT02165215|4119598|FG002|NOT COMPLETED|Induction Phase||0
3384487|NCT02165215|4119596|FG000|STARTED|Maintenance Phase||0
3384488|NCT02165215|4119597|FG001|STARTED|Maintenance Phase||108
3384489|NCT02165215|4119598|FG002|STARTED|Maintenance Phase||106
2912109|NCT00488982|3621993|FG001|STARTED|Course 1||25
2912110|NCT00488982|3621994|FG002|STARTED|Course 1||27
2912111|NCT00488982|3621992|FG000|COMPLETED|Course 1||0
2912112|NCT00488982|3621993|FG001|COMPLETED|Course 1||13
2912113|NCT00488982|3621994|FG002|COMPLETED|Course 1||13
2912114|NCT00488982|3621992|FG000|NOT COMPLETED|Course 1||0
2912115|NCT00488982|3621993|FG001|NOT COMPLETED|Course 1||12
2912116|NCT00488982|3621994|FG002|NOT COMPLETED|Course 1||14
2912117|NCT00488982|3621992|FG000|STARTED|Course 2||0
2912118|NCT00488982|3621993|FG001|STARTED|Course 2||13
2912119|NCT00488982|3621994|FG002|STARTED|Course 2||13
2912120|NCT00488982|3621992|FG000|COMPLETED|Course 2||0
2912121|NCT00488982|3621993|FG001|COMPLETED|Course 2||4
2912122|NCT00488982|3621994|FG002|COMPLETED|Course 2||8
2912123|NCT00488982|3621992|FG000|NOT COMPLETED|Course 2||0
2912124|NCT00488982|3621993|FG001|NOT COMPLETED|Course 2||9
2912125|NCT00488982|3621994|FG002|NOT COMPLETED|Course 2||5
2912126|NCT00488982|3621992|FG000|STARTED|Course 3||0
2912127|NCT00488982|3621993|FG001|STARTED|Course 3||4
2912128|NCT00488982|3621994|FG002|STARTED|Course 3||8
2912129|NCT00488982|3621992|FG000|COMPLETED|Course 3||0
2912130|NCT00488982|3621993|FG001|COMPLETED|Course 3||2
2912131|NCT00488982|3621994|FG002|COMPLETED|Course 3||3
2912132|NCT00488982|3621992|FG000|NOT COMPLETED|Course 3||0
2912133|NCT00488982|3621993|FG001|NOT COMPLETED|Course 3||2
2912134|NCT00488982|3621994|FG002|NOT COMPLETED|Course 3||5
2912135|NCT00488982|3621992|FG000|STARTED|Response to Course 3||0
2912136|NCT00488982|3621993|FG001|STARTED|Response to Course 3||2
2912137|NCT00488982|3621994|FG002|STARTED|Response to Course 3||3
2912138|NCT00488982|3621992|FG000|COMPLETED|Response to Course 3||0
2912139|NCT00488982|3621993|FG001|COMPLETED|Response to Course 3||1
2912140|NCT00488982|3621994|FG002|COMPLETED|Response to Course 3||0
2912141|NCT00488982|3621992|FG000|NOT COMPLETED|Response to Course 3||0
2912142|NCT00488982|3621993|FG001|NOT COMPLETED|Response to Course 3||1
2912143|NCT00488982|3621994|FG002|NOT COMPLETED|Response to Course 3||3
2912144|NCT00489086|3622008|FG000|STARTED|Overall Study||36
2912145|NCT00489086|3622008|FG000|Completed 18 Months|Overall Study||23
2912146|NCT00489086|3622008|FG000|COMPLETED|Overall Study||13
2912147|NCT00489086|3622008|FG000|NOT COMPLETED|Overall Study||23
2912148|NCT00489216|3622012|FG000|STARTED|Overall Study||2
2912149|NCT00489216|3622012|FG000|COMPLETED|Overall Study||1
2912150|NCT00489216|3622012|FG000|NOT COMPLETED|Overall Study||1
2912151|NCT00489255|3622018|FG000|STARTED|Screening and Initial Randomization|Total randomized subjects to receive Tigan|145
2912152|NCT00489255|3622019|FG001|STARTED|Screening and Initial Randomization|Total randomized subjects to receive placebo|49
2912153|NCT00489255|3622018|FG000|COMPLETED|Screening and Initial Randomization||136
2912154|NCT00489255|3622019|FG001|COMPLETED|Screening and Initial Randomization||46
2912155|NCT00489255|3622018|FG000|NOT COMPLETED|Screening and Initial Randomization||9
2912156|NCT00489255|3622019|FG001|NOT COMPLETED|Screening and Initial Randomization||3
2912157|NCT00489255|3622018|FG000|STARTED|Period 1: Days 1 to 28||136
2912158|NCT00489255|3622019|FG001|STARTED|Period 1: Days 1 to 28||46
2912159|NCT00489255|3622018|FG000|Completed and Follow Period 2|Period 1: Days 1 to 28||94
2912160|NCT00489255|3622019|FG001|Completed and Follow Period 2|Period 1: Days 1 to 28||29
3384490|NCT02165215|4119596|FG000|Dosed|Maintenance Phase||0
3384491|NCT02165215|4119597|FG001|Dosed|Maintenance Phase||108
3384492|NCT02165215|4119598|FG002|Dosed|Maintenance Phase||102
3384493|NCT02165215|4119596|FG000|COMPLETED|Maintenance Phase||0
3384494|NCT02165215|4119597|FG001|COMPLETED|Maintenance Phase||96
3384495|NCT02165215|4119598|FG002|COMPLETED|Maintenance Phase||101
3384496|NCT02165215|4119596|FG000|NOT COMPLETED|Maintenance Phase||0
3384497|NCT02165215|4119597|FG001|NOT COMPLETED|Maintenance Phase||12
3384498|NCT02165215|4119598|FG002|NOT COMPLETED|Maintenance Phase||5
3386345|NCT03092219|4121631|FG001|Pooled SAFT Population|Overall Study|2 subjects did not receive treatment at Visit 1b.|50
3386346|NCT03092219|4121630|FG000|COMPLETED|Overall Study||143
3386347|NCT03092219|4121631|FG001|COMPLETED|Overall Study||48
3386348|NCT03092219|4121630|FG000|NOT COMPLETED|Overall Study||7
3386349|NCT03092219|4121631|FG001|NOT COMPLETED|Overall Study||4
3386350|NCT03033069|4121644|FG000|STARTED|Overall Study||82
3386351|NCT03033069|4121645|FG001|STARTED|Overall Study||75
3386352|NCT03033069|4121646|FG002|STARTED|Overall Study||81
3386353|NCT03033069|4121647|FG003|STARTED|Overall Study||83
3386354|NCT03033069|4121644|FG000|Safety Sample|Overall Study||80
3386355|NCT03033069|4121645|FG001|Safety Sample|Overall Study||75
3386356|NCT03033069|4121646|FG002|Safety Sample|Overall Study||79
3386357|NCT03033069|4121647|FG003|Safety Sample|Overall Study||82
3386358|NCT03033069|4121644|FG000|Intent to Treat (ITT) Sample|Overall Study||79
3386359|NCT03033069|4121645|FG001|Intent to Treat (ITT) Sample|Overall Study||72
3386360|NCT03033069|4121646|FG002|Intent to Treat (ITT) Sample|Overall Study||77
3386361|NCT03033069|4121647|FG003|Intent to Treat (ITT) Sample|Overall Study||80
3386362|NCT03033069|4121644|FG000|COMPLETED|Overall Study||58
3386363|NCT03033069|4121645|FG001|COMPLETED|Overall Study||50
3386364|NCT03033069|4121646|FG002|COMPLETED|Overall Study||59
3386365|NCT03033069|4121647|FG003|COMPLETED|Overall Study||64
3386366|NCT03033069|4121644|FG000|NOT COMPLETED|Overall Study||24
3386367|NCT03033069|4121645|FG001|NOT COMPLETED|Overall Study||25
3386368|NCT03033069|4121646|FG002|NOT COMPLETED|Overall Study||22
3386369|NCT03033069|4121647|FG003|NOT COMPLETED|Overall Study||19
3386744|NCT02021773|4122069|FG001|COMPLETED|Overall Study||72
3386745|NCT02021773|4122070|FG002|COMPLETED|Overall Study||76
3386746|NCT02021773|4122068|FG000|NOT COMPLETED|Overall Study||12
3386747|NCT02021773|4122069|FG001|NOT COMPLETED|Overall Study||16
3386748|NCT02021773|4122070|FG002|NOT COMPLETED|Overall Study||11
3386749|NCT01530997|4122078|FG000|STARTED|Overall Study||45
3386750|NCT01530997|4122078|FG000|COMPLETED|Overall Study||43
3386751|NCT01530997|4122078|FG000|NOT COMPLETED|Overall Study||2
3386752|NCT01109004|4122092|FG000|STARTED|Overall Study||247
3386753|NCT01109004|4122093|FG001|STARTED|Overall Study||254
3386754|NCT01109004|4122094|FG002|STARTED|Overall Study||257
3386755|NCT01109004|4122092|FG000|COMPLETED|Overall Study||247
3386756|NCT01109004|4122093|FG001|COMPLETED|Overall Study||254
3386757|NCT01109004|4122094|FG002|COMPLETED|Overall Study||257
3386758|NCT01109004|4122092|FG000|NOT COMPLETED|Overall Study||0
3386759|NCT01109004|4122093|FG001|NOT COMPLETED|Overall Study||0
3386760|NCT01109004|4122094|FG002|NOT COMPLETED|Overall Study||0
3386761|NCT01067521|4122104|FG000|STARTED|Double-Blind Placebo-Controlled Period||943
3386762|NCT01067521|4122105|FG001|STARTED|Double-Blind Placebo-Controlled Period||461
3386763|NCT01067521|4122104|FG000|COMPLETED|Double-Blind Placebo-Controlled Period||859
3386764|NCT01067521|4122105|FG001|COMPLETED|Double-Blind Placebo-Controlled Period||430
3386765|NCT01067521|4122104|FG000|NOT COMPLETED|Double-Blind Placebo-Controlled Period||84
3386766|NCT01067521|4122105|FG001|NOT COMPLETED|Double-Blind Placebo-Controlled Period||31
3386767|NCT01067521|4122104|FG000|STARTED|Open-Label Period|Some participants did not continue into the open-label period.|834
3386768|NCT01067521|4122105|FG001|STARTED|Open-Label Period|Some participants did not continue into the open-label period.|419
3386769|NCT01067521|4122104|FG000|COMPLETED|Open-Label Period||580
3386770|NCT01067521|4122105|FG001|COMPLETED|Open-Label Period||261
3386771|NCT01067521|4122104|FG000|NOT COMPLETED|Open-Label Period||254
3386772|NCT01067521|4122105|FG001|NOT COMPLETED|Open-Label Period||158
3386798|NCT00861705|4122144|FG002|NOT COMPLETED|Overall Study||0
3386799|NCT00861705|4122145|FG003|NOT COMPLETED|Overall Study||1
3386800|NCT04689932|4122163|FG000|STARTED|Overall Study||12
3386801|NCT04689932|4122163|FG000|COMPLETED|Overall Study||12
3386802|NCT04689932|4122163|FG000|NOT COMPLETED|Overall Study||0
3386803|NCT04635579|4122170|FG000|STARTED|Overall Study||20
3386804|NCT04635579|4122171|FG001|STARTED|Overall Study||20
3386805|NCT04635579|4122170|FG000|COMPLETED|Overall Study||20
3386806|NCT04635579|4122171|FG001|COMPLETED|Overall Study||20
3386807|NCT04635579|4122170|FG000|NOT COMPLETED|Overall Study||0
3386808|NCT04635579|4122171|FG001|NOT COMPLETED|Overall Study||0
2912161|NCT00489255|3622018|FG000|Completed But Discontinued Study|Period 1: Days 1 to 28||13
2912162|NCT00489255|3622019|FG001|Completed But Discontinued Study|Period 1: Days 1 to 28||5
2912163|NCT00489255|3622018|FG000|COMPLETED|Period 1: Days 1 to 28||107
2912164|NCT00489255|3622019|FG001|COMPLETED|Period 1: Days 1 to 28||34
2912165|NCT00489255|3622018|FG000|NOT COMPLETED|Period 1: Days 1 to 28||29
2912166|NCT00489255|3622019|FG001|NOT COMPLETED|Period 1: Days 1 to 28||12
2912167|NCT00489255|3622018|FG000|STARTED|Period 2: Days 29 to 56||64
2912168|NCT00489255|3622019|FG001|STARTED|Period 2: Days 29 to 56|Re-randomized participants is 26.Sample sizes differed due to withdrawal&re-randomization design.|59
2912169|NCT00489255|3622018|FG000|Completed and Follow Period 3|Period 2: Days 29 to 56||58
2912170|NCT00489255|3622019|FG001|Completed and Follow Period 3|Period 2: Days 29 to 56|Re-randomized participants is 26.Sample sizes differed due to withdrawal&re-randomization design.|52
2912171|NCT00489255|3622018|FG000|Completed But Discontinued Study|Period 2: Days 29 to 56||3
2912172|NCT00489255|3622019|FG001|Completed But Discontinued Study|Period 2: Days 29 to 56|Re-randomized participants is 2.Sample sizes differed due to withdrawal&re-randomization design.|3
2912173|NCT00489255|3622018|FG000|COMPLETED|Period 2: Days 29 to 56||61
2912174|NCT00489255|3622019|FG001|COMPLETED|Period 2: Days 29 to 56|Re-randomized participants is 26.Sample sizes differed due to withdrawal&re-randomization design.|55
2912175|NCT00489255|3622018|FG000|NOT COMPLETED|Period 2: Days 29 to 56||3
2912176|NCT00489255|3622019|FG001|NOT COMPLETED|Period 2: Days 29 to 56||4
2912177|NCT00489255|3622018|FG000|STARTED|Period 3: Days 57 to 84||28
2912178|NCT00489255|3622019|FG001|STARTED|Period 3: Days 57 to 84|Re-randomized participants is 30.Sample sizes differed due to withdrawal&re-randomization design.|82
2912179|NCT00489255|3622018|FG000|COMPLETED|Period 3: Days 57 to 84||24
2912180|NCT00489255|3622019|FG001|COMPLETED|Period 3: Days 57 to 84|Re-randomized participants is 27.Sample sizes differed due to withdrawal&re-randomization design.|78
2912181|NCT00489255|3622018|FG000|NOT COMPLETED|Period 3: Days 57 to 84||4
2912182|NCT00489255|3622019|FG001|NOT COMPLETED|Period 3: Days 57 to 84||4
2912183|NCT00489268|3622030|FG000|STARTED|Overall Study||1
2912184|NCT00489268|3622031|FG001|STARTED|Overall Study||10
2912185|NCT00489268|3622032|FG002|STARTED|Overall Study||10
2912186|NCT00489268|3622033|FG003|STARTED|Overall Study||11
2912187|NCT00489268|3622034|FG004|STARTED|Overall Study||70
2912188|NCT00489268|3622030|FG000|COMPLETED|Overall Study||1
2912189|NCT00489268|3622031|FG001|COMPLETED|Overall Study||10
2912190|NCT00489268|3622032|FG002|COMPLETED|Overall Study||9
2912191|NCT00489268|3622033|FG003|COMPLETED|Overall Study||11
2912192|NCT00489268|3622034|FG004|COMPLETED|Overall Study||50
2912193|NCT00489268|3622030|FG000|NOT COMPLETED|Overall Study||0
2912194|NCT00489268|3622031|FG001|NOT COMPLETED|Overall Study||0
2912195|NCT00489268|3622032|FG002|NOT COMPLETED|Overall Study||1
2912196|NCT00489268|3622033|FG003|NOT COMPLETED|Overall Study||0
2912197|NCT00489268|3622034|FG004|NOT COMPLETED|Overall Study||20
2912198|NCT00489281|3622048|FG000|STARTED|Overall Study||29
2912199|NCT00489281|3622049|FG001|STARTED|Overall Study||13
2912200|NCT00489281|3622048|FG000|COMPLETED|Overall Study||29
2912201|NCT00489281|3622049|FG001|COMPLETED|Overall Study||13
2912202|NCT00489281|3622048|FG000|NOT COMPLETED|Overall Study||0
2912203|NCT00489281|3622049|FG001|NOT COMPLETED|Overall Study||0
2912204|NCT00489359|3622057|FG000|STARTED|Overall Study||20
2912205|NCT00489359|3622058|FG001|STARTED|Overall Study||66
2912206|NCT00489359|3622057|FG000|COMPLETED|Overall Study|Received at least 6 cycles of therapy. Not completed implies participant received <6 cycles.|13
2912207|NCT00489359|3622058|FG001|COMPLETED|Overall Study|Received at least 6 cycles of therapy. Not completed implies participant received <6 cycles.|37
2912208|NCT00489359|3622057|FG000|NOT COMPLETED|Overall Study||7
2912209|NCT00489359|3622058|FG001|NOT COMPLETED|Overall Study||29
2912210|NCT00489411|3622071|FG000|STARTED|Initial Treatment Period (Weeks 1-5)||115
2912211|NCT00489411|3622072|FG001|STARTED|Initial Treatment Period (Weeks 1-5)||116
2912212|NCT00489411|3622071|FG000|COMPLETED|Initial Treatment Period (Weeks 1-5)||87
2912213|NCT00489411|3622072|FG001|COMPLETED|Initial Treatment Period (Weeks 1-5)||94
2912214|NCT00489411|3622071|FG000|NOT COMPLETED|Initial Treatment Period (Weeks 1-5)||28
2912215|NCT00489411|3622072|FG001|NOT COMPLETED|Initial Treatment Period (Weeks 1-5)||22
2912216|NCT00489411|3622071|FG000|STARTED|Washout Period (Weeks 6-7)||87
2912217|NCT00489411|3622072|FG001|STARTED|Washout Period (Weeks 6-7)||94
2912218|NCT00489411|3622071|FG000|COMPLETED|Washout Period (Weeks 6-7)||85
2912219|NCT00489411|3622072|FG001|COMPLETED|Washout Period (Weeks 6-7)||93
2912220|NCT00489411|3622071|FG000|NOT COMPLETED|Washout Period (Weeks 6-7)||2
2912221|NCT00489411|3622072|FG001|NOT COMPLETED|Washout Period (Weeks 6-7)||1
2912222|NCT00489411|3622071|FG000|STARTED|Crossover Treatment Period (Weeks 8-12)||85
2912223|NCT00489411|3622072|FG001|STARTED|Crossover Treatment Period (Weeks 8-12)||93
2912224|NCT00489411|3622071|FG000|COMPLETED|Crossover Treatment Period (Weeks 8-12)||67
2912225|NCT00489411|3622072|FG001|COMPLETED|Crossover Treatment Period (Weeks 8-12)||74
2912226|NCT00489411|3622071|FG000|NOT COMPLETED|Crossover Treatment Period (Weeks 8-12)||18
2912227|NCT00489411|3622072|FG001|NOT COMPLETED|Crossover Treatment Period (Weeks 8-12)||19
2912228|NCT00489424|3622081|FG000|STARTED|Overall Study||267
2912229|NCT00489424|3622082|FG001|STARTED|Overall Study||264
2912230|NCT00489424|3622083|FG002|STARTED|Overall Study||262
2912231|NCT00489424|3622081|FG000|COMPLETED|Overall Study||263
2912232|NCT00489424|3622082|FG001|COMPLETED|Overall Study||259
2912233|NCT00489424|3622083|FG002|COMPLETED|Overall Study||257
2912234|NCT00489424|3622081|FG000|NOT COMPLETED|Overall Study||4
2912235|NCT00489424|3622082|FG001|NOT COMPLETED|Overall Study||5
2912236|NCT00489424|3622083|FG002|NOT COMPLETED|Overall Study||5
2912237|NCT00489476|3622095|FG000|STARTED|Overall Study||39
2912238|NCT00489476|3622096|FG001|STARTED|Overall Study||43
2912239|NCT00489476|3622097|FG002|STARTED|Overall Study||43
2912240|NCT00489476|3622098|FG003|STARTED|Overall Study||43
2912241|NCT00489476|3622095|FG000|COMPLETED|Overall Study||39
2912242|NCT00489476|3622096|FG001|COMPLETED|Overall Study||42
2912243|NCT00489476|3622097|FG002|COMPLETED|Overall Study||43
2912244|NCT00489476|3622098|FG003|COMPLETED|Overall Study||43
2912245|NCT00489476|3622095|FG000|NOT COMPLETED|Overall Study||0
2912246|NCT00489476|3622096|FG001|NOT COMPLETED|Overall Study||1
2912247|NCT00489476|3622097|FG002|NOT COMPLETED|Overall Study||0
2912248|NCT00489476|3622098|FG003|NOT COMPLETED|Overall Study||0
2912249|NCT00489489|3622111|FG000|STARTED|Overall Study|randomized|41
2912250|NCT00489489|3622112|FG001|STARTED|Overall Study|randomized|37
2912251|NCT00489489|3622113|FG002|STARTED|Overall Study|randomized|40
2912252|NCT00489489|3622111|FG000|Treated|Overall Study||41
2912253|NCT00489489|3622112|FG001|Treated|Overall Study||36
2912254|NCT00489489|3622113|FG002|Treated|Overall Study|One participant received teriflunomide 7 mg instead of teriflunomide 14 mg|39
2912255|NCT00489489|3622111|FG000|COMPLETED|Overall Study|completed treatment period|38
2912256|NCT00489489|3622112|FG001|COMPLETED|Overall Study|completed treatment period|32
2912257|NCT00489489|3622113|FG002|COMPLETED|Overall Study|completed treatment period|37
2912258|NCT00489489|3622111|FG000|NOT COMPLETED|Overall Study||3
2912259|NCT00489489|3622112|FG001|NOT COMPLETED|Overall Study||5
2912260|NCT00489489|3622113|FG002|NOT COMPLETED|Overall Study||3
2912261|NCT00489541|3622125|FG000|STARTED|12-Month Clinical Follow-up||224
2912262|NCT00489541|3622126|FG001|STARTED|12-Month Clinical Follow-up||125
2912263|NCT00489541|3622125|FG000|COMPLETED|12-Month Clinical Follow-up||215
2912264|NCT00489541|3622126|FG001|COMPLETED|12-Month Clinical Follow-up||120
2912265|NCT00489541|3622125|FG000|NOT COMPLETED|12-Month Clinical Follow-up||9
2912266|NCT00489541|3622126|FG001|NOT COMPLETED|12-Month Clinical Follow-up||5
2912267|NCT00489541|3622125|FG000|STARTED|9-Month Angiographic Follow-up||224
2912268|NCT00489541|3622126|FG001|STARTED|9-Month Angiographic Follow-up||125
2912269|NCT00489541|3622125|FG000|COMPLETED|9-Month Angiographic Follow-up||197
2912270|NCT00489541|3622126|FG001|COMPLETED|9-Month Angiographic Follow-up||108
2912271|NCT00489541|3622125|FG000|NOT COMPLETED|9-Month Angiographic Follow-up||27
2912272|NCT00489541|3622126|FG001|NOT COMPLETED|9-Month Angiographic Follow-up||17
2912273|NCT00489554|3622132|FG000|STARTED|Overall Study||230
2912274|NCT00489554|3622132|FG000|COMPLETED|Overall Study||226
2912275|NCT00489554|3622132|FG000|NOT COMPLETED|Overall Study||4
2912276|NCT00489736|3622138|FG000|STARTED|Overall Study|Randomized and treated patients|249
2912277|NCT00489736|3622139|FG001|STARTED|Overall Study|Randomized and treated patients|255
2912278|NCT00489736|3622138|FG000|COMPLETED|Overall Study|completed study drug period|153
2912279|NCT00489736|3622139|FG001|COMPLETED|Overall Study|completed study drug period|186
2912280|NCT00489736|3622138|FG000|NOT COMPLETED|Overall Study||96
2912281|NCT00489736|3622139|FG001|NOT COMPLETED|Overall Study||69
2912282|NCT00489827|3622147|FG000|STARTED|Overall Study||430
2912283|NCT00489827|3622148|FG001|STARTED|Overall Study||435
2912284|NCT00489827|3622147|FG000|COMPLETED|Overall Study||428
2912285|NCT00489827|3622148|FG001|COMPLETED|Overall Study||433
2912286|NCT00489827|3622147|FG000|NOT COMPLETED|Overall Study||2
2912287|NCT00489827|3622148|FG001|NOT COMPLETED|Overall Study||2
2912288|NCT00489853|3622154|FG000|STARTED|Treatment Period 1||36
2912289|NCT00489853|3622155|FG001|STARTED|Treatment Period 1||37
2912290|NCT00489853|3622156|FG002|STARTED|Treatment Period 1||38
2912291|NCT00489853|3622154|FG000|COMPLETED|Treatment Period 1||36
3310147|NCT03037541|4043469|FG000|STARTED|Overall Study||30
3310148|NCT03037541|4043470|FG001|STARTED|Overall Study||30
3310149|NCT03037541|4043469|FG000|COMPLETED|Overall Study||30
3310150|NCT03037541|4043470|FG001|COMPLETED|Overall Study||30
3310151|NCT03037541|4043469|FG000|NOT COMPLETED|Overall Study||0
2912292|NCT00489853|3622155|FG001|COMPLETED|Treatment Period 1||37
2912293|NCT00489853|3622156|FG002|COMPLETED|Treatment Period 1||38
2912294|NCT00489853|3622154|FG000|NOT COMPLETED|Treatment Period 1||0
2912295|NCT00489853|3622155|FG001|NOT COMPLETED|Treatment Period 1||0
2912296|NCT00489853|3622156|FG002|NOT COMPLETED|Treatment Period 1||0
2912297|NCT00489853|3622154|FG000|STARTED|Wash-out Period 1||36
2912298|NCT00489853|3622155|FG001|STARTED|Wash-out Period 1||37
2912299|NCT00489853|3622156|FG002|STARTED|Wash-out Period 1||38
2912300|NCT00489853|3622154|FG000|COMPLETED|Wash-out Period 1||35
2912301|NCT00489853|3622155|FG001|COMPLETED|Wash-out Period 1||34
2912302|NCT00489853|3622156|FG002|COMPLETED|Wash-out Period 1||32
2912303|NCT00489853|3622154|FG000|NOT COMPLETED|Wash-out Period 1||1
2912304|NCT00489853|3622155|FG001|NOT COMPLETED|Wash-out Period 1||3
2912305|NCT00489853|3622156|FG002|NOT COMPLETED|Wash-out Period 1||6
2912306|NCT00489853|3622154|FG000|STARTED|Treatment Period 2||33
2912307|NCT00489853|3622155|FG001|STARTED|Treatment Period 2||35
2912308|NCT00489853|3622156|FG002|STARTED|Treatment Period 2||33
2912309|NCT00489853|3622154|FG000|COMPLETED|Treatment Period 2||33
2912310|NCT00489853|3622155|FG001|COMPLETED|Treatment Period 2||35
2912311|NCT00489853|3622156|FG002|COMPLETED|Treatment Period 2||33
2912312|NCT00489853|3622154|FG000|NOT COMPLETED|Treatment Period 2||0
2912313|NCT00489853|3622155|FG001|NOT COMPLETED|Treatment Period 2||0
2912314|NCT00489853|3622156|FG002|NOT COMPLETED|Treatment Period 2||0
2912315|NCT00489853|3622154|FG000|STARTED|Wash-out Period 2||33
2912316|NCT00489853|3622155|FG001|STARTED|Wash-out Period 2||35
2912317|NCT00489853|3622156|FG002|STARTED|Wash-out Period 2||33
2912318|NCT00489853|3622154|FG000|COMPLETED|Wash-out Period 2||29
2912319|NCT00489853|3622155|FG001|COMPLETED|Wash-out Period 2||32
2912320|NCT00489853|3622156|FG002|COMPLETED|Wash-out Period 2||31
2912321|NCT00489853|3622154|FG000|NOT COMPLETED|Wash-out Period 2||4
2912322|NCT00489853|3622155|FG001|NOT COMPLETED|Wash-out Period 2||3
2912323|NCT00489853|3622156|FG002|NOT COMPLETED|Wash-out Period 2||2
2912324|NCT00489853|3622154|FG000|STARTED|Treatment Period 3||29
2912325|NCT00489853|3622155|FG001|STARTED|Treatment Period 3||30
2912326|NCT00489853|3622156|FG002|STARTED|Treatment Period 3||33
2912327|NCT00489853|3622154|FG000|COMPLETED|Treatment Period 3||29
2912328|NCT00489853|3622155|FG001|COMPLETED|Treatment Period 3||29
2912329|NCT00489853|3622156|FG002|COMPLETED|Treatment Period 3||33
2912330|NCT00489853|3622154|FG000|NOT COMPLETED|Treatment Period 3||0
2912331|NCT00489853|3622155|FG001|NOT COMPLETED|Treatment Period 3||1
2912332|NCT00489853|3622156|FG002|NOT COMPLETED|Treatment Period 3||0
2912333|NCT00489853|3622154|FG000|STARTED|Follow-up Period||29
2912334|NCT00489853|3622155|FG001|STARTED|Follow-up Period||29
2912335|NCT00489853|3622156|FG002|STARTED|Follow-up Period||33
2912336|NCT00489853|3622154|FG000|COMPLETED|Follow-up Period||29
2912337|NCT00489853|3622155|FG001|COMPLETED|Follow-up Period||29
2912338|NCT00489853|3622156|FG002|COMPLETED|Follow-up Period||33
2912339|NCT00489853|3622154|FG000|NOT COMPLETED|Follow-up Period||0
2912340|NCT00489853|3622155|FG001|NOT COMPLETED|Follow-up Period||0
2912341|NCT00489853|3622156|FG002|NOT COMPLETED|Follow-up Period||0
2912342|NCT00489866|3622166|FG000|STARTED|Overall Study||7
2912343|NCT00489866|3622167|FG001|STARTED|Overall Study||7
2912344|NCT00489866|3622166|FG000|COMPLETED|Overall Study||5
2912345|NCT00489866|3622167|FG001|COMPLETED|Overall Study||7
2912346|NCT00489866|3622166|FG000|NOT COMPLETED|Overall Study||2
2912347|NCT00489866|3622167|FG001|NOT COMPLETED|Overall Study||0
2912348|NCT00489918|3622186|FG000|STARTED|Overall Study||33
2912349|NCT00489918|3622187|FG001|STARTED|Overall Study||34
2912350|NCT00489918|3622188|FG002|STARTED|Overall Study||32
2912351|NCT00489918|3622189|FG003|STARTED|Overall Study||33
2912352|NCT00489918|3622190|FG004|STARTED|Overall Study||33
2912353|NCT00489918|3622186|FG000|COMPLETED|Overall Study||31
2912354|NCT00489918|3622187|FG001|COMPLETED|Overall Study||32
2912355|NCT00489918|3622188|FG002|COMPLETED|Overall Study||28
3310152|NCT03037541|4043470|FG001|NOT COMPLETED|Overall Study||0
3310153|NCT03037580|4043478|FG000|STARTED|Overall Study||41
2912356|NCT00489918|3622189|FG003|COMPLETED|Overall Study||32
2912357|NCT00489918|3622190|FG004|COMPLETED|Overall Study||32
2912358|NCT00489918|3622186|FG000|NOT COMPLETED|Overall Study||2
2912359|NCT00489918|3622187|FG001|NOT COMPLETED|Overall Study||2
3166325|NCT01904058|3893773|FG002|NOT COMPLETED|Overall Study||1
3166326|NCT01904058|3893774|FG003|NOT COMPLETED|Overall Study||1
3166327|NCT01904071|3893793|FG000|STARTED|Overall Study||24
2912360|NCT00489918|3622188|FG002|NOT COMPLETED|Overall Study||4
2912361|NCT00489918|3622189|FG003|NOT COMPLETED|Overall Study||1
2912362|NCT00489918|3622190|FG004|NOT COMPLETED|Overall Study||1
2912363|NCT00489970|3622205|FG000|STARTED|Persistence Year 1||1069
2912364|NCT00489970|3622206|FG001|STARTED|Persistence Year 1||523
2912365|NCT00489970|3622207|FG002|STARTED|Persistence Year 1||0
2912366|NCT00489970|3622205|FG000|COMPLETED|Persistence Year 1||1069
2912367|NCT00489970|3622206|FG001|COMPLETED|Persistence Year 1||523
2912368|NCT00489970|3622207|FG002|COMPLETED|Persistence Year 1||0
2912369|NCT00489970|3622205|FG000|NOT COMPLETED|Persistence Year 1||0
2912370|NCT00489970|3622206|FG001|NOT COMPLETED|Persistence Year 1||0
2912371|NCT00489970|3622207|FG002|NOT COMPLETED|Persistence Year 1||0
2912372|NCT00489970|3622205|FG000|STARTED|Persistence Year 3|Number of subjects who returned at Year 3|1019
2912373|NCT00489970|3622206|FG001|STARTED|Persistence Year 3|Number of subjects who returned at Year 3|486
2912374|NCT00489970|3622207|FG002|STARTED|Persistence Year 3||0
2912375|NCT00489970|3622205|FG000|COMPLETED|Persistence Year 3||1019
2912376|NCT00489970|3622206|FG001|COMPLETED|Persistence Year 3||486
2912377|NCT00489970|3622207|FG002|COMPLETED|Persistence Year 3||0
2912378|NCT00489970|3622205|FG000|NOT COMPLETED|Persistence Year 3||0
2912379|NCT00489970|3622206|FG001|NOT COMPLETED|Persistence Year 3||0
2912380|NCT00489970|3622207|FG002|NOT COMPLETED|Persistence Year 3||0
2912381|NCT00489970|3622205|FG000|STARTED|Persistence Year 5|Number of subjects who returned at Year 5|856
2912382|NCT00489970|3622206|FG001|STARTED|Persistence Year 5|Number of subjects who returned at Year 5|401
2912383|NCT00489970|3622207|FG002|STARTED|Persistence Year 5||0
2912384|NCT00489970|3622205|FG000|COMPLETED|Persistence Year 5||856
2912385|NCT00489970|3622206|FG001|COMPLETED|Persistence Year 5||401
2912386|NCT00489970|3622207|FG002|COMPLETED|Persistence Year 5||0
2912387|NCT00489970|3622205|FG000|NOT COMPLETED|Persistence Year 5||0
2912388|NCT00489970|3622206|FG001|NOT COMPLETED|Persistence Year 5||0
2912389|NCT00489970|3622207|FG002|NOT COMPLETED|Persistence Year 5||0
2912390|NCT00489970|3622205|FG000|STARTED|Persistence Year 9|Number of subjects who returned at Year 9.|309
2912391|NCT00489970|3622206|FG001|STARTED|Persistence Year 9|Number of subjects who returned at Year 9.|138
2912392|NCT00489970|3622207|FG002|STARTED|Persistence Year 9|Number of subjects who received the first dose at Year 9.|362
2912393|NCT00489970|3622205|FG000|COMPLETED|Persistence Year 9||306
2912394|NCT00489970|3622206|FG001|COMPLETED|Persistence Year 9||136
2912395|NCT00489970|3622207|FG002|COMPLETED|Persistence Year 9||357
2912396|NCT00489970|3622205|FG000|NOT COMPLETED|Persistence Year 9||3
2912397|NCT00489970|3622206|FG001|NOT COMPLETED|Persistence Year 9||2
2912398|NCT00489970|3622207|FG002|NOT COMPLETED|Persistence Year 9||5
2912399|NCT00490009|3622218|FG000|STARTED|Overall Study||9
2912400|NCT00490009|3622218|FG000|COMPLETED|Overall Study||9
2912401|NCT00490009|3622218|FG000|NOT COMPLETED|Overall Study||0
2912402|NCT00490022|3622225|FG000|STARTED|Overall Study||16
2912403|NCT00490022|3622226|FG001|STARTED|Overall Study||15
2912404|NCT00490022|3622225|FG000|COMPLETED|Overall Study||15
2912405|NCT00490022|3622226|FG001|COMPLETED|Overall Study||12
2912406|NCT00490022|3622225|FG000|NOT COMPLETED|Overall Study||1
2912407|NCT00490022|3622226|FG001|NOT COMPLETED|Overall Study||3
2912408|NCT00490035|3622236|FG000|STARTED|Overall Study||100
2912409|NCT00490035|3622237|FG001|STARTED|Overall Study||99
2912410|NCT00490035|3622238|FG002|STARTED|Overall Study||100
2912411|NCT00490035|3622239|FG003|STARTED|Overall Study||100
2912412|NCT00490035|3622236|FG000|COMPLETED|Overall Study||92
2912413|NCT00490035|3622237|FG001|COMPLETED|Overall Study||93
2912414|NCT00490035|3622238|FG002|COMPLETED|Overall Study||88
2912415|NCT00490035|3622239|FG003|COMPLETED|Overall Study||94
2912416|NCT00490035|3622236|FG000|NOT COMPLETED|Overall Study||8
2912417|NCT00490035|3622237|FG001|NOT COMPLETED|Overall Study||6
2912418|NCT00490035|3622238|FG002|NOT COMPLETED|Overall Study||12
2912419|NCT00490035|3622239|FG003|NOT COMPLETED|Overall Study||6
2912420|NCT00490061|3622249|FG000|STARTED|Overall Study||17
2912421|NCT00490061|3622249|FG000|COMPLETED|Overall Study||16
3310154|NCT03037580|4043479|FG001|STARTED|Overall Study||43
3310155|NCT03037580|4043478|FG000|COMPLETED|Overall Study||25
3310156|NCT03037580|4043479|FG001|COMPLETED|Overall Study||27
3310157|NCT03037580|4043478|FG000|NOT COMPLETED|Overall Study||16
3310158|NCT03037580|4043479|FG001|NOT COMPLETED|Overall Study||16
3310159|NCT03037619|4043487|FG000|STARTED|Overall Study||8
3317283|NCT03125200|4050829|FG000|COMPLETED|Overall Study||0
2912422|NCT00490061|3622249|FG000|NOT COMPLETED|Overall Study||1
2912423|NCT00490100|3622253|FG000|STARTED|Overall Study||6
2912424|NCT00490100|3622253|FG000|COMPLETED|Overall Study||3
2912425|NCT00490100|3622253|FG000|NOT COMPLETED|Overall Study||3
2912426|NCT00490139|3622262|FG000|STARTED|Overall Study||2093
2912427|NCT00490139|3622263|FG001|STARTED|Overall Study||2091
2912428|NCT00490139|3622264|FG002|STARTED|Overall Study||2100
2912429|NCT00490139|3622265|FG003|STARTED|Overall Study||2097
2912430|NCT00490139|3622262|FG000|COMPLETED|Overall Study||1785
2912431|NCT00490139|3622263|FG001|COMPLETED|Overall Study||1816
3166328|NCT01904071|3893794|FG001|STARTED|Overall Study||20
3166329|NCT01904071|3893795|FG002|STARTED|Overall Study||20
3166330|NCT01904071|3893793|FG000|COMPLETED|Overall Study||24
3166331|NCT01904071|3893794|FG001|COMPLETED|Overall Study||20
3166332|NCT01904071|3893795|FG002|COMPLETED|Overall Study||20
3166333|NCT01904071|3893793|FG000|NOT COMPLETED|Overall Study||0
3166334|NCT01904071|3893794|FG001|NOT COMPLETED|Overall Study||0
3166335|NCT01904071|3893795|FG002|NOT COMPLETED|Overall Study||0
3166336|NCT01904149|3893809|FG000|STARTED|Overall Study||152
3166337|NCT01904149|3893810|FG001|STARTED|Overall Study||151
3166338|NCT01904149|3893811|FG002|STARTED|Overall Study||150
3166339|NCT01904149|3893812|FG003|STARTED|Overall Study||51
3166340|NCT01904149|3893813|FG004|STARTED|Overall Study||51
3166341|NCT01904149|3893814|FG005|STARTED|Overall Study||51
3166342|NCT01904149|3893809|FG000|Single-dose Phase|Overall Study||152
3166343|NCT01904149|3893810|FG001|Single-dose Phase|Overall Study||151
3166344|NCT01904149|3893811|FG002|Single-dose Phase|Overall Study||150
3166345|NCT01904149|3893812|FG003|Single-dose Phase|Overall Study||51
2912432|NCT00490139|3622264|FG002|COMPLETED|Overall Study||1666
2912433|NCT00490139|3622265|FG003|COMPLETED|Overall Study||1790
2912434|NCT00490139|3622262|FG000|NOT COMPLETED|Overall Study||308
2912435|NCT00490139|3622263|FG001|NOT COMPLETED|Overall Study||275
2912436|NCT00490139|3622264|FG002|NOT COMPLETED|Overall Study||434
2912437|NCT00490139|3622265|FG003|NOT COMPLETED|Overall Study||307
2912438|NCT00490256|3622279|FG000|STARTED|Overall Study||7
2912439|NCT00490256|3622280|FG001|STARTED|Overall Study||7
2912440|NCT00490256|3622279|FG000|Intraoperative Portion of the Study|Overall Study|Intraoperative management|7
2912441|NCT00490256|3622280|FG001|Intraoperative Portion of the Study|Overall Study|Intraoperative management|7
2912442|NCT00490256|3622279|FG000|COMPLETED|Overall Study||7
2912443|NCT00490256|3622280|FG001|COMPLETED|Overall Study||7
2912444|NCT00490256|3622279|FG000|NOT COMPLETED|Overall Study||0
2912445|NCT00490256|3622280|FG001|NOT COMPLETED|Overall Study||0
2912446|NCT00490269|3622288|FG000|STARTED|Dronabinol Then Placebo||6
2912447|NCT00490269|3622289|FG001|STARTED|Dronabinol Then Placebo||6
2912448|NCT00490269|3622288|FG000|COMPLETED|Dronabinol Then Placebo||6
2912449|NCT00490269|3622289|FG001|COMPLETED|Dronabinol Then Placebo||6
2912450|NCT00490269|3622288|FG000|NOT COMPLETED|Dronabinol Then Placebo||0
2912451|NCT00490269|3622289|FG001|NOT COMPLETED|Dronabinol Then Placebo||0
2912452|NCT00490269|3622288|FG000|STARTED|Placebo Then Dronabinol||6
2912453|NCT00490269|3622289|FG001|STARTED|Placebo Then Dronabinol||6
3166346|NCT01904149|3893813|FG004|Single-dose Phase|Overall Study||51
2912454|NCT00490269|3622288|FG000|COMPLETED|Placebo Then Dronabinol||6
2912455|NCT00490269|3622289|FG001|COMPLETED|Placebo Then Dronabinol||6
2912456|NCT00490269|3622288|FG000|NOT COMPLETED|Placebo Then Dronabinol||0
2912457|NCT00490269|3622289|FG001|NOT COMPLETED|Placebo Then Dronabinol||0
2912458|NCT00490282|3622295|FG000|STARTED|Overall Study||25
2912459|NCT00490282|3622295|FG000|COMPLETED|Overall Study||22
2912460|NCT00490282|3622295|FG000|NOT COMPLETED|Overall Study||3
2912461|NCT00490451|3622302|FG000|STARTED|Overall Study||63
2912462|NCT00490451|3622303|FG001|STARTED|Overall Study||38
2912463|NCT00490451|3622302|FG000|COMPLETED|Overall Study||0
2912464|NCT00490451|3622303|FG001|COMPLETED|Overall Study||0
2912465|NCT00490451|3622302|FG000|NOT COMPLETED|Overall Study||63
2912466|NCT00490451|3622303|FG001|NOT COMPLETED|Overall Study||38
2912467|NCT00490477|3622311|FG000|STARTED|Overall Study||8
2912468|NCT00490477|3622312|FG001|STARTED|Overall Study||8
2912469|NCT00490477|3622311|FG000|COMPLETED|Overall Study||8
2912470|NCT00490477|3622312|FG001|COMPLETED|Overall Study||8
2912471|NCT00490477|3622311|FG000|NOT COMPLETED|Overall Study||0
3166347|NCT01904149|3893814|FG005|Single-dose Phase|Overall Study||51
3166348|NCT01904149|3893809|FG000|Multiple-dose Phase|Overall Study||150
3166349|NCT01904149|3893810|FG001|Multiple-dose Phase|Overall Study||146
3166350|NCT01904149|3893811|FG002|Multiple-dose Phase|Overall Study||149
3166351|NCT01904149|3893812|FG003|Multiple-dose Phase|Overall Study||48
3166352|NCT01904149|3893813|FG004|Multiple-dose Phase|Overall Study||48
3166353|NCT01904149|3893814|FG005|Multiple-dose Phase|Overall Study||49
3166354|NCT01904149|3893809|FG000|COMPLETED|Overall Study||147
3166355|NCT01904149|3893810|FG001|COMPLETED|Overall Study||140
3166356|NCT01904149|3893811|FG002|COMPLETED|Overall Study||148
3166357|NCT01904149|3893812|FG003|COMPLETED|Overall Study||47
3166358|NCT01904149|3893813|FG004|COMPLETED|Overall Study||46
3166359|NCT01904149|3893814|FG005|COMPLETED|Overall Study||48
3166360|NCT01904149|3893809|FG000|NOT COMPLETED|Overall Study||5
3166361|NCT01904149|3893810|FG001|NOT COMPLETED|Overall Study||11
3166362|NCT01904149|3893811|FG002|NOT COMPLETED|Overall Study||2
3166363|NCT01904149|3893812|FG003|NOT COMPLETED|Overall Study||4
3310160|NCT03037619|4043488|FG001|STARTED|Overall Study|8 participants and 7 buddies|15
3310161|NCT03037619|4043487|FG000|COMPLETED|Overall Study||8
3310162|NCT03037619|4043488|FG001|COMPLETED|Overall Study|7 participants and 7 buddies|14
3310163|NCT03037619|4043487|FG000|NOT COMPLETED|Overall Study||0
3310164|NCT03037619|4043488|FG001|NOT COMPLETED|Overall Study||1
3310165|NCT03037905|4043496|FG000|STARTED|Overall Study||50
3310166|NCT03037905|4043497|FG001|STARTED|Overall Study||50
3310167|NCT03037905|4043496|FG000|COMPLETED|Overall Study||50
3310168|NCT03037905|4043497|FG001|COMPLETED|Overall Study||50
3310169|NCT03037905|4043496|FG000|NOT COMPLETED|Overall Study||0
3310170|NCT03037905|4043497|FG001|NOT COMPLETED|Overall Study||0
3166364|NCT01904149|3893813|FG004|NOT COMPLETED|Overall Study||5
3166365|NCT01904149|3893814|FG005|NOT COMPLETED|Overall Study||3
2912472|NCT00490477|3622312|FG001|NOT COMPLETED|Overall Study||0
2912473|NCT00490490|3622318|FG000|STARTED|Completed Assessment for CR||8
2912474|NCT00490490|3622318|FG000|COMPLETED|Completed Assessment for CR||8
2912475|NCT00490490|3622318|FG000|NOT COMPLETED|Completed Assessment for CR||0
2912476|NCT00490490|3622318|FG000|STARTED|Completed Assessment for TTP||8
2912477|NCT00490490|3622318|FG000|COMPLETED|Completed Assessment for TTP||5
2912478|NCT00490490|3622318|FG000|NOT COMPLETED|Completed Assessment for TTP||3
2912479|NCT00490529|3622322|FG000|STARTED|Completed Pre-CpG-MCL Vaccine Procedures||59
2912480|NCT00490529|3622322|FG000|COMPLETED|Completed Pre-CpG-MCL Vaccine Procedures||48
2912481|NCT00490529|3622322|FG000|NOT COMPLETED|Completed Pre-CpG-MCL Vaccine Procedures||11
2912482|NCT00490529|3622322|FG000|STARTED|Treatment With CpG-MCL Vaccine||48
2912483|NCT00490529|3622322|FG000|COMPLETED|Treatment With CpG-MCL Vaccine||47
2912484|NCT00490529|3622322|FG000|NOT COMPLETED|Treatment With CpG-MCL Vaccine||1
2912485|NCT00490542|3622328|FG000|STARTED|Overall Study||38
2912486|NCT00490542|3622329|FG001|STARTED|Overall Study||35
2912487|NCT00490542|3622328|FG000|COMPLETED|Overall Study||31
2912488|NCT00490542|3622329|FG001|COMPLETED|Overall Study||31
2912489|NCT00490542|3622328|FG000|NOT COMPLETED|Overall Study||7
2912490|NCT00490542|3622329|FG001|NOT COMPLETED|Overall Study||4
2912491|NCT00490555|3622339|FG000|STARTED|Overall Study||8
2912492|NCT00490555|3622340|FG001|STARTED|Overall Study||8
2912493|NCT00490555|3622341|FG002|STARTED|Overall Study||9
2912494|NCT00490555|3622342|FG003|STARTED|Overall Study||7
2912495|NCT00490555|3622339|FG000|COMPLETED|Overall Study||8
2912496|NCT00490555|3622340|FG001|COMPLETED|Overall Study||8
2912497|NCT00490555|3622341|FG002|COMPLETED|Overall Study||7
2912498|NCT00490555|3622342|FG003|COMPLETED|Overall Study||7
3166366|NCT01904383|3893830|FG000|STARTED|Overall Study||4057
2912499|NCT00490555|3622339|FG000|NOT COMPLETED|Overall Study||0
2912500|NCT00490555|3622340|FG001|NOT COMPLETED|Overall Study||0
2912501|NCT00490555|3622341|FG002|NOT COMPLETED|Overall Study||2
2912502|NCT00490555|3622342|FG003|NOT COMPLETED|Overall Study||0
2912503|NCT00490568|3622352|FG000|STARTED|Overall Study||1461
2912504|NCT00490568|3622352|FG000|COMPLETED|Overall Study||97
3166367|NCT01904383|3893830|FG000|Treated|Overall Study||3940
3166368|NCT01904383|3893830|FG000|COMPLETED|Overall Study||2283
3166369|NCT01904383|3893830|FG000|NOT COMPLETED|Overall Study||1774
3166370|NCT01904448|3893834|FG000|STARTED|Overall Study||5
3166371|NCT01904448|3893834|FG000|COMPLETED|Overall Study||5
3166372|NCT01904448|3893834|FG000|NOT COMPLETED|Overall Study||0
3166373|NCT01904526|3893839|FG000|STARTED|Overall Study||5
3166374|NCT01904526|3893839|FG000|COMPLETED|Overall Study||5
3166375|NCT01904526|3893839|FG000|NOT COMPLETED|Overall Study||0
2912505|NCT00490568|3622352|FG000|NOT COMPLETED|Overall Study||1364
2912506|NCT00490646|3622359|FG000|STARTED|Overall Study||25
2912507|NCT00490646|3622360|FG001|STARTED|Overall Study||25
2912508|NCT00490646|3622359|FG000|Treated|Overall Study||24
2912509|NCT00490646|3622360|FG001|Treated|Overall Study||24
2912510|NCT00490646|3622359|FG000|COMPLETED|Overall Study|Completed=Off-treatment (Major reasons: Disease progression=14; study drug toxicity=4)|23
2912511|NCT00490646|3622360|FG001|COMPLETED|Overall Study|Completed=Off-treatment (Major reasons: Disease progression=13; study drug toxicity=1)|23
2912512|NCT00490646|3622359|FG000|NOT COMPLETED|Overall Study||2
2912513|NCT00490646|3622360|FG001|NOT COMPLETED|Overall Study||2
2912514|NCT00490698|3622366|FG000|STARTED|Overall Study||11
2912515|NCT00490698|3622366|FG000|COMPLETED|Overall Study||1
2912516|NCT00490698|3622366|FG000|NOT COMPLETED|Overall Study||10
2912517|NCT00490724|3622373|FG000|STARTED|Period I||21
2912518|NCT00490724|3622374|FG001|STARTED|Period I||20
2912519|NCT00490724|3622375|FG002|STARTED|Period I||20
2912520|NCT00490724|3622373|FG000|COMPLETED|Period I||21
2912521|NCT00490724|3622374|FG001|COMPLETED|Period I||20
2912522|NCT00490724|3622375|FG002|COMPLETED|Period I||19
2912523|NCT00490724|3622373|FG000|NOT COMPLETED|Period I||0
2912524|NCT00490724|3622374|FG001|NOT COMPLETED|Period I||0
2912525|NCT00490724|3622375|FG002|NOT COMPLETED|Period I||1
2912526|NCT00490724|3622373|FG000|STARTED|Period II||21
2912527|NCT00490724|3622374|FG001|STARTED|Period II||20
2912528|NCT00490724|3622375|FG002|STARTED|Period II||19
2912529|NCT00490724|3622373|FG000|COMPLETED|Period II||18
2912530|NCT00490724|3622374|FG001|COMPLETED|Period II||19
2912531|NCT00490724|3622375|FG002|COMPLETED|Period II||16
2912532|NCT00490724|3622373|FG000|NOT COMPLETED|Period II||3
2912533|NCT00490724|3622374|FG001|NOT COMPLETED|Period II||1
2912534|NCT00490724|3622375|FG002|NOT COMPLETED|Period II||3
2912535|NCT00490802|3622385|FG000|STARTED|Overall Study||10
2912536|NCT00490802|3622386|FG001|STARTED|Overall Study||9
2912537|NCT00490802|3622385|FG000|COMPLETED|Overall Study||9
2912538|NCT00490802|3622386|FG001|COMPLETED|Overall Study||7
2912539|NCT00490802|3622385|FG000|NOT COMPLETED|Overall Study||1
2912540|NCT00490802|3622386|FG001|NOT COMPLETED|Overall Study||2
2912541|NCT00490815|3622395|FG000|STARTED|Overall Study||20
2912542|NCT00490815|3622396|FG001|STARTED|Overall Study||17
2912543|NCT00490815|3622395|FG000|COMPLETED|Overall Study||12
2912544|NCT00490815|3622396|FG001|COMPLETED|Overall Study||8
2912545|NCT00490815|3622395|FG000|NOT COMPLETED|Overall Study||8
2912546|NCT00490815|3622396|FG001|NOT COMPLETED|Overall Study||9
2912547|NCT00490841|3622402|FG000|STARTED|Overall Study||202
2912548|NCT00490841|3622402|FG000|COMPLETED|Overall Study||189
2912549|NCT00490841|3622402|FG000|NOT COMPLETED|Overall Study||13
2912550|NCT00490919|3622409|FG000|STARTED|Open-label Run-in Period||1024
2912551|NCT00490919|3622410|FG001|STARTED|Open-label Run-in Period||0
2912552|NCT00490919|3622411|FG002|STARTED|Open-label Run-in Period||0
2912553|NCT00490919|3622409|FG000|COMPLETED|Open-label Run-in Period|Completed run-in and randomized; however 2 had no safety data after randomization visit (N = 539)|541
2912554|NCT00490919|3622410|FG001|COMPLETED|Open-label Run-in Period||0
2912555|NCT00490919|3622411|FG002|COMPLETED|Open-label Run-in Period||0
2912556|NCT00490919|3622409|FG000|NOT COMPLETED|Open-label Run-in Period||483
2912557|NCT00490919|3622410|FG001|NOT COMPLETED|Open-label Run-in Period||0
2912558|NCT00490919|3622411|FG002|NOT COMPLETED|Open-label Run-in Period||0
2912559|NCT00490919|3622409|FG000|STARTED|Double-blind Phase||0
2912560|NCT00490919|3622410|FG001|STARTED|Double-blind Phase|1 subject had no safety data in DB phase; therefore is excluded from randomized safety population.|256
2912561|NCT00490919|3622411|FG002|STARTED|Double-blind Phase|1 subject had no safety data in DB phase; therefore is excluded from randomized safety population.|283
2912562|NCT00490919|3622409|FG000|COMPLETED|Double-blind Phase||0
2912563|NCT00490919|3622410|FG001|COMPLETED|Double-blind Phase||170
2912564|NCT00490919|3622411|FG002|COMPLETED|Double-blind Phase||199
2912565|NCT00490919|3622409|FG000|NOT COMPLETED|Double-blind Phase||0
2912566|NCT00490919|3622410|FG001|NOT COMPLETED|Double-blind Phase||86
2912567|NCT00490919|3622411|FG002|NOT COMPLETED|Double-blind Phase||84
2912568|NCT00490945|3622423|FG000|STARTED|Overall Study||8
2912569|NCT00490945|3622424|FG001|STARTED|Overall Study||9
2912570|NCT00490945|3622425|FG002|STARTED|Overall Study||8
2912571|NCT00490945|3622426|FG003|STARTED|Overall Study||7
2912572|NCT00490945|3622427|FG004|STARTED|Overall Study||7
2912573|NCT00490945|3622423|FG000|COMPLETED|Overall Study||8
2912574|NCT00490945|3622424|FG001|COMPLETED|Overall Study||8
2912575|NCT00490945|3622425|FG002|COMPLETED|Overall Study||8
3310171|NCT03037983|4043507|FG000|STARTED|Overall Study||5
3310172|NCT03037983|4043508|FG001|STARTED|Overall Study||4
3310173|NCT03037983|4043507|FG000|COMPLETED|Overall Study||5
3310174|NCT03037983|4043508|FG001|COMPLETED|Overall Study||4
3310175|NCT03037983|4043507|FG000|NOT COMPLETED|Overall Study||0
3310176|NCT03037983|4043508|FG001|NOT COMPLETED|Overall Study||0
2912576|NCT00490945|3622426|FG003|COMPLETED|Overall Study||7
2912577|NCT00490945|3622427|FG004|COMPLETED|Overall Study||7
2912578|NCT00490945|3622423|FG000|NOT COMPLETED|Overall Study||0
2912579|NCT00490945|3622424|FG001|NOT COMPLETED|Overall Study||1
2912580|NCT00490945|3622425|FG002|NOT COMPLETED|Overall Study||0
2912581|NCT00490945|3622426|FG003|NOT COMPLETED|Overall Study||0
2912582|NCT00490945|3622427|FG004|NOT COMPLETED|Overall Study||0
2912583|NCT00490971|3622447|FG000|STARTED|Acute/Continuation|617 participants were assigned to paliperidone, out of which 614 took the study medication.|614
2912584|NCT00490971|3622448|FG001|STARTED|Acute/Continuation|149 participants were assigned to paliperidone, out of which 148 took the study medication.|148
2912585|NCT00490971|3622449|FG002|STARTED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
2912586|NCT00490971|3622450|FG003|STARTED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
2912587|NCT00490971|3622451|FG004|STARTED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
2912588|NCT00490971|3622447|FG000|COMPLETED|Acute/Continuation||308
2912589|NCT00490971|3622448|FG001|COMPLETED|Acute/Continuation||86
2912590|NCT00490971|3622449|FG002|COMPLETED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
2912591|NCT00490971|3622450|FG003|COMPLETED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
2912592|NCT00490971|3622451|FG004|COMPLETED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
2912593|NCT00490971|3622447|FG000|NOT COMPLETED|Acute/Continuation||306
2912594|NCT00490971|3622448|FG001|NOT COMPLETED|Acute/Continuation||62
2912595|NCT00490971|3622449|FG002|NOT COMPLETED|Acute/Continuation||0
2912596|NCT00490971|3622450|FG003|NOT COMPLETED|Acute/Continuation||0
2912597|NCT00490971|3622451|FG004|NOT COMPLETED|Acute/Continuation||0
2912598|NCT00490971|3622447|FG000|STARTED|Maintenance|"0 indicates this group is not relevant to maintenance period."|0
2912599|NCT00490971|3622448|FG001|STARTED|Maintenance|"0 indicates this group is not relevant to maintenance period."|0
2912600|NCT00490971|3622449|FG002|STARTED|Maintenance|148 participants were assigned to pali/placebo, out of which 147 took the study medication.|147
2912601|NCT00490971|3622450|FG003|STARTED|Maintenance|152 participants were assigned to pali/pali, out of which 149 took the study medication.|149
2912602|NCT00490971|3622451|FG004|STARTED|Maintenance||83
3166376|NCT01904604|3893850|FG000|STARTED|Overall Study||25
3166377|NCT01904604|3893851|FG001|STARTED|Overall Study||25
3166378|NCT01904604|3893852|FG002|STARTED|Overall Study||25
3166379|NCT01904604|3893850|FG000|Completed Week 52 OFC|Overall Study||22
3166380|NCT01904604|3893851|FG001|Completed Week 52 OFC|Overall Study||21
3166381|NCT01904604|3893852|FG002|Completed Week 52 OFC|Overall Study||25
3166382|NCT01904604|3893850|FG000|Began Crossover Treatment|Overall Study|2 participants who completed the Week 52 OFC did not crossover; 1 passed the OFC and 1 relocated.|20
3166383|NCT01904604|3893851|FG001|Began Crossover Treatment|Overall Study||21
3166384|NCT01904604|3893852|FG002|Began Crossover Treatment|Overall Study|Per protocol, this treatment group did not crossover.|0
3166385|NCT01904604|3893850|FG000|Completed Week 130 OFC|Overall Study||18
3166386|NCT01904604|3893851|FG001|Completed Week 130 OFC|Overall Study||18
3166387|NCT01904604|3893852|FG002|Completed Week 130 OFC|Overall Study||23
3166388|NCT01904604|3893850|FG000|COMPLETED|Overall Study|COMPLETED: Completed the Week 130 Oral Food Challenge (OFC).|18
3166389|NCT01904604|3893851|FG001|COMPLETED|Overall Study|COMPLETED: Completed the Week 130 Oral Food Challenge (OFC).|18
3166390|NCT01904604|3893852|FG002|COMPLETED|Overall Study|COMPLETED: Completed the Week 130 Oral Food Challenge (OFC).|23
3166391|NCT01904604|3893850|FG000|NOT COMPLETED|Overall Study||7
3166392|NCT01904604|3893851|FG001|NOT COMPLETED|Overall Study||7
3166393|NCT01904604|3893852|FG002|NOT COMPLETED|Overall Study||2
3166394|NCT01904721|3893870|FG000|STARTED|Overall Study||13
3166395|NCT01904721|3893871|FG001|STARTED|Overall Study||13
3166396|NCT01904721|3893872|FG002|STARTED|Overall Study||12
3166397|NCT01904721|3893873|FG003|STARTED|Overall Study||12
3166398|NCT01904721|3893874|FG004|STARTED|Overall Study||65
2912603|NCT00490971|3622447|FG000|COMPLETED|Maintenance|"0 indicates this group is not relevant to maintenance period."|0
2912604|NCT00490971|3622448|FG001|COMPLETED|Maintenance|"0 indicates this group is not relevant to maintenance period."|0
2912605|NCT00490971|3622449|FG002|COMPLETED|Maintenance||96
2912606|NCT00490971|3622450|FG003|COMPLETED|Maintenance||96
2912607|NCT00490971|3622451|FG004|COMPLETED|Maintenance||44
2912608|NCT00490971|3622447|FG000|NOT COMPLETED|Maintenance||0
2912609|NCT00490971|3622448|FG001|NOT COMPLETED|Maintenance||0
2912610|NCT00490971|3622449|FG002|NOT COMPLETED|Maintenance||51
2912611|NCT00490971|3622450|FG003|NOT COMPLETED|Maintenance||53
2912612|NCT00490971|3622451|FG004|NOT COMPLETED|Maintenance||39
2912613|NCT00491075|3622463|FG000|STARTED|Overall Study||16
2912614|NCT00491075|3622463|FG000|COMPLETED|Overall Study||14
2912615|NCT00491075|3622463|FG000|NOT COMPLETED|Overall Study||2
2912616|NCT00491179|3622469|FG000|STARTED|Overall Study||25
2912617|NCT00491179|3622470|FG001|STARTED|Overall Study||10
2912618|NCT00491179|3622469|FG000|COMPLETED|Overall Study||18
2912619|NCT00491179|3622470|FG001|COMPLETED|Overall Study||8
2912620|NCT00491179|3622469|FG000|NOT COMPLETED|Overall Study||7
2912621|NCT00491179|3622470|FG001|NOT COMPLETED|Overall Study||2
2912622|NCT00491244|3622478|FG000|STARTED|Overall Study||189
2912623|NCT00491244|3622479|FG001|STARTED|Overall Study||188
2912624|NCT00491244|3622478|FG000|COMPLETED|Overall Study||162
2912625|NCT00491244|3622479|FG001|COMPLETED|Overall Study||168
2912626|NCT00491244|3622478|FG000|NOT COMPLETED|Overall Study||27
2912627|NCT00491244|3622479|FG001|NOT COMPLETED|Overall Study||20
2912628|NCT00491322|3622487|FG000|STARTED|Overall Study||41
2912629|NCT00491322|3622488|FG001|STARTED|Overall Study||51
2912630|NCT00491322|3622487|FG000|COMPLETED|Overall Study||40
2912631|NCT00491322|3622488|FG001|COMPLETED|Overall Study||50
2912632|NCT00491322|3622487|FG000|NOT COMPLETED|Overall Study||1
2912633|NCT00491322|3622488|FG001|NOT COMPLETED|Overall Study||1
2912634|NCT00491374|3622496|FG000|STARTED|Overall Study||0
2912635|NCT00491374|3622497|FG001|STARTED|Overall Study||0
2912636|NCT00491374|3622496|FG000|COMPLETED|Overall Study||0
2912637|NCT00491374|3622497|FG001|COMPLETED|Overall Study||0
2912638|NCT00491374|3622496|FG000|NOT COMPLETED|Overall Study||0
2912639|NCT00491374|3622497|FG001|NOT COMPLETED|Overall Study||0
2912640|NCT00491491|3622505|FG000|STARTED|Overall Study||22
2912641|NCT00491491|3622506|FG001|STARTED|Overall Study||21
2912642|NCT00491491|3622505|FG000|COMPLETED|Overall Study||22
2912643|NCT00491491|3622506|FG001|COMPLETED|Overall Study||21
2912644|NCT00491491|3622505|FG000|NOT COMPLETED|Overall Study||0
2912645|NCT00491491|3622506|FG001|NOT COMPLETED|Overall Study||0
2912646|NCT00491530|3622515|FG000|STARTED|Overall Study||174
2912647|NCT00491530|3622516|FG001|STARTED|Overall Study||50
2912648|NCT00491530|3622517|FG002|STARTED|Overall Study||86
2912649|NCT00491530|3622515|FG000|COMPLETED|Overall Study||162
2912650|NCT00491530|3622516|FG001|COMPLETED|Overall Study||44
2912651|NCT00491530|3622517|FG002|COMPLETED|Overall Study||81
2912652|NCT00491530|3622515|FG000|NOT COMPLETED|Overall Study||12
2912653|NCT00491530|3622516|FG001|NOT COMPLETED|Overall Study||6
2912654|NCT00491530|3622517|FG002|NOT COMPLETED|Overall Study||5
2912655|NCT00491556|3622527|FG000|STARTED|Entry-Week (WK) 48: EXP/Standard Care||75
2912656|NCT00491556|3622528|FG001|STARTED|Entry-Week (WK) 48: EXP/Standard Care||27
2912657|NCT00491556|3622527|FG000|Wk 24 VL Suppressed (EXP)/WK 24 (STAND)|Entry-Week (WK) 48: EXP/Standard Care||53
3034119|NCT01130532|3753145|FG002|STARTED|Period III (Weeks 0-12)||209
3034120|NCT01130532|3753146|FG003|STARTED|Period III (Weeks 0-12)||0
3038335|NCT01153724|3757759|FG000|STARTED|Treatment Period 1||35
3166399|NCT01904721|3893875|FG005|STARTED|Overall Study||65
3166400|NCT01904721|3893876|FG006|STARTED|Overall Study||64
3166401|NCT01904721|3893870|FG000|COMPLETED|Overall Study||13
3166402|NCT01904721|3893871|FG001|COMPLETED|Overall Study||13
3166403|NCT01904721|3893872|FG002|COMPLETED|Overall Study||11
3166404|NCT01904721|3893873|FG003|COMPLETED|Overall Study||11
3166405|NCT01904721|3893874|FG004|COMPLETED|Overall Study||57
3166406|NCT01904721|3893875|FG005|COMPLETED|Overall Study||56
3166407|NCT01904721|3893876|FG006|COMPLETED|Overall Study||57
3166408|NCT01904721|3893870|FG000|NOT COMPLETED|Overall Study||0
3310177|NCT03038113|4043528|FG000|STARTED|Overall Study||8
3310178|NCT03038113|4043529|FG001|STARTED|Overall Study||8
3310179|NCT03038113|4043530|FG002|STARTED|Overall Study||8
3310180|NCT03038113|4043531|FG003|STARTED|Overall Study||8
3310181|NCT03038113|4043532|FG004|STARTED|Overall Study||8
3310182|NCT03038113|4043533|FG005|STARTED|Overall Study||8
3310183|NCT03038113|4043534|FG006|STARTED|Overall Study||12
3310184|NCT03038113|4043535|FG007|STARTED|Overall Study||6
3310185|NCT03038113|4043536|FG008|STARTED|Overall Study||7
3310186|NCT03038113|4043537|FG009|STARTED|Overall Study||6
3166409|NCT01904721|3893871|FG001|NOT COMPLETED|Overall Study||0
3166410|NCT01904721|3893872|FG002|NOT COMPLETED|Overall Study||1
2912658|NCT00491556|3622528|FG001|Wk 24 VL Suppressed (EXP)/WK 24 (STAND)|Entry-Week (WK) 48: EXP/Standard Care||27
2912659|NCT00491556|3622527|FG000|COMPLETED|Entry-Week (WK) 48: EXP/Standard Care||49
2912660|NCT00491556|3622528|FG001|COMPLETED|Entry-Week (WK) 48: EXP/Standard Care||27
2912661|NCT00491556|3622527|FG000|NOT COMPLETED|Entry-Week (WK) 48: EXP/Standard Care||26
2912662|NCT00491556|3622528|FG001|NOT COMPLETED|Entry-Week (WK) 48: EXP/Standard Care||0
2912663|NCT00491556|3622527|FG000|STARTED|Wk 48-152: EXP (On De-Int)/Standard Care||49
2912664|NCT00491556|3622528|FG001|STARTED|Wk 48-152: EXP (On De-Int)/Standard Care||27
2912665|NCT00491556|3622527|FG000|COMPLETED|Wk 48-152: EXP (On De-Int)/Standard Care||25
2912666|NCT00491556|3622528|FG001|COMPLETED|Wk 48-152: EXP (On De-Int)/Standard Care||22
2912667|NCT00491556|3622527|FG000|NOT COMPLETED|Wk 48-152: EXP (On De-Int)/Standard Care||24
2912668|NCT00491556|3622528|FG001|NOT COMPLETED|Wk 48-152: EXP (On De-Int)/Standard Care||5
2912669|NCT00491608|3622534|FG000|STARTED|Overall Study|Participants who received treatment|209
2912670|NCT00491608|3622534|FG000|COMPLETED|Overall Study||206
2912671|NCT00491608|3622534|FG000|NOT COMPLETED|Overall Study||3
2920596|NCT00537485|3631105|FG001|STARTED|Overall Study||90
2920597|NCT00537485|3631104|FG000|COMPLETED|Overall Study||75
2920598|NCT00537485|3631105|FG001|COMPLETED|Overall Study||80
2920599|NCT00537485|3631104|FG000|NOT COMPLETED|Overall Study||15
2920600|NCT00537485|3631105|FG001|NOT COMPLETED|Overall Study||10
2920601|NCT00537511|3631111|FG000|STARTED|Treatment Period (Combination)||22
2920602|NCT00537511|3631111|FG000|Intent-to-Treat (ITT) Populaton|Treatment Period (Combination)|ITT = all participants enrolled in the study.|22
2920603|NCT00537511|3631111|FG000|Safety Population|Treatment Period (Combination)|Safety = All participants who took ≥1 dose of study treatment.|22
2920604|NCT00537511|3631111|FG000|COMPLETED|Treatment Period (Combination)||17
2920605|NCT00537511|3631111|FG000|NOT COMPLETED|Treatment Period (Combination)||5
2920606|NCT00537511|3631111|FG000|STARTED|Extension Period (Combination)||17
2920607|NCT00537511|3631111|FG000|COMPLETED|Extension Period (Combination)||11
2920608|NCT00537511|3631111|FG000|NOT COMPLETED|Extension Period (Combination)||6
2920609|NCT00537511|3631111|FG000|STARTED|Recovery Period (Monotherapy)||11
2920610|NCT00537511|3631111|FG000|COMPLETED|Recovery Period (Monotherapy)||3
2920611|NCT00537511|3631111|FG000|NOT COMPLETED|Recovery Period (Monotherapy)||8
2920612|NCT00537511|3631111|FG000|STARTED|Maintenance Phase (Monotherapy)||8
2920613|NCT00537511|3631111|FG000|COMPLETED|Maintenance Phase (Monotherapy)||0
2920614|NCT00537511|3631111|FG000|NOT COMPLETED|Maintenance Phase (Monotherapy)||8
2920615|NCT00537576|3631134|FG000|STARTED|Overall Study||3
2920616|NCT00537576|3631135|FG001|STARTED|Overall Study||3
2920617|NCT00537576|3631136|FG002|STARTED|Overall Study||3
2920618|NCT00537576|3631137|FG003|STARTED|Overall Study||1
2920619|NCT00537576|3631138|FG004|STARTED|Overall Study||1
2920620|NCT00537576|3631139|FG005|STARTED|Overall Study||1
2920621|NCT00537576|3631134|FG000|COMPLETED|Overall Study||3
2920622|NCT00537576|3631135|FG001|COMPLETED|Overall Study||3
2920623|NCT00537576|3631136|FG002|COMPLETED|Overall Study||3
2920624|NCT00537576|3631137|FG003|COMPLETED|Overall Study||1
2920625|NCT00537576|3631138|FG004|COMPLETED|Overall Study||1
2920626|NCT00537576|3631139|FG005|COMPLETED|Overall Study||1
2920627|NCT00537576|3631134|FG000|NOT COMPLETED|Overall Study||0
2920628|NCT00537576|3631135|FG001|NOT COMPLETED|Overall Study||0
2920629|NCT00537576|3631136|FG002|NOT COMPLETED|Overall Study||0
2920630|NCT00537576|3631137|FG003|NOT COMPLETED|Overall Study||0
2920631|NCT00537576|3631138|FG004|NOT COMPLETED|Overall Study||0
2920632|NCT00537576|3631139|FG005|NOT COMPLETED|Overall Study||0
2920633|NCT00537680|3631156|FG000|STARTED|Overall Study||22
2920634|NCT00537680|3631157|FG001|STARTED|Overall Study||24
2920635|NCT00537680|3631158|FG002|STARTED|Overall Study||24
2920636|NCT00537680|3631156|FG000|COMPLETED|Overall Study||22
2920637|NCT00537680|3631157|FG001|COMPLETED|Overall Study||22
3166411|NCT01904721|3893873|FG003|NOT COMPLETED|Overall Study||1
3166412|NCT01904721|3893874|FG004|NOT COMPLETED|Overall Study||8
3166413|NCT01904721|3893875|FG005|NOT COMPLETED|Overall Study||9
3166414|NCT01904721|3893876|FG006|NOT COMPLETED|Overall Study||7
2912672|NCT00491751|3622541|FG000|STARTED|Overall Study||22
2912673|NCT00491751|3622542|FG001|STARTED|Overall Study||44
2912674|NCT00491751|3622543|FG002|STARTED|Overall Study||42
2912675|NCT00491751|3622541|FG000|COMPLETED|Overall Study||22
2912676|NCT00491751|3622542|FG001|COMPLETED|Overall Study||44
2912677|NCT00491751|3622543|FG002|COMPLETED|Overall Study||42
2912678|NCT00491751|3622541|FG000|NOT COMPLETED|Overall Study||0
2912679|NCT00491751|3622542|FG001|NOT COMPLETED|Overall Study||0
2912680|NCT00491751|3622543|FG002|NOT COMPLETED|Overall Study||0
2912681|NCT00491764|3622559|FG000|STARTED|Overall Study||37
2912682|NCT00491764|3622560|FG001|STARTED|Overall Study||37
2912683|NCT00491764|3622561|FG002|STARTED|Overall Study||36
2912684|NCT00491764|3622562|FG003|STARTED|Overall Study||36
2912685|NCT00491764|3622563|FG004|STARTED|Overall Study||36
2912686|NCT00491764|3622564|FG005|STARTED|Overall Study||36
2912687|NCT00491764|3622559|FG000|COMPLETED|Overall Study||32
2912688|NCT00491764|3622560|FG001|COMPLETED|Overall Study||30
2912689|NCT00491764|3622561|FG002|COMPLETED|Overall Study||28
2912690|NCT00491764|3622562|FG003|COMPLETED|Overall Study||28
2912691|NCT00491764|3622563|FG004|COMPLETED|Overall Study||33
2912692|NCT00491764|3622564|FG005|COMPLETED|Overall Study||27
2912693|NCT00491764|3622559|FG000|NOT COMPLETED|Overall Study||5
2912694|NCT00491764|3622560|FG001|NOT COMPLETED|Overall Study||7
2912695|NCT00491764|3622561|FG002|NOT COMPLETED|Overall Study||8
2912696|NCT00491764|3622562|FG003|NOT COMPLETED|Overall Study||8
2912697|NCT00491764|3622563|FG004|NOT COMPLETED|Overall Study||3
2912698|NCT00491764|3622564|FG005|NOT COMPLETED|Overall Study||9
2912699|NCT00491829|3622581|FG000|STARTED|Overall Study||311
2912700|NCT00491829|3622582|FG001|STARTED|Overall Study||316
2912701|NCT00491829|3622583|FG002|STARTED|Overall Study||318
2912702|NCT00491829|3622581|FG000|COMPLETED|Overall Study||216
2912703|NCT00491829|3622582|FG001|COMPLETED|Overall Study||202
2912704|NCT00491829|3622583|FG002|COMPLETED|Overall Study||243
2912705|NCT00491829|3622581|FG000|NOT COMPLETED|Overall Study||95
2912706|NCT00491829|3622582|FG001|NOT COMPLETED|Overall Study||114
2912707|NCT00491829|3622583|FG002|NOT COMPLETED|Overall Study||75
2912708|NCT00491894|3622591|FG000|STARTED|Overall Study||137
2912709|NCT00491894|3622591|FG000|COMPLETED|Overall Study||103
2912710|NCT00491894|3622591|FG000|NOT COMPLETED|Overall Study||34
2912711|NCT00492024|3622597|FG000|STARTED|Treatment||251
2912712|NCT00492024|3622598|FG001|STARTED|Treatment||123
2912713|NCT00492024|3622597|FG000|COMPLETED|Treatment||222
2912714|NCT00492024|3622598|FG001|COMPLETED|Treatment||101
2912715|NCT00492024|3622597|FG000|NOT COMPLETED|Treatment||29
2912716|NCT00492024|3622598|FG001|NOT COMPLETED|Treatment||22
2912717|NCT00492024|3622597|FG000|STARTED|Follow up||222
2912718|NCT00492024|3622598|FG001|STARTED|Follow up||101
2912719|NCT00492024|3622597|FG000|COMPLETED|Follow up||221
2912720|NCT00492024|3622598|FG001|COMPLETED|Follow up||99
2912721|NCT00492024|3622597|FG000|NOT COMPLETED|Follow up||1
2912722|NCT00492024|3622598|FG001|NOT COMPLETED|Follow up||2
2912723|NCT00492063|3622608|FG000|STARTED|Overall Study||652
2912724|NCT00492063|3622609|FG001|STARTED|Overall Study||648
2912725|NCT00492063|3622610|FG002|STARTED|Overall Study||678
2912726|NCT00492063|3622611|FG003|STARTED|Overall Study||676
2912727|NCT00492063|3622608|FG000|COMPLETED|Overall Study||642
2912728|NCT00492063|3622609|FG001|COMPLETED|Overall Study||634
2912729|NCT00492063|3622610|FG002|COMPLETED|Overall Study||667
2912730|NCT00492063|3622611|FG003|COMPLETED|Overall Study||666
2912731|NCT00492063|3622608|FG000|NOT COMPLETED|Overall Study||10
2912732|NCT00492063|3622609|FG001|NOT COMPLETED|Overall Study||14
2912733|NCT00492063|3622610|FG002|NOT COMPLETED|Overall Study||11
2912734|NCT00492063|3622611|FG003|NOT COMPLETED|Overall Study||10
2912735|NCT00492089|3622623|FG000|STARTED|First Intervention (6 Weeks)||5
2912736|NCT00492089|3622624|FG001|STARTED|First Intervention (6 Weeks)||6
2912737|NCT00492089|3622623|FG000|COMPLETED|First Intervention (6 Weeks)||5
2912738|NCT00492089|3622624|FG001|COMPLETED|First Intervention (6 Weeks)||6
2912739|NCT00492089|3622623|FG000|NOT COMPLETED|First Intervention (6 Weeks)||0
2912740|NCT00492089|3622624|FG001|NOT COMPLETED|First Intervention (6 Weeks)||0
2912741|NCT00492089|3622623|FG000|STARTED|Second Intervention (6 Weeks)||5
2912742|NCT00492089|3622624|FG001|STARTED|Second Intervention (6 Weeks)||6
2912743|NCT00492089|3622623|FG000|COMPLETED|Second Intervention (6 Weeks)||5
2912744|NCT00492089|3622624|FG001|COMPLETED|Second Intervention (6 Weeks)||6
2912745|NCT00492089|3622623|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||0
2912746|NCT00492089|3622624|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||0
3166415|NCT01904760|3893890|FG000|STARTED|Overall Study||40
3166416|NCT01904760|3893891|FG001|STARTED|Overall Study||40
3166417|NCT01904760|3893890|FG000|COMPLETED|Overall Study||39
2912747|NCT00492115|3622632|FG000|STARTED|Overall Study||19
2912748|NCT00492115|3622633|FG001|STARTED|Overall Study||19
2912749|NCT00492115|3622632|FG000|COMPLETED|Overall Study|3 dropped due to anxiety or not being able to tolerate CPAP|16
2912750|NCT00492115|3622633|FG001|COMPLETED|Overall Study|4 dropped due to not being able to tolerate CPAP|15
2912751|NCT00492115|3622632|FG000|NOT COMPLETED|Overall Study||3
2912752|NCT00492115|3622633|FG001|NOT COMPLETED|Overall Study||4
2912753|NCT00492206|3622639|FG000|STARTED|Overall Study||40
2912754|NCT00492206|3622639|FG000|COMPLETED|Overall Study||40
2912755|NCT00492206|3622639|FG000|NOT COMPLETED|Overall Study||0
2912756|NCT00492232|3622647|FG000|STARTED|Placebo Run-in||0
2912757|NCT00492232|3622648|FG001|STARTED|Placebo Run-in|All subjects received placebo in the placebo run-in period.|205
2912758|NCT00492232|3622647|FG000|COMPLETED|Placebo Run-in||0
2912759|NCT00492232|3622648|FG001|COMPLETED|Placebo Run-in|These subjects successfully completed the placebo run-in period and were randomized to the DBTP.|135
2912760|NCT00492232|3622647|FG000|NOT COMPLETED|Placebo Run-in||0
2912761|NCT00492232|3622648|FG001|NOT COMPLETED|Placebo Run-in||70
2912762|NCT00492232|3622647|FG000|STARTED|Double-Blind Treatment||65
2912763|NCT00492232|3622648|FG001|STARTED|Double-Blind Treatment||70
2912764|NCT00492232|3622647|FG000|COMPLETED|Double-Blind Treatment||47
2912765|NCT00492232|3622648|FG001|COMPLETED|Double-Blind Treatment||45
2912766|NCT00492232|3622647|FG000|NOT COMPLETED|Double-Blind Treatment||18
2912767|NCT00492232|3622648|FG001|NOT COMPLETED|Double-Blind Treatment||25
2912768|NCT00492232|3622647|FG000|STARTED|Open-Label Treatment|In the previous DBTP, 45 and 44 subjects were randomized to ramelteon and placebo, respectively.|89
2912769|NCT00492232|3622648|FG001|STARTED|Open-Label Treatment|All subjects received ramelteon in the OLTP.|0
2912770|NCT00492232|3622647|FG000|COMPLETED|Open-Label Treatment||88
2912771|NCT00492232|3622648|FG001|COMPLETED|Open-Label Treatment||0
2912772|NCT00492232|3622647|FG000|NOT COMPLETED|Open-Label Treatment||1
2912773|NCT00492232|3622648|FG001|NOT COMPLETED|Open-Label Treatment||0
2912774|NCT00492284|3622658|FG000|STARTED|Overall Study||39
2912775|NCT00492284|3622659|FG001|STARTED|Overall Study||39
2912776|NCT00492284|3622660|FG002|STARTED|Overall Study||43
2912777|NCT00492284|3622661|FG003|STARTED|Overall Study||41
2912778|NCT00492284|3622658|FG000|COMPLETED|Overall Study||38
2912779|NCT00492284|3622659|FG001|COMPLETED|Overall Study||35
2912780|NCT00492284|3622660|FG002|COMPLETED|Overall Study||37
2912781|NCT00492284|3622661|FG003|COMPLETED|Overall Study||31
2912782|NCT00492284|3622658|FG000|NOT COMPLETED|Overall Study||1
2912783|NCT00492284|3622659|FG001|NOT COMPLETED|Overall Study||4
2912784|NCT00492284|3622660|FG002|NOT COMPLETED|Overall Study||6
2912785|NCT00492284|3622661|FG003|NOT COMPLETED|Overall Study||10
2912786|NCT00492297|3622671|FG000|STARTED|Treatment||83
2912787|NCT00492297|3622671|FG000|First Stage of Simon Optimal Design|Treatment|32 subjects of 83 subjects enrolled were treated in first stage.|32
2912788|NCT00492297|3622671|FG000|Second Stage of Simon Optimal Design|Treatment|Recruitment continued into the second stage. 51 of 83 subjects were treated in the second stage.|51
2912789|NCT00492297|3622671|FG000|COMPLETED|Treatment||78
2912790|NCT00492297|3622671|FG000|NOT COMPLETED|Treatment||5
2912791|NCT00492297|3622671|FG000|STARTED|Active Follow-up 30(+4) Days Duration|AFU is 30(+4) days duration for subjects withdrawn from sorafenib due to PD.|78
2912792|NCT00492297|3622671|FG000|COMPLETED|Active Follow-up 30(+4) Days Duration||59
2912793|NCT00492297|3622671|FG000|NOT COMPLETED|Active Follow-up 30(+4) Days Duration||19
3166418|NCT01904760|3893891|FG001|COMPLETED|Overall Study||40
3166419|NCT01904760|3893890|FG000|NOT COMPLETED|Overall Study||1
3166420|NCT01904760|3893891|FG001|NOT COMPLETED|Overall Study||0
3166421|NCT01904773|3893897|FG000|STARTED|Screen||28
3166422|NCT01904773|3893898|FG001|STARTED|Screen||0
3166423|NCT01904773|3893899|FG002|STARTED|Screen||0
3166424|NCT01904773|3893900|FG003|STARTED|Screen||0
3166425|NCT01904773|3893901|FG004|STARTED|Screen||0
3166426|NCT01904773|3893902|FG005|STARTED|Screen||0
3166427|NCT01904773|3893903|FG006|STARTED|Screen||0
3166428|NCT01904773|3893904|FG007|STARTED|Screen||0
3166429|NCT01904773|3893905|FG008|STARTED|Screen||0
3166430|NCT01904773|3893897|FG000|COMPLETED|Screen||24
3166431|NCT01904773|3893898|FG001|COMPLETED|Screen||0
3166432|NCT01904773|3893899|FG002|COMPLETED|Screen||0
3166433|NCT01904773|3893900|FG003|COMPLETED|Screen||0
3166434|NCT01904773|3893901|FG004|COMPLETED|Screen||0
3166435|NCT01904773|3893902|FG005|COMPLETED|Screen||0
3166436|NCT01904773|3893903|FG006|COMPLETED|Screen||0
3166437|NCT01904773|3893904|FG007|COMPLETED|Screen||0
3166438|NCT01904773|3893905|FG008|COMPLETED|Screen||0
3166439|NCT01904773|3893897|FG000|NOT COMPLETED|Screen||4
3166440|NCT01904773|3893898|FG001|NOT COMPLETED|Screen||0
3166441|NCT01904773|3893899|FG002|NOT COMPLETED|Screen||0
3166442|NCT01904773|3893900|FG003|NOT COMPLETED|Screen||0
3166443|NCT01904773|3893901|FG004|NOT COMPLETED|Screen||0
3166444|NCT01904773|3893902|FG005|NOT COMPLETED|Screen||0
3166445|NCT01904773|3893903|FG006|NOT COMPLETED|Screen||0
3166446|NCT01904773|3893904|FG007|NOT COMPLETED|Screen||0
2912794|NCT00492297|3622671|FG000|STARTED|Survival Only Follow-up||59
3166447|NCT01904773|3893905|FG008|NOT COMPLETED|Screen||0
3166448|NCT01904773|3893897|FG000|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||24
3166449|NCT01904773|3893898|FG001|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
2912795|NCT00492297|3622671|FG000|COMPLETED|Survival Only Follow-up||0
2912796|NCT00492297|3622671|FG000|NOT COMPLETED|Survival Only Follow-up||59
2912797|NCT00492336|3622677|FG000|STARTED|Overall Study||28
2912798|NCT00492336|3622678|FG001|STARTED|Overall Study||29
2912799|NCT00492336|3622677|FG000|COMPLETED|Overall Study||26
2912800|NCT00492336|3622678|FG001|COMPLETED|Overall Study||23
2912801|NCT00492336|3622677|FG000|NOT COMPLETED|Overall Study||2
2912802|NCT00492336|3622678|FG001|NOT COMPLETED|Overall Study||6
2912803|NCT00492401|3622684|FG000|STARTED|Overall Study||55
2912804|NCT00492401|3622684|FG000|COMPLETED|Overall Study||55
3166450|NCT01904773|3893899|FG002|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
3310187|NCT03038113|4043538|FG010|STARTED|Overall Study||14
3310188|NCT03038113|4043539|FG011|STARTED|Overall Study||7
3310189|NCT03038113|4043540|FG012|STARTED|Overall Study||4
3310190|NCT03038113|4043541|FG013|STARTED|Overall Study||15
3310191|NCT03038113|4043528|FG000|COMPLETED|Overall Study||8
3310192|NCT03038113|4043529|FG001|COMPLETED|Overall Study||8
3310193|NCT03038113|4043530|FG002|COMPLETED|Overall Study||7
3310194|NCT03038113|4043531|FG003|COMPLETED|Overall Study||8
3310195|NCT03038113|4043532|FG004|COMPLETED|Overall Study||8
3310196|NCT03038113|4043533|FG005|COMPLETED|Overall Study||8
3310197|NCT03038113|4043534|FG006|COMPLETED|Overall Study||11
3310198|NCT03038113|4043535|FG007|COMPLETED|Overall Study||6
3310199|NCT03038113|4043536|FG008|COMPLETED|Overall Study||7
3310200|NCT03038113|4043537|FG009|COMPLETED|Overall Study||6
3310201|NCT03038113|4043538|FG010|COMPLETED|Overall Study||14
3310202|NCT03038113|4043539|FG011|COMPLETED|Overall Study||7
3310203|NCT03038113|4043540|FG012|COMPLETED|Overall Study||4
3310204|NCT03038113|4043541|FG013|COMPLETED|Overall Study||14
3310205|NCT03038113|4043528|FG000|NOT COMPLETED|Overall Study||0
3310206|NCT03038113|4043529|FG001|NOT COMPLETED|Overall Study||0
3166451|NCT01904773|3893900|FG003|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
3166452|NCT01904773|3893901|FG004|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
3166453|NCT01904773|3893902|FG005|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
3166454|NCT01904773|3893903|FG006|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
3310207|NCT03038113|4043530|FG002|NOT COMPLETED|Overall Study||1
3310208|NCT03038113|4043531|FG003|NOT COMPLETED|Overall Study||0
3310209|NCT03038113|4043532|FG004|NOT COMPLETED|Overall Study||0
3310210|NCT03038113|4043533|FG005|NOT COMPLETED|Overall Study||0
3166455|NCT01904773|3893904|FG007|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
3166456|NCT01904773|3893905|FG008|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
3166457|NCT01904773|3893897|FG000|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||24
3166458|NCT01904773|3893898|FG001|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
2912805|NCT00492401|3622684|FG000|NOT COMPLETED|Overall Study||0
2912806|NCT00492531|3622692|FG000|STARTED|Overall Study||37
2912807|NCT00492531|3622693|FG001|STARTED|Overall Study||37
2912808|NCT00492531|3622692|FG000|COMPLETED|Overall Study|Of 15 subjects who completed study, 13 were enrolled in Open label.|15
2912809|NCT00492531|3622693|FG001|COMPLETED|Overall Study|Of 14 subjects who completed study, 13 were enrolled in Open label.|14
2912810|NCT00492531|3622692|FG000|NOT COMPLETED|Overall Study||22
2912811|NCT00492531|3622693|FG001|NOT COMPLETED|Overall Study||23
2912812|NCT00492544|3622699|FG000|STARTED|Overall Study||100
2912813|NCT00492544|3622699|FG000|COMPLETED|Overall Study||100
2912814|NCT00492544|3622699|FG000|NOT COMPLETED|Overall Study||0
2912815|NCT00492557|3622705|FG000|STARTED|Overall Study||580
2912816|NCT00492557|3622706|FG001|STARTED|Overall Study||580
2912817|NCT00492557|3622705|FG000|Vaccinated Dose 1|Overall Study||577
2912818|NCT00492557|3622706|FG001|Vaccinated Dose 1|Overall Study||575
2912819|NCT00492557|3622705|FG000|Vaccinated Dose 2|Overall Study||560
2912820|NCT00492557|3622706|FG001|Vaccinated Dose 2|Overall Study||558
2912821|NCT00492557|3622705|FG000|COMPLETED|Overall Study||556
2912822|NCT00492557|3622706|FG001|COMPLETED|Overall Study||557
2912823|NCT00492557|3622705|FG000|NOT COMPLETED|Overall Study||24
2912824|NCT00492557|3622706|FG001|NOT COMPLETED|Overall Study||23
2912825|NCT00492583|3622717|FG000|STARTED|Overall Study||95
2912826|NCT00492583|3622718|FG001|STARTED|Overall Study||87
2912827|NCT00492583|3622717|FG000|COMPLETED|Overall Study||95
2912828|NCT00492583|3622718|FG001|COMPLETED|Overall Study||87
2912829|NCT00492583|3622717|FG000|NOT COMPLETED|Overall Study||0
2912830|NCT00492583|3622718|FG001|NOT COMPLETED|Overall Study||0
2912831|NCT00492622|3622724|FG000|STARTED|Overall Study|all subjects received the immediate release formulation|12
2912832|NCT00492622|3622724|FG000|COMPLETED|Overall Study||12
2912833|NCT00492622|3622724|FG000|NOT COMPLETED|Overall Study||0
2912834|NCT00492648|3622734|FG000|STARTED|Month 30 (109671 Study)||4
3166459|NCT01904773|3893899|FG002|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
3166460|NCT01904773|3893900|FG003|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
3166461|NCT01904773|3893901|FG004|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
3166462|NCT01904773|3893902|FG005|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
3166463|NCT01904773|3893903|FG006|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
3166464|NCT01904773|3893904|FG007|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
3166465|NCT01904773|3893905|FG008|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
3166466|NCT01904773|3893897|FG000|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
3166467|NCT01904773|3893898|FG001|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
3166468|NCT01904773|3893899|FG002|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
3166469|NCT01904773|3893900|FG003|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
3166470|NCT01904773|3893901|FG004|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
3166471|NCT01904773|3893902|FG005|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
3166472|NCT01904773|3893903|FG006|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
3166473|NCT01904773|3893904|FG007|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
2912835|NCT00492648|3622735|FG001|STARTED|Month 30 (109671 Study)||30
3310211|NCT03038113|4043534|FG006|NOT COMPLETED|Overall Study||1
3310212|NCT03038113|4043535|FG007|NOT COMPLETED|Overall Study||0
3310213|NCT03038113|4043536|FG008|NOT COMPLETED|Overall Study||0
3310214|NCT03038113|4043537|FG009|NOT COMPLETED|Overall Study||0
2912836|NCT00492648|3622734|FG000|COMPLETED|Month 30 (109671 Study)||4
2912837|NCT00492648|3622735|FG001|COMPLETED|Month 30 (109671 Study)||29
2912838|NCT00492648|3622734|FG000|NOT COMPLETED|Month 30 (109671 Study)||0
2912839|NCT00492648|3622735|FG001|NOT COMPLETED|Month 30 (109671 Study)||1
2912840|NCT00492648|3622734|FG000|STARTED|Month 42 (109674 Study)||3
2912841|NCT00492648|3622735|FG001|STARTED|Month 42 (109674 Study)||20
2912842|NCT00492648|3622734|FG000|COMPLETED|Month 42 (109674 Study)||3
2912843|NCT00492648|3622735|FG001|COMPLETED|Month 42 (109674 Study)||20
2912844|NCT00492648|3622734|FG000|NOT COMPLETED|Month 42 (109674 Study)||0
2912845|NCT00492648|3622735|FG001|NOT COMPLETED|Month 42 (109674 Study)||0
2912846|NCT00492726|3622743|FG000|STARTED|Overall Study||410
2912847|NCT00492726|3622744|FG001|STARTED|Overall Study||394
2912848|NCT00492726|3622743|FG000|End of Treatment (EOT, Day 5 to 14)|Overall Study||387
2912849|NCT00492726|3622744|FG001|End of Treatment (EOT, Day 5 to 14)|Overall Study||377
2912850|NCT00492726|3622743|FG000|End of Study|Overall Study||360
2912851|NCT00492726|3622744|FG001|End of Study|Overall Study||358
2912852|NCT00492726|3622743|FG000|COMPLETED|Overall Study||360
2912853|NCT00492726|3622744|FG001|COMPLETED|Overall Study||358
2912854|NCT00492726|3622743|FG000|NOT COMPLETED|Overall Study||50
2912855|NCT00492726|3622744|FG001|NOT COMPLETED|Overall Study||36
2912856|NCT00492752|3622752|FG000|STARTED|Double Blind Treatment||134
2912857|NCT00492752|3622753|FG001|STARTED|Double Blind Treatment||16
3166474|NCT01904773|3893905|FG008|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
3166475|NCT01904773|3893897|FG000|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||24
3166476|NCT01904773|3893898|FG001|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
3166477|NCT01904773|3893899|FG002|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
3166478|NCT01904773|3893900|FG003|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
3166479|NCT01904773|3893901|FG004|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
3166480|NCT01904773|3893902|FG005|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
2912858|NCT00492752|3622754|FG002|STARTED|Double Blind Treatment||70
2912859|NCT00492752|3622755|FG003|STARTED|Double Blind Treatment||6
2912860|NCT00492752|3622752|FG000|Received Treatment|Double Blind Treatment|Safety Population. 1 participant never received treatment due to an Adverse Event.|133
2912861|NCT00492752|3622753|FG001|Received Treatment|Double Blind Treatment|Safety Population|16
2912862|NCT00492752|3622754|FG002|Received Treatment|Double Blind Treatment|Safety Population. 1 participant never received treatment due to protocol violation.|69
2912863|NCT00492752|3622755|FG003|Received Treatment|Double Blind Treatment|Safety Population|6
2912864|NCT00492752|3622752|FG000|COMPLETED|Double Blind Treatment||120
2912865|NCT00492752|3622753|FG001|COMPLETED|Double Blind Treatment||16
2912866|NCT00492752|3622754|FG002|COMPLETED|Double Blind Treatment||67
2912867|NCT00492752|3622755|FG003|COMPLETED|Double Blind Treatment||6
2912868|NCT00492752|3622752|FG000|NOT COMPLETED|Double Blind Treatment||14
2912869|NCT00492752|3622753|FG001|NOT COMPLETED|Double Blind Treatment||0
2912870|NCT00492752|3622754|FG002|NOT COMPLETED|Double Blind Treatment||3
2912871|NCT00492752|3622755|FG003|NOT COMPLETED|Double Blind Treatment||0
2912872|NCT00492752|3622752|FG000|STARTED|Follow-up and/or Open Label Sorafenib||120
2912873|NCT00492752|3622753|FG001|STARTED|Follow-up and/or Open Label Sorafenib||16
2912874|NCT00492752|3622754|FG002|STARTED|Follow-up and/or Open Label Sorafenib||67
2912875|NCT00492752|3622755|FG003|STARTED|Follow-up and/or Open Label Sorafenib||6
2912876|NCT00492752|3622752|FG000|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Sorafenib||120
2912877|NCT00492752|3622753|FG001|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Sorafenib||0
2920638|NCT00537680|3631158|FG002|COMPLETED|Overall Study||24
2912878|NCT00492752|3622754|FG002|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Sorafenib||67
2912879|NCT00492752|3622755|FG003|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Sorafenib||0
2912880|NCT00492752|3622752|FG000|Follow-up First, Then Open Label|Follow-up and/or Open Label Sorafenib||0
2912881|NCT00492752|3622753|FG001|Follow-up First, Then Open Label|Follow-up and/or Open Label Sorafenib||16
2912882|NCT00492752|3622754|FG002|Follow-up First, Then Open Label|Follow-up and/or Open Label Sorafenib||0
2912883|NCT00492752|3622755|FG003|Follow-up First, Then Open Label|Follow-up and/or Open Label Sorafenib||6
2912884|NCT00492752|3622752|FG000|COMPLETED|Follow-up and/or Open Label Sorafenib|1 participant completed all assessments, 33 were followed up until the end of this trial|34
2912885|NCT00492752|3622753|FG001|COMPLETED|Follow-up and/or Open Label Sorafenib||0
2912886|NCT00492752|3622754|FG002|COMPLETED|Follow-up and/or Open Label Sorafenib|20 participants were followed up until the end of this trial|20
2912887|NCT00492752|3622755|FG003|COMPLETED|Follow-up and/or Open Label Sorafenib||0
2912888|NCT00492752|3622752|FG000|NOT COMPLETED|Follow-up and/or Open Label Sorafenib||86
2912889|NCT00492752|3622753|FG001|NOT COMPLETED|Follow-up and/or Open Label Sorafenib||16
2912890|NCT00492752|3622754|FG002|NOT COMPLETED|Follow-up and/or Open Label Sorafenib||47
2912891|NCT00492752|3622755|FG003|NOT COMPLETED|Follow-up and/or Open Label Sorafenib||6
2912892|NCT00492856|3622762|FG000|STARTED|Induction||105
2912893|NCT00492856|3622763|FG001|STARTED|Induction||0
2912894|NCT00492856|3622764|FG002|STARTED|Induction||0
2912895|NCT00492856|3622765|FG003|STARTED|Induction||0
2912896|NCT00492856|3622762|FG000|COMPLETED|Induction||99
2912897|NCT00492856|3622763|FG001|COMPLETED|Induction||0
2912898|NCT00492856|3622764|FG002|COMPLETED|Induction||0
2912899|NCT00492856|3622765|FG003|COMPLETED|Induction||0
2912900|NCT00492856|3622762|FG000|NOT COMPLETED|Induction||6
2912901|NCT00492856|3622763|FG001|NOT COMPLETED|Induction||0
2912902|NCT00492856|3622764|FG002|NOT COMPLETED|Induction||0
2912903|NCT00492856|3622765|FG003|NOT COMPLETED|Induction||0
2912904|NCT00492856|3622762|FG000|STARTED|Consolidation|Patients in CR (CRm), CRi, or PR after induction, register for consolidation and are eligible.|92
2912905|NCT00492856|3622763|FG001|STARTED|Consolidation||0
2912906|NCT00492856|3622764|FG002|STARTED|Consolidation||0
2912907|NCT00492856|3622765|FG003|STARTED|Consolidation||0
2912908|NCT00492856|3622762|FG000|COMPLETED|Consolidation||83
2912909|NCT00492856|3622763|FG001|COMPLETED|Consolidation||0
2912910|NCT00492856|3622764|FG002|COMPLETED|Consolidation||0
2912911|NCT00492856|3622765|FG003|COMPLETED|Consolidation||0
2912912|NCT00492856|3622762|FG000|NOT COMPLETED|Consolidation||9
2912913|NCT00492856|3622763|FG001|NOT COMPLETED|Consolidation||0
2912914|NCT00492856|3622764|FG002|NOT COMPLETED|Consolidation||0
2912915|NCT00492856|3622765|FG003|NOT COMPLETED|Consolidation||0
2912916|NCT00492856|3622762|FG000|STARTED|Post-consolidation|Patients who achieve CRm, are randomized to the treatment arm, and are eligible.|0
2912917|NCT00492856|3622763|FG001|STARTED|Post-consolidation||41
2912918|NCT00492856|3622764|FG002|STARTED|Post-consolidation||27
2912919|NCT00492856|3622765|FG003|STARTED|Post-consolidation||1
2912920|NCT00492856|3622762|FG000|COMPLETED|Post-consolidation||0
2912921|NCT00492856|3622763|FG001|COMPLETED|Post-consolidation||29
2912922|NCT00492856|3622764|FG002|COMPLETED|Post-consolidation||0
2912923|NCT00492856|3622765|FG003|COMPLETED|Post-consolidation||0
2912924|NCT00492856|3622762|FG000|NOT COMPLETED|Post-consolidation||0
2912925|NCT00492856|3622763|FG001|NOT COMPLETED|Post-consolidation||12
2912926|NCT00492856|3622764|FG002|NOT COMPLETED|Post-consolidation||27
2912927|NCT00492856|3622765|FG003|NOT COMPLETED|Post-consolidation||1
2912928|NCT00492921|3622777|FG000|STARTED|Overall Study||5
2912929|NCT00492921|3622778|FG001|STARTED|Overall Study||4
2912930|NCT00492921|3622779|FG002|STARTED|Overall Study||3
2912931|NCT00492921|3622777|FG000|COMPLETED|Overall Study||4
2912932|NCT00492921|3622778|FG001|COMPLETED|Overall Study||4
2912933|NCT00492921|3622779|FG002|COMPLETED|Overall Study||2
2912934|NCT00492921|3622777|FG000|NOT COMPLETED|Overall Study||1
2912935|NCT00492921|3622778|FG001|NOT COMPLETED|Overall Study||0
2912936|NCT00492921|3622779|FG002|NOT COMPLETED|Overall Study||1
2912937|NCT00492973|3622789|FG000|STARTED|Overall Study||37
2912938|NCT00492973|3622790|FG001|STARTED|Overall Study||39
2912939|NCT00492973|3622789|FG000|COMPLETED|Overall Study||37
2912940|NCT00492973|3622790|FG001|COMPLETED|Overall Study|One patient died of complications related to deep joint sepsis in the early postoperative period.|38
2912941|NCT00492973|3622789|FG000|NOT COMPLETED|Overall Study||0
2912942|NCT00492973|3622790|FG001|NOT COMPLETED|Overall Study||1
2912943|NCT00493012|3622798|FG000|STARTED|Overall Study||100
2912944|NCT00493012|3622799|FG001|STARTED|Overall Study||100
2912945|NCT00493012|3622798|FG000|COMPLETED|Overall Study||82
2912946|NCT00493012|3622799|FG001|COMPLETED|Overall Study||83
2912947|NCT00493012|3622798|FG000|NOT COMPLETED|Overall Study||18
2912948|NCT00493012|3622799|FG001|NOT COMPLETED|Overall Study||17
2912949|NCT00493038|3622807|FG000|STARTED|Treatment||147
2912950|NCT00493038|3622808|FG001|STARTED|Treatment||146
2912951|NCT00493038|3622807|FG000|Randomization|Treatment||147
2912952|NCT00493038|3622808|FG001|Randomization|Treatment||146
2912953|NCT00493038|3622807|FG000|Treated With Study Medication|Treatment||145
2912954|NCT00493038|3622808|FG001|Treated With Study Medication|Treatment||142
2912955|NCT00493038|3622807|FG000|Test-of-Cure Visit|Treatment||123
2912956|NCT00493038|3622808|FG001|Test-of-Cure Visit|Treatment||126
2912957|NCT00493038|3622807|FG000|COMPLETED|Treatment||123
3166481|NCT01904773|3893903|FG006|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
3166482|NCT01904773|3893904|FG007|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
3166483|NCT01904773|3893905|FG008|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
3166484|NCT01904773|3893897|FG000|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||20
2912958|NCT00493038|3622808|FG001|COMPLETED|Treatment||126
2912959|NCT00493038|3622807|FG000|NOT COMPLETED|Treatment||24
2912960|NCT00493038|3622808|FG001|NOT COMPLETED|Treatment||20
2912961|NCT00493038|3622807|FG000|STARTED|Follow-up||123
2912962|NCT00493038|3622808|FG001|STARTED|Follow-up||126
2912963|NCT00493038|3622807|FG000|COMPLETED|Follow-up||122
2912964|NCT00493038|3622808|FG001|COMPLETED|Follow-up||126
2912965|NCT00493038|3622807|FG000|NOT COMPLETED|Follow-up||1
2912966|NCT00493038|3622808|FG001|NOT COMPLETED|Follow-up||0
2912967|NCT00493064|3622814|FG000|STARTED|Overall Study||63
2912968|NCT00493064|3622814|FG000|COMPLETED|Overall Study||52
2912969|NCT00493064|3622814|FG000|NOT COMPLETED|Overall Study||11
2912970|NCT00493181|3622818|FG000|STARTED|Overall Study||8
2912971|NCT00493181|3622818|FG000|COMPLETED|Overall Study||8
2912972|NCT00493181|3622818|FG000|NOT COMPLETED|Overall Study||0
2912973|NCT00493220|3622828|FG000|STARTED|First Intervention||5
2912974|NCT00493220|3622829|FG001|STARTED|First Intervention||5
2912975|NCT00493220|3622830|FG002|STARTED|First Intervention||5
2912976|NCT00493220|3622831|FG003|STARTED|First Intervention||5
2912977|NCT00493220|3622832|FG004|STARTED|First Intervention||5
2912978|NCT00493220|3622833|FG005|STARTED|First Intervention||5
2912979|NCT00493220|3622828|FG000|COMPLETED|First Intervention||5
2912980|NCT00493220|3622829|FG001|COMPLETED|First Intervention||5
2912981|NCT00493220|3622830|FG002|COMPLETED|First Intervention||5
2912982|NCT00493220|3622831|FG003|COMPLETED|First Intervention||5
2912983|NCT00493220|3622832|FG004|COMPLETED|First Intervention||5
2912984|NCT00493220|3622833|FG005|COMPLETED|First Intervention||5
2912985|NCT00493220|3622828|FG000|NOT COMPLETED|First Intervention||0
2912986|NCT00493220|3622829|FG001|NOT COMPLETED|First Intervention||0
2912987|NCT00493220|3622830|FG002|NOT COMPLETED|First Intervention||0
2912988|NCT00493220|3622831|FG003|NOT COMPLETED|First Intervention||0
2912989|NCT00493220|3622832|FG004|NOT COMPLETED|First Intervention||0
3310215|NCT03038113|4043538|FG010|NOT COMPLETED|Overall Study||0
3310216|NCT03038113|4043539|FG011|NOT COMPLETED|Overall Study||0
3310217|NCT03038113|4043540|FG012|NOT COMPLETED|Overall Study||0
3310218|NCT03038113|4043541|FG013|NOT COMPLETED|Overall Study||1
3310219|NCT03038126|4043590|FG000|STARTED|Overall Study||63
3310220|NCT03038126|4043591|FG001|STARTED|Overall Study||55
3310221|NCT03038126|4043590|FG000|COMPLETED|Overall Study||54
3310222|NCT03038126|4043591|FG001|COMPLETED|Overall Study||51
2827330|NCT04446429|3528324|FG000|STARTED|Overall Study||134
2827331|NCT04446429|3528325|FG001|STARTED|Overall Study||134
2827332|NCT04446429|3528324|FG000|COMPLETED|Overall Study|In placebo group, 6 patients were lost to follow-up but were included in intention-to-treat analysis.|128
2827333|NCT04446429|3528325|FG001|COMPLETED|Overall Study||134
2827334|NCT04446429|3528324|FG000|NOT COMPLETED|Overall Study||6
2827335|NCT04446429|3528325|FG001|NOT COMPLETED|Overall Study||0
2827336|NCT04372017|3528335|FG000|STARTED|Overall Study||1
2827337|NCT04372017|3528336|FG001|STARTED|Overall Study||0
2827338|NCT04372017|3528337|FG002|STARTED|Overall Study||0
2827339|NCT04372017|3528338|FG003|STARTED|Overall Study||0
2827340|NCT04372017|3528335|FG000|COMPLETED|Overall Study||1
2827341|NCT04372017|3528336|FG001|COMPLETED|Overall Study||0
2827342|NCT04372017|3528337|FG002|COMPLETED|Overall Study||0
2827343|NCT04372017|3528338|FG003|COMPLETED|Overall Study||0
2827344|NCT04372017|3528335|FG000|NOT COMPLETED|Overall Study||0
2827345|NCT04372017|3528336|FG001|NOT COMPLETED|Overall Study||0
2827346|NCT04372017|3528337|FG002|NOT COMPLETED|Overall Study||0
2827347|NCT04372017|3528338|FG003|NOT COMPLETED|Overall Study||0
2827378|NCT03116685|3528393|FG000|STARTED|Overall Study||13
2827379|NCT03116685|3528394|FG001|STARTED|Overall Study||12
2827380|NCT03116685|3528393|FG000|COMPLETED|Overall Study||13
2827381|NCT03116685|3528394|FG001|COMPLETED|Overall Study||11
2827382|NCT03116685|3528393|FG000|NOT COMPLETED|Overall Study||0
2827383|NCT03116685|3528394|FG001|NOT COMPLETED|Overall Study||1
2827384|NCT03099304|3528405|FG000|STARTED|DB Period Day 1 to Week 24||32
2827385|NCT03099304|3528406|FG001|STARTED|DB Period Day 1 to Week 24||31
2827386|NCT03099304|3528407|FG002|STARTED|DB Period Day 1 to Week 24||31
2827387|NCT03099304|3528408|FG003|STARTED|DB Period Day 1 to Week 24||30
2827388|NCT03099304|3528409|FG004|STARTED|DB Period Day 1 to Week 24||33
2827389|NCT03099304|3528405|FG000|COMPLETED|DB Period Day 1 to Week 24||27
2827390|NCT03099304|3528406|FG001|COMPLETED|DB Period Day 1 to Week 24||26
2827391|NCT03099304|3528407|FG002|COMPLETED|DB Period Day 1 to Week 24||30
2827392|NCT03099304|3528408|FG003|COMPLETED|DB Period Day 1 to Week 24||26
2827393|NCT03099304|3528409|FG004|COMPLETED|DB Period Day 1 to Week 24||30
2827394|NCT03099304|3528405|FG000|NOT COMPLETED|DB Period Day 1 to Week 24||5
2827395|NCT03099304|3528406|FG001|NOT COMPLETED|DB Period Day 1 to Week 24||5
2827396|NCT03099304|3528407|FG002|NOT COMPLETED|DB Period Day 1 to Week 24||1
2827397|NCT03099304|3528408|FG003|NOT COMPLETED|DB Period Day 1 to Week 24||4
2827398|NCT03099304|3528409|FG004|NOT COMPLETED|DB Period Day 1 to Week 24||3
2827399|NCT03099304|3528405|FG000|STARTED|DB Period Weeks 24 to 52|Vehicle cream was not used after Week 24. After DB 24 week period, participants who met criteria were rerandomized to 1 of the 3 higher active blinded treatment groups.|0
2827400|NCT03099304|3528406|FG001|STARTED|DB Period Weeks 24 to 52|These subjects continued on the initial .15% QD treatment.|11
2827401|NCT03099304|3528407|FG002|STARTED|DB Period Weeks 24 to 52|Total participants include those initially randomized to 0.5% QD and those re-randomized from vehicle cream and .15% QD to 0.5% QD.|45
2827402|NCT03099304|3528408|FG003|STARTED|DB Period Weeks 24 to 52|Total participants include those initially randomized to 1.5% QD and those re-randomized from vehicle cream and .15% QD to 1.5% QD.|44
2827403|NCT03099304|3528409|FG004|STARTED|DB Period Weeks 24 to 52|Total participants include those initially randomized to 1.5% BID and those re-randomized from vehicle cream and .15% QD to 1.5% BID|47
2827404|NCT03099304|3528405|FG000|COMPLETED|DB Period Weeks 24 to 52||0
2827405|NCT03099304|3528406|FG001|COMPLETED|DB Period Weeks 24 to 52||10
2827406|NCT03099304|3528407|FG002|COMPLETED|DB Period Weeks 24 to 52||43
2827407|NCT03099304|3528408|FG003|COMPLETED|DB Period Weeks 24 to 52||37
2827408|NCT03099304|3528409|FG004|COMPLETED|DB Period Weeks 24 to 52||45
2827409|NCT03099304|3528405|FG000|NOT COMPLETED|DB Period Weeks 24 to 52||0
2827410|NCT03099304|3528406|FG001|NOT COMPLETED|DB Period Weeks 24 to 52||1
2827411|NCT03099304|3528407|FG002|NOT COMPLETED|DB Period Weeks 24 to 52||2
2827412|NCT03099304|3528408|FG003|NOT COMPLETED|DB Period Weeks 24 to 52||7
2827413|NCT03099304|3528409|FG004|NOT COMPLETED|DB Period Weeks 24 to 52||2
2827414|NCT03034863|3528430|FG000|STARTED|Overall Study||38
2827415|NCT03034863|3528431|FG001|STARTED|Overall Study||40
2827416|NCT03034863|3528430|FG000|Veterans|Overall Study||19
2827417|NCT03034863|3528431|FG001|Veterans|Overall Study||20
2827418|NCT03034863|3528430|FG000|Supporting Partners|Overall Study||19
2827419|NCT03034863|3528431|FG001|Supporting Partners|Overall Study||20
2827420|NCT03034863|3528430|FG000|COMPLETED|Overall Study||28
2827421|NCT03034863|3528431|FG001|COMPLETED|Overall Study||28
2827422|NCT03034863|3528430|FG000|NOT COMPLETED|Overall Study||10
2827423|NCT03034863|3528431|FG001|NOT COMPLETED|Overall Study||12
2827424|NCT02819050|3528444|FG000|STARTED|Overall Study||40
2827425|NCT02819050|3528445|FG001|STARTED|Overall Study||40
2827426|NCT02819050|3528444|FG000|COMPLETED|Overall Study||40
2827427|NCT02819050|3528445|FG001|COMPLETED|Overall Study||40
2827428|NCT02819050|3528444|FG000|NOT COMPLETED|Overall Study||0
2827429|NCT02819050|3528445|FG001|NOT COMPLETED|Overall Study||0
2827430|NCT02682901|3528455|FG000|STARTED|Overall Study||43
2827431|NCT02682901|3528456|FG001|STARTED|Overall Study||41
2827432|NCT02682901|3528455|FG000|Completed 4 Weeks|Overall Study||38
2827433|NCT02682901|3528456|FG001|Completed 4 Weeks|Overall Study||39
2827434|NCT02682901|3528455|FG000|Completed 12 Weeks|Overall Study||36
2827435|NCT02682901|3528456|FG001|Completed 12 Weeks|Overall Study||37
2827436|NCT02682901|3528455|FG000|COMPLETED|Overall Study||33
2827437|NCT02682901|3528456|FG001|COMPLETED|Overall Study||37
2827438|NCT02682901|3528455|FG000|NOT COMPLETED|Overall Study||10
2827439|NCT02682901|3528456|FG001|NOT COMPLETED|Overall Study||4
2827348|NCT04194528|3528348|FG000|STARTED|Overall Study||2
2827349|NCT04194528|3528348|FG000|COMPLETED|Overall Study||1
2827350|NCT04194528|3528348|FG000|NOT COMPLETED|Overall Study||1
2827351|NCT04147650|3528356|FG000|STARTED|Overall Study||127
2827352|NCT04147650|3528357|FG001|STARTED|Overall Study||126
2827353|NCT04147650|3528358|FG002|STARTED|Overall Study||128
2827354|NCT04147650|3528359|FG003|STARTED|Overall Study||127
2827355|NCT04147650|3528356|FG000|Modified Intent to Treat (mITT)|Overall Study||120
2827356|NCT04147650|3528357|FG001|Modified Intent to Treat (mITT)|Overall Study||119
2827357|NCT04147650|3528358|FG002|Modified Intent to Treat (mITT)|Overall Study||122
2827358|NCT04147650|3528359|FG003|Modified Intent to Treat (mITT)|Overall Study||121
2827359|NCT04147650|3528356|FG000|COMPLETED|Overall Study||116
2827360|NCT04147650|3528357|FG001|COMPLETED|Overall Study||107
2827361|NCT04147650|3528358|FG002|COMPLETED|Overall Study||121
2827362|NCT04147650|3528359|FG003|COMPLETED|Overall Study||120
2827363|NCT04147650|3528356|FG000|NOT COMPLETED|Overall Study||11
2827364|NCT04147650|3528357|FG001|NOT COMPLETED|Overall Study||19
2827365|NCT04147650|3528358|FG002|NOT COMPLETED|Overall Study||7
2827366|NCT04147650|3528359|FG003|NOT COMPLETED|Overall Study||7
2827367|NCT03907540|3528369|FG000|STARTED|Overall Study||5
2827368|NCT03907540|3528369|FG000|Completed Part 1|Overall Study||5
2827369|NCT03907540|3528369|FG000|Completed Part 2|Overall Study||5
2827370|NCT03907540|3528369|FG000|COMPLETED|Overall Study||5
2827371|NCT03907540|3528369|FG000|NOT COMPLETED|Overall Study||0
2827372|NCT03527238|3528384|FG000|STARTED|Overall Study||31
2827373|NCT03527238|3528385|FG001|STARTED|Overall Study||31
2827374|NCT03527238|3528384|FG000|COMPLETED|Overall Study||29
2827375|NCT03527238|3528385|FG001|COMPLETED|Overall Study||27
2827376|NCT03527238|3528384|FG000|NOT COMPLETED|Overall Study||2
2827377|NCT03527238|3528385|FG001|NOT COMPLETED|Overall Study||4
2827440|NCT02567825|3528464|FG000|STARTED|Overall Study||129
2827441|NCT02567825|3528465|FG001|STARTED|Overall Study||121
2827442|NCT02567825|3528464|FG000|COMPLETED|Overall Study||108
2827443|NCT02567825|3528465|FG001|COMPLETED|Overall Study||100
2827444|NCT02567825|3528464|FG000|NOT COMPLETED|Overall Study||21
2827445|NCT02567825|3528465|FG001|NOT COMPLETED|Overall Study||21
2827446|NCT02555657|3528473|FG000|STARTED|Overall Study||312
2827447|NCT02555657|3528474|FG001|STARTED|Overall Study||310
2827448|NCT02555657|3528473|FG000|Treated|Overall Study||309
2827449|NCT02555657|3528474|FG001|Treated|Overall Study||292
2827450|NCT02555657|3528473|FG000|COMPLETED|Overall Study||0
2827451|NCT02555657|3528474|FG001|COMPLETED|Overall Study||0
2827452|NCT02555657|3528473|FG000|NOT COMPLETED|Overall Study||312
2827453|NCT02555657|3528474|FG001|NOT COMPLETED|Overall Study||310
2827454|NCT02328014|3528485|FG000|STARTED|Overall Study||6
2827455|NCT02328014|3528486|FG001|STARTED|Overall Study||6
2827456|NCT02328014|3528487|FG002|STARTED|Overall Study||6
2827457|NCT02328014|3528488|FG003|STARTED|Overall Study||22
2827458|NCT02328014|3528485|FG000|COMPLETED|Overall Study||0
2827459|NCT02328014|3528486|FG001|COMPLETED|Overall Study||0
2827460|NCT02328014|3528487|FG002|COMPLETED|Overall Study||0
2827461|NCT02328014|3528488|FG003|COMPLETED|Overall Study||0
2827462|NCT02328014|3528485|FG000|NOT COMPLETED|Overall Study||6
2827463|NCT02328014|3528486|FG001|NOT COMPLETED|Overall Study||6
2827464|NCT02328014|3528487|FG002|NOT COMPLETED|Overall Study||6
2827465|NCT02328014|3528488|FG003|NOT COMPLETED|Overall Study||22
2827466|NCT02190721|3528501|FG000|STARTED|Overall Study||2
2827467|NCT02190721|3528502|FG001|STARTED|Overall Study||30
2827468|NCT02190721|3528503|FG002|STARTED|Overall Study||18
2827469|NCT02190721|3528501|FG000|Completed Treatment|Overall Study||2
2827470|NCT02190721|3528502|FG001|Completed Treatment|Overall Study||30
2827471|NCT02190721|3528503|FG002|Completed Treatment|Overall Study||18
2827472|NCT02190721|3528501|FG000|Completed 30 Day Follow-up|Overall Study||2
2827473|NCT02190721|3528502|FG001|Completed 30 Day Follow-up|Overall Study||29
2827474|NCT02190721|3528503|FG002|Completed 30 Day Follow-up|Overall Study||18
2827475|NCT02190721|3528501|FG000|Completed 90 Day Follow-up|Overall Study||2
2827476|NCT02190721|3528502|FG001|Completed 90 Day Follow-up|Overall Study||29
2827477|NCT02190721|3528503|FG002|Completed 90 Day Follow-up|Overall Study||18
2827478|NCT02190721|3528501|FG000|COMPLETED|Overall Study||2
2827479|NCT02190721|3528502|FG001|COMPLETED|Overall Study||29
2827480|NCT02190721|3528503|FG002|COMPLETED|Overall Study||18
2827481|NCT02190721|3528501|FG000|NOT COMPLETED|Overall Study||0
2827482|NCT02190721|3528502|FG001|NOT COMPLETED|Overall Study||1
2827483|NCT02190721|3528503|FG002|NOT COMPLETED|Overall Study||0
2827484|NCT00908687|3528517|FG000|STARTED|Overall Study||50
2827485|NCT00908687|3528518|FG001|STARTED|Overall Study||100
2827486|NCT00908687|3528519|FG002|STARTED|Overall Study||102
2827487|NCT00908687|3528520|FG003|STARTED|Overall Study||50
2827488|NCT00908687|3528521|FG004|STARTED|Overall Study||98
2827489|NCT00908687|3528522|FG005|STARTED|Overall Study||100
2827490|NCT00908687|3528517|FG000|COMPLETED|Overall Study||49
2827491|NCT00908687|3528518|FG001|COMPLETED|Overall Study||99
2827492|NCT00908687|3528519|FG002|COMPLETED|Overall Study||99
2827493|NCT00908687|3528520|FG003|COMPLETED|Overall Study||47
2827494|NCT00908687|3528521|FG004|COMPLETED|Overall Study||94
2827495|NCT00908687|3528522|FG005|COMPLETED|Overall Study||94
2827496|NCT00908687|3528517|FG000|NOT COMPLETED|Overall Study||1
2827497|NCT00908687|3528518|FG001|NOT COMPLETED|Overall Study||1
2827498|NCT00908687|3528519|FG002|NOT COMPLETED|Overall Study||3
2827499|NCT00908687|3528520|FG003|NOT COMPLETED|Overall Study||3
2827500|NCT00908687|3528521|FG004|NOT COMPLETED|Overall Study||4
2827501|NCT00908687|3528522|FG005|NOT COMPLETED|Overall Study||6
2827502|NCT00739401|3528536|FG000|STARTED|Overall Study||44
2827503|NCT00739401|3528536|FG000|COMPLETED|Overall Study||3
2827504|NCT00739401|3528536|FG000|NOT COMPLETED|Overall Study||41
2912990|NCT00493220|3622833|FG005|NOT COMPLETED|First Intervention||0
2912991|NCT00493220|3622828|FG000|STARTED|First 7-Day Washout & Safety Follow-up||5
2912992|NCT00493220|3622829|FG001|STARTED|First 7-Day Washout & Safety Follow-up||5
2912993|NCT00493220|3622830|FG002|STARTED|First 7-Day Washout & Safety Follow-up||5
3166485|NCT01904773|3893898|FG001|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
3166486|NCT01904773|3893899|FG002|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
3166487|NCT01904773|3893900|FG003|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
3166488|NCT01904773|3893901|FG004|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
2912994|NCT00493220|3622831|FG003|STARTED|First 7-Day Washout & Safety Follow-up||5
2912995|NCT00493220|3622832|FG004|STARTED|First 7-Day Washout & Safety Follow-up||5
2912996|NCT00493220|3622833|FG005|STARTED|First 7-Day Washout & Safety Follow-up||5
2912997|NCT00493220|3622828|FG000|COMPLETED|First 7-Day Washout & Safety Follow-up||5
2912998|NCT00493220|3622829|FG001|COMPLETED|First 7-Day Washout & Safety Follow-up||5
2912999|NCT00493220|3622830|FG002|COMPLETED|First 7-Day Washout & Safety Follow-up||5
2913000|NCT00493220|3622831|FG003|COMPLETED|First 7-Day Washout & Safety Follow-up||5
2913001|NCT00493220|3622832|FG004|COMPLETED|First 7-Day Washout & Safety Follow-up||5
2913002|NCT00493220|3622833|FG005|COMPLETED|First 7-Day Washout & Safety Follow-up||5
2913003|NCT00493220|3622828|FG000|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
2913004|NCT00493220|3622829|FG001|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
2913005|NCT00493220|3622830|FG002|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
2913006|NCT00493220|3622831|FG003|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
2913007|NCT00493220|3622832|FG004|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
2913008|NCT00493220|3622833|FG005|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
2913009|NCT00493220|3622828|FG000|STARTED|Second Intervention||5
2913010|NCT00493220|3622829|FG001|STARTED|Second Intervention||5
2913011|NCT00493220|3622830|FG002|STARTED|Second Intervention||5
2913012|NCT00493220|3622831|FG003|STARTED|Second Intervention||5
2913013|NCT00493220|3622832|FG004|STARTED|Second Intervention||5
2913014|NCT00493220|3622833|FG005|STARTED|Second Intervention||5
2913015|NCT00493220|3622828|FG000|COMPLETED|Second Intervention||5
2913016|NCT00493220|3622829|FG001|COMPLETED|Second Intervention||5
2913017|NCT00493220|3622830|FG002|COMPLETED|Second Intervention||5
2913018|NCT00493220|3622831|FG003|COMPLETED|Second Intervention||5
2913019|NCT00493220|3622832|FG004|COMPLETED|Second Intervention||5
2913020|NCT00493220|3622833|FG005|COMPLETED|Second Intervention||5
2913021|NCT00493220|3622828|FG000|NOT COMPLETED|Second Intervention||0
2913022|NCT00493220|3622829|FG001|NOT COMPLETED|Second Intervention||0
2913023|NCT00493220|3622830|FG002|NOT COMPLETED|Second Intervention||0
2913024|NCT00493220|3622831|FG003|NOT COMPLETED|Second Intervention||0
2913025|NCT00493220|3622832|FG004|NOT COMPLETED|Second Intervention||0
2913026|NCT00493220|3622833|FG005|NOT COMPLETED|Second Intervention||0
2913027|NCT00493220|3622828|FG000|STARTED|Second 7-Day Washout & Safety Follow-up||5
2913028|NCT00493220|3622829|FG001|STARTED|Second 7-Day Washout & Safety Follow-up||5
2913029|NCT00493220|3622830|FG002|STARTED|Second 7-Day Washout & Safety Follow-up||5
2913030|NCT00493220|3622831|FG003|STARTED|Second 7-Day Washout & Safety Follow-up||5
2913031|NCT00493220|3622832|FG004|STARTED|Second 7-Day Washout & Safety Follow-up||5
2913032|NCT00493220|3622833|FG005|STARTED|Second 7-Day Washout & Safety Follow-up||5
2913033|NCT00493220|3622828|FG000|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
2913034|NCT00493220|3622829|FG001|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
2913035|NCT00493220|3622830|FG002|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
2913036|NCT00493220|3622831|FG003|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
2913037|NCT00493220|3622832|FG004|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
2913038|NCT00493220|3622833|FG005|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
2913039|NCT00493220|3622828|FG000|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
2913040|NCT00493220|3622829|FG001|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
2913041|NCT00493220|3622830|FG002|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
2913042|NCT00493220|3622831|FG003|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
2913043|NCT00493220|3622832|FG004|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
2913044|NCT00493220|3622833|FG005|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
2913045|NCT00493220|3622828|FG000|STARTED|Third Intervention||5
2913046|NCT00493220|3622829|FG001|STARTED|Third Intervention||5
2913047|NCT00493220|3622830|FG002|STARTED|Third Intervention||5
2913048|NCT00493220|3622831|FG003|STARTED|Third Intervention||5
2913049|NCT00493220|3622832|FG004|STARTED|Third Intervention||5
2913050|NCT00493220|3622833|FG005|STARTED|Third Intervention||5
2913051|NCT00493220|3622828|FG000|COMPLETED|Third Intervention||4
2913052|NCT00493220|3622829|FG001|COMPLETED|Third Intervention||5
2913053|NCT00493220|3622830|FG002|COMPLETED|Third Intervention||5
2913054|NCT00493220|3622831|FG003|COMPLETED|Third Intervention||5
2913055|NCT00493220|3622832|FG004|COMPLETED|Third Intervention||5
2913056|NCT00493220|3622833|FG005|COMPLETED|Third Intervention||5
2913057|NCT00493220|3622828|FG000|NOT COMPLETED|Third Intervention||1
2913058|NCT00493220|3622829|FG001|NOT COMPLETED|Third Intervention||0
2913059|NCT00493220|3622830|FG002|NOT COMPLETED|Third Intervention||0
2913060|NCT00493220|3622831|FG003|NOT COMPLETED|Third Intervention||0
2827505|NCT00651742|3528540|FG000|STARTED|Overall Study||28
2827506|NCT00651742|3528540|FG000|Treated|Overall Study||27
2827507|NCT00651742|3528540|FG000|Efficacy Analysis Per Investigator|Overall Study||21
2827508|NCT00651742|3528540|FG000|Efficacy Analysis Per Independent Reader|Overall Study||25
2827509|NCT00651742|3528540|FG000|COMPLETED|Overall Study||0
2827510|NCT00651742|3528540|FG000|NOT COMPLETED|Overall Study||28
2827511|NCT00308516|3528546|FG000|STARTED|Overall Study||35
2827512|NCT00308516|3528547|FG001|STARTED|Overall Study||31
2827513|NCT00308516|3528546|FG000|COMPLETED|Overall Study||6
2827514|NCT00308516|3528547|FG001|COMPLETED|Overall Study||10
2827515|NCT00308516|3528546|FG000|NOT COMPLETED|Overall Study||29
2827516|NCT00308516|3528547|FG001|NOT COMPLETED|Overall Study||21
2827517|NCT04331366|3528553|FG000|STARTED|Overall Study||2
2827518|NCT04331366|3528553|FG000|COMPLETED|Overall Study||2
2827519|NCT04331366|3528553|FG000|NOT COMPLETED|Overall Study||0
2827520|NCT04930263|3528559|FG000|STARTED|Overall Study||33
2827521|NCT04930263|3528560|FG001|STARTED|Overall Study||33
2827522|NCT04930263|3528559|FG000|COMPLETED|Overall Study||30
2827523|NCT04930263|3528560|FG001|COMPLETED|Overall Study||28
2827524|NCT04930263|3528559|FG000|NOT COMPLETED|Overall Study||3
2827525|NCT04930263|3528560|FG001|NOT COMPLETED|Overall Study||5
2827526|NCT04524598|3528570|FG000|STARTED|Phase I - Feasibility||35
2827527|NCT04524598|3528571|FG001|STARTED|Phase I - Feasibility||25
2827528|NCT04524598|3528572|FG002|STARTED|Phase I - Feasibility||0
2827529|NCT04524598|3528573|FG003|STARTED|Phase I - Feasibility||0
2827530|NCT04524598|3528574|FG004|STARTED|Phase I - Feasibility||0
2827531|NCT04524598|3528570|FG000|COMPLETED|Phase I - Feasibility||31
2827532|NCT04524598|3528571|FG001|COMPLETED|Phase I - Feasibility||20
2827533|NCT04524598|3528572|FG002|COMPLETED|Phase I - Feasibility||0
2827534|NCT04524598|3528573|FG003|COMPLETED|Phase I - Feasibility||0
2827535|NCT04524598|3528574|FG004|COMPLETED|Phase I - Feasibility||0
2827536|NCT04524598|3528570|FG000|NOT COMPLETED|Phase I - Feasibility||4
2827537|NCT04524598|3528571|FG001|NOT COMPLETED|Phase I - Feasibility||5
2827538|NCT04524598|3528572|FG002|NOT COMPLETED|Phase I - Feasibility||0
2827539|NCT04524598|3528573|FG003|NOT COMPLETED|Phase I - Feasibility||0
2827540|NCT04524598|3528574|FG004|NOT COMPLETED|Phase I - Feasibility||0
2827541|NCT04524598|3528570|FG000|STARTED|Phase II - Outcomes||0
2827542|NCT04524598|3528571|FG001|STARTED|Phase II - Outcomes||0
2827543|NCT04524598|3528572|FG002|STARTED|Phase II - Outcomes||80
2827544|NCT04524598|3528573|FG003|STARTED|Phase II - Outcomes||80
2827545|NCT04524598|3528574|FG004|STARTED|Phase II - Outcomes||0
2827546|NCT04524598|3528570|FG000|Met PHQ-8 Threshold (Baseline >/= 10)|Phase II - Outcomes||0
2827547|NCT04524598|3528571|FG001|Met PHQ-8 Threshold (Baseline >/= 10)|Phase II - Outcomes||0
2827548|NCT04524598|3528572|FG002|Met PHQ-8 Threshold (Baseline >/= 10)|Phase II - Outcomes||63
2827549|NCT04524598|3528573|FG003|Met PHQ-8 Threshold (Baseline >/= 10)|Phase II - Outcomes||58
2827550|NCT04524598|3528574|FG004|Met PHQ-8 Threshold (Baseline >/= 10)|Phase II - Outcomes||0
2827551|NCT04524598|3528570|FG000|COMPLETED|Phase II - Outcomes||0
2827552|NCT04524598|3528571|FG001|COMPLETED|Phase II - Outcomes||0
2827553|NCT04524598|3528572|FG002|COMPLETED|Phase II - Outcomes||54
2827554|NCT04524598|3528573|FG003|COMPLETED|Phase II - Outcomes||67
2827555|NCT04524598|3528574|FG004|COMPLETED|Phase II - Outcomes||0
2827556|NCT04524598|3528570|FG000|NOT COMPLETED|Phase II - Outcomes||0
2827557|NCT04524598|3528571|FG001|NOT COMPLETED|Phase II - Outcomes||0
2827558|NCT04524598|3528572|FG002|NOT COMPLETED|Phase II - Outcomes||26
2827559|NCT04524598|3528573|FG003|NOT COMPLETED|Phase II - Outcomes||13
2827560|NCT04524598|3528574|FG004|NOT COMPLETED|Phase II - Outcomes||0
2827561|NCT04524598|3528570|FG000|STARTED|Phase II - Control Extension||0
2827562|NCT04524598|3528571|FG001|STARTED|Phase II - Control Extension||0
2827563|NCT04524598|3528572|FG002|STARTED|Phase II - Control Extension||0
2827564|NCT04524598|3528573|FG003|STARTED|Phase II - Control Extension||0
2827565|NCT04524598|3528574|FG004|STARTED|Phase II - Control Extension||66
2827566|NCT04524598|3528570|FG000|COMPLETED|Phase II - Control Extension||0
2827567|NCT04524598|3528571|FG001|COMPLETED|Phase II - Control Extension||0
2827568|NCT04524598|3528572|FG002|COMPLETED|Phase II - Control Extension||0
2827569|NCT04524598|3528573|FG003|COMPLETED|Phase II - Control Extension||0
2827570|NCT04524598|3528574|FG004|COMPLETED|Phase II - Control Extension||54
2827571|NCT04524598|3528570|FG000|NOT COMPLETED|Phase II - Control Extension||0
2827572|NCT04524598|3528571|FG001|NOT COMPLETED|Phase II - Control Extension||0
2827573|NCT04524598|3528572|FG002|NOT COMPLETED|Phase II - Control Extension||0
2827574|NCT04524598|3528573|FG003|NOT COMPLETED|Phase II - Control Extension||0
2827575|NCT04524598|3528574|FG004|NOT COMPLETED|Phase II - Control Extension||12
2827576|NCT04321252|3528597|FG000|STARTED|Overall Study||6
2827577|NCT04321252|3528598|FG001|STARTED|Overall Study||6
2827578|NCT04321252|3528599|FG002|STARTED|Overall Study||6
2827579|NCT04321252|3528600|FG003|STARTED|Overall Study||6
2827580|NCT04321252|3528601|FG004|STARTED|Overall Study||6
2827581|NCT04321252|3528602|FG005|STARTED|Overall Study||9
2827582|NCT04321252|3528603|FG006|STARTED|Overall Study||6
2827583|NCT04321252|3528604|FG007|STARTED|Overall Study||6
2827584|NCT04321252|3528605|FG008|STARTED|Overall Study||6
2827585|NCT04321252|3528597|FG000|PK Analysis Set|Overall Study||6
2827586|NCT04321252|3528598|FG001|PK Analysis Set|Overall Study||6
2827587|NCT04321252|3528599|FG002|PK Analysis Set|Overall Study||6
2827588|NCT04321252|3528600|FG003|PK Analysis Set|Overall Study||6
2827589|NCT04321252|3528601|FG004|PK Analysis Set|Overall Study||6
2827590|NCT04321252|3528602|FG005|PK Analysis Set|Overall Study||0
2827591|NCT04321252|3528603|FG006|PK Analysis Set|Overall Study||6
2827592|NCT04321252|3528604|FG007|PK Analysis Set|Overall Study||6
2827593|NCT04321252|3528605|FG008|PK Analysis Set|Overall Study||0
2827594|NCT04321252|3528597|FG000|COMPLETED|Overall Study||6
2827595|NCT04321252|3528598|FG001|COMPLETED|Overall Study||6
2827596|NCT04321252|3528599|FG002|COMPLETED|Overall Study||6
2827597|NCT04321252|3528600|FG003|COMPLETED|Overall Study||6
2827598|NCT04321252|3528601|FG004|COMPLETED|Overall Study||6
2827599|NCT04321252|3528602|FG005|COMPLETED|Overall Study||8
2827600|NCT04321252|3528603|FG006|COMPLETED|Overall Study||6
2827601|NCT04321252|3528604|FG007|COMPLETED|Overall Study||6
2827602|NCT04321252|3528605|FG008|COMPLETED|Overall Study||6
2827603|NCT04321252|3528597|FG000|NOT COMPLETED|Overall Study||0
2827604|NCT04321252|3528598|FG001|NOT COMPLETED|Overall Study||0
2827605|NCT04321252|3528599|FG002|NOT COMPLETED|Overall Study||0
2827606|NCT04321252|3528600|FG003|NOT COMPLETED|Overall Study||0
2827607|NCT04321252|3528601|FG004|NOT COMPLETED|Overall Study||0
2827608|NCT04321252|3528602|FG005|NOT COMPLETED|Overall Study||1
2827609|NCT04321252|3528603|FG006|NOT COMPLETED|Overall Study||0
2827610|NCT04321252|3528604|FG007|NOT COMPLETED|Overall Study||0
2827611|NCT04321252|3528605|FG008|NOT COMPLETED|Overall Study||0
2827612|NCT04285684|3528631|FG000|STARTED|Overall Study||4
2827613|NCT04285684|3528631|FG000|COMPLETED|Overall Study||4
2827614|NCT04285684|3528631|FG000|NOT COMPLETED|Overall Study||0
2827615|NCT04176445|3528635|FG000|STARTED|Overall Study||12
2827616|NCT04176445|3528636|FG001|STARTED|Overall Study||7
2827617|NCT04176445|3528635|FG000|COMPLETED|Overall Study||12
2827618|NCT04176445|3528636|FG001|COMPLETED|Overall Study||5
2827619|NCT04176445|3528635|FG000|NOT COMPLETED|Overall Study||0
2827620|NCT04176445|3528636|FG001|NOT COMPLETED|Overall Study||2
2827621|NCT04126213|3528648|FG000|STARTED|Overall Study||70
2827622|NCT04126213|3528649|FG001|STARTED|Overall Study||75
2827623|NCT04126213|3528650|FG002|STARTED|Overall Study||68
2827624|NCT04126213|3528651|FG003|STARTED|Overall Study||67
2827625|NCT04126213|3528652|FG004|STARTED|Overall Study||73
2827626|NCT04126213|3528653|FG005|STARTED|Overall Study||66
2827627|NCT04126213|3528648|FG000|COMPLETED|Overall Study||58
2827628|NCT04126213|3528649|FG001|COMPLETED|Overall Study||70
2827629|NCT04126213|3528650|FG002|COMPLETED|Overall Study||59
2827630|NCT04126213|3528651|FG003|COMPLETED|Overall Study||54
2827631|NCT04126213|3528652|FG004|COMPLETED|Overall Study||67
2827632|NCT04126213|3528653|FG005|COMPLETED|Overall Study||55
2827633|NCT04126213|3528648|FG000|NOT COMPLETED|Overall Study||12
2827634|NCT04126213|3528649|FG001|NOT COMPLETED|Overall Study||5
2827635|NCT04126213|3528650|FG002|NOT COMPLETED|Overall Study||9
2827636|NCT04126213|3528651|FG003|NOT COMPLETED|Overall Study||13
2827637|NCT04126213|3528652|FG004|NOT COMPLETED|Overall Study||6
2827638|NCT04126213|3528653|FG005|NOT COMPLETED|Overall Study||11
2827639|NCT03916458|3528670|FG000|STARTED|Overall Study||62
2827640|NCT03916458|3528670|FG000|COMPLETED|Overall Study|Out of these 62 participants, 2 participants died. But data available before censoring date for these 2 participants were observed and included in results.|62
2827641|NCT03916458|3528670|FG000|NOT COMPLETED|Overall Study||0
2827642|NCT03672188|3528689|FG000|STARTED|Overall Study||6
2827643|NCT03672188|3528690|FG001|STARTED|Overall Study||6
2827644|NCT03672188|3528691|FG002|STARTED|Overall Study||6
2827645|NCT03672188|3528692|FG003|STARTED|Overall Study||8
2827646|NCT03672188|3528693|FG004|STARTED|Overall Study||6
2827647|NCT03672188|3528694|FG005|STARTED|Overall Study||6
2827648|NCT03672188|3528695|FG006|STARTED|Overall Study||12
2827649|NCT03672188|3528696|FG007|STARTED|Overall Study||3
2827650|NCT03672188|3528697|FG008|STARTED|Overall Study||6
2827651|NCT03672188|3528698|FG009|STARTED|Overall Study||6
2827652|NCT03672188|3528699|FG010|STARTED|Overall Study||3
2827653|NCT03672188|3528700|FG011|STARTED|Overall Study||3
2827654|NCT03672188|3528701|FG012|STARTED|Overall Study||3
2827655|NCT03672188|3528702|FG013|STARTED|Overall Study||6
2827656|NCT03672188|3528703|FG014|STARTED|Overall Study||2
2827657|NCT03672188|3528689|FG000|Dosed|Overall Study||6
2827658|NCT03672188|3528690|FG001|Dosed|Overall Study||6
2827659|NCT03672188|3528691|FG002|Dosed|Overall Study||6
2827660|NCT03672188|3528692|FG003|Dosed|Overall Study|1 subject was not dosed and therefore not included in any analyses.|7
2827661|NCT03672188|3528693|FG004|Dosed|Overall Study||6
2827662|NCT03672188|3528694|FG005|Dosed|Overall Study||6
2827663|NCT03672188|3528695|FG006|Dosed|Overall Study||12
2827664|NCT03672188|3528696|FG007|Dosed|Overall Study||3
2827665|NCT03672188|3528697|FG008|Dosed|Overall Study||6
2827666|NCT03672188|3528698|FG009|Dosed|Overall Study||6
2827667|NCT03672188|3528699|FG010|Dosed|Overall Study||3
2827668|NCT03672188|3528700|FG011|Dosed|Overall Study||3
2827669|NCT03672188|3528701|FG012|Dosed|Overall Study||3
2827670|NCT03672188|3528702|FG013|Dosed|Overall Study||6
2827671|NCT03672188|3528703|FG014|Dosed|Overall Study||2
2827672|NCT03672188|3528689|FG000|COMPLETED|Overall Study||6
2827673|NCT03672188|3528690|FG001|COMPLETED|Overall Study||6
3166489|NCT01904773|3893902|FG005|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
3171819|NCT01937351|3899027|FG000|30-Day Follow-up|Overall Study||128
2827674|NCT03672188|3528691|FG002|COMPLETED|Overall Study|1 Subject could not attend last follow up (Week 12 visit)|5
2827675|NCT03672188|3528692|FG003|COMPLETED|Overall Study||5
2827676|NCT03672188|3528693|FG004|COMPLETED|Overall Study||6
2827677|NCT03672188|3528694|FG005|COMPLETED|Overall Study||6
2827678|NCT03672188|3528695|FG006|COMPLETED|Overall Study||12
2827679|NCT03672188|3528696|FG007|COMPLETED|Overall Study||3
3166490|NCT01904773|3893903|FG006|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
3166491|NCT01904773|3893904|FG007|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
3166492|NCT01904773|3893905|FG008|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
2827680|NCT03672188|3528697|FG008|COMPLETED|Overall Study||6
2827681|NCT03672188|3528698|FG009|COMPLETED|Overall Study||6
2827682|NCT03672188|3528699|FG010|COMPLETED|Overall Study||3
2827683|NCT03672188|3528700|FG011|COMPLETED|Overall Study||3
2827684|NCT03672188|3528701|FG012|COMPLETED|Overall Study|1 non-treatment related SAE of suicide during follow up period|2
2827685|NCT03672188|3528702|FG013|COMPLETED|Overall Study||6
2827686|NCT03672188|3528703|FG014|COMPLETED|Overall Study||2
2827687|NCT03672188|3528689|FG000|NOT COMPLETED|Overall Study||0
2827688|NCT03672188|3528690|FG001|NOT COMPLETED|Overall Study||0
2827689|NCT03672188|3528691|FG002|NOT COMPLETED|Overall Study||1
2827690|NCT03672188|3528692|FG003|NOT COMPLETED|Overall Study||3
2827691|NCT03672188|3528693|FG004|NOT COMPLETED|Overall Study||0
2827692|NCT03672188|3528694|FG005|NOT COMPLETED|Overall Study||0
2827693|NCT03672188|3528695|FG006|NOT COMPLETED|Overall Study||0
2827694|NCT03672188|3528696|FG007|NOT COMPLETED|Overall Study||0
2827695|NCT03672188|3528697|FG008|NOT COMPLETED|Overall Study||0
2827696|NCT03672188|3528698|FG009|NOT COMPLETED|Overall Study||0
2827697|NCT03672188|3528699|FG010|NOT COMPLETED|Overall Study||0
2827698|NCT03672188|3528700|FG011|NOT COMPLETED|Overall Study||0
2827699|NCT03672188|3528701|FG012|NOT COMPLETED|Overall Study||1
2827700|NCT03672188|3528702|FG013|NOT COMPLETED|Overall Study||0
2827701|NCT03672188|3528703|FG014|NOT COMPLETED|Overall Study||0
2827702|NCT03637959|3528769|FG000|STARTED|Overall Study||270
2827703|NCT03637959|3528769|FG000|COMPLETED|Overall Study||270
2827704|NCT03637959|3528769|FG000|NOT COMPLETED|Overall Study||0
2827705|NCT03573336|3528776|FG000|STARTED|Overall Study||2
2827706|NCT03573336|3528777|FG001|STARTED|Overall Study||4
2827707|NCT03573336|3528778|FG002|STARTED|Overall Study||2
2827708|NCT03573336|3528776|FG000|Treated|Overall Study||2
2827709|NCT03573336|3528777|FG001|Treated|Overall Study||4
2827710|NCT03573336|3528778|FG002|Treated|Overall Study||2
2827711|NCT03573336|3528776|FG000|COMPLETED|Overall Study||0
2827712|NCT03573336|3528777|FG001|COMPLETED|Overall Study||0
2827713|NCT03573336|3528778|FG002|COMPLETED|Overall Study||0
2827714|NCT03573336|3528776|FG000|NOT COMPLETED|Overall Study||2
2827715|NCT03573336|3528777|FG001|NOT COMPLETED|Overall Study||4
2827716|NCT03573336|3528778|FG002|NOT COMPLETED|Overall Study||2
2913061|NCT00493220|3622832|FG004|NOT COMPLETED|Third Intervention||0
2913062|NCT00493220|3622833|FG005|NOT COMPLETED|Third Intervention||0
2913063|NCT00493220|3622828|FG000|STARTED|Final 7-Day Safety Follow-up||4
2913064|NCT00493220|3622829|FG001|STARTED|Final 7-Day Safety Follow-up||5
2913065|NCT00493220|3622830|FG002|STARTED|Final 7-Day Safety Follow-up||5
2913066|NCT00493220|3622831|FG003|STARTED|Final 7-Day Safety Follow-up||5
2913067|NCT00493220|3622832|FG004|STARTED|Final 7-Day Safety Follow-up||5
2913068|NCT00493220|3622833|FG005|STARTED|Final 7-Day Safety Follow-up||5
2913069|NCT00493220|3622828|FG000|COMPLETED|Final 7-Day Safety Follow-up||4
2913070|NCT00493220|3622829|FG001|COMPLETED|Final 7-Day Safety Follow-up||5
2913071|NCT00493220|3622830|FG002|COMPLETED|Final 7-Day Safety Follow-up||5
2913072|NCT00493220|3622831|FG003|COMPLETED|Final 7-Day Safety Follow-up||5
2913073|NCT00493220|3622832|FG004|COMPLETED|Final 7-Day Safety Follow-up||5
2913074|NCT00493220|3622833|FG005|COMPLETED|Final 7-Day Safety Follow-up||5
2913075|NCT00493220|3622828|FG000|NOT COMPLETED|Final 7-Day Safety Follow-up||0
2913076|NCT00493220|3622829|FG001|NOT COMPLETED|Final 7-Day Safety Follow-up||0
2913077|NCT00493220|3622830|FG002|NOT COMPLETED|Final 7-Day Safety Follow-up||0
2913078|NCT00493220|3622831|FG003|NOT COMPLETED|Final 7-Day Safety Follow-up||0
2913079|NCT00493220|3622832|FG004|NOT COMPLETED|Final 7-Day Safety Follow-up||0
2913080|NCT00493220|3622833|FG005|NOT COMPLETED|Final 7-Day Safety Follow-up||0
2913081|NCT00493246|3622851|FG000|STARTED|Overall Study||2
2913082|NCT00493246|3622852|FG001|STARTED|Overall Study||1
2913083|NCT00493246|3622853|FG002|STARTED|Overall Study||12
2913084|NCT00493246|3622854|FG003|STARTED|Overall Study||13
2913085|NCT00493246|3622855|FG004|STARTED|Overall Study|All subjects who were randomized.Excludes 1 subject who was randomized in error.|9
2913086|NCT00493246|3622856|FG005|STARTED|Overall Study|All subjects who were randomized.|16
2913087|NCT00493246|3622857|FG006|STARTED|Overall Study|All subjects who were randomized.|12
2913088|NCT00493246|3622858|FG007|STARTED|Overall Study|All subjects who were randomized.|10
2913089|NCT00493246|3622851|FG000|COMPLETED|Overall Study|Completed study 30 days after the last dose|2
2913090|NCT00493246|3622852|FG001|COMPLETED|Overall Study|Completed study 30 days after the last dose|1
2913091|NCT00493246|3622853|FG002|COMPLETED|Overall Study|Completed study 30 days after the last dose|12
2913092|NCT00493246|3622854|FG003|COMPLETED|Overall Study|Completed study 30 days after the last dose|13
2913093|NCT00493246|3622855|FG004|COMPLETED|Overall Study|Completed study 30 days after the last dose|8
2913094|NCT00493246|3622856|FG005|COMPLETED|Overall Study|Completed study 30 days after the last dose|15
2913095|NCT00493246|3622857|FG006|COMPLETED|Overall Study|Completed study 30 days after the last dose|11
2913096|NCT00493246|3622858|FG007|COMPLETED|Overall Study|Completed study 30 days after the last dose|10
2913097|NCT00493246|3622851|FG000|NOT COMPLETED|Overall Study||0
2913098|NCT00493246|3622852|FG001|NOT COMPLETED|Overall Study||0
2913099|NCT00493246|3622853|FG002|NOT COMPLETED|Overall Study||0
2913100|NCT00493246|3622854|FG003|NOT COMPLETED|Overall Study||0
2913101|NCT00493246|3622855|FG004|NOT COMPLETED|Overall Study||1
2827717|NCT03230916|3528797|FG000|STARTED|Overall Study||7
2827718|NCT03230916|3528798|FG001|STARTED|Overall Study||6
2827719|NCT03230916|3528799|FG002|STARTED|Overall Study||6
2827720|NCT03230916|3528800|FG003|STARTED|Overall Study||4
2827721|NCT03230916|3528801|FG004|STARTED|Overall Study||4
2827722|NCT03230916|3528802|FG005|STARTED|Overall Study||6
2827723|NCT03230916|3528803|FG006|STARTED|Overall Study||3
2827724|NCT03230916|3528804|FG007|STARTED|Overall Study||2
2827725|NCT03230916|3528805|FG008|STARTED|Overall Study||2
2827726|NCT03230916|3528806|FG009|STARTED|Overall Study||3
2827727|NCT03230916|3528807|FG010|STARTED|Overall Study||4
2827728|NCT03230916|3528797|FG000|Treated|Overall Study||7
2827729|NCT03230916|3528798|FG001|Treated|Overall Study||6
2827730|NCT03230916|3528799|FG002|Treated|Overall Study||6
2827731|NCT03230916|3528800|FG003|Treated|Overall Study||4
2827732|NCT03230916|3528801|FG004|Treated|Overall Study||4
2827733|NCT03230916|3528802|FG005|Treated|Overall Study||5
2827734|NCT03230916|3528803|FG006|Treated|Overall Study||3
2827735|NCT03230916|3528804|FG007|Treated|Overall Study||2
2827736|NCT03230916|3528805|FG008|Treated|Overall Study||2
2827737|NCT03230916|3528806|FG009|Treated|Overall Study||3
2827738|NCT03230916|3528807|FG010|Treated|Overall Study||4
2827739|NCT03230916|3528797|FG000|COMPLETED|Overall Study||7
2827740|NCT03230916|3528798|FG001|COMPLETED|Overall Study||6
2827741|NCT03230916|3528799|FG002|COMPLETED|Overall Study||6
2827742|NCT03230916|3528800|FG003|COMPLETED|Overall Study||4
2827743|NCT03230916|3528801|FG004|COMPLETED|Overall Study||4
2827744|NCT03230916|3528802|FG005|COMPLETED|Overall Study||5
2827745|NCT03230916|3528803|FG006|COMPLETED|Overall Study||3
2827746|NCT03230916|3528804|FG007|COMPLETED|Overall Study||2
2827747|NCT03230916|3528805|FG008|COMPLETED|Overall Study||2
2827748|NCT03230916|3528806|FG009|COMPLETED|Overall Study||3
2827749|NCT03230916|3528807|FG010|COMPLETED|Overall Study||4
2827750|NCT03230916|3528797|FG000|NOT COMPLETED|Overall Study||0
2827751|NCT03230916|3528798|FG001|NOT COMPLETED|Overall Study||0
2827752|NCT03230916|3528799|FG002|NOT COMPLETED|Overall Study||0
2827753|NCT03230916|3528800|FG003|NOT COMPLETED|Overall Study||0
2827754|NCT03230916|3528801|FG004|NOT COMPLETED|Overall Study||0
2827755|NCT03230916|3528802|FG005|NOT COMPLETED|Overall Study||1
2827756|NCT03230916|3528803|FG006|NOT COMPLETED|Overall Study||0
3166493|NCT01904773|3893897|FG000|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||4
3166494|NCT01904773|3893898|FG001|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
3166495|NCT01904773|3893899|FG002|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
3166496|NCT01904773|3893900|FG003|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
3166497|NCT01904773|3893901|FG004|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
3166498|NCT01904773|3893902|FG005|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
3166499|NCT01904773|3893903|FG006|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
3171820|NCT01937351|3899028|FG001|30-Day Follow-up|Overall Study||27
2827757|NCT03230916|3528804|FG007|NOT COMPLETED|Overall Study||0
2827758|NCT03230916|3528805|FG008|NOT COMPLETED|Overall Study||0
2827759|NCT03230916|3528806|FG009|NOT COMPLETED|Overall Study||0
2827760|NCT03230916|3528807|FG010|NOT COMPLETED|Overall Study||0
2827761|NCT03195894|3528850|FG000|STARTED|Overall Study||59
2827762|NCT03195894|3528851|FG001|STARTED|Overall Study||56
2827763|NCT03195894|3528850|FG000|COMPLETED|Overall Study||26
2827764|NCT03195894|3528851|FG001|COMPLETED|Overall Study||28
2827765|NCT03195894|3528850|FG000|NOT COMPLETED|Overall Study||33
2827766|NCT03195894|3528851|FG001|NOT COMPLETED|Overall Study||28
2827767|NCT03032705|3528862|FG000|STARTED|Overall Study|"Number of participants are same (repeated) for both groups~unit = teeth"|51
2827768|NCT03032705|3528863|FG001|STARTED|Overall Study|"Number of participants are same (repeated) for both groups~unit = teeth"|51
2827769|NCT03032705|3528862|FG000|Completion of Restorations (V2)|Overall Study|"Number of participants are same (repeated) for both groups~unit = teeth"|45
2827770|NCT03032705|3528863|FG001|Completion of Restorations (V2)|Overall Study|"Number of participants are same (repeated) for both groups~unit = teeth"|45
2827771|NCT03032705|3528862|FG000|COMPLETED|Overall Study|"Number of participants are same (repeated) for both groups~unit = teeth"|29
2827772|NCT03032705|3528863|FG001|COMPLETED|Overall Study|"Number of participants are same (repeated) for both groups~unit = teeth"|28
2827773|NCT03032705|3528862|FG000|NOT COMPLETED|Overall Study||22
2827774|NCT03032705|3528863|FG001|NOT COMPLETED|Overall Study||23
2827775|NCT02573259|3528876|FG000|STARTED|Overall Study||2
2827776|NCT02573259|3528877|FG001|STARTED|Overall Study||8
2827777|NCT02573259|3528878|FG002|STARTED|Overall Study||8
2827778|NCT02573259|3528879|FG003|STARTED|Overall Study||7
2827779|NCT02573259|3528880|FG004|STARTED|Overall Study||15
2827780|NCT02573259|3528881|FG005|STARTED|Overall Study||68
2827781|NCT02573259|3528882|FG006|STARTED|Overall Study||39
2827782|NCT02573259|3528876|FG000|Treated|Overall Study||2
2827783|NCT02573259|3528877|FG001|Treated|Overall Study||8
2827784|NCT02573259|3528878|FG002|Treated|Overall Study||8
2827785|NCT02573259|3528879|FG003|Treated|Overall Study||7
2827786|NCT02573259|3528880|FG004|Treated|Overall Study||15
2827787|NCT02573259|3528881|FG005|Treated|Overall Study||68
2827788|NCT02573259|3528882|FG006|Treated|Overall Study||38
2827789|NCT02573259|3528876|FG000|COMPLETED|Overall Study||1
2827790|NCT02573259|3528877|FG001|COMPLETED|Overall Study||0
2827791|NCT02573259|3528878|FG002|COMPLETED|Overall Study||2
2827792|NCT02573259|3528879|FG003|COMPLETED|Overall Study||1
2827793|NCT02573259|3528880|FG004|COMPLETED|Overall Study||2
2827794|NCT02573259|3528881|FG005|COMPLETED|Overall Study||10
2827795|NCT02573259|3528882|FG006|COMPLETED|Overall Study||5
2827796|NCT02573259|3528876|FG000|NOT COMPLETED|Overall Study||1
2827797|NCT02573259|3528877|FG001|NOT COMPLETED|Overall Study||8
2827798|NCT02573259|3528878|FG002|NOT COMPLETED|Overall Study||6
2827799|NCT02573259|3528879|FG003|NOT COMPLETED|Overall Study||6
2827800|NCT02573259|3528880|FG004|NOT COMPLETED|Overall Study||13
2827801|NCT02573259|3528881|FG005|NOT COMPLETED|Overall Study||58
2827802|NCT02573259|3528882|FG006|NOT COMPLETED|Overall Study||34
2827803|NCT02318329|3528924|FG000|STARTED|Overall Study||3
2827804|NCT02318329|3528925|FG001|STARTED|Overall Study||4
2827805|NCT02318329|3528926|FG002|STARTED|Overall Study||3
2827806|NCT02318329|3528927|FG003|STARTED|Overall Study||3
2827807|NCT02318329|3528928|FG004|STARTED|Overall Study||3
2827808|NCT02318329|3528929|FG005|STARTED|Overall Study||3
2827809|NCT02318329|3528930|FG006|STARTED|Overall Study||1
2827810|NCT02318329|3528931|FG007|STARTED|Overall Study||1
2827811|NCT02318329|3528932|FG008|STARTED|Overall Study||6
2827812|NCT02318329|3528933|FG009|STARTED|Overall Study||52
2827813|NCT02318329|3528924|FG000|COMPLETED|Overall Study||0
2827814|NCT02318329|3528925|FG001|COMPLETED|Overall Study||0
2827815|NCT02318329|3528926|FG002|COMPLETED|Overall Study||0
2827816|NCT02318329|3528927|FG003|COMPLETED|Overall Study||0
2827817|NCT02318329|3528928|FG004|COMPLETED|Overall Study||0
2827818|NCT02318329|3528929|FG005|COMPLETED|Overall Study||0
2827819|NCT02318329|3528930|FG006|COMPLETED|Overall Study||0
2827820|NCT02318329|3528931|FG007|COMPLETED|Overall Study||0
2827821|NCT02318329|3528932|FG008|COMPLETED|Overall Study||0
2827822|NCT02318329|3528933|FG009|COMPLETED|Overall Study||0
2827823|NCT02318329|3528924|FG000|NOT COMPLETED|Overall Study||3
2827824|NCT02318329|3528925|FG001|NOT COMPLETED|Overall Study||4
2827825|NCT02318329|3528926|FG002|NOT COMPLETED|Overall Study||3
2827826|NCT02318329|3528927|FG003|NOT COMPLETED|Overall Study||3
2827827|NCT02318329|3528928|FG004|NOT COMPLETED|Overall Study||3
2827828|NCT02318329|3528929|FG005|NOT COMPLETED|Overall Study||3
2827829|NCT02318329|3528930|FG006|NOT COMPLETED|Overall Study||1
2827830|NCT02318329|3528931|FG007|NOT COMPLETED|Overall Study||1
2827831|NCT02318329|3528932|FG008|NOT COMPLETED|Overall Study||6
2827832|NCT02318329|3528933|FG009|NOT COMPLETED|Overall Study||52
2827833|NCT02097420|3528974|FG000|STARTED|Overall Study||20
2827834|NCT02097420|3528974|FG000|COMPLETED|Overall Study||6
2827835|NCT02097420|3528974|FG000|NOT COMPLETED|Overall Study||14
2827836|NCT01602666|3528980|FG000|STARTED|Induction Chemotherapy||107
2827837|NCT01602666|3528981|FG001|STARTED|Induction Chemotherapy||137
2827838|NCT01602666|3528980|FG000|COMPLETED|Induction Chemotherapy||70
2827839|NCT01602666|3528981|FG001|COMPLETED|Induction Chemotherapy||113
2827840|NCT01602666|3528980|FG000|NOT COMPLETED|Induction Chemotherapy||37
2827841|NCT01602666|3528981|FG001|NOT COMPLETED|Induction Chemotherapy||24
2827842|NCT01602666|3528980|FG000|STARTED|Radiation Therapy on Protocol||70
2827843|NCT01602666|3528981|FG001|STARTED|Radiation Therapy on Protocol||113
2827844|NCT01602666|3528980|FG000|Evaluable for Reduced Dose (30Gy)|Radiation Therapy on Protocol||66
2827845|NCT01602666|3528981|FG001|Evaluable for Reduced Dose (30Gy)|Radiation Therapy on Protocol||0
2827846|NCT01602666|3528980|FG000|Evaluable for Reduced Dose (18 Gy)|Radiation Therapy on Protocol||0
2827847|NCT01602666|3528981|FG001|Evaluable for Reduced Dose (18 Gy)|Radiation Therapy on Protocol||74
2827848|NCT01602666|3528980|FG000|Evaluable for RT Dose (24Gy)|Radiation Therapy on Protocol||0
2827849|NCT01602666|3528981|FG001|Evaluable for RT Dose (24Gy)|Radiation Therapy on Protocol||16
2827850|NCT01602666|3528980|FG000|COMPLETED|Radiation Therapy on Protocol||60
2827851|NCT01602666|3528981|FG001|COMPLETED|Radiation Therapy on Protocol||82
2827852|NCT01602666|3528980|FG000|NOT COMPLETED|Radiation Therapy on Protocol||10
2827853|NCT01602666|3528981|FG001|NOT COMPLETED|Radiation Therapy on Protocol||31
2827854|NCT01375959|3528991|FG000|STARTED|First Intervention (6 Weeks)||17
2827855|NCT01375959|3528992|FG001|STARTED|First Intervention (6 Weeks)||21
2827856|NCT01375959|3528991|FG000|Received Invertention|First Intervention (6 Weeks)||17
2827857|NCT01375959|3528992|FG001|Received Invertention|First Intervention (6 Weeks)||21
2827858|NCT01375959|3528991|FG000|COMPLETED|First Intervention (6 Weeks)|Two participants were withdrawn due to adverse events.|15
2827859|NCT01375959|3528992|FG001|COMPLETED|First Intervention (6 Weeks)|Three participants were withdrawn due to adverse events.|18
2827860|NCT01375959|3528991|FG000|NOT COMPLETED|First Intervention (6 Weeks)||2
2827861|NCT01375959|3528992|FG001|NOT COMPLETED|First Intervention (6 Weeks)||3
2827862|NCT01375959|3528991|FG000|STARTED|Wash-Out (3 Weeks)||15
2827863|NCT01375959|3528992|FG001|STARTED|Wash-Out (3 Weeks)||18
2827864|NCT01375959|3528991|FG000|COMPLETED|Wash-Out (3 Weeks)||15
2827865|NCT01375959|3528992|FG001|COMPLETED|Wash-Out (3 Weeks)||18
2827866|NCT01375959|3528991|FG000|NOT COMPLETED|Wash-Out (3 Weeks)||0
2827867|NCT01375959|3528992|FG001|NOT COMPLETED|Wash-Out (3 Weeks)||0
2827868|NCT01375959|3528991|FG000|STARTED|Second Intervention (6 Weeks)||15
2827869|NCT01375959|3528992|FG001|STARTED|Second Intervention (6 Weeks)||18
2827870|NCT01375959|3528991|FG000|COMPLETED|Second Intervention (6 Weeks)||15
2827871|NCT01375959|3528992|FG001|COMPLETED|Second Intervention (6 Weeks)||15
2827872|NCT01375959|3528991|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||0
2827873|NCT01375959|3528992|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||3
2827874|NCT01224106|3529003|FG000|STARTED|Double-Blind Treatment Phase||266
2827875|NCT01224106|3529004|FG001|STARTED|Double-Blind Treatment Phase||271
2827876|NCT01224106|3529005|FG002|STARTED|Double-Blind Treatment Phase||260
2827877|NCT01224106|3529006|FG003|STARTED|Double-Blind Treatment Phase||0
2827878|NCT01224106|3529007|FG004|STARTED|Double-Blind Treatment Phase||0
2827879|NCT01224106|3529003|FG000|COMPLETED|Double-Blind Treatment Phase||187
2827880|NCT01224106|3529004|FG001|COMPLETED|Double-Blind Treatment Phase||185
2827881|NCT01224106|3529005|FG002|COMPLETED|Double-Blind Treatment Phase||180
2827882|NCT01224106|3529006|FG003|COMPLETED|Double-Blind Treatment Phase||0
2827883|NCT01224106|3529007|FG004|COMPLETED|Double-Blind Treatment Phase||0
2827884|NCT01224106|3529003|FG000|NOT COMPLETED|Double-Blind Treatment Phase||79
2827885|NCT01224106|3529004|FG001|NOT COMPLETED|Double-Blind Treatment Phase||86
2827886|NCT01224106|3529005|FG002|NOT COMPLETED|Double-Blind Treatment Phase||80
2827887|NCT01224106|3529006|FG003|NOT COMPLETED|Double-Blind Treatment Phase||0
2827888|NCT01224106|3529007|FG004|NOT COMPLETED|Double-Blind Treatment Phase||0
2827889|NCT01224106|3529003|FG000|STARTED|Open-Label Extension (OLE) Phase||0
2827890|NCT01224106|3529004|FG001|STARTED|Open-Label Extension (OLE) Phase||0
2827891|NCT01224106|3529005|FG002|STARTED|Open-Label Extension (OLE) Phase||0
2827892|NCT01224106|3529006|FG003|STARTED|Open-Label Extension (OLE) Phase||49
2827893|NCT01224106|3529007|FG004|STARTED|Open-Label Extension (OLE) Phase||105
2827894|NCT01224106|3529003|FG000|COMPLETED|Open-Label Extension (OLE) Phase||0
2827895|NCT01224106|3529004|FG001|COMPLETED|Open-Label Extension (OLE) Phase||0
2827896|NCT01224106|3529005|FG002|COMPLETED|Open-Label Extension (OLE) Phase||0
2827897|NCT01224106|3529006|FG003|COMPLETED|Open-Label Extension (OLE) Phase||33
2827898|NCT01224106|3529007|FG004|COMPLETED|Open-Label Extension (OLE) Phase||71
2827899|NCT01224106|3529003|FG000|NOT COMPLETED|Open-Label Extension (OLE) Phase||0
2827900|NCT01224106|3529004|FG001|NOT COMPLETED|Open-Label Extension (OLE) Phase||0
2827901|NCT01224106|3529005|FG002|NOT COMPLETED|Open-Label Extension (OLE) Phase||0
2827902|NCT01224106|3529006|FG003|NOT COMPLETED|Open-Label Extension (OLE) Phase||16
2827903|NCT01224106|3529007|FG004|NOT COMPLETED|Open-Label Extension (OLE) Phase||34
2827904|NCT00999609|3529027|FG000|STARTED|Overall Study|Before intervention|21
2827905|NCT00999609|3529028|FG001|STARTED|Overall Study||10
2827906|NCT00999609|3529027|FG000|COMPLETED|Overall Study|1 year post intervention|20
2827907|NCT00999609|3529028|FG001|COMPLETED|Overall Study|1 year post intervention|9
2827908|NCT00999609|3529027|FG000|NOT COMPLETED|Overall Study||1
2827909|NCT00999609|3529028|FG001|NOT COMPLETED|Overall Study||1
2827910|NCT00567567|3529037|FG000|STARTED|Overall Study||210
2827911|NCT00567567|3529038|FG001|STARTED|Overall Study||176
2827912|NCT00567567|3529039|FG002|STARTED|Overall Study||279
2827913|NCT00567567|3529037|FG000|COMPLETED|Overall Study||58
2827914|NCT00567567|3529038|FG001|COMPLETED|Overall Study||42
2827915|NCT00567567|3529039|FG002|COMPLETED|Overall Study||1
2827916|NCT00567567|3529037|FG000|NOT COMPLETED|Overall Study||152
2827917|NCT00567567|3529038|FG001|NOT COMPLETED|Overall Study||134
2827918|NCT00567567|3529039|FG002|NOT COMPLETED|Overall Study||278
2827919|NCT00354835|3529051|FG000|STARTED|Overall Study||239
2827920|NCT00354835|3529052|FG001|STARTED|Overall Study||242
2827921|NCT00354835|3529051|FG000|COMPLETED|Overall Study||187
2827922|NCT00354835|3529052|FG001|COMPLETED|Overall Study||181
2827923|NCT00354835|3529051|FG000|NOT COMPLETED|Overall Study||52
2827924|NCT00354835|3529052|FG001|NOT COMPLETED|Overall Study||61
2913102|NCT00493246|3622856|FG005|NOT COMPLETED|Overall Study||1
2913103|NCT00493246|3622857|FG006|NOT COMPLETED|Overall Study||1
2913104|NCT00493246|3622858|FG007|NOT COMPLETED|Overall Study||0
2913105|NCT00493285|3622882|FG000|STARTED|Overall Study||13
2913106|NCT00493285|3622883|FG001|STARTED|Overall Study||6
2913107|NCT00493285|3622884|FG002|STARTED|Overall Study||9
2913108|NCT00493285|3622885|FG003|STARTED|Overall Study||6
2913109|NCT00493285|3622886|FG004|STARTED|Overall Study||10
2913110|NCT00493285|3622887|FG005|STARTED|Overall Study||5
2913111|NCT00493285|3622882|FG000|COMPLETED|Overall Study||13
2913112|NCT00493285|3622883|FG001|COMPLETED|Overall Study||6
2913113|NCT00493285|3622884|FG002|COMPLETED|Overall Study||9
2913114|NCT00493285|3622885|FG003|COMPLETED|Overall Study||6
2913115|NCT00493285|3622886|FG004|COMPLETED|Overall Study||9
2913116|NCT00493285|3622887|FG005|COMPLETED|Overall Study||5
2913117|NCT00493285|3622882|FG000|NOT COMPLETED|Overall Study||0
2913118|NCT00493285|3622883|FG001|NOT COMPLETED|Overall Study||0
2913119|NCT00493285|3622884|FG002|NOT COMPLETED|Overall Study||0
2913120|NCT00493285|3622885|FG003|NOT COMPLETED|Overall Study||0
2913121|NCT00493285|3622886|FG004|NOT COMPLETED|Overall Study||1
2913122|NCT00493285|3622887|FG005|NOT COMPLETED|Overall Study||0
2913123|NCT00493311|3622903|FG000|STARTED|Overall Study||29
2913124|NCT00493311|3622904|FG001|STARTED|Overall Study||31
2913125|NCT00493311|3622903|FG000|COMPLETED|Overall Study||27
2913126|NCT00493311|3622904|FG001|COMPLETED|Overall Study||29
2913127|NCT00493311|3622903|FG000|NOT COMPLETED|Overall Study||2
2913128|NCT00493311|3622904|FG001|NOT COMPLETED|Overall Study||2
2913129|NCT00493454|3622910|FG000|STARTED|Overall Study||6
2913130|NCT00493454|3622910|FG000|COMPLETED|Overall Study||5
2913131|NCT00493454|3622910|FG000|NOT COMPLETED|Overall Study||1
2913132|NCT00493467|3622914|FG000|STARTED|Overall Study||31
2913133|NCT00493467|3622914|FG000|COMPLETED|Overall Study||30
2913134|NCT00493467|3622914|FG000|NOT COMPLETED|Overall Study||1
2913135|NCT00493636|3622920|FG000|STARTED|Overall Study||81
2913136|NCT00493636|3622921|FG001|STARTED|Overall Study||79
2913137|NCT00493636|3622920|FG000|COMPLETED|Overall Study||79
2913138|NCT00493636|3622921|FG001|COMPLETED|Overall Study||77
2913139|NCT00493636|3622920|FG000|NOT COMPLETED|Overall Study||2
2913140|NCT00493636|3622921|FG001|NOT COMPLETED|Overall Study||2
2827925|NCT04531241|3529073|FG000|STARTED|Period 1||68
2827926|NCT04531241|3529074|FG001|STARTED|Period 1||67
2827927|NCT04531241|3529073|FG000|COMPLETED|Period 1||64
2827928|NCT04531241|3529074|FG001|COMPLETED|Period 1||65
2827929|NCT04531241|3529073|FG000|NOT COMPLETED|Period 1||4
2827930|NCT04531241|3529074|FG001|NOT COMPLETED|Period 1||2
2827931|NCT04531241|3529073|FG000|STARTED|Period 2||64
2827932|NCT04531241|3529074|FG001|STARTED|Period 2||65
2827933|NCT04531241|3529073|FG000|COMPLETED|Period 2||63
2827934|NCT04531241|3529074|FG001|COMPLETED|Period 2||64
2827935|NCT04531241|3529073|FG000|NOT COMPLETED|Period 2||1
2827936|NCT04531241|3529074|FG001|NOT COMPLETED|Period 2||1
2827937|NCT04456153|3529082|FG000|STARTED|Overall Study||19
2827938|NCT04456153|3529083|FG001|STARTED|Overall Study||41
2827939|NCT04456153|3529082|FG000|COMPLETED|Overall Study||19
2827940|NCT04456153|3529083|FG001|COMPLETED|Overall Study||41
2827941|NCT04456153|3529082|FG000|NOT COMPLETED|Overall Study||0
2827942|NCT04456153|3529083|FG001|NOT COMPLETED|Overall Study||0
2827943|NCT04351243|3529105|FG000|STARTED|Overall Study||114
2827944|NCT04351243|3529106|FG001|STARTED|Overall Study||113
2827945|NCT04351243|3529105|FG000|Completed Baseline Assessment|Overall Study||113
2827946|NCT04351243|3529106|FG001|Completed Baseline Assessment|Overall Study||112
2827947|NCT04351243|3529105|FG000|COMPLETED|Overall Study||74
2827948|NCT04351243|3529106|FG001|COMPLETED|Overall Study||75
2827949|NCT04351243|3529105|FG000|NOT COMPLETED|Overall Study||40
2827950|NCT04351243|3529106|FG001|NOT COMPLETED|Overall Study||38
2827972|NCT03600714|3529141|FG000|STARTED|Overall Study||26
2827973|NCT03600714|3529141|FG000|COMPLETED|Overall Study||25
2827974|NCT03600714|3529141|FG000|NOT COMPLETED|Overall Study||1
2827975|NCT03479307|3529148|FG000|STARTED|Overall Study||91
2827976|NCT03479307|3529149|FG001|STARTED|Overall Study||90
2827977|NCT03479307|3529150|FG002|STARTED|Overall Study||47
2827978|NCT03479307|3529148|FG000|COMPLETED|Overall Study||90
2827979|NCT03479307|3529149|FG001|COMPLETED|Overall Study||89
2827980|NCT03479307|3529150|FG002|COMPLETED|Overall Study||47
2827981|NCT03479307|3529148|FG000|NOT COMPLETED|Overall Study||1
2827982|NCT03479307|3529149|FG001|NOT COMPLETED|Overall Study||1
2827983|NCT03479307|3529150|FG002|NOT COMPLETED|Overall Study||0
2827984|NCT03470441|3529162|FG000|STARTED|Overall Study||29
2827985|NCT03470441|3529163|FG001|STARTED|Overall Study||31
2827986|NCT03470441|3529164|FG002|STARTED|Overall Study||31
2827987|NCT03470441|3529165|FG003|STARTED|Overall Study||29
2827988|NCT03470441|3529162|FG000|COMPLETED|Overall Study||28
2827989|NCT03470441|3529163|FG001|COMPLETED|Overall Study||26
2827990|NCT03470441|3529164|FG002|COMPLETED|Overall Study||29
2827991|NCT03470441|3529165|FG003|COMPLETED|Overall Study||25
2827992|NCT03470441|3529162|FG000|NOT COMPLETED|Overall Study||1
2827993|NCT03470441|3529163|FG001|NOT COMPLETED|Overall Study||5
2827994|NCT03470441|3529164|FG002|NOT COMPLETED|Overall Study||2
2827995|NCT03470441|3529165|FG003|NOT COMPLETED|Overall Study||4
2827996|NCT03452397|3529179|FG000|STARTED|Overall Study||41
2827997|NCT03452397|3529180|FG001|STARTED|Overall Study||41
2827998|NCT03452397|3529181|FG002|STARTED|Overall Study||41
2827999|NCT03452397|3529182|FG003|STARTED|Overall Study||42
2828000|NCT03452397|3529179|FG000|COMPLETED|Overall Study||40
2828001|NCT03452397|3529180|FG001|COMPLETED|Overall Study||41
2828002|NCT03452397|3529181|FG002|COMPLETED|Overall Study||39
2828003|NCT03452397|3529182|FG003|COMPLETED|Overall Study||41
2828004|NCT03452397|3529179|FG000|NOT COMPLETED|Overall Study||1
2828005|NCT03452397|3529180|FG001|NOT COMPLETED|Overall Study||0
2828006|NCT03452397|3529181|FG002|NOT COMPLETED|Overall Study||2
2828007|NCT03452397|3529182|FG003|NOT COMPLETED|Overall Study||1
2828008|NCT03448939|3529196|FG000|STARTED|Overall Study||243
2828009|NCT03448939|3529197|FG001|STARTED|Overall Study||118
2828010|NCT03448939|3529196|FG000|Received at Least 1 Dose of Study Drug|Overall Study||239
2828011|NCT03448939|3529197|FG001|Received at Least 1 Dose of Study Drug|Overall Study||113
2828012|NCT03448939|3529196|FG000|COMPLETED|Overall Study||222
2828013|NCT03448939|3529197|FG001|COMPLETED|Overall Study||107
2828014|NCT03448939|3529196|FG000|NOT COMPLETED|Overall Study||21
2828015|NCT03448939|3529197|FG001|NOT COMPLETED|Overall Study||11
2828016|NCT03410108|3529203|FG000|STARTED|Overall Study||104
2828017|NCT03410108|3529203|FG000|Safety Evaluation Lead-in Part|Overall Study||9
2828018|NCT03410108|3529203|FG000|Refractory Expansion Part: Main Cohort|Overall Study||47
2828019|NCT03410108|3529203|FG000|Refractory Expansion Part: Sub-Cohort|Overall Study||16
2828020|NCT03410108|3529203|FG000|Refractory Expansion Part|Overall Study||63
2828021|NCT03410108|3529203|FG000|All Refractory Participants|Overall Study||72
2828022|NCT03410108|3529203|FG000|TKI-Naive Expansion Cohort|Overall Study||32
2828023|NCT03410108|3529203|FG000|Completed|Overall Study||0
2828024|NCT03410108|3529203|FG000|COMPLETED|Overall Study||0
2828025|NCT03410108|3529203|FG000|NOT COMPLETED|Overall Study||104
2828026|NCT03377803|3529212|FG000|STARTED|Overall Study||150
2828027|NCT03377803|3529213|FG001|STARTED|Overall Study||112
2828028|NCT03377803|3529212|FG000|COMPLETED|Overall Study||139
2828029|NCT03377803|3529213|FG001|COMPLETED|Overall Study||108
2828030|NCT03377803|3529212|FG000|NOT COMPLETED|Overall Study||11
2828031|NCT03377803|3529213|FG001|NOT COMPLETED|Overall Study||4
2828032|NCT03283371|3529221|FG000|STARTED|Placebo-controlled||34
2828033|NCT03283371|3529222|FG001|STARTED|Placebo-controlled||33
2828034|NCT03283371|3529223|FG002|STARTED|Placebo-controlled||0
2828035|NCT03283371|3529224|FG003|STARTED|Placebo-controlled||0
2828036|NCT03283371|3529221|FG000|Number of Participants Dosed|Placebo-controlled||34
2827951|NCT04312256|3529112|FG000|STARTED|Overall Study||81
2827952|NCT04312256|3529112|FG000|COMPLETED|Overall Study||81
2827953|NCT04312256|3529112|FG000|NOT COMPLETED|Overall Study||0
2827954|NCT04185220|3529119|FG000|STARTED|Dose Escalation||3
2827955|NCT04185220|3529120|FG001|STARTED|Dose Escalation||3
2827956|NCT04185220|3529119|FG000|COMPLETED|Dose Escalation||3
2827957|NCT04185220|3529120|FG001|COMPLETED|Dose Escalation||1
2827958|NCT04185220|3529119|FG000|NOT COMPLETED|Dose Escalation||0
2827959|NCT04185220|3529120|FG001|NOT COMPLETED|Dose Escalation||2
2827960|NCT04185220|3529119|FG000|STARTED|Dose Expansion||0
3166500|NCT01904773|3893904|FG007|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
3166501|NCT01904773|3893905|FG008|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
3166502|NCT01904773|3893897|FG000|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||23
2827961|NCT04185220|3529120|FG001|STARTED|Dose Expansion||0
2827962|NCT04185220|3529119|FG000|COMPLETED|Dose Expansion||0
2827963|NCT04185220|3529120|FG001|COMPLETED|Dose Expansion||0
2827964|NCT04185220|3529119|FG000|NOT COMPLETED|Dose Expansion||0
2827965|NCT04185220|3529120|FG001|NOT COMPLETED|Dose Expansion||0
2827966|NCT03851107|3529127|FG000|STARTED|Overall Study||9
2827967|NCT03851107|3529127|FG000|COMPLETED|Overall Study||7
2827968|NCT03851107|3529127|FG000|NOT COMPLETED|Overall Study||2
2827969|NCT03815175|3529137|FG000|STARTED|Overall Study||1605
2827970|NCT03815175|3529137|FG000|COMPLETED|Overall Study||1439
2827971|NCT03815175|3529137|FG000|NOT COMPLETED|Overall Study||166
2828037|NCT03283371|3529222|FG001|Number of Participants Dosed|Placebo-controlled||32
2828038|NCT03283371|3529223|FG002|Number of Participants Dosed|Placebo-controlled||0
2828039|NCT03283371|3529224|FG003|Number of Participants Dosed|Placebo-controlled||0
2828040|NCT03283371|3529221|FG000|COMPLETED|Placebo-controlled||31
2828041|NCT03283371|3529222|FG001|COMPLETED|Placebo-controlled||30
2828042|NCT03283371|3529223|FG002|COMPLETED|Placebo-controlled||0
2828043|NCT03283371|3529224|FG003|COMPLETED|Placebo-controlled||0
2828044|NCT03283371|3529221|FG000|NOT COMPLETED|Placebo-controlled||3
2828045|NCT03283371|3529222|FG001|NOT COMPLETED|Placebo-controlled||3
2828046|NCT03283371|3529223|FG002|NOT COMPLETED|Placebo-controlled||0
2828047|NCT03283371|3529224|FG003|NOT COMPLETED|Placebo-controlled||0
2828048|NCT03283371|3529221|FG000|STARTED|Open-label Phase||0
2828049|NCT03283371|3529222|FG001|STARTED|Open-label Phase||0
2828050|NCT03283371|3529223|FG002|STARTED|Open-label Phase||31
2828051|NCT03283371|3529224|FG003|STARTED|Open-label Phase||30
2828052|NCT03283371|3529221|FG000|COMPLETED|Open-label Phase||0
2828053|NCT03283371|3529222|FG001|COMPLETED|Open-label Phase||0
2828054|NCT03283371|3529223|FG002|COMPLETED|Open-label Phase||27
2828055|NCT03283371|3529224|FG003|COMPLETED|Open-label Phase||29
2828056|NCT03283371|3529221|FG000|NOT COMPLETED|Open-label Phase||0
2828057|NCT03283371|3529222|FG001|NOT COMPLETED|Open-label Phase||0
2828058|NCT03283371|3529223|FG002|NOT COMPLETED|Open-label Phase||4
2828059|NCT03283371|3529224|FG003|NOT COMPLETED|Open-label Phase||1
2828060|NCT03257254|3529234|FG000|STARTED|Overall Study||76
2828061|NCT03257254|3529234|FG000|COMPLETED|Overall Study||55
2828062|NCT03257254|3529234|FG000|NOT COMPLETED|Overall Study||21
2828063|NCT03084718|3529243|FG000|STARTED|Overall Study||120
2828064|NCT03084718|3529244|FG001|STARTED|Overall Study||120
2828065|NCT03084718|3529245|FG002|STARTED|Overall Study||122
2828066|NCT03084718|3529246|FG003|STARTED|Overall Study||124
2828067|NCT03084718|3529247|FG004|STARTED|Overall Study||124
2828068|NCT03084718|3529243|FG000|COMPLETED|Overall Study||109
2828069|NCT03084718|3529244|FG001|COMPLETED|Overall Study||110
2828070|NCT03084718|3529245|FG002|COMPLETED|Overall Study||110
2828071|NCT03084718|3529246|FG003|COMPLETED|Overall Study||110
2828072|NCT03084718|3529247|FG004|COMPLETED|Overall Study||120
2828073|NCT03084718|3529243|FG000|NOT COMPLETED|Overall Study||11
2828074|NCT03084718|3529244|FG001|NOT COMPLETED|Overall Study||10
2828075|NCT03084718|3529245|FG002|NOT COMPLETED|Overall Study||12
2828076|NCT03084718|3529246|FG003|NOT COMPLETED|Overall Study||14
2828077|NCT03084718|3529247|FG004|NOT COMPLETED|Overall Study||4
2828078|NCT03069417|3529264|FG000|STARTED|Overall Study||14
2828079|NCT03069417|3529265|FG001|STARTED|Overall Study||9
2828080|NCT03069417|3529264|FG000|Post-Treatment Assessment|Overall Study||12
2828081|NCT03069417|3529265|FG001|Post-Treatment Assessment|Overall Study||6
2828082|NCT03069417|3529264|FG000|COMPLETED|Overall Study||8
2828083|NCT03069417|3529265|FG001|COMPLETED|Overall Study||2
2828084|NCT03069417|3529264|FG000|NOT COMPLETED|Overall Study||6
2828085|NCT03069417|3529265|FG001|NOT COMPLETED|Overall Study||7
2828086|NCT03063164|3529272|FG000|STARTED|Overall Study||7
2828087|NCT03063164|3529273|FG001|STARTED|Overall Study||7
2828088|NCT03063164|3529272|FG000|COMPLETED|Overall Study||7
2828089|NCT03063164|3529273|FG001|COMPLETED|Overall Study||7
2828090|NCT03063164|3529272|FG000|NOT COMPLETED|Overall Study||0
2828091|NCT03063164|3529273|FG001|NOT COMPLETED|Overall Study||0
2828092|NCT02952365|3529280|FG000|STARTED|Overall Study||2
2828093|NCT02952365|3529280|FG000|COMPLETED|Overall Study||2
2828094|NCT02952365|3529280|FG000|NOT COMPLETED|Overall Study||0
2828095|NCT02936323|3529294|FG000|STARTED|Phase 1 Dose Escalation|Participants in Phase 1 did not advance to Phase 2a.|2
2828096|NCT02936323|3529295|FG001|STARTED|Phase 1 Dose Escalation|Participants in Phase 1 did not advance to Phase 2a.|3
2828097|NCT02936323|3529296|FG002|STARTED|Phase 1 Dose Escalation|Participants in Phase 1 did not advance to Phase 2a.|3
2828098|NCT02936323|3529297|FG003|STARTED|Phase 1 Dose Escalation|Participants in Phase 1 did not advance to Phase 2a.|3
2913141|NCT00493649|3622927|FG000|STARTED|Overall Study||493
2828099|NCT02936323|3529298|FG004|STARTED|Phase 1 Dose Escalation|Participants in Phase 1 did not advance to Phase 2a.|3
2828100|NCT02936323|3529299|FG005|STARTED|Phase 1 Dose Escalation|Participants in Phase 1 did not advance to Phase 2a.|6
2828101|NCT02936323|3529300|FG006|STARTED|Phase 1 Dose Escalation|Participants in Phase 1 did not advance to Phase 2a.|3
2828102|NCT02936323|3529301|FG007|STARTED|Phase 1 Dose Escalation||0
2828103|NCT02936323|3529302|FG008|STARTED|Phase 1 Dose Escalation||0
2828104|NCT02936323|3529303|FG009|STARTED|Phase 1 Dose Escalation||0
2828105|NCT02936323|3529294|FG000|COMPLETED|Phase 1 Dose Escalation||0
2828106|NCT02936323|3529295|FG001|COMPLETED|Phase 1 Dose Escalation||1
2828107|NCT02936323|3529296|FG002|COMPLETED|Phase 1 Dose Escalation||0
2828108|NCT02936323|3529297|FG003|COMPLETED|Phase 1 Dose Escalation||1
2828109|NCT02936323|3529298|FG004|COMPLETED|Phase 1 Dose Escalation||0
2828110|NCT02936323|3529299|FG005|COMPLETED|Phase 1 Dose Escalation||1
2828111|NCT02936323|3529300|FG006|COMPLETED|Phase 1 Dose Escalation||0
2828112|NCT02936323|3529301|FG007|COMPLETED|Phase 1 Dose Escalation||0
2828113|NCT02936323|3529302|FG008|COMPLETED|Phase 1 Dose Escalation||0
2828114|NCT02936323|3529303|FG009|COMPLETED|Phase 1 Dose Escalation||0
2828115|NCT02936323|3529294|FG000|NOT COMPLETED|Phase 1 Dose Escalation||2
2828116|NCT02936323|3529295|FG001|NOT COMPLETED|Phase 1 Dose Escalation||2
2828117|NCT02936323|3529296|FG002|NOT COMPLETED|Phase 1 Dose Escalation||3
2828118|NCT02936323|3529297|FG003|NOT COMPLETED|Phase 1 Dose Escalation||2
2828119|NCT02936323|3529298|FG004|NOT COMPLETED|Phase 1 Dose Escalation||3
2828120|NCT02936323|3529299|FG005|NOT COMPLETED|Phase 1 Dose Escalation||5
2828121|NCT02936323|3529300|FG006|NOT COMPLETED|Phase 1 Dose Escalation||3
2828122|NCT02936323|3529301|FG007|NOT COMPLETED|Phase 1 Dose Escalation||0
2828123|NCT02936323|3529302|FG008|NOT COMPLETED|Phase 1 Dose Escalation||0
2828124|NCT02936323|3529303|FG009|NOT COMPLETED|Phase 1 Dose Escalation||0
2828125|NCT02936323|3529294|FG000|STARTED|Phase 2a Dose Expansion||0
2828126|NCT02936323|3529295|FG001|STARTED|Phase 2a Dose Expansion||0
2828127|NCT02936323|3529296|FG002|STARTED|Phase 2a Dose Expansion||0
2828128|NCT02936323|3529297|FG003|STARTED|Phase 2a Dose Expansion||0
2828129|NCT02936323|3529298|FG004|STARTED|Phase 2a Dose Expansion||0
2828130|NCT02936323|3529299|FG005|STARTED|Phase 2a Dose Expansion||0
2828131|NCT02936323|3529300|FG006|STARTED|Phase 2a Dose Expansion||0
2828132|NCT02936323|3529301|FG007|STARTED|Phase 2a Dose Expansion|Participants in Phase 2a did not participate in Phase 1|32
2828133|NCT02936323|3529302|FG008|STARTED|Phase 2a Dose Expansion|Participants in Phase 2a did not participate in Phase 1|15
2828134|NCT02936323|3529303|FG009|STARTED|Phase 2a Dose Expansion|Participants in Phase 2a did not participate in Phase 1|19
2828135|NCT02936323|3529294|FG000|COMPLETED|Phase 2a Dose Expansion||0
2828136|NCT02936323|3529295|FG001|COMPLETED|Phase 2a Dose Expansion||0
2828137|NCT02936323|3529296|FG002|COMPLETED|Phase 2a Dose Expansion||0
2828138|NCT02936323|3529297|FG003|COMPLETED|Phase 2a Dose Expansion||0
2828139|NCT02936323|3529298|FG004|COMPLETED|Phase 2a Dose Expansion||0
2828140|NCT02936323|3529299|FG005|COMPLETED|Phase 2a Dose Expansion||0
2828141|NCT02936323|3529300|FG006|COMPLETED|Phase 2a Dose Expansion||0
2828142|NCT02936323|3529301|FG007|COMPLETED|Phase 2a Dose Expansion||15
2828143|NCT02936323|3529302|FG008|COMPLETED|Phase 2a Dose Expansion||2
2828144|NCT02936323|3529303|FG009|COMPLETED|Phase 2a Dose Expansion||5
2828145|NCT02936323|3529294|FG000|NOT COMPLETED|Phase 2a Dose Expansion||0
2828146|NCT02936323|3529295|FG001|NOT COMPLETED|Phase 2a Dose Expansion||0
2828147|NCT02936323|3529296|FG002|NOT COMPLETED|Phase 2a Dose Expansion||0
2828148|NCT02936323|3529297|FG003|NOT COMPLETED|Phase 2a Dose Expansion||0
2828149|NCT02936323|3529298|FG004|NOT COMPLETED|Phase 2a Dose Expansion||0
2828150|NCT02936323|3529299|FG005|NOT COMPLETED|Phase 2a Dose Expansion||0
2828151|NCT02936323|3529300|FG006|NOT COMPLETED|Phase 2a Dose Expansion||0
2828152|NCT02936323|3529301|FG007|NOT COMPLETED|Phase 2a Dose Expansion||17
2828153|NCT02936323|3529302|FG008|NOT COMPLETED|Phase 2a Dose Expansion||13
2828154|NCT02936323|3529303|FG009|NOT COMPLETED|Phase 2a Dose Expansion||14
2828155|NCT02631837|3529337|FG000|STARTED|Overall Study||35
2828156|NCT02631837|3529338|FG001|STARTED|Overall Study||35
2828157|NCT02631837|3529337|FG000|COMPLETED|Overall Study||35
2828158|NCT02631837|3529338|FG001|COMPLETED|Overall Study||35
2828159|NCT02631837|3529337|FG000|NOT COMPLETED|Overall Study||0
2828160|NCT02631837|3529338|FG001|NOT COMPLETED|Overall Study||0
2828161|NCT02437318|3529346|FG000|STARTED|Overall Study||284
2828162|NCT02437318|3529347|FG001|STARTED|Overall Study||288
2828163|NCT02437318|3529346|FG000|End of Treatment (Didn't Complete)|Overall Study||229
2828164|NCT02437318|3529347|FG001|End of Treatment (Didn't Complete)|Overall Study||241
2828165|NCT02437318|3529346|FG000|Untreated (Protocol Deviation)|Overall Study||0
2828166|NCT02437318|3529347|FG001|Untreated (Protocol Deviation)|Overall Study||1
2828167|NCT02437318|3529346|FG000|COMPLETED|Overall Study||55
2828168|NCT02437318|3529347|FG001|COMPLETED|Overall Study||46
2828169|NCT02437318|3529346|FG000|NOT COMPLETED|Overall Study||229
2828170|NCT02437318|3529347|FG001|NOT COMPLETED|Overall Study||242
2828171|NCT02429791|3529355|FG000|STARTED|Early Switch Phase (Up to Week 52)||252
2828172|NCT02429791|3529356|FG001|STARTED|Early Switch Phase (Up to Week 52)||256
3166503|NCT01904773|3893898|FG001|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
3166504|NCT01904773|3893899|FG002|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
2828173|NCT02429791|3529355|FG000|COMPLETED|Early Switch Phase (Up to Week 52)||239
2828174|NCT02429791|3529356|FG001|COMPLETED|Early Switch Phase (Up to Week 52)||238
2828175|NCT02429791|3529355|FG000|NOT COMPLETED|Early Switch Phase (Up to Week 52)||13
2828176|NCT02429791|3529356|FG001|NOT COMPLETED|Early Switch Phase (Up to Week 52)||18
2828177|NCT02429791|3529355|FG000|STARTED|Late Switch Phase (Week 52 to Week 148)||239
2828178|NCT02429791|3529356|FG001|STARTED|Late Switch Phase (Week 52 to Week 148)||238
2828179|NCT02429791|3529355|FG000|COMPLETED|Late Switch Phase (Week 52 to Week 148)||214
2828180|NCT02429791|3529356|FG001|COMPLETED|Late Switch Phase (Week 52 to Week 148)||210
2828181|NCT02429791|3529355|FG000|NOT COMPLETED|Late Switch Phase (Week 52 to Week 148)||25
2828182|NCT02429791|3529356|FG001|NOT COMPLETED|Late Switch Phase (Week 52 to Week 148)||28
2828183|NCT02422797|3529371|FG000|STARTED|Early Switch Phase (Up to Week 52)||261
2828184|NCT02422797|3529372|FG001|STARTED|Early Switch Phase (Up to Week 52)||255
2828185|NCT02422797|3529371|FG000|COMPLETED|Early Switch Phase (Up to Week 52)||245
2828186|NCT02422797|3529372|FG001|COMPLETED|Early Switch Phase (Up to Week 52)||239
2828187|NCT02422797|3529371|FG000|NOT COMPLETED|Early Switch Phase (Up to Week 52)||16
2828188|NCT02422797|3529372|FG001|NOT COMPLETED|Early Switch Phase (Up to Week 52)||16
2828189|NCT02422797|3529371|FG000|STARTED|Late Switch Phase (Week 52 to Week 148)||245
2828190|NCT02422797|3529372|FG001|STARTED|Late Switch Phase (Week 52 to Week 148)||239
2828191|NCT02422797|3529371|FG000|COMPLETED|Late Switch Phase (Week 52 to Week 148)||222
2828192|NCT02422797|3529372|FG001|COMPLETED|Late Switch Phase (Week 52 to Week 148)||221
2828193|NCT02422797|3529371|FG000|NOT COMPLETED|Late Switch Phase (Week 52 to Week 148)||23
2828194|NCT02422797|3529372|FG001|NOT COMPLETED|Late Switch Phase (Week 52 to Week 148)||18
2828195|NCT02422615|3529390|FG000|STARTED|Overall Study||484
2828196|NCT02422615|3529391|FG001|STARTED|Overall Study||242
2828197|NCT02422615|3529390|FG000|Untreated|Overall Study||1
2828198|NCT02422615|3529391|FG001|Untreated|Overall Study||1
2828199|NCT02422615|3529390|FG000|COMPLETED|Overall Study||204
2828200|NCT02422615|3529391|FG001|COMPLETED|Overall Study||76
2828201|NCT02422615|3529390|FG000|NOT COMPLETED|Overall Study||280
2828202|NCT02422615|3529391|FG001|NOT COMPLETED|Overall Study||166
2913142|NCT00493649|3622927|FG000|COMPLETED|Overall Study||411
2913143|NCT00493649|3622927|FG000|NOT COMPLETED|Overall Study||82
2913144|NCT00493779|3622934|FG000|STARTED|Overall Study|Number of subjects who had discontinued clopidogrel treatment and entered follow-up phase|98
2913145|NCT00493779|3622934|FG000|COMPLETED|Overall Study|Completed follow-up phase|97
2913146|NCT00493779|3622934|FG000|NOT COMPLETED|Overall Study||1
2913147|NCT00493805|3622939|FG000|STARTED|Overall Study||17
2913148|NCT00493805|3622940|FG001|STARTED|Overall Study||42
2913149|NCT00493805|3622939|FG000|COMPLETED|Overall Study||17
2913150|NCT00493805|3622940|FG001|COMPLETED|Overall Study||42
2913151|NCT00493805|3622939|FG000|NOT COMPLETED|Overall Study||0
2913152|NCT00493805|3622940|FG001|NOT COMPLETED|Overall Study||0
2913153|NCT00493974|3622948|FG000|STARTED|Overall Study||60
2913154|NCT00493974|3622949|FG001|STARTED|Overall Study||59
2913155|NCT00493974|3622948|FG000|COMPLETED|Overall Study||47
2913156|NCT00493974|3622949|FG001|COMPLETED|Overall Study||45
2913157|NCT00493974|3622948|FG000|NOT COMPLETED|Overall Study||13
3166505|NCT01904773|3893900|FG003|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
3166506|NCT01904773|3893901|FG004|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
3166507|NCT01904773|3893902|FG005|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
3166508|NCT01904773|3893903|FG006|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
3166509|NCT01904773|3893904|FG007|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
3166510|NCT01904773|3893905|FG008|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
3166511|NCT01904773|3893897|FG000|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||1
3166512|NCT01904773|3893898|FG001|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
3166513|NCT01904773|3893899|FG002|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
2913158|NCT00493974|3622949|FG001|NOT COMPLETED|Overall Study||14
2913159|NCT00494013|3622957|FG000|STARTED|Overall Study||223
2913160|NCT00494013|3622958|FG001|STARTED|Overall Study||219
2913161|NCT00494013|3622957|FG000|Full Analysis Set (Intent to Treat)|Overall Study||219
2913162|NCT00494013|3622958|FG001|Full Analysis Set (Intent to Treat)|Overall Study||210
2913163|NCT00494013|3622957|FG000|COMPLETED|Overall Study||193
2913164|NCT00494013|3622958|FG001|COMPLETED|Overall Study||183
2913165|NCT00494013|3622957|FG000|NOT COMPLETED|Overall Study||30
2913166|NCT00494013|3622958|FG001|NOT COMPLETED|Overall Study||36
2913167|NCT00494026|3622964|FG000|STARTED|Overall Study||4
2913168|NCT00494026|3622964|FG000|COMPLETED|Overall Study|2 patients did receive the full study treatment prior to the study being terminated.|0
2913169|NCT00494026|3622964|FG000|NOT COMPLETED|Overall Study||4
2913170|NCT00494091|3622970|FG000|STARTED|Overall Study||6
2913171|NCT00494091|3622971|FG001|STARTED|Overall Study||76
2913172|NCT00494091|3622970|FG000|COMPLETED|Overall Study||0
3166514|NCT01904773|3893900|FG003|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
3166515|NCT01904773|3893901|FG004|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
3166516|NCT01904773|3893902|FG005|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
3166517|NCT01904773|3893903|FG006|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
3166518|NCT01904773|3893904|FG007|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
3166519|NCT01904773|3893905|FG008|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
3166520|NCT01904773|3893897|FG000|STARTED|First Intervention||0
3166521|NCT01904773|3893898|FG001|STARTED|First Intervention||2
3166522|NCT01904773|3893899|FG002|STARTED|First Intervention||1
3166523|NCT01904773|3893900|FG003|STARTED|First Intervention||2
3166524|NCT01904773|3893901|FG004|STARTED|First Intervention||3
3166525|NCT01904773|3893902|FG005|STARTED|First Intervention||4
3166526|NCT01904773|3893903|FG006|STARTED|First Intervention||4
3166527|NCT01904773|3893904|FG007|STARTED|First Intervention||3
3166528|NCT01904773|3893905|FG008|STARTED|First Intervention||4
3166529|NCT01904773|3893897|FG000|COMPLETED|First Intervention||0
3166530|NCT01904773|3893898|FG001|COMPLETED|First Intervention||2
3166531|NCT01904773|3893899|FG002|COMPLETED|First Intervention||1
3166532|NCT01904773|3893900|FG003|COMPLETED|First Intervention||2
3166533|NCT01904773|3893901|FG004|COMPLETED|First Intervention||3
3166534|NCT01904773|3893902|FG005|COMPLETED|First Intervention||4
3166535|NCT01904773|3893903|FG006|COMPLETED|First Intervention||3
3166536|NCT01904773|3893904|FG007|COMPLETED|First Intervention||3
3166537|NCT01904773|3893905|FG008|COMPLETED|First Intervention||4
3166538|NCT01904773|3893897|FG000|NOT COMPLETED|First Intervention||0
3166539|NCT01904773|3893898|FG001|NOT COMPLETED|First Intervention||0
3166540|NCT01904773|3893899|FG002|NOT COMPLETED|First Intervention||0
3166541|NCT01904773|3893900|FG003|NOT COMPLETED|First Intervention||0
3166542|NCT01904773|3893901|FG004|NOT COMPLETED|First Intervention||0
3166543|NCT01904773|3893902|FG005|NOT COMPLETED|First Intervention||0
3166544|NCT01904773|3893903|FG006|NOT COMPLETED|First Intervention||1
3166545|NCT01904773|3893904|FG007|NOT COMPLETED|First Intervention||0
3166546|NCT01904773|3893905|FG008|NOT COMPLETED|First Intervention||0
3166547|NCT01904773|3893897|FG000|STARTED|Placebo Washout First Intervention||0
3166548|NCT01904773|3893898|FG001|STARTED|Placebo Washout First Intervention||2
3166549|NCT01904773|3893899|FG002|STARTED|Placebo Washout First Intervention||1
3166550|NCT01904773|3893900|FG003|STARTED|Placebo Washout First Intervention||2
3166551|NCT01904773|3893901|FG004|STARTED|Placebo Washout First Intervention||3
3166552|NCT01904773|3893902|FG005|STARTED|Placebo Washout First Intervention||4
3166553|NCT01904773|3893903|FG006|STARTED|Placebo Washout First Intervention||3
3166554|NCT01904773|3893904|FG007|STARTED|Placebo Washout First Intervention||3
3166555|NCT01904773|3893905|FG008|STARTED|Placebo Washout First Intervention||4
3166556|NCT01904773|3893897|FG000|COMPLETED|Placebo Washout First Intervention||0
3166557|NCT01904773|3893898|FG001|COMPLETED|Placebo Washout First Intervention||1
3166558|NCT01904773|3893899|FG002|COMPLETED|Placebo Washout First Intervention||1
3166559|NCT01904773|3893900|FG003|COMPLETED|Placebo Washout First Intervention||2
3166560|NCT01904773|3893901|FG004|COMPLETED|Placebo Washout First Intervention||3
3166561|NCT01904773|3893902|FG005|COMPLETED|Placebo Washout First Intervention||4
3166562|NCT01904773|3893903|FG006|COMPLETED|Placebo Washout First Intervention||3
3166563|NCT01904773|3893904|FG007|COMPLETED|Placebo Washout First Intervention||3
3166564|NCT01904773|3893905|FG008|COMPLETED|Placebo Washout First Intervention||4
3166565|NCT01904773|3893897|FG000|NOT COMPLETED|Placebo Washout First Intervention||0
3166566|NCT01904773|3893898|FG001|NOT COMPLETED|Placebo Washout First Intervention||1
3166567|NCT01904773|3893899|FG002|NOT COMPLETED|Placebo Washout First Intervention||0
3166568|NCT01904773|3893900|FG003|NOT COMPLETED|Placebo Washout First Intervention||0
3166569|NCT01904773|3893901|FG004|NOT COMPLETED|Placebo Washout First Intervention||0
3166570|NCT01904773|3893902|FG005|NOT COMPLETED|Placebo Washout First Intervention||0
3166571|NCT01904773|3893903|FG006|NOT COMPLETED|Placebo Washout First Intervention||0
3166572|NCT01904773|3893904|FG007|NOT COMPLETED|Placebo Washout First Intervention||0
3166573|NCT01904773|3893905|FG008|NOT COMPLETED|Placebo Washout First Intervention||0
3166574|NCT01904773|3893897|FG000|STARTED|Second Intervention||0
3166575|NCT01904773|3893898|FG001|STARTED|Second Intervention||1
3166576|NCT01904773|3893899|FG002|STARTED|Second Intervention||1
3166577|NCT01904773|3893900|FG003|STARTED|Second Intervention||2
3166578|NCT01904773|3893901|FG004|STARTED|Second Intervention||3
3166579|NCT01904773|3893902|FG005|STARTED|Second Intervention||4
3166580|NCT01904773|3893903|FG006|STARTED|Second Intervention||3
3166581|NCT01904773|3893904|FG007|STARTED|Second Intervention||3
3166582|NCT01904773|3893905|FG008|STARTED|Second Intervention||4
3166583|NCT01904773|3893897|FG000|COMPLETED|Second Intervention||0
3166584|NCT01904773|3893898|FG001|COMPLETED|Second Intervention||1
3166585|NCT01904773|3893899|FG002|COMPLETED|Second Intervention||1
3166586|NCT01904773|3893900|FG003|COMPLETED|Second Intervention||2
3166587|NCT01904773|3893901|FG004|COMPLETED|Second Intervention||3
3166588|NCT01904773|3893902|FG005|COMPLETED|Second Intervention||4
3166589|NCT01904773|3893903|FG006|COMPLETED|Second Intervention||3
3166590|NCT01904773|3893904|FG007|COMPLETED|Second Intervention||3
3166591|NCT01904773|3893905|FG008|COMPLETED|Second Intervention||4
3166592|NCT01904773|3893897|FG000|NOT COMPLETED|Second Intervention||0
3166593|NCT01904773|3893898|FG001|NOT COMPLETED|Second Intervention||0
3166594|NCT01904773|3893899|FG002|NOT COMPLETED|Second Intervention||0
3166595|NCT01904773|3893900|FG003|NOT COMPLETED|Second Intervention||0
3166596|NCT01904773|3893901|FG004|NOT COMPLETED|Second Intervention||0
3166597|NCT01904773|3893902|FG005|NOT COMPLETED|Second Intervention||0
3166598|NCT01904773|3893903|FG006|NOT COMPLETED|Second Intervention||0
3166599|NCT01904773|3893904|FG007|NOT COMPLETED|Second Intervention||0
3166600|NCT01904773|3893905|FG008|NOT COMPLETED|Second Intervention||0
3166601|NCT01904773|3893897|FG000|STARTED|Placebo Washout Second Intervention||0
3166602|NCT01904773|3893898|FG001|STARTED|Placebo Washout Second Intervention||1
3166603|NCT01904773|3893899|FG002|STARTED|Placebo Washout Second Intervention||1
3166604|NCT01904773|3893900|FG003|STARTED|Placebo Washout Second Intervention||2
3166605|NCT01904773|3893901|FG004|STARTED|Placebo Washout Second Intervention||3
3166606|NCT01904773|3893902|FG005|STARTED|Placebo Washout Second Intervention||4
3166607|NCT01904773|3893903|FG006|STARTED|Placebo Washout Second Intervention||3
3166608|NCT01904773|3893904|FG007|STARTED|Placebo Washout Second Intervention||3
3166609|NCT01904773|3893905|FG008|STARTED|Placebo Washout Second Intervention||4
3166610|NCT01904773|3893897|FG000|COMPLETED|Placebo Washout Second Intervention||0
3166611|NCT01904773|3893898|FG001|COMPLETED|Placebo Washout Second Intervention||1
3166612|NCT01904773|3893899|FG002|COMPLETED|Placebo Washout Second Intervention||1
3166613|NCT01904773|3893900|FG003|COMPLETED|Placebo Washout Second Intervention||2
3166614|NCT01904773|3893901|FG004|COMPLETED|Placebo Washout Second Intervention||3
3166615|NCT01904773|3893902|FG005|COMPLETED|Placebo Washout Second Intervention||4
3166616|NCT01904773|3893903|FG006|COMPLETED|Placebo Washout Second Intervention||3
3166617|NCT01904773|3893904|FG007|COMPLETED|Placebo Washout Second Intervention||3
3166618|NCT01904773|3893905|FG008|COMPLETED|Placebo Washout Second Intervention||4
3166619|NCT01904773|3893897|FG000|NOT COMPLETED|Placebo Washout Second Intervention||0
3166620|NCT01904773|3893898|FG001|NOT COMPLETED|Placebo Washout Second Intervention||0
3166621|NCT01904773|3893899|FG002|NOT COMPLETED|Placebo Washout Second Intervention||0
3166622|NCT01904773|3893900|FG003|NOT COMPLETED|Placebo Washout Second Intervention||0
3166623|NCT01904773|3893901|FG004|NOT COMPLETED|Placebo Washout Second Intervention||0
3166624|NCT01904773|3893902|FG005|NOT COMPLETED|Placebo Washout Second Intervention||0
3166625|NCT01904773|3893903|FG006|NOT COMPLETED|Placebo Washout Second Intervention||0
3166626|NCT01904773|3893904|FG007|NOT COMPLETED|Placebo Washout Second Intervention||0
3166627|NCT01904773|3893905|FG008|NOT COMPLETED|Placebo Washout Second Intervention||0
3166628|NCT01904773|3893897|FG000|STARTED|Third Intervention||0
3166629|NCT01904773|3893898|FG001|STARTED|Third Intervention||1
3166630|NCT01904773|3893899|FG002|STARTED|Third Intervention||1
3166631|NCT01904773|3893900|FG003|STARTED|Third Intervention||2
3166632|NCT01904773|3893901|FG004|STARTED|Third Intervention||3
3166633|NCT01904773|3893902|FG005|STARTED|Third Intervention||4
3166634|NCT01904773|3893903|FG006|STARTED|Third Intervention||3
3166635|NCT01904773|3893904|FG007|STARTED|Third Intervention||3
3166636|NCT01904773|3893905|FG008|STARTED|Third Intervention||4
2828203|NCT02287493|3529399|FG000|STARTED|Overall Study||19
2828204|NCT02287493|3529400|FG001|STARTED|Overall Study||16
2828205|NCT02287493|3529399|FG000|COMPLETED|Overall Study||19
2828206|NCT02287493|3529400|FG001|COMPLETED|Overall Study||16
2828207|NCT02287493|3529399|FG000|NOT COMPLETED|Overall Study||0
2828208|NCT02287493|3529400|FG001|NOT COMPLETED|Overall Study||0
2828209|NCT02132611|3529410|FG000|STARTED|Overall Study||100
2828210|NCT02132611|3529410|FG000|COMPLETED|Overall Study||98
2828211|NCT02132611|3529410|FG000|NOT COMPLETED|Overall Study||2
2828212|NCT01796197|3529414|FG000|STARTED|Overall Study||23
2828213|NCT01796197|3529414|FG000|COMPLETED|Overall Study||21
2828214|NCT01796197|3529414|FG000|NOT COMPLETED|Overall Study||2
2828215|NCT01147822|3529420|FG000|STARTED|Overall Study||188
2828216|NCT01147822|3529421|FG001|STARTED|Overall Study||179
2828217|NCT01147822|3529420|FG000|Not Completed/Ongoing|Overall Study||111
2828218|NCT01147822|3529421|FG001|Not Completed/Ongoing|Overall Study||102
2828219|NCT01147822|3529420|FG000|COMPLETED|Overall Study||0
2828220|NCT01147822|3529421|FG001|COMPLETED|Overall Study||0
2828221|NCT01147822|3529420|FG000|NOT COMPLETED|Overall Study||188
2828222|NCT01147822|3529421|FG001|NOT COMPLETED|Overall Study||179
2828223|NCT00328653|3529430|FG000|STARTED|Period I||40
2828224|NCT00328653|3529431|FG001|STARTED|Period I||39
2828225|NCT00328653|3529432|FG002|STARTED|Period I||39
2828226|NCT00328653|3529430|FG000|COMPLETED|Period I||36
2828227|NCT00328653|3529431|FG001|COMPLETED|Period I||39
2828228|NCT00328653|3529432|FG002|COMPLETED|Period I||36
2828229|NCT00328653|3529430|FG000|NOT COMPLETED|Period I||4
2828230|NCT00328653|3529431|FG001|NOT COMPLETED|Period I||0
2828231|NCT00328653|3529432|FG002|NOT COMPLETED|Period I||3
2828232|NCT00328653|3529430|FG000|STARTED|Period II|Following completion of the first period of the trial, all patients were to be administered NOVA22007 (i.e. CsA 0.05% or 0.1%) as four times or twice daily instillations in both eyes for an additional 3 month period.|0
2828233|NCT00328653|3529431|FG001|STARTED|Period II||58
2828234|NCT00328653|3529432|FG002|STARTED|Period II||53
2828235|NCT00328653|3529430|FG000|COMPLETED|Period II||0
2828236|NCT00328653|3529431|FG001|COMPLETED|Period II||50
2828237|NCT00328653|3529432|FG002|COMPLETED|Period II||49
2828238|NCT00328653|3529430|FG000|NOT COMPLETED|Period II||0
2828239|NCT00328653|3529431|FG001|NOT COMPLETED|Period II||8
2828240|NCT00328653|3529432|FG002|NOT COMPLETED|Period II||4
2913173|NCT00494091|3622971|FG001|COMPLETED|Overall Study||0
2913174|NCT00494091|3622970|FG000|NOT COMPLETED|Overall Study||6
2913175|NCT00494091|3622971|FG001|NOT COMPLETED|Overall Study||76
2913176|NCT00494143|3622978|FG000|STARTED|Overall Study||1
2913177|NCT00494143|3622979|FG001|STARTED|Overall Study||2
2913178|NCT00494143|3622980|FG002|STARTED|Overall Study||3
2913179|NCT00494143|3622981|FG003|STARTED|Overall Study||0
2913180|NCT00494143|3622982|FG004|STARTED|Overall Study||1
2913181|NCT00494143|3622983|FG005|STARTED|Overall Study||0
2913182|NCT00494143|3622978|FG000|COMPLETED|Overall Study||1
2913183|NCT00494143|3622979|FG001|COMPLETED|Overall Study||2
2913184|NCT00494143|3622980|FG002|COMPLETED|Overall Study||3
2913185|NCT00494143|3622981|FG003|COMPLETED|Overall Study||0
3166637|NCT01904773|3893897|FG000|COMPLETED|Third Intervention||0
3166638|NCT01904773|3893898|FG001|COMPLETED|Third Intervention||1
3166639|NCT01904773|3893899|FG002|COMPLETED|Third Intervention||1
3166640|NCT01904773|3893900|FG003|COMPLETED|Third Intervention||2
3166641|NCT01904773|3893901|FG004|COMPLETED|Third Intervention||3
3166642|NCT01904773|3893902|FG005|COMPLETED|Third Intervention||4
3166643|NCT01904773|3893903|FG006|COMPLETED|Third Intervention||3
3166644|NCT01904773|3893904|FG007|COMPLETED|Third Intervention||3
3166645|NCT01904773|3893905|FG008|COMPLETED|Third Intervention||4
2913186|NCT00494143|3622982|FG004|COMPLETED|Overall Study||1
3166646|NCT01904773|3893897|FG000|NOT COMPLETED|Third Intervention||0
3166647|NCT01904773|3893898|FG001|NOT COMPLETED|Third Intervention||0
3310223|NCT03038126|4043590|FG000|NOT COMPLETED|Overall Study||9
2828241|NCT04476251|3529442|FG000|STARTED|Overall Study||1
2828242|NCT04476251|3529442|FG000|COMPLETED|Overall Study||0
2828243|NCT04476251|3529442|FG000|NOT COMPLETED|Overall Study||1
2828244|NCT03924765|3529446|FG000|STARTED|Overall Study||5
2828245|NCT03924765|3529446|FG000|COMPLETED|Overall Study||5
2828246|NCT03924765|3529446|FG000|NOT COMPLETED|Overall Study||0
2828247|NCT03915860|3529450|FG000|STARTED|Overall Study||47
2828248|NCT03915860|3529450|FG000|Treated|Overall Study||46
2828249|NCT03915860|3529450|FG000|COMPLETED|Overall Study||33
2828250|NCT03915860|3529450|FG000|NOT COMPLETED|Overall Study||14
2828251|NCT03817606|3529456|FG000|STARTED|Overall Study||2
2828252|NCT03817606|3529457|FG001|STARTED|Overall Study||2
2828253|NCT03817606|3529456|FG000|COMPLETED|Overall Study||0
2828254|NCT03817606|3529457|FG001|COMPLETED|Overall Study||0
2828255|NCT03817606|3529456|FG000|NOT COMPLETED|Overall Study||2
2828256|NCT03817606|3529457|FG001|NOT COMPLETED|Overall Study||2
2828257|NCT03795233|3529469|FG000|STARTED|Overall Study||4
2828258|NCT03795233|3529470|FG001|STARTED|Overall Study||1
2828259|NCT03795233|3529469|FG000|COMPLETED|Overall Study||0
2828260|NCT03795233|3529470|FG001|COMPLETED|Overall Study||0
2828261|NCT03795233|3529469|FG000|NOT COMPLETED|Overall Study||4
2828262|NCT03795233|3529470|FG001|NOT COMPLETED|Overall Study||1
2828263|NCT03786380|3529481|FG000|STARTED|Overall Study||35
2828264|NCT03786380|3529482|FG001|STARTED|Overall Study||22
2828265|NCT03786380|3529483|FG002|STARTED|Overall Study||54
2828266|NCT03786380|3529484|FG003|STARTED|Overall Study||63
2828267|NCT03786380|3529485|FG004|STARTED|Overall Study||28
3310224|NCT03038126|4043591|FG001|NOT COMPLETED|Overall Study||4
3310225|NCT03038308|4043597|FG000|STARTED|Overall Study||15
3310226|NCT03038308|4043597|FG000|COMPLETED|Overall Study||11
3310227|NCT03038308|4043597|FG000|NOT COMPLETED|Overall Study||4
3310228|NCT03038399|4043605|FG000|STARTED|Overall Study||11
3310229|NCT03038399|4043606|FG001|STARTED|Overall Study||12
3310230|NCT03038399|4043607|FG002|STARTED|Overall Study||12
3310231|NCT03038399|4043608|FG003|STARTED|Overall Study||11
3310232|NCT03038399|4043605|FG000|COMPLETED|Overall Study||10
3310233|NCT03038399|4043606|FG001|COMPLETED|Overall Study||11
3310234|NCT03038399|4043607|FG002|COMPLETED|Overall Study||11
3310235|NCT03038399|4043608|FG003|COMPLETED|Overall Study|Subjects escalated from lower dose groups|9
3310236|NCT03038399|4043605|FG000|NOT COMPLETED|Overall Study||1
2828268|NCT03786380|3529481|FG000|Safety Population|Overall Study||35
2828269|NCT03786380|3529482|FG001|Safety Population|Overall Study||22
2828270|NCT03786380|3529483|FG002|Safety Population|Overall Study||54
2828271|NCT03786380|3529484|FG003|Safety Population|Overall Study||62
2828272|NCT03786380|3529485|FG004|Safety Population|Overall Study||28
2828273|NCT03786380|3529481|FG000|COMPLETED|Overall Study||0
2828274|NCT03786380|3529482|FG001|COMPLETED|Overall Study||0
2828275|NCT03786380|3529483|FG002|COMPLETED|Overall Study||0
2828276|NCT03786380|3529484|FG003|COMPLETED|Overall Study||0
2828277|NCT03786380|3529485|FG004|COMPLETED|Overall Study||0
2828278|NCT03786380|3529481|FG000|NOT COMPLETED|Overall Study||35
2828279|NCT03786380|3529482|FG001|NOT COMPLETED|Overall Study||22
2828280|NCT03786380|3529483|FG002|NOT COMPLETED|Overall Study||54
2828281|NCT03786380|3529484|FG003|NOT COMPLETED|Overall Study||63
2828282|NCT03786380|3529485|FG004|NOT COMPLETED|Overall Study||28
2828283|NCT03769376|3529499|FG000|STARTED|Overall Study||20
2828284|NCT03769376|3529500|FG001|STARTED|Overall Study||18
2828285|NCT03769376|3529499|FG000|COMPLETED|Overall Study||13
2828286|NCT03769376|3529500|FG001|COMPLETED|Overall Study||11
2828287|NCT03769376|3529499|FG000|NOT COMPLETED|Overall Study||7
2828288|NCT03769376|3529500|FG001|NOT COMPLETED|Overall Study||7
2828289|NCT03645863|3529509|FG000|STARTED|Overall Study||21
2828290|NCT03645863|3529510|FG001|STARTED|Overall Study||20
2828291|NCT03645863|3529511|FG002|STARTED|Overall Study||20
2828292|NCT03645863|3529509|FG000|COMPLETED|Overall Study||20
2828293|NCT03645863|3529510|FG001|COMPLETED|Overall Study||20
2828294|NCT03645863|3529511|FG002|COMPLETED|Overall Study||20
2828295|NCT03645863|3529509|FG000|NOT COMPLETED|Overall Study||1
2828296|NCT03645863|3529510|FG001|NOT COMPLETED|Overall Study||0
2828297|NCT03645863|3529511|FG002|NOT COMPLETED|Overall Study||0
2828298|NCT03564145|3529519|FG000|STARTED|Overall Study||547
2828299|NCT03564145|3529519|FG000|Received at Least 1 Dose of Study Drug|Overall Study||535
2828300|NCT03564145|3529519|FG000|COMPLETED|Overall Study||323
2828301|NCT03564145|3529519|FG000|NOT COMPLETED|Overall Study||224
2828302|NCT03564119|3529525|FG000|STARTED|Overall Study||250
2828303|NCT03564119|3529526|FG001|STARTED|Overall Study||122
2828304|NCT03564119|3529525|FG000|Received at Least 1 Dose of Study Drug|Overall Study||249
2828305|NCT03564119|3529526|FG001|Received at Least 1 Dose of Study Drug|Overall Study||120
2828306|NCT03564119|3529525|FG000|COMPLETED|Overall Study||235
2828307|NCT03564119|3529526|FG001|COMPLETED|Overall Study||113
2828308|NCT03564119|3529525|FG000|NOT COMPLETED|Overall Study||15
2828309|NCT03564119|3529526|FG001|NOT COMPLETED|Overall Study||9
2828310|NCT03365635|3529538|FG000|STARTED|Overall Study||3
2828311|NCT03365635|3529539|FG001|STARTED|Overall Study||0
2828312|NCT03365635|3529540|FG002|STARTED|Overall Study||1
2828313|NCT03365635|3529541|FG003|STARTED|Overall Study||0
2828314|NCT03365635|3529542|FG004|STARTED|Overall Study||0
3310237|NCT03038399|4043606|FG001|NOT COMPLETED|Overall Study||1
3310238|NCT03038399|4043607|FG002|NOT COMPLETED|Overall Study||1
2828315|NCT03365635|3529543|FG005|STARTED|Overall Study||0
2828316|NCT03365635|3529538|FG000|COMPLETED|Overall Study||3
2828317|NCT03365635|3529539|FG001|COMPLETED|Overall Study||0
2828318|NCT03365635|3529540|FG002|COMPLETED|Overall Study||1
2828319|NCT03365635|3529541|FG003|COMPLETED|Overall Study||0
2828320|NCT03365635|3529542|FG004|COMPLETED|Overall Study||0
2828321|NCT03365635|3529543|FG005|COMPLETED|Overall Study||0
2828322|NCT03365635|3529538|FG000|NOT COMPLETED|Overall Study||0
2828323|NCT03365635|3529539|FG001|NOT COMPLETED|Overall Study||0
2828324|NCT03365635|3529540|FG002|NOT COMPLETED|Overall Study||0
2828325|NCT03365635|3529541|FG003|NOT COMPLETED|Overall Study||0
2828326|NCT03365635|3529542|FG004|NOT COMPLETED|Overall Study||0
2828327|NCT03365635|3529543|FG005|NOT COMPLETED|Overall Study||0
2828328|NCT03287050|3529557|FG000|STARTED|Overall Study||6
2828329|NCT03287050|3529557|FG000|COMPLETED|Overall Study||6
2828330|NCT03287050|3529557|FG000|NOT COMPLETED|Overall Study||0
2913187|NCT00494143|3622983|FG005|COMPLETED|Overall Study||0
2913188|NCT00494143|3622978|FG000|NOT COMPLETED|Overall Study||0
2913189|NCT00494143|3622979|FG001|NOT COMPLETED|Overall Study||0
2913190|NCT00494143|3622980|FG002|NOT COMPLETED|Overall Study||0
2913191|NCT00494143|3622981|FG003|NOT COMPLETED|Overall Study||0
2913192|NCT00494143|3622982|FG004|NOT COMPLETED|Overall Study||0
2913193|NCT00494143|3622983|FG005|NOT COMPLETED|Overall Study||0
2913194|NCT00494221|3622998|FG000|STARTED|Overall Study||58
2913195|NCT00494221|3622999|FG001|STARTED|Overall Study||56
2913196|NCT00494221|3623000|FG002|STARTED|Overall Study||58
2913197|NCT00494221|3622998|FG000|COMPLETED|Overall Study||42
2913198|NCT00494221|3622999|FG001|COMPLETED|Overall Study||45
2913199|NCT00494221|3623000|FG002|COMPLETED|Overall Study||44
2913200|NCT00494221|3622998|FG000|NOT COMPLETED|Overall Study||16
2913201|NCT00494221|3622999|FG001|NOT COMPLETED|Overall Study||11
2913202|NCT00494221|3623000|FG002|NOT COMPLETED|Overall Study||14
2913203|NCT00494234|3623010|FG000|STARTED|Overall Study||27
2913204|NCT00494234|3623011|FG001|STARTED|Overall Study||27
2913205|NCT00494234|3623010|FG000|COMPLETED|Overall Study||12
2913206|NCT00494234|3623011|FG001|COMPLETED|Overall Study||17
2913207|NCT00494234|3623010|FG000|NOT COMPLETED|Overall Study||15
2913208|NCT00494234|3623011|FG001|NOT COMPLETED|Overall Study||10
2913209|NCT00494299|3623023|FG000|STARTED|Overall Study||229
2913210|NCT00494299|3623024|FG001|STARTED|Overall Study||229
2913211|NCT00494299|3623023|FG000|Received Treatment|Overall Study||229
2913212|NCT00494299|3623024|FG001|Received Treatment|Overall Study||227
2913213|NCT00494299|3623023|FG000|COMPLETED|Overall Study||0
2913214|NCT00494299|3623024|FG001|COMPLETED|Overall Study||0
2913215|NCT00494299|3623023|FG000|NOT COMPLETED|Overall Study||229
2913216|NCT00494299|3623024|FG001|NOT COMPLETED|Overall Study||229
2913217|NCT00494442|3623032|FG000|STARTED|Overall Study|Patients received treatment|24
2913218|NCT00494442|3623033|FG001|STARTED|Overall Study|Patients received treatment|33
2913219|NCT00494442|3623032|FG000|COMPLETED|Overall Study|Patients completed the full study schedule (168 days treatment)|7
2913220|NCT00494442|3623033|FG001|COMPLETED|Overall Study|Patients completed the full study schedule (168 days treatment)|17
2913221|NCT00494442|3623032|FG000|NOT COMPLETED|Overall Study||17
2913222|NCT00494442|3623033|FG001|NOT COMPLETED|Overall Study||16
2913223|NCT00494481|3623041|FG000|STARTED|Overall Study|randomised patients|35
2913224|NCT00494481|3623042|FG001|STARTED|Overall Study|randomised patients|29
2913225|NCT00494481|3623041|FG000|COMPLETED|Overall Study|ongoing study treatment at data cut-off|6
2913226|NCT00494481|3623042|FG001|COMPLETED|Overall Study|ongoing study treatment at data cut-off|5
2913227|NCT00494481|3623041|FG000|NOT COMPLETED|Overall Study||29
2913228|NCT00494481|3623042|FG001|NOT COMPLETED|Overall Study||24
2913229|NCT00494494|3623050|FG000|STARTED|Overall Study||40
2913230|NCT00494494|3623051|FG001|STARTED|Overall Study||39
2913231|NCT00494494|3623050|FG000|COMPLETED|Overall Study||40
2913232|NCT00494494|3623051|FG001|COMPLETED|Overall Study||39
2913233|NCT00494494|3623050|FG000|NOT COMPLETED|Overall Study||0
2913234|NCT00494494|3623051|FG001|NOT COMPLETED|Overall Study||0
2913235|NCT00494507|3623061|FG000|STARTED|Double-Blind Phase||12
2913236|NCT00494507|3623062|FG001|STARTED|Double-Blind Phase||9
2913237|NCT00494507|3623063|FG002|STARTED|Double-Blind Phase||24
2913238|NCT00494507|3623064|FG003|STARTED|Double-Blind Phase||20
2913239|NCT00494507|3623061|FG000|Reached Endpoint of Acute Worsening|Double-Blind Phase||0
2913240|NCT00494507|3623062|FG001|Reached Endpoint of Acute Worsening|Double-Blind Phase||2
2913241|NCT00494507|3623063|FG002|Reached Endpoint of Acute Worsening|Double-Blind Phase||0
2913242|NCT00494507|3623064|FG003|Reached Endpoint of Acute Worsening|Double-Blind Phase||5
2913243|NCT00494507|3623061|FG000|COMPLETED|Double-Blind Phase||9
3166648|NCT01904773|3893899|FG002|NOT COMPLETED|Third Intervention||0
3166649|NCT01904773|3893900|FG003|NOT COMPLETED|Third Intervention||0
3166650|NCT01904773|3893901|FG004|NOT COMPLETED|Third Intervention||0
3166651|NCT01904773|3893902|FG005|NOT COMPLETED|Third Intervention||0
3166652|NCT01904773|3893903|FG006|NOT COMPLETED|Third Intervention||0
3166653|NCT01904773|3893904|FG007|NOT COMPLETED|Third Intervention||0
3166654|NCT01904773|3893905|FG008|NOT COMPLETED|Third Intervention||0
3166655|NCT01904773|3893897|FG000|STARTED|Placebo Washout Third Intervention||0
3166656|NCT01904773|3893898|FG001|STARTED|Placebo Washout Third Intervention||1
3166657|NCT01904773|3893899|FG002|STARTED|Placebo Washout Third Intervention||1
3166658|NCT01904773|3893900|FG003|STARTED|Placebo Washout Third Intervention||2
3166659|NCT01904773|3893901|FG004|STARTED|Placebo Washout Third Intervention||3
3166660|NCT01904773|3893902|FG005|STARTED|Placebo Washout Third Intervention||4
2828331|NCT03223350|3529563|FG000|STARTED|Overall Study||17
2828332|NCT03223350|3529564|FG001|STARTED|Overall Study||13
2828333|NCT03223350|3529563|FG000|COMPLETED|Overall Study||17
2828334|NCT03223350|3529564|FG001|COMPLETED|Overall Study||13
2828335|NCT03223350|3529563|FG000|NOT COMPLETED|Overall Study||0
2828336|NCT03223350|3529564|FG001|NOT COMPLETED|Overall Study||0
2828337|NCT03181828|3529572|FG000|STARTED|Overall Study||2
2828338|NCT03181828|3529573|FG001|STARTED|Overall Study||2
2828339|NCT03181828|3529572|FG000|COMPLETED|Overall Study||2
2828340|NCT03181828|3529573|FG001|COMPLETED|Overall Study||2
2828341|NCT03181828|3529572|FG000|NOT COMPLETED|Overall Study||0
2828342|NCT03181828|3529573|FG001|NOT COMPLETED|Overall Study||0
2828343|NCT03181529|3529581|FG000|STARTED|Overall Study||15
2828344|NCT03181529|3529582|FG001|STARTED|Overall Study||12
2828345|NCT03181529|3529581|FG000|COMPLETED|Overall Study||13
2828346|NCT03181529|3529582|FG001|COMPLETED|Overall Study||11
2828347|NCT03181529|3529581|FG000|NOT COMPLETED|Overall Study||2
2828348|NCT03181529|3529582|FG001|NOT COMPLETED|Overall Study||1
2828349|NCT03138096|3529593|FG000|STARTED|Overall Study||3
2828350|NCT03138096|3529594|FG001|STARTED|Overall Study||3
2828351|NCT03138096|3529595|FG002|STARTED|Overall Study||12
2828352|NCT03138096|3529596|FG003|STARTED|Overall Study||6
2828353|NCT03138096|3529597|FG004|STARTED|Overall Study|Phase 2 was not started because of unsufficient effectivity of the Pb(PfCS@UIS4) immunizations as pre-determined in the study protocol.|0
2828354|NCT03138096|3529593|FG000|COMPLETED|Overall Study||3
2828355|NCT03138096|3529594|FG001|COMPLETED|Overall Study||3
2828356|NCT03138096|3529595|FG002|COMPLETED|Overall Study||12
2828357|NCT03138096|3529596|FG003|COMPLETED|Overall Study||6
2828358|NCT03138096|3529597|FG004|COMPLETED|Overall Study||0
2828359|NCT03138096|3529593|FG000|NOT COMPLETED|Overall Study||0
2828360|NCT03138096|3529594|FG001|NOT COMPLETED|Overall Study||0
2828361|NCT03138096|3529595|FG002|NOT COMPLETED|Overall Study||0
2828362|NCT03138096|3529596|FG003|NOT COMPLETED|Overall Study||0
2828363|NCT03138096|3529597|FG004|NOT COMPLETED|Overall Study||0
2828364|NCT02993107|3529626|FG000|STARTED|Overall Study||113
2828365|NCT02993107|3529627|FG001|STARTED|Overall Study||120
2828366|NCT02993107|3529628|FG002|STARTED|Overall Study||50
2828367|NCT02993107|3529629|FG003|STARTED|Overall Study||35
2828368|NCT02993107|3529630|FG004|STARTED|Overall Study||34
2828369|NCT02993107|3529631|FG005|STARTED|Overall Study||36
2828370|NCT02993107|3529626|FG000|Adverse Event|Overall Study||12
2828371|NCT02993107|3529627|FG001|Adverse Event|Overall Study||4
2828372|NCT02993107|3529628|FG002|Adverse Event|Overall Study||1
2828373|NCT02993107|3529629|FG003|Adverse Event|Overall Study||1
2828374|NCT02993107|3529630|FG004|Adverse Event|Overall Study||3
2828375|NCT02993107|3529631|FG005|Adverse Event|Overall Study||5
2828376|NCT02993107|3529626|FG000|Physician Decision|Overall Study||1
2828377|NCT02993107|3529627|FG001|Physician Decision|Overall Study||0
2828378|NCT02993107|3529628|FG002|Physician Decision|Overall Study||1
2828379|NCT02993107|3529629|FG003|Physician Decision|Overall Study||0
2828380|NCT02993107|3529630|FG004|Physician Decision|Overall Study||0
2828381|NCT02993107|3529631|FG005|Physician Decision|Overall Study||0
2828382|NCT02993107|3529626|FG000|Withdrawal by Subject|Overall Study||32
2828383|NCT02993107|3529627|FG001|Withdrawal by Subject|Overall Study||7
2828384|NCT02993107|3529628|FG002|Withdrawal by Subject|Overall Study||7
2828385|NCT02993107|3529629|FG003|Withdrawal by Subject|Overall Study||3
2828386|NCT02993107|3529630|FG004|Withdrawal by Subject|Overall Study||6
2828387|NCT02993107|3529631|FG005|Withdrawal by Subject|Overall Study||2
2828388|NCT02993107|3529626|FG000|Lost to Follow-up|Overall Study||0
2828389|NCT02993107|3529627|FG001|Lost to Follow-up|Overall Study||1
2828390|NCT02993107|3529628|FG002|Lost to Follow-up|Overall Study||0
2828391|NCT02993107|3529629|FG003|Lost to Follow-up|Overall Study||0
2828392|NCT02993107|3529630|FG004|Lost to Follow-up|Overall Study||0
3166661|NCT01904773|3893903|FG006|STARTED|Placebo Washout Third Intervention||3
3166662|NCT01904773|3893904|FG007|STARTED|Placebo Washout Third Intervention||3
3166663|NCT01904773|3893905|FG008|STARTED|Placebo Washout Third Intervention||4
3166664|NCT01904773|3893897|FG000|COMPLETED|Placebo Washout Third Intervention||0
3166665|NCT01904773|3893898|FG001|COMPLETED|Placebo Washout Third Intervention||1
3166666|NCT01904773|3893899|FG002|COMPLETED|Placebo Washout Third Intervention||1
3166667|NCT01904773|3893900|FG003|COMPLETED|Placebo Washout Third Intervention||2
3166668|NCT01904773|3893901|FG004|COMPLETED|Placebo Washout Third Intervention||3
3166669|NCT01904773|3893902|FG005|COMPLETED|Placebo Washout Third Intervention||4
3166670|NCT01904773|3893903|FG006|COMPLETED|Placebo Washout Third Intervention||3
3166671|NCT01904773|3893904|FG007|COMPLETED|Placebo Washout Third Intervention||3
2828393|NCT02993107|3529631|FG005|Lost to Follow-up|Overall Study||1
2828394|NCT02993107|3529626|FG000|Sponsor Decision|Overall Study||4
2828395|NCT02993107|3529627|FG001|Sponsor Decision|Overall Study||0
2828396|NCT02993107|3529628|FG002|Sponsor Decision|Overall Study||1
2828397|NCT02993107|3529629|FG003|Sponsor Decision|Overall Study||1
2828398|NCT02993107|3529630|FG004|Sponsor Decision|Overall Study||0
2828399|NCT02993107|3529631|FG005|Sponsor Decision|Overall Study||4
2828400|NCT02993107|3529626|FG000|Protocol Deviation|Overall Study||0
2828401|NCT02993107|3529627|FG001|Protocol Deviation|Overall Study||0
2828402|NCT02993107|3529628|FG002|Protocol Deviation|Overall Study||0
2828403|NCT02993107|3529629|FG003|Protocol Deviation|Overall Study||0
2828404|NCT02993107|3529630|FG004|Protocol Deviation|Overall Study||1
2828405|NCT02993107|3529631|FG005|Protocol Deviation|Overall Study||0
2828406|NCT02993107|3529626|FG000|Other Reasons|Overall Study||2
2828407|NCT02993107|3529627|FG001|Other Reasons|Overall Study||1
2828408|NCT02993107|3529628|FG002|Other Reasons|Overall Study||1
2828409|NCT02993107|3529629|FG003|Other Reasons|Overall Study||1
2828410|NCT02993107|3529630|FG004|Other Reasons|Overall Study||2
2828411|NCT02993107|3529631|FG005|Other Reasons|Overall Study||3
2828412|NCT02993107|3529626|FG000|COMPLETED|Overall Study||62
2828413|NCT02993107|3529627|FG001|COMPLETED|Overall Study||107
2828414|NCT02993107|3529628|FG002|COMPLETED|Overall Study||39
2828415|NCT02993107|3529629|FG003|COMPLETED|Overall Study||29
2828416|NCT02993107|3529630|FG004|COMPLETED|Overall Study||22
2828417|NCT02993107|3529631|FG005|COMPLETED|Overall Study||21
2828418|NCT02993107|3529626|FG000|NOT COMPLETED|Overall Study||51
2828419|NCT02993107|3529627|FG001|NOT COMPLETED|Overall Study||13
2828420|NCT02993107|3529628|FG002|NOT COMPLETED|Overall Study||11
2828421|NCT02993107|3529629|FG003|NOT COMPLETED|Overall Study||6
2828422|NCT02993107|3529630|FG004|NOT COMPLETED|Overall Study||12
2828423|NCT02993107|3529631|FG005|NOT COMPLETED|Overall Study||15
2828424|NCT02946931|3529651|FG000|STARTED|Overall Study||1387
3166672|NCT01904773|3893905|FG008|COMPLETED|Placebo Washout Third Intervention||4
3166673|NCT01904773|3893897|FG000|NOT COMPLETED|Placebo Washout Third Intervention||0
3166674|NCT01904773|3893898|FG001|NOT COMPLETED|Placebo Washout Third Intervention||0
2828425|NCT02946931|3529651|FG000|Case Report Forms (CRFs) Collected|Overall Study||814
2828426|NCT02946931|3529651|FG000|COMPLETED|Overall Study||569
2828427|NCT02946931|3529651|FG000|NOT COMPLETED|Overall Study||818
2828428|NCT02779556|3529657|FG000|STARTED|Baseline||394
2828429|NCT02779556|3529658|FG001|STARTED|Baseline||362
2828430|NCT02779556|3529657|FG000|COMPLETED|Baseline||393
2828431|NCT02779556|3529658|FG001|COMPLETED|Baseline||362
2828432|NCT02779556|3529657|FG000|NOT COMPLETED|Baseline||1
2828433|NCT02779556|3529658|FG001|NOT COMPLETED|Baseline||0
2828434|NCT02779556|3529657|FG000|STARTED|3 Months||393
2828435|NCT02779556|3529658|FG001|STARTED|3 Months||362
2828436|NCT02779556|3529657|FG000|COMPLETED|3 Months||326
2828437|NCT02779556|3529658|FG001|COMPLETED|3 Months||314
2828438|NCT02779556|3529657|FG000|NOT COMPLETED|3 Months||67
2828439|NCT02779556|3529658|FG001|NOT COMPLETED|3 Months||48
2828440|NCT02779556|3529657|FG000|STARTED|6 Month|Those who were not lost to follow-up but missed the visit from the previous period were allowed to continue in the study and complete future interviews (314+19=333 Enhanced Usual Care).|353
2828441|NCT02779556|3529658|FG001|STARTED|6 Month|Those who were not lost to follow-up but missed the visit from the previous period were allowed to continue in the study and complete future interviews (326+27=353 Intervention).|333
2828442|NCT02779556|3529657|FG000|COMPLETED|6 Month||320
2828443|NCT02779556|3529658|FG001|COMPLETED|6 Month||294
2828444|NCT02779556|3529657|FG000|NOT COMPLETED|6 Month||33
3166675|NCT01904773|3893899|FG002|NOT COMPLETED|Placebo Washout Third Intervention||0
3166676|NCT01904773|3893900|FG003|NOT COMPLETED|Placebo Washout Third Intervention||0
3166677|NCT01904773|3893901|FG004|NOT COMPLETED|Placebo Washout Third Intervention||0
3166678|NCT01904773|3893902|FG005|NOT COMPLETED|Placebo Washout Third Intervention||0
3166679|NCT01904773|3893903|FG006|NOT COMPLETED|Placebo Washout Third Intervention||0
3166680|NCT01904773|3893904|FG007|NOT COMPLETED|Placebo Washout Third Intervention||0
3166681|NCT01904773|3893905|FG008|NOT COMPLETED|Placebo Washout Third Intervention||0
3166682|NCT01904773|3893897|FG000|STARTED|Fourth Intervention||0
3166683|NCT01904773|3893898|FG001|STARTED|Fourth Intervention||1
3166684|NCT01904773|3893899|FG002|STARTED|Fourth Intervention||1
2828445|NCT02779556|3529658|FG001|NOT COMPLETED|6 Month||39
2828446|NCT02779556|3529657|FG000|STARTED|6 Month HbA1c|All enrolled participants were eligible for the analysis of clinical values regardless of completion of 3 and 6 month interviews.|394
2828447|NCT02779556|3529658|FG001|STARTED|6 Month HbA1c|All enrolled participants were eligible for the analysis of clinical values regardless of completion of 3 and 6 month interviews.|362
2828448|NCT02779556|3529657|FG000|COMPLETED|6 Month HbA1c||325
2828449|NCT02779556|3529658|FG001|COMPLETED|6 Month HbA1c||312
2828450|NCT02779556|3529657|FG000|NOT COMPLETED|6 Month HbA1c||69
2828451|NCT02779556|3529658|FG001|NOT COMPLETED|6 Month HbA1c||50
2828452|NCT02779556|3529657|FG000|STARTED|12 Month HbA1c|All enrolled participants were eligible for the analysis of clinical values regardless of completion of 3 and 6 month interviews.|394
2828453|NCT02779556|3529658|FG001|STARTED|12 Month HbA1c|All enrolled participants were eligible for the analysis of clinical values regardless of completion of 3 and 6 month interviews.|362
2828454|NCT02779556|3529657|FG000|COMPLETED|12 Month HbA1c||256
2828455|NCT02779556|3529658|FG001|COMPLETED|12 Month HbA1c||260
2828456|NCT02779556|3529657|FG000|NOT COMPLETED|12 Month HbA1c||138
2828457|NCT02779556|3529658|FG001|NOT COMPLETED|12 Month HbA1c||102
2828458|NCT02724774|3529666|FG000|STARTED|Overall Study||127
2828459|NCT02724774|3529667|FG001|STARTED|Overall Study||125
2828460|NCT02724774|3529666|FG000|Infant 6 Months|Overall Study||122
2828461|NCT02724774|3529667|FG001|Infant 6 Months|Overall Study||122
2828462|NCT02724774|3529666|FG000|Infant 12 Months|Overall Study||120
2828463|NCT02724774|3529667|FG001|Infant 12 Months|Overall Study||123
2828464|NCT02724774|3529666|FG000|COMPLETED|Overall Study||120
2828465|NCT02724774|3529667|FG001|COMPLETED|Overall Study||123
2828466|NCT02724774|3529666|FG000|NOT COMPLETED|Overall Study||7
2828467|NCT02724774|3529667|FG001|NOT COMPLETED|Overall Study||2
2828468|NCT02722941|3529675|FG000|STARTED|Overall Study||15
2828469|NCT02722941|3529676|FG001|STARTED|Overall Study||15
2828470|NCT02722941|3529675|FG000|COMPLETED|Overall Study||15
2828471|NCT02722941|3529676|FG001|COMPLETED|Overall Study||15
2828472|NCT02722941|3529675|FG000|NOT COMPLETED|Overall Study||0
2828473|NCT02722941|3529676|FG001|NOT COMPLETED|Overall Study||0
2828474|NCT02675751|3529682|FG000|STARTED|Overall Study||167
2828475|NCT02675751|3529682|FG000|COMPLETED|Overall Study||151
2828476|NCT02675751|3529682|FG000|NOT COMPLETED|Overall Study||16
2828477|NCT02643381|3529688|FG000|STARTED|Overall Study||400
2828478|NCT02643381|3529689|FG001|STARTED|Overall Study||401
2828479|NCT02643381|3529688|FG000|COMPLETED|Overall Study||396
2828480|NCT02643381|3529689|FG001|COMPLETED|Overall Study||395
2828481|NCT02643381|3529688|FG000|NOT COMPLETED|Overall Study||4
2828482|NCT02643381|3529689|FG001|NOT COMPLETED|Overall Study||6
2828483|NCT02621424|3529697|FG000|STARTED|Overall Study||14
2828484|NCT02621424|3529698|FG001|STARTED|Overall Study||18
2828485|NCT02621424|3529697|FG000|COMPLETED|Overall Study||13
3166685|NCT01904773|3893900|FG003|STARTED|Fourth Intervention||2
3166686|NCT01904773|3893901|FG004|STARTED|Fourth Intervention||3
3166687|NCT01904773|3893902|FG005|STARTED|Fourth Intervention||4
2828486|NCT02621424|3529698|FG001|COMPLETED|Overall Study||16
2828487|NCT02621424|3529697|FG000|NOT COMPLETED|Overall Study||1
2828488|NCT02621424|3529698|FG001|NOT COMPLETED|Overall Study||2
2828489|NCT02611960|3529706|FG000|STARTED|Overall Study||117
2828490|NCT02611960|3529707|FG001|STARTED|Overall Study||116
2828491|NCT02611960|3529706|FG000|Treated|Overall Study||116
2828492|NCT02611960|3529707|FG001|Treated|Overall Study||112
2828493|NCT02611960|3529706|FG000|COMPLETED|Overall Study||0
2828494|NCT02611960|3529707|FG001|COMPLETED|Overall Study||0
2828495|NCT02611960|3529706|FG000|NOT COMPLETED|Overall Study||117
2828496|NCT02611960|3529707|FG001|NOT COMPLETED|Overall Study||116
2828497|NCT02595372|3529714|FG000|STARTED|Overall Study||42
2828498|NCT02595372|3529714|FG000|COMPLETED|Overall Study||33
2828499|NCT02595372|3529714|FG000|NOT COMPLETED|Overall Study||9
2828500|NCT02447133|3529718|FG000|STARTED|Overall Study||12
2828501|NCT02447133|3529718|FG000|COMPLETED|Overall Study||12
2828502|NCT02447133|3529718|FG000|NOT COMPLETED|Overall Study||0
2828503|NCT02434354|3529724|FG000|STARTED|Overall Study|Consented|33
2828504|NCT02434354|3529724|FG000|Post Consent Screening|Overall Study||30
2828505|NCT02434354|3529724|FG000|COMPLETED|Overall Study||30
2828506|NCT02434354|3529724|FG000|NOT COMPLETED|Overall Study||3
2828507|NCT02334722|3529730|FG000|STARTED|Overall Study||40
2828508|NCT02334722|3529731|FG001|STARTED|Overall Study||41
2828509|NCT02334722|3529730|FG000|COMPLETED|Overall Study||33
2828510|NCT02334722|3529731|FG001|COMPLETED|Overall Study||34
2828511|NCT02334722|3529730|FG000|NOT COMPLETED|Overall Study||7
2828512|NCT02334722|3529731|FG001|NOT COMPLETED|Overall Study||7
2828513|NCT02259725|3529737|FG000|STARTED|Overall Study||3
2828514|NCT02259725|3529737|FG000|COMPLETED|Overall Study||3
2828515|NCT02259725|3529737|FG000|NOT COMPLETED|Overall Study||0
2828516|NCT01966731|3529741|FG000|STARTED|Overall Study||635
2828517|NCT01966731|3529741|FG000|Initiated Hydroxyurea|Overall Study||606
2828518|NCT01966731|3529741|FG000|Completed 3 Months of Treatment|Overall Study||600
2828519|NCT01966731|3529741|FG000|Completed Study|Overall Study||0
2828520|NCT01966731|3529741|FG000|COMPLETED|Overall Study||0
2828521|NCT01966731|3529741|FG000|NOT COMPLETED|Overall Study||635
2828522|NCT01952288|3529747|FG000|STARTED|Overall Study||3
2828523|NCT01952288|3529748|FG001|STARTED|Overall Study||2
2828524|NCT01952288|3529747|FG000|COMPLETED|Overall Study||3
2828525|NCT01952288|3529748|FG001|COMPLETED|Overall Study||2
2828526|NCT01952288|3529747|FG000|NOT COMPLETED|Overall Study||0
2828527|NCT01952288|3529748|FG001|NOT COMPLETED|Overall Study||0
2828528|NCT01850082|3529756|FG000|STARTED|Overall Study||576
2828529|NCT01850082|3529757|FG001|STARTED|Overall Study||574
2828530|NCT01850082|3529756|FG000|COMPLETED|Overall Study||576
2828531|NCT01850082|3529757|FG001|COMPLETED|Overall Study||574
2828532|NCT01850082|3529756|FG000|NOT COMPLETED|Overall Study||0
2828533|NCT01850082|3529757|FG001|NOT COMPLETED|Overall Study||0
2828534|NCT01844518|3529765|FG000|STARTED|Overall Study||173
2828535|NCT01844518|3529766|FG001|STARTED|Overall Study||46
2828536|NCT01844518|3529765|FG000|COMPLETED|Overall Study||132
2828537|NCT01844518|3529766|FG001|COMPLETED|Overall Study||39
2828538|NCT01844518|3529765|FG000|NOT COMPLETED|Overall Study||41
2828539|NCT01844518|3529766|FG001|NOT COMPLETED|Overall Study||7
2828540|NCT01675479|3529775|FG000|STARTED|Overall Study||69
2828541|NCT01675479|3529775|FG000|COMPLETED|Overall Study||58
2828542|NCT01675479|3529775|FG000|NOT COMPLETED|Overall Study||11
2828543|NCT01398839|3529781|FG000|STARTED|Overall Study||35
2828544|NCT01398839|3529782|FG001|STARTED|Overall Study||37
2828545|NCT01398839|3529781|FG000|COMPLETED|Overall Study|The study was terminated. The exact number of patients completing all visits is unknown.|35
2828546|NCT01398839|3529782|FG001|COMPLETED|Overall Study|The study was terminated. The exact number of patients completing all visits is unknown.|37
2828547|NCT01398839|3529781|FG000|NOT COMPLETED|Overall Study||0
2828548|NCT01398839|3529782|FG001|NOT COMPLETED|Overall Study||0
2828549|NCT01349959|3529788|FG000|STARTED|Overall Study||40
2828550|NCT01349959|3529788|FG000|COMPLETED|Overall Study||33
2828551|NCT01349959|3529788|FG000|NOT COMPLETED|Overall Study||7
2828552|NCT01193842|3529797|FG000|STARTED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||3
2828553|NCT01193842|3529798|FG001|STARTED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
2828554|NCT01193842|3529799|FG002|STARTED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
2828555|NCT01193842|3529800|FG003|STARTED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
2828556|NCT01193842|3529801|FG004|STARTED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
2828557|NCT01193842|3529797|FG000|COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||3
2828558|NCT01193842|3529798|FG001|COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
2828559|NCT01193842|3529799|FG002|COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
3310239|NCT03038399|4043608|FG003|NOT COMPLETED|Overall Study||2
2828560|NCT01193842|3529800|FG003|COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
2828561|NCT01193842|3529801|FG004|COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
2828562|NCT01193842|3529797|FG000|NOT COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
2828563|NCT01193842|3529798|FG001|NOT COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
2828564|NCT01193842|3529799|FG002|NOT COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
2828565|NCT01193842|3529800|FG003|NOT COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
2828566|NCT01193842|3529801|FG004|NOT COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
2828567|NCT01193842|3529797|FG000|STARTED|Phase I: VR-DA-EPOCH, DL 2||0
2828568|NCT01193842|3529798|FG001|STARTED|Phase I: VR-DA-EPOCH, DL 2||7
2828569|NCT01193842|3529799|FG002|STARTED|Phase I: VR-DA-EPOCH, DL 2||0
2828570|NCT01193842|3529800|FG003|STARTED|Phase I: VR-DA-EPOCH, DL 2||0
2828571|NCT01193842|3529801|FG004|STARTED|Phase I: VR-DA-EPOCH, DL 2||0
2828572|NCT01193842|3529797|FG000|COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
2828573|NCT01193842|3529798|FG001|COMPLETED|Phase I: VR-DA-EPOCH, DL 2||6
2828574|NCT01193842|3529799|FG002|COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
2828575|NCT01193842|3529800|FG003|COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
2828576|NCT01193842|3529801|FG004|COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
2828577|NCT01193842|3529797|FG000|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
2828578|NCT01193842|3529798|FG001|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 2||1
2828579|NCT01193842|3529799|FG002|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
2828580|NCT01193842|3529800|FG003|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
2828581|NCT01193842|3529801|FG004|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
2828582|NCT01193842|3529797|FG000|STARTED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||4
2828583|NCT01193842|3529798|FG001|STARTED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
2828584|NCT01193842|3529799|FG002|STARTED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
2828585|NCT01193842|3529800|FG003|STARTED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
2828586|NCT01193842|3529801|FG004|STARTED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
2828587|NCT01193842|3529797|FG000|COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||3
2828588|NCT01193842|3529798|FG001|COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
2828589|NCT01193842|3529799|FG002|COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
2828590|NCT01193842|3529800|FG003|COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
2828591|NCT01193842|3529801|FG004|COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
2828592|NCT01193842|3529797|FG000|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||1
2828593|NCT01193842|3529798|FG001|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
2828594|NCT01193842|3529799|FG002|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
2828595|NCT01193842|3529800|FG003|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
2828596|NCT01193842|3529801|FG004|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
2828597|NCT01193842|3529797|FG000|STARTED|Phase I: VR-CHOP, DL 1||0
2828598|NCT01193842|3529798|FG001|STARTED|Phase I: VR-CHOP, DL 1||0
2828599|NCT01193842|3529799|FG002|STARTED|Phase I: VR-CHOP, DL 1||2
2828600|NCT01193842|3529800|FG003|STARTED|Phase I: VR-CHOP, DL 1||0
2828601|NCT01193842|3529801|FG004|STARTED|Phase I: VR-CHOP, DL 1||0
2828602|NCT01193842|3529797|FG000|COMPLETED|Phase I: VR-CHOP, DL 1||0
2828603|NCT01193842|3529798|FG001|COMPLETED|Phase I: VR-CHOP, DL 1||0
2828604|NCT01193842|3529799|FG002|COMPLETED|Phase I: VR-CHOP, DL 1||1
2828605|NCT01193842|3529800|FG003|COMPLETED|Phase I: VR-CHOP, DL 1||0
2828606|NCT01193842|3529801|FG004|COMPLETED|Phase I: VR-CHOP, DL 1||0
2828607|NCT01193842|3529797|FG000|NOT COMPLETED|Phase I: VR-CHOP, DL 1||0
2828608|NCT01193842|3529798|FG001|NOT COMPLETED|Phase I: VR-CHOP, DL 1||0
2828609|NCT01193842|3529799|FG002|NOT COMPLETED|Phase I: VR-CHOP, DL 1||1
2828610|NCT01193842|3529800|FG003|NOT COMPLETED|Phase I: VR-CHOP, DL 1||0
2828611|NCT01193842|3529801|FG004|NOT COMPLETED|Phase I: VR-CHOP, DL 1||0
2828612|NCT01193842|3529797|FG000|STARTED|Phase II: Randomized Groups||0
2828613|NCT01193842|3529798|FG001|STARTED|Phase II: Randomized Groups||0
2828614|NCT01193842|3529799|FG002|STARTED|Phase II: Randomized Groups||0
2828615|NCT01193842|3529800|FG003|STARTED|Phase II: Randomized Groups||45
2828616|NCT01193842|3529801|FG004|STARTED|Phase II: Randomized Groups||46
2828617|NCT01193842|3529797|FG000|COMPLETED|Phase II: Randomized Groups||0
2828618|NCT01193842|3529798|FG001|COMPLETED|Phase II: Randomized Groups||0
2828619|NCT01193842|3529799|FG002|COMPLETED|Phase II: Randomized Groups||0
2828620|NCT01193842|3529800|FG003|COMPLETED|Phase II: Randomized Groups||33
2828621|NCT01193842|3529801|FG004|COMPLETED|Phase II: Randomized Groups||36
2828622|NCT01193842|3529797|FG000|NOT COMPLETED|Phase II: Randomized Groups||0
2828623|NCT01193842|3529798|FG001|NOT COMPLETED|Phase II: Randomized Groups||0
2828624|NCT01193842|3529799|FG002|NOT COMPLETED|Phase II: Randomized Groups||0
2828625|NCT01193842|3529800|FG003|NOT COMPLETED|Phase II: Randomized Groups||12
2828626|NCT01193842|3529801|FG004|NOT COMPLETED|Phase II: Randomized Groups||10
2828627|NCT01168219|3529818|FG000|STARTED|Overall Study||68
2828628|NCT01168219|3529818|FG000|COMPLETED|Overall Study||63
2828629|NCT01168219|3529818|FG000|NOT COMPLETED|Overall Study||5
2913244|NCT00494507|3623062|FG001|COMPLETED|Double-Blind Phase||9
2913245|NCT00494507|3623063|FG002|COMPLETED|Double-Blind Phase||22
2913246|NCT00494507|3623064|FG003|COMPLETED|Double-Blind Phase||19
2913247|NCT00494507|3623061|FG000|NOT COMPLETED|Double-Blind Phase||3
2913248|NCT00494507|3623062|FG001|NOT COMPLETED|Double-Blind Phase||0
2913249|NCT00494507|3623063|FG002|NOT COMPLETED|Double-Blind Phase||2
2913250|NCT00494507|3623064|FG003|NOT COMPLETED|Double-Blind Phase||1
2913251|NCT00494507|3623061|FG000|STARTED|Open-Label Phase||9
2920639|NCT00537680|3631156|FG000|NOT COMPLETED|Overall Study||0
2828630|NCT01081262|3529826|FG000|STARTED|Overall Study||13
2828631|NCT01081262|3529827|FG001|STARTED|Overall Study||13
2828632|NCT01081262|3529828|FG002|STARTED|Overall Study||13
2828633|NCT01081262|3529829|FG003|STARTED|Overall Study||11
2828634|NCT01081262|3529826|FG000|COMPLETED|Overall Study||13
2828635|NCT01081262|3529827|FG001|COMPLETED|Overall Study||13
2828636|NCT01081262|3529828|FG002|COMPLETED|Overall Study||13
2828637|NCT01081262|3529829|FG003|COMPLETED|Overall Study||11
2828638|NCT01081262|3529826|FG000|NOT COMPLETED|Overall Study||0
2828639|NCT01081262|3529827|FG001|NOT COMPLETED|Overall Study||0
2828640|NCT01081262|3529828|FG002|NOT COMPLETED|Overall Study||0
2828641|NCT01081262|3529829|FG003|NOT COMPLETED|Overall Study||0
2828642|NCT01062425|3529841|FG000|STARTED|Overall Study||55
2828643|NCT01062425|3529842|FG001|STARTED|Overall Study||103
2828644|NCT01062425|3529841|FG000|COMPLETED|Overall Study|Randomized eligible subjects are considered to have completed the study.|52
2828645|NCT01062425|3529842|FG001|COMPLETED|Overall Study|Randomized eligible subjects are considered to have completed the study.|97
2828646|NCT01062425|3529841|FG000|NOT COMPLETED|Overall Study||3
2828647|NCT01062425|3529842|FG001|NOT COMPLETED|Overall Study||6
2828648|NCT00812708|3529848|FG000|STARTED|Overall Study|6 patients withdrew from the study before being taken to the operating room.|72
2828649|NCT00812708|3529848|FG000|Taken to Surgery for Device Implantation|Overall Study|2 patients could not be implanted because of intraoperative complications.|66
2828650|NCT00812708|3529848|FG000|COMPLETED|Overall Study||64
2828651|NCT00812708|3529848|FG000|NOT COMPLETED|Overall Study||8
2828652|NCT00792259|3529856|FG000|STARTED|Overall Study||15
2828653|NCT00792259|3529857|FG001|STARTED|Overall Study||20
2828654|NCT00792259|3529858|FG002|STARTED|Overall Study||13
2828655|NCT00792259|3529856|FG000|COMPLETED|Overall Study||14
2828656|NCT00792259|3529857|FG001|COMPLETED|Overall Study||20
2828657|NCT00792259|3529858|FG002|COMPLETED|Overall Study||13
2828658|NCT00792259|3529856|FG000|NOT COMPLETED|Overall Study||1
2828659|NCT00792259|3529857|FG001|NOT COMPLETED|Overall Study||0
2828660|NCT00792259|3529858|FG002|NOT COMPLETED|Overall Study||0
2828661|NCT00741988|3529868|FG000|STARTED|Overall Study||42
3310240|NCT03038620|4043622|FG000|STARTED|Overall Study||92
3310241|NCT03038620|4043623|FG001|STARTED|Overall Study||93
3310242|NCT03038620|4043622|FG000|COMPLETED|Overall Study||73
3310243|NCT03038620|4043623|FG001|COMPLETED|Overall Study||55
3310244|NCT03038620|4043622|FG000|NOT COMPLETED|Overall Study||19
2828662|NCT00741988|3529869|FG001|STARTED|Overall Study||40
2828663|NCT00741988|3529868|FG000|COMPLETED|Overall Study||38
2828664|NCT00741988|3529869|FG001|COMPLETED|Overall Study||36
2828665|NCT00741988|3529868|FG000|NOT COMPLETED|Overall Study||4
2828666|NCT00741988|3529869|FG001|NOT COMPLETED|Overall Study||4
2828667|NCT00563576|3529877|FG000|STARTED|Overall Study||35
2828668|NCT00563576|3529878|FG001|STARTED|Overall Study||36
2828669|NCT00563576|3529877|FG000|COMPLETED|Overall Study||21
2828670|NCT00563576|3529878|FG001|COMPLETED|Overall Study||22
2828671|NCT00563576|3529877|FG000|NOT COMPLETED|Overall Study||14
2828672|NCT00563576|3529878|FG001|NOT COMPLETED|Overall Study||14
2828673|NCT00515671|3529886|FG000|STARTED|Overall Study||60
2828674|NCT00515671|3529887|FG001|STARTED|Overall Study||58
2828675|NCT00515671|3529886|FG000|COMPLETED|Overall Study||43
2828676|NCT00515671|3529887|FG001|COMPLETED|Overall Study||41
2828677|NCT00515671|3529886|FG000|NOT COMPLETED|Overall Study||17
2828678|NCT00515671|3529887|FG001|NOT COMPLETED|Overall Study||17
2828679|NCT00455403|3529895|FG000|STARTED|Overall Study||59
2828680|NCT00455403|3529896|FG001|STARTED|Overall Study||57
2828681|NCT00455403|3529895|FG000|COMPLETED|Overall Study||56
2828682|NCT00455403|3529896|FG001|COMPLETED|Overall Study||51
2828683|NCT00455403|3529895|FG000|NOT COMPLETED|Overall Study||3
2828684|NCT00455403|3529896|FG001|NOT COMPLETED|Overall Study||6
2828685|NCT00238420|3529904|FG000|STARTED|Overall Study||22
2828686|NCT00238420|3529905|FG001|STARTED|Overall Study||48
2828687|NCT00238420|3529904|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|21
2828688|NCT00238420|3529905|FG001|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|47
2828689|NCT00238420|3529904|FG000|NOT COMPLETED|Overall Study||1
2828690|NCT00238420|3529905|FG001|NOT COMPLETED|Overall Study||1
2828691|NCT00085982|3529911|FG000|STARTED|Overall Study||11
2828692|NCT00085982|3529911|FG000|COMPLETED|Overall Study||5
2828693|NCT00085982|3529911|FG000|NOT COMPLETED|Overall Study||6
2828694|NCT04328961|3529917|FG000|STARTED|Overall Study||422
2828695|NCT04328961|3529918|FG001|STARTED|Overall Study||407
2828696|NCT04328961|3529917|FG000|COMPLETED|Overall Study||336
2828697|NCT04328961|3529918|FG001|COMPLETED|Overall Study||353
2828698|NCT04328961|3529917|FG000|NOT COMPLETED|Overall Study||86
2828699|NCT04328961|3529918|FG001|NOT COMPLETED|Overall Study||54
2828700|NCT04128319|3529924|FG000|STARTED|Overall Study||3
2828701|NCT04128319|3529924|FG000|Initiated T-Guard Treatment|Overall Study||3
2828702|NCT04128319|3529924|FG000|COMPLETED|Overall Study||0
2828703|NCT04128319|3529924|FG000|NOT COMPLETED|Overall Study||3
2828704|NCT03761810|3529930|FG000|STARTED|Overall Study||290
2828705|NCT03761810|3529931|FG001|STARTED|Overall Study||144
2828706|NCT03761810|3529930|FG000|Received at Least 1 Dose of Study Drug|Overall Study||281
2828707|NCT03761810|3529931|FG001|Received at Least 1 Dose of Study Drug|Overall Study||138
2828708|NCT03761810|3529930|FG000|COMPLETED|Overall Study||242
3310245|NCT03038620|4043623|FG001|NOT COMPLETED|Overall Study||38
3310246|NCT03038815|4043631|FG000|STARTED|Controll Condition, 1 Hour||10
2828709|NCT03761810|3529931|FG001|COMPLETED|Overall Study||132
2828710|NCT03761810|3529930|FG000|NOT COMPLETED|Overall Study||48
2828711|NCT03761810|3529931|FG001|NOT COMPLETED|Overall Study||12
2828712|NCT03761784|3529939|FG000|STARTED|Overall Study||281
2828713|NCT03761784|3529940|FG001|STARTED|Overall Study||143
2828714|NCT03761784|3529939|FG000|Received at Least 1 Dose of Study Drug|Overall Study||274
2828715|NCT03761784|3529940|FG001|Received at Least 1 Dose of Study Drug|Overall Study||139
2828716|NCT03761784|3529939|FG000|COMPLETED|Overall Study||249
2828717|NCT03761784|3529940|FG001|COMPLETED|Overall Study||131
2828718|NCT03761784|3529939|FG000|NOT COMPLETED|Overall Study||32
2828719|NCT03761784|3529940|FG001|NOT COMPLETED|Overall Study||12
2828720|NCT03541317|3529948|FG000|STARTED|Stage 1 of the Implementation||6
2828721|NCT03541317|3529949|FG001|STARTED|Stage 1 of the Implementation||37
2828722|NCT03541317|3529950|FG002|STARTED|Stage 1 of the Implementation||38
2828723|NCT03541317|3529951|FG003|STARTED|Stage 1 of the Implementation||9
2828724|NCT03541317|3529952|FG004|STARTED|Stage 1 of the Implementation||43
2828725|NCT03541317|3529953|FG005|STARTED|Stage 1 of the Implementation||36
2828726|NCT03541317|3529948|FG000|COMPLETED|Stage 1 of the Implementation||6
2828727|NCT03541317|3529949|FG001|COMPLETED|Stage 1 of the Implementation||37
2828728|NCT03541317|3529950|FG002|COMPLETED|Stage 1 of the Implementation||38
2828729|NCT03541317|3529951|FG003|COMPLETED|Stage 1 of the Implementation||9
2828730|NCT03541317|3529952|FG004|COMPLETED|Stage 1 of the Implementation||43
2828731|NCT03541317|3529953|FG005|COMPLETED|Stage 1 of the Implementation||36
2828732|NCT03541317|3529948|FG000|NOT COMPLETED|Stage 1 of the Implementation||0
2828733|NCT03541317|3529949|FG001|NOT COMPLETED|Stage 1 of the Implementation||0
2828734|NCT03541317|3529950|FG002|NOT COMPLETED|Stage 1 of the Implementation||0
2828735|NCT03541317|3529951|FG003|NOT COMPLETED|Stage 1 of the Implementation||0
2828736|NCT03541317|3529952|FG004|NOT COMPLETED|Stage 1 of the Implementation||0
2828737|NCT03541317|3529953|FG005|NOT COMPLETED|Stage 1 of the Implementation||0
2828738|NCT03541317|3529948|FG000|STARTED|Stage 2 of the Implementation||6
2828739|NCT03541317|3529949|FG001|STARTED|Stage 2 of the Implementation||37
2828740|NCT03541317|3529950|FG002|STARTED|Stage 2 of the Implementation||38
2828741|NCT03541317|3529951|FG003|STARTED|Stage 2 of the Implementation||9
2828742|NCT03541317|3529952|FG004|STARTED|Stage 2 of the Implementation||43
2828743|NCT03541317|3529953|FG005|STARTED|Stage 2 of the Implementation||36
2828744|NCT03541317|3529948|FG000|COMPLETED|Stage 2 of the Implementation||5
2828745|NCT03541317|3529949|FG001|COMPLETED|Stage 2 of the Implementation||37
2828746|NCT03541317|3529950|FG002|COMPLETED|Stage 2 of the Implementation||38
2828747|NCT03541317|3529951|FG003|COMPLETED|Stage 2 of the Implementation||9
2828748|NCT03541317|3529952|FG004|COMPLETED|Stage 2 of the Implementation||43
2828749|NCT03541317|3529953|FG005|COMPLETED|Stage 2 of the Implementation||36
2828750|NCT03541317|3529948|FG000|NOT COMPLETED|Stage 2 of the Implementation||1
2828751|NCT03541317|3529949|FG001|NOT COMPLETED|Stage 2 of the Implementation||0
2828752|NCT03541317|3529950|FG002|NOT COMPLETED|Stage 2 of the Implementation||0
2828753|NCT03541317|3529951|FG003|NOT COMPLETED|Stage 2 of the Implementation||0
2828754|NCT03541317|3529952|FG004|NOT COMPLETED|Stage 2 of the Implementation||0
2828755|NCT03541317|3529953|FG005|NOT COMPLETED|Stage 2 of the Implementation||0
2913252|NCT00494507|3623062|FG001|STARTED|Open-Label Phase|1 subject randomized to Acetazolamide in this phase is not included-drug arm was removed from trial.|8
2913253|NCT00494507|3623063|FG002|STARTED|Open-Label Phase||22
2913254|NCT00494507|3623064|FG003|STARTED|Open-Label Phase||19
2913255|NCT00494507|3623061|FG000|COMPLETED|Open-Label Phase||9
2913256|NCT00494507|3623062|FG001|COMPLETED|Open-Label Phase||7
2913257|NCT00494507|3623063|FG002|COMPLETED|Open-Label Phase||17
2913258|NCT00494507|3623064|FG003|COMPLETED|Open-Label Phase||14
2913259|NCT00494507|3623061|FG000|NOT COMPLETED|Open-Label Phase||0
3166688|NCT01904773|3893903|FG006|STARTED|Fourth Intervention||3
3166689|NCT01904773|3893904|FG007|STARTED|Fourth Intervention||3
3166690|NCT01904773|3893905|FG008|STARTED|Fourth Intervention||4
3166691|NCT01904773|3893897|FG000|COMPLETED|Fourth Intervention||0
2913260|NCT00494507|3623062|FG001|NOT COMPLETED|Open-Label Phase||1
2913261|NCT00494507|3623063|FG002|NOT COMPLETED|Open-Label Phase||5
2913262|NCT00494507|3623064|FG003|NOT COMPLETED|Open-Label Phase||5
2913263|NCT00494585|3623084|FG000|STARTED|Overall Study||22
2913264|NCT00494585|3623084|FG000|COMPLETED|Overall Study||22
2913265|NCT00494585|3623084|FG000|NOT COMPLETED|Overall Study||0
2913266|NCT00494676|3623088|FG000|STARTED|Allocation||37
2913267|NCT00494676|3623089|FG001|STARTED|Allocation||36
2913268|NCT00494676|3623088|FG000|COMPLETED|Allocation||35
2913269|NCT00494676|3623089|FG001|COMPLETED|Allocation||32
2913270|NCT00494676|3623088|FG000|NOT COMPLETED|Allocation||2
2913271|NCT00494676|3623089|FG001|NOT COMPLETED|Allocation||4
2913272|NCT00494676|3623088|FG000|STARTED|First Intervention||35
2913273|NCT00494676|3623089|FG001|STARTED|First Intervention||32
2913274|NCT00494676|3623088|FG000|COMPLETED|First Intervention||34
2913275|NCT00494676|3623089|FG001|COMPLETED|First Intervention||29
2913276|NCT00494676|3623088|FG000|NOT COMPLETED|First Intervention||1
2913277|NCT00494676|3623089|FG001|NOT COMPLETED|First Intervention||3
2913278|NCT00494676|3623088|FG000|STARTED|Second Intervention||34
2913279|NCT00494676|3623089|FG001|STARTED|Second Intervention||29
2913280|NCT00494676|3623088|FG000|COMPLETED|Second Intervention||33
2913281|NCT00494676|3623089|FG001|COMPLETED|Second Intervention||28
2913282|NCT00494676|3623088|FG000|NOT COMPLETED|Second Intervention||1
2913283|NCT00494676|3623089|FG001|NOT COMPLETED|Second Intervention||1
2828756|NCT03457129|3529967|FG000|STARTED|Overall Study||10
2828757|NCT03457129|3529968|FG001|STARTED|Overall Study||10
2828758|NCT03457129|3529967|FG000|COMPLETED|Overall Study||7
2828759|NCT03457129|3529968|FG001|COMPLETED|Overall Study||8
2828760|NCT03457129|3529967|FG000|NOT COMPLETED|Overall Study||3
2828761|NCT03457129|3529968|FG001|NOT COMPLETED|Overall Study||2
2828762|NCT03361865|3529976|FG000|STARTED|Overall Study||44
2828763|NCT03361865|3529977|FG001|STARTED|Overall Study||49
2828764|NCT03361865|3529976|FG000|Intention-to-Treat (ITT)|Overall Study||44
2828765|NCT03361865|3529977|FG001|Intention-to-Treat (ITT)|Overall Study||49
2828766|NCT03361865|3529976|FG000|All Participants as Treated (APaT)|Overall Study||43
2828767|NCT03361865|3529977|FG001|All Participants as Treated (APaT)|Overall Study||49
2828768|NCT03361865|3529976|FG000|COMPLETED|Overall Study||25
2828769|NCT03361865|3529977|FG001|COMPLETED|Overall Study||22
2828770|NCT03361865|3529976|FG000|NOT COMPLETED|Overall Study||19
2828771|NCT03361865|3529977|FG001|NOT COMPLETED|Overall Study||27
2828772|NCT03294304|3529984|FG000|STARTED|Overall Study||43
2828773|NCT03294304|3529984|FG000|COMPLETED|Overall Study||43
2828774|NCT03294304|3529984|FG000|NOT COMPLETED|Overall Study||0
2828775|NCT03122431|3529991|FG000|STARTED|Overall Study||41
2828776|NCT03122431|3529992|FG001|STARTED|Overall Study||32
2828777|NCT03122431|3529993|FG002|STARTED|Overall Study||20
2828778|NCT03122431|3529991|FG000|COMPLETED|Overall Study||41
2828779|NCT03122431|3529992|FG001|COMPLETED|Overall Study||32
2828780|NCT03122431|3529993|FG002|COMPLETED|Overall Study||9
2828781|NCT03122431|3529991|FG000|NOT COMPLETED|Overall Study||0
2828782|NCT03122431|3529992|FG001|NOT COMPLETED|Overall Study||0
2828783|NCT03122431|3529993|FG002|NOT COMPLETED|Overall Study||11
2828784|NCT02929056|3530003|FG000|STARTED|Overall Study||1
2828785|NCT02929056|3530004|FG001|STARTED|Overall Study||1
2828786|NCT02929056|3530003|FG000|COMPLETED|Overall Study||1
2828787|NCT02929056|3530004|FG001|COMPLETED|Overall Study||0
2828788|NCT02929056|3530003|FG000|NOT COMPLETED|Overall Study||0
2828789|NCT02929056|3530004|FG001|NOT COMPLETED|Overall Study||1
2828790|NCT02896855|3530012|FG000|STARTED|Overall Study||121
2828791|NCT02896855|3530013|FG001|STARTED|Overall Study||122
2828792|NCT02896855|3530012|FG000|Received Any Study Treatment|Overall Study||120
2828793|NCT02896855|3530013|FG001|Received Any Study Treatment|Overall Study||122
2828794|NCT02896855|3530012|FG000|Crossed Over From Placebo to Receive Pertuzumab|Overall Study|From 07-March-2020, 12 participants randomized to the Placebo arm crossed over to open-label pertuzumab.|12
2828795|NCT02896855|3530013|FG001|Crossed Over From Placebo to Receive Pertuzumab|Overall Study||0
2828796|NCT02896855|3530012|FG000|COMPLETED|Overall Study||49
2828797|NCT02896855|3530013|FG001|COMPLETED|Overall Study||69
2828798|NCT02896855|3530012|FG000|NOT COMPLETED|Overall Study||72
2828799|NCT02896855|3530013|FG001|NOT COMPLETED|Overall Study||53
2828800|NCT02871778|3530026|FG000|STARTED|Part A: Treatment Period 1||43
2828801|NCT02871778|3530027|FG001|STARTED|Part A: Treatment Period 1||41
2828802|NCT02871778|3530028|FG002|STARTED|Part A: Treatment Period 1||21
2828803|NCT02871778|3530029|FG003|STARTED|Part A: Treatment Period 1||18
2828804|NCT02871778|3530030|FG004|STARTED|Part A: Treatment Period 1||0
2828805|NCT02871778|3530031|FG005|STARTED|Part A: Treatment Period 1||0
2828806|NCT02871778|3530032|FG006|STARTED|Part A: Treatment Period 1||0
2828807|NCT02871778|3530033|FG007|STARTED|Part A: Treatment Period 1||0
2828808|NCT02871778|3530026|FG000|Safety Analysis Set|Part A: Treatment Period 1|1 participant was randomized to receive HS in Period 1, but instead received VX-371 in HS in Period 1.|44
2828809|NCT02871778|3530027|FG001|Safety Analysis Set|Part A: Treatment Period 1||40
2828810|NCT02871778|3530028|FG002|Safety Analysis Set|Part A: Treatment Period 1||21
2828811|NCT02871778|3530029|FG003|Safety Analysis Set|Part A: Treatment Period 1||18
2828812|NCT02871778|3530030|FG004|Safety Analysis Set|Part A: Treatment Period 1||0
2828813|NCT02871778|3530031|FG005|Safety Analysis Set|Part A: Treatment Period 1||0
2828814|NCT02871778|3530032|FG006|Safety Analysis Set|Part A: Treatment Period 1||0
2828815|NCT02871778|3530033|FG007|Safety Analysis Set|Part A: Treatment Period 1||0
2828816|NCT02871778|3530026|FG000|COMPLETED|Part A: Treatment Period 1||40
2828817|NCT02871778|3530027|FG001|COMPLETED|Part A: Treatment Period 1||37
2828818|NCT02871778|3530028|FG002|COMPLETED|Part A: Treatment Period 1||18
2828819|NCT02871778|3530029|FG003|COMPLETED|Part A: Treatment Period 1||16
2828820|NCT02871778|3530030|FG004|COMPLETED|Part A: Treatment Period 1||0
2828821|NCT02871778|3530031|FG005|COMPLETED|Part A: Treatment Period 1||0
2828822|NCT02871778|3530032|FG006|COMPLETED|Part A: Treatment Period 1||0
2828823|NCT02871778|3530033|FG007|COMPLETED|Part A: Treatment Period 1||0
2828824|NCT02871778|3530026|FG000|NOT COMPLETED|Part A: Treatment Period 1||3
2828825|NCT02871778|3530027|FG001|NOT COMPLETED|Part A: Treatment Period 1||4
2828826|NCT02871778|3530028|FG002|NOT COMPLETED|Part A: Treatment Period 1||3
2828827|NCT02871778|3530029|FG003|NOT COMPLETED|Part A: Treatment Period 1||2
2828828|NCT02871778|3530030|FG004|NOT COMPLETED|Part A: Treatment Period 1||0
2828829|NCT02871778|3530031|FG005|NOT COMPLETED|Part A: Treatment Period 1||0
2828830|NCT02871778|3530032|FG006|NOT COMPLETED|Part A: Treatment Period 1||0
2828831|NCT02871778|3530033|FG007|NOT COMPLETED|Part A: Treatment Period 1||0
2828832|NCT02871778|3530026|FG000|STARTED|Part A: Treatment Period 2||40
2828833|NCT02871778|3530027|FG001|STARTED|Part A: Treatment Period 2||37
2828834|NCT02871778|3530028|FG002|STARTED|Part A: Treatment Period 2||18
2828835|NCT02871778|3530029|FG003|STARTED|Part A: Treatment Period 2||16
2828836|NCT02871778|3530030|FG004|STARTED|Part A: Treatment Period 2||0
2828837|NCT02871778|3530031|FG005|STARTED|Part A: Treatment Period 2||0
2828838|NCT02871778|3530032|FG006|STARTED|Part A: Treatment Period 2||0
2828839|NCT02871778|3530033|FG007|STARTED|Part A: Treatment Period 2||0
2828840|NCT02871778|3530026|FG000|Safety Analysis Set|Part A: Treatment Period 2||40
2828841|NCT02871778|3530027|FG001|Safety Analysis Set|Part A: Treatment Period 2||37
2828842|NCT02871778|3530028|FG002|Safety Analysis Set|Part A: Treatment Period 2||18
2828843|NCT02871778|3530029|FG003|Safety Analysis Set|Part A: Treatment Period 2||16
2828844|NCT02871778|3530030|FG004|Safety Analysis Set|Part A: Treatment Period 2||0
2828845|NCT02871778|3530031|FG005|Safety Analysis Set|Part A: Treatment Period 2||0
2828846|NCT02871778|3530032|FG006|Safety Analysis Set|Part A: Treatment Period 2||0
2828847|NCT02871778|3530033|FG007|Safety Analysis Set|Part A: Treatment Period 2||0
2828848|NCT02871778|3530026|FG000|COMPLETED|Part A: Treatment Period 2||37
2828849|NCT02871778|3530027|FG001|COMPLETED|Part A: Treatment Period 2||35
2828850|NCT02871778|3530028|FG002|COMPLETED|Part A: Treatment Period 2||17
2828851|NCT02871778|3530029|FG003|COMPLETED|Part A: Treatment Period 2||15
2828852|NCT02871778|3530030|FG004|COMPLETED|Part A: Treatment Period 2||0
2828853|NCT02871778|3530031|FG005|COMPLETED|Part A: Treatment Period 2||0
2828854|NCT02871778|3530032|FG006|COMPLETED|Part A: Treatment Period 2||0
2828855|NCT02871778|3530033|FG007|COMPLETED|Part A: Treatment Period 2||0
2828856|NCT02871778|3530026|FG000|NOT COMPLETED|Part A: Treatment Period 2||3
2828857|NCT02871778|3530027|FG001|NOT COMPLETED|Part A: Treatment Period 2||2
2828858|NCT02871778|3530028|FG002|NOT COMPLETED|Part A: Treatment Period 2||1
2828859|NCT02871778|3530029|FG003|NOT COMPLETED|Part A: Treatment Period 2||1
2828860|NCT02871778|3530030|FG004|NOT COMPLETED|Part A: Treatment Period 2||0
2828861|NCT02871778|3530031|FG005|NOT COMPLETED|Part A: Treatment Period 2||0
2828862|NCT02871778|3530032|FG006|NOT COMPLETED|Part A: Treatment Period 2||0
2828863|NCT02871778|3530033|FG007|NOT COMPLETED|Part A: Treatment Period 2||0
2828864|NCT02871778|3530026|FG000|STARTED|Part B: Treatment Period 3||0
2828865|NCT02871778|3530027|FG001|STARTED|Part B: Treatment Period 3||0
2828866|NCT02871778|3530028|FG002|STARTED|Part B: Treatment Period 3||0
2828867|NCT02871778|3530029|FG003|STARTED|Part B: Treatment Period 3||0
2828868|NCT02871778|3530030|FG004|STARTED|Part B: Treatment Period 3|Out of 35 participants who were on VX-371 in HS in Treatment period 2 and completed Part A, 11 participants rolled-over to Part B.|11
2828869|NCT02871778|3530031|FG005|STARTED|Part B: Treatment Period 3|Out of 37 participants who were on HS in Treatment period 2 and completed Part A, 27 participants rolled-over to Part B.|27
2828870|NCT02871778|3530032|FG006|STARTED|Part B: Treatment Period 3|Out of 15 participants who were on VX-371 in Treatment period 2 and completed Part A, 7 participants rolled-over to Part B.|7
2828871|NCT02871778|3530033|FG007|STARTED|Part B: Treatment Period 3|Out of 17 participants who were on Placebo in Treatment period 2 and completed Part A, 12 participants rolled-over to Part B.|12
2828872|NCT02871778|3530026|FG000|Safety Analysis Set|Part B: Treatment Period 3||0
2828873|NCT02871778|3530027|FG001|Safety Analysis Set|Part B: Treatment Period 3||0
2828874|NCT02871778|3530028|FG002|Safety Analysis Set|Part B: Treatment Period 3||0
2828875|NCT02871778|3530029|FG003|Safety Analysis Set|Part B: Treatment Period 3||0
2828876|NCT02871778|3530030|FG004|Safety Analysis Set|Part B: Treatment Period 3||11
3166692|NCT01904773|3893898|FG001|COMPLETED|Fourth Intervention||1
3166693|NCT01904773|3893899|FG002|COMPLETED|Fourth Intervention||1
3166694|NCT01904773|3893900|FG003|COMPLETED|Fourth Intervention||2
2828877|NCT02871778|3530031|FG005|Safety Analysis Set|Part B: Treatment Period 3||27
2828878|NCT02871778|3530032|FG006|Safety Analysis Set|Part B: Treatment Period 3||7
2828879|NCT02871778|3530033|FG007|Safety Analysis Set|Part B: Treatment Period 3||12
2828880|NCT02871778|3530026|FG000|COMPLETED|Part B: Treatment Period 3||0
2828881|NCT02871778|3530027|FG001|COMPLETED|Part B: Treatment Period 3||0
2828882|NCT02871778|3530028|FG002|COMPLETED|Part B: Treatment Period 3||0
2828883|NCT02871778|3530029|FG003|COMPLETED|Part B: Treatment Period 3||0
2828884|NCT02871778|3530030|FG004|COMPLETED|Part B: Treatment Period 3||10
2828885|NCT02871778|3530031|FG005|COMPLETED|Part B: Treatment Period 3||26
2828886|NCT02871778|3530032|FG006|COMPLETED|Part B: Treatment Period 3||6
2828887|NCT02871778|3530033|FG007|COMPLETED|Part B: Treatment Period 3||12
2828888|NCT02871778|3530026|FG000|NOT COMPLETED|Part B: Treatment Period 3||0
2828889|NCT02871778|3530027|FG001|NOT COMPLETED|Part B: Treatment Period 3||0
2828890|NCT02871778|3530028|FG002|NOT COMPLETED|Part B: Treatment Period 3||0
2828891|NCT02871778|3530029|FG003|NOT COMPLETED|Part B: Treatment Period 3||0
2828892|NCT02871778|3530030|FG004|NOT COMPLETED|Part B: Treatment Period 3||1
2828893|NCT02871778|3530031|FG005|NOT COMPLETED|Part B: Treatment Period 3||1
2828894|NCT02871778|3530032|FG006|NOT COMPLETED|Part B: Treatment Period 3||1
2828895|NCT02871778|3530033|FG007|NOT COMPLETED|Part B: Treatment Period 3||0
2828896|NCT02769000|3530057|FG000|STARTED|Overall Study||5
2828897|NCT02769000|3530058|FG001|STARTED|Overall Study||0
2828898|NCT02769000|3530057|FG000|COMPLETED|Overall Study||5
2828899|NCT02769000|3530058|FG001|COMPLETED|Overall Study||0
2828900|NCT02769000|3530057|FG000|NOT COMPLETED|Overall Study||0
2828901|NCT02769000|3530058|FG001|NOT COMPLETED|Overall Study||0
2828902|NCT02756208|3530066|FG000|STARTED|Overall Study||18
2828903|NCT02756208|3530067|FG001|STARTED|Overall Study||16
2828904|NCT02756208|3530068|FG002|STARTED|Overall Study||15
2828905|NCT02756208|3530069|FG003|STARTED|Overall Study||16
3166695|NCT01904773|3893901|FG004|COMPLETED|Fourth Intervention||3
3166696|NCT01904773|3893902|FG005|COMPLETED|Fourth Intervention||4
3166697|NCT01904773|3893903|FG006|COMPLETED|Fourth Intervention||3
3166698|NCT01904773|3893904|FG007|COMPLETED|Fourth Intervention||3
3166699|NCT01904773|3893905|FG008|COMPLETED|Fourth Intervention||4
2828906|NCT02756208|3530066|FG000|COMPLETED|Overall Study||13
2828907|NCT02756208|3530067|FG001|COMPLETED|Overall Study||14
2828908|NCT02756208|3530068|FG002|COMPLETED|Overall Study||13
2828909|NCT02756208|3530069|FG003|COMPLETED|Overall Study||12
2828910|NCT02756208|3530066|FG000|NOT COMPLETED|Overall Study||5
2828911|NCT02756208|3530067|FG001|NOT COMPLETED|Overall Study||2
2828912|NCT02756208|3530068|FG002|NOT COMPLETED|Overall Study||2
2828913|NCT02756208|3530069|FG003|NOT COMPLETED|Overall Study||4
2828914|NCT02714218|3530082|FG000|STARTED|Overall Study||180
2828915|NCT02714218|3530083|FG001|STARTED|Overall Study||178
2828916|NCT02714218|3530084|FG002|STARTED|Overall Study||27
2828917|NCT02714218|3530082|FG000|COMPLETED|Overall Study||50
2828918|NCT02714218|3530083|FG001|COMPLETED|Overall Study||35
2828919|NCT02714218|3530084|FG002|COMPLETED|Overall Study||8
2828920|NCT02714218|3530082|FG000|NOT COMPLETED|Overall Study||130
2828921|NCT02714218|3530083|FG001|NOT COMPLETED|Overall Study||143
2828922|NCT02714218|3530084|FG002|NOT COMPLETED|Overall Study||19
2828923|NCT02564263|3530093|FG000|STARTED|Overall Study||314
2828924|NCT02564263|3530094|FG001|STARTED|Overall Study||314
2828925|NCT02564263|3530093|FG000|Treated|Overall Study||314
2828926|NCT02564263|3530094|FG001|Treated|Overall Study||296
2828927|NCT02564263|3530093|FG000|COMPLETED|Overall Study||0
2828928|NCT02564263|3530094|FG001|COMPLETED|Overall Study||0
2828929|NCT02564263|3530093|FG000|NOT COMPLETED|Overall Study||314
2828930|NCT02564263|3530094|FG001|NOT COMPLETED|Overall Study||314
2913284|NCT00494780|3623097|FG000|STARTED|Overall Study||29
2913285|NCT00494780|3623098|FG001|STARTED|Overall Study||30
2913286|NCT00494780|3623097|FG000|COMPLETED|Overall Study||18
2913287|NCT00494780|3623098|FG001|COMPLETED|Overall Study||17
2913288|NCT00494780|3623097|FG000|NOT COMPLETED|Overall Study||11
2913289|NCT00494780|3623098|FG001|NOT COMPLETED|Overall Study||13
2913290|NCT00494806|3623108|FG000|STARTED|Overall Study||34
2913291|NCT00494806|3623109|FG001|STARTED|Overall Study||32
2913292|NCT00494806|3623108|FG000|COMPLETED|Overall Study||34
2913293|NCT00494806|3623109|FG001|COMPLETED|Overall Study||32
2913294|NCT00494806|3623108|FG000|NOT COMPLETED|Overall Study||0
2913295|NCT00494806|3623109|FG001|NOT COMPLETED|Overall Study||0
2913296|NCT00494871|3623117|FG000|STARTED|Double-blind (DB) Treatment Period||640
2913297|NCT00494871|3623118|FG001|STARTED|Double-blind (DB) Treatment Period||640
2913298|NCT00494871|3623117|FG000|Started Treatment|Double-blind (DB) Treatment Period|Safety population|639
2913299|NCT00494871|3623118|FG001|Started Treatment|Double-blind (DB) Treatment Period|Safety population|639
2913300|NCT00494871|3623117|FG000|COMPLETED|Double-blind (DB) Treatment Period||480
2913301|NCT00494871|3623118|FG001|COMPLETED|Double-blind (DB) Treatment Period||468
2913302|NCT00494871|3623117|FG000|NOT COMPLETED|Double-blind (DB) Treatment Period||160
2913303|NCT00494871|3623118|FG001|NOT COMPLETED|Double-blind (DB) Treatment Period||172
2913304|NCT00494871|3623117|FG000|STARTED|Follow-up (FU) Period|All treated participants were to enter FU period, whether or not they completed the DB period|639
2913305|NCT00494871|3623118|FG001|STARTED|Follow-up (FU) Period|All treated participants were to enter FU period, whether or not they completed the DB period|639
2913306|NCT00494871|3623117|FG000|Entered FU and Valid for Safety|Follow-up (FU) Period|Safety population|628
2913307|NCT00494871|3623118|FG001|Entered FU and Valid for Safety|Follow-up (FU) Period|Safety population|630
2913308|NCT00494871|3623117|FG000|COMPLETED|Follow-up (FU) Period||610
2913309|NCT00494871|3623118|FG001|COMPLETED|Follow-up (FU) Period||616
2913310|NCT00494871|3623117|FG000|NOT COMPLETED|Follow-up (FU) Period||29
2913311|NCT00494871|3623118|FG001|NOT COMPLETED|Follow-up (FU) Period||23
2913312|NCT00494975|3623128|FG000|STARTED|Overall Study||10
2913313|NCT00494975|3623129|FG001|STARTED|Overall Study||11
2913314|NCT00494975|3623128|FG000|COMPLETED|Overall Study||8
2913315|NCT00494975|3623129|FG001|COMPLETED|Overall Study||10
2913316|NCT00494975|3623128|FG000|NOT COMPLETED|Overall Study||2
2913317|NCT00494975|3623129|FG001|NOT COMPLETED|Overall Study||1
2913318|NCT00495040|3623135|FG000|STARTED|Overall Study||38
2913319|NCT00495040|3623135|FG000|COMPLETED|Overall Study||35
2913320|NCT00495040|3623135|FG000|NOT COMPLETED|Overall Study||3
2913321|NCT00495079|3623139|FG000|STARTED|Overall Study||65
2913322|NCT00495079|3623139|FG000|COMPLETED|Overall Study||65
2913323|NCT00495079|3623139|FG000|NOT COMPLETED|Overall Study||0
2913324|NCT00495157|3623149|FG000|STARTED|Overall Study||113
2913325|NCT00495157|3623150|FG001|STARTED|Overall Study||115
2913326|NCT00495157|3623151|FG002|STARTED|Overall Study||114
2913327|NCT00495157|3623149|FG000|COMPLETED|Overall Study||97
2913328|NCT00495157|3623150|FG001|COMPLETED|Overall Study||92
2913329|NCT00495157|3623151|FG002|COMPLETED|Overall Study||101
2913330|NCT00495157|3623149|FG000|NOT COMPLETED|Overall Study||16
2913331|NCT00495157|3623150|FG001|NOT COMPLETED|Overall Study||23
2913332|NCT00495157|3623151|FG002|NOT COMPLETED|Overall Study||13
2913333|NCT00495170|3623159|FG000|STARTED|Overall Study||84
2913334|NCT00495170|3623159|FG000|COMPLETED|Overall Study||64
2913335|NCT00495170|3623159|FG000|NOT COMPLETED|Overall Study||20
2913336|NCT00495391|3623165|FG000|STARTED|Overall Study||42
2913337|NCT00495391|3623166|FG001|STARTED|Overall Study||22
2913338|NCT00495391|3623165|FG000|From Baseline to Week 8|Overall Study||31
2913339|NCT00495391|3623166|FG001|From Baseline to Week 8|Overall Study||20
2913340|NCT00495391|3623165|FG000|From Baseline to Week 16|Overall Study||24
2913341|NCT00495391|3623166|FG001|From Baseline to Week 16|Overall Study||11
2913342|NCT00495391|3623165|FG000|From Baseline to End of Treatment|Overall Study||6
2913343|NCT00495391|3623166|FG001|From Baseline to End of Treatment|Overall Study||1
2913344|NCT00495391|3623165|FG000|From Baseline to End of Follow up|Overall Study||6
2828931|NCT02450331|3530102|FG000|STARTED|Overall Study||403
2828932|NCT02450331|3530103|FG001|STARTED|Overall Study||406
2828933|NCT02450331|3530102|FG000|COMPLETED|Overall Study||0
2828934|NCT02450331|3530103|FG001|COMPLETED|Overall Study||0
2828935|NCT02450331|3530102|FG000|NOT COMPLETED|Overall Study||403
2828936|NCT02450331|3530103|FG001|NOT COMPLETED|Overall Study||406
2828937|NCT02149121|3530117|FG000|STARTED|Main Study Period||161
2828938|NCT02149121|3530118|FG001|STARTED|Main Study Period||151
2828939|NCT02149121|3530119|FG002|STARTED|Main Study Period||60
2828940|NCT02149121|3530120|FG003|STARTED|Main Study Period||0
2828941|NCT02149121|3530121|FG004|STARTED|Main Study Period||0
2828942|NCT02149121|3530122|FG005|STARTED|Main Study Period||0
2828943|NCT02149121|3530123|FG006|STARTED|Main Study Period||0
2828944|NCT02149121|3530117|FG000|COMPLETED|Main Study Period||140
2828945|NCT02149121|3530118|FG001|COMPLETED|Main Study Period||134
2828946|NCT02149121|3530119|FG002|COMPLETED|Main Study Period||56
2828947|NCT02149121|3530120|FG003|COMPLETED|Main Study Period||0
2828948|NCT02149121|3530121|FG004|COMPLETED|Main Study Period||0
2828949|NCT02149121|3530122|FG005|COMPLETED|Main Study Period||0
2828950|NCT02149121|3530123|FG006|COMPLETED|Main Study Period||0
2828951|NCT02149121|3530117|FG000|NOT COMPLETED|Main Study Period||21
2828952|NCT02149121|3530118|FG001|NOT COMPLETED|Main Study Period||17
2828953|NCT02149121|3530119|FG002|NOT COMPLETED|Main Study Period||4
2828954|NCT02149121|3530120|FG003|NOT COMPLETED|Main Study Period||0
2828955|NCT02149121|3530121|FG004|NOT COMPLETED|Main Study Period||0
2828956|NCT02149121|3530122|FG005|NOT COMPLETED|Main Study Period||0
2828957|NCT02149121|3530123|FG006|NOT COMPLETED|Main Study Period||0
2828958|NCT02149121|3530117|FG000|STARTED|Extension Study Period|This group is for the Main Study Period, not for the Extension Study Period.|0
2828959|NCT02149121|3530118|FG001|STARTED|Extension Study Period|This group is for the Main Study Period, not for the Extension Study Period.|0
2828960|NCT02149121|3530119|FG002|STARTED|Extension Study Period|This group is for the Main Study Period, not for the Extension Study Period.|0
2828961|NCT02149121|3530120|FG003|STARTED|Extension Study Period|"Some participants did not initiate the Extension Study Period (CT-P10: 19, Rituxan: 8, MabThera: 9).~From 19 patients in CT-P10 who did not initiate the extension study period, one patient did not initiate the treatment course but had been included to extension period and was monitored up to week 48"|122
2828962|NCT02149121|3530121|FG004|STARTED|Extension Study Period|Some participants did not initiate the Extension Study Period (CT-P10: 19, Rituxan: 8, MabThera: 9)|64
2828963|NCT02149121|3530122|FG005|STARTED|Extension Study Period|Some participants did not initiate the Extension Study Period (CT-P10: 19, Rituxan: 8, MabThera: 9)|62
2828964|NCT02149121|3530123|FG006|STARTED|Extension Study Period|Some participants did not initiate the Extension Study Period (CT-P10: 19, Rituxan: 8, MabThera: 9)|47
2828965|NCT02149121|3530117|FG000|COMPLETED|Extension Study Period||0
2828966|NCT02149121|3530118|FG001|COMPLETED|Extension Study Period||0
2828967|NCT02149121|3530119|FG002|COMPLETED|Extension Study Period||0
2828968|NCT02149121|3530120|FG003|COMPLETED|Extension Study Period||121
2828969|NCT02149121|3530121|FG004|COMPLETED|Extension Study Period||64
2828970|NCT02149121|3530122|FG005|COMPLETED|Extension Study Period||60
2828971|NCT02149121|3530123|FG006|COMPLETED|Extension Study Period||47
2828972|NCT02149121|3530117|FG000|NOT COMPLETED|Extension Study Period||0
2828973|NCT02149121|3530118|FG001|NOT COMPLETED|Extension Study Period||0
2828974|NCT02149121|3530119|FG002|NOT COMPLETED|Extension Study Period||0
2828975|NCT02149121|3530120|FG003|NOT COMPLETED|Extension Study Period||1
2828976|NCT02149121|3530121|FG004|NOT COMPLETED|Extension Study Period||0
2828977|NCT02149121|3530122|FG005|NOT COMPLETED|Extension Study Period||2
2828978|NCT02149121|3530123|FG006|NOT COMPLETED|Extension Study Period||0
2828979|NCT02066181|3530146|FG000|STARTED|Overall Study||50
2828980|NCT02066181|3530147|FG001|STARTED|Overall Study||37
2828981|NCT02066181|3530146|FG000|Crossed Over|Overall Study||0
2828982|NCT02066181|3530147|FG001|Crossed Over|Overall Study||28
2828983|NCT02066181|3530146|FG000|COMPLETED|Overall Study||49
2828984|NCT02066181|3530147|FG001|COMPLETED|Overall Study||36
3166700|NCT01904773|3893897|FG000|NOT COMPLETED|Fourth Intervention||0
3166701|NCT01904773|3893898|FG001|NOT COMPLETED|Fourth Intervention||0
3166702|NCT01904773|3893899|FG002|NOT COMPLETED|Fourth Intervention||0
3166703|NCT01904773|3893900|FG003|NOT COMPLETED|Fourth Intervention||0
3166704|NCT01904773|3893901|FG004|NOT COMPLETED|Fourth Intervention||0
3166705|NCT01904773|3893902|FG005|NOT COMPLETED|Fourth Intervention||0
3166706|NCT01904773|3893903|FG006|NOT COMPLETED|Fourth Intervention||0
3166707|NCT01904773|3893904|FG007|NOT COMPLETED|Fourth Intervention||0
3166708|NCT01904773|3893905|FG008|NOT COMPLETED|Fourth Intervention||0
3166709|NCT01904773|3893897|FG000|STARTED|Placebo Washout Fourth Intervention||0
3166710|NCT01904773|3893898|FG001|STARTED|Placebo Washout Fourth Intervention||1
3166711|NCT01904773|3893899|FG002|STARTED|Placebo Washout Fourth Intervention||1
3166712|NCT01904773|3893900|FG003|STARTED|Placebo Washout Fourth Intervention||2
3166713|NCT01904773|3893901|FG004|STARTED|Placebo Washout Fourth Intervention||3
3166714|NCT01904773|3893902|FG005|STARTED|Placebo Washout Fourth Intervention||4
3166715|NCT01904773|3893903|FG006|STARTED|Placebo Washout Fourth Intervention||3
3166716|NCT01904773|3893904|FG007|STARTED|Placebo Washout Fourth Intervention||3
3166717|NCT01904773|3893905|FG008|STARTED|Placebo Washout Fourth Intervention||4
3166718|NCT01904773|3893897|FG000|COMPLETED|Placebo Washout Fourth Intervention||0
3166719|NCT01904773|3893898|FG001|COMPLETED|Placebo Washout Fourth Intervention||1
2828985|NCT02066181|3530146|FG000|NOT COMPLETED|Overall Study||1
2828986|NCT02066181|3530147|FG001|NOT COMPLETED|Overall Study||1
2828987|NCT01933932|3530158|FG000|STARTED|Overall Study||254
2828988|NCT01933932|3530159|FG001|STARTED|Overall Study||256
2828989|NCT01933932|3530158|FG000|COMPLETED|Overall Study|These were the number of patients who were still ongoing at data cut-off|70
2828990|NCT01933932|3530159|FG001|COMPLETED|Overall Study|These were the number of patients who were still ongoing at data cut-off|78
2828991|NCT01933932|3530158|FG000|NOT COMPLETED|Overall Study||184
2828992|NCT01933932|3530159|FG001|NOT COMPLETED|Overall Study||178
2828993|NCT01927419|3530167|FG000|STARTED|Overall Study||95
2828994|NCT01927419|3530168|FG001|STARTED|Overall Study||47
2828995|NCT01927419|3530167|FG000|Received Treatment|Overall Study||94
2828996|NCT01927419|3530168|FG001|Received Treatment|Overall Study||46
2828997|NCT01927419|3530167|FG000|COMPLETED|Overall Study|All participants who did not discontinue study drug during treatment period (Parts 1 and 2)|25
2828998|NCT01927419|3530168|FG001|COMPLETED|Overall Study|All participants who did not discontinue study drug during treatment period (Parts 1 and 2)|19
2828999|NCT01927419|3530167|FG000|NOT COMPLETED|Overall Study||70
2829000|NCT01927419|3530168|FG001|NOT COMPLETED|Overall Study||28
2829001|NCT01889186|3530178|FG000|STARTED|Overall Study||107
2829002|NCT01889186|3530179|FG001|STARTED|Overall Study||51
2829003|NCT01889186|3530178|FG000|COMPLETED|Overall Study||0
2829004|NCT01889186|3530179|FG001|COMPLETED|Overall Study||0
2829005|NCT01889186|3530178|FG000|NOT COMPLETED|Overall Study||107
2829006|NCT01889186|3530179|FG001|NOT COMPLETED|Overall Study||51
2829007|NCT01850004|3530187|FG000|STARTED|Overall Study||84
2829008|NCT01850004|3530187|FG000|COMPLETED|Overall Study||76
2829009|NCT01850004|3530187|FG000|NOT COMPLETED|Overall Study||8
2829010|NCT01849263|3530192|FG000|STARTED|Overall Study||40
2829011|NCT01849263|3530192|FG000|COMPLETED|Overall Study||40
2829012|NCT01849263|3530192|FG000|NOT COMPLETED|Overall Study||0
2829013|NCT01844505|3530199|FG000|STARTED|Overall Study||313
2829014|NCT01844505|3530200|FG001|STARTED|Overall Study||313
2829015|NCT01844505|3530201|FG002|STARTED|Overall Study||311
2829016|NCT01844505|3530199|FG000|COMPLETED|Overall Study|Completed = Number of subjects continuing in the treatment period|64
2829017|NCT01844505|3530200|FG001|COMPLETED|Overall Study|Completed = Number of subjects continuing in the treatment period|44
2829018|NCT01844505|3530201|FG002|COMPLETED|Overall Study|Completed = Number of subjects continuing in the treatment period|16
2829019|NCT01844505|3530199|FG000|NOT COMPLETED|Overall Study||249
2829020|NCT01844505|3530200|FG001|NOT COMPLETED|Overall Study||269
2829021|NCT01844505|3530201|FG002|NOT COMPLETED|Overall Study||295
2829022|NCT01757535|3530211|FG000|STARTED|Overall Study||238
2829023|NCT01757535|3530212|FG001|STARTED|Overall Study||234
2829024|NCT01757535|3530211|FG000|Received Treatment|Overall Study||236
2829025|NCT01757535|3530212|FG001|Received Treatment|Overall Study||233
2829026|NCT01757535|3530211|FG000|COMPLETED|Overall Study||45
2829027|NCT01757535|3530212|FG001|COMPLETED|Overall Study||26
2829028|NCT01757535|3530211|FG000|NOT COMPLETED|Overall Study||193
2829029|NCT01757535|3530212|FG001|NOT COMPLETED|Overall Study||208
2829030|NCT01750281|3530221|FG000|STARTED|Overall Study||43
2829031|NCT01750281|3530222|FG001|STARTED|Overall Study||85
2829032|NCT01750281|3530223|FG002|STARTED|Overall Study||84
2829033|NCT01750281|3530221|FG000|Received Treatment|Overall Study||43
2829034|NCT01750281|3530222|FG001|Received Treatment|Overall Study||84
2829035|NCT01750281|3530223|FG002|Received Treatment|Overall Study||84
2829036|NCT01750281|3530221|FG000|Did Not Receive Treatment|Overall Study||0
2829037|NCT01750281|3530222|FG001|Did Not Receive Treatment|Overall Study||1
2829038|NCT01750281|3530223|FG002|Did Not Receive Treatment|Overall Study||0
2829039|NCT01750281|3530221|FG000|COMPLETED|Overall Study||0
2829040|NCT01750281|3530222|FG001|COMPLETED|Overall Study||0
2829041|NCT01750281|3530223|FG002|COMPLETED|Overall Study||0
2829042|NCT01750281|3530221|FG000|NOT COMPLETED|Overall Study||43
2829043|NCT01750281|3530222|FG001|NOT COMPLETED|Overall Study||85
2829044|NCT01750281|3530223|FG002|NOT COMPLETED|Overall Study||84
2829045|NCT01510184|3530233|FG000|STARTED|Overall Study||36
2829046|NCT01510184|3530234|FG001|STARTED|Overall Study||43
2829047|NCT01510184|3530233|FG000|COMPLETED|Overall Study||6
2829048|NCT01510184|3530234|FG001|COMPLETED|Overall Study||8
2829049|NCT01510184|3530233|FG000|NOT COMPLETED|Overall Study||30
2829050|NCT01510184|3530234|FG001|NOT COMPLETED|Overall Study||35
2829051|NCT01471444|3530242|FG000|STARTED|Overall Study||133
2829052|NCT01471444|3530243|FG001|STARTED|Overall Study||123
2829053|NCT01471444|3530242|FG000|COMPLETED|Overall Study||130
2829054|NCT01471444|3530243|FG001|COMPLETED|Overall Study||120
2829055|NCT01471444|3530242|FG000|NOT COMPLETED|Overall Study||3
2829056|NCT01471444|3530243|FG001|NOT COMPLETED|Overall Study||3
2829057|NCT01238211|3530250|FG000|STARTED|Overall Study||61
2829058|NCT01238211|3530250|FG000|COMPLETED|Overall Study||3
2829059|NCT01238211|3530250|FG000|NOT COMPLETED|Overall Study||58
2913345|NCT00495391|3623166|FG001|From Baseline to End of Follow up|Overall Study||1
2913346|NCT00495391|3623165|FG000|COMPLETED|Overall Study||6
2913347|NCT00495391|3623166|FG001|COMPLETED|Overall Study||1
2913348|NCT00495391|3623165|FG000|NOT COMPLETED|Overall Study||36
2913349|NCT00495391|3623166|FG001|NOT COMPLETED|Overall Study||21
2913350|NCT00495469|3623179|FG000|STARTED|Overall Study||36
2913351|NCT00495469|3623180|FG001|STARTED|Overall Study||37
2913352|NCT00495469|3623181|FG002|STARTED|Overall Study||34
2913353|NCT00495469|3623182|FG003|STARTED|Overall Study||36
2913354|NCT00495469|3623183|FG004|STARTED|Overall Study||36
2913355|NCT00495469|3623184|FG005|STARTED|Overall Study||36
2913356|NCT00495469|3623185|FG006|STARTED|Overall Study||35
2913357|NCT00495469|3623179|FG000|COMPLETED|Overall Study||30
2913358|NCT00495469|3623180|FG001|COMPLETED|Overall Study||30
2829060|NCT00545766|3530254|FG000|STARTED|Overall Study||41
2829061|NCT00545766|3530254|FG000|COMPLETED|Overall Study||36
2829062|NCT00545766|3530254|FG000|NOT COMPLETED|Overall Study||5
2829063|NCT04101890|3530258|FG000|STARTED|Routine Diaper Care||5
2829064|NCT04101890|3530258|FG000|COMPLETED|Routine Diaper Care||5
2829065|NCT04101890|3530258|FG000|NOT COMPLETED|Routine Diaper Care||0
2829066|NCT04101890|3530258|FG000|STARTED|Diaper Care With Theraworx||5
2829067|NCT04101890|3530258|FG000|COMPLETED|Diaper Care With Theraworx||5
2829068|NCT04101890|3530258|FG000|NOT COMPLETED|Diaper Care With Theraworx||0
2829069|NCT03993314|3530266|FG000|STARTED|Overall Study||9
2829070|NCT03993314|3530267|FG001|STARTED|Overall Study||6
2829071|NCT03993314|3530266|FG000|COMPLETED|Overall Study||9
2829072|NCT03993314|3530267|FG001|COMPLETED|Overall Study||6
2829073|NCT03993314|3530266|FG000|NOT COMPLETED|Overall Study||0
2829074|NCT03993314|3530267|FG001|NOT COMPLETED|Overall Study||0
2913359|NCT00495469|3623181|FG002|COMPLETED|Overall Study||27
2913360|NCT00495469|3623182|FG003|COMPLETED|Overall Study||32
2913361|NCT00495469|3623183|FG004|COMPLETED|Overall Study||31
2913362|NCT00495469|3623184|FG005|COMPLETED|Overall Study||31
2913363|NCT00495469|3623185|FG006|COMPLETED|Overall Study||30
2913364|NCT00495469|3623179|FG000|NOT COMPLETED|Overall Study||6
2913365|NCT00495469|3623180|FG001|NOT COMPLETED|Overall Study||7
2913366|NCT00495469|3623181|FG002|NOT COMPLETED|Overall Study||7
2913367|NCT00495469|3623182|FG003|NOT COMPLETED|Overall Study||4
2913368|NCT00495469|3623183|FG004|NOT COMPLETED|Overall Study||5
2913369|NCT00495469|3623184|FG005|NOT COMPLETED|Overall Study||5
2913370|NCT00495469|3623185|FG006|NOT COMPLETED|Overall Study||5
2913371|NCT00495495|3623208|FG000|STARTED|Overall Study||394
2913372|NCT00495495|3623208|FG000|COMPLETED|Overall Study||295
2913373|NCT00495495|3623208|FG000|NOT COMPLETED|Overall Study||99
2913374|NCT00495521|3623215|FG000|STARTED|Overall Study||1
2913375|NCT00495521|3623216|FG001|STARTED|Overall Study||1
2913376|NCT00495521|3623215|FG000|COMPLETED|Overall Study||1
2913377|NCT00495521|3623216|FG001|COMPLETED|Overall Study||0
2913378|NCT00495521|3623215|FG000|NOT COMPLETED|Overall Study||0
2913379|NCT00495521|3623216|FG001|NOT COMPLETED|Overall Study||1
2913380|NCT00495586|3623224|FG000|STARTED|Overall Study||156
2913381|NCT00495586|3623225|FG001|STARTED|Overall Study||162
2913382|NCT00495586|3623224|FG000|COMPLETED|Overall Study||152
2913383|NCT00495586|3623225|FG001|COMPLETED|Overall Study||158
2913384|NCT00495586|3623224|FG000|NOT COMPLETED|Overall Study||4
2913385|NCT00495586|3623225|FG001|NOT COMPLETED|Overall Study||4
2913386|NCT00495612|3623235|FG000|STARTED|Overall Study||36
2913387|NCT00495612|3623236|FG001|STARTED|Overall Study||33
2913388|NCT00495612|3623235|FG000|COMPLETED|Overall Study||32
2913389|NCT00495612|3623236|FG001|COMPLETED|Overall Study||33
2913390|NCT00495612|3623235|FG000|NOT COMPLETED|Overall Study||4
2913391|NCT00495612|3623236|FG001|NOT COMPLETED|Overall Study||0
2913392|NCT00495625|3623242|FG000|STARTED|Overall Study||33
2913393|NCT00495625|3623242|FG000|COMPLETED|Overall Study||23
2913394|NCT00495625|3623242|FG000|NOT COMPLETED|Overall Study||10
2913395|NCT00495677|3623253|FG000|STARTED|Stage 1 (25 Days)||2
2913396|NCT00495677|3623254|FG001|STARTED|Stage 1 (25 Days)||6
2913397|NCT00495677|3623255|FG002|STARTED|Stage 1 (25 Days)||6
2913398|NCT00495677|3623256|FG003|STARTED|Stage 1 (25 Days)||6
2913399|NCT00495677|3623257|FG004|STARTED|Stage 1 (25 Days)||0
3166720|NCT01904773|3893899|FG002|COMPLETED|Placebo Washout Fourth Intervention||1
3166721|NCT01904773|3893900|FG003|COMPLETED|Placebo Washout Fourth Intervention||2
3166722|NCT01904773|3893901|FG004|COMPLETED|Placebo Washout Fourth Intervention||3
3166723|NCT01904773|3893902|FG005|COMPLETED|Placebo Washout Fourth Intervention||4
3166724|NCT01904773|3893903|FG006|COMPLETED|Placebo Washout Fourth Intervention||3
3166725|NCT01904773|3893904|FG007|COMPLETED|Placebo Washout Fourth Intervention||3
3166726|NCT01904773|3893905|FG008|COMPLETED|Placebo Washout Fourth Intervention||4
2913400|NCT00495677|3623258|FG005|STARTED|Stage 1 (25 Days)||0
2913401|NCT00495677|3623259|FG006|STARTED|Stage 1 (25 Days)||0
2913402|NCT00495677|3623253|FG000|COMPLETED|Stage 1 (25 Days)||2
2913403|NCT00495677|3623254|FG001|COMPLETED|Stage 1 (25 Days)||6
2913404|NCT00495677|3623255|FG002|COMPLETED|Stage 1 (25 Days)||5
2913405|NCT00495677|3623256|FG003|COMPLETED|Stage 1 (25 Days)||6
2913406|NCT00495677|3623257|FG004|COMPLETED|Stage 1 (25 Days)||0
2913407|NCT00495677|3623258|FG005|COMPLETED|Stage 1 (25 Days)||0
2913408|NCT00495677|3623259|FG006|COMPLETED|Stage 1 (25 Days)||0
2913409|NCT00495677|3623253|FG000|NOT COMPLETED|Stage 1 (25 Days)||0
2913410|NCT00495677|3623254|FG001|NOT COMPLETED|Stage 1 (25 Days)||0
2913411|NCT00495677|3623255|FG002|NOT COMPLETED|Stage 1 (25 Days)||1
2913412|NCT00495677|3623256|FG003|NOT COMPLETED|Stage 1 (25 Days)||0
2913413|NCT00495677|3623257|FG004|NOT COMPLETED|Stage 1 (25 Days)||0
2913414|NCT00495677|3623258|FG005|NOT COMPLETED|Stage 1 (25 Days)||0
2913415|NCT00495677|3623259|FG006|NOT COMPLETED|Stage 1 (25 Days)||0
2913416|NCT00495677|3623253|FG000|STARTED|Stage 2 (25 Days)||0
2913417|NCT00495677|3623254|FG001|STARTED|Stage 2 (25 Days)||0
2913418|NCT00495677|3623255|FG002|STARTED|Stage 2 (25 Days)||0
2913419|NCT00495677|3623256|FG003|STARTED|Stage 2 (25 Days)||0
2913420|NCT00495677|3623257|FG004|STARTED|Stage 2 (25 Days)||8
2913421|NCT00495677|3623258|FG005|STARTED|Stage 2 (25 Days)||8
2913422|NCT00495677|3623259|FG006|STARTED|Stage 2 (25 Days)||7
2913423|NCT00495677|3623253|FG000|COMPLETED|Stage 2 (25 Days)||0
2913424|NCT00495677|3623254|FG001|COMPLETED|Stage 2 (25 Days)||0
2913425|NCT00495677|3623255|FG002|COMPLETED|Stage 2 (25 Days)||0
2913426|NCT00495677|3623256|FG003|COMPLETED|Stage 2 (25 Days)||0
2829075|NCT03874351|3530275|FG000|STARTED|Overall Study||11
2829076|NCT03874351|3530276|FG001|STARTED|Overall Study||11
2829077|NCT03874351|3530275|FG000|COMPLETED|Overall Study||7
2829078|NCT03874351|3530276|FG001|COMPLETED|Overall Study||9
2829079|NCT03874351|3530275|FG000|NOT COMPLETED|Overall Study||4
2829080|NCT03874351|3530276|FG001|NOT COMPLETED|Overall Study||2
2829081|NCT03856359|3530282|FG000|STARTED|Overall Study||10
2829082|NCT03856359|3530282|FG000|COMPLETED|Overall Study||9
2829083|NCT03856359|3530282|FG000|NOT COMPLETED|Overall Study||1
2829084|NCT03769519|3530288|FG000|STARTED|Overall Study||14
2829085|NCT03769519|3530289|FG001|STARTED|Overall Study||15
2829086|NCT03769519|3530288|FG000|COMPLETED|Overall Study||14
2829087|NCT03769519|3530289|FG001|COMPLETED|Overall Study||14
2829088|NCT03769519|3530288|FG000|NOT COMPLETED|Overall Study||0
2829089|NCT03769519|3530289|FG001|NOT COMPLETED|Overall Study||1
2829090|NCT03745651|3530298|FG000|STARTED|Vehicle Control Period (Day 1 to Week 8)||124
2829091|NCT03745651|3530299|FG001|STARTED|Vehicle Control Period (Day 1 to Week 8)||248
2829092|NCT03745651|3530300|FG002|STARTED|Vehicle Control Period (Day 1 to Week 8)||246
2829093|NCT03745651|3530301|FG003|STARTED|Vehicle Control Period (Day 1 to Week 8)||0
2829094|NCT03745651|3530302|FG004|STARTED|Vehicle Control Period (Day 1 to Week 8)||0
2829095|NCT03745651|3530303|FG005|STARTED|Vehicle Control Period (Day 1 to Week 8)||0
2829096|NCT03745651|3530304|FG006|STARTED|Vehicle Control Period (Day 1 to Week 8)||0
2829097|NCT03745651|3530298|FG000|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||105
2829098|NCT03745651|3530299|FG001|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||209
2829099|NCT03745651|3530300|FG002|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||224
2829100|NCT03745651|3530301|FG003|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0
2829101|NCT03745651|3530302|FG004|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0
2829102|NCT03745651|3530303|FG005|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0
2829103|NCT03745651|3530304|FG006|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0
2829104|NCT03745651|3530298|FG000|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||19
2829105|NCT03745651|3530299|FG001|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||39
2829106|NCT03745651|3530300|FG002|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||22
2829107|NCT03745651|3530301|FG003|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0
2829108|NCT03745651|3530302|FG004|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0
2829109|NCT03745651|3530303|FG005|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0
2829110|NCT03745651|3530304|FG006|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0
2829111|NCT03745651|3530298|FG000|STARTED|Long-Term Safety Period (Weeks 8 to 52)||0
2829112|NCT03745651|3530299|FG001|STARTED|Long-Term Safety Period (Weeks 8 to 52)||0
2829113|NCT03745651|3530300|FG002|STARTED|Long-Term Safety Period (Weeks 8 to 52)||0
2829114|NCT03745651|3530301|FG003|STARTED|Long-Term Safety Period (Weeks 8 to 52)||53
2829115|NCT03745651|3530302|FG004|STARTED|Long-Term Safety Period (Weeks 8 to 52)||52
2829116|NCT03745651|3530303|FG005|STARTED|Long-Term Safety Period (Weeks 8 to 52)||204
2829117|NCT03745651|3530304|FG006|STARTED|Long-Term Safety Period (Weeks 8 to 52)||221
2829118|NCT03745651|3530298|FG000|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||0
2829119|NCT03745651|3530299|FG001|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||0
2829120|NCT03745651|3530300|FG002|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||0
2829121|NCT03745651|3530301|FG003|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||33
2829122|NCT03745651|3530302|FG004|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||41
2829123|NCT03745651|3530303|FG005|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||151
2829124|NCT03745651|3530304|FG006|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||170
2829125|NCT03745651|3530298|FG000|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||0
2829126|NCT03745651|3530299|FG001|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||0
2829127|NCT03745651|3530300|FG002|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||0
2829128|NCT03745651|3530301|FG003|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||20
2829129|NCT03745651|3530302|FG004|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||11
2829130|NCT03745651|3530303|FG005|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||53
2829131|NCT03745651|3530304|FG006|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||51
2829132|NCT03745638|3530323|FG000|STARTED|Vehicle Control Period (Day 1 to Week 8)||126
2829133|NCT03745638|3530324|FG001|STARTED|Vehicle Control Period (Day 1 to Week 8)||252
2829134|NCT03745638|3530325|FG002|STARTED|Vehicle Control Period (Day 1 to Week 8)||253
2829135|NCT03745638|3530326|FG003|STARTED|Vehicle Control Period (Day 1 to Week 8)||0
2829136|NCT03745638|3530327|FG004|STARTED|Vehicle Control Period (Day 1 to Week 8)||0
2913427|NCT00495677|3623257|FG004|COMPLETED|Stage 2 (25 Days)||8
3166727|NCT01904773|3893897|FG000|NOT COMPLETED|Placebo Washout Fourth Intervention||0
3166728|NCT01904773|3893898|FG001|NOT COMPLETED|Placebo Washout Fourth Intervention||0
3166729|NCT01904773|3893899|FG002|NOT COMPLETED|Placebo Washout Fourth Intervention||0
3166730|NCT01904773|3893900|FG003|NOT COMPLETED|Placebo Washout Fourth Intervention||0
3166731|NCT01904773|3893901|FG004|NOT COMPLETED|Placebo Washout Fourth Intervention||0
3166732|NCT01904773|3893902|FG005|NOT COMPLETED|Placebo Washout Fourth Intervention||0
3166733|NCT01904773|3893903|FG006|NOT COMPLETED|Placebo Washout Fourth Intervention||0
3166734|NCT01904773|3893904|FG007|NOT COMPLETED|Placebo Washout Fourth Intervention||0
3166735|NCT01904773|3893905|FG008|NOT COMPLETED|Placebo Washout Fourth Intervention||0
3166736|NCT01904773|3893897|FG000|STARTED|Fifth Intervention||0
3166737|NCT01904773|3893898|FG001|STARTED|Fifth Intervention||1
3166738|NCT01904773|3893899|FG002|STARTED|Fifth Intervention||1
3166739|NCT01904773|3893900|FG003|STARTED|Fifth Intervention||2
3166740|NCT01904773|3893901|FG004|STARTED|Fifth Intervention||3
3166741|NCT01904773|3893902|FG005|STARTED|Fifth Intervention||4
3166742|NCT01904773|3893903|FG006|STARTED|Fifth Intervention||3
3166743|NCT01904773|3893904|FG007|STARTED|Fifth Intervention||3
3166744|NCT01904773|3893905|FG008|STARTED|Fifth Intervention||4
3166745|NCT01904773|3893897|FG000|COMPLETED|Fifth Intervention||0
3166746|NCT01904773|3893898|FG001|COMPLETED|Fifth Intervention||1
3166747|NCT01904773|3893899|FG002|COMPLETED|Fifth Intervention||1
3166748|NCT01904773|3893900|FG003|COMPLETED|Fifth Intervention||2
3166749|NCT01904773|3893901|FG004|COMPLETED|Fifth Intervention||3
3166750|NCT01904773|3893902|FG005|COMPLETED|Fifth Intervention||4
3166751|NCT01904773|3893903|FG006|COMPLETED|Fifth Intervention||3
3166752|NCT01904773|3893904|FG007|COMPLETED|Fifth Intervention||2
3166753|NCT01904773|3893905|FG008|COMPLETED|Fifth Intervention||4
3166754|NCT01904773|3893897|FG000|NOT COMPLETED|Fifth Intervention||0
3166755|NCT01904773|3893898|FG001|NOT COMPLETED|Fifth Intervention||0
3166756|NCT01904773|3893899|FG002|NOT COMPLETED|Fifth Intervention||0
3166757|NCT01904773|3893900|FG003|NOT COMPLETED|Fifth Intervention||0
3166758|NCT01904773|3893901|FG004|NOT COMPLETED|Fifth Intervention||0
3166759|NCT01904773|3893902|FG005|NOT COMPLETED|Fifth Intervention||0
3166760|NCT01904773|3893903|FG006|NOT COMPLETED|Fifth Intervention||0
2829137|NCT03745638|3530328|FG005|STARTED|Vehicle Control Period (Day 1 to Week 8)||0
2829138|NCT03745638|3530329|FG006|STARTED|Vehicle Control Period (Day 1 to Week 8)||0
2829139|NCT03745638|3530323|FG000|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||95
2829140|NCT03745638|3530324|FG001|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||222
2829141|NCT03745638|3530325|FG002|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||225
2829142|NCT03745638|3530326|FG003|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0
2829143|NCT03745638|3530327|FG004|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0
2829144|NCT03745638|3530328|FG005|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0
2829145|NCT03745638|3530329|FG006|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0
2829146|NCT03745638|3530323|FG000|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||31
2829147|NCT03745638|3530324|FG001|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||30
2829148|NCT03745638|3530325|FG002|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||28
2829149|NCT03745638|3530326|FG003|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0
2829150|NCT03745638|3530327|FG004|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0
2829151|NCT03745638|3530328|FG005|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0
2829152|NCT03745638|3530329|FG006|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0
2829153|NCT03745638|3530323|FG000|STARTED|Long-Term Safety Period (Weeks 8 to 52)||0
2829154|NCT03745638|3530324|FG001|STARTED|Long-Term Safety Period (Weeks 8 to 52)||0
2829155|NCT03745638|3530325|FG002|STARTED|Long-Term Safety Period (Weeks 8 to 52)||0
2829156|NCT03745638|3530326|FG003|STARTED|Long-Term Safety Period (Weeks 8 to 52)||48
2829157|NCT03745638|3530327|FG004|STARTED|Long-Term Safety Period (Weeks 8 to 52)||47
2829158|NCT03745638|3530328|FG005|STARTED|Long-Term Safety Period (Weeks 8 to 52)||222
2829159|NCT03745638|3530329|FG006|STARTED|Long-Term Safety Period (Weeks 8 to 52)||225
2829160|NCT03745638|3530323|FG000|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||0
2829161|NCT03745638|3530324|FG001|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||0
2829162|NCT03745638|3530325|FG002|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||0
2829163|NCT03745638|3530326|FG003|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||37
2829164|NCT03745638|3530327|FG004|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||38
2829165|NCT03745638|3530328|FG005|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||176
2829166|NCT03745638|3530329|FG006|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||174
2829167|NCT03745638|3530323|FG000|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||0
2829168|NCT03745638|3530324|FG001|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||0
2829169|NCT03745638|3530325|FG002|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||0
2829170|NCT03745638|3530326|FG003|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||11
2829171|NCT03745638|3530327|FG004|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||9
2829172|NCT03745638|3530328|FG005|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||46
2829173|NCT03745638|3530329|FG006|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||51
2829174|NCT03715764|3530348|FG000|STARTED|Baseline (Randomized (n=69)||35
2829175|NCT03715764|3530349|FG001|STARTED|Baseline (Randomized (n=69)||34
2829176|NCT03715764|3530348|FG000|COMPLETED|Baseline (Randomized (n=69)||33
2829177|NCT03715764|3530349|FG001|COMPLETED|Baseline (Randomized (n=69)||31
2829178|NCT03715764|3530348|FG000|NOT COMPLETED|Baseline (Randomized (n=69)||2
2829179|NCT03715764|3530349|FG001|NOT COMPLETED|Baseline (Randomized (n=69)||3
2829180|NCT03715764|3530348|FG000|STARTED|3 Month Follow-up||33
2829181|NCT03715764|3530349|FG001|STARTED|3 Month Follow-up||31
2829182|NCT03715764|3530348|FG000|COMPLETED|3 Month Follow-up||30
2829183|NCT03715764|3530349|FG001|COMPLETED|3 Month Follow-up||28
2829184|NCT03715764|3530348|FG000|NOT COMPLETED|3 Month Follow-up||3
2829185|NCT03715764|3530349|FG001|NOT COMPLETED|3 Month Follow-up||3
2829186|NCT03715764|3530348|FG000|STARTED|6 Month Follow-up||30
2829187|NCT03715764|3530349|FG001|STARTED|6 Month Follow-up||28
2829188|NCT03715764|3530348|FG000|COMPLETED|6 Month Follow-up||27
2829189|NCT03715764|3530349|FG001|COMPLETED|6 Month Follow-up||28
2829190|NCT03715764|3530348|FG000|NOT COMPLETED|6 Month Follow-up||3
2829191|NCT03715764|3530349|FG001|NOT COMPLETED|6 Month Follow-up||0
2829192|NCT03715764|3530348|FG000|STARTED|12 Month Follow-up||27
2829193|NCT03715764|3530349|FG001|STARTED|12 Month Follow-up||28
3166761|NCT01904773|3893904|FG007|NOT COMPLETED|Fifth Intervention||1
3166762|NCT01904773|3893905|FG008|NOT COMPLETED|Fifth Intervention||0
2829194|NCT03715764|3530348|FG000|COMPLETED|12 Month Follow-up||21
2829195|NCT03715764|3530349|FG001|COMPLETED|12 Month Follow-up||23
2829196|NCT03715764|3530348|FG000|NOT COMPLETED|12 Month Follow-up||6
2829197|NCT03715764|3530349|FG001|NOT COMPLETED|12 Month Follow-up||5
2829198|NCT03663855|3530355|FG000|STARTED|Overall Study||10
2829199|NCT03663855|3530355|FG000|COMPLETED|Overall Study||10
2829200|NCT03663855|3530355|FG000|NOT COMPLETED|Overall Study||0
2829201|NCT03654729|3530362|FG000|STARTED|Overall Study||97
2829202|NCT03654729|3530363|FG001|STARTED|Overall Study||96
2829203|NCT03654729|3530364|FG002|STARTED|Overall Study||98
2829204|NCT03654729|3530362|FG000|Treated|Overall Study||96
2829205|NCT03654729|3530363|FG001|Treated|Overall Study||93
2829206|NCT03654729|3530364|FG002|Treated|Overall Study||96
2829207|NCT03654729|3530362|FG000|COMPLETED|Overall Study||66
2829208|NCT03654729|3530363|FG001|COMPLETED|Overall Study||70
2829209|NCT03654729|3530364|FG002|COMPLETED|Overall Study||69
2829210|NCT03654729|3530362|FG000|NOT COMPLETED|Overall Study||31
2829211|NCT03654729|3530363|FG001|NOT COMPLETED|Overall Study||26
2829212|NCT03654729|3530364|FG002|NOT COMPLETED|Overall Study||29
2829213|NCT03531112|3530374|FG000|STARTED|Overall Study||20
2829214|NCT03531112|3530375|FG001|STARTED|Overall Study||0
2829215|NCT03531112|3530374|FG000|Month 4|Overall Study||17
2829216|NCT03531112|3530375|FG001|Month 4|Overall Study||0
2829217|NCT03531112|3530374|FG000|Month 6 (Follow-Up)|Overall Study||13
2829218|NCT03531112|3530375|FG001|Month 6 (Follow-Up)|Overall Study||0
2829219|NCT03531112|3530374|FG000|COMPLETED|Overall Study||13
2829220|NCT03531112|3530375|FG001|COMPLETED|Overall Study||0
2829221|NCT03531112|3530374|FG000|NOT COMPLETED|Overall Study||7
2829222|NCT03531112|3530375|FG001|NOT COMPLETED|Overall Study||0
2913428|NCT00495677|3623258|FG005|COMPLETED|Stage 2 (25 Days)||8
2913429|NCT00495677|3623259|FG006|COMPLETED|Stage 2 (25 Days)||7
2913430|NCT00495677|3623253|FG000|NOT COMPLETED|Stage 2 (25 Days)||0
2913431|NCT00495677|3623254|FG001|NOT COMPLETED|Stage 2 (25 Days)||0
2913432|NCT00495677|3623255|FG002|NOT COMPLETED|Stage 2 (25 Days)||0
2913433|NCT00495677|3623256|FG003|NOT COMPLETED|Stage 2 (25 Days)||0
2913434|NCT00495677|3623257|FG004|NOT COMPLETED|Stage 2 (25 Days)||0
2913435|NCT00495677|3623258|FG005|NOT COMPLETED|Stage 2 (25 Days)||0
2913436|NCT00495677|3623259|FG006|NOT COMPLETED|Stage 2 (25 Days)||0
2913437|NCT00495755|3623275|FG000|STARTED|Overall Study||13
2913438|NCT00495755|3623275|FG000|COMPLETED|Overall Study||10
2913439|NCT00495755|3623275|FG000|NOT COMPLETED|Overall Study||3
2913440|NCT00495794|3623282|FG000|STARTED|Overall Study||2319
2913441|NCT00495794|3623283|FG001|STARTED|Overall Study||2303
2913442|NCT00495794|3623282|FG000|COMPLETED|Overall Study||1797
2913443|NCT00495794|3623283|FG001|COMPLETED|Overall Study||2303
2913444|NCT00495794|3623282|FG000|NOT COMPLETED|Overall Study||522
2913445|NCT00495794|3623283|FG001|NOT COMPLETED|Overall Study||0
2913446|NCT00495820|3623291|FG000|STARTED|Overall Study||30
2913447|NCT00495820|3623292|FG001|STARTED|Overall Study||30
2913448|NCT00495820|3623291|FG000|COMPLETED|Overall Study||29
2913449|NCT00495820|3623292|FG001|COMPLETED|Overall Study||29
2913450|NCT00495820|3623291|FG000|NOT COMPLETED|Overall Study||1
2913451|NCT00495820|3623292|FG001|NOT COMPLETED|Overall Study||1
2913452|NCT00496015|3623303|FG000|STARTED|Overall Study||178
2913453|NCT00496015|3623304|FG001|STARTED|Overall Study||27
2913454|NCT00496015|3623305|FG002|STARTED|Overall Study||172
2913455|NCT00496015|3623306|FG003|STARTED|Overall Study||37
2913456|NCT00496015|3623307|FG004|STARTED|Overall Study||336
2913457|NCT00496015|3623303|FG000|COMPLETED|Overall Study||177
2913458|NCT00496015|3623304|FG001|COMPLETED|Overall Study||27
2913459|NCT00496015|3623305|FG002|COMPLETED|Overall Study||172
2913460|NCT00496015|3623306|FG003|COMPLETED|Overall Study||36
2913461|NCT00496015|3623307|FG004|COMPLETED|Overall Study||336
2913462|NCT00496015|3623303|FG000|NOT COMPLETED|Overall Study||1
2913463|NCT00496015|3623304|FG001|NOT COMPLETED|Overall Study||0
2913464|NCT00496015|3623305|FG002|NOT COMPLETED|Overall Study||0
2913465|NCT00496015|3623306|FG003|NOT COMPLETED|Overall Study||1
2913466|NCT00496015|3623307|FG004|NOT COMPLETED|Overall Study||0
2913467|NCT00496054|3623327|FG000|STARTED|Overall Study||110
2913468|NCT00496054|3623327|FG000|COMPLETED|Overall Study||102
2913469|NCT00496054|3623327|FG000|NOT COMPLETED|Overall Study||8
2913470|NCT00496080|3623331|FG000|STARTED|Overall Study||87
2913471|NCT00496080|3623331|FG000|COMPLETED|Overall Study||60
2913472|NCT00496080|3623331|FG000|NOT COMPLETED|Overall Study||27
2913473|NCT00496197|3623336|FG000|STARTED|Overall Study||282
2913474|NCT00496197|3623336|FG000|COMPLETED|Overall Study||160
2913475|NCT00496197|3623336|FG000|NOT COMPLETED|Overall Study||122
2913476|NCT00496262|3623340|FG000|STARTED|Overall Study||15
2913477|NCT00496262|3623340|FG000|COMPLETED|Overall Study||15
2913478|NCT00496262|3623340|FG000|NOT COMPLETED|Overall Study||0
2913479|NCT00496340|3623346|FG000|STARTED|Overall Study||42
2913480|NCT00496340|3623346|FG000|COMPLETED|Overall Study||42
2913481|NCT00496340|3623346|FG000|NOT COMPLETED|Overall Study||0
2913482|NCT00496366|3623350|FG000|STARTED|Overall Study||11
2913483|NCT00496366|3623350|FG000|COMPLETED|Overall Study||10
2913484|NCT00496366|3623350|FG000|NOT COMPLETED|Overall Study||1
2913485|NCT00496379|3623354|FG000|STARTED|Overall Study||15
2913486|NCT00496379|3623354|FG000|COMPLETED|Overall Study||15
2913487|NCT00496379|3623354|FG000|NOT COMPLETED|Overall Study||0
2913488|NCT00496470|3623360|FG000|STARTED|Overall Study||329
2913489|NCT00496470|3623361|FG001|STARTED|Overall Study||331
2913490|NCT00496470|3623360|FG000|Received Study Medication|Overall Study||329
2829223|NCT03112902|3530391|FG000|STARTED|Overall Study||2
2829224|NCT03112902|3530392|FG001|STARTED|Overall Study||2
2829225|NCT03112902|3530393|FG002|STARTED|Overall Study||3
2829226|NCT03112902|3530394|FG003|STARTED|Overall Study||1
2829227|NCT03112902|3530395|FG004|STARTED|Overall Study||1
2829228|NCT03112902|3530396|FG005|STARTED|Overall Study||3
2829229|NCT03112902|3530397|FG006|STARTED|Overall Study||9
2829230|NCT03112902|3530398|FG007|STARTED|Overall Study||3
2829231|NCT03112902|3530399|FG008|STARTED|Overall Study||0
2829232|NCT03112902|3530400|FG009|STARTED|Overall Study||0
2829233|NCT03112902|3530391|FG000|COMPLETED|Overall Study||0
2829234|NCT03112902|3530392|FG001|COMPLETED|Overall Study||2
2829235|NCT03112902|3530393|FG002|COMPLETED|Overall Study||2
2829236|NCT03112902|3530394|FG003|COMPLETED|Overall Study||0
2829237|NCT03112902|3530395|FG004|COMPLETED|Overall Study||1
2829238|NCT03112902|3530396|FG005|COMPLETED|Overall Study||0
2829239|NCT03112902|3530397|FG006|COMPLETED|Overall Study||1
2829240|NCT03112902|3530398|FG007|COMPLETED|Overall Study||1
2829241|NCT03112902|3530399|FG008|COMPLETED|Overall Study||0
2829242|NCT03112902|3530400|FG009|COMPLETED|Overall Study||0
2829243|NCT03112902|3530391|FG000|NOT COMPLETED|Overall Study||2
2829244|NCT03112902|3530392|FG001|NOT COMPLETED|Overall Study||0
2829245|NCT03112902|3530393|FG002|NOT COMPLETED|Overall Study||1
2829246|NCT03112902|3530394|FG003|NOT COMPLETED|Overall Study||1
2829247|NCT03112902|3530395|FG004|NOT COMPLETED|Overall Study||0
2829248|NCT03112902|3530396|FG005|NOT COMPLETED|Overall Study||3
2829249|NCT03112902|3530397|FG006|NOT COMPLETED|Overall Study||8
2829250|NCT03112902|3530398|FG007|NOT COMPLETED|Overall Study||2
2829251|NCT03112902|3530399|FG008|NOT COMPLETED|Overall Study||0
2829252|NCT03112902|3530400|FG009|NOT COMPLETED|Overall Study||0
2829253|NCT02976038|3530416|FG000|STARTED|Overall Study||28
2829254|NCT02976038|3530416|FG000|COMPLETED|Overall Study||0
2829255|NCT02976038|3530416|FG000|NOT COMPLETED|Overall Study||28
2829256|NCT02951767|3530430|FG000|STARTED|Overall Study||119
2829257|NCT02951767|3530430|FG000|COMPLETED|Overall Study||0
2829258|NCT02951767|3530430|FG000|NOT COMPLETED|Overall Study||119
3034121|NCT01130532|3753143|FG000|Received at Least 1 Dose of Study Drug|Period III (Weeks 0-12)||205
3034122|NCT01130532|3753144|FG001|Received at Least 1 Dose of Study Drug|Period III (Weeks 0-12)||205
3034123|NCT01130532|3753145|FG002|Received at Least 1 Dose of Study Drug|Period III (Weeks 0-12)||207
3034124|NCT01130532|3753146|FG003|Received at Least 1 Dose of Study Drug|Period III (Weeks 0-12)||0
2829265|NCT02631070|3530446|FG000|STARTED|Overall Study||153
2829266|NCT02631070|3530447|FG001|STARTED|Overall Study||76
2829267|NCT02631070|3530446|FG000|COMPLETED|Overall Study||4
2829268|NCT02631070|3530447|FG001|COMPLETED|Overall Study||12
2829269|NCT02631070|3530446|FG000|NOT COMPLETED|Overall Study||149
2829270|NCT02631070|3530447|FG001|NOT COMPLETED|Overall Study||64
2829271|NCT02557139|3530456|FG000|STARTED|Overall Study||8
2829272|NCT02557139|3530457|FG001|STARTED|Overall Study||8
2829273|NCT02557139|3530458|FG002|STARTED|Overall Study||7
2829274|NCT02557139|3530456|FG000|COMPLETED|Overall Study||6
2829275|NCT02557139|3530457|FG001|COMPLETED|Overall Study||8
2829276|NCT02557139|3530458|FG002|COMPLETED|Overall Study||5
2829277|NCT02557139|3530456|FG000|NOT COMPLETED|Overall Study||2
2829278|NCT02557139|3530457|FG001|NOT COMPLETED|Overall Study||0
2829279|NCT02557139|3530458|FG002|NOT COMPLETED|Overall Study||2
2829280|NCT02513667|3530477|FG000|STARTED|Overall Study||8
2829281|NCT02513667|3530478|FG001|STARTED|Overall Study||6
2829282|NCT02513667|3530477|FG000|COMPLETED|Overall Study||8
2829283|NCT02513667|3530478|FG001|COMPLETED|Overall Study||5
2829284|NCT02513667|3530477|FG000|NOT COMPLETED|Overall Study||0
2829285|NCT02513667|3530478|FG001|NOT COMPLETED|Overall Study||1
2829286|NCT02281955|3530484|FG000|STARTED|Overall Study||114
2829287|NCT02281955|3530484|FG000|COMPLETED|Overall Study||113
2829288|NCT02281955|3530484|FG000|NOT COMPLETED|Overall Study||1
2829289|NCT02202434|3530492|FG000|STARTED|Overall Study||607
2829290|NCT02202434|3530493|FG001|STARTED|Overall Study||305
2829291|NCT02202434|3530494|FG002|STARTED|Overall Study||102
2829292|NCT02202434|3530495|FG003|STARTED|Overall Study||295
2829293|NCT02202434|3530492|FG000|COMPLETED|Overall Study||498
2829294|NCT02202434|3530493|FG001|COMPLETED|Overall Study||236
2829295|NCT02202434|3530494|FG002|COMPLETED|Overall Study||87
2829296|NCT02202434|3530495|FG003|COMPLETED|Overall Study||258
2829297|NCT02202434|3530492|FG000|NOT COMPLETED|Overall Study||109
2829298|NCT02202434|3530493|FG001|NOT COMPLETED|Overall Study||69
2829299|NCT02202434|3530494|FG002|NOT COMPLETED|Overall Study||15
2829300|NCT02202434|3530495|FG003|NOT COMPLETED|Overall Study||37
2829301|NCT02108652|3530505|FG000|STARTED|Overall Study||310
2829302|NCT02108652|3530505|FG000|COMPLETED|Overall Study||0
2829303|NCT02108652|3530505|FG000|NOT COMPLETED|Overall Study||310
2829304|NCT02097134|3530509|FG000|STARTED|Overall Study||14
2829305|NCT02097134|3530509|FG000|COMPLETED|Overall Study||5
2829306|NCT02097134|3530509|FG000|NOT COMPLETED|Overall Study||9
2829307|NCT01727011|3530514|FG000|STARTED|Overall Study||31
2829308|NCT01727011|3530514|FG000|COMPLETED|Overall Study||26
2829309|NCT01727011|3530514|FG000|NOT COMPLETED|Overall Study||5
2829310|NCT01564537|3530520|FG000|STARTED|Overall Study||360
2829311|NCT01564537|3530521|FG001|STARTED|Overall Study||362
2829312|NCT01564537|3530520|FG000|Safety Population: Received Study Drug|Overall Study||360
2829313|NCT01564537|3530521|FG001|Safety Population: Received Study Drug|Overall Study||360
2829314|NCT01564537|3530520|FG000|COMPLETED|Overall Study|Completed=Participants who are ongoing as of 30 October 2014 or who have died on study.|354
2829315|NCT01564537|3530521|FG001|COMPLETED|Overall Study|Completed=Participants who are ongoing as of 30 October 2014 or who have died on study.|356
2829316|NCT01564537|3530520|FG000|NOT COMPLETED|Overall Study||6
2829317|NCT01564537|3530521|FG001|NOT COMPLETED|Overall Study||6
2829318|NCT01230242|3530528|FG000|STARTED|Overall Study||4
2829319|NCT01230242|3530528|FG000|COMPLETED|Overall Study||1
2829320|NCT01230242|3530528|FG000|NOT COMPLETED|Overall Study||3
2829321|NCT00983437|3530532|FG000|STARTED|Overall Study||47
2829322|NCT00983437|3530532|FG000|Safety Analysis Set (SAS)|Overall Study|Participants who received at least 1 dose of study drug were evaluable for safety.|47
2829323|NCT00983437|3530532|FG000|Full Analysis Set (FAS)|Overall Study|Participants had to have at least 1 postbaseline efficacy assessment to be evaluable for efficacy.|45
2829324|NCT00983437|3530532|FG000|COMPLETED|Overall Study|Completed 12 months of treatment with armodafinil.|0
2829325|NCT00983437|3530532|FG000|NOT COMPLETED|Overall Study||47
2829326|NCT00965757|3530538|FG000|STARTED|Double-blind Phase||165
2829327|NCT00965757|3530539|FG001|STARTED|Double-blind Phase||88
2829328|NCT00965757|3530540|FG002|STARTED|Double-blind Phase||0
2829329|NCT00965757|3530541|FG003|STARTED|Double-blind Phase||0
2829330|NCT00965757|3530538|FG000|COMPLETED|Double-blind Phase||148
2829331|NCT00965757|3530539|FG001|COMPLETED|Double-blind Phase||70
2829332|NCT00965757|3530540|FG002|COMPLETED|Double-blind Phase||0
2829333|NCT00965757|3530541|FG003|COMPLETED|Double-blind Phase||0
2829334|NCT00965757|3530538|FG000|NOT COMPLETED|Double-blind Phase||17
2829335|NCT00965757|3530539|FG001|NOT COMPLETED|Double-blind Phase||18
2829336|NCT00965757|3530540|FG002|NOT COMPLETED|Double-blind Phase||0
2829337|NCT00965757|3530541|FG003|NOT COMPLETED|Double-blind Phase||0
2829338|NCT00965757|3530538|FG000|STARTED|Extension Phase||0
2829339|NCT00965757|3530539|FG001|STARTED|Extension Phase||0
2829340|NCT00965757|3530540|FG002|STARTED|Extension Phase||165
2829341|NCT00965757|3530541|FG003|STARTED|Extension Phase||88
2829342|NCT00965757|3530538|FG000|COMPLETED|Extension Phase||0
2829343|NCT00965757|3530539|FG001|COMPLETED|Extension Phase||0
2829344|NCT00965757|3530540|FG002|COMPLETED|Extension Phase||132
2829345|NCT00965757|3530541|FG003|COMPLETED|Extension Phase||64
2829346|NCT00965757|3530538|FG000|NOT COMPLETED|Extension Phase||0
2829347|NCT00965757|3530539|FG001|NOT COMPLETED|Extension Phase||0
2829348|NCT00965757|3530540|FG002|NOT COMPLETED|Extension Phase||33
2829349|NCT00965757|3530541|FG003|NOT COMPLETED|Extension Phase||24
2829350|NCT00928447|3530549|FG000|STARTED|Overall Study||22
2829351|NCT00928447|3530549|FG000|Received at Least 1 Dose of rHuPH20|Overall Study||21
2829352|NCT00928447|3530549|FG000|Received at Least 1 Dose of Placebo|Overall Study||21
2829353|NCT00928447|3530549|FG000|COMPLETED|Overall Study||20
2829354|NCT00928447|3530549|FG000|NOT COMPLETED|Overall Study||2
2829355|NCT00893789|3530557|FG000|STARTED|Overall Study||29
2829356|NCT00893789|3530558|FG001|STARTED|Overall Study||30
2829357|NCT00893789|3530559|FG002|STARTED|Overall Study||29
2829358|NCT00893789|3530560|FG003|STARTED|Overall Study||29
2829359|NCT00893789|3530557|FG000|Safety Analysis Set (SAS)|Overall Study|SAS = all participants who received 1 or more doses of study drug.|29
2829360|NCT00893789|3530558|FG001|Safety Analysis Set (SAS)|Overall Study||30
2829361|NCT00893789|3530559|FG002|Safety Analysis Set (SAS)|Overall Study||29
2829362|NCT00893789|3530560|FG003|Safety Analysis Set (SAS)|Overall Study||29
2829363|NCT00893789|3530557|FG000|Full Analysis Set (FAS)|Overall Study|FAS = participants in the safety analysis set with ≥1 postbaseline primary efficacy assessment.|29
2829364|NCT00893789|3530558|FG001|Full Analysis Set (FAS)|Overall Study||29
2829365|NCT00893789|3530559|FG002|Full Analysis Set (FAS)|Overall Study||28
2829366|NCT00893789|3530560|FG003|Full Analysis Set (FAS)|Overall Study||27
2829367|NCT00893789|3530557|FG000|COMPLETED|Overall Study||23
2829368|NCT00893789|3530558|FG001|COMPLETED|Overall Study||26
2829369|NCT00893789|3530559|FG002|COMPLETED|Overall Study||22
2829370|NCT00893789|3530560|FG003|COMPLETED|Overall Study||16
2829371|NCT00893789|3530557|FG000|NOT COMPLETED|Overall Study||6
2829372|NCT00893789|3530558|FG001|NOT COMPLETED|Overall Study||4
2829373|NCT00893789|3530559|FG002|NOT COMPLETED|Overall Study||7
2829374|NCT00893789|3530560|FG003|NOT COMPLETED|Overall Study||13
2913491|NCT00496470|3623361|FG001|Received Study Medication|Overall Study||330
2913492|NCT00496470|3623360|FG000|COMPLETED|Overall Study||303
2913493|NCT00496470|3623361|FG001|COMPLETED|Overall Study||302
2913494|NCT00496470|3623360|FG000|NOT COMPLETED|Overall Study||26
2913495|NCT00496470|3623361|FG001|NOT COMPLETED|Overall Study||29
2913496|NCT00496483|3623367|FG000|STARTED|Overall Study||60
2913497|NCT00496483|3623367|FG000|Dosed|Overall Study||51
2913498|NCT00496483|3623367|FG000|COMPLETED|Overall Study||48
2913499|NCT00496483|3623367|FG000|NOT COMPLETED|Overall Study||12
2913500|NCT00496587|3623374|FG000|STARTED|Overall Study||34
2913501|NCT00496587|3623374|FG000|COMPLETED|Overall Study||3
2913502|NCT00496587|3623374|FG000|NOT COMPLETED|Overall Study||31
2913503|NCT00496626|3623380|FG000|STARTED|Overall Study||302
2913504|NCT00496626|3623381|FG001|STARTED|Overall Study||298
2913505|NCT00496626|3623380|FG000|COMPLETED|Overall Study||296
2913506|NCT00496626|3623381|FG001|COMPLETED|Overall Study||292
2913507|NCT00496626|3623380|FG000|NOT COMPLETED|Overall Study||6
2913508|NCT00496626|3623381|FG001|NOT COMPLETED|Overall Study||6
2913509|NCT00496769|3623393|FG000|STARTED|Double Blind|Randomized|2807
2913510|NCT00496769|3623394|FG001|STARTED|Double Blind|Randomized|2791
2913511|NCT00496769|3623395|FG002|STARTED|Double Blind||0
2913512|NCT00496769|3623393|FG000|Received Treatment|Double Blind||2798
2913513|NCT00496769|3623394|FG001|Received Treatment|Double Blind||2708
2913514|NCT00496769|3623395|FG002|Received Treatment|Double Blind||0
2829375|NCT04349150|3530570|FG000|STARTED|Overall Study||31
2829376|NCT04349150|3530570|FG000|COMPLETED|Overall Study||27
2829377|NCT04349150|3530570|FG000|NOT COMPLETED|Overall Study||4
2829378|NCT03948698|3530574|FG000|STARTED|Overall Study||4159533
2829379|NCT03948698|3530574|FG000|COMPLETED|Overall Study||4159533
2829380|NCT03948698|3530574|FG000|NOT COMPLETED|Overall Study||0
2829381|NCT03933449|3530580|FG000|STARTED|Overall Study||62
2829382|NCT03933449|3530581|FG001|STARTED|Overall Study||61
2829383|NCT03933449|3530580|FG000|Treated|Overall Study||62
2829384|NCT03933449|3530581|FG001|Treated|Overall Study||59
2829385|NCT03933449|3530580|FG000|COMPLETED|Overall Study||0
2829386|NCT03933449|3530581|FG001|COMPLETED|Overall Study||0
2829387|NCT03933449|3530580|FG000|NOT COMPLETED|Overall Study||62
2829388|NCT03933449|3530581|FG001|NOT COMPLETED|Overall Study||61
2829389|NCT03901144|3530587|FG000|STARTED|Overall Study||50
2829390|NCT03901144|3530588|FG001|STARTED|Overall Study||50
2829391|NCT03901144|3530589|FG002|STARTED|Overall Study||50
2829392|NCT03901144|3530590|FG003|STARTED|Overall Study||50
2829393|NCT03901144|3530587|FG000|COMPLETED|Overall Study||49
2829394|NCT03901144|3530588|FG001|COMPLETED|Overall Study||49
2829395|NCT03901144|3530589|FG002|COMPLETED|Overall Study||49
2829396|NCT03901144|3530590|FG003|COMPLETED|Overall Study||49
2829397|NCT03901144|3530587|FG000|NOT COMPLETED|Overall Study||1
2829398|NCT03901144|3530588|FG001|NOT COMPLETED|Overall Study||1
2829399|NCT03901144|3530589|FG002|NOT COMPLETED|Overall Study||1
2829400|NCT03901144|3530590|FG003|NOT COMPLETED|Overall Study||1
2829401|NCT03561701|3530602|FG000|STARTED|Overall Study||220
2829402|NCT03561701|3530603|FG001|STARTED|Overall Study||110
2829403|NCT03561701|3530602|FG000|COMPLETED|Overall Study||191
2829404|NCT03561701|3530603|FG001|COMPLETED|Overall Study||91
2829405|NCT03561701|3530602|FG000|NOT COMPLETED|Overall Study||29
3310247|NCT03038815|4043632|FG001|STARTED|Controll Condition, 1 Hour||10
3310248|NCT03038815|4043631|FG000|COMPLETED|Controll Condition, 1 Hour||10
3310249|NCT03038815|4043632|FG001|COMPLETED|Controll Condition, 1 Hour||10
2829406|NCT03561701|3530603|FG001|NOT COMPLETED|Overall Study||19
2829407|NCT03525808|3530609|FG000|STARTED|Overall Study||40
2829408|NCT03525808|3530609|FG000|COMPLETED|Overall Study||34
2829409|NCT03525808|3530609|FG000|NOT COMPLETED|Overall Study||6
2829410|NCT03461211|3530615|FG000|STARTED|Overall Study||37
2829411|NCT03461211|3530616|FG001|STARTED|Overall Study||14
2829412|NCT03461211|3530615|FG000|Proptosis Non-Responders in OPTIC|Overall Study||36
2829413|NCT03461211|3530616|FG001|Proptosis Non-Responders in OPTIC|Overall Study||5
2829414|NCT03461211|3530615|FG000|Relapsed During Follow-Up Period of OPTIC|Overall Study||1
2829415|NCT03461211|3530616|FG001|Relapsed During Follow-Up Period of OPTIC|Overall Study||9
2829416|NCT03461211|3530615|FG000|COMPLETED|Overall Study||36
2829417|NCT03461211|3530616|FG001|COMPLETED|Overall Study||12
2829418|NCT03461211|3530615|FG000|NOT COMPLETED|Overall Study||1
2829419|NCT03461211|3530616|FG001|NOT COMPLETED|Overall Study||2
2829420|NCT03282123|3530624|FG000|STARTED|Overall Study||38
2829421|NCT03282123|3530624|FG000|COMPLETED|Overall Study||33
2829422|NCT03282123|3530624|FG000|NOT COMPLETED|Overall Study||5
2829423|NCT03276780|3530631|FG000|STARTED|Overall Study||41
2829424|NCT03276780|3530632|FG001|STARTED|Overall Study||39
2829425|NCT03276780|3530631|FG000|COMPLETED|Overall Study||23
2829426|NCT03276780|3530632|FG001|COMPLETED|Overall Study||29
2829427|NCT03276780|3530631|FG000|NOT COMPLETED|Overall Study||18
2829428|NCT03276780|3530632|FG001|NOT COMPLETED|Overall Study||10
2829429|NCT03219333|3530642|FG000|STARTED|Overall Study||128
2829430|NCT03219333|3530643|FG001|STARTED|Overall Study||91
2829431|NCT03219333|3530642|FG000|Treated|Overall Study||125
2829432|NCT03219333|3530643|FG001|Treated|Overall Study||89
2829433|NCT03219333|3530642|FG000|COMPLETED|Overall Study|Cohort 1 Completed includes 4 participants on treatment and 19 participants in follow-up.|23
2829434|NCT03219333|3530643|FG001|COMPLETED|Overall Study|Cohort 2 Completed includes 16 participants on treatment and 26 participants in follow-up.|42
2829435|NCT03219333|3530642|FG000|NOT COMPLETED|Overall Study||105
2829436|NCT03219333|3530643|FG001|NOT COMPLETED|Overall Study||49
2829437|NCT03205553|3530651|FG000|STARTED|Overall Study||2
2829438|NCT03205553|3530652|FG001|STARTED|Overall Study||1
2829439|NCT03205553|3530651|FG000|COMPLETED|Overall Study||2
2829440|NCT03205553|3530652|FG001|COMPLETED|Overall Study||1
2829441|NCT03205553|3530651|FG000|NOT COMPLETED|Overall Study||0
2829442|NCT03205553|3530652|FG001|NOT COMPLETED|Overall Study||0
2829443|NCT03104205|3530658|FG000|STARTED|Overall Study||53
2829444|NCT03104205|3530658|FG000|COMPLETED|Overall Study||44
2829445|NCT03104205|3530658|FG000|NOT COMPLETED|Overall Study||9
2829446|NCT03100149|3530665|FG000|STARTED|Overall Study||105
2829447|NCT03100149|3530666|FG001|STARTED|Overall Study||105
2829448|NCT03100149|3530667|FG002|STARTED|Overall Study||106
2829449|NCT03100149|3530665|FG000|COMPLETED|Overall Study||105
2829450|NCT03100149|3530666|FG001|COMPLETED|Overall Study||101
2829451|NCT03100149|3530667|FG002|COMPLETED|Overall Study||104
2829452|NCT03100149|3530665|FG000|NOT COMPLETED|Overall Study||0
2829453|NCT03100149|3530666|FG001|NOT COMPLETED|Overall Study||4
2829454|NCT03100149|3530667|FG002|NOT COMPLETED|Overall Study||2
2829455|NCT03050814|3530678|FG000|STARTED|Overall Study||10
2829456|NCT03050814|3530679|FG001|STARTED|Overall Study||16
2829457|NCT03050814|3530680|FG002|STARTED|Overall Study||4
2829458|NCT03050814|3530678|FG000|COMPLETED|Overall Study||10
2829459|NCT03050814|3530679|FG001|COMPLETED|Overall Study||16
2829460|NCT03050814|3530680|FG002|COMPLETED|Overall Study||0
2829461|NCT03050814|3530678|FG000|NOT COMPLETED|Overall Study||0
2829462|NCT03050814|3530679|FG001|NOT COMPLETED|Overall Study||0
2829463|NCT03050814|3530680|FG002|NOT COMPLETED|Overall Study||4
2829464|NCT02797262|3530688|FG000|STARTED|Overall Study||65
2829465|NCT02797262|3530689|FG001|STARTED|Overall Study||65
2829466|NCT02797262|3530688|FG000|Baseline|Overall Study||54
2829467|NCT02797262|3530689|FG001|Baseline|Overall Study||58
2829468|NCT02797262|3530688|FG000|COMPLETED|Overall Study||45
2829469|NCT02797262|3530689|FG001|COMPLETED|Overall Study||54
2829470|NCT02797262|3530688|FG000|NOT COMPLETED|Overall Study||20
2829471|NCT02797262|3530689|FG001|NOT COMPLETED|Overall Study||11
2829472|NCT02639910|3530697|FG000|STARTED|Overall Study||11
2829473|NCT02639910|3530698|FG001|STARTED|Overall Study||13
2829474|NCT02639910|3530697|FG000|COMPLETED|Overall Study||7
2829475|NCT02639910|3530698|FG001|COMPLETED|Overall Study||5
2829476|NCT02639910|3530697|FG000|NOT COMPLETED|Overall Study||4
2829477|NCT02639910|3530698|FG001|NOT COMPLETED|Overall Study||8
2829478|NCT02409368|3530707|FG000|STARTED|Overall Study||173
2829479|NCT02409368|3530708|FG001|STARTED|Overall Study||534
2829480|NCT02409368|3530709|FG002|STARTED|Overall Study||103
2829481|NCT02409368|3530707|FG000|COMPLETED|Overall Study||25
2829482|NCT02409368|3530708|FG001|COMPLETED|Overall Study||45
2829483|NCT02409368|3530709|FG002|COMPLETED|Overall Study||4
2829484|NCT02409368|3530707|FG000|NOT COMPLETED|Overall Study||148
2829485|NCT02409368|3530708|FG001|NOT COMPLETED|Overall Study||489
2829486|NCT02409368|3530709|FG002|NOT COMPLETED|Overall Study||99
2829487|NCT02322593|3530720|FG000|STARTED|Overall Study||356
2829488|NCT02322593|3530721|FG001|STARTED|Overall Study||355
2829489|NCT02322593|3530720|FG000|COMPLETED|Overall Study||356
2829490|NCT02322593|3530721|FG001|COMPLETED|Overall Study||355
2829491|NCT02322593|3530720|FG000|NOT COMPLETED|Overall Study||0
2829492|NCT02322593|3530721|FG001|NOT COMPLETED|Overall Study||0
2829493|NCT02277119|3530730|FG000|STARTED|Overall Study||58
2829494|NCT02277119|3530731|FG001|STARTED|Overall Study||24
2829495|NCT02277119|3530732|FG002|STARTED|Overall Study||27
2829496|NCT02277119|3530730|FG000|COMPLETED|Overall Study||55
2829497|NCT02277119|3530731|FG001|COMPLETED|Overall Study||20
2829498|NCT02277119|3530732|FG002|COMPLETED|Overall Study||19
2829499|NCT02277119|3530730|FG000|NOT COMPLETED|Overall Study||3
2829500|NCT02277119|3530731|FG001|NOT COMPLETED|Overall Study||4
2829501|NCT02277119|3530732|FG002|NOT COMPLETED|Overall Study||8
2829502|NCT02220894|3530742|FG000|STARTED|Overall Study|1 additional participant was randomized in error|637
2829503|NCT02220894|3530743|FG001|STARTED|Overall Study||637
2829504|NCT02220894|3530742|FG000|Treated|Overall Study||636
2829505|NCT02220894|3530743|FG001|Treated|Overall Study||615
2829506|NCT02220894|3530742|FG000|COMPLETED|Overall Study||0
2829507|NCT02220894|3530743|FG001|COMPLETED|Overall Study||0
2829508|NCT02220894|3530742|FG000|NOT COMPLETED|Overall Study||637
2829509|NCT02220894|3530743|FG001|NOT COMPLETED|Overall Study||637
2829510|NCT02124824|3530751|FG000|STARTED|Overall Study||15
2829511|NCT02124824|3530752|FG001|STARTED|Overall Study||15
2829512|NCT02124824|3530751|FG000|COMPLETED|Overall Study||15
2829513|NCT02124824|3530752|FG001|COMPLETED|Overall Study||15
2829514|NCT02124824|3530751|FG000|NOT COMPLETED|Overall Study||0
2829515|NCT02124824|3530752|FG001|NOT COMPLETED|Overall Study||0
2829516|NCT01772004|3530781|FG000|STARTED|Dose Escalation Phase||4
2829517|NCT01772004|3530782|FG001|STARTED|Dose Escalation Phase||13
2829518|NCT01772004|3530783|FG002|STARTED|Dose Escalation Phase||15
2829519|NCT01772004|3530784|FG003|STARTED|Dose Escalation Phase||21
2829520|NCT01772004|3530785|FG004|STARTED|Dose Escalation Phase||8
2829521|NCT01772004|3530786|FG005|STARTED|Dose Escalation Phase||0
2829522|NCT01772004|3530787|FG006|STARTED|Dose Escalation Phase||0
2829523|NCT01772004|3530788|FG007|STARTED|Dose Escalation Phase||0
2829524|NCT01772004|3530789|FG008|STARTED|Dose Escalation Phase||0
2829525|NCT01772004|3530790|FG009|STARTED|Dose Escalation Phase||0
2829526|NCT01772004|3530791|FG010|STARTED|Dose Escalation Phase||0
2829527|NCT01772004|3530792|FG011|STARTED|Dose Escalation Phase||0
2829528|NCT01772004|3530793|FG012|STARTED|Dose Escalation Phase||0
2829529|NCT01772004|3530794|FG013|STARTED|Dose Escalation Phase||0
2829530|NCT01772004|3530795|FG014|STARTED|Dose Escalation Phase||0
2829531|NCT01772004|3530796|FG015|STARTED|Dose Escalation Phase||0
2829532|NCT01772004|3530797|FG016|STARTED|Dose Escalation Phase||0
2829533|NCT01772004|3530798|FG017|STARTED|Dose Escalation Phase||0
2829534|NCT01772004|3530799|FG018|STARTED|Dose Escalation Phase||0
2829535|NCT01772004|3530800|FG019|STARTED|Dose Escalation Phase||0
2829536|NCT01772004|3530801|FG020|STARTED|Dose Escalation Phase||0
2829537|NCT01772004|3530802|FG021|STARTED|Dose Escalation Phase||0
2829538|NCT01772004|3530803|FG022|STARTED|Dose Escalation Phase||0
2829539|NCT01772004|3530781|FG000|COMPLETED|Dose Escalation Phase||4
2829540|NCT01772004|3530782|FG001|COMPLETED|Dose Escalation Phase||13
2829541|NCT01772004|3530783|FG002|COMPLETED|Dose Escalation Phase||15
2829542|NCT01772004|3530784|FG003|COMPLETED|Dose Escalation Phase||21
2829543|NCT01772004|3530785|FG004|COMPLETED|Dose Escalation Phase||8
2829544|NCT01772004|3530786|FG005|COMPLETED|Dose Escalation Phase||0
2829545|NCT01772004|3530787|FG006|COMPLETED|Dose Escalation Phase||0
2829546|NCT01772004|3530788|FG007|COMPLETED|Dose Escalation Phase||0
2829547|NCT01772004|3530789|FG008|COMPLETED|Dose Escalation Phase||0
2829548|NCT01772004|3530790|FG009|COMPLETED|Dose Escalation Phase||0
2829549|NCT01772004|3530791|FG010|COMPLETED|Dose Escalation Phase||0
2829550|NCT01772004|3530792|FG011|COMPLETED|Dose Escalation Phase||0
2829551|NCT01772004|3530793|FG012|COMPLETED|Dose Escalation Phase||0
2829552|NCT01772004|3530794|FG013|COMPLETED|Dose Escalation Phase||0
2829553|NCT01772004|3530795|FG014|COMPLETED|Dose Escalation Phase||0
2829554|NCT01772004|3530796|FG015|COMPLETED|Dose Escalation Phase||0
2829555|NCT01772004|3530797|FG016|COMPLETED|Dose Escalation Phase||0
2829556|NCT01772004|3530798|FG017|COMPLETED|Dose Escalation Phase||0
2829557|NCT01772004|3530799|FG018|COMPLETED|Dose Escalation Phase||0
2829558|NCT01772004|3530800|FG019|COMPLETED|Dose Escalation Phase||0
2829559|NCT01772004|3530801|FG020|COMPLETED|Dose Escalation Phase||0
2829560|NCT01772004|3530802|FG021|COMPLETED|Dose Escalation Phase||0
2829561|NCT01772004|3530803|FG022|COMPLETED|Dose Escalation Phase||0
2829562|NCT01772004|3530781|FG000|NOT COMPLETED|Dose Escalation Phase||0
2829563|NCT01772004|3530782|FG001|NOT COMPLETED|Dose Escalation Phase||0
2829564|NCT01772004|3530783|FG002|NOT COMPLETED|Dose Escalation Phase||0
2829565|NCT01772004|3530784|FG003|NOT COMPLETED|Dose Escalation Phase||0
2829566|NCT01772004|3530785|FG004|NOT COMPLETED|Dose Escalation Phase||0
2829567|NCT01772004|3530786|FG005|NOT COMPLETED|Dose Escalation Phase||0
2829568|NCT01772004|3530787|FG006|NOT COMPLETED|Dose Escalation Phase||0
2829569|NCT01772004|3530788|FG007|NOT COMPLETED|Dose Escalation Phase||0
2829570|NCT01772004|3530789|FG008|NOT COMPLETED|Dose Escalation Phase||0
2829571|NCT01772004|3530790|FG009|NOT COMPLETED|Dose Escalation Phase||0
2829572|NCT01772004|3530791|FG010|NOT COMPLETED|Dose Escalation Phase||0
2829573|NCT01772004|3530792|FG011|NOT COMPLETED|Dose Escalation Phase||0
2829574|NCT01772004|3530793|FG012|NOT COMPLETED|Dose Escalation Phase||0
2829575|NCT01772004|3530794|FG013|NOT COMPLETED|Dose Escalation Phase||0
2829576|NCT01772004|3530795|FG014|NOT COMPLETED|Dose Escalation Phase||0
2829577|NCT01772004|3530796|FG015|NOT COMPLETED|Dose Escalation Phase||0
2829578|NCT01772004|3530797|FG016|NOT COMPLETED|Dose Escalation Phase||0
2829579|NCT01772004|3530798|FG017|NOT COMPLETED|Dose Escalation Phase||0
2829580|NCT01772004|3530799|FG018|NOT COMPLETED|Dose Escalation Phase||0
2829581|NCT01772004|3530800|FG019|NOT COMPLETED|Dose Escalation Phase||0
2829582|NCT01772004|3530801|FG020|NOT COMPLETED|Dose Escalation Phase||0
2829583|NCT01772004|3530802|FG021|NOT COMPLETED|Dose Escalation Phase||0
2829584|NCT01772004|3530803|FG022|NOT COMPLETED|Dose Escalation Phase||0
2829585|NCT01772004|3530781|FG000|STARTED|Dose Expansion Phase||0
2829586|NCT01772004|3530782|FG001|STARTED|Dose Expansion Phase||0
2829587|NCT01772004|3530783|FG002|STARTED|Dose Expansion Phase||0
2829588|NCT01772004|3530784|FG003|STARTED|Dose Expansion Phase||0
2829589|NCT01772004|3530785|FG004|STARTED|Dose Expansion Phase||0
2829590|NCT01772004|3530786|FG005|STARTED|Dose Expansion Phase||184
2829591|NCT01772004|3530787|FG006|STARTED|Dose Expansion Phase||156
2829592|NCT01772004|3530788|FG007|STARTED|Dose Expansion Phase||168
2829593|NCT01772004|3530789|FG008|STARTED|Dose Expansion Phase||60
2829594|NCT01772004|3530790|FG009|STARTED|Dose Expansion Phase||90
2829595|NCT01772004|3530791|FG010|STARTED|Dose Expansion Phase||21
2829596|NCT01772004|3530792|FG011|STARTED|Dose Expansion Phase||18
2829597|NCT01772004|3530793|FG012|STARTED|Dose Expansion Phase||50
2829598|NCT01772004|3530794|FG013|STARTED|Dose Expansion Phase||51
3166763|NCT01904773|3893897|FG000|STARTED|Placebo Washout Fifth Intervention||0
3166764|NCT01904773|3893898|FG001|STARTED|Placebo Washout Fifth Intervention||1
3166765|NCT01904773|3893899|FG002|STARTED|Placebo Washout Fifth Intervention||1
3166766|NCT01904773|3893900|FG003|STARTED|Placebo Washout Fifth Intervention||2
3166767|NCT01904773|3893901|FG004|STARTED|Placebo Washout Fifth Intervention||3
3166768|NCT01904773|3893902|FG005|STARTED|Placebo Washout Fifth Intervention||4
3166769|NCT01904773|3893903|FG006|STARTED|Placebo Washout Fifth Intervention||3
2829599|NCT01772004|3530795|FG014|STARTED|Dose Expansion Phase||53
2829600|NCT01772004|3530796|FG015|STARTED|Dose Expansion Phase||44
2829601|NCT01772004|3530797|FG016|STARTED|Dose Expansion Phase||125
2829602|NCT01772004|3530798|FG017|STARTED|Dose Expansion Phase||62
2829603|NCT01772004|3530799|FG018|STARTED|Dose Expansion Phase||20
2829604|NCT01772004|3530800|FG019|STARTED|Dose Expansion Phase||103
2829605|NCT01772004|3530801|FG020|STARTED|Dose Expansion Phase||205
2829606|NCT01772004|3530802|FG021|STARTED|Dose Expansion Phase||132
2829607|NCT01772004|3530803|FG022|STARTED|Dose Expansion Phase||153
2829608|NCT01772004|3530781|FG000|COMPLETED|Dose Expansion Phase||0
2829609|NCT01772004|3530782|FG001|COMPLETED|Dose Expansion Phase||0
2829610|NCT01772004|3530783|FG002|COMPLETED|Dose Expansion Phase||0
2829611|NCT01772004|3530784|FG003|COMPLETED|Dose Expansion Phase||0
2829612|NCT01772004|3530785|FG004|COMPLETED|Dose Expansion Phase||0
2829613|NCT01772004|3530786|FG005|COMPLETED|Dose Expansion Phase||184
2829614|NCT01772004|3530787|FG006|COMPLETED|Dose Expansion Phase||156
2829615|NCT01772004|3530788|FG007|COMPLETED|Dose Expansion Phase||168
2829616|NCT01772004|3530789|FG008|COMPLETED|Dose Expansion Phase||60
2829617|NCT01772004|3530790|FG009|COMPLETED|Dose Expansion Phase||90
2829618|NCT01772004|3530791|FG010|COMPLETED|Dose Expansion Phase||21
2829619|NCT01772004|3530792|FG011|COMPLETED|Dose Expansion Phase||18
2829620|NCT01772004|3530793|FG012|COMPLETED|Dose Expansion Phase||50
2829621|NCT01772004|3530794|FG013|COMPLETED|Dose Expansion Phase||51
2829622|NCT01772004|3530795|FG014|COMPLETED|Dose Expansion Phase||53
2829623|NCT01772004|3530796|FG015|COMPLETED|Dose Expansion Phase||44
2829624|NCT01772004|3530797|FG016|COMPLETED|Dose Expansion Phase||125
2829625|NCT01772004|3530798|FG017|COMPLETED|Dose Expansion Phase||62
2829626|NCT01772004|3530799|FG018|COMPLETED|Dose Expansion Phase||20
2829627|NCT01772004|3530800|FG019|COMPLETED|Dose Expansion Phase||103
2829628|NCT01772004|3530801|FG020|COMPLETED|Dose Expansion Phase||205
3166770|NCT01904773|3893904|FG007|STARTED|Placebo Washout Fifth Intervention||2
2829629|NCT01772004|3530802|FG021|COMPLETED|Dose Expansion Phase||132
2829630|NCT01772004|3530803|FG022|COMPLETED|Dose Expansion Phase||153
2829631|NCT01772004|3530781|FG000|NOT COMPLETED|Dose Expansion Phase||0
2829632|NCT01772004|3530782|FG001|NOT COMPLETED|Dose Expansion Phase||0
2829633|NCT01772004|3530783|FG002|NOT COMPLETED|Dose Expansion Phase||0
2829634|NCT01772004|3530784|FG003|NOT COMPLETED|Dose Expansion Phase||0
2829635|NCT01772004|3530785|FG004|NOT COMPLETED|Dose Expansion Phase||0
2829636|NCT01772004|3530786|FG005|NOT COMPLETED|Dose Expansion Phase||0
2829637|NCT01772004|3530787|FG006|NOT COMPLETED|Dose Expansion Phase||0
2829638|NCT01772004|3530788|FG007|NOT COMPLETED|Dose Expansion Phase||0
2829639|NCT01772004|3530789|FG008|NOT COMPLETED|Dose Expansion Phase||0
2829640|NCT01772004|3530790|FG009|NOT COMPLETED|Dose Expansion Phase||0
2829641|NCT01772004|3530791|FG010|NOT COMPLETED|Dose Expansion Phase||0
2829642|NCT01772004|3530792|FG011|NOT COMPLETED|Dose Expansion Phase||0
2829643|NCT01772004|3530793|FG012|NOT COMPLETED|Dose Expansion Phase||0
2829644|NCT01772004|3530794|FG013|NOT COMPLETED|Dose Expansion Phase||0
2829645|NCT01772004|3530795|FG014|NOT COMPLETED|Dose Expansion Phase||0
2829646|NCT01772004|3530796|FG015|NOT COMPLETED|Dose Expansion Phase||0
2829647|NCT01772004|3530797|FG016|NOT COMPLETED|Dose Expansion Phase||0
2829648|NCT01772004|3530798|FG017|NOT COMPLETED|Dose Expansion Phase||0
2829649|NCT01772004|3530799|FG018|NOT COMPLETED|Dose Expansion Phase||0
2829650|NCT01772004|3530800|FG019|NOT COMPLETED|Dose Expansion Phase||0
2829651|NCT01772004|3530801|FG020|NOT COMPLETED|Dose Expansion Phase||0
2829652|NCT01772004|3530802|FG021|NOT COMPLETED|Dose Expansion Phase||0
2829653|NCT01772004|3530803|FG022|NOT COMPLETED|Dose Expansion Phase||0
2829654|NCT01721759|3530898|FG000|STARTED|Overall Study||117
2829655|NCT01721759|3530898|FG000|COMPLETED|Overall Study|Completed=continuing to receive treatment|15
2829656|NCT01721759|3530898|FG000|NOT COMPLETED|Overall Study||102
2829657|NCT01322971|3530904|FG000|STARTED|Overall Study||1
2829658|NCT01322971|3530905|FG001|STARTED|Overall Study||1
2829659|NCT01322971|3530904|FG000|COMPLETED|Overall Study||0
2829660|NCT01322971|3530905|FG001|COMPLETED|Overall Study||0
2829661|NCT01322971|3530904|FG000|NOT COMPLETED|Overall Study||1
2829662|NCT01322971|3530905|FG001|NOT COMPLETED|Overall Study||1
2829663|NCT01285102|3530911|FG000|STARTED|Overall Study||4
2829664|NCT01285102|3530911|FG000|COMPLETED|Overall Study||0
2829665|NCT01285102|3530911|FG000|NOT COMPLETED|Overall Study||4
2829666|NCT01026220|3530915|FG000|STARTED|Induction||166
2829667|NCT01026220|3530916|FG001|STARTED|Induction||0
2829668|NCT01026220|3530917|FG002|STARTED|Induction||0
2829669|NCT01026220|3530915|FG000|COMPLETED|Induction||141
2829670|NCT01026220|3530916|FG001|COMPLETED|Induction||0
2829671|NCT01026220|3530917|FG002|COMPLETED|Induction||0
2829672|NCT01026220|3530915|FG000|NOT COMPLETED|Induction||25
2829673|NCT01026220|3530916|FG001|NOT COMPLETED|Induction||0
2829674|NCT01026220|3530917|FG002|NOT COMPLETED|Induction||0
2829675|NCT01026220|3530915|FG000|STARTED|Consolidation Maintenance||0
2829676|NCT01026220|3530916|FG001|STARTED|Consolidation Maintenance||81
2829677|NCT01026220|3530917|FG002|STARTED|Consolidation Maintenance||80
2829678|NCT01026220|3530915|FG000|COMPLETED|Consolidation Maintenance||0
2829679|NCT01026220|3530916|FG001|COMPLETED|Consolidation Maintenance||75
2829680|NCT01026220|3530917|FG002|COMPLETED|Consolidation Maintenance||66
2829681|NCT01026220|3530915|FG000|NOT COMPLETED|Consolidation Maintenance||0
2829682|NCT01026220|3530916|FG001|NOT COMPLETED|Consolidation Maintenance||6
2829683|NCT01026220|3530917|FG002|NOT COMPLETED|Consolidation Maintenance||14
2829684|NCT00952692|3530932|FG000|STARTED|Overall Study||12
2829685|NCT00952692|3530932|FG000|COMPLETED|Overall Study||12
2829686|NCT00952692|3530932|FG000|NOT COMPLETED|Overall Study||0
2829687|NCT00804713|3530936|FG000|STARTED|Overall Study||1978
2829688|NCT00804713|3530936|FG000|COMPLETED|Overall Study||1978
2829689|NCT00804713|3530936|FG000|NOT COMPLETED|Overall Study||0
2829690|NCT00677560|3530947|FG000|STARTED|Overall Study||20
2829691|NCT00677560|3530948|FG001|STARTED|Overall Study||23
2829692|NCT00677560|3530949|FG002|STARTED|Overall Study||29
2829693|NCT00677560|3530950|FG003|STARTED|Overall Study||20
2829694|NCT00677560|3530951|FG004|STARTED|Overall Study||34
2829695|NCT00677560|3530947|FG000|COMPLETED|Overall Study||5
2829696|NCT00677560|3530948|FG001|COMPLETED|Overall Study||13
2829697|NCT00677560|3530949|FG002|COMPLETED|Overall Study||6
2829698|NCT00677560|3530950|FG003|COMPLETED|Overall Study||3
2829699|NCT00677560|3530951|FG004|COMPLETED|Overall Study||21
2829700|NCT00677560|3530947|FG000|NOT COMPLETED|Overall Study||15
2829701|NCT00677560|3530948|FG001|NOT COMPLETED|Overall Study||10
2829702|NCT00677560|3530949|FG002|NOT COMPLETED|Overall Study||23
2829703|NCT00677560|3530950|FG003|NOT COMPLETED|Overall Study||17
2829704|NCT00677560|3530951|FG004|NOT COMPLETED|Overall Study||13
2829705|NCT00389649|3530976|FG000|STARTED|Overall Study||2
2829706|NCT00389649|3530977|FG001|STARTED|Overall Study||2
2829707|NCT00389649|3530978|FG002|STARTED|Overall Study||3
2829708|NCT00389649|3530979|FG003|STARTED|Overall Study||2
2829709|NCT00389649|3530980|FG004|STARTED|Overall Study||2
2829710|NCT00389649|3530981|FG005|STARTED|Overall Study||2
2829711|NCT00389649|3530976|FG000|COMPLETED|Overall Study||2
2829712|NCT00389649|3530977|FG001|COMPLETED|Overall Study||2
2829713|NCT00389649|3530978|FG002|COMPLETED|Overall Study||3
2829714|NCT00389649|3530979|FG003|COMPLETED|Overall Study||2
2829715|NCT00389649|3530980|FG004|COMPLETED|Overall Study||2
2829716|NCT00389649|3530981|FG005|COMPLETED|Overall Study||2
2829717|NCT00389649|3530976|FG000|NOT COMPLETED|Overall Study||0
2829718|NCT00389649|3530977|FG001|NOT COMPLETED|Overall Study||0
2829719|NCT00389649|3530978|FG002|NOT COMPLETED|Overall Study||0
2829720|NCT00389649|3530979|FG003|NOT COMPLETED|Overall Study||0
2829721|NCT00389649|3530980|FG004|NOT COMPLETED|Overall Study||0
2829722|NCT00389649|3530981|FG005|NOT COMPLETED|Overall Study||0
2913515|NCT00496769|3623393|FG000|COMPLETED|Double Blind||2249
2913516|NCT00496769|3623394|FG001|COMPLETED|Double Blind||2142
2913517|NCT00496769|3623395|FG002|COMPLETED|Double Blind||0
2913518|NCT00496769|3623393|FG000|NOT COMPLETED|Double Blind||558
2913519|NCT00496769|3623394|FG001|NOT COMPLETED|Double Blind||649
2913520|NCT00496769|3623395|FG002|NOT COMPLETED|Double Blind||0
2913521|NCT00496769|3623393|FG000|STARTED|Open Label||0
2913522|NCT00496769|3623394|FG001|STARTED|Open Label||0
2913523|NCT00496769|3623395|FG002|STARTED|Open Label||3275
2913524|NCT00496769|3623393|FG000|COMPLETED|Open Label||0
2913525|NCT00496769|3623394|FG001|COMPLETED|Open Label||0
2913526|NCT00496769|3623395|FG002|COMPLETED|Open Label||2264
2913527|NCT00496769|3623393|FG000|NOT COMPLETED|Open Label||0
2913528|NCT00496769|3623394|FG001|NOT COMPLETED|Open Label||0
2913529|NCT00496769|3623395|FG002|NOT COMPLETED|Open Label||1011
2913530|NCT00496808|3623404|FG000|STARTED|Overall Study||69
2913531|NCT00496808|3623404|FG000|COMPLETED|Overall Study||69
2913532|NCT00496808|3623404|FG000|NOT COMPLETED|Overall Study||0
2913533|NCT00496860|3623411|FG000|STARTED|Overall Study||4
2913534|NCT00496860|3623412|FG001|STARTED|Overall Study||16
2913535|NCT00496860|3623413|FG002|STARTED|Overall Study||6
2913536|NCT00496860|3623411|FG000|COMPLETED|Overall Study||3
2913537|NCT00496860|3623412|FG001|COMPLETED|Overall Study||15
2913538|NCT00496860|3623413|FG002|COMPLETED|Overall Study||6
2913539|NCT00496860|3623411|FG000|NOT COMPLETED|Overall Study||1
2913540|NCT00496860|3623412|FG001|NOT COMPLETED|Overall Study||1
2913541|NCT00496860|3623413|FG002|NOT COMPLETED|Overall Study||0
2913542|NCT00496873|3623421|FG000|STARTED|Overall Study||85
2913543|NCT00496873|3623421|FG000|COMPLETED|Overall Study||78
2913544|NCT00496873|3623421|FG000|NOT COMPLETED|Overall Study||7
2913545|NCT00496964|3623427|FG000|STARTED|Overall Study||1
2913546|NCT00496964|3623428|FG001|STARTED|Overall Study||4
2913547|NCT00496964|3623427|FG000|COMPLETED|Overall Study||1
2913548|NCT00496964|3623428|FG001|COMPLETED|Overall Study||3
2913549|NCT00496964|3623427|FG000|NOT COMPLETED|Overall Study||0
2913550|NCT00496964|3623428|FG001|NOT COMPLETED|Overall Study||1
2913551|NCT00497055|3623438|FG000|STARTED|Overall Study||45
2913552|NCT00497055|3623439|FG001|STARTED|Overall Study||45
2913553|NCT00497055|3623438|FG000|COMPLETED|Overall Study||35
2913554|NCT00497055|3623439|FG001|COMPLETED|Overall Study||40
2913555|NCT00497055|3623438|FG000|NOT COMPLETED|Overall Study||10
2913556|NCT00497055|3623439|FG001|NOT COMPLETED|Overall Study||5
2913557|NCT00497081|3623447|FG000|STARTED|Overall Study||30
2913558|NCT00497081|3623448|FG001|STARTED|Overall Study||30
2913559|NCT00497081|3623447|FG000|COMPLETED|Overall Study||28
2913560|NCT00497081|3623448|FG001|COMPLETED|Overall Study||28
2913561|NCT00497081|3623447|FG000|NOT COMPLETED|Overall Study||2
2913562|NCT00497081|3623448|FG001|NOT COMPLETED|Overall Study||2
2913563|NCT00497146|3623456|FG000|STARTED|Treatment Period||115
2913564|NCT00497146|3623457|FG001|STARTED|Treatment Period||112
2913565|NCT00497146|3623456|FG000|COMPLETED|Treatment Period||88
2913566|NCT00497146|3623457|FG001|COMPLETED|Treatment Period||91
2913567|NCT00497146|3623456|FG000|NOT COMPLETED|Treatment Period||27
2913568|NCT00497146|3623457|FG001|NOT COMPLETED|Treatment Period||21
2913569|NCT00497146|3623456|FG000|STARTED|Long-term Follow-up Period||65
2913570|NCT00497146|3623457|FG001|STARTED|Long-term Follow-up Period||72
2913571|NCT00497146|3623456|FG000|COMPLETED|Long-term Follow-up Period||50
2913572|NCT00497146|3623457|FG001|COMPLETED|Long-term Follow-up Period||66
2913573|NCT00497146|3623456|FG000|NOT COMPLETED|Long-term Follow-up Period||15
2913574|NCT00497146|3623457|FG001|NOT COMPLETED|Long-term Follow-up Period||6
2913575|NCT00497198|3623467|FG000|STARTED|Overall Study||92
2913576|NCT00497198|3623468|FG001|STARTED|Overall Study||91
2913577|NCT00497198|3623467|FG000|COMPLETED|Overall Study||87
2913578|NCT00497198|3623468|FG001|COMPLETED|Overall Study||86
2913579|NCT00497198|3623467|FG000|NOT COMPLETED|Overall Study||5
2913580|NCT00497198|3623468|FG001|NOT COMPLETED|Overall Study||5
2913581|NCT00497289|3623476|FG000|STARTED|Overall Study||24
2913582|NCT00497289|3623477|FG001|STARTED|Overall Study||24
2913583|NCT00497289|3623476|FG000|COMPLETED|Overall Study||19
2913584|NCT00497289|3623477|FG001|COMPLETED|Overall Study||18
2913585|NCT00497289|3623476|FG000|NOT COMPLETED|Overall Study||5
2913586|NCT00497289|3623477|FG001|NOT COMPLETED|Overall Study||6
2913587|NCT00497770|3623489|FG000|STARTED|Overall Study||304
2913588|NCT00497770|3623490|FG001|STARTED|Overall Study||65
2913589|NCT00497770|3623491|FG002|STARTED|Overall Study||37
2913590|NCT00497770|3623492|FG003|STARTED|Overall Study||28
2913591|NCT00497770|3623489|FG000|COMPLETED|Overall Study||304
2913592|NCT00497770|3623490|FG001|COMPLETED|Overall Study||65
2913593|NCT00497770|3623491|FG002|COMPLETED|Overall Study||37
2913594|NCT00497770|3623492|FG003|COMPLETED|Overall Study||28
2913595|NCT00497770|3623489|FG000|NOT COMPLETED|Overall Study||0
2913596|NCT00497770|3623490|FG001|NOT COMPLETED|Overall Study||0
2913597|NCT00497770|3623491|FG002|NOT COMPLETED|Overall Study||0
2913598|NCT00497770|3623492|FG003|NOT COMPLETED|Overall Study||0
2913599|NCT00497796|3623505|FG000|STARTED|Overall Study||147
2913600|NCT00497796|3623506|FG001|STARTED|Overall Study||160
2913601|NCT00497796|3623505|FG000|COMPLETED|Overall Study||62
2913602|NCT00497796|3623506|FG001|COMPLETED|Overall Study||101
2829723|NCT04644328|3530991|FG000|STARTED|Thanksgiving Period|"Two separate, sequential experiments were run within the study using the same counties (with differences in exclusion criteria explained in the pre-assignment details).~Thanksgiving experiment: 410 counties were assigned to high-intensity treatment. A total of 3,545 ZCTAs (of which 2,702 were in high-intensity counties) were treated.~Counties randomized to intervention, data collected at the population level, actual number of participants unknown."|
2829724|NCT04644328|3530992|FG001|STARTED|Thanksgiving Period|"Two separate, sequential experiments were run within the study using the same counties (with differences in exclusion criteria explained in the pre-assignment details).~Thanksgiving experiment: 410 counties were assigned to low-intensity treatment. A total of 3,453 ZCTAs (of which 2,549 were in low-intensity counties) were not treated.~Counties randomized to intervention, data collected at the population level, actual number of participants unknown."|
2829725|NCT04644328|3530991|FG000|COMPLETED|Thanksgiving Period|Counties randomized to intervention, data collected at the population level, actual number of participants unknown.|
2829726|NCT04644328|3530992|FG001|COMPLETED|Thanksgiving Period|Counties randomized to intervention, data collected at the population level, actual number of participants unknown.|
2829727|NCT04644328|3530991|FG000|NOT COMPLETED|Thanksgiving Period||
2829728|NCT04644328|3530992|FG001|NOT COMPLETED|Thanksgiving Period||
2829729|NCT04644328|3530991|FG000|STARTED|Christmas Period|"Two separate, sequential experiments were run within the study using the same counties (with differences in exclusion criteria explained in the pre-assignment details).~Christmas experiment: 386 counties were assigned to high-intensity treatment. A total of 5,077 ZCTAs (of which 3,818 were in high-intensity counties) were treated.~Counties randomized to intervention, data collected at the population level, actual number of participants unknown."|
2829730|NCT04644328|3530992|FG001|STARTED|Christmas Period|"Two separate, sequential experiments were run within the study using the same counties (with differences in exclusion criteria explained in the pre-assignment details).~Christmas experiment: 381 counties were assigned to low-intensity treatment. A total of 5,102 ZCTAs (of which 3,833 were in low-intensity counties) were not treated.~Counties randomized to intervention, data collected at the population level, actual number of participants unknown."|
2829731|NCT04644328|3530991|FG000|COMPLETED|Christmas Period|Counties randomized to intervention, data collected at the population level, actual number of participants unknown.|
2829732|NCT04644328|3530992|FG001|COMPLETED|Christmas Period|Counties randomized to intervention, data collected at the population level, actual number of participants unknown.|
2829733|NCT04644328|3530991|FG000|NOT COMPLETED|Christmas Period||
2829734|NCT04644328|3530992|FG001|NOT COMPLETED|Christmas Period||
2829735|NCT04246554|3531002|FG000|STARTED|Overall Study||26
2829736|NCT04246554|3531003|FG001|STARTED|Overall Study||23
2829737|NCT04246554|3531002|FG000|COMPLETED|Overall Study||26
2829738|NCT04246554|3531003|FG001|COMPLETED|Overall Study||22
2829739|NCT04246554|3531002|FG000|NOT COMPLETED|Overall Study||0
2829740|NCT04246554|3531003|FG001|NOT COMPLETED|Overall Study||1
2829741|NCT03877926|3531013|FG000|STARTED|Overall Study||1103
2829742|NCT03877926|3531014|FG001|STARTED|Overall Study||1103
2829743|NCT03877926|3531015|FG002|STARTED|Overall Study||1098
2829744|NCT03877926|3531016|FG003|STARTED|Overall Study||558
2829745|NCT03877926|3531013|FG000|Received at Least One Study Vaccination|Overall Study||1100
2829746|NCT03877926|3531014|FG001|Received at Least One Study Vaccination|Overall Study||1102
2829747|NCT03877926|3531015|FG002|Received at Least One Study Vaccination|Overall Study||1097
2829748|NCT03877926|3531016|FG003|Received at Least One Study Vaccination|Overall Study||558
2829749|NCT03877926|3531013|FG000|Did Not Receive Any Study Vaccination|Overall Study||3
2829750|NCT03877926|3531014|FG001|Did Not Receive Any Study Vaccination|Overall Study||1
2829751|NCT03877926|3531015|FG002|Did Not Receive Any Study Vaccination|Overall Study||1
2829752|NCT03877926|3531016|FG003|Did Not Receive Any Study Vaccination|Overall Study||0
2829753|NCT03877926|3531013|FG000|COMPLETED|Overall Study||1032
2829754|NCT03877926|3531014|FG001|COMPLETED|Overall Study||1026
2829755|NCT03877926|3531015|FG002|COMPLETED|Overall Study||1035
2829756|NCT03877926|3531016|FG003|COMPLETED|Overall Study||537
2829757|NCT03877926|3531013|FG000|NOT COMPLETED|Overall Study||71
2829758|NCT03877926|3531014|FG001|NOT COMPLETED|Overall Study||77
2829759|NCT03877926|3531015|FG002|NOT COMPLETED|Overall Study||63
2829760|NCT03877926|3531016|FG003|NOT COMPLETED|Overall Study||21
2829761|NCT03862807|3531039|FG000|STARTED|Overall Study||24
2829762|NCT03862807|3531039|FG000|Treated|Overall Study||23
2829763|NCT03862807|3531039|FG000|Completed Treatment|Overall Study||22
2829764|NCT03862807|3531039|FG000|COMPLETED|Overall Study||23
2829765|NCT03862807|3531039|FG000|NOT COMPLETED|Overall Study||1
2829766|NCT03857867|3531043|FG000|STARTED|Overall Study||7
2829767|NCT03857867|3531043|FG000|COMPLETED|Overall Study||6
2829768|NCT03857867|3531043|FG000|NOT COMPLETED|Overall Study||1
2829769|NCT03691571|3531050|FG000|STARTED|Overall Study||31
2829770|NCT03691571|3531051|FG001|STARTED|Overall Study||24
2829771|NCT03691571|3531050|FG000|COMPLETED|Overall Study||22
2829772|NCT03691571|3531051|FG001|COMPLETED|Overall Study||22
2829773|NCT03691571|3531050|FG000|NOT COMPLETED|Overall Study||9
2829774|NCT03691571|3531051|FG001|NOT COMPLETED|Overall Study||2
2829775|NCT03436199|3531061|FG000|STARTED|Overall Study||187
2829776|NCT03436199|3531062|FG001|STARTED|Overall Study||185
2829777|NCT03436199|3531063|FG002|STARTED|Overall Study||186
2829778|NCT03436199|3531061|FG000|COMPLETED|Overall Study||165
2829779|NCT03436199|3531062|FG001|COMPLETED|Overall Study||132
2829780|NCT03436199|3531063|FG002|COMPLETED|Overall Study||174
2829781|NCT03436199|3531061|FG000|NOT COMPLETED|Overall Study||22
2829782|NCT03436199|3531062|FG001|NOT COMPLETED|Overall Study||53
2829783|NCT03436199|3531063|FG002|NOT COMPLETED|Overall Study||12
2829784|NCT03417102|3531073|FG000|STARTED|Overall Study||19
2829785|NCT03417102|3531074|FG001|STARTED|Overall Study||38
2829786|NCT03417102|3531073|FG000|Safety Analysis Set|Overall Study||19
2829787|NCT03417102|3531074|FG001|Safety Analysis Set|Overall Study|3 participants were non-randomized but treated with Fitusiran considered in this arm for safety.|41
2829788|NCT03417102|3531073|FG000|COMPLETED|Overall Study||19
2829789|NCT03417102|3531074|FG001|COMPLETED|Overall Study||33
2829790|NCT03417102|3531073|FG000|NOT COMPLETED|Overall Study||0
2829791|NCT03417102|3531074|FG001|NOT COMPLETED|Overall Study||5
2829792|NCT03353233|3531082|FG000|STARTED|Overall Study||25
2829793|NCT03353233|3531083|FG001|STARTED|Overall Study||25
2829794|NCT03353233|3531082|FG000|COMPLETED|Overall Study||25
2829795|NCT03353233|3531083|FG001|COMPLETED|Overall Study||25
2829796|NCT03353233|3531082|FG000|NOT COMPLETED|Overall Study||0
2829797|NCT03353233|3531083|FG001|NOT COMPLETED|Overall Study||0
2829798|NCT03250273|3531091|FG000|STARTED|Overall Study||13
2829799|NCT03250273|3531092|FG001|STARTED|Overall Study||30
2829800|NCT03250273|3531091|FG000|COMPLETED|Overall Study||11
2829801|NCT03250273|3531092|FG001|COMPLETED|Overall Study||18
2829802|NCT03250273|3531091|FG000|NOT COMPLETED|Overall Study||2
2829803|NCT03250273|3531092|FG001|NOT COMPLETED|Overall Study||12
2829804|NCT03217136|3531100|FG000|STARTED|Overall Study||71
2829805|NCT03217136|3531101|FG001|STARTED|Overall Study||23
2829806|NCT03217136|3531100|FG000|Treated|Overall Study||70
2829807|NCT03217136|3531101|FG001|Treated|Overall Study||21
2829808|NCT03217136|3531100|FG000|COMPLETED|Overall Study||67
2829809|NCT03217136|3531101|FG001|COMPLETED|Overall Study||20
2829810|NCT03217136|3531100|FG000|NOT COMPLETED|Overall Study||4
2829811|NCT03217136|3531101|FG001|NOT COMPLETED|Overall Study||3
2829812|NCT03181542|3531109|FG000|STARTED|Overall Study||80
2829813|NCT03181542|3531110|FG001|STARTED|Overall Study||80
2829814|NCT03181542|3531109|FG000|COMPLETED|Overall Study||79
2829815|NCT03181542|3531110|FG001|COMPLETED|Overall Study||80
2829816|NCT03181542|3531109|FG000|NOT COMPLETED|Overall Study||1
2829817|NCT03181542|3531110|FG001|NOT COMPLETED|Overall Study||0
2829818|NCT02983617|3531118|FG000|STARTED|Overall Study||6
2829819|NCT02983617|3531119|FG001|STARTED|Overall Study||30
2829820|NCT02983617|3531118|FG000|COMPLETED|Overall Study||6
2829821|NCT02983617|3531119|FG001|COMPLETED|Overall Study||21
2829822|NCT02983617|3531118|FG000|NOT COMPLETED|Overall Study||0
2829823|NCT02983617|3531119|FG001|NOT COMPLETED|Overall Study||9
2829824|NCT02964377|3531128|FG000|STARTED|Overall Study||5
2829825|NCT02964377|3531129|FG001|STARTED|Overall Study||5
2829826|NCT02964377|3531130|FG002|STARTED|Overall Study||5
2829827|NCT02964377|3531128|FG000|COMPLETED|Overall Study||5
2829828|NCT02964377|3531129|FG001|COMPLETED|Overall Study||5
2829829|NCT02964377|3531130|FG002|COMPLETED|Overall Study||5
2829830|NCT02964377|3531128|FG000|NOT COMPLETED|Overall Study||0
2829831|NCT02964377|3531129|FG001|NOT COMPLETED|Overall Study||0
2829832|NCT02964377|3531130|FG002|NOT COMPLETED|Overall Study||0
2913603|NCT00497796|3623505|FG000|NOT COMPLETED|Overall Study||85
2913604|NCT00497796|3623506|FG001|NOT COMPLETED|Overall Study||59
2913605|NCT00497874|3623514|FG000|STARTED|Overall Study||443
2913606|NCT00497874|3623515|FG001|STARTED|Overall Study||459
2913607|NCT00497874|3623514|FG000|COMPLETED|Overall Study||296
2913608|NCT00497874|3623515|FG001|COMPLETED|Overall Study||343
2913609|NCT00497874|3623514|FG000|NOT COMPLETED|Overall Study||147
2913610|NCT00497874|3623515|FG001|NOT COMPLETED|Overall Study||116
2913611|NCT00498173|3623525|FG000|STARTED|Phase 1-Blinded Randomization (8 Weeks)||29
2913612|NCT00498173|3623526|FG001|STARTED|Phase 1-Blinded Randomization (8 Weeks)||31
2913613|NCT00498173|3623527|FG002|STARTED|Phase 1-Blinded Randomization (8 Weeks)||0
2913614|NCT00498173|3623525|FG000|COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||27
2913615|NCT00498173|3623526|FG001|COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||30
2913616|NCT00498173|3623527|FG002|COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||0
2913617|NCT00498173|3623525|FG000|NOT COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||2
2913618|NCT00498173|3623526|FG001|NOT COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||1
2913619|NCT00498173|3623527|FG002|NOT COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||0
2913620|NCT00498173|3623525|FG000|STARTED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
2913621|NCT00498173|3623526|FG001|STARTED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
2913622|NCT00498173|3623527|FG002|STARTED|Phase 2-Atomoxetine Open Label (8 Weeks)||26
2913623|NCT00498173|3623525|FG000|COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
2913624|NCT00498173|3623526|FG001|COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
2913625|NCT00498173|3623527|FG002|COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||26
2913626|NCT00498173|3623525|FG000|NOT COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
2913627|NCT00498173|3623526|FG001|NOT COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
2913628|NCT00498173|3623527|FG002|NOT COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
2913629|NCT00498186|3623535|FG000|STARTED|Overall Study||295
2913630|NCT00498186|3623535|FG000|COMPLETED|Overall Study||122
2913631|NCT00498186|3623535|FG000|NOT COMPLETED|Overall Study||173
2913632|NCT00498355|3623539|FG000|STARTED|Overall Study||7
2913633|NCT00498355|3623539|FG000|COMPLETED|Overall Study||6
2913634|NCT00498355|3623539|FG000|NOT COMPLETED|Overall Study||1
2920640|NCT00537680|3631157|FG001|NOT COMPLETED|Overall Study||2
2920641|NCT00537680|3631158|FG002|NOT COMPLETED|Overall Study||0
2920642|NCT00537745|3631166|FG000|STARTED|Overall Study|There were three screen fails and two early terminations.|14
2920643|NCT00537745|3631166|FG000|Began Intervention|Overall Study||11
2920644|NCT00537745|3631166|FG000|COMPLETED|Overall Study||9
2920645|NCT00537745|3631166|FG000|NOT COMPLETED|Overall Study||5
2920646|NCT00537771|3631173|FG000|STARTED|Overall Study||178
2829833|NCT02790034|3531141|FG000|STARTED|Overall Study||33
2829834|NCT02790034|3531142|FG001|STARTED|Overall Study||56
2829835|NCT02790034|3531143|FG002|STARTED|Overall Study||40
2829836|NCT02790034|3531141|FG000|COMPLETED|Overall Study||27
2829837|NCT02790034|3531142|FG001|COMPLETED|Overall Study||46
2829838|NCT02790034|3531143|FG002|COMPLETED|Overall Study||36
2829839|NCT02790034|3531141|FG000|NOT COMPLETED|Overall Study||6
2829840|NCT02790034|3531142|FG001|NOT COMPLETED|Overall Study||10
2829841|NCT02790034|3531143|FG002|NOT COMPLETED|Overall Study||4
2829842|NCT02649946|3531153|FG000|STARTED|Overall Study||142
2829843|NCT02649946|3531154|FG001|STARTED|Overall Study||138
2829844|NCT02649946|3531153|FG000|COMPLETED|Overall Study||130
2829845|NCT02649946|3531154|FG001|COMPLETED|Overall Study||123
2829846|NCT02649946|3531153|FG000|NOT COMPLETED|Overall Study||12
2829847|NCT02649946|3531154|FG001|NOT COMPLETED|Overall Study||15
2829848|NCT02431247|3531162|FG000|STARTED|BL to EOE-Test and BL to Switch- Control||362
2829849|NCT02431247|3531163|FG001|STARTED|BL to EOE-Test and BL to Switch- Control||363
2829850|NCT02431247|3531164|FG002|STARTED|BL to EOE-Test and BL to Switch- Control||0
2829851|NCT02431247|3531162|FG000|COMPLETED|BL to EOE-Test and BL to Switch- Control||296
2829852|NCT02431247|3531163|FG001|COMPLETED|BL to EOE-Test and BL to Switch- Control||322
2829853|NCT02431247|3531164|FG002|COMPLETED|BL to EOE-Test and BL to Switch- Control||0
2829854|NCT02431247|3531162|FG000|NOT COMPLETED|BL to EOE-Test and BL to Switch- Control||66
2829855|NCT02431247|3531163|FG001|NOT COMPLETED|BL to EOE-Test and BL to Switch- Control||41
2829856|NCT02431247|3531164|FG002|NOT COMPLETED|BL to EOE-Test and BL to Switch- Control||0
2829857|NCT02431247|3531162|FG000|STARTED|Switch to D/C/F/TAF (Until EOE)||0
2829858|NCT02431247|3531163|FG001|STARTED|Switch to D/C/F/TAF (Until EOE)|322 participants from DRV/COBI+ FTC/TDF (Control) group switched to D/C/F/TAF (Test) Group|0
2829859|NCT02431247|3531164|FG002|STARTED|Switch to D/C/F/TAF (Until EOE)|322 participants from DRV/COBI+ FTC/TDF (Control) group switched to D/C/F/TAF (Test) Group|322
2829860|NCT02431247|3531162|FG000|COMPLETED|Switch to D/C/F/TAF (Until EOE)||0
2829861|NCT02431247|3531163|FG001|COMPLETED|Switch to D/C/F/TAF (Until EOE)||0
2829862|NCT02431247|3531164|FG002|COMPLETED|Switch to D/C/F/TAF (Until EOE)||289
2829863|NCT02431247|3531162|FG000|NOT COMPLETED|Switch to D/C/F/TAF (Until EOE)||0
2829864|NCT02431247|3531163|FG001|NOT COMPLETED|Switch to D/C/F/TAF (Until EOE)||0
2829865|NCT02431247|3531164|FG002|NOT COMPLETED|Switch to D/C/F/TAF (Until EOE)||33
2829866|NCT02395666|3531178|FG000|STARTED|Overall Study||101
2829867|NCT02395666|3531179|FG001|STARTED|Overall Study||39
2829868|NCT02395666|3531178|FG000|COMPLETED|Overall Study||95
2829869|NCT02395666|3531179|FG001|COMPLETED|Overall Study||38
2829870|NCT02395666|3531178|FG000|NOT COMPLETED|Overall Study||6
2829871|NCT02395666|3531179|FG001|NOT COMPLETED|Overall Study||1
2829872|NCT02345850|3531192|FG000|STARTED|Overall Study||114
2829873|NCT02345850|3531193|FG001|STARTED|Overall Study||114
2829874|NCT02345850|3531194|FG002|STARTED|Overall Study||118
2829875|NCT02345850|3531192|FG000|COMPLETED|Overall Study||101
2829876|NCT02345850|3531193|FG001|COMPLETED|Overall Study||106
2829877|NCT02345850|3531194|FG002|COMPLETED|Overall Study||112
2829878|NCT02345850|3531192|FG000|NOT COMPLETED|Overall Study||13
2829879|NCT02345850|3531193|FG001|NOT COMPLETED|Overall Study||8
2829880|NCT02345850|3531194|FG002|NOT COMPLETED|Overall Study||6
2829881|NCT02343302|3531204|FG000|STARTED|Overall Study||1
2829882|NCT02343302|3531205|FG001|STARTED|Overall Study||1
2829883|NCT02343302|3531204|FG000|COMPLETED|Overall Study||0
2829884|NCT02343302|3531205|FG001|COMPLETED|Overall Study||0
2829885|NCT02343302|3531204|FG000|NOT COMPLETED|Overall Study||1
2829886|NCT02343302|3531205|FG001|NOT COMPLETED|Overall Study||1
2829887|NCT02281084|3531215|FG000|STARTED|Overall Study||32
2829888|NCT02281084|3531216|FG001|STARTED|Overall Study||22
2829889|NCT02281084|3531217|FG002|STARTED|Overall Study||6
2829890|NCT02281084|3531218|FG003|STARTED|Overall Study||5
2829891|NCT02281084|3531215|FG000|COMPLETED|Overall Study||10
2829892|NCT02281084|3531216|FG001|COMPLETED|Overall Study||4
2829893|NCT02281084|3531217|FG002|COMPLETED|Overall Study||2
2829894|NCT02281084|3531218|FG003|COMPLETED|Overall Study||0
2829895|NCT02281084|3531215|FG000|NOT COMPLETED|Overall Study||22
2829896|NCT02281084|3531216|FG001|NOT COMPLETED|Overall Study||18
2829897|NCT02281084|3531217|FG002|NOT COMPLETED|Overall Study||4
2829898|NCT02281084|3531218|FG003|NOT COMPLETED|Overall Study||5
2829899|NCT02053584|3531228|FG000|STARTED|Overall Study||230
2829900|NCT02053584|3531228|FG000|COMPLETED|Overall Study|68 subjects (day one participants) were excluded from the final analysis.|230
2829901|NCT02053584|3531228|FG000|NOT COMPLETED|Overall Study||0
2829902|NCT01962792|3531239|FG000|STARTED|Overall Study||3
2829903|NCT01962792|3531240|FG001|STARTED|Overall Study||5
2829904|NCT01962792|3531241|FG002|STARTED|Overall Study||17
2829905|NCT01962792|3531242|FG003|STARTED|Overall Study||59
2829906|NCT01962792|3531239|FG000|COMPLETED|Overall Study||3
2829907|NCT01962792|3531240|FG001|COMPLETED|Overall Study||5
2829908|NCT01962792|3531241|FG002|COMPLETED|Overall Study||17
2829909|NCT01962792|3531242|FG003|COMPLETED|Overall Study||59
2829910|NCT01962792|3531239|FG000|NOT COMPLETED|Overall Study||0
2829911|NCT01962792|3531240|FG001|NOT COMPLETED|Overall Study||0
2829912|NCT01962792|3531241|FG002|NOT COMPLETED|Overall Study||0
2829913|NCT01962792|3531242|FG003|NOT COMPLETED|Overall Study||0
2829914|NCT01878500|3531253|FG000|STARTED|Overall Study||47
2829915|NCT01878500|3531253|FG000|COMPLETED|Overall Study||47
2829916|NCT01878500|3531253|FG000|NOT COMPLETED|Overall Study||0
2829917|NCT01464164|3531264|FG000|STARTED|Overall Study||3
2829918|NCT01464164|3531265|FG001|STARTED|Overall Study||4
2829919|NCT01464164|3531266|FG002|STARTED|Overall Study||4
2829920|NCT01464164|3531267|FG003|STARTED|Overall Study||2
2829921|NCT01464164|3531268|FG004|STARTED|Overall Study||3
2829922|NCT01464164|3531269|FG005|STARTED|Overall Study||0
2829923|NCT01464164|3531270|FG006|STARTED|Overall Study||3
2829924|NCT01464164|3531264|FG000|COMPLETED|Overall Study||3
2829925|NCT01464164|3531265|FG001|COMPLETED|Overall Study||3
2829926|NCT01464164|3531266|FG002|COMPLETED|Overall Study||2
2829927|NCT01464164|3531267|FG003|COMPLETED|Overall Study||2
2829928|NCT01464164|3531268|FG004|COMPLETED|Overall Study||3
2829929|NCT01464164|3531269|FG005|COMPLETED|Overall Study||0
2829930|NCT01464164|3531270|FG006|COMPLETED|Overall Study||1
2829931|NCT01464164|3531264|FG000|NOT COMPLETED|Overall Study||0
2829932|NCT01464164|3531265|FG001|NOT COMPLETED|Overall Study||1
2829933|NCT01464164|3531266|FG002|NOT COMPLETED|Overall Study||2
2829934|NCT01464164|3531267|FG003|NOT COMPLETED|Overall Study||0
2829935|NCT01464164|3531268|FG004|NOT COMPLETED|Overall Study||0
2829936|NCT01464164|3531269|FG005|NOT COMPLETED|Overall Study||0
2829937|NCT01464164|3531270|FG006|NOT COMPLETED|Overall Study||2
2829938|NCT01318317|3531289|FG000|STARTED|Overall Study||1
2829939|NCT01318317|3531290|FG001|STARTED|Overall Study||4
2829940|NCT01318317|3531291|FG002|STARTED|Overall Study||3
2829941|NCT01318317|3531289|FG000|COMPLETED|Overall Study||1
2829942|NCT01318317|3531290|FG001|COMPLETED|Overall Study||4
2829943|NCT01318317|3531291|FG002|COMPLETED|Overall Study||3
2829944|NCT01318317|3531289|FG000|NOT COMPLETED|Overall Study||0
2829945|NCT01318317|3531290|FG001|NOT COMPLETED|Overall Study||0
2829946|NCT01318317|3531291|FG002|NOT COMPLETED|Overall Study||0
2829947|NCT01111565|3531300|FG000|STARTED|Phase B (Weeks 0 to 8)||137
2829948|NCT01111565|3531301|FG001|STARTED|Phase B (Weeks 0 to 8)||0
2829949|NCT01111565|3531302|FG002|STARTED|Phase B (Weeks 0 to 8)||0
2829950|NCT01111565|3531303|FG003|STARTED|Phase B (Weeks 0 to 8)||0
2829951|NCT01111565|3531304|FG004|STARTED|Phase B (Weeks 0 to 8)||0
2829952|NCT01111565|3531300|FG000|COMPLETED|Phase B (Weeks 0 to 8)||71
2829953|NCT01111565|3531301|FG001|COMPLETED|Phase B (Weeks 0 to 8)||0
2829954|NCT01111565|3531302|FG002|COMPLETED|Phase B (Weeks 0 to 8)||0
2829955|NCT01111565|3531303|FG003|COMPLETED|Phase B (Weeks 0 to 8)||0
2829956|NCT01111565|3531304|FG004|COMPLETED|Phase B (Weeks 0 to 8)||0
2829957|NCT01111565|3531300|FG000|NOT COMPLETED|Phase B (Weeks 0 to 8)||66
2829958|NCT01111565|3531301|FG001|NOT COMPLETED|Phase B (Weeks 0 to 8)||0
2829959|NCT01111565|3531302|FG002|NOT COMPLETED|Phase B (Weeks 0 to 8)||0
2829960|NCT01111565|3531303|FG003|NOT COMPLETED|Phase B (Weeks 0 to 8)||0
2829961|NCT01111565|3531304|FG004|NOT COMPLETED|Phase B (Weeks 0 to 8)||0
2829962|NCT01111565|3531300|FG000|STARTED|Phase B + and Phase C (Weeks 9 to 14)||0
2829963|NCT01111565|3531301|FG001|STARTED|Phase B + and Phase C (Weeks 9 to 14)||26
2829964|NCT01111565|3531302|FG002|STARTED|Phase B + and Phase C (Weeks 9 to 14)||16
2829965|NCT01111565|3531303|FG003|STARTED|Phase B + and Phase C (Weeks 9 to 14)||14
2829966|NCT01111565|3531304|FG004|STARTED|Phase B + and Phase C (Weeks 9 to 14)||15
2829967|NCT01111565|3531300|FG000|COMPLETED|Phase B + and Phase C (Weeks 9 to 14)||0
2829968|NCT01111565|3531301|FG001|COMPLETED|Phase B + and Phase C (Weeks 9 to 14)||19
2829969|NCT01111565|3531302|FG002|COMPLETED|Phase B + and Phase C (Weeks 9 to 14)||11
2829970|NCT01111565|3531303|FG003|COMPLETED|Phase B + and Phase C (Weeks 9 to 14)||10
2829971|NCT01111565|3531304|FG004|COMPLETED|Phase B + and Phase C (Weeks 9 to 14)||11
2829972|NCT01111565|3531300|FG000|NOT COMPLETED|Phase B + and Phase C (Weeks 9 to 14)||0
2829973|NCT01111565|3531301|FG001|NOT COMPLETED|Phase B + and Phase C (Weeks 9 to 14)||7
2829974|NCT01111565|3531302|FG002|NOT COMPLETED|Phase B + and Phase C (Weeks 9 to 14)||5
2829975|NCT01111565|3531303|FG003|NOT COMPLETED|Phase B + and Phase C (Weeks 9 to 14)||4
2829976|NCT01111565|3531304|FG004|NOT COMPLETED|Phase B + and Phase C (Weeks 9 to 14)||4
2829977|NCT01092117|3531314|FG000|STARTED|Index Procedure to 1 Month||161
2829978|NCT01092117|3531314|FG000|COMPLETED|Index Procedure to 1 Month||160
2829979|NCT01092117|3531314|FG000|NOT COMPLETED|Index Procedure to 1 Month||1
2829980|NCT01092117|3531314|FG000|STARTED|1 Month||160
2829981|NCT01092117|3531314|FG000|COMPLETED|1 Month||157
2829982|NCT01092117|3531314|FG000|NOT COMPLETED|1 Month||3
2829983|NCT01092117|3531314|FG000|STARTED|6 Months||157
2829984|NCT01092117|3531314|FG000|COMPLETED|6 Months||152
2829985|NCT01092117|3531314|FG000|NOT COMPLETED|6 Months||5
2829986|NCT01092117|3531314|FG000|STARTED|12 Month||152
2829987|NCT01092117|3531314|FG000|COMPLETED|12 Month||138
2829988|NCT01092117|3531314|FG000|NOT COMPLETED|12 Month||14
2829989|NCT01092117|3531314|FG000|STARTED|Year 2||138
2829990|NCT01092117|3531314|FG000|COMPLETED|Year 2||128
2829991|NCT01092117|3531314|FG000|NOT COMPLETED|Year 2||10
2829992|NCT01092117|3531314|FG000|STARTED|Year 3||128
2829993|NCT01092117|3531314|FG000|COMPLETED|Year 3||109
2829994|NCT01092117|3531314|FG000|NOT COMPLETED|Year 3||19
2829995|NCT01092117|3531314|FG000|STARTED|Year 4||109
2829996|NCT01092117|3531314|FG000|COMPLETED|Year 4||93
2829997|NCT01092117|3531314|FG000|NOT COMPLETED|Year 4||16
2829998|NCT00950989|3531322|FG000|STARTED|Overall Study||63
2829999|NCT00950989|3531323|FG001|STARTED|Overall Study||63
2830000|NCT00950989|3531324|FG002|STARTED|Overall Study||63
2830001|NCT00950989|3531325|FG003|STARTED|Overall Study||63
2830002|NCT00950989|3531322|FG000|COMPLETED|Overall Study||59
2830003|NCT00950989|3531323|FG001|COMPLETED|Overall Study||60
2830004|NCT00950989|3531324|FG002|COMPLETED|Overall Study||60
2830005|NCT00950989|3531325|FG003|COMPLETED|Overall Study||63
2830006|NCT00950989|3531322|FG000|NOT COMPLETED|Overall Study||4
2830007|NCT00950989|3531323|FG001|NOT COMPLETED|Overall Study||3
2830008|NCT00950989|3531324|FG002|NOT COMPLETED|Overall Study||3
2830009|NCT00950989|3531325|FG003|NOT COMPLETED|Overall Study||0
2830010|NCT00601900|3531340|FG000|STARTED|Overall Study||195
2830011|NCT00601900|3531341|FG001|STARTED|Overall Study||199
2830012|NCT00601900|3531340|FG000|COMPLETED|Overall Study||195
2830013|NCT00601900|3531341|FG001|COMPLETED|Overall Study||196
2830014|NCT00601900|3531340|FG000|NOT COMPLETED|Overall Study||0
2830015|NCT00601900|3531341|FG001|NOT COMPLETED|Overall Study||3
2830016|NCT00489307|3531349|FG000|STARTED|Overall Study||67
2830017|NCT00489307|3531350|FG001|STARTED|Overall Study||65
2830018|NCT00489307|3531349|FG000|COMPLETED|Overall Study||43
2830019|NCT00489307|3531350|FG001|COMPLETED|Overall Study||41
2830020|NCT00489307|3531349|FG000|NOT COMPLETED|Overall Study||24
2830021|NCT00489307|3531350|FG001|NOT COMPLETED|Overall Study||24
2830022|NCT00072410|3531358|FG000|STARTED|Overall Study||3
2830023|NCT00072410|3531359|FG001|STARTED|Overall Study||4
2830024|NCT00072410|3531358|FG000|COMPLETED|Overall Study||3
2830025|NCT00072410|3531359|FG001|COMPLETED|Overall Study||1
2830026|NCT00072410|3531358|FG000|NOT COMPLETED|Overall Study||0
2830027|NCT00072410|3531359|FG001|NOT COMPLETED|Overall Study||3
2913635|NCT00498368|3623546|FG000|STARTED|Overall Study||17
2913636|NCT00498368|3623547|FG001|STARTED|Overall Study||17
2913637|NCT00498368|3623546|FG000|COMPLETED|Overall Study||14
2913638|NCT00498368|3623547|FG001|COMPLETED|Overall Study||15
2913639|NCT00498368|3623546|FG000|NOT COMPLETED|Overall Study||3
2913640|NCT00498368|3623547|FG001|NOT COMPLETED|Overall Study||2
2913641|NCT00498433|3623556|FG000|STARTED|Part 1, Period 1:Placebo Run-in(2 Weeks)||10
2913642|NCT00498433|3623557|FG001|STARTED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
2913643|NCT00498433|3623558|FG002|STARTED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
2913644|NCT00498433|3623556|FG000|COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||10
2913645|NCT00498433|3623557|FG001|COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
2913646|NCT00498433|3623558|FG002|COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
2913647|NCT00498433|3623556|FG000|NOT COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
2913648|NCT00498433|3623557|FG001|NOT COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
2913649|NCT00498433|3623558|FG002|NOT COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
2913650|NCT00498433|3623556|FG000|STARTED|Part 1, Period 2: Aliskiren (4 Weeks)||0
2913651|NCT00498433|3623557|FG001|STARTED|Part 1, Period 2: Aliskiren (4 Weeks)||10
2913652|NCT00498433|3623558|FG002|STARTED|Part 1, Period 2: Aliskiren (4 Weeks)||0
2913653|NCT00498433|3623556|FG000|COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||0
2913654|NCT00498433|3623557|FG001|COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||10
2913655|NCT00498433|3623558|FG002|COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||0
2913656|NCT00498433|3623556|FG000|NOT COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||0
2913657|NCT00498433|3623557|FG001|NOT COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||0
2913658|NCT00498433|3623558|FG002|NOT COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||0
2913659|NCT00498433|3623556|FG000|STARTED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
2913660|NCT00498433|3623557|FG001|STARTED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
2913661|NCT00498433|3623558|FG002|STARTED|Part 1, Period 3: Amlodipine (4-8 Weeks)||10
2913662|NCT00498433|3623556|FG000|COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
2913663|NCT00498433|3623557|FG001|COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
2913664|NCT00498433|3623558|FG002|COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||10
2913665|NCT00498433|3623556|FG000|NOT COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
2913666|NCT00498433|3623557|FG001|NOT COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
2913667|NCT00498433|3623558|FG002|NOT COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
2913668|NCT00498433|3623556|FG000|STARTED|Part 2: Placebo Run-in (2 Weeks)||36
2913669|NCT00498433|3623557|FG001|STARTED|Part 2: Placebo Run-in (2 Weeks)|For part 2, this arm belongs to randomized, double blind period.|0
2913670|NCT00498433|3623558|FG002|STARTED|Part 2: Placebo Run-in (2 Weeks)|For part 2, this arm belongs to randomized, double blind period.|0
2913671|NCT00498433|3623556|FG000|COMPLETED|Part 2: Placebo Run-in (2 Weeks)||16
2913672|NCT00498433|3623557|FG001|COMPLETED|Part 2: Placebo Run-in (2 Weeks)||0
2913673|NCT00498433|3623558|FG002|COMPLETED|Part 2: Placebo Run-in (2 Weeks)||0
2913674|NCT00498433|3623556|FG000|NOT COMPLETED|Part 2: Placebo Run-in (2 Weeks)||20
2913675|NCT00498433|3623557|FG001|NOT COMPLETED|Part 2: Placebo Run-in (2 Weeks)||0
2913676|NCT00498433|3623558|FG002|NOT COMPLETED|Part 2: Placebo Run-in (2 Weeks)||0
2913677|NCT00498433|3623556|FG000|STARTED|Part 2: Double Blind (12 Weeks)||0
2913678|NCT00498433|3623557|FG001|STARTED|Part 2: Double Blind (12 Weeks)||8
2913679|NCT00498433|3623558|FG002|STARTED|Part 2: Double Blind (12 Weeks)||8
2913680|NCT00498433|3623556|FG000|COMPLETED|Part 2: Double Blind (12 Weeks)||0
2913681|NCT00498433|3623557|FG001|COMPLETED|Part 2: Double Blind (12 Weeks)||8
2913682|NCT00498433|3623558|FG002|COMPLETED|Part 2: Double Blind (12 Weeks)||8
2913683|NCT00498433|3623556|FG000|NOT COMPLETED|Part 2: Double Blind (12 Weeks)||0
2913684|NCT00498433|3623557|FG001|NOT COMPLETED|Part 2: Double Blind (12 Weeks)||0
2913685|NCT00498433|3623558|FG002|NOT COMPLETED|Part 2: Double Blind (12 Weeks)||0
2913686|NCT00498485|3623577|FG000|STARTED|Overall Study||7
2913687|NCT00498485|3623578|FG001|STARTED|Overall Study||10
2913688|NCT00498485|3623577|FG000|COMPLETED|Overall Study||6
2913689|NCT00498485|3623578|FG001|COMPLETED|Overall Study||5
2913690|NCT00498485|3623577|FG000|NOT COMPLETED|Overall Study||1
2913691|NCT00498485|3623578|FG001|NOT COMPLETED|Overall Study||5
2913692|NCT00498550|3623588|FG000|STARTED|Overall Study||15
2913693|NCT00498550|3623589|FG001|STARTED|Overall Study||16
2920647|NCT00537771|3631174|FG001|STARTED|Overall Study||175
3166771|NCT01904773|3893905|FG008|STARTED|Placebo Washout Fifth Intervention||4
2830028|NCT05057923|3531365|FG000|STARTED|Overall Study||6
2830029|NCT05057923|3531365|FG000|COMPLETED|Overall Study||6
2830030|NCT05057923|3531365|FG000|NOT COMPLETED|Overall Study||0
2830031|NCT04632706|3531373|FG000|STARTED|Overall Study||6
2830032|NCT04632706|3531374|FG001|STARTED|Overall Study||6
2830033|NCT04632706|3531375|FG002|STARTED|Overall Study||6
2830034|NCT04632706|3531376|FG003|STARTED|Overall Study||6
2830035|NCT04632706|3531373|FG000|COMPLETED|Overall Study||6
2830036|NCT04632706|3531374|FG001|COMPLETED|Overall Study||6
2830037|NCT04632706|3531375|FG002|COMPLETED|Overall Study||5
2830038|NCT04632706|3531376|FG003|COMPLETED|Overall Study||6
2830039|NCT04632706|3531373|FG000|NOT COMPLETED|Overall Study||0
2830040|NCT04632706|3531374|FG001|NOT COMPLETED|Overall Study||0
2830041|NCT04632706|3531375|FG002|NOT COMPLETED|Overall Study||1
2830042|NCT04632706|3531376|FG003|NOT COMPLETED|Overall Study||0
2830113|NCT04151290|3531448|FG000|STARTED|Overall Study||711
2830114|NCT04151290|3531448|FG000|COMPLETED|Overall Study||425
2830115|NCT04151290|3531448|FG000|NOT COMPLETED|Overall Study||286
2913694|NCT00498550|3623588|FG000|COMPLETED|Overall Study|13 of 15 received clozapine all 12 visits, two discontinued clozapine early but remained in study.|15
2913695|NCT00498550|3623589|FG001|COMPLETED|Overall Study||15
2913696|NCT00498550|3623588|FG000|NOT COMPLETED|Overall Study||0
2913697|NCT00498550|3623589|FG001|NOT COMPLETED|Overall Study||1
2913698|NCT00498602|3623602|FG000|STARTED|Overall Study||36
2913699|NCT00498602|3623603|FG001|STARTED|Overall Study||61
2913700|NCT00498602|3623604|FG002|STARTED|Overall Study||40
2913701|NCT00498602|3623605|FG003|STARTED|Overall Study||35
2913702|NCT00498602|3623606|FG004|STARTED|Overall Study||12
2913703|NCT00498602|3623607|FG005|STARTED|Overall Study||44
2913704|NCT00498602|3623608|FG006|STARTED|Overall Study||17
2913705|NCT00498602|3623602|FG000|Treated|Overall Study||36
2913706|NCT00498602|3623603|FG001|Treated|Overall Study|One participant discontinued due to an AE, with an outcome of death.|60
2913707|NCT00498602|3623604|FG002|Treated|Overall Study||40
2913708|NCT00498602|3623605|FG003|Treated|Overall Study||35
2913709|NCT00498602|3623606|FG004|Treated|Overall Study||12
2913710|NCT00498602|3623607|FG005|Treated|Overall Study||44
2913711|NCT00498602|3623608|FG006|Treated|Overall Study||17
2913712|NCT00498602|3623602|FG000|COMPLETED|Overall Study||26
2913713|NCT00498602|3623603|FG001|COMPLETED|Overall Study||51
2913714|NCT00498602|3623604|FG002|COMPLETED|Overall Study||32
2913715|NCT00498602|3623605|FG003|COMPLETED|Overall Study||30
2913716|NCT00498602|3623606|FG004|COMPLETED|Overall Study||8
2913717|NCT00498602|3623607|FG005|COMPLETED|Overall Study||31
2913718|NCT00498602|3623608|FG006|COMPLETED|Overall Study||15
2913719|NCT00498602|3623602|FG000|NOT COMPLETED|Overall Study||10
2913720|NCT00498602|3623603|FG001|NOT COMPLETED|Overall Study||10
2913721|NCT00498602|3623604|FG002|NOT COMPLETED|Overall Study||8
2913722|NCT00498602|3623605|FG003|NOT COMPLETED|Overall Study||5
2913723|NCT00498602|3623606|FG004|NOT COMPLETED|Overall Study||4
2913724|NCT00498602|3623607|FG005|NOT COMPLETED|Overall Study||13
2913725|NCT00498602|3623608|FG006|NOT COMPLETED|Overall Study||2
2913726|NCT00498615|3623624|FG000|STARTED|Fasudil 80mg||2
2913727|NCT00498615|3623625|FG001|STARTED|Fasudil 80mg||4
2913728|NCT00498615|3623626|FG002|STARTED|Fasudil 80mg||3
2913729|NCT00498615|3623627|FG003|STARTED|Fasudil 80mg||2
2913730|NCT00498615|3623628|FG004|STARTED|Fasudil 80mg||3
2913731|NCT00498615|3623629|FG005|STARTED|Fasudil 80mg||3
2913732|NCT00498615|3623624|FG000|COMPLETED|Fasudil 80mg||2
2913733|NCT00498615|3623625|FG001|COMPLETED|Fasudil 80mg||4
2913734|NCT00498615|3623626|FG002|COMPLETED|Fasudil 80mg||3
2913735|NCT00498615|3623627|FG003|COMPLETED|Fasudil 80mg||2
2913736|NCT00498615|3623628|FG004|COMPLETED|Fasudil 80mg||3
2913737|NCT00498615|3623629|FG005|COMPLETED|Fasudil 80mg||3
2913738|NCT00498615|3623624|FG000|NOT COMPLETED|Fasudil 80mg||0
2913739|NCT00498615|3623625|FG001|NOT COMPLETED|Fasudil 80mg||0
2913740|NCT00498615|3623626|FG002|NOT COMPLETED|Fasudil 80mg||0
2913741|NCT00498615|3623627|FG003|NOT COMPLETED|Fasudil 80mg||0
2913742|NCT00498615|3623628|FG004|NOT COMPLETED|Fasudil 80mg||0
2913743|NCT00498615|3623629|FG005|NOT COMPLETED|Fasudil 80mg||0
2913744|NCT00498615|3623624|FG000|STARTED|Fasudil 40mg||2
2913745|NCT00498615|3623625|FG001|STARTED|Fasudil 40mg||4
2913746|NCT00498615|3623626|FG002|STARTED|Fasudil 40mg||3
2913747|NCT00498615|3623627|FG003|STARTED|Fasudil 40mg||2
2913748|NCT00498615|3623628|FG004|STARTED|Fasudil 40mg||3
2913749|NCT00498615|3623629|FG005|STARTED|Fasudil 40mg||3
2913750|NCT00498615|3623624|FG000|COMPLETED|Fasudil 40mg||2
2913751|NCT00498615|3623625|FG001|COMPLETED|Fasudil 40mg||4
2913752|NCT00498615|3623626|FG002|COMPLETED|Fasudil 40mg||3
2913753|NCT00498615|3623627|FG003|COMPLETED|Fasudil 40mg||2
2913754|NCT00498615|3623628|FG004|COMPLETED|Fasudil 40mg||3
2913755|NCT00498615|3623629|FG005|COMPLETED|Fasudil 40mg||3
2913756|NCT00498615|3623624|FG000|NOT COMPLETED|Fasudil 40mg||0
2913757|NCT00498615|3623625|FG001|NOT COMPLETED|Fasudil 40mg||0
2913758|NCT00498615|3623626|FG002|NOT COMPLETED|Fasudil 40mg||0
2913759|NCT00498615|3623627|FG003|NOT COMPLETED|Fasudil 40mg||0
2913760|NCT00498615|3623628|FG004|NOT COMPLETED|Fasudil 40mg||0
2913761|NCT00498615|3623629|FG005|NOT COMPLETED|Fasudil 40mg||0
2913762|NCT00498615|3623624|FG000|STARTED|Placebo||2
2913763|NCT00498615|3623625|FG001|STARTED|Placebo||4
2913764|NCT00498615|3623626|FG002|STARTED|Placebo||3
2913765|NCT00498615|3623627|FG003|STARTED|Placebo||2
2913766|NCT00498615|3623628|FG004|STARTED|Placebo||3
2830043|NCT04544358|3531390|FG000|STARTED|Overall Study||12
2830044|NCT04544358|3531391|FG001|STARTED|Overall Study||10
2830045|NCT04544358|3531390|FG000|COMPLETED|Overall Study||12
2830046|NCT04544358|3531391|FG001|COMPLETED|Overall Study||10
2830047|NCT04544358|3531390|FG000|NOT COMPLETED|Overall Study||0
2830048|NCT04544358|3531391|FG001|NOT COMPLETED|Overall Study||0
2830049|NCT04498247|3531406|FG000|STARTED|Overall Study||21
2830050|NCT04498247|3531407|FG001|STARTED|Overall Study||80
2830051|NCT04498247|3531408|FG002|STARTED|Overall Study||4
2830052|NCT04498247|3531409|FG003|STARTED|Overall Study||81
2830053|NCT04498247|3531410|FG004|STARTED|Overall Study||4
2830054|NCT04498247|3531411|FG005|STARTED|Overall Study||20
2830055|NCT04498247|3531412|FG006|STARTED|Overall Study||51
2830056|NCT04498247|3531413|FG007|STARTED|Overall Study||2
2830057|NCT04498247|3531406|FG000|Vaccination 1|Overall Study||20
2830058|NCT04498247|3531407|FG001|Vaccination 1|Overall Study||80
2830059|NCT04498247|3531408|FG002|Vaccination 1|Overall Study||4
2830060|NCT04498247|3531409|FG003|Vaccination 1|Overall Study||81
2830061|NCT04498247|3531410|FG004|Vaccination 1|Overall Study||4
2830062|NCT04498247|3531411|FG005|Vaccination 1|Overall Study||20
2830063|NCT04498247|3531412|FG006|Vaccination 1|Overall Study||51
2830064|NCT04498247|3531413|FG007|Vaccination 1|Overall Study||2
2830065|NCT04498247|3531406|FG000|Vaccination 2|Overall Study||0
2830066|NCT04498247|3531407|FG001|Vaccination 2|Overall Study||0
2830067|NCT04498247|3531408|FG002|Vaccination 2|Overall Study||4
3166772|NCT01904773|3893897|FG000|COMPLETED|Placebo Washout Fifth Intervention||0
3166773|NCT01904773|3893898|FG001|COMPLETED|Placebo Washout Fifth Intervention||0
3166774|NCT01904773|3893899|FG002|COMPLETED|Placebo Washout Fifth Intervention||1
3166775|NCT01904773|3893900|FG003|COMPLETED|Placebo Washout Fifth Intervention||2
3166776|NCT01904773|3893901|FG004|COMPLETED|Placebo Washout Fifth Intervention||3
3166777|NCT01904773|3893902|FG005|COMPLETED|Placebo Washout Fifth Intervention||4
2830068|NCT04498247|3531409|FG003|Vaccination 2|Overall Study||0
2830069|NCT04498247|3531410|FG004|Vaccination 2|Overall Study||4
2830070|NCT04498247|3531411|FG005|Vaccination 2|Overall Study||0
2830071|NCT04498247|3531412|FG006|Vaccination 2|Overall Study||0
2830072|NCT04498247|3531413|FG007|Vaccination 2|Overall Study||2
2830073|NCT04498247|3531406|FG000|COMPLETED|Overall Study||20
2830074|NCT04498247|3531407|FG001|COMPLETED|Overall Study||68
2830075|NCT04498247|3531408|FG002|COMPLETED|Overall Study||4
2830076|NCT04498247|3531409|FG003|COMPLETED|Overall Study||70
2830077|NCT04498247|3531410|FG004|COMPLETED|Overall Study||4
2830078|NCT04498247|3531411|FG005|COMPLETED|Overall Study||20
2830079|NCT04498247|3531412|FG006|COMPLETED|Overall Study||43
2830080|NCT04498247|3531413|FG007|COMPLETED|Overall Study||2
2830081|NCT04498247|3531406|FG000|NOT COMPLETED|Overall Study||1
2830082|NCT04498247|3531407|FG001|NOT COMPLETED|Overall Study||12
2830083|NCT04498247|3531408|FG002|NOT COMPLETED|Overall Study||0
2830084|NCT04498247|3531409|FG003|NOT COMPLETED|Overall Study||11
2830085|NCT04498247|3531410|FG004|NOT COMPLETED|Overall Study||0
2830086|NCT04498247|3531411|FG005|NOT COMPLETED|Overall Study||0
2830087|NCT04498247|3531412|FG006|NOT COMPLETED|Overall Study||8
2830088|NCT04498247|3531413|FG007|NOT COMPLETED|Overall Study||0
2830089|NCT04472650|3531430|FG000|STARTED|Period 1 (Up to 15 Days)||13
2830090|NCT04472650|3531431|FG001|STARTED|Period 1 (Up to 15 Days)||13
2830091|NCT04472650|3531430|FG000|COMPLETED|Period 1 (Up to 15 Days)||13
2830092|NCT04472650|3531431|FG001|COMPLETED|Period 1 (Up to 15 Days)||13
2830093|NCT04472650|3531430|FG000|NOT COMPLETED|Period 1 (Up to 15 Days)||0
2830094|NCT04472650|3531431|FG001|NOT COMPLETED|Period 1 (Up to 15 Days)||0
2830095|NCT04472650|3531430|FG000|STARTED|Washout Period (Minimum 14 Days)||13
2830096|NCT04472650|3531431|FG001|STARTED|Washout Period (Minimum 14 Days)||13
2830097|NCT04472650|3531430|FG000|COMPLETED|Washout Period (Minimum 14 Days)||12
2830098|NCT04472650|3531431|FG001|COMPLETED|Washout Period (Minimum 14 Days)||13
2830099|NCT04472650|3531430|FG000|NOT COMPLETED|Washout Period (Minimum 14 Days)||1
2830100|NCT04472650|3531431|FG001|NOT COMPLETED|Washout Period (Minimum 14 Days)||0
2830101|NCT04472650|3531430|FG000|STARTED|Period 2 (Up to 15 Days)||12
2830102|NCT04472650|3531431|FG001|STARTED|Period 2 (Up to 15 Days)||13
2830103|NCT04472650|3531430|FG000|COMPLETED|Period 2 (Up to 15 Days)||12
2830104|NCT04472650|3531431|FG001|COMPLETED|Period 2 (Up to 15 Days)||13
2830105|NCT04472650|3531430|FG000|NOT COMPLETED|Period 2 (Up to 15 Days)||0
2830106|NCT04472650|3531431|FG001|NOT COMPLETED|Period 2 (Up to 15 Days)||0
2830107|NCT04359797|3531441|FG000|STARTED|Overall Study||243
2830108|NCT04359797|3531442|FG001|STARTED|Overall Study||258
2830109|NCT04359797|3531441|FG000|COMPLETED|Overall Study||243
2830110|NCT04359797|3531442|FG001|COMPLETED|Overall Study||258
2830111|NCT04359797|3531441|FG000|NOT COMPLETED|Overall Study||0
2830112|NCT04359797|3531442|FG001|NOT COMPLETED|Overall Study||0
3166778|NCT01904773|3893903|FG006|COMPLETED|Placebo Washout Fifth Intervention||3
2830152|NCT04038385|3531477|FG000|STARTED|Overall Study||160
2830153|NCT04038385|3531478|FG001|STARTED|Overall Study||137
2830154|NCT04038385|3531477|FG000|COMPLETED|Overall Study||143
2830155|NCT04038385|3531478|FG001|COMPLETED|Overall Study||130
2830156|NCT04038385|3531477|FG000|NOT COMPLETED|Overall Study||17
2830157|NCT04038385|3531478|FG001|NOT COMPLETED|Overall Study||7
2830158|NCT03978091|3531490|FG000|STARTED|Overall Study||8
2830159|NCT03978091|3531491|FG001|STARTED|Overall Study||8
2830160|NCT03978091|3531492|FG002|STARTED|Overall Study||8
2830161|NCT03978091|3531493|FG003|STARTED|Overall Study||8
2830162|NCT03978091|3531494|FG004|STARTED|Overall Study||8
2830163|NCT03978091|3531495|FG005|STARTED|Overall Study||8
2830164|NCT03978091|3531490|FG000|COMPLETED|Overall Study||8
2830165|NCT03978091|3531491|FG001|COMPLETED|Overall Study||8
2830166|NCT03978091|3531492|FG002|COMPLETED|Overall Study||7
2830167|NCT03978091|3531493|FG003|COMPLETED|Overall Study||7
2830168|NCT03978091|3531494|FG004|COMPLETED|Overall Study||7
2830169|NCT03978091|3531495|FG005|COMPLETED|Overall Study||8
2830170|NCT03978091|3531490|FG000|NOT COMPLETED|Overall Study||0
2830171|NCT03978091|3531491|FG001|NOT COMPLETED|Overall Study||0
2830172|NCT03978091|3531492|FG002|NOT COMPLETED|Overall Study||1
2830173|NCT03978091|3531493|FG003|NOT COMPLETED|Overall Study||1
2830174|NCT03978091|3531494|FG004|NOT COMPLETED|Overall Study||1
2830175|NCT03978091|3531495|FG005|NOT COMPLETED|Overall Study||0
2830176|NCT03923738|3531509|FG000|STARTED|Period 1||24
2830177|NCT03923738|3531509|FG000|COMPLETED|Period 1||22
2830178|NCT03923738|3531509|FG000|NOT COMPLETED|Period 1||2
2830179|NCT03923738|3531509|FG000|STARTED|Period 2||22
2830180|NCT03923738|3531509|FG000|COMPLETED|Period 2||22
2830181|NCT03923738|3531509|FG000|NOT COMPLETED|Period 2||0
2830182|NCT03887117|3531519|FG000|STARTED|Overall Study||25
2830183|NCT03887117|3531520|FG001|STARTED|Overall Study||15
2830184|NCT03887117|3531521|FG002|STARTED|Overall Study||26
2830185|NCT03887117|3531522|FG003|STARTED|Overall Study||27
2830186|NCT03887117|3531519|FG000|COMPLETED|Overall Study||25
2830187|NCT03887117|3531520|FG001|COMPLETED|Overall Study||14
2830188|NCT03887117|3531521|FG002|COMPLETED|Overall Study||25
2830189|NCT03887117|3531522|FG003|COMPLETED|Overall Study||25
2830190|NCT03887117|3531519|FG000|NOT COMPLETED|Overall Study||0
2830191|NCT03887117|3531520|FG001|NOT COMPLETED|Overall Study||1
2830192|NCT03887117|3531521|FG002|NOT COMPLETED|Overall Study||1
2830193|NCT03887117|3531522|FG003|NOT COMPLETED|Overall Study||2
2830194|NCT03858634|3531543|FG000|STARTED|Overall Study||39
2830195|NCT03858634|3531544|FG001|STARTED|Overall Study||19
2830196|NCT03858634|3531543|FG000|Participants With Chronic Idiopathic Urticaria (CIU)|Overall Study||4
2830197|NCT03858634|3531544|FG001|Participants With Chronic Idiopathic Urticaria (CIU)|Overall Study||2
2830198|NCT03858634|3531543|FG000|Participants With Chronic Idiopathic Pruritus (CIP)|Overall Study||14
2830199|NCT03858634|3531544|FG001|Participants With Chronic Idiopathic Pruritus (CIP)|Overall Study||9
2830200|NCT03858634|3531543|FG000|Participants With Lichen Planus (LP)|Overall Study||3
2830201|NCT03858634|3531544|FG001|Participants With Lichen Planus (LP)|Overall Study||0
2830202|NCT03858634|3531543|FG000|Participants With Lichen Simplex Chronicus (LSC)|Overall Study||4
2830203|NCT03858634|3531544|FG001|Participants With Lichen Simplex Chronicus (LSC)|Overall Study||1
2830204|NCT03858634|3531543|FG000|Participants With Plaque Psoriasis (PPs)|Overall Study||14
2830205|NCT03858634|3531544|FG001|Participants With Plaque Psoriasis (PPs)|Overall Study||7
2830206|NCT03858634|3531543|FG000|COMPLETED|Overall Study||36
2830207|NCT03858634|3531544|FG001|COMPLETED|Overall Study||17
2830208|NCT03858634|3531543|FG000|NOT COMPLETED|Overall Study||3
2830209|NCT03858634|3531544|FG001|NOT COMPLETED|Overall Study||2
2913767|NCT00498615|3623629|FG005|STARTED|Placebo||3
2913768|NCT00498615|3623624|FG000|COMPLETED|Placebo||2
2913769|NCT00498615|3623625|FG001|COMPLETED|Placebo||4
2913770|NCT00498615|3623626|FG002|COMPLETED|Placebo||3
2830210|NCT03819114|3531562|FG000|STARTED|Overall Study||17
2830211|NCT03819114|3531563|FG001|STARTED|Overall Study||36
2830212|NCT03819114|3531564|FG002|STARTED|Overall Study||35
2830213|NCT03819114|3531565|FG003|STARTED|Overall Study||34
2830214|NCT03819114|3531562|FG000|Received LNG Treatment|Overall Study||17
2830215|NCT03819114|3531563|FG001|Received LNG Treatment|Overall Study||36
2830216|NCT03819114|3531564|FG002|Received LNG Treatment|Overall Study||35
2830217|NCT03819114|3531565|FG003|Received LNG Treatment|Overall Study||34
2830218|NCT03819114|3531562|FG000|COMPLETED|Overall Study||17
2830219|NCT03819114|3531563|FG001|COMPLETED|Overall Study||35
2830220|NCT03819114|3531564|FG002|COMPLETED|Overall Study||33
2830221|NCT03819114|3531565|FG003|COMPLETED|Overall Study||34
2830222|NCT03819114|3531562|FG000|NOT COMPLETED|Overall Study||0
2830223|NCT03819114|3531563|FG001|NOT COMPLETED|Overall Study||1
2830224|NCT03819114|3531564|FG002|NOT COMPLETED|Overall Study||2
2830225|NCT03819114|3531565|FG003|NOT COMPLETED|Overall Study||0
2830226|NCT03804268|3531579|FG000|STARTED|Overall Study||160
2830227|NCT03804268|3531580|FG001|STARTED|Overall Study||163
2830228|NCT03804268|3531579|FG000|COMPLETED|Overall Study||153
2830229|NCT03804268|3531580|FG001|COMPLETED|Overall Study||161
2830230|NCT03804268|3531579|FG000|NOT COMPLETED|Overall Study||7
2830231|NCT03804268|3531580|FG001|NOT COMPLETED|Overall Study||2
2830232|NCT04721171|3531589|FG000|STARTED|Overall Study||2
2830233|NCT04721171|3531590|FG001|STARTED|Overall Study||2
2830234|NCT04721171|3531589|FG000|COMPLETED|Overall Study||2
2830235|NCT04721171|3531590|FG001|COMPLETED|Overall Study||2
2830236|NCT04721171|3531589|FG000|NOT COMPLETED|Overall Study||0
2830237|NCT04721171|3531590|FG001|NOT COMPLETED|Overall Study||0
2830238|NCT04435808|3531600|FG000|STARTED|Overall Study||0
2830239|NCT04435808|3531601|FG001|STARTED|Overall Study||1
2830240|NCT04435808|3531600|FG000|COMPLETED|Overall Study||0
2830241|NCT04435808|3531601|FG001|COMPLETED|Overall Study|Study stopped prior to any data collection for this lone participant|0
2830242|NCT04435808|3531600|FG000|NOT COMPLETED|Overall Study||0
2830243|NCT04435808|3531601|FG001|NOT COMPLETED|Overall Study||1
2830244|NCT04409262|3531609|FG000|STARTED|Overall Study||215
2830245|NCT04409262|3531610|FG001|STARTED|Overall Study||434
2830246|NCT04409262|3531609|FG000|COMPLETED|Overall Study||140
2830247|NCT04409262|3531610|FG001|COMPLETED|Overall Study||300
2830248|NCT04409262|3531609|FG000|NOT COMPLETED|Overall Study||75
2830249|NCT04409262|3531610|FG001|NOT COMPLETED|Overall Study||134
2830250|NCT04305912|3531619|FG000|STARTED|First Intervention||26
2830251|NCT04305912|3531620|FG001|STARTED|First Intervention||25
2830252|NCT04305912|3531619|FG000|COMPLETED|First Intervention||24
2830253|NCT04305912|3531620|FG001|COMPLETED|First Intervention||24
2830254|NCT04305912|3531619|FG000|NOT COMPLETED|First Intervention||2
2830255|NCT04305912|3531620|FG001|NOT COMPLETED|First Intervention||1
2830256|NCT04305912|3531619|FG000|STARTED|Second Intervention||24
2830257|NCT04305912|3531620|FG001|STARTED|Second Intervention||24
2830258|NCT04305912|3531619|FG000|COMPLETED|Second Intervention||24
2830259|NCT04305912|3531620|FG001|COMPLETED|Second Intervention||23
2830260|NCT04305912|3531619|FG000|NOT COMPLETED|Second Intervention||0
2830261|NCT04305912|3531620|FG001|NOT COMPLETED|Second Intervention||1
2830262|NCT04030416|3531626|FG000|STARTED|Overall Study||120
2830263|NCT04030416|3531626|FG000|COMPLETED|Overall Study||119
2830264|NCT04030416|3531626|FG000|NOT COMPLETED|Overall Study||1
2830265|NCT04028648|3531630|FG000|STARTED|Overall Study||150
2830266|NCT04028648|3531630|FG000|COMPLETED|Overall Study||150
2830267|NCT04028648|3531630|FG000|NOT COMPLETED|Overall Study||0
2830268|NCT03987919|3531639|FG000|STARTED|Overall Study||471
2830269|NCT03987919|3531640|FG001|STARTED|Overall Study||469
2830270|NCT03987919|3531641|FG002|STARTED|Overall Study||470
2830271|NCT03987919|3531642|FG003|STARTED|Overall Study||469
2830272|NCT03987919|3531639|FG000|Received at Least One Dose of Study Drug|Overall Study||470
2830273|NCT03987919|3531640|FG001|Received at Least One Dose of Study Drug|Overall Study||469
2830274|NCT03987919|3531641|FG002|Received at Least One Dose of Study Drug|Overall Study||470
2830275|NCT03987919|3531642|FG003|Received at Least One Dose of Study Drug|Overall Study||469
2830276|NCT03987919|3531639|FG000|COMPLETED|Overall Study||452
2830277|NCT03987919|3531640|FG001|COMPLETED|Overall Study||442
2830278|NCT03987919|3531641|FG002|COMPLETED|Overall Study||446
2830279|NCT03987919|3531642|FG003|COMPLETED|Overall Study||443
2830280|NCT03987919|3531639|FG000|NOT COMPLETED|Overall Study||19
2830281|NCT03987919|3531640|FG001|NOT COMPLETED|Overall Study||27
2830282|NCT03987919|3531641|FG002|NOT COMPLETED|Overall Study||24
2830283|NCT03987919|3531642|FG003|NOT COMPLETED|Overall Study||26
2830284|NCT03980145|3531659|FG000|STARTED|Overall Study||7
2830285|NCT03980145|3531660|FG001|STARTED|Overall Study||8
2830286|NCT03980145|3531659|FG000|COMPLETED|Overall Study||7
2830287|NCT03980145|3531660|FG001|COMPLETED|Overall Study||8
2830288|NCT03980145|3531659|FG000|NOT COMPLETED|Overall Study||0
2830289|NCT03980145|3531660|FG001|NOT COMPLETED|Overall Study||0
2830290|NCT03905694|3531668|FG000|STARTED|Primary Analysis Period||18
2830291|NCT03905694|3531668|FG000|COMPLETED|Primary Analysis Period||18
2830292|NCT03905694|3531668|FG000|NOT COMPLETED|Primary Analysis Period||0
2830293|NCT03905694|3531668|FG000|STARTED|Long-term Extension Period||18
2830294|NCT03905694|3531668|FG000|COMPLETED|Long-term Extension Period||0
2830295|NCT03905694|3531668|FG000|NOT COMPLETED|Long-term Extension Period||18
2830296|NCT03861039|3531675|FG000|STARTED|Overall Study||148
2830297|NCT03861039|3531676|FG001|STARTED|Overall Study||147
2830298|NCT03861039|3531677|FG002|STARTED|Overall Study||148
2830299|NCT03861039|3531675|FG000|Received at Least One Dose of Study Drug|Overall Study||148
2830300|NCT03861039|3531676|FG001|Received at Least One Dose of Study Drug|Overall Study||147
2830301|NCT03861039|3531677|FG002|Received at Least One Dose of Study Drug|Overall Study||148
2830302|NCT03861039|3531675|FG000|COMPLETED|Overall Study||145
2830303|NCT03861039|3531676|FG001|COMPLETED|Overall Study||139
2830304|NCT03861039|3531677|FG002|COMPLETED|Overall Study||133
2830305|NCT03861039|3531675|FG000|NOT COMPLETED|Overall Study||3
2830306|NCT03861039|3531676|FG001|NOT COMPLETED|Overall Study||8
2830307|NCT03861039|3531677|FG002|NOT COMPLETED|Overall Study||15
2830308|NCT03759587|3531687|FG000|STARTED|Overall Study||19
2830309|NCT03759587|3531687|FG000|COMPLETED|Overall Study||0
2830310|NCT03759587|3531687|FG000|NOT COMPLETED|Overall Study||19
2830311|NCT03730662|3531695|FG000|STARTED|Treatment Period (52 Weeks)||329
2830312|NCT03730662|3531696|FG001|STARTED|Treatment Period (52 Weeks)||330
2830313|NCT03730662|3531697|FG002|STARTED|Treatment Period (52 Weeks)||338
2830314|NCT03730662|3531698|FG003|STARTED|Treatment Period (52 Weeks)||1005
2830315|NCT03730662|3531695|FG000|Received at Least One Dose of Study Drug|Treatment Period (52 Weeks)||329
2830316|NCT03730662|3531696|FG001|Received at Least One Dose of Study Drug|Treatment Period (52 Weeks)||328
2830317|NCT03730662|3531697|FG002|Received at Least One Dose of Study Drug|Treatment Period (52 Weeks)||338
2830318|NCT03730662|3531698|FG003|Received at Least One Dose of Study Drug|Treatment Period (52 Weeks)||1000
2830319|NCT03730662|3531695|FG000|COMPLETED|Treatment Period (52 Weeks)||308
2830320|NCT03730662|3531696|FG001|COMPLETED|Treatment Period (52 Weeks)||319
2830321|NCT03730662|3531697|FG002|COMPLETED|Treatment Period (52 Weeks)||329
2830322|NCT03730662|3531698|FG003|COMPLETED|Treatment Period (52 Weeks)||953
2830323|NCT03730662|3531695|FG000|NOT COMPLETED|Treatment Period (52 Weeks)||21
2830324|NCT03730662|3531696|FG001|NOT COMPLETED|Treatment Period (52 Weeks)||11
2830325|NCT03730662|3531697|FG002|NOT COMPLETED|Treatment Period (52 Weeks)||9
2830326|NCT03730662|3531698|FG003|NOT COMPLETED|Treatment Period (52 Weeks)||52
2830327|NCT03730662|3531695|FG000|STARTED|Variable Treatment Period||308
2830328|NCT03730662|3531696|FG001|STARTED|Variable Treatment Period||319
2830329|NCT03730662|3531697|FG002|STARTED|Variable Treatment Period||329
2830330|NCT03730662|3531698|FG003|STARTED|Variable Treatment Period||953
2830331|NCT03730662|3531695|FG000|COMPLETED|Variable Treatment Period||294
2830332|NCT03730662|3531696|FG001|COMPLETED|Variable Treatment Period||312
2830333|NCT03730662|3531697|FG002|COMPLETED|Variable Treatment Period||313
2830334|NCT03730662|3531698|FG003|COMPLETED|Variable Treatment Period||882
2830335|NCT03730662|3531695|FG000|NOT COMPLETED|Variable Treatment Period||14
2830336|NCT03730662|3531696|FG001|NOT COMPLETED|Variable Treatment Period||7
2830337|NCT03730662|3531697|FG002|NOT COMPLETED|Variable Treatment Period||16
2830338|NCT03730662|3531698|FG003|NOT COMPLETED|Variable Treatment Period||71
2830339|NCT03681184|3531714|FG000|STARTED|6-Month Double-Blind Period||13
2830340|NCT03681184|3531715|FG001|STARTED|6-Month Double-Blind Period||26
2830341|NCT03681184|3531714|FG000|COMPLETED|6-Month Double-Blind Period||13
2830342|NCT03681184|3531715|FG001|COMPLETED|6-Month Double-Blind Period||25
2830343|NCT03681184|3531714|FG000|NOT COMPLETED|6-Month Double-Blind Period||0
2830344|NCT03681184|3531715|FG001|NOT COMPLETED|6-Month Double-Blind Period||1
2830345|NCT03681184|3531714|FG000|STARTED|3-Month Blinded Extension Period||13
2830346|NCT03681184|3531715|FG001|STARTED|3-Month Blinded Extension Period|1 participant discontinued study drug and entered safety follow up after the DB period.|24
2830347|NCT03681184|3531714|FG000|COMPLETED|3-Month Blinded Extension Period||1
2830348|NCT03681184|3531715|FG001|COMPLETED|3-Month Blinded Extension Period||1
2830349|NCT03681184|3531714|FG000|NOT COMPLETED|3-Month Blinded Extension Period||12
3166779|NCT01904773|3893904|FG007|COMPLETED|Placebo Washout Fifth Intervention||2
3166780|NCT01904773|3893905|FG008|COMPLETED|Placebo Washout Fifth Intervention||4
2830350|NCT03681184|3531715|FG001|NOT COMPLETED|3-Month Blinded Extension Period||23
2830351|NCT03681184|3531714|FG000|STARTED|Open-Label Extension Period||1
2830352|NCT03681184|3531715|FG001|STARTED|Open-Label Extension Period||1
2830353|NCT03681184|3531714|FG000|COMPLETED|Open-Label Extension Period||0
2830354|NCT03681184|3531715|FG001|COMPLETED|Open-Label Extension Period||0
2830355|NCT03681184|3531714|FG000|NOT COMPLETED|Open-Label Extension Period||1
2830356|NCT03681184|3531715|FG001|NOT COMPLETED|Open-Label Extension Period||1
2913771|NCT00498615|3623627|FG003|COMPLETED|Placebo||2
2913772|NCT00498615|3623628|FG004|COMPLETED|Placebo||3
2913773|NCT00498615|3623629|FG005|COMPLETED|Placebo||3
2913774|NCT00498615|3623624|FG000|NOT COMPLETED|Placebo||0
2913775|NCT00498615|3623625|FG001|NOT COMPLETED|Placebo||0
2913776|NCT00498615|3623626|FG002|NOT COMPLETED|Placebo||0
2913777|NCT00498615|3623627|FG003|NOT COMPLETED|Placebo||0
2913778|NCT00498615|3623628|FG004|NOT COMPLETED|Placebo||0
2913779|NCT00498615|3623629|FG005|NOT COMPLETED|Placebo||0
2913780|NCT00498628|3623645|FG000|STARTED|Overall Study||105
2913781|NCT00498628|3623646|FG001|STARTED|Overall Study||113
2913782|NCT00498628|3623645|FG000|COMPLETED|Overall Study||90
2913783|NCT00498628|3623646|FG001|COMPLETED|Overall Study||92
2913784|NCT00498628|3623645|FG000|NOT COMPLETED|Overall Study||15
2913785|NCT00498628|3623646|FG001|NOT COMPLETED|Overall Study||21
2913786|NCT00498706|3623656|FG000|STARTED|Overall Study||163
2913787|NCT00498706|3623657|FG001|STARTED|Overall Study||162
2913788|NCT00498706|3623656|FG000|Post Treatment Week 18|Overall Study||163
2913789|NCT00498706|3623657|FG001|Post Treatment Week 18|Overall Study||162
2913790|NCT00498706|3623656|FG000|COMPLETED|Overall Study||163
2913791|NCT00498706|3623657|FG001|COMPLETED|Overall Study||162
2913792|NCT00498706|3623656|FG000|NOT COMPLETED|Overall Study||0
2830357|NCT03538444|3531723|FG000|STARTED|Overall Study||4
2830358|NCT03538444|3531724|FG001|STARTED|Overall Study||3
2830359|NCT03538444|3531723|FG000|COMPLETED|Overall Study||3
2830360|NCT03538444|3531724|FG001|COMPLETED|Overall Study||3
2830361|NCT03538444|3531723|FG000|NOT COMPLETED|Overall Study||1
2830362|NCT03538444|3531724|FG001|NOT COMPLETED|Overall Study||0
2830363|NCT03410693|3531732|FG000|STARTED|Overall Study||87
2830364|NCT03410693|3531733|FG001|STARTED|Overall Study||88
2830365|NCT03410693|3531732|FG000|Started Treatment|Overall Study||86
2830366|NCT03410693|3531733|FG001|Started Treatment|Overall Study||82
2830367|NCT03410693|3531732|FG000|Active Follow-up Performed|Overall Study||61
2830368|NCT03410693|3531733|FG001|Active Follow-up Performed|Overall Study||56
2830369|NCT03410693|3531732|FG000|Entered Long Term Follow-up|Overall Study||56
2830370|NCT03410693|3531733|FG001|Entered Long Term Follow-up|Overall Study||69
2830371|NCT03410693|3531732|FG000|COMPLETED|Overall Study|Completed treatment|0
2830372|NCT03410693|3531733|FG001|COMPLETED|Overall Study|Completed treatment|0
2830373|NCT03410693|3531732|FG000|NOT COMPLETED|Overall Study||87
2830374|NCT03410693|3531733|FG001|NOT COMPLETED|Overall Study||88
2830375|NCT03369431|3531747|FG000|STARTED|Overall Study||35
2830376|NCT03369431|3531748|FG001|STARTED|Overall Study||34
2830377|NCT03369431|3531747|FG000|Taste Test (1 Week)|Overall Study||35
2830378|NCT03369431|3531748|FG001|Taste Test (1 Week)|Overall Study||34
2830379|NCT03369431|3531747|FG000|Part 1 Treatment (12 Weeks)|Overall Study||34
2830380|NCT03369431|3531748|FG001|Part 1 Treatment (12 Weeks)|Overall Study||34
2830381|NCT03369431|3531747|FG000|Washout (4 Weeks)|Overall Study||34
2830382|NCT03369431|3531748|FG001|Washout (4 Weeks)|Overall Study||32
2830383|NCT03369431|3531747|FG000|Part 2 Treatment (12 Weeks)|Overall Study||34
2830384|NCT03369431|3531748|FG001|Part 2 Treatment (12 Weeks)|Overall Study||32
2830385|NCT03369431|3531747|FG000|COMPLETED|Overall Study||31
2830386|NCT03369431|3531748|FG001|COMPLETED|Overall Study||27
2830387|NCT03369431|3531747|FG000|NOT COMPLETED|Overall Study||4
2830388|NCT03369431|3531748|FG001|NOT COMPLETED|Overall Study||7
2830389|NCT03359356|3531756|FG000|STARTED|Overall Study||20
2830390|NCT03359356|3531757|FG001|STARTED|Overall Study||40
2830391|NCT03359356|3531756|FG000|COMPLETED|Overall Study||20
2830392|NCT03359356|3531757|FG001|COMPLETED|Overall Study||40
2830393|NCT03359356|3531756|FG000|NOT COMPLETED|Overall Study||0
2830394|NCT03359356|3531757|FG001|NOT COMPLETED|Overall Study||0
2830395|NCT03252925|3531769|FG000|STARTED|Overall Study||80
2830396|NCT03252925|3531770|FG001|STARTED|Overall Study||80
2830397|NCT03252925|3531769|FG000|COMPLETED|Overall Study||66
2830398|NCT03252925|3531770|FG001|COMPLETED|Overall Study||74
2830399|NCT03252925|3531769|FG000|NOT COMPLETED|Overall Study||14
2830400|NCT03252925|3531770|FG001|NOT COMPLETED|Overall Study||6
2830401|NCT03185832|3531780|FG000|STARTED|Overall Study||69
3166781|NCT01904773|3893897|FG000|NOT COMPLETED|Placebo Washout Fifth Intervention||0
3166782|NCT01904773|3893898|FG001|NOT COMPLETED|Placebo Washout Fifth Intervention||1
3166783|NCT01904773|3893899|FG002|NOT COMPLETED|Placebo Washout Fifth Intervention||0
3166784|NCT01904773|3893900|FG003|NOT COMPLETED|Placebo Washout Fifth Intervention||0
3166785|NCT01904773|3893901|FG004|NOT COMPLETED|Placebo Washout Fifth Intervention||0
3310250|NCT03038815|4043631|FG000|NOT COMPLETED|Controll Condition, 1 Hour||0
2830402|NCT03185832|3531781|FG001|STARTED|Overall Study||102
2830403|NCT03185832|3531782|FG002|STARTED|Overall Study||68
2830404|NCT03185832|3531783|FG003|STARTED|Overall Study||115
2830405|NCT03185832|3531780|FG000|COMPLETED|Overall Study||60
2830406|NCT03185832|3531781|FG001|COMPLETED|Overall Study||87
2830407|NCT03185832|3531782|FG002|COMPLETED|Overall Study||58
2830408|NCT03185832|3531783|FG003|COMPLETED|Overall Study||104
2830409|NCT03185832|3531780|FG000|NOT COMPLETED|Overall Study||9
2830410|NCT03185832|3531781|FG001|NOT COMPLETED|Overall Study||15
2830411|NCT03185832|3531782|FG002|NOT COMPLETED|Overall Study||10
3310251|NCT03038815|4043632|FG001|NOT COMPLETED|Controll Condition, 1 Hour||0
3310252|NCT03038815|4043631|FG000|STARTED|Intervention 1, 1 Hour||10
3310253|NCT03038815|4043632|FG001|STARTED|Intervention 1, 1 Hour||10
2830412|NCT03185832|3531783|FG003|NOT COMPLETED|Overall Study||11
2830413|NCT02963714|3531793|FG000|STARTED|Overall Study||176
2830414|NCT02963714|3531794|FG001|STARTED|Overall Study||176
2830415|NCT02963714|3531793|FG000|COMPLETED|Overall Study||126
2830416|NCT02963714|3531794|FG001|COMPLETED|Overall Study||126
2830417|NCT02963714|3531793|FG000|NOT COMPLETED|Overall Study||50
2830418|NCT02963714|3531794|FG001|NOT COMPLETED|Overall Study||50
2830419|NCT02959918|3531814|FG000|STARTED|Overall Study||3
2830420|NCT02959918|3531815|FG001|STARTED|Overall Study||3
2830421|NCT02959918|3531816|FG002|STARTED|Overall Study||9
2830422|NCT02959918|3531817|FG003|STARTED|Overall Study||10
2830423|NCT02959918|3531818|FG004|STARTED|Overall Study||6
2830424|NCT02959918|3531819|FG005|STARTED|Overall Study||11
2830425|NCT02959918|3531820|FG006|STARTED|Overall Study||11
2830426|NCT02959918|3531821|FG007|STARTED|Overall Study||12
2830427|NCT02959918|3531822|FG008|STARTED|Overall Study||14
2830428|NCT02959918|3531823|FG009|STARTED|Overall Study||13
2830429|NCT02959918|3531824|FG010|STARTED|Overall Study||14
2830430|NCT02959918|3531825|FG011|STARTED|Overall Study||23
2830431|NCT02959918|3531826|FG012|STARTED|Overall Study||11
2830432|NCT02959918|3531827|FG013|STARTED|Overall Study||12
2830433|NCT02959918|3531814|FG000|COMPLETED|Overall Study||0
2830434|NCT02959918|3531815|FG001|COMPLETED|Overall Study||0
2830435|NCT02959918|3531816|FG002|COMPLETED|Overall Study||1
2830436|NCT02959918|3531817|FG003|COMPLETED|Overall Study||1
2830437|NCT02959918|3531818|FG004|COMPLETED|Overall Study||1
2830438|NCT02959918|3531819|FG005|COMPLETED|Overall Study||5
2830439|NCT02959918|3531820|FG006|COMPLETED|Overall Study||6
2830440|NCT02959918|3531821|FG007|COMPLETED|Overall Study||6
2830441|NCT02959918|3531822|FG008|COMPLETED|Overall Study||7
2830442|NCT02959918|3531823|FG009|COMPLETED|Overall Study||7
2830443|NCT02959918|3531824|FG010|COMPLETED|Overall Study||8
2830444|NCT02959918|3531825|FG011|COMPLETED|Overall Study||11
2830445|NCT02959918|3531826|FG012|COMPLETED|Overall Study||4
2830446|NCT02959918|3531827|FG013|COMPLETED|Overall Study||6
2830447|NCT02959918|3531814|FG000|NOT COMPLETED|Overall Study||3
2830448|NCT02959918|3531815|FG001|NOT COMPLETED|Overall Study||3
2830449|NCT02959918|3531816|FG002|NOT COMPLETED|Overall Study||8
2830450|NCT02959918|3531817|FG003|NOT COMPLETED|Overall Study||9
2830451|NCT02959918|3531818|FG004|NOT COMPLETED|Overall Study||5
2830452|NCT02959918|3531819|FG005|NOT COMPLETED|Overall Study||6
2830453|NCT02959918|3531820|FG006|NOT COMPLETED|Overall Study||5
2830454|NCT02959918|3531821|FG007|NOT COMPLETED|Overall Study||6
2830455|NCT02959918|3531822|FG008|NOT COMPLETED|Overall Study||7
2830456|NCT02959918|3531823|FG009|NOT COMPLETED|Overall Study||6
2830457|NCT02959918|3531824|FG010|NOT COMPLETED|Overall Study||6
2830458|NCT02959918|3531825|FG011|NOT COMPLETED|Overall Study||12
2830459|NCT02959918|3531826|FG012|NOT COMPLETED|Overall Study||7
2830460|NCT02959918|3531827|FG013|NOT COMPLETED|Overall Study||6
2830461|NCT02855944|3531862|FG000|STARTED|Period 1: Treatment||233
2830462|NCT02855944|3531863|FG001|STARTED|Period 1: Treatment||116
2830463|NCT02855944|3531862|FG000|COMPLETED|Period 1: Treatment||188
2830464|NCT02855944|3531863|FG001|COMPLETED|Period 1: Treatment||108
2830465|NCT02855944|3531862|FG000|NOT COMPLETED|Period 1: Treatment||45
2830466|NCT02855944|3531863|FG001|NOT COMPLETED|Period 1: Treatment||8
2830467|NCT02855944|3531862|FG000|STARTED|Period 2: Crossover to Rucaparib||0
2830468|NCT02855944|3531863|FG001|STARTED|Period 2: Crossover to Rucaparib||74
2830469|NCT02855944|3531862|FG000|COMPLETED|Period 2: Crossover to Rucaparib||0
2830470|NCT02855944|3531863|FG001|COMPLETED|Period 2: Crossover to Rucaparib||47
2830471|NCT02855944|3531862|FG000|NOT COMPLETED|Period 2: Crossover to Rucaparib||0
2830472|NCT02855944|3531863|FG001|NOT COMPLETED|Period 2: Crossover to Rucaparib||27
2913793|NCT00498706|3623657|FG001|NOT COMPLETED|Overall Study||0
2913794|NCT00498797|3623667|FG000|STARTED|Overall Study|randomised patients|43
2913795|NCT00498797|3623668|FG001|STARTED|Overall Study|randomised patients|43
2913796|NCT00498797|3623667|FG000|COMPLETED|Overall Study|ongoing study treatment at data cut-off|5
2913797|NCT00498797|3623668|FG001|COMPLETED|Overall Study|ongoing study treatment at data cut-off|14
2913798|NCT00498797|3623667|FG000|NOT COMPLETED|Overall Study||38
2913799|NCT00498797|3623668|FG001|NOT COMPLETED|Overall Study||29
2913800|NCT00498927|3623674|FG000|STARTED|Overall Study||47
2913801|NCT00498927|3623674|FG000|COMPLETED|Overall Study||47
2913802|NCT00498927|3623674|FG000|NOT COMPLETED|Overall Study||0
2913803|NCT00498940|3623680|FG000|STARTED|Overall Study||30
2913804|NCT00498940|3623681|FG001|STARTED|Overall Study||31
2913805|NCT00498940|3623680|FG000|COMPLETED|Overall Study||30
2913806|NCT00498940|3623681|FG001|COMPLETED|Overall Study||31
2913807|NCT00498940|3623680|FG000|NOT COMPLETED|Overall Study||0
2913808|NCT00498940|3623681|FG001|NOT COMPLETED|Overall Study||0
2913809|NCT00499031|3623687|FG000|STARTED|Overall Study|Total number participants enrolled on study|38
2913810|NCT00499031|3623687|FG000|COMPLETED|Overall Study|Total number participants that are eligible and evaluable.|35
2913811|NCT00499031|3623687|FG000|NOT COMPLETED|Overall Study||3
2913812|NCT00499083|3623691|FG000|STARTED|Overall Study||17
2913813|NCT00499083|3623691|FG000|Participants at UNMC|Overall Study||3
2913814|NCT00499083|3623691|FG000|Participants at Moffitt Cancer Center|Overall Study||14
2913815|NCT00499083|3623691|FG000|COMPLETED|Overall Study||14
2913816|NCT00499083|3623691|FG000|NOT COMPLETED|Overall Study||3
2913817|NCT00499096|3623697|FG000|STARTED|Overall Study||58
2913818|NCT00499096|3623698|FG001|STARTED|Overall Study||60
2913819|NCT00499096|3623697|FG000|COMPLETED|Overall Study||35
2913820|NCT00499096|3623698|FG001|COMPLETED|Overall Study||40
2913821|NCT00499096|3623697|FG000|NOT COMPLETED|Overall Study||23
2913822|NCT00499096|3623698|FG001|NOT COMPLETED|Overall Study||20
2913823|NCT00499109|3623708|FG000|STARTED|Overall Study||183
2913824|NCT00499109|3623709|FG001|STARTED|Overall Study||92
2913825|NCT00499109|3623708|FG000|COMPLETED|Overall Study||165
2913826|NCT00499109|3623709|FG001|COMPLETED|Overall Study||85
2913827|NCT00499109|3623708|FG000|NOT COMPLETED|Overall Study||18
2913828|NCT00499109|3623709|FG001|NOT COMPLETED|Overall Study||7
2913829|NCT00499122|3623718|FG000|STARTED|Overall Study||41
2913830|NCT00499122|3623718|FG000|COMPLETED|Overall Study||39
2913831|NCT00499122|3623718|FG000|NOT COMPLETED|Overall Study||2
2913832|NCT00499174|3623725|FG000|STARTED|Overall Study||78
2913833|NCT00499174|3623726|FG001|STARTED|Overall Study||102
2913834|NCT00499174|3623725|FG000|COMPLETED|Overall Study||0
2913835|NCT00499174|3623726|FG001|COMPLETED|Overall Study||93
2913836|NCT00499174|3623725|FG000|NOT COMPLETED|Overall Study||78
2913837|NCT00499174|3623726|FG001|NOT COMPLETED|Overall Study||9
2913838|NCT00499252|3623734|FG000|STARTED|Overall Study||51
2913839|NCT00499252|3623734|FG000|COMPLETED|Overall Study|Patients treated until disease progression; completed defined as off treatment due to progression.|39
2913840|NCT00499252|3623734|FG000|NOT COMPLETED|Overall Study||12
2913841|NCT00499343|3623744|FG000|STARTED|Overall Study||41
2913842|NCT00499343|3623745|FG001|STARTED|Overall Study||43
2913843|NCT00499343|3623744|FG000|COMPLETED|Overall Study||41
2913844|NCT00499343|3623745|FG001|COMPLETED|Overall Study||43
2830473|NCT02485691|3531872|FG000|STARTED|Overall Study||129
2830474|NCT02485691|3531873|FG001|STARTED|Overall Study||126
2830475|NCT02485691|3531872|FG000|Treated|Overall Study||126
2830476|NCT02485691|3531873|FG001|Treated|Overall Study||124
2830477|NCT02485691|3531872|FG000|COMPLETED|Overall Study||0
2830478|NCT02485691|3531873|FG001|COMPLETED|Overall Study||0
2830479|NCT02485691|3531872|FG000|NOT COMPLETED|Overall Study||129
2830480|NCT02485691|3531873|FG001|NOT COMPLETED|Overall Study||126
2830481|NCT02472964|3531882|FG000|STARTED|Part 1 (up to Week 24)||246
2830482|NCT02472964|3531883|FG001|STARTED|Part 1 (up to Week 24)||247
2830483|NCT02472964|3531882|FG000|COMPLETED|Part 1 (up to Week 24)||171
2830484|NCT02472964|3531883|FG001|COMPLETED|Part 1 (up to Week 24)||185
2830485|NCT02472964|3531882|FG000|NOT COMPLETED|Part 1 (up to Week 24)||75
2830486|NCT02472964|3531883|FG001|NOT COMPLETED|Part 1 (up to Week 24)||62
2830487|NCT02472964|3531882|FG000|STARTED|Part 2 (Week 24-week 48)||163
2830488|NCT02472964|3531883|FG001|STARTED|Part 2 (Week 24-week 48)||179
2830489|NCT02472964|3531882|FG000|COMPLETED|Part 2 (Week 24-week 48)||98
2830490|NCT02472964|3531883|FG001|COMPLETED|Part 2 (Week 24-week 48)||116
2830491|NCT02472964|3531882|FG000|NOT COMPLETED|Part 2 (Week 24-week 48)||65
2830492|NCT02472964|3531883|FG001|NOT COMPLETED|Part 2 (Week 24-week 48)||63
2830493|NCT02178722|3531894|FG000|STARTED|Overall Study||4
2830494|NCT02178722|3531895|FG001|STARTED|Overall Study||20
2830495|NCT02178722|3531896|FG002|STARTED|Overall Study||18
2830496|NCT02178722|3531897|FG003|STARTED|Overall Study||20
2830497|NCT02178722|3531898|FG004|STARTED|Overall Study||382
2830498|NCT02178722|3531894|FG000|COMPLETED|Overall Study||0
2830499|NCT02178722|3531895|FG001|COMPLETED|Overall Study||0
2830500|NCT02178722|3531896|FG002|COMPLETED|Overall Study||0
2830501|NCT02178722|3531897|FG003|COMPLETED|Overall Study||0
2830502|NCT02178722|3531898|FG004|COMPLETED|Overall Study||0
2830503|NCT02178722|3531894|FG000|NOT COMPLETED|Overall Study||4
2830504|NCT02178722|3531895|FG001|NOT COMPLETED|Overall Study||20
2830505|NCT02178722|3531896|FG002|NOT COMPLETED|Overall Study||18
2830506|NCT02178722|3531897|FG003|NOT COMPLETED|Overall Study||20
2830507|NCT02178722|3531898|FG004|NOT COMPLETED|Overall Study||382
2830508|NCT01258803|3531913|FG000|STARTED|Treatment Period 1 (1 Dose)||15
2830509|NCT01258803|3531914|FG001|STARTED|Treatment Period 1 (1 Dose)||16
2830510|NCT01258803|3531915|FG002|STARTED|Treatment Period 1 (1 Dose)||15
2830511|NCT01258803|3531916|FG003|STARTED|Treatment Period 1 (1 Dose)||15
2830512|NCT01258803|3531917|FG004|STARTED|Treatment Period 1 (1 Dose)||15
2830513|NCT01258803|3531918|FG005|STARTED|Treatment Period 1 (1 Dose)||16
2830514|NCT01258803|3531913|FG000|COMPLETED|Treatment Period 1 (1 Dose)||15
2830515|NCT01258803|3531914|FG001|COMPLETED|Treatment Period 1 (1 Dose)||16
2830516|NCT01258803|3531915|FG002|COMPLETED|Treatment Period 1 (1 Dose)||15
2830517|NCT01258803|3531916|FG003|COMPLETED|Treatment Period 1 (1 Dose)||15
2830518|NCT01258803|3531917|FG004|COMPLETED|Treatment Period 1 (1 Dose)||15
2830519|NCT01258803|3531918|FG005|COMPLETED|Treatment Period 1 (1 Dose)||16
2830520|NCT01258803|3531913|FG000|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
2830521|NCT01258803|3531914|FG001|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
2830522|NCT01258803|3531915|FG002|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
2830523|NCT01258803|3531916|FG003|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
2830524|NCT01258803|3531917|FG004|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
2830525|NCT01258803|3531918|FG005|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
2830526|NCT01258803|3531913|FG000|STARTED|Treatment Period 2 (1 Dose)||15
2830527|NCT01258803|3531914|FG001|STARTED|Treatment Period 2 (1 Dose)||16
2830528|NCT01258803|3531915|FG002|STARTED|Treatment Period 2 (1 Dose)||15
2830529|NCT01258803|3531916|FG003|STARTED|Treatment Period 2 (1 Dose)||15
2830530|NCT01258803|3531917|FG004|STARTED|Treatment Period 2 (1 Dose)||15
2830531|NCT01258803|3531918|FG005|STARTED|Treatment Period 2 (1 Dose)||16
2830532|NCT01258803|3531913|FG000|COMPLETED|Treatment Period 2 (1 Dose)||14
2830533|NCT01258803|3531914|FG001|COMPLETED|Treatment Period 2 (1 Dose)||14
2830534|NCT01258803|3531915|FG002|COMPLETED|Treatment Period 2 (1 Dose)||15
2830535|NCT01258803|3531916|FG003|COMPLETED|Treatment Period 2 (1 Dose)||15
2830536|NCT01258803|3531917|FG004|COMPLETED|Treatment Period 2 (1 Dose)||15
2830537|NCT01258803|3531918|FG005|COMPLETED|Treatment Period 2 (1 Dose)||15
2830538|NCT01258803|3531913|FG000|NOT COMPLETED|Treatment Period 2 (1 Dose)||1
2830539|NCT01258803|3531914|FG001|NOT COMPLETED|Treatment Period 2 (1 Dose)||2
2830540|NCT01258803|3531915|FG002|NOT COMPLETED|Treatment Period 2 (1 Dose)||0
2830541|NCT01258803|3531916|FG003|NOT COMPLETED|Treatment Period 2 (1 Dose)||0
2830542|NCT01258803|3531917|FG004|NOT COMPLETED|Treatment Period 2 (1 Dose)||0
2830543|NCT01258803|3531918|FG005|NOT COMPLETED|Treatment Period 2 (1 Dose)||1
2830544|NCT01258803|3531913|FG000|STARTED|Treatment Period 3 (1 Dose)||14
2830545|NCT01258803|3531914|FG001|STARTED|Treatment Period 3 (1 Dose)||14
2830546|NCT01258803|3531915|FG002|STARTED|Treatment Period 3 (1 Dose)||15
2830547|NCT01258803|3531916|FG003|STARTED|Treatment Period 3 (1 Dose)||15
2830548|NCT01258803|3531917|FG004|STARTED|Treatment Period 3 (1 Dose)||15
2830549|NCT01258803|3531918|FG005|STARTED|Treatment Period 3 (1 Dose)||15
2830550|NCT01258803|3531913|FG000|COMPLETED|Treatment Period 3 (1 Dose)||14
2830551|NCT01258803|3531914|FG001|COMPLETED|Treatment Period 3 (1 Dose)||14
2830552|NCT01258803|3531915|FG002|COMPLETED|Treatment Period 3 (1 Dose)||14
2830553|NCT01258803|3531916|FG003|COMPLETED|Treatment Period 3 (1 Dose)||15
2830554|NCT01258803|3531917|FG004|COMPLETED|Treatment Period 3 (1 Dose)||15
2830555|NCT01258803|3531918|FG005|COMPLETED|Treatment Period 3 (1 Dose)||15
2830556|NCT01258803|3531913|FG000|NOT COMPLETED|Treatment Period 3 (1 Dose)||0
2830557|NCT01258803|3531914|FG001|NOT COMPLETED|Treatment Period 3 (1 Dose)||0
2830558|NCT01258803|3531915|FG002|NOT COMPLETED|Treatment Period 3 (1 Dose)||1
2830559|NCT01258803|3531916|FG003|NOT COMPLETED|Treatment Period 3 (1 Dose)||0
2830560|NCT01258803|3531917|FG004|NOT COMPLETED|Treatment Period 3 (1 Dose)||0
2830561|NCT01258803|3531918|FG005|NOT COMPLETED|Treatment Period 3 (1 Dose)||0
2830562|NCT01258803|3531913|FG000|STARTED|Treatment Period 4 (1 Dose)||14
2830563|NCT01258803|3531914|FG001|STARTED|Treatment Period 4 (1 Dose)||14
2830564|NCT01258803|3531915|FG002|STARTED|Treatment Period 4 (1 Dose)||14
2830565|NCT01258803|3531916|FG003|STARTED|Treatment Period 4 (1 Dose)||15
2830566|NCT01258803|3531917|FG004|STARTED|Treatment Period 4 (1 Dose)||15
2830567|NCT01258803|3531918|FG005|STARTED|Treatment Period 4 (1 Dose)||15
2830568|NCT01258803|3531913|FG000|COMPLETED|Treatment Period 4 (1 Dose)||14
2830569|NCT01258803|3531914|FG001|COMPLETED|Treatment Period 4 (1 Dose)||14
2830570|NCT01258803|3531915|FG002|COMPLETED|Treatment Period 4 (1 Dose)||14
2830571|NCT01258803|3531916|FG003|COMPLETED|Treatment Period 4 (1 Dose)||15
2830572|NCT01258803|3531917|FG004|COMPLETED|Treatment Period 4 (1 Dose)||15
2830573|NCT01258803|3531918|FG005|COMPLETED|Treatment Period 4 (1 Dose)||15
2830574|NCT01258803|3531913|FG000|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
2830575|NCT01258803|3531914|FG001|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
2830576|NCT01258803|3531915|FG002|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
2830577|NCT01258803|3531916|FG003|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
2830578|NCT01258803|3531917|FG004|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
2830579|NCT01258803|3531918|FG005|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
2830580|NCT01104922|3531932|FG000|STARTED|Overall Study||48
2830581|NCT01104922|3531932|FG000|COMPLETED|Overall Study||48
2830582|NCT01104922|3531932|FG000|NOT COMPLETED|Overall Study||0
2830583|NCT00862251|3531939|FG000|STARTED|Overall Study||322
2830584|NCT00862251|3531940|FG001|STARTED|Overall Study||162
2830585|NCT00862251|3531941|FG002|STARTED|Overall Study||324
2830586|NCT00862251|3531939|FG000|COMPLETED|Overall Study||303
2830587|NCT00862251|3531940|FG001|COMPLETED|Overall Study||157
2830588|NCT00862251|3531941|FG002|COMPLETED|Overall Study||315
2830589|NCT00862251|3531939|FG000|NOT COMPLETED|Overall Study||19
2830590|NCT00862251|3531940|FG001|NOT COMPLETED|Overall Study||5
2830591|NCT00862251|3531941|FG002|NOT COMPLETED|Overall Study||9
2830592|NCT00783263|3531956|FG000|STARTED|Overall Study||99
2830593|NCT00783263|3531957|FG001|STARTED|Overall Study||98
2830594|NCT00783263|3531958|FG002|STARTED|Overall Study||122
2830595|NCT00783263|3531959|FG003|STARTED|Overall Study||121
2830596|NCT00783263|3531956|FG000|COMPLETED|Overall Study||95
2830597|NCT00783263|3531957|FG001|COMPLETED|Overall Study||96
2830598|NCT00783263|3531958|FG002|COMPLETED|Overall Study||119
2830599|NCT00783263|3531959|FG003|COMPLETED|Overall Study||118
2830600|NCT00783263|3531956|FG000|NOT COMPLETED|Overall Study||4
2830601|NCT00783263|3531957|FG001|NOT COMPLETED|Overall Study||2
2830602|NCT00783263|3531958|FG002|NOT COMPLETED|Overall Study||3
2830603|NCT00783263|3531959|FG003|NOT COMPLETED|Overall Study||3
2830604|NCT00782184|3531984|FG000|STARTED|Overall Study||120
2830605|NCT00782184|3531985|FG001|STARTED|Overall Study||130
2830606|NCT00782184|3531984|FG000|COMPLETED|Overall Study||116
2830607|NCT00782184|3531985|FG001|COMPLETED|Overall Study||125
2830608|NCT00782184|3531984|FG000|NOT COMPLETED|Overall Study||4
2830609|NCT00782184|3531985|FG001|NOT COMPLETED|Overall Study||5
2830610|NCT00635882|3531998|FG000|STARTED|Overall Study||20
2830611|NCT00635882|3531999|FG001|STARTED|Overall Study||17
2830612|NCT00635882|3532000|FG002|STARTED|Overall Study||12
2830613|NCT00635882|3532001|FG003|STARTED|Overall Study||15
2830614|NCT00635882|3532002|FG004|STARTED|Overall Study||16
2830615|NCT00635882|3532003|FG005|STARTED|Overall Study||13
2830616|NCT00635882|3531998|FG000|COMPLETED|Overall Study||19
2830617|NCT00635882|3531999|FG001|COMPLETED|Overall Study||17
2830618|NCT00635882|3532000|FG002|COMPLETED|Overall Study||12
2830619|NCT00635882|3532001|FG003|COMPLETED|Overall Study||15
2830620|NCT00635882|3532002|FG004|COMPLETED|Overall Study||16
2830621|NCT00635882|3532003|FG005|COMPLETED|Overall Study||13
2830622|NCT00635882|3531998|FG000|NOT COMPLETED|Overall Study||1
2830623|NCT00635882|3531999|FG001|NOT COMPLETED|Overall Study||0
2830624|NCT00635882|3532000|FG002|NOT COMPLETED|Overall Study||0
2830625|NCT00635882|3532001|FG003|NOT COMPLETED|Overall Study||0
2830626|NCT00635882|3532002|FG004|NOT COMPLETED|Overall Study||0
3310254|NCT03038815|4043631|FG000|COMPLETED|Intervention 1, 1 Hour||10
2830627|NCT00635882|3532003|FG005|NOT COMPLETED|Overall Study||0
2830628|NCT00594620|3532019|FG000|STARTED|Overall Study|Study was terminated early due to low accrual. Study was blinded and no data was collected|0
2830629|NCT00594620|3532020|FG001|STARTED|Overall Study|Study was terminated early due to low accrual. Study was blinded and no data was collected|0
2830630|NCT00594620|3532019|FG000|COMPLETED|Overall Study||0
2830631|NCT00594620|3532020|FG001|COMPLETED|Overall Study||0
2830632|NCT00594620|3532019|FG000|NOT COMPLETED|Overall Study||0
2830633|NCT00594620|3532020|FG001|NOT COMPLETED|Overall Study||0
2830634|NCT00535405|3532031|FG000|STARTED|Overall Study||257
2830635|NCT00535405|3532032|FG001|STARTED|Overall Study||259
2830636|NCT00535405|3532033|FG002|STARTED|Overall Study||259
2830637|NCT00535405|3532034|FG003|STARTED|Overall Study||257
2830638|NCT00535405|3532035|FG004|STARTED|Overall Study||257
2830639|NCT00535405|3532031|FG000|COMPLETED|Overall Study||240
2830640|NCT00535405|3532032|FG001|COMPLETED|Overall Study||233
2830641|NCT00535405|3532033|FG002|COMPLETED|Overall Study||241
2830642|NCT00535405|3532034|FG003|COMPLETED|Overall Study||235
3310255|NCT03038815|4043632|FG001|COMPLETED|Intervention 1, 1 Hour||10
2830643|NCT00535405|3532035|FG004|COMPLETED|Overall Study||241
2830644|NCT00535405|3532031|FG000|NOT COMPLETED|Overall Study||17
2830645|NCT00535405|3532032|FG001|NOT COMPLETED|Overall Study||26
2830646|NCT00535405|3532033|FG002|NOT COMPLETED|Overall Study||18
2830647|NCT00535405|3532034|FG003|NOT COMPLETED|Overall Study||22
2830648|NCT00535405|3532035|FG004|NOT COMPLETED|Overall Study||16
2830649|NCT00496730|3532049|FG000|STARTED|Overall Study||130
2830650|NCT00496730|3532050|FG001|STARTED|Overall Study||126
2830651|NCT00496730|3532049|FG000|COMPLETED|Overall Study||124
2830652|NCT00496730|3532050|FG001|COMPLETED|Overall Study||121
2830653|NCT00496730|3532049|FG000|NOT COMPLETED|Overall Study||6
2830654|NCT00496730|3532050|FG001|NOT COMPLETED|Overall Study||5
2830655|NCT00462748|3532059|FG000|STARTED|Overall Study||261
2830656|NCT00462748|3532060|FG001|STARTED|Overall Study||263
2830657|NCT00462748|3532061|FG002|STARTED|Overall Study||262
2830658|NCT00462748|3532059|FG000|COMPLETED|Overall Study||249
2830659|NCT00462748|3532060|FG001|COMPLETED|Overall Study||252
2830660|NCT00462748|3532061|FG002|COMPLETED|Overall Study||251
2830661|NCT00462748|3532059|FG000|NOT COMPLETED|Overall Study||12
2830662|NCT00462748|3532060|FG001|NOT COMPLETED|Overall Study||11
2830663|NCT00462748|3532061|FG002|NOT COMPLETED|Overall Study||11
2830664|NCT00418834|3532071|FG000|STARTED|Overall Study||526
2830665|NCT00418834|3532072|FG001|STARTED|Overall Study||527
2830666|NCT00418834|3532071|FG000|COMPLETED|Overall Study||503
2830667|NCT00418834|3532072|FG001|COMPLETED|Overall Study||507
2830668|NCT00418834|3532071|FG000|NOT COMPLETED|Overall Study||23
2830669|NCT00418834|3532072|FG001|NOT COMPLETED|Overall Study||20
2830670|NCT00409773|3532083|FG000|STARTED|Overall Study||229
2830671|NCT00409773|3532084|FG001|STARTED|Overall Study||229
2830672|NCT00409773|3532085|FG002|STARTED|Overall Study||229
2830673|NCT00409773|3532086|FG003|STARTED|Overall Study||228
2830674|NCT00409773|3532087|FG004|STARTED|Overall Study||228
2830675|NCT00409773|3532083|FG000|COMPLETED|Overall Study||220
2830676|NCT00409773|3532084|FG001|COMPLETED|Overall Study||222
2830677|NCT00409773|3532085|FG002|COMPLETED|Overall Study||220
2830678|NCT00409773|3532086|FG003|COMPLETED|Overall Study||216
2830679|NCT00409773|3532087|FG004|COMPLETED|Overall Study||218
2830680|NCT00409773|3532083|FG000|NOT COMPLETED|Overall Study||9
2830681|NCT00409773|3532084|FG001|NOT COMPLETED|Overall Study||7
2830682|NCT00409773|3532085|FG002|NOT COMPLETED|Overall Study||9
2830683|NCT00409773|3532086|FG003|NOT COMPLETED|Overall Study||12
2830684|NCT00409773|3532087|FG004|NOT COMPLETED|Overall Study||10
2830685|NCT00276484|3532101|FG000|STARTED|Overall Study||288
2830686|NCT00276484|3532102|FG001|STARTED|Overall Study||291
2830687|NCT00276484|3532101|FG000|COMPLETED|Overall Study||279
2830688|NCT00276484|3532102|FG001|COMPLETED|Overall Study||278
2830689|NCT00276484|3532101|FG000|NOT COMPLETED|Overall Study||9
2830690|NCT00276484|3532102|FG001|NOT COMPLETED|Overall Study||13
2830691|NCT00276458|3532110|FG000|STARTED|Overall Study||98
2830692|NCT00276458|3532111|FG001|STARTED|Overall Study||98
2830693|NCT00276458|3532110|FG000|COMPLETED|Overall Study||92
2830694|NCT00276458|3532111|FG001|COMPLETED|Overall Study||91
2830695|NCT00276458|3532110|FG000|NOT COMPLETED|Overall Study||6
2830696|NCT00276458|3532111|FG001|NOT COMPLETED|Overall Study||7
2830697|NCT00271817|3532120|FG000|STARTED|Part 1||272
2830698|NCT00271817|3532121|FG001|STARTED|Part 1||272
2830699|NCT00271817|3532122|FG002|STARTED|Part 1||676
2830700|NCT00271817|3532120|FG000|COMPLETED|Part 1|6 patients who completed Part 1 did not continue to Part 2; 1 patient never received drug in Part 2|166
2830701|NCT00271817|3532121|FG001|COMPLETED|Part 1|1 patient who completed Part 1 did not continue to Part 2|213
2830702|NCT00271817|3532122|FG002|COMPLETED|Part 1|11 patients who completed Part 1 did not continue to Part 2|391
2830703|NCT00271817|3532120|FG000|NOT COMPLETED|Part 1||106
2830704|NCT00271817|3532121|FG001|NOT COMPLETED|Part 1||59
2830705|NCT00271817|3532122|FG002|NOT COMPLETED|Part 1||285
2830706|NCT00271817|3532120|FG000|STARTED|Part 2|Patients completing the niacin group in Part 1, were re-allocated to one of the two arms in Part 2|0
2830707|NCT00271817|3532121|FG001|STARTED|Part 2|Includes 54 patients re-allocated from the niacin group in Part 1|266
2830708|NCT00271817|3532122|FG002|STARTED|Part 2|Includes 105 patients re-allocated from the niacin group in Part 1|485
2830709|NCT00271817|3532120|FG000|COMPLETED|Part 2||0
2830710|NCT00271817|3532121|FG001|COMPLETED|Part 2||234
2830711|NCT00271817|3532122|FG002|COMPLETED|Part 2||401
2830712|NCT00271817|3532120|FG000|NOT COMPLETED|Part 2||0
2830713|NCT00271817|3532121|FG001|NOT COMPLETED|Part 2||32
2830714|NCT00271817|3532122|FG002|NOT COMPLETED|Part 2||84
2913845|NCT00499343|3623744|FG000|NOT COMPLETED|Overall Study||0
2913846|NCT00499343|3623745|FG001|NOT COMPLETED|Overall Study||0
2913847|NCT00499369|3623756|FG000|STARTED|Overall Study||16
2913848|NCT00499369|3623757|FG001|STARTED|Overall Study||18
2913849|NCT00499369|3623758|FG002|STARTED|Overall Study||17
2913850|NCT00499369|3623759|FG003|STARTED|Overall Study||9
2913851|NCT00499369|3623760|FG004|STARTED|Overall Study||12
2913852|NCT00499369|3623756|FG000|Eligible|Overall Study||14
2913853|NCT00499369|3623757|FG001|Eligible|Overall Study||16
2913854|NCT00499369|3623758|FG002|Eligible|Overall Study||16
2913855|NCT00499369|3623759|FG003|Eligible|Overall Study||8
2913856|NCT00499369|3623760|FG004|Eligible|Overall Study||12
2913857|NCT00499369|3623756|FG000|COMPLETED|Overall Study||0
2913858|NCT00499369|3623757|FG001|COMPLETED|Overall Study||0
2913859|NCT00499369|3623758|FG002|COMPLETED|Overall Study||0
2913860|NCT00499369|3623759|FG003|COMPLETED|Overall Study||0
2913861|NCT00499369|3623760|FG004|COMPLETED|Overall Study||0
2913862|NCT00499369|3623756|FG000|NOT COMPLETED|Overall Study||16
2830715|NCT03660865|3532136|FG000|STARTED|Overall Study||105
2830716|NCT03660865|3532137|FG001|STARTED|Overall Study||105
2830717|NCT03660865|3532136|FG000|COMPLETED|Overall Study||105
2830718|NCT03660865|3532137|FG001|COMPLETED|Overall Study||105
2830719|NCT03660865|3532136|FG000|NOT COMPLETED|Overall Study||0
2830720|NCT03660865|3532137|FG001|NOT COMPLETED|Overall Study||0
2830721|NCT03493126|3532145|FG000|STARTED|Overall Study||31
2830722|NCT03493126|3532146|FG001|STARTED|Overall Study||28
2830723|NCT03493126|3532145|FG000|COMPLETED|Overall Study||28
2830724|NCT03493126|3532146|FG001|COMPLETED|Overall Study||28
2830725|NCT03493126|3532145|FG000|NOT COMPLETED|Overall Study||3
2830726|NCT03493126|3532146|FG001|NOT COMPLETED|Overall Study||0
2830727|NCT03420781|3532154|FG000|STARTED|Treatment Period (40 Weeks)||236
2830728|NCT03420781|3532155|FG001|STARTED|Treatment Period (40 Weeks)||231
2830729|NCT03420781|3532156|FG002|STARTED|Treatment Period (40 Weeks)||0
2830730|NCT03420781|3532157|FG003|STARTED|Treatment Period (40 Weeks)||0
2830731|NCT03420781|3532158|FG004|STARTED|Treatment Period (40 Weeks)||0
2830732|NCT03420781|3532154|FG000|Safety Population|Treatment Period (40 Weeks)||235
2830733|NCT03420781|3532155|FG001|Safety Population|Treatment Period (40 Weeks)||231
2830734|NCT03420781|3532156|FG002|Safety Population|Treatment Period (40 Weeks)||0
2830735|NCT03420781|3532157|FG003|Safety Population|Treatment Period (40 Weeks)||0
2830736|NCT03420781|3532158|FG004|Safety Population|Treatment Period (40 Weeks)||0
2830737|NCT03420781|3532154|FG000|COMPLETED|Treatment Period (40 Weeks)||92
2830738|NCT03420781|3532155|FG001|COMPLETED|Treatment Period (40 Weeks)||105
2830739|NCT03420781|3532156|FG002|COMPLETED|Treatment Period (40 Weeks)||0
2830740|NCT03420781|3532157|FG003|COMPLETED|Treatment Period (40 Weeks)||0
2830741|NCT03420781|3532158|FG004|COMPLETED|Treatment Period (40 Weeks)||0
2830742|NCT03420781|3532154|FG000|NOT COMPLETED|Treatment Period (40 Weeks)||144
2830743|NCT03420781|3532155|FG001|NOT COMPLETED|Treatment Period (40 Weeks)||126
2830744|NCT03420781|3532156|FG002|NOT COMPLETED|Treatment Period (40 Weeks)||0
2830745|NCT03420781|3532157|FG003|NOT COMPLETED|Treatment Period (40 Weeks)||0
2830746|NCT03420781|3532158|FG004|NOT COMPLETED|Treatment Period (40 Weeks)||0
2830747|NCT03420781|3532154|FG000|STARTED|RW Period: 6 Weeks (Week 41 to Week 46)||0
2830748|NCT03420781|3532155|FG001|STARTED|RW Period: 6 Weeks (Week 41 to Week 46)||0
2830749|NCT03420781|3532156|FG002|STARTED|RW Period: 6 Weeks (Week 41 to Week 46)||91
2830750|NCT03420781|3532157|FG003|STARTED|RW Period: 6 Weeks (Week 41 to Week 46)||59
2830751|NCT03420781|3532158|FG004|STARTED|RW Period: 6 Weeks (Week 41 to Week 46)||43
2830752|NCT03420781|3532154|FG000|COMPLETED|RW Period: 6 Weeks (Week 41 to Week 46)||0
2830753|NCT03420781|3532155|FG001|COMPLETED|RW Period: 6 Weeks (Week 41 to Week 46)||0
2830754|NCT03420781|3532156|FG002|COMPLETED|RW Period: 6 Weeks (Week 41 to Week 46)||85
2830755|NCT03420781|3532157|FG003|COMPLETED|RW Period: 6 Weeks (Week 41 to Week 46)||54
2830756|NCT03420781|3532158|FG004|COMPLETED|RW Period: 6 Weeks (Week 41 to Week 46)||38
2830757|NCT03420781|3532154|FG000|NOT COMPLETED|RW Period: 6 Weeks (Week 41 to Week 46)||0
2830758|NCT03420781|3532155|FG001|NOT COMPLETED|RW Period: 6 Weeks (Week 41 to Week 46)||0
2830759|NCT03420781|3532156|FG002|NOT COMPLETED|RW Period: 6 Weeks (Week 41 to Week 46)||6
2830760|NCT03420781|3532157|FG003|NOT COMPLETED|RW Period: 6 Weeks (Week 41 to Week 46)||5
2830761|NCT03420781|3532158|FG004|NOT COMPLETED|RW Period: 6 Weeks (Week 41 to Week 46)||5
2830762|NCT03316586|3532174|FG000|STARTED|Overall Study||18
2830763|NCT03316586|3532174|FG000|COMPLETED|Overall Study||0
2830764|NCT03316586|3532174|FG000|NOT COMPLETED|Overall Study||18
2830765|NCT03277066|3532181|FG000|STARTED|Overall Study||71
2830766|NCT03277066|3532182|FG001|STARTED|Overall Study||72
2830767|NCT03277066|3532183|FG002|STARTED|Overall Study||146
2830768|NCT03277066|3532181|FG000|COMPLETED|Overall Study||69
2830769|NCT03277066|3532182|FG001|COMPLETED|Overall Study||71
2830770|NCT03277066|3532183|FG002|COMPLETED|Overall Study||143
2830771|NCT03277066|3532181|FG000|NOT COMPLETED|Overall Study||2
2830772|NCT03277066|3532182|FG001|NOT COMPLETED|Overall Study||1
2830773|NCT03277066|3532183|FG002|NOT COMPLETED|Overall Study||3
2830774|NCT03269695|3532193|FG000|STARTED|Overall Study||10
2830775|NCT03269695|3532194|FG001|STARTED|Overall Study||10
2830776|NCT03269695|3532193|FG000|Treated|Overall Study||10
2830777|NCT03269695|3532194|FG001|Treated|Overall Study||10
2830778|NCT03269695|3532193|FG000|COMPLETED|Overall Study||8
2830779|NCT03269695|3532194|FG001|COMPLETED|Overall Study||7
2830780|NCT03269695|3532193|FG000|NOT COMPLETED|Overall Study||2
2830781|NCT03269695|3532194|FG001|NOT COMPLETED|Overall Study||3
2830782|NCT03227757|3532201|FG000|STARTED|Overall Study||85
2830783|NCT03227757|3532201|FG000|COMPLETED|Overall Study||69
2830784|NCT03227757|3532201|FG000|NOT COMPLETED|Overall Study||16
2830785|NCT03222128|3532205|FG000|STARTED|Overall Study||1074
2830786|NCT03222128|3532205|FG000|Valve-Implanted|Overall Study||1069
2830787|NCT03222128|3532205|FG000|COMPLETED|Overall Study||968
2830788|NCT03222128|3532205|FG000|NOT COMPLETED|Overall Study||106
2830789|NCT03142334|3532211|FG000|STARTED|Overall Study||496
2830790|NCT03142334|3532212|FG001|STARTED|Overall Study||498
2830791|NCT03142334|3532211|FG000|Treated|Overall Study||488
2830792|NCT03142334|3532212|FG001|Treated|Overall Study||496
2830793|NCT03142334|3532211|FG000|Continuing Study Treatment|Overall Study||0
2830794|NCT03142334|3532212|FG001|Continuing Study Treatment|Overall Study||1
2830795|NCT03142334|3532211|FG000|Completed Study Treatment|Overall Study||298
2830796|NCT03142334|3532212|FG001|Completed Study Treatment|Overall Study||365
2830797|NCT03142334|3532211|FG000|Discontinued Study Treatment|Overall Study||190
2830798|NCT03142334|3532212|FG001|Discontinued Study Treatment|Overall Study||130
2830799|NCT03142334|3532211|FG000|COMPLETED|Overall Study||0
2830800|NCT03142334|3532212|FG001|COMPLETED|Overall Study||0
2830801|NCT03142334|3532211|FG000|NOT COMPLETED|Overall Study||496
2830802|NCT03142334|3532212|FG001|NOT COMPLETED|Overall Study||498
2830803|NCT03093701|3532221|FG000|STARTED|Overall Study||10
2830804|NCT03093701|3532222|FG001|STARTED|Overall Study||10
2830805|NCT03093701|3532223|FG002|STARTED|Overall Study||11
2830806|NCT03093701|3532224|FG003|STARTED|Overall Study||0
2830807|NCT03093701|3532221|FG000|COMPLETED|Overall Study||10
2830808|NCT03093701|3532222|FG001|COMPLETED|Overall Study||7
2830809|NCT03093701|3532223|FG002|COMPLETED|Overall Study||11
2830810|NCT03093701|3532224|FG003|COMPLETED|Overall Study||0
2830811|NCT03093701|3532221|FG000|NOT COMPLETED|Overall Study||0
2830812|NCT03093701|3532222|FG001|NOT COMPLETED|Overall Study||3
2830813|NCT03093701|3532223|FG002|NOT COMPLETED|Overall Study||0
2830814|NCT03093701|3532224|FG003|NOT COMPLETED|Overall Study||0
2830815|NCT03093246|3532234|FG000|STARTED|Overall Study||19
2830816|NCT03093246|3532235|FG001|STARTED|Overall Study||19
2830817|NCT03093246|3532234|FG000|COMPLETED|Overall Study||19
2830818|NCT03093246|3532235|FG001|COMPLETED|Overall Study||19
2830819|NCT03093246|3532234|FG000|NOT COMPLETED|Overall Study||0
2830820|NCT03093246|3532235|FG001|NOT COMPLETED|Overall Study||0
2830821|NCT02991599|3532243|FG000|STARTED|Overall Study||98
2830822|NCT02991599|3532244|FG001|STARTED|Overall Study||98
2830823|NCT02991599|3532243|FG000|COMPLETED|Overall Study||60
2830824|NCT02991599|3532244|FG001|COMPLETED|Overall Study||61
2830825|NCT02991599|3532243|FG000|NOT COMPLETED|Overall Study||38
2830826|NCT02991599|3532244|FG001|NOT COMPLETED|Overall Study||37
2830827|NCT02976129|3532252|FG000|STARTED|Overall Study||82
2830828|NCT02976129|3532253|FG001|STARTED|Overall Study||43
2830829|NCT02976129|3532252|FG000|COMPLETED|Overall Study||77
2830830|NCT02976129|3532253|FG001|COMPLETED|Overall Study||41
2830831|NCT02976129|3532252|FG000|NOT COMPLETED|Overall Study||5
2830832|NCT02976129|3532253|FG001|NOT COMPLETED|Overall Study||2
2830833|NCT02970136|3532261|FG000|STARTED|Overall Study||377
2830834|NCT02970136|3532262|FG001|STARTED|Overall Study||377
2830835|NCT02970136|3532261|FG000|COMPLETED|Overall Study||297
2830836|NCT02970136|3532262|FG001|COMPLETED|Overall Study||282
2830837|NCT02970136|3532261|FG000|NOT COMPLETED|Overall Study||80
2830838|NCT02970136|3532262|FG001|NOT COMPLETED|Overall Study||95
2830839|NCT02969928|3532270|FG000|STARTED|Overall Study||23
2830840|NCT02969928|3532271|FG001|STARTED|Overall Study||23
2830841|NCT02969928|3532270|FG000|COMPLETED|Overall Study||23
2830842|NCT02969928|3532271|FG001|COMPLETED|Overall Study||23
2830843|NCT02969928|3532270|FG000|NOT COMPLETED|Overall Study||0
2830844|NCT02969928|3532271|FG001|NOT COMPLETED|Overall Study||0
2830845|NCT02949297|3532277|FG000|STARTED|1 Month||75
2830846|NCT02949297|3532277|FG000|COMPLETED|1 Month||75
2830847|NCT02949297|3532277|FG000|NOT COMPLETED|1 Month||0
2830848|NCT02949297|3532277|FG000|STARTED|6 Months||75
2830849|NCT02949297|3532277|FG000|COMPLETED|6 Months||72
2830850|NCT02949297|3532277|FG000|NOT COMPLETED|6 Months||3
2830851|NCT02949297|3532277|FG000|STARTED|12 Months||72
2830852|NCT02949297|3532277|FG000|COMPLETED|12 Months||67
2830853|NCT02949297|3532277|FG000|NOT COMPLETED|12 Months||5
2830854|NCT02945787|3532283|FG000|STARTED|Overall Study||714
2830855|NCT02945787|3532284|FG001|STARTED|Overall Study||703
2830856|NCT02945787|3532283|FG000|COMPLETED|Overall Study||714
2830857|NCT02945787|3532284|FG001|COMPLETED|Overall Study||703
2830858|NCT02945787|3532283|FG000|NOT COMPLETED|Overall Study||0
2830859|NCT02945787|3532284|FG001|NOT COMPLETED|Overall Study||0
2913863|NCT00499369|3623757|FG001|NOT COMPLETED|Overall Study||18
2913864|NCT00499369|3623758|FG002|NOT COMPLETED|Overall Study||17
2913865|NCT00499369|3623759|FG003|NOT COMPLETED|Overall Study||9
2913866|NCT00499369|3623760|FG004|NOT COMPLETED|Overall Study||12
2913867|NCT00499408|3623772|FG000|STARTED|Overall Study||26
2913868|NCT00499408|3623772|FG000|COMPLETED|Overall Study|Three patients did not have adequate testing to be evaluable for a response.|26
2913869|NCT00499408|3623772|FG000|NOT COMPLETED|Overall Study||0
2913870|NCT00499447|3623776|FG000|STARTED|Overall Study||13
2913871|NCT00499447|3623776|FG000|COMPLETED|Overall Study||13
2913872|NCT00499447|3623776|FG000|NOT COMPLETED|Overall Study||0
2913873|NCT00499460|3623782|FG000|STARTED|Intervention 1 (30 Days)||8
2913874|NCT00499460|3623783|FG001|STARTED|Intervention 1 (30 Days)||7
2913875|NCT00499460|3623782|FG000|COMPLETED|Intervention 1 (30 Days)||6
2913876|NCT00499460|3623783|FG001|COMPLETED|Intervention 1 (30 Days)||7
2913877|NCT00499460|3623782|FG000|NOT COMPLETED|Intervention 1 (30 Days)||2
2913878|NCT00499460|3623783|FG001|NOT COMPLETED|Intervention 1 (30 Days)||0
2913879|NCT00499460|3623782|FG000|STARTED|Intervention 2 (30 Days)||6
2913880|NCT00499460|3623783|FG001|STARTED|Intervention 2 (30 Days)||7
2913881|NCT00499460|3623782|FG000|COMPLETED|Intervention 2 (30 Days)||6
2913882|NCT00499460|3623783|FG001|COMPLETED|Intervention 2 (30 Days)||6
2913883|NCT00499460|3623782|FG000|NOT COMPLETED|Intervention 2 (30 Days)||0
2913884|NCT00499460|3623783|FG001|NOT COMPLETED|Intervention 2 (30 Days)||1
2913885|NCT00499473|3623801|FG000|STARTED|Overall Study||27
2913886|NCT00499473|3623802|FG001|STARTED|Overall Study||4
2913887|NCT00499473|3623801|FG000|COMPLETED|Overall Study|Patients evaluable|21
2913888|NCT00499473|3623802|FG001|COMPLETED|Overall Study||4
2913889|NCT00499473|3623801|FG000|NOT COMPLETED|Overall Study||6
2913890|NCT00499473|3623802|FG001|NOT COMPLETED|Overall Study||0
2913891|NCT00499486|3623808|FG000|STARTED|Overall Study||47
2913892|NCT00499486|3623808|FG000|COMPLETED|Overall Study||31
2913893|NCT00499486|3623808|FG000|NOT COMPLETED|Overall Study||16
2830860|NCT02908685|3532302|FG000|STARTED|Part 1 Exploratory||7
2830861|NCT02908685|3532303|FG001|STARTED|Part 1 Exploratory||7
2830862|NCT02908685|3532304|FG002|STARTED|Part 1 Exploratory||3
2830863|NCT02908685|3532305|FG003|STARTED|Part 1 Exploratory||3
2830864|NCT02908685|3532306|FG004|STARTED|Part 1 Exploratory||7
2830865|NCT02908685|3532307|FG005|STARTED|Part 1 Exploratory||7
2830866|NCT02908685|3532308|FG006|STARTED|Part 1 Exploratory||7
2830867|NCT02908685|3532309|FG007|STARTED|Part 1 Exploratory||3
2830868|NCT02908685|3532310|FG008|STARTED|Part 1 Exploratory||4
2830869|NCT02908685|3532311|FG009|STARTED|Part 1 Exploratory||3
2830870|NCT02908685|3532312|FG010|STARTED|Part 1 Exploratory||0
2830871|NCT02908685|3532313|FG011|STARTED|Part 1 Exploratory||0
2830872|NCT02908685|3532302|FG000|COMPLETED|Part 1 Exploratory||7
2830873|NCT02908685|3532303|FG001|COMPLETED|Part 1 Exploratory||6
2830874|NCT02908685|3532304|FG002|COMPLETED|Part 1 Exploratory||3
2830875|NCT02908685|3532305|FG003|COMPLETED|Part 1 Exploratory||3
2830876|NCT02908685|3532306|FG004|COMPLETED|Part 1 Exploratory||7
2830877|NCT02908685|3532307|FG005|COMPLETED|Part 1 Exploratory||7
2830878|NCT02908685|3532308|FG006|COMPLETED|Part 1 Exploratory||7
2830879|NCT02908685|3532309|FG007|COMPLETED|Part 1 Exploratory||3
2830880|NCT02908685|3532310|FG008|COMPLETED|Part 1 Exploratory||4
2830881|NCT02908685|3532311|FG009|COMPLETED|Part 1 Exploratory||3
2830882|NCT02908685|3532312|FG010|COMPLETED|Part 1 Exploratory||0
2830883|NCT02908685|3532313|FG011|COMPLETED|Part 1 Exploratory||0
2830884|NCT02908685|3532302|FG000|NOT COMPLETED|Part 1 Exploratory||0
2830885|NCT02908685|3532303|FG001|NOT COMPLETED|Part 1 Exploratory||1
2830886|NCT02908685|3532304|FG002|NOT COMPLETED|Part 1 Exploratory||0
2830887|NCT02908685|3532305|FG003|NOT COMPLETED|Part 1 Exploratory||0
2830888|NCT02908685|3532306|FG004|NOT COMPLETED|Part 1 Exploratory||0
2830889|NCT02908685|3532307|FG005|NOT COMPLETED|Part 1 Exploratory||0
2830890|NCT02908685|3532308|FG006|NOT COMPLETED|Part 1 Exploratory||0
2830891|NCT02908685|3532309|FG007|NOT COMPLETED|Part 1 Exploratory||0
2830892|NCT02908685|3532310|FG008|NOT COMPLETED|Part 1 Exploratory||0
2830893|NCT02908685|3532311|FG009|NOT COMPLETED|Part 1 Exploratory||0
2830894|NCT02908685|3532312|FG010|NOT COMPLETED|Part 1 Exploratory||0
2830895|NCT02908685|3532313|FG011|NOT COMPLETED|Part 1 Exploratory||0
2830896|NCT02908685|3532302|FG000|STARTED|Part 2 Confirmatory||0
2830897|NCT02908685|3532303|FG001|STARTED|Part 2 Confirmatory||0
2830898|NCT02908685|3532304|FG002|STARTED|Part 2 Confirmatory||0
2830899|NCT02908685|3532305|FG003|STARTED|Part 2 Confirmatory||0
2830900|NCT02908685|3532306|FG004|STARTED|Part 2 Confirmatory||0
2830901|NCT02908685|3532307|FG005|STARTED|Part 2 Confirmatory||0
2830902|NCT02908685|3532308|FG006|STARTED|Part 2 Confirmatory||0
2830903|NCT02908685|3532309|FG007|STARTED|Part 2 Confirmatory||0
2830904|NCT02908685|3532310|FG008|STARTED|Part 2 Confirmatory||0
2830905|NCT02908685|3532311|FG009|STARTED|Part 2 Confirmatory||0
2830906|NCT02908685|3532312|FG010|STARTED|Part 2 Confirmatory||120
2830907|NCT02908685|3532313|FG011|STARTED|Part 2 Confirmatory||60
2830908|NCT02908685|3532302|FG000|COMPLETED|Part 2 Confirmatory||0
2830909|NCT02908685|3532303|FG001|COMPLETED|Part 2 Confirmatory||0
2830910|NCT02908685|3532304|FG002|COMPLETED|Part 2 Confirmatory||0
2830911|NCT02908685|3532305|FG003|COMPLETED|Part 2 Confirmatory||0
2830912|NCT02908685|3532306|FG004|COMPLETED|Part 2 Confirmatory||0
2830913|NCT02908685|3532307|FG005|COMPLETED|Part 2 Confirmatory||0
2830914|NCT02908685|3532308|FG006|COMPLETED|Part 2 Confirmatory||0
2830915|NCT02908685|3532309|FG007|COMPLETED|Part 2 Confirmatory||0
2830916|NCT02908685|3532310|FG008|COMPLETED|Part 2 Confirmatory||0
2830917|NCT02908685|3532311|FG009|COMPLETED|Part 2 Confirmatory||0
2830918|NCT02908685|3532312|FG010|COMPLETED|Part 2 Confirmatory||117
2830919|NCT02908685|3532313|FG011|COMPLETED|Part 2 Confirmatory||59
2830920|NCT02908685|3532302|FG000|NOT COMPLETED|Part 2 Confirmatory||0
2830921|NCT02908685|3532303|FG001|NOT COMPLETED|Part 2 Confirmatory||0
2830922|NCT02908685|3532304|FG002|NOT COMPLETED|Part 2 Confirmatory||0
2830923|NCT02908685|3532305|FG003|NOT COMPLETED|Part 2 Confirmatory||0
2830924|NCT02908685|3532306|FG004|NOT COMPLETED|Part 2 Confirmatory||0
2830925|NCT02908685|3532307|FG005|NOT COMPLETED|Part 2 Confirmatory||0
2830926|NCT02908685|3532308|FG006|NOT COMPLETED|Part 2 Confirmatory||0
2830927|NCT02908685|3532309|FG007|NOT COMPLETED|Part 2 Confirmatory||0
2830928|NCT02908685|3532310|FG008|NOT COMPLETED|Part 2 Confirmatory||0
2830929|NCT02908685|3532311|FG009|NOT COMPLETED|Part 2 Confirmatory||0
2830930|NCT02908685|3532312|FG010|NOT COMPLETED|Part 2 Confirmatory||3
2830931|NCT02908685|3532313|FG011|NOT COMPLETED|Part 2 Confirmatory||1
2830932|NCT02857426|3532332|FG000|STARTED|Overall Study||47
2830933|NCT02857426|3532333|FG001|STARTED|Overall Study||19
2830934|NCT02857426|3532332|FG000|COMPLETED|Overall Study||0
2830935|NCT02857426|3532333|FG001|COMPLETED|Overall Study||0
2830936|NCT02857426|3532332|FG000|NOT COMPLETED|Overall Study||47
2830937|NCT02857426|3532333|FG001|NOT COMPLETED|Overall Study||19
2830938|NCT02855125|3532341|FG000|STARTED|Overall Study||64
2830939|NCT02855125|3532342|FG001|STARTED|Overall Study||64
2830940|NCT02855125|3532341|FG000|Treated|Overall Study||64
2830941|NCT02855125|3532342|FG001|Treated|Overall Study||63
2830942|NCT02855125|3532341|FG000|COMPLETED|Overall Study||0
2830943|NCT02855125|3532342|FG001|COMPLETED|Overall Study||0
2830944|NCT02855125|3532341|FG000|NOT COMPLETED|Overall Study||64
2830945|NCT02855125|3532342|FG001|NOT COMPLETED|Overall Study||64
2830946|NCT02836236|3532350|FG000|STARTED|Overall Study||105
2830947|NCT02836236|3532351|FG001|STARTED|Overall Study||50
2830948|NCT02836236|3532350|FG000|COMPLETED|Overall Study||0
2830949|NCT02836236|3532351|FG001|COMPLETED|Overall Study||0
2830950|NCT02836236|3532350|FG000|NOT COMPLETED|Overall Study||105
2830951|NCT02836236|3532351|FG001|NOT COMPLETED|Overall Study||50
2830952|NCT02831764|3532359|FG000|STARTED|Overall Study||360
2830953|NCT02831764|3532360|FG001|STARTED|Overall Study||359
2830954|NCT02831764|3532359|FG000|COMPLETED|Overall Study||0
2830955|NCT02831764|3532360|FG001|COMPLETED|Overall Study||0
2830956|NCT02831764|3532359|FG000|NOT COMPLETED|Overall Study||360
2830957|NCT02831764|3532360|FG001|NOT COMPLETED|Overall Study||359
2830958|NCT02728752|3532368|FG000|STARTED|First Period||48
3310256|NCT03038815|4043631|FG000|NOT COMPLETED|Intervention 1, 1 Hour||0
3310257|NCT03038815|4043632|FG001|NOT COMPLETED|Intervention 1, 1 Hour||0
3310258|NCT03038815|4043631|FG000|STARTED|Intervention 2, 1 Hour||10
3310259|NCT03038815|4043632|FG001|STARTED|Intervention 2, 1 Hour||10
3310260|NCT03038815|4043631|FG000|COMPLETED|Intervention 2, 1 Hour||10
3310261|NCT03038815|4043632|FG001|COMPLETED|Intervention 2, 1 Hour||10
3310262|NCT03038815|4043631|FG000|NOT COMPLETED|Intervention 2, 1 Hour||0
3310263|NCT03038815|4043632|FG001|NOT COMPLETED|Intervention 2, 1 Hour||0
3310264|NCT03038867|4043641|FG000|STARTED|Overall Study||37
2830959|NCT02728752|3532369|FG001|STARTED|First Period||47
2830960|NCT02728752|3532368|FG000|COMPLETED|First Period||46
2830961|NCT02728752|3532369|FG001|COMPLETED|First Period||45
2830962|NCT02728752|3532368|FG000|NOT COMPLETED|First Period||2
2830963|NCT02728752|3532369|FG001|NOT COMPLETED|First Period||2
2830964|NCT02728752|3532368|FG000|STARTED|Extension Period||46
2830965|NCT02728752|3532369|FG001|STARTED|Extension Period||45
2830966|NCT02728752|3532368|FG000|COMPLETED|Extension Period||35
2830967|NCT02728752|3532369|FG001|COMPLETED|Extension Period||34
2830968|NCT02728752|3532368|FG000|NOT COMPLETED|Extension Period||11
2830969|NCT02728752|3532369|FG001|NOT COMPLETED|Extension Period||11
2830970|NCT02680587|3532378|FG000|STARTED|Overall Study||18
2830971|NCT02680587|3532379|FG001|STARTED|Overall Study||36
2830972|NCT02680587|3532378|FG000|COMPLETED|Overall Study||17
2830973|NCT02680587|3532379|FG001|COMPLETED|Overall Study||36
2830974|NCT02680587|3532378|FG000|NOT COMPLETED|Overall Study||1
2830975|NCT02680587|3532379|FG001|NOT COMPLETED|Overall Study||0
2830976|NCT02667639|3532391|FG000|STARTED|Overall Study||25
2830977|NCT02667639|3532392|FG001|STARTED|Overall Study||10
2830978|NCT02667639|3532391|FG000|COMPLETED|Overall Study||25
2830979|NCT02667639|3532392|FG001|COMPLETED|Overall Study||10
2830980|NCT02667639|3532391|FG000|NOT COMPLETED|Overall Study||0
2830981|NCT02667639|3532392|FG001|NOT COMPLETED|Overall Study||0
2830982|NCT02652949|3532400|FG000|STARTED|30-Day Follow-up for Primary Endpoint|The 30-day primary endpoint was evaluated when 87 subjects completed 30-day follow-up.|87
2830983|NCT02652949|3532400|FG000|COMPLETED|30-Day Follow-up for Primary Endpoint||86
2830984|NCT02652949|3532400|FG000|NOT COMPLETED|30-Day Follow-up for Primary Endpoint||1
2830985|NCT02652949|3532400|FG000|STARTED|30-Day Follow-up for Secondary Endpoint|The 30-day secondary endpoint was evaluated when 100 subjects completed 30-day follow-up.|100
2830986|NCT02652949|3532400|FG000|COMPLETED|30-Day Follow-up for Secondary Endpoint||99
2830987|NCT02652949|3532400|FG000|NOT COMPLETED|30-Day Follow-up for Secondary Endpoint||1
2830988|NCT02652949|3532400|FG000|STARTED|6-Month Follow-up Secondary Endpoint|Note that 6-month follow up is not mandatory for OUS subjects.|99
2830989|NCT02652949|3532400|FG000|COMPLETED|6-Month Follow-up Secondary Endpoint||91
2830990|NCT02652949|3532400|FG000|NOT COMPLETED|6-Month Follow-up Secondary Endpoint||8
2830991|NCT02652949|3532400|FG000|STARTED|12-Month Follow-up Secondary Endpoint||91
2830992|NCT02652949|3532400|FG000|COMPLETED|12-Month Follow-up Secondary Endpoint||87
2830993|NCT02652949|3532400|FG000|NOT COMPLETED|12-Month Follow-up Secondary Endpoint||4
3310265|NCT03038867|4043642|FG001|STARTED|Overall Study||32
3310266|NCT03038867|4043641|FG000|COMPLETED|Overall Study||37
3310267|NCT03038867|4043642|FG001|COMPLETED|Overall Study||32
3310268|NCT03038867|4043641|FG000|NOT COMPLETED|Overall Study||0
3310269|NCT03038867|4043642|FG001|NOT COMPLETED|Overall Study||0
3310270|NCT03038880|4043651|FG000|STARTED|Overall Study||24
3310271|NCT03038880|4043652|FG001|STARTED|Overall Study||31
3310272|NCT03038880|4043653|FG002|STARTED|Overall Study||16
3310273|NCT03038880|4043651|FG000|COMPLETED|Overall Study||21
3310274|NCT03038880|4043652|FG001|COMPLETED|Overall Study||28
3310275|NCT03038880|4043653|FG002|COMPLETED|Overall Study||16
3310276|NCT03038880|4043651|FG000|NOT COMPLETED|Overall Study||3
3310277|NCT03038880|4043652|FG001|NOT COMPLETED|Overall Study||3
3310278|NCT03038880|4043653|FG002|NOT COMPLETED|Overall Study||0
3310279|NCT03039023|4043666|FG000|STARTED|Overall Study||19
3310280|NCT03039023|4043667|FG001|STARTED|Overall Study||20
3310281|NCT03039023|4043668|FG002|STARTED|Overall Study||17
3310282|NCT03039023|4043669|FG003|STARTED|Overall Study||20
3310283|NCT03039023|4043670|FG004|STARTED|Overall Study||10
3310284|NCT03039023|4043666|FG000|COMPLETED|Overall Study||18
3310285|NCT03039023|4043667|FG001|COMPLETED|Overall Study||20
3310286|NCT03039023|4043668|FG002|COMPLETED|Overall Study||16
3310287|NCT03039023|4043669|FG003|COMPLETED|Overall Study||18
3310288|NCT03039023|4043670|FG004|COMPLETED|Overall Study||10
3310289|NCT03039023|4043666|FG000|NOT COMPLETED|Overall Study||1
3310290|NCT03039023|4043667|FG001|NOT COMPLETED|Overall Study||0
3310291|NCT03039023|4043668|FG002|NOT COMPLETED|Overall Study||1
3310292|NCT03039023|4043669|FG003|NOT COMPLETED|Overall Study||2
3310293|NCT03039023|4043670|FG004|NOT COMPLETED|Overall Study||0
3310294|NCT03039088|4043684|FG000|STARTED|Overall Study||192
3310295|NCT03039088|4043685|FG001|STARTED|Overall Study||316
3310296|NCT03039088|4043684|FG000|COMPLETED|Overall Study||192
2830994|NCT02652949|3532400|FG000|STARTED|24-Month Follow-up Secondary Endpoint||87
2830995|NCT02652949|3532400|FG000|COMPLETED|24-Month Follow-up Secondary Endpoint||52
2830996|NCT02652949|3532400|FG000|NOT COMPLETED|24-Month Follow-up Secondary Endpoint||35
2830997|NCT02574455|3532412|FG000|STARTED|Overall Study||267
2830998|NCT02574455|3532413|FG001|STARTED|Overall Study||262
2830999|NCT02574455|3532412|FG000|Enrolled and Treated|Overall Study||258
2831000|NCT02574455|3532413|FG001|Enrolled and Treated|Overall Study||224
2831001|NCT02574455|3532412|FG000|COMPLETED|Overall Study||0
2831002|NCT02574455|3532413|FG001|COMPLETED|Overall Study||0
2831003|NCT02574455|3532412|FG000|NOT COMPLETED|Overall Study||267
2831004|NCT02574455|3532413|FG001|NOT COMPLETED|Overall Study||262
2831005|NCT02528500|3532419|FG000|STARTED|Overall Study||10
2831006|NCT02528500|3532419|FG000|COMPLETED|Overall Study||10
2831007|NCT02528500|3532419|FG000|NOT COMPLETED|Overall Study||0
2831008|NCT02527798|3532429|FG000|STARTED|Overall Study||32
2831009|NCT02527798|3532430|FG001|STARTED|Overall Study||10
2831010|NCT02527798|3532431|FG002|STARTED|Overall Study||30
3166786|NCT01904773|3893902|FG005|NOT COMPLETED|Placebo Washout Fifth Intervention||0
3166787|NCT01904773|3893903|FG006|NOT COMPLETED|Placebo Washout Fifth Intervention||0
3166788|NCT01904773|3893904|FG007|NOT COMPLETED|Placebo Washout Fifth Intervention||0
3166789|NCT01904773|3893905|FG008|NOT COMPLETED|Placebo Washout Fifth Intervention||0
3166790|NCT01904773|3893897|FG000|STARTED|Sixth Intervention||0
3166791|NCT01904773|3893898|FG001|STARTED|Sixth Intervention||0
2831011|NCT02527798|3532432|FG003|STARTED|Overall Study||10
2831012|NCT02527798|3532433|FG004|STARTED|Overall Study||0
2831013|NCT02527798|3532434|FG005|STARTED|Overall Study||0
2831014|NCT02527798|3532429|FG000|Randomized, Not Dosed|Overall Study||31
2831015|NCT02527798|3532430|FG001|Randomized, Not Dosed|Overall Study||9
3166792|NCT01904773|3893899|FG002|STARTED|Sixth Intervention||1
3166793|NCT01904773|3893900|FG003|STARTED|Sixth Intervention||2
3166794|NCT01904773|3893901|FG004|STARTED|Sixth Intervention||3
3166795|NCT01904773|3893902|FG005|STARTED|Sixth Intervention||4
3166796|NCT01904773|3893903|FG006|STARTED|Sixth Intervention||3
3166797|NCT01904773|3893904|FG007|STARTED|Sixth Intervention||2
2831016|NCT02527798|3532431|FG002|Randomized, Not Dosed|Overall Study||30
2831017|NCT02527798|3532432|FG003|Randomized, Not Dosed|Overall Study||10
2831018|NCT02527798|3532433|FG004|Randomized, Not Dosed|Overall Study||0
2831019|NCT02527798|3532434|FG005|Randomized, Not Dosed|Overall Study||0
2831020|NCT02527798|3532429|FG000|Pharmacokinetic (PK) Population|Overall Study||20
2831021|NCT02527798|3532430|FG001|Pharmacokinetic (PK) Population|Overall Study||0
2831022|NCT02527798|3532431|FG002|Pharmacokinetic (PK) Population|Overall Study||19
3166798|NCT01904773|3893905|FG008|STARTED|Sixth Intervention||4
3166799|NCT01904773|3893897|FG000|COMPLETED|Sixth Intervention||0
2831023|NCT02527798|3532432|FG003|Pharmacokinetic (PK) Population|Overall Study||0
2831024|NCT02527798|3532433|FG004|Pharmacokinetic (PK) Population|Overall Study||0
2831025|NCT02527798|3532434|FG005|Pharmacokinetic (PK) Population|Overall Study||0
2831026|NCT02527798|3532429|FG000|COMPLETED|Overall Study||29
2831027|NCT02527798|3532430|FG001|COMPLETED|Overall Study||8
2831028|NCT02527798|3532431|FG002|COMPLETED|Overall Study||25
2831029|NCT02527798|3532432|FG003|COMPLETED|Overall Study||9
2831030|NCT02527798|3532433|FG004|COMPLETED|Overall Study||0
2831031|NCT02527798|3532434|FG005|COMPLETED|Overall Study||0
2831032|NCT02527798|3532429|FG000|NOT COMPLETED|Overall Study||3
2831033|NCT02527798|3532430|FG001|NOT COMPLETED|Overall Study||2
2831034|NCT02527798|3532431|FG002|NOT COMPLETED|Overall Study||5
2831035|NCT02527798|3532432|FG003|NOT COMPLETED|Overall Study||1
2831036|NCT02527798|3532433|FG004|NOT COMPLETED|Overall Study||0
2831037|NCT02527798|3532434|FG005|NOT COMPLETED|Overall Study||0
2831038|NCT02416492|3532465|FG000|STARTED|Overall Study||15
2831039|NCT02416492|3532466|FG001|STARTED|Overall Study||15
2831040|NCT02416492|3532467|FG002|STARTED|Overall Study||16
2831041|NCT02416492|3532468|FG003|STARTED|Overall Study||15
2831042|NCT02416492|3532465|FG000|COMPLETED|Overall Study||15
2831043|NCT02416492|3532466|FG001|COMPLETED|Overall Study||15
2831044|NCT02416492|3532467|FG002|COMPLETED|Overall Study||16
2831045|NCT02416492|3532468|FG003|COMPLETED|Overall Study||15
2831046|NCT02416492|3532465|FG000|NOT COMPLETED|Overall Study||0
2831047|NCT02416492|3532466|FG001|NOT COMPLETED|Overall Study||0
2831048|NCT02416492|3532467|FG002|NOT COMPLETED|Overall Study||0
2831049|NCT02416492|3532468|FG003|NOT COMPLETED|Overall Study||0
2831050|NCT02324816|3532481|FG000|STARTED|Overall Study||19
2831051|NCT02324816|3532481|FG000|COMPLETED|Overall Study||19
2831052|NCT02324816|3532481|FG000|NOT COMPLETED|Overall Study||0
2831053|NCT02279745|3532485|FG000|STARTED|Overall Study||45
2831054|NCT02279745|3532485|FG000|COMPLETED|Overall Study||25
2831055|NCT02279745|3532485|FG000|NOT COMPLETED|Overall Study||20
2831056|NCT02112526|3532491|FG000|STARTED|Overall Study||11
2831057|NCT02112526|3532492|FG001|STARTED|Overall Study||10
2831058|NCT02112526|3532491|FG000|Enrolled|Overall Study||11
2831059|NCT02112526|3532492|FG001|Enrolled|Overall Study||10
2831060|NCT02112526|3532491|FG000|Received Study Medication|Overall Study||11
2831061|NCT02112526|3532492|FG001|Received Study Medication|Overall Study||10
2831062|NCT02112526|3532491|FG000|Discontinued Study|Overall Study||11
2831063|NCT02112526|3532492|FG001|Discontinued Study|Overall Study||9
2831064|NCT02112526|3532491|FG000|Subjects Continuing Study Medication|Overall Study||0
3166800|NCT01904773|3893898|FG001|COMPLETED|Sixth Intervention||0
3166801|NCT01904773|3893899|FG002|COMPLETED|Sixth Intervention||1
3166802|NCT01904773|3893900|FG003|COMPLETED|Sixth Intervention||2
2831065|NCT02112526|3532492|FG001|Subjects Continuing Study Medication|Overall Study||1
2831066|NCT02112526|3532491|FG000|COMPLETED|Overall Study||0
2831067|NCT02112526|3532492|FG001|COMPLETED|Overall Study||1
2831068|NCT02112526|3532491|FG000|NOT COMPLETED|Overall Study||11
2831069|NCT02112526|3532492|FG001|NOT COMPLETED|Overall Study||9
2831070|NCT02067975|3532500|FG000|STARTED|Overall Study||20
2831071|NCT02067975|3532501|FG001|STARTED|Overall Study||18
2831072|NCT02067975|3532502|FG002|STARTED|Overall Study||21
2831073|NCT02067975|3532503|FG003|STARTED|Overall Study||18
2831074|NCT02067975|3532504|FG004|STARTED|Overall Study||8
2831075|NCT02067975|3532505|FG005|STARTED|Overall Study||8
2831076|NCT02067975|3532500|FG000|COMPLETED|Overall Study||16
2831077|NCT02067975|3532501|FG001|COMPLETED|Overall Study||16
2831078|NCT02067975|3532502|FG002|COMPLETED|Overall Study||19
2831079|NCT02067975|3532503|FG003|COMPLETED|Overall Study||14
2831080|NCT02067975|3532504|FG004|COMPLETED|Overall Study||0
2831081|NCT02067975|3532505|FG005|COMPLETED|Overall Study||0
2831082|NCT02067975|3532500|FG000|NOT COMPLETED|Overall Study||4
2831083|NCT02067975|3532501|FG001|NOT COMPLETED|Overall Study||2
2831084|NCT02067975|3532502|FG002|NOT COMPLETED|Overall Study||2
2831085|NCT02067975|3532503|FG003|NOT COMPLETED|Overall Study||4
2831086|NCT02067975|3532504|FG004|NOT COMPLETED|Overall Study||8
2831087|NCT02067975|3532505|FG005|NOT COMPLETED|Overall Study||8
2831088|NCT02030938|3532517|FG000|STARTED|Overall Study||34
2831089|NCT02030938|3532517|FG000|COMPLETED|Overall Study||29
2831090|NCT02030938|3532517|FG000|NOT COMPLETED|Overall Study||5
2831091|NCT02006147|3532529|FG000|STARTED|Overall Study||5
2831092|NCT02006147|3532530|FG001|STARTED|Overall Study||9
2831093|NCT02006147|3532531|FG002|STARTED|Overall Study||0
2831094|NCT02006147|3532532|FG003|STARTED|Overall Study||0
2831095|NCT02006147|3532529|FG000|COMPLETED|Overall Study||3
2831096|NCT02006147|3532530|FG001|COMPLETED|Overall Study||7
2831097|NCT02006147|3532531|FG002|COMPLETED|Overall Study||0
2831098|NCT02006147|3532532|FG003|COMPLETED|Overall Study||0
2831099|NCT02006147|3532529|FG000|NOT COMPLETED|Overall Study||2
2831100|NCT02006147|3532530|FG001|NOT COMPLETED|Overall Study||2
2831101|NCT02006147|3532531|FG002|NOT COMPLETED|Overall Study||0
2831102|NCT02006147|3532532|FG003|NOT COMPLETED|Overall Study||0
2831103|NCT01999179|3532538|FG000|STARTED|Overall Study||27
2831104|NCT01999179|3532538|FG000|COMPLETED|Overall Study||20
2831105|NCT01999179|3532538|FG000|NOT COMPLETED|Overall Study||7
2913894|NCT00499603|3623814|FG000|STARTED|Overall Study||27
2913895|NCT00499603|3623815|FG001|STARTED|Overall Study||23
2913896|NCT00499603|3623814|FG000|COMPLETED|Overall Study||27
2913897|NCT00499603|3623815|FG001|COMPLETED|Overall Study||22
2913898|NCT00499603|3623814|FG000|NOT COMPLETED|Overall Study||0
2913899|NCT00499603|3623815|FG001|NOT COMPLETED|Overall Study||1
2913900|NCT00499616|3623827|FG000|STARTED|Overall Study||176
2913901|NCT00499616|3623828|FG001|STARTED|Overall Study||142
2913902|NCT00499616|3623829|FG002|STARTED|Overall Study||89
2913903|NCT00499616|3623830|FG003|STARTED|Overall Study||57
2913904|NCT00499616|3623827|FG000|COMPLETED|Overall Study||161
2913905|NCT00499616|3623828|FG001|COMPLETED|Overall Study||114
2913906|NCT00499616|3623829|FG002|COMPLETED|Overall Study||53
2913907|NCT00499616|3623830|FG003|COMPLETED|Overall Study||0
2913908|NCT00499616|3623827|FG000|NOT COMPLETED|Overall Study||15
2913909|NCT00499616|3623828|FG001|NOT COMPLETED|Overall Study||28
2913910|NCT00499616|3623829|FG002|NOT COMPLETED|Overall Study||36
2913911|NCT00499616|3623830|FG003|NOT COMPLETED|Overall Study||57
2913912|NCT00499655|3623845|FG000|STARTED|Overall Study||53
2913913|NCT00499655|3623846|FG001|STARTED|Overall Study||54
2913914|NCT00499655|3623845|FG000|COMPLETED|Overall Study||53
2913915|NCT00499655|3623846|FG001|COMPLETED|Overall Study||54
2913916|NCT00499655|3623845|FG000|NOT COMPLETED|Overall Study||0
2913917|NCT00499655|3623846|FG001|NOT COMPLETED|Overall Study||0
2913918|NCT00499681|3623855|FG000|STARTED|Overall Study||4
2913919|NCT00499681|3623856|FG001|STARTED|Overall Study||2
2913920|NCT00499681|3623855|FG000|COMPLETED|Overall Study||4
2913921|NCT00499681|3623856|FG001|COMPLETED|Overall Study||0
2913922|NCT00499681|3623855|FG000|NOT COMPLETED|Overall Study||0
2913923|NCT00499681|3623856|FG001|NOT COMPLETED|Overall Study||2
2913924|NCT00499694|3623862|FG000|STARTED|Overall Study||31
2913925|NCT00499694|3623862|FG000|COMPLETED|Overall Study||30
2913926|NCT00499694|3623862|FG000|NOT COMPLETED|Overall Study||1
2913927|NCT00499746|3623867|FG000|STARTED|Phase 1(6-9 One Day Sessions)||20
2913928|NCT00499746|3623867|FG000|COMPLETED|Phase 1(6-9 One Day Sessions)||8
2913929|NCT00499746|3623867|FG000|NOT COMPLETED|Phase 1(6-9 One Day Sessions)||12
2913930|NCT00499746|3623867|FG000|STARTED|Phase 2 (6-9 One Day Sessions)||8
2913931|NCT00499746|3623867|FG000|COMPLETED|Phase 2 (6-9 One Day Sessions)||8
2913932|NCT00499746|3623867|FG000|NOT COMPLETED|Phase 2 (6-9 One Day Sessions)||0
2913933|NCT00499746|3623867|FG000|STARTED|Phase 3 (9-14 One Day Sessions)||8
2913934|NCT00499746|3623867|FG000|COMPLETED|Phase 3 (9-14 One Day Sessions)||8
2913935|NCT00499746|3623867|FG000|NOT COMPLETED|Phase 3 (9-14 One Day Sessions)||0
2913936|NCT00499863|3623883|FG000|STARTED|Overall Study||145
2913937|NCT00499863|3623884|FG001|STARTED|Overall Study||72
2913938|NCT00499863|3623883|FG000|COMPLETED|Overall Study||95
2913939|NCT00499863|3623884|FG001|COMPLETED|Overall Study||29
2913940|NCT00499863|3623883|FG000|NOT COMPLETED|Overall Study||50
2913941|NCT00499863|3623884|FG001|NOT COMPLETED|Overall Study||43
2913942|NCT00499889|3623890|FG000|STARTED|Overall Study||42
2913943|NCT00499889|3623890|FG000|COMPLETED|Overall Study||41
2913944|NCT00499889|3623890|FG000|NOT COMPLETED|Overall Study||1
2831106|NCT01940341|3532544|FG000|STARTED|Double-Blind Phase||285
2831107|NCT01940341|3532545|FG001|STARTED|Double-Blind Phase||141
2831108|NCT01940341|3532544|FG000|COMPLETED|Double-Blind Phase||4
2831109|NCT01940341|3532545|FG001|COMPLETED|Double-Blind Phase||1
2831110|NCT01940341|3532544|FG000|NOT COMPLETED|Double-Blind Phase||281
2831111|NCT01940341|3532545|FG001|NOT COMPLETED|Double-Blind Phase||140
2831112|NCT01940341|3532544|FG000|STARTED|Open-label Extension Phase||4
2831113|NCT01940341|3532545|FG001|STARTED|Open-label Extension Phase||1
2831114|NCT01940341|3532544|FG000|COMPLETED|Open-label Extension Phase||0
2831115|NCT01940341|3532545|FG001|COMPLETED|Open-label Extension Phase||0
2831116|NCT01940341|3532544|FG000|NOT COMPLETED|Open-label Extension Phase||4
2831117|NCT01940341|3532545|FG001|NOT COMPLETED|Open-label Extension Phase||1
2831118|NCT01925794|3532553|FG000|STARTED|30 Days||296
2831119|NCT01925794|3532553|FG000|COMPLETED|30 Days||296
2831120|NCT01925794|3532553|FG000|NOT COMPLETED|30 Days||0
2831121|NCT01925794|3532553|FG000|STARTED|180 Days||296
2831122|NCT01925794|3532553|FG000|COMPLETED|180 Days||292
2831123|NCT01925794|3532553|FG000|NOT COMPLETED|180 Days||4
2831124|NCT01925794|3532553|FG000|STARTED|270 Days||292
2831125|NCT01925794|3532553|FG000|COMPLETED|270 Days||287
2831126|NCT01925794|3532553|FG000|NOT COMPLETED|270 Days||5
2831127|NCT01907360|3532563|FG000|STARTED|Overall Study||18
2831128|NCT01907360|3532564|FG001|STARTED|Overall Study||11
2831129|NCT01907360|3532563|FG000|COMPLETED|Overall Study||18
2831130|NCT01907360|3532564|FG001|COMPLETED|Overall Study||11
2831131|NCT01907360|3532563|FG000|NOT COMPLETED|Overall Study||0
2831132|NCT01907360|3532564|FG001|NOT COMPLETED|Overall Study||0
2831133|NCT01886872|3532573|FG000|STARTED|Overall Study||183
2831134|NCT01886872|3532574|FG001|STARTED|Overall Study||182
2831135|NCT01886872|3532575|FG002|STARTED|Overall Study||182
2831136|NCT01886872|3532573|FG000|Evaluable for Secondary Endpoints|Overall Study||183
2831137|NCT01886872|3532574|FG001|Evaluable for Secondary Endpoints|Overall Study||182
2831138|NCT01886872|3532575|FG002|Evaluable for Secondary Endpoints|Overall Study||182
2831139|NCT01886872|3532573|FG000|Evaluable for Adverse Events|Overall Study||176
2831140|NCT01886872|3532574|FG001|Evaluable for Adverse Events|Overall Study||180
2831141|NCT01886872|3532575|FG002|Evaluable for Adverse Events|Overall Study||181
2831142|NCT01886872|3532573|FG000|Crossover Cohort|Overall Study||30
2831143|NCT01886872|3532574|FG001|Crossover Cohort|Overall Study||0
2831144|NCT01886872|3532575|FG002|Crossover Cohort|Overall Study||0
2831145|NCT01886872|3532573|FG000|COMPLETED|Overall Study||176
2831146|NCT01886872|3532574|FG001|COMPLETED|Overall Study||178
2831147|NCT01886872|3532575|FG002|COMPLETED|Overall Study||170
2831148|NCT01886872|3532573|FG000|NOT COMPLETED|Overall Study||7
2831149|NCT01886872|3532574|FG001|NOT COMPLETED|Overall Study||4
2831150|NCT01886872|3532575|FG002|NOT COMPLETED|Overall Study||12
2831151|NCT01856868|3532584|FG000|STARTED|Overall Study||7
2831152|NCT01856868|3532584|FG000|COMPLETED|Overall Study||7
2831153|NCT01856868|3532584|FG000|NOT COMPLETED|Overall Study||0
2831154|NCT01849250|3532590|FG000|STARTED|Overall Study||32
2831155|NCT01849250|3532591|FG001|STARTED|Overall Study||32
2831156|NCT01849250|3532590|FG000|COMPLETED|Overall Study||25
2831157|NCT01849250|3532591|FG001|COMPLETED|Overall Study||29
2831158|NCT01849250|3532590|FG000|NOT COMPLETED|Overall Study||7
2831159|NCT01849250|3532591|FG001|NOT COMPLETED|Overall Study||3
2831160|NCT01609790|3532601|FG000|STARTED|Overall Study||7
2831161|NCT01609790|3532602|FG001|STARTED|Overall Study||65
2831162|NCT01609790|3532603|FG002|STARTED|Overall Study||65
2831163|NCT01609790|3532601|FG000|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|6
2831164|NCT01609790|3532602|FG001|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|58
2831165|NCT01609790|3532603|FG002|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|57
2831166|NCT01609790|3532601|FG000|NOT COMPLETED|Overall Study||1
2831167|NCT01609790|3532602|FG001|NOT COMPLETED|Overall Study||7
2831168|NCT01609790|3532603|FG002|NOT COMPLETED|Overall Study||8
2831169|NCT01592643|3532611|FG000|STARTED|Overall Study||30
2831170|NCT01592643|3532611|FG000|COMPLETED|Overall Study||30
2831171|NCT01592643|3532611|FG000|NOT COMPLETED|Overall Study||0
2831172|NCT01441115|3532615|FG000|STARTED|Overall Study||2
2831173|NCT01441115|3532615|FG000|COMPLETED|Overall Study||1
2831174|NCT01441115|3532615|FG000|NOT COMPLETED|Overall Study||1
2831175|NCT01295944|3532622|FG000|STARTED|Overall Study||35
2831176|NCT01295944|3532622|FG000|COMPLETED|Overall Study||17
2831177|NCT01295944|3532622|FG000|NOT COMPLETED|Overall Study||18
2831178|NCT01199302|3532630|FG000|STARTED|Overall Study||20
2831179|NCT01199302|3532631|FG001|STARTED|Overall Study||16
2831180|NCT01199302|3532632|FG002|STARTED|Overall Study||20
2831181|NCT01199302|3532633|FG003|STARTED|Overall Study||11
2831182|NCT01199302|3532630|FG000|COMPLETED|Overall Study||0
2831183|NCT01199302|3532631|FG001|COMPLETED|Overall Study||0
2831184|NCT01199302|3532632|FG002|COMPLETED|Overall Study||0
2831185|NCT01199302|3532633|FG003|COMPLETED|Overall Study||0
2831186|NCT01199302|3532630|FG000|NOT COMPLETED|Overall Study||20
2831187|NCT01199302|3532631|FG001|NOT COMPLETED|Overall Study||16
2831188|NCT01199302|3532632|FG002|NOT COMPLETED|Overall Study||20
2831189|NCT01199302|3532633|FG003|NOT COMPLETED|Overall Study||11
2831190|NCT01123707|3532644|FG000|STARTED|Overall Study||44
2831191|NCT01123707|3532645|FG001|STARTED|Overall Study||41
2831192|NCT01123707|3532646|FG002|STARTED|Overall Study||38
2831193|NCT01123707|3532647|FG003|STARTED|Overall Study||50
2831194|NCT01123707|3532644|FG000|Safety Sample|Overall Study||44
2831195|NCT01123707|3532645|FG001|Safety Sample|Overall Study||41
2831196|NCT01123707|3532646|FG002|Safety Sample|Overall Study||36
2831197|NCT01123707|3532647|FG003|Safety Sample|Overall Study||49
2831198|NCT01123707|3532644|FG000|COMPLETED|Overall Study||0
2831199|NCT01123707|3532645|FG001|COMPLETED|Overall Study||0
2831200|NCT01123707|3532646|FG002|COMPLETED|Overall Study||0
2831201|NCT01123707|3532647|FG003|COMPLETED|Overall Study||0
2831202|NCT01123707|3532644|FG000|NOT COMPLETED|Overall Study||44
2831203|NCT01123707|3532645|FG001|NOT COMPLETED|Overall Study||41
2831204|NCT01123707|3532646|FG002|NOT COMPLETED|Overall Study||38
2831205|NCT01123707|3532647|FG003|NOT COMPLETED|Overall Study||50
2831206|NCT00894244|3532657|FG000|STARTED|Overall Study||25
2831207|NCT00894244|3532657|FG000|COMPLETED|Overall Study||24
2831208|NCT00894244|3532657|FG000|NOT COMPLETED|Overall Study||1
2831209|NCT00462943|3532664|FG000|STARTED|Overall Study||46
2831210|NCT00462943|3532665|FG001|STARTED|Overall Study||31
2831211|NCT00462943|3532666|FG002|STARTED|Overall Study||23
2831212|NCT00462943|3532664|FG000|COMPLETED|Overall Study||1
2831213|NCT00462943|3532665|FG001|COMPLETED|Overall Study||1
2831214|NCT00462943|3532666|FG002|COMPLETED|Overall Study||0
2831215|NCT00462943|3532664|FG000|NOT COMPLETED|Overall Study||45
2831216|NCT00462943|3532665|FG001|NOT COMPLETED|Overall Study||30
2831217|NCT00462943|3532666|FG002|NOT COMPLETED|Overall Study||23
2831218|NCT00248287|3532676|FG000|STARTED|Overall Study||75
2831219|NCT00248287|3532677|FG001|STARTED|Overall Study||79
2831220|NCT00248287|3532676|FG000|COMPLETED|Overall Study||51
2831221|NCT00248287|3532677|FG001|COMPLETED|Overall Study||60
2831222|NCT00248287|3532676|FG000|NOT COMPLETED|Overall Study||24
2831223|NCT00248287|3532677|FG001|NOT COMPLETED|Overall Study||19
2831224|NCT00182728|3532683|FG000|STARTED|Overall Study||71
2831225|NCT00182728|3532683|FG000|COMPLETED|Overall Study||71
2831226|NCT00182728|3532683|FG000|NOT COMPLETED|Overall Study||0
2831227|NCT00105560|3532687|FG000|STARTED|Overall Study||59
2831228|NCT00105560|3532687|FG000|COMPLETED|Overall Study||58
2831229|NCT00105560|3532687|FG000|NOT COMPLETED|Overall Study||1
2831230|NCT00038727|3532703|FG000|STARTED|Overall Study|Includes all enrollees from DPPOS 1-3|916
2831231|NCT00038727|3532704|FG001|STARTED|Overall Study|Includes all enrollees from DPPOS 1-3|927
2831232|NCT00038727|3532705|FG002|STARTED|Overall Study|Includes all enrollees from DPPOS 1-3|936
2831233|NCT00038727|3532703|FG000|DPPOS Phase 1 Primary|Overall Study|As reported in the Lancet 2009|910
2831234|NCT00038727|3532704|FG001|DPPOS Phase 1 Primary|Overall Study|As reported in the Lancet 2009|924
2831235|NCT00038727|3532705|FG002|DPPOS Phase 1 Primary|Overall Study|As reported in the Lancet 2009|932
2831236|NCT00038727|3532703|FG000|DPPOS Phase 2 Enrolled|Overall Study|As reported in Lancet Diabetes and Endocrinology 2015|915
2831237|NCT00038727|3532704|FG001|DPPOS Phase 2 Enrolled|Overall Study|As reported in Lancet Diabetes and Endocrinology 2015|926
2831238|NCT00038727|3532705|FG002|DPPOS Phase 2 Enrolled|Overall Study|As reported in Lancet Diabetes and Endocrinology 2015|935
2831239|NCT00038727|3532703|FG000|DPPOS Phase 2 Primary|Overall Study|As reported in Lancet Diabetes and Endocrinology 2015|751
2831240|NCT00038727|3532704|FG001|DPPOS Phase 2 Primary|Overall Study|As reported in Lancet Diabetes and Endocrinology 2015|772
2831241|NCT00038727|3532705|FG002|DPPOS Phase 2 Primary|Overall Study|As reported in Lancet Diabetes and Endocrinology 2015|780
2831242|NCT00038727|3532703|FG000|DPPOS Phase 3 Enrolled|Overall Study||916
2831243|NCT00038727|3532704|FG001|DPPOS Phase 3 Enrolled|Overall Study||927
2831244|NCT00038727|3532705|FG002|DPPOS Phase 3 Enrolled|Overall Study||936
2831245|NCT00038727|3532703|FG000|COMPLETED|Overall Study||916
2831246|NCT00038727|3532704|FG001|COMPLETED|Overall Study||927
2831247|NCT00038727|3532705|FG002|COMPLETED|Overall Study||936
2831248|NCT00038727|3532703|FG000|NOT COMPLETED|Overall Study||0
2831249|NCT00038727|3532704|FG001|NOT COMPLETED|Overall Study||0
2831250|NCT00038727|3532705|FG002|NOT COMPLETED|Overall Study||0
2913945|NCT00499915|3623896|FG000|STARTED|Overall Study||83
2913946|NCT00499915|3623897|FG001|STARTED|Overall Study||82
2913947|NCT00499915|3623896|FG000|COMPLETED|Overall Study||68
2913948|NCT00499915|3623897|FG001|COMPLETED|Overall Study||76
2913949|NCT00499915|3623896|FG000|NOT COMPLETED|Overall Study||15
2913950|NCT00499915|3623897|FG001|NOT COMPLETED|Overall Study||6
2913951|NCT00500071|3623903|FG000|STARTED|Screening and Washout Phase||318
2913952|NCT00500071|3623903|FG000|COMPLETED|Screening and Washout Phase||317
2913953|NCT00500071|3623903|FG000|NOT COMPLETED|Screening and Washout Phase||1
2913954|NCT00500071|3623903|FG000|STARTED|Dose-optimization and Maintenance Phase|Safety population (i.e., received at least one dose of study medication)|317
2913955|NCT00500071|3623903|FG000|COMPLETED|Dose-optimization and Maintenance Phase||295
2913956|NCT00500071|3623903|FG000|NOT COMPLETED|Dose-optimization and Maintenance Phase||22
2913957|NCT00500071|3623903|FG000|STARTED|30-day Safety Follow-up||295
2913958|NCT00500071|3623903|FG000|COMPLETED|30-day Safety Follow-up||278
2913959|NCT00500071|3623903|FG000|NOT COMPLETED|30-day Safety Follow-up||17
2913960|NCT00500110|3623907|FG000|STARTED|Overall Study||39
2913961|NCT00500110|3623907|FG000|COMPLETED|Overall Study||36
2913962|NCT00500110|3623907|FG000|NOT COMPLETED|Overall Study||3
3166803|NCT01904773|3893901|FG004|COMPLETED|Sixth Intervention||3
3166804|NCT01904773|3893902|FG005|COMPLETED|Sixth Intervention||4
3166805|NCT01904773|3893903|FG006|COMPLETED|Sixth Intervention||3
3166806|NCT01904773|3893904|FG007|COMPLETED|Sixth Intervention||2
3310297|NCT03039088|4043685|FG001|COMPLETED|Overall Study||316
3310298|NCT03039088|4043684|FG000|NOT COMPLETED|Overall Study||0
3310299|NCT03039088|4043685|FG001|NOT COMPLETED|Overall Study||0
2831251|NCT04569786|3532721|FG000|STARTED|Overall Study||39
2831252|NCT04569786|3532722|FG001|STARTED|Overall Study||39
2831253|NCT04569786|3532723|FG002|STARTED|Overall Study||42
2831254|NCT04569786|3532724|FG003|STARTED|Overall Study||56
2831255|NCT04569786|3532725|FG004|STARTED|Overall Study||56
2831256|NCT04569786|3532721|FG000|COMPLETED|Overall Study||38
2831257|NCT04569786|3532722|FG001|COMPLETED|Overall Study||39
2831258|NCT04569786|3532723|FG002|COMPLETED|Overall Study||38
2831259|NCT04569786|3532724|FG003|COMPLETED|Overall Study||49
2831260|NCT04569786|3532725|FG004|COMPLETED|Overall Study||55
2831261|NCT04569786|3532721|FG000|NOT COMPLETED|Overall Study||1
2831262|NCT04569786|3532722|FG001|NOT COMPLETED|Overall Study||0
2831263|NCT04569786|3532723|FG002|NOT COMPLETED|Overall Study||4
2831264|NCT04569786|3532724|FG003|NOT COMPLETED|Overall Study||7
2831265|NCT04569786|3532725|FG004|NOT COMPLETED|Overall Study||1
2831266|NCT04409041|3532737|FG000|STARTED|Overall Study||43
2831267|NCT04409041|3532737|FG000|COMPLETED|Overall Study||26
2831268|NCT04409041|3532737|FG000|NOT COMPLETED|Overall Study||17
2831269|NCT04129944|3532746|FG000|STARTED|Overall Study||46
2831270|NCT04129944|3532747|FG001|STARTED|Overall Study||45
2831271|NCT04129944|3532748|FG002|STARTED|Overall Study||46
2831272|NCT04129944|3532749|FG003|STARTED|Overall Study||46
2831273|NCT04129944|3532746|FG000|COMPLETED|Overall Study||44
2831274|NCT04129944|3532747|FG001|COMPLETED|Overall Study||45
2831275|NCT04129944|3532748|FG002|COMPLETED|Overall Study||45
2831276|NCT04129944|3532749|FG003|COMPLETED|Overall Study||43
2831277|NCT04129944|3532746|FG000|NOT COMPLETED|Overall Study||2
2831278|NCT04129944|3532747|FG001|NOT COMPLETED|Overall Study||0
2831279|NCT04129944|3532748|FG002|NOT COMPLETED|Overall Study||1
2831280|NCT04129944|3532749|FG003|NOT COMPLETED|Overall Study||3
2831371|NCT03367429|3532887|FG001|STARTED|Overall Study||1
2831372|NCT03367429|3532888|FG002|STARTED|Overall Study||2
2831373|NCT03367429|3532886|FG000|COMPLETED|Overall Study||0
2831374|NCT03367429|3532887|FG001|COMPLETED|Overall Study||1
2831375|NCT03367429|3532888|FG002|COMPLETED|Overall Study||2
2831376|NCT03367429|3532886|FG000|NOT COMPLETED|Overall Study||0
2831377|NCT03367429|3532887|FG001|NOT COMPLETED|Overall Study||0
2831378|NCT03367429|3532888|FG002|NOT COMPLETED|Overall Study||0
2831379|NCT03332498|3532901|FG000|STARTED|Overall Study||4
2831380|NCT03332498|3532902|FG001|STARTED|Overall Study||4
2831381|NCT03332498|3532903|FG002|STARTED|Overall Study||32
2831382|NCT03332498|3532901|FG000|COMPLETED|Overall Study||4
2831383|NCT03332498|3532902|FG001|COMPLETED|Overall Study||4
2831384|NCT03332498|3532903|FG002|COMPLETED|Overall Study||30
2831385|NCT03332498|3532901|FG000|NOT COMPLETED|Overall Study||0
2831386|NCT03332498|3532902|FG001|NOT COMPLETED|Overall Study||0
2831387|NCT03332498|3532903|FG002|NOT COMPLETED|Overall Study||2
2913963|NCT00500149|3623911|FG000|STARTED|Enrolled (Dose-optimization Phase)||129
2913964|NCT00500149|3623912|FG001|STARTED|Enrolled (Dose-optimization Phase)||0
2913965|NCT00500149|3623911|FG000|COMPLETED|Enrolled (Dose-optimization Phase)||117
2913966|NCT00500149|3623912|FG001|COMPLETED|Enrolled (Dose-optimization Phase)||0
2913967|NCT00500149|3623911|FG000|NOT COMPLETED|Enrolled (Dose-optimization Phase)||12
2913968|NCT00500149|3623912|FG001|NOT COMPLETED|Enrolled (Dose-optimization Phase)||0
2913969|NCT00500149|3623911|FG000|STARTED|First Intervention (Cross-over Phase)||58
2913970|NCT00500149|3623912|FG001|STARTED|First Intervention (Cross-over Phase)||59
2913971|NCT00500149|3623911|FG000|COMPLETED|First Intervention (Cross-over Phase)||56
2913972|NCT00500149|3623912|FG001|COMPLETED|First Intervention (Cross-over Phase)||57
2913973|NCT00500149|3623911|FG000|NOT COMPLETED|First Intervention (Cross-over Phase)||2
2913974|NCT00500149|3623912|FG001|NOT COMPLETED|First Intervention (Cross-over Phase)||2
2913975|NCT00500149|3623911|FG000|STARTED|Second Intervention (Cross-over Phase)||56
2913976|NCT00500149|3623912|FG001|STARTED|Second Intervention (Cross-over Phase)||57
2913977|NCT00500149|3623911|FG000|COMPLETED|Second Intervention (Cross-over Phase)||54
2913978|NCT00500149|3623912|FG001|COMPLETED|Second Intervention (Cross-over Phase)||57
2913979|NCT00500149|3623911|FG000|NOT COMPLETED|Second Intervention (Cross-over Phase)||2
2913980|NCT00500149|3623912|FG001|NOT COMPLETED|Second Intervention (Cross-over Phase)||0
2913981|NCT00500240|3623920|FG000|STARTED|Overall Study||25
2913982|NCT00500240|3623921|FG001|STARTED|Overall Study||26
2913983|NCT00500240|3623920|FG000|COMPLETED|Overall Study||25
2913984|NCT00500240|3623921|FG001|COMPLETED|Overall Study||26
2913985|NCT00500240|3623920|FG000|NOT COMPLETED|Overall Study||0
2913986|NCT00500240|3623921|FG001|NOT COMPLETED|Overall Study||0
2913987|NCT00500266|3623929|FG000|STARTED|Overall Study||1053
2913988|NCT00500266|3623929|FG000|Treated|Overall Study||1049
2913989|NCT00500266|3623929|FG000|COMPLETED|Overall Study||1040
2913990|NCT00500266|3623929|FG000|NOT COMPLETED|Overall Study||13
2913991|NCT00500292|3623937|FG000|STARTED|Overall Study|randomised patients|32
2913992|NCT00500292|3623938|FG001|STARTED|Overall Study|randomised patients|35
2913993|NCT00500292|3623939|FG002|STARTED|Overall Study|randomised patients|37
2913994|NCT00500292|3623937|FG000|COMPLETED|Overall Study|Ongoing study treatment at data cut-off date 8 March 2008.|7
2913995|NCT00500292|3623938|FG001|COMPLETED|Overall Study|Ongoing study treatment at data cut-off date 8 March 2008.|4
2913996|NCT00500292|3623939|FG002|COMPLETED|Overall Study|Ongoing study treatment at data cut-off date 8 March 2008.|10
2913997|NCT00500292|3623937|FG000|NOT COMPLETED|Overall Study||25
2913998|NCT00500292|3623938|FG001|NOT COMPLETED|Overall Study||31
2913999|NCT00500292|3623939|FG002|NOT COMPLETED|Overall Study||27
2914000|NCT00500318|3623949|FG000|STARTED|Overall Study||86
2914001|NCT00500318|3623950|FG001|STARTED|Overall Study||95
2831281|NCT03861728|3532761|FG000|STARTED|Overall Study||6
2831282|NCT03861728|3532762|FG001|STARTED|Overall Study||5
2831283|NCT03861728|3532761|FG000|COMPLETED|Overall Study||6
2831284|NCT03861728|3532762|FG001|COMPLETED|Overall Study||5
2831285|NCT03861728|3532761|FG000|NOT COMPLETED|Overall Study||0
2831286|NCT03861728|3532762|FG001|NOT COMPLETED|Overall Study||0
2831287|NCT03857542|3532770|FG000|STARTED|Overall Study||215
2831288|NCT03857542|3532771|FG001|STARTED|Overall Study||212
2831289|NCT03857542|3532770|FG000|COMPLETED|Overall Study||209
2831290|NCT03857542|3532771|FG001|COMPLETED|Overall Study||207
2831291|NCT03857542|3532770|FG000|NOT COMPLETED|Overall Study||6
2831292|NCT03857542|3532771|FG001|NOT COMPLETED|Overall Study||5
2831293|NCT03848832|3532781|FG000|STARTED|Overall Study||10
2831294|NCT03848832|3532782|FG001|STARTED|Overall Study||9
2831295|NCT03848832|3532783|FG002|STARTED|Overall Study||10
2831296|NCT03848832|3532781|FG000|COMPLETED|Overall Study||7
2831297|NCT03848832|3532782|FG001|COMPLETED|Overall Study||6
2831298|NCT03848832|3532783|FG002|COMPLETED|Overall Study||4
2831299|NCT03848832|3532781|FG000|NOT COMPLETED|Overall Study||3
2831300|NCT03848832|3532782|FG001|NOT COMPLETED|Overall Study||3
2831301|NCT03848832|3532783|FG002|NOT COMPLETED|Overall Study||6
2831302|NCT03688802|3532795|FG000|STARTED|Overall Study||12
2831303|NCT03688802|3532796|FG001|STARTED|Overall Study||6
2831304|NCT03688802|3532795|FG000|COMPLETED|Overall Study||11
2831305|NCT03688802|3532796|FG001|COMPLETED|Overall Study||6
2831306|NCT03688802|3532795|FG000|NOT COMPLETED|Overall Study||1
2831307|NCT03688802|3532796|FG001|NOT COMPLETED|Overall Study||0
2831308|NCT03656744|3532805|FG000|STARTED|Overall Study||34
2831309|NCT03656744|3532806|FG001|STARTED|Overall Study||34
2831310|NCT03656744|3532807|FG002|STARTED|Overall Study||33
2831311|NCT03656744|3532805|FG000|COMPLETED|Overall Study||29
2831312|NCT03656744|3532806|FG001|COMPLETED|Overall Study||27
2831313|NCT03656744|3532807|FG002|COMPLETED|Overall Study||32
2831314|NCT03656744|3532805|FG000|NOT COMPLETED|Overall Study||5
2831315|NCT03656744|3532806|FG001|NOT COMPLETED|Overall Study||7
2831316|NCT03656744|3532807|FG002|NOT COMPLETED|Overall Study||1
2831317|NCT03510598|3532815|FG000|STARTED|Overall Study||16
2831318|NCT03510598|3532815|FG000|COMPLETED|Overall Study||15
2831319|NCT03510598|3532815|FG000|NOT COMPLETED|Overall Study||1
2831320|NCT03487796|3532823|FG000|STARTED|Overall Study||41
2831321|NCT03487796|3532824|FG001|STARTED|Overall Study||31
2831322|NCT03487796|3532823|FG000|2 Month Follow-up|Overall Study||24
2831323|NCT03487796|3532824|FG001|2 Month Follow-up|Overall Study||26
2831324|NCT03487796|3532823|FG000|COMPLETED|Overall Study||23
2831325|NCT03487796|3532824|FG001|COMPLETED|Overall Study||25
2831326|NCT03487796|3532823|FG000|NOT COMPLETED|Overall Study||18
2831327|NCT03487796|3532824|FG001|NOT COMPLETED|Overall Study||6
2831328|NCT03446612|3532838|FG000|STARTED|Overall Study||2
2831329|NCT03446612|3532839|FG001|STARTED|Overall Study||3
2831330|NCT03446612|3532838|FG000|COMPLETED|Overall Study||2
2831331|NCT03446612|3532839|FG001|COMPLETED|Overall Study||2
2831332|NCT03446612|3532838|FG000|NOT COMPLETED|Overall Study||0
2831333|NCT03446612|3532839|FG001|NOT COMPLETED|Overall Study||1
2831334|NCT03436433|3532850|FG000|STARTED|Overall Study||1
2831335|NCT03436433|3532851|FG001|STARTED|Overall Study||2
2831336|NCT03436433|3532852|FG002|STARTED|Overall Study||1
2831337|NCT03436433|3532850|FG000|COMPLETED|Overall Study||1
2831338|NCT03436433|3532851|FG001|COMPLETED|Overall Study||2
2831339|NCT03436433|3532852|FG002|COMPLETED|Overall Study||1
2831340|NCT03436433|3532850|FG000|NOT COMPLETED|Overall Study||0
2831341|NCT03436433|3532851|FG001|NOT COMPLETED|Overall Study||0
2831342|NCT03436433|3532852|FG002|NOT COMPLETED|Overall Study||0
2831343|NCT03434379|3532862|FG000|STARTED|Global Period||165
2831344|NCT03434379|3532863|FG001|STARTED|Global Period||336
2831345|NCT03434379|3532864|FG002|STARTED|Global Period||0
2831346|NCT03434379|3532865|FG003|STARTED|Global Period||0
2831347|NCT03434379|3532862|FG000|COMPLETED|Global Period||0
2831348|NCT03434379|3532863|FG001|COMPLETED|Global Period||0
2831349|NCT03434379|3532864|FG002|COMPLETED|Global Period||0
2831350|NCT03434379|3532865|FG003|COMPLETED|Global Period||0
2831351|NCT03434379|3532862|FG000|NOT COMPLETED|Global Period||165
2831352|NCT03434379|3532863|FG001|NOT COMPLETED|Global Period||336
2831353|NCT03434379|3532864|FG002|NOT COMPLETED|Global Period||0
2831354|NCT03434379|3532865|FG003|NOT COMPLETED|Global Period||0
2831355|NCT03434379|3532862|FG000|STARTED|China Extension Period||0
2831356|NCT03434379|3532863|FG001|STARTED|China Extension Period||0
2831357|NCT03434379|3532864|FG002|STARTED|China Extension Period|n=43 Chinese participants from the sorafenib Global population are included in the China population.|61
2831358|NCT03434379|3532865|FG003|STARTED|China Extension Period|n=94 Chinese participants from the Atezolizumab + Bevacizumab Global population are included in the China population.|133
2831359|NCT03434379|3532862|FG000|COMPLETED|China Extension Period||0
2831360|NCT03434379|3532863|FG001|COMPLETED|China Extension Period||0
2831361|NCT03434379|3532864|FG002|COMPLETED|China Extension Period||0
2831362|NCT03434379|3532865|FG003|COMPLETED|China Extension Period||0
2831363|NCT03434379|3532862|FG000|NOT COMPLETED|China Extension Period||0
2831364|NCT03434379|3532863|FG001|NOT COMPLETED|China Extension Period||0
2831365|NCT03434379|3532864|FG002|NOT COMPLETED|China Extension Period||61
2831366|NCT03434379|3532865|FG003|NOT COMPLETED|China Extension Period||133
2831367|NCT03370120|3532877|FG000|STARTED|Overall Study||406
2831368|NCT03370120|3532877|FG000|COMPLETED|Overall Study||0
2831369|NCT03370120|3532877|FG000|NOT COMPLETED|Overall Study||406
2831370|NCT03367429|3532886|FG000|STARTED|Overall Study||0
2831388|NCT03143829|3532912|FG000|STARTED|Overall Study||38
2831389|NCT03143829|3532913|FG001|STARTED|Overall Study||42
2831390|NCT03143829|3532912|FG000|COMPLETED|Overall Study||33
2831391|NCT03143829|3532913|FG001|COMPLETED|Overall Study||32
2831392|NCT03143829|3532912|FG000|NOT COMPLETED|Overall Study||5
2831393|NCT03143829|3532913|FG001|NOT COMPLETED|Overall Study||10
2831394|NCT03099863|3532921|FG000|STARTED|Overall Study||121
2831395|NCT03099863|3532922|FG001|STARTED|Overall Study||121
2831396|NCT03099863|3532921|FG000|COMPLETED|Overall Study||111
2831397|NCT03099863|3532922|FG001|COMPLETED|Overall Study||105
2831398|NCT03099863|3532921|FG000|NOT COMPLETED|Overall Study||10
2831399|NCT03099863|3532922|FG001|NOT COMPLETED|Overall Study||16
2831400|NCT02963610|3532928|FG000|STARTED|Overall Study||3
2831401|NCT02963610|3532928|FG000|COMPLETED|Overall Study||0
2831402|NCT02963610|3532928|FG000|NOT COMPLETED|Overall Study||3
2831403|NCT02766335|3532935|FG000|STARTED|Initial Registration||68
2831404|NCT02766335|3532936|FG001|STARTED|Initial Registration||30
2831405|NCT02766335|3532937|FG002|STARTED|Initial Registration||0
2831406|NCT02766335|3532935|FG000|Eligible Participants Enrolled Before Docetaxel Arm Closed|Initial Registration||32
2831407|NCT02766335|3532936|FG001|Eligible Participants Enrolled Before Docetaxel Arm Closed|Initial Registration||30
2831408|NCT02766335|3532937|FG002|Eligible Participants Enrolled Before Docetaxel Arm Closed|Initial Registration||0
2831409|NCT02766335|3532935|FG000|COMPLETED|Initial Registration||10
2831410|NCT02766335|3532936|FG001|COMPLETED|Initial Registration||0
2831411|NCT02766335|3532937|FG002|COMPLETED|Initial Registration||0
2831412|NCT02766335|3532935|FG000|NOT COMPLETED|Initial Registration||58
2831413|NCT02766335|3532936|FG001|NOT COMPLETED|Initial Registration||30
2831414|NCT02766335|3532937|FG002|NOT COMPLETED|Initial Registration||0
2831415|NCT02766335|3532935|FG000|STARTED|Re-registration of Arm I to MEDI4738||0
2831416|NCT02766335|3532936|FG001|STARTED|Re-registration of Arm I to MEDI4738||0
2831417|NCT02766335|3532937|FG002|STARTED|Re-registration of Arm I to MEDI4738||4
2831418|NCT02766335|3532935|FG000|COMPLETED|Re-registration of Arm I to MEDI4738||0
2831419|NCT02766335|3532936|FG001|COMPLETED|Re-registration of Arm I to MEDI4738||0
2831420|NCT02766335|3532937|FG002|COMPLETED|Re-registration of Arm I to MEDI4738||2
2831421|NCT02766335|3532935|FG000|NOT COMPLETED|Re-registration of Arm I to MEDI4738||0
2831422|NCT02766335|3532936|FG001|NOT COMPLETED|Re-registration of Arm I to MEDI4738||0
2831423|NCT02766335|3532937|FG002|NOT COMPLETED|Re-registration of Arm I to MEDI4738||2
2831424|NCT02606136|3532943|FG000|STARTED|Overall Study||21
2831425|NCT02606136|3532943|FG000|Received at Least 1 Dose of Study Drug|Overall Study||21
2831426|NCT02606136|3532943|FG000|COMPLETED|Overall Study||15
2831427|NCT02606136|3532943|FG000|NOT COMPLETED|Overall Study||6
2831428|NCT02228382|3532952|FG000|STARTED|Overall Study||46
2831429|NCT02228382|3532953|FG001|STARTED|Overall Study||61
2831430|NCT02228382|3532954|FG002|STARTED|Overall Study||49
2831431|NCT02228382|3532955|FG003|STARTED|Overall Study||4
2831432|NCT02228382|3532956|FG004|STARTED|Overall Study||3
2831433|NCT02228382|3532952|FG000|COMPLETED|Overall Study||36
2831434|NCT02228382|3532953|FG001|COMPLETED|Overall Study||43
2831435|NCT02228382|3532954|FG002|COMPLETED|Overall Study||28
2831436|NCT02228382|3532955|FG003|COMPLETED|Overall Study||2
2831437|NCT02228382|3532956|FG004|COMPLETED|Overall Study||1
2831438|NCT02228382|3532952|FG000|NOT COMPLETED|Overall Study||10
2831439|NCT02228382|3532953|FG001|NOT COMPLETED|Overall Study||18
2831440|NCT02228382|3532954|FG002|NOT COMPLETED|Overall Study||21
2831441|NCT02228382|3532955|FG003|NOT COMPLETED|Overall Study||2
2831442|NCT02228382|3532956|FG004|NOT COMPLETED|Overall Study||2
2831443|NCT02208024|3532973|FG000|STARTED|Overall Study||18
2831444|NCT02208024|3532973|FG000|COMPLETED|Overall Study||17
2831445|NCT02208024|3532973|FG000|NOT COMPLETED|Overall Study||1
2831446|NCT02128958|3532979|FG000|STARTED|Overall Study||50
2831447|NCT02128958|3532980|FG001|STARTED|Overall Study||28
2831448|NCT02128958|3532979|FG000|COMPLETED|Overall Study||29
2831449|NCT02128958|3532980|FG001|COMPLETED|Overall Study||18
2831450|NCT02128958|3532979|FG000|NOT COMPLETED|Overall Study||21
2831451|NCT02128958|3532980|FG001|NOT COMPLETED|Overall Study||10
2831452|NCT02090998|3532988|FG000|STARTED|Overall Study||2
2831453|NCT02090998|3532989|FG001|STARTED|Overall Study||8
2831454|NCT02090998|3532988|FG000|COMPLETED|Overall Study||2
2831455|NCT02090998|3532989|FG001|COMPLETED|Overall Study||8
2831456|NCT02090998|3532988|FG000|NOT COMPLETED|Overall Study||0
2831457|NCT02090998|3532989|FG001|NOT COMPLETED|Overall Study||0
2831458|NCT02051309|3532997|FG000|STARTED|Overall Study||58
2831459|NCT02051309|3532998|FG001|STARTED|Overall Study||63
2831460|NCT02051309|3532997|FG000|COMPLETED|Overall Study||26
2831461|NCT02051309|3532998|FG001|COMPLETED|Overall Study||35
2831462|NCT02051309|3532997|FG000|NOT COMPLETED|Overall Study||32
2831463|NCT02051309|3532998|FG001|NOT COMPLETED|Overall Study||28
2831464|NCT02001623|3533019|FG000|STARTED|Overall Study||3
2831465|NCT02001623|3533020|FG001|STARTED|Overall Study||3
2831466|NCT02001623|3533021|FG002|STARTED|Overall Study||3
2831467|NCT02001623|3533022|FG003|STARTED|Overall Study||3
2831468|NCT02001623|3533023|FG004|STARTED|Overall Study||3
2831469|NCT02001623|3533024|FG005|STARTED|Overall Study||3
2831470|NCT02001623|3533025|FG006|STARTED|Overall Study||3
2831471|NCT02001623|3533026|FG007|STARTED|Overall Study||6
2831472|NCT02001623|3533027|FG008|STARTED|Overall Study||15
2831473|NCT02001623|3533028|FG009|STARTED|Overall Study||55
2831474|NCT02001623|3533029|FG010|STARTED|Overall Study||14
2831475|NCT02001623|3533030|FG011|STARTED|Overall Study||15
2831476|NCT02001623|3533031|FG012|STARTED|Overall Study||15
2831477|NCT02001623|3533032|FG013|STARTED|Overall Study||36
2831478|NCT02001623|3533033|FG014|STARTED|Overall Study||18
2831479|NCT02001623|3533019|FG000|Completed 4 Cycles of Treatment|Overall Study||0
2831480|NCT02001623|3533020|FG001|Completed 4 Cycles of Treatment|Overall Study||1
2831481|NCT02001623|3533021|FG002|Completed 4 Cycles of Treatment|Overall Study||1
2831482|NCT02001623|3533022|FG003|Completed 4 Cycles of Treatment|Overall Study||2
2831483|NCT02001623|3533023|FG004|Completed 4 Cycles of Treatment|Overall Study||0
2831484|NCT02001623|3533024|FG005|Completed 4 Cycles of Treatment|Overall Study||2
2831485|NCT02001623|3533025|FG006|Completed 4 Cycles of Treatment|Overall Study||2
2831486|NCT02001623|3533026|FG007|Completed 4 Cycles of Treatment|Overall Study||1
2831487|NCT02001623|3533027|FG008|Completed 4 Cycles of Treatment|Overall Study||5
2831488|NCT02001623|3533028|FG009|Completed 4 Cycles of Treatment|Overall Study||31
2831489|NCT02001623|3533029|FG010|Completed 4 Cycles of Treatment|Overall Study||6
2831490|NCT02001623|3533030|FG011|Completed 4 Cycles of Treatment|Overall Study||4
2831491|NCT02001623|3533031|FG012|Completed 4 Cycles of Treatment|Overall Study||6
2831492|NCT02001623|3533032|FG013|Completed 4 Cycles of Treatment|Overall Study||22
2831493|NCT02001623|3533033|FG014|Completed 4 Cycles of Treatment|Overall Study||7
2831494|NCT02001623|3533019|FG000|Completed 12 Cycles of Treatment|Overall Study||0
2831495|NCT02001623|3533020|FG001|Completed 12 Cycles of Treatment|Overall Study||1
2831496|NCT02001623|3533021|FG002|Completed 12 Cycles of Treatment|Overall Study||0
2831497|NCT02001623|3533022|FG003|Completed 12 Cycles of Treatment|Overall Study||1
2831498|NCT02001623|3533023|FG004|Completed 12 Cycles of Treatment|Overall Study||0
2831499|NCT02001623|3533024|FG005|Completed 12 Cycles of Treatment|Overall Study||0
2831500|NCT02001623|3533025|FG006|Completed 12 Cycles of Treatment|Overall Study||0
2831501|NCT02001623|3533026|FG007|Completed 12 Cycles of Treatment|Overall Study||0
2831502|NCT02001623|3533027|FG008|Completed 12 Cycles of Treatment|Overall Study||0
2831503|NCT02001623|3533028|FG009|Completed 12 Cycles of Treatment|Overall Study||3
2831504|NCT02001623|3533029|FG010|Completed 12 Cycles of Treatment|Overall Study||0
2831505|NCT02001623|3533030|FG011|Completed 12 Cycles of Treatment|Overall Study||0
2831506|NCT02001623|3533031|FG012|Completed 12 Cycles of Treatment|Overall Study||1
2831507|NCT02001623|3533032|FG013|Completed 12 Cycles of Treatment|Overall Study||1
2831508|NCT02001623|3533033|FG014|Completed 12 Cycles of Treatment|Overall Study||0
2831509|NCT02001623|3533019|FG000|COMPLETED|Overall Study||0
2831510|NCT02001623|3533020|FG001|COMPLETED|Overall Study||0
2831511|NCT02001623|3533021|FG002|COMPLETED|Overall Study||0
2831512|NCT02001623|3533022|FG003|COMPLETED|Overall Study||1
2831513|NCT02001623|3533023|FG004|COMPLETED|Overall Study||0
2831514|NCT02001623|3533024|FG005|COMPLETED|Overall Study||0
2831515|NCT02001623|3533025|FG006|COMPLETED|Overall Study||0
2831516|NCT02001623|3533026|FG007|COMPLETED|Overall Study||0
2831517|NCT02001623|3533027|FG008|COMPLETED|Overall Study||0
2831518|NCT02001623|3533028|FG009|COMPLETED|Overall Study||2
2831519|NCT02001623|3533029|FG010|COMPLETED|Overall Study||0
2831520|NCT02001623|3533030|FG011|COMPLETED|Overall Study||0
2831521|NCT02001623|3533031|FG012|COMPLETED|Overall Study||1
2831522|NCT02001623|3533032|FG013|COMPLETED|Overall Study||1
2831523|NCT02001623|3533033|FG014|COMPLETED|Overall Study||0
2831524|NCT02001623|3533019|FG000|NOT COMPLETED|Overall Study||3
2831525|NCT02001623|3533020|FG001|NOT COMPLETED|Overall Study||3
2831526|NCT02001623|3533021|FG002|NOT COMPLETED|Overall Study||3
2831527|NCT02001623|3533022|FG003|NOT COMPLETED|Overall Study||2
2831528|NCT02001623|3533023|FG004|NOT COMPLETED|Overall Study||3
2831529|NCT02001623|3533024|FG005|NOT COMPLETED|Overall Study||3
2831530|NCT02001623|3533025|FG006|NOT COMPLETED|Overall Study||3
2831531|NCT02001623|3533026|FG007|NOT COMPLETED|Overall Study||6
2831532|NCT02001623|3533027|FG008|NOT COMPLETED|Overall Study||15
2831533|NCT02001623|3533028|FG009|NOT COMPLETED|Overall Study||53
2831534|NCT02001623|3533029|FG010|NOT COMPLETED|Overall Study||14
2831535|NCT02001623|3533030|FG011|NOT COMPLETED|Overall Study||15
2831536|NCT02001623|3533031|FG012|NOT COMPLETED|Overall Study||14
2831537|NCT02001623|3533032|FG013|NOT COMPLETED|Overall Study||35
2831538|NCT02001623|3533033|FG014|NOT COMPLETED|Overall Study||18
2831539|NCT01900002|3533082|FG000|STARTED|Overall Study||40
2831540|NCT01900002|3533082|FG000|COMPLETED|Overall Study||34
2831541|NCT01900002|3533082|FG000|NOT COMPLETED|Overall Study||6
2831542|NCT01595061|3533086|FG000|STARTED|Overall Study||57
2831543|NCT01595061|3533086|FG000|COMPLETED|Overall Study||53
2831544|NCT01595061|3533086|FG000|NOT COMPLETED|Overall Study||4
2914002|NCT00500318|3623949|FG000|COMPLETED|Overall Study||81
2914003|NCT00500318|3623950|FG001|COMPLETED|Overall Study||78
2914004|NCT00500318|3623949|FG000|NOT COMPLETED|Overall Study||5
2914005|NCT00500318|3623950|FG001|NOT COMPLETED|Overall Study||17
2914006|NCT00500331|3623963|FG000|STARTED|Overall Study||48
2914007|NCT00500331|3623964|FG001|STARTED|Overall Study||47
2914008|NCT00500331|3623965|FG002|STARTED|Overall Study||48
2914009|NCT00500331|3623966|FG003|STARTED|Overall Study||48
2914010|NCT00500331|3623967|FG004|STARTED|Overall Study||48
2914011|NCT00500331|3623968|FG005|STARTED|Overall Study||47
2914012|NCT00500331|3623969|FG006|STARTED|Overall Study||48
2914013|NCT00500331|3623963|FG000|COMPLETED|Overall Study||33
2914014|NCT00500331|3623964|FG001|COMPLETED|Overall Study||42
2914015|NCT00500331|3623965|FG002|COMPLETED|Overall Study||43
2914016|NCT00500331|3623966|FG003|COMPLETED|Overall Study||38
2914017|NCT00500331|3623967|FG004|COMPLETED|Overall Study||44
2914018|NCT00500331|3623968|FG005|COMPLETED|Overall Study||42
2831545|NCT04267276|3533090|FG000|STARTED|Overall Study||7
2831546|NCT04267276|3533090|FG000|Treated|Overall Study||7
2831547|NCT04267276|3533090|FG000|COMPLETED|Overall Study||7
2831548|NCT04267276|3533090|FG000|NOT COMPLETED|Overall Study||0
2831549|NCT04238429|3533096|FG000|STARTED|Overall Study||43
2831550|NCT04238429|3533097|FG001|STARTED|Overall Study||43
2831551|NCT04238429|3533096|FG000|COMPLETED|Overall Study||40
2831552|NCT04238429|3533097|FG001|COMPLETED|Overall Study||41
2831553|NCT04238429|3533096|FG000|NOT COMPLETED|Overall Study||3
2831554|NCT04238429|3533097|FG001|NOT COMPLETED|Overall Study||2
2831555|NCT04126083|3533103|FG000|STARTED|Overall Study||6
2831556|NCT04126083|3533103|FG000|COMPLETED|Overall Study||5
2831557|NCT04126083|3533103|FG000|NOT COMPLETED|Overall Study||1
2831558|NCT03901300|3533109|FG000|STARTED|Overall Study|Children were enrolled study participants. Parents were not study participants.|35
2831559|NCT03901300|3533110|FG001|STARTED|Overall Study||37
2831560|NCT03901300|3533109|FG000|COMPLETED|Overall Study||32
2831561|NCT03901300|3533110|FG001|COMPLETED|Overall Study||37
2831562|NCT03901300|3533109|FG000|NOT COMPLETED|Overall Study||3
2831563|NCT03901300|3533110|FG001|NOT COMPLETED|Overall Study||0
2831564|NCT03870880|3533122|FG000|STARTED|Overall Study||27
2831565|NCT03870880|3533123|FG001|STARTED|Overall Study||58
2831566|NCT03870880|3533124|FG002|STARTED|Overall Study||31
2831567|NCT03870880|3533125|FG003|STARTED|Overall Study||28
2831568|NCT03870880|3533126|FG004|STARTED|Overall Study||61
2831569|NCT03870880|3533127|FG005|STARTED|Overall Study||10
2831570|NCT03870880|3533122|FG000|COMPLETED|Overall Study||21
2831571|NCT03870880|3533123|FG001|COMPLETED|Overall Study||43
2831572|NCT03870880|3533124|FG002|COMPLETED|Overall Study||26
2831573|NCT03870880|3533125|FG003|COMPLETED|Overall Study||20
2831574|NCT03870880|3533126|FG004|COMPLETED|Overall Study||44
2831575|NCT03870880|3533127|FG005|COMPLETED|Overall Study||7
2831576|NCT03870880|3533122|FG000|NOT COMPLETED|Overall Study||6
2831577|NCT03870880|3533123|FG001|NOT COMPLETED|Overall Study||15
2831578|NCT03870880|3533124|FG002|NOT COMPLETED|Overall Study||5
2831579|NCT03870880|3533125|FG003|NOT COMPLETED|Overall Study||8
2831580|NCT03870880|3533126|FG004|NOT COMPLETED|Overall Study||17
2831581|NCT03870880|3533127|FG005|NOT COMPLETED|Overall Study||3
2831582|NCT03744637|3533156|FG000|STARTED|Overall Study||2
2831583|NCT03744637|3533157|FG001|STARTED|Overall Study||2
2831584|NCT03744637|3533158|FG002|STARTED|Overall Study||2
2831585|NCT03744637|3533159|FG003|STARTED|Overall Study||1
2831586|NCT03744637|3533160|FG004|STARTED|Overall Study||1
2831587|NCT03744637|3533161|FG005|STARTED|Overall Study||1
2831588|NCT03744637|3533162|FG006|STARTED|Overall Study||8
2831589|NCT03744637|3533163|FG007|STARTED|Overall Study||4
2831590|NCT03744637|3533164|FG008|STARTED|Overall Study||3
2831591|NCT03744637|3533165|FG009|STARTED|Overall Study||1
2831592|NCT03744637|3533156|FG000|COMPLETED|Overall Study||2
2831593|NCT03744637|3533157|FG001|COMPLETED|Overall Study||2
2831594|NCT03744637|3533158|FG002|COMPLETED|Overall Study||2
2831595|NCT03744637|3533159|FG003|COMPLETED|Overall Study||1
2831596|NCT03744637|3533160|FG004|COMPLETED|Overall Study|Participant did not receive MK-5475 240 ug in Part 2 as planned.|1
2831597|NCT03744637|3533161|FG005|COMPLETED|Overall Study|Participant received 165 ug in Part 2 Periods 2 and 3, instead of planned 360 ug.|1
2831598|NCT03744637|3533162|FG006|COMPLETED|Overall Study||8
2831599|NCT03744637|3533163|FG007|COMPLETED|Overall Study|Participants received 120 ug in Part 2 Periods 2 and 3, instead of planned 360 ug.|4
2831600|NCT03744637|3533164|FG008|COMPLETED|Overall Study||3
2831601|NCT03744637|3533165|FG009|COMPLETED|Overall Study|Participant did not receive 120 ug in Part 2 Period 3 as planned.|1
2831602|NCT03744637|3533156|FG000|NOT COMPLETED|Overall Study||0
2831603|NCT03744637|3533157|FG001|NOT COMPLETED|Overall Study||0
2831604|NCT03744637|3533158|FG002|NOT COMPLETED|Overall Study||0
2831605|NCT03744637|3533159|FG003|NOT COMPLETED|Overall Study||0
2831606|NCT03744637|3533160|FG004|NOT COMPLETED|Overall Study||0
2831607|NCT03744637|3533161|FG005|NOT COMPLETED|Overall Study||0
2831608|NCT03744637|3533162|FG006|NOT COMPLETED|Overall Study||0
2831609|NCT03744637|3533163|FG007|NOT COMPLETED|Overall Study||0
2831610|NCT03744637|3533164|FG008|NOT COMPLETED|Overall Study||0
2831611|NCT03744637|3533165|FG009|NOT COMPLETED|Overall Study||0
3166807|NCT01904773|3893905|FG008|COMPLETED|Sixth Intervention||4
3166808|NCT01904773|3893897|FG000|NOT COMPLETED|Sixth Intervention||0
3166809|NCT01904773|3893898|FG001|NOT COMPLETED|Sixth Intervention||0
3166810|NCT01904773|3893899|FG002|NOT COMPLETED|Sixth Intervention||0
3166811|NCT01904773|3893900|FG003|NOT COMPLETED|Sixth Intervention||0
2831612|NCT03586050|3533226|FG000|STARTED|Overall Study||33
2831613|NCT03586050|3533226|FG000|COMPLETED|Overall Study||33
2831614|NCT03586050|3533226|FG000|NOT COMPLETED|Overall Study||0
2831615|NCT03576144|3533236|FG000|STARTED|Overall Study||10
2831616|NCT03576144|3533237|FG001|STARTED|Overall Study||8
2831617|NCT03576144|3533238|FG002|STARTED|Overall Study||8
2831618|NCT03576144|3533239|FG003|STARTED|Overall Study||8
2831619|NCT03576144|3533240|FG004|STARTED|Overall Study||8
2831620|NCT03576144|3533241|FG005|STARTED|Overall Study||8
2831621|NCT03576144|3533236|FG000|COMPLETED|Overall Study||10
2831622|NCT03576144|3533237|FG001|COMPLETED|Overall Study||8
2831623|NCT03576144|3533238|FG002|COMPLETED|Overall Study||8
2831624|NCT03576144|3533239|FG003|COMPLETED|Overall Study||8
2831625|NCT03576144|3533240|FG004|COMPLETED|Overall Study||8
2831626|NCT03576144|3533241|FG005|COMPLETED|Overall Study||8
3166812|NCT01904773|3893901|FG004|NOT COMPLETED|Sixth Intervention||0
3166813|NCT01904773|3893902|FG005|NOT COMPLETED|Sixth Intervention||0
3166814|NCT01904773|3893903|FG006|NOT COMPLETED|Sixth Intervention||0
3166815|NCT01904773|3893904|FG007|NOT COMPLETED|Sixth Intervention||0
3310300|NCT03039179|4043693|FG000|STARTED|Overall Study||38
3310301|NCT03039179|4043694|FG001|STARTED|Overall Study||42
3310302|NCT03039179|4043693|FG000|COMPLETED|Overall Study||38
3310303|NCT03039179|4043694|FG001|COMPLETED|Overall Study||42
3310304|NCT03039179|4043693|FG000|NOT COMPLETED|Overall Study||0
3310305|NCT03039179|4043694|FG001|NOT COMPLETED|Overall Study||0
3310306|NCT03039192|4043702|FG000|STARTED|Overall Study||112
3310307|NCT03039192|4043703|FG001|STARTED|Overall Study||114
3166816|NCT01904773|3893905|FG008|NOT COMPLETED|Sixth Intervention||0
3166817|NCT01904864|3893919|FG000|STARTED|Overall Study||40
3166818|NCT01904864|3893920|FG001|STARTED|Overall Study||40
2831627|NCT03576144|3533236|FG000|NOT COMPLETED|Overall Study||0
2831628|NCT03576144|3533237|FG001|NOT COMPLETED|Overall Study||0
2831629|NCT03576144|3533238|FG002|NOT COMPLETED|Overall Study||0
2831630|NCT03576144|3533239|FG003|NOT COMPLETED|Overall Study||0
2831631|NCT03576144|3533240|FG004|NOT COMPLETED|Overall Study||0
2831632|NCT03576144|3533241|FG005|NOT COMPLETED|Overall Study||0
2831633|NCT03444038|3533260|FG000|STARTED|Overall Study||85
2831634|NCT03444038|3533260|FG000|COMPLETED|Overall Study||56
2831635|NCT03444038|3533260|FG000|NOT COMPLETED|Overall Study||29
2831636|NCT03432897|3533264|FG000|STARTED|Overall Study||1
2831637|NCT03432897|3533264|FG000|COMPLETED|Overall Study||1
2831638|NCT03432897|3533264|FG000|NOT COMPLETED|Overall Study||0
2831639|NCT03349723|3533276|FG000|STARTED|Overall Study||6
2831640|NCT03349723|3533277|FG001|STARTED|Overall Study||6
2831641|NCT03349723|3533278|FG002|STARTED|Overall Study||6
2831642|NCT03349723|3533279|FG003|STARTED|Overall Study||6
2831643|NCT03349723|3533280|FG004|STARTED|Overall Study||6
2831644|NCT03349723|3533281|FG005|STARTED|Overall Study||6
2831645|NCT03349723|3533282|FG006|STARTED|Overall Study||6
2831646|NCT03349723|3533283|FG007|STARTED|Overall Study||14
2831647|NCT03349723|3533276|FG000|COMPLETED|Overall Study||6
2831648|NCT03349723|3533277|FG001|COMPLETED|Overall Study||6
2831649|NCT03349723|3533278|FG002|COMPLETED|Overall Study||6
2831650|NCT03349723|3533279|FG003|COMPLETED|Overall Study||6
2831651|NCT03349723|3533280|FG004|COMPLETED|Overall Study||6
2831652|NCT03349723|3533281|FG005|COMPLETED|Overall Study||6
2831653|NCT03349723|3533282|FG006|COMPLETED|Overall Study||6
2831654|NCT03349723|3533283|FG007|COMPLETED|Overall Study||14
2831655|NCT03349723|3533276|FG000|NOT COMPLETED|Overall Study||0
2831656|NCT03349723|3533277|FG001|NOT COMPLETED|Overall Study||0
2831657|NCT03349723|3533278|FG002|NOT COMPLETED|Overall Study||0
2831658|NCT03349723|3533279|FG003|NOT COMPLETED|Overall Study||0
2831659|NCT03349723|3533280|FG004|NOT COMPLETED|Overall Study||0
2831660|NCT03349723|3533281|FG005|NOT COMPLETED|Overall Study||0
2831661|NCT03349723|3533282|FG006|NOT COMPLETED|Overall Study||0
2831662|NCT03349723|3533283|FG007|NOT COMPLETED|Overall Study||0
2831663|NCT03315039|3533303|FG000|STARTED|Overall Study||4
2831664|NCT03315039|3533304|FG001|STARTED|Overall Study||3
2831665|NCT03315039|3533303|FG000|COMPLETED|Overall Study||4
2831666|NCT03315039|3533304|FG001|COMPLETED|Overall Study||3
2831667|NCT03315039|3533303|FG000|NOT COMPLETED|Overall Study||0
2831668|NCT03315039|3533304|FG001|NOT COMPLETED|Overall Study||0
2831669|NCT03265665|3533315|FG000|STARTED|24-week Data Collection||25
2831670|NCT03265665|3533316|FG001|STARTED|24-week Data Collection||28
2831671|NCT03265665|3533315|FG000|COMPLETED|24-week Data Collection||19
2831672|NCT03265665|3533316|FG001|COMPLETED|24-week Data Collection||21
2831673|NCT03265665|3533315|FG000|NOT COMPLETED|24-week Data Collection||6
2831674|NCT03265665|3533316|FG001|NOT COMPLETED|24-week Data Collection||7
2831675|NCT03265665|3533315|FG000|STARTED|36-week Data Collection|Used the number of participants that did not withdraw from the study. If a participant did not complete the 24 week week data collection, they were still allowed to complete the 36-week data collection. Thus the number we started with for this period was the total number of participants in each group that did not withdraw from the study.|23
2831676|NCT03265665|3533316|FG001|STARTED|36-week Data Collection|Used the number of participants that did not withdraw from the study. If a participant did not complete the 24 week week data collection, they were still allowed to complete the 36-week data collection. Thus the number we started with for this period was the total number of participants in each group that did not withdraw from the study.|26
2831677|NCT03265665|3533315|FG000|COMPLETED|36-week Data Collection||17
2831678|NCT03265665|3533316|FG001|COMPLETED|36-week Data Collection||18
2831679|NCT03265665|3533315|FG000|NOT COMPLETED|36-week Data Collection||6
2831680|NCT03265665|3533316|FG001|NOT COMPLETED|36-week Data Collection||8
2831681|NCT03248531|3533327|FG000|STARTED|Overall Study||22
2831682|NCT03248531|3533328|FG001|STARTED|Overall Study||22
2831683|NCT03248531|3533329|FG002|STARTED|Overall Study||46
2831684|NCT03248531|3533327|FG000|Completed Week 12|Overall Study||19
2831685|NCT03248531|3533328|FG001|Completed Week 12|Overall Study||18
2831686|NCT03248531|3533329|FG002|Completed Week 12|Overall Study||42
2831687|NCT03248531|3533327|FG000|COMPLETED|Overall Study||18
2831688|NCT03248531|3533328|FG001|COMPLETED|Overall Study||17
2831689|NCT03248531|3533329|FG002|COMPLETED|Overall Study||38
2831690|NCT03248531|3533327|FG000|NOT COMPLETED|Overall Study||4
2831691|NCT03248531|3533328|FG001|NOT COMPLETED|Overall Study||5
2831692|NCT03248531|3533329|FG002|NOT COMPLETED|Overall Study||8
3166819|NCT01904864|3893919|FG000|COMPLETED|Overall Study||31
3310308|NCT03039192|4043702|FG000|Treated|Overall Study||112
3310309|NCT03039192|4043703|FG001|Treated|Overall Study||113
3310310|NCT03039192|4043702|FG000|COMPLETED|Overall Study||80
3310311|NCT03039192|4043703|FG001|COMPLETED|Overall Study||84
2831693|NCT03196180|3533344|FG000|STARTED|Overall Study||13
2831694|NCT03196180|3533344|FG000|COMPLETED|Overall Study||11
2831695|NCT03196180|3533344|FG000|NOT COMPLETED|Overall Study||2
2831696|NCT02741700|3533350|FG000|STARTED|Overall Study||152
2831697|NCT02741700|3533351|FG001|STARTED|Overall Study||154
2831698|NCT02741700|3533350|FG000|COMPLETED|Overall Study||126
2831699|NCT02741700|3533351|FG001|COMPLETED|Overall Study||135
2831700|NCT02741700|3533350|FG000|NOT COMPLETED|Overall Study||26
2831701|NCT02741700|3533351|FG001|NOT COMPLETED|Overall Study||19
2831702|NCT02725593|3533359|FG000|STARTED|Blinded Treatment Period||39
2831703|NCT02725593|3533360|FG001|STARTED|Blinded Treatment Period||33
2831704|NCT02725593|3533359|FG000|Received Treatment|Blinded Treatment Period||39
2831705|NCT02725593|3533360|FG001|Received Treatment|Blinded Treatment Period||33
2831706|NCT02725593|3533359|FG000|COMPLETED|Blinded Treatment Period||34
2831707|NCT02725593|3533360|FG001|COMPLETED|Blinded Treatment Period||27
2831708|NCT02725593|3533359|FG000|NOT COMPLETED|Blinded Treatment Period||5
2831709|NCT02725593|3533360|FG001|NOT COMPLETED|Blinded Treatment Period||6
2831710|NCT02725593|3533359|FG000|STARTED|Long Term Extension|1 participant who completed Period 1 did not enter the long-term extension period.|33
2831711|NCT02725593|3533360|FG001|STARTED|Long Term Extension||27
2831712|NCT02725593|3533359|FG000|COMPLETED|Long Term Extension||32
2831713|NCT02725593|3533360|FG001|COMPLETED|Long Term Extension||24
2831714|NCT02725593|3533359|FG000|NOT COMPLETED|Long Term Extension||1
2831715|NCT02725593|3533360|FG001|NOT COMPLETED|Long Term Extension||3
2831716|NCT02716675|3533369|FG000|STARTED|Overall Study||903
2831717|NCT02716675|3533370|FG001|STARTED|Overall Study||899
2831718|NCT02716675|3533371|FG002|STARTED|Overall Study||897
2831719|NCT02716675|3533369|FG000|Modified Intent-to-treat Population|Overall Study||898
2831720|NCT02716675|3533370|FG001|Modified Intent-to-treat Population|Overall Study||895
2831721|NCT02716675|3533371|FG002|Modified Intent-to-treat Population|Overall Study||894
2831722|NCT02716675|3533369|FG000|COMPLETED|Overall Study||703
2831723|NCT02716675|3533370|FG001|COMPLETED|Overall Study||702
2831724|NCT02716675|3533371|FG002|COMPLETED|Overall Study||686
2831725|NCT02716675|3533369|FG000|NOT COMPLETED|Overall Study||200
2831726|NCT02716675|3533370|FG001|NOT COMPLETED|Overall Study||197
2831727|NCT02716675|3533371|FG002|NOT COMPLETED|Overall Study||211
2831728|NCT02636946|3533386|FG000|STARTED|Cycle 1 (Day 1 to Week 15)||72
2831729|NCT02636946|3533387|FG001|STARTED|Cycle 1 (Day 1 to Week 15)||72
2831730|NCT02636946|3533386|FG000|Received Treatment in Either Eye|Cycle 1 (Day 1 to Week 15)||72
2831731|NCT02636946|3533387|FG001|Received Treatment in Either Eye|Cycle 1 (Day 1 to Week 15)||70
2831732|NCT02636946|3533386|FG000|COMPLETED|Cycle 1 (Day 1 to Week 15)||71
2831733|NCT02636946|3533387|FG001|COMPLETED|Cycle 1 (Day 1 to Week 15)||67
2831734|NCT02636946|3533386|FG000|NOT COMPLETED|Cycle 1 (Day 1 to Week 15)||1
2831735|NCT02636946|3533387|FG001|NOT COMPLETED|Cycle 1 (Day 1 to Week 15)||5
2831736|NCT02636946|3533386|FG000|STARTED|Cycle 2 (Week 16 to Week 31)||65
2831737|NCT02636946|3533387|FG001|STARTED|Cycle 2 (Week 16 to Week 31)||62
2831738|NCT02636946|3533386|FG000|COMPLETED|Cycle 2 (Week 16 to Week 31)||63
2831739|NCT02636946|3533387|FG001|COMPLETED|Cycle 2 (Week 16 to Week 31)||61
2831740|NCT02636946|3533386|FG000|NOT COMPLETED|Cycle 2 (Week 16 to Week 31)||2
2831741|NCT02636946|3533387|FG001|NOT COMPLETED|Cycle 2 (Week 16 to Week 31)||1
2831742|NCT02636946|3533386|FG000|STARTED|Cycle 3 (Week 32 to Week 52)||17
2831743|NCT02636946|3533387|FG001|STARTED|Cycle 3 (Week 32 to Week 52)||16
2831744|NCT02636946|3533386|FG000|COMPLETED|Cycle 3 (Week 32 to Week 52)||17
2831745|NCT02636946|3533387|FG001|COMPLETED|Cycle 3 (Week 32 to Week 52)||16
2831746|NCT02636946|3533386|FG000|NOT COMPLETED|Cycle 3 (Week 32 to Week 52)||0
2831747|NCT02636946|3533387|FG001|NOT COMPLETED|Cycle 3 (Week 32 to Week 52)||0
2831748|NCT02631941|3533403|FG000|STARTED|Overall Study||9
3166820|NCT01904864|3893920|FG001|COMPLETED|Overall Study||28
3166821|NCT01904864|3893919|FG000|NOT COMPLETED|Overall Study||9
3166822|NCT01904864|3893920|FG001|NOT COMPLETED|Overall Study||12
3166823|NCT01904903|3893926|FG000|STARTED|Overall Study||31
3166824|NCT01904903|3893926|FG000|COMPLETED|Overall Study||30
2831749|NCT02631941|3533404|FG001|STARTED|Overall Study||10
2831750|NCT02631941|3533405|FG002|STARTED|Overall Study||9
2831751|NCT02631941|3533406|FG003|STARTED|Overall Study||9
2831752|NCT02631941|3533407|FG004|STARTED|Overall Study||9
2831753|NCT02631941|3533408|FG005|STARTED|Overall Study||8
2831754|NCT02631941|3533409|FG006|STARTED|Overall Study||9
2831755|NCT02631941|3533410|FG007|STARTED|Overall Study||9
2831756|NCT02631941|3533411|FG008|STARTED|Overall Study||10
2831757|NCT02631941|3533412|FG009|STARTED|Overall Study||9
2831758|NCT02631941|3533403|FG000|A|Overall Study||9
2831759|NCT02631941|3533404|FG001|A|Overall Study||8
2831760|NCT02631941|3533405|FG002|A|Overall Study||9
2831761|NCT02631941|3533406|FG003|A|Overall Study||9
2831762|NCT02631941|3533407|FG004|A|Overall Study||9
2831763|NCT02631941|3533408|FG005|A|Overall Study||8
2831764|NCT02631941|3533409|FG006|A|Overall Study||9
2831765|NCT02631941|3533410|FG007|A|Overall Study||9
2831766|NCT02631941|3533411|FG008|A|Overall Study||9
2831767|NCT02631941|3533412|FG009|A|Overall Study||9
2831768|NCT02631941|3533403|FG000|B1|Overall Study||9
2831769|NCT02631941|3533404|FG001|B1|Overall Study||10
2831770|NCT02631941|3533405|FG002|B1|Overall Study||9
2831771|NCT02631941|3533406|FG003|B1|Overall Study||9
2831772|NCT02631941|3533407|FG004|B1|Overall Study||8
2831773|NCT02631941|3533408|FG005|B1|Overall Study||8
2831774|NCT02631941|3533409|FG006|B1|Overall Study||9
2831775|NCT02631941|3533410|FG007|B1|Overall Study||9
3166825|NCT01904903|3893926|FG000|NOT COMPLETED|Overall Study||1
3310312|NCT03039192|4043702|FG000|NOT COMPLETED|Overall Study||32
3310313|NCT03039192|4043703|FG001|NOT COMPLETED|Overall Study||30
3310314|NCT03039283|4043709|FG000|STARTED|Overall Study||162
3310315|NCT03039283|4043709|FG000|COMPLETED|Overall Study||160
3310316|NCT03039283|4043709|FG000|NOT COMPLETED|Overall Study||2
3310317|NCT03039543|4043715|FG000|STARTED|Overall Study||54
3310318|NCT03039543|4043716|FG001|STARTED|Overall Study||54
3310319|NCT03039543|4043715|FG000|COMPLETED|Overall Study||53
3310320|NCT03039543|4043716|FG001|COMPLETED|Overall Study||51
3310321|NCT03039543|4043715|FG000|NOT COMPLETED|Overall Study||1
3310322|NCT03039543|4043716|FG001|NOT COMPLETED|Overall Study||3
3310323|NCT03039569|4043724|FG000|STARTED|Overall Study||40
3310324|NCT03039569|4043725|FG001|STARTED|Overall Study||39
3310325|NCT03039569|4043724|FG000|COMPLETED|Overall Study||35
3310326|NCT03039569|4043725|FG001|COMPLETED|Overall Study||35
2831776|NCT02631941|3533411|FG008|B1|Overall Study||10
2831777|NCT02631941|3533412|FG009|B1|Overall Study||9
2831778|NCT02631941|3533403|FG000|B2|Overall Study||9
2831779|NCT02631941|3533404|FG001|B2|Overall Study||8
2831780|NCT02631941|3533405|FG002|B2|Overall Study||9
2831781|NCT02631941|3533406|FG003|B2|Overall Study||9
2831782|NCT02631941|3533407|FG004|B2|Overall Study||9
2831783|NCT02631941|3533408|FG005|B2|Overall Study||8
2831784|NCT02631941|3533409|FG006|B2|Overall Study||9
2831785|NCT02631941|3533410|FG007|B2|Overall Study||9
2831786|NCT02631941|3533411|FG008|B2|Overall Study||9
2831787|NCT02631941|3533412|FG009|B2|Overall Study||9
2831788|NCT02631941|3533403|FG000|C|Overall Study||9
2831789|NCT02631941|3533404|FG001|C|Overall Study||8
2831790|NCT02631941|3533405|FG002|C|Overall Study||9
2831791|NCT02631941|3533406|FG003|C|Overall Study||9
2831792|NCT02631941|3533407|FG004|C|Overall Study||8
2831793|NCT02631941|3533408|FG005|C|Overall Study||8
2831794|NCT02631941|3533409|FG006|C|Overall Study||9
2831795|NCT02631941|3533410|FG007|C|Overall Study||8
2831796|NCT02631941|3533411|FG008|C|Overall Study||9
2831797|NCT02631941|3533412|FG009|C|Overall Study||9
2831798|NCT02631941|3533403|FG000|D|Overall Study||9
2831799|NCT02631941|3533404|FG001|D|Overall Study||8
2831800|NCT02631941|3533405|FG002|D|Overall Study||9
2831801|NCT02631941|3533406|FG003|D|Overall Study||9
2831802|NCT02631941|3533407|FG004|D|Overall Study||8
2831803|NCT02631941|3533408|FG005|D|Overall Study||8
2831804|NCT02631941|3533409|FG006|D|Overall Study||9
2831805|NCT02631941|3533410|FG007|D|Overall Study||9
2831806|NCT02631941|3533411|FG008|D|Overall Study||9
2831807|NCT02631941|3533412|FG009|D|Overall Study||9
2831808|NCT02631941|3533403|FG000|COMPLETED|Overall Study||9
2831809|NCT02631941|3533404|FG001|COMPLETED|Overall Study||8
2831810|NCT02631941|3533405|FG002|COMPLETED|Overall Study||9
2831811|NCT02631941|3533406|FG003|COMPLETED|Overall Study||9
2831812|NCT02631941|3533407|FG004|COMPLETED|Overall Study||8
2831813|NCT02631941|3533408|FG005|COMPLETED|Overall Study||8
2831814|NCT02631941|3533409|FG006|COMPLETED|Overall Study||9
2831815|NCT02631941|3533410|FG007|COMPLETED|Overall Study||8
2831816|NCT02631941|3533411|FG008|COMPLETED|Overall Study||9
2831817|NCT02631941|3533412|FG009|COMPLETED|Overall Study||9
2831818|NCT02631941|3533403|FG000|NOT COMPLETED|Overall Study||0
2831819|NCT02631941|3533404|FG001|NOT COMPLETED|Overall Study||2
2831820|NCT02631941|3533405|FG002|NOT COMPLETED|Overall Study||0
2831821|NCT02631941|3533406|FG003|NOT COMPLETED|Overall Study||0
2831822|NCT02631941|3533407|FG004|NOT COMPLETED|Overall Study||1
2831823|NCT02631941|3533408|FG005|NOT COMPLETED|Overall Study||0
2831824|NCT02631941|3533409|FG006|NOT COMPLETED|Overall Study||0
2831825|NCT02631941|3533410|FG007|NOT COMPLETED|Overall Study||1
2831826|NCT02631941|3533411|FG008|NOT COMPLETED|Overall Study||1
2831827|NCT02631941|3533412|FG009|NOT COMPLETED|Overall Study||0
2831828|NCT02568215|3533425|FG000|STARTED|Overall Study||637
2831829|NCT02568215|3533426|FG001|STARTED|Overall Study||642
2831830|NCT02568215|3533427|FG002|STARTED|Overall Study||645
2831831|NCT02568215|3533425|FG000|Modified Intent-to-treat Population|Overall Study||637
2831832|NCT02568215|3533426|FG001|Modified Intent-to-treat Population|Overall Study||642
2831833|NCT02568215|3533427|FG002|Modified Intent-to-treat Population|Overall Study||645
2831834|NCT02568215|3533425|FG000|COMPLETED|Overall Study||558
2831835|NCT02568215|3533426|FG001|COMPLETED|Overall Study||562
2831836|NCT02568215|3533427|FG002|COMPLETED|Overall Study||555
2831837|NCT02568215|3533425|FG000|NOT COMPLETED|Overall Study||79
2831838|NCT02568215|3533426|FG001|NOT COMPLETED|Overall Study||80
2831839|NCT02568215|3533427|FG002|NOT COMPLETED|Overall Study||90
2831840|NCT02562378|3533443|FG000|STARTED|Overall Study||3
2831841|NCT02562378|3533444|FG001|STARTED|Overall Study||3
2831842|NCT02562378|3533445|FG002|STARTED|Overall Study||9
2831843|NCT02562378|3533443|FG000|COMPLETED|Overall Study||3
2831844|NCT02562378|3533444|FG001|COMPLETED|Overall Study||3
2831845|NCT02562378|3533445|FG002|COMPLETED|Overall Study||9
2831846|NCT02562378|3533443|FG000|NOT COMPLETED|Overall Study||0
2831847|NCT02562378|3533444|FG001|NOT COMPLETED|Overall Study||0
2831848|NCT02562378|3533445|FG002|NOT COMPLETED|Overall Study||0
2831849|NCT02528643|3533455|FG000|STARTED|DB (Median Duration up to 14.65 Months)||55
3310327|NCT03039569|4043724|FG000|NOT COMPLETED|Overall Study||5
3310328|NCT03039569|4043725|FG001|NOT COMPLETED|Overall Study||4
2831850|NCT02528643|3533456|FG001|STARTED|DB (Median Duration up to 14.65 Months)||110
2831851|NCT02528643|3533455|FG000|Treated|DB (Median Duration up to 14.65 Months)||55
2831852|NCT02528643|3533456|FG001|Treated|DB (Median Duration up to 14.65 Months)||107
2831853|NCT02528643|3533455|FG000|COMPLETED|DB (Median Duration up to 14.65 Months)||0
2831854|NCT02528643|3533456|FG001|COMPLETED|DB (Median Duration up to 14.65 Months)||0
2831855|NCT02528643|3533455|FG000|NOT COMPLETED|DB (Median Duration up to 14.65 Months)||55
2831856|NCT02528643|3533456|FG001|NOT COMPLETED|DB (Median Duration up to 14.65 Months)||110
2831857|NCT02528643|3533455|FG000|STARTED|OL (Median Duration up to 27.56 Months)||0
2831858|NCT02528643|3533456|FG001|STARTED|OL (Median Duration up to 27.56 Months)||1
2831859|NCT02528643|3533455|FG000|COMPLETED|OL (Median Duration up to 27.56 Months)||0
2831860|NCT02528643|3533456|FG001|COMPLETED|OL (Median Duration up to 27.56 Months)||0
2831861|NCT02528643|3533455|FG000|NOT COMPLETED|OL (Median Duration up to 27.56 Months)||0
2831862|NCT02528643|3533456|FG001|NOT COMPLETED|OL (Median Duration up to 27.56 Months)||1
2831863|NCT02527434|3533467|FG000|STARTED|Overall Study||32
2831864|NCT02527434|3533468|FG001|STARTED|Overall Study||12
2831865|NCT02527434|3533469|FG002|STARTED|Overall Study||20
2831866|NCT02527434|3533467|FG000|Started Retreatment Phase (COMBO)|Overall Study||7
2831867|NCT02527434|3533468|FG001|Started Retreatment Phase (COMBO)|Overall Study||5
2831868|NCT02527434|3533469|FG002|Started Retreatment Phase (COMBO)|Overall Study||4
2831869|NCT02527434|3533467|FG000|Started Retreatment Phase (MEDI)|Overall Study||4
2831870|NCT02527434|3533468|FG001|Started Retreatment Phase (MEDI)|Overall Study||0
2831871|NCT02527434|3533469|FG002|Started Retreatment Phase (MEDI)|Overall Study||1
2831872|NCT02527434|3533467|FG000|COMPLETED|Overall Study||4
2831873|NCT02527434|3533468|FG001|COMPLETED|Overall Study||1
2831874|NCT02527434|3533469|FG002|COMPLETED|Overall Study||0
2831875|NCT02527434|3533467|FG000|NOT COMPLETED|Overall Study||28
2831876|NCT02527434|3533468|FG001|NOT COMPLETED|Overall Study||11
2831877|NCT02527434|3533469|FG002|NOT COMPLETED|Overall Study||20
2831878|NCT02416011|3533490|FG000|STARTED|Overall Study||575
2831879|NCT02416011|3533491|FG001|STARTED|Overall Study||1154
2831880|NCT02416011|3533492|FG002|STARTED|Overall Study||1167
2831881|NCT02416011|3533490|FG000|COMPLETED|Overall Study||561
2831882|NCT02416011|3533491|FG001|COMPLETED|Overall Study||1101
2831883|NCT02416011|3533492|FG002|COMPLETED|Overall Study||1114
2831884|NCT02416011|3533490|FG000|NOT COMPLETED|Overall Study||14
2831885|NCT02416011|3533491|FG001|NOT COMPLETED|Overall Study||53
2831886|NCT02416011|3533492|FG002|NOT COMPLETED|Overall Study||53
2831887|NCT02294461|3533515|FG000|STARTED|Double-blind Period (up to 29.4 Months)||202
2831888|NCT02294461|3533516|FG001|STARTED|Double-blind Period (up to 29.4 Months)||193
2831889|NCT02294461|3533515|FG000|Treated/Received Study Drug|Double-blind Period (up to 29.4 Months)||202
2831890|NCT02294461|3533516|FG001|Treated/Received Study Drug|Double-blind Period (up to 29.4 Months)||193
2831891|NCT02294461|3533515|FG000|COMPLETED|Double-blind Period (up to 29.4 Months)||84
2831892|NCT02294461|3533516|FG001|COMPLETED|Double-blind Period (up to 29.4 Months)||1
2831893|NCT02294461|3533515|FG000|NOT COMPLETED|Double-blind Period (up to 29.4 Months)||118
2831894|NCT02294461|3533516|FG001|NOT COMPLETED|Double-blind Period (up to 29.4 Months)||192
2831895|NCT02294461|3533515|FG000|STARTED|Open-label Period (up to 54.3 Months)|Eligible participants who provided consent took part in open-label period.|85
2831896|NCT02294461|3533516|FG001|STARTED|Open-label Period (up to 54.3 Months)|Eligible participants who provided consent took part in open-label period.|51
2831897|NCT02294461|3533515|FG000|COMPLETED|Open-label Period (up to 54.3 Months)||0
2831898|NCT02294461|3533516|FG001|COMPLETED|Open-label Period (up to 54.3 Months)||0
2831899|NCT02294461|3533515|FG000|NOT COMPLETED|Open-label Period (up to 54.3 Months)||85
2831900|NCT02294461|3533516|FG001|NOT COMPLETED|Open-label Period (up to 54.3 Months)||51
2831901|NCT02258659|3533534|FG000|STARTED|Overall Study||62
2831902|NCT02258659|3533534|FG000|COMPLETED|Overall Study||61
2831903|NCT02258659|3533534|FG000|NOT COMPLETED|Overall Study||1
2831904|NCT02237508|3533548|FG000|STARTED|Overall Study||9
2831905|NCT02237508|3533549|FG001|STARTED|Overall Study||9
2831906|NCT02237508|3533550|FG002|STARTED|Overall Study||9
2831907|NCT02237508|3533551|FG003|STARTED|Overall Study||9
2831908|NCT02237508|3533552|FG004|STARTED|Overall Study||9
2831909|NCT02237508|3533553|FG005|STARTED|Overall Study||9
2831910|NCT02237508|3533554|FG006|STARTED|Overall Study||9
2831911|NCT02237508|3533555|FG007|STARTED|Overall Study||9
2831912|NCT02237508|3533556|FG008|STARTED|Overall Study||9
2831913|NCT02237508|3533557|FG009|STARTED|Overall Study||9
2831914|NCT02237508|3533548|FG000|A|Overall Study||9
2831915|NCT02237508|3533549|FG001|A|Overall Study||6
2831916|NCT02237508|3533550|FG002|A|Overall Study||8
2831917|NCT02237508|3533551|FG003|A|Overall Study||8
2831918|NCT02237508|3533552|FG004|A|Overall Study||9
2831919|NCT02237508|3533553|FG005|A|Overall Study||8
2831920|NCT02237508|3533554|FG006|A|Overall Study||8
2831921|NCT02237508|3533555|FG007|A|Overall Study||9
2831922|NCT02237508|3533556|FG008|A|Overall Study||9
2831923|NCT02237508|3533557|FG009|A|Overall Study||9
2831924|NCT02237508|3533548|FG000|B1|Overall Study||9
2831925|NCT02237508|3533549|FG001|B1|Overall Study||9
2831926|NCT02237508|3533550|FG002|B1|Overall Study||9
2831927|NCT02237508|3533551|FG003|B1|Overall Study||8
2831928|NCT02237508|3533552|FG004|B1|Overall Study||9
2831929|NCT02237508|3533553|FG005|B1|Overall Study||9
2831930|NCT02237508|3533554|FG006|B1|Overall Study||9
2831931|NCT02237508|3533555|FG007|B1|Overall Study||9
2831932|NCT02237508|3533556|FG008|B1|Overall Study||9
2831933|NCT02237508|3533557|FG009|B1|Overall Study||9
2831934|NCT02237508|3533548|FG000|B2|Overall Study||9
2831935|NCT02237508|3533549|FG001|B2|Overall Study||6
2831936|NCT02237508|3533550|FG002|B2|Overall Study||9
2831937|NCT02237508|3533551|FG003|B2|Overall Study||9
2831938|NCT02237508|3533552|FG004|B2|Overall Study||9
2831939|NCT02237508|3533553|FG005|B2|Overall Study||9
2831940|NCT02237508|3533554|FG006|B2|Overall Study||9
2831941|NCT02237508|3533555|FG007|B2|Overall Study||9
2831942|NCT02237508|3533556|FG008|B2|Overall Study||8
2831943|NCT02237508|3533557|FG009|B2|Overall Study||9
2831944|NCT02237508|3533548|FG000|C|Overall Study||9
2831945|NCT02237508|3533549|FG001|C|Overall Study||8
2831946|NCT02237508|3533550|FG002|C|Overall Study||9
2831947|NCT02237508|3533551|FG003|C|Overall Study||8
2831948|NCT02237508|3533552|FG004|C|Overall Study||9
2831949|NCT02237508|3533553|FG005|C|Overall Study||9
2831950|NCT02237508|3533554|FG006|C|Overall Study||9
2831951|NCT02237508|3533555|FG007|C|Overall Study||9
2831952|NCT02237508|3533556|FG008|C|Overall Study||9
2831953|NCT02237508|3533557|FG009|C|Overall Study||9
2831954|NCT02237508|3533548|FG000|D|Overall Study||9
2831955|NCT02237508|3533549|FG001|D|Overall Study||6
2831956|NCT02237508|3533550|FG002|D|Overall Study||9
2831957|NCT02237508|3533551|FG003|D|Overall Study||9
2831958|NCT02237508|3533552|FG004|D|Overall Study||9
2831959|NCT02237508|3533553|FG005|D|Overall Study||9
2831960|NCT02237508|3533554|FG006|D|Overall Study||9
2831961|NCT02237508|3533555|FG007|D|Overall Study||9
2831962|NCT02237508|3533556|FG008|D|Overall Study||8
2831963|NCT02237508|3533557|FG009|D|Overall Study||9
2831964|NCT02237508|3533548|FG000|COMPLETED|Overall Study||9
2831965|NCT02237508|3533549|FG001|COMPLETED|Overall Study||6
2831966|NCT02237508|3533550|FG002|COMPLETED|Overall Study||8
2831967|NCT02237508|3533551|FG003|COMPLETED|Overall Study||8
2831968|NCT02237508|3533552|FG004|COMPLETED|Overall Study||9
2831969|NCT02237508|3533553|FG005|COMPLETED|Overall Study||8
2831970|NCT02237508|3533554|FG006|COMPLETED|Overall Study||8
2831971|NCT02237508|3533555|FG007|COMPLETED|Overall Study||9
2831972|NCT02237508|3533556|FG008|COMPLETED|Overall Study||8
2831973|NCT02237508|3533557|FG009|COMPLETED|Overall Study||9
2831974|NCT02237508|3533548|FG000|NOT COMPLETED|Overall Study||0
2831975|NCT02237508|3533549|FG001|NOT COMPLETED|Overall Study||3
2831976|NCT02237508|3533550|FG002|NOT COMPLETED|Overall Study||1
2831977|NCT02237508|3533551|FG003|NOT COMPLETED|Overall Study||1
2831978|NCT02237508|3533552|FG004|NOT COMPLETED|Overall Study||0
2831979|NCT02237508|3533553|FG005|NOT COMPLETED|Overall Study||1
2831980|NCT02237508|3533554|FG006|NOT COMPLETED|Overall Study||1
2831981|NCT02237508|3533555|FG007|NOT COMPLETED|Overall Study||0
2831982|NCT02237508|3533556|FG008|NOT COMPLETED|Overall Study||1
2831983|NCT02237508|3533557|FG009|NOT COMPLETED|Overall Study||0
2831984|NCT02197234|3533575|FG000|STARTED|Part A: Day 1-2 (Simvastatin Alone)||52
2831985|NCT02197234|3533575|FG000|COMPLETED|Part A: Day 1-2 (Simvastatin Alone)||52
2831986|NCT02197234|3533575|FG000|NOT COMPLETED|Part A: Day 1-2 (Simvastatin Alone)||0
2831987|NCT02197234|3533575|FG000|STARTED|Part A: Day 3-30 (AZD9291 Alone)||52
2831988|NCT02197234|3533575|FG000|COMPLETED|Part A: Day 3-30 (AZD9291 Alone)||49
2831989|NCT02197234|3533575|FG000|NOT COMPLETED|Part A: Day 3-30 (AZD9291 Alone)||3
2831990|NCT02197234|3533575|FG000|STARTED|Part A: Day 31-32 (Simvastatin+AZD9291)||49
2831991|NCT02197234|3533575|FG000|COMPLETED|Part A: Day 31-32 (Simvastatin+AZD9291)||49
2831992|NCT02197234|3533575|FG000|NOT COMPLETED|Part A: Day 31-32 (Simvastatin+AZD9291)||0
2831993|NCT02197234|3533575|FG000|STARTED|Part B: Day 33 to End Part B (AZD9291)|49 completed Part A + 1 entered Part B without completing Part A (due to AE) = 50 started Part B|50
2831994|NCT02197234|3533575|FG000|COMPLETED|Part B: Day 33 to End Part B (AZD9291)||20
2831995|NCT02197234|3533575|FG000|NOT COMPLETED|Part B: Day 33 to End Part B (AZD9291)||30
2831996|NCT02163733|3533584|FG000|STARTED|Part A: Day 1-9 (1st Intervention)||18
2831997|NCT02163733|3533585|FG001|STARTED|Part A: Day 1-9 (1st Intervention)||20
2831998|NCT02163733|3533586|FG002|STARTED|Part A: Day 1-9 (1st Intervention)||0
2831999|NCT02163733|3533584|FG000|COMPLETED|Part A: Day 1-9 (1st Intervention)||18
2832000|NCT02163733|3533585|FG001|COMPLETED|Part A: Day 1-9 (1st Intervention)||20
2832001|NCT02163733|3533586|FG002|COMPLETED|Part A: Day 1-9 (1st Intervention)||0
2832002|NCT02163733|3533584|FG000|NOT COMPLETED|Part A: Day 1-9 (1st Intervention)||0
2832003|NCT02163733|3533585|FG001|NOT COMPLETED|Part A: Day 1-9 (1st Intervention)||0
2832004|NCT02163733|3533586|FG002|NOT COMPLETED|Part A: Day 1-9 (1st Intervention)||0
2832005|NCT02163733|3533584|FG000|STARTED|Part A: Day 10-15 (2nd Intervention)||18
2832006|NCT02163733|3533585|FG001|STARTED|Part A: Day 10-15 (2nd Intervention)||20
2832007|NCT02163733|3533586|FG002|STARTED|Part A: Day 10-15 (2nd Intervention)||0
2832008|NCT02163733|3533584|FG000|COMPLETED|Part A: Day 10-15 (2nd Intervention)||18
2832009|NCT02163733|3533585|FG001|COMPLETED|Part A: Day 10-15 (2nd Intervention)||20
2832010|NCT02163733|3533586|FG002|COMPLETED|Part A: Day 10-15 (2nd Intervention)||0
2832011|NCT02163733|3533584|FG000|NOT COMPLETED|Part A: Day 10-15 (2nd Intervention)||0
2832012|NCT02163733|3533585|FG001|NOT COMPLETED|Part A: Day 10-15 (2nd Intervention)||0
2832013|NCT02163733|3533586|FG002|NOT COMPLETED|Part A: Day 10-15 (2nd Intervention)||0
2832014|NCT02163733|3533584|FG000|STARTED|Part B: Day 15 to End Part B (AZD9291)|Only the AZD9291 once daily (Part B) arm is applicable for this period.|0
2832015|NCT02163733|3533585|FG001|STARTED|Part B: Day 15 to End Part B (AZD9291)|Only the AZD9291 once daily (Part B) arm is applicable for this period.|0
2832016|NCT02163733|3533586|FG002|STARTED|Part B: Day 15 to End Part B (AZD9291)|No patients completed previous period as relates to Part A and arm is applicable only for Part B.|38
2832017|NCT02163733|3533584|FG000|COMPLETED|Part B: Day 15 to End Part B (AZD9291)||0
2832018|NCT02163733|3533585|FG001|COMPLETED|Part B: Day 15 to End Part B (AZD9291)||0
2832019|NCT02163733|3533586|FG002|COMPLETED|Part B: Day 15 to End Part B (AZD9291)||14
2832020|NCT02163733|3533584|FG000|NOT COMPLETED|Part B: Day 15 to End Part B (AZD9291)||0
2832021|NCT02163733|3533585|FG001|NOT COMPLETED|Part B: Day 15 to End Part B (AZD9291)||0
2914019|NCT00500331|3623969|FG006|COMPLETED|Overall Study||46
2832022|NCT02163733|3533586|FG002|NOT COMPLETED|Part B: Day 15 to End Part B (AZD9291)||24
2832023|NCT02157883|3533593|FG000|STARTED|Part A: Day 1-5 (AZD9291 Alone)||39
2832024|NCT02157883|3533593|FG000|COMPLETED|Part A: Day 1-5 (AZD9291 Alone)||39
2832025|NCT02157883|3533593|FG000|NOT COMPLETED|Part A: Day 1-5 (AZD9291 Alone)||0
2832026|NCT02157883|3533593|FG000|STARTED|Part A: Day 6-18 (AZD9291+Itraconozole)||39
2832027|NCT02157883|3533593|FG000|COMPLETED|Part A: Day 6-18 (AZD9291+Itraconozole)||38
2832028|NCT02157883|3533593|FG000|NOT COMPLETED|Part A: Day 6-18 (AZD9291+Itraconozole)||1
2832029|NCT02157883|3533593|FG000|STARTED|Part B: Day 19 to End Part B (AZD9291)||38
2832030|NCT02157883|3533593|FG000|COMPLETED|Part B: Day 19 to End Part B (AZD9291)||16
2832031|NCT02157883|3533593|FG000|NOT COMPLETED|Part B: Day 19 to End Part B (AZD9291)||22
2832032|NCT01996449|3533602|FG000|STARTED|Period 1: First Drug||6
2832033|NCT01996449|3533603|FG001|STARTED|Period 1: First Drug||8
2832034|NCT01996449|3533602|FG000|COMPLETED|Period 1: First Drug||6
2832035|NCT01996449|3533603|FG001|COMPLETED|Period 1: First Drug||8
2832036|NCT01996449|3533602|FG000|NOT COMPLETED|Period 1: First Drug||0
2832037|NCT01996449|3533603|FG001|NOT COMPLETED|Period 1: First Drug||0
2832038|NCT01996449|3533602|FG000|STARTED|Period 2: Second Drug||6
2832039|NCT01996449|3533603|FG001|STARTED|Period 2: Second Drug||8
2832040|NCT01996449|3533602|FG000|COMPLETED|Period 2: Second Drug||6
2832041|NCT01996449|3533603|FG001|COMPLETED|Period 2: Second Drug||8
2832042|NCT01996449|3533602|FG000|NOT COMPLETED|Period 2: Second Drug||0
2832043|NCT01996449|3533603|FG001|NOT COMPLETED|Period 2: Second Drug||0
2832044|NCT01877655|3533611|FG000|STARTED|Overall Study||263
2832045|NCT01877655|3533612|FG001|STARTED|Overall Study||251
2832046|NCT01877655|3533611|FG000|Received Treatment|Overall Study||255
2832047|NCT01877655|3533612|FG001|Received Treatment|Overall Study||246
2832048|NCT01877655|3533611|FG000|COMPLETED|Overall Study||165
2832049|NCT01877655|3533612|FG001|COMPLETED|Overall Study||154
2832050|NCT01877655|3533611|FG000|NOT COMPLETED|Overall Study||98
2832051|NCT01877655|3533612|FG001|NOT COMPLETED|Overall Study||97
2832052|NCT01802632|3533624|FG000|STARTED|Overall Study||201
2832053|NCT01802632|3533625|FG001|STARTED|Overall Study||31
2832054|NCT01802632|3533626|FG002|STARTED|Overall Study||271
2832055|NCT01802632|3533627|FG003|STARTED|Overall Study||60
2832056|NCT01802632|3533628|FG004|STARTED|Overall Study||12
2832057|NCT01802632|3533629|FG005|STARTED|Overall Study||28
2832058|NCT01802632|3533624|FG000|COMPLETED|Overall Study||0
2832059|NCT01802632|3533625|FG001|COMPLETED|Overall Study||0
2832060|NCT01802632|3533626|FG002|COMPLETED|Overall Study||0
2832061|NCT01802632|3533627|FG003|COMPLETED|Overall Study||0
2832062|NCT01802632|3533628|FG004|COMPLETED|Overall Study||0
2832063|NCT01802632|3533629|FG005|COMPLETED|Overall Study||0
2832064|NCT01802632|3533624|FG000|NOT COMPLETED|Overall Study||201
2832065|NCT01802632|3533625|FG001|NOT COMPLETED|Overall Study||31
2832066|NCT01802632|3533626|FG002|NOT COMPLETED|Overall Study||271
2832067|NCT01802632|3533627|FG003|NOT COMPLETED|Overall Study||60
2832068|NCT01802632|3533628|FG004|NOT COMPLETED|Overall Study||12
2832069|NCT01802632|3533629|FG005|NOT COMPLETED|Overall Study||28
2832070|NCT01706705|3533641|FG000|STARTED|Overall Study||57
2832071|NCT01706705|3533641|FG000|COMPLETED|Overall Study||37
2832072|NCT01706705|3533641|FG000|NOT COMPLETED|Overall Study||20
2832073|NCT01625286|3533653|FG000|STARTED|Overall Study||12
2832074|NCT01625286|3533654|FG001|STARTED|Overall Study||8
2832075|NCT01625286|3533655|FG002|STARTED|Overall Study||5
2832076|NCT01625286|3533656|FG003|STARTED|Overall Study||7
2832077|NCT01625286|3533657|FG004|STARTED|Overall Study||6
2832078|NCT01625286|3533658|FG005|STARTED|Overall Study||54
2832079|NCT01625286|3533659|FG006|STARTED|Overall Study||56
2832080|NCT01625286|3533653|FG000|Received AZD5363/Placebo Treatment|Overall Study||12
2832081|NCT01625286|3533654|FG001|Received AZD5363/Placebo Treatment|Overall Study||8
2832082|NCT01625286|3533655|FG002|Received AZD5363/Placebo Treatment|Overall Study||5
2832083|NCT01625286|3533656|FG003|Received AZD5363/Placebo Treatment|Overall Study||7
2832084|NCT01625286|3533657|FG004|Received AZD5363/Placebo Treatment|Overall Study||6
2832085|NCT01625286|3533658|FG005|Received AZD5363/Placebo Treatment|Overall Study||54
2832086|NCT01625286|3533659|FG006|Received AZD5363/Placebo Treatment|Overall Study||55
2832087|NCT01625286|3533653|FG000|Did Not Receive AZD5363/Placebo Trt|Overall Study||0
2832088|NCT01625286|3533654|FG001|Did Not Receive AZD5363/Placebo Trt|Overall Study||0
2832089|NCT01625286|3533655|FG002|Did Not Receive AZD5363/Placebo Trt|Overall Study||0
2832090|NCT01625286|3533656|FG003|Did Not Receive AZD5363/Placebo Trt|Overall Study||0
2832091|NCT01625286|3533657|FG004|Did Not Receive AZD5363/Placebo Trt|Overall Study||0
2832092|NCT01625286|3533658|FG005|Did Not Receive AZD5363/Placebo Trt|Overall Study||0
2832093|NCT01625286|3533659|FG006|Did Not Receive AZD5363/Placebo Trt|Overall Study||1
2832094|NCT01625286|3533653|FG000|COMPLETED|Overall Study||0
2832095|NCT01625286|3533654|FG001|COMPLETED|Overall Study||0
2832096|NCT01625286|3533655|FG002|COMPLETED|Overall Study||0
2832097|NCT01625286|3533656|FG003|COMPLETED|Overall Study||0
2832098|NCT01625286|3533657|FG004|COMPLETED|Overall Study||0
2832099|NCT01625286|3533658|FG005|COMPLETED|Overall Study||0
2832100|NCT01625286|3533659|FG006|COMPLETED|Overall Study||0
2832101|NCT01625286|3533653|FG000|NOT COMPLETED|Overall Study||12
2832102|NCT01625286|3533654|FG001|NOT COMPLETED|Overall Study||8
2832103|NCT01625286|3533655|FG002|NOT COMPLETED|Overall Study||5
2832104|NCT01625286|3533656|FG003|NOT COMPLETED|Overall Study||7
2832105|NCT01625286|3533657|FG004|NOT COMPLETED|Overall Study||6
2832106|NCT01625286|3533658|FG005|NOT COMPLETED|Overall Study||54
2832107|NCT01625286|3533659|FG006|NOT COMPLETED|Overall Study||56
2832108|NCT01609842|3533679|FG000|STARTED|Pre-Intervention Control||0
2832109|NCT01609842|3533680|FG001|STARTED|Pre-Intervention Control|Intervention sites patients prior to enrollment period who did not receive the intervention|6081
2832110|NCT01609842|3533679|FG000|COMPLETED|Pre-Intervention Control||0
2832111|NCT01609842|3533680|FG001|COMPLETED|Pre-Intervention Control||6081
2832112|NCT01609842|3533679|FG000|NOT COMPLETED|Pre-Intervention Control||0
2832113|NCT01609842|3533680|FG001|NOT COMPLETED|Pre-Intervention Control||0
2832114|NCT01609842|3533679|FG000|STARTED|Post-Intervention Control||0
2832115|NCT01609842|3533680|FG001|STARTED|Post-Intervention Control|Intervention sites patients after enrollment period ended who did not receive the intervention.|2917
2832116|NCT01609842|3533679|FG000|COMPLETED|Post-Intervention Control||0
2832117|NCT01609842|3533680|FG001|COMPLETED|Post-Intervention Control||2917
2832118|NCT01609842|3533679|FG000|NOT COMPLETED|Post-Intervention Control||0
2832119|NCT01609842|3533680|FG001|NOT COMPLETED|Post-Intervention Control||0
2832120|NCT01609842|3533679|FG000|STARTED|Concurrent Intervention Control||708
2832121|NCT01609842|3533680|FG001|STARTED|Concurrent Intervention Control|Nonintervention sites patients during the period prior and post enrollment at the intervention sites|4869
2832122|NCT01609842|3533679|FG000|COMPLETED|Concurrent Intervention Control||706
2832123|NCT01609842|3533680|FG001|COMPLETED|Concurrent Intervention Control||4869
2832124|NCT01609842|3533679|FG000|NOT COMPLETED|Concurrent Intervention Control||2
2832125|NCT01609842|3533680|FG001|NOT COMPLETED|Concurrent Intervention Control||0
2832126|NCT01341600|3533693|FG000|STARTED|Clopidogrel 75 mg||6
2832127|NCT01341600|3533694|FG001|STARTED|Clopidogrel 75 mg||6
2832128|NCT01341600|3533695|FG002|STARTED|Clopidogrel 75 mg||6
2832129|NCT01341600|3533693|FG000|COMPLETED|Clopidogrel 75 mg||6
2832130|NCT01341600|3533694|FG001|COMPLETED|Clopidogrel 75 mg||6
2832131|NCT01341600|3533695|FG002|COMPLETED|Clopidogrel 75 mg||6
2832132|NCT01341600|3533693|FG000|NOT COMPLETED|Clopidogrel 75 mg||0
2832133|NCT01341600|3533694|FG001|NOT COMPLETED|Clopidogrel 75 mg||0
2832134|NCT01341600|3533695|FG002|NOT COMPLETED|Clopidogrel 75 mg||0
2832135|NCT01341600|3533693|FG000|STARTED|Clopidogrel 150 mg||6
2832136|NCT01341600|3533694|FG001|STARTED|Clopidogrel 150 mg||6
2832137|NCT01341600|3533695|FG002|STARTED|Clopidogrel 150 mg||6
2832138|NCT01341600|3533693|FG000|COMPLETED|Clopidogrel 150 mg||6
2832139|NCT01341600|3533694|FG001|COMPLETED|Clopidogrel 150 mg||6
2832140|NCT01341600|3533695|FG002|COMPLETED|Clopidogrel 150 mg||6
2832141|NCT01341600|3533693|FG000|NOT COMPLETED|Clopidogrel 150 mg||0
2832142|NCT01341600|3533694|FG001|NOT COMPLETED|Clopidogrel 150 mg||0
2832143|NCT01341600|3533695|FG002|NOT COMPLETED|Clopidogrel 150 mg||0
2832144|NCT01341600|3533693|FG000|STARTED|Clopidogrel 225 mg||6
2832145|NCT01341600|3533694|FG001|STARTED|Clopidogrel 225 mg||6
2832146|NCT01341600|3533695|FG002|STARTED|Clopidogrel 225 mg||6
2832147|NCT01341600|3533693|FG000|COMPLETED|Clopidogrel 225 mg||6
2832148|NCT01341600|3533694|FG001|COMPLETED|Clopidogrel 225 mg||6
2832149|NCT01341600|3533695|FG002|COMPLETED|Clopidogrel 225 mg||6
2832150|NCT01341600|3533693|FG000|NOT COMPLETED|Clopidogrel 225 mg||0
2832151|NCT01341600|3533694|FG001|NOT COMPLETED|Clopidogrel 225 mg||0
2832152|NCT01341600|3533695|FG002|NOT COMPLETED|Clopidogrel 225 mg||0
2832153|NCT01341600|3533693|FG000|STARTED|Clopidogrel Plus Omeprazole||5
2832154|NCT01341600|3533694|FG001|STARTED|Clopidogrel Plus Omeprazole||5
2832155|NCT01341600|3533695|FG002|STARTED|Clopidogrel Plus Omeprazole||4
2832156|NCT01341600|3533693|FG000|COMPLETED|Clopidogrel Plus Omeprazole||5
2832157|NCT01341600|3533694|FG001|COMPLETED|Clopidogrel Plus Omeprazole||5
2832158|NCT01341600|3533695|FG002|COMPLETED|Clopidogrel Plus Omeprazole||4
2832159|NCT01341600|3533693|FG000|NOT COMPLETED|Clopidogrel Plus Omeprazole||0
2832160|NCT01341600|3533694|FG001|NOT COMPLETED|Clopidogrel Plus Omeprazole||0
2832161|NCT01341600|3533695|FG002|NOT COMPLETED|Clopidogrel Plus Omeprazole||0
2832162|NCT01044901|3533705|FG000|STARTED|Overall Study||38
2832163|NCT01044901|3533706|FG001|STARTED|Overall Study||13
2832164|NCT01044901|3533705|FG000|COMPLETED|Overall Study||38
2832165|NCT01044901|3533706|FG001|COMPLETED|Overall Study||13
2832166|NCT01044901|3533705|FG000|NOT COMPLETED|Overall Study||0
2832167|NCT01044901|3533706|FG001|NOT COMPLETED|Overall Study||0
2832168|NCT00769379|3533714|FG000|STARTED|Overall Study||1008
2832169|NCT00769379|3533715|FG001|STARTED|Overall Study||1006
2832170|NCT00769379|3533714|FG000|COMPLETED|Overall Study||1005
2832171|NCT00769379|3533715|FG001|COMPLETED|Overall Study||993
2832172|NCT00769379|3533714|FG000|NOT COMPLETED|Overall Study||3
2832173|NCT00769379|3533715|FG001|NOT COMPLETED|Overall Study||13
2832174|NCT00288080|3533723|FG000|STARTED|Overall Study||307
2832175|NCT00288080|3533724|FG001|STARTED|Overall Study||305
3166826|NCT01905241|3893930|FG000|STARTED|Overall Study||20
3166827|NCT01905241|3893930|FG000|COMPLETED|Overall Study||20
3166828|NCT01905241|3893930|FG000|NOT COMPLETED|Overall Study||0
3166829|NCT01905254|3893934|FG000|STARTED|Overall Study||34
3166830|NCT01905254|3893934|FG000|COMPLETED|Overall Study||34
3166831|NCT01905254|3893934|FG000|NOT COMPLETED|Overall Study||0
3166832|NCT01905267|3893940|FG000|STARTED|Overall Study||17
3166833|NCT01905267|3893941|FG001|STARTED|Overall Study||16
2832176|NCT00288080|3533723|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|281
2832177|NCT00288080|3533724|FG001|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|282
2832178|NCT00288080|3533723|FG000|NOT COMPLETED|Overall Study||26
2832179|NCT00288080|3533724|FG001|NOT COMPLETED|Overall Study||23
3166834|NCT01905267|3893940|FG000|COMPLETED|Overall Study||15
3166835|NCT01905267|3893941|FG001|COMPLETED|Overall Study||14
2832180|NCT00099437|3533732|FG000|STARTED|Overall Study|randomised patients|374
2832181|NCT00099437|3533733|FG001|STARTED|Overall Study|randomised patients|362
2832182|NCT00099437|3533732|FG000|COMPLETED|Overall Study|ongoing study treatment at survival follow-up data cut-off|8
2832183|NCT00099437|3533733|FG001|COMPLETED|Overall Study|ongoing study treatment at survival follow-up data cut-off|13
2832184|NCT00099437|3533732|FG000|NOT COMPLETED|Overall Study||366
2832185|NCT00099437|3533733|FG001|NOT COMPLETED|Overall Study||349
2832186|NCT00003479|3533739|FG000|STARTED|Overall Study||9
2832187|NCT00003479|3533739|FG000|COMPLETED|Overall Study||6
2832188|NCT00003479|3533739|FG000|NOT COMPLETED|Overall Study||3
2832189|NCT00003458|3533743|FG000|STARTED|Overall Study||34
2832190|NCT00003458|3533743|FG000|COMPLETED|Overall Study||30
2832191|NCT00003458|3533743|FG000|NOT COMPLETED|Overall Study||4
2914020|NCT00500331|3623963|FG000|NOT COMPLETED|Overall Study||15
2914021|NCT00500331|3623964|FG001|NOT COMPLETED|Overall Study||5
2914022|NCT00500331|3623965|FG002|NOT COMPLETED|Overall Study||5
2914023|NCT00500331|3623966|FG003|NOT COMPLETED|Overall Study||10
2914024|NCT00500331|3623967|FG004|NOT COMPLETED|Overall Study||4
2914025|NCT00500331|3623968|FG005|NOT COMPLETED|Overall Study||5
2914026|NCT00500331|3623969|FG006|NOT COMPLETED|Overall Study||2
2914027|NCT00500357|3623986|FG000|STARTED|Overall Study||105
2914028|NCT00500357|3623986|FG000|Received 13vPnC (Vax 3)|Overall Study||105
2914029|NCT00500357|3623986|FG000|Evaluable Immunogenicity Population|Overall Study|Administered Vax 1 and Vax 2 in study 6115A1-500; Vax 3 and at least 1 assay result in 6115A1-3009.|98
2914030|NCT00500357|3623986|FG000|COMPLETED|Overall Study||104
2914031|NCT00500357|3623986|FG000|NOT COMPLETED|Overall Study||1
2914032|NCT00500370|3624003|FG000|STARTED|Overall Study||80
2914033|NCT00500370|3624004|FG001|STARTED|Overall Study||83
2914034|NCT00500370|3624003|FG000|Treatment Start-Baseline (Week 0)|Overall Study||73
2914035|NCT00500370|3624004|FG001|Treatment Start-Baseline (Week 0)|Overall Study||79
2914036|NCT00500370|3624003|FG000|Treatment Complete (Week 24)|Overall Study||48
2914037|NCT00500370|3624004|FG001|Treatment Complete (Week 24)|Overall Study||54
2914038|NCT00500370|3624003|FG000|COMPLETED|Overall Study|COMPLETED = completion of treatment period (Week 24) plus follow-up visit 4 weeks later|47
2914039|NCT00500370|3624004|FG001|COMPLETED|Overall Study|COMPLETED = completion of treatment period (Week 24) plus follow-up visit 4 weeks later|49
2914040|NCT00500370|3624003|FG000|NOT COMPLETED|Overall Study||33
2914041|NCT00500370|3624004|FG001|NOT COMPLETED|Overall Study||34
2914042|NCT00500448|3624012|FG000|STARTED|Overall Study||14
2914043|NCT00500448|3624013|FG001|STARTED|Overall Study||16
2914044|NCT00500448|3624012|FG000|COMPLETED|Overall Study||14
2914045|NCT00500448|3624013|FG001|COMPLETED|Overall Study||16
2914046|NCT00500448|3624012|FG000|NOT COMPLETED|Overall Study||0
2914047|NCT00500448|3624013|FG001|NOT COMPLETED|Overall Study||0
2914048|NCT00500539|3624019|FG000|STARTED|Treatment Period (24 Weeks)||155
2914049|NCT00500539|3624019|FG000|COMPLETED|Treatment Period (24 Weeks)||140
2914050|NCT00500539|3624019|FG000|NOT COMPLETED|Treatment Period (24 Weeks)||15
2914051|NCT00500539|3624019|FG000|STARTED|Follow-up Period (16 Weeks)|Participants could discontinue study drug and still enter the follow-up period.|148
2914052|NCT00500539|3624019|FG000|COMPLETED|Follow-up Period (16 Weeks)||136
2914053|NCT00500539|3624019|FG000|NOT COMPLETED|Follow-up Period (16 Weeks)||12
2914054|NCT00500578|3624028|FG000|STARTED|Overall Study||18
2914055|NCT00500578|3624029|FG001|STARTED|Overall Study||32
2914056|NCT00500578|3624028|FG000|COMPLETED|Overall Study|All completed|18
2914057|NCT00500578|3624029|FG001|COMPLETED|Overall Study|All completed|32
2914058|NCT00500578|3624028|FG000|NOT COMPLETED|Overall Study||0
2914059|NCT00500578|3624029|FG001|NOT COMPLETED|Overall Study||0
2914060|NCT00500656|3624039|FG000|STARTED|Controlled Phase||36
2914061|NCT00500656|3624040|FG001|STARTED|Controlled Phase||38
2914062|NCT00500656|3624041|FG002|STARTED|Controlled Phase||3
2914063|NCT00500656|3624042|FG003|STARTED|Controlled Phase||8
2914064|NCT00500656|3624039|FG000|COMPLETED|Controlled Phase||26
2914065|NCT00500656|3624040|FG001|COMPLETED|Controlled Phase||28
2914066|NCT00500656|3624041|FG002|COMPLETED|Controlled Phase||2
2914067|NCT00500656|3624042|FG003|COMPLETED|Controlled Phase||0
2914068|NCT00500656|3624039|FG000|NOT COMPLETED|Controlled Phase||10
2914069|NCT00500656|3624040|FG001|NOT COMPLETED|Controlled Phase||10
2914070|NCT00500656|3624041|FG002|NOT COMPLETED|Controlled Phase||1
2914071|NCT00500656|3624042|FG003|NOT COMPLETED|Controlled Phase||8
2914072|NCT00500656|3624039|FG000|STARTED|Open Label Extension (OLE) Phase|3 Subjects did not experience an angioedema attack after their first attack in the controlled phase|23
2914073|NCT00500656|3624040|FG001|STARTED|Open Label Extension (OLE) Phase|7 Subjects did not experience an angioedema attack after their first attack in the controlled phase|21
2914074|NCT00500656|3624041|FG002|STARTED|Open Label Extension (OLE) Phase||2
2914075|NCT00500656|3624042|FG003|STARTED|Open Label Extension (OLE) Phase|Subjects did not experience an angioedema attack during the controlled phase|8
2914076|NCT00500656|3624039|FG000|COMPLETED|Open Label Extension (OLE) Phase||16
2914077|NCT00500656|3624040|FG001|COMPLETED|Open Label Extension (OLE) Phase||9
2914078|NCT00500656|3624041|FG002|COMPLETED|Open Label Extension (OLE) Phase||1
2914079|NCT00500656|3624042|FG003|COMPLETED|Open Label Extension (OLE) Phase||6
2914080|NCT00500656|3624039|FG000|NOT COMPLETED|Open Label Extension (OLE) Phase||7
2914081|NCT00500656|3624040|FG001|NOT COMPLETED|Open Label Extension (OLE) Phase||12
2914082|NCT00500656|3624041|FG002|NOT COMPLETED|Open Label Extension (OLE) Phase||1
2914083|NCT00500656|3624042|FG003|NOT COMPLETED|Open Label Extension (OLE) Phase||2
2914084|NCT00500682|3624054|FG000|STARTED|Overall Study||510
2914085|NCT00500682|3624055|FG001|STARTED|Overall Study||510
2832192|NCT04160195|3533750|FG000|STARTED|Overall Study||2
2832193|NCT04160195|3533751|FG001|STARTED|Overall Study||0
2832194|NCT04160195|3533750|FG000|COMPLETED|Overall Study||1
2832195|NCT04160195|3533751|FG001|COMPLETED|Overall Study||0
2832196|NCT04160195|3533750|FG000|NOT COMPLETED|Overall Study||1
2832197|NCT04160195|3533751|FG001|NOT COMPLETED|Overall Study||0
2832198|NCT04152447|3533761|FG000|STARTED|Overall Study||16
2832199|NCT04152447|3533762|FG001|STARTED|Overall Study||19
2832200|NCT04152447|3533761|FG000|COMPLETED|Overall Study||13
2832201|NCT04152447|3533762|FG001|COMPLETED|Overall Study||14
2832202|NCT04152447|3533761|FG000|NOT COMPLETED|Overall Study||3
2832203|NCT04152447|3533762|FG001|NOT COMPLETED|Overall Study||5
2832204|NCT03834974|3533770|FG000|STARTED|Overall Study||34
2832205|NCT03834974|3533771|FG001|STARTED|Overall Study||32
2832206|NCT03834974|3533770|FG000|COMPLETED|Overall Study||34
2832207|NCT03834974|3533771|FG001|COMPLETED|Overall Study||32
2832208|NCT03834974|3533770|FG000|NOT COMPLETED|Overall Study||0
2832209|NCT03834974|3533771|FG001|NOT COMPLETED|Overall Study||0
2832210|NCT03794544|3533782|FG000|STARTED|Overall Study||27
2832211|NCT03794544|3533783|FG001|STARTED|Overall Study||21
2832212|NCT03794544|3533784|FG002|STARTED|Overall Study||20
3166836|NCT01905267|3893940|FG000|NOT COMPLETED|Overall Study||2
3166837|NCT01905267|3893941|FG001|NOT COMPLETED|Overall Study||2
3166838|NCT01905423|3893952|FG000|STARTED|Overall Study||4456
3166839|NCT01905423|3893953|FG001|STARTED|Overall Study||3297
3166840|NCT01905423|3893954|FG002|STARTED|Overall Study||4111
3166841|NCT01905423|3893955|FG003|STARTED|Overall Study||2757
3166842|NCT01905423|3893956|FG004|STARTED|Overall Study||2487
2832213|NCT03794544|3533785|FG003|STARTED|Overall Study||16
2832214|NCT03794544|3533782|FG000|Treated|Overall Study||26
2832215|NCT03794544|3533783|FG001|Treated|Overall Study||21
2832216|NCT03794544|3533784|FG002|Treated|Overall Study||20
2832217|NCT03794544|3533785|FG003|Treated|Overall Study||16
2832218|NCT03794544|3533782|FG000|COMPLETED|Overall Study||26
2832219|NCT03794544|3533783|FG001|COMPLETED|Overall Study||18
2832220|NCT03794544|3533784|FG002|COMPLETED|Overall Study||19
2832221|NCT03794544|3533785|FG003|COMPLETED|Overall Study||15
2832222|NCT03794544|3533782|FG000|NOT COMPLETED|Overall Study||1
2832223|NCT03794544|3533783|FG001|NOT COMPLETED|Overall Study||3
2832224|NCT03794544|3533784|FG002|NOT COMPLETED|Overall Study||1
2832225|NCT03794544|3533785|FG003|NOT COMPLETED|Overall Study||1
2832226|NCT03732807|3533802|FG000|STARTED|Treatment Period (up to Week 24)||132
2832227|NCT03732807|3533803|FG001|STARTED|Treatment Period (up to Week 24)||130
2832228|NCT03732807|3533804|FG002|STARTED|Treatment Period (up to Week 24)||130
2832229|NCT03732807|3533805|FG003|STARTED|Treatment Period (up to Week 24)||132
2832230|NCT03732807|3533806|FG004|STARTED|Treatment Period (up to Week 24)||63
2832231|NCT03732807|3533807|FG005|STARTED|Treatment Period (up to Week 24)||65
2832232|NCT03732807|3533808|FG006|STARTED|Treatment Period (up to Week 24)||66
2832233|NCT03732807|3533802|FG000|COMPLETED|Treatment Period (up to Week 24)||122
2832234|NCT03732807|3533803|FG001|COMPLETED|Treatment Period (up to Week 24)||124
2832235|NCT03732807|3533804|FG002|COMPLETED|Treatment Period (up to Week 24)||121
2832236|NCT03732807|3533805|FG003|COMPLETED|Treatment Period (up to Week 24)||117
2832237|NCT03732807|3533806|FG004|COMPLETED|Treatment Period (up to Week 24)||58
2832238|NCT03732807|3533807|FG005|COMPLETED|Treatment Period (up to Week 24)||63
2832239|NCT03732807|3533808|FG006|COMPLETED|Treatment Period (up to Week 24)||61
2832240|NCT03732807|3533802|FG000|NOT COMPLETED|Treatment Period (up to Week 24)||10
2832241|NCT03732807|3533803|FG001|NOT COMPLETED|Treatment Period (up to Week 24)||6
2832242|NCT03732807|3533804|FG002|NOT COMPLETED|Treatment Period (up to Week 24)||9
2832243|NCT03732807|3533805|FG003|NOT COMPLETED|Treatment Period (up to Week 24)||15
2832244|NCT03732807|3533806|FG004|NOT COMPLETED|Treatment Period (up to Week 24)||5
2832245|NCT03732807|3533807|FG005|NOT COMPLETED|Treatment Period (up to Week 24)||2
2832246|NCT03732807|3533808|FG006|NOT COMPLETED|Treatment Period (up to Week 24)||5
2832247|NCT03732807|3533802|FG000|STARTED|Treatment Extension (Week 25 up to 48)|Participants continued dosing according to their assigned sequence in the preceding period.|113
2832248|NCT03732807|3533803|FG001|STARTED|Treatment Extension (Week 25 up to 48)|Participants continued dosing according to their assigned sequence in the preceding period.|111
2832249|NCT03732807|3533804|FG002|STARTED|Treatment Extension (Week 25 up to 48)|Participants continued dosing according to their assigned sequence in the preceding period.|108
2832250|NCT03732807|3533805|FG003|STARTED|Treatment Extension (Week 25 up to 48)|Participants continued dosing according to their assigned sequence in the preceding period.|106
2832251|NCT03732807|3533806|FG004|STARTED|Treatment Extension (Week 25 up to 48)|Participants continued dosing according to their assigned sequence in the preceding period.|49
2832252|NCT03732807|3533807|FG005|STARTED|Treatment Extension (Week 25 up to 48)|Participants continued dosing according to their assigned sequence in the preceding period.|59
2832253|NCT03732807|3533808|FG006|STARTED|Treatment Extension (Week 25 up to 48)|Participants continued dosing according to their assigned sequence in the preceding period.|57
2832254|NCT03732807|3533802|FG000|COMPLETED|Treatment Extension (Week 25 up to 48)||107
2832255|NCT03732807|3533803|FG001|COMPLETED|Treatment Extension (Week 25 up to 48)||100
2832256|NCT03732807|3533804|FG002|COMPLETED|Treatment Extension (Week 25 up to 48)||103
2832257|NCT03732807|3533805|FG003|COMPLETED|Treatment Extension (Week 25 up to 48)||97
2832258|NCT03732807|3533806|FG004|COMPLETED|Treatment Extension (Week 25 up to 48)||44
2832259|NCT03732807|3533807|FG005|COMPLETED|Treatment Extension (Week 25 up to 48)||56
2832260|NCT03732807|3533808|FG006|COMPLETED|Treatment Extension (Week 25 up to 48)||53
3166843|NCT01905423|3893952|FG000|Baseline|Overall Study||1443
2832261|NCT03732807|3533802|FG000|NOT COMPLETED|Treatment Extension (Week 25 up to 48)||6
2832262|NCT03732807|3533803|FG001|NOT COMPLETED|Treatment Extension (Week 25 up to 48)||11
2832263|NCT03732807|3533804|FG002|NOT COMPLETED|Treatment Extension (Week 25 up to 48)||5
2832264|NCT03732807|3533805|FG003|NOT COMPLETED|Treatment Extension (Week 25 up to 48)||9
2832265|NCT03732807|3533806|FG004|NOT COMPLETED|Treatment Extension (Week 25 up to 48)||5
2832266|NCT03732807|3533807|FG005|NOT COMPLETED|Treatment Extension (Week 25 up to 48)||3
2832267|NCT03732807|3533808|FG006|NOT COMPLETED|Treatment Extension (Week 25 up to 48)||4
2914086|NCT00500682|3624054|FG000|COMPLETED|Overall Study||204
2914087|NCT00500682|3624055|FG001|COMPLETED|Overall Study||223
2914088|NCT00500682|3624054|FG000|NOT COMPLETED|Overall Study||306
2914089|NCT00500682|3624055|FG001|NOT COMPLETED|Overall Study||287
2914090|NCT00500760|3624063|FG000|STARTED|Overall Study||89
2914091|NCT00500760|3624064|FG001|STARTED|Overall Study||64
2914092|NCT00500760|3624063|FG000|Received Treatment|Overall Study||87
2914093|NCT00500760|3624064|FG001|Received Treatment|Overall Study||63
2914094|NCT00500760|3624063|FG000|COMPLETED|Overall Study||46
3166844|NCT01905423|3893953|FG001|Baseline|Overall Study||722
3166845|NCT01905423|3893954|FG002|Baseline|Overall Study||1033
3166846|NCT01905423|3893955|FG003|Baseline|Overall Study||1482
3166847|NCT01905423|3893956|FG004|Baseline|Overall Study||1326
3166848|NCT01905423|3893952|FG000|Year 1 Follow-up|Overall Study||994
2914095|NCT00500760|3624064|FG001|COMPLETED|Overall Study||40
2914096|NCT00500760|3624063|FG000|NOT COMPLETED|Overall Study||43
2914097|NCT00500760|3624064|FG001|NOT COMPLETED|Overall Study||24
2914098|NCT00500903|3624073|FG000|STARTED|Overall Study||65
2914099|NCT00500903|3624074|FG001|STARTED|Overall Study||2
2914100|NCT00500903|3624075|FG002|STARTED|Overall Study||20
2914101|NCT00500903|3624073|FG000|COMPLETED|Overall Study||0
2914102|NCT00500903|3624074|FG001|COMPLETED|Overall Study||0
2914103|NCT00500903|3624075|FG002|COMPLETED|Overall Study||0
2914104|NCT00500903|3624073|FG000|NOT COMPLETED|Overall Study||65
2914105|NCT00500903|3624074|FG001|NOT COMPLETED|Overall Study||2
2914106|NCT00500903|3624075|FG002|NOT COMPLETED|Overall Study||20
2914107|NCT00501007|3624113|FG000|STARTED|Overall Study||100
2914108|NCT00501007|3624114|FG001|STARTED|Overall Study||103
2914109|NCT00501007|3624113|FG000|COMPLETED|Overall Study||71
2914110|NCT00501007|3624114|FG001|COMPLETED|Overall Study||78
2914111|NCT00501007|3624113|FG000|NOT COMPLETED|Overall Study||29
2914112|NCT00501007|3624114|FG001|NOT COMPLETED|Overall Study||25
2914113|NCT00501046|3624122|FG000|STARTED|Overall Study||508
2914114|NCT00501046|3624123|FG001|STARTED|Overall Study||507
2914115|NCT00501046|3624122|FG000|COMPLETED|Overall Study||238
2914116|NCT00501046|3624123|FG001|COMPLETED|Overall Study||213
2914117|NCT00501046|3624122|FG000|NOT COMPLETED|Overall Study||270
2914118|NCT00501046|3624123|FG001|NOT COMPLETED|Overall Study||294
2914119|NCT00501059|3624131|FG000|STARTED|Overall Study||6270
2914120|NCT00501059|3624132|FG001|STARTED|Overall Study||6276
2914121|NCT00501059|3624131|FG000|COMPLETED|Overall Study||4402
2914122|NCT00501059|3624132|FG001|COMPLETED|Overall Study||4384
2914123|NCT00501059|3624131|FG000|NOT COMPLETED|Overall Study||1868
2914124|NCT00501059|3624132|FG001|NOT COMPLETED|Overall Study||1892
2914125|NCT00501085|3624140|FG000|STARTED|Overall Study|Number of participants who were treated with the LAP-BAND System.|515
2914126|NCT00501085|3624140|FG000|COMPLETED|Overall Study|Number of participants completing 5 year follow-up visit.|83
2914127|NCT00501085|3624140|FG000|NOT COMPLETED|Overall Study||432
2914128|NCT00501293|3624146|FG000|STARTED|Optimization Period||110
2914129|NCT00501293|3624147|FG001|STARTED|Optimization Period||53
2914130|NCT00501293|3624146|FG000|COMPLETED|Optimization Period||109
2914131|NCT00501293|3624147|FG001|COMPLETED|Optimization Period||53
2914132|NCT00501293|3624146|FG000|NOT COMPLETED|Optimization Period||1
2914133|NCT00501293|3624147|FG001|NOT COMPLETED|Optimization Period||0
2914134|NCT00501293|3624146|FG000|STARTED|Maintenance Period||109
2914135|NCT00501293|3624147|FG001|STARTED|Maintenance Period||53
2914136|NCT00501293|3624146|FG000|COMPLETED|Maintenance Period||63
2914137|NCT00501293|3624147|FG001|COMPLETED|Maintenance Period||25
2914138|NCT00501293|3624146|FG000|NOT COMPLETED|Maintenance Period||46
2914139|NCT00501293|3624147|FG001|NOT COMPLETED|Maintenance Period||28
2914140|NCT00501540|3624154|FG000|STARTED|Overall Study||15
2914141|NCT00501540|3624154|FG000|COMPLETED|Overall Study||10
2914142|NCT00501540|3624154|FG000|NOT COMPLETED|Overall Study||5
2914143|NCT00501592|3624161|FG000|STARTED|Overall Study||20
2914144|NCT00501592|3624162|FG001|STARTED|Overall Study||21
2914145|NCT00501592|3624163|FG002|STARTED|Overall Study||23
2914146|NCT00501592|3624161|FG000|COMPLETED|Overall Study||20
2914147|NCT00501592|3624162|FG001|COMPLETED|Overall Study||16
2914148|NCT00501592|3624163|FG002|COMPLETED|Overall Study||20
2914149|NCT00501592|3624161|FG000|NOT COMPLETED|Overall Study||0
2914150|NCT00501592|3624162|FG001|NOT COMPLETED|Overall Study||5
2914151|NCT00501592|3624163|FG002|NOT COMPLETED|Overall Study||3
2914152|NCT00501631|3624173|FG000|STARTED|Part A (Double-blind Period)||152
2914153|NCT00501631|3624174|FG001|STARTED|Part A (Double-blind Period)||148
2914154|NCT00501631|3624173|FG000|COMPLETED|Part A (Double-blind Period)||90
2914155|NCT00501631|3624174|FG001|COMPLETED|Part A (Double-blind Period)||99
2914156|NCT00501631|3624173|FG000|NOT COMPLETED|Part A (Double-blind Period)||62
2914157|NCT00501631|3624174|FG001|NOT COMPLETED|Part A (Double-blind Period)||49
3166849|NCT01905423|3893953|FG001|Year 1 Follow-up|Overall Study||846
3166850|NCT01905423|3893954|FG002|Year 1 Follow-up|Overall Study||1007
3166851|NCT01905423|3893955|FG003|Year 1 Follow-up|Overall Study||1275
2832268|NCT03731364|3533830|FG000|STARTED|Overall Study||9
2832269|NCT03731364|3533831|FG001|STARTED|Overall Study||9
2832270|NCT03731364|3533832|FG002|STARTED|Overall Study||13
2832271|NCT03731364|3533833|FG003|STARTED|Overall Study||13
2832272|NCT03731364|3533834|FG004|STARTED|Overall Study||11
2832273|NCT03731364|3533830|FG000|COMPLETED|Overall Study||9
2832274|NCT03731364|3533831|FG001|COMPLETED|Overall Study||9
2832275|NCT03731364|3533832|FG002|COMPLETED|Overall Study||12
2832276|NCT03731364|3533833|FG003|COMPLETED|Overall Study||11
2832277|NCT03731364|3533834|FG004|COMPLETED|Overall Study||10
2832278|NCT03731364|3533830|FG000|NOT COMPLETED|Overall Study||0
2832279|NCT03731364|3533831|FG001|NOT COMPLETED|Overall Study||0
2832280|NCT03731364|3533832|FG002|NOT COMPLETED|Overall Study||1
2832281|NCT03731364|3533833|FG003|NOT COMPLETED|Overall Study||2
2832282|NCT03731364|3533834|FG004|NOT COMPLETED|Overall Study||1
2914158|NCT00501631|3624173|FG000|STARTED|Part B (Open-label Period)||90
2914159|NCT00501631|3624174|FG001|STARTED|Part B (Open-label Period)||99
2914160|NCT00501631|3624173|FG000|COMPLETED|Part B (Open-label Period)||37
2914161|NCT00501631|3624174|FG001|COMPLETED|Part B (Open-label Period)||48
2914162|NCT00501631|3624173|FG000|NOT COMPLETED|Part B (Open-label Period)||53
2914163|NCT00501631|3624174|FG001|NOT COMPLETED|Part B (Open-label Period)||51
2914164|NCT00501644|3624180|FG000|STARTED|Overall Study||59
2914165|NCT00501644|3624180|FG000|COMPLETED|Overall Study||54
2914166|NCT00501644|3624180|FG000|NOT COMPLETED|Overall Study||5
2914167|NCT00501852|3624184|FG000|STARTED|Overall Study||83
2914168|NCT00501852|3624184|FG000|NVA237 12.5µg|Overall Study||55
2914169|NCT00501852|3624184|FG000|NVA237 25µg|Overall Study||51
2914170|NCT00501852|3624184|FG000|NVA237 50µg|Overall Study||53
2914171|NCT00501852|3624184|FG000|NVA237 100µg|Overall Study||54
2914172|NCT00501852|3624184|FG000|Placebo|Overall Study||55
2914173|NCT00501852|3624184|FG000|Tiotropium|Overall Study||55
2914174|NCT00501852|3624184|FG000|COMPLETED|Overall Study||78
2914175|NCT00501852|3624184|FG000|NOT COMPLETED|Overall Study||5
2914176|NCT00501891|3624198|FG000|STARTED|Overall Study||32
2914177|NCT00501891|3624198|FG000|COMPLETED|Overall Study||32
2914178|NCT00501891|3624198|FG000|NOT COMPLETED|Overall Study||0
2914179|NCT00501943|3624205|FG000|STARTED|Overall Study||22
2914180|NCT00501943|3624206|FG001|STARTED|Overall Study||21
2914181|NCT00501943|3624205|FG000|COMPLETED|Overall Study||20
2914182|NCT00501943|3624206|FG001|COMPLETED|Overall Study||18
2914183|NCT00501943|3624205|FG000|NOT COMPLETED|Overall Study||2
2914184|NCT00501943|3624206|FG001|NOT COMPLETED|Overall Study||3
2914185|NCT00501969|3624214|FG000|STARTED|Overall Study||395
2914186|NCT00501969|3624214|FG000|COMPLETED|Overall Study||189
2914187|NCT00501969|3624214|FG000|NOT COMPLETED|Overall Study||206
2914188|NCT00501995|3624218|FG000|STARTED|Overall Study||6
2914189|NCT00501995|3624218|FG000|COMPLETED|Overall Study||5
2914190|NCT00501995|3624218|FG000|NOT COMPLETED|Overall Study||1
2914191|NCT00502203|3624222|FG000|STARTED|Overall Study||23
2914192|NCT00502203|3624222|FG000|COMPLETED|Overall Study||22
2914193|NCT00502203|3624222|FG000|NOT COMPLETED|Overall Study||1
2914194|NCT00502216|3624228|FG000|STARTED|Overall Study||21
2914195|NCT00502216|3624229|FG001|STARTED|Overall Study||19
2914196|NCT00502216|3624228|FG000|COMPLETED|Overall Study||21
2914197|NCT00502216|3624229|FG001|COMPLETED|Overall Study||19
2914198|NCT00502216|3624228|FG000|NOT COMPLETED|Overall Study||0
2914199|NCT00502216|3624229|FG001|NOT COMPLETED|Overall Study||0
2914200|NCT00502242|3624237|FG000|STARTED|Overall Study||155
2914201|NCT00502242|3624238|FG001|STARTED|Overall Study||140
2914202|NCT00502242|3624237|FG000|COMPLETED|Overall Study||104
2914203|NCT00502242|3624238|FG001|COMPLETED|Overall Study||84
2914204|NCT00502242|3624237|FG000|NOT COMPLETED|Overall Study||51
2914205|NCT00502242|3624238|FG001|NOT COMPLETED|Overall Study||56
2914206|NCT00502307|3624244|FG000|STARTED|Open Label Period (16 Weeks)||272
2914207|NCT00502307|3624245|FG001|STARTED|Open Label Period (16 Weeks)||0
2914208|NCT00502307|3624246|FG002|STARTED|Open Label Period (16 Weeks)||0
2914209|NCT00502307|3624244|FG000|COMPLETED|Open Label Period (16 Weeks)||196
2914210|NCT00502307|3624245|FG001|COMPLETED|Open Label Period (16 Weeks)||0
2914211|NCT00502307|3624246|FG002|COMPLETED|Open Label Period (16 Weeks)||0
2914212|NCT00502307|3624244|FG000|NOT COMPLETED|Open Label Period (16 Weeks)||76
2914213|NCT00502307|3624245|FG001|NOT COMPLETED|Open Label Period (16 Weeks)||0
2914214|NCT00502307|3624246|FG002|NOT COMPLETED|Open Label Period (16 Weeks)||0
2914215|NCT00502307|3624244|FG000|STARTED|Double-Blind Period (12 Weeks)||0
2914216|NCT00502307|3624245|FG001|STARTED|Double-Blind Period (12 Weeks)||61
2914217|NCT00502307|3624246|FG002|STARTED|Double-Blind Period (12 Weeks)||57
2914218|NCT00502307|3624244|FG000|COMPLETED|Double-Blind Period (12 Weeks)||0
2914219|NCT00502307|3624245|FG001|COMPLETED|Double-Blind Period (12 Weeks)||35
2914220|NCT00502307|3624246|FG002|COMPLETED|Double-Blind Period (12 Weeks)||48
2914221|NCT00502307|3624244|FG000|NOT COMPLETED|Double-Blind Period (12 Weeks)||0
2914222|NCT00502307|3624245|FG001|NOT COMPLETED|Double-Blind Period (12 Weeks)||26
2914223|NCT00502307|3624246|FG002|NOT COMPLETED|Double-Blind Period (12 Weeks)||9
2914224|NCT00502307|3624244|FG000|STARTED|Maintenance Period||148
2914225|NCT00502307|3624245|FG001|STARTED|Maintenance Period||0
2914226|NCT00502307|3624246|FG002|STARTED|Maintenance Period||0
2914227|NCT00502307|3624244|FG000|COMPLETED|Maintenance Period||0
2914228|NCT00502307|3624245|FG001|COMPLETED|Maintenance Period||0
2914229|NCT00502307|3624246|FG002|COMPLETED|Maintenance Period||0
2914230|NCT00502307|3624244|FG000|NOT COMPLETED|Maintenance Period||148
2914231|NCT00502307|3624245|FG001|NOT COMPLETED|Maintenance Period||0
2832283|NCT03724422|3533848|FG000|STARTED|Overall Study||1
2832284|NCT03724422|3533849|FG001|STARTED|Overall Study||2
2832285|NCT03724422|3533848|FG000|COMPLETED|Overall Study||1
2832286|NCT03724422|3533849|FG001|COMPLETED|Overall Study|Patients had interval healing then lost follow up|0
2832287|NCT03724422|3533848|FG000|NOT COMPLETED|Overall Study||0
2832288|NCT03724422|3533849|FG001|NOT COMPLETED|Overall Study||2
2832289|NCT04598152|3533855|FG000|STARTED|Overall Study||3
2832290|NCT04598152|3533856|FG001|STARTED|Overall Study||1
2832291|NCT04598152|3533855|FG000|COMPLETED|Overall Study||3
2832292|NCT04598152|3533856|FG001|COMPLETED|Overall Study||0
2832293|NCT04598152|3533855|FG000|NOT COMPLETED|Overall Study||0
2832294|NCT04598152|3533856|FG001|NOT COMPLETED|Overall Study||1
2832295|NCT04353271|3533864|FG000|STARTED|Overall Study||1
2832296|NCT04353271|3533865|FG001|STARTED|Overall Study||2
2832297|NCT04353271|3533864|FG000|COMPLETED|Overall Study||1
2832298|NCT04353271|3533865|FG001|COMPLETED|Overall Study||1
2832299|NCT04353271|3533864|FG000|NOT COMPLETED|Overall Study||0
2832300|NCT04353271|3533865|FG001|NOT COMPLETED|Overall Study||1
2832301|NCT04246021|3533871|FG000|STARTED|Overall Study||84
2832302|NCT04246021|3533871|FG000|COMPLETED|Overall Study||84
2832303|NCT04246021|3533871|FG000|NOT COMPLETED|Overall Study||0
2832304|NCT04098497|3533885|FG000|STARTED|Overall Study||30
2832305|NCT04098497|3533885|FG000|Initial Interview|Overall Study||30
2832306|NCT04098497|3533885|FG000|Set Up Study App|Overall Study||29
2832307|NCT04098497|3533885|FG000|Logged Symptoms Into Study App at Least Once|Overall Study||26
2832308|NCT04098497|3533885|FG000|Linked Fitbit to Study Database|Overall Study||27
2832309|NCT04098497|3533885|FG000|Used Fitbit|Overall Study||24
2832310|NCT04098497|3533885|FG000|Exit Interview|Overall Study||29
2832311|NCT04098497|3533885|FG000|COMPLETED|Overall Study||30
2832312|NCT04098497|3533885|FG000|NOT COMPLETED|Overall Study||0
2832313|NCT03945825|3533895|FG000|STARTED|Overall Study||41
2832314|NCT03945825|3533896|FG001|STARTED|Overall Study||37
2832315|NCT03945825|3533897|FG002|STARTED|Overall Study||40
2832316|NCT03945825|3533898|FG003|STARTED|Overall Study||41
2832317|NCT03945825|3533899|FG004|STARTED|Overall Study||39
2832318|NCT03945825|3533900|FG005|STARTED|Overall Study||43
2832319|NCT03945825|3533895|FG000|COMPLETED|Overall Study||39
2832320|NCT03945825|3533896|FG001|COMPLETED|Overall Study||32
2832321|NCT03945825|3533897|FG002|COMPLETED|Overall Study||39
2832322|NCT03945825|3533898|FG003|COMPLETED|Overall Study||39
2832323|NCT03945825|3533899|FG004|COMPLETED|Overall Study||36
2832324|NCT03945825|3533900|FG005|COMPLETED|Overall Study||40
2832325|NCT03945825|3533895|FG000|NOT COMPLETED|Overall Study||2
2832326|NCT03945825|3533896|FG001|NOT COMPLETED|Overall Study||5
2832327|NCT03945825|3533897|FG002|NOT COMPLETED|Overall Study||1
2832328|NCT03945825|3533898|FG003|NOT COMPLETED|Overall Study||2
2832329|NCT03945825|3533899|FG004|NOT COMPLETED|Overall Study||3
2832330|NCT03945825|3533900|FG005|NOT COMPLETED|Overall Study||3
2832331|NCT03937141|3533923|FG000|STARTED|Overall Study||16
2832332|NCT03937141|3533923|FG000|COMPLETED|Overall Study||16
3166852|NCT01905423|3893956|FG004|Year 1 Follow-up|Overall Study||1161
3166853|NCT01905423|3893952|FG000|Year 2 Follow-up|Overall Study||1114
3166854|NCT01905423|3893953|FG001|Year 2 Follow-up|Overall Study||858
3166855|NCT01905423|3893954|FG002|Year 2 Follow-up|Overall Study||1043
3166856|NCT01905423|3893955|FG003|Year 2 Follow-up|Overall Study||0
2832333|NCT03937141|3533923|FG000|NOT COMPLETED|Overall Study||0
2832334|NCT03678402|3533927|FG000|STARTED|Overall Study||521
2832335|NCT03678402|3533927|FG000|COMPLETED|Overall Study||521
2832336|NCT03678402|3533927|FG000|NOT COMPLETED|Overall Study||0
2832337|NCT03641937|3533931|FG000|STARTED|Overall Study||10
2832338|NCT03641937|3533931|FG000|COMPLETED|Overall Study||10
2832339|NCT03641937|3533931|FG000|NOT COMPLETED|Overall Study||0
2832340|NCT03572244|3533937|FG000|STARTED|Overall Study||6
2832341|NCT03572244|3533938|FG001|STARTED|Overall Study||6
2832342|NCT03572244|3533937|FG000|COMPLETED|Overall Study||6
2832343|NCT03572244|3533938|FG001|COMPLETED|Overall Study||6
2832344|NCT03572244|3533937|FG000|NOT COMPLETED|Overall Study||0
2832345|NCT03572244|3533938|FG001|NOT COMPLETED|Overall Study||0
2832346|NCT03562767|3533947|FG000|STARTED|Overall Study||10
2832347|NCT03562767|3533948|FG001|STARTED|Overall Study||10
2832348|NCT03562767|3533949|FG002|STARTED|Overall Study||0
2832349|NCT03562767|3533947|FG000|COMPLETED|Overall Study||7
2832350|NCT03562767|3533948|FG001|COMPLETED|Overall Study||7
2832351|NCT03562767|3533949|FG002|COMPLETED|Overall Study||0
2832352|NCT03562767|3533947|FG000|NOT COMPLETED|Overall Study||3
2832353|NCT03562767|3533948|FG001|NOT COMPLETED|Overall Study||3
2832354|NCT03562767|3533949|FG002|NOT COMPLETED|Overall Study||0
2832355|NCT03559699|3533961|FG000|STARTED|Overall Study||27
2832356|NCT03559699|3533961|FG000|COMPLETED|Overall Study||20
2832357|NCT03559699|3533961|FG000|NOT COMPLETED|Overall Study||7
2832358|NCT03360396|3533967|FG000|STARTED|Overall Study||80
2832359|NCT03360396|3533968|FG001|STARTED|Overall Study||40
2832360|NCT03360396|3533967|FG000|COMPLETED|Overall Study||0
2832361|NCT03360396|3533968|FG001|COMPLETED|Overall Study||0
2832362|NCT03360396|3533967|FG000|NOT COMPLETED|Overall Study||80
2832363|NCT03360396|3533968|FG001|NOT COMPLETED|Overall Study||40
2832364|NCT03333057|3533977|FG000|STARTED|Overall Study||111
2832365|NCT03333057|3533978|FG001|STARTED|Overall Study||114
2832366|NCT03333057|3533979|FG002|STARTED|Overall Study||111
2832367|NCT03333057|3533977|FG000|COMPLETED|Overall Study||105
2832368|NCT03333057|3533978|FG001|COMPLETED|Overall Study||110
3166857|NCT01905423|3893956|FG004|Year 2 Follow-up|Overall Study||0
2832369|NCT03333057|3533979|FG002|COMPLETED|Overall Study||108
2832370|NCT03333057|3533977|FG000|NOT COMPLETED|Overall Study||6
2832371|NCT03333057|3533978|FG001|NOT COMPLETED|Overall Study||4
2832372|NCT03333057|3533979|FG002|NOT COMPLETED|Overall Study||3
2832373|NCT03305016|3533987|FG000|STARTED|Overall Study||146
2832374|NCT03305016|3533987|FG000|COMPLETED|Overall Study||144
2832375|NCT03305016|3533987|FG000|NOT COMPLETED|Overall Study||2
2832376|NCT03300336|3533993|FG000|STARTED|Overall Study||7267
2832377|NCT03300336|3533994|FG001|STARTED|Overall Study||6859
2832378|NCT03300336|3533993|FG000|COMPLETED|Overall Study||7267
2832379|NCT03300336|3533994|FG001|COMPLETED|Overall Study||6859
2832380|NCT03300336|3533993|FG000|NOT COMPLETED|Overall Study||0
2832381|NCT03300336|3533994|FG001|NOT COMPLETED|Overall Study||0
2832382|NCT03291067|3534004|FG000|STARTED|Overall Study||94
2832383|NCT03291067|3534005|FG001|STARTED|Overall Study||92
2832384|NCT03291067|3534006|FG002|STARTED|Overall Study||94
2832385|NCT03291067|3534007|FG003|STARTED|Overall Study||94
2832386|NCT03291067|3534004|FG000|Treated|Overall Study||95
2832387|NCT03291067|3534005|FG001|Treated|Overall Study||90
2832388|NCT03291067|3534006|FG002|Treated|Overall Study||93
2832389|NCT03291067|3534007|FG003|Treated|Overall Study||90
2832390|NCT03291067|3534004|FG000|COMPLETED|Overall Study||84
2832391|NCT03291067|3534005|FG001|COMPLETED|Overall Study||78
2832392|NCT03291067|3534006|FG002|COMPLETED|Overall Study||61
2832393|NCT03291067|3534007|FG003|COMPLETED|Overall Study||77
2832394|NCT03291067|3534004|FG000|NOT COMPLETED|Overall Study||10
2832395|NCT03291067|3534005|FG001|NOT COMPLETED|Overall Study||14
2832396|NCT03291067|3534006|FG002|NOT COMPLETED|Overall Study||33
2832397|NCT03291067|3534007|FG003|NOT COMPLETED|Overall Study||17
2832398|NCT03271047|3534021|FG000|STARTED|Phase 1b: Dose Finding Period||10
2832399|NCT03271047|3534022|FG001|STARTED|Phase 1b: Dose Finding Period||11
2832400|NCT03271047|3534023|FG002|STARTED|Phase 1b: Dose Finding Period||0
2832401|NCT03271047|3534024|FG003|STARTED|Phase 1b: Dose Finding Period||0
2832402|NCT03271047|3534021|FG000|COMPLETED|Phase 1b: Dose Finding Period||0
2832403|NCT03271047|3534022|FG001|COMPLETED|Phase 1b: Dose Finding Period||0
2832404|NCT03271047|3534023|FG002|COMPLETED|Phase 1b: Dose Finding Period||0
2832405|NCT03271047|3534024|FG003|COMPLETED|Phase 1b: Dose Finding Period||0
2832406|NCT03271047|3534021|FG000|NOT COMPLETED|Phase 1b: Dose Finding Period||10
2832407|NCT03271047|3534022|FG001|NOT COMPLETED|Phase 1b: Dose Finding Period||11
2832408|NCT03271047|3534023|FG002|NOT COMPLETED|Phase 1b: Dose Finding Period||0
2832409|NCT03271047|3534024|FG003|NOT COMPLETED|Phase 1b: Dose Finding Period||0
2832410|NCT03271047|3534021|FG000|STARTED|Randomized Phase 2 Period||0
2832411|NCT03271047|3534022|FG001|STARTED|Randomized Phase 2 Period||0
2832412|NCT03271047|3534023|FG002|STARTED|Randomized Phase 2 Period|Participants randomized to Phase 2 of the study.|27
2832413|NCT03271047|3534024|FG003|STARTED|Randomized Phase 2 Period|Participants randomized to Phase 2 of the study.|27
2832414|NCT03271047|3534021|FG000|COMPLETED|Randomized Phase 2 Period||0
2832415|NCT03271047|3534022|FG001|COMPLETED|Randomized Phase 2 Period||0
2832416|NCT03271047|3534023|FG002|COMPLETED|Randomized Phase 2 Period||0
3310329|NCT03039621|4043734|FG000|STARTED|Overall Study||143
3310330|NCT03039621|4043735|FG001|STARTED|Overall Study||144
3310331|NCT03039621|4043734|FG000|COMPLETED|Overall Study||131
3310332|NCT03039621|4043735|FG001|COMPLETED|Overall Study||128
3310333|NCT03039621|4043734|FG000|NOT COMPLETED|Overall Study||12
3310334|NCT03039621|4043735|FG001|NOT COMPLETED|Overall Study||16
3310335|NCT03039686|4043744|FG000|STARTED|Double-blind Period||56
3310336|NCT03039686|4043745|FG001|STARTED|Double-blind Period||55
3310337|NCT03039686|4043746|FG002|STARTED|Double-blind Period||55
3310338|NCT03039686|4043744|FG000|COMPLETED|Double-blind Period||29
3310339|NCT03039686|4043745|FG001|COMPLETED|Double-blind Period||26
3310340|NCT03039686|4043746|FG002|COMPLETED|Double-blind Period||32
3310341|NCT03039686|4043744|FG000|NOT COMPLETED|Double-blind Period||27
3310342|NCT03039686|4043745|FG001|NOT COMPLETED|Double-blind Period||29
3310343|NCT03039686|4043746|FG002|NOT COMPLETED|Double-blind Period||23
3310344|NCT03039686|4043744|FG000|STARTED|Open Label Period|Double-blind (DB) placebo participants switched to RO7239361 (RO) for the open label phase.|0
3310345|NCT03039686|4043745|FG001|STARTED|Open Label Period|14 DB placebo participants switched to the RO Low Dose for the open-label phase.|38
3310346|NCT03039686|4043746|FG002|STARTED|Open Label Period|13 DB placebo participants switched to the RO High Dose for the open-label phase.|42
3310347|NCT03039686|4043744|FG000|Completed DB, Did Not Start OL|Open Label Period||2
3310348|NCT03039686|4043745|FG001|Completed DB, Did Not Start OL|Open Label Period||2
3310349|NCT03039686|4043746|FG002|Completed DB, Did Not Start OL|Open Label Period||3
3310350|NCT03039686|4043744|FG000|COMPLETED|Open Label Period||0
3310351|NCT03039686|4043745|FG001|COMPLETED|Open Label Period||0
3310352|NCT03039686|4043746|FG002|COMPLETED|Open Label Period||0
3310353|NCT03039686|4043744|FG000|NOT COMPLETED|Open Label Period||0
3310354|NCT03039686|4043745|FG001|NOT COMPLETED|Open Label Period||38
3310355|NCT03039686|4043746|FG002|NOT COMPLETED|Open Label Period||42
3310356|NCT03039699|4043766|FG000|STARTED|Overall Study||127
3310357|NCT03039699|4043767|FG001|STARTED|Overall Study||132
3310358|NCT03039699|4043766|FG000|COMPLETED|Overall Study||105
3310359|NCT03039699|4043767|FG001|COMPLETED|Overall Study||97
3310360|NCT03039699|4043766|FG000|NOT COMPLETED|Overall Study||22
3310361|NCT03039699|4043767|FG001|NOT COMPLETED|Overall Study||35
3310362|NCT03039738|4043775|FG000|STARTED|Overall Study||206
3310363|NCT03039738|4043776|FG001|STARTED|Overall Study|This arm did not initiate. The study was terminated following the completion of the telemetry phase.|0
2832417|NCT03271047|3534024|FG003|COMPLETED|Randomized Phase 2 Period||0
2832418|NCT03271047|3534021|FG000|NOT COMPLETED|Randomized Phase 2 Period||0
2832419|NCT03271047|3534022|FG001|NOT COMPLETED|Randomized Phase 2 Period||0
2832420|NCT03271047|3534023|FG002|NOT COMPLETED|Randomized Phase 2 Period||27
2832421|NCT03271047|3534024|FG003|NOT COMPLETED|Randomized Phase 2 Period||27
2832422|NCT03257436|3534036|FG000|STARTED|Overall Study||584
2832423|NCT03257436|3534036|FG000|COMPLETED|Overall Study||489
2832424|NCT03257436|3534036|FG000|NOT COMPLETED|Overall Study||95
2832425|NCT03171480|3534042|FG000|STARTED|Overall Study||89
2832426|NCT03171480|3534043|FG001|STARTED|Overall Study||87
2832427|NCT03171480|3534042|FG000|COMPLETED|Overall Study||89
2832428|NCT03171480|3534043|FG001|COMPLETED|Overall Study||87
2832429|NCT03171480|3534042|FG000|NOT COMPLETED|Overall Study||0
2832430|NCT03171480|3534043|FG001|NOT COMPLETED|Overall Study||0
2832431|NCT03158285|3534053|FG000|STARTED|Placebo-controlled Period: Week 0 - 24||246
2832432|NCT03158285|3534054|FG001|STARTED|Placebo-controlled Period: Week 0 - 24||248
2832433|NCT03158285|3534055|FG002|STARTED|Placebo-controlled Period: Week 0 - 24||245
2832434|NCT03158285|3534053|FG000|Pooled Population: Enthesitis Assessment|Placebo-controlled Period: Week 0 - 24|Pooled population (255) = 77 (CNTO1959PSA3001[NCT03162796]) + 178 (CNTO1959PSA3002)|255
2832435|NCT03158285|3534054|FG001|Pooled Population: Enthesitis Assessment|Placebo-controlled Period: Week 0 - 24|Pooled population (230)= 72 (CNTO1959PSA3001) + 158 (CNTO1959PSA3002)|230
2832436|NCT03158285|3534055|FG002|Pooled Population: Enthesitis Assessment|Placebo-controlled Period: Week 0 - 24|Pooled population (243)= 73 (CNTO1959PSA3001) + 170 (CNTO1959PSA3002)|243
2832437|NCT03158285|3534053|FG000|Pooled Population: Dactylitis Assessment|Placebo-controlled Period: Week 0 - 24|Pooled population (154) = 55 (CNTO1959PSA3001) + 99 (CNTO1959PSA3002)|154
2832438|NCT03158285|3534054|FG001|Pooled Population: Dactylitis Assessment|Placebo-controlled Period: Week 0 - 24|Pooled population (160) = 49 (CNTO1959PSA3001) + 111 (CNTO1959PSA3002)|160
2832439|NCT03158285|3534055|FG002|Pooled Population: Dactylitis Assessment|Placebo-controlled Period: Week 0 - 24|Pooled population (159) = 38 (CNTO1959PSA3001) + 121 (CNTO1959PSA3002)|159
2832440|NCT03158285|3534053|FG000|COMPLETED|Placebo-controlled Period: Week 0 - 24||240
2832441|NCT03158285|3534054|FG001|COMPLETED|Placebo-controlled Period: Week 0 - 24||240
2832442|NCT03158285|3534055|FG002|COMPLETED|Placebo-controlled Period: Week 0 - 24||236
2832443|NCT03158285|3534053|FG000|NOT COMPLETED|Placebo-controlled Period: Week 0 - 24||6
2832444|NCT03158285|3534054|FG001|NOT COMPLETED|Placebo-controlled Period: Week 0 - 24||8
2832445|NCT03158285|3534055|FG002|NOT COMPLETED|Placebo-controlled Period: Week 0 - 24||9
2832446|NCT03158285|3534053|FG000|STARTED|Active Treatment Period: Week 24 - 52|2 participants did not enter the active treatment.|238
2832447|NCT03158285|3534054|FG001|STARTED|Active Treatment Period: Week 24 - 52||240
2832448|NCT03158285|3534055|FG002|STARTED|Active Treatment Period: Week 24 - 52|2 participants did not enter the active treatment.|234
2832449|NCT03158285|3534053|FG000|COMPLETED|Active Treatment Period: Week 24 - 52||228
2832450|NCT03158285|3534054|FG001|COMPLETED|Active Treatment Period: Week 24 - 52||234
2832451|NCT03158285|3534055|FG002|COMPLETED|Active Treatment Period: Week 24 - 52||227
2832452|NCT03158285|3534053|FG000|NOT COMPLETED|Active Treatment Period: Week 24 - 52||10
2832453|NCT03158285|3534054|FG001|NOT COMPLETED|Active Treatment Period: Week 24 - 52||6
2832454|NCT03158285|3534055|FG002|NOT COMPLETED|Active Treatment Period: Week 24 - 52||7
2832455|NCT03158285|3534053|FG000|STARTED|Active Treatment Period: Week 52-100||228
2832456|NCT03158285|3534054|FG001|STARTED|Active Treatment Period: Week 52-100|2 participants did not enter the active treatment.|232
2832457|NCT03158285|3534055|FG002|STARTED|Active Treatment Period: Week 52-100||227
2832458|NCT03158285|3534053|FG000|COMPLETED|Active Treatment Period: Week 52-100||210
2832459|NCT03158285|3534054|FG001|COMPLETED|Active Treatment Period: Week 52-100||223
2832460|NCT03158285|3534055|FG002|COMPLETED|Active Treatment Period: Week 52-100||219
2832461|NCT03158285|3534053|FG000|NOT COMPLETED|Active Treatment Period: Week 52-100||18
2832462|NCT03158285|3534054|FG001|NOT COMPLETED|Active Treatment Period: Week 52-100||9
2832463|NCT03158285|3534055|FG002|NOT COMPLETED|Active Treatment Period: Week 52-100||8
2832464|NCT03051217|3534071|FG000|STARTED|Initial Period (Week 0 to Week 16)||26
2832465|NCT03051217|3534072|FG001|STARTED|Initial Period (Week 0 to Week 16)||48
2832466|NCT03051217|3534073|FG002|STARTED|Initial Period (Week 0 to Week 16)||53
2832467|NCT03051217|3534074|FG003|STARTED|Initial Period (Week 0 to Week 16)||0
2832468|NCT03051217|3534075|FG004|STARTED|Initial Period (Week 0 to Week 16)||0
2832469|NCT03051217|3534076|FG005|STARTED|Initial Period (Week 0 to Week 16)||0
2832470|NCT03051217|3534077|FG006|STARTED|Initial Period (Week 0 to Week 16)||0
2832471|NCT03051217|3534071|FG000|COMPLETED|Initial Period (Week 0 to Week 16)||23
3166858|NCT01905423|3893952|FG000|Year 3 Follow-up|Overall Study||905
3166859|NCT01905423|3893953|FG001|Year 3 Follow-up|Overall Study||871
3166860|NCT01905423|3893954|FG002|Year 3 Follow-up|Overall Study||1028
3166861|NCT01905423|3893955|FG003|Year 3 Follow-up|Overall Study||0
3166862|NCT01905423|3893956|FG004|Year 3 Follow-up|Overall Study||0
3166863|NCT01905423|3893952|FG000|COMPLETED|Overall Study||4456
3166864|NCT01905423|3893953|FG001|COMPLETED|Overall Study||3297
3166865|NCT01905423|3893954|FG002|COMPLETED|Overall Study||4111
3166866|NCT01905423|3893955|FG003|COMPLETED|Overall Study||2757
3166867|NCT01905423|3893956|FG004|COMPLETED|Overall Study||2487
3166868|NCT01905423|3893952|FG000|NOT COMPLETED|Overall Study||0
3166869|NCT01905423|3893953|FG001|NOT COMPLETED|Overall Study||0
3166870|NCT01905423|3893954|FG002|NOT COMPLETED|Overall Study||0
3166871|NCT01905423|3893955|FG003|NOT COMPLETED|Overall Study||0
3166872|NCT01905423|3893956|FG004|NOT COMPLETED|Overall Study||0
3166873|NCT01905540|3893972|FG000|STARTED|Period 1||7
3166874|NCT01905540|3893973|FG001|STARTED|Period 1||7
2832472|NCT03051217|3534072|FG001|COMPLETED|Initial Period (Week 0 to Week 16)||46
2832473|NCT03051217|3534073|FG002|COMPLETED|Initial Period (Week 0 to Week 16)||51
2832474|NCT03051217|3534074|FG003|COMPLETED|Initial Period (Week 0 to Week 16)||0
2832475|NCT03051217|3534075|FG004|COMPLETED|Initial Period (Week 0 to Week 16)||0
2832476|NCT03051217|3534076|FG005|COMPLETED|Initial Period (Week 0 to Week 16)||0
2832477|NCT03051217|3534077|FG006|COMPLETED|Initial Period (Week 0 to Week 16)||0
2832478|NCT03051217|3534071|FG000|NOT COMPLETED|Initial Period (Week 0 to Week 16)||3
2832479|NCT03051217|3534072|FG001|NOT COMPLETED|Initial Period (Week 0 to Week 16)||2
2832480|NCT03051217|3534073|FG002|NOT COMPLETED|Initial Period (Week 0 to Week 16)||2
2832481|NCT03051217|3534074|FG003|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
2832482|NCT03051217|3534075|FG004|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
2832483|NCT03051217|3534076|FG005|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
2832484|NCT03051217|3534077|FG006|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
2832485|NCT03051217|3534071|FG000|STARTED|Maintenance Period (Week 16 to Week 52)||0
2832486|NCT03051217|3534072|FG001|STARTED|Maintenance Period (Week 16 to Week 52)||0
2832487|NCT03051217|3534073|FG002|STARTED|Maintenance Period (Week 16 to Week 52)||0
2832488|NCT03051217|3534074|FG003|STARTED|Maintenance Period (Week 16 to Week 52)||23
2832489|NCT03051217|3534075|FG004|STARTED|Maintenance Period (Week 16 to Week 52)||51
2832490|NCT03051217|3534076|FG005|STARTED|Maintenance Period (Week 16 to Week 52)||26
2832491|NCT03051217|3534077|FG006|STARTED|Maintenance Period (Week 16 to Week 52)||20
2832492|NCT03051217|3534071|FG000|Received Escape Treatment|Maintenance Period (Week 16 to Week 52)||0
2832493|NCT03051217|3534072|FG001|Received Escape Treatment|Maintenance Period (Week 16 to Week 52)||0
2832494|NCT03051217|3534073|FG002|Received Escape Treatment|Maintenance Period (Week 16 to Week 52)||0
2832495|NCT03051217|3534074|FG003|Received Escape Treatment|Maintenance Period (Week 16 to Week 52)||21
2832496|NCT03051217|3534075|FG004|Received Escape Treatment|Maintenance Period (Week 16 to Week 52)||3
2832497|NCT03051217|3534076|FG005|Received Escape Treatment|Maintenance Period (Week 16 to Week 52)||7
2832498|NCT03051217|3534077|FG006|Received Escape Treatment|Maintenance Period (Week 16 to Week 52)||3
2832499|NCT03051217|3534071|FG000|COMPLETED|Maintenance Period (Week 16 to Week 52)||0
2832500|NCT03051217|3534072|FG001|COMPLETED|Maintenance Period (Week 16 to Week 52)||0
2832501|NCT03051217|3534073|FG002|COMPLETED|Maintenance Period (Week 16 to Week 52)||0
2832502|NCT03051217|3534074|FG003|COMPLETED|Maintenance Period (Week 16 to Week 52)||20
2832503|NCT03051217|3534075|FG004|COMPLETED|Maintenance Period (Week 16 to Week 52)||48
2832504|NCT03051217|3534076|FG005|COMPLETED|Maintenance Period (Week 16 to Week 52)||24
2832505|NCT03051217|3534077|FG006|COMPLETED|Maintenance Period (Week 16 to Week 52)||19
2832506|NCT03051217|3534071|FG000|NOT COMPLETED|Maintenance Period (Week 16 to Week 52)||0
2832507|NCT03051217|3534072|FG001|NOT COMPLETED|Maintenance Period (Week 16 to Week 52)||0
2832508|NCT03051217|3534073|FG002|NOT COMPLETED|Maintenance Period (Week 16 to Week 52)||0
2832509|NCT03051217|3534074|FG003|NOT COMPLETED|Maintenance Period (Week 16 to Week 52)||3
3166875|NCT01905540|3893974|FG002|STARTED|Period 1||7
3166876|NCT01905540|3893975|FG003|STARTED|Period 1||7
3166877|NCT01905540|3893972|FG000|COMPLETED|Period 1||7
3166878|NCT01905540|3893973|FG001|COMPLETED|Period 1||7
3166879|NCT01905540|3893974|FG002|COMPLETED|Period 1||7
3166880|NCT01905540|3893975|FG003|COMPLETED|Period 1||7
3166881|NCT01905540|3893972|FG000|NOT COMPLETED|Period 1||0
3310364|NCT03039738|4043775|FG000|COMPLETED|Overall Study||152
3310365|NCT03039738|4043776|FG001|COMPLETED|Overall Study||0
3310366|NCT03039738|4043775|FG000|NOT COMPLETED|Overall Study||54
3310367|NCT03039738|4043776|FG001|NOT COMPLETED|Overall Study||0
3310368|NCT03040011|4043785|FG000|STARTED|Received Randomized Study Intervention||25
3310369|NCT03040011|4043786|FG001|STARTED|Received Randomized Study Intervention||25
3310370|NCT03040011|4043787|FG002|STARTED|Received Randomized Study Intervention||25
3310371|NCT03040011|4043785|FG000|COMPLETED|Received Randomized Study Intervention||25
3310372|NCT03040011|4043786|FG001|COMPLETED|Received Randomized Study Intervention||25
3310373|NCT03040011|4043787|FG002|COMPLETED|Received Randomized Study Intervention||25
3310374|NCT03040011|4043785|FG000|NOT COMPLETED|Received Randomized Study Intervention||0
3310375|NCT03040011|4043786|FG001|NOT COMPLETED|Received Randomized Study Intervention||0
3310376|NCT03040011|4043787|FG002|NOT COMPLETED|Received Randomized Study Intervention||0
3310377|NCT03040011|4043785|FG000|STARTED|Primary Outcome Follow Up||25
3310378|NCT03040011|4043786|FG001|STARTED|Primary Outcome Follow Up||25
3310379|NCT03040011|4043787|FG002|STARTED|Primary Outcome Follow Up||25
3310380|NCT03040011|4043785|FG000|COMPLETED|Primary Outcome Follow Up|Postoperative day one pain score not available for four patients|21
3310381|NCT03040011|4043786|FG001|COMPLETED|Primary Outcome Follow Up|Postoperative day one pain score not available for one patient|24
3310382|NCT03040011|4043787|FG002|COMPLETED|Primary Outcome Follow Up|Postoperative day one pain score not available for one patient|24
3310383|NCT03040011|4043785|FG000|NOT COMPLETED|Primary Outcome Follow Up||4
3310384|NCT03040011|4043786|FG001|NOT COMPLETED|Primary Outcome Follow Up||1
3310385|NCT03040011|4043787|FG002|NOT COMPLETED|Primary Outcome Follow Up||1
3310386|NCT03040024|4043798|FG000|STARTED|Overall Study||21
3310387|NCT03040024|4043799|FG001|STARTED|Overall Study||26
3310388|NCT03040024|4043800|FG002|STARTED|Overall Study||24
3310389|NCT03040024|4043798|FG000|COMPLETED|Overall Study||21
3310390|NCT03040024|4043799|FG001|COMPLETED|Overall Study||24
3310391|NCT03040024|4043800|FG002|COMPLETED|Overall Study||23
3310392|NCT03040024|4043798|FG000|NOT COMPLETED|Overall Study||0
3310393|NCT03040024|4043799|FG001|NOT COMPLETED|Overall Study||2
3310394|NCT03040024|4043800|FG002|NOT COMPLETED|Overall Study||1
3310395|NCT03040154|4043810|FG000|STARTED|Overall Study||110
2832510|NCT03051217|3534075|FG004|NOT COMPLETED|Maintenance Period (Week 16 to Week 52)||3
2832511|NCT03051217|3534076|FG005|NOT COMPLETED|Maintenance Period (Week 16 to Week 52)||2
2832512|NCT03051217|3534077|FG006|NOT COMPLETED|Maintenance Period (Week 16 to Week 52)||1
2832513|NCT03025542|3534093|FG000|STARTED|Overall Study||32
2832514|NCT03025542|3534094|FG001|STARTED|Overall Study||17
2832515|NCT03025542|3534093|FG000|COMPLETED|Overall Study||30
2832516|NCT03025542|3534094|FG001|COMPLETED|Overall Study||15
2832517|NCT03025542|3534093|FG000|NOT COMPLETED|Overall Study||2
2832518|NCT03025542|3534094|FG001|NOT COMPLETED|Overall Study||2
2832519|NCT02958319|3534106|FG000|STARTED|Overall Study||145
2832520|NCT02958319|3534107|FG001|STARTED|Overall Study||133
2832521|NCT02958319|3534106|FG000|COMPLETED|Overall Study||145
2832522|NCT02958319|3534107|FG001|COMPLETED|Overall Study||133
2832523|NCT02958319|3534106|FG000|NOT COMPLETED|Overall Study||0
2832524|NCT02958319|3534107|FG001|NOT COMPLETED|Overall Study||0
2832525|NCT02929069|3534116|FG000|STARTED|Overall Study||100
2832526|NCT02929069|3534117|FG001|STARTED|Overall Study||102
2832527|NCT02929069|3534118|FG002|STARTED|Overall Study||52
2832528|NCT02929069|3534116|FG000|Completed 4 Month Follow Up|Overall Study||83
2832529|NCT02929069|3534117|FG001|Completed 4 Month Follow Up|Overall Study||76
2832530|NCT02929069|3534118|FG002|Completed 4 Month Follow Up|Overall Study||43
2832531|NCT02929069|3534116|FG000|Completed 8 Month Follow Up|Overall Study||82
2832532|NCT02929069|3534117|FG001|Completed 8 Month Follow Up|Overall Study||77
2832533|NCT02929069|3534118|FG002|Completed 8 Month Follow Up|Overall Study||36
2832534|NCT02929069|3534116|FG000|Assessed STI 12 Month|Overall Study||74
2832535|NCT02929069|3534117|FG001|Assessed STI 12 Month|Overall Study||75
2832536|NCT02929069|3534118|FG002|Assessed STI 12 Month|Overall Study||38
2832537|NCT02929069|3534116|FG000|Assessed HIV 12 Month|Overall Study||76
2832538|NCT02929069|3534117|FG001|Assessed HIV 12 Month|Overall Study||76
2832539|NCT02929069|3534118|FG002|Assessed HIV 12 Month|Overall Study||39
2832540|NCT02929069|3534116|FG000|Complete 12 Month Follow Up|Overall Study||81
2832541|NCT02929069|3534117|FG001|Complete 12 Month Follow Up|Overall Study||81
2832542|NCT02929069|3534118|FG002|Complete 12 Month Follow Up|Overall Study||42
2832543|NCT02929069|3534116|FG000|COMPLETED|Overall Study||81
2832544|NCT02929069|3534117|FG001|COMPLETED|Overall Study||81
2832545|NCT02929069|3534118|FG002|COMPLETED|Overall Study||42
2832546|NCT02929069|3534116|FG000|NOT COMPLETED|Overall Study||19
2832547|NCT02929069|3534117|FG001|NOT COMPLETED|Overall Study||21
2832548|NCT02929069|3534118|FG002|NOT COMPLETED|Overall Study||10
2832549|NCT02889809|3534130|FG000|STARTED|Overall Study||239
2832550|NCT02889809|3534131|FG001|STARTED|Overall Study||238
2832551|NCT02889809|3534130|FG000|COMPLETED|Overall Study||196
2832552|NCT02889809|3534131|FG001|COMPLETED|Overall Study||205
2832553|NCT02889809|3534130|FG000|NOT COMPLETED|Overall Study||43
2832554|NCT02889809|3534131|FG001|NOT COMPLETED|Overall Study||33
2832555|NCT02849587|3534140|FG000|STARTED|Overall Study||65
2832556|NCT02849587|3534141|FG001|STARTED|Overall Study||70
2832557|NCT02849587|3534142|FG002|STARTED|Overall Study||64
2832558|NCT02849587|3534140|FG000|COMPLETED|Overall Study||63
2832559|NCT02849587|3534141|FG001|COMPLETED|Overall Study||66
2832560|NCT02849587|3534142|FG002|COMPLETED|Overall Study||62
2832561|NCT02849587|3534140|FG000|NOT COMPLETED|Overall Study||2
2832562|NCT02849587|3534141|FG001|NOT COMPLETED|Overall Study||4
2832563|NCT02849587|3534142|FG002|NOT COMPLETED|Overall Study||2
2832564|NCT02815540|3534154|FG000|STARTED|Overall Study||2
2832565|NCT02815540|3534154|FG000|COMPLETED|Overall Study||0
2832566|NCT02815540|3534154|FG000|NOT COMPLETED|Overall Study||2
2832567|NCT02814708|3534165|FG000|STARTED|Overall Study||20
2832568|NCT02814708|3534166|FG001|STARTED|Overall Study||20
2832569|NCT02814708|3534167|FG002|STARTED|Overall Study||20
2832570|NCT02814708|3534168|FG003|STARTED|Overall Study||20
2832571|NCT02814708|3534169|FG004|STARTED|Overall Study||20
2832572|NCT02814708|3534170|FG005|STARTED|Overall Study||20
2832573|NCT02814708|3534171|FG006|STARTED|Overall Study||20
2832574|NCT02814708|3534165|FG000|COMPLETED|Overall Study||18
2832575|NCT02814708|3534166|FG001|COMPLETED|Overall Study||17
2832576|NCT02814708|3534167|FG002|COMPLETED|Overall Study||19
2832577|NCT02814708|3534168|FG003|COMPLETED|Overall Study||20
2832578|NCT02814708|3534169|FG004|COMPLETED|Overall Study||17
2832579|NCT02814708|3534170|FG005|COMPLETED|Overall Study||16
2832580|NCT02814708|3534171|FG006|COMPLETED|Overall Study||19
2832581|NCT02814708|3534165|FG000|NOT COMPLETED|Overall Study||2
2832582|NCT02814708|3534166|FG001|NOT COMPLETED|Overall Study||3
2832583|NCT02814708|3534167|FG002|NOT COMPLETED|Overall Study||1
2832584|NCT02814708|3534168|FG003|NOT COMPLETED|Overall Study||0
2832585|NCT02814708|3534169|FG004|NOT COMPLETED|Overall Study||3
2832586|NCT02814708|3534170|FG005|NOT COMPLETED|Overall Study||4
2832587|NCT02814708|3534171|FG006|NOT COMPLETED|Overall Study||1
2832588|NCT02781727|3534189|FG000|STARTED|Pre-dosing Period|106 subjects were randomized to the lonapegsomatropin arm, but 1 subject withdrew consent before receiving the first dose of study drug.|106
2832589|NCT02781727|3534190|FG001|STARTED|Pre-dosing Period||56
2832590|NCT02781727|3534189|FG000|COMPLETED|Pre-dosing Period||105
2832591|NCT02781727|3534190|FG001|COMPLETED|Pre-dosing Period||56
2832592|NCT02781727|3534189|FG000|NOT COMPLETED|Pre-dosing Period||1
2832593|NCT02781727|3534190|FG001|NOT COMPLETED|Pre-dosing Period||0
2832594|NCT02781727|3534189|FG000|STARTED|Treatment Period||105
2832595|NCT02781727|3534190|FG001|STARTED|Treatment Period||56
2832596|NCT02781727|3534189|FG000|COMPLETED|Treatment Period||104
2832597|NCT02781727|3534190|FG001|COMPLETED|Treatment Period||55
2832598|NCT02781727|3534189|FG000|NOT COMPLETED|Treatment Period||1
2832599|NCT02781727|3534190|FG001|NOT COMPLETED|Treatment Period||1
2832600|NCT02778204|3534200|FG000|STARTED|Overall Study||8
2832601|NCT02778204|3534201|FG001|STARTED|Overall Study||7
2832602|NCT02778204|3534202|FG002|STARTED|Overall Study||16
2832603|NCT02778204|3534203|FG003|STARTED|Overall Study||16
2832604|NCT02778204|3534200|FG000|COMPLETED|Overall Study||6
2832605|NCT02778204|3534201|FG001|COMPLETED|Overall Study||7
2832606|NCT02778204|3534202|FG002|COMPLETED|Overall Study||12
2832607|NCT02778204|3534203|FG003|COMPLETED|Overall Study||12
2832608|NCT02778204|3534200|FG000|NOT COMPLETED|Overall Study||2
2832609|NCT02778204|3534201|FG001|NOT COMPLETED|Overall Study||0
2832610|NCT02778204|3534202|FG002|NOT COMPLETED|Overall Study||4
2832611|NCT02778204|3534203|FG003|NOT COMPLETED|Overall Study||4
2832612|NCT02743364|3534217|FG000|STARTED|Overall Study||6
2832613|NCT02743364|3534218|FG001|STARTED|Overall Study||2
2832614|NCT02743364|3534217|FG000|COMPLETED|Overall Study||6
2832615|NCT02743364|3534218|FG001|COMPLETED|Overall Study||2
2832616|NCT02743364|3534217|FG000|NOT COMPLETED|Overall Study||0
2832617|NCT02743364|3534218|FG001|NOT COMPLETED|Overall Study||0
2914232|NCT00502307|3624246|FG002|NOT COMPLETED|Maintenance Period||0
2914233|NCT00502320|3624265|FG000|STARTED|Overall Study||25
2914234|NCT00502320|3624266|FG001|STARTED|Overall Study||25
2914235|NCT00502320|3624265|FG000|Screening Visit|Overall Study||25
2914236|NCT00502320|3624266|FG001|Screening Visit|Overall Study|Participant signed informed consent but was a screen failure because she was nursing at the time.|24
2914237|NCT00502320|3624265|FG000|COMPLETED|Overall Study||19
2914238|NCT00502320|3624266|FG001|COMPLETED|Overall Study||18
2914239|NCT00502320|3624265|FG000|NOT COMPLETED|Overall Study||6
2914240|NCT00502320|3624266|FG001|NOT COMPLETED|Overall Study||7
2914241|NCT00502593|3624284|FG000|STARTED|Overall Study||51
2914242|NCT00502593|3624285|FG001|STARTED|Overall Study||18
2914243|NCT00502593|3624286|FG002|STARTED|Overall Study||51
2914244|NCT00502593|3624287|FG003|STARTED|Overall Study||18
2914245|NCT00502593|3624288|FG004|STARTED|Overall Study||51
2914246|NCT00502593|3624289|FG005|STARTED|Overall Study||17
2914247|NCT00502593|3624290|FG006|STARTED|Overall Study||49
2914248|NCT00502593|3624291|FG007|STARTED|Overall Study||17
2914249|NCT00502593|3624292|FG008|STARTED|Overall Study||49
2914250|NCT00502593|3624293|FG009|STARTED|Overall Study||17
2914251|NCT00502593|3624294|FG010|STARTED|Overall Study||49
2914252|NCT00502593|3624295|FG011|STARTED|Overall Study||18
2914253|NCT00502593|3624284|FG000|COMPLETED|Overall Study||48
2914254|NCT00502593|3624285|FG001|COMPLETED|Overall Study||16
2914255|NCT00502593|3624286|FG002|COMPLETED|Overall Study||41
2914256|NCT00502593|3624287|FG003|COMPLETED|Overall Study||14
2914257|NCT00502593|3624288|FG004|COMPLETED|Overall Study||47
2914258|NCT00502593|3624289|FG005|COMPLETED|Overall Study||17
2914259|NCT00502593|3624290|FG006|COMPLETED|Overall Study||44
2914260|NCT00502593|3624291|FG007|COMPLETED|Overall Study||17
2914261|NCT00502593|3624292|FG008|COMPLETED|Overall Study||43
2914262|NCT00502593|3624293|FG009|COMPLETED|Overall Study||17
2914263|NCT00502593|3624294|FG010|COMPLETED|Overall Study||47
2914264|NCT00502593|3624295|FG011|COMPLETED|Overall Study||18
2914265|NCT00502593|3624284|FG000|NOT COMPLETED|Overall Study||3
2914266|NCT00502593|3624285|FG001|NOT COMPLETED|Overall Study||2
2914267|NCT00502593|3624286|FG002|NOT COMPLETED|Overall Study||10
2914268|NCT00502593|3624287|FG003|NOT COMPLETED|Overall Study||4
2914269|NCT00502593|3624288|FG004|NOT COMPLETED|Overall Study||4
2914270|NCT00502593|3624289|FG005|NOT COMPLETED|Overall Study||0
2914271|NCT00502593|3624290|FG006|NOT COMPLETED|Overall Study||5
2914272|NCT00502593|3624291|FG007|NOT COMPLETED|Overall Study||0
2914273|NCT00502593|3624292|FG008|NOT COMPLETED|Overall Study||6
2914274|NCT00502593|3624293|FG009|NOT COMPLETED|Overall Study||0
2914275|NCT00502593|3624294|FG010|NOT COMPLETED|Overall Study||2
2914276|NCT00502593|3624295|FG011|NOT COMPLETED|Overall Study||0
2914277|NCT00502671|3624344|FG000|STARTED|Overall Study||228
2914278|NCT00502671|3624344|FG000|COMPLETED|Overall Study||151
2914279|NCT00502671|3624344|FG000|NOT COMPLETED|Overall Study||77
2914280|NCT00502697|3624350|FG000|STARTED|Overall Study||122
2914281|NCT00502697|3624351|FG001|STARTED|Overall Study||114
2914282|NCT00502697|3624350|FG000|COMPLETED|Overall Study||109
2914283|NCT00502697|3624351|FG001|COMPLETED|Overall Study||102
2914284|NCT00502697|3624350|FG000|NOT COMPLETED|Overall Study||13
2914285|NCT00502697|3624351|FG001|NOT COMPLETED|Overall Study||12
2914286|NCT00502775|3624360|FG000|STARTED|Overall Study||229
2914287|NCT00502775|3624361|FG001|STARTED|Overall Study||224
2914288|NCT00502775|3624362|FG002|STARTED|Overall Study||227
2914289|NCT00502775|3624360|FG000|COMPLETED|Overall Study||219
2914290|NCT00502775|3624361|FG001|COMPLETED|Overall Study||209
2914291|NCT00502775|3624362|FG002|COMPLETED|Overall Study||214
2914292|NCT00502775|3624360|FG000|NOT COMPLETED|Overall Study||10
2914293|NCT00502775|3624361|FG001|NOT COMPLETED|Overall Study||15
2914294|NCT00502775|3624362|FG002|NOT COMPLETED|Overall Study||13
2914295|NCT00502801|3624370|FG000|STARTED|Treatment Period||183
2914296|NCT00502801|3624370|FG000|COMPLETED|Treatment Period||129
2914297|NCT00502801|3624370|FG000|NOT COMPLETED|Treatment Period||54
2914298|NCT00502801|3624370|FG000|STARTED|End of Therapy to Test of Cure||129
2914299|NCT00502801|3624370|FG000|COMPLETED|End of Therapy to Test of Cure||121
2914300|NCT00502801|3624370|FG000|NOT COMPLETED|End of Therapy to Test of Cure||8
2914301|NCT00502840|3624374|FG000|STARTED|Overall Study||193
2914302|NCT00502840|3624374|FG000|COMPLETED|Overall Study||93
2914303|NCT00502840|3624374|FG000|NOT COMPLETED|Overall Study||100
2832618|NCT02496611|3534226|FG000|STARTED|Overall Study||33
2832619|NCT02496611|3534227|FG001|STARTED|Overall Study||33
2832620|NCT02496611|3534226|FG000|COMPLETED|Overall Study||26
2832621|NCT02496611|3534227|FG001|COMPLETED|Overall Study||30
2832622|NCT02496611|3534226|FG000|NOT COMPLETED|Overall Study||7
2832623|NCT02496611|3534227|FG001|NOT COMPLETED|Overall Study||3
2832624|NCT02245308|3534236|FG000|STARTED|Overall Study||63
2832625|NCT02245308|3534237|FG001|STARTED|Overall Study||64
2832626|NCT02245308|3534236|FG000|COMPLETED|Overall Study|Using intent-to-treat analyses, i.e., missing=smoking|63
2832627|NCT02245308|3534237|FG001|COMPLETED|Overall Study|Using intent-to-treat analyses, i.e., missing=smoking|64
2832628|NCT02245308|3534236|FG000|NOT COMPLETED|Overall Study||0
2832629|NCT02245308|3534237|FG001|NOT COMPLETED|Overall Study||0
2832630|NCT02227199|3534246|FG000|STARTED|Overall Study||3
2832631|NCT02227199|3534247|FG001|STARTED|Overall Study||3
2832632|NCT02227199|3534248|FG002|STARTED|Overall Study||39
2832633|NCT02227199|3534246|FG000|COMPLETED|Overall Study||3
2832634|NCT02227199|3534247|FG001|COMPLETED|Overall Study||3
2832635|NCT02227199|3534248|FG002|COMPLETED|Overall Study||35
2832636|NCT02227199|3534246|FG000|NOT COMPLETED|Overall Study||0
2832637|NCT02227199|3534247|FG001|NOT COMPLETED|Overall Study||0
2832638|NCT02227199|3534248|FG002|NOT COMPLETED|Overall Study||4
2832639|NCT02198794|3534260|FG000|STARTED|Part A: Open-Label (158 Weeks)||337
2832640|NCT02198794|3534261|FG001|STARTED|Part A: Open-Label (158 Weeks)||0
2832641|NCT02198794|3534262|FG002|STARTED|Part A: Open-Label (158 Weeks)||0
2832642|NCT02198794|3534263|FG003|STARTED|Part A: Open-Label (158 Weeks)||0
2832643|NCT02198794|3534260|FG000|Received at Least 1 Dose of Study Drug|Part A: Open-Label (158 Weeks)||337
2832644|NCT02198794|3534261|FG001|Received at Least 1 Dose of Study Drug|Part A: Open-Label (158 Weeks)||0
2832645|NCT02198794|3534262|FG002|Received at Least 1 Dose of Study Drug|Part A: Open-Label (158 Weeks)||0
2832646|NCT02198794|3534263|FG003|Received at Least 1 Dose of Study Drug|Part A: Open-Label (158 Weeks)||0
2832647|NCT02198794|3534260|FG000|Intent-to-Treat (ITT) Population|Part A: Open-Label (158 Weeks)||337
2832648|NCT02198794|3534261|FG001|Intent-to-Treat (ITT) Population|Part A: Open-Label (158 Weeks)||0
2832649|NCT02198794|3534262|FG002|Intent-to-Treat (ITT) Population|Part A: Open-Label (158 Weeks)||0
2832650|NCT02198794|3534263|FG003|Intent-to-Treat (ITT) Population|Part A: Open-Label (158 Weeks)||0
2832651|NCT02198794|3534260|FG000|Participants Who Participated in Part A But Not in Part B|Part A: Open-Label (158 Weeks)||195
2832652|NCT02198794|3534261|FG001|Participants Who Participated in Part A But Not in Part B|Part A: Open-Label (158 Weeks)||0
2832653|NCT02198794|3534262|FG002|Participants Who Participated in Part A But Not in Part B|Part A: Open-Label (158 Weeks)||0
2832654|NCT02198794|3534263|FG003|Participants Who Participated in Part A But Not in Part B|Part A: Open-Label (158 Weeks)||0
2832655|NCT02198794|3534260|FG000|Participants Who Agreed to Continue in Part B|Part A: Open-Label (158 Weeks)||142
2832656|NCT02198794|3534261|FG001|Participants Who Agreed to Continue in Part B|Part A: Open-Label (158 Weeks)||0
2832657|NCT02198794|3534262|FG002|Participants Who Agreed to Continue in Part B|Part A: Open-Label (158 Weeks)||0
2832658|NCT02198794|3534263|FG003|Participants Who Agreed to Continue in Part B|Part A: Open-Label (158 Weeks)||0
2832659|NCT02198794|3534260|FG000|COMPLETED|Part A: Open-Label (158 Weeks)||32
2832660|NCT02198794|3534261|FG001|COMPLETED|Part A: Open-Label (158 Weeks)||0
2832661|NCT02198794|3534262|FG002|COMPLETED|Part A: Open-Label (158 Weeks)||0
2832662|NCT02198794|3534263|FG003|COMPLETED|Part A: Open-Label (158 Weeks)||0
2832663|NCT02198794|3534260|FG000|NOT COMPLETED|Part A: Open-Label (158 Weeks)||305
2832664|NCT02198794|3534261|FG001|NOT COMPLETED|Part A: Open-Label (158 Weeks)||0
2832665|NCT02198794|3534262|FG002|NOT COMPLETED|Part A: Open-Label (158 Weeks)||0
2832666|NCT02198794|3534263|FG003|NOT COMPLETED|Part A: Open-Label (158 Weeks)||0
2832667|NCT02198794|3534260|FG000|STARTED|Part B: Randomized (13 Weeks)||0
2832668|NCT02198794|3534261|FG001|STARTED|Part B: Randomized (13 Weeks)|Participants of Part A who agreed to participate in Part B|71
2832669|NCT02198794|3534262|FG002|STARTED|Part B: Randomized (13 Weeks)|Participants of Part A who agreed to participate in Part B|71
2832670|NCT02198794|3534263|FG003|STARTED|Part B: Randomized (13 Weeks)||0
2832671|NCT02198794|3534260|FG000|Randomized Withdrawal mITT Population|Part B: Randomized (13 Weeks)||0
2832672|NCT02198794|3534261|FG001|Randomized Withdrawal mITT Population|Part B: Randomized (13 Weeks)||63
2832673|NCT02198794|3534262|FG002|Randomized Withdrawal mITT Population|Part B: Randomized (13 Weeks)||65
2832674|NCT02198794|3534263|FG003|Randomized Withdrawal mITT Population|Part B: Randomized (13 Weeks)||0
2832675|NCT02198794|3534260|FG000|COMPLETED|Part B: Randomized (13 Weeks)||0
2832676|NCT02198794|3534261|FG001|COMPLETED|Part B: Randomized (13 Weeks)||66
2832677|NCT02198794|3534262|FG002|COMPLETED|Part B: Randomized (13 Weeks)||68
2832678|NCT02198794|3534263|FG003|COMPLETED|Part B: Randomized (13 Weeks)||0
2832679|NCT02198794|3534260|FG000|NOT COMPLETED|Part B: Randomized (13 Weeks)||0
2832680|NCT02198794|3534261|FG001|NOT COMPLETED|Part B: Randomized (13 Weeks)||5
2832681|NCT02198794|3534262|FG002|NOT COMPLETED|Part B: Randomized (13 Weeks)||3
2832682|NCT02198794|3534263|FG003|NOT COMPLETED|Part B: Randomized (13 Weeks)||0
2832683|NCT02198794|3534260|FG000|STARTED|Part C: Safety Assessment (52 Weeks)||0
2832684|NCT02198794|3534261|FG001|STARTED|Part C: Safety Assessment (52 Weeks)||0
2832685|NCT02198794|3534262|FG002|STARTED|Part C: Safety Assessment (52 Weeks)||0
2832686|NCT02198794|3534263|FG003|STARTED|Part C: Safety Assessment (52 Weeks)||80
2832687|NCT02198794|3534260|FG000|COMPLETED|Part C: Safety Assessment (52 Weeks)||0
2832688|NCT02198794|3534261|FG001|COMPLETED|Part C: Safety Assessment (52 Weeks)||0
2832689|NCT02198794|3534262|FG002|COMPLETED|Part C: Safety Assessment (52 Weeks)||0
2832690|NCT02198794|3534263|FG003|COMPLETED|Part C: Safety Assessment (52 Weeks)||73
2832691|NCT02198794|3534260|FG000|NOT COMPLETED|Part C: Safety Assessment (52 Weeks)||0
2832692|NCT02198794|3534261|FG001|NOT COMPLETED|Part C: Safety Assessment (52 Weeks)||0
2832693|NCT02198794|3534262|FG002|NOT COMPLETED|Part C: Safety Assessment (52 Weeks)||0
2832694|NCT02198794|3534263|FG003|NOT COMPLETED|Part C: Safety Assessment (52 Weeks)||7
2832695|NCT02177695|3534274|FG000|STARTED|ITT Analysis||120
2832696|NCT02177695|3534275|FG001|STARTED|ITT Analysis||117
2832697|NCT02177695|3534274|FG000|COMPLETED|ITT Analysis||115
2832698|NCT02177695|3534275|FG001|COMPLETED|ITT Analysis||112
2832699|NCT02177695|3534274|FG000|NOT COMPLETED|ITT Analysis||5
2832700|NCT02177695|3534275|FG001|NOT COMPLETED|ITT Analysis||5
2832701|NCT02177695|3534274|FG000|STARTED|Primary COXEN Analysis||115
2832702|NCT02177695|3534275|FG001|STARTED|Primary COXEN Analysis||112
2832703|NCT02177695|3534274|FG000|Participants Excluded From Primary COXEN Analysis|Primary COXEN Analysis||33
2832704|NCT02177695|3534275|FG001|Participants Excluded From Primary COXEN Analysis|Primary COXEN Analysis||27
2832705|NCT02177695|3534274|FG000|COMPLETED|Primary COXEN Analysis||82
2832706|NCT02177695|3534275|FG001|COMPLETED|Primary COXEN Analysis||85
2832707|NCT02177695|3534274|FG000|NOT COMPLETED|Primary COXEN Analysis||33
2832708|NCT02177695|3534275|FG001|NOT COMPLETED|Primary COXEN Analysis||27
2832709|NCT02145403|3534287|FG000|STARTED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||3
3166882|NCT01905540|3893973|FG001|NOT COMPLETED|Period 1||0
3166883|NCT01905540|3893974|FG002|NOT COMPLETED|Period 1||0
3166884|NCT01905540|3893975|FG003|NOT COMPLETED|Period 1||0
3166885|NCT01905540|3893972|FG000|STARTED|Period 2||7
3166886|NCT01905540|3893973|FG001|STARTED|Period 2||7
3166887|NCT01905540|3893974|FG002|STARTED|Period 2||7
3166888|NCT01905540|3893975|FG003|STARTED|Period 2||7
3166889|NCT01905540|3893972|FG000|COMPLETED|Period 2||7
3166890|NCT01905540|3893973|FG001|COMPLETED|Period 2||7
3166891|NCT01905540|3893974|FG002|COMPLETED|Period 2||7
3166892|NCT01905540|3893975|FG003|COMPLETED|Period 2||7
3166893|NCT01905540|3893972|FG000|NOT COMPLETED|Period 2||0
3166894|NCT01905540|3893973|FG001|NOT COMPLETED|Period 2||0
3166895|NCT01905540|3893974|FG002|NOT COMPLETED|Period 2||0
3166896|NCT01905540|3893975|FG003|NOT COMPLETED|Period 2||0
3166897|NCT01905540|3893972|FG000|STARTED|Period 3||7
3166898|NCT01905540|3893973|FG001|STARTED|Period 3||7
3166899|NCT01905540|3893974|FG002|STARTED|Period 3||7
3166900|NCT01905540|3893975|FG003|STARTED|Period 3||7
3166901|NCT01905540|3893972|FG000|COMPLETED|Period 3||6
3166902|NCT01905540|3893973|FG001|COMPLETED|Period 3||7
3166903|NCT01905540|3893974|FG002|COMPLETED|Period 3||6
3166904|NCT01905540|3893975|FG003|COMPLETED|Period 3||6
3166905|NCT01905540|3893972|FG000|NOT COMPLETED|Period 3||1
3166906|NCT01905540|3893973|FG001|NOT COMPLETED|Period 3||0
3166907|NCT01905540|3893974|FG002|NOT COMPLETED|Period 3||1
3166908|NCT01905540|3893975|FG003|NOT COMPLETED|Period 3||1
3166909|NCT01905553|3893987|FG000|STARTED|Period 1||5
3166910|NCT01905553|3893988|FG001|STARTED|Period 1||4
3166911|NCT01905553|3893987|FG000|COMPLETED|Period 1||5
3166912|NCT01905553|3893988|FG001|COMPLETED|Period 1||4
3166913|NCT01905553|3893987|FG000|NOT COMPLETED|Period 1||0
2832710|NCT02145403|3534288|FG001|STARTED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
2832711|NCT02145403|3534289|FG002|STARTED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
2832712|NCT02145403|3534290|FG003|STARTED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
2832713|NCT02145403|3534287|FG000|COMPLETED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||3
2832714|NCT02145403|3534288|FG001|COMPLETED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
2832715|NCT02145403|3534289|FG002|COMPLETED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
2832716|NCT02145403|3534290|FG003|COMPLETED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
2832717|NCT02145403|3534287|FG000|NOT COMPLETED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
2832718|NCT02145403|3534288|FG001|NOT COMPLETED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
2832719|NCT02145403|3534289|FG002|NOT COMPLETED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
2832720|NCT02145403|3534290|FG003|NOT COMPLETED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
2832721|NCT02145403|3534287|FG000|STARTED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
2832722|NCT02145403|3534288|FG001|STARTED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||3
2832723|NCT02145403|3534289|FG002|STARTED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
2832724|NCT02145403|3534290|FG003|STARTED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
2832725|NCT02145403|3534287|FG000|COMPLETED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
2832726|NCT02145403|3534288|FG001|COMPLETED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||3
2832727|NCT02145403|3534289|FG002|COMPLETED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
2832728|NCT02145403|3534290|FG003|COMPLETED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
2832729|NCT02145403|3534287|FG000|NOT COMPLETED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
2832730|NCT02145403|3534288|FG001|NOT COMPLETED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
2832731|NCT02145403|3534289|FG002|NOT COMPLETED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
3166914|NCT01905553|3893988|FG001|NOT COMPLETED|Period 1||0
3166915|NCT01905553|3893987|FG000|STARTED|Period 2||5
3166916|NCT01905553|3893988|FG001|STARTED|Period 2||4
3166917|NCT01905553|3893987|FG000|COMPLETED|Period 2||4
3166918|NCT01905553|3893988|FG001|COMPLETED|Period 2||4
3166919|NCT01905553|3893987|FG000|NOT COMPLETED|Period 2||1
3166920|NCT01905553|3893988|FG001|NOT COMPLETED|Period 2||0
3166921|NCT01905592|3893996|FG000|STARTED|Overall Study||71
3166922|NCT01905592|3893997|FG001|STARTED|Overall Study||135
3166923|NCT01905592|3893996|FG000|COMPLETED|Overall Study||0
3166924|NCT01905592|3893997|FG001|COMPLETED|Overall Study||0
3166925|NCT01905592|3893996|FG000|NOT COMPLETED|Overall Study||71
3166926|NCT01905592|3893997|FG001|NOT COMPLETED|Overall Study||135
3166927|NCT01905657|3894006|FG000|STARTED|Overall Study||345
3166928|NCT01905657|3894007|FG001|STARTED|Overall Study||346
2832732|NCT02145403|3534290|FG003|NOT COMPLETED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
2832733|NCT02145403|3534287|FG000|STARTED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0
2832734|NCT02145403|3534288|FG001|STARTED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0
2832735|NCT02145403|3534289|FG002|STARTED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||4
2832736|NCT02145403|3534290|FG003|STARTED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0
2832737|NCT02145403|3534287|FG000|COMPLETED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0
2832738|NCT02145403|3534288|FG001|COMPLETED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0
2832739|NCT02145403|3534289|FG002|COMPLETED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||3
2832740|NCT02145403|3534290|FG003|COMPLETED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0
2832741|NCT02145403|3534287|FG000|NOT COMPLETED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0
2832742|NCT02145403|3534288|FG001|NOT COMPLETED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0
2832743|NCT02145403|3534289|FG002|NOT COMPLETED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||1
2832744|NCT02145403|3534290|FG003|NOT COMPLETED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0
2832745|NCT02145403|3534287|FG000|STARTED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0
2832746|NCT02145403|3534288|FG001|STARTED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0
2832747|NCT02145403|3534289|FG002|STARTED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0
2832748|NCT02145403|3534290|FG003|STARTED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||4
2832749|NCT02145403|3534287|FG000|COMPLETED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0
2832750|NCT02145403|3534288|FG001|COMPLETED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0
2832751|NCT02145403|3534289|FG002|COMPLETED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0
2832752|NCT02145403|3534290|FG003|COMPLETED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||2
2832753|NCT02145403|3534287|FG000|NOT COMPLETED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0
2832754|NCT02145403|3534288|FG001|NOT COMPLETED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0
2832755|NCT02145403|3534289|FG002|NOT COMPLETED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0
2832756|NCT02145403|3534290|FG003|NOT COMPLETED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||2
2832757|NCT02145403|3534287|FG000|STARTED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0
2832758|NCT02145403|3534288|FG001|STARTED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0
2832759|NCT02145403|3534289|FG002|STARTED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||37
2832760|NCT02145403|3534290|FG003|STARTED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0
2832761|NCT02145403|3534287|FG000|COMPLETED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0
2832762|NCT02145403|3534288|FG001|COMPLETED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0
3166929|NCT01905657|3894008|FG002|STARTED|Overall Study||343
3166930|NCT01905657|3894006|FG000|Treated|Overall Study||339
3166931|NCT01905657|3894007|FG001|Treated|Overall Study||343
3166932|NCT01905657|3894008|FG002|Treated|Overall Study||309
3166933|NCT01905657|3894006|FG000|Received Second Course of Pembrolizumab|Overall Study||14
3166934|NCT01905657|3894007|FG001|Received Second Course of Pembrolizumab|Overall Study||7
3310396|NCT03040154|4043811|FG001|STARTED|Overall Study||105
3310397|NCT03040154|4043810|FG000|COMPLETED|Overall Study||110
3310398|NCT03040154|4043811|FG001|COMPLETED|Overall Study||105
3310399|NCT03040154|4043810|FG000|NOT COMPLETED|Overall Study||0
3310400|NCT03040154|4043811|FG001|NOT COMPLETED|Overall Study||0
3310401|NCT03040336|4043819|FG000|STARTED|Overall Study||10
3310402|NCT03040336|4043820|FG001|STARTED|Overall Study||7
3310403|NCT03040336|4043819|FG000|COMPLETED|Overall Study||7
3310404|NCT03040336|4043820|FG001|COMPLETED|Overall Study||4
3310405|NCT03040336|4043819|FG000|NOT COMPLETED|Overall Study||3
3310406|NCT03040336|4043820|FG001|NOT COMPLETED|Overall Study||3
3310407|NCT03040362|4043827|FG000|STARTED|Overall Study||8
3310408|NCT03040362|4043827|FG000|Received at Least 1dose of Study Drug|Overall Study||8
3310409|NCT03040362|4043827|FG000|COMPLETED|Overall Study||8
3310410|NCT03040362|4043827|FG000|NOT COMPLETED|Overall Study||0
3310411|NCT03040414|4043833|FG000|STARTED|Overall Study||57
3310412|NCT03040414|4043834|FG001|STARTED|Overall Study||56
3310413|NCT03040414|4043833|FG000|Completed Period 1|Overall Study||56
3310414|NCT03040414|4043834|FG001|Completed Period 1|Overall Study||55
3310415|NCT03040414|4043833|FG000|Started Period 2|Overall Study||56
3310416|NCT03040414|4043834|FG001|Started Period 2|Overall Study||55
3310417|NCT03040414|4043833|FG000|COMPLETED|Overall Study||56
3310418|NCT03040414|4043834|FG001|COMPLETED|Overall Study||55
3310419|NCT03040414|4043833|FG000|NOT COMPLETED|Overall Study||1
3310420|NCT03040414|4043834|FG001|NOT COMPLETED|Overall Study||1
3310421|NCT03040427|4043843|FG000|STARTED|Overall Study||2
3310422|NCT03040427|4043844|FG001|STARTED|Overall Study||6
3310423|NCT03040427|4043845|FG002|STARTED|Overall Study||4
3310424|NCT03040427|4043843|FG000|COMPLETED|Overall Study||2
3310425|NCT03040427|4043844|FG001|COMPLETED|Overall Study||6
3310426|NCT03040427|4043845|FG002|COMPLETED|Overall Study||4
3310427|NCT03040427|4043843|FG000|NOT COMPLETED|Overall Study||0
3310428|NCT03040427|4043844|FG001|NOT COMPLETED|Overall Study||0
3310429|NCT03040427|4043845|FG002|NOT COMPLETED|Overall Study||0
3310430|NCT03040466|4043855|FG000|STARTED|Overall Study||65
3310431|NCT03040466|4043856|FG001|STARTED|Overall Study||115
3310432|NCT03040466|4043855|FG000|COMPLETED|Overall Study||65
3310433|NCT03040466|4043856|FG001|COMPLETED|Overall Study||115
3310434|NCT03040466|4043855|FG000|NOT COMPLETED|Overall Study||0
3310435|NCT03040466|4043856|FG001|NOT COMPLETED|Overall Study||0
3317166|NCT03124459|4050723|FG003|COMPLETED|Part 1-Open Label Dose Escalation|Patients in the double-blind placebo controlled study were not the same participants that participated in the Part 1 Open-Label Dose escalation portion of the study.|0
3317284|NCT03125200|4050830|FG001|COMPLETED|Overall Study||0
2832763|NCT02145403|3534289|FG002|COMPLETED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||36
2832764|NCT02145403|3534290|FG003|COMPLETED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0
2832765|NCT02145403|3534287|FG000|NOT COMPLETED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0
2832766|NCT02145403|3534288|FG001|NOT COMPLETED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0
2832767|NCT02145403|3534289|FG002|NOT COMPLETED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||1
2832768|NCT02145403|3534290|FG003|NOT COMPLETED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0
2832769|NCT02105636|3534305|FG000|STARTED|Overall Study||236
2832770|NCT02105636|3534306|FG001|STARTED|Overall Study||111
2832771|NCT02105636|3534305|FG000|COMPLETED|Overall Study|Completed=Still on Treatment|41
2832772|NCT02105636|3534306|FG001|COMPLETED|Overall Study|Completed=Still on Treatment|3
2832773|NCT02105636|3534305|FG000|NOT COMPLETED|Overall Study||195
2832774|NCT02105636|3534306|FG001|NOT COMPLETED|Overall Study||108
2832775|NCT02038946|3534313|FG000|STARTED|Overall Study||92
2832776|NCT02038946|3534313|FG000|COMPLETED|Overall Study||80
2832777|NCT02038946|3534313|FG000|NOT COMPLETED|Overall Study||12
2832778|NCT01988571|3534319|FG000|STARTED|Overall Study||139
2832779|NCT01988571|3534320|FG001|STARTED|Overall Study||140
2832780|NCT01988571|3534319|FG000|Completed Baseline|Overall Study||136
2832781|NCT01988571|3534320|FG001|Completed Baseline|Overall Study||139
2832782|NCT01988571|3534319|FG000|Completed 6 Month Visit|Overall Study||122
2832783|NCT01988571|3534320|FG001|Completed 6 Month Visit|Overall Study||126
2832784|NCT01988571|3534319|FG000|COMPLETED|Overall Study||100
2832785|NCT01988571|3534320|FG001|COMPLETED|Overall Study||105
2832786|NCT01988571|3534319|FG000|NOT COMPLETED|Overall Study||39
2832787|NCT01988571|3534320|FG001|NOT COMPLETED|Overall Study||35
2832788|NCT01841736|3534328|FG000|STARTED|Overall Study||97
2832789|NCT01841736|3534329|FG001|STARTED|Overall Study||74
2832790|NCT01841736|3534328|FG000|Crossover|Overall Study||0
2832791|NCT01841736|3534329|FG001|Crossover|Overall Study||49
2832792|NCT01841736|3534328|FG000|COMPLETED|Overall Study||97
2832793|NCT01841736|3534329|FG001|COMPLETED|Overall Study||74
2832794|NCT01841736|3534328|FG000|NOT COMPLETED|Overall Study||0
2832795|NCT01841736|3534329|FG001|NOT COMPLETED|Overall Study||0
2832796|NCT01715285|3534338|FG000|STARTED|Treatment Period||597
2832797|NCT01715285|3534339|FG001|STARTED|Treatment Period||602
2832798|NCT01715285|3534340|FG002|STARTED|Treatment Period||0
2832799|NCT01715285|3534338|FG000|ITT Population|Treatment Period||597
2832800|NCT01715285|3534339|FG001|ITT Population|Treatment Period||602
2832801|NCT01715285|3534340|FG002|ITT Population|Treatment Period||0
2832802|NCT01715285|3534338|FG000|Safety Population|Treatment Period||597
2832803|NCT01715285|3534339|FG001|Safety Population|Treatment Period||602
2832804|NCT01715285|3534340|FG002|Safety Population|Treatment Period||0
2832805|NCT01715285|3534338|FG000|COMPLETED|Treatment Period||0
2832806|NCT01715285|3534339|FG001|COMPLETED|Treatment Period||0
2832807|NCT01715285|3534340|FG002|COMPLETED|Treatment Period||0
2832808|NCT01715285|3534338|FG000|NOT COMPLETED|Treatment Period||597
2832809|NCT01715285|3534339|FG001|NOT COMPLETED|Treatment Period||602
2832810|NCT01715285|3534340|FG002|NOT COMPLETED|Treatment Period||0
2832811|NCT01715285|3534338|FG000|STARTED|Open-label (OL) Extension Phase||157
2832812|NCT01715285|3534339|FG001|STARTED|Open-label (OL) Extension Phase||0
2832813|NCT01715285|3534340|FG002|STARTED|Open-label (OL) Extension Phase||72
2832814|NCT01715285|3534338|FG000|COMPLETED|Open-label (OL) Extension Phase||0
2832815|NCT01715285|3534339|FG001|COMPLETED|Open-label (OL) Extension Phase||0
2832816|NCT01715285|3534340|FG002|COMPLETED|Open-label (OL) Extension Phase||0
2832817|NCT01715285|3534338|FG000|NOT COMPLETED|Open-label (OL) Extension Phase||157
2832818|NCT01715285|3534339|FG001|NOT COMPLETED|Open-label (OL) Extension Phase||0
3310436|NCT03040479|4043865|FG000|STARTED|Overall Study||8
3310437|NCT03040479|4043866|FG001|STARTED|Overall Study||8
3310438|NCT03040479|4043867|FG002|STARTED|Overall Study||8
3310439|NCT03040479|4043865|FG000|Received at Least 1 Dose of Study Drug|Overall Study||8
3310440|NCT03040479|4043866|FG001|Received at Least 1 Dose of Study Drug|Overall Study||8
3310441|NCT03040479|4043867|FG002|Received at Least 1 Dose of Study Drug|Overall Study||8
3310442|NCT03040479|4043865|FG000|COMPLETED|Overall Study||8
3310443|NCT03040479|4043866|FG001|COMPLETED|Overall Study||8
3310444|NCT03040479|4043867|FG002|COMPLETED|Overall Study||8
3310445|NCT03040479|4043865|FG000|NOT COMPLETED|Overall Study||0
3310446|NCT03040479|4043866|FG001|NOT COMPLETED|Overall Study||0
3310447|NCT03040479|4043867|FG002|NOT COMPLETED|Overall Study||0
3310448|NCT03040674|4043877|FG000|STARTED|Overall Study||489
3310449|NCT03040674|4043877|FG000|Participants Completing 3 Month Survey|Overall Study||351
3310450|NCT03040674|4043877|FG000|Participants Completing 6 Month Survey|Overall Study||241
3310451|NCT03040674|4043877|FG000|COMPLETED|Overall Study||241
3310452|NCT03040674|4043877|FG000|NOT COMPLETED|Overall Study||248
3310453|NCT03040687|4043885|FG000|STARTED|Overall Study||20
3310454|NCT03040687|4043886|FG001|STARTED|Overall Study||20
3310455|NCT03040687|4043887|FG002|STARTED|Overall Study||20
3310456|NCT03040687|4043885|FG000|COMPLETED|Overall Study||19
3310457|NCT03040687|4043886|FG001|COMPLETED|Overall Study||20
3310458|NCT03040687|4043887|FG002|COMPLETED|Overall Study||20
3310459|NCT03040687|4043885|FG000|NOT COMPLETED|Overall Study||1
3310460|NCT03040687|4043886|FG001|NOT COMPLETED|Overall Study||0
3310461|NCT03040687|4043887|FG002|NOT COMPLETED|Overall Study||0
3310462|NCT03040713|4043895|FG000|STARTED|Overall Study||16
3310463|NCT03040713|4043895|FG000|COMPLETED|Overall Study||13
3310464|NCT03040713|4043895|FG000|NOT COMPLETED|Overall Study||3
2832819|NCT01715285|3534340|FG002|NOT COMPLETED|Open-label (OL) Extension Phase||72
2832820|NCT01398852|3534347|FG000|STARTED|Overall Study|Due to termination of the study the exact number of participants enrolled is unknown at this time.|372
2832821|NCT01398852|3534347|FG000|COMPLETED|Overall Study||0
2832822|NCT01398852|3534347|FG000|NOT COMPLETED|Overall Study||372
2832823|NCT01332266|3534356|FG000|STARTED|Phase 1b||4
2832824|NCT01332266|3534357|FG001|STARTED|Phase 1b||5
2832825|NCT01332266|3534358|FG002|STARTED|Phase 1b||3
2832826|NCT01332266|3534359|FG003|STARTED|Phase 1b||0
2832827|NCT01332266|3534360|FG004|STARTED|Phase 1b||0
2832828|NCT01332266|3534356|FG000|COMPLETED|Phase 1b||0
2832829|NCT01332266|3534357|FG001|COMPLETED|Phase 1b||0
2832830|NCT01332266|3534358|FG002|COMPLETED|Phase 1b||0
2832831|NCT01332266|3534359|FG003|COMPLETED|Phase 1b||0
2832832|NCT01332266|3534360|FG004|COMPLETED|Phase 1b||0
2832833|NCT01332266|3534356|FG000|NOT COMPLETED|Phase 1b||4
2832834|NCT01332266|3534357|FG001|NOT COMPLETED|Phase 1b||5
2832835|NCT01332266|3534358|FG002|NOT COMPLETED|Phase 1b||3
2832836|NCT01332266|3534359|FG003|NOT COMPLETED|Phase 1b||0
2832837|NCT01332266|3534360|FG004|NOT COMPLETED|Phase 1b||0
2832838|NCT01332266|3534356|FG000|STARTED|Phase 2||0
2832839|NCT01332266|3534357|FG001|STARTED|Phase 2||0
2832840|NCT01332266|3534358|FG002|STARTED|Phase 2||0
2832841|NCT01332266|3534359|FG003|STARTED|Phase 2||42
2832842|NCT01332266|3534360|FG004|STARTED|Phase 2||41
2832843|NCT01332266|3534356|FG000|COMPLETED|Phase 2||0
2832844|NCT01332266|3534357|FG001|COMPLETED|Phase 2||0
2832845|NCT01332266|3534358|FG002|COMPLETED|Phase 2||0
2832846|NCT01332266|3534359|FG003|COMPLETED|Phase 2||0
2832847|NCT01332266|3534360|FG004|COMPLETED|Phase 2||0
2832848|NCT01332266|3534356|FG000|NOT COMPLETED|Phase 2||0
2832849|NCT01332266|3534357|FG001|NOT COMPLETED|Phase 2||0
2832850|NCT01332266|3534358|FG002|NOT COMPLETED|Phase 2||0
2832851|NCT01332266|3534359|FG003|NOT COMPLETED|Phase 2||42
2832852|NCT01332266|3534360|FG004|NOT COMPLETED|Phase 2||41
2832853|NCT01150890|3534377|FG000|STARTED|Overall Study||32
2832854|NCT01150890|3534378|FG001|STARTED|Overall Study||32
2832855|NCT01150890|3534379|FG002|STARTED|Overall Study||33
2832856|NCT01150890|3534380|FG003|STARTED|Overall Study||33
2832857|NCT01150890|3534377|FG000|Received Study Drug|Overall Study||32
2832858|NCT01150890|3534378|FG001|Received Study Drug|Overall Study||31
2832859|NCT01150890|3534379|FG002|Received Study Drug|Overall Study||32
2832860|NCT01150890|3534380|FG003|Received Study Drug|Overall Study||33
2832861|NCT01150890|3534377|FG000|COMPLETED|Overall Study||28
2832862|NCT01150890|3534378|FG001|COMPLETED|Overall Study||19
2832863|NCT01150890|3534379|FG002|COMPLETED|Overall Study||21
2832864|NCT01150890|3534380|FG003|COMPLETED|Overall Study||16
2832865|NCT01150890|3534377|FG000|NOT COMPLETED|Overall Study||4
2832866|NCT01150890|3534378|FG001|NOT COMPLETED|Overall Study||13
2832867|NCT01150890|3534379|FG002|NOT COMPLETED|Overall Study||12
2832868|NCT01150890|3534380|FG003|NOT COMPLETED|Overall Study||17
2832869|NCT01140867|3534393|FG000|STARTED|Overall Study||121
2832870|NCT01140867|3534393|FG000|COMPLETED|Overall Study||88
2832871|NCT01140867|3534393|FG000|NOT COMPLETED|Overall Study||33
2832872|NCT01137773|3534399|FG000|STARTED|Overall Study||33
2832873|NCT01137773|3534400|FG001|STARTED|Overall Study||23
2832874|NCT01137773|3534399|FG000|COMPLETED|Overall Study||24
2832875|NCT01137773|3534400|FG001|COMPLETED|Overall Study||20
2832876|NCT01137773|3534399|FG000|NOT COMPLETED|Overall Study||9
2832877|NCT01137773|3534400|FG001|NOT COMPLETED|Overall Study||3
2832878|NCT01127256|3534410|FG000|STARTED|Overall Study||96
2832879|NCT01127256|3534411|FG001|STARTED|Overall Study||104
2832880|NCT01127256|3534410|FG000|COMPLETED|Overall Study||57
2832881|NCT01127256|3534411|FG001|COMPLETED|Overall Study||65
2832882|NCT01127256|3534410|FG000|NOT COMPLETED|Overall Study||39
2832883|NCT01127256|3534411|FG001|NOT COMPLETED|Overall Study||39
2832884|NCT01004861|3534430|FG000|STARTED|Overall Study||3
2832885|NCT01004861|3534431|FG001|STARTED|Overall Study||6
2832886|NCT01004861|3534432|FG002|STARTED|Overall Study||6
2832887|NCT01004861|3534433|FG003|STARTED|Overall Study||6
2832888|NCT01004861|3534434|FG004|STARTED|Overall Study||7
2832889|NCT01004861|3534435|FG005|STARTED|Overall Study||6
2832890|NCT01004861|3534436|FG006|STARTED|Overall Study||7
2832891|NCT01004861|3534437|FG007|STARTED|Overall Study||4
2832892|NCT01004861|3534438|FG008|STARTED|Overall Study||39
2832893|NCT01004861|3534439|FG009|STARTED|Overall Study||11
2832894|NCT01004861|3534440|FG010|STARTED|Overall Study||9
2832895|NCT01004861|3534441|FG011|STARTED|Overall Study||8
2832896|NCT01004861|3534442|FG012|STARTED|Overall Study||20
2832897|NCT01004861|3534430|FG000|COMPLETED|Overall Study||0
2832898|NCT01004861|3534431|FG001|COMPLETED|Overall Study||0
2832899|NCT01004861|3534432|FG002|COMPLETED|Overall Study||0
2832900|NCT01004861|3534433|FG003|COMPLETED|Overall Study||0
2832901|NCT01004861|3534434|FG004|COMPLETED|Overall Study||0
2832902|NCT01004861|3534435|FG005|COMPLETED|Overall Study||0
2832903|NCT01004861|3534436|FG006|COMPLETED|Overall Study||0
2832904|NCT01004861|3534437|FG007|COMPLETED|Overall Study||0
2832905|NCT01004861|3534438|FG008|COMPLETED|Overall Study||0
2832906|NCT01004861|3534439|FG009|COMPLETED|Overall Study||0
2832907|NCT01004861|3534440|FG010|COMPLETED|Overall Study||0
2832908|NCT01004861|3534441|FG011|COMPLETED|Overall Study||0
2832909|NCT01004861|3534442|FG012|COMPLETED|Overall Study||0
2832910|NCT01004861|3534430|FG000|NOT COMPLETED|Overall Study||3
2832911|NCT01004861|3534431|FG001|NOT COMPLETED|Overall Study||6
2832912|NCT01004861|3534432|FG002|NOT COMPLETED|Overall Study||6
2832913|NCT01004861|3534433|FG003|NOT COMPLETED|Overall Study||6
2832914|NCT01004861|3534434|FG004|NOT COMPLETED|Overall Study||7
2832915|NCT01004861|3534435|FG005|NOT COMPLETED|Overall Study||6
2832916|NCT01004861|3534436|FG006|NOT COMPLETED|Overall Study||7
2832917|NCT01004861|3534437|FG007|NOT COMPLETED|Overall Study||4
2832918|NCT01004861|3534438|FG008|NOT COMPLETED|Overall Study||39
2832919|NCT01004861|3534439|FG009|NOT COMPLETED|Overall Study||11
2832920|NCT01004861|3534440|FG010|NOT COMPLETED|Overall Study||9
2832921|NCT01004861|3534441|FG011|NOT COMPLETED|Overall Study||8
2832922|NCT01004861|3534442|FG012|NOT COMPLETED|Overall Study||20
2832923|NCT00912223|3534474|FG000|STARTED|Overall Study||65
2832924|NCT00912223|3534474|FG000|COMPLETED|Overall Study||62
2832925|NCT00912223|3534474|FG000|NOT COMPLETED|Overall Study||3
2832926|NCT00381381|3534478|FG000|STARTED|Overall Study||199
2832927|NCT00381381|3534478|FG000|COMPLETED|Overall Study||135
2832928|NCT00381381|3534478|FG000|NOT COMPLETED|Overall Study||64
2832929|NCT00038675|3534482|FG000|STARTED|Overall Study||125
2832930|NCT00038675|3534482|FG000|COMPLETED|Overall Study||125
2832931|NCT00038675|3534482|FG000|NOT COMPLETED|Overall Study||0
2914304|NCT00502853|3624379|FG000|STARTED|Overall Study||10
2914305|NCT00502853|3624379|FG000|COMPLETED|Overall Study||10
2914306|NCT00502853|3624379|FG000|NOT COMPLETED|Overall Study||0
2914307|NCT00502905|3624384|FG000|STARTED|Overall Study||196
2914308|NCT00502905|3624384|FG000|COMPLETED|Overall Study||196
2914309|NCT00502905|3624384|FG000|NOT COMPLETED|Overall Study||0
2914310|NCT00502944|3624390|FG000|STARTED|Overall Study||2446
2914311|NCT00502944|3624391|FG001|STARTED|Overall Study||2409
2914312|NCT00502944|3624390|FG000|COMPLETED|Overall Study||1382
2914313|NCT00502944|3624391|FG001|COMPLETED|Overall Study||643
2914314|NCT00502944|3624390|FG000|NOT COMPLETED|Overall Study||1064
2914315|NCT00502944|3624391|FG001|NOT COMPLETED|Overall Study||1766
2914316|NCT00502996|3624397|FG000|STARTED|Overall Study||232
2914317|NCT00502996|3624397|FG000|COMPLETED|Overall Study||188
2914318|NCT00502996|3624397|FG000|NOT COMPLETED|Overall Study||44
2914319|NCT00503113|3624404|FG000|STARTED|Overall Study||268
2914320|NCT00503113|3624405|FG001|STARTED|Overall Study||264
2914321|NCT00503113|3624406|FG002|STARTED|Overall Study||269
2914322|NCT00503113|3624404|FG000|Intent to Treat Population (ITT)|Overall Study||262
2914323|NCT00503113|3624405|FG001|Intent to Treat Population (ITT)|Overall Study||261
2914324|NCT00503113|3624406|FG002|Intent to Treat Population (ITT)|Overall Study||268
2914325|NCT00503113|3624404|FG000|Per Protocol Population (PP)|Overall Study||246
2914326|NCT00503113|3624405|FG001|Per Protocol Population (PP)|Overall Study||243
2914327|NCT00503113|3624406|FG002|Per Protocol Population (PP)|Overall Study||241
2914328|NCT00503113|3624404|FG000|Safety Population|Overall Study||263
2914329|NCT00503113|3624405|FG001|Safety Population|Overall Study||263
2914330|NCT00503113|3624406|FG002|Safety Population|Overall Study||267
2914331|NCT00503113|3624404|FG000|COMPLETED|Overall Study||235
2914332|NCT00503113|3624405|FG001|COMPLETED|Overall Study||236
2914333|NCT00503113|3624406|FG002|COMPLETED|Overall Study||241
2914334|NCT00503113|3624404|FG000|NOT COMPLETED|Overall Study||33
2914335|NCT00503113|3624405|FG001|NOT COMPLETED|Overall Study||28
2914336|NCT00503113|3624406|FG002|NOT COMPLETED|Overall Study||28
2914337|NCT00503139|3624414|FG000|STARTED|Overall Study||684
2914338|NCT00503139|3624414|FG000|COMPLETED|Overall Study||676
2914339|NCT00503139|3624414|FG000|NOT COMPLETED|Overall Study||8
2914340|NCT00503308|3624420|FG000|STARTED|Overall Study||146
2914341|NCT00503308|3624421|FG001|STARTED|Overall Study||135
2914342|NCT00503308|3624420|FG000|COMPLETED|Overall Study||144
2914343|NCT00503308|3624421|FG001|COMPLETED|Overall Study||134
2914344|NCT00503308|3624420|FG000|NOT COMPLETED|Overall Study||2
2914345|NCT00503308|3624421|FG001|NOT COMPLETED|Overall Study||1
2914346|NCT00503399|3624429|FG000|STARTED|Overall Study||45
2914347|NCT00503399|3624430|FG001|STARTED|Overall Study||47
2914348|NCT00503399|3624429|FG000|COMPLETED|Overall Study||38
2914349|NCT00503399|3624430|FG001|COMPLETED|Overall Study||39
2914350|NCT00503399|3624429|FG000|NOT COMPLETED|Overall Study||7
2914351|NCT00503399|3624430|FG001|NOT COMPLETED|Overall Study||8
2914352|NCT00503425|3624436|FG000|STARTED|Overall Study||215
2914353|NCT00503425|3624436|FG000|COMPLETED|Overall Study||161
2914354|NCT00503425|3624436|FG000|NOT COMPLETED|Overall Study||54
2914355|NCT00503685|3624444|FG000|STARTED|Overall Study||23
2914356|NCT00503685|3624445|FG001|STARTED|Overall Study||22
2914357|NCT00503685|3624446|FG002|STARTED|Overall Study||20
2914358|NCT00503685|3624444|FG000|Received at Least 1 Dose of Study Drug|Overall Study||23
2914359|NCT00503685|3624445|FG001|Received at Least 1 Dose of Study Drug|Overall Study||21
2914360|NCT00503685|3624446|FG002|Received at Least 1 Dose of Study Drug|Overall Study||20
2914361|NCT00503685|3624444|FG000|COMPLETED|Overall Study||23
2914362|NCT00503685|3624445|FG001|COMPLETED|Overall Study||19
2914363|NCT00503685|3624446|FG002|COMPLETED|Overall Study||18
2914364|NCT00503685|3624444|FG000|NOT COMPLETED|Overall Study||0
2914365|NCT00503685|3624445|FG001|NOT COMPLETED|Overall Study||3
2914366|NCT00503685|3624446|FG002|NOT COMPLETED|Overall Study||2
2914367|NCT00503698|3624457|FG000|STARTED|Overall Study|Randomised|357
2914368|NCT00503698|3624458|FG001|STARTED|Overall Study|Randomised|355
2914369|NCT00503698|3624457|FG000|Exposed to Trial Drug|Overall Study|11 subjects randomised but not exposed to trial drug. Subjects not included in full analysis set.|346
2914370|NCT00503698|3624458|FG001|Exposed to Trial Drug|Overall Study|6 subjects randomised but not exposed to trial drug. Subjects not included in full analysis set.|349
2914371|NCT00503698|3624457|FG000|COMPLETED|Overall Study|Trial prematurely terminated|0
2914372|NCT00503698|3624458|FG001|COMPLETED|Overall Study|Trial prematurely terminated|0
2914373|NCT00503698|3624457|FG000|NOT COMPLETED|Overall Study||357
2832932|NCT04957498|3534488|FG000|STARTED|Overall Study||20
2832933|NCT04957498|3534489|FG001|STARTED|Overall Study||20
2832934|NCT04957498|3534488|FG000|COMPLETED|Overall Study||19
2832935|NCT04957498|3534489|FG001|COMPLETED|Overall Study||18
2832936|NCT04957498|3534488|FG000|NOT COMPLETED|Overall Study||1
2832937|NCT04957498|3534489|FG001|NOT COMPLETED|Overall Study||2
2832938|NCT04706403|3534502|FG000|STARTED|Overall Study||172
2832939|NCT04706403|3534503|FG001|STARTED|Overall Study||121
2832940|NCT04706403|3534504|FG002|STARTED|Overall Study||165
2832941|NCT04706403|3534505|FG003|STARTED|Overall Study||146
2832942|NCT04706403|3534506|FG004|STARTED|Overall Study||152
2832943|NCT04706403|3534502|FG000|COMPLETED|Overall Study||172
2832944|NCT04706403|3534503|FG001|COMPLETED|Overall Study||121
2832945|NCT04706403|3534504|FG002|COMPLETED|Overall Study||164
2832946|NCT04706403|3534505|FG003|COMPLETED|Overall Study||145
2832947|NCT04706403|3534506|FG004|COMPLETED|Overall Study||150
2832948|NCT04706403|3534502|FG000|NOT COMPLETED|Overall Study||0
2832949|NCT04706403|3534503|FG001|NOT COMPLETED|Overall Study||0
2832950|NCT04706403|3534504|FG002|NOT COMPLETED|Overall Study||1
2832951|NCT04706403|3534505|FG003|NOT COMPLETED|Overall Study||1
2832952|NCT04706403|3534506|FG004|NOT COMPLETED|Overall Study||2
2832953|NCT04389333|3534520|FG000|STARTED|Overall Study|From March 26th to April 26th, 2020, 20 patients were enrolled and underwent non-contract MCE in Changhai hpospital and the first medical center of PLA general hospital.|20
2832954|NCT04389333|3534521|FG001|STARTED|Overall Study|From March 26th to April 26th, 2020, 20 patients were enrolled and accept MCE in Changhai hpospital and the first medical center of PLA general hospital.|20
2832955|NCT04389333|3534520|FG000|COMPLETED|Overall Study||20
2832956|NCT04389333|3534521|FG001|COMPLETED|Overall Study||20
2832957|NCT04389333|3534520|FG000|NOT COMPLETED|Overall Study||0
2832958|NCT04389333|3534521|FG001|NOT COMPLETED|Overall Study||0
2832959|NCT03712124|3534530|FG000|STARTED|Overall Study||10
2832960|NCT03712124|3534531|FG001|STARTED|Overall Study||11
2832961|NCT03712124|3534530|FG000|Received at Least 1 Dose of Study Drug|Overall Study||10
2832962|NCT03712124|3534531|FG001|Received at Least 1 Dose of Study Drug|Overall Study||11
2832963|NCT03712124|3534530|FG000|COMPLETED|Overall Study||9
2832964|NCT03712124|3534531|FG001|COMPLETED|Overall Study||11
2832965|NCT03712124|3534530|FG000|NOT COMPLETED|Overall Study||1
2832966|NCT03712124|3534531|FG001|NOT COMPLETED|Overall Study||0
2832967|NCT03689582|3534537|FG000|STARTED|Overall Study||11
2832968|NCT03689582|3534537|FG000|COMPLETED|Overall Study||11
2832969|NCT03689582|3534537|FG000|NOT COMPLETED|Overall Study||0
2832970|NCT03535740|3534543|FG000|STARTED|Overall Study||103
2832971|NCT03535740|3534543|FG000|Participants Who Received Escalated Dose of Brigatinib 240 mg|Overall Study||13
2832972|NCT03535740|3534543|FG000|COMPLETED|Overall Study||0
2832973|NCT03535740|3534543|FG000|NOT COMPLETED|Overall Study||103
2833053|NCT02013167|3534639|FG000|STARTED|Overall Study||134
2833054|NCT02013167|3534640|FG001|STARTED|Overall Study||271
2833055|NCT02013167|3534639|FG000|Received Treatment|Overall Study||109
2833056|NCT02013167|3534640|FG001|Received Treatment|Overall Study||267
2833057|NCT02013167|3534639|FG000|COMPLETED|Overall Study|Indicates participants continuing study at time of data cut-off|33
2833058|NCT02013167|3534640|FG001|COMPLETED|Overall Study|Indicates participants continuing study at time of data cut-off; 22 were receiving treatment|93
2833059|NCT02013167|3534639|FG000|NOT COMPLETED|Overall Study||101
2833060|NCT02013167|3534640|FG001|NOT COMPLETED|Overall Study||178
2833061|NCT02004522|3534649|FG000|STARTED|Overall Study||160
2833062|NCT02004522|3534650|FG001|STARTED|Overall Study||159
2833063|NCT02004522|3534649|FG000|Number of Subjects Treated|Overall Study||158
2833064|NCT02004522|3534650|FG001|Number of Subjects Treated|Overall Study||155
2833065|NCT02004522|3534649|FG000|COMPLETED|Overall Study|Completed defined here as still on treatment.|34
2833066|NCT02004522|3534650|FG001|COMPLETED|Overall Study|Completed defined here as still on treatment.|0
2833067|NCT02004522|3534649|FG000|NOT COMPLETED|Overall Study||126
2833068|NCT02004522|3534650|FG001|NOT COMPLETED|Overall Study||159
2833069|NCT02000427|3534656|FG000|STARTED|Overall Study||45
2833070|NCT02000427|3534656|FG000|COMPLETED|Overall Study|Indicates participants ongoing in study as of the data cut-off date of 20 May 2015.|23
2833071|NCT02000427|3534656|FG000|NOT COMPLETED|Overall Study||22
2833072|NCT01981850|3534667|FG000|STARTED|Main Phase Stage 1||8
2833073|NCT01981850|3534668|FG001|STARTED|Main Phase Stage 1||7
2833074|NCT01981850|3534669|FG002|STARTED|Main Phase Stage 1||6
2833075|NCT01981850|3534670|FG003|STARTED|Main Phase Stage 1||6
2833076|NCT01981850|3534671|FG004|STARTED|Main Phase Stage 1||0
2833077|NCT01981850|3534672|FG005|STARTED|Main Phase Stage 1||0
2833078|NCT01981850|3534673|FG006|STARTED|Main Phase Stage 1||0
2833079|NCT01981850|3534674|FG007|STARTED|Main Phase Stage 1||0
2833080|NCT01981850|3534675|FG008|STARTED|Main Phase Stage 1||0
2833081|NCT01981850|3534676|FG009|STARTED|Main Phase Stage 1||0
2833082|NCT01981850|3534667|FG000|COMPLETED|Main Phase Stage 1||5
2833083|NCT01981850|3534668|FG001|COMPLETED|Main Phase Stage 1||5
2833084|NCT01981850|3534669|FG002|COMPLETED|Main Phase Stage 1||4
2833085|NCT01981850|3534670|FG003|COMPLETED|Main Phase Stage 1||6
2833086|NCT01981850|3534671|FG004|COMPLETED|Main Phase Stage 1||0
3166935|NCT01905657|3894008|FG002|Received Second Course of Pembrolizumab|Overall Study||0
3166936|NCT01905657|3894006|FG000|Switched Over to Pembrolizumab|Overall Study||0
3166937|NCT01905657|3894007|FG001|Switched Over to Pembrolizumab|Overall Study||0
3166938|NCT01905657|3894008|FG002|Switched Over to Pembrolizumab|Overall Study||8
3310465|NCT03040804|4043899|FG000|STARTED|Overall Study||2
3166939|NCT01905657|3894006|FG000|COMPLETED|Overall Study||142
2832974|NCT03503318|3534551|FG000|STARTED|Overall Study||181
2832975|NCT03503318|3534552|FG001|STARTED|Overall Study||183
2832976|NCT03503318|3534553|FG002|STARTED|Overall Study||180
2832977|NCT03503318|3534551|FG000|Received at Least 1 Dose of Study Drug|Overall Study||179
2832978|NCT03503318|3534552|FG001|Received at Least 1 Dose of Study Drug|Overall Study||183
2832979|NCT03503318|3534553|FG002|Received at Least 1 Dose of Study Drug|Overall Study||180
2832980|NCT03503318|3534551|FG000|COMPLETED|Overall Study||142
2832981|NCT03503318|3534552|FG001|COMPLETED|Overall Study||144
2832982|NCT03503318|3534553|FG002|COMPLETED|Overall Study||140
2832983|NCT03503318|3534551|FG000|NOT COMPLETED|Overall Study||39
2832984|NCT03503318|3534552|FG001|NOT COMPLETED|Overall Study||39
2832985|NCT03503318|3534553|FG002|NOT COMPLETED|Overall Study||40
2832986|NCT02986789|3534563|FG000|STARTED|Overall Study||43
2832987|NCT02986789|3534564|FG001|STARTED|Overall Study||0
2832988|NCT02986789|3534563|FG000|COMPLETED|Overall Study||43
2832989|NCT02986789|3534564|FG001|COMPLETED|Overall Study||0
2832990|NCT02986789|3534563|FG000|NOT COMPLETED|Overall Study||0
2832991|NCT02986789|3534564|FG001|NOT COMPLETED|Overall Study||0
2832992|NCT02974907|3534572|FG000|STARTED|Overall Study||299
2832993|NCT02974907|3534573|FG001|STARTED|Overall Study||302
2832994|NCT02974907|3534572|FG000|COMPLETED|Overall Study||286
2832995|NCT02974907|3534573|FG001|COMPLETED|Overall Study||292
2832996|NCT02974907|3534572|FG000|NOT COMPLETED|Overall Study||13
2832997|NCT02974907|3534573|FG001|NOT COMPLETED|Overall Study||10
2832998|NCT02921789|3534581|FG000|STARTED|Overall Study||34
2832999|NCT02921789|3534582|FG001|STARTED|Overall Study||29
2833000|NCT02921789|3534581|FG000|Randomized and Took Study Drug|Overall Study||34
2833001|NCT02921789|3534582|FG001|Randomized and Took Study Drug|Overall Study||29
2833002|NCT02921789|3534581|FG000|COMPLETED|Overall Study||26
2833003|NCT02921789|3534582|FG001|COMPLETED|Overall Study||25
2833004|NCT02921789|3534581|FG000|NOT COMPLETED|Overall Study||8
2833005|NCT02921789|3534582|FG001|NOT COMPLETED|Overall Study||4
2833006|NCT02918500|3534590|FG000|STARTED|Overall Study||2
2833007|NCT02918500|3534591|FG001|STARTED|Overall Study||2
2833008|NCT02918500|3534590|FG000|COMPLETED|Overall Study||2
2833009|NCT02918500|3534591|FG001|COMPLETED|Overall Study||2
2833010|NCT02918500|3534590|FG000|NOT COMPLETED|Overall Study||0
2833011|NCT02918500|3534591|FG001|NOT COMPLETED|Overall Study||0
2833012|NCT02896257|3534602|FG000|STARTED|Providers||88
2833013|NCT02896257|3534603|FG001|STARTED|Providers||93
2833014|NCT02896257|3534602|FG000|PCPs Assigned to 1 Primary Care Team|Providers||68
2833015|NCT02896257|3534603|FG001|PCPs Assigned to 1 Primary Care Team|Providers||79
2833016|NCT02896257|3534602|FG000|PCPs Assigned to Two Primary Care Teams|Providers||18
2833017|NCT02896257|3534603|FG001|PCPs Assigned to Two Primary Care Teams|Providers||12
2833018|NCT02896257|3534602|FG000|PCPs Assigned to 3 Primary Care Teams|Providers||1
2833019|NCT02896257|3534603|FG001|PCPs Assigned to 3 Primary Care Teams|Providers||2
2833020|NCT02896257|3534602|FG000|PCPs Assigned to Four Primary Care Teams|Providers||1
2833021|NCT02896257|3534603|FG001|PCPs Assigned to Four Primary Care Teams|Providers||0
2833022|NCT02896257|3534602|FG000|COMPLETED|Providers||67
2833023|NCT02896257|3534603|FG001|COMPLETED|Providers||65
2833024|NCT02896257|3534602|FG000|NOT COMPLETED|Providers||21
2833025|NCT02896257|3534603|FG001|NOT COMPLETED|Providers||28
2833026|NCT02896257|3534602|FG000|STARTED|Patients|Eligible patient participants assigned to a usual care PCP=344|344
2833027|NCT02896257|3534603|FG001|STARTED|Patients|Eligible patient participants assigned to an intervention PCP=342|342
2833028|NCT02896257|3534602|FG000|COMPLETED|Patients|Patients with an eligible primary care appointment with a usual care PCP who were assigned an index date=281|281
2833029|NCT02896257|3534603|FG001|COMPLETED|Patients|Patients with an eligible primary care appointment with an intervention PCP who were assigned an index date=269|269
2833030|NCT02896257|3534602|FG000|NOT COMPLETED|Patients||63
2833031|NCT02896257|3534603|FG001|NOT COMPLETED|Patients||73
2833032|NCT02774265|3534612|FG000|STARTED|Overall Study||164
2833033|NCT02774265|3534613|FG001|STARTED|Overall Study||165
2833034|NCT02774265|3534612|FG000|COMPLETED|Overall Study||151
2833035|NCT02774265|3534613|FG001|COMPLETED|Overall Study||159
2833036|NCT02774265|3534612|FG000|NOT COMPLETED|Overall Study||13
2833037|NCT02774265|3534613|FG001|NOT COMPLETED|Overall Study||6
2833038|NCT02736617|3534619|FG000|STARTED|Treatment||10
2833039|NCT02736617|3534619|FG000|COMPLETED|Treatment||7
2833040|NCT02736617|3534619|FG000|NOT COMPLETED|Treatment||3
2833041|NCT02736617|3534619|FG000|STARTED|Maintenance||7
2833042|NCT02736617|3534619|FG000|COMPLETED|Maintenance||2
2833043|NCT02736617|3534619|FG000|NOT COMPLETED|Maintenance||5
2833044|NCT02652468|3534624|FG000|STARTED|Overall Study||11
2833045|NCT02652468|3534624|FG000|COMPLETED|Overall Study||11
2833046|NCT02652468|3534624|FG000|NOT COMPLETED|Overall Study||0
2833047|NCT02579265|3534630|FG000|STARTED|Overall Study||83
2833048|NCT02579265|3534631|FG001|STARTED|Overall Study||78
2833049|NCT02579265|3534630|FG000|COMPLETED|Overall Study||33
2833050|NCT02579265|3534631|FG001|COMPLETED|Overall Study||33
2833051|NCT02579265|3534630|FG000|NOT COMPLETED|Overall Study||50
2833052|NCT02579265|3534631|FG001|NOT COMPLETED|Overall Study||45
2833087|NCT01981850|3534672|FG005|COMPLETED|Main Phase Stage 1||0
2833088|NCT01981850|3534673|FG006|COMPLETED|Main Phase Stage 1||0
2833089|NCT01981850|3534674|FG007|COMPLETED|Main Phase Stage 1||0
2833090|NCT01981850|3534675|FG008|COMPLETED|Main Phase Stage 1||0
2833091|NCT01981850|3534676|FG009|COMPLETED|Main Phase Stage 1||0
2833092|NCT01981850|3534667|FG000|NOT COMPLETED|Main Phase Stage 1||3
2833093|NCT01981850|3534668|FG001|NOT COMPLETED|Main Phase Stage 1||2
2833094|NCT01981850|3534669|FG002|NOT COMPLETED|Main Phase Stage 1||2
2833095|NCT01981850|3534670|FG003|NOT COMPLETED|Main Phase Stage 1||0
2833096|NCT01981850|3534671|FG004|NOT COMPLETED|Main Phase Stage 1||0
2833097|NCT01981850|3534672|FG005|NOT COMPLETED|Main Phase Stage 1||0
2833098|NCT01981850|3534673|FG006|NOT COMPLETED|Main Phase Stage 1||0
2833099|NCT01981850|3534674|FG007|NOT COMPLETED|Main Phase Stage 1||0
2833100|NCT01981850|3534675|FG008|NOT COMPLETED|Main Phase Stage 1||0
2833101|NCT01981850|3534676|FG009|NOT COMPLETED|Main Phase Stage 1||0
2833102|NCT01981850|3534667|FG000|STARTED|Main Phase Stage 2||0
2833103|NCT01981850|3534668|FG001|STARTED|Main Phase Stage 2||0
2833104|NCT01981850|3534669|FG002|STARTED|Main Phase Stage 2||0
2833105|NCT01981850|3534670|FG003|STARTED|Main Phase Stage 2||0
2833106|NCT01981850|3534671|FG004|STARTED|Main Phase Stage 2||33
2833107|NCT01981850|3534672|FG005|STARTED|Main Phase Stage 2||32
2833108|NCT01981850|3534673|FG006|STARTED|Main Phase Stage 2||32
2833109|NCT01981850|3534674|FG007|STARTED|Main Phase Stage 2||0
3133686|NCT01696942|3858598|FG000|NOT COMPLETED|Overall Study||2
3133687|NCT01696942|3858599|FG001|NOT COMPLETED|Overall Study||3
3133688|NCT01696955|3858607|FG000|STARTED|Main Study||42
2833110|NCT01981850|3534675|FG008|STARTED|Main Phase Stage 2||0
2833111|NCT01981850|3534676|FG009|STARTED|Main Phase Stage 2||0
2833112|NCT01981850|3534667|FG000|COMPLETED|Main Phase Stage 2||0
2833113|NCT01981850|3534668|FG001|COMPLETED|Main Phase Stage 2||0
2833114|NCT01981850|3534669|FG002|COMPLETED|Main Phase Stage 2||0
2833115|NCT01981850|3534670|FG003|COMPLETED|Main Phase Stage 2||0
2833116|NCT01981850|3534671|FG004|COMPLETED|Main Phase Stage 2||20
2833117|NCT01981850|3534672|FG005|COMPLETED|Main Phase Stage 2||16
2833118|NCT01981850|3534673|FG006|COMPLETED|Main Phase Stage 2||15
2833119|NCT01981850|3534674|FG007|COMPLETED|Main Phase Stage 2||0
2833120|NCT01981850|3534675|FG008|COMPLETED|Main Phase Stage 2||0
2833121|NCT01981850|3534676|FG009|COMPLETED|Main Phase Stage 2||0
2833122|NCT01981850|3534667|FG000|NOT COMPLETED|Main Phase Stage 2||0
2833123|NCT01981850|3534668|FG001|NOT COMPLETED|Main Phase Stage 2||0
2833124|NCT01981850|3534669|FG002|NOT COMPLETED|Main Phase Stage 2||0
2833125|NCT01981850|3534670|FG003|NOT COMPLETED|Main Phase Stage 2||0
2833126|NCT01981850|3534671|FG004|NOT COMPLETED|Main Phase Stage 2||13
2833127|NCT01981850|3534672|FG005|NOT COMPLETED|Main Phase Stage 2||16
2833128|NCT01981850|3534673|FG006|NOT COMPLETED|Main Phase Stage 2||17
2833129|NCT01981850|3534674|FG007|NOT COMPLETED|Main Phase Stage 2||0
2833130|NCT01981850|3534675|FG008|NOT COMPLETED|Main Phase Stage 2||0
2833131|NCT01981850|3534676|FG009|NOT COMPLETED|Main Phase Stage 2||0
2833132|NCT01981850|3534667|FG000|STARTED|Open Label Extension (OLE)||0
2833133|NCT01981850|3534668|FG001|STARTED|Open Label Extension (OLE)||0
2833134|NCT01981850|3534669|FG002|STARTED|Open Label Extension (OLE)||0
2833135|NCT01981850|3534670|FG003|STARTED|Open Label Extension (OLE)||0
2833136|NCT01981850|3534671|FG004|STARTED|Open Label Extension (OLE)||0
2833137|NCT01981850|3534672|FG005|STARTED|Open Label Extension (OLE)||0
2833138|NCT01981850|3534673|FG006|STARTED|Open Label Extension (OLE)||0
2833139|NCT01981850|3534674|FG007|STARTED|Open Label Extension (OLE)||13
2833140|NCT01981850|3534675|FG008|STARTED|Open Label Extension (OLE)||5
2833141|NCT01981850|3534676|FG009|STARTED|Open Label Extension (OLE)||48
2833142|NCT01981850|3534667|FG000|COMPLETED|Open Label Extension (OLE)||0
2833143|NCT01981850|3534668|FG001|COMPLETED|Open Label Extension (OLE)||0
2833144|NCT01981850|3534669|FG002|COMPLETED|Open Label Extension (OLE)||0
2833145|NCT01981850|3534670|FG003|COMPLETED|Open Label Extension (OLE)||0
3310466|NCT03040804|4043899|FG000|COMPLETED|Overall Study||2
3310467|NCT03040804|4043899|FG000|NOT COMPLETED|Overall Study||0
3310468|NCT03040986|4043905|FG000|STARTED|Overall Study||6
3310469|NCT03040986|4043906|FG001|STARTED|Overall Study||2
3310470|NCT03040986|4043905|FG000|COMPLETED|Overall Study||0
3310471|NCT03040986|4043906|FG001|COMPLETED|Overall Study||0
3310472|NCT03040986|4043905|FG000|NOT COMPLETED|Overall Study||6
3310473|NCT03040986|4043906|FG001|NOT COMPLETED|Overall Study||2
2833146|NCT01981850|3534671|FG004|COMPLETED|Open Label Extension (OLE)||0
3133689|NCT01696955|3858608|FG001|STARTED|Main Study||39
3133690|NCT01696955|3858607|FG000|COMPLETED|Main Study||40
3133691|NCT01696955|3858608|FG001|COMPLETED|Main Study||38
3133692|NCT01696955|3858607|FG000|NOT COMPLETED|Main Study||2
3133693|NCT01696955|3858608|FG001|NOT COMPLETED|Main Study||1
3133694|NCT01696955|3858607|FG000|STARTED|Failure on Cetuximab-Received Tivantinib||0
3133695|NCT01696955|3858608|FG001|STARTED|Failure on Cetuximab-Received Tivantinib||15
3133696|NCT01696955|3858607|FG000|COMPLETED|Failure on Cetuximab-Received Tivantinib||0
3133697|NCT01696955|3858608|FG001|COMPLETED|Failure on Cetuximab-Received Tivantinib|23 patients did not cross over|15
3133698|NCT01696955|3858607|FG000|NOT COMPLETED|Failure on Cetuximab-Received Tivantinib||0
3133699|NCT01696955|3858608|FG001|NOT COMPLETED|Failure on Cetuximab-Received Tivantinib||0
3133700|NCT01696968|3858623|FG000|STARTED|Overall Study||77456
3133701|NCT01696968|3858624|FG001|STARTED|Overall Study||77445
3133702|NCT01696968|3858623|FG000|COMPLETED|Overall Study||76255
3133703|NCT01696968|3858624|FG001|COMPLETED|Overall Study||70633
3133704|NCT01696968|3858623|FG000|NOT COMPLETED|Overall Study||1201
3133705|NCT01696968|3858624|FG001|NOT COMPLETED|Overall Study||6812
3133706|NCT01696981|3858633|FG000|STARTED|Overall Study||77455
3133707|NCT01696981|3858634|FG001|STARTED|Overall Study||77445
3133708|NCT01696981|3858633|FG000|COMPLETED|Overall Study||76254
3133709|NCT01696981|3858634|FG001|COMPLETED|Overall Study||67071
3133710|NCT01696981|3858633|FG000|NOT COMPLETED|Overall Study||1201
2833147|NCT01981850|3534672|FG005|COMPLETED|Open Label Extension (OLE)||0
2833148|NCT01981850|3534673|FG006|COMPLETED|Open Label Extension (OLE)||0
2833149|NCT01981850|3534674|FG007|COMPLETED|Open Label Extension (OLE)||1
2833150|NCT01981850|3534675|FG008|COMPLETED|Open Label Extension (OLE)||0
2833151|NCT01981850|3534676|FG009|COMPLETED|Open Label Extension (OLE)||0
2833152|NCT01981850|3534667|FG000|NOT COMPLETED|Open Label Extension (OLE)||0
2833153|NCT01981850|3534668|FG001|NOT COMPLETED|Open Label Extension (OLE)||0
2833154|NCT01981850|3534669|FG002|NOT COMPLETED|Open Label Extension (OLE)||0
2833155|NCT01981850|3534670|FG003|NOT COMPLETED|Open Label Extension (OLE)||0
2833156|NCT01981850|3534671|FG004|NOT COMPLETED|Open Label Extension (OLE)||0
2833157|NCT01981850|3534672|FG005|NOT COMPLETED|Open Label Extension (OLE)||0
2833158|NCT01981850|3534673|FG006|NOT COMPLETED|Open Label Extension (OLE)||0
2833159|NCT01981850|3534674|FG007|NOT COMPLETED|Open Label Extension (OLE)||12
2833160|NCT01981850|3534675|FG008|NOT COMPLETED|Open Label Extension (OLE)||5
2833161|NCT01981850|3534676|FG009|NOT COMPLETED|Open Label Extension (OLE)||48
2833162|NCT01804816|3534708|FG000|STARTED|No Acupuncture (Initial 5 Weeks)||14
2833163|NCT01804816|3534708|FG000|COMPLETED|No Acupuncture (Initial 5 Weeks)||11
2833164|NCT01804816|3534708|FG000|NOT COMPLETED|No Acupuncture (Initial 5 Weeks)||3
2833165|NCT01804816|3534708|FG000|STARTED|Acupuncture (Second 5 Weeks)||11
2833166|NCT01804816|3534708|FG000|COMPLETED|Acupuncture (Second 5 Weeks)||10
2833167|NCT01804816|3534708|FG000|NOT COMPLETED|Acupuncture (Second 5 Weeks)||1
2833168|NCT01572207|3534717|FG000|STARTED|Overall Study||14
2833169|NCT01572207|3534718|FG001|STARTED|Overall Study||16
2833170|NCT01572207|3534717|FG000|COMPLETED|Overall Study||12
2833171|NCT01572207|3534718|FG001|COMPLETED|Overall Study||13
2833172|NCT01572207|3534717|FG000|NOT COMPLETED|Overall Study||2
2833173|NCT01572207|3534718|FG001|NOT COMPLETED|Overall Study||3
2833174|NCT01550315|3534726|FG000|STARTED|Overall Study||7
2833175|NCT01550315|3534727|FG001|STARTED|Overall Study||7
2833176|NCT01550315|3534728|FG002|STARTED|Overall Study||6
2833177|NCT01550315|3534729|FG003|STARTED|Overall Study||7
2833178|NCT01550315|3534726|FG000|COMPLETED|Overall Study||7
2833179|NCT01550315|3534727|FG001|COMPLETED|Overall Study||7
2833180|NCT01550315|3534728|FG002|COMPLETED|Overall Study||6
2833181|NCT01550315|3534729|FG003|COMPLETED|Overall Study||7
2833182|NCT01550315|3534726|FG000|NOT COMPLETED|Overall Study||0
2833183|NCT01550315|3534727|FG001|NOT COMPLETED|Overall Study||0
2833184|NCT01550315|3534728|FG002|NOT COMPLETED|Overall Study||0
2833185|NCT01550315|3534729|FG003|NOT COMPLETED|Overall Study||0
2833186|NCT01519960|3534742|FG000|STARTED|Overall Study||101
2833187|NCT01519960|3534743|FG001|STARTED|Overall Study||50
2833188|NCT01519960|3534744|FG002|STARTED|Overall Study||10
2833189|NCT01519960|3534742|FG000|Completed Week 48|Overall Study||99
2833190|NCT01519960|3534743|FG001|Completed Week 48|Overall Study||47
2833191|NCT01519960|3534744|FG002|Completed Week 48|Overall Study||10
2833192|NCT01519960|3534742|FG000|Completed Follow-Up (FU) Week 12|Overall Study||101
2833193|NCT01519960|3534743|FG001|Completed Follow-Up (FU) Week 12|Overall Study||26
2833194|NCT01519960|3534744|FG002|Completed Follow-Up (FU) Week 12|Overall Study||10
2833195|NCT01519960|3534742|FG000|Completed FU Week 24|Overall Study||101
2833196|NCT01519960|3534743|FG001|Completed FU Week 24|Overall Study||15
3310474|NCT03041025|4043917|FG000|STARTED|Overall Study||8
3310475|NCT03041025|4043918|FG001|STARTED|Overall Study||3
3310476|NCT03041025|4043919|FG002|STARTED|Overall Study||24
3310477|NCT03041025|4043917|FG000|COMPLETED|Overall Study||7
3310478|NCT03041025|4043918|FG001|COMPLETED|Overall Study||3
3310479|NCT03041025|4043919|FG002|COMPLETED|Overall Study||22
3310480|NCT03041025|4043917|FG000|NOT COMPLETED|Overall Study||1
3310481|NCT03041025|4043918|FG001|NOT COMPLETED|Overall Study||0
3310482|NCT03041025|4043919|FG002|NOT COMPLETED|Overall Study||2
3310483|NCT03041038|4043932|FG000|STARTED|Overall Study||11
3310484|NCT03041038|4043933|FG001|STARTED|Overall Study||9
3310485|NCT03041038|4043932|FG000|Week 16|Overall Study||10
3310486|NCT03041038|4043933|FG001|Week 16|Overall Study||8
3310487|NCT03041038|4043932|FG000|Week 32|Overall Study||9
3310488|NCT03041038|4043933|FG001|Week 32|Overall Study||8
3310489|NCT03041038|4043932|FG000|COMPLETED|Overall Study||5
3310490|NCT03041038|4043933|FG001|COMPLETED|Overall Study||7
3310491|NCT03041038|4043932|FG000|NOT COMPLETED|Overall Study||6
3310492|NCT03041038|4043933|FG001|NOT COMPLETED|Overall Study||2
3310493|NCT03041090|4043943|FG000|STARTED|Overall Study||109
3310494|NCT03041090|4043944|FG001|STARTED|Overall Study||24
3310495|NCT03041090|4043943|FG000|COMPLETED|Overall Study||109
3310496|NCT03041090|4043944|FG001|COMPLETED|Overall Study|3 consented subjects in the dynamic arm were not included in analysis due to technical errors.|21
3310497|NCT03041090|4043943|FG000|NOT COMPLETED|Overall Study||0
3310498|NCT03041090|4043944|FG001|NOT COMPLETED|Overall Study||3
3310499|NCT03041116|4043952|FG000|STARTED|Double-blind||41
3310500|NCT03041116|4043953|FG001|STARTED|Double-blind||43
3310501|NCT03041116|4043952|FG000|Received at Least 1 Dose of Study Drug|Double-blind||41
3310502|NCT03041116|4043953|FG001|Received at Least 1 Dose of Study Drug|Double-blind||43
3310503|NCT03041116|4043952|FG000|COMPLETED|Double-blind||41
3310504|NCT03041116|4043953|FG001|COMPLETED|Double-blind||37
3310505|NCT03041116|4043952|FG000|NOT COMPLETED|Double-blind||0
3310506|NCT03041116|4043953|FG001|NOT COMPLETED|Double-blind||6
3310507|NCT03041116|4043952|FG000|STARTED|Open-label||41
3310508|NCT03041116|4043953|FG001|STARTED|Open-label||37
3310509|NCT03041116|4043952|FG000|Received At Least 1 Dose of Study Drug|Open-label||41
3310510|NCT03041116|4043953|FG001|Received At Least 1 Dose of Study Drug|Open-label||37
2833197|NCT01519960|3534744|FG002|Completed FU Week 24|Overall Study||10
2833198|NCT01519960|3534742|FG000|COMPLETED|Overall Study||0
2833199|NCT01519960|3534743|FG001|COMPLETED|Overall Study||0
2833200|NCT01519960|3534744|FG002|COMPLETED|Overall Study||0
2833201|NCT01519960|3534742|FG000|NOT COMPLETED|Overall Study||101
2833202|NCT01519960|3534743|FG001|NOT COMPLETED|Overall Study||50
2833203|NCT01519960|3534744|FG002|NOT COMPLETED|Overall Study||10
2833204|NCT00688376|3534757|FG000|STARTED|Double-Blind Phase||40
2833205|NCT00688376|3534758|FG001|STARTED|Double-Blind Phase||32
2833206|NCT00688376|3534757|FG000|Safety Population|Double-Blind Phase||40
2833207|NCT00688376|3534758|FG001|Safety Population|Double-Blind Phase||31
2833208|NCT00688376|3534757|FG000|COMPLETED|Double-Blind Phase||34
2833209|NCT00688376|3534758|FG001|COMPLETED|Double-Blind Phase||25
2833210|NCT00688376|3534757|FG000|NOT COMPLETED|Double-Blind Phase||6
2833211|NCT00688376|3534758|FG001|NOT COMPLETED|Double-Blind Phase||7
2833212|NCT00688376|3534757|FG000|STARTED|Blinded Extension Phase||34
2833213|NCT00688376|3534758|FG001|STARTED|Blinded Extension Phase||25
2833214|NCT00688376|3534757|FG000|COMPLETED|Blinded Extension Phase||29
3166940|NCT01905657|3894007|FG001|COMPLETED|Overall Study||159
3166941|NCT01905657|3894008|FG002|COMPLETED|Overall Study||143
3166942|NCT01905657|3894006|FG000|NOT COMPLETED|Overall Study||203
3166943|NCT01905657|3894007|FG001|NOT COMPLETED|Overall Study||187
3166944|NCT01905657|3894008|FG002|NOT COMPLETED|Overall Study||200
3166945|NCT01905683|3894019|FG000|STARTED|Overall Study||370
3166946|NCT01905683|3894019|FG000|COMPLETED|Overall Study||319
3166947|NCT01905683|3894019|FG000|NOT COMPLETED|Overall Study||51
3166948|NCT01905943|3894023|FG000|STARTED|Overall Study||972
2833215|NCT00688376|3534758|FG001|COMPLETED|Blinded Extension Phase||20
2833216|NCT00688376|3534757|FG000|NOT COMPLETED|Blinded Extension Phase||5
2833217|NCT00688376|3534758|FG001|NOT COMPLETED|Blinded Extension Phase||5
2833218|NCT00604201|3534766|FG000|STARTED|Overall Study||31
2833219|NCT00604201|3534766|FG000|COMPLETED|Overall Study||21
2833220|NCT00604201|3534766|FG000|NOT COMPLETED|Overall Study||10
3166949|NCT01905943|3894023|FG000|COMPLETED|Overall Study|All patients provide reason at final analysis|658
3166950|NCT01905943|3894023|FG000|NOT COMPLETED|Overall Study||314
3166951|NCT01905956|3894044|FG000|STARTED|Overall Study|Randomized|60
3310511|NCT03041116|4043952|FG000|COMPLETED|Open-label||0
3310512|NCT03041116|4043953|FG001|COMPLETED|Open-label||0
3310513|NCT03041116|4043952|FG000|NOT COMPLETED|Open-label||41
3310514|NCT03041116|4043953|FG001|NOT COMPLETED|Open-label||37
3310515|NCT03041181|4043965|FG000|STARTED|Overall Study||1
3310516|NCT03041181|4043966|FG001|STARTED|Overall Study||2
3310517|NCT03041181|4043965|FG000|COMPLETED|Overall Study||0
3310518|NCT03041181|4043966|FG001|COMPLETED|Overall Study||0
3310519|NCT03041181|4043965|FG000|NOT COMPLETED|Overall Study||1
3310520|NCT03041181|4043966|FG001|NOT COMPLETED|Overall Study||2
3310521|NCT03041298|4043972|FG000|STARTED|Overall Study||1537
3310522|NCT03041298|4043972|FG000|COMPLETED|Overall Study||1537
3310523|NCT03041298|4043972|FG000|NOT COMPLETED|Overall Study||0
3310524|NCT03041441|4043976|FG000|STARTED|Overall Study||5
3310525|NCT03041441|4043976|FG000|COMPLETED|Overall Study||3
3310526|NCT03041441|4043976|FG000|NOT COMPLETED|Overall Study||2
3310527|NCT03041467|4043983|FG000|STARTED|Overall Study||170
3310528|NCT03041467|4043984|FG001|STARTED|Overall Study||160
3310529|NCT03041467|4043983|FG000|COMPLETED|Overall Study||0
3310530|NCT03041467|4043984|FG001|COMPLETED|Overall Study||0
3310531|NCT03041467|4043983|FG000|NOT COMPLETED|Overall Study||170
3310532|NCT03041467|4043984|FG001|NOT COMPLETED|Overall Study||160
3310533|NCT03041636|4043992|FG000|STARTED|Overall Study||1
3310534|NCT03041636|4043992|FG000|COMPLETED|Overall Study||1
3310535|NCT03041636|4043992|FG000|NOT COMPLETED|Overall Study||0
3310536|NCT03041792|4043998|FG000|STARTED|Overall Study||32
3310537|NCT03041792|4043999|FG001|STARTED|Overall Study||29
3310538|NCT03041792|4043998|FG000|Received Treatment|Overall Study||32
3310539|NCT03041792|4043999|FG001|Received Treatment|Overall Study||28
3310540|NCT03041792|4043998|FG000|COMPLETED|Overall Study||28
3310541|NCT03041792|4043999|FG001|COMPLETED|Overall Study||26
3310542|NCT03041792|4043998|FG000|NOT COMPLETED|Overall Study||4
3310543|NCT03041792|4043999|FG001|NOT COMPLETED|Overall Study||3
3310544|NCT03041896|4044009|FG000|STARTED|Overall Study||1486
3310545|NCT03041896|4044010|FG001|STARTED|Overall Study||1009
3310546|NCT03041896|4044011|FG002|STARTED|Overall Study||2299
3310547|NCT03041896|4044012|FG003|STARTED|Overall Study||256
3310548|NCT03041896|4044009|FG000|COMPLETED|Overall Study||1486
3310549|NCT03041896|4044010|FG001|COMPLETED|Overall Study||1009
3310550|NCT03041896|4044011|FG002|COMPLETED|Overall Study||2236
3310551|NCT03041896|4044012|FG003|COMPLETED|Overall Study||253
3310552|NCT03041896|4044009|FG000|NOT COMPLETED|Overall Study||0
3310553|NCT03041896|4044010|FG001|NOT COMPLETED|Overall Study||0
3310554|NCT03041896|4044011|FG002|NOT COMPLETED|Overall Study||63
3310555|NCT03041896|4044012|FG003|NOT COMPLETED|Overall Study||3
3310556|NCT03041909|4044029|FG000|STARTED|Overall Study||3
3310557|NCT03041909|4044030|FG001|STARTED|Overall Study||1
3310558|NCT03041909|4044031|FG002|STARTED|Overall Study||1
3310559|NCT03041909|4044029|FG000|COMPLETED|Overall Study||3
3310560|NCT03041909|4044030|FG001|COMPLETED|Overall Study||1
2833221|NCT00492349|3534772|FG000|STARTED|Overall Study||35
2833222|NCT00492349|3534773|FG001|STARTED|Overall Study||34
2833223|NCT00492349|3534772|FG000|Week 2|Overall Study||32
3166952|NCT01905956|3894045|FG001|STARTED|Overall Study|Randomized|59
3310561|NCT03041909|4044031|FG002|COMPLETED|Overall Study||1
3310562|NCT03041909|4044029|FG000|NOT COMPLETED|Overall Study||0
2833224|NCT00492349|3534773|FG001|Week 2|Overall Study||33
2833225|NCT00492349|3534772|FG000|Week 8|Overall Study||32
2833226|NCT00492349|3534773|FG001|Week 8|Overall Study||27
2833227|NCT00492349|3534772|FG000|COMPLETED|Overall Study||32
2833228|NCT00492349|3534773|FG001|COMPLETED|Overall Study||27
2833229|NCT00492349|3534772|FG000|NOT COMPLETED|Overall Study||3
2833230|NCT00492349|3534773|FG001|NOT COMPLETED|Overall Study||7
2833231|NCT00121108|3534785|FG000|STARTED|Overall Study||710
2833232|NCT00121108|3534786|FG001|STARTED|Overall Study||1417
2833233|NCT00121108|3534785|FG000|COMPLETED|Overall Study||589
2833234|NCT00121108|3534786|FG001|COMPLETED|Overall Study||1192
2833235|NCT00121108|3534785|FG000|NOT COMPLETED|Overall Study||121
2833236|NCT00121108|3534786|FG001|NOT COMPLETED|Overall Study||225
2833237|NCT00003102|3534796|FG000|STARTED|Overall Study||3
2833238|NCT00003102|3534797|FG001|STARTED|Overall Study||9
2833239|NCT00003102|3534798|FG002|STARTED|Overall Study||3
2833240|NCT00003102|3534796|FG000|COMPLETED|Overall Study||2
2833241|NCT00003102|3534797|FG001|COMPLETED|Overall Study||6
2833242|NCT00003102|3534798|FG002|COMPLETED|Overall Study||1
2833243|NCT00003102|3534796|FG000|NOT COMPLETED|Overall Study||1
2833244|NCT00003102|3534797|FG001|NOT COMPLETED|Overall Study||3
2833245|NCT00003102|3534798|FG002|NOT COMPLETED|Overall Study||2
2914374|NCT00503698|3624458|FG001|NOT COMPLETED|Overall Study||355
2914375|NCT00503750|3624464|FG000|STARTED|Overall Study||27
2914376|NCT00503750|3624464|FG000|COMPLETED|Overall Study||27
2914377|NCT00503750|3624464|FG000|NOT COMPLETED|Overall Study||0
2914378|NCT00503776|3624472|FG000|STARTED|Overall Study||8
2914379|NCT00503776|3624473|FG001|STARTED|Overall Study||12
2914380|NCT00503776|3624474|FG002|STARTED|Overall Study|one patient withdrew before receiving protocol therapy|12
2914381|NCT00503776|3624475|FG003|STARTED|Overall Study|one patient withdrew before receiving protocol therapy|10
2914382|NCT00503776|3624472|FG000|COMPLETED|Overall Study||7
2914383|NCT00503776|3624473|FG001|COMPLETED|Overall Study||12
2914384|NCT00503776|3624474|FG002|COMPLETED|Overall Study||10
2914385|NCT00503776|3624475|FG003|COMPLETED|Overall Study||8
2914386|NCT00503776|3624472|FG000|NOT COMPLETED|Overall Study||1
2914387|NCT00503776|3624473|FG001|NOT COMPLETED|Overall Study||0
2914388|NCT00503776|3624474|FG002|NOT COMPLETED|Overall Study||2
2914389|NCT00503776|3624475|FG003|NOT COMPLETED|Overall Study||2
2914390|NCT00503867|3624490|FG000|STARTED|Overall Study||10
2914391|NCT00503867|3624490|FG000|COMPLETED|Overall Study||8
2914392|NCT00503867|3624490|FG000|NOT COMPLETED|Overall Study||2
2914393|NCT00503906|3624494|FG000|STARTED|Overall Study||30
2914394|NCT00503906|3624494|FG000|COMPLETED|Overall Study||29
2914395|NCT00503906|3624494|FG000|NOT COMPLETED|Overall Study||1
3310563|NCT03041909|4044030|FG001|NOT COMPLETED|Overall Study||0
3310564|NCT03041909|4044031|FG002|NOT COMPLETED|Overall Study||0
3310565|NCT03042299|4044041|FG000|STARTED|Intervention Period 1 (6 Days)||7
3310566|NCT03042299|4044042|FG001|STARTED|Intervention Period 1 (6 Days)||7
3310567|NCT03042299|4044041|FG000|COMPLETED|Intervention Period 1 (6 Days)||7
3310568|NCT03042299|4044042|FG001|COMPLETED|Intervention Period 1 (6 Days)||7
3310569|NCT03042299|4044041|FG000|NOT COMPLETED|Intervention Period 1 (6 Days)||0
3310570|NCT03042299|4044042|FG001|NOT COMPLETED|Intervention Period 1 (6 Days)||0
3310571|NCT03042299|4044041|FG000|STARTED|Washout Period (at Least 6 Days)||7
3310572|NCT03042299|4044042|FG001|STARTED|Washout Period (at Least 6 Days)||7
3310573|NCT03042299|4044041|FG000|COMPLETED|Washout Period (at Least 6 Days)||7
3310574|NCT03042299|4044042|FG001|COMPLETED|Washout Period (at Least 6 Days)||7
3310575|NCT03042299|4044041|FG000|NOT COMPLETED|Washout Period (at Least 6 Days)||0
3310576|NCT03042299|4044042|FG001|NOT COMPLETED|Washout Period (at Least 6 Days)||0
3310577|NCT03042299|4044041|FG000|STARTED|Intervention Period 2 (6 Days)||7
3310578|NCT03042299|4044042|FG001|STARTED|Intervention Period 2 (6 Days)||7
3310579|NCT03042299|4044041|FG000|COMPLETED|Intervention Period 2 (6 Days)||7
3310580|NCT03042299|4044042|FG001|COMPLETED|Intervention Period 2 (6 Days)||7
3310581|NCT03042299|4044041|FG000|NOT COMPLETED|Intervention Period 2 (6 Days)||0
3310582|NCT03042299|4044042|FG001|NOT COMPLETED|Intervention Period 2 (6 Days)||0
3310583|NCT03042312|4044050|FG000|STARTED|Overall Study||28
3310584|NCT03042312|4044051|FG001|STARTED|Overall Study||43
3310585|NCT03042312|4044050|FG000|Safety Population|Overall Study||23
3310586|NCT03042312|4044051|FG001|Safety Population|Overall Study||41
3310587|NCT03042312|4044050|FG000|COMPLETED|Overall Study||18
3310588|NCT03042312|4044051|FG001|COMPLETED|Overall Study||31
3310589|NCT03042312|4044050|FG000|NOT COMPLETED|Overall Study||10
3310590|NCT03042312|4044051|FG001|NOT COMPLETED|Overall Study||12
3310591|NCT03042559|4044059|FG000|STARTED|Overall Study||22
3310592|NCT03042559|4044060|FG001|STARTED|Overall Study||21
3310593|NCT03042559|4044059|FG000|COMPLETED|Overall Study||21
3310594|NCT03042559|4044060|FG001|COMPLETED|Overall Study||20
3310595|NCT03042559|4044059|FG000|NOT COMPLETED|Overall Study||1
3310596|NCT03042559|4044060|FG001|NOT COMPLETED|Overall Study||1
3310597|NCT03042702|4044066|FG000|STARTED|Overall Study||2
3310598|NCT03042702|4044066|FG000|COMPLETED|Overall Study||2
3310599|NCT03042702|4044066|FG000|NOT COMPLETED|Overall Study||0
3310600|NCT03042715|4044071|FG000|STARTED|Overall Study||6
3310601|NCT03042715|4044071|FG000|COMPLETED|Overall Study||5
3310602|NCT03042715|4044071|FG000|NOT COMPLETED|Overall Study||1
3310603|NCT03042767|4044077|FG000|STARTED|Overall Study||12
3310604|NCT03042767|4044078|FG001|STARTED|Overall Study||13
3310605|NCT03042767|4044077|FG000|COMPLETED|Overall Study||11
3310606|NCT03042767|4044078|FG001|COMPLETED|Overall Study||11
2833246|NCT04633837|3534808|FG000|STARTED|Overall Study||5
2833247|NCT04633837|3534809|FG001|STARTED|Overall Study||0
2833248|NCT04633837|3534808|FG000|COMPLETED|Overall Study||0
2833249|NCT04633837|3534809|FG001|COMPLETED|Overall Study||0
2833250|NCT04633837|3534808|FG000|NOT COMPLETED|Overall Study||5
2833251|NCT04633837|3534809|FG001|NOT COMPLETED|Overall Study||0
2833252|NCT04057937|3534817|FG000|STARTED|Placebo-controlled Phase||44
2833253|NCT04057937|3534818|FG001|STARTED|Placebo-controlled Phase||46
2833254|NCT04057937|3534817|FG000|COMPLETED|Placebo-controlled Phase||41
2833255|NCT04057937|3534818|FG001|COMPLETED|Placebo-controlled Phase||46
2833256|NCT04057937|3534817|FG000|NOT COMPLETED|Placebo-controlled Phase||3
2833257|NCT04057937|3534818|FG001|NOT COMPLETED|Placebo-controlled Phase||0
2833258|NCT04057937|3534817|FG000|STARTED|Active-treatment Phase||41
2833259|NCT04057937|3534818|FG001|STARTED|Active-treatment Phase||46
2833260|NCT04057937|3534817|FG000|COMPLETED|Active-treatment Phase||40
2833261|NCT04057937|3534818|FG001|COMPLETED|Active-treatment Phase||44
2833262|NCT04057937|3534817|FG000|NOT COMPLETED|Active-treatment Phase||1
2833263|NCT04057937|3534818|FG001|NOT COMPLETED|Active-treatment Phase||2
2833264|NCT03674112|3534827|FG000|STARTED|Overall Study||80
2833265|NCT03674112|3534828|FG001|STARTED|Overall Study||80
2833266|NCT03674112|3534827|FG000|Completed Cross-Over Treatment (Cycles 1 to 6)|Overall Study||80
2833267|NCT03674112|3534828|FG001|Completed Cross-Over Treatment (Cycles 1 to 6)|Overall Study||80
2833268|NCT03674112|3534827|FG000|Completed Continuation Treatment (Cycles 7 up to 18 Total)|Overall Study||34
2833269|NCT03674112|3534828|FG001|Completed Continuation Treatment (Cycles 7 up to 18 Total)|Overall Study||36
2833270|NCT03674112|3534827|FG000|Completed Post-Treatment Follow-Up (Up to 3 Years)|Overall Study||0
2833271|NCT03674112|3534828|FG001|Completed Post-Treatment Follow-Up (Up to 3 Years)|Overall Study||0
2833272|NCT03674112|3534827|FG000|COMPLETED|Overall Study||0
2833273|NCT03674112|3534828|FG001|COMPLETED|Overall Study||0
2833274|NCT03674112|3534827|FG000|NOT COMPLETED|Overall Study||80
2833275|NCT03674112|3534828|FG001|NOT COMPLETED|Overall Study||80
2833276|NCT03566732|3534854|FG000|STARTED|Overall Study|1683 eligible cases identified and screened, 914 participants enrolled.|914
2833277|NCT03566732|3534854|FG000|COMPLETED|Overall Study|914 completed questionnaires|914
2833278|NCT03566732|3534854|FG000|NOT COMPLETED|Overall Study||0
2833279|NCT03032510|3534860|FG000|STARTED|Overall Study||603
2833280|NCT03032510|3534861|FG001|STARTED|Overall Study||602
2833281|NCT03032510|3534860|FG000|COMPLETED|Overall Study||576
2833282|NCT03032510|3534861|FG001|COMPLETED|Overall Study||584
2833283|NCT03032510|3534860|FG000|NOT COMPLETED|Overall Study||27
2833284|NCT03032510|3534861|FG001|NOT COMPLETED|Overall Study||18
2833285|NCT03029000|3534871|FG000|STARTED|Overall Study||1
2833286|NCT03029000|3534871|FG000|COMPLETED|Overall Study||1
2833287|NCT03029000|3534871|FG000|NOT COMPLETED|Overall Study||0
2833288|NCT03022292|3534875|FG000|STARTED|Overall Study||26
2833289|NCT03022292|3534875|FG000|COMPLETED|Overall Study||24
2833290|NCT03022292|3534875|FG000|NOT COMPLETED|Overall Study||2
2833291|NCT02968602|3534881|FG000|STARTED|Overall Study||16
2833292|NCT02968602|3534882|FG001|STARTED|Overall Study||16
2833293|NCT02968602|3534881|FG000|COMPLETED|Overall Study||16
2833294|NCT02968602|3534882|FG001|COMPLETED|Overall Study||16
2833295|NCT02968602|3534881|FG000|NOT COMPLETED|Overall Study||0
2833296|NCT02968602|3534882|FG001|NOT COMPLETED|Overall Study||0
2833297|NCT02946047|3534892|FG000|STARTED|Overall Study||4
2833298|NCT02946047|3534893|FG001|STARTED|Overall Study||3
2833299|NCT02946047|3534894|FG002|STARTED|Overall Study||3
2833300|NCT02946047|3534895|FG003|STARTED|Overall Study||7
2833301|NCT02946047|3534892|FG000|COMPLETED|Overall Study||3
2833302|NCT02946047|3534893|FG001|COMPLETED|Overall Study||3
2833303|NCT02946047|3534894|FG002|COMPLETED|Overall Study||3
2833304|NCT02946047|3534895|FG003|COMPLETED|Overall Study||7
2833305|NCT02946047|3534892|FG000|NOT COMPLETED|Overall Study||1
2833306|NCT02946047|3534893|FG001|NOT COMPLETED|Overall Study||0
2833307|NCT02946047|3534894|FG002|NOT COMPLETED|Overall Study||0
2833308|NCT02946047|3534895|FG003|NOT COMPLETED|Overall Study||0
3310607|NCT03042767|4044077|FG000|NOT COMPLETED|Overall Study||1
3310608|NCT03042767|4044078|FG001|NOT COMPLETED|Overall Study||2
3310609|NCT03042910|4044084|FG000|STARTED|Overall Study||38
3310610|NCT03042910|4044084|FG000|Treated|Overall Study||37
3310611|NCT03042910|4044084|FG000|COMPLETED|Overall Study||31
3310612|NCT03042910|4044084|FG000|NOT COMPLETED|Overall Study||7
3310613|NCT03043079|4044091|FG000|STARTED|Overall Study||21
3310614|NCT03043079|4044092|FG001|STARTED|Overall Study||14
3310615|NCT03043079|4044093|FG002|STARTED|Overall Study||10
3310616|NCT03043079|4044091|FG000|COMPLETED|Overall Study||21
3310617|NCT03043079|4044092|FG001|COMPLETED|Overall Study||14
3310618|NCT03043079|4044093|FG002|COMPLETED|Overall Study||10
3310619|NCT03043079|4044091|FG000|NOT COMPLETED|Overall Study||0
3310620|NCT03043079|4044092|FG001|NOT COMPLETED|Overall Study||0
3310621|NCT03043079|4044093|FG002|NOT COMPLETED|Overall Study||0
3310622|NCT03043105|4044102|FG000|STARTED|Overall Study||25
3310623|NCT03043105|4044102|FG000|COMPLETED|Overall Study||25
3310624|NCT03043105|4044102|FG000|NOT COMPLETED|Overall Study||0
3310625|NCT03043274|4044108|FG000|STARTED|Overall Study||13
3310626|NCT03043274|4044109|FG001|STARTED|Overall Study||10
3310627|NCT03043274|4044108|FG000|COMPLETED|Overall Study|The study was terminated because of slow recruitment.|13
3310628|NCT03043274|4044109|FG001|COMPLETED|Overall Study|The study was terminated because of slow recruitment.|9
3310629|NCT03043274|4044108|FG000|NOT COMPLETED|Overall Study||0
3310630|NCT03043274|4044109|FG001|NOT COMPLETED|Overall Study||1
2833309|NCT02830165|3534905|FG000|STARTED|Overall Study||11
2833310|NCT02830165|3534905|FG000|COMPLETED|Overall Study||11
2833311|NCT02830165|3534905|FG000|NOT COMPLETED|Overall Study||0
2833312|NCT02784704|3534913|FG000|STARTED|Overall Study||250
2833313|NCT02784704|3534914|FG001|STARTED|Overall Study||250
2833314|NCT02784704|3534913|FG000|Treated|Overall Study||250
2833315|NCT02784704|3534914|FG001|Treated|Overall Study||249
2833316|NCT02784704|3534913|FG000|COMPLETED|Overall Study||237
2833317|NCT02784704|3534914|FG001|COMPLETED|Overall Study||241
2833318|NCT02784704|3534913|FG000|NOT COMPLETED|Overall Study||13
2833319|NCT02784704|3534914|FG001|NOT COMPLETED|Overall Study||9
2914396|NCT00503984|3624501|FG000|STARTED|Overall Study||3
2914397|NCT00503984|3624502|FG001|STARTED|Overall Study||3
2914398|NCT00503984|3624503|FG002|STARTED|Overall Study||3
2914399|NCT00503984|3624504|FG003|STARTED|Overall Study||6
2914400|NCT00503984|3624505|FG004|STARTED|Overall Study||6
2914401|NCT00503984|3624506|FG005|STARTED|Overall Study||1
2914402|NCT00503984|3624501|FG000|COMPLETED|Overall Study||3
2914403|NCT00503984|3624502|FG001|COMPLETED|Overall Study||1
2914404|NCT00503984|3624503|FG002|COMPLETED|Overall Study||3
2914405|NCT00503984|3624504|FG003|COMPLETED|Overall Study||6
2914406|NCT00503984|3624505|FG004|COMPLETED|Overall Study||5
2914407|NCT00503984|3624506|FG005|COMPLETED|Overall Study||1
2914408|NCT00503984|3624501|FG000|NOT COMPLETED|Overall Study||0
3166953|NCT01905956|3894044|FG000|Intention-to-treat Population|Overall Study|Intention-to-treat population|57
3166954|NCT01905956|3894045|FG001|Intention-to-treat Population|Overall Study|Intention-to-treat population|54
3166955|NCT01905956|3894044|FG000|COMPLETED|Overall Study|Per-protocol population|54
3166956|NCT01905956|3894045|FG001|COMPLETED|Overall Study|Per-protocol population|48
3310631|NCT03043365|4044117|FG000|STARTED|Weeks 0 to Week 8||20
3310632|NCT03043365|4044118|FG001|STARTED|Weeks 0 to Week 8||17
2914409|NCT00503984|3624502|FG001|NOT COMPLETED|Overall Study||2
2914410|NCT00503984|3624503|FG002|NOT COMPLETED|Overall Study||0
2914411|NCT00503984|3624504|FG003|NOT COMPLETED|Overall Study||0
2914412|NCT00503984|3624505|FG004|NOT COMPLETED|Overall Study||1
2914413|NCT00503984|3624506|FG005|NOT COMPLETED|Overall Study||0
2914414|NCT00503997|3624530|FG000|STARTED|Overall Study||42
2914415|NCT00503997|3624530|FG000|COMPLETED|Overall Study||34
2914416|NCT00503997|3624530|FG000|NOT COMPLETED|Overall Study||8
2914417|NCT00504023|3624534|FG000|STARTED|Overall Study||8
2914418|NCT00504023|3624534|FG000|COMPLETED|Overall Study||8
2914419|NCT00504023|3624534|FG000|NOT COMPLETED|Overall Study||0
2914420|NCT00504075|3624538|FG000|STARTED|Overall Study||35
2914421|NCT00504075|3624538|FG000|COMPLETED|Overall Study||27
2914422|NCT00504075|3624538|FG000|NOT COMPLETED|Overall Study||8
2914423|NCT00504153|3624543|FG000|STARTED|Overall Study||19
2914424|NCT00504153|3624543|FG000|COMPLETED|Overall Study||13
3166957|NCT01905956|3894044|FG000|NOT COMPLETED|Overall Study||6
3310633|NCT03043365|4044117|FG000|COMPLETED|Weeks 0 to Week 8||17
3310634|NCT03043365|4044118|FG001|COMPLETED|Weeks 0 to Week 8||14
3310635|NCT03043365|4044117|FG000|NOT COMPLETED|Weeks 0 to Week 8||3
3310636|NCT03043365|4044118|FG001|NOT COMPLETED|Weeks 0 to Week 8||3
3310637|NCT03043365|4044117|FG000|STARTED|Week 8 to Week 16 - Washout Period||17
3310638|NCT03043365|4044118|FG001|STARTED|Week 8 to Week 16 - Washout Period||14
3310639|NCT03043365|4044117|FG000|COMPLETED|Week 8 to Week 16 - Washout Period||16
3310640|NCT03043365|4044118|FG001|COMPLETED|Week 8 to Week 16 - Washout Period||14
3310641|NCT03043365|4044117|FG000|NOT COMPLETED|Week 8 to Week 16 - Washout Period||1
3310642|NCT03043365|4044118|FG001|NOT COMPLETED|Week 8 to Week 16 - Washout Period||0
3310643|NCT03043365|4044117|FG000|STARTED|Week 16 to Week 24||16
3310644|NCT03043365|4044118|FG001|STARTED|Week 16 to Week 24||14
3310645|NCT03043365|4044117|FG000|COMPLETED|Week 16 to Week 24||16
3310646|NCT03043365|4044118|FG001|COMPLETED|Week 16 to Week 24||14
3310647|NCT03043365|4044117|FG000|NOT COMPLETED|Week 16 to Week 24||0
3310648|NCT03043365|4044118|FG001|NOT COMPLETED|Week 16 to Week 24||0
3310649|NCT03043534|4044128|FG000|STARTED|Overall Study||15
3310650|NCT03043534|4044129|FG001|STARTED|Overall Study||14
3310651|NCT03043534|4044128|FG000|COMPLETED|Overall Study||15
3310652|NCT03043534|4044129|FG001|COMPLETED|Overall Study||14
3310653|NCT03043534|4044128|FG000|NOT COMPLETED|Overall Study||0
3310654|NCT03043534|4044129|FG001|NOT COMPLETED|Overall Study||0
3310655|NCT03043560|4044137|FG000|STARTED|Overall Study||21
3310656|NCT03043560|4044138|FG001|STARTED|Overall Study||24
3310657|NCT03043560|4044137|FG000|COMPLETED|Overall Study||20
3310658|NCT03043560|4044138|FG001|COMPLETED|Overall Study||21
3310659|NCT03043560|4044137|FG000|NOT COMPLETED|Overall Study||1
3310660|NCT03043560|4044138|FG001|NOT COMPLETED|Overall Study||3
3310661|NCT03043651|4044144|FG000|STARTED|Overall Study||48
3310662|NCT03043651|4044144|FG000|COMPLETED|Overall Study||0
3310663|NCT03043651|4044144|FG000|NOT COMPLETED|Overall Study||48
3310664|NCT03043872|4044151|FG000|STARTED|Overall Study||268
3310665|NCT03043872|4044152|FG001|STARTED|Overall Study||268
3310666|NCT03043872|4044153|FG002|STARTED|Overall Study||269
3310667|NCT03043872|4044151|FG000|Received Treatment|Overall Study||266
3310668|NCT03043872|4044152|FG001|Received Treatment|Overall Study||265
3310669|NCT03043872|4044153|FG002|Received Treatment|Overall Study||266
3310670|NCT03043872|4044151|FG000|COMPLETED|Overall Study||56
3310671|NCT03043872|4044152|FG001|COMPLETED|Overall Study||56
2914425|NCT00504153|3624543|FG000|NOT COMPLETED|Overall Study||6
2914426|NCT00504166|3624549|FG000|STARTED|Overall Study||26
2914427|NCT00504166|3624550|FG001|STARTED|Overall Study||27
2914428|NCT00504166|3624549|FG000|COMPLETED|Overall Study||20
2833320|NCT04876274|3534924|FG000|STARTED|Overall Study||91
2833321|NCT04876274|3534925|FG001|STARTED|Overall Study||90
2833322|NCT04876274|3534924|FG000|COMPLETED|Overall Study||82
2833323|NCT04876274|3534925|FG001|COMPLETED|Overall Study||78
2833324|NCT04876274|3534924|FG000|NOT COMPLETED|Overall Study||9
2833325|NCT04876274|3534925|FG001|NOT COMPLETED|Overall Study||12
2833326|NCT04831515|3534931|FG000|STARTED|First Intervention||24
2833327|NCT04831515|3534932|FG001|STARTED|First Intervention||24
2833328|NCT04831515|3534931|FG000|COMPLETED|First Intervention||24
2833329|NCT04831515|3534932|FG001|COMPLETED|First Intervention||23
2833330|NCT04831515|3534931|FG000|NOT COMPLETED|First Intervention||0
2833331|NCT04831515|3534932|FG001|NOT COMPLETED|First Intervention||1
2833332|NCT04831515|3534931|FG000|STARTED|Second Intervention||24
2833333|NCT04831515|3534932|FG001|STARTED|Second Intervention||23
2833334|NCT04831515|3534931|FG000|COMPLETED|Second Intervention||24
2833335|NCT04831515|3534932|FG001|COMPLETED|Second Intervention||23
2833336|NCT04831515|3534931|FG000|NOT COMPLETED|Second Intervention||0
2833337|NCT04831515|3534932|FG001|NOT COMPLETED|Second Intervention||0
2833338|NCT04343989|3534941|FG000|STARTED|Overall Study||78
2833339|NCT04343989|3534942|FG001|STARTED|Overall Study||26
2833340|NCT04343989|3534943|FG002|STARTED|Overall Study||74
2833341|NCT04343989|3534941|FG000|COMPLETED|Overall Study||78
2833342|NCT04343989|3534942|FG001|COMPLETED|Overall Study||26
3166958|NCT01905956|3894045|FG001|NOT COMPLETED|Overall Study||11
3166959|NCT01906008|3894053|FG000|STARTED|Overall Study||59
3166960|NCT01906008|3894054|FG001|STARTED|Overall Study||61
3166961|NCT01906008|3894053|FG000|COMPLETED|Overall Study||32
3166962|NCT01906008|3894054|FG001|COMPLETED|Overall Study||34
3166963|NCT01906008|3894053|FG000|NOT COMPLETED|Overall Study||27
3166964|NCT01906008|3894054|FG001|NOT COMPLETED|Overall Study||27
3166965|NCT01906346|3894060|FG000|STARTED|Overall Study||9
3166966|NCT01906346|3894060|FG000|COMPLETED|Overall Study||8
3166967|NCT01906346|3894060|FG000|NOT COMPLETED|Overall Study||1
3166968|NCT01906372|3894066|FG000|STARTED|Overall Study||12
3166969|NCT01906372|3894066|FG000|Visit 7: Treatment Phase Completed|Overall Study||10
3166970|NCT01906372|3894066|FG000|Visit 10: Follow up Phase Completed|Overall Study||8
3166971|NCT01906372|3894066|FG000|COMPLETED|Overall Study||10
3166972|NCT01906372|3894066|FG000|NOT COMPLETED|Overall Study||2
3166973|NCT01906476|3894073|FG000|STARTED|Overall Study||157
3166974|NCT01906476|3894074|FG001|STARTED|Overall Study||155
3310672|NCT03043872|4044153|FG002|COMPLETED|Overall Study||31
3310673|NCT03043872|4044151|FG000|NOT COMPLETED|Overall Study||212
3310674|NCT03043872|4044152|FG001|NOT COMPLETED|Overall Study||212
3310675|NCT03043872|4044153|FG002|NOT COMPLETED|Overall Study||238
3310676|NCT03043885|4044167|FG000|STARTED|Overall Study||10
3310677|NCT03043885|4044168|FG001|STARTED|Overall Study||10
3310678|NCT03043885|4044169|FG002|STARTED|Overall Study||10
3310679|NCT03043885|4044170|FG003|STARTED|Overall Study||10
3310680|NCT03043885|4044167|FG000|COMPLETED|Overall Study||10
3310681|NCT03043885|4044168|FG001|COMPLETED|Overall Study||10
3310682|NCT03043885|4044169|FG002|COMPLETED|Overall Study||10
3310683|NCT03043885|4044170|FG003|COMPLETED|Overall Study||10
3310684|NCT03043885|4044167|FG000|NOT COMPLETED|Overall Study||0
3310685|NCT03043885|4044168|FG001|NOT COMPLETED|Overall Study||0
3310686|NCT03043885|4044169|FG002|NOT COMPLETED|Overall Study||0
3310687|NCT03043885|4044170|FG003|NOT COMPLETED|Overall Study||0
3310688|NCT03044028|4044183|FG000|STARTED|Overall Study||22
3310689|NCT03044028|4044184|FG001|STARTED|Overall Study||22
3310690|NCT03044028|4044185|FG002|STARTED|Overall Study||22
3310691|NCT03044028|4044183|FG000|COMPLETED|Overall Study||12
3310692|NCT03044028|4044184|FG001|COMPLETED|Overall Study||12
3310693|NCT03044028|4044185|FG002|COMPLETED|Overall Study||22
3310694|NCT03044028|4044183|FG000|NOT COMPLETED|Overall Study||10
3310695|NCT03044028|4044184|FG001|NOT COMPLETED|Overall Study||10
3310696|NCT03044028|4044185|FG002|NOT COMPLETED|Overall Study||0
3310697|NCT03044106|4044194|FG000|STARTED|Visit 1||22
3310698|NCT03044106|4044195|FG001|STARTED|Visit 1||22
3310699|NCT03044106|4044194|FG000|COMPLETED|Visit 1||22
3310700|NCT03044106|4044195|FG001|COMPLETED|Visit 1||22
3310701|NCT03044106|4044194|FG000|NOT COMPLETED|Visit 1||0
3310702|NCT03044106|4044195|FG001|NOT COMPLETED|Visit 1||0
3310703|NCT03044106|4044194|FG000|STARTED|Washout (1 Week)||22
3310704|NCT03044106|4044195|FG001|STARTED|Washout (1 Week)||22
3310705|NCT03044106|4044194|FG000|COMPLETED|Washout (1 Week)||22
3310706|NCT03044106|4044195|FG001|COMPLETED|Washout (1 Week)||20
3310707|NCT03044106|4044194|FG000|NOT COMPLETED|Washout (1 Week)||0
3310708|NCT03044106|4044195|FG001|NOT COMPLETED|Washout (1 Week)||2
3310709|NCT03044106|4044194|FG000|STARTED|Visit 2||22
3310710|NCT03044106|4044195|FG001|STARTED|Visit 2||20
3310711|NCT03044106|4044194|FG000|COMPLETED|Visit 2||22
3310712|NCT03044106|4044195|FG001|COMPLETED|Visit 2||20
2833343|NCT04343989|3534943|FG002|COMPLETED|Overall Study||74
3166975|NCT01906476|3894073|FG000|COMPLETED|Overall Study||140
3166976|NCT01906476|3894074|FG001|COMPLETED|Overall Study||139
3166977|NCT01906476|3894073|FG000|NOT COMPLETED|Overall Study||17
3166978|NCT01906476|3894074|FG001|NOT COMPLETED|Overall Study||16
3166979|NCT01906515|3894082|FG000|STARTED|Overall Study||45
3166980|NCT01906515|3894083|FG001|STARTED|Overall Study||61
3310713|NCT03044106|4044194|FG000|NOT COMPLETED|Visit 2||0
3310714|NCT03044106|4044195|FG001|NOT COMPLETED|Visit 2||0
3310715|NCT03044197|4044210|FG000|STARTED|Overall Study||12
3310716|NCT03044197|4044211|FG001|STARTED|Overall Study||12
3310717|NCT03044197|4044210|FG000|COMPLETED|Overall Study||9
3310718|NCT03044197|4044211|FG001|COMPLETED|Overall Study||11
3166981|NCT01906515|3894082|FG000|COMPLETED|Overall Study||45
3166982|NCT01906515|3894083|FG001|COMPLETED|Overall Study||61
3166983|NCT01906515|3894082|FG000|NOT COMPLETED|Overall Study||0
3166984|NCT01906515|3894083|FG001|NOT COMPLETED|Overall Study||0
3166985|NCT01906658|3894094|FG000|STARTED|Overall Study||11
3166986|NCT01906658|3894095|FG001|STARTED|Overall Study||11
3166987|NCT01906658|3894096|FG002|STARTED|Overall Study||10
3166988|NCT01906658|3894097|FG003|STARTED|Overall Study||11
3166989|NCT01906658|3894094|FG000|COMPLETED|Overall Study||9
3166990|NCT01906658|3894095|FG001|COMPLETED|Overall Study||10
3166991|NCT01906658|3894096|FG002|COMPLETED|Overall Study||7
3166992|NCT01906658|3894097|FG003|COMPLETED|Overall Study||11
3166993|NCT01906658|3894094|FG000|NOT COMPLETED|Overall Study||2
3166994|NCT01906658|3894095|FG001|NOT COMPLETED|Overall Study||1
3166995|NCT01906658|3894096|FG002|NOT COMPLETED|Overall Study||3
3166996|NCT01906658|3894097|FG003|NOT COMPLETED|Overall Study||0
3166997|NCT01906866|3894109|FG000|STARTED|Overall Study||60
3166998|NCT01906866|3894110|FG001|STARTED|Overall Study||65
3166999|NCT01906866|3894109|FG000|COMPLETED|Overall Study||51
3167000|NCT01906866|3894110|FG001|COMPLETED|Overall Study||44
3167001|NCT01906866|3894109|FG000|NOT COMPLETED|Overall Study||9
3167002|NCT01906866|3894110|FG001|NOT COMPLETED|Overall Study||21
3310719|NCT03044197|4044210|FG000|NOT COMPLETED|Overall Study||3
3310720|NCT03044197|4044211|FG001|NOT COMPLETED|Overall Study||1
3310721|NCT03044249|4044219|FG000|STARTED|Overall Study||42
2833344|NCT04343989|3534941|FG000|NOT COMPLETED|Overall Study||0
2833345|NCT04343989|3534942|FG001|NOT COMPLETED|Overall Study||0
2833346|NCT04343989|3534943|FG002|NOT COMPLETED|Overall Study||0
2833347|NCT04253834|3534953|FG000|STARTED|Overall Study||10
2833348|NCT04253834|3534954|FG001|STARTED|Overall Study||10
2833349|NCT04253834|3534953|FG000|COMPLETED|Overall Study||10
2833350|NCT04253834|3534954|FG001|COMPLETED|Overall Study||10
2833351|NCT04253834|3534953|FG000|NOT COMPLETED|Overall Study||0
2833352|NCT04253834|3534954|FG001|NOT COMPLETED|Overall Study||0
2833353|NCT03881059|3534963|FG000|STARTED|Treatment Period - Part A||66
2833354|NCT03881059|3534964|FG001|STARTED|Treatment Period - Part A||70
2833355|NCT03881059|3534965|FG002|STARTED|Treatment Period - Part A||67
2833356|NCT03881059|3534963|FG000|COMPLETED|Treatment Period - Part A||58
2833357|NCT03881059|3534964|FG001|COMPLETED|Treatment Period - Part A||63
2833358|NCT03881059|3534965|FG002|COMPLETED|Treatment Period - Part A||59
2833359|NCT03881059|3534963|FG000|NOT COMPLETED|Treatment Period - Part A||8
2833360|NCT03881059|3534964|FG001|NOT COMPLETED|Treatment Period - Part A||7
2833361|NCT03881059|3534965|FG002|NOT COMPLETED|Treatment Period - Part A||8
2833362|NCT03881059|3534963|FG000|STARTED|Treatment Period - Part B||55
2833363|NCT03881059|3534964|FG001|STARTED|Treatment Period - Part B||60
2833364|NCT03881059|3534965|FG002|STARTED|Treatment Period - Part B||58
2833365|NCT03881059|3534963|FG000|Participants Maintaining Same Treatment as in Part A|Treatment Period - Part B||0
2833366|NCT03881059|3534964|FG001|Participants Maintaining Same Treatment as in Part A|Treatment Period - Part B||13
3310722|NCT03044249|4044220|FG001|STARTED|Overall Study||39
3310723|NCT03044249|4044219|FG000|Received at Least One Dose of Study Drug|Overall Study||42
3310724|NCT03044249|4044220|FG001|Received at Least One Dose of Study Drug|Overall Study||39
3310725|NCT03044249|4044219|FG000|COMPLETED|Overall Study||32
3310726|NCT03044249|4044220|FG001|COMPLETED|Overall Study||25
3310727|NCT03044249|4044219|FG000|NOT COMPLETED|Overall Study||10
3310728|NCT03044249|4044220|FG001|NOT COMPLETED|Overall Study||14
3310729|NCT03044353|4044234|FG000|STARTED|Overall Study||6
3310730|NCT03044353|4044235|FG001|STARTED|Overall Study||1
3310731|NCT03044353|4044236|FG002|STARTED|Overall Study|No participant was enrolled in Group-3 due to early termination of the study.|0
3310732|NCT03044353|4044234|FG000|COMPLETED|Overall Study||6
3310733|NCT03044353|4044235|FG001|COMPLETED|Overall Study||0
3310734|NCT03044353|4044236|FG002|COMPLETED|Overall Study||0
3310735|NCT03044353|4044234|FG000|NOT COMPLETED|Overall Study||0
3310736|NCT03044353|4044235|FG001|NOT COMPLETED|Overall Study||1
3310737|NCT03044353|4044236|FG002|NOT COMPLETED|Overall Study||0
3310738|NCT03044418|4044243|FG000|STARTED|Overall Study||30
3310739|NCT03044418|4044243|FG000|COMPLETED|Overall Study||30
3310740|NCT03044418|4044243|FG000|NOT COMPLETED|Overall Study||0
3310741|NCT03044431|4044247|FG000|STARTED|Overall Study||207
3310742|NCT03044431|4044247|FG000|COMPLETED|Overall Study||148
3310743|NCT03044431|4044247|FG000|NOT COMPLETED|Overall Study||59
3310744|NCT03044574|4044253|FG000|STARTED|Overall Study||204
3310745|NCT03044574|4044254|FG001|STARTED|Overall Study||203
3310746|NCT03044574|4044253|FG000|Inpatient Period|Overall Study||204
3310747|NCT03044574|4044254|FG001|Inpatient Period|Overall Study||203
3310748|NCT03044574|4044253|FG000|30 Days After Surgery|Overall Study||193
3310749|NCT03044574|4044254|FG001|30 Days After Surgery|Overall Study||194
3310750|NCT03044574|4044253|FG000|180 Days After Surgery|Overall Study||167
3310751|NCT03044574|4044254|FG001|180 Days After Surgery|Overall Study||158
2833367|NCT03881059|3534965|FG002|Participants Maintaining Same Treatment as in Part A|Treatment Period - Part B||16
2833368|NCT03881059|3534963|FG000|Participants Treated With Ustekinumab in Part B|Treatment Period - Part B||55
2914429|NCT00504166|3624550|FG001|COMPLETED|Overall Study||13
3167003|NCT01907087|3894119|FG000|STARTED|Overall Study||24
3167004|NCT01907087|3894119|FG000|COMPLETED|Overall Study||23
3167005|NCT01907087|3894119|FG000|NOT COMPLETED|Overall Study||1
3167006|NCT01907100|3894127|FG000|STARTED|Overall Study||43
3167007|NCT01907100|3894128|FG001|STARTED|Overall Study||44
3310752|NCT03044574|4044253|FG000|COMPLETED|Overall Study||167
3310753|NCT03044574|4044254|FG001|COMPLETED|Overall Study||158
2833369|NCT03881059|3534964|FG001|Participants Treated With Ustekinumab in Part B|Treatment Period - Part B||47
2833370|NCT03881059|3534965|FG002|Participants Treated With Ustekinumab in Part B|Treatment Period - Part B||42
2833371|NCT03881059|3534963|FG000|COMPLETED|Treatment Period - Part B||47
2833372|NCT03881059|3534964|FG001|COMPLETED|Treatment Period - Part B||54
2833373|NCT03881059|3534965|FG002|COMPLETED|Treatment Period - Part B||47
2833374|NCT03881059|3534963|FG000|NOT COMPLETED|Treatment Period - Part B||8
2833375|NCT03881059|3534964|FG001|NOT COMPLETED|Treatment Period - Part B||6
2833376|NCT03881059|3534965|FG002|NOT COMPLETED|Treatment Period - Part B||11
2833377|NCT03878277|3534978|FG000|STARTED|Overall Study||10
2833378|NCT03878277|3534978|FG000|COMPLETED|Overall Study||10
2833379|NCT03878277|3534978|FG000|NOT COMPLETED|Overall Study||0
2833380|NCT03817853|3534982|FG000|STARTED|Induction Phase||113
2833381|NCT03817853|3534983|FG001|STARTED|Induction Phase||0
2833382|NCT03817853|3534984|FG002|STARTED|Induction Phase||0
2833383|NCT03817853|3534982|FG000|COMPLETED|Induction Phase||62
2833384|NCT03817853|3534983|FG001|COMPLETED|Induction Phase||0
2833385|NCT03817853|3534984|FG002|COMPLETED|Induction Phase||0
2833386|NCT03817853|3534982|FG000|NOT COMPLETED|Induction Phase||51
2833387|NCT03817853|3534983|FG001|NOT COMPLETED|Induction Phase||0
2833388|NCT03817853|3534984|FG002|NOT COMPLETED|Induction Phase||0
2833389|NCT03817853|3534982|FG000|STARTED|Maintenance/ Follow-up Phase||0
2833390|NCT03817853|3534983|FG001|STARTED|Maintenance/ Follow-up Phase||56
2833391|NCT03817853|3534984|FG002|STARTED|Maintenance/ Follow-up Phase||17
2833392|NCT03817853|3534982|FG000|COMPLETED|Maintenance/ Follow-up Phase||0
2833393|NCT03817853|3534983|FG001|COMPLETED|Maintenance/ Follow-up Phase||0
2833394|NCT03817853|3534984|FG002|COMPLETED|Maintenance/ Follow-up Phase||11
2833395|NCT03817853|3534982|FG000|NOT COMPLETED|Maintenance/ Follow-up Phase||0
2833396|NCT03817853|3534983|FG001|NOT COMPLETED|Maintenance/ Follow-up Phase||56
2833397|NCT03817853|3534984|FG002|NOT COMPLETED|Maintenance/ Follow-up Phase||6
2914430|NCT00504166|3624549|FG000|NOT COMPLETED|Overall Study||6
2914431|NCT00504166|3624550|FG001|NOT COMPLETED|Overall Study||14
2914432|NCT00504231|3624560|FG000|STARTED|Overall Study||65
2914433|NCT00504231|3624561|FG001|STARTED|Overall Study||64
2914434|NCT00504231|3624562|FG002|STARTED|Overall Study||64
2914435|NCT00504231|3624563|FG003|STARTED|Overall Study||65
2914436|NCT00504231|3624560|FG000|COMPLETED|Overall Study||65
2914437|NCT00504231|3624561|FG001|COMPLETED|Overall Study||64
2914438|NCT00504231|3624562|FG002|COMPLETED|Overall Study||63
2914439|NCT00504231|3624563|FG003|COMPLETED|Overall Study||65
2914440|NCT00504231|3624560|FG000|NOT COMPLETED|Overall Study||0
2914441|NCT00504231|3624561|FG001|NOT COMPLETED|Overall Study||0
2914442|NCT00504231|3624562|FG002|NOT COMPLETED|Overall Study||1
2914443|NCT00504231|3624563|FG003|NOT COMPLETED|Overall Study||0
2914444|NCT00504257|3624577|FG000|STARTED|Overall Study||45
2914445|NCT00504257|3624577|FG000|COMPLETED|Overall Study||41
2914446|NCT00504257|3624577|FG000|NOT COMPLETED|Overall Study||4
2914447|NCT00504309|3624587|FG000|STARTED|Overall Study||7
2914448|NCT00504309|3624588|FG001|STARTED|Overall Study||5
2914449|NCT00504309|3624589|FG002|STARTED|Overall Study||2
2914450|NCT00504309|3624590|FG003|STARTED|Overall Study||3
2914451|NCT00504309|3624591|FG004|STARTED|Overall Study||8
2914452|NCT00504309|3624592|FG005|STARTED|Overall Study||3
3310754|NCT03044574|4044253|FG000|NOT COMPLETED|Overall Study||37
3310755|NCT03044574|4044254|FG001|NOT COMPLETED|Overall Study||45
3310756|NCT03044691|4044262|FG000|STARTED|Overall Study||0
3310757|NCT03044691|4044263|FG001|STARTED|Overall Study||84
3310758|NCT03044691|4044262|FG000|COMPLETED|Overall Study||0
3310759|NCT03044691|4044263|FG001|COMPLETED|Overall Study||84
3310760|NCT03044691|4044262|FG000|NOT COMPLETED|Overall Study||0
3310761|NCT03044691|4044263|FG001|NOT COMPLETED|Overall Study||0
3310762|NCT03044730|4044269|FG000|STARTED|3 Cycles of Pembro + Capecitab||30
3310763|NCT03044730|4044269|FG000|Attempted Cycle 1|3 Cycles of Pembro + Capecitab||30
3310764|NCT03044730|4044269|FG000|Attempted Cycle 2|3 Cycles of Pembro + Capecitab||28
3310765|NCT03044730|4044269|FG000|Attempted Cycle 3|3 Cycles of Pembro + Capecitab||26
3310766|NCT03044730|4044269|FG000|COMPLETED|3 Cycles of Pembro + Capecitab||26
3310767|NCT03044730|4044269|FG000|NOT COMPLETED|3 Cycles of Pembro + Capecitab||4
3310768|NCT03044730|4044269|FG000|STARTED|Cycles 4 and Beyond||26
3310769|NCT03044730|4044269|FG000|Assessed for Cycle 4|Cycles 4 and Beyond||26
3310770|NCT03044730|4044269|FG000|Started Cycle 4|Cycles 4 and Beyond||20
3310771|NCT03044730|4044269|FG000|Went on to Cycle 5 and Beyond|Cycles 4 and Beyond||16
3310772|NCT03044730|4044269|FG000|COMPLETED|Cycles 4 and Beyond||16
3310773|NCT03044730|4044269|FG000|NOT COMPLETED|Cycles 4 and Beyond||10
3310774|NCT03044730|4044269|FG000|STARTED|On Follow-up for 2 Years||29
2914453|NCT00504309|3624587|FG000|COMPLETED|Overall Study||7
2914454|NCT00504309|3624588|FG001|COMPLETED|Overall Study||5
3310775|NCT03044730|4044269|FG000|COMPLETED|On Follow-up for 2 Years||4
3310776|NCT03044730|4044269|FG000|NOT COMPLETED|On Follow-up for 2 Years||25
3310777|NCT03044886|4044277|FG000|STARTED|Overall Study||120
3310778|NCT03044886|4044278|FG001|STARTED|Overall Study||120
3310779|NCT03044886|4044279|FG002|STARTED|Overall Study||120
3310780|NCT03044886|4044277|FG000|COMPLETED|Overall Study||105
3310781|NCT03044886|4044278|FG001|COMPLETED|Overall Study||110
3310782|NCT03044886|4044279|FG002|COMPLETED|Overall Study||108
3310783|NCT03044886|4044277|FG000|NOT COMPLETED|Overall Study||15
3310784|NCT03044886|4044278|FG001|NOT COMPLETED|Overall Study||10
3310785|NCT03044886|4044279|FG002|NOT COMPLETED|Overall Study||12
3310786|NCT03045081|4044289|FG000|STARTED|Overall Study||51
3310787|NCT03045081|4044290|FG001|STARTED|Overall Study||48
2833398|NCT03450629|3534994|FG000|STARTED|Overall Study||341
2833399|NCT03450629|3534995|FG001|STARTED|Overall Study||341
2833400|NCT03450629|3534994|FG000|COMPLETED|Overall Study||293
2833401|NCT03450629|3534995|FG001|COMPLETED|Overall Study||307
2833402|NCT03450629|3534994|FG000|NOT COMPLETED|Overall Study||48
2833403|NCT03450629|3534995|FG001|NOT COMPLETED|Overall Study||34
2833404|NCT03367403|3535004|FG000|STARTED|Overall Study||131
2833405|NCT03367403|3535005|FG001|STARTED|Overall Study||126
2833406|NCT03367403|3535006|FG002|STARTED|Overall Study||15
2833407|NCT03367403|3535004|FG000|Received at Least One Dose of Study Drug|Overall Study||131
2833408|NCT03367403|3535005|FG001|Received at Least One Dose of Study Drug|Overall Study||125
2833409|NCT03367403|3535006|FG002|Received at Least One Dose of Study Drug|Overall Study||15
2833410|NCT03367403|3535004|FG000|COMPLETED|Overall Study||94
2833411|NCT03367403|3535005|FG001|COMPLETED|Overall Study||93
2833412|NCT03367403|3535006|FG002|COMPLETED|Overall Study||12
2833413|NCT03367403|3535004|FG000|NOT COMPLETED|Overall Study||37
2833414|NCT03367403|3535005|FG001|NOT COMPLETED|Overall Study||33
2833415|NCT03367403|3535006|FG002|NOT COMPLETED|Overall Study||3
2833416|NCT03286426|3535014|FG000|STARTED|Overall Study||3
2833417|NCT03286426|3535014|FG000|COMPLETED|Overall Study||0
2833418|NCT03286426|3535014|FG000|NOT COMPLETED|Overall Study||3
2833419|NCT03206476|3535020|FG000|STARTED|Overall Study||54
2833420|NCT03206476|3535021|FG001|STARTED|Overall Study||53
2833421|NCT03206476|3535020|FG000|COMPLETED|Overall Study||49
2833422|NCT03206476|3535021|FG001|COMPLETED|Overall Study||41
2833423|NCT03206476|3535020|FG000|NOT COMPLETED|Overall Study||5
2833424|NCT03206476|3535021|FG001|NOT COMPLETED|Overall Study||12
2833425|NCT03135249|3535027|FG000|STARTED|Overall Study|Nine patient entered the study|9
2833426|NCT03135249|3535027|FG000|COMPLETED|Overall Study|Eight patient completed the study.|7
2833427|NCT03135249|3535027|FG000|NOT COMPLETED|Overall Study||2
2833428|NCT03106779|3535033|FG000|STARTED|Overall Study||157
2833429|NCT03106779|3535034|FG001|STARTED|Overall Study||76
2833430|NCT03106779|3535033|FG000|Treated|Overall Study||156
2833431|NCT03106779|3535034|FG001|Treated|Overall Study||0
2833432|NCT03106779|3535033|FG000|Not Treated|Overall Study||1
2833433|NCT03106779|3535034|FG001|Not Treated|Overall Study||0
2833434|NCT03106779|3535033|FG000|COMPLETED|Overall Study||97
2833435|NCT03106779|3535034|FG001|COMPLETED|Overall Study||22
2833436|NCT03106779|3535033|FG000|NOT COMPLETED|Overall Study||60
2833437|NCT03106779|3535034|FG001|NOT COMPLETED|Overall Study||54
2833438|NCT02818582|3535042|FG000|STARTED|Overall Study||20
2833439|NCT02818582|3535043|FG001|STARTED|Overall Study||18
2833440|NCT02818582|3535042|FG000|COMPLETED|Overall Study||20
2833441|NCT02818582|3535043|FG001|COMPLETED|Overall Study||18
2833442|NCT02818582|3535042|FG000|NOT COMPLETED|Overall Study||0
2833443|NCT02818582|3535043|FG001|NOT COMPLETED|Overall Study||0
2833444|NCT02809677|3535049|FG000|STARTED|Overall Study||205
2833445|NCT02809677|3535049|FG000|COMPLETED|Overall Study||197
2833446|NCT02809677|3535049|FG000|NOT COMPLETED|Overall Study||8
2833447|NCT02728258|3535054|FG000|STARTED|Overall Study||11
2833448|NCT02728258|3535054|FG000|COMPLETED|Overall Study||11
2833449|NCT02728258|3535054|FG000|NOT COMPLETED|Overall Study||0
2833450|NCT02554253|3535060|FG000|STARTED|Overall Study||26
3310788|NCT03045081|4044289|FG000|COMPLETED|Overall Study||45
3310789|NCT03045081|4044290|FG001|COMPLETED|Overall Study||37
3310790|NCT03045081|4044289|FG000|NOT COMPLETED|Overall Study||6
2833451|NCT02554253|3535061|FG001|STARTED|Overall Study||26
2833452|NCT02554253|3535060|FG000|COMPLETED|Overall Study||25
2833453|NCT02554253|3535061|FG001|COMPLETED|Overall Study||24
2833454|NCT02554253|3535060|FG000|NOT COMPLETED|Overall Study||1
2833455|NCT02554253|3535061|FG001|NOT COMPLETED|Overall Study||2
2833456|NCT02498600|3535070|FG000|STARTED|Overall Study||49
2833457|NCT02498600|3535071|FG001|STARTED|Overall Study||51
2833458|NCT02498600|3535070|FG000|COMPLETED|Overall Study||49
2833459|NCT02498600|3535071|FG001|COMPLETED|Overall Study||51
2833460|NCT02498600|3535070|FG000|NOT COMPLETED|Overall Study||0
2833461|NCT02498600|3535071|FG001|NOT COMPLETED|Overall Study||0
2833462|NCT02476916|3535079|FG000|STARTED|Core Period||27
3310791|NCT03045081|4044290|FG001|NOT COMPLETED|Overall Study||11
3310792|NCT03045302|4044296|FG000|STARTED|Overall Study||4
3310793|NCT03045302|4044296|FG000|COMPLETED|Overall Study||3
3310794|NCT03045302|4044296|FG000|NOT COMPLETED|Overall Study||1
3310795|NCT03045328|4044300|FG000|STARTED|Overall Study||22
2833463|NCT02476916|3535080|FG001|STARTED|Core Period||25
2833464|NCT02476916|3535079|FG000|COMPLETED|Core Period||21
2833465|NCT02476916|3535080|FG001|COMPLETED|Core Period||22
2833466|NCT02476916|3535079|FG000|NOT COMPLETED|Core Period||6
2833467|NCT02476916|3535080|FG001|NOT COMPLETED|Core Period||3
2833468|NCT02476916|3535079|FG000|STARTED|Extension Period||18
2833469|NCT02476916|3535080|FG001|STARTED|Extension Period||18
2833470|NCT02476916|3535079|FG000|COMPLETED|Extension Period||0
2833471|NCT02476916|3535080|FG001|COMPLETED|Extension Period||0
2833472|NCT02476916|3535079|FG000|NOT COMPLETED|Extension Period||18
2833473|NCT02476916|3535080|FG001|NOT COMPLETED|Extension Period||18
2833474|NCT02462876|3535087|FG000|STARTED|Overall Study||60
3310796|NCT03045328|4044300|FG000|COMPLETED|Overall Study||20
3310797|NCT03045328|4044300|FG000|NOT COMPLETED|Overall Study||2
3310798|NCT03045653|4044304|FG000|STARTED|Overall Study||30
3310799|NCT03045653|4044304|FG000|COMPLETED|Overall Study||30
3310800|NCT03045653|4044304|FG000|NOT COMPLETED|Overall Study||0
3310801|NCT03045809|4044308|FG000|STARTED|Overall Study||705
3317285|NCT03125200|4050831|FG002|COMPLETED|Overall Study||0
2833475|NCT02462876|3535087|FG000|COMPLETED|Overall Study||33
2833476|NCT02462876|3535087|FG000|NOT COMPLETED|Overall Study||27
2833477|NCT02106195|3535091|FG000|STARTED|Overall Study||8
2833478|NCT02106195|3535091|FG000|COMPLETED|Overall Study|Includes all 3 periods of study: Screening, Treatment, Post-treatment|5
2833479|NCT02106195|3535091|FG000|NOT COMPLETED|Overall Study||3
2833480|NCT01524536|3535101|FG000|STARTED|Overall Study||23
2833481|NCT01524536|3535101|FG000|COMPLETED|Overall Study||23
2833482|NCT01524536|3535101|FG000|NOT COMPLETED|Overall Study||0
2914455|NCT00504309|3624589|FG002|COMPLETED|Overall Study|Participant dropped out during second period|1
2914456|NCT00504309|3624590|FG003|COMPLETED|Overall Study||3
2914457|NCT00504309|3624591|FG004|COMPLETED|Overall Study|Participant died during washout after 2nd period|7
2914458|NCT00504309|3624592|FG005|COMPLETED|Overall Study||3
2914459|NCT00504309|3624587|FG000|NOT COMPLETED|Overall Study||0
2914460|NCT00504309|3624588|FG001|NOT COMPLETED|Overall Study||0
2914461|NCT00504309|3624589|FG002|NOT COMPLETED|Overall Study||1
2914462|NCT00504309|3624590|FG003|NOT COMPLETED|Overall Study||0
2914463|NCT00504309|3624591|FG004|NOT COMPLETED|Overall Study||1
2914464|NCT00504309|3624592|FG005|NOT COMPLETED|Overall Study||0
2920648|NCT00537771|3631173|FG000|COMPLETED|Overall Study||149
2920649|NCT00537771|3631174|FG001|COMPLETED|Overall Study||114
2920650|NCT00537771|3631173|FG000|NOT COMPLETED|Overall Study||29
2920651|NCT00537771|3631174|FG001|NOT COMPLETED|Overall Study||61
2920652|NCT00537810|3631184|FG000|STARTED|Overall Study||26
2920653|NCT00537810|3631185|FG001|STARTED|Overall Study||27
2920654|NCT00537810|3631186|FG002|STARTED|Overall Study||25
2920655|NCT00537810|3631187|FG003|STARTED|Overall Study||26
2920656|NCT00537810|3631184|FG000|COMPLETED|Overall Study||20
2920657|NCT00537810|3631185|FG001|COMPLETED|Overall Study||14
2920658|NCT00537810|3631186|FG002|COMPLETED|Overall Study||21
2920659|NCT00537810|3631187|FG003|COMPLETED|Overall Study||22
2920660|NCT00537810|3631184|FG000|NOT COMPLETED|Overall Study||6
2920661|NCT00537810|3631185|FG001|NOT COMPLETED|Overall Study||13
2920662|NCT00537810|3631186|FG002|NOT COMPLETED|Overall Study||4
2920663|NCT00537810|3631187|FG003|NOT COMPLETED|Overall Study||4
2920664|NCT00537823|3631199|FG000|STARTED|Overall Study||7
2920665|NCT00537823|3631200|FG001|STARTED|Overall Study||2
2920666|NCT00537823|3631199|FG000|COMPLETED|Overall Study||5
2920667|NCT00537823|3631200|FG001|COMPLETED|Overall Study||2
2920668|NCT00537823|3631199|FG000|NOT COMPLETED|Overall Study||2
2920669|NCT00537823|3631200|FG001|NOT COMPLETED|Overall Study||0
2920670|NCT00537940|3631209|FG000|STARTED|Overall Study||241
3310802|NCT03045809|4044308|FG000|Attended an Additional Visit (if Needed)|Overall Study|(only if needed, for medical follow-up, to complete study procedures, or to report adverse events).|51
3310803|NCT03045809|4044308|FG000|COMPLETED|Overall Study||705
3310804|NCT03045809|4044308|FG000|NOT COMPLETED|Overall Study||0
3310805|NCT03045861|4044318|FG000|STARTED|Part A (Up to 10 Days)||0
3310806|NCT03045861|4044319|FG001|STARTED|Part A (Up to 10 Days)||0
3310807|NCT03045861|4044320|FG002|STARTED|Part A (Up to 10 Days)||10
3310808|NCT03045861|4044321|FG003|STARTED|Part A (Up to 10 Days)||0
3310809|NCT03045861|4044318|FG000|COMPLETED|Part A (Up to 10 Days)||0
3310810|NCT03045861|4044319|FG001|COMPLETED|Part A (Up to 10 Days)||0
3310811|NCT03045861|4044320|FG002|COMPLETED|Part A (Up to 10 Days)||10
3310812|NCT03045861|4044321|FG003|COMPLETED|Part A (Up to 10 Days)||0
3310813|NCT03045861|4044318|FG000|NOT COMPLETED|Part A (Up to 10 Days)||0
3310814|NCT03045861|4044319|FG001|NOT COMPLETED|Part A (Up to 10 Days)||0
3310815|NCT03045861|4044320|FG002|NOT COMPLETED|Part A (Up to 10 Days)||0
3310816|NCT03045861|4044321|FG003|NOT COMPLETED|Part A (Up to 10 Days)||0
3310817|NCT03045861|4044318|FG000|STARTED|Part B (Up to 10 Days)||7
3310818|NCT03045861|4044319|FG001|STARTED|Part B (Up to 10 Days)||8
3310819|NCT03045861|4044320|FG002|STARTED|Part B (Up to 10 Days)||0
3310820|NCT03045861|4044321|FG003|STARTED|Part B (Up to 10 Days)||8
3310821|NCT03045861|4044318|FG000|COMPLETED|Part B (Up to 10 Days)||7
3310822|NCT03045861|4044319|FG001|COMPLETED|Part B (Up to 10 Days)||8
3310823|NCT03045861|4044320|FG002|COMPLETED|Part B (Up to 10 Days)||0
3310824|NCT03045861|4044321|FG003|COMPLETED|Part B (Up to 10 Days)||8
3310825|NCT03045861|4044318|FG000|NOT COMPLETED|Part B (Up to 10 Days)||0
3310826|NCT03045861|4044319|FG001|NOT COMPLETED|Part B (Up to 10 Days)||0
3310827|NCT03045861|4044320|FG002|NOT COMPLETED|Part B (Up to 10 Days)||0
3310828|NCT03045861|4044321|FG003|NOT COMPLETED|Part B (Up to 10 Days)||0
3310829|NCT03045887|4044342|FG000|STARTED|Part A, Period (1 Day)||7
3310830|NCT03045887|4044343|FG001|STARTED|Part A, Period (1 Day)||4
3310831|NCT03045887|4044344|FG002|STARTED|Part A, Period (1 Day)||5
3310832|NCT03045887|4044345|FG003|STARTED|Part A, Period (1 Day)||5
3310833|NCT03045887|4044346|FG004|STARTED|Part A, Period (1 Day)||4
2920671|NCT00537940|3631210|FG001|STARTED|Overall Study||241
2920672|NCT00537940|3631209|FG000|Completed Titration Phase|Overall Study||213
2920673|NCT00537940|3631210|FG001|Completed Titration Phase|Overall Study||210
2920674|NCT00537940|3631209|FG000|Completed Maintenance Phase|Overall Study||187
3310834|NCT03045887|4044347|FG005|STARTED|Part A, Period (1 Day)||4
3310835|NCT03045887|4044348|FG006|STARTED|Part A, Period (1 Day)||4
3310836|NCT03045887|4044349|FG007|STARTED|Part A, Period (1 Day)||4
3310837|NCT03045887|4044350|FG008|STARTED|Part A, Period (1 Day)||0
3310838|NCT03045887|4044351|FG009|STARTED|Part A, Period (1 Day)||0
3310839|NCT03045887|4044342|FG000|COMPLETED|Part A, Period (1 Day)||7
3310840|NCT03045887|4044343|FG001|COMPLETED|Part A, Period (1 Day)||4
3310841|NCT03045887|4044344|FG002|COMPLETED|Part A, Period (1 Day)||5
3310842|NCT03045887|4044345|FG003|COMPLETED|Part A, Period (1 Day)||5
2833483|NCT01307046|3535113|FG000|STARTED|Overall Study||166
2833484|NCT01307046|3535114|FG001|STARTED|Overall Study||170
2833485|NCT01307046|3535113|FG000|COMPLETED|Overall Study||154
2833486|NCT01307046|3535114|FG001|COMPLETED|Overall Study||159
2833487|NCT01307046|3535113|FG000|NOT COMPLETED|Overall Study||12
2833488|NCT01307046|3535114|FG001|NOT COMPLETED|Overall Study||11
2833489|NCT01307033|3535122|FG000|STARTED|8-week Double-blind Period||144
2833490|NCT01307033|3535123|FG001|STARTED|8-week Double-blind Period||134
2833491|NCT01307033|3535124|FG002|STARTED|8-week Double-blind Period||0
2833492|NCT01307033|3535125|FG003|STARTED|8-week Double-blind Period||0
2833493|NCT01307033|3535122|FG000|COMPLETED|8-week Double-blind Period||131
2833494|NCT01307033|3535123|FG001|COMPLETED|8-week Double-blind Period||127
2833495|NCT01307033|3535124|FG002|COMPLETED|8-week Double-blind Period||0
2833496|NCT01307033|3535125|FG003|COMPLETED|8-week Double-blind Period||0
2833497|NCT01307033|3535122|FG000|NOT COMPLETED|8-week Double-blind Period||13
3167008|NCT01907100|3894129|FG002|STARTED|Overall Study||229
3167009|NCT01907100|3894130|FG003|STARTED|Overall Study||229
3167010|NCT01907100|3894127|FG000|Treated Patients|Overall Study||41
3310843|NCT03045887|4044346|FG004|COMPLETED|Part A, Period (1 Day)||4
3310844|NCT03045887|4044347|FG005|COMPLETED|Part A, Period (1 Day)||4
3310845|NCT03045887|4044348|FG006|COMPLETED|Part A, Period (1 Day)||4
2833498|NCT01307033|3535123|FG001|NOT COMPLETED|8-week Double-blind Period||7
2833499|NCT01307033|3535124|FG002|NOT COMPLETED|8-week Double-blind Period||0
2833500|NCT01307033|3535125|FG003|NOT COMPLETED|8-week Double-blind Period||0
2833501|NCT01307033|3535122|FG000|STARTED|44-week Open-label Extension||0
2833502|NCT01307033|3535123|FG001|STARTED|44-week Open-label Extension||0
2833503|NCT01307033|3535124|FG002|STARTED|44-week Open-label Extension||131
2833504|NCT01307033|3535125|FG003|STARTED|44-week Open-label Extension||127
2833505|NCT01307033|3535122|FG000|COMPLETED|44-week Open-label Extension||0
2833506|NCT01307033|3535123|FG001|COMPLETED|44-week Open-label Extension||0
2833507|NCT01307033|3535124|FG002|COMPLETED|44-week Open-label Extension||120
2833508|NCT01307033|3535125|FG003|COMPLETED|44-week Open-label Extension||115
2833509|NCT01307033|3535122|FG000|NOT COMPLETED|44-week Open-label Extension||0
2833510|NCT01307033|3535123|FG001|NOT COMPLETED|44-week Open-label Extension||0
2833511|NCT01307033|3535124|FG002|NOT COMPLETED|44-week Open-label Extension||11
3310846|NCT03045887|4044349|FG007|COMPLETED|Part A, Period (1 Day)||4
3310847|NCT03045887|4044350|FG008|COMPLETED|Part A, Period (1 Day)||0
3310848|NCT03045887|4044351|FG009|COMPLETED|Part A, Period (1 Day)||0
3310849|NCT03045887|4044342|FG000|NOT COMPLETED|Part A, Period (1 Day)||0
3310850|NCT03045887|4044343|FG001|NOT COMPLETED|Part A, Period (1 Day)||0
3310851|NCT03045887|4044344|FG002|NOT COMPLETED|Part A, Period (1 Day)||0
3310852|NCT03045887|4044345|FG003|NOT COMPLETED|Part A, Period (1 Day)||0
3310853|NCT03045887|4044346|FG004|NOT COMPLETED|Part A, Period (1 Day)||0
3310854|NCT03045887|4044347|FG005|NOT COMPLETED|Part A, Period (1 Day)||0
3310855|NCT03045887|4044348|FG006|NOT COMPLETED|Part A, Period (1 Day)||0
3310856|NCT03045887|4044349|FG007|NOT COMPLETED|Part A, Period (1 Day)||0
3310857|NCT03045887|4044350|FG008|NOT COMPLETED|Part A, Period (1 Day)||0
3310858|NCT03045887|4044351|FG009|NOT COMPLETED|Part A, Period (1 Day)||0
3310859|NCT03045887|4044342|FG000|STARTED|Part A,Washout Period 1(4 Weeks)||7
3310860|NCT03045887|4044343|FG001|STARTED|Part A,Washout Period 1(4 Weeks)||4
3310861|NCT03045887|4044344|FG002|STARTED|Part A,Washout Period 1(4 Weeks)||5
3310862|NCT03045887|4044345|FG003|STARTED|Part A,Washout Period 1(4 Weeks)||5
3310863|NCT03045887|4044346|FG004|STARTED|Part A,Washout Period 1(4 Weeks)||4
3310864|NCT03045887|4044347|FG005|STARTED|Part A,Washout Period 1(4 Weeks)||4
3310865|NCT03045887|4044348|FG006|STARTED|Part A,Washout Period 1(4 Weeks)||4
3310866|NCT03045887|4044349|FG007|STARTED|Part A,Washout Period 1(4 Weeks)||4
3310867|NCT03045887|4044350|FG008|STARTED|Part A,Washout Period 1(4 Weeks)||0
3310868|NCT03045887|4044351|FG009|STARTED|Part A,Washout Period 1(4 Weeks)||0
3310869|NCT03045887|4044342|FG000|COMPLETED|Part A,Washout Period 1(4 Weeks)||4
3310870|NCT03045887|4044343|FG001|COMPLETED|Part A,Washout Period 1(4 Weeks)||4
3310871|NCT03045887|4044344|FG002|COMPLETED|Part A,Washout Period 1(4 Weeks)||5
3310872|NCT03045887|4044345|FG003|COMPLETED|Part A,Washout Period 1(4 Weeks)||4
3310873|NCT03045887|4044346|FG004|COMPLETED|Part A,Washout Period 1(4 Weeks)||4
3310874|NCT03045887|4044347|FG005|COMPLETED|Part A,Washout Period 1(4 Weeks)||4
3310875|NCT03045887|4044348|FG006|COMPLETED|Part A,Washout Period 1(4 Weeks)||4
3310876|NCT03045887|4044349|FG007|COMPLETED|Part A,Washout Period 1(4 Weeks)||4
3310877|NCT03045887|4044350|FG008|COMPLETED|Part A,Washout Period 1(4 Weeks)||0
3310878|NCT03045887|4044351|FG009|COMPLETED|Part A,Washout Period 1(4 Weeks)||0
3310879|NCT03045887|4044342|FG000|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||3
3310880|NCT03045887|4044343|FG001|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0
3310881|NCT03045887|4044344|FG002|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0
3310882|NCT03045887|4044345|FG003|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||1
3310883|NCT03045887|4044346|FG004|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0
3310884|NCT03045887|4044347|FG005|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0
3310885|NCT03045887|4044348|FG006|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0
3167011|NCT01907100|3894128|FG001|Treated Patients|Overall Study||44
3167012|NCT01907100|3894129|FG002|Treated Patients|Overall Study||228
3310886|NCT03045887|4044349|FG007|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0
3310887|NCT03045887|4044350|FG008|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0
3310888|NCT03045887|4044351|FG009|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0
3310889|NCT03045887|4044342|FG000|STARTED|Part A, Period 2 (1 Day)||4
2833512|NCT01307033|3535125|FG003|NOT COMPLETED|44-week Open-label Extension||12
2833513|NCT00942331|3535139|FG000|STARTED|Overall Study||252
2833514|NCT00942331|3535140|FG001|STARTED|Overall Study||254
2833515|NCT00942331|3535139|FG000|COMPLETED|Overall Study||237
2833516|NCT00942331|3535140|FG001|COMPLETED|Overall Study||232
2833517|NCT00942331|3535139|FG000|NOT COMPLETED|Overall Study||15
2833518|NCT00942331|3535140|FG001|NOT COMPLETED|Overall Study||22
2833519|NCT00739674|3535148|FG000|STARTED|Overall Study||535
2833520|NCT00739674|3535149|FG001|STARTED|Overall Study||457
2833521|NCT00739674|3535148|FG000|Screening Failures|Overall Study||19
2833522|NCT00739674|3535149|FG001|Screening Failures|Overall Study|ITT population took at least one dose of the study medication and had one follow-up visit.|17
2833523|NCT00739674|3535148|FG000|Site 212 Removal|Overall Study|lack of source documentation & frequent discrepancies between source notes and case report entries.|19
2833524|NCT00739674|3535149|FG001|Site 212 Removal|Overall Study|lack of source documentation & frequent discrepancies between source notes and case report entries.|13
2833525|NCT00739674|3535148|FG000|No Follow-up Data|Overall Study||33
2833526|NCT00739674|3535149|FG001|No Follow-up Data|Overall Study||18
2833527|NCT00739674|3535148|FG000|Dietician Consultation >30 Days|Overall Study|Patients with dietician consultations >30 days after visit 1 were not included in the data analysis.|1
2833528|NCT00739674|3535149|FG001|Dietician Consultation >30 Days|Overall Study|Patients with dietician consultations >30 days after visit 1 were not included in the data analysis.|9
2833529|NCT00739674|3535148|FG000|Intent-to-treat (ITT) Population|Overall Study|ITT population took at least one dose of the study medication and had one follow-up visit.|463
2833530|NCT00739674|3535149|FG001|Intent-to-treat (ITT) Population|Overall Study|ITT population took at least one dose of the study medication and had one follow-up visit.|400
2833531|NCT00739674|3535148|FG000|COMPLETED|Overall Study||354
2833532|NCT00739674|3535149|FG001|COMPLETED|Overall Study||335
2833533|NCT00739674|3535148|FG000|NOT COMPLETED|Overall Study||181
2833534|NCT00739674|3535149|FG001|NOT COMPLETED|Overall Study||122
2833535|NCT00546754|3535157|FG000|STARTED|Overall Study|Number of patients enrolled and randomized|425
2833536|NCT00546754|3535158|FG001|STARTED|Overall Study|Number of patients enrolled and randomized|383
2833537|NCT00546754|3535157|FG000|Treated|Overall Study|Patients that received at least one dose of study medication and had 1 follow-up visit|416
2833538|NCT00546754|3535158|FG001|Treated|Overall Study|Patients that received at least one dose of study medication and had 1 follow-up visit|373
2833539|NCT00546754|3535157|FG000|Week 6|Overall Study||396
2833540|NCT00546754|3535158|FG001|Week 6|Overall Study||347
2833541|NCT00546754|3535157|FG000|Week 12|Overall Study||375
2833542|NCT00546754|3535158|FG001|Week 12|Overall Study||334
2833543|NCT00546754|3535157|FG000|COMPLETED|Overall Study||375
2833544|NCT00546754|3535158|FG001|COMPLETED|Overall Study||334
2833545|NCT00546754|3535157|FG000|NOT COMPLETED|Overall Study||50
2833546|NCT00546754|3535158|FG001|NOT COMPLETED|Overall Study||49
2833547|NCT00479713|3535166|FG000|STARTED|Overall Study||314
2833548|NCT00479713|3535167|FG001|STARTED|Overall Study||304
2833549|NCT00479713|3535166|FG000|COMPLETED|Overall Study||301
2833550|NCT00479713|3535167|FG001|COMPLETED|Overall Study||295
2833551|NCT00479713|3535166|FG000|NOT COMPLETED|Overall Study||13
2833552|NCT00479713|3535167|FG001|NOT COMPLETED|Overall Study||9
2833553|NCT00406783|3535175|FG000|STARTED|Overall Study||276
2833554|NCT00406783|3535176|FG001|STARTED|Overall Study||271
2833555|NCT00406783|3535175|FG000|COMPLETED|Overall Study||262
2833556|NCT00406783|3535176|FG001|COMPLETED|Overall Study||256
2833557|NCT00406783|3535175|FG000|NOT COMPLETED|Overall Study||14
2833558|NCT00406783|3535176|FG001|NOT COMPLETED|Overall Study||15
2833559|NCT00405964|3535184|FG000|STARTED|Overall Study||360
2833560|NCT00405964|3535185|FG001|STARTED|Overall Study||356
2833561|NCT00405964|3535184|FG000|COMPLETED|Overall Study||301
2833562|NCT00405964|3535185|FG001|COMPLETED|Overall Study||261
2833563|NCT00405964|3535184|FG000|NOT COMPLETED|Overall Study||59
2833564|NCT00405964|3535185|FG001|NOT COMPLETED|Overall Study||95
2833565|NCT00383721|3535196|FG000|STARTED|26-Week Double-Blind Treatment Period||225
2833566|NCT00383721|3535197|FG001|STARTED|26-Week Double-Blind Treatment Period||239
2833567|NCT00383721|3535198|FG002|STARTED|26-Week Double-Blind Treatment Period||253
2833568|NCT00383721|3535199|FG003|STARTED|26-Week Double-Blind Treatment Period||243
2833569|NCT00383721|3535200|FG004|STARTED|26-Week Double-Blind Treatment Period||236
2833570|NCT00383721|3535196|FG000|COMPLETED|26-Week Double-Blind Treatment Period|"1 participant listed as ongoing since the participant status could not be formally confirmed."|190
2833571|NCT00383721|3535197|FG001|COMPLETED|26-Week Double-Blind Treatment Period||202
2833572|NCT00383721|3535198|FG002|COMPLETED|26-Week Double-Blind Treatment Period||202
2833573|NCT00383721|3535199|FG003|COMPLETED|26-Week Double-Blind Treatment Period||193
2833574|NCT00383721|3535200|FG004|COMPLETED|26-Week Double-Blind Treatment Period||169
2833575|NCT00383721|3535196|FG000|NOT COMPLETED|26-Week Double-Blind Treatment Period||35
2833576|NCT00383721|3535197|FG001|NOT COMPLETED|26-Week Double-Blind Treatment Period||37
2833577|NCT00383721|3535198|FG002|NOT COMPLETED|26-Week Double-Blind Treatment Period||51
2833578|NCT00383721|3535199|FG003|NOT COMPLETED|26-Week Double-Blind Treatment Period||50
2833579|NCT00383721|3535200|FG004|NOT COMPLETED|26-Week Double-Blind Treatment Period||67
2833580|NCT00383721|3535196|FG000|STARTED|26-Week Treatment Safety Extension||145
2833581|NCT00383721|3535197|FG001|STARTED|26-Week Treatment Safety Extension||153
2833582|NCT00383721|3535198|FG002|STARTED|26-Week Treatment Safety Extension||149
2833583|NCT00383721|3535199|FG003|STARTED|26-Week Treatment Safety Extension||148
2833584|NCT00383721|3535200|FG004|STARTED|26-Week Treatment Safety Extension||8
2833585|NCT00383721|3535196|FG000|COMPLETED|26-Week Treatment Safety Extension||126
2833586|NCT00383721|3535197|FG001|COMPLETED|26-Week Treatment Safety Extension||136
2833587|NCT00383721|3535198|FG002|COMPLETED|26-Week Treatment Safety Extension||126
2833588|NCT00383721|3535199|FG003|COMPLETED|26-Week Treatment Safety Extension||131
2833589|NCT00383721|3535200|FG004|COMPLETED|26-Week Treatment Safety Extension||8
2833590|NCT00383721|3535196|FG000|NOT COMPLETED|26-Week Treatment Safety Extension||19
2833591|NCT00383721|3535197|FG001|NOT COMPLETED|26-Week Treatment Safety Extension||17
2833592|NCT00383721|3535198|FG002|NOT COMPLETED|26-Week Treatment Safety Extension||23
2833593|NCT00383721|3535199|FG003|NOT COMPLETED|26-Week Treatment Safety Extension||17
2833594|NCT00383721|3535200|FG004|NOT COMPLETED|26-Week Treatment Safety Extension||0
2833595|NCT00383552|3535216|FG000|STARTED|Overall Study||182
2833596|NCT00383552|3535217|FG001|STARTED|Overall Study||188
2833597|NCT00383552|3535218|FG002|STARTED|Overall Study||188
2833598|NCT00383552|3535219|FG003|STARTED|Overall Study||188
2833599|NCT00383552|3535216|FG000|COMPLETED|Overall Study||146
2833600|NCT00383552|3535217|FG001|COMPLETED|Overall Study||147
2833601|NCT00383552|3535218|FG002|COMPLETED|Overall Study||127
2833602|NCT00383552|3535219|FG003|COMPLETED|Overall Study||116
2833603|NCT00383552|3535216|FG000|NOT COMPLETED|Overall Study||36
2833604|NCT00383552|3535217|FG001|NOT COMPLETED|Overall Study||41
2833605|NCT00383552|3535218|FG002|NOT COMPLETED|Overall Study||61
2833606|NCT00383552|3535219|FG003|NOT COMPLETED|Overall Study||72
2833607|NCT00383435|3535239|FG000|STARTED|26-Week Double-Blind Treatment Period||217
2833608|NCT00383435|3535240|FG001|STARTED|26-Week Double-Blind Treatment Period||207
2833609|NCT00383435|3535241|FG002|STARTED|26-Week Double-Blind Treatment Period||210
2833610|NCT00383435|3535242|FG003|STARTED|26-Week Double-Blind Treatment Period||209
2833611|NCT00383435|3535243|FG004|STARTED|26-Week Double-Blind Treatment Period||212
2833612|NCT00383435|3535239|FG000|COMPLETED|26-Week Double-Blind Treatment Period||176
2833613|NCT00383435|3535240|FG001|COMPLETED|26-Week Double-Blind Treatment Period||169
2833614|NCT00383435|3535241|FG002|COMPLETED|26-Week Double-Blind Treatment Period||164
2833615|NCT00383435|3535242|FG003|COMPLETED|26-Week Double-Blind Treatment Period||172
2833616|NCT00383435|3535243|FG004|COMPLETED|26-Week Double-Blind Treatment Period||159
2833617|NCT00383435|3535239|FG000|NOT COMPLETED|26-Week Double-Blind Treatment Period||41
2833618|NCT00383435|3535240|FG001|NOT COMPLETED|26-Week Double-Blind Treatment Period||38
2833619|NCT00383435|3535241|FG002|NOT COMPLETED|26-Week Double-Blind Treatment Period||46
3310890|NCT03045887|4044343|FG001|STARTED|Part A, Period 2 (1 Day)||4
3310891|NCT03045887|4044344|FG002|STARTED|Part A, Period 2 (1 Day)||5
3310892|NCT03045887|4044345|FG003|STARTED|Part A, Period 2 (1 Day)||4
3310893|NCT03045887|4044346|FG004|STARTED|Part A, Period 2 (1 Day)||4
3310894|NCT03045887|4044347|FG005|STARTED|Part A, Period 2 (1 Day)||4
3310895|NCT03045887|4044348|FG006|STARTED|Part A, Period 2 (1 Day)||4
3310896|NCT03045887|4044349|FG007|STARTED|Part A, Period 2 (1 Day)||4
3310897|NCT03045887|4044350|FG008|STARTED|Part A, Period 2 (1 Day)||0
3310898|NCT03045887|4044351|FG009|STARTED|Part A, Period 2 (1 Day)||0
3310899|NCT03045887|4044342|FG000|COMPLETED|Part A, Period 2 (1 Day)||3
3310900|NCT03045887|4044343|FG001|COMPLETED|Part A, Period 2 (1 Day)||4
3310901|NCT03045887|4044344|FG002|COMPLETED|Part A, Period 2 (1 Day)||5
3310902|NCT03045887|4044345|FG003|COMPLETED|Part A, Period 2 (1 Day)||4
3310903|NCT03045887|4044346|FG004|COMPLETED|Part A, Period 2 (1 Day)||4
3310904|NCT03045887|4044347|FG005|COMPLETED|Part A, Period 2 (1 Day)||4
3310905|NCT03045887|4044348|FG006|COMPLETED|Part A, Period 2 (1 Day)||4
3310906|NCT03045887|4044349|FG007|COMPLETED|Part A, Period 2 (1 Day)||4
3310907|NCT03045887|4044350|FG008|COMPLETED|Part A, Period 2 (1 Day)||0
3310908|NCT03045887|4044351|FG009|COMPLETED|Part A, Period 2 (1 Day)||0
3310909|NCT03045887|4044342|FG000|NOT COMPLETED|Part A, Period 2 (1 Day)||1
3310910|NCT03045887|4044343|FG001|NOT COMPLETED|Part A, Period 2 (1 Day)||0
3310911|NCT03045887|4044344|FG002|NOT COMPLETED|Part A, Period 2 (1 Day)||0
3310912|NCT03045887|4044345|FG003|NOT COMPLETED|Part A, Period 2 (1 Day)||0
3310913|NCT03045887|4044346|FG004|NOT COMPLETED|Part A, Period 2 (1 Day)||0
3310914|NCT03045887|4044347|FG005|NOT COMPLETED|Part A, Period 2 (1 Day)||0
3310915|NCT03045887|4044348|FG006|NOT COMPLETED|Part A, Period 2 (1 Day)||0
3310916|NCT03045887|4044349|FG007|NOT COMPLETED|Part A, Period 2 (1 Day)||0
3310917|NCT03045887|4044350|FG008|NOT COMPLETED|Part A, Period 2 (1 Day)||0
3310918|NCT03045887|4044351|FG009|NOT COMPLETED|Part A, Period 2 (1 Day)||0
3310919|NCT03045887|4044342|FG000|STARTED|Part A,Washout Period 2 (4 Weeks)||3
3310920|NCT03045887|4044343|FG001|STARTED|Part A,Washout Period 2 (4 Weeks)||4
3310921|NCT03045887|4044344|FG002|STARTED|Part A,Washout Period 2 (4 Weeks)||5
3310922|NCT03045887|4044345|FG003|STARTED|Part A,Washout Period 2 (4 Weeks)||4
3310923|NCT03045887|4044346|FG004|STARTED|Part A,Washout Period 2 (4 Weeks)||4
3310924|NCT03045887|4044347|FG005|STARTED|Part A,Washout Period 2 (4 Weeks)||4
3310925|NCT03045887|4044348|FG006|STARTED|Part A,Washout Period 2 (4 Weeks)||4
3310926|NCT03045887|4044349|FG007|STARTED|Part A,Washout Period 2 (4 Weeks)||4
3310927|NCT03045887|4044350|FG008|STARTED|Part A,Washout Period 2 (4 Weeks)||0
3310928|NCT03045887|4044351|FG009|STARTED|Part A,Washout Period 2 (4 Weeks)||0
3310929|NCT03045887|4044342|FG000|COMPLETED|Part A,Washout Period 2 (4 Weeks)||3
3310930|NCT03045887|4044343|FG001|COMPLETED|Part A,Washout Period 2 (4 Weeks)||4
3310931|NCT03045887|4044344|FG002|COMPLETED|Part A,Washout Period 2 (4 Weeks)||4
3310932|NCT03045887|4044345|FG003|COMPLETED|Part A,Washout Period 2 (4 Weeks)||2
3310933|NCT03045887|4044346|FG004|COMPLETED|Part A,Washout Period 2 (4 Weeks)||4
3310934|NCT03045887|4044347|FG005|COMPLETED|Part A,Washout Period 2 (4 Weeks)||4
3310935|NCT03045887|4044348|FG006|COMPLETED|Part A,Washout Period 2 (4 Weeks)||4
3317286|NCT03125200|4050832|FG003|COMPLETED|Overall Study||0
2833620|NCT00383435|3535242|FG003|NOT COMPLETED|26-Week Double-Blind Treatment Period||37
2833621|NCT00383435|3535243|FG004|NOT COMPLETED|26-Week Double-Blind Treatment Period||53
2833622|NCT00383435|3535239|FG000|STARTED|26-Week Treatment Safety Extension||131
2833623|NCT00383435|3535240|FG001|STARTED|26-Week Treatment Safety Extension||130
2833624|NCT00383435|3535241|FG002|STARTED|26-Week Treatment Safety Extension||124
2833625|NCT00383435|3535242|FG003|STARTED|26-Week Treatment Safety Extension||131
2833626|NCT00383435|3535243|FG004|STARTED|26-Week Treatment Safety Extension||13
2833627|NCT00383435|3535239|FG000|COMPLETED|26-Week Treatment Safety Extension||117
2833628|NCT00383435|3535240|FG001|COMPLETED|26-Week Treatment Safety Extension||121
2833629|NCT00383435|3535241|FG002|COMPLETED|26-Week Treatment Safety Extension||108
2833630|NCT00383435|3535242|FG003|COMPLETED|26-Week Treatment Safety Extension||116
2833631|NCT00383435|3535243|FG004|COMPLETED|26-Week Treatment Safety Extension||10
2833632|NCT00383435|3535239|FG000|NOT COMPLETED|26-Week Treatment Safety Extension||14
2833633|NCT00383435|3535240|FG001|NOT COMPLETED|26-Week Treatment Safety Extension||9
3310936|NCT03045887|4044349|FG007|COMPLETED|Part A,Washout Period 2 (4 Weeks)||4
3310937|NCT03045887|4044350|FG008|COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
3310938|NCT03045887|4044351|FG009|COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
3310939|NCT03045887|4044342|FG000|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
3310940|NCT03045887|4044343|FG001|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
3310941|NCT03045887|4044344|FG002|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||1
3310942|NCT03045887|4044345|FG003|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||2
3310943|NCT03045887|4044346|FG004|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
3310944|NCT03045887|4044347|FG005|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
3310945|NCT03045887|4044348|FG006|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
3310946|NCT03045887|4044349|FG007|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
3310947|NCT03045887|4044350|FG008|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
3310948|NCT03045887|4044351|FG009|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
3310949|NCT03045887|4044342|FG000|STARTED|Part A, Period 3 (1 Day)||3
3310950|NCT03045887|4044343|FG001|STARTED|Part A, Period 3 (1 Day)||4
3310951|NCT03045887|4044344|FG002|STARTED|Part A, Period 3 (1 Day)||4
3310952|NCT03045887|4044345|FG003|STARTED|Part A, Period 3 (1 Day)||2
3310953|NCT03045887|4044346|FG004|STARTED|Part A, Period 3 (1 Day)||4
3310954|NCT03045887|4044347|FG005|STARTED|Part A, Period 3 (1 Day)||4
3310955|NCT03045887|4044348|FG006|STARTED|Part A, Period 3 (1 Day)||4
3310956|NCT03045887|4044349|FG007|STARTED|Part A, Period 3 (1 Day)||4
3310957|NCT03045887|4044350|FG008|STARTED|Part A, Period 3 (1 Day)||0
3310958|NCT03045887|4044351|FG009|STARTED|Part A, Period 3 (1 Day)||0
3310959|NCT03045887|4044342|FG000|COMPLETED|Part A, Period 3 (1 Day)||3
3310960|NCT03045887|4044343|FG001|COMPLETED|Part A, Period 3 (1 Day)||4
3310961|NCT03045887|4044344|FG002|COMPLETED|Part A, Period 3 (1 Day)||4
3310962|NCT03045887|4044345|FG003|COMPLETED|Part A, Period 3 (1 Day)||2
3310963|NCT03045887|4044346|FG004|COMPLETED|Part A, Period 3 (1 Day)||4
3310964|NCT03045887|4044347|FG005|COMPLETED|Part A, Period 3 (1 Day)||4
3310965|NCT03045887|4044348|FG006|COMPLETED|Part A, Period 3 (1 Day)||4
3310966|NCT03045887|4044349|FG007|COMPLETED|Part A, Period 3 (1 Day)||4
3310967|NCT03045887|4044350|FG008|COMPLETED|Part A, Period 3 (1 Day)||0
3310968|NCT03045887|4044351|FG009|COMPLETED|Part A, Period 3 (1 Day)||0
3310969|NCT03045887|4044342|FG000|NOT COMPLETED|Part A, Period 3 (1 Day)||0
3310970|NCT03045887|4044343|FG001|NOT COMPLETED|Part A, Period 3 (1 Day)||0
3310971|NCT03045887|4044344|FG002|NOT COMPLETED|Part A, Period 3 (1 Day)||0
3310972|NCT03045887|4044345|FG003|NOT COMPLETED|Part A, Period 3 (1 Day)||0
3310973|NCT03045887|4044346|FG004|NOT COMPLETED|Part A, Period 3 (1 Day)||0
3310974|NCT03045887|4044347|FG005|NOT COMPLETED|Part A, Period 3 (1 Day)||0
3310975|NCT03045887|4044348|FG006|NOT COMPLETED|Part A, Period 3 (1 Day)||0
3310976|NCT03045887|4044349|FG007|NOT COMPLETED|Part A, Period 3 (1 Day)||0
3310977|NCT03045887|4044350|FG008|NOT COMPLETED|Part A, Period 3 (1 Day)||0
3310978|NCT03045887|4044351|FG009|NOT COMPLETED|Part A, Period 3 (1 Day)||0
3310979|NCT03045887|4044342|FG000|STARTED|Part B (14 Days)||0
3310980|NCT03045887|4044343|FG001|STARTED|Part B (14 Days)||0
3310981|NCT03045887|4044344|FG002|STARTED|Part B (14 Days)||0
3310982|NCT03045887|4044345|FG003|STARTED|Part B (14 Days)||0
3310983|NCT03045887|4044346|FG004|STARTED|Part B (14 Days)||0
3310984|NCT03045887|4044347|FG005|STARTED|Part B (14 Days)||0
3310985|NCT03045887|4044348|FG006|STARTED|Part B (14 Days)||0
3310986|NCT03045887|4044349|FG007|STARTED|Part B (14 Days)||0
3310987|NCT03045887|4044350|FG008|STARTED|Part B (14 Days)||3
3310988|NCT03045887|4044351|FG009|STARTED|Part B (14 Days)||9
3310989|NCT03045887|4044342|FG000|COMPLETED|Part B (14 Days)||0
3310990|NCT03045887|4044343|FG001|COMPLETED|Part B (14 Days)||0
3310991|NCT03045887|4044344|FG002|COMPLETED|Part B (14 Days)||0
3310992|NCT03045887|4044345|FG003|COMPLETED|Part B (14 Days)||0
3310993|NCT03045887|4044346|FG004|COMPLETED|Part B (14 Days)||0
3310994|NCT03045887|4044347|FG005|COMPLETED|Part B (14 Days)||0
3310995|NCT03045887|4044348|FG006|COMPLETED|Part B (14 Days)||0
3310996|NCT03045887|4044349|FG007|COMPLETED|Part B (14 Days)||0
3310997|NCT03045887|4044350|FG008|COMPLETED|Part B (14 Days)||3
3310998|NCT03045887|4044351|FG009|COMPLETED|Part B (14 Days)||9
3310999|NCT03045887|4044342|FG000|NOT COMPLETED|Part B (14 Days)||0
3311000|NCT03045887|4044343|FG001|NOT COMPLETED|Part B (14 Days)||0
3311001|NCT03045887|4044344|FG002|NOT COMPLETED|Part B (14 Days)||0
3311002|NCT03045887|4044345|FG003|NOT COMPLETED|Part B (14 Days)||0
3311003|NCT03045887|4044346|FG004|NOT COMPLETED|Part B (14 Days)||0
2833634|NCT00383435|3535241|FG002|NOT COMPLETED|26-Week Treatment Safety Extension||16
2833635|NCT00383435|3535242|FG003|NOT COMPLETED|26-Week Treatment Safety Extension||15
2833636|NCT00383435|3535243|FG004|NOT COMPLETED|26-Week Treatment Safety Extension||3
2833637|NCT00381485|3535258|FG000|STARTED|Open-Label Run-In Period||834
3311004|NCT03045887|4044347|FG005|NOT COMPLETED|Part B (14 Days)||0
3311005|NCT03045887|4044348|FG006|NOT COMPLETED|Part B (14 Days)||0
3311006|NCT03045887|4044349|FG007|NOT COMPLETED|Part B (14 Days)||0
3311007|NCT03045887|4044350|FG008|NOT COMPLETED|Part B (14 Days)||0
3311008|NCT03045887|4044351|FG009|NOT COMPLETED|Part B (14 Days)||0
3311009|NCT03045926|4044378|FG000|STARTED|Overall Study||35
3311010|NCT03045926|4044378|FG000|COMPLETED|Overall Study||35
3311011|NCT03045926|4044378|FG000|NOT COMPLETED|Overall Study||0
3311012|NCT03046056|4044385|FG000|STARTED|Overall Study||28
3311013|NCT03046056|4044386|FG001|STARTED|Overall Study||32
3311014|NCT03046056|4044387|FG002|STARTED|Overall Study||18
3311015|NCT03046056|4044385|FG000|COMPLETED|Overall Study||16
3311016|NCT03046056|4044386|FG001|COMPLETED|Overall Study||16
3311017|NCT03046056|4044387|FG002|COMPLETED|Overall Study||11
3311018|NCT03046056|4044385|FG000|NOT COMPLETED|Overall Study||12
3311019|NCT03046056|4044386|FG001|NOT COMPLETED|Overall Study||16
3311020|NCT03046056|4044387|FG002|NOT COMPLETED|Overall Study||7
3311021|NCT03046212|4044397|FG000|STARTED|Overall Study||15
3311022|NCT03046212|4044398|FG001|STARTED|Overall Study||15
3311023|NCT03046212|4044397|FG000|COMPLETED|Overall Study||15
3311024|NCT03046212|4044398|FG001|COMPLETED|Overall Study||15
3311025|NCT03046212|4044397|FG000|NOT COMPLETED|Overall Study||0
3311026|NCT03046212|4044398|FG001|NOT COMPLETED|Overall Study||0
3311027|NCT03046225|4044406|FG000|STARTED|Overall Study||13
3311028|NCT03046225|4044407|FG001|STARTED|Overall Study||13
3311029|NCT03046225|4044406|FG000|COMPLETED|Overall Study||13
3311030|NCT03046225|4044407|FG001|COMPLETED|Overall Study||13
3311031|NCT03046225|4044406|FG000|NOT COMPLETED|Overall Study||0
3311032|NCT03046225|4044407|FG001|NOT COMPLETED|Overall Study||0
3311033|NCT03046446|4044413|FG000|STARTED|Overall Study||208
3311034|NCT03046446|4044413|FG000|Second Injection|Overall Study||179
3311035|NCT03046446|4044413|FG000|Completed at Week 12|Overall Study||10
3311036|NCT03046446|4044413|FG000|Completed at Week 24|Overall Study||6
3311037|NCT03046446|4044413|FG000|Completed at Week 52|Overall Study||133
3311038|NCT03046446|4044413|FG000|COMPLETED|Overall Study||149
3311039|NCT03046446|4044413|FG000|NOT COMPLETED|Overall Study||59
3311040|NCT03046472|4044419|FG000|STARTED|Overall Study||33
3311041|NCT03046472|4044420|FG001|STARTED|Overall Study||17
3311042|NCT03046472|4044419|FG000|COMPLETED|Overall Study||33
3311043|NCT03046472|4044420|FG001|COMPLETED|Overall Study||17
3311044|NCT03046472|4044419|FG000|NOT COMPLETED|Overall Study||0
3311045|NCT03046472|4044420|FG001|NOT COMPLETED|Overall Study||0
3311046|NCT03046966|4044428|FG000|STARTED|Overall Study||51
3311047|NCT03046966|4044429|FG001|STARTED|Overall Study||51
3311048|NCT03046966|4044428|FG000|COMPLETED|Overall Study||51
3311049|NCT03046966|4044429|FG001|COMPLETED|Overall Study||51
3311050|NCT03046966|4044428|FG000|NOT COMPLETED|Overall Study||0
3311051|NCT03046966|4044429|FG001|NOT COMPLETED|Overall Study||0
3311052|NCT03047174|4044437|FG000|STARTED|Overall Study||28
3311053|NCT03047174|4044438|FG001|STARTED|Overall Study||29
3311054|NCT03047174|4044437|FG000|COMPLETED|Overall Study||9
3311055|NCT03047174|4044438|FG001|COMPLETED|Overall Study||27
3311056|NCT03047174|4044437|FG000|NOT COMPLETED|Overall Study||19
3311057|NCT03047174|4044438|FG001|NOT COMPLETED|Overall Study||2
3311058|NCT03047447|4044461|FG000|STARTED|Overall Study||10
3311059|NCT03047447|4044462|FG001|STARTED|Overall Study||10
3311060|NCT03047447|4044463|FG002|STARTED|Overall Study||10
3311061|NCT03047447|4044461|FG000|COMPLETED|Overall Study||10
3311062|NCT03047447|4044462|FG001|COMPLETED|Overall Study||10
3311063|NCT03047447|4044463|FG002|COMPLETED|Overall Study||10
3311064|NCT03047447|4044461|FG000|NOT COMPLETED|Overall Study||0
3311065|NCT03047447|4044462|FG001|NOT COMPLETED|Overall Study||0
3311066|NCT03047447|4044463|FG002|NOT COMPLETED|Overall Study||0
3311067|NCT03047551|4044476|FG000|STARTED|Overall Study||319
3311068|NCT03047551|4044477|FG001|STARTED|Overall Study||315
3311069|NCT03047551|4044476|FG000|COMPLETED|Overall Study||317
3311070|NCT03047551|4044477|FG001|COMPLETED|Overall Study||312
3311071|NCT03047551|4044476|FG000|NOT COMPLETED|Overall Study||2
3311072|NCT03047551|4044477|FG001|NOT COMPLETED|Overall Study||3
3311073|NCT03047720|4044485|FG000|STARTED|First Intervention (6weeks)||12
3311074|NCT03047720|4044486|FG001|STARTED|First Intervention (6weeks)||0
3311075|NCT03047720|4044485|FG000|COMPLETED|First Intervention (6weeks)||5
3311076|NCT03047720|4044486|FG001|COMPLETED|First Intervention (6weeks)||0
3311077|NCT03047720|4044485|FG000|NOT COMPLETED|First Intervention (6weeks)||7
3311078|NCT03047720|4044486|FG001|NOT COMPLETED|First Intervention (6weeks)||0
3311079|NCT03047720|4044485|FG000|STARTED|Second Intervention (6weeks)||0
3311080|NCT03047720|4044486|FG001|STARTED|Second Intervention (6weeks)||0
3311081|NCT03047720|4044485|FG000|COMPLETED|Second Intervention (6weeks)||0
3311082|NCT03047720|4044486|FG001|COMPLETED|Second Intervention (6weeks)||0
3311083|NCT03047720|4044485|FG000|NOT COMPLETED|Second Intervention (6weeks)||0
3311084|NCT03047720|4044486|FG001|NOT COMPLETED|Second Intervention (6weeks)||0
3311085|NCT03047980|4044492|FG000|STARTED|Overall Study||10
3311086|NCT03047980|4044492|FG000|COMPLETED|Overall Study||9
3311087|NCT03047980|4044492|FG000|NOT COMPLETED|Overall Study||1
3311088|NCT03048006|4044496|FG000|STARTED|Overall Study||44456
3311089|NCT03048006|4044496|FG000|COMPLETED|Overall Study||44456
2833638|NCT00381485|3535259|FG001|STARTED|Open-Label Run-In Period||0
2833639|NCT00381485|3535260|FG002|STARTED|Open-Label Run-In Period||0
2833640|NCT00381485|3535261|FG003|STARTED|Open-Label Run-In Period||0
2833641|NCT00381485|3535258|FG000|COMPLETED|Open-Label Run-In Period||728
2833642|NCT00381485|3535259|FG001|COMPLETED|Open-Label Run-In Period||0
2833643|NCT00381485|3535260|FG002|COMPLETED|Open-Label Run-In Period||0
2833644|NCT00381485|3535261|FG003|COMPLETED|Open-Label Run-In Period||0
2833645|NCT00381485|3535258|FG000|NOT COMPLETED|Open-Label Run-In Period||106
2833646|NCT00381485|3535259|FG001|NOT COMPLETED|Open-Label Run-In Period||0
3311090|NCT03048006|4044496|FG000|NOT COMPLETED|Overall Study||0
3311091|NCT03048058|4044502|FG000|STARTED|Overall Study||10
3311092|NCT03048058|4044503|FG001|STARTED|Overall Study||10
3311093|NCT03048058|4044502|FG000|COMPLETED|Overall Study||6
3311094|NCT03048058|4044503|FG001|COMPLETED|Overall Study||6
3311095|NCT03048058|4044502|FG000|NOT COMPLETED|Overall Study||4
3311096|NCT03048058|4044503|FG001|NOT COMPLETED|Overall Study||4
3311097|NCT03048383|4044512|FG000|STARTED|Overall Study||28
3311098|NCT03048383|4044513|FG001|STARTED|Overall Study||21
3311099|NCT03048383|4044514|FG002|STARTED|Overall Study||22
3311100|NCT03048383|4044512|FG000|COMPLETED|Overall Study||15
3311101|NCT03048383|4044513|FG001|COMPLETED|Overall Study||13
3311102|NCT03048383|4044514|FG002|COMPLETED|Overall Study||10
3311103|NCT03048383|4044512|FG000|NOT COMPLETED|Overall Study||13
3311104|NCT03048383|4044513|FG001|NOT COMPLETED|Overall Study||8
3311105|NCT03048383|4044514|FG002|NOT COMPLETED|Overall Study||12
3311106|NCT03048500|4044522|FG000|STARTED|2 Cycles of Treatment||17
3311107|NCT03048500|4044522|FG000|Attempted 1st Cycle|2 Cycles of Treatment||17
3311108|NCT03048500|4044522|FG000|Attempted 2nd Cycle|2 Cycles of Treatment||16
3311109|NCT03048500|4044522|FG000|COMPLETED|2 Cycles of Treatment||16
3311110|NCT03048500|4044522|FG000|NOT COMPLETED|2 Cycles of Treatment||1
3311111|NCT03048500|4044522|FG000|STARTED|Reached 1st Response/Continued Treatment||16
3311112|NCT03048500|4044522|FG000|Assessed for First Response|Reached 1st Response/Continued Treatment||16
3311113|NCT03048500|4044522|FG000|Went on to Cycle 3 and Beyond|Reached 1st Response/Continued Treatment||9
3311114|NCT03048500|4044522|FG000|COMPLETED|Reached 1st Response/Continued Treatment||9
3311115|NCT03048500|4044522|FG000|NOT COMPLETED|Reached 1st Response/Continued Treatment||7
3311116|NCT03048500|4044522|FG000|STARTED|Follow up for 3 Years|1 patient died whilst on study.|16
3311117|NCT03048500|4044522|FG000|COMPLETED|Follow up for 3 Years||0
3311118|NCT03048500|4044522|FG000|NOT COMPLETED|Follow up for 3 Years||16
3311119|NCT03048747|4044526|FG000|STARTED|Overall Study||16
3311120|NCT03048747|4044526|FG000|COMPLETED|Overall Study||11
3311121|NCT03048747|4044526|FG000|NOT COMPLETED|Overall Study||5
3311122|NCT03049215|4044533|FG000|STARTED|Overall Study||1
3311123|NCT03049215|4044534|FG001|STARTED|Overall Study||0
3311124|NCT03049215|4044533|FG000|COMPLETED|Overall Study||1
3311125|NCT03049215|4044534|FG001|COMPLETED|Overall Study||0
3311126|NCT03049215|4044533|FG000|NOT COMPLETED|Overall Study||0
3311127|NCT03049215|4044534|FG001|NOT COMPLETED|Overall Study||0
3311128|NCT03049280|4044540|FG000|STARTED|Overall Study||33
3311129|NCT03049280|4044540|FG000|COMPLETED|Overall Study||32
3311130|NCT03049280|4044540|FG000|NOT COMPLETED|Overall Study||1
3311131|NCT03049488|4044552|FG000|STARTED|Overall Study||15
3311132|NCT03049488|4044553|FG001|STARTED|Overall Study||15
3311133|NCT03049488|4044554|FG002|STARTED|Overall Study||20
3311134|NCT03049488|4044555|FG003|STARTED|Overall Study||15
3311135|NCT03049488|4044556|FG004|STARTED|Overall Study||15
3311136|NCT03049488|4044557|FG005|STARTED|Overall Study||15
3311137|NCT03049488|4044552|FG000|Received First Product Administration|Overall Study||15
3311138|NCT03049488|4044553|FG001|Received First Product Administration|Overall Study||15
3311139|NCT03049488|4044554|FG002|Received First Product Administration|Overall Study||20
3311140|NCT03049488|4044555|FG003|Received First Product Administration|Overall Study||15
3311141|NCT03049488|4044556|FG004|Received First Product Administration|Overall Study||15
3311142|NCT03049488|4044557|FG005|Received First Product Administration|Overall Study||15
3311143|NCT03049488|4044552|FG000|Received Optional Second Dose|Overall Study||10
3311144|NCT03049488|4044553|FG001|Received Optional Second Dose|Overall Study||11
3311145|NCT03049488|4044554|FG002|Received Optional Second Dose|Overall Study||11
3311146|NCT03049488|4044555|FG003|Received Optional Second Dose|Overall Study||9
3311147|NCT03049488|4044556|FG004|Received Optional Second Dose|Overall Study||11
3311148|NCT03049488|4044557|FG005|Received Optional Second Dose|Overall Study||10
3311149|NCT03049488|4044552|FG000|COMPLETED|Overall Study||13
3311150|NCT03049488|4044553|FG001|COMPLETED|Overall Study||13
3311151|NCT03049488|4044554|FG002|COMPLETED|Overall Study||20
3311152|NCT03049488|4044555|FG003|COMPLETED|Overall Study||13
3311153|NCT03049488|4044556|FG004|COMPLETED|Overall Study||13
3311154|NCT03049488|4044557|FG005|COMPLETED|Overall Study||15
3311155|NCT03049488|4044552|FG000|NOT COMPLETED|Overall Study||2
3311156|NCT03049488|4044553|FG001|NOT COMPLETED|Overall Study||2
3311157|NCT03049488|4044554|FG002|NOT COMPLETED|Overall Study||0
3311158|NCT03049488|4044555|FG003|NOT COMPLETED|Overall Study||2
3311159|NCT03049488|4044556|FG004|NOT COMPLETED|Overall Study||2
3311160|NCT03049488|4044557|FG005|NOT COMPLETED|Overall Study||0
3311161|NCT03049501|4044574|FG000|STARTED|Overall Study||123
3311162|NCT03049501|4044575|FG001|STARTED|Overall Study||121
3311163|NCT03049501|4044574|FG000|6 Month Follow up|Overall Study||107
3311164|NCT03049501|4044575|FG001|6 Month Follow up|Overall Study||91
3311165|NCT03049501|4044574|FG000|12 Month Follow up|Overall Study||101
2833647|NCT00381485|3535260|FG002|NOT COMPLETED|Open-Label Run-In Period||0
2833648|NCT00381485|3535261|FG003|NOT COMPLETED|Open-Label Run-In Period||0
2833649|NCT00381485|3535258|FG000|STARTED|Double-Blind Treatment Period||0
2833650|NCT00381485|3535259|FG001|STARTED|Double-Blind Treatment Period||255
2833651|NCT00381485|3535260|FG002|STARTED|Double-Blind Treatment Period||233
2833652|NCT00381485|3535261|FG003|STARTED|Double-Blind Treatment Period||240
2833653|NCT00381485|3535258|FG000|COMPLETED|Double-Blind Treatment Period||0
2833654|NCT00381485|3535259|FG001|COMPLETED|Double-Blind Treatment Period||228
2833655|NCT00381485|3535260|FG002|COMPLETED|Double-Blind Treatment Period||208
2833656|NCT00381485|3535261|FG003|COMPLETED|Double-Blind Treatment Period||207
2833657|NCT00381485|3535258|FG000|NOT COMPLETED|Double-Blind Treatment Period||0
2833658|NCT00381485|3535259|FG001|NOT COMPLETED|Double-Blind Treatment Period||27
2833659|NCT00381485|3535260|FG002|NOT COMPLETED|Double-Blind Treatment Period||25
2833660|NCT00381485|3535261|FG003|NOT COMPLETED|Double-Blind Treatment Period||33
2833661|NCT00379288|3535274|FG000|STARTED|Overall Study||141
2833662|NCT00379288|3535275|FG001|STARTED|Overall Study||130
2833663|NCT00379288|3535276|FG002|STARTED|Overall Study||68
2833664|NCT00379288|3535277|FG003|STARTED|Overall Study||65
2833665|NCT00379288|3535274|FG000|COMPLETED|Overall Study||122
2833666|NCT00379288|3535275|FG001|COMPLETED|Overall Study||108
2833667|NCT00379288|3535276|FG002|COMPLETED|Overall Study||58
2833668|NCT00379288|3535277|FG003|COMPLETED|Overall Study||57
2833669|NCT00379288|3535274|FG000|NOT COMPLETED|Overall Study||19
2833670|NCT00379288|3535275|FG001|NOT COMPLETED|Overall Study||22
2833671|NCT00379288|3535276|FG002|NOT COMPLETED|Overall Study||10
2833672|NCT00379288|3535277|FG003|NOT COMPLETED|Overall Study||8
2833673|NCT00378378|3535290|FG000|STARTED|Overall Study||51
2833674|NCT00378378|3535291|FG001|STARTED|Overall Study||50
2833675|NCT00378378|3535292|FG002|STARTED|Overall Study||26
2833676|NCT00378378|3535290|FG000|COMPLETED|Overall Study||51
2833677|NCT00378378|3535291|FG001|COMPLETED|Overall Study||49
2833678|NCT00378378|3535292|FG002|COMPLETED|Overall Study||24
2833679|NCT00378378|3535290|FG000|NOT COMPLETED|Overall Study||0
2833680|NCT00378378|3535291|FG001|NOT COMPLETED|Overall Study||1
2833681|NCT00378378|3535292|FG002|NOT COMPLETED|Overall Study||2
2833682|NCT00089895|3535302|FG000|STARTED|Overall Study|Number of Subjects Randomized with Intent to Treat|4722
2833683|NCT00089895|3535303|FG001|STARTED|Overall Study|Number of Subjects Randomized with Intent to Treat|4684
2833684|NCT00089895|3535302|FG000|COMPLETED|Overall Study|Number of Subjects treated|4687
2833685|NCT00089895|3535303|FG001|COMPLETED|Overall Study|Number of Subjects treated|4642
2833686|NCT00089895|3535302|FG000|NOT COMPLETED|Overall Study||35
2833687|NCT00089895|3535303|FG001|NOT COMPLETED|Overall Study||42
2833688|NCT02614066|3535313|FG000|STARTED|Overall Study||6
3311166|NCT03049501|4044575|FG001|12 Month Follow up|Overall Study||92
3311167|NCT03049501|4044574|FG000|COMPLETED|Overall Study||101
3311168|NCT03049501|4044575|FG001|COMPLETED|Overall Study||92
3311169|NCT03049501|4044574|FG000|NOT COMPLETED|Overall Study||22
3311170|NCT03049501|4044575|FG001|NOT COMPLETED|Overall Study||29
3311171|NCT03049748|4044583|FG000|STARTED|Overall Study||20
3311172|NCT03049748|4044584|FG001|STARTED|Overall Study||20
3311173|NCT03049748|4044583|FG000|COMPLETED|Overall Study||16
3311174|NCT03049748|4044584|FG001|COMPLETED|Overall Study||14
3311175|NCT03049748|4044583|FG000|NOT COMPLETED|Overall Study||4
3311176|NCT03049748|4044584|FG001|NOT COMPLETED|Overall Study||6
3311177|NCT03049852|4044593|FG000|STARTED|Overall Study||24
3311178|NCT03049852|4044594|FG001|STARTED|Overall Study||25
3311179|NCT03049852|4044595|FG002|STARTED|Overall Study||26
3311180|NCT03049852|4044593|FG000|COMPLETED|Overall Study||24
3311181|NCT03049852|4044594|FG001|COMPLETED|Overall Study||24
3311182|NCT03049852|4044595|FG002|COMPLETED|Overall Study||26
3311183|NCT03049852|4044593|FG000|NOT COMPLETED|Overall Study||0
3311184|NCT03049852|4044594|FG001|NOT COMPLETED|Overall Study||1
3311185|NCT03049852|4044595|FG002|NOT COMPLETED|Overall Study||0
3311186|NCT03049917|4044610|FG000|STARTED|Overall Study||90
3311187|NCT03049917|4044611|FG001|STARTED|Overall Study||89
3311188|NCT03049917|4044612|FG002|STARTED|Overall Study||93
3311189|NCT03049917|4044613|FG003|STARTED|Overall Study||92
3311190|NCT03049917|4044614|FG004|STARTED|Overall Study||88
3311191|NCT03049917|4044610|FG000|COMPLETED|Overall Study||31
3311192|NCT03049917|4044611|FG001|COMPLETED|Overall Study||31
3311193|NCT03049917|4044612|FG002|COMPLETED|Overall Study||44
3311194|NCT03049917|4044613|FG003|COMPLETED|Overall Study||51
3311195|NCT03049917|4044614|FG004|COMPLETED|Overall Study||54
3311196|NCT03049917|4044610|FG000|NOT COMPLETED|Overall Study||59
3311197|NCT03049917|4044611|FG001|NOT COMPLETED|Overall Study||58
3311198|NCT03049917|4044612|FG002|NOT COMPLETED|Overall Study||49
3311199|NCT03049917|4044613|FG003|NOT COMPLETED|Overall Study||41
3311200|NCT03049917|4044614|FG004|NOT COMPLETED|Overall Study||34
3311201|NCT03050203|4044650|FG000|STARTED|Overall Study||19
3311202|NCT03050203|4044651|FG001|STARTED|Overall Study||18
3311203|NCT03050203|4044650|FG000|COMPLETED|Overall Study||19
3311204|NCT03050203|4044651|FG001|COMPLETED|Overall Study||18
3311205|NCT03050203|4044650|FG000|NOT COMPLETED|Overall Study||0
3311206|NCT03050203|4044651|FG001|NOT COMPLETED|Overall Study||0
3311207|NCT03050216|4044657|FG000|STARTED|Overall Study||8
3311208|NCT03050216|4044657|FG000|COMPLETED|Overall Study||8
3311209|NCT03050216|4044657|FG000|NOT COMPLETED|Overall Study||0
3311210|NCT03050294|4044665|FG000|STARTED|Overall Study||6
3311211|NCT03050294|4044666|FG001|STARTED|Overall Study||6
3311212|NCT03050294|4044667|FG002|STARTED|Overall Study||6
2833689|NCT02614066|3535314|FG001|STARTED|Overall Study||28
2833690|NCT02614066|3535315|FG002|STARTED|Overall Study||20
2833691|NCT02614066|3535316|FG003|STARTED|Overall Study||71
2833692|NCT02614066|3535313|FG000|COMPLETED|Overall Study||0
2833693|NCT02614066|3535314|FG001|COMPLETED|Overall Study||0
2833694|NCT02614066|3535315|FG002|COMPLETED|Overall Study||0
2833695|NCT02614066|3535316|FG003|COMPLETED|Overall Study||0
2833696|NCT02614066|3535313|FG000|NOT COMPLETED|Overall Study||6
2833697|NCT02614066|3535314|FG001|NOT COMPLETED|Overall Study||28
2833698|NCT02614066|3535315|FG002|NOT COMPLETED|Overall Study||20
2833699|NCT02614066|3535316|FG003|NOT COMPLETED|Overall Study||71
2833700|NCT02577354|3535326|FG000|STARTED|Overall Study||102
2833701|NCT02577354|3535327|FG001|STARTED|Overall Study||102
2833702|NCT02577354|3535326|FG000|120 Day Primary Endpoint|Overall Study||100
2833703|NCT02577354|3535327|FG001|120 Day Primary Endpoint|Overall Study||101
2833704|NCT02577354|3535326|FG000|COMPLETED|Overall Study||87
2833705|NCT02577354|3535327|FG001|COMPLETED|Overall Study||89
2833706|NCT02577354|3535326|FG000|NOT COMPLETED|Overall Study||15
2833707|NCT02577354|3535327|FG001|NOT COMPLETED|Overall Study||13
2833708|NCT02551718|3535343|FG000|STARTED|Overall Study||34
2833709|NCT02551718|3535343|FG000|COMPLETED|Overall Study||34
2833710|NCT02551718|3535343|FG000|NOT COMPLETED|Overall Study||0
2833711|NCT02471807|3535347|FG000|STARTED|Overall Study||34
2833712|NCT02471807|3535347|FG000|COMPLETED|Overall Study||11
2833713|NCT02471807|3535347|FG000|NOT COMPLETED|Overall Study||23
2833714|NCT02321514|3535351|FG000|STARTED|Overall Study||191
2833715|NCT02321514|3535351|FG000|COMPLETED|Overall Study||166
2833716|NCT02321514|3535351|FG000|NOT COMPLETED|Overall Study||25
2833717|NCT02118610|3535357|FG000|STARTED|Overall Study||30
2833718|NCT02118610|3535358|FG001|STARTED|Overall Study||33
2833719|NCT02118610|3535357|FG000|COMPLETED|Overall Study||29
2833720|NCT02118610|3535358|FG001|COMPLETED|Overall Study||32
2833721|NCT02118610|3535357|FG000|NOT COMPLETED|Overall Study||1
2833722|NCT02118610|3535358|FG001|NOT COMPLETED|Overall Study||1
2833723|NCT01909570|3535366|FG000|STARTED|Overall Study||84
2833724|NCT01909570|3535367|FG001|STARTED|Overall Study||91
2833725|NCT01909570|3535366|FG000|COMPLETED|Overall Study||57
2833726|NCT01909570|3535367|FG001|COMPLETED|Overall Study||64
2833727|NCT01909570|3535366|FG000|NOT COMPLETED|Overall Study||27
2833728|NCT01909570|3535367|FG001|NOT COMPLETED|Overall Study||27
3311213|NCT03050294|4044668|FG003|STARTED|Overall Study||6
3311214|NCT03050294|4044665|FG000|COMPLETED|Overall Study||6
3311215|NCT03050294|4044666|FG001|COMPLETED|Overall Study||6
3311216|NCT03050294|4044667|FG002|COMPLETED|Overall Study||6
3311217|NCT03050294|4044668|FG003|COMPLETED|Overall Study||6
3311218|NCT03050294|4044665|FG000|NOT COMPLETED|Overall Study||0
3311219|NCT03050294|4044666|FG001|NOT COMPLETED|Overall Study||0
3311220|NCT03050294|4044667|FG002|NOT COMPLETED|Overall Study||0
3311221|NCT03050294|4044668|FG003|NOT COMPLETED|Overall Study||0
3311222|NCT03050307|4044680|FG000|STARTED|Overall Study||115
3311223|NCT03050307|4044681|FG001|STARTED|Overall Study||119
3311224|NCT03050307|4044680|FG000|COMPLETED|Overall Study||107
3311225|NCT03050307|4044681|FG001|COMPLETED|Overall Study||110
3311226|NCT03050307|4044680|FG000|NOT COMPLETED|Overall Study||8
3311227|NCT03050307|4044681|FG001|NOT COMPLETED|Overall Study||9
3311228|NCT03050320|4044691|FG000|STARTED|Overall Study||21
3311229|NCT03050320|4044692|FG001|STARTED|Overall Study||22
3311230|NCT03050320|4044691|FG000|COMPLETED|Overall Study||20
3311231|NCT03050320|4044692|FG001|COMPLETED|Overall Study||21
3311232|NCT03050320|4044691|FG000|NOT COMPLETED|Overall Study||1
3311233|NCT03050320|4044692|FG001|NOT COMPLETED|Overall Study||1
3311234|NCT03050359|4044700|FG000|STARTED|Overall Study||265
3311235|NCT03050359|4044701|FG001|STARTED|Overall Study||268
3311236|NCT03050359|4044700|FG000|COMPLETED|Overall Study||248
3311237|NCT03050359|4044701|FG001|COMPLETED|Overall Study||248
3311238|NCT03050359|4044700|FG000|NOT COMPLETED|Overall Study||17
3311239|NCT03050359|4044701|FG001|NOT COMPLETED|Overall Study||20
3311240|NCT03050372|4044709|FG000|STARTED|Adaptation Night (Night #1 PSG)||6
3311241|NCT03050372|4044710|FG001|STARTED|Adaptation Night (Night #1 PSG)||6
3311242|NCT03050372|4044709|FG000|COMPLETED|Adaptation Night (Night #1 PSG)|N=1 subject removed from study due to mild sleep apnea during adaptation night|5
3311243|NCT03050372|4044710|FG001|COMPLETED|Adaptation Night (Night #1 PSG)||6
3311244|NCT03050372|4044709|FG000|NOT COMPLETED|Adaptation Night (Night #1 PSG)||1
3311245|NCT03050372|4044710|FG001|NOT COMPLETED|Adaptation Night (Night #1 PSG)||0
3311246|NCT03050372|4044709|FG000|STARTED|First Intervention (Nights #2 and #3)||5
3311247|NCT03050372|4044710|FG001|STARTED|First Intervention (Nights #2 and #3)||6
3311248|NCT03050372|4044709|FG000|COMPLETED|First Intervention (Nights #2 and #3)||5
3311249|NCT03050372|4044710|FG001|COMPLETED|First Intervention (Nights #2 and #3)||6
3311250|NCT03050372|4044709|FG000|NOT COMPLETED|First Intervention (Nights #2 and #3)||0
3311251|NCT03050372|4044710|FG001|NOT COMPLETED|First Intervention (Nights #2 and #3)||0
3311252|NCT03050372|4044709|FG000|STARTED|Second Intervention (Nights #4 and #5)||5
3311253|NCT03050372|4044710|FG001|STARTED|Second Intervention (Nights #4 and #5)||6
3311254|NCT03050372|4044709|FG000|COMPLETED|Second Intervention (Nights #4 and #5)||5
3311255|NCT03050372|4044710|FG001|COMPLETED|Second Intervention (Nights #4 and #5)|N=1 subject (blind only broken after double-blind analysis) moved out off State; lost to study|5
3311256|NCT03050372|4044709|FG000|NOT COMPLETED|Second Intervention (Nights #4 and #5)||0
3311257|NCT03050372|4044710|FG001|NOT COMPLETED|Second Intervention (Nights #4 and #5)||1
2914465|NCT00504348|3624604|FG000|STARTED|Overall Study||25
2914466|NCT00504348|3624604|FG000|COMPLETED|Overall Study||17
2833729|NCT01453946|3535373|FG000|STARTED|Overall Study||50
2833730|NCT01453946|3535373|FG000|COMPLETED|Overall Study||41
2833731|NCT01453946|3535373|FG000|NOT COMPLETED|Overall Study||9
2833732|NCT01444092|3535377|FG000|STARTED|Overall Study||108
2833733|NCT01444092|3535377|FG000|INFORMED CONSENT OBTAINED|Overall Study||108
2833734|NCT01444092|3535377|FG000|COMPLETED|Overall Study||91
2833735|NCT01444092|3535377|FG000|NOT COMPLETED|Overall Study||17
2833736|NCT01332968|3535383|FG000|STARTED|Induction Period||699
2833737|NCT01332968|3535384|FG001|STARTED|Induction Period||702
2833738|NCT01332968|3535385|FG002|STARTED|Induction Period||0
2833739|NCT01332968|3535386|FG003|STARTED|Induction Period||0
2833740|NCT01332968|3535387|FG004|STARTED|Induction Period||0
2833741|NCT01332968|3535388|FG005|STARTED|Induction Period||0
2833742|NCT01332968|3535389|FG006|STARTED|Induction Period||0
2833743|NCT01332968|3535390|FG007|STARTED|Induction Period||0
2833744|NCT01332968|3535383|FG000|COMPLETED|Induction Period||641
2833745|NCT01332968|3535384|FG001|COMPLETED|Induction Period||646
2833746|NCT01332968|3535385|FG002|COMPLETED|Induction Period||0
2833747|NCT01332968|3535386|FG003|COMPLETED|Induction Period||0
2833748|NCT01332968|3535387|FG004|COMPLETED|Induction Period||0
2833749|NCT01332968|3535388|FG005|COMPLETED|Induction Period||0
2833750|NCT01332968|3535389|FG006|COMPLETED|Induction Period||0
2833751|NCT01332968|3535390|FG007|COMPLETED|Induction Period||0
2833752|NCT01332968|3535383|FG000|NOT COMPLETED|Induction Period||58
2833753|NCT01332968|3535384|FG001|NOT COMPLETED|Induction Period||56
2833754|NCT01332968|3535385|FG002|NOT COMPLETED|Induction Period||0
2833755|NCT01332968|3535386|FG003|NOT COMPLETED|Induction Period||0
2833756|NCT01332968|3535387|FG004|NOT COMPLETED|Induction Period||0
2833757|NCT01332968|3535388|FG005|NOT COMPLETED|Induction Period||0
2833758|NCT01332968|3535389|FG006|NOT COMPLETED|Induction Period||0
2833759|NCT01332968|3535390|FG007|NOT COMPLETED|Induction Period||0
2833760|NCT01332968|3535383|FG000|STARTED|Maintenance/Observation Period||0
2833761|NCT01332968|3535384|FG001|STARTED|Maintenance/Observation Period||0
3311258|NCT03050450|4044720|FG000|STARTED|Overall Study||6
3311259|NCT03050450|4044721|FG001|STARTED|Overall Study||0
3311260|NCT03050450|4044722|FG002|STARTED|Overall Study||0
3311261|NCT03050450|4044723|FG003|STARTED|Overall Study||0
3311262|NCT03050450|4044724|FG004|STARTED|Overall Study||0
3311263|NCT03050450|4044720|FG000|COMPLETED|Overall Study||5
3311264|NCT03050450|4044721|FG001|COMPLETED|Overall Study||0
3311265|NCT03050450|4044722|FG002|COMPLETED|Overall Study||0
3311266|NCT03050450|4044723|FG003|COMPLETED|Overall Study||0
3311267|NCT03050450|4044724|FG004|COMPLETED|Overall Study||0
3167013|NCT01907100|3894130|FG003|Treated Patients|Overall Study||227
3167014|NCT01907100|3894127|FG000|COMPLETED|Overall Study||1
3167015|NCT01907100|3894128|FG001|COMPLETED|Overall Study||4
3167016|NCT01907100|3894129|FG002|COMPLETED|Overall Study||82
3167017|NCT01907100|3894130|FG003|COMPLETED|Overall Study||83
3167018|NCT01907100|3894127|FG000|NOT COMPLETED|Overall Study||42
3167019|NCT01907100|3894128|FG001|NOT COMPLETED|Overall Study||40
3167020|NCT01907100|3894129|FG002|NOT COMPLETED|Overall Study||147
3167021|NCT01907100|3894130|FG003|NOT COMPLETED|Overall Study||146
3167022|NCT01907113|3894143|FG000|STARTED|Overall Study||8
3167023|NCT01907113|3894144|FG001|STARTED|Overall Study||9
3167024|NCT01907113|3894145|FG002|STARTED|Overall Study||7
3167025|NCT01907113|3894146|FG003|STARTED|Overall Study||8
3167026|NCT01907113|3894147|FG004|STARTED|Overall Study||8
3167027|NCT01907113|3894143|FG000|COMPLETED|Overall Study||8
3311268|NCT03050450|4044720|FG000|NOT COMPLETED|Overall Study||1
3311269|NCT03050450|4044721|FG001|NOT COMPLETED|Overall Study||0
3311270|NCT03050450|4044722|FG002|NOT COMPLETED|Overall Study||0
3311271|NCT03050450|4044723|FG003|NOT COMPLETED|Overall Study||0
3311272|NCT03050450|4044724|FG004|NOT COMPLETED|Overall Study||0
3311273|NCT03050541|4044739|FG000|STARTED|Overall Study||28
3311274|NCT03050541|4044740|FG001|STARTED|Overall Study||28
3311275|NCT03050541|4044741|FG002|STARTED|Overall Study||28
3311276|NCT03050541|4044739|FG000|COMPLETED|Overall Study||20
3311277|NCT03050541|4044740|FG001|COMPLETED|Overall Study||20
3311278|NCT03050541|4044741|FG002|COMPLETED|Overall Study||20
3311279|NCT03050541|4044739|FG000|NOT COMPLETED|Overall Study||8
3311280|NCT03050541|4044740|FG001|NOT COMPLETED|Overall Study||8
3311281|NCT03050541|4044741|FG002|NOT COMPLETED|Overall Study||8
3311282|NCT03050619|4044755|FG000|STARTED|Overall Study||129
3311283|NCT03050619|4044756|FG001|STARTED|Overall Study||3926
3311284|NCT03050619|4044757|FG002|STARTED|Overall Study||6416
3311285|NCT03050619|4044758|FG003|STARTED|Overall Study||14007
2833762|NCT01332968|3535385|FG002|STARTED|Maintenance/Observation Period||612
2833763|NCT01332968|3535386|FG003|STARTED|Maintenance/Observation Period||624
2833764|NCT01332968|3535387|FG004|STARTED|Maintenance/Observation Period||12
2833765|NCT01332968|3535388|FG005|STARTED|Maintenance/Observation Period||11
2833766|NCT01332968|3535389|FG006|STARTED|Maintenance/Observation Period||0
3167028|NCT01907113|3894144|FG001|COMPLETED|Overall Study||9
3167029|NCT01907113|3894145|FG002|COMPLETED|Overall Study||7
3167030|NCT01907113|3894146|FG003|COMPLETED|Overall Study||8
3167031|NCT01907113|3894147|FG004|COMPLETED|Overall Study||8
3167032|NCT01907113|3894143|FG000|NOT COMPLETED|Overall Study||0
3311286|NCT03050619|4044759|FG004|STARTED|Overall Study||6079
3311287|NCT03050619|4044760|FG005|STARTED|Overall Study||1351
3311288|NCT03050619|4044755|FG000|COMPLETED|Overall Study||129
3167033|NCT01907113|3894144|FG001|NOT COMPLETED|Overall Study||0
3311289|NCT03050619|4044756|FG001|COMPLETED|Overall Study||3926
3167034|NCT01907113|3894145|FG002|NOT COMPLETED|Overall Study||0
2833767|NCT01332968|3535390|FG007|STARTED|Maintenance/Observation Period||0
2833768|NCT01332968|3535383|FG000|COMPLETED|Maintenance/Observation Period||0
2833769|NCT01332968|3535384|FG001|COMPLETED|Maintenance/Observation Period||0
2833770|NCT01332968|3535385|FG002|COMPLETED|Maintenance/Observation Period||399
3167035|NCT01907113|3894146|FG003|NOT COMPLETED|Overall Study||0
3167036|NCT01907113|3894147|FG004|NOT COMPLETED|Overall Study||0
3311290|NCT03050619|4044757|FG002|COMPLETED|Overall Study||6416
3311291|NCT03050619|4044758|FG003|COMPLETED|Overall Study||14007
3311292|NCT03050619|4044759|FG004|COMPLETED|Overall Study||6079
3167037|NCT01907217|3894161|FG000|STARTED|Overall Study||69
3167038|NCT01907217|3894162|FG001|STARTED|Overall Study||69
3167039|NCT01907217|3894161|FG000|COMPLETED|Overall Study||69
3167040|NCT01907217|3894162|FG001|COMPLETED|Overall Study||67
3167041|NCT01907217|3894161|FG000|NOT COMPLETED|Overall Study||0
3167042|NCT01907217|3894162|FG001|NOT COMPLETED|Overall Study||2
3167043|NCT01907269|3894172|FG000|STARTED|6 Month Outcome Measures Post-interventi||1342
3167044|NCT01907269|3894173|FG001|STARTED|6 Month Outcome Measures Post-interventi||1342
3167045|NCT01907269|3894172|FG000|COMPLETED|6 Month Outcome Measures Post-interventi||953
3167046|NCT01907269|3894173|FG001|COMPLETED|6 Month Outcome Measures Post-interventi||1053
3167047|NCT01907269|3894172|FG000|NOT COMPLETED|6 Month Outcome Measures Post-interventi||389
3167048|NCT01907269|3894173|FG001|NOT COMPLETED|6 Month Outcome Measures Post-interventi||289
3311293|NCT03050619|4044760|FG005|COMPLETED|Overall Study||1351
3311294|NCT03050619|4044755|FG000|NOT COMPLETED|Overall Study||0
3311295|NCT03050619|4044756|FG001|NOT COMPLETED|Overall Study||0
3311296|NCT03050619|4044757|FG002|NOT COMPLETED|Overall Study||0
3311297|NCT03050619|4044758|FG003|NOT COMPLETED|Overall Study||0
3311298|NCT03050619|4044759|FG004|NOT COMPLETED|Overall Study||0
3311299|NCT03050619|4044760|FG005|NOT COMPLETED|Overall Study||0
3311300|NCT03050697|4044774|FG000|STARTED|Overall Study||12
3311301|NCT03050697|4044774|FG000|COMPLETED|Overall Study||12
3311302|NCT03050697|4044774|FG000|NOT COMPLETED|Overall Study||0
3311303|NCT03050775|4044792|FG000|STARTED|Overall Study||35
3311304|NCT03050775|4044793|FG001|STARTED|Overall Study||35
3167049|NCT01907269|3894172|FG000|STARTED|18 Month Outcome Measures Post-intervent||1178
3167050|NCT01907269|3894173|FG001|STARTED|18 Month Outcome Measures Post-intervent||1250
3167051|NCT01907269|3894172|FG000|COMPLETED|18 Month Outcome Measures Post-intervent||859
3167052|NCT01907269|3894173|FG001|COMPLETED|18 Month Outcome Measures Post-intervent||970
3167053|NCT01907269|3894172|FG000|NOT COMPLETED|18 Month Outcome Measures Post-intervent||319
3167054|NCT01907269|3894173|FG001|NOT COMPLETED|18 Month Outcome Measures Post-intervent||280
3167055|NCT01907321|3894179|FG000|STARTED|Overall Study||14
3167056|NCT01907321|3894179|FG000|COMPLETED|Overall Study||12
3167057|NCT01907321|3894179|FG000|NOT COMPLETED|Overall Study||2
3167058|NCT01907334|3894183|FG000|STARTED|Overall Study||6
3167059|NCT01907334|3894184|FG001|STARTED|Overall Study||4
3167060|NCT01907334|3894183|FG000|COMPLETED|Overall Study||6
3167061|NCT01907334|3894184|FG001|COMPLETED|Overall Study||4
3167062|NCT01907334|3894183|FG000|NOT COMPLETED|Overall Study||0
3167063|NCT01907334|3894184|FG001|NOT COMPLETED|Overall Study||0
3167064|NCT01907490|3894189|FG000|STARTED|Overall Study||38
3311305|NCT03050775|4044792|FG000|COMPLETED|Overall Study||35
3311306|NCT03050775|4044793|FG001|COMPLETED|Overall Study||35
3311307|NCT03050775|4044792|FG000|NOT COMPLETED|Overall Study||0
3311308|NCT03050775|4044793|FG001|NOT COMPLETED|Overall Study||0
3311309|NCT03050801|4044805|FG000|STARTED|Experiment 1||3
3311310|NCT03050801|4044806|FG001|STARTED|Experiment 1||13
3311311|NCT03050801|4044807|FG002|STARTED|Experiment 1||8
3311312|NCT03050801|4044808|FG003|STARTED|Experiment 1||0
3311313|NCT03050801|4044809|FG004|STARTED|Experiment 1||0
3311314|NCT03050801|4044810|FG005|STARTED|Experiment 1||0
3311315|NCT03050801|4044805|FG000|COMPLETED|Experiment 1||3
3311316|NCT03050801|4044806|FG001|COMPLETED|Experiment 1||6
3311317|NCT03050801|4044807|FG002|COMPLETED|Experiment 1||6
3311318|NCT03050801|4044808|FG003|COMPLETED|Experiment 1||0
3311319|NCT03050801|4044809|FG004|COMPLETED|Experiment 1||0
3311320|NCT03050801|4044810|FG005|COMPLETED|Experiment 1||0
3311321|NCT03050801|4044805|FG000|NOT COMPLETED|Experiment 1||0
3167065|NCT01907490|3894189|FG000|COMPLETED|Overall Study||38
3167066|NCT01907490|3894189|FG000|NOT COMPLETED|Overall Study||0
3167067|NCT01907516|3894196|FG000|STARTED|First Intervention (3 Weeks)||50
3167068|NCT01907516|3894197|FG001|STARTED|First Intervention (3 Weeks)||50
3167069|NCT01907516|3894196|FG000|COMPLETED|First Intervention (3 Weeks)||40
3167070|NCT01907516|3894197|FG001|COMPLETED|First Intervention (3 Weeks)||34
3167071|NCT01907516|3894196|FG000|NOT COMPLETED|First Intervention (3 Weeks)||10
3167072|NCT01907516|3894197|FG001|NOT COMPLETED|First Intervention (3 Weeks)||16
3167073|NCT01907516|3894196|FG000|STARTED|Second Intervention (3 Weeks)||40
3167074|NCT01907516|3894197|FG001|STARTED|Second Intervention (3 Weeks)||34
3167075|NCT01907516|3894196|FG000|COMPLETED|Second Intervention (3 Weeks)||40
3167076|NCT01907516|3894197|FG001|COMPLETED|Second Intervention (3 Weeks)||34
3167077|NCT01907516|3894196|FG000|NOT COMPLETED|Second Intervention (3 Weeks)||0
3167078|NCT01907516|3894197|FG001|NOT COMPLETED|Second Intervention (3 Weeks)||0
3167079|NCT01907607|3894204|FG000|STARTED|Overall Study||29
3167080|NCT01907607|3894204|FG000|COMPLETED|Overall Study||29
3167081|NCT01907607|3894204|FG000|NOT COMPLETED|Overall Study||0
3167082|NCT01907737|3894208|FG000|STARTED|Overall Study||22
3311322|NCT03050801|4044806|FG001|NOT COMPLETED|Experiment 1||7
3311323|NCT03050801|4044807|FG002|NOT COMPLETED|Experiment 1||2
3311324|NCT03050801|4044808|FG003|NOT COMPLETED|Experiment 1||0
2833771|NCT01332968|3535386|FG003|COMPLETED|Maintenance/Observation Period||417
3167083|NCT01907737|3894208|FG000|COMPLETED|Overall Study||21
3167084|NCT01907737|3894208|FG000|NOT COMPLETED|Overall Study||1
3167085|NCT01907815|3894220|FG000|STARTED|Overall Study||17
3167086|NCT01907815|3894221|FG001|STARTED|Overall Study||7
3167087|NCT01907815|3894220|FG000|COMPLETED|Overall Study||16
3167088|NCT01907815|3894221|FG001|COMPLETED|Overall Study||7
3167089|NCT01907815|3894220|FG000|NOT COMPLETED|Overall Study||1
3167090|NCT01907815|3894221|FG001|NOT COMPLETED|Overall Study||0
3167091|NCT01907828|3894231|FG000|STARTED|Overall Study||39
3167092|NCT01907828|3894232|FG001|STARTED|Overall Study||22
3167093|NCT01907828|3894231|FG000|Underwent Procedure|Overall Study||39
3167094|NCT01907828|3894232|FG001|Underwent Procedure|Overall Study|2 participants terminated early|20
3167095|NCT01907828|3894231|FG000|1-month Follow-up|Overall Study|2 participants terminated early|37
3311325|NCT03050801|4044809|FG004|NOT COMPLETED|Experiment 1||0
3311326|NCT03050801|4044810|FG005|NOT COMPLETED|Experiment 1||0
3311327|NCT03050801|4044805|FG000|STARTED|Experiment 2||0
3311328|NCT03050801|4044806|FG001|STARTED|Experiment 2||0
3311329|NCT03050801|4044807|FG002|STARTED|Experiment 2||0
3311330|NCT03050801|4044808|FG003|STARTED|Experiment 2||21
3311331|NCT03050801|4044809|FG004|STARTED|Experiment 2||19
3311332|NCT03050801|4044810|FG005|STARTED|Experiment 2|Experiment 2 (Prefrontal Cortex Stimulation) was terminated early due to adverse events (intolerance of stimulation) in 2 of 4 participants.|4
3311333|NCT03050801|4044805|FG000|COMPLETED|Experiment 2||0
3311334|NCT03050801|4044806|FG001|COMPLETED|Experiment 2||0
3311335|NCT03050801|4044807|FG002|COMPLETED|Experiment 2||0
3311336|NCT03050801|4044808|FG003|COMPLETED|Experiment 2||15
3311337|NCT03050801|4044809|FG004|COMPLETED|Experiment 2||15
3311338|NCT03050801|4044810|FG005|COMPLETED|Experiment 2||2
3311339|NCT03050801|4044805|FG000|NOT COMPLETED|Experiment 2||0
3311340|NCT03050801|4044806|FG001|NOT COMPLETED|Experiment 2||0
3311341|NCT03050801|4044807|FG002|NOT COMPLETED|Experiment 2||0
3311342|NCT03050801|4044808|FG003|NOT COMPLETED|Experiment 2||6
3311343|NCT03050801|4044809|FG004|NOT COMPLETED|Experiment 2||4
3311344|NCT03050801|4044810|FG005|NOT COMPLETED|Experiment 2||2
3311345|NCT03050918|4044829|FG000|STARTED|Overall Study||1534
3311346|NCT03050918|4044830|FG001|STARTED|Overall Study||1520
3311347|NCT03050918|4044829|FG000|COMPLETED|Overall Study||1534
3311348|NCT03050918|4044830|FG001|COMPLETED|Overall Study||1520
3311349|NCT03050918|4044829|FG000|NOT COMPLETED|Overall Study||0
3311350|NCT03050918|4044830|FG001|NOT COMPLETED|Overall Study||0
3311351|NCT03051100|4044838|FG000|STARTED|Overall Study||20
3311352|NCT03051100|4044839|FG001|STARTED|Overall Study||43
3311353|NCT03051100|4044838|FG000|COMPLETED|Overall Study||19
3311354|NCT03051100|4044839|FG001|COMPLETED|Overall Study||43
3311355|NCT03051100|4044838|FG000|NOT COMPLETED|Overall Study||1
3311356|NCT03051100|4044839|FG001|NOT COMPLETED|Overall Study||0
3311357|NCT03051165|4044845|FG000|STARTED|Overall Study||13
3311358|NCT03051165|4044845|FG000|Completed Some Baseline Assessments|Overall Study||1
3311359|NCT03051165|4044845|FG000|Completed Some Day 105 Assessments|Overall Study||1
3311360|NCT03051165|4044845|FG000|Began HGNS Treatment Withdrawal|Overall Study||0
3311361|NCT03051165|4044845|FG000|Completed Some Day 137 Assessments|Overall Study||0
3311362|NCT03051165|4044845|FG000|COMPLETED|Overall Study||0
3311363|NCT03051165|4044845|FG000|NOT COMPLETED|Overall Study||13
3311364|NCT03051256|4044852|FG000|STARTED|Overall Study||19
3311365|NCT03051256|4044853|FG001|STARTED|Overall Study||21
3311366|NCT03051256|4044854|FG002|STARTED|Overall Study||22
3311367|NCT03051256|4044852|FG000|COMPLETED|Overall Study||19
3311368|NCT03051256|4044853|FG001|COMPLETED|Overall Study||21
3311369|NCT03051256|4044854|FG002|COMPLETED|Overall Study||21
3311370|NCT03051256|4044852|FG000|NOT COMPLETED|Overall Study||0
3311371|NCT03051256|4044853|FG001|NOT COMPLETED|Overall Study||0
3311372|NCT03051256|4044854|FG002|NOT COMPLETED|Overall Study||1
3311373|NCT03051607|4044863|FG000|STARTED|Overall Study||66
3311374|NCT03051607|4044863|FG000|COMPLETED|Overall Study||0
3311375|NCT03051607|4044863|FG000|NOT COMPLETED|Overall Study||66
3311376|NCT03051620|4044867|FG000|STARTED|Overall Study||142
3311377|NCT03051620|4044867|FG000|COMPLETED|Overall Study||124
3311378|NCT03051620|4044867|FG000|NOT COMPLETED|Overall Study||18
3311379|NCT03051633|4044873|FG000|STARTED|Overall Study||342
3311380|NCT03051633|4044874|FG001|STARTED|Overall Study||186
3311381|NCT03051633|4044873|FG000|COMPLETED|Overall Study||249
3311382|NCT03051633|4044874|FG001|COMPLETED|Overall Study||179
3311383|NCT03051633|4044873|FG000|NOT COMPLETED|Overall Study||93
3311384|NCT03051633|4044874|FG001|NOT COMPLETED|Overall Study||7
3311385|NCT03051646|4044882|FG000|STARTED|Overall Study||6
3311386|NCT03051646|4044883|FG001|STARTED|Overall Study||6
3311387|NCT03051646|4044882|FG000|COMPLETED|Overall Study||6
3311388|NCT03051646|4044883|FG001|COMPLETED|Overall Study||6
3311389|NCT03051646|4044882|FG000|NOT COMPLETED|Overall Study||0
3311390|NCT03051646|4044883|FG001|NOT COMPLETED|Overall Study||0
3311391|NCT03051672|4044891|FG000|STARTED|Overall Study||8
3311392|NCT03051672|4044891|FG000|Began Treatment|Overall Study||8
3311393|NCT03051672|4044891|FG000|COMPLETED|Overall Study||8
3167096|NCT01907828|3894232|FG001|1-month Follow-up|Overall Study|3 participants terminated early|17
3167097|NCT01907828|3894231|FG000|3-month Follow-up|Overall Study|1 participant terminated early|36
3311394|NCT03051672|4044891|FG000|NOT COMPLETED|Overall Study||0
3311395|NCT03052257|4044898|FG000|STARTED|Overall Study||100
3311396|NCT03052257|4044899|FG001|STARTED|Overall Study||100
3311397|NCT03052257|4044898|FG000|COMPLETED|Overall Study||95
2833772|NCT01332968|3535387|FG004|COMPLETED|Maintenance/Observation Period||2
2833773|NCT01332968|3535388|FG005|COMPLETED|Maintenance/Observation Period||2
2833774|NCT01332968|3535389|FG006|COMPLETED|Maintenance/Observation Period||0
2833775|NCT01332968|3535390|FG007|COMPLETED|Maintenance/Observation Period||0
2833776|NCT01332968|3535383|FG000|NOT COMPLETED|Maintenance/Observation Period||0
3311398|NCT03052257|4044899|FG001|COMPLETED|Overall Study||97
3311399|NCT03052257|4044898|FG000|NOT COMPLETED|Overall Study||5
3311400|NCT03052257|4044899|FG001|NOT COMPLETED|Overall Study||3
3311401|NCT03052322|4044907|FG000|STARTED|Overall Study||143
3311402|NCT03052322|4044908|FG001|STARTED|Overall Study||145
3311403|NCT03052322|4044907|FG000|COMPLETED|Overall Study||122
3311404|NCT03052322|4044908|FG001|COMPLETED|Overall Study||113
3311405|NCT03052322|4044907|FG000|NOT COMPLETED|Overall Study||21
3311406|NCT03052322|4044908|FG001|NOT COMPLETED|Overall Study||32
3317167|NCT03124459|4050724|FG004|COMPLETED|Part 1-Open Label Dose Escalation|Patients in the double-blind placebo controlled study were not the same participants that participated in the Part 1 Open-Label Dose escalation portion of the study.|0
3317168|NCT03124459|4050725|FG005|COMPLETED|Part 1-Open Label Dose Escalation|Patients in the double-blind placebo controlled study were not the same participants that participated in the Part 1 Open-Label Dose escalation portion of the study. Participants that completed the double-blind portion of the study then moved into this Part 2 open-label portion of the study.|0
3317169|NCT03124459|4050720|FG000|NOT COMPLETED|Part 1-Open Label Dose Escalation||0
3317170|NCT03124459|4050721|FG001|NOT COMPLETED|Part 1-Open Label Dose Escalation||0
3317171|NCT03124459|4050722|FG002|NOT COMPLETED|Part 1-Open Label Dose Escalation||0
3317172|NCT03124459|4050723|FG003|NOT COMPLETED|Part 1-Open Label Dose Escalation||0
3317173|NCT03124459|4050724|FG004|NOT COMPLETED|Part 1-Open Label Dose Escalation||0
3317174|NCT03124459|4050725|FG005|NOT COMPLETED|Part 1-Open Label Dose Escalation||0
3317175|NCT03124459|4050720|FG000|STARTED|Phase 2- Randomized Doubled-blind|Participants in Part 1 Open-Label Dose escalation portion of the study were not the same participants that participated in the double-blind placebo controlled study.|0
3317176|NCT03124459|4050721|FG001|STARTED|Phase 2- Randomized Doubled-blind|Participants in Part 1 Open-Label Dose escalation portion of the study were not the same participants that participated in the double-blind placebo controlled study.|0
3317177|NCT03124459|4050722|FG002|STARTED|Phase 2- Randomized Doubled-blind|Participants in Part 1 Open-Label Dose escalation portion of the study were not the same participants that participated in the double-blind placebo controlled study.|0
3317178|NCT03124459|4050723|FG003|STARTED|Phase 2- Randomized Doubled-blind|Participants in the double-blind placebo controlled study were not the same participants that participated in the Part 1 Open-Label Dose escalation portion of the study.|21
3317179|NCT03124459|4050724|FG004|STARTED|Phase 2- Randomized Doubled-blind|Participants in the double-blind placebo controlled study were not the same participants that participated in the Part 1 Open-Label Dose escalation portion of the study.|24
3317180|NCT03124459|4050725|FG005|STARTED|Phase 2- Randomized Doubled-blind|Participants in the double-blind placebo controlled study were not the same participants that participated in the Part 1 Open-Label Dose escalation portion of the study. Participants that completed the double-blind portion of the study then moved into this Part 2 open-label portion of the study.|0
3317181|NCT03124459|4050720|FG000|COMPLETED|Phase 2- Randomized Doubled-blind||0
3317182|NCT03124459|4050721|FG001|COMPLETED|Phase 2- Randomized Doubled-blind||0
3317183|NCT03124459|4050722|FG002|COMPLETED|Phase 2- Randomized Doubled-blind||0
3317184|NCT03124459|4050723|FG003|COMPLETED|Phase 2- Randomized Doubled-blind||9
3317185|NCT03124459|4050724|FG004|COMPLETED|Phase 2- Randomized Doubled-blind||5
3317186|NCT03124459|4050725|FG005|COMPLETED|Phase 2- Randomized Doubled-blind||0
3317187|NCT03124459|4050720|FG000|NOT COMPLETED|Phase 2- Randomized Doubled-blind||0
3317188|NCT03124459|4050721|FG001|NOT COMPLETED|Phase 2- Randomized Doubled-blind||0
3317189|NCT03124459|4050722|FG002|NOT COMPLETED|Phase 2- Randomized Doubled-blind||0
3317190|NCT03124459|4050723|FG003|NOT COMPLETED|Phase 2- Randomized Doubled-blind||12
3317191|NCT03124459|4050724|FG004|NOT COMPLETED|Phase 2- Randomized Doubled-blind||19
3317192|NCT03124459|4050725|FG005|NOT COMPLETED|Phase 2- Randomized Doubled-blind||0
3317193|NCT03124459|4050720|FG000|STARTED|Part 2- Open Label ACE-083||0
3317194|NCT03124459|4050721|FG001|STARTED|Part 2- Open Label ACE-083||0
3317195|NCT03124459|4050722|FG002|STARTED|Part 2- Open Label ACE-083||0
3317196|NCT03124459|4050723|FG003|STARTED|Part 2- Open Label ACE-083|Participants in the double-blind placebo controlled study were not the same participants that participated in the Part 1 Open-Label Dose escalation portion of the study. Participants that completed the double-blind placebo controlled portion of Part 2, moved into the open-label portion part 2 study.|0
3317197|NCT03124459|4050724|FG004|STARTED|Part 2- Open Label ACE-083|Participants in the double-blind placebo controlled study were not the same participants that participated in the Part 1 Open-Label Dose escalation portion of the study. Participants that completed the double-blind placebo controlled portion of Part 2, moved into the open-label portion part 2 study.|0
3317198|NCT03124459|4050725|FG005|STARTED|Part 2- Open Label ACE-083|The open-label portion of Part 2 are the participants that were enrolled in and completed the double-blind placebo-controlled portion of Part 2.|40
3317199|NCT03124459|4050720|FG000|COMPLETED|Part 2- Open Label ACE-083||0
3317200|NCT03124459|4050721|FG001|COMPLETED|Part 2- Open Label ACE-083||0
3317201|NCT03124459|4050722|FG002|COMPLETED|Part 2- Open Label ACE-083||0
3317202|NCT03124459|4050723|FG003|COMPLETED|Part 2- Open Label ACE-083||0
3317203|NCT03124459|4050724|FG004|COMPLETED|Part 2- Open Label ACE-083||0
3317204|NCT03124459|4050725|FG005|COMPLETED|Part 2- Open Label ACE-083||17
3317205|NCT03124459|4050720|FG000|NOT COMPLETED|Part 2- Open Label ACE-083||0
3317206|NCT03124459|4050721|FG001|NOT COMPLETED|Part 2- Open Label ACE-083||0
3317207|NCT03124459|4050722|FG002|NOT COMPLETED|Part 2- Open Label ACE-083||0
2833777|NCT01332968|3535384|FG001|NOT COMPLETED|Maintenance/Observation Period||0
2833778|NCT01332968|3535385|FG002|NOT COMPLETED|Maintenance/Observation Period||213
2833779|NCT01332968|3535386|FG003|NOT COMPLETED|Maintenance/Observation Period||207
2833780|NCT01332968|3535387|FG004|NOT COMPLETED|Maintenance/Observation Period||10
2833781|NCT01332968|3535388|FG005|NOT COMPLETED|Maintenance/Observation Period||9
2833782|NCT01332968|3535389|FG006|NOT COMPLETED|Maintenance/Observation Period||0
2833783|NCT01332968|3535390|FG007|NOT COMPLETED|Maintenance/Observation Period||0
2833784|NCT01332968|3535383|FG000|STARTED|Follow-Up Period||0
2833785|NCT01332968|3535384|FG001|STARTED|Follow-Up Period||0
2833786|NCT01332968|3535385|FG002|STARTED|Follow-Up Period||0
2833787|NCT01332968|3535386|FG003|STARTED|Follow-Up Period||0
2833788|NCT01332968|3535387|FG004|STARTED|Follow-Up Period||0
2833789|NCT01332968|3535388|FG005|STARTED|Follow-Up Period||0
2833790|NCT01332968|3535389|FG006|STARTED|Follow-Up Period||542
2833791|NCT01332968|3535390|FG007|STARTED|Follow-Up Period||531
2833792|NCT01332968|3535383|FG000|COMPLETED|Follow-Up Period||0
2833793|NCT01332968|3535384|FG001|COMPLETED|Follow-Up Period||0
2833794|NCT01332968|3535385|FG002|COMPLETED|Follow-Up Period||0
2833795|NCT01332968|3535386|FG003|COMPLETED|Follow-Up Period||0
2833796|NCT01332968|3535387|FG004|COMPLETED|Follow-Up Period||0
2833797|NCT01332968|3535388|FG005|COMPLETED|Follow-Up Period||0
2833798|NCT01332968|3535389|FG006|COMPLETED|Follow-Up Period||0
2833799|NCT01332968|3535390|FG007|COMPLETED|Follow-Up Period||0
2833800|NCT01332968|3535383|FG000|NOT COMPLETED|Follow-Up Period||0
2833801|NCT01332968|3535384|FG001|NOT COMPLETED|Follow-Up Period||0
2833802|NCT01332968|3535385|FG002|NOT COMPLETED|Follow-Up Period||0
2833803|NCT01332968|3535386|FG003|NOT COMPLETED|Follow-Up Period||0
2833804|NCT01332968|3535387|FG004|NOT COMPLETED|Follow-Up Period||0
2833805|NCT01332968|3535388|FG005|NOT COMPLETED|Follow-Up Period||0
2833806|NCT01332968|3535389|FG006|NOT COMPLETED|Follow-Up Period||542
2833807|NCT01332968|3535390|FG007|NOT COMPLETED|Follow-Up Period||531
2833808|NCT01265784|3535401|FG000|STARTED|Overall Study||56
2833809|NCT01265784|3535402|FG001|STARTED|Overall Study||57
2833810|NCT01265784|3535403|FG002|STARTED|Overall Study||30
2833811|NCT01265784|3535401|FG000|Received at Least 1 Dose of Study Drug|Overall Study|1 participant randomized to TP-434 1.5 mg/kg took ertapenem. Results are included in ertapenem arm.|54
2833812|NCT01265784|3535402|FG001|Received at Least 1 Dose of Study Drug|Overall Study||56
2833813|NCT01265784|3535403|FG002|Received at Least 1 Dose of Study Drug|Overall Study||29
2833814|NCT01265784|3535401|FG000|COMPLETED|Overall Study||44
2833815|NCT01265784|3535402|FG001|COMPLETED|Overall Study||49
2833816|NCT01265784|3535403|FG002|COMPLETED|Overall Study||26
2833817|NCT01265784|3535401|FG000|NOT COMPLETED|Overall Study||12
2833818|NCT01265784|3535402|FG001|NOT COMPLETED|Overall Study||8
2833819|NCT01265784|3535403|FG002|NOT COMPLETED|Overall Study||4
2833820|NCT00577577|3535413|FG000|STARTED|Overall Study||34
2833821|NCT00577577|3535414|FG001|STARTED|Overall Study||35
2833822|NCT00577577|3535413|FG000|Received Treatment|Overall Study||34
2833823|NCT00577577|3535414|FG001|Received Treatment|Overall Study||35
2833824|NCT00577577|3535413|FG000|COMPLETED|Overall Study||29
2833825|NCT00577577|3535414|FG001|COMPLETED|Overall Study||30
2833826|NCT00577577|3535413|FG000|NOT COMPLETED|Overall Study||5
2833827|NCT00577577|3535414|FG001|NOT COMPLETED|Overall Study||5
2833828|NCT00392327|3535428|FG000|STARTED|Overall Study||87
2833829|NCT00392327|3535429|FG001|STARTED|Overall Study||93
2833830|NCT00392327|3535430|FG002|STARTED|Overall Study||56
2833831|NCT00392327|3535431|FG003|STARTED|Overall Study||58
2833832|NCT00392327|3535432|FG004|STARTED|Overall Study||23
2833833|NCT00392327|3535433|FG005|STARTED|Overall Study||19
2833834|NCT00392327|3535434|FG006|STARTED|Overall Study||21
2833835|NCT00392327|3535435|FG007|STARTED|Overall Study||22
2833836|NCT00392327|3535428|FG000|COMPLETED|Overall Study||72
2833837|NCT00392327|3535429|FG001|COMPLETED|Overall Study||74
2833838|NCT00392327|3535430|FG002|COMPLETED|Overall Study||36
2833839|NCT00392327|3535431|FG003|COMPLETED|Overall Study||42
2833840|NCT00392327|3535432|FG004|COMPLETED|Overall Study||20
2833841|NCT00392327|3535433|FG005|COMPLETED|Overall Study||14
2833842|NCT00392327|3535434|FG006|COMPLETED|Overall Study||12
2833843|NCT00392327|3535435|FG007|COMPLETED|Overall Study||11
2833844|NCT00392327|3535428|FG000|NOT COMPLETED|Overall Study||15
2833845|NCT00392327|3535429|FG001|NOT COMPLETED|Overall Study||19
2833846|NCT00392327|3535430|FG002|NOT COMPLETED|Overall Study||20
2833847|NCT00392327|3535431|FG003|NOT COMPLETED|Overall Study||16
2833848|NCT00392327|3535432|FG004|NOT COMPLETED|Overall Study||3
3167098|NCT01907828|3894232|FG001|3-month Follow-up|Overall Study|1 participant terminated early|16
3167099|NCT01907828|3894231|FG000|6-month Follow-up|Overall Study|1 participant terminated early|35
3167100|NCT01907828|3894232|FG001|6-month Follow-up|Overall Study||16
3167101|NCT01907828|3894231|FG000|12-month Follow-up|Overall Study|1 participant terminated early|34
3167102|NCT01907828|3894232|FG001|12-month Follow-up|Overall Study||16
3167103|NCT01907828|3894231|FG000|24-month Follow-up|Overall Study|2 participants terminated early|32
3167104|NCT01907828|3894232|FG001|24-month Follow-up|Overall Study||16
3167105|NCT01907828|3894231|FG000|COMPLETED|Overall Study||32
3167106|NCT01907828|3894232|FG001|COMPLETED|Overall Study||16
2833849|NCT00392327|3535433|FG005|NOT COMPLETED|Overall Study||5
2833850|NCT00392327|3535434|FG006|NOT COMPLETED|Overall Study||9
2833851|NCT00392327|3535435|FG007|NOT COMPLETED|Overall Study||11
2833852|NCT00085202|3535455|FG000|STARTED|Overall Study||269
2833853|NCT00085202|3535456|FG001|STARTED|Overall Study||144
2833854|NCT00085202|3535455|FG000|COMPLETED|Overall Study||251
2833855|NCT00085202|3535456|FG001|COMPLETED|Overall Study||120
2833856|NCT00085202|3535455|FG000|NOT COMPLETED|Overall Study||18
2833857|NCT00085202|3535456|FG001|NOT COMPLETED|Overall Study||24
2914467|NCT00504348|3624604|FG000|NOT COMPLETED|Overall Study||8
2914468|NCT00504426|3624612|FG000|STARTED|Overall Study||32
2914469|NCT00504426|3624613|FG001|STARTED|Overall Study||23
2914470|NCT00504426|3624614|FG002|STARTED|Overall Study||22
2914471|NCT00504426|3624615|FG003|STARTED|Overall Study||24
2914472|NCT00504426|3624612|FG000|COMPLETED|Overall Study||29
2914473|NCT00504426|3624613|FG001|COMPLETED|Overall Study||22
2914474|NCT00504426|3624614|FG002|COMPLETED|Overall Study||18
2914475|NCT00504426|3624615|FG003|COMPLETED|Overall Study||24
2914476|NCT00504426|3624612|FG000|NOT COMPLETED|Overall Study||3
2914477|NCT00504426|3624613|FG001|NOT COMPLETED|Overall Study||1
2914478|NCT00504426|3624614|FG002|NOT COMPLETED|Overall Study||4
2914479|NCT00504426|3624615|FG003|NOT COMPLETED|Overall Study||0
2914480|NCT00504504|3624628|FG000|STARTED|Overall Study||82
2914481|NCT00504504|3624628|FG000|COMPLETED|Overall Study||82
2914482|NCT00504504|3624628|FG000|NOT COMPLETED|Overall Study||0
2914483|NCT00504556|3624637|FG000|STARTED|Overall Study||235
2914484|NCT00504556|3624638|FG001|STARTED|Overall Study||245
2914485|NCT00504556|3624639|FG002|STARTED|Overall Study||235
2914486|NCT00504556|3624640|FG003|STARTED|Overall Study||180
2914487|NCT00504556|3624641|FG004|STARTED|Overall Study||251
2914488|NCT00504556|3624637|FG000|Safety Analysis Set|Overall Study||235
2914489|NCT00504556|3624638|FG001|Safety Analysis Set|Overall Study||244
2914490|NCT00504556|3624639|FG002|Safety Analysis Set|Overall Study||234
2914491|NCT00504556|3624640|FG003|Safety Analysis Set|Overall Study||180
2914492|NCT00504556|3624641|FG004|Safety Analysis Set|Overall Study||250
2914493|NCT00504556|3624637|FG000|Per Protocol Analysis Set|Overall Study||235
2914494|NCT00504556|3624638|FG001|Per Protocol Analysis Set|Overall Study||243
2914495|NCT00504556|3624639|FG002|Per Protocol Analysis Set|Overall Study||234
2914496|NCT00504556|3624640|FG003|Per Protocol Analysis Set|Overall Study||180
2914497|NCT00504556|3624641|FG004|Per Protocol Analysis Set|Overall Study||250
2914498|NCT00504556|3624637|FG000|Pharmacodynamic Analysis Set|Overall Study||230
2914499|NCT00504556|3624638|FG001|Pharmacodynamic Analysis Set|Overall Study||236
2914500|NCT00504556|3624639|FG002|Pharmacodynamic Analysis Set|Overall Study||228
2914501|NCT00504556|3624640|FG003|Pharmacodynamic Analysis Set|Overall Study||170
2914502|NCT00504556|3624641|FG004|Pharmacodynamic Analysis Set|Overall Study||244
2914503|NCT00504556|3624637|FG000|COMPLETED|Overall Study||200
2914504|NCT00504556|3624638|FG001|COMPLETED|Overall Study||207
2914505|NCT00504556|3624639|FG002|COMPLETED|Overall Study||204
2914506|NCT00504556|3624640|FG003|COMPLETED|Overall Study||52
2914507|NCT00504556|3624641|FG004|COMPLETED|Overall Study||226
2914508|NCT00504556|3624637|FG000|NOT COMPLETED|Overall Study||35
2914509|NCT00504556|3624638|FG001|NOT COMPLETED|Overall Study||38
2914510|NCT00504556|3624639|FG002|NOT COMPLETED|Overall Study||31
2914511|NCT00504556|3624640|FG003|NOT COMPLETED|Overall Study||128
2914512|NCT00504556|3624641|FG004|NOT COMPLETED|Overall Study||25
2914513|NCT00504582|3624656|FG000|STARTED|Overall Study||47
2914514|NCT00504582|3624657|FG001|STARTED|Overall Study||45
2914515|NCT00504582|3624658|FG002|STARTED|Overall Study||20
2914516|NCT00504582|3624656|FG000|COMPLETED|Overall Study||46
2914517|NCT00504582|3624657|FG001|COMPLETED|Overall Study||45
2914518|NCT00504582|3624658|FG002|COMPLETED|Overall Study||20
2914519|NCT00504582|3624656|FG000|NOT COMPLETED|Overall Study||1
2914520|NCT00504582|3624657|FG001|NOT COMPLETED|Overall Study||0
2914521|NCT00504582|3624658|FG002|NOT COMPLETED|Overall Study||0
2914522|NCT00504595|3624670|FG000|STARTED|Overall Study||50
2914523|NCT00504595|3624671|FG001|STARTED|Overall Study||10
2914524|NCT00504595|3624672|FG002|STARTED|Overall Study||10
2914525|NCT00504595|3624673|FG003|STARTED|Overall Study||10
2914526|NCT00504595|3624670|FG000|COMPLETED|Overall Study||49
2914527|NCT00504595|3624671|FG001|COMPLETED|Overall Study||10
2914528|NCT00504595|3624672|FG002|COMPLETED|Overall Study||8
2914529|NCT00504595|3624673|FG003|COMPLETED|Overall Study||10
2914530|NCT00504595|3624670|FG000|NOT COMPLETED|Overall Study||1
3167107|NCT01907828|3894231|FG000|NOT COMPLETED|Overall Study||7
3167108|NCT01907828|3894232|FG001|NOT COMPLETED|Overall Study||6
3167109|NCT01907854|3894240|FG000|STARTED|Overall Study||203
3167110|NCT01907854|3894241|FG001|STARTED|Overall Study||204
3167111|NCT01907854|3894240|FG000|Exposed|Overall Study|One subject in lira arm was not exposed (Reason: withdrawal by subject)|202
2914531|NCT00504595|3624671|FG001|NOT COMPLETED|Overall Study||0
2914532|NCT00504595|3624672|FG002|NOT COMPLETED|Overall Study||2
2914533|NCT00504595|3624673|FG003|NOT COMPLETED|Overall Study||0
2914534|NCT00504660|3624685|FG000|STARTED|Overall Study||31
2914535|NCT00504660|3624686|FG001|STARTED|Overall Study||43
2914536|NCT00504660|3624685|FG000|COMPLETED|Overall Study||31
2914537|NCT00504660|3624686|FG001|COMPLETED|Overall Study||43
2914538|NCT00504660|3624685|FG000|NOT COMPLETED|Overall Study||0
2914539|NCT00504660|3624686|FG001|NOT COMPLETED|Overall Study||0
2914540|NCT00504725|3624694|FG000|STARTED|Overall Study||21
2914541|NCT00504725|3624695|FG001|STARTED|Overall Study||20
2914542|NCT00504725|3624694|FG000|COMPLETED|Overall Study|Prior to unblinding, one subject was discontinued due to elevated CRP levels at baseline.|20
2914543|NCT00504725|3624695|FG001|COMPLETED|Overall Study||20
2914544|NCT00504725|3624694|FG000|NOT COMPLETED|Overall Study||1
2914545|NCT00504725|3624695|FG001|NOT COMPLETED|Overall Study||0
2914546|NCT00504751|3624701|FG000|STARTED|Overall Study||15
3167112|NCT01907854|3894241|FG001|Exposed|Overall Study||204
2833858|NCT05007639|3535475|FG000|STARTED|Overall Study||274
2833859|NCT05007639|3535475|FG000|COMPLETED|Overall Study||274
2833860|NCT05007639|3535475|FG000|NOT COMPLETED|Overall Study||0
2833861|NCT04739735|3535481|FG000|STARTED|Overall Study||25
2833862|NCT04739735|3535482|FG001|STARTED|Overall Study||25
2833863|NCT04739735|3535481|FG000|COMPLETED|Overall Study||25
2833864|NCT04739735|3535482|FG001|COMPLETED|Overall Study||25
2833865|NCT04739735|3535481|FG000|NOT COMPLETED|Overall Study||0
2833866|NCT04739735|3535482|FG001|NOT COMPLETED|Overall Study||0
2833867|NCT04552535|3535490|FG000|STARTED|Overall Study||99
2833868|NCT04552535|3535491|FG001|STARTED|Overall Study||101
2833869|NCT04552535|3535490|FG000|COMPLETED|Overall Study||99
2833870|NCT04552535|3535491|FG001|COMPLETED|Overall Study||101
2833871|NCT04552535|3535490|FG000|NOT COMPLETED|Overall Study||0
2833872|NCT04552535|3535491|FG001|NOT COMPLETED|Overall Study||0
2833921|NCT04386616|3535557|FG000|STARTED|Overall Study||134
2833922|NCT04386616|3535558|FG001|STARTED|Overall Study||130
2833923|NCT04386616|3535559|FG002|STARTED|Overall Study||132
2833924|NCT04386616|3535557|FG000|Received at Least One Dose of Study Drug|Overall Study|In this arm, 68 and 66 participants received MSTT1041A-matched placebo and UTTR1147A-matched placebo, respectively.|134
2833925|NCT04386616|3535558|FG001|Received at Least One Dose of Study Drug|Overall Study||130
2833926|NCT04386616|3535559|FG002|Received at Least One Dose of Study Drug|Overall Study||132
2833927|NCT04386616|3535557|FG000|Completed Both Doses of Study Drug at Day 15|Overall Study||31
2833928|NCT04386616|3535558|FG001|Completed Both Doses of Study Drug at Day 15|Overall Study||27
2833929|NCT04386616|3535559|FG002|Completed Both Doses of Study Drug at Day 15|Overall Study||25
2833930|NCT04386616|3535557|FG000|COMPLETED|Overall Study||104
2833931|NCT04386616|3535558|FG001|COMPLETED|Overall Study||95
2833932|NCT04386616|3535559|FG002|COMPLETED|Overall Study||104
2833933|NCT04386616|3535557|FG000|NOT COMPLETED|Overall Study||30
3167113|NCT01907854|3894240|FG000|COMPLETED|Overall Study||187
3167114|NCT01907854|3894241|FG001|COMPLETED|Overall Study||191
3167115|NCT01907854|3894240|FG000|NOT COMPLETED|Overall Study||16
3167116|NCT01907854|3894241|FG001|NOT COMPLETED|Overall Study||13
2833934|NCT04386616|3535558|FG001|NOT COMPLETED|Overall Study||35
2833935|NCT04386616|3535559|FG002|NOT COMPLETED|Overall Study||28
2833936|NCT04377711|3535578|FG000|STARTED|Overall Study||197
2833937|NCT04377711|3535579|FG001|STARTED|Overall Study||203
2833938|NCT04377711|3535578|FG000|COMPLETED|Overall Study||178
2833939|NCT04377711|3535579|FG001|COMPLETED|Overall Study||181
2833940|NCT04377711|3535578|FG000|NOT COMPLETED|Overall Study||19
2833941|NCT04377711|3535579|FG001|NOT COMPLETED|Overall Study||22
2833942|NCT04347408|3535585|FG000|STARTED|Overall Study||992
2833943|NCT04347408|3535585|FG000|COMPLETED|Overall Study||992
2833944|NCT04347408|3535585|FG000|NOT COMPLETED|Overall Study||0
2833945|NCT04296942|3535592|FG000|STARTED|Overall Study||1
2833946|NCT04296942|3535593|FG001|STARTED|Overall Study||0
2833947|NCT04296942|3535594|FG002|STARTED|Overall Study||0
2833948|NCT04296942|3535592|FG000|COMPLETED|Overall Study||0
2833949|NCT04296942|3535593|FG001|COMPLETED|Overall Study||0
2833950|NCT04296942|3535594|FG002|COMPLETED|Overall Study||0
2833951|NCT04296942|3535592|FG000|NOT COMPLETED|Overall Study||1
2833952|NCT04296942|3535593|FG001|NOT COMPLETED|Overall Study||0
2833953|NCT04296942|3535594|FG002|NOT COMPLETED|Overall Study||0
2833954|NCT04278872|3535606|FG000|STARTED|Overall Study||7
2833955|NCT04278872|3535607|FG001|STARTED|Overall Study||6
2833956|NCT04278872|3535606|FG000|COMPLETED|Overall Study||4
2833957|NCT04278872|3535607|FG001|COMPLETED|Overall Study||5
2833958|NCT04278872|3535606|FG000|NOT COMPLETED|Overall Study||3
2833959|NCT04278872|3535607|FG001|NOT COMPLETED|Overall Study||1
2833960|NCT04213807|3535616|FG000|STARTED|Overall Study||5
2833961|NCT04213807|3535617|FG001|STARTED|Overall Study||6
2833962|NCT04213807|3535618|FG002|STARTED|Overall Study||7
2833963|NCT04213807|3535616|FG000|COMPLETED|Overall Study||5
2833964|NCT04213807|3535617|FG001|COMPLETED|Overall Study||6
2833965|NCT04213807|3535618|FG002|COMPLETED|Overall Study||6
2833966|NCT04213807|3535616|FG000|NOT COMPLETED|Overall Study||0
2833967|NCT04213807|3535617|FG001|NOT COMPLETED|Overall Study||0
2833968|NCT04213807|3535618|FG002|NOT COMPLETED|Overall Study||1
2833969|NCT04172467|3535628|FG000|STARTED|Overall Study||1086
2833970|NCT04172467|3535628|FG000|COMPLETED|Overall Study||1086
2833971|NCT04172467|3535628|FG000|NOT COMPLETED|Overall Study||0
2833972|NCT04132804|3535635|FG000|STARTED|Overall Study||31
2833973|NCT04132804|3535635|FG000|COMPLETED|Overall Study||20
2833974|NCT04132804|3535635|FG000|NOT COMPLETED|Overall Study||11
2833975|NCT03963011|3535641|FG000|STARTED|Overall Study||8
2833976|NCT03963011|3535642|FG001|STARTED|Overall Study||6
2833977|NCT03963011|3535641|FG000|COMPLETED|Overall Study||8
2833978|NCT03963011|3535642|FG001|COMPLETED|Overall Study||6
2833979|NCT03963011|3535641|FG000|NOT COMPLETED|Overall Study||0
2833980|NCT03963011|3535642|FG001|NOT COMPLETED|Overall Study||0
2834006|NCT03721328|3535696|FG000|COMPLETED|Overall Study||15
2834007|NCT03721328|3535696|FG000|NOT COMPLETED|Overall Study||0
2834008|NCT03721107|3535704|FG000|STARTED|Overall Study||80
2834009|NCT03721107|3535705|FG001|STARTED|Overall Study||84
2834010|NCT03721107|3535706|FG002|STARTED|Overall Study||98
2834011|NCT03721107|3535707|FG003|STARTED|Overall Study||104
2834012|NCT03721107|3535704|FG000|Treated|Overall Study||80
2834013|NCT03721107|3535705|FG001|Treated|Overall Study||84
2834014|NCT03721107|3535706|FG002|Treated|Overall Study||97
2834015|NCT03721107|3535707|FG003|Treated|Overall Study||104
3167117|NCT01907906|3894249|FG000|STARTED|Overall Study||16
2833873|NCT04502472|3535502|FG000|STARTED|Overall Study||61
2833874|NCT04502472|3535503|FG001|STARTED|Overall Study||48
2833875|NCT04502472|3535502|FG000|COMPLETED|Overall Study||58
2833876|NCT04502472|3535503|FG001|COMPLETED|Overall Study||45
2833877|NCT04502472|3535502|FG000|NOT COMPLETED|Overall Study||3
2833878|NCT04502472|3535503|FG001|NOT COMPLETED|Overall Study||3
2833879|NCT04495166|3535512|FG000|STARTED|Overall Study||37
2833880|NCT04495166|3535513|FG001|STARTED|Overall Study||44
2833881|NCT04495166|3535512|FG000|COMPLETED|Overall Study||30
2833882|NCT04495166|3535513|FG001|COMPLETED|Overall Study||41
2833883|NCT04495166|3535512|FG000|NOT COMPLETED|Overall Study||7
2833884|NCT04495166|3535513|FG001|NOT COMPLETED|Overall Study||3
2833885|NCT04461483|3535525|FG000|STARTED|Part 1 (Day 1)||6
2833886|NCT04461483|3535526|FG001|STARTED|Part 1 (Day 1)||6
2833887|NCT04461483|3535527|FG002|STARTED|Part 1 (Day 1)||6
2833888|NCT04461483|3535528|FG003|STARTED|Part 1 (Day 1)||6
2833889|NCT04461483|3535529|FG004|STARTED|Part 1 (Day 1)||0
2833890|NCT04461483|3535530|FG005|STARTED|Part 1 (Day 1)||0
3311407|NCT03052426|4044917|FG000|STARTED|Overall Study||6
3311408|NCT03052426|4044918|FG001|STARTED|Overall Study||6
3311409|NCT03052426|4044919|FG002|STARTED|Overall Study||6
3311410|NCT03052426|4044917|FG000|COMPLETED|Overall Study||4
3311411|NCT03052426|4044918|FG001|COMPLETED|Overall Study||5
3311412|NCT03052426|4044919|FG002|COMPLETED|Overall Study||5
2833891|NCT04461483|3535525|FG000|COMPLETED|Part 1 (Day 1)||6
2833892|NCT04461483|3535526|FG001|COMPLETED|Part 1 (Day 1)||6
2833893|NCT04461483|3535527|FG002|COMPLETED|Part 1 (Day 1)||6
2833894|NCT04461483|3535528|FG003|COMPLETED|Part 1 (Day 1)||6
2833895|NCT04461483|3535529|FG004|COMPLETED|Part 1 (Day 1)||0
2833896|NCT04461483|3535530|FG005|COMPLETED|Part 1 (Day 1)||0
2833897|NCT04461483|3535525|FG000|NOT COMPLETED|Part 1 (Day 1)||0
2833898|NCT04461483|3535526|FG001|NOT COMPLETED|Part 1 (Day 1)||0
2833899|NCT04461483|3535527|FG002|NOT COMPLETED|Part 1 (Day 1)||0
2833900|NCT04461483|3535528|FG003|NOT COMPLETED|Part 1 (Day 1)||0
2833901|NCT04461483|3535529|FG004|NOT COMPLETED|Part 1 (Day 1)||0
2833902|NCT04461483|3535530|FG005|NOT COMPLETED|Part 1 (Day 1)||0
2833903|NCT04461483|3535525|FG000|STARTED|Part 2 (Day 1 to 21)||0
2833904|NCT04461483|3535526|FG001|STARTED|Part 2 (Day 1 to 21)||0
2833905|NCT04461483|3535527|FG002|STARTED|Part 2 (Day 1 to 21)||0
2833906|NCT04461483|3535528|FG003|STARTED|Part 2 (Day 1 to 21)||0
2833907|NCT04461483|3535529|FG004|STARTED|Part 2 (Day 1 to 21)||3
2833908|NCT04461483|3535530|FG005|STARTED|Part 2 (Day 1 to 21)||6
2833909|NCT04461483|3535525|FG000|COMPLETED|Part 2 (Day 1 to 21)||0
2833910|NCT04461483|3535526|FG001|COMPLETED|Part 2 (Day 1 to 21)||0
2833911|NCT04461483|3535527|FG002|COMPLETED|Part 2 (Day 1 to 21)||0
2833912|NCT04461483|3535528|FG003|COMPLETED|Part 2 (Day 1 to 21)||0
2833913|NCT04461483|3535529|FG004|COMPLETED|Part 2 (Day 1 to 21)||3
2833914|NCT04461483|3535530|FG005|COMPLETED|Part 2 (Day 1 to 21)||6
2833915|NCT04461483|3535525|FG000|NOT COMPLETED|Part 2 (Day 1 to 21)||0
2833916|NCT04461483|3535526|FG001|NOT COMPLETED|Part 2 (Day 1 to 21)||0
2833917|NCT04461483|3535527|FG002|NOT COMPLETED|Part 2 (Day 1 to 21)||0
2833918|NCT04461483|3535528|FG003|NOT COMPLETED|Part 2 (Day 1 to 21)||0
2833919|NCT04461483|3535529|FG004|NOT COMPLETED|Part 2 (Day 1 to 21)||0
2833920|NCT04461483|3535530|FG005|NOT COMPLETED|Part 2 (Day 1 to 21)||0
2833981|NCT03894501|3535650|FG000|STARTED|Overall Study||15
2833982|NCT03894501|3535651|FG001|STARTED|Overall Study||15
2833983|NCT03894501|3535650|FG000|COMPLETED|Overall Study||15
2833984|NCT03894501|3535651|FG001|COMPLETED|Overall Study||15
2833985|NCT03894501|3535650|FG000|NOT COMPLETED|Overall Study||0
2833986|NCT03894501|3535651|FG001|NOT COMPLETED|Overall Study||0
2833987|NCT03874325|3535672|FG000|STARTED|Overall Study||17
2833988|NCT03874325|3535673|FG001|STARTED|Overall Study||0
2833989|NCT03874325|3535672|FG000|COMPLETED|Overall Study||17
2833990|NCT03874325|3535673|FG001|COMPLETED|Overall Study||0
2833991|NCT03874325|3535672|FG000|NOT COMPLETED|Overall Study||0
2833992|NCT03874325|3535673|FG001|NOT COMPLETED|Overall Study||0
2833993|NCT03837184|3535677|FG000|STARTED|Overall Study||2
2833994|NCT03837184|3535677|FG000|COMPLETED|Overall Study||2
2833995|NCT03837184|3535677|FG000|NOT COMPLETED|Overall Study||0
2833996|NCT03833661|3535681|FG000|STARTED|Overall Study||159
2833997|NCT03833661|3535681|FG000|COMPLETED|Overall Study||150
2833998|NCT03833661|3535681|FG000|NOT COMPLETED|Overall Study||9
2833999|NCT03735420|3535687|FG000|STARTED|Overall Study||16
2834000|NCT03735420|3535688|FG001|STARTED|Overall Study||14
2834001|NCT03735420|3535687|FG000|COMPLETED|Overall Study||16
2834002|NCT03735420|3535688|FG001|COMPLETED|Overall Study||14
2834003|NCT03735420|3535687|FG000|NOT COMPLETED|Overall Study||0
3167118|NCT01907906|3894250|FG001|STARTED|Overall Study||13
3167119|NCT01907906|3894249|FG000|COMPLETED|Overall Study||12
3167120|NCT01907906|3894250|FG001|COMPLETED|Overall Study||12
3167121|NCT01907906|3894249|FG000|NOT COMPLETED|Overall Study||4
3167122|NCT01907906|3894250|FG001|NOT COMPLETED|Overall Study||1
3167123|NCT01908062|3894260|FG000|STARTED|Overall Study||26
3167124|NCT01908062|3894261|FG001|STARTED|Overall Study||25
3167125|NCT01908062|3894260|FG000|COMPLETED|Overall Study||24
3167126|NCT01908062|3894261|FG001|COMPLETED|Overall Study||22
3167127|NCT01908062|3894260|FG000|NOT COMPLETED|Overall Study||2
2834004|NCT03735420|3535688|FG001|NOT COMPLETED|Overall Study||0
2834005|NCT03721328|3535696|FG000|STARTED|Overall Study||15
3167128|NCT01908062|3894261|FG001|NOT COMPLETED|Overall Study||3
3171821|NCT01937351|3899027|FG000|6-Month Follow-up|Overall Study||125
3311413|NCT03052426|4044917|FG000|NOT COMPLETED|Overall Study||2
2834016|NCT03721107|3535704|FG000|COMPLETED|Overall Study||75
2834017|NCT03721107|3535705|FG001|COMPLETED|Overall Study||81
2834018|NCT03721107|3535706|FG002|COMPLETED|Overall Study||83
2834019|NCT03721107|3535707|FG003|COMPLETED|Overall Study||92
2834020|NCT03721107|3535704|FG000|NOT COMPLETED|Overall Study||5
2834021|NCT03721107|3535705|FG001|NOT COMPLETED|Overall Study||3
2834022|NCT03721107|3535706|FG002|NOT COMPLETED|Overall Study||15
2834023|NCT03721107|3535707|FG003|NOT COMPLETED|Overall Study||12
2914547|NCT00504751|3624701|FG000|COMPLETED|Overall Study||15
2914548|NCT00504751|3624701|FG000|NOT COMPLETED|Overall Study||0
2914549|NCT00504777|3624705|FG000|STARTED|Overall Study||36
2914550|NCT00504777|3624705|FG000|COMPLETED|Overall Study||35
2914551|NCT00504777|3624705|FG000|NOT COMPLETED|Overall Study||1
2914552|NCT00504829|3624712|FG000|STARTED|Overall Study||73
2914553|NCT00504829|3624713|FG001|STARTED|Overall Study||74
2914554|NCT00504829|3624714|FG002|STARTED|Overall Study||73
2914555|NCT00504829|3624712|FG000|COMPLETED|Overall Study||67
2914556|NCT00504829|3624713|FG001|COMPLETED|Overall Study||70
2914557|NCT00504829|3624714|FG002|COMPLETED|Overall Study||63
2914558|NCT00504829|3624712|FG000|NOT COMPLETED|Overall Study||6
2914559|NCT00504829|3624713|FG001|NOT COMPLETED|Overall Study||4
2914560|NCT00504829|3624714|FG002|NOT COMPLETED|Overall Study||10
2914561|NCT00504881|3624724|FG000|STARTED|Overall Study||121
2914562|NCT00504881|3624725|FG001|STARTED|Overall Study||359
2914563|NCT00504881|3624724|FG000|COMPLETED|Overall Study||111
2914564|NCT00504881|3624725|FG001|COMPLETED|Overall Study||323
2914565|NCT00504881|3624724|FG000|NOT COMPLETED|Overall Study||10
2914566|NCT00504881|3624725|FG001|NOT COMPLETED|Overall Study||36
2914567|NCT00504894|3624736|FG000|STARTED|Overall Study||20
2914568|NCT00504894|3624737|FG001|STARTED|Overall Study||21
2914569|NCT00504894|3624738|FG002|STARTED|Overall Study||19
2914570|NCT00504894|3624736|FG000|COMPLETED|Overall Study||17
2914571|NCT00504894|3624737|FG001|COMPLETED|Overall Study||18
2914572|NCT00504894|3624738|FG002|COMPLETED|Overall Study||19
2914573|NCT00504894|3624736|FG000|NOT COMPLETED|Overall Study||3
2914574|NCT00504894|3624737|FG001|NOT COMPLETED|Overall Study||3
2914575|NCT00504894|3624738|FG002|NOT COMPLETED|Overall Study||0
2914576|NCT00505076|3624749|FG000|STARTED|Overall Study||22
2914577|NCT00505076|3624750|FG001|STARTED|Overall Study||19
2914578|NCT00505076|3624751|FG002|STARTED|Overall Study||22
2914579|NCT00505076|3624749|FG000|COMPLETED|Overall Study||19
2914580|NCT00505076|3624750|FG001|COMPLETED|Overall Study||17
2914581|NCT00505076|3624751|FG002|COMPLETED|Overall Study||17
2914582|NCT00505076|3624749|FG000|NOT COMPLETED|Overall Study||3
2914583|NCT00505076|3624750|FG001|NOT COMPLETED|Overall Study||2
2914584|NCT00505076|3624751|FG002|NOT COMPLETED|Overall Study||5
2914585|NCT00505284|3624764|FG000|STARTED|Overall Study||73
2914586|NCT00505284|3624765|FG001|STARTED|Overall Study||72
2914587|NCT00505284|3624766|FG002|STARTED|Overall Study||69
2914588|NCT00505284|3624767|FG003|STARTED|Overall Study||68
2914589|NCT00505284|3624768|FG004|STARTED|Overall Study||70
2914590|NCT00505284|3624764|FG000|COMPLETED|Overall Study||63
2914591|NCT00505284|3624765|FG001|COMPLETED|Overall Study||56
2914592|NCT00505284|3624766|FG002|COMPLETED|Overall Study||57
2914593|NCT00505284|3624767|FG003|COMPLETED|Overall Study||49
2914594|NCT00505284|3624768|FG004|COMPLETED|Overall Study||37
2914595|NCT00505284|3624764|FG000|NOT COMPLETED|Overall Study||10
2914596|NCT00505284|3624765|FG001|NOT COMPLETED|Overall Study||16
2914597|NCT00505284|3624766|FG002|NOT COMPLETED|Overall Study||12
2914598|NCT00505284|3624767|FG003|NOT COMPLETED|Overall Study||19
2914599|NCT00505284|3624768|FG004|NOT COMPLETED|Overall Study||33
2914600|NCT00505362|3624782|FG000|STARTED|Overall Study||35
2914601|NCT00505362|3624783|FG001|STARTED|Overall Study||28
2914602|NCT00505362|3624782|FG000|COMPLETED|Overall Study||35
2914603|NCT00505362|3624783|FG001|COMPLETED|Overall Study||28
2914604|NCT00505362|3624782|FG000|NOT COMPLETED|Overall Study||0
2914605|NCT00505362|3624783|FG001|NOT COMPLETED|Overall Study||0
2914606|NCT00505375|3624791|FG000|STARTED|Overall Study||77
2914607|NCT00505375|3624792|FG001|STARTED|Overall Study||35
2914608|NCT00505375|3624791|FG000|COMPLETED|Overall Study||73
2914609|NCT00505375|3624792|FG001|COMPLETED|Overall Study||30
2914610|NCT00505375|3624791|FG000|NOT COMPLETED|Overall Study||4
2914611|NCT00505375|3624792|FG001|NOT COMPLETED|Overall Study||5
2914612|NCT00505414|3624800|FG000|STARTED|Titration Phase||0
2914613|NCT00505414|3624801|FG001|STARTED|Titration Phase||0
2914614|NCT00505414|3624802|FG002|STARTED|Titration Phase||0
2914615|NCT00505414|3624803|FG003|STARTED|Titration Phase||62
2914616|NCT00505414|3624804|FG004|STARTED|Titration Phase||31
2914617|NCT00505414|3624800|FG000|COMPLETED|Titration Phase||0
2914618|NCT00505414|3624801|FG001|COMPLETED|Titration Phase||0
2914619|NCT00505414|3624802|FG002|COMPLETED|Titration Phase||0
2914620|NCT00505414|3624803|FG003|COMPLETED|Titration Phase||32
2914621|NCT00505414|3624804|FG004|COMPLETED|Titration Phase||19
2914622|NCT00505414|3624800|FG000|NOT COMPLETED|Titration Phase||0
2914623|NCT00505414|3624801|FG001|NOT COMPLETED|Titration Phase||0
2914624|NCT00505414|3624802|FG002|NOT COMPLETED|Titration Phase||0
2914625|NCT00505414|3624803|FG003|NOT COMPLETED|Titration Phase||30
2914626|NCT00505414|3624804|FG004|NOT COMPLETED|Titration Phase||12
2914627|NCT00505414|3624800|FG000|STARTED|Maintenance Phase|18 of the 19 morphine participants continued with morphine in the maintenance phase.|18
2914628|NCT00505414|3624801|FG001|STARTED|Maintenance Phase|15 of 32 tapentadol titration participants continued with tapentadol in the maintenance phase|15
2920675|NCT00537940|3631210|FG001|Completed Maintenance Phase|Overall Study||172
2834024|NCT03691727|3535719|FG000|STARTED|Overall Study||18
2834025|NCT03691727|3535720|FG001|STARTED|Overall Study||12
2834026|NCT03691727|3535719|FG000|COMPLETED|Overall Study||16
2834027|NCT03691727|3535720|FG001|COMPLETED|Overall Study||11
2834028|NCT03691727|3535719|FG000|NOT COMPLETED|Overall Study||2
2834029|NCT03691727|3535720|FG001|NOT COMPLETED|Overall Study||1
2834030|NCT03689920|3535728|FG000|STARTED|Overall Study||47
2834031|NCT03689920|3535729|FG001|STARTED|Overall Study||52
2834032|NCT03689920|3535728|FG000|COMPLETED|Overall Study||41
2834033|NCT03689920|3535729|FG001|COMPLETED|Overall Study||48
2834034|NCT03689920|3535728|FG000|NOT COMPLETED|Overall Study||6
2834035|NCT03689920|3535729|FG001|NOT COMPLETED|Overall Study||4
2834036|NCT03672227|3535737|FG000|STARTED|Overall Study||112
2834037|NCT03672227|3535738|FG001|STARTED|Overall Study||52
2834038|NCT03672227|3535737|FG000|Teachers Started|Overall Study||8
2834039|NCT03672227|3535738|FG001|Teachers Started|Overall Study||6
2834040|NCT03672227|3535737|FG000|Children Started|Overall Study||52
2834041|NCT03672227|3535738|FG001|Children Started|Overall Study||23
2834042|NCT03672227|3535737|FG000|Parents Started|Overall Study||52
2834043|NCT03672227|3535738|FG001|Parents Started|Overall Study||23
2834044|NCT03672227|3535737|FG000|COMPLETED|Overall Study||105
2834045|NCT03672227|3535738|FG001|COMPLETED|Overall Study||52
2834046|NCT03672227|3535737|FG000|NOT COMPLETED|Overall Study||7
2834047|NCT03672227|3535738|FG001|NOT COMPLETED|Overall Study||0
2834048|NCT03644849|3535747|FG000|STARTED|Overall Study||24
2834049|NCT03644849|3535748|FG001|STARTED|Overall Study||24
2834050|NCT03644849|3535747|FG000|COMPLETED|Overall Study||23
2834051|NCT03644849|3535748|FG001|COMPLETED|Overall Study||21
2834052|NCT03644849|3535747|FG000|NOT COMPLETED|Overall Study||1
2834053|NCT03644849|3535748|FG001|NOT COMPLETED|Overall Study||3
2834054|NCT03640949|3535756|FG000|STARTED|Overall Study||237
2834055|NCT03640949|3535757|FG001|STARTED|Overall Study||264
2834056|NCT03640949|3535756|FG000|COMPLETED|Overall Study||237
2834057|NCT03640949|3535757|FG001|COMPLETED|Overall Study||264
2834058|NCT03640949|3535756|FG000|NOT COMPLETED|Overall Study||0
2834059|NCT03640949|3535757|FG001|NOT COMPLETED|Overall Study||0
2834060|NCT03604159|3535765|FG000|STARTED|Overall Study||26
2834061|NCT03604159|3535766|FG001|STARTED|Overall Study||26
2834062|NCT03604159|3535765|FG000|COMPLETED|Overall Study||20
2834063|NCT03604159|3535766|FG001|COMPLETED|Overall Study||19
2834064|NCT03604159|3535765|FG000|NOT COMPLETED|Overall Study||6
2834065|NCT03604159|3535766|FG001|NOT COMPLETED|Overall Study||7
2834066|NCT03602885|3535774|FG000|STARTED|Overall Study||5
2834067|NCT03602885|3535775|FG001|STARTED|Overall Study||5
2834068|NCT03602885|3535774|FG000|COMPLETED|Overall Study||2
2834069|NCT03602885|3535775|FG001|COMPLETED|Overall Study||5
2834070|NCT03602885|3535774|FG000|NOT COMPLETED|Overall Study||3
2834071|NCT03602885|3535775|FG001|NOT COMPLETED|Overall Study||0
2834072|NCT03539601|3535785|FG000|STARTED|Overall Study||60
2834073|NCT03539601|3535786|FG001|STARTED|Overall Study||59
2834074|NCT03539601|3535787|FG002|STARTED|Overall Study||71
2834075|NCT03539601|3535788|FG003|STARTED|Overall Study||47
2834076|NCT03539601|3535785|FG000|Treated|Overall Study||59
2834077|NCT03539601|3535786|FG001|Treated|Overall Study||58
2834078|NCT03539601|3535787|FG002|Treated|Overall Study||71
2834079|NCT03539601|3535788|FG003|Treated|Overall Study||47
2834080|NCT03539601|3535785|FG000|COMPLETED|Overall Study||54
2834081|NCT03539601|3535786|FG001|COMPLETED|Overall Study||52
2834082|NCT03539601|3535787|FG002|COMPLETED|Overall Study||65
2834083|NCT03539601|3535788|FG003|COMPLETED|Overall Study||46
2834084|NCT03539601|3535785|FG000|NOT COMPLETED|Overall Study||6
2834085|NCT03539601|3535786|FG001|NOT COMPLETED|Overall Study||7
2834086|NCT03539601|3535787|FG002|NOT COMPLETED|Overall Study||6
2834087|NCT03539601|3535788|FG003|NOT COMPLETED|Overall Study||1
2834088|NCT03539458|3535806|FG000|STARTED|Overall Study||11
2834089|NCT03539458|3535806|FG000|COMPLETED|Overall Study||10
2834090|NCT03539458|3535806|FG000|NOT COMPLETED|Overall Study||1
2834091|NCT03532451|3535812|FG000|STARTED|Overall Study||13
2834092|NCT03532451|3535813|FG001|STARTED|Overall Study||30
2834093|NCT03532451|3535812|FG000|COMPLETED|Overall Study||12
2834094|NCT03532451|3535813|FG001|COMPLETED|Overall Study||29
2834095|NCT03532451|3535812|FG000|NOT COMPLETED|Overall Study||1
2834096|NCT03532451|3535813|FG001|NOT COMPLETED|Overall Study||1
2834097|NCT03505099|3535821|FG000|STARTED|Overall Study||14
2834098|NCT03505099|3535822|FG001|STARTED|Overall Study||15
2834099|NCT03505099|3535821|FG000|Received AVXS-101|Overall Study||14
2834100|NCT03505099|3535822|FG001|Received AVXS-101|Overall Study||15
2834101|NCT03505099|3535821|FG000|COMPLETED|Overall Study||14
2834102|NCT03505099|3535822|FG001|COMPLETED|Overall Study||15
2834103|NCT03505099|3535821|FG000|NOT COMPLETED|Overall Study||0
2834104|NCT03505099|3535822|FG001|NOT COMPLETED|Overall Study||0
2914629|NCT00505414|3624802|FG002|STARTED|Maintenance Phase|14 of 32 tapentadol titration participants were treated with placebo in the maintenance phase.|14
2914630|NCT00505414|3624803|FG003|STARTED|Maintenance Phase|29 of 32 participants were treated in the maintenance phase either with placebo or tapentadol|0
2914631|NCT00505414|3624804|FG004|STARTED|Maintenance Phase|18 of 19 participants completing the morphine titration phase were continued on morphine.|0
2914632|NCT00505414|3624800|FG000|Did Not Qualify for Maintenance Phase|Maintenance Phase||0
2914633|NCT00505414|3624801|FG001|Did Not Qualify for Maintenance Phase|Maintenance Phase||0
2914634|NCT00505414|3624802|FG002|Did Not Qualify for Maintenance Phase|Maintenance Phase||0
2914635|NCT00505414|3624803|FG003|Did Not Qualify for Maintenance Phase|Maintenance Phase||3
2834105|NCT03478956|3535830|FG000|STARTED|Overall Study||12
2834106|NCT03478956|3535831|FG001|STARTED|Overall Study||12
2834107|NCT03478956|3535830|FG000|Received at Least One Dose of Study Drug|Overall Study||12
2834108|NCT03478956|3535831|FG001|Received at Least One Dose of Study Drug|Overall Study||12
2834109|NCT03478956|3535830|FG000|Completed Randomized Treatment Phase|Overall Study||11
2834110|NCT03478956|3535831|FG001|Completed Randomized Treatment Phase|Overall Study||10
2834111|NCT03478956|3535830|FG000|Started OLE Treatment Phase|Overall Study||11
2834112|NCT03478956|3535831|FG001|Started OLE Treatment Phase|Overall Study||10
2834113|NCT03478956|3535830|FG000|Completed OLE Treatment Phase|Overall Study||0
2834114|NCT03478956|3535831|FG001|Completed OLE Treatment Phase|Overall Study||0
2834115|NCT03478956|3535830|FG000|Started PML Safety Monitoring Phase|Overall Study||1
2834116|NCT03478956|3535831|FG001|Started PML Safety Monitoring Phase|Overall Study||2
2834117|NCT03478956|3535830|FG000|COMPLETED|Overall Study||0
2834118|NCT03478956|3535831|FG001|COMPLETED|Overall Study||0
2834119|NCT03478956|3535830|FG000|NOT COMPLETED|Overall Study||12
2834120|NCT03478956|3535831|FG001|NOT COMPLETED|Overall Study||12
2834121|NCT03464136|3535839|FG000|STARTED|Overall Study||195
2834122|NCT03464136|3535840|FG001|STARTED|Overall Study||191
2834123|NCT03464136|3535839|FG000|COMPLETED|Overall Study||165
2834124|NCT03464136|3535840|FG001|COMPLETED|Overall Study||166
2834125|NCT03464136|3535839|FG000|NOT COMPLETED|Overall Study||30
2834126|NCT03464136|3535840|FG001|NOT COMPLETED|Overall Study||25
2834127|NCT03439657|3535848|FG000|STARTED|Overall Study||449
2834128|NCT03439657|3535849|FG001|STARTED|Overall Study||463
2834129|NCT03439657|3535848|FG000|COMPLETED|Overall Study||442
2834130|NCT03439657|3535849|FG001|COMPLETED|Overall Study||459
2834131|NCT03439657|3535848|FG000|NOT COMPLETED|Overall Study||7
2834132|NCT03439657|3535849|FG001|NOT COMPLETED|Overall Study||4
2834133|NCT03377790|3535859|FG000|STARTED|Overall Study||160
2834134|NCT03377790|3535860|FG001|STARTED|Overall Study||106
2834135|NCT03377790|3535859|FG000|COMPLETED|Overall Study||150
2834136|NCT03377790|3535860|FG001|COMPLETED|Overall Study||100
2834137|NCT03377790|3535859|FG000|NOT COMPLETED|Overall Study||10
2834138|NCT03377790|3535860|FG001|NOT COMPLETED|Overall Study||6
2834139|NCT03353675|3535866|FG000|STARTED|Overall Study||44
2834140|NCT03353675|3535866|FG000|COMPLETED|Overall Study||40
2834141|NCT03353675|3535866|FG000|NOT COMPLETED|Overall Study||4
2834142|NCT03294109|3535872|FG000|STARTED|Overall Study||46
2834143|NCT03294109|3535873|FG001|STARTED|Overall Study||57
2834144|NCT03294109|3535872|FG000|Underwent Surgery|Overall Study||40
2834145|NCT03294109|3535873|FG001|Underwent Surgery|Overall Study||52
2834146|NCT03294109|3535872|FG000|COMPLETED|Overall Study||40
2834147|NCT03294109|3535873|FG001|COMPLETED|Overall Study||52
2834148|NCT03294109|3535872|FG000|NOT COMPLETED|Overall Study||6
2834149|NCT03294109|3535873|FG001|NOT COMPLETED|Overall Study||5
2834150|NCT03268005|3535882|FG000|STARTED|Overall Study||546
2834151|NCT03268005|3535883|FG001|STARTED|Overall Study||545
2834152|NCT03268005|3535882|FG000|Full Analysis Set|Overall Study||546
2834153|NCT03268005|3535883|FG001|Full Analysis Set|Overall Study||545
2834154|NCT03268005|3535882|FG000|Safety Analysis Set|Overall Study||544
2834155|NCT03268005|3535883|FG001|Safety Analysis Set|Overall Study||544
2834156|NCT03268005|3535882|FG000|COMPLETED|Overall Study||531
2834157|NCT03268005|3535883|FG001|COMPLETED|Overall Study||531
2834158|NCT03268005|3535882|FG000|NOT COMPLETED|Overall Study||15
2834159|NCT03268005|3535883|FG001|NOT COMPLETED|Overall Study||14
2834160|NCT03225170|3535892|FG000|STARTED|Overall Study||23
2834161|NCT03225170|3535893|FG001|STARTED|Overall Study||22
2834162|NCT03225170|3535894|FG002|STARTED|Overall Study||2
2834163|NCT03225170|3535892|FG000|COMPLETED|Overall Study||19
2834164|NCT03225170|3535893|FG001|COMPLETED|Overall Study||17
2834165|NCT03225170|3535894|FG002|COMPLETED|Overall Study||2
2834166|NCT03225170|3535892|FG000|NOT COMPLETED|Overall Study||4
2834167|NCT03225170|3535893|FG001|NOT COMPLETED|Overall Study||5
2834168|NCT03225170|3535894|FG002|NOT COMPLETED|Overall Study||0
2834169|NCT03220854|3535903|FG000|STARTED|Overall Study||4
2834170|NCT03220854|3535904|FG001|STARTED|Overall Study||0
2834171|NCT03220854|3535905|FG002|STARTED|Overall Study||1
2834172|NCT03220854|3535903|FG000|COMPLETED|Overall Study||4
2834173|NCT03220854|3535904|FG001|COMPLETED|Overall Study||0
2834174|NCT03220854|3535905|FG002|COMPLETED|Overall Study||1
2834175|NCT03220854|3535903|FG000|NOT COMPLETED|Overall Study||0
2834176|NCT03220854|3535904|FG001|NOT COMPLETED|Overall Study||0
2834177|NCT03220854|3535905|FG002|NOT COMPLETED|Overall Study||0
2834178|NCT03219034|3535918|FG000|STARTED|Overall Study||31
2834179|NCT03219034|3535919|FG001|STARTED|Overall Study||31
2834180|NCT03219034|3535918|FG000|COMPLETED|Overall Study||20
2834181|NCT03219034|3535919|FG001|COMPLETED|Overall Study||16
2834182|NCT03219034|3535918|FG000|NOT COMPLETED|Overall Study||11
2834183|NCT03219034|3535919|FG001|NOT COMPLETED|Overall Study||15
2834184|NCT03181789|3535931|FG000|STARTED|Overall Study||25
2834185|NCT03181789|3535932|FG001|STARTED|Overall Study||25
2834186|NCT03181789|3535933|FG002|STARTED|Overall Study||3
2834187|NCT03181789|3535934|FG003|STARTED|Overall Study||3
2834188|NCT03181789|3535931|FG000|Safety Population|Overall Study||25
2834189|NCT03181789|3535932|FG001|Safety Population|Overall Study||25
2834190|NCT03181789|3535933|FG002|Safety Population|Overall Study||3
2834191|NCT03181789|3535934|FG003|Safety Population|Overall Study||3
2834192|NCT03181789|3535931|FG000|COMPLETED|Overall Study||18
2834193|NCT03181789|3535932|FG001|COMPLETED|Overall Study||22
2834194|NCT03181789|3535933|FG002|COMPLETED|Overall Study||2
2834195|NCT03181789|3535934|FG003|COMPLETED|Overall Study||3
2834196|NCT03181789|3535931|FG000|NOT COMPLETED|Overall Study||7
2834197|NCT03181789|3535932|FG001|NOT COMPLETED|Overall Study||3
2834198|NCT03181789|3535933|FG002|NOT COMPLETED|Overall Study||1
2834199|NCT03181789|3535934|FG003|NOT COMPLETED|Overall Study||0
2834200|NCT03168438|3535946|FG000|STARTED|Overall Study||3
2834201|NCT03168438|3535947|FG001|STARTED|Overall Study||3
2834202|NCT03168438|3535946|FG000|COMPLETED|Overall Study||3
2834203|NCT03168438|3535947|FG001|COMPLETED|Overall Study||2
2834204|NCT03168438|3535946|FG000|NOT COMPLETED|Overall Study||0
2834205|NCT03168438|3535947|FG001|NOT COMPLETED|Overall Study||1
2834206|NCT03110380|3535956|FG000|STARTED|Double-Blind Treatment Phase||284
2834207|NCT03110380|3535957|FG001|STARTED|Double-Blind Treatment Phase||283
2834208|NCT03110380|3535958|FG002|STARTED|Double-Blind Treatment Phase||0
2834209|NCT03110380|3535959|FG003|STARTED|Double-Blind Treatment Phase||0
2834210|NCT03110380|3535956|FG000|Safety Analysis Set|Double-Blind Treatment Phase||284
2834211|NCT03110380|3535957|FG001|Safety Analysis Set|Double-Blind Treatment Phase||281
2834212|NCT03110380|3535958|FG002|Safety Analysis Set|Double-Blind Treatment Phase||0
2834213|NCT03110380|3535959|FG003|Safety Analysis Set|Double-Blind Treatment Phase||0
2834214|NCT03110380|3535956|FG000|COMPLETED|Double-Blind Treatment Phase||263
2834215|NCT03110380|3535957|FG001|COMPLETED|Double-Blind Treatment Phase||253
2834216|NCT03110380|3535958|FG002|COMPLETED|Double-Blind Treatment Phase||0
2834217|NCT03110380|3535959|FG003|COMPLETED|Double-Blind Treatment Phase||0
2834218|NCT03110380|3535956|FG000|NOT COMPLETED|Double-Blind Treatment Phase||21
2834219|NCT03110380|3535957|FG001|NOT COMPLETED|Double-Blind Treatment Phase||30
2834220|NCT03110380|3535958|FG002|NOT COMPLETED|Double-Blind Treatment Phase||0
2834221|NCT03110380|3535959|FG003|NOT COMPLETED|Double-Blind Treatment Phase||0
2834222|NCT03110380|3535956|FG000|STARTED|Open-label B/F/TAF Extension Phase|Following the end of Double-Blind treatment phase, participants in a country where B/F/TAF FDC was not available were given the option to receive open-label B/F/TAF.|0
2834223|NCT03110380|3535957|FG001|STARTED|Open-label B/F/TAF Extension Phase|Following the end of Double-Blind treatment phase, participants in a country where B/F/TAF FDC was not available were given the option to receive open-label B/F/TAF.|0
2834224|NCT03110380|3535958|FG002|STARTED|Open-label B/F/TAF Extension Phase|138 participants completed the Double-Blind treatment phase, but did not continue in the Open-label B/F/TAF extension phase.|125
2834225|NCT03110380|3535959|FG003|STARTED|Open-label B/F/TAF Extension Phase|137 participants completed the Double-Blind treatment phase, but did not continue in the Open-label B/F/TAF extension phase.|116
2834226|NCT03110380|3535956|FG000|COMPLETED|Open-label B/F/TAF Extension Phase||0
2834227|NCT03110380|3535957|FG001|COMPLETED|Open-label B/F/TAF Extension Phase||0
2834228|NCT03110380|3535958|FG002|COMPLETED|Open-label B/F/TAF Extension Phase||121
2834229|NCT03110380|3535959|FG003|COMPLETED|Open-label B/F/TAF Extension Phase||113
2834230|NCT03110380|3535956|FG000|NOT COMPLETED|Open-label B/F/TAF Extension Phase||0
2834231|NCT03110380|3535957|FG001|NOT COMPLETED|Open-label B/F/TAF Extension Phase||0
2834232|NCT03110380|3535958|FG002|NOT COMPLETED|Open-label B/F/TAF Extension Phase||4
2834233|NCT03110380|3535959|FG003|NOT COMPLETED|Open-label B/F/TAF Extension Phase||3
2834234|NCT03109262|3535967|FG000|STARTED|Overall Study||42
2834235|NCT03109262|3535967|FG000|COMPLETED|Overall Study||42
2834236|NCT03109262|3535967|FG000|NOT COMPLETED|Overall Study||0
2834237|NCT03078478|3535975|FG000|STARTED|Titration Period (16 Weeks)||805
2834238|NCT03078478|3535976|FG001|STARTED|Titration Period (16 Weeks)||804
2834239|NCT03078478|3535975|FG000|Full Analysis Set|Titration Period (16 Weeks)||805
2834240|NCT03078478|3535976|FG001|Full Analysis Set|Titration Period (16 Weeks)||804
2834241|NCT03078478|3535975|FG000|Safety Analysis Set|Titration Period (16 Weeks)||802
2834242|NCT03078478|3535976|FG001|Safety Analysis Set|Titration Period (16 Weeks)||798
2834243|NCT03078478|3535975|FG000|COMPLETED|Titration Period (16 Weeks)||805
2834244|NCT03078478|3535976|FG001|COMPLETED|Titration Period (16 Weeks)||804
2834245|NCT03078478|3535975|FG000|NOT COMPLETED|Titration Period (16 Weeks)||0
2834246|NCT03078478|3535976|FG001|NOT COMPLETED|Titration Period (16 Weeks)||0
2834247|NCT03078478|3535975|FG000|STARTED|Maintenance Period 1 (36 Weeks)||805
2834248|NCT03078478|3535976|FG001|STARTED|Maintenance Period 1 (36 Weeks)||804
2834249|NCT03078478|3535975|FG000|COMPLETED|Maintenance Period 1 (36 Weeks)||758
2834250|NCT03078478|3535976|FG001|COMPLETED|Maintenance Period 1 (36 Weeks)||761
2834251|NCT03078478|3535975|FG000|NOT COMPLETED|Maintenance Period 1 (36 Weeks)||47
2834252|NCT03078478|3535976|FG001|NOT COMPLETED|Maintenance Period 1 (36 Weeks)||43
2834253|NCT03078478|3535975|FG000|STARTED|Maintencance Period 2 (36 Weeks)||758
2834254|NCT03078478|3535976|FG001|STARTED|Maintencance Period 2 (36 Weeks)||761
2834255|NCT03078478|3535975|FG000|COMPLETED|Maintencance Period 2 (36 Weeks)||733
2834256|NCT03078478|3535976|FG001|COMPLETED|Maintencance Period 2 (36 Weeks)||734
2834257|NCT03078478|3535975|FG000|NOT COMPLETED|Maintencance Period 2 (36 Weeks)||25
2834258|NCT03078478|3535976|FG001|NOT COMPLETED|Maintencance Period 2 (36 Weeks)||27
2834259|NCT03040661|3535984|FG000|STARTED|Overall Study||35
2834260|NCT03040661|3535985|FG001|STARTED|Overall Study||35
2834261|NCT03040661|3535984|FG000|COMPLETED|Overall Study||35
2834262|NCT03040661|3535985|FG001|COMPLETED|Overall Study||35
2834263|NCT03040661|3535984|FG000|NOT COMPLETED|Overall Study||0
2834264|NCT03040661|3535985|FG001|NOT COMPLETED|Overall Study||0
2834265|NCT02993263|3535991|FG000|STARTED|Overall Study||323
2834266|NCT02993263|3535991|FG000|COMPLETED|Overall Study||0
2834267|NCT02993263|3535991|FG000|NOT COMPLETED|Overall Study||323
2834268|NCT02985684|3535995|FG000|STARTED|6-Month Clinical Success Evaluation||125
2834269|NCT02985684|3535995|FG000|COMPLETED|6-Month Clinical Success Evaluation||120
2834270|NCT02985684|3535995|FG000|NOT COMPLETED|6-Month Clinical Success Evaluation||5
2834271|NCT02985684|3535995|FG000|STARTED|6-Month Closure Success Evaluation||120
2834272|NCT02985684|3535995|FG000|COMPLETED|6-Month Closure Success Evaluation||112
2834273|NCT02985684|3535995|FG000|NOT COMPLETED|6-Month Closure Success Evaluation||8
2834274|NCT02964897|3536001|FG000|STARTED|Overall Study||43
2834275|NCT02964897|3536002|FG001|STARTED|Overall Study||36
2834276|NCT02964897|3536001|FG000|COMPLETED|Overall Study||43
2834277|NCT02964897|3536002|FG001|COMPLETED|Overall Study||36
2834278|NCT02964897|3536001|FG000|NOT COMPLETED|Overall Study||0
2834279|NCT02964897|3536002|FG001|NOT COMPLETED|Overall Study||0
2834280|NCT02951052|3536010|FG000|STARTED|Overall Study||308
2834281|NCT02951052|3536011|FG001|STARTED|Overall Study||308
2834282|NCT02951052|3536010|FG000|COMPLETED|Overall Study||281
2834283|NCT02951052|3536011|FG001|COMPLETED|Overall Study||290
2834284|NCT02951052|3536010|FG000|NOT COMPLETED|Overall Study||27
2834285|NCT02951052|3536011|FG001|NOT COMPLETED|Overall Study||18
2834286|NCT02903914|3536029|FG000|STARTED|Overall Study||8
2834287|NCT02903914|3536030|FG001|STARTED|Overall Study||7
2834288|NCT02903914|3536031|FG002|STARTED|Overall Study||85
2834289|NCT02903914|3536032|FG003|STARTED|Overall Study||7
2834290|NCT02903914|3536033|FG004|STARTED|Overall Study||10
2834291|NCT02903914|3536034|FG005|STARTED|Overall Study||14
2834292|NCT02903914|3536035|FG006|STARTED|Overall Study||123
2834293|NCT02903914|3536036|FG007|STARTED|Overall Study||6
2834294|NCT02903914|3536029|FG000|COMPLETED|Overall Study||0
2834295|NCT02903914|3536030|FG001|COMPLETED|Overall Study||0
2834296|NCT02903914|3536031|FG002|COMPLETED|Overall Study||0
2834297|NCT02903914|3536032|FG003|COMPLETED|Overall Study||0
2834298|NCT02903914|3536033|FG004|COMPLETED|Overall Study||0
2834299|NCT02903914|3536034|FG005|COMPLETED|Overall Study||0
2834300|NCT02903914|3536035|FG006|COMPLETED|Overall Study||6
2834301|NCT02903914|3536036|FG007|COMPLETED|Overall Study||1
2834302|NCT02903914|3536029|FG000|NOT COMPLETED|Overall Study||8
2834303|NCT02903914|3536030|FG001|NOT COMPLETED|Overall Study||7
2834304|NCT02903914|3536031|FG002|NOT COMPLETED|Overall Study||85
2834305|NCT02903914|3536032|FG003|NOT COMPLETED|Overall Study||7
2834306|NCT02903914|3536033|FG004|NOT COMPLETED|Overall Study||10
2834307|NCT02903914|3536034|FG005|NOT COMPLETED|Overall Study||14
2834308|NCT02903914|3536035|FG006|NOT COMPLETED|Overall Study||117
2834309|NCT02903914|3536036|FG007|NOT COMPLETED|Overall Study||5
2834310|NCT02879448|3536058|FG000|STARTED|Overall Study||934
2834311|NCT02879448|3536059|FG001|STARTED|Overall Study||944
2834312|NCT02879448|3536058|FG000|COMPLETED|Overall Study||796
2834313|NCT02879448|3536059|FG001|COMPLETED|Overall Study||742
2834314|NCT02879448|3536058|FG000|NOT COMPLETED|Overall Study||138
2834315|NCT02879448|3536059|FG001|NOT COMPLETED|Overall Study||202
2834316|NCT02873195|3536067|FG000|STARTED|Overall Study||87
2834317|NCT02873195|3536068|FG001|STARTED|Overall Study||46
2834318|NCT02873195|3536067|FG000|Never Began Treatment (Cancel)|Overall Study||1
2834319|NCT02873195|3536068|FG001|Never Began Treatment (Cancel)|Overall Study||0
2834320|NCT02873195|3536067|FG000|COMPLETED|Overall Study||82
2834321|NCT02873195|3536068|FG001|COMPLETED|Overall Study||46
2834322|NCT02873195|3536067|FG000|NOT COMPLETED|Overall Study||5
2834323|NCT02873195|3536068|FG001|NOT COMPLETED|Overall Study||0
2914636|NCT00505414|3624804|FG004|Did Not Qualify for Maintenance Phase|Maintenance Phase||1
2914637|NCT00505414|3624800|FG000|COMPLETED|Maintenance Phase||12
2914638|NCT00505414|3624801|FG001|COMPLETED|Maintenance Phase||10
2914639|NCT00505414|3624802|FG002|COMPLETED|Maintenance Phase||6
2914640|NCT00505414|3624803|FG003|COMPLETED|Maintenance Phase||0
2914641|NCT00505414|3624804|FG004|COMPLETED|Maintenance Phase||0
2914642|NCT00505414|3624800|FG000|NOT COMPLETED|Maintenance Phase||6
2914643|NCT00505414|3624801|FG001|NOT COMPLETED|Maintenance Phase||5
2914644|NCT00505414|3624802|FG002|NOT COMPLETED|Maintenance Phase||8
2914645|NCT00505414|3624803|FG003|NOT COMPLETED|Maintenance Phase||0
2914646|NCT00505414|3624804|FG004|NOT COMPLETED|Maintenance Phase||0
2914647|NCT00505518|3624816|FG000|STARTED|Overall Study||9
2914648|NCT00505518|3624816|FG000|COMPLETED|Overall Study||9
2914649|NCT00505518|3624816|FG000|NOT COMPLETED|Overall Study||0
2914650|NCT00505622|3624823|FG000|STARTED|Overall Study||121
2914651|NCT00505622|3624824|FG001|STARTED|Overall Study||108
2914652|NCT00505622|3624825|FG002|STARTED|Overall Study||96
2914653|NCT00505622|3624823|FG000|COMPLETED|Overall Study||0
2914654|NCT00505622|3624824|FG001|COMPLETED|Overall Study||0
2914655|NCT00505622|3624825|FG002|COMPLETED|Overall Study||0
2914656|NCT00505622|3624823|FG000|NOT COMPLETED|Overall Study||121
2914657|NCT00505622|3624824|FG001|NOT COMPLETED|Overall Study||108
2914658|NCT00505622|3624825|FG002|NOT COMPLETED|Overall Study||96
2914659|NCT00505635|3624833|FG000|STARTED|Overall Study||5
2914660|NCT00505635|3624833|FG000|COMPLETED|Overall Study||5
2914661|NCT00505635|3624833|FG000|NOT COMPLETED|Overall Study||0
2914662|NCT00505661|3624837|FG000|STARTED|Overall Study||16
2914663|NCT00505661|3624837|FG000|COMPLETED|Overall Study||12
2914664|NCT00505661|3624837|FG000|NOT COMPLETED|Overall Study||4
2914665|NCT00505687|3624841|FG000|STARTED|Overall Study||186
2914666|NCT00505687|3624841|FG000|COMPLETED|Overall Study||91
2914667|NCT00505687|3624841|FG000|NOT COMPLETED|Overall Study||95
2914668|NCT00505752|3624849|FG000|STARTED|Overall Study||132
2914669|NCT00505752|3624850|FG001|STARTED|Overall Study||128
2914670|NCT00505752|3624851|FG002|STARTED|Overall Study||128
2914671|NCT00505752|3624852|FG003|STARTED|Overall Study||132
2914672|NCT00505752|3624849|FG000|COMPLETED|Overall Study||126
2914673|NCT00505752|3624850|FG001|COMPLETED|Overall Study||119
2834324|NCT02821000|3536074|FG000|STARTED|Overall Study||103
2834325|NCT02821000|3536074|FG000|Treated|Overall Study||103
2834326|NCT02821000|3536074|FG000|COMPLETED|Overall Study||0
2834327|NCT02821000|3536074|FG000|NOT COMPLETED|Overall Study||103
2834328|NCT02785952|3536080|FG000|STARTED|Overall Study||125
2834329|NCT02785952|3536081|FG001|STARTED|Overall Study||127
2834330|NCT02785952|3536080|FG000|COMPLETED|Overall Study||0
2834331|NCT02785952|3536081|FG001|COMPLETED|Overall Study||0
2834332|NCT02785952|3536080|FG000|NOT COMPLETED|Overall Study||125
2834333|NCT02785952|3536081|FG001|NOT COMPLETED|Overall Study||127
2834334|NCT02758717|3536089|FG000|STARTED|Overall Study||46
2834335|NCT02758717|3536089|FG000|COMPLETED|Overall Study||46
2834336|NCT02758717|3536089|FG000|NOT COMPLETED|Overall Study||0
2834337|NCT02748616|3536093|FG000|STARTED|Overall Study||9
2834338|NCT02748616|3536093|FG000|COMPLETED|Overall Study||2
2834339|NCT02748616|3536093|FG000|NOT COMPLETED|Overall Study||7
2834340|NCT02719522|3536097|FG000|STARTED|Overall Study|In 1 consented subject, device deployment was not attempted due to significant arterial stenosis.|204
2834341|NCT02719522|3536097|FG000|COMPLETED|Overall Study||193
2834342|NCT02719522|3536097|FG000|NOT COMPLETED|Overall Study||11
2834343|NCT02664181|3536103|FG000|STARTED|Overall Study||8
2834344|NCT02664181|3536104|FG001|STARTED|Overall Study||5
2834345|NCT02664181|3536103|FG000|COMPLETED|Overall Study||8
2834346|NCT02664181|3536104|FG001|COMPLETED|Overall Study||5
2834347|NCT02664181|3536103|FG000|NOT COMPLETED|Overall Study||0
2834348|NCT02664181|3536104|FG001|NOT COMPLETED|Overall Study||0
2834349|NCT02633241|3536110|FG000|STARTED|Overall Study||30
2834350|NCT02633241|3536110|FG000|COMPLETED|Overall Study||27
2834351|NCT02633241|3536110|FG000|NOT COMPLETED|Overall Study||3
2834352|NCT02586025|3536118|FG000|STARTED|Neoadjuvant Treatment||219
2834353|NCT02586025|3536119|FG001|STARTED|Neoadjuvant Treatment||110
2834354|NCT02586025|3536118|FG000|Received at Least One Dose of Study Drug|Neoadjuvant Treatment||218
2834355|NCT02586025|3536119|FG001|Received at Least One Dose of Study Drug|Neoadjuvant Treatment||110
2834356|NCT02586025|3536118|FG000|Completed Neoadjuvant Treatment|Neoadjuvant Treatment||214
2834357|NCT02586025|3536119|FG001|Completed Neoadjuvant Treatment|Neoadjuvant Treatment||108
2834358|NCT02586025|3536118|FG000|Underwent Surgery|Neoadjuvant Treatment||210
2834359|NCT02586025|3536119|FG001|Underwent Surgery|Neoadjuvant Treatment||105
2834360|NCT02586025|3536118|FG000|COMPLETED|Neoadjuvant Treatment||208
2834361|NCT02586025|3536119|FG001|COMPLETED|Neoadjuvant Treatment||103
2834362|NCT02586025|3536118|FG000|NOT COMPLETED|Neoadjuvant Treatment||11
2834363|NCT02586025|3536119|FG001|NOT COMPLETED|Neoadjuvant Treatment||7
2834364|NCT02586025|3536118|FG000|STARTED|Adjuvant Treatment||208
2834365|NCT02586025|3536119|FG001|STARTED|Adjuvant Treatment||103
2834366|NCT02586025|3536118|FG000|Started Adjuvant FEC Treatment|Adjuvant Treatment||208
2834367|NCT02586025|3536119|FG001|Started Adjuvant FEC Treatment|Adjuvant Treatment||103
2834368|NCT02586025|3536118|FG000|Started Adjuvant HER2 Treatment|Adjuvant Treatment||204
2834369|NCT02586025|3536119|FG001|Started Adjuvant HER2 Treatment|Adjuvant Treatment||99
2834370|NCT02586025|3536118|FG000|COMPLETED|Adjuvant Treatment||69
2834371|NCT02586025|3536119|FG001|COMPLETED|Adjuvant Treatment||34
2834372|NCT02586025|3536118|FG000|NOT COMPLETED|Adjuvant Treatment||139
2834373|NCT02586025|3536119|FG001|NOT COMPLETED|Adjuvant Treatment||69
2834374|NCT02586025|3536118|FG000|STARTED|Treatment-Free Follow-Up||59
2834375|NCT02586025|3536119|FG001|STARTED|Treatment-Free Follow-Up||38
2834376|NCT02586025|3536118|FG000|COMPLETED|Treatment-Free Follow-Up||3
2834377|NCT02586025|3536119|FG001|COMPLETED|Treatment-Free Follow-Up||3
2834378|NCT02586025|3536118|FG000|NOT COMPLETED|Treatment-Free Follow-Up||56
2834379|NCT02586025|3536119|FG001|NOT COMPLETED|Treatment-Free Follow-Up||35
2834380|NCT02585232|3536127|FG000|STARTED|Overall Study||40
2834381|NCT02585232|3536128|FG001|STARTED|Overall Study||42
2834382|NCT02585232|3536127|FG000|COMPLETED|Overall Study||28
2834383|NCT02585232|3536128|FG001|COMPLETED|Overall Study||26
2834384|NCT02585232|3536127|FG000|NOT COMPLETED|Overall Study||12
2834385|NCT02585232|3536128|FG001|NOT COMPLETED|Overall Study||16
2834386|NCT02583269|3536139|FG000|STARTED|Overall Study||3
2834387|NCT02583269|3536140|FG001|STARTED|Overall Study||7
2834388|NCT02583269|3536141|FG002|STARTED|Overall Study||3
2834389|NCT02583269|3536142|FG003|STARTED|Overall Study||5
2834390|NCT02583269|3536143|FG004|STARTED|Overall Study||6
2834391|NCT02583269|3536139|FG000|COMPLETED|Overall Study||2
2834392|NCT02583269|3536140|FG001|COMPLETED|Overall Study||7
2834393|NCT02583269|3536141|FG002|COMPLETED|Overall Study||3
2834394|NCT02583269|3536142|FG003|COMPLETED|Overall Study||5
2834395|NCT02583269|3536143|FG004|COMPLETED|Overall Study||6
2834396|NCT02583269|3536139|FG000|NOT COMPLETED|Overall Study||1
2834397|NCT02583269|3536140|FG001|NOT COMPLETED|Overall Study||0
2834398|NCT02583269|3536141|FG002|NOT COMPLETED|Overall Study||0
2834399|NCT02583269|3536142|FG003|NOT COMPLETED|Overall Study||0
2834400|NCT02583269|3536143|FG004|NOT COMPLETED|Overall Study||0
2834401|NCT02556606|3536160|FG000|STARTED|Overall Study||4
2834402|NCT02556606|3536161|FG001|STARTED|Overall Study||5
2834403|NCT02556606|3536162|FG002|STARTED|Overall Study||11
2834404|NCT02556606|3536163|FG003|STARTED|Overall Study||13
2834405|NCT02556606|3536160|FG000|COMPLETED|Overall Study||4
2834406|NCT02556606|3536161|FG001|COMPLETED|Overall Study||5
2834407|NCT02556606|3536162|FG002|COMPLETED|Overall Study||11
2834408|NCT02556606|3536163|FG003|COMPLETED|Overall Study||13
2834409|NCT02556606|3536160|FG000|NOT COMPLETED|Overall Study||0
2834410|NCT02556606|3536161|FG001|NOT COMPLETED|Overall Study||0
2834411|NCT02556606|3536162|FG002|NOT COMPLETED|Overall Study||0
2834412|NCT02556606|3536163|FG003|NOT COMPLETED|Overall Study||0
2834413|NCT02545283|3536179|FG000|STARTED|Overall Study||149
2834414|NCT02545283|3536180|FG001|STARTED|Overall Study||298
2834415|NCT02545283|3536179|FG000|Received Treatment|Overall Study||149
2834416|NCT02545283|3536180|FG001|Received Treatment|Overall Study||292
2834417|NCT02545283|3536179|FG000|Safety Follow Up|Overall Study|I participant was not treated and 1 participant entered from the Idasanutlin arm|149
2834418|NCT02545283|3536180|FG001|Safety Follow Up|Overall Study|5 participants were not treated, 1 participant did not receive Idasanutlin and was moved to the Placebo arm|292
2834419|NCT02545283|3536179|FG000|COMPLETED|Overall Study||0
2834420|NCT02545283|3536180|FG001|COMPLETED|Overall Study||0
2834421|NCT02545283|3536179|FG000|NOT COMPLETED|Overall Study||149
2834422|NCT02545283|3536180|FG001|NOT COMPLETED|Overall Study||298
2834423|NCT02524171|3536190|FG000|STARTED|6-month Follow-up||172
2834424|NCT02524171|3536191|FG001|STARTED|6-month Follow-up||169
2834425|NCT02524171|3536190|FG000|COMPLETED|6-month Follow-up||119
2834426|NCT02524171|3536191|FG001|COMPLETED|6-month Follow-up||124
2834427|NCT02524171|3536190|FG000|NOT COMPLETED|6-month Follow-up||53
2834428|NCT02524171|3536191|FG001|NOT COMPLETED|6-month Follow-up||45
2834429|NCT02524171|3536190|FG000|STARTED|12-month Follow-up Interview||172
2834430|NCT02524171|3536191|FG001|STARTED|12-month Follow-up Interview||169
2834431|NCT02524171|3536190|FG000|COMPLETED|12-month Follow-up Interview||127
2834432|NCT02524171|3536191|FG001|COMPLETED|12-month Follow-up Interview||128
2834433|NCT02524171|3536190|FG000|NOT COMPLETED|12-month Follow-up Interview||45
2834434|NCT02524171|3536191|FG001|NOT COMPLETED|12-month Follow-up Interview||41
2834435|NCT02489422|3536199|FG000|STARTED|Overall Study||23
2834436|NCT02489422|3536200|FG001|STARTED|Overall Study||21
2834437|NCT02489422|3536199|FG000|COMPLETED|Overall Study||23
2834438|NCT02489422|3536200|FG001|COMPLETED|Overall Study||21
2834439|NCT02489422|3536199|FG000|NOT COMPLETED|Overall Study||0
2834440|NCT02489422|3536200|FG001|NOT COMPLETED|Overall Study||0
2834441|NCT02487251|3536211|FG000|STARTED|Overall Study||434
2834442|NCT02487251|3536212|FG001|STARTED|Overall Study||65
2834443|NCT02487251|3536213|FG002|STARTED|Overall Study||152
2834444|NCT02487251|3536214|FG003|STARTED|Overall Study||159
2834445|NCT02487251|3536211|FG000|COMPLETED|Overall Study||366
2834446|NCT02487251|3536212|FG001|COMPLETED|Overall Study||55
2834447|NCT02487251|3536213|FG002|COMPLETED|Overall Study||125
2834448|NCT02487251|3536214|FG003|COMPLETED|Overall Study||134
2834449|NCT02487251|3536211|FG000|NOT COMPLETED|Overall Study||68
2834450|NCT02487251|3536212|FG001|NOT COMPLETED|Overall Study||10
2834451|NCT02487251|3536213|FG002|NOT COMPLETED|Overall Study||27
2834452|NCT02487251|3536214|FG003|NOT COMPLETED|Overall Study||25
2834453|NCT02476968|3536227|FG000|STARTED|Overall Study||145
2834454|NCT02476968|3536228|FG001|STARTED|Overall Study||33
2834455|NCT02476968|3536229|FG002|STARTED|Overall Study||3
2834456|NCT02476968|3536227|FG000|Received Treatment|Overall Study||143
2834457|NCT02476968|3536228|FG001|Received Treatment|Overall Study||32
2834458|NCT02476968|3536229|FG002|Received Treatment|Overall Study||2
2834459|NCT02476968|3536227|FG000|COMPLETED|Overall Study||71
2834460|NCT02476968|3536228|FG001|COMPLETED|Overall Study||18
2834461|NCT02476968|3536229|FG002|COMPLETED|Overall Study||1
2834462|NCT02476968|3536227|FG000|NOT COMPLETED|Overall Study||74
2834463|NCT02476968|3536228|FG001|NOT COMPLETED|Overall Study||15
2834464|NCT02476968|3536229|FG002|NOT COMPLETED|Overall Study||2
2834465|NCT02367040|3536241|FG000|STARTED|Overall Study||307
2834466|NCT02367040|3536242|FG001|STARTED|Overall Study||151
2834467|NCT02367040|3536241|FG000|Received Treatment|Overall Study||304
2834468|NCT02367040|3536242|FG001|Received Treatment|Overall Study||149
2834469|NCT02367040|3536241|FG000|COMPLETED|Overall Study||70
2834470|NCT02367040|3536242|FG001|COMPLETED|Overall Study||29
2834471|NCT02367040|3536241|FG000|NOT COMPLETED|Overall Study||237
2834472|NCT02367040|3536242|FG001|NOT COMPLETED|Overall Study||122
2914674|NCT00505752|3624851|FG002|COMPLETED|Overall Study||120
2914675|NCT00505752|3624852|FG003|COMPLETED|Overall Study||126
2914676|NCT00505752|3624849|FG000|NOT COMPLETED|Overall Study||6
2914677|NCT00505752|3624850|FG001|NOT COMPLETED|Overall Study||9
2914678|NCT00505752|3624851|FG002|NOT COMPLETED|Overall Study||8
2914679|NCT00505752|3624852|FG003|NOT COMPLETED|Overall Study||6
2914680|NCT00505765|3624865|FG000|STARTED|Overall Study||21
2914681|NCT00505765|3624866|FG001|STARTED|Overall Study||20
2914682|NCT00505765|3624867|FG002|STARTED|Overall Study||22
2914683|NCT00505765|3624865|FG000|Mid-Point Assessment|Overall Study||20
2914684|NCT00505765|3624866|FG001|Mid-Point Assessment|Overall Study||19
2914685|NCT00505765|3624867|FG002|Mid-Point Assessment|Overall Study||21
2914686|NCT00505765|3624865|FG000|COMPLETED|Overall Study||19
2914687|NCT00505765|3624866|FG001|COMPLETED|Overall Study||17
2914688|NCT00505765|3624867|FG002|COMPLETED|Overall Study||19
2914689|NCT00505765|3624865|FG000|NOT COMPLETED|Overall Study||2
2914690|NCT00505765|3624866|FG001|NOT COMPLETED|Overall Study||3
2914691|NCT00505765|3624867|FG002|NOT COMPLETED|Overall Study||3
2914692|NCT00505778|3624877|FG000|STARTED|Overall Study||514
2914693|NCT00505778|3624878|FG001|STARTED|Overall Study||513
2914694|NCT00505778|3624877|FG000|Intent to Treat (ITT) Population|Overall Study||512
2914695|NCT00505778|3624878|FG001|Intent to Treat (ITT) Population|Overall Study||511
2914696|NCT00505778|3624877|FG000|COMPLETED|Overall Study||380
2914697|NCT00505778|3624878|FG001|COMPLETED|Overall Study||378
2914698|NCT00505778|3624877|FG000|NOT COMPLETED|Overall Study||134
2914699|NCT00505778|3624878|FG001|NOT COMPLETED|Overall Study||135
2914700|NCT00505895|3624886|FG000|STARTED|Overall Study||27
2834473|NCT02306122|3536255|FG000|STARTED|Initial Physician Randomization||0
2834474|NCT02306122|3536256|FG001|STARTED|Initial Physician Randomization||0
2834475|NCT02306122|3536257|FG002|STARTED|Initial Physician Randomization||0
2834476|NCT02306122|3536258|FG003|STARTED|Initial Physician Randomization||0
2834477|NCT02306122|3536259|FG004|STARTED|Initial Physician Randomization||0
2834478|NCT02306122|3536260|FG005|STARTED|Initial Physician Randomization||0
2834479|NCT02306122|3536261|FG006|STARTED|Initial Physician Randomization||0
2834480|NCT02306122|3536262|FG007|STARTED|Initial Physician Randomization||0
2834481|NCT02306122|3536263|FG008|STARTED|Initial Physician Randomization||29
2834482|NCT02306122|3536264|FG009|STARTED|Initial Physician Randomization||31
2834483|NCT02306122|3536265|FG010|STARTED|Initial Physician Randomization||31
2834484|NCT02306122|3536255|FG000|COMPLETED|Initial Physician Randomization||0
2834485|NCT02306122|3536256|FG001|COMPLETED|Initial Physician Randomization||0
2834486|NCT02306122|3536257|FG002|COMPLETED|Initial Physician Randomization||0
2834487|NCT02306122|3536258|FG003|COMPLETED|Initial Physician Randomization||0
2834488|NCT02306122|3536259|FG004|COMPLETED|Initial Physician Randomization||0
2834489|NCT02306122|3536260|FG005|COMPLETED|Initial Physician Randomization||0
2834490|NCT02306122|3536261|FG006|COMPLETED|Initial Physician Randomization||0
2834491|NCT02306122|3536262|FG007|COMPLETED|Initial Physician Randomization||0
2834492|NCT02306122|3536263|FG008|COMPLETED|Initial Physician Randomization||28
2834493|NCT02306122|3536264|FG009|COMPLETED|Initial Physician Randomization||31
2834494|NCT02306122|3536265|FG010|COMPLETED|Initial Physician Randomization||31
2834495|NCT02306122|3536255|FG000|NOT COMPLETED|Initial Physician Randomization||0
2834496|NCT02306122|3536256|FG001|NOT COMPLETED|Initial Physician Randomization||0
2834497|NCT02306122|3536257|FG002|NOT COMPLETED|Initial Physician Randomization||0
2834498|NCT02306122|3536258|FG003|NOT COMPLETED|Initial Physician Randomization||0
2834499|NCT02306122|3536259|FG004|NOT COMPLETED|Initial Physician Randomization||0
2834500|NCT02306122|3536260|FG005|NOT COMPLETED|Initial Physician Randomization||0
2834501|NCT02306122|3536261|FG006|NOT COMPLETED|Initial Physician Randomization||0
2834502|NCT02306122|3536262|FG007|NOT COMPLETED|Initial Physician Randomization||0
2834503|NCT02306122|3536263|FG008|NOT COMPLETED|Initial Physician Randomization||1
2834504|NCT02306122|3536264|FG009|NOT COMPLETED|Initial Physician Randomization||0
2834505|NCT02306122|3536265|FG010|NOT COMPLETED|Initial Physician Randomization||0
2834506|NCT02306122|3536255|FG000|STARTED|Post Nonadherence Subgroup Randomization||244
2834507|NCT02306122|3536256|FG001|STARTED|Post Nonadherence Subgroup Randomization||123
2834508|NCT02306122|3536257|FG002|STARTED|Post Nonadherence Subgroup Randomization||121
2834509|NCT02306122|3536258|FG003|STARTED|Post Nonadherence Subgroup Randomization||274
2834510|NCT02306122|3536259|FG004|STARTED|Post Nonadherence Subgroup Randomization||134
2834511|NCT02306122|3536260|FG005|STARTED|Post Nonadherence Subgroup Randomization||137
2834512|NCT02306122|3536261|FG006|STARTED|Post Nonadherence Subgroup Randomization||220
2834513|NCT02306122|3536262|FG007|STARTED|Post Nonadherence Subgroup Randomization||221
2834514|NCT02306122|3536263|FG008|STARTED|Post Nonadherence Subgroup Randomization||28
2834515|NCT02306122|3536264|FG009|STARTED|Post Nonadherence Subgroup Randomization||31
2834516|NCT02306122|3536265|FG010|STARTED|Post Nonadherence Subgroup Randomization||31
2834517|NCT02306122|3536255|FG000|COMPLETED|Post Nonadherence Subgroup Randomization||244
2834518|NCT02306122|3536256|FG001|COMPLETED|Post Nonadherence Subgroup Randomization||123
2834519|NCT02306122|3536257|FG002|COMPLETED|Post Nonadherence Subgroup Randomization||121
2834520|NCT02306122|3536258|FG003|COMPLETED|Post Nonadherence Subgroup Randomization||274
2834521|NCT02306122|3536259|FG004|COMPLETED|Post Nonadherence Subgroup Randomization||134
2834522|NCT02306122|3536260|FG005|COMPLETED|Post Nonadherence Subgroup Randomization||137
2834523|NCT02306122|3536261|FG006|COMPLETED|Post Nonadherence Subgroup Randomization||220
2834524|NCT02306122|3536262|FG007|COMPLETED|Post Nonadherence Subgroup Randomization||221
2834525|NCT02306122|3536263|FG008|COMPLETED|Post Nonadherence Subgroup Randomization||28
2834526|NCT02306122|3536264|FG009|COMPLETED|Post Nonadherence Subgroup Randomization||31
2834527|NCT02306122|3536265|FG010|COMPLETED|Post Nonadherence Subgroup Randomization||31
2834528|NCT02306122|3536255|FG000|NOT COMPLETED|Post Nonadherence Subgroup Randomization||0
2834529|NCT02306122|3536256|FG001|NOT COMPLETED|Post Nonadherence Subgroup Randomization||0
2834530|NCT02306122|3536257|FG002|NOT COMPLETED|Post Nonadherence Subgroup Randomization||0
2834531|NCT02306122|3536258|FG003|NOT COMPLETED|Post Nonadherence Subgroup Randomization||0
2834532|NCT02306122|3536259|FG004|NOT COMPLETED|Post Nonadherence Subgroup Randomization||0
2834533|NCT02306122|3536260|FG005|NOT COMPLETED|Post Nonadherence Subgroup Randomization||0
2834534|NCT02306122|3536261|FG006|NOT COMPLETED|Post Nonadherence Subgroup Randomization||0
2834535|NCT02306122|3536262|FG007|NOT COMPLETED|Post Nonadherence Subgroup Randomization||0
2834536|NCT02306122|3536263|FG008|NOT COMPLETED|Post Nonadherence Subgroup Randomization||0
2834537|NCT02306122|3536264|FG009|NOT COMPLETED|Post Nonadherence Subgroup Randomization||0
2834538|NCT02306122|3536265|FG010|NOT COMPLETED|Post Nonadherence Subgroup Randomization||0
2834539|NCT02304991|3536285|FG000|STARTED|Overall Study||25
2834540|NCT02304991|3536286|FG001|STARTED|Overall Study||25
2834541|NCT02304991|3536285|FG000|COMPLETED|Overall Study||18
2834542|NCT02304991|3536286|FG001|COMPLETED|Overall Study||15
2834543|NCT02304991|3536285|FG000|NOT COMPLETED|Overall Study||7
2834544|NCT02304991|3536286|FG001|NOT COMPLETED|Overall Study||10
2834545|NCT02223520|3536294|FG000|STARTED|Overall Study||147
2834546|NCT02223520|3536295|FG001|STARTED|Overall Study||160
2834547|NCT02223520|3536294|FG000|COMPLETED|Overall Study|101 neonates of these parents were enrolled. 12 were lost to follow-up.|147
2914701|NCT00505895|3624887|FG001|STARTED|Overall Study||23
2834548|NCT02223520|3536295|FG001|COMPLETED|Overall Study|107 neonates of these parents were enrolled. 6 were lost to follow-up.|160
2834549|NCT02223520|3536294|FG000|NOT COMPLETED|Overall Study||0
2834550|NCT02223520|3536295|FG001|NOT COMPLETED|Overall Study||0
2834551|NCT02178709|3536301|FG000|STARTED|Overall Study||48
2834552|NCT02178709|3536301|FG000|COMPLETED|Overall Study||32
2834553|NCT02178709|3536301|FG000|NOT COMPLETED|Overall Study||16
2834554|NCT02147184|3536307|FG000|STARTED|Overall Study||127
2834555|NCT02147184|3536308|FG001|STARTED|Overall Study||137
2834556|NCT02147184|3536307|FG000|COMPLETED|Overall Study||78
2834557|NCT02147184|3536308|FG001|COMPLETED|Overall Study||110
2834558|NCT02147184|3536307|FG000|NOT COMPLETED|Overall Study||49
2834559|NCT02147184|3536308|FG001|NOT COMPLETED|Overall Study||27
2834560|NCT02122198|3536316|FG000|STARTED|Overall Study||5
2834561|NCT02122198|3536317|FG001|STARTED|Overall Study||12
3167129|NCT01908101|3894270|FG000|STARTED|Overall Study||68
3167130|NCT01908101|3894270|FG000|COMPLETED|Overall Study||59
3167131|NCT01908101|3894270|FG000|NOT COMPLETED|Overall Study||9
3167132|NCT01908127|3894276|FG000|STARTED|Overall Study||23
2834562|NCT02122198|3536316|FG000|COMPLETED|Overall Study||3
2834563|NCT02122198|3536317|FG001|COMPLETED|Overall Study||10
2834564|NCT02122198|3536316|FG000|NOT COMPLETED|Overall Study||2
2834565|NCT02122198|3536317|FG001|NOT COMPLETED|Overall Study||2
2834566|NCT02075840|3536326|FG000|STARTED|Overall Study||152
2834567|NCT02075840|3536327|FG001|STARTED|Overall Study||151
2834568|NCT02075840|3536326|FG000|COMPLETED|Overall Study||0
2834569|NCT02075840|3536327|FG001|COMPLETED|Overall Study||0
2834570|NCT02075840|3536326|FG000|NOT COMPLETED|Overall Study||152
2834571|NCT02075840|3536327|FG001|NOT COMPLETED|Overall Study||151
2834572|NCT02055053|3536335|FG000|STARTED|Overall Study||35
2834573|NCT02055053|3536336|FG001|STARTED|Overall Study||35
2834574|NCT02055053|3536335|FG000|COMPLETED|Overall Study||35
2834575|NCT02055053|3536336|FG001|COMPLETED|Overall Study||35
2834576|NCT02055053|3536335|FG000|NOT COMPLETED|Overall Study||0
2834577|NCT02055053|3536336|FG001|NOT COMPLETED|Overall Study||0
2834578|NCT02000219|3536342|FG000|STARTED|14-Week Study Period||12
2834579|NCT02000219|3536342|FG000|COMPLETED|14-Week Study Period||9
2834580|NCT02000219|3536342|FG000|NOT COMPLETED|14-Week Study Period||3
2834581|NCT02000219|3536342|FG000|STARTED|Continuation Period||8
2834582|NCT02000219|3536342|FG000|COMPLETED|Continuation Period||3
2834583|NCT02000219|3536342|FG000|NOT COMPLETED|Continuation Period||5
2834584|NCT01978938|3536348|FG000|STARTED|Overall Study||455
2834585|NCT01978938|3536349|FG001|STARTED|Overall Study||453
2834586|NCT01978938|3536348|FG000|Received at Least 1 Dose of Study Drug|Overall Study||454
2834587|NCT01978938|3536349|FG001|Received at Least 1 Dose of Study Drug|Overall Study||451
2834588|NCT01978938|3536348|FG000|COMPLETED|Overall Study||432
2834589|NCT01978938|3536349|FG001|COMPLETED|Overall Study||439
2834590|NCT01978938|3536348|FG000|NOT COMPLETED|Overall Study||23
2834591|NCT01978938|3536349|FG001|NOT COMPLETED|Overall Study||14
2834592|NCT01854385|3536355|FG000|STARTED|Pre-Treatment||40
2834593|NCT01854385|3536355|FG000|COMPLETED|Pre-Treatment||17
2834594|NCT01854385|3536355|FG000|NOT COMPLETED|Pre-Treatment||23
2834595|NCT01854385|3536355|FG000|STARTED|Treatment||17
2834596|NCT01854385|3536355|FG000|COMPLETED|Treatment||16
2834597|NCT01854385|3536355|FG000|NOT COMPLETED|Treatment||1
2834598|NCT01844856|3536361|FG000|STARTED|Overall Study||270
2834599|NCT01844856|3536362|FG001|STARTED|Overall Study||271
2834600|NCT01844856|3536361|FG000|Received at Least 1 Dose of Study Drug|Overall Study||270
2834601|NCT01844856|3536362|FG001|Received at Least 1 Dose of Study Drug|Overall Study||268
2834602|NCT01844856|3536361|FG000|COMPLETED|Overall Study||246
2834603|NCT01844856|3536362|FG001|COMPLETED|Overall Study||255
2834604|NCT01844856|3536361|FG000|NOT COMPLETED|Overall Study||24
2834605|NCT01844856|3536362|FG001|NOT COMPLETED|Overall Study||16
2834606|NCT01788306|3536370|FG000|STARTED|Overall Study||125
2834607|NCT01788306|3536371|FG001|STARTED|Overall Study||131
2834608|NCT01788306|3536370|FG000|COMPLETED|Overall Study||115
2834609|NCT01788306|3536371|FG001|COMPLETED|Overall Study||126
2834610|NCT01788306|3536370|FG000|NOT COMPLETED|Overall Study||10
2834611|NCT01788306|3536371|FG001|NOT COMPLETED|Overall Study||5
2834612|NCT01776723|3536388|FG000|STARTED|Overall Study||6
2834613|NCT01776723|3536389|FG001|STARTED|Overall Study||4
2834614|NCT01776723|3536390|FG002|STARTED|Overall Study||5
2834615|NCT01776723|3536391|FG003|STARTED|Overall Study||5
2834616|NCT01776723|3536392|FG004|STARTED|Overall Study||30
2834617|NCT01776723|3536388|FG000|COMPLETED|Overall Study||6
2834618|NCT01776723|3536389|FG001|COMPLETED|Overall Study||4
2834619|NCT01776723|3536390|FG002|COMPLETED|Overall Study||5
2834620|NCT01776723|3536391|FG003|COMPLETED|Overall Study||5
2834621|NCT01776723|3536392|FG004|COMPLETED|Overall Study||30
2834622|NCT01776723|3536388|FG000|NOT COMPLETED|Overall Study||0
2834623|NCT01776723|3536389|FG001|NOT COMPLETED|Overall Study||0
2834624|NCT01776723|3536390|FG002|NOT COMPLETED|Overall Study||0
2834625|NCT01776723|3536391|FG003|NOT COMPLETED|Overall Study||0
2834626|NCT01776723|3536392|FG004|NOT COMPLETED|Overall Study||0
2834627|NCT01744041|3536410|FG000|STARTED|Overall Study||21
2834628|NCT01744041|3536411|FG001|STARTED|Overall Study||21
2834629|NCT01744041|3536410|FG000|COMPLETED|Overall Study||15
2834630|NCT01744041|3536411|FG001|COMPLETED|Overall Study||13
2834631|NCT01744041|3536410|FG000|NOT COMPLETED|Overall Study||6
2834632|NCT01744041|3536411|FG001|NOT COMPLETED|Overall Study||8
2834633|NCT01733147|3536419|FG000|STARTED|Overall Study||30
3167133|NCT01908127|3894277|FG001|STARTED|Overall Study||23
2834634|NCT01733147|3536420|FG001|STARTED|Overall Study||30
2834635|NCT01733147|3536419|FG000|COMPLETED|Overall Study||30
2834636|NCT01733147|3536420|FG001|COMPLETED|Overall Study||30
2834637|NCT01733147|3536419|FG000|NOT COMPLETED|Overall Study||0
2834638|NCT01733147|3536420|FG001|NOT COMPLETED|Overall Study||0
2834639|NCT01712789|3536426|FG000|STARTED|Overall Study||682
2834640|NCT01712789|3536426|FG000|Received Study Treatment|Overall Study||676
2834641|NCT01712789|3536426|FG000|COMPLETED|Overall Study||0
2834642|NCT01712789|3536426|FG000|NOT COMPLETED|Overall Study||682
2834643|NCT01660451|3536433|FG000|STARTED|Overall Study||33
2834644|NCT01660451|3536434|FG001|STARTED|Overall Study||51
2834645|NCT01660451|3536435|FG002|STARTED|Overall Study||142
2834646|NCT01660451|3536433|FG000|COMPLETED|Overall Study||16
2834647|NCT01660451|3536434|FG001|COMPLETED|Overall Study||34
2834648|NCT01660451|3536435|FG002|COMPLETED|Overall Study||37
2834649|NCT01660451|3536433|FG000|NOT COMPLETED|Overall Study||17
2834650|NCT01660451|3536434|FG001|NOT COMPLETED|Overall Study||17
2834651|NCT01660451|3536435|FG002|NOT COMPLETED|Overall Study||105
2834652|NCT01651403|3536446|FG000|STARTED|Double-Blind Period (Through Week 48/72)||60
2834653|NCT01651403|3536447|FG001|STARTED|Double-Blind Period (Through Week 48/72)||30
2834654|NCT01651403|3536446|FG000|COMPLETED|Double-Blind Period (Through Week 48/72)||56
2834655|NCT01651403|3536447|FG001|COMPLETED|Double-Blind Period (Through Week 48/72)||25
2834656|NCT01651403|3536446|FG000|NOT COMPLETED|Double-Blind Period (Through Week 48/72)||4
2834657|NCT01651403|3536447|FG001|NOT COMPLETED|Double-Blind Period (Through Week 48/72)||5
2834658|NCT01651403|3536446|FG000|STARTED|Open-Label Phase (Weeks 49/73-192)||56
2834659|NCT01651403|3536447|FG001|STARTED|Open-Label Phase (Weeks 49/73-192)||25
2834660|NCT01651403|3536446|FG000|COMPLETED|Open-Label Phase (Weeks 49/73-192)||35
2834661|NCT01651403|3536447|FG001|COMPLETED|Open-Label Phase (Weeks 49/73-192)||11
2834662|NCT01651403|3536446|FG000|NOT COMPLETED|Open-Label Phase (Weeks 49/73-192)||21
2834663|NCT01651403|3536447|FG001|NOT COMPLETED|Open-Label Phase (Weeks 49/73-192)||14
2834664|NCT01543633|3536458|FG000|STARTED|Overall Study||36
2834665|NCT01543633|3536458|FG000|COMPLETED|Overall Study||17
2834666|NCT01543633|3536458|FG000|NOT COMPLETED|Overall Study||19
2834667|NCT01542736|3536462|FG000|STARTED|Overall Study||8
2834668|NCT01542736|3536462|FG000|COMPLETED|Overall Study||7
2834669|NCT01542736|3536462|FG000|NOT COMPLETED|Overall Study||1
2914702|NCT00505895|3624886|FG000|COMPLETED|Overall Study||27
2914703|NCT00505895|3624887|FG001|COMPLETED|Overall Study||23
2914704|NCT00505895|3624886|FG000|NOT COMPLETED|Overall Study||0
2914705|NCT00505895|3624887|FG001|NOT COMPLETED|Overall Study||0
2914706|NCT00505921|3624893|FG000|STARTED|Overall Study||27
2914707|NCT00505921|3624893|FG000|COMPLETED|Overall Study||18
2914708|NCT00505921|3624893|FG000|NOT COMPLETED|Overall Study||9
2914709|NCT00505934|3624897|FG000|STARTED|Overall Study|Of the 23 subjects screened, 19 were enrolled into the study and received levetiracetam IV (LEV IV).|19
2914710|NCT00505934|3624897|FG000|COMPLETED|Overall Study||16
2914711|NCT00505934|3624897|FG000|NOT COMPLETED|Overall Study||3
2914712|NCT00506025|3624904|FG000|STARTED|Overall Study||10
2914713|NCT00506025|3624905|FG001|STARTED|Overall Study||9
2914714|NCT00506025|3624906|FG002|STARTED|Overall Study||8
2914715|NCT00506025|3624904|FG000|COMPLETED|Overall Study||10
2914716|NCT00506025|3624905|FG001|COMPLETED|Overall Study||9
2914717|NCT00506025|3624906|FG002|COMPLETED|Overall Study||8
2914718|NCT00506025|3624904|FG000|NOT COMPLETED|Overall Study||0
2914719|NCT00506025|3624905|FG001|NOT COMPLETED|Overall Study||0
2914720|NCT00506025|3624906|FG002|NOT COMPLETED|Overall Study||0
2914721|NCT00506077|3624916|FG000|STARTED|Treatment Period 1||28
2914722|NCT00506077|3624917|FG001|STARTED|Treatment Period 1||27
2914723|NCT00506077|3624916|FG000|COMPLETED|Treatment Period 1||24
2914724|NCT00506077|3624917|FG001|COMPLETED|Treatment Period 1||24
2914725|NCT00506077|3624916|FG000|NOT COMPLETED|Treatment Period 1||4
2914726|NCT00506077|3624917|FG001|NOT COMPLETED|Treatment Period 1||3
2914727|NCT00506077|3624916|FG000|STARTED|Washout||24
2914728|NCT00506077|3624917|FG001|STARTED|Washout||24
2914729|NCT00506077|3624916|FG000|COMPLETED|Washout||24
2914730|NCT00506077|3624917|FG001|COMPLETED|Washout||24
2914731|NCT00506077|3624916|FG000|NOT COMPLETED|Washout||0
2914732|NCT00506077|3624917|FG001|NOT COMPLETED|Washout||0
2914733|NCT00506077|3624916|FG000|STARTED|Treatment Period 2||24
2914734|NCT00506077|3624917|FG001|STARTED|Treatment Period 2||24
2914735|NCT00506077|3624916|FG000|COMPLETED|Treatment Period 2||23
2914736|NCT00506077|3624917|FG001|COMPLETED|Treatment Period 2||23
2914737|NCT00506077|3624916|FG000|NOT COMPLETED|Treatment Period 2||1
2914738|NCT00506077|3624917|FG001|NOT COMPLETED|Treatment Period 2||1
2914739|NCT00506129|3624923|FG000|STARTED|Overall Study||33
2914740|NCT00506129|3624923|FG000|COMPLETED|Overall Study||11
2914741|NCT00506129|3624923|FG000|NOT COMPLETED|Overall Study||22
2914742|NCT00506142|3624929|FG000|STARTED|Overall Study||35
2914743|NCT00506142|3624930|FG001|STARTED|Overall Study||19
2914744|NCT00506142|3624929|FG000|COMPLETED|Overall Study||0
2914745|NCT00506142|3624930|FG001|COMPLETED|Overall Study||0
2914746|NCT00506142|3624929|FG000|NOT COMPLETED|Overall Study||35
2914747|NCT00506142|3624930|FG001|NOT COMPLETED|Overall Study||19
2914748|NCT00506155|3624936|FG000|STARTED|Overall Study||60
2914749|NCT00506155|3624936|FG000|COMPLETED|Overall Study||60
2914750|NCT00506155|3624936|FG000|NOT COMPLETED|Overall Study||0
2914751|NCT00506285|3624942|FG000|STARTED|3 Week Screening Phase||46
2914752|NCT00506285|3624943|FG001|STARTED|3 Week Screening Phase||46
2914753|NCT00506285|3624942|FG000|COMPLETED|3 Week Screening Phase||29
2834670|NCT01535807|3536468|FG000|STARTED|Overall Study||22
2834671|NCT01535807|3536469|FG001|STARTED|Overall Study||22
2834672|NCT01535807|3536468|FG000|COMPLETED|Overall Study||20
2834673|NCT01535807|3536469|FG001|COMPLETED|Overall Study||20
2834674|NCT01535807|3536468|FG000|NOT COMPLETED|Overall Study||2
2834675|NCT01535807|3536469|FG001|NOT COMPLETED|Overall Study||2
2834676|NCT01147666|3536490|FG000|STARTED|Dosing Period 1: 6-Week Treatment||12
2834677|NCT01147666|3536491|FG001|STARTED|Dosing Period 1: 6-Week Treatment||12
2834678|NCT01147666|3536492|FG002|STARTED|Dosing Period 1: 6-Week Treatment||12
2834679|NCT01147666|3536493|FG003|STARTED|Dosing Period 1: 6-Week Treatment||12
2834680|NCT01147666|3536494|FG004|STARTED|Dosing Period 1: 6-Week Treatment||12
2834681|NCT01147666|3536495|FG005|STARTED|Dosing Period 1: 6-Week Treatment||12
2834682|NCT01147666|3536496|FG006|STARTED|Dosing Period 1: 6-Week Treatment||12
2834683|NCT01147666|3536497|FG007|STARTED|Dosing Period 1: 6-Week Treatment||12
2834684|NCT01147666|3536498|FG008|STARTED|Dosing Period 1: 6-Week Treatment||2
2834685|NCT01147666|3536499|FG009|STARTED|Dosing Period 1: 6-Week Treatment||10
2834686|NCT01147666|3536500|FG010|STARTED|Dosing Period 1: 6-Week Treatment||36
2834687|NCT01147666|3536501|FG011|STARTED|Dosing Period 1: 6-Week Treatment||4
2834688|NCT01147666|3536502|FG012|STARTED|Dosing Period 1: 6-Week Treatment||5
2834689|NCT01147666|3536503|FG013|STARTED|Dosing Period 1: 6-Week Treatment||4
2834690|NCT01147666|3536504|FG014|STARTED|Dosing Period 1: 6-Week Treatment||4
2834691|NCT01147666|3536490|FG000|Received at Least 1 Dose of Study Drug|Dosing Period 1: 6-Week Treatment||12
2834692|NCT01147666|3536491|FG001|Received at Least 1 Dose of Study Drug|Dosing Period 1: 6-Week Treatment||12
2834693|NCT01147666|3536492|FG002|Received at Least 1 Dose of Study Drug|Dosing Period 1: 6-Week Treatment||12
2834694|NCT01147666|3536493|FG003|Received at Least 1 Dose of Study Drug|Dosing Period 1: 6-Week Treatment||12
2834695|NCT01147666|3536494|FG004|Received at Least 1 Dose of Study Drug|Dosing Period 1: 6-Week Treatment||12
2834696|NCT01147666|3536495|FG005|Received at Least 1 Dose of Study Drug|Dosing Period 1: 6-Week Treatment||12
2834697|NCT01147666|3536496|FG006|Received at Least 1 Dose of Study Drug|Dosing Period 1: 6-Week Treatment||12
2834698|NCT01147666|3536497|FG007|Received at Least 1 Dose of Study Drug|Dosing Period 1: 6-Week Treatment||12
2834699|NCT01147666|3536498|FG008|Received at Least 1 Dose of Study Drug|Dosing Period 1: 6-Week Treatment||2
2834700|NCT01147666|3536499|FG009|Received at Least 1 Dose of Study Drug|Dosing Period 1: 6-Week Treatment||10
2834701|NCT01147666|3536500|FG010|Received at Least 1 Dose of Study Drug|Dosing Period 1: 6-Week Treatment||36
2834702|NCT01147666|3536501|FG011|Received at Least 1 Dose of Study Drug|Dosing Period 1: 6-Week Treatment||4
2834703|NCT01147666|3536502|FG012|Received at Least 1 Dose of Study Drug|Dosing Period 1: 6-Week Treatment||5
2834704|NCT01147666|3536503|FG013|Received at Least 1 Dose of Study Drug|Dosing Period 1: 6-Week Treatment||4
2834705|NCT01147666|3536504|FG014|Received at Least 1 Dose of Study Drug|Dosing Period 1: 6-Week Treatment||4
2834706|NCT01147666|3536490|FG000|Efficacy Evaluable (EE) Population|Dosing Period 1: 6-Week Treatment||9
2834707|NCT01147666|3536491|FG001|Efficacy Evaluable (EE) Population|Dosing Period 1: 6-Week Treatment||10
2834708|NCT01147666|3536492|FG002|Efficacy Evaluable (EE) Population|Dosing Period 1: 6-Week Treatment||9
2834709|NCT01147666|3536493|FG003|Efficacy Evaluable (EE) Population|Dosing Period 1: 6-Week Treatment||11
2834710|NCT01147666|3536494|FG004|Efficacy Evaluable (EE) Population|Dosing Period 1: 6-Week Treatment||11
2834711|NCT01147666|3536495|FG005|Efficacy Evaluable (EE) Population|Dosing Period 1: 6-Week Treatment||11
2834712|NCT01147666|3536496|FG006|Efficacy Evaluable (EE) Population|Dosing Period 1: 6-Week Treatment||11
2834713|NCT01147666|3536497|FG007|Efficacy Evaluable (EE) Population|Dosing Period 1: 6-Week Treatment||10
2834714|NCT01147666|3536498|FG008|Efficacy Evaluable (EE) Population|Dosing Period 1: 6-Week Treatment||2
2834715|NCT01147666|3536499|FG009|Efficacy Evaluable (EE) Population|Dosing Period 1: 6-Week Treatment||10
2834716|NCT01147666|3536500|FG010|Efficacy Evaluable (EE) Population|Dosing Period 1: 6-Week Treatment||31
2834717|NCT01147666|3536501|FG011|Efficacy Evaluable (EE) Population|Dosing Period 1: 6-Week Treatment||1
2834718|NCT01147666|3536502|FG012|Efficacy Evaluable (EE) Population|Dosing Period 1: 6-Week Treatment||3
2834719|NCT01147666|3536503|FG013|Efficacy Evaluable (EE) Population|Dosing Period 1: 6-Week Treatment||4
2834720|NCT01147666|3536504|FG014|Efficacy Evaluable (EE) Population|Dosing Period 1: 6-Week Treatment||3
2834721|NCT01147666|3536490|FG000|COMPLETED|Dosing Period 1: 6-Week Treatment||10
2834722|NCT01147666|3536491|FG001|COMPLETED|Dosing Period 1: 6-Week Treatment||10
2834723|NCT01147666|3536492|FG002|COMPLETED|Dosing Period 1: 6-Week Treatment||11
2834724|NCT01147666|3536493|FG003|COMPLETED|Dosing Period 1: 6-Week Treatment||10
2834725|NCT01147666|3536494|FG004|COMPLETED|Dosing Period 1: 6-Week Treatment||7
2834726|NCT01147666|3536495|FG005|COMPLETED|Dosing Period 1: 6-Week Treatment||9
2834727|NCT01147666|3536496|FG006|COMPLETED|Dosing Period 1: 6-Week Treatment||9
2834728|NCT01147666|3536497|FG007|COMPLETED|Dosing Period 1: 6-Week Treatment||9
2834729|NCT01147666|3536498|FG008|COMPLETED|Dosing Period 1: 6-Week Treatment||2
2834730|NCT01147666|3536499|FG009|COMPLETED|Dosing Period 1: 6-Week Treatment||8
2834731|NCT01147666|3536500|FG010|COMPLETED|Dosing Period 1: 6-Week Treatment||33
2834732|NCT01147666|3536501|FG011|COMPLETED|Dosing Period 1: 6-Week Treatment||2
2834733|NCT01147666|3536502|FG012|COMPLETED|Dosing Period 1: 6-Week Treatment||1
2834734|NCT01147666|3536503|FG013|COMPLETED|Dosing Period 1: 6-Week Treatment||3
2834735|NCT01147666|3536504|FG014|COMPLETED|Dosing Period 1: 6-Week Treatment||0
2834736|NCT01147666|3536490|FG000|NOT COMPLETED|Dosing Period 1: 6-Week Treatment||2
2834737|NCT01147666|3536491|FG001|NOT COMPLETED|Dosing Period 1: 6-Week Treatment||2
2834738|NCT01147666|3536492|FG002|NOT COMPLETED|Dosing Period 1: 6-Week Treatment||1
2834739|NCT01147666|3536493|FG003|NOT COMPLETED|Dosing Period 1: 6-Week Treatment||2
2834740|NCT01147666|3536494|FG004|NOT COMPLETED|Dosing Period 1: 6-Week Treatment||5
2834741|NCT01147666|3536495|FG005|NOT COMPLETED|Dosing Period 1: 6-Week Treatment||3
2834742|NCT01147666|3536496|FG006|NOT COMPLETED|Dosing Period 1: 6-Week Treatment||3
2834743|NCT01147666|3536497|FG007|NOT COMPLETED|Dosing Period 1: 6-Week Treatment||3
2834744|NCT01147666|3536498|FG008|NOT COMPLETED|Dosing Period 1: 6-Week Treatment||0
2834745|NCT01147666|3536499|FG009|NOT COMPLETED|Dosing Period 1: 6-Week Treatment||2
3167134|NCT01908127|3894276|FG000|COMPLETED|Overall Study||22
3167135|NCT01908127|3894277|FG001|COMPLETED|Overall Study||23
2834746|NCT01147666|3536500|FG010|NOT COMPLETED|Dosing Period 1: 6-Week Treatment||3
2834747|NCT01147666|3536501|FG011|NOT COMPLETED|Dosing Period 1: 6-Week Treatment||2
2834748|NCT01147666|3536502|FG012|NOT COMPLETED|Dosing Period 1: 6-Week Treatment||4
2834749|NCT01147666|3536503|FG013|NOT COMPLETED|Dosing Period 1: 6-Week Treatment||1
2834750|NCT01147666|3536504|FG014|NOT COMPLETED|Dosing Period 1: 6-Week Treatment||4
2834751|NCT01147666|3536490|FG000|STARTED|Dosing Period 2: 19-Week Treatment||0
2834752|NCT01147666|3536491|FG001|STARTED|Dosing Period 2: 19-Week Treatment||0
2834753|NCT01147666|3536492|FG002|STARTED|Dosing Period 2: 19-Week Treatment||0
2834754|NCT01147666|3536493|FG003|STARTED|Dosing Period 2: 19-Week Treatment||7
2834755|NCT01147666|3536494|FG004|STARTED|Dosing Period 2: 19-Week Treatment||12
2834756|NCT01147666|3536495|FG005|STARTED|Dosing Period 2: 19-Week Treatment||12
2834757|NCT01147666|3536496|FG006|STARTED|Dosing Period 2: 19-Week Treatment||12
2834758|NCT01147666|3536497|FG007|STARTED|Dosing Period 2: 19-Week Treatment||12
2834759|NCT01147666|3536498|FG008|STARTED|Dosing Period 2: 19-Week Treatment||2
2834760|NCT01147666|3536499|FG009|STARTED|Dosing Period 2: 19-Week Treatment||10
2834761|NCT01147666|3536500|FG010|STARTED|Dosing Period 2: 19-Week Treatment||23
2834762|NCT01147666|3536501|FG011|STARTED|Dosing Period 2: 19-Week Treatment||0
2834763|NCT01147666|3536502|FG012|STARTED|Dosing Period 2: 19-Week Treatment||5
2834764|NCT01147666|3536503|FG013|STARTED|Dosing Period 2: 19-Week Treatment||3
2834765|NCT01147666|3536504|FG014|STARTED|Dosing Period 2: 19-Week Treatment||3
2834766|NCT01147666|3536490|FG000|Received at Least 1 Dose of Study Drug|Dosing Period 2: 19-Week Treatment||0
2834767|NCT01147666|3536491|FG001|Received at Least 1 Dose of Study Drug|Dosing Period 2: 19-Week Treatment||0
2834768|NCT01147666|3536492|FG002|Received at Least 1 Dose of Study Drug|Dosing Period 2: 19-Week Treatment||0
2834769|NCT01147666|3536493|FG003|Received at Least 1 Dose of Study Drug|Dosing Period 2: 19-Week Treatment||7
2834770|NCT01147666|3536494|FG004|Received at Least 1 Dose of Study Drug|Dosing Period 2: 19-Week Treatment||12
2834771|NCT01147666|3536495|FG005|Received at Least 1 Dose of Study Drug|Dosing Period 2: 19-Week Treatment||12
2834772|NCT01147666|3536496|FG006|Received at Least 1 Dose of Study Drug|Dosing Period 2: 19-Week Treatment||12
2834773|NCT01147666|3536497|FG007|Received at Least 1 Dose of Study Drug|Dosing Period 2: 19-Week Treatment||12
2834774|NCT01147666|3536498|FG008|Received at Least 1 Dose of Study Drug|Dosing Period 2: 19-Week Treatment||2
2834775|NCT01147666|3536499|FG009|Received at Least 1 Dose of Study Drug|Dosing Period 2: 19-Week Treatment||10
2834776|NCT01147666|3536500|FG010|Received at Least 1 Dose of Study Drug|Dosing Period 2: 19-Week Treatment||23
2834777|NCT01147666|3536501|FG011|Received at Least 1 Dose of Study Drug|Dosing Period 2: 19-Week Treatment||0
2834778|NCT01147666|3536502|FG012|Received at Least 1 Dose of Study Drug|Dosing Period 2: 19-Week Treatment||5
2834779|NCT01147666|3536503|FG013|Received at Least 1 Dose of Study Drug|Dosing Period 2: 19-Week Treatment||3
2834780|NCT01147666|3536504|FG014|Received at Least 1 Dose of Study Drug|Dosing Period 2: 19-Week Treatment||3
2834781|NCT01147666|3536490|FG000|EE Population for 19-week Treatment|Dosing Period 2: 19-Week Treatment||0
2834782|NCT01147666|3536491|FG001|EE Population for 19-week Treatment|Dosing Period 2: 19-Week Treatment||0
2834783|NCT01147666|3536492|FG002|EE Population for 19-week Treatment|Dosing Period 2: 19-Week Treatment||0
2834784|NCT01147666|3536493|FG003|EE Population for 19-week Treatment|Dosing Period 2: 19-Week Treatment||6
2834785|NCT01147666|3536494|FG004|EE Population for 19-week Treatment|Dosing Period 2: 19-Week Treatment||11
2834786|NCT01147666|3536495|FG005|EE Population for 19-week Treatment|Dosing Period 2: 19-Week Treatment||11
2834787|NCT01147666|3536496|FG006|EE Population for 19-week Treatment|Dosing Period 2: 19-Week Treatment||11
2834788|NCT01147666|3536497|FG007|EE Population for 19-week Treatment|Dosing Period 2: 19-Week Treatment||10
2834789|NCT01147666|3536498|FG008|EE Population for 19-week Treatment|Dosing Period 2: 19-Week Treatment||2
2834790|NCT01147666|3536499|FG009|EE Population for 19-week Treatment|Dosing Period 2: 19-Week Treatment||10
2834791|NCT01147666|3536500|FG010|EE Population for 19-week Treatment|Dosing Period 2: 19-Week Treatment||22
2834792|NCT01147666|3536501|FG011|EE Population for 19-week Treatment|Dosing Period 2: 19-Week Treatment||0
2834793|NCT01147666|3536502|FG012|EE Population for 19-week Treatment|Dosing Period 2: 19-Week Treatment||3
2834794|NCT01147666|3536503|FG013|EE Population for 19-week Treatment|Dosing Period 2: 19-Week Treatment||3
2834795|NCT01147666|3536504|FG014|EE Population for 19-week Treatment|Dosing Period 2: 19-Week Treatment||2
2834796|NCT01147666|3536490|FG000|COMPLETED|Dosing Period 2: 19-Week Treatment||0
2834797|NCT01147666|3536491|FG001|COMPLETED|Dosing Period 2: 19-Week Treatment||0
2834798|NCT01147666|3536492|FG002|COMPLETED|Dosing Period 2: 19-Week Treatment||0
2834799|NCT01147666|3536493|FG003|COMPLETED|Dosing Period 2: 19-Week Treatment||5
2834800|NCT01147666|3536494|FG004|COMPLETED|Dosing Period 2: 19-Week Treatment||7
2834801|NCT01147666|3536495|FG005|COMPLETED|Dosing Period 2: 19-Week Treatment||9
2834802|NCT01147666|3536496|FG006|COMPLETED|Dosing Period 2: 19-Week Treatment||9
2834803|NCT01147666|3536497|FG007|COMPLETED|Dosing Period 2: 19-Week Treatment||9
2834804|NCT01147666|3536498|FG008|COMPLETED|Dosing Period 2: 19-Week Treatment||2
2834805|NCT01147666|3536499|FG009|COMPLETED|Dosing Period 2: 19-Week Treatment||8
2834806|NCT01147666|3536500|FG010|COMPLETED|Dosing Period 2: 19-Week Treatment||21
2834807|NCT01147666|3536501|FG011|COMPLETED|Dosing Period 2: 19-Week Treatment||0
2834808|NCT01147666|3536502|FG012|COMPLETED|Dosing Period 2: 19-Week Treatment||1
2834809|NCT01147666|3536503|FG013|COMPLETED|Dosing Period 2: 19-Week Treatment||2
2834810|NCT01147666|3536504|FG014|COMPLETED|Dosing Period 2: 19-Week Treatment||0
2834811|NCT01147666|3536490|FG000|NOT COMPLETED|Dosing Period 2: 19-Week Treatment||0
2834812|NCT01147666|3536491|FG001|NOT COMPLETED|Dosing Period 2: 19-Week Treatment||0
2834813|NCT01147666|3536492|FG002|NOT COMPLETED|Dosing Period 2: 19-Week Treatment||0
2834814|NCT01147666|3536493|FG003|NOT COMPLETED|Dosing Period 2: 19-Week Treatment||2
2834815|NCT01147666|3536494|FG004|NOT COMPLETED|Dosing Period 2: 19-Week Treatment||5
2834816|NCT01147666|3536495|FG005|NOT COMPLETED|Dosing Period 2: 19-Week Treatment||3
2834817|NCT01147666|3536496|FG006|NOT COMPLETED|Dosing Period 2: 19-Week Treatment||3
2834818|NCT01147666|3536497|FG007|NOT COMPLETED|Dosing Period 2: 19-Week Treatment||3
2834819|NCT01147666|3536498|FG008|NOT COMPLETED|Dosing Period 2: 19-Week Treatment||0
2834820|NCT01147666|3536499|FG009|NOT COMPLETED|Dosing Period 2: 19-Week Treatment||2
2834821|NCT01147666|3536500|FG010|NOT COMPLETED|Dosing Period 2: 19-Week Treatment||2
2834822|NCT01147666|3536501|FG011|NOT COMPLETED|Dosing Period 2: 19-Week Treatment||0
2834823|NCT01147666|3536502|FG012|NOT COMPLETED|Dosing Period 2: 19-Week Treatment||4
2834824|NCT01147666|3536503|FG013|NOT COMPLETED|Dosing Period 2: 19-Week Treatment||1
2834825|NCT01147666|3536504|FG014|NOT COMPLETED|Dosing Period 2: 19-Week Treatment||3
2834826|NCT01065454|3536570|FG000|STARTED|Treatment||67
2834827|NCT01065454|3536571|FG001|STARTED|Treatment||33
2834828|NCT01065454|3536572|FG002|STARTED|Treatment||32
2834829|NCT01065454|3536573|FG003|STARTED|Treatment||69
2834830|NCT01065454|3536570|FG000|COMPLETED|Treatment||54
2834831|NCT01065454|3536571|FG001|COMPLETED|Treatment||28
2834832|NCT01065454|3536572|FG002|COMPLETED|Treatment||23
2834833|NCT01065454|3536573|FG003|COMPLETED|Treatment||57
2834834|NCT01065454|3536570|FG000|NOT COMPLETED|Treatment||13
2834835|NCT01065454|3536571|FG001|NOT COMPLETED|Treatment||5
2834836|NCT01065454|3536572|FG002|NOT COMPLETED|Treatment||9
2834837|NCT01065454|3536573|FG003|NOT COMPLETED|Treatment||12
2834838|NCT01065454|3536570|FG000|STARTED|Follow up||54
2834839|NCT01065454|3536571|FG001|STARTED|Follow up||28
2834840|NCT01065454|3536572|FG002|STARTED|Follow up||23
2834841|NCT01065454|3536573|FG003|STARTED|Follow up||57
2834842|NCT01065454|3536570|FG000|Entering Follow-up|Follow up||49
2834843|NCT01065454|3536571|FG001|Entering Follow-up|Follow up||27
2834844|NCT01065454|3536572|FG002|Entering Follow-up|Follow up||23
2834845|NCT01065454|3536573|FG003|Entering Follow-up|Follow up||51
2834846|NCT01065454|3536570|FG000|COMPLETED|Follow up||15
2834847|NCT01065454|3536571|FG001|COMPLETED|Follow up||4
2834848|NCT01065454|3536572|FG002|COMPLETED|Follow up||6
2834849|NCT01065454|3536573|FG003|COMPLETED|Follow up||13
2834850|NCT01065454|3536570|FG000|NOT COMPLETED|Follow up||39
2834851|NCT01065454|3536571|FG001|NOT COMPLETED|Follow up||24
2834852|NCT01065454|3536572|FG002|NOT COMPLETED|Follow up||17
2834853|NCT01065454|3536573|FG003|NOT COMPLETED|Follow up||44
2834854|NCT00982111|3536585|FG000|STARTED|Overall Study||315
2834855|NCT00982111|3536586|FG001|STARTED|Overall Study||318
2834856|NCT00982111|3536585|FG000|Received at Least 1 Dose of Study Drug|Overall Study||304
2834857|NCT00982111|3536586|FG001|Received at Least 1 Dose of Study Drug|Overall Study||312
2834858|NCT00982111|3536585|FG000|Death Due to Any Cause|Overall Study||236
2834859|NCT00982111|3536586|FG001|Death Due to Any Cause|Overall Study||246
2834860|NCT00982111|3536585|FG000|COMPLETED|Overall Study||236
2834861|NCT00982111|3536586|FG001|COMPLETED|Overall Study||246
2834862|NCT00982111|3536585|FG000|NOT COMPLETED|Overall Study||79
2834863|NCT00982111|3536586|FG001|NOT COMPLETED|Overall Study||72
2834864|NCT00193219|3536593|FG000|STARTED|Overall Study||36
2834865|NCT00193219|3536593|FG000|COMPLETED|Overall Study||6
2834866|NCT00193219|3536593|FG000|NOT COMPLETED|Overall Study||30
2834867|NCT00116142|3536600|FG000|STARTED|Overall Study||175
2834868|NCT00116142|3536601|FG001|STARTED|Overall Study||175
2834869|NCT00116142|3536600|FG000|Treated|Overall Study||174
2834870|NCT00116142|3536601|FG001|Treated|Overall Study||171
2834871|NCT00116142|3536600|FG000|COMPLETED|Overall Study||156
2834872|NCT00116142|3536601|FG001|COMPLETED|Overall Study||155
2834873|NCT00116142|3536600|FG000|NOT COMPLETED|Overall Study||19
2834874|NCT00116142|3536601|FG001|NOT COMPLETED|Overall Study||20
2834875|NCT00070018|3536610|FG000|STARTED|Overall Study||46
2834876|NCT00070018|3536610|FG000|Eligible|Overall Study||46
3311414|NCT03052426|4044918|FG001|NOT COMPLETED|Overall Study||1
3311415|NCT03052426|4044919|FG002|NOT COMPLETED|Overall Study||1
3311416|NCT03052517|4044935|FG000|STARTED|Overall Study||1093
3311417|NCT03052517|4044936|FG001|STARTED|Overall Study||1085
2834877|NCT00070018|3536610|FG000|Eligible and Began Protocol Therapy|Overall Study||46
2834878|NCT00070018|3536610|FG000|COMPLETED|Overall Study||42
2834879|NCT00070018|3536610|FG000|NOT COMPLETED|Overall Study||4
2914754|NCT00506285|3624943|FG001|COMPLETED|3 Week Screening Phase||36
2914755|NCT00506285|3624942|FG000|NOT COMPLETED|3 Week Screening Phase||17
2914756|NCT00506285|3624943|FG001|NOT COMPLETED|3 Week Screening Phase||10
2914757|NCT00506285|3624942|FG000|STARTED|Double Blind Cross-Over Phase||29
2914758|NCT00506285|3624943|FG001|STARTED|Double Blind Cross-Over Phase||36
3311418|NCT03052517|4044937|FG002|STARTED|Overall Study||360
3311419|NCT03052517|4044935|FG000|Safety Set (SAF)|Overall Study|One patient received placebo. This patient was not included in QAW039 150 mg group in the SAF|1092
2914759|NCT00506285|3624942|FG000|Received at Least 1 Dose MTS|Double Blind Cross-Over Phase||29
3167136|NCT01908127|3894276|FG000|NOT COMPLETED|Overall Study||1
3167137|NCT01908127|3894277|FG001|NOT COMPLETED|Overall Study||0
3167138|NCT01908140|3894285|FG000|STARTED|Overall Study||468
2834880|NCT04631796|3536614|FG000|STARTED|Overall Study||35
2834881|NCT04631796|3536614|FG000|COMPLETED|Overall Study||35
2834882|NCT04631796|3536614|FG000|NOT COMPLETED|Overall Study||0
2834883|NCT04447287|3536623|FG000|STARTED|Period 1: Run-in Period||23
2834884|NCT04447287|3536624|FG001|STARTED|Period 1: Run-in Period||0
2834885|NCT04447287|3536625|FG002|STARTED|Period 1: Run-in Period||0
2834886|NCT04447287|3536623|FG000|COMPLETED|Period 1: Run-in Period||19
2834887|NCT04447287|3536624|FG001|COMPLETED|Period 1: Run-in Period||0
2834888|NCT04447287|3536625|FG002|COMPLETED|Period 1: Run-in Period||0
2834889|NCT04447287|3536623|FG000|NOT COMPLETED|Period 1: Run-in Period||4
2834890|NCT04447287|3536624|FG001|NOT COMPLETED|Period 1: Run-in Period||0
2834891|NCT04447287|3536625|FG002|NOT COMPLETED|Period 1: Run-in Period||0
2834892|NCT04447287|3536623|FG000|STARTED|Period 2: Investigational Period||1
2834893|NCT04447287|3536624|FG001|STARTED|Period 2: Investigational Period||12
2834894|NCT04447287|3536625|FG002|STARTED|Period 2: Investigational Period||6
2834895|NCT04447287|3536623|FG000|COMPLETED|Period 2: Investigational Period||0
2834896|NCT04447287|3536624|FG001|COMPLETED|Period 2: Investigational Period||12
2834897|NCT04447287|3536625|FG002|COMPLETED|Period 2: Investigational Period||6
2834898|NCT04447287|3536623|FG000|NOT COMPLETED|Period 2: Investigational Period||1
2834899|NCT04447287|3536624|FG001|NOT COMPLETED|Period 2: Investigational Period||0
2834900|NCT04447287|3536625|FG002|NOT COMPLETED|Period 2: Investigational Period||0
2834901|NCT04447287|3536623|FG000|STARTED|Period 3: Down-Titration Period||0
2834902|NCT04447287|3536624|FG001|STARTED|Period 3: Down-Titration Period||12
2834903|NCT04447287|3536625|FG002|STARTED|Period 3: Down-Titration Period||6
2834904|NCT04447287|3536623|FG000|COMPLETED|Period 3: Down-Titration Period||0
2834905|NCT04447287|3536624|FG001|COMPLETED|Period 3: Down-Titration Period||12
2834906|NCT04447287|3536625|FG002|COMPLETED|Period 3: Down-Titration Period||6
2834907|NCT04447287|3536623|FG000|NOT COMPLETED|Period 3: Down-Titration Period||0
2834908|NCT04447287|3536624|FG001|NOT COMPLETED|Period 3: Down-Titration Period||0
2834909|NCT04447287|3536625|FG002|NOT COMPLETED|Period 3: Down-Titration Period||0
2834910|NCT04203537|3536648|FG000|STARTED|Overall Study||6
2834911|NCT04203537|3536649|FG001|STARTED|Overall Study||6
2834912|NCT04203537|3536650|FG002|STARTED|Overall Study||6
2834913|NCT04203537|3536651|FG003|STARTED|Overall Study||6
2834914|NCT04203537|3536652|FG004|STARTED|Overall Study||54
2834915|NCT04203537|3536653|FG005|STARTED|Overall Study||55
2834916|NCT04203537|3536654|FG006|STARTED|Overall Study||60
2834917|NCT04203537|3536648|FG000|COMPLETED|Overall Study||6
2834918|NCT04203537|3536649|FG001|COMPLETED|Overall Study||6
2834919|NCT04203537|3536650|FG002|COMPLETED|Overall Study||6
2834920|NCT04203537|3536651|FG003|COMPLETED|Overall Study||6
2834921|NCT04203537|3536652|FG004|COMPLETED|Overall Study||54
2834922|NCT04203537|3536653|FG005|COMPLETED|Overall Study||55
2834923|NCT04203537|3536654|FG006|COMPLETED|Overall Study||60
2834924|NCT04203537|3536648|FG000|NOT COMPLETED|Overall Study||0
3167139|NCT01908140|3894286|FG001|STARTED|Overall Study||465
3167140|NCT01908140|3894285|FG000|COMPLETED|Overall Study||402
3167141|NCT01908140|3894286|FG001|COMPLETED|Overall Study||386
3167142|NCT01908140|3894285|FG000|NOT COMPLETED|Overall Study||66
3167143|NCT01908140|3894286|FG001|NOT COMPLETED|Overall Study||79
3167144|NCT01908205|3894294|FG000|STARTED|Overall Study||30
2834925|NCT04203537|3536649|FG001|NOT COMPLETED|Overall Study||0
2834926|NCT04203537|3536650|FG002|NOT COMPLETED|Overall Study||0
2834927|NCT04203537|3536651|FG003|NOT COMPLETED|Overall Study||0
3167145|NCT01908205|3894295|FG001|STARTED|Overall Study||30
3167146|NCT01908205|3894294|FG000|COMPLETED|Overall Study||25
3167147|NCT01908205|3894295|FG001|COMPLETED|Overall Study||29
3167148|NCT01908205|3894294|FG000|NOT COMPLETED|Overall Study||5
3167149|NCT01908205|3894295|FG001|NOT COMPLETED|Overall Study||1
2834928|NCT04203537|3536652|FG004|NOT COMPLETED|Overall Study||0
2834929|NCT04203537|3536653|FG005|NOT COMPLETED|Overall Study||0
2834930|NCT04203537|3536654|FG006|NOT COMPLETED|Overall Study||0
2834931|NCT04125745|3536664|FG000|STARTED|Overall Study||1
2834932|NCT04125745|3536664|FG000|COMPLETED|Overall Study||1
2834933|NCT04125745|3536664|FG000|NOT COMPLETED|Overall Study||0
2834934|NCT04074928|3536670|FG000|STARTED|Overall Study||1605
2834935|NCT04074928|3536671|FG001|STARTED|Overall Study||809
2834936|NCT04074928|3536670|FG000|Received Study Vaccine|Overall Study||1597
2834937|NCT04074928|3536671|FG001|Received Study Vaccine|Overall Study||805
2834938|NCT04074928|3536670|FG000|COMPLETED|Overall Study||1370
2834939|NCT04074928|3536671|FG001|COMPLETED|Overall Study||710
2834940|NCT04074928|3536670|FG000|NOT COMPLETED|Overall Study||235
2834941|NCT04074928|3536671|FG001|NOT COMPLETED|Overall Study||99
2834942|NCT04039503|3536681|FG000|STARTED|Overall Study||116
2834943|NCT04039503|3536682|FG001|STARTED|Overall Study||119
2834944|NCT04039503|3536683|FG002|STARTED|Overall Study||120
2834945|NCT04039503|3536684|FG003|STARTED|Overall Study||120
2834946|NCT04039503|3536681|FG000|Received at Least One Dose of Study Drug|Overall Study||116
2834947|NCT04039503|3536682|FG001|Received at Least One Dose of Study Drug|Overall Study||119
2834948|NCT04039503|3536683|FG002|Received at Least One Dose of Study Drug|Overall Study||120
2834949|NCT04039503|3536684|FG003|Received at Least One Dose of Study Drug|Overall Study||120
2834950|NCT04039503|3536681|FG000|COMPLETED|Overall Study||109
2834951|NCT04039503|3536682|FG001|COMPLETED|Overall Study||115
3167150|NCT01908426|3894316|FG000|STARTED|Overall Study||470
2834952|NCT04039503|3536683|FG002|COMPLETED|Overall Study||110
2834953|NCT04039503|3536684|FG003|COMPLETED|Overall Study||117
2834954|NCT04039503|3536681|FG000|NOT COMPLETED|Overall Study||7
2834955|NCT04039503|3536682|FG001|NOT COMPLETED|Overall Study||4
2834956|NCT04039503|3536683|FG002|NOT COMPLETED|Overall Study||10
2834957|NCT04039503|3536684|FG003|NOT COMPLETED|Overall Study||3
2834958|NCT03695172|3536702|FG000|STARTED|Overall Study||5
2834959|NCT03695172|3536703|FG001|STARTED|Overall Study||4
2834960|NCT03695172|3536704|FG002|STARTED|Overall Study||3
2834961|NCT03695172|3536702|FG000|COMPLETED|Overall Study||4
2834962|NCT03695172|3536703|FG001|COMPLETED|Overall Study||3
2834963|NCT03695172|3536704|FG002|COMPLETED|Overall Study||3
2834964|NCT03695172|3536702|FG000|NOT COMPLETED|Overall Study||1
2834965|NCT03695172|3536703|FG001|NOT COMPLETED|Overall Study||1
2834966|NCT03695172|3536704|FG002|NOT COMPLETED|Overall Study||0
2834967|NCT03485287|3536712|FG000|STARTED|Overall Study||4
2834968|NCT03485287|3536712|FG000|COMPLETED|Overall Study||3
2834969|NCT03485287|3536712|FG000|NOT COMPLETED|Overall Study||1
2834970|NCT03433040|3536719|FG000|STARTED|Overall Study||19
2834971|NCT03433040|3536720|FG001|STARTED|Overall Study||16
2834972|NCT03433040|3536721|FG002|STARTED|Overall Study||9
2834973|NCT03433040|3536719|FG000|COMPLETED|Overall Study||17
2834974|NCT03433040|3536720|FG001|COMPLETED|Overall Study||8
2834975|NCT03433040|3536721|FG002|COMPLETED|Overall Study||5
2834976|NCT03433040|3536719|FG000|NOT COMPLETED|Overall Study||2
2834977|NCT03433040|3536720|FG001|NOT COMPLETED|Overall Study||8
2834978|NCT03433040|3536721|FG002|NOT COMPLETED|Overall Study||4
2834979|NCT03394027|3536732|FG000|STARTED|Overall Study||10
2834980|NCT03394027|3536733|FG001|STARTED|Overall Study||6
2834981|NCT03394027|3536734|FG002|STARTED|Overall Study||14
2834982|NCT03394027|3536732|FG000|COMPLETED|Overall Study||7
2834983|NCT03394027|3536733|FG001|COMPLETED|Overall Study||5
2834984|NCT03394027|3536734|FG002|COMPLETED|Overall Study||10
2834985|NCT03394027|3536732|FG000|NOT COMPLETED|Overall Study||3
2834986|NCT03394027|3536733|FG001|NOT COMPLETED|Overall Study||1
2834987|NCT03394027|3536734|FG002|NOT COMPLETED|Overall Study||4
2834988|NCT03357952|3536762|FG000|STARTED|Overall Study||9
2834989|NCT03357952|3536763|FG001|STARTED|Overall Study||1
2834990|NCT03357952|3536762|FG000|COMPLETED|Overall Study||0
2834991|NCT03357952|3536763|FG001|COMPLETED|Overall Study||0
2834992|NCT03357952|3536762|FG000|NOT COMPLETED|Overall Study||9
2834993|NCT03357952|3536763|FG001|NOT COMPLETED|Overall Study||1
2834994|NCT03287947|3536769|FG000|STARTED|Overall Study|Five subjects were enrolled to the study.|5
2834995|NCT03287947|3536769|FG000|COMPLETED|Overall Study|All subjects enrolled discontinued treatment and are now off study.|5
2834996|NCT03287947|3536769|FG000|NOT COMPLETED|Overall Study||0
2914760|NCT00506285|3624943|FG001|Received at Least 1 Dose MTS|Double Blind Cross-Over Phase||31
2914761|NCT00506285|3624942|FG000|COMPLETED|Double Blind Cross-Over Phase||20
2914762|NCT00506285|3624943|FG001|COMPLETED|Double Blind Cross-Over Phase||31
2914763|NCT00506285|3624942|FG000|NOT COMPLETED|Double Blind Cross-Over Phase||9
2914764|NCT00506285|3624943|FG001|NOT COMPLETED|Double Blind Cross-Over Phase||5
2914765|NCT00506285|3624942|FG000|STARTED|6-month Open Label Phase||20
2914766|NCT00506285|3624943|FG001|STARTED|6-month Open Label Phase||31
2914767|NCT00506285|3624942|FG000|COMPLETED|6-month Open Label Phase||10
2914768|NCT00506285|3624943|FG001|COMPLETED|6-month Open Label Phase||19
2914769|NCT00506285|3624942|FG000|NOT COMPLETED|6-month Open Label Phase||10
2914770|NCT00506285|3624943|FG001|NOT COMPLETED|6-month Open Label Phase||12
2914771|NCT00506350|3624960|FG000|STARTED|Overall Study||36
2914772|NCT00506350|3624961|FG001|STARTED|Overall Study||40
2914773|NCT00506350|3624962|FG002|STARTED|Overall Study||37
2914774|NCT00506350|3624963|FG003|STARTED|Overall Study||36
2914775|NCT00506350|3624964|FG004|STARTED|Overall Study||50
2914776|NCT00506350|3624965|FG005|STARTED|Overall Study||40
2914777|NCT00506350|3624966|FG006|STARTED|Overall Study||35
2914778|NCT00506350|3624967|FG007|STARTED|Overall Study||41
2914779|NCT00506350|3624968|FG008|STARTED|Overall Study||35
2914780|NCT00506350|3624960|FG000|COMPLETED|Overall Study||33
2914781|NCT00506350|3624961|FG001|COMPLETED|Overall Study||37
2914782|NCT00506350|3624962|FG002|COMPLETED|Overall Study||31
2914783|NCT00506350|3624963|FG003|COMPLETED|Overall Study||34
2914784|NCT00506350|3624964|FG004|COMPLETED|Overall Study||40
2914785|NCT00506350|3624965|FG005|COMPLETED|Overall Study||38
2914786|NCT00506350|3624966|FG006|COMPLETED|Overall Study||33
2914787|NCT00506350|3624967|FG007|COMPLETED|Overall Study||36
2914788|NCT00506350|3624968|FG008|COMPLETED|Overall Study||30
2914789|NCT00506350|3624960|FG000|NOT COMPLETED|Overall Study||3
2914790|NCT00506350|3624961|FG001|NOT COMPLETED|Overall Study||3
2914791|NCT00506350|3624962|FG002|NOT COMPLETED|Overall Study||6
2914792|NCT00506350|3624963|FG003|NOT COMPLETED|Overall Study||2
2914793|NCT00506350|3624964|FG004|NOT COMPLETED|Overall Study||10
2914794|NCT00506350|3624965|FG005|NOT COMPLETED|Overall Study||2
2914795|NCT00506350|3624966|FG006|NOT COMPLETED|Overall Study||2
2914796|NCT00506350|3624967|FG007|NOT COMPLETED|Overall Study||5
2914797|NCT00506350|3624968|FG008|NOT COMPLETED|Overall Study||5
2914798|NCT00506389|3624998|FG000|STARTED|In-treatment Period||143
2914799|NCT00506389|3624999|FG001|STARTED|In-treatment Period||139
2914800|NCT00506389|3625000|FG002|STARTED|In-treatment Period||137
2914801|NCT00506389|3624998|FG000|All Participants Treated|In-treatment Period||139
2914802|NCT00506389|3624999|FG001|All Participants Treated|In-treatment Period||138
2914803|NCT00506389|3625000|FG002|All Participants Treated|In-treatment Period||136
2834997|NCT03237234|3536775|FG000|STARTED|Overall Study||14
2834998|NCT03237234|3536776|FG001|STARTED|Overall Study||11
2834999|NCT03237234|3536775|FG000|COMPLETED|Overall Study||14
2835000|NCT03237234|3536776|FG001|COMPLETED|Overall Study||11
2835001|NCT03237234|3536775|FG000|NOT COMPLETED|Overall Study||0
2835002|NCT03237234|3536776|FG001|NOT COMPLETED|Overall Study||0
2835003|NCT03170869|3536782|FG000|STARTED|Overall Study||11
2835004|NCT03170869|3536782|FG000|COMPLETED|Overall Study||3
2835005|NCT03170869|3536782|FG000|NOT COMPLETED|Overall Study||8
2835006|NCT03066622|3536789|FG000|STARTED|Overall Study||61
2835007|NCT03066622|3536790|FG001|STARTED|Overall Study||61
2835008|NCT03066622|3536789|FG000|COMPLETED|Overall Study||35
2835009|NCT03066622|3536790|FG001|COMPLETED|Overall Study||35
2835010|NCT03066622|3536789|FG000|NOT COMPLETED|Overall Study||26
2835011|NCT03066622|3536790|FG001|NOT COMPLETED|Overall Study||26
2835012|NCT03052920|3536796|FG000|STARTED|Overall Study||40
2835013|NCT03052920|3536796|FG000|COMPLETED|Overall Study||39
2835014|NCT03052920|3536796|FG000|NOT COMPLETED|Overall Study||1
2835015|NCT03029104|3536803|FG000|STARTED|Overall Study||745
2835016|NCT03029104|3536804|FG001|STARTED|Overall Study||735
2835017|NCT03029104|3536805|FG002|STARTED|Overall Study||748
2835018|NCT03029104|3536803|FG000|COMPLETED|Overall Study||612
2835019|NCT03029104|3536804|FG001|COMPLETED|Overall Study||597
2835020|NCT03029104|3536805|FG002|COMPLETED|Overall Study||623
2835021|NCT03029104|3536803|FG000|NOT COMPLETED|Overall Study||133
2835022|NCT03029104|3536804|FG001|NOT COMPLETED|Overall Study||138
2835023|NCT03029104|3536805|FG002|NOT COMPLETED|Overall Study||125
2835024|NCT03016312|3536815|FG000|STARTED|Overall Study||391
2835025|NCT03016312|3536816|FG001|STARTED|Overall Study||380
2835026|NCT03016312|3536815|FG000|COMPLETED|Overall Study||150
2835027|NCT03016312|3536816|FG001|COMPLETED|Overall Study||162
2835028|NCT03016312|3536815|FG000|NOT COMPLETED|Overall Study||241
2835029|NCT03016312|3536816|FG001|NOT COMPLETED|Overall Study||218
2835030|NCT02876172|3536824|FG000|STARTED|Overall Study||6
2835031|NCT02876172|3536825|FG001|STARTED|Overall Study||6
2835032|NCT02876172|3536824|FG000|COMPLETED|Overall Study||6
2835033|NCT02876172|3536825|FG001|COMPLETED|Overall Study||6
2835034|NCT02876172|3536824|FG000|NOT COMPLETED|Overall Study||0
2835035|NCT02876172|3536825|FG001|NOT COMPLETED|Overall Study||0
2835036|NCT02722434|3536834|FG000|STARTED|Overall Study||25
2835037|NCT02722434|3536835|FG001|STARTED|Overall Study||25
2835038|NCT02722434|3536834|FG000|Started Treatment|Overall Study||24
2835039|NCT02722434|3536835|FG001|Started Treatment|Overall Study||25
2835040|NCT02722434|3536834|FG000|COMPLETED|Overall Study||24
2835041|NCT02722434|3536835|FG001|COMPLETED|Overall Study||22
2835042|NCT02722434|3536834|FG000|NOT COMPLETED|Overall Study||1
2835043|NCT02722434|3536835|FG001|NOT COMPLETED|Overall Study||3
2835044|NCT02721979|3536841|FG000|STARTED|Overall Study||23
2835045|NCT02721979|3536841|FG000|COMPLETED|Overall Study||22
2835046|NCT02721979|3536841|FG000|NOT COMPLETED|Overall Study||1
2835047|NCT02604511|3536845|FG000|STARTED|Overall Study||31
2835048|NCT02604511|3536845|FG000|COMPLETED|Overall Study||19
2835049|NCT02604511|3536845|FG000|NOT COMPLETED|Overall Study||12
2835062|NCT02369536|3536863|FG000|STARTED|Overall Study||62
2835063|NCT02369536|3536864|FG001|STARTED|Overall Study||64
2835064|NCT02369536|3536863|FG000|COMPLETED|Overall Study||55
2835065|NCT02369536|3536864|FG001|COMPLETED|Overall Study||58
2835066|NCT02369536|3536863|FG000|NOT COMPLETED|Overall Study||7
2835067|NCT02369536|3536864|FG001|NOT COMPLETED|Overall Study||6
2835068|NCT02358681|3536874|FG000|STARTED|Overall Study||29
2835069|NCT02358681|3536875|FG001|STARTED|Overall Study||30
2835070|NCT02358681|3536874|FG000|COMPLETED|Overall Study||27
2835071|NCT02358681|3536875|FG001|COMPLETED|Overall Study||29
2835072|NCT02358681|3536874|FG000|NOT COMPLETED|Overall Study||2
2835073|NCT02358681|3536875|FG001|NOT COMPLETED|Overall Study||1
2835074|NCT02101788|3536883|FG000|STARTED|Overall Study||130
2835075|NCT02101788|3536884|FG001|STARTED|Overall Study||130
2835076|NCT02101788|3536883|FG000|Crossover From Arm A to Arm B|Overall Study||88
2835077|NCT02101788|3536884|FG001|Crossover From Arm A to Arm B|Overall Study||0
2835078|NCT02101788|3536883|FG000|COMPLETED|Overall Study||120
2835079|NCT02101788|3536884|FG001|COMPLETED|Overall Study||116
2835080|NCT02101788|3536883|FG000|NOT COMPLETED|Overall Study||10
2835081|NCT02101788|3536884|FG001|NOT COMPLETED|Overall Study||14
2835082|NCT01963728|3536899|FG000|STARTED|Overall Study||0
2835083|NCT01963728|3536900|FG001|STARTED|Overall Study||1
2835084|NCT01963728|3536899|FG000|COMPLETED|Overall Study|study terminated early|0
2835085|NCT01963728|3536900|FG001|COMPLETED|Overall Study|study terminated early|0
2835086|NCT01963728|3536899|FG000|NOT COMPLETED|Overall Study||0
2835087|NCT01963728|3536900|FG001|NOT COMPLETED|Overall Study||1
2835088|NCT01248247|3536910|FG000|STARTED|Overall Study||22
2835089|NCT01248247|3536911|FG001|STARTED|Overall Study||42
2835090|NCT01248247|3536912|FG002|STARTED|Overall Study||75
2835091|NCT01248247|3536913|FG003|STARTED|Overall Study||61
2835092|NCT01248247|3536910|FG000|COMPLETED|Overall Study||0
2835093|NCT01248247|3536911|FG001|COMPLETED|Overall Study||0
2835094|NCT01248247|3536912|FG002|COMPLETED|Overall Study||0
2835095|NCT01248247|3536913|FG003|COMPLETED|Overall Study||0
2835096|NCT01248247|3536910|FG000|NOT COMPLETED|Overall Study||22
2835097|NCT01248247|3536911|FG001|NOT COMPLETED|Overall Study||42
2835098|NCT01248247|3536912|FG002|NOT COMPLETED|Overall Study||75
2835099|NCT01248247|3536913|FG003|NOT COMPLETED|Overall Study||61
2835100|NCT01164228|3536925|FG000|STARTED|Overall Study||47
2835101|NCT01164228|3536926|FG001|STARTED|Overall Study||40
2835102|NCT01164228|3536925|FG000|Receipt of Protocol Therapy|Overall Study||46
2835103|NCT01164228|3536926|FG001|Receipt of Protocol Therapy|Overall Study||37
2835104|NCT01164228|3536925|FG000|Treated and Eligible Patients|Overall Study||45
2835105|NCT01164228|3536926|FG001|Treated and Eligible Patients|Overall Study||37
2835106|NCT01164228|3536925|FG000|COMPLETED|Overall Study||3
2835107|NCT01164228|3536926|FG001|COMPLETED|Overall Study||2
2835108|NCT01164228|3536925|FG000|NOT COMPLETED|Overall Study||44
2835109|NCT01164228|3536926|FG001|NOT COMPLETED|Overall Study||38
2835110|NCT01012167|3536935|FG000|STARTED|Overall Study||17
2835111|NCT01012167|3536936|FG001|STARTED|Overall Study||20
2835112|NCT01012167|3536937|FG002|STARTED|Overall Study||21
2835113|NCT01012167|3536935|FG000|Withdrawn Prior to Study Drug Exposure|Overall Study||1
2835114|NCT01012167|3536936|FG001|Withdrawn Prior to Study Drug Exposure|Overall Study||0
2835115|NCT01012167|3536937|FG002|Withdrawn Prior to Study Drug Exposure|Overall Study||1
2835116|NCT01012167|3536935|FG000|Exposed to Study Drug|Overall Study||16
2835117|NCT01012167|3536936|FG001|Exposed to Study Drug|Overall Study||20
2835118|NCT01012167|3536937|FG002|Exposed to Study Drug|Overall Study||20
2835119|NCT01012167|3536935|FG000|COMPLETED|Overall Study||15
2835120|NCT01012167|3536936|FG001|COMPLETED|Overall Study||18
2835121|NCT01012167|3536937|FG002|COMPLETED|Overall Study||17
2835122|NCT01012167|3536935|FG000|NOT COMPLETED|Overall Study||2
2835123|NCT01012167|3536936|FG001|NOT COMPLETED|Overall Study||2
2835124|NCT01012167|3536937|FG002|NOT COMPLETED|Overall Study||4
2835125|NCT00924326|3536961|FG000|STARTED|Dose Administration||8
2835126|NCT00924326|3536962|FG001|STARTED|Dose Administration||2
2835127|NCT00924326|3536963|FG002|STARTED|Dose Administration||5
2835128|NCT00924326|3536964|FG003|STARTED|Dose Administration||6
2835129|NCT00924326|3536965|FG004|STARTED|Dose Administration||7
2835130|NCT00924326|3536966|FG005|STARTED|Dose Administration||10
2835131|NCT00924326|3536967|FG006|STARTED|Dose Administration||1
2835132|NCT00924326|3536968|FG007|STARTED|Dose Administration||2
2835133|NCT00924326|3536969|FG008|STARTED|Dose Administration||2
2835134|NCT00924326|3536961|FG000|COMPLETED|Dose Administration||8
2835135|NCT00924326|3536962|FG001|COMPLETED|Dose Administration||2
2835136|NCT00924326|3536963|FG002|COMPLETED|Dose Administration||5
2835137|NCT00924326|3536964|FG003|COMPLETED|Dose Administration||6
2835138|NCT00924326|3536965|FG004|COMPLETED|Dose Administration||7
2835139|NCT00924326|3536966|FG005|COMPLETED|Dose Administration||10
2835140|NCT00924326|3536967|FG006|COMPLETED|Dose Administration||1
2835141|NCT00924326|3536968|FG007|COMPLETED|Dose Administration||2
2835142|NCT00924326|3536969|FG008|COMPLETED|Dose Administration||2
2835143|NCT00924326|3536961|FG000|NOT COMPLETED|Dose Administration||0
2835144|NCT00924326|3536962|FG001|NOT COMPLETED|Dose Administration||0
2835145|NCT00924326|3536963|FG002|NOT COMPLETED|Dose Administration||0
2835146|NCT00924326|3536964|FG003|NOT COMPLETED|Dose Administration||0
2835147|NCT00924326|3536965|FG004|NOT COMPLETED|Dose Administration||0
2835148|NCT00924326|3536966|FG005|NOT COMPLETED|Dose Administration||0
2835149|NCT00924326|3536967|FG006|NOT COMPLETED|Dose Administration||0
2835150|NCT00924326|3536968|FG007|NOT COMPLETED|Dose Administration||0
2835151|NCT00924326|3536969|FG008|NOT COMPLETED|Dose Administration||0
2835152|NCT00924326|3536961|FG000|STARTED|1x10^9-1x10^10 + High Dose Retreat||3
2835153|NCT00924326|3536962|FG001|STARTED|1x10^9-1x10^10 + High Dose Retreat||0
2835154|NCT00924326|3536963|FG002|STARTED|1x10^9-1x10^10 + High Dose Retreat||0
2835155|NCT00924326|3536964|FG003|STARTED|1x10^9-1x10^10 + High Dose Retreat||0
2835156|NCT00924326|3536965|FG004|STARTED|1x10^9-1x10^10 + High Dose Retreat||0
2835157|NCT00924326|3536966|FG005|STARTED|1x10^9-1x10^10 + High Dose Retreat||0
2835158|NCT00924326|3536967|FG006|STARTED|1x10^9-1x10^10 + High Dose Retreat||0
2835159|NCT00924326|3536968|FG007|STARTED|1x10^9-1x10^10 + High Dose Retreat||0
2835160|NCT00924326|3536969|FG008|STARTED|1x10^9-1x10^10 + High Dose Retreat||0
2835161|NCT00924326|3536961|FG000|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||3
2835162|NCT00924326|3536962|FG001|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
2835163|NCT00924326|3536963|FG002|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
2835164|NCT00924326|3536964|FG003|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
2835165|NCT00924326|3536965|FG004|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
2835166|NCT00924326|3536966|FG005|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
2835167|NCT00924326|3536967|FG006|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
2835168|NCT00924326|3536968|FG007|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
2835169|NCT00924326|3536969|FG008|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
2835170|NCT00924326|3536961|FG000|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
2835171|NCT00924326|3536962|FG001|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
2835172|NCT00924326|3536963|FG002|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
2835173|NCT00924326|3536964|FG003|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
2835174|NCT00924326|3536965|FG004|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
2835175|NCT00924326|3536966|FG005|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
2835176|NCT00924326|3536967|FG006|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
2835177|NCT00924326|3536968|FG007|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
2835178|NCT00924326|3536969|FG008|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
2835179|NCT00591318|3536993|FG000|STARTED|Overall Study||5
2835180|NCT00591318|3536994|FG001|STARTED|Overall Study||5
2835181|NCT00591318|3536993|FG000|COMPLETED|Overall Study|For our protocol, participants in both treatment arms were considered completers if they completed at least 6 weeks. At the 6 week point, if response on PANS was not sufficient (15% or greater), they were considered unlikely to respond and therefore were not given the option of the 2 additional weeks of ceftriaxone or placebo. For the analysis, we used the last observed rating between baseline to week 8 for each participant, regardless of whether the participant completed the study treatments.|1
2835182|NCT00591318|3536994|FG001|COMPLETED|Overall Study|For our protocol, participants in both treatment arms were considered completers if they completed at least 6 weeks. At the 6 week point, if response on PANS was not sufficient (15% or greater), they were considered unlikely to respond and therefore were not given the option of the 2 additional weeks of ceftriaxone or placebo. For the analysis, we used the last observed rating between baseline to week 8 for each participant regardless of whether the participant completed the study treatments..|5
2835183|NCT00591318|3536993|FG000|NOT COMPLETED|Overall Study||4
2835184|NCT00591318|3536994|FG001|NOT COMPLETED|Overall Study||0
2835185|NCT00321100|3537006|FG000|STARTED|Overall Study||12
2835186|NCT00321100|3537007|FG001|STARTED|Overall Study||11
2835187|NCT00321100|3537006|FG000|COMPLETED|Overall Study||12
2835188|NCT00321100|3537007|FG001|COMPLETED|Overall Study||11
2835189|NCT00321100|3537006|FG000|NOT COMPLETED|Overall Study||0
2835190|NCT00321100|3537007|FG001|NOT COMPLETED|Overall Study||0
2914804|NCT00506389|3624998|FG000|COMPLETED|In-treatment Period||117
2914805|NCT00506389|3624999|FG001|COMPLETED|In-treatment Period||124
2914806|NCT00506389|3625000|FG002|COMPLETED|In-treatment Period||125
2914807|NCT00506389|3624998|FG000|NOT COMPLETED|In-treatment Period||26
2914808|NCT00506389|3624999|FG001|NOT COMPLETED|In-treatment Period||15
2914809|NCT00506389|3625000|FG002|NOT COMPLETED|In-treatment Period||12
2914810|NCT00506389|3624998|FG000|STARTED|Follow-up Period|22 participants who discontinued treatment entered the Follow-up Period.|139
2914811|NCT00506389|3624999|FG001|STARTED|Follow-up Period|14 participants who discontinued treatment entered the Follow-up Period.|138
2914812|NCT00506389|3625000|FG002|STARTED|Follow-up Period|11 participants who discontinued treatment entered the Follow-up Period.|136
2914813|NCT00506389|3624998|FG000|COMPLETED|Follow-up Period||139
2914814|NCT00506389|3624999|FG001|COMPLETED|Follow-up Period||138
2914815|NCT00506389|3625000|FG002|COMPLETED|Follow-up Period||136
2914816|NCT00506389|3624998|FG000|NOT COMPLETED|Follow-up Period||0
2914817|NCT00506389|3624999|FG001|NOT COMPLETED|Follow-up Period||0
2914818|NCT00506389|3625000|FG002|NOT COMPLETED|Follow-up Period||0
2914819|NCT00506415|3625011|FG000|STARTED|Initial Open Label (Maximum 48 Weeks)|Enrolled patients.|1584
2914820|NCT00506415|3625012|FG001|STARTED|Initial Open Label (Maximum 48 Weeks)||0
2914821|NCT00506415|3625013|FG002|STARTED|Initial Open Label (Maximum 48 Weeks)||0
2914822|NCT00506415|3625014|FG003|STARTED|Initial Open Label (Maximum 48 Weeks)||0
2914823|NCT00506415|3625011|FG000|Exposed to Study Drug|Initial Open Label (Maximum 48 Weeks)||1582
2914824|NCT00506415|3625012|FG001|Exposed to Study Drug|Initial Open Label (Maximum 48 Weeks)||0
2914825|NCT00506415|3625013|FG002|Exposed to Study Drug|Initial Open Label (Maximum 48 Weeks)||0
2914826|NCT00506415|3625014|FG003|Exposed to Study Drug|Initial Open Label (Maximum 48 Weeks)||0
2914827|NCT00506415|3625011|FG000|COMPLETED|Initial Open Label (Maximum 48 Weeks)||1085
2914828|NCT00506415|3625012|FG001|COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
2914829|NCT00506415|3625013|FG002|COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
2914830|NCT00506415|3625014|FG003|COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
2914831|NCT00506415|3625011|FG000|NOT COMPLETED|Initial Open Label (Maximum 48 Weeks)||499
2914832|NCT00506415|3625012|FG001|NOT COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
2914833|NCT00506415|3625013|FG002|NOT COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
2914834|NCT00506415|3625014|FG003|NOT COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
2914835|NCT00506415|3625011|FG000|STARTED|Double Blind (Maximum 48 Weeks )||0
2914836|NCT00506415|3625012|FG001|STARTED|Double Blind (Maximum 48 Weeks )|1 patient was randomized in error and did not receive study drug, hence excluded from this arm.|286
2914837|NCT00506415|3625013|FG002|STARTED|Double Blind (Maximum 48 Weeks )||280
2914838|NCT00506415|3625014|FG003|STARTED|Double Blind (Maximum 48 Weeks )||0
2914839|NCT00506415|3625011|FG000|COMPLETED|Double Blind (Maximum 48 Weeks )||0
3167151|NCT01908426|3894317|FG001|STARTED|Overall Study||237
3167152|NCT01908426|3894316|FG000|COMPLETED|Overall Study||73
3167153|NCT01908426|3894317|FG001|COMPLETED|Overall Study||26
2914840|NCT00506415|3625012|FG001|COMPLETED|Double Blind (Maximum 48 Weeks )||203
2914841|NCT00506415|3625013|FG002|COMPLETED|Double Blind (Maximum 48 Weeks )||207
2914842|NCT00506415|3625014|FG003|COMPLETED|Double Blind (Maximum 48 Weeks )||0
2914843|NCT00506415|3625011|FG000|NOT COMPLETED|Double Blind (Maximum 48 Weeks )||0
3311420|NCT03052517|4044936|FG001|Safety Set (SAF)|Overall Study|One patient had no treatment administered and thus was excluded from the SAF|1084
3311421|NCT03052517|4044937|FG002|Safety Set (SAF)|Overall Study|One patient in QAW039 150 mg group received placebo and was included in the placebo group in the SAF|361
3311422|NCT03052517|4044935|FG000|COMPLETED|Overall Study||76
3311423|NCT03052517|4044936|FG001|COMPLETED|Overall Study||71
2835191|NCT04534517|3537015|FG000|STARTED|Overall Study||114
2835192|NCT04534517|3537015|FG000|COMPLETED|Overall Study||110
2835193|NCT04534517|3537015|FG000|NOT COMPLETED|Overall Study||4
2835194|NCT04494646|3537021|FG000|STARTED|Overall Study||21
2835195|NCT04494646|3537022|FG001|STARTED|Overall Study||19
2835196|NCT04494646|3537021|FG000|COMPLETED|Overall Study||21
2835197|NCT04494646|3537022|FG001|COMPLETED|Overall Study||17
2835198|NCT04494646|3537021|FG000|NOT COMPLETED|Overall Study||0
2835199|NCT04494646|3537022|FG001|NOT COMPLETED|Overall Study||2
2835200|NCT04258020|3537030|FG000|STARTED|Overall Study||4
2835201|NCT04258020|3537031|FG001|STARTED|Overall Study||0
2835202|NCT04258020|3537030|FG000|COMPLETED|Overall Study||3
2835203|NCT04258020|3537031|FG001|COMPLETED|Overall Study||0
2835204|NCT04258020|3537030|FG000|NOT COMPLETED|Overall Study||1
2835205|NCT04258020|3537031|FG001|NOT COMPLETED|Overall Study||0
2835206|NCT04234464|3537039|FG000|STARTED|Period 1 (First Treatment Intervention)||29
2835207|NCT04234464|3537040|FG001|STARTED|Period 1 (First Treatment Intervention)||31
2835208|NCT04234464|3537039|FG000|COMPLETED|Period 1 (First Treatment Intervention)||29
2835209|NCT04234464|3537040|FG001|COMPLETED|Period 1 (First Treatment Intervention)||31
2835210|NCT04234464|3537039|FG000|NOT COMPLETED|Period 1 (First Treatment Intervention)||0
2835211|NCT04234464|3537040|FG001|NOT COMPLETED|Period 1 (First Treatment Intervention)||0
2835212|NCT04234464|3537039|FG000|STARTED|Period 2 (Second Treatment Intervention)||29
2835213|NCT04234464|3537040|FG001|STARTED|Period 2 (Second Treatment Intervention)||31
2835214|NCT04234464|3537039|FG000|COMPLETED|Period 2 (Second Treatment Intervention)||28
2835215|NCT04234464|3537040|FG001|COMPLETED|Period 2 (Second Treatment Intervention)||31
2835216|NCT04234464|3537039|FG000|NOT COMPLETED|Period 2 (Second Treatment Intervention)||1
2835217|NCT04234464|3537040|FG001|NOT COMPLETED|Period 2 (Second Treatment Intervention)||0
2835218|NCT04126733|3537046|FG000|STARTED|Treatment Period||70
2835219|NCT04126733|3537046|FG000|COMPLETED|Treatment Period||0
2835220|NCT04126733|3537046|FG000|NOT COMPLETED|Treatment Period||70
2835221|NCT04126733|3537046|FG000|STARTED|Active Follow-up Period|Participants had the option to decline participation in active follow-up.|34
2835222|NCT04126733|3537046|FG000|COMPLETED|Active Follow-up Period||14
2835223|NCT04126733|3537046|FG000|NOT COMPLETED|Active Follow-up Period||20
2835224|NCT04126733|3537046|FG000|STARTED|Long-term Follow-up Period|All participants who accepted long-term follow-up.|6
2835225|NCT04126733|3537046|FG000|COMPLETED|Long-term Follow-up Period||0
2835226|NCT04126733|3537046|FG000|NOT COMPLETED|Long-term Follow-up Period||6
2835227|NCT03860259|3537052|FG000|STARTED|Overall Study||25
2835228|NCT03860259|3537053|FG001|STARTED|Overall Study||25
2835229|NCT03860259|3537052|FG000|COMPLETED|Overall Study||19
2835230|NCT03860259|3537053|FG001|COMPLETED|Overall Study||20
2835231|NCT03860259|3537052|FG000|NOT COMPLETED|Overall Study||6
2835232|NCT03860259|3537053|FG001|NOT COMPLETED|Overall Study||5
2835233|NCT03852316|3537059|FG000|STARTED|Overall Study||1585
2835234|NCT03852316|3537059|FG000|COMPLETED|Overall Study||1581
2835235|NCT03852316|3537059|FG000|NOT COMPLETED|Overall Study||4
2835236|NCT03789318|3537068|FG000|STARTED|Overall Study||9
2835237|NCT03789318|3537069|FG001|STARTED|Overall Study||9
2835238|NCT03789318|3537070|FG002|STARTED|Overall Study||12
2835239|NCT03789318|3537071|FG003|STARTED|Overall Study||12
2835240|NCT03789318|3537072|FG004|STARTED|Overall Study||12
2835241|NCT03789318|3537068|FG000|COMPLETED|Overall Study||9
2835242|NCT03789318|3537069|FG001|COMPLETED|Overall Study||9
2835243|NCT03789318|3537070|FG002|COMPLETED|Overall Study||9
2835244|NCT03789318|3537071|FG003|COMPLETED|Overall Study||11
2835245|NCT03789318|3537072|FG004|COMPLETED|Overall Study||12
2835246|NCT03789318|3537068|FG000|NOT COMPLETED|Overall Study||0
2835247|NCT03789318|3537069|FG001|NOT COMPLETED|Overall Study||0
2835248|NCT03789318|3537070|FG002|NOT COMPLETED|Overall Study||3
2835249|NCT03789318|3537071|FG003|NOT COMPLETED|Overall Study||1
2835250|NCT03789318|3537072|FG004|NOT COMPLETED|Overall Study||0
2835251|NCT03774875|3537086|FG000|STARTED|Overall Study||92
2835252|NCT03774875|3537087|FG001|STARTED|Overall Study||185
2835253|NCT03774875|3537086|FG000|Received Study Drug|Overall Study||91
2835254|NCT03774875|3537087|FG001|Received Study Drug|Overall Study||185
2835255|NCT03774875|3537086|FG000|COMPLETED|Overall Study||69
2835256|NCT03774875|3537087|FG001|COMPLETED|Overall Study||152
2835257|NCT03774875|3537086|FG000|NOT COMPLETED|Overall Study||23
2835258|NCT03774875|3537087|FG001|NOT COMPLETED|Overall Study||33
2835259|NCT03613662|3537093|FG000|STARTED|Overall Study||19
2835260|NCT03613662|3537093|FG000|COMPLETED|Overall Study||19
2835261|NCT03613662|3537093|FG000|NOT COMPLETED|Overall Study||0
2835262|NCT03562156|3537099|FG000|STARTED|Overall Study||217
2835263|NCT03562156|3537100|FG001|STARTED|Overall Study||109
2835264|NCT03562156|3537099|FG000|COMPLETED|Overall Study||182
2835265|NCT03562156|3537100|FG001|COMPLETED|Overall Study||91
2835266|NCT03562156|3537099|FG000|NOT COMPLETED|Overall Study||35
2835267|NCT03562156|3537100|FG001|NOT COMPLETED|Overall Study||18
2835268|NCT03232736|3537108|FG000|STARTED|Overall Study||9
2835269|NCT03232736|3537109|FG001|STARTED|Overall Study||13
2835270|NCT03232736|3537108|FG000|COMPLETED|Overall Study||9
2835271|NCT03232736|3537109|FG001|COMPLETED|Overall Study||13
2835272|NCT03232736|3537108|FG000|NOT COMPLETED|Overall Study||0
2835273|NCT03232736|3537109|FG001|NOT COMPLETED|Overall Study||0
2835274|NCT03208530|3537119|FG000|STARTED|Overall Study||75
2835275|NCT03208530|3537119|FG000|COMPLETED|Overall Study||48
2835276|NCT03208530|3537119|FG000|NOT COMPLETED|Overall Study||27
2835277|NCT03158688|3537125|FG000|STARTED|Overall Study||154
2835278|NCT03158688|3537126|FG001|STARTED|Overall Study||312
2835279|NCT03158688|3537125|FG000|Treated|Overall Study||153
2835280|NCT03158688|3537126|FG001|Treated|Overall Study||308
2835281|NCT03158688|3537125|FG000|COMPLETED|Overall Study||0
2835282|NCT03158688|3537126|FG001|COMPLETED|Overall Study||0
2835283|NCT03158688|3537125|FG000|NOT COMPLETED|Overall Study||154
2835284|NCT03158688|3537126|FG001|NOT COMPLETED|Overall Study||312
2835285|NCT03103321|3537136|FG000|STARTED|Overall Study||25
2835286|NCT03103321|3537137|FG001|STARTED|Overall Study||39
2835287|NCT03103321|3537138|FG002|STARTED|Overall Study||44
2835288|NCT03103321|3537139|FG003|STARTED|Overall Study||50
2835289|NCT03103321|3537136|FG000|COMPLETED|Overall Study||24
2835290|NCT03103321|3537137|FG001|COMPLETED|Overall Study||38
2835291|NCT03103321|3537138|FG002|COMPLETED|Overall Study||43
2835292|NCT03103321|3537139|FG003|COMPLETED|Overall Study||50
2835293|NCT03103321|3537136|FG000|NOT COMPLETED|Overall Study||1
2835294|NCT03103321|3537137|FG001|NOT COMPLETED|Overall Study||1
2835295|NCT03103321|3537138|FG002|NOT COMPLETED|Overall Study||1
2835296|NCT03103321|3537139|FG003|NOT COMPLETED|Overall Study||0
2835297|NCT03079869|3537151|FG000|STARTED|Overall Study||28
2835298|NCT03079869|3537152|FG001|STARTED|Overall Study||27
2835299|NCT03079869|3537151|FG000|COMPLETED|Overall Study||15
2835300|NCT03079869|3537152|FG001|COMPLETED|Overall Study||16
2835301|NCT03079869|3537151|FG000|NOT COMPLETED|Overall Study||13
2835302|NCT03079869|3537152|FG001|NOT COMPLETED|Overall Study||11
2835303|NCT03033875|3537161|FG000|STARTED|Overall Study||96
2835304|NCT03033875|3537162|FG001|STARTED|Overall Study||111
2835305|NCT03033875|3537163|FG002|STARTED|Overall Study||54
2835306|NCT03033875|3537161|FG000|Completed Month 3 Assessment|Overall Study||71
2835307|NCT03033875|3537162|FG001|Completed Month 3 Assessment|Overall Study||83
2835308|NCT03033875|3537163|FG002|Completed Month 3 Assessment|Overall Study||43
2835309|NCT03033875|3537161|FG000|Completed Month 6 Assessment|Overall Study||73
2835310|NCT03033875|3537162|FG001|Completed Month 6 Assessment|Overall Study||81
2835311|NCT03033875|3537163|FG002|Completed Month 6 Assessment|Overall Study||46
2835312|NCT03033875|3537161|FG000|COMPLETED|Overall Study||77
2835313|NCT03033875|3537162|FG001|COMPLETED|Overall Study||87
2835314|NCT03033875|3537163|FG002|COMPLETED|Overall Study||42
2835315|NCT03033875|3537161|FG000|NOT COMPLETED|Overall Study||19
2835316|NCT03033875|3537162|FG001|NOT COMPLETED|Overall Study||24
2835317|NCT03033875|3537163|FG002|NOT COMPLETED|Overall Study||12
2835318|NCT02935595|3537171|FG000|STARTED|Overall Study||5
2835319|NCT02935595|3537171|FG000|COMPLETED|Overall Study||4
2835320|NCT02935595|3537171|FG000|NOT COMPLETED|Overall Study||1
2835321|NCT02887248|3537175|FG000|STARTED|Overall Study||3
2835322|NCT02887248|3537175|FG000|COMPLETED|Overall Study||0
2835323|NCT02887248|3537175|FG000|NOT COMPLETED|Overall Study||3
2914844|NCT00506415|3625012|FG001|NOT COMPLETED|Double Blind (Maximum 48 Weeks )||83
2914845|NCT00506415|3625013|FG002|NOT COMPLETED|Double Blind (Maximum 48 Weeks )||73
2914846|NCT00506415|3625014|FG003|NOT COMPLETED|Double Blind (Maximum 48 Weeks )||0
2914847|NCT00506415|3625011|FG000|STARTED|Extended Open Label (Maximum 48 Weeks)||0
2914848|NCT00506415|3625012|FG001|STARTED|Extended Open Label (Maximum 48 Weeks)||0
2914849|NCT00506415|3625013|FG002|STARTED|Extended Open Label (Maximum 48 Weeks)||0
2914850|NCT00506415|3625014|FG003|STARTED|Extended Open Label (Maximum 48 Weeks)|Two participants did not receive study drug, hence excluded from this arm.|457
2914851|NCT00506415|3625011|FG000|COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
2914852|NCT00506415|3625012|FG001|COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
2914853|NCT00506415|3625013|FG002|COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
2914854|NCT00506415|3625014|FG003|COMPLETED|Extended Open Label (Maximum 48 Weeks)||395
2914855|NCT00506415|3625011|FG000|NOT COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
2914856|NCT00506415|3625012|FG001|NOT COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
2914857|NCT00506415|3625013|FG002|NOT COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
2914858|NCT00506415|3625014|FG003|NOT COMPLETED|Extended Open Label (Maximum 48 Weeks)||62
2914859|NCT00506441|3625027|FG000|STARTED|Period 1; Open-label Period||245
2914860|NCT00506441|3625028|FG001|STARTED|Period 1; Open-label Period||0
2914861|NCT00506441|3625027|FG000|COMPLETED|Period 1; Open-label Period||169
2914862|NCT00506441|3625028|FG001|COMPLETED|Period 1; Open-label Period||0
2914863|NCT00506441|3625027|FG000|NOT COMPLETED|Period 1; Open-label Period||76
2914864|NCT00506441|3625028|FG001|NOT COMPLETED|Period 1; Open-label Period||0
2914865|NCT00506441|3625027|FG000|STARTED|Period 2; Double-blind Period||85
2914866|NCT00506441|3625028|FG001|STARTED|Period 2; Double-blind Period||84
2914867|NCT00506441|3625027|FG000|COMPLETED|Period 2; Double-blind Period||82
2914868|NCT00506441|3625028|FG001|COMPLETED|Period 2; Double-blind Period||79
2914869|NCT00506441|3625027|FG000|NOT COMPLETED|Period 2; Double-blind Period||3
2914870|NCT00506441|3625028|FG001|NOT COMPLETED|Period 2; Double-blind Period||5
2914871|NCT00506454|3625038|FG000|STARTED|Overall Study||11
2914872|NCT00506454|3625039|FG001|STARTED|Overall Study||11
2914873|NCT00506454|3625038|FG000|COMPLETED|Overall Study||10
2914874|NCT00506454|3625039|FG001|COMPLETED|Overall Study||10
2914875|NCT00506454|3625038|FG000|NOT COMPLETED|Overall Study||1
2914876|NCT00506454|3625039|FG001|NOT COMPLETED|Overall Study||1
2914877|NCT00506493|3625045|FG000|STARTED|Overall Study||75
2914878|NCT00506493|3625045|FG000|COMPLETED|Overall Study||64
2914879|NCT00506493|3625045|FG000|NOT COMPLETED|Overall Study||11
2914880|NCT00506519|3625054|FG000|STARTED|Overall Study||10
2914881|NCT00506519|3625055|FG001|STARTED|Overall Study||10
2914882|NCT00506519|3625056|FG002|STARTED|Overall Study||5
2914883|NCT00506519|3625054|FG000|Completed Treatment (Day 5)|Overall Study||8
2835324|NCT02849990|3537179|FG000|STARTED|Overall Study||22
2835325|NCT02849990|3537179|FG000|COMPLETED|Overall Study||20
2835326|NCT02849990|3537179|FG000|NOT COMPLETED|Overall Study||2
2835327|NCT02673151|3537183|FG000|STARTED|Overall Study||61
2835328|NCT02673151|3537183|FG000|COMPLETED|Overall Study||61
2835329|NCT02673151|3537183|FG000|NOT COMPLETED|Overall Study||0
2835330|NCT02523274|3537195|FG000|STARTED|Overall Study||20
2835331|NCT02523274|3537196|FG001|STARTED|Overall Study||20
2835332|NCT02523274|3537197|FG002|STARTED|Overall Study||20
2835333|NCT02523274|3537195|FG000|COMPLETED|Overall Study||19
2835334|NCT02523274|3537196|FG001|COMPLETED|Overall Study||18
2835335|NCT02523274|3537197|FG002|COMPLETED|Overall Study||18
2835336|NCT02523274|3537195|FG000|NOT COMPLETED|Overall Study||1
2835337|NCT02523274|3537196|FG001|NOT COMPLETED|Overall Study||2
2835338|NCT02523274|3537197|FG002|NOT COMPLETED|Overall Study||2
2835339|NCT02467270|3537212|FG000|STARTED|Overall Study||94
2835340|NCT02467270|3537213|FG001|STARTED|Overall Study||95
2835341|NCT02467270|3537214|FG002|STARTED|Overall Study||94
2835342|NCT02467270|3537212|FG000|Treated (Safety Population)|Overall Study||94
2835343|NCT02467270|3537213|FG001|Treated (Safety Population)|Overall Study||94
2835344|NCT02467270|3537214|FG002|Treated (Safety Population)|Overall Study||94
2835345|NCT02467270|3537212|FG000|COMPLETED|Overall Study||0
2835346|NCT02467270|3537213|FG001|COMPLETED|Overall Study||0
2835347|NCT02467270|3537214|FG002|COMPLETED|Overall Study||0
2835348|NCT02467270|3537212|FG000|NOT COMPLETED|Overall Study||94
2835349|NCT02467270|3537213|FG001|NOT COMPLETED|Overall Study||95
2835350|NCT02467270|3537214|FG002|NOT COMPLETED|Overall Study||94
2835351|NCT02452554|3537228|FG000|STARTED|Overall Study||17
2835352|NCT02452554|3537229|FG001|STARTED|Overall Study||17
2835353|NCT02452554|3537230|FG002|STARTED|Overall Study||12
2835354|NCT02452554|3537231|FG003|STARTED|Overall Study||1
2835355|NCT02452554|3537232|FG004|STARTED|Overall Study||5
2835356|NCT02452554|3537233|FG005|STARTED|Overall Study||10
2835357|NCT02452554|3537228|FG000|COMPLETED|Overall Study||0
2835358|NCT02452554|3537229|FG001|COMPLETED|Overall Study||0
2835359|NCT02452554|3537230|FG002|COMPLETED|Overall Study||1
2835360|NCT02452554|3537231|FG003|COMPLETED|Overall Study||0
2835361|NCT02452554|3537232|FG004|COMPLETED|Overall Study||0
2835362|NCT02452554|3537233|FG005|COMPLETED|Overall Study||1
2835363|NCT02452554|3537228|FG000|NOT COMPLETED|Overall Study||17
2835364|NCT02452554|3537229|FG001|NOT COMPLETED|Overall Study||17
2835365|NCT02452554|3537230|FG002|NOT COMPLETED|Overall Study||11
2835366|NCT02452554|3537231|FG003|NOT COMPLETED|Overall Study||1
2835367|NCT02452554|3537232|FG004|NOT COMPLETED|Overall Study||5
2835368|NCT02452554|3537233|FG005|NOT COMPLETED|Overall Study||9
2835369|NCT02427568|3537250|FG000|STARTED|Overall Study||5
2835370|NCT02427568|3537251|FG001|STARTED|Overall Study||13
2835371|NCT02427568|3537250|FG000|COMPLETED|Overall Study||5
2835372|NCT02427568|3537251|FG001|COMPLETED|Overall Study||13
2835373|NCT02427568|3537250|FG000|NOT COMPLETED|Overall Study||0
2835374|NCT02427568|3537251|FG001|NOT COMPLETED|Overall Study||0
2835375|NCT02335424|3537261|FG000|STARTED|Overall Study||374
2835376|NCT02335424|3537261|FG000|Treated|Overall Study||370
2835377|NCT02335424|3537261|FG000|COMPLETED|Overall Study||0
2835378|NCT02335424|3537261|FG000|NOT COMPLETED|Overall Study||374
2835379|NCT02318277|3537273|FG000|STARTED|Overall Study||6
2835380|NCT02318277|3537274|FG001|STARTED|Overall Study||3
2835381|NCT02318277|3537275|FG002|STARTED|Overall Study||4
2835382|NCT02318277|3537276|FG003|STARTED|Overall Study||4
2835383|NCT02318277|3537277|FG004|STARTED|Overall Study||8
2835384|NCT02318277|3537278|FG005|STARTED|Overall Study||9
2835385|NCT02318277|3537279|FG006|STARTED|Overall Study||49
2835386|NCT02318277|3537280|FG007|STARTED|Overall Study||93
2835387|NCT02318277|3537273|FG000|COMPLETED|Overall Study||0
2835388|NCT02318277|3537274|FG001|COMPLETED|Overall Study||0
2835389|NCT02318277|3537275|FG002|COMPLETED|Overall Study||0
2835390|NCT02318277|3537276|FG003|COMPLETED|Overall Study||0
2835391|NCT02318277|3537277|FG004|COMPLETED|Overall Study||0
2835392|NCT02318277|3537278|FG005|COMPLETED|Overall Study||0
2835393|NCT02318277|3537279|FG006|COMPLETED|Overall Study||0
2835394|NCT02318277|3537280|FG007|COMPLETED|Overall Study||0
2835395|NCT02318277|3537273|FG000|NOT COMPLETED|Overall Study||6
2835396|NCT02318277|3537274|FG001|NOT COMPLETED|Overall Study||3
2835397|NCT02318277|3537275|FG002|NOT COMPLETED|Overall Study||4
2835398|NCT02318277|3537276|FG003|NOT COMPLETED|Overall Study||4
2835399|NCT02318277|3537277|FG004|NOT COMPLETED|Overall Study||8
2835400|NCT02318277|3537278|FG005|NOT COMPLETED|Overall Study||9
2835401|NCT02318277|3537279|FG006|NOT COMPLETED|Overall Study||49
2835402|NCT02318277|3537280|FG007|NOT COMPLETED|Overall Study||93
2835403|NCT02296801|3537316|FG000|STARTED|Overall Study||103
2835404|NCT02296801|3537317|FG001|STARTED|Overall Study||68
2835405|NCT02296801|3537318|FG002|STARTED|Overall Study||69
2835406|NCT02296801|3537319|FG003|STARTED|Overall Study||67
2835407|NCT02296801|3537316|FG000|COMPLETED|Overall Study||83
2835408|NCT02296801|3537317|FG001|COMPLETED|Overall Study||53
2835409|NCT02296801|3537318|FG002|COMPLETED|Overall Study||50
2835410|NCT02296801|3537319|FG003|COMPLETED|Overall Study||58
2835411|NCT02296801|3537316|FG000|NOT COMPLETED|Overall Study||20
2835412|NCT02296801|3537317|FG001|NOT COMPLETED|Overall Study||15
2835413|NCT02296801|3537318|FG002|NOT COMPLETED|Overall Study||19
2835414|NCT02296801|3537319|FG003|NOT COMPLETED|Overall Study||9
2835415|NCT02143063|3537336|FG000|STARTED|Overall Study||61
2835416|NCT02143063|3537337|FG001|STARTED|Overall Study||105
2835417|NCT02143063|3537338|FG002|STARTED|Overall Study||108
2835418|NCT02143063|3537336|FG000|COMPLETED|Overall Study||45
2835419|NCT02143063|3537337|FG001|COMPLETED|Overall Study||75
2835420|NCT02143063|3537338|FG002|COMPLETED|Overall Study||78
2835421|NCT02143063|3537336|FG000|NOT COMPLETED|Overall Study||16
2835422|NCT02143063|3537337|FG001|NOT COMPLETED|Overall Study||30
2835423|NCT02143063|3537338|FG002|NOT COMPLETED|Overall Study||30
2835424|NCT02017964|3537346|FG000|STARTED|Overall Study||26
2835425|NCT02017964|3537346|FG000|COMPLETED|Overall Study||25
2835426|NCT02017964|3537346|FG000|NOT COMPLETED|Overall Study||1
2835427|NCT01968785|3537352|FG000|STARTED|Overall Study||2
2835428|NCT01968785|3537353|FG001|STARTED|Overall Study||0
2835429|NCT01968785|3537352|FG000|COMPLETED|Overall Study||1
2835430|NCT01968785|3537353|FG001|COMPLETED|Overall Study||0
2835431|NCT01968785|3537352|FG000|NOT COMPLETED|Overall Study||1
2835432|NCT01968785|3537353|FG001|NOT COMPLETED|Overall Study||0
2835433|NCT01956110|3537361|FG000|STARTED|Overall Study||665
2835434|NCT01956110|3537362|FG001|STARTED|Overall Study||661
2835435|NCT01956110|3537361|FG000|COMPLETED|Overall Study||630
2835436|NCT01956110|3537362|FG001|COMPLETED|Overall Study||639
2835437|NCT01956110|3537361|FG000|NOT COMPLETED|Overall Study||35
2835438|NCT01956110|3537362|FG001|NOT COMPLETED|Overall Study||22
2835439|NCT01648023|3537371|FG000|STARTED|Overall Study||25
2835440|NCT01648023|3537372|FG001|STARTED|Overall Study||24
2835441|NCT01648023|3537371|FG000|COMPLETED|Overall Study||24
2835442|NCT01648023|3537372|FG001|COMPLETED|Overall Study||22
2835443|NCT01648023|3537371|FG000|NOT COMPLETED|Overall Study||1
2835444|NCT01648023|3537372|FG001|NOT COMPLETED|Overall Study||2
2835445|NCT01335581|3537380|FG000|STARTED|Overall Study||9
2835446|NCT01335581|3537381|FG001|STARTED|Overall Study||9
2835447|NCT01335581|3537380|FG000|COMPLETED|Overall Study||5
2835448|NCT01335581|3537381|FG001|COMPLETED|Overall Study||3
2835449|NCT01335581|3537380|FG000|NOT COMPLETED|Overall Study||4
2835450|NCT01335581|3537381|FG001|NOT COMPLETED|Overall Study||6
2835451|NCT01209923|3537387|FG000|STARTED|Overall Study||362
2835452|NCT01209923|3537387|FG000|COMPLETED|Overall Study||362
2835453|NCT01209923|3537387|FG000|NOT COMPLETED|Overall Study||0
2835454|NCT01083433|3537395|FG000|STARTED|Overall Study||22
2835455|NCT01083433|3537396|FG001|STARTED|Overall Study||23
2835456|NCT01083433|3537397|FG002|STARTED|Overall Study||23
2835457|NCT01083433|3537395|FG000|COMPLETED|Overall Study||20
2835458|NCT01083433|3537396|FG001|COMPLETED|Overall Study||17
2835459|NCT01083433|3537397|FG002|COMPLETED|Overall Study||18
2835460|NCT01083433|3537395|FG000|NOT COMPLETED|Overall Study||2
2835461|NCT01083433|3537396|FG001|NOT COMPLETED|Overall Study||6
2835462|NCT01083433|3537397|FG002|NOT COMPLETED|Overall Study||5
2835463|NCT00920387|3537411|FG000|STARTED|Overall Study||8
2835464|NCT00920387|3537412|FG001|STARTED|Overall Study||4
2835465|NCT00920387|3537411|FG000|COMPLETED|Overall Study||8
2835466|NCT00920387|3537412|FG001|COMPLETED|Overall Study||3
2835467|NCT00920387|3537411|FG000|NOT COMPLETED|Overall Study||0
2835468|NCT00920387|3537412|FG001|NOT COMPLETED|Overall Study||1
2835469|NCT00787176|3537423|FG000|STARTED|Overall Study||69
2835470|NCT00787176|3537424|FG001|STARTED|Overall Study||62
2835471|NCT00787176|3537425|FG002|STARTED|Overall Study||60
2835472|NCT00787176|3537426|FG003|STARTED|Overall Study||60
2835473|NCT00787176|3537423|FG000|COMPLETED|Overall Study||62
2835474|NCT00787176|3537424|FG001|COMPLETED|Overall Study||59
2835475|NCT00787176|3537425|FG002|COMPLETED|Overall Study||54
2835476|NCT00787176|3537426|FG003|COMPLETED|Overall Study||55
2835477|NCT00787176|3537423|FG000|NOT COMPLETED|Overall Study||7
2835478|NCT00787176|3537424|FG001|NOT COMPLETED|Overall Study||3
2835479|NCT00787176|3537425|FG002|NOT COMPLETED|Overall Study||6
2835480|NCT00787176|3537426|FG003|NOT COMPLETED|Overall Study||5
2835481|NCT00352534|3537439|FG000|STARTED|Initial Staging||211
2835482|NCT00352534|3537440|FG001|STARTED|Initial Staging||597
2835483|NCT00352534|3537441|FG002|STARTED|Initial Staging||0
2835484|NCT00352534|3537442|FG003|STARTED|Initial Staging||0
2835485|NCT00352534|3537443|FG004|STARTED|Initial Staging||0
2835486|NCT00352534|3537444|FG005|STARTED|Initial Staging||0
2835487|NCT00352534|3537445|FG006|STARTED|Initial Staging||0
2835488|NCT00352534|3537439|FG000|COMPLETED|Initial Staging||203
2835489|NCT00352534|3537440|FG001|COMPLETED|Initial Staging||588
2835490|NCT00352534|3537441|FG002|COMPLETED|Initial Staging||0
2835491|NCT00352534|3537442|FG003|COMPLETED|Initial Staging||0
2835492|NCT00352534|3537443|FG004|COMPLETED|Initial Staging||0
2835493|NCT00352534|3537444|FG005|COMPLETED|Initial Staging||0
2835494|NCT00352534|3537445|FG006|COMPLETED|Initial Staging||0
2835495|NCT00352534|3537439|FG000|NOT COMPLETED|Initial Staging||8
2835496|NCT00352534|3537440|FG001|NOT COMPLETED|Initial Staging||9
2835497|NCT00352534|3537441|FG002|NOT COMPLETED|Initial Staging||0
2835498|NCT00352534|3537442|FG003|NOT COMPLETED|Initial Staging||0
2835499|NCT00352534|3537443|FG004|NOT COMPLETED|Initial Staging||0
2835500|NCT00352534|3537444|FG005|NOT COMPLETED|Initial Staging||0
2835501|NCT00352534|3537445|FG006|NOT COMPLETED|Initial Staging||0
2835502|NCT00352534|3537439|FG000|STARTED|Final Risk Group Assignment||0
2835503|NCT00352534|3537440|FG001|STARTED|Final Risk Group Assignment||0
2835504|NCT00352534|3537441|FG002|STARTED|Final Risk Group Assignment||119
2835505|NCT00352534|3537442|FG003|STARTED|Final Risk Group Assignment||52
2835506|NCT00352534|3537443|FG004|STARTED|Final Risk Group Assignment||32
2835507|NCT00352534|3537444|FG005|STARTED|Final Risk Group Assignment||548
2835508|NCT00352534|3537445|FG006|STARTED|Final Risk Group Assignment||40
2835509|NCT00352534|3537439|FG000|COMPLETED|Final Risk Group Assignment||0
2835510|NCT00352534|3537440|FG001|COMPLETED|Final Risk Group Assignment||0
2835511|NCT00352534|3537441|FG002|COMPLETED|Final Risk Group Assignment||116
2835512|NCT00352534|3537442|FG003|COMPLETED|Final Risk Group Assignment||49
2835513|NCT00352534|3537443|FG004|COMPLETED|Final Risk Group Assignment||31
2835514|NCT00352534|3537444|FG005|COMPLETED|Final Risk Group Assignment||503
2835515|NCT00352534|3537445|FG006|COMPLETED|Final Risk Group Assignment||1
2835516|NCT00352534|3537439|FG000|NOT COMPLETED|Final Risk Group Assignment||0
2835517|NCT00352534|3537440|FG001|NOT COMPLETED|Final Risk Group Assignment||0
2835518|NCT00352534|3537441|FG002|NOT COMPLETED|Final Risk Group Assignment||3
2835519|NCT00352534|3537442|FG003|NOT COMPLETED|Final Risk Group Assignment||3
2835520|NCT00352534|3537443|FG004|NOT COMPLETED|Final Risk Group Assignment||1
2835521|NCT00352534|3537444|FG005|NOT COMPLETED|Final Risk Group Assignment||45
2835522|NCT00352534|3537445|FG006|NOT COMPLETED|Final Risk Group Assignment||39
2835523|NCT00033293|3537457|FG000|STARTED|Overall Study||26
2835524|NCT00033293|3537458|FG001|STARTED|Overall Study||27
2835525|NCT00033293|3537457|FG000|COMPLETED|Overall Study||16
2835526|NCT00033293|3537458|FG001|COMPLETED|Overall Study||9
2835527|NCT00033293|3537457|FG000|NOT COMPLETED|Overall Study||10
2835528|NCT00033293|3537458|FG001|NOT COMPLETED|Overall Study||18
2914884|NCT00506519|3625055|FG001|Completed Treatment (Day 5)|Overall Study||7
2914885|NCT00506519|3625056|FG002|Completed Treatment (Day 5)|Overall Study||5
2914886|NCT00506519|3625054|FG000|Day 28 Follow up|Overall Study||8
2914887|NCT00506519|3625055|FG001|Day 28 Follow up|Overall Study||6
2914888|NCT00506519|3625056|FG002|Day 28 Follow up|Overall Study||5
2914889|NCT00506519|3625054|FG000|COMPLETED|Overall Study||5
2914890|NCT00506519|3625055|FG001|COMPLETED|Overall Study||4
2914891|NCT00506519|3625056|FG002|COMPLETED|Overall Study||5
2914892|NCT00506519|3625054|FG000|NOT COMPLETED|Overall Study||5
2914893|NCT00506519|3625055|FG001|NOT COMPLETED|Overall Study||6
2914894|NCT00506519|3625056|FG002|NOT COMPLETED|Overall Study||0
2914895|NCT00506597|3625067|FG000|STARTED|Overall Study||33
2914896|NCT00506597|3625067|FG000|COMPLETED|Overall Study||33
2914897|NCT00506597|3625067|FG000|NOT COMPLETED|Overall Study||0
2914898|NCT00506662|3625073|FG000|STARTED|Overall Study||38
2914899|NCT00506662|3625074|FG001|STARTED|Overall Study||48
2914900|NCT00506662|3625073|FG000|COMPLETED|Overall Study||21
2914901|NCT00506662|3625074|FG001|COMPLETED|Overall Study||20
2914902|NCT00506662|3625073|FG000|NOT COMPLETED|Overall Study||17
2914903|NCT00506662|3625074|FG001|NOT COMPLETED|Overall Study||28
2914904|NCT00506675|3625082|FG000|STARTED|Overall Study||27
2914905|NCT00506675|3625083|FG001|STARTED|Overall Study||28
2914906|NCT00506675|3625082|FG000|COMPLETED|Overall Study||27
2914907|NCT00506675|3625083|FG001|COMPLETED|Overall Study||28
2914908|NCT00506675|3625082|FG000|NOT COMPLETED|Overall Study||0
2914909|NCT00506675|3625083|FG001|NOT COMPLETED|Overall Study||0
2914910|NCT00506714|3625091|FG000|STARTED|Overall Study||13
2914911|NCT00506714|3625092|FG001|STARTED|Overall Study||13
2914912|NCT00506714|3625091|FG000|COMPLETED|Overall Study||13
2914913|NCT00506714|3625092|FG001|COMPLETED|Overall Study||13
2914914|NCT00506714|3625091|FG000|NOT COMPLETED|Overall Study||0
2914915|NCT00506714|3625092|FG001|NOT COMPLETED|Overall Study||0
3167154|NCT01908426|3894316|FG000|NOT COMPLETED|Overall Study||397
3167155|NCT01908426|3894317|FG001|NOT COMPLETED|Overall Study||211
3167156|NCT01908530|3894326|FG000|STARTED|Overall Study||8
3167157|NCT01908530|3894327|FG001|STARTED|Overall Study||8
3167158|NCT01908530|3894328|FG002|STARTED|Overall Study||10
2914916|NCT00506753|3625102|FG000|STARTED|Overall Study||100
2914917|NCT00506753|3625103|FG001|STARTED|Overall Study||99
2914918|NCT00506753|3625102|FG000|COMPLETED|Overall Study||79
2914919|NCT00506753|3625103|FG001|COMPLETED|Overall Study||84
2914920|NCT00506753|3625102|FG000|NOT COMPLETED|Overall Study||21
2914921|NCT00506753|3625103|FG001|NOT COMPLETED|Overall Study||15
2914922|NCT00506779|3625111|FG000|STARTED|Overall Study||4
2914923|NCT00506779|3625112|FG001|STARTED|Overall Study||6
2914924|NCT00506779|3625113|FG002|STARTED|Overall Study||2
2914925|NCT00506779|3625114|FG003|STARTED|Overall Study||5
2914926|NCT00506779|3625111|FG000|COMPLETED|Overall Study||3
2914927|NCT00506779|3625112|FG001|COMPLETED|Overall Study||5
2914928|NCT00506779|3625113|FG002|COMPLETED|Overall Study||0
2914929|NCT00506779|3625114|FG003|COMPLETED|Overall Study||4
2914930|NCT00506779|3625111|FG000|NOT COMPLETED|Overall Study||1
2914931|NCT00506779|3625112|FG001|NOT COMPLETED|Overall Study||1
2914932|NCT00506779|3625113|FG002|NOT COMPLETED|Overall Study||2
2914933|NCT00506779|3625114|FG003|NOT COMPLETED|Overall Study||1
2914934|NCT00506831|3625125|FG000|STARTED|Overall Study||9
2914935|NCT00506831|3625125|FG000|COMPLETED|Overall Study||7
2914936|NCT00506831|3625125|FG000|NOT COMPLETED|Overall Study||2
2914937|NCT00506857|3625129|FG000|STARTED|Overall Study||80
2914938|NCT00506857|3625129|FG000|COMPLETED|Overall Study||80
2914939|NCT00506857|3625129|FG000|NOT COMPLETED|Overall Study||0
2914940|NCT00506883|3625137|FG000|STARTED|Overall Study||52
2914941|NCT00506883|3625138|FG001|STARTED|Overall Study||74
2914942|NCT00506883|3625139|FG002|STARTED|Overall Study||59
2914943|NCT00506883|3625137|FG000|COMPLETED|Overall Study||45
2914944|NCT00506883|3625138|FG001|COMPLETED|Overall Study||71
2914945|NCT00506883|3625139|FG002|COMPLETED|Overall Study||55
2914946|NCT00506883|3625137|FG000|NOT COMPLETED|Overall Study||7
2914947|NCT00506883|3625138|FG001|NOT COMPLETED|Overall Study||3
2914948|NCT00506883|3625139|FG002|NOT COMPLETED|Overall Study||4
3167159|NCT01908530|3894326|FG000|COMPLETED|Overall Study||8
2835529|NCT04497415|3537468|FG000|STARTED|Overall Study||229
2835530|NCT04497415|3537469|FG001|STARTED|Overall Study||121
2835531|NCT04497415|3537468|FG000|Post-intervention Assessment (Day 1)|Overall Study||229
2835532|NCT04497415|3537469|FG001|Post-intervention Assessment (Day 1)|Overall Study||121
2835533|NCT04497415|3537468|FG000|First Follow-up Assessment (Day 14)|Overall Study||195
2835534|NCT04497415|3537469|FG001|First Follow-up Assessment (Day 14)|Overall Study||102
2835535|NCT04497415|3537468|FG000|COMPLETED|Overall Study||186
2835536|NCT04497415|3537469|FG001|COMPLETED|Overall Study||94
2835537|NCT04497415|3537468|FG000|NOT COMPLETED|Overall Study||43
2835538|NCT04497415|3537469|FG001|NOT COMPLETED|Overall Study||27
2835575|NCT03725293|3537532|FG000|STARTED|Overall Study||106
2835576|NCT03725293|3537533|FG001|STARTED|Overall Study||106
2835577|NCT03725293|3537532|FG000|COMPLETED|Overall Study||94
2835578|NCT03725293|3537533|FG001|COMPLETED|Overall Study||97
2835579|NCT03725293|3537532|FG000|NOT COMPLETED|Overall Study||12
2835580|NCT03725293|3537533|FG001|NOT COMPLETED|Overall Study||9
2835581|NCT03702231|3537542|FG000|STARTED|Overall Study||59
2835582|NCT03702231|3537543|FG001|STARTED|Overall Study||29
2835583|NCT03702231|3537544|FG002|STARTED|Overall Study||28
2835584|NCT03702231|3537542|FG000|COMPLETED|Overall Study||55
2835585|NCT03702231|3537543|FG001|COMPLETED|Overall Study||25
2835586|NCT03702231|3537544|FG002|COMPLETED|Overall Study||26
2835587|NCT03702231|3537542|FG000|NOT COMPLETED|Overall Study||4
2835588|NCT03702231|3537543|FG001|NOT COMPLETED|Overall Study||4
2835589|NCT03702231|3537544|FG002|NOT COMPLETED|Overall Study||2
2835590|NCT03690284|3537554|FG000|STARTED|Overall Study||25
2835591|NCT03690284|3537555|FG001|STARTED|Overall Study||25
2835592|NCT03690284|3537554|FG000|COMPLETED|Overall Study||25
2835593|NCT03690284|3537555|FG001|COMPLETED|Overall Study||25
2835594|NCT03690284|3537554|FG000|NOT COMPLETED|Overall Study||0
2835595|NCT03690284|3537555|FG001|NOT COMPLETED|Overall Study||0
2835596|NCT03670277|3537563|FG000|STARTED|Overall Study||20
2835597|NCT03670277|3537564|FG001|STARTED|Overall Study||8
2835598|NCT03670277|3537563|FG000|COMPLETED|Overall Study||20
2835599|NCT03670277|3537564|FG001|COMPLETED|Overall Study||8
2835600|NCT03670277|3537563|FG000|NOT COMPLETED|Overall Study||0
2835601|NCT03670277|3537564|FG001|NOT COMPLETED|Overall Study||0
2835602|NCT03600805|3537577|FG000|STARTED|Overall Study||28
2835603|NCT03600805|3537578|FG001|STARTED|Overall Study||14
2835604|NCT03600805|3537579|FG002|STARTED|Overall Study||14
2835605|NCT03600805|3537580|FG003|STARTED|Overall Study||27
2835606|NCT03600805|3537577|FG000|Week 52 Analysis Set Population|Overall Study||10
2835607|NCT03600805|3537578|FG001|Week 52 Analysis Set Population|Overall Study||6
2835608|NCT03600805|3537579|FG002|Week 52 Analysis Set Population|Overall Study||7
2835609|NCT03600805|3537580|FG003|Week 52 Analysis Set Population|Overall Study||13
2835610|NCT03600805|3537577|FG000|COMPLETED|Overall Study||9
2835611|NCT03600805|3537578|FG001|COMPLETED|Overall Study||6
2835612|NCT03600805|3537579|FG002|COMPLETED|Overall Study||6
2835613|NCT03600805|3537580|FG003|COMPLETED|Overall Study||8
2835614|NCT03600805|3537577|FG000|NOT COMPLETED|Overall Study||19
2835615|NCT03600805|3537578|FG001|NOT COMPLETED|Overall Study||8
2835616|NCT03600805|3537579|FG002|NOT COMPLETED|Overall Study||8
2835617|NCT03600805|3537580|FG003|NOT COMPLETED|Overall Study||19
2835618|NCT03556358|3537594|FG000|STARTED|Overall Study||404
2835619|NCT03556358|3537595|FG001|STARTED|Overall Study||405
2835620|NCT03556358|3537594|FG000|Subjects Treated|Overall Study||401
2835621|NCT03556358|3537595|FG001|Subjects Treated|Overall Study||405
2835622|NCT03556358|3537594|FG000|Subjects Receiving TX05 or Herceptin|Overall Study||394
2835623|NCT03556358|3537595|FG001|Subjects Receiving TX05 or Herceptin|Overall Study||400
2835624|NCT03556358|3537594|FG000|COMPLETED|Overall Study||393
2835625|NCT03556358|3537595|FG001|COMPLETED|Overall Study||393
2835626|NCT03556358|3537594|FG000|NOT COMPLETED|Overall Study||11
2835627|NCT03556358|3537595|FG001|NOT COMPLETED|Overall Study||12
2835628|NCT03290781|3537608|FG000|STARTED|Overall Study||73
2835629|NCT03290781|3537609|FG001|STARTED|Overall Study||71
2835630|NCT03290781|3537610|FG002|STARTED|Overall Study||86
2835631|NCT03290781|3537611|FG003|STARTED|Overall Study||82
2835632|NCT03290781|3537612|FG004|STARTED|Overall Study||11
2835633|NCT03290781|3537613|FG005|STARTED|Overall Study||22
2835634|NCT03290781|3537614|FG006|STARTED|Overall Study||21
2835635|NCT03290781|3537608|FG000|COMPLETED|Overall Study||24
2835636|NCT03290781|3537609|FG001|COMPLETED|Overall Study||53
2835637|NCT03290781|3537610|FG002|COMPLETED|Overall Study||30
2835638|NCT03290781|3537611|FG003|COMPLETED|Overall Study||59
2835639|NCT03290781|3537612|FG004|COMPLETED|Overall Study||6
2835640|NCT03290781|3537613|FG005|COMPLETED|Overall Study||19
2835641|NCT03290781|3537614|FG006|COMPLETED|Overall Study||17
2835642|NCT03290781|3537608|FG000|NOT COMPLETED|Overall Study||49
2835643|NCT03290781|3537609|FG001|NOT COMPLETED|Overall Study||18
2835644|NCT03290781|3537610|FG002|NOT COMPLETED|Overall Study||56
2835645|NCT03290781|3537611|FG003|NOT COMPLETED|Overall Study||23
2835646|NCT03290781|3537612|FG004|NOT COMPLETED|Overall Study||5
2835647|NCT03290781|3537613|FG005|NOT COMPLETED|Overall Study||3
2835648|NCT03290781|3537614|FG006|NOT COMPLETED|Overall Study||4
2835649|NCT03263195|3537641|FG000|STARTED|Overall Study||174
2835650|NCT03263195|3537642|FG001|STARTED|Overall Study||0
2835651|NCT03263195|3537643|FG002|STARTED|Overall Study||0
2835652|NCT03263195|3537644|FG003|STARTED|Overall Study||26
2835653|NCT03263195|3537645|FG004|STARTED|Overall Study||170
2835654|NCT03263195|3537646|FG005|STARTED|Overall Study||0
2835655|NCT03263195|3537647|FG006|STARTED|Overall Study||0
2835539|NCT04231396|3537475|FG000|STARTED|Overall Study||27
2835540|NCT04231396|3537475|FG000|COMPLETED|Overall Study||27
2835541|NCT04231396|3537475|FG000|NOT COMPLETED|Overall Study||0
2835542|NCT04118348|3537484|FG000|STARTED|Overall Study||3445
2835543|NCT04118348|3537485|FG001|STARTED|Overall Study||3312
2835544|NCT04118348|3537486|FG002|STARTED|Overall Study||3461
2835545|NCT04118348|3537487|FG003|STARTED|Overall Study||3262
2835546|NCT04118348|3537484|FG000|COMPLETED|Overall Study||3445
2835547|NCT04118348|3537485|FG001|COMPLETED|Overall Study||3312
2835548|NCT04118348|3537486|FG002|COMPLETED|Overall Study||3461
2835549|NCT04118348|3537487|FG003|COMPLETED|Overall Study||3262
2835550|NCT04118348|3537484|FG000|NOT COMPLETED|Overall Study||0
2835551|NCT04118348|3537485|FG001|NOT COMPLETED|Overall Study||0
2835552|NCT04118348|3537486|FG002|NOT COMPLETED|Overall Study||0
2835553|NCT04118348|3537487|FG003|NOT COMPLETED|Overall Study||0
2835554|NCT03894540|3537503|FG000|STARTED|Overall Study||1
2835555|NCT03894540|3537504|FG001|STARTED|Overall Study||1
2835556|NCT03894540|3537505|FG002|STARTED|Overall Study||1
2835557|NCT03894540|3537506|FG003|STARTED|Overall Study||4
2835558|NCT03894540|3537507|FG004|STARTED|Overall Study||11
2835559|NCT03894540|3537508|FG005|STARTED|Overall Study||4
2835560|NCT03894540|3537503|FG000|COMPLETED|Overall Study||0
2835561|NCT03894540|3537504|FG001|COMPLETED|Overall Study||0
2835562|NCT03894540|3537505|FG002|COMPLETED|Overall Study||0
2835563|NCT03894540|3537506|FG003|COMPLETED|Overall Study||0
2835564|NCT03894540|3537507|FG004|COMPLETED|Overall Study||0
2835565|NCT03894540|3537508|FG005|COMPLETED|Overall Study||0
2835566|NCT03894540|3537503|FG000|NOT COMPLETED|Overall Study||1
2835567|NCT03894540|3537504|FG001|NOT COMPLETED|Overall Study||1
2835568|NCT03894540|3537505|FG002|NOT COMPLETED|Overall Study||1
3311424|NCT03052517|4044937|FG002|COMPLETED|Overall Study||32
3311425|NCT03052517|4044935|FG000|NOT COMPLETED|Overall Study||1017
3311426|NCT03052517|4044936|FG001|NOT COMPLETED|Overall Study||1014
3311427|NCT03052517|4044937|FG002|NOT COMPLETED|Overall Study||328
3311428|NCT03052530|4044945|FG000|STARTED|Overall Study||61
2835569|NCT03894540|3537506|FG003|NOT COMPLETED|Overall Study||4
2835570|NCT03894540|3537507|FG004|NOT COMPLETED|Overall Study||11
2835571|NCT03894540|3537508|FG005|NOT COMPLETED|Overall Study||4
2835572|NCT03816202|3537526|FG000|STARTED|Overall Study||100
2835573|NCT03816202|3537526|FG000|COMPLETED|Overall Study||100
2835574|NCT03816202|3537526|FG000|NOT COMPLETED|Overall Study||0
2835656|NCT03263195|3537648|FG007|STARTED|Overall Study||25
2835657|NCT03263195|3537641|FG000|COMPLETED|Overall Study||168
2835658|NCT03263195|3537642|FG001|COMPLETED|Overall Study||0
2835659|NCT03263195|3537643|FG002|COMPLETED|Overall Study||0
2835660|NCT03263195|3537644|FG003|COMPLETED|Overall Study||23
2835661|NCT03263195|3537645|FG004|COMPLETED|Overall Study||155
2835662|NCT03263195|3537646|FG005|COMPLETED|Overall Study||0
2835663|NCT03263195|3537647|FG006|COMPLETED|Overall Study||0
2835664|NCT03263195|3537648|FG007|COMPLETED|Overall Study||19
2835665|NCT03263195|3537641|FG000|NOT COMPLETED|Overall Study||6
2835666|NCT03263195|3537642|FG001|NOT COMPLETED|Overall Study||0
2835667|NCT03263195|3537643|FG002|NOT COMPLETED|Overall Study||0
2835668|NCT03263195|3537644|FG003|NOT COMPLETED|Overall Study||3
2835669|NCT03263195|3537645|FG004|NOT COMPLETED|Overall Study||15
2835670|NCT03263195|3537646|FG005|NOT COMPLETED|Overall Study||0
2835671|NCT03263195|3537647|FG006|NOT COMPLETED|Overall Study||0
3167160|NCT01908530|3894327|FG001|COMPLETED|Overall Study||8
3167161|NCT01908530|3894328|FG002|COMPLETED|Overall Study||10
3167162|NCT01908530|3894326|FG000|NOT COMPLETED|Overall Study||0
3167163|NCT01908530|3894327|FG001|NOT COMPLETED|Overall Study||0
3167164|NCT01908530|3894328|FG002|NOT COMPLETED|Overall Study||0
3167165|NCT01908582|3894339|FG000|STARTED|Period 1||26
3167166|NCT01908582|3894339|FG000|Received at Least One Dose of Study Drug|Period 1||26
3167167|NCT01908582|3894339|FG000|COMPLETED|Period 1||26
3167168|NCT01908582|3894339|FG000|NOT COMPLETED|Period 1||0
3167169|NCT01908582|3894339|FG000|STARTED|Period 2||26
2835672|NCT03263195|3537648|FG007|NOT COMPLETED|Overall Study||6
2835673|NCT03228680|3537673|FG000|STARTED|Overall Study||170
2835674|NCT03228680|3537674|FG001|STARTED|Overall Study||178
2835675|NCT03228680|3537673|FG000|COMPLETED|Overall Study||147
2835676|NCT03228680|3537674|FG001|COMPLETED|Overall Study||143
2835677|NCT03228680|3537673|FG000|NOT COMPLETED|Overall Study||23
2835678|NCT03228680|3537674|FG001|NOT COMPLETED|Overall Study||35
2835679|NCT03196167|3537683|FG000|STARTED|Overall Study||45
2835680|NCT03196167|3537684|FG001|STARTED|Overall Study||45
2835681|NCT03196167|3537683|FG000|COMPLETED|Overall Study||40
2835682|NCT03196167|3537684|FG001|COMPLETED|Overall Study||43
2835683|NCT03196167|3537683|FG000|NOT COMPLETED|Overall Study||5
2835684|NCT03196167|3537684|FG001|NOT COMPLETED|Overall Study||2
2835685|NCT03170882|3537696|FG000|STARTED|Overall Study||49
2835686|NCT03170882|3537697|FG001|STARTED|Overall Study||73
2835687|NCT03170882|3537696|FG000|Treated: Safety Population|Overall Study||47
2835688|NCT03170882|3537697|FG001|Treated: Safety Population|Overall Study||72
2835689|NCT03170882|3537696|FG000|ITT PRO Population|Overall Study||45
2835690|NCT03170882|3537697|FG001|ITT PRO Population|Overall Study||70
2835691|NCT03170882|3537696|FG000|COMPLETED|Overall Study||20
2835692|NCT03170882|3537697|FG001|COMPLETED|Overall Study||22
2835693|NCT03170882|3537696|FG000|NOT COMPLETED|Overall Study||29
2835694|NCT03170882|3537697|FG001|NOT COMPLETED|Overall Study||51
3167170|NCT01908582|3894339|FG000|COMPLETED|Period 2||24
3167171|NCT01908582|3894339|FG000|NOT COMPLETED|Period 2||2
3311429|NCT03052530|4044945|FG000|COMPLETED|Overall Study||61
2835695|NCT03077204|3537703|FG000|STARTED|Overall Study||20
2835696|NCT03077204|3537703|FG000|COMPLETED|Overall Study||20
2835697|NCT03077204|3537703|FG000|NOT COMPLETED|Overall Study||0
2835698|NCT03064126|3537712|FG000|STARTED|Overall Study||278
2835699|NCT03064126|3537713|FG001|STARTED|Overall Study||98
2835700|NCT03064126|3537714|FG002|STARTED|Overall Study||52
2835701|NCT03064126|3537715|FG003|STARTED|Overall Study||12
2835702|NCT03064126|3537712|FG000|COMPLETED|Overall Study||252
2835703|NCT03064126|3537713|FG001|COMPLETED|Overall Study||91
2835704|NCT03064126|3537714|FG002|COMPLETED|Overall Study||49
2835705|NCT03064126|3537715|FG003|COMPLETED|Overall Study||11
2835706|NCT03064126|3537712|FG000|NOT COMPLETED|Overall Study||26
2835707|NCT03064126|3537713|FG001|NOT COMPLETED|Overall Study||7
2835708|NCT03064126|3537714|FG002|NOT COMPLETED|Overall Study||3
2835709|NCT03064126|3537715|FG003|NOT COMPLETED|Overall Study||1
2835710|NCT03029611|3537726|FG000|STARTED|Overall Study|We had 11 patients sign consent with 2 patients deciding not to continue to receive treatment.|9
2835711|NCT03029611|3537726|FG000|COMPLETED|Overall Study|Please note that we did not fully enroll this study due to lack of funding. The complete date here relates to the last treatment administration.|9
2835712|NCT03029611|3537726|FG000|NOT COMPLETED|Overall Study||0
2835713|NCT02891798|3537732|FG000|STARTED|Overall Study||62
2835714|NCT02891798|3537733|FG001|STARTED|Overall Study||16
2835715|NCT02891798|3537732|FG000|COMPLETED|Overall Study||62
2835716|NCT02891798|3537733|FG001|COMPLETED|Overall Study||16
2835717|NCT02891798|3537732|FG000|NOT COMPLETED|Overall Study||0
2835718|NCT02891798|3537733|FG001|NOT COMPLETED|Overall Study||0
2835719|NCT02679781|3537741|FG000|STARTED|Overall Study||37
2835720|NCT02679781|3537742|FG001|STARTED|Overall Study||33
2835721|NCT02679781|3537741|FG000|COMPLETED|Overall Study||30
2835722|NCT02679781|3537742|FG001|COMPLETED|Overall Study||30
2835723|NCT02679781|3537741|FG000|NOT COMPLETED|Overall Study||7
2835724|NCT02679781|3537742|FG001|NOT COMPLETED|Overall Study||3
2835725|NCT02624869|3537751|FG000|STARTED|Overall Study||49
2835726|NCT02624869|3537752|FG001|STARTED|Overall Study||101
2835727|NCT02624869|3537753|FG002|STARTED|Overall Study||13
2835728|NCT02624869|3537751|FG000|Received Study Drug|Overall Study||49
2835729|NCT02624869|3537752|FG001|Received Study Drug|Overall Study||101
2835730|NCT02624869|3537753|FG002|Received Study Drug|Overall Study||12
2835731|NCT02624869|3537751|FG000|COMPLETED|Overall Study||48
2835732|NCT02624869|3537752|FG001|COMPLETED|Overall Study||98
2835733|NCT02624869|3537753|FG002|COMPLETED|Overall Study||11
2835734|NCT02624869|3537751|FG000|NOT COMPLETED|Overall Study||1
2835735|NCT02624869|3537752|FG001|NOT COMPLETED|Overall Study||3
2835736|NCT02624869|3537753|FG002|NOT COMPLETED|Overall Study||2
2835737|NCT02614690|3537765|FG000|STARTED|Overall Study||20
2835738|NCT02614690|3537766|FG001|STARTED|Overall Study||20
2835739|NCT02614690|3537767|FG002|STARTED|Overall Study||20
2835740|NCT02614690|3537765|FG000|COMPLETED|Overall Study||20
2835741|NCT02614690|3537766|FG001|COMPLETED|Overall Study||20
2835742|NCT02614690|3537767|FG002|COMPLETED|Overall Study||20
2835743|NCT02614690|3537765|FG000|NOT COMPLETED|Overall Study||0
2835744|NCT02614690|3537766|FG001|NOT COMPLETED|Overall Study||0
2835745|NCT02614690|3537767|FG002|NOT COMPLETED|Overall Study||0
2835746|NCT02569242|3537777|FG000|STARTED|Overall Study|Included in intention-to-treat analysis for overall survival and progression-free survival|210
2835747|NCT02569242|3537778|FG001|STARTED|Overall Study|Included in intention-to-treat analysis for overall survival and progression-free survival|209
2835748|NCT02569242|3537777|FG000|COMPLETED|Overall Study|Analysed for safety|209
2835749|NCT02569242|3537778|FG001|COMPLETED|Overall Study|Analysed for safety|208
2835750|NCT02569242|3537777|FG000|NOT COMPLETED|Overall Study||1
2835751|NCT02569242|3537778|FG001|NOT COMPLETED|Overall Study||1
2914949|NCT00506922|3625152|FG000|STARTED|Overall Study||37
2914950|NCT00506922|3625153|FG001|STARTED|Overall Study||10
2914951|NCT00506922|3625154|FG002|STARTED|Overall Study||29
2914952|NCT00506922|3625155|FG003|STARTED|Overall Study||63
2914953|NCT00506922|3625156|FG004|STARTED|Overall Study||11
2914954|NCT00506922|3625152|FG000|COMPLETED|Overall Study||37
2914955|NCT00506922|3625153|FG001|COMPLETED|Overall Study||10
2914956|NCT00506922|3625154|FG002|COMPLETED|Overall Study||29
2914957|NCT00506922|3625155|FG003|COMPLETED|Overall Study||61
2914958|NCT00506922|3625156|FG004|COMPLETED|Overall Study||10
2914959|NCT00506922|3625152|FG000|NOT COMPLETED|Overall Study||0
2914960|NCT00506922|3625153|FG001|NOT COMPLETED|Overall Study||0
2914961|NCT00506922|3625154|FG002|NOT COMPLETED|Overall Study||0
2914962|NCT00506922|3625155|FG003|NOT COMPLETED|Overall Study||2
2914963|NCT00506922|3625156|FG004|NOT COMPLETED|Overall Study||1
2914964|NCT00506948|3625164|FG000|STARTED|Overall Study||10
2914965|NCT00506948|3625164|FG000|COMPLETED|Overall Study||0
2914966|NCT00506948|3625164|FG000|NOT COMPLETED|Overall Study||10
2914967|NCT00507026|3625171|FG000|STARTED|Overall Study||145
2914968|NCT00507026|3625172|FG001|STARTED|Overall Study||60
2914969|NCT00507026|3625173|FG002|STARTED|Overall Study||72
2914970|NCT00507026|3625171|FG000|COMPLETED|Overall Study||132
2914971|NCT00507026|3625172|FG001|COMPLETED|Overall Study||56
2914972|NCT00507026|3625173|FG002|COMPLETED|Overall Study||51
2914973|NCT00507026|3625171|FG000|NOT COMPLETED|Overall Study||13
2914974|NCT00507026|3625172|FG001|NOT COMPLETED|Overall Study||4
2914975|NCT00507026|3625173|FG002|NOT COMPLETED|Overall Study||21
2914976|NCT00507130|3625185|FG000|STARTED|Overall Study||9
2914977|NCT00507130|3625186|FG001|STARTED|Overall Study||9
2914978|NCT00507130|3625187|FG002|STARTED|Overall Study||9
2914979|NCT00507130|3625188|FG003|STARTED|Overall Study||9
2835752|NCT02516969|3537786|FG000|STARTED|Overall Study||3
2835753|NCT02516969|3537787|FG001|STARTED|Overall Study||4
2835754|NCT02516969|3537786|FG000|COMPLETED|Overall Study||3
2835755|NCT02516969|3537787|FG001|COMPLETED|Overall Study||4
2835756|NCT02516969|3537786|FG000|NOT COMPLETED|Overall Study||0
2835757|NCT02516969|3537787|FG001|NOT COMPLETED|Overall Study||0
2835758|NCT02507960|3537795|FG000|STARTED|Overall Study||17
2835759|NCT02507960|3537795|FG000|COMPLETED|Overall Study||17
2835760|NCT02507960|3537795|FG000|NOT COMPLETED|Overall Study||0
2835761|NCT02435433|3537801|FG000|STARTED|Overall Study||197
2835762|NCT02435433|3537802|FG001|STARTED|Overall Study||95
2835763|NCT02435433|3537803|FG002|STARTED|Overall Study||0
2835764|NCT02435433|3537804|FG003|STARTED|Overall Study||0
2835765|NCT02435433|3537805|FG004|STARTED|Overall Study||0
2835766|NCT02435433|3537801|FG000|Participants Who Received Study Drug|Overall Study||197
2835767|NCT02435433|3537802|FG001|Participants Who Received Study Drug|Overall Study||95
2835768|NCT02435433|3537803|FG002|Participants Who Received Study Drug|Overall Study||0
2835769|NCT02435433|3537804|FG003|Participants Who Received Study Drug|Overall Study||0
2835770|NCT02435433|3537805|FG004|Participants Who Received Study Drug|Overall Study||0
2835771|NCT02435433|3537801|FG000|COMPLETED|Overall Study||182
2835772|NCT02435433|3537802|FG001|COMPLETED|Overall Study||90
2835773|NCT02435433|3537803|FG002|COMPLETED|Overall Study||0
2835774|NCT02435433|3537804|FG003|COMPLETED|Overall Study||0
2835775|NCT02435433|3537805|FG004|COMPLETED|Overall Study||0
2835776|NCT02435433|3537801|FG000|NOT COMPLETED|Overall Study||15
2835777|NCT02435433|3537802|FG001|NOT COMPLETED|Overall Study||5
2835778|NCT02435433|3537803|FG002|NOT COMPLETED|Overall Study||0
2835779|NCT02435433|3537804|FG003|NOT COMPLETED|Overall Study||0
2835780|NCT02435433|3537805|FG004|NOT COMPLETED|Overall Study||0
2835781|NCT02426125|3537815|FG000|STARTED|Overall Study||263
2835782|NCT02426125|3537816|FG001|STARTED|Overall Study||267
2835783|NCT02426125|3537815|FG000|Received at Least One Dose of Study Drug|Overall Study||258
2835784|NCT02426125|3537816|FG001|Received at Least One Dose of Study Drug|Overall Study||265
2835785|NCT02426125|3537815|FG000|First Randomized Participants|Overall Study||216
2835786|NCT02426125|3537816|FG001|First Randomized Participants|Overall Study||221
2835787|NCT02426125|3537815|FG000|COMPLETED|Overall Study||234
2835788|NCT02426125|3537816|FG001|COMPLETED|Overall Study||241
2835789|NCT02426125|3537815|FG000|NOT COMPLETED|Overall Study||29
2835790|NCT02426125|3537816|FG001|NOT COMPLETED|Overall Study||26
2835791|NCT02417142|3537826|FG000|STARTED|Overall Study||35
2835792|NCT02417142|3537827|FG001|STARTED|Overall Study||35
2835793|NCT02417142|3537826|FG000|COMPLETED|Overall Study||19
2835794|NCT02417142|3537827|FG001|COMPLETED|Overall Study||22
2835795|NCT02417142|3537826|FG000|NOT COMPLETED|Overall Study||16
2835796|NCT02417142|3537827|FG001|NOT COMPLETED|Overall Study||13
2835797|NCT02368886|3537837|FG000|STARTED|Overall Study||29
2835798|NCT02368886|3537838|FG001|STARTED|Overall Study||27
2835799|NCT02368886|3537839|FG002|STARTED|Overall Study||34
2835800|NCT02368886|3537840|FG003|STARTED|Overall Study||33
2835801|NCT02368886|3537837|FG000|COMPLETED|Overall Study||28
2835802|NCT02368886|3537838|FG001|COMPLETED|Overall Study||26
2835803|NCT02368886|3537839|FG002|COMPLETED|Overall Study||33
2835804|NCT02368886|3537840|FG003|COMPLETED|Overall Study||29
2835805|NCT02368886|3537837|FG000|NOT COMPLETED|Overall Study||1
2835806|NCT02368886|3537838|FG001|NOT COMPLETED|Overall Study||1
2835807|NCT02368886|3537839|FG002|NOT COMPLETED|Overall Study||1
2835808|NCT02368886|3537840|FG003|NOT COMPLETED|Overall Study||4
2835809|NCT02354703|3537852|FG000|STARTED|Overall Study||12
2835810|NCT02354703|3537853|FG001|STARTED|Overall Study||34
2835811|NCT02354703|3537854|FG002|STARTED|Overall Study||39
2835812|NCT02354703|3537855|FG003|STARTED|Overall Study||10
2835813|NCT02354703|3537852|FG000|COMPLETED|Overall Study||9
2835814|NCT02354703|3537853|FG001|COMPLETED|Overall Study||26
2835815|NCT02354703|3537854|FG002|COMPLETED|Overall Study||28
2835816|NCT02354703|3537855|FG003|COMPLETED|Overall Study||7
2835817|NCT02354703|3537852|FG000|NOT COMPLETED|Overall Study||3
2835818|NCT02354703|3537853|FG001|NOT COMPLETED|Overall Study||8
2835819|NCT02354703|3537854|FG002|NOT COMPLETED|Overall Study||11
2835820|NCT02354703|3537855|FG003|NOT COMPLETED|Overall Study||3
2835821|NCT02312258|3537869|FG000|STARTED|Overall Study||281
2835822|NCT02312258|3537870|FG001|STARTED|Overall Study||425
2835823|NCT02312258|3537869|FG000|COMPLETED|Overall Study||30
2835824|NCT02312258|3537870|FG001|COMPLETED|Overall Study||66
2835825|NCT02312258|3537869|FG000|NOT COMPLETED|Overall Study||251
2835826|NCT02312258|3537870|FG001|NOT COMPLETED|Overall Study||359
2835827|NCT01981551|3537876|FG000|STARTED|Overall Study||17
2835828|NCT01981551|3537876|FG000|COMPLETED|Overall Study||8
2835829|NCT01981551|3537876|FG000|NOT COMPLETED|Overall Study||9
2835830|NCT01772472|3537882|FG000|STARTED|Overall Study||743
2835831|NCT01772472|3537883|FG001|STARTED|Overall Study||743
2835832|NCT01772472|3537882|FG000|COMPLETED|Overall Study||0
2835833|NCT01772472|3537883|FG001|COMPLETED|Overall Study||0
2835834|NCT01772472|3537882|FG000|NOT COMPLETED|Overall Study||743
2835835|NCT01772472|3537883|FG001|NOT COMPLETED|Overall Study||743
2835836|NCT00740181|3537889|FG000|STARTED|Overall Study||9
2835837|NCT00740181|3537889|FG000|COMPLETED|Overall Study||9
2835838|NCT00740181|3537889|FG000|NOT COMPLETED|Overall Study||0
2835839|NCT00468130|3537895|FG000|STARTED|Overall Study||7
2835840|NCT00468130|3537896|FG001|STARTED|Overall Study||6
2835841|NCT00468130|3537895|FG000|COMPLETED|Overall Study||5
2835842|NCT00468130|3537896|FG001|COMPLETED|Overall Study||4
2835843|NCT00468130|3537895|FG000|NOT COMPLETED|Overall Study||2
2835844|NCT00468130|3537896|FG001|NOT COMPLETED|Overall Study||2
2835845|NCT00384111|3537904|FG000|STARTED|Overall Study||26
2835846|NCT00384111|3537904|FG000|COMPLETED|Overall Study||0
2835847|NCT00384111|3537904|FG000|NOT COMPLETED|Overall Study||26
2914980|NCT00507130|3625185|FG000|COMPLETED|Overall Study||8
2914981|NCT00507130|3625186|FG001|COMPLETED|Overall Study||9
2914982|NCT00507130|3625187|FG002|COMPLETED|Overall Study||8
2914983|NCT00507130|3625188|FG003|COMPLETED|Overall Study||8
2914984|NCT00507130|3625185|FG000|NOT COMPLETED|Overall Study||1
2914985|NCT00507130|3625186|FG001|NOT COMPLETED|Overall Study||0
2914986|NCT00507130|3625187|FG002|NOT COMPLETED|Overall Study||1
2914987|NCT00507130|3625188|FG003|NOT COMPLETED|Overall Study||1
2914988|NCT00507208|3625200|FG000|STARTED|Overall Study||27
2914989|NCT00507208|3625201|FG001|STARTED|Overall Study||26
2914990|NCT00507208|3625200|FG000|Received Dynasplint in Crossover|Overall Study||0
2914991|NCT00507208|3625201|FG001|Received Dynasplint in Crossover|Overall Study||3
2914992|NCT00507208|3625200|FG000|COMPLETED|Overall Study||27
2914993|NCT00507208|3625201|FG001|COMPLETED|Overall Study||26
2914994|NCT00507208|3625200|FG000|NOT COMPLETED|Overall Study||0
2914995|NCT00507208|3625201|FG001|NOT COMPLETED|Overall Study||0
2914996|NCT00507416|3625210|FG000|STARTED|Overall Study||168
2914997|NCT00507416|3625211|FG001|STARTED|Overall Study||167
2914998|NCT00507416|3625212|FG002|STARTED|Overall Study||167
2914999|NCT00507416|3625210|FG000|Treated (Safety Population)|Overall Study||165
2915000|NCT00507416|3625211|FG001|Treated (Safety Population)|Overall Study||158
2915001|NCT00507416|3625212|FG002|Treated (Safety Population)|Overall Study||163
2915002|NCT00507416|3625210|FG000|Completed 8 Treatment Cycles|Overall Study||82
2915003|NCT00507416|3625211|FG001|Completed 8 Treatment Cycles|Overall Study||60
2915004|NCT00507416|3625212|FG002|Completed 8 Treatment Cycles|Overall Study||69
2915005|NCT00507416|3625210|FG000|COMPLETED|Overall Study|Completed is defined as having completed 13 treatment cycles.|50
2915006|NCT00507416|3625211|FG001|COMPLETED|Overall Study|Completed is defined as having completed 13 treatment cycles.|42
2915007|NCT00507416|3625212|FG002|COMPLETED|Overall Study|Completed is defined as having completed 13 treatment cycles.|53
2915008|NCT00507416|3625210|FG000|NOT COMPLETED|Overall Study||118
2915009|NCT00507416|3625211|FG001|NOT COMPLETED|Overall Study||125
2915010|NCT00507416|3625212|FG002|NOT COMPLETED|Overall Study||114
2915011|NCT00507429|3625222|FG000|STARTED|Treatment Phase|Randomized|55
2915012|NCT00507429|3625223|FG001|STARTED|Treatment Phase|Randomized|25
2915013|NCT00507429|3625222|FG000|COMPLETED|Treatment Phase||18
2915014|NCT00507429|3625223|FG001|COMPLETED|Treatment Phase||7
2915015|NCT00507429|3625222|FG000|NOT COMPLETED|Treatment Phase||37
2915016|NCT00507429|3625223|FG001|NOT COMPLETED|Treatment Phase||18
2915017|NCT00507429|3625222|FG000|STARTED|Maintenance Phase|2 subjects did not enter maintenance: 1/18 progressive disease; 1/18 lost to follow-up.|16
2915018|NCT00507429|3625223|FG001|STARTED|Maintenance Phase|Control arm subjects followed for survival only; not enrolled in Maintenance period|0
2915019|NCT00507429|3625222|FG000|COMPLETED|Maintenance Phase|14 subjects were withdrawn due to progressive disease, 2 subjects continued beyond data cut-off|2
2915020|NCT00507429|3625223|FG001|COMPLETED|Maintenance Phase||0
2915021|NCT00507429|3625222|FG000|NOT COMPLETED|Maintenance Phase||14
2915022|NCT00507429|3625223|FG001|NOT COMPLETED|Maintenance Phase||0
2915023|NCT00507442|3625235|FG000|STARTED|Overall Study||42
2915024|NCT00507442|3625236|FG001|STARTED|Overall Study||66
2915025|NCT00507442|3625237|FG002|STARTED|Overall Study||33
2915026|NCT00507442|3625238|FG003|STARTED|Overall Study||17
2915027|NCT00507442|3625235|FG000|COMPLETED|Overall Study||26
2915028|NCT00507442|3625236|FG001|COMPLETED|Overall Study||39
2915029|NCT00507442|3625237|FG002|COMPLETED|Overall Study||18
2915030|NCT00507442|3625238|FG003|COMPLETED|Overall Study||12
2915031|NCT00507442|3625235|FG000|NOT COMPLETED|Overall Study||16
2915032|NCT00507442|3625236|FG001|NOT COMPLETED|Overall Study||27
2915033|NCT00507442|3625237|FG002|NOT COMPLETED|Overall Study||15
2915034|NCT00507442|3625238|FG003|NOT COMPLETED|Overall Study||5
2915035|NCT00507455|3625255|FG000|STARTED|Overall Study||74
2915036|NCT00507455|3625256|FG001|STARTED|Overall Study||74
2915037|NCT00507455|3625257|FG002|STARTED|Overall Study||74
2915038|NCT00507455|3625255|FG000|COMPLETED|Overall Study||62
2915039|NCT00507455|3625256|FG001|COMPLETED|Overall Study||68
2915040|NCT00507455|3625257|FG002|COMPLETED|Overall Study||62
2915041|NCT00507455|3625255|FG000|NOT COMPLETED|Overall Study||12
2915042|NCT00507455|3625256|FG001|NOT COMPLETED|Overall Study||6
2915043|NCT00507455|3625257|FG002|NOT COMPLETED|Overall Study||12
2915044|NCT00507507|3625267|FG000|STARTED|Treatment Period||64
2915045|NCT00507507|3625268|FG001|STARTED|Treatment Period||62
2915046|NCT00507507|3625267|FG000|Completed 192 Weeks of Treatment|Treatment Period||52
2915047|NCT00507507|3625268|FG001|Completed 192 Weeks of Treatment|Treatment Period||52
2915048|NCT00507507|3625267|FG000|COMPLETED|Treatment Period||12
2915049|NCT00507507|3625268|FG001|COMPLETED|Treatment Period||9
2915050|NCT00507507|3625267|FG000|NOT COMPLETED|Treatment Period||52
2915051|NCT00507507|3625268|FG001|NOT COMPLETED|Treatment Period||53
2915052|NCT00507507|3625267|FG000|STARTED|24-week Treatment-free Follow-up Period|Participants who discontinued treatment early may have entered the treatment-free follow-up period.|26
2915053|NCT00507507|3625268|FG001|STARTED|24-week Treatment-free Follow-up Period|Participants who discontinued treatment early may have entered the treatment-free follow-up period.|29
2915054|NCT00507507|3625267|FG000|COMPLETED|24-week Treatment-free Follow-up Period||16
2915055|NCT00507507|3625268|FG001|COMPLETED|24-week Treatment-free Follow-up Period||12
2835848|NCT04854642|3537908|FG000|STARTED|Overall Study||18
3167172|NCT01908634|3894346|FG000|STARTED|Milk-based Strawberry Beverage With Meal||10
3167173|NCT01908634|3894346|FG000|COMPLETED|Milk-based Strawberry Beverage With Meal||10
3167174|NCT01908634|3894346|FG000|NOT COMPLETED|Milk-based Strawberry Beverage With Meal||0
3167175|NCT01908634|3894346|FG000|STARTED|Water-based Strawberry Beverage Wit Meal||10
3167176|NCT01908634|3894346|FG000|COMPLETED|Water-based Strawberry Beverage Wit Meal||9
3167177|NCT01908634|3894346|FG000|NOT COMPLETED|Water-based Strawberry Beverage Wit Meal||1
3167178|NCT01908634|3894346|FG000|STARTED|Milk-based Strawberry Beverage w/o Meal||9
3167179|NCT01908634|3894346|FG000|COMPLETED|Milk-based Strawberry Beverage w/o Meal||4
3167180|NCT01908634|3894346|FG000|NOT COMPLETED|Milk-based Strawberry Beverage w/o Meal||5
3167181|NCT01908634|3894346|FG000|STARTED|Water-based Strawberry Beverage w/o Meal||4
3167182|NCT01908634|3894346|FG000|COMPLETED|Water-based Strawberry Beverage w/o Meal||4
3167183|NCT01908634|3894346|FG000|NOT COMPLETED|Water-based Strawberry Beverage w/o Meal||0
3167184|NCT01908699|3894356|FG000|STARTED|Overall Study||137
3167185|NCT01908699|3894357|FG001|STARTED|Overall Study||136
3167186|NCT01908699|3894356|FG000|Received at Least 1 Dose of Study Drug|Overall Study||136
3167187|NCT01908699|3894357|FG001|Received at Least 1 Dose of Study Drug|Overall Study||135
3167188|NCT01908699|3894356|FG000|COMPLETED|Overall Study||62
3167189|NCT01908699|3894357|FG001|COMPLETED|Overall Study||58
3167190|NCT01908699|3894356|FG000|NOT COMPLETED|Overall Study||75
3167191|NCT01908699|3894357|FG001|NOT COMPLETED|Overall Study||78
3167192|NCT01908751|3894367|FG000|STARTED|Overall Study||22
3167193|NCT01908751|3894368|FG001|STARTED|Overall Study||23
3167194|NCT01908751|3894369|FG002|STARTED|Overall Study||21
3167195|NCT01908751|3894370|FG003|STARTED|Overall Study||20
3167196|NCT01908751|3894367|FG000|COMPLETED|Overall Study||17
3167197|NCT01908751|3894368|FG001|COMPLETED|Overall Study||18
3167198|NCT01908751|3894369|FG002|COMPLETED|Overall Study||16
3167199|NCT01908751|3894370|FG003|COMPLETED|Overall Study||16
3167200|NCT01908751|3894367|FG000|NOT COMPLETED|Overall Study||5
3167201|NCT01908751|3894368|FG001|NOT COMPLETED|Overall Study||5
3167202|NCT01908751|3894369|FG002|NOT COMPLETED|Overall Study||5
3167203|NCT01908751|3894370|FG003|NOT COMPLETED|Overall Study||4
2835849|NCT04854642|3537909|FG001|STARTED|Overall Study||18
2835850|NCT04854642|3537908|FG000|Safety Set|Overall Study||18
2835851|NCT04854642|3537909|FG001|Safety Set|Overall Study||18
2835852|NCT04854642|3537908|FG000|PK Set 1|Overall Study||18
2835853|NCT04854642|3537909|FG001|PK Set 1|Overall Study||18
2835854|NCT04854642|3537908|FG000|PK Set 2|Overall Study||18
2835855|NCT04854642|3537909|FG001|PK Set 2|Overall Study||18
2835856|NCT04854642|3537908|FG000|COMPLETED|Overall Study||17
2835857|NCT04854642|3537909|FG001|COMPLETED|Overall Study||15
2835858|NCT04854642|3537908|FG000|NOT COMPLETED|Overall Study||1
2835859|NCT04854642|3537909|FG001|NOT COMPLETED|Overall Study||3
2835860|NCT04608344|3537919|FG000|STARTED|Period 1 (AB: 3 Days, BA: 11 Days)||14
2835861|NCT04608344|3537920|FG001|STARTED|Period 1 (AB: 3 Days, BA: 11 Days)||13
2835862|NCT04608344|3537919|FG000|COMPLETED|Period 1 (AB: 3 Days, BA: 11 Days)||13
2835863|NCT04608344|3537920|FG001|COMPLETED|Period 1 (AB: 3 Days, BA: 11 Days)||12
2835864|NCT04608344|3537919|FG000|NOT COMPLETED|Period 1 (AB: 3 Days, BA: 11 Days)||1
2835865|NCT04608344|3537920|FG001|NOT COMPLETED|Period 1 (AB: 3 Days, BA: 11 Days)||1
2835866|NCT04608344|3537919|FG000|STARTED|Period 2 (AB: 11 Days, BA: 3 Days)||13
2835867|NCT04608344|3537920|FG001|STARTED|Period 2 (AB: 11 Days, BA: 3 Days)||12
2835868|NCT04608344|3537919|FG000|COMPLETED|Period 2 (AB: 11 Days, BA: 3 Days)||13
2835869|NCT04608344|3537920|FG001|COMPLETED|Period 2 (AB: 11 Days, BA: 3 Days)||12
2835870|NCT04608344|3537919|FG000|NOT COMPLETED|Period 2 (AB: 11 Days, BA: 3 Days)||0
2835871|NCT04608344|3537920|FG001|NOT COMPLETED|Period 2 (AB: 11 Days, BA: 3 Days)||0
2835872|NCT04583592|3537936|FG000|STARTED|Overall Study||194
2835873|NCT04583592|3537937|FG001|STARTED|Overall Study||101
2835874|NCT04583592|3537936|FG000|COMPLETED|Overall Study||194
2835875|NCT04583592|3537937|FG001|COMPLETED|Overall Study||100
2835876|NCT04583592|3537936|FG000|NOT COMPLETED|Overall Study||0
2835877|NCT04583592|3537937|FG001|NOT COMPLETED|Overall Study||1
2835878|NCT04572399|3537943|FG000|STARTED|Overall Study||5
2835879|NCT04572399|3537943|FG000|COMPLETED|Overall Study||5
2835880|NCT04572399|3537943|FG000|NOT COMPLETED|Overall Study||0
2835881|NCT04388787|3537947|FG000|STARTED|Blinded Period||16
2835882|NCT04388787|3537947|FG000|Completed First Assessment - Approximately 15 Minutes (Specific Treatment Unknown)|Blinded Period||15
2835883|NCT04388787|3537947|FG000|Completed Second Assessment - Approximately 15 Minutes (Specific Treatment Unknown)|Blinded Period||15
2835884|NCT04388787|3537947|FG000|COMPLETED|Blinded Period||15
2835885|NCT04388787|3537947|FG000|NOT COMPLETED|Blinded Period||1
2835886|NCT04388787|3537947|FG000|STARTED|Unblinded Period||15
2835887|NCT04388787|3537947|FG000|COMPLETED|Unblinded Period||6
3167204|NCT01908803|3894382|FG000|STARTED|Overall Study||46
3167205|NCT01908803|3894383|FG001|STARTED|Overall Study||24
3167206|NCT01908803|3894382|FG000|Treated|Overall Study|Two randomized subjects discontinued prior to receiving investigational product.|44
3167207|NCT01908803|3894383|FG001|Treated|Overall Study||24
3167208|NCT01908803|3894382|FG000|COMPLETED|Overall Study||42
3167209|NCT01908803|3894383|FG001|COMPLETED|Overall Study||23
3167210|NCT01908803|3894382|FG000|NOT COMPLETED|Overall Study||4
3167211|NCT01908803|3894383|FG001|NOT COMPLETED|Overall Study||1
2835888|NCT04388787|3537947|FG000|NOT COMPLETED|Unblinded Period||9
2835889|NCT04380090|3537957|FG000|STARTED|Overall Study||76
2835890|NCT04380090|3537958|FG001|STARTED|Overall Study||78
2835891|NCT04380090|3537957|FG000|COMPLETED|Overall Study||60
3167212|NCT01908816|3894394|FG000|STARTED|Overall Study||93
3167213|NCT01908816|3894395|FG001|STARTED|Overall Study||84
3167214|NCT01908816|3894396|FG002|STARTED|Overall Study||58
3167215|NCT01908816|3894397|FG003|STARTED|Overall Study||35
3167216|NCT01908816|3894394|FG000|COMPLETED|Overall Study||0
3167217|NCT01908816|3894395|FG001|COMPLETED|Overall Study||0
2835892|NCT04380090|3537958|FG001|COMPLETED|Overall Study||58
2835893|NCT04380090|3537957|FG000|NOT COMPLETED|Overall Study||16
2835894|NCT04380090|3537958|FG001|NOT COMPLETED|Overall Study||20
2835895|NCT04377620|3537971|FG000|STARTED|Overall Study||77
2835896|NCT04377620|3537972|FG001|STARTED|Overall Study||87
2835897|NCT04377620|3537973|FG002|STARTED|Overall Study||47
2835898|NCT04377620|3537971|FG000|COMPLETED|Overall Study||35
2835899|NCT04377620|3537972|FG001|COMPLETED|Overall Study||37
2835900|NCT04377620|3537973|FG002|COMPLETED|Overall Study||11
2835901|NCT04377620|3537971|FG000|NOT COMPLETED|Overall Study||42
2835902|NCT04377620|3537972|FG001|NOT COMPLETED|Overall Study||50
2835903|NCT04377620|3537973|FG002|NOT COMPLETED|Overall Study||36
2835904|NCT04355169|3537986|FG000|STARTED|Overall Study||0
2835905|NCT04355169|3537987|FG001|STARTED|Overall Study||0
2835906|NCT04355169|3537988|FG002|STARTED|Overall Study||0
2835907|NCT04355169|3537989|FG003|STARTED|Overall Study||0
2835908|NCT04355169|3537986|FG000|COMPLETED|Overall Study||0
2835909|NCT04355169|3537987|FG001|COMPLETED|Overall Study||0
2835910|NCT04355169|3537988|FG002|COMPLETED|Overall Study||0
2835911|NCT04355169|3537989|FG003|COMPLETED|Overall Study||0
2835912|NCT04355169|3537986|FG000|NOT COMPLETED|Overall Study||0
2835913|NCT04355169|3537987|FG001|NOT COMPLETED|Overall Study||0
2835914|NCT04355169|3537988|FG002|NOT COMPLETED|Overall Study||0
2835915|NCT04355169|3537989|FG003|NOT COMPLETED|Overall Study||0
2835916|NCT04338971|3537999|FG000|STARTED|Overall Study||24
2835917|NCT04338971|3537999|FG000|COMPLETED|Overall Study||17
2835918|NCT04338971|3537999|FG000|NOT COMPLETED|Overall Study||7
2835919|NCT04310566|3538004|FG000|STARTED|Period 1||31
2835920|NCT04310566|3538005|FG001|STARTED|Period 1||34
2835921|NCT04310566|3538004|FG000|COMPLETED|Period 1||15
2835922|NCT04310566|3538005|FG001|COMPLETED|Period 1||14
2835923|NCT04310566|3538004|FG000|NOT COMPLETED|Period 1||16
2835924|NCT04310566|3538005|FG001|NOT COMPLETED|Period 1||20
2835925|NCT04310566|3538004|FG000|STARTED|Period 2||15
2835926|NCT04310566|3538005|FG001|STARTED|Period 2||14
2835927|NCT04310566|3538004|FG000|COMPLETED|Period 2||8
2835928|NCT04310566|3538005|FG001|COMPLETED|Period 2||9
2835929|NCT04310566|3538004|FG000|NOT COMPLETED|Period 2||7
2835930|NCT04310566|3538005|FG001|NOT COMPLETED|Period 2||5
2835931|NCT04206020|3538013|FG000|STARTED|Overall Study||306
2835932|NCT04206020|3538014|FG001|STARTED|Overall Study||304
2835933|NCT04206020|3538013|FG000|COMPLETED|Overall Study||298
2835934|NCT04206020|3538014|FG001|COMPLETED|Overall Study||297
2835935|NCT04206020|3538013|FG000|NOT COMPLETED|Overall Study||8
2835936|NCT04206020|3538014|FG001|NOT COMPLETED|Overall Study||7
2915056|NCT00507507|3625267|FG000|NOT COMPLETED|24-week Treatment-free Follow-up Period||10
2915057|NCT00507507|3625268|FG001|NOT COMPLETED|24-week Treatment-free Follow-up Period||17
2915058|NCT00507546|3625278|FG000|STARTED|Overall Study||4
2915059|NCT00507546|3625279|FG001|STARTED|Overall Study||4
2915060|NCT00507546|3625278|FG000|COMPLETED|Overall Study||2
2915061|NCT00507546|3625279|FG001|COMPLETED|Overall Study||3
2915062|NCT00507546|3625278|FG000|NOT COMPLETED|Overall Study||2
2915063|NCT00507546|3625279|FG001|NOT COMPLETED|Overall Study||1
2915064|NCT00507559|3625287|FG000|STARTED|Overall Study||155
2915065|NCT00507559|3625287|FG000|COMPLETED|Overall Study||84
2915066|NCT00507559|3625287|FG000|NOT COMPLETED|Overall Study||71
2915067|NCT00507689|3625294|FG000|STARTED|Pre-Randomization Period||40
2915068|NCT00507689|3625295|FG001|STARTED|Pre-Randomization Period||0
2915069|NCT00507689|3625294|FG000|COMPLETED|Pre-Randomization Period||37
2915070|NCT00507689|3625295|FG001|COMPLETED|Pre-Randomization Period||0
2915071|NCT00507689|3625294|FG000|NOT COMPLETED|Pre-Randomization Period||3
2915072|NCT00507689|3625295|FG001|NOT COMPLETED|Pre-Randomization Period||0
2915073|NCT00507689|3625294|FG000|STARTED|Randomized Period|19 of 37 participants who completed the pre-randomization period were randomized to FTC/TDF+HBIg.|19
2915074|NCT00507689|3625295|FG001|STARTED|Randomized Period|18 of 37 participants who completed the pre-randomization period were randomized to FTC/TDF.|18
2915075|NCT00507689|3625294|FG000|COMPLETED|Randomized Period||18
2915076|NCT00507689|3625295|FG001|COMPLETED|Randomized Period||16
2915077|NCT00507689|3625294|FG000|NOT COMPLETED|Randomized Period||1
2915078|NCT00507689|3625295|FG001|NOT COMPLETED|Randomized Period||2
2915079|NCT00507728|3625305|FG000|STARTED|Randomization to Month 3||75
2915080|NCT00507728|3625306|FG001|STARTED|Randomization to Month 3||89
2915081|NCT00507728|3625307|FG002|STARTED|Randomization to Month 3||90
2915082|NCT00507728|3625305|FG000|COMPLETED|Randomization to Month 3||60
2915083|NCT00507728|3625306|FG001|COMPLETED|Randomization to Month 3||75
2915084|NCT00507728|3625307|FG002|COMPLETED|Randomization to Month 3||70
2915085|NCT00507728|3625305|FG000|NOT COMPLETED|Randomization to Month 3||15
2915086|NCT00507728|3625306|FG001|NOT COMPLETED|Randomization to Month 3||14
2915087|NCT00507728|3625307|FG002|NOT COMPLETED|Randomization to Month 3||20
2915088|NCT00507728|3625305|FG000|STARTED|From 3 Months to 6 Months||60
2915089|NCT00507728|3625306|FG001|STARTED|From 3 Months to 6 Months||75
2915090|NCT00507728|3625307|FG002|STARTED|From 3 Months to 6 Months||70
2915091|NCT00507728|3625305|FG000|COMPLETED|From 3 Months to 6 Months||54
2915092|NCT00507728|3625306|FG001|COMPLETED|From 3 Months to 6 Months||65
3167218|NCT01908816|3894396|FG002|COMPLETED|Overall Study||0
2835937|NCT04097301|3538020|FG000|STARTED|Overall Study|Enrolled patients. Overall, 8 patients were enrolled in the study and underwent the screening phase to evaluate the compliance to the clinical inclusion / exclusion criteria as well as the CD44v6 expression by tumor cells.|8
2835938|NCT04097301|3538020|FG000|Treated Patients|Overall Study|Of the 8 enrolled patients, 2 were treated with MLM-CAR44.1 T-cell at the first dose level.|2
2835939|NCT04097301|3538020|FG000|COMPLETED|Overall Study||1
2835940|NCT04097301|3538020|FG000|NOT COMPLETED|Overall Study||7
2835941|NCT04054375|3538026|FG000|STARTED|Overall Study||20
2835942|NCT04054375|3538026|FG000|COMPLETED|Overall Study|Due to COVID-19, some participants were not able to come to our site to complete all outcome measurements. Our study team worked with individuals to make them feel safe and collect as much data as we possibly could. This is the reason why some outcome metrics have less than 20 data points. All 20 patients completed the study and took the medication for all 24 weeks.|20
2835943|NCT04054375|3538026|FG000|NOT COMPLETED|Overall Study||0
2835944|NCT03953079|3538033|FG000|STARTED|Core Study||21
2835945|NCT03953079|3538034|FG001|STARTED|Core Study||22
2835946|NCT03953079|3538035|FG002|STARTED|Core Study||13
2835947|NCT03953079|3538033|FG000|COMPLETED|Core Study||20
2835948|NCT03953079|3538034|FG001|COMPLETED|Core Study||18
2835949|NCT03953079|3538035|FG002|COMPLETED|Core Study||12
2835950|NCT03953079|3538033|FG000|NOT COMPLETED|Core Study||1
2835951|NCT03953079|3538034|FG001|NOT COMPLETED|Core Study||4
2835952|NCT03953079|3538035|FG002|NOT COMPLETED|Core Study||1
2835953|NCT03953079|3538033|FG000|STARTED|Extension Study||12
2835954|NCT03953079|3538034|FG001|STARTED|Extension Study||10
2835955|NCT03953079|3538035|FG002|STARTED|Extension Study||6
2835956|NCT03953079|3538033|FG000|COMPLETED|Extension Study||6
2835957|NCT03953079|3538034|FG001|COMPLETED|Extension Study||4
2835958|NCT03953079|3538035|FG002|COMPLETED|Extension Study||1
2835959|NCT03953079|3538033|FG000|NOT COMPLETED|Extension Study||6
2835960|NCT03953079|3538034|FG001|NOT COMPLETED|Extension Study||6
2835961|NCT03953079|3538035|FG002|NOT COMPLETED|Extension Study||5
2835962|NCT03922750|3538047|FG000|STARTED|Overall Study||50
2835963|NCT03922750|3538048|FG001|STARTED|Overall Study||54
2835964|NCT03922750|3538049|FG002|STARTED|Overall Study||50
2835965|NCT03922750|3538047|FG000|Full Analysis Set (FAS)|Overall Study||50
2835966|NCT03922750|3538048|FG001|Full Analysis Set (FAS)|Overall Study||54
2835967|NCT03922750|3538049|FG002|Full Analysis Set (FAS)|Overall Study||50
2835968|NCT03922750|3538047|FG000|Safety Analysis Set (SAS)|Overall Study||50
2835969|NCT03922750|3538048|FG001|Safety Analysis Set (SAS)|Overall Study||54
2835970|NCT03922750|3538049|FG002|Safety Analysis Set (SAS)|Overall Study||50
2835971|NCT03922750|3538047|FG000|COMPLETED|Overall Study||50
2835972|NCT03922750|3538048|FG001|COMPLETED|Overall Study||53
2835973|NCT03922750|3538049|FG002|COMPLETED|Overall Study||49
2835974|NCT03922750|3538047|FG000|NOT COMPLETED|Overall Study||0
2835975|NCT03922750|3538048|FG001|NOT COMPLETED|Overall Study||1
2835976|NCT03922750|3538049|FG002|NOT COMPLETED|Overall Study||1
2835977|NCT03910673|3538062|FG000|STARTED|Overall Study||7
2835978|NCT03910673|3538063|FG001|STARTED|Overall Study||6
2835979|NCT03910673|3538064|FG002|STARTED|Overall Study||7
2835980|NCT03910673|3538065|FG003|STARTED|Overall Study||13
2835981|NCT03910673|3538066|FG004|STARTED|Overall Study||6
2835982|NCT03910673|3538062|FG000|Enrolled and Randomized|Overall Study||6
2835983|NCT03910673|3538063|FG001|Enrolled and Randomized|Overall Study||6
2835984|NCT03910673|3538064|FG002|Enrolled and Randomized|Overall Study||6
2835985|NCT03910673|3538065|FG003|Enrolled and Randomized|Overall Study||6
2835986|NCT03910673|3538066|FG004|Enrolled and Randomized|Overall Study||6
2835987|NCT03910673|3538062|FG000|Enrolled as Replacement|Overall Study||1
2835988|NCT03910673|3538063|FG001|Enrolled as Replacement|Overall Study||0
2835989|NCT03910673|3538064|FG002|Enrolled as Replacement|Overall Study||1
2835990|NCT03910673|3538065|FG003|Enrolled as Replacement|Overall Study||7
2835991|NCT03910673|3538066|FG004|Enrolled as Replacement|Overall Study||0
2835992|NCT03910673|3538062|FG000|Began Infusion of Dose 1|Overall Study||7
2835993|NCT03910673|3538063|FG001|Began Infusion of Dose 1|Overall Study||6
2835994|NCT03910673|3538064|FG002|Began Infusion of Dose 1|Overall Study||7
2835995|NCT03910673|3538065|FG003|Began Infusion of Dose 1|Overall Study||13
2835996|NCT03910673|3538066|FG004|Began Infusion of Dose 1|Overall Study||6
2835997|NCT03910673|3538062|FG000|Completed Dose 1|Overall Study||7
2835998|NCT03910673|3538063|FG001|Completed Dose 1|Overall Study||6
2835999|NCT03910673|3538064|FG002|Completed Dose 1|Overall Study||7
2836000|NCT03910673|3538065|FG003|Completed Dose 1|Overall Study||13
2836001|NCT03910673|3538066|FG004|Completed Dose 1|Overall Study||6
2836002|NCT03910673|3538062|FG000|Completed Dose 2|Overall Study||7
2836003|NCT03910673|3538063|FG001|Completed Dose 2|Overall Study||6
2836004|NCT03910673|3538064|FG002|Completed Dose 2|Overall Study||7
2836005|NCT03910673|3538065|FG003|Completed Dose 2|Overall Study||13
2836006|NCT03910673|3538066|FG004|Completed Dose 2|Overall Study||6
2836007|NCT03910673|3538062|FG000|Completed Dose 3|Overall Study||6
2836008|NCT03910673|3538063|FG001|Completed Dose 3|Overall Study||6
2836009|NCT03910673|3538064|FG002|Completed Dose 3|Overall Study||7
2836010|NCT03910673|3538065|FG003|Completed Dose 3|Overall Study||12
2836011|NCT03910673|3538066|FG004|Completed Dose 3|Overall Study||6
2836012|NCT03910673|3538062|FG000|Completed All Scheduled Treatment|Overall Study||6
2836013|NCT03910673|3538063|FG001|Completed All Scheduled Treatment|Overall Study||6
2836014|NCT03910673|3538064|FG002|Completed All Scheduled Treatment|Overall Study||7
2836015|NCT03910673|3538065|FG003|Completed All Scheduled Treatment|Overall Study||12
2836016|NCT03910673|3538066|FG004|Completed All Scheduled Treatment|Overall Study||6
2836017|NCT03910673|3538062|FG000|Completed All PK Blood Draws|Overall Study||6
2836018|NCT03910673|3538063|FG001|Completed All PK Blood Draws|Overall Study||6
2836019|NCT03910673|3538064|FG002|Completed All PK Blood Draws|Overall Study||6
2836020|NCT03910673|3538065|FG003|Completed All PK Blood Draws|Overall Study||6
2836021|NCT03910673|3538066|FG004|Completed All PK Blood Draws|Overall Study||6
2836022|NCT03910673|3538062|FG000|Completed Bronchoscopy With BAL|Overall Study||6
2836023|NCT03910673|3538063|FG001|Completed Bronchoscopy With BAL|Overall Study||6
2836024|NCT03910673|3538064|FG002|Completed Bronchoscopy With BAL|Overall Study||6
2836025|NCT03910673|3538065|FG003|Completed Bronchoscopy With BAL|Overall Study||6
2836026|NCT03910673|3538066|FG004|Completed Bronchoscopy With BAL|Overall Study||6
2836027|NCT03910673|3538062|FG000|Completed All Plasma Urea Samples|Overall Study||6
2836028|NCT03910673|3538063|FG001|Completed All Plasma Urea Samples|Overall Study||6
2836029|NCT03910673|3538064|FG002|Completed All Plasma Urea Samples|Overall Study||6
2836030|NCT03910673|3538065|FG003|Completed All Plasma Urea Samples|Overall Study||6
2836031|NCT03910673|3538066|FG004|Completed All Plasma Urea Samples|Overall Study||6
2836032|NCT03910673|3538062|FG000|At Least One PK Blood Draw Concurrent With BAL Timepoint|Overall Study||6
2836033|NCT03910673|3538063|FG001|At Least One PK Blood Draw Concurrent With BAL Timepoint|Overall Study||6
2836034|NCT03910673|3538064|FG002|At Least One PK Blood Draw Concurrent With BAL Timepoint|Overall Study||6
2836035|NCT03910673|3538065|FG003|At Least One PK Blood Draw Concurrent With BAL Timepoint|Overall Study||6
2836036|NCT03910673|3538066|FG004|At Least One PK Blood Draw Concurrent With BAL Timepoint|Overall Study||6
2836037|NCT03910673|3538062|FG000|COMPLETED|Overall Study||7
2836038|NCT03910673|3538063|FG001|COMPLETED|Overall Study||6
2836039|NCT03910673|3538064|FG002|COMPLETED|Overall Study||7
2836040|NCT03910673|3538065|FG003|COMPLETED|Overall Study||11
3167219|NCT01908816|3894397|FG003|COMPLETED|Overall Study||0
3167220|NCT01908816|3894394|FG000|NOT COMPLETED|Overall Study||93
3167221|NCT01908816|3894395|FG001|NOT COMPLETED|Overall Study||84
2836041|NCT03910673|3538066|FG004|COMPLETED|Overall Study||6
2836042|NCT03910673|3538062|FG000|NOT COMPLETED|Overall Study||0
2836043|NCT03910673|3538063|FG001|NOT COMPLETED|Overall Study||0
2836044|NCT03910673|3538064|FG002|NOT COMPLETED|Overall Study||0
2836045|NCT03910673|3538065|FG003|NOT COMPLETED|Overall Study||2
2836046|NCT03910673|3538066|FG004|NOT COMPLETED|Overall Study||0
2915093|NCT00507728|3625307|FG002|COMPLETED|From 3 Months to 6 Months||61
2915094|NCT00507728|3625305|FG000|NOT COMPLETED|From 3 Months to 6 Months||6
2915095|NCT00507728|3625306|FG001|NOT COMPLETED|From 3 Months to 6 Months||10
2915096|NCT00507728|3625307|FG002|NOT COMPLETED|From 3 Months to 6 Months||9
2915097|NCT00507767|3625321|FG000|STARTED|Overall Study||15
2915098|NCT00507767|3625321|FG000|COMPLETED|Overall Study||15
2915099|NCT00507767|3625321|FG000|NOT COMPLETED|Overall Study||0
2915100|NCT00507819|3625325|FG000|STARTED|First Intervention (6 Weeks)||14
2915101|NCT00507819|3625326|FG001|STARTED|First Intervention (6 Weeks)||14
2915102|NCT00507819|3625325|FG000|COMPLETED|First Intervention (6 Weeks)||14
2915103|NCT00507819|3625326|FG001|COMPLETED|First Intervention (6 Weeks)||14
2915104|NCT00507819|3625325|FG000|NOT COMPLETED|First Intervention (6 Weeks)||0
2915105|NCT00507819|3625326|FG001|NOT COMPLETED|First Intervention (6 Weeks)||0
2915106|NCT00507819|3625325|FG000|STARTED|Washout (6 Weeks)||14
2915107|NCT00507819|3625326|FG001|STARTED|Washout (6 Weeks)||14
2915108|NCT00507819|3625325|FG000|COMPLETED|Washout (6 Weeks)||13
2915109|NCT00507819|3625326|FG001|COMPLETED|Washout (6 Weeks)||14
2915110|NCT00507819|3625325|FG000|NOT COMPLETED|Washout (6 Weeks)||1
2915111|NCT00507819|3625326|FG001|NOT COMPLETED|Washout (6 Weeks)||0
2915112|NCT00507819|3625325|FG000|STARTED|Second Intervention (6 Weeks)||13
2915113|NCT00507819|3625326|FG001|STARTED|Second Intervention (6 Weeks)||14
2915114|NCT00507819|3625325|FG000|COMPLETED|Second Intervention (6 Weeks)||13
2915115|NCT00507819|3625326|FG001|COMPLETED|Second Intervention (6 Weeks)||14
2915116|NCT00507819|3625325|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||0
2915117|NCT00507819|3625326|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||0
2915118|NCT00508001|3625335|FG000|STARTED|Overall Study||19
2915119|NCT00508001|3625336|FG001|STARTED|Overall Study||25
2915120|NCT00508001|3625337|FG002|STARTED|Overall Study||23
2915121|NCT00508001|3625335|FG000|Secondary Treatment Phase|Overall Study||0
2915122|NCT00508001|3625336|FG001|Secondary Treatment Phase|Overall Study||13
2915123|NCT00508001|3625337|FG002|Secondary Treatment Phase|Overall Study||16
2915124|NCT00508001|3625335|FG000|COMPLETED|Overall Study||0
2915125|NCT00508001|3625336|FG001|COMPLETED|Overall Study||13
2915126|NCT00508001|3625337|FG002|COMPLETED|Overall Study||16
2915127|NCT00508001|3625335|FG000|NOT COMPLETED|Overall Study||19
2915128|NCT00508001|3625336|FG001|NOT COMPLETED|Overall Study||12
2915129|NCT00508001|3625337|FG002|NOT COMPLETED|Overall Study||7
2915130|NCT00508027|3625345|FG000|STARTED|Dose Level 1|The participants starting each dose period is a new cohort of subjects. 20 subjects started dose 1|20
2915131|NCT00508027|3625345|FG000|COMPLETED|Dose Level 1||12
2915132|NCT00508027|3625345|FG000|NOT COMPLETED|Dose Level 1||8
2915133|NCT00508027|3625345|FG000|STARTED|Dose Level 2|The participants starting each dose period is a new cohort of subjects. 20 new subjects in dose 2|20
2915134|NCT00508027|3625345|FG000|COMPLETED|Dose Level 2||16
2915135|NCT00508027|3625345|FG000|NOT COMPLETED|Dose Level 2||4
2915136|NCT00508027|3625345|FG000|STARTED|Dose Level 3|enrollment discontinued due to FDA recommendations regarding high dose (80mg/day) simvastatin|2
2915137|NCT00508027|3625345|FG000|COMPLETED|Dose Level 3||2
2915138|NCT00508027|3625345|FG000|NOT COMPLETED|Dose Level 3||0
2915139|NCT00508105|3625360|FG000|STARTED|Overall Study||44
2836047|NCT03885999|3538070|FG000|STARTED|Overall Study||12
2836048|NCT03885999|3538070|FG000|COMPLETED|Overall Study||11
2836049|NCT03885999|3538070|FG000|NOT COMPLETED|Overall Study||1
2836050|NCT03882970|3538078|FG000|STARTED|Overall Study||359
2836051|NCT03882970|3538079|FG001|STARTED|Overall Study||361
2836052|NCT03882970|3538080|FG002|STARTED|Overall Study||359
2836053|NCT03882970|3538081|FG003|STARTED|Overall Study||365
2836054|NCT03882970|3538078|FG000|Received at Least One Dose of Study Drug|Overall Study||358
2836055|NCT03882970|3538079|FG001|Received at Least One Dose of Study Drug|Overall Study||360
2836056|NCT03882970|3538080|FG002|Received at Least One Dose of Study Drug|Overall Study||359
2836057|NCT03882970|3538081|FG003|Received at Least One Dose of Study Drug|Overall Study||360
2836058|NCT03882970|3538078|FG000|COMPLETED|Overall Study||333
2836059|NCT03882970|3538079|FG001|COMPLETED|Overall Study||321
2836060|NCT03882970|3538080|FG002|COMPLETED|Overall Study||340
2836061|NCT03882970|3538081|FG003|COMPLETED|Overall Study||331
2836062|NCT03882970|3538078|FG000|NOT COMPLETED|Overall Study||26
2836063|NCT03882970|3538079|FG001|NOT COMPLETED|Overall Study||40
2836064|NCT03882970|3538080|FG002|NOT COMPLETED|Overall Study||19
2836065|NCT03882970|3538081|FG003|NOT COMPLETED|Overall Study||34
2836066|NCT03879525|3538097|FG000|STARTED|Overall Study||15
2836067|NCT03879525|3538098|FG001|STARTED|Overall Study||15
2836068|NCT03879525|3538097|FG000|COMPLETED|Overall Study||15
2836069|NCT03879525|3538098|FG001|COMPLETED|Overall Study||15
2836070|NCT03879525|3538097|FG000|NOT COMPLETED|Overall Study||0
2836071|NCT03879525|3538098|FG001|NOT COMPLETED|Overall Study||0
2836072|NCT03867734|3538105|FG000|STARTED|Overall Study||32
2836073|NCT03867734|3538105|FG000|COMPLETED|Overall Study||30
2836074|NCT03867734|3538105|FG000|NOT COMPLETED|Overall Study||2
2836075|NCT03787095|3538115|FG000|STARTED|Overall Study||4
2836076|NCT03787095|3538116|FG001|STARTED|Overall Study||1
2836077|NCT03787095|3538115|FG000|COMPLETED|Overall Study||4
2836078|NCT03787095|3538116|FG001|COMPLETED|Overall Study|Participant had final visit at study week 7 in accordance with decision from team after the study was closed.|1
2836079|NCT03787095|3538115|FG000|NOT COMPLETED|Overall Study||0
2836080|NCT03787095|3538116|FG001|NOT COMPLETED|Overall Study||0
2836081|NCT03781778|3538125|FG000|STARTED|Overall Study||4
2836082|NCT03781778|3538126|FG001|STARTED|Overall Study||6
2836083|NCT03781778|3538125|FG000|Started Intervention|Overall Study||3
2836084|NCT03781778|3538126|FG001|Started Intervention|Overall Study||4
2836085|NCT03781778|3538125|FG000|COMPLETED|Overall Study||2
2836086|NCT03781778|3538126|FG001|COMPLETED|Overall Study||4
2836087|NCT03781778|3538125|FG000|NOT COMPLETED|Overall Study||2
2836088|NCT03781778|3538126|FG001|NOT COMPLETED|Overall Study||2
2836089|NCT03770455|3538132|FG000|STARTED|Overall Study||5
2836090|NCT03770455|3538132|FG000|COMPLETED|Overall Study||5
2836091|NCT03770455|3538132|FG000|NOT COMPLETED|Overall Study||0
2836092|NCT03764735|3538139|FG000|STARTED|Overall Study||151
2836093|NCT03764735|3538140|FG001|STARTED|Overall Study||150
2836094|NCT03764735|3538141|FG002|STARTED|Overall Study||151
2836095|NCT03764735|3538139|FG000|COMPLETED|Overall Study||147
2836096|NCT03764735|3538140|FG001|COMPLETED|Overall Study||144
2836097|NCT03764735|3538141|FG002|COMPLETED|Overall Study||147
2836098|NCT03764735|3538139|FG000|NOT COMPLETED|Overall Study||4
2836099|NCT03764735|3538140|FG001|NOT COMPLETED|Overall Study||6
2836100|NCT03764735|3538141|FG002|NOT COMPLETED|Overall Study||4
2836101|NCT03730480|3538149|FG000|STARTED|Overall Study||372
2836102|NCT03730480|3538149|FG000|COMPLETED|Overall Study||371
2836103|NCT03730480|3538149|FG000|NOT COMPLETED|Overall Study||1
2836104|NCT03713073|3538154|FG000|STARTED|Overall Study||19
2836105|NCT03713073|3538154|FG000|Allogenic Amnion Chorion Membrane|Overall Study||19
2836106|NCT03713073|3538154|FG000|Collagen Dressing|Overall Study||19
2836107|NCT03713073|3538154|FG000|COMPLETED|Overall Study||19
2836108|NCT03713073|3538154|FG000|NOT COMPLETED|Overall Study||0
2836109|NCT03713034|3538162|FG000|STARTED|Overall Study||150
2836110|NCT03713034|3538163|FG001|STARTED|Overall Study||146
2836111|NCT03713034|3538162|FG000|COMPLETED|Overall Study||145
2836112|NCT03713034|3538163|FG001|COMPLETED|Overall Study||142
2836113|NCT03713034|3538162|FG000|NOT COMPLETED|Overall Study||5
2836114|NCT03713034|3538163|FG001|NOT COMPLETED|Overall Study||4
2836115|NCT03654404|3538171|FG000|STARTED|Overall Study||20
2836116|NCT03654404|3538171|FG000|COMPLETED|Overall Study||12
2836117|NCT03654404|3538171|FG000|NOT COMPLETED|Overall Study||8
2836118|NCT03567057|3538178|FG000|STARTED|Overall Study||159
2836119|NCT03567057|3538179|FG001|STARTED|Overall Study||151
2836120|NCT03567057|3538180|FG002|STARTED|Overall Study||114
2836121|NCT03567057|3538178|FG000|COMPLETED|Overall Study||64
2836122|NCT03567057|3538179|FG001|COMPLETED|Overall Study||64
2836123|NCT03567057|3538180|FG002|COMPLETED|Overall Study||68
2836124|NCT03567057|3538178|FG000|NOT COMPLETED|Overall Study||95
2836125|NCT03567057|3538179|FG001|NOT COMPLETED|Overall Study||87
2836126|NCT03567057|3538180|FG002|NOT COMPLETED|Overall Study||46
2836127|NCT03548987|3538190|FG000|STARTED|Run-in Period (Week 0 to Week 20)||902
2836128|NCT03548987|3538191|FG001|STARTED|Run-in Period (Week 0 to Week 20)||0
2836129|NCT03548987|3538190|FG000|Safety Analysis Set (SAS)|Run-in Period (Week 0 to Week 20)||902
2836130|NCT03548987|3538191|FG001|Safety Analysis Set (SAS)|Run-in Period (Week 0 to Week 20)||0
2836131|NCT03548987|3538190|FG000|COMPLETED|Run-in Period (Week 0 to Week 20)||803
2836132|NCT03548987|3538191|FG001|COMPLETED|Run-in Period (Week 0 to Week 20)||0
2836133|NCT03548987|3538190|FG000|NOT COMPLETED|Run-in Period (Week 0 to Week 20)||99
2836134|NCT03548987|3538191|FG001|NOT COMPLETED|Run-in Period (Week 0 to Week 20)||0
2836135|NCT03548987|3538190|FG000|STARTED|Maintenance Period (Week 20 to Week 68)||535
2836136|NCT03548987|3538191|FG001|STARTED|Maintenance Period (Week 20 to Week 68)||268
2836137|NCT03548987|3538190|FG000|Full Analysis Set (FAS)|Maintenance Period (Week 20 to Week 68)||535
2836138|NCT03548987|3538191|FG001|Full Analysis Set (FAS)|Maintenance Period (Week 20 to Week 68)||268
2836139|NCT03548987|3538190|FG000|COMPLETED|Maintenance Period (Week 20 to Week 68)||504
2836140|NCT03548987|3538191|FG001|COMPLETED|Maintenance Period (Week 20 to Week 68)||237
2836141|NCT03548987|3538190|FG000|NOT COMPLETED|Maintenance Period (Week 20 to Week 68)||31
2836142|NCT03548987|3538191|FG001|NOT COMPLETED|Maintenance Period (Week 20 to Week 68)||31
2915140|NCT00508105|3625361|FG001|STARTED|Overall Study||43
2915141|NCT00508105|3625360|FG000|COMPLETED|Overall Study||40
2915142|NCT00508105|3625361|FG001|COMPLETED|Overall Study||37
2915143|NCT00508105|3625360|FG000|NOT COMPLETED|Overall Study||4
2915144|NCT00508105|3625361|FG001|NOT COMPLETED|Overall Study||6
2915145|NCT00508118|3625370|FG000|STARTED|Overall Study||3
2915146|NCT00508118|3625371|FG001|STARTED|Overall Study|Documentation is not available for the 7th subject and treatment arm.|4
2915147|NCT00508118|3625370|FG000|COMPLETED|Overall Study||3
2915148|NCT00508118|3625371|FG001|COMPLETED|Overall Study||4
2915149|NCT00508118|3625370|FG000|NOT COMPLETED|Overall Study||0
2915150|NCT00508118|3625371|FG001|NOT COMPLETED|Overall Study||0
2915151|NCT00508144|3625378|FG000|STARTED|Overall Study||64
2915152|NCT00508144|3625378|FG000|COMPLETED|Overall Study||53
2915153|NCT00508144|3625378|FG000|NOT COMPLETED|Overall Study||11
2915154|NCT00508157|3625384|FG000|STARTED|Overall Study||26
2915155|NCT00508157|3625385|FG001|STARTED|Overall Study||26
2915156|NCT00508157|3625384|FG000|Randomized Sample|Overall Study||26
2915157|NCT00508157|3625385|FG001|Randomized Sample|Overall Study||26
2915158|NCT00508157|3625384|FG000|Safety Sample|Overall Study||26
2915159|NCT00508157|3625385|FG001|Safety Sample|Overall Study|1 participant was withdrawn from study prior to receiving study drug & excluded from safety sample.|25
2915160|NCT00508157|3625384|FG000|COMPLETED|Overall Study||24
2915161|NCT00508157|3625385|FG001|COMPLETED|Overall Study||23
2915162|NCT00508157|3625384|FG000|NOT COMPLETED|Overall Study||2
2915163|NCT00508157|3625385|FG001|NOT COMPLETED|Overall Study||3
2915164|NCT00508183|3625393|FG000|STARTED|Overall Study||48
2915165|NCT00508183|3625394|FG001|STARTED|Overall Study||42
2915166|NCT00508183|3625393|FG000|COMPLETED|Overall Study||39
2915167|NCT00508183|3625394|FG001|COMPLETED|Overall Study||34
2915168|NCT00508183|3625393|FG000|NOT COMPLETED|Overall Study||9
2915169|NCT00508183|3625394|FG001|NOT COMPLETED|Overall Study||8
2915170|NCT00508196|3625400|FG000|STARTED|Overall Study||11
2915171|NCT00508196|3625401|FG001|STARTED|Overall Study||11
2915172|NCT00508196|3625400|FG000|COMPLETED|Overall Study||11
2915173|NCT00508196|3625401|FG001|COMPLETED|Overall Study||11
2915174|NCT00508196|3625400|FG000|NOT COMPLETED|Overall Study||0
2915175|NCT00508196|3625401|FG001|NOT COMPLETED|Overall Study||0
2915176|NCT00508261|3625411|FG000|STARTED|Overall Study||222
2915177|NCT00508261|3625412|FG001|STARTED|Overall Study||220
2915178|NCT00508261|3625413|FG002|STARTED|Overall Study||224
2915179|NCT00508261|3625414|FG003|STARTED|Overall Study||127
2915180|NCT00508261|3625411|FG000|COMPLETED|Overall Study||219
3167222|NCT01908816|3894396|FG002|NOT COMPLETED|Overall Study||58
3167223|NCT01908816|3894397|FG003|NOT COMPLETED|Overall Study||35
3167224|NCT01908829|3894413|FG000|STARTED|Overall Study||727
3167225|NCT01908829|3894414|FG001|STARTED|Overall Study||728
3167226|NCT01908829|3894415|FG002|STARTED|Overall Study||719
2915181|NCT00508261|3625412|FG001|COMPLETED|Overall Study||212
2915182|NCT00508261|3625413|FG002|COMPLETED|Overall Study||218
2915183|NCT00508261|3625414|FG003|COMPLETED|Overall Study||126
2915184|NCT00508261|3625411|FG000|NOT COMPLETED|Overall Study||3
2915185|NCT00508261|3625412|FG001|NOT COMPLETED|Overall Study||8
2915186|NCT00508261|3625413|FG002|NOT COMPLETED|Overall Study||6
2915187|NCT00508261|3625414|FG003|NOT COMPLETED|Overall Study||1
2915188|NCT00508274|3625428|FG000|STARTED|Overall Study||52
2915189|NCT00508274|3625428|FG000|COMPLETED|Overall Study||2
2915190|NCT00508274|3625428|FG000|NOT COMPLETED|Overall Study||50
2915191|NCT00508300|3625434|FG000|STARTED|Overall Study||67
2915192|NCT00508300|3625435|FG001|STARTED|Overall Study||61
2915193|NCT00508300|3625434|FG000|COMPLETED|Overall Study||65
2915194|NCT00508300|3625435|FG001|COMPLETED|Overall Study||57
2915195|NCT00508300|3625434|FG000|NOT COMPLETED|Overall Study||2
2915196|NCT00508300|3625435|FG001|NOT COMPLETED|Overall Study||4
2915197|NCT00508391|3625443|FG000|STARTED|First Treatment||60
2915198|NCT00508391|3625444|FG001|STARTED|First Treatment||62
2915199|NCT00508391|3625443|FG000|COMPLETED|First Treatment||54
2915200|NCT00508391|3625444|FG001|COMPLETED|First Treatment||59
2915201|NCT00508391|3625443|FG000|NOT COMPLETED|First Treatment||6
2915202|NCT00508391|3625444|FG001|NOT COMPLETED|First Treatment||3
2915203|NCT00508391|3625443|FG000|STARTED|Second Treatment||54
2915204|NCT00508391|3625444|FG001|STARTED|Second Treatment||59
2915205|NCT00508391|3625443|FG000|COMPLETED|Second Treatment||52
2915206|NCT00508391|3625444|FG001|COMPLETED|Second Treatment||59
2915207|NCT00508391|3625443|FG000|NOT COMPLETED|Second Treatment||2
2915208|NCT00508391|3625444|FG001|NOT COMPLETED|Second Treatment||0
2915209|NCT00508404|3625452|FG000|STARTED|Overall Study||154
2915210|NCT00508404|3625452|FG000|COMPLETED|Overall Study|Completion of safety follow-up visit conducted 8 weeks after last dose|112
2915211|NCT00508404|3625452|FG000|NOT COMPLETED|Overall Study||42
2915212|NCT00508469|3625459|FG000|STARTED|Overall Study||52
2915213|NCT00508469|3625460|FG001|STARTED|Overall Study||50
2836143|NCT03548064|3538206|FG000|STARTED|Overall Study||12
2836144|NCT03548064|3538207|FG001|STARTED|Overall Study||12
2836145|NCT03548064|3538208|FG002|STARTED|Overall Study||6
2836146|NCT03548064|3538209|FG003|STARTED|Overall Study||12
2836147|NCT03548064|3538210|FG004|STARTED|Overall Study||12
2836148|NCT03548064|3538211|FG005|STARTED|Overall Study||6
2836149|NCT03548064|3538212|FG006|STARTED|Overall Study||12
2836150|NCT03548064|3538213|FG007|STARTED|Overall Study||3
2836151|NCT03548064|3538206|FG000|COMPLETED|Overall Study||12
2836152|NCT03548064|3538207|FG001|COMPLETED|Overall Study||12
2836153|NCT03548064|3538208|FG002|COMPLETED|Overall Study||6
2836154|NCT03548064|3538209|FG003|COMPLETED|Overall Study||11
2836155|NCT03548064|3538210|FG004|COMPLETED|Overall Study||0
2836156|NCT03548064|3538211|FG005|COMPLETED|Overall Study||3
2836157|NCT03548064|3538212|FG006|COMPLETED|Overall Study||12
2836158|NCT03548064|3538213|FG007|COMPLETED|Overall Study||3
2836159|NCT03548064|3538206|FG000|NOT COMPLETED|Overall Study||0
2836160|NCT03548064|3538207|FG001|NOT COMPLETED|Overall Study||0
2836161|NCT03548064|3538208|FG002|NOT COMPLETED|Overall Study||0
2836162|NCT03548064|3538209|FG003|NOT COMPLETED|Overall Study||1
2836163|NCT03548064|3538210|FG004|NOT COMPLETED|Overall Study||12
2836164|NCT03548064|3538211|FG005|NOT COMPLETED|Overall Study||3
2836165|NCT03548064|3538212|FG006|NOT COMPLETED|Overall Study||0
2836166|NCT03548064|3538213|FG007|NOT COMPLETED|Overall Study||0
2836167|NCT03446456|3538239|FG000|STARTED|Overall Study||20
2836168|NCT03446456|3538240|FG001|STARTED|Overall Study||20
2836169|NCT03446456|3538239|FG000|COMPLETED|Overall Study||16
2836170|NCT03446456|3538240|FG001|COMPLETED|Overall Study||16
2836171|NCT03446456|3538239|FG000|NOT COMPLETED|Overall Study||4
2836172|NCT03446456|3538240|FG001|NOT COMPLETED|Overall Study||4
2836173|NCT03382834|3538248|FG000|STARTED|Overall Study||21
2836174|NCT03382834|3538249|FG001|STARTED|Overall Study||10
2836175|NCT03382834|3538248|FG000|COMPLETED|Overall Study||20
2836176|NCT03382834|3538249|FG001|COMPLETED|Overall Study||9
2836177|NCT03382834|3538248|FG000|NOT COMPLETED|Overall Study||1
2836178|NCT03382834|3538249|FG001|NOT COMPLETED|Overall Study||1
2836179|NCT03371823|3538257|FG000|STARTED|Overall Study||8
2836180|NCT03371823|3538258|FG001|STARTED|Overall Study|We had trouble enrolling naive to therapy women with high blood pressure|0
2836181|NCT03371823|3538257|FG000|COMPLETED|Overall Study||7
2836182|NCT03371823|3538258|FG001|COMPLETED|Overall Study||0
2836183|NCT03371823|3538257|FG000|NOT COMPLETED|Overall Study||1
2836184|NCT03371823|3538258|FG001|NOT COMPLETED|Overall Study||0
2836185|NCT03366337|3538268|FG000|STARTED|Overall Study||31
2836186|NCT03366337|3538269|FG001|STARTED|Overall Study||26
2836187|NCT03366337|3538270|FG002|STARTED|Overall Study||28
2836188|NCT03366337|3538271|FG003|STARTED|Overall Study||18
2836189|NCT03366337|3538268|FG000|COMPLETED|Overall Study||28
2836190|NCT03366337|3538269|FG001|COMPLETED|Overall Study||26
2836191|NCT03366337|3538270|FG002|COMPLETED|Overall Study||26
2836192|NCT03366337|3538271|FG003|COMPLETED|Overall Study||17
2836193|NCT03366337|3538268|FG000|NOT COMPLETED|Overall Study||3
2836194|NCT03366337|3538269|FG001|NOT COMPLETED|Overall Study||0
2836195|NCT03366337|3538270|FG002|NOT COMPLETED|Overall Study||2
2836196|NCT03366337|3538271|FG003|NOT COMPLETED|Overall Study||1
2836197|NCT03353350|3538285|FG000|STARTED|30-week Core Treatment Period||102
2836198|NCT03353350|3538286|FG001|STARTED|30-week Core Treatment Period||100
2836199|NCT03353350|3538287|FG002|STARTED|30-week Core Treatment Period||101
2836200|NCT03353350|3538288|FG003|STARTED|30-week Core Treatment Period||103
2836201|NCT03353350|3538285|FG000|COMPLETED|30-week Core Treatment Period||80
2836202|NCT03353350|3538286|FG001|COMPLETED|30-week Core Treatment Period||81
2836203|NCT03353350|3538287|FG002|COMPLETED|30-week Core Treatment Period||77
2836204|NCT03353350|3538288|FG003|COMPLETED|30-week Core Treatment Period||81
2836205|NCT03353350|3538285|FG000|NOT COMPLETED|30-week Core Treatment Period||22
2836206|NCT03353350|3538286|FG001|NOT COMPLETED|30-week Core Treatment Period||19
2836207|NCT03353350|3538287|FG002|NOT COMPLETED|30-week Core Treatment Period||24
2836208|NCT03353350|3538288|FG003|NOT COMPLETED|30-week Core Treatment Period||22
2836209|NCT03353350|3538285|FG000|STARTED|26-week Treatment Extension Period||80
2836210|NCT03353350|3538286|FG001|STARTED|26-week Treatment Extension Period||81
2836211|NCT03353350|3538287|FG002|STARTED|26-week Treatment Extension Period||77
2836212|NCT03353350|3538288|FG003|STARTED|26-week Treatment Extension Period||81
2836213|NCT03353350|3538285|FG000|COMPLETED|26-week Treatment Extension Period||75
2836214|NCT03353350|3538286|FG001|COMPLETED|26-week Treatment Extension Period||78
2836215|NCT03353350|3538287|FG002|COMPLETED|26-week Treatment Extension Period||73
2836216|NCT03353350|3538288|FG003|COMPLETED|26-week Treatment Extension Period||67
2836217|NCT03353350|3538285|FG000|NOT COMPLETED|26-week Treatment Extension Period||5
2836218|NCT03353350|3538286|FG001|NOT COMPLETED|26-week Treatment Extension Period||3
2836219|NCT03353350|3538287|FG002|NOT COMPLETED|26-week Treatment Extension Period||4
2836220|NCT03353350|3538288|FG003|NOT COMPLETED|26-week Treatment Extension Period||14
2836221|NCT03350503|3538298|FG000|STARTED|Overall Study||121
2836222|NCT03350503|3538298|FG000|COMPLETED|Overall Study||116
2836223|NCT03350503|3538298|FG000|NOT COMPLETED|Overall Study||5
2836224|NCT03326193|3538302|FG000|STARTED|Overall Study||105
2836225|NCT03326193|3538302|FG000|COMPLETED|Overall Study||52
2836226|NCT03326193|3538302|FG000|NOT COMPLETED|Overall Study||53
2836227|NCT03287687|3538308|FG000|STARTED|Overall Study||88
2836228|NCT03287687|3538309|FG001|STARTED|Overall Study||90
2836229|NCT03287687|3538308|FG000|Procedures|Overall Study||88
2836230|NCT03287687|3538309|FG001|Procedures|Overall Study||90
2836231|NCT03287687|3538308|FG000|COMPLETED|Overall Study||88
2836232|NCT03287687|3538309|FG001|COMPLETED|Overall Study||90
2836233|NCT03287687|3538308|FG000|NOT COMPLETED|Overall Study||0
2836234|NCT03287687|3538309|FG001|NOT COMPLETED|Overall Study||0
2836235|NCT03282565|3538318|FG000|STARTED|Overall Study||10
2836236|NCT03282565|3538319|FG001|STARTED|Overall Study||10
2836237|NCT03282565|3538320|FG002|STARTED|Overall Study||10
2836238|NCT03282565|3538318|FG000|COMPLETED|Overall Study||10
2836239|NCT03282565|3538319|FG001|COMPLETED|Overall Study||8
2836240|NCT03282565|3538320|FG002|COMPLETED|Overall Study||8
2836241|NCT03282565|3538318|FG000|NOT COMPLETED|Overall Study||0
2836242|NCT03282565|3538319|FG001|NOT COMPLETED|Overall Study||2
2836243|NCT03282565|3538320|FG002|NOT COMPLETED|Overall Study||2
2836244|NCT03276936|3538330|FG000|STARTED|Overall Study||332
2836245|NCT03276936|3538331|FG001|STARTED|Overall Study||172
2836246|NCT03276936|3538330|FG000|COMPLETED|Overall Study||276
2836247|NCT03276936|3538331|FG001|COMPLETED|Overall Study||134
2836248|NCT03276936|3538330|FG000|NOT COMPLETED|Overall Study||56
2836249|NCT03276936|3538331|FG001|NOT COMPLETED|Overall Study||38
2836250|NCT03271021|3538339|FG000|STARTED|Overall Study||738
2836251|NCT03271021|3538340|FG001|STARTED|Overall Study||750
2836252|NCT03271021|3538339|FG000|COMPLETED|Overall Study||649
2836253|NCT03271021|3538340|FG001|COMPLETED|Overall Study||644
2836254|NCT03271021|3538339|FG000|NOT COMPLETED|Overall Study||89
2836255|NCT03271021|3538340|FG001|NOT COMPLETED|Overall Study||106
2836256|NCT03255083|3538350|FG000|STARTED|Overall Study||6
2836257|NCT03255083|3538351|FG001|STARTED|Overall Study||3
2836258|NCT03255083|3538352|FG002|STARTED|Overall Study||3
2836259|NCT03255083|3538353|FG003|STARTED|Overall Study||1
2836260|NCT03255083|3538350|FG000|COMPLETED|Overall Study||0
2836261|NCT03255083|3538351|FG001|COMPLETED|Overall Study||0
2836262|NCT03255083|3538352|FG002|COMPLETED|Overall Study||0
2836263|NCT03255083|3538353|FG003|COMPLETED|Overall Study||0
2836264|NCT03255083|3538350|FG000|NOT COMPLETED|Overall Study||6
2836265|NCT03255083|3538351|FG001|NOT COMPLETED|Overall Study||3
2836266|NCT03255083|3538352|FG002|NOT COMPLETED|Overall Study||3
2836267|NCT03255083|3538353|FG003|NOT COMPLETED|Overall Study||1
2836268|NCT03227471|3538378|FG000|STARTED|Overall Study||9
2836269|NCT03227471|3538379|FG001|STARTED|Overall Study||30
2836270|NCT03227471|3538380|FG002|STARTED|Overall Study||8
2836271|NCT03227471|3538381|FG003|STARTED|Overall Study||7
2836272|NCT03227471|3538382|FG004|STARTED|Overall Study||25
2836273|NCT03227471|3538383|FG005|STARTED|Overall Study||6
2836274|NCT03227471|3538384|FG006|STARTED|Overall Study||17
2836275|NCT03227471|3538385|FG007|STARTED|Overall Study||12
2836276|NCT03227471|3538386|FG008|STARTED|Overall Study||10
2836277|NCT03227471|3538387|FG009|STARTED|Overall Study||22
2836278|NCT03227471|3538388|FG010|STARTED|Overall Study||21
2836279|NCT03227471|3538389|FG011|STARTED|Overall Study||7
2836280|NCT03227471|3538390|FG012|STARTED|Overall Study||21
2836281|NCT03227471|3538391|FG013|STARTED|Overall Study||8
2836282|NCT03227471|3538392|FG014|STARTED|Overall Study||22
2836283|NCT03227471|3538378|FG000|Safety Set|Overall Study||9
2836284|NCT03227471|3538379|FG001|Safety Set|Overall Study||30
2836285|NCT03227471|3538380|FG002|Safety Set|Overall Study||8
2836286|NCT03227471|3538381|FG003|Safety Set|Overall Study||7
2836287|NCT03227471|3538382|FG004|Safety Set|Overall Study||25
2836288|NCT03227471|3538383|FG005|Safety Set|Overall Study||6
2836289|NCT03227471|3538384|FG006|Safety Set|Overall Study||17
2836290|NCT03227471|3538385|FG007|Safety Set|Overall Study||12
3167227|NCT01908829|3894413|FG000|Treated With Double-blind Drug|Overall Study||725
3167228|NCT01908829|3894414|FG001|Treated With Double-blind Drug|Overall Study||728
3167229|NCT01908829|3894415|FG002|Treated With Double-blind Drug|Overall Study||719
3167230|NCT01908829|3894413|FG000|COMPLETED|Overall Study||678
3167231|NCT01908829|3894414|FG001|COMPLETED|Overall Study||679
2836291|NCT03227471|3538386|FG008|Safety Set|Overall Study||10
2836292|NCT03227471|3538387|FG009|Safety Set|Overall Study||22
2836293|NCT03227471|3538388|FG010|Safety Set|Overall Study||21
2836294|NCT03227471|3538389|FG011|Safety Set|Overall Study||7
2836295|NCT03227471|3538390|FG012|Safety Set|Overall Study||21
2836296|NCT03227471|3538391|FG013|Safety Set|Overall Study||8
2836297|NCT03227471|3538392|FG014|Safety Set|Overall Study||21
2836298|NCT03227471|3538378|FG000|COMPLETED|Overall Study||9
2836299|NCT03227471|3538379|FG001|COMPLETED|Overall Study||30
2836300|NCT03227471|3538380|FG002|COMPLETED|Overall Study||8
2836301|NCT03227471|3538381|FG003|COMPLETED|Overall Study||7
2836302|NCT03227471|3538382|FG004|COMPLETED|Overall Study||24
2836303|NCT03227471|3538383|FG005|COMPLETED|Overall Study||6
2836304|NCT03227471|3538384|FG006|COMPLETED|Overall Study||17
2836305|NCT03227471|3538385|FG007|COMPLETED|Overall Study||12
2836306|NCT03227471|3538386|FG008|COMPLETED|Overall Study||10
2836307|NCT03227471|3538387|FG009|COMPLETED|Overall Study||22
2836308|NCT03227471|3538388|FG010|COMPLETED|Overall Study||21
2836309|NCT03227471|3538389|FG011|COMPLETED|Overall Study||7
2836310|NCT03227471|3538390|FG012|COMPLETED|Overall Study||20
2836311|NCT03227471|3538391|FG013|COMPLETED|Overall Study||8
2836312|NCT03227471|3538392|FG014|COMPLETED|Overall Study||21
2836313|NCT03227471|3538378|FG000|NOT COMPLETED|Overall Study||0
2836314|NCT03227471|3538379|FG001|NOT COMPLETED|Overall Study||0
2836315|NCT03227471|3538380|FG002|NOT COMPLETED|Overall Study||0
2836316|NCT03227471|3538381|FG003|NOT COMPLETED|Overall Study||0
2836317|NCT03227471|3538382|FG004|NOT COMPLETED|Overall Study||1
2836318|NCT03227471|3538383|FG005|NOT COMPLETED|Overall Study||0
2836319|NCT03227471|3538384|FG006|NOT COMPLETED|Overall Study||0
2836320|NCT03227471|3538385|FG007|NOT COMPLETED|Overall Study||0
2836321|NCT03227471|3538386|FG008|NOT COMPLETED|Overall Study||0
2836322|NCT03227471|3538387|FG009|NOT COMPLETED|Overall Study||0
2836323|NCT03227471|3538388|FG010|NOT COMPLETED|Overall Study||0
2836324|NCT03227471|3538389|FG011|NOT COMPLETED|Overall Study||0
2836325|NCT03227471|3538390|FG012|NOT COMPLETED|Overall Study||1
2836326|NCT03227471|3538391|FG013|NOT COMPLETED|Overall Study||0
2836327|NCT03227471|3538392|FG014|NOT COMPLETED|Overall Study||1
2836328|NCT03221842|3538453|FG000|STARTED|Period 1 (Open-label)||63
2836329|NCT03221842|3538454|FG001|STARTED|Period 1 (Open-label)||0
2836330|NCT03221842|3538453|FG000|COMPLETED|Period 1 (Open-label)||53
2836331|NCT03221842|3538454|FG001|COMPLETED|Period 1 (Open-label)||0
2836332|NCT03221842|3538453|FG000|NOT COMPLETED|Period 1 (Open-label)||10
2836333|NCT03221842|3538454|FG001|NOT COMPLETED|Period 1 (Open-label)||0
2836334|NCT03221842|3538453|FG000|STARTED|Period 2 (Randomized, Blinded)||7
2836335|NCT03221842|3538454|FG001|STARTED|Period 2 (Randomized, Blinded)||6
2836336|NCT03221842|3538453|FG000|COMPLETED|Period 2 (Randomized, Blinded)||6
2836337|NCT03221842|3538454|FG001|COMPLETED|Period 2 (Randomized, Blinded)||5
2836338|NCT03221842|3538453|FG000|NOT COMPLETED|Period 2 (Randomized, Blinded)||1
2836339|NCT03221842|3538454|FG001|NOT COMPLETED|Period 2 (Randomized, Blinded)||1
2836340|NCT03194321|3538464|FG000|STARTED|Overall Study||20
2836341|NCT03194321|3538464|FG000|COMPLETED|Overall Study||17
2836342|NCT03194321|3538464|FG000|NOT COMPLETED|Overall Study||3
2836343|NCT03165721|3538471|FG000|STARTED|Overall Study||7
2836344|NCT03165721|3538472|FG001|STARTED|Overall Study||1
2836345|NCT03165721|3538473|FG002|STARTED|Overall Study||1
2836346|NCT03165721|3538471|FG000|COMPLETED|Overall Study||3
2836347|NCT03165721|3538472|FG001|COMPLETED|Overall Study||1
2836348|NCT03165721|3538473|FG002|COMPLETED|Overall Study||1
2836349|NCT03165721|3538471|FG000|NOT COMPLETED|Overall Study||4
2836350|NCT03165721|3538472|FG001|NOT COMPLETED|Overall Study||0
2836351|NCT03165721|3538473|FG002|NOT COMPLETED|Overall Study||0
2915214|NCT00508469|3625459|FG000|COMPLETED|Overall Study||35
2915215|NCT00508469|3625460|FG001|COMPLETED|Overall Study||40
2915216|NCT00508469|3625459|FG000|NOT COMPLETED|Overall Study||17
2915217|NCT00508469|3625460|FG001|NOT COMPLETED|Overall Study||10
2915218|NCT00508482|3625469|FG000|STARTED|Over 4 Weeks of Treatment||237
2915219|NCT00508482|3625470|FG001|STARTED|Over 4 Weeks of Treatment||119
2915220|NCT00508482|3625471|FG002|STARTED|Over 4 Weeks of Treatment||119
2915221|NCT00508482|3625469|FG000|COMPLETED|Over 4 Weeks of Treatment||216
2915222|NCT00508482|3625470|FG001|COMPLETED|Over 4 Weeks of Treatment||102
2915223|NCT00508482|3625471|FG002|COMPLETED|Over 4 Weeks of Treatment||99
2915224|NCT00508482|3625469|FG000|NOT COMPLETED|Over 4 Weeks of Treatment||21
2915225|NCT00508482|3625470|FG001|NOT COMPLETED|Over 4 Weeks of Treatment||17
2915226|NCT00508482|3625471|FG002|NOT COMPLETED|Over 4 Weeks of Treatment||20
2915227|NCT00508482|3625469|FG000|STARTED|at the 4th Week of Follow-up||216
2915228|NCT00508482|3625470|FG001|STARTED|at the 4th Week of Follow-up||102
2915229|NCT00508482|3625471|FG002|STARTED|at the 4th Week of Follow-up||99
2915230|NCT00508482|3625469|FG000|COMPLETED|at the 4th Week of Follow-up||196
2915231|NCT00508482|3625470|FG001|COMPLETED|at the 4th Week of Follow-up||96
2915232|NCT00508482|3625471|FG002|COMPLETED|at the 4th Week of Follow-up||98
2915233|NCT00508482|3625469|FG000|NOT COMPLETED|at the 4th Week of Follow-up||20
2915234|NCT00508482|3625470|FG001|NOT COMPLETED|at the 4th Week of Follow-up||6
2915235|NCT00508482|3625471|FG002|NOT COMPLETED|at the 4th Week of Follow-up||1
2915236|NCT00508482|3625469|FG000|STARTED|at the 12th Week of Follow-up||196
2915237|NCT00508482|3625470|FG001|STARTED|at the 12th Week of Follow-up||96
2915238|NCT00508482|3625471|FG002|STARTED|at the 12th Week of Follow-up||98
2915239|NCT00508482|3625469|FG000|COMPLETED|at the 12th Week of Follow-up||196
2915240|NCT00508482|3625470|FG001|COMPLETED|at the 12th Week of Follow-up||96
2915241|NCT00508482|3625471|FG002|COMPLETED|at the 12th Week of Follow-up||98
2915242|NCT00508482|3625469|FG000|NOT COMPLETED|at the 12th Week of Follow-up||0
2915243|NCT00508482|3625470|FG001|NOT COMPLETED|at the 12th Week of Follow-up||0
2915244|NCT00508482|3625471|FG002|NOT COMPLETED|at the 12th Week of Follow-up||0
2915245|NCT00508521|3625480|FG000|STARTED|Overall Study||4
2915246|NCT00508521|3625480|FG000|COMPLETED|Overall Study||4
2915247|NCT00508521|3625480|FG000|NOT COMPLETED|Overall Study||0
2915248|NCT00508651|3625486|FG000|STARTED|Overall Study||20
2915249|NCT00508651|3625487|FG001|STARTED|Overall Study||10
2915250|NCT00508651|3625486|FG000|COMPLETED|Overall Study||16
2915251|NCT00508651|3625487|FG001|COMPLETED|Overall Study||8
2915252|NCT00508651|3625486|FG000|NOT COMPLETED|Overall Study||4
2915253|NCT00508651|3625487|FG001|NOT COMPLETED|Overall Study||2
2915254|NCT00508716|3625495|FG000|STARTED|Overall Study||61
2915255|NCT00508716|3625496|FG001|STARTED|Overall Study||63
2915256|NCT00508716|3625495|FG000|COMPLETED|Overall Study||61
2915257|NCT00508716|3625496|FG001|COMPLETED|Overall Study||63
2915258|NCT00508716|3625495|FG000|NOT COMPLETED|Overall Study||0
2915259|NCT00508716|3625496|FG001|NOT COMPLETED|Overall Study||0
2915260|NCT00508742|3625504|FG000|STARTED|Period 1: Infant Series||932
2915261|NCT00508742|3625505|FG001|STARTED|Period 1: Infant Series||934
2915262|NCT00508742|3625504|FG000|Vaccinated Dose 1 (at 2 Months of Age)|Period 1: Infant Series||930
2915263|NCT00508742|3625505|FG001|Vaccinated Dose 1 (at 2 Months of Age)|Period 1: Infant Series||933
2915264|NCT00508742|3625504|FG000|Vaccinated Dose 2 (at 4 Months of Age)|Period 1: Infant Series||904
2915265|NCT00508742|3625505|FG001|Vaccinated Dose 2 (at 4 Months of Age)|Period 1: Infant Series||902
2836352|NCT03085095|3538483|FG000|STARTED|Overall Study||624
2836353|NCT03085095|3538484|FG001|STARTED|Overall Study||310
2836354|NCT03085095|3538483|FG000|Received at Least 1 Dose of Study Drug|Overall Study||622
2836355|NCT03085095|3538484|FG001|Received at Least 1 Dose of Study Drug|Overall Study||308
2836356|NCT03085095|3538483|FG000|COMPLETED|Overall Study||563
2836357|NCT03085095|3538484|FG001|COMPLETED|Overall Study||276
2836358|NCT03085095|3538483|FG000|NOT COMPLETED|Overall Study||61
2836359|NCT03085095|3538484|FG001|NOT COMPLETED|Overall Study||34
2836360|NCT03048422|3538496|FG000|STARTED|Overall Study||217
2836361|NCT03048422|3538497|FG001|STARTED|Overall Study||215
2836362|NCT03048422|3538498|FG002|STARTED|Overall Study||211
2836363|NCT03048422|3538496|FG000|COMPLETED|Overall Study||200
2836364|NCT03048422|3538497|FG001|COMPLETED|Overall Study||205
2836365|NCT03048422|3538498|FG002|COMPLETED|Overall Study||202
2836366|NCT03048422|3538496|FG000|NOT COMPLETED|Overall Study||17
2836367|NCT03048422|3538497|FG001|NOT COMPLETED|Overall Study||10
2836368|NCT03048422|3538498|FG002|NOT COMPLETED|Overall Study||9
2836369|NCT03032068|3538516|FG000|STARTED|Overall Study||10
2836370|NCT03032068|3538516|FG000|Preoperative Visit|Overall Study||10
2836371|NCT03032068|3538516|FG000|Postoperative Home Care Visit 1|Overall Study||10
2836372|NCT03032068|3538516|FG000|Postoperative Home Care Visit 2|Overall Study||10
2836373|NCT03032068|3538516|FG000|Postoperative Home Care Visit 3|Overall Study||10
2836374|NCT03032068|3538516|FG000|4 Weeks Postoperative Visit|Overall Study||9
2836375|NCT03032068|3538516|FG000|8 Weeks Postoperative Visit|Overall Study||9
2836376|NCT03032068|3538516|FG000|12 Weeks Postoperative Visit|Overall Study||9
2836377|NCT03032068|3538516|FG000|COMPLETED|Overall Study||9
2836378|NCT03032068|3538516|FG000|NOT COMPLETED|Overall Study||1
2836379|NCT02965729|3538523|FG000|STARTED|Overall Study||24
2836380|NCT02965729|3538524|FG001|STARTED|Overall Study||25
2836381|NCT02965729|3538525|FG002|STARTED|Overall Study||56
2836382|NCT02965729|3538523|FG000|COMPLETED|Overall Study||17
2836383|NCT02965729|3538524|FG001|COMPLETED|Overall Study||22
2836384|NCT02965729|3538525|FG002|COMPLETED|Overall Study||45
2836385|NCT02965729|3538523|FG000|NOT COMPLETED|Overall Study||7
2836386|NCT02965729|3538524|FG001|NOT COMPLETED|Overall Study||3
2836387|NCT02965729|3538525|FG002|NOT COMPLETED|Overall Study||11
2836388|NCT02908672|3538535|FG000|STARTED|Overall Study||258
2836389|NCT02908672|3538536|FG001|STARTED|Overall Study||256
2836390|NCT02908672|3538535|FG000|COMPLETED|Overall Study||0
2836391|NCT02908672|3538536|FG001|COMPLETED|Overall Study||0
2836392|NCT02908672|3538535|FG000|NOT COMPLETED|Overall Study||258
2836393|NCT02908672|3538536|FG001|NOT COMPLETED|Overall Study||256
2836394|NCT02864407|3538542|FG000|STARTED|Overall Study||3223
2836395|NCT02864407|3538542|FG000|Effectiveness Analysis Set|Overall Study||2105
2836396|NCT02864407|3538542|FG000|Long-term Safety Analysis Set|Overall Study||813
2836397|NCT02864407|3538542|FG000|Long-term Effectiveness Analysis Set|Overall Study||767
2836398|NCT02864407|3538542|FG000|COMPLETED|Overall Study||3100
2836399|NCT02864407|3538542|FG000|NOT COMPLETED|Overall Study||123
2836400|NCT02835690|3538549|FG000|STARTED|Overall Study||14
2836401|NCT02835690|3538550|FG001|STARTED|Overall Study||15
2836402|NCT02835690|3538551|FG002|STARTED|Overall Study||15
2836403|NCT02835690|3538549|FG000|Treated|Overall Study||14
2836404|NCT02835690|3538550|FG001|Treated|Overall Study||13
2836405|NCT02835690|3538551|FG002|Treated|Overall Study||15
2836406|NCT02835690|3538549|FG000|COMPLETED|Overall Study||0
2836407|NCT02835690|3538550|FG001|COMPLETED|Overall Study||0
2836408|NCT02835690|3538551|FG002|COMPLETED|Overall Study||0
2836409|NCT02835690|3538549|FG000|NOT COMPLETED|Overall Study||14
2836410|NCT02835690|3538550|FG001|NOT COMPLETED|Overall Study||15
2836411|NCT02835690|3538551|FG002|NOT COMPLETED|Overall Study||15
2836412|NCT02828982|3538559|FG000|STARTED|First Intervention (3 Weeks)||5
2836413|NCT02828982|3538560|FG001|STARTED|First Intervention (3 Weeks)||7
2836414|NCT02828982|3538559|FG000|Received Intervention|First Intervention (3 Weeks)||5
2836415|NCT02828982|3538560|FG001|Received Intervention|First Intervention (3 Weeks)||7
2836416|NCT02828982|3538559|FG000|COMPLETED|First Intervention (3 Weeks)||4
2836417|NCT02828982|3538560|FG001|COMPLETED|First Intervention (3 Weeks)||6
2836418|NCT02828982|3538559|FG000|NOT COMPLETED|First Intervention (3 Weeks)||1
2836419|NCT02828982|3538560|FG001|NOT COMPLETED|First Intervention (3 Weeks)||1
2836420|NCT02828982|3538559|FG000|STARTED|Second Intervention (3 Weeks)||4
2836421|NCT02828982|3538560|FG001|STARTED|Second Intervention (3 Weeks)||6
2836422|NCT02828982|3538559|FG000|Received Intervention|Second Intervention (3 Weeks)||4
2836423|NCT02828982|3538560|FG001|Received Intervention|Second Intervention (3 Weeks)||6
2836424|NCT02828982|3538559|FG000|COMPLETED|Second Intervention (3 Weeks)||4
2836425|NCT02828982|3538560|FG001|COMPLETED|Second Intervention (3 Weeks)||6
2836426|NCT02828982|3538559|FG000|NOT COMPLETED|Second Intervention (3 Weeks)||0
2836427|NCT02828982|3538560|FG001|NOT COMPLETED|Second Intervention (3 Weeks)||0
2836428|NCT02823457|3538568|FG000|STARTED|Overall Study||20
2836429|NCT02823457|3538568|FG000|COMPLETED|Overall Study||15
2836430|NCT02823457|3538568|FG000|NOT COMPLETED|Overall Study||5
2836431|NCT02815280|3538574|FG000|STARTED|Double-Blind Phase||333
2836432|NCT02815280|3538575|FG001|STARTED|Double-Blind Phase||162
2836433|NCT02815280|3538574|FG000|COMPLETED|Double-Blind Phase||297
2836434|NCT02815280|3538575|FG001|COMPLETED|Double-Blind Phase||137
2836435|NCT02815280|3538574|FG000|NOT COMPLETED|Double-Blind Phase||36
2836436|NCT02815280|3538575|FG001|NOT COMPLETED|Double-Blind Phase||25
2836437|NCT02815280|3538574|FG000|STARTED|Open-Label Phase||256
2836438|NCT02815280|3538575|FG001|STARTED|Open-Label Phase||117
2836439|NCT02815280|3538574|FG000|COMPLETED|Open-Label Phase||169
2836440|NCT02815280|3538575|FG001|COMPLETED|Open-Label Phase||73
2836441|NCT02815280|3538574|FG000|NOT COMPLETED|Open-Label Phase||87
2836442|NCT02815280|3538575|FG001|NOT COMPLETED|Open-Label Phase||44
2836443|NCT02815267|3538587|FG000|STARTED|Double-Blind Phase||307
2836444|NCT02815267|3538588|FG001|STARTED|Double-Blind Phase||159
2836445|NCT02815267|3538587|FG000|COMPLETED|Double-Blind Phase||274
2836446|NCT02815267|3538588|FG001|COMPLETED|Double-Blind Phase||128
2836447|NCT02815267|3538587|FG000|NOT COMPLETED|Double-Blind Phase||33
2836448|NCT02815267|3538588|FG001|NOT COMPLETED|Double-Blind Phase||31
2836449|NCT02815267|3538587|FG000|STARTED|Open-Label Phase||193
2836450|NCT02815267|3538588|FG001|STARTED|Open-Label Phase||91
2836451|NCT02815267|3538587|FG000|COMPLETED|Open-Label Phase||122
2836452|NCT02815267|3538588|FG001|COMPLETED|Open-Label Phase||50
2836453|NCT02815267|3538587|FG000|NOT COMPLETED|Open-Label Phase||71
2836454|NCT02815267|3538588|FG001|NOT COMPLETED|Open-Label Phase||41
2836455|NCT02802228|3538600|FG000|STARTED|Overall Study||20
2836456|NCT02802228|3538601|FG001|STARTED|Overall Study||10
2836457|NCT02802228|3538600|FG000|COMPLETED|Overall Study||15
2836458|NCT02802228|3538601|FG001|COMPLETED|Overall Study||10
2836459|NCT02802228|3538600|FG000|NOT COMPLETED|Overall Study||5
2836460|NCT02802228|3538601|FG001|NOT COMPLETED|Overall Study||0
2836461|NCT02719691|3538612|FG000|STARTED|Overall Study||3
2836462|NCT02719691|3538613|FG001|STARTED|Overall Study||4
2836463|NCT02719691|3538614|FG002|STARTED|Overall Study||6
2836464|NCT02719691|3538615|FG003|STARTED|Overall Study||2
2836465|NCT02719691|3538616|FG004|STARTED|Overall Study||31
2836466|NCT02719691|3538612|FG000|COMPLETED|Overall Study||3
2836467|NCT02719691|3538613|FG001|COMPLETED|Overall Study||4
2836468|NCT02719691|3538614|FG002|COMPLETED|Overall Study||6
2836469|NCT02719691|3538615|FG003|COMPLETED|Overall Study||2
2836470|NCT02719691|3538616|FG004|COMPLETED|Overall Study||31
2836471|NCT02719691|3538612|FG000|NOT COMPLETED|Overall Study||0
2836472|NCT02719691|3538613|FG001|NOT COMPLETED|Overall Study||0
2836473|NCT02719691|3538614|FG002|NOT COMPLETED|Overall Study||0
2836474|NCT02719691|3538615|FG003|NOT COMPLETED|Overall Study||0
2836475|NCT02719691|3538616|FG004|NOT COMPLETED|Overall Study||0
2836476|NCT02701283|3538633|FG000|STARTED|Overall Study||737
2836477|NCT02701283|3538634|FG001|STARTED|Overall Study||741
2836478|NCT02701283|3538635|FG002|STARTED|Overall Study||745
2836479|NCT02701283|3538633|FG000|As Treated (Attempted Implant)|Overall Study||730
2836480|NCT02701283|3538634|FG001|As Treated (Attempted Implant)|Overall Study||684
2836481|NCT02701283|3538635|FG002|As Treated (Attempted Implant)|Overall Study||745
2836482|NCT02701283|3538633|FG000|Implanted|Overall Study||727
2836483|NCT02701283|3538634|FG001|Implanted|Overall Study||686
2836484|NCT02701283|3538635|FG002|Implanted|Overall Study||745
2836485|NCT02701283|3538633|FG000|COMPLETED|Overall Study||668
2836486|NCT02701283|3538634|FG001|COMPLETED|Overall Study||579
2836487|NCT02701283|3538635|FG002|COMPLETED|Overall Study||724
2836488|NCT02701283|3538633|FG000|NOT COMPLETED|Overall Study||69
2836489|NCT02701283|3538634|FG001|NOT COMPLETED|Overall Study||162
2836490|NCT02701283|3538635|FG002|NOT COMPLETED|Overall Study||21
2836491|NCT02674516|3538648|FG000|STARTED|Overall Study||17
2836492|NCT02674516|3538649|FG001|STARTED|Overall Study||15
2836493|NCT02674516|3538648|FG000|COMPLETED|Overall Study||13
2836494|NCT02674516|3538649|FG001|COMPLETED|Overall Study||11
2836495|NCT02674516|3538648|FG000|NOT COMPLETED|Overall Study||4
2836496|NCT02674516|3538649|FG001|NOT COMPLETED|Overall Study||4
2836497|NCT02655016|3538657|FG000|STARTED|Overall Study||246
2836498|NCT02655016|3538658|FG001|STARTED|Overall Study||487
2836499|NCT02655016|3538657|FG000|Received Study Treatment|Overall Study|2 participants never received treatment due to screen failure after randomization.|244
2836500|NCT02655016|3538658|FG001|Received Study Treatment|Overall Study|3 participants never received treatment (2 failed screening & 1 withdrew consent before first dose).|484
2836501|NCT02655016|3538657|FG000|Ongoing With Treatment in the Study|Overall Study||69
2836502|NCT02655016|3538658|FG001|Ongoing With Treatment in the Study|Overall Study||177
2836503|NCT02655016|3538657|FG000|COMPLETED|Overall Study|69 participants are ongoing in the study.|191
2836504|NCT02655016|3538658|FG001|COMPLETED|Overall Study|177 participants are ongoing in the study.|397
2836505|NCT02655016|3538657|FG000|NOT COMPLETED|Overall Study||55
2836506|NCT02655016|3538658|FG001|NOT COMPLETED|Overall Study||90
2836507|NCT02607046|3538667|FG000|STARTED|Overall Study||22
2836508|NCT02607046|3538668|FG001|STARTED|Overall Study||13
2836509|NCT02607046|3538667|FG000|COMPLETED|Overall Study||14
2836510|NCT02607046|3538668|FG001|COMPLETED|Overall Study||10
2836511|NCT02607046|3538667|FG000|NOT COMPLETED|Overall Study||8
2836512|NCT02607046|3538668|FG001|NOT COMPLETED|Overall Study||3
2836513|NCT02505425|3538678|FG000|STARTED|Overall Study||208
2836514|NCT02505425|3538679|FG001|STARTED|Overall Study||207
2836515|NCT02505425|3538680|FG002|STARTED|Overall Study||82
2836516|NCT02505425|3538681|FG003|STARTED|Overall Study||76
2836517|NCT02505425|3538678|FG000|COMPLETED|Overall Study||120
2836518|NCT02505425|3538679|FG001|COMPLETED|Overall Study||125
2836519|NCT02505425|3538680|FG002|COMPLETED|Overall Study||32
2836520|NCT02505425|3538681|FG003|COMPLETED|Overall Study||50
2836521|NCT02505425|3538678|FG000|NOT COMPLETED|Overall Study||88
2836522|NCT02505425|3538679|FG001|NOT COMPLETED|Overall Study||82
2836523|NCT02505425|3538680|FG002|NOT COMPLETED|Overall Study||50
2836524|NCT02505425|3538681|FG003|NOT COMPLETED|Overall Study||26
2836525|NCT02487979|3538691|FG000|STARTED|Overall Study||22
2836526|NCT02487979|3538691|FG000|COMPLETED|Overall Study||1
2836527|NCT02487979|3538691|FG000|NOT COMPLETED|Overall Study||21
2836528|NCT02463448|3538695|FG000|STARTED|Enrollment Through 6 Months||23
2836529|NCT02463448|3538695|FG000|COMPLETED|Enrollment Through 6 Months||20
2836530|NCT02463448|3538695|FG000|NOT COMPLETED|Enrollment Through 6 Months||3
2836531|NCT02463448|3538695|FG000|STARTED|6 Months Through 12 Months||20
2836532|NCT02463448|3538695|FG000|COMPLETED|6 Months Through 12 Months||18
2836533|NCT02463448|3538695|FG000|NOT COMPLETED|6 Months Through 12 Months||2
2836534|NCT02463448|3538695|FG000|STARTED|12 Months Through End of Study||18
2836535|NCT02463448|3538695|FG000|COMPLETED|12 Months Through End of Study||17
2836536|NCT02463448|3538695|FG000|NOT COMPLETED|12 Months Through End of Study||1
2915266|NCT00508742|3625504|FG000|Vaccinated Dose 3 (at 6 Months of Age)|Period 1: Infant Series||898
2915267|NCT00508742|3625505|FG001|Vaccinated Dose 3 (at 6 Months of Age)|Period 1: Infant Series||892
2915268|NCT00508742|3625504|FG000|COMPLETED|Period 1: Infant Series||890
2915269|NCT00508742|3625505|FG001|COMPLETED|Period 1: Infant Series||889
2915270|NCT00508742|3625504|FG000|NOT COMPLETED|Period 1: Infant Series||42
2915271|NCT00508742|3625505|FG001|NOT COMPLETED|Period 1: Infant Series||45
2915272|NCT00508742|3625504|FG000|STARTED|Period 2: After Infant Series||890
2915273|NCT00508742|3625505|FG001|STARTED|Period 2: After Infant Series||889
2915274|NCT00508742|3625504|FG000|COMPLETED|Period 2: After Infant Series||883
2915275|NCT00508742|3625505|FG001|COMPLETED|Period 2: After Infant Series||878
2915276|NCT00508742|3625504|FG000|NOT COMPLETED|Period 2: After Infant Series||7
2915277|NCT00508742|3625505|FG001|NOT COMPLETED|Period 2: After Infant Series||11
2915278|NCT00508742|3625504|FG000|STARTED|Period 3: Toddler Dose||883
2915279|NCT00508742|3625505|FG001|STARTED|Period 3: Toddler Dose||878
2915280|NCT00508742|3625504|FG000|COMPLETED|Period 3: Toddler Dose||858
2915281|NCT00508742|3625505|FG001|COMPLETED|Period 3: Toddler Dose||863
2915282|NCT00508742|3625504|FG000|NOT COMPLETED|Period 3: Toddler Dose||25
2915283|NCT00508742|3625505|FG001|NOT COMPLETED|Period 3: Toddler Dose||15
2915284|NCT00508755|3625517|FG000|STARTED|Overall Study||6
2915285|NCT00508755|3625517|FG000|COMPLETED|Overall Study||5
2915286|NCT00508755|3625517|FG000|NOT COMPLETED|Overall Study||1
2915287|NCT00508820|3625525|FG000|STARTED|Overall Study||168
2915288|NCT00508820|3625526|FG001|STARTED|Overall Study||239
2915289|NCT00508820|3625525|FG000|COMPLETED|Overall Study||113
2915290|NCT00508820|3625526|FG001|COMPLETED|Overall Study||175
2915291|NCT00508820|3625525|FG000|NOT COMPLETED|Overall Study||55
2915292|NCT00508820|3625526|FG001|NOT COMPLETED|Overall Study||64
2915293|NCT00508924|3625536|FG000|STARTED|Overall Study||36
2915294|NCT00508924|3625537|FG001|STARTED|Overall Study||38
2915295|NCT00508924|3625538|FG002|STARTED|Overall Study||32
2915296|NCT00508924|3625539|FG003|STARTED|Overall Study||34
2915297|NCT00508924|3625536|FG000|COMPLETED|Overall Study||36
2915298|NCT00508924|3625537|FG001|COMPLETED|Overall Study||38
2915299|NCT00508924|3625538|FG002|COMPLETED|Overall Study||31
2915300|NCT00508924|3625539|FG003|COMPLETED|Overall Study||33
2915301|NCT00508924|3625536|FG000|NOT COMPLETED|Overall Study||0
2915302|NCT00508924|3625537|FG001|NOT COMPLETED|Overall Study||0
2915303|NCT00508924|3625538|FG002|NOT COMPLETED|Overall Study||1
2915304|NCT00508924|3625539|FG003|NOT COMPLETED|Overall Study||1
2915305|NCT00509002|3625549|FG000|STARTED|Overall Study||37
2915306|NCT00509002|3625549|FG000|COMPLETED|Overall Study||37
2915307|NCT00509002|3625549|FG000|NOT COMPLETED|Overall Study||0
2915308|NCT00509028|3625555|FG000|STARTED|Overall Study||121
2915309|NCT00509028|3625556|FG001|STARTED|Overall Study||120
2915310|NCT00509028|3625555|FG000|COMPLETED|Overall Study||109
2915311|NCT00509028|3625556|FG001|COMPLETED|Overall Study||113
2915312|NCT00509028|3625555|FG000|NOT COMPLETED|Overall Study||12
2915313|NCT00509028|3625556|FG001|NOT COMPLETED|Overall Study||7
2915314|NCT00509041|3625562|FG000|STARTED|Overall Study||43
2915315|NCT00509041|3625562|FG000|COMPLETED|Overall Study||43
2915316|NCT00509041|3625562|FG000|NOT COMPLETED|Overall Study||0
2915317|NCT00509067|3625568|FG000|STARTED|Overall Study||19
2915318|NCT00509067|3625569|FG001|STARTED|Overall Study||24
2915319|NCT00509067|3625568|FG000|COMPLETED|Overall Study||15
2915320|NCT00509067|3625569|FG001|COMPLETED|Overall Study||19
2915321|NCT00509067|3625568|FG000|NOT COMPLETED|Overall Study||4
2915322|NCT00509067|3625569|FG001|NOT COMPLETED|Overall Study||5
2915323|NCT00509093|3625579|FG000|STARTED|Overall Study||32
2915324|NCT00509093|3625579|FG000|COMPLETED|Overall Study||8
2915325|NCT00509093|3625579|FG000|NOT COMPLETED|Overall Study||24
2915326|NCT00509106|3625585|FG000|STARTED|Overall Study||315
2915327|NCT00509106|3625586|FG001|STARTED|Overall Study||307
2915328|NCT00509106|3625585|FG000|COMPLETED|Overall Study||284
2915329|NCT00509106|3625586|FG001|COMPLETED|Overall Study||278
2915330|NCT00509106|3625585|FG000|NOT COMPLETED|Overall Study||31
2915331|NCT00509106|3625586|FG001|NOT COMPLETED|Overall Study||29
2915332|NCT00509145|3625594|FG000|STARTED|Overall Study||550
2915333|NCT00509145|3625595|FG001|STARTED|Overall Study||556
2915334|NCT00509145|3625594|FG000|COMPLETED|Overall Study||437
2915335|NCT00509145|3625595|FG001|COMPLETED|Overall Study||427
2915336|NCT00509145|3625594|FG000|NOT COMPLETED|Overall Study||113
2915337|NCT00509145|3625595|FG001|NOT COMPLETED|Overall Study||129
2915338|NCT00509171|3625603|FG000|STARTED|Overall Study||11
2915339|NCT00509171|3625604|FG001|STARTED|Overall Study||11
2915340|NCT00509171|3625603|FG000|COMPLETED|Overall Study||11
2915341|NCT00509171|3625604|FG001|COMPLETED|Overall Study||11
2915342|NCT00509171|3625603|FG000|NOT COMPLETED|Overall Study||0
2915343|NCT00509171|3625604|FG001|NOT COMPLETED|Overall Study||0
2915344|NCT00509197|3625612|FG000|STARTED|Overall Study||6
2836537|NCT02288897|3538701|FG000|STARTED|Overall Study||12
2836538|NCT02288897|3538702|FG001|STARTED|Overall Study||8
2836539|NCT02288897|3538701|FG000|COMPLETED|Overall Study||12
2836540|NCT02288897|3538702|FG001|COMPLETED|Overall Study||8
2836541|NCT02288897|3538701|FG000|NOT COMPLETED|Overall Study||0
2836542|NCT02288897|3538702|FG001|NOT COMPLETED|Overall Study||0
2836543|NCT02276547|3538708|FG000|STARTED|Overall Study||27
2836544|NCT02276547|3538708|FG000|COMPLETED|Overall Study||23
2836545|NCT02276547|3538708|FG000|NOT COMPLETED|Overall Study||4
2836546|NCT02263885|3538712|FG000|STARTED|Overall Study||20
2836547|NCT02263885|3538712|FG000|COMPLETED|Overall Study||10
2836548|NCT02263885|3538712|FG000|NOT COMPLETED|Overall Study||10
3034125|NCT01130532|3753143|FG000|COMPLETED|Period III (Weeks 0-12)||186
3034126|NCT01130532|3753144|FG001|COMPLETED|Period III (Weeks 0-12)||189
3034127|NCT01130532|3753145|FG002|COMPLETED|Period III (Weeks 0-12)||190
3034128|NCT01130532|3753146|FG003|COMPLETED|Period III (Weeks 0-12)||0
3034129|NCT01130532|3753143|FG000|NOT COMPLETED|Period III (Weeks 0-12)||21
3034130|NCT01130532|3753144|FG001|NOT COMPLETED|Period III (Weeks 0-12)||18
2836555|NCT02213926|3538726|FG000|STARTED|Overall Study||124
2836556|NCT02213926|3538726|FG000|COMPLETED|Overall Study||0
2836557|NCT02213926|3538726|FG000|NOT COMPLETED|Overall Study||124
3034131|NCT01130532|3753145|FG002|NOT COMPLETED|Period III (Weeks 0-12)||19
3034132|NCT01130532|3753146|FG003|NOT COMPLETED|Period III (Weeks 0-12)||0
3034133|NCT01130532|3753143|FG000|STARTED|Period IV (Weeks 13-16)||0
3034134|NCT01130532|3753144|FG001|STARTED|Period IV (Weeks 13-16)||0
3034135|NCT01130532|3753145|FG002|STARTED|Period IV (Weeks 13-16)||0
3034136|NCT01130532|3753146|FG003|STARTED|Period IV (Weeks 13-16)|Three participants who completed Period III chose not to continue into Period IV.|562
3034137|NCT01130532|3753143|FG000|Received at Least 1 Dose of Study Drug|Period IV (Weeks 13-16)||0
3034138|NCT01130532|3753144|FG001|Received at Least 1 Dose of Study Drug|Period IV (Weeks 13-16)||0
3034139|NCT01130532|3753145|FG002|Received at Least 1 Dose of Study Drug|Period IV (Weeks 13-16)||0
3034140|NCT01130532|3753146|FG003|Received at Least 1 Dose of Study Drug|Period IV (Weeks 13-16)||546
3167232|NCT01908829|3894415|FG002|COMPLETED|Overall Study||680
3167233|NCT01908829|3894413|FG000|NOT COMPLETED|Overall Study||49
2836570|NCT02008396|3538744|FG000|STARTED|Overall Study||4
2836571|NCT02008396|3538745|FG001|STARTED|Overall Study||8
2836572|NCT02008396|3538744|FG000|COMPLETED|Overall Study||4
2836573|NCT02008396|3538745|FG001|COMPLETED|Overall Study||7
2836574|NCT02008396|3538744|FG000|NOT COMPLETED|Overall Study||0
2836575|NCT02008396|3538745|FG001|NOT COMPLETED|Overall Study||1
2836576|NCT01995175|3538752|FG000|STARTED|Overall Study||2401
2836577|NCT01995175|3538752|FG000|COMPLETED|Overall Study||2148
2836578|NCT01995175|3538752|FG000|NOT COMPLETED|Overall Study||253
2836579|NCT01883804|3538756|FG000|STARTED|Overall Study||25
2836580|NCT01883804|3538756|FG000|COMPLETED|Overall Study||20
2836581|NCT01883804|3538756|FG000|NOT COMPLETED|Overall Study||5
2836582|NCT01804296|3538760|FG000|STARTED|Overall Study||4
2836583|NCT01804296|3538760|FG000|COMPLETED|Overall Study||4
2836584|NCT01804296|3538760|FG000|NOT COMPLETED|Overall Study||0
2836585|NCT01804270|3538766|FG000|STARTED|Overall Study||2
2836586|NCT01804270|3538767|FG001|STARTED|Overall Study||4
2836587|NCT01804270|3538766|FG000|COMPLETED|Overall Study||1
2836588|NCT01804270|3538767|FG001|COMPLETED|Overall Study||3
2836589|NCT01804270|3538766|FG000|NOT COMPLETED|Overall Study||1
2836590|NCT01804270|3538767|FG001|NOT COMPLETED|Overall Study||1
3167234|NCT01908829|3894414|FG001|NOT COMPLETED|Overall Study||49
3167235|NCT01908829|3894415|FG002|NOT COMPLETED|Overall Study||39
3167236|NCT01908842|3894425|FG000|STARTED|Induction||383
3167237|NCT01908842|3894426|FG001|STARTED|Induction||375
3167238|NCT01908842|3894425|FG000|COMPLETED|Induction||357
3167239|NCT01908842|3894426|FG001|COMPLETED|Induction||344
2836591|NCT01781390|3538776|FG000|STARTED|Overall Study||35
2836592|NCT01781390|3538777|FG001|STARTED|Overall Study||35
2836593|NCT01781390|3538778|FG002|STARTED|Overall Study||36
2836594|NCT01781390|3538776|FG000|COMPLETED|Overall Study||32
2836595|NCT01781390|3538777|FG001|COMPLETED|Overall Study||28
2836596|NCT01781390|3538778|FG002|COMPLETED|Overall Study||32
2836597|NCT01781390|3538776|FG000|NOT COMPLETED|Overall Study||3
2836598|NCT01781390|3538777|FG001|NOT COMPLETED|Overall Study||7
2836599|NCT01781390|3538778|FG002|NOT COMPLETED|Overall Study||4
2836600|NCT01566695|3538788|FG000|STARTED|Overall Study||107
2836601|NCT01566695|3538789|FG001|STARTED|Overall Study||109
2836602|NCT01566695|3538788|FG000|COMPLETED|Overall Study||12
2836603|NCT01566695|3538789|FG001|COMPLETED|Overall Study||10
2836604|NCT01566695|3538788|FG000|NOT COMPLETED|Overall Study||95
2836605|NCT01566695|3538789|FG001|NOT COMPLETED|Overall Study||99
2836606|NCT01412333|3538797|FG000|STARTED|Overall Study||418
2836607|NCT01412333|3538798|FG001|STARTED|Overall Study||417
2836608|NCT01412333|3538797|FG000|COMPLETED|Overall Study||320
2836609|NCT01412333|3538798|FG001|COMPLETED|Overall Study||360
2836610|NCT01412333|3538797|FG000|NOT COMPLETED|Overall Study||98
2836611|NCT01412333|3538798|FG001|NOT COMPLETED|Overall Study||57
2836612|NCT01338636|3538805|FG000|STARTED|Overall Study||30
2836613|NCT01338636|3538805|FG000|COMPLETED|Overall Study||22
2836614|NCT01338636|3538805|FG000|NOT COMPLETED|Overall Study||8
2836615|NCT01253161|3538809|FG000|STARTED|Overall Study||29
2836616|NCT01253161|3538809|FG000|COMPLETED|Overall Study||28
2836617|NCT01253161|3538809|FG000|NOT COMPLETED|Overall Study||1
2836618|NCT01247324|3538815|FG000|STARTED|Overall Study||411
2836619|NCT01247324|3538816|FG001|STARTED|Overall Study||410
2836620|NCT01247324|3538815|FG000|COMPLETED|Overall Study||340
2836621|NCT01247324|3538816|FG001|COMPLETED|Overall Study||366
2836622|NCT01247324|3538815|FG000|NOT COMPLETED|Overall Study||71
2836623|NCT01247324|3538816|FG001|NOT COMPLETED|Overall Study||44
2836624|NCT01208974|3538823|FG000|STARTED|NAC-Sparing Mastectomy||21
2836625|NCT01208974|3538824|FG001|STARTED|NAC-Sparing Mastectomy||0
2836626|NCT01208974|3538825|FG002|STARTED|NAC-Sparing Mastectomy||0
2836627|NCT01208974|3538826|FG003|STARTED|NAC-Sparing Mastectomy||0
2836628|NCT01208974|3538823|FG000|COMPLETED|NAC-Sparing Mastectomy||21
2836629|NCT01208974|3538824|FG001|COMPLETED|NAC-Sparing Mastectomy||0
2836630|NCT01208974|3538825|FG002|COMPLETED|NAC-Sparing Mastectomy||0
2836631|NCT01208974|3538826|FG003|COMPLETED|NAC-Sparing Mastectomy||0
2836632|NCT01208974|3538823|FG000|NOT COMPLETED|NAC-Sparing Mastectomy||0
2836633|NCT01208974|3538824|FG001|NOT COMPLETED|NAC-Sparing Mastectomy||0
2836634|NCT01208974|3538825|FG002|NOT COMPLETED|NAC-Sparing Mastectomy||0
2836635|NCT01208974|3538826|FG003|NOT COMPLETED|NAC-Sparing Mastectomy||0
2836636|NCT01208974|3538823|FG000|STARTED|Post-Mastectomy Period (Weeks 1 to 4)||21
2836637|NCT01208974|3538824|FG001|STARTED|Post-Mastectomy Period (Weeks 1 to 4)||0
2836638|NCT01208974|3538825|FG002|STARTED|Post-Mastectomy Period (Weeks 1 to 4)||0
2836639|NCT01208974|3538826|FG003|STARTED|Post-Mastectomy Period (Weeks 1 to 4)||0
2836640|NCT01208974|3538823|FG000|COMPLETED|Post-Mastectomy Period (Weeks 1 to 4)||18
2836641|NCT01208974|3538824|FG001|COMPLETED|Post-Mastectomy Period (Weeks 1 to 4)||0
2836642|NCT01208974|3538825|FG002|COMPLETED|Post-Mastectomy Period (Weeks 1 to 4)||0
2836643|NCT01208974|3538826|FG003|COMPLETED|Post-Mastectomy Period (Weeks 1 to 4)||0
2836644|NCT01208974|3538823|FG000|NOT COMPLETED|Post-Mastectomy Period (Weeks 1 to 4)||3
2836645|NCT01208974|3538824|FG001|NOT COMPLETED|Post-Mastectomy Period (Weeks 1 to 4)||0
2836646|NCT01208974|3538825|FG002|NOT COMPLETED|Post-Mastectomy Period (Weeks 1 to 4)||0
2836647|NCT01208974|3538826|FG003|NOT COMPLETED|Post-Mastectomy Period (Weeks 1 to 4)||0
2836648|NCT01208974|3538823|FG000|STARTED|Prophylactic NAC RT (Weeks 5 to 8)||0
2836649|NCT01208974|3538824|FG001|STARTED|Prophylactic NAC RT (Weeks 5 to 8)||6
2836650|NCT01208974|3538825|FG002|STARTED|Prophylactic NAC RT (Weeks 5 to 8)||6
2836651|NCT01208974|3538826|FG003|STARTED|Prophylactic NAC RT (Weeks 5 to 8)||6
2836652|NCT01208974|3538823|FG000|Cohort 1: Starting Dose|Prophylactic NAC RT (Weeks 5 to 8)||0
2836653|NCT01208974|3538824|FG001|Cohort 1: Starting Dose|Prophylactic NAC RT (Weeks 5 to 8)||6
2836654|NCT01208974|3538825|FG002|Cohort 1: Starting Dose|Prophylactic NAC RT (Weeks 5 to 8)||0
2836655|NCT01208974|3538826|FG003|Cohort 1: Starting Dose|Prophylactic NAC RT (Weeks 5 to 8)||0
2836656|NCT01208974|3538823|FG000|Cohort 2: 1st Dose Escalation|Prophylactic NAC RT (Weeks 5 to 8)||0
2836657|NCT01208974|3538824|FG001|Cohort 2: 1st Dose Escalation|Prophylactic NAC RT (Weeks 5 to 8)||0
2836658|NCT01208974|3538825|FG002|Cohort 2: 1st Dose Escalation|Prophylactic NAC RT (Weeks 5 to 8)||6
2836659|NCT01208974|3538826|FG003|Cohort 2: 1st Dose Escalation|Prophylactic NAC RT (Weeks 5 to 8)||0
2836660|NCT01208974|3538823|FG000|Cohort 3: 2nd Dose Escalation|Prophylactic NAC RT (Weeks 5 to 8)||0
2836661|NCT01208974|3538824|FG001|Cohort 3: 2nd Dose Escalation|Prophylactic NAC RT (Weeks 5 to 8)||0
2836662|NCT01208974|3538825|FG002|Cohort 3: 2nd Dose Escalation|Prophylactic NAC RT (Weeks 5 to 8)||0
2836663|NCT01208974|3538826|FG003|Cohort 3: 2nd Dose Escalation|Prophylactic NAC RT (Weeks 5 to 8)||6
2836664|NCT01208974|3538823|FG000|COMPLETED|Prophylactic NAC RT (Weeks 5 to 8)||0
2836665|NCT01208974|3538824|FG001|COMPLETED|Prophylactic NAC RT (Weeks 5 to 8)||6
2836666|NCT01208974|3538825|FG002|COMPLETED|Prophylactic NAC RT (Weeks 5 to 8)||6
2836667|NCT01208974|3538826|FG003|COMPLETED|Prophylactic NAC RT (Weeks 5 to 8)||6
2836668|NCT01208974|3538823|FG000|NOT COMPLETED|Prophylactic NAC RT (Weeks 5 to 8)||0
2836669|NCT01208974|3538824|FG001|NOT COMPLETED|Prophylactic NAC RT (Weeks 5 to 8)||0
2836670|NCT01208974|3538825|FG002|NOT COMPLETED|Prophylactic NAC RT (Weeks 5 to 8)||0
2836671|NCT01208974|3538826|FG003|NOT COMPLETED|Prophylactic NAC RT (Weeks 5 to 8)||0
2836672|NCT01063517|3538835|FG000|STARTED|Overall Study||62
2836673|NCT01063517|3538836|FG001|STARTED|Overall Study||62
2836674|NCT01063517|3538835|FG000|Received Randomised Treatment|Overall Study||61
2836675|NCT01063517|3538836|FG001|Received Randomised Treatment|Overall Study||62
2836676|NCT01063517|3538835|FG000|COMPLETED|Overall Study||4
2836677|NCT01063517|3538836|FG001|COMPLETED|Overall Study||2
2836678|NCT01063517|3538835|FG000|NOT COMPLETED|Overall Study||58
2836679|NCT01063517|3538836|FG001|NOT COMPLETED|Overall Study||60
2836680|NCT00938912|3538842|FG000|STARTED|Overall Study||365
2836681|NCT00938912|3538842|FG000|COMPLETED|Overall Study||254
2836682|NCT00938912|3538842|FG000|NOT COMPLETED|Overall Study||111
2836683|NCT00925652|3538853|FG000|STARTED|Overall Study||13
2836684|NCT00925652|3538854|FG001|STARTED|Overall Study||13
2836685|NCT00925652|3538855|FG002|STARTED|Overall Study||11
2836686|NCT00925652|3538856|FG003|STARTED|Overall Study||13
2836687|NCT00925652|3538853|FG000|Withdraw|Overall Study||6
2836688|NCT00925652|3538854|FG001|Withdraw|Overall Study||5
2836689|NCT00925652|3538855|FG002|Withdraw|Overall Study||3
2836690|NCT00925652|3538856|FG003|Withdraw|Overall Study||1
2836691|NCT00925652|3538853|FG000|Off Treatment Because of Other Complicating Disease|Overall Study||0
2836692|NCT00925652|3538854|FG001|Off Treatment Because of Other Complicating Disease|Overall Study||0
2836693|NCT00925652|3538855|FG002|Off Treatment Because of Other Complicating Disease|Overall Study||2
2836694|NCT00925652|3538856|FG003|Off Treatment Because of Other Complicating Disease|Overall Study||3
2836695|NCT00925652|3538853|FG000|Off Treatment Because of Disease Recurrence|Overall Study||1
2836696|NCT00925652|3538854|FG001|Off Treatment Because of Disease Recurrence|Overall Study||3
2836697|NCT00925652|3538855|FG002|Off Treatment Because of Disease Recurrence|Overall Study||0
2836698|NCT00925652|3538856|FG003|Off Treatment Because of Disease Recurrence|Overall Study||0
2836699|NCT00925652|3538853|FG000|Lost of Follow-up|Overall Study||0
2836700|NCT00925652|3538854|FG001|Lost of Follow-up|Overall Study||1
2836701|NCT00925652|3538855|FG002|Lost of Follow-up|Overall Study||0
2836702|NCT00925652|3538856|FG003|Lost of Follow-up|Overall Study||0
2836703|NCT00925652|3538853|FG000|Death|Overall Study||0
2836704|NCT00925652|3538854|FG001|Death|Overall Study||0
2836705|NCT00925652|3538855|FG002|Death|Overall Study||0
2836706|NCT00925652|3538856|FG003|Death|Overall Study||3
2836707|NCT00925652|3538853|FG000|COMPLETED|Overall Study||6
2836708|NCT00925652|3538854|FG001|COMPLETED|Overall Study||4
2836709|NCT00925652|3538855|FG002|COMPLETED|Overall Study||6
2836710|NCT00925652|3538856|FG003|COMPLETED|Overall Study||6
2836711|NCT00925652|3538853|FG000|NOT COMPLETED|Overall Study||7
2836712|NCT00925652|3538854|FG001|NOT COMPLETED|Overall Study||9
2836713|NCT00925652|3538855|FG002|NOT COMPLETED|Overall Study||5
2836714|NCT00925652|3538856|FG003|NOT COMPLETED|Overall Study||7
2836715|NCT00792948|3538874|FG000|STARTED|Overall Study|Patients registered to induction/consolidation step|97
2836716|NCT00792948|3538874|FG000|COMPLETED|Overall Study|Patients who completed induction/consolidation step|69
2836717|NCT00792948|3538874|FG000|NOT COMPLETED|Overall Study||28
2836718|NCT00676715|3538885|FG000|STARTED|Overall Study||54
2836719|NCT00676715|3538886|FG001|STARTED|Overall Study||55
2836720|NCT00676715|3538887|FG002|STARTED|Overall Study||55
2836721|NCT00676715|3538888|FG003|STARTED|Overall Study||54
2836722|NCT00676715|3538885|FG000|COMPLETED|Overall Study||14
2836723|NCT00676715|3538886|FG001|COMPLETED|Overall Study||8
2836724|NCT00676715|3538887|FG002|COMPLETED|Overall Study||14
2836725|NCT00676715|3538888|FG003|COMPLETED|Overall Study||14
2836726|NCT00676715|3538885|FG000|NOT COMPLETED|Overall Study||40
2836727|NCT00676715|3538886|FG001|NOT COMPLETED|Overall Study||47
2836728|NCT00676715|3538887|FG002|NOT COMPLETED|Overall Study||41
2836729|NCT00676715|3538888|FG003|NOT COMPLETED|Overall Study||40
2836730|NCT00579826|3538900|FG000|STARTED|Overall Study||29
2836731|NCT00579826|3538901|FG001|STARTED|Overall Study||26
2836732|NCT00579826|3538900|FG000|6 Months|Overall Study|RPFNA for assessment for primary endpoint.|28
2836733|NCT00579826|3538901|FG001|6 Months|Overall Study|RPFNA for assessment for primary endpoint.|25
2836734|NCT00579826|3538900|FG000|COMPLETED|Overall Study|Optional open label letrozole months 6-12; followed by RPFNA,|24
2836735|NCT00579826|3538901|FG001|COMPLETED|Overall Study|Optional open label letrozole months 6-12; followed by RPFNA,|23
2836736|NCT00579826|3538900|FG000|NOT COMPLETED|Overall Study||5
2836737|NCT00579826|3538901|FG001|NOT COMPLETED|Overall Study||3
2836738|NCT00322218|3538909|FG000|STARTED|Overall Study||34
2836739|NCT00322218|3538910|FG001|STARTED|Overall Study||34
2836740|NCT00322218|3538909|FG000|Per-Protocol Set|Overall Study||33
2836741|NCT00322218|3538910|FG001|Per-Protocol Set|Overall Study||32
2836742|NCT00322218|3538909|FG000|COMPLETED|Overall Study||31
2836743|NCT00322218|3538910|FG001|COMPLETED|Overall Study||28
2836744|NCT00322218|3538909|FG000|NOT COMPLETED|Overall Study||3
3167240|NCT01908842|3894425|FG000|NOT COMPLETED|Induction||26
3167241|NCT01908842|3894426|FG001|NOT COMPLETED|Induction||31
3167242|NCT01908842|3894425|FG000|STARTED|Switch to Other BNX Formulation (Day 15)||357
3167243|NCT01908842|3894426|FG001|STARTED|Switch to Other BNX Formulation (Day 15)||344
3167244|NCT01908842|3894425|FG000|COMPLETED|Switch to Other BNX Formulation (Day 15)||287
3167245|NCT01908842|3894426|FG001|COMPLETED|Switch to Other BNX Formulation (Day 15)||279
3167246|NCT01908842|3894425|FG000|NOT COMPLETED|Switch to Other BNX Formulation (Day 15)||70
3167247|NCT01908842|3894426|FG001|NOT COMPLETED|Switch to Other BNX Formulation (Day 15)||65
3167248|NCT01908842|3894425|FG000|STARTED|Day 22: Film (Col 1); Tablets (Col 2)||287
3167249|NCT01908842|3894426|FG001|STARTED|Day 22: Film (Col 1); Tablets (Col 2)||279
3167250|NCT01908842|3894425|FG000|COMPLETED|Day 22: Film (Col 1); Tablets (Col 2)||262
3167251|NCT01908842|3894426|FG001|COMPLETED|Day 22: Film (Col 1); Tablets (Col 2)||262
3167252|NCT01908842|3894425|FG000|NOT COMPLETED|Day 22: Film (Col 1); Tablets (Col 2)||25
3167253|NCT01908842|3894426|FG001|NOT COMPLETED|Day 22: Film (Col 1); Tablets (Col 2)||17
3167254|NCT01908907|3894434|FG000|STARTED|Overall Study||31
3167255|NCT01908907|3894435|FG001|STARTED|Overall Study||29
3167256|NCT01908907|3894434|FG000|COMPLETED|Overall Study||29
3167257|NCT01908907|3894435|FG001|COMPLETED|Overall Study||29
3167258|NCT01908907|3894434|FG000|NOT COMPLETED|Overall Study||2
3167259|NCT01908907|3894435|FG001|NOT COMPLETED|Overall Study||0
3167260|NCT01908972|3894447|FG000|STARTED|Overall Study||17
3167261|NCT01908972|3894448|FG001|STARTED|Overall Study||17
3167262|NCT01908972|3894447|FG000|COMPLETED|Overall Study||15
3167263|NCT01908972|3894448|FG001|COMPLETED|Overall Study||17
3167264|NCT01908972|3894447|FG000|NOT COMPLETED|Overall Study||2
3167265|NCT01908972|3894448|FG001|NOT COMPLETED|Overall Study||0
3167266|NCT01909011|3894456|FG000|STARTED|Overall Study||7
3167267|NCT01909011|3894457|FG001|STARTED|Overall Study||9
2836745|NCT00322218|3538910|FG001|NOT COMPLETED|Overall Study||6
2836746|NCT00186888|3538919|FG000|STARTED|Overall Study||23
2836747|NCT00186888|3538920|FG001|STARTED|Overall Study||27
2836748|NCT00186888|3538921|FG002|STARTED|Overall Study||55
2836749|NCT00186888|3538919|FG000|Window Therapy|Overall Study||0
2836750|NCT00186888|3538920|FG001|Window Therapy|Overall Study||27
2836751|NCT00186888|3538921|FG002|Window Therapy|Overall Study||0
2836752|NCT00186888|3538919|FG000|COMPLETED|Overall Study||19
2836753|NCT00186888|3538920|FG001|COMPLETED|Overall Study||24
2836754|NCT00186888|3538921|FG002|COMPLETED|Overall Study||55
2836755|NCT00186888|3538919|FG000|NOT COMPLETED|Overall Study||4
2836756|NCT00186888|3538920|FG001|NOT COMPLETED|Overall Study||3
2836757|NCT00186888|3538921|FG002|NOT COMPLETED|Overall Study||0
2915345|NCT00509197|3625613|FG001|STARTED|Overall Study||6
2915346|NCT00509197|3625612|FG000|COMPLETED|Overall Study||6
2915347|NCT00509197|3625613|FG001|COMPLETED|Overall Study||6
2915348|NCT00509197|3625612|FG000|NOT COMPLETED|Overall Study||0
2915349|NCT00509197|3625613|FG001|NOT COMPLETED|Overall Study||0
2915350|NCT00509223|3625623|FG000|STARTED|Overall Study||207
3311430|NCT03052530|4044945|FG000|NOT COMPLETED|Overall Study||0
3311431|NCT03052725|4044951|FG000|STARTED|Overall Study||194
3311432|NCT03052725|4044952|FG001|STARTED|Overall Study||197
3311433|NCT03052725|4044951|FG000|Safety Analysis Set|Overall Study||194
3311434|NCT03052725|4044952|FG001|Safety Analysis Set|Overall Study||196
3311435|NCT03052725|4044951|FG000|COMPLETED|Overall Study||46
3311436|NCT03052725|4044952|FG001|COMPLETED|Overall Study||47
2915351|NCT00509223|3625624|FG001|STARTED|Overall Study||209
2915352|NCT00509223|3625623|FG000|COMPLETED|Overall Study||119
2915353|NCT00509223|3625624|FG001|COMPLETED|Overall Study||137
2915354|NCT00509223|3625623|FG000|NOT COMPLETED|Overall Study||88
2915355|NCT00509223|3625624|FG001|NOT COMPLETED|Overall Study||72
2915356|NCT00509236|3625632|FG000|STARTED|Overall Study||64
2915357|NCT00509236|3625633|FG001|STARTED|Overall Study||65
2915358|NCT00509236|3625632|FG000|COMPLETED|Overall Study||47
2915359|NCT00509236|3625633|FG001|COMPLETED|Overall Study||45
2915360|NCT00509236|3625632|FG000|NOT COMPLETED|Overall Study||17
2915361|NCT00509236|3625633|FG001|NOT COMPLETED|Overall Study||20
2920676|NCT00537940|3631209|FG000|Entered Opt Blinded Continuation Phase|Overall Study||140
2920677|NCT00537940|3631210|FG001|Entered Opt Blinded Continuation Phase|Overall Study||139
2920678|NCT00537940|3631209|FG000|COMPLETED|Overall Study|2 participants had both treatment related and non-treatment related AE leading to discontinuation.|58
2920679|NCT00537940|3631210|FG001|COMPLETED|Overall Study||62
2920680|NCT00537940|3631209|FG000|NOT COMPLETED|Overall Study||183
2920681|NCT00537940|3631210|FG001|NOT COMPLETED|Overall Study||179
2920682|NCT00537979|3631218|FG000|STARTED|Overall Study||38
2920683|NCT00537979|3631219|FG001|STARTED|Overall Study||109
2920684|NCT00537979|3631218|FG000|COMPLETED|Overall Study||32
2920685|NCT00537979|3631219|FG001|COMPLETED|Overall Study||89
2920686|NCT00537979|3631218|FG000|NOT COMPLETED|Overall Study||6
2920687|NCT00537979|3631219|FG001|NOT COMPLETED|Overall Study||20
2920688|NCT00538213|3631229|FG000|STARTED|Overall Study||55
2920689|NCT00538213|3631230|FG001|STARTED|Overall Study||40
2920690|NCT00538213|3631231|FG002|STARTED|Overall Study||38
2920691|NCT00538213|3631229|FG000|COMPLETED|Overall Study||55
2920692|NCT00538213|3631230|FG001|COMPLETED|Overall Study||40
3167268|NCT01909011|3894456|FG000|COMPLETED|Overall Study||7
3167269|NCT01909011|3894457|FG001|COMPLETED|Overall Study||9
2920693|NCT00538213|3631231|FG002|COMPLETED|Overall Study||38
2920694|NCT00538213|3631229|FG000|NOT COMPLETED|Overall Study||0
2920695|NCT00538213|3631230|FG001|NOT COMPLETED|Overall Study||0
2920696|NCT00538213|3631231|FG002|NOT COMPLETED|Overall Study||0
2920697|NCT00538291|3631240|FG000|STARTED|Overall Study||13
2920698|NCT00538291|3631240|FG000|COMPLETED|Overall Study||10
2920699|NCT00538291|3631240|FG000|NOT COMPLETED|Overall Study||3
2920700|NCT00538304|3631246|FG000|STARTED|Overall Study||151
2920701|NCT00538304|3631247|FG001|STARTED|Overall Study||71
2920702|NCT00538304|3631246|FG000|COMPLETED|Overall Study||144
2920703|NCT00538304|3631247|FG001|COMPLETED|Overall Study||66
2920704|NCT00538304|3631246|FG000|NOT COMPLETED|Overall Study||7
2920705|NCT00538304|3631247|FG001|NOT COMPLETED|Overall Study||5
2920706|NCT00538434|3631257|FG000|STARTED|Overall Study||56
2920707|NCT00538434|3631258|FG001|STARTED|Overall Study||57
2920708|NCT00538434|3631259|FG002|STARTED|Overall Study||57
2920709|NCT00538434|3631260|FG003|STARTED|Overall Study||57
2920710|NCT00538434|3631257|FG000|Intent-to-treat (ITT) Population|Overall Study|1 participant was randomized but not treated|55
2920711|NCT00538434|3631258|FG001|Intent-to-treat (ITT) Population|Overall Study||57
2920712|NCT00538434|3631259|FG002|Intent-to-treat (ITT) Population|Overall Study||57
2920713|NCT00538434|3631260|FG003|Intent-to-treat (ITT) Population|Overall Study||57
2920714|NCT00538434|3631257|FG000|COMPLETED|Overall Study|Completed all scheduled study visits|47
2920715|NCT00538434|3631258|FG001|COMPLETED|Overall Study|Completed all scheduled study visits|46
2920716|NCT00538434|3631259|FG002|COMPLETED|Overall Study|Completed all scheduled study visits|50
2920717|NCT00538434|3631260|FG003|COMPLETED|Overall Study|Completed all scheduled study visits|51
2920718|NCT00538434|3631257|FG000|NOT COMPLETED|Overall Study||9
2920719|NCT00538434|3631258|FG001|NOT COMPLETED|Overall Study||11
2920720|NCT00538434|3631259|FG002|NOT COMPLETED|Overall Study||7
2920721|NCT00538434|3631260|FG003|NOT COMPLETED|Overall Study||6
2920722|NCT00538473|3631273|FG000|STARTED|Overall Study||33
2920723|NCT00538473|3631274|FG001|STARTED|Overall Study||35
2920724|NCT00538473|3631273|FG000|COMPLETED|Overall Study||32
2920725|NCT00538473|3631274|FG001|COMPLETED|Overall Study||35
2920726|NCT00538473|3631273|FG000|NOT COMPLETED|Overall Study||1
2920727|NCT00538473|3631274|FG001|NOT COMPLETED|Overall Study||0
2920728|NCT00538512|3631283|FG000|STARTED|Overall Study||814
2920729|NCT00538512|3631284|FG001|STARTED|Overall Study||813
2920730|NCT00538512|3631285|FG002|STARTED|Overall Study||325
2920731|NCT00538512|3631283|FG000|COMPLETED|Overall Study||787
2920732|NCT00538512|3631284|FG001|COMPLETED|Overall Study||783
2920733|NCT00538512|3631285|FG002|COMPLETED|Overall Study||312
3311437|NCT03052725|4044951|FG000|NOT COMPLETED|Overall Study||148
3311438|NCT03052725|4044952|FG001|NOT COMPLETED|Overall Study||150
2836758|NCT04579549|3538956|FG000|STARTED|Overall Study||464
2836759|NCT04579549|3538956|FG000|Number of Individuals Trained In COVID-19 Assay|Overall Study||11
2836760|NCT04579549|3538956|FG000|COMPLETED|Overall Study||464
2836761|NCT04579549|3538956|FG000|NOT COMPLETED|Overall Study||0
2836762|NCT04460690|3538962|FG000|STARTED|Overall Study||93
2836763|NCT04460690|3538962|FG000|Community Participants|Overall Study||83
2836764|NCT04460690|3538962|FG000|Investigator Participants|Overall Study||10
2836765|NCT04460690|3538962|FG000|COMPLETED|Overall Study||93
2836766|NCT04460690|3538962|FG000|NOT COMPLETED|Overall Study||0
2836832|NCT03597295|3539031|FG000|STARTED|Overall Study||94
2836833|NCT03597295|3539031|FG000|COMPLETED|Overall Study||0
2836834|NCT03597295|3539031|FG000|NOT COMPLETED|Overall Study||94
2836835|NCT03086369|3539041|FG000|STARTED|Overall Study||3
2836836|NCT03086369|3539042|FG001|STARTED|Overall Study||7
2836837|NCT03086369|3539043|FG002|STARTED|Overall Study||12
2836838|NCT03086369|3539044|FG003|STARTED|Overall Study||82
2836839|NCT03086369|3539045|FG004|STARTED|Overall Study||80
2836840|NCT03086369|3539041|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
2836841|NCT03086369|3539042|FG001|Received at Least 1 Dose of Study Drug|Overall Study||7
2836842|NCT03086369|3539043|FG002|Received at Least 1 Dose of Study Drug|Overall Study||12
2836843|NCT03086369|3539044|FG003|Received at Least 1 Dose of Study Drug|Overall Study||81
2836844|NCT03086369|3539045|FG004|Received at Least 1 Dose of Study Drug|Overall Study||78
2836845|NCT03086369|3539041|FG000|COMPLETED|Overall Study||2
2836846|NCT03086369|3539042|FG001|COMPLETED|Overall Study||7
2836847|NCT03086369|3539043|FG002|COMPLETED|Overall Study||12
2836848|NCT03086369|3539044|FG003|COMPLETED|Overall Study||55
2836849|NCT03086369|3539045|FG004|COMPLETED|Overall Study||59
2836850|NCT03086369|3539041|FG000|NOT COMPLETED|Overall Study||1
2836851|NCT03086369|3539042|FG001|NOT COMPLETED|Overall Study||0
2836852|NCT03086369|3539043|FG002|NOT COMPLETED|Overall Study||0
2836853|NCT03086369|3539044|FG003|NOT COMPLETED|Overall Study||27
2836854|NCT03086369|3539045|FG004|NOT COMPLETED|Overall Study||21
2836855|NCT03053362|3539061|FG000|STARTED|Overall Study||100
2836856|NCT03053362|3539062|FG001|STARTED|Overall Study||58
2836857|NCT03053362|3539061|FG000|COMPLETED|Overall Study||83
2836858|NCT03053362|3539062|FG001|COMPLETED|Overall Study||50
2836859|NCT03053362|3539061|FG000|NOT COMPLETED|Overall Study||17
2836860|NCT03053362|3539062|FG001|NOT COMPLETED|Overall Study||8
2836861|NCT02849626|3539071|FG000|STARTED|Core Phase (up to 23 Weeks)||149
2836862|NCT02849626|3539072|FG001|STARTED|Core Phase (up to 23 Weeks)||31
2836863|NCT02849626|3539071|FG000|COMPLETED|Core Phase (up to 23 Weeks)||122
2836864|NCT02849626|3539072|FG001|COMPLETED|Core Phase (up to 23 Weeks)||24
2836865|NCT02849626|3539071|FG000|NOT COMPLETED|Core Phase (up to 23 Weeks)||27
2836866|NCT02849626|3539072|FG001|NOT COMPLETED|Core Phase (up to 23 Weeks)||7
2836867|NCT02849626|3539071|FG000|STARTED|Extension Phase A (up to 29 Weeks)||116
2836868|NCT02849626|3539072|FG001|STARTED|Extension Phase A (up to 29 Weeks)||20
2836869|NCT02849626|3539071|FG000|COMPLETED|Extension Phase A (up to 29 Weeks)||105
2836870|NCT02849626|3539072|FG001|COMPLETED|Extension Phase A (up to 29 Weeks)||17
2836871|NCT02849626|3539071|FG000|NOT COMPLETED|Extension Phase A (up to 29 Weeks)||11
2836872|NCT02849626|3539072|FG001|NOT COMPLETED|Extension Phase A (up to 29 Weeks)||3
2836873|NCT02810418|3539095|FG000|STARTED|Arm A Dose Escalation||6
2836874|NCT02810418|3539096|FG001|STARTED|Arm A Dose Escalation||8
2836875|NCT02810418|3539097|FG002|STARTED|Arm A Dose Escalation||0
2836876|NCT02810418|3539098|FG003|STARTED|Arm A Dose Escalation||0
2836877|NCT02810418|3539099|FG004|STARTED|Arm A Dose Escalation||0
2836878|NCT02810418|3539100|FG005|STARTED|Arm A Dose Escalation||0
2836879|NCT02810418|3539101|FG006|STARTED|Arm A Dose Escalation||0
2836880|NCT02810418|3539095|FG000|COMPLETED|Arm A Dose Escalation||4
2836881|NCT02810418|3539096|FG001|COMPLETED|Arm A Dose Escalation||7
2836882|NCT02810418|3539097|FG002|COMPLETED|Arm A Dose Escalation||0
2836883|NCT02810418|3539098|FG003|COMPLETED|Arm A Dose Escalation||0
2836884|NCT02810418|3539099|FG004|COMPLETED|Arm A Dose Escalation||0
2836885|NCT02810418|3539100|FG005|COMPLETED|Arm A Dose Escalation||0
2836886|NCT02810418|3539101|FG006|COMPLETED|Arm A Dose Escalation||0
2836887|NCT02810418|3539095|FG000|NOT COMPLETED|Arm A Dose Escalation||2
2836888|NCT02810418|3539096|FG001|NOT COMPLETED|Arm A Dose Escalation||1
2836889|NCT02810418|3539097|FG002|NOT COMPLETED|Arm A Dose Escalation||0
2836890|NCT02810418|3539098|FG003|NOT COMPLETED|Arm A Dose Escalation||0
2836891|NCT02810418|3539099|FG004|NOT COMPLETED|Arm A Dose Escalation||0
2836892|NCT02810418|3539100|FG005|NOT COMPLETED|Arm A Dose Escalation||0
2836893|NCT02810418|3539101|FG006|NOT COMPLETED|Arm A Dose Escalation||0
2836894|NCT02810418|3539095|FG000|STARTED|Dose Expansion||0
2836895|NCT02810418|3539096|FG001|STARTED|Dose Expansion||8
2836896|NCT02810418|3539097|FG002|STARTED|Dose Expansion||6
2836897|NCT02810418|3539098|FG003|STARTED|Dose Expansion||0
2836898|NCT02810418|3539099|FG004|STARTED|Dose Expansion||0
2836899|NCT02810418|3539100|FG005|STARTED|Dose Expansion||0
2836900|NCT02810418|3539101|FG006|STARTED|Dose Expansion||0
2836901|NCT02810418|3539095|FG000|COMPLETED|Dose Expansion||0
2836902|NCT02810418|3539096|FG001|COMPLETED|Dose Expansion||7
2836903|NCT02810418|3539097|FG002|COMPLETED|Dose Expansion||3
2836904|NCT02810418|3539098|FG003|COMPLETED|Dose Expansion||0
2836905|NCT02810418|3539099|FG004|COMPLETED|Dose Expansion||0
2836906|NCT02810418|3539100|FG005|COMPLETED|Dose Expansion||0
2836907|NCT02810418|3539101|FG006|COMPLETED|Dose Expansion||0
2836908|NCT02810418|3539095|FG000|NOT COMPLETED|Dose Expansion||0
2836909|NCT02810418|3539096|FG001|NOT COMPLETED|Dose Expansion||1
2836767|NCT04374019|3538973|FG000|STARTED|Overall Study||1
2836768|NCT04374019|3538974|FG001|STARTED|Overall Study||1
2836769|NCT04374019|3538975|FG002|STARTED|Overall Study||6
2836770|NCT04374019|3538976|FG003|STARTED|Overall Study||5
2836771|NCT04374019|3538973|FG000|COMPLETED|Overall Study||1
2836772|NCT04374019|3538974|FG001|COMPLETED|Overall Study||1
2836773|NCT04374019|3538975|FG002|COMPLETED|Overall Study||5
2836774|NCT04374019|3538976|FG003|COMPLETED|Overall Study||5
2836775|NCT04374019|3538973|FG000|NOT COMPLETED|Overall Study||0
2836776|NCT04374019|3538974|FG001|NOT COMPLETED|Overall Study||0
2836777|NCT04374019|3538975|FG002|NOT COMPLETED|Overall Study||1
2836778|NCT04374019|3538976|FG003|NOT COMPLETED|Overall Study||0
2836779|NCT04357730|3538990|FG000|STARTED|Phase 1||17
2836780|NCT04357730|3538991|FG001|STARTED|Phase 1||19
2836781|NCT04357730|3538992|FG002|STARTED|Phase 1||0
2836782|NCT04357730|3538990|FG000|COMPLETED|Phase 1||17
2836783|NCT04357730|3538991|FG001|COMPLETED|Phase 1||19
2836784|NCT04357730|3538992|FG002|COMPLETED|Phase 1||0
2836785|NCT04357730|3538990|FG000|NOT COMPLETED|Phase 1||0
2836786|NCT04357730|3538991|FG001|NOT COMPLETED|Phase 1||0
2836787|NCT04357730|3538992|FG002|NOT COMPLETED|Phase 1||0
2836788|NCT04357730|3538990|FG000|STARTED|Phase 2||8
2836789|NCT04357730|3538991|FG001|STARTED|Phase 2||0
2836790|NCT04357730|3538992|FG002|STARTED|Phase 2||6
2836791|NCT04357730|3538990|FG000|COMPLETED|Phase 2||8
2836792|NCT04357730|3538991|FG001|COMPLETED|Phase 2||0
2836793|NCT04357730|3538992|FG002|COMPLETED|Phase 2||6
2836794|NCT04357730|3538990|FG000|NOT COMPLETED|Phase 2||0
2836795|NCT04357730|3538991|FG001|NOT COMPLETED|Phase 2||0
2836796|NCT04357730|3538992|FG002|NOT COMPLETED|Phase 2||0
2836797|NCT04311463|3539006|FG000|STARTED|Period 1 (Up to Day 3)||19
2836798|NCT04311463|3539007|FG001|STARTED|Period 1 (Up to Day 3)||19
2836799|NCT04311463|3539006|FG000|COMPLETED|Period 1 (Up to Day 3)||18
2836800|NCT04311463|3539007|FG001|COMPLETED|Period 1 (Up to Day 3)||19
2836801|NCT04311463|3539006|FG000|NOT COMPLETED|Period 1 (Up to Day 3)||1
2836802|NCT04311463|3539007|FG001|NOT COMPLETED|Period 1 (Up to Day 3)||0
2836803|NCT04311463|3539006|FG000|STARTED|Washout Period (Up to Day 7)||18
2836804|NCT04311463|3539007|FG001|STARTED|Washout Period (Up to Day 7)||19
2836805|NCT04311463|3539006|FG000|COMPLETED|Washout Period (Up to Day 7)||17
2836806|NCT04311463|3539007|FG001|COMPLETED|Washout Period (Up to Day 7)||18
2836807|NCT04311463|3539006|FG000|NOT COMPLETED|Washout Period (Up to Day 7)||1
2836808|NCT04311463|3539007|FG001|NOT COMPLETED|Washout Period (Up to Day 7)||1
2836809|NCT04311463|3539006|FG000|STARTED|Period 2 (Up to Day 3)||17
2836810|NCT04311463|3539007|FG001|STARTED|Period 2 (Up to Day 3)||18
2836811|NCT04311463|3539006|FG000|COMPLETED|Period 2 (Up to Day 3)||15
2836812|NCT04311463|3539007|FG001|COMPLETED|Period 2 (Up to Day 3)||17
2836813|NCT04311463|3539006|FG000|NOT COMPLETED|Period 2 (Up to Day 3)||2
2836814|NCT04311463|3539007|FG001|NOT COMPLETED|Period 2 (Up to Day 3)||1
2836815|NCT04175509|3539016|FG000|STARTED|Overall Study||19
2836816|NCT04175509|3539017|FG001|STARTED|Overall Study||21
2836817|NCT04175509|3539016|FG000|COMPLETED|Overall Study||17
2836818|NCT04175509|3539017|FG001|COMPLETED|Overall Study||19
2836819|NCT04175509|3539016|FG000|NOT COMPLETED|Overall Study||2
2836820|NCT04175509|3539017|FG001|NOT COMPLETED|Overall Study||2
2836821|NCT03930186|3539023|FG000|STARTED|Weeks 0 to 16||152
2836822|NCT03930186|3539023|FG000|Received Study Drug|Weeks 0 to 16||152
2836823|NCT03930186|3539023|FG000|COMPLETED|Weeks 0 to 16||140
2836824|NCT03930186|3539023|FG000|NOT COMPLETED|Weeks 0 to 16||12
2836825|NCT03930186|3539023|FG000|STARTED|Weeks 16 to 32||140
2836826|NCT03930186|3539023|FG000|COMPLETED|Weeks 16 to 32||136
2836827|NCT03930186|3539023|FG000|NOT COMPLETED|Weeks 16 to 32||4
2836828|NCT03740100|3539027|FG000|STARTED|Overall Study|Note: Ten patients were consented, but two died before starting therapy.|8
2836829|NCT03740100|3539027|FG000|Confirmed Partial Response|Overall Study|"Using a Simon's optimal two-stage design, we planned to enroll up to 10 evaluable patients in the first stage.~Two of eight treated patients were not evaluable for response based on toxicity.~We did not reach this milestone."|1
2836830|NCT03740100|3539027|FG000|COMPLETED|Overall Study||6
2836831|NCT03740100|3539027|FG000|NOT COMPLETED|Overall Study||2
2836910|NCT02810418|3539097|FG002|NOT COMPLETED|Dose Expansion||3
2836911|NCT02810418|3539098|FG003|NOT COMPLETED|Dose Expansion||0
2836912|NCT02810418|3539099|FG004|NOT COMPLETED|Dose Expansion||0
2836913|NCT02810418|3539100|FG005|NOT COMPLETED|Dose Expansion||0
2836914|NCT02810418|3539101|FG006|NOT COMPLETED|Dose Expansion||0
2836915|NCT02810418|3539095|FG000|STARTED|Arm B Dose Escalation||0
2836916|NCT02810418|3539096|FG001|STARTED|Arm B Dose Escalation||0
2836917|NCT02810418|3539097|FG002|STARTED|Arm B Dose Escalation||0
2836918|NCT02810418|3539098|FG003|STARTED|Arm B Dose Escalation||6
2836919|NCT02810418|3539099|FG004|STARTED|Arm B Dose Escalation||3
2836920|NCT02810418|3539100|FG005|STARTED|Arm B Dose Escalation||6
2836921|NCT02810418|3539101|FG006|STARTED|Arm B Dose Escalation||0
2836922|NCT02810418|3539095|FG000|COMPLETED|Arm B Dose Escalation||0
2836923|NCT02810418|3539096|FG001|COMPLETED|Arm B Dose Escalation||0
2836924|NCT02810418|3539097|FG002|COMPLETED|Arm B Dose Escalation||0
2836925|NCT02810418|3539098|FG003|COMPLETED|Arm B Dose Escalation||6
2836926|NCT02810418|3539099|FG004|COMPLETED|Arm B Dose Escalation||2
2836927|NCT02810418|3539100|FG005|COMPLETED|Arm B Dose Escalation||4
2836928|NCT02810418|3539101|FG006|COMPLETED|Arm B Dose Escalation||0
3167270|NCT01909011|3894456|FG000|NOT COMPLETED|Overall Study||0
3167271|NCT01909011|3894457|FG001|NOT COMPLETED|Overall Study||0
3167272|NCT01909141|3894465|FG000|STARTED|Overall Study||50
3167273|NCT01909141|3894466|FG001|STARTED|Overall Study||50
2836929|NCT02810418|3539095|FG000|NOT COMPLETED|Arm B Dose Escalation||0
2836930|NCT02810418|3539096|FG001|NOT COMPLETED|Arm B Dose Escalation||0
2836931|NCT02810418|3539097|FG002|NOT COMPLETED|Arm B Dose Escalation||0
2836932|NCT02810418|3539098|FG003|NOT COMPLETED|Arm B Dose Escalation||0
2836933|NCT02810418|3539099|FG004|NOT COMPLETED|Arm B Dose Escalation||1
2836934|NCT02810418|3539100|FG005|NOT COMPLETED|Arm B Dose Escalation||2
2836935|NCT02810418|3539101|FG006|NOT COMPLETED|Arm B Dose Escalation||0
2836936|NCT02810418|3539095|FG000|STARTED|Arm B Combination Therapy||0
2836937|NCT02810418|3539096|FG001|STARTED|Arm B Combination Therapy||0
2836938|NCT02810418|3539097|FG002|STARTED|Arm B Combination Therapy||0
2836939|NCT02810418|3539098|FG003|STARTED|Arm B Combination Therapy||0
2836940|NCT02810418|3539099|FG004|STARTED|Arm B Combination Therapy||0
2836941|NCT02810418|3539100|FG005|STARTED|Arm B Combination Therapy||0
2836942|NCT02810418|3539101|FG006|STARTED|Arm B Combination Therapy||5
2836943|NCT02810418|3539095|FG000|COMPLETED|Arm B Combination Therapy||0
2836944|NCT02810418|3539096|FG001|COMPLETED|Arm B Combination Therapy||0
2836945|NCT02810418|3539097|FG002|COMPLETED|Arm B Combination Therapy||0
2836946|NCT02810418|3539098|FG003|COMPLETED|Arm B Combination Therapy||0
2836947|NCT02810418|3539099|FG004|COMPLETED|Arm B Combination Therapy||0
2836948|NCT02810418|3539100|FG005|COMPLETED|Arm B Combination Therapy||0
2836949|NCT02810418|3539101|FG006|COMPLETED|Arm B Combination Therapy||5
2836950|NCT02810418|3539095|FG000|NOT COMPLETED|Arm B Combination Therapy||0
2836951|NCT02810418|3539096|FG001|NOT COMPLETED|Arm B Combination Therapy||0
2836952|NCT02810418|3539097|FG002|NOT COMPLETED|Arm B Combination Therapy||0
2836953|NCT02810418|3539098|FG003|NOT COMPLETED|Arm B Combination Therapy||0
2836954|NCT02810418|3539099|FG004|NOT COMPLETED|Arm B Combination Therapy||0
2836955|NCT02810418|3539100|FG005|NOT COMPLETED|Arm B Combination Therapy||0
2836956|NCT02810418|3539101|FG006|NOT COMPLETED|Arm B Combination Therapy||0
2836957|NCT02779855|3539167|FG000|STARTED|Overall Study||4
2836958|NCT02779855|3539168|FG001|STARTED|Overall Study||6
2836959|NCT02779855|3539169|FG002|STARTED|Overall Study||40
2836960|NCT02779855|3539167|FG000|COMPLETED|Overall Study||3
2836961|NCT02779855|3539168|FG001|COMPLETED|Overall Study||6
2836962|NCT02779855|3539169|FG002|COMPLETED|Overall Study||40
2836963|NCT02779855|3539167|FG000|NOT COMPLETED|Overall Study||1
2836964|NCT02779855|3539168|FG001|NOT COMPLETED|Overall Study||0
2836965|NCT02779855|3539169|FG002|NOT COMPLETED|Overall Study||0
2836966|NCT02654132|3539180|FG000|STARTED|Overall Study||60
2836967|NCT02654132|3539181|FG001|STARTED|Overall Study||57
2836968|NCT02654132|3539180|FG000|COMPLETED|Overall Study||24
2836969|NCT02654132|3539181|FG001|COMPLETED|Overall Study||11
2836970|NCT02654132|3539180|FG000|NOT COMPLETED|Overall Study||36
2836971|NCT02654132|3539181|FG001|NOT COMPLETED|Overall Study||46
2836972|NCT02603432|3539190|FG000|STARTED|Overall Study||350
2836973|NCT02603432|3539191|FG001|STARTED|Overall Study||350
2836974|NCT02603432|3539190|FG000|COMPLETED|Overall Study||0
2836975|NCT02603432|3539191|FG001|COMPLETED|Overall Study||0
2836976|NCT02603432|3539190|FG000|NOT COMPLETED|Overall Study||350
2836977|NCT02603432|3539191|FG001|NOT COMPLETED|Overall Study||350
2836978|NCT02600923|3539197|FG000|STARTED|Overall Study||131
2836979|NCT02600923|3539197|FG000|Treated|Overall Study||130
2836980|NCT02600923|3539197|FG000|COMPLETED|Overall Study||0
2836981|NCT02600923|3539197|FG000|NOT COMPLETED|Overall Study||131
2836982|NCT02597790|3539203|FG000|STARTED|Overall Study||45
2836983|NCT02597790|3539204|FG001|STARTED|Overall Study||41
2836984|NCT02597790|3539203|FG000|COMPLETED|Overall Study||36
2836985|NCT02597790|3539204|FG001|COMPLETED|Overall Study||29
2836986|NCT02597790|3539203|FG000|NOT COMPLETED|Overall Study||9
2836987|NCT02597790|3539204|FG001|NOT COMPLETED|Overall Study||12
2836988|NCT02484664|3539215|FG000|STARTED|Overall Study||12
2836989|NCT02484664|3539215|FG000|COMPLETED|Overall Study||9
2836990|NCT02484664|3539215|FG000|NOT COMPLETED|Overall Study||3
2915362|NCT00509249|3625639|FG000|STARTED|Overall Study||18
2915363|NCT00509249|3625639|FG000|COMPLETED|Overall Study||18
2915364|NCT00509249|3625639|FG000|NOT COMPLETED|Overall Study||0
2915365|NCT00509262|3625645|FG000|STARTED|Overall Study||211
2915366|NCT00509262|3625646|FG001|STARTED|Overall Study||212
2915367|NCT00509262|3625645|FG000|COMPLETED|Overall Study||164
2915368|NCT00509262|3625646|FG001|COMPLETED|Overall Study||170
2915369|NCT00509262|3625645|FG000|NOT COMPLETED|Overall Study||47
2915370|NCT00509262|3625646|FG001|NOT COMPLETED|Overall Study||42
2915371|NCT00509288|3625654|FG000|STARTED|Overall Study||21
2915372|NCT00509288|3625655|FG001|STARTED|Overall Study||3
2915373|NCT00509288|3625654|FG000|COMPLETED|Overall Study||21
2915374|NCT00509288|3625655|FG001|COMPLETED|Overall Study||3
2915375|NCT00509288|3625654|FG000|NOT COMPLETED|Overall Study||0
2915376|NCT00509288|3625655|FG001|NOT COMPLETED|Overall Study||0
2915377|NCT00509366|3625666|FG000|STARTED|Overall Study|Registered patients who were assigned cisplatin/gemcitabine treatment.|18
2915378|NCT00509366|3625667|FG001|STARTED|Overall Study|Registered patients who were assigned cisplatin/pemetrexed treatment.|8
2915379|NCT00509366|3625668|FG002|STARTED|Overall Study|Registered patients who were assigned pemetrexed/gemcitabine treatment.|22
2915380|NCT00509366|3625669|FG003|STARTED|Overall Study|Registered patients who were assigned docetaxel/gemcitabine treatment.|2
2915381|NCT00509366|3625670|FG004|STARTED|Overall Study|Registered patients who were neither assigned nor treated with protocol-based therapy.|51
2915382|NCT00509366|3625666|FG000|Assigned Treatment|Overall Study|Patients who were assigned to cisplatin/gemcitabine treatment arm.|18
2915383|NCT00509366|3625667|FG001|Assigned Treatment|Overall Study|Patients who were assigned to cisplatin/pemetrexed treatment arm.|8
2836991|NCT02412735|3539222|FG000|STARTED|Overall Study||143
2836992|NCT02412735|3539223|FG001|STARTED|Overall Study||129
2836993|NCT02412735|3539224|FG002|STARTED|Overall Study||132
2836994|NCT02412735|3539222|FG000|Received Treatment|Overall Study||140
2836995|NCT02412735|3539223|FG001|Received Treatment|Overall Study||128
2836996|NCT02412735|3539224|FG002|Received Treatment|Overall Study||130
2836997|NCT02412735|3539222|FG000|COMPLETED|Overall Study||97
2836998|NCT02412735|3539223|FG001|COMPLETED|Overall Study||85
2836999|NCT02412735|3539224|FG002|COMPLETED|Overall Study||86
2837000|NCT02412735|3539222|FG000|NOT COMPLETED|Overall Study||46
2837001|NCT02412735|3539223|FG001|NOT COMPLETED|Overall Study||44
2837002|NCT02412735|3539224|FG002|NOT COMPLETED|Overall Study||46
2837003|NCT02371889|3539234|FG000|STARTED|Overall Study||85
2837004|NCT02371889|3539235|FG001|STARTED|Overall Study||85
2837005|NCT02371889|3539234|FG000|COMPLETED|Overall Study||66
2837006|NCT02371889|3539235|FG001|COMPLETED|Overall Study||71
2837007|NCT02371889|3539234|FG000|NOT COMPLETED|Overall Study||19
2837008|NCT02371889|3539235|FG001|NOT COMPLETED|Overall Study||14
2837009|NCT02337829|3539249|FG000|STARTED|Overall Study||18
2837010|NCT02337829|3539250|FG001|STARTED|Overall Study||14
2837011|NCT02337829|3539251|FG002|STARTED|Overall Study||6
2837012|NCT02337829|3539252|FG003|STARTED|Overall Study||10
2837013|NCT02337829|3539249|FG000|COMPLETED|Overall Study||0
2837014|NCT02337829|3539250|FG001|COMPLETED|Overall Study||0
2837015|NCT02337829|3539251|FG002|COMPLETED|Overall Study||0
2837016|NCT02337829|3539252|FG003|COMPLETED|Overall Study||0
2837017|NCT02337829|3539249|FG000|NOT COMPLETED|Overall Study||18
2837018|NCT02337829|3539250|FG001|NOT COMPLETED|Overall Study||14
2837019|NCT02337829|3539251|FG002|NOT COMPLETED|Overall Study||6
2837020|NCT02337829|3539252|FG003|NOT COMPLETED|Overall Study||10
2837021|NCT02272803|3539266|FG000|STARTED|Overall Study||40
2837022|NCT02272803|3539267|FG001|STARTED|Overall Study||42
2837023|NCT02272803|3539266|FG000|COMPLETED|Overall Study|Completed = Still receiving treatment|31
2837024|NCT02272803|3539267|FG001|COMPLETED|Overall Study|Completed = Still receiving treatment|25
2837025|NCT02272803|3539266|FG000|NOT COMPLETED|Overall Study||9
2837026|NCT02272803|3539267|FG001|NOT COMPLETED|Overall Study||17
2837027|NCT02186834|3539273|FG000|STARTED|Dose Escalation||6
2837028|NCT02186834|3539274|FG001|STARTED|Dose Escalation||3
2837029|NCT02186834|3539275|FG002|STARTED|Dose Escalation||0
2837030|NCT02186834|3539276|FG003|STARTED|Dose Escalation||7
2837031|NCT02186834|3539277|FG004|STARTED|Dose Escalation||4
2837032|NCT02186834|3539278|FG005|STARTED|Dose Escalation||0
2837033|NCT02186834|3539273|FG000|COMPLETED|Dose Escalation||6
2837034|NCT02186834|3539274|FG001|COMPLETED|Dose Escalation||3
2837035|NCT02186834|3539275|FG002|COMPLETED|Dose Escalation||0
2837036|NCT02186834|3539276|FG003|COMPLETED|Dose Escalation||6
2837037|NCT02186834|3539277|FG004|COMPLETED|Dose Escalation||4
2837038|NCT02186834|3539278|FG005|COMPLETED|Dose Escalation||0
2837039|NCT02186834|3539273|FG000|NOT COMPLETED|Dose Escalation||0
2837040|NCT02186834|3539274|FG001|NOT COMPLETED|Dose Escalation||0
2837041|NCT02186834|3539275|FG002|NOT COMPLETED|Dose Escalation||0
2837042|NCT02186834|3539276|FG003|NOT COMPLETED|Dose Escalation||1
2837043|NCT02186834|3539277|FG004|NOT COMPLETED|Dose Escalation||0
2837044|NCT02186834|3539278|FG005|NOT COMPLETED|Dose Escalation||0
2837045|NCT02186834|3539273|FG000|STARTED|Treatment at RP2D||0
2837046|NCT02186834|3539274|FG001|STARTED|Treatment at RP2D||0
2837047|NCT02186834|3539275|FG002|STARTED|Treatment at RP2D||0
2837048|NCT02186834|3539276|FG003|STARTED|Treatment at RP2D||0
2837049|NCT02186834|3539277|FG004|STARTED|Treatment at RP2D||0
2837050|NCT02186834|3539278|FG005|STARTED|Treatment at RP2D||14
2837051|NCT02186834|3539273|FG000|COMPLETED|Treatment at RP2D||0
2837052|NCT02186834|3539274|FG001|COMPLETED|Treatment at RP2D||0
2837053|NCT02186834|3539275|FG002|COMPLETED|Treatment at RP2D||0
2837054|NCT02186834|3539276|FG003|COMPLETED|Treatment at RP2D||0
2837055|NCT02186834|3539277|FG004|COMPLETED|Treatment at RP2D||0
2837056|NCT02186834|3539278|FG005|COMPLETED|Treatment at RP2D||13
2837057|NCT02186834|3539273|FG000|NOT COMPLETED|Treatment at RP2D||0
2837058|NCT02186834|3539274|FG001|NOT COMPLETED|Treatment at RP2D||0
2837059|NCT02186834|3539275|FG002|NOT COMPLETED|Treatment at RP2D||0
2837060|NCT02186834|3539276|FG003|NOT COMPLETED|Treatment at RP2D||0
2837061|NCT02186834|3539277|FG004|NOT COMPLETED|Treatment at RP2D||0
2837062|NCT02186834|3539278|FG005|NOT COMPLETED|Treatment at RP2D||1
2837063|NCT02121158|3539289|FG000|STARTED|Overall Study||85
2837064|NCT02121158|3539290|FG001|STARTED|Overall Study||82
2837065|NCT02121158|3539289|FG000|COMPLETED|Overall Study||85
2837066|NCT02121158|3539290|FG001|COMPLETED|Overall Study||82
2837067|NCT02121158|3539289|FG000|NOT COMPLETED|Overall Study||0
2837068|NCT02121158|3539290|FG001|NOT COMPLETED|Overall Study||0
2837069|NCT02100722|3539298|FG000|STARTED|Overall Study||757
2837070|NCT02100722|3539299|FG001|STARTED|Overall Study||743
2837071|NCT02100722|3539298|FG000|Underwent Alternate Procedure|Overall Study||11
2837072|NCT02100722|3539299|FG001|Underwent Alternate Procedure|Overall Study||37
2837073|NCT02100722|3539298|FG000|COMPLETED|Overall Study||0
2837074|NCT02100722|3539299|FG001|COMPLETED|Overall Study||0
2837075|NCT02100722|3539298|FG000|NOT COMPLETED|Overall Study||757
2837076|NCT02100722|3539299|FG001|NOT COMPLETED|Overall Study||743
2837077|NCT02059265|3539306|FG000|STARTED|Overall Study||32
3167274|NCT01909141|3894465|FG000|COMPLETED|Overall Study||50
3167275|NCT01909141|3894466|FG001|COMPLETED|Overall Study||50
2837078|NCT02059265|3539306|FG000|COMPLETED|Overall Study||28
2837079|NCT02059265|3539306|FG000|NOT COMPLETED|Overall Study||4
2837080|NCT02046096|3539312|FG000|STARTED|Overall Study||149
2837081|NCT02046096|3539313|FG001|STARTED|Overall Study||324
2837082|NCT02046096|3539312|FG000|COMPLETED|Overall Study||105
2837083|NCT02046096|3539313|FG001|COMPLETED|Overall Study||223
2837084|NCT02046096|3539312|FG000|NOT COMPLETED|Overall Study||44
2837085|NCT02046096|3539313|FG001|NOT COMPLETED|Overall Study||101
2837086|NCT01945775|3539323|FG000|STARTED|Overall Study||287
2837087|NCT01945775|3539324|FG001|STARTED|Overall Study||144
2837088|NCT01945775|3539323|FG000|Treated|Overall Study||286
2837089|NCT01945775|3539324|FG001|Treated|Overall Study||126
2837090|NCT01945775|3539323|FG000|COMPLETED|Overall Study||0
2837091|NCT01945775|3539324|FG001|COMPLETED|Overall Study||0
2837092|NCT01945775|3539323|FG000|NOT COMPLETED|Overall Study||287
2837093|NCT01945775|3539324|FG001|NOT COMPLETED|Overall Study||144
2837094|NCT01781637|3539332|FG000|STARTED|Overall Study||28
2837095|NCT01781637|3539333|FG001|STARTED|Overall Study||8
2837096|NCT01781637|3539332|FG000|COMPLETED|Overall Study||24
2837097|NCT01781637|3539333|FG001|COMPLETED|Overall Study||2
2837098|NCT01781637|3539332|FG000|NOT COMPLETED|Overall Study||4
2837099|NCT01781637|3539333|FG001|NOT COMPLETED|Overall Study||6
2837100|NCT01711541|3539344|FG000|STARTED|Overall Study||4
2837101|NCT01711541|3539345|FG001|STARTED|Overall Study||4
2837102|NCT01711541|3539346|FG002|STARTED|Overall Study||3
2837103|NCT01711541|3539347|FG003|STARTED|Overall Study||6
2837104|NCT01711541|3539348|FG004|STARTED|Overall Study||7
2837105|NCT01711541|3539344|FG000|COMPLETED|Overall Study||4
2837106|NCT01711541|3539345|FG001|COMPLETED|Overall Study||3
2837107|NCT01711541|3539346|FG002|COMPLETED|Overall Study||3
2837108|NCT01711541|3539347|FG003|COMPLETED|Overall Study||5
2837109|NCT01711541|3539348|FG004|COMPLETED|Overall Study||7
2837110|NCT01711541|3539344|FG000|NOT COMPLETED|Overall Study||0
2837111|NCT01711541|3539345|FG001|NOT COMPLETED|Overall Study||1
2837112|NCT01711541|3539346|FG002|NOT COMPLETED|Overall Study||0
2837113|NCT01711541|3539347|FG003|NOT COMPLETED|Overall Study||1
2837114|NCT01711541|3539348|FG004|NOT COMPLETED|Overall Study||0
2837115|NCT01670539|3539365|FG000|STARTED|Overall Study||26
2837116|NCT01670539|3539366|FG001|STARTED|Overall Study||21
2837117|NCT01670539|3539365|FG000|COMPLETED|Overall Study||20
2837118|NCT01670539|3539366|FG001|COMPLETED|Overall Study||16
2837119|NCT01670539|3539365|FG000|NOT COMPLETED|Overall Study||6
2837120|NCT01670539|3539366|FG001|NOT COMPLETED|Overall Study||5
2837121|NCT01371981|3539379|FG000|STARTED|Overall Study||580
2837122|NCT01371981|3539380|FG001|STARTED|Overall Study||591
2837123|NCT01371981|3539381|FG002|STARTED|Overall Study||12
2837124|NCT01371981|3539382|FG003|STARTED|Overall Study||33
2837125|NCT01371981|3539383|FG004|STARTED|Overall Study||47
2837126|NCT01371981|3539384|FG005|STARTED|Overall Study||382
2837127|NCT01371981|3539379|FG000|COMPLETED|Overall Study||396
2837128|NCT01371981|3539380|FG001|COMPLETED|Overall Study||399
2837129|NCT01371981|3539381|FG002|COMPLETED|Overall Study||6
2837130|NCT01371981|3539382|FG003|COMPLETED|Overall Study||12
2837131|NCT01371981|3539383|FG004|COMPLETED|Overall Study||15
2837132|NCT01371981|3539384|FG005|COMPLETED|Overall Study||368
2837133|NCT01371981|3539379|FG000|NOT COMPLETED|Overall Study||184
2837134|NCT01371981|3539380|FG001|NOT COMPLETED|Overall Study||192
2837135|NCT01371981|3539381|FG002|NOT COMPLETED|Overall Study||6
2837136|NCT01371981|3539382|FG003|NOT COMPLETED|Overall Study||21
2837137|NCT01371981|3539383|FG004|NOT COMPLETED|Overall Study||32
2837138|NCT01371981|3539384|FG005|NOT COMPLETED|Overall Study||14
2837139|NCT01196390|3539405|FG000|STARTED|Overall Study||102
2837140|NCT01196390|3539406|FG001|STARTED|Overall Study||101
2837141|NCT01196390|3539405|FG000|Eligible|Overall Study||98
2837142|NCT01196390|3539406|FG001|Eligible|Overall Study||96
2837143|NCT01196390|3539405|FG000|Eligible and Started Study Treatment|Overall Study||95
2837144|NCT01196390|3539406|FG001|Eligible and Started Study Treatment|Overall Study||96
2837145|NCT01196390|3539405|FG000|Eligible and Had Surgery|Overall Study||82
2837146|NCT01196390|3539406|FG001|Eligible and Had Surgery|Overall Study||78
2837147|NCT01196390|3539405|FG000|COMPLETED|Overall Study||98
2837148|NCT01196390|3539406|FG001|COMPLETED|Overall Study||96
2837149|NCT01196390|3539405|FG000|NOT COMPLETED|Overall Study||4
2837150|NCT01196390|3539406|FG001|NOT COMPLETED|Overall Study||5
2837151|NCT00980460|3539419|FG000|STARTED|Overall Study||8
2837152|NCT00980460|3539420|FG001|STARTED|Overall Study||51
2837153|NCT00980460|3539421|FG002|STARTED|Overall Study||105
2837154|NCT00980460|3539422|FG003|STARTED|Overall Study||32
2837155|NCT00980460|3539423|FG004|STARTED|Overall Study||40
2837156|NCT00980460|3539419|FG000|COMPLETED|Overall Study||8
2837157|NCT00980460|3539420|FG001|COMPLETED|Overall Study||47
2837158|NCT00980460|3539421|FG002|COMPLETED|Overall Study||70
2837159|NCT00980460|3539422|FG003|COMPLETED|Overall Study||14
2837160|NCT00980460|3539423|FG004|COMPLETED|Overall Study||24
2837161|NCT00980460|3539419|FG000|NOT COMPLETED|Overall Study||0
2837162|NCT00980460|3539420|FG001|NOT COMPLETED|Overall Study||4
2837163|NCT00980460|3539421|FG002|NOT COMPLETED|Overall Study||35
2837164|NCT00980460|3539422|FG003|NOT COMPLETED|Overall Study||18
2837165|NCT00980460|3539423|FG004|NOT COMPLETED|Overall Study||16
2837166|NCT00407602|3539442|FG000|STARTED|Overall Study||30
2837167|NCT00407602|3539442|FG000|COMPLETED|Overall Study||23
2837168|NCT00407602|3539442|FG000|NOT COMPLETED|Overall Study||7
2837169|NCT00345345|3539449|FG000|STARTED|Overall Study||29
2837170|NCT00345345|3539449|FG000|COMPLETED|Overall Study||27
2837171|NCT00345345|3539449|FG000|NOT COMPLETED|Overall Study||2
2920734|NCT00538512|3631283|FG000|NOT COMPLETED|Overall Study||27
2837172|NCT05143541|3539453|FG000|STARTED|Overall Study||80
2837173|NCT05143541|3539453|FG000|COMPLETED|Overall Study||80
2837174|NCT05143541|3539453|FG000|NOT COMPLETED|Overall Study||0
2837175|NCT04685213|3539459|FG000|STARTED|Overall Study||9
2837176|NCT04685213|3539460|FG001|STARTED|Overall Study||10
2837177|NCT04685213|3539459|FG000|COMPLETED|Overall Study||8
2837178|NCT04685213|3539460|FG001|COMPLETED|Overall Study||7
2837179|NCT04685213|3539459|FG000|NOT COMPLETED|Overall Study||1
2837180|NCT04685213|3539460|FG001|NOT COMPLETED|Overall Study||3
2837181|NCT04567186|3539466|FG000|STARTED|Period 1||38
2837182|NCT04567186|3539467|FG001|STARTED|Period 1||40
2837183|NCT04567186|3539466|FG000|COMPLETED|Period 1||37
2837184|NCT04567186|3539467|FG001|COMPLETED|Period 1||37
2837185|NCT04567186|3539466|FG000|NOT COMPLETED|Period 1||1
2837186|NCT04567186|3539467|FG001|NOT COMPLETED|Period 1||3
2837187|NCT04567186|3539466|FG000|STARTED|Period 2||37
2837188|NCT04567186|3539467|FG001|STARTED|Period 2||37
2837189|NCT04567186|3539466|FG000|COMPLETED|Period 2||37
2837190|NCT04567186|3539467|FG001|COMPLETED|Period 2||34
2837191|NCT04567186|3539466|FG000|NOT COMPLETED|Period 2||0
2837192|NCT04567186|3539467|FG001|NOT COMPLETED|Period 2||3
2837193|NCT04567186|3539466|FG000|STARTED|Period 3||37
2837194|NCT04567186|3539467|FG001|STARTED|Period 3||34
2837195|NCT04567186|3539466|FG000|COMPLETED|Period 3||36
2837196|NCT04567186|3539467|FG001|COMPLETED|Period 3||34
2837197|NCT04567186|3539466|FG000|NOT COMPLETED|Period 3||1
2837198|NCT04567186|3539467|FG001|NOT COMPLETED|Period 3||0
2837199|NCT04190693|3539477|FG000|STARTED|Overall Study||4
2837200|NCT04190693|3539478|FG001|STARTED|Overall Study||7
2837201|NCT04190693|3539479|FG002|STARTED|Overall Study||12
2837202|NCT04190693|3539480|FG003|STARTED|Overall Study||7
2837203|NCT04190693|3539477|FG000|COMPLETED|Overall Study||4
2837204|NCT04190693|3539478|FG001|COMPLETED|Overall Study||7
2837205|NCT04190693|3539479|FG002|COMPLETED|Overall Study||12
2837206|NCT04190693|3539480|FG003|COMPLETED|Overall Study||7
2837207|NCT04190693|3539477|FG000|NOT COMPLETED|Overall Study||0
2837208|NCT04190693|3539478|FG001|NOT COMPLETED|Overall Study||0
2837209|NCT04190693|3539479|FG002|NOT COMPLETED|Overall Study||0
2837210|NCT04190693|3539480|FG003|NOT COMPLETED|Overall Study||0
2837211|NCT04065074|3539490|FG000|STARTED|Overall Study||16
2837212|NCT04065074|3539490|FG000|COMPLETED|Overall Study||14
2837213|NCT04065074|3539490|FG000|NOT COMPLETED|Overall Study||2
2837214|NCT03980730|3539496|FG000|STARTED|Overall Study||21
2837215|NCT03980730|3539497|FG001|STARTED|Overall Study||22
2837216|NCT03980730|3539496|FG000|COMPLETED|Overall Study||19
2837217|NCT03980730|3539497|FG001|COMPLETED|Overall Study||18
2837218|NCT03980730|3539496|FG000|NOT COMPLETED|Overall Study||2
2837219|NCT03980730|3539497|FG001|NOT COMPLETED|Overall Study||4
2837220|NCT03793010|3539505|FG000|STARTED|Overall Study||35
2837221|NCT03793010|3539506|FG001|STARTED|Overall Study||35
2837222|NCT03793010|3539505|FG000|Randomized But Not Dosed|Overall Study||2
2837223|NCT03793010|3539506|FG001|Randomized But Not Dosed|Overall Study||0
2837224|NCT03793010|3539505|FG000|COMPLETED|Overall Study||7
2837225|NCT03793010|3539506|FG001|COMPLETED|Overall Study||8
2837226|NCT03793010|3539505|FG000|NOT COMPLETED|Overall Study||28
2837227|NCT03793010|3539506|FG001|NOT COMPLETED|Overall Study||27
2837228|NCT03644017|3539512|FG000|STARTED|Overall Study||46
2837229|NCT03644017|3539512|FG000|COMPLETED|Overall Study||39
2837230|NCT03644017|3539512|FG000|NOT COMPLETED|Overall Study||7
2837231|NCT03592186|3539518|FG000|STARTED|Overall Study||60
2837232|NCT03592186|3539519|FG001|STARTED|Overall Study||62
2837233|NCT03592186|3539518|FG000|6-week Follow-up|Overall Study||49
2837234|NCT03592186|3539519|FG001|6-week Follow-up|Overall Study||56
2837235|NCT03592186|3539518|FG000|12-week Follow-up|Overall Study||47
2837236|NCT03592186|3539519|FG001|12-week Follow-up|Overall Study||51
2837237|NCT03592186|3539518|FG000|COMPLETED|Overall Study||43
2837238|NCT03592186|3539519|FG001|COMPLETED|Overall Study||51
2837239|NCT03592186|3539518|FG000|NOT COMPLETED|Overall Study||17
3167276|NCT01909141|3894465|FG000|NOT COMPLETED|Overall Study||0
3167277|NCT01909141|3894466|FG001|NOT COMPLETED|Overall Study||0
3167278|NCT01909154|3894474|FG000|STARTED|Overall Study||12
3167279|NCT01909154|3894474|FG000|COMPLETED|Overall Study||12
3167280|NCT01909154|3894474|FG000|NOT COMPLETED|Overall Study||0
2837240|NCT03592186|3539519|FG001|NOT COMPLETED|Overall Study||11
2837241|NCT03529942|3539525|FG000|STARTED|Overall Study||129
2837242|NCT03529942|3539525|FG000|Reached Week 6 With Paired MRI|Overall Study||108
2837243|NCT03529942|3539525|FG000|COMPLETED|Overall Study||106
2837244|NCT03529942|3539525|FG000|NOT COMPLETED|Overall Study||23
2837245|NCT03373760|3539534|FG000|STARTED|Overall Study||58
2837246|NCT03373760|3539534|FG000|COMPLETED|Overall Study||0
2837247|NCT03373760|3539534|FG000|NOT COMPLETED|Overall Study||58
2837248|NCT03349775|3539543|FG000|STARTED|Overall Study||10
2837249|NCT03349775|3539544|FG001|STARTED|Overall Study||11
2837250|NCT03349775|3539543|FG000|COMPLETED|Overall Study||8
2837251|NCT03349775|3539544|FG001|COMPLETED|Overall Study||7
2837252|NCT03349775|3539543|FG000|NOT COMPLETED|Overall Study||2
2837253|NCT03349775|3539544|FG001|NOT COMPLETED|Overall Study||4
2837254|NCT03292471|3539552|FG000|STARTED|Overall Study||8
2837255|NCT03292471|3539553|FG001|STARTED|Overall Study||8
2837256|NCT03292471|3539552|FG000|COMPLETED|Overall Study||8
2837257|NCT03292471|3539553|FG001|COMPLETED|Overall Study||8
2837258|NCT03292471|3539552|FG000|NOT COMPLETED|Overall Study||0
2837259|NCT03292471|3539553|FG001|NOT COMPLETED|Overall Study||0
2837260|NCT03256344|3539561|FG000|STARTED|Overall Study||11
2837261|NCT03256344|3539562|FG001|STARTED|Overall Study||25
2837262|NCT03256344|3539561|FG000|Received Talimogene Laherparepvec|Overall Study||8
2837263|NCT03256344|3539562|FG001|Received Talimogene Laherparepvec|Overall Study||23
2837264|NCT03256344|3539561|FG000|Received Atezolizumab|Overall Study||10
2837265|NCT03256344|3539562|FG001|Received Atezolizumab|Overall Study||24
2837266|NCT03256344|3539561|FG000|COMPLETED|Overall Study||0
2837267|NCT03256344|3539562|FG001|COMPLETED|Overall Study||0
2837268|NCT03256344|3539561|FG000|NOT COMPLETED|Overall Study||11
2837269|NCT03256344|3539562|FG001|NOT COMPLETED|Overall Study||25
2837270|NCT03207815|3539570|FG000|STARTED|Overall Study||38
2837271|NCT03207815|3539571|FG001|STARTED|Overall Study||36
2837272|NCT03207815|3539570|FG000|COMPLETED|Overall Study||30
2837273|NCT03207815|3539571|FG001|COMPLETED|Overall Study||29
2837274|NCT03207815|3539570|FG000|NOT COMPLETED|Overall Study||8
2837275|NCT03207815|3539571|FG001|NOT COMPLETED|Overall Study||7
2837276|NCT03077737|3539579|FG000|STARTED|Week 6 (10 Weeks After Enrollment)||97
2837277|NCT03077737|3539580|FG001|STARTED|Week 6 (10 Weeks After Enrollment)||93
2837278|NCT03077737|3539579|FG000|COMPLETED|Week 6 (10 Weeks After Enrollment)||89
2837279|NCT03077737|3539580|FG001|COMPLETED|Week 6 (10 Weeks After Enrollment)||79
2837280|NCT03077737|3539579|FG000|NOT COMPLETED|Week 6 (10 Weeks After Enrollment)||8
2837281|NCT03077737|3539580|FG001|NOT COMPLETED|Week 6 (10 Weeks After Enrollment)||14
2837282|NCT03077737|3539579|FG000|STARTED|Week 14 (18 Weeks After Enrollment)||97
2837283|NCT03077737|3539580|FG001|STARTED|Week 14 (18 Weeks After Enrollment)||93
2837284|NCT03077737|3539579|FG000|COMPLETED|Week 14 (18 Weeks After Enrollment)||83
2837285|NCT03077737|3539580|FG001|COMPLETED|Week 14 (18 Weeks After Enrollment)||76
2837286|NCT03077737|3539579|FG000|NOT COMPLETED|Week 14 (18 Weeks After Enrollment)||14
2837287|NCT03077737|3539580|FG001|NOT COMPLETED|Week 14 (18 Weeks After Enrollment)||17
2837288|NCT03077737|3539579|FG000|STARTED|Week 28 (32 Weeks After Enrollment)||49
2837289|NCT03077737|3539580|FG001|STARTED|Week 28 (32 Weeks After Enrollment)||47
2837290|NCT03077737|3539579|FG000|COMPLETED|Week 28 (32 Weeks After Enrollment)||39
2837291|NCT03077737|3539580|FG001|COMPLETED|Week 28 (32 Weeks After Enrollment)||40
2837292|NCT03077737|3539579|FG000|NOT COMPLETED|Week 28 (32 Weeks After Enrollment)||10
2837293|NCT03077737|3539580|FG001|NOT COMPLETED|Week 28 (32 Weeks After Enrollment)||7
2837294|NCT03073733|3539589|FG000|STARTED|Overall Study||29
3167281|NCT01909180|3894478|FG000|STARTED|Overall Study||49
3167282|NCT01909180|3894478|FG000|COMPLETED|Overall Study||49
3167283|NCT01909180|3894478|FG000|NOT COMPLETED|Overall Study||0
2837295|NCT03073733|3539590|FG001|STARTED|Overall Study||27
2837296|NCT03073733|3539591|FG002|STARTED|Overall Study||27
2837297|NCT03073733|3539589|FG000|COMPLETED|Overall Study||28
2837298|NCT03073733|3539590|FG001|COMPLETED|Overall Study||26
2837299|NCT03073733|3539591|FG002|COMPLETED|Overall Study||26
2837300|NCT03073733|3539589|FG000|NOT COMPLETED|Overall Study||1
2837301|NCT03073733|3539590|FG001|NOT COMPLETED|Overall Study||1
2837302|NCT03073733|3539591|FG002|NOT COMPLETED|Overall Study||1
2837303|NCT02991937|3539601|FG000|STARTED|Overall Study||20
2837304|NCT02991937|3539602|FG001|STARTED|Overall Study||19
2837305|NCT02991937|3539601|FG000|COMPLETED|Overall Study||20
2837306|NCT02991937|3539602|FG001|COMPLETED|Overall Study||19
2837307|NCT02991937|3539601|FG000|NOT COMPLETED|Overall Study||0
2837308|NCT02991937|3539602|FG001|NOT COMPLETED|Overall Study||0
2837309|NCT02968563|3539610|FG000|STARTED|Overall Study||5
2837310|NCT02968563|3539611|FG001|STARTED|Overall Study||30
2837311|NCT02968563|3539610|FG000|COMPLETED|Overall Study||4
2837312|NCT02968563|3539611|FG001|COMPLETED|Overall Study||22
2837313|NCT02968563|3539610|FG000|NOT COMPLETED|Overall Study||1
2837314|NCT02968563|3539611|FG001|NOT COMPLETED|Overall Study||8
2837315|NCT02915783|3539617|FG000|STARTED|Overall Study||31
2837316|NCT02915783|3539617|FG000|COMPLETED|Overall Study||17
2837317|NCT02915783|3539617|FG000|NOT COMPLETED|Overall Study||14
2837318|NCT02913482|3539624|FG000|STARTED|Overall Study||4
2837319|NCT02913482|3539625|FG001|STARTED|Overall Study||17
2837320|NCT02913482|3539626|FG002|STARTED|Overall Study||41
2837321|NCT02913482|3539624|FG000|COMPLETED|Overall Study|Participants remaining in the study at CCOD of 12 Nov 2020|3
2837322|NCT02913482|3539625|FG001|COMPLETED|Overall Study|Participants remaining in the study at CCOD of 12 Nov 2020|14
2837323|NCT02913482|3539626|FG002|COMPLETED|Overall Study|Participants remaining in the study at CCOD of 12 Nov 2020|38
2837324|NCT02913482|3539624|FG000|NOT COMPLETED|Overall Study||1
2837325|NCT02913482|3539625|FG001|NOT COMPLETED|Overall Study||3
2837326|NCT02913482|3539626|FG002|NOT COMPLETED|Overall Study||3
2837327|NCT02787044|3539638|FG000|STARTED|Overall Study||2630
2837328|NCT02787044|3539639|FG001|STARTED|Overall Study||2630
2837329|NCT02787044|3539638|FG000|COMPLETED|Overall Study||2615
2837330|NCT02787044|3539639|FG001|COMPLETED|Overall Study||2611
2837331|NCT02787044|3539638|FG000|NOT COMPLETED|Overall Study||15
2837332|NCT02787044|3539639|FG001|NOT COMPLETED|Overall Study||19
2837333|NCT02698163|3539651|FG000|STARTED|Overall Study||1
2837334|NCT02698163|3539652|FG001|STARTED|Overall Study||3
2837335|NCT02698163|3539651|FG000|COMPLETED|Overall Study||1
2837336|NCT02698163|3539652|FG001|COMPLETED|Overall Study||2
2837337|NCT02698163|3539651|FG000|NOT COMPLETED|Overall Study||0
2837338|NCT02698163|3539652|FG001|NOT COMPLETED|Overall Study||1
2837339|NCT02586857|3539660|FG000|STARTED|Overall Study||15
2837340|NCT02586857|3539661|FG001|STARTED|Overall Study||9
2837341|NCT02586857|3539660|FG000|Enrolled|Overall Study||15
2837342|NCT02586857|3539661|FG001|Enrolled|Overall Study||9
2837343|NCT02586857|3539660|FG000|Received Study Medication|Overall Study||15
2837344|NCT02586857|3539661|FG001|Received Study Medication|Overall Study||9
2837345|NCT02586857|3539660|FG000|Discontinued Study|Overall Study||14
2837346|NCT02586857|3539661|FG001|Discontinued Study|Overall Study||9
2837347|NCT02586857|3539660|FG000|COMPLETED|Overall Study||14
2837348|NCT02586857|3539661|FG001|COMPLETED|Overall Study||9
2837349|NCT02586857|3539660|FG000|NOT COMPLETED|Overall Study||1
2837350|NCT02586857|3539661|FG001|NOT COMPLETED|Overall Study||0
2837351|NCT02586675|3539667|FG000|STARTED|Overall Study||7
2837352|NCT02586675|3539667|FG000|COMPLETED|Overall Study||7
2837353|NCT02586675|3539667|FG000|NOT COMPLETED|Overall Study||0
2837354|NCT02367105|3539673|FG000|STARTED|Overall Study||41
2837355|NCT02367105|3539674|FG001|STARTED|Overall Study||42
2837356|NCT02367105|3539673|FG000|COMPLETED|Overall Study||36
2837357|NCT02367105|3539674|FG001|COMPLETED|Overall Study||34
2837358|NCT02367105|3539673|FG000|NOT COMPLETED|Overall Study||5
2837359|NCT02367105|3539674|FG001|NOT COMPLETED|Overall Study||8
2837360|NCT02352948|3539692|FG000|STARTED|Overall Study||62
2837361|NCT02352948|3539693|FG001|STARTED|Overall Study||64
2837362|NCT02352948|3539694|FG002|STARTED|Overall Study||174
2837363|NCT02352948|3539695|FG003|STARTED|Overall Study||118
2837364|NCT02352948|3539696|FG004|STARTED|Overall Study||117
3167284|NCT01909336|3894487|FG000|STARTED|Overall Study||53
3167285|NCT01909336|3894488|FG001|STARTED|Overall Study||53
3167286|NCT01909336|3894489|FG002|STARTED|Overall Study||55
3167287|NCT01909336|3894487|FG000|COMPLETED|Overall Study||49
3167288|NCT01909336|3894488|FG001|COMPLETED|Overall Study||50
2837365|NCT02352948|3539697|FG005|STARTED|Overall Study||60
2837366|NCT02352948|3539692|FG000|Received Treatment|Overall Study||62
2837367|NCT02352948|3539693|FG001|Received Treatment|Overall Study||63
2837368|NCT02352948|3539694|FG002|Received Treatment|Overall Study||173
2837369|NCT02352948|3539695|FG003|Received Treatment|Overall Study||110
2837370|NCT02352948|3539696|FG004|Received Treatment|Overall Study||117
2837371|NCT02352948|3539697|FG005|Received Treatment|Overall Study||60
2837372|NCT02352948|3539692|FG000|Completed Study Treatment|Overall Study||15
2837373|NCT02352948|3539693|FG001|Completed Study Treatment|Overall Study||0
2837374|NCT02352948|3539694|FG002|Completed Study Treatment|Overall Study||36
2837375|NCT02352948|3539695|FG003|Completed Study Treatment|Overall Study||0
2837376|NCT02352948|3539696|FG004|Completed Study Treatment|Overall Study||23
2837377|NCT02352948|3539697|FG005|Completed Study Treatment|Overall Study||4
2837378|NCT02352948|3539692|FG000|COMPLETED|Overall Study||13
2837379|NCT02352948|3539693|FG001|COMPLETED|Overall Study||5
2837380|NCT02352948|3539694|FG002|COMPLETED|Overall Study||45
2837381|NCT02352948|3539695|FG003|COMPLETED|Overall Study||19
2837382|NCT02352948|3539696|FG004|COMPLETED|Overall Study||29
2837383|NCT02352948|3539697|FG005|COMPLETED|Overall Study||11
2837384|NCT02352948|3539692|FG000|NOT COMPLETED|Overall Study||49
2837385|NCT02352948|3539693|FG001|NOT COMPLETED|Overall Study||59
2837386|NCT02352948|3539694|FG002|NOT COMPLETED|Overall Study||129
2837387|NCT02352948|3539695|FG003|NOT COMPLETED|Overall Study||99
2837388|NCT02352948|3539696|FG004|NOT COMPLETED|Overall Study||88
2837389|NCT02352948|3539697|FG005|NOT COMPLETED|Overall Study||49
2837390|NCT02332590|3539719|FG000|STARTED|DB Period (up to 24 Weeks)||185
2837391|NCT02332590|3539720|FG001|STARTED|DB Period (up to 24 Weeks)||184
2837392|NCT02332590|3539719|FG000|Treated|DB Period (up to 24 Weeks)||184
2837393|NCT02332590|3539720|FG001|Treated|DB Period (up to 24 Weeks)||184
2837394|NCT02332590|3539719|FG000|COMPLETED|DB Period (up to 24 Weeks)|155 participants entered OLE period and 1 did not enroll.|156
2837395|NCT02332590|3539720|FG001|COMPLETED|DB Period (up to 24 Weeks)||165
2837396|NCT02332590|3539719|FG000|NOT COMPLETED|DB Period (up to 24 Weeks)||29
2837397|NCT02332590|3539720|FG001|NOT COMPLETED|DB Period (up to 24 Weeks)||19
2837398|NCT02332590|3539719|FG000|STARTED|OLE Period (Week 24 up to Week 300)||155
2837399|NCT02332590|3539720|FG001|STARTED|OLE Period (Week 24 up to Week 300)||165
2837400|NCT02332590|3539719|FG000|COMPLETED|OLE Period (Week 24 up to Week 300)||108
2837401|NCT02332590|3539720|FG001|COMPLETED|OLE Period (Week 24 up to Week 300)||120
2837402|NCT02332590|3539719|FG000|NOT COMPLETED|OLE Period (Week 24 up to Week 300)||47
2837403|NCT02332590|3539720|FG001|NOT COMPLETED|OLE Period (Week 24 up to Week 300)||45
2837404|NCT02256631|3539735|FG000|STARTED|Overall Study||13
2837405|NCT02256631|3539736|FG001|STARTED|Overall Study||14
2837406|NCT02256631|3539737|FG002|STARTED|Overall Study||13
2837407|NCT02256631|3539738|FG003|STARTED|Overall Study||10
2837408|NCT02256631|3539739|FG004|STARTED|Overall Study||11
2837409|NCT02256631|3539740|FG005|STARTED|Overall Study||11
2837410|NCT02256631|3539741|FG006|STARTED|Overall Study||11
2837411|NCT02256631|3539735|FG000|COMPLETED|Overall Study||12
2837412|NCT02256631|3539736|FG001|COMPLETED|Overall Study||11
2837413|NCT02256631|3539737|FG002|COMPLETED|Overall Study||13
2837414|NCT02256631|3539738|FG003|COMPLETED|Overall Study||6
2837415|NCT02256631|3539739|FG004|COMPLETED|Overall Study||10
2837416|NCT02256631|3539740|FG005|COMPLETED|Overall Study||9
2837417|NCT02256631|3539741|FG006|COMPLETED|Overall Study||7
2837418|NCT02256631|3539735|FG000|NOT COMPLETED|Overall Study||1
2837419|NCT02256631|3539736|FG001|NOT COMPLETED|Overall Study||3
2837420|NCT02256631|3539737|FG002|NOT COMPLETED|Overall Study||0
2837421|NCT02256631|3539738|FG003|NOT COMPLETED|Overall Study||4
2837422|NCT02256631|3539739|FG004|NOT COMPLETED|Overall Study||1
2837423|NCT02256631|3539740|FG005|NOT COMPLETED|Overall Study||2
2837424|NCT02256631|3539741|FG006|NOT COMPLETED|Overall Study||4
2837425|NCT01972217|3539761|FG000|STARTED|Part A: Open-label Safety Run-in Period||3
3167289|NCT01909336|3894489|FG002|COMPLETED|Overall Study||52
2837426|NCT01972217|3539762|FG001|STARTED|Part A: Open-label Safety Run-in Period||13
2837427|NCT01972217|3539763|FG002|STARTED|Part A: Open-label Safety Run-in Period||0
2837428|NCT01972217|3539764|FG003|STARTED|Part A: Open-label Safety Run-in Period||0
2837429|NCT01972217|3539761|FG000|COMPLETED|Part A: Open-label Safety Run-in Period||2
2837430|NCT01972217|3539762|FG001|COMPLETED|Part A: Open-label Safety Run-in Period||1
2837431|NCT01972217|3539763|FG002|COMPLETED|Part A: Open-label Safety Run-in Period||0
2837432|NCT01972217|3539764|FG003|COMPLETED|Part A: Open-label Safety Run-in Period||0
2837433|NCT01972217|3539761|FG000|NOT COMPLETED|Part A: Open-label Safety Run-in Period||1
2837434|NCT01972217|3539762|FG001|NOT COMPLETED|Part A: Open-label Safety Run-in Period||12
2837435|NCT01972217|3539763|FG002|NOT COMPLETED|Part A: Open-label Safety Run-in Period||0
2837436|NCT01972217|3539764|FG003|NOT COMPLETED|Part A: Open-label Safety Run-in Period||0
2837437|NCT01972217|3539761|FG000|STARTED|Part B Double-blind, Randomised Period|Patients recruited to Part A did not participate in Part B.|0
2837438|NCT01972217|3539762|FG001|STARTED|Part B Double-blind, Randomised Period|Patients recruited to Part A did not participate in Part B.|0
2837439|NCT01972217|3539763|FG002|STARTED|Part B Double-blind, Randomised Period|Patients recruited to Part B did not participate in Part A.|71
2837440|NCT01972217|3539764|FG003|STARTED|Part B Double-blind, Randomised Period|Patients recruited to Part B did not participate in Part A.|71
2837441|NCT01972217|3539761|FG000|Received Olaparib/Placebo|Part B Double-blind, Randomised Period||0
2837442|NCT01972217|3539762|FG001|Received Olaparib/Placebo|Part B Double-blind, Randomised Period||0
2837443|NCT01972217|3539763|FG002|Received Olaparib/Placebo|Part B Double-blind, Randomised Period||71
2837444|NCT01972217|3539764|FG003|Received Olaparib/Placebo|Part B Double-blind, Randomised Period||71
2837445|NCT01972217|3539761|FG000|Received Abiraterone|Part B Double-blind, Randomised Period||0
2837446|NCT01972217|3539762|FG001|Received Abiraterone|Part B Double-blind, Randomised Period||0
2837447|NCT01972217|3539763|FG002|Received Abiraterone|Part B Double-blind, Randomised Period||71
2837448|NCT01972217|3539764|FG003|Received Abiraterone|Part B Double-blind, Randomised Period||71
2837449|NCT01972217|3539761|FG000|COMPLETED|Part B Double-blind, Randomised Period||0
2837450|NCT01972217|3539762|FG001|COMPLETED|Part B Double-blind, Randomised Period||0
2837451|NCT01972217|3539763|FG002|COMPLETED|Part B Double-blind, Randomised Period||25
2837452|NCT01972217|3539764|FG003|COMPLETED|Part B Double-blind, Randomised Period||24
2837453|NCT01972217|3539761|FG000|NOT COMPLETED|Part B Double-blind, Randomised Period||0
2837454|NCT01972217|3539762|FG001|NOT COMPLETED|Part B Double-blind, Randomised Period||0
2837455|NCT01972217|3539763|FG002|NOT COMPLETED|Part B Double-blind, Randomised Period||46
2837456|NCT01972217|3539764|FG003|NOT COMPLETED|Part B Double-blind, Randomised Period||47
2837457|NCT01816165|3539778|FG000|STARTED|Overall Study||5
2837458|NCT01816165|3539779|FG001|STARTED|Overall Study||4
2837459|NCT01816165|3539780|FG002|STARTED|Overall Study||5
2837460|NCT01816165|3539781|FG003|STARTED|Overall Study||4
2837461|NCT01816165|3539778|FG000|Completed Intervention 1|Overall Study||4
2837462|NCT01816165|3539779|FG001|Completed Intervention 1|Overall Study||4
2837463|NCT01816165|3539780|FG002|Completed Intervention 1|Overall Study||5
2837464|NCT01816165|3539781|FG003|Completed Intervention 1|Overall Study||4
2837465|NCT01816165|3539778|FG000|Completed ~2 Week Washout|Overall Study||4
2837466|NCT01816165|3539779|FG001|Completed ~2 Week Washout|Overall Study||4
2837467|NCT01816165|3539780|FG002|Completed ~2 Week Washout|Overall Study||5
2837468|NCT01816165|3539781|FG003|Completed ~2 Week Washout|Overall Study||4
2837469|NCT01816165|3539778|FG000|Started Second Intervention|Overall Study||4
2837470|NCT01816165|3539779|FG001|Started Second Intervention|Overall Study||4
2837471|NCT01816165|3539780|FG002|Started Second Intervention|Overall Study||5
2837472|NCT01816165|3539781|FG003|Started Second Intervention|Overall Study||4
2837473|NCT01816165|3539778|FG000|COMPLETED|Overall Study||4
2837474|NCT01816165|3539779|FG001|COMPLETED|Overall Study||4
2837475|NCT01816165|3539780|FG002|COMPLETED|Overall Study||5
2837476|NCT01816165|3539781|FG003|COMPLETED|Overall Study||4
2837477|NCT01816165|3539778|FG000|NOT COMPLETED|Overall Study||1
2837478|NCT01816165|3539779|FG001|NOT COMPLETED|Overall Study||0
2837479|NCT01816165|3539780|FG002|NOT COMPLETED|Overall Study||0
2837480|NCT01816165|3539781|FG003|NOT COMPLETED|Overall Study||0
2837481|NCT01813929|3539803|FG000|STARTED|Overall Study||5
2837482|NCT01813929|3539804|FG001|STARTED|Overall Study||12
2837483|NCT01813929|3539803|FG000|Completed Intervention 1|Overall Study||5
2837484|NCT01813929|3539804|FG001|Completed Intervention 1|Overall Study||12
2837485|NCT01813929|3539803|FG000|Completed Washout (2weeks up to 2 Months)|Overall Study||5
2837486|NCT01813929|3539804|FG001|Completed Washout (2weeks up to 2 Months)|Overall Study||11
2837487|NCT01813929|3539803|FG000|Started Intervention 2|Overall Study||5
3167290|NCT01909336|3894487|FG000|NOT COMPLETED|Overall Study||4
3167291|NCT01909336|3894488|FG001|NOT COMPLETED|Overall Study||3
3311439|NCT03052751|4044959|FG000|STARTED|Dosing Period 1||22
3311440|NCT03052751|4044960|FG001|STARTED|Dosing Period 1||21
3311441|NCT03052751|4044961|FG002|STARTED|Dosing Period 1||0
2837488|NCT01813929|3539804|FG001|Started Intervention 2|Overall Study||11
2837489|NCT01813929|3539803|FG000|COMPLETED|Overall Study||5
2837490|NCT01813929|3539804|FG001|COMPLETED|Overall Study||11
2837491|NCT01813929|3539803|FG000|NOT COMPLETED|Overall Study||0
2837492|NCT01813929|3539804|FG001|NOT COMPLETED|Overall Study||1
2915384|NCT00509366|3625668|FG002|Assigned Treatment|Overall Study|Patients who were assigned to pemetrexed/gemcitabine treatment arm.|22
2915385|NCT00509366|3625669|FG003|Assigned Treatment|Overall Study|Patients who were assigned to docetaxel/gemcitabine treatment arm.|2
3311442|NCT03052751|4044962|FG003|STARTED|Dosing Period 1||0
2837493|NCT01502085|3539810|FG000|STARTED|Overall Study||25
2837494|NCT01502085|3539810|FG000|COMPLETED|Overall Study||25
2837495|NCT01502085|3539810|FG000|NOT COMPLETED|Overall Study||0
2837496|NCT01178814|3539814|FG000|STARTED|Overall Study||57
2837497|NCT01178814|3539814|FG000|COMPLETED|Overall Study||57
2837498|NCT01178814|3539814|FG000|NOT COMPLETED|Overall Study||0
2837499|NCT01125176|3539818|FG000|STARTED|Treatment Phase||14
2837500|NCT01125176|3539818|FG000|COMPLETED|Treatment Phase||13
2837501|NCT01125176|3539818|FG000|NOT COMPLETED|Treatment Phase||1
2837502|NCT01125176|3539818|FG000|STARTED|Post-treatment Follow-up Phase||13
2837503|NCT01125176|3539818|FG000|COMPLETED|Post-treatment Follow-up Phase||2
2837504|NCT01125176|3539818|FG000|NOT COMPLETED|Post-treatment Follow-up Phase||11
2837505|NCT00882050|3539825|FG000|STARTED|Overall Study||32
2837506|NCT00882050|3539826|FG001|STARTED|Overall Study||33
2837507|NCT00882050|3539827|FG002|STARTED|Overall Study||39
2837508|NCT00882050|3539825|FG000|COMPLETED|Overall Study||31
2837509|NCT00882050|3539826|FG001|COMPLETED|Overall Study||33
2837510|NCT00882050|3539827|FG002|COMPLETED|Overall Study||39
2837511|NCT00882050|3539825|FG000|NOT COMPLETED|Overall Study||1
2837512|NCT00882050|3539826|FG001|NOT COMPLETED|Overall Study||0
2837513|NCT00882050|3539827|FG002|NOT COMPLETED|Overall Study||0
2837514|NCT00070564|3539841|FG000|STARTED|Overall Study||678
2837515|NCT00070564|3539842|FG001|STARTED|Overall Study||693
2837516|NCT00070564|3539843|FG002|STARTED|Overall Study||697
2837517|NCT00070564|3539844|FG003|STARTED|Overall Study||648
2837518|NCT00070564|3539845|FG004|STARTED|Overall Study||282
2837519|NCT00070564|3539846|FG005|STARTED|Overall Study||296
2837520|NCT00070564|3539841|FG000|COMPLETED|Overall Study||478
3167292|NCT01909336|3894489|FG002|NOT COMPLETED|Overall Study||3
3167293|NCT01909453|3894502|FG000|STARTED|Overall Study||192
3167294|NCT01909453|3894503|FG001|STARTED|Overall Study||194
3167295|NCT01909453|3894504|FG002|STARTED|Overall Study||191
3167296|NCT01909453|3894505|FG003|STARTED|Overall Study||258
3167297|NCT01909453|3894506|FG004|STARTED|Overall Study||86
3167298|NCT01909453|3894502|FG000|COMPLETED|Overall Study||0
3167299|NCT01909453|3894503|FG001|COMPLETED|Overall Study||0
3167300|NCT01909453|3894504|FG002|COMPLETED|Overall Study||0
3167301|NCT01909453|3894505|FG003|COMPLETED|Overall Study||0
3167302|NCT01909453|3894506|FG004|COMPLETED|Overall Study||0
3167303|NCT01909453|3894502|FG000|NOT COMPLETED|Overall Study||192
3167304|NCT01909453|3894503|FG001|NOT COMPLETED|Overall Study||194
3167305|NCT01909453|3894504|FG002|NOT COMPLETED|Overall Study||191
3167306|NCT01909453|3894505|FG003|NOT COMPLETED|Overall Study||258
3167307|NCT01909453|3894506|FG004|NOT COMPLETED|Overall Study||86
3167308|NCT01909466|3894524|FG000|STARTED|Overall Study||68
3167309|NCT01909466|3894525|FG001|STARTED|Overall Study||73
3167310|NCT01909466|3894524|FG000|COMPLETED|Overall Study||46
3167311|NCT01909466|3894525|FG001|COMPLETED|Overall Study||50
3167312|NCT01909466|3894524|FG000|NOT COMPLETED|Overall Study||22
3167313|NCT01909466|3894525|FG001|NOT COMPLETED|Overall Study||23
3167314|NCT01909674|3894531|FG000|STARTED|Overall Study||12
3167315|NCT01909674|3894532|FG001|STARTED|Overall Study||9
3167316|NCT01909674|3894531|FG000|COMPLETED|Overall Study||7
3167317|NCT01909674|3894532|FG001|COMPLETED|Overall Study||7
3167318|NCT01909674|3894531|FG000|NOT COMPLETED|Overall Study||5
3167319|NCT01909674|3894532|FG001|NOT COMPLETED|Overall Study||2
3167320|NCT01909713|3894538|FG000|STARTED|Overall Study||35
3167321|NCT01909713|3894538|FG000|COMPLETED|Overall Study||35
3167322|NCT01909713|3894538|FG000|NOT COMPLETED|Overall Study||0
3167323|NCT01909778|3894563|FG000|STARTED|Overall Study||2
3167324|NCT01909778|3894563|FG000|COMPLETED|Overall Study||1
3167325|NCT01909778|3894563|FG000|NOT COMPLETED|Overall Study||1
3167326|NCT01909791|3894572|FG000|STARTED|Overall Study||226
3167327|NCT01909791|3894573|FG001|STARTED|Overall Study||240
3167328|NCT01909791|3894574|FG002|STARTED|Overall Study||236
3167329|NCT01909791|3894572|FG000|COMPLETED|Overall Study||205
3167330|NCT01909791|3894573|FG001|COMPLETED|Overall Study||212
3167331|NCT01909791|3894574|FG002|COMPLETED|Overall Study||208
3167332|NCT01909791|3894572|FG000|NOT COMPLETED|Overall Study||21
3167333|NCT01909791|3894573|FG001|NOT COMPLETED|Overall Study||28
3167334|NCT01909791|3894574|FG002|NOT COMPLETED|Overall Study||28
3167335|NCT01909804|3894599|FG000|STARTED|Overall Study||26
3167336|NCT01909804|3894600|FG001|STARTED|Overall Study||28
2837521|NCT00070564|3539842|FG001|COMPLETED|Overall Study||490
2837522|NCT00070564|3539843|FG002|COMPLETED|Overall Study||526
2837523|NCT00070564|3539844|FG003|COMPLETED|Overall Study||481
2837524|NCT00070564|3539845|FG004|COMPLETED|Overall Study||203
2837525|NCT00070564|3539846|FG005|COMPLETED|Overall Study||244
2837526|NCT00070564|3539841|FG000|NOT COMPLETED|Overall Study||200
3167337|NCT01909804|3894601|FG002|STARTED|Overall Study||27
3167338|NCT01909804|3894602|FG003|STARTED|Overall Study||26
3167339|NCT01909804|3894603|FG004|STARTED|Overall Study||26
3167340|NCT01909804|3894604|FG005|STARTED|Overall Study||25
3167341|NCT01909804|3894605|FG006|STARTED|Overall Study||27
3167342|NCT01909804|3894606|FG007|STARTED|Overall Study||26
3167343|NCT01909804|3894607|FG008|STARTED|Overall Study||27
3167344|NCT01909804|3894608|FG009|STARTED|Overall Study||29
2837527|NCT00070564|3539842|FG001|NOT COMPLETED|Overall Study||203
2837528|NCT00070564|3539843|FG002|NOT COMPLETED|Overall Study||171
3167345|NCT01909804|3894609|FG010|STARTED|Overall Study||27
3167346|NCT01909804|3894610|FG011|STARTED|Overall Study||29
3167347|NCT01909804|3894599|FG000|COMPLETED|Overall Study||22
3167348|NCT01909804|3894600|FG001|COMPLETED|Overall Study||27
3167349|NCT01909804|3894601|FG002|COMPLETED|Overall Study||27
2837529|NCT00070564|3539844|FG003|NOT COMPLETED|Overall Study||167
2837530|NCT00070564|3539845|FG004|NOT COMPLETED|Overall Study||79
2837531|NCT00070564|3539846|FG005|NOT COMPLETED|Overall Study||52
2915386|NCT00509366|3625670|FG004|Assigned Treatment|Overall Study||0
2915387|NCT00509366|3625666|FG000|COMPLETED|Overall Study|Patients assigned to treatment and treated with cisplatin/gemcitabine treatment combination.|17
2915388|NCT00509366|3625667|FG001|COMPLETED|Overall Study|Patients assigned to treatment and treated with cisplatin/pemetrexed treatment combination.|7
2915389|NCT00509366|3625668|FG002|COMPLETED|Overall Study|Patients assigned to treatment and treated with pemetrexed/gemcitabine treatment combination.|21
2915390|NCT00509366|3625669|FG003|COMPLETED|Overall Study|Patients assigned to treatment and treated with docetaxel/gemcitabine treatment combination.|2
2915391|NCT00509366|3625670|FG004|COMPLETED|Overall Study|Patients who were neither assigned nor treated with protocol-based therapy.|51
2915392|NCT00509366|3625666|FG000|NOT COMPLETED|Overall Study||1
2915393|NCT00509366|3625667|FG001|NOT COMPLETED|Overall Study||1
2915394|NCT00509366|3625668|FG002|NOT COMPLETED|Overall Study||1
2915395|NCT00509366|3625669|FG003|NOT COMPLETED|Overall Study||0
2915396|NCT00509366|3625670|FG004|NOT COMPLETED|Overall Study||0
2915397|NCT00509392|3625682|FG000|STARTED|Overall Study||32
2915398|NCT00509392|3625683|FG001|STARTED|Overall Study||33
2915399|NCT00509392|3625684|FG002|STARTED|Overall Study||4
2915400|NCT00509392|3625682|FG000|COMPLETED|Overall Study||32
2915401|NCT00509392|3625683|FG001|COMPLETED|Overall Study||33
2915402|NCT00509392|3625684|FG002|COMPLETED|Overall Study||4
2915403|NCT00509392|3625682|FG000|NOT COMPLETED|Overall Study||0
2915404|NCT00509392|3625683|FG001|NOT COMPLETED|Overall Study||0
2915405|NCT00509392|3625684|FG002|NOT COMPLETED|Overall Study||0
2915406|NCT00509496|3625692|FG000|STARTED|Overall Study||19
2915407|NCT00509496|3625693|FG001|STARTED|Overall Study||2
2915408|NCT00509496|3625692|FG000|COMPLETED|Overall Study||19
2915409|NCT00509496|3625693|FG001|COMPLETED|Overall Study||2
2915410|NCT00509496|3625692|FG000|NOT COMPLETED|Overall Study||0
2915411|NCT00509496|3625693|FG001|NOT COMPLETED|Overall Study||0
2915412|NCT00509587|3625699|FG000|STARTED|Overall Study||21
2915413|NCT00509587|3625699|FG000|COMPLETED|Overall Study||21
2915414|NCT00509587|3625699|FG000|NOT COMPLETED|Overall Study||0
2915415|NCT00509665|3625703|FG000|STARTED|Overall Study||18
2915416|NCT00509665|3625703|FG000|COMPLETED|Overall Study||18
2915417|NCT00509665|3625703|FG000|NOT COMPLETED|Overall Study||0
2915418|NCT00509769|3625707|FG000|STARTED|Overall Study||112
2915419|NCT00509769|3625707|FG000|COMPLETED|Overall Study||21
2915420|NCT00509769|3625707|FG000|NOT COMPLETED|Overall Study||91
2915421|NCT00509795|3625715|FG000|STARTED|Overall Study||306
2915422|NCT00509795|3625716|FG001|STARTED|Overall Study||304
2915423|NCT00509795|3625717|FG002|STARTED|Overall Study||304
2915424|NCT00509795|3625718|FG003|STARTED|Overall Study||303
2915425|NCT00509795|3625715|FG000|Patients Received Treatment (SAF)|Overall Study||304
2915426|NCT00509795|3625716|FG001|Patients Received Treatment (SAF)|Overall Study||304
2915427|NCT00509795|3625717|FG002|Patients Received Treatment (SAF)|Overall Study||304
2915428|NCT00509795|3625718|FG003|Patients Received Treatment (SAF)|Overall Study||303
2915429|NCT00509795|3625715|FG000|Full Analysis Set (FAS) Population|Overall Study||304
2915430|NCT00509795|3625716|FG001|Full Analysis Set (FAS) Population|Overall Study||304
2915431|NCT00509795|3625717|FG002|Full Analysis Set (FAS) Population|Overall Study||301
2915432|NCT00509795|3625718|FG003|Full Analysis Set (FAS) Population|Overall Study||301
2915433|NCT00509795|3625715|FG000|Per Protocol Set (PPS) Population|Overall Study||269
2915434|NCT00509795|3625716|FG001|Per Protocol Set (PPS) Population|Overall Study||285
2915435|NCT00509795|3625717|FG002|Per Protocol Set (PPS) Population|Overall Study||270
2915436|NCT00509795|3625718|FG003|Per Protocol Set (PPS) Population|Overall Study||265
2915437|NCT00509795|3625715|FG000|COMPLETED|Overall Study||284
2915438|NCT00509795|3625716|FG001|COMPLETED|Overall Study||293
2915439|NCT00509795|3625717|FG002|COMPLETED|Overall Study||277
2915440|NCT00509795|3625718|FG003|COMPLETED|Overall Study||276
2915441|NCT00509795|3625715|FG000|NOT COMPLETED|Overall Study||22
2915442|NCT00509795|3625716|FG001|NOT COMPLETED|Overall Study||11
2915443|NCT00509795|3625717|FG002|NOT COMPLETED|Overall Study||27
2915444|NCT00509795|3625718|FG003|NOT COMPLETED|Overall Study||27
2915445|NCT00509821|3625731|FG000|STARTED|Study Period 1 (Induction)||3
2915446|NCT00509821|3625732|FG001|STARTED|Study Period 1 (Induction)||57
2915447|NCT00509821|3625731|FG000|Received at Least 1 Dose of Study Drug|Study Period 1 (Induction)||3
3311443|NCT03052751|4044963|FG004|STARTED|Dosing Period 1||0
3311444|NCT03052751|4044964|FG005|STARTED|Dosing Period 1||0
3311445|NCT03052751|4044959|FG000|Completed Period 1|Dosing Period 1||22
3311446|NCT03052751|4044960|FG001|Completed Period 1|Dosing Period 1||21
3311447|NCT03052751|4044961|FG002|Completed Period 1|Dosing Period 1||0
2915448|NCT00509821|3625732|FG001|Received at Least 1 Dose of Study Drug|Study Period 1 (Induction)||57
2915449|NCT00509821|3625731|FG000|COMPLETED|Study Period 1 (Induction)||3
2915450|NCT00509821|3625732|FG001|COMPLETED|Study Period 1 (Induction)||53
2915451|NCT00509821|3625731|FG000|NOT COMPLETED|Study Period 1 (Induction)||0
2915452|NCT00509821|3625732|FG001|NOT COMPLETED|Study Period 1 (Induction)||4
2915453|NCT00509821|3625731|FG000|STARTED|Study Period 2 (Radiation)|Participants moved to Radiation Phase.|3
2915454|NCT00509821|3625732|FG001|STARTED|Study Period 2 (Radiation)|Participants moved to Radiation Phase.|53
2915455|NCT00509821|3625731|FG000|COMPLETED|Study Period 2 (Radiation)||3
2915456|NCT00509821|3625732|FG001|COMPLETED|Study Period 2 (Radiation)||0
2915457|NCT00509821|3625731|FG000|NOT COMPLETED|Study Period 2 (Radiation)||0
3311448|NCT03052751|4044962|FG003|Completed Period 1|Dosing Period 1||0
2837532|NCT05167370|3539866|FG000|STARTED|Overall Study||2
2837533|NCT05167370|3539866|FG000|COMPLETED|Overall Study||2
2837534|NCT05167370|3539866|FG000|NOT COMPLETED|Overall Study||0
2837535|NCT04753710|3539872|FG000|STARTED|Overall||67
2837536|NCT04753710|3539873|FG001|STARTED|Overall||29
2837537|NCT04753710|3539872|FG000|COMPLETED|Overall||67
2837538|NCT04753710|3539873|FG001|COMPLETED|Overall||29
2837539|NCT04753710|3539872|FG000|NOT COMPLETED|Overall||0
2837540|NCT04753710|3539873|FG001|NOT COMPLETED|Overall||0
2837541|NCT04753710|3539872|FG000|STARTED|First Phase||27
2837542|NCT04753710|3539873|FG001|STARTED|First Phase||9
2837543|NCT04753710|3539872|FG000|COMPLETED|First Phase||27
2837544|NCT04753710|3539873|FG001|COMPLETED|First Phase||9
2837545|NCT04753710|3539872|FG000|NOT COMPLETED|First Phase||0
2837546|NCT04753710|3539873|FG001|NOT COMPLETED|First Phase||0
2837547|NCT04753710|3539872|FG000|STARTED|Second Phase||40
2837548|NCT04753710|3539873|FG001|STARTED|Second Phase||20
2837549|NCT04753710|3539872|FG000|COMPLETED|Second Phase||40
2837550|NCT04753710|3539873|FG001|COMPLETED|Second Phase||20
2837551|NCT04753710|3539872|FG000|NOT COMPLETED|Second Phase||0
2837552|NCT04753710|3539873|FG001|NOT COMPLETED|Second Phase||0
2837553|NCT04500821|3539879|FG000|STARTED|Overall Study||44
2837554|NCT04500821|3539879|FG000|COMPLETED|Overall Study||44
2837555|NCT04500821|3539879|FG000|NOT COMPLETED|Overall Study||0
2837556|NCT04425720|3539886|FG000|STARTED|Overall Study||150
2837557|NCT04425720|3539887|FG001|STARTED|Overall Study||150
2837558|NCT04425720|3539886|FG000|COMPLETED|Overall Study||150
2837559|NCT04425720|3539887|FG001|COMPLETED|Overall Study||130
2837560|NCT04425720|3539886|FG000|NOT COMPLETED|Overall Study||0
2837561|NCT04425720|3539887|FG001|NOT COMPLETED|Overall Study||20
2837562|NCT04409509|3539896|FG000|STARTED|Overall Study||61
2837563|NCT04409509|3539897|FG001|STARTED|Overall Study||63
2837564|NCT04409509|3539896|FG000|COMPLETED|Overall Study||48
2837565|NCT04409509|3539897|FG001|COMPLETED|Overall Study||43
2837566|NCT04409509|3539896|FG000|NOT COMPLETED|Overall Study||13
2837567|NCT04409509|3539897|FG001|NOT COMPLETED|Overall Study||20
2837602|NCT04136548|3539935|FG000|STARTED|Enrolled & Randomized||19
2837603|NCT04136548|3539936|FG001|STARTED|Enrolled & Randomized||19
2837604|NCT04136548|3539935|FG000|COMPLETED|Enrolled & Randomized||13
2837605|NCT04136548|3539936|FG001|COMPLETED|Enrolled & Randomized||15
2837606|NCT04136548|3539935|FG000|NOT COMPLETED|Enrolled & Randomized||6
2837607|NCT04136548|3539936|FG001|NOT COMPLETED|Enrolled & Randomized||4
2837608|NCT04136548|3539935|FG000|STARTED|First Visit||13
2837609|NCT04136548|3539936|FG001|STARTED|First Visit||15
2837610|NCT04136548|3539935|FG000|COMPLETED|First Visit||13
2837611|NCT04136548|3539936|FG001|COMPLETED|First Visit||15
2837612|NCT04136548|3539935|FG000|NOT COMPLETED|First Visit||0
2837613|NCT04136548|3539936|FG001|NOT COMPLETED|First Visit||0
2837614|NCT04136548|3539935|FG000|STARTED|Washout (at Least 48 Hours)||13
2837615|NCT04136548|3539936|FG001|STARTED|Washout (at Least 48 Hours)||15
2837616|NCT04136548|3539935|FG000|COMPLETED|Washout (at Least 48 Hours)||13
2837617|NCT04136548|3539936|FG001|COMPLETED|Washout (at Least 48 Hours)||15
2837618|NCT04136548|3539935|FG000|NOT COMPLETED|Washout (at Least 48 Hours)||0
2837619|NCT04136548|3539936|FG001|NOT COMPLETED|Washout (at Least 48 Hours)||0
2837620|NCT04136548|3539935|FG000|STARTED|Second Visit||13
2837621|NCT04136548|3539936|FG001|STARTED|Second Visit||15
2837622|NCT04136548|3539935|FG000|COMPLETED|Second Visit||13
2837623|NCT04136548|3539936|FG001|COMPLETED|Second Visit||15
2837624|NCT04136548|3539935|FG000|NOT COMPLETED|Second Visit||0
2837625|NCT04136548|3539936|FG001|NOT COMPLETED|Second Visit||0
2837626|NCT04126057|3539944|FG000|STARTED|Overall Study||50
2837627|NCT04126057|3539945|FG001|STARTED|Overall Study||50
2837628|NCT04126057|3539944|FG000|COMPLETED|Overall Study||47
2837629|NCT04126057|3539945|FG001|COMPLETED|Overall Study||46
2837630|NCT04126057|3539944|FG000|NOT COMPLETED|Overall Study||3
2837631|NCT04126057|3539945|FG001|NOT COMPLETED|Overall Study||4
2837632|NCT04087395|3539951|FG000|STARTED|Overall Study||30
2837633|NCT04087395|3539951|FG000|COMPLETED|Overall Study||30
2837634|NCT04087395|3539951|FG000|NOT COMPLETED|Overall Study||0
2837635|NCT04072432|3539962|FG000|STARTED|Overall Study||6
2837636|NCT04072432|3539963|FG001|STARTED|Overall Study||6
2837637|NCT04072432|3539964|FG002|STARTED|Overall Study||6
2837638|NCT04072432|3539962|FG000|COMPLETED|Overall Study||6
2837639|NCT04072432|3539963|FG001|COMPLETED|Overall Study||6
2837640|NCT04072432|3539964|FG002|COMPLETED|Overall Study||6
2837641|NCT04072432|3539962|FG000|NOT COMPLETED|Overall Study||0
2837642|NCT04072432|3539963|FG001|NOT COMPLETED|Overall Study||0
2837643|NCT04072432|3539964|FG002|NOT COMPLETED|Overall Study||0
2837644|NCT04069585|3539972|FG000|STARTED|Overall Study||30
2837645|NCT04069585|3539972|FG000|COMPLETED|Overall Study||30
2837646|NCT04069585|3539972|FG000|NOT COMPLETED|Overall Study||0
2837647|NCT03922321|3539978|FG000|STARTED|Overall Study||7
2837648|NCT03922321|3539978|FG000|COMPLETED|Overall Study||5
2837649|NCT03922321|3539978|FG000|NOT COMPLETED|Overall Study||2
2837650|NCT03911713|3539987|FG000|STARTED|Overall Study||12
2837651|NCT03911713|3539988|FG001|STARTED|Overall Study||6
2837652|NCT03911713|3539989|FG002|STARTED|Overall Study||11
2837653|NCT03911713|3539990|FG003|STARTED|Overall Study||24
2837654|NCT03911713|3539991|FG004|STARTED|Overall Study||24
2837655|NCT03911713|3539987|FG000|Full Analysis Set|Overall Study||11
2837656|NCT03911713|3539988|FG001|Full Analysis Set|Overall Study||6
2837657|NCT03911713|3539989|FG002|Full Analysis Set|Overall Study||11
2837658|NCT03911713|3539990|FG003|Full Analysis Set|Overall Study||23
2837568|NCT04380519|3539907|FG000|STARTED|Overall Study||124
2837569|NCT04380519|3539908|FG001|STARTED|Overall Study||124
2837570|NCT04380519|3539909|FG002|STARTED|Overall Study||124
2837571|NCT04380519|3539907|FG000|Intent-to-Treat (ITT)|Overall Study||124
2837572|NCT04380519|3539908|FG001|Intent-to-Treat (ITT)|Overall Study||124
2837573|NCT04380519|3539909|FG002|Intent-to-Treat (ITT)|Overall Study||124
2837574|NCT04380519|3539907|FG000|Modified Intent-to-Treat (mITT)|Overall Study||115
2837575|NCT04380519|3539908|FG001|Modified Intent-to-Treat (mITT)|Overall Study||119
2837576|NCT04380519|3539909|FG002|Modified Intent-to-Treat (mITT)|Overall Study||118
2837577|NCT04380519|3539907|FG000|Safety Population|Overall Study||123
2837578|NCT04380519|3539908|FG001|Safety Population|Overall Study||124
2837579|NCT04380519|3539909|FG002|Safety Population|Overall Study||124
2837580|NCT04380519|3539907|FG000|COMPLETED|Overall Study||106
2837581|NCT04380519|3539908|FG001|COMPLETED|Overall Study||113
2837582|NCT04380519|3539909|FG002|COMPLETED|Overall Study||117
2837583|NCT04380519|3539907|FG000|NOT COMPLETED|Overall Study||18
2837584|NCT04380519|3539908|FG001|NOT COMPLETED|Overall Study||11
2837585|NCT04380519|3539909|FG002|NOT COMPLETED|Overall Study||7
2837586|NCT04362813|3539919|FG000|STARTED|Overall Study||227
2837587|NCT04362813|3539920|FG001|STARTED|Overall Study||227
2837588|NCT04362813|3539919|FG000|Safety Set|Overall Study||225
2837589|NCT04362813|3539920|FG001|Safety Set|Overall Study||223
2837590|NCT04362813|3539919|FG000|Completed Day 29|Overall Study||211
2837591|NCT04362813|3539920|FG001|Completed Day 29|Overall Study||206
2837592|NCT04362813|3539919|FG000|COMPLETED|Overall Study||209
2837593|NCT04362813|3539920|FG001|COMPLETED|Overall Study||202
2837594|NCT04362813|3539919|FG000|NOT COMPLETED|Overall Study||18
2837595|NCT04362813|3539920|FG001|NOT COMPLETED|Overall Study||25
2837596|NCT04231409|3539928|FG000|STARTED|Overall Study||5
2837597|NCT04231409|3539929|FG001|STARTED|Overall Study||4
2837598|NCT04231409|3539928|FG000|COMPLETED|Overall Study||0
2837599|NCT04231409|3539929|FG001|COMPLETED|Overall Study||0
2837600|NCT04231409|3539928|FG000|NOT COMPLETED|Overall Study||5
2837601|NCT04231409|3539929|FG001|NOT COMPLETED|Overall Study||4
2837659|NCT03911713|3539991|FG004|Full Analysis Set|Overall Study||24
2837660|NCT03911713|3539987|FG000|COMPLETED|Overall Study||11
2837661|NCT03911713|3539988|FG001|COMPLETED|Overall Study||4
2837662|NCT03911713|3539989|FG002|COMPLETED|Overall Study||11
2837663|NCT03911713|3539990|FG003|COMPLETED|Overall Study||22
2837664|NCT03911713|3539991|FG004|COMPLETED|Overall Study||24
2837665|NCT03911713|3539987|FG000|NOT COMPLETED|Overall Study||1
2837666|NCT03911713|3539988|FG001|NOT COMPLETED|Overall Study||2
2837667|NCT03911713|3539989|FG002|NOT COMPLETED|Overall Study||0
2837668|NCT03911713|3539990|FG003|NOT COMPLETED|Overall Study||2
2837669|NCT03911713|3539991|FG004|NOT COMPLETED|Overall Study||0
2837670|NCT03879642|3540007|FG000|STARTED|Overall Study||22
2837671|NCT03879642|3540008|FG001|STARTED|Overall Study||21
2837672|NCT03879642|3540007|FG000|COMPLETED|Overall Study||19
2837673|NCT03879642|3540008|FG001|COMPLETED|Overall Study||18
2837674|NCT03879642|3540007|FG000|NOT COMPLETED|Overall Study||3
2837675|NCT03879642|3540008|FG001|NOT COMPLETED|Overall Study||3
2837676|NCT03852459|3540016|FG000|STARTED|Overall Study||126
2837677|NCT03852459|3540017|FG001|STARTED|Overall Study||125
2837678|NCT03852459|3540016|FG000|COMPLETED|Overall Study||123
2837679|NCT03852459|3540017|FG001|COMPLETED|Overall Study||122
2837680|NCT03852459|3540016|FG000|NOT COMPLETED|Overall Study||3
2837681|NCT03852459|3540017|FG001|NOT COMPLETED|Overall Study||3
2837682|NCT03740919|3540026|FG000|STARTED|Lead-in Period||751
2837683|NCT03740919|3540027|FG001|STARTED|Lead-in Period||0
2837684|NCT03740919|3540028|FG002|STARTED|Lead-in Period||0
2837685|NCT03740919|3540029|FG003|STARTED|Lead-in Period||0
2837686|NCT03740919|3540026|FG000|Received at Least One Dose of Study Drug|Lead-in Period||751
2837687|NCT03740919|3540027|FG001|Received at Least One Dose of Study Drug|Lead-in Period||0
2837688|NCT03740919|3540028|FG002|Received at Least One Dose of Study Drug|Lead-in Period||0
2837689|NCT03740919|3540029|FG003|Received at Least One Dose of Study Drug|Lead-in Period||0
2837690|NCT03740919|3540026|FG000|COMPLETED|Lead-in Period||716
2837691|NCT03740919|3540027|FG001|COMPLETED|Lead-in Period||0
2837692|NCT03740919|3540028|FG002|COMPLETED|Lead-in Period||0
2837693|NCT03740919|3540029|FG003|COMPLETED|Lead-in Period||0
2837694|NCT03740919|3540026|FG000|NOT COMPLETED|Lead-in Period||35
2837695|NCT03740919|3540027|FG001|NOT COMPLETED|Lead-in Period||0
2837696|NCT03740919|3540028|FG002|NOT COMPLETED|Lead-in Period||0
2837697|NCT03740919|3540029|FG003|NOT COMPLETED|Lead-in Period||0
2837698|NCT03740919|3540026|FG000|STARTED|Treatment Period||0
2837699|NCT03740919|3540027|FG001|STARTED|Treatment Period|Participants were randomized from Lead-in Period to Insulin Lispro (Humalog).|298
2837700|NCT03740919|3540028|FG002|STARTED|Treatment Period|Participants were randomized from Lead-in Period to LY900014.|280
2837701|NCT03740919|3540029|FG003|STARTED|Treatment Period|Participants were randomized from Lead-in Period to open-label LY900014.|138
2837702|NCT03740919|3540026|FG000|Received at Least One Dose of Study Drug|Treatment Period||0
2837703|NCT03740919|3540027|FG001|Received at Least One Dose of Study Drug|Treatment Period||298
2837704|NCT03740919|3540028|FG002|Received at Least One Dose of Study Drug|Treatment Period||280
2837705|NCT03740919|3540029|FG003|Received at Least One Dose of Study Drug|Treatment Period||138
2837706|NCT03740919|3540026|FG000|COMPLETED|Treatment Period||0
2837707|NCT03740919|3540027|FG001|COMPLETED|Treatment Period||288
3167350|NCT01909804|3894602|FG003|COMPLETED|Overall Study||26
3167351|NCT01909804|3894603|FG004|COMPLETED|Overall Study||18
3167352|NCT01909804|3894604|FG005|COMPLETED|Overall Study||21
3167353|NCT01909804|3894605|FG006|COMPLETED|Overall Study||25
2837708|NCT03740919|3540028|FG002|COMPLETED|Treatment Period||266
2837709|NCT03740919|3540029|FG003|COMPLETED|Treatment Period||135
2837710|NCT03740919|3540026|FG000|NOT COMPLETED|Treatment Period||0
2837711|NCT03740919|3540027|FG001|NOT COMPLETED|Treatment Period||10
2837712|NCT03740919|3540028|FG002|NOT COMPLETED|Treatment Period||14
2837713|NCT03740919|3540029|FG003|NOT COMPLETED|Treatment Period||3
2837714|NCT03700970|3540042|FG000|STARTED|Overall Study||30
2837715|NCT03700970|3540043|FG001|STARTED|Overall Study||30
2837716|NCT03700970|3540042|FG000|COMPLETED|Overall Study||21
2837717|NCT03700970|3540043|FG001|COMPLETED|Overall Study||19
2837718|NCT03700970|3540042|FG000|NOT COMPLETED|Overall Study||9
2837719|NCT03700970|3540043|FG001|NOT COMPLETED|Overall Study||11
2837720|NCT03652454|3540053|FG000|STARTED|Overall Study||14
2837721|NCT03652454|3540054|FG001|STARTED|Overall Study||14
2837722|NCT03652454|3540053|FG000|COMPLETED|Overall Study||14
2837723|NCT03652454|3540054|FG001|COMPLETED|Overall Study||14
2837724|NCT03652454|3540053|FG000|NOT COMPLETED|Overall Study||0
2837725|NCT03652454|3540054|FG001|NOT COMPLETED|Overall Study||0
2837726|NCT03647488|3540063|FG000|STARTED|Overall Study||18
2837727|NCT03647488|3540064|FG001|STARTED|Overall Study|Randomized part was not opened|0
2837728|NCT03647488|3540065|FG002|STARTED|Overall Study|Randomized part was not opened|0
2837729|NCT03647488|3540063|FG000|COMPLETED|Overall Study||0
2837730|NCT03647488|3540064|FG001|COMPLETED|Overall Study||0
2837731|NCT03647488|3540065|FG002|COMPLETED|Overall Study||0
2837732|NCT03647488|3540063|FG000|NOT COMPLETED|Overall Study||18
2837733|NCT03647488|3540064|FG001|NOT COMPLETED|Overall Study||0
2837734|NCT03647488|3540065|FG002|NOT COMPLETED|Overall Study||0
2837735|NCT03614923|3540074|FG000|STARTED|Overall Study||35
2837736|NCT03614923|3540075|FG001|STARTED|Overall Study||35
2837737|NCT03614923|3540076|FG002|STARTED|Overall Study||35
2837738|NCT03614923|3540074|FG000|COMPLETED|Overall Study||30
2837739|NCT03614923|3540075|FG001|COMPLETED|Overall Study||30
2837740|NCT03614923|3540076|FG002|COMPLETED|Overall Study||30
2837741|NCT03614923|3540074|FG000|NOT COMPLETED|Overall Study||5
2837742|NCT03614923|3540075|FG001|NOT COMPLETED|Overall Study||5
2837743|NCT03614923|3540076|FG002|NOT COMPLETED|Overall Study||5
2915458|NCT00509821|3625732|FG001|NOT COMPLETED|Study Period 2 (Radiation)||53
2915459|NCT00509821|3625731|FG000|STARTED|Study Period 3 (Maintenance)||3
2915460|NCT00509821|3625732|FG001|STARTED|Study Period 3 (Maintenance)|4 participants completed Radiation Phase but did not enter Maintenance Phase.|49
2915461|NCT00509821|3625731|FG000|COMPLETED|Study Period 3 (Maintenance)||3
2915462|NCT00509821|3625732|FG001|COMPLETED|Study Period 3 (Maintenance)||0
2915463|NCT00509821|3625731|FG000|NOT COMPLETED|Study Period 3 (Maintenance)||0
2915464|NCT00509821|3625732|FG001|NOT COMPLETED|Study Period 3 (Maintenance)||49
2915465|NCT00509821|3625731|FG000|STARTED|Study Period 4 (Follow Up)|1 Participant completed Maintenance Phase but did not enter Follow-Up.|2
2915466|NCT00509821|3625732|FG001|STARTED|Study Period 4 (Follow Up)|1 Participant completed Radiation Phase, did not enter Maintenance Phase but entered Follow Up.|50
2915467|NCT00509821|3625731|FG000|COMPLETED|Study Period 4 (Follow Up)||2
2915468|NCT00509821|3625732|FG001|COMPLETED|Study Period 4 (Follow Up)||50
2915469|NCT00509821|3625731|FG000|NOT COMPLETED|Study Period 4 (Follow Up)||0
2915470|NCT00509821|3625732|FG001|NOT COMPLETED|Study Period 4 (Follow Up)||0
2915471|NCT00509873|3625745|FG000|STARTED|Overall Study||287
2915472|NCT00509873|3625746|FG001|STARTED|Overall Study||291
2915473|NCT00509873|3625745|FG000|COMPLETED|Overall Study||276
2915474|NCT00509873|3625746|FG001|COMPLETED|Overall Study||276
2915475|NCT00509873|3625745|FG000|NOT COMPLETED|Overall Study||11
2915476|NCT00509873|3625746|FG001|NOT COMPLETED|Overall Study||15
2915477|NCT00509899|3625760|FG000|STARTED|Overall Study||30
2915478|NCT00509899|3625761|FG001|STARTED|Overall Study||35
2915479|NCT00509899|3625762|FG002|STARTED|Overall Study||47
2915480|NCT00509899|3625763|FG003|STARTED|Overall Study||5
2915481|NCT00509899|3625764|FG004|STARTED|Overall Study||6
2915482|NCT00509899|3625765|FG005|STARTED|Overall Study||22
2915483|NCT00509899|3625766|FG006|STARTED|Overall Study||6
2915484|NCT00509899|3625767|FG007|STARTED|Overall Study||3
2915485|NCT00509899|3625760|FG000|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|14
3311449|NCT03052751|4044963|FG004|Completed Period 1|Dosing Period 1||0
3311450|NCT03052751|4044964|FG005|Completed Period 1|Dosing Period 1||0
3311451|NCT03052751|4044959|FG000|Completed Period 1 and Started Period 2|Dosing Period 1||22
3311452|NCT03052751|4044960|FG001|Completed Period 1 and Started Period 2|Dosing Period 1||20
3311453|NCT03052751|4044961|FG002|Completed Period 1 and Started Period 2|Dosing Period 1||0
3311454|NCT03052751|4044962|FG003|Completed Period 1 and Started Period 2|Dosing Period 1||0
3311455|NCT03052751|4044963|FG004|Completed Period 1 and Started Period 2|Dosing Period 1||0
3311456|NCT03052751|4044964|FG005|Completed Period 1 and Started Period 2|Dosing Period 1||0
3311457|NCT03052751|4044959|FG000|COMPLETED|Dosing Period 1||22
3311458|NCT03052751|4044960|FG001|COMPLETED|Dosing Period 1||20
3311459|NCT03052751|4044961|FG002|COMPLETED|Dosing Period 1||0
3311460|NCT03052751|4044962|FG003|COMPLETED|Dosing Period 1||0
3311461|NCT03052751|4044963|FG004|COMPLETED|Dosing Period 1||0
3311462|NCT03052751|4044964|FG005|COMPLETED|Dosing Period 1||0
2915486|NCT00509899|3625761|FG001|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|26
2915487|NCT00509899|3625762|FG002|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|27
2920735|NCT00538512|3631284|FG001|NOT COMPLETED|Overall Study||30
2837744|NCT03517540|3540088|FG000|STARTED|Overall Study||50
2837745|NCT03517540|3540089|FG001|STARTED|Overall Study||48
2837746|NCT03517540|3540090|FG002|STARTED|Overall Study||47
2837747|NCT03517540|3540091|FG003|STARTED|Overall Study||48
2837748|NCT03517540|3540088|FG000|COMPLETED|Overall Study||36
2837749|NCT03517540|3540089|FG001|COMPLETED|Overall Study||41
3311463|NCT03052751|4044959|FG000|NOT COMPLETED|Dosing Period 1||0
3311464|NCT03052751|4044960|FG001|NOT COMPLETED|Dosing Period 1||1
3311465|NCT03052751|4044961|FG002|NOT COMPLETED|Dosing Period 1||0
3311466|NCT03052751|4044962|FG003|NOT COMPLETED|Dosing Period 1||0
3311467|NCT03052751|4044963|FG004|NOT COMPLETED|Dosing Period 1||0
3311468|NCT03052751|4044964|FG005|NOT COMPLETED|Dosing Period 1||0
3311469|NCT03052751|4044959|FG000|STARTED|Dosing Period 2||0
3311470|NCT03052751|4044960|FG001|STARTED|Dosing Period 2||0
3311471|NCT03052751|4044961|FG002|STARTED|Dosing Period 2||11
3311472|NCT03052751|4044962|FG003|STARTED|Dosing Period 2||11
3311473|NCT03052751|4044963|FG004|STARTED|Dosing Period 2||10
3311474|NCT03052751|4044964|FG005|STARTED|Dosing Period 2||10
3311475|NCT03052751|4044959|FG000|COMPLETED|Dosing Period 2||0
3311476|NCT03052751|4044960|FG001|COMPLETED|Dosing Period 2||0
3311477|NCT03052751|4044961|FG002|COMPLETED|Dosing Period 2||8
3311478|NCT03052751|4044962|FG003|COMPLETED|Dosing Period 2||11
3311479|NCT03052751|4044963|FG004|COMPLETED|Dosing Period 2||10
3311480|NCT03052751|4044964|FG005|COMPLETED|Dosing Period 2||10
3311481|NCT03052751|4044959|FG000|NOT COMPLETED|Dosing Period 2||0
3311482|NCT03052751|4044960|FG001|NOT COMPLETED|Dosing Period 2||0
3311483|NCT03052751|4044961|FG002|NOT COMPLETED|Dosing Period 2||3
3311484|NCT03052751|4044962|FG003|NOT COMPLETED|Dosing Period 2||0
3311485|NCT03052751|4044963|FG004|NOT COMPLETED|Dosing Period 2||0
3311486|NCT03052751|4044964|FG005|NOT COMPLETED|Dosing Period 2||0
3311487|NCT03052751|4044959|FG000|STARTED|Observation Period||22
3311488|NCT03052751|4044960|FG001|STARTED|Observation Period||21
3311489|NCT03052751|4044961|FG002|STARTED|Observation Period||11
3311490|NCT03052751|4044962|FG003|STARTED|Observation Period||11
3311491|NCT03052751|4044963|FG004|STARTED|Observation Period||10
3311492|NCT03052751|4044964|FG005|STARTED|Observation Period||10
3311493|NCT03052751|4044959|FG000|COMPLETED|Observation Period||22
3311494|NCT03052751|4044960|FG001|COMPLETED|Observation Period||21
3311495|NCT03052751|4044961|FG002|COMPLETED|Observation Period||11
3311496|NCT03052751|4044962|FG003|COMPLETED|Observation Period||11
3311497|NCT03052751|4044963|FG004|COMPLETED|Observation Period||9
3311498|NCT03052751|4044964|FG005|COMPLETED|Observation Period||10
3311499|NCT03052751|4044959|FG000|NOT COMPLETED|Observation Period||0
3311500|NCT03052751|4044960|FG001|NOT COMPLETED|Observation Period||0
3311501|NCT03052751|4044961|FG002|NOT COMPLETED|Observation Period||0
3311502|NCT03052751|4044962|FG003|NOT COMPLETED|Observation Period||0
3311503|NCT03052751|4044963|FG004|NOT COMPLETED|Observation Period||1
3311504|NCT03052751|4044964|FG005|NOT COMPLETED|Observation Period||0
3311505|NCT03052764|4044976|FG000|STARTED|Double-Blind Treatment Period||80
3311506|NCT03052764|4044977|FG001|STARTED|Double-Blind Treatment Period||40
3311507|NCT03052764|4044976|FG000|mITT|Double-Blind Treatment Period||78
3311508|NCT03052764|4044977|FG001|mITT|Double-Blind Treatment Period||39
3311509|NCT03052764|4044976|FG000|COMPLETED|Double-Blind Treatment Period||70
3311510|NCT03052764|4044977|FG001|COMPLETED|Double-Blind Treatment Period||37
3311511|NCT03052764|4044976|FG000|NOT COMPLETED|Double-Blind Treatment Period||10
3311512|NCT03052764|4044977|FG001|NOT COMPLETED|Double-Blind Treatment Period||3
3311513|NCT03052764|4044976|FG000|STARTED|Open-Label Re-Treatment Period||58
3311514|NCT03052764|4044977|FG001|STARTED|Open-Label Re-Treatment Period||33
3311515|NCT03052764|4044976|FG000|COMPLETED|Open-Label Re-Treatment Period||58
3311516|NCT03052764|4044977|FG001|COMPLETED|Open-Label Re-Treatment Period||33
3311517|NCT03052764|4044976|FG000|NOT COMPLETED|Open-Label Re-Treatment Period||0
3311518|NCT03052764|4044977|FG001|NOT COMPLETED|Open-Label Re-Treatment Period||0
3311519|NCT03052816|4044987|FG000|STARTED|Overall Study||33
3311520|NCT03052816|4044988|FG001|STARTED|Overall Study||33
3311521|NCT03052816|4044987|FG000|COMPLETED|Overall Study||30
3311522|NCT03052816|4044988|FG001|COMPLETED|Overall Study||33
3311523|NCT03052816|4044987|FG000|NOT COMPLETED|Overall Study||3
3311524|NCT03052816|4044988|FG001|NOT COMPLETED|Overall Study||0
3311525|NCT03052959|4044998|FG000|STARTED|Overall Study||59
3311526|NCT03052959|4044999|FG001|STARTED|Overall Study||66
3311527|NCT03052959|4044998|FG000|COMPLETED|Overall Study||55
3311528|NCT03052959|4044999|FG001|COMPLETED|Overall Study||61
3311529|NCT03052959|4044998|FG000|NOT COMPLETED|Overall Study||4
3311530|NCT03052959|4044999|FG001|NOT COMPLETED|Overall Study||5
3311531|NCT03052972|4045008|FG000|STARTED|Overall Study||18
2837750|NCT03517540|3540090|FG002|COMPLETED|Overall Study||38
2837751|NCT03517540|3540091|FG003|COMPLETED|Overall Study||43
2837752|NCT03517540|3540088|FG000|NOT COMPLETED|Overall Study||14
2837753|NCT03517540|3540089|FG001|NOT COMPLETED|Overall Study||7
2837754|NCT03517540|3540090|FG002|NOT COMPLETED|Overall Study||9
2837755|NCT03517540|3540091|FG003|NOT COMPLETED|Overall Study||5
3311532|NCT03052972|4045009|FG001|STARTED|Overall Study||5
3311533|NCT03052972|4045008|FG000|COMPLETED|Overall Study||18
3311534|NCT03052972|4045009|FG001|COMPLETED|Overall Study||5
3311535|NCT03052972|4045008|FG000|NOT COMPLETED|Overall Study||0
3311536|NCT03052972|4045009|FG001|NOT COMPLETED|Overall Study||0
3311537|NCT03053050|4045019|FG000|STARTED|Randomized Phase||324
3311538|NCT03053050|4045020|FG001|STARTED|Randomized Phase||323
3311539|NCT03053050|4045021|FG002|STARTED|Randomized Phase||161
2837756|NCT03502187|3540104|FG000|STARTED|Overall Study||43
2837757|NCT03502187|3540105|FG001|STARTED|Overall Study||43
2837758|NCT03502187|3540106|FG002|STARTED|Overall Study||42
2837759|NCT03502187|3540104|FG000|COMPLETED|Overall Study||34
2837760|NCT03502187|3540105|FG001|COMPLETED|Overall Study||36
2837761|NCT03502187|3540106|FG002|COMPLETED|Overall Study||34
2837762|NCT03502187|3540104|FG000|NOT COMPLETED|Overall Study||9
2837763|NCT03502187|3540105|FG001|NOT COMPLETED|Overall Study||7
2837764|NCT03502187|3540106|FG002|NOT COMPLETED|Overall Study||8
2837765|NCT03447262|3540114|FG000|STARTED|Overall Study||481
2837766|NCT03447262|3540114|FG000|COMPLETED|Overall Study||2
2837767|NCT03447262|3540114|FG000|NOT COMPLETED|Overall Study||479
2837768|NCT03432819|3540123|FG000|STARTED|Overall Study||38
2837769|NCT03432819|3540124|FG001|STARTED|Overall Study||38
2837770|NCT03432819|3540123|FG000|COMPLETED|Overall Study||31
2837771|NCT03432819|3540124|FG001|COMPLETED|Overall Study||33
2837772|NCT03432819|3540123|FG000|NOT COMPLETED|Overall Study||7
2837773|NCT03432819|3540124|FG001|NOT COMPLETED|Overall Study||5
2837774|NCT03365791|3540130|FG000|STARTED|Overall Study||76
2837775|NCT03365791|3540130|FG000|Full Analysis Set (FAS)|Overall Study||75
2837776|NCT03365791|3540130|FG000|COMPLETED|Overall Study||4
2837777|NCT03365791|3540130|FG000|NOT COMPLETED|Overall Study||72
2837778|NCT03323749|3540137|FG000|STARTED|Double-blind Period||109
2837779|NCT03323749|3540138|FG001|STARTED|Double-blind Period||109
2837780|NCT03323749|3540137|FG000|COMPLETED|Double-blind Period||102
2837781|NCT03323749|3540138|FG001|COMPLETED|Double-blind Period||103
2837782|NCT03323749|3540137|FG000|NOT COMPLETED|Double-blind Period||7
2837783|NCT03323749|3540138|FG001|NOT COMPLETED|Double-blind Period||6
2837784|NCT03323749|3540137|FG000|STARTED|Open-Label Period||93
2837785|NCT03323749|3540138|FG001|STARTED|Open-Label Period||103
2837786|NCT03323749|3540137|FG000|COMPLETED|Open-Label Period||0
2837787|NCT03323749|3540138|FG001|COMPLETED|Open-Label Period||0
2837788|NCT03323749|3540137|FG000|NOT COMPLETED|Open-Label Period||93
2837789|NCT03323749|3540138|FG001|NOT COMPLETED|Open-Label Period||103
2837790|NCT03322566|3540151|FG000|STARTED|Overall Study||91
2837791|NCT03322566|3540152|FG001|STARTED|Overall Study||87
2837792|NCT03322566|3540153|FG002|STARTED|Overall Study||55
2837793|NCT03322566|3540151|FG000|COMPLETED|Overall Study||46
2837794|NCT03322566|3540152|FG001|COMPLETED|Overall Study||42
2837795|NCT03322566|3540153|FG002|COMPLETED|Overall Study||22
2837796|NCT03322566|3540151|FG000|NOT COMPLETED|Overall Study||45
2837797|NCT03322566|3540152|FG001|NOT COMPLETED|Overall Study||45
2837798|NCT03322566|3540153|FG002|NOT COMPLETED|Overall Study||33
2837799|NCT03322540|3540163|FG000|STARTED|Overall Study||77
2837800|NCT03322540|3540164|FG001|STARTED|Overall Study||77
2837801|NCT03322540|3540163|FG000|Number of Subjects Received Treatment (Actual Treatment) (ASaT)|Overall Study||75
2837802|NCT03322540|3540164|FG001|Number of Subjects Received Treatment (Actual Treatment) (ASaT)|Overall Study||77
2837803|NCT03322540|3540163|FG000|COMPLETED|Overall Study||46
2837804|NCT03322540|3540164|FG001|COMPLETED|Overall Study||40
2837805|NCT03322540|3540163|FG000|NOT COMPLETED|Overall Study||31
2837806|NCT03322540|3540164|FG001|NOT COMPLETED|Overall Study||37
2837807|NCT03240601|3540174|FG000|STARTED|Overall Study||9
2837808|NCT03240601|3540175|FG001|STARTED|Overall Study||9
2837809|NCT03240601|3540174|FG000|COMPLETED|Overall Study||8
2837810|NCT03240601|3540175|FG001|COMPLETED|Overall Study||8
2837811|NCT03240601|3540174|FG000|NOT COMPLETED|Overall Study||1
2837812|NCT03240601|3540175|FG001|NOT COMPLETED|Overall Study||1
2837813|NCT03189719|3540183|FG000|STARTED|Overall Study||373
2837814|NCT03189719|3540184|FG001|STARTED|Overall Study||376
2837815|NCT03189719|3540183|FG000|Treated|Overall Study||370
2837816|NCT03189719|3540184|FG001|Treated|Overall Study||370
2837817|NCT03189719|3540183|FG000|COMPLETED|Overall Study||0
2837818|NCT03189719|3540184|FG001|COMPLETED|Overall Study||0
2837819|NCT03189719|3540183|FG000|NOT COMPLETED|Overall Study||373
2837820|NCT03189719|3540184|FG001|NOT COMPLETED|Overall Study||376
2837821|NCT03155997|3540192|FG000|STARTED|Overall Study||2808
2837822|NCT03155997|3540193|FG001|STARTED|Overall Study||2829
2837823|NCT03155997|3540192|FG000|Received at Least One Dose of Study Drug|Overall Study||2791
2837824|NCT03155997|3540193|FG001|Received at Least One Dose of Study Drug|Overall Study||2800
2837825|NCT03155997|3540192|FG000|COMPLETED|Overall Study||650
2837826|NCT03155997|3540193|FG001|COMPLETED|Overall Study||607
2837827|NCT03155997|3540192|FG000|NOT COMPLETED|Overall Study||2158
2837828|NCT03155997|3540193|FG001|NOT COMPLETED|Overall Study||2222
2915488|NCT00509899|3625763|FG003|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|1
2915489|NCT00509899|3625764|FG004|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|1
2915490|NCT00509899|3625765|FG005|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|12
2915491|NCT00509899|3625766|FG006|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|5
2915492|NCT00509899|3625767|FG007|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|2
2915493|NCT00509899|3625760|FG000|NOT COMPLETED|Overall Study||16
2915494|NCT00509899|3625761|FG001|NOT COMPLETED|Overall Study||9
2915495|NCT00509899|3625762|FG002|NOT COMPLETED|Overall Study||20
2915496|NCT00509899|3625763|FG003|NOT COMPLETED|Overall Study||4
2915497|NCT00509899|3625764|FG004|NOT COMPLETED|Overall Study||5
2915498|NCT00509899|3625765|FG005|NOT COMPLETED|Overall Study||10
2837829|NCT03104400|3540203|FG000|STARTED|Overall Study||211
2837830|NCT03104400|3540204|FG001|STARTED|Overall Study||212
2837831|NCT03104400|3540205|FG002|STARTED|Overall Study||429
2837832|NCT03104400|3540206|FG003|STARTED|Overall Study||430
2837833|NCT03104400|3540207|FG004|STARTED|Overall Study||423
2837834|NCT03104400|3540203|FG000|Received Study Drug|Overall Study||211
2837835|NCT03104400|3540204|FG001|Received Study Drug|Overall Study||212
2837836|NCT03104400|3540205|FG002|Received Study Drug|Overall Study||429
2837837|NCT03104400|3540206|FG003|Received Study Drug|Overall Study||429
2837838|NCT03104400|3540207|FG004|Received Study Drug|Overall Study||423
2837839|NCT03104400|3540203|FG000|Completed Week 24|Overall Study||190
2837840|NCT03104400|3540204|FG001|Completed Week 24|Overall Study||193
2837841|NCT03104400|3540205|FG002|Completed Week 24|Overall Study||404
2837842|NCT03104400|3540206|FG003|Completed Week 24|Overall Study||408
2837843|NCT03104400|3540207|FG004|Completed Week 24|Overall Study||394
2837844|NCT03104400|3540203|FG000|COMPLETED|Overall Study||177
2837845|NCT03104400|3540204|FG001|COMPLETED|Overall Study||178
2837846|NCT03104400|3540205|FG002|COMPLETED|Overall Study||370
2837847|NCT03104400|3540206|FG003|COMPLETED|Overall Study||379
2837848|NCT03104400|3540207|FG004|COMPLETED|Overall Study||366
2837849|NCT03104400|3540203|FG000|NOT COMPLETED|Overall Study||34
2837850|NCT03104400|3540204|FG001|NOT COMPLETED|Overall Study||34
2837851|NCT03104400|3540205|FG002|NOT COMPLETED|Overall Study||59
2837852|NCT03104400|3540206|FG003|NOT COMPLETED|Overall Study||51
2837853|NCT03104400|3540207|FG004|NOT COMPLETED|Overall Study||57
2837854|NCT03104374|3540224|FG000|STARTED|Overall Study||106
2837855|NCT03104374|3540225|FG001|STARTED|Overall Study||106
2837856|NCT03104374|3540226|FG002|STARTED|Overall Study||211
2837857|NCT03104374|3540227|FG003|STARTED|Overall Study||219
2837858|NCT03104374|3540224|FG000|Received Study Drug|Overall Study||106
2837859|NCT03104374|3540225|FG001|Received Study Drug|Overall Study||106
2837860|NCT03104374|3540226|FG002|Received Study Drug|Overall Study||211
2837861|NCT03104374|3540227|FG003|Received Study Drug|Overall Study||218
2837862|NCT03104374|3540224|FG000|Completed Week 24|Overall Study||81
2837863|NCT03104374|3540225|FG001|Completed Week 24|Overall Study||92
2837864|NCT03104374|3540226|FG002|Completed Week 24|Overall Study||192
2837865|NCT03104374|3540227|FG003|Completed Week 24|Overall Study||195
2837866|NCT03104374|3540224|FG000|COMPLETED|Overall Study||69
2837867|NCT03104374|3540225|FG001|COMPLETED|Overall Study||77
2837868|NCT03104374|3540226|FG002|COMPLETED|Overall Study||167
2837869|NCT03104374|3540227|FG003|COMPLETED|Overall Study||166
2837870|NCT03104374|3540224|FG000|NOT COMPLETED|Overall Study||37
2837871|NCT03104374|3540225|FG001|NOT COMPLETED|Overall Study||29
2837872|NCT03104374|3540226|FG002|NOT COMPLETED|Overall Study||44
2837873|NCT03104374|3540227|FG003|NOT COMPLETED|Overall Study||53
2837874|NCT03072043|3540240|FG000|STARTED|Overall Study||3
2837875|NCT03072043|3540241|FG001|STARTED|Overall Study||3
2837876|NCT03072043|3540242|FG002|STARTED|Overall Study||49
2837877|NCT03072043|3540240|FG000|COMPLETED|Overall Study||3
2837878|NCT03072043|3540241|FG001|COMPLETED|Overall Study||3
2837879|NCT03072043|3540242|FG002|COMPLETED|Overall Study||40
2837880|NCT03072043|3540240|FG000|NOT COMPLETED|Overall Study||0
2837881|NCT03072043|3540241|FG001|NOT COMPLETED|Overall Study||0
2837882|NCT03072043|3540242|FG002|NOT COMPLETED|Overall Study||9
2837883|NCT02970981|3540254|FG000|STARTED|Overall Study||16
2837884|NCT02970981|3540254|FG000|COMPLETED|Overall Study||16
2837885|NCT02970981|3540254|FG000|NOT COMPLETED|Overall Study||0
2837886|NCT02946853|3540260|FG000|STARTED|Overall Study||13
2837887|NCT02946853|3540261|FG001|STARTED|Overall Study||13
2837888|NCT02946853|3540260|FG000|COMPLETED|Overall Study||12
2837889|NCT02946853|3540261|FG001|COMPLETED|Overall Study||13
2837890|NCT02946853|3540260|FG000|NOT COMPLETED|Overall Study||1
2837891|NCT02946853|3540261|FG001|NOT COMPLETED|Overall Study||0
2837892|NCT02905032|3540270|FG000|STARTED|Overall Study||467
2837893|NCT02905032|3540271|FG001|STARTED|Overall Study||475
2837894|NCT02905032|3540272|FG002|STARTED|Overall Study||244
3167354|NCT01909804|3894606|FG007|COMPLETED|Overall Study||25
3167355|NCT01909804|3894607|FG008|COMPLETED|Overall Study||27
3167356|NCT01909804|3894608|FG009|COMPLETED|Overall Study||28
3167357|NCT01909804|3894609|FG010|COMPLETED|Overall Study||26
3167358|NCT01909804|3894610|FG011|COMPLETED|Overall Study||26
3167359|NCT01909804|3894599|FG000|NOT COMPLETED|Overall Study||4
2837895|NCT02905032|3540270|FG000|COMPLETED|Overall Study||459
2837896|NCT02905032|3540271|FG001|COMPLETED|Overall Study||463
2837897|NCT02905032|3540272|FG002|COMPLETED|Overall Study||244
2837898|NCT02905032|3540270|FG000|NOT COMPLETED|Overall Study||8
2837899|NCT02905032|3540271|FG001|NOT COMPLETED|Overall Study||12
2837900|NCT02905032|3540272|FG002|NOT COMPLETED|Overall Study||0
2837901|NCT02837029|3540282|FG000|STARTED|Screening||15
2837902|NCT02837029|3540283|FG001|STARTED|Screening||12
2837903|NCT02837029|3540284|FG002|STARTED|Screening||0
2837904|NCT02837029|3540282|FG000|COMPLETED|Screening||8
2837905|NCT02837029|3540283|FG001|COMPLETED|Screening||9
2837906|NCT02837029|3540284|FG002|COMPLETED|Screening||0
2837907|NCT02837029|3540282|FG000|NOT COMPLETED|Screening||7
2837908|NCT02837029|3540283|FG001|NOT COMPLETED|Screening||3
2837909|NCT02837029|3540284|FG002|NOT COMPLETED|Screening||0
2837910|NCT02837029|3540282|FG000|STARTED|Induction Treatment With Y90||8
2837911|NCT02837029|3540283|FG001|STARTED|Induction Treatment With Y90||9
2837912|NCT02837029|3540284|FG002|STARTED|Induction Treatment With Y90||0
3167360|NCT01909804|3894600|FG001|NOT COMPLETED|Overall Study||1
3167361|NCT01909804|3894601|FG002|NOT COMPLETED|Overall Study||0
2837913|NCT02837029|3540282|FG000|COMPLETED|Induction Treatment With Y90||8
2837914|NCT02837029|3540283|FG001|COMPLETED|Induction Treatment With Y90||9
2837915|NCT02837029|3540284|FG002|COMPLETED|Induction Treatment With Y90||0
2837916|NCT02837029|3540282|FG000|NOT COMPLETED|Induction Treatment With Y90||0
2837917|NCT02837029|3540283|FG001|NOT COMPLETED|Induction Treatment With Y90||0
2837918|NCT02837029|3540284|FG002|NOT COMPLETED|Induction Treatment With Y90||0
2837919|NCT02837029|3540282|FG000|STARTED|Cycle 1 (DLT Monitoring Period)||8
2837920|NCT02837029|3540283|FG001|STARTED|Cycle 1 (DLT Monitoring Period)||9
2837921|NCT02837029|3540284|FG002|STARTED|Cycle 1 (DLT Monitoring Period)||0
2837922|NCT02837029|3540282|FG000|Received Nivolumab Dose|Cycle 1 (DLT Monitoring Period)||6
2837923|NCT02837029|3540283|FG001|Received Nivolumab Dose|Cycle 1 (DLT Monitoring Period)||7
2837924|NCT02837029|3540284|FG002|Received Nivolumab Dose|Cycle 1 (DLT Monitoring Period)||0
2837925|NCT02837029|3540282|FG000|COMPLETED|Cycle 1 (DLT Monitoring Period)||6
2837926|NCT02837029|3540283|FG001|COMPLETED|Cycle 1 (DLT Monitoring Period)||6
2837927|NCT02837029|3540284|FG002|COMPLETED|Cycle 1 (DLT Monitoring Period)||0
2837928|NCT02837029|3540282|FG000|NOT COMPLETED|Cycle 1 (DLT Monitoring Period)||2
2837929|NCT02837029|3540283|FG001|NOT COMPLETED|Cycle 1 (DLT Monitoring Period)||3
2837930|NCT02837029|3540284|FG002|NOT COMPLETED|Cycle 1 (DLT Monitoring Period)||0
2837931|NCT02837029|3540282|FG000|STARTED|Cycle 2 and Beyond||6
2837932|NCT02837029|3540283|FG001|STARTED|Cycle 2 and Beyond||6
2837933|NCT02837029|3540284|FG002|STARTED|Cycle 2 and Beyond||0
2837934|NCT02837029|3540282|FG000|COMPLETED|Cycle 2 and Beyond||5
2837935|NCT02837029|3540283|FG001|COMPLETED|Cycle 2 and Beyond||6
2837936|NCT02837029|3540284|FG002|COMPLETED|Cycle 2 and Beyond||0
2837937|NCT02837029|3540282|FG000|NOT COMPLETED|Cycle 2 and Beyond||1
2837938|NCT02837029|3540283|FG001|NOT COMPLETED|Cycle 2 and Beyond||0
2837939|NCT02837029|3540284|FG002|NOT COMPLETED|Cycle 2 and Beyond||0
2837940|NCT02837029|3540282|FG000|STARTED|2 Year Follow-up|All patients who receive at least one dose of nivolumab go into follow-up.|6
2837941|NCT02837029|3540283|FG001|STARTED|2 Year Follow-up|All patients who receive at least one dose of nivolumab go into follow-up.|7
2837942|NCT02837029|3540284|FG002|STARTED|2 Year Follow-up||0
2837943|NCT02837029|3540282|FG000|COMPLETED|2 Year Follow-up||0
2837944|NCT02837029|3540283|FG001|COMPLETED|2 Year Follow-up||0
2837945|NCT02837029|3540284|FG002|COMPLETED|2 Year Follow-up||0
2837946|NCT02837029|3540282|FG000|NOT COMPLETED|2 Year Follow-up||6
2837947|NCT02837029|3540283|FG001|NOT COMPLETED|2 Year Follow-up||7
2837948|NCT02837029|3540284|FG002|NOT COMPLETED|2 Year Follow-up||0
2837949|NCT02740127|3540295|FG000|STARTED|Overall Study||24
2837950|NCT02740127|3540296|FG001|STARTED|Overall Study||28
2837951|NCT02740127|3540295|FG000|COMPLETED|Overall Study||24
2837952|NCT02740127|3540296|FG001|COMPLETED|Overall Study||28
2837953|NCT02740127|3540295|FG000|NOT COMPLETED|Overall Study||0
2837954|NCT02740127|3540296|FG001|NOT COMPLETED|Overall Study||0
2837955|NCT02737553|3540304|FG000|STARTED|Overall Study||49
2837956|NCT02737553|3540305|FG001|STARTED|Overall Study||48
2837957|NCT02737553|3540304|FG000|COMPLETED|Overall Study||49
2837958|NCT02737553|3540305|FG001|COMPLETED|Overall Study||48
2837959|NCT02737553|3540304|FG000|NOT COMPLETED|Overall Study||0
2837960|NCT02737553|3540305|FG001|NOT COMPLETED|Overall Study||0
2837961|NCT02737475|3540339|FG000|STARTED|Overall Study||4
2837962|NCT02737475|3540340|FG001|STARTED|Overall Study||4
2837963|NCT02737475|3540341|FG002|STARTED|Overall Study||4
2837964|NCT02737475|3540342|FG003|STARTED|Overall Study||4
2837965|NCT02737475|3540343|FG004|STARTED|Overall Study||4
2837966|NCT02737475|3540344|FG005|STARTED|Overall Study||7
2837967|NCT02737475|3540345|FG006|STARTED|Overall Study||8
2837968|NCT02737475|3540346|FG007|STARTED|Overall Study||12
2837969|NCT02737475|3540347|FG008|STARTED|Overall Study||8
2837970|NCT02737475|3540348|FG009|STARTED|Overall Study||8
2837971|NCT02737475|3540349|FG010|STARTED|Overall Study||4
2837972|NCT02737475|3540350|FG011|STARTED|Overall Study||10
2837973|NCT02737475|3540351|FG012|STARTED|Overall Study||7
2837974|NCT02737475|3540352|FG013|STARTED|Overall Study||8
2837975|NCT02737475|3540353|FG014|STARTED|Overall Study||6
2837976|NCT02737475|3540354|FG015|STARTED|Overall Study||18
2837977|NCT02737475|3540355|FG016|STARTED|Overall Study||12
2837978|NCT02737475|3540356|FG017|STARTED|Overall Study||6
2837979|NCT02737475|3540357|FG018|STARTED|Overall Study||7
2837980|NCT02737475|3540358|FG019|STARTED|Overall Study||1
2837981|NCT02737475|3540359|FG020|STARTED|Overall Study||6
2837982|NCT02737475|3540360|FG021|STARTED|Overall Study||9
2837983|NCT02737475|3540361|FG022|STARTED|Overall Study||2
2837984|NCT02737475|3540362|FG023|STARTED|Overall Study||2
2837985|NCT02737475|3540363|FG024|STARTED|Overall Study||2
2837986|NCT02737475|3540364|FG025|STARTED|Overall Study||2
2837987|NCT02737475|3540365|FG026|STARTED|Overall Study||1
2837988|NCT02737475|3540339|FG000|COMPLETED|Overall Study||3
2837989|NCT02737475|3540340|FG001|COMPLETED|Overall Study||4
2837990|NCT02737475|3540341|FG002|COMPLETED|Overall Study||4
2837991|NCT02737475|3540342|FG003|COMPLETED|Overall Study||3
2837992|NCT02737475|3540343|FG004|COMPLETED|Overall Study||3
2837993|NCT02737475|3540344|FG005|COMPLETED|Overall Study||4
2837994|NCT02737475|3540345|FG006|COMPLETED|Overall Study||8
2837995|NCT02737475|3540346|FG007|COMPLETED|Overall Study||10
2837996|NCT02737475|3540347|FG008|COMPLETED|Overall Study||7
2837997|NCT02737475|3540348|FG009|COMPLETED|Overall Study||8
2837998|NCT02737475|3540349|FG010|COMPLETED|Overall Study||3
2837999|NCT02737475|3540350|FG011|COMPLETED|Overall Study||6
2838000|NCT02737475|3540351|FG012|COMPLETED|Overall Study||5
2838001|NCT02737475|3540352|FG013|COMPLETED|Overall Study||6
2838002|NCT02737475|3540353|FG014|COMPLETED|Overall Study||5
2838003|NCT02737475|3540354|FG015|COMPLETED|Overall Study||15
2838004|NCT02737475|3540355|FG016|COMPLETED|Overall Study||10
2838005|NCT02737475|3540356|FG017|COMPLETED|Overall Study||2
2838006|NCT02737475|3540357|FG018|COMPLETED|Overall Study||5
2838007|NCT02737475|3540358|FG019|COMPLETED|Overall Study||1
2838008|NCT02737475|3540359|FG020|COMPLETED|Overall Study||4
2838009|NCT02737475|3540360|FG021|COMPLETED|Overall Study||8
2838010|NCT02737475|3540361|FG022|COMPLETED|Overall Study||2
2838011|NCT02737475|3540362|FG023|COMPLETED|Overall Study||1
2838012|NCT02737475|3540363|FG024|COMPLETED|Overall Study||1
2838013|NCT02737475|3540364|FG025|COMPLETED|Overall Study||1
2838014|NCT02737475|3540365|FG026|COMPLETED|Overall Study||0
2838015|NCT02737475|3540339|FG000|NOT COMPLETED|Overall Study||1
2838016|NCT02737475|3540340|FG001|NOT COMPLETED|Overall Study||0
2838017|NCT02737475|3540341|FG002|NOT COMPLETED|Overall Study||0
2838018|NCT02737475|3540342|FG003|NOT COMPLETED|Overall Study||1
2838019|NCT02737475|3540343|FG004|NOT COMPLETED|Overall Study||1
2838020|NCT02737475|3540344|FG005|NOT COMPLETED|Overall Study||3
2838021|NCT02737475|3540345|FG006|NOT COMPLETED|Overall Study||0
2838022|NCT02737475|3540346|FG007|NOT COMPLETED|Overall Study||2
2838023|NCT02737475|3540347|FG008|NOT COMPLETED|Overall Study||1
2838024|NCT02737475|3540348|FG009|NOT COMPLETED|Overall Study||0
2838025|NCT02737475|3540349|FG010|NOT COMPLETED|Overall Study||1
3167362|NCT01909804|3894602|FG003|NOT COMPLETED|Overall Study||0
3167363|NCT01909804|3894603|FG004|NOT COMPLETED|Overall Study||8
3167364|NCT01909804|3894604|FG005|NOT COMPLETED|Overall Study||4
3167365|NCT01909804|3894605|FG006|NOT COMPLETED|Overall Study||2
3167366|NCT01909804|3894606|FG007|NOT COMPLETED|Overall Study||1
3311540|NCT03053050|4045022|FG003|STARTED|Randomized Phase||0
2838026|NCT02737475|3540350|FG011|NOT COMPLETED|Overall Study||4
2838027|NCT02737475|3540351|FG012|NOT COMPLETED|Overall Study||2
2838028|NCT02737475|3540352|FG013|NOT COMPLETED|Overall Study||2
3311541|NCT03053050|4045019|FG000|COMPLETED|Randomized Phase||0
3311542|NCT03053050|4045020|FG001|COMPLETED|Randomized Phase||0
3311543|NCT03053050|4045021|FG002|COMPLETED|Randomized Phase||0
3311544|NCT03053050|4045022|FG003|COMPLETED|Randomized Phase||0
3311545|NCT03053050|4045019|FG000|NOT COMPLETED|Randomized Phase||324
3311546|NCT03053050|4045020|FG001|NOT COMPLETED|Randomized Phase||323
3311547|NCT03053050|4045021|FG002|NOT COMPLETED|Randomized Phase||161
3311548|NCT03053050|4045022|FG003|NOT COMPLETED|Randomized Phase||0
3311549|NCT03053050|4045019|FG000|STARTED|Open-label Phase||0
3311550|NCT03053050|4045020|FG001|STARTED|Open-label Phase||0
3311551|NCT03053050|4045021|FG002|STARTED|Open-label Phase||0
3311552|NCT03053050|4045022|FG003|STARTED|Open-label Phase|Participants with hepatic clinical event or progression to cirrhosis had option to go into OL Phase.|99
3311553|NCT03053050|4045019|FG000|COMPLETED|Open-label Phase||0
3311554|NCT03053050|4045020|FG001|COMPLETED|Open-label Phase||0
3311555|NCT03053050|4045021|FG002|COMPLETED|Open-label Phase||0
3311556|NCT03053050|4045022|FG003|COMPLETED|Open-label Phase||0
3311557|NCT03053050|4045019|FG000|NOT COMPLETED|Open-label Phase||0
3311558|NCT03053050|4045020|FG001|NOT COMPLETED|Open-label Phase||0
3311559|NCT03053050|4045021|FG002|NOT COMPLETED|Open-label Phase||0
3311560|NCT03053050|4045022|FG003|NOT COMPLETED|Open-label Phase||99
3311561|NCT03053063|4045034|FG000|STARTED|Randomized Phase||355
3311562|NCT03053063|4045035|FG001|STARTED|Randomized Phase||354
3311563|NCT03053063|4045036|FG002|STARTED|Randomized Phase||174
3311564|NCT03053063|4045037|FG003|STARTED|Randomized Phase||0
3311565|NCT03053063|4045034|FG000|COMPLETED|Randomized Phase||0
3311566|NCT03053063|4045035|FG001|COMPLETED|Randomized Phase||0
3311567|NCT03053063|4045036|FG002|COMPLETED|Randomized Phase||0
3311568|NCT03053063|4045037|FG003|COMPLETED|Randomized Phase||0
3311569|NCT03053063|4045034|FG000|NOT COMPLETED|Randomized Phase||355
3311570|NCT03053063|4045035|FG001|NOT COMPLETED|Randomized Phase||354
3311571|NCT03053063|4045036|FG002|NOT COMPLETED|Randomized Phase||174
3311572|NCT03053063|4045037|FG003|NOT COMPLETED|Randomized Phase||0
3311573|NCT03053063|4045034|FG000|STARTED|Open-Label Phase||0
3311574|NCT03053063|4045035|FG001|STARTED|Open-Label Phase||0
3311575|NCT03053063|4045036|FG002|STARTED|Open-Label Phase||0
3311576|NCT03053063|4045037|FG003|STARTED|Open-Label Phase|Participants who experienced a hepatic clinical event had the option to roll over into the OL Phase.|23
3311577|NCT03053063|4045034|FG000|COMPLETED|Open-Label Phase||0
3311578|NCT03053063|4045035|FG001|COMPLETED|Open-Label Phase||0
3311579|NCT03053063|4045036|FG002|COMPLETED|Open-Label Phase||0
3311580|NCT03053063|4045037|FG003|COMPLETED|Open-Label Phase||0
3311581|NCT03053063|4045034|FG000|NOT COMPLETED|Open-Label Phase||0
3311582|NCT03053063|4045035|FG001|NOT COMPLETED|Open-Label Phase||0
3311583|NCT03053063|4045036|FG002|NOT COMPLETED|Open-Label Phase||0
3311584|NCT03053063|4045037|FG003|NOT COMPLETED|Open-Label Phase||23
3311585|NCT03053102|4045046|FG000|STARTED|Study Part 1: 28-Day Treatment||10
3311586|NCT03053102|4045046|FG000|Received at Least 1 Dose of Study Drug|Study Part 1: 28-Day Treatment||10
3311587|NCT03053102|4045046|FG000|COMPLETED|Study Part 1: 28-Day Treatment||10
3311588|NCT03053102|4045046|FG000|NOT COMPLETED|Study Part 1: 28-Day Treatment||0
3311589|NCT03053102|4045046|FG000|STARTED|Study Part 2: 84-Day Treatment||10
2838029|NCT02737475|3540353|FG014|NOT COMPLETED|Overall Study||1
2838030|NCT02737475|3540354|FG015|NOT COMPLETED|Overall Study||3
2838031|NCT02737475|3540355|FG016|NOT COMPLETED|Overall Study||2
2838032|NCT02737475|3540356|FG017|NOT COMPLETED|Overall Study||4
2838033|NCT02737475|3540357|FG018|NOT COMPLETED|Overall Study||2
2838034|NCT02737475|3540358|FG019|NOT COMPLETED|Overall Study||0
2838035|NCT02737475|3540359|FG020|NOT COMPLETED|Overall Study||2
2838036|NCT02737475|3540360|FG021|NOT COMPLETED|Overall Study||1
2838037|NCT02737475|3540361|FG022|NOT COMPLETED|Overall Study||0
2838038|NCT02737475|3540362|FG023|NOT COMPLETED|Overall Study||1
2838039|NCT02737475|3540363|FG024|NOT COMPLETED|Overall Study||1
2838040|NCT02737475|3540364|FG025|NOT COMPLETED|Overall Study||1
2838041|NCT02737475|3540365|FG026|NOT COMPLETED|Overall Study||1
2838042|NCT02703714|3540453|FG000|STARTED|Overall Study||42
2838043|NCT02703714|3540453|FG000|COMPLETED|Overall Study||42
2838044|NCT02703714|3540453|FG000|NOT COMPLETED|Overall Study||0
2838045|NCT02642965|3540457|FG000|STARTED|Overall Study||38
2838046|NCT02642965|3540457|FG000|COMPLETED|Overall Study||25
2838047|NCT02642965|3540457|FG000|NOT COMPLETED|Overall Study||13
2838048|NCT02629159|3540464|FG000|STARTED|Overall Study||651
2838049|NCT02629159|3540465|FG001|STARTED|Overall Study||327
2838050|NCT02629159|3540466|FG002|STARTED|Overall Study||651
2838051|NCT02629159|3540464|FG000|Received Assigned Study Drug|Overall Study||651
2838052|NCT02629159|3540465|FG001|Received Assigned Study Drug|Overall Study||327
2838053|NCT02629159|3540466|FG002|Received Assigned Study Drug|Overall Study|One participant received a placebo injection but no oral study drug before discontinuing the study|650
2838054|NCT02629159|3540464|FG000|Completed Week 14 on Study Drug|Overall Study||620
2838055|NCT02629159|3540465|FG001|Completed Week 14 on Study Drug|Overall Study||300
2838056|NCT02629159|3540466|FG002|Completed Week 14 on Study Drug|Overall Study||620
2838057|NCT02629159|3540464|FG000|Rescued at Week 14|Overall Study||231
2838058|NCT02629159|3540465|FG001|Rescued at Week 14|Overall Study||56
2838059|NCT02629159|3540466|FG002|Rescued at Week 14|Overall Study||78
2838060|NCT02629159|3540464|FG000|Rescued at Week 18|Overall Study|One participant rescued at week 18 did not receive any dose of upadacitinib|48
2838061|NCT02629159|3540465|FG001|Rescued at Week 18|Overall Study||14
2838062|NCT02629159|3540466|FG002|Rescued at Week 18|Overall Study||29
2838063|NCT02629159|3540464|FG000|Rescued at Week 22|Overall Study||26
2838064|NCT02629159|3540465|FG001|Rescued at Week 22|Overall Study||7
3167367|NCT01909804|3894607|FG008|NOT COMPLETED|Overall Study||0
3167368|NCT01909804|3894608|FG009|NOT COMPLETED|Overall Study||1
3167369|NCT01909804|3894609|FG010|NOT COMPLETED|Overall Study||1
3167370|NCT01909804|3894610|FG011|NOT COMPLETED|Overall Study||3
3167371|NCT01909973|3894634|FG000|STARTED|Overall Study||8
2838065|NCT02629159|3540466|FG002|Rescued at Week 22|Overall Study||18
2838066|NCT02629159|3540464|FG000|COMPLETED|Overall Study||595
2838067|NCT02629159|3540465|FG001|COMPLETED|Overall Study||288
2838068|NCT02629159|3540466|FG002|COMPLETED|Overall Study||600
2838069|NCT02629159|3540464|FG000|NOT COMPLETED|Overall Study||56
2838070|NCT02629159|3540465|FG001|NOT COMPLETED|Overall Study||39
2838071|NCT02629159|3540466|FG002|NOT COMPLETED|Overall Study||51
2838072|NCT02604433|3540479|FG000|STARTED|Overall Study||224
2838073|NCT02604433|3540480|FG001|STARTED|Overall Study||112
2838074|NCT02604433|3540479|FG000|Participants Treated|Overall Study||223
2838075|NCT02604433|3540480|FG001|Participants Treated|Overall Study||109
2838076|NCT02604433|3540479|FG000|Completed 24 Weeks of Treatment|Overall Study||211
2838077|NCT02604433|3540480|FG001|Completed 24 Weeks of Treatment|Overall Study||102
2838078|NCT02604433|3540479|FG000|Completed 48 Weeks of Treatment|Overall Study||202
2838079|NCT02604433|3540480|FG001|Completed 48 Weeks of Treatment|Overall Study||96
2838080|NCT02604433|3540479|FG000|Completed 96 Weeks of Treatment|Overall Study||155
2838081|NCT02604433|3540480|FG001|Completed 96 Weeks of Treatment|Overall Study||3
2838082|NCT02604433|3540479|FG000|Completed 144 Weeks of Treatment|Overall Study||125
2838083|NCT02604433|3540480|FG001|Completed 144 Weeks of Treatment|Overall Study||0
2838084|NCT02604433|3540479|FG000|Completed 192 Weeks of Treatment|Overall Study||6
2838085|NCT02604433|3540480|FG001|Completed 192 Weeks of Treatment|Overall Study||0
2838086|NCT02604433|3540479|FG000|COMPLETED|Overall Study||6
2838087|NCT02604433|3540480|FG001|COMPLETED|Overall Study||6
2838088|NCT02604433|3540479|FG000|NOT COMPLETED|Overall Study||218
2838089|NCT02604433|3540480|FG001|NOT COMPLETED|Overall Study||106
2838090|NCT02550652|3540488|FG000|STARTED|Overall Study||63
2838091|NCT02550652|3540489|FG001|STARTED|Overall Study||62
2838092|NCT02550652|3540488|FG000|COMPLETED|Overall Study||42
2838093|NCT02550652|3540489|FG001|COMPLETED|Overall Study||41
2838094|NCT02550652|3540488|FG000|NOT COMPLETED|Overall Study||21
2838095|NCT02550652|3540489|FG001|NOT COMPLETED|Overall Study||21
2838096|NCT02519738|3540498|FG000|STARTED|Overall Study||20
2838097|NCT02519738|3540499|FG001|STARTED|Overall Study||17
2838098|NCT02519738|3540500|FG002|STARTED|Overall Study||15
2838099|NCT02519738|3540498|FG000|COMPLETED|Overall Study||6
2838100|NCT02519738|3540499|FG001|COMPLETED|Overall Study||4
2838101|NCT02519738|3540500|FG002|COMPLETED|Overall Study||3
2838102|NCT02519738|3540498|FG000|NOT COMPLETED|Overall Study||14
2838103|NCT02519738|3540499|FG001|NOT COMPLETED|Overall Study||13
2838104|NCT02519738|3540500|FG002|NOT COMPLETED|Overall Study||12
2915499|NCT00509899|3625766|FG006|NOT COMPLETED|Overall Study||1
2915500|NCT00509899|3625767|FG007|NOT COMPLETED|Overall Study||1
2915501|NCT00509925|3625781|FG000|STARTED|Overall Study||12
2915502|NCT00509925|3625782|FG001|STARTED|Overall Study||11
2915503|NCT00509925|3625781|FG000|COMPLETED|Overall Study||12
2915504|NCT00509925|3625782|FG001|COMPLETED|Overall Study||10
2915505|NCT00509925|3625781|FG000|NOT COMPLETED|Overall Study||0
2915506|NCT00509925|3625782|FG001|NOT COMPLETED|Overall Study||1
2915507|NCT00510068|3625792|FG000|STARTED|Double-blind Period||207
2838105|NCT02502071|3540508|FG000|STARTED|Overall Study||45
2838106|NCT02502071|3540508|FG000|COMPLETED|Overall Study||45
2838107|NCT02502071|3540508|FG000|NOT COMPLETED|Overall Study||0
2838108|NCT02420821|3540514|FG000|STARTED|Overall Study||461
2838109|NCT02420821|3540515|FG001|STARTED|Overall Study||454
2838110|NCT02420821|3540514|FG000|COMPLETED|Overall Study||293
2838111|NCT02420821|3540515|FG001|COMPLETED|Overall Study||317
2838112|NCT02420821|3540514|FG000|NOT COMPLETED|Overall Study||168
2838113|NCT02420821|3540515|FG001|NOT COMPLETED|Overall Study||137
2838114|NCT02412670|3540524|FG000|STARTED|Overall Study||30
2838115|NCT02412670|3540525|FG001|STARTED|Overall Study||6
2838116|NCT02412670|3540524|FG000|Eligible and Treated|Overall Study||29
2838117|NCT02412670|3540525|FG001|Eligible and Treated|Overall Study||6
2838118|NCT02412670|3540524|FG000|COMPLETED|Overall Study||23
2838119|NCT02412670|3540525|FG001|COMPLETED|Overall Study||5
2838120|NCT02412670|3540524|FG000|NOT COMPLETED|Overall Study||7
2838121|NCT02412670|3540525|FG001|NOT COMPLETED|Overall Study||1
2838122|NCT02410343|3540533|FG000|STARTED|Core Period (24 Weeks)||6
2838123|NCT02410343|3540534|FG001|STARTED|Core Period (24 Weeks)||8
2838124|NCT02410343|3540533|FG000|COMPLETED|Core Period (24 Weeks)||1
2838125|NCT02410343|3540534|FG001|COMPLETED|Core Period (24 Weeks)||1
2838126|NCT02410343|3540533|FG000|NOT COMPLETED|Core Period (24 Weeks)||5
2838127|NCT02410343|3540534|FG001|NOT COMPLETED|Core Period (24 Weeks)||7
2838128|NCT02410343|3540533|FG000|STARTED|Extension Period (12 Months)||1
2838129|NCT02410343|3540534|FG001|STARTED|Extension Period (12 Months)||1
2838130|NCT02410343|3540533|FG000|COMPLETED|Extension Period (12 Months)||0
2838131|NCT02410343|3540534|FG001|COMPLETED|Extension Period (12 Months)||0
2838132|NCT02410343|3540533|FG000|NOT COMPLETED|Extension Period (12 Months)||1
2838133|NCT02410343|3540534|FG001|NOT COMPLETED|Extension Period (12 Months)||1
2838134|NCT02343224|3540541|FG000|STARTED|Overall Study||9
2838135|NCT02343224|3540541|FG000|COMPLETED|Overall Study||0
2838136|NCT02343224|3540541|FG000|NOT COMPLETED|Overall Study||9
2838137|NCT02339740|3540547|FG000|STARTED|Overall Study||101
2838138|NCT02339740|3540548|FG001|STARTED|Overall Study||57
2838139|NCT02339740|3540547|FG000|COMPLETED|Overall Study||92
2838140|NCT02339740|3540548|FG001|COMPLETED|Overall Study||53
2838141|NCT02339740|3540547|FG000|NOT COMPLETED|Overall Study||9
2838142|NCT02339740|3540548|FG001|NOT COMPLETED|Overall Study||4
2838143|NCT02291445|3540556|FG000|STARTED|Overall Study||4
2838144|NCT02291445|3540557|FG001|STARTED|Overall Study||4
2838145|NCT02291445|3540556|FG000|COMPLETED|Overall Study||4
2838146|NCT02291445|3540557|FG001|COMPLETED|Overall Study||4
2838147|NCT02291445|3540556|FG000|NOT COMPLETED|Overall Study||0
2838148|NCT02291445|3540557|FG001|NOT COMPLETED|Overall Study||0
2838149|NCT02248688|3540565|FG000|STARTED|Overall Study||5
2838150|NCT02248688|3540565|FG000|COMPLETED|Overall Study||5
2838151|NCT02248688|3540565|FG000|NOT COMPLETED|Overall Study||0
2838152|NCT02125461|3540571|FG000|STARTED|Overall Study||476
2838153|NCT02125461|3540572|FG001|STARTED|Overall Study||237
2838154|NCT02125461|3540571|FG000|Full Analysis Set (FAS)|Overall Study||476
2838155|NCT02125461|3540572|FG001|Full Analysis Set (FAS)|Overall Study||237
2838156|NCT02125461|3540571|FG000|Received Treatment|Overall Study||473
2838157|NCT02125461|3540572|FG001|Received Treatment|Overall Study||236
2838158|NCT02125461|3540571|FG000|Safety Analysis Set|Overall Study||475
2838159|NCT02125461|3540572|FG001|Safety Analysis Set|Overall Study||234
2838160|NCT02125461|3540571|FG000|Completed 12 Months of Treatment|Overall Study||232
2838161|NCT02125461|3540572|FG001|Completed 12 Months of Treatment|Overall Study||82
2838162|NCT02125461|3540571|FG000|COMPLETED|Overall Study||178
2838163|NCT02125461|3540572|FG001|COMPLETED|Overall Study||68
2838164|NCT02125461|3540571|FG000|NOT COMPLETED|Overall Study||298
2838165|NCT02125461|3540572|FG001|NOT COMPLETED|Overall Study||169
2838166|NCT02045303|3540580|FG000|STARTED|Overall Study||6
2838167|NCT02045303|3540581|FG001|STARTED|Overall Study||3
2838168|NCT02045303|3540582|FG002|STARTED|Overall Study||2
2838169|NCT02045303|3540580|FG000|COMPLETED|Overall Study||4
2838170|NCT02045303|3540581|FG001|COMPLETED|Overall Study||0
2838171|NCT02045303|3540582|FG002|COMPLETED|Overall Study||2
2838172|NCT02045303|3540580|FG000|NOT COMPLETED|Overall Study||2
2838173|NCT02045303|3540581|FG001|NOT COMPLETED|Overall Study||3
2838174|NCT02045303|3540582|FG002|NOT COMPLETED|Overall Study||0
2838175|NCT02025556|3540594|FG000|STARTED|Overall Study||104
2838176|NCT02025556|3540595|FG001|STARTED|Overall Study||96
2838177|NCT02025556|3540596|FG002|STARTED|Overall Study||97
2838178|NCT02025556|3540594|FG000|Safety Analysis Set|Overall Study||104
2838179|NCT02025556|3540595|FG001|Safety Analysis Set|Overall Study||96
2838180|NCT02025556|3540596|FG002|Safety Analysis Set|Overall Study||96
2838181|NCT02025556|3540594|FG000|Intent-to-treat (ITT) Set|Overall Study||104
2838182|NCT02025556|3540595|FG001|Intent-to-treat (ITT) Set|Overall Study||95
2838183|NCT02025556|3540596|FG002|Intent-to-treat (ITT) Set|Overall Study||96
2838184|NCT02025556|3540594|FG000|COMPLETED|Overall Study||98
2838185|NCT02025556|3540595|FG001|COMPLETED|Overall Study||83
2838186|NCT02025556|3540596|FG002|COMPLETED|Overall Study||88
2838187|NCT02025556|3540594|FG000|NOT COMPLETED|Overall Study||6
2838188|NCT02025556|3540595|FG001|NOT COMPLETED|Overall Study||13
2838189|NCT02025556|3540596|FG002|NOT COMPLETED|Overall Study||9
2838190|NCT01986933|3540609|FG000|STARTED|Placebo-controlled (Part A)||53
2838191|NCT01986933|3540610|FG001|STARTED|Placebo-controlled (Part A)||53
2838192|NCT01986933|3540611|FG002|STARTED|Placebo-controlled (Part A)||54
2838193|NCT01986933|3540612|FG003|STARTED|Placebo-controlled (Part A)||52
2838194|NCT01986933|3540613|FG004|STARTED|Placebo-controlled (Part A)||52
2838195|NCT01986933|3540609|FG000|COMPLETED|Placebo-controlled (Part A)||44
2838196|NCT01986933|3540610|FG001|COMPLETED|Placebo-controlled (Part A)||44
2838197|NCT01986933|3540611|FG002|COMPLETED|Placebo-controlled (Part A)||45
2838198|NCT01986933|3540612|FG003|COMPLETED|Placebo-controlled (Part A)||45
2838199|NCT01986933|3540613|FG004|COMPLETED|Placebo-controlled (Part A)||38
2838200|NCT01986933|3540609|FG000|NOT COMPLETED|Placebo-controlled (Part A)||9
2838201|NCT01986933|3540610|FG001|NOT COMPLETED|Placebo-controlled (Part A)||9
2838202|NCT01986933|3540611|FG002|NOT COMPLETED|Placebo-controlled (Part A)||9
2838203|NCT01986933|3540612|FG003|NOT COMPLETED|Placebo-controlled (Part A)||7
2838204|NCT01986933|3540613|FG004|NOT COMPLETED|Placebo-controlled (Part A)||14
2838205|NCT01986933|3540609|FG000|STARTED|Active-to-active (Part B)||0
2838206|NCT01986933|3540610|FG001|STARTED|Active-to-active (Part B)||41
2838207|NCT01986933|3540611|FG002|STARTED|Active-to-active (Part B)||38
2838208|NCT01986933|3540612|FG003|STARTED|Active-to-active (Part B)||39
2838209|NCT01986933|3540613|FG004|STARTED|Active-to-active (Part B)||35
2838210|NCT01986933|3540609|FG000|COMPLETED|Active-to-active (Part B)||0
2838211|NCT01986933|3540610|FG001|COMPLETED|Active-to-active (Part B)||31
2838212|NCT01986933|3540611|FG002|COMPLETED|Active-to-active (Part B)||28
2838213|NCT01986933|3540612|FG003|COMPLETED|Active-to-active (Part B)||30
2838214|NCT01986933|3540613|FG004|COMPLETED|Active-to-active (Part B)||19
2838215|NCT01986933|3540609|FG000|NOT COMPLETED|Active-to-active (Part B)||0
2838216|NCT01986933|3540610|FG001|NOT COMPLETED|Active-to-active (Part B)||10
2838217|NCT01986933|3540611|FG002|NOT COMPLETED|Active-to-active (Part B)||10
2838218|NCT01986933|3540612|FG003|NOT COMPLETED|Active-to-active (Part B)||9
2838219|NCT01986933|3540613|FG004|NOT COMPLETED|Active-to-active (Part B)||16
2838220|NCT01986933|3540609|FG000|STARTED|Placebo-to-active (Part B)||0
2838221|NCT01986933|3540610|FG001|STARTED|Placebo-to-active (Part B)|Patients in the initial placebo group were re-randomized into Nemoliozumab groups (0.1, 0.5 or 2.0 mg/kg Q4W) in Part B.|13
2838222|NCT01986933|3540611|FG002|STARTED|Placebo-to-active (Part B)|Patients in the initial placebo group were re-randomized into Nemoliozumab groups (0.1, 0.5 or 2.0 mg/kg Q4W) in Part B.|12
2838223|NCT01986933|3540612|FG003|STARTED|Placebo-to-active (Part B)|Patients in the initial placebo group were re-randomized into Nemoliozumab groups (0.1, 0.5 or 2.0 mg/kg Q4W) in Part B.|13
2838224|NCT01986933|3540613|FG004|STARTED|Placebo-to-active (Part B)|Patients in the initial placebo group were not re-randomized into Nemoliozumab (2.0 mg/kg) Q8W group in Part B.|0
2838225|NCT01986933|3540609|FG000|COMPLETED|Placebo-to-active (Part B)||0
2838226|NCT01986933|3540610|FG001|COMPLETED|Placebo-to-active (Part B)||8
2838227|NCT01986933|3540611|FG002|COMPLETED|Placebo-to-active (Part B)||7
2838228|NCT01986933|3540612|FG003|COMPLETED|Placebo-to-active (Part B)||8
2838229|NCT01986933|3540613|FG004|COMPLETED|Placebo-to-active (Part B)||0
2838230|NCT01986933|3540609|FG000|NOT COMPLETED|Placebo-to-active (Part B)||0
2838231|NCT01986933|3540610|FG001|NOT COMPLETED|Placebo-to-active (Part B)||5
2838232|NCT01986933|3540611|FG002|NOT COMPLETED|Placebo-to-active (Part B)||5
2838233|NCT01986933|3540612|FG003|NOT COMPLETED|Placebo-to-active (Part B)||5
2838234|NCT01986933|3540613|FG004|NOT COMPLETED|Placebo-to-active (Part B)||0
2838235|NCT01986075|3540635|FG000|STARTED|Initial CBT + CM (Pre-randomization)||0
2838236|NCT01986075|3540636|FG001|STARTED|Initial CBT + CM (Pre-randomization)||0
2838237|NCT01986075|3540637|FG002|STARTED|Initial CBT + CM (Pre-randomization)||145
2838238|NCT01986075|3540635|FG000|COMPLETED|Initial CBT + CM (Pre-randomization)||0
2838239|NCT01986075|3540636|FG001|COMPLETED|Initial CBT + CM (Pre-randomization)||0
2838240|NCT01986075|3540637|FG002|COMPLETED|Initial CBT + CM (Pre-randomization)||86
2838241|NCT01986075|3540635|FG000|NOT COMPLETED|Initial CBT + CM (Pre-randomization)||0
2838242|NCT01986075|3540636|FG001|NOT COMPLETED|Initial CBT + CM (Pre-randomization)||0
2838243|NCT01986075|3540637|FG002|NOT COMPLETED|Initial CBT + CM (Pre-randomization)||59
2838244|NCT01986075|3540635|FG000|STARTED|Randomized Intervention||45
2838245|NCT01986075|3540636|FG001|STARTED|Randomized Intervention||41
2838246|NCT01986075|3540637|FG002|STARTED|Randomized Intervention||0
2838247|NCT01986075|3540635|FG000|COMPLETED|Randomized Intervention||30
2838248|NCT01986075|3540636|FG001|COMPLETED|Randomized Intervention||27
2838249|NCT01986075|3540637|FG002|COMPLETED|Randomized Intervention||0
2838250|NCT01986075|3540635|FG000|NOT COMPLETED|Randomized Intervention||15
2838251|NCT01986075|3540636|FG001|NOT COMPLETED|Randomized Intervention||14
2838252|NCT01986075|3540637|FG002|NOT COMPLETED|Randomized Intervention||0
2838253|NCT01841333|3540644|FG000|STARTED|Overall Study||31
2838254|NCT01841333|3540644|FG000|COMPLETED|Overall Study||31
2838255|NCT01841333|3540644|FG000|NOT COMPLETED|Overall Study||0
2838256|NCT01835145|3540650|FG000|STARTED|Overall Study||32
2838257|NCT01835145|3540651|FG001|STARTED|Overall Study||15
2838258|NCT01835145|3540650|FG000|COMPLETED|Overall Study||31
2838259|NCT01835145|3540651|FG001|COMPLETED|Overall Study||15
2838260|NCT01835145|3540650|FG000|NOT COMPLETED|Overall Study||1
2838261|NCT01835145|3540651|FG001|NOT COMPLETED|Overall Study||0
2838262|NCT01802788|3540661|FG000|STARTED|Overall Study||941
2838263|NCT01802788|3540662|FG001|STARTED|Overall Study||59
2838264|NCT01802788|3540661|FG000|COMPLETED|Overall Study||755
2838265|NCT01802788|3540662|FG001|COMPLETED|Overall Study||59
2838266|NCT01802788|3540661|FG000|NOT COMPLETED|Overall Study||186
2838267|NCT01802788|3540662|FG001|NOT COMPLETED|Overall Study||0
2838268|NCT01701674|3540666|FG000|STARTED|Overall Study||13
2838269|NCT01701674|3540666|FG000|COMPLETED|Overall Study||12
2838270|NCT01701674|3540666|FG000|NOT COMPLETED|Overall Study||1
2838271|NCT01597388|3540679|FG000|STARTED|Overall Study||6
2838272|NCT01597388|3540680|FG001|STARTED|Overall Study||13
2838273|NCT01597388|3540681|FG002|STARTED|Overall Study||14
2838274|NCT01597388|3540682|FG003|STARTED|Overall Study||10
2838275|NCT01597388|3540683|FG004|STARTED|Overall Study||37
2838276|NCT01597388|3540684|FG005|STARTED|Overall Study||4
2838277|NCT01597388|3540685|FG006|STARTED|Overall Study||8
2838278|NCT01597388|3540686|FG007|STARTED|Overall Study||5
2838279|NCT01597388|3540687|FG008|STARTED|Overall Study||2
2838280|NCT01597388|3540679|FG000|COMPLETED|Overall Study||6
2838281|NCT01597388|3540680|FG001|COMPLETED|Overall Study||13
2838282|NCT01597388|3540681|FG002|COMPLETED|Overall Study||14
2838283|NCT01597388|3540682|FG003|COMPLETED|Overall Study||10
2838284|NCT01597388|3540683|FG004|COMPLETED|Overall Study||37
2838285|NCT01597388|3540684|FG005|COMPLETED|Overall Study||4
2838286|NCT01597388|3540685|FG006|COMPLETED|Overall Study||8
2838287|NCT01597388|3540686|FG007|COMPLETED|Overall Study||5
2838288|NCT01597388|3540687|FG008|COMPLETED|Overall Study||2
2838289|NCT01597388|3540679|FG000|NOT COMPLETED|Overall Study||0
2838290|NCT01597388|3540680|FG001|NOT COMPLETED|Overall Study||0
2838291|NCT01597388|3540681|FG002|NOT COMPLETED|Overall Study||0
2838292|NCT01597388|3540682|FG003|NOT COMPLETED|Overall Study||0
2838293|NCT01597388|3540683|FG004|NOT COMPLETED|Overall Study||0
2838294|NCT01597388|3540684|FG005|NOT COMPLETED|Overall Study||0
2838295|NCT01597388|3540685|FG006|NOT COMPLETED|Overall Study||0
2838296|NCT01597388|3540686|FG007|NOT COMPLETED|Overall Study||0
2838297|NCT01597388|3540687|FG008|NOT COMPLETED|Overall Study||0
3167372|NCT01909973|3894635|FG001|STARTED|Overall Study||7
3167373|NCT01909973|3894634|FG000|COMPLETED|Overall Study||7
3167374|NCT01909973|3894635|FG001|COMPLETED|Overall Study||7
3167375|NCT01909973|3894634|FG000|NOT COMPLETED|Overall Study||1
3167376|NCT01909973|3894635|FG001|NOT COMPLETED|Overall Study||0
3167377|NCT01910064|3894641|FG000|STARTED|Overall Study||436
3167378|NCT01910064|3894641|FG000|COMPLETED|Overall Study||391
3167379|NCT01910064|3894641|FG000|NOT COMPLETED|Overall Study||45
3167380|NCT01910116|3894647|FG000|STARTED|Overall Study||110
3167381|NCT01910116|3894648|FG001|STARTED|Overall Study||110
3167382|NCT01910116|3894647|FG000|Week 4|Overall Study||106
3167383|NCT01910116|3894648|FG001|Week 4|Overall Study||102
3167384|NCT01910116|3894647|FG000|Week 8|Overall Study||98
3167385|NCT01910116|3894648|FG001|Week 8|Overall Study||99
3167386|NCT01910116|3894647|FG000|Week 12|Overall Study||97
3167387|NCT01910116|3894648|FG001|Week 12|Overall Study||96
3167388|NCT01910116|3894647|FG000|Week 16|Overall Study||96
3167389|NCT01910116|3894648|FG001|Week 16|Overall Study||94
3167390|NCT01910116|3894647|FG000|COMPLETED|Overall Study||96
3167391|NCT01910116|3894648|FG001|COMPLETED|Overall Study||94
3167392|NCT01910116|3894647|FG000|NOT COMPLETED|Overall Study||14
3167393|NCT01910116|3894648|FG001|NOT COMPLETED|Overall Study||16
2838298|NCT01563107|3540728|FG000|STARTED|Overall Study|12 Healthy Controls were randomized to receive LS diet followed by HS diet|12
2838299|NCT01563107|3540729|FG001|STARTED|Overall Study|5 Healthy Controls were randomized to receive HS diet followed by LS diet|5
2838300|NCT01563107|3540730|FG002|STARTED|Overall Study|10 POTS patients were randomized to receive LS diet followed by HS diet|10
2838301|NCT01563107|3540731|FG003|STARTED|Overall Study|11 POTS patients were randomized to receive HS diet followed by LS diet|11
2838302|NCT01563107|3540728|FG000|Phase 1 Baseline Labs|Overall Study||12
2838303|NCT01563107|3540729|FG001|Phase 1 Baseline Labs|Overall Study|1 healthy control was unable to find time to schedule study|4
2838304|NCT01563107|3540730|FG002|Phase 1 Baseline Labs|Overall Study|2 patients with POTS did not discontinue medication that was prohibited by protocol.|8
2838305|NCT01563107|3540731|FG003|Phase 1 Baseline Labs|Overall Study|1 patient with POTS did not discontinue medication that was prohibited by protocol, 1 patient was unable to find time to schedule the study, 1 was noted to be too old to participate, and 1 became pregnant between enrollment and the start of phase 1.|7
2838306|NCT01563107|3540728|FG000|Phase 1-150 mEq Sodium/Day|Overall Study||12
2838307|NCT01563107|3540729|FG001|Phase 1-150 mEq Sodium/Day|Overall Study||4
2838308|NCT01563107|3540730|FG002|Phase 1-150 mEq Sodium/Day|Overall Study||8
2838309|NCT01563107|3540731|FG003|Phase 1-150 mEq Sodium/Day|Overall Study||7
2838310|NCT01563107|3540728|FG000|Phase 1-start Low Sodium or High Sodium Diet|Overall Study||12
2838311|NCT01563107|3540729|FG001|Phase 1-start Low Sodium or High Sodium Diet|Overall Study||4
2838312|NCT01563107|3540730|FG002|Phase 1-start Low Sodium or High Sodium Diet|Overall Study||8
2838313|NCT01563107|3540731|FG003|Phase 1-start Low Sodium or High Sodium Diet|Overall Study||7
2838314|NCT01563107|3540728|FG000|Phase 1-finish|Overall Study|1 healthy control withdrew with migraines during phase 1 (low Na+).|11
2838315|NCT01563107|3540729|FG001|Phase 1-finish|Overall Study|2 healthy controls withdrew during phase 1 (high Na+): 1 unable to tolerate study diet and another with difficulty cooperating with investigators.|2
2838316|NCT01563107|3540730|FG002|Phase 1-finish|Overall Study||8
2838317|NCT01563107|3540731|FG003|Phase 1-finish|Overall Study|1 patient with POTS withdrew during phase 1 due to a family illness.|6
2838318|NCT01563107|3540728|FG000|Phase 2-150 mEq Sodium/Day|Overall Study||11
2838319|NCT01563107|3540729|FG001|Phase 2-150 mEq Sodium/Day|Overall Study||2
2838320|NCT01563107|3540730|FG002|Phase 2-150 mEq Sodium/Day|Overall Study||8
2838321|NCT01563107|3540731|FG003|Phase 2-150 mEq Sodium/Day|Overall Study||6
2838322|NCT01563107|3540728|FG000|Phase 2-start Low Sodium or High Sodium Diet|Overall Study||11
2838323|NCT01563107|3540729|FG001|Phase 2-start Low Sodium or High Sodium Diet|Overall Study||2
2838324|NCT01563107|3540730|FG002|Phase 2-start Low Sodium or High Sodium Diet|Overall Study||8
3167394|NCT01910129|3894656|FG000|STARTED|Run-in Period Phase 1||0
3167395|NCT01910129|3894657|FG001|STARTED|Run-in Period Phase 1||0
2838325|NCT01563107|3540731|FG003|Phase 2-start Low Sodium or High Sodium Diet|Overall Study||6
2838326|NCT01563107|3540728|FG000|Phase 2-finish|Overall Study||11
2838327|NCT01563107|3540729|FG001|Phase 2-finish|Overall Study||2
2838328|NCT01563107|3540730|FG002|Phase 2-finish|Overall Study||8
2838329|NCT01563107|3540731|FG003|Phase 2-finish|Overall Study||6
2838330|NCT01563107|3540728|FG000|COMPLETED|Overall Study||11
2838331|NCT01563107|3540729|FG001|COMPLETED|Overall Study||2
2838332|NCT01563107|3540730|FG002|COMPLETED|Overall Study||8
2838333|NCT01563107|3540731|FG003|COMPLETED|Overall Study||6
2838334|NCT01563107|3540728|FG000|NOT COMPLETED|Overall Study||1
2838335|NCT01563107|3540729|FG001|NOT COMPLETED|Overall Study||3
2838336|NCT01563107|3540730|FG002|NOT COMPLETED|Overall Study||2
2838337|NCT01563107|3540731|FG003|NOT COMPLETED|Overall Study||5
2838338|NCT01320072|3540793|FG000|STARTED|Overall Study||16
2838339|NCT01320072|3540794|FG001|STARTED|Overall Study||13
2838340|NCT01320072|3540793|FG000|COMPLETED|Overall Study||16
2838341|NCT01320072|3540794|FG001|COMPLETED|Overall Study||13
2838342|NCT01320072|3540793|FG000|NOT COMPLETED|Overall Study||0
2838343|NCT01320072|3540794|FG001|NOT COMPLETED|Overall Study||0
2838344|NCT01194570|3540803|FG000|STARTED|Overall Study||244
2838345|NCT01194570|3540804|FG001|STARTED|Overall Study||488
2838346|NCT01194570|3540803|FG000|COMPLETED|Overall Study|"Reason for discontinuation were provided for Core Treatment Completion."|0
2838347|NCT01194570|3540804|FG001|COMPLETED|Overall Study||0
2838348|NCT01194570|3540803|FG000|NOT COMPLETED|Overall Study||244
2838349|NCT01194570|3540804|FG001|NOT COMPLETED|Overall Study||488
2838350|NCT01146652|3540812|FG000|STARTED|Overall Study||1912
2838351|NCT01146652|3540813|FG001|STARTED|Overall Study||111
2838352|NCT01146652|3540812|FG000|Treated|Overall Study||1910
2838353|NCT01146652|3540813|FG001|Treated|Overall Study||111
2838354|NCT01146652|3540812|FG000|Enrolled in the Sub-study|Overall Study||110
2838355|NCT01146652|3540813|FG001|Enrolled in the Sub-study|Overall Study||14
2838356|NCT01146652|3540812|FG000|Discontinued From the Sub-study|Overall Study||1
2838357|NCT01146652|3540813|FG001|Discontinued From the Sub-study|Overall Study||2
3311590|NCT03053102|4045046|FG000|COMPLETED|Study Part 2: 84-Day Treatment||8
3311591|NCT03053102|4045046|FG000|NOT COMPLETED|Study Part 2: 84-Day Treatment||2
2838358|NCT01146652|3540812|FG000|Switched Back to Main Study|Overall Study||108
2838359|NCT01146652|3540813|FG001|Switched Back to Main Study|Overall Study||13
2838360|NCT01146652|3540812|FG000|COMPLETED|Overall Study||961
2838361|NCT01146652|3540813|FG001|COMPLETED|Overall Study||66
2838362|NCT01146652|3540812|FG000|NOT COMPLETED|Overall Study||951
2838363|NCT01146652|3540813|FG001|NOT COMPLETED|Overall Study||45
2838364|NCT01116648|3540841|FG000|STARTED|Phase 1 Dose Level 0||3
2838365|NCT01116648|3540842|FG001|STARTED|Phase 1 Dose Level 0||0
2838366|NCT01116648|3540843|FG002|STARTED|Phase 1 Dose Level 0||0
2838367|NCT01116648|3540844|FG003|STARTED|Phase 1 Dose Level 0||0
2838368|NCT01116648|3540845|FG004|STARTED|Phase 1 Dose Level 0||0
2838369|NCT01116648|3540846|FG005|STARTED|Phase 1 Dose Level 0||0
2838370|NCT01116648|3540847|FG006|STARTED|Phase 1 Dose Level 0||0
2838371|NCT01116648|3540848|FG007|STARTED|Phase 1 Dose Level 0||0
2838372|NCT01116648|3540849|FG008|STARTED|Phase 1 Dose Level 0||0
2838373|NCT01116648|3540850|FG009|STARTED|Phase 1 Dose Level 0||0
2838374|NCT01116648|3540851|FG010|STARTED|Phase 1 Dose Level 0||0
2838375|NCT01116648|3540852|FG011|STARTED|Phase 1 Dose Level 0||0
2838376|NCT01116648|3540853|FG012|STARTED|Phase 1 Dose Level 0||0
2838377|NCT01116648|3540854|FG013|STARTED|Phase 1 Dose Level 0||0
2838378|NCT01116648|3540855|FG014|STARTED|Phase 1 Dose Level 0||0
2838379|NCT01116648|3540841|FG000|COMPLETED|Phase 1 Dose Level 0||3
2838380|NCT01116648|3540842|FG001|COMPLETED|Phase 1 Dose Level 0||0
2838381|NCT01116648|3540843|FG002|COMPLETED|Phase 1 Dose Level 0||0
2838382|NCT01116648|3540844|FG003|COMPLETED|Phase 1 Dose Level 0||0
2838383|NCT01116648|3540845|FG004|COMPLETED|Phase 1 Dose Level 0||0
2838384|NCT01116648|3540846|FG005|COMPLETED|Phase 1 Dose Level 0||0
2838385|NCT01116648|3540847|FG006|COMPLETED|Phase 1 Dose Level 0||0
2838386|NCT01116648|3540848|FG007|COMPLETED|Phase 1 Dose Level 0||0
2838387|NCT01116648|3540849|FG008|COMPLETED|Phase 1 Dose Level 0||0
2838388|NCT01116648|3540850|FG009|COMPLETED|Phase 1 Dose Level 0||0
2838389|NCT01116648|3540851|FG010|COMPLETED|Phase 1 Dose Level 0||0
2838390|NCT01116648|3540852|FG011|COMPLETED|Phase 1 Dose Level 0||0
2838391|NCT01116648|3540853|FG012|COMPLETED|Phase 1 Dose Level 0||0
2838392|NCT01116648|3540854|FG013|COMPLETED|Phase 1 Dose Level 0||0
2838393|NCT01116648|3540855|FG014|COMPLETED|Phase 1 Dose Level 0||0
2838394|NCT01116648|3540841|FG000|NOT COMPLETED|Phase 1 Dose Level 0||0
2838395|NCT01116648|3540842|FG001|NOT COMPLETED|Phase 1 Dose Level 0||0
2838396|NCT01116648|3540843|FG002|NOT COMPLETED|Phase 1 Dose Level 0||0
2838397|NCT01116648|3540844|FG003|NOT COMPLETED|Phase 1 Dose Level 0||0
2838398|NCT01116648|3540845|FG004|NOT COMPLETED|Phase 1 Dose Level 0||0
2838399|NCT01116648|3540846|FG005|NOT COMPLETED|Phase 1 Dose Level 0||0
2838400|NCT01116648|3540847|FG006|NOT COMPLETED|Phase 1 Dose Level 0||0
2838401|NCT01116648|3540848|FG007|NOT COMPLETED|Phase 1 Dose Level 0||0
2838402|NCT01116648|3540849|FG008|NOT COMPLETED|Phase 1 Dose Level 0||0
2838403|NCT01116648|3540850|FG009|NOT COMPLETED|Phase 1 Dose Level 0||0
2838404|NCT01116648|3540851|FG010|NOT COMPLETED|Phase 1 Dose Level 0||0
2838405|NCT01116648|3540852|FG011|NOT COMPLETED|Phase 1 Dose Level 0||0
2838406|NCT01116648|3540853|FG012|NOT COMPLETED|Phase 1 Dose Level 0||0
2838407|NCT01116648|3540854|FG013|NOT COMPLETED|Phase 1 Dose Level 0||0
2838408|NCT01116648|3540855|FG014|NOT COMPLETED|Phase 1 Dose Level 0||0
2838409|NCT01116648|3540841|FG000|STARTED|Phase 1 Dose Level 1||0
2838410|NCT01116648|3540842|FG001|STARTED|Phase 1 Dose Level 1||3
2838411|NCT01116648|3540843|FG002|STARTED|Phase 1 Dose Level 1||0
2838412|NCT01116648|3540844|FG003|STARTED|Phase 1 Dose Level 1||0
2838413|NCT01116648|3540845|FG004|STARTED|Phase 1 Dose Level 1||0
2838414|NCT01116648|3540846|FG005|STARTED|Phase 1 Dose Level 1||0
2838415|NCT01116648|3540847|FG006|STARTED|Phase 1 Dose Level 1||0
2838416|NCT01116648|3540848|FG007|STARTED|Phase 1 Dose Level 1||0
2838417|NCT01116648|3540849|FG008|STARTED|Phase 1 Dose Level 1||0
2838418|NCT01116648|3540850|FG009|STARTED|Phase 1 Dose Level 1||0
2838419|NCT01116648|3540851|FG010|STARTED|Phase 1 Dose Level 1||0
2838420|NCT01116648|3540852|FG011|STARTED|Phase 1 Dose Level 1||0
2838421|NCT01116648|3540853|FG012|STARTED|Phase 1 Dose Level 1||0
2838422|NCT01116648|3540854|FG013|STARTED|Phase 1 Dose Level 1||0
2838423|NCT01116648|3540855|FG014|STARTED|Phase 1 Dose Level 1||0
2838424|NCT01116648|3540841|FG000|COMPLETED|Phase 1 Dose Level 1||0
2838425|NCT01116648|3540842|FG001|COMPLETED|Phase 1 Dose Level 1||3
2838426|NCT01116648|3540843|FG002|COMPLETED|Phase 1 Dose Level 1||0
2838427|NCT01116648|3540844|FG003|COMPLETED|Phase 1 Dose Level 1||0
2838428|NCT01116648|3540845|FG004|COMPLETED|Phase 1 Dose Level 1||0
2838429|NCT01116648|3540846|FG005|COMPLETED|Phase 1 Dose Level 1||0
2838430|NCT01116648|3540847|FG006|COMPLETED|Phase 1 Dose Level 1||0
2838431|NCT01116648|3540848|FG007|COMPLETED|Phase 1 Dose Level 1||0
2838432|NCT01116648|3540849|FG008|COMPLETED|Phase 1 Dose Level 1||0
2838433|NCT01116648|3540850|FG009|COMPLETED|Phase 1 Dose Level 1||0
2838434|NCT01116648|3540851|FG010|COMPLETED|Phase 1 Dose Level 1||0
2838435|NCT01116648|3540852|FG011|COMPLETED|Phase 1 Dose Level 1||0
2838436|NCT01116648|3540853|FG012|COMPLETED|Phase 1 Dose Level 1||0
2838437|NCT01116648|3540854|FG013|COMPLETED|Phase 1 Dose Level 1||0
2838438|NCT01116648|3540855|FG014|COMPLETED|Phase 1 Dose Level 1||0
2838439|NCT01116648|3540841|FG000|NOT COMPLETED|Phase 1 Dose Level 1||0
2838440|NCT01116648|3540842|FG001|NOT COMPLETED|Phase 1 Dose Level 1||0
2838441|NCT01116648|3540843|FG002|NOT COMPLETED|Phase 1 Dose Level 1||0
2838442|NCT01116648|3540844|FG003|NOT COMPLETED|Phase 1 Dose Level 1||0
2838443|NCT01116648|3540845|FG004|NOT COMPLETED|Phase 1 Dose Level 1||0
2838444|NCT01116648|3540846|FG005|NOT COMPLETED|Phase 1 Dose Level 1||0
2838445|NCT01116648|3540847|FG006|NOT COMPLETED|Phase 1 Dose Level 1||0
2838446|NCT01116648|3540848|FG007|NOT COMPLETED|Phase 1 Dose Level 1||0
2838447|NCT01116648|3540849|FG008|NOT COMPLETED|Phase 1 Dose Level 1||0
2838448|NCT01116648|3540850|FG009|NOT COMPLETED|Phase 1 Dose Level 1||0
2838449|NCT01116648|3540851|FG010|NOT COMPLETED|Phase 1 Dose Level 1||0
2838450|NCT01116648|3540852|FG011|NOT COMPLETED|Phase 1 Dose Level 1||0
2838451|NCT01116648|3540853|FG012|NOT COMPLETED|Phase 1 Dose Level 1||0
2838452|NCT01116648|3540854|FG013|NOT COMPLETED|Phase 1 Dose Level 1||0
2838453|NCT01116648|3540855|FG014|NOT COMPLETED|Phase 1 Dose Level 1||0
2838454|NCT01116648|3540841|FG000|STARTED|Phase 1 Dose Level 2||0
2838455|NCT01116648|3540842|FG001|STARTED|Phase 1 Dose Level 2||0
2838456|NCT01116648|3540843|FG002|STARTED|Phase 1 Dose Level 2||7
2838457|NCT01116648|3540844|FG003|STARTED|Phase 1 Dose Level 2||0
2838458|NCT01116648|3540845|FG004|STARTED|Phase 1 Dose Level 2||0
2838459|NCT01116648|3540846|FG005|STARTED|Phase 1 Dose Level 2||0
2838460|NCT01116648|3540847|FG006|STARTED|Phase 1 Dose Level 2||0
2838461|NCT01116648|3540848|FG007|STARTED|Phase 1 Dose Level 2||0
2838462|NCT01116648|3540849|FG008|STARTED|Phase 1 Dose Level 2||0
2838463|NCT01116648|3540850|FG009|STARTED|Phase 1 Dose Level 2||0
2838464|NCT01116648|3540851|FG010|STARTED|Phase 1 Dose Level 2||0
2838465|NCT01116648|3540852|FG011|STARTED|Phase 1 Dose Level 2||0
2838466|NCT01116648|3540853|FG012|STARTED|Phase 1 Dose Level 2||0
2838467|NCT01116648|3540854|FG013|STARTED|Phase 1 Dose Level 2||0
2838468|NCT01116648|3540855|FG014|STARTED|Phase 1 Dose Level 2||0
2838469|NCT01116648|3540841|FG000|COMPLETED|Phase 1 Dose Level 2||0
2838470|NCT01116648|3540842|FG001|COMPLETED|Phase 1 Dose Level 2||0
2838471|NCT01116648|3540843|FG002|COMPLETED|Phase 1 Dose Level 2||7
2838472|NCT01116648|3540844|FG003|COMPLETED|Phase 1 Dose Level 2||0
2838473|NCT01116648|3540845|FG004|COMPLETED|Phase 1 Dose Level 2||0
2838474|NCT01116648|3540846|FG005|COMPLETED|Phase 1 Dose Level 2||0
2838475|NCT01116648|3540847|FG006|COMPLETED|Phase 1 Dose Level 2||0
2838476|NCT01116648|3540848|FG007|COMPLETED|Phase 1 Dose Level 2||0
2838477|NCT01116648|3540849|FG008|COMPLETED|Phase 1 Dose Level 2||0
2838478|NCT01116648|3540850|FG009|COMPLETED|Phase 1 Dose Level 2||0
2838479|NCT01116648|3540851|FG010|COMPLETED|Phase 1 Dose Level 2||0
2838480|NCT01116648|3540852|FG011|COMPLETED|Phase 1 Dose Level 2||0
2838481|NCT01116648|3540853|FG012|COMPLETED|Phase 1 Dose Level 2||0
2838482|NCT01116648|3540854|FG013|COMPLETED|Phase 1 Dose Level 2||0
2838483|NCT01116648|3540855|FG014|COMPLETED|Phase 1 Dose Level 2||0
2838484|NCT01116648|3540841|FG000|NOT COMPLETED|Phase 1 Dose Level 2||0
2838485|NCT01116648|3540842|FG001|NOT COMPLETED|Phase 1 Dose Level 2||0
2838486|NCT01116648|3540843|FG002|NOT COMPLETED|Phase 1 Dose Level 2||0
2838487|NCT01116648|3540844|FG003|NOT COMPLETED|Phase 1 Dose Level 2||0
2838488|NCT01116648|3540845|FG004|NOT COMPLETED|Phase 1 Dose Level 2||0
2838489|NCT01116648|3540846|FG005|NOT COMPLETED|Phase 1 Dose Level 2||0
2838490|NCT01116648|3540847|FG006|NOT COMPLETED|Phase 1 Dose Level 2||0
2838491|NCT01116648|3540848|FG007|NOT COMPLETED|Phase 1 Dose Level 2||0
2838492|NCT01116648|3540849|FG008|NOT COMPLETED|Phase 1 Dose Level 2||0
2838493|NCT01116648|3540850|FG009|NOT COMPLETED|Phase 1 Dose Level 2||0
2838494|NCT01116648|3540851|FG010|NOT COMPLETED|Phase 1 Dose Level 2||0
2838495|NCT01116648|3540852|FG011|NOT COMPLETED|Phase 1 Dose Level 2||0
2838496|NCT01116648|3540853|FG012|NOT COMPLETED|Phase 1 Dose Level 2||0
2838497|NCT01116648|3540854|FG013|NOT COMPLETED|Phase 1 Dose Level 2||0
2838498|NCT01116648|3540855|FG014|NOT COMPLETED|Phase 1 Dose Level 2||0
2838499|NCT01116648|3540841|FG000|STARTED|Phase 1 Dose Level 3||0
2838500|NCT01116648|3540842|FG001|STARTED|Phase 1 Dose Level 3||0
2838501|NCT01116648|3540843|FG002|STARTED|Phase 1 Dose Level 3||0
2838502|NCT01116648|3540844|FG003|STARTED|Phase 1 Dose Level 3||6
2838503|NCT01116648|3540845|FG004|STARTED|Phase 1 Dose Level 3||0
2838504|NCT01116648|3540846|FG005|STARTED|Phase 1 Dose Level 3||0
2838505|NCT01116648|3540847|FG006|STARTED|Phase 1 Dose Level 3||0
2838506|NCT01116648|3540848|FG007|STARTED|Phase 1 Dose Level 3||0
2838507|NCT01116648|3540849|FG008|STARTED|Phase 1 Dose Level 3||0
2838508|NCT01116648|3540850|FG009|STARTED|Phase 1 Dose Level 3||0
2838509|NCT01116648|3540851|FG010|STARTED|Phase 1 Dose Level 3||0
2838510|NCT01116648|3540852|FG011|STARTED|Phase 1 Dose Level 3||0
2838511|NCT01116648|3540853|FG012|STARTED|Phase 1 Dose Level 3||0
2838512|NCT01116648|3540854|FG013|STARTED|Phase 1 Dose Level 3||0
2838513|NCT01116648|3540855|FG014|STARTED|Phase 1 Dose Level 3||0
2838514|NCT01116648|3540841|FG000|COMPLETED|Phase 1 Dose Level 3||0
2838515|NCT01116648|3540842|FG001|COMPLETED|Phase 1 Dose Level 3||0
2838516|NCT01116648|3540843|FG002|COMPLETED|Phase 1 Dose Level 3||0
2838517|NCT01116648|3540844|FG003|COMPLETED|Phase 1 Dose Level 3||4
2838518|NCT01116648|3540845|FG004|COMPLETED|Phase 1 Dose Level 3||0
2838519|NCT01116648|3540846|FG005|COMPLETED|Phase 1 Dose Level 3||0
2838520|NCT01116648|3540847|FG006|COMPLETED|Phase 1 Dose Level 3||0
2838521|NCT01116648|3540848|FG007|COMPLETED|Phase 1 Dose Level 3||0
2838522|NCT01116648|3540849|FG008|COMPLETED|Phase 1 Dose Level 3||0
2838523|NCT01116648|3540850|FG009|COMPLETED|Phase 1 Dose Level 3||0
2838524|NCT01116648|3540851|FG010|COMPLETED|Phase 1 Dose Level 3||0
2838525|NCT01116648|3540852|FG011|COMPLETED|Phase 1 Dose Level 3||0
2838526|NCT01116648|3540853|FG012|COMPLETED|Phase 1 Dose Level 3||0
2838527|NCT01116648|3540854|FG013|COMPLETED|Phase 1 Dose Level 3||0
2838528|NCT01116648|3540855|FG014|COMPLETED|Phase 1 Dose Level 3||0
2838529|NCT01116648|3540841|FG000|NOT COMPLETED|Phase 1 Dose Level 3||0
2838530|NCT01116648|3540842|FG001|NOT COMPLETED|Phase 1 Dose Level 3||0
2838531|NCT01116648|3540843|FG002|NOT COMPLETED|Phase 1 Dose Level 3||0
2838532|NCT01116648|3540844|FG003|NOT COMPLETED|Phase 1 Dose Level 3||2
2838533|NCT01116648|3540845|FG004|NOT COMPLETED|Phase 1 Dose Level 3||0
2838534|NCT01116648|3540846|FG005|NOT COMPLETED|Phase 1 Dose Level 3||0
2838535|NCT01116648|3540847|FG006|NOT COMPLETED|Phase 1 Dose Level 3||0
2838536|NCT01116648|3540848|FG007|NOT COMPLETED|Phase 1 Dose Level 3||0
2838537|NCT01116648|3540849|FG008|NOT COMPLETED|Phase 1 Dose Level 3||0
2838538|NCT01116648|3540850|FG009|NOT COMPLETED|Phase 1 Dose Level 3||0
2838539|NCT01116648|3540851|FG010|NOT COMPLETED|Phase 1 Dose Level 3||0
2838540|NCT01116648|3540852|FG011|NOT COMPLETED|Phase 1 Dose Level 3||0
2838541|NCT01116648|3540853|FG012|NOT COMPLETED|Phase 1 Dose Level 3||0
2838542|NCT01116648|3540854|FG013|NOT COMPLETED|Phase 1 Dose Level 3||0
2838543|NCT01116648|3540855|FG014|NOT COMPLETED|Phase 1 Dose Level 3||0
2838544|NCT01116648|3540841|FG000|STARTED|Expansion at Maximum Tolerated Dose||0
2838545|NCT01116648|3540842|FG001|STARTED|Expansion at Maximum Tolerated Dose||0
2838546|NCT01116648|3540843|FG002|STARTED|Expansion at Maximum Tolerated Dose||0
2838547|NCT01116648|3540844|FG003|STARTED|Expansion at Maximum Tolerated Dose||0
2838548|NCT01116648|3540845|FG004|STARTED|Expansion at Maximum Tolerated Dose||9
2838549|NCT01116648|3540846|FG005|STARTED|Expansion at Maximum Tolerated Dose||0
2838550|NCT01116648|3540847|FG006|STARTED|Expansion at Maximum Tolerated Dose||0
2838551|NCT01116648|3540848|FG007|STARTED|Expansion at Maximum Tolerated Dose||0
2838552|NCT01116648|3540849|FG008|STARTED|Expansion at Maximum Tolerated Dose||0
2838553|NCT01116648|3540850|FG009|STARTED|Expansion at Maximum Tolerated Dose||0
2838554|NCT01116648|3540851|FG010|STARTED|Expansion at Maximum Tolerated Dose||0
2838555|NCT01116648|3540852|FG011|STARTED|Expansion at Maximum Tolerated Dose||0
2838556|NCT01116648|3540853|FG012|STARTED|Expansion at Maximum Tolerated Dose||0
2838557|NCT01116648|3540854|FG013|STARTED|Expansion at Maximum Tolerated Dose||0
2838558|NCT01116648|3540855|FG014|STARTED|Expansion at Maximum Tolerated Dose||0
2838559|NCT01116648|3540841|FG000|COMPLETED|Expansion at Maximum Tolerated Dose||0
2838560|NCT01116648|3540842|FG001|COMPLETED|Expansion at Maximum Tolerated Dose||0
2838561|NCT01116648|3540843|FG002|COMPLETED|Expansion at Maximum Tolerated Dose||0
2838562|NCT01116648|3540844|FG003|COMPLETED|Expansion at Maximum Tolerated Dose||0
2838563|NCT01116648|3540845|FG004|COMPLETED|Expansion at Maximum Tolerated Dose||9
2838564|NCT01116648|3540846|FG005|COMPLETED|Expansion at Maximum Tolerated Dose||0
2838565|NCT01116648|3540847|FG006|COMPLETED|Expansion at Maximum Tolerated Dose||0
2838566|NCT01116648|3540848|FG007|COMPLETED|Expansion at Maximum Tolerated Dose||0
2838567|NCT01116648|3540849|FG008|COMPLETED|Expansion at Maximum Tolerated Dose||0
2838568|NCT01116648|3540850|FG009|COMPLETED|Expansion at Maximum Tolerated Dose||0
2838569|NCT01116648|3540851|FG010|COMPLETED|Expansion at Maximum Tolerated Dose||0
2838570|NCT01116648|3540852|FG011|COMPLETED|Expansion at Maximum Tolerated Dose||0
3167396|NCT01910129|3894658|FG002|STARTED|Run-in Period Phase 1||13
3167397|NCT01910129|3894656|FG000|COMPLETED|Run-in Period Phase 1||0
3167398|NCT01910129|3894657|FG001|COMPLETED|Run-in Period Phase 1||0
3167399|NCT01910129|3894658|FG002|COMPLETED|Run-in Period Phase 1||13
3167400|NCT01910129|3894656|FG000|NOT COMPLETED|Run-in Period Phase 1||0
2838571|NCT01116648|3540853|FG012|COMPLETED|Expansion at Maximum Tolerated Dose||0
2838572|NCT01116648|3540854|FG013|COMPLETED|Expansion at Maximum Tolerated Dose||0
2838573|NCT01116648|3540855|FG014|COMPLETED|Expansion at Maximum Tolerated Dose||0
2838574|NCT01116648|3540841|FG000|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
2838575|NCT01116648|3540842|FG001|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
2838576|NCT01116648|3540843|FG002|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
2838577|NCT01116648|3540844|FG003|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
2838578|NCT01116648|3540845|FG004|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
2838579|NCT01116648|3540846|FG005|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
2838580|NCT01116648|3540847|FG006|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
2838581|NCT01116648|3540848|FG007|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
2838582|NCT01116648|3540849|FG008|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
2838583|NCT01116648|3540850|FG009|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
2838584|NCT01116648|3540851|FG010|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
2838585|NCT01116648|3540852|FG011|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
2838586|NCT01116648|3540853|FG012|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
2838587|NCT01116648|3540854|FG013|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
2838588|NCT01116648|3540855|FG014|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
2838589|NCT01116648|3540841|FG000|STARTED|Phase 2||0
2838590|NCT01116648|3540842|FG001|STARTED|Phase 2||0
2838591|NCT01116648|3540843|FG002|STARTED|Phase 2||0
2838592|NCT01116648|3540844|FG003|STARTED|Phase 2||0
2838593|NCT01116648|3540845|FG004|STARTED|Phase 2||0
2838594|NCT01116648|3540846|FG005|STARTED|Phase 2||46
2838595|NCT01116648|3540847|FG006|STARTED|Phase 2||44
2838596|NCT01116648|3540848|FG007|STARTED|Phase 2||0
2838597|NCT01116648|3540849|FG008|STARTED|Phase 2||0
2838598|NCT01116648|3540850|FG009|STARTED|Phase 2||0
2838599|NCT01116648|3540851|FG010|STARTED|Phase 2||0
2838600|NCT01116648|3540852|FG011|STARTED|Phase 2||0
2838601|NCT01116648|3540853|FG012|STARTED|Phase 2||0
2838602|NCT01116648|3540854|FG013|STARTED|Phase 2||0
2838603|NCT01116648|3540855|FG014|STARTED|Phase 2||0
2838604|NCT01116648|3540841|FG000|COMPLETED|Phase 2||0
2838605|NCT01116648|3540842|FG001|COMPLETED|Phase 2||0
2838606|NCT01116648|3540843|FG002|COMPLETED|Phase 2||0
2838607|NCT01116648|3540844|FG003|COMPLETED|Phase 2||0
2838608|NCT01116648|3540845|FG004|COMPLETED|Phase 2||0
2838609|NCT01116648|3540846|FG005|COMPLETED|Phase 2||46
2838610|NCT01116648|3540847|FG006|COMPLETED|Phase 2||44
2838611|NCT01116648|3540848|FG007|COMPLETED|Phase 2||0
2838612|NCT01116648|3540849|FG008|COMPLETED|Phase 2||0
2838613|NCT01116648|3540850|FG009|COMPLETED|Phase 2||0
2838614|NCT01116648|3540851|FG010|COMPLETED|Phase 2||0
2838615|NCT01116648|3540852|FG011|COMPLETED|Phase 2||0
2838616|NCT01116648|3540853|FG012|COMPLETED|Phase 2||0
2838617|NCT01116648|3540854|FG013|COMPLETED|Phase 2||0
2838618|NCT01116648|3540855|FG014|COMPLETED|Phase 2||0
2838619|NCT01116648|3540841|FG000|NOT COMPLETED|Phase 2||0
2838620|NCT01116648|3540842|FG001|NOT COMPLETED|Phase 2||0
2838621|NCT01116648|3540843|FG002|NOT COMPLETED|Phase 2||0
2838622|NCT01116648|3540844|FG003|NOT COMPLETED|Phase 2||0
2838623|NCT01116648|3540845|FG004|NOT COMPLETED|Phase 2||0
2838624|NCT01116648|3540846|FG005|NOT COMPLETED|Phase 2||0
2838625|NCT01116648|3540847|FG006|NOT COMPLETED|Phase 2||0
2838626|NCT01116648|3540848|FG007|NOT COMPLETED|Phase 2||0
2838627|NCT01116648|3540849|FG008|NOT COMPLETED|Phase 2||0
2838628|NCT01116648|3540850|FG009|NOT COMPLETED|Phase 2||0
2838629|NCT01116648|3540851|FG010|NOT COMPLETED|Phase 2||0
2838630|NCT01116648|3540852|FG011|NOT COMPLETED|Phase 2||0
2838631|NCT01116648|3540853|FG012|NOT COMPLETED|Phase 2||0
2838632|NCT01116648|3540854|FG013|NOT COMPLETED|Phase 2||0
2838633|NCT01116648|3540855|FG014|NOT COMPLETED|Phase 2||0
2838634|NCT01116648|3540841|FG000|STARTED|Phase 1-T Dose Level 0-TA||0
2838635|NCT01116648|3540842|FG001|STARTED|Phase 1-T Dose Level 0-TA||0
2838636|NCT01116648|3540843|FG002|STARTED|Phase 1-T Dose Level 0-TA||0
2838637|NCT01116648|3540844|FG003|STARTED|Phase 1-T Dose Level 0-TA||0
2838638|NCT01116648|3540845|FG004|STARTED|Phase 1-T Dose Level 0-TA||0
2838639|NCT01116648|3540846|FG005|STARTED|Phase 1-T Dose Level 0-TA||0
2838640|NCT01116648|3540847|FG006|STARTED|Phase 1-T Dose Level 0-TA||0
2838641|NCT01116648|3540848|FG007|STARTED|Phase 1-T Dose Level 0-TA||3
2838642|NCT01116648|3540849|FG008|STARTED|Phase 1-T Dose Level 0-TA||0
2838643|NCT01116648|3540850|FG009|STARTED|Phase 1-T Dose Level 0-TA||0
2838644|NCT01116648|3540851|FG010|STARTED|Phase 1-T Dose Level 0-TA||0
2838645|NCT01116648|3540852|FG011|STARTED|Phase 1-T Dose Level 0-TA||0
2838646|NCT01116648|3540853|FG012|STARTED|Phase 1-T Dose Level 0-TA||0
2838647|NCT01116648|3540854|FG013|STARTED|Phase 1-T Dose Level 0-TA||0
2838648|NCT01116648|3540855|FG014|STARTED|Phase 1-T Dose Level 0-TA||0
2838649|NCT01116648|3540841|FG000|COMPLETED|Phase 1-T Dose Level 0-TA||0
2838650|NCT01116648|3540842|FG001|COMPLETED|Phase 1-T Dose Level 0-TA||0
2838651|NCT01116648|3540843|FG002|COMPLETED|Phase 1-T Dose Level 0-TA||0
2838652|NCT01116648|3540844|FG003|COMPLETED|Phase 1-T Dose Level 0-TA||0
2838653|NCT01116648|3540845|FG004|COMPLETED|Phase 1-T Dose Level 0-TA||0
2838654|NCT01116648|3540846|FG005|COMPLETED|Phase 1-T Dose Level 0-TA||0
2838655|NCT01116648|3540847|FG006|COMPLETED|Phase 1-T Dose Level 0-TA||0
2838656|NCT01116648|3540848|FG007|COMPLETED|Phase 1-T Dose Level 0-TA||3
2838657|NCT01116648|3540849|FG008|COMPLETED|Phase 1-T Dose Level 0-TA||0
2838658|NCT01116648|3540850|FG009|COMPLETED|Phase 1-T Dose Level 0-TA||0
2838659|NCT01116648|3540851|FG010|COMPLETED|Phase 1-T Dose Level 0-TA||0
2838660|NCT01116648|3540852|FG011|COMPLETED|Phase 1-T Dose Level 0-TA||0
2838661|NCT01116648|3540853|FG012|COMPLETED|Phase 1-T Dose Level 0-TA||0
2838662|NCT01116648|3540854|FG013|COMPLETED|Phase 1-T Dose Level 0-TA||0
2838663|NCT01116648|3540855|FG014|COMPLETED|Phase 1-T Dose Level 0-TA||0
2838664|NCT01116648|3540841|FG000|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
2838665|NCT01116648|3540842|FG001|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
2838666|NCT01116648|3540843|FG002|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
2838667|NCT01116648|3540844|FG003|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
2838668|NCT01116648|3540845|FG004|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
2838669|NCT01116648|3540846|FG005|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
2838670|NCT01116648|3540847|FG006|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
2838671|NCT01116648|3540848|FG007|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
2838672|NCT01116648|3540849|FG008|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
2838673|NCT01116648|3540850|FG009|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
2838674|NCT01116648|3540851|FG010|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
2838675|NCT01116648|3540852|FG011|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
2838676|NCT01116648|3540853|FG012|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
2838677|NCT01116648|3540854|FG013|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
2838678|NCT01116648|3540855|FG014|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
2838679|NCT01116648|3540841|FG000|STARTED|Phase 1-T Dose Level 1-TA||0
2838680|NCT01116648|3540842|FG001|STARTED|Phase 1-T Dose Level 1-TA||0
2838681|NCT01116648|3540843|FG002|STARTED|Phase 1-T Dose Level 1-TA||0
2838682|NCT01116648|3540844|FG003|STARTED|Phase 1-T Dose Level 1-TA||0
2838683|NCT01116648|3540845|FG004|STARTED|Phase 1-T Dose Level 1-TA||0
2838684|NCT01116648|3540846|FG005|STARTED|Phase 1-T Dose Level 1-TA||0
2838685|NCT01116648|3540847|FG006|STARTED|Phase 1-T Dose Level 1-TA||0
2838686|NCT01116648|3540848|FG007|STARTED|Phase 1-T Dose Level 1-TA||0
2838687|NCT01116648|3540849|FG008|STARTED|Phase 1-T Dose Level 1-TA||6
2838688|NCT01116648|3540850|FG009|STARTED|Phase 1-T Dose Level 1-TA||0
2838689|NCT01116648|3540851|FG010|STARTED|Phase 1-T Dose Level 1-TA||0
2838690|NCT01116648|3540852|FG011|STARTED|Phase 1-T Dose Level 1-TA||0
2838691|NCT01116648|3540853|FG012|STARTED|Phase 1-T Dose Level 1-TA||0
2838692|NCT01116648|3540854|FG013|STARTED|Phase 1-T Dose Level 1-TA||0
3167401|NCT01910129|3894657|FG001|NOT COMPLETED|Run-in Period Phase 1||0
3167402|NCT01910129|3894658|FG002|NOT COMPLETED|Run-in Period Phase 1||0
2838693|NCT01116648|3540855|FG014|STARTED|Phase 1-T Dose Level 1-TA||0
2838694|NCT01116648|3540841|FG000|COMPLETED|Phase 1-T Dose Level 1-TA||0
2838695|NCT01116648|3540842|FG001|COMPLETED|Phase 1-T Dose Level 1-TA||0
2838696|NCT01116648|3540843|FG002|COMPLETED|Phase 1-T Dose Level 1-TA||0
2838697|NCT01116648|3540844|FG003|COMPLETED|Phase 1-T Dose Level 1-TA||0
2838698|NCT01116648|3540845|FG004|COMPLETED|Phase 1-T Dose Level 1-TA||0
2838699|NCT01116648|3540846|FG005|COMPLETED|Phase 1-T Dose Level 1-TA||0
2838700|NCT01116648|3540847|FG006|COMPLETED|Phase 1-T Dose Level 1-TA||0
2838701|NCT01116648|3540848|FG007|COMPLETED|Phase 1-T Dose Level 1-TA||0
2838702|NCT01116648|3540849|FG008|COMPLETED|Phase 1-T Dose Level 1-TA||6
2838703|NCT01116648|3540850|FG009|COMPLETED|Phase 1-T Dose Level 1-TA||0
2838704|NCT01116648|3540851|FG010|COMPLETED|Phase 1-T Dose Level 1-TA||0
2838705|NCT01116648|3540852|FG011|COMPLETED|Phase 1-T Dose Level 1-TA||0
2838706|NCT01116648|3540853|FG012|COMPLETED|Phase 1-T Dose Level 1-TA||0
2838707|NCT01116648|3540854|FG013|COMPLETED|Phase 1-T Dose Level 1-TA||0
2838708|NCT01116648|3540855|FG014|COMPLETED|Phase 1-T Dose Level 1-TA||0
2838709|NCT01116648|3540841|FG000|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
2838710|NCT01116648|3540842|FG001|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
2838711|NCT01116648|3540843|FG002|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
2838712|NCT01116648|3540844|FG003|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
2838713|NCT01116648|3540845|FG004|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
2838714|NCT01116648|3540846|FG005|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
2838715|NCT01116648|3540847|FG006|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
2838716|NCT01116648|3540848|FG007|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
2838717|NCT01116648|3540849|FG008|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
2838718|NCT01116648|3540850|FG009|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
2838719|NCT01116648|3540851|FG010|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
2838720|NCT01116648|3540852|FG011|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
2838721|NCT01116648|3540853|FG012|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
2838722|NCT01116648|3540854|FG013|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
2838723|NCT01116648|3540855|FG014|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
2838724|NCT01116648|3540841|FG000|STARTED|Phase 1-T Dose Level 2-TA||0
2838725|NCT01116648|3540842|FG001|STARTED|Phase 1-T Dose Level 2-TA||0
2838726|NCT01116648|3540843|FG002|STARTED|Phase 1-T Dose Level 2-TA||0
2838727|NCT01116648|3540844|FG003|STARTED|Phase 1-T Dose Level 2-TA||0
2838728|NCT01116648|3540845|FG004|STARTED|Phase 1-T Dose Level 2-TA||0
2838729|NCT01116648|3540846|FG005|STARTED|Phase 1-T Dose Level 2-TA||0
2838730|NCT01116648|3540847|FG006|STARTED|Phase 1-T Dose Level 2-TA||0
2838731|NCT01116648|3540848|FG007|STARTED|Phase 1-T Dose Level 2-TA||0
2838732|NCT01116648|3540849|FG008|STARTED|Phase 1-T Dose Level 2-TA||0
2838733|NCT01116648|3540850|FG009|STARTED|Phase 1-T Dose Level 2-TA||3
2838734|NCT01116648|3540851|FG010|STARTED|Phase 1-T Dose Level 2-TA||0
2838735|NCT01116648|3540852|FG011|STARTED|Phase 1-T Dose Level 2-TA||0
2838736|NCT01116648|3540853|FG012|STARTED|Phase 1-T Dose Level 2-TA||0
2838737|NCT01116648|3540854|FG013|STARTED|Phase 1-T Dose Level 2-TA||0
2838738|NCT01116648|3540855|FG014|STARTED|Phase 1-T Dose Level 2-TA||0
2838739|NCT01116648|3540841|FG000|COMPLETED|Phase 1-T Dose Level 2-TA||0
2838740|NCT01116648|3540842|FG001|COMPLETED|Phase 1-T Dose Level 2-TA||0
2838741|NCT01116648|3540843|FG002|COMPLETED|Phase 1-T Dose Level 2-TA||0
2838742|NCT01116648|3540844|FG003|COMPLETED|Phase 1-T Dose Level 2-TA||0
2838743|NCT01116648|3540845|FG004|COMPLETED|Phase 1-T Dose Level 2-TA||0
2838744|NCT01116648|3540846|FG005|COMPLETED|Phase 1-T Dose Level 2-TA||0
2838745|NCT01116648|3540847|FG006|COMPLETED|Phase 1-T Dose Level 2-TA||0
2838746|NCT01116648|3540848|FG007|COMPLETED|Phase 1-T Dose Level 2-TA||0
2838747|NCT01116648|3540849|FG008|COMPLETED|Phase 1-T Dose Level 2-TA||0
2838748|NCT01116648|3540850|FG009|COMPLETED|Phase 1-T Dose Level 2-TA||3
2838749|NCT01116648|3540851|FG010|COMPLETED|Phase 1-T Dose Level 2-TA||0
2838750|NCT01116648|3540852|FG011|COMPLETED|Phase 1-T Dose Level 2-TA||0
2838751|NCT01116648|3540853|FG012|COMPLETED|Phase 1-T Dose Level 2-TA||0
2838752|NCT01116648|3540854|FG013|COMPLETED|Phase 1-T Dose Level 2-TA||0
2838753|NCT01116648|3540855|FG014|COMPLETED|Phase 1-T Dose Level 2-TA||0
2838754|NCT01116648|3540841|FG000|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
2838755|NCT01116648|3540842|FG001|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
2838756|NCT01116648|3540843|FG002|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
2838757|NCT01116648|3540844|FG003|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
2838758|NCT01116648|3540845|FG004|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
2838759|NCT01116648|3540846|FG005|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
2838760|NCT01116648|3540847|FG006|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
2838761|NCT01116648|3540848|FG007|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
2838762|NCT01116648|3540849|FG008|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
2838763|NCT01116648|3540850|FG009|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
2838764|NCT01116648|3540851|FG010|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
2838765|NCT01116648|3540852|FG011|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
2838766|NCT01116648|3540853|FG012|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
2838767|NCT01116648|3540854|FG013|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
2838768|NCT01116648|3540855|FG014|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
2838769|NCT01116648|3540841|FG000|STARTED|Phase 1-T Dose Level 0-TB||0
2838770|NCT01116648|3540842|FG001|STARTED|Phase 1-T Dose Level 0-TB||0
2838771|NCT01116648|3540843|FG002|STARTED|Phase 1-T Dose Level 0-TB||0
2838772|NCT01116648|3540844|FG003|STARTED|Phase 1-T Dose Level 0-TB||0
2838773|NCT01116648|3540845|FG004|STARTED|Phase 1-T Dose Level 0-TB||0
2838774|NCT01116648|3540846|FG005|STARTED|Phase 1-T Dose Level 0-TB||0
2838775|NCT01116648|3540847|FG006|STARTED|Phase 1-T Dose Level 0-TB||0
2838776|NCT01116648|3540848|FG007|STARTED|Phase 1-T Dose Level 0-TB||0
2838777|NCT01116648|3540849|FG008|STARTED|Phase 1-T Dose Level 0-TB||0
2838778|NCT01116648|3540850|FG009|STARTED|Phase 1-T Dose Level 0-TB||0
2838779|NCT01116648|3540851|FG010|STARTED|Phase 1-T Dose Level 0-TB||3
2838780|NCT01116648|3540852|FG011|STARTED|Phase 1-T Dose Level 0-TB||0
2838781|NCT01116648|3540853|FG012|STARTED|Phase 1-T Dose Level 0-TB||0
2838782|NCT01116648|3540854|FG013|STARTED|Phase 1-T Dose Level 0-TB||0
2838783|NCT01116648|3540855|FG014|STARTED|Phase 1-T Dose Level 0-TB||0
2838784|NCT01116648|3540841|FG000|COMPLETED|Phase 1-T Dose Level 0-TB||0
2838785|NCT01116648|3540842|FG001|COMPLETED|Phase 1-T Dose Level 0-TB||0
2838786|NCT01116648|3540843|FG002|COMPLETED|Phase 1-T Dose Level 0-TB||0
2838787|NCT01116648|3540844|FG003|COMPLETED|Phase 1-T Dose Level 0-TB||0
2838788|NCT01116648|3540845|FG004|COMPLETED|Phase 1-T Dose Level 0-TB||0
2838789|NCT01116648|3540846|FG005|COMPLETED|Phase 1-T Dose Level 0-TB||0
2838790|NCT01116648|3540847|FG006|COMPLETED|Phase 1-T Dose Level 0-TB||0
2838791|NCT01116648|3540848|FG007|COMPLETED|Phase 1-T Dose Level 0-TB||0
2838792|NCT01116648|3540849|FG008|COMPLETED|Phase 1-T Dose Level 0-TB||0
2838793|NCT01116648|3540850|FG009|COMPLETED|Phase 1-T Dose Level 0-TB||0
2838794|NCT01116648|3540851|FG010|COMPLETED|Phase 1-T Dose Level 0-TB||3
2838795|NCT01116648|3540852|FG011|COMPLETED|Phase 1-T Dose Level 0-TB||0
2838796|NCT01116648|3540853|FG012|COMPLETED|Phase 1-T Dose Level 0-TB||0
2838797|NCT01116648|3540854|FG013|COMPLETED|Phase 1-T Dose Level 0-TB||0
2838798|NCT01116648|3540855|FG014|COMPLETED|Phase 1-T Dose Level 0-TB||0
2838799|NCT01116648|3540841|FG000|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
2838800|NCT01116648|3540842|FG001|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
2838801|NCT01116648|3540843|FG002|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
2838802|NCT01116648|3540844|FG003|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
2838803|NCT01116648|3540845|FG004|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
2838804|NCT01116648|3540846|FG005|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
2838805|NCT01116648|3540847|FG006|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
2838806|NCT01116648|3540848|FG007|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
2838807|NCT01116648|3540849|FG008|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
2838808|NCT01116648|3540850|FG009|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
2838809|NCT01116648|3540851|FG010|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
2838810|NCT01116648|3540852|FG011|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
2838811|NCT01116648|3540853|FG012|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
2838812|NCT01116648|3540854|FG013|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
2838813|NCT01116648|3540855|FG014|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
2838814|NCT01116648|3540841|FG000|STARTED|Phase 1-T Dose Level 1-TB||0
2838815|NCT01116648|3540842|FG001|STARTED|Phase 1-T Dose Level 1-TB||0
2838816|NCT01116648|3540843|FG002|STARTED|Phase 1-T Dose Level 1-TB||0
2838817|NCT01116648|3540844|FG003|STARTED|Phase 1-T Dose Level 1-TB||0
2838818|NCT01116648|3540845|FG004|STARTED|Phase 1-T Dose Level 1-TB||0
2838819|NCT01116648|3540846|FG005|STARTED|Phase 1-T Dose Level 1-TB||0
2838820|NCT01116648|3540847|FG006|STARTED|Phase 1-T Dose Level 1-TB||0
2838821|NCT01116648|3540848|FG007|STARTED|Phase 1-T Dose Level 1-TB||0
2838822|NCT01116648|3540849|FG008|STARTED|Phase 1-T Dose Level 1-TB||0
2838823|NCT01116648|3540850|FG009|STARTED|Phase 1-T Dose Level 1-TB||0
2838824|NCT01116648|3540851|FG010|STARTED|Phase 1-T Dose Level 1-TB||0
2838825|NCT01116648|3540852|FG011|STARTED|Phase 1-T Dose Level 1-TB||3
2838826|NCT01116648|3540853|FG012|STARTED|Phase 1-T Dose Level 1-TB||0
2838827|NCT01116648|3540854|FG013|STARTED|Phase 1-T Dose Level 1-TB||0
2838828|NCT01116648|3540855|FG014|STARTED|Phase 1-T Dose Level 1-TB||0
2838829|NCT01116648|3540841|FG000|COMPLETED|Phase 1-T Dose Level 1-TB||0
2838830|NCT01116648|3540842|FG001|COMPLETED|Phase 1-T Dose Level 1-TB||0
2838831|NCT01116648|3540843|FG002|COMPLETED|Phase 1-T Dose Level 1-TB||0
2838832|NCT01116648|3540844|FG003|COMPLETED|Phase 1-T Dose Level 1-TB||0
2838833|NCT01116648|3540845|FG004|COMPLETED|Phase 1-T Dose Level 1-TB||0
2838834|NCT01116648|3540846|FG005|COMPLETED|Phase 1-T Dose Level 1-TB||0
2838835|NCT01116648|3540847|FG006|COMPLETED|Phase 1-T Dose Level 1-TB||0
2838836|NCT01116648|3540848|FG007|COMPLETED|Phase 1-T Dose Level 1-TB||0
2838837|NCT01116648|3540849|FG008|COMPLETED|Phase 1-T Dose Level 1-TB||0
2838838|NCT01116648|3540850|FG009|COMPLETED|Phase 1-T Dose Level 1-TB||0
2838839|NCT01116648|3540851|FG010|COMPLETED|Phase 1-T Dose Level 1-TB||0
2838840|NCT01116648|3540852|FG011|COMPLETED|Phase 1-T Dose Level 1-TB||3
2838841|NCT01116648|3540853|FG012|COMPLETED|Phase 1-T Dose Level 1-TB||0
2838842|NCT01116648|3540854|FG013|COMPLETED|Phase 1-T Dose Level 1-TB||0
2838843|NCT01116648|3540855|FG014|COMPLETED|Phase 1-T Dose Level 1-TB||0
2838844|NCT01116648|3540841|FG000|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
2838845|NCT01116648|3540842|FG001|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
2838846|NCT01116648|3540843|FG002|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
2838847|NCT01116648|3540844|FG003|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
2838848|NCT01116648|3540845|FG004|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
2838849|NCT01116648|3540846|FG005|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
2838850|NCT01116648|3540847|FG006|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
2838851|NCT01116648|3540848|FG007|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
2838852|NCT01116648|3540849|FG008|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
2838853|NCT01116648|3540850|FG009|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
2838854|NCT01116648|3540851|FG010|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
2838855|NCT01116648|3540852|FG011|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
2838856|NCT01116648|3540853|FG012|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
2838857|NCT01116648|3540854|FG013|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
2838858|NCT01116648|3540855|FG014|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
2838859|NCT01116648|3540841|FG000|STARTED|Phase 1-T Dose Level 2-TB||0
2838860|NCT01116648|3540842|FG001|STARTED|Phase 1-T Dose Level 2-TB||0
2838861|NCT01116648|3540843|FG002|STARTED|Phase 1-T Dose Level 2-TB||0
2838862|NCT01116648|3540844|FG003|STARTED|Phase 1-T Dose Level 2-TB||0
2838863|NCT01116648|3540845|FG004|STARTED|Phase 1-T Dose Level 2-TB||0
2838864|NCT01116648|3540846|FG005|STARTED|Phase 1-T Dose Level 2-TB||0
2838865|NCT01116648|3540847|FG006|STARTED|Phase 1-T Dose Level 2-TB||0
2838866|NCT01116648|3540848|FG007|STARTED|Phase 1-T Dose Level 2-TB||0
2838867|NCT01116648|3540849|FG008|STARTED|Phase 1-T Dose Level 2-TB||0
2838868|NCT01116648|3540850|FG009|STARTED|Phase 1-T Dose Level 2-TB||0
2838869|NCT01116648|3540851|FG010|STARTED|Phase 1-T Dose Level 2-TB||0
2838870|NCT01116648|3540852|FG011|STARTED|Phase 1-T Dose Level 2-TB||0
2838871|NCT01116648|3540853|FG012|STARTED|Phase 1-T Dose Level 2-TB||6
2838872|NCT01116648|3540854|FG013|STARTED|Phase 1-T Dose Level 2-TB||0
2838873|NCT01116648|3540855|FG014|STARTED|Phase 1-T Dose Level 2-TB||0
2838874|NCT01116648|3540841|FG000|COMPLETED|Phase 1-T Dose Level 2-TB||0
2838875|NCT01116648|3540842|FG001|COMPLETED|Phase 1-T Dose Level 2-TB||0
2838876|NCT01116648|3540843|FG002|COMPLETED|Phase 1-T Dose Level 2-TB||0
2838877|NCT01116648|3540844|FG003|COMPLETED|Phase 1-T Dose Level 2-TB||0
2838878|NCT01116648|3540845|FG004|COMPLETED|Phase 1-T Dose Level 2-TB||0
2838879|NCT01116648|3540846|FG005|COMPLETED|Phase 1-T Dose Level 2-TB||0
2838880|NCT01116648|3540847|FG006|COMPLETED|Phase 1-T Dose Level 2-TB||0
2838881|NCT01116648|3540848|FG007|COMPLETED|Phase 1-T Dose Level 2-TB||0
2838882|NCT01116648|3540849|FG008|COMPLETED|Phase 1-T Dose Level 2-TB||0
2838883|NCT01116648|3540850|FG009|COMPLETED|Phase 1-T Dose Level 2-TB||0
2838884|NCT01116648|3540851|FG010|COMPLETED|Phase 1-T Dose Level 2-TB||0
2838885|NCT01116648|3540852|FG011|COMPLETED|Phase 1-T Dose Level 2-TB||0
2838886|NCT01116648|3540853|FG012|COMPLETED|Phase 1-T Dose Level 2-TB||6
2838887|NCT01116648|3540854|FG013|COMPLETED|Phase 1-T Dose Level 2-TB||0
2838888|NCT01116648|3540855|FG014|COMPLETED|Phase 1-T Dose Level 2-TB||0
2838889|NCT01116648|3540841|FG000|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
2838890|NCT01116648|3540842|FG001|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
2838891|NCT01116648|3540843|FG002|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
2838892|NCT01116648|3540844|FG003|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
2838893|NCT01116648|3540845|FG004|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
2838894|NCT01116648|3540846|FG005|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
2838895|NCT01116648|3540847|FG006|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
2838896|NCT01116648|3540848|FG007|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
2838897|NCT01116648|3540849|FG008|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
2838898|NCT01116648|3540850|FG009|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
2838899|NCT01116648|3540851|FG010|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
2838900|NCT01116648|3540852|FG011|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
2838901|NCT01116648|3540853|FG012|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
2838902|NCT01116648|3540854|FG013|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
2838903|NCT01116648|3540855|FG014|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
2838904|NCT01116648|3540841|FG000|STARTED|Phase 1-T PKOlap Expansion||0
2838905|NCT01116648|3540842|FG001|STARTED|Phase 1-T PKOlap Expansion||0
2838906|NCT01116648|3540843|FG002|STARTED|Phase 1-T PKOlap Expansion||0
2838907|NCT01116648|3540844|FG003|STARTED|Phase 1-T PKOlap Expansion||0
2838908|NCT01116648|3540845|FG004|STARTED|Phase 1-T PKOlap Expansion||0
2838909|NCT01116648|3540846|FG005|STARTED|Phase 1-T PKOlap Expansion||0
2838910|NCT01116648|3540847|FG006|STARTED|Phase 1-T PKOlap Expansion||0
2838911|NCT01116648|3540848|FG007|STARTED|Phase 1-T PKOlap Expansion||0
2838912|NCT01116648|3540849|FG008|STARTED|Phase 1-T PKOlap Expansion||0
2838913|NCT01116648|3540850|FG009|STARTED|Phase 1-T PKOlap Expansion||0
2838914|NCT01116648|3540851|FG010|STARTED|Phase 1-T PKOlap Expansion||0
2838915|NCT01116648|3540852|FG011|STARTED|Phase 1-T PKOlap Expansion||0
2838916|NCT01116648|3540853|FG012|STARTED|Phase 1-T PKOlap Expansion||0
2838917|NCT01116648|3540854|FG013|STARTED|Phase 1-T PKOlap Expansion||6
2838918|NCT01116648|3540855|FG014|STARTED|Phase 1-T PKOlap Expansion||0
2838919|NCT01116648|3540841|FG000|COMPLETED|Phase 1-T PKOlap Expansion||0
2838920|NCT01116648|3540842|FG001|COMPLETED|Phase 1-T PKOlap Expansion||0
2838921|NCT01116648|3540843|FG002|COMPLETED|Phase 1-T PKOlap Expansion||0
2838922|NCT01116648|3540844|FG003|COMPLETED|Phase 1-T PKOlap Expansion||0
2838923|NCT01116648|3540845|FG004|COMPLETED|Phase 1-T PKOlap Expansion||0
2838924|NCT01116648|3540846|FG005|COMPLETED|Phase 1-T PKOlap Expansion||0
2838925|NCT01116648|3540847|FG006|COMPLETED|Phase 1-T PKOlap Expansion||0
2838926|NCT01116648|3540848|FG007|COMPLETED|Phase 1-T PKOlap Expansion||0
2838927|NCT01116648|3540849|FG008|COMPLETED|Phase 1-T PKOlap Expansion||0
2838928|NCT01116648|3540850|FG009|COMPLETED|Phase 1-T PKOlap Expansion||0
2838929|NCT01116648|3540851|FG010|COMPLETED|Phase 1-T PKOlap Expansion||0
2838930|NCT01116648|3540852|FG011|COMPLETED|Phase 1-T PKOlap Expansion||0
2838931|NCT01116648|3540853|FG012|COMPLETED|Phase 1-T PKOlap Expansion||0
2838932|NCT01116648|3540854|FG013|COMPLETED|Phase 1-T PKOlap Expansion||6
2838933|NCT01116648|3540855|FG014|COMPLETED|Phase 1-T PKOlap Expansion||0
2838934|NCT01116648|3540841|FG000|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
2838935|NCT01116648|3540842|FG001|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
2838936|NCT01116648|3540843|FG002|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
2838937|NCT01116648|3540844|FG003|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
2838938|NCT01116648|3540845|FG004|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
2838939|NCT01116648|3540846|FG005|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
2838940|NCT01116648|3540847|FG006|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
2838941|NCT01116648|3540848|FG007|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
2838942|NCT01116648|3540849|FG008|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
2838943|NCT01116648|3540850|FG009|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
2838944|NCT01116648|3540851|FG010|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
2838945|NCT01116648|3540852|FG011|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
2838946|NCT01116648|3540853|FG012|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
2838947|NCT01116648|3540854|FG013|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
2838948|NCT01116648|3540855|FG014|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
2838949|NCT01116648|3540841|FG000|STARTED|Phase 1-T PKCed Expansion||0
2838950|NCT01116648|3540842|FG001|STARTED|Phase 1-T PKCed Expansion||0
2838951|NCT01116648|3540843|FG002|STARTED|Phase 1-T PKCed Expansion||0
2838952|NCT01116648|3540844|FG003|STARTED|Phase 1-T PKCed Expansion||0
2838953|NCT01116648|3540845|FG004|STARTED|Phase 1-T PKCed Expansion||0
2838954|NCT01116648|3540846|FG005|STARTED|Phase 1-T PKCed Expansion||0
2838955|NCT01116648|3540847|FG006|STARTED|Phase 1-T PKCed Expansion||0
2838956|NCT01116648|3540848|FG007|STARTED|Phase 1-T PKCed Expansion||0
2838957|NCT01116648|3540849|FG008|STARTED|Phase 1-T PKCed Expansion||0
2838958|NCT01116648|3540850|FG009|STARTED|Phase 1-T PKCed Expansion||0
2838959|NCT01116648|3540851|FG010|STARTED|Phase 1-T PKCed Expansion||0
2838960|NCT01116648|3540852|FG011|STARTED|Phase 1-T PKCed Expansion||0
2838961|NCT01116648|3540853|FG012|STARTED|Phase 1-T PKCed Expansion||0
2838962|NCT01116648|3540854|FG013|STARTED|Phase 1-T PKCed Expansion||0
2838963|NCT01116648|3540855|FG014|STARTED|Phase 1-T PKCed Expansion||7
2838964|NCT01116648|3540841|FG000|COMPLETED|Phase 1-T PKCed Expansion||0
2838965|NCT01116648|3540842|FG001|COMPLETED|Phase 1-T PKCed Expansion||0
2838966|NCT01116648|3540843|FG002|COMPLETED|Phase 1-T PKCed Expansion||0
2838967|NCT01116648|3540844|FG003|COMPLETED|Phase 1-T PKCed Expansion||0
2838968|NCT01116648|3540845|FG004|COMPLETED|Phase 1-T PKCed Expansion||0
2838969|NCT01116648|3540846|FG005|COMPLETED|Phase 1-T PKCed Expansion||0
2838970|NCT01116648|3540847|FG006|COMPLETED|Phase 1-T PKCed Expansion||0
2838971|NCT01116648|3540848|FG007|COMPLETED|Phase 1-T PKCed Expansion||0
2838972|NCT01116648|3540849|FG008|COMPLETED|Phase 1-T PKCed Expansion||0
2838973|NCT01116648|3540850|FG009|COMPLETED|Phase 1-T PKCed Expansion||0
2838974|NCT01116648|3540851|FG010|COMPLETED|Phase 1-T PKCed Expansion||0
2838975|NCT01116648|3540852|FG011|COMPLETED|Phase 1-T PKCed Expansion||0
2838976|NCT01116648|3540853|FG012|COMPLETED|Phase 1-T PKCed Expansion||0
2838977|NCT01116648|3540854|FG013|COMPLETED|Phase 1-T PKCed Expansion||0
2838978|NCT01116648|3540855|FG014|COMPLETED|Phase 1-T PKCed Expansion||7
2838979|NCT01116648|3540841|FG000|NOT COMPLETED|Phase 1-T PKCed Expansion||0
2838980|NCT01116648|3540842|FG001|NOT COMPLETED|Phase 1-T PKCed Expansion||0
2838981|NCT01116648|3540843|FG002|NOT COMPLETED|Phase 1-T PKCed Expansion||0
2838982|NCT01116648|3540844|FG003|NOT COMPLETED|Phase 1-T PKCed Expansion||0
2838983|NCT01116648|3540845|FG004|NOT COMPLETED|Phase 1-T PKCed Expansion||0
2838984|NCT01116648|3540846|FG005|NOT COMPLETED|Phase 1-T PKCed Expansion||0
2838985|NCT01116648|3540847|FG006|NOT COMPLETED|Phase 1-T PKCed Expansion||0
2838986|NCT01116648|3540848|FG007|NOT COMPLETED|Phase 1-T PKCed Expansion||0
2838987|NCT01116648|3540849|FG008|NOT COMPLETED|Phase 1-T PKCed Expansion||0
2838988|NCT01116648|3540850|FG009|NOT COMPLETED|Phase 1-T PKCed Expansion||0
3167403|NCT01910129|3894656|FG000|STARTED|Randomized Phase 2||7
2838989|NCT01116648|3540851|FG010|NOT COMPLETED|Phase 1-T PKCed Expansion||0
2838990|NCT01116648|3540852|FG011|NOT COMPLETED|Phase 1-T PKCed Expansion||0
2838991|NCT01116648|3540853|FG012|NOT COMPLETED|Phase 1-T PKCed Expansion||0
2838992|NCT01116648|3540854|FG013|NOT COMPLETED|Phase 1-T PKCed Expansion||0
2838993|NCT01116648|3540855|FG014|NOT COMPLETED|Phase 1-T PKCed Expansion||0
2838994|NCT01064648|3540883|FG000|STARTED|Phase I Cohort1: Dose Level 1||7
2838995|NCT01064648|3540884|FG001|STARTED|Phase I Cohort1: Dose Level 1||0
2838996|NCT01064648|3540885|FG002|STARTED|Phase I Cohort1: Dose Level 1||0
2838997|NCT01064648|3540886|FG003|STARTED|Phase I Cohort1: Dose Level 1||0
2838998|NCT01064648|3540883|FG000|COMPLETED|Phase I Cohort1: Dose Level 1||0
2838999|NCT01064648|3540884|FG001|COMPLETED|Phase I Cohort1: Dose Level 1||0
2839000|NCT01064648|3540885|FG002|COMPLETED|Phase I Cohort1: Dose Level 1||0
3311592|NCT03053180|4045051|FG000|STARTED|Overall Study||60
3311593|NCT03053180|4045051|FG000|COMPLETED|Overall Study||59
3311594|NCT03053180|4045051|FG000|NOT COMPLETED|Overall Study||1
2839001|NCT01064648|3540886|FG003|COMPLETED|Phase I Cohort1: Dose Level 1||0
2839002|NCT01064648|3540883|FG000|NOT COMPLETED|Phase I Cohort1: Dose Level 1||7
2839003|NCT01064648|3540884|FG001|NOT COMPLETED|Phase I Cohort1: Dose Level 1||0
2839004|NCT01064648|3540885|FG002|NOT COMPLETED|Phase I Cohort1: Dose Level 1||0
2839005|NCT01064648|3540886|FG003|NOT COMPLETED|Phase I Cohort1: Dose Level 1||0
2839006|NCT01064648|3540883|FG000|STARTED|Phase I Cohort 2: Dose Level 2||0
2839007|NCT01064648|3540884|FG001|STARTED|Phase I Cohort 2: Dose Level 2||13
2839008|NCT01064648|3540885|FG002|STARTED|Phase I Cohort 2: Dose Level 2||0
2839009|NCT01064648|3540886|FG003|STARTED|Phase I Cohort 2: Dose Level 2||0
2839010|NCT01064648|3540883|FG000|COMPLETED|Phase I Cohort 2: Dose Level 2||0
2839011|NCT01064648|3540884|FG001|COMPLETED|Phase I Cohort 2: Dose Level 2||0
2839012|NCT01064648|3540885|FG002|COMPLETED|Phase I Cohort 2: Dose Level 2||0
2839013|NCT01064648|3540886|FG003|COMPLETED|Phase I Cohort 2: Dose Level 2||0
2839014|NCT01064648|3540883|FG000|NOT COMPLETED|Phase I Cohort 2: Dose Level 2||0
2839015|NCT01064648|3540884|FG001|NOT COMPLETED|Phase I Cohort 2: Dose Level 2||13
2839016|NCT01064648|3540885|FG002|NOT COMPLETED|Phase I Cohort 2: Dose Level 2||0
2839017|NCT01064648|3540886|FG003|NOT COMPLETED|Phase I Cohort 2: Dose Level 2||0
2839018|NCT01064648|3540883|FG000|STARTED|Phase II||0
2839019|NCT01064648|3540884|FG001|STARTED|Phase II||0
2839020|NCT01064648|3540885|FG002|STARTED|Phase II||49
2839021|NCT01064648|3540886|FG003|STARTED|Phase II||48
2839022|NCT01064648|3540883|FG000|COMPLETED|Phase II||0
2839023|NCT01064648|3540884|FG001|COMPLETED|Phase II||0
2839024|NCT01064648|3540885|FG002|COMPLETED|Phase II||0
2839025|NCT01064648|3540886|FG003|COMPLETED|Phase II||0
2839026|NCT01064648|3540883|FG000|NOT COMPLETED|Phase II||0
2839027|NCT01064648|3540884|FG001|NOT COMPLETED|Phase II||0
2839028|NCT01064648|3540885|FG002|NOT COMPLETED|Phase II||49
2839029|NCT01064648|3540886|FG003|NOT COMPLETED|Phase II||48
2839030|NCT01064479|3540901|FG000|STARTED|Overall Study||60
2839031|NCT01064479|3540902|FG001|STARTED|Overall Study||59
2839032|NCT01064479|3540901|FG000|COMPLETED|Overall Study||45
2839033|NCT01064479|3540902|FG001|COMPLETED|Overall Study||42
2839034|NCT01064479|3540901|FG000|NOT COMPLETED|Overall Study||15
2839035|NCT01064479|3540902|FG001|NOT COMPLETED|Overall Study||17
2839036|NCT01042522|3540910|FG000|STARTED|Overall Study||31
2839037|NCT01042522|3540911|FG001|STARTED|Overall Study||32
2839038|NCT01042522|3540910|FG000|COMPLETED|Overall Study|Completed 6 cycles of protocol regimen|23
2839039|NCT01042522|3540911|FG001|COMPLETED|Overall Study|Completed 4 cycles of protocol regimen|26
2839040|NCT01042522|3540910|FG000|NOT COMPLETED|Overall Study||8
2839041|NCT01042522|3540911|FG001|NOT COMPLETED|Overall Study||6
2839042|NCT00944528|3540920|FG000|STARTED|Overall Study||9
2839043|NCT00944528|3540921|FG001|STARTED|Overall Study||10
2839044|NCT00944528|3540922|FG002|STARTED|Overall Study||16
2839045|NCT00944528|3540920|FG000|COMPLETED|Overall Study||8
2839046|NCT00944528|3540921|FG001|COMPLETED|Overall Study||8
2839047|NCT00944528|3540922|FG002|COMPLETED|Overall Study||16
2839048|NCT00944528|3540920|FG000|NOT COMPLETED|Overall Study||1
2839049|NCT00944528|3540921|FG001|NOT COMPLETED|Overall Study||2
2839050|NCT00944528|3540922|FG002|NOT COMPLETED|Overall Study||0
2839051|NCT00941915|3540931|FG000|STARTED|Overall Study||60
2839052|NCT00941915|3540931|FG000|COMPLETED|Overall Study||60
2839053|NCT00941915|3540931|FG000|NOT COMPLETED|Overall Study||0
2839054|NCT00826462|3540938|FG000|STARTED|Overall Study||59
2839055|NCT00826462|3540939|FG001|STARTED|Overall Study||58
2839056|NCT00826462|3540940|FG002|STARTED|Overall Study||60
2839057|NCT00826462|3540938|FG000|COMPLETED|Overall Study||52
2839058|NCT00826462|3540939|FG001|COMPLETED|Overall Study||53
2839059|NCT00826462|3540940|FG002|COMPLETED|Overall Study||52
2839060|NCT00826462|3540938|FG000|NOT COMPLETED|Overall Study||7
2839061|NCT00826462|3540939|FG001|NOT COMPLETED|Overall Study||5
2839062|NCT00826462|3540940|FG002|NOT COMPLETED|Overall Study||8
2839063|NCT00710970|3540950|FG000|STARTED|Overall Study||28
2839064|NCT00710970|3540950|FG000|COMPLETED|Overall Study||25
2839065|NCT00710970|3540950|FG000|NOT COMPLETED|Overall Study||3
2839066|NCT00685919|3540958|FG000|STARTED|Overall Study|8 healthy controls were randomized to receive placebo followed by carbidopa. 1 received only 50 mg doses of carbidopa and her data were excluded.|8
2839067|NCT00685919|3540959|FG001|STARTED|Overall Study|9 healthy controls were randomized to receive carbidopa followed by placebo.|9
2915508|NCT00510068|3625793|FG001|STARTED|Double-blind Period||203
3311595|NCT03053271|4045055|FG000|STARTED|Overall Study||4
2839068|NCT00685919|3540960|FG002|STARTED|Overall Study|8 patients with POTS were randomized to receive placebo followed by carbidopa. 1 of these received only 50 mg doses of carbidopa and her data are excluded.|8
2839069|NCT00685919|3540961|FG003|STARTED|Overall Study|3 patients with POTS were randomized to receive carbidopa followed by placebo.|3
2839070|NCT00685919|3540958|FG000|Baseline A|Overall Study|After achieving sodium balance on 200 mEq/day sodium diet, subjects collected baseline 24hr urine. They fasted from 7pm until the next morning. In the morning, while still supine, heart rate and blood pressure were recorded and blood was drawn. Participants then stood for 10 min. Heart rate and blood pressure were measured at intervals and an upright blood sample was collected. Urine was collected to end the 24hr collection.|8
2839071|NCT00685919|3540959|FG001|Baseline A|Overall Study|After achieving sodium balance on 200 mEq/day sodium diet, subjects collected baseline 24hr urine. They fasted from 7pm until the next morning. In the morning, while still supine, heart rate and blood pressure were recorded and blood was drawn. Participants then stood for 10 min. Heart rate and blood pressure were measured at intervals and an upright blood sample was collected. Urine was collected to end the 24hr collection. 1 patient withdrew after orthostatic symptoms during baseline.|9
2839072|NCT00685919|3540960|FG002|Baseline A|Overall Study|After achieving sodium balance on 200 mEq/day sodium diet, subjects collected baseline 24hr urine. They fasted from 7pm until the next morning. In the morning, while still supine, heart rate and blood pressure were recorded and blood was drawn. Participants then stood for 10 min. Heart rate and blood pressure were measured at intervals and an upright blood sample was collected. Urine was collected to end the 24hr collection. 1 patient withdrew after orthostatic symptoms during baseline.|8
2839073|NCT00685919|3540961|FG003|Baseline A|Overall Study|After achieving sodium balance on 200 mEq/day sodium diet, subjects collected baseline 24hr urine. They fasted from 7pm until the next morning. In the morning, while still supine, heart rate and blood pressure were recorded and blood was drawn. Participants then stood for 10 min. Heart rate and blood pressure were measured at intervals and an upright blood sample was collected. Urine was collected to end the 24hr collection.|3
2839074|NCT00685919|3540958|FG000|Treatment A|Overall Study|Following the urine collection to end the baseline urine and the baseline testing, placebo was given orally. Additional doses were given every 6 hours with the last dose at 7am the following morning. Urine was collected over 24hr and supine and upright heart rates, blood pressures and blood samples were collected.|7
2839075|NCT00685919|3540959|FG001|Treatment A|Overall Study|Following the urine collection to end the baseline urine and the baseline testing, carbidopa 200 mg was given orally. Additional doses were given every 6 hours with the last dose at 7am the following morning. Urine was collected over 24hr and supine and upright heart rates, blood pressures and blood samples were collected.|9
2839076|NCT00685919|3540960|FG002|Treatment A|Overall Study|Following the urine collection to end the baseline urine and the baseline testing, placebo was given orally. Additional doses were given every 6 hours with the last dose at 7am the following morning. Urine was collected over 24hr and supine and upright heart rates, blood pressures and blood samples were collected.|8
2839077|NCT00685919|3540961|FG003|Treatment A|Overall Study|Following the urine collection to end the baseline urine and the baseline testing, carbidopa 200 mg was given orally. Additional doses were given every 6 hours with the last dose at 7am the following morning. Urine was collected over 24hr and supine and upright heart rates, blood pressures and blood samples were collected.|3
2839078|NCT00685919|3540958|FG000|24 hr Post-treatment A|Overall Study|Urine was collected for 24 hr after the last dose of Treatment A.|7
2839079|NCT00685919|3540959|FG001|24 hr Post-treatment A|Overall Study|Urine was collected for 24 hr after the last dose of Treatment A.|9
2839080|NCT00685919|3540960|FG002|24 hr Post-treatment A|Overall Study|Urine was collected for 24 hr after the last dose of Treatment A.|7
2839081|NCT00685919|3540961|FG003|24 hr Post-treatment A|Overall Study|Urine was collected for 24 hr after the last dose of Treatment A.|3
2839082|NCT00685919|3540958|FG000|Baseline B|Overall Study|After at least a 1-day washout period, patients underwent baseline procedures as described previously.|7
2839083|NCT00685919|3540959|FG001|Baseline B|Overall Study|After at least a 1-day washout period, patients underwent baseline procedures as described previously.|9
2839084|NCT00685919|3540960|FG002|Baseline B|Overall Study|After at least a 1-day washout period, patients underwent baseline procedures as described previously.|7
2839085|NCT00685919|3540961|FG003|Baseline B|Overall Study|After at least a 1-day washout period, patients underwent baseline procedures as described previously.|3
2839086|NCT00685919|3540958|FG000|Treatment B|Overall Study|Following the urine collection to end the baseline urine and the baseline testing, carbidopa 200 mg was given orally. Additional doses were given every 6 hours with the last dose at 7am the following morning. Urine was collected over 24hr and supine and upright heart rates, blood pressures and blood samples were collected.|7
2839087|NCT00685919|3540959|FG001|Treatment B|Overall Study|Following the urine collection to end the baseline urine and the baseline testing, placebo was given orally. Additional doses were given every 6 hours with the last dose at 7am the following morning. Urine was collected over 24hr and supine and upright heart rates, blood pressures and blood samples were collected.|9
2839088|NCT00685919|3540960|FG002|Treatment B|Overall Study|Following the urine collection to end the baseline urine and the baseline testing, carbidopa 200 mg was given orally. Additional doses were given every 6 hours with the last dose at 7am the following morning. Urine was collected over 24hr and supine and upright heart rates, blood pressures and blood samples were collected.|7
2839089|NCT00685919|3540961|FG003|Treatment B|Overall Study|Following the urine collection to end the baseline urine and the baseline testing, placebo was given orally. Additional doses were given every 6 hours with the last dose at 7am the following morning. Urine was collected over 24hr and supine and upright heart rates, blood pressures and blood samples were collected.|3
2839090|NCT00685919|3540958|FG000|24 hr Post Treatment B|Overall Study|Urine was collected for 24 hr after last dose of Treatment B.|7
2839091|NCT00685919|3540959|FG001|24 hr Post Treatment B|Overall Study|Urine was collected for 24 hr after last dose of Treatment B.|9
2839092|NCT00685919|3540960|FG002|24 hr Post Treatment B|Overall Study|Urine was collected for 24 hr after last dose of Treatment B.|7
2915509|NCT00510068|3625792|FG000|Safety Population|Double-blind Period||204
2839093|NCT00685919|3540961|FG003|24 hr Post Treatment B|Overall Study|Urine was collected for 24 hr after last dose of Treatment B.|3
2839094|NCT00685919|3540958|FG000|COMPLETED|Overall Study||7
2839095|NCT00685919|3540959|FG001|COMPLETED|Overall Study||9
2839096|NCT00685919|3540960|FG002|COMPLETED|Overall Study||7
2839097|NCT00685919|3540961|FG003|COMPLETED|Overall Study||3
2839098|NCT00685919|3540958|FG000|NOT COMPLETED|Overall Study||1
2839099|NCT00685919|3540959|FG001|NOT COMPLETED|Overall Study||0
2839100|NCT00685919|3540960|FG002|NOT COMPLETED|Overall Study||1
2839101|NCT00685919|3540961|FG003|NOT COMPLETED|Overall Study||0
2915510|NCT00510068|3625793|FG001|Safety Population|Double-blind Period||203
2915511|NCT00510068|3625792|FG000|COMPLETED|Double-blind Period||0
2915512|NCT00510068|3625793|FG001|COMPLETED|Double-blind Period||0
2915513|NCT00510068|3625792|FG000|NOT COMPLETED|Double-blind Period||207
2915514|NCT00510068|3625793|FG001|NOT COMPLETED|Double-blind Period||203
2915515|NCT00510068|3625792|FG000|STARTED|Open-label Period|172 patients switched over from placebo & 53 who were initially randomized to Everolimus arm.|225
2915516|NCT00510068|3625793|FG001|STARTED|Open-label Period||0
2915517|NCT00510068|3625792|FG000|COMPLETED|Open-label Period||0
2915518|NCT00510068|3625793|FG001|COMPLETED|Open-label Period||0
2915519|NCT00510068|3625792|FG000|NOT COMPLETED|Open-label Period||225
2915520|NCT00510068|3625793|FG001|NOT COMPLETED|Open-label Period||0
2915521|NCT00510146|3625803|FG000|STARTED|Double-Blind Treatment||343
2915522|NCT00510146|3625804|FG001|STARTED|Double-Blind Treatment||171
2915523|NCT00510146|3625803|FG000|COMPLETED|Double-Blind Treatment||267
2915524|NCT00510146|3625804|FG001|COMPLETED|Double-Blind Treatment||122
2915525|NCT00510146|3625803|FG000|NOT COMPLETED|Double-Blind Treatment||76
2915526|NCT00510146|3625804|FG001|NOT COMPLETED|Double-Blind Treatment||49
2915527|NCT00510146|3625803|FG000|STARTED|Open-Label Treatment||267
2915528|NCT00510146|3625804|FG001|STARTED|Open-Label Treatment||122
2915529|NCT00510146|3625803|FG000|COMPLETED|Open-Label Treatment||196
2915530|NCT00510146|3625804|FG001|COMPLETED|Open-Label Treatment||96
2915531|NCT00510146|3625803|FG000|NOT COMPLETED|Open-Label Treatment||71
2915532|NCT00510146|3625804|FG001|NOT COMPLETED|Open-Label Treatment||26
2915533|NCT00510198|3625814|FG000|STARTED|Overall Study||59
2915534|NCT00510198|3625815|FG001|STARTED|Overall Study||58
2915535|NCT00510198|3625814|FG000|COMPLETED|Overall Study||54
2915536|NCT00510198|3625815|FG001|COMPLETED|Overall Study||54
2915537|NCT00510198|3625814|FG000|NOT COMPLETED|Overall Study||5
2915538|NCT00510198|3625815|FG001|NOT COMPLETED|Overall Study||4
2915539|NCT00510224|3625823|FG000|STARTED|Overall Study||13
2915540|NCT00510224|3625823|FG000|COMPLETED|Overall Study||10
2915541|NCT00510224|3625823|FG000|NOT COMPLETED|Overall Study||3
2915542|NCT00510276|3625829|FG000|STARTED|Acute Double-Blind Phase||220
2915543|NCT00510276|3625830|FG001|STARTED|Acute Double-Blind Phase||225
2915544|NCT00510276|3625829|FG000|COMPLETED|Acute Double-Blind Phase||115
2915545|NCT00510276|3625830|FG001|COMPLETED|Acute Double-Blind Phase||130
2915546|NCT00510276|3625829|FG000|NOT COMPLETED|Acute Double-Blind Phase||105
2915547|NCT00510276|3625830|FG001|NOT COMPLETED|Acute Double-Blind Phase||95
2915548|NCT00510276|3625829|FG000|STARTED|Extension Open-Label Phase|4 patients who completed acute phase did not participate in the optional atomoxetine extension phase|111
2915549|NCT00510276|3625830|FG001|STARTED|Extension Open-Label Phase|1 patient who completed acute phase did not participate in the optional atometine extension phase|129
2915550|NCT00510276|3625829|FG000|COMPLETED|Extension Open-Label Phase||78
2915551|NCT00510276|3625830|FG001|COMPLETED|Extension Open-Label Phase||81
2915552|NCT00510276|3625829|FG000|NOT COMPLETED|Extension Open-Label Phase||33
2915553|NCT00510276|3625830|FG001|NOT COMPLETED|Extension Open-Label Phase||48
2915554|NCT00510289|3625843|FG000|STARTED|Overall Study|All patients who consented|19
2915555|NCT00510289|3625843|FG000|Started Study Drug|Overall Study|3 patients progressed prior to starting study drug|16
2915556|NCT00510289|3625843|FG000|COMPLETED|Overall Study|Completed at least one cycle of study drug and had disease assessments|7
2915557|NCT00510289|3625843|FG000|NOT COMPLETED|Overall Study||12
2915558|NCT00510458|3625848|FG000|STARTED|Overall Study||74
2915559|NCT00510458|3625848|FG000|COMPLETED|Overall Study||27
2915560|NCT00510458|3625848|FG000|NOT COMPLETED|Overall Study||47
2915561|NCT00510484|3625855|FG000|STARTED|Period 1||16
2915562|NCT00510484|3625856|FG001|STARTED|Period 1||16
2915563|NCT00510484|3625855|FG000|COMPLETED|Period 1||16
2915564|NCT00510484|3625856|FG001|COMPLETED|Period 1||16
2915565|NCT00510484|3625855|FG000|NOT COMPLETED|Period 1||0
2915566|NCT00510484|3625856|FG001|NOT COMPLETED|Period 1||0
2915567|NCT00510484|3625855|FG000|STARTED|Wash-out Period||16
2915568|NCT00510484|3625856|FG001|STARTED|Wash-out Period||16
2915569|NCT00510484|3625855|FG000|COMPLETED|Wash-out Period||16
2915570|NCT00510484|3625856|FG001|COMPLETED|Wash-out Period||15
2915571|NCT00510484|3625855|FG000|NOT COMPLETED|Wash-out Period||0
2915572|NCT00510484|3625856|FG001|NOT COMPLETED|Wash-out Period||1
2915573|NCT00510484|3625855|FG000|STARTED|Period 2||16
2915574|NCT00510484|3625856|FG001|STARTED|Period 2||15
2915575|NCT00510484|3625855|FG000|COMPLETED|Period 2||16
2915576|NCT00510484|3625856|FG001|COMPLETED|Period 2||15
2915577|NCT00510484|3625855|FG000|NOT COMPLETED|Period 2||0
2915578|NCT00510484|3625856|FG001|NOT COMPLETED|Period 2||0
2915579|NCT00510497|3625862|FG000|STARTED|Overall Study||11
2915580|NCT00510497|3625862|FG000|COMPLETED|Overall Study||8
2915581|NCT00510497|3625862|FG000|NOT COMPLETED|Overall Study||3
2915582|NCT00510510|3625869|FG000|STARTED|Overall Study||92
2915583|NCT00510510|3625870|FG001|STARTED|Overall Study||98
2915584|NCT00510510|3625871|FG002|STARTED|Overall Study||91
2915585|NCT00510510|3625869|FG000|COMPLETED|Overall Study||87
2839102|NCT00344487|3540971|FG000|STARTED|Overall Study||3
2839103|NCT00344487|3540971|FG000|COMPLETED|Overall Study|One subject was withdrawn at month 9 because he was considered an immunologic failure on study.|2
2839104|NCT00344487|3540971|FG000|NOT COMPLETED|Overall Study||1
2839105|NCT00281658|3540979|FG000|STARTED|Double-blind, Randomized Phase||222
2839106|NCT00281658|3540980|FG001|STARTED|Double-blind, Randomized Phase|Of these participants, 149 entered the open-label extension phase.|222
2839107|NCT00281658|3540981|FG002|STARTED|Double-blind, Randomized Phase||0
2839108|NCT00281658|3540979|FG000|COMPLETED|Double-blind, Randomized Phase|For the purposes of this report, completed pts are pts ongoing at the time of the analysis.|85
2839109|NCT00281658|3540980|FG001|COMPLETED|Double-blind, Randomized Phase|For the purposes of this report, completed pts are pts ongoing at the time of the analysis.|168
2839110|NCT00281658|3540981|FG002|COMPLETED|Double-blind, Randomized Phase||0
2839111|NCT00281658|3540979|FG000|NOT COMPLETED|Double-blind, Randomized Phase||137
2839112|NCT00281658|3540980|FG001|NOT COMPLETED|Double-blind, Randomized Phase||54
2839113|NCT00281658|3540981|FG002|NOT COMPLETED|Double-blind, Randomized Phase||0
2839114|NCT00281658|3540979|FG000|STARTED|Open-label Monotherapy Extension Phase||0
2839115|NCT00281658|3540980|FG001|STARTED|Open-label Monotherapy Extension Phase||0
2839116|NCT00281658|3540981|FG002|STARTED|Open-label Monotherapy Extension Phase||149
2839117|NCT00281658|3540979|FG000|COMPLETED|Open-label Monotherapy Extension Phase||0
2839118|NCT00281658|3540980|FG001|COMPLETED|Open-label Monotherapy Extension Phase||0
2839119|NCT00281658|3540981|FG002|COMPLETED|Open-label Monotherapy Extension Phase|For the purposes of this report, completed pts are pts ongoing at the time of the analysis.|48
2839120|NCT00281658|3540979|FG000|NOT COMPLETED|Open-label Monotherapy Extension Phase||0
2839121|NCT00281658|3540980|FG001|NOT COMPLETED|Open-label Monotherapy Extension Phase||0
2839122|NCT00281658|3540981|FG002|NOT COMPLETED|Open-label Monotherapy Extension Phase||101
2915586|NCT00510510|3625870|FG001|COMPLETED|Overall Study||89
2915587|NCT00510510|3625871|FG002|COMPLETED|Overall Study||74
2915588|NCT00510510|3625869|FG000|NOT COMPLETED|Overall Study||5
2915589|NCT00510510|3625870|FG001|NOT COMPLETED|Overall Study||9
2915590|NCT00510510|3625871|FG002|NOT COMPLETED|Overall Study||17
2915591|NCT00510653|3625879|FG000|STARTED|Overall Study||24
2915592|NCT00510653|3625879|FG000|COMPLETED|Overall Study||13
2915593|NCT00510653|3625879|FG000|NOT COMPLETED|Overall Study||11
2915594|NCT00510692|3625885|FG000|STARTED|Overall Study||29
2915595|NCT00510692|3625886|FG001|STARTED|Overall Study||29
2915596|NCT00510692|3625885|FG000|COMPLETED|Overall Study||27
2915597|NCT00510692|3625886|FG001|COMPLETED|Overall Study||26
2915598|NCT00510692|3625885|FG000|NOT COMPLETED|Overall Study||2
2915599|NCT00510692|3625886|FG001|NOT COMPLETED|Overall Study||3
2915600|NCT00510718|3625901|FG000|STARTED|Single Dose Period: 1 Week||15
2915601|NCT00510718|3625902|FG001|STARTED|Single Dose Period: 1 Week||12
2915602|NCT00510718|3625901|FG000|30 mg/Day|Single Dose Period: 1 Week||3
2915603|NCT00510718|3625902|FG001|30 mg/Day|Single Dose Period: 1 Week||0
2915604|NCT00510718|3625901|FG000|60 mg/Day|Single Dose Period: 1 Week||3
2915605|NCT00510718|3625902|FG001|60 mg/Day|Single Dose Period: 1 Week||0
2915606|NCT00510718|3625901|FG000|150/160 mg/Day|Single Dose Period: 1 Week||2
2915607|NCT00510718|3625902|FG001|150/160 mg/Day|Single Dose Period: 1 Week||1
2915608|NCT00510718|3625901|FG000|240 mg/Day|Single Dose Period: 1 Week||3
2915609|NCT00510718|3625902|FG001|240 mg/Day|Single Dose Period: 1 Week||0
2915610|NCT00510718|3625901|FG000|360 mg/Day|Single Dose Period: 1 Week||4
2915611|NCT00510718|3625902|FG001|360 mg/Day|Single Dose Period: 1 Week||2
2915612|NCT00510718|3625901|FG000|480 mg/Day|Single Dose Period: 1 Week||0
2915613|NCT00510718|3625902|FG001|480 mg/Day|Single Dose Period: 1 Week||6
2915614|NCT00510718|3625901|FG000|600 mg/Day|Single Dose Period: 1 Week||0
2915615|NCT00510718|3625902|FG001|600 mg/Day|Single Dose Period: 1 Week||3
2915616|NCT00510718|3625901|FG000|COMPLETED|Single Dose Period: 1 Week||15
2915617|NCT00510718|3625902|FG001|COMPLETED|Single Dose Period: 1 Week||12
2915618|NCT00510718|3625901|FG000|NOT COMPLETED|Single Dose Period: 1 Week||0
2915619|NCT00510718|3625902|FG001|NOT COMPLETED|Single Dose Period: 1 Week||0
2915620|NCT00510718|3625901|FG000|STARTED|Multiple Dose Period: 12 Weeks|Participants who completed single dose period + new participants enrolled in multiple dose period.|65
2915621|NCT00510718|3625902|FG001|STARTED|Multiple Dose Period: 12 Weeks|Participants who completed single dose period + new participants enrolled in multiple dose period.|75
2915622|NCT00510718|3625901|FG000|30 mg/Day|Multiple Dose Period: 12 Weeks||3
2915623|NCT00510718|3625902|FG001|30 mg/Day|Multiple Dose Period: 12 Weeks||0
2915624|NCT00510718|3625901|FG000|60 mg/Day|Multiple Dose Period: 12 Weeks||15
2915625|NCT00510718|3625902|FG001|60 mg/Day|Multiple Dose Period: 12 Weeks||12
2915626|NCT00510718|3625901|FG000|150/160 mg/Day|Multiple Dose Period: 12 Weeks||15
2915627|NCT00510718|3625902|FG001|150/160 mg/Day|Multiple Dose Period: 12 Weeks||13
2915628|NCT00510718|3625901|FG000|240 mg/Day|Multiple Dose Period: 12 Weeks||17
2915629|NCT00510718|3625902|FG001|240 mg/Day|Multiple Dose Period: 12 Weeks||12
2915630|NCT00510718|3625901|FG000|360 mg/Day|Multiple Dose Period: 12 Weeks||15
2915631|NCT00510718|3625902|FG001|360 mg/Day|Multiple Dose Period: 12 Weeks||13
2915632|NCT00510718|3625901|FG000|480 mg/Day|Multiple Dose Period: 12 Weeks||0
2915633|NCT00510718|3625902|FG001|480 mg/Day|Multiple Dose Period: 12 Weeks||22
2915634|NCT00510718|3625901|FG000|600 mg/Day|Multiple Dose Period: 12 Weeks||0
2915635|NCT00510718|3625902|FG001|600 mg/Day|Multiple Dose Period: 12 Weeks||3
2915636|NCT00510718|3625901|FG000|COMPLETED|Multiple Dose Period: 12 Weeks||50
2915637|NCT00510718|3625902|FG001|COMPLETED|Multiple Dose Period: 12 Weeks||43
2915638|NCT00510718|3625901|FG000|NOT COMPLETED|Multiple Dose Period: 12 Weeks||15
2915639|NCT00510718|3625902|FG001|NOT COMPLETED|Multiple Dose Period: 12 Weeks||32
2839123|NCT04368910|3540990|FG000|STARTED|Overall Study||15
2839124|NCT04368910|3540991|FG001|STARTED|Overall Study||15
2839125|NCT04368910|3540990|FG000|COMPLETED|Overall Study||15
2839126|NCT04368910|3540991|FG001|COMPLETED|Overall Study||15
2839127|NCT04368910|3540990|FG000|NOT COMPLETED|Overall Study||0
2839128|NCT04368910|3540991|FG001|NOT COMPLETED|Overall Study||0
2839129|NCT04365985|3541000|FG000|STARTED|Overall Study||9
2839130|NCT04365985|3541001|FG001|STARTED|Overall Study||9
2839131|NCT04365985|3541002|FG002|STARTED|Overall Study||52
2839132|NCT04365985|3541000|FG000|COMPLETED|Overall Study||9
2839133|NCT04365985|3541001|FG001|COMPLETED|Overall Study||9
2839134|NCT04365985|3541002|FG002|COMPLETED|Overall Study||52
2839135|NCT04365985|3541000|FG000|NOT COMPLETED|Overall Study||0
2839136|NCT04365985|3541001|FG001|NOT COMPLETED|Overall Study||0
2839137|NCT04365985|3541002|FG002|NOT COMPLETED|Overall Study||0
2839138|NCT04034355|3541012|FG000|STARTED|Overall Study||151
2839139|NCT04034355|3541013|FG001|STARTED|Overall Study||150
2839140|NCT04034355|3541012|FG000|Treated|Overall Study||147
2839141|NCT04034355|3541013|FG001|Treated|Overall Study||150
2839142|NCT04034355|3541012|FG000|COMPLETED|Overall Study||117
2839143|NCT04034355|3541013|FG001|COMPLETED|Overall Study||115
2839144|NCT04034355|3541012|FG000|NOT COMPLETED|Overall Study||34
2839145|NCT04034355|3541013|FG001|NOT COMPLETED|Overall Study||35
2839146|NCT03781726|3541019|FG000|STARTED|Overall Study||30
2839147|NCT03781726|3541019|FG000|COMPLETED|Overall Study||28
2839148|NCT03781726|3541019|FG000|NOT COMPLETED|Overall Study||2
2839149|NCT03721276|3541025|FG000|STARTED|Overall Study||30
2839150|NCT03721276|3541026|FG001|STARTED|Overall Study||30
2839151|NCT03721276|3541025|FG000|Three-month Pre-intervention|Overall Study|Participants in this arm started therapy immediately after randomization, and therefore, did not have a three-month waiting period prior to receiving the intervention.|0
2839152|NCT03721276|3541026|FG001|Three-month Pre-intervention|Overall Study||30
2839153|NCT03721276|3541025|FG000|Immediate Pre-intervention|Overall Study||30
2839154|NCT03721276|3541026|FG001|Immediate Pre-intervention|Overall Study||29
2839155|NCT03721276|3541025|FG000|Post-intervention|Overall Study||25
2839156|NCT03721276|3541026|FG001|Post-intervention|Overall Study||26
2839157|NCT03721276|3541025|FG000|Three-month Follow-up (Post Intervention)|Overall Study||25
2839158|NCT03721276|3541026|FG001|Three-month Follow-up (Post Intervention)|Overall Study|Participants in this arm started therapy three months after randomization (waitlist) and therefore, were not assessed at the three-month follow-up time point due to completion of the study|0
2839159|NCT03721276|3541025|FG000|COMPLETED|Overall Study||25
2839160|NCT03721276|3541026|FG001|COMPLETED|Overall Study||26
2839161|NCT03721276|3541025|FG000|NOT COMPLETED|Overall Study||5
2839162|NCT03721276|3541026|FG001|NOT COMPLETED|Overall Study||4
2839163|NCT03700658|3541032|FG000|STARTED|Overall Study||27
2839164|NCT03700658|3541032|FG000|Received at Least 1 Dose of Study Drug|Overall Study||27
2839165|NCT03700658|3541032|FG000|COMPLETED|Overall Study||27
2839166|NCT03700658|3541032|FG000|NOT COMPLETED|Overall Study||0
2839167|NCT03637491|3541049|FG000|STARTED|Overall Study||10
2839168|NCT03637491|3541050|FG001|STARTED|Overall Study||12
2839169|NCT03637491|3541051|FG002|STARTED|Overall Study||7
2839170|NCT03637491|3541052|FG003|STARTED|Overall Study||6
2839171|NCT03637491|3541049|FG000|Received Treatment|Overall Study||10
2839172|NCT03637491|3541050|FG001|Received Treatment|Overall Study||12
2839173|NCT03637491|3541051|FG002|Received Treatment|Overall Study||7
2839174|NCT03637491|3541052|FG003|Received Treatment|Overall Study||6
2839175|NCT03637491|3541049|FG000|COMPLETED|Overall Study||0
2839176|NCT03637491|3541050|FG001|COMPLETED|Overall Study||0
2839177|NCT03637491|3541051|FG002|COMPLETED|Overall Study||0
2839178|NCT03637491|3541052|FG003|COMPLETED|Overall Study||0
2839179|NCT03637491|3541049|FG000|NOT COMPLETED|Overall Study||10
2839180|NCT03637491|3541050|FG001|NOT COMPLETED|Overall Study||12
2839181|NCT03637491|3541051|FG002|NOT COMPLETED|Overall Study||7
2839182|NCT03637491|3541052|FG003|NOT COMPLETED|Overall Study||6
2839183|NCT03610334|3541076|FG000|STARTED|Period 1: 2.5mg (1 Day)||6
2839184|NCT03610334|3541077|FG001|STARTED|Period 1: 2.5mg (1 Day)||2
2839185|NCT03610334|3541078|FG002|STARTED|Period 1: 2.5mg (1 Day)||0
2839186|NCT03610334|3541079|FG003|STARTED|Period 1: 2.5mg (1 Day)||0
2839187|NCT03610334|3541080|FG004|STARTED|Period 1: 2.5mg (1 Day)||0
2839188|NCT03610334|3541081|FG005|STARTED|Period 1: 2.5mg (1 Day)||0
2839189|NCT03610334|3541082|FG006|STARTED|Period 1: 2.5mg (1 Day)||0
2839190|NCT03610334|3541083|FG007|STARTED|Period 1: 2.5mg (1 Day)||0
2839191|NCT03610334|3541084|FG008|STARTED|Period 1: 2.5mg (1 Day)||0
2839192|NCT03610334|3541085|FG009|STARTED|Period 1: 2.5mg (1 Day)||0
2839193|NCT03610334|3541086|FG010|STARTED|Period 1: 2.5mg (1 Day)||0
2839194|NCT03610334|3541087|FG011|STARTED|Period 1: 2.5mg (1 Day)||0
2839195|NCT03610334|3541088|FG012|STARTED|Period 1: 2.5mg (1 Day)||0
2839196|NCT03610334|3541089|FG013|STARTED|Period 1: 2.5mg (1 Day)||0
2839197|NCT03610334|3541090|FG014|STARTED|Period 1: 2.5mg (1 Day)||0
2839198|NCT03610334|3541091|FG015|STARTED|Period 1: 2.5mg (1 Day)||0
2839199|NCT03610334|3541092|FG016|STARTED|Period 1: 2.5mg (1 Day)||0
2839200|NCT03610334|3541093|FG017|STARTED|Period 1: 2.5mg (1 Day)||0
2839201|NCT03610334|3541076|FG000|COMPLETED|Period 1: 2.5mg (1 Day)||6
3167404|NCT01910129|3894657|FG001|STARTED|Randomized Phase 2||6
3167405|NCT01910129|3894658|FG002|STARTED|Randomized Phase 2||0
3167406|NCT01910129|3894656|FG000|COMPLETED|Randomized Phase 2||5
2839202|NCT03610334|3541077|FG001|COMPLETED|Period 1: 2.5mg (1 Day)||2
2839203|NCT03610334|3541078|FG002|COMPLETED|Period 1: 2.5mg (1 Day)||0
3167407|NCT01910129|3894657|FG001|COMPLETED|Randomized Phase 2||5
2839204|NCT03610334|3541079|FG003|COMPLETED|Period 1: 2.5mg (1 Day)||0
2839205|NCT03610334|3541080|FG004|COMPLETED|Period 1: 2.5mg (1 Day)||0
2839206|NCT03610334|3541081|FG005|COMPLETED|Period 1: 2.5mg (1 Day)||0
2839207|NCT03610334|3541082|FG006|COMPLETED|Period 1: 2.5mg (1 Day)||0
2839208|NCT03610334|3541083|FG007|COMPLETED|Period 1: 2.5mg (1 Day)||0
2839209|NCT03610334|3541084|FG008|COMPLETED|Period 1: 2.5mg (1 Day)||0
2839210|NCT03610334|3541085|FG009|COMPLETED|Period 1: 2.5mg (1 Day)||0
2839211|NCT03610334|3541086|FG010|COMPLETED|Period 1: 2.5mg (1 Day)||0
2839212|NCT03610334|3541087|FG011|COMPLETED|Period 1: 2.5mg (1 Day)||0
2839213|NCT03610334|3541088|FG012|COMPLETED|Period 1: 2.5mg (1 Day)||0
2839214|NCT03610334|3541089|FG013|COMPLETED|Period 1: 2.5mg (1 Day)||0
2839215|NCT03610334|3541090|FG014|COMPLETED|Period 1: 2.5mg (1 Day)||0
2839216|NCT03610334|3541091|FG015|COMPLETED|Period 1: 2.5mg (1 Day)||0
2839217|NCT03610334|3541092|FG016|COMPLETED|Period 1: 2.5mg (1 Day)||0
2839218|NCT03610334|3541093|FG017|COMPLETED|Period 1: 2.5mg (1 Day)||0
2839219|NCT03610334|3541076|FG000|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0
2839220|NCT03610334|3541077|FG001|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0
2839221|NCT03610334|3541078|FG002|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0
2839222|NCT03610334|3541079|FG003|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0
2839223|NCT03610334|3541080|FG004|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0
2839224|NCT03610334|3541081|FG005|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0
2839225|NCT03610334|3541082|FG006|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0
2839226|NCT03610334|3541083|FG007|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0
2839227|NCT03610334|3541084|FG008|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0
2839228|NCT03610334|3541085|FG009|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0
2839229|NCT03610334|3541086|FG010|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0
2839230|NCT03610334|3541087|FG011|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0
2839231|NCT03610334|3541088|FG012|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0
2839232|NCT03610334|3541089|FG013|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0
2839233|NCT03610334|3541090|FG014|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0
2839234|NCT03610334|3541091|FG015|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0
2839235|NCT03610334|3541092|FG016|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0
2839236|NCT03610334|3541093|FG017|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0
2839237|NCT03610334|3541076|FG000|STARTED|Period 2: 5.0mg (1 Day)||6
2839238|NCT03610334|3541077|FG001|STARTED|Period 2: 5.0mg (1 Day)||2
2839239|NCT03610334|3541078|FG002|STARTED|Period 2: 5.0mg (1 Day)||6
2839240|NCT03610334|3541079|FG003|STARTED|Period 2: 5.0mg (1 Day)||2
2839241|NCT03610334|3541080|FG004|STARTED|Period 2: 5.0mg (1 Day)||0
2839242|NCT03610334|3541081|FG005|STARTED|Period 2: 5.0mg (1 Day)||0
2839243|NCT03610334|3541082|FG006|STARTED|Period 2: 5.0mg (1 Day)||0
2839244|NCT03610334|3541083|FG007|STARTED|Period 2: 5.0mg (1 Day)||0
2839245|NCT03610334|3541084|FG008|STARTED|Period 2: 5.0mg (1 Day)||0
2839246|NCT03610334|3541085|FG009|STARTED|Period 2: 5.0mg (1 Day)||0
2839247|NCT03610334|3541086|FG010|STARTED|Period 2: 5.0mg (1 Day)||0
2839248|NCT03610334|3541087|FG011|STARTED|Period 2: 5.0mg (1 Day)||0
2839249|NCT03610334|3541088|FG012|STARTED|Period 2: 5.0mg (1 Day)||0
2839250|NCT03610334|3541089|FG013|STARTED|Period 2: 5.0mg (1 Day)||0
2839251|NCT03610334|3541090|FG014|STARTED|Period 2: 5.0mg (1 Day)||0
2839252|NCT03610334|3541091|FG015|STARTED|Period 2: 5.0mg (1 Day)||0
2839253|NCT03610334|3541092|FG016|STARTED|Period 2: 5.0mg (1 Day)||0
2839254|NCT03610334|3541093|FG017|STARTED|Period 2: 5.0mg (1 Day)||0
2839255|NCT03610334|3541076|FG000|COMPLETED|Period 2: 5.0mg (1 Day)||6
2839256|NCT03610334|3541077|FG001|COMPLETED|Period 2: 5.0mg (1 Day)||2
2839257|NCT03610334|3541078|FG002|COMPLETED|Period 2: 5.0mg (1 Day)||6
2839258|NCT03610334|3541079|FG003|COMPLETED|Period 2: 5.0mg (1 Day)||2
2839259|NCT03610334|3541080|FG004|COMPLETED|Period 2: 5.0mg (1 Day)||0
2839260|NCT03610334|3541081|FG005|COMPLETED|Period 2: 5.0mg (1 Day)||0
2839261|NCT03610334|3541082|FG006|COMPLETED|Period 2: 5.0mg (1 Day)||0
2839262|NCT03610334|3541083|FG007|COMPLETED|Period 2: 5.0mg (1 Day)||0
2839263|NCT03610334|3541084|FG008|COMPLETED|Period 2: 5.0mg (1 Day)||0
2839264|NCT03610334|3541085|FG009|COMPLETED|Period 2: 5.0mg (1 Day)||0
2839265|NCT03610334|3541086|FG010|COMPLETED|Period 2: 5.0mg (1 Day)||0
2839266|NCT03610334|3541087|FG011|COMPLETED|Period 2: 5.0mg (1 Day)||0
2839267|NCT03610334|3541088|FG012|COMPLETED|Period 2: 5.0mg (1 Day)||0
2839268|NCT03610334|3541089|FG013|COMPLETED|Period 2: 5.0mg (1 Day)||0
2839269|NCT03610334|3541090|FG014|COMPLETED|Period 2: 5.0mg (1 Day)||0
2839270|NCT03610334|3541091|FG015|COMPLETED|Period 2: 5.0mg (1 Day)||0
2839271|NCT03610334|3541092|FG016|COMPLETED|Period 2: 5.0mg (1 Day)||0
2839272|NCT03610334|3541093|FG017|COMPLETED|Period 2: 5.0mg (1 Day)||0
2839273|NCT03610334|3541076|FG000|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0
2839274|NCT03610334|3541077|FG001|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0
2839275|NCT03610334|3541078|FG002|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0
2839276|NCT03610334|3541079|FG003|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0
2839277|NCT03610334|3541080|FG004|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0
2839278|NCT03610334|3541081|FG005|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0
2839279|NCT03610334|3541082|FG006|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0
2839280|NCT03610334|3541083|FG007|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0
2839281|NCT03610334|3541084|FG008|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0
2839282|NCT03610334|3541085|FG009|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0
2839283|NCT03610334|3541086|FG010|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0
2839284|NCT03610334|3541087|FG011|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0
2839285|NCT03610334|3541088|FG012|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0
2839286|NCT03610334|3541089|FG013|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0
2839287|NCT03610334|3541090|FG014|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0
2839288|NCT03610334|3541091|FG015|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0
2839289|NCT03610334|3541092|FG016|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0
2839290|NCT03610334|3541093|FG017|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0
2839291|NCT03610334|3541076|FG000|STARTED|Period 3: 10.0mg (1 Day)||6
2839292|NCT03610334|3541077|FG001|STARTED|Period 3: 10.0mg (1 Day)||2
2839293|NCT03610334|3541078|FG002|STARTED|Period 3: 10.0mg (1 Day)||6
2839294|NCT03610334|3541079|FG003|STARTED|Period 3: 10.0mg (1 Day)||2
2839295|NCT03610334|3541080|FG004|STARTED|Period 3: 10.0mg (1 Day)||6
2839296|NCT03610334|3541081|FG005|STARTED|Period 3: 10.0mg (1 Day)||2
2839297|NCT03610334|3541082|FG006|STARTED|Period 3: 10.0mg (1 Day)||0
2839298|NCT03610334|3541083|FG007|STARTED|Period 3: 10.0mg (1 Day)||0
2839299|NCT03610334|3541084|FG008|STARTED|Period 3: 10.0mg (1 Day)||0
2839300|NCT03610334|3541085|FG009|STARTED|Period 3: 10.0mg (1 Day)||0
2839301|NCT03610334|3541086|FG010|STARTED|Period 3: 10.0mg (1 Day)||0
2839302|NCT03610334|3541087|FG011|STARTED|Period 3: 10.0mg (1 Day)||0
2839303|NCT03610334|3541088|FG012|STARTED|Period 3: 10.0mg (1 Day)||0
2839304|NCT03610334|3541089|FG013|STARTED|Period 3: 10.0mg (1 Day)||0
2839305|NCT03610334|3541090|FG014|STARTED|Period 3: 10.0mg (1 Day)||0
2839306|NCT03610334|3541091|FG015|STARTED|Period 3: 10.0mg (1 Day)||0
2839307|NCT03610334|3541092|FG016|STARTED|Period 3: 10.0mg (1 Day)||0
2839308|NCT03610334|3541093|FG017|STARTED|Period 3: 10.0mg (1 Day)||0
2839309|NCT03610334|3541076|FG000|COMPLETED|Period 3: 10.0mg (1 Day)||6
2839310|NCT03610334|3541077|FG001|COMPLETED|Period 3: 10.0mg (1 Day)||2
2839311|NCT03610334|3541078|FG002|COMPLETED|Period 3: 10.0mg (1 Day)||6
2839312|NCT03610334|3541079|FG003|COMPLETED|Period 3: 10.0mg (1 Day)||2
2839313|NCT03610334|3541080|FG004|COMPLETED|Period 3: 10.0mg (1 Day)||6
2839314|NCT03610334|3541081|FG005|COMPLETED|Period 3: 10.0mg (1 Day)||2
2839315|NCT03610334|3541082|FG006|COMPLETED|Period 3: 10.0mg (1 Day)||0
2839316|NCT03610334|3541083|FG007|COMPLETED|Period 3: 10.0mg (1 Day)||0
2839317|NCT03610334|3541084|FG008|COMPLETED|Period 3: 10.0mg (1 Day)||0
2839318|NCT03610334|3541085|FG009|COMPLETED|Period 3: 10.0mg (1 Day)||0
2839319|NCT03610334|3541086|FG010|COMPLETED|Period 3: 10.0mg (1 Day)||0
2839320|NCT03610334|3541087|FG011|COMPLETED|Period 3: 10.0mg (1 Day)||0
2839321|NCT03610334|3541088|FG012|COMPLETED|Period 3: 10.0mg (1 Day)||0
2839322|NCT03610334|3541089|FG013|COMPLETED|Period 3: 10.0mg (1 Day)||0
2839323|NCT03610334|3541090|FG014|COMPLETED|Period 3: 10.0mg (1 Day)||0
2839324|NCT03610334|3541091|FG015|COMPLETED|Period 3: 10.0mg (1 Day)||0
2839325|NCT03610334|3541092|FG016|COMPLETED|Period 3: 10.0mg (1 Day)||0
2839326|NCT03610334|3541093|FG017|COMPLETED|Period 3: 10.0mg (1 Day)||0
2839327|NCT03610334|3541076|FG000|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0
2839328|NCT03610334|3541077|FG001|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0
2839329|NCT03610334|3541078|FG002|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0
2839330|NCT03610334|3541079|FG003|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0
2839331|NCT03610334|3541080|FG004|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0
2839332|NCT03610334|3541081|FG005|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0
2839333|NCT03610334|3541082|FG006|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0
2839334|NCT03610334|3541083|FG007|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0
2839335|NCT03610334|3541084|FG008|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0
2839336|NCT03610334|3541085|FG009|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0
2839337|NCT03610334|3541086|FG010|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0
2839338|NCT03610334|3541087|FG011|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0
2839339|NCT03610334|3541088|FG012|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0
2839340|NCT03610334|3541089|FG013|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0
2839341|NCT03610334|3541090|FG014|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0
2839342|NCT03610334|3541091|FG015|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0
2839343|NCT03610334|3541092|FG016|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0
2839344|NCT03610334|3541093|FG017|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0
2839345|NCT03610334|3541076|FG000|STARTED|Period 4: 20.0mg (1 Day)||6
2839346|NCT03610334|3541077|FG001|STARTED|Period 4: 20.0mg (1 Day)||2
2839347|NCT03610334|3541078|FG002|STARTED|Period 4: 20.0mg (1 Day)||6
2839348|NCT03610334|3541079|FG003|STARTED|Period 4: 20.0mg (1 Day)||2
2839349|NCT03610334|3541080|FG004|STARTED|Period 4: 20.0mg (1 Day)||6
2839350|NCT03610334|3541081|FG005|STARTED|Period 4: 20.0mg (1 Day)||2
2839351|NCT03610334|3541082|FG006|STARTED|Period 4: 20.0mg (1 Day)||6
2839352|NCT03610334|3541083|FG007|STARTED|Period 4: 20.0mg (1 Day)||2
2839353|NCT03610334|3541084|FG008|STARTED|Period 4: 20.0mg (1 Day)||0
2839354|NCT03610334|3541085|FG009|STARTED|Period 4: 20.0mg (1 Day)||0
2839355|NCT03610334|3541086|FG010|STARTED|Period 4: 20.0mg (1 Day)||0
2839356|NCT03610334|3541087|FG011|STARTED|Period 4: 20.0mg (1 Day)||0
2839357|NCT03610334|3541088|FG012|STARTED|Period 4: 20.0mg (1 Day)||0
2839358|NCT03610334|3541089|FG013|STARTED|Period 4: 20.0mg (1 Day)||0
2839359|NCT03610334|3541090|FG014|STARTED|Period 4: 20.0mg (1 Day)||0
2839360|NCT03610334|3541091|FG015|STARTED|Period 4: 20.0mg (1 Day)||0
2839361|NCT03610334|3541092|FG016|STARTED|Period 4: 20.0mg (1 Day)||0
2839362|NCT03610334|3541093|FG017|STARTED|Period 4: 20.0mg (1 Day)||0
2839363|NCT03610334|3541076|FG000|COMPLETED|Period 4: 20.0mg (1 Day)||6
2839364|NCT03610334|3541077|FG001|COMPLETED|Period 4: 20.0mg (1 Day)||2
2839365|NCT03610334|3541078|FG002|COMPLETED|Period 4: 20.0mg (1 Day)||6
2839366|NCT03610334|3541079|FG003|COMPLETED|Period 4: 20.0mg (1 Day)||2
2839367|NCT03610334|3541080|FG004|COMPLETED|Period 4: 20.0mg (1 Day)||6
2839368|NCT03610334|3541081|FG005|COMPLETED|Period 4: 20.0mg (1 Day)||2
2839369|NCT03610334|3541082|FG006|COMPLETED|Period 4: 20.0mg (1 Day)||6
2839370|NCT03610334|3541083|FG007|COMPLETED|Period 4: 20.0mg (1 Day)||2
2839371|NCT03610334|3541084|FG008|COMPLETED|Period 4: 20.0mg (1 Day)||0
2839372|NCT03610334|3541085|FG009|COMPLETED|Period 4: 20.0mg (1 Day)||0
2839373|NCT03610334|3541086|FG010|COMPLETED|Period 4: 20.0mg (1 Day)||0
3167408|NCT01910129|3894658|FG002|COMPLETED|Randomized Phase 2||0
3167409|NCT01910129|3894656|FG000|NOT COMPLETED|Randomized Phase 2||2
3311596|NCT03053271|4045055|FG000|COMPLETED|Overall Study|All completed the open-label dose escalation, but did not meet criteria for randomization|0
2839374|NCT03610334|3541087|FG011|COMPLETED|Period 4: 20.0mg (1 Day)||0
2839375|NCT03610334|3541088|FG012|COMPLETED|Period 4: 20.0mg (1 Day)||0
2839376|NCT03610334|3541089|FG013|COMPLETED|Period 4: 20.0mg (1 Day)||0
2839377|NCT03610334|3541090|FG014|COMPLETED|Period 4: 20.0mg (1 Day)||0
2839378|NCT03610334|3541091|FG015|COMPLETED|Period 4: 20.0mg (1 Day)||0
2839379|NCT03610334|3541092|FG016|COMPLETED|Period 4: 20.0mg (1 Day)||0
2839380|NCT03610334|3541093|FG017|COMPLETED|Period 4: 20.0mg (1 Day)||0
2839381|NCT03610334|3541076|FG000|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0
2839382|NCT03610334|3541077|FG001|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0
2839383|NCT03610334|3541078|FG002|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0
2839384|NCT03610334|3541079|FG003|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0
2839385|NCT03610334|3541080|FG004|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0
2839386|NCT03610334|3541081|FG005|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0
2839387|NCT03610334|3541082|FG006|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0
2839388|NCT03610334|3541083|FG007|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0
2839389|NCT03610334|3541084|FG008|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0
2839390|NCT03610334|3541085|FG009|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0
2839391|NCT03610334|3541086|FG010|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0
2839392|NCT03610334|3541087|FG011|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0
2839393|NCT03610334|3541088|FG012|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0
2839394|NCT03610334|3541089|FG013|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0
3311597|NCT03053271|4045055|FG000|NOT COMPLETED|Overall Study||4
3311598|NCT03053401|4045061|FG000|STARTED|Overall Study||26
3311599|NCT03053401|4045062|FG001|STARTED|Overall Study||26
3311600|NCT03053401|4045061|FG000|COMPLETED|Overall Study||26
3311601|NCT03053401|4045062|FG001|COMPLETED|Overall Study||26
3311602|NCT03053401|4045061|FG000|NOT COMPLETED|Overall Study||0
3311603|NCT03053401|4045062|FG001|NOT COMPLETED|Overall Study||0
3311604|NCT03053427|4045071|FG000|STARTED|Overall Study||186
3311605|NCT03053427|4045072|FG001|STARTED|Overall Study||189
3311606|NCT03053427|4045071|FG000|COMPLETED|Overall Study||173
3311607|NCT03053427|4045072|FG001|COMPLETED|Overall Study||173
3311608|NCT03053427|4045071|FG000|NOT COMPLETED|Overall Study||13
3311609|NCT03053427|4045072|FG001|NOT COMPLETED|Overall Study||16
3311610|NCT03053492|4045080|FG000|STARTED|Overall Study||33
3311611|NCT03053492|4045081|FG001|STARTED|Overall Study||33
3311612|NCT03053492|4045080|FG000|COMPLETED|Overall Study||25
3311613|NCT03053492|4045081|FG001|COMPLETED|Overall Study||27
3311614|NCT03053492|4045080|FG000|NOT COMPLETED|Overall Study||8
3311615|NCT03053492|4045081|FG001|NOT COMPLETED|Overall Study||6
3311616|NCT03054051|4045089|FG000|STARTED|Overall Study||30
3311617|NCT03054051|4045090|FG001|STARTED|Overall Study||30
3311618|NCT03054051|4045089|FG000|COMPLETED|Overall Study||30
3311619|NCT03054051|4045090|FG001|COMPLETED|Overall Study||30
3311620|NCT03054051|4045089|FG000|NOT COMPLETED|Overall Study||0
3311621|NCT03054051|4045090|FG001|NOT COMPLETED|Overall Study||0
3311622|NCT03054064|4045098|FG000|STARTED|Overall Study||48
3311623|NCT03054064|4045098|FG000|Screen Failure|Overall Study||2
2839395|NCT03610334|3541090|FG014|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0
2839396|NCT03610334|3541091|FG015|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0
2839397|NCT03610334|3541092|FG016|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0
2839398|NCT03610334|3541093|FG017|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0
2839399|NCT03610334|3541076|FG000|STARTED|Period 5: 40.0mg (1 Day)||6
2839400|NCT03610334|3541077|FG001|STARTED|Period 5: 40.0mg (1 Day)||2
2839401|NCT03610334|3541078|FG002|STARTED|Period 5: 40.0mg (1 Day)||6
2839402|NCT03610334|3541079|FG003|STARTED|Period 5: 40.0mg (1 Day)||2
2839403|NCT03610334|3541080|FG004|STARTED|Period 5: 40.0mg (1 Day)||6
2839404|NCT03610334|3541081|FG005|STARTED|Period 5: 40.0mg (1 Day)||2
2839405|NCT03610334|3541082|FG006|STARTED|Period 5: 40.0mg (1 Day)||6
2839406|NCT03610334|3541083|FG007|STARTED|Period 5: 40.0mg (1 Day)||2
2839407|NCT03610334|3541084|FG008|STARTED|Period 5: 40.0mg (1 Day)||6
2839408|NCT03610334|3541085|FG009|STARTED|Period 5: 40.0mg (1 Day)||2
2839409|NCT03610334|3541086|FG010|STARTED|Period 5: 40.0mg (1 Day)||0
2839410|NCT03610334|3541087|FG011|STARTED|Period 5: 40.0mg (1 Day)||0
2839411|NCT03610334|3541088|FG012|STARTED|Period 5: 40.0mg (1 Day)||0
2839412|NCT03610334|3541089|FG013|STARTED|Period 5: 40.0mg (1 Day)||0
2839413|NCT03610334|3541090|FG014|STARTED|Period 5: 40.0mg (1 Day)||0
2839414|NCT03610334|3541091|FG015|STARTED|Period 5: 40.0mg (1 Day)||0
2839415|NCT03610334|3541092|FG016|STARTED|Period 5: 40.0mg (1 Day)||0
2839416|NCT03610334|3541093|FG017|STARTED|Period 5: 40.0mg (1 Day)||0
2839417|NCT03610334|3541076|FG000|COMPLETED|Period 5: 40.0mg (1 Day)||6
2839418|NCT03610334|3541077|FG001|COMPLETED|Period 5: 40.0mg (1 Day)||2
2839419|NCT03610334|3541078|FG002|COMPLETED|Period 5: 40.0mg (1 Day)||6
2839420|NCT03610334|3541079|FG003|COMPLETED|Period 5: 40.0mg (1 Day)||2
2839421|NCT03610334|3541080|FG004|COMPLETED|Period 5: 40.0mg (1 Day)||6
2839422|NCT03610334|3541081|FG005|COMPLETED|Period 5: 40.0mg (1 Day)||2
2839423|NCT03610334|3541082|FG006|COMPLETED|Period 5: 40.0mg (1 Day)||6
2839424|NCT03610334|3541083|FG007|COMPLETED|Period 5: 40.0mg (1 Day)||2
2839425|NCT03610334|3541084|FG008|COMPLETED|Period 5: 40.0mg (1 Day)||6
2839426|NCT03610334|3541085|FG009|COMPLETED|Period 5: 40.0mg (1 Day)||2
3311624|NCT03054064|4045098|FG000|COMPLETED|Overall Study||42
3311625|NCT03054064|4045098|FG000|NOT COMPLETED|Overall Study||6
3311626|NCT03054077|4045104|FG000|STARTED|Overall Study||12
2839427|NCT03610334|3541086|FG010|COMPLETED|Period 5: 40.0mg (1 Day)||0
2839428|NCT03610334|3541087|FG011|COMPLETED|Period 5: 40.0mg (1 Day)||0
2839429|NCT03610334|3541088|FG012|COMPLETED|Period 5: 40.0mg (1 Day)||0
2839430|NCT03610334|3541089|FG013|COMPLETED|Period 5: 40.0mg (1 Day)||0
2839431|NCT03610334|3541090|FG014|COMPLETED|Period 5: 40.0mg (1 Day)||0
2839432|NCT03610334|3541091|FG015|COMPLETED|Period 5: 40.0mg (1 Day)||0
2839433|NCT03610334|3541092|FG016|COMPLETED|Period 5: 40.0mg (1 Day)||0
2839434|NCT03610334|3541093|FG017|COMPLETED|Period 5: 40.0mg (1 Day)||0
2839435|NCT03610334|3541076|FG000|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0
2839436|NCT03610334|3541077|FG001|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0
2839437|NCT03610334|3541078|FG002|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0
2839438|NCT03610334|3541079|FG003|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0
2839439|NCT03610334|3541080|FG004|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0
2839440|NCT03610334|3541081|FG005|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0
2839441|NCT03610334|3541082|FG006|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0
2839442|NCT03610334|3541083|FG007|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0
2839443|NCT03610334|3541084|FG008|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0
2839444|NCT03610334|3541085|FG009|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0
2839445|NCT03610334|3541086|FG010|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0
2839446|NCT03610334|3541087|FG011|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0
2839447|NCT03610334|3541088|FG012|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0
2839448|NCT03610334|3541089|FG013|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0
2839449|NCT03610334|3541090|FG014|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0
2839450|NCT03610334|3541091|FG015|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0
2839451|NCT03610334|3541092|FG016|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0
2839452|NCT03610334|3541093|FG017|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0
2839453|NCT03610334|3541076|FG000|STARTED|Period 6: 60.0mg (1 Day)||6
2839454|NCT03610334|3541077|FG001|STARTED|Period 6: 60.0mg (1 Day)||2
2839455|NCT03610334|3541078|FG002|STARTED|Period 6: 60.0mg (1 Day)||6
2839456|NCT03610334|3541079|FG003|STARTED|Period 6: 60.0mg (1 Day)||2
2839457|NCT03610334|3541080|FG004|STARTED|Period 6: 60.0mg (1 Day)||6
2839458|NCT03610334|3541081|FG005|STARTED|Period 6: 60.0mg (1 Day)||2
2839459|NCT03610334|3541082|FG006|STARTED|Period 6: 60.0mg (1 Day)||6
2839460|NCT03610334|3541083|FG007|STARTED|Period 6: 60.0mg (1 Day)||2
2839461|NCT03610334|3541084|FG008|STARTED|Period 6: 60.0mg (1 Day)||6
2839462|NCT03610334|3541085|FG009|STARTED|Period 6: 60.0mg (1 Day)||2
2839463|NCT03610334|3541086|FG010|STARTED|Period 6: 60.0mg (1 Day)||6
2839464|NCT03610334|3541087|FG011|STARTED|Period 6: 60.0mg (1 Day)||2
2839465|NCT03610334|3541088|FG012|STARTED|Period 6: 60.0mg (1 Day)||0
2839466|NCT03610334|3541089|FG013|STARTED|Period 6: 60.0mg (1 Day)||0
2839467|NCT03610334|3541090|FG014|STARTED|Period 6: 60.0mg (1 Day)||0
2839468|NCT03610334|3541091|FG015|STARTED|Period 6: 60.0mg (1 Day)||0
2839469|NCT03610334|3541092|FG016|STARTED|Period 6: 60.0mg (1 Day)||0
2839470|NCT03610334|3541093|FG017|STARTED|Period 6: 60.0mg (1 Day)||0
2839471|NCT03610334|3541076|FG000|COMPLETED|Period 6: 60.0mg (1 Day)||6
2839472|NCT03610334|3541077|FG001|COMPLETED|Period 6: 60.0mg (1 Day)||2
2839473|NCT03610334|3541078|FG002|COMPLETED|Period 6: 60.0mg (1 Day)||6
2839474|NCT03610334|3541079|FG003|COMPLETED|Period 6: 60.0mg (1 Day)||2
2839475|NCT03610334|3541080|FG004|COMPLETED|Period 6: 60.0mg (1 Day)||6
2839476|NCT03610334|3541081|FG005|COMPLETED|Period 6: 60.0mg (1 Day)||2
2839477|NCT03610334|3541082|FG006|COMPLETED|Period 6: 60.0mg (1 Day)||6
2839478|NCT03610334|3541083|FG007|COMPLETED|Period 6: 60.0mg (1 Day)||2
2839479|NCT03610334|3541084|FG008|COMPLETED|Period 6: 60.0mg (1 Day)||6
2839480|NCT03610334|3541085|FG009|COMPLETED|Period 6: 60.0mg (1 Day)||2
2839481|NCT03610334|3541086|FG010|COMPLETED|Period 6: 60.0mg (1 Day)||6
2839482|NCT03610334|3541087|FG011|COMPLETED|Period 6: 60.0mg (1 Day)||2
2839483|NCT03610334|3541088|FG012|COMPLETED|Period 6: 60.0mg (1 Day)||0
2839484|NCT03610334|3541089|FG013|COMPLETED|Period 6: 60.0mg (1 Day)||0
2839485|NCT03610334|3541090|FG014|COMPLETED|Period 6: 60.0mg (1 Day)||0
2839486|NCT03610334|3541091|FG015|COMPLETED|Period 6: 60.0mg (1 Day)||0
2839487|NCT03610334|3541092|FG016|COMPLETED|Period 6: 60.0mg (1 Day)||0
2839488|NCT03610334|3541093|FG017|COMPLETED|Period 6: 60.0mg (1 Day)||0
2839489|NCT03610334|3541076|FG000|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0
2839490|NCT03610334|3541077|FG001|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0
2839491|NCT03610334|3541078|FG002|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0
2839492|NCT03610334|3541079|FG003|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0
2839493|NCT03610334|3541080|FG004|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0
2839494|NCT03610334|3541081|FG005|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0
2839495|NCT03610334|3541082|FG006|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0
2839496|NCT03610334|3541083|FG007|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0
2839497|NCT03610334|3541084|FG008|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0
2839498|NCT03610334|3541085|FG009|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0
2839499|NCT03610334|3541086|FG010|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0
2839500|NCT03610334|3541087|FG011|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0
2839501|NCT03610334|3541088|FG012|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0
2839502|NCT03610334|3541089|FG013|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0
2839503|NCT03610334|3541090|FG014|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0
2839504|NCT03610334|3541091|FG015|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0
2839505|NCT03610334|3541092|FG016|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0
2839506|NCT03610334|3541093|FG017|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0
2839507|NCT03610334|3541076|FG000|STARTED|Period 7: 15.0mg (Day 1 to 14)||6
2839508|NCT03610334|3541077|FG001|STARTED|Period 7: 15.0mg (Day 1 to 14)||2
2839509|NCT03610334|3541078|FG002|STARTED|Period 7: 15.0mg (Day 1 to 14)||6
2839510|NCT03610334|3541079|FG003|STARTED|Period 7: 15.0mg (Day 1 to 14)||2
2839511|NCT03610334|3541080|FG004|STARTED|Period 7: 15.0mg (Day 1 to 14)||6
2839512|NCT03610334|3541081|FG005|STARTED|Period 7: 15.0mg (Day 1 to 14)||2
2839513|NCT03610334|3541082|FG006|STARTED|Period 7: 15.0mg (Day 1 to 14)||6
2839514|NCT03610334|3541083|FG007|STARTED|Period 7: 15.0mg (Day 1 to 14)||2
2839515|NCT03610334|3541084|FG008|STARTED|Period 7: 15.0mg (Day 1 to 14)||6
2839516|NCT03610334|3541085|FG009|STARTED|Period 7: 15.0mg (Day 1 to 14)||2
2839517|NCT03610334|3541086|FG010|STARTED|Period 7: 15.0mg (Day 1 to 14)||6
2839518|NCT03610334|3541087|FG011|STARTED|Period 7: 15.0mg (Day 1 to 14)||2
2839519|NCT03610334|3541088|FG012|STARTED|Period 7: 15.0mg (Day 1 to 14)||6
2839520|NCT03610334|3541089|FG013|STARTED|Period 7: 15.0mg (Day 1 to 14)||2
2839521|NCT03610334|3541090|FG014|STARTED|Period 7: 15.0mg (Day 1 to 14)||0
2839522|NCT03610334|3541091|FG015|STARTED|Period 7: 15.0mg (Day 1 to 14)||0
2839523|NCT03610334|3541092|FG016|STARTED|Period 7: 15.0mg (Day 1 to 14)||0
2839524|NCT03610334|3541093|FG017|STARTED|Period 7: 15.0mg (Day 1 to 14)||0
2839525|NCT03610334|3541076|FG000|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||6
2839526|NCT03610334|3541077|FG001|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||2
2839527|NCT03610334|3541078|FG002|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||6
2839528|NCT03610334|3541079|FG003|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||2
2839529|NCT03610334|3541080|FG004|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||6
2839530|NCT03610334|3541081|FG005|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||2
2839531|NCT03610334|3541082|FG006|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||6
2839532|NCT03610334|3541083|FG007|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||2
2839533|NCT03610334|3541084|FG008|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||6
2839534|NCT03610334|3541085|FG009|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||2
2839535|NCT03610334|3541086|FG010|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||6
2839536|NCT03610334|3541087|FG011|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||2
2839537|NCT03610334|3541088|FG012|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||6
2839538|NCT03610334|3541089|FG013|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||2
2839539|NCT03610334|3541090|FG014|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
2839540|NCT03610334|3541091|FG015|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
2839541|NCT03610334|3541092|FG016|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
2839542|NCT03610334|3541093|FG017|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
2839543|NCT03610334|3541076|FG000|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
2839544|NCT03610334|3541077|FG001|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
2839545|NCT03610334|3541078|FG002|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
2839546|NCT03610334|3541079|FG003|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
2839547|NCT03610334|3541080|FG004|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
2839548|NCT03610334|3541081|FG005|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
2839549|NCT03610334|3541082|FG006|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
2839550|NCT03610334|3541083|FG007|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
2839551|NCT03610334|3541084|FG008|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
2839552|NCT03610334|3541085|FG009|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
2839553|NCT03610334|3541086|FG010|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
2839554|NCT03610334|3541087|FG011|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
2839555|NCT03610334|3541088|FG012|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
2839556|NCT03610334|3541089|FG013|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
2839557|NCT03610334|3541090|FG014|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
2839558|NCT03610334|3541091|FG015|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
2839559|NCT03610334|3541092|FG016|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
2839560|NCT03610334|3541093|FG017|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
2839561|NCT03610334|3541076|FG000|STARTED|Period 8: 30.0mg (Day 1 to 14)||6
2839562|NCT03610334|3541077|FG001|STARTED|Period 8: 30.0mg (Day 1 to 14)||2
2839563|NCT03610334|3541078|FG002|STARTED|Period 8: 30.0mg (Day 1 to 14)||6
2839564|NCT03610334|3541079|FG003|STARTED|Period 8: 30.0mg (Day 1 to 14)||2
2839565|NCT03610334|3541080|FG004|STARTED|Period 8: 30.0mg (Day 1 to 14)||6
2839566|NCT03610334|3541081|FG005|STARTED|Period 8: 30.0mg (Day 1 to 14)||2
2839567|NCT03610334|3541082|FG006|STARTED|Period 8: 30.0mg (Day 1 to 14)||6
2839568|NCT03610334|3541083|FG007|STARTED|Period 8: 30.0mg (Day 1 to 14)||2
2839569|NCT03610334|3541084|FG008|STARTED|Period 8: 30.0mg (Day 1 to 14)||6
2839570|NCT03610334|3541085|FG009|STARTED|Period 8: 30.0mg (Day 1 to 14)||2
2839571|NCT03610334|3541086|FG010|STARTED|Period 8: 30.0mg (Day 1 to 14)||6
2839572|NCT03610334|3541087|FG011|STARTED|Period 8: 30.0mg (Day 1 to 14)||2
2839573|NCT03610334|3541088|FG012|STARTED|Period 8: 30.0mg (Day 1 to 14)||6
2839574|NCT03610334|3541089|FG013|STARTED|Period 8: 30.0mg (Day 1 to 14)||2
2839575|NCT03610334|3541090|FG014|STARTED|Period 8: 30.0mg (Day 1 to 14)||6
2839576|NCT03610334|3541091|FG015|STARTED|Period 8: 30.0mg (Day 1 to 14)||2
2839577|NCT03610334|3541092|FG016|STARTED|Period 8: 30.0mg (Day 1 to 14)||0
2839578|NCT03610334|3541093|FG017|STARTED|Period 8: 30.0mg (Day 1 to 14)||0
2839579|NCT03610334|3541076|FG000|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||6
2839580|NCT03610334|3541077|FG001|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||2
2839581|NCT03610334|3541078|FG002|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||6
2839582|NCT03610334|3541079|FG003|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||2
2839583|NCT03610334|3541080|FG004|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||6
2839584|NCT03610334|3541081|FG005|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||2
2839585|NCT03610334|3541082|FG006|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||6
2839586|NCT03610334|3541083|FG007|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||2
2839587|NCT03610334|3541084|FG008|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||6
2839588|NCT03610334|3541085|FG009|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||2
2839589|NCT03610334|3541086|FG010|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||6
2839590|NCT03610334|3541087|FG011|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||2
2839591|NCT03610334|3541088|FG012|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||6
2839592|NCT03610334|3541089|FG013|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||2
2839593|NCT03610334|3541090|FG014|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||6
2839594|NCT03610334|3541091|FG015|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||2
2839595|NCT03610334|3541092|FG016|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0
2839596|NCT03610334|3541093|FG017|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0
2839597|NCT03610334|3541076|FG000|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0
2839598|NCT03610334|3541077|FG001|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0
2839599|NCT03610334|3541078|FG002|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0
2839600|NCT03610334|3541079|FG003|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0
2839601|NCT03610334|3541080|FG004|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0
2839602|NCT03610334|3541081|FG005|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0
2839603|NCT03610334|3541082|FG006|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0
2839604|NCT03610334|3541083|FG007|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0
2839605|NCT03610334|3541084|FG008|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0
2839606|NCT03610334|3541085|FG009|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0
2839607|NCT03610334|3541086|FG010|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0
2839608|NCT03610334|3541087|FG011|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0
2839609|NCT03610334|3541088|FG012|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0
2839610|NCT03610334|3541089|FG013|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0
2839611|NCT03610334|3541090|FG014|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0
2839612|NCT03610334|3541091|FG015|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0
2839613|NCT03610334|3541092|FG016|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0
2839614|NCT03610334|3541093|FG017|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0
2839615|NCT03610334|3541076|FG000|STARTED|Period 9: 50.0mg (Day 1 to 14)||6
2839616|NCT03610334|3541077|FG001|STARTED|Period 9: 50.0mg (Day 1 to 14)||2
2839617|NCT03610334|3541078|FG002|STARTED|Period 9: 50.0mg (Day 1 to 14)||6
2839618|NCT03610334|3541079|FG003|STARTED|Period 9: 50.0mg (Day 1 to 14)||2
2839619|NCT03610334|3541080|FG004|STARTED|Period 9: 50.0mg (Day 1 to 14)||6
2839620|NCT03610334|3541081|FG005|STARTED|Period 9: 50.0mg (Day 1 to 14)||2
2839621|NCT03610334|3541082|FG006|STARTED|Period 9: 50.0mg (Day 1 to 14)||6
2839622|NCT03610334|3541083|FG007|STARTED|Period 9: 50.0mg (Day 1 to 14)||2
2839623|NCT03610334|3541084|FG008|STARTED|Period 9: 50.0mg (Day 1 to 14)||6
2839624|NCT03610334|3541085|FG009|STARTED|Period 9: 50.0mg (Day 1 to 14)||2
2839625|NCT03610334|3541086|FG010|STARTED|Period 9: 50.0mg (Day 1 to 14)||6
2839626|NCT03610334|3541087|FG011|STARTED|Period 9: 50.0mg (Day 1 to 14)||2
2839627|NCT03610334|3541088|FG012|STARTED|Period 9: 50.0mg (Day 1 to 14)||6
2839628|NCT03610334|3541089|FG013|STARTED|Period 9: 50.0mg (Day 1 to 14)||2
2839629|NCT03610334|3541090|FG014|STARTED|Period 9: 50.0mg (Day 1 to 14)||6
2839630|NCT03610334|3541091|FG015|STARTED|Period 9: 50.0mg (Day 1 to 14)||2
2839631|NCT03610334|3541092|FG016|STARTED|Period 9: 50.0mg (Day 1 to 14)||6
2839632|NCT03610334|3541093|FG017|STARTED|Period 9: 50.0mg (Day 1 to 14)||2
2839633|NCT03610334|3541076|FG000|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||6
2839634|NCT03610334|3541077|FG001|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||2
2839635|NCT03610334|3541078|FG002|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||6
2839636|NCT03610334|3541079|FG003|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||2
2839637|NCT03610334|3541080|FG004|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||6
2839638|NCT03610334|3541081|FG005|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||2
2839639|NCT03610334|3541082|FG006|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||6
2839640|NCT03610334|3541083|FG007|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||2
2839641|NCT03610334|3541084|FG008|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||6
2839642|NCT03610334|3541085|FG009|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||2
2839643|NCT03610334|3541086|FG010|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||6
2839644|NCT03610334|3541087|FG011|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||2
2839645|NCT03610334|3541088|FG012|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||6
2839646|NCT03610334|3541089|FG013|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||2
2839647|NCT03610334|3541090|FG014|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||6
2839648|NCT03610334|3541091|FG015|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||2
2839649|NCT03610334|3541092|FG016|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||6
2839650|NCT03610334|3541093|FG017|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||2
2839651|NCT03610334|3541076|FG000|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0
2839652|NCT03610334|3541077|FG001|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0
2839653|NCT03610334|3541078|FG002|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0
2839654|NCT03610334|3541079|FG003|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0
2839655|NCT03610334|3541080|FG004|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0
2839656|NCT03610334|3541081|FG005|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0
2839657|NCT03610334|3541082|FG006|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0
2839658|NCT03610334|3541083|FG007|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0
2839659|NCT03610334|3541084|FG008|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0
2839660|NCT03610334|3541085|FG009|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0
2839661|NCT03610334|3541086|FG010|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0
2839662|NCT03610334|3541087|FG011|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0
2839663|NCT03610334|3541088|FG012|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0
2839664|NCT03610334|3541089|FG013|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0
2839665|NCT03610334|3541090|FG014|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0
2839666|NCT03610334|3541091|FG015|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0
2839667|NCT03610334|3541092|FG016|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0
2839668|NCT03610334|3541093|FG017|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0
2839669|NCT03584464|3541140|FG000|STARTED|Overall Study||205
2839670|NCT03584464|3541140|FG000|COMPLETED|Overall Study|Number of subjects that competed 1 year follow up or had a CEC event|204
2839671|NCT03584464|3541140|FG000|NOT COMPLETED|Overall Study||1
2839672|NCT03334539|3541147|FG000|STARTED|Overall Study||50
2839673|NCT03334539|3541148|FG001|STARTED|Overall Study||50
2839674|NCT03334539|3541149|FG002|STARTED|Overall Study||50
2839675|NCT03334539|3541147|FG000|COMPLETED|Overall Study||46
2839676|NCT03334539|3541148|FG001|COMPLETED|Overall Study||43
2839677|NCT03334539|3541149|FG002|COMPLETED|Overall Study||49
2839678|NCT03334539|3541147|FG000|NOT COMPLETED|Overall Study||4
2839679|NCT03334539|3541148|FG001|NOT COMPLETED|Overall Study||7
2839680|NCT03334539|3541149|FG002|NOT COMPLETED|Overall Study||1
2839681|NCT03311854|3541162|FG000|STARTED|Overall Study||14
2839682|NCT03311854|3541162|FG000|COMPLETED|Overall Study||14
2839683|NCT03311854|3541162|FG000|NOT COMPLETED|Overall Study||0
2839684|NCT03269344|3541171|FG000|STARTED|Overall Study||33
2839685|NCT03269344|3541172|FG001|STARTED|Overall Study||32
2839686|NCT03269344|3541171|FG000|COMPLETED|Overall Study||29
2839687|NCT03269344|3541172|FG001|COMPLETED|Overall Study||29
2839688|NCT03269344|3541171|FG000|NOT COMPLETED|Overall Study||4
2839689|NCT03269344|3541172|FG001|NOT COMPLETED|Overall Study||3
2839690|NCT03079284|3541178|FG000|STARTED|Overall Study||10
2839691|NCT03079284|3541178|FG000|COMPLETED|Overall Study||10
2839692|NCT03079284|3541178|FG000|NOT COMPLETED|Overall Study||0
2839693|NCT03076775|3541186|FG000|STARTED|Overall Study||44
2839694|NCT03076775|3541187|FG001|STARTED|Overall Study||42
2839695|NCT03076775|3541186|FG000|Neonates Born During Study|Overall Study||43
2839696|NCT03076775|3541187|FG001|Neonates Born During Study|Overall Study||42
2839697|NCT03076775|3541186|FG000|Umbilical Cord Blood Collected|Overall Study||33
2839698|NCT03076775|3541187|FG001|Umbilical Cord Blood Collected|Overall Study||38
2839699|NCT03076775|3541186|FG000|COMPLETED|Overall Study||43
2839700|NCT03076775|3541187|FG001|COMPLETED|Overall Study||42
2839701|NCT03076775|3541186|FG000|NOT COMPLETED|Overall Study||1
2839702|NCT03076775|3541187|FG001|NOT COMPLETED|Overall Study||0
2915640|NCT00510744|3625921|FG000|STARTED|Overall Study||5
2915641|NCT00510744|3625921|FG000|COMPLETED|Overall Study||5
2915642|NCT00510744|3625921|FG000|NOT COMPLETED|Overall Study||0
2915643|NCT00510783|3625927|FG000|STARTED|Overall Study||82
2915644|NCT00510783|3625928|FG001|STARTED|Overall Study||76
2915645|NCT00510783|3625927|FG000|COMPLETED|Overall Study||51
2915646|NCT00510783|3625928|FG001|COMPLETED|Overall Study||47
2915647|NCT00510783|3625927|FG000|NOT COMPLETED|Overall Study||31
2915648|NCT00510783|3625928|FG001|NOT COMPLETED|Overall Study||29
2915649|NCT00510809|3625937|FG000|STARTED|Overall Study||18
2915650|NCT00510809|3625938|FG001|STARTED|Overall Study||18
2915651|NCT00510809|3625939|FG002|STARTED|Overall Study||18
2915652|NCT00510809|3625937|FG000|COMPLETED|Overall Study||18
2915653|NCT00510809|3625938|FG001|COMPLETED|Overall Study||18
2915654|NCT00510809|3625939|FG002|COMPLETED|Overall Study||18
2915655|NCT00510809|3625937|FG000|NOT COMPLETED|Overall Study||0
2915656|NCT00510809|3625938|FG001|NOT COMPLETED|Overall Study||0
2915657|NCT00510809|3625939|FG002|NOT COMPLETED|Overall Study||0
2915658|NCT00510835|3625950|FG000|STARTED|Overall Study||445
2915659|NCT00510835|3625951|FG001|STARTED|Overall Study||448
2915660|NCT00510835|3625952|FG002|STARTED|Overall Study||458
2915661|NCT00510835|3625950|FG000|COMPLETED|Overall Study||439
2915662|NCT00510835|3625951|FG001|COMPLETED|Overall Study||446
2915663|NCT00510835|3625952|FG002|COMPLETED|Overall Study||456
2915664|NCT00510835|3625950|FG000|NOT COMPLETED|Overall Study||6
2915665|NCT00510835|3625951|FG001|NOT COMPLETED|Overall Study||2
2915666|NCT00510835|3625952|FG002|NOT COMPLETED|Overall Study||2
2915667|NCT00510874|3625967|FG000|STARTED|Overall Study||78
2915668|NCT00510874|3625968|FG001|STARTED|Overall Study||152
2915669|NCT00510874|3625969|FG002|STARTED|Overall Study||151
2915670|NCT00510874|3625970|FG003|STARTED|Overall Study||151
2915671|NCT00510874|3625971|FG004|STARTED|Overall Study||148
2915672|NCT00510874|3625972|FG005|STARTED|Overall Study||50
2915673|NCT00510874|3625973|FG006|STARTED|Overall Study||50
2915674|NCT00510874|3625967|FG000|COMPLETED|Overall Study|Upto Day 182|75
2915675|NCT00510874|3625968|FG001|COMPLETED|Overall Study|Upto Day 182|148
2915676|NCT00510874|3625969|FG002|COMPLETED|Overall Study|Upto Day 182|150
2915677|NCT00510874|3625970|FG003|COMPLETED|Overall Study|Upto Day 182|148
2915678|NCT00510874|3625971|FG004|COMPLETED|Overall Study|Upto Day 182|141
2915679|NCT00510874|3625972|FG005|COMPLETED|Overall Study|Upto Day 182|50
2915680|NCT00510874|3625973|FG006|COMPLETED|Overall Study|Upto Day 182|49
2915681|NCT00510874|3625967|FG000|NOT COMPLETED|Overall Study||3
2915682|NCT00510874|3625968|FG001|NOT COMPLETED|Overall Study||4
2915683|NCT00510874|3625969|FG002|NOT COMPLETED|Overall Study||1
2915684|NCT00510874|3625970|FG003|NOT COMPLETED|Overall Study||3
2915685|NCT00510874|3625971|FG004|NOT COMPLETED|Overall Study||7
2915686|NCT00510874|3625972|FG005|NOT COMPLETED|Overall Study||0
2915687|NCT00510874|3625973|FG006|NOT COMPLETED|Overall Study||1
2915688|NCT00510887|3625990|FG000|STARTED|Overall Study||12
2915689|NCT00510887|3625990|FG000|COMPLETED|Overall Study||11
2915690|NCT00510887|3625990|FG000|NOT COMPLETED|Overall Study||1
2915691|NCT00510952|3625996|FG000|STARTED|Overall Study||235
2915692|NCT00510952|3625997|FG001|STARTED|Overall Study||236
3311627|NCT03054077|4045105|FG001|STARTED|Overall Study||12
3311628|NCT03054077|4045104|FG000|COMPLETED|Overall Study||12
3311629|NCT03054077|4045105|FG001|COMPLETED|Overall Study||12
3311630|NCT03054077|4045104|FG000|NOT COMPLETED|Overall Study||0
3311631|NCT03054077|4045105|FG001|NOT COMPLETED|Overall Study||0
3311632|NCT03054103|4045114|FG000|STARTED|Overall Study||41
3311633|NCT03054103|4045115|FG001|STARTED|Overall Study||29
3311634|NCT03054103|4045116|FG002|STARTED|Overall Study||35
3311635|NCT03054103|4045114|FG000|COMPLETED|Overall Study||41
3311636|NCT03054103|4045115|FG001|COMPLETED|Overall Study||29
3311637|NCT03054103|4045116|FG002|COMPLETED|Overall Study||35
3311638|NCT03054103|4045114|FG000|NOT COMPLETED|Overall Study||0
3311639|NCT03054103|4045115|FG001|NOT COMPLETED|Overall Study||0
3311640|NCT03054103|4045116|FG002|NOT COMPLETED|Overall Study||0
3311641|NCT03054337|4045130|FG000|STARTED|Primary Efficacy Period (6 Weeks)||12
2839703|NCT02933944|3541197|FG000|STARTED|Overall Study||6
2839704|NCT02933944|3541197|FG000|COMPLETED|Overall Study||6
2839705|NCT02933944|3541197|FG000|NOT COMPLETED|Overall Study||0
2839706|NCT02921997|3541206|FG000|STARTED|Overall Study||10
2839707|NCT02921997|3541207|FG001|STARTED|Overall Study||10
2839708|NCT02921997|3541208|FG002|STARTED|Overall Study||10
2839709|NCT02921997|3541206|FG000|COMPLETED|Overall Study||10
2839710|NCT02921997|3541207|FG001|COMPLETED|Overall Study||10
2839711|NCT02921997|3541208|FG002|COMPLETED|Overall Study||10
2839712|NCT02921997|3541206|FG000|NOT COMPLETED|Overall Study||0
2839713|NCT02921997|3541207|FG001|NOT COMPLETED|Overall Study||0
2839714|NCT02921997|3541208|FG002|NOT COMPLETED|Overall Study||0
2839715|NCT02833935|3541220|FG000|STARTED|Overall Study||12
2839716|NCT02833935|3541221|FG001|STARTED|Overall Study||12
2839717|NCT02833935|3541220|FG000|COMPLETED|Overall Study||10
2839718|NCT02833935|3541221|FG001|COMPLETED|Overall Study||12
2839719|NCT02833935|3541220|FG000|NOT COMPLETED|Overall Study||2
2839720|NCT02833935|3541221|FG001|NOT COMPLETED|Overall Study||0
2839721|NCT02660827|3541227|FG000|STARTED|From Study to End of Continued Access||151
2839722|NCT02660827|3541227|FG000|COMPLETED|From Study to End of Continued Access||120
2839723|NCT02660827|3541227|FG000|NOT COMPLETED|From Study to End of Continued Access||31
2839724|NCT02660827|3541227|FG000|STARTED|Period 1: Study Period||151
2839725|NCT02660827|3541227|FG000|COMPLETED|Period 1: Study Period||150
2839726|NCT02660827|3541227|FG000|NOT COMPLETED|Period 1: Study Period||1
2839727|NCT02660827|3541227|FG000|STARTED|Period 2: Continued Access Period||145
2839728|NCT02660827|3541227|FG000|COMPLETED|Period 2: Continued Access Period||120
2839729|NCT02660827|3541227|FG000|NOT COMPLETED|Period 2: Continued Access Period||25
2839730|NCT02627963|3541236|FG000|STARTED|Overall Study||175
2839731|NCT02627963|3541237|FG001|STARTED|Overall Study||175
2839732|NCT02627963|3541236|FG000|COMPLETED|Overall Study||139
2839733|NCT02627963|3541237|FG001|COMPLETED|Overall Study||161
2839734|NCT02627963|3541236|FG000|NOT COMPLETED|Overall Study||36
2839735|NCT02627963|3541237|FG001|NOT COMPLETED|Overall Study||14
2839736|NCT02581930|3541243|FG000|STARTED|Overall Study||18
2839737|NCT02581930|3541243|FG000|COMPLETED|Overall Study||16
2839738|NCT02581930|3541243|FG000|NOT COMPLETED|Overall Study||2
2839739|NCT02496676|3541249|FG000|STARTED|Phase 1 - Period 1||2
2839740|NCT02496676|3541250|FG001|STARTED|Phase 1 - Period 1||3
2839741|NCT02496676|3541249|FG000|COMPLETED|Phase 1 - Period 1||2
2839742|NCT02496676|3541250|FG001|COMPLETED|Phase 1 - Period 1||2
2839743|NCT02496676|3541249|FG000|NOT COMPLETED|Phase 1 - Period 1||0
2839744|NCT02496676|3541250|FG001|NOT COMPLETED|Phase 1 - Period 1||1
2839745|NCT02496676|3541249|FG000|STARTED|Phase 1 - Period 2||2
2839746|NCT02496676|3541250|FG001|STARTED|Phase 1 - Period 2||2
2839747|NCT02496676|3541249|FG000|COMPLETED|Phase 1 - Period 2||2
2839748|NCT02496676|3541250|FG001|COMPLETED|Phase 1 - Period 2||2
2839749|NCT02496676|3541249|FG000|NOT COMPLETED|Phase 1 - Period 2||0
2839750|NCT02496676|3541250|FG001|NOT COMPLETED|Phase 1 - Period 2||0
2839751|NCT02496676|3541249|FG000|STARTED|Washout Period||2
2839752|NCT02496676|3541250|FG001|STARTED|Washout Period||2
2839753|NCT02496676|3541249|FG000|COMPLETED|Washout Period||2
2839754|NCT02496676|3541250|FG001|COMPLETED|Washout Period||2
2839755|NCT02496676|3541249|FG000|NOT COMPLETED|Washout Period||0
2839756|NCT02496676|3541250|FG001|NOT COMPLETED|Washout Period||0
2839757|NCT02496676|3541249|FG000|STARTED|Phase 2 - IV MgSO4||2
2839758|NCT02496676|3541250|FG001|STARTED|Phase 2 - IV MgSO4||2
2839759|NCT02496676|3541249|FG000|COMPLETED|Phase 2 - IV MgSO4||2
2839760|NCT02496676|3541250|FG001|COMPLETED|Phase 2 - IV MgSO4||1
3167410|NCT01910129|3894657|FG001|NOT COMPLETED|Randomized Phase 2||1
3167411|NCT01910129|3894658|FG002|NOT COMPLETED|Randomized Phase 2||0
3167412|NCT01910129|3894656|FG000|STARTED|Randomized Phase 3||5
2839761|NCT02496676|3541249|FG000|NOT COMPLETED|Phase 2 - IV MgSO4||0
2839762|NCT02496676|3541250|FG001|NOT COMPLETED|Phase 2 - IV MgSO4||1
3167413|NCT01910129|3894657|FG001|STARTED|Randomized Phase 3||5
2839763|NCT02496676|3541249|FG000|STARTED|Phase 2 - Oral Magnesium||2
2839764|NCT02496676|3541250|FG001|STARTED|Phase 2 - Oral Magnesium||1
2839765|NCT02496676|3541249|FG000|COMPLETED|Phase 2 - Oral Magnesium||2
2839766|NCT02496676|3541250|FG001|COMPLETED|Phase 2 - Oral Magnesium||1
2839767|NCT02496676|3541249|FG000|NOT COMPLETED|Phase 2 - Oral Magnesium||0
2839768|NCT02496676|3541250|FG001|NOT COMPLETED|Phase 2 - Oral Magnesium||0
2839769|NCT02425644|3541266|FG000|STARTED|Overall Study||567
3311642|NCT03054337|4045131|FG001|STARTED|Primary Efficacy Period (6 Weeks)||12
3311643|NCT03054337|4045132|FG002|STARTED|Primary Efficacy Period (6 Weeks)||13
3311644|NCT03054337|4045133|FG003|STARTED|Primary Efficacy Period (6 Weeks)||5
2839770|NCT02425644|3541267|FG001|STARTED|Overall Study||566
2839771|NCT02425644|3541266|FG000|Treated|Overall Study||565
2839772|NCT02425644|3541267|FG001|Treated|Overall Study||566
2839773|NCT02425644|3541266|FG000|COMPLETED|Overall Study||490
2839774|NCT02425644|3541267|FG001|COMPLETED|Overall Study||495
2839775|NCT02425644|3541266|FG000|NOT COMPLETED|Overall Study||77
2839776|NCT02425644|3541267|FG001|NOT COMPLETED|Overall Study||71
2839777|NCT02395614|3541273|FG000|STARTED|Overall Study||88
2839778|NCT02395614|3541273|FG000|Chlorhexidine Irrigation|Overall Study||88
2839779|NCT02395614|3541273|FG000|Triple Antibiotic Irrigation|Overall Study||88
2839780|NCT02395614|3541273|FG000|COMPLETED|Overall Study||88
2839781|NCT02395614|3541273|FG000|NOT COMPLETED|Overall Study||0
2839782|NCT02340221|3541280|FG000|STARTED|Overall Study||214
2839783|NCT02340221|3541281|FG001|STARTED|Overall Study||417
2839784|NCT02340221|3541280|FG000|COMPLETED|Overall Study||0
2839785|NCT02340221|3541281|FG001|COMPLETED|Overall Study||0
2839786|NCT02340221|3541280|FG000|NOT COMPLETED|Overall Study||214
2839787|NCT02340221|3541281|FG001|NOT COMPLETED|Overall Study||417
2839788|NCT02270957|3541290|FG000|STARTED|Overall Study||31
2839789|NCT02270957|3541291|FG001|STARTED|Overall Study||35
2839790|NCT02270957|3541290|FG000|COMPLETED|Overall Study||27
2839791|NCT02270957|3541291|FG001|COMPLETED|Overall Study||31
2839792|NCT02270957|3541290|FG000|NOT COMPLETED|Overall Study||4
2839793|NCT02270957|3541291|FG001|NOT COMPLETED|Overall Study||4
2839794|NCT02134925|3541300|FG000|STARTED|Overall Study||54
2839795|NCT02134925|3541301|FG001|STARTED|Overall Study||56
2839796|NCT02134925|3541300|FG000|Received at Least One Dose of Treatment|Overall Study||53
2839797|NCT02134925|3541301|FG001|Received at Least One Dose of Treatment|Overall Study||50
2839798|NCT02134925|3541300|FG000|COMPLETED|Overall Study||52
2839799|NCT02134925|3541301|FG001|COMPLETED|Overall Study||50
2839800|NCT02134925|3541300|FG000|NOT COMPLETED|Overall Study||2
2839801|NCT02134925|3541301|FG001|NOT COMPLETED|Overall Study||6
2839802|NCT02054104|3541309|FG000|STARTED|Overall Study||10
2839803|NCT02054104|3541310|FG001|STARTED|Overall Study||11
2839804|NCT02054104|3541309|FG000|COMPLETED|Overall Study||2
2839805|NCT02054104|3541310|FG001|COMPLETED|Overall Study||2
2839806|NCT02054104|3541309|FG000|NOT COMPLETED|Overall Study||8
2839807|NCT02054104|3541310|FG001|NOT COMPLETED|Overall Study||9
2839808|NCT01899144|3541316|FG000|STARTED|Treatment Period 1||61
2839809|NCT01899144|3541316|FG000|COMPLETED|Treatment Period 1||61
2839810|NCT01899144|3541316|FG000|NOT COMPLETED|Treatment Period 1||0
2839811|NCT01899144|3541316|FG000|STARTED|Treatment Period 2||61
2839812|NCT01899144|3541316|FG000|COMPLETED|Treatment Period 2|Last treatment taken by the patient who discontinued was placebo.|60
2839813|NCT01899144|3541316|FG000|NOT COMPLETED|Treatment Period 2||1
2839814|NCT01899144|3541316|FG000|STARTED|Treatment Period 3||60
2839815|NCT01899144|3541316|FG000|COMPLETED|Treatment Period 3|Last treatment taken by patients who discontinued were ABS Spiromax 180 mcg and ABS Spiromax 90 mcg.|58
2839816|NCT01899144|3541316|FG000|NOT COMPLETED|Treatment Period 3||2
2839817|NCT01899144|3541316|FG000|STARTED|Treatment Period 4||58
2839818|NCT01899144|3541316|FG000|COMPLETED|Treatment Period 4||58
2839819|NCT01899144|3541316|FG000|NOT COMPLETED|Treatment Period 4||0
2839820|NCT01899144|3541316|FG000|STARTED|Treatment Period 5||58
2839821|NCT01899144|3541316|FG000|COMPLETED|Treatment Period 5|Last treatment taken by the patient who discontinued was ABS Spiromax 180 mcg.|57
2839822|NCT01899144|3541316|FG000|NOT COMPLETED|Treatment Period 5||1
2839823|NCT01793610|3541331|FG000|STARTED|Overall Study||6
2839824|NCT01793610|3541332|FG001|STARTED|Overall Study||9
2839825|NCT01793610|3541333|FG002|STARTED|Overall Study||13
2839826|NCT01793610|3541331|FG000|COMPLETED|Overall Study||5
2839827|NCT01793610|3541332|FG001|COMPLETED|Overall Study||9
2839828|NCT01793610|3541333|FG002|COMPLETED|Overall Study||12
2839829|NCT01793610|3541331|FG000|NOT COMPLETED|Overall Study||1
2839830|NCT01793610|3541332|FG001|NOT COMPLETED|Overall Study||0
2839831|NCT01793610|3541333|FG002|NOT COMPLETED|Overall Study||1
2839832|NCT01757665|3541347|FG000|STARTED|Overall Study||694
2839833|NCT01757665|3541348|FG001|STARTED|Overall Study||83
2839834|NCT01757665|3541347|FG000|Implanted With Device|Overall Study||689
2839835|NCT01757665|3541348|FG001|Implanted With Device|Overall Study||82
2839836|NCT01757665|3541347|FG000|COMPLETED|Overall Study||0
2839837|NCT01757665|3541348|FG001|COMPLETED|Overall Study||0
2839838|NCT01757665|3541347|FG000|NOT COMPLETED|Overall Study||694
2839839|NCT01757665|3541348|FG001|NOT COMPLETED|Overall Study||83
2839840|NCT01482195|3541369|FG000|STARTED|Overall Study||6
2839841|NCT01482195|3541369|FG000|One Year Results|Overall Study||6
2839842|NCT01482195|3541369|FG000|COMPLETED|Overall Study||6
2839843|NCT01482195|3541369|FG000|NOT COMPLETED|Overall Study||0
2839844|NCT01468831|3541376|FG000|STARTED|Overall Study||4
2839845|NCT01468831|3541377|FG001|STARTED|Overall Study||5
2839846|NCT01468831|3541376|FG000|Month 12 (Primary Outcome)|Overall Study||4
2839847|NCT01468831|3541377|FG001|Month 12 (Primary Outcome)|Overall Study||4
2839848|NCT01468831|3541376|FG000|COMPLETED|Overall Study||4
2839849|NCT01468831|3541377|FG001|COMPLETED|Overall Study||4
2839850|NCT01468831|3541376|FG000|NOT COMPLETED|Overall Study||0
2839851|NCT01468831|3541377|FG001|NOT COMPLETED|Overall Study||1
2839852|NCT01383109|3541383|FG000|STARTED|Overall Study||6
2839853|NCT01383109|3541383|FG000|COMPLETED|Overall Study||6
2839854|NCT01383109|3541383|FG000|NOT COMPLETED|Overall Study||0
2839855|NCT00822120|3541389|FG000|STARTED|Initial Registration||358
2839856|NCT00822120|3541390|FG001|STARTED|Initial Registration||13
2839857|NCT00822120|3541391|FG002|STARTED|Initial Registration||0
2839858|NCT00822120|3541392|FG003|STARTED|Initial Registration||0
2839859|NCT00822120|3541393|FG004|STARTED|Initial Registration||0
2839860|NCT00822120|3541394|FG005|STARTED|Initial Registration||0
2839861|NCT00822120|3541389|FG000|Eligible and Evaluable Patients|Initial Registration||336
2839862|NCT00822120|3541390|FG001|Eligible and Evaluable Patients|Initial Registration||12
2839863|NCT00822120|3541391|FG002|Eligible and Evaluable Patients|Initial Registration||0
2839864|NCT00822120|3541392|FG003|Eligible and Evaluable Patients|Initial Registration||0
2839865|NCT00822120|3541393|FG004|Eligible and Evaluable Patients|Initial Registration||0
2839866|NCT00822120|3541394|FG005|Eligible and Evaluable Patients|Initial Registration||0
2839867|NCT00822120|3541389|FG000|COMPLETED|Initial Registration||332
2839868|NCT00822120|3541390|FG001|COMPLETED|Initial Registration||12
2839869|NCT00822120|3541391|FG002|COMPLETED|Initial Registration||0
2839870|NCT00822120|3541392|FG003|COMPLETED|Initial Registration||0
2839871|NCT00822120|3541393|FG004|COMPLETED|Initial Registration||0
2839872|NCT00822120|3541394|FG005|COMPLETED|Initial Registration||0
2839873|NCT00822120|3541389|FG000|NOT COMPLETED|Initial Registration||26
2839874|NCT00822120|3541390|FG001|NOT COMPLETED|Initial Registration||1
2839875|NCT00822120|3541391|FG002|NOT COMPLETED|Initial Registration||0
2839876|NCT00822120|3541392|FG003|NOT COMPLETED|Initial Registration||0
2839877|NCT00822120|3541393|FG004|NOT COMPLETED|Initial Registration||0
2839878|NCT00822120|3541394|FG005|NOT COMPLETED|Initial Registration||0
2839879|NCT00822120|3541389|FG000|STARTED|PET-directed Therapy||0
2839880|NCT00822120|3541390|FG001|STARTED|PET-directed Therapy||0
2839881|NCT00822120|3541391|FG002|STARTED|PET-directed Therapy||270
2839882|NCT00822120|3541392|FG003|STARTED|PET-directed Therapy||55
2839883|NCT00822120|3541393|FG004|STARTED|PET-directed Therapy||10
2839884|NCT00822120|3541394|FG005|STARTED|PET-directed Therapy||1
2839885|NCT00822120|3541389|FG000|Eligibile and Evaluable Patients|PET-directed Therapy||0
2839886|NCT00822120|3541390|FG001|Eligibile and Evaluable Patients|PET-directed Therapy||0
2839887|NCT00822120|3541391|FG002|Eligibile and Evaluable Patients|PET-directed Therapy||270
3167414|NCT01910129|3894658|FG002|STARTED|Randomized Phase 3||0
3167415|NCT01910129|3894656|FG000|COMPLETED|Randomized Phase 3||5
3167416|NCT01910129|3894657|FG001|COMPLETED|Randomized Phase 3||4
3167417|NCT01910129|3894658|FG002|COMPLETED|Randomized Phase 3||0
3167418|NCT01910129|3894656|FG000|NOT COMPLETED|Randomized Phase 3||0
3167419|NCT01910129|3894657|FG001|NOT COMPLETED|Randomized Phase 3||1
3167420|NCT01910129|3894658|FG002|NOT COMPLETED|Randomized Phase 3||0
3167421|NCT01910181|3894676|FG000|STARTED|Overall Study||46
3167422|NCT01910181|3894676|FG000|PK Cohort|Overall Study||20
3167423|NCT01910181|3894676|FG000|Expansion Cohort|Overall Study||26
3167424|NCT01910181|3894676|FG000|COMPLETED|Overall Study||0
3167425|NCT01910181|3894676|FG000|NOT COMPLETED|Overall Study||46
3167426|NCT01910298|3894683|FG000|STARTED|Overall Study||76
3167427|NCT01910298|3894684|FG001|STARTED|Overall Study||55
3167428|NCT01910298|3894683|FG000|Safety Set|Overall Study||76
3167429|NCT01910298|3894684|FG001|Safety Set|Overall Study|4 participants did not have first surgery date and were not included in Safety Set.|51
3167430|NCT01910298|3894683|FG000|COMPLETED|Overall Study||71
3167431|NCT01910298|3894684|FG001|COMPLETED|Overall Study||23
2839888|NCT00822120|3541392|FG003|Eligibile and Evaluable Patients|PET-directed Therapy||55
2839889|NCT00822120|3541393|FG004|Eligibile and Evaluable Patients|PET-directed Therapy||10
2839890|NCT00822120|3541394|FG005|Eligibile and Evaluable Patients|PET-directed Therapy||1
2839891|NCT00822120|3541389|FG000|COMPLETED|PET-directed Therapy||0
2839892|NCT00822120|3541390|FG001|COMPLETED|PET-directed Therapy||0
2839893|NCT00822120|3541391|FG002|COMPLETED|PET-directed Therapy||270
2839894|NCT00822120|3541392|FG003|COMPLETED|PET-directed Therapy||45
2839895|NCT00822120|3541393|FG004|COMPLETED|PET-directed Therapy||10
2839896|NCT00822120|3541394|FG005|COMPLETED|PET-directed Therapy||1
2839897|NCT00822120|3541389|FG000|NOT COMPLETED|PET-directed Therapy||0
2839898|NCT00822120|3541390|FG001|NOT COMPLETED|PET-directed Therapy||0
2839899|NCT00822120|3541391|FG002|NOT COMPLETED|PET-directed Therapy||0
2839900|NCT00822120|3541392|FG003|NOT COMPLETED|PET-directed Therapy||10
2839901|NCT00822120|3541393|FG004|NOT COMPLETED|PET-directed Therapy||0
2839902|NCT00822120|3541394|FG005|NOT COMPLETED|PET-directed Therapy||0
2915693|NCT00510952|3625996|FG000|Full Analysis Set (Intent to Treat)|Overall Study||229
2915694|NCT00510952|3625997|FG001|Full Analysis Set (Intent to Treat)|Overall Study||229
2915695|NCT00510952|3625996|FG000|COMPLETED|Overall Study||209
2915696|NCT00510952|3625997|FG001|COMPLETED|Overall Study||220
2915697|NCT00510952|3625996|FG000|NOT COMPLETED|Overall Study||26
2915698|NCT00510952|3625997|FG001|NOT COMPLETED|Overall Study||16
2915699|NCT00511004|3626006|FG000|STARTED|Overall Study||13
2915700|NCT00511004|3626007|FG001|STARTED|Overall Study||13
2915701|NCT00511004|3626008|FG002|STARTED|Overall Study||14
2915702|NCT00511004|3626006|FG000|COMPLETED|Overall Study||13
2915703|NCT00511004|3626007|FG001|COMPLETED|Overall Study||13
2915704|NCT00511004|3626008|FG002|COMPLETED|Overall Study||10
2915705|NCT00511004|3626006|FG000|NOT COMPLETED|Overall Study||0
2915706|NCT00511004|3626007|FG001|NOT COMPLETED|Overall Study||0
2915707|NCT00511004|3626008|FG002|NOT COMPLETED|Overall Study||4
2915708|NCT00511095|3626019|FG000|STARTED|Overall Study||207
2915709|NCT00511095|3626019|FG000|COMPLETED|Overall Study||196
2915710|NCT00511095|3626019|FG000|NOT COMPLETED|Overall Study||11
2915711|NCT00511108|3626033|FG000|STARTED|Overall Study||52
2915712|NCT00511108|3626034|FG001|STARTED|Overall Study||54
3167432|NCT01910298|3894683|FG000|NOT COMPLETED|Overall Study||5
2839903|NCT00603954|3541417|FG000|STARTED|Overall Study|5 patients in Screening failure between inclusion and transplantation|50
2839904|NCT00603954|3541418|FG001|STARTED|Overall Study|5 patients in Screening failure between inclusion and transplantation|47
2839905|NCT00603954|3541417|FG000|COMPLETED|Overall Study||49
2839906|NCT00603954|3541418|FG001|COMPLETED|Overall Study||45
2839907|NCT00603954|3541417|FG000|NOT COMPLETED|Overall Study||1
2839908|NCT00603954|3541418|FG001|NOT COMPLETED|Overall Study||2
2915713|NCT00511108|3626035|FG002|STARTED|Overall Study||52
2915714|NCT00511108|3626036|FG003|STARTED|Overall Study||53
2915715|NCT00511108|3626033|FG000|COMPLETED|Overall Study||46
2915716|NCT00511108|3626034|FG001|COMPLETED|Overall Study||52
2915717|NCT00511108|3626035|FG002|COMPLETED|Overall Study||47
2915718|NCT00511108|3626036|FG003|COMPLETED|Overall Study||48
2915719|NCT00511108|3626033|FG000|NOT COMPLETED|Overall Study||6
2915720|NCT00511108|3626034|FG001|NOT COMPLETED|Overall Study||2
2915721|NCT00511108|3626035|FG002|NOT COMPLETED|Overall Study||5
2915722|NCT00511108|3626036|FG003|NOT COMPLETED|Overall Study||5
2915723|NCT00511134|3626048|FG000|STARTED|Overall Study||1
2915724|NCT00511134|3626049|FG001|STARTED|Overall Study||3
2915725|NCT00511134|3626048|FG000|COMPLETED|Overall Study||1
2915726|NCT00511134|3626049|FG001|COMPLETED|Overall Study||1
3167433|NCT01910298|3894684|FG001|NOT COMPLETED|Overall Study||32
3167434|NCT01910311|3894690|FG000|STARTED|Period 1 (Days 1-2)||18
3167435|NCT01910311|3894690|FG000|Received Baricitinib|Period 1 (Days 1-2)||18
3167436|NCT01910311|3894690|FG000|COMPLETED|Period 1 (Days 1-2)||18
3167437|NCT01910311|3894690|FG000|NOT COMPLETED|Period 1 (Days 1-2)||0
3167438|NCT01910311|3894690|FG000|STARTED|Period 2 (Days 3-32)||18
3167439|NCT01910311|3894690|FG000|Received Baricitinib|Period 2 (Days 3-32)||18
3167440|NCT01910311|3894690|FG000|Received At Least 1 Dose of Rifampicin|Period 2 (Days 3-32)||18
3167441|NCT01910311|3894690|FG000|COMPLETED|Period 2 (Days 3-32)||18
2915727|NCT00511134|3626048|FG000|NOT COMPLETED|Overall Study||0
2915728|NCT00511134|3626049|FG001|NOT COMPLETED|Overall Study||2
2915729|NCT00511147|3626055|FG000|STARTED|Overall Study||64
2915730|NCT00511147|3626055|FG000|COMPLETED|Overall Study||57
2915731|NCT00511147|3626055|FG000|NOT COMPLETED|Overall Study||7
2915732|NCT00511173|3626059|FG000|STARTED|Overall Study||102
2915733|NCT00511173|3626059|FG000|COMPLETED|Overall Study||102
2915734|NCT00511173|3626059|FG000|NOT COMPLETED|Overall Study||0
2915735|NCT00511238|3626066|FG000|STARTED|Overall Study||46
2915736|NCT00511238|3626067|FG001|STARTED|Overall Study||266
2915737|NCT00511238|3626066|FG000|COMPLETED|Overall Study|Number of patients who completed 12 cycles of treatment|4
2915738|NCT00511238|3626067|FG001|COMPLETED|Overall Study|Number of patients who completed 12 cycles of treatment|40
2915739|NCT00511238|3626066|FG000|NOT COMPLETED|Overall Study||42
2915740|NCT00511238|3626067|FG001|NOT COMPLETED|Overall Study||226
2915741|NCT00511472|3626085|FG000|STARTED|Overall Study||47
2915742|NCT00511472|3626086|FG001|STARTED|Overall Study||23
2915743|NCT00511472|3626085|FG000|COMPLETED|Overall Study||44
2915744|NCT00511472|3626086|FG001|COMPLETED|Overall Study||17
2915745|NCT00511472|3626085|FG000|NOT COMPLETED|Overall Study||3
2915746|NCT00511472|3626086|FG001|NOT COMPLETED|Overall Study||6
2915747|NCT00511667|3626103|FG000|STARTED|Overall Study||52
2915748|NCT00511667|3626104|FG001|STARTED|Overall Study||18
2915749|NCT00511667|3626103|FG000|COMPLETED|Overall Study||40
2915750|NCT00511667|3626104|FG001|COMPLETED|Overall Study||15
2915751|NCT00511667|3626103|FG000|NOT COMPLETED|Overall Study||12
2915752|NCT00511667|3626104|FG001|NOT COMPLETED|Overall Study||3
2915753|NCT00511706|3626118|FG000|STARTED|Overall Study||123
2915754|NCT00511706|3626119|FG001|STARTED|Overall Study||120
2915755|NCT00511706|3626118|FG000|COMPLETED|Overall Study||115
2915756|NCT00511706|3626119|FG001|COMPLETED|Overall Study||115
2915757|NCT00511706|3626118|FG000|NOT COMPLETED|Overall Study||8
2915758|NCT00511706|3626119|FG001|NOT COMPLETED|Overall Study||5
2915759|NCT00511797|3626129|FG000|STARTED|Overall Study||62
2915760|NCT00511797|3626130|FG001|STARTED|Overall Study||63
2915761|NCT00511797|3626131|FG002|STARTED|Overall Study||62
2915762|NCT00511797|3626132|FG003|STARTED|Overall Study||62
2915763|NCT00511797|3626129|FG000|Subjects Dispensed Drugs|Overall Study||61
2915764|NCT00511797|3626130|FG001|Subjects Dispensed Drugs|Overall Study||63
2915765|NCT00511797|3626131|FG002|Subjects Dispensed Drugs|Overall Study||61
2915766|NCT00511797|3626132|FG003|Subjects Dispensed Drugs|Overall Study||59
2915767|NCT00511797|3626129|FG000|Subjects Received Treatment|Overall Study|FAS|61
2915768|NCT00511797|3626130|FG001|Subjects Received Treatment|Overall Study|FAS|62
2915769|NCT00511797|3626131|FG002|Subjects Received Treatment|Overall Study|FAS|61
2915770|NCT00511797|3626132|FG003|Subjects Received Treatment|Overall Study|FAS|58
2915771|NCT00511797|3626129|FG000|COMPLETED|Overall Study||55
2915772|NCT00511797|3626130|FG001|COMPLETED|Overall Study||55
2915773|NCT00511797|3626131|FG002|COMPLETED|Overall Study||51
2915774|NCT00511797|3626132|FG003|COMPLETED|Overall Study||47
2915775|NCT00511797|3626129|FG000|NOT COMPLETED|Overall Study||7
2915776|NCT00511797|3626130|FG001|NOT COMPLETED|Overall Study||8
2915777|NCT00511797|3626131|FG002|NOT COMPLETED|Overall Study||11
2915778|NCT00511797|3626132|FG003|NOT COMPLETED|Overall Study||15
2915779|NCT00511810|3626144|FG000|STARTED|Overall Study||8
2915780|NCT00511810|3626145|FG001|STARTED|Overall Study||12
2915781|NCT00511810|3626144|FG000|COMPLETED|Overall Study||7
2915782|NCT00511810|3626145|FG001|COMPLETED|Overall Study|2 terminated for worsening symptoms;1 refused a scan;2 lost to follow up (could not be contacted)|7
3167442|NCT01910311|3894690|FG000|NOT COMPLETED|Period 2 (Days 3-32)||0
2839909|NCT05087524|3541425|FG000|STARTED|Overall Study||65
2839910|NCT05087524|3541425|FG000|COMPLETED|Overall Study||65
2839911|NCT05087524|3541425|FG000|NOT COMPLETED|Overall Study||0
2839912|NCT04532294|3541432|FG000|STARTED|Overall Study||4
2839913|NCT04532294|3541433|FG001|STARTED|Overall Study||6
2839914|NCT04532294|3541434|FG002|STARTED|Overall Study||8
2839915|NCT04532294|3541432|FG000|COMPLETED|Overall Study||4
2839916|NCT04532294|3541433|FG001|COMPLETED|Overall Study||6
2839917|NCT04532294|3541434|FG002|COMPLETED|Overall Study||5
2839918|NCT04532294|3541432|FG000|NOT COMPLETED|Overall Study||0
2839919|NCT04532294|3541433|FG001|NOT COMPLETED|Overall Study||0
2839920|NCT04532294|3541434|FG002|NOT COMPLETED|Overall Study||3
2839921|NCT04250077|3541447|FG000|STARTED|Overall Study||15
2839922|NCT04250077|3541448|FG001|STARTED|Overall Study||15
2839923|NCT04250077|3541449|FG002|STARTED|Overall Study||15
2839924|NCT04250077|3541447|FG000|COMPLETED|Overall Study||13
2839925|NCT04250077|3541448|FG001|COMPLETED|Overall Study||11
2839926|NCT04250077|3541449|FG002|COMPLETED|Overall Study||15
2839927|NCT04250077|3541447|FG000|NOT COMPLETED|Overall Study||2
2839928|NCT04250077|3541448|FG001|NOT COMPLETED|Overall Study||4
2839929|NCT04250077|3541449|FG002|NOT COMPLETED|Overall Study||0
2839930|NCT04068142|3541461|FG000|STARTED|Overall Study||17
2839931|NCT04068142|3541462|FG001|STARTED|Overall Study||20
2839932|NCT04068142|3541461|FG000|COMPLETED|Overall Study||15
2839933|NCT04068142|3541462|FG001|COMPLETED|Overall Study||16
2839934|NCT04068142|3541461|FG000|NOT COMPLETED|Overall Study||2
2839935|NCT04068142|3541462|FG001|NOT COMPLETED|Overall Study||4
2839942|NCT03702439|3541476|FG000|STARTED|Overall Study||408
2839943|NCT03702439|3541476|FG000|COMPLETED|Overall Study||408
2839944|NCT03702439|3541476|FG000|NOT COMPLETED|Overall Study||0
2839945|NCT03687190|3541484|FG000|STARTED|Overall Study||12
2839946|NCT03687190|3541485|FG001|STARTED|Overall Study||9
2839947|NCT03687190|3541484|FG000|COMPLETED|Overall Study||12
2839948|NCT03687190|3541485|FG001|COMPLETED|Overall Study||9
2839949|NCT03687190|3541484|FG000|NOT COMPLETED|Overall Study||0
2839950|NCT03687190|3541485|FG001|NOT COMPLETED|Overall Study||0
2839951|NCT03583931|3541493|FG000|STARTED|Overall Study||5
2839952|NCT03583931|3541494|FG001|STARTED|Overall Study||5
2839953|NCT03583931|3541493|FG000|COMPLETED|Overall Study||5
2839954|NCT03583931|3541494|FG001|COMPLETED|Overall Study||5
2839955|NCT03583931|3541493|FG000|NOT COMPLETED|Overall Study||0
2839956|NCT03583931|3541494|FG001|NOT COMPLETED|Overall Study||0
2839957|NCT03441360|3541503|FG000|STARTED|Overall Study||8
2839958|NCT03441360|3541504|FG001|STARTED|Overall Study||8
2839959|NCT03441360|3541505|FG002|STARTED|Overall Study||5
2839960|NCT03441360|3541503|FG000|COMPLETED|Overall Study||0
2839961|NCT03441360|3541504|FG001|COMPLETED|Overall Study||0
2839962|NCT03441360|3541505|FG002|COMPLETED|Overall Study||0
2839963|NCT03441360|3541503|FG000|NOT COMPLETED|Overall Study||8
2839964|NCT03441360|3541504|FG001|NOT COMPLETED|Overall Study||8
2839965|NCT03441360|3541505|FG002|NOT COMPLETED|Overall Study||5
2839966|NCT03412565|3541517|FG000|STARTED|Overall Study||67
2839967|NCT03412565|3541518|FG001|STARTED|Overall Study||67
2839968|NCT03412565|3541519|FG002|STARTED|Overall Study||65
2839969|NCT03412565|3541520|FG003|STARTED|Overall Study||66
2839970|NCT03412565|3541517|FG000|COMPLETED|Overall Study||66
2839971|NCT03412565|3541518|FG001|COMPLETED|Overall Study||2
2839972|NCT03412565|3541519|FG002|COMPLETED|Overall Study||3
2839973|NCT03412565|3541520|FG003|COMPLETED|Overall Study||12
2839974|NCT03412565|3541517|FG000|NOT COMPLETED|Overall Study||1
2839975|NCT03412565|3541518|FG001|NOT COMPLETED|Overall Study||65
2839976|NCT03412565|3541519|FG002|NOT COMPLETED|Overall Study||62
2839977|NCT03412565|3541520|FG003|NOT COMPLETED|Overall Study||54
2839978|NCT03296553|3541537|FG000|STARTED|Overall Study||20
2839979|NCT03296553|3541538|FG001|STARTED|Overall Study||20
2839980|NCT03296553|3541537|FG000|COMPLETED|Overall Study||18
2839981|NCT03296553|3541538|FG001|COMPLETED|Overall Study||19
2839982|NCT03296553|3541537|FG000|NOT COMPLETED|Overall Study||2
3167443|NCT01910519|3894700|FG000|STARTED|Overall Study||35
3167444|NCT01910519|3894701|FG001|STARTED|Overall Study||15
3167445|NCT01910519|3894700|FG000|COMPLETED|Overall Study||31
3167446|NCT01910519|3894701|FG001|COMPLETED|Overall Study||15
3167447|NCT01910519|3894700|FG000|NOT COMPLETED|Overall Study||4
3167448|NCT01910519|3894701|FG001|NOT COMPLETED|Overall Study||0
3167449|NCT01910636|3894709|FG000|STARTED|Overall Study||90
3167450|NCT01910636|3894710|FG001|STARTED|Overall Study||63
3167451|NCT01910636|3894709|FG000|COMPLETED|Overall Study||90
3167452|NCT01910636|3894710|FG001|COMPLETED|Overall Study||63
3167453|NCT01910636|3894709|FG000|NOT COMPLETED|Overall Study||0
3167454|NCT01910636|3894710|FG001|NOT COMPLETED|Overall Study||0
3167455|NCT01910688|3894716|FG000|STARTED|Overall Study||25
3167456|NCT01910688|3894716|FG000|3.5month|Overall Study||25
3167457|NCT01910688|3894716|FG000|2nd RFA Treatment|Overall Study||22
3167458|NCT01910688|3894716|FG000|7.5months|Overall Study||24
3167459|NCT01910688|3894716|FG000|3rd RFA Treatment|Overall Study||18
2839983|NCT03296553|3541538|FG001|NOT COMPLETED|Overall Study||1
3034141|NCT01130532|3753143|FG000|COMPLETED|Period IV (Weeks 13-16)||0
3034142|NCT01130532|3753144|FG001|COMPLETED|Period IV (Weeks 13-16)||0
3034143|NCT01130532|3753145|FG002|COMPLETED|Period IV (Weeks 13-16)||0
3034144|NCT01130532|3753146|FG003|COMPLETED|Period IV (Weeks 13-16)||552
3034145|NCT01130532|3753143|FG000|NOT COMPLETED|Period IV (Weeks 13-16)||0
3034146|NCT01130532|3753144|FG001|NOT COMPLETED|Period IV (Weeks 13-16)||0
3034147|NCT01130532|3753145|FG002|NOT COMPLETED|Period IV (Weeks 13-16)||0
3167460|NCT01910688|3894716|FG000|12months|Overall Study||22
3167461|NCT01910688|3894716|FG000|COMPLETED|Overall Study||20
3167462|NCT01910688|3894716|FG000|NOT COMPLETED|Overall Study||5
3167463|NCT01910792|3894722|FG000|STARTED|Overall Study||9
3167464|NCT01910792|3894723|FG001|STARTED|Overall Study||10
3167465|NCT01910792|3894722|FG000|COMPLETED|Overall Study||9
3167466|NCT01910792|3894723|FG001|COMPLETED|Overall Study||10
3167467|NCT01910792|3894722|FG000|NOT COMPLETED|Overall Study||0
3167468|NCT01910792|3894723|FG001|NOT COMPLETED|Overall Study||0
3167469|NCT01910831|3894729|FG000|STARTED|Overall Study||20
3167470|NCT01910831|3894729|FG000|COMPLETED|Overall Study||19
3167471|NCT01910831|3894729|FG000|NOT COMPLETED|Overall Study||1
3167472|NCT01911065|3894736|FG000|STARTED|Overall Study||45
3167473|NCT01911065|3894737|FG001|STARTED|Overall Study||9
3167474|NCT01911065|3894736|FG000|COMPLETED|Overall Study||45
3167475|NCT01911065|3894737|FG001|COMPLETED|Overall Study||9
3167476|NCT01911065|3894736|FG000|NOT COMPLETED|Overall Study||0
3167477|NCT01911065|3894737|FG001|NOT COMPLETED|Overall Study||0
2839936|NCT03961009|3541468|FG000|STARTED|Overall Study||47
2839937|NCT03961009|3541468|FG000|COMPLETED|Overall Study||47
2839938|NCT03961009|3541468|FG000|NOT COMPLETED|Overall Study||0
2839939|NCT03875495|3541472|FG000|STARTED|Overall Study||3
2839940|NCT03875495|3541472|FG000|COMPLETED|Overall Study||0
2839941|NCT03875495|3541472|FG000|NOT COMPLETED|Overall Study||3
3034148|NCT01130532|3753146|FG003|NOT COMPLETED|Period IV (Weeks 13-16)||10
3034149|NCT01130597|3753158|FG000|STARTED|Overall Study||63
3034150|NCT01130597|3753158|FG000|COMPLETED|Overall Study||56
3034151|NCT01130597|3753158|FG000|NOT COMPLETED|Overall Study||7
3034152|NCT01130740|3753164|FG000|STARTED|Overall Study||149
3034153|NCT01130740|3753165|FG001|STARTED|Overall Study||151
3034154|NCT01130740|3753164|FG000|COMPLETED|Overall Study||137
3034155|NCT01130740|3753165|FG001|COMPLETED|Overall Study||136
3034156|NCT01130740|3753164|FG000|NOT COMPLETED|Overall Study||12
3034157|NCT01130740|3753165|FG001|NOT COMPLETED|Overall Study||15
3034158|NCT01130831|3753171|FG000|STARTED|Overall Study||66
3034159|NCT01130831|3753171|FG000|COMPLETED|Overall Study||52
3034160|NCT01130831|3753171|FG000|NOT COMPLETED|Overall Study||14
2840004|NCT03194646|3541569|FG000|STARTED|Overall Study||363
2840005|NCT03194646|3541570|FG001|STARTED|Overall Study||361
2840006|NCT03194646|3541571|FG002|STARTED|Overall Study||183
2840007|NCT03194646|3541572|FG003|STARTED|Overall Study||365
2840008|NCT03194646|3541569|FG000|Treated|Overall Study||349
2840009|NCT03194646|3541570|FG001|Treated|Overall Study||347
2840010|NCT03194646|3541571|FG002|Treated|Overall Study||177
2840011|NCT03194646|3541572|FG003|Treated|Overall Study||365
2840012|NCT03194646|3541569|FG000|COMPLETED|Overall Study||61
2840013|NCT03194646|3541570|FG001|COMPLETED|Overall Study||93
2840014|NCT03194646|3541571|FG002|COMPLETED|Overall Study||44
2840015|NCT03194646|3541572|FG003|COMPLETED|Overall Study||85
2840016|NCT03194646|3541569|FG000|NOT COMPLETED|Overall Study||302
2840017|NCT03194646|3541570|FG001|NOT COMPLETED|Overall Study||268
2840018|NCT03194646|3541571|FG002|NOT COMPLETED|Overall Study||139
2840019|NCT03194646|3541572|FG003|NOT COMPLETED|Overall Study||280
2840020|NCT03148795|3541587|FG000|STARTED|Overall Study||128
2840021|NCT03148795|3541587|FG000|Treated|Overall Study||127
2840022|NCT03148795|3541587|FG000|COMPLETED|Overall Study||0
2840023|NCT03148795|3541587|FG000|NOT COMPLETED|Overall Study||128
2840024|NCT03143218|3541594|FG000|STARTED|Overall Study||1965
2840025|NCT03143218|3541595|FG001|STARTED|Overall Study||1988
2840026|NCT03143218|3541596|FG002|STARTED|Overall Study||1967
2840027|NCT03143218|3541594|FG000|COMPLETED|Overall Study||1716
2840028|NCT03143218|3541595|FG001|COMPLETED|Overall Study||1734
2840029|NCT03143218|3541596|FG002|COMPLETED|Overall Study||1740
2840030|NCT03143218|3541594|FG000|NOT COMPLETED|Overall Study||249
2840031|NCT03143218|3541595|FG001|NOT COMPLETED|Overall Study||254
2840032|NCT03143218|3541596|FG002|NOT COMPLETED|Overall Study||227
2840033|NCT03052608|3541606|FG000|STARTED|Treatment Phase||149
2840034|NCT03052608|3541607|FG001|STARTED|Treatment Phase||147
2840035|NCT03052608|3541606|FG000|COMPLETED|Treatment Phase||26
2840036|NCT03052608|3541607|FG001|COMPLETED|Treatment Phase||83
2840037|NCT03052608|3541606|FG000|NOT COMPLETED|Treatment Phase||123
2840038|NCT03052608|3541607|FG001|NOT COMPLETED|Treatment Phase||64
2840039|NCT03052608|3541606|FG000|STARTED|Long-Term Follow-up Phase||149
2840040|NCT03052608|3541607|FG001|STARTED|Long-Term Follow-up Phase||147
2840041|NCT03052608|3541606|FG000|COMPLETED|Long-Term Follow-up Phase||0
2840042|NCT03052608|3541607|FG001|COMPLETED|Long-Term Follow-up Phase||0
2840043|NCT03052608|3541606|FG000|NOT COMPLETED|Long-Term Follow-up Phase||149
2840044|NCT03052608|3541607|FG001|NOT COMPLETED|Long-Term Follow-up Phase||147
2840045|NCT03038438|3541613|FG000|STARTED|Overall Study||200
2840046|NCT03038438|3541613|FG000|30-Day Follow-Up|Overall Study||198
2840047|NCT03038438|3541613|FG000|6-Month Follow-up|Overall Study||193
2840048|NCT03038438|3541613|FG000|12-Month Follow-up|Overall Study||191
2840049|NCT03038438|3541613|FG000|24-Month Follow-up|Overall Study||148
2840050|NCT03038438|3541613|FG000|COMPLETED|Overall Study||148
2840051|NCT03038438|3541613|FG000|NOT COMPLETED|Overall Study||52
3167478|NCT01911169|3894745|FG000|STARTED|Overall Study||6
3167479|NCT01911169|3894746|FG001|STARTED|Overall Study||3
3167480|NCT01911169|3894745|FG000|COMPLETED|Overall Study||6
3167481|NCT01911169|3894746|FG001|COMPLETED|Overall Study||3
3167482|NCT01911169|3894745|FG000|NOT COMPLETED|Overall Study||0
3167483|NCT01911169|3894746|FG001|NOT COMPLETED|Overall Study||0
3167484|NCT01911221|3894752|FG000|STARTED|Overall Study||13
3167485|NCT01911221|3894752|FG000|COMPLETED|Overall Study||13
2840052|NCT03000569|3541619|FG000|STARTED|Overall Study||15
2840053|NCT03000569|3541620|FG001|STARTED|Overall Study||14
2840054|NCT03000569|3541619|FG000|COMPLETED|Overall Study||14
2840055|NCT03000569|3541620|FG001|COMPLETED|Overall Study||14
2840056|NCT03000569|3541619|FG000|NOT COMPLETED|Overall Study||1
2840057|NCT03000569|3541620|FG001|NOT COMPLETED|Overall Study||0
2840058|NCT03000530|3541637|FG000|STARTED|Overall Study||13
2840059|NCT03000530|3541638|FG001|STARTED|Overall Study||44
2840060|NCT03000530|3541639|FG002|STARTED|Overall Study||45
2840061|NCT03000530|3541637|FG000|COMPLETED|Overall Study||13
3311645|NCT03054337|4045134|FG004|STARTED|Primary Efficacy Period (6 Weeks)||4
3311646|NCT03054337|4045135|FG005|STARTED|Primary Efficacy Period (6 Weeks)||5
3311647|NCT03054337|4045130|FG000|COMPLETED|Primary Efficacy Period (6 Weeks)||12
3311648|NCT03054337|4045131|FG001|COMPLETED|Primary Efficacy Period (6 Weeks)||12
3311649|NCT03054337|4045132|FG002|COMPLETED|Primary Efficacy Period (6 Weeks)||13
3311650|NCT03054337|4045133|FG003|COMPLETED|Primary Efficacy Period (6 Weeks)||5
3311651|NCT03054337|4045134|FG004|COMPLETED|Primary Efficacy Period (6 Weeks)||4
3311652|NCT03054337|4045135|FG005|COMPLETED|Primary Efficacy Period (6 Weeks)||5
3311653|NCT03054337|4045130|FG000|NOT COMPLETED|Primary Efficacy Period (6 Weeks)||0
3311654|NCT03054337|4045131|FG001|NOT COMPLETED|Primary Efficacy Period (6 Weeks)||0
3311655|NCT03054337|4045132|FG002|NOT COMPLETED|Primary Efficacy Period (6 Weeks)||0
3311656|NCT03054337|4045133|FG003|NOT COMPLETED|Primary Efficacy Period (6 Weeks)||0
3311657|NCT03054337|4045134|FG004|NOT COMPLETED|Primary Efficacy Period (6 Weeks)||0
3311658|NCT03054337|4045135|FG005|NOT COMPLETED|Primary Efficacy Period (6 Weeks)||0
3311659|NCT03054337|4045130|FG000|STARTED|Dose Adjustment and Maintenance Period||12
3311660|NCT03054337|4045131|FG001|STARTED|Dose Adjustment and Maintenance Period||12
3311661|NCT03054337|4045132|FG002|STARTED|Dose Adjustment and Maintenance Period||13
3311662|NCT03054337|4045133|FG003|STARTED|Dose Adjustment and Maintenance Period||5
3311663|NCT03054337|4045134|FG004|STARTED|Dose Adjustment and Maintenance Period||4
3311664|NCT03054337|4045135|FG005|STARTED|Dose Adjustment and Maintenance Period||5
3311665|NCT03054337|4045130|FG000|COMPLETED|Dose Adjustment and Maintenance Period||11
3311666|NCT03054337|4045131|FG001|COMPLETED|Dose Adjustment and Maintenance Period||10
3311667|NCT03054337|4045132|FG002|COMPLETED|Dose Adjustment and Maintenance Period||12
3311668|NCT03054337|4045133|FG003|COMPLETED|Dose Adjustment and Maintenance Period||5
3311669|NCT03054337|4045134|FG004|COMPLETED|Dose Adjustment and Maintenance Period||4
3311670|NCT03054337|4045135|FG005|COMPLETED|Dose Adjustment and Maintenance Period||4
3311671|NCT03054337|4045130|FG000|NOT COMPLETED|Dose Adjustment and Maintenance Period||1
3311672|NCT03054337|4045131|FG001|NOT COMPLETED|Dose Adjustment and Maintenance Period||2
3311673|NCT03054337|4045132|FG002|NOT COMPLETED|Dose Adjustment and Maintenance Period||1
3311674|NCT03054337|4045133|FG003|NOT COMPLETED|Dose Adjustment and Maintenance Period||0
3311675|NCT03054337|4045134|FG004|NOT COMPLETED|Dose Adjustment and Maintenance Period||0
3311676|NCT03054337|4045135|FG005|NOT COMPLETED|Dose Adjustment and Maintenance Period||1
3311677|NCT03054350|4045168|FG000|STARTED|Primary Efficacy Period (6 Weeks)||15
3311678|NCT03054350|4045169|FG001|STARTED|Primary Efficacy Period (6 Weeks)||15
2840062|NCT03000530|3541638|FG001|COMPLETED|Overall Study||39
2840063|NCT03000530|3541639|FG002|COMPLETED|Overall Study||41
2840064|NCT03000530|3541637|FG000|NOT COMPLETED|Overall Study||0
2840065|NCT03000530|3541638|FG001|NOT COMPLETED|Overall Study||5
2840066|NCT03000530|3541639|FG002|NOT COMPLETED|Overall Study||4
2840067|NCT02978781|3541653|FG000|STARTED|Part A||2
2840068|NCT02978781|3541654|FG001|STARTED|Part A||14
2840069|NCT02978781|3541655|FG002|STARTED|Part A||0
2840070|NCT02978781|3541656|FG003|STARTED|Part A||0
2840071|NCT02978781|3541657|FG004|STARTED|Part A||0
2840072|NCT02978781|3541653|FG000|COMPLETED|Part A||1
2840073|NCT02978781|3541654|FG001|COMPLETED|Part A||12
2840074|NCT02978781|3541655|FG002|COMPLETED|Part A||0
2840075|NCT02978781|3541656|FG003|COMPLETED|Part A||0
2840076|NCT02978781|3541657|FG004|COMPLETED|Part A||0
2840077|NCT02978781|3541653|FG000|NOT COMPLETED|Part A||1
2840078|NCT02978781|3541654|FG001|NOT COMPLETED|Part A||2
2840079|NCT02978781|3541655|FG002|NOT COMPLETED|Part A||0
2840080|NCT02978781|3541656|FG003|NOT COMPLETED|Part A||0
2840081|NCT02978781|3541657|FG004|NOT COMPLETED|Part A||0
2840082|NCT02978781|3541653|FG000|STARTED|Part B||0
2840083|NCT02978781|3541654|FG001|STARTED|Part B||0
2840084|NCT02978781|3541655|FG002|STARTED|Part B|Include participants who tolerated a dose ≥10 mg in Part A and achieved response on Day 8.|4
2840085|NCT02978781|3541656|FG003|STARTED|Part B|Include participants who tolerated a dose ≥10 mg in Part A and achieved response on Day 8.|4
2840086|NCT02978781|3541657|FG004|STARTED|Part B||0
2840087|NCT02978781|3541653|FG000|COMPLETED|Part B||0
2840088|NCT02978781|3541654|FG001|COMPLETED|Part B||0
3167486|NCT01911221|3894752|FG000|NOT COMPLETED|Overall Study||0
3167487|NCT01911260|3894760|FG000|STARTED|Supplementation Period||50
3167488|NCT01911260|3894761|FG001|STARTED|Supplementation Period||50
3167489|NCT01911260|3894762|FG002|STARTED|Supplementation Period||49
3167490|NCT01911260|3894763|FG003|STARTED|Supplementation Period||50
3167491|NCT01911260|3894760|FG000|COMPLETED|Supplementation Period||40
3167492|NCT01911260|3894761|FG001|COMPLETED|Supplementation Period||38
3167493|NCT01911260|3894762|FG002|COMPLETED|Supplementation Period||39
2840089|NCT02978781|3541655|FG002|COMPLETED|Part B||4
2840090|NCT02978781|3541656|FG003|COMPLETED|Part B||3
2840091|NCT02978781|3541657|FG004|COMPLETED|Part B||0
2840092|NCT02978781|3541653|FG000|NOT COMPLETED|Part B||0
3167494|NCT01911260|3894763|FG003|COMPLETED|Supplementation Period||42
2840093|NCT02978781|3541654|FG001|NOT COMPLETED|Part B||0
2840094|NCT02978781|3541655|FG002|NOT COMPLETED|Part B||0
2840095|NCT02978781|3541656|FG003|NOT COMPLETED|Part B||1
2840096|NCT02978781|3541657|FG004|NOT COMPLETED|Part B||0
2840097|NCT02978781|3541653|FG000|STARTED|Part C||0
2840098|NCT02978781|3541654|FG001|STARTED|Part C||0
2840099|NCT02978781|3541655|FG002|STARTED|Part C||0
2840100|NCT02978781|3541656|FG003|STARTED|Part C||0
2840101|NCT02978781|3541657|FG004|STARTED|Part C||18
2840102|NCT02978781|3541653|FG000|COMPLETED|Part C||0
2840103|NCT02978781|3541654|FG001|COMPLETED|Part C||0
2840104|NCT02978781|3541655|FG002|COMPLETED|Part C||0
2840105|NCT02978781|3541656|FG003|COMPLETED|Part C||0
2840106|NCT02978781|3541657|FG004|COMPLETED|Part C||14
2840107|NCT02978781|3541653|FG000|NOT COMPLETED|Part C||0
2840108|NCT02978781|3541654|FG001|NOT COMPLETED|Part C||0
2840109|NCT02978781|3541655|FG002|NOT COMPLETED|Part C||0
2840110|NCT02978781|3541656|FG003|NOT COMPLETED|Part C||0
2840111|NCT02978781|3541657|FG004|NOT COMPLETED|Part C||4
2840112|NCT02964507|3541691|FG000|STARTED|Overall Study||33
2840113|NCT02964507|3541692|FG001|STARTED|Overall Study||12
2840114|NCT02964507|3541693|FG002|STARTED|Overall Study||42
2840115|NCT02964507|3541694|FG003|STARTED|Overall Study||7
2840116|NCT02964507|3541695|FG004|STARTED|Overall Study||18
2840117|NCT02964507|3541696|FG005|STARTED|Overall Study||11
2840118|NCT02964507|3541697|FG006|STARTED|Overall Study||0
2840119|NCT02964507|3541698|FG007|STARTED|Overall Study||0
2840120|NCT02964507|3541691|FG000|COMPLETED|Overall Study||7
2840121|NCT02964507|3541692|FG001|COMPLETED|Overall Study||1
2840122|NCT02964507|3541693|FG002|COMPLETED|Overall Study||17
2840123|NCT02964507|3541694|FG003|COMPLETED|Overall Study||1
2840124|NCT02964507|3541695|FG004|COMPLETED|Overall Study||2
2840125|NCT02964507|3541696|FG005|COMPLETED|Overall Study||3
2840126|NCT02964507|3541697|FG006|COMPLETED|Overall Study||0
2840127|NCT02964507|3541698|FG007|COMPLETED|Overall Study||0
2840128|NCT02964507|3541691|FG000|NOT COMPLETED|Overall Study||26
2840129|NCT02964507|3541692|FG001|NOT COMPLETED|Overall Study||11
2840130|NCT02964507|3541693|FG002|NOT COMPLETED|Overall Study||25
2840131|NCT02964507|3541694|FG003|NOT COMPLETED|Overall Study||6
2840132|NCT02964507|3541695|FG004|NOT COMPLETED|Overall Study||16
2840133|NCT02964507|3541696|FG005|NOT COMPLETED|Overall Study||8
2840134|NCT02964507|3541697|FG006|NOT COMPLETED|Overall Study||0
2840135|NCT02964507|3541698|FG007|NOT COMPLETED|Overall Study||0
2840136|NCT02964078|3541717|FG000|STARTED|Overall Study||27
2840137|NCT02964078|3541717|FG000|COMPLETED|Overall Study||27
2840138|NCT02964078|3541717|FG000|NOT COMPLETED|Overall Study||0
2840139|NCT02942277|3541732|FG000|STARTED|Year 1||5
2840140|NCT02942277|3541733|FG001|STARTED|Year 1||10
2840141|NCT02942277|3541734|FG002|STARTED|Year 1||5
2840142|NCT02942277|3541735|FG003|STARTED|Year 1||10
2840143|NCT02942277|3541736|FG004|STARTED|Year 1||56
2840144|NCT02942277|3541737|FG005|STARTED|Year 1||61
2840145|NCT02942277|3541738|FG006|STARTED|Year 1||5
2840146|NCT02942277|3541739|FG007|STARTED|Year 1||10
2840147|NCT02942277|3541740|FG008|STARTED|Year 1||10
2840148|NCT02942277|3541741|FG009|STARTED|Year 1||10
2840149|NCT02942277|3541742|FG010|STARTED|Year 1||119
2840150|NCT02942277|3541732|FG000|COMPLETED|Year 1||5
2840151|NCT02942277|3541733|FG001|COMPLETED|Year 1||8
2840152|NCT02942277|3541734|FG002|COMPLETED|Year 1||5
2840153|NCT02942277|3541735|FG003|COMPLETED|Year 1||9
2840154|NCT02942277|3541736|FG004|COMPLETED|Year 1||49
2840155|NCT02942277|3541737|FG005|COMPLETED|Year 1||51
2840156|NCT02942277|3541738|FG006|COMPLETED|Year 1||5
2840157|NCT02942277|3541739|FG007|COMPLETED|Year 1||9
2840158|NCT02942277|3541740|FG008|COMPLETED|Year 1||10
2840159|NCT02942277|3541741|FG009|COMPLETED|Year 1||10
2840160|NCT02942277|3541742|FG010|COMPLETED|Year 1||104
2840161|NCT02942277|3541732|FG000|NOT COMPLETED|Year 1||0
2840162|NCT02942277|3541733|FG001|NOT COMPLETED|Year 1||2
2840163|NCT02942277|3541734|FG002|NOT COMPLETED|Year 1||0
2840164|NCT02942277|3541735|FG003|NOT COMPLETED|Year 1||1
2840165|NCT02942277|3541736|FG004|NOT COMPLETED|Year 1||7
2840166|NCT02942277|3541737|FG005|NOT COMPLETED|Year 1||10
2840167|NCT02942277|3541738|FG006|NOT COMPLETED|Year 1||0
2840168|NCT02942277|3541739|FG007|NOT COMPLETED|Year 1||1
2840169|NCT02942277|3541740|FG008|NOT COMPLETED|Year 1||0
2840170|NCT02942277|3541741|FG009|NOT COMPLETED|Year 1||0
2840171|NCT02942277|3541742|FG010|NOT COMPLETED|Year 1||15
2840172|NCT02942277|3541732|FG000|STARTED|Year 2||5
2840173|NCT02942277|3541733|FG001|STARTED|Year 2||8
2840174|NCT02942277|3541734|FG002|STARTED|Year 2||5
2840175|NCT02942277|3541735|FG003|STARTED|Year 2||9
2840176|NCT02942277|3541736|FG004|STARTED|Year 2||49
2840177|NCT02942277|3541737|FG005|STARTED|Year 2||51
2840178|NCT02942277|3541738|FG006|STARTED|Year 2||5
2840179|NCT02942277|3541739|FG007|STARTED|Year 2||9
2840180|NCT02942277|3541740|FG008|STARTED|Year 2||10
2840181|NCT02942277|3541741|FG009|STARTED|Year 2||10
2840182|NCT02942277|3541742|FG010|STARTED|Year 2||104
2840183|NCT02942277|3541732|FG000|COMPLETED|Year 2||5
2840184|NCT02942277|3541733|FG001|COMPLETED|Year 2||7
2840185|NCT02942277|3541734|FG002|COMPLETED|Year 2||4
2840186|NCT02942277|3541735|FG003|COMPLETED|Year 2||8
2840187|NCT02942277|3541736|FG004|COMPLETED|Year 2||36
2840188|NCT02942277|3541737|FG005|COMPLETED|Year 2||40
2840189|NCT02942277|3541738|FG006|COMPLETED|Year 2||4
2840190|NCT02942277|3541739|FG007|COMPLETED|Year 2||8
2840191|NCT02942277|3541740|FG008|COMPLETED|Year 2||10
2840192|NCT02942277|3541741|FG009|COMPLETED|Year 2||9
2840193|NCT02942277|3541742|FG010|COMPLETED|Year 2||79
2840194|NCT02942277|3541732|FG000|NOT COMPLETED|Year 2||0
2840195|NCT02942277|3541733|FG001|NOT COMPLETED|Year 2||1
2840196|NCT02942277|3541734|FG002|NOT COMPLETED|Year 2||1
2840197|NCT02942277|3541735|FG003|NOT COMPLETED|Year 2||1
2840198|NCT02942277|3541736|FG004|NOT COMPLETED|Year 2||13
2840199|NCT02942277|3541737|FG005|NOT COMPLETED|Year 2||11
2840200|NCT02942277|3541738|FG006|NOT COMPLETED|Year 2||1
2840201|NCT02942277|3541739|FG007|NOT COMPLETED|Year 2||1
2840202|NCT02942277|3541740|FG008|NOT COMPLETED|Year 2||0
2840203|NCT02942277|3541741|FG009|NOT COMPLETED|Year 2||1
2840204|NCT02942277|3541742|FG010|NOT COMPLETED|Year 2||25
2840205|NCT02942017|3541771|FG000|STARTED|Overall Study||54
2840206|NCT02942017|3541772|FG001|STARTED|Overall Study||54
2840207|NCT02942017|3541771|FG000|Treated|Overall Study||53
2840208|NCT02942017|3541772|FG001|Treated|Overall Study||51
2840209|NCT02942017|3541771|FG000|COMPLETED|Overall Study||52
2840210|NCT02942017|3541772|FG001|COMPLETED|Overall Study||48
2840211|NCT02942017|3541771|FG000|NOT COMPLETED|Overall Study||2
2840212|NCT02942017|3541772|FG001|NOT COMPLETED|Overall Study||6
2840213|NCT02942004|3541781|FG000|STARTED|Overall Study||46
2840214|NCT02942004|3541782|FG001|STARTED|Overall Study||47
2840215|NCT02942004|3541783|FG002|STARTED|Overall Study||45
2840216|NCT02942004|3541781|FG000|Participants Who Received Study Drug|Overall Study||43
2840217|NCT02942004|3541782|FG001|Participants Who Received Study Drug|Overall Study||38
2840218|NCT02942004|3541783|FG002|Participants Who Received Study Drug|Overall Study||41
2840219|NCT02942004|3541781|FG000|COMPLETED|Overall Study||42
2840220|NCT02942004|3541782|FG001|COMPLETED|Overall Study||35
2840221|NCT02942004|3541783|FG002|COMPLETED|Overall Study||36
2840222|NCT02942004|3541781|FG000|NOT COMPLETED|Overall Study||4
2840223|NCT02942004|3541782|FG001|NOT COMPLETED|Overall Study||12
2840224|NCT02942004|3541783|FG002|NOT COMPLETED|Overall Study||9
2915783|NCT00511810|3626144|FG000|NOT COMPLETED|Overall Study||1
2915784|NCT00511810|3626145|FG001|NOT COMPLETED|Overall Study||5
2915785|NCT00511836|3626153|FG000|STARTED|Double-blind Period||16
2915786|NCT00511836|3626154|FG001|STARTED|Double-blind Period||15
2915787|NCT00511836|3626153|FG000|COMPLETED|Double-blind Period||15
2915788|NCT00511836|3626154|FG001|COMPLETED|Double-blind Period||15
2915789|NCT00511836|3626153|FG000|NOT COMPLETED|Double-blind Period||1
2915790|NCT00511836|3626154|FG001|NOT COMPLETED|Double-blind Period||0
2915791|NCT00511836|3626153|FG000|STARTED|Optional Open-label VIVITROL (2 Months)|Subjects who received placebo during Month 1 switched to VIVITROL for the optional extension phase.|22
2915792|NCT00511836|3626154|FG001|STARTED|Optional Open-label VIVITROL (2 Months)|Not all subjects from the double-blind phase entered the optional open-label extension.|0
2915793|NCT00511836|3626153|FG000|COMPLETED|Optional Open-label VIVITROL (2 Months)||6
3167495|NCT01911260|3894760|FG000|NOT COMPLETED|Supplementation Period||10
3167496|NCT01911260|3894761|FG001|NOT COMPLETED|Supplementation Period||12
3167497|NCT01911260|3894762|FG002|NOT COMPLETED|Supplementation Period||10
3167498|NCT01911260|3894763|FG003|NOT COMPLETED|Supplementation Period||8
3167499|NCT01911260|3894760|FG000|STARTED|Follow-up Period||40
2915794|NCT00511836|3626154|FG001|COMPLETED|Optional Open-label VIVITROL (2 Months)||0
2915795|NCT00511836|3626153|FG000|NOT COMPLETED|Optional Open-label VIVITROL (2 Months)||16
2915796|NCT00511836|3626154|FG001|NOT COMPLETED|Optional Open-label VIVITROL (2 Months)||0
2915797|NCT00511862|3626164|FG000|STARTED|Overall Study||61
2915798|NCT00511862|3626165|FG001|STARTED|Overall Study||43
2915799|NCT00511862|3626166|FG002|STARTED|Overall Study||47
2915800|NCT00511862|3626164|FG000|COMPLETED|Overall Study||61
2915801|NCT00511862|3626165|FG001|COMPLETED|Overall Study||43
2915802|NCT00511862|3626166|FG002|COMPLETED|Overall Study||47
2915803|NCT00511862|3626164|FG000|NOT COMPLETED|Overall Study||0
2915804|NCT00511862|3626165|FG001|NOT COMPLETED|Overall Study||0
2915805|NCT00511862|3626166|FG002|NOT COMPLETED|Overall Study||0
2915806|NCT00511875|3626178|FG000|STARTED|Overall Study||15
2915807|NCT00511875|3626179|FG001|STARTED|Overall Study||15
2915808|NCT00511875|3626178|FG000|COMPLETED|Overall Study||10
2915809|NCT00511875|3626179|FG001|COMPLETED|Overall Study||15
2915810|NCT00511875|3626178|FG000|NOT COMPLETED|Overall Study||5
2915811|NCT00511875|3626179|FG001|NOT COMPLETED|Overall Study||0
2915812|NCT00511901|3626187|FG000|STARTED|Overall Study||11
2915813|NCT00511901|3626188|FG001|STARTED|Overall Study||11
2915814|NCT00511901|3626187|FG000|COMPLETED|Overall Study||10
2915815|NCT00511901|3626188|FG001|COMPLETED|Overall Study||8
2915816|NCT00511901|3626187|FG000|NOT COMPLETED|Overall Study||1
2915817|NCT00511901|3626188|FG001|NOT COMPLETED|Overall Study||3
2915818|NCT00511914|3626196|FG000|STARTED|Overall Study||68
2915819|NCT00511914|3626197|FG001|STARTED|Overall Study||67
2915820|NCT00511914|3626196|FG000|COMPLETED|Overall Study||68
2915821|NCT00511914|3626197|FG001|COMPLETED|Overall Study||67
2915822|NCT00511914|3626196|FG000|NOT COMPLETED|Overall Study||0
2915823|NCT00511914|3626197|FG001|NOT COMPLETED|Overall Study||0
2915824|NCT00511992|3626203|FG000|STARTED|Overall Study||20
2915825|NCT00511992|3626203|FG000|COMPLETED|Overall Study||13
2915826|NCT00511992|3626203|FG000|NOT COMPLETED|Overall Study||7
2915827|NCT00512096|3626207|FG000|STARTED|Overall Study||30
2915828|NCT00512096|3626207|FG000|COMPLETED|Overall Study||23
2915829|NCT00512096|3626207|FG000|NOT COMPLETED|Overall Study||7
2915830|NCT00512135|3626211|FG000|STARTED|Overall Study||801
2915831|NCT00512135|3626211|FG000|Treated|Overall Study||796
2915832|NCT00512135|3626211|FG000|COMPLETED|Overall Study||717
3167500|NCT01911260|3894761|FG001|STARTED|Follow-up Period||38
3167501|NCT01911260|3894762|FG002|STARTED|Follow-up Period||39
3167502|NCT01911260|3894763|FG003|STARTED|Follow-up Period||42
3311679|NCT03054350|4045170|FG002|STARTED|Primary Efficacy Period (6 Weeks)||15
2840225|NCT02924064|3541793|FG000|STARTED|Overall Study||123
2840226|NCT02924064|3541794|FG001|STARTED|Overall Study||124
2840227|NCT02924064|3541793|FG000|COMPLETED|Overall Study||99
2840228|NCT02924064|3541794|FG001|COMPLETED|Overall Study||81
2840229|NCT02924064|3541793|FG000|NOT COMPLETED|Overall Study||24
2840230|NCT02924064|3541794|FG001|NOT COMPLETED|Overall Study||43
2840231|NCT02916706|3541802|FG000|STARTED|Overall Study||127
2840232|NCT02916706|3541803|FG001|STARTED|Overall Study||127
2840233|NCT02916706|3541802|FG000|COMPLETED|Overall Study||112
2840234|NCT02916706|3541803|FG001|COMPLETED|Overall Study||96
2840235|NCT02916706|3541802|FG000|NOT COMPLETED|Overall Study||15
2840236|NCT02916706|3541803|FG001|NOT COMPLETED|Overall Study||31
2840237|NCT02890355|3541811|FG000|STARTED|Overall Study||59
2840238|NCT02890355|3541812|FG001|STARTED|Overall Study||58
2840239|NCT02890355|3541811|FG000|Treated & Assessed for AEs|Overall Study||56
2840240|NCT02890355|3541812|FG001|Treated & Assessed for AEs|Overall Study||50
2840241|NCT02890355|3541811|FG000|COMPLETED|Overall Study||0
2840242|NCT02890355|3541812|FG001|COMPLETED|Overall Study||0
2840243|NCT02890355|3541811|FG000|NOT COMPLETED|Overall Study||59
2840244|NCT02890355|3541812|FG001|NOT COMPLETED|Overall Study||58
3034161|NCT01130844|3753190|FG000|STARTED|Overall Study||21
3034162|NCT01130844|3753191|FG001|STARTED|Overall Study||22
3034163|NCT01130844|3753192|FG002|STARTED|Overall Study||9
3034164|NCT01130844|3753190|FG000|COMPLETED|Overall Study||21
3034165|NCT01130844|3753191|FG001|COMPLETED|Overall Study||22
3034166|NCT01130844|3753192|FG002|COMPLETED|Overall Study||9
3034167|NCT01130844|3753190|FG000|NOT COMPLETED|Overall Study||0
3034168|NCT01130844|3753191|FG001|NOT COMPLETED|Overall Study||0
3034169|NCT01130844|3753192|FG002|NOT COMPLETED|Overall Study||0
3034170|NCT01130883|3753203|FG000|STARTED|Overall Study||3130
3034171|NCT01130883|3753203|FG000|Participants Analyzed|Overall Study||3128
3034172|NCT01130883|3753203|FG000|COMPLETED|Overall Study||3120
2840257|NCT02861014|3541833|FG000|STARTED|Primary Analysis||680
2840258|NCT02861014|3541833|FG000|COMPLETED|Primary Analysis||641
2840259|NCT02861014|3541833|FG000|NOT COMPLETED|Primary Analysis||39
2840260|NCT02861014|3541833|FG000|STARTED|Safety Follow-up||64
2840261|NCT02861014|3541833|FG000|COMPLETED|Safety Follow-up||14
2840262|NCT02861014|3541833|FG000|NOT COMPLETED|Safety Follow-up||50
2840263|NCT02775435|3541841|FG000|STARTED|Overall Study||278
2840264|NCT02775435|3541842|FG001|STARTED|Overall Study||281
2840265|NCT02775435|3541841|FG000|Treated|Overall Study||278
2840266|NCT02775435|3541842|FG001|Treated|Overall Study||280
2840267|NCT02775435|3541841|FG000|Switched to Pembrolizumab+Chemotherapy|Overall Study||0
2840268|NCT02775435|3541842|FG001|Switched to Pembrolizumab+Chemotherapy|Overall Study||75
2840269|NCT02775435|3541841|FG000|COMPLETED|Overall Study||0
2840270|NCT02775435|3541842|FG001|COMPLETED|Overall Study||0
2840271|NCT02775435|3541841|FG000|NOT COMPLETED|Overall Study||278
2840272|NCT02775435|3541842|FG001|NOT COMPLETED|Overall Study||281
2840273|NCT02767531|3541848|FG000|STARTED|Period 1|Orlistat therapy|1
2840274|NCT02767531|3541849|FG001|STARTED|Period 1|Off Orlistat|1
2840275|NCT02767531|3541848|FG000|COMPLETED|Period 1||1
2840276|NCT02767531|3541849|FG001|COMPLETED|Period 1||1
2840277|NCT02767531|3541848|FG000|NOT COMPLETED|Period 1||0
2840278|NCT02767531|3541849|FG001|NOT COMPLETED|Period 1||0
2840279|NCT02767531|3541848|FG000|STARTED|Period 2|Off Orlistat|1
2840280|NCT02767531|3541849|FG001|STARTED|Period 2|Orlistat Therapy|1
2840281|NCT02767531|3541848|FG000|COMPLETED|Period 2||1
2840282|NCT02767531|3541849|FG001|COMPLETED|Period 2||1
2840283|NCT02767531|3541848|FG000|NOT COMPLETED|Period 2||0
2840284|NCT02767531|3541849|FG001|NOT COMPLETED|Period 2||0
2840285|NCT02767531|3541848|FG000|STARTED|Period 3|Orlistat Therapy|1
2840286|NCT02767531|3541849|FG001|STARTED|Period 3|Off Orlistat|1
2840287|NCT02767531|3541848|FG000|COMPLETED|Period 3||1
2840288|NCT02767531|3541849|FG001|COMPLETED|Period 3||1
2840289|NCT02767531|3541848|FG000|NOT COMPLETED|Period 3||0
2840290|NCT02767531|3541849|FG001|NOT COMPLETED|Period 3||0
2840291|NCT02767531|3541848|FG000|STARTED|Period 4|Off Orlistat|1
2840292|NCT02767531|3541849|FG001|STARTED|Period 4|Orlistat Therapy|1
2840293|NCT02767531|3541848|FG000|COMPLETED|Period 4||1
2840294|NCT02767531|3541849|FG001|COMPLETED|Period 4||1
2840295|NCT02767531|3541848|FG000|NOT COMPLETED|Period 4||0
2840296|NCT02767531|3541849|FG001|NOT COMPLETED|Period 4||0
2840297|NCT02726880|3541857|FG000|STARTED|Overall Study||17
2840298|NCT02726880|3541858|FG001|STARTED|Overall Study||19
2840299|NCT02726880|3541857|FG000|COMPLETED|Overall Study||14
2840300|NCT02726880|3541858|FG001|COMPLETED|Overall Study||16
2840301|NCT02726880|3541857|FG000|NOT COMPLETED|Overall Study||3
2840302|NCT02726880|3541858|FG001|NOT COMPLETED|Overall Study||3
3034173|NCT01130883|3753203|FG000|NOT COMPLETED|Overall Study||10
3034174|NCT01130896|3753207|FG000|STARTED|Overall Study||1509
3034175|NCT01130896|3753207|FG000|COMPLETED|Overall Study||1509
3034176|NCT01130896|3753207|FG000|NOT COMPLETED|Overall Study||0
3034177|NCT01130974|3753213|FG000|STARTED|Overall Study||100
3034178|NCT01130974|3753214|FG001|STARTED|Overall Study||100
3034179|NCT01130974|3753213|FG000|COMPLETED|Overall Study||85
3034180|NCT01130974|3753214|FG001|COMPLETED|Overall Study||87
3034181|NCT01130974|3753213|FG000|NOT COMPLETED|Overall Study||15
3034182|NCT01130974|3753214|FG001|NOT COMPLETED|Overall Study||13
3034183|NCT01131052|3753223|FG000|STARTED|Overall Study||75
3034184|NCT01131052|3753224|FG001|STARTED|Overall Study||75
3034185|NCT01131052|3753223|FG000|COMPLETED|Overall Study||75
3034186|NCT01131052|3753224|FG001|COMPLETED|Overall Study||75
3034187|NCT01131052|3753223|FG000|NOT COMPLETED|Overall Study||0
3034188|NCT01131052|3753224|FG001|NOT COMPLETED|Overall Study||0
3034189|NCT01131065|3753230|FG000|STARTED|Overall Study||15
3034190|NCT01131065|3753230|FG000|COMPLETED|Overall Study||15
3034191|NCT01131065|3753230|FG000|NOT COMPLETED|Overall Study||0
3034192|NCT01131078|3753237|FG000|STARTED|Overall Study||101
2840323|NCT02642042|3541895|FG000|STARTED|Overall Study||54
2840324|NCT02642042|3541895|FG000|COMPLETED|Overall Study||0
2840325|NCT02642042|3541895|FG000|NOT COMPLETED|Overall Study||54
2840326|NCT02614547|3541901|FG000|STARTED|Overall Study||11
2840327|NCT02614547|3541902|FG001|STARTED|Overall Study||10
2840328|NCT02614547|3541901|FG000|COMPLETED|Overall Study||11
2840329|NCT02614547|3541902|FG001|COMPLETED|Overall Study||10
2840330|NCT02614547|3541901|FG000|NOT COMPLETED|Overall Study||0
2840331|NCT02614547|3541902|FG001|NOT COMPLETED|Overall Study||0
2840332|NCT02601209|3541918|FG000|STARTED|Initial Treatment (Up to 4 Months)|Pre-registered|4
2840333|NCT02601209|3541919|FG001|STARTED|Initial Treatment (Up to 4 Months)|Pre-registered|4
2840334|NCT02601209|3541920|FG002|STARTED|Initial Treatment (Up to 4 Months)|Pre-registered|4
2840335|NCT02601209|3541921|FG003|STARTED|Initial Treatment (Up to 4 Months)|Randomized|6
2840336|NCT02601209|3541922|FG004|STARTED|Initial Treatment (Up to 4 Months)|Randomized|13
2840337|NCT02601209|3541923|FG005|STARTED|Initial Treatment (Up to 4 Months)|Randomized|15
2840338|NCT02601209|3541924|FG006|STARTED|Initial Treatment (Up to 4 Months)|Randomized|56
2840339|NCT02601209|3541925|FG007|STARTED|Initial Treatment (Up to 4 Months)|Randomized|6
2840340|NCT02601209|3541926|FG008|STARTED|Initial Treatment (Up to 4 Months)|Randomized|43
2840341|NCT02601209|3541918|FG000|COMPLETED|Initial Treatment (Up to 4 Months)|Registered|3
2840342|NCT02601209|3541919|FG001|COMPLETED|Initial Treatment (Up to 4 Months)|Registered|3
2840343|NCT02601209|3541920|FG002|COMPLETED|Initial Treatment (Up to 4 Months)|Registered|3
2840344|NCT02601209|3541921|FG003|COMPLETED|Initial Treatment (Up to 4 Months)|Received treatment; included in safety analysis|6
2840345|NCT02601209|3541922|FG004|COMPLETED|Initial Treatment (Up to 4 Months)|Received treatment; included in safety analysis|12
2840346|NCT02601209|3541923|FG005|COMPLETED|Initial Treatment (Up to 4 Months)|Received treatment; included in safety analysis|13
2840347|NCT02601209|3541924|FG006|COMPLETED|Initial Treatment (Up to 4 Months)|Received treatment; included in safety analysis|55
2840348|NCT02601209|3541925|FG007|COMPLETED|Initial Treatment (Up to 4 Months)|Received treatment; included in safety analysis|6
2840349|NCT02601209|3541926|FG008|COMPLETED|Initial Treatment (Up to 4 Months)|Received treatment; included in safety analysis|43
2840350|NCT02601209|3541918|FG000|NOT COMPLETED|Initial Treatment (Up to 4 Months)||1
2840351|NCT02601209|3541919|FG001|NOT COMPLETED|Initial Treatment (Up to 4 Months)||1
2840352|NCT02601209|3541920|FG002|NOT COMPLETED|Initial Treatment (Up to 4 Months)||1
2840353|NCT02601209|3541921|FG003|NOT COMPLETED|Initial Treatment (Up to 4 Months)||0
2840354|NCT02601209|3541922|FG004|NOT COMPLETED|Initial Treatment (Up to 4 Months)||1
2840355|NCT02601209|3541923|FG005|NOT COMPLETED|Initial Treatment (Up to 4 Months)||2
2840356|NCT02601209|3541924|FG006|NOT COMPLETED|Initial Treatment (Up to 4 Months)||1
2840357|NCT02601209|3541925|FG007|NOT COMPLETED|Initial Treatment (Up to 4 Months)||0
2840358|NCT02601209|3541926|FG008|NOT COMPLETED|Initial Treatment (Up to 4 Months)||0
2840359|NCT02601209|3541918|FG000|STARTED|Optional Crossover (Up to 2 Months)||0
2840360|NCT02601209|3541919|FG001|STARTED|Optional Crossover (Up to 2 Months)||0
2840361|NCT02601209|3541920|FG002|STARTED|Optional Crossover (Up to 2 Months)||0
2840362|NCT02601209|3541921|FG003|STARTED|Optional Crossover (Up to 2 Months)||0
2840363|NCT02601209|3541922|FG004|STARTED|Optional Crossover (Up to 2 Months)||0
2840364|NCT02601209|3541923|FG005|STARTED|Optional Crossover (Up to 2 Months)||0
2840365|NCT02601209|3541924|FG006|STARTED|Optional Crossover (Up to 2 Months)||0
2840366|NCT02601209|3541925|FG007|STARTED|Optional Crossover (Up to 2 Months)|PD on pazopanib|6
2840367|NCT02601209|3541926|FG008|STARTED|Optional Crossover (Up to 2 Months)|PD on pazopanib|43
2840368|NCT02601209|3541918|FG000|COMPLETED|Optional Crossover (Up to 2 Months)||0
2840369|NCT02601209|3541919|FG001|COMPLETED|Optional Crossover (Up to 2 Months)||0
2840370|NCT02601209|3541920|FG002|COMPLETED|Optional Crossover (Up to 2 Months)||0
2840371|NCT02601209|3541921|FG003|COMPLETED|Optional Crossover (Up to 2 Months)||0
2840372|NCT02601209|3541922|FG004|COMPLETED|Optional Crossover (Up to 2 Months)||0
2840373|NCT02601209|3541923|FG005|COMPLETED|Optional Crossover (Up to 2 Months)||0
3167503|NCT01911260|3894760|FG000|COMPLETED|Follow-up Period||27
3167504|NCT01911260|3894761|FG001|COMPLETED|Follow-up Period||18
3167505|NCT01911260|3894762|FG002|COMPLETED|Follow-up Period||24
3167506|NCT01911260|3894763|FG003|COMPLETED|Follow-up Period||30
3167507|NCT01911260|3894760|FG000|NOT COMPLETED|Follow-up Period||13
3167508|NCT01911260|3894761|FG001|NOT COMPLETED|Follow-up Period||20
2840374|NCT02601209|3541924|FG006|COMPLETED|Optional Crossover (Up to 2 Months)||0
2840375|NCT02601209|3541925|FG007|COMPLETED|Optional Crossover (Up to 2 Months)|Initiated crossover to MLN0128 following PD on pazopanib|4
2840376|NCT02601209|3541926|FG008|COMPLETED|Optional Crossover (Up to 2 Months)|Initiated crossover to MLN0128 following PD on pazopanib|26
2840377|NCT02601209|3541918|FG000|NOT COMPLETED|Optional Crossover (Up to 2 Months)||0
2840378|NCT02601209|3541919|FG001|NOT COMPLETED|Optional Crossover (Up to 2 Months)||0
2840379|NCT02601209|3541920|FG002|NOT COMPLETED|Optional Crossover (Up to 2 Months)||0
3167509|NCT01911260|3894762|FG002|NOT COMPLETED|Follow-up Period||15
3167510|NCT01911260|3894763|FG003|NOT COMPLETED|Follow-up Period||12
3167511|NCT01911273|3894775|FG000|STARTED|Overall Study||1
3167512|NCT01911273|3894776|FG001|STARTED|Overall Study||2
2840380|NCT02601209|3541921|FG003|NOT COMPLETED|Optional Crossover (Up to 2 Months)||0
2840381|NCT02601209|3541922|FG004|NOT COMPLETED|Optional Crossover (Up to 2 Months)||0
2840382|NCT02601209|3541923|FG005|NOT COMPLETED|Optional Crossover (Up to 2 Months)||0
2840383|NCT02601209|3541924|FG006|NOT COMPLETED|Optional Crossover (Up to 2 Months)||0
2840384|NCT02601209|3541925|FG007|NOT COMPLETED|Optional Crossover (Up to 2 Months)||2
2840385|NCT02601209|3541926|FG008|NOT COMPLETED|Optional Crossover (Up to 2 Months)||17
2840386|NCT02592551|3541943|FG000|STARTED|Overall Study||9
2840387|NCT02592551|3541944|FG001|STARTED|Overall Study||11
2840388|NCT02592551|3541945|FG002|STARTED|Overall Study||4
2840389|NCT02592551|3541943|FG000|COMPLETED|Overall Study|One participant completed all study procedures and got the tumor sample for analysis. However, the sample was too small to analyze in the lab and so that it was not evaluable for primary and secondary analysis.|8
2840390|NCT02592551|3541944|FG001|COMPLETED|Overall Study||8
2840391|NCT02592551|3541945|FG002|COMPLETED|Overall Study||4
2840392|NCT02592551|3541943|FG000|NOT COMPLETED|Overall Study||1
2840393|NCT02592551|3541944|FG001|NOT COMPLETED|Overall Study||3
2840394|NCT02592551|3541945|FG002|NOT COMPLETED|Overall Study||0
2840395|NCT02583048|3541957|FG000|STARTED|Overall Study||28
2840396|NCT02583048|3541958|FG001|STARTED|Overall Study||28
2840397|NCT02583048|3541959|FG002|STARTED|Overall Study||28
2840398|NCT02583048|3541957|FG000|COMPLETED|Overall Study||28
2840399|NCT02583048|3541958|FG001|COMPLETED|Overall Study||27
2840400|NCT02583048|3541959|FG002|COMPLETED|Overall Study||27
2840401|NCT02583048|3541957|FG000|NOT COMPLETED|Overall Study||0
2840402|NCT02583048|3541958|FG001|NOT COMPLETED|Overall Study||1
2840403|NCT02583048|3541959|FG002|NOT COMPLETED|Overall Study||1
2840404|NCT02574481|3541974|FG000|STARTED|Overall Study||309
2840405|NCT02574481|3541975|FG001|STARTED|Overall Study||156
2840406|NCT02574481|3541976|FG002|STARTED|Overall Study||50
2840407|NCT02574481|3541977|FG003|STARTED|Overall Study||13
2840408|NCT02574481|3541974|FG000|COMPLETED|Overall Study||282
2840409|NCT02574481|3541975|FG001|COMPLETED|Overall Study||142
2840410|NCT02574481|3541976|FG002|COMPLETED|Overall Study||47
2840411|NCT02574481|3541977|FG003|COMPLETED|Overall Study||13
2840412|NCT02574481|3541974|FG000|NOT COMPLETED|Overall Study||27
2840413|NCT02574481|3541975|FG001|NOT COMPLETED|Overall Study||14
2840414|NCT02574481|3541976|FG002|NOT COMPLETED|Overall Study||3
2840415|NCT02574481|3541977|FG003|NOT COMPLETED|Overall Study||0
2840416|NCT02546986|3541992|FG000|STARTED|Treatment Period||51
2840417|NCT02546986|3541993|FG001|STARTED|Treatment Period||49
2840418|NCT02546986|3541992|FG000|COMPLETED|Treatment Period||0
2840419|NCT02546986|3541993|FG001|COMPLETED|Treatment Period||0
2840420|NCT02546986|3541992|FG000|NOT COMPLETED|Treatment Period||51
2840421|NCT02546986|3541993|FG001|NOT COMPLETED|Treatment Period||49
2840422|NCT02546986|3541992|FG000|STARTED|Survival Follow-Up Phase||36
2840423|NCT02546986|3541993|FG001|STARTED|Survival Follow-Up Phase||35
2840424|NCT02546986|3541992|FG000|COMPLETED|Survival Follow-Up Phase||0
2840425|NCT02546986|3541993|FG001|COMPLETED|Survival Follow-Up Phase||0
2840426|NCT02546986|3541992|FG000|NOT COMPLETED|Survival Follow-Up Phase||36
2840427|NCT02546986|3541993|FG001|NOT COMPLETED|Survival Follow-Up Phase||35
2840428|NCT02539160|3542001|FG000|STARTED|Phase 1 Pre-crossover||24
2840429|NCT02539160|3542002|FG001|STARTED|Phase 1 Pre-crossover||24
2840430|NCT02539160|3542003|FG002|STARTED|Phase 1 Pre-crossover||22
2840431|NCT02539160|3542004|FG003|STARTED|Phase 1 Pre-crossover||22
2840432|NCT02539160|3542001|FG000|COMPLETED|Phase 1 Pre-crossover||19
2840433|NCT02539160|3542002|FG001|COMPLETED|Phase 1 Pre-crossover||20
2840434|NCT02539160|3542003|FG002|COMPLETED|Phase 1 Pre-crossover||19
2840435|NCT02539160|3542004|FG003|COMPLETED|Phase 1 Pre-crossover||19
2840436|NCT02539160|3542001|FG000|NOT COMPLETED|Phase 1 Pre-crossover||5
2840437|NCT02539160|3542002|FG001|NOT COMPLETED|Phase 1 Pre-crossover||4
2840438|NCT02539160|3542003|FG002|NOT COMPLETED|Phase 1 Pre-crossover||3
2840439|NCT02539160|3542004|FG003|NOT COMPLETED|Phase 1 Pre-crossover||3
2840440|NCT02539160|3542001|FG000|STARTED|Phase 2 Post-crossover||19
2840441|NCT02539160|3542002|FG001|STARTED|Phase 2 Post-crossover||20
2840442|NCT02539160|3542003|FG002|STARTED|Phase 2 Post-crossover||19
2840443|NCT02539160|3542004|FG003|STARTED|Phase 2 Post-crossover||19
2840444|NCT02539160|3542001|FG000|COMPLETED|Phase 2 Post-crossover||19
2840445|NCT02539160|3542002|FG001|COMPLETED|Phase 2 Post-crossover||20
2840446|NCT02539160|3542003|FG002|COMPLETED|Phase 2 Post-crossover||19
2840447|NCT02539160|3542004|FG003|COMPLETED|Phase 2 Post-crossover||19
2840448|NCT02539160|3542001|FG000|NOT COMPLETED|Phase 2 Post-crossover||0
2840449|NCT02539160|3542002|FG001|NOT COMPLETED|Phase 2 Post-crossover||0
2840450|NCT02539160|3542003|FG002|NOT COMPLETED|Phase 2 Post-crossover||0
2840451|NCT02539160|3542004|FG003|NOT COMPLETED|Phase 2 Post-crossover||0
2840452|NCT02507973|3542014|FG000|STARTED|Overall Study||8
2840453|NCT02507973|3542014|FG000|COMPLETED|Overall Study||7
2840454|NCT02507973|3542014|FG000|NOT COMPLETED|Overall Study||1
2840455|NCT02500797|3542028|FG000|STARTED|Overall Study||43
2840456|NCT02500797|3542029|FG001|STARTED|Overall Study||42
2840457|NCT02500797|3542030|FG002|STARTED|Overall Study||15
2840458|NCT02500797|3542031|FG003|STARTED|Overall Study||14
2840459|NCT02500797|3542032|FG004|STARTED|Overall Study||14
2840460|NCT02500797|3542033|FG005|STARTED|Overall Study||15
2840461|NCT02500797|3542034|FG006|STARTED|Overall Study||10
2840462|NCT02500797|3542035|FG007|STARTED|Overall Study||11
2840463|NCT02500797|3542028|FG000|Arm I Crossover|Overall Study||4
2840464|NCT02500797|3542029|FG001|Arm I Crossover|Overall Study||0
2840465|NCT02500797|3542030|FG002|Arm I Crossover|Overall Study||6
2840466|NCT02500797|3542031|FG003|Arm I Crossover|Overall Study||0
2840467|NCT02500797|3542032|FG004|Arm I Crossover|Overall Study||1
2840468|NCT02500797|3542033|FG005|Arm I Crossover|Overall Study||0
2840469|NCT02500797|3542034|FG006|Arm I Crossover|Overall Study||2
2840470|NCT02500797|3542035|FG007|Arm I Crossover|Overall Study||0
2840471|NCT02500797|3542028|FG000|COMPLETED|Overall Study||42
2840472|NCT02500797|3542029|FG001|COMPLETED|Overall Study||42
2840473|NCT02500797|3542030|FG002|COMPLETED|Overall Study||15
2840474|NCT02500797|3542031|FG003|COMPLETED|Overall Study||14
2840475|NCT02500797|3542032|FG004|COMPLETED|Overall Study||13
2840476|NCT02500797|3542033|FG005|COMPLETED|Overall Study||14
2840477|NCT02500797|3542034|FG006|COMPLETED|Overall Study||10
2840478|NCT02500797|3542035|FG007|COMPLETED|Overall Study||11
2840479|NCT02500797|3542028|FG000|NOT COMPLETED|Overall Study||1
2840480|NCT02500797|3542029|FG001|NOT COMPLETED|Overall Study||0
2840481|NCT02500797|3542030|FG002|NOT COMPLETED|Overall Study||0
2840482|NCT02500797|3542031|FG003|NOT COMPLETED|Overall Study||0
2840483|NCT02500797|3542032|FG004|NOT COMPLETED|Overall Study||1
2840484|NCT02500797|3542033|FG005|NOT COMPLETED|Overall Study||1
2840485|NCT02500797|3542034|FG006|NOT COMPLETED|Overall Study||0
2840486|NCT02500797|3542035|FG007|NOT COMPLETED|Overall Study||0
3034193|NCT01131078|3753238|FG001|STARTED|Overall Study||102
3034194|NCT01131078|3753239|FG002|STARTED|Overall Study||103
3034195|NCT01131078|3753237|FG000|COMPLETED|Overall Study||0
3034196|NCT01131078|3753238|FG001|COMPLETED|Overall Study||1
3034197|NCT01131078|3753239|FG002|COMPLETED|Overall Study||1
3034198|NCT01131078|3753237|FG000|NOT COMPLETED|Overall Study||101
3034199|NCT01131078|3753238|FG001|NOT COMPLETED|Overall Study||101
3034200|NCT01131078|3753239|FG002|NOT COMPLETED|Overall Study||102
3034201|NCT01131104|3753249|FG000|STARTED|Overall Study||345
3034202|NCT01131104|3753249|FG000|Study Set|Overall Study||344
3034203|NCT01131104|3753249|FG000|Adjudication-Confirmed NAION Set|Overall Study||279
3034204|NCT01131104|3753249|FG000|30-Day Analysis Set|Overall Study||24
2840499|NCT02477696|3542072|FG000|STARTED|Overall Study|3 patients withdrew after being randomized but prior to receiving Acalabrutinib treatment.|268
2840500|NCT02477696|3542073|FG001|STARTED|Overall Study|1 patient withdrew after being randomized but prior to receiving Ibrutinib treatment.|265
2840501|NCT02477696|3542072|FG000|COMPLETED|Overall Study||127
2840502|NCT02477696|3542073|FG001|COMPLETED|Overall Study||110
2840503|NCT02477696|3542072|FG000|NOT COMPLETED|Overall Study||141
2840504|NCT02477696|3542073|FG001|NOT COMPLETED|Overall Study||155
2840505|NCT02477618|3542081|FG000|STARTED|Overall Study||65
2840506|NCT02477618|3542082|FG001|STARTED|Overall Study||67
2840507|NCT02477618|3542081|FG000|Intent-to-Treat Analysis Set|Overall Study||66
2840508|NCT02477618|3542082|FG001|Intent-to-Treat Analysis Set|Overall Study||66
2840509|NCT02477618|3542081|FG000|COMPLETED|Overall Study||50
2840510|NCT02477618|3542082|FG001|COMPLETED|Overall Study||53
2840511|NCT02477618|3542081|FG000|NOT COMPLETED|Overall Study||15
2840512|NCT02477618|3542082|FG001|NOT COMPLETED|Overall Study||14
2915833|NCT00512135|3626211|FG000|NOT COMPLETED|Overall Study||84
2915834|NCT00512148|3626216|FG000|STARTED|Primay Study Period||7
2915835|NCT00512148|3626216|FG000|COMPLETED|Primay Study Period||6
2915836|NCT00512148|3626216|FG000|NOT COMPLETED|Primay Study Period||1
2915837|NCT00512148|3626216|FG000|STARTED|Long Term Follow Up Period||6
2915838|NCT00512148|3626216|FG000|COMPLETED|Long Term Follow Up Period|6 patients are being followed in long term follow up|0
2915839|NCT00512148|3626216|FG000|NOT COMPLETED|Long Term Follow Up Period||6
2915840|NCT00512252|3626225|FG000|STARTED|Overall Study||3
2915841|NCT00512252|3626226|FG001|STARTED|Overall Study||3
2915842|NCT00512252|3626227|FG002|STARTED|Overall Study||46
2915843|NCT00512252|3626225|FG000|COMPLETED|Overall Study||3
2915844|NCT00512252|3626226|FG001|COMPLETED|Overall Study||3
2915845|NCT00512252|3626227|FG002|COMPLETED|Overall Study||43
2915846|NCT00512252|3626225|FG000|NOT COMPLETED|Overall Study||0
2915847|NCT00512252|3626226|FG001|NOT COMPLETED|Overall Study||0
2915848|NCT00512252|3626227|FG002|NOT COMPLETED|Overall Study||3
2915849|NCT00512278|3626244|FG000|STARTED|Overall Study||73
2915850|NCT00512278|3626245|FG001|STARTED|Overall Study||73
2915851|NCT00512278|3626244|FG000|COMPLETED|Overall Study||45
2915852|NCT00512278|3626245|FG001|COMPLETED|Overall Study||56
2915853|NCT00512278|3626244|FG000|NOT COMPLETED|Overall Study||28
2915854|NCT00512278|3626245|FG001|NOT COMPLETED|Overall Study||17
2915855|NCT00512707|3626255|FG000|STARTED|Overall Study||70
2915856|NCT00512707|3626256|FG001|STARTED|Overall Study||70
2915857|NCT00512707|3626255|FG000|COMPLETED|Overall Study||60
2915858|NCT00512707|3626256|FG001|COMPLETED|Overall Study||58
2915859|NCT00512707|3626255|FG000|NOT COMPLETED|Overall Study||10
2915860|NCT00512707|3626256|FG001|NOT COMPLETED|Overall Study||12
2915861|NCT00512798|3626264|FG000|STARTED|Overall Study||19
2915862|NCT00512798|3626265|FG001|STARTED|Overall Study||28
2915863|NCT00512798|3626264|FG000|COMPLETED|Overall Study||0
2915864|NCT00512798|3626265|FG001|COMPLETED|Overall Study||1
2915865|NCT00512798|3626264|FG000|NOT COMPLETED|Overall Study||19
2915866|NCT00512798|3626265|FG001|NOT COMPLETED|Overall Study||27
2915867|NCT00512876|3626272|FG000|STARTED|Overall Study||24
2915868|NCT00512876|3626272|FG000|COMPLETED|Overall Study||20
2915869|NCT00512876|3626272|FG000|NOT COMPLETED|Overall Study||4
2915870|NCT00512902|3626276|FG000|STARTED|Overall Study||20
2915871|NCT00512902|3626276|FG000|COMPLETED|Overall Study||12
2915872|NCT00512902|3626276|FG000|NOT COMPLETED|Overall Study||8
2915873|NCT00513019|3626282|FG000|STARTED|Overall Study||17
2915874|NCT00513019|3626283|FG001|STARTED|Overall Study||18
2915875|NCT00513019|3626282|FG000|COMPLETED|Overall Study||12
2840513|NCT02424851|3542090|FG000|STARTED|Overall Study||16
2840514|NCT02424851|3542091|FG001|STARTED|Overall Study||15
2840515|NCT02424851|3542090|FG000|COMPLETED|Overall Study||14
2840516|NCT02424851|3542091|FG001|COMPLETED|Overall Study||12
2840517|NCT02424851|3542090|FG000|NOT COMPLETED|Overall Study||2
2840518|NCT02424851|3542091|FG001|NOT COMPLETED|Overall Study||3
2840519|NCT02285504|3542097|FG000|STARTED|Overall Study||4
2840520|NCT02285504|3542097|FG000|COMPLETED|Overall Study||4
2840521|NCT02285504|3542097|FG000|NOT COMPLETED|Overall Study||0
3034205|NCT01131104|3753249|FG000|42-Day Analysis Set|Overall Study||28
3034206|NCT01131104|3753249|FG000|12-Month Analysis Set|Overall Study||26
3034207|NCT01131104|3753249|FG000|COMPLETED|Overall Study||332
3034208|NCT01131104|3753249|FG000|NOT COMPLETED|Overall Study||13
2840526|NCT02257528|3542105|FG000|STARTED|Overall Study||26
2840527|NCT02257528|3542105|FG000|COMPLETED|Overall Study||25
2840528|NCT02257528|3542105|FG000|NOT COMPLETED|Overall Study||1
3034209|NCT01131130|3753253|FG000|STARTED|Period 1 - Baseline||118
3034210|NCT01131130|3753253|FG000|COMPLETED|Period 1 - Baseline|Participant was discontinued 1 day following dispensing and not reported in result tables|117
3034211|NCT01131130|3753253|FG000|NOT COMPLETED|Period 1 - Baseline||1
3034212|NCT01131130|3753253|FG000|STARTED|Period 2 - Crossover||117
3034213|NCT01131130|3753253|FG000|COMPLETED|Period 2 - Crossover||117
3034214|NCT01131130|3753253|FG000|NOT COMPLETED|Period 2 - Crossover||0
3034215|NCT01131130|3753253|FG000|STARTED|Period 3- Crossover||117
3034216|NCT01131130|3753253|FG000|COMPLETED|Period 3- Crossover||116
2840537|NCT02227394|3542118|FG000|STARTED|Overall Study||10
2840538|NCT02227394|3542119|FG001|STARTED|Overall Study||10
2840539|NCT02227394|3542118|FG000|COMPLETED|Overall Study||10
2840540|NCT02227394|3542119|FG001|COMPLETED|Overall Study||10
2840541|NCT02227394|3542118|FG000|NOT COMPLETED|Overall Study||0
2840542|NCT02227394|3542119|FG001|NOT COMPLETED|Overall Study||0
3034217|NCT01131130|3753253|FG000|NOT COMPLETED|Period 3- Crossover||1
3034218|NCT01131182|3753263|FG000|STARTED|Overall Study||529
3034219|NCT01131182|3753264|FG001|STARTED|Overall Study||537
3034220|NCT01131182|3753263|FG000|COMPLETED|Overall Study||513
3034221|NCT01131182|3753264|FG001|COMPLETED|Overall Study||521
3034222|NCT01131182|3753263|FG000|NOT COMPLETED|Overall Study||16
3034223|NCT01131182|3753264|FG001|NOT COMPLETED|Overall Study||16
3034224|NCT01131260|3753272|FG000|STARTED|Overall Study||5532
3034225|NCT01131260|3753273|FG001|STARTED|Overall Study||5576
3034226|NCT01131260|3753272|FG000|COMPLETED|Overall Study||5488
3034227|NCT01131260|3753273|FG001|COMPLETED|Overall Study||5529
3034228|NCT01131260|3753272|FG000|NOT COMPLETED|Overall Study||44
3034229|NCT01131260|3753273|FG001|NOT COMPLETED|Overall Study||47
3034230|NCT01131299|3753281|FG000|STARTED|Overall Study||42
3034231|NCT01131299|3753282|FG001|STARTED|Overall Study||44
3034232|NCT01131299|3753281|FG000|COMPLETED|Overall Study||38
3034233|NCT01131299|3753282|FG001|COMPLETED|Overall Study||37
3034234|NCT01131299|3753281|FG000|NOT COMPLETED|Overall Study||4
3034235|NCT01131299|3753282|FG001|NOT COMPLETED|Overall Study||7
3034236|NCT01131312|3753290|FG000|STARTED|Overall Study||1839
3034237|NCT01131312|3753291|FG001|STARTED|Overall Study||1385
3034238|NCT01131312|3753292|FG002|STARTED|Overall Study||1836
3034239|NCT01131312|3753290|FG000|COMPLETED|Overall Study||1414
3034240|NCT01131312|3753291|FG001|COMPLETED|Overall Study||1156
2840567|NCT02073968|3542152|FG000|STARTED|Overall Study||35
2840568|NCT02073968|3542152|FG000|COMPLETED|Overall Study||35
2840569|NCT02073968|3542152|FG000|NOT COMPLETED|Overall Study||0
2840570|NCT02003924|3542158|FG000|STARTED|Double-blind Phase||933
2840571|NCT02003924|3542159|FG001|STARTED|Double-blind Phase||468
3167513|NCT01911273|3894775|FG000|COMPLETED|Overall Study||0
3167514|NCT01911273|3894776|FG001|COMPLETED|Overall Study||0
3167515|NCT01911273|3894775|FG000|NOT COMPLETED|Overall Study||1
3167516|NCT01911273|3894776|FG001|NOT COMPLETED|Overall Study||2
2840572|NCT02003924|3542160|FG002|STARTED|Double-blind Phase||0
2840573|NCT02003924|3542158|FG000|Treated|Double-blind Phase||930
2840574|NCT02003924|3542159|FG001|Treated|Double-blind Phase||465
2840575|NCT02003924|3542160|FG002|Treated|Double-blind Phase||0
2840576|NCT02003924|3542158|FG000|COMPLETED|Double-blind Phase||478
2840577|NCT02003924|3542159|FG001|COMPLETED|Double-blind Phase||87
2840578|NCT02003924|3542160|FG002|COMPLETED|Double-blind Phase||0
2840579|NCT02003924|3542158|FG000|NOT COMPLETED|Double-blind Phase||455
2840580|NCT02003924|3542159|FG001|NOT COMPLETED|Double-blind Phase||381
2840581|NCT02003924|3542160|FG002|NOT COMPLETED|Double-blind Phase||0
2840582|NCT02003924|3542158|FG000|STARTED|Open-label Phase||478
2840583|NCT02003924|3542159|FG001|STARTED|Open-label Phase|Participants were offered to switch from double blind placebo to open label Enzalutamide.|0
2840584|NCT02003924|3542160|FG002|STARTED|Open-label Phase|Participants previously treated with placebo, switched to receive open label Enzalutamide.|87
2840585|NCT02003924|3542158|FG000|Treated|Open-label Phase||478
2840586|NCT02003924|3542159|FG001|Treated|Open-label Phase||0
2840587|NCT02003924|3542160|FG002|Treated|Open-label Phase||87
2840588|NCT02003924|3542158|FG000|COMPLETED|Open-label Phase||378
2840589|NCT02003924|3542159|FG001|COMPLETED|Open-label Phase||0
2840590|NCT02003924|3542160|FG002|COMPLETED|Open-label Phase||70
2840591|NCT02003924|3542158|FG000|NOT COMPLETED|Open-label Phase||100
2840592|NCT02003924|3542159|FG001|NOT COMPLETED|Open-label Phase||0
2840593|NCT02003924|3542160|FG002|NOT COMPLETED|Open-label Phase||17
2840594|NCT02003924|3542158|FG000|STARTED|Long-term Follow-up Phase|Participants followed up after discontinuing study drug in either double blind or open label phase.|933
3167517|NCT01911351|3894784|FG000|STARTED|Overall Study||39
2840595|NCT02003924|3542159|FG001|STARTED|Long-term Follow-up Phase|Participants were followed up after study drug discontinuation in double blind phase.|381
2840596|NCT02003924|3542160|FG002|STARTED|Long-term Follow-up Phase|Participants were followed up after study drug discontinuation in open label phase.|87
2840597|NCT02003924|3542158|FG000|COMPLETED|Long-term Follow-up Phase||566
2840598|NCT02003924|3542159|FG001|COMPLETED|Long-term Follow-up Phase||144
2840599|NCT02003924|3542160|FG002|COMPLETED|Long-term Follow-up Phase||80
2840600|NCT02003924|3542158|FG000|NOT COMPLETED|Long-term Follow-up Phase||367
2840601|NCT02003924|3542159|FG001|NOT COMPLETED|Long-term Follow-up Phase||237
2840602|NCT02003924|3542160|FG002|NOT COMPLETED|Long-term Follow-up Phase||7
2840603|NCT01971970|3542169|FG000|STARTED|Baseline Until Week 6||24
2840604|NCT01971970|3542170|FG001|STARTED|Baseline Until Week 6||21
2840605|NCT01971970|3542169|FG000|Receiving Standard Therapy|Baseline Until Week 6||23
2840606|NCT01971970|3542170|FG001|Receiving Standard Therapy|Baseline Until Week 6||21
2840607|NCT01971970|3542169|FG000|Therapy Escalation|Baseline Until Week 6||1
2840608|NCT01971970|3542170|FG001|Therapy Escalation|Baseline Until Week 6||0
2840609|NCT01971970|3542169|FG000|COMPLETED|Baseline Until Week 6||23
2840610|NCT01971970|3542170|FG001|COMPLETED|Baseline Until Week 6||21
2840611|NCT01971970|3542169|FG000|NOT COMPLETED|Baseline Until Week 6||1
2840612|NCT01971970|3542170|FG001|NOT COMPLETED|Baseline Until Week 6||0
2840613|NCT01971970|3542169|FG000|STARTED|Week 6 Until Week 8||23
2840614|NCT01971970|3542170|FG001|STARTED|Week 6 Until Week 8||21
2840615|NCT01971970|3542169|FG000|Receiving Standard Therapy|Week 6 Until Week 8||23
2840616|NCT01971970|3542170|FG001|Receiving Standard Therapy|Week 6 Until Week 8||20
2840617|NCT01971970|3542169|FG000|COMPLETED|Week 6 Until Week 8||23
2840618|NCT01971970|3542170|FG001|COMPLETED|Week 6 Until Week 8||20
2840619|NCT01971970|3542169|FG000|NOT COMPLETED|Week 6 Until Week 8||0
2840620|NCT01971970|3542170|FG001|NOT COMPLETED|Week 6 Until Week 8||1
2840621|NCT01971970|3542169|FG000|STARTED|Week 8 Until Week 14||23
2840622|NCT01971970|3542170|FG001|STARTED|Week 8 Until Week 14||20
2840623|NCT01971970|3542169|FG000|Receiving Standard Therapy|Week 8 Until Week 14||16
2840624|NCT01971970|3542170|FG001|Receiving Standard Therapy|Week 8 Until Week 14||19
2840625|NCT01971970|3542169|FG000|Therapy Escalation|Week 8 Until Week 14||7
2840626|NCT01971970|3542170|FG001|Therapy Escalation|Week 8 Until Week 14||1
2840627|NCT01971970|3542169|FG000|COMPLETED|Week 8 Until Week 14||23
2840628|NCT01971970|3542170|FG001|COMPLETED|Week 8 Until Week 14||20
2840629|NCT01971970|3542169|FG000|NOT COMPLETED|Week 8 Until Week 14||0
2840630|NCT01971970|3542170|FG001|NOT COMPLETED|Week 8 Until Week 14||0
2840631|NCT01971970|3542169|FG000|STARTED|Week 14 Until Week 22||23
2840632|NCT01971970|3542170|FG001|STARTED|Week 14 Until Week 22||20
2840633|NCT01971970|3542169|FG000|Receiving Standard Therapy|Week 14 Until Week 22||12
2840634|NCT01971970|3542170|FG001|Receiving Standard Therapy|Week 14 Until Week 22||16
2840635|NCT01971970|3542169|FG000|Therapy Escalation|Week 14 Until Week 22||3
2840636|NCT01971970|3542170|FG001|Therapy Escalation|Week 14 Until Week 22||2
2840637|NCT01971970|3542169|FG000|COMPLETED|Week 14 Until Week 22||23
2840638|NCT01971970|3542170|FG001|COMPLETED|Week 14 Until Week 22||19
2840639|NCT01971970|3542169|FG000|NOT COMPLETED|Week 14 Until Week 22||0
2840640|NCT01971970|3542170|FG001|NOT COMPLETED|Week 14 Until Week 22||1
2840641|NCT01971970|3542169|FG000|STARTED|Week 22 Until Week 52||23
2840642|NCT01971970|3542170|FG001|STARTED|Week 22 Until Week 52||19
2840643|NCT01971970|3542169|FG000|Receiving Standard Therapy|Week 22 Until Week 52||5
2840644|NCT01971970|3542170|FG001|Receiving Standard Therapy|Week 22 Until Week 52||9
2840645|NCT01971970|3542169|FG000|Therapy Escalation|Week 22 Until Week 52||6
2840646|NCT01971970|3542170|FG001|Therapy Escalation|Week 22 Until Week 52||6
2840647|NCT01971970|3542169|FG000|COMPLETED|Week 22 Until Week 52||15
2840648|NCT01971970|3542170|FG001|COMPLETED|Week 22 Until Week 52||15
2840649|NCT01971970|3542169|FG000|NOT COMPLETED|Week 22 Until Week 52||8
2840650|NCT01971970|3542170|FG001|NOT COMPLETED|Week 22 Until Week 52||4
2840651|NCT01971970|3542169|FG000|STARTED|Week 52 Until Week 78||15
2840652|NCT01971970|3542170|FG001|STARTED|Week 52 Until Week 78||15
2840653|NCT01971970|3542169|FG000|COMPLETED|Week 52 Until Week 78||14
2840654|NCT01971970|3542170|FG001|COMPLETED|Week 52 Until Week 78||12
2840655|NCT01971970|3542169|FG000|NOT COMPLETED|Week 52 Until Week 78||1
2840656|NCT01971970|3542170|FG001|NOT COMPLETED|Week 52 Until Week 78||3
2840657|NCT01969409|3542183|FG000|STARTED|Overall Study||28
2840658|NCT01969409|3542184|FG001|STARTED|Overall Study||30
2840659|NCT01969409|3542183|FG000|COMPLETED|Overall Study||25
2840660|NCT01969409|3542184|FG001|COMPLETED|Overall Study||26
2840661|NCT01969409|3542183|FG000|NOT COMPLETED|Overall Study||3
2840662|NCT01969409|3542184|FG001|NOT COMPLETED|Overall Study||4
3034241|NCT01131312|3753292|FG002|COMPLETED|Overall Study||1485
3034242|NCT01131312|3753290|FG000|NOT COMPLETED|Overall Study||425
3034243|NCT01131312|3753291|FG001|NOT COMPLETED|Overall Study||229
3034244|NCT01131312|3753292|FG002|NOT COMPLETED|Overall Study||351
3034245|NCT01131325|3753300|FG000|STARTED|Overall Study||3
3034246|NCT01131325|3753300|FG000|COMPLETED|Overall Study||0
3034247|NCT01131325|3753300|FG000|NOT COMPLETED|Overall Study||3
2840671|NCT01853748|3542201|FG000|STARTED|Allocation||384
2840672|NCT01853748|3542202|FG001|STARTED|Allocation||128
2840673|NCT01853748|3542201|FG000|COMPLETED|Allocation||383
2840674|NCT01853748|3542202|FG001|COMPLETED|Allocation||114
2840675|NCT01853748|3542201|FG000|NOT COMPLETED|Allocation||1
2840676|NCT01853748|3542202|FG001|NOT COMPLETED|Allocation||14
2840677|NCT01853748|3542201|FG000|STARTED|Follow-Up||383
2840678|NCT01853748|3542202|FG001|STARTED|Follow-Up||114
2840679|NCT01853748|3542201|FG000|COMPLETED|Follow-Up||293
2840680|NCT01853748|3542202|FG001|COMPLETED|Follow-Up||97
2840681|NCT01853748|3542201|FG000|NOT COMPLETED|Follow-Up||90
2840682|NCT01853748|3542202|FG001|NOT COMPLETED|Follow-Up||17
2840683|NCT01665144|3542219|FG000|STARTED|Overall Study||1105
2840684|NCT01665144|3542220|FG001|STARTED|Overall Study||546
2840685|NCT01665144|3542219|FG000|Safety Set|Overall Study||1099
2840686|NCT01665144|3542220|FG001|Safety Set|Overall Study||546
2840687|NCT01665144|3542219|FG000|Full Analysis Set|Overall Study||1099
2840688|NCT01665144|3542220|FG001|Full Analysis Set|Overall Study||546
2840689|NCT01665144|3542219|FG000|COMPLETED|Overall Study||903
2840690|NCT01665144|3542220|FG001|COMPLETED|Overall Study||424
2840691|NCT01665144|3542219|FG000|NOT COMPLETED|Overall Study||202
2840692|NCT01665144|3542220|FG001|NOT COMPLETED|Overall Study||122
3034248|NCT01131351|3753306|FG000|STARTED|Overall Study||5
3034249|NCT01131351|3753307|FG001|STARTED|Overall Study||5
3034250|NCT01131351|3753306|FG000|COMPLETED|Overall Study||5
3034251|NCT01131351|3753307|FG001|COMPLETED|Overall Study||2
3034252|NCT01131351|3753306|FG000|NOT COMPLETED|Overall Study||0
3034253|NCT01131351|3753307|FG001|NOT COMPLETED|Overall Study||3
3034254|NCT01131494|3753313|FG000|STARTED|Overall Study||17
3034255|NCT01131494|3753313|FG000|COMPLETED|Overall Study||15
3034256|NCT01131494|3753313|FG000|NOT COMPLETED|Overall Study||2
3034257|NCT01131507|3753318|FG000|STARTED|Overall Study||15
3034258|NCT01131507|3753318|FG000|COMPLETED|Overall Study||12
3034259|NCT01131507|3753318|FG000|NOT COMPLETED|Overall Study||3
3034260|NCT01131520|3753324|FG000|STARTED|Overall Study||180
3034261|NCT01131520|3753325|FG001|STARTED|Overall Study||180
3034262|NCT01131520|3753324|FG000|COMPLETED|Overall Study||179
2840708|NCT01385176|3542249|FG000|STARTED|Randomization Phase|The randomization phase of the study started after implant of the investigational device system.|63
2840709|NCT01385176|3542250|FG001|STARTED|Randomization Phase|The randomization phase of the study started after implant of the investigational device system.|32
2840710|NCT01385176|3542249|FG000|COMPLETED|Randomization Phase|The study randomization phase ended after all patients have had their 6 month follow-up visit.|62
2840711|NCT01385176|3542250|FG001|COMPLETED|Randomization Phase|The study randomization phase ended after all patients have had their 6 month follow-up visit.|30
2840712|NCT01385176|3542249|FG000|NOT COMPLETED|Randomization Phase||1
2840713|NCT01385176|3542250|FG001|NOT COMPLETED|Randomization Phase||2
2840714|NCT01385176|3542249|FG000|STARTED|6-18 Month All VNS Active|Primary Study Phase ended with completion of the 18 months follow-up visit for the last patient|62
2840715|NCT01385176|3542250|FG001|STARTED|6-18 Month All VNS Active|Primary Study Phase ended with completion of the 18 months follow-up visit for the last patient|30
2840716|NCT01385176|3542249|FG000|COMPLETED|6-18 Month All VNS Active||58
2840717|NCT01385176|3542250|FG001|COMPLETED|6-18 Month All VNS Active||27
2840718|NCT01385176|3542249|FG000|NOT COMPLETED|6-18 Month All VNS Active||4
2840719|NCT01385176|3542250|FG001|NOT COMPLETED|6-18 Month All VNS Active||3
2915876|NCT00513019|3626283|FG001|COMPLETED|Overall Study||13
2915877|NCT00513019|3626282|FG000|NOT COMPLETED|Overall Study||5
2915878|NCT00513019|3626283|FG001|NOT COMPLETED|Overall Study||5
3311680|NCT03054350|4045171|FG003|STARTED|Primary Efficacy Period (6 Weeks)||5
3311681|NCT03054350|4045172|FG004|STARTED|Primary Efficacy Period (6 Weeks)||5
3311682|NCT03054350|4045173|FG005|STARTED|Primary Efficacy Period (6 Weeks)||5
3311683|NCT03054350|4045168|FG000|COMPLETED|Primary Efficacy Period (6 Weeks)||11
3311684|NCT03054350|4045169|FG001|COMPLETED|Primary Efficacy Period (6 Weeks)||13
3311685|NCT03054350|4045170|FG002|COMPLETED|Primary Efficacy Period (6 Weeks)||13
3311686|NCT03054350|4045171|FG003|COMPLETED|Primary Efficacy Period (6 Weeks)||3
3311687|NCT03054350|4045172|FG004|COMPLETED|Primary Efficacy Period (6 Weeks)||1
3311688|NCT03054350|4045173|FG005|COMPLETED|Primary Efficacy Period (6 Weeks)||2
2915879|NCT00513071|3626289|FG000|STARTED|Overall Study||28
2915880|NCT00513071|3626289|FG000|COMPLETED|Overall Study||23
2915881|NCT00513071|3626289|FG000|NOT COMPLETED|Overall Study||5
2915882|NCT00513240|3626295|FG000|STARTED|Overall Study|3 did not have intended surgery; 28 had all 3 doses; 4 had 1 dose but no more due to delayed surgery|35
2915883|NCT00513240|3626296|FG001|STARTED|Overall Study|25 had 3 doses; 1 had 1 dose due to rash; 1 had 2 doses and 1 dose of EPO due to pharmacy error|27
2915884|NCT00513240|3626295|FG000|Clinical Data Collection &Pre/Postop MRI|Overall Study|3 not having intended surgery are subtracted from original 35 subjects, leaving 32|32
2915885|NCT00513240|3626296|FG001|Clinical Data Collection &Pre/Postop MRI|Overall Study||27
2915886|NCT00513240|3626295|FG000|COMPLETED|Overall Study|Competed 12 month neurodevelopmental exam, which are the only results published at this time.|22
2915887|NCT00513240|3626296|FG001|COMPLETED|Overall Study|Competed 12 month neurodevelopmental exam, which are the only results published at this time.|20
2915888|NCT00513240|3626295|FG000|NOT COMPLETED|Overall Study||13
2915889|NCT00513240|3626296|FG001|NOT COMPLETED|Overall Study||7
2915890|NCT00513292|3626307|FG000|STARTED|Overall Study||138
2915891|NCT00513292|3626308|FG001|STARTED|Overall Study||142
2915892|NCT00513292|3626307|FG000|COMPLETED|Overall Study||138
2915893|NCT00513292|3626308|FG001|COMPLETED|Overall Study||142
2915894|NCT00513292|3626307|FG000|NOT COMPLETED|Overall Study||0
2915895|NCT00513292|3626308|FG001|NOT COMPLETED|Overall Study||0
2915896|NCT00513305|3626316|FG000|STARTED|Overall Study||33
2915897|NCT00513305|3626317|FG001|STARTED|Overall Study|One subject withdrew prior to receiving study medication|34
2915898|NCT00513305|3626316|FG000|COMPLETED|Overall Study||5
2915899|NCT00513305|3626317|FG001|COMPLETED|Overall Study||7
2915900|NCT00513305|3626316|FG000|NOT COMPLETED|Overall Study||28
2915901|NCT00513305|3626317|FG001|NOT COMPLETED|Overall Study||27
3034263|NCT01131520|3753325|FG001|COMPLETED|Overall Study||176
2840723|NCT01307787|3542267|FG000|STARTED|Overall Study||19
2840724|NCT01307787|3542268|FG001|STARTED|Overall Study||15
2840725|NCT01307787|3542267|FG000|T1= After 9 Weeks Post Intervention|Overall Study||18
2840726|NCT01307787|3542268|FG001|T1= After 9 Weeks Post Intervention|Overall Study||15
2840727|NCT01307787|3542267|FG000|T2= After 22 Weeks at Follow-up|Overall Study||17
2840728|NCT01307787|3542268|FG001|T2= After 22 Weeks at Follow-up|Overall Study||15
2840729|NCT01307787|3542267|FG000|COMPLETED|Overall Study||17
2840730|NCT01307787|3542268|FG001|COMPLETED|Overall Study||15
2840731|NCT01307787|3542267|FG000|NOT COMPLETED|Overall Study||2
2840732|NCT01307787|3542268|FG001|NOT COMPLETED|Overall Study||0
2840733|NCT01275677|3542281|FG000|STARTED|Overall Study||1630
2840734|NCT01275677|3542282|FG001|STARTED|Overall Study||1640
2840735|NCT01275677|3542281|FG000|COMPLETED|Overall Study||1602
2840736|NCT01275677|3542282|FG001|COMPLETED|Overall Study||1598
2840737|NCT01275677|3542281|FG000|NOT COMPLETED|Overall Study||28
2840738|NCT01275677|3542282|FG001|NOT COMPLETED|Overall Study||42
2840739|NCT01250912|3542288|FG000|STARTED|Overall Study||20
2840740|NCT01250912|3542288|FG000|COMPLETED|Overall Study||19
2840741|NCT01250912|3542288|FG000|NOT COMPLETED|Overall Study||1
2840742|NCT01218555|3542295|FG000|STARTED|Overall Study||3
2840743|NCT01218555|3542296|FG001|STARTED|Overall Study||3
2840744|NCT01218555|3542297|FG002|STARTED|Overall Study||5
2840745|NCT01218555|3542298|FG003|STARTED|Overall Study||3
2840746|NCT01218555|3542299|FG004|STARTED|Overall Study||8
2840747|NCT01218555|3542300|FG005|STARTED|Overall Study||22
2840748|NCT01218555|3542295|FG000|COMPLETED|Overall Study||3
2840749|NCT01218555|3542296|FG001|COMPLETED|Overall Study||3
2840750|NCT01218555|3542297|FG002|COMPLETED|Overall Study||5
2840751|NCT01218555|3542298|FG003|COMPLETED|Overall Study||3
2840752|NCT01218555|3542299|FG004|COMPLETED|Overall Study||8
2840753|NCT01218555|3542300|FG005|COMPLETED|Overall Study||22
2840754|NCT01218555|3542295|FG000|NOT COMPLETED|Overall Study||0
2840755|NCT01218555|3542296|FG001|NOT COMPLETED|Overall Study||0
2840756|NCT01218555|3542297|FG002|NOT COMPLETED|Overall Study||0
2840757|NCT01218555|3542298|FG003|NOT COMPLETED|Overall Study||0
2840758|NCT01218555|3542299|FG004|NOT COMPLETED|Overall Study||0
2840759|NCT01218555|3542300|FG005|NOT COMPLETED|Overall Study||0
2840772|NCT01141712|3542324|FG000|STARTED|Overall Study||43
2840773|NCT01141712|3542324|FG000|COMPLETED|Overall Study||40
2840774|NCT01141712|3542324|FG000|NOT COMPLETED|Overall Study||3
2840775|NCT01111305|3542330|FG000|STARTED|Overall Study||4
2840776|NCT01111305|3542331|FG001|STARTED|Overall Study||4
2840777|NCT01111305|3542330|FG000|COMPLETED|Overall Study||4
2840778|NCT01111305|3542331|FG001|COMPLETED|Overall Study||4
2840779|NCT01111305|3542330|FG000|NOT COMPLETED|Overall Study||0
2840780|NCT01111305|3542331|FG001|NOT COMPLETED|Overall Study||0
2840781|NCT00843882|3542342|FG000|STARTED|Step 1||38
2840782|NCT00843882|3542343|FG001|STARTED|Step 1||103
2840783|NCT00843882|3542344|FG002|STARTED|Step 1||106
2840784|NCT00843882|3542342|FG000|Treated Patients|Step 1||36
2840785|NCT00843882|3542343|FG001|Treated Patients|Step 1||103
2840786|NCT00843882|3542344|FG002|Treated Patients|Step 1||106
2840787|NCT00843882|3542342|FG000|Evaluable Patients Included in Primary Analysis|Step 1||0
2840788|NCT00843882|3542343|FG001|Evaluable Patients Included in Primary Analysis|Step 1||96
2840789|NCT00843882|3542344|FG002|Evaluable Patients Included in Primary Analysis|Step 1||99
2840790|NCT00843882|3542342|FG000|Patients With Cytogenetic Response Data Available|Step 1||0
2840791|NCT00843882|3542343|FG001|Patients With Cytogenetic Response Data Available|Step 1||55
2840792|NCT00843882|3542344|FG002|Patients With Cytogenetic Response Data Available|Step 1||51
2840793|NCT00843882|3542342|FG000|COMPLETED|Step 1||6
2840794|NCT00843882|3542343|FG001|COMPLETED|Step 1||48
2840795|NCT00843882|3542344|FG002|COMPLETED|Step 1||41
2840796|NCT00843882|3542342|FG000|NOT COMPLETED|Step 1||32
2840797|NCT00843882|3542343|FG001|NOT COMPLETED|Step 1||55
2840798|NCT00843882|3542344|FG002|NOT COMPLETED|Step 1||65
2840799|NCT00843882|3542342|FG000|STARTED|Step 2 (Cross-over to Arm B)|All patients in Arm A that did not achieve major erythroid response (MER) were offered to receive combined treatment in Step 2.|7
2840800|NCT00843882|3542343|FG001|STARTED|Step 2 (Cross-over to Arm B)|All patients in Arm A that did not achieve major erythroid response (MER) were offered to receive combined treatment in Step 2.|46
2840801|NCT00843882|3542344|FG002|STARTED|Step 2 (Cross-over to Arm B)|Only patients in Arm A that did not achieve major erythroid response (MER) were offered to receive combined treatment in Step 2.|0
2840802|NCT00843882|3542342|FG000|Evaluable Patients Included in Primary Analysis|Step 2 (Cross-over to Arm B)||7
2840803|NCT00843882|3542343|FG001|Evaluable Patients Included in Primary Analysis|Step 2 (Cross-over to Arm B)||37
2915902|NCT00513344|3626323|FG000|STARTED|Diet Restriction (3 Days)||5
2915903|NCT00513344|3626323|FG000|COMPLETED|Diet Restriction (3 Days)||5
2915904|NCT00513344|3626323|FG000|NOT COMPLETED|Diet Restriction (3 Days)||0
2915905|NCT00513344|3626323|FG000|STARTED|1st Intervention 1 Day||5
2915906|NCT00513344|3626323|FG000|COMPLETED|1st Intervention 1 Day||5
2915907|NCT00513344|3626323|FG000|NOT COMPLETED|1st Intervention 1 Day||0
2915908|NCT00513344|3626323|FG000|STARTED|Washout Period 3 Days||5
2915909|NCT00513344|3626323|FG000|COMPLETED|Washout Period 3 Days||5
2915910|NCT00513344|3626323|FG000|NOT COMPLETED|Washout Period 3 Days||0
2915911|NCT00513344|3626323|FG000|STARTED|2nd Intervention 1 Day||5
2915912|NCT00513344|3626323|FG000|COMPLETED|2nd Intervention 1 Day||5
2915913|NCT00513344|3626323|FG000|NOT COMPLETED|2nd Intervention 1 Day||0
2915914|NCT00513344|3626323|FG000|STARTED|Washout Period 3 Days||5
2915915|NCT00513344|3626323|FG000|COMPLETED|Washout Period 3 Days||5
2840804|NCT00843882|3542344|FG002|Evaluable Patients Included in Primary Analysis|Step 2 (Cross-over to Arm B)||0
2840805|NCT00843882|3542342|FG000|COMPLETED|Step 2 (Cross-over to Arm B)||3
2840806|NCT00843882|3542343|FG001|COMPLETED|Step 2 (Cross-over to Arm B)||20
2840807|NCT00843882|3542344|FG002|COMPLETED|Step 2 (Cross-over to Arm B)||0
2840808|NCT00843882|3542342|FG000|NOT COMPLETED|Step 2 (Cross-over to Arm B)||4
2840809|NCT00843882|3542343|FG001|NOT COMPLETED|Step 2 (Cross-over to Arm B)||26
2840810|NCT00843882|3542344|FG002|NOT COMPLETED|Step 2 (Cross-over to Arm B)||0
2840811|NCT00659646|3542359|FG000|STARTED|Overall Study||38
2840812|NCT00659646|3542360|FG001|STARTED|Overall Study||18
2840813|NCT00659646|3542359|FG000|COMPLETED|Overall Study||23
2840814|NCT00659646|3542360|FG001|COMPLETED|Overall Study||10
2840815|NCT00659646|3542359|FG000|NOT COMPLETED|Overall Study||15
2840816|NCT00659646|3542360|FG001|NOT COMPLETED|Overall Study||8
2840817|NCT00567580|3542371|FG000|STARTED|Overall Study||592
2840818|NCT00567580|3542372|FG001|STARTED|Overall Study||602
2840819|NCT00567580|3542373|FG002|STARTED|Overall Study||598
2840820|NCT00567580|3542371|FG000|Eligible|Overall Study||564
2840821|NCT00567580|3542372|FG001|Eligible|Overall Study||578
2840822|NCT00567580|3542373|FG002|Eligible|Overall Study||574
2840823|NCT00567580|3542371|FG000|Eligible, Started Study Treatment, and Have Adverse Event Data|Overall Study||547
2840824|NCT00567580|3542372|FG001|Eligible, Started Study Treatment, and Have Adverse Event Data|Overall Study||563
2840825|NCT00567580|3542373|FG002|Eligible, Started Study Treatment, and Have Adverse Event Data|Overall Study||563
2840826|NCT00567580|3542371|FG000|COMPLETED|Overall Study||564
2840827|NCT00567580|3542372|FG001|COMPLETED|Overall Study||578
2840828|NCT00567580|3542373|FG002|COMPLETED|Overall Study||574
2840829|NCT00567580|3542371|FG000|NOT COMPLETED|Overall Study||28
2840830|NCT00567580|3542372|FG001|NOT COMPLETED|Overall Study||24
2840831|NCT00567580|3542373|FG002|NOT COMPLETED|Overall Study||24
2840832|NCT00477412|3542388|FG000|STARTED|Overall Study||4
2840833|NCT00477412|3542389|FG001|STARTED|Overall Study||3
2840834|NCT00477412|3542390|FG002|STARTED|Overall Study||5
2840835|NCT00477412|3542391|FG003|STARTED|Overall Study||95
2840836|NCT00477412|3542388|FG000|COMPLETED|Overall Study||3
2840837|NCT00477412|3542389|FG001|COMPLETED|Overall Study||3
2840838|NCT00477412|3542390|FG002|COMPLETED|Overall Study||4
2840839|NCT00477412|3542391|FG003|COMPLETED|Overall Study||87
2840840|NCT00477412|3542388|FG000|NOT COMPLETED|Overall Study||1
2840841|NCT00477412|3542389|FG001|NOT COMPLETED|Overall Study||0
2840842|NCT00477412|3542390|FG002|NOT COMPLETED|Overall Study||1
2840843|NCT00477412|3542391|FG003|NOT COMPLETED|Overall Study||8
2840844|NCT00369317|3542399|FG000|STARTED|Overall Study||205
2840845|NCT00369317|3542399|FG000|COMPLETED|Overall Study||185
2840846|NCT00369317|3542399|FG000|NOT COMPLETED|Overall Study||20
2840847|NCT00261807|3542404|FG000|STARTED|Overall Study||25
2840848|NCT00261807|3542404|FG000|COMPLETED|Overall Study||18
2840849|NCT00261807|3542404|FG000|NOT COMPLETED|Overall Study||7
2915916|NCT00513344|3626323|FG000|NOT COMPLETED|Washout Period 3 Days||0
2915917|NCT00513344|3626323|FG000|STARTED|3rd Intervention 1 Day||5
2915918|NCT00513344|3626323|FG000|COMPLETED|3rd Intervention 1 Day||5
2915919|NCT00513344|3626323|FG000|NOT COMPLETED|3rd Intervention 1 Day||0
2915920|NCT00513357|3626333|FG000|STARTED|Overall Study||38
2915921|NCT00513357|3626334|FG001|STARTED|Overall Study||35
2915922|NCT00513357|3626333|FG000|COMPLETED|Overall Study||23
2915923|NCT00513357|3626334|FG001|COMPLETED|Overall Study||25
2915924|NCT00513357|3626333|FG000|NOT COMPLETED|Overall Study||15
2915925|NCT00513357|3626334|FG001|NOT COMPLETED|Overall Study||10
2915926|NCT00513370|3626340|FG000|STARTED|Overall Study||203
2915927|NCT00513370|3626340|FG000|COMPLETED|Overall Study||179
2915928|NCT00513370|3626340|FG000|NOT COMPLETED|Overall Study||24
2915929|NCT00513409|3626348|FG000|STARTED|Overall Study||84
2915930|NCT00513409|3626349|FG001|STARTED|Overall Study||79
2915931|NCT00513409|3626348|FG000|COMPLETED|Overall Study||82
2915932|NCT00513409|3626349|FG001|COMPLETED|Overall Study||73
2915933|NCT00513409|3626348|FG000|NOT COMPLETED|Overall Study||2
2915934|NCT00513409|3626349|FG001|NOT COMPLETED|Overall Study||6
2915935|NCT00513435|3626355|FG000|STARTED|Overall Study||9
2915936|NCT00513435|3626355|FG000|COMPLETED|Overall Study||9
2915937|NCT00513435|3626355|FG000|NOT COMPLETED|Overall Study||0
2915938|NCT00513461|3626361|FG000|STARTED|Overall Study||57
2915939|NCT00513461|3626362|FG001|STARTED|Overall Study||53
2915940|NCT00513461|3626361|FG000|COMPLETED|Overall Study||44
2915941|NCT00513461|3626362|FG001|COMPLETED|Overall Study||43
2915942|NCT00513461|3626361|FG000|NOT COMPLETED|Overall Study||13
2915943|NCT00513461|3626362|FG001|NOT COMPLETED|Overall Study||10
2915944|NCT00513474|3626370|FG000|STARTED|Overall Study||25
2915945|NCT00513474|3626371|FG001|STARTED|Overall Study||21
2915946|NCT00513474|3626370|FG000|Received Rasburicase Per Protocol|Overall Study||24
2915947|NCT00513474|3626371|FG001|Received Rasburicase Per Protocol|Overall Study||0
2915948|NCT00513474|3626370|FG000|COMPLETED|Overall Study||18
2915949|NCT00513474|3626371|FG001|COMPLETED|Overall Study||12
2915950|NCT00513474|3626370|FG000|NOT COMPLETED|Overall Study||7
2915951|NCT00513474|3626371|FG001|NOT COMPLETED|Overall Study||9
2915952|NCT00513500|3626379|FG000|STARTED|Overall Study||1017
2915953|NCT00513500|3626380|FG001|STARTED|Overall Study||2108
2915954|NCT00513500|3626379|FG000|COMPLETED|Overall Study||976
2915955|NCT00513500|3626380|FG001|COMPLETED|Overall Study||2054
2915956|NCT00513500|3626379|FG000|NOT COMPLETED|Overall Study||41
2915957|NCT00513500|3626380|FG001|NOT COMPLETED|Overall Study||54
2915958|NCT00513526|3626386|FG000|STARTED|Overall Study||109
2840850|NCT04964193|3542409|FG000|STARTED|1st Intervention||12
2840851|NCT04964193|3542410|FG001|STARTED|1st Intervention||12
2840852|NCT04964193|3542409|FG000|COMPLETED|1st Intervention||12
2840853|NCT04964193|3542410|FG001|COMPLETED|1st Intervention||12
2840854|NCT04964193|3542409|FG000|NOT COMPLETED|1st Intervention||0
2840855|NCT04964193|3542410|FG001|NOT COMPLETED|1st Intervention||0
2840856|NCT04964193|3542409|FG000|STARTED|Washout = Three Weeks||12
2840857|NCT04964193|3542410|FG001|STARTED|Washout = Three Weeks||12
2840858|NCT04964193|3542409|FG000|COMPLETED|Washout = Three Weeks||12
2840859|NCT04964193|3542410|FG001|COMPLETED|Washout = Three Weeks||12
2840860|NCT04964193|3542409|FG000|NOT COMPLETED|Washout = Three Weeks||0
2840861|NCT04964193|3542410|FG001|NOT COMPLETED|Washout = Three Weeks||0
2840862|NCT04964193|3542409|FG000|STARTED|2nd Intervention||12
2840863|NCT04964193|3542410|FG001|STARTED|2nd Intervention||12
2840864|NCT04964193|3542409|FG000|COMPLETED|2nd Intervention||12
2840865|NCT04964193|3542410|FG001|COMPLETED|2nd Intervention||12
2840866|NCT04964193|3542409|FG000|NOT COMPLETED|2nd Intervention||0
2840867|NCT04964193|3542410|FG001|NOT COMPLETED|2nd Intervention||0
2840868|NCT04826731|3542418|FG000|STARTED|Overall Study||10
2840869|NCT04826731|3542419|FG001|STARTED|Overall Study||4
2840870|NCT04826731|3542418|FG000|COMPLETED|Overall Study|All patients were initially accepted as the study group per study design, with those unable to utilize respiratory exerciser (n=4) were later removed to standard care group.|10
2840871|NCT04826731|3542419|FG001|COMPLETED|Overall Study|Patients who could not use the respiratory exerciser (n=2) or refused to do so (n=2) were accepted as the control group.|4
2840872|NCT04826731|3542418|FG000|NOT COMPLETED|Overall Study||0
2840873|NCT04826731|3542419|FG001|NOT COMPLETED|Overall Study||0
2840874|NCT04620798|3542427|FG000|STARTED|Overall Study||536
2840875|NCT04620798|3542428|FG001|STARTED|Overall Study||540
2840876|NCT04620798|3542427|FG000|Completed Behavioral Survey|Overall Study||477
2840877|NCT04620798|3542428|FG001|Completed Behavioral Survey|Overall Study||508
2840878|NCT04620798|3542427|FG000|COMPLETED|Overall Study||410
2840879|NCT04620798|3542428|FG001|COMPLETED|Overall Study||402
2840880|NCT04620798|3542427|FG000|NOT COMPLETED|Overall Study||126
2840881|NCT04620798|3542428|FG001|NOT COMPLETED|Overall Study||138
2840882|NCT04507321|3542434|FG000|STARTED|Treatment Period 1 (8 Days)||5
2840883|NCT04507321|3542434|FG000|COMPLETED|Treatment Period 1 (8 Days)||5
2840884|NCT04507321|3542434|FG000|NOT COMPLETED|Treatment Period 1 (8 Days)||0
2840885|NCT04507321|3542434|FG000|STARTED|Treatment Period 2 (8 Days)||5
2840886|NCT04507321|3542434|FG000|COMPLETED|Treatment Period 2 (8 Days)||5
2840887|NCT04507321|3542434|FG000|NOT COMPLETED|Treatment Period 2 (8 Days)||0
2840888|NCT04256629|3542453|FG000|STARTED|Overall Study||4
2840889|NCT04256629|3542454|FG001|STARTED|Overall Study||4
2840890|NCT04256629|3542455|FG002|STARTED|Overall Study||4
2840891|NCT04256629|3542456|FG003|STARTED|Overall Study||4
2840892|NCT04256629|3542457|FG004|STARTED|Overall Study||4
2840893|NCT04256629|3542458|FG005|STARTED|Overall Study||4
2840894|NCT04256629|3542453|FG000|COMPLETED|Overall Study||4
2840895|NCT04256629|3542454|FG001|COMPLETED|Overall Study||3
2840896|NCT04256629|3542455|FG002|COMPLETED|Overall Study||4
2840897|NCT04256629|3542456|FG003|COMPLETED|Overall Study||4
2840898|NCT04256629|3542457|FG004|COMPLETED|Overall Study||4
2840899|NCT04256629|3542458|FG005|COMPLETED|Overall Study||3
2840900|NCT04256629|3542453|FG000|NOT COMPLETED|Overall Study||0
2840901|NCT04256629|3542454|FG001|NOT COMPLETED|Overall Study||1
2840902|NCT04256629|3542455|FG002|NOT COMPLETED|Overall Study||0
2840903|NCT04256629|3542456|FG003|NOT COMPLETED|Overall Study||0
2840904|NCT04256629|3542457|FG004|NOT COMPLETED|Overall Study||0
2840905|NCT04256629|3542458|FG005|NOT COMPLETED|Overall Study||1
2840906|NCT04174521|3542466|FG000|STARTED|Overall Study|A unit is defined as a mother-child pair; each unit was comprised of two participants: the mother and the child.|20670
2840907|NCT04174521|3542466|FG000|COMPLETED|Overall Study|This was a retrospective observational study so there really was no drop-out.|20670
2840908|NCT04174521|3542466|FG000|NOT COMPLETED|Overall Study||0
2840909|NCT04014075|3542470|FG000|STARTED|Overall Study||79
2840910|NCT04014075|3542470|FG000|COMPLETED|Overall Study||23
2840911|NCT04014075|3542470|FG000|NOT COMPLETED|Overall Study||56
2840912|NCT03554850|3542474|FG000|STARTED|Overall Study||201
2840913|NCT03554850|3542474|FG000|COMPLETED|Overall Study||190
2840914|NCT03554850|3542474|FG000|NOT COMPLETED|Overall Study||11
2840915|NCT03284853|3542484|FG000|STARTED|Overall Study||218
2840916|NCT03284853|3542485|FG001|STARTED|Overall Study||212
2840917|NCT03284853|3542484|FG000|Intent-to-Treat Population|Overall Study||218
2840918|NCT03284853|3542485|FG001|Intent-to-Treat Population|Overall Study||212
2840919|NCT03284853|3542484|FG000|Per-Protocol Population|Overall Study||169
2840920|NCT03284853|3542485|FG001|Per-Protocol Population|Overall Study||170
2840921|NCT03284853|3542484|FG000|Safety Population|Overall Study||218
2840922|NCT03284853|3542485|FG001|Safety Population|Overall Study||212
2840923|NCT03284853|3542484|FG000|COMPLETED|Overall Study||163
2840924|NCT03284853|3542485|FG001|COMPLETED|Overall Study||199
2840925|NCT03284853|3542484|FG000|NOT COMPLETED|Overall Study||55
2840926|NCT03284853|3542485|FG001|NOT COMPLETED|Overall Study||13
2840927|NCT03032250|3542493|FG000|STARTED|Overall Study||17
2840928|NCT03032250|3542494|FG001|STARTED|Overall Study||18
2840929|NCT03032250|3542493|FG000|COMPLETED|Overall Study||17
2840930|NCT03032250|3542494|FG001|COMPLETED|Overall Study||18
2840931|NCT03032250|3542493|FG000|NOT COMPLETED|Overall Study||0
2840932|NCT03032250|3542494|FG001|NOT COMPLETED|Overall Study||0
2840933|NCT02942966|3542502|FG000|STARTED|Overall Study|Intent to Treat (ITT) population.|233
2840934|NCT02942966|3542502|FG000|COMPLETED|Overall Study|Completed 6-month follow-up|205
2840935|NCT02942966|3542502|FG000|NOT COMPLETED|Overall Study||28
2840936|NCT02774889|3542508|FG000|STARTED|Overall Study||23
2840937|NCT02774889|3542509|FG001|STARTED|Overall Study||22
2840938|NCT02774889|3542508|FG000|COMPLETED|Overall Study||21
2840939|NCT02774889|3542509|FG001|COMPLETED|Overall Study||21
2840940|NCT02774889|3542508|FG000|NOT COMPLETED|Overall Study||2
2840941|NCT02774889|3542509|FG001|NOT COMPLETED|Overall Study||1
2840942|NCT02721069|3542517|FG000|STARTED|Overall Study||175
2840943|NCT02721069|3542517|FG000|COMPLETED|Overall Study||117
2840944|NCT02721069|3542517|FG000|NOT COMPLETED|Overall Study||58
2840945|NCT02625090|3542527|FG000|STARTED|Overall Study||42
2840946|NCT02625090|3542527|FG000|COMPLETED|Overall Study||0
2840947|NCT02625090|3542527|FG000|NOT COMPLETED|Overall Study||42
2840948|NCT02367456|3542535|FG000|STARTED|Overall Study||12
2840949|NCT02367456|3542536|FG001|STARTED|Overall Study||30
2840950|NCT02367456|3542537|FG002|STARTED|Overall Study||30
2840951|NCT02367456|3542535|FG000|COMPLETED|Overall Study||0
2840952|NCT02367456|3542536|FG001|COMPLETED|Overall Study||0
2840953|NCT02367456|3542537|FG002|COMPLETED|Overall Study||0
2840954|NCT02367456|3542535|FG000|NOT COMPLETED|Overall Study||12
2840955|NCT02367456|3542536|FG001|NOT COMPLETED|Overall Study||30
2840956|NCT02367456|3542537|FG002|NOT COMPLETED|Overall Study||30
2840957|NCT02297438|3542552|FG000|STARTED|Overall Study||169
2840958|NCT02297438|3542553|FG001|STARTED|Overall Study||171
2840959|NCT02297438|3542552|FG000|Received Treatment|Overall Study||168
2840960|NCT02297438|3542553|FG001|Received Treatment|Overall Study||171
2840961|NCT02297438|3542552|FG000|COMPLETED|Overall Study||0
2840962|NCT02297438|3542553|FG001|COMPLETED|Overall Study||0
2840963|NCT02297438|3542552|FG000|NOT COMPLETED|Overall Study||169
2840964|NCT02297438|3542553|FG001|NOT COMPLETED|Overall Study||171
2840965|NCT02297412|3542561|FG000|STARTED|Overall Study||23
2840966|NCT02297412|3542562|FG001|STARTED|Overall Study||24
2840967|NCT02297412|3542561|FG000|COMPLETED|Overall Study||22
2840968|NCT02297412|3542562|FG001|COMPLETED|Overall Study||23
2840969|NCT02297412|3542561|FG000|NOT COMPLETED|Overall Study||1
2840970|NCT02297412|3542562|FG001|NOT COMPLETED|Overall Study||1
2840971|NCT02292758|3542570|FG000|STARTED|Overall Study||19
2840972|NCT02292758|3542571|FG001|STARTED|Overall Study||17
2840973|NCT02292758|3542570|FG000|COMPLETED|Overall Study||19
2840974|NCT02292758|3542571|FG001|COMPLETED|Overall Study||17
2840975|NCT02292758|3542570|FG000|NOT COMPLETED|Overall Study||0
2840976|NCT02292758|3542571|FG001|NOT COMPLETED|Overall Study||0
2840977|NCT02288247|3542577|FG000|STARTED|Period 1: OL Treatment (Max: 315 Weeks)||688
2840978|NCT02288247|3542578|FG001|STARTED|Period 1: OL Treatment (Max: 315 Weeks)||0
2840979|NCT02288247|3542577|FG000|Treated|Period 1: OL Treatment (Max: 315 Weeks)||687
2840980|NCT02288247|3542578|FG001|Treated|Period 1: OL Treatment (Max: 315 Weeks)||0
2840981|NCT02288247|3542577|FG000|COMPLETED|Period 1: OL Treatment (Max: 315 Weeks)||41
2840982|NCT02288247|3542578|FG001|COMPLETED|Period 1: OL Treatment (Max: 315 Weeks)||0
2840983|NCT02288247|3542577|FG000|NOT COMPLETED|Period 1: OL Treatment (Max: 315 Weeks)||647
2840984|NCT02288247|3542578|FG001|NOT COMPLETED|Period 1: OL Treatment (Max: 315 Weeks)||0
2840985|NCT02288247|3542577|FG000|STARTED|Period 2: DB Treatment (Max: 180 Weeks)|137 participants from period 1 were randomized to period 2.|137
2840986|NCT02288247|3542578|FG001|STARTED|Period 2: DB Treatment (Max: 180 Weeks)|136 participants from period 1 were randomized to period 2.|136
2840987|NCT02288247|3542577|FG000|Treated|Period 2: DB Treatment (Max: 180 Weeks)||136
2840988|NCT02288247|3542578|FG001|Treated|Period 2: DB Treatment (Max: 180 Weeks)||135
2840989|NCT02288247|3542577|FG000|COMPLETED|Period 2: DB Treatment (Max: 180 Weeks)||1
2840990|NCT02288247|3542578|FG001|COMPLETED|Period 2: DB Treatment (Max: 180 Weeks)||1
2840991|NCT02288247|3542577|FG000|NOT COMPLETED|Period 2: DB Treatment (Max: 180 Weeks)||136
2840992|NCT02288247|3542578|FG001|NOT COMPLETED|Period 2: DB Treatment (Max: 180 Weeks)||135
2840993|NCT02250326|3542589|FG000|STARTED|Treatment Period||81
2840994|NCT02250326|3542590|FG001|STARTED|Treatment Period||79
2840995|NCT02250326|3542591|FG002|STARTED|Treatment Period||80
2840996|NCT02250326|3542589|FG000|Treated Population|Treatment Period||79
2840997|NCT02250326|3542590|FG001|Treated Population|Treatment Period||78
2840998|NCT02250326|3542591|FG002|Treated Population|Treatment Period||79
2840999|NCT02250326|3542589|FG000|COMPLETED|Treatment Period|Data Cut-off Date = 30 August 2017|0
2841000|NCT02250326|3542590|FG001|COMPLETED|Treatment Period|Data Cut-off Date = 23 December 2017|15
2841001|NCT02250326|3542591|FG002|COMPLETED|Treatment Period|Data Cut-off Date = 30 August 2017|3
2841002|NCT02250326|3542589|FG000|NOT COMPLETED|Treatment Period||81
2841003|NCT02250326|3542590|FG001|NOT COMPLETED|Treatment Period||64
3167518|NCT01911351|3894785|FG001|STARTED|Overall Study||43
3167519|NCT01911351|3894784|FG000|COMPLETED|Overall Study||39
2841004|NCT02250326|3542591|FG002|NOT COMPLETED|Treatment Period||77
2841005|NCT02250326|3542589|FG000|STARTED|Follow-Up Period||67
2841006|NCT02250326|3542590|FG001|STARTED|Follow-Up Period||43
2841007|NCT02250326|3542591|FG002|STARTED|Follow-Up Period||64
2841008|NCT02250326|3542589|FG000|COMPLETED|Follow-Up Period||18
2841009|NCT02250326|3542590|FG001|COMPLETED|Follow-Up Period||13
2841010|NCT02250326|3542591|FG002|COMPLETED|Follow-Up Period||26
2841011|NCT02250326|3542589|FG000|NOT COMPLETED|Follow-Up Period||49
2841012|NCT02250326|3542590|FG001|NOT COMPLETED|Follow-Up Period||30
2841013|NCT02250326|3542591|FG002|NOT COMPLETED|Follow-Up Period||38
2841014|NCT01856270|3542602|FG000|STARTED|Overall Study||24
2841015|NCT01856270|3542603|FG001|STARTED|Overall Study||26
3167520|NCT01911351|3894785|FG001|COMPLETED|Overall Study||43
2841016|NCT01856270|3542602|FG000|COMPLETED|Overall Study||13
2841017|NCT01856270|3542603|FG001|COMPLETED|Overall Study||14
2841018|NCT01856270|3542602|FG000|NOT COMPLETED|Overall Study||11
2841019|NCT01856270|3542603|FG001|NOT COMPLETED|Overall Study||12
2841020|NCT01503515|3542613|FG000|STARTED|Overall Study||145
2841021|NCT01503515|3542614|FG001|STARTED|Overall Study||147
2841022|NCT01503515|3542613|FG000|COMPLETED|Overall Study||124
2841023|NCT01503515|3542614|FG001|COMPLETED|Overall Study||112
2841024|NCT01503515|3542613|FG000|NOT COMPLETED|Overall Study||21
2841025|NCT01503515|3542614|FG001|NOT COMPLETED|Overall Study||35
2841026|NCT01491893|3542620|FG000|STARTED|Overall Study||1
2841027|NCT01491893|3542621|FG001|STARTED|Overall Study||1
2841028|NCT01491893|3542622|FG002|STARTED|Overall Study||1
2841029|NCT01491893|3542623|FG003|STARTED|Overall Study||1
2841030|NCT01491893|3542624|FG004|STARTED|Overall Study||4
2841031|NCT01491893|3542625|FG005|STARTED|Overall Study||1
2841032|NCT01491893|3542626|FG006|STARTED|Overall Study||6
2841033|NCT01491893|3542627|FG007|STARTED|Overall Study||24
2841034|NCT01491893|3542628|FG008|STARTED|Overall Study||15
2841035|NCT01491893|3542629|FG009|STARTED|Overall Study||7
2841036|NCT01491893|3542620|FG000|COMPLETED|Overall Study||1
2841037|NCT01491893|3542621|FG001|COMPLETED|Overall Study||1
2841038|NCT01491893|3542622|FG002|COMPLETED|Overall Study||1
2841039|NCT01491893|3542623|FG003|COMPLETED|Overall Study||1
2841040|NCT01491893|3542624|FG004|COMPLETED|Overall Study||4
2841041|NCT01491893|3542625|FG005|COMPLETED|Overall Study||1
2841042|NCT01491893|3542626|FG006|COMPLETED|Overall Study||6
2841043|NCT01491893|3542627|FG007|COMPLETED|Overall Study||24
2841044|NCT01491893|3542628|FG008|COMPLETED|Overall Study||15
2841045|NCT01491893|3542629|FG009|COMPLETED|Overall Study||7
2841046|NCT01491893|3542620|FG000|NOT COMPLETED|Overall Study||0
2841047|NCT01491893|3542621|FG001|NOT COMPLETED|Overall Study||0
2841048|NCT01491893|3542622|FG002|NOT COMPLETED|Overall Study||0
2841049|NCT01491893|3542623|FG003|NOT COMPLETED|Overall Study||0
2841050|NCT01491893|3542624|FG004|NOT COMPLETED|Overall Study||0
2841051|NCT01491893|3542625|FG005|NOT COMPLETED|Overall Study||0
2841052|NCT01491893|3542626|FG006|NOT COMPLETED|Overall Study||0
2841053|NCT01491893|3542627|FG007|NOT COMPLETED|Overall Study||0
2841054|NCT01491893|3542628|FG008|NOT COMPLETED|Overall Study||0
2841055|NCT01491893|3542629|FG009|NOT COMPLETED|Overall Study||0
2841056|NCT00565851|3542653|FG000|STARTED|Surgical Assignment||316
2841057|NCT00565851|3542654|FG001|STARTED|Surgical Assignment||456
2841058|NCT00565851|3542655|FG002|STARTED|Surgical Assignment||33
2841059|NCT00565851|3542656|FG003|STARTED|Surgical Assignment||165
2841060|NCT00565851|3542657|FG004|STARTED|Surgical Assignment||6
2841061|NCT00565851|3542658|FG005|STARTED|Surgical Assignment||34
2841062|NCT00565851|3542659|FG006|STARTED|Surgical Assignment||5
2841063|NCT00565851|3542660|FG007|STARTED|Surgical Assignment||37
2841064|NCT00565851|3542653|FG000|Randomized - Yes Surgery|Surgical Assignment||0
2841065|NCT00565851|3542654|FG001|Randomized - Yes Surgery|Surgical Assignment||0
2841066|NCT00565851|3542655|FG002|Randomized - Yes Surgery|Surgical Assignment||33
2841067|NCT00565851|3542656|FG003|Randomized - Yes Surgery|Surgical Assignment||165
2841068|NCT00565851|3542657|FG004|Randomized - Yes Surgery|Surgical Assignment||0
2841069|NCT00565851|3542658|FG005|Randomized - Yes Surgery|Surgical Assignment||0
2841070|NCT00565851|3542659|FG006|Randomized - Yes Surgery|Surgical Assignment||5
2841071|NCT00565851|3542660|FG007|Randomized - Yes Surgery|Surgical Assignment||37
2841072|NCT00565851|3542653|FG000|Randomized - no Surgery|Surgical Assignment||33
2841073|NCT00565851|3542654|FG001|Randomized - no Surgery|Surgical Assignment||172
2841074|NCT00565851|3542655|FG002|Randomized - no Surgery|Surgical Assignment||0
2841075|NCT00565851|3542656|FG003|Randomized - no Surgery|Surgical Assignment||0
2841076|NCT00565851|3542657|FG004|Randomized - no Surgery|Surgical Assignment||6
2841077|NCT00565851|3542658|FG005|Randomized - no Surgery|Surgical Assignment||34
2841078|NCT00565851|3542659|FG006|Randomized - no Surgery|Surgical Assignment||0
2841079|NCT00565851|3542660|FG007|Randomized - no Surgery|Surgical Assignment||0
2841080|NCT00565851|3542653|FG000|Not Surgical Candidate|Surgical Assignment||283
2841081|NCT00565851|3542654|FG001|Not Surgical Candidate|Surgical Assignment||284
2841082|NCT00565851|3542655|FG002|Not Surgical Candidate|Surgical Assignment||0
2841083|NCT00565851|3542656|FG003|Not Surgical Candidate|Surgical Assignment||0
2841084|NCT00565851|3542657|FG004|Not Surgical Candidate|Surgical Assignment||0
2841085|NCT00565851|3542658|FG005|Not Surgical Candidate|Surgical Assignment||0
2841086|NCT00565851|3542659|FG006|Not Surgical Candidate|Surgical Assignment||0
2841087|NCT00565851|3542660|FG007|Not Surgical Candidate|Surgical Assignment||0
2841088|NCT00565851|3542653|FG000|COMPLETED|Surgical Assignment||313
2841089|NCT00565851|3542654|FG001|COMPLETED|Surgical Assignment||454
2841090|NCT00565851|3542655|FG002|COMPLETED|Surgical Assignment||31
2841091|NCT00565851|3542656|FG003|COMPLETED|Surgical Assignment||154
2841092|NCT00565851|3542657|FG004|COMPLETED|Surgical Assignment||6
2841093|NCT00565851|3542658|FG005|COMPLETED|Surgical Assignment||34
2841094|NCT00565851|3542659|FG006|COMPLETED|Surgical Assignment||5
2841095|NCT00565851|3542660|FG007|COMPLETED|Surgical Assignment||35
2841096|NCT00565851|3542653|FG000|NOT COMPLETED|Surgical Assignment||3
2841097|NCT00565851|3542654|FG001|NOT COMPLETED|Surgical Assignment||2
2841098|NCT00565851|3542655|FG002|NOT COMPLETED|Surgical Assignment||2
2841099|NCT00565851|3542656|FG003|NOT COMPLETED|Surgical Assignment||11
2841100|NCT00565851|3542657|FG004|NOT COMPLETED|Surgical Assignment||0
2841101|NCT00565851|3542658|FG005|NOT COMPLETED|Surgical Assignment||0
2841102|NCT00565851|3542659|FG006|NOT COMPLETED|Surgical Assignment||0
2841103|NCT00565851|3542660|FG007|NOT COMPLETED|Surgical Assignment||2
2841104|NCT00565851|3542653|FG000|STARTED|Chemotherapy Assignment||316
2841105|NCT00565851|3542654|FG001|STARTED|Chemotherapy Assignment||456
2841106|NCT00565851|3542655|FG002|STARTED|Chemotherapy Assignment||33
2841107|NCT00565851|3542656|FG003|STARTED|Chemotherapy Assignment||165
2841108|NCT00565851|3542657|FG004|STARTED|Chemotherapy Assignment||6
2841109|NCT00565851|3542658|FG005|STARTED|Chemotherapy Assignment||34
2841110|NCT00565851|3542659|FG006|STARTED|Chemotherapy Assignment||5
2841111|NCT00565851|3542660|FG007|STARTED|Chemotherapy Assignment||37
2841112|NCT00565851|3542653|FG000|Randomized to Chemo|Chemotherapy Assignment||310
2841113|NCT00565851|3542654|FG001|Randomized to Chemo|Chemotherapy Assignment||311
2841114|NCT00565851|3542655|FG002|Randomized to Chemo|Chemotherapy Assignment||27
2841115|NCT00565851|3542656|FG003|Randomized to Chemo|Chemotherapy Assignment||26
2841116|NCT00565851|3542657|FG004|Randomized to Chemo|Chemotherapy Assignment||0
2841117|NCT00565851|3542658|FG005|Randomized to Chemo|Chemotherapy Assignment||0
2841118|NCT00565851|3542659|FG006|Randomized to Chemo|Chemotherapy Assignment||0
2841119|NCT00565851|3542660|FG007|Randomized to Chemo|Chemotherapy Assignment||0
2841120|NCT00565851|3542653|FG000|Pre-specified Chemo|Chemotherapy Assignment||6
2841121|NCT00565851|3542654|FG001|Pre-specified Chemo|Chemotherapy Assignment||145
2841122|NCT00565851|3542655|FG002|Pre-specified Chemo|Chemotherapy Assignment||6
2841123|NCT00565851|3542656|FG003|Pre-specified Chemo|Chemotherapy Assignment||139
2841124|NCT00565851|3542657|FG004|Pre-specified Chemo|Chemotherapy Assignment||6
2841125|NCT00565851|3542658|FG005|Pre-specified Chemo|Chemotherapy Assignment||34
2841126|NCT00565851|3542659|FG006|Pre-specified Chemo|Chemotherapy Assignment||5
2841127|NCT00565851|3542660|FG007|Pre-specified Chemo|Chemotherapy Assignment||37
2841128|NCT00565851|3542653|FG000|COMPLETED|Chemotherapy Assignment||307
2841129|NCT00565851|3542654|FG001|COMPLETED|Chemotherapy Assignment||433
2841130|NCT00565851|3542655|FG002|COMPLETED|Chemotherapy Assignment||30
2841131|NCT00565851|3542656|FG003|COMPLETED|Chemotherapy Assignment||129
2841132|NCT00565851|3542657|FG004|COMPLETED|Chemotherapy Assignment||6
2841133|NCT00565851|3542658|FG005|COMPLETED|Chemotherapy Assignment||31
2841134|NCT00565851|3542659|FG006|COMPLETED|Chemotherapy Assignment||5
2841135|NCT00565851|3542660|FG007|COMPLETED|Chemotherapy Assignment||34
2841136|NCT00565851|3542653|FG000|NOT COMPLETED|Chemotherapy Assignment||9
2841137|NCT00565851|3542654|FG001|NOT COMPLETED|Chemotherapy Assignment||23
2841138|NCT00565851|3542655|FG002|NOT COMPLETED|Chemotherapy Assignment||3
2841139|NCT00565851|3542656|FG003|NOT COMPLETED|Chemotherapy Assignment||36
2841140|NCT00565851|3542657|FG004|NOT COMPLETED|Chemotherapy Assignment||0
2841141|NCT00565851|3542658|FG005|NOT COMPLETED|Chemotherapy Assignment||3
2841142|NCT00565851|3542659|FG006|NOT COMPLETED|Chemotherapy Assignment||0
2841143|NCT00565851|3542660|FG007|NOT COMPLETED|Chemotherapy Assignment||3
2841144|NCT00245960|3542684|FG000|STARTED|Period 1 (Double Blind): 1-12 Weeks||379
2841145|NCT00245960|3542685|FG001|STARTED|Period 1 (Double Blind): 1-12 Weeks||373
2841146|NCT00245960|3542684|FG000|COMPLETED|Period 1 (Double Blind): 1-12 Weeks||364
2841147|NCT00245960|3542685|FG001|COMPLETED|Period 1 (Double Blind): 1-12 Weeks||362
2841148|NCT00245960|3542684|FG000|NOT COMPLETED|Period 1 (Double Blind): 1-12 Weeks||15
2841149|NCT00245960|3542685|FG001|NOT COMPLETED|Period 1 (Double Blind): 1-12 Weeks||11
2841150|NCT00245960|3542684|FG000|STARTED|Period 2 (Open Label): 13-24 Weeks||364
2841151|NCT00245960|3542685|FG001|STARTED|Period 2 (Open Label): 13-24 Weeks||362
2841152|NCT00245960|3542684|FG000|COMPLETED|Period 2 (Open Label): 13-24 Weeks||350
2841153|NCT00245960|3542685|FG001|COMPLETED|Period 2 (Open Label): 13-24 Weeks||344
2841154|NCT00245960|3542684|FG000|NOT COMPLETED|Period 2 (Open Label): 13-24 Weeks||14
2841155|NCT00245960|3542685|FG001|NOT COMPLETED|Period 2 (Open Label): 13-24 Weeks||18
2915959|NCT00513526|3626386|FG000|COMPLETED|Overall Study||92
2915960|NCT00513526|3626386|FG000|NOT COMPLETED|Overall Study||17
2915961|NCT00513604|3626397|FG000|STARTED|Overall Study|Cohort 1 = unselected TIL|26
2915962|NCT00513604|3626398|FG001|STARTED|Overall Study|Cohort 2 = CD4+ depleted (selected) TIL|39
2915963|NCT00513604|3626399|FG002|STARTED|Overall Study|Cohort 3 = CD4+ depleted (selected) TIL + 600Gy radiation|24
2915964|NCT00513604|3626400|FG003|STARTED|Overall Study|Cohort 4 = unselected TIL - it is the SAME as cohort 1|34
2915965|NCT00513604|3626401|FG004|STARTED|Overall Study|Cohort 5 = CD4+ depleted TIL-it is the SAME as cohort 2|35
2915966|NCT00513604|3626397|FG000|COMPLETED|Overall Study||24
2915967|NCT00513604|3626398|FG001|COMPLETED|Overall Study||36
2915968|NCT00513604|3626399|FG002|COMPLETED|Overall Study||21
2915969|NCT00513604|3626400|FG003|COMPLETED|Overall Study||34
2915970|NCT00513604|3626401|FG004|COMPLETED|Overall Study||35
2915971|NCT00513604|3626397|FG000|NOT COMPLETED|Overall Study||2
2915972|NCT00513604|3626398|FG001|NOT COMPLETED|Overall Study||3
2915973|NCT00513604|3626399|FG002|NOT COMPLETED|Overall Study||3
2915974|NCT00513604|3626400|FG003|NOT COMPLETED|Overall Study||0
2915975|NCT00513604|3626401|FG004|NOT COMPLETED|Overall Study||0
2915976|NCT00513682|3626413|FG000|STARTED|Screening Phase||9
2915977|NCT00513682|3626413|FG000|COMPLETED|Screening Phase||9
2915978|NCT00513682|3626413|FG000|NOT COMPLETED|Screening Phase||0
2915979|NCT00513682|3626413|FG000|STARTED|Washout Phase||9
2915980|NCT00513682|3626413|FG000|COMPLETED|Washout Phase||7
2915981|NCT00513682|3626413|FG000|NOT COMPLETED|Washout Phase||2
2915982|NCT00513682|3626413|FG000|STARTED|Treatment Phase||7
2915983|NCT00513682|3626413|FG000|COMPLETED|Treatment Phase||7
2915984|NCT00513682|3626413|FG000|NOT COMPLETED|Treatment Phase||0
2915985|NCT00513695|3626420|FG000|STARTED|Overall Study||68
2841156|NCT04565353|3542711|FG000|STARTED|Overall Study||3742
2841157|NCT04565353|3542712|FG001|STARTED|Overall Study||3737
2841158|NCT04565353|3542713|FG002|STARTED|Overall Study||3709
2841159|NCT04565353|3542714|FG003|STARTED|Overall Study||3735
2841160|NCT04565353|3542715|FG004|STARTED|Overall Study||3758
2841161|NCT04565353|3542716|FG005|STARTED|Overall Study||3769
2841162|NCT04565353|3542717|FG006|STARTED|Overall Study||3719
2841163|NCT04565353|3542718|FG007|STARTED|Overall Study||3732
2841164|NCT04565353|3542719|FG008|STARTED|Overall Study||3728
2841165|NCT04565353|3542720|FG009|STARTED|Overall Study||3777
3167521|NCT01911351|3894784|FG000|NOT COMPLETED|Overall Study||0
3167522|NCT01911351|3894785|FG001|NOT COMPLETED|Overall Study||0
3167523|NCT01911390|3894795|FG000|STARTED|Overall Study||10
3167524|NCT01911390|3894796|FG001|STARTED|Overall Study||10
3167525|NCT01911390|3894797|FG002|STARTED|Overall Study||10
3167526|NCT01911390|3894798|FG003|STARTED|Overall Study||11
3167527|NCT01911390|3894795|FG000|COMPLETED|Overall Study||9
3167528|NCT01911390|3894796|FG001|COMPLETED|Overall Study||10
2841166|NCT04565353|3542721|FG010|STARTED|Overall Study||3672
2841167|NCT04565353|3542722|FG011|STARTED|Overall Study||3751
2841168|NCT04565353|3542723|FG012|STARTED|Overall Study||3737
2841169|NCT04565353|3542724|FG013|STARTED|Overall Study||3714
2841170|NCT04565353|3542725|FG014|STARTED|Overall Study||3773
2841171|NCT04565353|3542726|FG015|STARTED|Overall Study||3739
2841172|NCT04565353|3542727|FG016|STARTED|Overall Study||3776
2841173|NCT04565353|3542728|FG017|STARTED|Overall Study||3744
2841174|NCT04565353|3542729|FG018|STARTED|Overall Study||3741
2841175|NCT04565353|3542730|FG019|STARTED|Overall Study||3758
2841176|NCT04565353|3542711|FG000|COMPLETED|Overall Study||3742
2841177|NCT04565353|3542712|FG001|COMPLETED|Overall Study||3688
2841178|NCT04565353|3542713|FG002|COMPLETED|Overall Study||3670
2841179|NCT04565353|3542714|FG003|COMPLETED|Overall Study||3693
2841180|NCT04565353|3542715|FG004|COMPLETED|Overall Study||3717
2841181|NCT04565353|3542716|FG005|COMPLETED|Overall Study||3716
2841182|NCT04565353|3542717|FG006|COMPLETED|Overall Study||3665
2841183|NCT04565353|3542718|FG007|COMPLETED|Overall Study||3693
2841184|NCT04565353|3542719|FG008|COMPLETED|Overall Study||3662
2841185|NCT04565353|3542720|FG009|COMPLETED|Overall Study||3734
2841186|NCT04565353|3542721|FG010|COMPLETED|Overall Study||3623
2841187|NCT04565353|3542722|FG011|COMPLETED|Overall Study||3710
2841188|NCT04565353|3542723|FG012|COMPLETED|Overall Study||3685
2841189|NCT04565353|3542724|FG013|COMPLETED|Overall Study||3664
2841190|NCT04565353|3542725|FG014|COMPLETED|Overall Study||3736
2841191|NCT04565353|3542726|FG015|COMPLETED|Overall Study||3690
2841192|NCT04565353|3542727|FG016|COMPLETED|Overall Study||3734
2841193|NCT04565353|3542728|FG017|COMPLETED|Overall Study||3696
2841194|NCT04565353|3542729|FG018|COMPLETED|Overall Study||3698
2841195|NCT04565353|3542730|FG019|COMPLETED|Overall Study||3712
2841196|NCT04565353|3542711|FG000|NOT COMPLETED|Overall Study||0
2841197|NCT04565353|3542712|FG001|NOT COMPLETED|Overall Study||49
2841198|NCT04565353|3542713|FG002|NOT COMPLETED|Overall Study||39
2841199|NCT04565353|3542714|FG003|NOT COMPLETED|Overall Study||42
2841200|NCT04565353|3542715|FG004|NOT COMPLETED|Overall Study||41
2841201|NCT04565353|3542716|FG005|NOT COMPLETED|Overall Study||53
2841202|NCT04565353|3542717|FG006|NOT COMPLETED|Overall Study||54
2841203|NCT04565353|3542718|FG007|NOT COMPLETED|Overall Study||39
2841204|NCT04565353|3542719|FG008|NOT COMPLETED|Overall Study||66
2841205|NCT04565353|3542720|FG009|NOT COMPLETED|Overall Study||43
2841206|NCT04565353|3542721|FG010|NOT COMPLETED|Overall Study||49
2841207|NCT04565353|3542722|FG011|NOT COMPLETED|Overall Study||41
2841208|NCT04565353|3542723|FG012|NOT COMPLETED|Overall Study||52
2841209|NCT04565353|3542724|FG013|NOT COMPLETED|Overall Study||50
2841210|NCT04565353|3542725|FG014|NOT COMPLETED|Overall Study||37
2841211|NCT04565353|3542726|FG015|NOT COMPLETED|Overall Study||49
2841212|NCT04565353|3542727|FG016|NOT COMPLETED|Overall Study||42
2841213|NCT04565353|3542728|FG017|NOT COMPLETED|Overall Study||48
2841214|NCT04565353|3542729|FG018|NOT COMPLETED|Overall Study||43
2841215|NCT04565353|3542730|FG019|NOT COMPLETED|Overall Study||46
2841216|NCT04015336|3542772|FG000|STARTED|Overall Study||1
2841217|NCT04015336|3542772|FG000|COMPLETED|Overall Study||0
2841218|NCT04015336|3542772|FG000|NOT COMPLETED|Overall Study||1
2841219|NCT03972813|3542794|FG000|STARTED|Overall Study||85
2841220|NCT03972813|3542795|FG001|STARTED|Overall Study||49
2841221|NCT03972813|3542796|FG002|STARTED|Overall Study||58
2841222|NCT03972813|3542797|FG003|STARTED|Overall Study||55
2841223|NCT03972813|3542798|FG004|STARTED|Overall Study||52
2841224|NCT03972813|3542799|FG005|STARTED|Overall Study||51
2841225|NCT03972813|3542800|FG006|STARTED|Overall Study||53
2841226|NCT03972813|3542801|FG007|STARTED|Overall Study||55
2841227|NCT03972813|3542802|FG008|STARTED|Overall Study||58
2841228|NCT03972813|3542803|FG009|STARTED|Overall Study||60
2841229|NCT03972813|3542804|FG010|STARTED|Overall Study||62
2841230|NCT03972813|3542805|FG011|STARTED|Overall Study||55
2841231|NCT03972813|3542806|FG012|STARTED|Overall Study||58
2841232|NCT03972813|3542807|FG013|STARTED|Overall Study||55
2841233|NCT03972813|3542808|FG014|STARTED|Overall Study||58
2841234|NCT03972813|3542809|FG015|STARTED|Overall Study||56
2841235|NCT03972813|3542810|FG016|STARTED|Overall Study||51
2841236|NCT03972813|3542811|FG017|STARTED|Overall Study||50
2841237|NCT03972813|3542794|FG000|COMPLETED|Overall Study||79
2841238|NCT03972813|3542795|FG001|COMPLETED|Overall Study||45
2841239|NCT03972813|3542796|FG002|COMPLETED|Overall Study||52
3167529|NCT01911390|3894797|FG002|COMPLETED|Overall Study||9
3167530|NCT01911390|3894798|FG003|COMPLETED|Overall Study||10
2841240|NCT03972813|3542797|FG003|COMPLETED|Overall Study||51
2841241|NCT03972813|3542798|FG004|COMPLETED|Overall Study||48
2841242|NCT03972813|3542799|FG005|COMPLETED|Overall Study||49
2841243|NCT03972813|3542800|FG006|COMPLETED|Overall Study||49
2841244|NCT03972813|3542801|FG007|COMPLETED|Overall Study||52
2841245|NCT03972813|3542802|FG008|COMPLETED|Overall Study||53
2841246|NCT03972813|3542803|FG009|COMPLETED|Overall Study||58
2841247|NCT03972813|3542804|FG010|COMPLETED|Overall Study||57
2841248|NCT03972813|3542805|FG011|COMPLETED|Overall Study||51
2841249|NCT03972813|3542806|FG012|COMPLETED|Overall Study||55
2841250|NCT03972813|3542807|FG013|COMPLETED|Overall Study||52
2841251|NCT03972813|3542808|FG014|COMPLETED|Overall Study||56
2841252|NCT03972813|3542809|FG015|COMPLETED|Overall Study||50
2841253|NCT03972813|3542810|FG016|COMPLETED|Overall Study||48
2841254|NCT03972813|3542811|FG017|COMPLETED|Overall Study||48
2841255|NCT03972813|3542794|FG000|NOT COMPLETED|Overall Study||6
2841256|NCT03972813|3542795|FG001|NOT COMPLETED|Overall Study||4
2841257|NCT03972813|3542796|FG002|NOT COMPLETED|Overall Study||6
2841258|NCT03972813|3542797|FG003|NOT COMPLETED|Overall Study||4
2841259|NCT03972813|3542798|FG004|NOT COMPLETED|Overall Study||4
2841260|NCT03972813|3542799|FG005|NOT COMPLETED|Overall Study||2
2841261|NCT03972813|3542800|FG006|NOT COMPLETED|Overall Study||4
2841262|NCT03972813|3542801|FG007|NOT COMPLETED|Overall Study||3
2841263|NCT03972813|3542802|FG008|NOT COMPLETED|Overall Study||5
2841264|NCT03972813|3542803|FG009|NOT COMPLETED|Overall Study||2
2841265|NCT03972813|3542804|FG010|NOT COMPLETED|Overall Study||5
2841266|NCT03972813|3542805|FG011|NOT COMPLETED|Overall Study||4
2841267|NCT03972813|3542806|FG012|NOT COMPLETED|Overall Study||3
2841268|NCT03972813|3542807|FG013|NOT COMPLETED|Overall Study||3
2841269|NCT03972813|3542808|FG014|NOT COMPLETED|Overall Study||2
2841270|NCT03972813|3542809|FG015|NOT COMPLETED|Overall Study||6
2841271|NCT03972813|3542810|FG016|NOT COMPLETED|Overall Study||3
2841272|NCT03972813|3542811|FG017|NOT COMPLETED|Overall Study||2
2841273|NCT03920280|3542851|FG000|STARTED|Overall Study||41
2841274|NCT03920280|3542852|FG001|STARTED|Overall Study||78
2841275|NCT03920280|3542851|FG000|COMPLETED|Overall Study||38
2841276|NCT03920280|3542852|FG001|COMPLETED|Overall Study||72
2841277|NCT03920280|3542851|FG000|NOT COMPLETED|Overall Study||3
2841278|NCT03920280|3542852|FG001|NOT COMPLETED|Overall Study||6
2841279|NCT03913091|3542863|FG000|STARTED|Overall Study||92
2841280|NCT03913091|3542864|FG001|STARTED|Overall Study||92
2841281|NCT03913091|3542863|FG000|COMPLETED|Overall Study||72
2841282|NCT03913091|3542864|FG001|COMPLETED|Overall Study||78
2841283|NCT03913091|3542863|FG000|NOT COMPLETED|Overall Study||20
2841284|NCT03913091|3542864|FG001|NOT COMPLETED|Overall Study||14
2841285|NCT03802565|3542875|FG000|STARTED|Overall Study||82
2841286|NCT03802565|3542876|FG001|STARTED|Overall Study||87
2841287|NCT03802565|3542877|FG002|STARTED|Overall Study||83
2841288|NCT03802565|3542878|FG003|STARTED|Overall Study||85
2841289|NCT03802565|3542879|FG004|STARTED|Overall Study||78
2841290|NCT03802565|3542875|FG000|COMPLETED|Overall Study||77
2841291|NCT03802565|3542876|FG001|COMPLETED|Overall Study||83
2841292|NCT03802565|3542877|FG002|COMPLETED|Overall Study||74
2841293|NCT03802565|3542878|FG003|COMPLETED|Overall Study||77
2841294|NCT03802565|3542879|FG004|COMPLETED|Overall Study||72
2841295|NCT03802565|3542875|FG000|NOT COMPLETED|Overall Study||5
2841296|NCT03802565|3542876|FG001|NOT COMPLETED|Overall Study||4
2841297|NCT03802565|3542877|FG002|NOT COMPLETED|Overall Study||9
2841298|NCT03802565|3542878|FG003|NOT COMPLETED|Overall Study||8
2841299|NCT03802565|3542879|FG004|NOT COMPLETED|Overall Study||6
2841300|NCT03769194|3542895|FG000|STARTED|Overall Study||29
2841301|NCT03769194|3542896|FG001|STARTED|Overall Study||214
2841302|NCT03769194|3542897|FG002|STARTED|Overall Study||205
2841303|NCT03769194|3542898|FG003|STARTED|Overall Study||124
2841304|NCT03769194|3542895|FG000|COMPLETED|Overall Study||25
2841305|NCT03769194|3542896|FG001|COMPLETED|Overall Study||196
2841306|NCT03769194|3542897|FG002|COMPLETED|Overall Study||197
2841307|NCT03769194|3542898|FG003|COMPLETED|Overall Study||115
2841308|NCT03769194|3542895|FG000|NOT COMPLETED|Overall Study||4
2841309|NCT03769194|3542896|FG001|NOT COMPLETED|Overall Study||18
2841310|NCT03769194|3542897|FG002|NOT COMPLETED|Overall Study||8
2841311|NCT03769194|3542898|FG003|NOT COMPLETED|Overall Study||9
2841312|NCT03738332|3542908|FG000|STARTED|Overall Study||12
2841313|NCT03738332|3542908|FG000|COMPLETED|Overall Study||11
2841314|NCT03738332|3542908|FG000|NOT COMPLETED|Overall Study||1
2915986|NCT00513695|3626420|FG000|COMPLETED|Overall Study||63
2915987|NCT00513695|3626420|FG000|NOT COMPLETED|Overall Study||5
2915988|NCT00513708|3626427|FG000|STARTED|Overall Study||50
2915989|NCT00513708|3626428|FG001|STARTED|Overall Study||50
2915990|NCT00513708|3626429|FG002|STARTED|Overall Study||50
2915991|NCT00513708|3626427|FG000|COMPLETED|Overall Study||46
2915992|NCT00513708|3626428|FG001|COMPLETED|Overall Study||46
2915993|NCT00513708|3626429|FG002|COMPLETED|Overall Study||46
2915994|NCT00513708|3626427|FG000|NOT COMPLETED|Overall Study||4
2915995|NCT00513708|3626428|FG001|NOT COMPLETED|Overall Study||4
2915996|NCT00513708|3626429|FG002|NOT COMPLETED|Overall Study||4
2915997|NCT00513747|3626440|FG000|STARTED|Overall Study||17
2841321|NCT03451786|3542922|FG000|STARTED|Overall Study||369
2841322|NCT03451786|3542922|FG000|COMPLETED|Overall Study||310
2841323|NCT03451786|3542922|FG000|NOT COMPLETED|Overall Study||59
2841324|NCT03416179|3542930|FG000|STARTED|Overall Study||201
2841325|NCT03416179|3542931|FG001|STARTED|Overall Study||203
2841326|NCT03416179|3542932|FG002|STARTED|Overall Study||163
2841327|NCT03416179|3542933|FG003|STARTED|Overall Study||162
2841328|NCT03416179|3542930|FG000|COMPLETED|Overall Study||0
2841329|NCT03416179|3542931|FG001|COMPLETED|Overall Study||0
2841330|NCT03416179|3542932|FG002|COMPLETED|Overall Study||0
2841331|NCT03416179|3542933|FG003|COMPLETED|Overall Study||0
2841332|NCT03416179|3542930|FG000|NOT COMPLETED|Overall Study||201
2841333|NCT03416179|3542931|FG001|NOT COMPLETED|Overall Study||203
2841334|NCT03416179|3542932|FG002|NOT COMPLETED|Overall Study||163
2841335|NCT03416179|3542933|FG003|NOT COMPLETED|Overall Study||162
2841336|NCT03353922|3542943|FG000|STARTED|Overall Study||6
2841337|NCT03353922|3542944|FG001|STARTED|Overall Study||6
2841338|NCT03353922|3542945|FG002|STARTED|Overall Study||6
2841339|NCT03353922|3542946|FG003|STARTED|Overall Study||6
2841340|NCT03353922|3542947|FG004|STARTED|Overall Study||5
2841341|NCT03353922|3542948|FG005|STARTED|Overall Study||6
2841342|NCT03353922|3542943|FG000|COMPLETED|Overall Study||5
2841343|NCT03353922|3542944|FG001|COMPLETED|Overall Study||5
2841344|NCT03353922|3542945|FG002|COMPLETED|Overall Study||5
2841345|NCT03353922|3542946|FG003|COMPLETED|Overall Study||5
2841346|NCT03353922|3542947|FG004|COMPLETED|Overall Study||5
2841347|NCT03353922|3542948|FG005|COMPLETED|Overall Study||6
2841348|NCT03353922|3542943|FG000|NOT COMPLETED|Overall Study||1
2841349|NCT03353922|3542944|FG001|NOT COMPLETED|Overall Study||1
2841350|NCT03353922|3542945|FG002|NOT COMPLETED|Overall Study||1
2841351|NCT03353922|3542946|FG003|NOT COMPLETED|Overall Study||1
2841352|NCT03353922|3542947|FG004|NOT COMPLETED|Overall Study||0
2841353|NCT03353922|3542948|FG005|NOT COMPLETED|Overall Study||0
2841354|NCT03322384|3542959|FG000|STARTED|Overall Study||20
2841355|NCT03322384|3542959|FG000|COMPLETED|Overall Study||14
2841356|NCT03322384|3542959|FG000|NOT COMPLETED|Overall Study||6
2841357|NCT03243071|3542965|FG000|STARTED|Overall Study||59
2841358|NCT03243071|3542966|FG001|STARTED|Overall Study||53
2841359|NCT03243071|3542965|FG000|COMPLETED|Overall Study||59
2841360|NCT03243071|3542966|FG001|COMPLETED|Overall Study||53
2841361|NCT03243071|3542965|FG000|NOT COMPLETED|Overall Study||0
2841362|NCT03243071|3542966|FG001|NOT COMPLETED|Overall Study||0
2841363|NCT03173456|3542983|FG000|STARTED|Baseline||120
2841364|NCT03173456|3542984|FG001|STARTED|Baseline||120
2841365|NCT03173456|3542985|FG002|STARTED|Baseline||120
2841366|NCT03173456|3542986|FG003|STARTED|Baseline||120
2841367|NCT03173456|3542987|FG004|STARTED|Baseline||120
2841368|NCT03173456|3542983|FG000|COMPLETED|Baseline||120
2841369|NCT03173456|3542984|FG001|COMPLETED|Baseline||119
2841370|NCT03173456|3542985|FG002|COMPLETED|Baseline||120
2841371|NCT03173456|3542986|FG003|COMPLETED|Baseline||120
2841372|NCT03173456|3542987|FG004|COMPLETED|Baseline||118
2841373|NCT03173456|3542983|FG000|NOT COMPLETED|Baseline||0
2841374|NCT03173456|3542984|FG001|NOT COMPLETED|Baseline||1
2841375|NCT03173456|3542985|FG002|NOT COMPLETED|Baseline||0
2841376|NCT03173456|3542986|FG003|NOT COMPLETED|Baseline||0
2841377|NCT03173456|3542987|FG004|NOT COMPLETED|Baseline||2
2841378|NCT03173456|3542983|FG000|STARTED|2 Hour Follow-up||120
2841379|NCT03173456|3542984|FG001|STARTED|2 Hour Follow-up||119
2841380|NCT03173456|3542985|FG002|STARTED|2 Hour Follow-up||120
2841381|NCT03173456|3542986|FG003|STARTED|2 Hour Follow-up||120
2841382|NCT03173456|3542987|FG004|STARTED|2 Hour Follow-up||118
2841383|NCT03173456|3542983|FG000|COMPLETED|2 Hour Follow-up||120
2841384|NCT03173456|3542984|FG001|COMPLETED|2 Hour Follow-up||118
2841385|NCT03173456|3542985|FG002|COMPLETED|2 Hour Follow-up||119
2841386|NCT03173456|3542986|FG003|COMPLETED|2 Hour Follow-up||119
2841387|NCT03173456|3542987|FG004|COMPLETED|2 Hour Follow-up||116
2841388|NCT03173456|3542983|FG000|NOT COMPLETED|2 Hour Follow-up||0
2841389|NCT03173456|3542984|FG001|NOT COMPLETED|2 Hour Follow-up||1
2841390|NCT03173456|3542985|FG002|NOT COMPLETED|2 Hour Follow-up||1
2841391|NCT03173456|3542986|FG003|NOT COMPLETED|2 Hour Follow-up||1
2841392|NCT03173456|3542987|FG004|NOT COMPLETED|2 Hour Follow-up||2
2841393|NCT03101566|3543001|FG000|STARTED|Overall Study||37
2841394|NCT03101566|3543002|FG001|STARTED|Overall Study||38
2841395|NCT03101566|3543001|FG000|Received at Least One Dose of Protocol Therapy|Overall Study||35
2841396|NCT03101566|3543002|FG001|Received at Least One Dose of Protocol Therapy|Overall Study||33
2841397|NCT03101566|3543001|FG000|Assessed for Primary and Secondary Progression-free Survival|Overall Study||32
2841398|NCT03101566|3543002|FG001|Assessed for Primary and Secondary Progression-free Survival|Overall Study||33
2841399|NCT03101566|3543001|FG000|COMPLETED|Overall Study||31
2841400|NCT03101566|3543002|FG001|COMPLETED|Overall Study||31
2841401|NCT03101566|3543001|FG000|NOT COMPLETED|Overall Study||6
2841402|NCT03101566|3543002|FG001|NOT COMPLETED|Overall Study||7
2841403|NCT03020160|3543010|FG000|STARTED|Overall Study||7
3167531|NCT01911390|3894795|FG000|NOT COMPLETED|Overall Study||1
2841404|NCT03020160|3543011|FG001|STARTED|Overall Study||41
2841405|NCT03020160|3543010|FG000|Completed 24 Weeks in the Study|Overall Study||7
2841406|NCT03020160|3543011|FG001|Completed 24 Weeks in the Study|Overall Study||41
2841407|NCT03020160|3543010|FG000|COMPLETED|Overall Study||0
2841408|NCT03020160|3543011|FG001|COMPLETED|Overall Study||0
2841409|NCT03020160|3543010|FG000|NOT COMPLETED|Overall Study||7
2841410|NCT03020160|3543011|FG001|NOT COMPLETED|Overall Study||41
2841411|NCT03003520|3543020|FG000|STARTED|Induction||43
2841412|NCT03003520|3543021|FG001|STARTED|Induction||3
2841413|NCT03003520|3543020|FG000|Safety Population|Induction||43
2841414|NCT03003520|3543021|FG001|Safety Population|Induction||3
2841415|NCT03003520|3543020|FG000|Efficacy Evaluable Population|Induction||37
2841416|NCT03003520|3543021|FG001|Efficacy Evaluable Population|Induction||3
2841417|NCT03003520|3543020|FG000|COMPLETED|Induction||30
2841418|NCT03003520|3543021|FG001|COMPLETED|Induction||3
2841419|NCT03003520|3543020|FG000|NOT COMPLETED|Induction||13
2841420|NCT03003520|3543021|FG001|NOT COMPLETED|Induction||0
2841421|NCT03003520|3543020|FG000|STARTED|Consolidation||25
2841422|NCT03003520|3543021|FG001|STARTED|Consolidation||3
2841423|NCT03003520|3543020|FG000|COMPLETED|Consolidation||1
3167532|NCT01911390|3894796|FG001|NOT COMPLETED|Overall Study||0
3167533|NCT01911390|3894797|FG002|NOT COMPLETED|Overall Study||1
3167534|NCT01911390|3894798|FG003|NOT COMPLETED|Overall Study||1
2841424|NCT03003520|3543021|FG001|COMPLETED|Consolidation||2
2841425|NCT03003520|3543020|FG000|NOT COMPLETED|Consolidation||24
2841426|NCT03003520|3543021|FG001|NOT COMPLETED|Consolidation||1
2841427|NCT03003520|3543020|FG000|STARTED|Follow-up||14
2841428|NCT03003520|3543021|FG001|STARTED|Follow-up||3
2841429|NCT03003520|3543020|FG000|COMPLETED|Follow-up||0
2841430|NCT03003520|3543021|FG001|COMPLETED|Follow-up||0
2841431|NCT03003520|3543020|FG000|NOT COMPLETED|Follow-up||14
2841432|NCT03003520|3543021|FG001|NOT COMPLETED|Follow-up||3
2841433|NCT02862457|3543042|FG000|STARTED|Overall Study||3
2841434|NCT02862457|3543043|FG001|STARTED|Overall Study||3
2841435|NCT02862457|3543044|FG002|STARTED|Overall Study||3
2841436|NCT02862457|3543045|FG003|STARTED|Overall Study||6
2841437|NCT02862457|3543046|FG004|STARTED|Overall Study||7
2841438|NCT02862457|3543047|FG005|STARTED|Overall Study||6
2841439|NCT02862457|3543048|FG006|STARTED|Overall Study||6
2841440|NCT02862457|3543042|FG000|COMPLETED|Overall Study||1
2841441|NCT02862457|3543043|FG001|COMPLETED|Overall Study||0
2841442|NCT02862457|3543044|FG002|COMPLETED|Overall Study||0
2841443|NCT02862457|3543045|FG003|COMPLETED|Overall Study||2
2841444|NCT02862457|3543046|FG004|COMPLETED|Overall Study||7
2841445|NCT02862457|3543047|FG005|COMPLETED|Overall Study||3
2841446|NCT02862457|3543048|FG006|COMPLETED|Overall Study||5
2841447|NCT02862457|3543042|FG000|NOT COMPLETED|Overall Study||2
2841448|NCT02862457|3543043|FG001|NOT COMPLETED|Overall Study||3
2841449|NCT02862457|3543044|FG002|NOT COMPLETED|Overall Study||3
2841450|NCT02862457|3543045|FG003|NOT COMPLETED|Overall Study||4
2841451|NCT02862457|3543046|FG004|NOT COMPLETED|Overall Study||0
2841452|NCT02862457|3543047|FG005|NOT COMPLETED|Overall Study||3
2841453|NCT02862457|3543048|FG006|NOT COMPLETED|Overall Study||1
2841454|NCT02820753|3543074|FG000|STARTED|Baseline||256
2841455|NCT02820753|3543075|FG001|STARTED|Baseline||421
2841456|NCT02820753|3543074|FG000|COMPLETED|Baseline||256
2841457|NCT02820753|3543075|FG001|COMPLETED|Baseline||421
2841458|NCT02820753|3543074|FG000|NOT COMPLETED|Baseline||0
2841459|NCT02820753|3543075|FG001|NOT COMPLETED|Baseline||0
2841460|NCT02820753|3543074|FG000|STARTED|2 Month||256
2841461|NCT02820753|3543075|FG001|STARTED|2 Month||421
2841462|NCT02820753|3543074|FG000|COMPLETED|2 Month||178
2841463|NCT02820753|3543075|FG001|COMPLETED|2 Month||379
2841464|NCT02820753|3543074|FG000|NOT COMPLETED|2 Month||78
2841465|NCT02820753|3543075|FG001|NOT COMPLETED|2 Month||42
2841466|NCT02820753|3543074|FG000|STARTED|6 Month||253
2841467|NCT02820753|3543075|FG001|STARTED|6 Month||418
2841468|NCT02820753|3543074|FG000|COMPLETED|6 Month||150
2841469|NCT02820753|3543075|FG001|COMPLETED|6 Month||307
2841470|NCT02820753|3543074|FG000|NOT COMPLETED|6 Month||103
2841471|NCT02820753|3543075|FG001|NOT COMPLETED|6 Month||111
2841472|NCT02733042|3543100|FG000|STARTED|Treatment Period||3
2841473|NCT02733042|3543101|FG001|STARTED|Treatment Period||3
2841474|NCT02733042|3543102|FG002|STARTED|Treatment Period||8
2841475|NCT02733042|3543103|FG003|STARTED|Treatment Period||3
2841476|NCT02733042|3543104|FG004|STARTED|Treatment Period||4
2841477|NCT02733042|3543105|FG005|STARTED|Treatment Period||3
2841478|NCT02733042|3543106|FG006|STARTED|Treatment Period||1
2841479|NCT02733042|3543107|FG007|STARTED|Treatment Period||4
2841480|NCT02733042|3543108|FG008|STARTED|Treatment Period||5
2841481|NCT02733042|3543109|FG009|STARTED|Treatment Period||10
2841482|NCT02733042|3543110|FG010|STARTED|Treatment Period||10
2841483|NCT02733042|3543111|FG011|STARTED|Treatment Period||10
2841484|NCT02733042|3543112|FG012|STARTED|Treatment Period||10
2841485|NCT02733042|3543113|FG013|STARTED|Treatment Period||5
2841486|NCT02733042|3543114|FG014|STARTED|Treatment Period||5
2841487|NCT02733042|3543115|FG015|STARTED|Treatment Period||10
2841488|NCT02733042|3543116|FG016|STARTED|Treatment Period||2
2841489|NCT02733042|3543117|FG017|STARTED|Treatment Period||5
2841490|NCT02733042|3543118|FG018|STARTED|Treatment Period||5
2841491|NCT02733042|3543100|FG000|COMPLETED|Treatment Period||0
2841492|NCT02733042|3543101|FG001|COMPLETED|Treatment Period||1
2841493|NCT02733042|3543102|FG002|COMPLETED|Treatment Period||1
2841494|NCT02733042|3543103|FG003|COMPLETED|Treatment Period||0
2841495|NCT02733042|3543104|FG004|COMPLETED|Treatment Period||0
3167535|NCT01911403|3894810|FG000|STARTED|Overall Study||61
2841496|NCT02733042|3543105|FG005|COMPLETED|Treatment Period||0
2841497|NCT02733042|3543106|FG006|COMPLETED|Treatment Period||0
2841498|NCT02733042|3543107|FG007|COMPLETED|Treatment Period||1
2841499|NCT02733042|3543108|FG008|COMPLETED|Treatment Period||0
2841500|NCT02733042|3543109|FG009|COMPLETED|Treatment Period||0
2841501|NCT02733042|3543110|FG010|COMPLETED|Treatment Period||0
2841502|NCT02733042|3543111|FG011|COMPLETED|Treatment Period||4
2841503|NCT02733042|3543112|FG012|COMPLETED|Treatment Period||1
2841504|NCT02733042|3543113|FG013|COMPLETED|Treatment Period||1
2841505|NCT02733042|3543114|FG014|COMPLETED|Treatment Period||0
2841506|NCT02733042|3543115|FG015|COMPLETED|Treatment Period||0
2841507|NCT02733042|3543116|FG016|COMPLETED|Treatment Period||0
2841508|NCT02733042|3543117|FG017|COMPLETED|Treatment Period||0
2841509|NCT02733042|3543118|FG018|COMPLETED|Treatment Period||0
2841510|NCT02733042|3543100|FG000|NOT COMPLETED|Treatment Period||3
2841511|NCT02733042|3543101|FG001|NOT COMPLETED|Treatment Period||2
2841512|NCT02733042|3543102|FG002|NOT COMPLETED|Treatment Period||7
2841513|NCT02733042|3543103|FG003|NOT COMPLETED|Treatment Period||3
2841514|NCT02733042|3543104|FG004|NOT COMPLETED|Treatment Period||4
2841515|NCT02733042|3543105|FG005|NOT COMPLETED|Treatment Period||3
2841516|NCT02733042|3543106|FG006|NOT COMPLETED|Treatment Period||1
2841517|NCT02733042|3543107|FG007|NOT COMPLETED|Treatment Period||3
2841518|NCT02733042|3543108|FG008|NOT COMPLETED|Treatment Period||5
2841519|NCT02733042|3543109|FG009|NOT COMPLETED|Treatment Period||10
2841520|NCT02733042|3543110|FG010|NOT COMPLETED|Treatment Period||10
2841521|NCT02733042|3543111|FG011|NOT COMPLETED|Treatment Period||6
2841522|NCT02733042|3543112|FG012|NOT COMPLETED|Treatment Period||9
2841523|NCT02733042|3543113|FG013|NOT COMPLETED|Treatment Period||4
2841524|NCT02733042|3543114|FG014|NOT COMPLETED|Treatment Period||5
2841525|NCT02733042|3543115|FG015|NOT COMPLETED|Treatment Period||10
2841526|NCT02733042|3543116|FG016|NOT COMPLETED|Treatment Period||2
2841527|NCT02733042|3543117|FG017|NOT COMPLETED|Treatment Period||5
2841528|NCT02733042|3543118|FG018|NOT COMPLETED|Treatment Period||5
2841529|NCT02733042|3543100|FG000|STARTED|Follow-up Period||3
2841530|NCT02733042|3543101|FG001|STARTED|Follow-up Period||3
2841531|NCT02733042|3543102|FG002|STARTED|Follow-up Period||6
2841532|NCT02733042|3543103|FG003|STARTED|Follow-up Period||3
2841533|NCT02733042|3543104|FG004|STARTED|Follow-up Period||1
2841534|NCT02733042|3543105|FG005|STARTED|Follow-up Period||2
2841535|NCT02733042|3543106|FG006|STARTED|Follow-up Period||0
2841536|NCT02733042|3543107|FG007|STARTED|Follow-up Period||4
2841537|NCT02733042|3543108|FG008|STARTED|Follow-up Period||4
2841538|NCT02733042|3543109|FG009|STARTED|Follow-up Period||2
2841539|NCT02733042|3543110|FG010|STARTED|Follow-up Period||5
2841540|NCT02733042|3543111|FG011|STARTED|Follow-up Period||9
2841541|NCT02733042|3543112|FG012|STARTED|Follow-up Period||9
2841542|NCT02733042|3543113|FG013|STARTED|Follow-up Period||4
3167536|NCT01911403|3894811|FG001|STARTED|Overall Study||62
3167537|NCT01911403|3894810|FG000|COMPLETED|Overall Study||52
3167538|NCT01911403|3894811|FG001|COMPLETED|Overall Study||59
3167539|NCT01911403|3894810|FG000|NOT COMPLETED|Overall Study||9
3167540|NCT01911403|3894811|FG001|NOT COMPLETED|Overall Study||3
3167541|NCT01911429|3894820|FG000|STARTED|Overall Study||108
3167542|NCT01911429|3894821|FG001|STARTED|Overall Study|Subjects received lurasidone 40/mg day from Days 1-3, and 80mg/day from days 4 to Week 6 visit|106
3167543|NCT01911429|3894822|FG002|STARTED|Overall Study|one subject randomized to Placebo group was never dosed for study medication, making the total 112|113
3167544|NCT01911429|3894820|FG000|COMPLETED|Overall Study||96
3167545|NCT01911429|3894821|FG001|COMPLETED|Overall Study||96
3167546|NCT01911429|3894822|FG002|COMPLETED|Overall Study||93
3167547|NCT01911429|3894820|FG000|NOT COMPLETED|Overall Study||12
3167548|NCT01911429|3894821|FG001|NOT COMPLETED|Overall Study||10
3167549|NCT01911429|3894822|FG002|NOT COMPLETED|Overall Study||20
3167550|NCT01911442|3894833|FG000|STARTED|Overall Study||49
3167551|NCT01911442|3894834|FG001|STARTED|Overall Study||51
3167552|NCT01911442|3894835|FG002|STARTED|Overall Study||50
3167553|NCT01911442|3894833|FG000|COMPLETED|Overall Study||43
3167554|NCT01911442|3894834|FG001|COMPLETED|Overall Study||47
3167555|NCT01911442|3894835|FG002|COMPLETED|Overall Study||38
3167556|NCT01911442|3894833|FG000|NOT COMPLETED|Overall Study||6
3167557|NCT01911442|3894834|FG001|NOT COMPLETED|Overall Study||4
3167558|NCT01911442|3894835|FG002|NOT COMPLETED|Overall Study||12
3167559|NCT01911546|3894847|FG000|STARTED|Overall Study||20
3167560|NCT01911546|3894847|FG000|COMPLETED|Overall Study||14
3167561|NCT01911546|3894847|FG000|NOT COMPLETED|Overall Study||6
3167562|NCT01911689|3894853|FG000|STARTED|Overall Study||117
3167563|NCT01911689|3894854|FG001|STARTED|Overall Study||51
3167564|NCT01911689|3894853|FG000|COMPLETED|Overall Study||117
3167565|NCT01911689|3894854|FG001|COMPLETED|Overall Study||51
3167566|NCT01911689|3894853|FG000|NOT COMPLETED|Overall Study||0
3167567|NCT01911689|3894854|FG001|NOT COMPLETED|Overall Study||0
3167568|NCT01911780|3894869|FG000|STARTED|Double-blind Period (8 Weeks)||68
3167569|NCT01911780|3894870|FG001|STARTED|Double-blind Period (8 Weeks)||64
3167570|NCT01911780|3894869|FG000|COMPLETED|Double-blind Period (8 Weeks)||65
3167571|NCT01911780|3894870|FG001|COMPLETED|Double-blind Period (8 Weeks)||61
3167572|NCT01911780|3894869|FG000|NOT COMPLETED|Double-blind Period (8 Weeks)||3
3167573|NCT01911780|3894870|FG001|NOT COMPLETED|Double-blind Period (8 Weeks)||3
3167574|NCT01911780|3894869|FG000|STARTED|Extension Period (52 Weeks)||65
2841543|NCT02733042|3543114|FG014|STARTED|Follow-up Period||1
2841544|NCT02733042|3543115|FG015|STARTED|Follow-up Period||5
2841545|NCT02733042|3543116|FG016|STARTED|Follow-up Period||0
2841546|NCT02733042|3543117|FG017|STARTED|Follow-up Period||3
2841547|NCT02733042|3543118|FG018|STARTED|Follow-up Period||2
2841548|NCT02733042|3543100|FG000|COMPLETED|Follow-up Period||0
2841549|NCT02733042|3543101|FG001|COMPLETED|Follow-up Period||0
3167575|NCT01911780|3894870|FG001|STARTED|Extension Period (52 Weeks)||61
3167576|NCT01911780|3894869|FG000|COMPLETED|Extension Period (52 Weeks)||61
3167577|NCT01911780|3894870|FG001|COMPLETED|Extension Period (52 Weeks)||58
3167578|NCT01911780|3894869|FG000|NOT COMPLETED|Extension Period (52 Weeks)||4
3167579|NCT01911780|3894870|FG001|NOT COMPLETED|Extension Period (52 Weeks)||3
3167580|NCT01911819|3894883|FG000|STARTED|Overall Study||10
3167581|NCT01911819|3894884|FG001|STARTED|Overall Study|One of 10 sinuses was replaced to another sinus due to infection.|11
3167582|NCT01911819|3894885|FG002|STARTED|Overall Study||10
2841550|NCT02733042|3543102|FG002|COMPLETED|Follow-up Period||0
2841551|NCT02733042|3543103|FG003|COMPLETED|Follow-up Period||0
2841552|NCT02733042|3543104|FG004|COMPLETED|Follow-up Period||0
2841553|NCT02733042|3543105|FG005|COMPLETED|Follow-up Period||0
2841554|NCT02733042|3543106|FG006|COMPLETED|Follow-up Period||0
2841555|NCT02733042|3543107|FG007|COMPLETED|Follow-up Period||0
2841556|NCT02733042|3543108|FG008|COMPLETED|Follow-up Period||0
2841557|NCT02733042|3543109|FG009|COMPLETED|Follow-up Period||0
2841558|NCT02733042|3543110|FG010|COMPLETED|Follow-up Period||0
2841559|NCT02733042|3543111|FG011|COMPLETED|Follow-up Period||0
2841560|NCT02733042|3543112|FG012|COMPLETED|Follow-up Period||0
2841561|NCT02733042|3543113|FG013|COMPLETED|Follow-up Period||0
2841562|NCT02733042|3543114|FG014|COMPLETED|Follow-up Period||0
2841563|NCT02733042|3543115|FG015|COMPLETED|Follow-up Period||0
2841564|NCT02733042|3543116|FG016|COMPLETED|Follow-up Period||0
2841565|NCT02733042|3543117|FG017|COMPLETED|Follow-up Period||1
2841566|NCT02733042|3543118|FG018|COMPLETED|Follow-up Period||0
2841567|NCT02733042|3543100|FG000|NOT COMPLETED|Follow-up Period||3
2841568|NCT02733042|3543101|FG001|NOT COMPLETED|Follow-up Period||3
2841569|NCT02733042|3543102|FG002|NOT COMPLETED|Follow-up Period||6
2841570|NCT02733042|3543103|FG003|NOT COMPLETED|Follow-up Period||3
2841571|NCT02733042|3543104|FG004|NOT COMPLETED|Follow-up Period||1
2841572|NCT02733042|3543105|FG005|NOT COMPLETED|Follow-up Period||2
2841573|NCT02733042|3543106|FG006|NOT COMPLETED|Follow-up Period||0
2841574|NCT02733042|3543107|FG007|NOT COMPLETED|Follow-up Period||4
2841575|NCT02733042|3543108|FG008|NOT COMPLETED|Follow-up Period||4
2841576|NCT02733042|3543109|FG009|NOT COMPLETED|Follow-up Period||2
2841577|NCT02733042|3543110|FG010|NOT COMPLETED|Follow-up Period||5
2841578|NCT02733042|3543111|FG011|NOT COMPLETED|Follow-up Period||9
2841579|NCT02733042|3543112|FG012|NOT COMPLETED|Follow-up Period||9
2841580|NCT02733042|3543113|FG013|NOT COMPLETED|Follow-up Period||4
2841581|NCT02733042|3543114|FG014|NOT COMPLETED|Follow-up Period||1
2841582|NCT02733042|3543115|FG015|NOT COMPLETED|Follow-up Period||5
2841583|NCT02733042|3543116|FG016|NOT COMPLETED|Follow-up Period||0
2841584|NCT02733042|3543117|FG017|NOT COMPLETED|Follow-up Period||2
2841585|NCT02733042|3543118|FG018|NOT COMPLETED|Follow-up Period||2
2841586|NCT02668874|3543168|FG000|STARTED|Overall Study||104
2841587|NCT02668874|3543169|FG001|STARTED|Overall Study||104
2841588|NCT02668874|3543168|FG000|6 Months After Placement|Overall Study||59
2841589|NCT02668874|3543169|FG001|6 Months After Placement|Overall Study||59
2841590|NCT02668874|3543168|FG000|COMPLETED|Overall Study||47
2841591|NCT02668874|3543169|FG001|COMPLETED|Overall Study||47
2841592|NCT02668874|3543168|FG000|NOT COMPLETED|Overall Study||57
2841593|NCT02668874|3543169|FG001|NOT COMPLETED|Overall Study||57
2915998|NCT00513747|3626441|FG001|STARTED|Overall Study||11
2915999|NCT00513747|3626442|FG002|STARTED|Overall Study||55
2916000|NCT00513747|3626440|FG000|Received at Least One Dose of Treatment|Overall Study||9
2916001|NCT00513747|3626441|FG001|Received at Least One Dose of Treatment|Overall Study||11
2916002|NCT00513747|3626442|FG002|Received at Least One Dose of Treatment|Overall Study||40
2916003|NCT00513747|3626440|FG000|COMPLETED|Overall Study||17
2916004|NCT00513747|3626441|FG001|COMPLETED|Overall Study||11
2916005|NCT00513747|3626442|FG002|COMPLETED|Overall Study||55
2916006|NCT00513747|3626440|FG000|NOT COMPLETED|Overall Study||0
2916007|NCT00513747|3626441|FG001|NOT COMPLETED|Overall Study||0
2916008|NCT00513747|3626442|FG002|NOT COMPLETED|Overall Study||0
2916009|NCT00513799|3626456|FG000|STARTED|One-Month Follow-Up||75
2916010|NCT00513799|3626457|FG001|STARTED|One-Month Follow-Up||75
2916011|NCT00513799|3626458|FG002|STARTED|One-Month Follow-Up||75
2916012|NCT00513799|3626459|FG003|STARTED|One-Month Follow-Up||75
2916013|NCT00513799|3626456|FG000|COMPLETED|One-Month Follow-Up||64
2916014|NCT00513799|3626457|FG001|COMPLETED|One-Month Follow-Up||62
2916015|NCT00513799|3626458|FG002|COMPLETED|One-Month Follow-Up||64
2916016|NCT00513799|3626459|FG003|COMPLETED|One-Month Follow-Up||54
2916017|NCT00513799|3626456|FG000|NOT COMPLETED|One-Month Follow-Up||11
2916018|NCT00513799|3626457|FG001|NOT COMPLETED|One-Month Follow-Up||13
2916019|NCT00513799|3626458|FG002|NOT COMPLETED|One-Month Follow-Up||11
2916020|NCT00513799|3626459|FG003|NOT COMPLETED|One-Month Follow-Up||21
2916021|NCT00513799|3626456|FG000|STARTED|Four-Month Follow-Up||64
2916022|NCT00513799|3626457|FG001|STARTED|Four-Month Follow-Up||62
2916023|NCT00513799|3626458|FG002|STARTED|Four-Month Follow-Up||64
2916024|NCT00513799|3626459|FG003|STARTED|Four-Month Follow-Up||54
2916025|NCT00513799|3626456|FG000|COMPLETED|Four-Month Follow-Up||64
2916026|NCT00513799|3626457|FG001|COMPLETED|Four-Month Follow-Up||57
2916027|NCT00513799|3626458|FG002|COMPLETED|Four-Month Follow-Up||57
2916028|NCT00513799|3626459|FG003|COMPLETED|Four-Month Follow-Up||51
2916029|NCT00513799|3626456|FG000|NOT COMPLETED|Four-Month Follow-Up||0
2916030|NCT00513799|3626457|FG001|NOT COMPLETED|Four-Month Follow-Up||5
2916031|NCT00513799|3626458|FG002|NOT COMPLETED|Four-Month Follow-Up||7
2916032|NCT00513799|3626459|FG003|NOT COMPLETED|Four-Month Follow-Up||3
3167583|NCT01911819|3894883|FG000|COMPLETED|Overall Study||9
3167584|NCT01911819|3894884|FG001|COMPLETED|Overall Study||9
2841594|NCT02609737|3543175|FG000|STARTED|Overall Study||20
2841595|NCT02609737|3543175|FG000|COMPLETED|Overall Study||20
2841596|NCT02609737|3543175|FG000|NOT COMPLETED|Overall Study||0
2841597|NCT02574286|3543179|FG000|STARTED|Overall Study||21
2841598|NCT02574286|3543179|FG000|COMPLETED|Overall Study||16
2841599|NCT02574286|3543179|FG000|NOT COMPLETED|Overall Study||5
2841600|NCT02471144|3543187|FG000|STARTED|Induction Period (Up to Week 12)||40
2841601|NCT02471144|3543188|FG001|STARTED|Induction Period (Up to Week 12)||40
2841602|NCT02471144|3543189|FG002|STARTED|Induction Period (Up to Week 12)||41
2841603|NCT02471144|3543190|FG003|STARTED|Induction Period (Up to Week 12)||41
2841604|NCT02471144|3543191|FG004|STARTED|Induction Period (Up to Week 12)||0
2841605|NCT02471144|3543192|FG005|STARTED|Induction Period (Up to Week 12)||0
2841606|NCT02471144|3543193|FG006|STARTED|Induction Period (Up to Week 12)||0
2841607|NCT02471144|3543194|FG007|STARTED|Induction Period (Up to Week 12)||0
2841608|NCT02471144|3543195|FG008|STARTED|Induction Period (Up to Week 12)||0
2841609|NCT02471144|3543196|FG009|STARTED|Induction Period (Up to Week 12)||0
2841610|NCT02471144|3543197|FG010|STARTED|Induction Period (Up to Week 12)||0
2841611|NCT02471144|3543187|FG000|COMPLETED|Induction Period (Up to Week 12)||39
2841612|NCT02471144|3543188|FG001|COMPLETED|Induction Period (Up to Week 12)||38
2841613|NCT02471144|3543189|FG002|COMPLETED|Induction Period (Up to Week 12)||39
2841614|NCT02471144|3543190|FG003|COMPLETED|Induction Period (Up to Week 12)||40
2841615|NCT02471144|3543191|FG004|COMPLETED|Induction Period (Up to Week 12)||0
2841616|NCT02471144|3543192|FG005|COMPLETED|Induction Period (Up to Week 12)||0
2841617|NCT02471144|3543193|FG006|COMPLETED|Induction Period (Up to Week 12)||0
2841618|NCT02471144|3543194|FG007|COMPLETED|Induction Period (Up to Week 12)||0
2841619|NCT02471144|3543195|FG008|COMPLETED|Induction Period (Up to Week 12)||0
2841620|NCT02471144|3543196|FG009|COMPLETED|Induction Period (Up to Week 12)||0
2841621|NCT02471144|3543197|FG010|COMPLETED|Induction Period (Up to Week 12)||0
2841622|NCT02471144|3543187|FG000|NOT COMPLETED|Induction Period (Up to Week 12)||1
2841623|NCT02471144|3543188|FG001|NOT COMPLETED|Induction Period (Up to Week 12)||2
2841624|NCT02471144|3543189|FG002|NOT COMPLETED|Induction Period (Up to Week 12)||2
2841625|NCT02471144|3543190|FG003|NOT COMPLETED|Induction Period (Up to Week 12)||1
2841626|NCT02471144|3543191|FG004|NOT COMPLETED|Induction Period (Up to Week 12)||0
2841627|NCT02471144|3543192|FG005|NOT COMPLETED|Induction Period (Up to Week 12)||0
2841628|NCT02471144|3543193|FG006|NOT COMPLETED|Induction Period (Up to Week 12)||0
2841629|NCT02471144|3543194|FG007|NOT COMPLETED|Induction Period (Up to Week 12)||0
2841630|NCT02471144|3543195|FG008|NOT COMPLETED|Induction Period (Up to Week 12)||0
2841631|NCT02471144|3543196|FG009|NOT COMPLETED|Induction Period (Up to Week 12)||0
2841632|NCT02471144|3543197|FG010|NOT COMPLETED|Induction Period (Up to Week 12)||0
2841633|NCT02471144|3543187|FG000|STARTED|Maintenance Period (Week 12 to Week 52)||0
2841634|NCT02471144|3543188|FG001|STARTED|Maintenance Period (Week 12 to Week 52)||0
2841635|NCT02471144|3543189|FG002|STARTED|Maintenance Period (Week 12 to Week 52)||0
2841636|NCT02471144|3543190|FG003|STARTED|Maintenance Period (Week 12 to Week 52)||0
2841637|NCT02471144|3543191|FG004|STARTED|Maintenance Period (Week 12 to Week 52)||39
2841638|NCT02471144|3543192|FG005|STARTED|Maintenance Period (Week 12 to Week 52)||38
2841639|NCT02471144|3543193|FG006|STARTED|Maintenance Period (Week 12 to Week 52)||16
2841640|NCT02471144|3543194|FG007|STARTED|Maintenance Period (Week 12 to Week 52)||18
2841641|NCT02471144|3543195|FG008|STARTED|Maintenance Period (Week 12 to Week 52)||40
2841642|NCT02471144|3543196|FG009|STARTED|Maintenance Period (Week 12 to Week 52)||0
2841643|NCT02471144|3543197|FG010|STARTED|Maintenance Period (Week 12 to Week 52)||0
2841644|NCT02471144|3543187|FG000|COMPLETED|Maintenance Period (Week 12 to Week 52)||0
2841645|NCT02471144|3543188|FG001|COMPLETED|Maintenance Period (Week 12 to Week 52)||0
2841646|NCT02471144|3543189|FG002|COMPLETED|Maintenance Period (Week 12 to Week 52)||0
2841647|NCT02471144|3543190|FG003|COMPLETED|Maintenance Period (Week 12 to Week 52)||0
2841648|NCT02471144|3543191|FG004|COMPLETED|Maintenance Period (Week 12 to Week 52)||38
2841649|NCT02471144|3543192|FG005|COMPLETED|Maintenance Period (Week 12 to Week 52)||37
2841650|NCT02471144|3543193|FG006|COMPLETED|Maintenance Period (Week 12 to Week 52)||15
2841651|NCT02471144|3543194|FG007|COMPLETED|Maintenance Period (Week 12 to Week 52)||16
2841652|NCT02471144|3543195|FG008|COMPLETED|Maintenance Period (Week 12 to Week 52)||34
2841653|NCT02471144|3543196|FG009|COMPLETED|Maintenance Period (Week 12 to Week 52)||0
2841654|NCT02471144|3543197|FG010|COMPLETED|Maintenance Period (Week 12 to Week 52)||0
2841655|NCT02471144|3543187|FG000|NOT COMPLETED|Maintenance Period (Week 12 to Week 52)||0
2841656|NCT02471144|3543188|FG001|NOT COMPLETED|Maintenance Period (Week 12 to Week 52)||0
2841657|NCT02471144|3543189|FG002|NOT COMPLETED|Maintenance Period (Week 12 to Week 52)||0
2841658|NCT02471144|3543190|FG003|NOT COMPLETED|Maintenance Period (Week 12 to Week 52)||0
2841659|NCT02471144|3543191|FG004|NOT COMPLETED|Maintenance Period (Week 12 to Week 52)||1
2841660|NCT02471144|3543192|FG005|NOT COMPLETED|Maintenance Period (Week 12 to Week 52)||1
2841661|NCT02471144|3543193|FG006|NOT COMPLETED|Maintenance Period (Week 12 to Week 52)||1
2841662|NCT02471144|3543194|FG007|NOT COMPLETED|Maintenance Period (Week 12 to Week 52)||2
2841663|NCT02471144|3543195|FG008|NOT COMPLETED|Maintenance Period (Week 12 to Week 52)||6
2841664|NCT02471144|3543196|FG009|NOT COMPLETED|Maintenance Period (Week 12 to Week 52)||0
2841665|NCT02471144|3543197|FG010|NOT COMPLETED|Maintenance Period (Week 12 to Week 52)||0
2841666|NCT02471144|3543187|FG000|STARTED|Extension Period (Week 52 to Week 236)||0
2841667|NCT02471144|3543188|FG001|STARTED|Extension Period (Week 52 to Week 236)||0
2841668|NCT02471144|3543189|FG002|STARTED|Extension Period (Week 52 to Week 236)||0
2920736|NCT00538512|3631285|FG002|NOT COMPLETED|Overall Study||13
2841669|NCT02471144|3543190|FG003|STARTED|Extension Period (Week 52 to Week 236)||0
2841670|NCT02471144|3543191|FG004|STARTED|Extension Period (Week 52 to Week 236)||0
2841671|NCT02471144|3543192|FG005|STARTED|Extension Period (Week 52 to Week 236)||0
2841672|NCT02471144|3543193|FG006|STARTED|Extension Period (Week 52 to Week 236)||0
2841673|NCT02471144|3543194|FG007|STARTED|Extension Period (Week 52 to Week 236)||0
2841674|NCT02471144|3543195|FG008|STARTED|Extension Period (Week 52 to Week 236)||0
2841675|NCT02471144|3543196|FG009|STARTED|Extension Period (Week 52 to Week 236)||53
2841676|NCT02471144|3543197|FG010|STARTED|Extension Period (Week 52 to Week 236)||53
2841677|NCT02471144|3543187|FG000|COMPLETED|Extension Period (Week 52 to Week 236)||0
2841678|NCT02471144|3543188|FG001|COMPLETED|Extension Period (Week 52 to Week 236)||0
2841679|NCT02471144|3543189|FG002|COMPLETED|Extension Period (Week 52 to Week 236)||0
2841680|NCT02471144|3543190|FG003|COMPLETED|Extension Period (Week 52 to Week 236)||0
2841681|NCT02471144|3543191|FG004|COMPLETED|Extension Period (Week 52 to Week 236)||0
2841682|NCT02471144|3543192|FG005|COMPLETED|Extension Period (Week 52 to Week 236)||0
2841683|NCT02471144|3543193|FG006|COMPLETED|Extension Period (Week 52 to Week 236)||0
2841684|NCT02471144|3543194|FG007|COMPLETED|Extension Period (Week 52 to Week 236)||0
2841685|NCT02471144|3543195|FG008|COMPLETED|Extension Period (Week 52 to Week 236)||0
2841686|NCT02471144|3543196|FG009|COMPLETED|Extension Period (Week 52 to Week 236)||46
2841687|NCT02471144|3543197|FG010|COMPLETED|Extension Period (Week 52 to Week 236)||49
2841688|NCT02471144|3543187|FG000|NOT COMPLETED|Extension Period (Week 52 to Week 236)||0
2841689|NCT02471144|3543188|FG001|NOT COMPLETED|Extension Period (Week 52 to Week 236)||0
2841690|NCT02471144|3543189|FG002|NOT COMPLETED|Extension Period (Week 52 to Week 236)||0
2841691|NCT02471144|3543190|FG003|NOT COMPLETED|Extension Period (Week 52 to Week 236)||0
2841692|NCT02471144|3543191|FG004|NOT COMPLETED|Extension Period (Week 52 to Week 236)||0
2841693|NCT02471144|3543192|FG005|NOT COMPLETED|Extension Period (Week 52 to Week 236)||0
2841694|NCT02471144|3543193|FG006|NOT COMPLETED|Extension Period (Week 52 to Week 236)||0
2841695|NCT02471144|3543194|FG007|NOT COMPLETED|Extension Period (Week 52 to Week 236)||0
2841696|NCT02471144|3543195|FG008|NOT COMPLETED|Extension Period (Week 52 to Week 236)||0
2841697|NCT02471144|3543196|FG009|NOT COMPLETED|Extension Period (Week 52 to Week 236)||7
2841698|NCT02471144|3543197|FG010|NOT COMPLETED|Extension Period (Week 52 to Week 236)||4
2841699|NCT02440464|3543215|FG000|STARTED|Overall Study||21
2841700|NCT02440464|3543216|FG001|STARTED|Overall Study||22
2841701|NCT02440464|3543215|FG000|COMPLETED|Overall Study||18
2841702|NCT02440464|3543216|FG001|COMPLETED|Overall Study||20
2841703|NCT02440464|3543215|FG000|NOT COMPLETED|Overall Study||3
2841704|NCT02440464|3543216|FG001|NOT COMPLETED|Overall Study||2
2841705|NCT02384421|3543223|FG000|STARTED|Overall Study||22
2841706|NCT02384421|3543223|FG000|COMPLETED|Overall Study||22
2841707|NCT02384421|3543223|FG000|NOT COMPLETED|Overall Study||0
2841708|NCT02366728|3543233|FG000|STARTED|Overall Study||27
2841709|NCT02366728|3543234|FG001|STARTED|Overall Study||28
2841710|NCT02366728|3543235|FG002|STARTED|Overall Study||9
2841711|NCT02366728|3543233|FG000|Received at Least One ppp65 Vaccine|Overall Study||25
2841712|NCT02366728|3543234|FG001|Received at Least One ppp65 Vaccine|Overall Study||27
2841713|NCT02366728|3543235|FG002|Received at Least One ppp65 Vaccine|Overall Study||8
2841714|NCT02366728|3543233|FG000|COMPLETED|Overall Study||23
2841715|NCT02366728|3543234|FG001|COMPLETED|Overall Study||27
2841716|NCT02366728|3543235|FG002|COMPLETED|Overall Study||8
2841717|NCT02366728|3543233|FG000|NOT COMPLETED|Overall Study||4
2841718|NCT02366728|3543234|FG001|NOT COMPLETED|Overall Study||1
2841719|NCT02366728|3543235|FG002|NOT COMPLETED|Overall Study||1
2841720|NCT02236572|3543243|FG000|STARTED|Overall Study||17
2841721|NCT02236572|3543243|FG000|COMPLETED|Overall Study||14
2841722|NCT02236572|3543243|FG000|NOT COMPLETED|Overall Study||3
2841723|NCT02083354|3543247|FG000|STARTED|Overall Study||77
2841724|NCT02083354|3543247|FG000|COMPLETED|Overall Study||13
2841725|NCT02083354|3543247|FG000|NOT COMPLETED|Overall Study||64
2841726|NCT01885078|3543259|FG000|STARTED|Treatment Period||451
2841727|NCT01885078|3543260|FG001|STARTED|Treatment Period||1091
2841728|NCT01885078|3543261|FG002|STARTED|Treatment Period||180
2841729|NCT01885078|3543262|FG003|STARTED|Treatment Period||403
2841730|NCT01885078|3543263|FG004|STARTED|Treatment Period||117
2841731|NCT01885078|3543264|FG005|STARTED|Treatment Period||331
2841732|NCT01885078|3543265|FG006|STARTED|Treatment Period||221
2841733|NCT01885078|3543266|FG007|STARTED|Treatment Period||83
2841734|NCT01885078|3543267|FG008|STARTED|Treatment Period||0
2841735|NCT01885078|3543268|FG009|STARTED|Treatment Period||0
2841736|NCT01885078|3543259|FG000|Received at Least Once Dose of Study Drug|Treatment Period||451
2841737|NCT01885078|3543260|FG001|Received at Least Once Dose of Study Drug|Treatment Period||1090
2841738|NCT01885078|3543261|FG002|Received at Least Once Dose of Study Drug|Treatment Period||180
2841739|NCT01885078|3543262|FG003|Received at Least Once Dose of Study Drug|Treatment Period||403
2841740|NCT01885078|3543263|FG004|Received at Least Once Dose of Study Drug|Treatment Period||117
2841741|NCT01885078|3543264|FG005|Received at Least Once Dose of Study Drug|Treatment Period||331
2841742|NCT01885078|3543265|FG006|Received at Least Once Dose of Study Drug|Treatment Period||221
2841743|NCT01885078|3543266|FG007|Received at Least Once Dose of Study Drug|Treatment Period||83
2841744|NCT01885078|3543267|FG008|Received at Least Once Dose of Study Drug|Treatment Period||0
2841745|NCT01885078|3543268|FG009|Received at Least Once Dose of Study Drug|Treatment Period||0
2841746|NCT01885078|3543259|FG000|COMPLETED|Treatment Period||19
2841747|NCT01885078|3543260|FG001|COMPLETED|Treatment Period||64
2841748|NCT01885078|3543261|FG002|COMPLETED|Treatment Period||49
2841749|NCT01885078|3543262|FG003|COMPLETED|Treatment Period||120
2841750|NCT01885078|3543263|FG004|COMPLETED|Treatment Period||27
2841751|NCT01885078|3543264|FG005|COMPLETED|Treatment Period||81
2841752|NCT01885078|3543265|FG006|COMPLETED|Treatment Period||0
2841753|NCT01885078|3543266|FG007|COMPLETED|Treatment Period||55
2841754|NCT01885078|3543267|FG008|COMPLETED|Treatment Period||0
2841755|NCT01885078|3543268|FG009|COMPLETED|Treatment Period||0
2841756|NCT01885078|3543259|FG000|NOT COMPLETED|Treatment Period||432
2841757|NCT01885078|3543260|FG001|NOT COMPLETED|Treatment Period||1027
2841758|NCT01885078|3543261|FG002|NOT COMPLETED|Treatment Period||131
2841759|NCT01885078|3543262|FG003|NOT COMPLETED|Treatment Period||283
2841760|NCT01885078|3543263|FG004|NOT COMPLETED|Treatment Period||90
2841761|NCT01885078|3543264|FG005|NOT COMPLETED|Treatment Period||250
2841762|NCT01885078|3543265|FG006|NOT COMPLETED|Treatment Period||221
2841763|NCT01885078|3543266|FG007|NOT COMPLETED|Treatment Period||28
2841764|NCT01885078|3543267|FG008|NOT COMPLETED|Treatment Period||0
2841765|NCT01885078|3543268|FG009|NOT COMPLETED|Treatment Period||0
2841766|NCT01885078|3543259|FG000|STARTED|Step-down Period|Not all participants were eligible to enter the Step-Down Period.|0
2841767|NCT01885078|3543260|FG001|STARTED|Step-down Period|Not all participants were eligible to enter the Step-Down Period.|0
2841768|NCT01885078|3543261|FG002|STARTED|Step-down Period|Not all participants were eligible to enter the Step-Down Period.|0
2841769|NCT01885078|3543262|FG003|STARTED|Step-down Period|Not all participants were eligible to enter the Step-Down Period.|0
2841770|NCT01885078|3543263|FG004|STARTED|Step-down Period|Not all participants were eligible to enter the Step-Down Period.|0
2841771|NCT01885078|3543264|FG005|STARTED|Step-down Period|Not all participants were eligible to enter the Step-Down Period.|0
2841772|NCT01885078|3543265|FG006|STARTED|Step-down Period||0
2841773|NCT01885078|3543266|FG007|STARTED|Step-down Period|Not all participants were eligible to enter the Step-Down Period.|0
2841774|NCT01885078|3543267|FG008|STARTED|Step-down Period|Eligible participants were offered the option of participating in the Step-Down Period.|592
2841775|NCT01885078|3543268|FG009|STARTED|Step-down Period|Eligible participants were offered the option of participating in the Step-Down Period.|594
2841776|NCT01885078|3543259|FG000|Complete Through Week 96|Step-down Period||0
2841777|NCT01885078|3543260|FG001|Complete Through Week 96|Step-down Period||0
2841778|NCT01885078|3543261|FG002|Complete Through Week 96|Step-down Period||0
2841779|NCT01885078|3543262|FG003|Complete Through Week 96|Step-down Period||0
2841780|NCT01885078|3543263|FG004|Complete Through Week 96|Step-down Period||0
2841781|NCT01885078|3543264|FG005|Complete Through Week 96|Step-down Period||0
2841782|NCT01885078|3543265|FG006|Complete Through Week 96|Step-down Period||0
2841783|NCT01885078|3543266|FG007|Complete Through Week 96|Step-down Period||0
2841784|NCT01885078|3543267|FG008|Complete Through Week 96|Step-down Period||407
2841785|NCT01885078|3543268|FG009|Complete Through Week 96|Step-down Period||455
2841786|NCT01885078|3543259|FG000|COMPLETED|Step-down Period||0
2841787|NCT01885078|3543260|FG001|COMPLETED|Step-down Period||0
2841788|NCT01885078|3543261|FG002|COMPLETED|Step-down Period||0
2841789|NCT01885078|3543262|FG003|COMPLETED|Step-down Period||0
2841790|NCT01885078|3543263|FG004|COMPLETED|Step-down Period||0
2841791|NCT01885078|3543264|FG005|COMPLETED|Step-down Period||0
2841792|NCT01885078|3543265|FG006|COMPLETED|Step-down Period||0
2841793|NCT01885078|3543266|FG007|COMPLETED|Step-down Period||0
2841794|NCT01885078|3543267|FG008|COMPLETED|Step-down Period||523
2841795|NCT01885078|3543268|FG009|COMPLETED|Step-down Period||533
2841796|NCT01885078|3543259|FG000|NOT COMPLETED|Step-down Period||0
2841797|NCT01885078|3543260|FG001|NOT COMPLETED|Step-down Period||0
2841798|NCT01885078|3543261|FG002|NOT COMPLETED|Step-down Period||0
2841799|NCT01885078|3543262|FG003|NOT COMPLETED|Step-down Period||0
2841800|NCT01885078|3543263|FG004|NOT COMPLETED|Step-down Period||0
2841801|NCT01885078|3543264|FG005|NOT COMPLETED|Step-down Period||0
2841802|NCT01885078|3543265|FG006|NOT COMPLETED|Step-down Period||0
2841803|NCT01885078|3543266|FG007|NOT COMPLETED|Step-down Period||0
2841804|NCT01885078|3543267|FG008|NOT COMPLETED|Step-down Period||69
2841805|NCT01885078|3543268|FG009|NOT COMPLETED|Step-down Period||61
2841806|NCT01775813|3543293|FG000|STARTED|Overall Study||47
2841807|NCT01775813|3543294|FG001|STARTED|Overall Study||13
2841808|NCT01775813|3543295|FG002|STARTED|Overall Study||24
2841809|NCT01775813|3543296|FG003|STARTED|Overall Study||20
2841810|NCT01775813|3543293|FG000|Study Visit 2 (Tanner 4)|Overall Study||36
2841811|NCT01775813|3543294|FG001|Study Visit 2 (Tanner 4)|Overall Study||4
2841812|NCT01775813|3543295|FG002|Study Visit 2 (Tanner 4)|Overall Study||11
2841813|NCT01775813|3543296|FG003|Study Visit 2 (Tanner 4)|Overall Study||11
2841814|NCT01775813|3543293|FG000|Study Visit 3 (Tanner 5)|Overall Study||34
2841815|NCT01775813|3543294|FG001|Study Visit 3 (Tanner 5)|Overall Study||8
2841816|NCT01775813|3543295|FG002|Study Visit 3 (Tanner 5)|Overall Study||12
2841817|NCT01775813|3543296|FG003|Study Visit 3 (Tanner 5)|Overall Study||11
2841818|NCT01775813|3543293|FG000|Study Visit 4 (Post-Puberty)|Overall Study||10
2841819|NCT01775813|3543294|FG001|Study Visit 4 (Post-Puberty)|Overall Study||0
2841820|NCT01775813|3543295|FG002|Study Visit 4 (Post-Puberty)|Overall Study||13
2841821|NCT01775813|3543296|FG003|Study Visit 4 (Post-Puberty)|Overall Study||11
2841822|NCT01775813|3543293|FG000|COMPLETED|Overall Study||34
2841823|NCT01775813|3543294|FG001|COMPLETED|Overall Study||8
2841824|NCT01775813|3543295|FG002|COMPLETED|Overall Study||12
2841825|NCT01775813|3543296|FG003|COMPLETED|Overall Study||11
2841826|NCT01775813|3543293|FG000|NOT COMPLETED|Overall Study||13
2841827|NCT01775813|3543294|FG001|NOT COMPLETED|Overall Study||5
2841828|NCT01775813|3543295|FG002|NOT COMPLETED|Overall Study||12
2841829|NCT01775813|3543296|FG003|NOT COMPLETED|Overall Study||9
2841830|NCT01694069|3543313|FG000|STARTED|Overall Study||6
2841831|NCT01694069|3543313|FG000|COMPLETED|Overall Study||6
2841832|NCT01694069|3543313|FG000|NOT COMPLETED|Overall Study||0
2841833|NCT01446016|3543319|FG000|STARTED|Overall Study||38
2841834|NCT01446016|3543319|FG000|COMPLETED|Overall Study||31
2841835|NCT01446016|3543319|FG000|NOT COMPLETED|Overall Study||7
2841836|NCT01445327|3543326|FG000|STARTED|Overall Study||3
2841837|NCT01445327|3543327|FG001|STARTED|Overall Study||1
2841838|NCT01445327|3543328|FG002|STARTED|Overall Study||5
2841839|NCT01445327|3543326|FG000|COMPLETED|Overall Study||3
2841840|NCT01445327|3543327|FG001|COMPLETED|Overall Study||1
2841841|NCT01445327|3543328|FG002|COMPLETED|Overall Study||5
2841842|NCT01445327|3543326|FG000|NOT COMPLETED|Overall Study||0
2841843|NCT01445327|3543327|FG001|NOT COMPLETED|Overall Study||0
3167585|NCT01911819|3894885|FG002|COMPLETED|Overall Study||10
3167586|NCT01911819|3894883|FG000|NOT COMPLETED|Overall Study||1
3167587|NCT01911819|3894884|FG001|NOT COMPLETED|Overall Study||2
2841844|NCT01445327|3543328|FG002|NOT COMPLETED|Overall Study||0
2841845|NCT01434602|3543341|FG000|STARTED|Phase I Dose Escalation||6
2841846|NCT01434602|3543342|FG001|STARTED|Phase I Dose Escalation||7
2841847|NCT01434602|3543343|FG002|STARTED|Phase I Dose Escalation||0
2841848|NCT01434602|3543344|FG003|STARTED|Phase I Dose Escalation||0
2841849|NCT01434602|3543345|FG004|STARTED|Phase I Dose Escalation||0
2841850|NCT01434602|3543341|FG000|COMPLETED|Phase I Dose Escalation||6
2841851|NCT01434602|3543342|FG001|COMPLETED|Phase I Dose Escalation||6
2841852|NCT01434602|3543343|FG002|COMPLETED|Phase I Dose Escalation||0
2841853|NCT01434602|3543344|FG003|COMPLETED|Phase I Dose Escalation||0
2841854|NCT01434602|3543345|FG004|COMPLETED|Phase I Dose Escalation||0
2841855|NCT01434602|3543341|FG000|NOT COMPLETED|Phase I Dose Escalation||0
2841856|NCT01434602|3543342|FG001|NOT COMPLETED|Phase I Dose Escalation||1
2841857|NCT01434602|3543343|FG002|NOT COMPLETED|Phase I Dose Escalation||0
2841858|NCT01434602|3543344|FG003|NOT COMPLETED|Phase I Dose Escalation||0
2841859|NCT01434602|3543345|FG004|NOT COMPLETED|Phase I Dose Escalation||0
2841860|NCT01434602|3543341|FG000|STARTED|Phase II Recommended Phase 2 Dose||0
2841861|NCT01434602|3543342|FG001|STARTED|Phase II Recommended Phase 2 Dose||0
2841862|NCT01434602|3543343|FG002|STARTED|Phase II Recommended Phase 2 Dose||12
2841863|NCT01434602|3543344|FG003|STARTED|Phase II Recommended Phase 2 Dose||40
2841864|NCT01434602|3543345|FG004|STARTED|Phase II Recommended Phase 2 Dose||21
2841865|NCT01434602|3543341|FG000|COMPLETED|Phase II Recommended Phase 2 Dose||0
2841866|NCT01434602|3543342|FG001|COMPLETED|Phase II Recommended Phase 2 Dose||0
2841867|NCT01434602|3543343|FG002|COMPLETED|Phase II Recommended Phase 2 Dose||12
2841868|NCT01434602|3543344|FG003|COMPLETED|Phase II Recommended Phase 2 Dose||31
2841869|NCT01434602|3543345|FG004|COMPLETED|Phase II Recommended Phase 2 Dose||19
2841870|NCT01434602|3543341|FG000|NOT COMPLETED|Phase II Recommended Phase 2 Dose||0
2841871|NCT01434602|3543342|FG001|NOT COMPLETED|Phase II Recommended Phase 2 Dose||0
2841872|NCT01434602|3543343|FG002|NOT COMPLETED|Phase II Recommended Phase 2 Dose||0
2841873|NCT01434602|3543344|FG003|NOT COMPLETED|Phase II Recommended Phase 2 Dose||9
2841874|NCT01434602|3543345|FG004|NOT COMPLETED|Phase II Recommended Phase 2 Dose||2
2841875|NCT01411332|3543366|FG000|STARTED|Overall Study||10
2841876|NCT01411332|3543367|FG001|STARTED|Overall Study||9
2841877|NCT01411332|3543366|FG000|COMPLETED|Overall Study||8
2841878|NCT01411332|3543367|FG001|COMPLETED|Overall Study||7
2841879|NCT01411332|3543366|FG000|NOT COMPLETED|Overall Study||2
2841880|NCT01411332|3543367|FG001|NOT COMPLETED|Overall Study||2
2841881|NCT01399918|3543373|FG000|STARTED|Overall Study||57
2841882|NCT01399918|3543373|FG000|COMPLETED|Overall Study||55
2841883|NCT01399918|3543373|FG000|NOT COMPLETED|Overall Study||2
2841884|NCT01377753|3543377|FG000|STARTED|Overall Study||15
2841885|NCT01377753|3543377|FG000|COMPLETED|Overall Study||15
2841886|NCT01377753|3543377|FG000|NOT COMPLETED|Overall Study||0
2841887|NCT01147653|3543383|FG000|STARTED|Year 1||32
2841888|NCT01147653|3543384|FG001|STARTED|Year 1||31
2841889|NCT01147653|3543383|FG000|COMPLETED|Year 1||32
2841890|NCT01147653|3543384|FG001|COMPLETED|Year 1||31
2841891|NCT01147653|3543383|FG000|NOT COMPLETED|Year 1||0
2841892|NCT01147653|3543384|FG001|NOT COMPLETED|Year 1||0
2841893|NCT01147653|3543383|FG000|STARTED|Year 2||32
2841894|NCT01147653|3543384|FG001|STARTED|Year 2||31
2841895|NCT01147653|3543383|FG000|COMPLETED|Year 2||30
2841896|NCT01147653|3543384|FG001|COMPLETED|Year 2||28
2841897|NCT01147653|3543383|FG000|NOT COMPLETED|Year 2||2
2841898|NCT01147653|3543384|FG001|NOT COMPLETED|Year 2||3
2841899|NCT01078454|3543404|FG000|STARTED|Overall Study||6
2841900|NCT01078454|3543405|FG001|STARTED|Overall Study||5
2841901|NCT01078454|3543404|FG000|COMPLETED|Overall Study||5
2841902|NCT01078454|3543405|FG001|COMPLETED|Overall Study||3
2841903|NCT01078454|3543404|FG000|NOT COMPLETED|Overall Study||1
2841904|NCT01078454|3543405|FG001|NOT COMPLETED|Overall Study||2
2841905|NCT00687596|3543413|FG000|STARTED|Overall Study||26
2841906|NCT00687596|3543414|FG001|STARTED|Overall Study||26
2841907|NCT00687596|3543413|FG000|COMPLETED|Overall Study||0
2841908|NCT00687596|3543414|FG001|COMPLETED|Overall Study||0
2841909|NCT00687596|3543413|FG000|NOT COMPLETED|Overall Study||26
2841910|NCT00687596|3543414|FG001|NOT COMPLETED|Overall Study||26
2841911|NCT00458536|3543420|FG000|STARTED|Overall Study||38
3167588|NCT01911819|3894885|FG002|NOT COMPLETED|Overall Study||0
3167589|NCT01911845|3894893|FG000|STARTED|Overall Study||38
3167590|NCT01911845|3894893|FG000|Completed Study Drug|Overall Study||37
2841912|NCT00458536|3543420|FG000|COMPLETED|Overall Study||19
2841913|NCT00458536|3543420|FG000|NOT COMPLETED|Overall Study||19
2841914|NCT00112840|3543427|FG000|STARTED|Overall Study||8
2841915|NCT00112840|3543428|FG001|STARTED|Overall Study||6
2841916|NCT00112840|3543429|FG002|STARTED|Overall Study||46
2841917|NCT00112840|3543427|FG000|COMPLETED|Overall Study||6
2841918|NCT00112840|3543428|FG001|COMPLETED|Overall Study||6
2841919|NCT00112840|3543429|FG002|COMPLETED|Overall Study||40
2841920|NCT00112840|3543427|FG000|NOT COMPLETED|Overall Study||2
2841921|NCT00112840|3543428|FG001|NOT COMPLETED|Overall Study||0
2841922|NCT00112840|3543429|FG002|NOT COMPLETED|Overall Study||6
2916033|NCT00514020|3626473|FG000|STARTED|Overall Study|two patients withdrew before treatment; one withdrew after treatment|33
2916034|NCT00514020|3626473|FG000|COMPLETED|Overall Study||5
2916035|NCT00514020|3626473|FG000|NOT COMPLETED|Overall Study||28
2916036|NCT00514046|3626486|FG000|STARTED|Overall Study||5
2916037|NCT00514046|3626487|FG001|STARTED|Overall Study||1
2916038|NCT00514046|3626488|FG002|STARTED|Overall Study||5
2916039|NCT00514046|3626489|FG003|STARTED|Overall Study||1
2916040|NCT00514046|3626490|FG004|STARTED|Overall Study||1
2916041|NCT00514046|3626491|FG005|STARTED|Overall Study||1
2916042|NCT00514046|3626492|FG006|STARTED|Overall Study||1
2916043|NCT00514046|3626493|FG007|STARTED|Overall Study||1
2916044|NCT00514046|3626494|FG008|STARTED|Overall Study||1
2916045|NCT00514046|3626486|FG000|COMPLETED|Overall Study||2
2916046|NCT00514046|3626487|FG001|COMPLETED|Overall Study||0
2916047|NCT00514046|3626488|FG002|COMPLETED|Overall Study||0
2916048|NCT00514046|3626489|FG003|COMPLETED|Overall Study||1
2916049|NCT00514046|3626490|FG004|COMPLETED|Overall Study||0
2916050|NCT00514046|3626491|FG005|COMPLETED|Overall Study||0
2916051|NCT00514046|3626492|FG006|COMPLETED|Overall Study||1
2916052|NCT00514046|3626493|FG007|COMPLETED|Overall Study||0
2916053|NCT00514046|3626494|FG008|COMPLETED|Overall Study||0
2916054|NCT00514046|3626486|FG000|NOT COMPLETED|Overall Study||3
2916055|NCT00514046|3626487|FG001|NOT COMPLETED|Overall Study||1
2916056|NCT00514046|3626488|FG002|NOT COMPLETED|Overall Study||5
2916057|NCT00514046|3626489|FG003|NOT COMPLETED|Overall Study||0
2916058|NCT00514046|3626490|FG004|NOT COMPLETED|Overall Study||1
2916059|NCT00514046|3626491|FG005|NOT COMPLETED|Overall Study||1
2916060|NCT00514046|3626492|FG006|NOT COMPLETED|Overall Study||0
2916061|NCT00514046|3626493|FG007|NOT COMPLETED|Overall Study||1
2916062|NCT00514046|3626494|FG008|NOT COMPLETED|Overall Study||1
2916063|NCT00514137|3626516|FG000|STARTED|Overall Study||13
2916064|NCT00514137|3626516|FG000|COMPLETED|Overall Study||13
2916065|NCT00514137|3626516|FG000|NOT COMPLETED|Overall Study||0
2916066|NCT00514215|3626520|FG000|STARTED|Overall Study||8
2916067|NCT00514215|3626520|FG000|COMPLETED|Overall Study||8
2916068|NCT00514215|3626520|FG000|NOT COMPLETED|Overall Study||0
2916069|NCT00514449|3626526|FG000|STARTED|Overall Study||12
2916070|NCT00514449|3626527|FG001|STARTED|Overall Study||12
2916071|NCT00514449|3626526|FG000|COMPLETED|Overall Study||9
2916072|NCT00514449|3626527|FG001|COMPLETED|Overall Study||8
2916073|NCT00514449|3626526|FG000|NOT COMPLETED|Overall Study||3
2916074|NCT00514449|3626527|FG001|NOT COMPLETED|Overall Study||4
2916075|NCT00514501|3626536|FG000|STARTED|Overall Study||510
2916076|NCT00514501|3626536|FG000|COMPLETED|Overall Study||507
2916077|NCT00514501|3626536|FG000|NOT COMPLETED|Overall Study||3
2916078|NCT00514514|3626543|FG000|STARTED|Pre-phase|All enrolled patients received standard regimen for 3 months|802
2916079|NCT00514514|3626544|FG001|STARTED|Pre-phase||0
2916080|NCT00514514|3626545|FG002|STARTED|Pre-phase||0
2916081|NCT00514514|3626543|FG000|COMPLETED|Pre-phase||499
2916082|NCT00514514|3626544|FG001|COMPLETED|Pre-phase||0
2916083|NCT00514514|3626545|FG002|COMPLETED|Pre-phase||0
2916084|NCT00514514|3626543|FG000|NOT COMPLETED|Pre-phase||303
2916085|NCT00514514|3626544|FG001|NOT COMPLETED|Pre-phase||0
2916086|NCT00514514|3626545|FG002|NOT COMPLETED|Pre-phase||0
2916087|NCT00514514|3626543|FG000|STARTED|Randomized - 9 Month||166
2916088|NCT00514514|3626544|FG001|STARTED|Randomized - 9 Month||171
3167591|NCT01911845|3894893|FG000|COMPLETED|Overall Study||32
3167592|NCT01911845|3894893|FG000|NOT COMPLETED|Overall Study||6
3167593|NCT01911910|3894901|FG000|STARTED|Overall Study||197
3167594|NCT01911910|3894902|FG001|STARTED|Overall Study||205
3167595|NCT01911910|3894901|FG000|COMPLETED|Overall Study||184
2916089|NCT00514514|3626545|FG002|STARTED|Randomized - 9 Month||162
2916090|NCT00514514|3626543|FG000|Randomized - Received Treatment|Randomized - 9 Month||165
2916091|NCT00514514|3626544|FG001|Randomized - Received Treatment|Randomized - 9 Month||171
2916092|NCT00514514|3626545|FG002|Randomized - Received Treatment|Randomized - 9 Month||161
2916093|NCT00514514|3626543|FG000|COMPLETED|Randomized - 9 Month||127
2916094|NCT00514514|3626544|FG001|COMPLETED|Randomized - 9 Month||110
2916095|NCT00514514|3626545|FG002|COMPLETED|Randomized - 9 Month||124
2916096|NCT00514514|3626543|FG000|NOT COMPLETED|Randomized - 9 Month||39
2916097|NCT00514514|3626544|FG001|NOT COMPLETED|Randomized - 9 Month||61
2916098|NCT00514514|3626545|FG002|NOT COMPLETED|Randomized - 9 Month||38
2916099|NCT00514514|3626543|FG000|STARTED|Extension - 4 Years||145
2916100|NCT00514514|3626544|FG001|STARTED|Extension - 4 Years||139
2916101|NCT00514514|3626545|FG002|STARTED|Extension - 4 Years||134
2916102|NCT00514514|3626543|FG000|Non-randomized (Followed)|Extension - 4 Years|Patients were not randomized but continued on standard regimen and entered follow up.|95
3167596|NCT01911910|3894902|FG001|COMPLETED|Overall Study||194
3167597|NCT01911910|3894901|FG000|NOT COMPLETED|Overall Study||13
3167598|NCT01911910|3894902|FG001|NOT COMPLETED|Overall Study||11
2841923|NCT04957732|3543444|FG000|STARTED|Overall Study||19
2841924|NCT04957732|3543445|FG001|STARTED|Overall Study||16
2841925|NCT04957732|3543444|FG000|COMPLETED|Overall Study||18
2841926|NCT04957732|3543445|FG001|COMPLETED|Overall Study||12
2841927|NCT04957732|3543444|FG000|NOT COMPLETED|Overall Study||1
2841928|NCT04957732|3543445|FG001|NOT COMPLETED|Overall Study||4
3034264|NCT01131520|3753324|FG000|NOT COMPLETED|Overall Study||1
3034265|NCT01131520|3753325|FG001|NOT COMPLETED|Overall Study||4
2841932|NCT04207749|3543462|FG000|STARTED|Overall Study||78
2841933|NCT04207749|3543463|FG001|STARTED|Overall Study||156
2841934|NCT04207749|3543462|FG000|COMPLETED|Overall Study||74
2841935|NCT04207749|3543463|FG001|COMPLETED|Overall Study||149
2841936|NCT04207749|3543462|FG000|NOT COMPLETED|Overall Study||4
2841937|NCT04207749|3543463|FG001|NOT COMPLETED|Overall Study||7
2841938|NCT04167345|3543477|FG000|STARTED|Overall Study||10
2841939|NCT04167345|3543478|FG001|STARTED|Overall Study||4
2841940|NCT04167345|3543479|FG002|STARTED|Overall Study||3
2841941|NCT04167345|3543480|FG003|STARTED|Overall Study||13
2841942|NCT04167345|3543481|FG004|STARTED|Overall Study||18
2841943|NCT04167345|3543477|FG000|COMPLETED|Overall Study||9
2841944|NCT04167345|3543478|FG001|COMPLETED|Overall Study||3
2841945|NCT04167345|3543479|FG002|COMPLETED|Overall Study||3
2841946|NCT04167345|3543480|FG003|COMPLETED|Overall Study||13
2841947|NCT04167345|3543481|FG004|COMPLETED|Overall Study||18
2841948|NCT04167345|3543477|FG000|NOT COMPLETED|Overall Study||1
2841949|NCT04167345|3543478|FG001|NOT COMPLETED|Overall Study||1
2841950|NCT04167345|3543479|FG002|NOT COMPLETED|Overall Study||0
2841951|NCT04167345|3543480|FG003|NOT COMPLETED|Overall Study||0
2841952|NCT04167345|3543481|FG004|NOT COMPLETED|Overall Study||0
2841953|NCT04042077|3543499|FG000|STARTED|Overall Study||134
2841954|NCT04042077|3543500|FG001|STARTED|Overall Study||132
2841955|NCT04042077|3543499|FG000|Vancomycin IV|Overall Study||0
2841956|NCT04042077|3543500|FG001|Vancomycin IV|Overall Study||2
2841957|NCT04042077|3543499|FG000|Linezolid IV, With the Option to Switch to Linezolid Oral|Overall Study||0
2841958|NCT04042077|3543500|FG001|Linezolid IV, With the Option to Switch to Linezolid Oral|Overall Study||8
2841959|NCT04042077|3543499|FG000|Piperacillin/Tazobactam IV|Overall Study||0
2841960|NCT04042077|3543500|FG001|Piperacillin/Tazobactam IV|Overall Study||68
2841961|NCT04042077|3543499|FG000|Tigecycline IV|Overall Study||0
2841962|NCT04042077|3543500|FG001|Tigecycline IV|Overall Study||54
2841963|NCT04042077|3543499|FG000|COMPLETED|Overall Study||127
2841964|NCT04042077|3543500|FG001|COMPLETED|Overall Study||127
2841965|NCT04042077|3543499|FG000|NOT COMPLETED|Overall Study||7
2841966|NCT04042077|3543500|FG001|NOT COMPLETED|Overall Study||5
2841967|NCT04001803|3543512|FG000|STARTED|Overall Study||115
2841968|NCT04001803|3543512|FG000|COMPLETED|Overall Study||1
2841969|NCT04001803|3543512|FG000|NOT COMPLETED|Overall Study||114
2841970|NCT03936699|3543519|FG000|STARTED|Overall Study||83
2841971|NCT03936699|3543520|FG001|STARTED|Overall Study||78
2841972|NCT03936699|3543519|FG000|COMPLETED|Overall Study||61
2841973|NCT03936699|3543520|FG001|COMPLETED|Overall Study||55
2841974|NCT03936699|3543519|FG000|NOT COMPLETED|Overall Study||22
2841975|NCT03936699|3543520|FG001|NOT COMPLETED|Overall Study||23
2841976|NCT03925324|3543528|FG000|STARTED|Overall Study||2
2841977|NCT03925324|3543529|FG001|STARTED|Overall Study||2
2841978|NCT03925324|3543528|FG000|COMPLETED|Overall Study||1
2841979|NCT03925324|3543529|FG001|COMPLETED|Overall Study||1
2841980|NCT03925324|3543528|FG000|NOT COMPLETED|Overall Study||1
2841981|NCT03925324|3543529|FG001|NOT COMPLETED|Overall Study||1
2841982|NCT03875092|3543537|FG000|STARTED|Overall Study||65
2841983|NCT03875092|3543538|FG001|STARTED|Overall Study||60
2841984|NCT03875092|3543537|FG000|Treated|Overall Study||65
2841985|NCT03875092|3543538|FG001|Treated|Overall Study||60
2841986|NCT03875092|3543537|FG000|Switched to Pembrolizumab+Chemotherapy|Overall Study||0
2841987|NCT03875092|3543538|FG001|Switched to Pembrolizumab+Chemotherapy|Overall Study||38
2841988|NCT03875092|3543537|FG000|COMPLETED|Overall Study||0
2841989|NCT03875092|3543538|FG001|COMPLETED|Overall Study||0
2841990|NCT03875092|3543537|FG000|NOT COMPLETED|Overall Study||65
2841991|NCT03875092|3543538|FG001|NOT COMPLETED|Overall Study||60
2841992|NCT03814382|3543544|FG000|STARTED|Overall Study||10
2841993|NCT03814382|3543544|FG000|COMPLETED|Overall Study||10
2841994|NCT03814382|3543544|FG000|NOT COMPLETED|Overall Study||0
2841995|NCT03738397|3543550|FG000|STARTED|Overall Study||344
2841996|NCT03738397|3543551|FG001|STARTED|Overall Study||348
2841997|NCT03738397|3543550|FG000|COMPLETED|Overall Study||320
2841998|NCT03738397|3543551|FG001|COMPLETED|Overall Study||318
2841999|NCT03738397|3543550|FG000|NOT COMPLETED|Overall Study||24
2842000|NCT03738397|3543551|FG001|NOT COMPLETED|Overall Study||30
2842001|NCT03666624|3543559|FG000|STARTED|Overall Study||15
2842002|NCT03666624|3543560|FG001|STARTED|Overall Study||15
2842003|NCT03666624|3543559|FG000|COMPLETED|Overall Study||14
2842004|NCT03666624|3543560|FG001|COMPLETED|Overall Study||15
2842005|NCT03666624|3543559|FG000|NOT COMPLETED|Overall Study||1
2842006|NCT03666624|3543560|FG001|NOT COMPLETED|Overall Study||0
2842007|NCT03649217|3543566|FG000|STARTED|Overall Study||23
2842008|NCT03649217|3543566|FG000|COMPLETED|Overall Study||21
2842009|NCT03649217|3543566|FG000|NOT COMPLETED|Overall Study||2
2842010|NCT03633461|3543572|FG000|STARTED|Overall Study||34
2842011|NCT03633461|3543573|FG001|STARTED|Overall Study||19
2842012|NCT03633461|3543572|FG000|COMPLETED|Overall Study||34
2842013|NCT03633461|3543573|FG001|COMPLETED|Overall Study||18
2842014|NCT03633461|3543572|FG000|NOT COMPLETED|Overall Study||0
2842015|NCT03633461|3543573|FG001|NOT COMPLETED|Overall Study||1
2842016|NCT03576976|3543581|FG000|STARTED|Overall Study||27
2842017|NCT03576976|3543582|FG001|STARTED|Overall Study||28
3167599|NCT01912222|3894911|FG000|STARTED|Part A: Pharmacokinetic Period||13
3167600|NCT01912222|3894912|FG001|STARTED|Part A: Pharmacokinetic Period||15
3167601|NCT01912222|3894913|FG002|STARTED|Part A: Pharmacokinetic Period||20
3167602|NCT01912222|3894911|FG000|COMPLETED|Part A: Pharmacokinetic Period||12
2842018|NCT03576976|3543581|FG000|COMPLETED|Overall Study||18
2842019|NCT03576976|3543582|FG001|COMPLETED|Overall Study||17
2842020|NCT03576976|3543581|FG000|NOT COMPLETED|Overall Study||9
2842021|NCT03576976|3543582|FG001|NOT COMPLETED|Overall Study||11
2842022|NCT03569293|3543594|FG000|STARTED|Overall Study||241
2842023|NCT03569293|3543595|FG001|STARTED|Overall Study||239
2842024|NCT03569293|3543596|FG002|STARTED|Overall Study||243
2842025|NCT03569293|3543597|FG003|STARTED|Overall Study||61
2842026|NCT03569293|3543598|FG004|STARTED|Overall Study||64
2842027|NCT03569293|3543599|FG005|STARTED|Overall Study||64
2842028|NCT03569293|3543594|FG000|Received Study Drug|Overall Study||241
2842029|NCT03569293|3543595|FG001|Received Study Drug|Overall Study||239
2842030|NCT03569293|3543596|FG002|Received Study Drug|Overall Study||243
2842031|NCT03569293|3543597|FG003|Received Study Drug|Overall Study||61
2842032|NCT03569293|3543598|FG004|Received Study Drug|Overall Study||64
2842033|NCT03569293|3543599|FG005|Received Study Drug|Overall Study||64
2842034|NCT03569293|3543594|FG000|COMPLETED|Overall Study||204
2842035|NCT03569293|3543595|FG001|COMPLETED|Overall Study||230
2842036|NCT03569293|3543596|FG002|COMPLETED|Overall Study||229
2842037|NCT03569293|3543597|FG003|COMPLETED|Overall Study||57
2842038|NCT03569293|3543598|FG004|COMPLETED|Overall Study||64
2842039|NCT03569293|3543599|FG005|COMPLETED|Overall Study||64
2842040|NCT03569293|3543594|FG000|NOT COMPLETED|Overall Study||37
2842041|NCT03569293|3543595|FG001|NOT COMPLETED|Overall Study||9
2842042|NCT03569293|3543596|FG002|NOT COMPLETED|Overall Study||14
2842043|NCT03569293|3543597|FG003|NOT COMPLETED|Overall Study||4
2842044|NCT03569293|3543598|FG004|NOT COMPLETED|Overall Study||0
2842045|NCT03569293|3543599|FG005|NOT COMPLETED|Overall Study||0
2842046|NCT03564353|3543617|FG000|STARTED|Overall Study||10
2842047|NCT03564353|3543618|FG001|STARTED|Overall Study||10
2842048|NCT03564353|3543619|FG002|STARTED|Overall Study||10
2842049|NCT03564353|3543620|FG003|STARTED|Overall Study||10
2842050|NCT03564353|3543617|FG000|COMPLETED|Overall Study||10
2842051|NCT03564353|3543618|FG001|COMPLETED|Overall Study||10
2842052|NCT03564353|3543619|FG002|COMPLETED|Overall Study||10
2842053|NCT03564353|3543620|FG003|COMPLETED|Overall Study||10
2842054|NCT03564353|3543617|FG000|NOT COMPLETED|Overall Study||0
2842055|NCT03564353|3543618|FG001|NOT COMPLETED|Overall Study||0
2842056|NCT03564353|3543619|FG002|NOT COMPLETED|Overall Study||0
2842057|NCT03564353|3543620|FG003|NOT COMPLETED|Overall Study||0
2842058|NCT03541499|3543634|FG000|STARTED|Overall Study||15
2842059|NCT03541499|3543635|FG001|STARTED|Overall Study||15
2842060|NCT03541499|3543636|FG002|STARTED|Overall Study||5
2842061|NCT03541499|3543637|FG003|STARTED|Overall Study||15
2842062|NCT03541499|3543634|FG000|COMPLETED|Overall Study||15
2842063|NCT03541499|3543635|FG001|COMPLETED|Overall Study||15
2842064|NCT03541499|3543636|FG002|COMPLETED|Overall Study||5
2842065|NCT03541499|3543637|FG003|COMPLETED|Overall Study||15
2842066|NCT03541499|3543634|FG000|NOT COMPLETED|Overall Study||0
2842067|NCT03541499|3543635|FG001|NOT COMPLETED|Overall Study||0
2842068|NCT03541499|3543636|FG002|NOT COMPLETED|Overall Study||0
2842069|NCT03541499|3543637|FG003|NOT COMPLETED|Overall Study||0
2916103|NCT00514514|3626544|FG001|Non-randomized (Followed)|Extension - 4 Years||0
2916104|NCT00514514|3626545|FG002|Non-randomized (Followed)|Extension - 4 Years||0
2916105|NCT00514514|3626543|FG000|COMPLETED|Extension - 4 Years||108
2916106|NCT00514514|3626544|FG001|COMPLETED|Extension - 4 Years||117
2916107|NCT00514514|3626545|FG002|COMPLETED|Extension - 4 Years||113
2916108|NCT00514514|3626543|FG000|NOT COMPLETED|Extension - 4 Years||37
2916109|NCT00514514|3626544|FG001|NOT COMPLETED|Extension - 4 Years||22
2916110|NCT00514514|3626545|FG002|NOT COMPLETED|Extension - 4 Years||21
2916111|NCT00514540|3626553|FG000|STARTED|First-Line Chemo||113
2916112|NCT00514540|3626553|FG000|COMPLETED|First-Line Chemo||105
2916113|NCT00514540|3626553|FG000|NOT COMPLETED|First-Line Chemo||8
2916114|NCT00514540|3626553|FG000|STARTED|Second-Line||105
2916115|NCT00514540|3626553|FG000|COMPLETED|Second-Line||74
2916116|NCT00514540|3626553|FG000|NOT COMPLETED|Second-Line||31
2916117|NCT00514592|3626561|FG000|STARTED|Overall Study||230
2916118|NCT00514592|3626561|FG000|COMPLETED|Overall Study||230
2916119|NCT00514592|3626561|FG000|NOT COMPLETED|Overall Study||0
2916120|NCT00514683|3626570|FG000|STARTED|Overall Study|Randomised|87
2916121|NCT00514683|3626571|FG001|STARTED|Overall Study|Randomised|87
2916122|NCT00514683|3626572|FG002|STARTED|Overall Study|Randomised|86
2916123|NCT00514683|3626573|FG003|STARTED|Overall Study|Randomised|86
2916124|NCT00514683|3626574|FG004|STARTED|Overall Study|Randomised|86
2916125|NCT00514683|3626570|FG000|COMPLETED|Overall Study||61
2916126|NCT00514683|3626571|FG001|COMPLETED|Overall Study||62
2916127|NCT00514683|3626572|FG002|COMPLETED|Overall Study||68
2916128|NCT00514683|3626573|FG003|COMPLETED|Overall Study||72
2916129|NCT00514683|3626574|FG004|COMPLETED|Overall Study||53
2916130|NCT00514683|3626570|FG000|NOT COMPLETED|Overall Study||26
2916131|NCT00514683|3626571|FG001|NOT COMPLETED|Overall Study||25
2916132|NCT00514683|3626572|FG002|NOT COMPLETED|Overall Study||18
2916133|NCT00514683|3626573|FG003|NOT COMPLETED|Overall Study||14
2916134|NCT00514683|3626574|FG004|NOT COMPLETED|Overall Study||33
2842070|NCT03473977|3543649|FG000|STARTED|Overall Study||13
2842071|NCT03473977|3543650|FG001|STARTED|Overall Study||13
2842072|NCT03473977|3543649|FG000|COMPLETED|Overall Study||13
2842073|NCT03473977|3543650|FG001|COMPLETED|Overall Study||13
2842074|NCT03473977|3543649|FG000|NOT COMPLETED|Overall Study||0
2842075|NCT03473977|3543650|FG001|NOT COMPLETED|Overall Study||0
2842076|NCT03415022|3543658|FG000|STARTED|Overall Study||21
2842077|NCT03415022|3543659|FG001|STARTED|Overall Study||20
2842078|NCT03415022|3543658|FG000|COMPLETED|Overall Study||16
2842079|NCT03415022|3543659|FG001|COMPLETED|Overall Study||15
2842080|NCT03415022|3543658|FG000|NOT COMPLETED|Overall Study||5
2842081|NCT03415022|3543659|FG001|NOT COMPLETED|Overall Study||5
2842082|NCT03400943|3543669|FG000|STARTED|Treatment Period 1||23
2842083|NCT03400943|3543670|FG001|STARTED|Treatment Period 1||23
2842084|NCT03400943|3543671|FG002|STARTED|Treatment Period 1||24
2842085|NCT03400943|3543672|FG003|STARTED|Treatment Period 1||23
2842086|NCT03400943|3543669|FG000|Treated|Treatment Period 1||18
2842087|NCT03400943|3543670|FG001|Treated|Treatment Period 1||21
2842088|NCT03400943|3543671|FG002|Treated|Treatment Period 1||20
2842089|NCT03400943|3543672|FG003|Treated|Treatment Period 1||20
2842090|NCT03400943|3543669|FG000|COMPLETED|Treatment Period 1||18
2842091|NCT03400943|3543670|FG001|COMPLETED|Treatment Period 1||21
2842092|NCT03400943|3543671|FG002|COMPLETED|Treatment Period 1||18
2842093|NCT03400943|3543672|FG003|COMPLETED|Treatment Period 1||18
2842094|NCT03400943|3543669|FG000|NOT COMPLETED|Treatment Period 1||5
2842095|NCT03400943|3543670|FG001|NOT COMPLETED|Treatment Period 1||2
2842096|NCT03400943|3543671|FG002|NOT COMPLETED|Treatment Period 1||6
2842097|NCT03400943|3543672|FG003|NOT COMPLETED|Treatment Period 1||5
2842098|NCT03400943|3543669|FG000|STARTED|Post-treatment Period 1||18
2842099|NCT03400943|3543670|FG001|STARTED|Post-treatment Period 1||0
2842100|NCT03400943|3543671|FG002|STARTED|Post-treatment Period 1||18
2842101|NCT03400943|3543672|FG003|STARTED|Post-treatment Period 1||18
2842102|NCT03400943|3543669|FG000|COMPLETED|Post-treatment Period 1||7
2842103|NCT03400943|3543670|FG001|COMPLETED|Post-treatment Period 1||0
2842104|NCT03400943|3543671|FG002|COMPLETED|Post-treatment Period 1||7
2842105|NCT03400943|3543672|FG003|COMPLETED|Post-treatment Period 1||5
2842106|NCT03400943|3543669|FG000|NOT COMPLETED|Post-treatment Period 1||11
2842107|NCT03400943|3543670|FG001|NOT COMPLETED|Post-treatment Period 1||0
2842108|NCT03400943|3543671|FG002|NOT COMPLETED|Post-treatment Period 1||11
2842109|NCT03400943|3543672|FG003|NOT COMPLETED|Post-treatment Period 1||13
2842110|NCT03400943|3543669|FG000|STARTED|Treatment Period 2||7
2842111|NCT03400943|3543670|FG001|STARTED|Treatment Period 2||21
2842112|NCT03400943|3543671|FG002|STARTED|Treatment Period 2||7
2842113|NCT03400943|3543672|FG003|STARTED|Treatment Period 2||5
2842114|NCT03400943|3543669|FG000|COMPLETED|Treatment Period 2||6
2842115|NCT03400943|3543670|FG001|COMPLETED|Treatment Period 2||13
2842116|NCT03400943|3543671|FG002|COMPLETED|Treatment Period 2||7
2842117|NCT03400943|3543672|FG003|COMPLETED|Treatment Period 2||5
2842118|NCT03400943|3543669|FG000|NOT COMPLETED|Treatment Period 2||1
2842119|NCT03400943|3543670|FG001|NOT COMPLETED|Treatment Period 2||8
2842120|NCT03400943|3543671|FG002|NOT COMPLETED|Treatment Period 2||0
2842121|NCT03400943|3543672|FG003|NOT COMPLETED|Treatment Period 2||0
2842122|NCT03400943|3543669|FG000|STARTED|Follow-up Period||7
2842123|NCT03400943|3543670|FG001|STARTED|Follow-up Period||15
2842124|NCT03400943|3543671|FG002|STARTED|Follow-up Period||7
2842125|NCT03400943|3543672|FG003|STARTED|Follow-up Period||5
2842126|NCT03400943|3543669|FG000|COMPLETED|Follow-up Period||6
2842127|NCT03400943|3543670|FG001|COMPLETED|Follow-up Period||15
2842128|NCT03400943|3543671|FG002|COMPLETED|Follow-up Period||7
2842129|NCT03400943|3543672|FG003|COMPLETED|Follow-up Period||5
2842130|NCT03400943|3543669|FG000|NOT COMPLETED|Follow-up Period||1
2842131|NCT03400943|3543670|FG001|NOT COMPLETED|Follow-up Period||0
2842132|NCT03400943|3543671|FG002|NOT COMPLETED|Follow-up Period||0
2842133|NCT03400943|3543672|FG003|NOT COMPLETED|Follow-up Period||0
2842134|NCT03373110|3543687|FG000|STARTED|Overall Study||133
2842135|NCT03373110|3543688|FG001|STARTED|Overall Study||137
2842136|NCT03373110|3543689|FG002|STARTED|Overall Study||70
2842137|NCT03373110|3543687|FG000|Provided Fitbit Data|Overall Study||123
2842138|NCT03373110|3543688|FG001|Provided Fitbit Data|Overall Study||130
2842139|NCT03373110|3543689|FG002|Provided Fitbit Data|Overall Study||63
2842140|NCT03373110|3543687|FG000|COMPLETED|Overall Study||55
2842141|NCT03373110|3543688|FG001|COMPLETED|Overall Study||58
2842142|NCT03373110|3543689|FG002|COMPLETED|Overall Study||26
2842143|NCT03373110|3543687|FG000|NOT COMPLETED|Overall Study||78
2842144|NCT03373110|3543688|FG001|NOT COMPLETED|Overall Study||79
2842145|NCT03373110|3543689|FG002|NOT COMPLETED|Overall Study||44
2842146|NCT03370133|3543700|FG000|STARTED|Initial Treatment Period (WK 16)||83
2842147|NCT03370133|3543701|FG001|STARTED|Initial Treatment Period (WK 16)||321
2842148|NCT03370133|3543702|FG002|STARTED|Initial Treatment Period (WK 16)||163
2842149|NCT03370133|3543703|FG003|STARTED|Initial Treatment Period (WK 16)||0
2842150|NCT03370133|3543704|FG004|STARTED|Initial Treatment Period (WK 16)||0
2842151|NCT03370133|3543705|FG005|STARTED|Initial Treatment Period (WK 16)||0
2842152|NCT03370133|3543700|FG000|COMPLETED|Initial Treatment Period (WK 16)||74
2842153|NCT03370133|3543701|FG001|COMPLETED|Initial Treatment Period (WK 16)||306
2842154|NCT03370133|3543702|FG002|COMPLETED|Initial Treatment Period (WK 16)||157
2842155|NCT03370133|3543703|FG003|COMPLETED|Initial Treatment Period (WK 16)||0
2842156|NCT03370133|3543704|FG004|COMPLETED|Initial Treatment Period (WK 16)||0
2842157|NCT03370133|3543705|FG005|COMPLETED|Initial Treatment Period (WK 16)||0
2842158|NCT03370133|3543700|FG000|NOT COMPLETED|Initial Treatment Period (WK 16)||9
2842159|NCT03370133|3543701|FG001|NOT COMPLETED|Initial Treatment Period (WK 16)||15
2842160|NCT03370133|3543702|FG002|NOT COMPLETED|Initial Treatment Period (WK 16)||6
2842161|NCT03370133|3543703|FG003|NOT COMPLETED|Initial Treatment Period (WK 16)||0
2842162|NCT03370133|3543704|FG004|NOT COMPLETED|Initial Treatment Period (WK 16)||0
2842163|NCT03370133|3543705|FG005|NOT COMPLETED|Initial Treatment Period (WK 16)||0
2842164|NCT03370133|3543700|FG000|STARTED|Maintenance Treatment Period (WK 52)||0
2842165|NCT03370133|3543701|FG001|STARTED|Maintenance Treatment Period (WK 52)||0
2842166|NCT03370133|3543702|FG002|STARTED|Maintenance Treatment Period (WK 52)||0
2842167|NCT03370133|3543703|FG003|STARTED|Maintenance Treatment Period (WK 52)||74
2842168|NCT03370133|3543704|FG004|STARTED|Maintenance Treatment Period (WK 52)||306
2842169|NCT03370133|3543705|FG005|STARTED|Maintenance Treatment Period (WK 52)||157
2842170|NCT03370133|3543700|FG000|COMPLETED|Maintenance Treatment Period (WK 52)||0
2842171|NCT03370133|3543701|FG001|COMPLETED|Maintenance Treatment Period (WK 52)||0
2842172|NCT03370133|3543702|FG002|COMPLETED|Maintenance Treatment Period (WK 52)||0
2842173|NCT03370133|3543703|FG003|COMPLETED|Maintenance Treatment Period (WK 52)||69
2842174|NCT03370133|3543704|FG004|COMPLETED|Maintenance Treatment Period (WK 52)||283
2842175|NCT03370133|3543705|FG005|COMPLETED|Maintenance Treatment Period (WK 52)||141
2842176|NCT03370133|3543700|FG000|NOT COMPLETED|Maintenance Treatment Period (WK 52)||0
2842177|NCT03370133|3543701|FG001|NOT COMPLETED|Maintenance Treatment Period (WK 52)||0
2842178|NCT03370133|3543702|FG002|NOT COMPLETED|Maintenance Treatment Period (WK 52)||0
2842179|NCT03370133|3543703|FG003|NOT COMPLETED|Maintenance Treatment Period (WK 52)||5
2842180|NCT03370133|3543704|FG004|NOT COMPLETED|Maintenance Treatment Period (WK 52)||23
2842181|NCT03370133|3543705|FG005|NOT COMPLETED|Maintenance Treatment Period (WK 52)||16
2842182|NCT03365102|3543726|FG000|STARTED|Overall Study||22
2842183|NCT03365102|3543727|FG001|STARTED|Overall Study||22
2842184|NCT03365102|3543728|FG002|STARTED|Overall Study||20
2842185|NCT03365102|3543726|FG000|COMPLETED|Overall Study||18
2842186|NCT03365102|3543727|FG001|COMPLETED|Overall Study||21
2842187|NCT03365102|3543728|FG002|COMPLETED|Overall Study||19
2842188|NCT03365102|3543726|FG000|NOT COMPLETED|Overall Study||4
2842189|NCT03365102|3543727|FG001|NOT COMPLETED|Overall Study||1
2842190|NCT03365102|3543728|FG002|NOT COMPLETED|Overall Study||1
2842191|NCT03318003|3543738|FG000|STARTED|Overall Study||21
2842192|NCT03318003|3543739|FG001|STARTED|Overall Study||22
2842193|NCT03318003|3543738|FG000|COMPLETED|Overall Study|completed means the presence of 3rd trimester ultrasound and delivery information.|20
2842194|NCT03318003|3543739|FG001|COMPLETED|Overall Study||20
2842195|NCT03318003|3543738|FG000|NOT COMPLETED|Overall Study||1
3167603|NCT01912222|3894912|FG001|COMPLETED|Part A: Pharmacokinetic Period||13
3167604|NCT01912222|3894913|FG002|COMPLETED|Part A: Pharmacokinetic Period||18
3167605|NCT01912222|3894911|FG000|NOT COMPLETED|Part A: Pharmacokinetic Period||1
3167606|NCT01912222|3894912|FG001|NOT COMPLETED|Part A: Pharmacokinetic Period||2
2842196|NCT03318003|3543739|FG001|NOT COMPLETED|Overall Study||2
2842197|NCT03309072|3543747|FG000|STARTED|Overall Study||15
2842198|NCT03309072|3543748|FG001|STARTED|Overall Study||15
2842199|NCT03309072|3543747|FG000|COMPLETED|Overall Study||15
2842200|NCT03309072|3543748|FG001|COMPLETED|Overall Study||15
2842201|NCT03309072|3543747|FG000|NOT COMPLETED|Overall Study||0
2842202|NCT03309072|3543748|FG001|NOT COMPLETED|Overall Study||0
2842203|NCT03216499|3543754|FG000|STARTED|Overall Study||24
2842204|NCT03216499|3543754|FG000|COMPLETED|Overall Study||24
2842205|NCT03216499|3543754|FG000|NOT COMPLETED|Overall Study||0
2842206|NCT03138590|3543760|FG000|STARTED|Overall Study||10
2842207|NCT03138590|3543761|FG001|STARTED|Overall Study||10
2842208|NCT03138590|3543760|FG000|COMPLETED|Overall Study||10
2842209|NCT03138590|3543761|FG001|COMPLETED|Overall Study||10
2842210|NCT03138590|3543760|FG000|NOT COMPLETED|Overall Study||0
2842211|NCT03138590|3543761|FG001|NOT COMPLETED|Overall Study||0
2842212|NCT03132753|3543769|FG000|STARTED|Baseline - 6 Month Follow-Up||46
2842213|NCT03132753|3543770|FG001|STARTED|Baseline - 6 Month Follow-Up||54
2842214|NCT03132753|3543769|FG000|COMPLETED|Baseline - 6 Month Follow-Up||19
2842215|NCT03132753|3543770|FG001|COMPLETED|Baseline - 6 Month Follow-Up||22
2842216|NCT03132753|3543769|FG000|NOT COMPLETED|Baseline - 6 Month Follow-Up||27
2842217|NCT03132753|3543770|FG001|NOT COMPLETED|Baseline - 6 Month Follow-Up||32
2842218|NCT03132753|3543769|FG000|STARTED|6 Month Follow-Up - 12 Month Follow-Up||19
2842219|NCT03132753|3543770|FG001|STARTED|6 Month Follow-Up - 12 Month Follow-Up||22
2842220|NCT03132753|3543769|FG000|COMPLETED|6 Month Follow-Up - 12 Month Follow-Up||13
2842221|NCT03132753|3543770|FG001|COMPLETED|6 Month Follow-Up - 12 Month Follow-Up||20
2842222|NCT03132753|3543769|FG000|NOT COMPLETED|6 Month Follow-Up - 12 Month Follow-Up||6
2842223|NCT03132753|3543770|FG001|NOT COMPLETED|6 Month Follow-Up - 12 Month Follow-Up||2
2842224|NCT03085680|3543778|FG000|STARTED|Overall Study||9
2842225|NCT03085680|3543779|FG001|STARTED|Overall Study||8
2842226|NCT03085680|3543778|FG000|COMPLETED|Overall Study||9
2842227|NCT03085680|3543779|FG001|COMPLETED|Overall Study||8
2842228|NCT03085680|3543778|FG000|NOT COMPLETED|Overall Study||0
2842229|NCT03085680|3543779|FG001|NOT COMPLETED|Overall Study||0
2842230|NCT03084471|3543785|FG000|STARTED|Overall Study||867
2842231|NCT03084471|3543785|FG000|COMPLETED|Overall Study||0
2842232|NCT03084471|3543785|FG000|NOT COMPLETED|Overall Study||867
2842233|NCT03067077|3543792|FG000|STARTED|Overall Study||44
3167607|NCT01912222|3894913|FG002|NOT COMPLETED|Part A: Pharmacokinetic Period||2
2842234|NCT03067077|3543793|FG001|STARTED|Overall Study||44
2842235|NCT03067077|3543792|FG000|Received Surgery|Overall Study||40
2842236|NCT03067077|3543793|FG001|Received Surgery|Overall Study||39
2842237|NCT03067077|3543792|FG000|COMPLETED|Overall Study||37
2842238|NCT03067077|3543793|FG001|COMPLETED|Overall Study||37
2842239|NCT03067077|3543792|FG000|NOT COMPLETED|Overall Study||7
2842240|NCT03067077|3543793|FG001|NOT COMPLETED|Overall Study||7
2842241|NCT03059446|3543799|FG000|STARTED|Overall Study||167
2842242|NCT03059446|3543799|FG000|COMPLETED|Overall Study||0
2842243|NCT03059446|3543799|FG000|NOT COMPLETED|Overall Study||167
2916135|NCT00514709|3626592|FG000|STARTED|Overall Study||1230
2916136|NCT00514709|3626593|FG001|STARTED|Overall Study||613
2916137|NCT00514709|3626592|FG000|COMPLETED|Overall Study||1230
2916138|NCT00514709|3626593|FG001|COMPLETED|Overall Study||613
2916139|NCT00514709|3626592|FG000|NOT COMPLETED|Overall Study||0
2916140|NCT00514709|3626593|FG001|NOT COMPLETED|Overall Study||0
2916141|NCT00514735|3626603|FG000|STARTED|Overall Study||138
2916142|NCT00514735|3626604|FG001|STARTED|Overall Study||72
2916143|NCT00514735|3626603|FG000|COMPLETED|Overall Study||124
2916144|NCT00514735|3626604|FG001|COMPLETED|Overall Study||66
2916145|NCT00514735|3626603|FG000|NOT COMPLETED|Overall Study||14
2916146|NCT00514735|3626604|FG001|NOT COMPLETED|Overall Study||6
2916147|NCT00514852|3626614|FG000|STARTED|Overall Study||157
2916148|NCT00514852|3626615|FG001|STARTED|Overall Study||159
2916149|NCT00514852|3626614|FG000|COMPLETED|Overall Study||152
2916150|NCT00514852|3626615|FG001|COMPLETED|Overall Study||154
2916151|NCT00514852|3626614|FG000|NOT COMPLETED|Overall Study||5
2916152|NCT00514852|3626615|FG001|NOT COMPLETED|Overall Study||5
2916153|NCT00514904|3626623|FG000|STARTED|Overall Study||1125
2916154|NCT00514904|3626624|FG001|STARTED|Overall Study||376
2916155|NCT00514904|3626623|FG000|COMPLETED|Overall Study||1101
2916156|NCT00514904|3626624|FG001|COMPLETED|Overall Study||371
2916157|NCT00514904|3626623|FG000|NOT COMPLETED|Overall Study||24
2916158|NCT00514904|3626624|FG001|NOT COMPLETED|Overall Study||5
2916159|NCT00514917|3626632|FG000|STARTED|Overall Study||207
2916160|NCT00514917|3626633|FG001|STARTED|Overall Study||206
2916161|NCT00514917|3626632|FG000|Treated|Overall Study||196
2916162|NCT00514917|3626633|FG001|Treated|Overall Study||204
2916163|NCT00514917|3626632|FG000|Completed Study Treatment|Overall Study||170
2916164|NCT00514917|3626633|FG001|Completed Study Treatment|Overall Study||182
2916165|NCT00514917|3626632|FG000|Testosterone-Specific Evaluable|Overall Study||122
2916166|NCT00514917|3626633|FG001|Testosterone-Specific Evaluable|Overall Study||124
2916167|NCT00514917|3626632|FG000|COMPLETED|Overall Study||81
2916168|NCT00514917|3626633|FG001|COMPLETED|Overall Study||91
2916169|NCT00514917|3626632|FG000|NOT COMPLETED|Overall Study||126
2916170|NCT00514917|3626633|FG001|NOT COMPLETED|Overall Study||115
2916171|NCT00514943|3626643|FG000|STARTED|Stage 1|1 randomized patient was not treated|62
2916172|NCT00514943|3626644|FG001|STARTED|Stage 1|2 randomized patients were not treated|62
2916173|NCT00514943|3626643|FG000|COMPLETED|Stage 1||32
2916174|NCT00514943|3626644|FG001|COMPLETED|Stage 1||36
2916175|NCT00514943|3626643|FG000|NOT COMPLETED|Stage 1||30
2916176|NCT00514943|3626644|FG001|NOT COMPLETED|Stage 1||26
2916177|NCT00514943|3626643|FG000|STARTED|Stage 2||32
2916178|NCT00514943|3626644|FG001|STARTED|Stage 2||36
2916179|NCT00514943|3626643|FG000|COMPLETED|Stage 2||0
2916180|NCT00514943|3626644|FG001|COMPLETED|Stage 2||0
2916181|NCT00514943|3626643|FG000|NOT COMPLETED|Stage 2||32
2916182|NCT00514943|3626644|FG001|NOT COMPLETED|Stage 2||36
2916183|NCT00515008|3626667|FG000|STARTED|Overall Study||33
2916184|NCT00515008|3626668|FG001|STARTED|Overall Study||33
2916185|NCT00515008|3626667|FG000|Completed 12 Week Evaluation|Overall Study||32
2916186|NCT00515008|3626668|FG001|Completed 12 Week Evaluation|Overall Study||29
2916187|NCT00515008|3626667|FG000|COMPLETED|Overall Study||30
2916188|NCT00515008|3626668|FG001|COMPLETED|Overall Study||29
2916189|NCT00515008|3626667|FG000|NOT COMPLETED|Overall Study||3
2916190|NCT00515008|3626668|FG001|NOT COMPLETED|Overall Study||4
2916191|NCT00515021|3626679|FG000|STARTED|Overall Study||9
2916192|NCT00515021|3626680|FG001|STARTED|Overall Study||11
2916193|NCT00515021|3626679|FG000|COMPLETED|Overall Study||9
2916194|NCT00515021|3626680|FG001|COMPLETED|Overall Study||11
2916195|NCT00515021|3626679|FG000|NOT COMPLETED|Overall Study||0
2916196|NCT00515021|3626680|FG001|NOT COMPLETED|Overall Study||0
2916197|NCT00515034|3626692|FG000|STARTED|Overall Study||49
2916198|NCT00515034|3626693|FG001|STARTED|Overall Study||15
2916199|NCT00515034|3626694|FG002|STARTED|Overall Study||62
2916200|NCT00515034|3626695|FG003|STARTED|Overall Study||20
2916201|NCT00515034|3626692|FG000|TREATED|Overall Study||48
2916202|NCT00515034|3626693|FG001|TREATED|Overall Study||15
2916203|NCT00515034|3626694|FG002|TREATED|Overall Study||61
2916204|NCT00515034|3626695|FG003|TREATED|Overall Study||19
2916205|NCT00515034|3626692|FG000|COMPLETED|Overall Study||41
2916206|NCT00515034|3626693|FG001|COMPLETED|Overall Study||13
2916207|NCT00515034|3626694|FG002|COMPLETED|Overall Study||54
2916208|NCT00515034|3626695|FG003|COMPLETED|Overall Study||15
2916209|NCT00515034|3626692|FG000|NOT COMPLETED|Overall Study||8
2916210|NCT00515034|3626693|FG001|NOT COMPLETED|Overall Study||2
2916211|NCT00515034|3626694|FG002|NOT COMPLETED|Overall Study||8
2916212|NCT00515034|3626695|FG003|NOT COMPLETED|Overall Study||5
2920737|NCT00538590|3631295|FG000|STARTED|Overall Study||10
2920738|NCT00538590|3631296|FG001|STARTED|Overall Study||10
2920739|NCT00538590|3631295|FG000|COMPLETED|Overall Study|Deceased 8 months after surgery due to known cardiovascular co-morbidity.|9
2920740|NCT00538590|3631296|FG001|COMPLETED|Overall Study||10
2842244|NCT03035409|3543803|FG000|STARTED|Overall Study||45
2842245|NCT03035409|3543803|FG000|Day 15|Overall Study||28
2842246|NCT03035409|3543803|FG000|Day 29|Overall Study||28
2842247|NCT03035409|3543803|FG000|Day 43|Overall Study||28
2842248|NCT03035409|3543803|FG000|COMPLETED|Overall Study||28
2842249|NCT03035409|3543803|FG000|NOT COMPLETED|Overall Study||17
2842250|NCT03019575|3543807|FG000|STARTED|Overall Study||17
2842251|NCT03019575|3543807|FG000|COMPLETED|Overall Study||17
2842252|NCT03019575|3543807|FG000|NOT COMPLETED|Overall Study||0
2842253|NCT03011034|3543813|FG000|STARTED|Overall Study||1
2842254|NCT03011034|3543814|FG001|STARTED|Overall Study||33
2842255|NCT03011034|3543813|FG000|COMPLETED|Overall Study||0
2842256|NCT03011034|3543814|FG001|COMPLETED|Overall Study||33
2842257|NCT03011034|3543813|FG000|NOT COMPLETED|Overall Study||1
2842258|NCT03011034|3543814|FG001|NOT COMPLETED|Overall Study||0
2842259|NCT02980666|3543822|FG000|STARTED|Overall Study||8
2842260|NCT02980666|3543823|FG001|STARTED|Overall Study||2
2842261|NCT02980666|3543822|FG000|COMPLETED|Overall Study||8
2842262|NCT02980666|3543823|FG001|COMPLETED|Overall Study||2
2842263|NCT02980666|3543822|FG000|NOT COMPLETED|Overall Study||0
2842264|NCT02980666|3543823|FG001|NOT COMPLETED|Overall Study||0
2842265|NCT02962102|3543832|FG000|STARTED|Overall Study||51
2842266|NCT02962102|3543833|FG001|STARTED|Overall Study||50
2842267|NCT02962102|3543834|FG002|STARTED|Overall Study||49
2842268|NCT02962102|3543832|FG000|COMPLETED|Overall Study||51
2842269|NCT02962102|3543833|FG001|COMPLETED|Overall Study||50
2842270|NCT02962102|3543834|FG002|COMPLETED|Overall Study||49
2842271|NCT02962102|3543832|FG000|NOT COMPLETED|Overall Study||0
2842272|NCT02962102|3543833|FG001|NOT COMPLETED|Overall Study||0
2842273|NCT02962102|3543834|FG002|NOT COMPLETED|Overall Study||0
2842274|NCT02921971|3543844|FG000|STARTED|Overall Study||49
2842275|NCT02921971|3543845|FG001|STARTED|Overall Study||48
2842276|NCT02921971|3543844|FG000|COMPLETED|Overall Study||43
2842277|NCT02921971|3543845|FG001|COMPLETED|Overall Study||44
2842278|NCT02921971|3543844|FG000|NOT COMPLETED|Overall Study||6
2842279|NCT02921971|3543845|FG001|NOT COMPLETED|Overall Study||4
2842280|NCT02853331|3543853|FG000|STARTED|Overall Study||432
2842281|NCT02853331|3543854|FG001|STARTED|Overall Study||429
2842282|NCT02853331|3543853|FG000|Treated|Overall Study||429
2842283|NCT02853331|3543854|FG001|Treated|Overall Study||425
2842284|NCT02853331|3543853|FG000|COMPLETED|Overall Study||0
2842285|NCT02853331|3543854|FG001|COMPLETED|Overall Study||0
2842286|NCT02853331|3543853|FG000|NOT COMPLETED|Overall Study||432
2842287|NCT02853331|3543854|FG001|NOT COMPLETED|Overall Study||429
2842288|NCT02847637|3543864|FG000|STARTED|Overall Study||18
2842289|NCT02847637|3543865|FG001|STARTED|Overall Study||36
2842290|NCT02847637|3543866|FG002|STARTED|Overall Study||35
2842291|NCT02847637|3543867|FG003|STARTED|Overall Study||63
2842292|NCT02847637|3543864|FG000|Completed 24 Weeks on No Prophylaxis|Overall Study|One participant switched to emicizumab prior to completing 24 weeks No Prophylaxis (at 23.5 weeks).|16
2842293|NCT02847637|3543865|FG001|Completed 24 Weeks on No Prophylaxis|Overall Study||0
2842294|NCT02847637|3543866|FG002|Completed 24 Weeks on No Prophylaxis|Overall Study||0
2842295|NCT02847637|3543867|FG003|Completed 24 Weeks on No Prophylaxis|Overall Study||0
2842296|NCT02847637|3543864|FG000|Switched to Emicizumab 3 mg/kg/2 Weeks|Overall Study||16
2842297|NCT02847637|3543865|FG001|Switched to Emicizumab 3 mg/kg/2 Weeks|Overall Study||0
2842298|NCT02847637|3543866|FG002|Switched to Emicizumab 3 mg/kg/2 Weeks|Overall Study||0
2842299|NCT02847637|3543867|FG003|Switched to Emicizumab 3 mg/kg/2 Weeks|Overall Study||0
2842300|NCT02847637|3543864|FG000|Completed 24 Weeks Emicizumab Treatment|Overall Study|Participants started on 24 weeks No Prophylaxis first before switching to emicizumab.|1
2842301|NCT02847637|3543865|FG001|Completed 24 Weeks Emicizumab Treatment|Overall Study||35
2842302|NCT02847637|3543866|FG002|Completed 24 Weeks Emicizumab Treatment|Overall Study||34
2842303|NCT02847637|3543867|FG003|Completed 24 Weeks Emicizumab Treatment|Overall Study||58
2842304|NCT02847637|3543864|FG000|COMPLETED|Overall Study||1
2842305|NCT02847637|3543865|FG001|COMPLETED|Overall Study||1
2842306|NCT02847637|3543866|FG002|COMPLETED|Overall Study||0
2842307|NCT02847637|3543867|FG003|COMPLETED|Overall Study||0
2842308|NCT02847637|3543864|FG000|NOT COMPLETED|Overall Study||17
2842309|NCT02847637|3543865|FG001|NOT COMPLETED|Overall Study||35
2842310|NCT02847637|3543866|FG002|NOT COMPLETED|Overall Study||35
2842311|NCT02847637|3543867|FG003|NOT COMPLETED|Overall Study||63
2842312|NCT02841644|3543889|FG000|STARTED|Overall Study||60
2842313|NCT02841644|3543890|FG001|STARTED|Overall Study||120
2842314|NCT02841644|3543889|FG000|COMPLETED|Overall Study||60
2842315|NCT02841644|3543890|FG001|COMPLETED|Overall Study||120
2842316|NCT02841644|3543889|FG000|NOT COMPLETED|Overall Study||0
2842317|NCT02841644|3543890|FG001|NOT COMPLETED|Overall Study||0
2842318|NCT02781584|3543909|FG000|STARTED|Pre-treatment Phase||0
2842319|NCT02781584|3543910|FG001|STARTED|Pre-treatment Phase||0
2842320|NCT02781584|3543911|FG002|STARTED|Pre-treatment Phase||0
2842321|NCT02781584|3543912|FG003|STARTED|Pre-treatment Phase||0
2842322|NCT02781584|3543913|FG004|STARTED|Pre-treatment Phase||0
2842323|NCT02781584|3543914|FG005|STARTED|Pre-treatment Phase||0
2842324|NCT02781584|3543915|FG006|STARTED|Pre-treatment Phase||0
2842325|NCT02781584|3543916|FG007|STARTED|Pre-treatment Phase||0
2842326|NCT02781584|3543917|FG008|STARTED|Pre-treatment Phase||0
2842327|NCT02781584|3543918|FG009|STARTED|Pre-treatment Phase||15
2842328|NCT02781584|3543919|FG010|STARTED|Pre-treatment Phase||16
2842329|NCT02781584|3543920|FG011|STARTED|Pre-treatment Phase||33
2842330|NCT02781584|3543921|FG012|STARTED|Pre-treatment Phase||33
2842331|NCT02781584|3543909|FG000|COMPLETED|Pre-treatment Phase||0
2842332|NCT02781584|3543910|FG001|COMPLETED|Pre-treatment Phase||0
2842333|NCT02781584|3543911|FG002|COMPLETED|Pre-treatment Phase||0
2842334|NCT02781584|3543912|FG003|COMPLETED|Pre-treatment Phase||0
2842335|NCT02781584|3543913|FG004|COMPLETED|Pre-treatment Phase||0
2842336|NCT02781584|3543914|FG005|COMPLETED|Pre-treatment Phase||0
2842337|NCT02781584|3543915|FG006|COMPLETED|Pre-treatment Phase||0
2842338|NCT02781584|3543916|FG007|COMPLETED|Pre-treatment Phase||0
2842339|NCT02781584|3543917|FG008|COMPLETED|Pre-treatment Phase||0
2842340|NCT02781584|3543918|FG009|COMPLETED|Pre-treatment Phase||15
2842341|NCT02781584|3543919|FG010|COMPLETED|Pre-treatment Phase||16
2842342|NCT02781584|3543920|FG011|COMPLETED|Pre-treatment Phase||30
2842343|NCT02781584|3543921|FG012|COMPLETED|Pre-treatment Phase||32
2842344|NCT02781584|3543909|FG000|NOT COMPLETED|Pre-treatment Phase||0
2842345|NCT02781584|3543910|FG001|NOT COMPLETED|Pre-treatment Phase||0
2842346|NCT02781584|3543911|FG002|NOT COMPLETED|Pre-treatment Phase||0
2842347|NCT02781584|3543912|FG003|NOT COMPLETED|Pre-treatment Phase||0
2842348|NCT02781584|3543913|FG004|NOT COMPLETED|Pre-treatment Phase||0
2842349|NCT02781584|3543914|FG005|NOT COMPLETED|Pre-treatment Phase||0
2842350|NCT02781584|3543915|FG006|NOT COMPLETED|Pre-treatment Phase||0
2842351|NCT02781584|3543916|FG007|NOT COMPLETED|Pre-treatment Phase||0
2842352|NCT02781584|3543917|FG008|NOT COMPLETED|Pre-treatment Phase||0
2842353|NCT02781584|3543918|FG009|NOT COMPLETED|Pre-treatment Phase||0
2842354|NCT02781584|3543919|FG010|NOT COMPLETED|Pre-treatment Phase||0
2842355|NCT02781584|3543920|FG011|NOT COMPLETED|Pre-treatment Phase||3
2842356|NCT02781584|3543921|FG012|NOT COMPLETED|Pre-treatment Phase||1
2842357|NCT02781584|3543909|FG000|STARTED|Treatment Phase|Only participants in Cohorts 10-13 received pre-treatment.|10
2842358|NCT02781584|3543910|FG001|STARTED|Treatment Phase|Only participants in Cohorts 10-13 received pre-treatment.|10
2842359|NCT02781584|3543911|FG002|STARTED|Treatment Phase|Only participants in Cohorts 10-13 received pre-treatment.|10
2842360|NCT02781584|3543912|FG003|STARTED|Treatment Phase|Only participants in Cohorts 10-13 received pre-treatment.|20
2842361|NCT02781584|3543913|FG004|STARTED|Treatment Phase|Only participants in Cohorts 10-13 received pre-treatment.|20
2842362|NCT02781584|3543914|FG005|STARTED|Treatment Phase|Only participants in Cohorts 10-13 received pre-treatment.|20
2842363|NCT02781584|3543915|FG006|STARTED|Treatment Phase|Only participants in Cohorts 10-13 received pre-treatment.|10
2842364|NCT02781584|3543916|FG007|STARTED|Treatment Phase|Only participants in Cohorts 10-13 received pre-treatment.|10
2842365|NCT02781584|3543917|FG008|STARTED|Treatment Phase|Only participants in Cohorts 10-13 received pre-treatment.|13
2842366|NCT02781584|3543918|FG009|STARTED|Treatment Phase||15
2842367|NCT02781584|3543919|FG010|STARTED|Treatment Phase||16
2842368|NCT02781584|3543920|FG011|STARTED|Treatment Phase||30
2842369|NCT02781584|3543921|FG012|STARTED|Treatment Phase||32
2842370|NCT02781584|3543909|FG000|COMPLETED|Treatment Phase||10
2842371|NCT02781584|3543910|FG001|COMPLETED|Treatment Phase||10
2842372|NCT02781584|3543911|FG002|COMPLETED|Treatment Phase||10
2842373|NCT02781584|3543912|FG003|COMPLETED|Treatment Phase||20
2842374|NCT02781584|3543913|FG004|COMPLETED|Treatment Phase||20
2842375|NCT02781584|3543914|FG005|COMPLETED|Treatment Phase||19
2842376|NCT02781584|3543915|FG006|COMPLETED|Treatment Phase||10
2842377|NCT02781584|3543916|FG007|COMPLETED|Treatment Phase||9
2842378|NCT02781584|3543917|FG008|COMPLETED|Treatment Phase||13
2842379|NCT02781584|3543918|FG009|COMPLETED|Treatment Phase||15
2842380|NCT02781584|3543919|FG010|COMPLETED|Treatment Phase||15
2842381|NCT02781584|3543920|FG011|COMPLETED|Treatment Phase||28
2842382|NCT02781584|3543921|FG012|COMPLETED|Treatment Phase||32
2842383|NCT02781584|3543909|FG000|NOT COMPLETED|Treatment Phase||0
2842384|NCT02781584|3543910|FG001|NOT COMPLETED|Treatment Phase||0
2842385|NCT02781584|3543911|FG002|NOT COMPLETED|Treatment Phase||0
2842386|NCT02781584|3543912|FG003|NOT COMPLETED|Treatment Phase||0
2842387|NCT02781584|3543913|FG004|NOT COMPLETED|Treatment Phase||0
2842388|NCT02781584|3543914|FG005|NOT COMPLETED|Treatment Phase||1
2842389|NCT02781584|3543915|FG006|NOT COMPLETED|Treatment Phase||0
2842390|NCT02781584|3543916|FG007|NOT COMPLETED|Treatment Phase||1
2842391|NCT02781584|3543917|FG008|NOT COMPLETED|Treatment Phase||0
2842392|NCT02781584|3543918|FG009|NOT COMPLETED|Treatment Phase||0
2842393|NCT02781584|3543919|FG010|NOT COMPLETED|Treatment Phase||1
2842394|NCT02781584|3543920|FG011|NOT COMPLETED|Treatment Phase||2
2842395|NCT02781584|3543921|FG012|NOT COMPLETED|Treatment Phase||0
2842396|NCT02749045|3543949|FG000|STARTED|Overall Study||27
2842397|NCT02749045|3543949|FG000|COMPLETED|Overall Study||27
2842398|NCT02749045|3543949|FG000|NOT COMPLETED|Overall Study||0
2842399|NCT02667587|3543955|FG000|STARTED|Pre-Treatment||358
2842400|NCT02667587|3543956|FG001|STARTED|Pre-Treatment||358
2842401|NCT02667587|3543955|FG000|COMPLETED|Pre-Treatment||354
2842402|NCT02667587|3543956|FG001|COMPLETED|Pre-Treatment||355
2842403|NCT02667587|3543955|FG000|NOT COMPLETED|Pre-Treatment||4
2842404|NCT02667587|3543956|FG001|NOT COMPLETED|Pre-Treatment||3
2842405|NCT02667587|3543955|FG000|STARTED|End of Treatment|1 participant was randomized to Radiotherapy, Temozolomide plus Placebo but received Radiotherapy, Temozolomide plus Nivolumab.|355
2842406|NCT02667587|3543956|FG001|STARTED|End of Treatment|1 participant was randomized to Radiotherapy, Temozolomide plus Placebo but received Radiotherapy, Temozolomide plus Nivolumab.|354
2842407|NCT02667587|3543955|FG000|COMPLETED|End of Treatment||37
2842408|NCT02667587|3543956|FG001|COMPLETED|End of Treatment||44
2842409|NCT02667587|3543955|FG000|NOT COMPLETED|End of Treatment||318
2842410|NCT02667587|3543956|FG001|NOT COMPLETED|End of Treatment||310
2842411|NCT02659605|3543964|FG000|STARTED|Overall Study||40
2842412|NCT02659605|3543965|FG001|STARTED|Overall Study||34
2842413|NCT02659605|3543964|FG000|COMPLETED|Overall Study||31
2842414|NCT02659605|3543965|FG001|COMPLETED|Overall Study||30
2842415|NCT02659605|3543964|FG000|NOT COMPLETED|Overall Study||9
2842416|NCT02659605|3543965|FG001|NOT COMPLETED|Overall Study||4
2842417|NCT02601014|3543973|FG000|STARTED|Overall Study||15
2842418|NCT02601014|3543974|FG001|STARTED|Overall Study||15
2842419|NCT02601014|3543973|FG000|COMPLETED|Overall Study||5
2842420|NCT02601014|3543974|FG001|COMPLETED|Overall Study||3
2842421|NCT02601014|3543973|FG000|NOT COMPLETED|Overall Study||10
2842422|NCT02601014|3543974|FG001|NOT COMPLETED|Overall Study||12
2842423|NCT02579096|3543982|FG000|STARTED|Phase 1, Weeks 0 - 24||468
2842424|NCT02579096|3543983|FG001|STARTED|Phase 1, Weeks 0 - 24||472
2842425|NCT02579096|3543982|FG000|COMPLETED|Phase 1, Weeks 0 - 24||411
2842426|NCT02579096|3543983|FG001|COMPLETED|Phase 1, Weeks 0 - 24||422
2842427|NCT02579096|3543982|FG000|NOT COMPLETED|Phase 1, Weeks 0 - 24||57
2842428|NCT02579096|3543983|FG001|NOT COMPLETED|Phase 1, Weeks 0 - 24||50
2842429|NCT02579096|3543982|FG000|STARTED|Phase 2, Weeks 25 - 48||411
2842430|NCT02579096|3543983|FG001|STARTED|Phase 2, Weeks 25 - 48||422
2842431|NCT02579096|3543982|FG000|COMPLETED|Phase 2, Weeks 25 - 48||389
2842432|NCT02579096|3543983|FG001|COMPLETED|Phase 2, Weeks 25 - 48||391
2842433|NCT02579096|3543982|FG000|NOT COMPLETED|Phase 2, Weeks 25 - 48||22
2842434|NCT02579096|3543983|FG001|NOT COMPLETED|Phase 2, Weeks 25 - 48||31
2842435|NCT02579096|3543982|FG000|STARTED|Phase 3, Weeks 49 - 72||389
2842436|NCT02579096|3543983|FG001|STARTED|Phase 3, Weeks 49 - 72||391
2842437|NCT02579096|3543982|FG000|COMPLETED|Phase 3, Weeks 49 - 72||367
2842438|NCT02579096|3543983|FG001|COMPLETED|Phase 3, Weeks 49 - 72||373
2842439|NCT02579096|3543982|FG000|NOT COMPLETED|Phase 3, Weeks 49 - 72||22
2842440|NCT02579096|3543983|FG001|NOT COMPLETED|Phase 3, Weeks 49 - 72||18
2842441|NCT02545868|3543992|FG000|STARTED|Immunization Study Period (ISP)||33
2842442|NCT02545868|3543993|FG001|STARTED|Immunization Study Period (ISP)||35
2842443|NCT02545868|3543994|FG002|STARTED|Immunization Study Period (ISP)||34
2842444|NCT02545868|3543992|FG000|COMPLETED|Immunization Study Period (ISP)||33
2842445|NCT02545868|3543993|FG001|COMPLETED|Immunization Study Period (ISP)||35
2842446|NCT02545868|3543994|FG002|COMPLETED|Immunization Study Period (ISP)||34
2842447|NCT02545868|3543992|FG000|NOT COMPLETED|Immunization Study Period (ISP)||0
2842448|NCT02545868|3543993|FG001|NOT COMPLETED|Immunization Study Period (ISP)||0
2842449|NCT02545868|3543994|FG002|NOT COMPLETED|Immunization Study Period (ISP)||0
2842450|NCT02545868|3543992|FG000|STARTED|Optional Ocrelizumab Ext (OOE) Period||33
2842451|NCT02545868|3543993|FG001|STARTED|Optional Ocrelizumab Ext (OOE) Period||35
2842452|NCT02545868|3543994|FG002|STARTED|Optional Ocrelizumab Ext (OOE) Period||34
2842453|NCT02545868|3543992|FG000|COMPLETED|Optional Ocrelizumab Ext (OOE) Period||0
2842454|NCT02545868|3543993|FG001|COMPLETED|Optional Ocrelizumab Ext (OOE) Period||0
2842455|NCT02545868|3543994|FG002|COMPLETED|Optional Ocrelizumab Ext (OOE) Period||0
2842456|NCT02545868|3543992|FG000|NOT COMPLETED|Optional Ocrelizumab Ext (OOE) Period||33
2842457|NCT02545868|3543993|FG001|NOT COMPLETED|Optional Ocrelizumab Ext (OOE) Period||35
2842458|NCT02545868|3543994|FG002|NOT COMPLETED|Optional Ocrelizumab Ext (OOE) Period||34
2842459|NCT02538666|3544010|FG000|STARTED|Overall Study||275
2842460|NCT02538666|3544011|FG001|STARTED|Overall Study||280
2842461|NCT02538666|3544012|FG002|STARTED|Overall Study||279
2842462|NCT02538666|3544010|FG000|COMPLETED|Overall Study||273
2842463|NCT02538666|3544011|FG001|COMPLETED|Overall Study||279
2842464|NCT02538666|3544012|FG002|COMPLETED|Overall Study||278
2842465|NCT02538666|3544010|FG000|NOT COMPLETED|Overall Study||2
2842466|NCT02538666|3544011|FG001|NOT COMPLETED|Overall Study||1
2842467|NCT02538666|3544012|FG002|NOT COMPLETED|Overall Study||1
2842468|NCT02527200|3544025|FG000|STARTED|Overall Study||20
2842469|NCT02527200|3544026|FG001|STARTED|Overall Study||12
3167608|NCT01912222|3894911|FG000|STARTED|Part B: Treatment Period||13
3167609|NCT01912222|3894912|FG001|STARTED|Part B: Treatment Period||15
3167610|NCT01912222|3894913|FG002|STARTED|Part B: Treatment Period||20
3167611|NCT01912222|3894911|FG000|COMPLETED|Part B: Treatment Period||0
3167612|NCT01912222|3894912|FG001|COMPLETED|Part B: Treatment Period||0
3167613|NCT01912222|3894913|FG002|COMPLETED|Part B: Treatment Period||0
3167614|NCT01912222|3894911|FG000|NOT COMPLETED|Part B: Treatment Period||13
3167615|NCT01912222|3894912|FG001|NOT COMPLETED|Part B: Treatment Period||15
3167616|NCT01912222|3894913|FG002|NOT COMPLETED|Part B: Treatment Period||20
3167617|NCT01912274|3894922|FG000|STARTED|Overall Study||50
3167618|NCT01912274|3894922|FG000|COMPLETED|Overall Study||50
3167619|NCT01912274|3894922|FG000|NOT COMPLETED|Overall Study||0
3167620|NCT01912287|3894929|FG000|STARTED|Overall Study||93
3167621|NCT01912287|3894930|FG001|STARTED|Overall Study||90
3167622|NCT01912287|3894931|FG002|STARTED|Overall Study||43
2842470|NCT02527200|3544027|FG002|STARTED|Overall Study||17
2842471|NCT02527200|3544028|FG003|STARTED|Overall Study||7
2842472|NCT02527200|3544025|FG000|Safety Analysis Set (SAS)|Overall Study||20
2842473|NCT02527200|3544026|FG001|Safety Analysis Set (SAS)|Overall Study||12
2842474|NCT02527200|3544027|FG002|Safety Analysis Set (SAS)|Overall Study||17
2842475|NCT02527200|3544028|FG003|Safety Analysis Set (SAS)|Overall Study||7
2842476|NCT02527200|3544025|FG000|Full Analysis Set (FAS)|Overall Study||19
2842477|NCT02527200|3544026|FG001|Full Analysis Set (FAS)|Overall Study||12
2842478|NCT02527200|3544027|FG002|Full Analysis Set (FAS)|Overall Study||17
2842479|NCT02527200|3544028|FG003|Full Analysis Set (FAS)|Overall Study||7
2842480|NCT02527200|3544025|FG000|COMPLETED|Overall Study||17
2842481|NCT02527200|3544026|FG001|COMPLETED|Overall Study||9
2842482|NCT02527200|3544027|FG002|COMPLETED|Overall Study||15
2842483|NCT02527200|3544028|FG003|COMPLETED|Overall Study||7
2842484|NCT02527200|3544025|FG000|NOT COMPLETED|Overall Study||3
2842485|NCT02527200|3544026|FG001|NOT COMPLETED|Overall Study||3
2842486|NCT02527200|3544027|FG002|NOT COMPLETED|Overall Study||2
2842487|NCT02527200|3544028|FG003|NOT COMPLETED|Overall Study||0
2842488|NCT02511106|3544044|FG000|STARTED|Overall Study||339
2842489|NCT02511106|3544045|FG001|STARTED|Overall Study||343
2842490|NCT02511106|3544044|FG000|Received Treatment|Overall Study||337
2842491|NCT02511106|3544045|FG001|Received Treatment|Overall Study||343
2842492|NCT02511106|3544044|FG000|COMPLETED|Overall Study||8
2842493|NCT02511106|3544045|FG001|COMPLETED|Overall Study||20
2842494|NCT02511106|3544044|FG000|NOT COMPLETED|Overall Study||331
2842495|NCT02511106|3544045|FG001|NOT COMPLETED|Overall Study||323
2842496|NCT02477358|3544055|FG000|STARTED|Overall Study||18
2842497|NCT02477358|3544056|FG001|STARTED|Overall Study||18
2842498|NCT02477358|3544055|FG000|COMPLETED|Overall Study||18
2842499|NCT02477358|3544056|FG001|COMPLETED|Overall Study||18
2842500|NCT02477358|3544055|FG000|NOT COMPLETED|Overall Study||0
2842501|NCT02477358|3544056|FG001|NOT COMPLETED|Overall Study||0
2842502|NCT02432209|3544066|FG000|STARTED|Overall Study||188
2842503|NCT02432209|3544067|FG001|STARTED|Overall Study||191
2842504|NCT02432209|3544066|FG000|COMPLETED|Overall Study||157
2842505|NCT02432209|3544067|FG001|COMPLETED|Overall Study||151
2842506|NCT02432209|3544066|FG000|NOT COMPLETED|Overall Study||31
2842507|NCT02432209|3544067|FG001|NOT COMPLETED|Overall Study||40
2916213|NCT00515073|3626705|FG000|STARTED|Overall Study||30
2916214|NCT00515073|3626705|FG000|COMPLETED|Overall Study||28
2916215|NCT00515073|3626705|FG000|NOT COMPLETED|Overall Study||2
2916216|NCT00515086|3626713|FG000|STARTED|Overall Study||24
2916217|NCT00515086|3626714|FG001|STARTED|Overall Study||6
2916218|NCT00515086|3626715|FG002|STARTED|Overall Study||5
2916219|NCT00515086|3626716|FG003|STARTED|Overall Study||6
2916220|NCT00515086|3626713|FG000|COMPLETED|Overall Study||0
2916221|NCT00515086|3626714|FG001|COMPLETED|Overall Study||0
2916222|NCT00515086|3626715|FG002|COMPLETED|Overall Study||0
2916223|NCT00515086|3626716|FG003|COMPLETED|Overall Study||0
2916224|NCT00515086|3626713|FG000|NOT COMPLETED|Overall Study||24
2916225|NCT00515086|3626714|FG001|NOT COMPLETED|Overall Study||6
2916226|NCT00515086|3626715|FG002|NOT COMPLETED|Overall Study||5
2916227|NCT00515086|3626716|FG003|NOT COMPLETED|Overall Study||6
2916228|NCT00515099|3626734|FG000|STARTED|Overall Study||38
2916229|NCT00515099|3626735|FG001|STARTED|Overall Study||20
2916230|NCT00515099|3626734|FG000|COMPLETED|Overall Study||35
2916231|NCT00515099|3626735|FG001|COMPLETED|Overall Study||16
2916232|NCT00515099|3626734|FG000|NOT COMPLETED|Overall Study||3
2916233|NCT00515099|3626735|FG001|NOT COMPLETED|Overall Study||4
2916234|NCT00515177|3626743|FG000|STARTED|Overall Study||20
2916235|NCT00515177|3626744|FG001|STARTED|Overall Study||10
2916236|NCT00515177|3626743|FG000|COMPLETED|Overall Study||18
2916237|NCT00515177|3626744|FG001|COMPLETED|Overall Study||9
2916238|NCT00515177|3626743|FG000|NOT COMPLETED|Overall Study||2
2916239|NCT00515177|3626744|FG001|NOT COMPLETED|Overall Study||1
2916240|NCT00515203|3626753|FG000|STARTED|Overall Study||17
2916241|NCT00515203|3626754|FG001|STARTED|Overall Study||5
2916242|NCT00515203|3626753|FG000|COMPLETED|Overall Study||17
2916243|NCT00515203|3626754|FG001|COMPLETED|Overall Study||5
2916244|NCT00515203|3626753|FG000|NOT COMPLETED|Overall Study||0
2916245|NCT00515203|3626754|FG001|NOT COMPLETED|Overall Study||0
2916246|NCT00515216|3626760|FG000|STARTED|Overall Study||26
2916247|NCT00515216|3626760|FG000|COMPLETED|Overall Study||25
2916248|NCT00515216|3626760|FG000|NOT COMPLETED|Overall Study||1
2916249|NCT00515294|3626769|FG000|STARTED|Overall Study||38
2916250|NCT00515294|3626770|FG001|STARTED|Overall Study||39
2916251|NCT00515294|3626771|FG002|STARTED|Overall Study||38
2916252|NCT00515294|3626772|FG003|STARTED|Overall Study||39
2916253|NCT00515294|3626769|FG000|COMPLETED|Overall Study||29
2916254|NCT00515294|3626770|FG001|COMPLETED|Overall Study||36
2916255|NCT00515294|3626771|FG002|COMPLETED|Overall Study||27
2916256|NCT00515294|3626772|FG003|COMPLETED|Overall Study||35
2916257|NCT00515294|3626769|FG000|NOT COMPLETED|Overall Study||9
2916258|NCT00515294|3626770|FG001|NOT COMPLETED|Overall Study||3
2916259|NCT00515294|3626771|FG002|NOT COMPLETED|Overall Study||11
2916260|NCT00515294|3626772|FG003|NOT COMPLETED|Overall Study||4
2916261|NCT00515411|3626785|FG000|STARTED|Overall Study||54
2916262|NCT00515411|3626786|FG001|STARTED|Overall Study||31
2916263|NCT00515411|3626787|FG002|STARTED|Overall Study||26
2916264|NCT00515411|3626785|FG000|COMPLETED|Overall Study||54
2916265|NCT00515411|3626786|FG001|COMPLETED|Overall Study||31
2916266|NCT00515411|3626787|FG002|COMPLETED|Overall Study||26
2916267|NCT00515411|3626785|FG000|NOT COMPLETED|Overall Study||0
2916268|NCT00515411|3626786|FG001|NOT COMPLETED|Overall Study||0
2916269|NCT00515411|3626787|FG002|NOT COMPLETED|Overall Study||0
2916270|NCT00515437|3626799|FG000|STARTED|Overall Study||14
2916271|NCT00515437|3626800|FG001|STARTED|Overall Study||12
2916272|NCT00515437|3626801|FG002|STARTED|Overall Study||13
2916273|NCT00515437|3626802|FG003|STARTED|Overall Study||15
2916274|NCT00515437|3626799|FG000|COMPLETED|Overall Study||14
2916275|NCT00515437|3626800|FG001|COMPLETED|Overall Study||12
2916276|NCT00515437|3626801|FG002|COMPLETED|Overall Study||13
2916277|NCT00515437|3626802|FG003|COMPLETED|Overall Study||14
2916278|NCT00515437|3626799|FG000|NOT COMPLETED|Overall Study||0
2916279|NCT00515437|3626800|FG001|NOT COMPLETED|Overall Study||0
2916280|NCT00515437|3626801|FG002|NOT COMPLETED|Overall Study||0
2916281|NCT00515437|3626802|FG003|NOT COMPLETED|Overall Study||1
2842508|NCT02392637|3544075|FG000|STARTED|Overall Study||32
2842509|NCT02392637|3544076|FG001|STARTED|Overall Study||28
2842510|NCT02392637|3544075|FG000|COMPLETED|Overall Study||32
2842511|NCT02392637|3544076|FG001|COMPLETED|Overall Study||28
2842512|NCT02392637|3544075|FG000|NOT COMPLETED|Overall Study||0
2842513|NCT02392637|3544076|FG001|NOT COMPLETED|Overall Study||0
2842514|NCT02253316|3544085|FG000|STARTED|Consolidation||236
2842515|NCT02253316|3544086|FG001|STARTED|Consolidation||0
2842516|NCT02253316|3544087|FG002|STARTED|Consolidation||0
2842517|NCT02253316|3544085|FG000|COMPLETED|Consolidation||220
2842518|NCT02253316|3544086|FG001|COMPLETED|Consolidation||0
2842519|NCT02253316|3544087|FG002|COMPLETED|Consolidation||0
2842520|NCT02253316|3544085|FG000|NOT COMPLETED|Consolidation||16
2842521|NCT02253316|3544086|FG001|NOT COMPLETED|Consolidation||0
2842522|NCT02253316|3544087|FG002|NOT COMPLETED|Consolidation||0
2842523|NCT02253316|3544085|FG000|STARTED|Maintenance||0
2842524|NCT02253316|3544086|FG001|STARTED|Maintenance||99
2842525|NCT02253316|3544087|FG002|STARTED|Maintenance||116
2842526|NCT02253316|3544085|FG000|COMPLETED|Maintenance||0
2842527|NCT02253316|3544086|FG001|COMPLETED|Maintenance||53
2842528|NCT02253316|3544087|FG002|COMPLETED|Maintenance||49
2842529|NCT02253316|3544085|FG000|NOT COMPLETED|Maintenance||0
2842530|NCT02253316|3544086|FG001|NOT COMPLETED|Maintenance||46
2842531|NCT02253316|3544087|FG002|NOT COMPLETED|Maintenance||67
2842532|NCT02224573|3544097|FG000|STARTED|Treatment Phase||315
2842533|NCT02224573|3544098|FG001|STARTED|Treatment Phase||366
2842534|NCT02224573|3544097|FG000|COMPLETED|Treatment Phase||170
2842535|NCT02224573|3544098|FG001|COMPLETED|Treatment Phase||243
2842536|NCT02224573|3544097|FG000|NOT COMPLETED|Treatment Phase||145
2842537|NCT02224573|3544098|FG001|NOT COMPLETED|Treatment Phase||123
2842538|NCT02224573|3544097|FG000|STARTED|Taper Phase|The number of participants to start the Taper Phase is not equal to the number who completed the Treatment Phase because not all participants tapered IMP.|79
2842539|NCT02224573|3544098|FG001|STARTED|Taper Phase|The number of participants to start the Taper Phase is not equal to the number who completed the Treatment Phase because not all participants tapered IMP.|71
2842540|NCT02224573|3544097|FG000|COMPLETED|Taper Phase||76
2842541|NCT02224573|3544098|FG001|COMPLETED|Taper Phase||67
2842542|NCT02224573|3544097|FG000|NOT COMPLETED|Taper Phase||3
2842543|NCT02224573|3544098|FG001|NOT COMPLETED|Taper Phase||4
2842544|NCT01991067|3544107|FG000|STARTED|Overall Study||19
2842545|NCT01991067|3544108|FG001|STARTED|Overall Study||15
2842546|NCT01991067|3544107|FG000|COMPLETED|Overall Study||13
2842547|NCT01991067|3544108|FG001|COMPLETED|Overall Study||10
2842548|NCT01991067|3544107|FG000|NOT COMPLETED|Overall Study||6
2842549|NCT01991067|3544108|FG001|NOT COMPLETED|Overall Study||5
2842550|NCT01966471|3544116|FG000|STARTED|Overall Study||918
2842551|NCT01966471|3544117|FG001|STARTED|Overall Study||928
2842552|NCT01966471|3544116|FG000|COMPLETED|Overall Study||815
2842553|NCT01966471|3544117|FG001|COMPLETED|Overall Study||815
2842554|NCT01966471|3544116|FG000|NOT COMPLETED|Overall Study||103
2842555|NCT01966471|3544117|FG001|NOT COMPLETED|Overall Study||113
2842556|NCT01928732|3544125|FG000|STARTED|Overall Study||455
2842557|NCT01928732|3544126|FG001|STARTED|Overall Study||461
2842558|NCT01928732|3544125|FG000|COMPLETED|Overall Study||326
2842559|NCT01928732|3544126|FG001|COMPLETED|Overall Study||334
2842560|NCT01928732|3544125|FG000|NOT COMPLETED|Overall Study||129
2842561|NCT01928732|3544126|FG001|NOT COMPLETED|Overall Study||127
2842562|NCT01925573|3544132|FG000|STARTED|Overall Study||7
2842563|NCT01925573|3544132|FG000|COMPLETED|Overall Study||0
3167623|NCT01912287|3894929|FG000|COMPLETED|Overall Study||60
3167624|NCT01912287|3894930|FG001|COMPLETED|Overall Study||67
3167625|NCT01912287|3894931|FG002|COMPLETED|Overall Study||28
2842564|NCT01925573|3544132|FG000|NOT COMPLETED|Overall Study||7
2842565|NCT01774721|3544138|FG000|STARTED|Overall Study||227
2842566|NCT01774721|3544139|FG001|STARTED|Overall Study||225
2842567|NCT01774721|3544138|FG000|Treated|Overall Study||227
2842568|NCT01774721|3544139|FG001|Treated|Overall Study||224
2842569|NCT01774721|3544138|FG000|COMPLETED|Overall Study||0
2842570|NCT01774721|3544139|FG001|COMPLETED|Overall Study||0
2842571|NCT01774721|3544138|FG000|NOT COMPLETED|Overall Study||227
2842572|NCT01774721|3544139|FG001|NOT COMPLETED|Overall Study||225
2842573|NCT01747447|3544149|FG000|STARTED|Overall Study||388
2842574|NCT01747447|3544150|FG001|STARTED|Overall Study||383
2842575|NCT01747447|3544149|FG000|COMPLETED|Overall Study||347
2842576|NCT01747447|3544150|FG001|COMPLETED|Overall Study||340
2842577|NCT01747447|3544149|FG000|NOT COMPLETED|Overall Study||41
2842578|NCT01747447|3544150|FG001|NOT COMPLETED|Overall Study||43
2842579|NCT01709331|3544156|FG000|STARTED|Overall Study||18
2842580|NCT01709331|3544156|FG000|COMPLETED|Overall Study||17
2842581|NCT01709331|3544156|FG000|NOT COMPLETED|Overall Study||1
2842582|NCT01689740|3544163|FG000|STARTED|Overall Study||2
2842583|NCT01689740|3544164|FG001|STARTED|Overall Study||3
2842584|NCT01689740|3544165|FG002|STARTED|Overall Study||5
2842585|NCT01689740|3544163|FG000|COMPLETED|Overall Study||2
2842586|NCT01689740|3544164|FG001|COMPLETED|Overall Study||3
2842587|NCT01689740|3544165|FG002|COMPLETED|Overall Study||5
2842588|NCT01689740|3544163|FG000|NOT COMPLETED|Overall Study||0
2842589|NCT01689740|3544164|FG001|NOT COMPLETED|Overall Study||0
2842590|NCT01689740|3544165|FG002|NOT COMPLETED|Overall Study||0
2842591|NCT01659151|3544175|FG000|STARTED|Overall Study||17
2842592|NCT01659151|3544175|FG000|COMPLETED|Overall Study||16
2842593|NCT01659151|3544175|FG000|NOT COMPLETED|Overall Study||1
2842594|NCT01656434|3544181|FG000|STARTED|Overall Study||2553
2842595|NCT01656434|3544182|FG001|STARTED|Overall Study||620
2842596|NCT01656434|3544181|FG000|Treated|Overall Study|One treated participant had incomplete data and was not included in the Safety Analyses.|2466
2842597|NCT01656434|3544182|FG001|Treated|Overall Study||604
2842598|NCT01656434|3544181|FG000|COMPLETED|Overall Study||152
2842599|NCT01656434|3544182|FG001|COMPLETED|Overall Study||40
2842600|NCT01656434|3544181|FG000|NOT COMPLETED|Overall Study||2401
2842601|NCT01656434|3544182|FG001|NOT COMPLETED|Overall Study||580
2842602|NCT01518517|3544191|FG000|STARTED|Overall Study||29
2842603|NCT01518517|3544192|FG001|STARTED|Overall Study||30
2842604|NCT01518517|3544193|FG002|STARTED|Overall Study||26
2842605|NCT01518517|3544191|FG000|COMPLETED|Overall Study||1
2842606|NCT01518517|3544192|FG001|COMPLETED|Overall Study||3
2842607|NCT01518517|3544193|FG002|COMPLETED|Overall Study||0
2842608|NCT01518517|3544191|FG000|NOT COMPLETED|Overall Study||28
2842609|NCT01518517|3544192|FG001|NOT COMPLETED|Overall Study||27
2842610|NCT01518517|3544193|FG002|NOT COMPLETED|Overall Study||26
2842611|NCT01496118|3544211|FG000|STARTED|Overall Study||4
2842612|NCT01496118|3544212|FG001|STARTED|Overall Study||3
2842613|NCT01496118|3544213|FG002|STARTED|Overall Study||3
2842614|NCT01496118|3544214|FG003|STARTED|Overall Study||3
2842615|NCT01496118|3544215|FG004|STARTED|Overall Study||3
2842616|NCT01496118|3544216|FG005|STARTED|Overall Study||3
2842617|NCT01496118|3544217|FG006|STARTED|Overall Study||31
2842618|NCT01496118|3544218|FG007|STARTED|Overall Study||30
2842619|NCT01496118|3544211|FG000|COMPLETED|Overall Study||0
2842620|NCT01496118|3544212|FG001|COMPLETED|Overall Study||0
2842621|NCT01496118|3544213|FG002|COMPLETED|Overall Study||0
2842622|NCT01496118|3544214|FG003|COMPLETED|Overall Study||0
2842623|NCT01496118|3544215|FG004|COMPLETED|Overall Study||0
2842624|NCT01496118|3544216|FG005|COMPLETED|Overall Study||0
2842625|NCT01496118|3544217|FG006|COMPLETED|Overall Study||0
2842626|NCT01496118|3544218|FG007|COMPLETED|Overall Study||0
2842627|NCT01496118|3544211|FG000|NOT COMPLETED|Overall Study||4
2842628|NCT01496118|3544212|FG001|NOT COMPLETED|Overall Study||3
2842629|NCT01496118|3544213|FG002|NOT COMPLETED|Overall Study||3
2842630|NCT01496118|3544214|FG003|NOT COMPLETED|Overall Study||3
2842631|NCT01496118|3544215|FG004|NOT COMPLETED|Overall Study||3
2842632|NCT01496118|3544216|FG005|NOT COMPLETED|Overall Study||3
2842633|NCT01496118|3544217|FG006|NOT COMPLETED|Overall Study||31
2842634|NCT01496118|3544218|FG007|NOT COMPLETED|Overall Study||30
2842635|NCT01350934|3544238|FG000|STARTED|Base Study||111
2842636|NCT01350934|3544239|FG001|STARTED|Base Study||108
2842637|NCT01350934|3544238|FG000|COMPLETED|Base Study||100
2842638|NCT01350934|3544239|FG001|COMPLETED|Base Study||105
2842639|NCT01350934|3544238|FG000|NOT COMPLETED|Base Study||11
2842640|NCT01350934|3544239|FG001|NOT COMPLETED|Base Study||3
2842641|NCT01350934|3544238|FG000|STARTED|Extension Study||100
2842642|NCT01350934|3544239|FG001|STARTED|Extension Study||105
2842643|NCT01350934|3544238|FG000|COMPLETED|Extension Study||95
2842644|NCT01350934|3544239|FG001|COMPLETED|Extension Study||101
2842645|NCT01350934|3544238|FG000|NOT COMPLETED|Extension Study||5
2842646|NCT01350934|3544239|FG001|NOT COMPLETED|Extension Study||4
2842647|NCT01286207|3544248|FG000|STARTED|Overall Study||751
2842648|NCT01286207|3544249|FG001|STARTED|Overall Study||857
2842649|NCT01286207|3544250|FG002|STARTED|Overall Study||351
2842650|NCT01286207|3544248|FG000|COMPLETED|Overall Study||453
2842651|NCT01286207|3544249|FG001|COMPLETED|Overall Study||609
2842652|NCT01286207|3544250|FG002|COMPLETED|Overall Study||261
2842653|NCT01286207|3544248|FG000|NOT COMPLETED|Overall Study||298
2842654|NCT01286207|3544249|FG001|NOT COMPLETED|Overall Study||248
2842655|NCT01286207|3544250|FG002|NOT COMPLETED|Overall Study||90
2842656|NCT01263769|3544258|FG000|STARTED|Overall Study||25
2842657|NCT01263769|3544258|FG000|COMPLETED|Overall Study||24
2842658|NCT01263769|3544258|FG000|NOT COMPLETED|Overall Study||1
2842659|NCT01227187|3544266|FG000|STARTED|Overall Study||1
2842660|NCT01227187|3544267|FG001|STARTED|Overall Study||3
2842661|NCT01227187|3544268|FG002|STARTED|Overall Study||3
2842662|NCT01227187|3544269|FG003|STARTED|Overall Study||5
2842663|NCT01227187|3544266|FG000|COMPLETED|Overall Study||1
2842664|NCT01227187|3544267|FG001|COMPLETED|Overall Study||3
2842665|NCT01227187|3544268|FG002|COMPLETED|Overall Study||3
2842666|NCT01227187|3544269|FG003|COMPLETED|Overall Study||4
2842667|NCT01227187|3544266|FG000|NOT COMPLETED|Overall Study||0
2842668|NCT01227187|3544267|FG001|NOT COMPLETED|Overall Study||0
2842669|NCT01227187|3544268|FG002|NOT COMPLETED|Overall Study||0
2842670|NCT01227187|3544269|FG003|NOT COMPLETED|Overall Study||1
2842671|NCT01222247|3544281|FG000|STARTED|Overall Study||1429
2842672|NCT01222247|3544282|FG001|STARTED|Overall Study||1402
2842673|NCT01222247|3544281|FG000|Received 2 Doses|Overall Study||860
2842674|NCT01222247|3544282|FG001|Received 2 Doses|Overall Study||826
2842675|NCT01222247|3544281|FG000|Received 1 Dose|Overall Study||568
2842676|NCT01222247|3544282|FG001|Received 1 Dose|Overall Study||571
2842677|NCT01222247|3544281|FG000|Did Not Receive Assigned Medication|Overall Study||1
2842678|NCT01222247|3544282|FG001|Did Not Receive Assigned Medication|Overall Study||5
2842679|NCT01222247|3544281|FG000|COMPLETED|Overall Study||1427
2842680|NCT01222247|3544282|FG001|COMPLETED|Overall Study||1400
2842681|NCT01222247|3544281|FG000|NOT COMPLETED|Overall Study||2
2842682|NCT01222247|3544282|FG001|NOT COMPLETED|Overall Study||2
2842683|NCT01211405|3544291|FG000|STARTED|Overall Study||7
2842684|NCT01211405|3544292|FG001|STARTED|Overall Study||7
2842685|NCT01211405|3544293|FG002|STARTED|Overall Study||12
2842686|NCT01211405|3544291|FG000|Completed Primary Endpoint|Overall Study||7
2842687|NCT01211405|3544292|FG001|Completed Primary Endpoint|Overall Study||7
2842688|NCT01211405|3544293|FG002|Completed Primary Endpoint|Overall Study||12
2842689|NCT01211405|3544291|FG000|Completed Three Open-Label Sessions, Secondary, and End of Stage 2 Assessment|Overall Study||6
2842690|NCT01211405|3544292|FG001|Completed Three Open-Label Sessions, Secondary, and End of Stage 2 Assessment|Overall Study||6
2842691|NCT01211405|3544293|FG002|Completed Three Open-Label Sessions, Secondary, and End of Stage 2 Assessment|Overall Study||12
2842692|NCT01211405|3544291|FG000|COMPLETED|Overall Study||6
2842693|NCT01211405|3544292|FG001|COMPLETED|Overall Study||7
2842694|NCT01211405|3544293|FG002|COMPLETED|Overall Study||11
2842695|NCT01211405|3544291|FG000|NOT COMPLETED|Overall Study||1
2842696|NCT01211405|3544292|FG001|NOT COMPLETED|Overall Study||0
2842697|NCT01211405|3544293|FG002|NOT COMPLETED|Overall Study||1
2842698|NCT01146418|3544303|FG000|STARTED|Base Study P06029 (NCT01144416)||694
2842699|NCT01146418|3544304|FG001|STARTED|Base Study P06029 (NCT01144416)||696
2842700|NCT01146418|3544305|FG002|STARTED|Base Study P06029 (NCT01144416)||0
2842701|NCT01146418|3544306|FG003|STARTED|Base Study P06029 (NCT01144416)||0
2842702|NCT01146418|3544303|FG000|COMPLETED|Base Study P06029 (NCT01144416)|Participants who underwent ET in base study|632
2842703|NCT01146418|3544304|FG001|COMPLETED|Base Study P06029 (NCT01144416)|Participants who underwent ET in base study|647
2842704|NCT01146418|3544305|FG002|COMPLETED|Base Study P06029 (NCT01144416)||0
2842705|NCT01146418|3544306|FG003|COMPLETED|Base Study P06029 (NCT01144416)||0
2842706|NCT01146418|3544303|FG000|NOT COMPLETED|Base Study P06029 (NCT01144416)||62
2842707|NCT01146418|3544304|FG001|NOT COMPLETED|Base Study P06029 (NCT01144416)||49
2842708|NCT01146418|3544305|FG002|NOT COMPLETED|Base Study P06029 (NCT01144416)||0
2842709|NCT01146418|3544306|FG003|NOT COMPLETED|Base Study P06029 (NCT01144416)||0
2842710|NCT01146418|3544303|FG000|STARTED|Women/Expectant Mother Follow Up|Participants from Base Study P06029 with at least one embryo thawed for use in FTET cycle.|157
2842711|NCT01146418|3544304|FG001|STARTED|Women/Expectant Mother Follow Up|Participants from base study P06029 with at least one embryo thawed for use in FTET cycle.|150
2842712|NCT01146418|3544305|FG002|STARTED|Women/Expectant Mother Follow Up||0
2842713|NCT01146418|3544306|FG003|STARTED|Women/Expectant Mother Follow Up||0
2842714|NCT01146418|3544303|FG000|Participants With Embryo Transfer (ET)|Women/Expectant Mother Follow Up||151
2842715|NCT01146418|3544304|FG001|Participants With Embryo Transfer (ET)|Women/Expectant Mother Follow Up||147
2842716|NCT01146418|3544305|FG002|Participants With Embryo Transfer (ET)|Women/Expectant Mother Follow Up||0
2842717|NCT01146418|3544306|FG003|Participants With Embryo Transfer (ET)|Women/Expectant Mother Follow Up||0
2842718|NCT01146418|3544303|FG000|Participants With an Ongoing Pregnancy|Women/Expectant Mother Follow Up|Ongoing pregnancy defined as intra-uterine pregnancy with fetal heart beat on USS 10 weeks after ET|52
2842719|NCT01146418|3544304|FG001|Participants With an Ongoing Pregnancy|Women/Expectant Mother Follow Up|Ongoing pregnancy defined as intra-uterine pregnancy with fetal heart beat on USS 10 weeks after ET|50
2842720|NCT01146418|3544305|FG002|Participants With an Ongoing Pregnancy|Women/Expectant Mother Follow Up||0
2842721|NCT01146418|3544306|FG003|Participants With an Ongoing Pregnancy|Women/Expectant Mother Follow Up||0
2842722|NCT01146418|3544303|FG000|COMPLETED|Women/Expectant Mother Follow Up|Participants with ET transfer who completed follow-up study|113
2842723|NCT01146418|3544304|FG001|COMPLETED|Women/Expectant Mother Follow Up|Participants with ET transfer who completed follow-up study|110
2842724|NCT01146418|3544305|FG002|COMPLETED|Women/Expectant Mother Follow Up||0
2842725|NCT01146418|3544306|FG003|COMPLETED|Women/Expectant Mother Follow Up||0
2842726|NCT01146418|3544303|FG000|NOT COMPLETED|Women/Expectant Mother Follow Up||44
2842727|NCT01146418|3544304|FG001|NOT COMPLETED|Women/Expectant Mother Follow Up||40
2842728|NCT01146418|3544305|FG002|NOT COMPLETED|Women/Expectant Mother Follow Up||0
2842729|NCT01146418|3544306|FG003|NOT COMPLETED|Women/Expectant Mother Follow Up||0
2842730|NCT01146418|3544303|FG000|STARTED|Live-Born Infant Follow Up||0
2842731|NCT01146418|3544304|FG001|STARTED|Live-Born Infant Follow Up||0
2842732|NCT01146418|3544305|FG002|STARTED|Live-Born Infant Follow Up||61
2842733|NCT01146418|3544306|FG003|STARTED|Live-Born Infant Follow Up||56
2842734|NCT01146418|3544303|FG000|COMPLETED|Live-Born Infant Follow Up||0
2842735|NCT01146418|3544304|FG001|COMPLETED|Live-Born Infant Follow Up||0
2842736|NCT01146418|3544305|FG002|COMPLETED|Live-Born Infant Follow Up|Infants who completed follow up|55
2842737|NCT01146418|3544306|FG003|COMPLETED|Live-Born Infant Follow Up|Infants who completed follow up|51
2842738|NCT01146418|3544303|FG000|NOT COMPLETED|Live-Born Infant Follow Up||0
2842739|NCT01146418|3544304|FG001|NOT COMPLETED|Live-Born Infant Follow Up||0
2842740|NCT01146418|3544305|FG002|NOT COMPLETED|Live-Born Infant Follow Up||6
2842741|NCT01146418|3544306|FG003|NOT COMPLETED|Live-Born Infant Follow Up||5
2842742|NCT01144416|3544318|FG000|STARTED|Intervention Period||694
2842743|NCT01144416|3544319|FG001|STARTED|Intervention Period||696
2842744|NCT01144416|3544318|FG000|COMPLETED|Intervention Period||632
2842745|NCT01144416|3544319|FG001|COMPLETED|Intervention Period||647
2842746|NCT01144416|3544318|FG000|NOT COMPLETED|Intervention Period||62
2842747|NCT01144416|3544319|FG001|NOT COMPLETED|Intervention Period||49
2842748|NCT01144416|3544318|FG000|STARTED|Pregnancy Follow-up Period|Participants received 150 ug SCH 900962 in Intervention Period and became pregnant.|154
2842749|NCT01144416|3544319|FG001|STARTED|Pregnancy Follow-up Period|Participants received daily injections of 300 IU recFSH in Intervention Period and became pregnant.|167
2842750|NCT01144416|3544318|FG000|COMPLETED|Pregnancy Follow-up Period||146
2842751|NCT01144416|3544319|FG001|COMPLETED|Pregnancy Follow-up Period||157
2842752|NCT01144416|3544318|FG000|NOT COMPLETED|Pregnancy Follow-up Period||8
2842753|NCT01144416|3544319|FG001|NOT COMPLETED|Pregnancy Follow-up Period||10
2842754|NCT01140048|3544329|FG000|STARTED|Overall Study||343
2842755|NCT01140048|3544329|FG000|COMPLETED|Overall Study||298
2842756|NCT01140048|3544329|FG000|NOT COMPLETED|Overall Study||45
2842757|NCT01077817|3544333|FG000|STARTED|Overall Study|STARTED and COMPLETED is the number of participants meeting incl./excl. criteria in the GPRD.|684815
2842758|NCT01077817|3544333|FG000|COMPLETED|Overall Study||684815
2842759|NCT01077817|3544333|FG000|NOT COMPLETED|Overall Study||0
2842760|NCT01065779|3544344|FG000|STARTED|Overall Study||880
2842761|NCT01065779|3544344|FG000|COMPLETED|Overall Study||798
2842762|NCT01065779|3544344|FG000|NOT COMPLETED|Overall Study||82
2916282|NCT00515463|3626814|FG000|STARTED|Overall Study||155
2916283|NCT00515463|3626815|FG001|STARTED|Overall Study||156
2916284|NCT00515463|3626814|FG000|Received Study Medication|Overall Study||154
2916285|NCT00515463|3626815|FG001|Received Study Medication|Overall Study||156
2916286|NCT00515463|3626814|FG000|COMPLETED|Overall Study||141
2916287|NCT00515463|3626815|FG001|COMPLETED|Overall Study||142
2916288|NCT00515463|3626814|FG000|NOT COMPLETED|Overall Study||14
2916289|NCT00515463|3626815|FG001|NOT COMPLETED|Overall Study||14
2916290|NCT00515502|3626822|FG000|STARTED|Treatment Period 1||1
2916291|NCT00515502|3626823|FG001|STARTED|Treatment Period 1||4
2916292|NCT00515502|3626824|FG002|STARTED|Treatment Period 1||4
2916293|NCT00515502|3626825|FG003|STARTED|Treatment Period 1||3
2916294|NCT00515502|3626826|FG004|STARTED|Treatment Period 1||3
2916295|NCT00515502|3626827|FG005|STARTED|Treatment Period 1||1
2916296|NCT00515502|3626828|FG006|STARTED|Treatment Period 1||2
2916297|NCT00515502|3626829|FG007|STARTED|Treatment Period 1||1
2916298|NCT00515502|3626830|FG008|STARTED|Treatment Period 1||1
2916299|NCT00515502|3626831|FG009|STARTED|Treatment Period 1||2
2916300|NCT00515502|3626832|FG010|STARTED|Treatment Period 1||1
2916301|NCT00515502|3626833|FG011|STARTED|Treatment Period 1||1
2916302|NCT00515502|3626822|FG000|COMPLETED|Treatment Period 1||1
2916303|NCT00515502|3626823|FG001|COMPLETED|Treatment Period 1||4
2916304|NCT00515502|3626824|FG002|COMPLETED|Treatment Period 1||4
2916305|NCT00515502|3626825|FG003|COMPLETED|Treatment Period 1||3
2916306|NCT00515502|3626826|FG004|COMPLETED|Treatment Period 1||3
2916307|NCT00515502|3626827|FG005|COMPLETED|Treatment Period 1||1
2916308|NCT00515502|3626828|FG006|COMPLETED|Treatment Period 1||1
2916309|NCT00515502|3626829|FG007|COMPLETED|Treatment Period 1||1
2916310|NCT00515502|3626830|FG008|COMPLETED|Treatment Period 1||0
2916311|NCT00515502|3626831|FG009|COMPLETED|Treatment Period 1||2
2916312|NCT00515502|3626832|FG010|COMPLETED|Treatment Period 1||1
2916313|NCT00515502|3626833|FG011|COMPLETED|Treatment Period 1||0
2916314|NCT00515502|3626822|FG000|NOT COMPLETED|Treatment Period 1||0
2916315|NCT00515502|3626823|FG001|NOT COMPLETED|Treatment Period 1||0
2916316|NCT00515502|3626824|FG002|NOT COMPLETED|Treatment Period 1||0
2916317|NCT00515502|3626825|FG003|NOT COMPLETED|Treatment Period 1||0
2916318|NCT00515502|3626826|FG004|NOT COMPLETED|Treatment Period 1||0
2916319|NCT00515502|3626827|FG005|NOT COMPLETED|Treatment Period 1||0
2916320|NCT00515502|3626828|FG006|NOT COMPLETED|Treatment Period 1||1
2916321|NCT00515502|3626829|FG007|NOT COMPLETED|Treatment Period 1||0
2916322|NCT00515502|3626830|FG008|NOT COMPLETED|Treatment Period 1||1
2916323|NCT00515502|3626831|FG009|NOT COMPLETED|Treatment Period 1||0
2916324|NCT00515502|3626832|FG010|NOT COMPLETED|Treatment Period 1||0
2916325|NCT00515502|3626833|FG011|NOT COMPLETED|Treatment Period 1||1
2916326|NCT00515502|3626822|FG000|STARTED|Washout Period 1||1
2916327|NCT00515502|3626823|FG001|STARTED|Washout Period 1||4
2916328|NCT00515502|3626824|FG002|STARTED|Washout Period 1||4
2916329|NCT00515502|3626825|FG003|STARTED|Washout Period 1||3
2916330|NCT00515502|3626826|FG004|STARTED|Washout Period 1||3
2916331|NCT00515502|3626827|FG005|STARTED|Washout Period 1||1
2916332|NCT00515502|3626828|FG006|STARTED|Washout Period 1||1
2916333|NCT00515502|3626829|FG007|STARTED|Washout Period 1||1
2916334|NCT00515502|3626830|FG008|STARTED|Washout Period 1||0
2916335|NCT00515502|3626831|FG009|STARTED|Washout Period 1||2
2916336|NCT00515502|3626832|FG010|STARTED|Washout Period 1||1
2916337|NCT00515502|3626833|FG011|STARTED|Washout Period 1||0
2916338|NCT00515502|3626822|FG000|COMPLETED|Washout Period 1||1
2916339|NCT00515502|3626823|FG001|COMPLETED|Washout Period 1||4
2916340|NCT00515502|3626824|FG002|COMPLETED|Washout Period 1||4
2916341|NCT00515502|3626825|FG003|COMPLETED|Washout Period 1||3
2916342|NCT00515502|3626826|FG004|COMPLETED|Washout Period 1||3
2916343|NCT00515502|3626827|FG005|COMPLETED|Washout Period 1||1
2916344|NCT00515502|3626828|FG006|COMPLETED|Washout Period 1||1
2916345|NCT00515502|3626829|FG007|COMPLETED|Washout Period 1||1
2916346|NCT00515502|3626830|FG008|COMPLETED|Washout Period 1||0
2916347|NCT00515502|3626831|FG009|COMPLETED|Washout Period 1||2
2916348|NCT00515502|3626832|FG010|COMPLETED|Washout Period 1||1
2916349|NCT00515502|3626833|FG011|COMPLETED|Washout Period 1||0
2916350|NCT00515502|3626822|FG000|NOT COMPLETED|Washout Period 1||0
2916351|NCT00515502|3626823|FG001|NOT COMPLETED|Washout Period 1||0
2916352|NCT00515502|3626824|FG002|NOT COMPLETED|Washout Period 1||0
2916353|NCT00515502|3626825|FG003|NOT COMPLETED|Washout Period 1||0
2916354|NCT00515502|3626826|FG004|NOT COMPLETED|Washout Period 1||0
2916355|NCT00515502|3626827|FG005|NOT COMPLETED|Washout Period 1||0
2916356|NCT00515502|3626828|FG006|NOT COMPLETED|Washout Period 1||0
2916357|NCT00515502|3626829|FG007|NOT COMPLETED|Washout Period 1||0
2916358|NCT00515502|3626830|FG008|NOT COMPLETED|Washout Period 1||0
2916359|NCT00515502|3626831|FG009|NOT COMPLETED|Washout Period 1||0
2916360|NCT00515502|3626832|FG010|NOT COMPLETED|Washout Period 1||0
2916361|NCT00515502|3626833|FG011|NOT COMPLETED|Washout Period 1||0
2916362|NCT00515502|3626822|FG000|STARTED|Treatment Period 2||1
2916363|NCT00515502|3626823|FG001|STARTED|Treatment Period 2||4
2842763|NCT00974571|3544351|FG000|STARTED|Overall Study||630
2842764|NCT00974571|3544352|FG001|STARTED|Overall Study||122
3167626|NCT01912287|3894929|FG000|NOT COMPLETED|Overall Study||33
3167627|NCT01912287|3894930|FG001|NOT COMPLETED|Overall Study||23
3167628|NCT01912287|3894931|FG002|NOT COMPLETED|Overall Study||15
2842765|NCT00974571|3544353|FG002|STARTED|Overall Study||613
2842766|NCT00974571|3544351|FG000|COMPLETED|Overall Study||562
2842767|NCT00974571|3544352|FG001|COMPLETED|Overall Study||106
2842768|NCT00974571|3544353|FG002|COMPLETED|Overall Study||530
2842769|NCT00974571|3544351|FG000|NOT COMPLETED|Overall Study||68
2842770|NCT00974571|3544352|FG001|NOT COMPLETED|Overall Study||16
2842771|NCT00974571|3544353|FG002|NOT COMPLETED|Overall Study||83
2842772|NCT00972738|3544364|FG000|STARTED|Overall Study||522
2842773|NCT00972738|3544365|FG001|STARTED|Overall Study||171
2842774|NCT00972738|3544366|FG002|STARTED|Overall Study||521
2842775|NCT00972738|3544364|FG000|COMPLETED|Overall Study||501
2842776|NCT00972738|3544365|FG001|COMPLETED|Overall Study||165
2842777|NCT00972738|3544366|FG002|COMPLETED|Overall Study||492
2842778|NCT00972738|3544364|FG000|NOT COMPLETED|Overall Study||21
2842779|NCT00972738|3544365|FG001|NOT COMPLETED|Overall Study||6
2842780|NCT00972738|3544366|FG002|NOT COMPLETED|Overall Study||29
2842781|NCT00968201|3544376|FG000|STARTED|Base Study - (Period II)|Includes patients who completed Period I (2-week placebo run-in) and were randomized to placebo.|228
2842782|NCT00968201|3544377|FG001|STARTED|Base Study - (Period II)||0
2842783|NCT00968201|3544378|FG002|STARTED|Base Study - (Period II)|Includes patients who completed Period I (2-week placebo run-in) and were randomized to montelukast.|461
2842784|NCT00968201|3544376|FG000|COMPLETED|Base Study - (Period II)|Patients completing Period II were eligible to enter the optional Period III|202
2842785|NCT00968201|3544377|FG001|COMPLETED|Base Study - (Period II)||0
2842786|NCT00968201|3544378|FG002|COMPLETED|Base Study - (Period II)|Patients completing Period II were eligible to enter the optional Period III|416
2842787|NCT00968201|3544376|FG000|NOT COMPLETED|Base Study - (Period II)||26
2842788|NCT00968201|3544377|FG001|NOT COMPLETED|Base Study - (Period II)||0
2842789|NCT00968201|3544378|FG002|NOT COMPLETED|Base Study - (Period II)||45
2842790|NCT00968201|3544376|FG000|STARTED|Extension Study - (Period III)||0
2842791|NCT00968201|3544377|FG001|STARTED|Extension Study - (Period III)|Eligible Patients who completed Period II and entered the optional Extension Study (Period III)|157
2842792|NCT00968201|3544378|FG002|STARTED|Extension Study - (Period III)|Eligible Patients who completed Period II and entered the optional Extension Study (Period III)|364
2842793|NCT00968201|3544376|FG000|COMPLETED|Extension Study - (Period III)||0
2842794|NCT00968201|3544377|FG001|COMPLETED|Extension Study - (Period III)||33
2842795|NCT00968201|3544378|FG002|COMPLETED|Extension Study - (Period III)||84
2842796|NCT00968201|3544376|FG000|NOT COMPLETED|Extension Study - (Period III)||0
2842797|NCT00968201|3544377|FG001|NOT COMPLETED|Extension Study - (Period III)||124
2842798|NCT00968201|3544378|FG002|NOT COMPLETED|Extension Study - (Period III)||280
2842799|NCT00968149|3544389|FG000|STARTED|Overall Study||280
2842800|NCT00968149|3544390|FG001|STARTED|Overall Study||133
2842801|NCT00968149|3544389|FG000|COMPLETED|Overall Study||269
2842802|NCT00968149|3544390|FG001|COMPLETED|Overall Study||127
2842803|NCT00968149|3544389|FG000|NOT COMPLETED|Overall Study||11
2842804|NCT00968149|3544390|FG001|NOT COMPLETED|Overall Study||6
2842805|NCT00963469|3544399|FG000|STARTED|Overall Study||451
2842806|NCT00963469|3544400|FG001|STARTED|Overall Study||448
2842807|NCT00963469|3544401|FG002|STARTED|Overall Study||180
2842808|NCT00963469|3544399|FG000|COMPLETED|Overall Study||410
2842809|NCT00963469|3544400|FG001|COMPLETED|Overall Study||420
2842810|NCT00963469|3544401|FG002|COMPLETED|Overall Study||170
2842811|NCT00963469|3544399|FG000|NOT COMPLETED|Overall Study||41
2842812|NCT00963469|3544400|FG001|NOT COMPLETED|Overall Study||28
2842813|NCT00963469|3544401|FG002|NOT COMPLETED|Overall Study||10
2842814|NCT00960141|3544412|FG000|STARTED|Overall Study||333
2842815|NCT00960141|3544413|FG001|STARTED|Overall Study||326
2842816|NCT00960141|3544414|FG002|STARTED|Overall Study||170
2842817|NCT00960141|3544412|FG000|COMPLETED|Overall Study||323
2842818|NCT00960141|3544413|FG001|COMPLETED|Overall Study||309
2842819|NCT00960141|3544414|FG002|COMPLETED|Overall Study||163
2842820|NCT00960141|3544412|FG000|NOT COMPLETED|Overall Study||10
2842821|NCT00960141|3544413|FG001|NOT COMPLETED|Overall Study||17
2842822|NCT00960141|3544414|FG002|NOT COMPLETED|Overall Study||7
2842823|NCT00943683|3544424|FG000|STARTED|Overall Study||81
2842824|NCT00943683|3544425|FG001|STARTED|Overall Study||175
2842825|NCT00943683|3544424|FG000|COMPLETED|Overall Study||74
2842826|NCT00943683|3544425|FG001|COMPLETED|Overall Study||169
2842827|NCT00943683|3544424|FG000|NOT COMPLETED|Overall Study||7
2842828|NCT00943683|3544425|FG001|NOT COMPLETED|Overall Study||6
2842829|NCT00943397|3544433|FG000|STARTED|Overall Study||32
2842830|NCT00943397|3544434|FG001|STARTED|Overall Study||158
2842831|NCT00943397|3544433|FG000|COMPLETED|Overall Study|Site terminated - Merck administrative decision (11); Discontinued for other (1)|17
2842832|NCT00943397|3544434|FG001|COMPLETED|Overall Study|Site terminated - Merck administrative decision (52); Patient moved (1); Discontinued for other (3)|86
2842833|NCT00943397|3544433|FG000|NOT COMPLETED|Overall Study||15
2842834|NCT00943397|3544434|FG001|NOT COMPLETED|Overall Study||72
2842835|NCT00937937|3544440|FG000|STARTED|Overall Study||72
2842836|NCT00937937|3544440|FG000|COMPLETED|Overall Study||0
2842837|NCT00937937|3544440|FG000|NOT COMPLETED|Overall Study||72
2842838|NCT00911547|3544449|FG000|STARTED|Overall Study|Efficacy in last 10 wks to minimize confounding effect of beclo in 1st 4 wks & allow beclo washout.|48
3167629|NCT01912339|3894941|FG000|STARTED|Blinded (0 to 3 Months)||136
3167630|NCT01912339|3894942|FG001|STARTED|Blinded (0 to 3 Months)||61
2842839|NCT00911547|3544450|FG001|STARTED|Overall Study|Efficacy in last 10 wks to minimize confounding effect of beclo in 1st 4 wks & allow beclo washout.|201
2842840|NCT00911547|3544451|FG002|STARTED|Overall Study|Efficacy analyses were over the 16 weeks of treatment.|200
2842841|NCT00911547|3544452|FG003|STARTED|Overall Study|Efficacy analyses were over the 16 weeks of treatment.|193
2842842|NCT00911547|3544449|FG000|COMPLETED|Overall Study||37
2842843|NCT00911547|3544450|FG001|COMPLETED|Overall Study||159
2842844|NCT00911547|3544451|FG002|COMPLETED|Overall Study||178
2842845|NCT00911547|3544452|FG003|COMPLETED|Overall Study||177
2842846|NCT00911547|3544449|FG000|NOT COMPLETED|Overall Study||11
2842847|NCT00911547|3544450|FG001|NOT COMPLETED|Overall Study||42
2842848|NCT00911547|3544451|FG002|NOT COMPLETED|Overall Study||22
2842849|NCT00911547|3544452|FG003|NOT COMPLETED|Overall Study||16
2842850|NCT00899379|3544467|FG000|STARTED|Overall Study|Patients who were allocated study drug|95
2842851|NCT00899379|3544468|FG001|STARTED|Overall Study|Patients who were allocated study drug|95
2842852|NCT00899379|3544469|FG002|STARTED|Overall Study|Patients who were allocated study drug|95
2842853|NCT00899379|3544470|FG003|STARTED|Overall Study|Patients who were allocated study drug|94
3167631|NCT01912339|3894943|FG002|STARTED|Blinded (0 to 3 Months)||0
3167632|NCT01912339|3894941|FG000|COMPLETED|Blinded (0 to 3 Months)||134
3167633|NCT01912339|3894942|FG001|COMPLETED|Blinded (0 to 3 Months)||61
3167634|NCT01912339|3894943|FG002|COMPLETED|Blinded (0 to 3 Months)||0
3167635|NCT01912339|3894941|FG000|NOT COMPLETED|Blinded (0 to 3 Months)||2
2842854|NCT00899379|3544471|FG004|STARTED|Overall Study|Patients who were allocated study drug|94
2842855|NCT00899379|3544467|FG000|Patients Treated|Overall Study|Patients who took study drug|83
2842856|NCT00899379|3544468|FG001|Patients Treated|Overall Study|Patients who took study drug|82
2842857|NCT00899379|3544469|FG002|Patients Treated|Overall Study|Patients who took study drug|84
2842858|NCT00899379|3544470|FG003|Patients Treated|Overall Study|Patients who took study drug|77
2842859|NCT00899379|3544471|FG004|Patients Treated|Overall Study|Patients who took study drug|81
2842860|NCT00899379|3544467|FG000|Patients Not Treated|Overall Study|Patients who did not take study drug|12
2842861|NCT00899379|3544468|FG001|Patients Not Treated|Overall Study|Patients who did not take study drug|13
2842862|NCT00899379|3544469|FG002|Patients Not Treated|Overall Study|Patients who did not take study drug|11
2842863|NCT00899379|3544470|FG003|Patients Not Treated|Overall Study|Patients who did not take study drug|17
2842864|NCT00899379|3544471|FG004|Patients Not Treated|Overall Study|Patients who did not take study drug|13
2842865|NCT00899379|3544467|FG000|COMPLETED|Overall Study|Patients who took study drug and completed the study|61
2842866|NCT00899379|3544468|FG001|COMPLETED|Overall Study|Patients who took study drug and completed the study|66
2842867|NCT00899379|3544469|FG002|COMPLETED|Overall Study|Patients who took study drug and completed the study|66
2842868|NCT00899379|3544470|FG003|COMPLETED|Overall Study|Patients who took study drug and completed the study|57
2842869|NCT00899379|3544471|FG004|COMPLETED|Overall Study|Patients who took study drug and completed the study|63
2842870|NCT00899379|3544467|FG000|NOT COMPLETED|Overall Study||34
2842871|NCT00899379|3544468|FG001|NOT COMPLETED|Overall Study||29
2842872|NCT00899379|3544469|FG002|NOT COMPLETED|Overall Study||29
2842873|NCT00899379|3544470|FG003|NOT COMPLETED|Overall Study||37
2842874|NCT00899379|3544471|FG004|NOT COMPLETED|Overall Study||31
2842875|NCT00898677|3544481|FG000|STARTED|Overall Study||180
2842876|NCT00898677|3544482|FG001|STARTED|Overall Study||455
2842877|NCT00898677|3544483|FG002|STARTED|Overall Study||455
2842878|NCT00898677|3544484|FG003|STARTED|Overall Study||178
2842879|NCT00898677|3544481|FG000|Patients Treated|Overall Study|Patients Not Treated: 16|164
2842880|NCT00898677|3544482|FG001|Patients Treated|Overall Study|Patients Not Treated: 68|387
2842881|NCT00898677|3544483|FG002|Patients Treated|Overall Study|Patients Not Treated: 67|388
2842882|NCT00898677|3544484|FG003|Patients Treated|Overall Study|Patients Not Treated: 18|160
2842883|NCT00898677|3544481|FG000|COMPLETED|Overall Study||163
2842884|NCT00898677|3544482|FG001|COMPLETED|Overall Study||386
2842885|NCT00898677|3544483|FG002|COMPLETED|Overall Study||383
2842886|NCT00898677|3544484|FG003|COMPLETED|Overall Study||159
2842887|NCT00898677|3544481|FG000|NOT COMPLETED|Overall Study||17
2842888|NCT00898677|3544482|FG001|NOT COMPLETED|Overall Study||69
2842889|NCT00898677|3544483|FG002|NOT COMPLETED|Overall Study||72
2842890|NCT00898677|3544484|FG003|NOT COMPLETED|Overall Study||19
2842891|NCT00897949|3544497|FG000|STARTED|Overall Study|Patients who were allocated study drug|554
2842892|NCT00897949|3544498|FG001|STARTED|Overall Study|Patients who were allocated study drug|549
2842893|NCT00897949|3544499|FG002|STARTED|Overall Study|Patients who were allocated study drug|370
2842894|NCT00897949|3544497|FG000|Patients Treated|Overall Study|Patients who took study drug|458
2842895|NCT00897949|3544498|FG001|Patients Treated|Overall Study|Patients who took study drug|456
2842896|NCT00897949|3544499|FG002|Patients Treated|Overall Study|Patients who took study drug|304
2842897|NCT00897949|3544497|FG000|COMPLETED|Overall Study|Patients who took study drug and completed the study|450
2842898|NCT00897949|3544498|FG001|COMPLETED|Overall Study|Patients who took study drug and completed the study|446
2842899|NCT00897949|3544499|FG002|COMPLETED|Overall Study|Patients who took study drug and completed the study|301
2842900|NCT00897949|3544497|FG000|NOT COMPLETED|Overall Study||104
2842901|NCT00897949|3544498|FG001|NOT COMPLETED|Overall Study||103
2842902|NCT00897949|3544499|FG002|NOT COMPLETED|Overall Study||69
2916364|NCT00515502|3626824|FG002|STARTED|Treatment Period 2||4
3167636|NCT01912339|3894942|FG001|NOT COMPLETED|Blinded (0 to 3 Months)||0
3167637|NCT01912339|3894943|FG002|NOT COMPLETED|Blinded (0 to 3 Months)||0
3167638|NCT01912339|3894941|FG000|STARTED|Unblinded (3 to 6 Months/Crossover)||134
2842903|NCT00897104|3544516|FG000|STARTED|Overall Study|Participants who were allocated study drug|418
2842904|NCT00897104|3544517|FG001|STARTED|Overall Study|Participants who were allocated study drug|428
2842905|NCT00897104|3544518|FG002|STARTED|Overall Study|Participants who were allocated study drug|87
2842906|NCT00897104|3544516|FG000|Participants Treated|Overall Study|Participants who took study drug|355
2842907|NCT00897104|3544517|FG001|Participants Treated|Overall Study|Participants who took study drug|357
2842908|NCT00897104|3544518|FG002|Participants Treated|Overall Study|Participants who took study drug|80
2842909|NCT00897104|3544516|FG000|Participants Not Treated|Overall Study|Participants who did not take study drug|63
2842910|NCT00897104|3544517|FG001|Participants Not Treated|Overall Study|Participants who did not take study drug|71
2842911|NCT00897104|3544518|FG002|Participants Not Treated|Overall Study|Participants who did not take study drug|7
2842912|NCT00897104|3544516|FG000|COMPLETED|Overall Study|Participants who took study drug and completed the study|354
2842913|NCT00897104|3544517|FG001|COMPLETED|Overall Study|Participants who took study drug and completed the study|357
2842914|NCT00897104|3544518|FG002|COMPLETED|Overall Study|Participants who took study drug and completed the study|79
2842915|NCT00897104|3544516|FG000|NOT COMPLETED|Overall Study||64
2842916|NCT00897104|3544517|FG001|NOT COMPLETED|Overall Study||71
2842917|NCT00897104|3544518|FG002|NOT COMPLETED|Overall Study||8
2842918|NCT00803790|3544528|FG000|STARTED|Period 1||125
2842919|NCT00803790|3544529|FG001|STARTED|Period 1||126
2842920|NCT00803790|3544530|FG002|STARTED|Period 1||32
2842921|NCT00803790|3544531|FG003|STARTED|Period 1||35
2842922|NCT00803790|3544528|FG000|COMPLETED|Period 1||116
2842923|NCT00803790|3544529|FG001|COMPLETED|Period 1||114
2842924|NCT00803790|3544530|FG002|COMPLETED|Period 1||31
2842925|NCT00803790|3544531|FG003|COMPLETED|Period 1||31
2842926|NCT00803790|3544528|FG000|NOT COMPLETED|Period 1||9
2842927|NCT00803790|3544529|FG001|NOT COMPLETED|Period 1||12
2842928|NCT00803790|3544530|FG002|NOT COMPLETED|Period 1||1
2842929|NCT00803790|3544531|FG003|NOT COMPLETED|Period 1||4
2842930|NCT00803790|3544528|FG000|STARTED|Period 2||116
2842931|NCT00803790|3544529|FG001|STARTED|Period 2||114
2842932|NCT00803790|3544530|FG002|STARTED|Period 2||31
2842933|NCT00803790|3544531|FG003|STARTED|Period 2||31
2842934|NCT00803790|3544528|FG000|COMPLETED|Period 2||114
2842935|NCT00803790|3544529|FG001|COMPLETED|Period 2||114
2842936|NCT00803790|3544530|FG002|COMPLETED|Period 2||30
2842937|NCT00803790|3544531|FG003|COMPLETED|Period 2||30
2842938|NCT00803790|3544528|FG000|NOT COMPLETED|Period 2||2
2842939|NCT00803790|3544529|FG001|NOT COMPLETED|Period 2||0
2842940|NCT00803790|3544530|FG002|NOT COMPLETED|Period 2||1
2842941|NCT00803790|3544531|FG003|NOT COMPLETED|Period 2||1
2842942|NCT00725491|3544544|FG000|STARTED|Overall Study|Intent-to-Treat Group|113
2842943|NCT00725491|3544545|FG001|STARTED|Overall Study|Intent-to-Treat Group|120
2842944|NCT00725491|3544544|FG000|COMPLETED|Overall Study||104
2842945|NCT00725491|3544545|FG001|COMPLETED|Overall Study||102
2842946|NCT00725491|3544544|FG000|NOT COMPLETED|Overall Study||9
2842947|NCT00725491|3544545|FG001|NOT COMPLETED|Overall Study||18
2842948|NCT00703014|3544553|FG000|STARTED|Mothers Base Trial P05787 (NCT00696800)|Randomized in Base Trial P05787 (NCT00696800)|757
2842949|NCT00703014|3544554|FG001|STARTED|Mothers Base Trial P05787 (NCT00696800)|Randomized in Base Trial P05787 (NCT00696800)|752
2842950|NCT00703014|3544555|FG002|STARTED|Mothers Base Trial P05787 (NCT00696800)||0
2842951|NCT00703014|3544556|FG003|STARTED|Mothers Base Trial P05787 (NCT00696800)||0
2842952|NCT00703014|3544553|FG000|Treated|Mothers Base Trial P05787 (NCT00696800)|Intent-To-Treat (ITT) group in Base Trial P05787 (NCT00696800)|756
2842953|NCT00703014|3544554|FG001|Treated|Mothers Base Trial P05787 (NCT00696800)|ITT group in Base Trial P05787 (NCT006968000)|750
2842954|NCT00703014|3544555|FG002|Treated|Mothers Base Trial P05787 (NCT00696800)||0
2842955|NCT00703014|3544556|FG003|Treated|Mothers Base Trial P05787 (NCT00696800)||0
2842956|NCT00703014|3544553|FG000|Embryo Transfer|Mothers Base Trial P05787 (NCT00696800)|Embryo transfer (ET) in Base Trial P05787 (NCT006968000)|672
2842957|NCT00703014|3544554|FG001|Embryo Transfer|Mothers Base Trial P05787 (NCT00696800)|Embryo transfer (ET) in Base Trial P05787 (NCT006968000)|704
2842958|NCT00703014|3544555|FG002|Embryo Transfer|Mothers Base Trial P05787 (NCT00696800)||0
2842959|NCT00703014|3544556|FG003|Embryo Transfer|Mothers Base Trial P05787 (NCT00696800)||0
2842960|NCT00703014|3544553|FG000|COMPLETED|Mothers Base Trial P05787 (NCT00696800)|ITT group in P05712, ongoing pregnancy at 10 weeks after ET in Base Trial P05787 (NCT006968000)|295
2842961|NCT00703014|3544554|FG001|COMPLETED|Mothers Base Trial P05787 (NCT00696800)|ITT group in P05712, ongoing pregnancy at 10 weeks after ET in Base Trial P05787 (NCT006968000)|286
2842962|NCT00703014|3544555|FG002|COMPLETED|Mothers Base Trial P05787 (NCT00696800)||0
2842963|NCT00703014|3544556|FG003|COMPLETED|Mothers Base Trial P05787 (NCT00696800)||0
2842964|NCT00703014|3544553|FG000|NOT COMPLETED|Mothers Base Trial P05787 (NCT00696800)||462
2842965|NCT00703014|3544554|FG001|NOT COMPLETED|Mothers Base Trial P05787 (NCT00696800)||466
2842966|NCT00703014|3544555|FG002|NOT COMPLETED|Mothers Base Trial P05787 (NCT00696800)||0
2842967|NCT00703014|3544556|FG003|NOT COMPLETED|Mothers Base Trial P05787 (NCT00696800)||0
2842968|NCT00703014|3544553|FG000|STARTED|Mothers Follow Up Trial P05712|Eligible participants who completed Base Trial P05787 and then enrolled in Follow Up Trial P05712|274
2842969|NCT00703014|3544554|FG001|STARTED|Mothers Follow Up Trial P05712|Eligible participants who completed Base Trial P05787 and then enrolled in Follow Up Trial P05712|267
2842970|NCT00703014|3544555|FG002|STARTED|Mothers Follow Up Trial P05712||0
2842971|NCT00703014|3544556|FG003|STARTED|Mothers Follow Up Trial P05712||0
2842972|NCT00703014|3544553|FG000|COMPLETED|Mothers Follow Up Trial P05712|Completed Follow Up in Trial P05712|241
2842973|NCT00703014|3544554|FG001|COMPLETED|Mothers Follow Up Trial P05712|Completed Follow Up in Trial P05712|235
2842974|NCT00703014|3544555|FG002|COMPLETED|Mothers Follow Up Trial P05712||0
2842975|NCT00703014|3544556|FG003|COMPLETED|Mothers Follow Up Trial P05712||0
2842976|NCT00703014|3544553|FG000|NOT COMPLETED|Mothers Follow Up Trial P05712||33
2842977|NCT00703014|3544554|FG001|NOT COMPLETED|Mothers Follow Up Trial P05712||32
2842978|NCT00703014|3544555|FG002|NOT COMPLETED|Mothers Follow Up Trial P05712||0
2842979|NCT00703014|3544556|FG003|NOT COMPLETED|Mothers Follow Up Trial P05712||0
2842980|NCT00703014|3544553|FG000|STARTED|Fetuses/Infants Follow Up Trial P05712||0
2842981|NCT00703014|3544554|FG001|STARTED|Fetuses/Infants Follow Up Trial P05712||0
2842982|NCT00703014|3544555|FG002|STARTED|Fetuses/Infants Follow Up Trial P05712|Fetuses in Follow Up Trial P05712|352
2842983|NCT00703014|3544556|FG003|STARTED|Fetuses/Infants Follow Up Trial P05712|Fetuses in Follow Up Trial P05712|326
2842984|NCT00703014|3544553|FG000|Live Born Infants|Fetuses/Infants Follow Up Trial P05712||0
2842985|NCT00703014|3544554|FG001|Live Born Infants|Fetuses/Infants Follow Up Trial P05712||0
2842986|NCT00703014|3544555|FG002|Live Born Infants|Fetuses/Infants Follow Up Trial P05712|Live born infants in Follow Up Trail P05712|344
2842987|NCT00703014|3544556|FG003|Live Born Infants|Fetuses/Infants Follow Up Trial P05712|Live born infants in Follow Up Trail P05712|315
2842988|NCT00703014|3544553|FG000|COMPLETED|Fetuses/Infants Follow Up Trial P05712||0
2842989|NCT00703014|3544554|FG001|COMPLETED|Fetuses/Infants Follow Up Trial P05712||0
2842990|NCT00703014|3544555|FG002|COMPLETED|Fetuses/Infants Follow Up Trial P05712|Infants in P05712 with Follow Up Completed|305
2842991|NCT00703014|3544556|FG003|COMPLETED|Fetuses/Infants Follow Up Trial P05712|Infants in P05712 with Follow Up Completed|284
3167639|NCT01912339|3894942|FG001|STARTED|Unblinded (3 to 6 Months/Crossover)||61
3167640|NCT01912339|3894943|FG002|STARTED|Unblinded (3 to 6 Months/Crossover)||0
2842992|NCT00703014|3544553|FG000|NOT COMPLETED|Fetuses/Infants Follow Up Trial P05712||0
2842993|NCT00703014|3544554|FG001|NOT COMPLETED|Fetuses/Infants Follow Up Trial P05712||0
2842994|NCT00703014|3544555|FG002|NOT COMPLETED|Fetuses/Infants Follow Up Trial P05712||47
2842995|NCT00703014|3544556|FG003|NOT COMPLETED|Fetuses/Infants Follow Up Trial P05712||42
2842996|NCT00702845|3544568|FG000|STARTED|Overall Study||268
2842997|NCT00702845|3544569|FG001|STARTED|Overall Study|Includes one treated participant who was not randomized|129
2842998|NCT00702845|3544568|FG000|Randomized|Overall Study||268
2842999|NCT00702845|3544569|FG001|Randomized|Overall Study||128
2843000|NCT00702845|3544568|FG000|COMPLETED|Overall Study||246
2843001|NCT00702845|3544569|FG001|COMPLETED|Overall Study||121
2843002|NCT00702845|3544568|FG000|NOT COMPLETED|Overall Study||22
2843003|NCT00702845|3544569|FG001|NOT COMPLETED|Overall Study||8
2843004|NCT00702624|3544577|FG000|STARTED|Base Study P05690 (NCT00702845)||268
2843005|NCT00702624|3544578|FG001|STARTED|Base Study P05690 (NCT00702845)||128
2843006|NCT00702624|3544579|FG002|STARTED|Base Study P05690 (NCT00702845)||0
2843007|NCT00702624|3544580|FG003|STARTED|Base Study P05690 (NCT00702845)||0
2843008|NCT00702624|3544577|FG000|COMPLETED|Base Study P05690 (NCT00702845)|To complete study, participants from the base study P05690 (NCT00702845) had embryos transferred.|246
2843009|NCT00702624|3544578|FG001|COMPLETED|Base Study P05690 (NCT00702845)|To complete study, participants from the base study P05690 (NCT00702845) had embryos transferred.|121
3384499|NCT02180217|4119612|FG000|STARTED|Overall Study||36
3384500|NCT02180217|4119613|FG001|STARTED|Overall Study||35
3384501|NCT02180217|4119614|FG002|STARTED|Overall Study||66
3384502|NCT02180217|4119612|FG000|Discontinued at/Prior to Week 12 (W12)|Overall Study||0
2843010|NCT00702624|3544579|FG002|COMPLETED|Base Study P05690 (NCT00702845)||0
2843011|NCT00702624|3544580|FG003|COMPLETED|Base Study P05690 (NCT00702845)||0
2843012|NCT00702624|3544577|FG000|NOT COMPLETED|Base Study P05690 (NCT00702845)||22
2843013|NCT00702624|3544578|FG001|NOT COMPLETED|Base Study P05690 (NCT00702845)||7
2843014|NCT00702624|3544579|FG002|NOT COMPLETED|Base Study P05690 (NCT00702845)||0
2843015|NCT00702624|3544580|FG003|NOT COMPLETED|Base Study P05690 (NCT00702845)||0
2843016|NCT00702624|3544577|FG000|STARTED|Expectant Mother Follow-up||68
2843017|NCT00702624|3544578|FG001|STARTED|Expectant Mother Follow-up||45
2843018|NCT00702624|3544579|FG002|STARTED|Expectant Mother Follow-up||0
2843019|NCT00702624|3544580|FG003|STARTED|Expectant Mother Follow-up||0
2843020|NCT00702624|3544577|FG000|COMPLETED|Expectant Mother Follow-up|To complete the study, participants must have completed a follow-up visit at 4-12 weeks postpartum.|61
2843021|NCT00702624|3544578|FG001|COMPLETED|Expectant Mother Follow-up|To complete the study, participants must have completed a follow-up visit at 4-12 weeks postpartum.|45
2843022|NCT00702624|3544579|FG002|COMPLETED|Expectant Mother Follow-up||0
2843023|NCT00702624|3544580|FG003|COMPLETED|Expectant Mother Follow-up||0
2843024|NCT00702624|3544577|FG000|NOT COMPLETED|Expectant Mother Follow-up||7
2843025|NCT00702624|3544578|FG001|NOT COMPLETED|Expectant Mother Follow-up||0
2843026|NCT00702624|3544579|FG002|NOT COMPLETED|Expectant Mother Follow-up||0
2843027|NCT00702624|3544580|FG003|NOT COMPLETED|Expectant Mother Follow-up||0
2843028|NCT00702624|3544577|FG000|STARTED|Fetuses/Infant Follow-up||0
2843029|NCT00702624|3544578|FG001|STARTED|Fetuses/Infant Follow-up||0
2843030|NCT00702624|3544579|FG002|STARTED|Fetuses/Infant Follow-up||88
2843031|NCT00702624|3544580|FG003|STARTED|Fetuses/Infant Follow-up||55
2843032|NCT00702624|3544577|FG000|Live Born Infants|Fetuses/Infant Follow-up||0
2843033|NCT00702624|3544578|FG001|Live Born Infants|Fetuses/Infant Follow-up||0
2843034|NCT00702624|3544579|FG002|Live Born Infants|Fetuses/Infant Follow-up|Infants born to eligible mothers were followed for safety and efficacy|80
2843035|NCT00702624|3544580|FG003|Live Born Infants|Fetuses/Infant Follow-up|Infants born to eligible mothers were followed for safety and efficacy.|55
2843036|NCT00702624|3544577|FG000|COMPLETED|Fetuses/Infant Follow-up||0
2843037|NCT00702624|3544578|FG001|COMPLETED|Fetuses/Infant Follow-up||0
2843038|NCT00702624|3544579|FG002|COMPLETED|Fetuses/Infant Follow-up|To complete the study, infants must have completed a follow-up visit at 4-12 weeks postpartum.|78
2843039|NCT00702624|3544580|FG003|COMPLETED|Fetuses/Infant Follow-up|To complete the study, infants must have completed a follow-up visit at 4-12 weeks postpartum.|55
2843040|NCT00702624|3544577|FG000|NOT COMPLETED|Fetuses/Infant Follow-up||0
2843041|NCT00702624|3544578|FG001|NOT COMPLETED|Fetuses/Infant Follow-up||0
2843042|NCT00702624|3544579|FG002|NOT COMPLETED|Fetuses/Infant Follow-up||10
2843043|NCT00702624|3544580|FG003|NOT COMPLETED|Fetuses/Infant Follow-up||0
2843044|NCT00702546|3544595|FG000|STARTED|Base Study P05690 (NCT00702845)||268
2843045|NCT00702546|3544596|FG001|STARTED|Base Study P05690 (NCT00702845)||128
2843046|NCT00702546|3544595|FG000|COMPLETED|Base Study P05690 (NCT00702845)|To complete study, participants from the base study P05690 (NCT00702845) had embryos transferred.|246
2843047|NCT00702546|3544596|FG001|COMPLETED|Base Study P05690 (NCT00702845)|To complete study, participants from the base study P05690 (NCT00702845) had embryos transferred.|121
2843048|NCT00702546|3544595|FG000|NOT COMPLETED|Base Study P05690 (NCT00702845)||22
2843049|NCT00702546|3544596|FG001|NOT COMPLETED|Base Study P05690 (NCT00702845)||7
2843050|NCT00702546|3544595|FG000|STARTED|Follow Up Study P05711 (NCT00702546)|Participants from base study P05690 with at least one embryo thawed for use in FTET cycle.|77
2843051|NCT00702546|3544596|FG001|STARTED|Follow Up Study P05711 (NCT00702546)|Participants from base study P05690 with at least one embryo thawed for use in FTET cycle.|25
2843052|NCT00702546|3544595|FG000|COMPLETED|Follow Up Study P05711 (NCT00702546)|Participants with embryo transfer in any FTET cycle|72
2843053|NCT00702546|3544596|FG001|COMPLETED|Follow Up Study P05711 (NCT00702546)|Participants with embryo transfer in any FTET cycle|24
2843054|NCT00702546|3544595|FG000|NOT COMPLETED|Follow Up Study P05711 (NCT00702546)||5
2843055|NCT00702546|3544596|FG001|NOT COMPLETED|Follow Up Study P05711 (NCT00702546)||1
2843056|NCT00702520|3544604|FG000|STARTED|Base Study P05788 - Assigned Treatment||25
2843057|NCT00702520|3544605|FG001|STARTED|Base Study P05788 - Assigned Treatment||25
2843058|NCT00702520|3544606|FG002|STARTED|Base Study P05788 - Assigned Treatment||0
2843059|NCT00702520|3544607|FG003|STARTED|Base Study P05788 - Assigned Treatment||0
2843060|NCT00702520|3544604|FG000|Treated With Corifollitropin Alpha|Base Study P05788 - Assigned Treatment||25
2843061|NCT00702520|3544605|FG001|Treated With Corifollitropin Alpha|Base Study P05788 - Assigned Treatment||24
2843062|NCT00702520|3544606|FG002|Treated With Corifollitropin Alpha|Base Study P05788 - Assigned Treatment||0
2843063|NCT00702520|3544607|FG003|Treated With Corifollitropin Alpha|Base Study P05788 - Assigned Treatment||0
2843064|NCT00702520|3544604|FG000|Treated With hCG and Had Oocyte Pick-up|Base Study P05788 - Assigned Treatment||25
2843065|NCT00702520|3544605|FG001|Treated With hCG and Had Oocyte Pick-up|Base Study P05788 - Assigned Treatment||24
2843066|NCT00702520|3544606|FG002|Treated With hCG and Had Oocyte Pick-up|Base Study P05788 - Assigned Treatment||0
2843067|NCT00702520|3544607|FG003|Treated With hCG and Had Oocyte Pick-up|Base Study P05788 - Assigned Treatment||0
2843068|NCT00702520|3544604|FG000|COMPLETED|Base Study P05788 - Assigned Treatment||25
2843069|NCT00702520|3544605|FG001|COMPLETED|Base Study P05788 - Assigned Treatment||24
2843070|NCT00702520|3544606|FG002|COMPLETED|Base Study P05788 - Assigned Treatment||0
2843071|NCT00702520|3544607|FG003|COMPLETED|Base Study P05788 - Assigned Treatment||0
2843072|NCT00702520|3544604|FG000|NOT COMPLETED|Base Study P05788 - Assigned Treatment||0
2843073|NCT00702520|3544605|FG001|NOT COMPLETED|Base Study P05788 - Assigned Treatment||1
2843074|NCT00702520|3544606|FG002|NOT COMPLETED|Base Study P05788 - Assigned Treatment||0
2843075|NCT00702520|3544607|FG003|NOT COMPLETED|Base Study P05788 - Assigned Treatment||0
2843076|NCT00702520|3544604|FG000|STARTED|Base Study P05788 - Embryo Transfer||25
2843077|NCT00702520|3544605|FG001|STARTED|Base Study P05788 - Embryo Transfer||24
2843078|NCT00702520|3544606|FG002|STARTED|Base Study P05788 - Embryo Transfer||0
2843079|NCT00702520|3544607|FG003|STARTED|Base Study P05788 - Embryo Transfer||0
2843080|NCT00702520|3544604|FG000|Embryo Transfer|Base Study P05788 - Embryo Transfer||22
2843081|NCT00702520|3544605|FG001|Embryo Transfer|Base Study P05788 - Embryo Transfer||18
2843082|NCT00702520|3544606|FG002|Embryo Transfer|Base Study P05788 - Embryo Transfer||0
2843083|NCT00702520|3544607|FG003|Embryo Transfer|Base Study P05788 - Embryo Transfer||0
2843084|NCT00702520|3544604|FG000|COMPLETED|Base Study P05788 - Embryo Transfer||22
2843085|NCT00702520|3544605|FG001|COMPLETED|Base Study P05788 - Embryo Transfer||18
2843086|NCT00702520|3544606|FG002|COMPLETED|Base Study P05788 - Embryo Transfer||0
2843087|NCT00702520|3544607|FG003|COMPLETED|Base Study P05788 - Embryo Transfer||0
2843088|NCT00702520|3544604|FG000|NOT COMPLETED|Base Study P05788 - Embryo Transfer||3
2843089|NCT00702520|3544605|FG001|NOT COMPLETED|Base Study P05788 - Embryo Transfer||6
2843090|NCT00702520|3544606|FG002|NOT COMPLETED|Base Study P05788 - Embryo Transfer||0
2843091|NCT00702520|3544607|FG003|NOT COMPLETED|Base Study P05788 - Embryo Transfer||0
2843092|NCT00702520|3544604|FG000|STARTED|Base Study P05788 - Follow-Up||22
2843093|NCT00702520|3544605|FG001|STARTED|Base Study P05788 - Follow-Up||18
2843094|NCT00702520|3544606|FG002|STARTED|Base Study P05788 - Follow-Up||0
2843095|NCT00702520|3544607|FG003|STARTED|Base Study P05788 - Follow-Up||0
2843096|NCT00702520|3544604|FG000|Ongoing Pregnancy at 10 Weeks|Base Study P05788 - Follow-Up||7
2843097|NCT00702520|3544605|FG001|Ongoing Pregnancy at 10 Weeks|Base Study P05788 - Follow-Up||8
2843098|NCT00702520|3544606|FG002|Ongoing Pregnancy at 10 Weeks|Base Study P05788 - Follow-Up||0
2843099|NCT00702520|3544607|FG003|Ongoing Pregnancy at 10 Weeks|Base Study P05788 - Follow-Up||0
2843100|NCT00702520|3544604|FG000|COMPLETED|Base Study P05788 - Follow-Up||7
2843101|NCT00702520|3544605|FG001|COMPLETED|Base Study P05788 - Follow-Up||8
2843102|NCT00702520|3544606|FG002|COMPLETED|Base Study P05788 - Follow-Up||0
2843103|NCT00702520|3544607|FG003|COMPLETED|Base Study P05788 - Follow-Up||0
2843104|NCT00702520|3544604|FG000|NOT COMPLETED|Base Study P05788 - Follow-Up||15
2843105|NCT00702520|3544605|FG001|NOT COMPLETED|Base Study P05788 - Follow-Up||10
2843106|NCT00702520|3544606|FG002|NOT COMPLETED|Base Study P05788 - Follow-Up||0
2843107|NCT00702520|3544607|FG003|NOT COMPLETED|Base Study P05788 - Follow-Up||0
2843108|NCT00702520|3544604|FG000|STARTED|Follow-up Study P05783||7
2843109|NCT00702520|3544605|FG001|STARTED|Follow-up Study P05783||8
2843110|NCT00702520|3544606|FG002|STARTED|Follow-up Study P05783|This is the number of infants born from mothers administered Corifollitropin alpha 100 ug.|8
2843111|NCT00702520|3544607|FG003|STARTED|Follow-up Study P05783|This is the number of infants born from mothers administered Corifollitropin alpha 150 ug.|11
2843112|NCT00702520|3544604|FG000|COMPLETED|Follow-up Study P05783||7
2843113|NCT00702520|3544605|FG001|COMPLETED|Follow-up Study P05783||8
2843114|NCT00702520|3544606|FG002|COMPLETED|Follow-up Study P05783||8
2843115|NCT00702520|3544607|FG003|COMPLETED|Follow-up Study P05783||11
2843116|NCT00702520|3544604|FG000|NOT COMPLETED|Follow-up Study P05783||0
2843117|NCT00702520|3544605|FG001|NOT COMPLETED|Follow-up Study P05783||0
2843118|NCT00702520|3544606|FG002|NOT COMPLETED|Follow-up Study P05783||0
2843119|NCT00702520|3544607|FG003|NOT COMPLETED|Follow-up Study P05783||0
2843120|NCT00702338|3544617|FG000|STARTED|Base Study (NCT00697255)||5
2843121|NCT00702338|3544618|FG001|STARTED|Base Study (NCT00697255)||3
2843122|NCT00702338|3544619|FG002|STARTED|Base Study (NCT00697255)||0
2843123|NCT00702338|3544617|FG000|COMPLETED|Base Study (NCT00697255)|To complete the study, participants must have received hCG bolus injection.|2
2843124|NCT00702338|3544618|FG001|COMPLETED|Base Study (NCT00697255)|To complete the study, participants must have received hCG bolus injection.|1
2843125|NCT00702338|3544619|FG002|COMPLETED|Base Study (NCT00697255)||0
2843126|NCT00702338|3544617|FG000|NOT COMPLETED|Base Study (NCT00697255)||3
2843127|NCT00702338|3544618|FG001|NOT COMPLETED|Base Study (NCT00697255)||2
2843128|NCT00702338|3544619|FG002|NOT COMPLETED|Base Study (NCT00697255)||0
2843129|NCT00702338|3544617|FG000|STARTED|Follow-up Study: Expectant Mothers FU|To enroll in follow-up study, confirmed pregnancy at ≥10 wks after hCG bolus injection was required|0
2843130|NCT00702338|3544618|FG001|STARTED|Follow-up Study: Expectant Mothers FU|To enroll in follow-up study, confirmed pregnancy at ≥10 wks after hCG bolus injection was required|1
2843131|NCT00702338|3544619|FG002|STARTED|Follow-up Study: Expectant Mothers FU||0
2843132|NCT00702338|3544617|FG000|COMPLETED|Follow-up Study: Expectant Mothers FU||0
2843133|NCT00702338|3544618|FG001|COMPLETED|Follow-up Study: Expectant Mothers FU|To complete the study, participants must have completed a follow-up visit at 4-12 weeks postpartum.|0
2843134|NCT00702338|3544619|FG002|COMPLETED|Follow-up Study: Expectant Mothers FU||0
2843135|NCT00702338|3544617|FG000|NOT COMPLETED|Follow-up Study: Expectant Mothers FU||0
2843136|NCT00702338|3544618|FG001|NOT COMPLETED|Follow-up Study: Expectant Mothers FU||1
2843137|NCT00702338|3544619|FG002|NOT COMPLETED|Follow-up Study: Expectant Mothers FU||0
2843138|NCT00702338|3544617|FG000|STARTED|Follow-up Study: Infant FU||0
2843139|NCT00702338|3544618|FG001|STARTED|Follow-up Study: Infant FU||0
2843140|NCT00702338|3544619|FG002|STARTED|Follow-up Study: Infant FU|Participants died on day of delivery, did not complete follow-up visit at 4-12 weeks postpartum.|2
2843141|NCT00702338|3544617|FG000|COMPLETED|Follow-up Study: Infant FU||0
2843142|NCT00702338|3544618|FG001|COMPLETED|Follow-up Study: Infant FU||0
2843143|NCT00702338|3544619|FG002|COMPLETED|Follow-up Study: Infant FU||0
2843144|NCT00702338|3544617|FG000|NOT COMPLETED|Follow-up Study: Infant FU||0
2843145|NCT00702338|3544618|FG001|NOT COMPLETED|Follow-up Study: Infant FU||0
2843146|NCT00702338|3544619|FG002|NOT COMPLETED|Follow-up Study: Infant FU||2
2843147|NCT00702273|3544629|FG000|STARTED|Base Study P05787 (NCT00696800)|Participants randomized to the base study P05787 (NCT00696800)|757
2843148|NCT00702273|3544630|FG001|STARTED|Base Study P05787 (NCT00696800)|Participants randomized to the base study P05787 (NCT00696800)|752
3167641|NCT01912339|3894941|FG000|COMPLETED|Unblinded (3 to 6 Months/Crossover)|Still in study|133
3167642|NCT01912339|3894942|FG001|COMPLETED|Unblinded (3 to 6 Months/Crossover)|Of the 61 subjects, there were 53 crossover subjects and 8 that completed their study participation.|61
3167643|NCT01912339|3894943|FG002|COMPLETED|Unblinded (3 to 6 Months/Crossover)|Still in study|0
3167644|NCT01912339|3894941|FG000|NOT COMPLETED|Unblinded (3 to 6 Months/Crossover)||1
3167645|NCT01912339|3894942|FG001|NOT COMPLETED|Unblinded (3 to 6 Months/Crossover)||0
3167646|NCT01912339|3894943|FG002|NOT COMPLETED|Unblinded (3 to 6 Months/Crossover)||0
2843149|NCT00702273|3544629|FG000|Treated|Base Study P05787 (NCT00696800)|Participants from the Intent to Treat group (ITT) from the base study P05787 (NCT00696800)|756
2843150|NCT00702273|3544630|FG001|Treated|Base Study P05787 (NCT00696800)|Participants from the Intent to Treat group (ITT) from the base study P05787 (NCT00696800)|750
2916365|NCT00515502|3626825|FG003|STARTED|Treatment Period 2||3
3167647|NCT01912339|3894941|FG000|STARTED|Unblinded (6 Months/Crossover to 5 Yrs)||133
3167648|NCT01912339|3894942|FG001|STARTED|Unblinded (6 Months/Crossover to 5 Yrs)|All subjects for the control group either completed study or crossed over.|0
3167649|NCT01912339|3894943|FG002|STARTED|Unblinded (6 Months/Crossover to 5 Yrs)|Control subjects that have crossed over.|53
3167650|NCT01912339|3894941|FG000|COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||0
3167651|NCT01912339|3894942|FG001|COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||0
3167652|NCT01912339|3894943|FG002|COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||0
3167653|NCT01912339|3894941|FG000|NOT COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||133
3167654|NCT01912339|3894942|FG001|NOT COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||0
3167655|NCT01912339|3894943|FG002|NOT COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||53
3167656|NCT01912352|3894949|FG000|STARTED|Overall Study||83
3167657|NCT01912352|3894949|FG000|COMPLETED|Overall Study||78
3167658|NCT01912352|3894949|FG000|NOT COMPLETED|Overall Study||5
2843151|NCT00702273|3544629|FG000|COMPLETED|Base Study P05787 (NCT00696800)|To complete study, participants from the base study P05787 (NCT00696800) had embryos transferred|672
2843152|NCT00702273|3544630|FG001|COMPLETED|Base Study P05787 (NCT00696800)|To complete study, participants from the base study P05787 (NCT00696800) had embryos transferred|704
2843153|NCT00702273|3544629|FG000|NOT COMPLETED|Base Study P05787 (NCT00696800)||85
2843154|NCT00702273|3544630|FG001|NOT COMPLETED|Base Study P05787 (NCT00696800)||48
2843155|NCT00702273|3544629|FG000|STARTED|Follow Up Study P05716 (NCT00702273)|Participants from base study,who had at least one embryo thawed for a FTET cycle.|168
2843156|NCT00702273|3544630|FG001|STARTED|Follow Up Study P05716 (NCT00702273)|Participants from base study, who had at least one embryo thawed for a FTET cycle|176
2843157|NCT00702273|3544629|FG000|COMPLETED|Follow Up Study P05716 (NCT00702273)|Participants with embryo transfer in any FTET cycle|148
2843158|NCT00702273|3544630|FG001|COMPLETED|Follow Up Study P05716 (NCT00702273)|Participants with embryo transfer in any FTET cycle|147
2843159|NCT00702273|3544629|FG000|NOT COMPLETED|Follow Up Study P05716 (NCT00702273)||20
2843160|NCT00702273|3544630|FG001|NOT COMPLETED|Follow Up Study P05716 (NCT00702273)||29
2843161|NCT00702234|3544636|FG000|STARTED|Base Study (NCT00696878)||682
2843162|NCT00702234|3544637|FG001|STARTED|Base Study (NCT00696878)||0
2843163|NCT00702234|3544636|FG000|COMPLETED|Base Study (NCT00696878)||178
2843164|NCT00702234|3544637|FG001|COMPLETED|Base Study (NCT00696878)||0
2843165|NCT00702234|3544636|FG000|NOT COMPLETED|Base Study (NCT00696878)||504
2843166|NCT00702234|3544637|FG001|NOT COMPLETED|Base Study (NCT00696878)||0
2843167|NCT00702234|3544636|FG000|STARTED|Follow-up Study: Expectant Mothers|"A participant could enter follow-up study without meeting definition for Completion of base study"|268
2843168|NCT00702234|3544637|FG001|STARTED|Follow-up Study: Expectant Mothers||0
2843169|NCT00702234|3544636|FG000|COMPLETED|Follow-up Study: Expectant Mothers||246
2843170|NCT00702234|3544637|FG001|COMPLETED|Follow-up Study: Expectant Mothers||0
2843171|NCT00702234|3544636|FG000|NOT COMPLETED|Follow-up Study: Expectant Mothers||22
2843172|NCT00702234|3544637|FG001|NOT COMPLETED|Follow-up Study: Expectant Mothers||0
2843173|NCT00702234|3544636|FG000|STARTED|Follow-up Study: Fetuses/Infants||0
2843174|NCT00702234|3544637|FG001|STARTED|Follow-up Study: Fetuses/Infants|Fetuses present 10 weeks after fresh ET and/or at enrollment of expectant mother in follow-up study|315
2843175|NCT00702234|3544636|FG000|Live Born Infants|Follow-up Study: Fetuses/Infants||0
2843176|NCT00702234|3544637|FG001|Live Born Infants|Follow-up Study: Fetuses/Infants|Of the 11 that were not live born infants, outcome is known for 8 (fetus was lost) and unknown for 3|304
2843177|NCT00702234|3544636|FG000|COMPLETED|Follow-up Study: Fetuses/Infants||0
2843178|NCT00702234|3544637|FG001|COMPLETED|Follow-up Study: Fetuses/Infants|All 288 who completed were live born infants|288
2843179|NCT00702234|3544636|FG000|NOT COMPLETED|Follow-up Study: Fetuses/Infants||0
2843180|NCT00702234|3544637|FG001|NOT COMPLETED|Follow-up Study: Fetuses/Infants||27
2843181|NCT00697255|3544646|FG000|STARTED|Stage 1a||5
2843182|NCT00697255|3544647|FG001|STARTED|Stage 1a||0
2843183|NCT00697255|3544646|FG000|COMPLETED|Stage 1a|Participants who completed 1a received hCG bolus injection and did not proceed further in the trial|2
2843184|NCT00697255|3544647|FG001|COMPLETED|Stage 1a||0
2843185|NCT00697255|3544646|FG000|NOT COMPLETED|Stage 1a||3
2843186|NCT00697255|3544647|FG001|NOT COMPLETED|Stage 1a||0
2843187|NCT00697255|3544646|FG000|STARTED|Stage 1b||0
2843188|NCT00697255|3544647|FG001|STARTED|Stage 1b|After enrollment in Stage 1a completed, a new cohort of participants enrolled in Stage 1b.|3
2843189|NCT00697255|3544646|FG000|COMPLETED|Stage 1b||0
2843190|NCT00697255|3544647|FG001|COMPLETED|Stage 1b|Participants who completed 1b received hCG bolus injection and did not proceed further in the trial|1
2843191|NCT00697255|3544646|FG000|NOT COMPLETED|Stage 1b||0
2843192|NCT00697255|3544647|FG001|NOT COMPLETED|Stage 1b||2
2843193|NCT00696878|3544653|FG000|STARTED|Overall Study||682
2843194|NCT00696878|3544653|FG000|COMPLETED|Overall Study||178
2843195|NCT00696878|3544653|FG000|NOT COMPLETED|Overall Study||504
2843196|NCT00696800|3544659|FG000|STARTED|Overall Study||757
2843197|NCT00696800|3544660|FG001|STARTED|Overall Study||752
2843198|NCT00696800|3544659|FG000|Treated (ITT)|Overall Study|The ITT group|756
2843199|NCT00696800|3544660|FG001|Treated (ITT)|Overall Study|The ITT group|750
2843200|NCT00696800|3544659|FG000|COMPLETED|Overall Study|Participants who had embryos transferred|672
2843201|NCT00696800|3544660|FG001|COMPLETED|Overall Study|Participants who had embryos transferred|704
2843202|NCT00696800|3544659|FG000|NOT COMPLETED|Overall Study||85
2843203|NCT00696800|3544660|FG001|NOT COMPLETED|Overall Study||48
2843204|NCT00616967|3544668|FG000|STARTED|Overall Study||6
2843205|NCT00616967|3544669|FG001|STARTED|Overall Study||31
2843206|NCT00616967|3544670|FG002|STARTED|Overall Study||31
2843207|NCT00616967|3544668|FG000|COMPLETED|Overall Study||6
2843208|NCT00616967|3544669|FG001|COMPLETED|Overall Study||31
2843209|NCT00616967|3544670|FG002|COMPLETED|Overall Study||30
2843210|NCT00616967|3544668|FG000|NOT COMPLETED|Overall Study||0
2843211|NCT00616967|3544669|FG001|NOT COMPLETED|Overall Study||0
2843212|NCT00616967|3544670|FG002|NOT COMPLETED|Overall Study||1
2843213|NCT00461032|3544690|FG000|STARTED|Overall Study||582
2843214|NCT00461032|3544691|FG001|STARTED|Overall Study||580
2843215|NCT00461032|3544690|FG000|COMPLETED|Overall Study||545
2843216|NCT00461032|3544691|FG001|COMPLETED|Overall Study||536
2843217|NCT00461032|3544690|FG000|NOT COMPLETED|Overall Study||37
2843218|NCT00461032|3544691|FG001|NOT COMPLETED|Overall Study||44
2843219|NCT00442338|3544700|FG000|STARTED|Overall Study||30
2843220|NCT00442338|3544701|FG001|STARTED|Overall Study||30
2843221|NCT00442338|3544702|FG002|STARTED|Overall Study||31
2843222|NCT00442338|3544700|FG000|COMPLETED|Overall Study||30
2843223|NCT00442338|3544701|FG001|COMPLETED|Overall Study||30
2843224|NCT00442338|3544702|FG002|COMPLETED|Overall Study||31
2843225|NCT00442338|3544700|FG000|NOT COMPLETED|Overall Study||0
2843226|NCT00442338|3544701|FG001|NOT COMPLETED|Overall Study||0
2843227|NCT00442338|3544702|FG002|NOT COMPLETED|Overall Study||0
2843228|NCT00353938|3544712|FG000|STARTED|Overall Study||9
2843229|NCT00353938|3544713|FG001|STARTED|Overall Study||4
2843230|NCT00353938|3544712|FG000|COMPLETED|Overall Study||8
2843231|NCT00353938|3544713|FG001|COMPLETED|Overall Study||4
2843232|NCT00353938|3544712|FG000|NOT COMPLETED|Overall Study||1
2843233|NCT00353938|3544713|FG001|NOT COMPLETED|Overall Study||0
2843234|NCT00335777|3544721|FG000|STARTED|Enrolled and Dispensed Study Medication|64 subjects enrolled. 35 treated 2 headaches, but 22/35 at appropriate times, as per protocol.|64
2843235|NCT00335777|3544721|FG000|COMPLETED|Enrolled and Dispensed Study Medication||35
2843236|NCT00335777|3544721|FG000|NOT COMPLETED|Enrolled and Dispensed Study Medication||29
2843237|NCT00335777|3544721|FG000|STARTED|Treated 2 Headaches Per Protocol||35
2843238|NCT00335777|3544721|FG000|COMPLETED|Treated 2 Headaches Per Protocol||22
2843239|NCT00335777|3544721|FG000|NOT COMPLETED|Treated 2 Headaches Per Protocol||13
2843240|NCT00289874|3544728|FG000|STARTED|Overall Study||203
2843241|NCT00289874|3544729|FG001|STARTED|Overall Study||218
2843242|NCT00289874|3544728|FG000|COMPLETED|Overall Study||197
2843243|NCT00289874|3544729|FG001|COMPLETED|Overall Study||210
2843244|NCT00289874|3544728|FG000|NOT COMPLETED|Overall Study||6
2843245|NCT00289874|3544729|FG001|NOT COMPLETED|Overall Study||8
2843246|NCT00250458|3544737|FG000|STARTED|Overall Study||232
2843247|NCT00250458|3544738|FG001|STARTED|Overall Study||114
2843248|NCT00250458|3544737|FG000|COMPLETED|Overall Study||200
2843249|NCT00250458|3544738|FG001|COMPLETED|Overall Study||97
2843250|NCT00250458|3544737|FG000|NOT COMPLETED|Overall Study||32
2843251|NCT00250458|3544738|FG001|NOT COMPLETED|Overall Study||17
2843252|NCT00245570|3544744|FG000|STARTED|Treatment Period II||7
2843253|NCT00245570|3544745|FG001|STARTED|Treatment Period II||8
2843254|NCT00245570|3544746|FG002|STARTED|Treatment Period II||8
2843255|NCT00245570|3544747|FG003|STARTED|Treatment Period II||8
2843256|NCT00245570|3544748|FG004|STARTED|Treatment Period II||8
2843257|NCT00245570|3544749|FG005|STARTED|Treatment Period II||8
2843258|NCT00245570|3544744|FG000|COMPLETED|Treatment Period II||7
2843259|NCT00245570|3544745|FG001|COMPLETED|Treatment Period II||8
2843260|NCT00245570|3544746|FG002|COMPLETED|Treatment Period II||8
2843261|NCT00245570|3544747|FG003|COMPLETED|Treatment Period II||8
2843262|NCT00245570|3544748|FG004|COMPLETED|Treatment Period II||8
2843263|NCT00245570|3544749|FG005|COMPLETED|Treatment Period II||8
2843264|NCT00245570|3544744|FG000|NOT COMPLETED|Treatment Period II||0
2843265|NCT00245570|3544745|FG001|NOT COMPLETED|Treatment Period II||0
2843266|NCT00245570|3544746|FG002|NOT COMPLETED|Treatment Period II||0
2843267|NCT00245570|3544747|FG003|NOT COMPLETED|Treatment Period II||0
2843268|NCT00245570|3544748|FG004|NOT COMPLETED|Treatment Period II||0
2843269|NCT00245570|3544749|FG005|NOT COMPLETED|Treatment Period II||0
2843270|NCT00245570|3544744|FG000|STARTED|Washout Between Periods II and III||7
2843271|NCT00245570|3544745|FG001|STARTED|Washout Between Periods II and III||8
2843272|NCT00245570|3544746|FG002|STARTED|Washout Between Periods II and III||8
2843273|NCT00245570|3544747|FG003|STARTED|Washout Between Periods II and III||8
2843274|NCT00245570|3544748|FG004|STARTED|Washout Between Periods II and III||8
2843275|NCT00245570|3544749|FG005|STARTED|Washout Between Periods II and III||8
2843276|NCT00245570|3544744|FG000|COMPLETED|Washout Between Periods II and III||7
2843277|NCT00245570|3544745|FG001|COMPLETED|Washout Between Periods II and III||8
2843278|NCT00245570|3544746|FG002|COMPLETED|Washout Between Periods II and III||8
2843279|NCT00245570|3544747|FG003|COMPLETED|Washout Between Periods II and III||8
2843280|NCT00245570|3544748|FG004|COMPLETED|Washout Between Periods II and III||8
2843281|NCT00245570|3544749|FG005|COMPLETED|Washout Between Periods II and III||8
2843282|NCT00245570|3544744|FG000|NOT COMPLETED|Washout Between Periods II and III||0
2843283|NCT00245570|3544745|FG001|NOT COMPLETED|Washout Between Periods II and III||0
2843284|NCT00245570|3544746|FG002|NOT COMPLETED|Washout Between Periods II and III||0
2843285|NCT00245570|3544747|FG003|NOT COMPLETED|Washout Between Periods II and III||0
2843286|NCT00245570|3544748|FG004|NOT COMPLETED|Washout Between Periods II and III||0
2843287|NCT00245570|3544749|FG005|NOT COMPLETED|Washout Between Periods II and III||0
2843288|NCT00245570|3544744|FG000|STARTED|Treatment Period III||7
2843289|NCT00245570|3544745|FG001|STARTED|Treatment Period III||8
2843290|NCT00245570|3544746|FG002|STARTED|Treatment Period III||8
2843291|NCT00245570|3544747|FG003|STARTED|Treatment Period III||8
2843292|NCT00245570|3544748|FG004|STARTED|Treatment Period III||8
2843293|NCT00245570|3544749|FG005|STARTED|Treatment Period III||8
2843294|NCT00245570|3544744|FG000|COMPLETED|Treatment Period III||7
2843295|NCT00245570|3544745|FG001|COMPLETED|Treatment Period III||8
2843296|NCT00245570|3544746|FG002|COMPLETED|Treatment Period III||8
2843297|NCT00245570|3544747|FG003|COMPLETED|Treatment Period III||8
2843298|NCT00245570|3544748|FG004|COMPLETED|Treatment Period III||8
2843299|NCT00245570|3544749|FG005|COMPLETED|Treatment Period III||8
2843300|NCT00245570|3544744|FG000|NOT COMPLETED|Treatment Period III||0
2843301|NCT00245570|3544745|FG001|NOT COMPLETED|Treatment Period III||0
2843302|NCT00245570|3544746|FG002|NOT COMPLETED|Treatment Period III||0
2843303|NCT00245570|3544747|FG003|NOT COMPLETED|Treatment Period III||0
2843304|NCT00245570|3544748|FG004|NOT COMPLETED|Treatment Period III||0
2843305|NCT00245570|3544749|FG005|NOT COMPLETED|Treatment Period III||0
2843306|NCT00245570|3544744|FG000|STARTED|Washout Between Periods III and IV||7
2843307|NCT00245570|3544745|FG001|STARTED|Washout Between Periods III and IV|1 pt in the montelukast/placebo/salmeterol group discontinued during washout period 2 after placebo|8
2843308|NCT00245570|3544746|FG002|STARTED|Washout Between Periods III and IV||8
2843309|NCT00245570|3544747|FG003|STARTED|Washout Between Periods III and IV||8
2843310|NCT00245570|3544748|FG004|STARTED|Washout Between Periods III and IV||8
2843311|NCT00245570|3544749|FG005|STARTED|Washout Between Periods III and IV||8
2843312|NCT00245570|3544744|FG000|COMPLETED|Washout Between Periods III and IV||7
2843313|NCT00245570|3544745|FG001|COMPLETED|Washout Between Periods III and IV||7
2843314|NCT00245570|3544746|FG002|COMPLETED|Washout Between Periods III and IV||8
2843315|NCT00245570|3544747|FG003|COMPLETED|Washout Between Periods III and IV||8
2843316|NCT00245570|3544748|FG004|COMPLETED|Washout Between Periods III and IV||8
2843317|NCT00245570|3544749|FG005|COMPLETED|Washout Between Periods III and IV||8
2843318|NCT00245570|3544744|FG000|NOT COMPLETED|Washout Between Periods III and IV||0
2843319|NCT00245570|3544745|FG001|NOT COMPLETED|Washout Between Periods III and IV||1
2843320|NCT00245570|3544746|FG002|NOT COMPLETED|Washout Between Periods III and IV||0
2843321|NCT00245570|3544747|FG003|NOT COMPLETED|Washout Between Periods III and IV||0
2843322|NCT00245570|3544748|FG004|NOT COMPLETED|Washout Between Periods III and IV||0
2843323|NCT00245570|3544749|FG005|NOT COMPLETED|Washout Between Periods III and IV||0
2843324|NCT00245570|3544744|FG000|STARTED|Treatment Period IV||7
2843325|NCT00245570|3544745|FG001|STARTED|Treatment Period IV||7
2843326|NCT00245570|3544746|FG002|STARTED|Treatment Period IV||8
3167659|NCT01912456|3894955|FG000|STARTED|Period 1||22
3167660|NCT01912456|3894956|FG001|STARTED|Period 1||23
3167661|NCT01912456|3894957|FG002|STARTED|Period 1||23
3167662|NCT01912456|3894958|FG003|STARTED|Period 1||22
3167663|NCT01912456|3894955|FG000|COMPLETED|Period 1||20
3167664|NCT01912456|3894956|FG001|COMPLETED|Period 1||22
3167665|NCT01912456|3894957|FG002|COMPLETED|Period 1||21
3167666|NCT01912456|3894958|FG003|COMPLETED|Period 1||19
3167667|NCT01912456|3894955|FG000|NOT COMPLETED|Period 1||2
2843327|NCT00245570|3544747|FG003|STARTED|Treatment Period IV||8
2843328|NCT00245570|3544748|FG004|STARTED|Treatment Period IV||8
2843329|NCT00245570|3544749|FG005|STARTED|Treatment Period IV||8
2843330|NCT00245570|3544744|FG000|COMPLETED|Treatment Period IV||7
2843331|NCT00245570|3544745|FG001|COMPLETED|Treatment Period IV||7
2843332|NCT00245570|3544746|FG002|COMPLETED|Treatment Period IV||8
2843333|NCT00245570|3544747|FG003|COMPLETED|Treatment Period IV||8
2843334|NCT00245570|3544748|FG004|COMPLETED|Treatment Period IV||8
2843335|NCT00245570|3544749|FG005|COMPLETED|Treatment Period IV||8
2843336|NCT00245570|3544744|FG000|NOT COMPLETED|Treatment Period IV||0
2843337|NCT00245570|3544745|FG001|NOT COMPLETED|Treatment Period IV||0
2843338|NCT00245570|3544746|FG002|NOT COMPLETED|Treatment Period IV||0
2843339|NCT00245570|3544747|FG003|NOT COMPLETED|Treatment Period IV||0
2843340|NCT00245570|3544748|FG004|NOT COMPLETED|Treatment Period IV||0
2843341|NCT00245570|3544749|FG005|NOT COMPLETED|Treatment Period IV||0
2843342|NCT00229970|3544763|FG000|STARTED|Overall Study||78
2843343|NCT00229970|3544764|FG001|STARTED|Overall Study||72
2843344|NCT00229970|3544765|FG002|STARTED|Overall Study||75
2843345|NCT00229970|3544763|FG000|COMPLETED|Overall Study||78
2843346|NCT00229970|3544764|FG001|COMPLETED|Overall Study||72
2843347|NCT00229970|3544765|FG002|COMPLETED|Overall Study||75
2843348|NCT00229970|3544763|FG000|NOT COMPLETED|Overall Study||0
2843349|NCT00229970|3544764|FG001|NOT COMPLETED|Overall Study||0
2843350|NCT00229970|3544765|FG002|NOT COMPLETED|Overall Study||0
2843351|NCT00092131|3544773|FG000|STARTED|Treatment Period I|1 patient discontinued due to influenza which started in washout (11 days after Period I medication)|25
2843352|NCT00092131|3544774|FG001|STARTED|Treatment Period I||26
2843353|NCT00092131|3544773|FG000|COMPLETED|Treatment Period I||24
2843354|NCT00092131|3544774|FG001|COMPLETED|Treatment Period I||26
2843355|NCT00092131|3544773|FG000|NOT COMPLETED|Treatment Period I||1
2843356|NCT00092131|3544774|FG001|NOT COMPLETED|Treatment Period I||0
2843357|NCT00092131|3544773|FG000|STARTED|Treatment Period II||24
2843358|NCT00092131|3544774|FG001|STARTED|Treatment Period II|1 patient discontinued after taking Period II study medication, due to asthma exacerbation|26
2843359|NCT00092131|3544773|FG000|COMPLETED|Treatment Period II||24
2843360|NCT00092131|3544774|FG001|COMPLETED|Treatment Period II||25
2843361|NCT00092131|3544773|FG000|NOT COMPLETED|Treatment Period II||0
2843362|NCT00092131|3544774|FG001|NOT COMPLETED|Treatment Period II||1
2843363|NCT00092118|3544782|FG000|STARTED|Overall Study|1 patient discontinued after randomization due to a adverse experience that began pre-randomization.|990
2843364|NCT00092118|3544783|FG001|STARTED|Overall Study|2 patients discontinued after randomization due to adverse experience that began pre-randomization.|1002
2843365|NCT00092118|3544782|FG000|COMPLETED|Overall Study||906
2843366|NCT00092118|3544783|FG001|COMPLETED|Overall Study||913
2843367|NCT00092118|3544782|FG000|NOT COMPLETED|Overall Study||84
2843368|NCT00092118|3544783|FG001|NOT COMPLETED|Overall Study||89
2843369|NCT00090142|3544789|FG000|STARTED|Treatment Period I|1 patient was lost to follow-up after randomization and did not receive any study drug.|31
2843370|NCT00090142|3544790|FG001|STARTED|Treatment Period I||31
2843371|NCT00090142|3544789|FG000|COMPLETED|Treatment Period I||26
2843372|NCT00090142|3544790|FG001|COMPLETED|Treatment Period I||28
3167668|NCT01912456|3894956|FG001|NOT COMPLETED|Period 1||1
3167669|NCT01912456|3894957|FG002|NOT COMPLETED|Period 1||2
3167670|NCT01912456|3894958|FG003|NOT COMPLETED|Period 1||3
3167671|NCT01912456|3894955|FG000|STARTED|Period 2||20
3167672|NCT01912456|3894956|FG001|STARTED|Period 2||22
3167673|NCT01912456|3894957|FG002|STARTED|Period 2||21
3167674|NCT01912456|3894958|FG003|STARTED|Period 2||19
2843373|NCT00090142|3544789|FG000|NOT COMPLETED|Treatment Period I||5
2843374|NCT00090142|3544790|FG001|NOT COMPLETED|Treatment Period I||3
2843375|NCT00090142|3544789|FG000|STARTED|Treatment Period II||26
2843376|NCT00090142|3544790|FG001|STARTED|Treatment Period II||28
2843377|NCT00090142|3544789|FG000|COMPLETED|Treatment Period II||25
2843378|NCT00090142|3544790|FG001|COMPLETED|Treatment Period II||28
2843379|NCT00090142|3544789|FG000|NOT COMPLETED|Treatment Period II||1
2843380|NCT00090142|3544790|FG001|NOT COMPLETED|Treatment Period II||0
2843381|NCT00043108|3544796|FG000|STARTED|Overall Study||19
2843382|NCT00043108|3544796|FG000|COMPLETED|Overall Study||19
2843383|NCT00043108|3544796|FG000|NOT COMPLETED|Overall Study||0
2916366|NCT00515502|3626826|FG004|STARTED|Treatment Period 2||3
2916367|NCT00515502|3626827|FG005|STARTED|Treatment Period 2||1
2916368|NCT00515502|3626828|FG006|STARTED|Treatment Period 2||1
2916369|NCT00515502|3626829|FG007|STARTED|Treatment Period 2||1
2916370|NCT00515502|3626830|FG008|STARTED|Treatment Period 2||0
2916371|NCT00515502|3626831|FG009|STARTED|Treatment Period 2||2
2916372|NCT00515502|3626832|FG010|STARTED|Treatment Period 2||1
2916373|NCT00515502|3626833|FG011|STARTED|Treatment Period 2||0
2916374|NCT00515502|3626822|FG000|COMPLETED|Treatment Period 2||1
2916375|NCT00515502|3626823|FG001|COMPLETED|Treatment Period 2||3
2916376|NCT00515502|3626824|FG002|COMPLETED|Treatment Period 2||4
2916377|NCT00515502|3626825|FG003|COMPLETED|Treatment Period 2||3
2916378|NCT00515502|3626826|FG004|COMPLETED|Treatment Period 2||3
2916379|NCT00515502|3626827|FG005|COMPLETED|Treatment Period 2||1
2916380|NCT00515502|3626828|FG006|COMPLETED|Treatment Period 2||1
2916381|NCT00515502|3626829|FG007|COMPLETED|Treatment Period 2||1
2916382|NCT00515502|3626830|FG008|COMPLETED|Treatment Period 2||0
2916383|NCT00515502|3626831|FG009|COMPLETED|Treatment Period 2||2
2916384|NCT00515502|3626832|FG010|COMPLETED|Treatment Period 2||1
2916385|NCT00515502|3626833|FG011|COMPLETED|Treatment Period 2||0
2916386|NCT00515502|3626822|FG000|NOT COMPLETED|Treatment Period 2||0
3167675|NCT01912456|3894955|FG000|COMPLETED|Period 2||20
3167676|NCT01912456|3894956|FG001|COMPLETED|Period 2||20
2916387|NCT00515502|3626823|FG001|NOT COMPLETED|Treatment Period 2||1
2916388|NCT00515502|3626824|FG002|NOT COMPLETED|Treatment Period 2||0
2916389|NCT00515502|3626825|FG003|NOT COMPLETED|Treatment Period 2||0
2916390|NCT00515502|3626826|FG004|NOT COMPLETED|Treatment Period 2||0
2916391|NCT00515502|3626827|FG005|NOT COMPLETED|Treatment Period 2||0
2916392|NCT00515502|3626828|FG006|NOT COMPLETED|Treatment Period 2||0
2916393|NCT00515502|3626829|FG007|NOT COMPLETED|Treatment Period 2||0
2916394|NCT00515502|3626830|FG008|NOT COMPLETED|Treatment Period 2||0
2916395|NCT00515502|3626831|FG009|NOT COMPLETED|Treatment Period 2||0
2916396|NCT00515502|3626832|FG010|NOT COMPLETED|Treatment Period 2||0
2916397|NCT00515502|3626833|FG011|NOT COMPLETED|Treatment Period 2||0
2916398|NCT00515502|3626822|FG000|STARTED|Washout Period 2||1
2916399|NCT00515502|3626823|FG001|STARTED|Washout Period 2||3
2916400|NCT00515502|3626824|FG002|STARTED|Washout Period 2||4
2916401|NCT00515502|3626825|FG003|STARTED|Washout Period 2||3
2916402|NCT00515502|3626826|FG004|STARTED|Washout Period 2||3
2916403|NCT00515502|3626827|FG005|STARTED|Washout Period 2||1
2916404|NCT00515502|3626828|FG006|STARTED|Washout Period 2||1
2916405|NCT00515502|3626829|FG007|STARTED|Washout Period 2||1
2916406|NCT00515502|3626830|FG008|STARTED|Washout Period 2||0
2916407|NCT00515502|3626831|FG009|STARTED|Washout Period 2||2
2916408|NCT00515502|3626832|FG010|STARTED|Washout Period 2||1
2916409|NCT00515502|3626833|FG011|STARTED|Washout Period 2||0
2916410|NCT00515502|3626822|FG000|COMPLETED|Washout Period 2||1
2916411|NCT00515502|3626823|FG001|COMPLETED|Washout Period 2||3
2916412|NCT00515502|3626824|FG002|COMPLETED|Washout Period 2||4
2916413|NCT00515502|3626825|FG003|COMPLETED|Washout Period 2||3
2916414|NCT00515502|3626826|FG004|COMPLETED|Washout Period 2||3
2916415|NCT00515502|3626827|FG005|COMPLETED|Washout Period 2||1
2916416|NCT00515502|3626828|FG006|COMPLETED|Washout Period 2||1
2916417|NCT00515502|3626829|FG007|COMPLETED|Washout Period 2||1
2916418|NCT00515502|3626830|FG008|COMPLETED|Washout Period 2||0
2916419|NCT00515502|3626831|FG009|COMPLETED|Washout Period 2||2
2916420|NCT00515502|3626832|FG010|COMPLETED|Washout Period 2||1
2916421|NCT00515502|3626833|FG011|COMPLETED|Washout Period 2||0
2916422|NCT00515502|3626822|FG000|NOT COMPLETED|Washout Period 2||0
2916423|NCT00515502|3626823|FG001|NOT COMPLETED|Washout Period 2||0
2916424|NCT00515502|3626824|FG002|NOT COMPLETED|Washout Period 2||0
2916425|NCT00515502|3626825|FG003|NOT COMPLETED|Washout Period 2||0
2916426|NCT00515502|3626826|FG004|NOT COMPLETED|Washout Period 2||0
2916427|NCT00515502|3626827|FG005|NOT COMPLETED|Washout Period 2||0
2916428|NCT00515502|3626828|FG006|NOT COMPLETED|Washout Period 2||0
2916429|NCT00515502|3626829|FG007|NOT COMPLETED|Washout Period 2||0
2916430|NCT00515502|3626830|FG008|NOT COMPLETED|Washout Period 2||0
2916431|NCT00515502|3626831|FG009|NOT COMPLETED|Washout Period 2||0
2916432|NCT00515502|3626832|FG010|NOT COMPLETED|Washout Period 2||0
2916433|NCT00515502|3626833|FG011|NOT COMPLETED|Washout Period 2||0
2916434|NCT00515502|3626822|FG000|STARTED|Treatment Period 3||1
2916435|NCT00515502|3626823|FG001|STARTED|Treatment Period 3||3
2916436|NCT00515502|3626824|FG002|STARTED|Treatment Period 3||4
2916437|NCT00515502|3626825|FG003|STARTED|Treatment Period 3||3
2916438|NCT00515502|3626826|FG004|STARTED|Treatment Period 3||3
2916439|NCT00515502|3626827|FG005|STARTED|Treatment Period 3||1
2916440|NCT00515502|3626828|FG006|STARTED|Treatment Period 3||1
2916441|NCT00515502|3626829|FG007|STARTED|Treatment Period 3||1
3167677|NCT01912456|3894957|FG002|COMPLETED|Period 2||21
2843384|NCT04771013|3544802|FG000|STARTED|Overall Study||22
2843385|NCT04771013|3544803|FG001|STARTED|Overall Study||22
2843386|NCT04771013|3544802|FG000|COMPLETED|Overall Study||20
2843387|NCT04771013|3544803|FG001|COMPLETED|Overall Study||16
2843388|NCT04771013|3544802|FG000|NOT COMPLETED|Overall Study||2
2843389|NCT04771013|3544803|FG001|NOT COMPLETED|Overall Study||6
2843390|NCT04497987|3544811|FG000|STARTED|Overall Study||592
2843391|NCT04497987|3544812|FG001|STARTED|Overall Study||588
2843392|NCT04497987|3544811|FG000|Received at Least One Dose of Study Drug|Overall Study||587
2843393|NCT04497987|3544812|FG001|Received at Least One Dose of Study Drug|Overall Study||588
2843394|NCT04497987|3544811|FG000|Prevention Population|Overall Study||485
2843395|NCT04497987|3544812|FG001|Prevention Population|Overall Study||487
2843396|NCT04497987|3544811|FG000|Treatment Population|Overall Study||68
2843397|NCT04497987|3544812|FG001|Treatment Population|Overall Study||66
2843398|NCT04497987|3544811|FG000|Serology Positive|Overall Study||36
2843399|NCT04497987|3544812|FG001|Serology Positive|Overall Study||35
2843400|NCT04497987|3544811|FG000|COMPLETED|Overall Study||493
2843401|NCT04497987|3544812|FG001|COMPLETED|Overall Study||521
2843402|NCT04497987|3544811|FG000|NOT COMPLETED|Overall Study||99
2843403|NCT04497987|3544812|FG001|NOT COMPLETED|Overall Study||67
2843404|NCT04198584|3544821|FG000|STARTED|Overall Study||24
2843405|NCT04198584|3544822|FG001|STARTED|Overall Study||8
2843406|NCT04198584|3544821|FG000|Randomized to Wave 1|Overall Study||5
2843407|NCT04198584|3544822|FG001|Randomized to Wave 1|Overall Study||2
2843408|NCT04198584|3544821|FG000|Randomized to Wave 2|Overall Study||7
2843409|NCT04198584|3544822|FG001|Randomized to Wave 2|Overall Study||2
2843410|NCT04198584|3544821|FG000|Randomized to Wave 3|Overall Study||6
2843411|NCT04198584|3544822|FG001|Randomized to Wave 3|Overall Study||2
2843412|NCT04198584|3544821|FG000|Randomized to Wave 4|Overall Study||6
2843413|NCT04198584|3544822|FG001|Randomized to Wave 4|Overall Study||2
2843414|NCT04198584|3544821|FG000|Total Randomized|Overall Study||24
2843415|NCT04198584|3544822|FG001|Total Randomized|Overall Study||8
2843416|NCT04198584|3544821|FG000|Actually Received Treatment|Overall Study||21
2843417|NCT04198584|3544822|FG001|Actually Received Treatment|Overall Study||8
2843418|NCT04198584|3544821|FG000|COMPLETED|Overall Study||19
2843419|NCT04198584|3544822|FG001|COMPLETED|Overall Study||8
2843420|NCT04198584|3544821|FG000|NOT COMPLETED|Overall Study||5
2843421|NCT04198584|3544822|FG001|NOT COMPLETED|Overall Study||0
2843422|NCT04013932|3544835|FG000|STARTED|Overall Study||33
2843423|NCT04013932|3544836|FG001|STARTED|Overall Study||33
2843424|NCT04013932|3544835|FG000|COMPLETED|Overall Study||33
2843425|NCT04013932|3544836|FG001|COMPLETED|Overall Study||28
2843426|NCT04013932|3544835|FG000|NOT COMPLETED|Overall Study||0
2843427|NCT04013932|3544836|FG001|NOT COMPLETED|Overall Study||5
2843428|NCT03840616|3544846|FG000|STARTED|2-Week Induction Phase||147
2843429|NCT03840616|3544847|FG001|STARTED|2-Week Induction Phase||72
2843430|NCT03840616|3544846|FG000|COMPLETED|2-Week Induction Phase||123
2843431|NCT03840616|3544847|FG001|COMPLETED|2-Week Induction Phase||62
2843432|NCT03840616|3544846|FG000|NOT COMPLETED|2-Week Induction Phase||24
2843433|NCT03840616|3544847|FG001|NOT COMPLETED|2-Week Induction Phase||10
2843434|NCT03840616|3544846|FG000|STARTED|48-Week Maintenance Phase||123
2843435|NCT03840616|3544847|FG001|STARTED|48-Week Maintenance Phase||62
2843436|NCT03840616|3544846|FG000|COMPLETED|48-Week Maintenance Phase||112
2843437|NCT03840616|3544847|FG001|COMPLETED|48-Week Maintenance Phase||55
2843438|NCT03840616|3544846|FG000|NOT COMPLETED|48-Week Maintenance Phase||11
2843439|NCT03840616|3544847|FG001|NOT COMPLETED|48-Week Maintenance Phase||7
2843440|NCT03623373|3544855|FG000|STARTED|Overall Study||13
2843441|NCT03623373|3544855|FG000|COMPLETED|Overall Study||13
2843442|NCT03623373|3544855|FG000|NOT COMPLETED|Overall Study||0
2843443|NCT03581279|3544861|FG000|STARTED|Overall Study||18
2843444|NCT03581279|3544862|FG001|STARTED|Overall Study||0
2843445|NCT03581279|3544861|FG000|COMPLETED|Overall Study||16
2843446|NCT03581279|3544862|FG001|COMPLETED|Overall Study||0
2843447|NCT03581279|3544861|FG000|NOT COMPLETED|Overall Study||2
2843448|NCT03581279|3544862|FG001|NOT COMPLETED|Overall Study||0
2843449|NCT03512210|3544868|FG000|STARTED|Step 1: MINMON Intervention||400
2843450|NCT03512210|3544868|FG000|COMPLETED|Step 1: MINMON Intervention||396
2843451|NCT03512210|3544868|FG000|NOT COMPLETED|Step 1: MINMON Intervention||4
2843452|NCT03512210|3544868|FG000|STARTED|Step 2:Post-MINMON||396
2843453|NCT03512210|3544868|FG000|COMPLETED|Step 2:Post-MINMON||362
2843454|NCT03512210|3544868|FG000|NOT COMPLETED|Step 2:Post-MINMON||34
2843455|NCT03506412|3544874|FG000|STARTED|Overall Study||18
2843456|NCT03506412|3544875|FG001|STARTED|Overall Study||19
2843457|NCT03506412|3544874|FG000|COMPLETED|Overall Study||18
2843458|NCT03506412|3544875|FG001|COMPLETED|Overall Study||19
2843459|NCT03506412|3544874|FG000|NOT COMPLETED|Overall Study||0
2843460|NCT03506412|3544875|FG001|NOT COMPLETED|Overall Study||0
2843461|NCT03493854|3544883|FG000|STARTED|Neoadjuvant Treatment Phase (24 Weeks)|This includes all randomized participants.|252
2843462|NCT03493854|3544884|FG001|STARTED|Neoadjuvant Treatment Phase (24 Weeks)|This includes all randomized participants.|248
2843463|NCT03493854|3544883|FG000|Received at Least One Dose of Study Drug|Neoadjuvant Treatment Phase (24 Weeks)||252
2843464|NCT03493854|3544884|FG001|Received at Least One Dose of Study Drug|Neoadjuvant Treatment Phase (24 Weeks)||248
2843465|NCT03493854|3544883|FG000|COMPLETED|Neoadjuvant Treatment Phase (24 Weeks)||242
2843466|NCT03493854|3544884|FG001|COMPLETED|Neoadjuvant Treatment Phase (24 Weeks)||234
2843467|NCT03493854|3544883|FG000|NOT COMPLETED|Neoadjuvant Treatment Phase (24 Weeks)||10
2843468|NCT03493854|3544884|FG001|NOT COMPLETED|Neoadjuvant Treatment Phase (24 Weeks)||14
2843469|NCT03493854|3544883|FG000|STARTED|Surgery & Adjuvant Treatment (42 Weeks)||242
2843470|NCT03493854|3544884|FG001|STARTED|Surgery & Adjuvant Treatment (42 Weeks)||234
2843471|NCT03493854|3544883|FG000|Completed Surgery|Surgery & Adjuvant Treatment (42 Weeks)||239
2843472|NCT03493854|3544884|FG001|Completed Surgery|Surgery & Adjuvant Treatment (42 Weeks)||234
2843473|NCT03493854|3544883|FG000|COMPLETED|Surgery & Adjuvant Treatment (42 Weeks)||0
2843474|NCT03493854|3544884|FG001|COMPLETED|Surgery & Adjuvant Treatment (42 Weeks)||0
2843475|NCT03493854|3544883|FG000|NOT COMPLETED|Surgery & Adjuvant Treatment (42 Weeks)||242
2843476|NCT03493854|3544884|FG001|NOT COMPLETED|Surgery & Adjuvant Treatment (42 Weeks)||234
2843477|NCT03493854|3544883|FG000|STARTED|Treatment-Free Follow-Up (up to 3 Years)|Participants prematurely withdrew from treatment in other periods and entered the follow-up phase.|19
2843478|NCT03493854|3544884|FG001|STARTED|Treatment-Free Follow-Up (up to 3 Years)|Participants prematurely withdrew from treatment in other periods and entered the follow-up phase.|17
2843479|NCT03493854|3544883|FG000|COMPLETED|Treatment-Free Follow-Up (up to 3 Years)||0
2843480|NCT03493854|3544884|FG001|COMPLETED|Treatment-Free Follow-Up (up to 3 Years)||0
2843481|NCT03493854|3544883|FG000|NOT COMPLETED|Treatment-Free Follow-Up (up to 3 Years)||19
2843482|NCT03493854|3544884|FG001|NOT COMPLETED|Treatment-Free Follow-Up (up to 3 Years)||17
2843483|NCT03420768|3544893|FG000|STARTED|Overall Study||18
2843484|NCT03420768|3544894|FG001|STARTED|Overall Study||28
2843485|NCT03420768|3544895|FG002|STARTED|Overall Study||15
2843486|NCT03420768|3544893|FG000|COMPLETED|Overall Study||18
2843487|NCT03420768|3544894|FG001|COMPLETED|Overall Study||28
2843488|NCT03420768|3544895|FG002|COMPLETED|Overall Study||15
2843489|NCT03420768|3544893|FG000|NOT COMPLETED|Overall Study||0
2843490|NCT03420768|3544894|FG001|NOT COMPLETED|Overall Study||0
2843491|NCT03420768|3544895|FG002|NOT COMPLETED|Overall Study||0
2843492|NCT03417245|3544905|FG000|STARTED|Overall Study||40
2843493|NCT03417245|3544906|FG001|STARTED|Overall Study||80
2843494|NCT03417245|3544905|FG000|Treated|Overall Study||40
2843495|NCT03417245|3544906|FG001|Treated|Overall Study||79
2843496|NCT03417245|3544905|FG000|COMPLETED|Overall Study||37
2843497|NCT03417245|3544906|FG001|COMPLETED|Overall Study||79
2843498|NCT03417245|3544905|FG000|NOT COMPLETED|Overall Study||3
2843499|NCT03417245|3544906|FG001|NOT COMPLETED|Overall Study||1
2843500|NCT03395288|3544915|FG000|STARTED|Overall Study||28
2843501|NCT03395288|3544916|FG001|STARTED|Overall Study||29
2843502|NCT03395288|3544917|FG002|STARTED|Overall Study||4
2843503|NCT03395288|3544915|FG000|COMPLETED|Overall Study||19
2843504|NCT03395288|3544916|FG001|COMPLETED|Overall Study||25
2843505|NCT03395288|3544917|FG002|COMPLETED|Overall Study||3
2843506|NCT03395288|3544915|FG000|NOT COMPLETED|Overall Study||9
2843507|NCT03395288|3544916|FG001|NOT COMPLETED|Overall Study||4
2843508|NCT03395288|3544917|FG002|NOT COMPLETED|Overall Study||1
2843509|NCT03180307|3544927|FG000|STARTED|Overall Study||134
2843510|NCT03180307|3544928|FG001|STARTED|Overall Study||6
2843511|NCT03180307|3544927|FG000|Safety Analysis Set|Overall Study||134
2843512|NCT03180307|3544928|FG001|Safety Analysis Set|Overall Study||16
2843513|NCT03180307|3544927|FG000|Full Analysis Set/ Intent to Image Set|Overall Study||134
2843514|NCT03180307|3544928|FG001|Full Analysis Set/ Intent to Image Set|Overall Study||0
2843515|NCT03180307|3544927|FG000|Per Protocol Analysis Set|Overall Study||106
2843516|NCT03180307|3544928|FG001|Per Protocol Analysis Set|Overall Study||0
2843517|NCT03180307|3544927|FG000|Pharmacokinetic Analysis Set|Overall Study||122
2843518|NCT03180307|3544928|FG001|Pharmacokinetic Analysis Set|Overall Study||6
2843519|NCT03180307|3544927|FG000|COMPLETED|Overall Study||128
2843520|NCT03180307|3544928|FG001|COMPLETED|Overall Study||6
2843521|NCT03180307|3544927|FG000|NOT COMPLETED|Overall Study||6
2843522|NCT03180307|3544928|FG001|NOT COMPLETED|Overall Study||0
2843523|NCT03151083|3544935|FG000|STARTED|Overall Study||27
2843524|NCT03151083|3544936|FG001|STARTED|Overall Study||20
2843525|NCT03151083|3544937|FG002|STARTED|Overall Study||30
2843526|NCT03151083|3544935|FG000|COMPLETED|Overall Study||25
2843527|NCT03151083|3544936|FG001|COMPLETED|Overall Study||19
2843528|NCT03151083|3544937|FG002|COMPLETED|Overall Study||26
2843529|NCT03151083|3544935|FG000|NOT COMPLETED|Overall Study||2
2843530|NCT03151083|3544936|FG001|NOT COMPLETED|Overall Study||1
2843531|NCT03151083|3544937|FG002|NOT COMPLETED|Overall Study||4
2843532|NCT02831673|3544947|FG000|STARTED|Overall Study||356
2843533|NCT02831673|3544948|FG001|STARTED|Overall Study||358
2843534|NCT02831673|3544947|FG000|COMPLETED|Overall Study||0
2843535|NCT02831673|3544948|FG001|COMPLETED|Overall Study||0
2843536|NCT02831673|3544947|FG000|NOT COMPLETED|Overall Study||356
2843537|NCT02831673|3544948|FG001|NOT COMPLETED|Overall Study||358
2843538|NCT02668822|3544956|FG000|STARTED|Overall Study||9
2843539|NCT02668822|3544957|FG001|STARTED|Overall Study||9
2843540|NCT02668822|3544956|FG000|COMPLETED|Overall Study||0
2843541|NCT02668822|3544957|FG001|COMPLETED|Overall Study||0
2843542|NCT02668822|3544956|FG000|NOT COMPLETED|Overall Study||9
2843543|NCT02668822|3544957|FG001|NOT COMPLETED|Overall Study||9
2843544|NCT02668783|3544965|FG000|STARTED|Overall Study||13
2843545|NCT02668783|3544966|FG001|STARTED|Overall Study||12
2843546|NCT02668783|3544965|FG000|Treated|Overall Study||13
2843547|NCT02668783|3544966|FG001|Treated|Overall Study||11
2843548|NCT02668783|3544965|FG000|COMPLETED|Overall Study||0
2843549|NCT02668783|3544966|FG001|COMPLETED|Overall Study||0
2843550|NCT02668783|3544965|FG000|NOT COMPLETED|Overall Study||13
2843551|NCT02668783|3544966|FG001|NOT COMPLETED|Overall Study||12
2843552|NCT02616146|3544974|FG000|STARTED|Overall Study||1512
2843553|NCT02616146|3544975|FG001|STARTED|Overall Study||504
2843554|NCT02616146|3544974|FG000|COMPLETED|Overall Study|Due to termination of study, ENG-E2 reporting group received only up to 10 cycles of treatment.|0
2843555|NCT02616146|3544975|FG001|COMPLETED|Overall Study|Due to termination of study, LNG-EE reporting group received only up to 9 cycles of treatment.|0
2843556|NCT02616146|3544974|FG000|NOT COMPLETED|Overall Study||1512
2843557|NCT02616146|3544975|FG001|NOT COMPLETED|Overall Study||504
2843558|NCT02538510|3544983|FG000|STARTED|Overall Study||25
2843559|NCT02538510|3544984|FG001|STARTED|Overall Study||25
2843560|NCT02538510|3544983|FG000|COMPLETED|Overall Study||25
2843561|NCT02538510|3544984|FG001|COMPLETED|Overall Study||25
2843562|NCT02538510|3544983|FG000|NOT COMPLETED|Overall Study||0
2843563|NCT02538510|3544984|FG001|NOT COMPLETED|Overall Study||0
2843564|NCT02524288|3544994|FG000|STARTED|Overall Study||1941
2843565|NCT02524288|3544994|FG000|Treated|Overall Study||1936
2843566|NCT02524288|3544994|FG000|COMPLETED|Overall Study||0
2843567|NCT02524288|3544994|FG000|NOT COMPLETED|Overall Study||1941
2843568|NCT02489942|3544998|FG000|STARTED|Overall Study||8145
2843569|NCT02489942|3544998|FG000|Case Report Form (CRF) Collected|Overall Study||8059
2843570|NCT02489942|3544998|FG000|Treated|Overall Study||8057
2843571|NCT02489942|3544998|FG000|COMPLETED|Overall Study||4729
2843572|NCT02489942|3544998|FG000|NOT COMPLETED|Overall Study||3416
2843573|NCT02409342|3545004|FG000|STARTED|Overall Study||287
2843574|NCT02409342|3545005|FG001|STARTED|Overall Study||285
2843575|NCT02409342|3545004|FG000|COMPLETED|Overall Study||0
2843576|NCT02409342|3545005|FG001|COMPLETED|Overall Study||0
2843577|NCT02409342|3545004|FG000|NOT COMPLETED|Overall Study||287
2843578|NCT02409342|3545005|FG001|NOT COMPLETED|Overall Study||285
2843579|NCT02293655|3545015|FG000|STARTED|Overall Study||92
2843580|NCT02293655|3545016|FG001|STARTED|Overall Study||17
2843581|NCT02293655|3545015|FG000|COMPLETED|Overall Study||85
2843582|NCT02293655|3545016|FG001|COMPLETED|Overall Study||15
2843583|NCT02293655|3545015|FG000|NOT COMPLETED|Overall Study||7
2843584|NCT02293655|3545016|FG001|NOT COMPLETED|Overall Study||2
2916442|NCT00515502|3626830|FG008|STARTED|Treatment Period 3||0
2916443|NCT00515502|3626831|FG009|STARTED|Treatment Period 3||2
2916444|NCT00515502|3626832|FG010|STARTED|Treatment Period 3||1
2916445|NCT00515502|3626833|FG011|STARTED|Treatment Period 3||0
2916446|NCT00515502|3626822|FG000|COMPLETED|Treatment Period 3||1
2916447|NCT00515502|3626823|FG001|COMPLETED|Treatment Period 3||3
2916448|NCT00515502|3626824|FG002|COMPLETED|Treatment Period 3||4
2916449|NCT00515502|3626825|FG003|COMPLETED|Treatment Period 3||3
2916450|NCT00515502|3626826|FG004|COMPLETED|Treatment Period 3||3
2916451|NCT00515502|3626827|FG005|COMPLETED|Treatment Period 3||1
2916452|NCT00515502|3626828|FG006|COMPLETED|Treatment Period 3||1
2916453|NCT00515502|3626829|FG007|COMPLETED|Treatment Period 3||1
2916454|NCT00515502|3626830|FG008|COMPLETED|Treatment Period 3||0
2916455|NCT00515502|3626831|FG009|COMPLETED|Treatment Period 3||2
2916456|NCT00515502|3626832|FG010|COMPLETED|Treatment Period 3||1
2916457|NCT00515502|3626833|FG011|COMPLETED|Treatment Period 3||0
2916458|NCT00515502|3626822|FG000|NOT COMPLETED|Treatment Period 3||0
2916459|NCT00515502|3626823|FG001|NOT COMPLETED|Treatment Period 3||0
2916460|NCT00515502|3626824|FG002|NOT COMPLETED|Treatment Period 3||0
2916461|NCT00515502|3626825|FG003|NOT COMPLETED|Treatment Period 3||0
2916462|NCT00515502|3626826|FG004|NOT COMPLETED|Treatment Period 3||0
2916463|NCT00515502|3626827|FG005|NOT COMPLETED|Treatment Period 3||0
2916464|NCT00515502|3626828|FG006|NOT COMPLETED|Treatment Period 3||0
2916465|NCT00515502|3626829|FG007|NOT COMPLETED|Treatment Period 3||0
2916466|NCT00515502|3626830|FG008|NOT COMPLETED|Treatment Period 3||0
2916467|NCT00515502|3626831|FG009|NOT COMPLETED|Treatment Period 3||0
2916468|NCT00515502|3626832|FG010|NOT COMPLETED|Treatment Period 3||0
2916469|NCT00515502|3626833|FG011|NOT COMPLETED|Treatment Period 3||0
2916470|NCT00515502|3626822|FG000|STARTED|Washout Period 3||1
2916471|NCT00515502|3626823|FG001|STARTED|Washout Period 3||3
2916472|NCT00515502|3626824|FG002|STARTED|Washout Period 3||4
2916473|NCT00515502|3626825|FG003|STARTED|Washout Period 3||3
2916474|NCT00515502|3626826|FG004|STARTED|Washout Period 3||3
2916475|NCT00515502|3626827|FG005|STARTED|Washout Period 3||1
2916476|NCT00515502|3626828|FG006|STARTED|Washout Period 3||1
2916477|NCT00515502|3626829|FG007|STARTED|Washout Period 3||1
2916478|NCT00515502|3626830|FG008|STARTED|Washout Period 3||0
2916479|NCT00515502|3626831|FG009|STARTED|Washout Period 3||2
2916480|NCT00515502|3626832|FG010|STARTED|Washout Period 3||1
2916481|NCT00515502|3626833|FG011|STARTED|Washout Period 3||0
2916482|NCT00515502|3626822|FG000|COMPLETED|Washout Period 3||1
2916483|NCT00515502|3626823|FG001|COMPLETED|Washout Period 3||3
2916484|NCT00515502|3626824|FG002|COMPLETED|Washout Period 3||4
2916485|NCT00515502|3626825|FG003|COMPLETED|Washout Period 3||3
2916486|NCT00515502|3626826|FG004|COMPLETED|Washout Period 3||3
2916487|NCT00515502|3626827|FG005|COMPLETED|Washout Period 3||1
2916488|NCT00515502|3626828|FG006|COMPLETED|Washout Period 3||1
2916489|NCT00515502|3626829|FG007|COMPLETED|Washout Period 3||1
2916490|NCT00515502|3626830|FG008|COMPLETED|Washout Period 3||0
2916491|NCT00515502|3626831|FG009|COMPLETED|Washout Period 3||2
2916492|NCT00515502|3626832|FG010|COMPLETED|Washout Period 3||1
2916493|NCT00515502|3626833|FG011|COMPLETED|Washout Period 3||0
2916494|NCT00515502|3626822|FG000|NOT COMPLETED|Washout Period 3||0
2916495|NCT00515502|3626823|FG001|NOT COMPLETED|Washout Period 3||0
2916496|NCT00515502|3626824|FG002|NOT COMPLETED|Washout Period 3||0
2916497|NCT00515502|3626825|FG003|NOT COMPLETED|Washout Period 3||0
2916498|NCT00515502|3626826|FG004|NOT COMPLETED|Washout Period 3||0
2843585|NCT02275546|3545022|FG000|STARTED|Treatment Period 1||81
2843586|NCT02275546|3545023|FG001|STARTED|Treatment Period 1||83
2843587|NCT02275546|3545022|FG000|COMPLETED|Treatment Period 1||81
2843588|NCT02275546|3545023|FG001|COMPLETED|Treatment Period 1||83
2843589|NCT02275546|3545022|FG000|NOT COMPLETED|Treatment Period 1||0
2843590|NCT02275546|3545023|FG001|NOT COMPLETED|Treatment Period 1||0
2843591|NCT02275546|3545022|FG000|STARTED|Treatment Period 2||81
2843592|NCT02275546|3545023|FG001|STARTED|Treatment Period 2||83
2843593|NCT02275546|3545022|FG000|COMPLETED|Treatment Period 2||79
2843594|NCT02275546|3545023|FG001|COMPLETED|Treatment Period 2||81
2843595|NCT02275546|3545022|FG000|NOT COMPLETED|Treatment Period 2||2
2843596|NCT02275546|3545023|FG001|NOT COMPLETED|Treatment Period 2||2
2843597|NCT02227238|3545031|FG000|STARTED|Overall Study||312
2843598|NCT02227238|3545032|FG001|STARTED|Overall Study||312
2843599|NCT02227238|3545031|FG000|COMPLETED|Overall Study||275
2843600|NCT02227238|3545032|FG001|COMPLETED|Overall Study||245
2843601|NCT02227238|3545031|FG000|NOT COMPLETED|Overall Study||37
2843602|NCT02227238|3545032|FG001|NOT COMPLETED|Overall Study||67
2843603|NCT02077166|3545045|FG000|STARTED|Overall Study||12
2843604|NCT02077166|3545046|FG001|STARTED|Overall Study||7
2843605|NCT02077166|3545047|FG002|STARTED|Overall Study||9
2843606|NCT02077166|3545048|FG003|STARTED|Overall Study||9
2843607|NCT02077166|3545049|FG004|STARTED|Overall Study||8
2843608|NCT02077166|3545050|FG005|STARTED|Overall Study||55
2843609|NCT02077166|3545051|FG006|STARTED|Overall Study||34
2843610|NCT02077166|3545045|FG000|COMPLETED|Overall Study||0
2843611|NCT02077166|3545046|FG001|COMPLETED|Overall Study||0
2843612|NCT02077166|3545047|FG002|COMPLETED|Overall Study||0
2843613|NCT02077166|3545048|FG003|COMPLETED|Overall Study||0
2843614|NCT02077166|3545049|FG004|COMPLETED|Overall Study||0
2843615|NCT02077166|3545050|FG005|COMPLETED|Overall Study||0
3167678|NCT01912456|3894958|FG003|COMPLETED|Period 2||18
3167679|NCT01912456|3894955|FG000|NOT COMPLETED|Period 2||0
3167680|NCT01912456|3894956|FG001|NOT COMPLETED|Period 2||2
3167681|NCT01912456|3894957|FG002|NOT COMPLETED|Period 2||0
3167682|NCT01912456|3894958|FG003|NOT COMPLETED|Period 2||1
2843616|NCT02077166|3545051|FG006|COMPLETED|Overall Study||0
2843617|NCT02077166|3545045|FG000|NOT COMPLETED|Overall Study||12
2843618|NCT02077166|3545046|FG001|NOT COMPLETED|Overall Study||7
2843619|NCT02077166|3545047|FG002|NOT COMPLETED|Overall Study||9
2843620|NCT02077166|3545048|FG003|NOT COMPLETED|Overall Study||9
2843621|NCT02077166|3545049|FG004|NOT COMPLETED|Overall Study||8
2843622|NCT02077166|3545050|FG005|NOT COMPLETED|Overall Study||55
2843623|NCT02077166|3545051|FG006|NOT COMPLETED|Overall Study||34
2843624|NCT01891344|3545076|FG000|STARTED|Overall Study||40
2843625|NCT01891344|3545077|FG001|STARTED|Overall Study||82
2843626|NCT01891344|3545078|FG002|STARTED|Overall Study||70
2843627|NCT01891344|3545079|FG003|STARTED|Overall Study||12
2843628|NCT01891344|3545080|FG004|STARTED|Overall Study||84
2843629|NCT01891344|3545081|FG005|STARTED|Overall Study||73
2843630|NCT01891344|3545082|FG006|STARTED|Overall Study||107
2843631|NCT01891344|3545083|FG007|STARTED|Overall Study||23
2843632|NCT01891344|3545076|FG000|COMPLETED|Overall Study||34
2843633|NCT01891344|3545077|FG001|COMPLETED|Overall Study||80
2843634|NCT01891344|3545078|FG002|COMPLETED|Overall Study||70
2843635|NCT01891344|3545079|FG003|COMPLETED|Overall Study||11
2843636|NCT01891344|3545080|FG004|COMPLETED|Overall Study||80
2843637|NCT01891344|3545081|FG005|COMPLETED|Overall Study||72
2843638|NCT01891344|3545082|FG006|COMPLETED|Overall Study||107
2843639|NCT01891344|3545083|FG007|COMPLETED|Overall Study||23
2843640|NCT01891344|3545076|FG000|NOT COMPLETED|Overall Study||6
2843641|NCT01891344|3545077|FG001|NOT COMPLETED|Overall Study||2
2843642|NCT01891344|3545078|FG002|NOT COMPLETED|Overall Study||0
2843643|NCT01891344|3545079|FG003|NOT COMPLETED|Overall Study||1
2843644|NCT01891344|3545080|FG004|NOT COMPLETED|Overall Study||4
2843645|NCT01891344|3545081|FG005|NOT COMPLETED|Overall Study||1
2843646|NCT01891344|3545082|FG006|NOT COMPLETED|Overall Study||0
2843647|NCT01891344|3545083|FG007|NOT COMPLETED|Overall Study||0
2843648|NCT01847274|3545105|FG000|STARTED|Overall Study||138
2843649|NCT01847274|3545106|FG001|STARTED|Overall Study||65
2843650|NCT01847274|3545107|FG002|STARTED|Overall Study||234
2843651|NCT01847274|3545108|FG003|STARTED|Overall Study||116
2843652|NCT01847274|3545105|FG000|COMPLETED|Overall Study||47
2843653|NCT01847274|3545106|FG001|COMPLETED|Overall Study||4
2843654|NCT01847274|3545107|FG002|COMPLETED|Overall Study||46
2843655|NCT01847274|3545108|FG003|COMPLETED|Overall Study||12
2843656|NCT01847274|3545105|FG000|NOT COMPLETED|Overall Study||91
2843657|NCT01847274|3545106|FG001|NOT COMPLETED|Overall Study||61
2843658|NCT01847274|3545107|FG002|NOT COMPLETED|Overall Study||188
2843659|NCT01847274|3545108|FG003|NOT COMPLETED|Overall Study||104
2843660|NCT01670656|3545123|FG000|STARTED|Overall Study||86
2843661|NCT01670656|3545124|FG001|STARTED|Overall Study||91
2843662|NCT01670656|3545125|FG002|STARTED|Overall Study||87
2843663|NCT01670656|3545126|FG003|STARTED|Overall Study||85
2843664|NCT01670656|3545127|FG004|STARTED|Overall Study||90
2843665|NCT01670656|3545123|FG000|Treated|Overall Study||86
2843666|NCT01670656|3545124|FG001|Treated|Overall Study||91
2843667|NCT01670656|3545125|FG002|Treated|Overall Study||86
3167683|NCT01912495|3894968|FG000|STARTED|Overall Study|8 patients had only screening visit, total enrollment: 65|57
3167684|NCT01912495|3894968|FG000|COMPLETED|Overall Study||57
3167685|NCT01912495|3894968|FG000|NOT COMPLETED|Overall Study||0
3167686|NCT01912599|3894977|FG000|STARTED|Overall Study||20
3167687|NCT01912599|3894978|FG001|STARTED|Overall Study||16
2843668|NCT01670656|3545126|FG003|Treated|Overall Study||85
2843669|NCT01670656|3545127|FG004|Treated|Overall Study||90
2843670|NCT01670656|3545123|FG000|COMPLETED|Overall Study||83
2843671|NCT01670656|3545124|FG001|COMPLETED|Overall Study||84
2843672|NCT01670656|3545125|FG002|COMPLETED|Overall Study||79
2843673|NCT01670656|3545126|FG003|COMPLETED|Overall Study||79
2843674|NCT01670656|3545127|FG004|COMPLETED|Overall Study||79
2843675|NCT01670656|3545123|FG000|NOT COMPLETED|Overall Study||3
2843676|NCT01670656|3545124|FG001|NOT COMPLETED|Overall Study||7
2843677|NCT01670656|3545125|FG002|NOT COMPLETED|Overall Study||8
2843678|NCT01670656|3545126|FG003|NOT COMPLETED|Overall Study||6
2843679|NCT01670656|3545127|FG004|NOT COMPLETED|Overall Study||11
2843680|NCT01501955|3545141|FG000|STARTED|Overall Study||11
2843681|NCT01501955|3545142|FG001|STARTED|Overall Study||9
2843682|NCT01501955|3545141|FG000|Surgery|Overall Study||11
2843683|NCT01501955|3545142|FG001|Surgery|Overall Study||9
2843684|NCT01501955|3545141|FG000|6 Weeks Postop|Overall Study|1 patient withdrew on own request|10
2843685|NCT01501955|3545142|FG001|6 Weeks Postop|Overall Study||9
2843686|NCT01501955|3545141|FG000|1 Year Postop|Overall Study|1 patient terminated due to stem revision|9
2843687|NCT01501955|3545142|FG001|1 Year Postop|Overall Study|2 patients terminated due to stem revision|7
2843688|NCT01501955|3545141|FG000|2 Years Postop|Overall Study||9
2843689|NCT01501955|3545142|FG001|2 Years Postop|Overall Study|1 patient terminated due to stem revision|6
2843690|NCT01501955|3545141|FG000|COMPLETED|Overall Study||9
2843691|NCT01501955|3545142|FG001|COMPLETED|Overall Study||6
2843692|NCT01501955|3545141|FG000|NOT COMPLETED|Overall Study||2
2843693|NCT01501955|3545142|FG001|NOT COMPLETED|Overall Study||3
2843694|NCT01335399|3545150|FG000|STARTED|Pre-treatment Period||374
2843695|NCT01335399|3545151|FG001|STARTED|Pre-treatment Period||374
2843696|NCT01335399|3545150|FG000|COMPLETED|Pre-treatment Period||371
2843697|NCT01335399|3545151|FG001|COMPLETED|Pre-treatment Period||371
2843698|NCT01335399|3545150|FG000|NOT COMPLETED|Pre-treatment Period||3
2843699|NCT01335399|3545151|FG001|NOT COMPLETED|Pre-treatment Period||3
2843700|NCT01335399|3545150|FG000|STARTED|Treatment Period||371
2843701|NCT01335399|3545151|FG001|STARTED|Treatment Period||371
2843702|NCT01335399|3545150|FG000|COMPLETED|Treatment Period||38
2843703|NCT01335399|3545151|FG001|COMPLETED|Treatment Period||32
2843704|NCT01335399|3545150|FG000|NOT COMPLETED|Treatment Period||333
2843705|NCT01335399|3545151|FG001|NOT COMPLETED|Treatment Period||339
2843706|NCT01277211|3545159|FG000|STARTED|Overall Study||738
2843707|NCT01277211|3545160|FG001|STARTED|Overall Study||245
2843708|NCT01277211|3545159|FG000|Treated|Overall Study||714
2843709|NCT01277211|3545160|FG001|Treated|Overall Study||232
2843710|NCT01277211|3545159|FG000|COMPLETED|Overall Study||588
2843711|NCT01277211|3545160|FG001|COMPLETED|Overall Study||182
2843712|NCT01277211|3545159|FG000|NOT COMPLETED|Overall Study||150
3167688|NCT01912599|3894977|FG000|COMPLETED|Overall Study||20
3167689|NCT01912599|3894978|FG001|COMPLETED|Overall Study||15
3167690|NCT01912599|3894977|FG000|NOT COMPLETED|Overall Study||0
3167691|NCT01912599|3894978|FG001|NOT COMPLETED|Overall Study||1
3167692|NCT01912612|3894986|FG000|STARTED|Overall Study||36
2843713|NCT01277211|3545160|FG001|NOT COMPLETED|Overall Study||63
2843714|NCT01267812|3545166|FG000|STARTED|Overall Study||23
2843715|NCT01267812|3545166|FG000|COMPLETED|Overall Study||23
2843716|NCT01267812|3545166|FG000|NOT COMPLETED|Overall Study||0
2843717|NCT01244828|3545170|FG000|STARTED|Overall Study|Received study drug|157
2843718|NCT01244828|3545170|FG000|COMPLETED|Overall Study||79
2843719|NCT01244828|3545170|FG000|NOT COMPLETED|Overall Study||78
2843720|NCT01207492|3545174|FG000|STARTED|Overall Study||17
2843721|NCT01207492|3545174|FG000|COMPLETED|Overall Study||2
2843722|NCT01207492|3545174|FG000|NOT COMPLETED|Overall Study||15
2843723|NCT01181778|3545178|FG000|STARTED|Overall Study||1919
2843724|NCT01181778|3545178|FG000|COMPLETED|Overall Study||1871
2843725|NCT01181778|3545178|FG000|NOT COMPLETED|Overall Study||48
2843726|NCT01047540|3545189|FG000|STARTED|Overall Study||34
2843727|NCT01047540|3545190|FG001|STARTED|Overall Study||32
2843728|NCT01047540|3545191|FG002|STARTED|Overall Study||29
2843729|NCT01047540|3545192|FG003|STARTED|Overall Study||31
2843730|NCT01047540|3545193|FG004|STARTED|Overall Study||30
2843731|NCT01047540|3545189|FG000|COMPLETED|Overall Study||29
2843732|NCT01047540|3545190|FG001|COMPLETED|Overall Study||32
2843733|NCT01047540|3545191|FG002|COMPLETED|Overall Study||26
2843734|NCT01047540|3545192|FG003|COMPLETED|Overall Study||31
2843735|NCT01047540|3545193|FG004|COMPLETED|Overall Study||29
2843736|NCT01047540|3545189|FG000|NOT COMPLETED|Overall Study||5
2843737|NCT01047540|3545190|FG001|NOT COMPLETED|Overall Study||0
2843738|NCT01047540|3545191|FG002|NOT COMPLETED|Overall Study||3
2843739|NCT01047540|3545192|FG003|NOT COMPLETED|Overall Study||0
2843740|NCT01047540|3545193|FG004|NOT COMPLETED|Overall Study||1
2843741|NCT01044056|3545208|FG000|STARTED|Overall Study||8
2843742|NCT01044056|3545209|FG001|STARTED|Overall Study||8
2843743|NCT01044056|3545210|FG002|STARTED|Overall Study||8
2843744|NCT01044056|3545208|FG000|COMPLETED|Overall Study||8
2843745|NCT01044056|3545209|FG001|COMPLETED|Overall Study||8
2843746|NCT01044056|3545210|FG002|COMPLETED|Overall Study||8
2843747|NCT01044056|3545208|FG000|NOT COMPLETED|Overall Study||0
3167693|NCT01912612|3894987|FG001|STARTED|Overall Study||40
3167694|NCT01912612|3894988|FG002|STARTED|Overall Study||3
3167695|NCT01912612|3894986|FG000|COMPLETED|Overall Study||31
3167696|NCT01912612|3894987|FG001|COMPLETED|Overall Study||40
3167697|NCT01912612|3894988|FG002|COMPLETED|Overall Study||0
3167698|NCT01912612|3894986|FG000|NOT COMPLETED|Overall Study||5
2843748|NCT01044056|3545209|FG001|NOT COMPLETED|Overall Study||0
2843749|NCT01044056|3545210|FG002|NOT COMPLETED|Overall Study||0
2843750|NCT00944216|3545218|FG000|STARTED|Overall Study||1
2843751|NCT00944216|3545218|FG000|COMPLETED|Overall Study||1
2843752|NCT00944216|3545218|FG000|NOT COMPLETED|Overall Study||0
2843753|NCT00886691|3545225|FG000|STARTED|Overall Study||75
2843754|NCT00886691|3545226|FG001|STARTED|Overall Study||75
2843755|NCT00886691|3545225|FG000|COMPLETED|Overall Study||75
2843756|NCT00886691|3545226|FG001|COMPLETED|Overall Study||75
2843757|NCT00886691|3545225|FG000|NOT COMPLETED|Overall Study||0
2843758|NCT00886691|3545226|FG001|NOT COMPLETED|Overall Study||0
2843759|NCT00778999|3545238|FG000|STARTED|Overall Study||223
2843760|NCT00778999|3545239|FG001|STARTED|Overall Study||219
2843761|NCT00778999|3545238|FG000|COMPLETED|Overall Study||195
2843762|NCT00778999|3545239|FG001|COMPLETED|Overall Study||185
2843763|NCT00778999|3545238|FG000|NOT COMPLETED|Overall Study||28
2843764|NCT00778999|3545239|FG001|NOT COMPLETED|Overall Study||34
2843765|NCT00620464|3545247|FG000|STARTED|Overall Study||52
2843766|NCT00620464|3545248|FG001|STARTED|Overall Study||56
2843767|NCT00620464|3545247|FG000|COMPLETED|Overall Study||32
2843768|NCT00620464|3545248|FG001|COMPLETED|Overall Study||32
2843769|NCT00620464|3545247|FG000|NOT COMPLETED|Overall Study||20
2843770|NCT00620464|3545248|FG001|NOT COMPLETED|Overall Study||24
2843771|NCT00620035|3545254|FG000|STARTED|Overall Study||301
2843772|NCT00620035|3545254|FG000|COMPLETED|Overall Study||156
2843773|NCT00620035|3545254|FG000|NOT COMPLETED|Overall Study||145
2843774|NCT00210249|3545258|FG000|STARTED|Overall Study||364
2843775|NCT00210249|3545258|FG000|COMPLETED|Overall Study||348
2843776|NCT00210249|3545258|FG000|NOT COMPLETED|Overall Study||16
2916499|NCT00515502|3626827|FG005|NOT COMPLETED|Washout Period 3||0
2916500|NCT00515502|3626828|FG006|NOT COMPLETED|Washout Period 3||0
2916501|NCT00515502|3626829|FG007|NOT COMPLETED|Washout Period 3||0
2916502|NCT00515502|3626830|FG008|NOT COMPLETED|Washout Period 3||0
2916503|NCT00515502|3626831|FG009|NOT COMPLETED|Washout Period 3||0
2916504|NCT00515502|3626832|FG010|NOT COMPLETED|Washout Period 3||0
2916505|NCT00515502|3626833|FG011|NOT COMPLETED|Washout Period 3||0
2916506|NCT00515502|3626822|FG000|STARTED|Treatment Period 4||1
2916507|NCT00515502|3626823|FG001|STARTED|Treatment Period 4||3
2916508|NCT00515502|3626824|FG002|STARTED|Treatment Period 4||4
2916509|NCT00515502|3626825|FG003|STARTED|Treatment Period 4||3
2916510|NCT00515502|3626826|FG004|STARTED|Treatment Period 4||3
2916511|NCT00515502|3626827|FG005|STARTED|Treatment Period 4||1
2916512|NCT00515502|3626828|FG006|STARTED|Treatment Period 4||1
2916513|NCT00515502|3626829|FG007|STARTED|Treatment Period 4||1
2916514|NCT00515502|3626830|FG008|STARTED|Treatment Period 4||0
2916515|NCT00515502|3626831|FG009|STARTED|Treatment Period 4||2
2916516|NCT00515502|3626832|FG010|STARTED|Treatment Period 4||1
2916517|NCT00515502|3626833|FG011|STARTED|Treatment Period 4||0
2916518|NCT00515502|3626822|FG000|COMPLETED|Treatment Period 4||1
2916519|NCT00515502|3626823|FG001|COMPLETED|Treatment Period 4||3
2916520|NCT00515502|3626824|FG002|COMPLETED|Treatment Period 4||4
2916521|NCT00515502|3626825|FG003|COMPLETED|Treatment Period 4||3
2916522|NCT00515502|3626826|FG004|COMPLETED|Treatment Period 4||3
2916523|NCT00515502|3626827|FG005|COMPLETED|Treatment Period 4||1
2916524|NCT00515502|3626828|FG006|COMPLETED|Treatment Period 4||1
2916525|NCT00515502|3626829|FG007|COMPLETED|Treatment Period 4||1
2916526|NCT00515502|3626830|FG008|COMPLETED|Treatment Period 4||0
2916527|NCT00515502|3626831|FG009|COMPLETED|Treatment Period 4||2
2916528|NCT00515502|3626832|FG010|COMPLETED|Treatment Period 4||1
2916529|NCT00515502|3626833|FG011|COMPLETED|Treatment Period 4||0
2916530|NCT00515502|3626822|FG000|NOT COMPLETED|Treatment Period 4||0
2916531|NCT00515502|3626823|FG001|NOT COMPLETED|Treatment Period 4||0
2916532|NCT00515502|3626824|FG002|NOT COMPLETED|Treatment Period 4||0
2916533|NCT00515502|3626825|FG003|NOT COMPLETED|Treatment Period 4||0
2916534|NCT00515502|3626826|FG004|NOT COMPLETED|Treatment Period 4||0
2916535|NCT00515502|3626827|FG005|NOT COMPLETED|Treatment Period 4||0
2916536|NCT00515502|3626828|FG006|NOT COMPLETED|Treatment Period 4||0
2916537|NCT00515502|3626829|FG007|NOT COMPLETED|Treatment Period 4||0
2916538|NCT00515502|3626830|FG008|NOT COMPLETED|Treatment Period 4||0
2916539|NCT00515502|3626831|FG009|NOT COMPLETED|Treatment Period 4||0
2916540|NCT00515502|3626832|FG010|NOT COMPLETED|Treatment Period 4||0
2916541|NCT00515502|3626833|FG011|NOT COMPLETED|Treatment Period 4||0
2916542|NCT00515528|3626852|FG000|STARTED|Overall Study||10
2916543|NCT00515528|3626853|FG001|STARTED|Overall Study||7
2916544|NCT00515528|3626852|FG000|COMPLETED|Overall Study||10
2916545|NCT00515528|3626853|FG001|COMPLETED|Overall Study||7
2916546|NCT00515528|3626852|FG000|NOT COMPLETED|Overall Study||0
2916547|NCT00515528|3626853|FG001|NOT COMPLETED|Overall Study||0
2916548|NCT00515541|3626863|FG000|STARTED|Overall Study||10
2916549|NCT00515541|3626864|FG001|STARTED|Overall Study||12
2916550|NCT00515541|3626865|FG002|STARTED|Overall Study||10
2916551|NCT00515541|3626866|FG003|STARTED|Overall Study||11
2916552|NCT00515541|3626863|FG000|6 Weeks (1 gm Lovaza)|Overall Study||10
2920741|NCT00538590|3631295|FG000|NOT COMPLETED|Overall Study||1
2920742|NCT00538590|3631296|FG001|NOT COMPLETED|Overall Study||0
3167699|NCT01912612|3894987|FG001|NOT COMPLETED|Overall Study||0
3167700|NCT01912612|3894988|FG002|NOT COMPLETED|Overall Study||3
3167701|NCT01912716|3894996|FG000|STARTED|Overall Study|receipt of 1st dose of indomethacin|522
3167702|NCT01912716|3894997|FG001|STARTED|Overall Study||515
3167703|NCT01912716|3894996|FG000|Receipt of 2nd Dose|Overall Study||511
3167704|NCT01912716|3894997|FG001|Receipt of 2nd Dose|Overall Study||503
3167705|NCT01912716|3894996|FG000|5-day Follow-up|Overall Study||522
3167706|NCT01912716|3894997|FG001|5-day Follow-up|Overall Study||515
3167707|NCT01912716|3894996|FG000|3-day Follow-up|Overall Study||521
3167708|NCT01912716|3894997|FG001|3-day Follow-up|Overall Study||513
3167709|NCT01912716|3894996|FG000|COMPLETED|Overall Study||522
3167710|NCT01912716|3894997|FG001|COMPLETED|Overall Study||515
3167711|NCT01912716|3894996|FG000|NOT COMPLETED|Overall Study||0
3167712|NCT01912716|3894997|FG001|NOT COMPLETED|Overall Study||0
3167713|NCT01912729|3895007|FG000|STARTED|Overall Study||20
3167714|NCT01912729|3895008|FG001|STARTED|Overall Study||20
3167715|NCT01912729|3895007|FG000|COMPLETED|Overall Study||20
3167716|NCT01912729|3895008|FG001|COMPLETED|Overall Study||19
3167717|NCT01912729|3895007|FG000|NOT COMPLETED|Overall Study||0
3167718|NCT01912729|3895008|FG001|NOT COMPLETED|Overall Study||1
3167719|NCT01912768|3895016|FG000|STARTED|Overall Study||239
3167720|NCT01912768|3895017|FG001|STARTED|Overall Study||113
3167721|NCT01912768|3895016|FG000|COMPLETED|Overall Study||229
3167722|NCT01912768|3895017|FG001|COMPLETED|Overall Study||109
3167723|NCT01912768|3895016|FG000|NOT COMPLETED|Overall Study||10
3167724|NCT01912768|3895017|FG001|NOT COMPLETED|Overall Study||4
3167725|NCT01912781|3895026|FG000|STARTED|Overall Study||71
3167726|NCT01912781|3895027|FG001|STARTED|Overall Study||35
3167727|NCT01912781|3895026|FG000|COMPLETED|Overall Study||69
3167728|NCT01912781|3895027|FG001|COMPLETED|Overall Study||35
3167729|NCT01912781|3895026|FG000|NOT COMPLETED|Overall Study||2
3167730|NCT01912781|3895027|FG001|NOT COMPLETED|Overall Study||0
3167731|NCT01912807|3895036|FG000|STARTED|Overall Study|Enrolment phase: Recruiting of participants started December 11, 2013|150
3167732|NCT01912807|3895037|FG001|STARTED|Overall Study|Enrolment phase: Recruitment of participants started December 11, 2013|150
3167733|NCT01912807|3895036|FG000|Randomized|Overall Study||144
3167734|NCT01912807|3895037|FG001|Randomized|Overall Study||146
3167735|NCT01912807|3895036|FG000|COMPLETED|Overall Study|"n=108 completed study and immediate follow up~n=36 participants were lost to follow up at 24 hr"|108
3167736|NCT01912807|3895037|FG001|COMPLETED|Overall Study|"n=109 completed study and immediate follow up~n=37 participants were lost to follow up at 24 hr"|109
3167737|NCT01912807|3895036|FG000|NOT COMPLETED|Overall Study||42
3167738|NCT01912807|3895037|FG001|NOT COMPLETED|Overall Study||41
3167739|NCT01912872|3895047|FG000|STARTED|Overall Study||16
3167740|NCT01912872|3895048|FG001|STARTED|Overall Study||17
3167741|NCT01912872|3895049|FG002|STARTED|Overall Study||40
3167742|NCT01912872|3895050|FG003|STARTED|Overall Study||39
3167743|NCT01912872|3895047|FG000|Completed Study Treatment at Month 12|Overall Study||11
3167744|NCT01912872|3895048|FG001|Completed Study Treatment at Month 12|Overall Study||13
3167745|NCT01912872|3895049|FG002|Completed Study Treatment at Month 12|Overall Study||30
3167746|NCT01912872|3895050|FG003|Completed Study Treatment at Month 12|Overall Study||27
3167747|NCT01912872|3895047|FG000|Discontinued Treatment Prior to Month 12|Overall Study||5
3167748|NCT01912872|3895048|FG001|Discontinued Treatment Prior to Month 12|Overall Study||4
3167749|NCT01912872|3895049|FG002|Discontinued Treatment Prior to Month 12|Overall Study||10
3167750|NCT01912872|3895050|FG003|Discontinued Treatment Prior to Month 12|Overall Study||11
3167751|NCT01912872|3895047|FG000|COMPLETED|Overall Study||11
3167752|NCT01912872|3895048|FG001|COMPLETED|Overall Study||13
3167753|NCT01912872|3895049|FG002|COMPLETED|Overall Study||30
3167754|NCT01912872|3895050|FG003|COMPLETED|Overall Study||27
3167755|NCT01912872|3895047|FG000|NOT COMPLETED|Overall Study||5
3167756|NCT01912872|3895048|FG001|NOT COMPLETED|Overall Study||4
3167757|NCT01912872|3895049|FG002|NOT COMPLETED|Overall Study||10
3167758|NCT01912872|3895050|FG003|NOT COMPLETED|Overall Study||12
3167759|NCT01912963|3895064|FG000|STARTED|Overall Study||6
3167760|NCT01912963|3895065|FG001|STARTED|Overall Study||19
3167761|NCT01912963|3895066|FG002|STARTED|Overall Study||7
3167762|NCT01912963|3895064|FG000|COMPLETED|Overall Study||0
3167763|NCT01912963|3895065|FG001|COMPLETED|Overall Study||0
3167764|NCT01912963|3895066|FG002|COMPLETED|Overall Study||0
3167765|NCT01912963|3895064|FG000|NOT COMPLETED|Overall Study||6
3167766|NCT01912963|3895065|FG001|NOT COMPLETED|Overall Study||19
3167767|NCT01912963|3895066|FG002|NOT COMPLETED|Overall Study||7
3167768|NCT01913041|3895074|FG000|STARTED|Overall Study||869
3167769|NCT01913041|3895074|FG000|COMPLETED|Overall Study||830
3167770|NCT01913041|3895074|FG000|NOT COMPLETED|Overall Study||39
3167771|NCT01913314|3895078|FG000|STARTED|Overall Study||6
3167772|NCT01913314|3895078|FG000|Received Study Drug|Overall Study||6
3167773|NCT01913314|3895078|FG000|COMPLETED|Overall Study||6
3167774|NCT01913314|3895078|FG000|NOT COMPLETED|Overall Study||0
3167775|NCT01913340|3895084|FG000|STARTED|Overall Study|22 (92%) received all 5 doses, 1 (4%) received 4 doses, and 1 (4%) only received 1 dose.|24
3167776|NCT01913340|3895085|FG001|STARTED|Overall Study||26
3167777|NCT01913340|3895084|FG000|COMPLETED|Overall Study||21
3167778|NCT01913340|3895085|FG001|COMPLETED|Overall Study||20
3167779|NCT01913340|3895084|FG000|NOT COMPLETED|Overall Study||3
3167780|NCT01913340|3895085|FG001|NOT COMPLETED|Overall Study||6
3167781|NCT01913353|3895093|FG000|STARTED|Overall Study||221
3167782|NCT01913353|3895094|FG001|STARTED|Overall Study||219
3167783|NCT01913353|3895093|FG000|COMPLETED|Overall Study||189
3167784|NCT01913353|3895094|FG001|COMPLETED|Overall Study||204
3167785|NCT01913353|3895093|FG000|NOT COMPLETED|Overall Study||32
3167786|NCT01913353|3895094|FG001|NOT COMPLETED|Overall Study||15
3167787|NCT01913405|3895107|FG000|STARTED|Overall Study||22
3167788|NCT01913405|3895107|FG000|COMPLETED|Overall Study||20
3167789|NCT01913405|3895107|FG000|NOT COMPLETED|Overall Study||2
3167790|NCT01913470|3895126|FG000|STARTED|Overall Study||5
3167791|NCT01913470|3895127|FG001|STARTED|Overall Study||7
3167792|NCT01913470|3895126|FG000|COMPLETED|Overall Study||5
3167793|NCT01913470|3895127|FG001|COMPLETED|Overall Study||4
3167794|NCT01913470|3895126|FG000|NOT COMPLETED|Overall Study||0
3167795|NCT01913470|3895127|FG001|NOT COMPLETED|Overall Study||3
3167796|NCT01913483|3895136|FG000|STARTED|Overall Study||367
3167797|NCT01913483|3895137|FG001|STARTED|Overall Study||365
3167798|NCT01913483|3895136|FG000|Received at Least 1 Dose of Study Drug|Overall Study||335
3167799|NCT01913483|3895137|FG001|Received at Least 1 Dose of Study Drug|Overall Study||321
3167800|NCT01913483|3895136|FG000|COMPLETED|Overall Study||346
3167801|NCT01913483|3895137|FG001|COMPLETED|Overall Study||343
3167802|NCT01913483|3895136|FG000|NOT COMPLETED|Overall Study||21
3167803|NCT01913483|3895137|FG001|NOT COMPLETED|Overall Study||22
3167804|NCT01913535|3895148|FG000|STARTED|Phase 1 (Days 0-2)||2
3167805|NCT01913535|3895149|FG001|STARTED|Phase 1 (Days 0-2)||2
3167806|NCT01913535|3895150|FG002|STARTED|Phase 1 (Days 0-2)||1
3167807|NCT01913535|3895151|FG003|STARTED|Phase 1 (Days 0-2)||2
3167808|NCT01913535|3895152|FG004|STARTED|Phase 1 (Days 0-2)||1
3167809|NCT01913535|3895148|FG000|COMPLETED|Phase 1 (Days 0-2)||2
3167810|NCT01913535|3895149|FG001|COMPLETED|Phase 1 (Days 0-2)||2
3167811|NCT01913535|3895150|FG002|COMPLETED|Phase 1 (Days 0-2)||1
3167812|NCT01913535|3895151|FG003|COMPLETED|Phase 1 (Days 0-2)||2
3167813|NCT01913535|3895152|FG004|COMPLETED|Phase 1 (Days 0-2)||1
3167814|NCT01913535|3895148|FG000|NOT COMPLETED|Phase 1 (Days 0-2)||0
3167815|NCT01913535|3895149|FG001|NOT COMPLETED|Phase 1 (Days 0-2)||0
3167816|NCT01913535|3895150|FG002|NOT COMPLETED|Phase 1 (Days 0-2)||0
3167817|NCT01913535|3895151|FG003|NOT COMPLETED|Phase 1 (Days 0-2)||0
3167818|NCT01913535|3895152|FG004|NOT COMPLETED|Phase 1 (Days 0-2)||0
3167819|NCT01913535|3895148|FG000|STARTED|Phase 2 (Days 3-5)||2
3167820|NCT01913535|3895149|FG001|STARTED|Phase 2 (Days 3-5)||2
2843777|NCT03604549|3545264|FG000|STARTED|Overall Study||29
2843778|NCT03604549|3545265|FG001|STARTED|Overall Study||29
2843779|NCT03604549|3545264|FG000|COMPLETED|Overall Study||24
2843780|NCT03604549|3545265|FG001|COMPLETED|Overall Study||24
2843781|NCT03604549|3545264|FG000|NOT COMPLETED|Overall Study||5
2843782|NCT03604549|3545265|FG001|NOT COMPLETED|Overall Study||5
2843783|NCT03513068|3545273|FG000|STARTED|Overall Study||54
2843784|NCT03513068|3545274|FG001|STARTED|Overall Study||54
2843785|NCT03513068|3545273|FG000|COMPLETED|Overall Study||49
2843786|NCT03513068|3545274|FG001|COMPLETED|Overall Study||48
2843787|NCT03513068|3545273|FG000|NOT COMPLETED|Overall Study||5
2843788|NCT03513068|3545274|FG001|NOT COMPLETED|Overall Study||6
2843789|NCT03502811|3545280|FG000|STARTED|Overall Study||1041
2843790|NCT03502811|3545280|FG000|COMPLETED|Overall Study||722
2843791|NCT03502811|3545280|FG000|NOT COMPLETED|Overall Study||319
2843792|NCT03272711|3545286|FG000|STARTED|Overall Study||51
2843793|NCT03272711|3545287|FG001|STARTED|Overall Study||49
2843794|NCT03272711|3545286|FG000|COMPLETED|Overall Study||44
2843795|NCT03272711|3545287|FG001|COMPLETED|Overall Study||41
2843796|NCT03272711|3545286|FG000|NOT COMPLETED|Overall Study||7
2843797|NCT03272711|3545287|FG001|NOT COMPLETED|Overall Study||8
2843798|NCT03221270|3545297|FG000|STARTED|Overall Study||8
2843799|NCT03221270|3545298|FG001|STARTED|Overall Study||6
2843800|NCT03221270|3545299|FG002|STARTED|Overall Study||5
2843801|NCT03221270|3545300|FG003|STARTED|Overall Study||6
2843802|NCT03221270|3545297|FG000|Completed 5-Day Treatment|Overall Study||8
2843803|NCT03221270|3545298|FG001|Completed 5-Day Treatment|Overall Study||6
2843804|NCT03221270|3545299|FG002|Completed 5-Day Treatment|Overall Study||5
2843805|NCT03221270|3545300|FG003|Completed 5-Day Treatment|Overall Study||6
2843806|NCT03221270|3545297|FG000|Completed 8-Week Maintenance|Overall Study||4
2843807|NCT03221270|3545298|FG001|Completed 8-Week Maintenance|Overall Study||6
2843808|NCT03221270|3545299|FG002|Completed 8-Week Maintenance|Overall Study||5
2843809|NCT03221270|3545300|FG003|Completed 8-Week Maintenance|Overall Study||5
2843810|NCT03221270|3545297|FG000|COMPLETED|Overall Study||4
2843811|NCT03221270|3545298|FG001|COMPLETED|Overall Study||6
2843812|NCT03221270|3545299|FG002|COMPLETED|Overall Study||5
2843813|NCT03221270|3545300|FG003|COMPLETED|Overall Study||5
2843814|NCT03221270|3545297|FG000|NOT COMPLETED|Overall Study||4
2843815|NCT03221270|3545298|FG001|NOT COMPLETED|Overall Study||0
2843816|NCT03221270|3545299|FG002|NOT COMPLETED|Overall Study||0
2843817|NCT03221270|3545300|FG003|NOT COMPLETED|Overall Study||1
2843818|NCT03191903|3545313|FG000|STARTED|Overall Study||251
2843819|NCT03191903|3545314|FG001|STARTED|Overall Study||251
2843820|NCT03191903|3545315|FG002|STARTED|Overall Study||74
2843821|NCT03191903|3545313|FG000|Intent to Treat Population|Overall Study||251
2843822|NCT03191903|3545314|FG001|Intent to Treat Population|Overall Study||251
2843823|NCT03191903|3545315|FG002|Intent to Treat Population|Overall Study||74
2843824|NCT03191903|3545313|FG000|COMPLETED|Overall Study||244
2843825|NCT03191903|3545314|FG001|COMPLETED|Overall Study||246
2843826|NCT03191903|3545315|FG002|COMPLETED|Overall Study||70
3167821|NCT01913535|3895150|FG002|STARTED|Phase 2 (Days 3-5)||1
3167822|NCT01913535|3895151|FG003|STARTED|Phase 2 (Days 3-5)||2
2843827|NCT03191903|3545313|FG000|NOT COMPLETED|Overall Study||7
2843828|NCT03191903|3545314|FG001|NOT COMPLETED|Overall Study||5
2843829|NCT03191903|3545315|FG002|NOT COMPLETED|Overall Study||4
2843830|NCT04425538|3545328|FG000|STARTED|Overall Study||17
2843831|NCT04425538|3545328|FG000|COMPLETED|Overall Study||17
2843832|NCT04425538|3545328|FG000|NOT COMPLETED|Overall Study||0
2843833|NCT04422990|3545334|FG000|STARTED|Overall Study||50
2843834|NCT04422990|3545335|FG001|STARTED|Overall Study||97
2843835|NCT04422990|3545334|FG000|COMPLETED|Overall Study||47
2843836|NCT04422990|3545335|FG001|COMPLETED|Overall Study||96
2843837|NCT04422990|3545334|FG000|NOT COMPLETED|Overall Study||3
2843838|NCT04422990|3545335|FG001|NOT COMPLETED|Overall Study||1
3034266|NCT01131585|3753333|FG000|STARTED|Overall Study||85
3034267|NCT01131585|3753334|FG001|STARTED|Overall Study||43
3034268|NCT01131585|3753333|FG000|COMPLETED|Overall Study||0
3034269|NCT01131585|3753334|FG001|COMPLETED|Overall Study||0
3034270|NCT01131585|3753333|FG000|NOT COMPLETED|Overall Study||85
3034271|NCT01131585|3753334|FG001|NOT COMPLETED|Overall Study||43
2843845|NCT04289051|3545353|FG000|STARTED|Overall Study||13
2843846|NCT04289051|3545354|FG001|STARTED|Overall Study||13
2843847|NCT04289051|3545355|FG002|STARTED|Overall Study||13
2843848|NCT04289051|3545353|FG000|First Intervention (2 Weeks)|Overall Study||13
2843849|NCT04289051|3545354|FG001|First Intervention (2 Weeks)|Overall Study||13
2843850|NCT04289051|3545355|FG002|First Intervention (2 Weeks)|Overall Study||11
2843851|NCT04289051|3545353|FG000|Washout (1 Week)|Overall Study||13
2843852|NCT04289051|3545354|FG001|Washout (1 Week)|Overall Study||13
2843853|NCT04289051|3545355|FG002|Washout (1 Week)|Overall Study||11
2843854|NCT04289051|3545353|FG000|Second Intervention (2 Weeks)|Overall Study||13
2843855|NCT04289051|3545354|FG001|Second Intervention (2 Weeks)|Overall Study||13
2843856|NCT04289051|3545355|FG002|Second Intervention (2 Weeks)|Overall Study||11
2843857|NCT04289051|3545353|FG000|Washout (1 Week)|Overall Study||13
2843858|NCT04289051|3545354|FG001|Washout (1 Week)|Overall Study||13
2843859|NCT04289051|3545355|FG002|Washout (1 Week)|Overall Study||11
2843860|NCT04289051|3545353|FG000|Third Intervention (2 Weeks)|Overall Study||13
2843861|NCT04289051|3545354|FG001|Third Intervention (2 Weeks)|Overall Study||13
2843862|NCT04289051|3545355|FG002|Third Intervention (2 Weeks)|Overall Study||11
2843863|NCT04289051|3545353|FG000|COMPLETED|Overall Study||13
2843864|NCT04289051|3545354|FG001|COMPLETED|Overall Study||13
2843865|NCT04289051|3545355|FG002|COMPLETED|Overall Study||11
2843866|NCT04289051|3545353|FG000|NOT COMPLETED|Overall Study||0
2843867|NCT04289051|3545354|FG001|NOT COMPLETED|Overall Study||0
2843868|NCT04289051|3545355|FG002|NOT COMPLETED|Overall Study||2
2843869|NCT04210180|3545363|FG000|STARTED|Overall Study||25
2843870|NCT04210180|3545363|FG000|COMPLETED|Overall Study||23
2843871|NCT04210180|3545363|FG000|NOT COMPLETED|Overall Study||2
2843872|NCT04097223|3545367|FG000|STARTED|Overall Study||17464
2843873|NCT04097223|3545367|FG000|COMPLETED|Overall Study||17464
2843874|NCT04097223|3545367|FG000|NOT COMPLETED|Overall Study||0
2843875|NCT04095416|3545406|FG000|STARTED|Overall Study||13
3167823|NCT01913535|3895152|FG004|STARTED|Phase 2 (Days 3-5)||1
3167824|NCT01913535|3895148|FG000|COMPLETED|Phase 2 (Days 3-5)||2
3167825|NCT01913535|3895149|FG001|COMPLETED|Phase 2 (Days 3-5)||2
3167826|NCT01913535|3895150|FG002|COMPLETED|Phase 2 (Days 3-5)||1
3167827|NCT01913535|3895151|FG003|COMPLETED|Phase 2 (Days 3-5)||2
3167828|NCT01913535|3895152|FG004|COMPLETED|Phase 2 (Days 3-5)||1
3167829|NCT01913535|3895148|FG000|NOT COMPLETED|Phase 2 (Days 3-5)||0
3167830|NCT01913535|3895149|FG001|NOT COMPLETED|Phase 2 (Days 3-5)||0
2843876|NCT04095416|3545407|FG001|STARTED|Overall Study||19
2843877|NCT04095416|3545406|FG000|COMPLETED|Overall Study||10
2843878|NCT04095416|3545407|FG001|COMPLETED|Overall Study||19
2843879|NCT04095416|3545406|FG000|NOT COMPLETED|Overall Study||3
2843880|NCT04095416|3545407|FG001|NOT COMPLETED|Overall Study||0
2843881|NCT03675308|3545415|FG000|STARTED|Overall Study||481
2843882|NCT03675308|3545416|FG001|STARTED|Overall Study||483
2843883|NCT03675308|3545415|FG000|COMPLETED|Overall Study||467
2843884|NCT03675308|3545416|FG001|COMPLETED|Overall Study||473
2843885|NCT03675308|3545415|FG000|NOT COMPLETED|Overall Study||14
2843886|NCT03675308|3545416|FG001|NOT COMPLETED|Overall Study||10
2843887|NCT03573817|3545424|FG000|STARTED|Overall Study||63
2843888|NCT03573817|3545425|FG001|STARTED|Overall Study||59
2843889|NCT03573817|3545424|FG000|Randomized and Treated With Study Drug|Overall Study||63
2843890|NCT03573817|3545425|FG001|Randomized and Treated With Study Drug|Overall Study||59
2843891|NCT03573817|3545424|FG000|COMPLETED|Overall Study||62
2843892|NCT03573817|3545425|FG001|COMPLETED|Overall Study||55
2843893|NCT03573817|3545424|FG000|NOT COMPLETED|Overall Study||1
2843894|NCT03573817|3545425|FG001|NOT COMPLETED|Overall Study||4
2843895|NCT03318861|3545441|FG000|STARTED|Overall Study||3
2843896|NCT03318861|3545442|FG001|STARTED|Overall Study||4
2843897|NCT03318861|3545443|FG002|STARTED|Overall Study||3
2843898|NCT03318861|3545444|FG003|STARTED|Overall Study||4
2843899|NCT03318861|3545445|FG004|STARTED|Overall Study||3
2843900|NCT03318861|3545441|FG000|COMPLETED|Overall Study||0
2843901|NCT03318861|3545442|FG001|COMPLETED|Overall Study||0
2843902|NCT03318861|3545443|FG002|COMPLETED|Overall Study||0
2843903|NCT03318861|3545444|FG003|COMPLETED|Overall Study||0
2843904|NCT03318861|3545445|FG004|COMPLETED|Overall Study||0
2843905|NCT03318861|3545441|FG000|NOT COMPLETED|Overall Study||3
2843906|NCT03318861|3545442|FG001|NOT COMPLETED|Overall Study||4
2843907|NCT03318861|3545443|FG002|NOT COMPLETED|Overall Study||3
2843908|NCT03318861|3545444|FG003|NOT COMPLETED|Overall Study||4
2843909|NCT03318861|3545445|FG004|NOT COMPLETED|Overall Study||3
2843910|NCT03170349|3545457|FG000|STARTED|At 30 Days Follow-up||124
2843911|NCT03170349|3545457|FG000|COMPLETED|At 30 Days Follow-up||123
2843912|NCT03170349|3545457|FG000|NOT COMPLETED|At 30 Days Follow-up||1
2843913|NCT03170349|3545457|FG000|STARTED|At 6 Months Follow-up||123
2843914|NCT03170349|3545457|FG000|COMPLETED|At 6 Months Follow-up||114
2843915|NCT03170349|3545457|FG000|NOT COMPLETED|At 6 Months Follow-up||9
2843916|NCT03119064|3545463|FG000|STARTED|Overall Study||9
2843917|NCT03119064|3545464|FG001|STARTED|Overall Study||3
2843918|NCT03119064|3545465|FG002|STARTED|Overall Study||0
2843919|NCT03119064|3545463|FG000|COMPLETED|Overall Study||9
2843920|NCT03119064|3545464|FG001|COMPLETED|Overall Study||3
2843921|NCT03119064|3545465|FG002|COMPLETED|Overall Study||0
2843922|NCT03119064|3545463|FG000|NOT COMPLETED|Overall Study||0
2843923|NCT03119064|3545464|FG001|NOT COMPLETED|Overall Study||0
2843924|NCT03119064|3545465|FG002|NOT COMPLETED|Overall Study||0
2843925|NCT03097328|3545472|FG000|STARTED|Overall Study||39
2843926|NCT03097328|3545472|FG000|Treated|Overall Study||38
2843927|NCT03097328|3545472|FG000|COMPLETED|Overall Study||0
2843928|NCT03097328|3545472|FG000|NOT COMPLETED|Overall Study||39
2843929|NCT03095456|3545478|FG000|STARTED|Overall Study||103
2843930|NCT03095456|3545479|FG001|STARTED|Overall Study||104
2843931|NCT03095456|3545478|FG000|COMPLETED|Overall Study||99
2843932|NCT03095456|3545479|FG001|COMPLETED|Overall Study||96
2843933|NCT03095456|3545478|FG000|NOT COMPLETED|Overall Study||4
2843934|NCT03095456|3545479|FG001|NOT COMPLETED|Overall Study||8
2843935|NCT03064113|3545489|FG000|STARTED|Intervention 1 (2 Days)||8
2843936|NCT03064113|3545490|FG001|STARTED|Intervention 1 (2 Days)||8
2843937|NCT03064113|3545491|FG002|STARTED|Intervention 1 (2 Days)||8
2843938|NCT03064113|3545492|FG003|STARTED|Intervention 1 (2 Days)||8
2843939|NCT03064113|3545489|FG000|COMPLETED|Intervention 1 (2 Days)||8
2843940|NCT03064113|3545490|FG001|COMPLETED|Intervention 1 (2 Days)||8
2843941|NCT03064113|3545491|FG002|COMPLETED|Intervention 1 (2 Days)||8
2843942|NCT03064113|3545492|FG003|COMPLETED|Intervention 1 (2 Days)||8
2843943|NCT03064113|3545489|FG000|NOT COMPLETED|Intervention 1 (2 Days)||0
2843944|NCT03064113|3545490|FG001|NOT COMPLETED|Intervention 1 (2 Days)||0
2843945|NCT03064113|3545491|FG002|NOT COMPLETED|Intervention 1 (2 Days)||0
2843946|NCT03064113|3545492|FG003|NOT COMPLETED|Intervention 1 (2 Days)||0
2843947|NCT03064113|3545489|FG000|STARTED|Washout (7 Days)||8
2843948|NCT03064113|3545490|FG001|STARTED|Washout (7 Days)||8
2843949|NCT03064113|3545491|FG002|STARTED|Washout (7 Days)||8
2843950|NCT03064113|3545492|FG003|STARTED|Washout (7 Days)||8
2843951|NCT03064113|3545489|FG000|COMPLETED|Washout (7 Days)||8
2843952|NCT03064113|3545490|FG001|COMPLETED|Washout (7 Days)||8
2843953|NCT03064113|3545491|FG002|COMPLETED|Washout (7 Days)||8
2843954|NCT03064113|3545492|FG003|COMPLETED|Washout (7 Days)||8
2843955|NCT03064113|3545489|FG000|NOT COMPLETED|Washout (7 Days)||0
2843956|NCT03064113|3545490|FG001|NOT COMPLETED|Washout (7 Days)||0
2843957|NCT03064113|3545491|FG002|NOT COMPLETED|Washout (7 Days)||0
2843958|NCT03064113|3545492|FG003|NOT COMPLETED|Washout (7 Days)||0
2843959|NCT03064113|3545489|FG000|STARTED|Intervention 2 (2 Days)||8
2843960|NCT03064113|3545490|FG001|STARTED|Intervention 2 (2 Days)||8
2843961|NCT03064113|3545491|FG002|STARTED|Intervention 2 (2 Days)||8
2843962|NCT03064113|3545492|FG003|STARTED|Intervention 2 (2 Days)||8
2843963|NCT03064113|3545489|FG000|COMPLETED|Intervention 2 (2 Days)||8
2843964|NCT03064113|3545490|FG001|COMPLETED|Intervention 2 (2 Days)||8
2843965|NCT03064113|3545491|FG002|COMPLETED|Intervention 2 (2 Days)||8
2843966|NCT03064113|3545492|FG003|COMPLETED|Intervention 2 (2 Days)||8
2843967|NCT03064113|3545489|FG000|NOT COMPLETED|Intervention 2 (2 Days)||0
2843968|NCT03064113|3545490|FG001|NOT COMPLETED|Intervention 2 (2 Days)||0
2843969|NCT03064113|3545491|FG002|NOT COMPLETED|Intervention 2 (2 Days)||0
2843970|NCT03064113|3545492|FG003|NOT COMPLETED|Intervention 2 (2 Days)||0
2843971|NCT03064113|3545489|FG000|STARTED|Washout (7 Days)||8
2843972|NCT03064113|3545490|FG001|STARTED|Washout (7 Days)||8
2843973|NCT03064113|3545491|FG002|STARTED|Washout (7 Days)||8
2843974|NCT03064113|3545492|FG003|STARTED|Washout (7 Days)||8
2843975|NCT03064113|3545489|FG000|COMPLETED|Washout (7 Days)||8
2843976|NCT03064113|3545490|FG001|COMPLETED|Washout (7 Days)||8
2843977|NCT03064113|3545491|FG002|COMPLETED|Washout (7 Days)||8
2843978|NCT03064113|3545492|FG003|COMPLETED|Washout (7 Days)||8
2843979|NCT03064113|3545489|FG000|NOT COMPLETED|Washout (7 Days)||0
2843980|NCT03064113|3545490|FG001|NOT COMPLETED|Washout (7 Days)||0
2843981|NCT03064113|3545491|FG002|NOT COMPLETED|Washout (7 Days)||0
2843982|NCT03064113|3545492|FG003|NOT COMPLETED|Washout (7 Days)||0
2843983|NCT03064113|3545489|FG000|STARTED|Intervention 3 (2 Days)||8
2843984|NCT03064113|3545490|FG001|STARTED|Intervention 3 (2 Days)||8
2843985|NCT03064113|3545491|FG002|STARTED|Intervention 3 (2 Days)||8
2843986|NCT03064113|3545492|FG003|STARTED|Intervention 3 (2 Days)||8
2843987|NCT03064113|3545489|FG000|COMPLETED|Intervention 3 (2 Days)||8
2843988|NCT03064113|3545490|FG001|COMPLETED|Intervention 3 (2 Days)||8
2843989|NCT03064113|3545491|FG002|COMPLETED|Intervention 3 (2 Days)||8
2843990|NCT03064113|3545492|FG003|COMPLETED|Intervention 3 (2 Days)||8
2843991|NCT03064113|3545489|FG000|NOT COMPLETED|Intervention 3 (2 Days)||0
2843992|NCT03064113|3545490|FG001|NOT COMPLETED|Intervention 3 (2 Days)||0
2843993|NCT03064113|3545491|FG002|NOT COMPLETED|Intervention 3 (2 Days)||0
2843994|NCT03064113|3545492|FG003|NOT COMPLETED|Intervention 3 (2 Days)||0
2843995|NCT03064113|3545489|FG000|STARTED|Washout (7 Days)||8
2843996|NCT03064113|3545490|FG001|STARTED|Washout (7 Days)||8
2843997|NCT03064113|3545491|FG002|STARTED|Washout (7 Days)||8
2843998|NCT03064113|3545492|FG003|STARTED|Washout (7 Days)||8
2843999|NCT03064113|3545489|FG000|COMPLETED|Washout (7 Days)||8
2844000|NCT03064113|3545490|FG001|COMPLETED|Washout (7 Days)||8
2844001|NCT03064113|3545491|FG002|COMPLETED|Washout (7 Days)||8
2844002|NCT03064113|3545492|FG003|COMPLETED|Washout (7 Days)||8
2844003|NCT03064113|3545489|FG000|NOT COMPLETED|Washout (7 Days)||0
2844004|NCT03064113|3545490|FG001|NOT COMPLETED|Washout (7 Days)||0
2844005|NCT03064113|3545491|FG002|NOT COMPLETED|Washout (7 Days)||0
2844006|NCT03064113|3545492|FG003|NOT COMPLETED|Washout (7 Days)||0
2844007|NCT03064113|3545489|FG000|STARTED|Intervention 4 (2 Days)||8
2844008|NCT03064113|3545490|FG001|STARTED|Intervention 4 (2 Days)||8
2844009|NCT03064113|3545491|FG002|STARTED|Intervention 4 (2 Days)||8
2844010|NCT03064113|3545492|FG003|STARTED|Intervention 4 (2 Days)||8
2844011|NCT03064113|3545489|FG000|COMPLETED|Intervention 4 (2 Days)||8
2844012|NCT03064113|3545490|FG001|COMPLETED|Intervention 4 (2 Days)||8
2844013|NCT03064113|3545491|FG002|COMPLETED|Intervention 4 (2 Days)||8
2844014|NCT03064113|3545492|FG003|COMPLETED|Intervention 4 (2 Days)||8
2844015|NCT03064113|3545489|FG000|NOT COMPLETED|Intervention 4 (2 Days)||0
2844016|NCT03064113|3545490|FG001|NOT COMPLETED|Intervention 4 (2 Days)||0
2844017|NCT03064113|3545491|FG002|NOT COMPLETED|Intervention 4 (2 Days)||0
2844018|NCT03064113|3545492|FG003|NOT COMPLETED|Intervention 4 (2 Days)||0
2844019|NCT03064113|3545489|FG000|STARTED|Washout (7 Days)||8
2844020|NCT03064113|3545490|FG001|STARTED|Washout (7 Days)||8
2844021|NCT03064113|3545491|FG002|STARTED|Washout (7 Days)||8
2844022|NCT03064113|3545492|FG003|STARTED|Washout (7 Days)||8
2844023|NCT03064113|3545489|FG000|COMPLETED|Washout (7 Days)||8
2844024|NCT03064113|3545490|FG001|COMPLETED|Washout (7 Days)||8
2844025|NCT03064113|3545491|FG002|COMPLETED|Washout (7 Days)||8
2844026|NCT03064113|3545492|FG003|COMPLETED|Washout (7 Days)||8
2844027|NCT03064113|3545489|FG000|NOT COMPLETED|Washout (7 Days)||0
2844028|NCT03064113|3545490|FG001|NOT COMPLETED|Washout (7 Days)||0
2844029|NCT03064113|3545491|FG002|NOT COMPLETED|Washout (7 Days)||0
2844030|NCT03064113|3545492|FG003|NOT COMPLETED|Washout (7 Days)||0
2844031|NCT02938013|3545505|FG000|STARTED|Overall Study||5
2844032|NCT02938013|3545506|FG001|STARTED|Overall Study||5
2844033|NCT02938013|3545507|FG002|STARTED|Overall Study||5
2844034|NCT02938013|3545505|FG000|COMPLETED|Overall Study||5
2844035|NCT02938013|3545506|FG001|COMPLETED|Overall Study||5
2844036|NCT02938013|3545507|FG002|COMPLETED|Overall Study||5
2844037|NCT02938013|3545505|FG000|NOT COMPLETED|Overall Study||0
2844038|NCT02938013|3545506|FG001|NOT COMPLETED|Overall Study||0
2844039|NCT02938013|3545507|FG002|NOT COMPLETED|Overall Study||0
2844040|NCT02919683|3545517|FG000|STARTED|Pre-Surgery Intervention||15
2844041|NCT02919683|3545518|FG001|STARTED|Pre-Surgery Intervention||15
2844042|NCT02919683|3545517|FG000|COMPLETED|Pre-Surgery Intervention||15
2844043|NCT02919683|3545518|FG001|COMPLETED|Pre-Surgery Intervention||15
2844044|NCT02919683|3545517|FG000|NOT COMPLETED|Pre-Surgery Intervention||0
2844045|NCT02919683|3545518|FG001|NOT COMPLETED|Pre-Surgery Intervention||0
2844046|NCT02919683|3545517|FG000|STARTED|Post-Surgery Follow-Up||15
2844047|NCT02919683|3545518|FG001|STARTED|Post-Surgery Follow-Up||15
2844048|NCT02919683|3545517|FG000|COMPLETED|Post-Surgery Follow-Up||12
2844049|NCT02919683|3545518|FG001|COMPLETED|Post-Surgery Follow-Up||13
2844050|NCT02919683|3545517|FG000|NOT COMPLETED|Post-Surgery Follow-Up||3
2844051|NCT02919683|3545518|FG001|NOT COMPLETED|Post-Surgery Follow-Up||2
2844052|NCT02901548|3545525|FG000|STARTED|Overall Study||17
2844053|NCT02901548|3545525|FG000|COMPLETED|Overall Study||13
2844054|NCT02901548|3545525|FG000|NOT COMPLETED|Overall Study||4
2844055|NCT02790138|3545531|FG000|STARTED|Overall Study||51
2844056|NCT02790138|3545532|FG001|STARTED|Overall Study||51
2844057|NCT02790138|3545531|FG000|COMPLETED|Overall Study||30
2844058|NCT02790138|3545532|FG001|COMPLETED|Overall Study||32
2844059|NCT02790138|3545531|FG000|NOT COMPLETED|Overall Study||21
2844060|NCT02790138|3545532|FG001|NOT COMPLETED|Overall Study||19
2844061|NCT02642315|3545539|FG000|STARTED|Overall Study||10
2844062|NCT02642315|3545539|FG000|COMPLETED|Overall Study||8
2844063|NCT02642315|3545539|FG000|NOT COMPLETED|Overall Study||2
2844064|NCT02518139|3545546|FG000|STARTED|Overall Study||364
2844065|NCT02518139|3545547|FG001|STARTED|Overall Study||335
2844066|NCT02518139|3545548|FG002|STARTED|Overall Study||356
2844067|NCT02518139|3545546|FG000|COMPLETED|Overall Study||219
2844068|NCT02518139|3545547|FG001|COMPLETED|Overall Study||191
2844069|NCT02518139|3545548|FG002|COMPLETED|Overall Study||262
2844070|NCT02518139|3545546|FG000|NOT COMPLETED|Overall Study||145
2844071|NCT02518139|3545547|FG001|NOT COMPLETED|Overall Study||144
2844072|NCT02518139|3545548|FG002|NOT COMPLETED|Overall Study||94
2844073|NCT02514239|3545566|FG000|STARTED|Overall Study||5
2844074|NCT02514239|3545567|FG001|STARTED|Overall Study||4
2844075|NCT02514239|3545568|FG002|STARTED|Overall Study||3
2844076|NCT02514239|3545569|FG003|STARTED|Overall Study||3
2844077|NCT02514239|3545570|FG004|STARTED|Overall Study||3
2844078|NCT02514239|3545571|FG005|STARTED|Overall Study||5
2844079|NCT02514239|3545572|FG006|STARTED|Overall Study||4
2844080|NCT02514239|3545573|FG007|STARTED|Overall Study||3
2844081|NCT02514239|3545574|FG008|STARTED|Overall Study||10
2844082|NCT02514239|3545575|FG009|STARTED|Overall Study||3
2844083|NCT02514239|3545566|FG000|Treated|Overall Study||5
2844084|NCT02514239|3545567|FG001|Treated|Overall Study||3
2844085|NCT02514239|3545568|FG002|Treated|Overall Study||3
2844086|NCT02514239|3545569|FG003|Treated|Overall Study||3
2844087|NCT02514239|3545570|FG004|Treated|Overall Study||3
2844088|NCT02514239|3545571|FG005|Treated|Overall Study||5
2844089|NCT02514239|3545572|FG006|Treated|Overall Study||4
2844090|NCT02514239|3545573|FG007|Treated|Overall Study||3
2844091|NCT02514239|3545574|FG008|Treated|Overall Study||10
2844092|NCT02514239|3545575|FG009|Treated|Overall Study||3
2844093|NCT02514239|3545566|FG000|COMPLETED|Overall Study||0
2844094|NCT02514239|3545567|FG001|COMPLETED|Overall Study||0
2844095|NCT02514239|3545568|FG002|COMPLETED|Overall Study||1
2844096|NCT02514239|3545569|FG003|COMPLETED|Overall Study||0
2844097|NCT02514239|3545570|FG004|COMPLETED|Overall Study||0
2844098|NCT02514239|3545571|FG005|COMPLETED|Overall Study||1
2844099|NCT02514239|3545572|FG006|COMPLETED|Overall Study||0
2844100|NCT02514239|3545573|FG007|COMPLETED|Overall Study||0
2844101|NCT02514239|3545574|FG008|COMPLETED|Overall Study||2
2844102|NCT02514239|3545575|FG009|COMPLETED|Overall Study||0
2844103|NCT02514239|3545566|FG000|NOT COMPLETED|Overall Study||5
2844104|NCT02514239|3545567|FG001|NOT COMPLETED|Overall Study||4
2844105|NCT02514239|3545568|FG002|NOT COMPLETED|Overall Study||2
2844106|NCT02514239|3545569|FG003|NOT COMPLETED|Overall Study||3
2844107|NCT02514239|3545570|FG004|NOT COMPLETED|Overall Study||3
2844108|NCT02514239|3545571|FG005|NOT COMPLETED|Overall Study||4
2844109|NCT02514239|3545572|FG006|NOT COMPLETED|Overall Study||4
2844110|NCT02514239|3545573|FG007|NOT COMPLETED|Overall Study||3
2844111|NCT02514239|3545574|FG008|NOT COMPLETED|Overall Study||8
2844112|NCT02514239|3545575|FG009|NOT COMPLETED|Overall Study||3
2844113|NCT02512510|3545618|FG000|STARTED|Overall Study||205
2844114|NCT02512510|3545619|FG001|STARTED|Overall Study||197
2844115|NCT02512510|3545620|FG002|STARTED|Overall Study||209
2844116|NCT02512510|3545618|FG000|COMPLETED|Overall Study||163
2844117|NCT02512510|3545619|FG001|COMPLETED|Overall Study||162
2844118|NCT02512510|3545620|FG002|COMPLETED|Overall Study||157
2844119|NCT02512510|3545618|FG000|NOT COMPLETED|Overall Study||42
2844120|NCT02512510|3545619|FG001|NOT COMPLETED|Overall Study||35
2844121|NCT02512510|3545620|FG002|NOT COMPLETED|Overall Study||52
2844122|NCT02481830|3545630|FG000|STARTED|Overall Study||284
2844123|NCT02481830|3545631|FG001|STARTED|Overall Study||285
2844124|NCT02481830|3545630|FG000|COMPLETED|Overall Study||282
2844125|NCT02481830|3545631|FG001|COMPLETED|Overall Study||265
2844126|NCT02481830|3545630|FG000|NOT COMPLETED|Overall Study||2
2844127|NCT02481830|3545631|FG001|NOT COMPLETED|Overall Study||20
2844128|NCT02459080|3545640|FG000|STARTED|Overall Study||212
2844129|NCT02459080|3545641|FG001|STARTED|Overall Study||198
2844130|NCT02459080|3545642|FG002|STARTED|Overall Study||209
2844131|NCT02459080|3545640|FG000|COMPLETED|Overall Study||168
2844132|NCT02459080|3545641|FG001|COMPLETED|Overall Study||158
2844133|NCT02459080|3545642|FG002|COMPLETED|Overall Study||151
2844134|NCT02459080|3545640|FG000|NOT COMPLETED|Overall Study||44
2844135|NCT02459080|3545641|FG001|NOT COMPLETED|Overall Study||40
2844136|NCT02459080|3545642|FG002|NOT COMPLETED|Overall Study||58
2844137|NCT02245672|3545653|FG000|STARTED|Overall Study||512
2844138|NCT02245672|3545654|FG001|STARTED|Overall Study||513
2844139|NCT02245672|3545655|FG002|STARTED|Overall Study||103
2844140|NCT02245672|3545653|FG000|COMPLETED|Overall Study||499
2844141|NCT02245672|3545654|FG001|COMPLETED|Overall Study||500
2844142|NCT02245672|3545655|FG002|COMPLETED|Overall Study||98
2844143|NCT02245672|3545653|FG000|NOT COMPLETED|Overall Study||13
2844144|NCT02245672|3545654|FG001|NOT COMPLETED|Overall Study||13
2844145|NCT02245672|3545655|FG002|NOT COMPLETED|Overall Study||5
2844146|NCT02109172|3545663|FG000|STARTED|Overall Study||11
2844147|NCT02109172|3545664|FG001|STARTED|Overall Study||11
2844148|NCT02109172|3545665|FG002|STARTED|Overall Study||10
2844149|NCT02109172|3545666|FG003|STARTED|Overall Study||11
2844150|NCT02109172|3545667|FG004|STARTED|Overall Study||10
2844151|NCT02109172|3545668|FG005|STARTED|Overall Study||11
2844152|NCT02109172|3545663|FG000|COMPLETED|Overall Study||10
2844153|NCT02109172|3545664|FG001|COMPLETED|Overall Study||11
2844154|NCT02109172|3545665|FG002|COMPLETED|Overall Study||9
2844155|NCT02109172|3545666|FG003|COMPLETED|Overall Study||10
2844156|NCT02109172|3545667|FG004|COMPLETED|Overall Study||9
2844157|NCT02109172|3545668|FG005|COMPLETED|Overall Study||10
2844158|NCT02109172|3545663|FG000|NOT COMPLETED|Overall Study||1
2844159|NCT02109172|3545664|FG001|NOT COMPLETED|Overall Study||0
2844160|NCT02109172|3545665|FG002|NOT COMPLETED|Overall Study||1
2844161|NCT02109172|3545666|FG003|NOT COMPLETED|Overall Study||1
2844162|NCT02109172|3545667|FG004|NOT COMPLETED|Overall Study||1
2844163|NCT02109172|3545668|FG005|NOT COMPLETED|Overall Study||1
2844164|NCT02040792|3545681|FG000|STARTED|Overall Study||70
2844165|NCT02040792|3545682|FG001|STARTED|Overall Study||68
2844166|NCT02040792|3545683|FG002|STARTED|Overall Study||71
2844167|NCT02040792|3545684|FG003|STARTED|Overall Study||71
2844168|NCT02040792|3545685|FG004|STARTED|Overall Study||74
2844169|NCT02040792|3545681|FG000|COMPLETED|Overall Study||64
2844170|NCT02040792|3545682|FG001|COMPLETED|Overall Study||65
2844171|NCT02040792|3545683|FG002|COMPLETED|Overall Study||68
2844172|NCT02040792|3545684|FG003|COMPLETED|Overall Study||64
2844173|NCT02040792|3545685|FG004|COMPLETED|Overall Study||67
2844174|NCT02040792|3545681|FG000|NOT COMPLETED|Overall Study||6
2844175|NCT02040792|3545682|FG001|NOT COMPLETED|Overall Study||3
2844176|NCT02040792|3545683|FG002|NOT COMPLETED|Overall Study||3
2844177|NCT02040792|3545684|FG003|NOT COMPLETED|Overall Study||7
2844178|NCT02040792|3545685|FG004|NOT COMPLETED|Overall Study||7
2844179|NCT01979003|3545697|FG000|STARTED|Overall Study||100
2844180|NCT01979003|3545697|FG000|COMPLETED|Overall Study||72
2844181|NCT01979003|3545697|FG000|NOT COMPLETED|Overall Study||28
2844182|NCT01892722|3545703|FG000|STARTED|Overall Study||107
2844183|NCT01892722|3545704|FG001|STARTED|Overall Study||108
2844184|NCT01892722|3545703|FG000|Full Analysis Set|Overall Study||107
2844185|NCT01892722|3545704|FG001|Full Analysis Set|Overall Study||107
2844186|NCT01892722|3545703|FG000|COMPLETED|Overall Study||100
2844187|NCT01892722|3545704|FG001|COMPLETED|Overall Study||88
2844188|NCT01892722|3545703|FG000|NOT COMPLETED|Overall Study||7
2844189|NCT01892722|3545704|FG001|NOT COMPLETED|Overall Study||20
2844190|NCT01879228|3545712|FG000|STARTED|Overall Study||13
2844191|NCT01879228|3545713|FG001|STARTED|Overall Study||13
2844192|NCT01879228|3545712|FG000|COMPLETED|Overall Study||12
2844193|NCT01879228|3545713|FG001|COMPLETED|Overall Study||12
2844194|NCT01879228|3545712|FG000|NOT COMPLETED|Overall Study||1
2844195|NCT01879228|3545713|FG001|NOT COMPLETED|Overall Study||1
2844196|NCT01704404|3545719|FG000|STARTED|Overall Study||11
2844197|NCT01704404|3545720|FG001|STARTED|Overall Study||10
2844198|NCT01704404|3545721|FG002|STARTED|Overall Study||10
2844199|NCT01704404|3545722|FG003|STARTED|Overall Study||11
2844200|NCT01704404|3545723|FG004|STARTED|Overall Study||11
2844201|NCT01704404|3545724|FG005|STARTED|Overall Study||9
2844202|NCT01704404|3545719|FG000|COMPLETED|Overall Study||10
2844203|NCT01704404|3545720|FG001|COMPLETED|Overall Study||9
2844204|NCT01704404|3545721|FG002|COMPLETED|Overall Study||9
2844205|NCT01704404|3545722|FG003|COMPLETED|Overall Study||8
2844206|NCT01704404|3545723|FG004|COMPLETED|Overall Study||10
2844207|NCT01704404|3545724|FG005|COMPLETED|Overall Study||9
2844208|NCT01704404|3545719|FG000|NOT COMPLETED|Overall Study||1
2844209|NCT01704404|3545720|FG001|NOT COMPLETED|Overall Study||1
2844210|NCT01704404|3545721|FG002|NOT COMPLETED|Overall Study||1
2844211|NCT01704404|3545722|FG003|NOT COMPLETED|Overall Study||3
2844212|NCT01704404|3545723|FG004|NOT COMPLETED|Overall Study||1
2844213|NCT01704404|3545724|FG005|NOT COMPLETED|Overall Study||0
2916553|NCT00515541|3626864|FG001|6 Weeks (1 gm Lovaza)|Overall Study|One subject pulled after baseline. One subject pulled due to no show for appt.after baseline|10
2916554|NCT00515541|3626865|FG002|6 Weeks (1 gm Lovaza)|Overall Study||10
2916555|NCT00515541|3626866|FG003|6 Weeks (1 gm Lovaza)|Overall Study|One subject pulled due to no show for appt. after baseline.|10
2916556|NCT00515541|3626863|FG000|12 Weeks (2 gm Lovaza)|Overall Study||10
2916557|NCT00515541|3626864|FG001|12 Weeks (2 gm Lovaza)|Overall Study||10
2916558|NCT00515541|3626865|FG002|12 Weeks (2 gm Lovaza)|Overall Study||10
2916559|NCT00515541|3626866|FG003|12 Weeks (2 gm Lovaza)|Overall Study||10
2916560|NCT00515541|3626863|FG000|18 Weeks (4 gm Lovaza)|Overall Study||10
2916561|NCT00515541|3626864|FG001|18 Weeks (4 gm Lovaza)|Overall Study|One subject withdrew at 12 weeks due to acquired bleeding disorder present before enrolling.|9
2916562|NCT00515541|3626865|FG002|18 Weeks (4 gm Lovaza)|Overall Study||10
2916563|NCT00515541|3626866|FG003|18 Weeks (4 gm Lovaza)|Overall Study|One subject withdrew at 14 weeks with GI problems.|9
2916564|NCT00515541|3626863|FG000|24 Weeks (8 gm Lovaza)|Overall Study||10
2916565|NCT00515541|3626864|FG001|24 Weeks (8 gm Lovaza)|Overall Study|Two subjects withdrew at 20 and 21 weeks due to nausea. Subjects were closed out early.|7
2916566|NCT00515541|3626865|FG002|24 Weeks (8 gm Lovaza)|Overall Study||10
2916567|NCT00515541|3626866|FG003|24 Weeks (8 gm Lovaza)|Overall Study|Three subjects withdrew after 18 weeks (1 GI problem, 1 undefined medical problem, 1 no show)|6
2916568|NCT00515541|3626863|FG000|COMPLETED|Overall Study|All subjects completed 24 weeks.|10
2916569|NCT00515541|3626864|FG001|COMPLETED|Overall Study||7
2916570|NCT00515541|3626865|FG002|COMPLETED|Overall Study|All subjects completed 24 weeks.|10
2916571|NCT00515541|3626866|FG003|COMPLETED|Overall Study||6
2916572|NCT00515541|3626863|FG000|NOT COMPLETED|Overall Study||0
2916573|NCT00515541|3626864|FG001|NOT COMPLETED|Overall Study||5
2916574|NCT00515541|3626865|FG002|NOT COMPLETED|Overall Study||0
2916575|NCT00515541|3626866|FG003|NOT COMPLETED|Overall Study||5
2916576|NCT00515619|3626876|FG000|STARTED|Overall Study||376
2916577|NCT00515619|3626876|FG000|Safety Set|Overall Study||376
2916578|NCT00515619|3626876|FG000|COMPLETED|Overall Study||160
2916579|NCT00515619|3626876|FG000|NOT COMPLETED|Overall Study||216
3311689|NCT03054350|4045168|FG000|NOT COMPLETED|Primary Efficacy Period (6 Weeks)||4
3311690|NCT03054350|4045169|FG001|NOT COMPLETED|Primary Efficacy Period (6 Weeks)||2
3311691|NCT03054350|4045170|FG002|NOT COMPLETED|Primary Efficacy Period (6 Weeks)||2
3311692|NCT03054350|4045171|FG003|NOT COMPLETED|Primary Efficacy Period (6 Weeks)||2
3311693|NCT03054350|4045172|FG004|NOT COMPLETED|Primary Efficacy Period (6 Weeks)||4
3311694|NCT03054350|4045173|FG005|NOT COMPLETED|Primary Efficacy Period (6 Weeks)||3
3311695|NCT03054350|4045168|FG000|STARTED|Dose Adjustment and Maintenance Period||11
3311696|NCT03054350|4045169|FG001|STARTED|Dose Adjustment and Maintenance Period||13
3317208|NCT03124459|4050723|FG003|NOT COMPLETED|Part 2- Open Label ACE-083||0
2916580|NCT00515697|3626880|FG000|STARTED|Overall Study||39
2916581|NCT00515697|3626880|FG000|Received at Least 1 Dose of Study Drug|Overall Study||39
2916582|NCT00515697|3626880|FG000|COMPLETED|Overall Study||39
2916583|NCT00515697|3626880|FG000|NOT COMPLETED|Overall Study||0
2916584|NCT00515723|3626888|FG000|STARTED|Overall Study||25
2916585|NCT00515723|3626889|FG001|STARTED|Overall Study||22
2916586|NCT00515723|3626890|FG002|STARTED|Overall Study||22
2916587|NCT00515723|3626891|FG003|STARTED|Overall Study||27
2916588|NCT00515723|3626888|FG000|COMPLETED|Overall Study||20
2916589|NCT00515723|3626889|FG001|COMPLETED|Overall Study||21
2916590|NCT00515723|3626890|FG002|COMPLETED|Overall Study||21
2916591|NCT00515723|3626891|FG003|COMPLETED|Overall Study||21
2916592|NCT00515723|3626888|FG000|NOT COMPLETED|Overall Study||5
2916593|NCT00515723|3626889|FG001|NOT COMPLETED|Overall Study||1
2916594|NCT00515723|3626890|FG002|NOT COMPLETED|Overall Study||1
2916595|NCT00515723|3626891|FG003|NOT COMPLETED|Overall Study||6
2916596|NCT00515827|3626904|FG000|STARTED|First Intervention (12 Weeks)||27
2916597|NCT00515827|3626905|FG001|STARTED|First Intervention (12 Weeks)||26
2916598|NCT00515827|3626904|FG000|COMPLETED|First Intervention (12 Weeks)||26
2844214|NCT01307813|3545740|FG000|STARTED|Overall Study||4
2844215|NCT01307813|3545740|FG000|COMPLETED|Overall Study||4
2844216|NCT01307813|3545740|FG000|NOT COMPLETED|Overall Study||0
2844217|NCT00799396|3545744|FG000|STARTED|Clopidogrel Treatment||682
2844218|NCT00799396|3545744|FG000|COMPLETED|Clopidogrel Treatment||669
2844219|NCT00799396|3545744|FG000|NOT COMPLETED|Clopidogrel Treatment||13
2844220|NCT00799396|3545744|FG000|STARTED|Clopidogrel Plus Aspirin||669
2844221|NCT00799396|3545744|FG000|COMPLETED|Clopidogrel Plus Aspirin||663
2844222|NCT00799396|3545744|FG000|NOT COMPLETED|Clopidogrel Plus Aspirin||6
2844223|NCT00308685|3545750|FG000|STARTED|Overall Study||50
2844224|NCT00308685|3545751|FG001|STARTED|Overall Study||45
2844225|NCT00308685|3545750|FG000|Received at Least 1 Dose of Study Drug|Overall Study||50
2844226|NCT00308685|3545751|FG001|Received at Least 1 Dose of Study Drug|Overall Study||45
2844227|NCT00308685|3545750|FG000|COMPLETED|Overall Study||47
2844228|NCT00308685|3545751|FG001|COMPLETED|Overall Study||40
2844229|NCT00308685|3545750|FG000|NOT COMPLETED|Overall Study||3
2844230|NCT00308685|3545751|FG001|NOT COMPLETED|Overall Study||5
2844231|NCT00069238|3545757|FG000|STARTED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||25
2844232|NCT00069238|3545758|FG001|STARTED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
2844233|NCT00069238|3545759|FG002|STARTED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
2844234|NCT00069238|3545757|FG000|COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||16
2844235|NCT00069238|3545758|FG001|COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
2844236|NCT00069238|3545759|FG002|COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
2844237|NCT00069238|3545757|FG000|NOT COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||9
2844238|NCT00069238|3545758|FG001|NOT COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
2844239|NCT00069238|3545759|FG002|NOT COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
2844240|NCT00069238|3545757|FG000|STARTED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
2844241|NCT00069238|3545758|FG001|STARTED|Cohort 2 - Dose Level 2 (Weeks 1-18)||3
2844242|NCT00069238|3545759|FG002|STARTED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
2844243|NCT00069238|3545757|FG000|COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
3167831|NCT01913535|3895150|FG002|NOT COMPLETED|Phase 2 (Days 3-5)||0
3167832|NCT01913535|3895151|FG003|NOT COMPLETED|Phase 2 (Days 3-5)||0
3167833|NCT01913535|3895152|FG004|NOT COMPLETED|Phase 2 (Days 3-5)||0
3167834|NCT01913600|3895165|FG000|STARTED|Overall Study||56
3167835|NCT01913600|3895165|FG000|COMPLETED|Overall Study||55
3167836|NCT01913600|3895165|FG000|NOT COMPLETED|Overall Study||1
2844244|NCT00069238|3545758|FG001|COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||1
2844245|NCT00069238|3545759|FG002|COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
2844246|NCT00069238|3545757|FG000|NOT COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
2844247|NCT00069238|3545758|FG001|NOT COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||2
2844248|NCT00069238|3545759|FG002|NOT COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
2844249|NCT00069238|3545757|FG000|STARTED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
2844250|NCT00069238|3545758|FG001|STARTED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
3167837|NCT01913639|3895169|FG000|STARTED|Overall Study||39
3167838|NCT01913639|3895169|FG000|COMPLETED|Overall Study||36
3167839|NCT01913639|3895169|FG000|NOT COMPLETED|Overall Study||3
3167840|NCT01913795|3895177|FG000|STARTED|Overall Study||4
3167841|NCT01913795|3895178|FG001|STARTED|Overall Study||10
3167842|NCT01913795|3895179|FG002|STARTED|Overall Study||9
3167843|NCT01913795|3895180|FG003|STARTED|Overall Study||6
3167844|NCT01913795|3895177|FG000|COMPLETED|Overall Study||4
3167845|NCT01913795|3895178|FG001|COMPLETED|Overall Study||7
3167846|NCT01913795|3895179|FG002|COMPLETED|Overall Study||9
3167847|NCT01913795|3895180|FG003|COMPLETED|Overall Study||5
3167848|NCT01913795|3895177|FG000|NOT COMPLETED|Overall Study||0
3167849|NCT01913795|3895178|FG001|NOT COMPLETED|Overall Study||3
3167850|NCT01913795|3895179|FG002|NOT COMPLETED|Overall Study||0
3167851|NCT01913795|3895180|FG003|NOT COMPLETED|Overall Study||1
3167852|NCT01914003|3895192|FG000|STARTED|Overall Study||27
3167853|NCT01914003|3895193|FG001|STARTED|Overall Study||26
3167854|NCT01914003|3895192|FG000|COMPLETED|Overall Study|Number of subjects who completed through study and qualify as evaluable|19
3167855|NCT01914003|3895193|FG001|COMPLETED|Overall Study|Number of subjects who completed through study and qualify as evaluable|14
3167856|NCT01914003|3895192|FG000|NOT COMPLETED|Overall Study||8
3167857|NCT01914003|3895193|FG001|NOT COMPLETED|Overall Study||12
3167858|NCT01914159|3895199|FG000|STARTED|Overall Study||24
3167859|NCT01914159|3895199|FG000|COMPLETED|Overall Study||21
3167860|NCT01914159|3895199|FG000|NOT COMPLETED|Overall Study||3
3167861|NCT01914393|3895206|FG000|STARTED|Overall Study||271
3167862|NCT01914393|3895207|FG001|STARTED|Overall Study||125
3167863|NCT01914393|3895208|FG002|STARTED|Overall Study||306
3167864|NCT01914393|3895206|FG000|COMPLETED|Overall Study||156
3167865|NCT01914393|3895207|FG001|COMPLETED|Overall Study||54
3167866|NCT01914393|3895208|FG002|COMPLETED|Overall Study||168
3167867|NCT01914393|3895206|FG000|NOT COMPLETED|Overall Study||115
3167868|NCT01914393|3895207|FG001|NOT COMPLETED|Overall Study||71
3167869|NCT01914393|3895208|FG002|NOT COMPLETED|Overall Study||138
3167870|NCT01914510|3895220|FG000|STARTED|Overall Study||40
3167871|NCT01914510|3895220|FG000|COMPLETED|Overall Study||38
3167872|NCT01914510|3895220|FG000|NOT COMPLETED|Overall Study||2
3167873|NCT01914666|3895228|FG000|STARTED|Treatment Period||68
3167874|NCT01914666|3895229|FG001|STARTED|Treatment Period||42
3167875|NCT01914666|3895230|FG002|STARTED|Treatment Period||41
3167876|NCT01914666|3895228|FG000|Received at Least 1 Dose of Study Drug|Treatment Period||68
3167877|NCT01914666|3895229|FG001|Received at Least 1 Dose of Study Drug|Treatment Period||42
3167878|NCT01914666|3895230|FG002|Received at Least 1 Dose of Study Drug|Treatment Period||41
3167879|NCT01914666|3895228|FG000|COMPLETED|Treatment Period||55
3167880|NCT01914666|3895229|FG001|COMPLETED|Treatment Period||36
3167881|NCT01914666|3895230|FG002|COMPLETED|Treatment Period||33
3167882|NCT01914666|3895228|FG000|NOT COMPLETED|Treatment Period||13
3167883|NCT01914666|3895229|FG001|NOT COMPLETED|Treatment Period||6
3167884|NCT01914666|3895230|FG002|NOT COMPLETED|Treatment Period||8
3167885|NCT01914666|3895228|FG000|STARTED|Tapering Period|4 Pts who discontinued, and 55 Pts who completed Treatment Period entered Tapering Period.|59
3167886|NCT01914666|3895229|FG001|STARTED|Tapering Period|3 Pts who discontinued, and 36 Pts who completed Treatment Period entered Tapering Period.|39
3167887|NCT01914666|3895230|FG002|STARTED|Tapering Period|7 Pts who discontinued, and 33 Pts who completed Treatment Period entered Tapering Period.|40
3167888|NCT01914666|3895228|FG000|COMPLETED|Tapering Period||59
3167889|NCT01914666|3895229|FG001|COMPLETED|Tapering Period||39
3167890|NCT01914666|3895230|FG002|COMPLETED|Tapering Period||40
3167891|NCT01914666|3895228|FG000|NOT COMPLETED|Tapering Period||0
3167892|NCT01914666|3895229|FG001|NOT COMPLETED|Tapering Period||0
3167893|NCT01914666|3895230|FG002|NOT COMPLETED|Tapering Period||0
3167894|NCT01914679|3895236|FG000|STARTED|Overall Study||17
3167895|NCT01914679|3895236|FG000|Began 12 Week Actual RINCE Treatment|Overall Study||17
3167896|NCT01914679|3895236|FG000|COMPLETED|Overall Study||12
3167897|NCT01914679|3895236|FG000|NOT COMPLETED|Overall Study||5
3167898|NCT01914757|3895243|FG000|STARTED|Overall Study||425
3167899|NCT01914757|3895244|FG001|STARTED|Overall Study||441
3167900|NCT01914757|3895245|FG002|STARTED|Overall Study||440
3167901|NCT01914757|3895243|FG000|COMPLETED|Overall Study||389
3167902|NCT01914757|3895244|FG001|COMPLETED|Overall Study||390
3167903|NCT01914757|3895245|FG002|COMPLETED|Overall Study||402
3167904|NCT01914757|3895243|FG000|NOT COMPLETED|Overall Study||36
3167905|NCT01914757|3895244|FG001|NOT COMPLETED|Overall Study||51
3167906|NCT01914757|3895245|FG002|NOT COMPLETED|Overall Study||38
3167907|NCT01914926|3895255|FG000|STARTED|Overall Study||29
3167908|NCT01914926|3895256|FG001|STARTED|Overall Study||25
3167909|NCT01914926|3895255|FG000|COMPLETED|Overall Study||28
3167910|NCT01914926|3895256|FG001|COMPLETED|Overall Study||24
3167911|NCT01914926|3895255|FG000|NOT COMPLETED|Overall Study||1
3167912|NCT01914926|3895256|FG001|NOT COMPLETED|Overall Study||1
3167913|NCT01915095|3895269|FG000|STARTED|Overall Study||10
3167914|NCT01915095|3895270|FG001|STARTED|Overall Study||10
3167915|NCT01915095|3895271|FG002|STARTED|Overall Study||5
3167916|NCT01915095|3895272|FG003|STARTED|Overall Study||8
3167917|NCT01915095|3895273|FG004|STARTED|Overall Study||9
3167918|NCT01915095|3895269|FG000|SCI|Overall Study||5
3167919|NCT01915095|3895270|FG001|SCI|Overall Study||5
3167920|NCT01915095|3895271|FG002|SCI|Overall Study||5
3167921|NCT01915095|3895272|FG003|SCI|Overall Study||8
3167922|NCT01915095|3895273|FG004|SCI|Overall Study||9
3167923|NCT01915095|3895269|FG000|Control|Overall Study||5
3167924|NCT01915095|3895270|FG001|Control|Overall Study||5
3167925|NCT01915095|3895271|FG002|Control|Overall Study||0
3167926|NCT01915095|3895272|FG003|Control|Overall Study||0
3167927|NCT01915095|3895273|FG004|Control|Overall Study||0
3167928|NCT01915095|3895269|FG000|COMPLETED|Overall Study||10
3167929|NCT01915095|3895270|FG001|COMPLETED|Overall Study||10
3167930|NCT01915095|3895271|FG002|COMPLETED|Overall Study||5
3167931|NCT01915095|3895272|FG003|COMPLETED|Overall Study||4
3167932|NCT01915095|3895273|FG004|COMPLETED|Overall Study||3
3167933|NCT01915095|3895269|FG000|NOT COMPLETED|Overall Study||0
3167934|NCT01915095|3895270|FG001|NOT COMPLETED|Overall Study||0
3167935|NCT01915095|3895271|FG002|NOT COMPLETED|Overall Study||0
3167936|NCT01915095|3895272|FG003|NOT COMPLETED|Overall Study||4
3167937|NCT01915095|3895273|FG004|NOT COMPLETED|Overall Study||6
3167938|NCT01915108|3895298|FG000|STARTED|Overall Study||32
3167939|NCT01915108|3895299|FG001|STARTED|Overall Study||32
3167940|NCT01915108|3895300|FG002|STARTED|Overall Study||32
3167941|NCT01915108|3895301|FG003|STARTED|Overall Study||32
3167942|NCT01915108|3895298|FG000|COMPLETED|Overall Study|two patients were excluded from the study|30
3167943|NCT01915108|3895299|FG001|COMPLETED|Overall Study|three patients were excluded from the study|29
3167944|NCT01915108|3895300|FG002|COMPLETED|Overall Study|one patients were excluded from the study|31
3167945|NCT01915108|3895301|FG003|COMPLETED|Overall Study|two patients were excluded from the study|30
3167946|NCT01915108|3895298|FG000|NOT COMPLETED|Overall Study||2
3167947|NCT01915108|3895299|FG001|NOT COMPLETED|Overall Study||3
3167948|NCT01915108|3895300|FG002|NOT COMPLETED|Overall Study||1
3167949|NCT01915108|3895301|FG003|NOT COMPLETED|Overall Study||2
3167950|NCT01915173|3895315|FG000|STARTED|Overall Study||6
3167951|NCT01915173|3895316|FG001|STARTED|Overall Study||6
3167952|NCT01915173|3895317|FG002|STARTED|Overall Study||6
3167953|NCT01915173|3895318|FG003|STARTED|Overall Study||6
3167954|NCT01915173|3895315|FG000|COMPLETED|Overall Study||6
3167955|NCT01915173|3895316|FG001|COMPLETED|Overall Study||6
3167956|NCT01915173|3895317|FG002|COMPLETED|Overall Study||6
3167957|NCT01915173|3895318|FG003|COMPLETED|Overall Study||6
3167958|NCT01915173|3895315|FG000|NOT COMPLETED|Overall Study||0
3167959|NCT01915173|3895316|FG001|NOT COMPLETED|Overall Study||0
3167960|NCT01915173|3895317|FG002|NOT COMPLETED|Overall Study||0
3167961|NCT01915173|3895318|FG003|NOT COMPLETED|Overall Study||0
3167962|NCT01915303|3895328|FG000|STARTED|Core Phase||68
3167963|NCT01915303|3895328|FG000|COMPLETED|Core Phase||52
3167964|NCT01915303|3895328|FG000|NOT COMPLETED|Core Phase||16
3167965|NCT01915303|3895328|FG000|STARTED|Extension Phase||29
3167966|NCT01915303|3895328|FG000|COMPLETED|Extension Phase||12
3167967|NCT01915303|3895328|FG000|NOT COMPLETED|Extension Phase||17
3167968|NCT01915563|3895334|FG000|STARTED|Overall Study||243
3167969|NCT01915563|3895335|FG001|STARTED|Overall Study||227
3167970|NCT01915563|3895334|FG000|COMPLETED|Overall Study||243
3167971|NCT01915563|3895335|FG001|COMPLETED|Overall Study||227
3167972|NCT01915563|3895334|FG000|NOT COMPLETED|Overall Study||0
3167973|NCT01915563|3895335|FG001|NOT COMPLETED|Overall Study||0
3167974|NCT01915732|3895343|FG000|STARTED|Overall Study||500
3167975|NCT01915732|3895344|FG001|STARTED|Overall Study||516
3167976|NCT01915732|3895343|FG000|COMPLETED|Overall Study||430
3167977|NCT01915732|3895344|FG001|COMPLETED|Overall Study||445
3167978|NCT01915732|3895343|FG000|NOT COMPLETED|Overall Study||70
3167979|NCT01915732|3895344|FG001|NOT COMPLETED|Overall Study||71
3167980|NCT01915771|3895350|FG000|STARTED|Day 1||15
3167981|NCT01915771|3895350|FG000|COMPLETED|Day 1||14
3167982|NCT01915771|3895350|FG000|NOT COMPLETED|Day 1||1
3167983|NCT01915771|3895350|FG000|STARTED|Day 15||14
3167984|NCT01915771|3895350|FG000|COMPLETED|Day 15||13
3167985|NCT01915771|3895350|FG000|NOT COMPLETED|Day 15||1
3167986|NCT01915823|3895360|FG000|STARTED|Overall Study||173
3167987|NCT01915823|3895361|FG001|STARTED|Overall Study||175
3167988|NCT01915823|3895360|FG000|COMPLETED|Overall Study||171
3167989|NCT01915823|3895361|FG001|COMPLETED|Overall Study||173
3167990|NCT01915823|3895360|FG000|NOT COMPLETED|Overall Study||2
3167991|NCT01915823|3895361|FG001|NOT COMPLETED|Overall Study||2
3167992|NCT01915849|3895371|FG000|STARTED|Treatment Period 1 (4 Days)||5
3167993|NCT01915849|3895372|FG001|STARTED|Treatment Period 1 (4 Days)||3
3167994|NCT01915849|3895373|FG002|STARTED|Treatment Period 1 (4 Days)||3
3167995|NCT01915849|3895374|FG003|STARTED|Treatment Period 1 (4 Days)||3
3167996|NCT01915849|3895371|FG000|COMPLETED|Treatment Period 1 (4 Days)||3
3167997|NCT01915849|3895372|FG001|COMPLETED|Treatment Period 1 (4 Days)||3
3167998|NCT01915849|3895373|FG002|COMPLETED|Treatment Period 1 (4 Days)||3
3167999|NCT01915849|3895374|FG003|COMPLETED|Treatment Period 1 (4 Days)||3
3168000|NCT01915849|3895371|FG000|NOT COMPLETED|Treatment Period 1 (4 Days)||2
3168001|NCT01915849|3895372|FG001|NOT COMPLETED|Treatment Period 1 (4 Days)||0
3168002|NCT01915849|3895373|FG002|NOT COMPLETED|Treatment Period 1 (4 Days)||0
3168003|NCT01915849|3895374|FG003|NOT COMPLETED|Treatment Period 1 (4 Days)||0
3168004|NCT01915849|3895371|FG000|STARTED|Treatment Period 2 (4 Days)||3
3168005|NCT01915849|3895372|FG001|STARTED|Treatment Period 2 (4 Days)||3
3168006|NCT01915849|3895373|FG002|STARTED|Treatment Period 2 (4 Days)||3
3168007|NCT01915849|3895374|FG003|STARTED|Treatment Period 2 (4 Days)||3
3168008|NCT01915849|3895371|FG000|COMPLETED|Treatment Period 2 (4 Days)||3
3168009|NCT01915849|3895372|FG001|COMPLETED|Treatment Period 2 (4 Days)||3
3168010|NCT01915849|3895373|FG002|COMPLETED|Treatment Period 2 (4 Days)||3
3168011|NCT01915849|3895374|FG003|COMPLETED|Treatment Period 2 (4 Days)||3
3168012|NCT01915849|3895371|FG000|NOT COMPLETED|Treatment Period 2 (4 Days)||0
3168013|NCT01915849|3895372|FG001|NOT COMPLETED|Treatment Period 2 (4 Days)||0
3168014|NCT01915849|3895373|FG002|NOT COMPLETED|Treatment Period 2 (4 Days)||0
3168015|NCT01915849|3895374|FG003|NOT COMPLETED|Treatment Period 2 (4 Days)||0
3168016|NCT01915849|3895371|FG000|STARTED|Treatment Period 3 (4 Days)||3
3168017|NCT01915849|3895372|FG001|STARTED|Treatment Period 3 (4 Days)||3
3168018|NCT01915849|3895373|FG002|STARTED|Treatment Period 3 (4 Days)||3
3168019|NCT01915849|3895374|FG003|STARTED|Treatment Period 3 (4 Days)||3
3168020|NCT01915849|3895371|FG000|COMPLETED|Treatment Period 3 (4 Days)||3
3168021|NCT01915849|3895372|FG001|COMPLETED|Treatment Period 3 (4 Days)||3
3168022|NCT01915849|3895373|FG002|COMPLETED|Treatment Period 3 (4 Days)||3
3168023|NCT01915849|3895374|FG003|COMPLETED|Treatment Period 3 (4 Days)||3
3168024|NCT01915849|3895371|FG000|NOT COMPLETED|Treatment Period 3 (4 Days)||0
3168025|NCT01915849|3895372|FG001|NOT COMPLETED|Treatment Period 3 (4 Days)||0
3168026|NCT01915849|3895373|FG002|NOT COMPLETED|Treatment Period 3 (4 Days)||0
3168027|NCT01915849|3895374|FG003|NOT COMPLETED|Treatment Period 3 (4 Days)||0
3168028|NCT01915849|3895371|FG000|STARTED|Treatment Period 4 (4 Days)||3
3168029|NCT01915849|3895372|FG001|STARTED|Treatment Period 4 (4 Days)||3
3168030|NCT01915849|3895373|FG002|STARTED|Treatment Period 4 (4 Days)||3
3168031|NCT01915849|3895374|FG003|STARTED|Treatment Period 4 (4 Days)||3
3168032|NCT01915849|3895371|FG000|COMPLETED|Treatment Period 4 (4 Days)||3
3168033|NCT01915849|3895372|FG001|COMPLETED|Treatment Period 4 (4 Days)||3
3168034|NCT01915849|3895373|FG002|COMPLETED|Treatment Period 4 (4 Days)||3
3168035|NCT01915849|3895374|FG003|COMPLETED|Treatment Period 4 (4 Days)||3
3168036|NCT01915849|3895371|FG000|NOT COMPLETED|Treatment Period 4 (4 Days)||0
3168037|NCT01915849|3895372|FG001|NOT COMPLETED|Treatment Period 4 (4 Days)||0
3168038|NCT01915849|3895373|FG002|NOT COMPLETED|Treatment Period 4 (4 Days)||0
3168039|NCT01915849|3895374|FG003|NOT COMPLETED|Treatment Period 4 (4 Days)||0
3171774|NCT01937026|3898964|FG000|Received Probenecid on Days 3 Through 7|Period 2 (At Dosing Day 3 Through Day 8)||18
3171775|NCT01937026|3898964|FG000|COMPLETED|Period 2 (At Dosing Day 3 Through Day 8)||18
3171776|NCT01937026|3898964|FG000|NOT COMPLETED|Period 2 (At Dosing Day 3 Through Day 8)||0
3171777|NCT01937117|3898971|FG000|STARTED|Overall Study||88
3171778|NCT01937117|3898971|FG000|COMPLETED|Overall Study||75
3171779|NCT01937117|3898971|FG000|NOT COMPLETED|Overall Study||13
3171780|NCT01937130|3898979|FG000|STARTED|Overall Study||5
3171781|NCT01937130|3898980|FG001|STARTED|Overall Study||7
3171782|NCT01937130|3898981|FG002|STARTED|Overall Study||5
3171783|NCT01937130|3898982|FG003|STARTED|Overall Study||4
3171784|NCT01937130|3898979|FG000|COMPLETED|Overall Study||0
3171785|NCT01937130|3898980|FG001|COMPLETED|Overall Study||3
3168040|NCT01915914|3895384|FG000|STARTED|Acute Phase||123
3168041|NCT01915914|3895385|FG001|STARTED|Acute Phase||0
3168042|NCT01915914|3895386|FG002|STARTED|Acute Phase||0
3168043|NCT01915914|3895387|FG003|STARTED|Acute Phase||0
3168044|NCT01915914|3895384|FG000|Completed-Not Entered Maintenance Phase|Acute Phase||4
3168045|NCT01915914|3895385|FG001|Completed-Not Entered Maintenance Phase|Acute Phase||0
3168046|NCT01915914|3895386|FG002|Completed-Not Entered Maintenance Phase|Acute Phase||0
3168047|NCT01915914|3895387|FG003|Completed-Not Entered Maintenance Phase|Acute Phase||0
3168048|NCT01915914|3895384|FG000|COMPLETED|Acute Phase||111
3168049|NCT01915914|3895385|FG001|COMPLETED|Acute Phase||0
3168050|NCT01915914|3895386|FG002|COMPLETED|Acute Phase||0
3168051|NCT01915914|3895387|FG003|COMPLETED|Acute Phase||0
3168052|NCT01915914|3895384|FG000|NOT COMPLETED|Acute Phase||12
3168053|NCT01915914|3895385|FG001|NOT COMPLETED|Acute Phase||0
3168054|NCT01915914|3895386|FG002|NOT COMPLETED|Acute Phase||0
3168055|NCT01915914|3895387|FG003|NOT COMPLETED|Acute Phase||0
3168056|NCT01915914|3895384|FG000|STARTED|Maintenance Phase||0
3168057|NCT01915914|3895385|FG001|STARTED|Maintenance Phase||54
3168058|NCT01915914|3895386|FG002|STARTED|Maintenance Phase||53
3168059|NCT01915914|3895387|FG003|STARTED|Maintenance Phase||0
3168060|NCT01915914|3895384|FG000|COMPLETED|Maintenance Phase||0
3168061|NCT01915914|3895385|FG001|COMPLETED|Maintenance Phase||48
3168062|NCT01915914|3895386|FG002|COMPLETED|Maintenance Phase||51
3168063|NCT01915914|3895387|FG003|COMPLETED|Maintenance Phase||0
3168064|NCT01915914|3895384|FG000|NOT COMPLETED|Maintenance Phase||0
3168065|NCT01915914|3895385|FG001|NOT COMPLETED|Maintenance Phase||6
3168066|NCT01915914|3895386|FG002|NOT COMPLETED|Maintenance Phase||2
3168067|NCT01915914|3895387|FG003|NOT COMPLETED|Maintenance Phase||0
3168068|NCT01915914|3895384|FG000|STARTED|Follow-up Phase||0
3168069|NCT01915914|3895385|FG001|STARTED|Follow-up Phase||0
3168070|NCT01915914|3895386|FG002|STARTED|Follow-up Phase||0
3168071|NCT01915914|3895387|FG003|STARTED|Follow-up Phase||66
3168072|NCT01915914|3895384|FG000|COMPLETED|Follow-up Phase||0
3168073|NCT01915914|3895385|FG001|COMPLETED|Follow-up Phase||0
3168074|NCT01915914|3895386|FG002|COMPLETED|Follow-up Phase||0
3168075|NCT01915914|3895387|FG003|COMPLETED|Follow-up Phase||64
3168076|NCT01915914|3895384|FG000|NOT COMPLETED|Follow-up Phase||0
3168077|NCT01915914|3895385|FG001|NOT COMPLETED|Follow-up Phase||0
3168078|NCT01915914|3895386|FG002|NOT COMPLETED|Follow-up Phase||0
3168079|NCT01915914|3895387|FG003|NOT COMPLETED|Follow-up Phase||2
3168080|NCT01915940|3895407|FG000|STARTED|Pre-randomization Washout Period||169
3168081|NCT01915940|3895408|FG001|STARTED|Pre-randomization Washout Period||0
3168082|NCT01915940|3895409|FG002|STARTED|Pre-randomization Washout Period||0
3168083|NCT01915940|3895407|FG000|COMPLETED|Pre-randomization Washout Period||130
3168084|NCT01915940|3895408|FG001|COMPLETED|Pre-randomization Washout Period||0
3168085|NCT01915940|3895409|FG002|COMPLETED|Pre-randomization Washout Period||0
3168086|NCT01915940|3895407|FG000|NOT COMPLETED|Pre-randomization Washout Period||39
2844251|NCT00069238|3545759|FG002|STARTED|Cohort 3 - Dose Level 3 (Weeks 1-18)||3
2844252|NCT00069238|3545757|FG000|COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
2844253|NCT00069238|3545758|FG001|COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
2844254|NCT00069238|3545759|FG002|COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||1
2844255|NCT00069238|3545757|FG000|NOT COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
2844256|NCT00069238|3545758|FG001|NOT COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
2844257|NCT00069238|3545759|FG002|NOT COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||2
2844258|NCT00001322|3545764|FG000|STARTED|Phase 1 - Lupron Only||92
2844259|NCT00001322|3545765|FG001|STARTED|Phase 1 - Lupron Only||0
2844260|NCT00001322|3545766|FG002|STARTED|Phase 1 - Lupron Only||0
2844261|NCT00001322|3545764|FG000|COMPLETED|Phase 1 - Lupron Only||92
2844262|NCT00001322|3545765|FG001|COMPLETED|Phase 1 - Lupron Only||0
2844263|NCT00001322|3545766|FG002|COMPLETED|Phase 1 - Lupron Only||0
2844264|NCT00001322|3545764|FG000|NOT COMPLETED|Phase 1 - Lupron Only||0
2844265|NCT00001322|3545765|FG001|NOT COMPLETED|Phase 1 - Lupron Only||0
2844266|NCT00001322|3545766|FG002|NOT COMPLETED|Phase 1 - Lupron Only||0
2844267|NCT00001322|3545764|FG000|STARTED|Phase 2, Period 1 - Crossover Phase||0
2844268|NCT00001322|3545765|FG001|STARTED|Phase 2, Period 1 - Crossover Phase||42
2844269|NCT00001322|3545766|FG002|STARTED|Phase 2, Period 1 - Crossover Phase||40
2844270|NCT00001322|3545764|FG000|COMPLETED|Phase 2, Period 1 - Crossover Phase||0
2844271|NCT00001322|3545765|FG001|COMPLETED|Phase 2, Period 1 - Crossover Phase||42
2844272|NCT00001322|3545766|FG002|COMPLETED|Phase 2, Period 1 - Crossover Phase||40
2844273|NCT00001322|3545764|FG000|NOT COMPLETED|Phase 2, Period 1 - Crossover Phase||0
2844274|NCT00001322|3545765|FG001|NOT COMPLETED|Phase 2, Period 1 - Crossover Phase||0
2844275|NCT00001322|3545766|FG002|NOT COMPLETED|Phase 2, Period 1 - Crossover Phase||0
2844276|NCT00001322|3545764|FG000|STARTED|Phase 2, Period 2 - Crossover Phase||0
2844277|NCT00001322|3545765|FG001|STARTED|Phase 2, Period 2 - Crossover Phase||42
2844278|NCT00001322|3545766|FG002|STARTED|Phase 2, Period 2 - Crossover Phase||40
2844279|NCT00001322|3545764|FG000|COMPLETED|Phase 2, Period 2 - Crossover Phase||0
2844280|NCT00001322|3545765|FG001|COMPLETED|Phase 2, Period 2 - Crossover Phase||42
3168087|NCT01915940|3895408|FG001|NOT COMPLETED|Pre-randomization Washout Period||0
3168088|NCT01915940|3895409|FG002|NOT COMPLETED|Pre-randomization Washout Period||0
3168089|NCT01915940|3895407|FG000|STARTED|Treatment Period||0
3168090|NCT01915940|3895408|FG001|STARTED|Treatment Period||64
3168091|NCT01915940|3895409|FG002|STARTED|Treatment Period||66
3168092|NCT01915940|3895407|FG000|COMPLETED|Treatment Period||0
3168093|NCT01915940|3895408|FG001|COMPLETED|Treatment Period||53
2844281|NCT00001322|3545766|FG002|COMPLETED|Phase 2, Period 2 - Crossover Phase||40
2844282|NCT00001322|3545764|FG000|NOT COMPLETED|Phase 2, Period 2 - Crossover Phase||0
2844283|NCT00001322|3545765|FG001|NOT COMPLETED|Phase 2, Period 2 - Crossover Phase||0
2844284|NCT00001322|3545766|FG002|NOT COMPLETED|Phase 2, Period 2 - Crossover Phase||0
2916599|NCT00515827|3626905|FG001|COMPLETED|First Intervention (12 Weeks)||25
2916600|NCT00515827|3626904|FG000|NOT COMPLETED|First Intervention (12 Weeks)||1
2916601|NCT00515827|3626905|FG001|NOT COMPLETED|First Intervention (12 Weeks)||1
2916602|NCT00515827|3626904|FG000|STARTED|Second Intervention (12 Weeks)||26
2916603|NCT00515827|3626905|FG001|STARTED|Second Intervention (12 Weeks)||25
2916604|NCT00515827|3626904|FG000|COMPLETED|Second Intervention (12 Weeks)||25
2916605|NCT00515827|3626905|FG001|COMPLETED|Second Intervention (12 Weeks)||25
2916606|NCT00515827|3626904|FG000|NOT COMPLETED|Second Intervention (12 Weeks)||1
2916607|NCT00515827|3626905|FG001|NOT COMPLETED|Second Intervention (12 Weeks)||0
2916608|NCT00515879|3626915|FG000|STARTED|Overall Study||87
2916609|NCT00515879|3626916|FG001|STARTED|Overall Study||82
2916610|NCT00515879|3626915|FG000|COMPLETED|Overall Study||62
2916611|NCT00515879|3626916|FG001|COMPLETED|Overall Study||62
2916612|NCT00515879|3626915|FG000|NOT COMPLETED|Overall Study||25
2916613|NCT00515879|3626916|FG001|NOT COMPLETED|Overall Study||20
2916614|NCT00516048|3626926|FG000|STARTED|Overall Study||15
2916615|NCT00516048|3626927|FG001|STARTED|Overall Study||42
2916616|NCT00516048|3626928|FG002|STARTED|Overall Study||1
2916617|NCT00516048|3626926|FG000|COMPLETED|Overall Study||15
2916618|NCT00516048|3626927|FG001|COMPLETED|Overall Study||40
2916619|NCT00516048|3626928|FG002|COMPLETED|Overall Study||0
2916620|NCT00516048|3626926|FG000|NOT COMPLETED|Overall Study||0
2916621|NCT00516048|3626927|FG001|NOT COMPLETED|Overall Study||2
2916622|NCT00516048|3626928|FG002|NOT COMPLETED|Overall Study||1
2916623|NCT00516074|3626938|FG000|STARTED|Overall Study||28
2916624|NCT00516074|3626939|FG001|STARTED|Overall Study||26
2916625|NCT00516074|3626938|FG000|COMPLETED|Overall Study||22
2916626|NCT00516074|3626939|FG001|COMPLETED|Overall Study||23
2916627|NCT00516074|3626938|FG000|NOT COMPLETED|Overall Study||6
2916628|NCT00516074|3626939|FG001|NOT COMPLETED|Overall Study||3
2916629|NCT00516139|3626945|FG000|STARTED|Overall Study||122
2916630|NCT00516139|3626945|FG000|COMPLETED|Overall Study|Study completers completed Escalation, AM, and either AO or both Conversion and Monotherapy Phases.|84
2916631|NCT00516139|3626945|FG000|NOT COMPLETED|Overall Study||38
2916632|NCT00516165|3626953|FG000|STARTED|Overall Study||28
2916633|NCT00516165|3626953|FG000|COMPLETED|Overall Study||28
2916634|NCT00516165|3626953|FG000|NOT COMPLETED|Overall Study||0
2916635|NCT00516217|3626957|FG000|STARTED|Overall Study||29
2916636|NCT00516217|3626957|FG000|COMPLETED|Overall Study||29
2916637|NCT00516217|3626957|FG000|NOT COMPLETED|Overall Study||0
2916638|NCT00516269|3626963|FG000|STARTED|Overall Study||19
2916639|NCT00516269|3626964|FG001|STARTED|Overall Study||19
2916640|NCT00516269|3626963|FG000|COMPLETED|Overall Study|2 patients had an early termination|17
2916641|NCT00516269|3626964|FG001|COMPLETED|Overall Study|2 patients did not complete the study and 1 randomized to placebo twice.|16
2916642|NCT00516269|3626963|FG000|NOT COMPLETED|Overall Study||2
2916643|NCT00516269|3626964|FG001|NOT COMPLETED|Overall Study||3
2916644|NCT00516295|3626973|FG000|STARTED|Overall Study||7
2916645|NCT00516295|3626974|FG001|STARTED|Overall Study||0
2916646|NCT00516295|3626975|FG002|STARTED|Overall Study||0
2916647|NCT00516295|3626973|FG000|COMPLETED|Overall Study||4
2916648|NCT00516295|3626974|FG001|COMPLETED|Overall Study||0
2916649|NCT00516295|3626975|FG002|COMPLETED|Overall Study||0
2916650|NCT00516295|3626973|FG000|NOT COMPLETED|Overall Study||3
2916651|NCT00516295|3626974|FG001|NOT COMPLETED|Overall Study||0
2916652|NCT00516295|3626975|FG002|NOT COMPLETED|Overall Study||0
2916653|NCT00516321|3626985|FG000|STARTED|Open-label (OL) Pre-Antiviral Treatment||715
2916654|NCT00516321|3626986|FG001|STARTED|Open-label (OL) Pre-Antiviral Treatment||0
2916655|NCT00516321|3626987|FG002|STARTED|Open-label (OL) Pre-Antiviral Treatment||0
2916656|NCT00516321|3626985|FG000|COMPLETED|Open-label (OL) Pre-Antiviral Treatment||682
2916657|NCT00516321|3626986|FG001|COMPLETED|Open-label (OL) Pre-Antiviral Treatment||0
2916658|NCT00516321|3626987|FG002|COMPLETED|Open-label (OL) Pre-Antiviral Treatment||0
2916659|NCT00516321|3626985|FG000|NOT COMPLETED|Open-label (OL) Pre-Antiviral Treatment||33
2916660|NCT00516321|3626986|FG001|NOT COMPLETED|Open-label (OL) Pre-Antiviral Treatment||0
2916661|NCT00516321|3626987|FG002|NOT COMPLETED|Open-label (OL) Pre-Antiviral Treatment||0
2916662|NCT00516321|3626985|FG000|STARTED|Double-blind (DB) Antiviral Treatment||0
2916663|NCT00516321|3626986|FG001|STARTED|Double-blind (DB) Antiviral Treatment||232
2916664|NCT00516321|3626987|FG002|STARTED|Double-blind (DB) Antiviral Treatment||450
2916665|NCT00516321|3626985|FG000|COMPLETED|Double-blind (DB) Antiviral Treatment||0
2916666|NCT00516321|3626986|FG001|COMPLETED|Double-blind (DB) Antiviral Treatment||197
2916667|NCT00516321|3626987|FG002|COMPLETED|Double-blind (DB) Antiviral Treatment||396
2916668|NCT00516321|3626985|FG000|NOT COMPLETED|Double-blind (DB) Antiviral Treatment||0
2916669|NCT00516321|3626986|FG001|NOT COMPLETED|Double-blind (DB) Antiviral Treatment||35
2916670|NCT00516321|3626987|FG002|NOT COMPLETED|Double-blind (DB) Antiviral Treatment||54
2916671|NCT00516386|3626995|FG000|STARTED|Overall Study||16
2916672|NCT00516386|3626995|FG000|COMPLETED|Overall Study||10
2916673|NCT00516386|3626995|FG000|NOT COMPLETED|Overall Study||6
2916674|NCT00516503|3627001|FG000|STARTED|Overall Study||101
2916675|NCT00516503|3627002|FG001|STARTED|Overall Study||102
2916676|NCT00516503|3627001|FG000|COMPLETED|Overall Study||101
2916677|NCT00516503|3627002|FG001|COMPLETED|Overall Study||102
2844285|NCT03082898|3545776|FG000|STARTED|Overall Study||27
2844286|NCT03082898|3545777|FG001|STARTED|Overall Study||12
2844287|NCT03082898|3545776|FG000|COMPLETED|Overall Study||24
2844288|NCT03082898|3545777|FG001|COMPLETED|Overall Study||11
2844289|NCT03082898|3545776|FG000|NOT COMPLETED|Overall Study||3
2844290|NCT03082898|3545777|FG001|NOT COMPLETED|Overall Study||1
2844291|NCT03056443|3545783|FG000|STARTED|Overall Study||13
2844292|NCT03056443|3545783|FG000|COMPLETED|Overall Study||13
2844293|NCT03056443|3545783|FG000|NOT COMPLETED|Overall Study||0
2844294|NCT04748783|3545792|FG000|STARTED|Overall Study||0
2844295|NCT04748783|3545793|FG001|STARTED|Overall Study||1
2844296|NCT04748783|3545794|FG002|STARTED|Overall Study||0
2844297|NCT04748783|3545795|FG003|STARTED|Overall Study||0
2844298|NCT04748783|3545796|FG004|STARTED|Overall Study||1
2844299|NCT04748783|3545792|FG000|COMPLETED|Overall Study||0
2844300|NCT04748783|3545793|FG001|COMPLETED|Overall Study||1
2844301|NCT04748783|3545794|FG002|COMPLETED|Overall Study||0
2844302|NCT04748783|3545795|FG003|COMPLETED|Overall Study||0
2844303|NCT04748783|3545796|FG004|COMPLETED|Overall Study||1
2844304|NCT04748783|3545792|FG000|NOT COMPLETED|Overall Study||0
2844305|NCT04748783|3545793|FG001|NOT COMPLETED|Overall Study||0
2844306|NCT04748783|3545794|FG002|NOT COMPLETED|Overall Study||0
2844307|NCT04748783|3545795|FG003|NOT COMPLETED|Overall Study||0
2844308|NCT04748783|3545796|FG004|NOT COMPLETED|Overall Study||0
2844309|NCT04482647|3545809|FG000|STARTED|Overall Study||100
2844310|NCT04482647|3545809|FG000|COMPLETED|Overall Study||88
2844311|NCT04482647|3545809|FG000|NOT COMPLETED|Overall Study||12
2844312|NCT04405570|3545817|FG000|STARTED|Overall Study||23
2844313|NCT04405570|3545818|FG001|STARTED|Overall Study||64
2844314|NCT04405570|3545819|FG002|STARTED|Overall Study||55
2844315|NCT04405570|3545820|FG003|STARTED|Overall Study||62
2844316|NCT04405570|3545817|FG000|Number of Subjects Randomized Not Dosed|Overall Study||0
2844317|NCT04405570|3545818|FG001|Number of Subjects Randomized Not Dosed|Overall Study||2
2844318|NCT04405570|3545819|FG002|Number of Subjects Randomized Not Dosed|Overall Study||0
2844319|NCT04405570|3545820|FG003|Number of Subjects Randomized Not Dosed|Overall Study||0
2844320|NCT04405570|3545817|FG000|Number of Subjects in the Safety Population|Overall Study||23
2844321|NCT04405570|3545818|FG001|Number of Subjects in the Safety Population|Overall Study||62
2844322|NCT04405570|3545819|FG002|Number of Subjects in the Safety Population|Overall Study||55
2844323|NCT04405570|3545820|FG003|Number of Subjects in the Safety Population|Overall Study||62
2844324|NCT04405570|3545817|FG000|Number of Subjects in the mITT Population|Overall Study||23
2844325|NCT04405570|3545818|FG001|Number of Subjects in the mITT Population|Overall Study||61
2844326|NCT04405570|3545819|FG002|Number of Subjects in the mITT Population|Overall Study||53
2844327|NCT04405570|3545820|FG003|Number of Subjects in the mITT Population|Overall Study||61
2844328|NCT04405570|3545817|FG000|COMPLETED|Overall Study||23
2844329|NCT04405570|3545818|FG001|COMPLETED|Overall Study||59
2844330|NCT04405570|3545819|FG002|COMPLETED|Overall Study||52
2844331|NCT04405570|3545820|FG003|COMPLETED|Overall Study||61
2844332|NCT04405570|3545817|FG000|NOT COMPLETED|Overall Study||0
2844333|NCT04405570|3545818|FG001|NOT COMPLETED|Overall Study||5
2844334|NCT04405570|3545819|FG002|NOT COMPLETED|Overall Study||3
2844335|NCT04405570|3545820|FG003|NOT COMPLETED|Overall Study||1
2844336|NCT04135937|3545833|FG000|STARTED|Overall Study||12
2844337|NCT04135937|3545833|FG000|COMPLETED|Overall Study||9
2844338|NCT04135937|3545833|FG000|NOT COMPLETED|Overall Study||3
2844339|NCT03989232|3545839|FG000|STARTED|Overall Study||481
2844340|NCT03989232|3545840|FG001|STARTED|Overall Study||480
2844341|NCT03989232|3545839|FG000|Exposed|Overall Study||480
2844342|NCT03989232|3545840|FG001|Exposed|Overall Study||479
2844343|NCT03989232|3545839|FG000|Safety Analysis Set (SAS)|Overall Study||480
2844344|NCT03989232|3545840|FG001|Safety Analysis Set (SAS)|Overall Study||479
2844345|NCT03989232|3545839|FG000|Full Analysis Set (FAS)|Overall Study||481
2844346|NCT03989232|3545840|FG001|Full Analysis Set (FAS)|Overall Study||480
2844347|NCT03989232|3545839|FG000|COMPLETED|Overall Study||471
2844348|NCT03989232|3545840|FG001|COMPLETED|Overall Study||462
2844349|NCT03989232|3545839|FG000|NOT COMPLETED|Overall Study||10
2844350|NCT03989232|3545840|FG001|NOT COMPLETED|Overall Study||18
2844351|NCT03926611|3545853|FG000|STARTED|Overall Study||44
2844352|NCT03926611|3545854|FG001|STARTED|Overall Study||44
2844353|NCT03926611|3545855|FG002|STARTED|Overall Study||47
2844354|NCT03926611|3545856|FG003|STARTED|Overall Study||44
2844355|NCT03926611|3545857|FG004|STARTED|Overall Study||44
2844356|NCT03926611|3545858|FG005|STARTED|Overall Study||45
2844357|NCT03926611|3545859|FG006|STARTED|Overall Study||43
2844358|NCT03926611|3545853|FG000|Randomized Set (RAN)|Overall Study||44
2844359|NCT03926611|3545854|FG001|Randomized Set (RAN)|Overall Study||44
2844360|NCT03926611|3545855|FG002|Randomized Set (RAN)|Overall Study||47
2844361|NCT03926611|3545856|FG003|Randomized Set (RAN)|Overall Study||44
2844362|NCT03926611|3545857|FG004|Randomized Set (RAN)|Overall Study||44
2844363|NCT03926611|3545858|FG005|Randomized Set (RAN)|Overall Study||45
2844364|NCT03926611|3545859|FG006|Randomized Set (RAN)|Overall Study||43
2844365|NCT03926611|3545853|FG000|Full Analysis Set (FAS)|Overall Study||44
2844366|NCT03926611|3545854|FG001|Full Analysis Set (FAS)|Overall Study||44
2844367|NCT03926611|3545855|FG002|Full Analysis Set (FAS)|Overall Study||47
2844368|NCT03926611|3545856|FG003|Full Analysis Set (FAS)|Overall Study||44
2844369|NCT03926611|3545857|FG004|Full Analysis Set (FAS)|Overall Study||43
2844370|NCT03926611|3545858|FG005|Full Analysis Set (FAS)|Overall Study||45
2844371|NCT03926611|3545859|FG006|Full Analysis Set (FAS)|Overall Study||42
2844372|NCT03926611|3545853|FG000|Safety Set (SAF)|Overall Study||44
2844373|NCT03926611|3545854|FG001|Safety Set (SAF)|Overall Study||44
2844374|NCT03926611|3545855|FG002|Safety Set (SAF)|Overall Study||47
2844375|NCT03926611|3545856|FG003|Safety Set (SAF)|Overall Study||44
2844376|NCT03926611|3545857|FG004|Safety Set (SAF)|Overall Study||43
2844377|NCT03926611|3545858|FG005|Safety Set (SAF)|Overall Study||45
2844378|NCT03926611|3545859|FG006|Safety Set (SAF)|Overall Study||42
2844379|NCT03926611|3545853|FG000|COMPLETED|Overall Study||41
2844380|NCT03926611|3545854|FG001|COMPLETED|Overall Study||41
2844381|NCT03926611|3545855|FG002|COMPLETED|Overall Study||45
2844382|NCT03926611|3545856|FG003|COMPLETED|Overall Study||40
2844383|NCT03926611|3545857|FG004|COMPLETED|Overall Study||40
2844384|NCT03926611|3545858|FG005|COMPLETED|Overall Study||36
2844385|NCT03926611|3545859|FG006|COMPLETED|Overall Study||38
2844386|NCT03926611|3545853|FG000|NOT COMPLETED|Overall Study||3
2844387|NCT03926611|3545854|FG001|NOT COMPLETED|Overall Study||3
2844388|NCT03926611|3545855|FG002|NOT COMPLETED|Overall Study||2
2844389|NCT03926611|3545856|FG003|NOT COMPLETED|Overall Study||4
2844390|NCT03926611|3545857|FG004|NOT COMPLETED|Overall Study||4
2844391|NCT03926611|3545858|FG005|NOT COMPLETED|Overall Study||9
2844392|NCT03926611|3545859|FG006|NOT COMPLETED|Overall Study||5
2916678|NCT00516503|3627001|FG000|NOT COMPLETED|Overall Study||0
2916679|NCT00516503|3627002|FG001|NOT COMPLETED|Overall Study||0
2916680|NCT00516893|3627008|FG000|STARTED|Overall Study||113
2916681|NCT00516893|3627008|FG000|Received Study Treatment|Overall Study||112
2916682|NCT00516893|3627008|FG000|COMPLETED|Overall Study||92
2916683|NCT00516893|3627008|FG000|NOT COMPLETED|Overall Study||21
2916684|NCT00516906|3627014|FG000|STARTED|Overall Study||36
2916685|NCT00516906|3627015|FG001|STARTED|Overall Study|33 patients were randomized but one patient was discharged prior to treatment.|32
2916686|NCT00516906|3627014|FG000|COMPLETED|Overall Study|Thirty patients were required to complete. Patients not completing were replaced.|30
2916687|NCT00516906|3627015|FG001|COMPLETED|Overall Study|Thirty patients were required to complete. Patients not completing were replaced.|30
2916688|NCT00516906|3627014|FG000|NOT COMPLETED|Overall Study||6
2916689|NCT00516906|3627015|FG001|NOT COMPLETED|Overall Study||2
2916690|NCT00516919|3627021|FG000|STARTED|Overall Study||40
2916691|NCT00516919|3627022|FG001|STARTED|Overall Study||39
2916692|NCT00516919|3627021|FG000|COMPLETED|Overall Study||30
2916693|NCT00516919|3627022|FG001|COMPLETED|Overall Study||32
2916694|NCT00516919|3627021|FG000|NOT COMPLETED|Overall Study||10
2916695|NCT00516919|3627022|FG001|NOT COMPLETED|Overall Study||7
2916696|NCT00517010|3627028|FG000|STARTED|Overall Study||6
2916697|NCT00517010|3627028|FG000|COMPLETED|Overall Study||5
2916698|NCT00517010|3627028|FG000|NOT COMPLETED|Overall Study||1
2916699|NCT00517296|3627034|FG000|STARTED|Overall Study||10
2916700|NCT00517296|3627035|FG001|STARTED|Overall Study||11
2916701|NCT00517296|3627034|FG000|COMPLETED|Overall Study||9
2916702|NCT00517296|3627035|FG001|COMPLETED|Overall Study||11
2916703|NCT00517296|3627034|FG000|NOT COMPLETED|Overall Study||1
2916704|NCT00517296|3627035|FG001|NOT COMPLETED|Overall Study||0
2916705|NCT00517413|3627041|FG000|STARTED|Overall Study||163
2916706|NCT00517413|3627041|FG000|COMPLETED|Overall Study||102
2916707|NCT00517413|3627041|FG000|NOT COMPLETED|Overall Study||61
2916708|NCT00517530|3627052|FG000|STARTED|Overall Study||21
2916709|NCT00517530|3627053|FG001|STARTED|Overall Study||13
2916710|NCT00517530|3627054|FG002|STARTED|Overall Study||18
2916711|NCT00517530|3627055|FG003|STARTED|Overall Study||22
2916712|NCT00517530|3627056|FG004|STARTED|Overall Study||21
2916713|NCT00517530|3627057|FG005|STARTED|Overall Study||19
2916714|NCT00517530|3627058|FG006|STARTED|Overall Study||20
2916715|NCT00517530|3627052|FG000|Completed Treatment|Overall Study||11
2916716|NCT00517530|3627053|FG001|Completed Treatment|Overall Study||13
2916717|NCT00517530|3627054|FG002|Completed Treatment|Overall Study||13
2916718|NCT00517530|3627055|FG003|Completed Treatment|Overall Study||18
2916719|NCT00517530|3627056|FG004|Completed Treatment|Overall Study||9
2916720|NCT00517530|3627057|FG005|Completed Treatment|Overall Study||9
2916721|NCT00517530|3627058|FG006|Completed Treatment|Overall Study||13
2916722|NCT00517530|3627052|FG000|Started Follow-up|Overall Study||20
2916723|NCT00517530|3627053|FG001|Started Follow-up|Overall Study||13
2916724|NCT00517530|3627054|FG002|Started Follow-up|Overall Study||17
2916725|NCT00517530|3627055|FG003|Started Follow-up|Overall Study||21
2916726|NCT00517530|3627056|FG004|Started Follow-up|Overall Study||17
2916727|NCT00517530|3627057|FG005|Started Follow-up|Overall Study||16
2916728|NCT00517530|3627058|FG006|Started Follow-up|Overall Study||19
2916729|NCT00517530|3627052|FG000|Completed Follow-up|Overall Study||2
2916730|NCT00517530|3627053|FG001|Completed Follow-up|Overall Study||0
2916731|NCT00517530|3627054|FG002|Completed Follow-up|Overall Study||0
2916732|NCT00517530|3627055|FG003|Completed Follow-up|Overall Study||1
2916733|NCT00517530|3627056|FG004|Completed Follow-up|Overall Study||0
2916734|NCT00517530|3627057|FG005|Completed Follow-up|Overall Study||0
2916735|NCT00517530|3627058|FG006|Completed Follow-up|Overall Study||1
2916736|NCT00517530|3627052|FG000|Retreated Population|Overall Study||2
2916737|NCT00517530|3627053|FG001|Retreated Population|Overall Study||2
2916738|NCT00517530|3627054|FG002|Retreated Population|Overall Study||1
2916739|NCT00517530|3627055|FG003|Retreated Population|Overall Study||4
2916740|NCT00517530|3627056|FG004|Retreated Population|Overall Study||2
2916741|NCT00517530|3627057|FG005|Retreated Population|Overall Study||2
2916742|NCT00517530|3627058|FG006|Retreated Population|Overall Study||0
2916743|NCT00517530|3627052|FG000|COMPLETED|Overall Study||2
2916744|NCT00517530|3627053|FG001|COMPLETED|Overall Study||0
2844393|NCT03896295|3545881|FG000|STARTED|Overall Study||7
2844394|NCT03896295|3545882|FG001|STARTED|Overall Study||30
2844395|NCT03896295|3545881|FG000|COMPLETED|Overall Study||0
2844396|NCT03896295|3545882|FG001|COMPLETED|Overall Study||0
2844397|NCT03896295|3545881|FG000|NOT COMPLETED|Overall Study||7
2844398|NCT03896295|3545882|FG001|NOT COMPLETED|Overall Study||30
2844399|NCT03213457|3545896|FG000|STARTED|Overall Study||194
2844400|NCT03213457|3545897|FG001|STARTED|Overall Study||98
2844401|NCT03213457|3545898|FG002|STARTED|Overall Study||389
2844402|NCT03213457|3545896|FG000|Randomized and Treated|Overall Study||193
2844403|NCT03213457|3545897|FG001|Randomized and Treated|Overall Study||97
2844404|NCT03213457|3545898|FG002|Randomized and Treated|Overall Study||389
2844405|NCT03213457|3545896|FG000|COMPLETED|Overall Study||106
2844406|NCT03213457|3545897|FG001|COMPLETED|Overall Study||59
2844407|NCT03213457|3545898|FG002|COMPLETED|Overall Study||215
2844408|NCT03213457|3545896|FG000|NOT COMPLETED|Overall Study||88
2844409|NCT03213457|3545897|FG001|NOT COMPLETED|Overall Study||39
2844410|NCT03213457|3545898|FG002|NOT COMPLETED|Overall Study||174
2844411|NCT02982720|3545906|FG000|STARTED|Overall Study||4
2844412|NCT02982720|3545906|FG000|COMPLETED|Overall Study||0
2844413|NCT02982720|3545906|FG000|NOT COMPLETED|Overall Study||4
2916745|NCT00517530|3627054|FG002|COMPLETED|Overall Study||0
2916746|NCT00517530|3627055|FG003|COMPLETED|Overall Study||1
2916747|NCT00517530|3627056|FG004|COMPLETED|Overall Study||1
2916748|NCT00517530|3627057|FG005|COMPLETED|Overall Study||0
2916749|NCT00517530|3627058|FG006|COMPLETED|Overall Study||1
2916750|NCT00517530|3627052|FG000|NOT COMPLETED|Overall Study||19
2916751|NCT00517530|3627053|FG001|NOT COMPLETED|Overall Study||13
2916752|NCT00517530|3627054|FG002|NOT COMPLETED|Overall Study||18
2916753|NCT00517530|3627055|FG003|NOT COMPLETED|Overall Study||21
2916754|NCT00517530|3627056|FG004|NOT COMPLETED|Overall Study||20
2916755|NCT00517530|3627057|FG005|NOT COMPLETED|Overall Study||19
2916756|NCT00517530|3627058|FG006|NOT COMPLETED|Overall Study||19
2916757|NCT00517556|3627091|FG000|STARTED|Overall Study||19
2916758|NCT00517556|3627092|FG001|STARTED|Overall Study||19
2916759|NCT00517556|3627091|FG000|COMPLETED|Overall Study||15
2916760|NCT00517556|3627092|FG001|COMPLETED|Overall Study||14
2916761|NCT00517556|3627091|FG000|NOT COMPLETED|Overall Study||4
2916762|NCT00517556|3627092|FG001|NOT COMPLETED|Overall Study||5
2916763|NCT00517595|3627098|FG000|STARTED|Overall Study||48
2916764|NCT00517595|3627098|FG000|COMPLETED|Overall Study||48
2916765|NCT00517595|3627098|FG000|NOT COMPLETED|Overall Study||0
2916766|NCT00517634|3627102|FG000|STARTED|First Treatment Period||4
2916767|NCT00517634|3627103|FG001|STARTED|First Treatment Period||4
2916768|NCT00517634|3627104|FG002|STARTED|First Treatment Period||4
2916769|NCT00517634|3627105|FG003|STARTED|First Treatment Period||3
2916770|NCT00517634|3627106|FG004|STARTED|First Treatment Period||4
2916771|NCT00517634|3627107|FG005|STARTED|First Treatment Period||4
2916772|NCT00517634|3627102|FG000|COMPLETED|First Treatment Period||4
2916773|NCT00517634|3627103|FG001|COMPLETED|First Treatment Period||4
2916774|NCT00517634|3627104|FG002|COMPLETED|First Treatment Period||4
2916775|NCT00517634|3627105|FG003|COMPLETED|First Treatment Period||3
2916776|NCT00517634|3627106|FG004|COMPLETED|First Treatment Period||4
2916777|NCT00517634|3627107|FG005|COMPLETED|First Treatment Period||4
2916778|NCT00517634|3627102|FG000|NOT COMPLETED|First Treatment Period||0
2916779|NCT00517634|3627103|FG001|NOT COMPLETED|First Treatment Period||0
2916780|NCT00517634|3627104|FG002|NOT COMPLETED|First Treatment Period||0
2916781|NCT00517634|3627105|FG003|NOT COMPLETED|First Treatment Period||0
2916782|NCT00517634|3627106|FG004|NOT COMPLETED|First Treatment Period||0
2916783|NCT00517634|3627107|FG005|NOT COMPLETED|First Treatment Period||0
2916784|NCT00517634|3627102|FG000|STARTED|Second Treatment Period||4
2916785|NCT00517634|3627103|FG001|STARTED|Second Treatment Period||4
2916786|NCT00517634|3627104|FG002|STARTED|Second Treatment Period||4
2916787|NCT00517634|3627105|FG003|STARTED|Second Treatment Period||3
2916788|NCT00517634|3627106|FG004|STARTED|Second Treatment Period||4
2916789|NCT00517634|3627107|FG005|STARTED|Second Treatment Period||4
2916790|NCT00517634|3627102|FG000|COMPLETED|Second Treatment Period||4
2916791|NCT00517634|3627103|FG001|COMPLETED|Second Treatment Period||4
2916792|NCT00517634|3627104|FG002|COMPLETED|Second Treatment Period||4
2916793|NCT00517634|3627105|FG003|COMPLETED|Second Treatment Period||3
2916794|NCT00517634|3627106|FG004|COMPLETED|Second Treatment Period||3
2916795|NCT00517634|3627107|FG005|COMPLETED|Second Treatment Period||4
2916796|NCT00517634|3627102|FG000|NOT COMPLETED|Second Treatment Period||0
2916797|NCT00517634|3627103|FG001|NOT COMPLETED|Second Treatment Period||0
2916798|NCT00517634|3627104|FG002|NOT COMPLETED|Second Treatment Period||0
2916799|NCT00517634|3627105|FG003|NOT COMPLETED|Second Treatment Period||0
2916800|NCT00517634|3627106|FG004|NOT COMPLETED|Second Treatment Period||1
2916801|NCT00517634|3627107|FG005|NOT COMPLETED|Second Treatment Period||0
2916802|NCT00517634|3627102|FG000|STARTED|Third Treatment Period||4
2916803|NCT00517634|3627103|FG001|STARTED|Third Treatment Period||4
2916804|NCT00517634|3627104|FG002|STARTED|Third Treatment Period||4
2916805|NCT00517634|3627105|FG003|STARTED|Third Treatment Period||3
2916806|NCT00517634|3627106|FG004|STARTED|Third Treatment Period||3
2916807|NCT00517634|3627107|FG005|STARTED|Third Treatment Period||4
2916808|NCT00517634|3627102|FG000|COMPLETED|Third Treatment Period||4
2916809|NCT00517634|3627103|FG001|COMPLETED|Third Treatment Period||4
2916810|NCT00517634|3627104|FG002|COMPLETED|Third Treatment Period||4
2916811|NCT00517634|3627105|FG003|COMPLETED|Third Treatment Period||3
2916812|NCT00517634|3627106|FG004|COMPLETED|Third Treatment Period||3
2844414|NCT02548754|3545912|FG000|STARTED|Overall Study||26
2844415|NCT02548754|3545913|FG001|STARTED|Overall Study||27
2844416|NCT02548754|3545912|FG000|COMPLETED|Overall Study||24
2844417|NCT02548754|3545913|FG001|COMPLETED|Overall Study||23
2844418|NCT02548754|3545912|FG000|NOT COMPLETED|Overall Study||2
2844419|NCT02548754|3545913|FG001|NOT COMPLETED|Overall Study||4
2844420|NCT02425904|3545921|FG000|STARTED|Overall Study||20
2844421|NCT02425904|3545922|FG001|STARTED|Overall Study||5
2844422|NCT02425904|3545921|FG000|Efficacy Analysis|Overall Study||20
2844423|NCT02425904|3545922|FG001|Efficacy Analysis|Overall Study|1 patient was incorrectly assigned to LCH-related disorders cohort but it is actually LCH patients, so excluded from efficacy analysis.|4
2844424|NCT02425904|3545921|FG000|COMPLETED|Overall Study||17
2844425|NCT02425904|3545922|FG001|COMPLETED|Overall Study||2
2844426|NCT02425904|3545921|FG000|NOT COMPLETED|Overall Study||3
2844427|NCT02425904|3545922|FG001|NOT COMPLETED|Overall Study||3
2844428|NCT02421939|3545931|FG000|STARTED|Overall Study||247
2844429|NCT02421939|3545932|FG001|STARTED|Overall Study||124
2844430|NCT02421939|3545931|FG000|Treated|Overall Study||246
2844431|NCT02421939|3545932|FG001|Treated|Overall Study||109
2844432|NCT02421939|3545931|FG000|COMPLETED|Overall Study||38
2844433|NCT02421939|3545932|FG001|COMPLETED|Overall Study||0
2844434|NCT02421939|3545931|FG000|NOT COMPLETED|Overall Study||209
2844435|NCT02421939|3545932|FG001|NOT COMPLETED|Overall Study||124
2844436|NCT02375672|3545938|FG000|STARTED|Overall Study||30
2844437|NCT02375672|3545938|FG000|COMPLETED|Overall Study||10
2844438|NCT02375672|3545938|FG000|NOT COMPLETED|Overall Study||20
2844439|NCT02329327|3545944|FG000|STARTED|Overall Study||477
2844440|NCT02329327|3545945|FG001|STARTED|Overall Study||2
2844441|NCT02329327|3545944|FG000|Received At Least 1 Dose of Study Drug|Overall Study||477
2844442|NCT02329327|3545945|FG001|Received At Least 1 Dose of Study Drug|Overall Study||2
2844443|NCT02329327|3545944|FG000|Efficacy Population|Overall Study||347
2844444|NCT02329327|3545945|FG001|Efficacy Population|Overall Study||2
2844445|NCT02329327|3545944|FG000|Death|Overall Study||3
2844446|NCT02329327|3545945|FG001|Death|Overall Study||0
2844447|NCT02329327|3545944|FG000|COMPLETED|Overall Study||392
2844448|NCT02329327|3545945|FG001|COMPLETED|Overall Study||2
2844449|NCT02329327|3545944|FG000|NOT COMPLETED|Overall Study||85
2844450|NCT02329327|3545945|FG001|NOT COMPLETED|Overall Study||0
2844451|NCT02153645|3545967|FG000|STARTED|Overall Study||30
2844452|NCT02153645|3545968|FG001|STARTED|Overall Study||29
2844453|NCT02153645|3545969|FG002|STARTED|Overall Study||28
2844454|NCT02153645|3545967|FG000|COMPLETED|Overall Study||17
2844455|NCT02153645|3545968|FG001|COMPLETED|Overall Study||19
2844456|NCT02153645|3545969|FG002|COMPLETED|Overall Study||18
2844457|NCT02153645|3545967|FG000|NOT COMPLETED|Overall Study||13
2844458|NCT02153645|3545968|FG001|NOT COMPLETED|Overall Study||10
2844459|NCT02153645|3545969|FG002|NOT COMPLETED|Overall Study||10
2844460|NCT02153632|3545980|FG000|STARTED|Overall Study||45
2844461|NCT02153632|3545981|FG001|STARTED|Overall Study||46
2844462|NCT02153632|3545982|FG002|STARTED|Overall Study||44
2844463|NCT02153632|3545980|FG000|COMPLETED|Overall Study||27
2844464|NCT02153632|3545981|FG001|COMPLETED|Overall Study||27
2844465|NCT02153632|3545982|FG002|COMPLETED|Overall Study||25
2844466|NCT02153632|3545980|FG000|NOT COMPLETED|Overall Study||18
2844467|NCT02153632|3545981|FG001|NOT COMPLETED|Overall Study||19
2844468|NCT02153632|3545982|FG002|NOT COMPLETED|Overall Study||19
2844469|NCT02063724|3545990|FG000|STARTED|Overall Study||15
2844470|NCT02063724|3545990|FG000|COMPLETED|Overall Study||14
2844471|NCT02063724|3545990|FG000|NOT COMPLETED|Overall Study||1
2844472|NCT01942135|3545996|FG000|STARTED|Overall Study||347
2844473|NCT01942135|3545997|FG001|STARTED|Overall Study||174
2844474|NCT01942135|3545996|FG000|COMPLETED|Overall Study||0
2844475|NCT01942135|3545997|FG001|COMPLETED|Overall Study||0
2844476|NCT01942135|3545996|FG000|NOT COMPLETED|Overall Study||347
2844477|NCT01942135|3545997|FG001|NOT COMPLETED|Overall Study||174
2844478|NCT01689909|3546005|FG000|STARTED|Overall Study||51
2844479|NCT01689909|3546006|FG001|STARTED|Overall Study||52
2844480|NCT01689909|3546005|FG000|COMPLETED|Overall Study||51
2844481|NCT01689909|3546006|FG001|COMPLETED|Overall Study||52
2844482|NCT01689909|3546005|FG000|NOT COMPLETED|Overall Study||0
2844483|NCT01689909|3546006|FG001|NOT COMPLETED|Overall Study||0
2844484|NCT01566149|3546016|FG000|STARTED|Overall Study||24
2844485|NCT01566149|3546017|FG001|STARTED|Overall Study||25
2844486|NCT01566149|3546016|FG000|COMPLETED|Overall Study||21
2844487|NCT01566149|3546017|FG001|COMPLETED|Overall Study||23
2844488|NCT01566149|3546016|FG000|NOT COMPLETED|Overall Study||3
2844489|NCT01566149|3546017|FG001|NOT COMPLETED|Overall Study||2
2844490|NCT01481935|3546025|FG000|STARTED|Overall Study||97
2844491|NCT01481935|3546026|FG001|STARTED|Overall Study||93
2844492|NCT01481935|3546025|FG000|COMPLETED|Overall Study||97
2844493|NCT01481935|3546026|FG001|COMPLETED|Overall Study||93
2844494|NCT01481935|3546025|FG000|NOT COMPLETED|Overall Study||0
2844495|NCT01481935|3546026|FG001|NOT COMPLETED|Overall Study||0
2844496|NCT01386125|3546034|FG000|STARTED|Overall Study||375
2844497|NCT01386125|3546035|FG001|STARTED|Overall Study||373
2844498|NCT01386125|3546034|FG000|COMPLETED|Overall Study||350
2844499|NCT01386125|3546035|FG001|COMPLETED|Overall Study||336
2844500|NCT01386125|3546034|FG000|NOT COMPLETED|Overall Study||25
2844501|NCT01386125|3546035|FG001|NOT COMPLETED|Overall Study||37
2844502|NCT01257568|3546041|FG000|STARTED|Overall Study||40
2844503|NCT01257568|3546041|FG000|COMPLETED|Overall Study||7
2844504|NCT01257568|3546041|FG000|NOT COMPLETED|Overall Study||33
2844505|NCT01165424|3546047|FG000|STARTED|Overall Study||80
2844506|NCT01165424|3546047|FG000|COMPLETED|Overall Study||76
2844507|NCT01165424|3546047|FG000|NOT COMPLETED|Overall Study||4
2844508|NCT01135134|3546053|FG000|STARTED|Overall Study||220
2844509|NCT01135134|3546054|FG001|STARTED|Overall Study||113
2844510|NCT01135134|3546053|FG000|COMPLETED|Overall Study||218
2844511|NCT01135134|3546054|FG001|COMPLETED|Overall Study||112
2844512|NCT01135134|3546053|FG000|NOT COMPLETED|Overall Study||2
2844513|NCT01135134|3546054|FG001|NOT COMPLETED|Overall Study||1
2844514|NCT00867165|3546062|FG000|STARTED|Overall Study||93
2844515|NCT00867165|3546063|FG001|STARTED|Overall Study||45
2844516|NCT00867165|3546062|FG000|COMPLETED|Overall Study||89
2844517|NCT00867165|3546063|FG001|COMPLETED|Overall Study||45
2844518|NCT00867165|3546062|FG000|NOT COMPLETED|Overall Study||4
2844519|NCT00867165|3546063|FG001|NOT COMPLETED|Overall Study||0
2844520|NCT00733005|3546071|FG000|STARTED|Overall Study||162
2844521|NCT00733005|3546072|FG001|STARTED|Overall Study||162
2844522|NCT00733005|3546071|FG000|COMPLETED|Overall Study||160
2844523|NCT00733005|3546072|FG001|COMPLETED|Overall Study||159
2844524|NCT00733005|3546071|FG000|NOT COMPLETED|Overall Study||2
2844525|NCT00733005|3546072|FG001|NOT COMPLETED|Overall Study||3
2844526|NCT00732381|3546080|FG000|STARTED|Overall Study||176
2844527|NCT00732381|3546081|FG001|STARTED|Overall Study||175
2844528|NCT00732381|3546080|FG000|COMPLETED|Overall Study||174
2844529|NCT00732381|3546081|FG001|COMPLETED|Overall Study||174
2844530|NCT00732381|3546080|FG000|NOT COMPLETED|Overall Study||2
2844531|NCT00732381|3546081|FG001|NOT COMPLETED|Overall Study||1
2916813|NCT00517634|3627107|FG005|COMPLETED|Third Treatment Period||4
2916814|NCT00517634|3627102|FG000|NOT COMPLETED|Third Treatment Period||0
2916815|NCT00517634|3627103|FG001|NOT COMPLETED|Third Treatment Period||0
2916816|NCT00517634|3627104|FG002|NOT COMPLETED|Third Treatment Period||0
2916817|NCT00517634|3627105|FG003|NOT COMPLETED|Third Treatment Period||0
2916818|NCT00517634|3627106|FG004|NOT COMPLETED|Third Treatment Period||0
2916819|NCT00517634|3627107|FG005|NOT COMPLETED|Third Treatment Period||0
2916820|NCT00517751|3627115|FG000|STARTED|Overall Study||162
2916821|NCT00517751|3627115|FG000|COMPLETED|Overall Study||33
2916822|NCT00517751|3627115|FG000|NOT COMPLETED|Overall Study||129
2916823|NCT00517829|3627121|FG000|STARTED|Overall Study||75
2916824|NCT00517829|3627122|FG001|STARTED|Overall Study||75
2916825|NCT00517829|3627121|FG000|COMPLETED|Overall Study||0
2916826|NCT00517829|3627122|FG001|COMPLETED|Overall Study||0
2916827|NCT00517829|3627121|FG000|NOT COMPLETED|Overall Study||75
2916828|NCT00517829|3627122|FG001|NOT COMPLETED|Overall Study||75
2916829|NCT00517881|3627128|FG000|STARTED|Overall Study||29
2916830|NCT00517881|3627128|FG000|COMPLETED|Overall Study||24
2916831|NCT00517881|3627128|FG000|NOT COMPLETED|Overall Study||5
2916832|NCT00517933|3627134|FG000|STARTED|Period 1|Patients decreased due to death, adverse event, lost to follow up and other (see below)|89
2916833|NCT00517933|3627135|FG001|STARTED|Period 1|Patients decreased due to death, adverse event and other (see below)|91
2916834|NCT00517933|3627134|FG000|COMPLETED|Period 1||81
2916835|NCT00517933|3627135|FG001|COMPLETED|Period 1||85
2916836|NCT00517933|3627134|FG000|NOT COMPLETED|Period 1||8
2916837|NCT00517933|3627135|FG001|NOT COMPLETED|Period 1||6
2916838|NCT00517933|3627134|FG000|STARTED|Period 2|2 patients terminated after completion of period one, but before starting period 2|79
2916839|NCT00517933|3627135|FG001|STARTED|Period 2|2 patients terminated after completion of period one, but before starting period 2|83
2916840|NCT00517933|3627134|FG000|COMPLETED|Period 2||73
2916841|NCT00517933|3627135|FG001|COMPLETED|Period 2||70
2916842|NCT00517933|3627134|FG000|NOT COMPLETED|Period 2||6
2916843|NCT00517933|3627135|FG001|NOT COMPLETED|Period 2||13
2916844|NCT00518011|3627146|FG000|STARTED|Overall Study||9
2916845|NCT00518011|3627147|FG001|STARTED|Overall Study||8
2916846|NCT00518011|3627146|FG000|COMPLETED|Overall Study||0
2916847|NCT00518011|3627147|FG001|COMPLETED|Overall Study||0
2916848|NCT00518011|3627146|FG000|NOT COMPLETED|Overall Study||9
2916849|NCT00518011|3627147|FG001|NOT COMPLETED|Overall Study||8
2916850|NCT00518089|3627156|FG000|STARTED|Overall Study||430
2916851|NCT00518089|3627157|FG001|STARTED|Overall Study||429
2916852|NCT00518089|3627156|FG000|COMPLETED|Overall Study||402
2916853|NCT00518089|3627157|FG001|COMPLETED|Overall Study||398
2916854|NCT00518089|3627156|FG000|NOT COMPLETED|Overall Study||28
2916855|NCT00518089|3627157|FG001|NOT COMPLETED|Overall Study||31
2916856|NCT00518115|3627173|FG000|STARTED|Overall Study||52
2916857|NCT00518115|3627174|FG001|STARTED|Overall Study||35
2916858|NCT00518115|3627175|FG002|STARTED|Overall Study||36
2916859|NCT00518115|3627176|FG003|STARTED|Overall Study||35
2916860|NCT00518115|3627177|FG004|STARTED|Overall Study||31
2916861|NCT00518115|3627178|FG005|STARTED|Overall Study||34
2916862|NCT00518115|3627179|FG006|STARTED|Overall Study||33
2916863|NCT00518115|3627180|FG007|STARTED|Overall Study||35
3168094|NCT01915940|3895409|FG002|COMPLETED|Treatment Period||62
3168095|NCT01915940|3895407|FG000|NOT COMPLETED|Treatment Period||0
3168096|NCT01915940|3895408|FG001|NOT COMPLETED|Treatment Period||11
3168097|NCT01915940|3895409|FG002|NOT COMPLETED|Treatment Period||4
3168098|NCT01916109|3895415|FG000|STARTED|Overall Study||4
2916864|NCT00518115|3627181|FG008|STARTED|Overall Study||35
2916865|NCT00518115|3627182|FG009|STARTED|Overall Study||35
2916866|NCT00518115|3627173|FG000|Safety Population|Overall Study|These participants received at least one dose of study drug.|51
2916867|NCT00518115|3627174|FG001|Safety Population|Overall Study|These participants received at least one dose of study drug.|35
2920743|NCT00538616|3631304|FG000|STARTED|Overall Study||5
2844532|NCT00654095|3546087|FG000|STARTED|Overall Study||146
2844533|NCT00654095|3546087|FG000|COMPLETED|Overall Study||114
2844534|NCT00654095|3546087|FG000|NOT COMPLETED|Overall Study||32
2844535|NCT00653523|3546091|FG000|STARTED|Overall Study||151
2844536|NCT00653523|3546091|FG000|COMPLETED|Overall Study||132
2844537|NCT00653523|3546091|FG000|NOT COMPLETED|Overall Study||19
2844538|NCT00599027|3546097|FG000|STARTED|Overall Study||26
2844539|NCT00599027|3546098|FG001|STARTED|Overall Study||25
2844540|NCT00599027|3546097|FG000|COMPLETED|Overall Study||25
2844541|NCT00599027|3546098|FG001|COMPLETED|Overall Study||22
2844542|NCT00599027|3546097|FG000|NOT COMPLETED|Overall Study||1
2844543|NCT00599027|3546098|FG001|NOT COMPLETED|Overall Study||3
2844544|NCT00552032|3546106|FG000|STARTED|Overall Study||66
2844545|NCT00552032|3546107|FG001|STARTED|Overall Study||66
2844546|NCT00552032|3546106|FG000|COMPLETED|Overall Study||49
2844547|NCT00552032|3546107|FG001|COMPLETED|Overall Study||47
2844548|NCT00552032|3546106|FG000|NOT COMPLETED|Overall Study||17
2844549|NCT00552032|3546107|FG001|NOT COMPLETED|Overall Study||19
2844550|NCT00546052|3546113|FG000|STARTED|Overall Study||1738
2844551|NCT00546052|3546113|FG000|Week 4|Overall Study||1714
2844552|NCT00546052|3546113|FG000|Week 8|Overall Study||1680
2844553|NCT00546052|3546113|FG000|Week 12|Overall Study||1650
2844554|NCT00546052|3546113|FG000|Week 32|Overall Study||1583
2844555|NCT00546052|3546113|FG000|Week 52|Overall Study||1511
2844556|NCT00546052|3546113|FG000|COMPLETED|Overall Study||1511
2844557|NCT00546052|3546113|FG000|NOT COMPLETED|Overall Study||227
2844558|NCT00442117|3546122|FG000|STARTED|Overall Study||85
2844559|NCT00442117|3546123|FG001|STARTED|Overall Study||87
2844560|NCT00442117|3546122|FG000|COMPLETED|Overall Study||47
2844561|NCT00442117|3546123|FG001|COMPLETED|Overall Study||49
2844562|NCT00442117|3546122|FG000|NOT COMPLETED|Overall Study||38
2844563|NCT00442117|3546123|FG001|NOT COMPLETED|Overall Study||38
2844564|NCT00424008|3546131|FG000|STARTED|Overall Study||371
2844565|NCT00424008|3546132|FG001|STARTED|Overall Study||351
2844566|NCT00424008|3546131|FG000|COMPLETED|Overall Study||22
2844567|NCT00424008|3546132|FG001|COMPLETED|Overall Study||16
2844568|NCT00424008|3546131|FG000|NOT COMPLETED|Overall Study||349
2844569|NCT00424008|3546132|FG001|NOT COMPLETED|Overall Study||335
2844570|NCT00423176|3546141|FG000|STARTED|Overall Study||114
2844571|NCT00423176|3546142|FG001|STARTED|Overall Study||123
2844572|NCT00423176|3546141|FG000|COMPLETED|Overall Study||98
2844573|NCT00423176|3546142|FG001|COMPLETED|Overall Study||94
2844574|NCT00423176|3546141|FG000|NOT COMPLETED|Overall Study||16
2844575|NCT00423176|3546142|FG001|NOT COMPLETED|Overall Study||29
2844576|NCT00383240|3546152|FG000|STARTED|Overall Study||191
2844577|NCT00383240|3546153|FG001|STARTED|Overall Study||192
2844578|NCT00383240|3546154|FG002|STARTED|Overall Study||202
2844579|NCT00383240|3546155|FG003|STARTED|Overall Study||196
2844580|NCT00383240|3546152|FG000|COMPLETED|Overall Study||156
2844581|NCT00383240|3546153|FG001|COMPLETED|Overall Study||159
2844582|NCT00383240|3546154|FG002|COMPLETED|Overall Study||117
2844583|NCT00383240|3546155|FG003|COMPLETED|Overall Study||119
2844584|NCT00383240|3546152|FG000|NOT COMPLETED|Overall Study||35
2844585|NCT00383240|3546153|FG001|NOT COMPLETED|Overall Study||33
2844586|NCT00383240|3546154|FG002|NOT COMPLETED|Overall Study||85
2844587|NCT00383240|3546155|FG003|NOT COMPLETED|Overall Study||77
2844588|NCT04471935|3546166|FG000|STARTED|Overall Study||10
2844589|NCT04471935|3546166|FG000|COMPLETED|Overall Study||8
2844590|NCT04471935|3546166|FG000|NOT COMPLETED|Overall Study||2
2844591|NCT04439344|3546170|FG000|STARTED|Overall Study||53
2844592|NCT04439344|3546170|FG000|Started Protocol Therapy|Overall Study||50
2844593|NCT04439344|3546170|FG000|Eligible|Overall Study||47
2844594|NCT04439344|3546170|FG000|COMPLETED|Overall Study||0
2844595|NCT04439344|3546170|FG000|NOT COMPLETED|Overall Study||53
2844596|NCT04439279|3546174|FG000|STARTED|Overall Study||35
2844597|NCT04439279|3546174|FG000|Started Protocol Therapy|Overall Study||35
2844598|NCT04439279|3546174|FG000|Eligible|Overall Study||33
2844599|NCT04439279|3546174|FG000|Reported Adverse Events Data|Overall Study|Adverse event was not assessed on one patient before discontinuing therapy due to withdraw/refusal|34
2844600|NCT04439279|3546174|FG000|COMPLETED|Overall Study|Treatment continued until disease progression or intolerability.|0
2844601|NCT04439279|3546174|FG000|NOT COMPLETED|Overall Study||35
2844615|NCT03912298|3546195|FG000|STARTED|Overall Study||7
2844616|NCT03912298|3546195|FG000|COMPLETED|Overall Study||7
2844617|NCT03912298|3546195|FG000|NOT COMPLETED|Overall Study||0
3311697|NCT03054350|4045170|FG002|STARTED|Dose Adjustment and Maintenance Period||13
3311698|NCT03054350|4045171|FG003|STARTED|Dose Adjustment and Maintenance Period||3
3311699|NCT03054350|4045172|FG004|STARTED|Dose Adjustment and Maintenance Period||1
3311700|NCT03054350|4045173|FG005|STARTED|Dose Adjustment and Maintenance Period||2
3311701|NCT03054350|4045168|FG000|COMPLETED|Dose Adjustment and Maintenance Period||10
3311702|NCT03054350|4045169|FG001|COMPLETED|Dose Adjustment and Maintenance Period||13
3317209|NCT03124459|4050724|FG004|NOT COMPLETED|Part 2- Open Label ACE-083||0
2844618|NCT02498132|3546202|FG000|STARTED|Overall Study||24
2844619|NCT02498132|3546203|FG001|STARTED|Overall Study||19
2844620|NCT02498132|3546204|FG002|STARTED|Overall Study||9
2844621|NCT02498132|3546202|FG000|COMPLETED|Overall Study||22
2844622|NCT02498132|3546203|FG001|COMPLETED|Overall Study||18
2844623|NCT02498132|3546204|FG002|COMPLETED|Overall Study||9
2844624|NCT02498132|3546202|FG000|NOT COMPLETED|Overall Study||2
2844625|NCT02498132|3546203|FG001|NOT COMPLETED|Overall Study||1
2844626|NCT02498132|3546204|FG002|NOT COMPLETED|Overall Study||0
2844627|NCT02450760|3546214|FG000|STARTED|Overall Study||15
2844602|NCT04439123|3546178|FG000|STARTED|Overall Study|All 35 patients enrolled were eligible and treated in the arm|35
2844603|NCT04439123|3546178|FG000|COMPLETED|Overall Study||0
2844604|NCT04439123|3546178|FG000|NOT COMPLETED|Overall Study||35
2844605|NCT04439110|3546182|FG000|STARTED|Overall Study||38
2844606|NCT04439110|3546182|FG000|Eligible|Overall Study||36
2844607|NCT04439110|3546182|FG000|COMPLETED|Overall Study||0
2844608|NCT04439110|3546182|FG000|NOT COMPLETED|Overall Study||38
2844609|NCT04180540|3546188|FG000|STARTED|Overall Study||55
2844610|NCT04180540|3546189|FG001|STARTED|Overall Study||54
2844611|NCT04180540|3546188|FG000|COMPLETED|Overall Study||53
2844612|NCT04180540|3546189|FG001|COMPLETED|Overall Study||54
2844613|NCT04180540|3546188|FG000|NOT COMPLETED|Overall Study||2
2844614|NCT04180540|3546189|FG001|NOT COMPLETED|Overall Study||0
2844628|NCT02450760|3546215|FG001|STARTED|Overall Study||18
2844629|NCT02450760|3546214|FG000|COMPLETED|Overall Study||15
2844630|NCT02450760|3546215|FG001|COMPLETED|Overall Study||18
2844631|NCT02450760|3546214|FG000|NOT COMPLETED|Overall Study||0
2844632|NCT02450760|3546215|FG001|NOT COMPLETED|Overall Study||0
2916868|NCT00518115|3627175|FG002|Safety Population|Overall Study|These participants received at least one dose of study drug.|35
2916869|NCT00518115|3627176|FG003|Safety Population|Overall Study|These participants received at least one dose of study drug.|35
2916870|NCT00518115|3627177|FG004|Safety Population|Overall Study|These participants received at least one dose of study drug.|31
2916871|NCT00518115|3627178|FG005|Safety Population|Overall Study|These participants received at least one dose of study drug.|33
2916872|NCT00518115|3627179|FG006|Safety Population|Overall Study|These participants received at least one dose of study drug.|32
2916873|NCT00518115|3627180|FG007|Safety Population|Overall Study|These participants received at least one dose of study drug.|35
2916874|NCT00518115|3627181|FG008|Safety Population|Overall Study|These participants received at least one dose of study drug.|35
2916875|NCT00518115|3627182|FG009|Safety Population|Overall Study|These participants received at least one dose of study drug.|34
2916876|NCT00518115|3627173|FG000|COMPLETED|Overall Study||40
2916877|NCT00518115|3627174|FG001|COMPLETED|Overall Study||29
2916878|NCT00518115|3627175|FG002|COMPLETED|Overall Study||19
2916879|NCT00518115|3627176|FG003|COMPLETED|Overall Study||24
2916880|NCT00518115|3627177|FG004|COMPLETED|Overall Study||21
2916881|NCT00518115|3627178|FG005|COMPLETED|Overall Study||19
2916882|NCT00518115|3627179|FG006|COMPLETED|Overall Study||25
2916883|NCT00518115|3627180|FG007|COMPLETED|Overall Study||20
2916884|NCT00518115|3627181|FG008|COMPLETED|Overall Study||30
2916885|NCT00518115|3627182|FG009|COMPLETED|Overall Study||20
2916886|NCT00518115|3627173|FG000|NOT COMPLETED|Overall Study||12
2916887|NCT00518115|3627174|FG001|NOT COMPLETED|Overall Study||6
2916888|NCT00518115|3627175|FG002|NOT COMPLETED|Overall Study||17
2916889|NCT00518115|3627176|FG003|NOT COMPLETED|Overall Study||11
2916890|NCT00518115|3627177|FG004|NOT COMPLETED|Overall Study||10
2916891|NCT00518115|3627178|FG005|NOT COMPLETED|Overall Study||15
2916892|NCT00518115|3627179|FG006|NOT COMPLETED|Overall Study||8
2916893|NCT00518115|3627180|FG007|NOT COMPLETED|Overall Study||15
2916894|NCT00518115|3627181|FG008|NOT COMPLETED|Overall Study||5
2916895|NCT00518115|3627182|FG009|NOT COMPLETED|Overall Study||15
2916896|NCT00518154|3627205|FG000|STARTED|Overall Study||7
2916897|NCT00518154|3627205|FG000|COMPLETED|Overall Study||7
2916898|NCT00518154|3627205|FG000|NOT COMPLETED|Overall Study||0
2916899|NCT00518180|3627212|FG000|STARTED|Overall Study||540
2916900|NCT00518180|3627213|FG001|STARTED|Overall Study||541
2916901|NCT00518180|3627214|FG002|STARTED|Overall Study||539
2916902|NCT00518180|3627212|FG000|COMPLETED|Overall Study||475
2916903|NCT00518180|3627213|FG001|COMPLETED|Overall Study||472
2916904|NCT00518180|3627214|FG002|COMPLETED|Overall Study||457
2916905|NCT00518180|3627212|FG000|NOT COMPLETED|Overall Study||65
2916906|NCT00518180|3627213|FG001|NOT COMPLETED|Overall Study||69
2916907|NCT00518180|3627214|FG002|NOT COMPLETED|Overall Study||82
2916908|NCT00518206|3627233|FG000|STARTED|Overall Study||27
2916909|NCT00518206|3627234|FG001|STARTED|Overall Study||19
2916910|NCT00518206|3627233|FG000|COMPLETED|Overall Study||16
2916911|NCT00518206|3627234|FG001|COMPLETED|Overall Study||13
2916912|NCT00518206|3627233|FG000|NOT COMPLETED|Overall Study||11
2916913|NCT00518206|3627234|FG001|NOT COMPLETED|Overall Study||6
2916914|NCT00518284|3627244|FG000|STARTED|Overall Study||0
2916915|NCT00518284|3627245|FG001|STARTED|Overall Study||3
2916916|NCT00518284|3627246|FG002|STARTED|Overall Study||1
2916917|NCT00518284|3627247|FG003|STARTED|Overall Study||2
2916918|NCT00518284|3627244|FG000|COMPLETED|Overall Study||0
2916919|NCT00518284|3627245|FG001|COMPLETED|Overall Study||0
2916920|NCT00518284|3627246|FG002|COMPLETED|Overall Study||0
2916921|NCT00518284|3627247|FG003|COMPLETED|Overall Study||0
2916922|NCT00518284|3627244|FG000|NOT COMPLETED|Overall Study||0
2916923|NCT00518284|3627245|FG001|NOT COMPLETED|Overall Study||3
2916924|NCT00518284|3627246|FG002|NOT COMPLETED|Overall Study||1
2916925|NCT00518284|3627247|FG003|NOT COMPLETED|Overall Study||2
2916926|NCT00518323|3627261|FG000|STARTED|Overall Study||54
2916927|NCT00518323|3627262|FG001|STARTED|Overall Study||48
2916928|NCT00518323|3627263|FG002|STARTED|Overall Study||48
2916929|NCT00518323|3627264|FG003|STARTED|Overall Study||51
2916930|NCT00518323|3627261|FG000|COMPLETED|Overall Study||35
2916931|NCT00518323|3627262|FG001|COMPLETED|Overall Study||40
2916932|NCT00518323|3627263|FG002|COMPLETED|Overall Study||37
2916933|NCT00518323|3627264|FG003|COMPLETED|Overall Study||26
2916934|NCT00518323|3627261|FG000|NOT COMPLETED|Overall Study||19
2916935|NCT00518323|3627262|FG001|NOT COMPLETED|Overall Study||8
2844633|NCT03618056|3546226|FG000|STARTED|Overall Study||1
2844634|NCT03618056|3546226|FG000|COMPLETED|Overall Study||1
2844635|NCT03618056|3546226|FG000|NOT COMPLETED|Overall Study||0
2844636|NCT03503617|3546232|FG000|STARTED|Overall Study||14
2844637|NCT03503617|3546233|FG001|STARTED|Overall Study||13
2844638|NCT03503617|3546232|FG000|COMPLETED|Overall Study||14
2844639|NCT03503617|3546233|FG001|COMPLETED|Overall Study||10
2844640|NCT03503617|3546232|FG000|NOT COMPLETED|Overall Study||0
2844641|NCT03503617|3546233|FG001|NOT COMPLETED|Overall Study||3
2844642|NCT03298867|3546241|FG000|STARTED|Double-Masked 24-Week Treatment Period||42
2844643|NCT03298867|3546242|FG001|STARTED|Double-Masked 24-Week Treatment Period||41
2844644|NCT03298867|3546241|FG000|COMPLETED|Double-Masked 24-Week Treatment Period|36 participants who completed the double-masked treatment period as nonresponders chose to enroll in the OPTIC-X open-label extension study (NCT03461211).|40
2844645|NCT03298867|3546242|FG001|COMPLETED|Double-Masked 24-Week Treatment Period|3 participants who completed the double-masked treatment period as nonresponders chose to enroll in the OPTIC-X open-label extension study (NCT03461211).|39
2844646|NCT03298867|3546241|FG000|NOT COMPLETED|Double-Masked 24-Week Treatment Period||2
2844647|NCT03298867|3546242|FG001|NOT COMPLETED|Double-Masked 24-Week Treatment Period||2
2844648|NCT03298867|3546241|FG000|STARTED|48-Week Follow-Up Period (Weeks 24-72)||4
2844649|NCT03298867|3546242|FG001|STARTED|48-Week Follow-Up Period (Weeks 24-72)||36
2844650|NCT03298867|3546241|FG000|COMPLETED|48-Week Follow-Up Period (Weeks 24-72)||3
2844651|NCT03298867|3546242|FG001|COMPLETED|48-Week Follow-Up Period (Weeks 24-72)||20
2844652|NCT03298867|3546241|FG000|NOT COMPLETED|48-Week Follow-Up Period (Weeks 24-72)||1
2844653|NCT03298867|3546242|FG001|NOT COMPLETED|48-Week Follow-Up Period (Weeks 24-72)||16
2844654|NCT03298867|3546241|FG000|STARTED|48-Week Follow-Up Contact (Weeks 96-120)||3
2844655|NCT03298867|3546242|FG001|STARTED|48-Week Follow-Up Contact (Weeks 96-120)||20
2844656|NCT03298867|3546241|FG000|COMPLETED|48-Week Follow-Up Contact (Weeks 96-120)||3
2844657|NCT03298867|3546242|FG001|COMPLETED|48-Week Follow-Up Contact (Weeks 96-120)||19
2844658|NCT03298867|3546241|FG000|NOT COMPLETED|48-Week Follow-Up Contact (Weeks 96-120)||0
2844659|NCT03298867|3546242|FG001|NOT COMPLETED|48-Week Follow-Up Contact (Weeks 96-120)||1
2844660|NCT03227224|3546252|FG000|STARTED|Double-blind Treatment Period (6 Weeks)||138
2844661|NCT03227224|3546253|FG001|STARTED|Double-blind Treatment Period (6 Weeks)||33
2844662|NCT03227224|3546254|FG002|STARTED|Double-blind Treatment Period (6 Weeks)||63
2844663|NCT03227224|3546255|FG003|STARTED|Double-blind Treatment Period (6 Weeks)||53
2844664|NCT03227224|3546252|FG000|Treated|Double-blind Treatment Period (6 Weeks)||137
2844665|NCT03227224|3546253|FG001|Treated|Double-blind Treatment Period (6 Weeks)||33
2844666|NCT03227224|3546254|FG002|Treated|Double-blind Treatment Period (6 Weeks)||61
2844667|NCT03227224|3546255|FG003|Treated|Double-blind Treatment Period (6 Weeks)||52
2844668|NCT03227224|3546252|FG000|COMPLETED|Double-blind Treatment Period (6 Weeks)||123
2844669|NCT03227224|3546253|FG001|COMPLETED|Double-blind Treatment Period (6 Weeks)||27
2844670|NCT03227224|3546254|FG002|COMPLETED|Double-blind Treatment Period (6 Weeks)||55
2844671|NCT03227224|3546255|FG003|COMPLETED|Double-blind Treatment Period (6 Weeks)||46
2844672|NCT03227224|3546252|FG000|NOT COMPLETED|Double-blind Treatment Period (6 Weeks)||15
2844673|NCT03227224|3546253|FG001|NOT COMPLETED|Double-blind Treatment Period (6 Weeks)||6
2844674|NCT03227224|3546254|FG002|NOT COMPLETED|Double-blind Treatment Period (6 Weeks)||8
2844675|NCT03227224|3546255|FG003|NOT COMPLETED|Double-blind Treatment Period (6 Weeks)||7
2844676|NCT03227224|3546252|FG000|STARTED|Follow-up Phase (2 Weeks)|All participants that started the double-blind period were followed-up for follow-up phase.|138
2844677|NCT03227224|3546253|FG001|STARTED|Follow-up Phase (2 Weeks)|All participants that started the double-blind period were followed-up for follow-up phase.|33
2844678|NCT03227224|3546254|FG002|STARTED|Follow-up Phase (2 Weeks)|All participants that started the double-blind period were followed-up for follow-up phase.|63
2844679|NCT03227224|3546255|FG003|STARTED|Follow-up Phase (2 Weeks)|All participants that started the double-blind period were followed-up for follow-up phase.|53
2844680|NCT03227224|3546252|FG000|COMPLETED|Follow-up Phase (2 Weeks)||134
2844681|NCT03227224|3546253|FG001|COMPLETED|Follow-up Phase (2 Weeks)||29
2844682|NCT03227224|3546254|FG002|COMPLETED|Follow-up Phase (2 Weeks)||57
2844683|NCT03227224|3546255|FG003|COMPLETED|Follow-up Phase (2 Weeks)||50
2844684|NCT03227224|3546252|FG000|NOT COMPLETED|Follow-up Phase (2 Weeks)||4
2844685|NCT03227224|3546253|FG001|NOT COMPLETED|Follow-up Phase (2 Weeks)||4
2844686|NCT03227224|3546254|FG002|NOT COMPLETED|Follow-up Phase (2 Weeks)||6
2844687|NCT03227224|3546255|FG003|NOT COMPLETED|Follow-up Phase (2 Weeks)||3
2844688|NCT03220581|3546274|FG000|STARTED|Overall Study||28
2844689|NCT03220581|3546275|FG001|STARTED|Overall Study||32
2844690|NCT03220581|3546274|FG000|COMPLETED|Overall Study||25
2844691|NCT03220581|3546275|FG001|COMPLETED|Overall Study||25
2844692|NCT03220581|3546274|FG000|NOT COMPLETED|Overall Study||3
2844693|NCT03220581|3546275|FG001|NOT COMPLETED|Overall Study||7
2844694|NCT03099486|3546283|FG000|STARTED|Overall Study||2
2844695|NCT03099486|3546283|FG000|COMPLETED|Overall Study||2
2844696|NCT03099486|3546283|FG000|NOT COMPLETED|Overall Study||0
2844697|NCT02991482|3546289|FG000|STARTED|Overall Study||73
2844698|NCT02991482|3546290|FG001|STARTED|Overall Study||71
2844699|NCT02991482|3546289|FG000|Crossed-over to Pembrolizumab at Progression|Overall Study||0
2844700|NCT02991482|3546290|FG001|Crossed-over to Pembrolizumab at Progression|Overall Study||45
2844701|NCT02991482|3546289|FG000|COMPLETED|Overall Study||8
2844702|NCT02991482|3546290|FG001|COMPLETED|Overall Study||5
2844703|NCT02991482|3546289|FG000|NOT COMPLETED|Overall Study||65
2844704|NCT02991482|3546290|FG001|NOT COMPLETED|Overall Study||66
2844705|NCT02768870|3546296|FG000|STARTED|Overall Study||26
2844706|NCT02768870|3546296|FG000|Implanted With Device|Overall Study||24
2844707|NCT02768870|3546296|FG000|COMPLETED|Overall Study||0
2844708|NCT02768870|3546296|FG000|NOT COMPLETED|Overall Study||26
2844709|NCT02648698|3546302|FG000|STARTED|Overall Study||60
2844710|NCT02648698|3546303|FG001|STARTED|Overall Study||60
2844711|NCT02648698|3546302|FG000|COMPLETED|Overall Study||59
2844712|NCT02648698|3546303|FG001|COMPLETED|Overall Study||55
2844713|NCT02648698|3546302|FG000|NOT COMPLETED|Overall Study||1
2844714|NCT02648698|3546303|FG001|NOT COMPLETED|Overall Study||5
2844715|NCT02432196|3546309|FG000|STARTED|Overall Study||26
2844716|NCT02432196|3546309|FG000|Implanted With Device|Overall Study||25
2844717|NCT02432196|3546309|FG000|COMPLETED|Overall Study||0
2844718|NCT02432196|3546309|FG000|NOT COMPLETED|Overall Study||26
2844719|NCT02340676|3546313|FG000|STARTED|Overall Study||25
2844720|NCT02340676|3546313|FG000|COMPLETED|Overall Study||25
2844721|NCT02340676|3546313|FG000|NOT COMPLETED|Overall Study||0
2844722|NCT02000882|3546317|FG000|STARTED|Overall Study||10
2844723|NCT02000882|3546317|FG000|COMPLETED|Overall Study||4
2844724|NCT02000882|3546317|FG000|NOT COMPLETED|Overall Study||6
2844725|NCT01654315|3546324|FG000|STARTED|Overall Study||15
2844726|NCT01654315|3546325|FG001|STARTED|Overall Study||10
2844727|NCT01654315|3546326|FG002|STARTED|Overall Study||9
2844728|NCT01654315|3546324|FG000|COMPLETED|Overall Study||15
2844729|NCT01654315|3546325|FG001|COMPLETED|Overall Study||10
2844730|NCT01654315|3546326|FG002|COMPLETED|Overall Study||9
2844731|NCT01654315|3546324|FG000|NOT COMPLETED|Overall Study||0
2844732|NCT01654315|3546325|FG001|NOT COMPLETED|Overall Study||0
2844733|NCT01654315|3546326|FG002|NOT COMPLETED|Overall Study||0
2844734|NCT01642004|3546336|FG000|STARTED|Randomization||135
2844735|NCT01642004|3546337|FG001|STARTED|Randomization||137
2844736|NCT01642004|3546336|FG000|COMPLETED|Randomization||131
2844737|NCT01642004|3546337|FG001|COMPLETED|Randomization||129
2844738|NCT01642004|3546336|FG000|NOT COMPLETED|Randomization||4
2844739|NCT01642004|3546337|FG001|NOT COMPLETED|Randomization||8
2844740|NCT01642004|3546336|FG000|STARTED|Treatment||131
2844741|NCT01642004|3546337|FG001|STARTED|Treatment||129
2844742|NCT01642004|3546336|FG000|COMPLETED|Treatment||21
2844743|NCT01642004|3546337|FG001|COMPLETED|Treatment||2
2844744|NCT01642004|3546336|FG000|NOT COMPLETED|Treatment||110
2844745|NCT01642004|3546337|FG001|NOT COMPLETED|Treatment||127
2844746|NCT01366092|3546343|FG000|STARTED|Overall Study||35
2844747|NCT01366092|3546343|FG000|COMPLETED|Overall Study||31
2844748|NCT01366092|3546343|FG000|NOT COMPLETED|Overall Study||4
2844749|NCT01326104|3546349|FG000|STARTED|Overall Study||7
2844750|NCT01326104|3546350|FG001|STARTED|Overall Study||19
2844751|NCT01326104|3546349|FG000|COMPLETED|Overall Study||7
2844752|NCT01326104|3546350|FG001|COMPLETED|Overall Study||15
2844753|NCT01326104|3546349|FG000|NOT COMPLETED|Overall Study||0
2844754|NCT01326104|3546350|FG001|NOT COMPLETED|Overall Study||4
2844755|NCT01244815|3546360|FG000|STARTED|Overall Study|Randomized|101
2844756|NCT01244815|3546361|FG001|STARTED|Overall Study|Randomized|105
2844757|NCT01244815|3546362|FG002|STARTED|Overall Study|Randomized|99
2844758|NCT01244815|3546363|FG003|STARTED|Overall Study|Randomized|99
2844759|NCT01244815|3546360|FG000|Treated|Overall Study||101
2844760|NCT01244815|3546361|FG001|Treated|Overall Study||104
2844761|NCT01244815|3546362|FG002|Treated|Overall Study||99
2844762|NCT01244815|3546363|FG003|Treated|Overall Study||99
2844763|NCT01244815|3546360|FG000|COMPLETED|Overall Study||87
2844764|NCT01244815|3546361|FG001|COMPLETED|Overall Study||88
2844765|NCT01244815|3546362|FG002|COMPLETED|Overall Study||88
2844766|NCT01244815|3546363|FG003|COMPLETED|Overall Study||87
2844767|NCT01244815|3546360|FG000|NOT COMPLETED|Overall Study||14
2844768|NCT01244815|3546361|FG001|NOT COMPLETED|Overall Study||17
2844769|NCT01244815|3546362|FG002|NOT COMPLETED|Overall Study||11
2844770|NCT01244815|3546363|FG003|NOT COMPLETED|Overall Study||12
2844771|NCT01142596|3546375|FG000|STARTED|Overall Study||44
2844772|NCT01142596|3546376|FG001|STARTED|Overall Study||157
2844773|NCT01142596|3546375|FG000|COMPLETED|Overall Study||15
2844774|NCT01142596|3546376|FG001|COMPLETED|Overall Study||71
2844775|NCT01142596|3546375|FG000|NOT COMPLETED|Overall Study||29
2844776|NCT01142596|3546376|FG001|NOT COMPLETED|Overall Study||86
2844777|NCT01098110|3546385|FG000|STARTED|Overall Study|Randomized participants|176
2844778|NCT01098110|3546386|FG001|STARTED|Overall Study|Randomized participants|182
2844779|NCT01098110|3546387|FG002|STARTED|Overall Study|Randomized participants|174
2844780|NCT01098110|3546385|FG000|Treated|Overall Study|Received at least one dose of trial medication|175
2844781|NCT01098110|3546386|FG001|Treated|Overall Study|Received at least one dose of trial medication|181
2844782|NCT01098110|3546387|FG002|Treated|Overall Study|Received at least one dose of trial medication|174
2844783|NCT01098110|3546385|FG000|COMPLETED|Overall Study||114
2844784|NCT01098110|3546386|FG001|COMPLETED|Overall Study||109
2844785|NCT01098110|3546387|FG002|COMPLETED|Overall Study||80
2844786|NCT01098110|3546385|FG000|NOT COMPLETED|Overall Study||62
2844787|NCT01098110|3546386|FG001|NOT COMPLETED|Overall Study||73
2844788|NCT01098110|3546387|FG002|NOT COMPLETED|Overall Study||94
2844789|NCT01006265|3546399|FG000|STARTED|Overall Study||119
2844790|NCT01006265|3546400|FG001|STARTED|Overall Study||116
3311703|NCT03054350|4045170|FG002|COMPLETED|Dose Adjustment and Maintenance Period||12
3311704|NCT03054350|4045171|FG003|COMPLETED|Dose Adjustment and Maintenance Period||2
3311705|NCT03054350|4045172|FG004|COMPLETED|Dose Adjustment and Maintenance Period||1
2844791|NCT01006265|3546401|FG002|STARTED|Overall Study||108
2844792|NCT01006265|3546402|FG003|STARTED|Overall Study||121
2844793|NCT01006265|3546399|FG000|Treated|Overall Study||119
2844794|NCT01006265|3546400|FG001|Treated|Overall Study||114
2844795|NCT01006265|3546401|FG002|Treated|Overall Study||108
2844796|NCT01006265|3546402|FG003|Treated|Overall Study||121
2844797|NCT01006265|3546399|FG000|COMPLETED|Overall Study||113
2844798|NCT01006265|3546400|FG001|COMPLETED|Overall Study||107
2844799|NCT01006265|3546401|FG002|COMPLETED|Overall Study||99
2844800|NCT01006265|3546402|FG003|COMPLETED|Overall Study||116
2844801|NCT01006265|3546399|FG000|NOT COMPLETED|Overall Study||6
2844802|NCT01006265|3546400|FG001|NOT COMPLETED|Overall Study||9
2844803|NCT01006265|3546401|FG002|NOT COMPLETED|Overall Study||9
2844804|NCT01006265|3546402|FG003|NOT COMPLETED|Overall Study||5
2916936|NCT00518323|3627263|FG002|NOT COMPLETED|Overall Study||11
2916937|NCT00518323|3627264|FG003|NOT COMPLETED|Overall Study||25
2916938|NCT00518336|3627276|FG000|STARTED|Year 7||222
2916939|NCT00518336|3627277|FG001|STARTED|Year 7||211
2916940|NCT00518336|3627276|FG000|COMPLETED|Year 7||220
2916941|NCT00518336|3627277|FG001|COMPLETED|Year 7||208
2916942|NCT00518336|3627276|FG000|NOT COMPLETED|Year 7||2
2916943|NCT00518336|3627277|FG001|NOT COMPLETED|Year 7||3
2916944|NCT00518336|3627276|FG000|STARTED|Year 8|1 subject withdrawn at Year 7 came back and was therefore no longer considered as withdrawn.|223
2916945|NCT00518336|3627277|FG001|STARTED|Year 8|2 subjects withdrawn at Year 7 came back and were therefore no longer considered as withdrawn.|213
2916946|NCT00518336|3627276|FG000|COMPLETED|Year 8||222
2916947|NCT00518336|3627277|FG001|COMPLETED|Year 8||211
2916948|NCT00518336|3627276|FG000|NOT COMPLETED|Year 8||1
2916949|NCT00518336|3627277|FG001|NOT COMPLETED|Year 8||2
2916950|NCT00518336|3627276|FG000|STARTED|Year 9|1 subject did not particpate at the previous timepoint, came back and was added in the Total cohort|224
2916951|NCT00518336|3627277|FG001|STARTED|Year 9||213
2916952|NCT00518336|3627276|FG000|COMPLETED|Year 9||219
2916953|NCT00518336|3627277|FG001|COMPLETED|Year 9||212
2916954|NCT00518336|3627276|FG000|NOT COMPLETED|Year 9||5
2916955|NCT00518336|3627277|FG001|NOT COMPLETED|Year 9||1
2916956|NCT00518349|3627285|FG000|STARTED|Overall Study||60
2916957|NCT00518349|3627286|FG001|STARTED|Overall Study||60
2916958|NCT00518349|3627285|FG000|COMPLETED|Overall Study||60
2916959|NCT00518349|3627286|FG001|COMPLETED|Overall Study||60
2916960|NCT00518349|3627285|FG000|NOT COMPLETED|Overall Study||0
2916961|NCT00518349|3627286|FG001|NOT COMPLETED|Overall Study||0
2916962|NCT00518531|3627294|FG000|STARTED|Treatment Period 1||124
2916963|NCT00518531|3627295|FG001|STARTED|Treatment Period 1||126
2916964|NCT00518531|3627294|FG000|Received Treatment|Treatment Period 1||119
2916965|NCT00518531|3627295|FG001|Received Treatment|Treatment Period 1||124
2916966|NCT00518531|3627294|FG000|COMPLETED|Treatment Period 1||106
2916967|NCT00518531|3627295|FG001|COMPLETED|Treatment Period 1|Participants who completed Treatment Period 1 may choose not to start Treatment Period 2|114
2916968|NCT00518531|3627294|FG000|NOT COMPLETED|Treatment Period 1||18
2916969|NCT00518531|3627295|FG001|NOT COMPLETED|Treatment Period 1||12
2916970|NCT00518531|3627294|FG000|STARTED|Treatment Period 2||106
2916971|NCT00518531|3627295|FG001|STARTED|Treatment Period 2|Participants can start Treatment Period 2 without completing Treatment Period 1.|115
2916972|NCT00518531|3627294|FG000|Received Treatment|Treatment Period 2||106
2916973|NCT00518531|3627295|FG001|Received Treatment|Treatment Period 2||110
2916974|NCT00518531|3627294|FG000|COMPLETED|Treatment Period 2||103
2916975|NCT00518531|3627295|FG001|COMPLETED|Treatment Period 2||95
2916976|NCT00518531|3627294|FG000|NOT COMPLETED|Treatment Period 2||3
2916977|NCT00518531|3627295|FG001|NOT COMPLETED|Treatment Period 2||20
2916978|NCT00518622|3627311|FG000|STARTED|Overall Study||3
2916979|NCT00518622|3627312|FG001|STARTED|Overall Study||6
2916980|NCT00518622|3627313|FG002|STARTED|Overall Study||6
2916981|NCT00518622|3627314|FG003|STARTED|Overall Study||5
2916982|NCT00518622|3627315|FG004|STARTED|Overall Study||6
2916983|NCT00518622|3627316|FG005|STARTED|Overall Study||5
2916984|NCT00518622|3627317|FG006|STARTED|Overall Study||4
2916985|NCT00518622|3627318|FG007|STARTED|Overall Study||5
2916986|NCT00518622|3627311|FG000|Completed Therapy|Overall Study|Completed therapy defined if participant has taken 8 days of study medication per the protocol.|3
2916987|NCT00518622|3627312|FG001|Completed Therapy|Overall Study||5
2916988|NCT00518622|3627313|FG002|Completed Therapy|Overall Study||6
2916989|NCT00518622|3627314|FG003|Completed Therapy|Overall Study||5
2916990|NCT00518622|3627315|FG004|Completed Therapy|Overall Study||6
2916991|NCT00518622|3627316|FG005|Completed Therapy|Overall Study||5
2916992|NCT00518622|3627317|FG006|Completed Therapy|Overall Study||4
2916993|NCT00518622|3627318|FG007|Completed Therapy|Overall Study||5
2916994|NCT00518622|3627311|FG000|Discontinued Therapy|Overall Study|Discontinued therapy defined if participant has not taken 8 days of medication per the protocol.|0
3168099|NCT01916109|3895415|FG000|COMPLETED|Overall Study||3
3168100|NCT01916109|3895415|FG000|NOT COMPLETED|Overall Study||1
2916995|NCT00518622|3627312|FG001|Discontinued Therapy|Overall Study||1
2916996|NCT00518622|3627313|FG002|Discontinued Therapy|Overall Study||0
2916997|NCT00518622|3627314|FG003|Discontinued Therapy|Overall Study||0
2916998|NCT00518622|3627315|FG004|Discontinued Therapy|Overall Study||0
2916999|NCT00518622|3627316|FG005|Discontinued Therapy|Overall Study||0
2917000|NCT00518622|3627317|FG006|Discontinued Therapy|Overall Study||0
2917001|NCT00518622|3627318|FG007|Discontinued Therapy|Overall Study||0
2917002|NCT00518622|3627311|FG000|COMPLETED|Overall Study||3
2917003|NCT00518622|3627312|FG001|COMPLETED|Overall Study||5
2917004|NCT00518622|3627313|FG002|COMPLETED|Overall Study||5
2917005|NCT00518622|3627314|FG003|COMPLETED|Overall Study||5
3168101|NCT01916226|3895423|FG000|STARTED|Overall Study||170
2844805|NCT00591227|3546414|FG000|STARTED|Overall Study||89
2844806|NCT00591227|3546415|FG001|STARTED|Overall Study||87
2844807|NCT00591227|3546414|FG000|COMPLETED|Overall Study||89
2844808|NCT00591227|3546415|FG001|COMPLETED|Overall Study||87
2844809|NCT00591227|3546414|FG000|NOT COMPLETED|Overall Study||0
2844810|NCT00591227|3546415|FG001|NOT COMPLETED|Overall Study||0
2844811|NCT00534976|3546424|FG000|STARTED|Period 1: Placebo Run-in||33
2844812|NCT00534976|3546425|FG001|STARTED|Period 1: Placebo Run-in||33
2844813|NCT00534976|3546424|FG000|COMPLETED|Period 1: Placebo Run-in||33
2844814|NCT00534976|3546425|FG001|COMPLETED|Period 1: Placebo Run-in||33
2844815|NCT00534976|3546424|FG000|NOT COMPLETED|Period 1: Placebo Run-in||0
2844816|NCT00534976|3546425|FG001|NOT COMPLETED|Period 1: Placebo Run-in||0
2844817|NCT00534976|3546424|FG000|STARTED|Period 2: Treatment Montelukast/ Placebo||33
2844818|NCT00534976|3546425|FG001|STARTED|Period 2: Treatment Montelukast/ Placebo||33
2844819|NCT00534976|3546424|FG000|COMPLETED|Period 2: Treatment Montelukast/ Placebo||33
2844820|NCT00534976|3546425|FG001|COMPLETED|Period 2: Treatment Montelukast/ Placebo||32
2844821|NCT00534976|3546424|FG000|NOT COMPLETED|Period 2: Treatment Montelukast/ Placebo||0
2844822|NCT00534976|3546425|FG001|NOT COMPLETED|Period 2: Treatment Montelukast/ Placebo||1
2844823|NCT00534976|3546424|FG000|STARTED|Period 3: Crossover Placebo/ Montelukast||33
2844824|NCT00534976|3546425|FG001|STARTED|Period 3: Crossover Placebo/ Montelukast||32
2844825|NCT00534976|3546424|FG000|COMPLETED|Period 3: Crossover Placebo/ Montelukast||31
2844826|NCT00534976|3546425|FG001|COMPLETED|Period 3: Crossover Placebo/ Montelukast||32
2844827|NCT00534976|3546424|FG000|NOT COMPLETED|Period 3: Crossover Placebo/ Montelukast||2
2844828|NCT00534976|3546425|FG001|NOT COMPLETED|Period 3: Crossover Placebo/ Montelukast||0
2844829|NCT00337675|3546434|FG000|STARTED|Overall Study||589
2844830|NCT00337675|3546435|FG001|STARTED|Overall Study||591
2844831|NCT00337675|3546436|FG002|STARTED|Overall Study||591
2844832|NCT00337675|3546434|FG000|COMPLETED|Overall Study||492
2844833|NCT00337675|3546435|FG001|COMPLETED|Overall Study||488
2844834|NCT00337675|3546436|FG002|COMPLETED|Overall Study||492
2844835|NCT00337675|3546434|FG000|NOT COMPLETED|Overall Study||97
2844836|NCT00337675|3546435|FG001|NOT COMPLETED|Overall Study||103
2844837|NCT00337675|3546436|FG002|NOT COMPLETED|Overall Study||99
2844838|NCT00317772|3546448|FG000|STARTED|Overall Study||3
2844839|NCT00317772|3546449|FG001|STARTED|Overall Study||3
2844840|NCT00317772|3546450|FG002|STARTED|Overall Study||3
2844841|NCT00317772|3546451|FG003|STARTED|Overall Study||10
2844842|NCT00317772|3546448|FG000|COMPLETED|Overall Study||1
2844843|NCT00317772|3546449|FG001|COMPLETED|Overall Study||1
2844844|NCT00317772|3546450|FG002|COMPLETED|Overall Study||2
2844845|NCT00317772|3546451|FG003|COMPLETED|Overall Study||1
2844846|NCT00317772|3546448|FG000|NOT COMPLETED|Overall Study||2
2844847|NCT00317772|3546449|FG001|NOT COMPLETED|Overall Study||2
2844848|NCT00317772|3546450|FG002|NOT COMPLETED|Overall Study||1
2844849|NCT00317772|3546451|FG003|NOT COMPLETED|Overall Study||9
2844850|NCT00291486|3546467|FG000|STARTED|Overall Study||3
2844851|NCT00291486|3546468|FG001|STARTED|Overall Study||6
2844852|NCT00291486|3546469|FG002|STARTED|Overall Study||3
2844853|NCT00291486|3546470|FG003|STARTED|Overall Study||3
2844854|NCT00291486|3546471|FG004|STARTED|Overall Study||4
2844855|NCT00291486|3546467|FG000|COMPLETED|Overall Study||2
2844856|NCT00291486|3546468|FG001|COMPLETED|Overall Study||3
2844857|NCT00291486|3546469|FG002|COMPLETED|Overall Study||2
2844858|NCT00291486|3546470|FG003|COMPLETED|Overall Study||2
2844859|NCT00291486|3546471|FG004|COMPLETED|Overall Study||3
2844860|NCT00291486|3546467|FG000|NOT COMPLETED|Overall Study||1
2844861|NCT00291486|3546468|FG001|NOT COMPLETED|Overall Study||3
2844862|NCT00291486|3546469|FG002|NOT COMPLETED|Overall Study||1
2844863|NCT00291486|3546470|FG003|NOT COMPLETED|Overall Study||1
2844864|NCT00291486|3546471|FG004|NOT COMPLETED|Overall Study||1
2844865|NCT00284856|3546495|FG000|STARTED|Overall Study||347
2844866|NCT00284856|3546496|FG001|STARTED|Overall Study||336
2844867|NCT00284856|3546497|FG002|STARTED|Overall Study||336
2844868|NCT00284856|3546495|FG000|COMPLETED|Overall Study||296
2844869|NCT00284856|3546496|FG001|COMPLETED|Overall Study||286
2844870|NCT00284856|3546497|FG002|COMPLETED|Overall Study||276
2844871|NCT00284856|3546495|FG000|NOT COMPLETED|Overall Study||51
2844872|NCT00284856|3546496|FG001|NOT COMPLETED|Overall Study||50
2844873|NCT00284856|3546497|FG002|NOT COMPLETED|Overall Study||60
2844874|NCT00070707|3546507|FG000|STARTED|Overall Study||113
2844875|NCT00070707|3546508|FG001|STARTED|Overall Study||75
2844876|NCT00070707|3546507|FG000|COMPLETED|Overall Study||99
2844877|NCT00070707|3546508|FG001|COMPLETED|Overall Study||68
2844878|NCT00070707|3546507|FG000|NOT COMPLETED|Overall Study||14
2844879|NCT00070707|3546508|FG001|NOT COMPLETED|Overall Study||7
2917006|NCT00518622|3627315|FG004|COMPLETED|Overall Study||6
2917007|NCT00518622|3627316|FG005|COMPLETED|Overall Study||5
2917008|NCT00518622|3627317|FG006|COMPLETED|Overall Study||4
2917009|NCT00518622|3627318|FG007|COMPLETED|Overall Study||5
2917010|NCT00518622|3627311|FG000|NOT COMPLETED|Overall Study||0
2917011|NCT00518622|3627312|FG001|NOT COMPLETED|Overall Study||1
2917012|NCT00518622|3627313|FG002|NOT COMPLETED|Overall Study||1
2917013|NCT00518622|3627314|FG003|NOT COMPLETED|Overall Study||0
2917014|NCT00518622|3627315|FG004|NOT COMPLETED|Overall Study||0
2917015|NCT00518622|3627316|FG005|NOT COMPLETED|Overall Study||0
2917016|NCT00518622|3627317|FG006|NOT COMPLETED|Overall Study||0
2917017|NCT00518622|3627318|FG007|NOT COMPLETED|Overall Study||0
2917018|NCT00518687|3627338|FG000|STARTED|Overall Study|An additional 10 participants were not analyzed because of questionable clinical practices at 1 site|4005
2844880|NCT02358993|3546516|FG000|STARTED|Overall Study||105
2844881|NCT02358993|3546517|FG001|STARTED|Overall Study||96
2844882|NCT02358993|3546516|FG000|COMPLETED|Overall Study||103
2844883|NCT02358993|3546517|FG001|COMPLETED|Overall Study||94
2844884|NCT02358993|3546516|FG000|NOT COMPLETED|Overall Study||2
2844885|NCT02358993|3546517|FG001|NOT COMPLETED|Overall Study||2
2844886|NCT03566199|3546523|FG000|STARTED|Overall Study||1
2844887|NCT03566199|3546524|FG001|STARTED|Overall Study||0
2844888|NCT03566199|3546525|FG002|STARTED|Overall Study||1
2844889|NCT03566199|3546526|FG003|STARTED|Overall Study||0
2844890|NCT03566199|3546527|FG004|STARTED|Overall Study||1
2844891|NCT03566199|3546528|FG005|STARTED|Overall Study||0
2844892|NCT03566199|3546529|FG006|STARTED|Overall Study||4
2844893|NCT03566199|3546530|FG007|STARTED|Overall Study||0
2844894|NCT03566199|3546523|FG000|COMPLETED|Overall Study||1
2844895|NCT03566199|3546524|FG001|COMPLETED|Overall Study||0
2844896|NCT03566199|3546525|FG002|COMPLETED|Overall Study||1
2844897|NCT03566199|3546526|FG003|COMPLETED|Overall Study||0
2844898|NCT03566199|3546527|FG004|COMPLETED|Overall Study||1
2844899|NCT03566199|3546528|FG005|COMPLETED|Overall Study||0
2844900|NCT03566199|3546529|FG006|COMPLETED|Overall Study||4
2844901|NCT03566199|3546530|FG007|COMPLETED|Overall Study||0
2844902|NCT03566199|3546523|FG000|NOT COMPLETED|Overall Study||0
2844903|NCT03566199|3546524|FG001|NOT COMPLETED|Overall Study||0
2844904|NCT03566199|3546525|FG002|NOT COMPLETED|Overall Study||0
2844905|NCT03566199|3546526|FG003|NOT COMPLETED|Overall Study||0
2844906|NCT03566199|3546527|FG004|NOT COMPLETED|Overall Study||0
2844907|NCT03566199|3546528|FG005|NOT COMPLETED|Overall Study||0
2844908|NCT03566199|3546529|FG006|NOT COMPLETED|Overall Study||0
2844909|NCT03566199|3546530|FG007|NOT COMPLETED|Overall Study||0
2844910|NCT03414983|3546536|FG000|STARTED|Pre-Treatment||127
2844911|NCT03414983|3546537|FG001|STARTED|Pre-Treatment||68
2844912|NCT03414983|3546536|FG000|COMPLETED|Pre-Treatment||123
2844913|NCT03414983|3546537|FG001|COMPLETED|Pre-Treatment||62
2844914|NCT03414983|3546536|FG000|NOT COMPLETED|Pre-Treatment||4
2844915|NCT03414983|3546537|FG001|NOT COMPLETED|Pre-Treatment||6
2844916|NCT03414983|3546536|FG000|STARTED|Treatment||123
2844917|NCT03414983|3546537|FG001|STARTED|Treatment||62
2844918|NCT03414983|3546536|FG000|COMPLETED|Treatment||4
2844919|NCT03414983|3546537|FG001|COMPLETED|Treatment||2
2844920|NCT03414983|3546536|FG000|NOT COMPLETED|Treatment||119
2844921|NCT03414983|3546537|FG001|NOT COMPLETED|Treatment||60
2844922|NCT03275168|3546545|FG000|STARTED|Overall Study||34
2844923|NCT03275168|3546546|FG001|STARTED|Overall Study||34
2844924|NCT03275168|3546545|FG000|COMPLETED|Overall Study||27
2844925|NCT03275168|3546546|FG001|COMPLETED|Overall Study||25
2844926|NCT03275168|3546545|FG000|NOT COMPLETED|Overall Study||7
3311706|NCT03054350|4045173|FG005|COMPLETED|Dose Adjustment and Maintenance Period||2
3311707|NCT03054350|4045168|FG000|NOT COMPLETED|Dose Adjustment and Maintenance Period||1
2844927|NCT03275168|3546546|FG001|NOT COMPLETED|Overall Study||9
2844928|NCT04528641|3546558|FG000|STARTED|Overall Study||15
2844929|NCT04528641|3546559|FG001|STARTED|Overall Study||15
2844930|NCT04528641|3546560|FG002|STARTED|Overall Study||15
2844931|NCT04528641|3546561|FG003|STARTED|Overall Study||16
2844932|NCT04528641|3546562|FG004|STARTED|Overall Study||15
2844933|NCT04528641|3546563|FG005|STARTED|Overall Study||15
2844934|NCT04528641|3546558|FG000|COMPLETED|Overall Study||15
2844935|NCT04528641|3546559|FG001|COMPLETED|Overall Study||15
2844936|NCT04528641|3546560|FG002|COMPLETED|Overall Study||15
2844937|NCT04528641|3546561|FG003|COMPLETED|Overall Study||15
2844938|NCT04528641|3546562|FG004|COMPLETED|Overall Study||15
2844939|NCT04528641|3546563|FG005|COMPLETED|Overall Study||14
2844940|NCT04528641|3546558|FG000|NOT COMPLETED|Overall Study||0
2844941|NCT04528641|3546559|FG001|NOT COMPLETED|Overall Study||0
2844942|NCT04528641|3546560|FG002|NOT COMPLETED|Overall Study||0
2844943|NCT04528641|3546561|FG003|NOT COMPLETED|Overall Study||1
2844944|NCT04528641|3546562|FG004|NOT COMPLETED|Overall Study||0
2844945|NCT04528641|3546563|FG005|NOT COMPLETED|Overall Study||1
2844946|NCT04498832|3546582|FG000|STARTED|Overall Study||1049
2844947|NCT04498832|3546583|FG001|STARTED|Overall Study||1051
2844948|NCT04498832|3546582|FG000|COMPLETED|Overall Study||1048
2844949|NCT04498832|3546583|FG001|COMPLETED|Overall Study||1047
2844950|NCT04498832|3546582|FG000|NOT COMPLETED|Overall Study||1
2844951|NCT04498832|3546583|FG001|NOT COMPLETED|Overall Study||4
2844952|NCT04497883|3546591|FG000|STARTED|Treatment Period 1 (2 Days)||12
2844953|NCT04497883|3546592|FG001|STARTED|Treatment Period 1 (2 Days)||12
2844954|NCT04497883|3546593|FG002|STARTED|Treatment Period 1 (2 Days)||0
2844955|NCT04497883|3546594|FG003|STARTED|Treatment Period 1 (2 Days)||0
2844956|NCT04497883|3546591|FG000|COMPLETED|Treatment Period 1 (2 Days)||12
2844957|NCT04497883|3546592|FG001|COMPLETED|Treatment Period 1 (2 Days)||12
2844958|NCT04497883|3546593|FG002|COMPLETED|Treatment Period 1 (2 Days)||0
2844959|NCT04497883|3546594|FG003|COMPLETED|Treatment Period 1 (2 Days)||0
2844960|NCT04497883|3546591|FG000|NOT COMPLETED|Treatment Period 1 (2 Days)||0
2844961|NCT04497883|3546592|FG001|NOT COMPLETED|Treatment Period 1 (2 Days)||0
2844962|NCT04497883|3546593|FG002|NOT COMPLETED|Treatment Period 1 (2 Days)||0
2844963|NCT04497883|3546594|FG003|NOT COMPLETED|Treatment Period 1 (2 Days)||0
2844964|NCT04497883|3546591|FG000|STARTED|Washout Period 1 (72 Hours)||12
2844965|NCT04497883|3546592|FG001|STARTED|Washout Period 1 (72 Hours)||12
2844966|NCT04497883|3546593|FG002|STARTED|Washout Period 1 (72 Hours)||0
2844967|NCT04497883|3546594|FG003|STARTED|Washout Period 1 (72 Hours)||0
2844968|NCT04497883|3546591|FG000|COMPLETED|Washout Period 1 (72 Hours)||12
2844969|NCT04497883|3546592|FG001|COMPLETED|Washout Period 1 (72 Hours)||12
2844970|NCT04497883|3546593|FG002|COMPLETED|Washout Period 1 (72 Hours)||0
2844971|NCT04497883|3546594|FG003|COMPLETED|Washout Period 1 (72 Hours)||0
2844972|NCT04497883|3546591|FG000|NOT COMPLETED|Washout Period 1 (72 Hours)||0
2844973|NCT04497883|3546592|FG001|NOT COMPLETED|Washout Period 1 (72 Hours)||0
2844974|NCT04497883|3546593|FG002|NOT COMPLETED|Washout Period 1 (72 Hours)||0
2844975|NCT04497883|3546594|FG003|NOT COMPLETED|Washout Period 1 (72 Hours)||0
2844976|NCT04497883|3546591|FG000|STARTED|Treatment Period 2 (2 Days)||0
2844977|NCT04497883|3546592|FG001|STARTED|Treatment Period 2 (2 Days)||0
2844978|NCT04497883|3546593|FG002|STARTED|Treatment Period 2 (2 Days)||6
2844979|NCT04497883|3546594|FG003|STARTED|Treatment Period 2 (2 Days)||6
2844980|NCT04497883|3546591|FG000|COMPLETED|Treatment Period 2 (2 Days)||0
2844981|NCT04497883|3546592|FG001|COMPLETED|Treatment Period 2 (2 Days)||0
2844982|NCT04497883|3546593|FG002|COMPLETED|Treatment Period 2 (2 Days)||6
2844983|NCT04497883|3546594|FG003|COMPLETED|Treatment Period 2 (2 Days)||6
2844984|NCT04497883|3546591|FG000|NOT COMPLETED|Treatment Period 2 (2 Days)||0
2844985|NCT04497883|3546592|FG001|NOT COMPLETED|Treatment Period 2 (2 Days)||0
2844986|NCT04497883|3546593|FG002|NOT COMPLETED|Treatment Period 2 (2 Days)||0
2844987|NCT04497883|3546594|FG003|NOT COMPLETED|Treatment Period 2 (2 Days)||0
2844988|NCT04497883|3546591|FG000|STARTED|Washout Period 2 (72 Hours)||0
2844989|NCT04497883|3546592|FG001|STARTED|Washout Period 2 (72 Hours)||0
2844990|NCT04497883|3546593|FG002|STARTED|Washout Period 2 (72 Hours)||6
2844991|NCT04497883|3546594|FG003|STARTED|Washout Period 2 (72 Hours)||6
2844992|NCT04497883|3546591|FG000|COMPLETED|Washout Period 2 (72 Hours)||0
2844993|NCT04497883|3546592|FG001|COMPLETED|Washout Period 2 (72 Hours)||0
2844994|NCT04497883|3546593|FG002|COMPLETED|Washout Period 2 (72 Hours)||6
2844995|NCT04497883|3546594|FG003|COMPLETED|Washout Period 2 (72 Hours)||6
2844996|NCT04497883|3546591|FG000|NOT COMPLETED|Washout Period 2 (72 Hours)||0
2844997|NCT04497883|3546592|FG001|NOT COMPLETED|Washout Period 2 (72 Hours)||0
2844998|NCT04497883|3546593|FG002|NOT COMPLETED|Washout Period 2 (72 Hours)||0
2844999|NCT04497883|3546594|FG003|NOT COMPLETED|Washout Period 2 (72 Hours)||0
2845000|NCT04497883|3546591|FG000|STARTED|Treatment Period 3 (2 Days)||0
2845001|NCT04497883|3546592|FG001|STARTED|Treatment Period 3 (2 Days)||0
2845002|NCT04497883|3546593|FG002|STARTED|Treatment Period 3 (2 Days)||6
2845003|NCT04497883|3546594|FG003|STARTED|Treatment Period 3 (2 Days)||6
2845004|NCT04497883|3546591|FG000|COMPLETED|Treatment Period 3 (2 Days)||0
2845005|NCT04497883|3546592|FG001|COMPLETED|Treatment Period 3 (2 Days)||0
2845006|NCT04497883|3546593|FG002|COMPLETED|Treatment Period 3 (2 Days)||6
2845007|NCT04497883|3546594|FG003|COMPLETED|Treatment Period 3 (2 Days)||6
2845008|NCT04497883|3546591|FG000|NOT COMPLETED|Treatment Period 3 (2 Days)||0
2845009|NCT04497883|3546592|FG001|NOT COMPLETED|Treatment Period 3 (2 Days)||0
2845010|NCT04497883|3546593|FG002|NOT COMPLETED|Treatment Period 3 (2 Days)||0
2845011|NCT04497883|3546594|FG003|NOT COMPLETED|Treatment Period 3 (2 Days)||0
2917019|NCT00518687|3627339|FG001|STARTED|Overall Study|An additional 11 participants were not analyzed because of questionable clinical practices at 1 site|4005
2917020|NCT00518687|3627338|FG000|Vaccinated|Overall Study||3981
2917021|NCT00518687|3627339|FG001|Vaccinated|Overall Study||3982
2917022|NCT00518687|3627338|FG000|COMPLETED|Overall Study||2568
2917023|NCT00518687|3627339|FG001|COMPLETED|Overall Study||2585
2917024|NCT00518687|3627338|FG000|NOT COMPLETED|Overall Study||1437
2917025|NCT00518687|3627339|FG001|NOT COMPLETED|Overall Study||1420
2917026|NCT00518713|3627349|FG000|STARTED|Overall Study||58
2917027|NCT00518713|3627350|FG001|STARTED|Overall Study||62
2917028|NCT00518713|3627351|FG002|STARTED|Overall Study||59
2917029|NCT00518713|3627352|FG003|STARTED|Overall Study||59
2917030|NCT00518713|3627349|FG000|Modified Intent-to-Treat Population|Overall Study||53
2917031|NCT00518713|3627350|FG001|Modified Intent-to-Treat Population|Overall Study||58
2917032|NCT00518713|3627351|FG002|Modified Intent-to-Treat Population|Overall Study||49
2917033|NCT00518713|3627352|FG003|Modified Intent-to-Treat Population|Overall Study||57
2917034|NCT00518713|3627349|FG000|COMPLETED|Overall Study||50
2917035|NCT00518713|3627350|FG001|COMPLETED|Overall Study||45
2917036|NCT00518713|3627351|FG002|COMPLETED|Overall Study||41
2917037|NCT00518713|3627352|FG003|COMPLETED|Overall Study||41
2917038|NCT00518713|3627349|FG000|NOT COMPLETED|Overall Study||8
2917039|NCT00518713|3627350|FG001|NOT COMPLETED|Overall Study||17
2917040|NCT00518713|3627351|FG002|NOT COMPLETED|Overall Study||18
2917041|NCT00518713|3627352|FG003|NOT COMPLETED|Overall Study||18
2917042|NCT00518882|3627364|FG000|STARTED|Double-Blind, Week 0-26|2 subjects exposed to study drug before randomisation. Subjects only included in safety analysis set|235
2917043|NCT00518882|3627365|FG001|STARTED|Double-Blind, Week 0-26|1 subject exposed to study drug before randomisation. Subject only included in safety analysis set|232
2917044|NCT00518882|3627364|FG000|Randomised|Double-Blind, Week 0-26||233
2917045|NCT00518882|3627365|FG001|Randomised|Double-Blind, Week 0-26||231
2917046|NCT00518882|3627364|FG000|COMPLETED|Double-Blind, Week 0-26||202
2917047|NCT00518882|3627365|FG001|COMPLETED|Double-Blind, Week 0-26||187
2917048|NCT00518882|3627364|FG000|NOT COMPLETED|Double-Blind, Week 0-26||33
2917049|NCT00518882|3627365|FG001|NOT COMPLETED|Double-Blind, Week 0-26||45
2917050|NCT00518882|3627364|FG000|STARTED|Open-Label Extension, Week 26-78||202
2917051|NCT00518882|3627365|FG001|STARTED|Open-Label Extension, Week 26-78||187
2917052|NCT00518882|3627364|FG000|COMPLETED|Open-Label Extension, Week 26-78||161
2917053|NCT00518882|3627365|FG001|COMPLETED|Open-Label Extension, Week 26-78||138
2917054|NCT00518882|3627364|FG000|NOT COMPLETED|Open-Label Extension, Week 26-78||41
2917055|NCT00518882|3627365|FG001|NOT COMPLETED|Open-Label Extension, Week 26-78||49
2845012|NCT04034238|3546608|FG000|STARTED|Dose Escalation Phase||7
2845013|NCT04034238|3546609|FG001|STARTED|Dose Escalation Phase||3
2845014|NCT04034238|3546610|FG002|STARTED|Dose Escalation Phase||0
2845015|NCT04034238|3546611|FG003|STARTED|Dose Escalation Phase||2
2845016|NCT04034238|3546608|FG000|COMPLETED|Dose Escalation Phase||6
2845017|NCT04034238|3546609|FG001|COMPLETED|Dose Escalation Phase||3
2845018|NCT04034238|3546610|FG002|COMPLETED|Dose Escalation Phase||0
2845019|NCT04034238|3546611|FG003|COMPLETED|Dose Escalation Phase||0
2845020|NCT04034238|3546608|FG000|NOT COMPLETED|Dose Escalation Phase||1
2845021|NCT04034238|3546609|FG001|NOT COMPLETED|Dose Escalation Phase||0
2845022|NCT04034238|3546610|FG002|NOT COMPLETED|Dose Escalation Phase||0
2845023|NCT04034238|3546611|FG003|NOT COMPLETED|Dose Escalation Phase||2
2845024|NCT04034238|3546608|FG000|STARTED|Dose Expansion Phase||0
2845025|NCT04034238|3546609|FG001|STARTED|Dose Expansion Phase||0
2845026|NCT04034238|3546610|FG002|STARTED|Dose Expansion Phase||6
2845027|NCT04034238|3546611|FG003|STARTED|Dose Expansion Phase||1
2845028|NCT04034238|3546608|FG000|COMPLETED|Dose Expansion Phase||0
2845029|NCT04034238|3546609|FG001|COMPLETED|Dose Expansion Phase||0
2845030|NCT04034238|3546610|FG002|COMPLETED|Dose Expansion Phase||5
2845031|NCT04034238|3546611|FG003|COMPLETED|Dose Expansion Phase||0
2845032|NCT04034238|3546608|FG000|NOT COMPLETED|Dose Expansion Phase||0
2845033|NCT04034238|3546609|FG001|NOT COMPLETED|Dose Expansion Phase||0
2845034|NCT04034238|3546610|FG002|NOT COMPLETED|Dose Expansion Phase||1
2845035|NCT04034238|3546611|FG003|NOT COMPLETED|Dose Expansion Phase||1
2845036|NCT03984305|3546624|FG000|STARTED|Overall Study||23
2845037|NCT03984305|3546625|FG001|STARTED|Overall Study||18
2845038|NCT03984305|3546624|FG000|COMPLETED|Overall Study||0
2845039|NCT03984305|3546625|FG001|COMPLETED|Overall Study||0
2845040|NCT03984305|3546624|FG000|NOT COMPLETED|Overall Study||23
2845041|NCT03984305|3546625|FG001|NOT COMPLETED|Overall Study||18
2845042|NCT03982368|3546634|FG000|STARTED|Overall Study||87
2845043|NCT03982368|3546635|FG001|STARTED|Overall Study||86
2845044|NCT03982368|3546636|FG002|STARTED|Overall Study||88
2845045|NCT03982368|3546634|FG000|FAS Popuation|Overall Study||81
2845046|NCT03982368|3546635|FG001|FAS Popuation|Overall Study||82
2845047|NCT03982368|3546636|FG002|FAS Popuation|Overall Study||84
2845048|NCT03982368|3546634|FG000|PP Population|Overall Study||72
2845049|NCT03982368|3546635|FG001|PP Population|Overall Study||71
2845050|NCT03982368|3546636|FG002|PP Population|Overall Study||80
2845051|NCT03982368|3546634|FG000|COMPLETED|Overall Study||74
2845052|NCT03982368|3546635|FG001|COMPLETED|Overall Study||79
2845053|NCT03982368|3546636|FG002|COMPLETED|Overall Study||83
2845054|NCT03982368|3546634|FG000|NOT COMPLETED|Overall Study||13
2845055|NCT03982368|3546635|FG001|NOT COMPLETED|Overall Study||7
2845056|NCT03982368|3546636|FG002|NOT COMPLETED|Overall Study||5
2845057|NCT03952143|3546649|FG000|STARTED|Lead-In Period||628
3168102|NCT01916226|3895424|FG001|STARTED|Overall Study||170
3168103|NCT01916226|3895425|FG002|STARTED|Overall Study||171
3168104|NCT01916226|3895426|FG003|STARTED|Overall Study||171
3168105|NCT01916226|3895423|FG000|COMPLETED|Overall Study||169
3168106|NCT01916226|3895424|FG001|COMPLETED|Overall Study||169
3168107|NCT01916226|3895425|FG002|COMPLETED|Overall Study||168
2845058|NCT03952143|3546650|FG001|STARTED|Lead-In Period||0
2845059|NCT03952143|3546651|FG002|STARTED|Lead-In Period||0
2845060|NCT03952143|3546649|FG000|Participants Who Received at Least One Dose|Lead-In Period||628
2845061|NCT03952143|3546650|FG001|Participants Who Received at Least One Dose|Lead-In Period||0
2845062|NCT03952143|3546651|FG002|Participants Who Received at Least One Dose|Lead-In Period||0
2845063|NCT03952143|3546649|FG000|COMPLETED|Lead-In Period||595
2845064|NCT03952143|3546650|FG001|COMPLETED|Lead-In Period||0
2845065|NCT03952143|3546651|FG002|COMPLETED|Lead-In Period||0
2845066|NCT03952143|3546649|FG000|NOT COMPLETED|Lead-In Period||33
2845067|NCT03952143|3546650|FG001|NOT COMPLETED|Lead-In Period||0
2845068|NCT03952143|3546651|FG002|NOT COMPLETED|Lead-In Period||0
2845069|NCT03952143|3546649|FG000|STARTED|Treatment Period|Participants received Insulin Lispro during Lead-in Period|0
2845070|NCT03952143|3546650|FG001|STARTED|Treatment Period|Participants were randomized to either Insulin lispro or LY900014 in Treatment Period.|200
2845071|NCT03952143|3546651|FG002|STARTED|Treatment Period|Participants were randomized to either Insulin lispro or LY900014 in Treatment Period.|395
2845072|NCT03952143|3546649|FG000|Participants Who Received at Least One Dose|Treatment Period||0
2845073|NCT03952143|3546650|FG001|Participants Who Received at Least One Dose|Treatment Period||200
2845074|NCT03952143|3546651|FG002|Participants Who Received at Least One Dose|Treatment Period||395
2845075|NCT03952143|3546649|FG000|COMPLETED|Treatment Period||0
2845076|NCT03952143|3546650|FG001|COMPLETED|Treatment Period||191
2845077|NCT03952143|3546651|FG002|COMPLETED|Treatment Period||359
2845078|NCT03952143|3546649|FG000|NOT COMPLETED|Treatment Period||0
2845079|NCT03952143|3546650|FG001|NOT COMPLETED|Treatment Period||9
2845080|NCT03952143|3546651|FG002|NOT COMPLETED|Treatment Period||36
2845081|NCT03924752|3546658|FG000|STARTED|Overall Study||10
2845082|NCT03924752|3546658|FG000|COMPLETED|Overall Study||10
2845083|NCT03924752|3546658|FG000|NOT COMPLETED|Overall Study||0
2845084|NCT03829514|3546662|FG000|STARTED|Overall Study||10
2845085|NCT03829514|3546662|FG000|COMPLETED|Overall Study||10
2845086|NCT03829514|3546662|FG000|NOT COMPLETED|Overall Study||0
2845087|NCT03691428|3546668|FG000|STARTED|Overall Study||48
2845088|NCT03691428|3546669|FG001|STARTED|Overall Study||42
2845089|NCT03691428|3546668|FG000|COMPLETED|Overall Study||42
2845090|NCT03691428|3546669|FG001|COMPLETED|Overall Study||34
3168108|NCT01916226|3895426|FG003|COMPLETED|Overall Study||167
2845091|NCT03691428|3546668|FG000|NOT COMPLETED|Overall Study||6
2845092|NCT03691428|3546669|FG001|NOT COMPLETED|Overall Study||8
2845093|NCT03685708|3546678|FG000|STARTED|Overall Study||14
2845094|NCT03685708|3546679|FG001|STARTED|Overall Study||18
2845095|NCT03685708|3546680|FG002|STARTED|Overall Study||46
2845096|NCT03685708|3546678|FG000|COMPLETED|Overall Study||13
2845097|NCT03685708|3546679|FG001|COMPLETED|Overall Study||16
2845098|NCT03685708|3546680|FG002|COMPLETED|Overall Study||37
2845099|NCT03685708|3546678|FG000|NOT COMPLETED|Overall Study||1
2845100|NCT03685708|3546679|FG001|NOT COMPLETED|Overall Study||2
2845101|NCT03685708|3546680|FG002|NOT COMPLETED|Overall Study||9
2845102|NCT03669588|3546690|FG000|STARTED|Overall Study||84
2845103|NCT03669588|3546691|FG001|STARTED|Overall Study||83
2845104|NCT03669588|3546690|FG000|COMPLETED|Overall Study||80
2845105|NCT03669588|3546691|FG001|COMPLETED|Overall Study||76
2845106|NCT03669588|3546690|FG000|NOT COMPLETED|Overall Study||4
2845107|NCT03669588|3546691|FG001|NOT COMPLETED|Overall Study||7
2845108|NCT03531632|3546700|FG000|STARTED|Overall Study||5
2845109|NCT03531632|3546701|FG001|STARTED|Overall Study||3
2845110|NCT03531632|3546702|FG002|STARTED|Overall Study||28
2845111|NCT03531632|3546700|FG000|Safety Population|Overall Study|At least 1 dose of study drug|5
2845112|NCT03531632|3546701|FG001|Safety Population|Overall Study||3
2845113|NCT03531632|3546702|FG002|Safety Population|Overall Study||28
2845114|NCT03531632|3546700|FG000|Response Evaluable Population|Overall Study|All patients who received at least one dose of any study drug, had baseline measurable disease, and had at least one post-baseline radiographic tumor assessment or discontinued treatment due to clearly documented, clinically progressive disease or death.|5
2845115|NCT03531632|3546701|FG001|Response Evaluable Population|Overall Study||3
2845116|NCT03531632|3546702|FG002|Response Evaluable Population|Overall Study||24
2845117|NCT03531632|3546700|FG000|COMPLETED|Overall Study||0
2845118|NCT03531632|3546701|FG001|COMPLETED|Overall Study||0
2845119|NCT03531632|3546702|FG002|COMPLETED|Overall Study||2
2845120|NCT03531632|3546700|FG000|NOT COMPLETED|Overall Study||5
2845121|NCT03531632|3546701|FG001|NOT COMPLETED|Overall Study||3
2845122|NCT03531632|3546702|FG002|NOT COMPLETED|Overall Study||26
2845123|NCT03488030|3546713|FG000|STARTED|Overall Study||101
2845124|NCT03488030|3546714|FG001|STARTED|Overall Study||145
2845125|NCT03488030|3546713|FG000|COMPLETED|Overall Study||101
2845126|NCT03488030|3546714|FG001|COMPLETED|Overall Study||145
2845127|NCT03488030|3546713|FG000|NOT COMPLETED|Overall Study||0
2845128|NCT03488030|3546714|FG001|NOT COMPLETED|Overall Study||0
2845129|NCT03474107|3546727|FG000|STARTED|Overall Study||301
2845130|NCT03474107|3546728|FG001|STARTED|Overall Study||307
2845131|NCT03474107|3546727|FG000|Treated|Overall Study||296
2845132|NCT03474107|3546728|FG001|Treated|Overall Study||291
2845133|NCT03474107|3546727|FG000|COMPLETED|Overall Study|Participants still on treatment as of data cut-off date 15-Jul-2020|56
2845134|NCT03474107|3546728|FG001|COMPLETED|Overall Study|Participants still on treatment as of data cut-off date 15-Jul-2020|22
2845135|NCT03474107|3546727|FG000|NOT COMPLETED|Overall Study||245
2845136|NCT03474107|3546728|FG001|NOT COMPLETED|Overall Study||285
2845137|NCT03412604|3546734|FG000|STARTED|Overall Study||5
2845138|NCT03412604|3546734|FG000|COMPLETED|Overall Study||4
2845139|NCT03412604|3546734|FG000|NOT COMPLETED|Overall Study||1
2845140|NCT03206073|3546742|FG000|STARTED|Overall Study||4
2845141|NCT03206073|3546743|FG001|STARTED|Overall Study||12
2845142|NCT03206073|3546744|FG002|STARTED|Overall Study||4
2845143|NCT03206073|3546745|FG003|STARTED|Overall Study||14
2845144|NCT03206073|3546742|FG000|COMPLETED|Overall Study||3
2845145|NCT03206073|3546743|FG001|COMPLETED|Overall Study||11
2845146|NCT03206073|3546744|FG002|COMPLETED|Overall Study||0
2845147|NCT03206073|3546745|FG003|COMPLETED|Overall Study||14
2845148|NCT03206073|3546742|FG000|NOT COMPLETED|Overall Study||1
2845149|NCT03206073|3546743|FG001|NOT COMPLETED|Overall Study||1
2845150|NCT03206073|3546744|FG002|NOT COMPLETED|Overall Study||4
2845151|NCT03206073|3546745|FG003|NOT COMPLETED|Overall Study||0
2845152|NCT03195127|3546757|FG000|STARTED|Overall Study||15
2845153|NCT03195127|3546758|FG001|STARTED|Overall Study||18
2845154|NCT03195127|3546757|FG000|COMPLETED|Overall Study||15
2845155|NCT03195127|3546758|FG001|COMPLETED|Overall Study||17
2845156|NCT03195127|3546757|FG000|NOT COMPLETED|Overall Study||0
2845157|NCT03195127|3546758|FG001|NOT COMPLETED|Overall Study||1
2917056|NCT00518973|3627373|FG000|STARTED|Overall Study||9
2917057|NCT00518973|3627374|FG001|STARTED|Overall Study||6
2917058|NCT00518973|3627373|FG000|COMPLETED|Overall Study||6
2917059|NCT00518973|3627374|FG001|COMPLETED|Overall Study||4
2917060|NCT00518973|3627373|FG000|NOT COMPLETED|Overall Study||3
2917061|NCT00518973|3627374|FG001|NOT COMPLETED|Overall Study||2
2917062|NCT00518986|3627382|FG000|STARTED|Overall Study|One subject discontinued before treatment, only 124 subjects in each treatment group were dosed.|125
2917063|NCT00518986|3627383|FG001|STARTED|Overall Study||124
2917064|NCT00518986|3627382|FG000|COMPLETED|Overall Study||99
2917065|NCT00518986|3627383|FG001|COMPLETED|Overall Study||98
2917066|NCT00518986|3627382|FG000|NOT COMPLETED|Overall Study||26
2917067|NCT00518986|3627383|FG001|NOT COMPLETED|Overall Study||26
2917068|NCT00519077|3627389|FG000|STARTED|Overall Study||44
2917069|NCT00519077|3627389|FG000|COMPLETED|Overall Study||36
2917070|NCT00519077|3627389|FG000|NOT COMPLETED|Overall Study||8
2917071|NCT00519194|3627393|FG000|STARTED|Overall Study||112
2917072|NCT00519194|3627393|FG000|COMPLETED|Overall Study||91
2917073|NCT00519194|3627393|FG000|NOT COMPLETED|Overall Study||21
2917074|NCT00519285|3627399|FG000|STARTED|Overall Study|Randomized|612
2845158|NCT03102034|3546770|FG000|STARTED|Overall Study||21
2845159|NCT03102034|3546771|FG001|STARTED|Overall Study||11
2845160|NCT03102034|3546770|FG000|COMPLETED|Overall Study||20
2845161|NCT03102034|3546771|FG001|COMPLETED|Overall Study||11
2845162|NCT03102034|3546770|FG000|NOT COMPLETED|Overall Study||1
2845163|NCT03102034|3546771|FG001|NOT COMPLETED|Overall Study||0
2845164|NCT03076164|3546777|FG000|STARTED|Overall Study||24
2845165|NCT03076164|3546777|FG000|COMPLETED|Overall Study||24
2845166|NCT03076164|3546777|FG000|NOT COMPLETED|Overall Study||0
2845167|NCT02723864|3546788|FG000|STARTED|Overall Study||3
2845168|NCT02723864|3546789|FG001|STARTED|Overall Study||3
2845169|NCT02723864|3546790|FG002|STARTED|Overall Study||6
2845170|NCT02723864|3546791|FG003|STARTED|Overall Study||7
2845171|NCT02723864|3546792|FG004|STARTED|Overall Study||3
2845172|NCT02723864|3546793|FG005|STARTED|Overall Study||25
2845173|NCT02723864|3546794|FG006|STARTED|Overall Study||6
2845174|NCT02723864|3546788|FG000|COMPLETED|Overall Study||2
2845175|NCT02723864|3546789|FG001|COMPLETED|Overall Study||2
2845176|NCT02723864|3546790|FG002|COMPLETED|Overall Study||5
2845177|NCT02723864|3546791|FG003|COMPLETED|Overall Study||7
2845178|NCT02723864|3546792|FG004|COMPLETED|Overall Study||2
2845179|NCT02723864|3546793|FG005|COMPLETED|Overall Study||14
2845180|NCT02723864|3546794|FG006|COMPLETED|Overall Study||4
2845181|NCT02723864|3546788|FG000|NOT COMPLETED|Overall Study||1
2845182|NCT02723864|3546789|FG001|NOT COMPLETED|Overall Study||1
2845183|NCT02723864|3546790|FG002|NOT COMPLETED|Overall Study||1
2845184|NCT02723864|3546791|FG003|NOT COMPLETED|Overall Study||0
2845185|NCT02723864|3546792|FG004|NOT COMPLETED|Overall Study||1
2845186|NCT02723864|3546793|FG005|NOT COMPLETED|Overall Study||11
2845187|NCT02723864|3546794|FG006|NOT COMPLETED|Overall Study||2
2845188|NCT02701556|3546833|FG000|STARTED|Overall Study||198
2845189|NCT02701556|3546834|FG001|STARTED|Overall Study||198
2845190|NCT02701556|3546833|FG000|COMPLETED|Overall Study||175
2845191|NCT02701556|3546834|FG001|COMPLETED|Overall Study||178
2845192|NCT02701556|3546833|FG000|NOT COMPLETED|Overall Study||23
2845193|NCT02701556|3546834|FG001|NOT COMPLETED|Overall Study||20
2845194|NCT02691013|3546842|FG000|STARTED|Overall Study||61
2845195|NCT02691013|3546843|FG001|STARTED|Overall Study||59
2845196|NCT02691013|3546842|FG000|COMPLETED|Overall Study||58
2845197|NCT02691013|3546843|FG001|COMPLETED|Overall Study||59
2845198|NCT02691013|3546842|FG000|NOT COMPLETED|Overall Study||3
2845199|NCT02691013|3546843|FG001|NOT COMPLETED|Overall Study||0
2845200|NCT02597062|3546851|FG000|STARTED|Overall Study||76
2845201|NCT02597062|3546851|FG000|COMPLETED|Overall Study||75
2845202|NCT02597062|3546851|FG000|NOT COMPLETED|Overall Study||1
2845209|NCT02130882|3546866|FG000|STARTED|Overall Study||10
2845210|NCT02130882|3546867|FG001|STARTED|Overall Study||10
2845211|NCT02130882|3546866|FG000|COMPLETED|Overall Study||10
2845212|NCT02130882|3546867|FG001|COMPLETED|Overall Study||9
2845213|NCT02130882|3546866|FG000|NOT COMPLETED|Overall Study||0
2845214|NCT02130882|3546867|FG001|NOT COMPLETED|Overall Study||1
2845215|NCT01920932|3546873|FG000|STARTED|Overall Study||77
2845216|NCT01920932|3546873|FG000|COMPLETED|Overall Study||75
2845217|NCT01920932|3546873|FG000|NOT COMPLETED|Overall Study||2
2845218|NCT01850563|3546896|FG000|STARTED|Overall Study||22
2845219|NCT01850563|3546897|FG001|STARTED|Overall Study||19
2845220|NCT01850563|3546896|FG000|HBO Treatment Completed|Overall Study||19
2845221|NCT01850563|3546897|FG001|HBO Treatment Completed|Overall Study||0
2845222|NCT01850563|3546896|FG000|COMPLETED|Overall Study||19
2845223|NCT01850563|3546897|FG001|COMPLETED|Overall Study||19
2845224|NCT01850563|3546896|FG000|NOT COMPLETED|Overall Study||3
2845225|NCT01850563|3546897|FG001|NOT COMPLETED|Overall Study||0
2845226|NCT01827111|3546904|FG000|STARTED|Overall Study||19
2845227|NCT01827111|3546904|FG000|COMPLETED|Overall Study||18
2845228|NCT01827111|3546904|FG000|NOT COMPLETED|Overall Study||1
2845229|NCT01729754|3546912|FG000|STARTED|Part 1||20
2845230|NCT01729754|3546913|FG001|STARTED|Part 1||184
2845231|NCT01729754|3546914|FG002|STARTED|Part 1||110
2845232|NCT01729754|3546915|FG003|STARTED|Part 1||18
2845233|NCT01729754|3546916|FG004|STARTED|Part 1||21
2845234|NCT01729754|3546917|FG005|STARTED|Part 1||268
2845235|NCT01729754|3546918|FG006|STARTED|Part 1||14
2845236|NCT01729754|3546919|FG007|STARTED|Part 1||72
2845237|NCT01729754|3546920|FG008|STARTED|Part 1||70
2845238|NCT01729754|3546921|FG009|STARTED|Part 1||313
2845239|NCT01729754|3546912|FG000|COMPLETED|Part 1||6
2845240|NCT01729754|3546913|FG001|COMPLETED|Part 1||184
2845241|NCT01729754|3546914|FG002|COMPLETED|Part 1||110
2845242|NCT01729754|3546915|FG003|COMPLETED|Part 1||6
2845243|NCT01729754|3546916|FG004|COMPLETED|Part 1||21
2845244|NCT01729754|3546917|FG005|COMPLETED|Part 1||268
2845245|NCT01729754|3546918|FG006|COMPLETED|Part 1||0
2845246|NCT01729754|3546919|FG007|COMPLETED|Part 1||72
2845247|NCT01729754|3546920|FG008|COMPLETED|Part 1||70
2845248|NCT01729754|3546921|FG009|COMPLETED|Part 1||289
2845249|NCT01729754|3546912|FG000|NOT COMPLETED|Part 1||14
2845250|NCT01729754|3546913|FG001|NOT COMPLETED|Part 1||0
2845251|NCT01729754|3546914|FG002|NOT COMPLETED|Part 1||0
2845252|NCT01729754|3546915|FG003|NOT COMPLETED|Part 1||12
2845253|NCT01729754|3546916|FG004|NOT COMPLETED|Part 1||0
2845254|NCT01729754|3546917|FG005|NOT COMPLETED|Part 1||0
2845255|NCT01729754|3546918|FG006|NOT COMPLETED|Part 1||14
2845256|NCT01729754|3546919|FG007|NOT COMPLETED|Part 1||0
2845257|NCT01729754|3546920|FG008|NOT COMPLETED|Part 1||0
2845258|NCT01729754|3546921|FG009|NOT COMPLETED|Part 1||24
2845259|NCT01729754|3546912|FG000|STARTED|Part 2||6
2845260|NCT01729754|3546913|FG001|STARTED|Part 2||184
2845261|NCT01729754|3546914|FG002|STARTED|Part 2||110
2845262|NCT01729754|3546915|FG003|STARTED|Part 2|1 participant completed Part 1 but did not enter Part 2|5
2845263|NCT01729754|3546916|FG004|STARTED|Part 2||21
2845264|NCT01729754|3546917|FG005|STARTED|Part 2||268
2845265|NCT01729754|3546918|FG006|STARTED|Part 2||0
2845266|NCT01729754|3546919|FG007|STARTED|Part 2||72
2845267|NCT01729754|3546920|FG008|STARTED|Part 2||70
2845268|NCT01729754|3546921|FG009|STARTED|Part 2||289
2845269|NCT01729754|3546912|FG000|COMPLETED|Part 2||0
2845270|NCT01729754|3546913|FG001|COMPLETED|Part 2||184
2845271|NCT01729754|3546914|FG002|COMPLETED|Part 2||110
2845272|NCT01729754|3546915|FG003|COMPLETED|Part 2||0
2845273|NCT01729754|3546916|FG004|COMPLETED|Part 2||21
2845274|NCT01729754|3546917|FG005|COMPLETED|Part 2||268
2845275|NCT01729754|3546918|FG006|COMPLETED|Part 2||0
2845276|NCT01729754|3546919|FG007|COMPLETED|Part 2||69
2845277|NCT01729754|3546920|FG008|COMPLETED|Part 2||66
2845278|NCT01729754|3546921|FG009|COMPLETED|Part 2||277
2845279|NCT01729754|3546912|FG000|NOT COMPLETED|Part 2||6
2845280|NCT01729754|3546913|FG001|NOT COMPLETED|Part 2||0
2845281|NCT01729754|3546914|FG002|NOT COMPLETED|Part 2||0
2845282|NCT01729754|3546915|FG003|NOT COMPLETED|Part 2||5
2845283|NCT01729754|3546916|FG004|NOT COMPLETED|Part 2||0
2845284|NCT01729754|3546917|FG005|NOT COMPLETED|Part 2||0
2845285|NCT01729754|3546918|FG006|NOT COMPLETED|Part 2||0
2845286|NCT01729754|3546919|FG007|NOT COMPLETED|Part 2||3
2845287|NCT01729754|3546920|FG008|NOT COMPLETED|Part 2||4
2845288|NCT01729754|3546921|FG009|NOT COMPLETED|Part 2||12
2845289|NCT01729754|3546912|FG000|STARTED|Part 3||0
2845290|NCT01729754|3546913|FG001|STARTED|Part 3|14 participants completed Part 2 but did not enter Part 3|170
2845291|NCT01729754|3546914|FG002|STARTED|Part 3||110
2845292|NCT01729754|3546915|FG003|STARTED|Part 3||0
2845293|NCT01729754|3546916|FG004|STARTED|Part 3||21
2845294|NCT01729754|3546917|FG005|STARTED|Part 3|31 participants completed Part 2 but did not enter Part 3|237
2845295|NCT01729754|3546918|FG006|STARTED|Part 3||0
2845296|NCT01729754|3546919|FG007|STARTED|Part 3||69
2845297|NCT01729754|3546920|FG008|STARTED|Part 3||66
2845298|NCT01729754|3546921|FG009|STARTED|Part 3|156 participants completed Part 2 but did not enter Part 3|121
2845299|NCT01729754|3546912|FG000|COMPLETED|Part 3||0
2845300|NCT01729754|3546913|FG001|COMPLETED|Part 3||165
2845301|NCT01729754|3546914|FG002|COMPLETED|Part 3||105
2845302|NCT01729754|3546915|FG003|COMPLETED|Part 3||0
2845303|NCT01729754|3546916|FG004|COMPLETED|Part 3||17
2845304|NCT01729754|3546917|FG005|COMPLETED|Part 3||224
2845305|NCT01729754|3546918|FG006|COMPLETED|Part 3||0
2845306|NCT01729754|3546919|FG007|COMPLETED|Part 3||66
2845307|NCT01729754|3546920|FG008|COMPLETED|Part 3||65
2845308|NCT01729754|3546921|FG009|COMPLETED|Part 3||114
2845309|NCT01729754|3546912|FG000|NOT COMPLETED|Part 3||0
2845310|NCT01729754|3546913|FG001|NOT COMPLETED|Part 3||5
2845311|NCT01729754|3546914|FG002|NOT COMPLETED|Part 3||5
2845312|NCT01729754|3546915|FG003|NOT COMPLETED|Part 3||0
2845313|NCT01729754|3546916|FG004|NOT COMPLETED|Part 3||4
2845314|NCT01729754|3546917|FG005|NOT COMPLETED|Part 3||13
2845315|NCT01729754|3546918|FG006|NOT COMPLETED|Part 3||0
2845316|NCT01729754|3546919|FG007|NOT COMPLETED|Part 3||3
2845317|NCT01729754|3546920|FG008|NOT COMPLETED|Part 3||1
2845318|NCT01729754|3546921|FG009|NOT COMPLETED|Part 3||7
2845319|NCT01553149|3546953|FG000|STARTED|Overall Study||37
2845320|NCT01553149|3546954|FG001|STARTED|Overall Study||38
2845321|NCT01553149|3546953|FG000|COMPLETED|Overall Study||32
2845322|NCT01553149|3546954|FG001|COMPLETED|Overall Study||18
2845323|NCT01553149|3546953|FG000|NOT COMPLETED|Overall Study||5
2845324|NCT01553149|3546954|FG001|NOT COMPLETED|Overall Study||20
2845325|NCT01437111|3546960|FG000|STARTED|Overall Study||200
2845326|NCT01437111|3546960|FG000|Treated Participants|Overall Study||198
2845327|NCT01437111|3546960|FG000|COMPLETED|Overall Study||182
2845328|NCT01437111|3546960|FG000|NOT COMPLETED|Overall Study||18
2845329|NCT01386385|3546972|FG000|STARTED|Phase I 40mg: Concurrent CRT||8
2845330|NCT01386385|3546973|FG001|STARTED|Phase I 40mg: Concurrent CRT||0
2845331|NCT01386385|3546974|FG002|STARTED|Phase I 40mg: Concurrent CRT||0
2845332|NCT01386385|3546975|FG003|STARTED|Phase I 40mg: Concurrent CRT||0
2845333|NCT01386385|3546976|FG004|STARTED|Phase I 40mg: Concurrent CRT||0
2845334|NCT01386385|3546977|FG005|STARTED|Phase I 40mg: Concurrent CRT||0
2845335|NCT01386385|3546978|FG006|STARTED|Phase I 40mg: Concurrent CRT||0
2845336|NCT01386385|3546979|FG007|STARTED|Phase I 40mg: Concurrent CRT||0
2845337|NCT01386385|3546972|FG000|COMPLETED|Phase I 40mg: Concurrent CRT||6
2845338|NCT01386385|3546973|FG001|COMPLETED|Phase I 40mg: Concurrent CRT||0
2845339|NCT01386385|3546974|FG002|COMPLETED|Phase I 40mg: Concurrent CRT||0
2845340|NCT01386385|3546975|FG003|COMPLETED|Phase I 40mg: Concurrent CRT||0
2845341|NCT01386385|3546976|FG004|COMPLETED|Phase I 40mg: Concurrent CRT||0
2845342|NCT01386385|3546977|FG005|COMPLETED|Phase I 40mg: Concurrent CRT||0
2845343|NCT01386385|3546978|FG006|COMPLETED|Phase I 40mg: Concurrent CRT||0
2845344|NCT01386385|3546979|FG007|COMPLETED|Phase I 40mg: Concurrent CRT||0
2845345|NCT01386385|3546972|FG000|NOT COMPLETED|Phase I 40mg: Concurrent CRT||2
2845346|NCT01386385|3546973|FG001|NOT COMPLETED|Phase I 40mg: Concurrent CRT||0
2845347|NCT01386385|3546974|FG002|NOT COMPLETED|Phase I 40mg: Concurrent CRT||0
2845348|NCT01386385|3546975|FG003|NOT COMPLETED|Phase I 40mg: Concurrent CRT||0
2845349|NCT01386385|3546976|FG004|NOT COMPLETED|Phase I 40mg: Concurrent CRT||0
2845350|NCT01386385|3546977|FG005|NOT COMPLETED|Phase I 40mg: Concurrent CRT||0
2845351|NCT01386385|3546978|FG006|NOT COMPLETED|Phase I 40mg: Concurrent CRT||0
2845352|NCT01386385|3546979|FG007|NOT COMPLETED|Phase I 40mg: Concurrent CRT||0
2845353|NCT01386385|3546972|FG000|STARTED|Phase I 40mg: Consolidation Therapy||0
2845354|NCT01386385|3546973|FG001|STARTED|Phase I 40mg: Consolidation Therapy||4
2845355|NCT01386385|3546974|FG002|STARTED|Phase I 40mg: Consolidation Therapy||0
2845356|NCT01386385|3546975|FG003|STARTED|Phase I 40mg: Consolidation Therapy||0
2845357|NCT01386385|3546976|FG004|STARTED|Phase I 40mg: Consolidation Therapy||0
2845358|NCT01386385|3546977|FG005|STARTED|Phase I 40mg: Consolidation Therapy||0
2845359|NCT01386385|3546978|FG006|STARTED|Phase I 40mg: Consolidation Therapy||0
2845360|NCT01386385|3546979|FG007|STARTED|Phase I 40mg: Consolidation Therapy||0
2845361|NCT01386385|3546972|FG000|COMPLETED|Phase I 40mg: Consolidation Therapy||0
2845362|NCT01386385|3546973|FG001|COMPLETED|Phase I 40mg: Consolidation Therapy||4
2845363|NCT01386385|3546974|FG002|COMPLETED|Phase I 40mg: Consolidation Therapy||0
2845364|NCT01386385|3546975|FG003|COMPLETED|Phase I 40mg: Consolidation Therapy||0
2845365|NCT01386385|3546976|FG004|COMPLETED|Phase I 40mg: Consolidation Therapy||0
2845366|NCT01386385|3546977|FG005|COMPLETED|Phase I 40mg: Consolidation Therapy||0
2845367|NCT01386385|3546978|FG006|COMPLETED|Phase I 40mg: Consolidation Therapy||0
2845368|NCT01386385|3546979|FG007|COMPLETED|Phase I 40mg: Consolidation Therapy||0
2845369|NCT01386385|3546972|FG000|NOT COMPLETED|Phase I 40mg: Consolidation Therapy||0
2845370|NCT01386385|3546973|FG001|NOT COMPLETED|Phase I 40mg: Consolidation Therapy||0
2845371|NCT01386385|3546974|FG002|NOT COMPLETED|Phase I 40mg: Consolidation Therapy||0
2845372|NCT01386385|3546975|FG003|NOT COMPLETED|Phase I 40mg: Consolidation Therapy||0
2845373|NCT01386385|3546976|FG004|NOT COMPLETED|Phase I 40mg: Consolidation Therapy||0
2845374|NCT01386385|3546977|FG005|NOT COMPLETED|Phase I 40mg: Consolidation Therapy||0
2845375|NCT01386385|3546978|FG006|NOT COMPLETED|Phase I 40mg: Consolidation Therapy||0
2845376|NCT01386385|3546979|FG007|NOT COMPLETED|Phase I 40mg: Consolidation Therapy||0
2845377|NCT01386385|3546972|FG000|STARTED|Phase I 80mg: Concurrent CRT||0
2845378|NCT01386385|3546973|FG001|STARTED|Phase I 80mg: Concurrent CRT||0
2845379|NCT01386385|3546974|FG002|STARTED|Phase I 80mg: Concurrent CRT||7
2845380|NCT01386385|3546975|FG003|STARTED|Phase I 80mg: Concurrent CRT||0
2845381|NCT01386385|3546976|FG004|STARTED|Phase I 80mg: Concurrent CRT||0
2845382|NCT01386385|3546977|FG005|STARTED|Phase I 80mg: Concurrent CRT||0
2845383|NCT01386385|3546978|FG006|STARTED|Phase I 80mg: Concurrent CRT||0
2845384|NCT01386385|3546979|FG007|STARTED|Phase I 80mg: Concurrent CRT||0
2845385|NCT01386385|3546972|FG000|COMPLETED|Phase I 80mg: Concurrent CRT||0
2845386|NCT01386385|3546973|FG001|COMPLETED|Phase I 80mg: Concurrent CRT||0
2845387|NCT01386385|3546974|FG002|COMPLETED|Phase I 80mg: Concurrent CRT||5
2845388|NCT01386385|3546975|FG003|COMPLETED|Phase I 80mg: Concurrent CRT||0
2845389|NCT01386385|3546976|FG004|COMPLETED|Phase I 80mg: Concurrent CRT||0
2845390|NCT01386385|3546977|FG005|COMPLETED|Phase I 80mg: Concurrent CRT||0
2845391|NCT01386385|3546978|FG006|COMPLETED|Phase I 80mg: Concurrent CRT||0
2845392|NCT01386385|3546979|FG007|COMPLETED|Phase I 80mg: Concurrent CRT||0
2845393|NCT01386385|3546972|FG000|NOT COMPLETED|Phase I 80mg: Concurrent CRT||0
2845394|NCT01386385|3546973|FG001|NOT COMPLETED|Phase I 80mg: Concurrent CRT||0
3168109|NCT01916226|3895423|FG000|NOT COMPLETED|Overall Study||1
3168110|NCT01916226|3895424|FG001|NOT COMPLETED|Overall Study||1
3168111|NCT01916226|3895425|FG002|NOT COMPLETED|Overall Study||3
3168112|NCT01916226|3895426|FG003|NOT COMPLETED|Overall Study||4
3168113|NCT01916304|3895437|FG000|STARTED|Overall Study||101
3168114|NCT01916304|3895437|FG000|Safety Set|Overall Study||101
3168115|NCT01916304|3895437|FG000|Intent-to-Treat Set|Overall Study||84
3168116|NCT01916304|3895437|FG000|COMPLETED|Overall Study||84
3168117|NCT01916304|3895437|FG000|NOT COMPLETED|Overall Study||17
2845395|NCT01386385|3546974|FG002|NOT COMPLETED|Phase I 80mg: Concurrent CRT||2
2845396|NCT01386385|3546975|FG003|NOT COMPLETED|Phase I 80mg: Concurrent CRT||0
2845397|NCT01386385|3546976|FG004|NOT COMPLETED|Phase I 80mg: Concurrent CRT||0
2845398|NCT01386385|3546977|FG005|NOT COMPLETED|Phase I 80mg: Concurrent CRT||0
2845399|NCT01386385|3546978|FG006|NOT COMPLETED|Phase I 80mg: Concurrent CRT||0
2845400|NCT01386385|3546979|FG007|NOT COMPLETED|Phase I 80mg: Concurrent CRT||0
2845401|NCT01386385|3546972|FG000|STARTED|Phase I 80mg: Consolidation Therapy||0
2845402|NCT01386385|3546973|FG001|STARTED|Phase I 80mg: Consolidation Therapy||0
2845403|NCT01386385|3546974|FG002|STARTED|Phase I 80mg: Consolidation Therapy||0
2845404|NCT01386385|3546975|FG003|STARTED|Phase I 80mg: Consolidation Therapy||5
2845405|NCT01386385|3546976|FG004|STARTED|Phase I 80mg: Consolidation Therapy||0
2845406|NCT01386385|3546977|FG005|STARTED|Phase I 80mg: Consolidation Therapy||0
2845407|NCT01386385|3546978|FG006|STARTED|Phase I 80mg: Consolidation Therapy||0
2845408|NCT01386385|3546979|FG007|STARTED|Phase I 80mg: Consolidation Therapy||0
2845409|NCT01386385|3546972|FG000|COMPLETED|Phase I 80mg: Consolidation Therapy||0
2845410|NCT01386385|3546973|FG001|COMPLETED|Phase I 80mg: Consolidation Therapy||0
2845411|NCT01386385|3546974|FG002|COMPLETED|Phase I 80mg: Consolidation Therapy||0
3168118|NCT01916629|3895443|FG000|STARTED|Overall Study||7
3168119|NCT01916629|3895444|FG001|STARTED|Overall Study||5
2845412|NCT01386385|3546975|FG003|COMPLETED|Phase I 80mg: Consolidation Therapy||5
2845413|NCT01386385|3546976|FG004|COMPLETED|Phase I 80mg: Consolidation Therapy||0
2845414|NCT01386385|3546977|FG005|COMPLETED|Phase I 80mg: Consolidation Therapy||0
2845415|NCT01386385|3546978|FG006|COMPLETED|Phase I 80mg: Consolidation Therapy||0
2845416|NCT01386385|3546979|FG007|COMPLETED|Phase I 80mg: Consolidation Therapy||0
2845417|NCT01386385|3546972|FG000|NOT COMPLETED|Phase I 80mg: Consolidation Therapy||0
2845418|NCT01386385|3546973|FG001|NOT COMPLETED|Phase I 80mg: Consolidation Therapy||0
2845419|NCT01386385|3546974|FG002|NOT COMPLETED|Phase I 80mg: Consolidation Therapy||0
2845420|NCT01386385|3546975|FG003|NOT COMPLETED|Phase I 80mg: Consolidation Therapy||0
2845421|NCT01386385|3546976|FG004|NOT COMPLETED|Phase I 80mg: Consolidation Therapy||0
2845422|NCT01386385|3546977|FG005|NOT COMPLETED|Phase I 80mg: Consolidation Therapy||0
2845423|NCT01386385|3546978|FG006|NOT COMPLETED|Phase I 80mg: Consolidation Therapy||0
2845424|NCT01386385|3546979|FG007|NOT COMPLETED|Phase I 80mg: Consolidation Therapy||0
2845425|NCT01386385|3546972|FG000|STARTED|Phase I 120mg: Concurrent CRT||0
2845426|NCT01386385|3546973|FG001|STARTED|Phase I 120mg: Concurrent CRT||0
2845427|NCT01386385|3546974|FG002|STARTED|Phase I 120mg: Concurrent CRT||0
2845428|NCT01386385|3546975|FG003|STARTED|Phase I 120mg: Concurrent CRT||0
2845429|NCT01386385|3546976|FG004|STARTED|Phase I 120mg: Concurrent CRT||6
2845430|NCT01386385|3546977|FG005|STARTED|Phase I 120mg: Concurrent CRT||0
2845431|NCT01386385|3546978|FG006|STARTED|Phase I 120mg: Concurrent CRT||0
2845432|NCT01386385|3546979|FG007|STARTED|Phase I 120mg: Concurrent CRT||0
2845433|NCT01386385|3546972|FG000|COMPLETED|Phase I 120mg: Concurrent CRT||0
3168120|NCT01916629|3895443|FG000|COMPLETED|Overall Study||7
3168121|NCT01916629|3895444|FG001|COMPLETED|Overall Study||5
3168122|NCT01916629|3895443|FG000|NOT COMPLETED|Overall Study||0
3168123|NCT01916629|3895444|FG001|NOT COMPLETED|Overall Study||0
3168124|NCT01916655|3895453|FG000|STARTED|Overall Study||131
3168125|NCT01916655|3895454|FG001|STARTED|Overall Study||109
2845434|NCT01386385|3546973|FG001|COMPLETED|Phase I 120mg: Concurrent CRT||0
2845435|NCT01386385|3546974|FG002|COMPLETED|Phase I 120mg: Concurrent CRT||0
2845436|NCT01386385|3546975|FG003|COMPLETED|Phase I 120mg: Concurrent CRT||0
2845437|NCT01386385|3546976|FG004|COMPLETED|Phase I 120mg: Concurrent CRT||5
2845438|NCT01386385|3546977|FG005|COMPLETED|Phase I 120mg: Concurrent CRT||0
2845439|NCT01386385|3546978|FG006|COMPLETED|Phase I 120mg: Concurrent CRT||0
2845440|NCT01386385|3546979|FG007|COMPLETED|Phase I 120mg: Concurrent CRT||0
2845441|NCT01386385|3546972|FG000|NOT COMPLETED|Phase I 120mg: Concurrent CRT||0
2845442|NCT01386385|3546973|FG001|NOT COMPLETED|Phase I 120mg: Concurrent CRT||0
2845443|NCT01386385|3546974|FG002|NOT COMPLETED|Phase I 120mg: Concurrent CRT||0
2845444|NCT01386385|3546975|FG003|NOT COMPLETED|Phase I 120mg: Concurrent CRT||0
2845445|NCT01386385|3546976|FG004|NOT COMPLETED|Phase I 120mg: Concurrent CRT||1
2845446|NCT01386385|3546977|FG005|NOT COMPLETED|Phase I 120mg: Concurrent CRT||0
2845447|NCT01386385|3546978|FG006|NOT COMPLETED|Phase I 120mg: Concurrent CRT||0
2845448|NCT01386385|3546979|FG007|NOT COMPLETED|Phase I 120mg: Concurrent CRT||0
2845449|NCT01386385|3546972|FG000|STARTED|Phase I 120mg: Consolidation Therapy||0
2845450|NCT01386385|3546973|FG001|STARTED|Phase I 120mg: Consolidation Therapy||0
2845451|NCT01386385|3546974|FG002|STARTED|Phase I 120mg: Consolidation Therapy||0
2845452|NCT01386385|3546975|FG003|STARTED|Phase I 120mg: Consolidation Therapy||0
2845453|NCT01386385|3546976|FG004|STARTED|Phase I 120mg: Consolidation Therapy||0
2845454|NCT01386385|3546977|FG005|STARTED|Phase I 120mg: Consolidation Therapy||5
2845455|NCT01386385|3546978|FG006|STARTED|Phase I 120mg: Consolidation Therapy||0
2845456|NCT01386385|3546979|FG007|STARTED|Phase I 120mg: Consolidation Therapy||0
2845457|NCT01386385|3546972|FG000|COMPLETED|Phase I 120mg: Consolidation Therapy||0
2845458|NCT01386385|3546973|FG001|COMPLETED|Phase I 120mg: Consolidation Therapy||0
2845459|NCT01386385|3546974|FG002|COMPLETED|Phase I 120mg: Consolidation Therapy||0
2845460|NCT01386385|3546975|FG003|COMPLETED|Phase I 120mg: Consolidation Therapy||0
2845461|NCT01386385|3546976|FG004|COMPLETED|Phase I 120mg: Consolidation Therapy||0
2845462|NCT01386385|3546977|FG005|COMPLETED|Phase I 120mg: Consolidation Therapy||5
2845463|NCT01386385|3546978|FG006|COMPLETED|Phase I 120mg: Consolidation Therapy||0
2845464|NCT01386385|3546979|FG007|COMPLETED|Phase I 120mg: Consolidation Therapy||0
2845465|NCT01386385|3546972|FG000|NOT COMPLETED|Phase I 120mg: Consolidation Therapy||0
2845466|NCT01386385|3546973|FG001|NOT COMPLETED|Phase I 120mg: Consolidation Therapy||0
2845467|NCT01386385|3546974|FG002|NOT COMPLETED|Phase I 120mg: Consolidation Therapy||0
2845468|NCT01386385|3546975|FG003|NOT COMPLETED|Phase I 120mg: Consolidation Therapy||0
2845469|NCT01386385|3546976|FG004|NOT COMPLETED|Phase I 120mg: Consolidation Therapy||0
2845470|NCT01386385|3546977|FG005|NOT COMPLETED|Phase I 120mg: Consolidation Therapy||0
2845471|NCT01386385|3546978|FG006|NOT COMPLETED|Phase I 120mg: Consolidation Therapy||0
2845472|NCT01386385|3546979|FG007|NOT COMPLETED|Phase I 120mg: Consolidation Therapy||0
2845473|NCT01386385|3546972|FG000|STARTED|Phase II Concurrent CRT||0
2845474|NCT01386385|3546973|FG001|STARTED|Phase II Concurrent CRT||0
2845475|NCT01386385|3546974|FG002|STARTED|Phase II Concurrent CRT||0
2845476|NCT01386385|3546975|FG003|STARTED|Phase II Concurrent CRT||0
2845477|NCT01386385|3546976|FG004|STARTED|Phase II Concurrent CRT||0
2845478|NCT01386385|3546977|FG005|STARTED|Phase II Concurrent CRT||0
2845479|NCT01386385|3546978|FG006|STARTED|Phase II Concurrent CRT||18
2845480|NCT01386385|3546979|FG007|STARTED|Phase II Concurrent CRT||13
2845481|NCT01386385|3546972|FG000|COMPLETED|Phase II Concurrent CRT||0
3168126|NCT01916655|3895455|FG002|STARTED|Overall Study||120
3168127|NCT01916655|3895453|FG000|COMPLETED|Overall Study||116
2845482|NCT01386385|3546973|FG001|COMPLETED|Phase II Concurrent CRT||0
2845483|NCT01386385|3546974|FG002|COMPLETED|Phase II Concurrent CRT||0
2845484|NCT01386385|3546975|FG003|COMPLETED|Phase II Concurrent CRT||0
2845485|NCT01386385|3546976|FG004|COMPLETED|Phase II Concurrent CRT||0
2845486|NCT01386385|3546977|FG005|COMPLETED|Phase II Concurrent CRT||0
2845487|NCT01386385|3546978|FG006|COMPLETED|Phase II Concurrent CRT||12
2845488|NCT01386385|3546979|FG007|COMPLETED|Phase II Concurrent CRT||10
2845489|NCT01386385|3546972|FG000|NOT COMPLETED|Phase II Concurrent CRT||0
2845490|NCT01386385|3546973|FG001|NOT COMPLETED|Phase II Concurrent CRT||0
2845491|NCT01386385|3546974|FG002|NOT COMPLETED|Phase II Concurrent CRT||0
2845492|NCT01386385|3546975|FG003|NOT COMPLETED|Phase II Concurrent CRT||0
2845493|NCT01386385|3546976|FG004|NOT COMPLETED|Phase II Concurrent CRT||0
2845494|NCT01386385|3546977|FG005|NOT COMPLETED|Phase II Concurrent CRT||0
2845495|NCT01386385|3546978|FG006|NOT COMPLETED|Phase II Concurrent CRT||6
2845496|NCT01386385|3546979|FG007|NOT COMPLETED|Phase II Concurrent CRT||3
2845497|NCT01386385|3546972|FG000|STARTED|Phase II: Consolidation Therapy||0
2845498|NCT01386385|3546973|FG001|STARTED|Phase II: Consolidation Therapy||0
2845499|NCT01386385|3546974|FG002|STARTED|Phase II: Consolidation Therapy||0
2845500|NCT01386385|3546975|FG003|STARTED|Phase II: Consolidation Therapy||0
2845501|NCT01386385|3546976|FG004|STARTED|Phase II: Consolidation Therapy||0
2845502|NCT01386385|3546977|FG005|STARTED|Phase II: Consolidation Therapy||0
2845503|NCT01386385|3546978|FG006|STARTED|Phase II: Consolidation Therapy||13
2845504|NCT01386385|3546979|FG007|STARTED|Phase II: Consolidation Therapy||10
2845505|NCT01386385|3546972|FG000|COMPLETED|Phase II: Consolidation Therapy||0
2845506|NCT01386385|3546973|FG001|COMPLETED|Phase II: Consolidation Therapy||0
2845507|NCT01386385|3546974|FG002|COMPLETED|Phase II: Consolidation Therapy||0
2845508|NCT01386385|3546975|FG003|COMPLETED|Phase II: Consolidation Therapy||0
2845509|NCT01386385|3546976|FG004|COMPLETED|Phase II: Consolidation Therapy||0
2845510|NCT01386385|3546977|FG005|COMPLETED|Phase II: Consolidation Therapy||0
2845511|NCT01386385|3546978|FG006|COMPLETED|Phase II: Consolidation Therapy||8
2845512|NCT01386385|3546979|FG007|COMPLETED|Phase II: Consolidation Therapy||8
2845513|NCT01386385|3546972|FG000|NOT COMPLETED|Phase II: Consolidation Therapy||0
2845514|NCT01386385|3546973|FG001|NOT COMPLETED|Phase II: Consolidation Therapy||0
2845515|NCT01386385|3546974|FG002|NOT COMPLETED|Phase II: Consolidation Therapy||0
2845516|NCT01386385|3546975|FG003|NOT COMPLETED|Phase II: Consolidation Therapy||0
2845517|NCT01386385|3546976|FG004|NOT COMPLETED|Phase II: Consolidation Therapy||0
2845518|NCT01386385|3546977|FG005|NOT COMPLETED|Phase II: Consolidation Therapy||0
2845519|NCT01386385|3546978|FG006|NOT COMPLETED|Phase II: Consolidation Therapy||5
2845520|NCT01386385|3546979|FG007|NOT COMPLETED|Phase II: Consolidation Therapy||2
2845521|NCT01057121|3547002|FG000|STARTED|Phase I: 10 mg/Day Lenalidomide||3
2845522|NCT01057121|3547003|FG001|STARTED|Phase I: 10 mg/Day Lenalidomide||0
2845523|NCT01057121|3547004|FG002|STARTED|Phase I: 10 mg/Day Lenalidomide||0
2845524|NCT01057121|3547005|FG003|STARTED|Phase I: 10 mg/Day Lenalidomide||0
2845525|NCT01057121|3547006|FG004|STARTED|Phase I: 10 mg/Day Lenalidomide||0
2845526|NCT01057121|3547002|FG000|COMPLETED|Phase I: 10 mg/Day Lenalidomide||3
2845527|NCT01057121|3547003|FG001|COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
2845528|NCT01057121|3547004|FG002|COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
2845529|NCT01057121|3547005|FG003|COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
2845530|NCT01057121|3547006|FG004|COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
2845531|NCT01057121|3547002|FG000|NOT COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
2845532|NCT01057121|3547003|FG001|NOT COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
2845533|NCT01057121|3547004|FG002|NOT COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
2845534|NCT01057121|3547005|FG003|NOT COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
2845535|NCT01057121|3547006|FG004|NOT COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
2845536|NCT01057121|3547002|FG000|STARTED|Phase I: 15 mg/Day Lenolidomide||0
2845537|NCT01057121|3547003|FG001|STARTED|Phase I: 15 mg/Day Lenolidomide||3
2845538|NCT01057121|3547004|FG002|STARTED|Phase I: 15 mg/Day Lenolidomide||0
2845539|NCT01057121|3547005|FG003|STARTED|Phase I: 15 mg/Day Lenolidomide||0
2845540|NCT01057121|3547006|FG004|STARTED|Phase I: 15 mg/Day Lenolidomide||0
2845541|NCT01057121|3547002|FG000|COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
2845542|NCT01057121|3547003|FG001|COMPLETED|Phase I: 15 mg/Day Lenolidomide||3
2845543|NCT01057121|3547004|FG002|COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
2845544|NCT01057121|3547005|FG003|COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
2845545|NCT01057121|3547006|FG004|COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
2845546|NCT01057121|3547002|FG000|NOT COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
2845547|NCT01057121|3547003|FG001|NOT COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
2845548|NCT01057121|3547004|FG002|NOT COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
2845549|NCT01057121|3547005|FG003|NOT COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
2845550|NCT01057121|3547006|FG004|NOT COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
2845551|NCT01057121|3547002|FG000|STARTED|Phase I: 20 mg/Day Lenalidomide||0
2845552|NCT01057121|3547003|FG001|STARTED|Phase I: 20 mg/Day Lenalidomide||0
2845553|NCT01057121|3547004|FG002|STARTED|Phase I: 20 mg/Day Lenalidomide||3
2845554|NCT01057121|3547005|FG003|STARTED|Phase I: 20 mg/Day Lenalidomide||0
2845555|NCT01057121|3547006|FG004|STARTED|Phase I: 20 mg/Day Lenalidomide||0
2845556|NCT01057121|3547002|FG000|COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
2845557|NCT01057121|3547003|FG001|COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
2845558|NCT01057121|3547004|FG002|COMPLETED|Phase I: 20 mg/Day Lenalidomide||3
2845559|NCT01057121|3547005|FG003|COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
2845560|NCT01057121|3547006|FG004|COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
2845561|NCT01057121|3547002|FG000|NOT COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
2845562|NCT01057121|3547003|FG001|NOT COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
2845563|NCT01057121|3547004|FG002|NOT COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
2845564|NCT01057121|3547005|FG003|NOT COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
2845565|NCT01057121|3547006|FG004|NOT COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
2845566|NCT01057121|3547002|FG000|STARTED|Phase I: 25 mg/Day Lenalidomide||0
2845567|NCT01057121|3547003|FG001|STARTED|Phase I: 25 mg/Day Lenalidomide||0
2845568|NCT01057121|3547004|FG002|STARTED|Phase I: 25 mg/Day Lenalidomide||0
2845569|NCT01057121|3547005|FG003|STARTED|Phase I: 25 mg/Day Lenalidomide||6
2845570|NCT01057121|3547006|FG004|STARTED|Phase I: 25 mg/Day Lenalidomide||0
2845571|NCT01057121|3547002|FG000|COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
2845572|NCT01057121|3547003|FG001|COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
2845573|NCT01057121|3547004|FG002|COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
2845574|NCT01057121|3547005|FG003|COMPLETED|Phase I: 25 mg/Day Lenalidomide||6
2845575|NCT01057121|3547006|FG004|COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
2845576|NCT01057121|3547002|FG000|NOT COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
2845577|NCT01057121|3547003|FG001|NOT COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
2845578|NCT01057121|3547004|FG002|NOT COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
2845579|NCT01057121|3547005|FG003|NOT COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
2845580|NCT01057121|3547006|FG004|NOT COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
2845581|NCT01057121|3547002|FG000|STARTED|Phase II: 25 mg/Day Lenalidomide||0
2845582|NCT01057121|3547003|FG001|STARTED|Phase II: 25 mg/Day Lenalidomide||0
2845583|NCT01057121|3547004|FG002|STARTED|Phase II: 25 mg/Day Lenalidomide||0
2845584|NCT01057121|3547005|FG003|STARTED|Phase II: 25 mg/Day Lenalidomide||0
2845585|NCT01057121|3547006|FG004|STARTED|Phase II: 25 mg/Day Lenalidomide||23
2845586|NCT01057121|3547002|FG000|COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
2845587|NCT01057121|3547003|FG001|COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
2845588|NCT01057121|3547004|FG002|COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
2845589|NCT01057121|3547005|FG003|COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
2845590|NCT01057121|3547006|FG004|COMPLETED|Phase II: 25 mg/Day Lenalidomide||23
2845591|NCT01057121|3547002|FG000|NOT COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
2845592|NCT01057121|3547003|FG001|NOT COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
2845593|NCT01057121|3547004|FG002|NOT COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
2845594|NCT01057121|3547005|FG003|NOT COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
2845595|NCT01057121|3547006|FG004|NOT COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
2845596|NCT01004263|3547030|FG000|STARTED|Overall Study|Participants who took study drug|606
2845597|NCT01004263|3547030|FG000|COMPLETED|Overall Study||427
2845598|NCT01004263|3547030|FG000|NOT COMPLETED|Overall Study||179
2845599|NCT01001234|3547039|FG000|STARTED|Overall Study|Participants who were randomized to study drug|492
2845600|NCT01001234|3547040|FG001|STARTED|Overall Study|Participants who were randomized to study drug|31
2845601|NCT01001234|3547041|FG002|STARTED|Overall Study|Participants who were randomized to study drug|409
2845602|NCT01001234|3547042|FG003|STARTED|Overall Study|Participants who were randomized to study drug|410
2845603|NCT01001234|3547043|FG004|STARTED|Overall Study|Participants who were randomized to study drug|40
2845604|NCT01001234|3547039|FG000|Particpants Treated|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2|124
2845605|NCT01001234|3547040|FG001|Particpants Treated|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2|8
2845606|NCT01001234|3547041|FG002|Particpants Treated|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2|400
2845607|NCT01001234|3547042|FG003|Particpants Treated|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2|405
2845608|NCT01001234|3547043|FG004|Particpants Treated|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2|40
2845609|NCT01001234|3547039|FG000|Participants Not Treated|Overall Study|Participants who did not take study drug|368
2845610|NCT01001234|3547040|FG001|Participants Not Treated|Overall Study|Participants who did not take study drug|23
2845611|NCT01001234|3547041|FG002|Participants Not Treated|Overall Study|Participants who did not take study drug|9
2845612|NCT01001234|3547042|FG003|Participants Not Treated|Overall Study|Participants who did not take study drug|5
2845613|NCT01001234|3547043|FG004|Participants Not Treated|Overall Study|Participants who did not take study drug|0
2845614|NCT01001234|3547039|FG000|COMPLETED|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2 and completed study|87
2845615|NCT01001234|3547040|FG001|COMPLETED|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2 and completed study|5
2845616|NCT01001234|3547041|FG002|COMPLETED|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2 and completed study|377
2845617|NCT01001234|3547042|FG003|COMPLETED|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2 and completed study|385
2845618|NCT01001234|3547043|FG004|COMPLETED|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2 and completed study|40
2845619|NCT01001234|3547039|FG000|NOT COMPLETED|Overall Study||405
2845620|NCT01001234|3547040|FG001|NOT COMPLETED|Overall Study||26
2845621|NCT01001234|3547041|FG002|NOT COMPLETED|Overall Study||32
2845622|NCT01001234|3547042|FG003|NOT COMPLETED|Overall Study||25
2845623|NCT01001234|3547043|FG004|NOT COMPLETED|Overall Study||0
2845624|NCT00924170|3547051|FG000|STARTED|Overall Study||10
2845625|NCT00924170|3547052|FG001|STARTED|Overall Study||8
2845626|NCT00924170|3547051|FG000|COMPLETED|Overall Study||3
2845627|NCT00924170|3547052|FG001|COMPLETED|Overall Study||0
2845628|NCT00924170|3547051|FG000|NOT COMPLETED|Overall Study||7
2845629|NCT00924170|3547052|FG001|NOT COMPLETED|Overall Study||8
2845630|NCT00894556|3547067|FG000|STARTED|Baseline Phase||0
2845631|NCT00894556|3547068|FG001|STARTED|Baseline Phase||0
2845632|NCT00894556|3547069|FG002|STARTED|Baseline Phase||0
2845633|NCT00894556|3547070|FG003|STARTED|Baseline Phase||194
2845634|NCT00894556|3547067|FG000|COMPLETED|Baseline Phase||0
2845635|NCT00894556|3547068|FG001|COMPLETED|Baseline Phase||0
2845636|NCT00894556|3547069|FG002|COMPLETED|Baseline Phase||0
2845637|NCT00894556|3547070|FG003|COMPLETED|Baseline Phase||109
2845638|NCT00894556|3547067|FG000|NOT COMPLETED|Baseline Phase||0
2845639|NCT00894556|3547068|FG001|NOT COMPLETED|Baseline Phase||0
2845640|NCT00894556|3547069|FG002|NOT COMPLETED|Baseline Phase||0
2845641|NCT00894556|3547070|FG003|NOT COMPLETED|Baseline Phase||85
2845642|NCT00894556|3547067|FG000|STARTED|Treatment Phase|Participants who were randomized into the treatment phase|37
2845643|NCT00894556|3547068|FG001|STARTED|Treatment Phase|Participants who were randomized into the treatment phase|36
2845644|NCT00894556|3547069|FG002|STARTED|Treatment Phase|Participants who were randomized into the treatment phase|36
2845645|NCT00894556|3547070|FG003|STARTED|Treatment Phase||0
2845646|NCT00894556|3547067|FG000|COMPLETED|Treatment Phase|Participants who treated 3 acute migraine attacks with study medication during the treatment phase|33
2845647|NCT00894556|3547068|FG001|COMPLETED|Treatment Phase|Participants who treated 3 acute migraine attacks with study medication during the treatment phase|32
2845648|NCT00894556|3547069|FG002|COMPLETED|Treatment Phase|Participants who treated 3 acute migraine attacks with study medication during the treatment phase|35
2845649|NCT00894556|3547070|FG003|COMPLETED|Treatment Phase||0
2845650|NCT00894556|3547067|FG000|NOT COMPLETED|Treatment Phase||4
2845651|NCT00894556|3547068|FG001|NOT COMPLETED|Treatment Phase||4
2845652|NCT00894556|3547069|FG002|NOT COMPLETED|Treatment Phase||1
2845653|NCT00894556|3547070|FG003|NOT COMPLETED|Treatment Phase||0
2845654|NCT00840177|3547080|FG000|STARTED|Overall Study||36
2845655|NCT00840177|3547081|FG001|STARTED|Overall Study||29
2845656|NCT00840177|3547082|FG002|STARTED|Overall Study||50
2845657|NCT00840177|3547080|FG000|Treated|Overall Study||36
2845658|NCT00840177|3547081|FG001|Treated|Overall Study||29
2845659|NCT00840177|3547082|FG002|Treated|Overall Study||46
2845660|NCT00840177|3547080|FG000|Assessed for AEs|Overall Study||35
2845661|NCT00840177|3547081|FG001|Assessed for AEs|Overall Study||29
2845662|NCT00840177|3547082|FG002|Assessed for AEs|Overall Study||46
2845663|NCT00840177|3547080|FG000|COMPLETED|Overall Study||18
2845664|NCT00840177|3547081|FG001|COMPLETED|Overall Study||20
2845665|NCT00840177|3547082|FG002|COMPLETED|Overall Study||39
2845666|NCT00840177|3547080|FG000|NOT COMPLETED|Overall Study||18
3168128|NCT01916655|3895454|FG001|COMPLETED|Overall Study||89
3168129|NCT01916655|3895455|FG002|COMPLETED|Overall Study||91
3168130|NCT01916655|3895453|FG000|NOT COMPLETED|Overall Study||15
3168131|NCT01916655|3895454|FG001|NOT COMPLETED|Overall Study||20
3168132|NCT01916655|3895455|FG002|NOT COMPLETED|Overall Study||29
3168133|NCT01916681|3895467|FG000|STARTED|Overall Study||123
3168134|NCT01916681|3895468|FG001|STARTED|Overall Study||120
2845667|NCT00840177|3547081|FG001|NOT COMPLETED|Overall Study||9
2845668|NCT00840177|3547082|FG002|NOT COMPLETED|Overall Study||11
2845669|NCT00820950|3547095|FG000|STARTED|Overall Study||6
2845670|NCT00820950|3547096|FG001|STARTED|Overall Study||6
2845671|NCT00820950|3547097|FG002|STARTED|Overall Study||6
2845672|NCT00820950|3547098|FG003|STARTED|Overall Study||6
2845673|NCT00820950|3547099|FG004|STARTED|Overall Study||6
2845674|NCT00820950|3547100|FG005|STARTED|Overall Study||6
2845675|NCT00820950|3547101|FG006|STARTED|Overall Study||6
2845676|NCT00820950|3547102|FG007|STARTED|Overall Study||6
2845677|NCT00820950|3547103|FG008|STARTED|Overall Study||5
2845678|NCT00820950|3547104|FG009|STARTED|Overall Study||5
2845679|NCT00820950|3547095|FG000|COMPLETED|Overall Study||5
2845680|NCT00820950|3547096|FG001|COMPLETED|Overall Study||5
2845681|NCT00820950|3547097|FG002|COMPLETED|Overall Study||6
2845682|NCT00820950|3547098|FG003|COMPLETED|Overall Study||6
2845683|NCT00820950|3547099|FG004|COMPLETED|Overall Study||6
2845684|NCT00820950|3547100|FG005|COMPLETED|Overall Study||6
2845685|NCT00820950|3547101|FG006|COMPLETED|Overall Study||5
2845686|NCT00820950|3547102|FG007|COMPLETED|Overall Study||5
2845687|NCT00820950|3547103|FG008|COMPLETED|Overall Study||5
2845688|NCT00820950|3547104|FG009|COMPLETED|Overall Study||5
2845689|NCT00820950|3547095|FG000|NOT COMPLETED|Overall Study||1
2845690|NCT00820950|3547096|FG001|NOT COMPLETED|Overall Study||1
2845691|NCT00820950|3547097|FG002|NOT COMPLETED|Overall Study||0
2845692|NCT00820950|3547098|FG003|NOT COMPLETED|Overall Study||0
2845693|NCT00820950|3547099|FG004|NOT COMPLETED|Overall Study||0
2845694|NCT00820950|3547100|FG005|NOT COMPLETED|Overall Study||0
2845695|NCT00820950|3547101|FG006|NOT COMPLETED|Overall Study||1
2845696|NCT00820950|3547102|FG007|NOT COMPLETED|Overall Study||1
2845697|NCT00820950|3547103|FG008|NOT COMPLETED|Overall Study||0
2845698|NCT00820950|3547104|FG009|NOT COMPLETED|Overall Study||0
2845699|NCT00806416|3547146|FG000|STARTED|Period 1 - Part I||107
2845700|NCT00806416|3547147|FG001|STARTED|Period 1 - Part I||107
2845701|NCT00806416|3547148|FG002|STARTED|Period 1 - Part I||0
2845702|NCT00806416|3547149|FG003|STARTED|Period 1 - Part I||0
2845703|NCT00806416|3547146|FG000|COMPLETED|Period 1 - Part I||104
2845704|NCT00806416|3547147|FG001|COMPLETED|Period 1 - Part I||103
2845705|NCT00806416|3547148|FG002|COMPLETED|Period 1 - Part I||0
2845706|NCT00806416|3547149|FG003|COMPLETED|Period 1 - Part I||0
2845707|NCT00806416|3547146|FG000|NOT COMPLETED|Period 1 - Part I||3
2845708|NCT00806416|3547147|FG001|NOT COMPLETED|Period 1 - Part I||4
2845709|NCT00806416|3547148|FG002|NOT COMPLETED|Period 1 - Part I||0
3168135|NCT01916681|3895469|FG002|STARTED|Overall Study||123
3168136|NCT01916681|3895470|FG003|STARTED|Overall Study||125
3168137|NCT01916681|3895467|FG000|COMPLETED|Overall Study||123
2845710|NCT00806416|3547149|FG003|NOT COMPLETED|Period 1 - Part I||0
2845711|NCT00806416|3547146|FG000|STARTED|Period 2 - Part I||104
2845712|NCT00806416|3547147|FG001|STARTED|Period 2 - Part I||103
2845713|NCT00806416|3547148|FG002|STARTED|Period 2 - Part I||0
2845714|NCT00806416|3547149|FG003|STARTED|Period 2 - Part I||0
2845715|NCT00806416|3547146|FG000|COMPLETED|Period 2 - Part I||104
2845716|NCT00806416|3547147|FG001|COMPLETED|Period 2 - Part I||103
2845717|NCT00806416|3547148|FG002|COMPLETED|Period 2 - Part I||0
2845718|NCT00806416|3547149|FG003|COMPLETED|Period 2 - Part I||0
2845719|NCT00806416|3547146|FG000|NOT COMPLETED|Period 2 - Part I||0
2845720|NCT00806416|3547147|FG001|NOT COMPLETED|Period 2 - Part I||0
2845721|NCT00806416|3547148|FG002|NOT COMPLETED|Period 2 - Part I||0
2845722|NCT00806416|3547149|FG003|NOT COMPLETED|Period 2 - Part I||0
2845723|NCT00806416|3547146|FG000|STARTED|Period 1 - Part II||0
2845724|NCT00806416|3547147|FG001|STARTED|Period 1 - Part II||0
2845725|NCT00806416|3547148|FG002|STARTED|Period 1 - Part II||14
2845726|NCT00806416|3547149|FG003|STARTED|Period 1 - Part II||16
2845727|NCT00806416|3547146|FG000|COMPLETED|Period 1 - Part II||0
2845728|NCT00806416|3547147|FG001|COMPLETED|Period 1 - Part II||0
2845729|NCT00806416|3547148|FG002|COMPLETED|Period 1 - Part II||14
2845730|NCT00806416|3547149|FG003|COMPLETED|Period 1 - Part II||14
2845731|NCT00806416|3547146|FG000|NOT COMPLETED|Period 1 - Part II||0
2845732|NCT00806416|3547147|FG001|NOT COMPLETED|Period 1 - Part II||0
2845733|NCT00806416|3547148|FG002|NOT COMPLETED|Period 1 - Part II||0
2845734|NCT00806416|3547149|FG003|NOT COMPLETED|Period 1 - Part II||2
2845735|NCT00806416|3547146|FG000|STARTED|Period 2 - Part II||0
2845736|NCT00806416|3547147|FG001|STARTED|Period 2 - Part II||0
2845737|NCT00806416|3547148|FG002|STARTED|Period 2 - Part II||14
2845738|NCT00806416|3547149|FG003|STARTED|Period 2 - Part II||14
2845739|NCT00806416|3547146|FG000|COMPLETED|Period 2 - Part II||0
2845740|NCT00806416|3547147|FG001|COMPLETED|Period 2 - Part II||0
2845741|NCT00806416|3547148|FG002|COMPLETED|Period 2 - Part II||14
2845742|NCT00806416|3547149|FG003|COMPLETED|Period 2 - Part II||14
2845743|NCT00806416|3547146|FG000|NOT COMPLETED|Period 2 - Part II||0
2845744|NCT00806416|3547147|FG001|NOT COMPLETED|Period 2 - Part II||0
2845745|NCT00806416|3547148|FG002|NOT COMPLETED|Period 2 - Part II||0
2845746|NCT00806416|3547149|FG003|NOT COMPLETED|Period 2 - Part II||0
2917075|NCT00519285|3627400|FG001|STARTED|Overall Study|Randomized|612
2917076|NCT00519285|3627399|FG000|TREATED|Overall Study|Received at least part of one dose of placebo|604
2917077|NCT00519285|3627400|FG001|TREATED|Overall Study|Received at least part of one dose of aflibercept|605
2917078|NCT00519285|3627399|FG000|Still Treated at Cut-off Date|Overall Study|The cut-off date for analysis was defined as 07 February 2012, date at which 873 deaths has occurred|1
2917079|NCT00519285|3627400|FG001|Still Treated at Cut-off Date|Overall Study||2
2917080|NCT00519285|3627399|FG000|COMPLETED|Overall Study|Participants were treated until progressive disease, unacceptable toxicity, or refusal of treatment|0
2917081|NCT00519285|3627400|FG001|COMPLETED|Overall Study||0
2917082|NCT00519285|3627399|FG000|NOT COMPLETED|Overall Study||612
2917083|NCT00519285|3627400|FG001|NOT COMPLETED|Overall Study||612
2917084|NCT00519376|3627406|FG000|STARTED|Treatment Period 1||2
2917085|NCT00519376|3627407|FG001|STARTED|Treatment Period 1||2
2917086|NCT00519376|3627408|FG002|STARTED|Treatment Period 1||2
2917087|NCT00519376|3627409|FG003|STARTED|Treatment Period 1||2
2917088|NCT00519376|3627410|FG004|STARTED|Treatment Period 1||1
2917089|NCT00519376|3627411|FG005|STARTED|Treatment Period 1||1
2917090|NCT00519376|3627412|FG006|STARTED|Treatment Period 1||1
2917091|NCT00519376|3627413|FG007|STARTED|Treatment Period 1||1
2917092|NCT00519376|3627414|FG008|STARTED|Treatment Period 1||1
2917093|NCT00519376|3627415|FG009|STARTED|Treatment Period 1||1
2917094|NCT00519376|3627416|FG010|STARTED|Treatment Period 1||1
2917095|NCT00519376|3627417|FG011|STARTED|Treatment Period 1||1
2917096|NCT00519376|3627418|FG012|STARTED|Treatment Period 1||1
2917097|NCT00519376|3627419|FG013|STARTED|Treatment Period 1||1
2917098|NCT00519376|3627420|FG014|STARTED|Treatment Period 1||1
2917099|NCT00519376|3627421|FG015|STARTED|Treatment Period 1||1
2917100|NCT00519376|3627406|FG000|COMPLETED|Treatment Period 1||2
2917101|NCT00519376|3627407|FG001|COMPLETED|Treatment Period 1||2
2917102|NCT00519376|3627408|FG002|COMPLETED|Treatment Period 1||2
2917103|NCT00519376|3627409|FG003|COMPLETED|Treatment Period 1||2
2917104|NCT00519376|3627410|FG004|COMPLETED|Treatment Period 1||1
2917105|NCT00519376|3627411|FG005|COMPLETED|Treatment Period 1||1
2917106|NCT00519376|3627412|FG006|COMPLETED|Treatment Period 1||1
2917107|NCT00519376|3627413|FG007|COMPLETED|Treatment Period 1||1
2917108|NCT00519376|3627414|FG008|COMPLETED|Treatment Period 1||1
2917109|NCT00519376|3627415|FG009|COMPLETED|Treatment Period 1||1
2917110|NCT00519376|3627416|FG010|COMPLETED|Treatment Period 1||1
2917111|NCT00519376|3627417|FG011|COMPLETED|Treatment Period 1||1
2917112|NCT00519376|3627418|FG012|COMPLETED|Treatment Period 1||1
2917113|NCT00519376|3627419|FG013|COMPLETED|Treatment Period 1||1
2917114|NCT00519376|3627420|FG014|COMPLETED|Treatment Period 1||1
2917115|NCT00519376|3627421|FG015|COMPLETED|Treatment Period 1||1
2917116|NCT00519376|3627406|FG000|NOT COMPLETED|Treatment Period 1||0
2917117|NCT00519376|3627407|FG001|NOT COMPLETED|Treatment Period 1||0
2917118|NCT00519376|3627408|FG002|NOT COMPLETED|Treatment Period 1||0
2917119|NCT00519376|3627409|FG003|NOT COMPLETED|Treatment Period 1||0
2917120|NCT00519376|3627410|FG004|NOT COMPLETED|Treatment Period 1||0
2917121|NCT00519376|3627411|FG005|NOT COMPLETED|Treatment Period 1||0
2917122|NCT00519376|3627412|FG006|NOT COMPLETED|Treatment Period 1||0
2845747|NCT00729651|3547159|FG000|STARTED|Overall Study||173
2845748|NCT00729651|3547160|FG001|STARTED|Overall Study||170
2845749|NCT00729651|3547159|FG000|COMPLETED|Overall Study||154
2845750|NCT00729651|3547160|FG001|COMPLETED|Overall Study||152
2845751|NCT00729651|3547159|FG000|NOT COMPLETED|Overall Study||19
2845752|NCT00729651|3547160|FG001|NOT COMPLETED|Overall Study||18
2845753|NCT00698815|3547169|FG000|STARTED|Overall Study||42
2845754|NCT00698815|3547170|FG001|STARTED|Overall Study||47
2845755|NCT00698815|3547171|FG002|STARTED|Overall Study||41
2845756|NCT00698815|3547169|FG000|COMPLETED|Overall Study||32
2845757|NCT00698815|3547170|FG001|COMPLETED|Overall Study||33
2845758|NCT00698815|3547171|FG002|COMPLETED|Overall Study||31
2845759|NCT00698815|3547169|FG000|NOT COMPLETED|Overall Study||10
2845760|NCT00698815|3547170|FG001|NOT COMPLETED|Overall Study||14
2845761|NCT00698815|3547171|FG002|NOT COMPLETED|Overall Study||10
2845762|NCT00698022|3547182|FG000|STARTED|Overall Study||30
2845763|NCT00698022|3547183|FG001|STARTED|Overall Study||30
2845764|NCT00698022|3547184|FG002|STARTED|Overall Study||16
2845765|NCT00698022|3547182|FG000|COMPLETED|Overall Study||14
2845766|NCT00698022|3547183|FG001|COMPLETED|Overall Study||20
2845767|NCT00698022|3547184|FG002|COMPLETED|Overall Study||14
2845768|NCT00698022|3547182|FG000|NOT COMPLETED|Overall Study||16
2845769|NCT00698022|3547183|FG001|NOT COMPLETED|Overall Study||10
2845770|NCT00698022|3547184|FG002|NOT COMPLETED|Overall Study||2
2845771|NCT00692913|3547194|FG000|STARTED|Overall Study||257
2845772|NCT00692913|3547195|FG001|STARTED|Overall Study||258
2845773|NCT00692913|3547194|FG000|COMPLETED|Overall Study||228
2845774|NCT00692913|3547195|FG001|COMPLETED|Overall Study||228
2845775|NCT00692913|3547194|FG000|NOT COMPLETED|Overall Study||29
2845776|NCT00692913|3547195|FG001|NOT COMPLETED|Overall Study||30
2845777|NCT00617994|3547206|FG000|STARTED|Overall Study||5
2845778|NCT00617994|3547207|FG001|STARTED|Overall Study||5
2845779|NCT00617994|3547208|FG002|STARTED|Overall Study||5
2845780|NCT00617994|3547209|FG003|STARTED|Overall Study||5
2845781|NCT00617994|3547210|FG004|STARTED|Overall Study||5
2845782|NCT00617994|3547206|FG000|COMPLETED|Overall Study||5
2845783|NCT00617994|3547207|FG001|COMPLETED|Overall Study||5
2845784|NCT00617994|3547208|FG002|COMPLETED|Overall Study||5
2845785|NCT00617994|3547209|FG003|COMPLETED|Overall Study||5
2845786|NCT00617994|3547210|FG004|COMPLETED|Overall Study||5
2845787|NCT00617994|3547206|FG000|NOT COMPLETED|Overall Study||0
2845788|NCT00617994|3547207|FG001|NOT COMPLETED|Overall Study||0
2845789|NCT00617994|3547208|FG002|NOT COMPLETED|Overall Study||0
2845790|NCT00617994|3547209|FG003|NOT COMPLETED|Overall Study||0
2845791|NCT00617994|3547210|FG004|NOT COMPLETED|Overall Study||0
2845792|NCT00617708|3547241|FG000|STARTED|Overall Study||10
2845793|NCT00617708|3547242|FG001|STARTED|Overall Study||60
2845794|NCT00617708|3547243|FG002|STARTED|Overall Study||64
2845795|NCT00617708|3547241|FG000|Eligible and Began Protocol Therapy|Overall Study||9
2845796|NCT00617708|3547242|FG001|Eligible and Began Protocol Therapy|Overall Study||57
2845797|NCT00617708|3547243|FG002|Eligible and Began Protocol Therapy|Overall Study||59
2845798|NCT00617708|3547241|FG000|COMPLETED|Overall Study||0
2845799|NCT00617708|3547242|FG001|COMPLETED|Overall Study||0
2845800|NCT00617708|3547243|FG002|COMPLETED|Overall Study||0
2845801|NCT00617708|3547241|FG000|NOT COMPLETED|Overall Study||10
2845802|NCT00617708|3547242|FG001|NOT COMPLETED|Overall Study||60
2845803|NCT00617708|3547243|FG002|NOT COMPLETED|Overall Study||64
2845804|NCT00516737|3547255|FG000|STARTED|Overall Study||103
2845805|NCT00516737|3547256|FG001|STARTED|Overall Study||104
2845806|NCT00516737|3547255|FG000|COMPLETED|Overall Study||92
2845807|NCT00516737|3547256|FG001|COMPLETED|Overall Study||96
2845808|NCT00516737|3547255|FG000|NOT COMPLETED|Overall Study||11
2845809|NCT00516737|3547256|FG001|NOT COMPLETED|Overall Study||8
2845810|NCT00358527|3547264|FG000|STARTED|Overall Study||267
2845811|NCT00358527|3547265|FG001|STARTED|Overall Study||134
2845812|NCT00358527|3547264|FG000|COMPLETED|Overall Study||254
2845813|NCT00358527|3547265|FG001|COMPLETED|Overall Study||131
2845814|NCT00358527|3547264|FG000|NOT COMPLETED|Overall Study||13
2845815|NCT00358527|3547265|FG001|NOT COMPLETED|Overall Study||3
2845816|NCT00326898|3547274|FG000|STARTED|Overall Study||647
2845817|NCT00326898|3547275|FG001|STARTED|Overall Study||649
2845818|NCT00326898|3547276|FG002|STARTED|Overall Study||647
2845819|NCT00326898|3547274|FG000|Patients With Toxicity Data|Overall Study||625
2845820|NCT00326898|3547275|FG001|Patients With Toxicity Data|Overall Study||628
2845821|NCT00326898|3547276|FG002|Patients With Toxicity Data|Overall Study||626
2845822|NCT00326898|3547274|FG000|Patients With Clear Cell Histology|Overall Study||542
2845823|NCT00326898|3547275|FG001|Patients With Clear Cell Histology|Overall Study||540
2845824|NCT00326898|3547276|FG002|Patients With Clear Cell Histology|Overall Study||540
2845825|NCT00326898|3547274|FG000|Patients With >=1 Follow-up MUGA Scan|Overall Study||513
2845826|NCT00326898|3547275|FG001|Patients With >=1 Follow-up MUGA Scan|Overall Study||510
2845827|NCT00326898|3547276|FG002|Patients With >=1 Follow-up MUGA Scan|Overall Study||580
2845828|NCT00326898|3547274|FG000|COMPLETED|Overall Study||296
2845829|NCT00326898|3547275|FG001|COMPLETED|Overall Study||306
2845830|NCT00326898|3547276|FG002|COMPLETED|Overall Study||444
2845831|NCT00326898|3547274|FG000|NOT COMPLETED|Overall Study||351
2845832|NCT00326898|3547275|FG001|NOT COMPLETED|Overall Study||343
2845833|NCT00326898|3547276|FG002|NOT COMPLETED|Overall Study||203
2845834|NCT00156065|3547287|FG000|STARTED|Overall Study||51
2845835|NCT00156065|3547288|FG001|STARTED|Overall Study||93
2845836|NCT00156065|3547289|FG002|STARTED|Overall Study||43
2845837|NCT00156065|3547287|FG000|COMPLETED|Overall Study||20
2845838|NCT00156065|3547288|FG001|COMPLETED|Overall Study||30
2845839|NCT00156065|3547289|FG002|COMPLETED|Overall Study||16
2845840|NCT00156065|3547287|FG000|NOT COMPLETED|Overall Study||31
2845841|NCT00156065|3547288|FG001|NOT COMPLETED|Overall Study||63
2845842|NCT00156065|3547289|FG002|NOT COMPLETED|Overall Study||27
2845843|NCT00150176|3547299|FG000|STARTED|Overall Study|subjects who were screened and received at least one dose of double-blind trial medication|194
2845844|NCT00150176|3547300|FG001|STARTED|Overall Study|subjects who were screened and received at least one dose of double-blind trial medication|192
2845845|NCT00150176|3547299|FG000|COMPLETED|Overall Study||135
2845846|NCT00150176|3547300|FG001|COMPLETED|Overall Study||72
2845847|NCT00150176|3547299|FG000|NOT COMPLETED|Overall Study||59
2845848|NCT00150176|3547300|FG001|NOT COMPLETED|Overall Study||120
2845849|NCT00145509|3547309|FG000|STARTED|Overall Study||41
2845850|NCT00145509|3547310|FG001|STARTED|Overall Study||36
2845851|NCT00145509|3547309|FG000|COMPLETED|Overall Study||19
2845852|NCT00145509|3547310|FG001|COMPLETED|Overall Study||15
2845853|NCT00145509|3547309|FG000|NOT COMPLETED|Overall Study||22
2845854|NCT00145509|3547310|FG001|NOT COMPLETED|Overall Study||21
2845855|NCT00145496|3547318|FG000|STARTED|Overall Study|Subjects who received randomized treatment assignment and at least one dose of study medication.|244
2845856|NCT00145496|3547319|FG001|STARTED|Overall Study|Subjects who received randomized treatment assignment and at least one dose of study medication.|224
2845857|NCT00145496|3547318|FG000|COMPLETED|Overall Study||121
2845858|NCT00145496|3547319|FG001|COMPLETED|Overall Study||143
2845859|NCT00145496|3547318|FG000|NOT COMPLETED|Overall Study||123
2845860|NCT00145496|3547319|FG001|NOT COMPLETED|Overall Study||81
2845861|NCT00145470|3547327|FG000|STARTED|Overall Study||167
2845862|NCT00145470|3547328|FG001|STARTED|Overall Study||159
2845863|NCT00145470|3547327|FG000|Treated|Overall Study||166
2845864|NCT00145470|3547328|FG001|Treated|Overall Study||158
2845865|NCT00145470|3547327|FG000|COMPLETED|Overall Study||55
2845866|NCT00145470|3547328|FG001|COMPLETED|Overall Study||61
2845867|NCT00145470|3547327|FG000|NOT COMPLETED|Overall Study||112
2845868|NCT00145470|3547328|FG001|NOT COMPLETED|Overall Study||98
2845869|NCT00129402|3547336|FG000|STARTED|Start Period1 to End Period1 (Week 1-6)||43
2845870|NCT00129402|3547337|FG001|STARTED|Start Period1 to End Period1 (Week 1-6)||40
2845871|NCT00129402|3547338|FG002|STARTED|Start Period1 to End Period1 (Week 1-6)||43
2845872|NCT00129402|3547339|FG003|STARTED|Start Period1 to End Period1 (Week 1-6)||40
2845873|NCT00129402|3547340|FG004|STARTED|Start Period1 to End Period1 (Week 1-6)||40
2845874|NCT00129402|3547341|FG005|STARTED|Start Period1 to End Period1 (Week 1-6)||42
2845875|NCT00129402|3547342|FG006|STARTED|Start Period1 to End Period1 (Week 1-6)||0
2845876|NCT00129402|3547336|FG000|COMPLETED|Start Period1 to End Period1 (Week 1-6)||43
2845877|NCT00129402|3547337|FG001|COMPLETED|Start Period1 to End Period1 (Week 1-6)||39
2845878|NCT00129402|3547338|FG002|COMPLETED|Start Period1 to End Period1 (Week 1-6)||41
2845879|NCT00129402|3547339|FG003|COMPLETED|Start Period1 to End Period1 (Week 1-6)||39
2845880|NCT00129402|3547340|FG004|COMPLETED|Start Period1 to End Period1 (Week 1-6)||39
2845881|NCT00129402|3547341|FG005|COMPLETED|Start Period1 to End Period1 (Week 1-6)||40
2845882|NCT00129402|3547342|FG006|COMPLETED|Start Period1 to End Period1 (Week 1-6)||0
2845883|NCT00129402|3547336|FG000|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||0
2845884|NCT00129402|3547337|FG001|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||1
2845885|NCT00129402|3547338|FG002|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||2
2845886|NCT00129402|3547339|FG003|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||1
2845887|NCT00129402|3547340|FG004|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||1
2845888|NCT00129402|3547341|FG005|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||2
2845889|NCT00129402|3547342|FG006|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||0
2845890|NCT00129402|3547336|FG000|STARTED|Start Period2 to End Period2 (Week 7-33)||0
2845891|NCT00129402|3547337|FG001|STARTED|Start Period2 to End Period2 (Week 7-33)||0
2845892|NCT00129402|3547338|FG002|STARTED|Start Period2 to End Period2 (Week 7-33)|# of subjects were combined from the 3 arms in Period 1 who received ezetimibe with simvastatin|122
2845893|NCT00129402|3547339|FG003|STARTED|Start Period2 to End Period2 (Week 7-33)||0
2845894|NCT00129402|3547340|FG004|STARTED|Start Period2 to End Period2 (Week 7-33)||0
2845895|NCT00129402|3547341|FG005|STARTED|Start Period2 to End Period2 (Week 7-33)|# of subjects were combined from the 3 arms in Period 1 who received simvastatin monotherapy|118
2845896|NCT00129402|3547342|FG006|STARTED|Start Period2 to End Period2 (Week 7-33)||0
2845897|NCT00129402|3547336|FG000|COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
2845898|NCT00129402|3547337|FG001|COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
2845899|NCT00129402|3547338|FG002|COMPLETED|Start Period2 to End Period2 (Week 7-33)|One subject who completed Period 1, did not enter Period 2, but entered and completed Period 3.|114
2845900|NCT00129402|3547339|FG003|COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
2845901|NCT00129402|3547340|FG004|COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
2845902|NCT00129402|3547341|FG005|COMPLETED|Start Period2 to End Period2 (Week 7-33)|One subject who completed Period 1, did not enter Period 2, but entered and completed Period 3.|113
2845903|NCT00129402|3547342|FG006|COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
2845904|NCT00129402|3547336|FG000|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
2845905|NCT00129402|3547337|FG001|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
2845906|NCT00129402|3547338|FG002|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||8
2845907|NCT00129402|3547339|FG003|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
2845908|NCT00129402|3547340|FG004|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
2845909|NCT00129402|3547341|FG005|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||5
2845910|NCT00129402|3547342|FG006|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
2845911|NCT00129402|3547336|FG000|STARTED|Start Period3 to End Period3(Week 34-53)||0
2845912|NCT00129402|3547337|FG001|STARTED|Start Period3 to End Period3(Week 34-53)||0
2845913|NCT00129402|3547338|FG002|STARTED|Start Period3 to End Period3(Week 34-53)||0
2845914|NCT00129402|3547339|FG003|STARTED|Start Period3 to End Period3(Week 34-53)||0
2845915|NCT00129402|3547340|FG004|STARTED|Start Period3 to End Period3(Week 34-53)||0
2845916|NCT00129402|3547341|FG005|STARTED|Start Period3 to End Period3(Week 34-53)||0
2845917|NCT00129402|3547342|FG006|STARTED|Start Period3 to End Period3(Week 34-53)|In Period 3, all subjects from Period 1 and Period 2 were combined into one treatment group.|228
2845918|NCT00129402|3547336|FG000|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
2845919|NCT00129402|3547337|FG001|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
2845920|NCT00129402|3547338|FG002|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
2845921|NCT00129402|3547339|FG003|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
2845922|NCT00129402|3547340|FG004|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
2845923|NCT00129402|3547341|FG005|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
2845924|NCT00129402|3547342|FG006|COMPLETED|Start Period3 to End Period3(Week 34-53)|One subject who completed Period 1, did not enter Period 2, but entered and completed Period 3.|222
2845925|NCT00129402|3547336|FG000|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
2845926|NCT00129402|3547337|FG001|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
2845927|NCT00129402|3547338|FG002|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
2845928|NCT00129402|3547339|FG003|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
2845929|NCT00129402|3547340|FG004|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
2845930|NCT00129402|3547341|FG005|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
2845931|NCT00129402|3547342|FG006|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||6
2845932|NCT00101439|3547352|FG000|STARTED|Period 1||28
2845933|NCT00101439|3547353|FG001|STARTED|Period 1||30
2845934|NCT00101439|3547352|FG000|COMPLETED|Period 1||28
2845935|NCT00101439|3547353|FG001|COMPLETED|Period 1||30
2845936|NCT00101439|3547352|FG000|NOT COMPLETED|Period 1||0
2845937|NCT00101439|3547353|FG001|NOT COMPLETED|Period 1||0
2845938|NCT00101439|3547352|FG000|STARTED|Period 2||28
2845939|NCT00101439|3547353|FG001|STARTED|Period 2||30
2845940|NCT00101439|3547352|FG000|COMPLETED|Period 2||28
2845941|NCT00101439|3547353|FG001|COMPLETED|Period 2||28
2845942|NCT00101439|3547352|FG000|NOT COMPLETED|Period 2||0
2845943|NCT00101439|3547353|FG001|NOT COMPLETED|Period 2||2
2845944|NCT00096200|3547362|FG000|STARTED|Overall Study||9
2845945|NCT00096200|3547363|FG001|STARTED|Overall Study||30
2845946|NCT00096200|3547364|FG002|STARTED|Overall Study||5
2845947|NCT00096200|3547362|FG000|COMPLETED|Overall Study||8
2845948|NCT00096200|3547363|FG001|COMPLETED|Overall Study||23
2845949|NCT00096200|3547364|FG002|COMPLETED|Overall Study||5
2845950|NCT00096200|3547362|FG000|NOT COMPLETED|Overall Study||1
2845951|NCT00096200|3547363|FG001|NOT COMPLETED|Overall Study||7
2845952|NCT00096200|3547364|FG002|NOT COMPLETED|Overall Study||0
2917123|NCT00519376|3627413|FG007|NOT COMPLETED|Treatment Period 1||0
2917124|NCT00519376|3627414|FG008|NOT COMPLETED|Treatment Period 1||0
2917125|NCT00519376|3627415|FG009|NOT COMPLETED|Treatment Period 1||0
2917126|NCT00519376|3627416|FG010|NOT COMPLETED|Treatment Period 1||0
2917127|NCT00519376|3627417|FG011|NOT COMPLETED|Treatment Period 1||0
2917128|NCT00519376|3627418|FG012|NOT COMPLETED|Treatment Period 1||0
2917129|NCT00519376|3627419|FG013|NOT COMPLETED|Treatment Period 1||0
2917130|NCT00519376|3627420|FG014|NOT COMPLETED|Treatment Period 1||0
2917131|NCT00519376|3627421|FG015|NOT COMPLETED|Treatment Period 1||0
2917132|NCT00519376|3627406|FG000|STARTED|Washout Period 1||2
2917133|NCT00519376|3627407|FG001|STARTED|Washout Period 1||2
2917134|NCT00519376|3627408|FG002|STARTED|Washout Period 1||2
2917135|NCT00519376|3627409|FG003|STARTED|Washout Period 1||2
2917136|NCT00519376|3627410|FG004|STARTED|Washout Period 1||1
2917137|NCT00519376|3627411|FG005|STARTED|Washout Period 1||1
2917138|NCT00519376|3627412|FG006|STARTED|Washout Period 1||1
2917139|NCT00519376|3627413|FG007|STARTED|Washout Period 1||1
2917140|NCT00519376|3627414|FG008|STARTED|Washout Period 1||1
2917141|NCT00519376|3627415|FG009|STARTED|Washout Period 1||1
2917142|NCT00519376|3627416|FG010|STARTED|Washout Period 1||1
2917143|NCT00519376|3627417|FG011|STARTED|Washout Period 1||1
2917144|NCT00519376|3627418|FG012|STARTED|Washout Period 1||1
2917145|NCT00519376|3627419|FG013|STARTED|Washout Period 1||1
2917146|NCT00519376|3627420|FG014|STARTED|Washout Period 1||1
2917147|NCT00519376|3627421|FG015|STARTED|Washout Period 1||1
2917148|NCT00519376|3627406|FG000|COMPLETED|Washout Period 1||2
2917149|NCT00519376|3627407|FG001|COMPLETED|Washout Period 1||2
2917150|NCT00519376|3627408|FG002|COMPLETED|Washout Period 1||2
2917151|NCT00519376|3627409|FG003|COMPLETED|Washout Period 1||2
2917152|NCT00519376|3627410|FG004|COMPLETED|Washout Period 1||1
2917153|NCT00519376|3627411|FG005|COMPLETED|Washout Period 1||1
2917154|NCT00519376|3627412|FG006|COMPLETED|Washout Period 1||1
2917155|NCT00519376|3627413|FG007|COMPLETED|Washout Period 1||1
2917156|NCT00519376|3627414|FG008|COMPLETED|Washout Period 1||1
2917157|NCT00519376|3627415|FG009|COMPLETED|Washout Period 1||1
2917158|NCT00519376|3627416|FG010|COMPLETED|Washout Period 1||1
2917159|NCT00519376|3627417|FG011|COMPLETED|Washout Period 1||1
2917160|NCT00519376|3627418|FG012|COMPLETED|Washout Period 1||1
2917161|NCT00519376|3627419|FG013|COMPLETED|Washout Period 1||1
2917162|NCT00519376|3627420|FG014|COMPLETED|Washout Period 1||1
2917163|NCT00519376|3627421|FG015|COMPLETED|Washout Period 1||1
2845953|NCT04498273|3547376|FG000|STARTED|Overall Study||165
2845954|NCT04498273|3547377|FG001|STARTED|Overall Study||164
2845955|NCT04498273|3547378|FG002|STARTED|Overall Study||164
2845956|NCT04498273|3547379|FG003|STARTED|Overall Study||164
2845957|NCT04498273|3547376|FG000|COMPLETED|Overall Study||134
2845958|NCT04498273|3547377|FG001|COMPLETED|Overall Study||140
2845959|NCT04498273|3547378|FG002|COMPLETED|Overall Study||143
2845960|NCT04498273|3547379|FG003|COMPLETED|Overall Study||133
2845961|NCT04498273|3547376|FG000|NOT COMPLETED|Overall Study||31
2845962|NCT04498273|3547377|FG001|NOT COMPLETED|Overall Study||24
2845963|NCT04498273|3547378|FG002|NOT COMPLETED|Overall Study||21
2845964|NCT04498273|3547379|FG003|NOT COMPLETED|Overall Study||31
2845965|NCT05224453|3547391|FG000|STARTED|Overall Study||38
2845966|NCT05224453|3547392|FG001|STARTED|Overall Study||38
2845967|NCT05224453|3547391|FG000|COMPLETED|Overall Study||36
2845968|NCT05224453|3547392|FG001|COMPLETED|Overall Study||35
2845969|NCT05224453|3547391|FG000|NOT COMPLETED|Overall Study||2
2845970|NCT05224453|3547392|FG001|NOT COMPLETED|Overall Study||3
2845971|NCT04823221|3547398|FG000|STARTED|Overall Study||22
2845972|NCT04823221|3547398|FG000|COMPLETED|Overall Study||22
2845973|NCT04823221|3547398|FG000|NOT COMPLETED|Overall Study||0
2845974|NCT04723173|3547402|FG000|STARTED|Measure of Detection Threshold (in dB)||10
2845975|NCT04723173|3547402|FG000|Feature for Soft Sounds On|Measure of Detection Threshold (in dB)||10
2845976|NCT04723173|3547402|FG000|Feature for Soft Sounds Off|Measure of Detection Threshold (in dB)||10
2845977|NCT04723173|3547402|FG000|COMPLETED|Measure of Detection Threshold (in dB)||10
2845978|NCT04723173|3547402|FG000|NOT COMPLETED|Measure of Detection Threshold (in dB)||0
2845979|NCT04723173|3547402|FG000|STARTED|Subjective Listening Effort Scaling|The test in this test period is independent (also temporally) from the previous test period. That is the reason, why the number of participants, who started this test period is lesser than the number of participants, who completed the previous period.|9
2845980|NCT04723173|3547402|FG000|DNC on|Subjective Listening Effort Scaling||9
2845981|NCT04723173|3547402|FG000|DNC Off|Subjective Listening Effort Scaling||9
2845982|NCT04723173|3547402|FG000|COMPLETED|Subjective Listening Effort Scaling||8
2845983|NCT04723173|3547402|FG000|NOT COMPLETED|Subjective Listening Effort Scaling||1
2845984|NCT04723173|3547402|FG000|STARTED|Subjective Ratings of Sound Samples|The test in this test period is independent (also temporal) from the previous test period. That is the reason, why the number of participants, who started this test period is greater than the number of participants, who completed the previous period.|9
2845985|NCT04723173|3547402|FG000|DNC on|Subjective Ratings of Sound Samples||9
2845986|NCT04723173|3547402|FG000|DNC Off|Subjective Ratings of Sound Samples||9
2845987|NCT04723173|3547402|FG000|COMPLETED|Subjective Ratings of Sound Samples|"All participants completed this study period, but just the results of 8 participants could be used.~This was because technical issues limited the reliability of the measures made for one participant.~N.B. this test was independent from the other tests in the study. Therefore the results are not influenced by other test periods. The number of people included in the analysis described here relates only to this test."|9
2845988|NCT04723173|3547402|FG000|NOT COMPLETED|Subjective Ratings of Sound Samples||0
2845989|NCT04537078|3547416|FG000|STARTED|Overall Study||45
2845990|NCT04537078|3547417|FG001|STARTED|Overall Study||45
2845991|NCT04537078|3547416|FG000|COMPLETED|Overall Study||41
2845992|NCT04537078|3547417|FG001|COMPLETED|Overall Study||42
2845993|NCT04537078|3547416|FG000|NOT COMPLETED|Overall Study||4
2845994|NCT04537078|3547417|FG001|NOT COMPLETED|Overall Study||3
2845995|NCT04425252|3547432|FG000|STARTED|Overall Study||8
2845996|NCT04425252|3547433|FG001|STARTED|Overall Study||15
2845997|NCT04425252|3547432|FG000|COMPLETED|Overall Study||4
2845998|NCT04425252|3547433|FG001|COMPLETED|Overall Study||13
2845999|NCT04425252|3547432|FG000|NOT COMPLETED|Overall Study||4
2846000|NCT04425252|3547433|FG001|NOT COMPLETED|Overall Study||2
2846001|NCT04368260|3547442|FG000|STARTED|Overall Study||40
2846002|NCT04368260|3547442|FG000|COMPLETED|Overall Study||40
2846003|NCT04368260|3547442|FG000|NOT COMPLETED|Overall Study||0
2846004|NCT03940326|3547450|FG000|STARTED|Overall Study||45
2846005|NCT03940326|3547451|FG001|STARTED|Overall Study||58
2846006|NCT03940326|3547450|FG000|COMPLETED|Overall Study||45
2846007|NCT03940326|3547451|FG001|COMPLETED|Overall Study||58
2846008|NCT03940326|3547450|FG000|NOT COMPLETED|Overall Study||0
2846009|NCT03940326|3547451|FG001|NOT COMPLETED|Overall Study||0
2846085|NCT03132467|3547509|FG000|STARTED|Overall Study||8
2846086|NCT03132467|3547509|FG000|COMPLETED|Overall Study||4
2846087|NCT03132467|3547509|FG000|NOT COMPLETED|Overall Study||4
2846088|NCT03096288|3547518|FG000|STARTED|Overall Study||19
2846089|NCT03096288|3547519|FG001|STARTED|Overall Study||18
2846090|NCT03096288|3547520|FG002|STARTED|Overall Study||22
2846091|NCT03096288|3547521|FG003|STARTED|Overall Study||25
2846092|NCT03096288|3547518|FG000|COMPLETED|Overall Study||19
2846093|NCT03096288|3547519|FG001|COMPLETED|Overall Study||17
2846094|NCT03096288|3547520|FG002|COMPLETED|Overall Study||22
2846095|NCT03096288|3547521|FG003|COMPLETED|Overall Study||24
2846096|NCT03096288|3547518|FG000|NOT COMPLETED|Overall Study||0
2846097|NCT03096288|3547519|FG001|NOT COMPLETED|Overall Study||1
2846098|NCT03096288|3547520|FG002|NOT COMPLETED|Overall Study||0
2846099|NCT03096288|3547521|FG003|NOT COMPLETED|Overall Study||1
2846100|NCT02919436|3547533|FG000|STARTED|Overall Study||305
2846101|NCT02919436|3547534|FG001|STARTED|Overall Study||305
2846102|NCT02919436|3547533|FG000|COMPLETED|Overall Study||245
2846103|NCT02919436|3547534|FG001|COMPLETED|Overall Study||252
2846104|NCT02919436|3547533|FG000|NOT COMPLETED|Overall Study||60
2846105|NCT02919436|3547534|FG001|NOT COMPLETED|Overall Study||53
2846010|NCT03875313|3547462|FG000|STARTED|Overall Study||3
2846011|NCT03875313|3547463|FG001|STARTED|Overall Study||16
2846012|NCT03875313|3547464|FG002|STARTED|Overall Study||6
2846013|NCT03875313|3547465|FG003|STARTED|Overall Study||4
2846014|NCT03875313|3547466|FG004|STARTED|Overall Study||4
2846015|NCT03875313|3547462|FG000|COMPLETED|Overall Study||0
2846016|NCT03875313|3547463|FG001|COMPLETED|Overall Study||0
2846017|NCT03875313|3547464|FG002|COMPLETED|Overall Study||0
2846018|NCT03875313|3547465|FG003|COMPLETED|Overall Study||0
2846019|NCT03875313|3547466|FG004|COMPLETED|Overall Study||0
2846020|NCT03875313|3547462|FG000|NOT COMPLETED|Overall Study||3
2846021|NCT03875313|3547463|FG001|NOT COMPLETED|Overall Study||16
2846022|NCT03875313|3547464|FG002|NOT COMPLETED|Overall Study||6
2846023|NCT03875313|3547465|FG003|NOT COMPLETED|Overall Study||4
2846024|NCT03875313|3547466|FG004|NOT COMPLETED|Overall Study||4
2846025|NCT03694353|3547478|FG000|STARTED|Overall Study||37
2846026|NCT03694353|3547478|FG000|COMPLETED|Overall Study||35
2846027|NCT03694353|3547478|FG000|NOT COMPLETED|Overall Study||2
2846028|NCT03692052|3547482|FG000|STARTED|Core Period (Day 1 to Week 24)||20
2846029|NCT03692052|3547482|FG000|COMPLETED|Core Period (Day 1 to Week 24)||19
2846030|NCT03692052|3547482|FG000|NOT COMPLETED|Core Period (Day 1 to Week 24)||1
2846031|NCT03692052|3547482|FG000|STARTED|Extension Period (Week 25 to 10 Years)||19
2846032|NCT03692052|3547482|FG000|COMPLETED|Extension Period (Week 25 to 10 Years)||0
2846033|NCT03692052|3547482|FG000|NOT COMPLETED|Extension Period (Week 25 to 10 Years)||19
2846034|NCT03583554|3547486|FG000|STARTED|Period 1||4
2846035|NCT03583554|3547487|FG001|STARTED|Period 1||4
2846036|NCT03583554|3547488|FG002|STARTED|Period 1||4
2846037|NCT03583554|3547486|FG000|COMPLETED|Period 1||4
2846038|NCT03583554|3547487|FG001|COMPLETED|Period 1||4
2846039|NCT03583554|3547488|FG002|COMPLETED|Period 1||4
2846040|NCT03583554|3547486|FG000|NOT COMPLETED|Period 1||0
2846041|NCT03583554|3547487|FG001|NOT COMPLETED|Period 1||0
2846042|NCT03583554|3547488|FG002|NOT COMPLETED|Period 1||0
2846043|NCT03583554|3547486|FG000|STARTED|Period 2||4
2846044|NCT03583554|3547487|FG001|STARTED|Period 2||4
2846045|NCT03583554|3547488|FG002|STARTED|Period 2||4
2846046|NCT03583554|3547486|FG000|COMPLETED|Period 2||3
2846047|NCT03583554|3547487|FG001|COMPLETED|Period 2||4
2846048|NCT03583554|3547488|FG002|COMPLETED|Period 2||3
2846049|NCT03583554|3547486|FG000|NOT COMPLETED|Period 2||1
2846050|NCT03583554|3547487|FG001|NOT COMPLETED|Period 2||0
2846051|NCT03583554|3547488|FG002|NOT COMPLETED|Period 2||1
2846052|NCT03583554|3547486|FG000|STARTED|Period 3||3
2846053|NCT03583554|3547487|FG001|STARTED|Period 3||4
2846054|NCT03583554|3547488|FG002|STARTED|Period 3||3
2846055|NCT03583554|3547486|FG000|COMPLETED|Period 3||3
2846056|NCT03583554|3547487|FG001|COMPLETED|Period 3||4
2846057|NCT03583554|3547488|FG002|COMPLETED|Period 3||3
2846058|NCT03583554|3547486|FG000|NOT COMPLETED|Period 3||0
2846059|NCT03583554|3547487|FG001|NOT COMPLETED|Period 3||0
2846060|NCT03583554|3547488|FG002|NOT COMPLETED|Period 3||0
2846061|NCT03538717|3547499|FG000|STARTED|Overall Study||157
2846062|NCT03538717|3547499|FG000|COMPLETED|Overall Study||157
2846063|NCT03538717|3547499|FG000|NOT COMPLETED|Overall Study||0
2846064|NCT03408873|3547505|FG000|STARTED|Visit 1 Assessment (Baseline)||30
2846065|NCT03408873|3547505|FG000|COMPLETED|Visit 1 Assessment (Baseline)||27
2846066|NCT03408873|3547505|FG000|NOT COMPLETED|Visit 1 Assessment (Baseline)||3
3168138|NCT01916681|3895468|FG001|COMPLETED|Overall Study||120
3168139|NCT01916681|3895469|FG002|COMPLETED|Overall Study||123
3168140|NCT01916681|3895470|FG003|COMPLETED|Overall Study||125
2846067|NCT03408873|3547505|FG000|STARTED|Visit 2 Assessment||27
2846068|NCT03408873|3547505|FG000|COMPLETED|Visit 2 Assessment||26
2846069|NCT03408873|3547505|FG000|NOT COMPLETED|Visit 2 Assessment||1
2846070|NCT03408873|3547505|FG000|STARTED|Visit 3 Assessment||26
2846071|NCT03408873|3547505|FG000|COMPLETED|Visit 3 Assessment||25
2846072|NCT03408873|3547505|FG000|NOT COMPLETED|Visit 3 Assessment||1
2846073|NCT03408873|3547505|FG000|STARTED|Visit 4 Assessment||25
2846074|NCT03408873|3547505|FG000|COMPLETED|Visit 4 Assessment||23
2846075|NCT03408873|3547505|FG000|NOT COMPLETED|Visit 4 Assessment||2
2846076|NCT03408873|3547505|FG000|STARTED|Visit 5 Assessment||23
2846077|NCT03408873|3547505|FG000|COMPLETED|Visit 5 Assessment||22
2846078|NCT03408873|3547505|FG000|NOT COMPLETED|Visit 5 Assessment||1
2846079|NCT03408873|3547505|FG000|STARTED|Visit 6 Assessment||22
2846080|NCT03408873|3547505|FG000|COMPLETED|Visit 6 Assessment||21
2846081|NCT03408873|3547505|FG000|NOT COMPLETED|Visit 6 Assessment||1
2846082|NCT03408873|3547505|FG000|STARTED|Visit 7 Assessment||21
2846083|NCT03408873|3547505|FG000|COMPLETED|Visit 7 Assessment||21
2846084|NCT03408873|3547505|FG000|NOT COMPLETED|Visit 7 Assessment||0
2846106|NCT02877134|3547549|FG000|STARTED|Overall Study||72
2846107|NCT02877134|3547550|FG001|STARTED|Overall Study||73
2846108|NCT02877134|3547551|FG002|STARTED|Overall Study||48
2846109|NCT02877134|3547552|FG003|STARTED|Overall Study||50
3168141|NCT01916681|3895467|FG000|NOT COMPLETED|Overall Study||0
2846110|NCT02877134|3547553|FG004|STARTED|Overall Study||49
2846111|NCT02877134|3547554|FG005|STARTED|Overall Study||49
2846112|NCT02877134|3547555|FG006|STARTED|Overall Study||47
2846113|NCT02877134|3547549|FG000|Placebo Non Responders at Week 12|Overall Study||44
2846114|NCT02877134|3547550|FG001|Placebo Non Responders at Week 12|Overall Study||0
2846115|NCT02877134|3547551|FG002|Placebo Non Responders at Week 12|Overall Study||31
2846116|NCT02877134|3547552|FG003|Placebo Non Responders at Week 12|Overall Study||0
3168142|NCT01916681|3895468|FG001|NOT COMPLETED|Overall Study||0
2846117|NCT02877134|3547553|FG004|Placebo Non Responders at Week 12|Overall Study||0
2846118|NCT02877134|3547554|FG005|Placebo Non Responders at Week 12|Overall Study||0
2846119|NCT02877134|3547555|FG006|Placebo Non Responders at Week 12|Overall Study||0
2846120|NCT02877134|3547549|FG000|COMPLETED|Overall Study||58
2846121|NCT02877134|3547550|FG001|COMPLETED|Overall Study||48
2846122|NCT02877134|3547551|FG002|COMPLETED|Overall Study||42
2846123|NCT02877134|3547552|FG003|COMPLETED|Overall Study||37
2846124|NCT02877134|3547553|FG004|COMPLETED|Overall Study||43
2846125|NCT02877134|3547554|FG005|COMPLETED|Overall Study||42
2846126|NCT02877134|3547555|FG006|COMPLETED|Overall Study||46
2846127|NCT02877134|3547549|FG000|NOT COMPLETED|Overall Study||14
2846128|NCT02877134|3547550|FG001|NOT COMPLETED|Overall Study||25
2846129|NCT02877134|3547551|FG002|NOT COMPLETED|Overall Study||6
2846130|NCT02877134|3547552|FG003|NOT COMPLETED|Overall Study||13
2846131|NCT02877134|3547553|FG004|NOT COMPLETED|Overall Study||6
2846132|NCT02877134|3547554|FG005|NOT COMPLETED|Overall Study||7
2846133|NCT02877134|3547555|FG006|NOT COMPLETED|Overall Study||1
2846134|NCT02446600|3547577|FG000|STARTED|Overall Study||187
2846135|NCT02446600|3547578|FG001|STARTED|Overall Study|Duplicate enrollment patient has been excluded from all analyses.|190
2846136|NCT02446600|3547579|FG002|STARTED|Overall Study||189
2846137|NCT02446600|3547580|FG003|STARTED|Overall Study||13
2846138|NCT02446600|3547577|FG000|COMPLETED|Overall Study|Completed status includes all clinical reasons for suspending treatment, including disease progression, death and adverse events.|147
2846139|NCT02446600|3547578|FG001|COMPLETED|Overall Study|Completed status includes all clinical reasons for suspending treatment, including disease progression, death and adverse events.|178
2846140|NCT02446600|3547579|FG002|COMPLETED|Overall Study|Completed status includes all clinical reasons for suspending treatment, including disease progression, death and adverse events.|162
2846141|NCT02446600|3547580|FG003|COMPLETED|Overall Study|Completed status includes all clinical reasons for suspending treatment, including disease progression, death and adverse events.|12
2846142|NCT02446600|3547577|FG000|NOT COMPLETED|Overall Study||40
2846143|NCT02446600|3547578|FG001|NOT COMPLETED|Overall Study||12
2846144|NCT02446600|3547579|FG002|NOT COMPLETED|Overall Study||27
2846145|NCT02446600|3547580|FG003|NOT COMPLETED|Overall Study||1
2846146|NCT02315703|3547598|FG000|STARTED|Overall Study||50
2846147|NCT02315703|3547599|FG001|STARTED|Overall Study||49
2846148|NCT02315703|3547600|FG002|STARTED|Overall Study||49
2846149|NCT02315703|3547601|FG003|STARTED|Overall Study||48
2846150|NCT02315703|3547602|FG004|STARTED|Overall Study||49
2846151|NCT02315703|3547603|FG005|STARTED|Overall Study||49
2846152|NCT02315703|3547604|FG006|STARTED|Overall Study||50
2846153|NCT02315703|3547605|FG007|STARTED|Overall Study||49
2846154|NCT02315703|3547598|FG000|COMPLETED|Overall Study||44
2846155|NCT02315703|3547599|FG001|COMPLETED|Overall Study||39
2846156|NCT02315703|3547600|FG002|COMPLETED|Overall Study||44
2846157|NCT02315703|3547601|FG003|COMPLETED|Overall Study||39
2846158|NCT02315703|3547602|FG004|COMPLETED|Overall Study||41
2846159|NCT02315703|3547603|FG005|COMPLETED|Overall Study||43
2846160|NCT02315703|3547604|FG006|COMPLETED|Overall Study||37
2846161|NCT02315703|3547605|FG007|COMPLETED|Overall Study||42
2846162|NCT02315703|3547598|FG000|NOT COMPLETED|Overall Study||6
2846163|NCT02315703|3547599|FG001|NOT COMPLETED|Overall Study||10
2846164|NCT02315703|3547600|FG002|NOT COMPLETED|Overall Study||5
2846165|NCT02315703|3547601|FG003|NOT COMPLETED|Overall Study||9
2846166|NCT02315703|3547602|FG004|NOT COMPLETED|Overall Study||8
2846167|NCT02315703|3547603|FG005|NOT COMPLETED|Overall Study||6
2846168|NCT02315703|3547604|FG006|NOT COMPLETED|Overall Study||13
2846169|NCT02315703|3547605|FG007|NOT COMPLETED|Overall Study||7
2846170|NCT02135484|3547623|FG000|STARTED|Overall Study||25
2846171|NCT02135484|3547623|FG000|COMPLETED|Overall Study||25
2846172|NCT02135484|3547623|FG000|NOT COMPLETED|Overall Study||0
2846173|NCT02091960|3547627|FG000|STARTED|Overall Study||103
2846174|NCT02091960|3547627|FG000|Received Treatment|Overall Study||103
2846175|NCT02091960|3547627|FG000|COMPLETED|Overall Study|Completed indicates participants with disease progression|52
2846176|NCT02091960|3547627|FG000|NOT COMPLETED|Overall Study||51
2917164|NCT00519376|3627406|FG000|NOT COMPLETED|Washout Period 1||0
2917165|NCT00519376|3627407|FG001|NOT COMPLETED|Washout Period 1||0
2917166|NCT00519376|3627408|FG002|NOT COMPLETED|Washout Period 1||0
2917167|NCT00519376|3627409|FG003|NOT COMPLETED|Washout Period 1||0
2917168|NCT00519376|3627410|FG004|NOT COMPLETED|Washout Period 1||0
2917169|NCT00519376|3627411|FG005|NOT COMPLETED|Washout Period 1||0
2917170|NCT00519376|3627412|FG006|NOT COMPLETED|Washout Period 1||0
2917171|NCT00519376|3627413|FG007|NOT COMPLETED|Washout Period 1||0
2917172|NCT00519376|3627414|FG008|NOT COMPLETED|Washout Period 1||0
2917173|NCT00519376|3627415|FG009|NOT COMPLETED|Washout Period 1||0
2917174|NCT00519376|3627416|FG010|NOT COMPLETED|Washout Period 1||0
2917175|NCT00519376|3627417|FG011|NOT COMPLETED|Washout Period 1||0
2917176|NCT00519376|3627418|FG012|NOT COMPLETED|Washout Period 1||0
2917177|NCT00519376|3627419|FG013|NOT COMPLETED|Washout Period 1||0
2917178|NCT00519376|3627420|FG014|NOT COMPLETED|Washout Period 1||0
2917179|NCT00519376|3627421|FG015|NOT COMPLETED|Washout Period 1||0
2917180|NCT00519376|3627406|FG000|STARTED|Treatment Period 2||2
2917181|NCT00519376|3627407|FG001|STARTED|Treatment Period 2||2
2917182|NCT00519376|3627408|FG002|STARTED|Treatment Period 2||2
2917183|NCT00519376|3627409|FG003|STARTED|Treatment Period 2||2
2917184|NCT00519376|3627410|FG004|STARTED|Treatment Period 2||1
2917185|NCT00519376|3627411|FG005|STARTED|Treatment Period 2||1
2917186|NCT00519376|3627412|FG006|STARTED|Treatment Period 2||1
2846177|NCT02028884|3547633|FG000|STARTED|Double-blind Period||42
2846178|NCT02028884|3547634|FG001|STARTED|Double-blind Period||41
2846179|NCT02028884|3547633|FG000|COMPLETED|Double-blind Period||24
2846180|NCT02028884|3547634|FG001|COMPLETED|Double-blind Period||18
2846181|NCT02028884|3547633|FG000|NOT COMPLETED|Double-blind Period||18
2846182|NCT02028884|3547634|FG001|NOT COMPLETED|Double-blind Period||23
2846183|NCT02028884|3547633|FG000|STARTED|Open-label Extension Period||24
2846184|NCT02028884|3547634|FG001|STARTED|Open-label Extension Period||18
2846185|NCT02028884|3547633|FG000|COMPLETED|Open-label Extension Period||0
2846186|NCT02028884|3547634|FG001|COMPLETED|Open-label Extension Period||0
2846187|NCT02028884|3547633|FG000|NOT COMPLETED|Open-label Extension Period||24
2846188|NCT02028884|3547634|FG001|NOT COMPLETED|Open-label Extension Period||18
2846189|NCT01983774|3547645|FG000|STARTED|Overall Study||9
2846190|NCT01983774|3547646|FG001|STARTED|Overall Study||8
2846191|NCT01983774|3547645|FG000|COMPLETED|Overall Study||8
2846192|NCT01983774|3547646|FG001|COMPLETED|Overall Study||7
2846193|NCT01983774|3547645|FG000|NOT COMPLETED|Overall Study||1
2846194|NCT01983774|3547646|FG001|NOT COMPLETED|Overall Study||1
2846195|NCT01974206|3547656|FG000|STARTED|Overall Study||74
2846196|NCT01974206|3547657|FG001|STARTED|Overall Study||76
2846197|NCT01974206|3547656|FG000|Received Treatment|Overall Study||74
2846198|NCT01974206|3547657|FG001|Received Treatment|Overall Study||75
2846199|NCT01974206|3547656|FG000|COMPLETED|Overall Study||68
2846200|NCT01974206|3547657|FG001|COMPLETED|Overall Study||75
2846201|NCT01974206|3547656|FG000|NOT COMPLETED|Overall Study||6
2846202|NCT01974206|3547657|FG001|NOT COMPLETED|Overall Study||1
2846203|NCT01970865|3547680|FG000|STARTED|Overall Study||3
2846204|NCT01970865|3547681|FG001|STARTED|Overall Study||3
2846205|NCT01970865|3547682|FG002|STARTED|Overall Study||3
2846206|NCT01970865|3547683|FG003|STARTED|Overall Study||13
2846207|NCT01970865|3547684|FG004|STARTED|Overall Study||17
2846208|NCT01970865|3547685|FG005|STARTED|Overall Study||3
2846209|NCT01970865|3547686|FG006|STARTED|Overall Study||3
2846210|NCT01970865|3547687|FG007|STARTED|Overall Study||3
2846211|NCT01970865|3547688|FG008|STARTED|Overall Study||3
2846212|NCT01970865|3547689|FG009|STARTED|Overall Study||4
2846213|NCT01970865|3547690|FG010|STARTED|Overall Study||30
2846214|NCT01970865|3547691|FG011|STARTED|Overall Study||27
2846215|NCT01970865|3547692|FG012|STARTED|Overall Study||60
2846216|NCT01970865|3547693|FG013|STARTED|Overall Study||66
2846217|NCT01970865|3547694|FG014|STARTED|Overall Study||46
2846218|NCT01970865|3547695|FG015|STARTED|Overall Study||47
2846219|NCT01970865|3547696|FG016|STARTED|Overall Study||3
2846220|NCT01970865|3547680|FG000|Received Treatment|Overall Study||3
2846221|NCT01970865|3547681|FG001|Received Treatment|Overall Study||3
2846222|NCT01970865|3547682|FG002|Received Treatment|Overall Study||3
2846223|NCT01970865|3547683|FG003|Received Treatment|Overall Study||12
2846224|NCT01970865|3547684|FG004|Received Treatment|Overall Study||17
2846225|NCT01970865|3547685|FG005|Received Treatment|Overall Study||3
2846226|NCT01970865|3547686|FG006|Received Treatment|Overall Study||3
2846227|NCT01970865|3547687|FG007|Received Treatment|Overall Study||3
2846228|NCT01970865|3547688|FG008|Received Treatment|Overall Study||3
2846229|NCT01970865|3547689|FG009|Received Treatment|Overall Study||4
2846230|NCT01970865|3547690|FG010|Received Treatment|Overall Study||30
2846231|NCT01970865|3547691|FG011|Received Treatment|Overall Study||27
2846232|NCT01970865|3547692|FG012|Received Treatment|Overall Study||60
2846233|NCT01970865|3547693|FG013|Received Treatment|Overall Study||65
2846234|NCT01970865|3547694|FG014|Received Treatment|Overall Study||46
2846235|NCT01970865|3547695|FG015|Received Treatment|Overall Study||47
2846236|NCT01970865|3547696|FG016|Received Treatment|Overall Study||3
2846237|NCT01970865|3547680|FG000|COMPLETED|Overall Study||0
2846238|NCT01970865|3547681|FG001|COMPLETED|Overall Study||0
2846239|NCT01970865|3547682|FG002|COMPLETED|Overall Study||0
2846240|NCT01970865|3547683|FG003|COMPLETED|Overall Study||0
2846241|NCT01970865|3547684|FG004|COMPLETED|Overall Study||0
2846242|NCT01970865|3547685|FG005|COMPLETED|Overall Study||0
2846243|NCT01970865|3547686|FG006|COMPLETED|Overall Study||0
2846244|NCT01970865|3547687|FG007|COMPLETED|Overall Study||0
2846245|NCT01970865|3547688|FG008|COMPLETED|Overall Study||0
2846246|NCT01970865|3547689|FG009|COMPLETED|Overall Study||0
2846247|NCT01970865|3547690|FG010|COMPLETED|Overall Study||0
2846248|NCT01970865|3547691|FG011|COMPLETED|Overall Study||0
2846249|NCT01970865|3547692|FG012|COMPLETED|Overall Study||0
2846250|NCT01970865|3547693|FG013|COMPLETED|Overall Study||0
2846251|NCT01970865|3547694|FG014|COMPLETED|Overall Study||0
2846252|NCT01970865|3547695|FG015|COMPLETED|Overall Study||0
2846253|NCT01970865|3547696|FG016|COMPLETED|Overall Study||0
2846254|NCT01970865|3547680|FG000|NOT COMPLETED|Overall Study||3
2846255|NCT01970865|3547681|FG001|NOT COMPLETED|Overall Study||3
2846256|NCT01970865|3547682|FG002|NOT COMPLETED|Overall Study||3
2846257|NCT01970865|3547683|FG003|NOT COMPLETED|Overall Study||13
2846258|NCT01970865|3547684|FG004|NOT COMPLETED|Overall Study||17
2846259|NCT01970865|3547685|FG005|NOT COMPLETED|Overall Study||3
2846260|NCT01970865|3547686|FG006|NOT COMPLETED|Overall Study||3
2846261|NCT01970865|3547687|FG007|NOT COMPLETED|Overall Study||3
2846262|NCT01970865|3547688|FG008|NOT COMPLETED|Overall Study||3
2846263|NCT01970865|3547689|FG009|NOT COMPLETED|Overall Study||4
2846264|NCT01970865|3547690|FG010|NOT COMPLETED|Overall Study||30
2846265|NCT01970865|3547691|FG011|NOT COMPLETED|Overall Study||27
2846266|NCT01970865|3547692|FG012|NOT COMPLETED|Overall Study||60
2846267|NCT01970865|3547693|FG013|NOT COMPLETED|Overall Study||66
2846268|NCT01970865|3547694|FG014|NOT COMPLETED|Overall Study||46
2846269|NCT01970865|3547695|FG015|NOT COMPLETED|Overall Study||47
2846270|NCT01970865|3547696|FG016|NOT COMPLETED|Overall Study||3
2846271|NCT01896531|3547759|FG000|STARTED|Overall Study||71
2846272|NCT01896531|3547760|FG001|STARTED|Overall Study||82
2846273|NCT01896531|3547759|FG000|Treated|Overall Study||70
2846274|NCT01896531|3547760|FG001|Treated|Overall Study||82
2846275|NCT01896531|3547759|FG000|COMPLETED|Overall Study||0
2846276|NCT01896531|3547760|FG001|COMPLETED|Overall Study||0
2846277|NCT01896531|3547759|FG000|NOT COMPLETED|Overall Study||71
2846278|NCT01896531|3547760|FG001|NOT COMPLETED|Overall Study||82
2846279|NCT01856192|3547768|FG000|STARTED|Overall Study||173
3311708|NCT03054350|4045169|FG001|NOT COMPLETED|Dose Adjustment and Maintenance Period||0
3311709|NCT03054350|4045170|FG002|NOT COMPLETED|Dose Adjustment and Maintenance Period||1
3311710|NCT03054350|4045171|FG003|NOT COMPLETED|Dose Adjustment and Maintenance Period||1
3311711|NCT03054350|4045172|FG004|NOT COMPLETED|Dose Adjustment and Maintenance Period||0
2846280|NCT01856192|3547769|FG001|STARTED|Overall Study||176
2846281|NCT01856192|3547768|FG000|Treated Patients|Overall Study||166
2846282|NCT01856192|3547769|FG001|Treated Patients|Overall Study||171
2846283|NCT01856192|3547768|FG000|Evaluable Patients (Eligible and Treated)|Overall Study||145
2846284|NCT01856192|3547769|FG001|Evaluable Patients (Eligible and Treated)|Overall Study||135
2846285|NCT01856192|3547768|FG000|COMPLETED|Overall Study||124
2846286|NCT01856192|3547769|FG001|COMPLETED|Overall Study||116
2846287|NCT01856192|3547768|FG000|NOT COMPLETED|Overall Study||49
2846288|NCT01856192|3547769|FG001|NOT COMPLETED|Overall Study||60
2846289|NCT01622868|3547777|FG000|STARTED|Overall Study||72
2846290|NCT01622868|3547778|FG001|STARTED|Overall Study||71
2846291|NCT01622868|3547777|FG000|Eligible|Overall Study||65
2846292|NCT01622868|3547778|FG001|Eligible|Overall Study||71
2846293|NCT01622868|3547777|FG000|Eligible, Started Study Treatment, Has Adverse Event Data|Overall Study||63
2846294|NCT01622868|3547778|FG001|Eligible, Started Study Treatment, Has Adverse Event Data|Overall Study||71
2846295|NCT01622868|3547777|FG000|COMPLETED|Overall Study||65
2846296|NCT01622868|3547778|FG001|COMPLETED|Overall Study||71
2846297|NCT01622868|3547777|FG000|NOT COMPLETED|Overall Study||7
2846298|NCT01622868|3547778|FG001|NOT COMPLETED|Overall Study||0
2846299|NCT01592370|3547791|FG000|STARTED|Overall Study||105
2846300|NCT01592370|3547792|FG001|STARTED|Overall Study||65
2846301|NCT01592370|3547793|FG002|STARTED|Overall Study||72
2846302|NCT01592370|3547794|FG003|STARTED|Overall Study||6
2846303|NCT01592370|3547795|FG004|STARTED|Overall Study||5
2846304|NCT01592370|3547796|FG005|STARTED|Overall Study||41
2846305|NCT01592370|3547797|FG006|STARTED|Overall Study||22
2846306|NCT01592370|3547791|FG000|COMPLETED|Overall Study||1
2846307|NCT01592370|3547792|FG001|COMPLETED|Overall Study||40
2846308|NCT01592370|3547793|FG002|COMPLETED|Overall Study||0
2846309|NCT01592370|3547794|FG003|COMPLETED|Overall Study||1
2846310|NCT01592370|3547795|FG004|COMPLETED|Overall Study||1
2846311|NCT01592370|3547796|FG005|COMPLETED|Overall Study||7
2846312|NCT01592370|3547797|FG006|COMPLETED|Overall Study||6
2846313|NCT01592370|3547791|FG000|NOT COMPLETED|Overall Study||104
2846314|NCT01592370|3547792|FG001|NOT COMPLETED|Overall Study||25
2846315|NCT01592370|3547793|FG002|NOT COMPLETED|Overall Study||72
2846316|NCT01592370|3547794|FG003|NOT COMPLETED|Overall Study||5
2846317|NCT01592370|3547795|FG004|NOT COMPLETED|Overall Study||4
2846318|NCT01592370|3547796|FG005|NOT COMPLETED|Overall Study||34
2846319|NCT01592370|3547797|FG006|NOT COMPLETED|Overall Study||16
2846320|NCT01015833|3547819|FG000|STARTED|Overall Study||180
2846321|NCT01015833|3547820|FG001|STARTED|Overall Study||176
2846322|NCT01015833|3547819|FG000|COMPLETED|Overall Study||167
2846323|NCT01015833|3547820|FG001|COMPLETED|Overall Study||171
2846324|NCT01015833|3547819|FG000|NOT COMPLETED|Overall Study||13
2846325|NCT01015833|3547820|FG001|NOT COMPLETED|Overall Study||5
2846326|NCT00980538|3547826|FG000|STARTED|Overall Study||180
2846327|NCT00980538|3547826|FG000|COMPLETED|Overall Study||0
2846328|NCT00980538|3547826|FG000|NOT COMPLETED|Overall Study||180
2846329|NCT00589420|3547830|FG000|STARTED|Overall Study||18
2846330|NCT00589420|3547830|FG000|COMPLETED|Overall Study||17
2846331|NCT00589420|3547830|FG000|NOT COMPLETED|Overall Study||1
2846332|NCT00588770|3547836|FG000|STARTED|Overall Study||200
2846333|NCT00588770|3547837|FG001|STARTED|Overall Study||203
2846334|NCT00588770|3547836|FG000|Eligible|Overall Study||188
2846335|NCT00588770|3547837|FG001|Eligible|Overall Study||183
2846336|NCT00588770|3547836|FG000|Start Protocol Therapy|Overall Study||200
2846337|NCT00588770|3547837|FG001|Start Protocol Therapy|Overall Study||194
2846338|NCT00588770|3547836|FG000|COMPLETED|Overall Study||41
2846339|NCT00588770|3547837|FG001|COMPLETED|Overall Study||3
2846340|NCT00588770|3547836|FG000|NOT COMPLETED|Overall Study||159
2846341|NCT00588770|3547837|FG001|NOT COMPLETED|Overall Study||200
2846342|NCT00433511|3547846|FG000|STARTED|Step 1||1000
2846343|NCT00433511|3547847|FG001|STARTED|Step 1||1986
2846344|NCT00433511|3547848|FG002|STARTED|Step 1||2008
2846345|NCT00433511|3547846|FG000|Patients Who Received Treatment|Step 1||972
2846346|NCT00433511|3547847|FG001|Patients Who Received Treatment|Step 1||1922
2846347|NCT00433511|3547848|FG002|Patients Who Received Treatment|Step 1||1942
2846348|NCT00433511|3547846|FG000|Patients in Genetic Ancestry Analysis|Step 1||575
2846349|NCT00433511|3547847|FG001|Patients in Genetic Ancestry Analysis|Step 1||1126
2846350|NCT00433511|3547848|FG002|Patients in Genetic Ancestry Analysis|Step 1||1158
2846351|NCT00433511|3547846|FG000|COMPLETED|Step 1||864
2846352|NCT00433511|3547847|FG001|COMPLETED|Step 1||1601
2846353|NCT00433511|3547848|FG002|COMPLETED|Step 1||1618
2846354|NCT00433511|3547846|FG000|NOT COMPLETED|Step 1||136
2846355|NCT00433511|3547847|FG001|NOT COMPLETED|Step 1||385
2846356|NCT00433511|3547848|FG002|NOT COMPLETED|Step 1||390
2846357|NCT00433511|3547846|FG000|STARTED|Step 2 (Arm D)|Only Arm C patients at Step 1 who did not end protocol therapy early were eligible for Step 2, Arm D|0
2846358|NCT00433511|3547847|FG001|STARTED|Step 2 (Arm D)|Only Arm C patients at Step 1 who did not end protocol therapy early were eligible for Step 2, Arm D|0
2846359|NCT00433511|3547848|FG002|STARTED|Step 2 (Arm D)|Only Arm C patients at Step 1 who did not end protocol therapy early were eligible for Step 2, Arm D|1316
2846360|NCT00433511|3547846|FG000|Patients Who Received Treatment|Step 2 (Arm D)||0
2846361|NCT00433511|3547847|FG001|Patients Who Received Treatment|Step 2 (Arm D)||0
2846362|NCT00433511|3547848|FG002|Patients Who Received Treatment|Step 2 (Arm D)||1168
2846363|NCT00433511|3547846|FG000|COMPLETED|Step 2 (Arm D)||0
2846364|NCT00433511|3547847|FG001|COMPLETED|Step 2 (Arm D)||0
2846365|NCT00433511|3547848|FG002|COMPLETED|Step 2 (Arm D)||825
2846366|NCT00433511|3547846|FG000|NOT COMPLETED|Step 2 (Arm D)||0
2846367|NCT00433511|3547847|FG001|NOT COMPLETED|Step 2 (Arm D)||0
2846368|NCT00433511|3547848|FG002|NOT COMPLETED|Step 2 (Arm D)||491
2846369|NCT00324805|3547861|FG000|STARTED|Overall Study||749
2846370|NCT00324805|3547862|FG001|STARTED|Overall Study||752
2846371|NCT00324805|3547861|FG000|Started Assigned Therapy|Overall Study||737
2846372|NCT00324805|3547862|FG001|Started Assigned Therapy|Overall Study||735
2846373|NCT00324805|3547861|FG000|COMPLETED|Overall Study||599
2846374|NCT00324805|3547862|FG001|COMPLETED|Overall Study||269
2846375|NCT00324805|3547861|FG000|NOT COMPLETED|Overall Study||150
2846376|NCT00324805|3547862|FG001|NOT COMPLETED|Overall Study||483
2917187|NCT00519376|3627413|FG007|STARTED|Treatment Period 2||1
2917188|NCT00519376|3627414|FG008|STARTED|Treatment Period 2||1
2917189|NCT00519376|3627415|FG009|STARTED|Treatment Period 2||1
2917190|NCT00519376|3627416|FG010|STARTED|Treatment Period 2||1
2917191|NCT00519376|3627417|FG011|STARTED|Treatment Period 2||1
2917192|NCT00519376|3627418|FG012|STARTED|Treatment Period 2||1
2917193|NCT00519376|3627419|FG013|STARTED|Treatment Period 2||1
2917194|NCT00519376|3627420|FG014|STARTED|Treatment Period 2||1
2917195|NCT00519376|3627421|FG015|STARTED|Treatment Period 2||1
2917196|NCT00519376|3627406|FG000|COMPLETED|Treatment Period 2||2
2917197|NCT00519376|3627407|FG001|COMPLETED|Treatment Period 2||2
2917198|NCT00519376|3627408|FG002|COMPLETED|Treatment Period 2||2
2917199|NCT00519376|3627409|FG003|COMPLETED|Treatment Period 2||2
2917200|NCT00519376|3627410|FG004|COMPLETED|Treatment Period 2||1
2917201|NCT00519376|3627411|FG005|COMPLETED|Treatment Period 2||1
2917202|NCT00519376|3627412|FG006|COMPLETED|Treatment Period 2||1
2917203|NCT00519376|3627413|FG007|COMPLETED|Treatment Period 2||1
2917204|NCT00519376|3627414|FG008|COMPLETED|Treatment Period 2||1
2917205|NCT00519376|3627415|FG009|COMPLETED|Treatment Period 2||1
2917206|NCT00519376|3627416|FG010|COMPLETED|Treatment Period 2||1
2917207|NCT00519376|3627417|FG011|COMPLETED|Treatment Period 2||1
2917208|NCT00519376|3627418|FG012|COMPLETED|Treatment Period 2||0
2917209|NCT00519376|3627419|FG013|COMPLETED|Treatment Period 2||1
2917210|NCT00519376|3627420|FG014|COMPLETED|Treatment Period 2||1
2917211|NCT00519376|3627421|FG015|COMPLETED|Treatment Period 2||1
2917212|NCT00519376|3627406|FG000|NOT COMPLETED|Treatment Period 2||0
2917213|NCT00519376|3627407|FG001|NOT COMPLETED|Treatment Period 2||0
2917214|NCT00519376|3627408|FG002|NOT COMPLETED|Treatment Period 2||0
2917215|NCT00519376|3627409|FG003|NOT COMPLETED|Treatment Period 2||0
2917216|NCT00519376|3627410|FG004|NOT COMPLETED|Treatment Period 2||0
2917217|NCT00519376|3627411|FG005|NOT COMPLETED|Treatment Period 2||0
2917218|NCT00519376|3627412|FG006|NOT COMPLETED|Treatment Period 2||0
2917219|NCT00519376|3627413|FG007|NOT COMPLETED|Treatment Period 2||0
2917220|NCT00519376|3627414|FG008|NOT COMPLETED|Treatment Period 2||0
2917221|NCT00519376|3627415|FG009|NOT COMPLETED|Treatment Period 2||0
2917222|NCT00519376|3627416|FG010|NOT COMPLETED|Treatment Period 2||0
2917223|NCT00519376|3627417|FG011|NOT COMPLETED|Treatment Period 2||0
2917224|NCT00519376|3627418|FG012|NOT COMPLETED|Treatment Period 2||1
2917225|NCT00519376|3627419|FG013|NOT COMPLETED|Treatment Period 2||0
2917226|NCT00519376|3627420|FG014|NOT COMPLETED|Treatment Period 2||0
2917227|NCT00519376|3627421|FG015|NOT COMPLETED|Treatment Period 2||0
2917228|NCT00519376|3627406|FG000|STARTED|Washout Period 2||2
2917229|NCT00519376|3627407|FG001|STARTED|Washout Period 2||2
2917230|NCT00519376|3627408|FG002|STARTED|Washout Period 2||2
2917231|NCT00519376|3627409|FG003|STARTED|Washout Period 2||2
2917232|NCT00519376|3627410|FG004|STARTED|Washout Period 2||1
2917233|NCT00519376|3627411|FG005|STARTED|Washout Period 2||1
2917234|NCT00519376|3627412|FG006|STARTED|Washout Period 2||1
2917235|NCT00519376|3627413|FG007|STARTED|Washout Period 2||1
2917236|NCT00519376|3627414|FG008|STARTED|Washout Period 2||1
2917237|NCT00519376|3627415|FG009|STARTED|Washout Period 2||1
2917238|NCT00519376|3627416|FG010|STARTED|Washout Period 2||1
2917239|NCT00519376|3627417|FG011|STARTED|Washout Period 2||1
3168143|NCT01916681|3895469|FG002|NOT COMPLETED|Overall Study||0
3168144|NCT01916681|3895470|FG003|NOT COMPLETED|Overall Study||0
3168145|NCT01916824|3895483|FG000|STARTED|Overall Study||24
3168146|NCT01916824|3895484|FG001|STARTED|Overall Study||29
3168147|NCT01916824|3895483|FG000|COMPLETED|Overall Study||17
3168148|NCT01916824|3895484|FG001|COMPLETED|Overall Study||20
2917240|NCT00519376|3627418|FG012|STARTED|Washout Period 2||0
2917241|NCT00519376|3627419|FG013|STARTED|Washout Period 2||1
2917242|NCT00519376|3627420|FG014|STARTED|Washout Period 2||1
3168149|NCT01916824|3895483|FG000|NOT COMPLETED|Overall Study||7
2846377|NCT00310180|3547872|FG000|STARTED|Overall Study||1629
2846378|NCT00310180|3547873|FG001|STARTED|Overall Study||3458
2846379|NCT00310180|3547874|FG002|STARTED|Overall Study||3449
2846380|NCT00310180|3547875|FG003|STARTED|Overall Study||1737
2846381|NCT00310180|3547872|FG000|No On-study Data|Overall Study||0
2846382|NCT00310180|3547873|FG001|No On-study Data|Overall Study||2
2846383|NCT00310180|3547874|FG002|No On-study Data|Overall Study||10
2846384|NCT00310180|3547875|FG003|No On-study Data|Overall Study||172
2846385|NCT00310180|3547872|FG000|Ineligible|Overall Study||3
2846386|NCT00310180|3547873|FG001|Ineligible|Overall Study||4
2846387|NCT00310180|3547874|FG002|Ineligible|Overall Study||6
2846388|NCT00310180|3547875|FG003|Ineligible|Overall Study||7
2846389|NCT00310180|3547872|FG000|No Follow-up Data|Overall Study||7
2846390|NCT00310180|3547873|FG001|No Follow-up Data|Overall Study||55
2846391|NCT00310180|3547874|FG002|No Follow-up Data|Overall Study||131
2846392|NCT00310180|3547875|FG003|No Follow-up Data|Overall Study||245
2846393|NCT00310180|3547872|FG000|COMPLETED|Overall Study||1619
2846394|NCT00310180|3547873|FG001|COMPLETED|Overall Study||3399
2846395|NCT00310180|3547874|FG002|COMPLETED|Overall Study||3312
2846396|NCT00310180|3547875|FG003|COMPLETED|Overall Study||1389
2846397|NCT00310180|3547872|FG000|NOT COMPLETED|Overall Study||10
2846398|NCT00310180|3547873|FG001|NOT COMPLETED|Overall Study||59
2846399|NCT00310180|3547874|FG002|NOT COMPLETED|Overall Study||137
2846400|NCT00310180|3547875|FG003|NOT COMPLETED|Overall Study||348
2917243|NCT00519376|3627421|FG015|STARTED|Washout Period 2||1
2917244|NCT00519376|3627406|FG000|COMPLETED|Washout Period 2||2
2917245|NCT00519376|3627407|FG001|COMPLETED|Washout Period 2||2
2917246|NCT00519376|3627408|FG002|COMPLETED|Washout Period 2||2
2917247|NCT00519376|3627409|FG003|COMPLETED|Washout Period 2||2
2917248|NCT00519376|3627410|FG004|COMPLETED|Washout Period 2||1
2917249|NCT00519376|3627411|FG005|COMPLETED|Washout Period 2||1
2917250|NCT00519376|3627412|FG006|COMPLETED|Washout Period 2||1
2917251|NCT00519376|3627413|FG007|COMPLETED|Washout Period 2||1
2917252|NCT00519376|3627414|FG008|COMPLETED|Washout Period 2||1
2917253|NCT00519376|3627415|FG009|COMPLETED|Washout Period 2||1
2917254|NCT00519376|3627416|FG010|COMPLETED|Washout Period 2||1
2917255|NCT00519376|3627417|FG011|COMPLETED|Washout Period 2||1
2917256|NCT00519376|3627418|FG012|COMPLETED|Washout Period 2||0
2917257|NCT00519376|3627419|FG013|COMPLETED|Washout Period 2||1
2917258|NCT00519376|3627420|FG014|COMPLETED|Washout Period 2||1
2917259|NCT00519376|3627421|FG015|COMPLETED|Washout Period 2||1
2917260|NCT00519376|3627406|FG000|NOT COMPLETED|Washout Period 2||0
2917261|NCT00519376|3627407|FG001|NOT COMPLETED|Washout Period 2||0
2917262|NCT00519376|3627408|FG002|NOT COMPLETED|Washout Period 2||0
2917263|NCT00519376|3627409|FG003|NOT COMPLETED|Washout Period 2||0
3168150|NCT01916824|3895484|FG001|NOT COMPLETED|Overall Study||9
3168151|NCT01916928|3895490|FG000|STARTED|Overall Study||50
3168152|NCT01916928|3895490|FG000|COMPLETED|Overall Study||50
3168153|NCT01916928|3895490|FG000|NOT COMPLETED|Overall Study||0
3168154|NCT01916941|3895496|FG000|STARTED|Overall Study||18
3168155|NCT01916941|3895497|FG001|STARTED|Overall Study||18
3168156|NCT01916941|3895496|FG000|COMPLETED|Overall Study||13
3168157|NCT01916941|3895497|FG001|COMPLETED|Overall Study||14
3168158|NCT01916941|3895496|FG000|NOT COMPLETED|Overall Study||5
3168159|NCT01916941|3895497|FG001|NOT COMPLETED|Overall Study||4
3168160|NCT01917006|3895510|FG000|STARTED|Randomized-treatment Period||5
3168161|NCT01917006|3895511|FG001|STARTED|Randomized-treatment Period||7
3168162|NCT01917006|3895512|FG002|STARTED|Randomized-treatment Period||8
3168163|NCT01917006|3895513|FG003|STARTED|Randomized-treatment Period||8
3168164|NCT01917006|3895514|FG004|STARTED|Randomized-treatment Period||8
3168165|NCT01917006|3895515|FG005|STARTED|Randomized-treatment Period||8
3168166|NCT01917006|3895516|FG006|STARTED|Randomized-treatment Period||15
3168167|NCT01917006|3895517|FG007|STARTED|Randomized-treatment Period||0
3168168|NCT01917006|3895510|FG000|COMPLETED|Randomized-treatment Period||3
3168169|NCT01917006|3895511|FG001|COMPLETED|Randomized-treatment Period||7
3168170|NCT01917006|3895512|FG002|COMPLETED|Randomized-treatment Period||8
3168171|NCT01917006|3895513|FG003|COMPLETED|Randomized-treatment Period||7
3168172|NCT01917006|3895514|FG004|COMPLETED|Randomized-treatment Period||8
3168173|NCT01917006|3895515|FG005|COMPLETED|Randomized-treatment Period||7
3168174|NCT01917006|3895516|FG006|COMPLETED|Randomized-treatment Period||14
3168175|NCT01917006|3895517|FG007|COMPLETED|Randomized-treatment Period||0
3168176|NCT01917006|3895510|FG000|NOT COMPLETED|Randomized-treatment Period||2
3168177|NCT01917006|3895511|FG001|NOT COMPLETED|Randomized-treatment Period||0
3168178|NCT01917006|3895512|FG002|NOT COMPLETED|Randomized-treatment Period||0
3168179|NCT01917006|3895513|FG003|NOT COMPLETED|Randomized-treatment Period||1
3168180|NCT01917006|3895514|FG004|NOT COMPLETED|Randomized-treatment Period||0
3168181|NCT01917006|3895515|FG005|NOT COMPLETED|Randomized-treatment Period||1
3168182|NCT01917006|3895516|FG006|NOT COMPLETED|Randomized-treatment Period||1
3168183|NCT01917006|3895517|FG007|NOT COMPLETED|Randomized-treatment Period||0
3168184|NCT01917006|3895510|FG000|STARTED|Open-label Period||0
3168185|NCT01917006|3895511|FG001|STARTED|Open-label Period||0
3168186|NCT01917006|3895512|FG002|STARTED|Open-label Period||0
3168187|NCT01917006|3895513|FG003|STARTED|Open-label Period||0
3168188|NCT01917006|3895514|FG004|STARTED|Open-label Period||0
3168189|NCT01917006|3895515|FG005|STARTED|Open-label Period||0
3168190|NCT01917006|3895516|FG006|STARTED|Open-label Period||0
3168191|NCT01917006|3895517|FG007|STARTED|Open-label Period||8
3168192|NCT01917006|3895510|FG000|COMPLETED|Open-label Period||0
3168193|NCT01917006|3895511|FG001|COMPLETED|Open-label Period||0
3168194|NCT01917006|3895512|FG002|COMPLETED|Open-label Period||0
3168195|NCT01917006|3895513|FG003|COMPLETED|Open-label Period||0
3168196|NCT01917006|3895514|FG004|COMPLETED|Open-label Period||0
3168197|NCT01917006|3895515|FG005|COMPLETED|Open-label Period||0
3168198|NCT01917006|3895516|FG006|COMPLETED|Open-label Period||0
3168199|NCT01917006|3895517|FG007|COMPLETED|Open-label Period||6
2846401|NCT05043142|3547885|FG000|STARTED|Overall Study||3632
2846402|NCT05043142|3547885|FG000|COMPLETED|Overall Study||3443
2846403|NCT05043142|3547885|FG000|NOT COMPLETED|Overall Study||189
2846404|NCT04993339|3547891|FG000|STARTED|Overall Study||14
2846405|NCT04993339|3547892|FG001|STARTED|Overall Study||12
2846406|NCT04993339|3547891|FG000|COMPLETED|Overall Study||11
2846407|NCT04993339|3547892|FG001|COMPLETED|Overall Study||10
2846408|NCT04993339|3547891|FG000|NOT COMPLETED|Overall Study||3
2846409|NCT04993339|3547892|FG001|NOT COMPLETED|Overall Study||2
2846410|NCT04992442|3547898|FG000|STARTED|Treatment Period 1||6
2846411|NCT04992442|3547898|FG000|COMPLETED|Treatment Period 1||6
2846412|NCT04992442|3547898|FG000|NOT COMPLETED|Treatment Period 1||0
2846413|NCT04992442|3547898|FG000|STARTED|Washout Period||6
2846414|NCT04992442|3547898|FG000|COMPLETED|Washout Period||6
2846415|NCT04992442|3547898|FG000|NOT COMPLETED|Washout Period||0
2846416|NCT04992442|3547898|FG000|STARTED|Treatment Period 2||6
2846417|NCT04992442|3547898|FG000|COMPLETED|Treatment Period 2||6
2846418|NCT04992442|3547898|FG000|NOT COMPLETED|Treatment Period 2||0
2846419|NCT04929522|3547914|FG000|STARTED|Overall Study||40
2846420|NCT04929522|3547915|FG001|STARTED|Overall Study||40
2846421|NCT04929522|3547916|FG002|STARTED|Overall Study||40
2846422|NCT04929522|3547917|FG003|STARTED|Overall Study||40
2846423|NCT04929522|3547914|FG000|COMPLETED|Overall Study||40
2846424|NCT04929522|3547915|FG001|COMPLETED|Overall Study||40
2846425|NCT04929522|3547916|FG002|COMPLETED|Overall Study||40
2846426|NCT04929522|3547917|FG003|COMPLETED|Overall Study||40
2846427|NCT04929522|3547914|FG000|NOT COMPLETED|Overall Study||0
2846428|NCT04929522|3547915|FG001|NOT COMPLETED|Overall Study||0
2846429|NCT04929522|3547916|FG002|NOT COMPLETED|Overall Study||0
2846430|NCT04929522|3547917|FG003|NOT COMPLETED|Overall Study||0
2846435|NCT04919161|3547934|FG000|STARTED|Overall Study||16
2846436|NCT04919161|3547935|FG001|STARTED|Overall Study||16
2846437|NCT04919161|3547934|FG000|COMPLETED|Overall Study||15
2846438|NCT04919161|3547935|FG001|COMPLETED|Overall Study||14
2846439|NCT04919161|3547934|FG000|NOT COMPLETED|Overall Study||1
2846440|NCT04919161|3547935|FG001|NOT COMPLETED|Overall Study||2
2846441|NCT04912700|3547966|FG000|STARTED|Overall Study||10880
2846442|NCT04912700|3547967|FG001|STARTED|Overall Study||825
2846443|NCT04912700|3547968|FG002|STARTED|Overall Study||129
2846444|NCT04912700|3547966|FG000|COMPLETED|Overall Study||10880
2846445|NCT04912700|3547967|FG001|COMPLETED|Overall Study||825
2846446|NCT04912700|3547968|FG002|COMPLETED|Overall Study||129
2846447|NCT04912700|3547966|FG000|NOT COMPLETED|Overall Study||0
2846448|NCT04912700|3547967|FG001|NOT COMPLETED|Overall Study||0
2846449|NCT04912700|3547968|FG002|NOT COMPLETED|Overall Study||0
2846456|NCT04904640|3547985|FG000|STARTED|Overall Study||150
2846457|NCT04904640|3547985|FG000|COMPLETED|Overall Study||150
2846458|NCT04904640|3547985|FG000|NOT COMPLETED|Overall Study||0
2846468|NCT04891874|3548008|FG000|STARTED|Overall Study|Participants in this period were recruited from August 1, 2015 to December 31, 2016.|38
2846469|NCT04891874|3548009|FG001|STARTED|Overall Study||38
2846470|NCT04891874|3548008|FG000|COMPLETED|Overall Study||38
2846471|NCT04891874|3548009|FG001|COMPLETED|Overall Study||38
2846472|NCT04891874|3548008|FG000|NOT COMPLETED|Overall Study||0
2846473|NCT04891874|3548009|FG001|NOT COMPLETED|Overall Study||0
2846474|NCT04883541|3548017|FG000|STARTED|Overall Study||46
2846475|NCT04883541|3548018|FG001|STARTED|Overall Study||69
2846476|NCT04883541|3548017|FG000|COMPLETED|Overall Study||30
2846477|NCT04883541|3548018|FG001|COMPLETED|Overall Study||60
2846478|NCT04883541|3548017|FG000|NOT COMPLETED|Overall Study||16
2846479|NCT04883541|3548018|FG001|NOT COMPLETED|Overall Study||9
2846480|NCT04881968|3548024|FG000|STARTED|Overall Study||1261
2846481|NCT04881968|3548024|FG000|COMPLETED|Overall Study||1261
2846482|NCT04881968|3548024|FG000|NOT COMPLETED|Overall Study||0
2846483|NCT04486560|3548028|FG000|STARTED|Overall Study||51
2846484|NCT04486560|3548028|FG000|COMPLETED|Overall Study||50
2846485|NCT04486560|3548028|FG000|NOT COMPLETED|Overall Study||1
2846486|NCT04357782|3548034|FG000|STARTED|Overall Study||10
2846487|NCT04357782|3548035|FG001|STARTED|Overall Study||10
2846488|NCT04357782|3548034|FG000|COMPLETED|Overall Study||9
2846489|NCT04357782|3548035|FG001|COMPLETED|Overall Study||8
2846490|NCT04357782|3548034|FG000|NOT COMPLETED|Overall Study||1
2846491|NCT04357782|3548035|FG001|NOT COMPLETED|Overall Study||2
2846492|NCT04153435|3548043|FG000|STARTED|Overall Study||197
2846493|NCT04153435|3548044|FG001|STARTED|Overall Study||200
2846494|NCT04153435|3548043|FG000|COMPLETED|Overall Study||197
2846495|NCT04153435|3548044|FG001|COMPLETED|Overall Study||200
2846496|NCT04153435|3548043|FG000|NOT COMPLETED|Overall Study||0
2846497|NCT04153435|3548044|FG001|NOT COMPLETED|Overall Study||0
2846498|NCT04090658|3548052|FG000|STARTED|Overall Study||20
2846499|NCT04090658|3548053|FG001|STARTED|Overall Study||20
2846500|NCT04090658|3548052|FG000|COMPLETED|Overall Study||20
2846501|NCT04090658|3548053|FG001|COMPLETED|Overall Study||20
2846502|NCT04090658|3548052|FG000|NOT COMPLETED|Overall Study||0
3168200|NCT01917006|3895510|FG000|NOT COMPLETED|Open-label Period||0
3168201|NCT01917006|3895511|FG001|NOT COMPLETED|Open-label Period||0
2846431|NCT04927858|3547927|FG000|STARTED|Overall Study||460558
2846432|NCT04927858|3547927|FG000|Treated With Empagliflozin|Overall Study||16985
2846433|NCT04927858|3547927|FG000|COMPLETED|Overall Study||460558
2846434|NCT04927858|3547927|FG000|NOT COMPLETED|Overall Study||0
2846450|NCT04912297|3547978|FG000|STARTED|Overall Study||99
2846451|NCT04912297|3547979|FG001|STARTED|Overall Study||87
2846452|NCT04912297|3547978|FG000|COMPLETED|Overall Study||68
2846453|NCT04912297|3547979|FG001|COMPLETED|Overall Study||54
2846454|NCT04912297|3547978|FG000|NOT COMPLETED|Overall Study||31
2846455|NCT04912297|3547979|FG001|NOT COMPLETED|Overall Study||33
2846459|NCT04901897|3547996|FG000|STARTED|Overall Study||398
2846460|NCT04901897|3547997|FG001|STARTED|Overall Study||202
2846461|NCT04901897|3547998|FG002|STARTED|Overall Study||205
2846462|NCT04901897|3547996|FG000|COMPLETED|Overall Study||393
2846463|NCT04901897|3547997|FG001|COMPLETED|Overall Study||200
2846464|NCT04901897|3547998|FG002|COMPLETED|Overall Study||203
2846465|NCT04901897|3547996|FG000|NOT COMPLETED|Overall Study||5
2846466|NCT04901897|3547997|FG001|NOT COMPLETED|Overall Study||2
2846467|NCT04901897|3547998|FG002|NOT COMPLETED|Overall Study||2
2846503|NCT04090658|3548053|FG001|NOT COMPLETED|Overall Study||0
2846504|NCT03811028|3548061|FG000|STARTED|Overall Study||3
2846505|NCT03811028|3548062|FG001|STARTED|Overall Study||3
2846506|NCT03811028|3548061|FG000|COMPLETED|Overall Study||3
2846507|NCT03811028|3548062|FG001|COMPLETED|Overall Study||3
2846508|NCT03811028|3548061|FG000|NOT COMPLETED|Overall Study||0
2846509|NCT03811028|3548062|FG001|NOT COMPLETED|Overall Study||0
2846510|NCT03760068|3548071|FG000|STARTED|Overall Study||238
2846511|NCT03760068|3548072|FG001|STARTED|Overall Study||240
2846512|NCT03760068|3548071|FG000|COMPLETED|Overall Study||224
2846513|NCT03760068|3548072|FG001|COMPLETED|Overall Study||217
2846514|NCT03760068|3548071|FG000|NOT COMPLETED|Overall Study||14
2846515|NCT03760068|3548072|FG001|NOT COMPLETED|Overall Study||23
2846516|NCT03742986|3548081|FG000|STARTED|Overall Study||4
2846517|NCT03742986|3548082|FG001|STARTED|Overall Study||4
2846518|NCT03742986|3548081|FG000|COMPLETED|Overall Study||4
2846519|NCT03742986|3548082|FG001|COMPLETED|Overall Study||4
2846520|NCT03742986|3548081|FG000|NOT COMPLETED|Overall Study||0
2846521|NCT03742986|3548082|FG001|NOT COMPLETED|Overall Study||0
2846522|NCT03628781|3548090|FG000|STARTED|Overall Study||85
2846523|NCT03628781|3548091|FG001|STARTED|Overall Study||84
2846524|NCT03628781|3548090|FG000|6-month Timepoint|Overall Study||63
2846525|NCT03628781|3548091|FG001|6-month Timepoint|Overall Study||79
2846526|NCT03628781|3548090|FG000|12-month Timepoint|Overall Study||53
2846527|NCT03628781|3548091|FG001|12-month Timepoint|Overall Study||75
2846528|NCT03628781|3548090|FG000|COMPLETED|Overall Study||53
2846529|NCT03628781|3548091|FG001|COMPLETED|Overall Study||75
2846530|NCT03628781|3548090|FG000|NOT COMPLETED|Overall Study||32
2846531|NCT03628781|3548091|FG001|NOT COMPLETED|Overall Study||9
2846532|NCT03560206|3548099|FG000|STARTED|Overall Study||158
2846533|NCT03560206|3548100|FG001|STARTED|Overall Study||158
2846534|NCT03560206|3548099|FG000|COMPLETED|Overall Study||108
2846535|NCT03560206|3548100|FG001|COMPLETED|Overall Study||140
2846536|NCT03560206|3548099|FG000|NOT COMPLETED|Overall Study||50
2846537|NCT03560206|3548100|FG001|NOT COMPLETED|Overall Study||18
2846538|NCT03443635|3548108|FG000|STARTED|Overall Study||2616
2846539|NCT03443635|3548109|FG001|STARTED|Overall Study||4576
2846540|NCT03443635|3548108|FG000|COMPLETED|Overall Study||2127
2846541|NCT03443635|3548109|FG001|COMPLETED|Overall Study||3720
2846542|NCT03443635|3548108|FG000|NOT COMPLETED|Overall Study||489
2846543|NCT03443635|3548109|FG001|NOT COMPLETED|Overall Study||856
2846544|NCT03340766|3548118|FG000|STARTED|Overall Study||12
2846545|NCT03340766|3548119|FG001|STARTED|Overall Study||10
2846546|NCT03340766|3548120|FG002|STARTED|Overall Study||9
2846547|NCT03340766|3548118|FG000|Received Blinatumomab|Overall Study||12
2846548|NCT03340766|3548119|FG001|Received Blinatumomab|Overall Study||10
2846549|NCT03340766|3548120|FG002|Received Blinatumomab|Overall Study||9
2846550|NCT03340766|3548118|FG000|Received Pembrolizumab|Overall Study||10
2846551|NCT03340766|3548119|FG001|Received Pembrolizumab|Overall Study||7
2846552|NCT03340766|3548120|FG002|Received Pembrolizumab|Overall Study||7
2846553|NCT03340766|3548118|FG000|COMPLETED|Overall Study||1
2846554|NCT03340766|3548119|FG001|COMPLETED|Overall Study||0
2846555|NCT03340766|3548120|FG002|COMPLETED|Overall Study||0
2846556|NCT03340766|3548118|FG000|NOT COMPLETED|Overall Study||11
2846557|NCT03340766|3548119|FG001|NOT COMPLETED|Overall Study||10
2846558|NCT03340766|3548120|FG002|NOT COMPLETED|Overall Study||9
2846559|NCT03277105|3548136|FG000|STARTED|Overall Study||259
2846560|NCT03277105|3548137|FG001|STARTED|Overall Study||263
2846561|NCT03277105|3548136|FG000|Safety Analysis Set|Overall Study||258
2846562|NCT03277105|3548137|FG001|Safety Analysis Set|Overall Study||260
2846563|NCT03277105|3548136|FG000|COMPLETED|Overall Study||0
2846564|NCT03277105|3548137|FG001|COMPLETED|Overall Study||0
2846565|NCT03277105|3548136|FG000|NOT COMPLETED|Overall Study||259
2846566|NCT03277105|3548137|FG001|NOT COMPLETED|Overall Study||263
2846567|NCT03201965|3548146|FG000|STARTED|Overall Study||28
2846568|NCT03201965|3548147|FG001|STARTED|Overall Study||193
2846569|NCT03201965|3548148|FG002|STARTED|Overall Study||195
2846570|NCT03201965|3548146|FG000|Treated|Overall Study||28
2846571|NCT03201965|3548147|FG001|Treated|Overall Study||188
2846572|NCT03201965|3548148|FG002|Treated|Overall Study||193
2846573|NCT03201965|3548146|FG000|COMPLETED|Overall Study||0
2846574|NCT03201965|3548147|FG001|COMPLETED|Overall Study||0
2846575|NCT03201965|3548148|FG002|COMPLETED|Overall Study||0
2846576|NCT03201965|3548146|FG000|NOT COMPLETED|Overall Study||28
2846577|NCT03201965|3548147|FG001|NOT COMPLETED|Overall Study||193
2846578|NCT03201965|3548148|FG002|NOT COMPLETED|Overall Study||195
2846579|NCT03043599|3548155|FG000|STARTED|Overall Study||21
2846580|NCT03043599|3548155|FG000|COMPLETED|Overall Study||21
2846581|NCT03043599|3548155|FG000|NOT COMPLETED|Overall Study||0
2846582|NCT02968381|3548161|FG000|STARTED|Overall Study||61
2846583|NCT02968381|3548162|FG001|STARTED|Overall Study||60
2846584|NCT02968381|3548161|FG000|COMPLETED|Overall Study||56
2846585|NCT02968381|3548162|FG001|COMPLETED|Overall Study||50
2846586|NCT02968381|3548161|FG000|NOT COMPLETED|Overall Study||5
2846587|NCT02968381|3548162|FG001|NOT COMPLETED|Overall Study||10
2846588|NCT02874742|3548171|FG000|STARTED|Overall Study||103
2846589|NCT02874742|3548172|FG001|STARTED|Overall Study||104
2846590|NCT02874742|3548173|FG002|STARTED|Overall Study||16
2846591|NCT02874742|3548171|FG000|Safety|Overall Study||102
2846592|NCT02874742|3548172|FG001|Safety|Overall Study||99
2846593|NCT02874742|3548173|FG002|Safety|Overall Study||16
2846594|NCT02874742|3548171|FG000|COMPLETED|Overall Study||0
2846595|NCT02874742|3548172|FG001|COMPLETED|Overall Study||0
2846596|NCT02874742|3548173|FG002|COMPLETED|Overall Study||0
2846597|NCT02874742|3548171|FG000|NOT COMPLETED|Overall Study||103
2846598|NCT02874742|3548172|FG001|NOT COMPLETED|Overall Study||104
2846599|NCT02874742|3548173|FG002|NOT COMPLETED|Overall Study||16
2846600|NCT02720185|3548181|FG000|STARTED|Overall Study||5
2846601|NCT02720185|3548181|FG000|COMPLETED|Overall Study||5
2846602|NCT02720185|3548181|FG000|NOT COMPLETED|Overall Study||0
2846603|NCT02706847|3548188|FG000|STARTED|Day 1 to Week 12||85
2846604|NCT02706847|3548189|FG001|STARTED|Day 1 to Week 12||84
2846605|NCT02706847|3548190|FG002|STARTED|Day 1 to Week 12||165
2846606|NCT02706847|3548191|FG003|STARTED|Day 1 to Week 12||165
2846607|NCT02706847|3548188|FG000|Received Study Treatment|Day 1 to Week 12||85
2846608|NCT02706847|3548189|FG001|Received Study Treatment|Day 1 to Week 12||84
2846609|NCT02706847|3548190|FG002|Received Study Treatment|Day 1 to Week 12||164
2846610|NCT02706847|3548191|FG003|Received Study Treatment|Day 1 to Week 12||165
2846611|NCT02706847|3548188|FG000|COMPLETED|Day 1 to Week 12||75
2846612|NCT02706847|3548189|FG001|COMPLETED|Day 1 to Week 12||76
2846613|NCT02706847|3548190|FG002|COMPLETED|Day 1 to Week 12||157
2846614|NCT02706847|3548191|FG003|COMPLETED|Day 1 to Week 12||149
2846615|NCT02706847|3548188|FG000|NOT COMPLETED|Day 1 to Week 12||10
2846616|NCT02706847|3548189|FG001|NOT COMPLETED|Day 1 to Week 12||8
2846617|NCT02706847|3548190|FG002|NOT COMPLETED|Day 1 to Week 12||8
2846618|NCT02706847|3548191|FG003|NOT COMPLETED|Day 1 to Week 12||16
2846619|NCT02706847|3548188|FG000|STARTED|Week 12 to Week 24||75
2846620|NCT02706847|3548189|FG001|STARTED|Week 12 to Week 24||76
2846621|NCT02706847|3548190|FG002|STARTED|Week 12 to Week 24||157
2846622|NCT02706847|3548191|FG003|STARTED|Week 12 to Week 24||149
2846623|NCT02706847|3548188|FG000|Received Study Treatment|Week 12 to Week 24||72
2846624|NCT02706847|3548189|FG001|Received Study Treatment|Week 12 to Week 24||75
2846625|NCT02706847|3548190|FG002|Received Study Treatment|Week 12 to Week 24||156
2846626|NCT02706847|3548191|FG003|Received Study Treatment|Week 12 to Week 24||148
2846627|NCT02706847|3548188|FG000|COMPLETED|Week 12 to Week 24||72
2846628|NCT02706847|3548189|FG001|COMPLETED|Week 12 to Week 24||74
2846629|NCT02706847|3548190|FG002|COMPLETED|Week 12 to Week 24||153
2846630|NCT02706847|3548191|FG003|COMPLETED|Week 12 to Week 24||135
2846631|NCT02706847|3548188|FG000|NOT COMPLETED|Week 12 to Week 24||3
2846632|NCT02706847|3548189|FG001|NOT COMPLETED|Week 12 to Week 24||2
2846633|NCT02706847|3548190|FG002|NOT COMPLETED|Week 12 to Week 24||4
2846634|NCT02706847|3548191|FG003|NOT COMPLETED|Week 12 to Week 24||14
2846635|NCT02701777|3548205|FG000|STARTED|Overall Study||17
2846636|NCT02701777|3548206|FG001|STARTED|Overall Study||16
2846637|NCT02701777|3548207|FG002|STARTED|Overall Study||16
2846638|NCT02701777|3548208|FG003|STARTED|Overall Study||13
2846639|NCT02701777|3548205|FG000|COMPLETED|Overall Study||13
2846640|NCT02701777|3548206|FG001|COMPLETED|Overall Study||13
2846641|NCT02701777|3548207|FG002|COMPLETED|Overall Study||12
2846642|NCT02701777|3548208|FG003|COMPLETED|Overall Study||11
2846643|NCT02701777|3548205|FG000|NOT COMPLETED|Overall Study||4
2846644|NCT02701777|3548206|FG001|NOT COMPLETED|Overall Study||3
2846645|NCT02701777|3548207|FG002|NOT COMPLETED|Overall Study||4
2846646|NCT02701777|3548208|FG003|NOT COMPLETED|Overall Study||2
2846647|NCT02677896|3548224|FG000|STARTED|Overall Study||574
2846648|NCT02677896|3548225|FG001|STARTED|Overall Study||576
2846649|NCT02677896|3548224|FG000|Treated|Overall Study||572
2846650|NCT02677896|3548225|FG001|Treated|Overall Study||574
2846651|NCT02677896|3548224|FG000|COMPLETED|Overall Study||437
2846652|NCT02677896|3548225|FG001|COMPLETED|Overall Study||332
2846653|NCT02677896|3548224|FG000|NOT COMPLETED|Overall Study||137
2846654|NCT02677896|3548225|FG001|NOT COMPLETED|Overall Study||244
2846655|NCT02657434|3548233|FG000|STARTED|Overall Study||286
2846656|NCT02657434|3548234|FG001|STARTED|Overall Study||292
2846657|NCT02657434|3548233|FG000|COMPLETED|Overall Study||0
2846658|NCT02657434|3548234|FG001|COMPLETED|Overall Study||0
2846659|NCT02657434|3548233|FG000|NOT COMPLETED|Overall Study||286
2846660|NCT02657434|3548234|FG001|NOT COMPLETED|Overall Study||292
2846661|NCT02564900|3548256|FG000|STARTED|Dose Escalation||3
2846662|NCT02564900|3548257|FG001|STARTED|Dose Escalation||3
2846663|NCT02564900|3548258|FG002|STARTED|Dose Escalation||3
2846664|NCT02564900|3548259|FG003|STARTED|Dose Escalation||6
2846665|NCT02564900|3548260|FG004|STARTED|Dose Escalation||6
2846666|NCT02564900|3548261|FG005|STARTED|Dose Escalation||6
2846667|NCT02564900|3548262|FG006|STARTED|Dose Escalation||0
2846668|NCT02564900|3548263|FG007|STARTED|Dose Escalation||0
2846669|NCT02564900|3548264|FG008|STARTED|Dose Escalation||0
2846670|NCT02564900|3548265|FG009|STARTED|Dose Escalation||0
2846671|NCT02564900|3548266|FG010|STARTED|Dose Escalation||0
2846672|NCT02564900|3548267|FG011|STARTED|Dose Escalation||0
2846673|NCT02564900|3548268|FG012|STARTED|Dose Escalation||0
2846674|NCT02564900|3548269|FG013|STARTED|Dose Escalation||0
2846675|NCT02564900|3548270|FG014|STARTED|Dose Escalation||0
2846676|NCT02564900|3548256|FG000|COMPLETED|Dose Escalation||0
2846677|NCT02564900|3548257|FG001|COMPLETED|Dose Escalation||0
2846678|NCT02564900|3548258|FG002|COMPLETED|Dose Escalation||0
2846679|NCT02564900|3548259|FG003|COMPLETED|Dose Escalation||0
2846680|NCT02564900|3548260|FG004|COMPLETED|Dose Escalation||0
2846681|NCT02564900|3548261|FG005|COMPLETED|Dose Escalation||0
2846682|NCT02564900|3548262|FG006|COMPLETED|Dose Escalation||0
2846683|NCT02564900|3548263|FG007|COMPLETED|Dose Escalation||0
2846684|NCT02564900|3548264|FG008|COMPLETED|Dose Escalation||0
2846685|NCT02564900|3548265|FG009|COMPLETED|Dose Escalation||0
2846686|NCT02564900|3548266|FG010|COMPLETED|Dose Escalation||0
2846687|NCT02564900|3548267|FG011|COMPLETED|Dose Escalation||0
2846688|NCT02564900|3548268|FG012|COMPLETED|Dose Escalation||0
2846689|NCT02564900|3548269|FG013|COMPLETED|Dose Escalation||0
2846690|NCT02564900|3548270|FG014|COMPLETED|Dose Escalation||0
2846691|NCT02564900|3548256|FG000|NOT COMPLETED|Dose Escalation||3
2846692|NCT02564900|3548257|FG001|NOT COMPLETED|Dose Escalation||3
2846693|NCT02564900|3548258|FG002|NOT COMPLETED|Dose Escalation||3
2846694|NCT02564900|3548259|FG003|NOT COMPLETED|Dose Escalation||6
2846695|NCT02564900|3548260|FG004|NOT COMPLETED|Dose Escalation||6
2846696|NCT02564900|3548261|FG005|NOT COMPLETED|Dose Escalation||6
2846697|NCT02564900|3548262|FG006|NOT COMPLETED|Dose Escalation||0
2846698|NCT02564900|3548263|FG007|NOT COMPLETED|Dose Escalation||0
2846699|NCT02564900|3548264|FG008|NOT COMPLETED|Dose Escalation||0
2846700|NCT02564900|3548265|FG009|NOT COMPLETED|Dose Escalation||0
2846701|NCT02564900|3548266|FG010|NOT COMPLETED|Dose Escalation||0
2846702|NCT02564900|3548267|FG011|NOT COMPLETED|Dose Escalation||0
2846703|NCT02564900|3548268|FG012|NOT COMPLETED|Dose Escalation||0
2846704|NCT02564900|3548269|FG013|NOT COMPLETED|Dose Escalation||0
2846705|NCT02564900|3548270|FG014|NOT COMPLETED|Dose Escalation||0
2846706|NCT02564900|3548256|FG000|STARTED|Dose Expansion||0
2846707|NCT02564900|3548257|FG001|STARTED|Dose Expansion||0
2846708|NCT02564900|3548258|FG002|STARTED|Dose Expansion||0
2846709|NCT02564900|3548259|FG003|STARTED|Dose Expansion||0
2846710|NCT02564900|3548260|FG004|STARTED|Dose Expansion||0
2846711|NCT02564900|3548261|FG005|STARTED|Dose Expansion||0
2846712|NCT02564900|3548262|FG006|STARTED|Dose Expansion||49
2846713|NCT02564900|3548263|FG007|STARTED|Dose Expansion||62
2846714|NCT02564900|3548264|FG008|STARTED|Dose Expansion||20
2846715|NCT02564900|3548265|FG009|STARTED|Dose Expansion||33
2846716|NCT02564900|3548266|FG010|STARTED|Dose Expansion||17
2846717|NCT02564900|3548267|FG011|STARTED|Dose Expansion||24
2846718|NCT02564900|3548268|FG012|STARTED|Dose Expansion||18
2846719|NCT02564900|3548269|FG013|STARTED|Dose Expansion||20
2846720|NCT02564900|3548270|FG014|STARTED|Dose Expansion||22
2846721|NCT02564900|3548256|FG000|Enrolled, But Not Dosed|Dose Expansion||0
2846722|NCT02564900|3548257|FG001|Enrolled, But Not Dosed|Dose Expansion||0
2846723|NCT02564900|3548258|FG002|Enrolled, But Not Dosed|Dose Expansion||0
2846724|NCT02564900|3548259|FG003|Enrolled, But Not Dosed|Dose Expansion||0
2846725|NCT02564900|3548260|FG004|Enrolled, But Not Dosed|Dose Expansion||0
2846726|NCT02564900|3548261|FG005|Enrolled, But Not Dosed|Dose Expansion||0
2846727|NCT02564900|3548262|FG006|Enrolled, But Not Dosed|Dose Expansion||1
2846728|NCT02564900|3548263|FG007|Enrolled, But Not Dosed|Dose Expansion||1
2846729|NCT02564900|3548264|FG008|Enrolled, But Not Dosed|Dose Expansion||0
2846730|NCT02564900|3548265|FG009|Enrolled, But Not Dosed|Dose Expansion||0
2846731|NCT02564900|3548266|FG010|Enrolled, But Not Dosed|Dose Expansion||0
2846732|NCT02564900|3548267|FG011|Enrolled, But Not Dosed|Dose Expansion||0
2846733|NCT02564900|3548268|FG012|Enrolled, But Not Dosed|Dose Expansion||0
2846734|NCT02564900|3548269|FG013|Enrolled, But Not Dosed|Dose Expansion||0
2846735|NCT02564900|3548270|FG014|Enrolled, But Not Dosed|Dose Expansion||1
2846736|NCT02564900|3548256|FG000|COMPLETED|Dose Expansion||0
2846737|NCT02564900|3548257|FG001|COMPLETED|Dose Expansion||0
2846738|NCT02564900|3548258|FG002|COMPLETED|Dose Expansion||0
2846739|NCT02564900|3548259|FG003|COMPLETED|Dose Expansion||0
2846740|NCT02564900|3548260|FG004|COMPLETED|Dose Expansion||0
2846741|NCT02564900|3548261|FG005|COMPLETED|Dose Expansion||0
2846742|NCT02564900|3548262|FG006|COMPLETED|Dose Expansion||0
2846743|NCT02564900|3548263|FG007|COMPLETED|Dose Expansion||0
2846744|NCT02564900|3548264|FG008|COMPLETED|Dose Expansion||0
2846745|NCT02564900|3548265|FG009|COMPLETED|Dose Expansion||0
2846746|NCT02564900|3548266|FG010|COMPLETED|Dose Expansion||0
2846747|NCT02564900|3548267|FG011|COMPLETED|Dose Expansion||0
2846748|NCT02564900|3548268|FG012|COMPLETED|Dose Expansion||0
2846749|NCT02564900|3548269|FG013|COMPLETED|Dose Expansion||0
2846750|NCT02564900|3548270|FG014|COMPLETED|Dose Expansion||0
2846751|NCT02564900|3548256|FG000|NOT COMPLETED|Dose Expansion||0
2846752|NCT02564900|3548257|FG001|NOT COMPLETED|Dose Expansion||0
2846753|NCT02564900|3548258|FG002|NOT COMPLETED|Dose Expansion||0
2846754|NCT02564900|3548259|FG003|NOT COMPLETED|Dose Expansion||0
2846755|NCT02564900|3548260|FG004|NOT COMPLETED|Dose Expansion||0
2846756|NCT02564900|3548261|FG005|NOT COMPLETED|Dose Expansion||0
2846757|NCT02564900|3548262|FG006|NOT COMPLETED|Dose Expansion||49
2846758|NCT02564900|3548263|FG007|NOT COMPLETED|Dose Expansion||62
2846759|NCT02564900|3548264|FG008|NOT COMPLETED|Dose Expansion||20
2846760|NCT02564900|3548265|FG009|NOT COMPLETED|Dose Expansion||33
2846761|NCT02564900|3548266|FG010|NOT COMPLETED|Dose Expansion||17
2846762|NCT02564900|3548267|FG011|NOT COMPLETED|Dose Expansion||24
2846763|NCT02564900|3548268|FG012|NOT COMPLETED|Dose Expansion||18
2846764|NCT02564900|3548269|FG013|NOT COMPLETED|Dose Expansion||20
2846765|NCT02564900|3548270|FG014|NOT COMPLETED|Dose Expansion||22
2846766|NCT02561299|3548313|FG000|STARTED|Overall Study||32
2846767|NCT02561299|3548314|FG001|STARTED|Overall Study||34
2846768|NCT02561299|3548313|FG000|COMPLETED|Overall Study||27
2846769|NCT02561299|3548314|FG001|COMPLETED|Overall Study||28
2846770|NCT02561299|3548313|FG000|NOT COMPLETED|Overall Study||5
2846771|NCT02561299|3548314|FG001|NOT COMPLETED|Overall Study||6
2846772|NCT02548143|3548322|FG000|STARTED|Overall Study||6
2846773|NCT02548143|3548323|FG001|STARTED|Overall Study||6
2846774|NCT02548143|3548322|FG000|COMPLETED|Overall Study||5
2846775|NCT02548143|3548323|FG001|COMPLETED|Overall Study||5
2846776|NCT02548143|3548322|FG000|NOT COMPLETED|Overall Study||1
2846777|NCT02548143|3548323|FG001|NOT COMPLETED|Overall Study||1
2846778|NCT02489318|3548331|FG000|STARTED|Randomized||527
2846779|NCT02489318|3548332|FG001|STARTED|Randomized||525
2846780|NCT02489318|3548331|FG000|COMPLETED|Randomized||527
2846781|NCT02489318|3548332|FG001|COMPLETED|Randomized||524
2846782|NCT02489318|3548331|FG000|NOT COMPLETED|Randomized||0
2846783|NCT02489318|3548332|FG001|NOT COMPLETED|Randomized||1
2846784|NCT02489318|3548331|FG000|STARTED|Treated||527
2846785|NCT02489318|3548332|FG001|STARTED|Treated||524
2846786|NCT02489318|3548331|FG000|COMPLETED|Treated|Participants crossed over from placebo to apalutamide after positive results at interim analysis.|208
2846787|NCT02489318|3548332|FG001|COMPLETED|Treated||0
2846788|NCT02489318|3548331|FG000|NOT COMPLETED|Treated||319
2846789|NCT02489318|3548332|FG001|NOT COMPLETED|Treated||524
2846790|NCT02448680|3548341|FG000|STARTED|Overall Study||12
2846791|NCT02448680|3548342|FG001|STARTED|Overall Study||13
2846792|NCT02448680|3548341|FG000|COMPLETED|Overall Study||11
2846793|NCT02448680|3548342|FG001|COMPLETED|Overall Study||10
2846794|NCT02448680|3548341|FG000|NOT COMPLETED|Overall Study||1
2846795|NCT02448680|3548342|FG001|NOT COMPLETED|Overall Study||3
2846796|NCT02393859|3548352|FG000|STARTED|Overall Study||54
2846797|NCT02393859|3548353|FG001|STARTED|Overall Study||54
2846798|NCT02393859|3548352|FG000|COMPLETED|Overall Study||0
2846799|NCT02393859|3548353|FG001|COMPLETED|Overall Study||0
2846800|NCT02393859|3548352|FG000|NOT COMPLETED|Overall Study||54
2846801|NCT02393859|3548353|FG001|NOT COMPLETED|Overall Study||54
2846802|NCT02352103|3548362|FG000|STARTED|Overall Study||60
2846803|NCT02352103|3548363|FG001|STARTED|Overall Study||60
2846804|NCT02352103|3548362|FG000|COMPLETED|Overall Study||60
2846805|NCT02352103|3548363|FG001|COMPLETED|Overall Study||59
2846806|NCT02352103|3548362|FG000|NOT COMPLETED|Overall Study||0
2846807|NCT02352103|3548363|FG001|NOT COMPLETED|Overall Study||1
2846808|NCT02277444|3548369|FG000|STARTED|Overall Study||130
2846809|NCT02277444|3548369|FG000|Treated|Overall Study||127
2846810|NCT02277444|3548369|FG000|COMPLETED|Overall Study||0
2846811|NCT02277444|3548369|FG000|NOT COMPLETED|Overall Study||130
2846812|NCT02273362|3548376|FG000|STARTED|Overall Study||5
2846813|NCT02273362|3548377|FG001|STARTED|Overall Study||6
2846814|NCT02273362|3548378|FG002|STARTED|Overall Study||14
2846815|NCT02273362|3548376|FG000|COMPLETED|Overall Study||5
2846816|NCT02273362|3548377|FG001|COMPLETED|Overall Study||6
2846817|NCT02273362|3548378|FG002|COMPLETED|Overall Study||14
2846818|NCT02273362|3548376|FG000|NOT COMPLETED|Overall Study||0
2846819|NCT02273362|3548377|FG001|NOT COMPLETED|Overall Study||0
2846820|NCT02273362|3548378|FG002|NOT COMPLETED|Overall Study||0
2846821|NCT02257736|3548388|FG000|STARTED|Overall Study||490
2846822|NCT02257736|3548389|FG001|STARTED|Overall Study||492
2846823|NCT02257736|3548388|FG000|COMPLETED|Overall Study||39
2846824|NCT02257736|3548389|FG001|COMPLETED|Overall Study||45
2846825|NCT02257736|3548388|FG000|NOT COMPLETED|Overall Study||451
2846826|NCT02257736|3548389|FG001|NOT COMPLETED|Overall Study||447
2846827|NCT02252172|3548397|FG000|STARTED|Overall Study||369
2846828|NCT02252172|3548398|FG001|STARTED|Overall Study||368
2846829|NCT02252172|3548397|FG000|Treated|Overall Study||365
2846830|NCT02252172|3548398|FG001|Treated|Overall Study||364
2846831|NCT02252172|3548397|FG000|COMPLETED|Overall Study||90
2846832|NCT02252172|3548398|FG001|COMPLETED|Overall Study||69
2846833|NCT02252172|3548397|FG000|NOT COMPLETED|Overall Study||279
2846834|NCT02252172|3548398|FG001|NOT COMPLETED|Overall Study||299
2846835|NCT02195479|3548406|FG000|STARTED|Overall Study||356
2846836|NCT02195479|3548407|FG001|STARTED|Overall Study||350
2846837|NCT02195479|3548406|FG000|Treated|Overall Study||354
2846838|NCT02195479|3548407|FG001|Treated|Overall Study||346
2846839|NCT02195479|3548406|FG000|COMPLETED|Overall Study|None of the participants completed the study as the study is still on-going.|0
2846840|NCT02195479|3548407|FG001|COMPLETED|Overall Study|None of the participants completed the study as the study is still on-going.|0
2846841|NCT02195479|3548406|FG000|NOT COMPLETED|Overall Study||356
2846842|NCT02195479|3548407|FG001|NOT COMPLETED|Overall Study||350
2846843|NCT02178358|3548416|FG000|STARTED|Overall Study||20
2846844|NCT02178358|3548417|FG001|STARTED|Overall Study||74
2846845|NCT02178358|3548418|FG002|STARTED|Overall Study||38
2846846|NCT02178358|3548416|FG000|Received at Least 1 Dose of Study Drug|Overall Study||20
2846847|NCT02178358|3548417|FG001|Received at Least 1 Dose of Study Drug|Overall Study||74
2846848|NCT02178358|3548418|FG002|Received at Least 1 Dose of Study Drug|Overall Study||38
2846849|NCT02178358|3548416|FG000|COMPLETED|Overall Study||19
2846850|NCT02178358|3548417|FG001|COMPLETED|Overall Study||72
2846851|NCT02178358|3548418|FG002|COMPLETED|Overall Study||36
2846852|NCT02178358|3548416|FG000|NOT COMPLETED|Overall Study||1
2846853|NCT02178358|3548417|FG001|NOT COMPLETED|Overall Study||2
2846854|NCT02178358|3548418|FG002|NOT COMPLETED|Overall Study||2
2846855|NCT02136134|3548429|FG000|STARTED|Overall Study||247
2846856|NCT02136134|3548430|FG001|STARTED|Overall Study||251
2846857|NCT02136134|3548429|FG000|Treated|Overall Study||237
2846858|NCT02136134|3548430|FG001|Treated|Overall Study||243
2846859|NCT02136134|3548429|FG000|COMPLETED|Overall Study||0
2846860|NCT02136134|3548430|FG001|COMPLETED|Overall Study||0
2846861|NCT02136134|3548429|FG000|NOT COMPLETED|Overall Study||247
2846862|NCT02136134|3548430|FG001|NOT COMPLETED|Overall Study||251
2846863|NCT02076009|3548438|FG000|STARTED|Overall Study||283
2846864|NCT02076009|3548439|FG001|STARTED|Overall Study||286
2846865|NCT02076009|3548438|FG000|Treated|Overall Study||281
2846866|NCT02076009|3548439|FG001|Treated|Overall Study||283
2846867|NCT02076009|3548438|FG000|COMPLETED|Overall Study||0
2846868|NCT02076009|3548439|FG001|COMPLETED|Overall Study||0
2846869|NCT02076009|3548438|FG000|NOT COMPLETED|Overall Study||283
2846870|NCT02076009|3548439|FG001|NOT COMPLETED|Overall Study||286
2846871|NCT02073279|3548447|FG000|STARTED|Double-blind Period||32
2846872|NCT02073279|3548448|FG001|STARTED|Double-blind Period||63
2846873|NCT02073279|3548447|FG000|COMPLETED|Double-blind Period||17
2846874|NCT02073279|3548448|FG001|COMPLETED|Double-blind Period||16
2846875|NCT02073279|3548447|FG000|NOT COMPLETED|Double-blind Period||15
2846876|NCT02073279|3548448|FG001|NOT COMPLETED|Double-blind Period||47
2846877|NCT02073279|3548447|FG000|STARTED|Open-label Extension Period||17
2846878|NCT02073279|3548448|FG001|STARTED|Open-label Extension Period||16
2846879|NCT02073279|3548447|FG000|COMPLETED|Open-label Extension Period||0
2846880|NCT02073279|3548448|FG001|COMPLETED|Open-label Extension Period||0
2846881|NCT02073279|3548447|FG000|NOT COMPLETED|Open-label Extension Period||17
2846882|NCT02073279|3548448|FG001|NOT COMPLETED|Open-label Extension Period||16
2846883|NCT02051933|3548459|FG000|STARTED|Overall Study||5
2846884|NCT02051933|3548460|FG001|STARTED|Overall Study||5
2846885|NCT02051933|3548459|FG000|COMPLETED|Overall Study||5
2846886|NCT02051933|3548460|FG001|COMPLETED|Overall Study||4
2846887|NCT02051933|3548459|FG000|NOT COMPLETED|Overall Study||0
2846888|NCT02051933|3548460|FG001|NOT COMPLETED|Overall Study||1
2846889|NCT01946204|3548473|FG000|STARTED|Overall Study||401
2846890|NCT01946204|3548474|FG001|STARTED|Overall Study||806
2846891|NCT01946204|3548473|FG000|Treated|Overall Study||398
2846892|NCT01946204|3548474|FG001|Treated|Overall Study||803
2846893|NCT01946204|3548473|FG000|COMPLETED|Overall Study||0
2846894|NCT01946204|3548474|FG001|COMPLETED|Overall Study||0
2846895|NCT01946204|3548473|FG000|NOT COMPLETED|Overall Study||401
2846896|NCT01946204|3548474|FG001|NOT COMPLETED|Overall Study||806
2846897|NCT01615029|3548485|FG000|STARTED|Overall Study||3
2846898|NCT01615029|3548486|FG001|STARTED|Overall Study||3
2846899|NCT01615029|3548487|FG002|STARTED|Overall Study||4
2846900|NCT01615029|3548488|FG003|STARTED|Overall Study||3
2846901|NCT01615029|3548489|FG004|STARTED|Overall Study||32
2846902|NCT01615029|3548485|FG000|COMPLETED|Overall Study||0
2846903|NCT01615029|3548486|FG001|COMPLETED|Overall Study||0
2846904|NCT01615029|3548487|FG002|COMPLETED|Overall Study||0
2846905|NCT01615029|3548488|FG003|COMPLETED|Overall Study||0
2846906|NCT01615029|3548489|FG004|COMPLETED|Overall Study||0
2846907|NCT01615029|3548485|FG000|NOT COMPLETED|Overall Study||3
2846908|NCT01615029|3548486|FG001|NOT COMPLETED|Overall Study||3
2846909|NCT01615029|3548487|FG002|NOT COMPLETED|Overall Study||4
2846910|NCT01615029|3548488|FG003|NOT COMPLETED|Overall Study||3
2846911|NCT01615029|3548489|FG004|NOT COMPLETED|Overall Study||32
2846912|NCT01544127|3548504|FG000|STARTED|Overall Study||33
2846913|NCT01544127|3548505|FG001|STARTED|Overall Study||33
2846914|NCT01544127|3548506|FG002|STARTED|Overall Study||66
2846915|NCT01544127|3548504|FG000|COMPLETED|Overall Study||22
2846916|NCT01544127|3548505|FG001|COMPLETED|Overall Study||27
2846917|NCT01544127|3548506|FG002|COMPLETED|Overall Study||52
2846918|NCT01544127|3548504|FG000|NOT COMPLETED|Overall Study||11
2846919|NCT01544127|3548505|FG001|NOT COMPLETED|Overall Study||6
2846920|NCT01544127|3548506|FG002|NOT COMPLETED|Overall Study||14
2846921|NCT01314118|3548515|FG000|STARTED|Overall Study||131
2846922|NCT01314118|3548515|FG000|COMPLETED|Overall Study||0
2846923|NCT01314118|3548515|FG000|NOT COMPLETED|Overall Study||131
2846924|NCT01171898|3548523|FG000|STARTED|Overall Study||30
2846925|NCT01171898|3548524|FG001|STARTED|Overall Study||51
2846926|NCT01171898|3548525|FG002|STARTED|Overall Study||25
2846927|NCT01171898|3548526|FG003|STARTED|Overall Study||21
2846928|NCT01171898|3548523|FG000|COMPLETED|Overall Study||26
2846929|NCT01171898|3548524|FG001|COMPLETED|Overall Study||32
2846930|NCT01171898|3548525|FG002|COMPLETED|Overall Study||13
2846931|NCT01171898|3548526|FG003|COMPLETED|Overall Study||15
2846932|NCT01171898|3548523|FG000|NOT COMPLETED|Overall Study||4
2846933|NCT01171898|3548524|FG001|NOT COMPLETED|Overall Study||19
2846934|NCT01171898|3548525|FG002|NOT COMPLETED|Overall Study||12
2846935|NCT01171898|3548526|FG003|NOT COMPLETED|Overall Study||6
2846936|NCT00806390|3548541|FG000|STARTED|Overall Study||7
2846937|NCT00806390|3548542|FG001|STARTED|Overall Study||8
2846938|NCT00806390|3548541|FG000|COMPLETED|Overall Study||7
2846939|NCT00806390|3548542|FG001|COMPLETED|Overall Study||8
2846940|NCT00806390|3548541|FG000|NOT COMPLETED|Overall Study||0
2846941|NCT00806390|3548542|FG001|NOT COMPLETED|Overall Study||0
2846942|NCT00777036|3548551|FG000|STARTED|On Treatment||29
2846943|NCT00777036|3548552|FG001|STARTED|On Treatment||17
2846944|NCT00777036|3548553|FG002|STARTED|On Treatment||84
2846945|NCT00777036|3548551|FG000|COMPLETED|On Treatment|Completed = Still on treatment|14
2846946|NCT00777036|3548552|FG001|COMPLETED|On Treatment|Completed = Still on treatment|1
2846947|NCT00777036|3548553|FG002|COMPLETED|On Treatment|Completed = Still on treatment|61
3168202|NCT01917006|3895512|FG002|NOT COMPLETED|Open-label Period||0
3168203|NCT01917006|3895513|FG003|NOT COMPLETED|Open-label Period||0
3168204|NCT01917006|3895514|FG004|NOT COMPLETED|Open-label Period||0
3168205|NCT01917006|3895515|FG005|NOT COMPLETED|Open-label Period||0
3168206|NCT01917006|3895516|FG006|NOT COMPLETED|Open-label Period||0
2846948|NCT00777036|3548551|FG000|NOT COMPLETED|On Treatment||15
2846949|NCT00777036|3548552|FG001|NOT COMPLETED|On Treatment||16
2846950|NCT00777036|3548553|FG002|NOT COMPLETED|On Treatment||23
2846951|NCT00777036|3548551|FG000|STARTED|Follow-Up|Not all participants who discontinued treatment entered the follow-up period|14
2846952|NCT00777036|3548552|FG001|STARTED|Follow-Up|Not all participants who discontinued treatment entered the follow-up period|13
2846953|NCT00777036|3548553|FG002|STARTED|Follow-Up|Not all participants who discontinued treatment entered the follow-up period|23
2846954|NCT00777036|3548551|FG000|COMPLETED|Follow-Up|Completed = Still in Follow-up|9
2846955|NCT00777036|3548552|FG001|COMPLETED|Follow-Up|Completed = Still in Follow-up|5
2846956|NCT00777036|3548553|FG002|COMPLETED|Follow-Up|Completed = Still in Follow-up|19
2846957|NCT00777036|3548551|FG000|NOT COMPLETED|Follow-Up||5
2846958|NCT00777036|3548552|FG001|NOT COMPLETED|Follow-Up||8
2846959|NCT00777036|3548553|FG002|NOT COMPLETED|Follow-Up||4
2846960|NCT00566618|3548568|FG000|STARTED|Overall Study||1
2846961|NCT00566618|3548569|FG001|STARTED|Overall Study||6
2846962|NCT00566618|3548570|FG002|STARTED|Overall Study||18
2846963|NCT00566618|3548568|FG000|COMPLETED|Overall Study||0
2846964|NCT00566618|3548569|FG001|COMPLETED|Overall Study||0
2846965|NCT00566618|3548570|FG002|COMPLETED|Overall Study||0
2846966|NCT00566618|3548568|FG000|NOT COMPLETED|Overall Study||1
2846967|NCT00566618|3548569|FG001|NOT COMPLETED|Overall Study||6
2846968|NCT00566618|3548570|FG002|NOT COMPLETED|Overall Study||18
2846969|NCT00442559|3548577|FG000|STARTED|Overall Study||100
2846970|NCT00442559|3548578|FG001|STARTED|Overall Study||91
2846971|NCT00442559|3548577|FG000|12 Weeks After Randomization|Overall Study|12 weeks after randomization was pre-specified as the time point for analysis|68
2846972|NCT00442559|3548578|FG001|12 Weeks After Randomization|Overall Study|12 weeks after randomization was pre-specified as the time point for analysis|60
2846973|NCT00442559|3548577|FG000|COMPLETED|Overall Study|12 weeks after randomization was pre-specified as the time point for analysis|66
2846974|NCT00442559|3548578|FG001|COMPLETED|Overall Study|12 weeks after randomization was pre-specified as the time point for analysis|56
2846975|NCT00442559|3548577|FG000|NOT COMPLETED|Overall Study||34
2846976|NCT00442559|3548578|FG001|NOT COMPLETED|Overall Study||35
2846977|NCT00117338|3548592|FG000|STARTED|Overall Study||145
2846978|NCT00117338|3548593|FG001|STARTED|Overall Study||131
2846979|NCT00117338|3548592|FG000|COMPLETED|Overall Study||140
2846980|NCT00117338|3548593|FG001|COMPLETED|Overall Study||127
2846981|NCT00117338|3548592|FG000|NOT COMPLETED|Overall Study||5
2846982|NCT00117338|3548593|FG001|NOT COMPLETED|Overall Study||4
2917264|NCT00519376|3627410|FG004|NOT COMPLETED|Washout Period 2||0
2917265|NCT00519376|3627411|FG005|NOT COMPLETED|Washout Period 2||0
2917266|NCT00519376|3627412|FG006|NOT COMPLETED|Washout Period 2||0
2917267|NCT00519376|3627413|FG007|NOT COMPLETED|Washout Period 2||0
2917268|NCT00519376|3627414|FG008|NOT COMPLETED|Washout Period 2||0
3168207|NCT01917006|3895517|FG007|NOT COMPLETED|Open-label Period||2
2917269|NCT00519376|3627415|FG009|NOT COMPLETED|Washout Period 2||0
2917270|NCT00519376|3627416|FG010|NOT COMPLETED|Washout Period 2||0
2917271|NCT00519376|3627417|FG011|NOT COMPLETED|Washout Period 2||0
2917272|NCT00519376|3627418|FG012|NOT COMPLETED|Washout Period 2||0
2917273|NCT00519376|3627419|FG013|NOT COMPLETED|Washout Period 2||0
2917274|NCT00519376|3627420|FG014|NOT COMPLETED|Washout Period 2||0
2917275|NCT00519376|3627421|FG015|NOT COMPLETED|Washout Period 2||0
2917276|NCT00519376|3627406|FG000|STARTED|Treatment Period 3||2
2917277|NCT00519376|3627407|FG001|STARTED|Treatment Period 3||2
2917278|NCT00519376|3627408|FG002|STARTED|Treatment Period 3||2
2917279|NCT00519376|3627409|FG003|STARTED|Treatment Period 3||2
2917280|NCT00519376|3627410|FG004|STARTED|Treatment Period 3||1
2917281|NCT00519376|3627411|FG005|STARTED|Treatment Period 3||1
2917282|NCT00519376|3627412|FG006|STARTED|Treatment Period 3||1
2917283|NCT00519376|3627413|FG007|STARTED|Treatment Period 3||1
2917284|NCT00519376|3627414|FG008|STARTED|Treatment Period 3||1
2917285|NCT00519376|3627415|FG009|STARTED|Treatment Period 3||1
2917286|NCT00519376|3627416|FG010|STARTED|Treatment Period 3||1
2917287|NCT00519376|3627417|FG011|STARTED|Treatment Period 3||1
2917288|NCT00519376|3627418|FG012|STARTED|Treatment Period 3||0
2917289|NCT00519376|3627419|FG013|STARTED|Treatment Period 3||1
2917290|NCT00519376|3627420|FG014|STARTED|Treatment Period 3||1
2917291|NCT00519376|3627421|FG015|STARTED|Treatment Period 3||1
2917292|NCT00519376|3627406|FG000|COMPLETED|Treatment Period 3||2
2917293|NCT00519376|3627407|FG001|COMPLETED|Treatment Period 3||2
2917294|NCT00519376|3627408|FG002|COMPLETED|Treatment Period 3||2
2917295|NCT00519376|3627409|FG003|COMPLETED|Treatment Period 3||2
2917296|NCT00519376|3627410|FG004|COMPLETED|Treatment Period 3||1
2917297|NCT00519376|3627411|FG005|COMPLETED|Treatment Period 3||1
3168208|NCT01917084|3895534|FG000|STARTED|Overall Study||20
2846983|NCT04871815|3548599|FG000|STARTED|Baseline Day 1-7||22
2846984|NCT04871815|3548599|FG000|COMPLETED|Baseline Day 1-7||22
2846985|NCT04871815|3548599|FG000|NOT COMPLETED|Baseline Day 1-7||0
2846986|NCT04871815|3548599|FG000|STARTED|N115 Treatment Day 8-14||22
2846987|NCT04871815|3548599|FG000|COMPLETED|N115 Treatment Day 8-14||22
2846988|NCT04871815|3548599|FG000|NOT COMPLETED|N115 Treatment Day 8-14||0
2846989|NCT04851314|3548613|FG000|STARTED|Overall Study||55
2846990|NCT04851314|3548614|FG001|STARTED|Overall Study||55
2846991|NCT04851314|3548613|FG000|COMPLETED|Overall Study||52
2846992|NCT04851314|3548614|FG001|COMPLETED|Overall Study||51
2846993|NCT04851314|3548613|FG000|NOT COMPLETED|Overall Study||3
2846994|NCT04851314|3548614|FG001|NOT COMPLETED|Overall Study||4
2846995|NCT04845633|3548624|FG000|STARTED|Overall Study||12
2846996|NCT04845633|3548625|FG001|STARTED|Overall Study||12
2846997|NCT04845633|3548626|FG002|STARTED|Overall Study||12
2846998|NCT04845633|3548627|FG003|STARTED|Overall Study||12
2846999|NCT04845633|3548624|FG000|COMPLETED|Overall Study||12
2847000|NCT04845633|3548625|FG001|COMPLETED|Overall Study||12
2847001|NCT04845633|3548626|FG002|COMPLETED|Overall Study||12
2847002|NCT04845633|3548627|FG003|COMPLETED|Overall Study||12
2847003|NCT04845633|3548624|FG000|NOT COMPLETED|Overall Study||0
2847004|NCT04845633|3548625|FG001|NOT COMPLETED|Overall Study||0
2847005|NCT04845633|3548626|FG002|NOT COMPLETED|Overall Study||0
2847006|NCT04845633|3548627|FG003|NOT COMPLETED|Overall Study||0
2847007|NCT04821245|3548639|FG000|STARTED|Overall Study||36
2847008|NCT04821245|3548639|FG000|COMPLETED|Overall Study||27
2847009|NCT04821245|3548639|FG000|NOT COMPLETED|Overall Study||9
2847010|NCT04814459|3548647|FG000|STARTED|Overall Study||72
2847011|NCT04814459|3548648|FG001|STARTED|Overall Study||72
2847012|NCT04814459|3548647|FG000|COMPLETED|Overall Study||72
2847013|NCT04814459|3548648|FG001|COMPLETED|Overall Study||72
2847014|NCT04814459|3548647|FG000|NOT COMPLETED|Overall Study||0
2847015|NCT04814459|3548648|FG001|NOT COMPLETED|Overall Study||0
2847016|NCT04799782|3548654|FG000|STARTED|First Intervention||8
2847017|NCT04799782|3548655|FG001|STARTED|First Intervention||7
2847018|NCT04799782|3548654|FG000|COMPLETED|First Intervention||8
2847019|NCT04799782|3548655|FG001|COMPLETED|First Intervention||7
2847020|NCT04799782|3548654|FG000|NOT COMPLETED|First Intervention||0
2847021|NCT04799782|3548655|FG001|NOT COMPLETED|First Intervention||0
2847022|NCT04799782|3548654|FG000|STARTED|Washout||8
2847023|NCT04799782|3548655|FG001|STARTED|Washout||7
2847024|NCT04799782|3548654|FG000|COMPLETED|Washout||6
2847025|NCT04799782|3548655|FG001|COMPLETED|Washout||4
2847026|NCT04799782|3548654|FG000|NOT COMPLETED|Washout||2
2847027|NCT04799782|3548655|FG001|NOT COMPLETED|Washout||3
2847028|NCT04799782|3548654|FG000|STARTED|Second Intervention||6
2847029|NCT04799782|3548655|FG001|STARTED|Second Intervention||4
2847030|NCT04799782|3548654|FG000|COMPLETED|Second Intervention||6
2847031|NCT04799782|3548655|FG001|COMPLETED|Second Intervention||4
2847032|NCT04799782|3548654|FG000|NOT COMPLETED|Second Intervention||0
2847033|NCT04799782|3548655|FG001|NOT COMPLETED|Second Intervention||0
2847034|NCT04780919|3548663|FG000|STARTED|Overall Study||9
2847035|NCT04780919|3548664|FG001|STARTED|Overall Study||9
2847036|NCT04780919|3548663|FG000|COMPLETED|Overall Study||9
2847037|NCT04780919|3548664|FG001|COMPLETED|Overall Study||9
2847038|NCT04780919|3548663|FG000|NOT COMPLETED|Overall Study||0
2847039|NCT04780919|3548664|FG001|NOT COMPLETED|Overall Study||0
2847052|NCT04773028|3548683|FG000|STARTED|Overall Study||24
2847053|NCT04773028|3548684|FG001|STARTED|Overall Study||24
2847054|NCT04773028|3548683|FG000|COMPLETED|Overall Study||24
2847055|NCT04773028|3548684|FG001|COMPLETED|Overall Study||24
2847056|NCT04773028|3548683|FG000|NOT COMPLETED|Overall Study||0
2847057|NCT04773028|3548684|FG001|NOT COMPLETED|Overall Study||0
2847058|NCT04755595|3548690|FG000|STARTED|Overall Study||20
2847059|NCT04755595|3548690|FG000|COMPLETED|Overall Study||19
2847060|NCT04755595|3548690|FG000|NOT COMPLETED|Overall Study||1
2847061|NCT04749745|3548695|FG000|STARTED|Overall Study||5
2847062|NCT04749745|3548696|FG001|STARTED|Overall Study||6
2847063|NCT04749745|3548695|FG000|First Intervention|Overall Study||4
2847064|NCT04749745|3548696|FG001|First Intervention|Overall Study||6
2847065|NCT04749745|3548695|FG000|Washout|Overall Study||4
2847066|NCT04749745|3548696|FG001|Washout|Overall Study||6
2847067|NCT04749745|3548695|FG000|Second Intervention|Overall Study||4
2847068|NCT04749745|3548696|FG001|Second Intervention|Overall Study||6
2847069|NCT04749745|3548695|FG000|COMPLETED|Overall Study||4
2847070|NCT04749745|3548696|FG001|COMPLETED|Overall Study||6
2847071|NCT04749745|3548695|FG000|NOT COMPLETED|Overall Study||1
2847072|NCT04749745|3548696|FG001|NOT COMPLETED|Overall Study||0
2847079|NCT04737278|3548713|FG000|STARTED|Overall Study||28
2847080|NCT04737278|3548714|FG001|STARTED|Overall Study||28
2847081|NCT04737278|3548713|FG000|COMPLETED|Overall Study||24
2847082|NCT04737278|3548714|FG001|COMPLETED|Overall Study||25
2847083|NCT04737278|3548713|FG000|NOT COMPLETED|Overall Study||4
2847084|NCT04737278|3548714|FG001|NOT COMPLETED|Overall Study||3
2847091|NCT04732819|3548737|FG000|STARTED|Overall Study||12582
2847092|NCT04732819|3548738|FG001|STARTED|Overall Study||11186
2847093|NCT04732819|3548737|FG000|COMPLETED|Overall Study||12582
2847094|NCT04732819|3548738|FG001|COMPLETED|Overall Study||11186
2847095|NCT04732819|3548737|FG000|NOT COMPLETED|Overall Study||0
2847096|NCT04732819|3548738|FG001|NOT COMPLETED|Overall Study||0
2847097|NCT04732338|3548746|FG000|STARTED|Overall Study||13
2847098|NCT04732338|3548747|FG001|STARTED|Overall Study||13
2847099|NCT04732338|3548746|FG000|COMPLETED|Overall Study||10
2847040|NCT04779606|3548674|FG000|STARTED|First Phase: Tolerability and Safety||16
2847041|NCT04779606|3548675|FG001|STARTED|First Phase: Tolerability and Safety||4
2847042|NCT04779606|3548674|FG000|COMPLETED|First Phase: Tolerability and Safety||16
2847043|NCT04779606|3548675|FG001|COMPLETED|First Phase: Tolerability and Safety||4
2847044|NCT04779606|3548674|FG000|NOT COMPLETED|First Phase: Tolerability and Safety||0
2847045|NCT04779606|3548675|FG001|NOT COMPLETED|First Phase: Tolerability and Safety||0
2847046|NCT04779606|3548674|FG000|STARTED|Second Phase: Efficacy||68
2847047|NCT04779606|3548675|FG001|STARTED|Second Phase: Efficacy||17
2847048|NCT04779606|3548674|FG000|COMPLETED|Second Phase: Efficacy||68
2847049|NCT04779606|3548675|FG001|COMPLETED|Second Phase: Efficacy||17
2847050|NCT04779606|3548674|FG000|NOT COMPLETED|Second Phase: Efficacy||0
2847051|NCT04779606|3548675|FG001|NOT COMPLETED|Second Phase: Efficacy||0
2847073|NCT04748341|3548704|FG000|STARTED|Overall Study||31
2847074|NCT04748341|3548705|FG001|STARTED|Overall Study||31
2847075|NCT04748341|3548704|FG000|COMPLETED|Overall Study||30
2847076|NCT04748341|3548705|FG001|COMPLETED|Overall Study||30
2847077|NCT04748341|3548704|FG000|NOT COMPLETED|Overall Study||1
2847078|NCT04748341|3548705|FG001|NOT COMPLETED|Overall Study||1
2847085|NCT04736069|3548722|FG000|STARTED|Overall Study||30
3168209|NCT01917084|3895534|FG000|COMPLETED|Overall Study||19
3168210|NCT01917084|3895534|FG000|NOT COMPLETED|Overall Study||1
2847086|NCT04736069|3548723|FG001|STARTED|Overall Study||30
2847087|NCT04736069|3548722|FG000|COMPLETED|Overall Study||30
2847088|NCT04736069|3548723|FG001|COMPLETED|Overall Study||22
2847089|NCT04736069|3548722|FG000|NOT COMPLETED|Overall Study||0
2847090|NCT04736069|3548723|FG001|NOT COMPLETED|Overall Study||8
2847100|NCT04732338|3548747|FG001|COMPLETED|Overall Study||10
2847101|NCT04732338|3548746|FG000|NOT COMPLETED|Overall Study||3
2847102|NCT04732338|3548747|FG001|NOT COMPLETED|Overall Study||3
2917298|NCT00519376|3627412|FG006|COMPLETED|Treatment Period 3||1
2917299|NCT00519376|3627413|FG007|COMPLETED|Treatment Period 3||1
2917300|NCT00519376|3627414|FG008|COMPLETED|Treatment Period 3||1
2917301|NCT00519376|3627415|FG009|COMPLETED|Treatment Period 3||1
2917302|NCT00519376|3627416|FG010|COMPLETED|Treatment Period 3||1
2917303|NCT00519376|3627417|FG011|COMPLETED|Treatment Period 3||1
2917304|NCT00519376|3627418|FG012|COMPLETED|Treatment Period 3||0
2917305|NCT00519376|3627419|FG013|COMPLETED|Treatment Period 3||1
2917306|NCT00519376|3627420|FG014|COMPLETED|Treatment Period 3||1
2917307|NCT00519376|3627421|FG015|COMPLETED|Treatment Period 3||1
2917308|NCT00519376|3627406|FG000|NOT COMPLETED|Treatment Period 3||0
2917309|NCT00519376|3627407|FG001|NOT COMPLETED|Treatment Period 3||0
2917310|NCT00519376|3627408|FG002|NOT COMPLETED|Treatment Period 3||0
2917311|NCT00519376|3627409|FG003|NOT COMPLETED|Treatment Period 3||0
2917312|NCT00519376|3627410|FG004|NOT COMPLETED|Treatment Period 3||0
2917313|NCT00519376|3627411|FG005|NOT COMPLETED|Treatment Period 3||0
2917314|NCT00519376|3627412|FG006|NOT COMPLETED|Treatment Period 3||0
2917315|NCT00519376|3627413|FG007|NOT COMPLETED|Treatment Period 3||0
2917316|NCT00519376|3627414|FG008|NOT COMPLETED|Treatment Period 3||0
2917317|NCT00519376|3627415|FG009|NOT COMPLETED|Treatment Period 3||0
2917318|NCT00519376|3627416|FG010|NOT COMPLETED|Treatment Period 3||0
2917319|NCT00519376|3627417|FG011|NOT COMPLETED|Treatment Period 3||0
2917320|NCT00519376|3627418|FG012|NOT COMPLETED|Treatment Period 3||0
2917321|NCT00519376|3627419|FG013|NOT COMPLETED|Treatment Period 3||0
2917322|NCT00519376|3627420|FG014|NOT COMPLETED|Treatment Period 3||0
2917323|NCT00519376|3627421|FG015|NOT COMPLETED|Treatment Period 3||0
2917324|NCT00519376|3627406|FG000|STARTED|Washout Period 3||2
2917325|NCT00519376|3627407|FG001|STARTED|Washout Period 3||2
2917326|NCT00519376|3627408|FG002|STARTED|Washout Period 3||2
2917327|NCT00519376|3627409|FG003|STARTED|Washout Period 3||2
2917328|NCT00519376|3627410|FG004|STARTED|Washout Period 3||1
2917329|NCT00519376|3627411|FG005|STARTED|Washout Period 3||1
2917330|NCT00519376|3627412|FG006|STARTED|Washout Period 3||1
2917331|NCT00519376|3627413|FG007|STARTED|Washout Period 3||1
2917332|NCT00519376|3627414|FG008|STARTED|Washout Period 3||1
2917333|NCT00519376|3627415|FG009|STARTED|Washout Period 3||1
2917334|NCT00519376|3627416|FG010|STARTED|Washout Period 3||1
2917335|NCT00519376|3627417|FG011|STARTED|Washout Period 3||1
2917336|NCT00519376|3627418|FG012|STARTED|Washout Period 3||0
2917337|NCT00519376|3627419|FG013|STARTED|Washout Period 3||1
2917338|NCT00519376|3627420|FG014|STARTED|Washout Period 3||1
2917339|NCT00519376|3627421|FG015|STARTED|Washout Period 3||1
2917340|NCT00519376|3627406|FG000|COMPLETED|Washout Period 3||2
2917341|NCT00519376|3627407|FG001|COMPLETED|Washout Period 3||2
2917342|NCT00519376|3627408|FG002|COMPLETED|Washout Period 3||2
2917343|NCT00519376|3627409|FG003|COMPLETED|Washout Period 3||2
2917344|NCT00519376|3627410|FG004|COMPLETED|Washout Period 3||1
2917345|NCT00519376|3627411|FG005|COMPLETED|Washout Period 3||1
2917346|NCT00519376|3627412|FG006|COMPLETED|Washout Period 3||1
2917347|NCT00519376|3627413|FG007|COMPLETED|Washout Period 3||1
2917348|NCT00519376|3627414|FG008|COMPLETED|Washout Period 3||1
2917349|NCT00519376|3627415|FG009|COMPLETED|Washout Period 3||1
2917350|NCT00519376|3627416|FG010|COMPLETED|Washout Period 3||1
2917351|NCT00519376|3627417|FG011|COMPLETED|Washout Period 3||1
2917352|NCT00519376|3627418|FG012|COMPLETED|Washout Period 3||0
2917353|NCT00519376|3627419|FG013|COMPLETED|Washout Period 3||1
2917354|NCT00519376|3627420|FG014|COMPLETED|Washout Period 3||1
2917355|NCT00519376|3627421|FG015|COMPLETED|Washout Period 3||1
2917356|NCT00519376|3627406|FG000|NOT COMPLETED|Washout Period 3||0
3168211|NCT01917136|3895538|FG000|STARTED|Overall Study||21
2847103|NCT04728802|3548755|FG000|STARTED|Overall Study||317
2847104|NCT04728802|3548756|FG001|STARTED|Overall Study||328
2847105|NCT04728802|3548755|FG000|COMPLETED|Overall Study||288
2847106|NCT04728802|3548756|FG001|COMPLETED|Overall Study||292
2847107|NCT04728802|3548755|FG000|NOT COMPLETED|Overall Study||29
2847108|NCT04728802|3548756|FG001|NOT COMPLETED|Overall Study||36
2847109|NCT04728594|3548765|FG000|STARTED|Overall Study|The number of participants who were sent a follow up email (delayed, three days after the other two arms) was used to see how many started.|3178
2847110|NCT04728594|3548766|FG001|STARTED|Overall Study||3198
2847111|NCT04728594|3548767|FG002|STARTED|Overall Study||3190
2847112|NCT04728594|3548765|FG000|COMPLETED|Overall Study||3178
2847113|NCT04728594|3548766|FG001|COMPLETED|Overall Study||3198
2847114|NCT04728594|3548767|FG002|COMPLETED|Overall Study||3190
2847115|NCT04728594|3548765|FG000|NOT COMPLETED|Overall Study||0
2847116|NCT04728594|3548766|FG001|NOT COMPLETED|Overall Study||0
2847117|NCT04728594|3548767|FG002|NOT COMPLETED|Overall Study||0
2847118|NCT04725500|3548777|FG000|STARTED|Screening||42
2847119|NCT04725500|3548777|FG000|COMPLETED|Screening||15
2847120|NCT04725500|3548777|FG000|NOT COMPLETED|Screening||27
2847121|NCT04725500|3548777|FG000|STARTED|Overnight Polysomnography (PSG)||15
2847122|NCT04725500|3548777|FG000|COMPLETED|Overnight Polysomnography (PSG)||15
2847123|NCT04725500|3548777|FG000|NOT COMPLETED|Overnight Polysomnography (PSG)||0
2847124|NCT04725500|3548777|FG000|STARTED|2 Week Take Home||15
2847125|NCT04725500|3548777|FG000|COMPLETED|2 Week Take Home||10
2847126|NCT04725500|3548777|FG000|NOT COMPLETED|2 Week Take Home||5
2847133|NCT04716426|3548792|FG000|STARTED|Overall Study||50
2847134|NCT04716426|3548793|FG001|STARTED|Overall Study||50
2847135|NCT04716426|3548792|FG000|COMPLETED|Overall Study||48
2847136|NCT04716426|3548793|FG001|COMPLETED|Overall Study||49
2847137|NCT04716426|3548792|FG000|NOT COMPLETED|Overall Study||2
2847138|NCT04716426|3548793|FG001|NOT COMPLETED|Overall Study||1
2847139|NCT04709068|3548799|FG000|STARTED|Overall Study||8
2847140|NCT04709068|3548799|FG000|COMPLETED|Overall Study||8
2847141|NCT04709068|3548799|FG000|NOT COMPLETED|Overall Study||0
2847142|NCT04704713|3548805|FG000|STARTED|Overall Study||15
2847143|NCT04704713|3548806|FG001|STARTED|Overall Study||16
2847144|NCT04704713|3548805|FG000|COMPLETED|Overall Study||11
2847145|NCT04704713|3548806|FG001|COMPLETED|Overall Study||12
2847146|NCT04704713|3548805|FG000|NOT COMPLETED|Overall Study||4
2847147|NCT04704713|3548806|FG001|NOT COMPLETED|Overall Study||4
2847154|NCT04698993|3548825|FG000|STARTED|Overall Study||275
2847155|NCT04698993|3548826|FG001|STARTED|Overall Study||113
2847156|NCT04698993|3548825|FG000|COMPLETED|Overall Study||272
2847157|NCT04698993|3548826|FG001|COMPLETED|Overall Study||106
2847158|NCT04698993|3548825|FG000|NOT COMPLETED|Overall Study||3
2847159|NCT04698993|3548826|FG001|NOT COMPLETED|Overall Study||7
2847163|NCT04693078|3548836|FG000|STARTED|Overall Study||100
2847164|NCT04693078|3548836|FG000|COMPLETED|Overall Study||100
2847165|NCT04693078|3548836|FG000|NOT COMPLETED|Overall Study||0
2847166|NCT04688346|3548842|FG000|STARTED|Overall Study||6
2847167|NCT04688346|3548843|FG001|STARTED|Overall Study||7
2847168|NCT04688346|3548842|FG000|First Intervention|Overall Study||6
2847169|NCT04688346|3548843|FG001|First Intervention|Overall Study||7
2847170|NCT04688346|3548842|FG000|Second Intervention|Overall Study||6
2847171|NCT04688346|3548843|FG001|Second Intervention|Overall Study||7
2847172|NCT04688346|3548842|FG000|COMPLETED|Overall Study||6
2847173|NCT04688346|3548843|FG001|COMPLETED|Overall Study||7
2847174|NCT04688346|3548842|FG000|NOT COMPLETED|Overall Study||0
2847175|NCT04688346|3548843|FG001|NOT COMPLETED|Overall Study||0
2847176|NCT04684992|3548849|FG000|STARTED|Overall Study||36
2847177|NCT04684992|3548849|FG000|COMPLETED|Overall Study||34
2847178|NCT04684992|3548849|FG000|NOT COMPLETED|Overall Study||2
2847179|NCT04674644|3548853|FG000|STARTED|Overall Study||850
2847180|NCT04674644|3548853|FG000|COMPLETED|Overall Study||813
2847181|NCT04674644|3548853|FG000|NOT COMPLETED|Overall Study||37
2847190|NCT04668989|3548871|FG000|STARTED|First Intervention||36
2847191|NCT04668989|3548872|FG001|STARTED|First Intervention||30
2847192|NCT04668989|3548871|FG000|COMPLETED|First Intervention||36
2847193|NCT04668989|3548872|FG001|COMPLETED|First Intervention||29
2847194|NCT04668989|3548871|FG000|NOT COMPLETED|First Intervention||0
2847195|NCT04668989|3548872|FG001|NOT COMPLETED|First Intervention||1
2847196|NCT04668989|3548871|FG000|STARTED|Second Intervention||36
2847197|NCT04668989|3548872|FG001|STARTED|Second Intervention||29
2847198|NCT04668989|3548871|FG000|COMPLETED|Second Intervention||36
2847199|NCT04668989|3548872|FG001|COMPLETED|Second Intervention||28
2847200|NCT04668989|3548871|FG000|NOT COMPLETED|Second Intervention||0
2847201|NCT04668989|3548872|FG001|NOT COMPLETED|Second Intervention||1
2847208|NCT04653766|3548892|FG000|STARTED|Overall Study||6
2847209|NCT04653766|3548893|FG001|STARTED|Overall Study||6
2847210|NCT04653766|3548894|FG002|STARTED|Overall Study||6
2847211|NCT04653766|3548895|FG003|STARTED|Overall Study||6
2847212|NCT04653766|3548896|FG004|STARTED|Overall Study||8
2847213|NCT04653766|3548892|FG000|COMPLETED|Overall Study||6
2847214|NCT04653766|3548893|FG001|COMPLETED|Overall Study||6
2847215|NCT04653766|3548894|FG002|COMPLETED|Overall Study||6
2847216|NCT04653766|3548895|FG003|COMPLETED|Overall Study||6
2847217|NCT04653766|3548896|FG004|COMPLETED|Overall Study||8
2847218|NCT04653766|3548892|FG000|NOT COMPLETED|Overall Study||0
2847219|NCT04653766|3548893|FG001|NOT COMPLETED|Overall Study||0
2847220|NCT04653766|3548894|FG002|NOT COMPLETED|Overall Study||0
2847221|NCT04653766|3548895|FG003|NOT COMPLETED|Overall Study||0
3311712|NCT03054350|4045173|FG005|NOT COMPLETED|Dose Adjustment and Maintenance Period||0
3311713|NCT03054428|4045207|FG000|STARTED|Overall Study||85
3311714|NCT03054428|4045208|FG001|STARTED|Overall Study||84
3311715|NCT03054428|4045209|FG002|STARTED|Overall Study||82
2847127|NCT04724538|3548783|FG000|STARTED|Overall Study||11
2847128|NCT04724538|3548784|FG001|STARTED|Overall Study||14
2847129|NCT04724538|3548783|FG000|COMPLETED|Overall Study||11
2847130|NCT04724538|3548784|FG001|COMPLETED|Overall Study||14
2847131|NCT04724538|3548783|FG000|NOT COMPLETED|Overall Study||0
2847132|NCT04724538|3548784|FG001|NOT COMPLETED|Overall Study||0
2847148|NCT04701814|3548814|FG000|STARTED|Overall Study||20
2847149|NCT04701814|3548815|FG001|STARTED|Overall Study||18
2847150|NCT04701814|3548814|FG000|COMPLETED|Overall Study||15
2847151|NCT04701814|3548815|FG001|COMPLETED|Overall Study||15
2847152|NCT04701814|3548814|FG000|NOT COMPLETED|Overall Study||5
2847153|NCT04701814|3548815|FG001|NOT COMPLETED|Overall Study||3
2847160|NCT04697888|3548832|FG000|STARTED|Overall Study||2
2847161|NCT04697888|3548832|FG000|COMPLETED|Overall Study||2
2847162|NCT04697888|3548832|FG000|NOT COMPLETED|Overall Study||0
2847182|NCT04673214|3548860|FG000|STARTED|Overall Study||67
2847183|NCT04673214|3548861|FG001|STARTED|Overall Study||47
2847184|NCT04673214|3548860|FG000|Lost to Follow up|Overall Study|These patients were discontinued, given in the first days of their follow-up by video call, they presented major symptoms such as dyspnea of movement, dyspnea at rest, and chest pain; Following the protocol's follow-up criteria, patients were informed of their clinical care at the hospital level immediately, and the protocol was no longer followed. Subsequently, when capturing information in the data analysis, the clinical status of the patients is searched, registering their death.|2
2847185|NCT04673214|3548861|FG001|Lost to Follow up|Overall Study|This patient was stopped being followed up in the first days of his follow-up by video call. He presented major symptoms such as dyspnea of movement, dyspnea at rest, and chest pain; With the follow-up criteria of the protocol, the patient was informed of their clinical care at the hospital level immediately, and the protocol was no longer followed. Subsequently, when capturing information in the data analysis, the clinical status of the patient is searched, registering death.|1
2847186|NCT04673214|3548860|FG000|COMPLETED|Overall Study||65
2847187|NCT04673214|3548861|FG001|COMPLETED|Overall Study||46
2847188|NCT04673214|3548860|FG000|NOT COMPLETED|Overall Study||2
2847189|NCT04673214|3548861|FG001|NOT COMPLETED|Overall Study||1
2847202|NCT04668352|3548880|FG000|STARTED|Overall Study||511
2847203|NCT04668352|3548881|FG001|STARTED|Overall Study||513
2847204|NCT04668352|3548880|FG000|COMPLETED|Overall Study||510
2847205|NCT04668352|3548881|FG001|COMPLETED|Overall Study||511
2847206|NCT04668352|3548880|FG000|NOT COMPLETED|Overall Study||1
2847207|NCT04668352|3548881|FG001|NOT COMPLETED|Overall Study||2
2847222|NCT04653766|3548896|FG004|NOT COMPLETED|Overall Study||0
2917357|NCT00519376|3627407|FG001|NOT COMPLETED|Washout Period 3||0
2917358|NCT00519376|3627408|FG002|NOT COMPLETED|Washout Period 3||0
2917359|NCT00519376|3627409|FG003|NOT COMPLETED|Washout Period 3||0
2917360|NCT00519376|3627410|FG004|NOT COMPLETED|Washout Period 3||0
2917361|NCT00519376|3627411|FG005|NOT COMPLETED|Washout Period 3||0
2917362|NCT00519376|3627412|FG006|NOT COMPLETED|Washout Period 3||0
2917363|NCT00519376|3627413|FG007|NOT COMPLETED|Washout Period 3||0
2917364|NCT00519376|3627414|FG008|NOT COMPLETED|Washout Period 3||0
2917365|NCT00519376|3627415|FG009|NOT COMPLETED|Washout Period 3||0
2917366|NCT00519376|3627416|FG010|NOT COMPLETED|Washout Period 3||0
2917367|NCT00519376|3627417|FG011|NOT COMPLETED|Washout Period 3||0
2917368|NCT00519376|3627418|FG012|NOT COMPLETED|Washout Period 3||0
2917369|NCT00519376|3627419|FG013|NOT COMPLETED|Washout Period 3||0
2917370|NCT00519376|3627420|FG014|NOT COMPLETED|Washout Period 3||0
2917371|NCT00519376|3627421|FG015|NOT COMPLETED|Washout Period 3||0
2917372|NCT00519376|3627406|FG000|STARTED|Treatment Period 4||2
2917373|NCT00519376|3627407|FG001|STARTED|Treatment Period 4||2
2917374|NCT00519376|3627408|FG002|STARTED|Treatment Period 4||2
2917375|NCT00519376|3627409|FG003|STARTED|Treatment Period 4||2
2917376|NCT00519376|3627410|FG004|STARTED|Treatment Period 4||1
3168212|NCT01917136|3895538|FG000|COMPLETED|Overall Study||21
3168213|NCT01917136|3895538|FG000|NOT COMPLETED|Overall Study||0
2917377|NCT00519376|3627411|FG005|STARTED|Treatment Period 4||1
2917378|NCT00519376|3627412|FG006|STARTED|Treatment Period 4||1
2917379|NCT00519376|3627413|FG007|STARTED|Treatment Period 4||1
2917380|NCT00519376|3627414|FG008|STARTED|Treatment Period 4||1
2917381|NCT00519376|3627415|FG009|STARTED|Treatment Period 4||1
2917382|NCT00519376|3627416|FG010|STARTED|Treatment Period 4||1
2917383|NCT00519376|3627417|FG011|STARTED|Treatment Period 4||1
2917384|NCT00519376|3627418|FG012|STARTED|Treatment Period 4||0
2917385|NCT00519376|3627419|FG013|STARTED|Treatment Period 4||1
2917386|NCT00519376|3627420|FG014|STARTED|Treatment Period 4||1
2917387|NCT00519376|3627421|FG015|STARTED|Treatment Period 4||1
2917388|NCT00519376|3627406|FG000|COMPLETED|Treatment Period 4||2
2917389|NCT00519376|3627407|FG001|COMPLETED|Treatment Period 4||2
2917390|NCT00519376|3627408|FG002|COMPLETED|Treatment Period 4||1
2917391|NCT00519376|3627409|FG003|COMPLETED|Treatment Period 4||2
2917392|NCT00519376|3627410|FG004|COMPLETED|Treatment Period 4||1
2917393|NCT00519376|3627411|FG005|COMPLETED|Treatment Period 4||1
2917394|NCT00519376|3627412|FG006|COMPLETED|Treatment Period 4||1
2917395|NCT00519376|3627413|FG007|COMPLETED|Treatment Period 4||1
2917396|NCT00519376|3627414|FG008|COMPLETED|Treatment Period 4||1
2917397|NCT00519376|3627415|FG009|COMPLETED|Treatment Period 4||1
3311716|NCT03054428|4045207|FG000|Completed Wk 16 End of Treatment (EOT)|Overall Study||80
2847223|NCT04646291|3548920|FG000|STARTED|Overall Study||272
2847224|NCT04646291|3548921|FG001|STARTED|Overall Study||70
2847225|NCT04646291|3548922|FG002|STARTED|Overall Study||8
2847226|NCT04646291|3548920|FG000|COMPLETED|Overall Study||272
2847227|NCT04646291|3548921|FG001|COMPLETED|Overall Study||70
2847228|NCT04646291|3548922|FG002|COMPLETED|Overall Study||8
2847229|NCT04646291|3548920|FG000|NOT COMPLETED|Overall Study||0
2847230|NCT04646291|3548921|FG001|NOT COMPLETED|Overall Study||0
2847231|NCT04646291|3548922|FG002|NOT COMPLETED|Overall Study||0
2847238|NCT04637997|3548948|FG000|STARTED|Overall Study||9
2847239|NCT04637997|3548949|FG001|STARTED|Overall Study||9
2847240|NCT04637997|3548948|FG000|COMPLETED|Overall Study||9
2847241|NCT04637997|3548949|FG001|COMPLETED|Overall Study||9
2847242|NCT04637997|3548948|FG000|NOT COMPLETED|Overall Study||0
2847243|NCT04637997|3548949|FG001|NOT COMPLETED|Overall Study||0
2847244|NCT04634903|3548962|FG000|STARTED|Overall Study||818
2847245|NCT04634903|3548963|FG001|STARTED|Overall Study||821
2847246|NCT04634903|3548964|FG002|STARTED|Overall Study||813
2847247|NCT04634903|3548962|FG000|COMPLETED|Overall Study||669
2847248|NCT04634903|3548963|FG001|COMPLETED|Overall Study||732
2847249|NCT04634903|3548964|FG002|COMPLETED|Overall Study||653
2847250|NCT04634903|3548962|FG000|NOT COMPLETED|Overall Study||149
2847251|NCT04634903|3548963|FG001|NOT COMPLETED|Overall Study||89
2847252|NCT04634903|3548964|FG002|NOT COMPLETED|Overall Study||160
2847274|NCT04628221|3548995|FG000|STARTED|Overall Study||40
2847275|NCT04628221|3548995|FG000|COMPLETED|Overall Study||40
2847276|NCT04628221|3548995|FG000|NOT COMPLETED|Overall Study||0
2847277|NCT04625426|3549002|FG000|STARTED|Overall Study||23
2847278|NCT04625426|3549003|FG001|STARTED|Overall Study||37
2847279|NCT04625426|3549004|FG002|STARTED|Overall Study||24
2847280|NCT04625426|3549002|FG000|COMPLETED|Overall Study||9
2847281|NCT04625426|3549003|FG001|COMPLETED|Overall Study||12
2847282|NCT04625426|3549004|FG002|COMPLETED|Overall Study||12
2847283|NCT04625426|3549002|FG000|NOT COMPLETED|Overall Study||14
2847284|NCT04625426|3549003|FG001|NOT COMPLETED|Overall Study||25
2847285|NCT04625426|3549004|FG002|NOT COMPLETED|Overall Study||12
2847286|NCT04617509|3549012|FG000|STARTED|Period 1: Part 1 Formulation A||14
2847287|NCT04617509|3549013|FG001|STARTED|Period 1: Part 1 Formulation A||0
2847288|NCT04617509|3549014|FG002|STARTED|Period 1: Part 1 Formulation A|Subjects were expected to participate in both Part I and Part II, seven visits in total. Subject 112 was prematurely withdrawn from the study due to self-reported Covid-19-like symptoms via phone after Visit 5, i.e. after receiving both GS-248 formulations but prior to the food interaction part. This means subject 112 was withdrawn after Part I Formulation B but before Part II which cannot be visualized in the Period section. The correct number of subjects started Part II is thus 13.|0
2847289|NCT04617509|3549012|FG000|COMPLETED|Period 1: Part 1 Formulation A||14
2847290|NCT04617509|3549013|FG001|COMPLETED|Period 1: Part 1 Formulation A||0
2847291|NCT04617509|3549014|FG002|COMPLETED|Period 1: Part 1 Formulation A||0
2847292|NCT04617509|3549012|FG000|NOT COMPLETED|Period 1: Part 1 Formulation A||0
2847293|NCT04617509|3549013|FG001|NOT COMPLETED|Period 1: Part 1 Formulation A||0
2847294|NCT04617509|3549014|FG002|NOT COMPLETED|Period 1: Part 1 Formulation A||0
2847295|NCT04617509|3549012|FG000|STARTED|Period 2: Part 1 Formulation B||0
2847296|NCT04617509|3549013|FG001|STARTED|Period 2: Part 1 Formulation B||14
2847297|NCT04617509|3549014|FG002|STARTED|Period 2: Part 1 Formulation B||0
2847298|NCT04617509|3549012|FG000|COMPLETED|Period 2: Part 1 Formulation B||0
2847299|NCT04617509|3549013|FG001|COMPLETED|Period 2: Part 1 Formulation B||14
2847300|NCT04617509|3549014|FG002|COMPLETED|Period 2: Part 1 Formulation B||0
2847301|NCT04617509|3549012|FG000|NOT COMPLETED|Period 2: Part 1 Formulation B||0
2847302|NCT04617509|3549013|FG001|NOT COMPLETED|Period 2: Part 1 Formulation B||0
2847303|NCT04617509|3549014|FG002|NOT COMPLETED|Period 2: Part 1 Formulation B||0
2847304|NCT04617509|3549012|FG000|STARTED|Period 3: Part 2 Formulation A Fed Cond.||0
2847305|NCT04617509|3549013|FG001|STARTED|Period 3: Part 2 Formulation A Fed Cond.||0
2847306|NCT04617509|3549014|FG002|STARTED|Period 3: Part 2 Formulation A Fed Cond.||14
2847307|NCT04617509|3549012|FG000|COMPLETED|Period 3: Part 2 Formulation A Fed Cond.||0
2847308|NCT04617509|3549013|FG001|COMPLETED|Period 3: Part 2 Formulation A Fed Cond.||0
2847309|NCT04617509|3549014|FG002|COMPLETED|Period 3: Part 2 Formulation A Fed Cond.||13
2847310|NCT04617509|3549012|FG000|NOT COMPLETED|Period 3: Part 2 Formulation A Fed Cond.||0
2847311|NCT04617509|3549013|FG001|NOT COMPLETED|Period 3: Part 2 Formulation A Fed Cond.||0
2847312|NCT04617509|3549014|FG002|NOT COMPLETED|Period 3: Part 2 Formulation A Fed Cond.||1
2847322|NCT04610489|3549037|FG000|STARTED|Overall Study||117
2847323|NCT04610489|3549037|FG000|COMPLETED|Overall Study||117
2847324|NCT04610489|3549037|FG000|NOT COMPLETED|Overall Study||0
2847334|NCT04599959|3549055|FG000|STARTED|Overall Study||151
2847335|NCT04599959|3549055|FG000|COMPLETED|Overall Study||151
2847336|NCT04599959|3549055|FG000|NOT COMPLETED|Overall Study||0
2847337|NCT04596085|3549063|FG000|STARTED|Overall Study||59
2847338|NCT04596085|3549064|FG001|STARTED|Overall Study||59
2847339|NCT04596085|3549063|FG000|COMPLETED|Overall Study||59
2847340|NCT04596085|3549064|FG001|COMPLETED|Overall Study||59
2847341|NCT04596085|3549063|FG000|NOT COMPLETED|Overall Study||0
2847342|NCT04596085|3549064|FG001|NOT COMPLETED|Overall Study||0
2847343|NCT04590027|3549074|FG000|STARTED|Overall Study||47
2847344|NCT04590027|3549075|FG001|STARTED|Overall Study||39
2847345|NCT04590027|3549074|FG000|COMPLETED|Overall Study||30
2847346|NCT04590027|3549075|FG001|COMPLETED|Overall Study||22
2847347|NCT04590027|3549074|FG000|NOT COMPLETED|Overall Study||17
2847348|NCT04590027|3549075|FG001|NOT COMPLETED|Overall Study||17
2847232|NCT04646109|3548938|FG000|STARTED|Overall Study||30
2847233|NCT04646109|3548939|FG001|STARTED|Overall Study||36
2847234|NCT04646109|3548938|FG000|COMPLETED|Overall Study||30
2847235|NCT04646109|3548939|FG001|COMPLETED|Overall Study||30
2847236|NCT04646109|3548938|FG000|NOT COMPLETED|Overall Study||0
2847237|NCT04646109|3548939|FG001|NOT COMPLETED|Overall Study||6
2847253|NCT04633642|3548974|FG000|STARTED|Overall Study|27 participants|27
2847254|NCT04633642|3548975|FG001|STARTED|Overall Study|24 participants|24
2847255|NCT04633642|3548974|FG000|COMPLETED|Overall Study|26 participants|26
2847256|NCT04633642|3548975|FG001|COMPLETED|Overall Study|22 participants|22
2847257|NCT04633642|3548974|FG000|NOT COMPLETED|Overall Study||1
2847258|NCT04633642|3548975|FG001|NOT COMPLETED|Overall Study||2
2847259|NCT04633564|3548983|FG000|STARTED|Period 1||335
2847260|NCT04633564|3548984|FG001|STARTED|Period 1||329
2847261|NCT04633564|3548983|FG000|COMPLETED|Period 1||227
2847262|NCT04633564|3548984|FG001|COMPLETED|Period 1||220
2847263|NCT04633564|3548983|FG000|NOT COMPLETED|Period 1||108
2847264|NCT04633564|3548984|FG001|NOT COMPLETED|Period 1||109
2847265|NCT04633564|3548983|FG000|STARTED|Period 2||200
2847266|NCT04633564|3548984|FG001|STARTED|Period 2||199
2847267|NCT04633564|3548983|FG000|COMPLETED|Period 2||107
2847268|NCT04633564|3548984|FG001|COMPLETED|Period 2||102
2847269|NCT04633564|3548983|FG000|NOT COMPLETED|Period 2||93
2847270|NCT04633564|3548984|FG001|NOT COMPLETED|Period 2||97
2847271|NCT04633174|3548990|FG000|STARTED|Overall Study||1
2847272|NCT04633174|3548990|FG000|COMPLETED|Overall Study||1
2847273|NCT04633174|3548990|FG000|NOT COMPLETED|Overall Study||0
2847313|NCT04616430|3549027|FG000|STARTED|Overall Study||30
2847314|NCT04616430|3549028|FG001|STARTED|Overall Study||30
2847315|NCT04616430|3549029|FG002|STARTED|Overall Study||30
2847316|NCT04616430|3549027|FG000|COMPLETED|Overall Study||23
2847317|NCT04616430|3549028|FG001|COMPLETED|Overall Study||2
2847318|NCT04616430|3549029|FG002|COMPLETED|Overall Study||0
2847319|NCT04616430|3549027|FG000|NOT COMPLETED|Overall Study||7
2847320|NCT04616430|3549028|FG001|NOT COMPLETED|Overall Study||28
2847321|NCT04616430|3549029|FG002|NOT COMPLETED|Overall Study||30
2847325|NCT04608500|3549044|FG000|STARTED|Overall Study||514
2847326|NCT04608500|3549045|FG001|STARTED|Overall Study||257
2847327|NCT04608500|3549044|FG000|COMPLETED|Overall Study||479
2847328|NCT04608500|3549045|FG001|COMPLETED|Overall Study||239
2847329|NCT04608500|3549044|FG000|NOT COMPLETED|Overall Study||35
2847330|NCT04608500|3549045|FG001|NOT COMPLETED|Overall Study||18
2847349|NCT04578457|3549085|FG000|STARTED|Hearing Aid Without NR Enabled (0)||19
2847350|NCT04578457|3549085|FG000|COMPLETED|Hearing Aid Without NR Enabled (0)||17
2847351|NCT04578457|3549085|FG000|NOT COMPLETED|Hearing Aid Without NR Enabled (0)||2
2847352|NCT04578457|3549085|FG000|STARTED|Hearing Aid With NR (1)||19
2847353|NCT04578457|3549085|FG000|COMPLETED|Hearing Aid With NR (1)||17
2847354|NCT04578457|3549085|FG000|NOT COMPLETED|Hearing Aid With NR (1)||2
2847355|NCT04578457|3549085|FG000|STARTED|Hearing Aid With NR (2)||19
2847356|NCT04578457|3549085|FG000|COMPLETED|Hearing Aid With NR (2)||17
2847357|NCT04578457|3549085|FG000|NOT COMPLETED|Hearing Aid With NR (2)||2
2847358|NCT04578457|3549085|FG000|STARTED|Hearing Aid With NR (4)||19
2847359|NCT04578457|3549085|FG000|COMPLETED|Hearing Aid With NR (4)||17
2847360|NCT04578457|3549085|FG000|NOT COMPLETED|Hearing Aid With NR (4)||2
2917398|NCT00519376|3627416|FG010|COMPLETED|Treatment Period 4||1
2917399|NCT00519376|3627417|FG011|COMPLETED|Treatment Period 4||1
2917400|NCT00519376|3627418|FG012|COMPLETED|Treatment Period 4||0
2917401|NCT00519376|3627419|FG013|COMPLETED|Treatment Period 4||1
2917402|NCT00519376|3627420|FG014|COMPLETED|Treatment Period 4||1
2917403|NCT00519376|3627421|FG015|COMPLETED|Treatment Period 4||1
2917404|NCT00519376|3627406|FG000|NOT COMPLETED|Treatment Period 4||0
2917405|NCT00519376|3627407|FG001|NOT COMPLETED|Treatment Period 4||0
2917406|NCT00519376|3627408|FG002|NOT COMPLETED|Treatment Period 4||1
2917407|NCT00519376|3627409|FG003|NOT COMPLETED|Treatment Period 4||0
2917408|NCT00519376|3627410|FG004|NOT COMPLETED|Treatment Period 4||0
2917409|NCT00519376|3627411|FG005|NOT COMPLETED|Treatment Period 4||0
2917410|NCT00519376|3627412|FG006|NOT COMPLETED|Treatment Period 4||0
2917411|NCT00519376|3627413|FG007|NOT COMPLETED|Treatment Period 4||0
2917412|NCT00519376|3627414|FG008|NOT COMPLETED|Treatment Period 4||0
2917413|NCT00519376|3627415|FG009|NOT COMPLETED|Treatment Period 4||0
2917414|NCT00519376|3627416|FG010|NOT COMPLETED|Treatment Period 4||0
2917415|NCT00519376|3627417|FG011|NOT COMPLETED|Treatment Period 4||0
2917416|NCT00519376|3627418|FG012|NOT COMPLETED|Treatment Period 4||0
2917417|NCT00519376|3627419|FG013|NOT COMPLETED|Treatment Period 4||0
2917418|NCT00519376|3627420|FG014|NOT COMPLETED|Treatment Period 4||0
2917419|NCT00519376|3627421|FG015|NOT COMPLETED|Treatment Period 4||0
2917420|NCT00519428|3627436|FG000|STARTED|Overall Study||78
2917421|NCT00519428|3627437|FG001|STARTED|Overall Study||84
2917422|NCT00519428|3627438|FG002|STARTED|Overall Study||83
2917423|NCT00519428|3627436|FG000|COMPLETED|Overall Study||57
2917424|NCT00519428|3627437|FG001|COMPLETED|Overall Study||69
2917425|NCT00519428|3627438|FG002|COMPLETED|Overall Study||58
2917426|NCT00519428|3627436|FG000|NOT COMPLETED|Overall Study||21
2917427|NCT00519428|3627437|FG001|NOT COMPLETED|Overall Study||15
2917428|NCT00519428|3627438|FG002|NOT COMPLETED|Overall Study||25
2917429|NCT00519532|3627449|FG000|STARTED|Overall Study||84
2917430|NCT00519532|3627449|FG000|COMPLETED|Overall Study||66
2917431|NCT00519532|3627449|FG000|NOT COMPLETED|Overall Study||18
2917432|NCT00519584|3627457|FG000|STARTED|Overall Study||54
2917433|NCT00519584|3627458|FG001|STARTED|Overall Study||54
2917434|NCT00519584|3627459|FG002|STARTED|Overall Study||54
2847331|NCT04607291|3549051|FG000|STARTED|Overall Study||183
2847332|NCT04607291|3549051|FG000|COMPLETED|Overall Study||183
2847333|NCT04607291|3549051|FG000|NOT COMPLETED|Overall Study||0
2847361|NCT04578496|3549093|FG000|STARTED|Overall Study||16
2847362|NCT04578496|3549093|FG000|COMPLETED|Overall Study||12
2847363|NCT04578496|3549093|FG000|NOT COMPLETED|Overall Study||4
2917435|NCT00519584|3627460|FG003|STARTED|Overall Study||56
2917436|NCT00519584|3627457|FG000|COMPLETED|Overall Study||54
2917437|NCT00519584|3627458|FG001|COMPLETED|Overall Study||54
2917438|NCT00519584|3627459|FG002|COMPLETED|Overall Study||54
2917439|NCT00519584|3627460|FG003|COMPLETED|Overall Study||56
2917440|NCT00519584|3627457|FG000|NOT COMPLETED|Overall Study||0
2917441|NCT00519584|3627458|FG001|NOT COMPLETED|Overall Study||0
2917442|NCT00519584|3627459|FG002|NOT COMPLETED|Overall Study||0
2917443|NCT00519584|3627460|FG003|NOT COMPLETED|Overall Study||0
2917444|NCT00519623|3627470|FG000|STARTED|Overall Study||9
2917445|NCT00519623|3627470|FG000|COMPLETED|Overall Study||8
2917446|NCT00519623|3627470|FG000|NOT COMPLETED|Overall Study||1
2917447|NCT00519636|3627478|FG000|STARTED|Treatment Period 1||91
2917448|NCT00519636|3627479|FG001|STARTED|Treatment Period 1||86
2917449|NCT00519636|3627480|FG002|STARTED|Treatment Period 1||90
2917450|NCT00519636|3627481|FG003|STARTED|Treatment Period 1||93
2917451|NCT00519636|3627478|FG000|COMPLETED|Treatment Period 1||89
2917452|NCT00519636|3627479|FG001|COMPLETED|Treatment Period 1||86
2917453|NCT00519636|3627480|FG002|COMPLETED|Treatment Period 1||89
2917454|NCT00519636|3627481|FG003|COMPLETED|Treatment Period 1||93
2917455|NCT00519636|3627478|FG000|NOT COMPLETED|Treatment Period 1||2
2917456|NCT00519636|3627479|FG001|NOT COMPLETED|Treatment Period 1||0
2917457|NCT00519636|3627480|FG002|NOT COMPLETED|Treatment Period 1||1
2917458|NCT00519636|3627481|FG003|NOT COMPLETED|Treatment Period 1||0
2917459|NCT00519636|3627478|FG000|STARTED|Washout Period||89
2917460|NCT00519636|3627479|FG001|STARTED|Washout Period||86
2917461|NCT00519636|3627480|FG002|STARTED|Washout Period||89
2917462|NCT00519636|3627481|FG003|STARTED|Washout Period||93
2917463|NCT00519636|3627478|FG000|COMPLETED|Washout Period||69
2917464|NCT00519636|3627479|FG001|COMPLETED|Washout Period||72
2917465|NCT00519636|3627480|FG002|COMPLETED|Washout Period||75
2917466|NCT00519636|3627481|FG003|COMPLETED|Washout Period||88
2917467|NCT00519636|3627478|FG000|NOT COMPLETED|Washout Period||20
2917468|NCT00519636|3627479|FG001|NOT COMPLETED|Washout Period||14
2917469|NCT00519636|3627480|FG002|NOT COMPLETED|Washout Period||14
2917470|NCT00519636|3627481|FG003|NOT COMPLETED|Washout Period||5
2917471|NCT00519636|3627478|FG000|STARTED|Treatment Period 2||69
2917472|NCT00519636|3627479|FG001|STARTED|Treatment Period 2||72
2917473|NCT00519636|3627480|FG002|STARTED|Treatment Period 2||75
2917474|NCT00519636|3627481|FG003|STARTED|Treatment Period 2||88
2917475|NCT00519636|3627478|FG000|COMPLETED|Treatment Period 2||69
2917476|NCT00519636|3627479|FG001|COMPLETED|Treatment Period 2||71
2917477|NCT00519636|3627480|FG002|COMPLETED|Treatment Period 2||74
2917478|NCT00519636|3627481|FG003|COMPLETED|Treatment Period 2||86
3168214|NCT01917188|3895545|FG000|STARTED|Overall Study||29
3168215|NCT01917188|3895546|FG001|STARTED|Overall Study||23
3168216|NCT01917188|3895547|FG002|STARTED|Overall Study||20
3168217|NCT01917188|3895545|FG000|COMPLETED|Overall Study||17
3168218|NCT01917188|3895546|FG001|COMPLETED|Overall Study||17
2917479|NCT00519636|3627478|FG000|NOT COMPLETED|Treatment Period 2||0
2917480|NCT00519636|3627479|FG001|NOT COMPLETED|Treatment Period 2||1
2917481|NCT00519636|3627480|FG002|NOT COMPLETED|Treatment Period 2||1
2917482|NCT00519636|3627481|FG003|NOT COMPLETED|Treatment Period 2||2
2917483|NCT00519636|3627478|FG000|STARTED|Post Study Period||69
2917484|NCT00519636|3627479|FG001|STARTED|Post Study Period||71
2917485|NCT00519636|3627480|FG002|STARTED|Post Study Period||74
2917486|NCT00519636|3627481|FG003|STARTED|Post Study Period||86
2917487|NCT00519636|3627478|FG000|COMPLETED|Post Study Period||69
2917488|NCT00519636|3627479|FG001|COMPLETED|Post Study Period||71
2917489|NCT00519636|3627480|FG002|COMPLETED|Post Study Period||74
2917490|NCT00519636|3627481|FG003|COMPLETED|Post Study Period||85
2917491|NCT00519636|3627478|FG000|NOT COMPLETED|Post Study Period||0
2917492|NCT00519636|3627479|FG001|NOT COMPLETED|Post Study Period||0
2917493|NCT00519636|3627480|FG002|NOT COMPLETED|Post Study Period||0
2917494|NCT00519636|3627481|FG003|NOT COMPLETED|Post Study Period||1
2917495|NCT00519649|3627495|FG000|STARTED|Overall Study||300
2917496|NCT00519649|3627495|FG000|COMPLETED|Overall Study||299
2917497|NCT00519649|3627495|FG000|NOT COMPLETED|Overall Study||1
2917498|NCT00519779|3627501|FG000|STARTED|Overall Study||34
2917499|NCT00519779|3627502|FG001|STARTED|Overall Study||34
2917500|NCT00519779|3627501|FG000|COMPLETED|Overall Study||34
2917501|NCT00519779|3627502|FG001|COMPLETED|Overall Study||33
2917502|NCT00519779|3627501|FG000|NOT COMPLETED|Overall Study||0
2917503|NCT00519779|3627502|FG001|NOT COMPLETED|Overall Study||1
2917504|NCT00519818|3627508|FG000|STARTED|Overall Study||14
2917505|NCT00519818|3627508|FG000|COMPLETED|Overall Study||14
2917506|NCT00519818|3627508|FG000|NOT COMPLETED|Overall Study||0
2917507|NCT00519831|3627514|FG000|STARTED|Overall Study||16
2917508|NCT00519831|3627514|FG000|COMPLETED|Overall Study||13
2917509|NCT00519831|3627514|FG000|NOT COMPLETED|Overall Study||3
2917510|NCT00519896|3627518|FG000|STARTED|Overall Study||35
2917511|NCT00519896|3627518|FG000|COMPLETED|Overall Study||33
2917512|NCT00519896|3627518|FG000|NOT COMPLETED|Overall Study||2
3168219|NCT01917188|3895547|FG002|COMPLETED|Overall Study||11
3168220|NCT01917188|3895545|FG000|NOT COMPLETED|Overall Study||12
3168221|NCT01917188|3895546|FG001|NOT COMPLETED|Overall Study||6
2847364|NCT04577183|3549097|FG000|STARTED|Overall Study||13
2847365|NCT04577183|3549097|FG000|COMPLETED|Overall Study||7
2847366|NCT04577183|3549097|FG000|NOT COMPLETED|Overall Study||6
2917513|NCT00520013|3627525|FG000|STARTED|Overall Study||23
2917514|NCT00520013|3627526|FG001|STARTED|Overall Study||25
2917515|NCT00520013|3627527|FG002|STARTED|Overall Study|Excludes a pt who went off-study (on reg day) due to consent that may not have been informed (ESL).|11
2917516|NCT00520013|3627525|FG000|Treated|Overall Study||23
2917517|NCT00520013|3627526|FG001|Treated|Overall Study||25
2917518|NCT00520013|3627527|FG002|Treated|Overall Study||11
2917519|NCT00520013|3627525|FG000|COMPLETED|Overall Study||11
2917520|NCT00520013|3627526|FG001|COMPLETED|Overall Study||10
2917521|NCT00520013|3627527|FG002|COMPLETED|Overall Study||0
2917522|NCT00520013|3627525|FG000|NOT COMPLETED|Overall Study||12
2917523|NCT00520013|3627526|FG001|NOT COMPLETED|Overall Study||15
2917524|NCT00520013|3627527|FG002|NOT COMPLETED|Overall Study||11
2917525|NCT00520039|3627535|FG000|STARTED|Overall Study||28
2917526|NCT00520039|3627536|FG001|STARTED|Overall Study||24
2917527|NCT00520039|3627535|FG000|COMPLETED|Overall Study||21
2917528|NCT00520039|3627536|FG001|COMPLETED|Overall Study||19
2917529|NCT00520039|3627535|FG000|NOT COMPLETED|Overall Study||7
2917530|NCT00520039|3627536|FG001|NOT COMPLETED|Overall Study||5
2917531|NCT00520130|3627546|FG000|STARTED|Overall Study||44
2917532|NCT00520130|3627547|FG001|STARTED|Overall Study||45
2917533|NCT00520130|3627546|FG000|COMPLETED|Overall Study||39
2917534|NCT00520130|3627547|FG001|COMPLETED|Overall Study||44
2917535|NCT00520130|3627546|FG000|NOT COMPLETED|Overall Study||5
2917536|NCT00520130|3627547|FG001|NOT COMPLETED|Overall Study||1
2917537|NCT00520234|3627559|FG000|STARTED|Overall Study||118
2917538|NCT00520234|3627560|FG001|STARTED|Overall Study||104
2917539|NCT00520234|3627559|FG000|COMPLETED|Overall Study||117
2917540|NCT00520234|3627560|FG001|COMPLETED|Overall Study||102
2917541|NCT00520234|3627559|FG000|NOT COMPLETED|Overall Study||1
2917542|NCT00520234|3627560|FG001|NOT COMPLETED|Overall Study||2
2917543|NCT00520286|3627569|FG000|STARTED|Overall Study||142
2917544|NCT00520286|3627570|FG001|STARTED|Overall Study||68
2917545|NCT00520286|3627569|FG000|COMPLETED|Overall Study||76
2917546|NCT00520286|3627570|FG001|COMPLETED|Overall Study||36
2917547|NCT00520286|3627569|FG000|NOT COMPLETED|Overall Study||66
2917548|NCT00520286|3627570|FG001|NOT COMPLETED|Overall Study||32
2917549|NCT00520299|3627579|FG000|STARTED|Overall Study||6
2917550|NCT00520299|3627580|FG001|STARTED|Overall Study||6
2917551|NCT00520299|3627581|FG002|STARTED|Overall Study||19
2917552|NCT00520299|3627579|FG000|COMPLETED|Overall Study|Defined as completion of 1 treatment cycle|6
2917553|NCT00520299|3627580|FG001|COMPLETED|Overall Study||3
2917554|NCT00520299|3627581|FG002|COMPLETED|Overall Study||13
2917555|NCT00520299|3627579|FG000|NOT COMPLETED|Overall Study||0
2917556|NCT00520299|3627580|FG001|NOT COMPLETED|Overall Study||3
2917557|NCT00520299|3627581|FG002|NOT COMPLETED|Overall Study||6
2917558|NCT00520351|3627591|FG000|STARTED|First Intervention|Start date is Sep.06, 2007|15
2917559|NCT00520351|3627592|FG001|STARTED|First Intervention|Start date is Sep.06, 2007|15
2917560|NCT00520351|3627591|FG000|COMPLETED|First Intervention|End date is Feb.25, 2008|14
2917561|NCT00520351|3627592|FG001|COMPLETED|First Intervention|End date is Feb.25, 2008|14
2917562|NCT00520351|3627591|FG000|NOT COMPLETED|First Intervention||1
2917563|NCT00520351|3627592|FG001|NOT COMPLETED|First Intervention||1
2917564|NCT00520351|3627591|FG000|STARTED|Second Intervention||14
2917565|NCT00520351|3627592|FG001|STARTED|Second Intervention||14
2917566|NCT00520351|3627591|FG000|COMPLETED|Second Intervention||14
2917567|NCT00520351|3627592|FG001|COMPLETED|Second Intervention||14
2917568|NCT00520351|3627591|FG000|NOT COMPLETED|Second Intervention||0
2917569|NCT00520351|3627592|FG001|NOT COMPLETED|Second Intervention||0
2917570|NCT00520403|3627598|FG000|STARTED|Bevacizumab + IFN/Vinblastine||25
2917571|NCT00520403|3627598|FG000|COMPLETED|Bevacizumab + IFN/Vinblastine||7
2917572|NCT00520403|3627598|FG000|NOT COMPLETED|Bevacizumab + IFN/Vinblastine||18
2917573|NCT00520403|3627598|FG000|STARTED|Bevacizumab Monotherapy|2 of 7 participants completing Bevacizumab+IFN/vinblastine cycles initiated bevacizumab monotherapy|2
2917574|NCT00520403|3627598|FG000|COMPLETED|Bevacizumab Monotherapy||0
2917575|NCT00520403|3627598|FG000|NOT COMPLETED|Bevacizumab Monotherapy||2
2917576|NCT00520468|3627602|FG000|STARTED|Overall Study||14
2917577|NCT00520468|3627602|FG000|COMPLETED|Overall Study||14
2917578|NCT00520468|3627602|FG000|NOT COMPLETED|Overall Study||0
2917579|NCT00520481|3627608|FG000|STARTED|Overall Study||31
2917580|NCT00520481|3627609|FG001|STARTED|Overall Study||10
2917581|NCT00520481|3627608|FG000|Received at Least 1 Dose of Study Drug|Overall Study||31
2917582|NCT00520481|3627609|FG001|Received at Least 1 Dose of Study Drug|Overall Study||10
2917583|NCT00520481|3627608|FG000|COMPLETED|Overall Study||24
2917584|NCT00520481|3627609|FG001|COMPLETED|Overall Study||9
2917585|NCT00520481|3627608|FG000|NOT COMPLETED|Overall Study||7
2917586|NCT00520481|3627609|FG001|NOT COMPLETED|Overall Study||1
2917587|NCT00520494|3627617|FG000|STARTED|Overall Study||18
2917588|NCT00520494|3627617|FG000|COMPLETED|Overall Study||17
2917589|NCT00520494|3627617|FG000|NOT COMPLETED|Overall Study||1
2917590|NCT00520533|3627621|FG000|STARTED|Overall Study||8
2917591|NCT00520533|3627621|FG000|COMPLETED|Overall Study||4
2917592|NCT00520533|3627621|FG000|NOT COMPLETED|Overall Study||4
2917593|NCT00520546|3627626|FG000|STARTED|Overall Study||44
2917594|NCT00520546|3627626|FG000|COMPLETED|Overall Study||38
2917595|NCT00520546|3627626|FG000|NOT COMPLETED|Overall Study||6
2920744|NCT00538616|3631305|FG001|STARTED|Overall Study||3
2847367|NCT04574999|3549103|FG000|STARTED|Overall Study||114
2847368|NCT04574999|3549104|FG001|STARTED|Overall Study||53
2847369|NCT04574999|3549103|FG000|COMPLETED|Overall Study||105
2847370|NCT04574999|3549104|FG001|COMPLETED|Overall Study||48
2847371|NCT04574999|3549103|FG000|NOT COMPLETED|Overall Study||9
2847372|NCT04574999|3549104|FG001|NOT COMPLETED|Overall Study||5
2917596|NCT00520572|3627641|FG000|STARTED|Overall Study|Participants randomised. One of these participants did not subsequently receive treatment.|64
2917597|NCT00520572|3627642|FG001|STARTED|Overall Study|Participants randomised.|64
2917598|NCT00520572|3627643|FG002|STARTED|Overall Study|Participants randomised. One of these participants did not subsequently receive treatment.|64
2917599|NCT00520572|3627644|FG003|STARTED|Overall Study|Participants randomised.|64
2917600|NCT00520572|3627645|FG004|STARTED|Overall Study|Participants randomised.|65
2917601|NCT00520572|3627646|FG005|STARTED|Overall Study|Participants randomised.|64
2917602|NCT00520572|3627641|FG000|COMPLETED|Overall Study|Participants completed the study.|52
2917603|NCT00520572|3627642|FG001|COMPLETED|Overall Study|Participants completed the study.|50
2917604|NCT00520572|3627643|FG002|COMPLETED|Overall Study|Participants completed the study.|49
2917605|NCT00520572|3627644|FG003|COMPLETED|Overall Study|Participants completed the study.|50
2917606|NCT00520572|3627645|FG004|COMPLETED|Overall Study|Participants completed the study.|53
2917607|NCT00520572|3627646|FG005|COMPLETED|Overall Study|Participants completed the study.|62
2917608|NCT00520572|3627641|FG000|NOT COMPLETED|Overall Study||12
2917609|NCT00520572|3627642|FG001|NOT COMPLETED|Overall Study||14
2917610|NCT00520572|3627643|FG002|NOT COMPLETED|Overall Study||15
2917611|NCT00520572|3627644|FG003|NOT COMPLETED|Overall Study||14
2917612|NCT00520572|3627645|FG004|NOT COMPLETED|Overall Study||12
2917613|NCT00520572|3627646|FG005|NOT COMPLETED|Overall Study||2
2917614|NCT00520676|3627662|FG000|STARTED|Overall Study||128
2917615|NCT00520676|3627663|FG001|STARTED|Overall Study||132
2917616|NCT00520676|3627662|FG000|Received at Least 1 Dose of Study Drug|Overall Study||118
2917617|NCT00520676|3627663|FG001|Received at Least 1 Dose of Study Drug|Overall Study||127
2917618|NCT00520676|3627662|FG000|Qualified Intent-to-treat (Q-ITT)|Overall Study||106
2917619|NCT00520676|3627663|FG001|Qualified Intent-to-treat (Q-ITT)|Overall Study||105
2917620|NCT00520676|3627662|FG000|COMPLETED|Overall Study||27
2917621|NCT00520676|3627663|FG001|COMPLETED|Overall Study||29
2917622|NCT00520676|3627662|FG000|NOT COMPLETED|Overall Study||101
2917623|NCT00520676|3627663|FG001|NOT COMPLETED|Overall Study||103
2917624|NCT00520741|3627671|FG000|STARTED|Overall Study||106
2917625|NCT00520741|3627672|FG001|STARTED|Overall Study|One subject was randomized at 2 sites and excluded from the Safety Set.|319
2917626|NCT00520741|3627671|FG000|COMPLETED|Overall Study||69
2917627|NCT00520741|3627672|FG001|COMPLETED|Overall Study||194
2917628|NCT00520741|3627671|FG000|NOT COMPLETED|Overall Study||37
2917629|NCT00520741|3627672|FG001|NOT COMPLETED|Overall Study||125
2917630|NCT00520767|3627680|FG000|STARTED|Overall Study||35
2917631|NCT00520767|3627680|FG000|COMPLETED|Overall Study||33
2917632|NCT00520767|3627680|FG000|NOT COMPLETED|Overall Study||2
2917633|NCT00520845|3627684|FG000|STARTED|Overall Study||23
2917634|NCT00520845|3627684|FG000|COMPLETED|Overall Study||1
2917635|NCT00520845|3627684|FG000|NOT COMPLETED|Overall Study||22
2917636|NCT00520884|3627690|FG000|STARTED|Overall Study||3
2917637|NCT00520884|3627691|FG001|STARTED|Overall Study||2
2917638|NCT00520884|3627692|FG002|STARTED|Overall Study||2
2917639|NCT00520884|3627693|FG003|STARTED|Overall Study||3
2917640|NCT00520884|3627690|FG000|COMPLETED|Overall Study||3
2917641|NCT00520884|3627691|FG001|COMPLETED|Overall Study||2
2917642|NCT00520884|3627692|FG002|COMPLETED|Overall Study||2
2917643|NCT00520884|3627693|FG003|COMPLETED|Overall Study||3
2917644|NCT00520884|3627690|FG000|NOT COMPLETED|Overall Study||0
2917645|NCT00520884|3627691|FG001|NOT COMPLETED|Overall Study||0
2917646|NCT00520884|3627692|FG002|NOT COMPLETED|Overall Study||0
2917647|NCT00520884|3627693|FG003|NOT COMPLETED|Overall Study||0
2917648|NCT00520910|3627702|FG000|STARTED|Overall Study||5
2917649|NCT00520910|3627703|FG001|STARTED|Overall Study||5
2917650|NCT00520910|3627702|FG000|COMPLETED|Overall Study||5
2917651|NCT00520910|3627703|FG001|COMPLETED|Overall Study||5
2917652|NCT00520910|3627702|FG000|NOT COMPLETED|Overall Study||0
2917653|NCT00520910|3627703|FG001|NOT COMPLETED|Overall Study||0
2917654|NCT00520936|3627717|FG000|STARTED|Overall Study|75 participants entered the study and 72 were enrolled and received study drug.|10
2917655|NCT00520936|3627718|FG001|STARTED|Overall Study||11
2917656|NCT00520936|3627719|FG002|STARTED|Overall Study||9
2917657|NCT00520936|3627720|FG003|STARTED|Overall Study||5
2917658|NCT00520936|3627721|FG004|STARTED|Overall Study||6
2917659|NCT00520936|3627722|FG005|STARTED|Overall Study||10
2917660|NCT00520936|3627723|FG006|STARTED|Overall Study||11
2917661|NCT00520936|3627724|FG007|STARTED|Overall Study||10
2917662|NCT00520936|3627717|FG000|COMPLETED|Overall Study|Study completion defined as treated until disease progression. Completed=progressive disease.|10
2917663|NCT00520936|3627718|FG001|COMPLETED|Overall Study||7
2917664|NCT00520936|3627719|FG002|COMPLETED|Overall Study||7
2917665|NCT00520936|3627720|FG003|COMPLETED|Overall Study||5
2917666|NCT00520936|3627721|FG004|COMPLETED|Overall Study||5
2917667|NCT00520936|3627722|FG005|COMPLETED|Overall Study||10
2917668|NCT00520936|3627723|FG006|COMPLETED|Overall Study||7
2917669|NCT00520936|3627724|FG007|COMPLETED|Overall Study||9
2917670|NCT00520936|3627717|FG000|NOT COMPLETED|Overall Study||0
2917671|NCT00520936|3627718|FG001|NOT COMPLETED|Overall Study||4
2917672|NCT00520936|3627719|FG002|NOT COMPLETED|Overall Study||2
2917673|NCT00520936|3627720|FG003|NOT COMPLETED|Overall Study||0
2847373|NCT04572997|3549110|FG000|STARTED|Overall Study||21
2847374|NCT04572997|3549110|FG000|COMPLETED|Overall Study||20
2847375|NCT04572997|3549110|FG000|NOT COMPLETED|Overall Study||1
2847382|NCT04563767|3549127|FG000|STARTED|Overall Study||4
2847383|NCT04563767|3549127|FG000|COMPLETED|Overall Study||4
2847384|NCT04563767|3549127|FG000|NOT COMPLETED|Overall Study||0
2847385|NCT04560374|3549133|FG000|STARTED|Overall Study||50
2847386|NCT04560374|3549134|FG001|STARTED|Overall Study||50
2847387|NCT04560374|3549133|FG000|COMPLETED|Overall Study||50
2847388|NCT04560374|3549134|FG001|COMPLETED|Overall Study||50
2847389|NCT04560374|3549133|FG000|NOT COMPLETED|Overall Study||0
2847390|NCT04560374|3549134|FG001|NOT COMPLETED|Overall Study||0
2847391|NCT04555525|3549144|FG000|STARTED|Overall Study||75
2847392|NCT04555525|3549145|FG001|STARTED|Overall Study||25
2847393|NCT04555525|3549144|FG000|COMPLETED|Overall Study||72
2847394|NCT04555525|3549145|FG001|COMPLETED|Overall Study||25
2847395|NCT04555525|3549144|FG000|NOT COMPLETED|Overall Study||3
2847396|NCT04555525|3549145|FG001|NOT COMPLETED|Overall Study||0
2847415|NCT04548622|3549176|FG000|STARTED|Overall Study||15
2847416|NCT04548622|3549176|FG000|COMPLETED|Overall Study||15
2847417|NCT04548622|3549176|FG000|NOT COMPLETED|Overall Study||0
2847439|NCT04542694|3549211|FG000|STARTED|Overall Study||100
2847440|NCT04542694|3549212|FG001|STARTED|Overall Study||100
2847441|NCT04542694|3549211|FG000|COMPLETED|Overall Study||96
2847442|NCT04542694|3549212|FG001|COMPLETED|Overall Study||100
2847443|NCT04542694|3549211|FG000|NOT COMPLETED|Overall Study||4
2847444|NCT04542694|3549212|FG001|NOT COMPLETED|Overall Study||0
2847445|NCT04542226|3549218|FG000|STARTED|Overall Study||81
2847446|NCT04542226|3549218|FG000|COMPLETED|Overall Study||81
2847447|NCT04542226|3549218|FG000|NOT COMPLETED|Overall Study||0
2847472|NCT04534764|3549247|FG000|STARTED|Period 1||18
2847473|NCT04534764|3549248|FG001|STARTED|Period 1||17
2847474|NCT04534764|3549247|FG000|COMPLETED|Period 1||18
2847475|NCT04534764|3549248|FG001|COMPLETED|Period 1||17
2847476|NCT04534764|3549247|FG000|NOT COMPLETED|Period 1||0
2847477|NCT04534764|3549248|FG001|NOT COMPLETED|Period 1||0
2847478|NCT04534764|3549247|FG000|STARTED|Period 2||18
2847479|NCT04534764|3549248|FG001|STARTED|Period 2||17
2847480|NCT04534764|3549247|FG000|COMPLETED|Period 2||18
2847481|NCT04534764|3549248|FG001|COMPLETED|Period 2||17
2847482|NCT04534764|3549247|FG000|NOT COMPLETED|Period 2||0
2847483|NCT04534764|3549248|FG001|NOT COMPLETED|Period 2||0
2847484|NCT04534491|3549254|FG000|STARTED|Overall Study||855
2847485|NCT04534491|3549254|FG000|Treated|Overall Study||727
2847486|NCT04534491|3549254|FG000|COMPLETED|Overall Study||703
2847487|NCT04534491|3549254|FG000|NOT COMPLETED|Overall Study||152
2847488|NCT04534465|3549258|FG000|STARTED|Overall Study||10
2847489|NCT04534465|3549259|FG001|STARTED|Overall Study||10
2847490|NCT04534465|3549260|FG002|STARTED|Overall Study||10
2847491|NCT04534465|3549261|FG003|STARTED|Overall Study||10
2847492|NCT04534465|3549262|FG004|STARTED|Overall Study||10
2847493|NCT04534465|3549258|FG000|COMPLETED|Overall Study||10
2847494|NCT04534465|3549259|FG001|COMPLETED|Overall Study||10
2847495|NCT04534465|3549260|FG002|COMPLETED|Overall Study||10
2847496|NCT04534465|3549261|FG003|COMPLETED|Overall Study||10
2847497|NCT04534465|3549262|FG004|COMPLETED|Overall Study||10
2847498|NCT04534465|3549258|FG000|NOT COMPLETED|Overall Study||0
2847499|NCT04534465|3549259|FG001|NOT COMPLETED|Overall Study||0
2847500|NCT04534465|3549260|FG002|NOT COMPLETED|Overall Study||0
2847501|NCT04534465|3549261|FG003|NOT COMPLETED|Overall Study||0
2847502|NCT04534465|3549262|FG004|NOT COMPLETED|Overall Study||0
2847528|NCT04615832|3549304|FG000|STARTED|Overall Study||44
2847529|NCT04615832|3549304|FG000|COMPLETED|Overall Study||44
2847530|NCT04615832|3549304|FG000|NOT COMPLETED|Overall Study||0
2847531|NCT04432272|3549310|FG000|STARTED|Overall Study||33
2847532|NCT04432272|3549311|FG001|STARTED|Overall Study||21
2847533|NCT04432272|3549310|FG000|COMPLETED|Overall Study||33
2847534|NCT04432272|3549311|FG001|COMPLETED|Overall Study||21
2847535|NCT04432272|3549310|FG000|NOT COMPLETED|Overall Study||0
2847536|NCT04432272|3549311|FG001|NOT COMPLETED|Overall Study||0
2847537|NCT04246541|3549320|FG000|STARTED|Overall Study||25
2847538|NCT04246541|3549321|FG001|STARTED|Overall Study||23
2847539|NCT04246541|3549320|FG000|COMPLETED|Overall Study||22
2847540|NCT04246541|3549321|FG001|COMPLETED|Overall Study||20
2847541|NCT04246541|3549320|FG000|NOT COMPLETED|Overall Study||3
2847542|NCT04246541|3549321|FG001|NOT COMPLETED|Overall Study||3
2847543|NCT04093258|3549327|FG000|STARTED|Period 1||21
2847544|NCT04093258|3549328|FG001|STARTED|Period 1||20
2847545|NCT04093258|3549327|FG000|COMPLETED|Period 1||21
2847546|NCT04093258|3549328|FG001|COMPLETED|Period 1||20
2847547|NCT04093258|3549327|FG000|NOT COMPLETED|Period 1||0
2847548|NCT04093258|3549328|FG001|NOT COMPLETED|Period 1||0
2847549|NCT04093258|3549327|FG000|STARTED|Period 2||21
2847550|NCT04093258|3549328|FG001|STARTED|Period 2||20
2847551|NCT04093258|3549327|FG000|COMPLETED|Period 2||20
2847552|NCT04093258|3549328|FG001|COMPLETED|Period 2||20
2847553|NCT04093258|3549327|FG000|NOT COMPLETED|Period 2||1
2847554|NCT04093258|3549328|FG001|NOT COMPLETED|Period 2||0
2847555|NCT04011826|3549334|FG000|STARTED|Overall Study||45
2847556|NCT04011826|3549334|FG000|COMPLETED|Overall Study||45
2847557|NCT04011826|3549334|FG000|NOT COMPLETED|Overall Study||0
2847558|NCT03993379|3549342|FG000|STARTED|Overall Study||0
2847559|NCT03993379|3549343|FG001|STARTED|Overall Study||3
2847560|NCT03993379|3549344|FG002|STARTED|Overall Study||0
2847561|NCT03993379|3549345|FG003|STARTED|Overall Study||0
2847376|NCT04570670|3549120|FG000|STARTED|Overall Study||25
2847377|NCT04570670|3549121|FG001|STARTED|Overall Study||25
2847378|NCT04570670|3549120|FG000|COMPLETED|Overall Study||24
2847379|NCT04570670|3549121|FG001|COMPLETED|Overall Study||25
2847380|NCT04570670|3549120|FG000|NOT COMPLETED|Overall Study||1
2847381|NCT04570670|3549121|FG001|NOT COMPLETED|Overall Study||0
2847397|NCT04553497|3549153|FG000|STARTED|Overall Study||17
2847398|NCT04553497|3549154|FG001|STARTED|Overall Study||18
2847399|NCT04553497|3549153|FG000|COMPLETED|Overall Study||15
2847400|NCT04553497|3549154|FG001|COMPLETED|Overall Study||17
2847401|NCT04553497|3549153|FG000|NOT COMPLETED|Overall Study||2
2847402|NCT04553497|3549154|FG001|NOT COMPLETED|Overall Study||1
2847418|NCT04547036|3549180|FG000|STARTED|Overall Study||129
2847419|NCT04547036|3549180|FG000|COMPLETED|Overall Study||129
2847420|NCT04547036|3549180|FG000|NOT COMPLETED|Overall Study||0
2847448|NCT04540627|3549225|FG000|STARTED|Open-label Treatment: PK Sentinel|Participants were not enrolled in this arm in the double-blind period.|6
2847449|NCT04540627|3549226|FG001|STARTED|Open-label Treatment: PK Sentinel|Participants were not enrolled in this arm in the open-label period.|0
2847450|NCT04540627|3549227|FG002|STARTED|Open-label Treatment: PK Sentinel|Participants were not enrolled in this arm in the open-label period.|0
2847451|NCT04540627|3549225|FG000|COMPLETED|Open-label Treatment: PK Sentinel||6
2847452|NCT04540627|3549226|FG001|COMPLETED|Open-label Treatment: PK Sentinel||0
2847453|NCT04540627|3549227|FG002|COMPLETED|Open-label Treatment: PK Sentinel||0
2847454|NCT04540627|3549225|FG000|NOT COMPLETED|Open-label Treatment: PK Sentinel||0
2847455|NCT04540627|3549226|FG001|NOT COMPLETED|Open-label Treatment: PK Sentinel||0
2847456|NCT04540627|3549227|FG002|NOT COMPLETED|Open-label Treatment: PK Sentinel||0
2847457|NCT04540627|3549225|FG000|STARTED|Double-blind Treatment: Viral Challenge|Participants were not enrolled in this arm in the double-blind period.|0
2847458|NCT04540627|3549226|FG001|STARTED|Double-blind Treatment: Viral Challenge|Participants were not enrolled in this arm in the open-label period.|25
2847459|NCT04540627|3549227|FG002|STARTED|Double-blind Treatment: Viral Challenge|Participants were not enrolled in this arm in the open-label period.|25
2847460|NCT04540627|3549225|FG000|COMPLETED|Double-blind Treatment: Viral Challenge||0
2847461|NCT04540627|3549226|FG001|COMPLETED|Double-blind Treatment: Viral Challenge||25
2847462|NCT04540627|3549227|FG002|COMPLETED|Double-blind Treatment: Viral Challenge||25
2847463|NCT04540627|3549225|FG000|NOT COMPLETED|Double-blind Treatment: Viral Challenge||0
2847464|NCT04540627|3549226|FG001|NOT COMPLETED|Double-blind Treatment: Viral Challenge||0
2847465|NCT04540627|3549227|FG002|NOT COMPLETED|Double-blind Treatment: Viral Challenge||0
2847466|NCT04540510|3549240|FG000|STARTED|Overall Study||5
2847467|NCT04540510|3549241|FG001|STARTED|Overall Study||6
2847468|NCT04540510|3549240|FG000|COMPLETED|Overall Study||5
2847469|NCT04540510|3549241|FG001|COMPLETED|Overall Study||6
2847470|NCT04540510|3549240|FG000|NOT COMPLETED|Overall Study||0
2847471|NCT04540510|3549241|FG001|NOT COMPLETED|Overall Study||0
2847503|NCT04533204|3549276|FG000|STARTED|Overall Study||29
2847504|NCT04533204|3549277|FG001|STARTED|Overall Study||30
2847505|NCT04533204|3549276|FG000|COMPLETED|Overall Study||28
2847506|NCT04533204|3549277|FG001|COMPLETED|Overall Study||29
2847507|NCT04533204|3549276|FG000|NOT COMPLETED|Overall Study||1
2847508|NCT04533204|3549277|FG001|NOT COMPLETED|Overall Study||1
2847562|NCT03993379|3549342|FG000|COMPLETED|Overall Study|No subjects enrolled in this arm/group.|0
2847563|NCT03993379|3549343|FG001|COMPLETED|Overall Study|Subjects did not complete due to early termination of the study due to business reasons.|0
2847564|NCT03993379|3549344|FG002|COMPLETED|Overall Study|No subjects enrolled in this arm/group.|0
2847565|NCT03993379|3549345|FG003|COMPLETED|Overall Study|No subjects enrolled in this arm/group.|0
2847566|NCT03993379|3549342|FG000|NOT COMPLETED|Overall Study||0
2847567|NCT03993379|3549343|FG001|NOT COMPLETED|Overall Study||3
2847568|NCT03993379|3549344|FG002|NOT COMPLETED|Overall Study||0
2847569|NCT03993379|3549345|FG003|NOT COMPLETED|Overall Study||0
2847570|NCT03956615|3549355|FG000|STARTED|Overall Study||10
2847571|NCT03956615|3549355|FG000|COMPLETED|Overall Study||3
2847572|NCT03956615|3549355|FG000|NOT COMPLETED|Overall Study||7
2847573|NCT03803059|3549359|FG000|STARTED|Overall Study||35
2847574|NCT03803059|3549359|FG000|COMPLETED|Overall Study||32
2847575|NCT03803059|3549359|FG000|NOT COMPLETED|Overall Study||3
2847576|NCT03723590|3549364|FG000|STARTED|Overall Study||5
2847577|NCT03723590|3549364|FG000|COMPLETED|Overall Study||2
2847578|NCT03723590|3549364|FG000|NOT COMPLETED|Overall Study||3
2847579|NCT03720392|3549370|FG000|STARTED|Overall Study||3
2847580|NCT03720392|3549371|FG001|STARTED|Overall Study||3
2847581|NCT03720392|3549370|FG000|COMPLETED|Overall Study||3
2847582|NCT03720392|3549371|FG001|COMPLETED|Overall Study||3
2847583|NCT03720392|3549370|FG000|NOT COMPLETED|Overall Study||0
2847584|NCT03720392|3549371|FG001|NOT COMPLETED|Overall Study||0
2847585|NCT03515226|3549379|FG000|STARTED|Overall Study||10
2847586|NCT03515226|3549380|FG001|STARTED|Overall Study||15
2847587|NCT03515226|3549379|FG000|COMPLETED|Overall Study||8
2847588|NCT03515226|3549380|FG001|COMPLETED|Overall Study||11
2847589|NCT03515226|3549379|FG000|NOT COMPLETED|Overall Study||2
2847590|NCT03515226|3549380|FG001|NOT COMPLETED|Overall Study||4
2847591|NCT03430895|3549387|FG000|STARTED|Overall Study||15
2847592|NCT03430895|3549387|FG000|COMPLETED|Overall Study||13
2847593|NCT03430895|3549387|FG000|NOT COMPLETED|Overall Study||2
2847594|NCT03402841|3549391|FG000|STARTED|Overall Study||279
2847595|NCT03402841|3549391|FG000|COMPLETED|Overall Study||187
2847596|NCT03402841|3549391|FG000|NOT COMPLETED|Overall Study||92
2847597|NCT03388138|3549397|FG000|STARTED|Overall Study||94
2847403|NCT04551677|3549166|FG000|STARTED|Overall Study||29
2847404|NCT04551677|3549167|FG001|STARTED|Overall Study||31
2847405|NCT04551677|3549168|FG002|STARTED|Overall Study||30
2847406|NCT04551677|3549166|FG000|Vaccinated|Overall Study||29
2847407|NCT04551677|3549167|FG001|Vaccinated|Overall Study||31
2847408|NCT04551677|3549168|FG002|Vaccinated|Overall Study||30
2847409|NCT04551677|3549166|FG000|COMPLETED|Overall Study||29
2847410|NCT04551677|3549167|FG001|COMPLETED|Overall Study||31
2847411|NCT04551677|3549168|FG002|COMPLETED|Overall Study||30
2847412|NCT04551677|3549166|FG000|NOT COMPLETED|Overall Study||0
2847413|NCT04551677|3549167|FG001|NOT COMPLETED|Overall Study||0
2847414|NCT04551677|3549168|FG002|NOT COMPLETED|Overall Study||0
2847421|NCT04544566|3549190|FG000|STARTED|Overall Study||2
2847422|NCT04544566|3549191|FG001|STARTED|Overall Study||2
2847423|NCT04544566|3549192|FG002|STARTED|Overall Study||2
2847424|NCT04544566|3549193|FG003|STARTED|Overall Study||2
2847425|NCT04544566|3549194|FG004|STARTED|Overall Study||2
2847426|NCT04544566|3549195|FG005|STARTED|Overall Study||2
2847427|NCT04544566|3549190|FG000|COMPLETED|Overall Study||2
2847428|NCT04544566|3549191|FG001|COMPLETED|Overall Study||2
2847429|NCT04544566|3549192|FG002|COMPLETED|Overall Study||2
2847430|NCT04544566|3549193|FG003|COMPLETED|Overall Study||2
2847431|NCT04544566|3549194|FG004|COMPLETED|Overall Study||2
2847432|NCT04544566|3549195|FG005|COMPLETED|Overall Study||2
2847433|NCT04544566|3549190|FG000|NOT COMPLETED|Overall Study||0
2847434|NCT04544566|3549191|FG001|NOT COMPLETED|Overall Study||0
2847435|NCT04544566|3549192|FG002|NOT COMPLETED|Overall Study||0
2847436|NCT04544566|3549193|FG003|NOT COMPLETED|Overall Study||0
2847437|NCT04544566|3549194|FG004|NOT COMPLETED|Overall Study||0
2847438|NCT04544566|3549195|FG005|NOT COMPLETED|Overall Study||0
2847509|NCT04532164|3549283|FG000|STARTED|Overall Study||137
2847510|NCT04532164|3549283|FG000|Treated|Overall Study||132
2847511|NCT04532164|3549283|FG000|COMPLETED|Overall Study||113
2847512|NCT04532164|3549283|FG000|NOT COMPLETED|Overall Study||24
2847513|NCT04531813|3549288|FG000|STARTED|Overall Study||32
2847514|NCT04531813|3549288|FG000|Treated|Overall Study||31
2847515|NCT04531813|3549288|FG000|COMPLETED|Overall Study||30
2847516|NCT04531813|3549288|FG000|NOT COMPLETED|Overall Study||2
2847517|NCT04531527|3549292|FG000|STARTED|Overall Study||32
2847518|NCT04531527|3549292|FG000|Treated|Overall Study||29
2847519|NCT04531527|3549292|FG000|COMPLETED|Overall Study||29
2847520|NCT04531527|3549292|FG000|NOT COMPLETED|Overall Study||3
2847521|NCT04531540|3549296|FG000|STARTED|Overall Study||225
2847522|NCT04531540|3549296|FG000|Treated|Overall Study||222
2847523|NCT04531540|3549296|FG000|COMPLETED|Overall Study||216
2847524|NCT04531540|3549296|FG000|NOT COMPLETED|Overall Study||9
2847598|NCT03388138|3549398|FG001|STARTED|Overall Study||47
2847599|NCT03388138|3549397|FG000|COMPLETED|Overall Study||93
2847600|NCT03388138|3549398|FG001|COMPLETED|Overall Study||47
2847601|NCT03388138|3549397|FG000|NOT COMPLETED|Overall Study||1
2847602|NCT03388138|3549398|FG001|NOT COMPLETED|Overall Study||0
2847603|NCT03321617|3549408|FG000|STARTED|Overall Study||3
2847604|NCT03321617|3549409|FG001|STARTED|Overall Study||3
2847605|NCT03321617|3549410|FG002|STARTED|Overall Study||2
2847606|NCT03321617|3549411|FG003|STARTED|Overall Study||3
2847607|NCT03321617|3549408|FG000|COMPLETED|Overall Study||2
2847608|NCT03321617|3549409|FG001|COMPLETED|Overall Study||3
2847609|NCT03321617|3549410|FG002|COMPLETED|Overall Study||2
2847610|NCT03321617|3549411|FG003|COMPLETED|Overall Study||2
2847611|NCT03321617|3549408|FG000|NOT COMPLETED|Overall Study||1
2847612|NCT03321617|3549409|FG001|NOT COMPLETED|Overall Study||0
2847613|NCT03321617|3549410|FG002|NOT COMPLETED|Overall Study||0
2847614|NCT03321617|3549411|FG003|NOT COMPLETED|Overall Study||1
2847615|NCT03230838|3549423|FG000|STARTED|Overall Study||101
2847616|NCT03230838|3549424|FG001|STARTED|Overall Study||33
2847617|NCT03230838|3549423|FG000|Treated|Overall Study||100
2847618|NCT03230838|3549424|FG001|Treated|Overall Study||33
2847619|NCT03230838|3549423|FG000|COMPLETED|Overall Study||97
2847620|NCT03230838|3549424|FG001|COMPLETED|Overall Study||33
2847621|NCT03230838|3549423|FG000|NOT COMPLETED|Overall Study||4
2847622|NCT03230838|3549424|FG001|NOT COMPLETED|Overall Study||0
2847623|NCT03183778|3549430|FG000|STARTED|Overall Study||3
2847624|NCT03183778|3549430|FG000|COMPLETED|Overall Study||2
2847625|NCT03183778|3549430|FG000|NOT COMPLETED|Overall Study||1
2847626|NCT03113955|3549434|FG000|STARTED|Overall Study||109
2847627|NCT03113955|3549434|FG000|COMPLETED|Overall Study||92
2847628|NCT03113955|3549434|FG000|NOT COMPLETED|Overall Study||17
2847629|NCT03029234|3549438|FG000|STARTED|Overall Study||126
2847630|NCT03029234|3549438|FG000|Received Carfilzomib|Overall Study||123
2847631|NCT03029234|3549438|FG000|COMPLETED|Overall Study||59
2847632|NCT03029234|3549438|FG000|NOT COMPLETED|Overall Study||67
2847633|NCT02995694|3549445|FG000|STARTED|Overall Study||215
2847634|NCT02995694|3549446|FG001|STARTED|Overall Study||211
2847635|NCT02995694|3549447|FG002|STARTED|Overall Study||109
2847636|NCT02995694|3549445|FG000|COMPLETED|Overall Study||181
2847637|NCT02995694|3549446|FG001|COMPLETED|Overall Study||183
2847638|NCT02995694|3549447|FG002|COMPLETED|Overall Study||94
2847639|NCT02995694|3549445|FG000|NOT COMPLETED|Overall Study||34
2847640|NCT02995694|3549446|FG001|NOT COMPLETED|Overall Study||28
2847641|NCT02995694|3549447|FG002|NOT COMPLETED|Overall Study||15
2847642|NCT02937818|3549462|FG000|STARTED|Overall Study||21
2847643|NCT02937818|3549463|FG001|STARTED|Overall Study||20
2847644|NCT02937818|3549464|FG002|STARTED|Overall Study||10
2847645|NCT02937818|3549465|FG003|STARTED|Overall Study||21
2847525|NCT04530591|3549300|FG000|STARTED|Overall Study||97
2847526|NCT04530591|3549300|FG000|COMPLETED|Overall Study||97
2847527|NCT04530591|3549300|FG000|NOT COMPLETED|Overall Study||0
2847646|NCT02937818|3549462|FG000|COMPLETED|Overall Study||0
2847647|NCT02937818|3549463|FG001|COMPLETED|Overall Study||0
2847648|NCT02937818|3549464|FG002|COMPLETED|Overall Study||0
2847649|NCT02937818|3549465|FG003|COMPLETED|Overall Study||0
2847650|NCT02937818|3549462|FG000|NOT COMPLETED|Overall Study||21
2847651|NCT02937818|3549463|FG001|NOT COMPLETED|Overall Study||20
2847652|NCT02937818|3549464|FG002|NOT COMPLETED|Overall Study||10
2847653|NCT02937818|3549465|FG003|NOT COMPLETED|Overall Study||21
2847654|NCT02926833|3549482|FG000|STARTED|Overall Study||3
2847655|NCT02926833|3549483|FG001|STARTED|Overall Study||4
2847656|NCT02926833|3549484|FG002|STARTED|Overall Study||7
2847657|NCT02926833|3549485|FG003|STARTED|Overall Study||23
2847658|NCT02926833|3549482|FG000|COMPLETED|Overall Study||0
2847659|NCT02926833|3549483|FG001|COMPLETED|Overall Study||0
2847660|NCT02926833|3549484|FG002|COMPLETED|Overall Study||0
2847661|NCT02926833|3549485|FG003|COMPLETED|Overall Study||0
2847662|NCT02926833|3549482|FG000|NOT COMPLETED|Overall Study||3
2847663|NCT02926833|3549483|FG001|NOT COMPLETED|Overall Study||4
2847664|NCT02926833|3549484|FG002|NOT COMPLETED|Overall Study||7
2847665|NCT02926833|3549485|FG003|NOT COMPLETED|Overall Study||23
2917674|NCT00520936|3627721|FG004|NOT COMPLETED|Overall Study||1
2917675|NCT00520936|3627722|FG005|NOT COMPLETED|Overall Study||0
2917676|NCT00520936|3627723|FG006|NOT COMPLETED|Overall Study||4
2917677|NCT00520936|3627724|FG007|NOT COMPLETED|Overall Study||1
2917678|NCT00520975|3627737|FG000|STARTED|Overall Study||48
2917679|NCT00520975|3627738|FG001|STARTED|Overall Study||48
2917680|NCT00520975|3627737|FG000|Treated and Reported Adverse Events Data|Overall Study||47
2917681|NCT00520975|3627738|FG001|Treated and Reported Adverse Events Data|Overall Study||45
2917682|NCT00520975|3627737|FG000|COMPLETED|Overall Study|Treatment continued until progression or intolerable toxicity.|0
2917683|NCT00520975|3627738|FG001|COMPLETED|Overall Study|Treatment continued until progression or intolerable toxicity.|0
2917684|NCT00520975|3627737|FG000|NOT COMPLETED|Overall Study||48
2917685|NCT00520975|3627738|FG001|NOT COMPLETED|Overall Study||48
2917686|NCT00521001|3627744|FG000|STARTED|Overall Study||49
2917687|NCT00521001|3627744|FG000|COMPLETED|Overall Study||48
2917688|NCT00521001|3627744|FG000|NOT COMPLETED|Overall Study||1
2917689|NCT00521014|3627748|FG000|STARTED|Overall Study||14
2917690|NCT00521014|3627748|FG000|COMPLETED|Overall Study||13
2917691|NCT00521014|3627748|FG000|NOT COMPLETED|Overall Study||1
2917692|NCT00521053|3627752|FG000|STARTED|Treatment Phase||80
2917693|NCT00521053|3627752|FG000|Received 1 Cycle of PV-10|Treatment Phase||35
2917694|NCT00521053|3627752|FG000|Received 2 Cycles of PV-10|Treatment Phase||26
2917695|NCT00521053|3627752|FG000|Received 3 Cycles of PV-10|Treatment Phase||16
2917696|NCT00521053|3627752|FG000|Received 4 Cycles of PV-10|Treatment Phase||3
2917697|NCT00521053|3627752|FG000|COMPLETED|Treatment Phase||80
2917698|NCT00521053|3627752|FG000|NOT COMPLETED|Treatment Phase||0
2917699|NCT00521053|3627752|FG000|STARTED|Observation Phase||80
2917700|NCT00521053|3627752|FG000|COMPLETED|Observation Phase||12
2917701|NCT00521053|3627752|FG000|NOT COMPLETED|Observation Phase||68
2917702|NCT00521079|3627761|FG000|STARTED|Overall Study||192
2917703|NCT00521079|3627762|FG001|STARTED|Overall Study||102
2917704|NCT00521079|3627761|FG000|Surgical Roll-In|Overall Study||9
2917705|NCT00521079|3627762|FG001|Surgical Roll-In|Overall Study||5
2917706|NCT00521079|3627761|FG000|COMPLETED|Overall Study||178
2917707|NCT00521079|3627762|FG001|COMPLETED|Overall Study||97
2917708|NCT00521079|3627761|FG000|NOT COMPLETED|Overall Study||14
2917709|NCT00521079|3627762|FG001|NOT COMPLETED|Overall Study||5
2917710|NCT00521144|3627773|FG000|STARTED|Overall Study||6
2917711|NCT00521144|3627774|FG001|STARTED|Overall Study||5
2917712|NCT00521144|3627775|FG002|STARTED|Overall Study||3
2917713|NCT00521144|3627776|FG003|STARTED|Overall Study||1
2917714|NCT00521144|3627777|FG004|STARTED|Overall Study||7
2917715|NCT00521144|3627773|FG000|COMPLETED|Overall Study||2
2917716|NCT00521144|3627774|FG001|COMPLETED|Overall Study||2
2917717|NCT00521144|3627775|FG002|COMPLETED|Overall Study||1
2917718|NCT00521144|3627776|FG003|COMPLETED|Overall Study||0
2917719|NCT00521144|3627777|FG004|COMPLETED|Overall Study||0
2917720|NCT00521144|3627773|FG000|NOT COMPLETED|Overall Study||4
2917721|NCT00521144|3627774|FG001|NOT COMPLETED|Overall Study||3
2917722|NCT00521144|3627775|FG002|NOT COMPLETED|Overall Study||2
2917723|NCT00521144|3627776|FG003|NOT COMPLETED|Overall Study||1
2917724|NCT00521144|3627777|FG004|NOT COMPLETED|Overall Study||7
2920745|NCT00538616|3631304|FG000|COMPLETED|Overall Study||5
2920746|NCT00538616|3631305|FG001|COMPLETED|Overall Study||3
2920747|NCT00538616|3631304|FG000|NOT COMPLETED|Overall Study||0
2920748|NCT00538616|3631305|FG001|NOT COMPLETED|Overall Study||0
2920749|NCT00538629|3631311|FG000|STARTED|Overall Study||471
2920750|NCT00538629|3631311|FG000|COMPLETED|Overall Study||449
2920751|NCT00538629|3631311|FG000|NOT COMPLETED|Overall Study||22
2920752|NCT00538642|3631317|FG000|STARTED|Overall Study||10
2920753|NCT00538642|3631318|FG001|STARTED|Overall Study||14
2920754|NCT00538642|3631317|FG000|COMPLETED|Overall Study||9
2920755|NCT00538642|3631318|FG001|COMPLETED|Overall Study||9
2920756|NCT00538642|3631317|FG000|NOT COMPLETED|Overall Study||1
2920757|NCT00538642|3631318|FG001|NOT COMPLETED|Overall Study||5
2920758|NCT00538681|3631329|FG000|STARTED|Overall Study||9
2920759|NCT00538681|3631330|FG001|STARTED|Overall Study||4
2920760|NCT00538681|3631331|FG002|STARTED|Overall Study||11
2847666|NCT02700698|3549498|FG000|STARTED|Overall Study||17
2847667|NCT02700698|3549499|FG001|STARTED|Overall Study||18
2847668|NCT02700698|3549498|FG000|COMPLETED|Overall Study||16
2847669|NCT02700698|3549499|FG001|COMPLETED|Overall Study||18
2847670|NCT02700698|3549498|FG000|NOT COMPLETED|Overall Study||1
2847671|NCT02700698|3549499|FG001|NOT COMPLETED|Overall Study||0
2847672|NCT02699086|3549505|FG000|STARTED|Overall Study||0
2847673|NCT02699086|3549506|FG001|STARTED|Overall Study||6
2847674|NCT02699086|3549505|FG000|COMPLETED|Overall Study||0
2847675|NCT02699086|3549506|FG001|COMPLETED|Overall Study||6
2847676|NCT02699086|3549505|FG000|NOT COMPLETED|Overall Study||0
2847677|NCT02699086|3549506|FG001|NOT COMPLETED|Overall Study||0
2847678|NCT02698865|3549516|FG000|STARTED|Overall Study||140
2847679|NCT02698865|3549517|FG001|STARTED|Overall Study||80
2847680|NCT02698865|3549516|FG000|Treated|Overall Study||140
2847681|NCT02698865|3549517|FG001|Treated|Overall Study||80
2847682|NCT02698865|3549516|FG000|COMPLETED|Overall Study||105
2847683|NCT02698865|3549517|FG001|COMPLETED|Overall Study||47
2847684|NCT02698865|3549516|FG000|NOT COMPLETED|Overall Study||35
2847685|NCT02698865|3549517|FG001|NOT COMPLETED|Overall Study||33
2847686|NCT02660086|3549525|FG000|STARTED|Overall Study- 12-month||299
2847687|NCT02660086|3549526|FG001|STARTED|Overall Study- 12-month||303
2847688|NCT02660086|3549525|FG000|COMPLETED|Overall Study- 12-month||273
2847689|NCT02660086|3549526|FG001|COMPLETED|Overall Study- 12-month||274
2847690|NCT02660086|3549525|FG000|NOT COMPLETED|Overall Study- 12-month||26
2847691|NCT02660086|3549526|FG001|NOT COMPLETED|Overall Study- 12-month||29
2847692|NCT02660086|3549525|FG000|STARTED|Overall Study: 24-month Follow-up||281
2847693|NCT02660086|3549526|FG001|STARTED|Overall Study: 24-month Follow-up||278
2847694|NCT02660086|3549525|FG000|COMPLETED|Overall Study: 24-month Follow-up||255
2847695|NCT02660086|3549526|FG001|COMPLETED|Overall Study: 24-month Follow-up||254
2847696|NCT02660086|3549525|FG000|NOT COMPLETED|Overall Study: 24-month Follow-up||26
2847697|NCT02660086|3549526|FG001|NOT COMPLETED|Overall Study: 24-month Follow-up||24
2847698|NCT02653482|3549534|FG000|STARTED|Overall Study||131
2847699|NCT02653482|3549535|FG001|STARTED|Overall Study||132
2847700|NCT02653482|3549534|FG000|COMPLETED|Overall Study||130
2847701|NCT02653482|3549535|FG001|COMPLETED|Overall Study||131
2847702|NCT02653482|3549534|FG000|NOT COMPLETED|Overall Study||1
2847703|NCT02653482|3549535|FG001|NOT COMPLETED|Overall Study||1
2847704|NCT02454933|3549543|FG000|STARTED|Overall Study||17
2847705|NCT02454933|3549544|FG001|STARTED|Overall Study|2 subjects switched to osimertinib monotherapy Cycle 1 Day 1|12
2847706|NCT02454933|3549543|FG000|Treatment Group Randomised to|Overall Study||15
2847707|NCT02454933|3549544|FG001|Treatment Group Randomised to|Overall Study||14
2847708|NCT02454933|3549543|FG000|COMPLETED|Overall Study||9
2847709|NCT02454933|3549544|FG001|COMPLETED|Overall Study||4
2847710|NCT02454933|3549543|FG000|NOT COMPLETED|Overall Study||8
2847711|NCT02454933|3549544|FG001|NOT COMPLETED|Overall Study||8
2847712|NCT02335749|3549549|FG000|STARTED|Overall Study||40
2847713|NCT02335749|3549549|FG000|COMPLETED|Overall Study||40
2847714|NCT02335749|3549549|FG000|NOT COMPLETED|Overall Study||0
2847715|NCT02282020|3549555|FG000|STARTED|Overall Study||178
2847716|NCT02282020|3549556|FG001|STARTED|Overall Study||88
2847717|NCT02282020|3549555|FG000|Received Treatment|Overall Study||178
2847718|NCT02282020|3549556|FG001|Received Treatment|Overall Study||76
2847719|NCT02282020|3549555|FG000|COMPLETED|Overall Study||43
2847720|NCT02282020|3549556|FG001|COMPLETED|Overall Study||1
2847721|NCT02282020|3549555|FG000|NOT COMPLETED|Overall Study||135
2847722|NCT02282020|3549556|FG001|NOT COMPLETED|Overall Study||87
2847723|NCT02129647|3549562|FG000|STARTED|Overall Study||13
2847724|NCT02129647|3549562|FG000|COMPLETED|Overall Study||10
2847725|NCT02129647|3549562|FG000|NOT COMPLETED|Overall Study||3
2847726|NCT02071901|3549566|FG000|STARTED|Overall Study||31
2847727|NCT02071901|3549566|FG000|COMPLETED|Overall Study||31
2847728|NCT02071901|3549566|FG000|NOT COMPLETED|Overall Study||0
2847729|NCT01959139|3549574|FG000|STARTED|Phase I: Cohort 1||5
2847730|NCT01959139|3549575|FG001|STARTED|Phase I: Cohort 1||0
2847731|NCT01959139|3549576|FG002|STARTED|Phase I: Cohort 1||0
2847732|NCT01959139|3549577|FG003|STARTED|Phase I: Cohort 1||0
2847733|NCT01959139|3549574|FG000|COMPLETED|Phase I: Cohort 1||5
2847734|NCT01959139|3549575|FG001|COMPLETED|Phase I: Cohort 1||0
2847735|NCT01959139|3549576|FG002|COMPLETED|Phase I: Cohort 1||0
2847736|NCT01959139|3549577|FG003|COMPLETED|Phase I: Cohort 1||0
2847737|NCT01959139|3549574|FG000|NOT COMPLETED|Phase I: Cohort 1||0
2847738|NCT01959139|3549575|FG001|NOT COMPLETED|Phase I: Cohort 1||0
2847739|NCT01959139|3549576|FG002|NOT COMPLETED|Phase I: Cohort 1||0
2847740|NCT01959139|3549577|FG003|NOT COMPLETED|Phase I: Cohort 1||0
2847741|NCT01959139|3549574|FG000|STARTED|Phase I: Cohort 2||0
2847742|NCT01959139|3549575|FG001|STARTED|Phase I: Cohort 2||6
2847743|NCT01959139|3549576|FG002|STARTED|Phase I: Cohort 2||0
2847744|NCT01959139|3549577|FG003|STARTED|Phase I: Cohort 2||0
2847745|NCT01959139|3549574|FG000|COMPLETED|Phase I: Cohort 2||0
2847746|NCT01959139|3549575|FG001|COMPLETED|Phase I: Cohort 2||6
2847747|NCT01959139|3549576|FG002|COMPLETED|Phase I: Cohort 2||0
2847748|NCT01959139|3549577|FG003|COMPLETED|Phase I: Cohort 2||0
2847749|NCT01959139|3549574|FG000|NOT COMPLETED|Phase I: Cohort 2||0
2847750|NCT01959139|3549575|FG001|NOT COMPLETED|Phase I: Cohort 2||0
2847751|NCT01959139|3549576|FG002|NOT COMPLETED|Phase I: Cohort 2||0
2847752|NCT01959139|3549577|FG003|NOT COMPLETED|Phase I: Cohort 2||0
2847753|NCT01959139|3549574|FG000|STARTED|Phase II||0
2847754|NCT01959139|3549575|FG001|STARTED|Phase II||0
2847755|NCT01959139|3549576|FG002|STARTED|Phase II||56
2847756|NCT01959139|3549577|FG003|STARTED|Phase II||55
3168222|NCT01917188|3895547|FG002|NOT COMPLETED|Overall Study||9
3168223|NCT01917214|3895555|FG000|STARTED|Overall Study||212
3168224|NCT01917214|3895555|FG000|COMPLETED|Overall Study||212
2847757|NCT01959139|3549574|FG000|Assessed for AEs|Phase II||0
2847758|NCT01959139|3549575|FG001|Assessed for AEs|Phase II||0
2847759|NCT01959139|3549576|FG002|Assessed for AEs|Phase II||54
2847760|NCT01959139|3549577|FG003|Assessed for AEs|Phase II||51
2847761|NCT01959139|3549574|FG000|COMPLETED|Phase II||0
2847762|NCT01959139|3549575|FG001|COMPLETED|Phase II||0
2847763|NCT01959139|3549576|FG002|COMPLETED|Phase II||0
2847764|NCT01959139|3549577|FG003|COMPLETED|Phase II||0
2847765|NCT01959139|3549574|FG000|NOT COMPLETED|Phase II||0
2847766|NCT01959139|3549575|FG001|NOT COMPLETED|Phase II||0
2847767|NCT01959139|3549576|FG002|NOT COMPLETED|Phase II||56
2847768|NCT01959139|3549577|FG003|NOT COMPLETED|Phase II||55
2847769|NCT01874353|3549594|FG000|STARTED|Overall Study||196
2847770|NCT01874353|3549595|FG001|STARTED|Overall Study||99
2847771|NCT01874353|3549596|FG002|STARTED|Overall Study||22
2847772|NCT01874353|3549597|FG003|STARTED|Overall Study||10
2847773|NCT01874353|3549594|FG000|COMPLETED|Overall Study||69
2847774|NCT01874353|3549595|FG001|COMPLETED|Overall Study||26
2847775|NCT01874353|3549596|FG002|COMPLETED|Overall Study||7
2847776|NCT01874353|3549597|FG003|COMPLETED|Overall Study||3
2847777|NCT01874353|3549594|FG000|NOT COMPLETED|Overall Study||127
2847778|NCT01874353|3549595|FG001|NOT COMPLETED|Overall Study||73
2847779|NCT01874353|3549596|FG002|NOT COMPLETED|Overall Study||15
2847780|NCT01874353|3549597|FG003|NOT COMPLETED|Overall Study||7
2847781|NCT01597778|3549611|FG000|STARTED|Overall Study||186
2847782|NCT01597778|3549612|FG001|STARTED|Overall Study||182
2847783|NCT01597778|3549611|FG000|COMPLETED|Overall Study||172
2847784|NCT01597778|3549612|FG001|COMPLETED|Overall Study||153
2847785|NCT01597778|3549611|FG000|NOT COMPLETED|Overall Study||14
2847786|NCT01597778|3549612|FG001|NOT COMPLETED|Overall Study||29
2847787|NCT01522976|3549621|FG000|STARTED|Overall Study||97
2847788|NCT01522976|3549622|FG001|STARTED|Overall Study||92
2847789|NCT01522976|3549623|FG002|STARTED|Overall Study||93
2847790|NCT01522976|3549621|FG000|COMPLETED|Overall Study||0
2847791|NCT01522976|3549622|FG001|COMPLETED|Overall Study||0
2847792|NCT01522976|3549623|FG002|COMPLETED|Overall Study||0
2847793|NCT01522976|3549621|FG000|NOT COMPLETED|Overall Study||97
2847794|NCT01522976|3549622|FG001|NOT COMPLETED|Overall Study||92
2847795|NCT01522976|3549623|FG002|NOT COMPLETED|Overall Study||93
2847796|NCT01286272|3549636|FG000|STARTED|Overall Study||67
2847797|NCT01286272|3549637|FG001|STARTED|Overall Study||65
2847798|NCT01286272|3549636|FG000|COMPLETED|Overall Study||66
2847799|NCT01286272|3549637|FG001|COMPLETED|Overall Study||62
2847800|NCT01286272|3549636|FG000|NOT COMPLETED|Overall Study||1
2847801|NCT01286272|3549637|FG001|NOT COMPLETED|Overall Study||3
2847802|NCT01145495|3549643|FG000|STARTED|Overall Study||63
2847803|NCT01145495|3549643|FG000|COMPLETED|Overall Study||51
2847804|NCT01145495|3549643|FG000|NOT COMPLETED|Overall Study||12
2847805|NCT01134601|3549647|FG000|STARTED|Overall Study||1
2847806|NCT01134601|3549647|FG000|COMPLETED|Overall Study||1
2847807|NCT01134601|3549647|FG000|NOT COMPLETED|Overall Study||0
2847808|NCT01118026|3549651|FG000|STARTED|Overall Study||101
2847809|NCT01118026|3549651|FG000|COMPLETED|Overall Study||101
2847810|NCT01118026|3549651|FG000|NOT COMPLETED|Overall Study||0
2847811|NCT00879086|3549658|FG000|STARTED|Overall Study||52
2847812|NCT00879086|3549659|FG001|STARTED|Overall Study||52
2847813|NCT00879086|3549658|FG000|Safety Analysis Set (SAS)|Overall Study||51
2847814|NCT00879086|3549659|FG001|Safety Analysis Set (SAS)|Overall Study||50
2847815|NCT00879086|3549658|FG000|COMPLETED|Overall Study||0
2847816|NCT00879086|3549659|FG001|COMPLETED|Overall Study||0
2847817|NCT00879086|3549658|FG000|NOT COMPLETED|Overall Study||52
2847818|NCT00879086|3549659|FG001|NOT COMPLETED|Overall Study||52
2847819|NCT00864227|3549665|FG000|STARTED|Overall Study||54
2847820|NCT00864227|3549665|FG000|COMPLETED|Overall Study||50
2847821|NCT00864227|3549665|FG000|NOT COMPLETED|Overall Study||4
2847822|NCT00731731|3549672|FG000|STARTED|Overall Study||12
2847823|NCT00731731|3549673|FG001|STARTED|Overall Study||3
2847824|NCT00731731|3549674|FG002|STARTED|Overall Study||110
2847825|NCT00731731|3549672|FG000|COMPLETED|Overall Study||12
2847826|NCT00731731|3549673|FG001|COMPLETED|Overall Study||3
2847827|NCT00731731|3549674|FG002|COMPLETED|Overall Study||107
2847828|NCT00731731|3549672|FG000|NOT COMPLETED|Overall Study||0
2847829|NCT00731731|3549673|FG001|NOT COMPLETED|Overall Study||0
2847830|NCT00731731|3549674|FG002|NOT COMPLETED|Overall Study||3
2847831|NCT00685360|3549690|FG000|STARTED|Overall Study||161
2847832|NCT00685360|3549691|FG001|STARTED|Overall Study||160
2847833|NCT00685360|3549692|FG002|STARTED|Overall Study||160
2847834|NCT00685360|3549690|FG000|Modified Intent-to-Treat (MITT)|Overall Study||141
2847835|NCT00685360|3549691|FG001|Modified Intent-to-Treat (MITT)|Overall Study||136
2847836|NCT00685360|3549692|FG002|Modified Intent-to-Treat (MITT)|Overall Study||125
2847837|NCT00685360|3549690|FG000|MITT (Solid Culture)|Overall Study||119
2847838|NCT00685360|3549691|FG001|MITT (Solid Culture)|Overall Study||115
2847839|NCT00685360|3549692|FG002|MITT (Solid Culture)|Overall Study||113
2847840|NCT00685360|3549690|FG000|COMPLETED|Overall Study||143
2847841|NCT00685360|3549691|FG001|COMPLETED|Overall Study||146
3168225|NCT01917214|3895555|FG000|NOT COMPLETED|Overall Study||0
2847842|NCT00685360|3549692|FG002|COMPLETED|Overall Study||145
2847843|NCT00685360|3549690|FG000|NOT COMPLETED|Overall Study||18
2847844|NCT00685360|3549691|FG001|NOT COMPLETED|Overall Study||14
2847845|NCT00685360|3549692|FG002|NOT COMPLETED|Overall Study||15
2847846|NCT00299728|3549702|FG000|STARTED|Overall Study||11
2847847|NCT00299728|3549703|FG001|STARTED|Overall Study||11
2847848|NCT00299728|3549702|FG000|COMPLETED|Overall Study||11
2847849|NCT00299728|3549703|FG001|COMPLETED|Overall Study||8
2847850|NCT00299728|3549702|FG000|NOT COMPLETED|Overall Study||0
2847851|NCT00299728|3549703|FG001|NOT COMPLETED|Overall Study||3
2847852|NCT00159588|3549712|FG000|STARTED|5 Month Follow-up||19
2847853|NCT00159588|3549713|FG001|STARTED|5 Month Follow-up||22
2847854|NCT00159588|3549714|FG002|STARTED|5 Month Follow-up||20
2847855|NCT00159588|3549712|FG000|COMPLETED|5 Month Follow-up||17
2847856|NCT00159588|3549713|FG001|COMPLETED|5 Month Follow-up||18
2847857|NCT00159588|3549714|FG002|COMPLETED|5 Month Follow-up||18
2847858|NCT00159588|3549712|FG000|NOT COMPLETED|5 Month Follow-up||2
2847859|NCT00159588|3549713|FG001|NOT COMPLETED|5 Month Follow-up||4
2847860|NCT00159588|3549714|FG002|NOT COMPLETED|5 Month Follow-up||2
2847861|NCT00159588|3549712|FG000|STARTED|1-year Follow-up for Group 1 and 2||17
2847862|NCT00159588|3549713|FG001|STARTED|1-year Follow-up for Group 1 and 2||18
2847863|NCT00159588|3549714|FG002|STARTED|1-year Follow-up for Group 1 and 2||18
2847864|NCT00159588|3549712|FG000|COMPLETED|1-year Follow-up for Group 1 and 2||16
2847865|NCT00159588|3549713|FG001|COMPLETED|1-year Follow-up for Group 1 and 2||14
2847866|NCT00159588|3549714|FG002|COMPLETED|1-year Follow-up for Group 1 and 2||18
2847867|NCT00159588|3549712|FG000|NOT COMPLETED|1-year Follow-up for Group 1 and 2||1
2847868|NCT00159588|3549713|FG001|NOT COMPLETED|1-year Follow-up for Group 1 and 2||4
3168226|NCT01917344|3895560|FG000|STARTED|Overall Study||10
3168227|NCT01917344|3895560|FG000|COMPLETED|Overall Study||9
3168228|NCT01917344|3895560|FG000|NOT COMPLETED|Overall Study||1
3168229|NCT01917513|3895566|FG000|STARTED|Overall Study||502
3168230|NCT01917513|3895567|FG001|STARTED|Overall Study||498
3168231|NCT01917513|3895566|FG000|COMPLETED|Overall Study||407
3168232|NCT01917513|3895567|FG001|COMPLETED|Overall Study||396
3168233|NCT01917513|3895566|FG000|NOT COMPLETED|Overall Study||95
3168234|NCT01917513|3895567|FG001|NOT COMPLETED|Overall Study||102
3168235|NCT01917526|3895575|FG000|STARTED|Overall Study||250
3168236|NCT01917526|3895576|FG001|STARTED|Overall Study||250
3168237|NCT01917526|3895575|FG000|COMPLETED|Overall Study|One patient in oxygen mask received oxygen cannula|249
2847869|NCT00159588|3549714|FG002|NOT COMPLETED|1-year Follow-up for Group 1 and 2||0
2847870|NCT00095784|3549722|FG000|STARTED|Overall Study||21
2847871|NCT00095784|3549722|FG000|COMPLETED|Overall Study||21
2847872|NCT00095784|3549722|FG000|NOT COMPLETED|Overall Study||0
2847873|NCT00070499|3549731|FG000|STARTED|Overall Study||75
2847874|NCT00070499|3549732|FG001|STARTED|Overall Study||78
2847875|NCT00070499|3549733|FG002|STARTED|Overall Study||126
2847876|NCT00070499|3549734|FG003|STARTED|Overall Study||127
2847877|NCT00070499|3549731|FG000|Eligible|Overall Study||73
2847878|NCT00070499|3549732|FG001|Eligible|Overall Study||73
3168238|NCT01917526|3895576|FG001|COMPLETED|Overall Study|1 patient in oxygen cannula group receive oxygen mask|249
3168239|NCT01917526|3895575|FG000|NOT COMPLETED|Overall Study||1
3168240|NCT01917526|3895576|FG001|NOT COMPLETED|Overall Study||1
3168241|NCT01917656|3895584|FG000|STARTED|Overall Study||172
3168242|NCT01917656|3895585|FG001|STARTED|Overall Study||171
3168243|NCT01917656|3895584|FG000|Exposed|Overall Study|1 subject was withdrawn prior to exposure to trial products|171
3168244|NCT01917656|3895585|FG001|Exposed|Overall Study|1 subject was withdrawn prior to exposure to first SU dose after randomisation|170
3168245|NCT01917656|3895584|FG000|Exposed During Ramadan (Fasting)|Overall Study||152
3168246|NCT01917656|3895585|FG001|Exposed During Ramadan (Fasting)|Overall Study||163
3168247|NCT01917656|3895584|FG000|COMPLETED|Overall Study||146
3168248|NCT01917656|3895585|FG001|COMPLETED|Overall Study||147
3168249|NCT01917656|3895584|FG000|NOT COMPLETED|Overall Study||26
3168250|NCT01917656|3895585|FG001|NOT COMPLETED|Overall Study||24
3168251|NCT01917682|3895591|FG000|STARTED|Overall Study||754
3168252|NCT01917682|3895591|FG000|COMPLETED|Overall Study||754
3168253|NCT01917682|3895591|FG000|NOT COMPLETED|Overall Study||0
3168254|NCT01917747|3895598|FG000|STARTED|Overall Study||60
3168255|NCT01917747|3895599|FG001|STARTED|Overall Study||46
3168256|NCT01917747|3895598|FG000|COMPLETED|Overall Study||41
3168257|NCT01917747|3895599|FG001|COMPLETED|Overall Study||35
3168258|NCT01917747|3895598|FG000|NOT COMPLETED|Overall Study||19
3168259|NCT01917747|3895599|FG001|NOT COMPLETED|Overall Study||11
3168260|NCT01917773|3895609|FG000|STARTED|Overall Study||13
3168261|NCT01917773|3895609|FG000|COMPLETED|Overall Study||13
3168262|NCT01917773|3895609|FG000|NOT COMPLETED|Overall Study||0
3168263|NCT01917812|3895618|FG000|STARTED|Overall Study||16
3168264|NCT01917812|3895619|FG001|STARTED|Overall Study||16
3168265|NCT01917812|3895620|FG002|STARTED|Overall Study||16
3168266|NCT01917812|3895618|FG000|COMPLETED|Overall Study||15
3168267|NCT01917812|3895619|FG001|COMPLETED|Overall Study||16
3168268|NCT01917812|3895620|FG002|COMPLETED|Overall Study||16
3168269|NCT01917812|3895618|FG000|NOT COMPLETED|Overall Study||1
3168270|NCT01917812|3895619|FG001|NOT COMPLETED|Overall Study||0
2847879|NCT00070499|3549733|FG002|Eligible|Overall Study||123
2847880|NCT00070499|3549734|FG003|Eligible|Overall Study||125
2847881|NCT00070499|3549731|FG000|Eligible and Treated|Overall Study||72
2847882|NCT00070499|3549732|FG001|Eligible and Treated|Overall Study||73
2847883|NCT00070499|3549733|FG002|Eligible and Treated|Overall Study||123
2847884|NCT00070499|3549734|FG003|Eligible and Treated|Overall Study||123
3168271|NCT01917812|3895620|FG002|NOT COMPLETED|Overall Study||0
3168272|NCT01917968|3895630|FG000|STARTED|Overall Study||225
3168273|NCT01917968|3895631|FG001|STARTED|Overall Study||485
3168274|NCT01917968|3895630|FG000|COMPLETED|Overall Study||171
3168275|NCT01917968|3895631|FG001|COMPLETED|Overall Study||401
3168276|NCT01917968|3895630|FG000|NOT COMPLETED|Overall Study||54
3168277|NCT01917968|3895631|FG001|NOT COMPLETED|Overall Study||84
3168278|NCT01918072|3895644|FG000|STARTED|Controlled Trial Step One - Six Months||11
3168279|NCT01918072|3895645|FG001|STARTED|Controlled Trial Step One - Six Months||0
3168280|NCT01918072|3895646|FG002|STARTED|Controlled Trial Step One - Six Months||0
3168281|NCT01918072|3895644|FG000|Intervention|Controlled Trial Step One - Six Months||1
3168282|NCT01918072|3895645|FG001|Intervention|Controlled Trial Step One - Six Months||0
3168283|NCT01918072|3895646|FG002|Intervention|Controlled Trial Step One - Six Months||0
3168284|NCT01918072|3895644|FG000|Control|Controlled Trial Step One - Six Months||10
3168285|NCT01918072|3895645|FG001|Control|Controlled Trial Step One - Six Months||0
3168286|NCT01918072|3895646|FG002|Control|Controlled Trial Step One - Six Months||0
3168287|NCT01918072|3895644|FG000|COMPLETED|Controlled Trial Step One - Six Months||11
3168288|NCT01918072|3895645|FG001|COMPLETED|Controlled Trial Step One - Six Months||0
3168289|NCT01918072|3895646|FG002|COMPLETED|Controlled Trial Step One - Six Months||0
3168290|NCT01918072|3895644|FG000|NOT COMPLETED|Controlled Trial Step One - Six Months||0
3168291|NCT01918072|3895645|FG001|NOT COMPLETED|Controlled Trial Step One - Six Months||0
3168292|NCT01918072|3895646|FG002|NOT COMPLETED|Controlled Trial Step One - Six Months||0
3168293|NCT01918072|3895644|FG000|STARTED|Controlled Trial Step Two - Six Months||11
3168294|NCT01918072|3895645|FG001|STARTED|Controlled Trial Step Two - Six Months||0
3168295|NCT01918072|3895646|FG002|STARTED|Controlled Trial Step Two - Six Months||0
3168296|NCT01918072|3895644|FG000|Intervention|Controlled Trial Step Two - Six Months||7
3168297|NCT01918072|3895645|FG001|Intervention|Controlled Trial Step Two - Six Months||0
3168298|NCT01918072|3895646|FG002|Intervention|Controlled Trial Step Two - Six Months||0
3168299|NCT01918072|3895644|FG000|Control|Controlled Trial Step Two - Six Months||4
3168300|NCT01918072|3895645|FG001|Control|Controlled Trial Step Two - Six Months||0
3168301|NCT01918072|3895646|FG002|Control|Controlled Trial Step Two - Six Months||0
3168302|NCT01918072|3895644|FG000|COMPLETED|Controlled Trial Step Two - Six Months||11
3168303|NCT01918072|3895645|FG001|COMPLETED|Controlled Trial Step Two - Six Months||0
3168304|NCT01918072|3895646|FG002|COMPLETED|Controlled Trial Step Two - Six Months||0
3168305|NCT01918072|3895644|FG000|NOT COMPLETED|Controlled Trial Step Two - Six Months||0
3168306|NCT01918072|3895645|FG001|NOT COMPLETED|Controlled Trial Step Two - Six Months||0
3168307|NCT01918072|3895646|FG002|NOT COMPLETED|Controlled Trial Step Two - Six Months||0
3168308|NCT01918072|3895644|FG000|STARTED|Controlled Trial Step Three - Six Months||11
3168309|NCT01918072|3895645|FG001|STARTED|Controlled Trial Step Three - Six Months||0
3168310|NCT01918072|3895646|FG002|STARTED|Controlled Trial Step Three - Six Months||0
3168311|NCT01918072|3895644|FG000|Intervention|Controlled Trial Step Three - Six Months||9
3168312|NCT01918072|3895645|FG001|Intervention|Controlled Trial Step Three - Six Months||0
3168313|NCT01918072|3895646|FG002|Intervention|Controlled Trial Step Three - Six Months||0
3168314|NCT01918072|3895644|FG000|Control|Controlled Trial Step Three - Six Months||2
3168315|NCT01918072|3895645|FG001|Control|Controlled Trial Step Three - Six Months||0
3168316|NCT01918072|3895646|FG002|Control|Controlled Trial Step Three - Six Months||0
2847885|NCT00070499|3549731|FG000|COMPLETED|Overall Study||37
2847886|NCT00070499|3549732|FG001|COMPLETED|Overall Study||52
2847887|NCT00070499|3549733|FG002|COMPLETED|Overall Study||6
2847888|NCT00070499|3549734|FG003|COMPLETED|Overall Study||17
2847889|NCT00070499|3549731|FG000|NOT COMPLETED|Overall Study||38
2847890|NCT00070499|3549732|FG001|NOT COMPLETED|Overall Study||26
2847891|NCT00070499|3549733|FG002|NOT COMPLETED|Overall Study||120
2847892|NCT00070499|3549734|FG003|NOT COMPLETED|Overall Study||110
2917725|NCT00521339|3627789|FG000|STARTED|Treatment Phase||31
2917726|NCT00521339|3627790|FG001|STARTED|Treatment Phase||0
2917727|NCT00521339|3627791|FG002|STARTED|Treatment Phase||0
2917728|NCT00521339|3627789|FG000|Received Apremilast|Treatment Phase|1 participant withdrew consent prior to first visit and was excluded from safety population|30
2917729|NCT00521339|3627790|FG001|Received Apremilast|Treatment Phase||0
2917730|NCT00521339|3627791|FG002|Received Apremilast|Treatment Phase||0
2917731|NCT00521339|3627789|FG000|COMPLETED|Treatment Phase||19
2917732|NCT00521339|3627790|FG001|COMPLETED|Treatment Phase||0
2917733|NCT00521339|3627791|FG002|COMPLETED|Treatment Phase||0
3168317|NCT01918072|3895644|FG000|COMPLETED|Controlled Trial Step Three - Six Months||11
3168318|NCT01918072|3895645|FG001|COMPLETED|Controlled Trial Step Three - Six Months||0
3168319|NCT01918072|3895646|FG002|COMPLETED|Controlled Trial Step Three - Six Months||0
3168320|NCT01918072|3895644|FG000|NOT COMPLETED|Controlled Trial Step Three - Six Months||0
3168321|NCT01918072|3895645|FG001|NOT COMPLETED|Controlled Trial Step Three - Six Months||0
3168322|NCT01918072|3895646|FG002|NOT COMPLETED|Controlled Trial Step Three - Six Months||0
2917734|NCT00521339|3627789|FG000|NOT COMPLETED|Treatment Phase||12
2917735|NCT00521339|3627790|FG001|NOT COMPLETED|Treatment Phase||0
2917736|NCT00521339|3627791|FG002|NOT COMPLETED|Treatment Phase||0
2917737|NCT00521339|3627789|FG000|STARTED|Treatment Extension Phase||0
2917738|NCT00521339|3627790|FG001|STARTED|Treatment Extension Phase|Some participants had completed the treatment phase prior to inception of extension phase|4
2917739|NCT00521339|3627791|FG002|STARTED|Treatment Extension Phase|Some participants had completed the treatment phase prior to inception of extension phase|7
2917740|NCT00521339|3627789|FG000|COMPLETED|Treatment Extension Phase||0
2917741|NCT00521339|3627790|FG001|COMPLETED|Treatment Extension Phase||4
2847893|NCT04450823|3549752|FG000|STARTED|Overall Study||61
2847894|NCT04450823|3549752|FG000|COMPLETED|Overall Study||58
2847895|NCT04450823|3549752|FG000|NOT COMPLETED|Overall Study||3
2847896|NCT04446247|3549756|FG000|STARTED|Overall Study||14
2847897|NCT04446247|3549756|FG000|COMPLETED|Overall Study||14
2847898|NCT04446247|3549756|FG000|NOT COMPLETED|Overall Study||0
2847899|NCT04347564|3549762|FG000|STARTED|Overall Study||45
2847900|NCT04347564|3549762|FG000|COMPLETED|Overall Study||45
2847901|NCT04347564|3549762|FG000|NOT COMPLETED|Overall Study||0
2847905|NCT04274556|3549778|FG000|STARTED|Overall Study||86
2847906|NCT04274556|3549778|FG000|COMPLETED|Overall Study||86
2847907|NCT04274556|3549778|FG000|NOT COMPLETED|Overall Study||0
2847908|NCT04270292|3549782|FG000|STARTED|Overall Study||164
2847909|NCT04270292|3549782|FG000|COMPLETED|Overall Study||164
2847910|NCT04270292|3549782|FG000|NOT COMPLETED|Overall Study||0
2847911|NCT04182217|3549786|FG000|STARTED|Overall Study||91
2847912|NCT04182217|3549786|FG000|COMPLETED|Overall Study||91
2847913|NCT04182217|3549786|FG000|NOT COMPLETED|Overall Study||0
2847917|NCT04083404|3549795|FG000|STARTED|Overall Study||202
2847918|NCT04083404|3549795|FG000|COMPLETED|Overall Study||202
2847919|NCT04083404|3549795|FG000|NOT COMPLETED|Overall Study||0
2847948|NCT03977818|3549832|FG000|STARTED|Overall Study||2165
2847949|NCT03977818|3549832|FG000|COMPLETED|Overall Study||2165
2847950|NCT03977818|3549832|FG000|NOT COMPLETED|Overall Study||0
2847951|NCT03976531|3549836|FG000|STARTED|Overall Study||42
2847952|NCT03976531|3549836|FG000|COMPLETED|Overall Study||42
2847953|NCT03976531|3549836|FG000|NOT COMPLETED|Overall Study||0
2847954|NCT03964649|3549850|FG000|STARTED|Overall Study||349
2847955|NCT03964649|3549851|FG001|STARTED|Overall Study||304
2847956|NCT03964649|3549852|FG002|STARTED|Overall Study||2728
2847957|NCT03964649|3549853|FG003|STARTED|Overall Study||192
2847958|NCT03964649|3549854|FG004|STARTED|Overall Study||1948
2847959|NCT03964649|3549855|FG005|STARTED|Overall Study||349
2847960|NCT03964649|3549856|FG006|STARTED|Overall Study||376
2847961|NCT03964649|3549857|FG007|STARTED|Overall Study||325
2847962|NCT03964649|3549858|FG008|STARTED|Overall Study||204
2847963|NCT03964649|3549859|FG009|STARTED|Overall Study||533
2847964|NCT03964649|3549850|FG000|COMPLETED|Overall Study||349
2847965|NCT03964649|3549851|FG001|COMPLETED|Overall Study||304
2847966|NCT03964649|3549852|FG002|COMPLETED|Overall Study||2728
2847967|NCT03964649|3549853|FG003|COMPLETED|Overall Study||192
2847968|NCT03964649|3549854|FG004|COMPLETED|Overall Study||1948
2847969|NCT03964649|3549855|FG005|COMPLETED|Overall Study||349
2847970|NCT03964649|3549856|FG006|COMPLETED|Overall Study||376
2847971|NCT03964649|3549857|FG007|COMPLETED|Overall Study||325
2847972|NCT03964649|3549858|FG008|COMPLETED|Overall Study||204
2847973|NCT03964649|3549859|FG009|COMPLETED|Overall Study||533
2847974|NCT03964649|3549850|FG000|NOT COMPLETED|Overall Study||0
2847975|NCT03964649|3549851|FG001|NOT COMPLETED|Overall Study||0
2847976|NCT03964649|3549852|FG002|NOT COMPLETED|Overall Study||0
2847977|NCT03964649|3549853|FG003|NOT COMPLETED|Overall Study||0
2847978|NCT03964649|3549854|FG004|NOT COMPLETED|Overall Study||0
2847979|NCT03964649|3549855|FG005|NOT COMPLETED|Overall Study||0
2847980|NCT03964649|3549856|FG006|NOT COMPLETED|Overall Study||0
2847981|NCT03964649|3549857|FG007|NOT COMPLETED|Overall Study||0
3168323|NCT01918072|3895644|FG000|STARTED|Controlled Trial Step Four - Six Months||11
3168324|NCT01918072|3895645|FG001|STARTED|Controlled Trial Step Four - Six Months||0
3168325|NCT01918072|3895646|FG002|STARTED|Controlled Trial Step Four - Six Months||0
3168326|NCT01918072|3895644|FG000|Intervention|Controlled Trial Step Four - Six Months||11
2847982|NCT03964649|3549858|FG008|NOT COMPLETED|Overall Study||0
2847983|NCT03964649|3549859|FG009|NOT COMPLETED|Overall Study||0
2847984|NCT03941015|3549883|FG000|STARTED|Overall Study||38
2847985|NCT03941015|3549884|FG001|STARTED|Overall Study||207
2847986|NCT03941015|3549883|FG000|COMPLETED|Overall Study||38
2847987|NCT03941015|3549884|FG001|COMPLETED|Overall Study||204
2847988|NCT03941015|3549883|FG000|NOT COMPLETED|Overall Study||0
2847989|NCT03941015|3549884|FG001|NOT COMPLETED|Overall Study||3
2847990|NCT03889028|3549893|FG000|STARTED|Overall Study||144
2847991|NCT03889028|3549894|FG001|STARTED|Overall Study||422
2847992|NCT03889028|3549895|FG002|STARTED|Overall Study||312
2847993|NCT03889028|3549893|FG000|COMPLETED|Overall Study||144
2847994|NCT03889028|3549894|FG001|COMPLETED|Overall Study||422
2847995|NCT03889028|3549895|FG002|COMPLETED|Overall Study||312
2847996|NCT03889028|3549893|FG000|NOT COMPLETED|Overall Study||0
2847997|NCT03889028|3549894|FG001|NOT COMPLETED|Overall Study||0
2847998|NCT03889028|3549895|FG002|NOT COMPLETED|Overall Study||0
2847999|NCT03842683|3549902|FG000|STARTED|Overall Study||472
2848000|NCT03842683|3549902|FG000|COMPLETED|Overall Study||472
2848001|NCT03842683|3549902|FG000|NOT COMPLETED|Overall Study||0
2848002|NCT03839511|3549907|FG000|STARTED|Overall Study||4
2848003|NCT03839511|3549907|FG000|COMPLETED|Overall Study||4
2848004|NCT03839511|3549907|FG000|NOT COMPLETED|Overall Study||0
2848005|NCT03835546|3549914|FG000|STARTED|Overall Study||15
2848006|NCT03835546|3549915|FG001|STARTED|Overall Study||15
2848007|NCT03835546|3549916|FG002|STARTED|Overall Study||15
2848008|NCT03835546|3549914|FG000|COMPLETED|Overall Study||12
2848009|NCT03835546|3549915|FG001|COMPLETED|Overall Study||15
2848010|NCT03835546|3549916|FG002|COMPLETED|Overall Study||15
2848011|NCT03835546|3549914|FG000|NOT COMPLETED|Overall Study||3
2848012|NCT03835546|3549915|FG001|NOT COMPLETED|Overall Study||0
2848013|NCT03835546|3549916|FG002|NOT COMPLETED|Overall Study||0
2848032|NCT03727373|3549956|FG000|STARTED|Overall Study||8
2848033|NCT03727373|3549956|FG000|COMPLETED|Overall Study||8
2847902|NCT04330157|3549769|FG000|STARTED|Overall Study||50
2847903|NCT04330157|3549769|FG000|COMPLETED|Overall Study||43
2847904|NCT04330157|3549769|FG000|NOT COMPLETED|Overall Study||7
2847914|NCT04160988|3549790|FG000|STARTED|Overall Study||703
2847915|NCT04160988|3549790|FG000|COMPLETED|Overall Study||675
2847916|NCT04160988|3549790|FG000|NOT COMPLETED|Overall Study||28
2847920|NCT04079114|3549799|FG000|STARTED|Overall Study||166
2847921|NCT04079114|3549799|FG000|COMPLETED|Overall Study|Study prematurely terminated.|0
2847922|NCT04079114|3549799|FG000|NOT COMPLETED|Overall Study||166
2847923|NCT04075279|3549803|FG000|STARTED|Overall Study||19
2847924|NCT04075279|3549803|FG000|COMPLETED|Overall Study||19
2847925|NCT04075279|3549803|FG000|NOT COMPLETED|Overall Study||0
2847926|NCT04066686|3549809|FG000|STARTED|Overall Study||14
2847927|NCT04066686|3549810|FG001|STARTED|Overall Study||13
2847928|NCT04066686|3549809|FG000|COMPLETED|Overall Study||12
2847929|NCT04066686|3549810|FG001|COMPLETED|Overall Study||13
2847930|NCT04066686|3549809|FG000|NOT COMPLETED|Overall Study||2
2847931|NCT04066686|3549810|FG001|NOT COMPLETED|Overall Study||0
2848014|NCT03825393|3549926|FG000|STARTED|Overall Study||100
2848015|NCT03825393|3549927|FG001|STARTED|Overall Study||100
2848016|NCT03825393|3549926|FG000|COMPLETED|Overall Study||100
2848017|NCT03825393|3549927|FG001|COMPLETED|Overall Study||100
2848018|NCT03825393|3549926|FG000|NOT COMPLETED|Overall Study||0
2848019|NCT03825393|3549927|FG001|NOT COMPLETED|Overall Study||0
2848034|NCT03727373|3549956|FG000|NOT COMPLETED|Overall Study||0
2917742|NCT00521339|3627791|FG002|COMPLETED|Treatment Extension Phase||4
2917743|NCT00521339|3627789|FG000|NOT COMPLETED|Treatment Extension Phase||0
2917744|NCT00521339|3627790|FG001|NOT COMPLETED|Treatment Extension Phase||0
2917745|NCT00521339|3627791|FG002|NOT COMPLETED|Treatment Extension Phase||3
2917746|NCT00521339|3627789|FG000|STARTED|Observational Follow Up Phase||14
2917747|NCT00521339|3627790|FG001|STARTED|Observational Follow Up Phase||4
2917748|NCT00521339|3627791|FG002|STARTED|Observational Follow Up Phase||4
2917749|NCT00521339|3627789|FG000|COMPLETED|Observational Follow Up Phase||14
2917750|NCT00521339|3627790|FG001|COMPLETED|Observational Follow Up Phase||4
2917751|NCT00521339|3627791|FG002|COMPLETED|Observational Follow Up Phase||4
2917752|NCT00521339|3627789|FG000|NOT COMPLETED|Observational Follow Up Phase||0
2917753|NCT00521339|3627790|FG001|NOT COMPLETED|Observational Follow Up Phase||0
2917754|NCT00521339|3627791|FG002|NOT COMPLETED|Observational Follow Up Phase||0
2917755|NCT00521352|3627814|FG000|STARTED|Overall Study||12
2917756|NCT00521352|3627815|FG001|STARTED|Overall Study||13
2917757|NCT00521352|3627814|FG000|COMPLETED|Overall Study||11
2917758|NCT00521352|3627815|FG001|COMPLETED|Overall Study||10
2917759|NCT00521352|3627814|FG000|NOT COMPLETED|Overall Study||1
2917760|NCT00521352|3627815|FG001|NOT COMPLETED|Overall Study||3
2917761|NCT00521365|3627821|FG000|STARTED|Overall Study|98 participants were screened and obtain 88 patients who receive study treatment|88
2917762|NCT00521365|3627821|FG000|Modified Intention to Treat (mITT)|Overall Study|Participants who have an YMRS assessment at inclusion, and at least one assessment after inclusion|88
2917763|NCT00521365|3627821|FG000|Per Protocol (PP) Population|Overall Study|All participants without protocol deviations|68
2917764|NCT00521365|3627821|FG000|Safety Analysis Set|Overall Study|All participants who received study treatment|88
2917765|NCT00521365|3627821|FG000|COMPLETED|Overall Study|68 participants completed the study and 68 completed without protocol deviations|68
2917766|NCT00521365|3627821|FG000|NOT COMPLETED|Overall Study||20
2917767|NCT00521404|3627825|FG000|STARTED|Overall Study||62
2917768|NCT00521404|3627825|FG000|COMPLETED|Overall Study||0
2917769|NCT00521404|3627825|FG000|NOT COMPLETED|Overall Study||62
2917770|NCT00521456|3627831|FG000|STARTED|Overall Study||176
2917771|NCT00521456|3627832|FG001|STARTED|Overall Study||87
2917772|NCT00521456|3627831|FG000|COMPLETED|Overall Study||163
2917773|NCT00521456|3627832|FG001|COMPLETED|Overall Study||59
2917774|NCT00521456|3627831|FG000|NOT COMPLETED|Overall Study||13
2917775|NCT00521456|3627832|FG001|NOT COMPLETED|Overall Study||28
2917776|NCT00521586|3627840|FG000|STARTED|Initial Vaccination (Year 0)||554
2917777|NCT00521586|3627841|FG001|STARTED|Initial Vaccination (Year 0)||562
2917778|NCT00521586|3627840|FG000|Vaccinated Dose 1|Initial Vaccination (Year 0)||551
2917779|NCT00521586|3627841|FG001|Vaccinated Dose 1|Initial Vaccination (Year 0)||560
2917780|NCT00521586|3627840|FG000|Vaccinated Dose 2|Initial Vaccination (Year 0)||538
2917781|NCT00521586|3627841|FG001|Vaccinated Dose 2|Initial Vaccination (Year 0)||543
2917782|NCT00521586|3627840|FG000|Initially Reported to Complete Year 0|Initial Vaccination (Year 0)|Initially 1060 participants were reported to complete follow-up(Year 0),but 1066 actually completed.|531
2917783|NCT00521586|3627841|FG001|Initially Reported to Complete Year 0|Initial Vaccination (Year 0)|Initially 1060 participants were reported to complete follow-up(Year 0),but 1066 actually completed.|529
2917784|NCT00521586|3627840|FG000|COMPLETED|Initial Vaccination (Year 0)|6 additional participants initially reported to have withdrawn, actually completed follow-up(Year 0)|533
2917785|NCT00521586|3627841|FG001|COMPLETED|Initial Vaccination (Year 0)|6 additional participants initially reported to have withdrawn, actually completed follow-up(Year 0)|533
2917786|NCT00521586|3627840|FG000|NOT COMPLETED|Initial Vaccination (Year 0)||21
2917787|NCT00521586|3627841|FG001|NOT COMPLETED|Initial Vaccination (Year 0)||29
2917788|NCT00521586|3627840|FG000|STARTED|Follow-up (From 6-month[Year 0]-Year 5)||533
3168327|NCT01918072|3895645|FG001|Intervention|Controlled Trial Step Four - Six Months||0
3168328|NCT01918072|3895646|FG002|Intervention|Controlled Trial Step Four - Six Months||0
3168329|NCT01918072|3895644|FG000|Control|Controlled Trial Step Four - Six Months||0
3168330|NCT01918072|3895645|FG001|Control|Controlled Trial Step Four - Six Months||0
2847932|NCT04058626|3549816|FG000|STARTED|Overall Study||305
2847933|NCT04058626|3549816|FG000|COMPLETED|Overall Study||305
2847934|NCT04058626|3549816|FG000|NOT COMPLETED|Overall Study||0
2847935|NCT04057235|3549820|FG000|STARTED|Overall Study||129
2847936|NCT04057235|3549820|FG000|Had Radiographic Data|Overall Study||58
2847937|NCT04057235|3549820|FG000|Had ODI Data|Overall Study||43
2847938|NCT04057235|3549820|FG000|Had VAS Back Data|Overall Study||45
2847939|NCT04057235|3549820|FG000|Had VAS Leg Data|Overall Study||45
2847940|NCT04057235|3549820|FG000|COMPLETED|Overall Study|All 129 participants had data for at least one of the primary/secondary outcomes or adverse events|129
2847941|NCT04057235|3549820|FG000|NOT COMPLETED|Overall Study||0
2848020|NCT03813719|3549935|FG000|STARTED|Overall Study||250
2848021|NCT03813719|3549935|FG000|COMPLETED|Overall Study||250
2848022|NCT03813719|3549935|FG000|NOT COMPLETED|Overall Study||0
2848023|NCT03798756|3549941|FG000|STARTED|Overall Study||9274
2848024|NCT03798756|3549941|FG000|COMPLETED|Overall Study||9274
2848025|NCT03798756|3549941|FG000|NOT COMPLETED|Overall Study||0
2848035|NCT05017493|3549962|FG000|STARTED|Overall Study||483
2848036|NCT05017493|3549963|FG001|STARTED|Overall Study||178
2848037|NCT05017493|3549962|FG000|Treatment & Care|Overall Study||483
2848038|NCT05017493|3549963|FG001|Treatment & Care|Overall Study||178
2848039|NCT05017493|3549962|FG000|Follow up|Overall Study||483
2848040|NCT05017493|3549963|FG001|Follow up|Overall Study||178
2848041|NCT05017493|3549962|FG000|Mortality Check|Overall Study||483
2848042|NCT05017493|3549963|FG001|Mortality Check|Overall Study||178
2848043|NCT05017493|3549962|FG000|COMPLETED|Overall Study||361
2848044|NCT05017493|3549963|FG001|COMPLETED|Overall Study||178
2848045|NCT05017493|3549962|FG000|NOT COMPLETED|Overall Study||122
2848046|NCT05017493|3549963|FG001|NOT COMPLETED|Overall Study||0
2848070|NCT04347941|3550005|FG000|STARTED|Overall Study||12
2848071|NCT04347941|3550006|FG001|STARTED|Overall Study||12
2848072|NCT04347941|3550005|FG000|COMPLETED|Overall Study||12
2848073|NCT04347941|3550006|FG001|COMPLETED|Overall Study||12
2848074|NCT04347941|3550005|FG000|NOT COMPLETED|Overall Study||0
2848075|NCT04347941|3550006|FG001|NOT COMPLETED|Overall Study||0
2848076|NCT04308694|3550015|FG000|STARTED|Overall Study||20
2848077|NCT04308694|3550015|FG000|COMPLETED|Overall Study||16
2848078|NCT04308694|3550015|FG000|NOT COMPLETED|Overall Study||4
2848079|NCT03999411|3550022|FG000|STARTED|Overall Study||13
2848080|NCT03999411|3550023|FG001|STARTED|Overall Study||13
2848081|NCT03999411|3550024|FG002|STARTED|Overall Study||13
2848082|NCT03999411|3550022|FG000|COMPLETED|Overall Study||12
2848083|NCT03999411|3550023|FG001|COMPLETED|Overall Study||11
2848084|NCT03999411|3550024|FG002|COMPLETED|Overall Study||13
2848085|NCT03999411|3550022|FG000|NOT COMPLETED|Overall Study||1
2848086|NCT03999411|3550023|FG001|NOT COMPLETED|Overall Study||2
2848087|NCT03999411|3550024|FG002|NOT COMPLETED|Overall Study||0
2848088|NCT03803605|3550033|FG000|STARTED|Overall Study||15
2848089|NCT03803605|3550033|FG000|Step 1: Participants With an RCI Measurement > 0.30 Per Million Cells|Overall Study||8
2848090|NCT03803605|3550033|FG000|Steps 2-4: Participants Receiving Study Intervention|Overall Study||8
2848091|NCT03803605|3550033|FG000|COMPLETED|Overall Study||8
2848092|NCT03803605|3550033|FG000|NOT COMPLETED|Overall Study||7
2848093|NCT03799198|3550040|FG000|STARTED|Overall Study||100
2848094|NCT03799198|3550041|FG001|STARTED|Overall Study||100
2848095|NCT03799198|3550040|FG000|Full Analysis Set (FAS)|Overall Study||100
2848096|NCT03799198|3550041|FG001|Full Analysis Set (FAS)|Overall Study||100
2848097|NCT03799198|3550040|FG000|COMPLETED|Overall Study||96
2848098|NCT03799198|3550041|FG001|COMPLETED|Overall Study||91
2848099|NCT03799198|3550040|FG000|NOT COMPLETED|Overall Study||4
2848100|NCT03799198|3550041|FG001|NOT COMPLETED|Overall Study||9
2848101|NCT03770728|3550051|FG000|STARTED|Overall Study||79
2848102|NCT03770728|3550052|FG001|STARTED|Overall Study||78
2848103|NCT03770728|3550053|FG002|STARTED|Overall Study||77
2848104|NCT03770728|3550054|FG003|STARTED|Overall Study||78
2848105|NCT03770728|3550051|FG000|Safety Population|Overall Study||79
2848106|NCT03770728|3550052|FG001|Safety Population|Overall Study||78
2848107|NCT03770728|3550053|FG002|Safety Population|Overall Study|For safety analysis, participants were included in the treatment group that they were exposed for longer duration. 3 participants randomized to Efpeglenatide 6 mg received 4 mg dose for longer duration; and considered in Efpeglenatide 4 mg group for safety analysis.|80
2848108|NCT03770728|3550054|FG003|Safety Population|Overall Study||75
2848109|NCT03770728|3550051|FG000|COMPLETED|Overall Study||41
2848110|NCT03770728|3550052|FG001|COMPLETED|Overall Study||47
2848111|NCT03770728|3550053|FG002|COMPLETED|Overall Study||45
2848112|NCT03770728|3550054|FG003|COMPLETED|Overall Study||43
2848113|NCT03770728|3550051|FG000|NOT COMPLETED|Overall Study||38
2848114|NCT03770728|3550052|FG001|NOT COMPLETED|Overall Study||31
2848115|NCT03770728|3550053|FG002|NOT COMPLETED|Overall Study||32
2848116|NCT03770728|3550054|FG003|NOT COMPLETED|Overall Study||35
2848117|NCT03760146|3550072|FG000|STARTED|Overall Study||1514
2848118|NCT03760146|3550073|FG001|STARTED|Overall Study||1495
2848119|NCT03760146|3550074|FG002|STARTED|Overall Study||334
2848120|NCT03760146|3550075|FG003|STARTED|Overall Study||111
2848121|NCT03760146|3550076|FG004|STARTED|Overall Study||336
2848122|NCT03760146|3550077|FG005|STARTED|Overall Study||112
2848123|NCT03760146|3550072|FG000|Evaluable 13-Matched Immunogenicity Population|Overall Study||1435
2848124|NCT03760146|3550073|FG001|Evaluable 13-Matched Immunogenicity Population|Overall Study||1420
2848125|NCT03760146|3550074|FG002|Evaluable 13-Matched Immunogenicity Population|Overall Study||0
2848126|NCT03760146|3550075|FG003|Evaluable 13-Matched Immunogenicity Population|Overall Study||0
2847942|NCT04041037|3549824|FG000|STARTED|Overall Study||2
2847943|NCT04041037|3549824|FG000|COMPLETED|Overall Study||2
2847944|NCT04041037|3549824|FG000|NOT COMPLETED|Overall Study||0
2847945|NCT04034043|3549828|FG000|STARTED|Overall Study||68
2847946|NCT04034043|3549828|FG000|COMPLETED|Overall Study||68
2847947|NCT04034043|3549828|FG000|NOT COMPLETED|Overall Study||0
2848026|NCT03790917|3549946|FG000|STARTED|Overall Study||201
2848027|NCT03790917|3549946|FG000|COMPLETED|Overall Study||200
2848028|NCT03790917|3549946|FG000|NOT COMPLETED|Overall Study||1
2848029|NCT03790306|3549951|FG000|STARTED|Overall Study||207
2848030|NCT03790306|3549951|FG000|COMPLETED|Overall Study||207
2848031|NCT03790306|3549951|FG000|NOT COMPLETED|Overall Study||0
2848047|NCT04870138|3549972|FG000|STARTED|Overall Study||5
2848048|NCT04870138|3549973|FG001|STARTED|Overall Study||5
2848049|NCT04870138|3549974|FG002|STARTED|Overall Study||6
2848050|NCT04870138|3549972|FG000|COMPLETED|Overall Study||5
2848051|NCT04870138|3549973|FG001|COMPLETED|Overall Study||5
2848052|NCT04870138|3549974|FG002|COMPLETED|Overall Study||6
2848053|NCT04870138|3549972|FG000|NOT COMPLETED|Overall Study||0
2848054|NCT04870138|3549973|FG001|NOT COMPLETED|Overall Study||0
2848055|NCT04870138|3549974|FG002|NOT COMPLETED|Overall Study||0
2848056|NCT04374149|3549987|FG000|STARTED|Overall Study||10
2848057|NCT04374149|3549988|FG001|STARTED|Overall Study||10
2848058|NCT04374149|3549987|FG000|COMPLETED|Overall Study||10
2848059|NCT04374149|3549988|FG001|COMPLETED|Overall Study||10
2848060|NCT04374149|3549987|FG000|NOT COMPLETED|Overall Study||0
2848061|NCT04374149|3549988|FG001|NOT COMPLETED|Overall Study||0
2848062|NCT04348500|3549996|FG000|STARTED|Overall Study||8
2848063|NCT04348500|3549997|FG001|STARTED|Overall Study||9
2848064|NCT04348500|3549996|FG000|Treated|Overall Study||8
2848065|NCT04348500|3549997|FG001|Treated|Overall Study||8
2848066|NCT04348500|3549996|FG000|COMPLETED|Overall Study||6
2848067|NCT04348500|3549997|FG001|COMPLETED|Overall Study||6
2848068|NCT04348500|3549996|FG000|NOT COMPLETED|Overall Study||2
2848069|NCT04348500|3549997|FG001|NOT COMPLETED|Overall Study||3
2848127|NCT03760146|3550076|FG004|Evaluable 13-Matched Immunogenicity Population|Overall Study||0
2848128|NCT03760146|3550077|FG005|Evaluable 13-Matched Immunogenicity Population|Overall Study||0
2848129|NCT03760146|3550072|FG000|Evaluable 7-Additional Immunogenicity Population|Overall Study||1433
2848130|NCT03760146|3550073|FG001|Evaluable 7-Additional Immunogenicity Population|Overall Study||1383
2848131|NCT03760146|3550074|FG002|Evaluable 7-Additional Immunogenicity Population|Overall Study||0
2848132|NCT03760146|3550075|FG003|Evaluable 7-Additional Immunogenicity Population|Overall Study||0
2848133|NCT03760146|3550076|FG004|Evaluable 7-Additional Immunogenicity Population|Overall Study||0
2848134|NCT03760146|3550077|FG005|Evaluable 7-Additional Immunogenicity Population|Overall Study||0
2848135|NCT03760146|3550072|FG000|Vaccination 1|Overall Study||1507
2848136|NCT03760146|3550073|FG001|Vaccination 1|Overall Study||1490
2848137|NCT03760146|3550074|FG002|Vaccination 1|Overall Study||334
2848138|NCT03760146|3550075|FG003|Vaccination 1|Overall Study||111
2848139|NCT03760146|3550076|FG004|Vaccination 1|Overall Study||335
2848140|NCT03760146|3550077|FG005|Vaccination 1|Overall Study||112
2848141|NCT03760146|3550072|FG000|Vaccination 2|Overall Study||1461
2848142|NCT03760146|3550073|FG001|Vaccination 2|Overall Study||1446
2848143|NCT03760146|3550074|FG002|Vaccination 2|Overall Study||0
2848144|NCT03760146|3550075|FG003|Vaccination 2|Overall Study||0
2848145|NCT03760146|3550076|FG004|Vaccination 2|Overall Study||0
2848146|NCT03760146|3550077|FG005|Vaccination 2|Overall Study||0
2848147|NCT03760146|3550072|FG000|Safety Population|Overall Study||1507
2848148|NCT03760146|3550073|FG001|Safety Population|Overall Study||1490
2848149|NCT03760146|3550074|FG002|Safety Population|Overall Study||334
2848150|NCT03760146|3550075|FG003|Safety Population|Overall Study||111
2848151|NCT03760146|3550076|FG004|Safety Population|Overall Study||335
2848152|NCT03760146|3550077|FG005|Safety Population|Overall Study||112
2848153|NCT03760146|3550072|FG000|Evaluable-20 Immunogenicity Population|Overall Study|Only for 60-64 years of age.|946
2848154|NCT03760146|3550073|FG001|Evaluable-20 Immunogenicity Population|Overall Study||0
2848155|NCT03760146|3550074|FG002|Evaluable-20 Immunogenicity Population|Overall Study||321
2848156|NCT03760146|3550075|FG003|Evaluable-20 Immunogenicity Population|Overall Study||0
2848157|NCT03760146|3550076|FG004|Evaluable-20 Immunogenicity Population|Overall Study||317
2848158|NCT03760146|3550077|FG005|Evaluable-20 Immunogenicity Population|Overall Study||0
2848159|NCT03760146|3550072|FG000|COMPLETED|Overall Study||1418
2848160|NCT03760146|3550073|FG001|COMPLETED|Overall Study||1417
2848161|NCT03760146|3550074|FG002|COMPLETED|Overall Study||323
2848162|NCT03760146|3550075|FG003|COMPLETED|Overall Study||109
2848163|NCT03760146|3550076|FG004|COMPLETED|Overall Study||319
2848164|NCT03760146|3550077|FG005|COMPLETED|Overall Study||104
2848165|NCT03760146|3550072|FG000|NOT COMPLETED|Overall Study||96
2848166|NCT03760146|3550073|FG001|NOT COMPLETED|Overall Study||78
2848167|NCT03760146|3550074|FG002|NOT COMPLETED|Overall Study||11
2848168|NCT03760146|3550075|FG003|NOT COMPLETED|Overall Study||2
2848169|NCT03760146|3550076|FG004|NOT COMPLETED|Overall Study||17
2848170|NCT03760146|3550077|FG005|NOT COMPLETED|Overall Study||8
2848171|NCT03760081|3550097|FG000|STARTED|Overall Study||6
2848172|NCT03760081|3550098|FG001|STARTED|Overall Study||13
2848173|NCT03760081|3550097|FG000|COMPLETED|Overall Study||0
2848174|NCT03760081|3550098|FG001|COMPLETED|Overall Study||1
2848175|NCT03760081|3550097|FG000|NOT COMPLETED|Overall Study||6
2848176|NCT03760081|3550098|FG001|NOT COMPLETED|Overall Study||12
2848177|NCT03737110|3550108|FG000|STARTED|Run-in (RI) Period||86
2848178|NCT03737110|3550109|FG001|STARTED|Run-in (RI) Period||0
2848179|NCT03737110|3550110|FG002|STARTED|Run-in (RI) Period||0
2848180|NCT03737110|3550108|FG000|Continue to RW Period|Run-in (RI) Period||61
2848181|NCT03737110|3550109|FG001|Continue to RW Period|Run-in (RI) Period||0
2848182|NCT03737110|3550110|FG002|Continue to RW Period|Run-in (RI) Period||0
2848183|NCT03737110|3550108|FG000|Continue Directly to LTE Period|Run-in (RI) Period||15
2848184|NCT03737110|3550109|FG001|Continue Directly to LTE Period|Run-in (RI) Period||0
3168331|NCT01918072|3895646|FG002|Control|Controlled Trial Step Four - Six Months||0
3168332|NCT01918072|3895644|FG000|COMPLETED|Controlled Trial Step Four - Six Months||11
3168333|NCT01918072|3895645|FG001|COMPLETED|Controlled Trial Step Four - Six Months||0
3168334|NCT01918072|3895646|FG002|COMPLETED|Controlled Trial Step Four - Six Months||0
3168335|NCT01918072|3895644|FG000|NOT COMPLETED|Controlled Trial Step Four - Six Months||0
3168336|NCT01918072|3895645|FG001|NOT COMPLETED|Controlled Trial Step Four - Six Months||0
2848185|NCT03737110|3550110|FG002|Continue Directly to LTE Period|Run-in (RI) Period||0
2848186|NCT03737110|3550108|FG000|COMPLETED|Run-in (RI) Period||76
2848187|NCT03737110|3550109|FG001|COMPLETED|Run-in (RI) Period||0
2848188|NCT03737110|3550110|FG002|COMPLETED|Run-in (RI) Period||0
2848189|NCT03737110|3550108|FG000|NOT COMPLETED|Run-in (RI) Period||10
2848190|NCT03737110|3550109|FG001|NOT COMPLETED|Run-in (RI) Period||0
2848191|NCT03737110|3550110|FG002|NOT COMPLETED|Run-in (RI) Period||0
2848192|NCT03737110|3550108|FG000|STARTED|Randomized Withdrawal (RW) Period||0
2848193|NCT03737110|3550109|FG001|STARTED|Randomized Withdrawal (RW) Period||30
2848194|NCT03737110|3550110|FG002|STARTED|Randomized Withdrawal (RW) Period||31
2848195|NCT03737110|3550108|FG000|COMPLETED|Randomized Withdrawal (RW) Period||0
2848196|NCT03737110|3550109|FG001|COMPLETED|Randomized Withdrawal (RW) Period||29
2848197|NCT03737110|3550110|FG002|COMPLETED|Randomized Withdrawal (RW) Period||30
2848198|NCT03737110|3550108|FG000|NOT COMPLETED|Randomized Withdrawal (RW) Period||0
2848199|NCT03737110|3550109|FG001|NOT COMPLETED|Randomized Withdrawal (RW) Period||1
2848200|NCT03737110|3550110|FG002|NOT COMPLETED|Randomized Withdrawal (RW) Period||1
2848201|NCT03737110|3550108|FG000|STARTED|Long-Term Extension (LTE) Period|Participants who entered the LTE directly from RI after protocol-specified 22 adjudicated pericarditis recurrence events had accrued.|15
2848202|NCT03737110|3550109|FG001|STARTED|Long-Term Extension (LTE) Period|1 participant withdrew consent prior to entering LTE.|29
3168337|NCT01918072|3895646|FG002|NOT COMPLETED|Controlled Trial Step Four - Six Months||0
3168338|NCT01918072|3895644|FG000|STARTED|Controlled Trial Step Five - Four Months||11
3168339|NCT01918072|3895645|FG001|STARTED|Controlled Trial Step Five - Four Months||0
3168340|NCT01918072|3895646|FG002|STARTED|Controlled Trial Step Five - Four Months||0
3168341|NCT01918072|3895644|FG000|Intervention|Controlled Trial Step Five - Four Months||11
2848203|NCT03737110|3550110|FG002|STARTED|Long-Term Extension (LTE) Period||30
2848204|NCT03737110|3550108|FG000|COMPLETED|Long-Term Extension (LTE) Period||0
2848205|NCT03737110|3550109|FG001|COMPLETED|Long-Term Extension (LTE) Period||0
2848206|NCT03737110|3550110|FG002|COMPLETED|Long-Term Extension (LTE) Period||0
2848207|NCT03737110|3550108|FG000|NOT COMPLETED|Long-Term Extension (LTE) Period||15
2848208|NCT03737110|3550109|FG001|NOT COMPLETED|Long-Term Extension (LTE) Period||29
2848209|NCT03737110|3550110|FG002|NOT COMPLETED|Long-Term Extension (LTE) Period||30
2848210|NCT03713684|3550132|FG000|STARTED|Overall Study||92
2848211|NCT03713684|3550133|FG001|STARTED|Overall Study||92
2848212|NCT03713684|3550134|FG002|STARTED|Overall Study||93
2848213|NCT03713684|3550135|FG003|STARTED|Overall Study||93
2848214|NCT03713684|3550132|FG000|Safety Population|Overall Study||92
2848215|NCT03713684|3550133|FG001|Safety Population|Overall Study||92
2848216|NCT03713684|3550134|FG002|Safety Population|Overall Study|For safety analysis participants were included in the treatment arm that they were exposed for longer duration. 3 participants randomized to Efpeglenatide 6 mg arm received 4 mg dose for longer duration; and considered in Efpeglenatide 4 mg arm for safety analysis.|96
2848217|NCT03713684|3550135|FG003|Safety Population|Overall Study||90
2848218|NCT03713684|3550132|FG000|Completed 30-Week Core Treatment Period|Overall Study||50
2848219|NCT03713684|3550133|FG001|Completed 30-Week Core Treatment Period|Overall Study||52
2848220|NCT03713684|3550134|FG002|Completed 30-Week Core Treatment Period|Overall Study||51
2848221|NCT03713684|3550135|FG003|Completed 30-Week Core Treatment Period|Overall Study||49
2848222|NCT03713684|3550132|FG000|COMPLETED|Overall Study||6
2848223|NCT03713684|3550133|FG001|COMPLETED|Overall Study||5
2848224|NCT03713684|3550134|FG002|COMPLETED|Overall Study||5
2848225|NCT03713684|3550135|FG003|COMPLETED|Overall Study||6
2848226|NCT03713684|3550132|FG000|NOT COMPLETED|Overall Study||86
2848227|NCT03713684|3550133|FG001|NOT COMPLETED|Overall Study||87
2848228|NCT03713684|3550134|FG002|NOT COMPLETED|Overall Study||88
2848229|NCT03713684|3550135|FG003|NOT COMPLETED|Overall Study||87
2848230|NCT03644550|3550145|FG000|STARTED|Overall Study||18
2848231|NCT03644550|3550145|FG000|COMPLETED|Overall Study||0
2848232|NCT03644550|3550145|FG000|NOT COMPLETED|Overall Study||18
2848233|NCT03557970|3550152|FG000|STARTED|Overall Study||1
2848234|NCT03557970|3550153|FG001|STARTED|Overall Study||2
2848235|NCT03557970|3550152|FG000|COMPLETED|Overall Study||0
2848236|NCT03557970|3550153|FG001|COMPLETED|Overall Study||0
2848237|NCT03557970|3550152|FG000|NOT COMPLETED|Overall Study||1
2848238|NCT03557970|3550153|FG001|NOT COMPLETED|Overall Study||2
2917789|NCT00521586|3627841|FG001|STARTED|Follow-up (From 6-month[Year 0]-Year 5)||533
2917790|NCT00521586|3627840|FG000|COMPLETED|Follow-up (From 6-month[Year 0]-Year 5)||364
2917791|NCT00521586|3627841|FG001|COMPLETED|Follow-up (From 6-month[Year 0]-Year 5)||363
3038336|NCT01153724|3757759|FG000|COMPLETED|Treatment Period 1||34
2848239|NCT03369197|3550161|FG000|STARTED|Overall Study||53
2848240|NCT03369197|3550162|FG001|STARTED|Overall Study||57
2848241|NCT03369197|3550161|FG000|COMPLETED|Overall Study||53
2848242|NCT03369197|3550162|FG001|COMPLETED|Overall Study||57
2848243|NCT03369197|3550161|FG000|NOT COMPLETED|Overall Study||0
2848244|NCT03369197|3550162|FG001|NOT COMPLETED|Overall Study||0
2848245|NCT03368196|3550168|FG000|STARTED|Overall Study||12
2848246|NCT03368196|3550168|FG000|COMPLETED|Overall Study||12
2848247|NCT03368196|3550168|FG000|NOT COMPLETED|Overall Study||0
2848248|NCT03332095|3550174|FG000|STARTED|Overall Study||10
2848249|NCT03332095|3550175|FG001|STARTED|Overall Study||45
2848250|NCT03332095|3550174|FG000|Received at Least One Dose of Study Treatment|Overall Study||9
2848251|NCT03332095|3550175|FG001|Received at Least One Dose of Study Treatment|Overall Study||45
2848252|NCT03332095|3550174|FG000|COMPLETED|Overall Study||9
2848253|NCT03332095|3550175|FG001|COMPLETED|Overall Study||44
2848254|NCT03332095|3550174|FG000|NOT COMPLETED|Overall Study||1
2848255|NCT03332095|3550175|FG001|NOT COMPLETED|Overall Study||1
2848256|NCT03022461|3550181|FG000|STARTED|Overall Study||25
2848257|NCT03022461|3550181|FG000|COMPLETED|Overall Study||22
2848258|NCT03022461|3550181|FG000|NOT COMPLETED|Overall Study||3
2848259|NCT02979587|3550186|FG000|STARTED|Overall Study||50
2848260|NCT02979587|3550186|FG000|Catheterized|Overall Study||50
2848261|NCT02979587|3550186|FG000|Implanted|Overall Study||50
2848262|NCT02979587|3550186|FG000|Implanted > 24 Hours|Overall Study||48
2848263|NCT02979587|3550186|FG000|COMPLETED|Overall Study||48
2848264|NCT02979587|3550186|FG000|NOT COMPLETED|Overall Study||2
2848265|NCT02964039|3550197|FG000|STARTED|Overall Study||18
2848266|NCT02964039|3550198|FG001|STARTED|Overall Study||18
2848267|NCT02964039|3550199|FG002|STARTED|Overall Study||18
2848268|NCT02964039|3550197|FG000|Received Allocated Intervention|Overall Study||15
2848269|NCT02964039|3550198|FG001|Received Allocated Intervention|Overall Study||17
2848270|NCT02964039|3550199|FG002|Received Allocated Intervention|Overall Study||14
2848271|NCT02964039|3550197|FG000|COMPLETED|Overall Study||14
2848272|NCT02964039|3550198|FG001|COMPLETED|Overall Study||17
2848273|NCT02964039|3550199|FG002|COMPLETED|Overall Study||13
2848274|NCT02964039|3550197|FG000|NOT COMPLETED|Overall Study||4
2848275|NCT02964039|3550198|FG001|NOT COMPLETED|Overall Study||1
2848276|NCT02964039|3550199|FG002|NOT COMPLETED|Overall Study||5
2848277|NCT02930889|3550207|FG000|STARTED|Overall Study||21
2848278|NCT02930889|3550207|FG000|COMPLETED|Overall Study||5
2848279|NCT02930889|3550207|FG000|NOT COMPLETED|Overall Study||16
2848280|NCT02919618|3550211|FG000|STARTED|Overall Study||19
2848281|NCT02919618|3550211|FG000|Primary Safety Endpoint (</=90 Days)|Overall Study||19
2848282|NCT02919618|3550211|FG000|Primary Efficacy Endpoint (6 Months)|Overall Study||18
2848283|NCT02919618|3550211|FG000|COMPLETED|Overall Study||18
2848284|NCT02919618|3550211|FG000|NOT COMPLETED|Overall Study||1
2848285|NCT02844946|3550228|FG000|STARTED|Overall Study||27
2848286|NCT02844946|3550229|FG001|STARTED|Overall Study||12
2848287|NCT02844946|3550228|FG000|COMPLETED|Overall Study||20
2848288|NCT02844946|3550229|FG001|COMPLETED|Overall Study||12
2848289|NCT02844946|3550228|FG000|NOT COMPLETED|Overall Study||7
2848290|NCT02844946|3550229|FG001|NOT COMPLETED|Overall Study||0
2848291|NCT02675114|3550237|FG000|STARTED|Overall Study||497
2848292|NCT02675114|3550238|FG001|STARTED|Overall Study||503
2848293|NCT02675114|3550237|FG000|As Treated|Overall Study||454
2848294|NCT02675114|3550238|FG001|As Treated|Overall Study||496
2848295|NCT02675114|3550237|FG000|Valve Implant|Overall Study||453
2848296|NCT02675114|3550238|FG001|Valve Implant|Overall Study||495
2848297|NCT02675114|3550237|FG000|COMPLETED|Overall Study||424
2848298|NCT02675114|3550238|FG001|COMPLETED|Overall Study||490
2848299|NCT02675114|3550237|FG000|NOT COMPLETED|Overall Study||73
2848300|NCT02675114|3550238|FG001|NOT COMPLETED|Overall Study||13
2848301|NCT02564796|3550246|FG000|STARTED|Overall Study||2
2848302|NCT02564796|3550247|FG001|STARTED|Overall Study||2
2848303|NCT02564796|3550246|FG000|COMPLETED|Overall Study||0
2848304|NCT02564796|3550247|FG001|COMPLETED|Overall Study||0
2848305|NCT02564796|3550246|FG000|NOT COMPLETED|Overall Study||2
2848306|NCT02564796|3550247|FG001|NOT COMPLETED|Overall Study||2
2848307|NCT02562716|3550255|FG000|STARTED|Overall Study||55
2848308|NCT02562716|3550256|FG001|STARTED|Overall Study||47
2848309|NCT02562716|3550255|FG000|Participants Assessed for AEs|Overall Study||53
2848310|NCT02562716|3550256|FG001|Participants Assessed for AEs|Overall Study||45
2848311|NCT02562716|3550255|FG000|COMPLETED|Overall Study||27
2848312|NCT02562716|3550256|FG001|COMPLETED|Overall Study||19
3311717|NCT03054428|4045208|FG001|Completed Wk 16 End of Treatment (EOT)|Overall Study||81
3311718|NCT03054428|4045209|FG002|Completed Wk 16 End of Treatment (EOT)|Overall Study||79
3311719|NCT03054428|4045207|FG000|Completed Week 28 (End of Study)|Overall Study||2
3311720|NCT03054428|4045208|FG001|Completed Week 28 (End of Study)|Overall Study||4
3311721|NCT03054428|4045209|FG002|Completed Week 28 (End of Study)|Overall Study||3
3311722|NCT03054428|4045207|FG000|COMPLETED|Overall Study||2
2848313|NCT02562716|3550255|FG000|NOT COMPLETED|Overall Study||28
2848314|NCT02562716|3550256|FG001|NOT COMPLETED|Overall Study||28
2848315|NCT02442349|3550264|FG000|STARTED|Overall Study||171
2848316|NCT02442349|3550264|FG000|COMPLETED|Overall Study||0
2848317|NCT02442349|3550264|FG000|NOT COMPLETED|Overall Study||171
2848318|NCT02211131|3550270|FG000|STARTED|Overall Study||74
2848319|NCT02211131|3550271|FG001|STARTED|Overall Study||76
2848320|NCT02211131|3550270|FG000|COMPLETED|Overall Study||0
2848321|NCT02211131|3550271|FG001|COMPLETED|Overall Study||0
2848322|NCT02211131|3550270|FG000|NOT COMPLETED|Overall Study||74
2848323|NCT02211131|3550271|FG001|NOT COMPLETED|Overall Study||76
2848324|NCT02094261|3550284|FG000|STARTED|Overall Study||210
2848325|NCT02094261|3550284|FG000|COMPLETED|Overall Study||0
2848326|NCT02094261|3550284|FG000|NOT COMPLETED|Overall Study||210
2848327|NCT01803854|3550288|FG000|STARTED|Overall Study||1275
2848328|NCT01803854|3550288|FG000|COMPLETED|Overall Study||1275
2848329|NCT01803854|3550288|FG000|NOT COMPLETED|Overall Study||0
2848330|NCT01496976|3550293|FG000|STARTED|Overall Study||45
2848331|NCT01496976|3550293|FG000|COMPLETED|Overall Study||44
2848332|NCT01496976|3550293|FG000|NOT COMPLETED|Overall Study||1
2848333|NCT01472081|3550303|FG000|STARTED|Overall Study||7
2848334|NCT01472081|3550304|FG001|STARTED|Overall Study||26
2848335|NCT01472081|3550305|FG002|STARTED|Overall Study||20
2848336|NCT01472081|3550306|FG003|STARTED|Overall Study||47
2848337|NCT01472081|3550307|FG004|STARTED|Overall Study||47
2848338|NCT01472081|3550308|FG005|STARTED|Overall Study||6
2848339|NCT01472081|3550303|FG000|COMPLETED|Overall Study||0
2848340|NCT01472081|3550304|FG001|COMPLETED|Overall Study||0
2848341|NCT01472081|3550305|FG002|COMPLETED|Overall Study||0
2848342|NCT01472081|3550306|FG003|COMPLETED|Overall Study||1
2848343|NCT01472081|3550307|FG004|COMPLETED|Overall Study||0
2848344|NCT01472081|3550308|FG005|COMPLETED|Overall Study||0
2848345|NCT01472081|3550303|FG000|NOT COMPLETED|Overall Study||7
2848346|NCT01472081|3550304|FG001|NOT COMPLETED|Overall Study||26
2848347|NCT01472081|3550305|FG002|NOT COMPLETED|Overall Study||20
2848348|NCT01472081|3550306|FG003|NOT COMPLETED|Overall Study||46
2848349|NCT01472081|3550307|FG004|NOT COMPLETED|Overall Study||47
2848350|NCT01472081|3550308|FG005|NOT COMPLETED|Overall Study||6
2917792|NCT00521586|3627840|FG000|NOT COMPLETED|Follow-up (From 6-month[Year 0]-Year 5)||169
2917793|NCT00521586|3627841|FG001|NOT COMPLETED|Follow-up (From 6-month[Year 0]-Year 5)||170
2917794|NCT00521586|3627840|FG000|STARTED|Revaccination With 13vPnC (Year 5)||364
2917795|NCT00521586|3627841|FG001|STARTED|Revaccination With 13vPnC (Year 5)||363
2917796|NCT00521586|3627840|FG000|Vaccinated 13vPnC (Year 5)|Revaccination With 13vPnC (Year 5)||364
2917797|NCT00521586|3627841|FG001|Vaccinated 13vPnC (Year 5)|Revaccination With 13vPnC (Year 5)||363
2917798|NCT00521586|3627840|FG000|Completed 1 Month Follow-up|Revaccination With 13vPnC (Year 5)||363
2917799|NCT00521586|3627841|FG001|Completed 1 Month Follow-up|Revaccination With 13vPnC (Year 5)||359
2917800|NCT00521586|3627840|FG000|Completed 6 Month Follow-up|Revaccination With 13vPnC (Year 5)||361
2917801|NCT00521586|3627841|FG001|Completed 6 Month Follow-up|Revaccination With 13vPnC (Year 5)||351
2917802|NCT00521586|3627840|FG000|COMPLETED|Revaccination With 13vPnC (Year 5)||361
2917803|NCT00521586|3627841|FG001|COMPLETED|Revaccination With 13vPnC (Year 5)||351
2917804|NCT00521586|3627840|FG000|NOT COMPLETED|Revaccination With 13vPnC (Year 5)||3
2917805|NCT00521586|3627841|FG001|NOT COMPLETED|Revaccination With 13vPnC (Year 5)||12
2917806|NCT00521976|3627859|FG000|STARTED|Overall Study||871
2917807|NCT00521976|3627859|FG000|COMPLETED|Overall Study||871
2917808|NCT00521976|3627859|FG000|NOT COMPLETED|Overall Study||0
2917809|NCT00521989|3627868|FG000|STARTED|Overall Study||56
2917810|NCT00521989|3627869|FG001|STARTED|Overall Study||54
2917811|NCT00521989|3627870|FG002|STARTED|Overall Study||57
2917812|NCT00521989|3627871|FG003|STARTED|Overall Study||54
2917813|NCT00521989|3627872|FG004|STARTED|Overall Study||58
2917814|NCT00521989|3627868|FG000|COMPLETED|Overall Study||36
2917815|NCT00521989|3627869|FG001|COMPLETED|Overall Study||37
2917816|NCT00521989|3627870|FG002|COMPLETED|Overall Study||41
2917817|NCT00521989|3627871|FG003|COMPLETED|Overall Study||42
2917818|NCT00521989|3627872|FG004|COMPLETED|Overall Study||35
2917819|NCT00521989|3627868|FG000|NOT COMPLETED|Overall Study||20
2917820|NCT00521989|3627869|FG001|NOT COMPLETED|Overall Study||17
2917821|NCT00521989|3627870|FG002|NOT COMPLETED|Overall Study||16
2917822|NCT00521989|3627871|FG003|NOT COMPLETED|Overall Study||12
2917823|NCT00521989|3627872|FG004|NOT COMPLETED|Overall Study||23
2917824|NCT00522041|3627886|FG000|STARTED|Overall Study||123
2917825|NCT00522041|3627887|FG001|STARTED|Overall Study||125
2917826|NCT00522041|3627886|FG000|Received Treatment|Overall Study||123
2917827|NCT00522041|3627887|FG001|Received Treatment|Overall Study||124
2917828|NCT00522041|3627886|FG000|COMPLETED|Overall Study||106
2917829|NCT00522041|3627887|FG001|COMPLETED|Overall Study||113
2917830|NCT00522041|3627886|FG000|NOT COMPLETED|Overall Study||17
2917831|NCT00522041|3627887|FG001|NOT COMPLETED|Overall Study||12
2917832|NCT00522171|3627896|FG000|STARTED|Overall Study||15
2917833|NCT00522171|3627897|FG001|STARTED|Overall Study||15
2917834|NCT00522171|3627896|FG000|COMPLETED|Overall Study||15
2917835|NCT00522171|3627897|FG001|COMPLETED|Overall Study||15
2917836|NCT00522171|3627896|FG000|NOT COMPLETED|Overall Study||0
2917837|NCT00522171|3627897|FG001|NOT COMPLETED|Overall Study||0
2917838|NCT00522275|3627903|FG000|STARTED|Overall Study||308
2917839|NCT00522275|3627903|FG000|COMPLETED|Overall Study||138
2917840|NCT00522275|3627903|FG000|NOT COMPLETED|Overall Study||170
2917841|NCT00522379|3627912|FG000|STARTED|Overall Study||101
2917842|NCT00522379|3627913|FG001|STARTED|Overall Study||107
2917843|NCT00522379|3627914|FG002|STARTED|Overall Study||104
2917844|NCT00522379|3627915|FG003|STARTED|Overall Study||94
2917845|NCT00522379|3627916|FG004|STARTED|Overall Study||108
2917846|NCT00522379|3627912|FG000|COMPLETED|Overall Study||79
2917847|NCT00522379|3627913|FG001|COMPLETED|Overall Study||84
2917848|NCT00522379|3627914|FG002|COMPLETED|Overall Study||82
2917849|NCT00522379|3627915|FG003|COMPLETED|Overall Study||80
2917850|NCT00522379|3627916|FG004|COMPLETED|Overall Study||81
2917851|NCT00522379|3627912|FG000|NOT COMPLETED|Overall Study||22
2848351|NCT01309672|3550321|FG000|STARTED|Overall Study||41
2848352|NCT01309672|3550321|FG000|Received Protocol Treatment|Overall Study||40
2848353|NCT01309672|3550321|FG000|COMPLETED|Overall Study||4
2848354|NCT01309672|3550321|FG000|NOT COMPLETED|Overall Study||37
2848355|NCT01131169|3550328|FG000|STARTED|Overall Study||47
2848356|NCT01131169|3550329|FG001|STARTED|Overall Study||19
2848357|NCT01131169|3550328|FG000|COMPLETED|Overall Study||47
2848358|NCT01131169|3550329|FG001|COMPLETED|Overall Study||19
2848359|NCT01131169|3550328|FG000|NOT COMPLETED|Overall Study||0
2848360|NCT01131169|3550329|FG001|NOT COMPLETED|Overall Study||0
2848361|NCT00774345|3550338|FG000|STARTED|Pre-treatment||160
2848362|NCT00774345|3550339|FG001|STARTED|Pre-treatment||157
2848363|NCT00774345|3550338|FG000|COMPLETED|Pre-treatment||158
2848364|NCT00774345|3550339|FG001|COMPLETED|Pre-treatment||157
2848365|NCT00774345|3550338|FG000|NOT COMPLETED|Pre-treatment||2
2848366|NCT00774345|3550339|FG001|NOT COMPLETED|Pre-treatment||0
3168342|NCT01918072|3895645|FG001|Intervention|Controlled Trial Step Five - Four Months||0
3168343|NCT01918072|3895646|FG002|Intervention|Controlled Trial Step Five - Four Months||0
3168344|NCT01918072|3895644|FG000|Control|Controlled Trial Step Five - Four Months||0
3168345|NCT01918072|3895645|FG001|Control|Controlled Trial Step Five - Four Months||0
3168346|NCT01918072|3895646|FG002|Control|Controlled Trial Step Five - Four Months||0
3168347|NCT01918072|3895644|FG000|COMPLETED|Controlled Trial Step Five - Four Months||11
3168348|NCT01918072|3895645|FG001|COMPLETED|Controlled Trial Step Five - Four Months||0
3168349|NCT01918072|3895646|FG002|COMPLETED|Controlled Trial Step Five - Four Months||0
3168350|NCT01918072|3895644|FG000|NOT COMPLETED|Controlled Trial Step Five - Four Months||0
3168351|NCT01918072|3895645|FG001|NOT COMPLETED|Controlled Trial Step Five - Four Months||0
3168352|NCT01918072|3895646|FG002|NOT COMPLETED|Controlled Trial Step Five - Four Months||0
3168353|NCT01918072|3895644|FG000|STARTED|E-consult Assessment Period||0
3168354|NCT01918072|3895645|FG001|STARTED|E-consult Assessment Period||42
3311723|NCT03054428|4045208|FG001|COMPLETED|Overall Study||4
3311724|NCT03054428|4045209|FG002|COMPLETED|Overall Study||3
3311725|NCT03054428|4045207|FG000|NOT COMPLETED|Overall Study||83
2848367|NCT00774345|3550338|FG000|STARTED|Treatment||158
2848368|NCT00774345|3550339|FG001|STARTED|Treatment||157
2848369|NCT00774345|3550338|FG000|Participants Escalated to 5mg|Treatment||129
2848370|NCT00774345|3550339|FG001|Participants Escalated to 5mg|Treatment||149
2848371|NCT00774345|3550338|FG000|Participants Escalated to 10mg|Treatment||68
2848372|NCT00774345|3550339|FG001|Participants Escalated to 10mg|Treatment||88
2848373|NCT00774345|3550338|FG000|COMPLETED|Treatment||0
2848374|NCT00774345|3550339|FG001|COMPLETED|Treatment||0
2848375|NCT00774345|3550338|FG000|NOT COMPLETED|Treatment||158
2848376|NCT00774345|3550339|FG001|NOT COMPLETED|Treatment||157
2848377|NCT00457951|3550348|FG000|STARTED|Overall Study||13
2848378|NCT00457951|3550349|FG001|STARTED|Overall Study||66
2848379|NCT00457951|3550350|FG002|STARTED|Overall Study||72
2848380|NCT00457951|3550348|FG000|COMPLETED|Overall Study||13
2848381|NCT00457951|3550349|FG001|COMPLETED|Overall Study||50
2848382|NCT00457951|3550350|FG002|COMPLETED|Overall Study||60
2848383|NCT00457951|3550348|FG000|NOT COMPLETED|Overall Study||0
2848384|NCT00457951|3550349|FG001|NOT COMPLETED|Overall Study||16
2848385|NCT00457951|3550350|FG002|NOT COMPLETED|Overall Study||12
2848386|NCT00345943|3550359|FG000|STARTED|Overall Study||38
2848387|NCT00345943|3550360|FG001|STARTED|Overall Study||33
2848388|NCT00345943|3550359|FG000|COMPLETED|Overall Study||33
2848389|NCT00345943|3550360|FG001|COMPLETED|Overall Study||28
2848390|NCT00345943|3550359|FG000|NOT COMPLETED|Overall Study||5
2848391|NCT00345943|3550360|FG001|NOT COMPLETED|Overall Study||5
2848392|NCT00258427|3550370|FG000|STARTED|Overall Study||3
2848393|NCT00258427|3550371|FG001|STARTED|Overall Study||8
2848394|NCT00258427|3550372|FG002|STARTED|Overall Study||2
2848395|NCT00258427|3550373|FG003|STARTED|Overall Study||1
2848396|NCT00258427|3550370|FG000|COMPLETED|Overall Study||3
2848397|NCT00258427|3550371|FG001|COMPLETED|Overall Study||8
2848398|NCT00258427|3550372|FG002|COMPLETED|Overall Study||2
2848399|NCT00258427|3550373|FG003|COMPLETED|Overall Study||1
2848400|NCT00258427|3550370|FG000|NOT COMPLETED|Overall Study||0
2848401|NCT00258427|3550371|FG001|NOT COMPLETED|Overall Study||0
2848402|NCT00258427|3550372|FG002|NOT COMPLETED|Overall Study||0
2848403|NCT00258427|3550373|FG003|NOT COMPLETED|Overall Study||0
2848404|NCT03722810|3550385|FG000|STARTED|Overall Study||157
2848405|NCT03722810|3550386|FG001|STARTED|Overall Study||160
2848406|NCT03722810|3550385|FG000|COMPLETED|Overall Study||150
2848407|NCT03722810|3550386|FG001|COMPLETED|Overall Study||156
2848408|NCT03722810|3550385|FG000|NOT COMPLETED|Overall Study||7
2848409|NCT03722810|3550386|FG001|NOT COMPLETED|Overall Study||4
2848410|NCT00000125|3550401|FG000|STARTED|Overall Study||819
2848411|NCT00000125|3550402|FG001|STARTED|Overall Study||817
2848412|NCT00000125|3550401|FG000|Completed OHTS Phase I, June 2002|Overall Study||706
2848413|NCT00000125|3550402|FG001|Completed OHTS Phase I, June 2002|Overall Study||702
2848414|NCT00000125|3550401|FG000|COMPLETED|Overall Study|Completed OHTS Phase 2, through March 2009|580
2848415|NCT00000125|3550402|FG001|COMPLETED|Overall Study|Completed OHTS Phase 2, through March 2009|579
2848416|NCT00000125|3550401|FG000|NOT COMPLETED|Overall Study||239
2848417|NCT00000125|3550402|FG001|NOT COMPLETED|Overall Study||238
2848418|NCT00000134|3550411|FG000|STARTED|Overall Study||89
2848419|NCT00000134|3550412|FG001|STARTED|Overall Study||94
2848420|NCT00000134|3550413|FG002|STARTED|Overall Study||96
2848421|NCT00000134|3550411|FG000|COMPLETED|Overall Study||89
2848422|NCT00000134|3550412|FG001|COMPLETED|Overall Study||94
2848423|NCT00000134|3550413|FG002|COMPLETED|Overall Study||96
2848424|NCT00000134|3550411|FG000|NOT COMPLETED|Overall Study||0
2848425|NCT00000134|3550412|FG001|NOT COMPLETED|Overall Study||0
2848426|NCT00000134|3550413|FG002|NOT COMPLETED|Overall Study||0
2848427|NCT00000135|3550423|FG000|STARTED|Overall Study||104
2848428|NCT00000135|3550424|FG001|STARTED|Overall Study||105
2848429|NCT00000135|3550423|FG000|COMPLETED|Overall Study||77
2848430|NCT00000135|3550424|FG001|COMPLETED|Overall Study||91
2848431|NCT00000135|3550423|FG000|NOT COMPLETED|Overall Study||27
2848432|NCT00000135|3550424|FG001|NOT COMPLETED|Overall Study||14
2848433|NCT00000136|3550432|FG000|STARTED|Overall Study||107
2848434|NCT00000136|3550433|FG001|STARTED|Overall Study||127
2848435|NCT00000136|3550432|FG000|COMPLETED|Overall Study||107
2848436|NCT00000136|3550433|FG001|COMPLETED|Overall Study||127
2848437|NCT00000136|3550432|FG000|NOT COMPLETED|Overall Study||0
2848438|NCT00000136|3550433|FG001|NOT COMPLETED|Overall Study||0
2848439|NCT00000142|3550442|FG000|STARTED|Overall Study||26
2848440|NCT00000142|3550443|FG001|STARTED|Overall Study||26
2848441|NCT00000142|3550444|FG002|STARTED|Overall Study||12
2848442|NCT00000142|3550442|FG000|COMPLETED|Overall Study||26
2848443|NCT00000142|3550443|FG001|COMPLETED|Overall Study||26
2848444|NCT00000142|3550444|FG002|COMPLETED|Overall Study||12
2848445|NCT00000142|3550442|FG000|NOT COMPLETED|Overall Study||0
2848446|NCT00000142|3550443|FG001|NOT COMPLETED|Overall Study||0
2848447|NCT00000142|3550444|FG002|NOT COMPLETED|Overall Study||0
2848448|NCT00000143|3550454|FG000|STARTED|Overall Study||31
2848449|NCT00000143|3550455|FG001|STARTED|Overall Study||30
2848450|NCT00000143|3550454|FG000|COMPLETED|Overall Study||31
2848451|NCT00000143|3550455|FG001|COMPLETED|Overall Study||30
2848452|NCT00000143|3550454|FG000|NOT COMPLETED|Overall Study||0
2848453|NCT00000143|3550455|FG001|NOT COMPLETED|Overall Study||0
2848454|NCT00000371|3550463|FG000|STARTED|Overall Study||27
2848455|NCT00000371|3550464|FG001|STARTED|Overall Study||28
2848456|NCT00000371|3550463|FG000|COMPLETED|Overall Study||14
2848457|NCT00000371|3550464|FG001|COMPLETED|Overall Study||12
2848458|NCT00000371|3550463|FG000|NOT COMPLETED|Overall Study||13
2848459|NCT00000371|3550464|FG001|NOT COMPLETED|Overall Study||16
2848460|NCT00000378|3550472|FG000|STARTED|Overall Study||58
2848461|NCT00000378|3550473|FG001|STARTED|Overall Study||52
2848462|NCT00000378|3550472|FG000|COMPLETED|Overall Study||42
2848463|NCT00000378|3550473|FG001|COMPLETED|Overall Study||38
2848464|NCT00000378|3550472|FG000|NOT COMPLETED|Overall Study||16
2848465|NCT00000378|3550473|FG001|NOT COMPLETED|Overall Study||14
2848466|NCT00000392|3550481|FG000|STARTED|Overall Study||106
2848467|NCT00000392|3550482|FG001|STARTED|Overall Study||109
2848468|NCT00000392|3550481|FG000|COMPLETED|Overall Study|provided complete NP outcome data constituted the sample for the primary efficacy analyses|66
2848469|NCT00000392|3550482|FG001|COMPLETED|Overall Study|provided complete NP outcome data constituted the sample for the primary efficacy analyses|77
2848470|NCT00000392|3550481|FG000|NOT COMPLETED|Overall Study||40
2848471|NCT00000392|3550482|FG001|NOT COMPLETED|Overall Study||32
2848472|NCT00000479|3550492|FG000|STARTED|Overall Study||9968
2848473|NCT00000479|3550493|FG001|STARTED|Overall Study||9971
2848474|NCT00000479|3550494|FG002|STARTED|Overall Study||9966
2848475|NCT00000479|3550495|FG003|STARTED|Overall Study||9971
2848476|NCT00000479|3550492|FG000|COMPLETED|Overall Study||9968
2848477|NCT00000479|3550493|FG001|COMPLETED|Overall Study||9971
2848478|NCT00000479|3550494|FG002|COMPLETED|Overall Study||9966
2848479|NCT00000479|3550495|FG003|COMPLETED|Overall Study||9971
2848480|NCT00000479|3550492|FG000|NOT COMPLETED|Overall Study||0
2848481|NCT00000479|3550493|FG001|NOT COMPLETED|Overall Study||0
2848482|NCT00000479|3550494|FG002|NOT COMPLETED|Overall Study||0
2848483|NCT00000479|3550495|FG003|NOT COMPLETED|Overall Study||0
2848484|NCT00000575|3550508|FG000|STARTED|Overall Study||311
2848485|NCT00000575|3550509|FG001|STARTED|Overall Study||312
2848486|NCT00000575|3550510|FG002|STARTED|Overall Study||418
2848487|NCT00000575|3550508|FG000|COMPLETED|Overall Study||311
2848488|NCT00000575|3550509|FG001|COMPLETED|Overall Study||312
2848489|NCT00000575|3550510|FG002|COMPLETED|Overall Study||418
2848490|NCT00000575|3550508|FG000|NOT COMPLETED|Overall Study||0
2848491|NCT00000575|3550509|FG001|NOT COMPLETED|Overall Study||0
2848492|NCT00000575|3550510|FG002|NOT COMPLETED|Overall Study||0
2848493|NCT00000620|3550520|FG000|STARTED|Overall Study||1178
2848494|NCT00000620|3550521|FG001|STARTED|Overall Study||1193
2848495|NCT00000620|3550522|FG002|STARTED|Overall Study||1374
2848496|NCT00000620|3550523|FG003|STARTED|Overall Study||1383
2848497|NCT00000620|3550524|FG004|STARTED|Overall Study||1184
2848498|NCT00000620|3550525|FG005|STARTED|Overall Study||1178
2848499|NCT00000620|3550526|FG006|STARTED|Overall Study||1391
2848500|NCT00000620|3550527|FG007|STARTED|Overall Study||1370
2848501|NCT00000620|3550520|FG000|COMPLETED|Overall Study||1016
2848502|NCT00000620|3550521|FG001|COMPLETED|Overall Study||1057
2848503|NCT00000620|3550522|FG002|COMPLETED|Overall Study||1204
2848504|NCT00000620|3550523|FG003|COMPLETED|Overall Study||1205
2848505|NCT00000620|3550524|FG004|COMPLETED|Overall Study||1049
2848506|NCT00000620|3550525|FG005|COMPLETED|Overall Study||1026
2848507|NCT00000620|3550526|FG006|COMPLETED|Overall Study||1242
2848508|NCT00000620|3550527|FG007|COMPLETED|Overall Study||1224
2848509|NCT00000620|3550520|FG000|NOT COMPLETED|Overall Study||162
2848510|NCT00000620|3550521|FG001|NOT COMPLETED|Overall Study||136
2848511|NCT00000620|3550522|FG002|NOT COMPLETED|Overall Study||170
2848512|NCT00000620|3550523|FG003|NOT COMPLETED|Overall Study||178
2848513|NCT00000620|3550524|FG004|NOT COMPLETED|Overall Study||135
2848514|NCT00000620|3550525|FG005|NOT COMPLETED|Overall Study||152
2848515|NCT00000620|3550526|FG006|NOT COMPLETED|Overall Study||149
2848516|NCT00000620|3550527|FG007|NOT COMPLETED|Overall Study||146
2848517|NCT00001151|3550539|FG000|STARTED|Overall Study||6
2848518|NCT00001151|3550539|FG000|COMPLETED|Overall Study||1
2848519|NCT00001151|3550539|FG000|NOT COMPLETED|Overall Study||5
2848520|NCT00001213|3550543|FG000|STARTED|Overall Study||328
2848521|NCT00001213|3550543|FG000|COMPLETED|Overall Study||310
2848522|NCT00001213|3550543|FG000|NOT COMPLETED|Overall Study||18
2848523|NCT00001262|3550550|FG000|STARTED|Overall Study||35
2848524|NCT00001262|3550551|FG001|STARTED|Overall Study||22
2848525|NCT00001262|3550552|FG002|STARTED|Overall Study||3
2848526|NCT00001262|3550550|FG000|COMPLETED|Overall Study||25
2848527|NCT00001262|3550551|FG001|COMPLETED|Overall Study||8
2848528|NCT00001262|3550552|FG002|COMPLETED|Overall Study||3
2848529|NCT00001262|3550550|FG000|NOT COMPLETED|Overall Study||10
2848530|NCT00001262|3550551|FG001|NOT COMPLETED|Overall Study||14
2848531|NCT00001262|3550552|FG002|NOT COMPLETED|Overall Study||0
2848532|NCT00001304|3550562|FG000|STARTED|Overall Study||13
2848533|NCT00001304|3550563|FG001|STARTED|Overall Study||14
2848534|NCT00001304|3550562|FG000|COMPLETED|Overall Study||13
2848535|NCT00001304|3550563|FG001|COMPLETED|Overall Study||14
2848536|NCT00001304|3550562|FG000|NOT COMPLETED|Overall Study||0
2848537|NCT00001304|3550563|FG001|NOT COMPLETED|Overall Study||0
2848538|NCT00001305|3550569|FG000|STARTED|Overall Study||42
2848539|NCT00001305|3550569|FG000|COMPLETED|Overall Study||42
2848540|NCT00001305|3550569|FG000|NOT COMPLETED|Overall Study||0
2848541|NCT00001566|3550573|FG000|STARTED|Overall Study||42
2848542|NCT00001566|3550573|FG000|Completed Immunotherapy|Overall Study||23
2848543|NCT00001566|3550573|FG000|COMPLETED|Overall Study||23
2848544|NCT00001566|3550573|FG000|NOT COMPLETED|Overall Study||19
2848545|NCT00001575|3550577|FG000|STARTED|Overall Study||87
2848546|NCT00001575|3550577|FG000|Treated|Overall Study||65
2848547|NCT00001575|3550577|FG000|COMPLETED|Overall Study||42
2848548|NCT00001575|3550577|FG000|NOT COMPLETED|Overall Study||45
2848549|NCT00001586|3550583|FG000|STARTED|Overall Study||49
2848550|NCT00001586|3550584|FG001|STARTED|Overall Study||56
2848551|NCT00001586|3550583|FG000|COMPLETED|Overall Study||49
2848552|NCT00001586|3550584|FG001|COMPLETED|Overall Study||56
2848553|NCT00001586|3550583|FG000|NOT COMPLETED|Overall Study||0
2848554|NCT00001586|3550584|FG001|NOT COMPLETED|Overall Study||0
2848555|NCT00001596|3550592|FG000|STARTED|Overall Study||23
2848556|NCT00001596|3550593|FG001|STARTED|Overall Study||12
2848557|NCT00001596|3550592|FG000|COMPLETED|Overall Study||6
2848558|NCT00001596|3550593|FG001|COMPLETED|Overall Study||2
2848559|NCT00001596|3550592|FG000|NOT COMPLETED|Overall Study||17
2848560|NCT00001596|3550593|FG001|NOT COMPLETED|Overall Study||10
2848561|NCT00001656|3550601|FG000|STARTED|Overall Study||13
2848562|NCT00001656|3550602|FG001|STARTED|Overall Study||12
2848563|NCT00001656|3550601|FG000|COMPLETED|Overall Study||12
2848564|NCT00001656|3550602|FG001|COMPLETED|Overall Study||12
2848565|NCT00001656|3550601|FG000|NOT COMPLETED|Overall Study||1
2848566|NCT00001656|3550602|FG001|NOT COMPLETED|Overall Study||0
2848567|NCT00001703|3550608|FG000|STARTED|Overall Study||6
2848568|NCT00001703|3550608|FG000|Peptide Stock Completed|Overall Study|off therapy reason for 3 patients|3
2848569|NCT00001703|3550608|FG000|COMPLETED|Overall Study||1
2848570|NCT00001703|3550608|FG000|NOT COMPLETED|Overall Study||5
2848571|NCT00001723|3550614|FG000|STARTED|Overall Study||100
2848572|NCT00001723|3550615|FG001|STARTED|Overall Study||100
2848573|NCT00001723|3550614|FG000|COMPLETED|Overall Study||87
2848574|NCT00001723|3550615|FG001|COMPLETED|Overall Study||84
2848575|NCT00001723|3550614|FG000|NOT COMPLETED|Overall Study||13
2848576|NCT00001723|3550615|FG001|NOT COMPLETED|Overall Study||16
2848577|NCT00001832|3550639|FG000|STARTED|Apheresis Period||170
2848578|NCT00001832|3550640|FG001|STARTED|Apheresis Period||0
2848579|NCT00001832|3550641|FG002|STARTED|Apheresis Period||0
2848580|NCT00001832|3550642|FG003|STARTED|Apheresis Period||0
2848581|NCT00001832|3550643|FG004|STARTED|Apheresis Period||0
2848582|NCT00001832|3550644|FG005|STARTED|Apheresis Period||0
2848583|NCT00001832|3550645|FG006|STARTED|Apheresis Period||0
2848584|NCT00001832|3550646|FG007|STARTED|Apheresis Period||0
2848585|NCT00001832|3550647|FG008|STARTED|Apheresis Period||0
2848586|NCT00001832|3550648|FG009|STARTED|Apheresis Period||0
2848587|NCT00001832|3550649|FG010|STARTED|Apheresis Period||0
2848588|NCT00001832|3550650|FG011|STARTED|Apheresis Period||0
2848589|NCT00001832|3550651|FG012|STARTED|Apheresis Period||0
2848590|NCT00001832|3550652|FG013|STARTED|Apheresis Period||0
2848591|NCT00001832|3550653|FG014|STARTED|Apheresis Period||0
2848592|NCT00001832|3550639|FG000|COMPLETED|Apheresis Period||110
2848593|NCT00001832|3550640|FG001|COMPLETED|Apheresis Period||0
2848594|NCT00001832|3550641|FG002|COMPLETED|Apheresis Period||0
2848595|NCT00001832|3550642|FG003|COMPLETED|Apheresis Period||0
2848596|NCT00001832|3550643|FG004|COMPLETED|Apheresis Period||0
2848597|NCT00001832|3550644|FG005|COMPLETED|Apheresis Period||0
2848598|NCT00001832|3550645|FG006|COMPLETED|Apheresis Period||0
2848599|NCT00001832|3550646|FG007|COMPLETED|Apheresis Period||0
2848600|NCT00001832|3550647|FG008|COMPLETED|Apheresis Period||0
2848601|NCT00001832|3550648|FG009|COMPLETED|Apheresis Period||0
2848602|NCT00001832|3550649|FG010|COMPLETED|Apheresis Period||0
2848603|NCT00001832|3550650|FG011|COMPLETED|Apheresis Period||0
2848604|NCT00001832|3550651|FG012|COMPLETED|Apheresis Period||0
2848605|NCT00001832|3550652|FG013|COMPLETED|Apheresis Period||0
2848606|NCT00001832|3550653|FG014|COMPLETED|Apheresis Period||0
2848607|NCT00001832|3550639|FG000|NOT COMPLETED|Apheresis Period||60
2848608|NCT00001832|3550640|FG001|NOT COMPLETED|Apheresis Period||0
2848609|NCT00001832|3550641|FG002|NOT COMPLETED|Apheresis Period||0
2848610|NCT00001832|3550642|FG003|NOT COMPLETED|Apheresis Period||0
2848611|NCT00001832|3550643|FG004|NOT COMPLETED|Apheresis Period||0
2848612|NCT00001832|3550644|FG005|NOT COMPLETED|Apheresis Period||0
2848613|NCT00001832|3550645|FG006|NOT COMPLETED|Apheresis Period||0
2848614|NCT00001832|3550646|FG007|NOT COMPLETED|Apheresis Period||0
2848615|NCT00001832|3550647|FG008|NOT COMPLETED|Apheresis Period||0
2848616|NCT00001832|3550648|FG009|NOT COMPLETED|Apheresis Period||0
2848617|NCT00001832|3550649|FG010|NOT COMPLETED|Apheresis Period||0
2848618|NCT00001832|3550650|FG011|NOT COMPLETED|Apheresis Period||0
2848619|NCT00001832|3550651|FG012|NOT COMPLETED|Apheresis Period||0
2848620|NCT00001832|3550652|FG013|NOT COMPLETED|Apheresis Period||0
2848621|NCT00001832|3550653|FG014|NOT COMPLETED|Apheresis Period||0
2848622|NCT00001832|3550639|FG000|STARTED|Treatment Period||0
2848623|NCT00001832|3550640|FG001|STARTED|Treatment Period||3
2848624|NCT00001832|3550641|FG002|STARTED|Treatment Period||3
2848625|NCT00001832|3550642|FG003|STARTED|Treatment Period||3
2848626|NCT00001832|3550643|FG004|STARTED|Treatment Period||6
2848627|NCT00001832|3550644|FG005|STARTED|Treatment Period||51
2848628|NCT00001832|3550645|FG006|STARTED|Treatment Period||4
2848629|NCT00001832|3550646|FG007|STARTED|Treatment Period||7
2848630|NCT00001832|3550647|FG008|STARTED|Treatment Period||8
2848631|NCT00001832|3550648|FG009|STARTED|Treatment Period||6
2848632|NCT00001832|3550649|FG010|STARTED|Treatment Period||1
2848633|NCT00001832|3550650|FG011|STARTED|Treatment Period||7
2848634|NCT00001832|3550651|FG012|STARTED|Treatment Period||6
2848635|NCT00001832|3550652|FG013|STARTED|Treatment Period||3
2848636|NCT00001832|3550653|FG014|STARTED|Treatment Period||2
2848637|NCT00001832|3550639|FG000|COMPLETED|Treatment Period||0
2848638|NCT00001832|3550640|FG001|COMPLETED|Treatment Period||3
2848639|NCT00001832|3550641|FG002|COMPLETED|Treatment Period||3
2848640|NCT00001832|3550642|FG003|COMPLETED|Treatment Period||3
2848641|NCT00001832|3550643|FG004|COMPLETED|Treatment Period||6
2848642|NCT00001832|3550644|FG005|COMPLETED|Treatment Period||50
2848643|NCT00001832|3550645|FG006|COMPLETED|Treatment Period||4
2848644|NCT00001832|3550646|FG007|COMPLETED|Treatment Period||6
2848645|NCT00001832|3550647|FG008|COMPLETED|Treatment Period||8
2848646|NCT00001832|3550648|FG009|COMPLETED|Treatment Period||6
2848647|NCT00001832|3550649|FG010|COMPLETED|Treatment Period||1
2848648|NCT00001832|3550650|FG011|COMPLETED|Treatment Period||7
2848649|NCT00001832|3550651|FG012|COMPLETED|Treatment Period||6
2848650|NCT00001832|3550652|FG013|COMPLETED|Treatment Period||3
2848651|NCT00001832|3550653|FG014|COMPLETED|Treatment Period||2
2848652|NCT00001832|3550639|FG000|NOT COMPLETED|Treatment Period||0
2848653|NCT00001832|3550640|FG001|NOT COMPLETED|Treatment Period||0
2848654|NCT00001832|3550641|FG002|NOT COMPLETED|Treatment Period||0
2848655|NCT00001832|3550642|FG003|NOT COMPLETED|Treatment Period||0
2848656|NCT00001832|3550643|FG004|NOT COMPLETED|Treatment Period||0
2848657|NCT00001832|3550644|FG005|NOT COMPLETED|Treatment Period||1
2848658|NCT00001832|3550645|FG006|NOT COMPLETED|Treatment Period||0
2848659|NCT00001832|3550646|FG007|NOT COMPLETED|Treatment Period||1
2848660|NCT00001832|3550647|FG008|NOT COMPLETED|Treatment Period||0
2848661|NCT00001832|3550648|FG009|NOT COMPLETED|Treatment Period||0
2848662|NCT00001832|3550649|FG010|NOT COMPLETED|Treatment Period||0
2848663|NCT00001832|3550650|FG011|NOT COMPLETED|Treatment Period||0
2848664|NCT00001832|3550651|FG012|NOT COMPLETED|Treatment Period||0
2848665|NCT00001832|3550652|FG013|NOT COMPLETED|Treatment Period||0
2848666|NCT00001832|3550653|FG014|NOT COMPLETED|Treatment Period||0
2848667|NCT00001849|3550683|FG000|STARTED|Overall Study||68
2848668|NCT00001849|3550683|FG000|COMPLETED|Overall Study|Patients completed when an ectopic ACTH-secreting tumor was identified|54
2848669|NCT00001849|3550683|FG000|NOT COMPLETED|Overall Study||14
2848670|NCT00001880|3550696|FG000|STARTED|Overall Study||42
2848671|NCT00001880|3550696|FG000|COMPLETED|Overall Study||28
2848672|NCT00001880|3550696|FG000|NOT COMPLETED|Overall Study||14
2848673|NCT00001941|3550700|FG000|STARTED|Overall Study||3
2848674|NCT00001941|3550701|FG001|STARTED|Overall Study||5
2848675|NCT00001941|3550702|FG002|STARTED|Overall Study||3
2848676|NCT00001941|3550703|FG003|STARTED|Overall Study||3
2848677|NCT00001941|3550704|FG004|STARTED|Overall Study||20
2848678|NCT00001941|3550700|FG000|COMPLETED|Overall Study||3
2848679|NCT00001941|3550701|FG001|COMPLETED|Overall Study||5
2848680|NCT00001941|3550702|FG002|COMPLETED|Overall Study||3
2848681|NCT00001941|3550703|FG003|COMPLETED|Overall Study||3
2848682|NCT00001941|3550704|FG004|COMPLETED|Overall Study||19
2848683|NCT00001941|3550700|FG000|NOT COMPLETED|Overall Study||0
2848684|NCT00001941|3550701|FG001|NOT COMPLETED|Overall Study||0
2848685|NCT00001941|3550702|FG002|NOT COMPLETED|Overall Study||0
3311726|NCT03054428|4045208|FG001|NOT COMPLETED|Overall Study||80
3311727|NCT03054428|4045209|FG002|NOT COMPLETED|Overall Study||79
3311728|NCT03054506|4045220|FG000|STARTED|Overall Study||20
2848686|NCT00001941|3550703|FG003|NOT COMPLETED|Overall Study||0
2848687|NCT00001941|3550704|FG004|NOT COMPLETED|Overall Study||1
2848688|NCT00001959|3550709|FG000|STARTED|Overall Study||21
2848689|NCT00001959|3550709|FG000|COMPLETED|Overall Study||18
2848690|NCT00001959|3550709|FG000|NOT COMPLETED|Overall Study||3
2848691|NCT00001962|3550713|FG000|STARTED|Overall Study||100
2848692|NCT00001962|3550713|FG000|COMPLETED|Overall Study||72
2848693|NCT00001962|3550713|FG000|NOT COMPLETED|Overall Study||28
2848694|NCT00001984|3550717|FG000|STARTED|Overall Study||5
2848695|NCT00001984|3550717|FG000|COMPLETED|Overall Study||5
2848696|NCT00001984|3550717|FG000|NOT COMPLETED|Overall Study||0
2848697|NCT00002525|3550723|FG000|STARTED|Overall Study|859 patients were enrolled to the study, but 4 patients were not randomized to any treatment arm|427
2848698|NCT00002525|3550724|FG001|STARTED|Overall Study||428
2848699|NCT00002525|3550723|FG000|Treated|Overall Study||419
2848700|NCT00002525|3550724|FG001|Treated|Overall Study|"Patients on No perioperative 5-FU arm received no perioperative chemotherapy"|0
2848701|NCT00002525|3550723|FG000|Dukes' B3 or C Stage|Overall Study|"Primary population: pts with Duke's B3, C disease. 158 such pts on No perioperative 5-FU arm"|156
2848702|NCT00002525|3550724|FG001|Dukes' B3 or C Stage|Overall Study||158
2848703|NCT00002525|3550723|FG000|Dukes' B2 Stage|Overall Study||150
2848704|NCT00002525|3550724|FG001|Dukes' B2 Stage|Overall Study||139
2848705|NCT00002525|3550723|FG000|COMPLETED|Overall Study||241
2848706|NCT00002525|3550724|FG001|COMPLETED|Overall Study|"Patients on No perioperative 5-FU arm received no perioperative chemotherapy"|428
2848707|NCT00002525|3550723|FG000|NOT COMPLETED|Overall Study||186
2848708|NCT00002525|3550724|FG001|NOT COMPLETED|Overall Study||0
2848709|NCT00002540|3550734|FG000|STARTED|Overall Study||38345
2848710|NCT00002540|3550735|FG001|STARTED|Overall Study||38340
2848711|NCT00002540|3550734|FG000|COMPLETED|Overall Study||37544
2848712|NCT00002540|3550735|FG001|COMPLETED|Overall Study||35876
2848713|NCT00002540|3550734|FG000|NOT COMPLETED|Overall Study||801
2848714|NCT00002540|3550735|FG001|NOT COMPLETED|Overall Study||2464
2848715|NCT00002558|3550743|FG000|STARTED|Overall Study||92
2848716|NCT00002558|3550744|FG001|STARTED|Overall Study||16
2848717|NCT00002558|3550743|FG000|COMPLETED|Overall Study||92
2848718|NCT00002558|3550744|FG001|COMPLETED|Overall Study||15
2848719|NCT00002558|3550743|FG000|NOT COMPLETED|Overall Study||0
2848720|NCT00002558|3550744|FG001|NOT COMPLETED|Overall Study||1
2848721|NCT00002597|3550752|FG000|STARTED|Overall Study||1013
2848722|NCT00002597|3550753|FG001|STARTED|Overall Study||1015
2848723|NCT00002597|3550752|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|987
2848724|NCT00002597|3550753|FG001|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|992
2848725|NCT00002597|3550752|FG000|NOT COMPLETED|Overall Study||26
2848726|NCT00002597|3550753|FG001|NOT COMPLETED|Overall Study||23
2848727|NCT00002601|3550759|FG000|STARTED|Overall Study||13
2848728|NCT00002601|3550759|FG000|COMPLETED|Overall Study||13
2848729|NCT00002601|3550759|FG000|NOT COMPLETED|Overall Study||0
2848730|NCT00002651|3550767|FG000|STARTED|Induction||3040
2848731|NCT00002651|3550768|FG001|STARTED|Induction||0
2848732|NCT00002651|3550769|FG002|STARTED|Induction||0
2848733|NCT00002651|3550767|FG000|Eligible|Induction||2950
2848734|NCT00002651|3550768|FG001|Eligible|Induction||0
2848735|NCT00002651|3550769|FG002|Eligible|Induction||0
2848736|NCT00002651|3550767|FG000|Eligible and Began Protocol Therapy|Induction||2950
2848737|NCT00002651|3550768|FG001|Eligible and Began Protocol Therapy|Induction||0
2848738|NCT00002651|3550769|FG002|Eligible and Began Protocol Therapy|Induction||0
2848739|NCT00002651|3550767|FG000|COMPLETED|Induction||1697
2848740|NCT00002651|3550768|FG001|COMPLETED|Induction||0
2848741|NCT00002651|3550769|FG002|COMPLETED|Induction||0
2848742|NCT00002651|3550767|FG000|NOT COMPLETED|Induction||1343
2848743|NCT00002651|3550768|FG001|NOT COMPLETED|Induction||0
2848744|NCT00002651|3550769|FG002|NOT COMPLETED|Induction||0
2848745|NCT00002651|3550767|FG000|STARTED|Consolidation and Randomization||0
2848746|NCT00002651|3550768|FG001|STARTED|Consolidation and Randomization|After induction,patients with stable or declining PSA (≤ 4.0 ng/mL) were eligible for randomization|867
2848747|NCT00002651|3550769|FG002|STARTED|Consolidation and Randomization|After induction,patients with stable or declining PSA (≤ 4.0 ng/mL) were eligible for randomization|882
2848748|NCT00002651|3550767|FG000|Eligible|Consolidation and Randomization||0
2848749|NCT00002651|3550768|FG001|Eligible|Consolidation and Randomization||765
2848750|NCT00002651|3550769|FG002|Eligible|Consolidation and Randomization||770
2848751|NCT00002651|3550767|FG000|Assessable for Toxicity|Consolidation and Randomization||0
2848752|NCT00002651|3550768|FG001|Assessable for Toxicity|Consolidation and Randomization||732
2848753|NCT00002651|3550769|FG002|Assessable for Toxicity|Consolidation and Randomization||702
2848754|NCT00002651|3550767|FG000|COMPLETED|Consolidation and Randomization||0
2848755|NCT00002651|3550768|FG001|COMPLETED|Consolidation and Randomization||29
2848756|NCT00002651|3550769|FG002|COMPLETED|Consolidation and Randomization||22
2848757|NCT00002651|3550767|FG000|NOT COMPLETED|Consolidation and Randomization||0
2848758|NCT00002651|3550768|FG001|NOT COMPLETED|Consolidation and Randomization||838
2848759|NCT00002651|3550769|FG002|NOT COMPLETED|Consolidation and Randomization||860
2848760|NCT00002766|3550779|FG000|STARTED|Overall Study||81
2848761|NCT00002766|3550780|FG001|STARTED|Overall Study||89
2848762|NCT00002766|3550779|FG000|COMPLETED|Overall Study||78
2848763|NCT00002766|3550780|FG001|COMPLETED|Overall Study||85
2848764|NCT00002766|3550779|FG000|NOT COMPLETED|Overall Study||3
2848765|NCT00002766|3550780|FG001|NOT COMPLETED|Overall Study||4
2848766|NCT00002842|3550786|FG000|STARTED|Overall Study||49
2848767|NCT00002842|3550786|FG000|COMPLETED|Overall Study||22
2848768|NCT00002842|3550786|FG000|NOT COMPLETED|Overall Study||27
2848769|NCT00002850|3550793|FG000|STARTED|Overall Study||69
2848770|NCT00002850|3550794|FG001|STARTED|Overall Study||76
2848771|NCT00002850|3550795|FG002|STARTED|Overall Study||67
2848772|NCT00002850|3550793|FG000|COMPLETED|Overall Study||64
2848773|NCT00002850|3550794|FG001|COMPLETED|Overall Study||74
2848774|NCT00002850|3550795|FG002|COMPLETED|Overall Study||63
2848775|NCT00002850|3550793|FG000|NOT COMPLETED|Overall Study||5
2848776|NCT00002850|3550794|FG001|NOT COMPLETED|Overall Study||2
2848777|NCT00002850|3550795|FG002|NOT COMPLETED|Overall Study||4
2848778|NCT00002874|3550805|FG000|STARTED|Overall Study||421
2848779|NCT00002874|3550806|FG001|STARTED|Overall Study||419
2848780|NCT00002874|3550805|FG000|COMPLETED|Overall Study||376
2848781|NCT00002874|3550806|FG001|COMPLETED|Overall Study||384
2848782|NCT00002874|3550805|FG000|NOT COMPLETED|Overall Study||45
2848783|NCT00002874|3550806|FG001|NOT COMPLETED|Overall Study||35
2848784|NCT00002931|3550812|FG000|STARTED|Overall Study||48
2848785|NCT00002931|3550812|FG000|COMPLETED|Overall Study||46
2848786|NCT00002931|3550812|FG000|NOT COMPLETED|Overall Study||2
2848787|NCT00003042|3550818|FG000|STARTED|Overall Study||14
2848788|NCT00003042|3550819|FG001|STARTED|Overall Study||27
2848789|NCT00003042|3550818|FG000|COMPLETED|Overall Study||14
2848790|NCT00003042|3550819|FG001|COMPLETED|Overall Study||27
2848791|NCT00003042|3550818|FG000|NOT COMPLETED|Overall Study||0
2848792|NCT00003042|3550819|FG001|NOT COMPLETED|Overall Study||0
2848793|NCT00003138|3550827|FG000|STARTED|Step 1||61
2848794|NCT00003138|3550828|FG001|STARTED|Step 1||57
2848795|NCT00003138|3550827|FG000|Patients With Complete Data|Step 1||57
2848796|NCT00003138|3550828|FG001|Patients With Complete Data|Step 1||53
2848797|NCT00003138|3550827|FG000|Treated|Step 1||56
2848798|NCT00003138|3550828|FG001|Treated|Step 1||53
2848799|NCT00003138|3550827|FG000|Eligible and Treated|Step 1||52
2848800|NCT00003138|3550828|FG001|Eligible and Treated|Step 1||50
2848801|NCT00003138|3550827|FG000|Patients With QOL Data at 4 Months|Step 1||42
2848802|NCT00003138|3550828|FG001|Patients With QOL Data at 4 Months|Step 1||42
2848803|NCT00003138|3550827|FG000|Patients With Transfusion Data|Step 1||37
2848804|NCT00003138|3550828|FG001|Patients With Transfusion Data|Step 1||42
2848805|NCT00003138|3550827|FG000|COMPLETED|Step 1||0
2848806|NCT00003138|3550828|FG001|COMPLETED|Step 1||0
2848807|NCT00003138|3550827|FG000|NOT COMPLETED|Step 1||61
2848808|NCT00003138|3550828|FG001|NOT COMPLETED|Step 1||57
2848809|NCT00003138|3550827|FG000|STARTED|Step 2 (Cross Over)||26
2848810|NCT00003138|3550828|FG001|STARTED|Step 2 (Cross Over)|Only patients in the supportive care arm are eligible to cross over to the Erythropoietin arm.|0
2848811|NCT00003138|3550827|FG000|COMPLETED|Step 2 (Cross Over)||0
2848812|NCT00003138|3550828|FG001|COMPLETED|Step 2 (Cross Over)||0
2848813|NCT00003138|3550827|FG000|NOT COMPLETED|Step 2 (Cross Over)||26
2848814|NCT00003138|3550828|FG001|NOT COMPLETED|Step 2 (Cross Over)||0
2848815|NCT00003138|3550827|FG000|STARTED|Step 3 (EPO 150 Units/kg and G-CSF)||12
2848816|NCT00003138|3550828|FG001|STARTED|Step 3 (EPO 150 Units/kg and G-CSF)||20
2848817|NCT00003138|3550827|FG000|Treated|Step 3 (EPO 150 Units/kg and G-CSF)||12
2848818|NCT00003138|3550828|FG001|Treated|Step 3 (EPO 150 Units/kg and G-CSF)||19
2848819|NCT00003138|3550827|FG000|COMPLETED|Step 3 (EPO 150 Units/kg and G-CSF)||0
2848820|NCT00003138|3550828|FG001|COMPLETED|Step 3 (EPO 150 Units/kg and G-CSF)||0
2848821|NCT00003138|3550827|FG000|NOT COMPLETED|Step 3 (EPO 150 Units/kg and G-CSF)||12
2848822|NCT00003138|3550828|FG001|NOT COMPLETED|Step 3 (EPO 150 Units/kg and G-CSF)||20
2848823|NCT00003138|3550827|FG000|STARTED|Step 4 (EPO 300 Units/kg and G-CSF)||6
2848824|NCT00003138|3550828|FG001|STARTED|Step 4 (EPO 300 Units/kg and G-CSF)||7
2848825|NCT00003138|3550827|FG000|COMPLETED|Step 4 (EPO 300 Units/kg and G-CSF)||0
2848826|NCT00003138|3550828|FG001|COMPLETED|Step 4 (EPO 300 Units/kg and G-CSF)||0
2848827|NCT00003138|3550827|FG000|NOT COMPLETED|Step 4 (EPO 300 Units/kg and G-CSF)||6
2848828|NCT00003138|3550828|FG001|NOT COMPLETED|Step 4 (EPO 300 Units/kg and G-CSF)||7
2848829|NCT00003199|3550837|FG000|STARTED|Overall Study||50
2848830|NCT00003199|3550837|FG000|COMPLETED|Overall Study||28
2848831|NCT00003199|3550837|FG000|NOT COMPLETED|Overall Study||22
2848832|NCT00003222|3550843|FG000|STARTED|Overall Study||13
2848833|NCT00003222|3550844|FG001|STARTED|Overall Study||28
2848834|NCT00003222|3550843|FG000|COMPLETED|Overall Study||13
2848835|NCT00003222|3550844|FG001|COMPLETED|Overall Study|Decline in performance status between enrollment and initiation of therapy.|27
2848836|NCT00003222|3550843|FG000|NOT COMPLETED|Overall Study||0
2848837|NCT00003222|3550844|FG001|NOT COMPLETED|Overall Study||1
2848838|NCT00003224|3550856|FG000|STARTED|Overall Study||4
2848839|NCT00003224|3550857|FG001|STARTED|Overall Study||5
2848840|NCT00003224|3550858|FG002|STARTED|Overall Study||4
2848841|NCT00003224|3550859|FG003|STARTED|Overall Study||2
2848842|NCT00003224|3550860|FG004|STARTED|Overall Study||4
2848843|NCT00003224|3550861|FG005|STARTED|Overall Study||3
2848844|NCT00003224|3550856|FG000|COMPLETED|Overall Study||4
2848845|NCT00003224|3550857|FG001|COMPLETED|Overall Study||5
2848846|NCT00003224|3550858|FG002|COMPLETED|Overall Study||4
2848847|NCT00003224|3550859|FG003|COMPLETED|Overall Study||2
2848848|NCT00003224|3550860|FG004|COMPLETED|Overall Study||4
2848849|NCT00003224|3550861|FG005|COMPLETED|Overall Study||3
2848850|NCT00003224|3550856|FG000|NOT COMPLETED|Overall Study||0
2848851|NCT00003224|3550857|FG001|NOT COMPLETED|Overall Study||0
2848852|NCT00003224|3550858|FG002|NOT COMPLETED|Overall Study||0
2848853|NCT00003224|3550859|FG003|NOT COMPLETED|Overall Study||0
2848854|NCT00003224|3550860|FG004|NOT COMPLETED|Overall Study||0
2848855|NCT00003224|3550861|FG005|NOT COMPLETED|Overall Study||0
2848856|NCT00003270|3550873|FG000|STARTED|Overall Study||20
2848857|NCT00003270|3550873|FG000|COMPLETED|Overall Study||20
2848858|NCT00003270|3550873|FG000|NOT COMPLETED|Overall Study||0
2917852|NCT00522379|3627913|FG001|NOT COMPLETED|Overall Study||23
2917853|NCT00522379|3627914|FG002|NOT COMPLETED|Overall Study||22
2848859|NCT04617860|3550880|FG000|STARTED|Overall Study||8
2848860|NCT04617860|3550881|FG001|STARTED|Overall Study||10
2848861|NCT04617860|3550882|FG002|STARTED|Overall Study||18
2848862|NCT04617860|3550880|FG000|Dose Modified to 8 mg|Overall Study||8
2848863|NCT04617860|3550881|FG001|Dose Modified to 8 mg|Overall Study||1
2848864|NCT04617860|3550882|FG002|Dose Modified to 8 mg|Overall Study||0
2848865|NCT04617860|3550880|FG000|Dose Modified to 16 mg|Overall Study||8
2848866|NCT04617860|3550881|FG001|Dose Modified to 16 mg|Overall Study||9
2848867|NCT04617860|3550882|FG002|Dose Modified to 16 mg|Overall Study||8
2848868|NCT04617860|3550880|FG000|Dose Modified to 32 mg|Overall Study||2
2848869|NCT04617860|3550881|FG001|Dose Modified to 32 mg|Overall Study||4
2848870|NCT04617860|3550882|FG002|Dose Modified to 32 mg|Overall Study||11
2848871|NCT04617860|3550880|FG000|COMPLETED|Overall Study||0
2848872|NCT04617860|3550881|FG001|COMPLETED|Overall Study||0
2848873|NCT04617860|3550882|FG002|COMPLETED|Overall Study||0
2848874|NCT04617860|3550880|FG000|NOT COMPLETED|Overall Study||8
2848875|NCT04617860|3550881|FG001|NOT COMPLETED|Overall Study||10
2848876|NCT04617860|3550882|FG002|NOT COMPLETED|Overall Study||18
2848877|NCT04617847|3550894|FG000|STARTED|Overall Study||3
2848878|NCT04617847|3550895|FG001|STARTED|Overall Study||24
2848879|NCT04617847|3550894|FG000|Dose Modified to 16 mg WVE-120101|Overall Study||3
2848880|NCT04617847|3550895|FG001|Dose Modified to 16 mg WVE-120101|Overall Study||1
2848881|NCT04617847|3550894|FG000|Dose Modified to 32 mg WVE-120101|Overall Study||0
2848882|NCT04617847|3550895|FG001|Dose Modified to 32 mg WVE-120101|Overall Study||5
2848883|NCT04617847|3550894|FG000|COMPLETED|Overall Study||0
2848884|NCT04617847|3550895|FG001|COMPLETED|Overall Study||0
2848885|NCT04617847|3550894|FG000|NOT COMPLETED|Overall Study||3
2848886|NCT04617847|3550895|FG001|NOT COMPLETED|Overall Study||24
2848887|NCT04426318|3550905|FG000|STARTED|Overall Study||346
2848888|NCT04426318|3550906|FG001|STARTED|Overall Study||320
2848889|NCT04426318|3550905|FG000|Failed Attention Checks|Overall Study||4
2848890|NCT04426318|3550906|FG001|Failed Attention Checks|Overall Study||6
2848891|NCT04426318|3550905|FG000|Downloaded HMP App|Overall Study||329
2848892|NCT04426318|3550906|FG001|Downloaded HMP App|Overall Study||0
2848893|NCT04426318|3550905|FG000|Completed T2 Assessment|Overall Study||281
2848894|NCT04426318|3550906|FG001|Completed T2 Assessment|Overall Study||280
2848895|NCT04426318|3550905|FG000|Completed T3 Assessment|Overall Study||261
2848896|NCT04426318|3550906|FG001|Completed T3 Assessment|Overall Study||274
2848897|NCT04426318|3550905|FG000|Completed T4 Assessment|Overall Study||261
2848898|NCT04426318|3550906|FG001|Completed T4 Assessment|Overall Study||275
2848899|NCT04426318|3550905|FG000|Completed T5 Assessment|Overall Study||284
2848900|NCT04426318|3550906|FG001|Completed T5 Assessment|Overall Study||293
2848901|NCT04426318|3550905|FG000|Completed T6 Assessment|Overall Study||286
2848902|NCT04426318|3550906|FG001|Completed T6 Assessment|Overall Study||293
2848903|NCT04426318|3550905|FG000|Final Intent to Treat Sample|Overall Study||344
2848904|NCT04426318|3550906|FG001|Final Intent to Treat Sample|Overall Study||318
2848905|NCT04426318|3550905|FG000|COMPLETED|Overall Study||344
2848906|NCT04426318|3550906|FG001|COMPLETED|Overall Study||318
2848907|NCT04426318|3550905|FG000|NOT COMPLETED|Overall Study||2
2848908|NCT04426318|3550906|FG001|NOT COMPLETED|Overall Study||2
2848909|NCT04255381|3550912|FG000|STARTED|Overall Study||20
2848910|NCT04255381|3550912|FG000|COMPLETED|Overall Study||20
2848911|NCT04255381|3550912|FG000|NOT COMPLETED|Overall Study||0
2848912|NCT04063657|3550918|FG000|STARTED|Overall Study||1
2848913|NCT04063657|3550919|FG001|STARTED|Overall Study||0
2848914|NCT04063657|3550918|FG000|COMPLETED|Overall Study||0
2848915|NCT04063657|3550919|FG001|COMPLETED|Overall Study||0
2848916|NCT04063657|3550918|FG000|NOT COMPLETED|Overall Study||1
2848917|NCT04063657|3550919|FG001|NOT COMPLETED|Overall Study||0
2848918|NCT04042623|3550925|FG000|STARTED|Overall Study||1
2848919|NCT04042623|3550925|FG000|COMPLETED|Overall Study||0
2848920|NCT04042623|3550925|FG000|NOT COMPLETED|Overall Study||1
2848921|NCT03882047|3550932|FG000|STARTED|Overall Study||104
2848922|NCT03882047|3550933|FG001|STARTED|Overall Study||105
3168355|NCT01918072|3895646|FG002|STARTED|E-consult Assessment Period||0
3168356|NCT01918072|3895644|FG000|COMPLETED|E-consult Assessment Period||0
3168357|NCT01918072|3895645|FG001|COMPLETED|E-consult Assessment Period||42
3168358|NCT01918072|3895646|FG002|COMPLETED|E-consult Assessment Period||0
3168359|NCT01918072|3895644|FG000|NOT COMPLETED|E-consult Assessment Period||0
3168360|NCT01918072|3895645|FG001|NOT COMPLETED|E-consult Assessment Period||0
3168361|NCT01918072|3895646|FG002|NOT COMPLETED|E-consult Assessment Period||0
3168362|NCT01918072|3895644|FG000|STARTED|Quality Assessment Period||0
3168363|NCT01918072|3895645|FG001|STARTED|Quality Assessment Period||0
3168364|NCT01918072|3895646|FG002|STARTED|Quality Assessment Period||202
3168365|NCT01918072|3895644|FG000|COMPLETED|Quality Assessment Period||0
3168366|NCT01918072|3895645|FG001|COMPLETED|Quality Assessment Period||0
2848923|NCT03882047|3550934|FG002|STARTED|Overall Study||104
2848924|NCT03882047|3550932|FG000|Treated|Overall Study||104
2848925|NCT03882047|3550933|FG001|Treated|Overall Study||104
2848926|NCT03882047|3550934|FG002|Treated|Overall Study||103
2848927|NCT03882047|3550932|FG000|COMPLETED|Overall Study||98
2848928|NCT03882047|3550933|FG001|COMPLETED|Overall Study||95
2848929|NCT03882047|3550934|FG002|COMPLETED|Overall Study||88
2848930|NCT03882047|3550932|FG000|NOT COMPLETED|Overall Study||6
2848931|NCT03882047|3550933|FG001|NOT COMPLETED|Overall Study||10
2848932|NCT03882047|3550934|FG002|NOT COMPLETED|Overall Study||16
2848933|NCT03879772|3550947|FG000|STARTED|Overall Study||137
2848934|NCT03879772|3550948|FG001|STARTED|Overall Study||135
2848935|NCT03879772|3550949|FG002|STARTED|Overall Study||133
2848936|NCT03879772|3550950|FG003|STARTED|Overall Study||138
2848937|NCT03879772|3550951|FG004|STARTED|Overall Study||136
2848938|NCT03879772|3550947|FG000|COMPLETED|Overall Study||133
2848939|NCT03879772|3550948|FG001|COMPLETED|Overall Study||132
2848940|NCT03879772|3550949|FG002|COMPLETED|Overall Study||123
2848941|NCT03879772|3550950|FG003|COMPLETED|Overall Study||130
2848942|NCT03879772|3550951|FG004|COMPLETED|Overall Study||128
2848943|NCT03879772|3550947|FG000|NOT COMPLETED|Overall Study||4
2848944|NCT03879772|3550948|FG001|NOT COMPLETED|Overall Study||3
2848945|NCT03879772|3550949|FG002|NOT COMPLETED|Overall Study||10
2848946|NCT03879772|3550950|FG003|NOT COMPLETED|Overall Study||8
2848947|NCT03879772|3550951|FG004|NOT COMPLETED|Overall Study||8
2848948|NCT03861559|3550965|FG000|STARTED|Overall Study||101
2848949|NCT03861559|3550966|FG001|STARTED|Overall Study||100
2848950|NCT03861559|3550965|FG000|COMPLETED|Overall Study||99
2848951|NCT03861559|3550966|FG001|COMPLETED|Overall Study||95
2848952|NCT03861559|3550965|FG000|NOT COMPLETED|Overall Study||2
2848953|NCT03861559|3550966|FG001|NOT COMPLETED|Overall Study||5
2848954|NCT03855228|3550976|FG000|STARTED|Overall Study||169
2848955|NCT03855228|3550977|FG001|STARTED|Overall Study||176
2848956|NCT03855228|3550978|FG002|STARTED|Overall Study||182
2848957|NCT03855228|3550979|FG003|STARTED|Overall Study||177
2848958|NCT03855228|3550976|FG000|Treated|Overall Study||169
2848959|NCT03855228|3550977|FG001|Treated|Overall Study||176
2848960|NCT03855228|3550978|FG002|Treated|Overall Study|1 participant immediately dropped out prior to starting study intervention.|181
2848961|NCT03855228|3550979|FG003|Treated|Overall Study|1 participant immediately dropped out prior to starting study intervention.|176
2848962|NCT03855228|3550976|FG000|COMPLETED|Overall Study||166
2848963|NCT03855228|3550977|FG001|COMPLETED|Overall Study||167
2848964|NCT03855228|3550978|FG002|COMPLETED|Overall Study||174
2848965|NCT03855228|3550979|FG003|COMPLETED|Overall Study||158
2848966|NCT03855228|3550976|FG000|NOT COMPLETED|Overall Study||3
2848967|NCT03855228|3550977|FG001|NOT COMPLETED|Overall Study||9
2848968|NCT03855228|3550978|FG002|NOT COMPLETED|Overall Study||8
2848969|NCT03855228|3550979|FG003|NOT COMPLETED|Overall Study||19
2848970|NCT03855189|3550992|FG000|STARTED|Overall Study||113
2848971|NCT03855189|3550993|FG001|STARTED|Overall Study||116
2848972|NCT03855189|3550994|FG002|STARTED|Overall Study||116
2848973|NCT03855189|3550992|FG000|Treated|Overall Study|Does not include 1 participant who received first dose but was excluded from safety analysis.|112
2848974|NCT03855189|3550993|FG001|Treated|Overall Study||116
2848975|NCT03855189|3550994|FG002|Treated|Overall Study||116
2848976|NCT03855189|3550992|FG000|COMPLETED|Overall Study||103
2848977|NCT03855189|3550993|FG001|COMPLETED|Overall Study||109
2848978|NCT03855189|3550994|FG002|COMPLETED|Overall Study||110
2848979|NCT03855189|3550992|FG000|NOT COMPLETED|Overall Study||10
2848980|NCT03855189|3550993|FG001|NOT COMPLETED|Overall Study||7
2848981|NCT03855189|3550994|FG002|NOT COMPLETED|Overall Study||6
2848982|NCT03847974|3551002|FG000|STARTED|Overall Study||32
2848983|NCT03847974|3551002|FG000|COMPLETED|Overall Study||26
2848984|NCT03847974|3551002|FG000|NOT COMPLETED|Overall Study||6
2848985|NCT03764631|3551008|FG000|STARTED|Overall Study||751
2848986|NCT03764631|3551009|FG001|STARTED|Overall Study||751
2848987|NCT03764631|3551008|FG000|COMPLETED|Overall Study||710
2848988|NCT03764631|3551009|FG001|COMPLETED|Overall Study||698
2848989|NCT03764631|3551008|FG000|NOT COMPLETED|Overall Study||41
2848990|NCT03764631|3551009|FG001|NOT COMPLETED|Overall Study||53
2848991|NCT03764072|3551021|FG000|STARTED|Overall Study||46
2848992|NCT03764072|3551022|FG001|STARTED|Overall Study||42
2848993|NCT03764072|3551023|FG002|STARTED|Overall Study||44
2848994|NCT03764072|3551024|FG003|STARTED|Overall Study||45
2848995|NCT03764072|3551025|FG004|STARTED|Overall Study||46
2848996|NCT03764072|3551026|FG005|STARTED|Overall Study||27
2848997|NCT03764072|3551021|FG000|COMPLETED|Overall Study||46
2848998|NCT03764072|3551022|FG001|COMPLETED|Overall Study||42
2848999|NCT03764072|3551023|FG002|COMPLETED|Overall Study||43
2849000|NCT03764072|3551024|FG003|COMPLETED|Overall Study||45
2849001|NCT03764072|3551025|FG004|COMPLETED|Overall Study||45
2849002|NCT03764072|3551026|FG005|COMPLETED|Overall Study||26
2849003|NCT03764072|3551021|FG000|NOT COMPLETED|Overall Study||0
2849004|NCT03764072|3551022|FG001|NOT COMPLETED|Overall Study||0
3168367|NCT01918072|3895646|FG002|COMPLETED|Quality Assessment Period||202
3168368|NCT01918072|3895644|FG000|NOT COMPLETED|Quality Assessment Period||0
3168369|NCT01918072|3895645|FG001|NOT COMPLETED|Quality Assessment Period||0
2849005|NCT03764072|3551023|FG002|NOT COMPLETED|Overall Study||1
2849006|NCT03764072|3551024|FG003|NOT COMPLETED|Overall Study||0
2849007|NCT03764072|3551025|FG004|NOT COMPLETED|Overall Study||1
2849008|NCT03764072|3551026|FG005|NOT COMPLETED|Overall Study||1
2849018|NCT03645408|3551060|FG000|STARTED|Overall Study||1
2849019|NCT03645408|3551061|FG001|STARTED|Overall Study||2
2849020|NCT03645408|3551060|FG000|COMPLETED|Overall Study||1
2849021|NCT03645408|3551061|FG001|COMPLETED|Overall Study||2
2849022|NCT03645408|3551060|FG000|NOT COMPLETED|Overall Study||0
2849023|NCT03645408|3551061|FG001|NOT COMPLETED|Overall Study||0
2849024|NCT03578809|3551071|FG000|STARTED|Overall Study||94
2849025|NCT03578809|3551072|FG001|STARTED|Overall Study||185
2849026|NCT03578809|3551073|FG002|STARTED|Overall Study||112
2849027|NCT03578809|3551074|FG003|STARTED|Overall Study||202
2849028|NCT03578809|3551071|FG000|Treated|Overall Study||90
2849029|NCT03578809|3551072|FG001|Treated|Overall Study||179
2849030|NCT03578809|3551073|FG002|Treated|Overall Study||111
2849031|NCT03578809|3551074|FG003|Treated|Overall Study||195
2849032|NCT03578809|3551071|FG000|COMPLETED|Overall Study||88
2849033|NCT03578809|3551072|FG001|COMPLETED|Overall Study||171
2849034|NCT03578809|3551073|FG002|COMPLETED|Overall Study||108
2849035|NCT03578809|3551074|FG003|COMPLETED|Overall Study||193
2849036|NCT03578809|3551071|FG000|NOT COMPLETED|Overall Study||6
2849037|NCT03578809|3551072|FG001|NOT COMPLETED|Overall Study||14
2849038|NCT03578809|3551073|FG002|NOT COMPLETED|Overall Study||4
2849039|NCT03578809|3551074|FG003|NOT COMPLETED|Overall Study||9
2917854|NCT00522379|3627915|FG003|NOT COMPLETED|Overall Study||14
2917855|NCT00522379|3627916|FG004|NOT COMPLETED|Overall Study||27
2917856|NCT00522392|3627930|FG000|STARTED|Overall Study||23
2917857|NCT00522392|3627931|FG001|STARTED|Overall Study||25
2917858|NCT00522392|3627930|FG000|Pts w/ Measurable Disease at Baseline|Overall Study||16
2917859|NCT00522392|3627931|FG001|Pts w/ Measurable Disease at Baseline|Overall Study||16
2917860|NCT00522392|3627930|FG000|Pts w/ QOL Assessments Complete|Overall Study||12
2917861|NCT00522392|3627931|FG001|Pts w/ QOL Assessments Complete|Overall Study||8
2917862|NCT00522392|3627930|FG000|COMPLETED|Overall Study||15
2917863|NCT00522392|3627931|FG001|COMPLETED|Overall Study||12
2917864|NCT00522392|3627930|FG000|NOT COMPLETED|Overall Study||8
2917865|NCT00522392|3627931|FG001|NOT COMPLETED|Overall Study||13
2917866|NCT00522418|3627939|FG000|STARTED|Overall Study||59
2917867|NCT00522418|3627940|FG001|STARTED|Overall Study||63
2917868|NCT00522418|3627939|FG000|Safety Set|Overall Study|Data of 5 randomized patients removed due to lack of ICF approval by site's local ethics committee.|54
2917869|NCT00522418|3627940|FG001|Safety Set|Overall Study|Data of 5 randomized patients removed due to lack of ICF approval by site's local ethics committee.|58
2917870|NCT00522418|3627939|FG000|Efficacy Set|Overall Study|6 pts. data excluded: exited prior to collection of baseline data & one postbaseline followup QOLIE|48
2917871|NCT00522418|3627940|FG001|Efficacy Set|Overall Study|10 pts. data excluded: exited prior to collection of baseline data & one postbaseline followup QOLIE|48
2917872|NCT00522418|3627939|FG000|Baseline and Month 3|Overall Study|Completed Baseline and Month 3|47
2917873|NCT00522418|3627940|FG001|Baseline and Month 3|Overall Study|Completed Baseline and Month 3|47
2917874|NCT00522418|3627939|FG000|Baseline and Month 6|Overall Study|Completed Baseline and Month 6|38
3168370|NCT01918072|3895646|FG002|NOT COMPLETED|Quality Assessment Period||0
2917875|NCT00522418|3627940|FG001|Baseline and Month 6|Overall Study|Completed Baseline and Month 6|45
2917876|NCT00522418|3627939|FG000|Baseline and Month 9|Overall Study|Completed Baseline and Month 9|33
2917877|NCT00522418|3627940|FG001|Baseline and Month 9|Overall Study|Completed Baseline and Month 9|35
2917878|NCT00522418|3627939|FG000|Baseline and Month 12|Overall Study|Completed Baseline and Month 12|31
2917879|NCT00522418|3627940|FG001|Baseline and Month 12|Overall Study|Completed Baseline and Month 12|29
2917880|NCT00522418|3627939|FG000|COMPLETED|Overall Study|Completed 2-year follow-up|2
2917881|NCT00522418|3627940|FG001|COMPLETED|Overall Study|Completed 2-year follow-up|5
2917882|NCT00522418|3627939|FG000|NOT COMPLETED|Overall Study||57
2917883|NCT00522418|3627940|FG001|NOT COMPLETED|Overall Study||58
2917884|NCT00522431|3627948|FG000|STARTED|Overall Study||149
2917885|NCT00522431|3627948|FG000|COMPLETED|Overall Study||138
2917886|NCT00522431|3627948|FG000|NOT COMPLETED|Overall Study||11
2917887|NCT00522548|3627954|FG000|STARTED|Overall Study||18
2917888|NCT00522548|3627955|FG001|STARTED|Overall Study||19
2917889|NCT00522548|3627954|FG000|Consented to Pharmacokinetic Study|Overall Study||11
2917890|NCT00522548|3627955|FG001|Consented to Pharmacokinetic Study|Overall Study||10
2917891|NCT00522548|3627954|FG000|Completed 0/2 PK Visits|Overall Study||3
2917892|NCT00522548|3627955|FG001|Completed 0/2 PK Visits|Overall Study||4
2917893|NCT00522548|3627954|FG000|Completed 1/2 PK Visits|Overall Study||1
2917894|NCT00522548|3627955|FG001|Completed 1/2 PK Visits|Overall Study||1
2917895|NCT00522548|3627954|FG000|Completed 2/2 PK Visits|Overall Study||7
2917896|NCT00522548|3627955|FG001|Completed 2/2 PK Visits|Overall Study||5
2917897|NCT00522548|3627954|FG000|COMPLETED|Overall Study||16
2917898|NCT00522548|3627955|FG001|COMPLETED|Overall Study||15
2917899|NCT00522548|3627954|FG000|NOT COMPLETED|Overall Study||2
2917900|NCT00522548|3627955|FG001|NOT COMPLETED|Overall Study||4
2917901|NCT00522626|3627961|FG000|STARTED|Overall Study||19
2917902|NCT00522626|3627961|FG000|COMPLETED|Overall Study||12
2917903|NCT00522626|3627961|FG000|NOT COMPLETED|Overall Study||7
2917904|NCT00522795|3627965|FG000|STARTED|Overall Study||40
2917905|NCT00522795|3627965|FG000|COMPLETED|Overall Study||40
2917906|NCT00522795|3627965|FG000|NOT COMPLETED|Overall Study||0
2917907|NCT00522873|3627971|FG000|STARTED|Overall Study||490
2917908|NCT00522873|3627972|FG001|STARTED|Overall Study||172
2917909|NCT00522873|3627971|FG000|Received Treatment|Overall Study||489
2917910|NCT00522873|3627972|FG001|Received Treatment|Overall Study||172
2917911|NCT00522873|3627971|FG000|COMPLETED|Overall Study|394 women completed study medication. 398 women completed the study.|394
2917912|NCT00522873|3627972|FG001|COMPLETED|Overall Study|128 women completed study medication. 129 women completed the study.|128
2917913|NCT00522873|3627971|FG000|NOT COMPLETED|Overall Study||96
2849040|NCT03571204|3551090|FG000|STARTED|Overall Study||8
2849041|NCT03571204|3551091|FG001|STARTED|Overall Study||8
2849042|NCT03571204|3551092|FG002|STARTED|Overall Study||5
2849043|NCT03571204|3551090|FG000|COMPLETED|Overall Study||7
2849044|NCT03571204|3551091|FG001|COMPLETED|Overall Study||6
2849045|NCT03571204|3551092|FG002|COMPLETED|Overall Study||5
2849046|NCT03571204|3551090|FG000|NOT COMPLETED|Overall Study||1
2849047|NCT03571204|3551091|FG001|NOT COMPLETED|Overall Study||2
2849048|NCT03571204|3551092|FG002|NOT COMPLETED|Overall Study||0
2849049|NCT03523091|3551103|FG000|STARTED|Overall Study||1
2849050|NCT03523091|3551104|FG001|STARTED|Overall Study||5
2849051|NCT03523091|3551103|FG000|COMPLETED|Overall Study||0
2849052|NCT03523091|3551104|FG001|COMPLETED|Overall Study||1
2849053|NCT03523091|3551103|FG000|NOT COMPLETED|Overall Study||1
2849054|NCT03523091|3551104|FG001|NOT COMPLETED|Overall Study||4
2849055|NCT03503474|3551112|FG000|STARTED|Overall Study|The number of participant with a diarrhoeal sample that returned a positive test result at the coordinating laboratory. There is no intervention as this is an observational study only.|103
2849056|NCT03503474|3551113|FG001|STARTED|Overall Study|The number of participant with a diarrhoeal sample that returned a negative test result at the coordinating laboratory. There is no intervention as this is an observational study only.|3050
2849057|NCT03503474|3551112|FG000|COMPLETED|Overall Study||103
2849058|NCT03503474|3551113|FG001|COMPLETED|Overall Study||3050
2849059|NCT03503474|3551112|FG000|NOT COMPLETED|Overall Study||0
2849060|NCT03503474|3551113|FG001|NOT COMPLETED|Overall Study||0
2849061|NCT03476317|3551122|FG000|STARTED|Overall Study|Group 1 study was not completed|0
2849062|NCT03476317|3551123|FG001|STARTED|Overall Study|Group 1 study was not completed|0
2849063|NCT03476317|3551124|FG002|STARTED|Overall Study||10
2849064|NCT03476317|3551122|FG000|COMPLETED|Overall Study|Group 1 study was not completed|0
2849065|NCT03476317|3551123|FG001|COMPLETED|Overall Study|Group 1 study was not completed|0
2849066|NCT03476317|3551124|FG002|COMPLETED|Overall Study||10
2849067|NCT03476317|3551122|FG000|NOT COMPLETED|Overall Study||0
2849068|NCT03476317|3551123|FG001|NOT COMPLETED|Overall Study||0
2849069|NCT03476317|3551124|FG002|NOT COMPLETED|Overall Study||0
2849070|NCT03391960|3551132|FG000|STARTED|Overall Study|Units were not assessed for this Arm/Group. Data was collected from the health care worker surveys for the retrospective study to monitor compliance with the scrub-the-hub protocol (signed informed consent and were enrolled)|165
2849071|NCT03391960|3551133|FG001|STARTED|Overall Study|No individual patient was recruited into the study. Data was collected from the compliance audits to monitor compliance with the disinfecting barrier cap protocol.|
2849072|NCT03391960|3551132|FG000|COMPLETED|Overall Study||165
2849073|NCT03391960|3551133|FG001|COMPLETED|Overall Study|No individual patient was recruited into the study. Data was collected from the compliance audits to monitor compliance with the disinfecting barrier cap protocol.|
2849074|NCT03391960|3551132|FG000|NOT COMPLETED|Overall Study||0
2849075|NCT03391960|3551133|FG001|NOT COMPLETED|Overall Study||
2849076|NCT03362190|3551152|FG000|STARTED|Overall Study||10
2849077|NCT03362190|3551153|FG001|STARTED|Overall Study||10
2849078|NCT03362190|3551154|FG002|STARTED|Overall Study||22
2849079|NCT03362190|3551155|FG003|STARTED|Overall Study||22
2849080|NCT03362190|3551152|FG000|COMPLETED|Overall Study||10
2849081|NCT03362190|3551153|FG001|COMPLETED|Overall Study||10
2849082|NCT03362190|3551154|FG002|COMPLETED|Overall Study||22
2849083|NCT03362190|3551155|FG003|COMPLETED|Overall Study||20
2849084|NCT03362190|3551152|FG000|NOT COMPLETED|Overall Study||0
2849085|NCT03362190|3551153|FG001|NOT COMPLETED|Overall Study||0
2849086|NCT03362190|3551154|FG002|NOT COMPLETED|Overall Study||0
2849087|NCT03362190|3551155|FG003|NOT COMPLETED|Overall Study||2
2849088|NCT03338790|3551172|FG000|STARTED|Overall Study||88
2849089|NCT03338790|3551173|FG001|STARTED|Overall Study||71
2849090|NCT03338790|3551174|FG002|STARTED|Overall Study||84
2849091|NCT03338790|3551175|FG003|STARTED|Overall Study||49
2849092|NCT03338790|3551172|FG000|COMPLETED|Overall Study||4
2849093|NCT03338790|3551173|FG001|COMPLETED|Overall Study||4
2849094|NCT03338790|3551174|FG002|COMPLETED|Overall Study||8
2849095|NCT03338790|3551175|FG003|COMPLETED|Overall Study||4
2849096|NCT03338790|3551172|FG000|NOT COMPLETED|Overall Study||84
2849097|NCT03338790|3551173|FG001|NOT COMPLETED|Overall Study||67
2849098|NCT03338790|3551174|FG002|NOT COMPLETED|Overall Study||76
2849099|NCT03338790|3551175|FG003|NOT COMPLETED|Overall Study||45
2849100|NCT03252522|3551187|FG000|STARTED|Overall Study||78
2849101|NCT03252522|3551188|FG001|STARTED|Overall Study||57
2849102|NCT03252522|3551189|FG002|STARTED|Overall Study||0
2849103|NCT03252522|3551187|FG000|COMPLETED|Overall Study||69
2849104|NCT03252522|3551188|FG001|COMPLETED|Overall Study||54
2849105|NCT03252522|3551189|FG002|COMPLETED|Overall Study||0
2849106|NCT03252522|3551187|FG000|NOT COMPLETED|Overall Study||9
2849107|NCT03252522|3551188|FG001|NOT COMPLETED|Overall Study||3
2849108|NCT03252522|3551189|FG002|NOT COMPLETED|Overall Study||0
2849109|NCT03235544|3551204|FG000|STARTED|Overall Study||12
2849110|NCT03235544|3551205|FG001|STARTED|Overall Study||41
2849111|NCT03235544|3551206|FG002|STARTED|Overall Study||31
2849112|NCT03235544|3551207|FG003|STARTED|Overall Study||77
2849113|NCT03235544|3551204|FG000|COMPLETED|Overall Study||0
2849114|NCT03235544|3551205|FG001|COMPLETED|Overall Study||0
2849115|NCT03235544|3551206|FG002|COMPLETED|Overall Study||0
2849116|NCT03235544|3551207|FG003|COMPLETED|Overall Study||0
2849117|NCT03235544|3551204|FG000|NOT COMPLETED|Overall Study||12
2849118|NCT03235544|3551205|FG001|NOT COMPLETED|Overall Study||41
2849119|NCT03235544|3551206|FG002|NOT COMPLETED|Overall Study||31
2849120|NCT03235544|3551207|FG003|NOT COMPLETED|Overall Study||77
2849121|NCT03225833|3551224|FG000|STARTED|Overall Study||16
2849122|NCT03225833|3551225|FG001|STARTED|Overall Study||9
2849123|NCT03225833|3551226|FG002|STARTED|Overall Study||9
2849124|NCT03225833|3551227|FG003|STARTED|Overall Study||9
2849125|NCT03225833|3551228|FG004|STARTED|Overall Study||8
2849126|NCT03225833|3551229|FG005|STARTED|Overall Study||10
2849127|NCT03225833|3551224|FG000|Single Dose Period Only|Overall Study||1
2849128|NCT03225833|3551225|FG001|Single Dose Period Only|Overall Study||1
2849129|NCT03225833|3551226|FG002|Single Dose Period Only|Overall Study||2
2849130|NCT03225833|3551227|FG003|Single Dose Period Only|Overall Study||0
2849131|NCT03225833|3551228|FG004|Single Dose Period Only|Overall Study||0
2849132|NCT03225833|3551229|FG005|Single Dose Period Only|Overall Study||4
2849133|NCT03225833|3551224|FG000|Multiple Dose Period Only|Overall Study||0
2849134|NCT03225833|3551225|FG001|Multiple Dose Period Only|Overall Study||0
2849135|NCT03225833|3551226|FG002|Multiple Dose Period Only|Overall Study||0
2849136|NCT03225833|3551227|FG003|Multiple Dose Period Only|Overall Study||0
2849137|NCT03225833|3551228|FG004|Multiple Dose Period Only|Overall Study||0
2849138|NCT03225833|3551229|FG005|Multiple Dose Period Only|Overall Study||1
2849139|NCT03225833|3551224|FG000|Single Dose and Multiple Dose Periods|Overall Study||15
2849140|NCT03225833|3551225|FG001|Single Dose and Multiple Dose Periods|Overall Study||8
2849141|NCT03225833|3551226|FG002|Single Dose and Multiple Dose Periods|Overall Study||7
2849142|NCT03225833|3551227|FG003|Single Dose and Multiple Dose Periods|Overall Study||9
2849143|NCT03225833|3551228|FG004|Single Dose and Multiple Dose Periods|Overall Study||8
2849144|NCT03225833|3551229|FG005|Single Dose and Multiple Dose Periods|Overall Study||5
2849145|NCT03225833|3551224|FG000|COMPLETED|Overall Study||11
2849146|NCT03225833|3551225|FG001|COMPLETED|Overall Study||8
2849147|NCT03225833|3551226|FG002|COMPLETED|Overall Study||7
2849148|NCT03225833|3551227|FG003|COMPLETED|Overall Study||9
2849149|NCT03225833|3551228|FG004|COMPLETED|Overall Study||7
2849150|NCT03225833|3551229|FG005|COMPLETED|Overall Study||0
2849151|NCT03225833|3551224|FG000|NOT COMPLETED|Overall Study||5
2849152|NCT03225833|3551225|FG001|NOT COMPLETED|Overall Study||1
2849153|NCT03225833|3551226|FG002|NOT COMPLETED|Overall Study||2
2849154|NCT03225833|3551227|FG003|NOT COMPLETED|Overall Study||0
2849155|NCT03225833|3551228|FG004|NOT COMPLETED|Overall Study||1
2849156|NCT03225833|3551229|FG005|NOT COMPLETED|Overall Study||10
2917914|NCT00522873|3627972|FG001|NOT COMPLETED|Overall Study||44
2917915|NCT00522925|3627981|FG000|STARTED|Overall Study||36
2917916|NCT00522925|3627982|FG001|STARTED|Overall Study||39
2917917|NCT00522925|3627983|FG002|STARTED|Overall Study||38
2917918|NCT00522925|3627981|FG000|COMPLETED|Overall Study||28
2917919|NCT00522925|3627982|FG001|COMPLETED|Overall Study||38
2917920|NCT00522925|3627983|FG002|COMPLETED|Overall Study||36
2917921|NCT00522925|3627981|FG000|NOT COMPLETED|Overall Study||8
2917922|NCT00522925|3627982|FG001|NOT COMPLETED|Overall Study||1
2917923|NCT00522925|3627983|FG002|NOT COMPLETED|Overall Study||2
2917924|NCT00522951|3627991|FG000|STARTED|Period 1||86
2917925|NCT00522951|3627992|FG001|STARTED|Period 1||79
2917926|NCT00522951|3627991|FG000|Received Treatment|Period 1||86
2917927|NCT00522951|3627992|FG001|Received Treatment|Period 1||78
2917928|NCT00522951|3627991|FG000|COMPLETED|Period 1||86
2917929|NCT00522951|3627992|FG001|COMPLETED|Period 1||78
2917930|NCT00522951|3627991|FG000|NOT COMPLETED|Period 1||0
2917931|NCT00522951|3627992|FG001|NOT COMPLETED|Period 1||1
2917932|NCT00522951|3627991|FG000|STARTED|Washout Period||86
2917933|NCT00522951|3627992|FG001|STARTED|Washout Period||78
2917934|NCT00522951|3627991|FG000|COMPLETED|Washout Period||86
2917935|NCT00522951|3627992|FG001|COMPLETED|Washout Period||76
2917936|NCT00522951|3627991|FG000|NOT COMPLETED|Washout Period||0
2917937|NCT00522951|3627992|FG001|NOT COMPLETED|Washout Period||2
2917938|NCT00522951|3627991|FG000|STARTED|Period 2||86
2917939|NCT00522951|3627992|FG001|STARTED|Period 2||76
2917940|NCT00522951|3627991|FG000|Subjects Received Treatment|Period 2||84
2917941|NCT00522951|3627992|FG001|Subjects Received Treatment|Period 2||75
2917942|NCT00522951|3627991|FG000|COMPLETED|Period 2||84
2917943|NCT00522951|3627992|FG001|COMPLETED|Period 2||75
2917944|NCT00522951|3627991|FG000|NOT COMPLETED|Period 2||2
2917945|NCT00522951|3627992|FG001|NOT COMPLETED|Period 2||1
2917946|NCT00523237|3628002|FG000|STARTED|Overall Study||14
2917947|NCT00523237|3628002|FG000|COMPLETED|Overall Study||14
2917948|NCT00523237|3628002|FG000|NOT COMPLETED|Overall Study||0
2917949|NCT00523302|3628008|FG000|STARTED|Overall Study||10
2917950|NCT00523302|3628009|FG001|STARTED|Overall Study||10
2917951|NCT00523302|3628008|FG000|COMPLETED|Overall Study||10
2917952|NCT00523302|3628009|FG001|COMPLETED|Overall Study||10
2917953|NCT00523302|3628008|FG000|NOT COMPLETED|Overall Study||0
2917954|NCT00523302|3628009|FG001|NOT COMPLETED|Overall Study||0
2917955|NCT00523341|3628017|FG000|STARTED|Overall Study||2207
2917956|NCT00523341|3628018|FG001|STARTED|Overall Study||2343
2917957|NCT00523341|3628017|FG000|Received Treatment|Overall Study||2206
2917958|NCT00523341|3628018|FG001|Received Treatment|Overall Study||2343
2917959|NCT00523341|3628017|FG000|COMPLETED|Overall Study||1283
2917960|NCT00523341|3628018|FG001|COMPLETED|Overall Study||1343
2917961|NCT00523341|3628017|FG000|NOT COMPLETED|Overall Study||924
2917962|NCT00523341|3628018|FG001|NOT COMPLETED|Overall Study||1000
2917963|NCT00523367|3628024|FG000|STARTED|Overall Study||25
2917964|NCT00523367|3628024|FG000|COMPLETED|Overall Study||2
2917965|NCT00523367|3628024|FG000|NOT COMPLETED|Overall Study||23
2917966|NCT00523419|3628028|FG000|STARTED|Overall Study||32
2917967|NCT00523419|3628028|FG000|COMPLETED|Overall Study||0
2849157|NCT03167242|3551260|FG000|STARTED|Overall Study||12
2849158|NCT03167242|3551261|FG001|STARTED|Overall Study||51
2849159|NCT03167242|3551262|FG002|STARTED|Overall Study||51
2849160|NCT03167242|3551263|FG003|STARTED|Overall Study||51
2849161|NCT03167242|3551264|FG004|STARTED|Overall Study||54
2849162|NCT03167242|3551265|FG005|STARTED|Overall Study||51
2849163|NCT03167242|3551266|FG006|STARTED|Overall Study||52
2849164|NCT03167242|3551267|FG007|STARTED|Overall Study||27
2849165|NCT03167242|3551268|FG008|STARTED|Overall Study||53
2849166|NCT03167242|3551269|FG009|STARTED|Overall Study||53
2849167|NCT03167242|3551270|FG010|STARTED|Overall Study||45
2849168|NCT03167242|3551271|FG011|STARTED|Overall Study||24
2849169|NCT03167242|3551260|FG000|Full Analysis Set (FAS)|Overall Study||12
2849170|NCT03167242|3551261|FG001|Full Analysis Set (FAS)|Overall Study||51
2849171|NCT03167242|3551262|FG002|Full Analysis Set (FAS)|Overall Study||51
2849172|NCT03167242|3551263|FG003|Full Analysis Set (FAS)|Overall Study||51
2849173|NCT03167242|3551264|FG004|Full Analysis Set (FAS)|Overall Study||54
2849174|NCT03167242|3551265|FG005|Full Analysis Set (FAS)|Overall Study||51
2849175|NCT03167242|3551266|FG006|Full Analysis Set (FAS)|Overall Study||52
2849176|NCT03167242|3551267|FG007|Full Analysis Set (FAS)|Overall Study||27
2849177|NCT03167242|3551268|FG008|Full Analysis Set (FAS)|Overall Study||52
2849178|NCT03167242|3551269|FG009|Full Analysis Set (FAS)|Overall Study||53
2849179|NCT03167242|3551270|FG010|Full Analysis Set (FAS)|Overall Study||45
2849180|NCT03167242|3551271|FG011|Full Analysis Set (FAS)|Overall Study||24
2849181|NCT03167242|3551260|FG000|Pharmacokinetics (PK) Analysis Set|Overall Study||12
2849182|NCT03167242|3551261|FG001|Pharmacokinetics (PK) Analysis Set|Overall Study||47
2849183|NCT03167242|3551262|FG002|Pharmacokinetics (PK) Analysis Set|Overall Study||51
2849184|NCT03167242|3551263|FG003|Pharmacokinetics (PK) Analysis Set|Overall Study||46
2849185|NCT03167242|3551264|FG004|Pharmacokinetics (PK) Analysis Set|Overall Study||48
2849186|NCT03167242|3551265|FG005|Pharmacokinetics (PK) Analysis Set|Overall Study||46
2849187|NCT03167242|3551266|FG006|Pharmacokinetics (PK) Analysis Set|Overall Study||45
2849188|NCT03167242|3551267|FG007|Pharmacokinetics (PK) Analysis Set|Overall Study||24
2849189|NCT03167242|3551268|FG008|Pharmacokinetics (PK) Analysis Set|Overall Study||48
2849190|NCT03167242|3551269|FG009|Pharmacokinetics (PK) Analysis Set|Overall Study||46
2849191|NCT03167242|3551270|FG010|Pharmacokinetics (PK) Analysis Set|Overall Study||41
2849192|NCT03167242|3551271|FG011|Pharmacokinetics (PK) Analysis Set|Overall Study||24
2849193|NCT03167242|3551260|FG000|Per-Protocol Set (PPS)|Overall Study||12
2849194|NCT03167242|3551261|FG001|Per-Protocol Set (PPS)|Overall Study||50
2849195|NCT03167242|3551262|FG002|Per-Protocol Set (PPS)|Overall Study||48
2849196|NCT03167242|3551263|FG003|Per-Protocol Set (PPS)|Overall Study||48
2849197|NCT03167242|3551264|FG004|Per-Protocol Set (PPS)|Overall Study||47
2849198|NCT03167242|3551265|FG005|Per-Protocol Set (PPS)|Overall Study||44
2849199|NCT03167242|3551266|FG006|Per-Protocol Set (PPS)|Overall Study||43
2849200|NCT03167242|3551267|FG007|Per-Protocol Set (PPS)|Overall Study||25
2849201|NCT03167242|3551268|FG008|Per-Protocol Set (PPS)|Overall Study||48
2849202|NCT03167242|3551269|FG009|Per-Protocol Set (PPS)|Overall Study||46
2849203|NCT03167242|3551270|FG010|Per-Protocol Set (PPS)|Overall Study||40
2849204|NCT03167242|3551271|FG011|Per-Protocol Set (PPS)|Overall Study||22
2849205|NCT03167242|3551260|FG000|Rich Pharmacokinetics (PK) Analysis Subset|Overall Study||12
2849206|NCT03167242|3551261|FG001|Rich Pharmacokinetics (PK) Analysis Subset|Overall Study||5
2849207|NCT03167242|3551262|FG002|Rich Pharmacokinetics (PK) Analysis Subset|Overall Study||6
2849208|NCT03167242|3551263|FG003|Rich Pharmacokinetics (PK) Analysis Subset|Overall Study||6
2849209|NCT03167242|3551264|FG004|Rich Pharmacokinetics (PK) Analysis Subset|Overall Study||6
2849210|NCT03167242|3551265|FG005|Rich Pharmacokinetics (PK) Analysis Subset|Overall Study||12
2849211|NCT03167242|3551266|FG006|Rich Pharmacokinetics (PK) Analysis Subset|Overall Study||5
2849212|NCT03167242|3551267|FG007|Rich Pharmacokinetics (PK) Analysis Subset|Overall Study||0
3168371|NCT01918085|3895658|FG000|STARTED|Test Period 1: Strata Strip||10
3168372|NCT01918085|3895659|FG001|STARTED|Test Period 1: Strata Strip||12
3168373|NCT01918085|3895658|FG000|COMPLETED|Test Period 1: Strata Strip||10
3168374|NCT01918085|3895659|FG001|COMPLETED|Test Period 1: Strata Strip||11
3168375|NCT01918085|3895658|FG000|NOT COMPLETED|Test Period 1: Strata Strip||0
3168376|NCT01918085|3895659|FG001|NOT COMPLETED|Test Period 1: Strata Strip||1
3168377|NCT01918085|3895658|FG000|STARTED|Test Period 1: Hydrocolloid Strip||10
3168378|NCT01918085|3895659|FG001|STARTED|Test Period 1: Hydrocolloid Strip||11
3168379|NCT01918085|3895658|FG000|COMPLETED|Test Period 1: Hydrocolloid Strip||10
3168380|NCT01918085|3895659|FG001|COMPLETED|Test Period 1: Hydrocolloid Strip||11
3168381|NCT01918085|3895658|FG000|NOT COMPLETED|Test Period 1: Hydrocolloid Strip||0
3168382|NCT01918085|3895659|FG001|NOT COMPLETED|Test Period 1: Hydrocolloid Strip||0
2849213|NCT03167242|3551268|FG008|Rich Pharmacokinetics (PK) Analysis Subset|Overall Study||0
2849214|NCT03167242|3551269|FG009|Rich Pharmacokinetics (PK) Analysis Subset|Overall Study||0
2849215|NCT03167242|3551270|FG010|Rich Pharmacokinetics (PK) Analysis Subset|Overall Study||0
2849216|NCT03167242|3551271|FG011|Rich Pharmacokinetics (PK) Analysis Subset|Overall Study||0
2849217|NCT03167242|3551260|FG000|COMPLETED|Overall Study||12
2849218|NCT03167242|3551261|FG001|COMPLETED|Overall Study||50
2849219|NCT03167242|3551262|FG002|COMPLETED|Overall Study||48
2849220|NCT03167242|3551263|FG003|COMPLETED|Overall Study||50
2849221|NCT03167242|3551264|FG004|COMPLETED|Overall Study||53
2849222|NCT03167242|3551265|FG005|COMPLETED|Overall Study||49
2849223|NCT03167242|3551266|FG006|COMPLETED|Overall Study||50
2849224|NCT03167242|3551267|FG007|COMPLETED|Overall Study||26
2849225|NCT03167242|3551268|FG008|COMPLETED|Overall Study||52
2849226|NCT03167242|3551269|FG009|COMPLETED|Overall Study||53
2849227|NCT03167242|3551270|FG010|COMPLETED|Overall Study||43
2849228|NCT03167242|3551271|FG011|COMPLETED|Overall Study||23
2849229|NCT03167242|3551260|FG000|NOT COMPLETED|Overall Study||0
2849230|NCT03167242|3551261|FG001|NOT COMPLETED|Overall Study||1
2849231|NCT03167242|3551262|FG002|NOT COMPLETED|Overall Study||3
2849232|NCT03167242|3551263|FG003|NOT COMPLETED|Overall Study||1
2849233|NCT03167242|3551264|FG004|NOT COMPLETED|Overall Study||1
2849234|NCT03167242|3551265|FG005|NOT COMPLETED|Overall Study||2
2849235|NCT03167242|3551266|FG006|NOT COMPLETED|Overall Study||2
2849236|NCT03167242|3551267|FG007|NOT COMPLETED|Overall Study||1
2849237|NCT03167242|3551268|FG008|NOT COMPLETED|Overall Study||1
2849238|NCT03167242|3551269|FG009|NOT COMPLETED|Overall Study||0
2849239|NCT03167242|3551270|FG010|NOT COMPLETED|Overall Study||2
2849240|NCT03167242|3551271|FG011|NOT COMPLETED|Overall Study||1
2849241|NCT03144674|3551311|FG000|STARTED|Overall Study||4
2849242|NCT03144674|3551312|FG001|STARTED|Overall Study||6
2849243|NCT03144674|3551313|FG002|STARTED|Overall Study||28
2849244|NCT03144674|3551314|FG003|STARTED|Overall Study||72
2849245|NCT03144674|3551311|FG000|COMPLETED|Overall Study||0
2849246|NCT03144674|3551312|FG001|COMPLETED|Overall Study||0
2849247|NCT03144674|3551313|FG002|COMPLETED|Overall Study||0
2849248|NCT03144674|3551314|FG003|COMPLETED|Overall Study||0
2849249|NCT03144674|3551311|FG000|NOT COMPLETED|Overall Study||4
2849250|NCT03144674|3551312|FG001|NOT COMPLETED|Overall Study||6
2849251|NCT03144674|3551313|FG002|NOT COMPLETED|Overall Study||28
2849252|NCT03144674|3551314|FG003|NOT COMPLETED|Overall Study||72
2849253|NCT03137537|3551331|FG000|STARTED|Overall Study||12
2849254|NCT03137537|3551332|FG001|STARTED|Overall Study||11
2849255|NCT03137537|3551331|FG000|COMPLETED|Overall Study||12
2849256|NCT03137537|3551332|FG001|COMPLETED|Overall Study||10
2849257|NCT03137537|3551331|FG000|NOT COMPLETED|Overall Study||0
2849258|NCT03137537|3551332|FG001|NOT COMPLETED|Overall Study||1
2849259|NCT03126019|3551340|FG000|STARTED|Overall Study||23
2849260|NCT03126019|3551341|FG001|STARTED|Overall Study||103
2849261|NCT03126019|3551340|FG000|COMPLETED|Overall Study||0
2849262|NCT03126019|3551341|FG001|COMPLETED|Overall Study||0
2849263|NCT03126019|3551340|FG000|NOT COMPLETED|Overall Study||23
2849264|NCT03126019|3551341|FG001|NOT COMPLETED|Overall Study||103
2849265|NCT03113383|3551348|FG000|STARTED|Overall Study||4
2849266|NCT03113383|3551349|FG001|STARTED|Overall Study||0
2849267|NCT03113383|3551348|FG000|COMPLETED|Overall Study||0
3168383|NCT01918085|3895658|FG000|STARTED|Test Period 2: Strata Strip||10
3168384|NCT01918085|3895659|FG001|STARTED|Test Period 2: Strata Strip||11
3168385|NCT01918085|3895658|FG000|COMPLETED|Test Period 2: Strata Strip||10
3168386|NCT01918085|3895659|FG001|COMPLETED|Test Period 2: Strata Strip||11
3168387|NCT01918085|3895658|FG000|NOT COMPLETED|Test Period 2: Strata Strip||0
3168388|NCT01918085|3895659|FG001|NOT COMPLETED|Test Period 2: Strata Strip||0
3168389|NCT01918085|3895658|FG000|STARTED|Test Period 2: Hydrocolloid Strip||10
3168390|NCT01918085|3895659|FG001|STARTED|Test Period 2: Hydrocolloid Strip||11
3168391|NCT01918085|3895658|FG000|COMPLETED|Test Period 2: Hydrocolloid Strip||10
3168392|NCT01918085|3895659|FG001|COMPLETED|Test Period 2: Hydrocolloid Strip||11
2849268|NCT03113383|3551349|FG001|COMPLETED|Overall Study||0
2849269|NCT03113383|3551348|FG000|NOT COMPLETED|Overall Study||4
2849270|NCT03113383|3551349|FG001|NOT COMPLETED|Overall Study||0
2849271|NCT03057106|3551357|FG000|STARTED|Overall Study|1 patient refused the treatment|149
2849272|NCT03057106|3551358|FG001|STARTED|Overall Study|3 patients refused the treatment|148
2849273|NCT03057106|3551357|FG000|COMPLETED|Overall Study||149
2849274|NCT03057106|3551358|FG001|COMPLETED|Overall Study||148
2849275|NCT03057106|3551357|FG000|NOT COMPLETED|Overall Study||0
2849276|NCT03057106|3551358|FG001|NOT COMPLETED|Overall Study||0
2849277|NCT03028896|3551366|FG000|STARTED|Overall Study||66
2849278|NCT03028896|3551367|FG001|STARTED|Overall Study||66
2849279|NCT03028896|3551366|FG000|COMPLETED|Overall Study||63
2849280|NCT03028896|3551367|FG001|COMPLETED|Overall Study||66
2849281|NCT03028896|3551366|FG000|NOT COMPLETED|Overall Study||3
2849282|NCT03028896|3551367|FG001|NOT COMPLETED|Overall Study||0
2849283|NCT03008369|3551373|FG000|STARTED|Overall Study||3
2849284|NCT03008369|3551373|FG000|COMPLETED|Overall Study||3
2849285|NCT03008369|3551373|FG000|NOT COMPLETED|Overall Study||0
2849286|NCT02978326|3551380|FG000|STARTED|Part A (Up to 75 Days)||1
2849287|NCT02978326|3551381|FG001|STARTED|Part A (Up to 75 Days)||0
2849288|NCT02978326|3551382|FG002|STARTED|Part A (Up to 75 Days)||0
2849289|NCT02978326|3551380|FG000|COMPLETED|Part A (Up to 75 Days)||1
2849290|NCT02978326|3551381|FG001|COMPLETED|Part A (Up to 75 Days)||0
2849291|NCT02978326|3551382|FG002|COMPLETED|Part A (Up to 75 Days)||0
2849292|NCT02978326|3551380|FG000|NOT COMPLETED|Part A (Up to 75 Days)||0
2849293|NCT02978326|3551381|FG001|NOT COMPLETED|Part A (Up to 75 Days)||0
2849294|NCT02978326|3551382|FG002|NOT COMPLETED|Part A (Up to 75 Days)||0
2849295|NCT02978326|3551380|FG000|STARTED|Part B (Up to 45 Days)||0
2849296|NCT02978326|3551381|FG001|STARTED|Part B (Up to 45 Days)||76
2849297|NCT02978326|3551382|FG002|STARTED|Part B (Up to 45 Days)||77
2849298|NCT02978326|3551380|FG000|Received Study Drug|Part B (Up to 45 Days)||0
2849299|NCT02978326|3551381|FG001|Received Study Drug|Part B (Up to 45 Days)||73
2849300|NCT02978326|3551382|FG002|Received Study Drug|Part B (Up to 45 Days)|Two participants were randomized to placebo but received at least 1 dose of SAGE-217 in error and were included in the SAGE-217 group for 'Received Study Drug' and for 'Safety Analysis'.|78
2849301|NCT02978326|3551380|FG000|Safety Set (Part B)|Part B (Up to 45 Days)||0
2849302|NCT02978326|3551381|FG001|Safety Set (Part B)|Part B (Up to 45 Days)||73
2849303|NCT02978326|3551382|FG002|Safety Set (Part B)|Part B (Up to 45 Days)||78
2849304|NCT02978326|3551380|FG000|Efficacy Set (Part B)|Part B (Up to 45 Days)||0
2849305|NCT02978326|3551381|FG001|Efficacy Set (Part B)|Part B (Up to 45 Days)||74
2849306|NCT02978326|3551382|FG002|Efficacy Set (Part B)|Part B (Up to 45 Days)||76
2849307|NCT02978326|3551380|FG000|COMPLETED|Part B (Up to 45 Days)||0
2849308|NCT02978326|3551381|FG001|COMPLETED|Part B (Up to 45 Days)||69
2849309|NCT02978326|3551382|FG002|COMPLETED|Part B (Up to 45 Days)||73
2849310|NCT02978326|3551380|FG000|NOT COMPLETED|Part B (Up to 45 Days)||0
2849311|NCT02978326|3551381|FG001|NOT COMPLETED|Part B (Up to 45 Days)||7
2849312|NCT02978326|3551382|FG002|NOT COMPLETED|Part B (Up to 45 Days)||4
2849313|NCT02970929|3551392|FG000|STARTED|Overall Study||157
2849314|NCT02970929|3551392|FG000|Subjects Who Received Study Medication|Overall Study||156
2849315|NCT02970929|3551392|FG000|COMPLETED|Overall Study||105
2849316|NCT02970929|3551392|FG000|NOT COMPLETED|Overall Study||52
2849317|NCT02963493|3551398|FG000|STARTED|Overall Study||157
2849318|NCT02963493|3551398|FG000|COMPLETED|Overall Study||157
2849319|NCT02963493|3551398|FG000|NOT COMPLETED|Overall Study||0
2849320|NCT02899078|3551409|FG000|STARTED|Overall Study||31
2849321|NCT02899078|3551409|FG000|COMPLETED|Overall Study||28
2849322|NCT02899078|3551409|FG000|NOT COMPLETED|Overall Study||3
2849323|NCT02873975|3551416|FG000|STARTED|Overall Study||8
2849324|NCT02873975|3551417|FG001|STARTED|Overall Study||10
2849325|NCT02873975|3551418|FG002|STARTED|Overall Study||9
2849326|NCT02873975|3551416|FG000|COMPLETED|Overall Study||8
2849327|NCT02873975|3551417|FG001|COMPLETED|Overall Study||10
2849328|NCT02873975|3551418|FG002|COMPLETED|Overall Study||9
2849329|NCT02873975|3551416|FG000|NOT COMPLETED|Overall Study||0
2849330|NCT02873975|3551417|FG001|NOT COMPLETED|Overall Study||0
2849331|NCT02873975|3551418|FG002|NOT COMPLETED|Overall Study||0
2849332|NCT02797951|3551426|FG000|STARTED|Overall Study||165
2849333|NCT02797951|3551426|FG000|Received at Least One Dose of Study Drug|Overall Study||164
2849334|NCT02797951|3551426|FG000|COMPLETED|Overall Study||116
2849335|NCT02797951|3551426|FG000|NOT COMPLETED|Overall Study||49
2849336|NCT02753751|3551432|FG000|STARTED|Overall Study||2971
2849337|NCT02753751|3551433|FG001|STARTED|Overall Study||3059
2849338|NCT02753751|3551432|FG000|COMPLETED|Overall Study||2971
2849339|NCT02753751|3551433|FG001|COMPLETED|Overall Study||3059
2849340|NCT02753751|3551432|FG000|NOT COMPLETED|Overall Study||0
2849341|NCT02753751|3551433|FG001|NOT COMPLETED|Overall Study||0
2849342|NCT02748057|3551441|FG000|STARTED|Overall Study||114
2849343|NCT02748057|3551442|FG001|STARTED|Overall Study||21
2849344|NCT02748057|3551441|FG000|COMPLETED|Overall Study||109
2849345|NCT02748057|3551442|FG001|COMPLETED|Overall Study||19
2849346|NCT02748057|3551441|FG000|NOT COMPLETED|Overall Study||5
2849347|NCT02748057|3551442|FG001|NOT COMPLETED|Overall Study||2
2849348|NCT02741271|3551450|FG000|STARTED|Overall Study||91
2849349|NCT02741271|3551451|FG001|STARTED|Overall Study||90
2849350|NCT02741271|3551450|FG000|COMPLETED|Overall Study||89
2849351|NCT02741271|3551451|FG001|COMPLETED|Overall Study||88
2849352|NCT02741271|3551450|FG000|NOT COMPLETED|Overall Study||2
2849353|NCT02741271|3551451|FG001|NOT COMPLETED|Overall Study||2
2849354|NCT02741245|3551464|FG000|STARTED|Overall Study||35
2849355|NCT02741245|3551465|FG001|STARTED|Overall Study||72
2849356|NCT02741245|3551466|FG002|STARTED|Overall Study||71
2849357|NCT02741245|3551467|FG003|STARTED|Overall Study||71
2849358|NCT02741245|3551468|FG004|STARTED|Overall Study||72
2849359|NCT02741245|3551464|FG000|COMPLETED|Overall Study||35
2849360|NCT02741245|3551465|FG001|COMPLETED|Overall Study||71
2849361|NCT02741245|3551466|FG002|COMPLETED|Overall Study||71
2849362|NCT02741245|3551467|FG003|COMPLETED|Overall Study||67
2849363|NCT02741245|3551468|FG004|COMPLETED|Overall Study||70
2849364|NCT02741245|3551464|FG000|NOT COMPLETED|Overall Study||0
2849365|NCT02741245|3551465|FG001|NOT COMPLETED|Overall Study||1
2849366|NCT02741245|3551466|FG002|NOT COMPLETED|Overall Study||0
2849367|NCT02741245|3551467|FG003|NOT COMPLETED|Overall Study||4
2849368|NCT02741245|3551468|FG004|NOT COMPLETED|Overall Study||2
2849369|NCT02717611|3551480|FG000|STARTED|Overall Study||60
2849370|NCT02717611|3551480|FG000|COMPLETED|Overall Study||0
2849371|NCT02717611|3551480|FG000|NOT COMPLETED|Overall Study||60
2917968|NCT00523419|3628028|FG000|NOT COMPLETED|Overall Study||32
2917969|NCT00523549|3628034|FG000|STARTED|Overall Study||114
2917970|NCT00523549|3628035|FG001|STARTED|Overall Study||115
2917971|NCT00523549|3628034|FG000|COMPLETED|Overall Study||95
2917972|NCT00523549|3628035|FG001|COMPLETED|Overall Study||99
2917973|NCT00523549|3628034|FG000|NOT COMPLETED|Overall Study||19
2917974|NCT00523549|3628035|FG001|NOT COMPLETED|Overall Study||16
2917975|NCT00523614|3628043|FG000|STARTED|Overall Study|"As this is a case-control study the categories started and completed are not really applicable."|680
2917976|NCT00523614|3628044|FG001|STARTED|Overall Study|"As this is a case-control study the categories started and completed are not really applicable."|2720
2917977|NCT00523614|3628043|FG000|COMPLETED|Overall Study|"As this is a case-control study the categories started and completed are not really applicable."|680
2917978|NCT00523614|3628044|FG001|COMPLETED|Overall Study|"As this is a case-control study the categories started and completed are not really applicable."|2720
2917979|NCT00523614|3628043|FG000|NOT COMPLETED|Overall Study||0
2917980|NCT00523614|3628044|FG001|NOT COMPLETED|Overall Study||0
2917981|NCT00523640|3628050|FG000|STARTED|Overall Study||30
2917982|NCT00523640|3628050|FG000|COMPLETED|Overall Study|1 patient died before starting treatment|29
2917983|NCT00523640|3628050|FG000|NOT COMPLETED|Overall Study||1
2849372|NCT02688608|3551484|FG000|STARTED|Overall Study||6
2849373|NCT02688608|3551484|FG000|COMPLETED|Overall Study||5
2849374|NCT02688608|3551484|FG000|NOT COMPLETED|Overall Study||1
2849375|NCT02675231|3551491|FG000|STARTED|Overall Study||79
2849376|NCT02675231|3551492|FG001|STARTED|Overall Study||79
2849377|NCT02675231|3551493|FG002|STARTED|Overall Study||79
2849378|NCT02675231|3551491|FG000|Received at Least One Dose of Drug|Overall Study||78
2849379|NCT02675231|3551492|FG001|Received at Least One Dose of Drug|Overall Study||77
2849380|NCT02675231|3551493|FG002|Received at Least One Dose of Drug|Overall Study||72
2849381|NCT02675231|3551491|FG000|COMPLETED|Overall Study||53
2849382|NCT02675231|3551492|FG001|COMPLETED|Overall Study||43
2849383|NCT02675231|3551493|FG002|COMPLETED|Overall Study||53
2849384|NCT02675231|3551491|FG000|NOT COMPLETED|Overall Study||26
2849385|NCT02675231|3551492|FG001|NOT COMPLETED|Overall Study||36
2849386|NCT02675231|3551493|FG002|NOT COMPLETED|Overall Study||26
2849387|NCT02659514|3551504|FG000|STARTED|Overall Study||33
2849388|NCT02659514|3551505|FG001|STARTED|Overall Study||34
2849389|NCT02659514|3551504|FG000|Safety Population|Overall Study||33
2849390|NCT02659514|3551505|FG001|Safety Population|Overall Study||34
2849391|NCT02659514|3551504|FG000|Evaluable Population|Overall Study||30
2849392|NCT02659514|3551505|FG001|Evaluable Population|Overall Study||27
2849393|NCT02659514|3551504|FG000|COMPLETED|Overall Study||1
2849394|NCT02659514|3551505|FG001|COMPLETED|Overall Study||0
2849395|NCT02659514|3551504|FG000|NOT COMPLETED|Overall Study||32
2849396|NCT02659514|3551505|FG001|NOT COMPLETED|Overall Study||34
2849397|NCT02634268|3551513|FG000|STARTED|Overall Study||346
2849398|NCT02634268|3551514|FG001|STARTED|Overall Study||338
2849399|NCT02634268|3551513|FG000|COMPLETED|Overall Study|In-person visit completion = 267 for both groups. Some participants completed only surveys because of Covid-19 restrictions.|287
2849400|NCT02634268|3551514|FG001|COMPLETED|Overall Study|In-person visit completion = 267 for both groups. Some participants completed only surveys because of Covid-19 restrictions.|291
2849401|NCT02634268|3551513|FG000|NOT COMPLETED|Overall Study||59
2849402|NCT02634268|3551514|FG001|NOT COMPLETED|Overall Study||47
2849403|NCT02605967|3551522|FG000|STARTED|Overall Study||82
2849404|NCT02605967|3551523|FG001|STARTED|Overall Study||40
2849405|NCT02605967|3551522|FG000|Safety Set|Overall Study||82
2849406|NCT02605967|3551523|FG001|Safety Set|Overall Study||39
2849407|NCT02605967|3551522|FG000|Crossover to Spartalizumab|Overall Study||0
2849408|NCT02605967|3551523|FG001|Crossover to Spartalizumab|Overall Study||27
2849409|NCT02605967|3551522|FG000|COMPLETED|Overall Study||0
2849410|NCT02605967|3551523|FG001|COMPLETED|Overall Study||0
2849411|NCT02605967|3551522|FG000|NOT COMPLETED|Overall Study||82
2849412|NCT02605967|3551523|FG001|NOT COMPLETED|Overall Study||40
2849413|NCT02584634|3551535|FG000|STARTED|Overall Study||12
2849414|NCT02584634|3551536|FG001|STARTED|Overall Study||31
2849415|NCT02584634|3551535|FG000|COMPLETED|Overall Study||0
2849416|NCT02584634|3551536|FG001|COMPLETED|Overall Study||0
2849417|NCT02584634|3551535|FG000|NOT COMPLETED|Overall Study||12
2849418|NCT02584634|3551536|FG001|NOT COMPLETED|Overall Study||31
2849419|NCT02581137|3551545|FG000|STARTED|Overall Study||26
2849420|NCT02581137|3551545|FG000|COMPLETED|Overall Study||22
2849421|NCT02581137|3551545|FG000|NOT COMPLETED|Overall Study||4
2849422|NCT02562235|3551549|FG000|STARTED|Overall Study||24
2849423|NCT02562235|3551549|FG000|COMPLETED|Overall Study||21
2849424|NCT02562235|3551549|FG000|NOT COMPLETED|Overall Study||3
2849425|NCT02553265|3551558|FG000|STARTED|Enrollment||9
2849426|NCT02553265|3551559|FG001|STARTED|Enrollment||7
2849427|NCT02553265|3551560|FG002|STARTED|Enrollment||6
2849428|NCT02553265|3551558|FG000|COMPLETED|Enrollment||9
2849429|NCT02553265|3551559|FG001|COMPLETED|Enrollment||7
2849430|NCT02553265|3551560|FG002|COMPLETED|Enrollment||5
2849431|NCT02553265|3551558|FG000|NOT COMPLETED|Enrollment||0
2849432|NCT02553265|3551559|FG001|NOT COMPLETED|Enrollment||0
2849433|NCT02553265|3551560|FG002|NOT COMPLETED|Enrollment||1
2849434|NCT02553265|3551558|FG000|STARTED|First Intervention (28 Days)||9
2849435|NCT02553265|3551559|FG001|STARTED|First Intervention (28 Days)||7
2849436|NCT02553265|3551560|FG002|STARTED|First Intervention (28 Days)||5
2849437|NCT02553265|3551558|FG000|COMPLETED|First Intervention (28 Days)||8
2849438|NCT02553265|3551559|FG001|COMPLETED|First Intervention (28 Days)||7
2849439|NCT02553265|3551560|FG002|COMPLETED|First Intervention (28 Days)||4
2849440|NCT02553265|3551558|FG000|NOT COMPLETED|First Intervention (28 Days)||1
2849441|NCT02553265|3551559|FG001|NOT COMPLETED|First Intervention (28 Days)||0
2849442|NCT02553265|3551560|FG002|NOT COMPLETED|First Intervention (28 Days)||1
2849443|NCT02553265|3551558|FG000|STARTED|Second Intervention (28 Days)||8
2849444|NCT02553265|3551559|FG001|STARTED|Second Intervention (28 Days)||7
2849445|NCT02553265|3551560|FG002|STARTED|Second Intervention (28 Days)||4
2849446|NCT02553265|3551558|FG000|COMPLETED|Second Intervention (28 Days)||7
2849447|NCT02553265|3551559|FG001|COMPLETED|Second Intervention (28 Days)||7
2849448|NCT02553265|3551560|FG002|COMPLETED|Second Intervention (28 Days)||4
2849449|NCT02553265|3551558|FG000|NOT COMPLETED|Second Intervention (28 Days)||1
2849450|NCT02553265|3551559|FG001|NOT COMPLETED|Second Intervention (28 Days)||0
2849451|NCT02553265|3551560|FG002|NOT COMPLETED|Second Intervention (28 Days)||0
2849452|NCT02553265|3551558|FG000|STARTED|Third Intervention (28 Days)||7
2849453|NCT02553265|3551559|FG001|STARTED|Third Intervention (28 Days)||7
2849454|NCT02553265|3551560|FG002|STARTED|Third Intervention (28 Days)||4
2849455|NCT02553265|3551558|FG000|COMPLETED|Third Intervention (28 Days)||6
2849456|NCT02553265|3551559|FG001|COMPLETED|Third Intervention (28 Days)||7
2849457|NCT02553265|3551560|FG002|COMPLETED|Third Intervention (28 Days)||3
2849458|NCT02553265|3551558|FG000|NOT COMPLETED|Third Intervention (28 Days)||1
2849459|NCT02553265|3551559|FG001|NOT COMPLETED|Third Intervention (28 Days)||0
2849460|NCT02553265|3551560|FG002|NOT COMPLETED|Third Intervention (28 Days)||1
2849461|NCT02550288|3551576|FG000|STARTED|Overall Study||35
2849462|NCT02550288|3551577|FG001|STARTED|Overall Study||68
2849463|NCT02550288|3551578|FG002|STARTED|Overall Study||69
2849464|NCT02550288|3551579|FG003|STARTED|Overall Study||68
2849465|NCT02550288|3551580|FG004|STARTED|Overall Study||69
2849466|NCT02550288|3551576|FG000|COMPLETED|Overall Study||33
2849467|NCT02550288|3551577|FG001|COMPLETED|Overall Study||65
2849468|NCT02550288|3551578|FG002|COMPLETED|Overall Study||68
2849469|NCT02550288|3551579|FG003|COMPLETED|Overall Study||65
2849470|NCT02550288|3551580|FG004|COMPLETED|Overall Study||66
2849471|NCT02550288|3551576|FG000|NOT COMPLETED|Overall Study||2
2849472|NCT02550288|3551577|FG001|NOT COMPLETED|Overall Study||3
2849473|NCT02550288|3551578|FG002|NOT COMPLETED|Overall Study||1
2849474|NCT02550288|3551579|FG003|NOT COMPLETED|Overall Study||3
2849475|NCT02550288|3551580|FG004|NOT COMPLETED|Overall Study||3
2849476|NCT02510040|3551595|FG000|STARTED|Overall Study||81
2849477|NCT02510040|3551596|FG001|STARTED|Overall Study||114
2849478|NCT02510040|3551597|FG002|STARTED|Overall Study||22
2849479|NCT02510040|3551595|FG000|COMPLETED|Overall Study||63
2849480|NCT02510040|3551596|FG001|COMPLETED|Overall Study||111
2849481|NCT02510040|3551597|FG002|COMPLETED|Overall Study||21
2849482|NCT02510040|3551595|FG000|NOT COMPLETED|Overall Study||18
2849483|NCT02510040|3551596|FG001|NOT COMPLETED|Overall Study||3
2849484|NCT02510040|3551597|FG002|NOT COMPLETED|Overall Study||1
2849485|NCT02499328|3551625|FG000|STARTED|Overall Study||4
2849486|NCT02499328|3551626|FG001|STARTED|Overall Study||7
2849487|NCT02499328|3551627|FG002|STARTED|Overall Study||10
2849488|NCT02499328|3551628|FG003|STARTED|Overall Study||11
2849489|NCT02499328|3551629|FG004|STARTED|Overall Study||15
2849490|NCT02499328|3551630|FG005|STARTED|Overall Study||9
2849491|NCT02499328|3551631|FG006|STARTED|Overall Study||7
2849492|NCT02499328|3551632|FG007|STARTED|Overall Study||6
2849493|NCT02499328|3551633|FG008|STARTED|Overall Study||14
2849494|NCT02499328|3551634|FG009|STARTED|Overall Study||24
2849495|NCT02499328|3551635|FG010|STARTED|Overall Study||20
2849496|NCT02499328|3551636|FG011|STARTED|Overall Study||54
2849497|NCT02499328|3551637|FG012|STARTED|Overall Study||25
2849498|NCT02499328|3551638|FG013|STARTED|Overall Study||17
2849499|NCT02499328|3551639|FG014|STARTED|Overall Study||10
2849500|NCT02499328|3551640|FG015|STARTED|Overall Study||1
2849501|NCT02499328|3551641|FG016|STARTED|Overall Study||1
2849502|NCT02499328|3551642|FG017|STARTED|Overall Study||55
2849503|NCT02499328|3551643|FG018|STARTED|Overall Study||50
2849504|NCT02499328|3551625|FG000|COMPLETED|Overall Study||0
2849505|NCT02499328|3551626|FG001|COMPLETED|Overall Study||0
2849506|NCT02499328|3551627|FG002|COMPLETED|Overall Study||0
2849507|NCT02499328|3551628|FG003|COMPLETED|Overall Study||0
2849508|NCT02499328|3551629|FG004|COMPLETED|Overall Study||0
2849509|NCT02499328|3551630|FG005|COMPLETED|Overall Study||0
2849510|NCT02499328|3551631|FG006|COMPLETED|Overall Study||0
2849511|NCT02499328|3551632|FG007|COMPLETED|Overall Study||0
2849512|NCT02499328|3551633|FG008|COMPLETED|Overall Study||0
2849513|NCT02499328|3551634|FG009|COMPLETED|Overall Study||0
2849514|NCT02499328|3551635|FG010|COMPLETED|Overall Study||0
2849515|NCT02499328|3551636|FG011|COMPLETED|Overall Study||0
2849516|NCT02499328|3551637|FG012|COMPLETED|Overall Study||0
2849517|NCT02499328|3551638|FG013|COMPLETED|Overall Study||0
2849518|NCT02499328|3551639|FG014|COMPLETED|Overall Study||0
2849519|NCT02499328|3551640|FG015|COMPLETED|Overall Study||0
2849520|NCT02499328|3551641|FG016|COMPLETED|Overall Study||0
2849521|NCT02499328|3551642|FG017|COMPLETED|Overall Study||0
2849522|NCT02499328|3551643|FG018|COMPLETED|Overall Study||1
2849523|NCT02499328|3551625|FG000|NOT COMPLETED|Overall Study||4
2849524|NCT02499328|3551626|FG001|NOT COMPLETED|Overall Study||7
2849525|NCT02499328|3551627|FG002|NOT COMPLETED|Overall Study||10
2849526|NCT02499328|3551628|FG003|NOT COMPLETED|Overall Study||11
2849527|NCT02499328|3551629|FG004|NOT COMPLETED|Overall Study||15
2849528|NCT02499328|3551630|FG005|NOT COMPLETED|Overall Study||9
2849529|NCT02499328|3551631|FG006|NOT COMPLETED|Overall Study||7
2849530|NCT02499328|3551632|FG007|NOT COMPLETED|Overall Study||6
2849531|NCT02499328|3551633|FG008|NOT COMPLETED|Overall Study||14
2849532|NCT02499328|3551634|FG009|NOT COMPLETED|Overall Study||24
2849533|NCT02499328|3551635|FG010|NOT COMPLETED|Overall Study||20
2849534|NCT02499328|3551636|FG011|NOT COMPLETED|Overall Study||54
2849535|NCT02499328|3551637|FG012|NOT COMPLETED|Overall Study||25
2849536|NCT02499328|3551638|FG013|NOT COMPLETED|Overall Study||17
2849537|NCT02499328|3551639|FG014|NOT COMPLETED|Overall Study||10
2849538|NCT02499328|3551640|FG015|NOT COMPLETED|Overall Study||1
2849539|NCT02499328|3551641|FG016|NOT COMPLETED|Overall Study||1
2849540|NCT02499328|3551642|FG017|NOT COMPLETED|Overall Study||55
2849541|NCT02499328|3551643|FG018|NOT COMPLETED|Overall Study||49
2849542|NCT02463981|3551728|FG000|STARTED|Overall Study||21
2849543|NCT02463981|3551729|FG001|STARTED|Overall Study||16
2849544|NCT02463981|3551728|FG000|COMPLETED|Overall Study||18
2849545|NCT02463981|3551729|FG001|COMPLETED|Overall Study||14
2849546|NCT02463981|3551728|FG000|NOT COMPLETED|Overall Study||3
2849547|NCT02463981|3551729|FG001|NOT COMPLETED|Overall Study||2
2849548|NCT02460224|3551764|FG000|STARTED|Overall Study||17
2849549|NCT02460224|3551765|FG001|STARTED|Overall Study||12
2849550|NCT02460224|3551766|FG002|STARTED|Overall Study||6
2849551|NCT02460224|3551767|FG003|STARTED|Overall Study||6
2849552|NCT02460224|3551768|FG004|STARTED|Overall Study||6
2849553|NCT02460224|3551769|FG005|STARTED|Overall Study||30
2849554|NCT02460224|3551770|FG006|STARTED|Overall Study||30
2849555|NCT02460224|3551771|FG007|STARTED|Overall Study||5
2849556|NCT02460224|3551772|FG008|STARTED|Overall Study||6
2849557|NCT02460224|3551773|FG009|STARTED|Overall Study||11
2849558|NCT02460224|3551774|FG010|STARTED|Overall Study||5
2849559|NCT02460224|3551775|FG011|STARTED|Overall Study||6
2849560|NCT02460224|3551776|FG012|STARTED|Overall Study||6
2849561|NCT02460224|3551777|FG013|STARTED|Overall Study||6
2849562|NCT02460224|3551778|FG014|STARTED|Overall Study||5
2849563|NCT02460224|3551779|FG015|STARTED|Overall Study||6
2849564|NCT02460224|3551780|FG016|STARTED|Overall Study||20
2849565|NCT02460224|3551781|FG017|STARTED|Overall Study||6
2849566|NCT02460224|3551782|FG018|STARTED|Overall Study||12
2849567|NCT02460224|3551783|FG019|STARTED|Overall Study||7
2849568|NCT02460224|3551784|FG020|STARTED|Overall Study||6
2849569|NCT02460224|3551785|FG021|STARTED|Overall Study||12
2849570|NCT02460224|3551786|FG022|STARTED|Overall Study||6
2849571|NCT02460224|3551787|FG023|STARTED|Overall Study||11
2849572|NCT02460224|3551788|FG024|STARTED|Overall Study||6
2849573|NCT02460224|3551789|FG025|STARTED|Overall Study||6
2849574|NCT02460224|3551790|FG026|STARTED|Overall Study||121
2849575|NCT02460224|3551791|FG027|STARTED|Overall Study||21
2849576|NCT02460224|3551792|FG028|STARTED|Overall Study||93
2849577|NCT02460224|3551764|FG000|Rest of the World Patients in the Dose Escalation Part|Overall Study||13
2849578|NCT02460224|3551765|FG001|Rest of the World Patients in the Dose Escalation Part|Overall Study||12
2849579|NCT02460224|3551766|FG002|Rest of the World Patients in the Dose Escalation Part|Overall Study||6
2849580|NCT02460224|3551767|FG003|Rest of the World Patients in the Dose Escalation Part|Overall Study||6
2849581|NCT02460224|3551768|FG004|Rest of the World Patients in the Dose Escalation Part|Overall Study||6
2849582|NCT02460224|3551769|FG005|Rest of the World Patients in the Dose Escalation Part|Overall Study||25
2849583|NCT02460224|3551770|FG006|Rest of the World Patients in the Dose Escalation Part|Overall Study||24
2849584|NCT02460224|3551771|FG007|Rest of the World Patients in the Dose Escalation Part|Overall Study||5
2849585|NCT02460224|3551772|FG008|Rest of the World Patients in the Dose Escalation Part|Overall Study||6
2849586|NCT02460224|3551773|FG009|Rest of the World Patients in the Dose Escalation Part|Overall Study||11
2849587|NCT02460224|3551774|FG010|Rest of the World Patients in the Dose Escalation Part|Overall Study||5
2849588|NCT02460224|3551775|FG011|Rest of the World Patients in the Dose Escalation Part|Overall Study||6
2849589|NCT02460224|3551776|FG012|Rest of the World Patients in the Dose Escalation Part|Overall Study||6
2849590|NCT02460224|3551777|FG013|Rest of the World Patients in the Dose Escalation Part|Overall Study||6
2849591|NCT02460224|3551778|FG014|Rest of the World Patients in the Dose Escalation Part|Overall Study||5
2849592|NCT02460224|3551779|FG015|Rest of the World Patients in the Dose Escalation Part|Overall Study||6
2849593|NCT02460224|3551780|FG016|Rest of the World Patients in the Dose Escalation Part|Overall Study||20
3168393|NCT01918085|3895658|FG000|NOT COMPLETED|Test Period 2: Hydrocolloid Strip||0
3168394|NCT01918085|3895659|FG001|NOT COMPLETED|Test Period 2: Hydrocolloid Strip||0
3168395|NCT01918189|3895667|FG000|STARTED|Overall Study||59
3168396|NCT01918189|3895667|FG000|Completed Baseline Assessment|Overall Study||58
3168397|NCT01918189|3895667|FG000|Completed Follow-up Assessment|Overall Study||41
3168398|NCT01918189|3895667|FG000|COMPLETED|Overall Study||41
2849594|NCT02460224|3551781|FG017|Rest of the World Patients in the Dose Escalation Part|Overall Study||6
2849595|NCT02460224|3551782|FG018|Rest of the World Patients in the Dose Escalation Part|Overall Study||12
2849596|NCT02460224|3551783|FG019|Rest of the World Patients in the Dose Escalation Part|Overall Study||7
2849597|NCT02460224|3551784|FG020|Rest of the World Patients in the Dose Escalation Part|Overall Study||6
2849598|NCT02460224|3551785|FG021|Rest of the World Patients in the Dose Escalation Part|Overall Study||12
2849599|NCT02460224|3551786|FG022|Rest of the World Patients in the Dose Escalation Part|Overall Study||6
2849600|NCT02460224|3551787|FG023|Rest of the World Patients in the Dose Escalation Part|Overall Study||11
2849601|NCT02460224|3551788|FG024|Rest of the World Patients in the Dose Escalation Part|Overall Study||6
2849602|NCT02460224|3551789|FG025|Rest of the World Patients in the Dose Escalation Part|Overall Study||6
2849603|NCT02460224|3551790|FG026|Rest of the World Patients in the Dose Escalation Part|Overall Study||0
2849604|NCT02460224|3551791|FG027|Rest of the World Patients in the Dose Escalation Part|Overall Study||0
2849605|NCT02460224|3551792|FG028|Rest of the World Patients in the Dose Escalation Part|Overall Study||0
2849606|NCT02460224|3551764|FG000|Japanese Patients in the Dose Escalation Part|Overall Study||4
2849607|NCT02460224|3551765|FG001|Japanese Patients in the Dose Escalation Part|Overall Study||0
2849608|NCT02460224|3551766|FG002|Japanese Patients in the Dose Escalation Part|Overall Study||0
2849609|NCT02460224|3551767|FG003|Japanese Patients in the Dose Escalation Part|Overall Study||0
2849610|NCT02460224|3551768|FG004|Japanese Patients in the Dose Escalation Part|Overall Study||0
2849611|NCT02460224|3551769|FG005|Japanese Patients in the Dose Escalation Part|Overall Study||5
2849612|NCT02460224|3551770|FG006|Japanese Patients in the Dose Escalation Part|Overall Study||6
2849613|NCT02460224|3551771|FG007|Japanese Patients in the Dose Escalation Part|Overall Study||0
2849614|NCT02460224|3551772|FG008|Japanese Patients in the Dose Escalation Part|Overall Study||0
2849615|NCT02460224|3551773|FG009|Japanese Patients in the Dose Escalation Part|Overall Study||0
2849616|NCT02460224|3551774|FG010|Japanese Patients in the Dose Escalation Part|Overall Study||0
2849617|NCT02460224|3551775|FG011|Japanese Patients in the Dose Escalation Part|Overall Study||0
2849618|NCT02460224|3551776|FG012|Japanese Patients in the Dose Escalation Part|Overall Study||0
2849619|NCT02460224|3551777|FG013|Japanese Patients in the Dose Escalation Part|Overall Study||0
2849620|NCT02460224|3551778|FG014|Japanese Patients in the Dose Escalation Part|Overall Study||0
2849621|NCT02460224|3551779|FG015|Japanese Patients in the Dose Escalation Part|Overall Study||0
2849622|NCT02460224|3551780|FG016|Japanese Patients in the Dose Escalation Part|Overall Study||0
2849623|NCT02460224|3551781|FG017|Japanese Patients in the Dose Escalation Part|Overall Study||0
2849624|NCT02460224|3551782|FG018|Japanese Patients in the Dose Escalation Part|Overall Study||0
2849625|NCT02460224|3551783|FG019|Japanese Patients in the Dose Escalation Part|Overall Study||0
2849626|NCT02460224|3551784|FG020|Japanese Patients in the Dose Escalation Part|Overall Study||0
2849627|NCT02460224|3551785|FG021|Japanese Patients in the Dose Escalation Part|Overall Study||0
2849628|NCT02460224|3551786|FG022|Japanese Patients in the Dose Escalation Part|Overall Study||0
2849629|NCT02460224|3551787|FG023|Japanese Patients in the Dose Escalation Part|Overall Study||0
2849630|NCT02460224|3551788|FG024|Japanese Patients in the Dose Escalation Part|Overall Study||0
2849631|NCT02460224|3551789|FG025|Japanese Patients in the Dose Escalation Part|Overall Study||0
2849632|NCT02460224|3551790|FG026|Japanese Patients in the Dose Escalation Part|Overall Study||0
2849633|NCT02460224|3551791|FG027|Japanese Patients in the Dose Escalation Part|Overall Study||0
2849634|NCT02460224|3551792|FG028|Japanese Patients in the Dose Escalation Part|Overall Study||0
2849635|NCT02460224|3551764|FG000|COMPLETED|Overall Study||0
2849636|NCT02460224|3551765|FG001|COMPLETED|Overall Study||0
2849637|NCT02460224|3551766|FG002|COMPLETED|Overall Study||0
2849638|NCT02460224|3551767|FG003|COMPLETED|Overall Study||0
2849639|NCT02460224|3551768|FG004|COMPLETED|Overall Study||0
2849640|NCT02460224|3551769|FG005|COMPLETED|Overall Study||0
2849641|NCT02460224|3551770|FG006|COMPLETED|Overall Study||0
2849642|NCT02460224|3551771|FG007|COMPLETED|Overall Study||0
2849643|NCT02460224|3551772|FG008|COMPLETED|Overall Study||0
2849644|NCT02460224|3551773|FG009|COMPLETED|Overall Study||0
2849645|NCT02460224|3551774|FG010|COMPLETED|Overall Study||0
2849646|NCT02460224|3551775|FG011|COMPLETED|Overall Study||0
2849647|NCT02460224|3551776|FG012|COMPLETED|Overall Study||0
2849648|NCT02460224|3551777|FG013|COMPLETED|Overall Study||0
2849649|NCT02460224|3551778|FG014|COMPLETED|Overall Study||0
2849650|NCT02460224|3551779|FG015|COMPLETED|Overall Study||0
2849651|NCT02460224|3551780|FG016|COMPLETED|Overall Study||0
2849652|NCT02460224|3551781|FG017|COMPLETED|Overall Study||0
2849653|NCT02460224|3551782|FG018|COMPLETED|Overall Study||0
2849654|NCT02460224|3551783|FG019|COMPLETED|Overall Study||0
2849655|NCT02460224|3551784|FG020|COMPLETED|Overall Study||0
2849656|NCT02460224|3551785|FG021|COMPLETED|Overall Study||0
2849657|NCT02460224|3551786|FG022|COMPLETED|Overall Study||0
2849658|NCT02460224|3551787|FG023|COMPLETED|Overall Study||0
2849659|NCT02460224|3551788|FG024|COMPLETED|Overall Study||0
2849660|NCT02460224|3551789|FG025|COMPLETED|Overall Study||0
2849661|NCT02460224|3551790|FG026|COMPLETED|Overall Study||0
2849662|NCT02460224|3551791|FG027|COMPLETED|Overall Study||0
2849663|NCT02460224|3551792|FG028|COMPLETED|Overall Study||0
2849664|NCT02460224|3551764|FG000|NOT COMPLETED|Overall Study||17
2849665|NCT02460224|3551765|FG001|NOT COMPLETED|Overall Study||12
2849666|NCT02460224|3551766|FG002|NOT COMPLETED|Overall Study||6
2849667|NCT02460224|3551767|FG003|NOT COMPLETED|Overall Study||6
2849668|NCT02460224|3551768|FG004|NOT COMPLETED|Overall Study||6
2849669|NCT02460224|3551769|FG005|NOT COMPLETED|Overall Study||30
2849670|NCT02460224|3551770|FG006|NOT COMPLETED|Overall Study||30
2849671|NCT02460224|3551771|FG007|NOT COMPLETED|Overall Study||5
2849672|NCT02460224|3551772|FG008|NOT COMPLETED|Overall Study||6
2849673|NCT02460224|3551773|FG009|NOT COMPLETED|Overall Study||11
2849674|NCT02460224|3551774|FG010|NOT COMPLETED|Overall Study||5
2849675|NCT02460224|3551775|FG011|NOT COMPLETED|Overall Study||6
2849676|NCT02460224|3551776|FG012|NOT COMPLETED|Overall Study||6
2849677|NCT02460224|3551777|FG013|NOT COMPLETED|Overall Study||6
2849678|NCT02460224|3551778|FG014|NOT COMPLETED|Overall Study||5
2849679|NCT02460224|3551779|FG015|NOT COMPLETED|Overall Study||6
2849680|NCT02460224|3551780|FG016|NOT COMPLETED|Overall Study||20
2849681|NCT02460224|3551781|FG017|NOT COMPLETED|Overall Study||6
2849682|NCT02460224|3551782|FG018|NOT COMPLETED|Overall Study||12
2849683|NCT02460224|3551783|FG019|NOT COMPLETED|Overall Study||7
2849684|NCT02460224|3551784|FG020|NOT COMPLETED|Overall Study||6
2849685|NCT02460224|3551785|FG021|NOT COMPLETED|Overall Study||12
2849686|NCT02460224|3551786|FG022|NOT COMPLETED|Overall Study||6
2849687|NCT02460224|3551787|FG023|NOT COMPLETED|Overall Study||11
2849688|NCT02460224|3551788|FG024|NOT COMPLETED|Overall Study||6
2849689|NCT02460224|3551789|FG025|NOT COMPLETED|Overall Study||6
2849690|NCT02460224|3551790|FG026|NOT COMPLETED|Overall Study||121
2849691|NCT02460224|3551791|FG027|NOT COMPLETED|Overall Study||21
2849692|NCT02460224|3551792|FG028|NOT COMPLETED|Overall Study||93
2849693|NCT02460159|3551866|FG000|STARTED|Overall Study||117
2849694|NCT02460159|3551867|FG001|STARTED|Overall Study||18
2849695|NCT02460159|3551866|FG000|COMPLETED|Overall Study||111
2849696|NCT02460159|3551867|FG001|COMPLETED|Overall Study||17
2849697|NCT02460159|3551866|FG000|NOT COMPLETED|Overall Study||6
2849698|NCT02460159|3551867|FG001|NOT COMPLETED|Overall Study||1
2849699|NCT02457910|3551879|FG000|STARTED|Overall Study||3
2849700|NCT02457910|3551880|FG001|STARTED|Overall Study|In dose escalation, two patients receiving the 4 mg dose of taselisib were removed for toxicities|5
2849701|NCT02457910|3551881|FG002|STARTED|Overall Study||3
2849702|NCT02457910|3551882|FG003|STARTED|Overall Study||2
2849703|NCT02457910|3551883|FG004|STARTED|Overall Study|3 participants crossed over to enzalutamide and taselisib|5
2849704|NCT02457910|3551884|FG005|STARTED|Overall Study||12
2849705|NCT02457910|3551879|FG000|COMPLETED|Overall Study||0
2849706|NCT02457910|3551880|FG001|COMPLETED|Overall Study||0
2849707|NCT02457910|3551881|FG002|COMPLETED|Overall Study||0
2849708|NCT02457910|3551882|FG003|COMPLETED|Overall Study||0
2849709|NCT02457910|3551883|FG004|COMPLETED|Overall Study||0
2849710|NCT02457910|3551884|FG005|COMPLETED|Overall Study||1
2849711|NCT02457910|3551879|FG000|NOT COMPLETED|Overall Study||3
2849712|NCT02457910|3551880|FG001|NOT COMPLETED|Overall Study||5
2849713|NCT02457910|3551881|FG002|NOT COMPLETED|Overall Study||3
2849714|NCT02457910|3551882|FG003|NOT COMPLETED|Overall Study||2
2849715|NCT02457910|3551883|FG004|NOT COMPLETED|Overall Study||5
2849716|NCT02457910|3551884|FG005|NOT COMPLETED|Overall Study||11
2849717|NCT02407236|3551909|FG000|STARTED|Induction Study (8 Weeks)||319
2849718|NCT02407236|3551910|FG001|STARTED|Induction Study (8 Weeks)||320
2849719|NCT02407236|3551911|FG002|STARTED|Induction Study (8 Weeks)||322
2849720|NCT02407236|3551912|FG003|STARTED|Induction Study (8 Weeks)||0
2849721|NCT02407236|3551913|FG004|STARTED|Induction Study (8 Weeks)||0
2849722|NCT02407236|3551914|FG005|STARTED|Induction Study (8 Weeks)||0
2849723|NCT02407236|3551915|FG006|STARTED|Induction Study (8 Weeks)||0
2849724|NCT02407236|3551916|FG007|STARTED|Induction Study (8 Weeks)||0
2849725|NCT02407236|3551909|FG000|Clinical Response at IS Week 8|Induction Study (8 Weeks)||103
2849726|NCT02407236|3551910|FG001|Clinical Response at IS Week 8|Induction Study (8 Weeks)||172
2849727|NCT02407236|3551911|FG002|Clinical Response at IS Week 8|Induction Study (8 Weeks)||208
2849728|NCT02407236|3551912|FG003|Clinical Response at IS Week 8|Induction Study (8 Weeks)||0
2849729|NCT02407236|3551913|FG004|Clinical Response at IS Week 8|Induction Study (8 Weeks)||0
2849730|NCT02407236|3551914|FG005|Clinical Response at IS Week 8|Induction Study (8 Weeks)||0
2849731|NCT02407236|3551915|FG006|Clinical Response at IS Week 8|Induction Study (8 Weeks)||0
2849732|NCT02407236|3551916|FG007|Clinical Response at IS Week 8|Induction Study (8 Weeks)||0
2849733|NCT02407236|3551909|FG000|Clinical Response at IS Week 16|Induction Study (8 Weeks)||143
2849734|NCT02407236|3551910|FG001|Clinical Response at IS Week 16|Induction Study (8 Weeks)||90
2849735|NCT02407236|3551911|FG002|Clinical Response at IS Week 16|Induction Study (8 Weeks)||67
2849736|NCT02407236|3551912|FG003|Clinical Response at IS Week 16|Induction Study (8 Weeks)||0
2849737|NCT02407236|3551913|FG004|Clinical Response at IS Week 16|Induction Study (8 Weeks)||0
2849738|NCT02407236|3551914|FG005|Clinical Response at IS Week 16|Induction Study (8 Weeks)||0
2849739|NCT02407236|3551915|FG006|Clinical Response at IS Week 16|Induction Study (8 Weeks)||0
2849740|NCT02407236|3551916|FG007|Clinical Response at IS Week 16|Induction Study (8 Weeks)||0
2849741|NCT02407236|3551909|FG000|Completed Safety Follow-up|Induction Study (8 Weeks)|17 participants from Induction Week (IW)- 8 and 33 participants from IW- 16.|50
2849742|NCT02407236|3551910|FG001|Completed Safety Follow-up|Induction Study (8 Weeks)|10 participants from IW- 8 and 37 from IW- 16.|47
2849743|NCT02407236|3551911|FG002|Completed Safety Follow-up|Induction Study (8 Weeks)|10 participants from IW- 8 and 22 from IW- 16.|32
2849744|NCT02407236|3551912|FG003|Completed Safety Follow-up|Induction Study (8 Weeks)||0
2849745|NCT02407236|3551913|FG004|Completed Safety Follow-up|Induction Study (8 Weeks)||0
2849746|NCT02407236|3551914|FG005|Completed Safety Follow-up|Induction Study (8 Weeks)||0
2849747|NCT02407236|3551915|FG006|Completed Safety Follow-up|Induction Study (8 Weeks)||0
2849748|NCT02407236|3551916|FG007|Completed Safety Follow-up|Induction Study (8 Weeks)||0
2849749|NCT02407236|3551909|FG000|Safety Analysis Set|Induction Study (8 Weeks)||319
2849750|NCT02407236|3551910|FG001|Safety Analysis Set|Induction Study (8 Weeks)|1 participant of ustekinumab 130mg never had drug, 2 participants planned to 6 mg/kg but had 130mg.|321
2849751|NCT02407236|3551911|FG002|Safety Analysis Set|Induction Study (8 Weeks)||320
2849752|NCT02407236|3551912|FG003|Safety Analysis Set|Induction Study (8 Weeks)||0
2849753|NCT02407236|3551913|FG004|Safety Analysis Set|Induction Study (8 Weeks)||0
2849754|NCT02407236|3551914|FG005|Safety Analysis Set|Induction Study (8 Weeks)||0
2849755|NCT02407236|3551915|FG006|Safety Analysis Set|Induction Study (8 Weeks)||0
2849756|NCT02407236|3551916|FG007|Safety Analysis Set|Induction Study (8 Weeks)||0
2849757|NCT02407236|3551909|FG000|Non-responders at Week 8|Induction Study (8 Weeks)||184
2849758|NCT02407236|3551910|FG001|Non-responders at Week 8|Induction Study (8 Weeks)||132
2849759|NCT02407236|3551911|FG002|Non-responders at Week 8|Induction Study (8 Weeks)||101
2849760|NCT02407236|3551912|FG003|Non-responders at Week 8|Induction Study (8 Weeks)||0
2849761|NCT02407236|3551913|FG004|Non-responders at Week 8|Induction Study (8 Weeks)||0
2849762|NCT02407236|3551914|FG005|Non-responders at Week 8|Induction Study (8 Weeks)||0
2849763|NCT02407236|3551915|FG006|Non-responders at Week 8|Induction Study (8 Weeks)||0
2849764|NCT02407236|3551916|FG007|Non-responders at Week 8|Induction Study (8 Weeks)||0
2849765|NCT02407236|3551909|FG000|COMPLETED|Induction Study (8 Weeks)||296
2849766|NCT02407236|3551910|FG001|COMPLETED|Induction Study (8 Weeks)||309
2849767|NCT02407236|3551911|FG002|COMPLETED|Induction Study (8 Weeks)||307
2849768|NCT02407236|3551912|FG003|COMPLETED|Induction Study (8 Weeks)||0
2849769|NCT02407236|3551913|FG004|COMPLETED|Induction Study (8 Weeks)||0
2849770|NCT02407236|3551914|FG005|COMPLETED|Induction Study (8 Weeks)||0
2849771|NCT02407236|3551915|FG006|COMPLETED|Induction Study (8 Weeks)||0
2849772|NCT02407236|3551916|FG007|COMPLETED|Induction Study (8 Weeks)||0
2849773|NCT02407236|3551909|FG000|NOT COMPLETED|Induction Study (8 Weeks)||23
2849774|NCT02407236|3551910|FG001|NOT COMPLETED|Induction Study (8 Weeks)||11
2849775|NCT02407236|3551911|FG002|NOT COMPLETED|Induction Study (8 Weeks)||15
2849776|NCT02407236|3551912|FG003|NOT COMPLETED|Induction Study (8 Weeks)||0
2849777|NCT02407236|3551913|FG004|NOT COMPLETED|Induction Study (8 Weeks)||0
2849778|NCT02407236|3551914|FG005|NOT COMPLETED|Induction Study (8 Weeks)||0
2849779|NCT02407236|3551915|FG006|NOT COMPLETED|Induction Study (8 Weeks)||0
2849780|NCT02407236|3551916|FG007|NOT COMPLETED|Induction Study (8 Weeks)||0
2849781|NCT02407236|3551909|FG000|STARTED|Maintenance Study (44 Weeks)||0
2849782|NCT02407236|3551910|FG001|STARTED|Maintenance Study (44 Weeks)||0
2849783|NCT02407236|3551911|FG002|STARTED|Maintenance Study (44 Weeks)||0
2849784|NCT02407236|3551912|FG003|STARTED|Maintenance Study (44 Weeks)||175
2849785|NCT02407236|3551913|FG004|STARTED|Maintenance Study (44 Weeks)||172
2849786|NCT02407236|3551914|FG005|STARTED|Maintenance Study (44 Weeks)||176
2849787|NCT02407236|3551915|FG006|STARTED|Maintenance Study (44 Weeks)||103
2849788|NCT02407236|3551916|FG007|STARTED|Maintenance Study (44 Weeks)||157
2849789|NCT02407236|3551909|FG000|COMPLETED|Maintenance Study (44 Weeks)||0
2849790|NCT02407236|3551910|FG001|COMPLETED|Maintenance Study (44 Weeks)||0
3168399|NCT01918189|3895667|FG000|NOT COMPLETED|Overall Study||18
3168400|NCT01918306|3895674|FG000|STARTED|Overall Study||6
3168401|NCT01918306|3895675|FG001|STARTED|Overall Study|No patients enrolled|0
3168402|NCT01918306|3895676|FG002|STARTED|Overall Study|1 participant Crossed-over to ARM 2|2
3168403|NCT01918306|3895677|FG003|STARTED|Overall Study||3
3168404|NCT01918306|3895674|FG000|COMPLETED|Overall Study||0
3168405|NCT01918306|3895675|FG001|COMPLETED|Overall Study||0
3168406|NCT01918306|3895676|FG002|COMPLETED|Overall Study||0
3168407|NCT01918306|3895677|FG003|COMPLETED|Overall Study||0
3168408|NCT01918306|3895674|FG000|NOT COMPLETED|Overall Study||6
3168409|NCT01918306|3895675|FG001|NOT COMPLETED|Overall Study||0
3168410|NCT01918306|3895676|FG002|NOT COMPLETED|Overall Study||2
3168411|NCT01918306|3895677|FG003|NOT COMPLETED|Overall Study||3
3168412|NCT01918332|3895701|FG000|STARTED|Overall Study||43
3168413|NCT01918332|3895702|FG001|STARTED|Overall Study||41
3168414|NCT01918332|3895703|FG002|STARTED|Overall Study||39
3168415|NCT01918332|3895704|FG003|STARTED|Overall Study||45
3168416|NCT01918332|3895701|FG000|COMPLETED|Overall Study||35
3168417|NCT01918332|3895702|FG001|COMPLETED|Overall Study||36
3168418|NCT01918332|3895703|FG002|COMPLETED|Overall Study||30
3168419|NCT01918332|3895704|FG003|COMPLETED|Overall Study||38
3168420|NCT01918332|3895701|FG000|NOT COMPLETED|Overall Study||8
3168421|NCT01918332|3895702|FG001|NOT COMPLETED|Overall Study||5
3168422|NCT01918332|3895703|FG002|NOT COMPLETED|Overall Study||9
2849791|NCT02407236|3551911|FG002|COMPLETED|Maintenance Study (44 Weeks)||0
2849792|NCT02407236|3551912|FG003|COMPLETED|Maintenance Study (44 Weeks)||165
2849793|NCT02407236|3551913|FG004|COMPLETED|Maintenance Study (44 Weeks)||161
2849794|NCT02407236|3551914|FG005|COMPLETED|Maintenance Study (44 Weeks)||168
2849795|NCT02407236|3551915|FG006|COMPLETED|Maintenance Study (44 Weeks)||94
2849796|NCT02407236|3551916|FG007|COMPLETED|Maintenance Study (44 Weeks)||149
2849797|NCT02407236|3551909|FG000|NOT COMPLETED|Maintenance Study (44 Weeks)||0
2849798|NCT02407236|3551910|FG001|NOT COMPLETED|Maintenance Study (44 Weeks)||0
2849799|NCT02407236|3551911|FG002|NOT COMPLETED|Maintenance Study (44 Weeks)||0
2849800|NCT02407236|3551912|FG003|NOT COMPLETED|Maintenance Study (44 Weeks)||10
2849801|NCT02407236|3551913|FG004|NOT COMPLETED|Maintenance Study (44 Weeks)||11
2849802|NCT02407236|3551914|FG005|NOT COMPLETED|Maintenance Study (44 Weeks)||8
2849803|NCT02407236|3551915|FG006|NOT COMPLETED|Maintenance Study (44 Weeks)||9
2849804|NCT02407236|3551916|FG007|NOT COMPLETED|Maintenance Study (44 Weeks)||8
2849805|NCT02320396|3551936|FG000|STARTED|Overall Study||224
2849806|NCT02320396|3551937|FG001|STARTED|Overall Study||225
2849807|NCT02320396|3551936|FG000|Treated (Full Analysis Set)|Overall Study||223
2849808|NCT02320396|3551937|FG001|Treated (Full Analysis Set)|Overall Study||225
2849809|NCT02320396|3551936|FG000|COMPLETED|Overall Study||220
2849810|NCT02320396|3551937|FG001|COMPLETED|Overall Study||221
2849811|NCT02320396|3551936|FG000|NOT COMPLETED|Overall Study||4
2849812|NCT02320396|3551937|FG001|NOT COMPLETED|Overall Study||4
2849813|NCT02282345|3551945|FG000|STARTED|Overall Study||13
2849814|NCT02282345|3551946|FG001|STARTED|Overall Study||20
2849815|NCT02282345|3551945|FG000|COMPLETED|Overall Study||13
2849816|NCT02282345|3551946|FG001|COMPLETED|Overall Study||19
2849817|NCT02282345|3551945|FG000|NOT COMPLETED|Overall Study||0
2849818|NCT02282345|3551946|FG001|NOT COMPLETED|Overall Study||1
2849819|NCT02230410|3551955|FG000|STARTED|Overall Study||18
2849820|NCT02230410|3551955|FG000|COMPLETED|Overall Study||15
2849821|NCT02230410|3551955|FG000|NOT COMPLETED|Overall Study||3
2849822|NCT02053246|3551959|FG000|STARTED|Overall Study||11
2849823|NCT02053246|3551959|FG000|COMPLETED|Overall Study||7
2849824|NCT02053246|3551959|FG000|NOT COMPLETED|Overall Study||4
2849825|NCT02043678|3551965|FG000|STARTED|Overall Study||401
3168423|NCT01918332|3895704|FG003|NOT COMPLETED|Overall Study||7
3168424|NCT01918371|3895716|FG000|STARTED|Overall Study||166
3168425|NCT01918371|3895717|FG001|STARTED|Overall Study||157
3311729|NCT03054506|4045221|FG001|STARTED|Overall Study||11
3311730|NCT03054506|4045222|FG002|STARTED|Overall Study||9
3311731|NCT03054506|4045220|FG000|COMPLETED|Overall Study||19
3311732|NCT03054506|4045221|FG001|COMPLETED|Overall Study||11
3311733|NCT03054506|4045222|FG002|COMPLETED|Overall Study||9
3311734|NCT03054506|4045220|FG000|NOT COMPLETED|Overall Study||1
3311735|NCT03054506|4045221|FG001|NOT COMPLETED|Overall Study||0
3311736|NCT03054506|4045222|FG002|NOT COMPLETED|Overall Study||0
3311737|NCT03054649|4045230|FG000|STARTED|Overall Study||27
2849826|NCT02043678|3551966|FG001|STARTED|Overall Study||405
2849827|NCT02043678|3551965|FG000|Treated|Overall Study||390
2849828|NCT02043678|3551966|FG001|Treated|Overall Study||396
2849829|NCT02043678|3551965|FG000|COMPLETED|Overall Study||0
2849830|NCT02043678|3551966|FG001|COMPLETED|Overall Study||0
2849831|NCT02043678|3551965|FG000|NOT COMPLETED|Overall Study||401
2849832|NCT02043678|3551966|FG001|NOT COMPLETED|Overall Study||405
2849833|NCT02005471|3551974|FG000|STARTED|Overall Study||195
2849834|NCT02005471|3551975|FG001|STARTED|Overall Study||194
2849835|NCT02005471|3551974|FG000|Treated|Overall Study||188
2849836|NCT02005471|3551975|FG001|Treated|Overall Study||194
2849837|NCT02005471|3551974|FG000|COMPLETED|Overall Study||0
2849838|NCT02005471|3551975|FG001|COMPLETED|Overall Study||0
2849839|NCT02005471|3551974|FG000|NOT COMPLETED|Overall Study||195
2849840|NCT02005471|3551975|FG001|NOT COMPLETED|Overall Study||194
2849841|NCT01984346|3551986|FG000|STARTED|Overall Study|Date of full approval was 8/22/13. Date of first treated patient was 01/08/14|115
2849842|NCT01984346|3551987|FG001|STARTED|Overall Study||55
2849843|NCT01984346|3551986|FG000|Treated|Overall Study||102
2849844|NCT01984346|3551987|FG001|Treated|Overall Study||51
2849845|NCT01984346|3551986|FG000|COMPLETED|Overall Study||98
2849846|NCT01984346|3551987|FG001|COMPLETED|Overall Study||50
2849847|NCT01984346|3551986|FG000|NOT COMPLETED|Overall Study||17
2849848|NCT01984346|3551987|FG001|NOT COMPLETED|Overall Study||5
2849849|NCT01980940|3552001|FG000|STARTED|Overall Study||5
3168426|NCT01918371|3895716|FG000|Participants With Complete Data|Overall Study||165
3168427|NCT01918371|3895717|FG001|Participants With Complete Data|Overall Study||156
3168428|NCT01918371|3895716|FG000|COMPLETED|Overall Study||165
3168429|NCT01918371|3895717|FG001|COMPLETED|Overall Study||156
3168430|NCT01918371|3895716|FG000|NOT COMPLETED|Overall Study||1
3168431|NCT01918371|3895717|FG001|NOT COMPLETED|Overall Study||1
3311738|NCT03054649|4045231|FG001|STARTED|Overall Study||27
3311739|NCT03054649|4045230|FG000|COMPLETED|Overall Study||27
3311740|NCT03054649|4045231|FG001|COMPLETED|Overall Study||27
3311741|NCT03054649|4045230|FG000|NOT COMPLETED|Overall Study||0
3311742|NCT03054649|4045231|FG001|NOT COMPLETED|Overall Study||0
3311743|NCT03054740|4045262|FG000|STARTED|Overall Study||15
3311744|NCT03054740|4045263|FG001|STARTED|Overall Study||15
3311745|NCT03054740|4045262|FG000|COMPLETED|Overall Study||15
3311746|NCT03054740|4045263|FG001|COMPLETED|Overall Study||15
3311747|NCT03054740|4045262|FG000|NOT COMPLETED|Overall Study||0
3311748|NCT03054740|4045263|FG001|NOT COMPLETED|Overall Study||0
3311749|NCT03054805|4045272|FG000|STARTED|Overall Study||58
3311750|NCT03054805|4045273|FG001|STARTED|Overall Study||51
3311751|NCT03054805|4045274|FG002|STARTED|Overall Study||44
3311752|NCT03054805|4045272|FG000|COMPLETED|Overall Study||42
3311753|NCT03054805|4045273|FG001|COMPLETED|Overall Study||41
3311754|NCT03054805|4045274|FG002|COMPLETED|Overall Study||42
3311755|NCT03054805|4045272|FG000|NOT COMPLETED|Overall Study||16
3311756|NCT03054805|4045273|FG001|NOT COMPLETED|Overall Study||10
3311757|NCT03054805|4045274|FG002|NOT COMPLETED|Overall Study||2
3311758|NCT03054844|4045284|FG000|STARTED|Overall Study||28
3311759|NCT03054844|4045285|FG001|STARTED|Overall Study||27
3311760|NCT03054844|4045284|FG000|COMPLETED|Overall Study||25
3311761|NCT03054844|4045285|FG001|COMPLETED|Overall Study||26
3311762|NCT03054844|4045284|FG000|NOT COMPLETED|Overall Study||3
3311763|NCT03054844|4045285|FG001|NOT COMPLETED|Overall Study||1
3311764|NCT03054857|4045293|FG000|STARTED|Overall Study||50
3311765|NCT03054857|4045294|FG001|STARTED|Overall Study||50
3311766|NCT03054857|4045293|FG000|COMPLETED|Overall Study||49
3311767|NCT03054857|4045294|FG001|COMPLETED|Overall Study||50
3311768|NCT03054857|4045293|FG000|NOT COMPLETED|Overall Study||1
3311769|NCT03054857|4045294|FG001|NOT COMPLETED|Overall Study||0
3311770|NCT03054870|4045304|FG000|STARTED|Day of Ventilation Imaging|16 of 226 enrolled subjects were withdrawn from the study prior to receiving Technegas and were not included in further study assessments.|210
3311771|NCT03054870|4045304|FG000|COMPLETED|Day of Ventilation Imaging||205
3311772|NCT03054870|4045304|FG000|NOT COMPLETED|Day of Ventilation Imaging||5
3311773|NCT03054870|4045304|FG000|STARTED|24-hour Follow-up|24-hour follow-up was omitted from Protocol Amendment 1, so 92 subjects enrolled under Amendment 1 not included.|118
3311774|NCT03054870|4045304|FG000|COMPLETED|24-hour Follow-up||118
3311775|NCT03054870|4045304|FG000|NOT COMPLETED|24-hour Follow-up||0
3311776|NCT03054870|4045304|FG000|STARTED|Blinded Read of Images|At time of study termination, 200 subjects had completed the blinded read assessments. The decision to terminate was based on the positive results of an unplanned interim analysis of these blind read data by a third party statistician.|200
3311777|NCT03054870|4045304|FG000|COMPLETED|Blinded Read of Images||200
3311778|NCT03054870|4045304|FG000|NOT COMPLETED|Blinded Read of Images||0
2849850|NCT01980940|3552002|FG001|STARTED|Overall Study||5
2849851|NCT01980940|3552003|FG002|STARTED|Overall Study||5
2849852|NCT01980940|3552004|FG003|STARTED|Overall Study||3
2849853|NCT01980940|3552005|FG004|STARTED|Overall Study||2
2849854|NCT01980940|3552006|FG005|STARTED|Overall Study||2
2849855|NCT01980940|3552007|FG006|STARTED|Overall Study||24
3311779|NCT03054922|4045322|FG000|STARTED|Overall Study||20
3311780|NCT03054922|4045323|FG001|STARTED|Overall Study||19
3311781|NCT03054922|4045324|FG002|STARTED|Overall Study||20
3311782|NCT03054922|4045322|FG000|COMPLETED|Overall Study||20
3311783|NCT03054922|4045323|FG001|COMPLETED|Overall Study||19
3311784|NCT03054922|4045324|FG002|COMPLETED|Overall Study||20
3311785|NCT03054922|4045322|FG000|NOT COMPLETED|Overall Study||0
3311786|NCT03054922|4045323|FG001|NOT COMPLETED|Overall Study||0
3311787|NCT03054922|4045324|FG002|NOT COMPLETED|Overall Study||0
2849856|NCT01980940|3552008|FG007|STARTED|Overall Study||24
2849857|NCT01980940|3552001|FG000|Treated|Overall Study||5
2849858|NCT01980940|3552002|FG001|Treated|Overall Study||5
2849859|NCT01980940|3552003|FG002|Treated|Overall Study||5
2849860|NCT01980940|3552004|FG003|Treated|Overall Study||3
2849861|NCT01980940|3552005|FG004|Treated|Overall Study||2
2849862|NCT01980940|3552006|FG005|Treated|Overall Study||2
2849863|NCT01980940|3552007|FG006|Treated|Overall Study||24
2849864|NCT01980940|3552008|FG007|Treated|Overall Study||24
2849865|NCT01980940|3552001|FG000|COMPLETED|Overall Study||5
2849866|NCT01980940|3552002|FG001|COMPLETED|Overall Study||5
2849867|NCT01980940|3552003|FG002|COMPLETED|Overall Study||5
2849868|NCT01980940|3552004|FG003|COMPLETED|Overall Study||3
2849869|NCT01980940|3552005|FG004|COMPLETED|Overall Study||2
2849870|NCT01980940|3552006|FG005|COMPLETED|Overall Study||0
2849871|NCT01980940|3552007|FG006|COMPLETED|Overall Study||24
2849872|NCT01980940|3552008|FG007|COMPLETED|Overall Study||24
2849873|NCT01980940|3552001|FG000|NOT COMPLETED|Overall Study||0
2849874|NCT01980940|3552002|FG001|NOT COMPLETED|Overall Study||0
2849875|NCT01980940|3552003|FG002|NOT COMPLETED|Overall Study||0
2849876|NCT01980940|3552004|FG003|NOT COMPLETED|Overall Study||0
2849877|NCT01980940|3552005|FG004|NOT COMPLETED|Overall Study||0
2849878|NCT01980940|3552006|FG005|NOT COMPLETED|Overall Study||2
2849879|NCT01980940|3552007|FG006|NOT COMPLETED|Overall Study||0
2849880|NCT01980940|3552008|FG007|NOT COMPLETED|Overall Study||0
2849881|NCT01958593|3552034|FG000|STARTED|Overall Study||2
2849882|NCT01958593|3552035|FG001|STARTED|Overall Study||4
2849883|NCT01958593|3552034|FG000|COMPLETED|Overall Study||2
2849884|NCT01958593|3552035|FG001|COMPLETED|Overall Study||4
2849885|NCT01958593|3552034|FG000|NOT COMPLETED|Overall Study||0
2849886|NCT01958593|3552035|FG001|NOT COMPLETED|Overall Study||0
2849887|NCT01923298|3552042|FG000|STARTED|Overall Study||14
2849888|NCT01923298|3552042|FG000|COMPLETED|Overall Study||14
2849889|NCT01923298|3552042|FG000|NOT COMPLETED|Overall Study||0
2849890|NCT01918033|3552049|FG000|STARTED|Overall Study||203
2849891|NCT01918033|3552050|FG001|STARTED|Overall Study||203
2849892|NCT01918033|3552051|FG002|STARTED|Overall Study||202
3311788|NCT03055000|4045335|FG000|STARTED|Overall Study||16
3311789|NCT03055000|4045336|FG001|STARTED|Overall Study||17
3311790|NCT03055000|4045337|FG002|STARTED|Overall Study||16
3311791|NCT03055000|4045335|FG000|COMPLETED|Overall Study||16
3311792|NCT03055000|4045336|FG001|COMPLETED|Overall Study||17
3311793|NCT03055000|4045337|FG002|COMPLETED|Overall Study||16
3311794|NCT03055000|4045335|FG000|NOT COMPLETED|Overall Study||0
3311795|NCT03055000|4045336|FG001|NOT COMPLETED|Overall Study||0
3311796|NCT03055000|4045337|FG002|NOT COMPLETED|Overall Study||0
3311797|NCT03055156|4045347|FG000|STARTED|Overall Study||281
3311798|NCT03055156|4045348|FG001|STARTED|Overall Study||273
3311799|NCT03055156|4045347|FG000|COMPLETED|Overall Study||281
3311800|NCT03055156|4045348|FG001|COMPLETED|Overall Study||273
3311801|NCT03055156|4045347|FG000|NOT COMPLETED|Overall Study||0
3311802|NCT03055156|4045348|FG001|NOT COMPLETED|Overall Study||0
3311803|NCT03055195|4045356|FG000|STARTED|Overall Study||16
3311804|NCT03055195|4045357|FG001|STARTED|Overall Study||18
3311805|NCT03055195|4045356|FG000|COMPLETED|Overall Study||4
3311806|NCT03055195|4045357|FG001|COMPLETED|Overall Study||4
3311807|NCT03055195|4045356|FG000|NOT COMPLETED|Overall Study||12
3311808|NCT03055195|4045357|FG001|NOT COMPLETED|Overall Study||14
3311809|NCT03055221|4045363|FG000|STARTED|Overall Study||16
3311810|NCT03055221|4045363|FG000|COMPLETED|Overall Study||0
3311811|NCT03055221|4045363|FG000|NOT COMPLETED|Overall Study||16
3311812|NCT03055260|4045369|FG000|STARTED|Overall Study||8
3311813|NCT03055260|4045370|FG001|STARTED|Overall Study||0
3311814|NCT03055260|4045369|FG000|COMPLETED|Overall Study||7
3311815|NCT03055260|4045370|FG001|COMPLETED|Overall Study||0
3311816|NCT03055260|4045369|FG000|NOT COMPLETED|Overall Study||1
3311817|NCT03055260|4045370|FG001|NOT COMPLETED|Overall Study||0
3311818|NCT03055338|4045379|FG000|STARTED|Overall Study||90
3311819|NCT03055338|4045380|FG001|STARTED|Overall Study||45
3311820|NCT03055338|4045381|FG002|STARTED|Overall Study||89
3311821|NCT03055338|4045379|FG000|COMPLETED|Overall Study||72
3311822|NCT03055338|4045380|FG001|COMPLETED|Overall Study||34
3311823|NCT03055338|4045381|FG002|COMPLETED|Overall Study||77
3311824|NCT03055338|4045379|FG000|NOT COMPLETED|Overall Study||18
3311825|NCT03055338|4045380|FG001|NOT COMPLETED|Overall Study||11
3311826|NCT03055338|4045381|FG002|NOT COMPLETED|Overall Study||12
3311827|NCT03055494|4045391|FG000|STARTED|Overall Study||54
3311828|NCT03055494|4045392|FG001|STARTED|Overall Study||28
3311829|NCT03055494|4045391|FG000|COMPLETED|Overall Study||44
3311830|NCT03055494|4045392|FG001|COMPLETED|Overall Study||27
3311831|NCT03055494|4045391|FG000|NOT COMPLETED|Overall Study||10
3311832|NCT03055494|4045392|FG001|NOT COMPLETED|Overall Study||1
3311833|NCT03055624|4045399|FG000|STARTED|Overall Study||9
3311834|NCT03055624|4045399|FG000|COMPLETED|Overall Study||0
3311835|NCT03055624|4045399|FG000|NOT COMPLETED|Overall Study||9
3311836|NCT03055650|4045403|FG000|STARTED|Overall Study||30
3311837|NCT03055650|4045403|FG000|COMPLETED|Overall Study||30
2849893|NCT01918033|3552049|FG000|Treated|Overall Study|One randomized participant did not receive study drug.|202
2849894|NCT01918033|3552050|FG001|Treated|Overall Study||203
3311838|NCT03055650|4045403|FG000|NOT COMPLETED|Overall Study||0
3311839|NCT03055806|4045411|FG000|STARTED|Overall Study||48
3311840|NCT03055806|4045412|FG001|STARTED|Overall Study||48
3311841|NCT03055806|4045413|FG002|STARTED|Overall Study||71
2849895|NCT01918033|3552051|FG002|Treated|Overall Study|One randomized participant did not receive study drug.|201
2849896|NCT01918033|3552049|FG000|COMPLETED|Overall Study||198
2849897|NCT01918033|3552050|FG001|COMPLETED|Overall Study||201
2849898|NCT01918033|3552051|FG002|COMPLETED|Overall Study||199
2849899|NCT01918033|3552049|FG000|NOT COMPLETED|Overall Study||5
2849900|NCT01918033|3552050|FG001|NOT COMPLETED|Overall Study||2
2849901|NCT01918033|3552051|FG002|NOT COMPLETED|Overall Study||3
2849902|NCT01916980|3552061|FG000|STARTED|Overall Study||65
2849903|NCT01916980|3552062|FG001|STARTED|Overall Study||29
2849904|NCT01916980|3552061|FG000|COMPLETED|Overall Study||58
2849905|NCT01916980|3552062|FG001|COMPLETED|Overall Study||25
2849906|NCT01916980|3552061|FG000|NOT COMPLETED|Overall Study||7
2849907|NCT01916980|3552062|FG001|NOT COMPLETED|Overall Study||4
2849908|NCT01916967|3552071|FG000|STARTED|Overall Study||80
2849909|NCT01916967|3552072|FG001|STARTED|Overall Study||79
2849910|NCT01916967|3552073|FG002|STARTED|Overall Study||80
2849911|NCT01916967|3552071|FG000|COMPLETED|Overall Study||80
2849912|NCT01916967|3552072|FG001|COMPLETED|Overall Study||78
2849913|NCT01916967|3552073|FG002|COMPLETED|Overall Study||71
2849914|NCT01916967|3552071|FG000|NOT COMPLETED|Overall Study||0
2849915|NCT01916967|3552072|FG001|NOT COMPLETED|Overall Study||1
2849916|NCT01916967|3552073|FG002|NOT COMPLETED|Overall Study||9
2849917|NCT01910402|3552085|FG000|STARTED|Randomized Phase||248
2849918|NCT01910402|3552086|FG001|STARTED|Randomized Phase||247
2849919|NCT01910402|3552085|FG000|COMPLETED|Randomized Phase||206
2849920|NCT01910402|3552086|FG001|COMPLETED|Randomized Phase||192
2849921|NCT01910402|3552085|FG000|NOT COMPLETED|Randomized Phase||42
2849922|NCT01910402|3552086|FG001|NOT COMPLETED|Randomized Phase||55
2849923|NCT01910402|3552085|FG000|STARTED|Continuation Phase||120
2849924|NCT01910402|3552086|FG001|STARTED|Continuation Phase||0
2849925|NCT01910402|3552085|FG000|COMPLETED|Continuation Phase||30
2849926|NCT01910402|3552086|FG001|COMPLETED|Continuation Phase||0
2849927|NCT01910402|3552085|FG000|NOT COMPLETED|Continuation Phase||90
2849928|NCT01910402|3552086|FG001|NOT COMPLETED|Continuation Phase||0
2849929|NCT01893320|3552096|FG000|STARTED|Overall Study||7
2849930|NCT01893320|3552097|FG001|STARTED|Overall Study||59
2849931|NCT01893320|3552096|FG000|COMPLETED|Overall Study||7
2849932|NCT01893320|3552097|FG001|COMPLETED|Overall Study||59
2849933|NCT01893320|3552096|FG000|NOT COMPLETED|Overall Study||0
2849934|NCT01893320|3552097|FG001|NOT COMPLETED|Overall Study||0
2849935|NCT01870401|3552105|FG000|STARTED|Overall Study||287
2849936|NCT01870401|3552106|FG001|STARTED|Overall Study||155
2849937|NCT01870401|3552105|FG000|COMPLETED|Overall Study||137
2849938|NCT01870401|3552106|FG001|COMPLETED|Overall Study||59
2849939|NCT01870401|3552105|FG000|NOT COMPLETED|Overall Study||150
2849940|NCT01870401|3552106|FG001|NOT COMPLETED|Overall Study||96
2849941|NCT01867606|3552116|FG000|STARTED|Overall Study||26
2849942|NCT01867606|3552117|FG001|STARTED|Overall Study||32
2849943|NCT01867606|3552116|FG000|COMPLETED|Overall Study||16
2849944|NCT01867606|3552117|FG001|COMPLETED|Overall Study||17
2849945|NCT01867606|3552116|FG000|NOT COMPLETED|Overall Study||10
2849946|NCT01867606|3552117|FG001|NOT COMPLETED|Overall Study||15
2849947|NCT01857063|3552131|FG000|STARTED|Period 1 (7 Days)||110
2849948|NCT01857063|3552132|FG001|STARTED|Period 1 (7 Days)||110
2849949|NCT01857063|3552131|FG000|COMPLETED|Period 1 (7 Days)||108
2849950|NCT01857063|3552132|FG001|COMPLETED|Period 1 (7 Days)||106
2849951|NCT01857063|3552131|FG000|NOT COMPLETED|Period 1 (7 Days)||2
2849952|NCT01857063|3552132|FG001|NOT COMPLETED|Period 1 (7 Days)||4
2849953|NCT01857063|3552131|FG000|STARTED|Period 2 (7 Days)||108
2849954|NCT01857063|3552132|FG001|STARTED|Period 2 (7 Days)||106
2849955|NCT01857063|3552131|FG000|COMPLETED|Period 2 (7 Days)||104
2849956|NCT01857063|3552132|FG001|COMPLETED|Period 2 (7 Days)||104
2849957|NCT01857063|3552131|FG000|NOT COMPLETED|Period 2 (7 Days)||4
2849958|NCT01857063|3552132|FG001|NOT COMPLETED|Period 2 (7 Days)||2
2849959|NCT01854268|3552138|FG000|STARTED|Overall Study||25
2849960|NCT01854268|3552138|FG000|COMPLETED|Overall Study||25
2849961|NCT01854268|3552138|FG000|NOT COMPLETED|Overall Study||0
2917984|NCT00523705|3628056|FG000|STARTED|Overall Study||7
2917985|NCT00523705|3628057|FG001|STARTED|Overall Study||4
2917986|NCT00523705|3628056|FG000|COMPLETED|Overall Study||7
2917987|NCT00523705|3628057|FG001|COMPLETED|Overall Study|1 withdrew due to no time|3
2917988|NCT00523705|3628056|FG000|NOT COMPLETED|Overall Study||0
2917989|NCT00523705|3628057|FG001|NOT COMPLETED|Overall Study||1
2917990|NCT00523718|3628065|FG000|STARTED|Overall Study||20
2917991|NCT00523718|3628066|FG001|STARTED|Overall Study||18
2917992|NCT00523718|3628065|FG000|COMPLETED|Overall Study||17
2917993|NCT00523718|3628066|FG001|COMPLETED|Overall Study||18
2917994|NCT00523718|3628065|FG000|NOT COMPLETED|Overall Study||3
2917995|NCT00523718|3628066|FG001|NOT COMPLETED|Overall Study||0
2917996|NCT00523744|3628072|FG000|STARTED|Phase 1 - Amlodipine+Olmesartan||257
2917997|NCT00523744|3628072|FG000|COMPLETED|Phase 1 - Amlodipine+Olmesartan||251
2917998|NCT00523744|3628072|FG000|NOT COMPLETED|Phase 1 - Amlodipine+Olmesartan||6
2917999|NCT00523744|3628072|FG000|STARTED|Phase 2 - Amlodipine+Valsartan|Only patients with mean sitting diastolic BP ≥ 90 mmHg at the end of Phase 1 entered this phase.|176
2918000|NCT00523744|3628072|FG000|COMPLETED|Phase 2 - Amlodipine+Valsartan||173
2918001|NCT00523744|3628072|FG000|NOT COMPLETED|Phase 2 - Amlodipine+Valsartan||3
2918002|NCT00523744|3628072|FG000|STARTED|Phase 3 - Amlodipine+Valsartan+HCTZ|Only patients with systolic BP ≥ 140 mmHg or diastolic BP ≥ 90 mmHg at the end of Phase 2.|91
2918003|NCT00523744|3628072|FG000|COMPLETED|Phase 3 - Amlodipine+Valsartan+HCTZ||91
2918004|NCT00523744|3628072|FG000|NOT COMPLETED|Phase 3 - Amlodipine+Valsartan+HCTZ||0
2849962|NCT01852812|3552145|FG000|STARTED|Overall Study||51
2849963|NCT01852812|3552146|FG001|STARTED|Overall Study||18
2849964|NCT01852812|3552147|FG002|STARTED|Overall Study||18
2849965|NCT01852812|3552145|FG000|COMPLETED|Overall Study||51
2849966|NCT01852812|3552146|FG001|COMPLETED|Overall Study||17
2849967|NCT01852812|3552147|FG002|COMPLETED|Overall Study||17
2849968|NCT01852812|3552145|FG000|NOT COMPLETED|Overall Study||0
2849969|NCT01852812|3552146|FG001|NOT COMPLETED|Overall Study||1
2849970|NCT01852812|3552147|FG002|NOT COMPLETED|Overall Study||1
2849971|NCT01844986|3552157|FG000|STARTED|Overall Study||260
2849972|NCT01844986|3552158|FG001|STARTED|Overall Study||131
2849973|NCT01844986|3552157|FG000|COMPLETED|Overall Study||183
2849974|NCT01844986|3552158|FG001|COMPLETED|Overall Study||91
2849975|NCT01844986|3552157|FG000|NOT COMPLETED|Overall Study||77
2849976|NCT01844986|3552158|FG001|NOT COMPLETED|Overall Study||40
2849977|NCT01828021|3552164|FG000|STARTED|Overall Study||25
2849978|NCT01828021|3552164|FG000|COMPLETED|Overall Study||0
2849979|NCT01828021|3552164|FG000|NOT COMPLETED|Overall Study||25
2849980|NCT01709318|3552175|FG000|STARTED|Overall Study||82
2849981|NCT01709318|3552176|FG001|STARTED|Overall Study||85
2849982|NCT01709318|3552177|FG002|STARTED|Overall Study||77
2849983|NCT01709318|3552178|FG003|STARTED|Overall Study||78
2849984|NCT01709318|3552179|FG004|STARTED|Overall Study||78
2849985|NCT01709318|3552180|FG005|STARTED|Overall Study||84
2849986|NCT01709318|3552181|FG006|STARTED|Overall Study||182
2849987|NCT01709318|3552175|FG000|Treated|Overall Study||79
2849988|NCT01709318|3552176|FG001|Treated|Overall Study||85
2849989|NCT01709318|3552177|FG002|Treated|Overall Study||78
2849990|NCT01709318|3552178|FG003|Treated|Overall Study||77
2849991|NCT01709318|3552179|FG004|Treated|Overall Study||77
2849992|NCT01709318|3552180|FG005|Treated|Overall Study||86
2849993|NCT01709318|3552181|FG006|Treated|Overall Study||178
2849994|NCT01709318|3552175|FG000|COMPLETED|Overall Study||73
2849995|NCT01709318|3552176|FG001|COMPLETED|Overall Study||78
2849996|NCT01709318|3552177|FG002|COMPLETED|Overall Study||71
3311842|NCT03055806|4045414|FG003|STARTED|Overall Study||72
3311843|NCT03055806|4045411|FG000|COMPLETED|Overall Study||42
3311844|NCT03055806|4045412|FG001|COMPLETED|Overall Study||41
3311845|NCT03055806|4045413|FG002|COMPLETED|Overall Study||58
3311846|NCT03055806|4045414|FG003|COMPLETED|Overall Study||57
3311847|NCT03055806|4045411|FG000|NOT COMPLETED|Overall Study||6
3311848|NCT03055806|4045412|FG001|NOT COMPLETED|Overall Study||7
3311849|NCT03055806|4045413|FG002|NOT COMPLETED|Overall Study||13
3311850|NCT03055806|4045414|FG003|NOT COMPLETED|Overall Study||15
3311851|NCT03055832|4045426|FG000|STARTED|Baseline||71
3311852|NCT03055832|4045427|FG001|STARTED|Baseline||71
3311853|NCT03055832|4045426|FG000|COMPLETED|Baseline||71
3311854|NCT03055832|4045427|FG001|COMPLETED|Baseline||71
3311855|NCT03055832|4045426|FG000|NOT COMPLETED|Baseline||0
3311856|NCT03055832|4045427|FG001|NOT COMPLETED|Baseline||0
3311857|NCT03055832|4045426|FG000|STARTED|Immediately Post-Procedure (Hour 1)||71
3311858|NCT03055832|4045427|FG001|STARTED|Immediately Post-Procedure (Hour 1)||71
3311859|NCT03055832|4045426|FG000|COMPLETED|Immediately Post-Procedure (Hour 1)||71
3311860|NCT03055832|4045427|FG001|COMPLETED|Immediately Post-Procedure (Hour 1)||71
3311861|NCT03055832|4045426|FG000|NOT COMPLETED|Immediately Post-Procedure (Hour 1)||0
3311862|NCT03055832|4045427|FG001|NOT COMPLETED|Immediately Post-Procedure (Hour 1)||0
3311863|NCT03055832|4045426|FG000|STARTED|Day 1||71
3311864|NCT03055832|4045427|FG001|STARTED|Day 1||71
3311865|NCT03055832|4045426|FG000|COMPLETED|Day 1||71
3311866|NCT03055832|4045427|FG001|COMPLETED|Day 1||71
3311867|NCT03055832|4045426|FG000|NOT COMPLETED|Day 1||0
3311868|NCT03055832|4045427|FG001|NOT COMPLETED|Day 1||0
3311869|NCT03055832|4045426|FG000|STARTED|Week 2||71
3311870|NCT03055832|4045427|FG001|STARTED|Week 2||71
3311871|NCT03055832|4045426|FG000|COMPLETED|Week 2||70
3311872|NCT03055832|4045427|FG001|COMPLETED|Week 2||71
3311873|NCT03055832|4045426|FG000|NOT COMPLETED|Week 2||1
3311874|NCT03055832|4045427|FG001|NOT COMPLETED|Week 2||0
3311875|NCT03055832|4045426|FG000|STARTED|Week 4||70
3311876|NCT03055832|4045427|FG001|STARTED|Week 4||71
3311877|NCT03055832|4045426|FG000|COMPLETED|Week 4||70
3311878|NCT03055832|4045427|FG001|COMPLETED|Week 4||71
3311879|NCT03055832|4045426|FG000|NOT COMPLETED|Week 4||0
3311880|NCT03055832|4045427|FG001|NOT COMPLETED|Week 4||0
3311881|NCT03055858|4045447|FG000|STARTED|Overall Study||200
3311882|NCT03055858|4045447|FG000|IDE Cohort|Overall Study||50
3311883|NCT03055858|4045447|FG000|CAP Cohort|Overall Study||150
3311884|NCT03055858|4045447|FG000|COMPLETED|Overall Study||194
3311885|NCT03055858|4045447|FG000|NOT COMPLETED|Overall Study||6
3311886|NCT03055897|4045451|FG000|STARTED|Overall Study||15
3311887|NCT03055897|4045451|FG000|COMPLETED|Overall Study||15
3311888|NCT03055897|4045451|FG000|NOT COMPLETED|Overall Study||0
3311889|NCT03055936|4045459|FG000|STARTED|Overall Study||14
3311890|NCT03055936|4045460|FG001|STARTED|Overall Study||14
3311891|NCT03055936|4045461|FG002|STARTED|Overall Study||14
3311892|NCT03055936|4045462|FG003|STARTED|Overall Study||14
3311893|NCT03055936|4045459|FG000|COMPLETED|Overall Study||12
2849997|NCT01709318|3552178|FG003|COMPLETED|Overall Study||72
3311894|NCT03055936|4045460|FG001|COMPLETED|Overall Study||13
3311895|NCT03055936|4045461|FG002|COMPLETED|Overall Study||12
3311896|NCT03055936|4045462|FG003|COMPLETED|Overall Study||13
3311897|NCT03055936|4045459|FG000|NOT COMPLETED|Overall Study||2
3311898|NCT03055936|4045460|FG001|NOT COMPLETED|Overall Study||1
3311899|NCT03055936|4045461|FG002|NOT COMPLETED|Overall Study||2
3311900|NCT03055936|4045462|FG003|NOT COMPLETED|Overall Study||1
2849998|NCT01709318|3552179|FG004|COMPLETED|Overall Study||74
2849999|NCT01709318|3552180|FG005|COMPLETED|Overall Study||80
2850000|NCT01709318|3552181|FG006|COMPLETED|Overall Study||171
2850001|NCT01709318|3552175|FG000|NOT COMPLETED|Overall Study||9
2850002|NCT01709318|3552176|FG001|NOT COMPLETED|Overall Study||7
2850003|NCT01709318|3552177|FG002|NOT COMPLETED|Overall Study||6
2850004|NCT01709318|3552178|FG003|NOT COMPLETED|Overall Study||6
2850005|NCT01709318|3552179|FG004|NOT COMPLETED|Overall Study||4
2850006|NCT01709318|3552180|FG005|NOT COMPLETED|Overall Study||4
2850007|NCT01709318|3552181|FG006|NOT COMPLETED|Overall Study||11
2850008|NCT01698918|3552197|FG000|STARTED|First Line Treatment (Core+Extension)||202
2850009|NCT01698918|3552197|FG000|Dexamethasone Randomized Set (Stomatitis Sub-study)|First Line Treatment (Core+Extension)||11
2850010|NCT01698918|3552197|FG000|Standard of Care Randomized Set (Stomatitis Sub-study)|First Line Treatment (Core+Extension)||13
2850011|NCT01698918|3552197|FG000|COMPLETED|First Line Treatment (Core+Extension)||29
2850012|NCT01698918|3552197|FG000|NOT COMPLETED|First Line Treatment (Core+Extension)||173
2850013|NCT01698918|3552197|FG000|STARTED|Second Line Treatment (Core+Extension)||53
2850014|NCT01698918|3552197|FG000|COMPLETED|Second Line Treatment (Core+Extension)||7
2850015|NCT01698918|3552197|FG000|NOT COMPLETED|Second Line Treatment (Core+Extension)||46
2850016|NCT01673620|3552211|FG000|STARTED|Overall Study||47
2850017|NCT01673620|3552212|FG001|STARTED|Overall Study||22
2850018|NCT01673620|3552211|FG000|COMPLETED|Overall Study||46
2850019|NCT01673620|3552212|FG001|COMPLETED|Overall Study||22
2850020|NCT01673620|3552211|FG000|NOT COMPLETED|Overall Study||1
2850021|NCT01673620|3552212|FG001|NOT COMPLETED|Overall Study||0
2850022|NCT01660243|3552222|FG000|STARTED|Overall Study||10
2850023|NCT01660243|3552223|FG001|STARTED|Overall Study||13
2850024|NCT01660243|3552224|FG002|STARTED|Overall Study||11
2850025|NCT01660243|3552225|FG003|STARTED|Overall Study||11
2850026|NCT01660243|3552222|FG000|COMPLETED|Overall Study||8
2850027|NCT01660243|3552223|FG001|COMPLETED|Overall Study||13
2850028|NCT01660243|3552224|FG002|COMPLETED|Overall Study||9
2850029|NCT01660243|3552225|FG003|COMPLETED|Overall Study||10
2850030|NCT01660243|3552222|FG000|NOT COMPLETED|Overall Study||2
2850031|NCT01660243|3552223|FG001|NOT COMPLETED|Overall Study||0
2850032|NCT01660243|3552224|FG002|NOT COMPLETED|Overall Study||2
2850033|NCT01660243|3552225|FG003|NOT COMPLETED|Overall Study||1
2850034|NCT01617187|3552239|FG000|STARTED|Randomization Through Start Treatment|Randomized|98
2850035|NCT01617187|3552240|FG001|STARTED|Randomization Through Start Treatment|Randomized|113
2850036|NCT01617187|3552241|FG002|STARTED|Randomization Through Start Treatment|Randomized|46
2850037|NCT01617187|3552242|FG003|STARTED|Randomization Through Start Treatment|Randomized|103
2850038|NCT01617187|3552239|FG000|COMPLETED|Randomization Through Start Treatment||97
2850039|NCT01617187|3552240|FG001|COMPLETED|Randomization Through Start Treatment||113
2850040|NCT01617187|3552241|FG002|COMPLETED|Randomization Through Start Treatment||46
2850041|NCT01617187|3552242|FG003|COMPLETED|Randomization Through Start Treatment||101
2850042|NCT01617187|3552239|FG000|NOT COMPLETED|Randomization Through Start Treatment||1
2850043|NCT01617187|3552240|FG001|NOT COMPLETED|Randomization Through Start Treatment||0
3311901|NCT03055988|4045496|FG000|STARTED|Period 1||38
3311902|NCT03055988|4045497|FG001|STARTED|Period 1||38
3311903|NCT03055988|4045496|FG000|COMPLETED|Period 1||37
3311904|NCT03055988|4045497|FG001|COMPLETED|Period 1||33
3311905|NCT03055988|4045496|FG000|NOT COMPLETED|Period 1||1
3311906|NCT03055988|4045497|FG001|NOT COMPLETED|Period 1||5
3311907|NCT03055988|4045496|FG000|STARTED|Period 2||37
3311908|NCT03055988|4045497|FG001|STARTED|Period 2||33
3311909|NCT03055988|4045496|FG000|COMPLETED|Period 2||36
3311910|NCT03055988|4045497|FG001|COMPLETED|Period 2||31
3311911|NCT03055988|4045496|FG000|NOT COMPLETED|Period 2||1
3311912|NCT03055988|4045497|FG001|NOT COMPLETED|Period 2||2
3311913|NCT03056040|4045505|FG000|STARTED|Primary Evaluation Period||97
3311914|NCT03056040|4045506|FG001|STARTED|Primary Evaluation Period||98
3311915|NCT03056040|4045505|FG000|Received at Least 1 Dose of Study Drug|Primary Evaluation Period||97
3311916|NCT03056040|4045506|FG001|Received at Least 1 Dose of Study Drug|Primary Evaluation Period||98
3311917|NCT03056040|4045505|FG000|COMPLETED|Primary Evaluation Period||96
3311918|NCT03056040|4045506|FG001|COMPLETED|Primary Evaluation Period||95
3311919|NCT03056040|4045505|FG000|NOT COMPLETED|Primary Evaluation Period||1
3311920|NCT03056040|4045506|FG001|NOT COMPLETED|Primary Evaluation Period||3
3311921|NCT03056040|4045505|FG000|STARTED|Extension Period||96
3311922|NCT03056040|4045506|FG001|STARTED|Extension Period||95
3311923|NCT03056040|4045505|FG000|Received at Least 1 Dose of Ravulizumab|Extension Period||96
3311924|NCT03056040|4045506|FG001|Received at Least 1 Dose of Ravulizumab|Extension Period||95
3311925|NCT03056040|4045505|FG000|COMPLETED|Extension Period||0
3311926|NCT03056040|4045506|FG001|COMPLETED|Extension Period||0
3311927|NCT03056040|4045505|FG000|NOT COMPLETED|Extension Period||96
3311928|NCT03056040|4045506|FG001|NOT COMPLETED|Extension Period||95
3311929|NCT03056144|4045512|FG000|STARTED|Overall Study||1
3311930|NCT03056144|4045512|FG000|COMPLETED|Overall Study||1
3311931|NCT03056144|4045512|FG000|NOT COMPLETED|Overall Study||0
3311932|NCT03056300|4045516|FG000|STARTED|Overall Study||50
3311933|NCT03056300|4045516|FG000|COMPLETED|Overall Study||47
3311934|NCT03056300|4045516|FG000|NOT COMPLETED|Overall Study||3
3311935|NCT03056352|4045520|FG000|STARTED|Overall Study||21
3311936|NCT03056352|4045520|FG000|COMPLETED|Overall Study||20
3311937|NCT03056352|4045520|FG000|NOT COMPLETED|Overall Study||1
3311938|NCT03056456|4045524|FG000|STARTED|Period 1||6
3311939|NCT03056456|4045525|FG001|STARTED|Period 1||6
3311940|NCT03056456|4045526|FG002|STARTED|Period 1||6
2850044|NCT01617187|3552241|FG002|NOT COMPLETED|Randomization Through Start Treatment||0
2850045|NCT01617187|3552242|FG003|NOT COMPLETED|Randomization Through Start Treatment||2
2850046|NCT01617187|3552239|FG000|STARTED|Treatment Through Study Completion|Treated|97
2850047|NCT01617187|3552240|FG001|STARTED|Treatment Through Study Completion|Treated|113
2850048|NCT01617187|3552241|FG002|STARTED|Treatment Through Study Completion|Treated|46
2850049|NCT01617187|3552242|FG003|STARTED|Treatment Through Study Completion|Treated|101
2850050|NCT01617187|3552239|FG000|COMPLETED|Treatment Through Study Completion|Excludes the participant who did not receive study drug but completed study in database|86
2850051|NCT01617187|3552240|FG001|COMPLETED|Treatment Through Study Completion||102
2850052|NCT01617187|3552241|FG002|COMPLETED|Treatment Through Study Completion||41
2850053|NCT01617187|3552242|FG003|COMPLETED|Treatment Through Study Completion||91
2850054|NCT01617187|3552239|FG000|NOT COMPLETED|Treatment Through Study Completion||11
2850055|NCT01617187|3552240|FG001|NOT COMPLETED|Treatment Through Study Completion||11
2850056|NCT01617187|3552241|FG002|NOT COMPLETED|Treatment Through Study Completion||5
2850057|NCT01617187|3552242|FG003|NOT COMPLETED|Treatment Through Study Completion||10
2850058|NCT01611883|3552254|FG000|STARTED|Overall Study||75
2850059|NCT01611883|3552255|FG001|STARTED|Overall Study||77
2850060|NCT01611883|3552254|FG000|COMPLETED|Overall Study||74
2850061|NCT01611883|3552255|FG001|COMPLETED|Overall Study||76
2850062|NCT01611883|3552254|FG000|NOT COMPLETED|Overall Study||1
2850063|NCT01611883|3552255|FG001|NOT COMPLETED|Overall Study||1
2850064|NCT01572675|3552263|FG000|STARTED|Overall Study||268
2850065|NCT01572675|3552264|FG001|STARTED|Overall Study||279
2850066|NCT01572675|3552263|FG000|COMPLETED|Overall Study||31
2850067|NCT01572675|3552264|FG001|COMPLETED|Overall Study||56
2850068|NCT01572675|3552263|FG000|NOT COMPLETED|Overall Study||237
2850069|NCT01572675|3552264|FG001|NOT COMPLETED|Overall Study||223
2850070|NCT01554163|3552285|FG000|STARTED|Overall Study||120
2850071|NCT01554163|3552286|FG001|STARTED|Overall Study||119
2850072|NCT01554163|3552285|FG000|Number Treated|Overall Study||119
2850073|NCT01554163|3552286|FG001|Number Treated|Overall Study||119
2850074|NCT01554163|3552285|FG000|COMPLETED|Overall Study||112
2850075|NCT01554163|3552286|FG001|COMPLETED|Overall Study||109
2850076|NCT01554163|3552285|FG000|NOT COMPLETED|Overall Study||8
2850077|NCT01554163|3552286|FG001|NOT COMPLETED|Overall Study||10
2850078|NCT01502371|3552297|FG000|STARTED|Overall Study||120
2850079|NCT01502371|3552298|FG001|STARTED|Overall Study||113
2850080|NCT01502371|3552299|FG002|STARTED|Overall Study||108
2850081|NCT01502371|3552300|FG003|STARTED|Overall Study||125
2850082|NCT01502371|3552301|FG004|STARTED|Overall Study||112
2850083|NCT01502371|3552297|FG000|COMPLETED|Overall Study||79
2850084|NCT01502371|3552298|FG001|COMPLETED|Overall Study||81
2850085|NCT01502371|3552299|FG002|COMPLETED|Overall Study||83
2850086|NCT01502371|3552300|FG003|COMPLETED|Overall Study||88
2850087|NCT01502371|3552301|FG004|COMPLETED|Overall Study||60
2850088|NCT01502371|3552297|FG000|NOT COMPLETED|Overall Study||41
2850089|NCT01502371|3552298|FG001|NOT COMPLETED|Overall Study||32
2850090|NCT01502371|3552299|FG002|NOT COMPLETED|Overall Study||25
2850091|NCT01502371|3552300|FG003|NOT COMPLETED|Overall Study||37
2850092|NCT01502371|3552301|FG004|NOT COMPLETED|Overall Study||52
2850093|NCT01490190|3552314|FG000|STARTED|Overall Study||252
2850094|NCT01490190|3552314|FG000|COMPLETED|Overall Study||204
2850095|NCT01490190|3552314|FG000|NOT COMPLETED|Overall Study||48
2850096|NCT01471340|3552320|FG000|STARTED|Overall Study|This value corresponds to randomized participants who received at least of dose of study medication|5868
2850097|NCT01471340|3552321|FG001|STARTED|Overall Study|This value corresponds to randomized participants who received at least of dose of study medication|5861
2850098|NCT01471340|3552320|FG000|COMPLETED|Overall Study||5862
2850099|NCT01471340|3552321|FG001|COMPLETED|Overall Study||5855
2850100|NCT01471340|3552320|FG000|NOT COMPLETED|Overall Study||6
2850101|NCT01471340|3552321|FG001|NOT COMPLETED|Overall Study||6
3168432|NCT01918761|3895723|FG000|STARTED|Overall Study||5
3168433|NCT01918761|3895723|FG000|COMPLETED|Overall Study||5
2850102|NCT01462370|3552327|FG000|STARTED|Overall Study||69
2850103|NCT01462370|3552328|FG001|STARTED|Overall Study||70
2850104|NCT01462370|3552327|FG000|COMPLETED|Overall Study||68
2850105|NCT01462370|3552328|FG001|COMPLETED|Overall Study||65
2850106|NCT01462370|3552327|FG000|NOT COMPLETED|Overall Study||1
2850107|NCT01462370|3552328|FG001|NOT COMPLETED|Overall Study||5
2850108|NCT01436253|3552334|FG000|STARTED|Overall Study||2196
2850109|NCT01436253|3552334|FG000|COMPLETED|Overall Study||1897
2850110|NCT01436253|3552334|FG000|NOT COMPLETED|Overall Study||299
2850111|NCT01414192|3552342|FG000|STARTED|Overall Study||490
2850112|NCT01414192|3552343|FG001|STARTED|Overall Study||575
2850113|NCT01414192|3552344|FG002|STARTED|Overall Study||424
2850114|NCT01414192|3552345|FG003|STARTED|Overall Study||1726
2850115|NCT01414192|3552342|FG000|COMPLETED|Overall Study||490
2850116|NCT01414192|3552343|FG001|COMPLETED|Overall Study||575
2850117|NCT01414192|3552344|FG002|COMPLETED|Overall Study||424
2850118|NCT01414192|3552345|FG003|COMPLETED|Overall Study||1726
2850119|NCT01414192|3552342|FG000|NOT COMPLETED|Overall Study||0
2850120|NCT01414192|3552343|FG001|NOT COMPLETED|Overall Study||0
2850121|NCT01414192|3552344|FG002|NOT COMPLETED|Overall Study||0
2850122|NCT01414192|3552345|FG003|NOT COMPLETED|Overall Study||0
2850123|NCT01390415|3552361|FG000|STARTED|Overall Study||99
2850124|NCT01390415|3552362|FG001|STARTED|Overall Study||37
2850125|NCT01390415|3552361|FG000|COMPLETED|Overall Study||99
2850126|NCT01390415|3552362|FG001|COMPLETED|Overall Study||37
2850127|NCT01390415|3552361|FG000|NOT COMPLETED|Overall Study||0
2850128|NCT01390415|3552362|FG001|NOT COMPLETED|Overall Study||0
2850129|NCT01381679|3552368|FG000|STARTED|Overall Study||1682
2850130|NCT01381679|3552368|FG000|COMPLETED|Overall Study||794
2850131|NCT01381679|3552368|FG000|NOT COMPLETED|Overall Study||888
2850132|NCT01370603|3552374|FG000|STARTED|Period 1||164
2850133|NCT01370603|3552375|FG001|STARTED|Period 1||164
2850134|NCT01370603|3552374|FG000|COMPLETED|Period 1||150
2850135|NCT01370603|3552375|FG001|COMPLETED|Period 1||154
2850136|NCT01370603|3552374|FG000|NOT COMPLETED|Period 1||14
2850137|NCT01370603|3552375|FG001|NOT COMPLETED|Period 1||10
2850138|NCT01370603|3552374|FG000|STARTED|Crossover Washout||150
2850139|NCT01370603|3552375|FG001|STARTED|Crossover Washout||154
2850140|NCT01370603|3552374|FG000|COMPLETED|Crossover Washout||141
2850141|NCT01370603|3552375|FG001|COMPLETED|Crossover Washout||150
2850142|NCT01370603|3552374|FG000|NOT COMPLETED|Crossover Washout||9
2850143|NCT01370603|3552375|FG001|NOT COMPLETED|Crossover Washout||4
2850144|NCT01370603|3552374|FG000|STARTED|Period 2||141
2850145|NCT01370603|3552375|FG001|STARTED|Period 2||150
2850146|NCT01370603|3552374|FG000|COMPLETED|Period 2||138
2850147|NCT01370603|3552375|FG001|COMPLETED|Period 2||146
2850148|NCT01370603|3552374|FG000|NOT COMPLETED|Period 2||3
2850149|NCT01370603|3552375|FG001|NOT COMPLETED|Period 2||4
2850150|NCT01370590|3552383|FG000|STARTED|Period 1||203
2850151|NCT01370590|3552384|FG001|STARTED|Period 1||203
2850152|NCT01370590|3552383|FG000|COMPLETED|Period 1||187
2850153|NCT01370590|3552384|FG001|COMPLETED|Period 1||192
2850154|NCT01370590|3552383|FG000|NOT COMPLETED|Period 1||16
2850155|NCT01370590|3552384|FG001|NOT COMPLETED|Period 1||11
2850156|NCT01370590|3552383|FG000|STARTED|Crossover Washout Period||187
2850157|NCT01370590|3552384|FG001|STARTED|Crossover Washout Period||192
2850158|NCT01370590|3552383|FG000|COMPLETED|Crossover Washout Period||181
2850159|NCT01370590|3552384|FG001|COMPLETED|Crossover Washout Period||186
2850160|NCT01370590|3552383|FG000|NOT COMPLETED|Crossover Washout Period||6
2850161|NCT01370590|3552384|FG001|NOT COMPLETED|Crossover Washout Period||6
2850162|NCT01370590|3552383|FG000|STARTED|Period 2||181
2850163|NCT01370590|3552384|FG001|STARTED|Period 2||186
2850164|NCT01370590|3552383|FG000|COMPLETED|Period 2||180
2850165|NCT01370590|3552384|FG001|COMPLETED|Period 2||184
2850166|NCT01370590|3552383|FG000|NOT COMPLETED|Period 2||1
2850167|NCT01370590|3552384|FG001|NOT COMPLETED|Period 2||2
2850168|NCT01368185|3552390|FG000|STARTED|Overall Study||1705
2850169|NCT01368185|3552390|FG000|COMPLETED|Overall Study||1705
2850170|NCT01368185|3552390|FG000|NOT COMPLETED|Overall Study||0
2850171|NCT01349907|3552396|FG000|STARTED|Overall Study|Enrolled and Treated|241
2850172|NCT01349907|3552397|FG001|STARTED|Overall Study|Enrolled and Treated|81
2850173|NCT01349907|3552396|FG000|COMPLETED|Overall Study||102
2850174|NCT01349907|3552397|FG001|COMPLETED|Overall Study||38
2850175|NCT01349907|3552396|FG000|NOT COMPLETED|Overall Study||139
2850176|NCT01349907|3552397|FG001|NOT COMPLETED|Overall Study||43
2850177|NCT01345786|3552407|FG000|STARTED|Overall Study|Number randomized|41
3311941|NCT03056456|4045527|FG003|STARTED|Period 1||6
3311942|NCT03056456|4045524|FG000|Received One Dose of Study Drug|Period 1||6
3311943|NCT03056456|4045525|FG001|Received One Dose of Study Drug|Period 1||6
3311944|NCT03056456|4045526|FG002|Received One Dose of Study Drug|Period 1||6
3311945|NCT03056456|4045527|FG003|Received One Dose of Study Drug|Period 1||6
3311946|NCT03056456|4045524|FG000|COMPLETED|Period 1||6
3311947|NCT03056456|4045525|FG001|COMPLETED|Period 1||6
3311948|NCT03056456|4045526|FG002|COMPLETED|Period 1||6
3311949|NCT03056456|4045527|FG003|COMPLETED|Period 1||6
3311950|NCT03056456|4045524|FG000|NOT COMPLETED|Period 1||0
3311951|NCT03056456|4045525|FG001|NOT COMPLETED|Period 1||0
3311952|NCT03056456|4045526|FG002|NOT COMPLETED|Period 1||0
3311953|NCT03056456|4045527|FG003|NOT COMPLETED|Period 1||0
3311954|NCT03056456|4045524|FG000|STARTED|Period 2||6
3311955|NCT03056456|4045525|FG001|STARTED|Period 2||6
3311956|NCT03056456|4045526|FG002|STARTED|Period 2||6
3311957|NCT03056456|4045527|FG003|STARTED|Period 2||6
3311958|NCT03056456|4045524|FG000|COMPLETED|Period 2||6
3311959|NCT03056456|4045525|FG001|COMPLETED|Period 2||6
3311960|NCT03056456|4045526|FG002|COMPLETED|Period 2||6
3311961|NCT03056456|4045527|FG003|COMPLETED|Period 2||6
3311962|NCT03056456|4045524|FG000|NOT COMPLETED|Period 2||0
3311963|NCT03056456|4045525|FG001|NOT COMPLETED|Period 2||0
3311964|NCT03056456|4045526|FG002|NOT COMPLETED|Period 2||0
3311965|NCT03056456|4045527|FG003|NOT COMPLETED|Period 2||0
3311966|NCT03056456|4045524|FG000|STARTED|Period 3||6
3311967|NCT03056456|4045525|FG001|STARTED|Period 3||6
3311968|NCT03056456|4045526|FG002|STARTED|Period 3||6
3311969|NCT03056456|4045527|FG003|STARTED|Period 3||6
3311970|NCT03056456|4045524|FG000|COMPLETED|Period 3||6
3311971|NCT03056456|4045525|FG001|COMPLETED|Period 3||6
3311972|NCT03056456|4045526|FG002|COMPLETED|Period 3||6
3311973|NCT03056456|4045527|FG003|COMPLETED|Period 3||6
3311974|NCT03056456|4045524|FG000|NOT COMPLETED|Period 3||0
3311975|NCT03056456|4045525|FG001|NOT COMPLETED|Period 3||0
3311976|NCT03056456|4045526|FG002|NOT COMPLETED|Period 3||0
2850178|NCT01345786|3552408|FG001|STARTED|Overall Study|Number randomized|41
2850179|NCT01345786|3552409|FG002|STARTED|Overall Study|Number randomized|38
3311977|NCT03056456|4045527|FG003|NOT COMPLETED|Period 3||0
3311978|NCT03056456|4045524|FG000|STARTED|Period 4||6
3311979|NCT03056456|4045525|FG001|STARTED|Period 4||6
3311980|NCT03056456|4045526|FG002|STARTED|Period 4||6
3311981|NCT03056456|4045527|FG003|STARTED|Period 4|Participant deviated from 1 week maximum between consecutive periods and did not start Period 4.|5
3311982|NCT03056456|4045524|FG000|COMPLETED|Period 4||6
2850180|NCT01345786|3552410|FG003|STARTED|Overall Study|Number randomized|38
2850181|NCT01345786|3552407|FG000|Treated|Overall Study||41
2850182|NCT01345786|3552408|FG001|Treated|Overall Study||41
2850183|NCT01345786|3552409|FG002|Treated|Overall Study||37
2850184|NCT01345786|3552410|FG003|Treated|Overall Study||37
2850185|NCT01345786|3552407|FG000|COMPLETED|Overall Study||35
2850186|NCT01345786|3552408|FG001|COMPLETED|Overall Study||33
2850187|NCT01345786|3552409|FG002|COMPLETED|Overall Study||33
2850188|NCT01345786|3552410|FG003|COMPLETED|Overall Study||35
2850189|NCT01345786|3552407|FG000|NOT COMPLETED|Overall Study||6
2850190|NCT01345786|3552408|FG001|NOT COMPLETED|Overall Study||8
2850191|NCT01345786|3552409|FG002|NOT COMPLETED|Overall Study||5
2850192|NCT01345786|3552410|FG003|NOT COMPLETED|Overall Study||3
2850193|NCT01306929|3552420|FG000|STARTED|Overall Study||134
2850194|NCT01306929|3552420|FG000|COMPLETED|Overall Study||40
2850195|NCT01306929|3552420|FG000|NOT COMPLETED|Overall Study||94
2850196|NCT01294696|3552426|FG000|STARTED|Overall Study||1261
2850197|NCT01294696|3552426|FG000|COMPLETED|Overall Study||1187
2850198|NCT01294696|3552426|FG000|NOT COMPLETED|Overall Study||74
2850199|NCT01277822|3552433|FG000|STARTED|Overall Study||168
2850200|NCT01277822|3552434|FG001|STARTED|Overall Study||166
2850201|NCT01277822|3552433|FG000|COMPLETED|Overall Study||153
2850202|NCT01277822|3552434|FG001|COMPLETED|Overall Study||155
2850203|NCT01277822|3552433|FG000|NOT COMPLETED|Overall Study||15
2850204|NCT01277822|3552434|FG001|NOT COMPLETED|Overall Study||11
2850205|NCT01261247|3552440|FG000|STARTED|Overall Study||41
2850206|NCT01261247|3552440|FG000|COMPLETED|Overall Study||39
2850207|NCT01261247|3552440|FG000|NOT COMPLETED|Overall Study||2
2850208|NCT01244763|3552450|FG000|STARTED|Overall Study||24
2850209|NCT01244763|3552451|FG001|STARTED|Overall Study||24
2850210|NCT01244763|3552452|FG002|STARTED|Overall Study||24
2850211|NCT01244763|3552453|FG003|STARTED|Overall Study||24
2850212|NCT01244763|3552454|FG004|STARTED|Overall Study||24
2850213|NCT01244763|3552455|FG005|STARTED|Overall Study||25
2850214|NCT01244763|3552450|FG000|Safety Population|Overall Study||24
2850215|NCT01244763|3552451|FG001|Safety Population|Overall Study||24
2850216|NCT01244763|3552452|FG002|Safety Population|Overall Study||24
2850217|NCT01244763|3552453|FG003|Safety Population|Overall Study||24
2850218|NCT01244763|3552454|FG004|Safety Population|Overall Study||24
2850219|NCT01244763|3552455|FG005|Safety Population|Overall Study||25
2850220|NCT01244763|3552450|FG000|Efficacy Evaluable (EE) Population|Overall Study||23
2850221|NCT01244763|3552451|FG001|Efficacy Evaluable (EE) Population|Overall Study||24
2850222|NCT01244763|3552452|FG002|Efficacy Evaluable (EE) Population|Overall Study||23
2850223|NCT01244763|3552453|FG003|Efficacy Evaluable (EE) Population|Overall Study||24
2850224|NCT01244763|3552454|FG004|Efficacy Evaluable (EE) Population|Overall Study||24
2850225|NCT01244763|3552455|FG005|Efficacy Evaluable (EE) Population|Overall Study||25
2850226|NCT01244763|3552450|FG000|COMPLETED|Overall Study||21
2850227|NCT01244763|3552451|FG001|COMPLETED|Overall Study||21
2850228|NCT01244763|3552452|FG002|COMPLETED|Overall Study||22
3311983|NCT03056456|4045525|FG001|COMPLETED|Period 4||6
3311984|NCT03056456|4045526|FG002|COMPLETED|Period 4||6
3311985|NCT03056456|4045527|FG003|COMPLETED|Period 4||5
3311986|NCT03056456|4045524|FG000|NOT COMPLETED|Period 4||0
3311987|NCT03056456|4045525|FG001|NOT COMPLETED|Period 4||0
3311988|NCT03056456|4045526|FG002|NOT COMPLETED|Period 4||0
3311989|NCT03056456|4045527|FG003|NOT COMPLETED|Period 4||0
3311990|NCT03056573|4045542|FG000|STARTED|Overall Study||45
3311991|NCT03056573|4045543|FG001|STARTED|Overall Study||19
3311992|NCT03056573|4045542|FG000|COMPLETED|Overall Study||40
3311993|NCT03056573|4045543|FG001|COMPLETED|Overall Study||14
3311994|NCT03056573|4045542|FG000|NOT COMPLETED|Overall Study||5
3311995|NCT03056573|4045543|FG001|NOT COMPLETED|Overall Study||5
3311996|NCT03056690|4045551|FG000|STARTED|Overall Study||95
3311997|NCT03056690|4045552|FG001|STARTED|Overall Study||91
3311998|NCT03056690|4045551|FG000|Treated|Overall Study||94
3311999|NCT03056690|4045552|FG001|Treated|Overall Study||90
3312000|NCT03056690|4045551|FG000|COMPLETED|Overall Study||81
3312001|NCT03056690|4045552|FG001|COMPLETED|Overall Study||75
3312002|NCT03056690|4045551|FG000|NOT COMPLETED|Overall Study||14
3312003|NCT03056690|4045552|FG001|NOT COMPLETED|Overall Study||16
3312004|NCT03057132|4045558|FG000|STARTED|Overall Study||1
3312005|NCT03057132|4045558|FG000|COMPLETED|Overall Study||1
3312006|NCT03057132|4045558|FG000|NOT COMPLETED|Overall Study||0
3312007|NCT03057366|4045563|FG000|STARTED|Part A||8
3312008|NCT03057366|4045564|FG001|STARTED|Part A||0
3312009|NCT03057366|4045565|FG002|STARTED|Part A||0
3312010|NCT03057366|4045563|FG000|COMPLETED|Part A||8
3312011|NCT03057366|4045564|FG001|COMPLETED|Part A||0
3312012|NCT03057366|4045565|FG002|COMPLETED|Part A||0
3312013|NCT03057366|4045563|FG000|NOT COMPLETED|Part A||0
3312014|NCT03057366|4045564|FG001|NOT COMPLETED|Part A||0
3312015|NCT03057366|4045565|FG002|NOT COMPLETED|Part A||0
2850229|NCT01244763|3552453|FG003|COMPLETED|Overall Study||23
2850230|NCT01244763|3552454|FG004|COMPLETED|Overall Study||21
2850231|NCT01244763|3552455|FG005|COMPLETED|Overall Study||21
2850232|NCT01244763|3552450|FG000|NOT COMPLETED|Overall Study||3
2850233|NCT01244763|3552451|FG001|NOT COMPLETED|Overall Study||3
2850234|NCT01244763|3552452|FG002|NOT COMPLETED|Overall Study||2
2850235|NCT01244763|3552453|FG003|NOT COMPLETED|Overall Study||1
2850236|NCT01244763|3552454|FG004|NOT COMPLETED|Overall Study||3
3312016|NCT03057366|4045563|FG000|STARTED|Part B||0
3312017|NCT03057366|4045564|FG001|STARTED|Part B|Participants completed Part A, met eligibility criteria, and provided consent for Part B.|5
2850237|NCT01244763|3552455|FG005|NOT COMPLETED|Overall Study||4
2850238|NCT01208207|3552472|FG000|STARTED|Part I||702
2850239|NCT01208207|3552473|FG001|STARTED|Part I||156
2850240|NCT01208207|3552474|FG002|STARTED|Part I||157
2850241|NCT01208207|3552475|FG003|STARTED|Part I||0
2850242|NCT01208207|3552476|FG004|STARTED|Part I||0
2850243|NCT01208207|3552477|FG005|STARTED|Part I||0
2850244|NCT01208207|3552478|FG006|STARTED|Part I||0
2850245|NCT01208207|3552472|FG000|COMPLETED|Part I||632
2850246|NCT01208207|3552473|FG001|COMPLETED|Part I||145
2850247|NCT01208207|3552474|FG002|COMPLETED|Part I||142
2850248|NCT01208207|3552475|FG003|COMPLETED|Part I||0
2850249|NCT01208207|3552476|FG004|COMPLETED|Part I||0
2850250|NCT01208207|3552477|FG005|COMPLETED|Part I||0
2850251|NCT01208207|3552478|FG006|COMPLETED|Part I||0
2850252|NCT01208207|3552472|FG000|NOT COMPLETED|Part I||70
2850253|NCT01208207|3552473|FG001|NOT COMPLETED|Part I||11
2850254|NCT01208207|3552474|FG002|NOT COMPLETED|Part I||15
2850255|NCT01208207|3552475|FG003|NOT COMPLETED|Part I||0
2850256|NCT01208207|3552476|FG004|NOT COMPLETED|Part I||0
2850257|NCT01208207|3552477|FG005|NOT COMPLETED|Part I||0
2850258|NCT01208207|3552478|FG006|NOT COMPLETED|Part I||0
2850259|NCT01208207|3552472|FG000|STARTED|Part II||0
2850260|NCT01208207|3552473|FG001|STARTED|Part II||0
2850261|NCT01208207|3552474|FG002|STARTED|Part II||0
2850262|NCT01208207|3552475|FG003|STARTED|Part II||314
2850263|NCT01208207|3552476|FG004|STARTED|Part II||318
2850264|NCT01208207|3552477|FG005|STARTED|Part II||145
2850265|NCT01208207|3552478|FG006|STARTED|Part II||142
2850266|NCT01208207|3552472|FG000|COMPLETED|Part II||0
2850267|NCT01208207|3552473|FG001|COMPLETED|Part II||0
2850268|NCT01208207|3552474|FG002|COMPLETED|Part II||0
2850269|NCT01208207|3552475|FG003|COMPLETED|Part II||282
2850270|NCT01208207|3552476|FG004|COMPLETED|Part II||295
2850271|NCT01208207|3552477|FG005|COMPLETED|Part II||129
2850272|NCT01208207|3552478|FG006|COMPLETED|Part II||131
2850273|NCT01208207|3552472|FG000|NOT COMPLETED|Part II||0
2850274|NCT01208207|3552473|FG001|NOT COMPLETED|Part II||0
2850275|NCT01208207|3552474|FG002|NOT COMPLETED|Part II||0
2850276|NCT01208207|3552475|FG003|NOT COMPLETED|Part II||32
2850277|NCT01208207|3552476|FG004|NOT COMPLETED|Part II||23
2850278|NCT01208207|3552477|FG005|NOT COMPLETED|Part II||16
2850279|NCT01208207|3552478|FG006|NOT COMPLETED|Part II||11
2850280|NCT01208181|3552503|FG000|STARTED|Part 1||818
2850281|NCT01208181|3552504|FG001|STARTED|Part 1||468
2850282|NCT01208181|3552505|FG002|STARTED|Part 1||0
2850283|NCT01208181|3552506|FG003|STARTED|Part 1||0
2850284|NCT01208181|3552507|FG004|STARTED|Part 1||118
2850285|NCT01208181|3552503|FG000|COMPLETED|Part 1|Six participants from this arm did not continue into Part II of the study|719
2850286|NCT01208181|3552504|FG001|COMPLETED|Part 1|Per protocol, participants in this arm did not continue into Part II of the study|413
2850287|NCT01208181|3552505|FG002|COMPLETED|Part 1||0
2850288|NCT01208181|3552506|FG003|COMPLETED|Part 1||0
3312018|NCT03057366|4045565|FG002|STARTED|Part B|Participants completed Part A, met eligibility criteria, and provided consent for Part B.|2
3312019|NCT03057366|4045563|FG000|COMPLETED|Part B||0
3312020|NCT03057366|4045564|FG001|COMPLETED|Part B||5
3312021|NCT03057366|4045565|FG002|COMPLETED|Part B||2
3312022|NCT03057366|4045563|FG000|NOT COMPLETED|Part B||0
3312023|NCT03057366|4045564|FG001|NOT COMPLETED|Part B||0
3312024|NCT03057366|4045565|FG002|NOT COMPLETED|Part B||0
3312025|NCT03057496|4045575|FG000|STARTED|Overall Study||49
3312026|NCT03057496|4045575|FG000|Started Home-use Trial|Overall Study||36
3312027|NCT03057496|4045575|FG000|COMPLETED|Overall Study||31
3312028|NCT03057496|4045575|FG000|NOT COMPLETED|Overall Study||18
3312029|NCT03057613|4045581|FG000|STARTED|Overall Study||18
3312030|NCT03057613|4045581|FG000|COMPLETED|Overall Study||18
3312031|NCT03057613|4045581|FG000|NOT COMPLETED|Overall Study||0
3312032|NCT03057704|4045587|FG000|STARTED|Overall Study||25
3312033|NCT03057704|4045588|FG001|STARTED|Overall Study||25
3312034|NCT03057704|4045587|FG000|COMPLETED|Overall Study||25
3312035|NCT03057704|4045588|FG001|COMPLETED|Overall Study||25
3312036|NCT03057704|4045587|FG000|NOT COMPLETED|Overall Study||0
3312037|NCT03057704|4045588|FG001|NOT COMPLETED|Overall Study||0
3312038|NCT03057977|4045596|FG000|STARTED|Discontinuation From Treatment||1867
3312039|NCT03057977|4045597|FG001|STARTED|Discontinuation From Treatment||1863
3312040|NCT03057977|4045596|FG000|Treated|Discontinuation From Treatment||1863
3312041|NCT03057977|4045597|FG001|Treated|Discontinuation From Treatment||1863
3312042|NCT03057977|4045596|FG000|COMPLETED|Discontinuation From Treatment||1352
3312043|NCT03057977|4045597|FG001|COMPLETED|Discontinuation From Treatment||1381
3312044|NCT03057977|4045596|FG000|NOT COMPLETED|Discontinuation From Treatment||515
3312045|NCT03057977|4045597|FG001|NOT COMPLETED|Discontinuation From Treatment||482
3312046|NCT03057977|4045596|FG000|STARTED|Discontinuation From Trial||1867
3312047|NCT03057977|4045597|FG001|STARTED|Discontinuation From Trial||1863
3312048|NCT03057977|4045596|FG000|Treated|Discontinuation From Trial||1863
3312049|NCT03057977|4045597|FG001|Treated|Discontinuation From Trial||1863
3312050|NCT03057977|4045596|FG000|COMPLETED|Discontinuation From Trial||1847
2850289|NCT01208181|3552507|FG004|COMPLETED|Part 1|Per protocol, participants in this arm did not continue into Part II of the study|96
2850290|NCT01208181|3552503|FG000|NOT COMPLETED|Part 1||99
2850291|NCT01208181|3552504|FG001|NOT COMPLETED|Part 1||55
2850292|NCT01208181|3552505|FG002|NOT COMPLETED|Part 1||0
2850293|NCT01208181|3552506|FG003|NOT COMPLETED|Part 1||0
2850294|NCT01208181|3552507|FG004|NOT COMPLETED|Part 1||22
2850295|NCT01208181|3552503|FG000|STARTED|Part 2|Per protocol, there were no participants in this arm during Part II of the study|0
2850296|NCT01208181|3552504|FG001|STARTED|Part 2|Per protocol, there were no participants in this arm during Part II of the study|0
2850297|NCT01208181|3552505|FG002|STARTED|Part 2|Participants receiving etoricoxib 60 mg in Part I received etoricoxib 60 mg in Part II of the study|350
2850298|NCT01208181|3552506|FG003|STARTED|Part 2|Participants receiving etoricoxib 60 mg in Part I received etoricoxib 90 mg in Part II of the study|363
2850299|NCT01208181|3552507|FG004|STARTED|Part 2|Per protocol, participants did not receive placebo during Part II of the study|0
2850300|NCT01208181|3552503|FG000|COMPLETED|Part 2||0
2850301|NCT01208181|3552504|FG001|COMPLETED|Part 2||0
2850302|NCT01208181|3552505|FG002|COMPLETED|Part 2||334
2850303|NCT01208181|3552506|FG003|COMPLETED|Part 2||343
2850304|NCT01208181|3552507|FG004|COMPLETED|Part 2||0
2850305|NCT01208181|3552503|FG000|NOT COMPLETED|Part 2||0
2850306|NCT01208181|3552504|FG001|NOT COMPLETED|Part 2||0
2850307|NCT01208181|3552505|FG002|NOT COMPLETED|Part 2||16
2850308|NCT01208181|3552506|FG003|NOT COMPLETED|Part 2||20
2850309|NCT01208181|3552507|FG004|NOT COMPLETED|Part 2||0
2850310|NCT01206517|3552530|FG000|STARTED|Overall Study||6
2850311|NCT01206517|3552531|FG001|STARTED|Overall Study||6
2850312|NCT01206517|3552532|FG002|STARTED|Overall Study||6
2850313|NCT01206517|3552533|FG003|STARTED|Overall Study||4
2850314|NCT01206517|3552534|FG004|STARTED|Overall Study||4
2850315|NCT01206517|3552535|FG005|STARTED|Overall Study||4
2850316|NCT01206517|3552530|FG000|COMPLETED|Overall Study||6
2850317|NCT01206517|3552531|FG001|COMPLETED|Overall Study||6
2850318|NCT01206517|3552532|FG002|COMPLETED|Overall Study||4
2850319|NCT01206517|3552533|FG003|COMPLETED|Overall Study||4
2850320|NCT01206517|3552534|FG004|COMPLETED|Overall Study||3
2850321|NCT01206517|3552535|FG005|COMPLETED|Overall Study||4
2850322|NCT01206517|3552530|FG000|NOT COMPLETED|Overall Study||0
2850323|NCT01206517|3552531|FG001|NOT COMPLETED|Overall Study||0
2850324|NCT01206517|3552532|FG002|NOT COMPLETED|Overall Study||2
2850325|NCT01206517|3552533|FG003|NOT COMPLETED|Overall Study||0
2850326|NCT01206517|3552534|FG004|NOT COMPLETED|Overall Study||1
2850327|NCT01206517|3552535|FG005|NOT COMPLETED|Overall Study||0
2850328|NCT01190267|3552548|FG000|STARTED|Overall Study||196
2850329|NCT01190267|3552549|FG001|STARTED|Overall Study||8
2850330|NCT01190267|3552548|FG000|COMPLETED|Overall Study||155
2850331|NCT01190267|3552549|FG001|COMPLETED|Overall Study||4
2850332|NCT01190267|3552548|FG000|NOT COMPLETED|Overall Study||41
2850333|NCT01190267|3552549|FG001|NOT COMPLETED|Overall Study||4
2850334|NCT01190254|3552558|FG000|STARTED|Overall Study||102
2850335|NCT01190254|3552559|FG001|STARTED|Overall Study||98
2850336|NCT01190254|3552560|FG002|STARTED|Overall Study||106
2850337|NCT01190254|3552558|FG000|Treated|Overall Study||102
2850338|NCT01190254|3552559|FG001|Treated|Overall Study||98
2850339|NCT01190254|3552560|FG002|Treated|Overall Study||106
2850340|NCT01190254|3552558|FG000|COMPLETED|Overall Study||81
2850341|NCT01190254|3552559|FG001|COMPLETED|Overall Study||81
2850342|NCT01190254|3552560|FG002|COMPLETED|Overall Study||84
2850343|NCT01190254|3552558|FG000|NOT COMPLETED|Overall Study||21
2850344|NCT01190254|3552559|FG001|NOT COMPLETED|Overall Study||17
2850345|NCT01190254|3552560|FG002|NOT COMPLETED|Overall Study||22
2850346|NCT01154036|3552571|FG000|STARTED|Phase I||120
2850347|NCT01154036|3552572|FG001|STARTED|Phase I||483
2850348|NCT01154036|3552573|FG002|STARTED|Phase I||944
2850349|NCT01154036|3552574|FG003|STARTED|Phase I||0
2850350|NCT01154036|3552575|FG004|STARTED|Phase I||0
2850351|NCT01154036|3552576|FG005|STARTED|Phase I||0
2850352|NCT01154036|3552577|FG006|STARTED|Phase I||0
2850353|NCT01154036|3552578|FG007|STARTED|Phase I||0
2850354|NCT01154036|3552571|FG000|COMPLETED|Phase I|Not all completers were eligible for Phase II|117
2850355|NCT01154036|3552572|FG001|COMPLETED|Phase I|Not all completers were eligible for Phase II|455
2850356|NCT01154036|3552573|FG002|COMPLETED|Phase I|Not all completers were eligible for Phase II|888
2850357|NCT01154036|3552574|FG003|COMPLETED|Phase I||0
2850358|NCT01154036|3552575|FG004|COMPLETED|Phase I||0
2850359|NCT01154036|3552576|FG005|COMPLETED|Phase I||0
2850360|NCT01154036|3552577|FG006|COMPLETED|Phase I||0
2850361|NCT01154036|3552578|FG007|COMPLETED|Phase I||0
2850362|NCT01154036|3552571|FG000|NOT COMPLETED|Phase I||3
2850363|NCT01154036|3552572|FG001|NOT COMPLETED|Phase I||28
2850364|NCT01154036|3552573|FG002|NOT COMPLETED|Phase I||56
2850365|NCT01154036|3552574|FG003|NOT COMPLETED|Phase I||0
2850366|NCT01154036|3552575|FG004|NOT COMPLETED|Phase I||0
2850367|NCT01154036|3552576|FG005|NOT COMPLETED|Phase I||0
2850368|NCT01154036|3552577|FG006|NOT COMPLETED|Phase I||0
2850369|NCT01154036|3552578|FG007|NOT COMPLETED|Phase I||0
2850370|NCT01154036|3552571|FG000|STARTED|Phase II||0
2850371|NCT01154036|3552572|FG001|STARTED|Phase II||0
2850372|NCT01154036|3552573|FG002|STARTED|Phase II||0
2850373|NCT01154036|3552574|FG003|STARTED|Phase II|Only participants who did not meet LDL-C goals at the end of Phase I, were eligible for Phase II|28
2850374|NCT01154036|3552575|FG004|STARTED|Phase II|Only participants who did not meet LDL-C goals at the end of Phase I, were eligible for Phase II|124
2850375|NCT01154036|3552576|FG005|STARTED|Phase II|Only participants who did not meet LDL-C goals at the end of Phase I, were eligible for Phase II|126
2850376|NCT01154036|3552577|FG006|STARTED|Phase II|Only participants who did not meet LDL-C goals at the end of Phase I, were eligible for Phase II|234
2850377|NCT01154036|3552578|FG007|STARTED|Phase II|Only participants who did not meet LDL-C goals at the end of Phase I, were eligible for Phase II|206
2850378|NCT01154036|3552571|FG000|COMPLETED|Phase II||0
2850379|NCT01154036|3552572|FG001|COMPLETED|Phase II||0
2850380|NCT01154036|3552573|FG002|COMPLETED|Phase II||0
2850381|NCT01154036|3552574|FG003|COMPLETED|Phase II||27
2850382|NCT01154036|3552575|FG004|COMPLETED|Phase II||116
2850383|NCT01154036|3552576|FG005|COMPLETED|Phase II||121
2850384|NCT01154036|3552577|FG006|COMPLETED|Phase II||225
2850385|NCT01154036|3552578|FG007|COMPLETED|Phase II||200
2850386|NCT01154036|3552571|FG000|NOT COMPLETED|Phase II||0
2850387|NCT01154036|3552572|FG001|NOT COMPLETED|Phase II||0
2850388|NCT01154036|3552573|FG002|NOT COMPLETED|Phase II||0
2850389|NCT01154036|3552574|FG003|NOT COMPLETED|Phase II||1
2850390|NCT01154036|3552575|FG004|NOT COMPLETED|Phase II||8
2850391|NCT01154036|3552576|FG005|NOT COMPLETED|Phase II||5
2850392|NCT01154036|3552577|FG006|NOT COMPLETED|Phase II||9
2850393|NCT01154036|3552578|FG007|NOT COMPLETED|Phase II||6
2850394|NCT01101464|3552600|FG000|STARTED|Day 1 Through AM Dose of Day 5||4
2850395|NCT01101464|3552601|FG001|STARTED|Day 1 Through AM Dose of Day 5||4
2850396|NCT01101464|3552600|FG000|COMPLETED|Day 1 Through AM Dose of Day 5||4
2850397|NCT01101464|3552601|FG001|COMPLETED|Day 1 Through AM Dose of Day 5||4
2850398|NCT01101464|3552600|FG000|NOT COMPLETED|Day 1 Through AM Dose of Day 5||0
2850399|NCT01101464|3552601|FG001|NOT COMPLETED|Day 1 Through AM Dose of Day 5||0
2850400|NCT01101464|3552600|FG000|STARTED|PM Dose of Day 5 Through AM Dose of Day7||4
2850401|NCT01101464|3552601|FG001|STARTED|PM Dose of Day 5 Through AM Dose of Day7||4
2850402|NCT01101464|3552600|FG000|COMPLETED|PM Dose of Day 5 Through AM Dose of Day7||4
2850403|NCT01101464|3552601|FG001|COMPLETED|PM Dose of Day 5 Through AM Dose of Day7||4
2850404|NCT01101464|3552600|FG000|NOT COMPLETED|PM Dose of Day 5 Through AM Dose of Day7||0
2850405|NCT01101464|3552601|FG001|NOT COMPLETED|PM Dose of Day 5 Through AM Dose of Day7||0
2850406|NCT01098071|3552609|FG000|STARTED|Overall Study||34
2850407|NCT01098071|3552609|FG000|COMPLETED|Overall Study||19
2850408|NCT01098071|3552609|FG000|NOT COMPLETED|Overall Study||15
2850409|NCT01077830|3552615|FG000|STARTED|Overall Study||677
2850410|NCT01077830|3552616|FG001|STARTED|Overall Study||682
2850411|NCT01077830|3552615|FG000|COMPLETED|Overall Study||677
2850412|NCT01077830|3552616|FG001|COMPLETED|Overall Study||682
2850413|NCT01077830|3552615|FG000|NOT COMPLETED|Overall Study||0
2850414|NCT01077830|3552616|FG001|NOT COMPLETED|Overall Study||0
2850415|NCT01070966|3552622|FG000|STARTED|Participants for Safety Evaluation||2089
2850416|NCT01070966|3552622|FG000|COMPLETED|Participants for Safety Evaluation||2011
2850417|NCT01070966|3552622|FG000|NOT COMPLETED|Participants for Safety Evaluation||78
2850418|NCT01070966|3552622|FG000|STARTED|Participants for Efficacy Evaluation||2011
2850419|NCT01070966|3552622|FG000|COMPLETED|Participants for Efficacy Evaluation||1929
3168434|NCT01918761|3895723|FG000|NOT COMPLETED|Overall Study||0
3168435|NCT01918774|3895727|FG000|STARTED|Overall Study||57
3168436|NCT01918774|3895727|FG000|COMPLETED|Overall Study||52
2850420|NCT01070966|3552622|FG000|NOT COMPLETED|Participants for Efficacy Evaluation||82
2850421|NCT01070953|3552633|FG000|STARTED|Participants for Safety Evaluation||4467
2850422|NCT01070953|3552633|FG000|COMPLETED|Participants for Safety Evaluation||3536
2850423|NCT01070953|3552633|FG000|NOT COMPLETED|Participants for Safety Evaluation||931
2850424|NCT01070953|3552633|FG000|STARTED|Participants for Efficacy Evaluation||3536
2850425|NCT01070953|3552633|FG000|COMPLETED|Participants for Efficacy Evaluation||3309
2850426|NCT01070953|3552633|FG000|NOT COMPLETED|Participants for Efficacy Evaluation||227
2850427|NCT01030341|3552643|FG000|STARTED|Overall Study|45 participants met all enrollment criteria by completing the screening and run-in phases|45
2850428|NCT01030341|3552643|FG000|COMPLETED|Overall Study|42 participants completed the study|42
2850429|NCT01030341|3552643|FG000|NOT COMPLETED|Overall Study||3
2850430|NCT00979901|3552651|FG000|STARTED|Overall Study||352
2850431|NCT00979901|3552652|FG001|STARTED|Overall Study||348
2850432|NCT00979901|3552653|FG002|STARTED|Overall Study||602
2850433|NCT00979901|3552654|FG003|STARTED|Overall Study||275
2850434|NCT00979901|3552651|FG000|COMPLETED|Overall Study||334
2850435|NCT00979901|3552652|FG001|COMPLETED|Overall Study||336
2850436|NCT00979901|3552653|FG002|COMPLETED|Overall Study||573
2850437|NCT00979901|3552654|FG003|COMPLETED|Overall Study||159
2850438|NCT00979901|3552651|FG000|NOT COMPLETED|Overall Study||18
2850439|NCT00979901|3552652|FG001|NOT COMPLETED|Overall Study||12
2850440|NCT00979901|3552653|FG002|NOT COMPLETED|Overall Study||29
2850441|NCT00979901|3552654|FG003|NOT COMPLETED|Overall Study||116
2850442|NCT00977574|3552666|FG000|STARTED|Overall Study||116
2850443|NCT00977574|3552667|FG001|STARTED|Overall Study||115
2850444|NCT00977574|3552668|FG002|STARTED|Overall Study||118
2850445|NCT00977574|3552666|FG000|COMPLETED|Overall Study||112
2850446|NCT00977574|3552667|FG001|COMPLETED|Overall Study||113
2850447|NCT00977574|3552668|FG002|COMPLETED|Overall Study||114
2850448|NCT00977574|3552666|FG000|NOT COMPLETED|Overall Study||4
2850449|NCT00977574|3552667|FG001|NOT COMPLETED|Overall Study||2
2850450|NCT00977574|3552668|FG002|NOT COMPLETED|Overall Study||4
2850451|NCT00963599|3552680|FG000|STARTED|Overall Study||149
2850452|NCT00963599|3552681|FG001|STARTED|Overall Study||155
2850453|NCT00963599|3552682|FG002|STARTED|Overall Study||301
2850454|NCT00963599|3552683|FG003|STARTED|Overall Study||302
2850455|NCT00963599|3552680|FG000|COMPLETED|Overall Study||143
2850456|NCT00963599|3552681|FG001|COMPLETED|Overall Study||149
2850457|NCT00963599|3552682|FG002|COMPLETED|Overall Study||292
2850458|NCT00963599|3552683|FG003|COMPLETED|Overall Study||288
2850459|NCT00963599|3552680|FG000|NOT COMPLETED|Overall Study||6
2850460|NCT00963599|3552681|FG001|NOT COMPLETED|Overall Study||6
2850461|NCT00963599|3552682|FG002|NOT COMPLETED|Overall Study||9
2850462|NCT00963599|3552683|FG003|NOT COMPLETED|Overall Study||14
2850463|NCT00954915|3552693|FG000|STARTED|Overall Study||1
2850464|NCT00954915|3552693|FG000|COMPLETED|Overall Study||1
2850465|NCT00954915|3552693|FG000|NOT COMPLETED|Overall Study||0
2850466|NCT00953680|3552698|FG000|STARTED|Period 1||38
2850467|NCT00953680|3552699|FG001|STARTED|Period 1||39
2850468|NCT00953680|3552698|FG000|COMPLETED|Period 1||38
2850469|NCT00953680|3552699|FG001|COMPLETED|Period 1||38
2850470|NCT00953680|3552698|FG000|NOT COMPLETED|Period 1||0
2850471|NCT00953680|3552699|FG001|NOT COMPLETED|Period 1||1
2850472|NCT00953680|3552698|FG000|STARTED|Period 2||38
2850473|NCT00953680|3552699|FG001|STARTED|Period 2||38
2850474|NCT00953680|3552698|FG000|COMPLETED|Period 2||38
2850475|NCT00953680|3552699|FG001|COMPLETED|Period 2||38
2850476|NCT00953680|3552698|FG000|NOT COMPLETED|Period 2||0
2850477|NCT00953680|3552699|FG001|NOT COMPLETED|Period 2||0
2850478|NCT00945035|3552705|FG000|STARTED|Period 1||18
2850479|NCT00945035|3552706|FG001|STARTED|Period 1||18
2850480|NCT00945035|3552705|FG000|COMPLETED|Period 1||18
2850481|NCT00945035|3552706|FG001|COMPLETED|Period 1||18
2850482|NCT00945035|3552705|FG000|NOT COMPLETED|Period 1||0
2850483|NCT00945035|3552706|FG001|NOT COMPLETED|Period 1||0
2850484|NCT00945035|3552705|FG000|STARTED|Period 2||18
2850485|NCT00945035|3552706|FG001|STARTED|Period 2||18
2850486|NCT00945035|3552705|FG000|COMPLETED|Period 2||18
2850487|NCT00945035|3552706|FG001|COMPLETED|Period 2||18
2850488|NCT00945035|3552705|FG000|NOT COMPLETED|Period 2||0
2850489|NCT00945035|3552706|FG001|NOT COMPLETED|Period 2||0
2850490|NCT00943852|3552712|FG000|STARTED|First Period of Treatment Intervention||2
2850491|NCT00943852|3552713|FG001|STARTED|First Period of Treatment Intervention||1
2850492|NCT00943852|3552714|FG002|STARTED|First Period of Treatment Intervention||1
2850493|NCT00943852|3552715|FG003|STARTED|First Period of Treatment Intervention||2
2850494|NCT00943852|3552716|FG004|STARTED|First Period of Treatment Intervention||1
2850495|NCT00943852|3552717|FG005|STARTED|First Period of Treatment Intervention||1
2850496|NCT00943852|3552718|FG006|STARTED|First Period of Treatment Intervention||2
2850497|NCT00943852|3552719|FG007|STARTED|First Period of Treatment Intervention||1
2850498|NCT00943852|3552720|FG008|STARTED|First Period of Treatment Intervention||1
2850499|NCT00943852|3552721|FG009|STARTED|First Period of Treatment Intervention||1
2850500|NCT00943852|3552712|FG000|COMPLETED|First Period of Treatment Intervention||2
2850501|NCT00943852|3552713|FG001|COMPLETED|First Period of Treatment Intervention||1
2850502|NCT00943852|3552714|FG002|COMPLETED|First Period of Treatment Intervention||1
2850503|NCT00943852|3552715|FG003|COMPLETED|First Period of Treatment Intervention||2
2850504|NCT00943852|3552716|FG004|COMPLETED|First Period of Treatment Intervention||1
2850505|NCT00943852|3552717|FG005|COMPLETED|First Period of Treatment Intervention||1
2850506|NCT00943852|3552718|FG006|COMPLETED|First Period of Treatment Intervention||2
2850507|NCT00943852|3552719|FG007|COMPLETED|First Period of Treatment Intervention||1
2850508|NCT00943852|3552720|FG008|COMPLETED|First Period of Treatment Intervention||1
2850509|NCT00943852|3552721|FG009|COMPLETED|First Period of Treatment Intervention||1
2850510|NCT00943852|3552712|FG000|NOT COMPLETED|First Period of Treatment Intervention||0
2850511|NCT00943852|3552713|FG001|NOT COMPLETED|First Period of Treatment Intervention||0
2850512|NCT00943852|3552714|FG002|NOT COMPLETED|First Period of Treatment Intervention||0
2850513|NCT00943852|3552715|FG003|NOT COMPLETED|First Period of Treatment Intervention||0
2850514|NCT00943852|3552716|FG004|NOT COMPLETED|First Period of Treatment Intervention||0
2850515|NCT00943852|3552717|FG005|NOT COMPLETED|First Period of Treatment Intervention||0
2850516|NCT00943852|3552718|FG006|NOT COMPLETED|First Period of Treatment Intervention||0
2850517|NCT00943852|3552719|FG007|NOT COMPLETED|First Period of Treatment Intervention||0
2850518|NCT00943852|3552720|FG008|NOT COMPLETED|First Period of Treatment Intervention||0
2850519|NCT00943852|3552721|FG009|NOT COMPLETED|First Period of Treatment Intervention||0
2850520|NCT00943852|3552712|FG000|STARTED|Washout Period After Period 1 Treatment||2
2850521|NCT00943852|3552713|FG001|STARTED|Washout Period After Period 1 Treatment||1
2850522|NCT00943852|3552714|FG002|STARTED|Washout Period After Period 1 Treatment||1
2850523|NCT00943852|3552715|FG003|STARTED|Washout Period After Period 1 Treatment||2
2850524|NCT00943852|3552716|FG004|STARTED|Washout Period After Period 1 Treatment||1
3312051|NCT03057977|4045597|FG001|COMPLETED|Discontinuation From Trial||1841
3312052|NCT03057977|4045596|FG000|NOT COMPLETED|Discontinuation From Trial||20
3312053|NCT03057977|4045597|FG001|NOT COMPLETED|Discontinuation From Trial||22
3312054|NCT03058679|4045605|FG000|STARTED|Baseline to Week 6|3 randomized to SCD withdrew before starting diet;2 randomized pts w/ baseline sCDAI<150 excluded.|99
3312055|NCT03058679|4045606|FG001|STARTED|Baseline to Week 6|Due to an error 1 participant was randomized with a baseline sCDAI<150. This pt was excluded.|92
3312056|NCT03058679|4045605|FG000|COMPLETED|Baseline to Week 6||81
3312057|NCT03058679|4045606|FG001|COMPLETED|Baseline to Week 6||77
3312058|NCT03058679|4045605|FG000|NOT COMPLETED|Baseline to Week 6||18
3312059|NCT03058679|4045606|FG001|NOT COMPLETED|Baseline to Week 6||15
3312060|NCT03058679|4045605|FG000|STARTED|Week 6 to Week 12||81
3312061|NCT03058679|4045606|FG001|STARTED|Week 6 to Week 12||77
3312062|NCT03058679|4045605|FG000|COMPLETED|Week 6 to Week 12||61
3312063|NCT03058679|4045606|FG001|COMPLETED|Week 6 to Week 12||60
3312064|NCT03058679|4045605|FG000|NOT COMPLETED|Week 6 to Week 12||20
3312065|NCT03058679|4045606|FG001|NOT COMPLETED|Week 6 to Week 12||17
3312066|NCT03058692|4045614|FG000|STARTED|Overall Study||61
3312067|NCT03058692|4045615|FG001|STARTED|Overall Study||59
3312068|NCT03058692|4045614|FG000|COMPLETED|Overall Study||58
3312069|NCT03058692|4045615|FG001|COMPLETED|Overall Study||57
3312070|NCT03058692|4045614|FG000|NOT COMPLETED|Overall Study||3
3312071|NCT03058692|4045615|FG001|NOT COMPLETED|Overall Study||2
3312072|NCT03058991|4045625|FG000|STARTED|Overall Study||39
3312073|NCT03058991|4045626|FG001|STARTED|Overall Study||32
2850525|NCT00943852|3552717|FG005|STARTED|Washout Period After Period 1 Treatment||1
2850526|NCT00943852|3552718|FG006|STARTED|Washout Period After Period 1 Treatment||2
2850527|NCT00943852|3552719|FG007|STARTED|Washout Period After Period 1 Treatment||1
2850528|NCT00943852|3552720|FG008|STARTED|Washout Period After Period 1 Treatment||1
2850529|NCT00943852|3552721|FG009|STARTED|Washout Period After Period 1 Treatment||1
2850530|NCT00943852|3552712|FG000|COMPLETED|Washout Period After Period 1 Treatment||2
2850531|NCT00943852|3552713|FG001|COMPLETED|Washout Period After Period 1 Treatment||1
2850532|NCT00943852|3552714|FG002|COMPLETED|Washout Period After Period 1 Treatment||1
2850533|NCT00943852|3552715|FG003|COMPLETED|Washout Period After Period 1 Treatment||1
2850534|NCT00943852|3552716|FG004|COMPLETED|Washout Period After Period 1 Treatment||1
2850535|NCT00943852|3552717|FG005|COMPLETED|Washout Period After Period 1 Treatment||1
2850536|NCT00943852|3552718|FG006|COMPLETED|Washout Period After Period 1 Treatment||2
2850537|NCT00943852|3552719|FG007|COMPLETED|Washout Period After Period 1 Treatment||1
2850538|NCT00943852|3552720|FG008|COMPLETED|Washout Period After Period 1 Treatment||1
2850539|NCT00943852|3552721|FG009|COMPLETED|Washout Period After Period 1 Treatment||1
2850540|NCT00943852|3552712|FG000|NOT COMPLETED|Washout Period After Period 1 Treatment||0
2850541|NCT00943852|3552713|FG001|NOT COMPLETED|Washout Period After Period 1 Treatment||0
2850542|NCT00943852|3552714|FG002|NOT COMPLETED|Washout Period After Period 1 Treatment||0
2850543|NCT00943852|3552715|FG003|NOT COMPLETED|Washout Period After Period 1 Treatment||1
2850544|NCT00943852|3552716|FG004|NOT COMPLETED|Washout Period After Period 1 Treatment||0
2850545|NCT00943852|3552717|FG005|NOT COMPLETED|Washout Period After Period 1 Treatment||0
2850546|NCT00943852|3552718|FG006|NOT COMPLETED|Washout Period After Period 1 Treatment||0
2850547|NCT00943852|3552719|FG007|NOT COMPLETED|Washout Period After Period 1 Treatment||0
2850548|NCT00943852|3552720|FG008|NOT COMPLETED|Washout Period After Period 1 Treatment||0
2850549|NCT00943852|3552721|FG009|NOT COMPLETED|Washout Period After Period 1 Treatment||0
3312074|NCT03058991|4045627|FG002|STARTED|Overall Study||37
3312075|NCT03058991|4045625|FG000|1-Week Follow Up|Overall Study||23
3312076|NCT03058991|4045626|FG001|1-Week Follow Up|Overall Study||27
3312077|NCT03058991|4045627|FG002|1-Week Follow Up|Overall Study||28
3312078|NCT03058991|4045625|FG000|COMPLETED|Overall Study||21
3312079|NCT03058991|4045626|FG001|COMPLETED|Overall Study||20
3312080|NCT03058991|4045627|FG002|COMPLETED|Overall Study||25
3312081|NCT03058991|4045625|FG000|NOT COMPLETED|Overall Study||18
3312082|NCT03058991|4045626|FG001|NOT COMPLETED|Overall Study||12
3312083|NCT03058991|4045627|FG002|NOT COMPLETED|Overall Study||12
3312084|NCT03059810|4045635|FG000|STARTED|Overall Study||63
3312085|NCT03059810|4045635|FG000|COMPLETED|Overall Study||63
3312086|NCT03059810|4045635|FG000|NOT COMPLETED|Overall Study||0
3312087|NCT03059901|4045641|FG000|STARTED|Overall Study||30
3312088|NCT03059901|4045642|FG001|STARTED|Overall Study||30
3312089|NCT03059901|4045641|FG000|COMPLETED|Overall Study||26
3312090|NCT03059901|4045642|FG001|COMPLETED|Overall Study||28
3312091|NCT03059901|4045641|FG000|NOT COMPLETED|Overall Study||4
3312092|NCT03059901|4045642|FG001|NOT COMPLETED|Overall Study||2
3312093|NCT03060447|4045650|FG000|STARTED|Overall Study||17
3312094|NCT03060447|4045651|FG001|STARTED|Overall Study||8
3312095|NCT03060447|4045650|FG000|COMPLETED|Overall Study||15
3312096|NCT03060447|4045651|FG001|COMPLETED|Overall Study||8
3312097|NCT03060447|4045650|FG000|NOT COMPLETED|Overall Study||2
3312098|NCT03060447|4045651|FG001|NOT COMPLETED|Overall Study||0
3312099|NCT03060486|4045663|FG000|STARTED|Overall Study||15
3312100|NCT03060486|4045663|FG000|COMPLETED|Overall Study||15
3312101|NCT03060486|4045663|FG000|NOT COMPLETED|Overall Study||0
3312102|NCT03060512|4045669|FG000|STARTED|Overall Study||137
3312103|NCT03060512|4045670|FG001|STARTED|Overall Study||139
3312104|NCT03060512|4045669|FG000|Treated With Movantik|Overall Study||136
3312105|NCT03060512|4045670|FG001|Treated With Movantik|Overall Study||135
3312106|NCT03060512|4045669|FG000|Treated With PEG 3350|Overall Study||130
3312107|NCT03060512|4045670|FG001|Treated With PEG 3350|Overall Study||138
3312108|NCT03060512|4045669|FG000|COMPLETED|Overall Study||130
3312109|NCT03060512|4045670|FG001|COMPLETED|Overall Study||130
3312110|NCT03060512|4045669|FG000|NOT COMPLETED|Overall Study||7
3312111|NCT03060512|4045670|FG001|NOT COMPLETED|Overall Study||9
3312112|NCT03060551|4045681|FG000|STARTED|Overall Study||20
3312113|NCT03060551|4045681|FG000|COMPLETED|Overall Study||18
3312114|NCT03060551|4045681|FG000|NOT COMPLETED|Overall Study||2
3312115|NCT03060759|4045687|FG000|STARTED|Overall Study||20
3312116|NCT03060759|4045688|FG001|STARTED|Overall Study||15
3312117|NCT03060759|4045687|FG000|COMPLETED|Overall Study||15
3312118|NCT03060759|4045688|FG001|COMPLETED|Overall Study||12
3312119|NCT03060759|4045687|FG000|NOT COMPLETED|Overall Study||5
3312120|NCT03060759|4045688|FG001|NOT COMPLETED|Overall Study||3
3312121|NCT03061097|4045696|FG000|STARTED|Overall Study||4
3312122|NCT03061097|4045697|FG001|STARTED|Overall Study||3
3312123|NCT03061097|4045696|FG000|COMPLETED|Overall Study||4
3312124|NCT03061097|4045697|FG001|COMPLETED|Overall Study||0
3312125|NCT03061097|4045696|FG000|NOT COMPLETED|Overall Study||0
3312126|NCT03061097|4045697|FG001|NOT COMPLETED|Overall Study||3
3312127|NCT03061175|4045705|FG000|STARTED|Baseline||47
3312128|NCT03061175|4045706|FG001|STARTED|Baseline||47
3312129|NCT03061175|4045705|FG000|COMPLETED|Baseline||46
3312130|NCT03061175|4045706|FG001|COMPLETED|Baseline||47
3312131|NCT03061175|4045705|FG000|NOT COMPLETED|Baseline||1
3312132|NCT03061175|4045706|FG001|NOT COMPLETED|Baseline||0
3312133|NCT03061175|4045705|FG000|STARTED|Followup 1 at 2-4 Weeks Post-surgery|1 Participant dropped out of the study before the follow-up survey was to be sent|45
2850550|NCT00943852|3552712|FG000|STARTED|Second Period of Treatment Intervention||2
2850551|NCT00943852|3552713|FG001|STARTED|Second Period of Treatment Intervention||1
2850552|NCT00943852|3552714|FG002|STARTED|Second Period of Treatment Intervention||1
2850553|NCT00943852|3552715|FG003|STARTED|Second Period of Treatment Intervention||1
2850554|NCT00943852|3552716|FG004|STARTED|Second Period of Treatment Intervention||1
2850555|NCT00943852|3552717|FG005|STARTED|Second Period of Treatment Intervention||1
2850556|NCT00943852|3552718|FG006|STARTED|Second Period of Treatment Intervention||2
2850557|NCT00943852|3552719|FG007|STARTED|Second Period of Treatment Intervention||1
2850558|NCT00943852|3552720|FG008|STARTED|Second Period of Treatment Intervention||1
2850559|NCT00943852|3552721|FG009|STARTED|Second Period of Treatment Intervention||1
2850560|NCT00943852|3552712|FG000|COMPLETED|Second Period of Treatment Intervention||2
2850561|NCT00943852|3552713|FG001|COMPLETED|Second Period of Treatment Intervention||1
2850562|NCT00943852|3552714|FG002|COMPLETED|Second Period of Treatment Intervention||1
2850563|NCT00943852|3552715|FG003|COMPLETED|Second Period of Treatment Intervention||1
2850564|NCT00943852|3552716|FG004|COMPLETED|Second Period of Treatment Intervention||1
2850565|NCT00943852|3552717|FG005|COMPLETED|Second Period of Treatment Intervention||1
2850566|NCT00943852|3552718|FG006|COMPLETED|Second Period of Treatment Intervention||2
2850567|NCT00943852|3552719|FG007|COMPLETED|Second Period of Treatment Intervention||1
2850568|NCT00943852|3552720|FG008|COMPLETED|Second Period of Treatment Intervention||1
2850569|NCT00943852|3552721|FG009|COMPLETED|Second Period of Treatment Intervention||1
2850570|NCT00943852|3552712|FG000|NOT COMPLETED|Second Period of Treatment Intervention||0
2850571|NCT00943852|3552713|FG001|NOT COMPLETED|Second Period of Treatment Intervention||0
2850572|NCT00943852|3552714|FG002|NOT COMPLETED|Second Period of Treatment Intervention||0
2850573|NCT00943852|3552715|FG003|NOT COMPLETED|Second Period of Treatment Intervention||0
2850574|NCT00943852|3552716|FG004|NOT COMPLETED|Second Period of Treatment Intervention||0
2850575|NCT00943852|3552717|FG005|NOT COMPLETED|Second Period of Treatment Intervention||0
2850576|NCT00943852|3552718|FG006|NOT COMPLETED|Second Period of Treatment Intervention||0
2850577|NCT00943852|3552719|FG007|NOT COMPLETED|Second Period of Treatment Intervention||0
2850578|NCT00943852|3552720|FG008|NOT COMPLETED|Second Period of Treatment Intervention||0
2850579|NCT00943852|3552721|FG009|NOT COMPLETED|Second Period of Treatment Intervention||0
2850580|NCT00943852|3552712|FG000|STARTED|Washout Period After Period 2 Treatment||2
2850581|NCT00943852|3552713|FG001|STARTED|Washout Period After Period 2 Treatment||1
2850582|NCT00943852|3552714|FG002|STARTED|Washout Period After Period 2 Treatment||1
2850583|NCT00943852|3552715|FG003|STARTED|Washout Period After Period 2 Treatment||1
3312134|NCT03061175|4045706|FG001|STARTED|Followup 1 at 2-4 Weeks Post-surgery||47
3312135|NCT03061175|4045705|FG000|COMPLETED|Followup 1 at 2-4 Weeks Post-surgery|39 participants completed the follow-up survey out of the 45 who were sent the survey|39
3312136|NCT03061175|4045706|FG001|COMPLETED|Followup 1 at 2-4 Weeks Post-surgery|44 participants completed the follow-up survey out of the 47 who were sent the survey|44
3312137|NCT03061175|4045705|FG000|NOT COMPLETED|Followup 1 at 2-4 Weeks Post-surgery||6
3312138|NCT03061175|4045706|FG001|NOT COMPLETED|Followup 1 at 2-4 Weeks Post-surgery||3
3312139|NCT03061175|4045705|FG000|STARTED|Followup 2 at 6 Months|Participants who skipped the first follow-up survey were still sent the second FU survey|45
3312140|NCT03061175|4045706|FG001|STARTED|Followup 2 at 6 Months|1 participant withdrew from the study in between the 1st and 2nd follow-up survey so only 46 sent|46
3312141|NCT03061175|4045705|FG000|COMPLETED|Followup 2 at 6 Months|41 participants completed the 2nd follow-up survey out of the 45 who were sent the survey|41
3312142|NCT03061175|4045706|FG001|COMPLETED|Followup 2 at 6 Months|39 participants completed the follow-up survey out of the 46 who were sent the survey|39
3312143|NCT03061175|4045705|FG000|NOT COMPLETED|Followup 2 at 6 Months||4
3312144|NCT03061175|4045706|FG001|NOT COMPLETED|Followup 2 at 6 Months||7
3312145|NCT03061188|4045716|FG000|STARTED|Completed 1st Cycle||0
3312146|NCT03061188|4045717|FG001|STARTED|Completed 1st Cycle||3
3312147|NCT03061188|4045718|FG002|STARTED|Completed 1st Cycle||6
3312148|NCT03061188|4045719|FG003|STARTED|Completed 1st Cycle||6
3312149|NCT03061188|4045716|FG000|COMPLETED|Completed 1st Cycle||0
3312150|NCT03061188|4045717|FG001|COMPLETED|Completed 1st Cycle||3
3312151|NCT03061188|4045718|FG002|COMPLETED|Completed 1st Cycle||6
3312152|NCT03061188|4045719|FG003|COMPLETED|Completed 1st Cycle||6
3312153|NCT03061188|4045716|FG000|NOT COMPLETED|Completed 1st Cycle||0
3312154|NCT03061188|4045717|FG001|NOT COMPLETED|Completed 1st Cycle||0
3312155|NCT03061188|4045718|FG002|NOT COMPLETED|Completed 1st Cycle||0
3312156|NCT03061188|4045719|FG003|NOT COMPLETED|Completed 1st Cycle||0
3312157|NCT03061188|4045716|FG000|STARTED|Went on to Cycle 2 and Beyond||0
3312158|NCT03061188|4045717|FG001|STARTED|Went on to Cycle 2 and Beyond||3
3312159|NCT03061188|4045718|FG002|STARTED|Went on to Cycle 2 and Beyond||6
3312160|NCT03061188|4045719|FG003|STARTED|Went on to Cycle 2 and Beyond||6
3312161|NCT03061188|4045716|FG000|Received Dose of Study Drugs|Went on to Cycle 2 and Beyond||0
3312162|NCT03061188|4045717|FG001|Received Dose of Study Drugs|Went on to Cycle 2 and Beyond||3
3312163|NCT03061188|4045718|FG002|Received Dose of Study Drugs|Went on to Cycle 2 and Beyond||5
3312164|NCT03061188|4045719|FG003|Received Dose of Study Drugs|Went on to Cycle 2 and Beyond||5
3312165|NCT03061188|4045716|FG000|COMPLETED|Went on to Cycle 2 and Beyond||0
3312166|NCT03061188|4045717|FG001|COMPLETED|Went on to Cycle 2 and Beyond||3
3312167|NCT03061188|4045718|FG002|COMPLETED|Went on to Cycle 2 and Beyond||5
2850584|NCT00943852|3552716|FG004|STARTED|Washout Period After Period 2 Treatment||1
2850585|NCT00943852|3552717|FG005|STARTED|Washout Period After Period 2 Treatment||1
2850586|NCT00943852|3552718|FG006|STARTED|Washout Period After Period 2 Treatment||2
2850587|NCT00943852|3552719|FG007|STARTED|Washout Period After Period 2 Treatment||1
2850588|NCT00943852|3552720|FG008|STARTED|Washout Period After Period 2 Treatment||1
2850589|NCT00943852|3552721|FG009|STARTED|Washout Period After Period 2 Treatment||1
2850590|NCT00943852|3552712|FG000|COMPLETED|Washout Period After Period 2 Treatment||2
2850591|NCT00943852|3552713|FG001|COMPLETED|Washout Period After Period 2 Treatment||1
2850592|NCT00943852|3552714|FG002|COMPLETED|Washout Period After Period 2 Treatment||1
2850593|NCT00943852|3552715|FG003|COMPLETED|Washout Period After Period 2 Treatment||1
2850594|NCT00943852|3552716|FG004|COMPLETED|Washout Period After Period 2 Treatment||1
2850595|NCT00943852|3552717|FG005|COMPLETED|Washout Period After Period 2 Treatment||0
2850596|NCT00943852|3552718|FG006|COMPLETED|Washout Period After Period 2 Treatment||2
2850597|NCT00943852|3552719|FG007|COMPLETED|Washout Period After Period 2 Treatment||1
2850598|NCT00943852|3552720|FG008|COMPLETED|Washout Period After Period 2 Treatment||1
2850599|NCT00943852|3552721|FG009|COMPLETED|Washout Period After Period 2 Treatment||1
2850600|NCT00943852|3552712|FG000|NOT COMPLETED|Washout Period After Period 2 Treatment||0
2850601|NCT00943852|3552713|FG001|NOT COMPLETED|Washout Period After Period 2 Treatment||0
3168437|NCT01918774|3895727|FG000|NOT COMPLETED|Overall Study||5
3312168|NCT03061188|4045719|FG003|COMPLETED|Went on to Cycle 2 and Beyond||5
3312169|NCT03061188|4045716|FG000|NOT COMPLETED|Went on to Cycle 2 and Beyond||0
2850602|NCT00943852|3552714|FG002|NOT COMPLETED|Washout Period After Period 2 Treatment||0
2850603|NCT00943852|3552715|FG003|NOT COMPLETED|Washout Period After Period 2 Treatment||0
2850604|NCT00943852|3552716|FG004|NOT COMPLETED|Washout Period After Period 2 Treatment||0
2850605|NCT00943852|3552717|FG005|NOT COMPLETED|Washout Period After Period 2 Treatment||1
3312170|NCT03061188|4045717|FG001|NOT COMPLETED|Went on to Cycle 2 and Beyond||0
3312171|NCT03061188|4045718|FG002|NOT COMPLETED|Went on to Cycle 2 and Beyond||1
3312172|NCT03061188|4045719|FG003|NOT COMPLETED|Went on to Cycle 2 and Beyond||1
3312173|NCT03061188|4045716|FG000|STARTED|On Follow-up for 3 Years||0
3312174|NCT03061188|4045717|FG001|STARTED|On Follow-up for 3 Years||3
3312175|NCT03061188|4045718|FG002|STARTED|On Follow-up for 3 Years|Patients who received at least one dose of study drug go into follow-up.|6
3312176|NCT03061188|4045719|FG003|STARTED|On Follow-up for 3 Years|Patients who receive at least one dose of study drug go into follow-up.|6
3312177|NCT03061188|4045716|FG000|COMPLETED|On Follow-up for 3 Years||0
3312178|NCT03061188|4045717|FG001|COMPLETED|On Follow-up for 3 Years||0
3312179|NCT03061188|4045718|FG002|COMPLETED|On Follow-up for 3 Years||1
3312180|NCT03061188|4045719|FG003|COMPLETED|On Follow-up for 3 Years||1
3312181|NCT03061188|4045716|FG000|NOT COMPLETED|On Follow-up for 3 Years||0
3312182|NCT03061188|4045717|FG001|NOT COMPLETED|On Follow-up for 3 Years||3
3312183|NCT03061188|4045718|FG002|NOT COMPLETED|On Follow-up for 3 Years||5
3312184|NCT03061188|4045719|FG003|NOT COMPLETED|On Follow-up for 3 Years||5
3312185|NCT03061214|4045737|FG000|STARTED|Overall Study||288
3312186|NCT03061214|4045738|FG001|STARTED|Overall Study||290
3312187|NCT03061214|4045739|FG002|STARTED|Overall Study||290
3312188|NCT03061214|4045737|FG000|Exposed|Overall Study||287
3312189|NCT03061214|4045738|FG001|Exposed|Overall Study||290
3312190|NCT03061214|4045739|FG002|Exposed|Overall Study||290
3312191|NCT03061214|4045737|FG000|Full Analysis Set (FAS)|Overall Study||288
3312192|NCT03061214|4045738|FG001|Full Analysis Set (FAS)|Overall Study||290
3312193|NCT03061214|4045739|FG002|Full Analysis Set (FAS)|Overall Study||290
3312194|NCT03061214|4045737|FG000|Safety Analysis Set (SAS)|Overall Study||287
3312195|NCT03061214|4045738|FG001|Safety Analysis Set (SAS)|Overall Study||290
3312196|NCT03061214|4045739|FG002|Safety Analysis Set (SAS)|Overall Study||290
3312197|NCT03061214|4045737|FG000|COMPLETED|Overall Study||263
3312198|NCT03061214|4045738|FG001|COMPLETED|Overall Study||262
3312199|NCT03061214|4045739|FG002|COMPLETED|Overall Study||280
3312200|NCT03061214|4045737|FG000|NOT COMPLETED|Overall Study||25
3312201|NCT03061214|4045738|FG001|NOT COMPLETED|Overall Study||28
3312202|NCT03061214|4045739|FG002|NOT COMPLETED|Overall Study||10
3312203|NCT03061331|4045749|FG000|STARTED|Treatment Period 1 (8 Weeks)||10
3312204|NCT03061331|4045750|FG001|STARTED|Treatment Period 1 (8 Weeks)||10
3312205|NCT03061331|4045749|FG000|COMPLETED|Treatment Period 1 (8 Weeks)||10
3312206|NCT03061331|4045750|FG001|COMPLETED|Treatment Period 1 (8 Weeks)||10
3312207|NCT03061331|4045749|FG000|NOT COMPLETED|Treatment Period 1 (8 Weeks)||0
3312208|NCT03061331|4045750|FG001|NOT COMPLETED|Treatment Period 1 (8 Weeks)||0
3312209|NCT03061331|4045749|FG000|STARTED|Washout Period (8 Weeks)||10
3312210|NCT03061331|4045750|FG001|STARTED|Washout Period (8 Weeks)||10
3312211|NCT03061331|4045749|FG000|COMPLETED|Washout Period (8 Weeks)||8
3312212|NCT03061331|4045750|FG001|COMPLETED|Washout Period (8 Weeks)||9
3312213|NCT03061331|4045749|FG000|NOT COMPLETED|Washout Period (8 Weeks)||2
3312214|NCT03061331|4045750|FG001|NOT COMPLETED|Washout Period (8 Weeks)||1
3312215|NCT03061331|4045749|FG000|STARTED|Treatment Period 2 (8 Weeks)||8
3312216|NCT03061331|4045750|FG001|STARTED|Treatment Period 2 (8 Weeks)||9
3312217|NCT03061331|4045749|FG000|COMPLETED|Treatment Period 2 (8 Weeks)||8
3312218|NCT03061331|4045750|FG001|COMPLETED|Treatment Period 2 (8 Weeks)||9
3312219|NCT03061331|4045749|FG000|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0
3312220|NCT03061331|4045750|FG001|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0
3312221|NCT03061513|4045758|FG000|STARTED|Overall Study||6
3312222|NCT03061513|4045759|FG001|STARTED|Overall Study||5
3312223|NCT03061513|4045758|FG000|COMPLETED|Overall Study||6
3312224|NCT03061513|4045759|FG001|COMPLETED|Overall Study||4
3312225|NCT03061513|4045758|FG000|NOT COMPLETED|Overall Study||0
3312226|NCT03061513|4045759|FG001|NOT COMPLETED|Overall Study||1
3312227|NCT03061812|4045767|FG000|STARTED|Overall Study||148
2850606|NCT00943852|3552718|FG006|NOT COMPLETED|Washout Period After Period 2 Treatment||0
2850607|NCT00943852|3552719|FG007|NOT COMPLETED|Washout Period After Period 2 Treatment||0
2850608|NCT00943852|3552720|FG008|NOT COMPLETED|Washout Period After Period 2 Treatment||0
2850609|NCT00943852|3552721|FG009|NOT COMPLETED|Washout Period After Period 2 Treatment||0
2850610|NCT00943852|3552712|FG000|STARTED|Third Period of Treatment Intervention||2
2850611|NCT00943852|3552713|FG001|STARTED|Third Period of Treatment Intervention||1
2850612|NCT00943852|3552714|FG002|STARTED|Third Period of Treatment Intervention||1
2850613|NCT00943852|3552715|FG003|STARTED|Third Period of Treatment Intervention||1
2850614|NCT00943852|3552716|FG004|STARTED|Third Period of Treatment Intervention||1
2850615|NCT00943852|3552717|FG005|STARTED|Third Period of Treatment Intervention||0
2850616|NCT00943852|3552718|FG006|STARTED|Third Period of Treatment Intervention||2
2850617|NCT00943852|3552719|FG007|STARTED|Third Period of Treatment Intervention||1
2850618|NCT00943852|3552720|FG008|STARTED|Third Period of Treatment Intervention||1
2850619|NCT00943852|3552721|FG009|STARTED|Third Period of Treatment Intervention||1
2850620|NCT00943852|3552712|FG000|COMPLETED|Third Period of Treatment Intervention||2
2850621|NCT00943852|3552713|FG001|COMPLETED|Third Period of Treatment Intervention||1
2850622|NCT00943852|3552714|FG002|COMPLETED|Third Period of Treatment Intervention||1
2850623|NCT00943852|3552715|FG003|COMPLETED|Third Period of Treatment Intervention||1
2850624|NCT00943852|3552716|FG004|COMPLETED|Third Period of Treatment Intervention||1
2850625|NCT00943852|3552717|FG005|COMPLETED|Third Period of Treatment Intervention||0
2850626|NCT00943852|3552718|FG006|COMPLETED|Third Period of Treatment Intervention||2
2850627|NCT00943852|3552719|FG007|COMPLETED|Third Period of Treatment Intervention||1
2850628|NCT00943852|3552720|FG008|COMPLETED|Third Period of Treatment Intervention||1
2850629|NCT00943852|3552721|FG009|COMPLETED|Third Period of Treatment Intervention||1
2850630|NCT00943852|3552712|FG000|NOT COMPLETED|Third Period of Treatment Intervention||0
2850631|NCT00943852|3552713|FG001|NOT COMPLETED|Third Period of Treatment Intervention||0
2850632|NCT00943852|3552714|FG002|NOT COMPLETED|Third Period of Treatment Intervention||0
2850633|NCT00943852|3552715|FG003|NOT COMPLETED|Third Period of Treatment Intervention||0
2850634|NCT00943852|3552716|FG004|NOT COMPLETED|Third Period of Treatment Intervention||0
2850635|NCT00943852|3552717|FG005|NOT COMPLETED|Third Period of Treatment Intervention||0
2850636|NCT00943852|3552718|FG006|NOT COMPLETED|Third Period of Treatment Intervention||0
2850637|NCT00943852|3552719|FG007|NOT COMPLETED|Third Period of Treatment Intervention||0
3312228|NCT03061812|4045768|FG001|STARTED|Overall Study||296
3312229|NCT03061812|4045767|FG000|COMPLETED|Overall Study||148
3312230|NCT03061812|4045768|FG001|COMPLETED|Overall Study||296
3312231|NCT03061812|4045767|FG000|NOT COMPLETED|Overall Study||0
3312232|NCT03061812|4045768|FG001|NOT COMPLETED|Overall Study||0
3312233|NCT03062228|4045774|FG000|STARTED|Overall Study||162
3312234|NCT03062228|4045774|FG000|COMPLETED|Overall Study||162
3312235|NCT03062228|4045774|FG000|NOT COMPLETED|Overall Study||0
3312236|NCT03062267|4045780|FG000|STARTED|Overall Study||12
3312237|NCT03062267|4045781|FG001|STARTED|Overall Study||37
3312238|NCT03062267|4045780|FG000|COMPLETED|Overall Study||10
3312239|NCT03062267|4045781|FG001|COMPLETED|Overall Study||32
3312240|NCT03062267|4045780|FG000|NOT COMPLETED|Overall Study||2
3312241|NCT03062267|4045781|FG001|NOT COMPLETED|Overall Study||5
3312242|NCT03062488|4045790|FG000|STARTED|Overall Study||51
3312243|NCT03062488|4045791|FG001|STARTED|Overall Study||51
3312244|NCT03062488|4045792|FG002|STARTED|Overall Study||41
3312245|NCT03062488|4045790|FG000|COMPLETED|Overall Study||51
3312246|NCT03062488|4045791|FG001|COMPLETED|Overall Study||51
3312247|NCT03062488|4045792|FG002|COMPLETED|Overall Study||41
3312248|NCT03062488|4045790|FG000|NOT COMPLETED|Overall Study||0
3312249|NCT03062488|4045791|FG001|NOT COMPLETED|Overall Study||0
3312250|NCT03062488|4045792|FG002|NOT COMPLETED|Overall Study||0
3312251|NCT03062605|4045802|FG000|STARTED|Overall Study||25
3312252|NCT03062605|4045803|FG001|STARTED|Overall Study||23
3312253|NCT03062605|4045802|FG000|COMPLETED|Overall Study||14
3312254|NCT03062605|4045803|FG001|COMPLETED|Overall Study||13
3312255|NCT03062605|4045802|FG000|NOT COMPLETED|Overall Study||11
3312256|NCT03062605|4045803|FG001|NOT COMPLETED|Overall Study||10
3312257|NCT03062891|4045811|FG000|STARTED|Overall Study||99
3312258|NCT03062891|4045812|FG001|STARTED|Overall Study||100
3312259|NCT03062891|4045811|FG000|Mid-intervention|Overall Study||68
3312260|NCT03062891|4045812|FG001|Mid-intervention|Overall Study||74
3312261|NCT03062891|4045811|FG000|End of Intervention|Overall Study||67
3312262|NCT03062891|4045812|FG001|End of Intervention|Overall Study||78
3312263|NCT03062891|4045811|FG000|Followup|Overall Study||47
3312264|NCT03062891|4045812|FG001|Followup|Overall Study||62
3312265|NCT03062891|4045811|FG000|COMPLETED|Overall Study||47
3312266|NCT03062891|4045812|FG001|COMPLETED|Overall Study||62
3312267|NCT03062891|4045811|FG000|NOT COMPLETED|Overall Study||52
3312268|NCT03062891|4045812|FG001|NOT COMPLETED|Overall Study||38
3312269|NCT03062917|4045824|FG000|STARTED|Overall Study||32
3312270|NCT03062917|4045825|FG001|STARTED|Overall Study||51
3312271|NCT03062917|4045826|FG002|STARTED|Overall Study||49
3312272|NCT03062917|4045827|FG003|STARTED|Overall Study||20
3312273|NCT03062917|4045828|FG004|STARTED|Overall Study||0
3312274|NCT03062917|4045824|FG000|COMPLETED|Overall Study||32
3312275|NCT03062917|4045825|FG001|COMPLETED|Overall Study||51
3312276|NCT03062917|4045826|FG002|COMPLETED|Overall Study||49
3312277|NCT03062917|4045827|FG003|COMPLETED|Overall Study||20
3312278|NCT03062917|4045828|FG004|COMPLETED|Overall Study||0
3312279|NCT03062917|4045824|FG000|NOT COMPLETED|Overall Study||0
2850638|NCT00943852|3552720|FG008|NOT COMPLETED|Third Period of Treatment Intervention||0
2850639|NCT00943852|3552721|FG009|NOT COMPLETED|Third Period of Treatment Intervention||0
2850640|NCT00943852|3552712|FG000|STARTED|Washout Period After Period 3 Treatment||2
2850641|NCT00943852|3552713|FG001|STARTED|Washout Period After Period 3 Treatment||1
2850642|NCT00943852|3552714|FG002|STARTED|Washout Period After Period 3 Treatment||1
2850643|NCT00943852|3552715|FG003|STARTED|Washout Period After Period 3 Treatment||1
2850644|NCT00943852|3552716|FG004|STARTED|Washout Period After Period 3 Treatment||1
2850645|NCT00943852|3552717|FG005|STARTED|Washout Period After Period 3 Treatment||0
2850646|NCT00943852|3552718|FG006|STARTED|Washout Period After Period 3 Treatment||2
2850647|NCT00943852|3552719|FG007|STARTED|Washout Period After Period 3 Treatment||1
2850648|NCT00943852|3552720|FG008|STARTED|Washout Period After Period 3 Treatment||1
2850649|NCT00943852|3552721|FG009|STARTED|Washout Period After Period 3 Treatment||1
2850650|NCT00943852|3552712|FG000|COMPLETED|Washout Period After Period 3 Treatment||2
2850651|NCT00943852|3552713|FG001|COMPLETED|Washout Period After Period 3 Treatment||1
2850652|NCT00943852|3552714|FG002|COMPLETED|Washout Period After Period 3 Treatment||1
2850653|NCT00943852|3552715|FG003|COMPLETED|Washout Period After Period 3 Treatment||1
2850654|NCT00943852|3552716|FG004|COMPLETED|Washout Period After Period 3 Treatment||1
2850655|NCT00943852|3552717|FG005|COMPLETED|Washout Period After Period 3 Treatment||0
2850656|NCT00943852|3552718|FG006|COMPLETED|Washout Period After Period 3 Treatment||1
2850657|NCT00943852|3552719|FG007|COMPLETED|Washout Period After Period 3 Treatment||1
2850658|NCT00943852|3552720|FG008|COMPLETED|Washout Period After Period 3 Treatment||1
2850659|NCT00943852|3552721|FG009|COMPLETED|Washout Period After Period 3 Treatment||1
2850660|NCT00943852|3552712|FG000|NOT COMPLETED|Washout Period After Period 3 Treatment||0
2850661|NCT00943852|3552713|FG001|NOT COMPLETED|Washout Period After Period 3 Treatment||0
2850662|NCT00943852|3552714|FG002|NOT COMPLETED|Washout Period After Period 3 Treatment||0
2850663|NCT00943852|3552715|FG003|NOT COMPLETED|Washout Period After Period 3 Treatment||0
2850664|NCT00943852|3552716|FG004|NOT COMPLETED|Washout Period After Period 3 Treatment||0
2850665|NCT00943852|3552717|FG005|NOT COMPLETED|Washout Period After Period 3 Treatment||0
2850666|NCT00943852|3552718|FG006|NOT COMPLETED|Washout Period After Period 3 Treatment||1
2850667|NCT00943852|3552719|FG007|NOT COMPLETED|Washout Period After Period 3 Treatment||0
2850668|NCT00943852|3552720|FG008|NOT COMPLETED|Washout Period After Period 3 Treatment||0
2850669|NCT00943852|3552721|FG009|NOT COMPLETED|Washout Period After Period 3 Treatment||0
2850670|NCT00943852|3552712|FG000|STARTED|Fourth Period of Treatment Intervention||2
3312280|NCT03062917|4045825|FG001|NOT COMPLETED|Overall Study||0
3312281|NCT03062917|4045826|FG002|NOT COMPLETED|Overall Study||0
3312282|NCT03062917|4045827|FG003|NOT COMPLETED|Overall Study||0
3312283|NCT03062917|4045828|FG004|NOT COMPLETED|Overall Study||0
3312284|NCT03063086|4045839|FG000|STARTED|Overall Study||19
3312285|NCT03063086|4045840|FG001|STARTED|Overall Study||20
3312286|NCT03063086|4045841|FG002|STARTED|Overall Study||18
3312287|NCT03063086|4045842|FG003|STARTED|Overall Study||20
3312288|NCT03063086|4045843|FG004|STARTED|Overall Study||20
3312289|NCT03063086|4045844|FG005|STARTED|Overall Study||19
3312290|NCT03063086|4045839|FG000|COMPLETED|Overall Study||16
3312291|NCT03063086|4045840|FG001|COMPLETED|Overall Study||19
3312292|NCT03063086|4045841|FG002|COMPLETED|Overall Study||17
3312293|NCT03063086|4045842|FG003|COMPLETED|Overall Study||17
3312294|NCT03063086|4045843|FG004|COMPLETED|Overall Study||20
3312295|NCT03063086|4045844|FG005|COMPLETED|Overall Study||18
3312296|NCT03063086|4045839|FG000|NOT COMPLETED|Overall Study||3
3312297|NCT03063086|4045840|FG001|NOT COMPLETED|Overall Study||1
3312298|NCT03063086|4045841|FG002|NOT COMPLETED|Overall Study||1
3312299|NCT03063086|4045842|FG003|NOT COMPLETED|Overall Study||3
3312300|NCT03063086|4045843|FG004|NOT COMPLETED|Overall Study||0
3312301|NCT03063086|4045844|FG005|NOT COMPLETED|Overall Study||1
3312302|NCT03063125|4045853|FG000|STARTED|Overall Study||25
3312303|NCT03063125|4045853|FG000|COMPLETED|Overall Study||23
3312304|NCT03063125|4045853|FG000|NOT COMPLETED|Overall Study||2
3312305|NCT03063255|4045859|FG000|STARTED|Overall Study||30
3312306|NCT03063255|4045860|FG001|STARTED|Overall Study||30
3312307|NCT03063255|4045859|FG000|COMPLETED|Overall Study||29
3312308|NCT03063255|4045860|FG001|COMPLETED|Overall Study||30
3312309|NCT03063255|4045859|FG000|NOT COMPLETED|Overall Study||1
3312310|NCT03063255|4045860|FG001|NOT COMPLETED|Overall Study||0
3312311|NCT03063294|4045868|FG000|STARTED|Overall Study|2463 equals the sum of 1241 cross-sectional survey respondents at baseline and 1222 at follow-up.|2463
3312312|NCT03063294|4045869|FG001|STARTED|Overall Study|2502 equals the sum of 1243 cross-sectional survey respondents at baseline and 1259 at follow-up.|2502
3312313|NCT03063294|4045868|FG000|COMPLETED|Overall Study|2463 equals the sum of 1241 cross-sectional survey respondents at baseline and 1222 at follow-up.|2463
3312314|NCT03063294|4045869|FG001|COMPLETED|Overall Study|2502 equals the sum of 1243 cross-sectional survey respondents at baseline and 1259 at follow-up.|2502
3312315|NCT03063294|4045868|FG000|NOT COMPLETED|Overall Study||0
3312316|NCT03063294|4045869|FG001|NOT COMPLETED|Overall Study||0
3312317|NCT03063385|4045877|FG000|STARTED|Overall Study||330
3312318|NCT03063385|4045878|FG001|STARTED|Overall Study||330
3312319|NCT03063385|4045877|FG000|3-month Follow-up|Overall Study||257
3312320|NCT03063385|4045878|FG001|3-month Follow-up|Overall Study||259
3312321|NCT03063385|4045877|FG000|6-month Follow-up|Overall Study||265
3312322|NCT03063385|4045878|FG001|6-month Follow-up|Overall Study||259
3312323|NCT03063385|4045877|FG000|12-month Follow-up|Overall Study||243
3312324|NCT03063385|4045878|FG001|12-month Follow-up|Overall Study||254
3312325|NCT03063385|4045877|FG000|COMPLETED|Overall Study||243
2850671|NCT00943852|3552713|FG001|STARTED|Fourth Period of Treatment Intervention||1
2850672|NCT00943852|3552714|FG002|STARTED|Fourth Period of Treatment Intervention||1
2850673|NCT00943852|3552715|FG003|STARTED|Fourth Period of Treatment Intervention||1
2850674|NCT00943852|3552716|FG004|STARTED|Fourth Period of Treatment Intervention||1
2850675|NCT00943852|3552717|FG005|STARTED|Fourth Period of Treatment Intervention||0
2850676|NCT00943852|3552718|FG006|STARTED|Fourth Period of Treatment Intervention||1
2850677|NCT00943852|3552719|FG007|STARTED|Fourth Period of Treatment Intervention||1
2850678|NCT00943852|3552720|FG008|STARTED|Fourth Period of Treatment Intervention||1
2850679|NCT00943852|3552721|FG009|STARTED|Fourth Period of Treatment Intervention||1
2850680|NCT00943852|3552712|FG000|COMPLETED|Fourth Period of Treatment Intervention||2
2850681|NCT00943852|3552713|FG001|COMPLETED|Fourth Period of Treatment Intervention||1
2850682|NCT00943852|3552714|FG002|COMPLETED|Fourth Period of Treatment Intervention||1
2850683|NCT00943852|3552715|FG003|COMPLETED|Fourth Period of Treatment Intervention||1
2850684|NCT00943852|3552716|FG004|COMPLETED|Fourth Period of Treatment Intervention||1
2850685|NCT00943852|3552717|FG005|COMPLETED|Fourth Period of Treatment Intervention||0
2850686|NCT00943852|3552718|FG006|COMPLETED|Fourth Period of Treatment Intervention||1
2850687|NCT00943852|3552719|FG007|COMPLETED|Fourth Period of Treatment Intervention||1
3312326|NCT03063385|4045878|FG001|COMPLETED|Overall Study||254
3312327|NCT03063385|4045877|FG000|NOT COMPLETED|Overall Study||87
3312328|NCT03063385|4045878|FG001|NOT COMPLETED|Overall Study||76
3312329|NCT03063437|4045886|FG000|STARTED|Overall Study||4
3312330|NCT03063437|4045887|FG001|STARTED|Overall Study||5
3312331|NCT03063437|4045886|FG000|COMPLETED|Overall Study||4
3312332|NCT03063437|4045887|FG001|COMPLETED|Overall Study||5
3312333|NCT03063437|4045886|FG000|NOT COMPLETED|Overall Study||0
3312334|NCT03063437|4045887|FG001|NOT COMPLETED|Overall Study||0
3312335|NCT03063476|4045893|FG000|STARTED|Overall Study||2
3312336|NCT03063476|4045893|FG000|COMPLETED|Overall Study||2
3312337|NCT03063476|4045893|FG000|NOT COMPLETED|Overall Study||0
3312338|NCT03064152|4045899|FG000|STARTED|Overall Study||26
3312339|NCT03064152|4045900|FG001|STARTED|Overall Study||23
3312340|NCT03064152|4045899|FG000|COMPLETED|Overall Study||26
3312341|NCT03064152|4045900|FG001|COMPLETED|Overall Study||23
3312342|NCT03064152|4045899|FG000|NOT COMPLETED|Overall Study||0
3312343|NCT03064152|4045900|FG001|NOT COMPLETED|Overall Study||0
3312344|NCT03064438|4045908|FG000|STARTED|Overall Study||27
3312345|NCT03064438|4045909|FG001|STARTED|Overall Study||13
3312346|NCT03064438|4045908|FG000|COMPLETED|Overall Study||26
3312347|NCT03064438|4045909|FG001|COMPLETED|Overall Study||12
3312348|NCT03064438|4045908|FG000|NOT COMPLETED|Overall Study||1
3312349|NCT03064438|4045909|FG001|NOT COMPLETED|Overall Study||1
3312350|NCT03064451|4045915|FG000|STARTED|Overall Study||60
3312351|NCT03064451|4045915|FG000|Safety Population|Overall Study||52
3312352|NCT03064451|4045915|FG000|COMPLETED|Overall Study||46
3312353|NCT03064451|4045915|FG000|NOT COMPLETED|Overall Study||14
3312354|NCT03064841|4045919|FG000|STARTED|Overall Study||1537
3312355|NCT03064841|4045919|FG000|COMPLETED|Overall Study||1520
3312356|NCT03064841|4045919|FG000|NOT COMPLETED|Overall Study||17
3312357|NCT03065023|4045927|FG000|STARTED|Overall Study||3
3312358|NCT03065023|4045928|FG001|STARTED|Overall Study||3
3312359|NCT03065023|4045929|FG002|STARTED|Overall Study||3
3312360|NCT03065023|4045930|FG003|STARTED|Overall Study||6
3312361|NCT03065023|4045931|FG004|STARTED|Overall Study|Group B not started for business reasons.|0
3312362|NCT03065023|4045927|FG000|COMPLETED|Overall Study||1
3312363|NCT03065023|4045928|FG001|COMPLETED|Overall Study||1
3312364|NCT03065023|4045929|FG002|COMPLETED|Overall Study||2
3312365|NCT03065023|4045930|FG003|COMPLETED|Overall Study||3
3312366|NCT03065023|4045931|FG004|COMPLETED|Overall Study||0
3312367|NCT03065023|4045927|FG000|NOT COMPLETED|Overall Study||2
3312368|NCT03065023|4045928|FG001|NOT COMPLETED|Overall Study||2
3312369|NCT03065023|4045929|FG002|NOT COMPLETED|Overall Study||1
3312370|NCT03065023|4045930|FG003|NOT COMPLETED|Overall Study||3
3312371|NCT03065023|4045931|FG004|NOT COMPLETED|Overall Study||0
3312372|NCT03065075|4045943|FG000|STARTED|Overall Study||76
3312373|NCT03065075|4045944|FG001|STARTED|Overall Study||76
3312374|NCT03065075|4045943|FG000|Intent-to-treat Analysis|Overall Study||72
3312375|NCT03065075|4045944|FG001|Intent-to-treat Analysis|Overall Study||74
3312376|NCT03065075|4045943|FG000|As-treated Analysis|Overall Study||69
3312377|NCT03065075|4045944|FG001|As-treated Analysis|Overall Study||77
3312378|NCT03065075|4045943|FG000|COMPLETED|Overall Study||76
3312379|NCT03065075|4045944|FG001|COMPLETED|Overall Study||76
3312380|NCT03065075|4045943|FG000|NOT COMPLETED|Overall Study||0
3312381|NCT03065075|4045944|FG001|NOT COMPLETED|Overall Study||0
3312382|NCT03065179|4045950|FG000|STARTED|Overall Study||25
3312383|NCT03065179|4045950|FG000|COMPLETED|Overall Study||25
3312384|NCT03065179|4045950|FG000|NOT COMPLETED|Overall Study||0
3312385|NCT03065205|4045954|FG000|STARTED|Overall Study||65
3312386|NCT03065205|4045954|FG000|COMPLETED|Overall Study||53
3312387|NCT03065205|4045954|FG000|NOT COMPLETED|Overall Study||12
3312388|NCT03065283|4045961|FG000|STARTED|Overall Study||50
3312389|NCT03065283|4045962|FG001|STARTED|Overall Study||25
3312390|NCT03065283|4045961|FG000|COMPLETED|Overall Study||50
3312391|NCT03065283|4045962|FG001|COMPLETED|Overall Study||25
3312392|NCT03065283|4045961|FG000|NOT COMPLETED|Overall Study||0
3312393|NCT03065283|4045962|FG001|NOT COMPLETED|Overall Study||0
3312394|NCT03065400|4045968|FG000|STARTED|Overall Study||10
3312395|NCT03065400|4045968|FG000|COMPLETED|Overall Study||0
3312396|NCT03065400|4045968|FG000|NOT COMPLETED|Overall Study||10
2850688|NCT00943852|3552720|FG008|COMPLETED|Fourth Period of Treatment Intervention||1
2850689|NCT00943852|3552721|FG009|COMPLETED|Fourth Period of Treatment Intervention||1
2850690|NCT00943852|3552712|FG000|NOT COMPLETED|Fourth Period of Treatment Intervention||0
2850691|NCT00943852|3552713|FG001|NOT COMPLETED|Fourth Period of Treatment Intervention||0
2850692|NCT00943852|3552714|FG002|NOT COMPLETED|Fourth Period of Treatment Intervention||0
2850693|NCT00943852|3552715|FG003|NOT COMPLETED|Fourth Period of Treatment Intervention||0
2850694|NCT00943852|3552716|FG004|NOT COMPLETED|Fourth Period of Treatment Intervention||0
2850695|NCT00943852|3552717|FG005|NOT COMPLETED|Fourth Period of Treatment Intervention||0
2850696|NCT00943852|3552718|FG006|NOT COMPLETED|Fourth Period of Treatment Intervention||0
2850697|NCT00943852|3552719|FG007|NOT COMPLETED|Fourth Period of Treatment Intervention||0
2850698|NCT00943852|3552720|FG008|NOT COMPLETED|Fourth Period of Treatment Intervention||0
2850699|NCT00943852|3552721|FG009|NOT COMPLETED|Fourth Period of Treatment Intervention||0
2850700|NCT00943852|3552712|FG000|STARTED|Washout Period After Period 4 Treatment||2
2850701|NCT00943852|3552713|FG001|STARTED|Washout Period After Period 4 Treatment||1
2850702|NCT00943852|3552714|FG002|STARTED|Washout Period After Period 4 Treatment||1
2850703|NCT00943852|3552715|FG003|STARTED|Washout Period After Period 4 Treatment||1
2850704|NCT00943852|3552716|FG004|STARTED|Washout Period After Period 4 Treatment||1
2850705|NCT00943852|3552717|FG005|STARTED|Washout Period After Period 4 Treatment||0
2850706|NCT00943852|3552718|FG006|STARTED|Washout Period After Period 4 Treatment||1
2850707|NCT00943852|3552719|FG007|STARTED|Washout Period After Period 4 Treatment||1
2850708|NCT00943852|3552720|FG008|STARTED|Washout Period After Period 4 Treatment||1
2850709|NCT00943852|3552721|FG009|STARTED|Washout Period After Period 4 Treatment||1
2850710|NCT00943852|3552712|FG000|COMPLETED|Washout Period After Period 4 Treatment||1
2850711|NCT00943852|3552713|FG001|COMPLETED|Washout Period After Period 4 Treatment||1
2850712|NCT00943852|3552714|FG002|COMPLETED|Washout Period After Period 4 Treatment||0
2850713|NCT00943852|3552715|FG003|COMPLETED|Washout Period After Period 4 Treatment||0
2850714|NCT00943852|3552716|FG004|COMPLETED|Washout Period After Period 4 Treatment||1
2850715|NCT00943852|3552717|FG005|COMPLETED|Washout Period After Period 4 Treatment||0
2850716|NCT00943852|3552718|FG006|COMPLETED|Washout Period After Period 4 Treatment||0
2850717|NCT00943852|3552719|FG007|COMPLETED|Washout Period After Period 4 Treatment||0
2850718|NCT00943852|3552720|FG008|COMPLETED|Washout Period After Period 4 Treatment||1
2850719|NCT00943852|3552721|FG009|COMPLETED|Washout Period After Period 4 Treatment||1
2850720|NCT00943852|3552712|FG000|NOT COMPLETED|Washout Period After Period 4 Treatment||1
2850721|NCT00943852|3552713|FG001|NOT COMPLETED|Washout Period After Period 4 Treatment||0
3034272|NCT01131676|3753343|FG000|STARTED|Discontinuation From Treatment|Randomised|2337
3034273|NCT01131676|3753344|FG001|STARTED|Discontinuation From Treatment|Randomised|2347
3034274|NCT01131676|3753345|FG002|STARTED|Discontinuation From Treatment|Randomised|2344
3034275|NCT01131676|3753343|FG000|COMPLETED|Discontinuation From Treatment|Not prematurely discontinued from trial medication|1650
3034276|NCT01131676|3753344|FG001|COMPLETED|Discontinuation From Treatment|Not prematurely discontinued from trial medication|1790
3034277|NCT01131676|3753345|FG002|COMPLETED|Discontinuation From Treatment|Not prematurely discontinued from trial medication|1800
3034278|NCT01131676|3753343|FG000|NOT COMPLETED|Discontinuation From Treatment||687
3034279|NCT01131676|3753344|FG001|NOT COMPLETED|Discontinuation From Treatment||557
3312397|NCT03065530|4045976|FG000|STARTED|Overall Study||30
3312398|NCT03065530|4045977|FG001|STARTED|Overall Study||30
3312399|NCT03065530|4045978|FG002|STARTED|Overall Study||30
3312400|NCT03065530|4045979|FG003|STARTED|Overall Study||30
3312401|NCT03065530|4045976|FG000|COMPLETED|Overall Study||28
3312402|NCT03065530|4045977|FG001|COMPLETED|Overall Study||29
3312403|NCT03065530|4045978|FG002|COMPLETED|Overall Study||29
3312404|NCT03065530|4045979|FG003|COMPLETED|Overall Study||28
3312405|NCT03065530|4045976|FG000|NOT COMPLETED|Overall Study||2
3312406|NCT03065530|4045977|FG001|NOT COMPLETED|Overall Study||1
3312407|NCT03065530|4045978|FG002|NOT COMPLETED|Overall Study||1
3312408|NCT03065530|4045979|FG003|NOT COMPLETED|Overall Study||2
3312409|NCT03065647|4045999|FG000|STARTED|Overall Study||3
3312410|NCT03065647|4046000|FG001|STARTED|Overall Study||12
3312411|NCT03065647|4045999|FG000|COMPLETED|Overall Study||3
3312412|NCT03065647|4046000|FG001|COMPLETED|Overall Study||12
3034280|NCT01131676|3753345|FG002|NOT COMPLETED|Discontinuation From Treatment||544
3034281|NCT01131676|3753343|FG000|STARTED|Discontinuation From Study (Treated Set)||2333
3034282|NCT01131676|3753344|FG001|STARTED|Discontinuation From Study (Treated Set)||2345
3034283|NCT01131676|3753345|FG002|STARTED|Discontinuation From Study (Treated Set)||2342
3038337|NCT01153724|3757759|FG000|NOT COMPLETED|Treatment Period 1||1
3312413|NCT03065647|4045999|FG000|NOT COMPLETED|Overall Study||0
3312414|NCT03065647|4046000|FG001|NOT COMPLETED|Overall Study||0
3312415|NCT03066102|4046006|FG000|STARTED|Overall Study||30
3312416|NCT03066102|4046006|FG000|COMPLETED|Overall Study||30
3312417|NCT03066102|4046006|FG000|NOT COMPLETED|Overall Study||0
3312418|NCT03066193|4046010|FG000|STARTED|Overall Study||17
3312419|NCT03066193|4046010|FG000|COMPLETED|Overall Study||16
3312420|NCT03066193|4046010|FG000|NOT COMPLETED|Overall Study||1
3312421|NCT03066609|4046017|FG000|STARTED|INDUCTION||136
3312422|NCT03066609|4046018|FG001|STARTED|INDUCTION||272
3312423|NCT03066609|4046019|FG002|STARTED|INDUCTION||135
3312424|NCT03066609|4046020|FG003|STARTED|INDUCTION||0
3312425|NCT03066609|4046017|FG000|COMPLETED|INDUCTION||134
3312426|NCT03066609|4046018|FG001|COMPLETED|INDUCTION||270
3312427|NCT03066609|4046019|FG002|COMPLETED|INDUCTION||133
3312428|NCT03066609|4046020|FG003|COMPLETED|INDUCTION||0
3312429|NCT03066609|4046017|FG000|NOT COMPLETED|INDUCTION||2
2850722|NCT00943852|3552714|FG002|NOT COMPLETED|Washout Period After Period 4 Treatment||1
2850723|NCT00943852|3552715|FG003|NOT COMPLETED|Washout Period After Period 4 Treatment||1
2850724|NCT00943852|3552716|FG004|NOT COMPLETED|Washout Period After Period 4 Treatment||0
2850725|NCT00943852|3552717|FG005|NOT COMPLETED|Washout Period After Period 4 Treatment||0
2850726|NCT00943852|3552718|FG006|NOT COMPLETED|Washout Period After Period 4 Treatment||1
2850727|NCT00943852|3552719|FG007|NOT COMPLETED|Washout Period After Period 4 Treatment||1
2850728|NCT00943852|3552720|FG008|NOT COMPLETED|Washout Period After Period 4 Treatment||0
3312430|NCT03066609|4046018|FG001|NOT COMPLETED|INDUCTION||2
3312431|NCT03066609|4046019|FG002|NOT COMPLETED|INDUCTION||2
3312432|NCT03066609|4046020|FG003|NOT COMPLETED|INDUCTION||0
3312433|NCT03066609|4046017|FG000|STARTED|MAINTENANCE||134
3312434|NCT03066609|4046018|FG001|STARTED|MAINTENANCE||270
3312435|NCT03066609|4046019|FG002|STARTED|MAINTENANCE||4
3312436|NCT03066609|4046020|FG003|STARTED|MAINTENANCE||129
3312437|NCT03066609|4046017|FG000|COMPLETED|MAINTENANCE||127
3312438|NCT03066609|4046018|FG001|COMPLETED|MAINTENANCE||266
3312439|NCT03066609|4046019|FG002|COMPLETED|MAINTENANCE||2
3312440|NCT03066609|4046020|FG003|COMPLETED|MAINTENANCE||126
3312441|NCT03066609|4046017|FG000|NOT COMPLETED|MAINTENANCE||7
3312442|NCT03066609|4046018|FG001|NOT COMPLETED|MAINTENANCE||4
3312443|NCT03066609|4046019|FG002|NOT COMPLETED|MAINTENANCE||2
3312444|NCT03066609|4046020|FG003|NOT COMPLETED|MAINTENANCE||3
3312445|NCT03066609|4046017|FG000|STARTED|OVERALL STUDY||136
3312446|NCT03066609|4046018|FG001|STARTED|OVERALL STUDY||272
3312447|NCT03066609|4046019|FG002|STARTED|OVERALL STUDY||6
3312448|NCT03066609|4046020|FG003|STARTED|OVERALL STUDY||129
3312449|NCT03066609|4046017|FG000|COMPLETED|OVERALL STUDY||126
3312450|NCT03066609|4046018|FG001|COMPLETED|OVERALL STUDY||264
3312451|NCT03066609|4046019|FG002|COMPLETED|OVERALL STUDY||2
3312452|NCT03066609|4046020|FG003|COMPLETED|OVERALL STUDY||124
3312453|NCT03066609|4046017|FG000|NOT COMPLETED|OVERALL STUDY||10
3312454|NCT03066609|4046018|FG001|NOT COMPLETED|OVERALL STUDY||8
3312455|NCT03066609|4046019|FG002|NOT COMPLETED|OVERALL STUDY||4
3312456|NCT03066609|4046020|FG003|NOT COMPLETED|OVERALL STUDY||5
3312457|NCT03066778|4046033|FG000|STARTED|Overall Study||228
3312458|NCT03066778|4046034|FG001|STARTED|Overall Study||225
3312459|NCT03066778|4046033|FG000|Treated|Overall Study|1 participant randomized to the pembrolizumab+etoposide arm was treated with placebo+etoposide.|223
3312460|NCT03066778|4046034|FG001|Treated|Overall Study|1 participant randomized to the pembrolizumab+etoposide arm was treated with placebo+etoposide.|223
3312461|NCT03066778|4046033|FG000|COMPLETED|Overall Study||0
3312462|NCT03066778|4046034|FG001|COMPLETED|Overall Study||0
3312463|NCT03066778|4046033|FG000|NOT COMPLETED|Overall Study||228
3312464|NCT03066778|4046034|FG001|NOT COMPLETED|Overall Study||225
3312465|NCT03066804|4046042|FG000|STARTED|Overall Study||1286
3312466|NCT03066804|4046043|FG001|STARTED|Overall Study||1286
3312467|NCT03066804|4046042|FG000|COMPLETED|Overall Study||1235
3312468|NCT03066804|4046043|FG001|COMPLETED|Overall Study||1236
3312469|NCT03066804|4046042|FG000|NOT COMPLETED|Overall Study||51
3312470|NCT03066804|4046043|FG001|NOT COMPLETED|Overall Study||50
3312471|NCT03066830|4046052|FG000|STARTED|Overall Study||254
3312472|NCT03066830|4046053|FG001|STARTED|Overall Study||253
3312473|NCT03066830|4046052|FG000|COMPLETED|Overall Study||221
3312474|NCT03066830|4046053|FG001|COMPLETED|Overall Study||231
3312475|NCT03066830|4046052|FG000|NOT COMPLETED|Overall Study||33
3312476|NCT03066830|4046053|FG001|NOT COMPLETED|Overall Study||22
3312477|NCT03066947|4046060|FG000|STARTED|Overall Study||24
3312478|NCT03066947|4046060|FG000|COMPLETED|Overall Study||14
3312479|NCT03066947|4046060|FG000|NOT COMPLETED|Overall Study||10
3312480|NCT03066999|4046067|FG000|STARTED|Overall Study||2
3312481|NCT03066999|4046068|FG001|STARTED|Overall Study||3
3312482|NCT03066999|4046067|FG000|COMPLETED|Overall Study||2
3312483|NCT03066999|4046068|FG001|COMPLETED|Overall Study||1
3312484|NCT03066999|4046067|FG000|NOT COMPLETED|Overall Study||0
3312485|NCT03066999|4046068|FG001|NOT COMPLETED|Overall Study||2
3312486|NCT03067129|4046079|FG000|STARTED|Overall Study||47
3312487|NCT03067129|4046080|FG001|STARTED|Overall Study||29
3312488|NCT03067129|4046081|FG002|STARTED|Overall Study||27
3312489|NCT03067129|4046082|FG003|STARTED|Overall Study||24
3312490|NCT03067129|4046079|FG000|COMPLETED|Overall Study||2
3312491|NCT03067129|4046080|FG001|COMPLETED|Overall Study||1
3312492|NCT03067129|4046081|FG002|COMPLETED|Overall Study||0
3312493|NCT03067129|4046082|FG003|COMPLETED|Overall Study||0
3312494|NCT03067129|4046079|FG000|NOT COMPLETED|Overall Study||45
3312495|NCT03067129|4046080|FG001|NOT COMPLETED|Overall Study||28
3312496|NCT03067129|4046081|FG002|NOT COMPLETED|Overall Study||27
3312497|NCT03067129|4046082|FG003|NOT COMPLETED|Overall Study||24
3312498|NCT03067311|4046102|FG000|STARTED|Overall Study||19
3312499|NCT03067311|4046103|FG001|STARTED|Overall Study||19
3312500|NCT03067311|4046102|FG000|COMPLETED|Overall Study||17
3312501|NCT03067311|4046103|FG001|COMPLETED|Overall Study||17
3312502|NCT03067311|4046102|FG000|NOT COMPLETED|Overall Study||2
3312503|NCT03067311|4046103|FG001|NOT COMPLETED|Overall Study||2
3312504|NCT03067441|4046111|FG000|STARTED|Overall Study||492
3312505|NCT03067441|4046112|FG001|STARTED|Overall Study||970
3312506|NCT03067441|4046111|FG000|COMPLETED|Overall Study||459
3312507|NCT03067441|4046112|FG001|COMPLETED|Overall Study||913
3312508|NCT03067441|4046111|FG000|NOT COMPLETED|Overall Study||33
3312509|NCT03067441|4046112|FG001|NOT COMPLETED|Overall Study||57
3312510|NCT03067506|4046121|FG000|STARTED|Overall Study||30
3312511|NCT03067506|4046121|FG000|COMPLETED|Overall Study||30
2850729|NCT00943852|3552721|FG009|NOT COMPLETED|Washout Period After Period 4 Treatment||0
2850730|NCT00943852|3552712|FG000|STARTED|Fifth Period of Treatment Intervention||1
2850731|NCT00943852|3552713|FG001|STARTED|Fifth Period of Treatment Intervention||1
2850732|NCT00943852|3552714|FG002|STARTED|Fifth Period of Treatment Intervention||0
2850733|NCT00943852|3552715|FG003|STARTED|Fifth Period of Treatment Intervention||0
2850734|NCT00943852|3552716|FG004|STARTED|Fifth Period of Treatment Intervention||1
2850735|NCT00943852|3552717|FG005|STARTED|Fifth Period of Treatment Intervention||0
2850736|NCT00943852|3552718|FG006|STARTED|Fifth Period of Treatment Intervention||0
2850737|NCT00943852|3552719|FG007|STARTED|Fifth Period of Treatment Intervention||0
2850738|NCT00943852|3552720|FG008|STARTED|Fifth Period of Treatment Intervention||1
2850739|NCT00943852|3552721|FG009|STARTED|Fifth Period of Treatment Intervention||1
2850740|NCT00943852|3552712|FG000|COMPLETED|Fifth Period of Treatment Intervention||1
2850741|NCT00943852|3552713|FG001|COMPLETED|Fifth Period of Treatment Intervention||1
2850742|NCT00943852|3552714|FG002|COMPLETED|Fifth Period of Treatment Intervention||0
2850743|NCT00943852|3552715|FG003|COMPLETED|Fifth Period of Treatment Intervention||0
2850744|NCT00943852|3552716|FG004|COMPLETED|Fifth Period of Treatment Intervention||1
2850745|NCT00943852|3552717|FG005|COMPLETED|Fifth Period of Treatment Intervention||0
2850746|NCT00943852|3552718|FG006|COMPLETED|Fifth Period of Treatment Intervention||0
2850747|NCT00943852|3552719|FG007|COMPLETED|Fifth Period of Treatment Intervention||0
2850748|NCT00943852|3552720|FG008|COMPLETED|Fifth Period of Treatment Intervention||1
2850749|NCT00943852|3552721|FG009|COMPLETED|Fifth Period of Treatment Intervention||1
2850750|NCT00943852|3552712|FG000|NOT COMPLETED|Fifth Period of Treatment Intervention||0
2850751|NCT00943852|3552713|FG001|NOT COMPLETED|Fifth Period of Treatment Intervention||0
2850752|NCT00943852|3552714|FG002|NOT COMPLETED|Fifth Period of Treatment Intervention||0
2850753|NCT00943852|3552715|FG003|NOT COMPLETED|Fifth Period of Treatment Intervention||0
2850754|NCT00943852|3552716|FG004|NOT COMPLETED|Fifth Period of Treatment Intervention||0
2850755|NCT00943852|3552717|FG005|NOT COMPLETED|Fifth Period of Treatment Intervention||0
2850756|NCT00943852|3552718|FG006|NOT COMPLETED|Fifth Period of Treatment Intervention||0
2850757|NCT00943852|3552719|FG007|NOT COMPLETED|Fifth Period of Treatment Intervention||0
2850758|NCT00943852|3552720|FG008|NOT COMPLETED|Fifth Period of Treatment Intervention||0
2850759|NCT00943852|3552721|FG009|NOT COMPLETED|Fifth Period of Treatment Intervention||0
2850760|NCT00927953|3552733|FG000|STARTED|Overall Study||6
2850761|NCT00927953|3552734|FG001|STARTED|Overall Study||7
3312512|NCT03067506|4046121|FG000|NOT COMPLETED|Overall Study||0
3312513|NCT03067948|4046125|FG000|STARTED|Overall Study||32
3312514|NCT03067948|4046125|FG000|COMPLETED|Overall Study||32
3312515|NCT03067948|4046125|FG000|NOT COMPLETED|Overall Study||0
3312516|NCT03067987|4046131|FG000|STARTED|Overall Study||50
3312517|NCT03067987|4046132|FG001|STARTED|Overall Study||53
3312518|NCT03067987|4046131|FG000|COMPLETED|Overall Study||40
3312519|NCT03067987|4046132|FG001|COMPLETED|Overall Study||40
3312520|NCT03067987|4046131|FG000|NOT COMPLETED|Overall Study||10
3312521|NCT03067987|4046132|FG001|NOT COMPLETED|Overall Study||13
3312522|NCT03068091|4046138|FG000|STARTED|Overall Study||25
3312523|NCT03068091|4046138|FG000|COMPLETED|Overall Study||24
3312524|NCT03068091|4046138|FG000|NOT COMPLETED|Overall Study||1
3312525|NCT03068312|4046145|FG000|STARTED|Overall Study||19
3312526|NCT03068312|4046146|FG001|STARTED|Overall Study||19
3312527|NCT03068312|4046145|FG000|COMPLETED|Overall Study||19
3312528|NCT03068312|4046146|FG001|COMPLETED|Overall Study||19
3312529|NCT03068312|4046145|FG000|NOT COMPLETED|Overall Study||0
3312530|NCT03068312|4046146|FG001|NOT COMPLETED|Overall Study||0
3312531|NCT03068455|4046154|FG000|STARTED|Pre-treatment Period||920
3312532|NCT03068455|4046155|FG001|STARTED|Pre-treatment Period||924
3312533|NCT03068455|4046154|FG000|COMPLETED|Pre-treatment Period||916
3312534|NCT03068455|4046155|FG001|COMPLETED|Pre-treatment Period||917
3312535|NCT03068455|4046154|FG000|NOT COMPLETED|Pre-treatment Period||4
3312536|NCT03068455|4046155|FG001|NOT COMPLETED|Pre-treatment Period||7
3312537|NCT03068455|4046154|FG000|STARTED|Treatment Period||916
3312538|NCT03068455|4046155|FG001|STARTED|Treatment Period||917
3312539|NCT03068455|4046154|FG000|COMPLETED|Treatment Period||364
3312540|NCT03068455|4046155|FG001|COMPLETED|Treatment Period||561
3312541|NCT03068455|4046154|FG000|NOT COMPLETED|Treatment Period||552
3312542|NCT03068455|4046155|FG001|NOT COMPLETED|Treatment Period||356
3312543|NCT03068468|4046163|FG000|STARTED|Placebo-Controlled Period||166
3312544|NCT03068468|4046164|FG001|STARTED|Placebo-Controlled Period||324
3312545|NCT03068468|4046165|FG002|STARTED|Placebo-Controlled Period||0
3312546|NCT03068468|4046166|FG003|STARTED|Placebo-Controlled Period||0
3312547|NCT03068468|4046163|FG000|Treated|Placebo-Controlled Period||165
3312548|NCT03068468|4046164|FG001|Treated|Placebo-Controlled Period||321
3312549|NCT03068468|4046165|FG002|Treated|Placebo-Controlled Period||0
3312550|NCT03068468|4046166|FG003|Treated|Placebo-Controlled Period||0
3312551|NCT03068468|4046163|FG000|COMPLETED|Placebo-Controlled Period||144
3312552|NCT03068468|4046164|FG001|COMPLETED|Placebo-Controlled Period||279
3312553|NCT03068468|4046165|FG002|COMPLETED|Placebo-Controlled Period||0
3312554|NCT03068468|4046166|FG003|COMPLETED|Placebo-Controlled Period||0
3312555|NCT03068468|4046163|FG000|NOT COMPLETED|Placebo-Controlled Period||22
3312556|NCT03068468|4046164|FG001|NOT COMPLETED|Placebo-Controlled Period||45
3312557|NCT03068468|4046165|FG002|NOT COMPLETED|Placebo-Controlled Period||0
3312558|NCT03068468|4046166|FG003|NOT COMPLETED|Placebo-Controlled Period||0
3312559|NCT03068468|4046163|FG000|STARTED|Open-Label Extension Period||0
3312560|NCT03068468|4046164|FG001|STARTED|Open-Label Extension Period||0
2850762|NCT00927953|3552733|FG000|COMPLETED|Overall Study||4
2850763|NCT00927953|3552734|FG001|COMPLETED|Overall Study||6
2850764|NCT00927953|3552733|FG000|NOT COMPLETED|Overall Study||2
2850765|NCT00927953|3552734|FG001|NOT COMPLETED|Overall Study||1
2850766|NCT00909389|3552741|FG000|STARTED|Overall Study||4748
2850767|NCT00909389|3552741|FG000|COMPLETED|Overall Study||4615
2850768|NCT00909389|3552741|FG000|NOT COMPLETED|Overall Study||133
2850775|NCT00820027|3552758|FG000|STARTED|Overall Study||224
2850776|NCT00820027|3552759|FG001|STARTED|Overall Study||230
2850777|NCT00820027|3552760|FG002|STARTED|Overall Study||224
2850778|NCT00820027|3552761|FG003|STARTED|Overall Study||98
2850779|NCT00820027|3552758|FG000|COMPLETED|Overall Study||198
2850780|NCT00820027|3552759|FG001|COMPLETED|Overall Study||216
2850781|NCT00820027|3552760|FG002|COMPLETED|Overall Study||203
2850782|NCT00820027|3552761|FG003|COMPLETED|Overall Study||85
2850783|NCT00820027|3552758|FG000|NOT COMPLETED|Overall Study||26
2850784|NCT00820027|3552759|FG001|NOT COMPLETED|Overall Study||14
2850785|NCT00820027|3552760|FG002|NOT COMPLETED|Overall Study||21
2850786|NCT00820027|3552761|FG003|NOT COMPLETED|Overall Study||13
2850787|NCT00788710|3552775|FG000|STARTED|Overall Study||144
2850788|NCT00788710|3552776|FG001|STARTED|Overall Study||142
2850789|NCT00788710|3552777|FG002|STARTED|Overall Study||144
2850790|NCT00788710|3552775|FG000|COMPLETED|Overall Study||139
2850791|NCT00788710|3552776|FG001|COMPLETED|Overall Study||134
2850792|NCT00788710|3552777|FG002|COMPLETED|Overall Study||138
2850793|NCT00788710|3552775|FG000|NOT COMPLETED|Overall Study||5
2850794|NCT00788710|3552776|FG001|NOT COMPLETED|Overall Study||8
2850795|NCT00788710|3552777|FG002|NOT COMPLETED|Overall Study||6
2850796|NCT00785291|3552788|FG000|STARTED|Overall Study||283
2850797|NCT00785291|3552789|FG001|STARTED|Overall Study||271
2850798|NCT00785291|3552790|FG002|STARTED|Overall Study||245
2850799|NCT00785291|3552788|FG000|COMPLETED|Overall Study||147
2850800|NCT00785291|3552789|FG001|COMPLETED|Overall Study||122
2850801|NCT00785291|3552790|FG002|COMPLETED|Overall Study||139
3312561|NCT03068468|4046165|FG002|STARTED|Open-Label Extension Period|4 participants did not enter OLE period.|140
3312562|NCT03068468|4046166|FG003|STARTED|Open-Label Extension Period|3 participants did not enter OLE period.|276
3312563|NCT03068468|4046163|FG000|COMPLETED|Open-Label Extension Period||0
3312564|NCT03068468|4046164|FG001|COMPLETED|Open-Label Extension Period||0
3312565|NCT03068468|4046165|FG002|COMPLETED|Open-Label Extension Period||0
3312566|NCT03068468|4046166|FG003|COMPLETED|Open-Label Extension Period||0
3312567|NCT03068468|4046163|FG000|NOT COMPLETED|Open-Label Extension Period||0
3312568|NCT03068468|4046164|FG001|NOT COMPLETED|Open-Label Extension Period||0
3312569|NCT03068468|4046165|FG002|NOT COMPLETED|Open-Label Extension Period||140
3312570|NCT03068468|4046166|FG003|NOT COMPLETED|Open-Label Extension Period||276
3312571|NCT03068611|4046176|FG000|STARTED|Overall Study||61
3312572|NCT03068611|4046177|FG001|STARTED|Overall Study||58
3312573|NCT03068611|4046176|FG000|COMPLETED|Overall Study|This is the number of participants followed through 6 months from enrollment.|30
3312574|NCT03068611|4046177|FG001|COMPLETED|Overall Study|This is the number of participants followed through 6 months from enrollment.|33
3312575|NCT03068611|4046176|FG000|NOT COMPLETED|Overall Study||31
3312576|NCT03068611|4046177|FG001|NOT COMPLETED|Overall Study||25
3312577|NCT03068715|4046185|FG000|STARTED|Overall Study||15
3312578|NCT03068715|4046186|FG001|STARTED|Overall Study||15
3312579|NCT03068715|4046185|FG000|COMPLETED|Overall Study||14
3312580|NCT03068715|4046186|FG001|COMPLETED|Overall Study||15
3312581|NCT03068715|4046185|FG000|NOT COMPLETED|Overall Study||1
3312582|NCT03068715|4046186|FG001|NOT COMPLETED|Overall Study||0
3312583|NCT03068754|4046196|FG000|STARTED|Randomized Treatment Period (RTP)||95
3312584|NCT03068754|4046197|FG001|STARTED|Randomized Treatment Period (RTP)||48
3312585|NCT03068754|4046198|FG002|STARTED|Randomized Treatment Period (RTP)|OLE Arms were not included during the RTP|0
3312586|NCT03068754|4046199|FG003|STARTED|Randomized Treatment Period (RTP)||0
3312587|NCT03068754|4046196|FG000|Intention to Treat (ITT) Population|Randomized Treatment Period (RTP)||95
3312588|NCT03068754|4046197|FG001|Intention to Treat (ITT) Population|Randomized Treatment Period (RTP)||48
3312589|NCT03068754|4046198|FG002|Intention to Treat (ITT) Population|Randomized Treatment Period (RTP)||0
3312590|NCT03068754|4046199|FG003|Intention to Treat (ITT) Population|Randomized Treatment Period (RTP)||0
3312591|NCT03068754|4046196|FG000|Safety Population|Randomized Treatment Period (RTP)||95
3312592|NCT03068754|4046197|FG001|Safety Population|Randomized Treatment Period (RTP)||47
3312593|NCT03068754|4046198|FG002|Safety Population|Randomized Treatment Period (RTP)||0
3312594|NCT03068754|4046199|FG003|Safety Population|Randomized Treatment Period (RTP)||0
3312595|NCT03068754|4046196|FG000|Modified ITT (mITT)|Randomized Treatment Period (RTP)||93
3312596|NCT03068754|4046197|FG001|Modified ITT (mITT)|Randomized Treatment Period (RTP)||46
3312597|NCT03068754|4046198|FG002|Modified ITT (mITT)|Randomized Treatment Period (RTP)||0
3312598|NCT03068754|4046199|FG003|Modified ITT (mITT)|Randomized Treatment Period (RTP)||0
3312599|NCT03068754|4046196|FG000|Completed Taper|Randomized Treatment Period (RTP)||58
3312600|NCT03068754|4046197|FG001|Completed Taper|Randomized Treatment Period (RTP)||28
2850802|NCT00785291|3552788|FG000|NOT COMPLETED|Overall Study||136
2850803|NCT00785291|3552789|FG001|NOT COMPLETED|Overall Study||149
2850804|NCT00785291|3552790|FG002|NOT COMPLETED|Overall Study||106
2850805|NCT00783224|3552802|FG000|STARTED|Overall Study||32
2850806|NCT00783224|3552803|FG001|STARTED|Overall Study||34
2850807|NCT00783224|3552804|FG002|STARTED|Overall Study||143
2850808|NCT00783224|3552805|FG003|STARTED|Overall Study||142
2850809|NCT00783224|3552802|FG000|COMPLETED|Overall Study||32
2850810|NCT00783224|3552803|FG001|COMPLETED|Overall Study||34
2850811|NCT00783224|3552804|FG002|COMPLETED|Overall Study||142
2850812|NCT00783224|3552805|FG003|COMPLETED|Overall Study||140
2850813|NCT00783224|3552802|FG000|NOT COMPLETED|Overall Study||0
2850814|NCT00783224|3552803|FG001|NOT COMPLETED|Overall Study||0
2850815|NCT00783224|3552804|FG002|NOT COMPLETED|Overall Study||1
2850816|NCT00783224|3552805|FG003|NOT COMPLETED|Overall Study||2
2850817|NCT00780403|3552814|FG000|STARTED|First Intervention||109
2850818|NCT00780403|3552815|FG001|STARTED|First Intervention||111
2850819|NCT00780403|3552814|FG000|COMPLETED|First Intervention||109
2850820|NCT00780403|3552815|FG001|COMPLETED|First Intervention||111
2850821|NCT00780403|3552814|FG000|NOT COMPLETED|First Intervention||0
2850822|NCT00780403|3552815|FG001|NOT COMPLETED|First Intervention||0
2850823|NCT00780403|3552814|FG000|STARTED|Interval Between Doses (8-10 Minutes)||109
2850824|NCT00780403|3552815|FG001|STARTED|Interval Between Doses (8-10 Minutes)||111
2850825|NCT00780403|3552814|FG000|COMPLETED|Interval Between Doses (8-10 Minutes)||109
2850826|NCT00780403|3552815|FG001|COMPLETED|Interval Between Doses (8-10 Minutes)||111
2850827|NCT00780403|3552814|FG000|NOT COMPLETED|Interval Between Doses (8-10 Minutes)||0
3312601|NCT03068754|4046198|FG002|Completed Taper|Randomized Treatment Period (RTP)||0
3312602|NCT03068754|4046199|FG003|Completed Taper|Randomized Treatment Period (RTP)||0
3312603|NCT03068754|4046196|FG000|Completed 36 Weeks of Treatment|Randomized Treatment Period (RTP)||28
3312604|NCT03068754|4046197|FG001|Completed 36 Weeks of Treatment|Randomized Treatment Period (RTP)||9
3312605|NCT03068754|4046198|FG002|Completed 36 Weeks of Treatment|Randomized Treatment Period (RTP)||0
3312606|NCT03068754|4046199|FG003|Completed 36 Weeks of Treatment|Randomized Treatment Period (RTP)||0
3312607|NCT03068754|4046196|FG000|Completed RTP|Randomized Treatment Period (RTP)||27
3312608|NCT03068754|4046197|FG001|Completed RTP|Randomized Treatment Period (RTP)||9
3312609|NCT03068754|4046198|FG002|Completed RTP|Randomized Treatment Period (RTP)||0
3312610|NCT03068754|4046199|FG003|Completed RTP|Randomized Treatment Period (RTP)||0
3312611|NCT03068754|4046196|FG000|Enrolled in OLE Period|Randomized Treatment Period (RTP)||25
3312612|NCT03068754|4046197|FG001|Enrolled in OLE Period|Randomized Treatment Period (RTP)||8
3312613|NCT03068754|4046198|FG002|Enrolled in OLE Period|Randomized Treatment Period (RTP)||0
3312614|NCT03068754|4046199|FG003|Enrolled in OLE Period|Randomized Treatment Period (RTP)||0
3312615|NCT03068754|4046196|FG000|COMPLETED|Randomized Treatment Period (RTP)||28
3312616|NCT03068754|4046197|FG001|COMPLETED|Randomized Treatment Period (RTP)||9
3312617|NCT03068754|4046198|FG002|COMPLETED|Randomized Treatment Period (RTP)||0
3312618|NCT03068754|4046199|FG003|COMPLETED|Randomized Treatment Period (RTP)||0
3312619|NCT03068754|4046196|FG000|NOT COMPLETED|Randomized Treatment Period (RTP)||67
3312620|NCT03068754|4046197|FG001|NOT COMPLETED|Randomized Treatment Period (RTP)||39
3312621|NCT03068754|4046198|FG002|NOT COMPLETED|Randomized Treatment Period (RTP)||0
3312622|NCT03068754|4046199|FG003|NOT COMPLETED|Randomized Treatment Period (RTP)||0
3312623|NCT03068754|4046196|FG000|STARTED|Open Label Extension Period (OLE)|RTP arms were not included during the OLE period|0
3312624|NCT03068754|4046197|FG001|STARTED|Open Label Extension Period (OLE)||0
3312625|NCT03068754|4046198|FG002|STARTED|Open Label Extension Period (OLE)||25
3312626|NCT03068754|4046199|FG003|STARTED|Open Label Extension Period (OLE)||8
3312627|NCT03068754|4046196|FG000|Completed Taper|Open Label Extension Period (OLE)||0
3312628|NCT03068754|4046197|FG001|Completed Taper|Open Label Extension Period (OLE)||0
3312629|NCT03068754|4046198|FG002|Completed Taper|Open Label Extension Period (OLE)||19
3312630|NCT03068754|4046199|FG003|Completed Taper|Open Label Extension Period (OLE)||7
3312631|NCT03068754|4046196|FG000|Completed OLE Period|Open Label Extension Period (OLE)||0
3312632|NCT03068754|4046197|FG001|Completed OLE Period|Open Label Extension Period (OLE)||0
3312633|NCT03068754|4046198|FG002|Completed OLE Period|Open Label Extension Period (OLE)||3
3312634|NCT03068754|4046199|FG003|Completed OLE Period|Open Label Extension Period (OLE)||2
3312635|NCT03068754|4046196|FG000|Completed Treatment in OLE|Open Label Extension Period (OLE)||0
3312636|NCT03068754|4046197|FG001|Completed Treatment in OLE|Open Label Extension Period (OLE)||0
3312637|NCT03068754|4046198|FG002|Completed Treatment in OLE|Open Label Extension Period (OLE)||4
3312638|NCT03068754|4046199|FG003|Completed Treatment in OLE|Open Label Extension Period (OLE)||2
3312639|NCT03068754|4046196|FG000|COMPLETED|Open Label Extension Period (OLE)||0
3312640|NCT03068754|4046197|FG001|COMPLETED|Open Label Extension Period (OLE)||0
3312641|NCT03068754|4046198|FG002|COMPLETED|Open Label Extension Period (OLE)||4
3312642|NCT03068754|4046199|FG003|COMPLETED|Open Label Extension Period (OLE)||2
3312643|NCT03068754|4046196|FG000|NOT COMPLETED|Open Label Extension Period (OLE)||0
3312644|NCT03068754|4046197|FG001|NOT COMPLETED|Open Label Extension Period (OLE)||0
3312645|NCT03068754|4046198|FG002|NOT COMPLETED|Open Label Extension Period (OLE)||21
3312646|NCT03068754|4046199|FG003|NOT COMPLETED|Open Label Extension Period (OLE)||6
3312647|NCT03068767|4046211|FG000|STARTED|Overall Study|from August 2017 to September 2018|75
3312648|NCT03068767|4046212|FG001|STARTED|Overall Study|from August 2017 to September 2018|74
3312649|NCT03068767|4046211|FG000|COMPLETED|Overall Study|December 2018|65
3312650|NCT03068767|4046212|FG001|COMPLETED|Overall Study|December 2018|71
3312651|NCT03068767|4046211|FG000|NOT COMPLETED|Overall Study||10
3312652|NCT03068767|4046212|FG001|NOT COMPLETED|Overall Study||3
2850828|NCT00780403|3552815|FG001|NOT COMPLETED|Interval Between Doses (8-10 Minutes)||0
2850829|NCT00780403|3552814|FG000|STARTED|Second Intervention||109
2850830|NCT00780403|3552815|FG001|STARTED|Second Intervention||111
2850831|NCT00780403|3552814|FG000|COMPLETED|Second Intervention||109
2850832|NCT00780403|3552815|FG001|COMPLETED|Second Intervention||111
2850833|NCT00780403|3552814|FG000|NOT COMPLETED|Second Intervention||0
2850834|NCT00780403|3552815|FG001|NOT COMPLETED|Second Intervention||0
2850835|NCT00779116|3552822|FG000|STARTED|First Intervention||109
2850836|NCT00779116|3552823|FG001|STARTED|First Intervention||108
2850837|NCT00779116|3552822|FG000|COMPLETED|First Intervention||109
2850838|NCT00779116|3552823|FG001|COMPLETED|First Intervention||108
2850839|NCT00779116|3552822|FG000|NOT COMPLETED|First Intervention||0
3312653|NCT03068897|4046222|FG000|STARTED|Overall Study||80
3312654|NCT03068897|4046223|FG001|STARTED|Overall Study||80
3312655|NCT03068897|4046224|FG002|STARTED|Overall Study||80
3312656|NCT03068897|4046225|FG003|STARTED|Overall Study||80
3312657|NCT03068897|4046222|FG000|COMPLETED|Overall Study||76
3312658|NCT03068897|4046223|FG001|COMPLETED|Overall Study||76
3312659|NCT03068897|4046224|FG002|COMPLETED|Overall Study||79
3312660|NCT03068897|4046225|FG003|COMPLETED|Overall Study||74
3312661|NCT03068897|4046222|FG000|NOT COMPLETED|Overall Study||4
3312662|NCT03068897|4046223|FG001|NOT COMPLETED|Overall Study||4
3312663|NCT03068897|4046224|FG002|NOT COMPLETED|Overall Study||1
3312664|NCT03068897|4046225|FG003|NOT COMPLETED|Overall Study||6
3312665|NCT03068949|4046239|FG000|STARTED|Overall Study||113
3312666|NCT03068949|4046240|FG001|STARTED|Overall Study||102
3312667|NCT03068949|4046241|FG002|STARTED|Overall Study||122
3312668|NCT03068949|4046242|FG003|STARTED|Overall Study||76
3312669|NCT03068949|4046239|FG000|COMPLETED|Overall Study||105
3312670|NCT03068949|4046240|FG001|COMPLETED|Overall Study||90
3312671|NCT03068949|4046241|FG002|COMPLETED|Overall Study||113
3312672|NCT03068949|4046242|FG003|COMPLETED|Overall Study||63
3312673|NCT03068949|4046239|FG000|NOT COMPLETED|Overall Study||8
3312674|NCT03068949|4046240|FG001|NOT COMPLETED|Overall Study||12
3312675|NCT03068949|4046241|FG002|NOT COMPLETED|Overall Study||9
3312676|NCT03068949|4046242|FG003|NOT COMPLETED|Overall Study||13
3312677|NCT03069313|4046252|FG000|STARTED|Overall Study||41
3312678|NCT03069313|4046252|FG000|COMPLETED|Overall Study||36
3312679|NCT03069313|4046252|FG000|NOT COMPLETED|Overall Study||5
3312680|NCT03069352|4046258|FG000|STARTED|Overall Study||68
3312681|NCT03069352|4046259|FG001|STARTED|Overall Study||143
3312682|NCT03069352|4046258|FG000|Received Treatment|Overall Study||68
3312683|NCT03069352|4046259|FG001|Received Treatment|Overall Study||142
3312684|NCT03069352|4046258|FG000|COMPLETED|Overall Study||56
3312685|NCT03069352|4046259|FG001|COMPLETED|Overall Study||103
3312686|NCT03069352|4046258|FG000|NOT COMPLETED|Overall Study||12
3312687|NCT03069352|4046259|FG001|NOT COMPLETED|Overall Study||40
3312688|NCT03069365|4046265|FG000|STARTED|Overall Study||101
3312689|NCT03069365|4046265|FG000|COMPLETED|Overall Study||100
3312690|NCT03069365|4046265|FG000|NOT COMPLETED|Overall Study||1
3312691|NCT03069482|4046271|FG000|STARTED|Overall Study||34
3312692|NCT03069482|4046272|FG001|STARTED|Overall Study||29
3312693|NCT03069482|4046271|FG000|COMPLETED|Overall Study||33
3312694|NCT03069482|4046272|FG001|COMPLETED|Overall Study||28
3312695|NCT03069482|4046271|FG000|NOT COMPLETED|Overall Study||1
3312696|NCT03069482|4046272|FG001|NOT COMPLETED|Overall Study||1
3312697|NCT03069677|4046283|FG000|STARTED|Overall Study||80
3312698|NCT03069677|4046284|FG001|STARTED|Overall Study||80
3312699|NCT03069677|4046283|FG000|COMPLETED|Overall Study||77
3312700|NCT03069677|4046284|FG001|COMPLETED|Overall Study||77
3312701|NCT03069677|4046283|FG000|NOT COMPLETED|Overall Study||3
3312702|NCT03069677|4046284|FG001|NOT COMPLETED|Overall Study||3
3312703|NCT03069716|4046292|FG000|STARTED|Run-in Period (2 Weeks)||49
3312704|NCT03069716|4046293|FG001|STARTED|Run-in Period (2 Weeks)||0
3312705|NCT03069716|4046294|FG002|STARTED|Run-in Period (2 Weeks)||0
3312706|NCT03069716|4046292|FG000|COMPLETED|Run-in Period (2 Weeks)||42
3312707|NCT03069716|4046293|FG001|COMPLETED|Run-in Period (2 Weeks)||0
3312708|NCT03069716|4046294|FG002|COMPLETED|Run-in Period (2 Weeks)||0
3312709|NCT03069716|4046292|FG000|NOT COMPLETED|Run-in Period (2 Weeks)||7
3312710|NCT03069716|4046293|FG001|NOT COMPLETED|Run-in Period (2 Weeks)||0
3312711|NCT03069716|4046294|FG002|NOT COMPLETED|Run-in Period (2 Weeks)||0
3312712|NCT03069716|4046292|FG000|STARTED|Randomized Treatment||0
3312713|NCT03069716|4046293|FG001|STARTED|Randomized Treatment||20
3312714|NCT03069716|4046294|FG002|STARTED|Randomized Treatment||22
3312715|NCT03069716|4046292|FG000|COMPLETED|Randomized Treatment||0
3312716|NCT03069716|4046293|FG001|COMPLETED|Randomized Treatment||18
3312717|NCT03069716|4046294|FG002|COMPLETED|Randomized Treatment||22
3312718|NCT03069716|4046292|FG000|NOT COMPLETED|Randomized Treatment||0
3312719|NCT03069716|4046293|FG001|NOT COMPLETED|Randomized Treatment||2
3312720|NCT03069716|4046294|FG002|NOT COMPLETED|Randomized Treatment||0
3312721|NCT03069989|4046303|FG000|STARTED|Dosing Period 1 (Up to 2 Days)||3
3312722|NCT03069989|4046304|FG001|STARTED|Dosing Period 1 (Up to 2 Days)||5
3312723|NCT03069989|4046303|FG000|COMPLETED|Dosing Period 1 (Up to 2 Days)||3
3312724|NCT03069989|4046304|FG001|COMPLETED|Dosing Period 1 (Up to 2 Days)||5
3312725|NCT03069989|4046303|FG000|NOT COMPLETED|Dosing Period 1 (Up to 2 Days)||0
3312726|NCT03069989|4046304|FG001|NOT COMPLETED|Dosing Period 1 (Up to 2 Days)||0
3312727|NCT03069989|4046303|FG000|STARTED|Wash Out Period (Up to 28 Days))||3
3312728|NCT03069989|4046304|FG001|STARTED|Wash Out Period (Up to 28 Days))||5
3312729|NCT03069989|4046303|FG000|COMPLETED|Wash Out Period (Up to 28 Days))||3
2850840|NCT00779116|3552823|FG001|NOT COMPLETED|First Intervention||0
2850841|NCT00779116|3552822|FG000|STARTED|Interval Between Doses (8-10 Minutes)||109
2850842|NCT00779116|3552823|FG001|STARTED|Interval Between Doses (8-10 Minutes)||108
2850843|NCT00779116|3552822|FG000|COMPLETED|Interval Between Doses (8-10 Minutes)||109
2850844|NCT00779116|3552823|FG001|COMPLETED|Interval Between Doses (8-10 Minutes)||108
2850845|NCT00779116|3552822|FG000|NOT COMPLETED|Interval Between Doses (8-10 Minutes)||0
2850846|NCT00779116|3552823|FG001|NOT COMPLETED|Interval Between Doses (8-10 Minutes)||0
2850847|NCT00779116|3552822|FG000|STARTED|Second Intervention||109
2850848|NCT00779116|3552823|FG001|STARTED|Second Intervention||108
2850849|NCT00779116|3552822|FG000|COMPLETED|Second Intervention||109
2850850|NCT00779116|3552823|FG001|COMPLETED|Second Intervention||108
2850851|NCT00779116|3552822|FG000|NOT COMPLETED|Second Intervention||0
2850852|NCT00779116|3552823|FG001|NOT COMPLETED|Second Intervention||0
2850853|NCT00778700|3552834|FG000|STARTED|Overall Study||50
2850854|NCT00778700|3552835|FG001|STARTED|Overall Study||51
2850855|NCT00778700|3552836|FG002|STARTED|Overall Study||49
2850856|NCT00778700|3552837|FG003|STARTED|Overall Study||49
2850857|NCT00778700|3552834|FG000|COMPLETED|Overall Study||32
2850858|NCT00778700|3552835|FG001|COMPLETED|Overall Study||44
2850859|NCT00778700|3552836|FG002|COMPLETED|Overall Study||43
2850860|NCT00778700|3552837|FG003|COMPLETED|Overall Study||36
3312730|NCT03069989|4046304|FG001|COMPLETED|Wash Out Period (Up to 28 Days))||5
3312731|NCT03069989|4046303|FG000|NOT COMPLETED|Wash Out Period (Up to 28 Days))||0
3312732|NCT03069989|4046304|FG001|NOT COMPLETED|Wash Out Period (Up to 28 Days))||0
3312733|NCT03069989|4046303|FG000|STARTED|Dosing Period 2 (Up to 16 Days)||3
3312734|NCT03069989|4046304|FG001|STARTED|Dosing Period 2 (Up to 16 Days)||5
3312735|NCT03069989|4046303|FG000|COMPLETED|Dosing Period 2 (Up to 16 Days)||2
3312736|NCT03069989|4046304|FG001|COMPLETED|Dosing Period 2 (Up to 16 Days)||5
3312737|NCT03069989|4046303|FG000|NOT COMPLETED|Dosing Period 2 (Up to 16 Days)||1
3312738|NCT03069989|4046304|FG001|NOT COMPLETED|Dosing Period 2 (Up to 16 Days)||0
3312739|NCT03070171|4046313|FG000|STARTED|Treatment Period 1 + Washout||80
3312740|NCT03070171|4046314|FG001|STARTED|Treatment Period 1 + Washout||80
3312741|NCT03070171|4046313|FG000|COMPLETED|Treatment Period 1 + Washout||80
3312742|NCT03070171|4046314|FG001|COMPLETED|Treatment Period 1 + Washout||80
3312743|NCT03070171|4046313|FG000|NOT COMPLETED|Treatment Period 1 + Washout||0
3312744|NCT03070171|4046314|FG001|NOT COMPLETED|Treatment Period 1 + Washout||0
3312745|NCT03070171|4046313|FG000|STARTED|Treatment Period 2 + Washout||80
3312746|NCT03070171|4046314|FG001|STARTED|Treatment Period 2 + Washout||80
3312747|NCT03070171|4046313|FG000|COMPLETED|Treatment Period 2 + Washout||80
3312748|NCT03070171|4046314|FG001|COMPLETED|Treatment Period 2 + Washout||79
3312749|NCT03070171|4046313|FG000|NOT COMPLETED|Treatment Period 2 + Washout||0
3312750|NCT03070171|4046314|FG001|NOT COMPLETED|Treatment Period 2 + Washout||1
3312751|NCT03070171|4046313|FG000|STARTED|Treatment Period 3 + Washout||80
3312752|NCT03070171|4046314|FG001|STARTED|Treatment Period 3 + Washout||79
3312753|NCT03070171|4046313|FG000|COMPLETED|Treatment Period 3 + Washout||80
3312754|NCT03070171|4046314|FG001|COMPLETED|Treatment Period 3 + Washout||79
3312755|NCT03070171|4046313|FG000|NOT COMPLETED|Treatment Period 3 + Washout||0
3312756|NCT03070171|4046314|FG001|NOT COMPLETED|Treatment Period 3 + Washout||0
3312757|NCT03070171|4046313|FG000|STARTED|Treatment Period 4 + Washout||80
3312758|NCT03070171|4046314|FG001|STARTED|Treatment Period 4 + Washout||79
3312759|NCT03070171|4046313|FG000|COMPLETED|Treatment Period 4 + Washout||80
3312760|NCT03070171|4046314|FG001|COMPLETED|Treatment Period 4 + Washout||78
3312761|NCT03070171|4046313|FG000|NOT COMPLETED|Treatment Period 4 + Washout||0
3312762|NCT03070171|4046314|FG001|NOT COMPLETED|Treatment Period 4 + Washout||1
3312763|NCT03070236|4046322|FG000|STARTED|Overall Study||912
3312764|NCT03070236|4046322|FG000|Guideline Concordant Care (GCC) Arm|Overall Study||538
3312765|NCT03070236|4046322|FG000|Active Surveillance (AS) Arm|Overall Study||374
3312766|NCT03070236|4046322|FG000|COMPLETED|Overall Study||912
3312767|NCT03070236|4046322|FG000|NOT COMPLETED|Overall Study||0
3312768|NCT03070392|4046329|FG000|STARTED|Overall Study||252
3312769|NCT03070392|4046330|FG001|STARTED|Overall Study||7
3312770|NCT03070392|4046331|FG002|STARTED|Overall Study||16
3312771|NCT03070392|4046332|FG003|STARTED|Overall Study||103
3312772|NCT03070392|4046329|FG000|COMPLETED|Overall Study||0
3312773|NCT03070392|4046330|FG001|COMPLETED|Overall Study||0
3312774|NCT03070392|4046331|FG002|COMPLETED|Overall Study||10
3312775|NCT03070392|4046332|FG003|COMPLETED|Overall Study||0
3312776|NCT03070392|4046329|FG000|NOT COMPLETED|Overall Study||252
3312777|NCT03070392|4046330|FG001|NOT COMPLETED|Overall Study||7
3312778|NCT03070392|4046331|FG002|NOT COMPLETED|Overall Study||6
3312779|NCT03070392|4046332|FG003|NOT COMPLETED|Overall Study||103
3312780|NCT03070431|4046338|FG000|STARTED|Overall Study||44
3312781|NCT03070431|4046338|FG000|COMPLETED|Overall Study||40
3312782|NCT03070431|4046338|FG000|NOT COMPLETED|Overall Study||4
3312783|NCT03070470|4046353|FG000|STARTED|Overall Study||10
3312784|NCT03070470|4046354|FG001|STARTED|Overall Study||10
3312785|NCT03070470|4046355|FG002|STARTED|Overall Study||10
3312786|NCT03070470|4046356|FG003|STARTED|Overall Study||10
3312787|NCT03070470|4046357|FG004|STARTED|Overall Study||10
3312788|NCT03070470|4046358|FG005|STARTED|Overall Study||10
3312789|NCT03070470|4046353|FG000|COMPLETED|Overall Study||10
3312790|NCT03070470|4046354|FG001|COMPLETED|Overall Study||9
3312791|NCT03070470|4046355|FG002|COMPLETED|Overall Study||10
3312792|NCT03070470|4046356|FG003|COMPLETED|Overall Study||10
3312793|NCT03070470|4046357|FG004|COMPLETED|Overall Study||10
2850861|NCT00778700|3552834|FG000|NOT COMPLETED|Overall Study||18
2850862|NCT00778700|3552835|FG001|NOT COMPLETED|Overall Study||7
2850863|NCT00778700|3552836|FG002|NOT COMPLETED|Overall Study||6
3312794|NCT03070470|4046358|FG005|COMPLETED|Overall Study||8
3312795|NCT03070470|4046353|FG000|NOT COMPLETED|Overall Study||0
3312796|NCT03070470|4046354|FG001|NOT COMPLETED|Overall Study||1
3312797|NCT03070470|4046355|FG002|NOT COMPLETED|Overall Study||0
3312798|NCT03070470|4046356|FG003|NOT COMPLETED|Overall Study||0
3312799|NCT03070470|4046357|FG004|NOT COMPLETED|Overall Study||0
3312800|NCT03070470|4046358|FG005|NOT COMPLETED|Overall Study||2
3312801|NCT03070483|4046374|FG000|STARTED|Overall Study||5
3312802|NCT03070483|4046374|FG000|COMPLETED|Overall Study||3
3312803|NCT03070483|4046374|FG000|NOT COMPLETED|Overall Study||2
3312804|NCT03070548|4046379|FG000|STARTED|Overall Study||6
3312805|NCT03070548|4046379|FG000|COMPLETED|Overall Study||6
3312806|NCT03070548|4046379|FG000|NOT COMPLETED|Overall Study||0
3312807|NCT03070730|4046386|FG000|STARTED|Overall Study||0
3312808|NCT03070730|4046387|FG001|STARTED|Overall Study||0
3312809|NCT03070730|4046388|FG002|STARTED|Overall Study||0
3312810|NCT03070730|4046386|FG000|COMPLETED|Overall Study||0
3312811|NCT03070730|4046387|FG001|COMPLETED|Overall Study||0
3312812|NCT03070730|4046388|FG002|COMPLETED|Overall Study||0
3312813|NCT03070730|4046386|FG000|NOT COMPLETED|Overall Study||0
3312814|NCT03070730|4046387|FG001|NOT COMPLETED|Overall Study||0
3312815|NCT03070730|4046388|FG002|NOT COMPLETED|Overall Study||0
3312816|NCT03070782|4046402|FG000|STARTED|Overall Study||48
3312817|NCT03070782|4046403|FG001|STARTED|Overall Study||48
3312818|NCT03070782|4046404|FG002|STARTED|Overall Study||47
3312819|NCT03070782|4046405|FG003|STARTED|Overall Study||48
3312820|NCT03070782|4046406|FG004|STARTED|Overall Study||48
3312821|NCT03070782|4046407|FG005|STARTED|Overall Study||47
3312822|NCT03070782|4046402|FG000|COMPLETED|Overall Study||41
3312823|NCT03070782|4046403|FG001|COMPLETED|Overall Study||47
3312824|NCT03070782|4046404|FG002|COMPLETED|Overall Study||43
3312825|NCT03070782|4046405|FG003|COMPLETED|Overall Study||43
3312826|NCT03070782|4046406|FG004|COMPLETED|Overall Study||36
3312827|NCT03070782|4046407|FG005|COMPLETED|Overall Study||40
3312828|NCT03070782|4046402|FG000|NOT COMPLETED|Overall Study||7
3312829|NCT03070782|4046403|FG001|NOT COMPLETED|Overall Study||1
3312830|NCT03070782|4046404|FG002|NOT COMPLETED|Overall Study||4
3312831|NCT03070782|4046405|FG003|NOT COMPLETED|Overall Study||5
3312832|NCT03070782|4046406|FG004|NOT COMPLETED|Overall Study||12
3312833|NCT03070782|4046407|FG005|NOT COMPLETED|Overall Study||7
3312834|NCT03070964|4046421|FG000|STARTED|Overall Study||14
3312835|NCT03070964|4046421|FG000|COMPLETED|Overall Study||0
3312836|NCT03070964|4046421|FG000|NOT COMPLETED|Overall Study||14
3312837|NCT03071094|4046427|FG000|STARTED|Overall Study||7
3312838|NCT03071094|4046428|FG001|STARTED|Overall Study||5
3312839|NCT03071094|4046427|FG000|COMPLETED|Overall Study||5
3312840|NCT03071094|4046428|FG001|COMPLETED|Overall Study||4
3312841|NCT03071094|4046427|FG000|NOT COMPLETED|Overall Study||2
3312842|NCT03071094|4046428|FG001|NOT COMPLETED|Overall Study||1
3312843|NCT03071263|4046436|FG000|STARTED|Overall Study||147
3312844|NCT03071263|4046437|FG001|STARTED|Overall Study||148
3312845|NCT03071263|4046436|FG000|COMPLETED|Overall Study||144
3312846|NCT03071263|4046437|FG001|COMPLETED|Overall Study||141
3312847|NCT03071263|4046436|FG000|NOT COMPLETED|Overall Study||3
3312848|NCT03071263|4046437|FG001|NOT COMPLETED|Overall Study||7
3312849|NCT03071276|4046443|FG000|STARTED|Overall Study||37
3312850|NCT03071276|4046443|FG000|COMPLETED|Overall Study||22
3312851|NCT03071276|4046443|FG000|NOT COMPLETED|Overall Study||15
3312852|NCT03071744|4046447|FG000|STARTED|Overall Study||6
3312853|NCT03071744|4046447|FG000|COMPLETED|Overall Study||4
3312854|NCT03071744|4046447|FG000|NOT COMPLETED|Overall Study||2
3312855|NCT03071887|4046451|FG000|STARTED|Overall Study||13
3312856|NCT03071887|4046451|FG000|COMPLETED|Overall Study||7
3312857|NCT03071887|4046451|FG000|NOT COMPLETED|Overall Study||6
3312858|NCT03072160|4046457|FG000|STARTED|Overall Study||13
3312859|NCT03072160|4046458|FG001|STARTED|Overall Study||4
3312860|NCT03072160|4046457|FG000|COMPLETED|Overall Study||2
3312861|NCT03072160|4046458|FG001|COMPLETED|Overall Study||0
3312862|NCT03072160|4046457|FG000|NOT COMPLETED|Overall Study||11
3312863|NCT03072160|4046458|FG001|NOT COMPLETED|Overall Study||4
3312864|NCT03072186|4046496|FG000|STARTED|Overall Study||23
3312865|NCT03072186|4046496|FG000|COMPLETED|Overall Study||17
3312866|NCT03072186|4046496|FG000|NOT COMPLETED|Overall Study||6
3312867|NCT03072550|4046500|FG000|STARTED|Overall Study||26
3312868|NCT03072550|4046500|FG000|COMPLETED|Overall Study||24
3312869|NCT03072550|4046500|FG000|NOT COMPLETED|Overall Study||2
3312870|NCT03072602|4046506|FG000|STARTED|Overall Study||39
3312871|NCT03072602|4046507|FG001|STARTED|Overall Study||42
3312872|NCT03072602|4046506|FG000|Total Participant Screened for the Purpose of Eligibilty|Overall Study||47
3312873|NCT03072602|4046507|FG001|Total Participant Screened for the Purpose of Eligibilty|Overall Study||47
3312874|NCT03072602|4046506|FG000|Ineligible Participants|Overall Study||8
3312875|NCT03072602|4046507|FG001|Ineligible Participants|Overall Study||5
3312876|NCT03072602|4046506|FG000|Participant Received Standardized Meals|Overall Study||39
3312877|NCT03072602|4046507|FG001|Participant Received Standardized Meals|Overall Study||42
2850864|NCT00778700|3552837|FG003|NOT COMPLETED|Overall Study||13
3312878|NCT03072602|4046506|FG000|Study Dropouts|Overall Study||4
3312879|NCT03072602|4046507|FG001|Study Dropouts|Overall Study||3
3312880|NCT03072602|4046506|FG000|Participants Returned for Glucose Challenge Protocol|Overall Study||35
2850865|NCT00764478|3552854|FG000|STARTED|Overall Study||122
2850866|NCT00764478|3552855|FG001|STARTED|Overall Study||119
2850867|NCT00764478|3552856|FG002|STARTED|Overall Study||126
2850868|NCT00764478|3552854|FG000|COMPLETED|Overall Study||107
2850869|NCT00764478|3552855|FG001|COMPLETED|Overall Study||97
2850870|NCT00764478|3552856|FG002|COMPLETED|Overall Study||118
2850871|NCT00764478|3552854|FG000|NOT COMPLETED|Overall Study||15
2850872|NCT00764478|3552855|FG001|NOT COMPLETED|Overall Study||22
2850873|NCT00764478|3552856|FG002|NOT COMPLETED|Overall Study||8
2850874|NCT00761527|3552864|FG000|STARTED|Overall Study||2980
2850875|NCT00761527|3552864|FG000|Received One Dose of Study Medication|Overall Study||2978
2850876|NCT00761527|3552864|FG000|COMPLETED|Overall Study||2958
2850877|NCT00761527|3552864|FG000|NOT COMPLETED|Overall Study||22
2850878|NCT00757627|3552868|FG000|STARTED|Overall Study||500
2850879|NCT00757627|3552868|FG000|COMPLETED|Overall Study||419
2850880|NCT00757627|3552868|FG000|NOT COMPLETED|Overall Study||81
2850881|NCT00756938|3552880|FG000|STARTED|12-week Base Study||33
2850882|NCT00756938|3552881|FG001|STARTED|12-week Base Study||34
3312881|NCT03072602|4046507|FG001|Participants Returned for Glucose Challenge Protocol|Overall Study||39
3312882|NCT03072602|4046506|FG000|Unable to Complete the Protocol|Overall Study||1
3312883|NCT03072602|4046507|FG001|Unable to Complete the Protocol|Overall Study||1
3312884|NCT03072602|4046506|FG000|COMPLETED|Overall Study||34
3312885|NCT03072602|4046507|FG001|COMPLETED|Overall Study||38
3312886|NCT03072602|4046506|FG000|NOT COMPLETED|Overall Study||5
3312887|NCT03072602|4046507|FG001|NOT COMPLETED|Overall Study||4
3312888|NCT03072719|4046515|FG000|STARTED|Overall Study||60
3312889|NCT03072719|4046516|FG001|STARTED|Overall Study||60
3312890|NCT03072719|4046515|FG000|COMPLETED|Overall Study||59
3312891|NCT03072719|4046516|FG001|COMPLETED|Overall Study||59
3312892|NCT03072719|4046515|FG000|NOT COMPLETED|Overall Study||1
3312893|NCT03072719|4046516|FG001|NOT COMPLETED|Overall Study||1
3312894|NCT03072732|4046524|FG000|STARTED|Overall Study||20
3312895|NCT03072732|4046525|FG001|STARTED|Overall Study||20
3312896|NCT03072732|4046524|FG000|COMPLETED|Overall Study||20
3312897|NCT03072732|4046525|FG001|COMPLETED|Overall Study||20
3312898|NCT03072732|4046524|FG000|NOT COMPLETED|Overall Study||0
3312899|NCT03072732|4046525|FG001|NOT COMPLETED|Overall Study||0
3312900|NCT03072875|4046531|FG000|STARTED|Overall Study||26
3312901|NCT03072875|4046531|FG000|COMPLETED|Overall Study||25
3312902|NCT03072875|4046531|FG000|NOT COMPLETED|Overall Study||1
3312903|NCT03072953|4046536|FG000|STARTED|Overall Study||2
3312904|NCT03072953|4046536|FG000|COMPLETED|Overall Study||2
3312905|NCT03072953|4046536|FG000|NOT COMPLETED|Overall Study||0
3312906|NCT03073005|4046544|FG000|STARTED|Overall Study||33
3312907|NCT03073005|4046545|FG001|STARTED|Overall Study||37
3312908|NCT03073005|4046546|FG002|STARTED|Overall Study||36
3312909|NCT03073005|4046547|FG003|STARTED|Overall Study||37
3312910|NCT03073005|4046544|FG000|Received Initial Training|Overall Study|29 pairs (29 patients plus their caregivers)|29
3312911|NCT03073005|4046545|FG001|Received Initial Training|Overall Study||29
3312912|NCT03073005|4046546|FG002|Received Initial Training|Overall Study|33 pairs (33 patients plus their caregivers)|33
3312913|NCT03073005|4046547|FG003|Received Initial Training|Overall Study||33
3312914|NCT03073005|4046544|FG000|COMPLETED|Overall Study|25 pairs (25 patients plus their caregivers)|25
3312915|NCT03073005|4046545|FG001|COMPLETED|Overall Study||25
3312916|NCT03073005|4046546|FG002|COMPLETED|Overall Study|24 pairs (24 patients plus their caregivers)|24
3312917|NCT03073005|4046547|FG003|COMPLETED|Overall Study||24
3312918|NCT03073005|4046544|FG000|NOT COMPLETED|Overall Study||8
3312919|NCT03073005|4046545|FG001|NOT COMPLETED|Overall Study||12
3312920|NCT03073005|4046546|FG002|NOT COMPLETED|Overall Study||12
3312921|NCT03073005|4046547|FG003|NOT COMPLETED|Overall Study||13
3312922|NCT03073109|4046562|FG000|STARTED|Overall Study||100
3312923|NCT03073109|4046563|FG001|STARTED|Overall Study||70
3312924|NCT03073109|4046562|FG000|COMPLETED|Overall Study||90
3312925|NCT03073109|4046563|FG001|COMPLETED|Overall Study||68
3312926|NCT03073109|4046562|FG000|NOT COMPLETED|Overall Study||10
3312927|NCT03073109|4046563|FG001|NOT COMPLETED|Overall Study||2
3312928|NCT03073148|4046585|FG000|STARTED|Overall Study||21
3312929|NCT03073148|4046586|FG001|STARTED|Overall Study||10
3312930|NCT03073148|4046587|FG002|STARTED|Overall Study||4
3312931|NCT03073148|4046585|FG000|COMPLETED|Overall Study||21
3312932|NCT03073148|4046586|FG001|COMPLETED|Overall Study||10
3312933|NCT03073148|4046587|FG002|COMPLETED|Overall Study||0
3312934|NCT03073148|4046585|FG000|NOT COMPLETED|Overall Study||0
3312935|NCT03073148|4046586|FG001|NOT COMPLETED|Overall Study||0
3312936|NCT03073148|4046587|FG002|NOT COMPLETED|Overall Study||4
3312937|NCT03073200|4046598|FG000|STARTED|Double Blind Treatment Period||56
3312938|NCT03073200|4046599|FG001|STARTED|Double Blind Treatment Period||115
3312939|NCT03073200|4046600|FG002|STARTED|Double Blind Treatment Period||30
3312940|NCT03073200|4046601|FG003|STARTED|Double Blind Treatment Period||0
3312941|NCT03073200|4046602|FG004|STARTED|Double Blind Treatment Period||0
3312942|NCT03073200|4046603|FG005|STARTED|Double Blind Treatment Period||0
3312943|NCT03073200|4046604|FG006|STARTED|Double Blind Treatment Period||0
3312944|NCT03073200|4046605|FG007|STARTED|Double Blind Treatment Period||0
3312945|NCT03073200|4046606|FG008|STARTED|Double Blind Treatment Period||0
3312946|NCT03073200|4046607|FG009|STARTED|Double Blind Treatment Period||0
3312947|NCT03073200|4046608|FG010|STARTED|Double Blind Treatment Period||0
3312948|NCT03073200|4046609|FG011|STARTED|Double Blind Treatment Period||0
2850883|NCT00756938|3552882|FG002|STARTED|12-week Base Study||34
2850884|NCT00756938|3552883|FG003|STARTED|12-week Base Study||0
2850885|NCT00756938|3552880|FG000|COMPLETED|12-week Base Study||31
2850886|NCT00756938|3552881|FG001|COMPLETED|12-week Base Study||34
2850887|NCT00756938|3552882|FG002|COMPLETED|12-week Base Study||32
2850888|NCT00756938|3552883|FG003|COMPLETED|12-week Base Study||0
2850889|NCT00756938|3552880|FG000|NOT COMPLETED|12-week Base Study||2
2850890|NCT00756938|3552881|FG001|NOT COMPLETED|12-week Base Study||0
2850891|NCT00756938|3552882|FG002|NOT COMPLETED|12-week Base Study||2
2850892|NCT00756938|3552883|FG003|NOT COMPLETED|12-week Base Study||0
2850893|NCT00756938|3552880|FG000|STARTED|Optional Extension||0
2850894|NCT00756938|3552881|FG001|STARTED|Optional Extension||0
2850895|NCT00756938|3552882|FG002|STARTED|Optional Extension||0
2850896|NCT00756938|3552883|FG003|STARTED|Optional Extension|7 participants who completed base study opted not to enter extension|90
2850897|NCT00756938|3552880|FG000|COMPLETED|Optional Extension||0
2850898|NCT00756938|3552881|FG001|COMPLETED|Optional Extension||0
2850899|NCT00756938|3552882|FG002|COMPLETED|Optional Extension||0
2850900|NCT00756938|3552883|FG003|COMPLETED|Optional Extension||53
2850901|NCT00756938|3552880|FG000|NOT COMPLETED|Optional Extension||0
2850902|NCT00756938|3552881|FG001|NOT COMPLETED|Optional Extension||0
2850903|NCT00756938|3552882|FG002|NOT COMPLETED|Optional Extension||0
2850904|NCT00756938|3552883|FG003|NOT COMPLETED|Optional Extension||37
3312949|NCT03073200|4046610|FG012|STARTED|Double Blind Treatment Period||0
3312950|NCT03073200|4046611|FG013|STARTED|Double Blind Treatment Period||0
3312951|NCT03073200|4046612|FG014|STARTED|Double Blind Treatment Period||0
3312952|NCT03073200|4046598|FG000|Participants in Etanercept Approved Countries|Double Blind Treatment Period||19
3312953|NCT03073200|4046599|FG001|Participants in Etanercept Approved Countries|Double Blind Treatment Period||38
3312954|NCT03073200|4046600|FG002|Participants in Etanercept Approved Countries|Double Blind Treatment Period||30
3312955|NCT03073200|4046601|FG003|Participants in Etanercept Approved Countries|Double Blind Treatment Period||0
3312956|NCT03073200|4046602|FG004|Participants in Etanercept Approved Countries|Double Blind Treatment Period||0
3312957|NCT03073200|4046603|FG005|Participants in Etanercept Approved Countries|Double Blind Treatment Period||0
3312958|NCT03073200|4046604|FG006|Participants in Etanercept Approved Countries|Double Blind Treatment Period||0
3312959|NCT03073200|4046605|FG007|Participants in Etanercept Approved Countries|Double Blind Treatment Period||0
3312960|NCT03073200|4046606|FG008|Participants in Etanercept Approved Countries|Double Blind Treatment Period||0
3312961|NCT03073200|4046607|FG009|Participants in Etanercept Approved Countries|Double Blind Treatment Period||0
3312962|NCT03073200|4046608|FG010|Participants in Etanercept Approved Countries|Double Blind Treatment Period||0
3312963|NCT03073200|4046609|FG011|Participants in Etanercept Approved Countries|Double Blind Treatment Period||0
3312964|NCT03073200|4046610|FG012|Participants in Etanercept Approved Countries|Double Blind Treatment Period||0
3312965|NCT03073200|4046611|FG013|Participants in Etanercept Approved Countries|Double Blind Treatment Period||0
3312966|NCT03073200|4046612|FG014|Participants in Etanercept Approved Countries|Double Blind Treatment Period||0
3312967|NCT03073200|4046598|FG000|COMPLETED|Double Blind Treatment Period||54
3312968|NCT03073200|4046599|FG001|COMPLETED|Double Blind Treatment Period||114
3312969|NCT03073200|4046600|FG002|COMPLETED|Double Blind Treatment Period||30
3312970|NCT03073200|4046601|FG003|COMPLETED|Double Blind Treatment Period||0
3312971|NCT03073200|4046602|FG004|COMPLETED|Double Blind Treatment Period||0
3312972|NCT03073200|4046603|FG005|COMPLETED|Double Blind Treatment Period||0
3312973|NCT03073200|4046604|FG006|COMPLETED|Double Blind Treatment Period||0
3312974|NCT03073200|4046605|FG007|COMPLETED|Double Blind Treatment Period||0
3312975|NCT03073200|4046606|FG008|COMPLETED|Double Blind Treatment Period||0
3312976|NCT03073200|4046607|FG009|COMPLETED|Double Blind Treatment Period||0
3312977|NCT03073200|4046608|FG010|COMPLETED|Double Blind Treatment Period||0
3312978|NCT03073200|4046609|FG011|COMPLETED|Double Blind Treatment Period||0
3312979|NCT03073200|4046610|FG012|COMPLETED|Double Blind Treatment Period||0
3312980|NCT03073200|4046611|FG013|COMPLETED|Double Blind Treatment Period||0
3312981|NCT03073200|4046612|FG014|COMPLETED|Double Blind Treatment Period||0
3312982|NCT03073200|4046598|FG000|NOT COMPLETED|Double Blind Treatment Period||2
3312983|NCT03073200|4046599|FG001|NOT COMPLETED|Double Blind Treatment Period||1
3312984|NCT03073200|4046600|FG002|NOT COMPLETED|Double Blind Treatment Period||0
3312985|NCT03073200|4046601|FG003|NOT COMPLETED|Double Blind Treatment Period||0
3312986|NCT03073200|4046602|FG004|NOT COMPLETED|Double Blind Treatment Period||0
3312987|NCT03073200|4046603|FG005|NOT COMPLETED|Double Blind Treatment Period||0
3312988|NCT03073200|4046604|FG006|NOT COMPLETED|Double Blind Treatment Period||0
3312989|NCT03073200|4046605|FG007|NOT COMPLETED|Double Blind Treatment Period||0
3312990|NCT03073200|4046606|FG008|NOT COMPLETED|Double Blind Treatment Period||0
3312991|NCT03073200|4046607|FG009|NOT COMPLETED|Double Blind Treatment Period||0
3312992|NCT03073200|4046608|FG010|NOT COMPLETED|Double Blind Treatment Period||0
3312993|NCT03073200|4046609|FG011|NOT COMPLETED|Double Blind Treatment Period||0
3312994|NCT03073200|4046610|FG012|NOT COMPLETED|Double Blind Treatment Period||0
3312995|NCT03073200|4046611|FG013|NOT COMPLETED|Double Blind Treatment Period||0
3312996|NCT03073200|4046612|FG014|NOT COMPLETED|Double Blind Treatment Period||0
3312997|NCT03073200|4046598|FG000|STARTED|Open-Label Maintenance Period|This period is to report Maintenance Period participants.|0
3312998|NCT03073200|4046599|FG001|STARTED|Open-Label Maintenance Period|This period is to report Maintenance Period participants.|0
3312999|NCT03073200|4046600|FG002|STARTED|Open-Label Maintenance Period|This period is to report Maintenance Period participants.|0
3317210|NCT03124459|4050725|FG005|NOT COMPLETED|Part 2- Open Label ACE-083||23
2850905|NCT00746590|3552901|FG000|STARTED|Overall Study||1
2850906|NCT00746590|3552901|FG000|COMPLETED|Overall Study||0
2850907|NCT00746590|3552901|FG000|NOT COMPLETED|Overall Study||1
2850908|NCT00730132|3552905|FG000|STARTED|Overall Study||712
2850909|NCT00730132|3552905|FG000|COMPLETED|Overall Study||557
2850910|NCT00730132|3552905|FG000|NOT COMPLETED|Overall Study||155
2850911|NCT00728416|3552914|FG000|STARTED|Overall Study||168
2850912|NCT00728416|3552915|FG001|STARTED|Overall Study||165
3313000|NCT03073200|4046601|FG003|STARTED|Open-Label Maintenance Period|This period is to report Maintenance Period participants.|53
3313001|NCT03073200|4046602|FG004|STARTED|Open-Label Maintenance Period|This period is to report Maintenance Period participants.|113
3313002|NCT03073200|4046603|FG005|STARTED|Open-Label Maintenance Period|This period is to report Maintenance Period participants.|28
3313003|NCT03073200|4046604|FG006|STARTED|Open-Label Maintenance Period||0
3313004|NCT03073200|4046605|FG007|STARTED|Open-Label Maintenance Period||0
3313005|NCT03073200|4046606|FG008|STARTED|Open-Label Maintenance Period||0
3313006|NCT03073200|4046607|FG009|STARTED|Open-Label Maintenance Period||0
3313007|NCT03073200|4046608|FG010|STARTED|Open-Label Maintenance Period||0
3313008|NCT03073200|4046609|FG011|STARTED|Open-Label Maintenance Period||0
3313009|NCT03073200|4046610|FG012|STARTED|Open-Label Maintenance Period||0
3313010|NCT03073200|4046611|FG013|STARTED|Open-Label Maintenance Period||0
3313011|NCT03073200|4046612|FG014|STARTED|Open-Label Maintenance Period||0
3313012|NCT03073200|4046598|FG000|COMPLETED|Open-Label Maintenance Period||0
3313013|NCT03073200|4046599|FG001|COMPLETED|Open-Label Maintenance Period||0
3313014|NCT03073200|4046600|FG002|COMPLETED|Open-Label Maintenance Period||0
3313015|NCT03073200|4046601|FG003|COMPLETED|Open-Label Maintenance Period||49
3313016|NCT03073200|4046602|FG004|COMPLETED|Open-Label Maintenance Period||109
3313017|NCT03073200|4046603|FG005|COMPLETED|Open-Label Maintenance Period||28
3313018|NCT03073200|4046604|FG006|COMPLETED|Open-Label Maintenance Period||0
3313019|NCT03073200|4046605|FG007|COMPLETED|Open-Label Maintenance Period||0
3313020|NCT03073200|4046606|FG008|COMPLETED|Open-Label Maintenance Period||0
3313021|NCT03073200|4046607|FG009|COMPLETED|Open-Label Maintenance Period||0
3313022|NCT03073200|4046608|FG010|COMPLETED|Open-Label Maintenance Period||0
3313023|NCT03073200|4046609|FG011|COMPLETED|Open-Label Maintenance Period||0
3313024|NCT03073200|4046610|FG012|COMPLETED|Open-Label Maintenance Period||0
3313025|NCT03073200|4046611|FG013|COMPLETED|Open-Label Maintenance Period||0
3313026|NCT03073200|4046612|FG014|COMPLETED|Open-Label Maintenance Period||0
3313027|NCT03073200|4046598|FG000|NOT COMPLETED|Open-Label Maintenance Period||0
3313028|NCT03073200|4046599|FG001|NOT COMPLETED|Open-Label Maintenance Period||0
3313029|NCT03073200|4046600|FG002|NOT COMPLETED|Open-Label Maintenance Period||0
3313030|NCT03073200|4046601|FG003|NOT COMPLETED|Open-Label Maintenance Period||4
3313031|NCT03073200|4046602|FG004|NOT COMPLETED|Open-Label Maintenance Period||4
3313032|NCT03073200|4046603|FG005|NOT COMPLETED|Open-Label Maintenance Period||0
3313033|NCT03073200|4046604|FG006|NOT COMPLETED|Open-Label Maintenance Period||0
3313034|NCT03073200|4046605|FG007|NOT COMPLETED|Open-Label Maintenance Period||0
3313035|NCT03073200|4046606|FG008|NOT COMPLETED|Open-Label Maintenance Period||0
3313036|NCT03073200|4046607|FG009|NOT COMPLETED|Open-Label Maintenance Period||0
3313037|NCT03073200|4046608|FG010|NOT COMPLETED|Open-Label Maintenance Period||0
3313038|NCT03073200|4046609|FG011|NOT COMPLETED|Open-Label Maintenance Period||0
3313039|NCT03073200|4046610|FG012|NOT COMPLETED|Open-Label Maintenance Period||0
3313040|NCT03073200|4046611|FG013|NOT COMPLETED|Open-Label Maintenance Period||0
3313041|NCT03073200|4046612|FG014|NOT COMPLETED|Open-Label Maintenance Period||0
3313042|NCT03073200|4046598|FG000|STARTED|Extension Period||0
3313043|NCT03073200|4046599|FG001|STARTED|Extension Period||0
3313044|NCT03073200|4046600|FG002|STARTED|Extension Period||0
3313045|NCT03073200|4046601|FG003|STARTED|Extension Period|This period is to report Extension Period participants.|0
3313046|NCT03073200|4046602|FG004|STARTED|Extension Period|This period is to report Extension Period participants.|0
3313047|NCT03073200|4046603|FG005|STARTED|Extension Period|This period is to report Extension Period participants.|0
3313048|NCT03073200|4046604|FG006|STARTED|Extension Period|This period is to report Extension Period participants.|34
3313049|NCT03073200|4046605|FG007|STARTED|Extension Period|This period is to report Extension Period participants.|68
3313050|NCT03073200|4046606|FG008|STARTED|Extension Period|This period is to report Extension Period participants.|9
3313051|NCT03073200|4046607|FG009|STARTED|Extension Period||0
3313052|NCT03073200|4046608|FG010|STARTED|Extension Period||0
3313053|NCT03073200|4046609|FG011|STARTED|Extension Period||0
3313054|NCT03073200|4046610|FG012|STARTED|Extension Period||0
3313055|NCT03073200|4046611|FG013|STARTED|Extension Period||0
3313056|NCT03073200|4046612|FG014|STARTED|Extension Period||0
3313057|NCT03073200|4046598|FG000|COMPLETED|Extension Period||0
3313058|NCT03073200|4046599|FG001|COMPLETED|Extension Period||0
3313059|NCT03073200|4046600|FG002|COMPLETED|Extension Period||0
3313060|NCT03073200|4046601|FG003|COMPLETED|Extension Period||0
3313061|NCT03073200|4046602|FG004|COMPLETED|Extension Period||0
3313062|NCT03073200|4046603|FG005|COMPLETED|Extension Period||0
3313063|NCT03073200|4046604|FG006|COMPLETED|Extension Period||31
3313064|NCT03073200|4046605|FG007|COMPLETED|Extension Period||62
3313065|NCT03073200|4046606|FG008|COMPLETED|Extension Period||7
3313066|NCT03073200|4046607|FG009|COMPLETED|Extension Period||0
3313067|NCT03073200|4046608|FG010|COMPLETED|Extension Period||0
3313068|NCT03073200|4046609|FG011|COMPLETED|Extension Period||0
3313069|NCT03073200|4046610|FG012|COMPLETED|Extension Period||0
2850913|NCT00728416|3552914|FG000|COMPLETED|Overall Study||166
3313070|NCT03073200|4046611|FG013|COMPLETED|Extension Period||0
3313071|NCT03073200|4046612|FG014|COMPLETED|Extension Period||0
3313072|NCT03073200|4046598|FG000|NOT COMPLETED|Extension Period||0
3313073|NCT03073200|4046599|FG001|NOT COMPLETED|Extension Period||0
3313074|NCT03073200|4046600|FG002|NOT COMPLETED|Extension Period||0
3313075|NCT03073200|4046601|FG003|NOT COMPLETED|Extension Period||0
3313076|NCT03073200|4046602|FG004|NOT COMPLETED|Extension Period||0
3313077|NCT03073200|4046603|FG005|NOT COMPLETED|Extension Period||0
3313078|NCT03073200|4046604|FG006|NOT COMPLETED|Extension Period||3
3313079|NCT03073200|4046605|FG007|NOT COMPLETED|Extension Period||6
3313080|NCT03073200|4046606|FG008|NOT COMPLETED|Extension Period||2
3313081|NCT03073200|4046607|FG009|NOT COMPLETED|Extension Period||0
3313082|NCT03073200|4046608|FG010|NOT COMPLETED|Extension Period||0
3313083|NCT03073200|4046609|FG011|NOT COMPLETED|Extension Period||0
3313084|NCT03073200|4046610|FG012|NOT COMPLETED|Extension Period||0
3313085|NCT03073200|4046611|FG013|NOT COMPLETED|Extension Period||0
3313086|NCT03073200|4046612|FG014|NOT COMPLETED|Extension Period||0
3313087|NCT03073200|4046598|FG000|STARTED|Randomized Withdrawal Period||0
3313088|NCT03073200|4046599|FG001|STARTED|Randomized Withdrawal Period||0
3313089|NCT03073200|4046600|FG002|STARTED|Randomized Withdrawal Period||0
3313090|NCT03073200|4046601|FG003|STARTED|Randomized Withdrawal Period||0
3313091|NCT03073200|4046602|FG004|STARTED|Randomized Withdrawal Period||0
3313092|NCT03073200|4046603|FG005|STARTED|Randomized Withdrawal Period||0
3313093|NCT03073200|4046604|FG006|STARTED|Randomized Withdrawal Period|This period is to report randomized withdrawal period participants.|0
3313094|NCT03073200|4046605|FG007|STARTED|Randomized Withdrawal Period|This period is to report randomized withdrawal period participants.|0
3313095|NCT03073200|4046606|FG008|STARTED|Randomized Withdrawal Period|This period is to report randomized withdrawal period participants.|0
3313096|NCT03073200|4046607|FG009|STARTED|Randomized Withdrawal Period|This period is to report randomized withdrawal period participants.|33
3313097|NCT03073200|4046608|FG010|STARTED|Randomized Withdrawal Period|This period is to report randomized withdrawal period participants.|34
3313098|NCT03073200|4046609|FG011|STARTED|Randomized Withdrawal Period|This period is to report randomized withdrawal period participants.|33
3313099|NCT03073200|4046610|FG012|STARTED|Randomized Withdrawal Period||0
3313100|NCT03073200|4046611|FG013|STARTED|Randomized Withdrawal Period||0
3313101|NCT03073200|4046612|FG014|STARTED|Randomized Withdrawal Period||0
2850914|NCT00728416|3552915|FG001|COMPLETED|Overall Study||163
2850915|NCT00728416|3552914|FG000|NOT COMPLETED|Overall Study||2
2850916|NCT00728416|3552915|FG001|NOT COMPLETED|Overall Study||2
3313102|NCT03073200|4046598|FG000|COMPLETED|Randomized Withdrawal Period||0
3313103|NCT03073200|4046599|FG001|COMPLETED|Randomized Withdrawal Period||0
3313104|NCT03073200|4046600|FG002|COMPLETED|Randomized Withdrawal Period||0
3313105|NCT03073200|4046601|FG003|COMPLETED|Randomized Withdrawal Period||0
3313106|NCT03073200|4046602|FG004|COMPLETED|Randomized Withdrawal Period||0
3313107|NCT03073200|4046603|FG005|COMPLETED|Randomized Withdrawal Period||0
3313108|NCT03073200|4046604|FG006|COMPLETED|Randomized Withdrawal Period||0
3313109|NCT03073200|4046605|FG007|COMPLETED|Randomized Withdrawal Period||0
3313110|NCT03073200|4046606|FG008|COMPLETED|Randomized Withdrawal Period||0
3313111|NCT03073200|4046607|FG009|COMPLETED|Randomized Withdrawal Period||33
3313112|NCT03073200|4046608|FG010|COMPLETED|Randomized Withdrawal Period||32
3313113|NCT03073200|4046609|FG011|COMPLETED|Randomized Withdrawal Period||30
3313114|NCT03073200|4046610|FG012|COMPLETED|Randomized Withdrawal Period||0
3313115|NCT03073200|4046611|FG013|COMPLETED|Randomized Withdrawal Period||0
3313116|NCT03073200|4046612|FG014|COMPLETED|Randomized Withdrawal Period||0
3313117|NCT03073200|4046598|FG000|NOT COMPLETED|Randomized Withdrawal Period||0
3313118|NCT03073200|4046599|FG001|NOT COMPLETED|Randomized Withdrawal Period||0
3313119|NCT03073200|4046600|FG002|NOT COMPLETED|Randomized Withdrawal Period||0
3313120|NCT03073200|4046601|FG003|NOT COMPLETED|Randomized Withdrawal Period||0
3313121|NCT03073200|4046602|FG004|NOT COMPLETED|Randomized Withdrawal Period||0
3313122|NCT03073200|4046603|FG005|NOT COMPLETED|Randomized Withdrawal Period||0
3313123|NCT03073200|4046604|FG006|NOT COMPLETED|Randomized Withdrawal Period||0
3313124|NCT03073200|4046605|FG007|NOT COMPLETED|Randomized Withdrawal Period||0
3313125|NCT03073200|4046606|FG008|NOT COMPLETED|Randomized Withdrawal Period||0
3313126|NCT03073200|4046607|FG009|NOT COMPLETED|Randomized Withdrawal Period||0
3313127|NCT03073200|4046608|FG010|NOT COMPLETED|Randomized Withdrawal Period||2
3168438|NCT01918800|3895733|FG000|STARTED|Overall Study||109
3168439|NCT01918800|3895734|FG001|STARTED|Overall Study||109
3168440|NCT01918800|3895733|FG000|COMPLETED|Overall Study||100
3168441|NCT01918800|3895734|FG001|COMPLETED|Overall Study||104
3168442|NCT01918800|3895733|FG000|NOT COMPLETED|Overall Study||9
3168443|NCT01918800|3895734|FG001|NOT COMPLETED|Overall Study||5
3168444|NCT01919112|3895743|FG000|STARTED|Primary Analysis-day 5 of Intervention||14
3168445|NCT01919112|3895744|FG001|STARTED|Primary Analysis-day 5 of Intervention||13
3168446|NCT01919112|3895745|FG002|STARTED|Primary Analysis-day 5 of Intervention||15
3168447|NCT01919112|3895743|FG000|COMPLETED|Primary Analysis-day 5 of Intervention||14
3168448|NCT01919112|3895744|FG001|COMPLETED|Primary Analysis-day 5 of Intervention||13
3168449|NCT01919112|3895745|FG002|COMPLETED|Primary Analysis-day 5 of Intervention||15
3168450|NCT01919112|3895743|FG000|NOT COMPLETED|Primary Analysis-day 5 of Intervention||0
3168451|NCT01919112|3895744|FG001|NOT COMPLETED|Primary Analysis-day 5 of Intervention||0
3168452|NCT01919112|3895745|FG002|NOT COMPLETED|Primary Analysis-day 5 of Intervention||0
3168453|NCT01919112|3895743|FG000|STARTED|Secondary Analysis-day 30||14
2850917|NCT00724477|3552921|FG000|STARTED|Overall Study|This safety population (SAF)analysed consisted of all patients who took at least one tablet of INEGY|1663
2850918|NCT00724477|3552921|FG000|COMPLETED|Overall Study||1663
2850919|NCT00724477|3552921|FG000|NOT COMPLETED|Overall Study||0
2850920|NCT00723736|3552925|FG000|STARTED|Overall Study||100
2850921|NCT00723736|3552925|FG000|COMPLETED|Overall Study|Subject's caregiver did not wish to continue, reasons unrelated.|99
2850922|NCT00723736|3552925|FG000|NOT COMPLETED|Overall Study||1
2850923|NCT00705081|3552931|FG000|STARTED|Overall Study||255
2850924|NCT00705081|3552932|FG001|STARTED|Overall Study||198
2850925|NCT00705081|3552931|FG000|COMPLETED|Overall Study||255
2850926|NCT00705081|3552932|FG001|COMPLETED|Overall Study||198
2850927|NCT00705081|3552931|FG000|NOT COMPLETED|Overall Study||0
2850928|NCT00705081|3552932|FG001|NOT COMPLETED|Overall Study||0
2850929|NCT00704769|3552938|FG000|STARTED|Overall Study||591
2850930|NCT00704769|3552938|FG000|COMPLETED|Overall Study||591
2850931|NCT00704769|3552938|FG000|NOT COMPLETED|Overall Study||0
2850932|NCT00704535|3552942|FG000|STARTED|Overall Study||4105
2850933|NCT00704535|3552942|FG000|COMPLETED|Overall Study||3959
2850934|NCT00704535|3552942|FG000|NOT COMPLETED|Overall Study||146
2918005|NCT00523848|3628079|FG000|STARTED|Overall Study||46
2918006|NCT00523848|3628079|FG000|Treated With Study Therapy|Overall Study||44
2918007|NCT00523848|3628079|FG000|COMPLETED|Overall Study||22
2918008|NCT00523848|3628079|FG000|NOT COMPLETED|Overall Study||24
2918009|NCT00523978|3628085|FG000|STARTED|Overall Study||171
2918010|NCT00523978|3628086|FG001|STARTED|Overall Study||87
2918011|NCT00523978|3628085|FG000|COMPLETED|Overall Study||162
2918012|NCT00523978|3628086|FG001|COMPLETED|Overall Study||79
2918013|NCT00523978|3628085|FG000|NOT COMPLETED|Overall Study||9
2918014|NCT00523978|3628086|FG001|NOT COMPLETED|Overall Study||8
2918015|NCT00523991|3628095|FG000|STARTED|Overall Study||219
2918016|NCT00523991|3628096|FG001|STARTED|Overall Study||238
3313128|NCT03073200|4046609|FG011|NOT COMPLETED|Randomized Withdrawal Period||3
3313129|NCT03073200|4046610|FG012|NOT COMPLETED|Randomized Withdrawal Period||0
3313130|NCT03073200|4046611|FG013|NOT COMPLETED|Randomized Withdrawal Period||0
3313131|NCT03073200|4046612|FG014|NOT COMPLETED|Randomized Withdrawal Period||0
3313132|NCT03073200|4046598|FG000|STARTED|Post-Treatment Follow-Up Period||0
3313133|NCT03073200|4046599|FG001|STARTED|Post-Treatment Follow-Up Period||0
3313134|NCT03073200|4046600|FG002|STARTED|Post-Treatment Follow-Up Period||0
3313135|NCT03073200|4046601|FG003|STARTED|Post-Treatment Follow-Up Period||0
3313136|NCT03073200|4046602|FG004|STARTED|Post-Treatment Follow-Up Period||0
3313137|NCT03073200|4046603|FG005|STARTED|Post-Treatment Follow-Up Period||0
3313138|NCT03073200|4046604|FG006|STARTED|Post-Treatment Follow-Up Period||0
3313139|NCT03073200|4046605|FG007|STARTED|Post-Treatment Follow-Up Period||0
3313140|NCT03073200|4046606|FG008|STARTED|Post-Treatment Follow-Up Period||0
3313141|NCT03073200|4046607|FG009|STARTED|Post-Treatment Follow-Up Period|This period is to report Follow-Up period participants.|0
3313142|NCT03073200|4046608|FG010|STARTED|Post-Treatment Follow-Up Period|This period is to report Follow-Up period participants.|0
3313143|NCT03073200|4046609|FG011|STARTED|Post-Treatment Follow-Up Period|This period is to report Follow-Up period participants.|0
3313144|NCT03073200|4046610|FG012|STARTED|Post-Treatment Follow-Up Period|This period is to report Follow-Up period participants.|6
3313145|NCT03073200|4046611|FG013|STARTED|Post-Treatment Follow-Up Period|This period is to report Follow-Up period participants.|166
3313146|NCT03073200|4046612|FG014|STARTED|Post-Treatment Follow-Up Period|This period is to report Follow-Up period participants.|2
3313147|NCT03073200|4046598|FG000|COMPLETED|Post-Treatment Follow-Up Period||0
3313148|NCT03073200|4046599|FG001|COMPLETED|Post-Treatment Follow-Up Period||0
3313149|NCT03073200|4046600|FG002|COMPLETED|Post-Treatment Follow-Up Period||0
3313150|NCT03073200|4046601|FG003|COMPLETED|Post-Treatment Follow-Up Period||0
3313151|NCT03073200|4046602|FG004|COMPLETED|Post-Treatment Follow-Up Period||0
3313152|NCT03073200|4046603|FG005|COMPLETED|Post-Treatment Follow-Up Period||0
3313153|NCT03073200|4046604|FG006|COMPLETED|Post-Treatment Follow-Up Period||0
3313154|NCT03073200|4046605|FG007|COMPLETED|Post-Treatment Follow-Up Period||0
3313155|NCT03073200|4046606|FG008|COMPLETED|Post-Treatment Follow-Up Period||0
3313156|NCT03073200|4046607|FG009|COMPLETED|Post-Treatment Follow-Up Period||0
3313157|NCT03073200|4046608|FG010|COMPLETED|Post-Treatment Follow-Up Period||0
3313158|NCT03073200|4046609|FG011|COMPLETED|Post-Treatment Follow-Up Period||0
3313159|NCT03073200|4046610|FG012|COMPLETED|Post-Treatment Follow-Up Period||6
3313160|NCT03073200|4046611|FG013|COMPLETED|Post-Treatment Follow-Up Period||139
3313161|NCT03073200|4046612|FG014|COMPLETED|Post-Treatment Follow-Up Period||1
3313162|NCT03073200|4046598|FG000|NOT COMPLETED|Post-Treatment Follow-Up Period||0
3313163|NCT03073200|4046599|FG001|NOT COMPLETED|Post-Treatment Follow-Up Period||0
3313164|NCT03073200|4046600|FG002|NOT COMPLETED|Post-Treatment Follow-Up Period||0
3313165|NCT03073200|4046601|FG003|NOT COMPLETED|Post-Treatment Follow-Up Period||0
3313166|NCT03073200|4046602|FG004|NOT COMPLETED|Post-Treatment Follow-Up Period||0
3313167|NCT03073200|4046603|FG005|NOT COMPLETED|Post-Treatment Follow-Up Period||0
3313168|NCT03073200|4046604|FG006|NOT COMPLETED|Post-Treatment Follow-Up Period||0
3313169|NCT03073200|4046605|FG007|NOT COMPLETED|Post-Treatment Follow-Up Period||0
3313170|NCT03073200|4046606|FG008|NOT COMPLETED|Post-Treatment Follow-Up Period||0
3313171|NCT03073200|4046607|FG009|NOT COMPLETED|Post-Treatment Follow-Up Period||0
3313172|NCT03073200|4046608|FG010|NOT COMPLETED|Post-Treatment Follow-Up Period||0
3313173|NCT03073200|4046609|FG011|NOT COMPLETED|Post-Treatment Follow-Up Period||0
3317211|NCT03124537|4050740|FG000|STARTED|Overall Study||41
2918017|NCT00523991|3628095|FG000|COMPLETED|Overall Study||198
2918018|NCT00523991|3628096|FG001|COMPLETED|Overall Study||211
2850935|NCT00694369|3552951|FG000|STARTED|Overall Study||46
2850936|NCT00694369|3552952|FG001|STARTED|Overall Study||191
2850937|NCT00694369|3552953|FG002|STARTED|Overall Study||97
2850938|NCT00694369|3552954|FG003|STARTED|Overall Study||192
2850939|NCT00694369|3552955|FG004|STARTED|Overall Study||62
2850940|NCT00694369|3552951|FG000|COMPLETED|Overall Study||45
2850941|NCT00694369|3552952|FG001|COMPLETED|Overall Study||188
2850942|NCT00694369|3552953|FG002|COMPLETED|Overall Study||95
2850943|NCT00694369|3552954|FG003|COMPLETED|Overall Study||189
2850944|NCT00694369|3552955|FG004|COMPLETED|Overall Study||56
2850945|NCT00694369|3552951|FG000|NOT COMPLETED|Overall Study||1
2850946|NCT00694369|3552952|FG001|NOT COMPLETED|Overall Study||3
2850947|NCT00694369|3552953|FG002|NOT COMPLETED|Overall Study||2
2850948|NCT00694369|3552954|FG003|NOT COMPLETED|Overall Study||3
2850949|NCT00694369|3552955|FG004|NOT COMPLETED|Overall Study||6
2850950|NCT00671528|3552970|FG000|STARTED|Overall Study||1
2850951|NCT00671528|3552971|FG001|STARTED|Overall Study||1
2850952|NCT00671528|3552972|FG002|STARTED|Overall Study||1
2850953|NCT00671528|3552970|FG000|COMPLETED|Overall Study||1
2850954|NCT00671528|3552971|FG001|COMPLETED|Overall Study||1
2850955|NCT00671528|3552972|FG002|COMPLETED|Overall Study||1
2850956|NCT00671528|3552970|FG000|NOT COMPLETED|Overall Study||0
2850957|NCT00671528|3552971|FG001|NOT COMPLETED|Overall Study||0
2850958|NCT00671528|3552972|FG002|NOT COMPLETED|Overall Study||0
2850959|NCT00667823|3552980|FG000|STARTED|Overall Study||550
2850960|NCT00667823|3552980|FG000|COMPLETED|Overall Study||334
2850961|NCT00667823|3552980|FG000|NOT COMPLETED|Overall Study||216
2850962|NCT00652327|3552986|FG000|STARTED|Overall Study|Participants who recieved randomized treatment assignment to ezetimibe and ongoing statin|42
2850963|NCT00652327|3552987|FG001|STARTED|Overall Study|Participants who recieved randomized treatment assignment to double the dose of ongoing statin|41
2850964|NCT00652327|3552986|FG000|COMPLETED|Overall Study||42
2850965|NCT00652327|3552987|FG001|COMPLETED|Overall Study||36
2850966|NCT00652327|3552986|FG000|NOT COMPLETED|Overall Study||0
2850967|NCT00652327|3552987|FG001|NOT COMPLETED|Overall Study||5
2850968|NCT00604500|3552993|FG000|STARTED|Overall Study||272
2850969|NCT00604500|3552993|FG000|COMPLETED|Overall Study|There were 233 participants who took at least 90% of the labeled actuations (Completer Population).|261
2850970|NCT00604500|3552993|FG000|NOT COMPLETED|Overall Study||11
2850971|NCT00602641|3552999|FG000|STARTED|Overall Study||154
2850972|NCT00602641|3553000|FG001|STARTED|Overall Study||152
2850973|NCT00602641|3552999|FG000|Started Protocol Therapy|Overall Study||148
2850974|NCT00602641|3553000|FG001|Started Protocol Therapy|Overall Study||150
2850975|NCT00602641|3552999|FG000|COMPLETED|Overall Study|Treatment continued until progression of disease, unacceptable toxicity or patient withdrawal.|0
2850976|NCT00602641|3553000|FG001|COMPLETED|Overall Study|Treatment continued until progression of disease, unacceptable toxicity or patient withdrawal.|0
2850977|NCT00602641|3552999|FG000|NOT COMPLETED|Overall Study||154
2850978|NCT00602641|3553000|FG001|NOT COMPLETED|Overall Study||152
2850979|NCT00568178|3553008|FG000|STARTED|Double Blind Base Study||122
2850980|NCT00568178|3553009|FG001|STARTED|Double Blind Base Study||124
2850981|NCT00568178|3553010|FG002|STARTED|Double Blind Base Study||30
2850982|NCT00568178|3553011|FG003|STARTED|Double Blind Base Study||30
2850983|NCT00568178|3553012|FG004|STARTED|Double Blind Base Study||0
3168454|NCT01919112|3895744|FG001|STARTED|Secondary Analysis-day 30||13
3168455|NCT01919112|3895745|FG002|STARTED|Secondary Analysis-day 30||15
3168456|NCT01919112|3895743|FG000|COMPLETED|Secondary Analysis-day 30||12
3168457|NCT01919112|3895744|FG001|COMPLETED|Secondary Analysis-day 30||12
2850984|NCT00568178|3553013|FG005|STARTED|Double Blind Base Study||0
2850985|NCT00568178|3553008|FG000|COMPLETED|Double Blind Base Study||116
2850986|NCT00568178|3553009|FG001|COMPLETED|Double Blind Base Study||118
2850987|NCT00568178|3553010|FG002|COMPLETED|Double Blind Base Study||29
2850988|NCT00568178|3553011|FG003|COMPLETED|Double Blind Base Study||25
2850989|NCT00568178|3553012|FG004|COMPLETED|Double Blind Base Study||0
2850990|NCT00568178|3553013|FG005|COMPLETED|Double Blind Base Study||0
2850991|NCT00568178|3553008|FG000|NOT COMPLETED|Double Blind Base Study||6
2850992|NCT00568178|3553009|FG001|NOT COMPLETED|Double Blind Base Study||6
2850993|NCT00568178|3553010|FG002|NOT COMPLETED|Double Blind Base Study||1
2850994|NCT00568178|3553011|FG003|NOT COMPLETED|Double Blind Base Study||5
2850995|NCT00568178|3553012|FG004|NOT COMPLETED|Double Blind Base Study||0
2850996|NCT00568178|3553013|FG005|NOT COMPLETED|Double Blind Base Study||0
2850997|NCT00568178|3553008|FG000|STARTED|Open Label Extension||0
2850998|NCT00568178|3553009|FG001|STARTED|Open Label Extension||0
3168458|NCT01919112|3895745|FG002|COMPLETED|Secondary Analysis-day 30||14
2850999|NCT00568178|3553010|FG002|STARTED|Open Label Extension||0
2851000|NCT00568178|3553011|FG003|STARTED|Open Label Extension||0
2851001|NCT00568178|3553012|FG004|STARTED|Open Label Extension||134
2851002|NCT00568178|3553013|FG005|STARTED|Open Label Extension||134
2851003|NCT00568178|3553008|FG000|COMPLETED|Open Label Extension||0
2851004|NCT00568178|3553009|FG001|COMPLETED|Open Label Extension||0
2851005|NCT00568178|3553010|FG002|COMPLETED|Open Label Extension||0
2851006|NCT00568178|3553011|FG003|COMPLETED|Open Label Extension||0
2851007|NCT00568178|3553012|FG004|COMPLETED|Open Label Extension||55
2851008|NCT00568178|3553013|FG005|COMPLETED|Open Label Extension||54
2851009|NCT00568178|3553008|FG000|NOT COMPLETED|Open Label Extension||0
2851010|NCT00568178|3553009|FG001|NOT COMPLETED|Open Label Extension||0
2851011|NCT00568178|3553010|FG002|NOT COMPLETED|Open Label Extension||0
2851012|NCT00568178|3553011|FG003|NOT COMPLETED|Open Label Extension||0
2851013|NCT00568178|3553012|FG004|NOT COMPLETED|Open Label Extension||79
2851014|NCT00568178|3553013|FG005|NOT COMPLETED|Open Label Extension||80
2851015|NCT00549848|3553030|FG000|STARTED|Overall Study||206
2851016|NCT00549848|3553031|FG001|STARTED|Overall Study||208
2851017|NCT00549848|3553032|FG002|STARTED|Overall Study||184
2851018|NCT00549848|3553030|FG000|COMPLETED|Overall Study||194
2851019|NCT00549848|3553031|FG001|COMPLETED|Overall Study||188
3168459|NCT01919112|3895743|FG000|NOT COMPLETED|Secondary Analysis-day 30||2
3313174|NCT03073200|4046610|FG012|NOT COMPLETED|Post-Treatment Follow-Up Period||0
3313175|NCT03073200|4046611|FG013|NOT COMPLETED|Post-Treatment Follow-Up Period||27
3313176|NCT03073200|4046612|FG014|NOT COMPLETED|Post-Treatment Follow-Up Period||1
3313177|NCT03073213|4046637|FG000|STARTED|Single Dose Period||12
3313178|NCT03073213|4046638|FG001|STARTED|Single Dose Period||0
3313179|NCT03073213|4046639|FG002|STARTED|Single Dose Period||0
3313180|NCT03073213|4046637|FG000|COMPLETED|Single Dose Period||12
3313181|NCT03073213|4046638|FG001|COMPLETED|Single Dose Period||0
3313182|NCT03073213|4046639|FG002|COMPLETED|Single Dose Period||0
3313183|NCT03073213|4046637|FG000|NOT COMPLETED|Single Dose Period||0
3313184|NCT03073213|4046638|FG001|NOT COMPLETED|Single Dose Period||0
3313185|NCT03073213|4046639|FG002|NOT COMPLETED|Single Dose Period||0
3313186|NCT03073213|4046637|FG000|STARTED|Multiple Dose Period||0
3313187|NCT03073213|4046638|FG001|STARTED|Multiple Dose Period|Participants who completed single dose had option to enroll into multiple dose.|14
3313188|NCT03073213|4046639|FG002|STARTED|Multiple Dose Period|Participants who completed single dose had option to enroll into multiple dose.|15
3313189|NCT03073213|4046637|FG000|Participants Enrolled From Single Dose|Multiple Dose Period||0
3313190|NCT03073213|4046638|FG001|Participants Enrolled From Single Dose|Multiple Dose Period||7
3313191|NCT03073213|4046639|FG002|Participants Enrolled From Single Dose|Multiple Dose Period||2
3313192|NCT03073213|4046637|FG000|COMPLETED|Multiple Dose Period||0
3313193|NCT03073213|4046638|FG001|COMPLETED|Multiple Dose Period||14
3313194|NCT03073213|4046639|FG002|COMPLETED|Multiple Dose Period||14
3313195|NCT03073213|4046637|FG000|NOT COMPLETED|Multiple Dose Period||0
3313196|NCT03073213|4046638|FG001|NOT COMPLETED|Multiple Dose Period||0
3313197|NCT03073213|4046639|FG002|NOT COMPLETED|Multiple Dose Period||1
3313198|NCT03073486|4046650|FG000|STARTED|Overall Study||493
3313199|NCT03073486|4046651|FG001|STARTED|Overall Study||251
3313200|NCT03073486|4046650|FG000|COMPLETED|Overall Study||405
3313201|NCT03073486|4046651|FG001|COMPLETED|Overall Study||207
3313202|NCT03073486|4046650|FG000|NOT COMPLETED|Overall Study||88
3313203|NCT03073486|4046651|FG001|NOT COMPLETED|Overall Study||44
3313204|NCT03073759|4046659|FG000|STARTED|Overall Study||2
3313205|NCT03073759|4046660|FG001|STARTED|Overall Study||2
3168460|NCT01919112|3895744|FG001|NOT COMPLETED|Secondary Analysis-day 30||1
3313206|NCT03073759|4046659|FG000|COMPLETED|Overall Study||2
3313207|NCT03073759|4046660|FG001|COMPLETED|Overall Study||2
3313208|NCT03073759|4046659|FG000|NOT COMPLETED|Overall Study||0
3313209|NCT03073759|4046660|FG001|NOT COMPLETED|Overall Study||0
3313210|NCT03073798|4046667|FG000|STARTED|Overall Study||12
3313211|NCT03073798|4046667|FG000|COMPLETED|Overall Study||10
3313212|NCT03073798|4046667|FG000|NOT COMPLETED|Overall Study||2
3313213|NCT03073876|4046674|FG000|STARTED|Overall Study||12
3313214|NCT03073876|4046675|FG001|STARTED|Overall Study||11
3313215|NCT03073876|4046674|FG000|COMPLETED|Overall Study||12
3313216|NCT03073876|4046675|FG001|COMPLETED|Overall Study||11
3313217|NCT03073876|4046674|FG000|NOT COMPLETED|Overall Study||0
3313218|NCT03073876|4046675|FG001|NOT COMPLETED|Overall Study||0
3313219|NCT03074162|4046692|FG000|STARTED|Period 1 Including Washout 1||8
3313220|NCT03074162|4046693|FG001|STARTED|Period 1 Including Washout 1||8
3313221|NCT03074162|4046694|FG002|STARTED|Period 1 Including Washout 1||8
3313222|NCT03074162|4046695|FG003|STARTED|Period 1 Including Washout 1||8
3313223|NCT03074162|4046696|FG004|STARTED|Period 1 Including Washout 1||8
3313224|NCT03074162|4046697|FG005|STARTED|Period 1 Including Washout 1||8
3313225|NCT03074162|4046692|FG000|COMPLETED|Period 1 Including Washout 1||8
3313226|NCT03074162|4046693|FG001|COMPLETED|Period 1 Including Washout 1||8
3313227|NCT03074162|4046694|FG002|COMPLETED|Period 1 Including Washout 1||7
3313228|NCT03074162|4046695|FG003|COMPLETED|Period 1 Including Washout 1||8
3313229|NCT03074162|4046696|FG004|COMPLETED|Period 1 Including Washout 1||8
3313230|NCT03074162|4046697|FG005|COMPLETED|Period 1 Including Washout 1||8
3313231|NCT03074162|4046692|FG000|NOT COMPLETED|Period 1 Including Washout 1||0
3313232|NCT03074162|4046693|FG001|NOT COMPLETED|Period 1 Including Washout 1||0
3313233|NCT03074162|4046694|FG002|NOT COMPLETED|Period 1 Including Washout 1||1
3313234|NCT03074162|4046695|FG003|NOT COMPLETED|Period 1 Including Washout 1||0
3313235|NCT03074162|4046696|FG004|NOT COMPLETED|Period 1 Including Washout 1||0
3313236|NCT03074162|4046697|FG005|NOT COMPLETED|Period 1 Including Washout 1||0
3313237|NCT03074162|4046692|FG000|STARTED|Period 2 Including Washout 2||8
3313238|NCT03074162|4046693|FG001|STARTED|Period 2 Including Washout 2||8
3313239|NCT03074162|4046694|FG002|STARTED|Period 2 Including Washout 2||7
3313240|NCT03074162|4046695|FG003|STARTED|Period 2 Including Washout 2||8
3313241|NCT03074162|4046696|FG004|STARTED|Period 2 Including Washout 2||8
3313242|NCT03074162|4046697|FG005|STARTED|Period 2 Including Washout 2||8
3313243|NCT03074162|4046692|FG000|COMPLETED|Period 2 Including Washout 2||8
3313244|NCT03074162|4046693|FG001|COMPLETED|Period 2 Including Washout 2||8
3313245|NCT03074162|4046694|FG002|COMPLETED|Period 2 Including Washout 2||6
3313246|NCT03074162|4046695|FG003|COMPLETED|Period 2 Including Washout 2||8
3313247|NCT03074162|4046696|FG004|COMPLETED|Period 2 Including Washout 2||8
2851020|NCT00549848|3553032|FG002|COMPLETED|Overall Study||133
2851021|NCT00549848|3553030|FG000|NOT COMPLETED|Overall Study||12
2851022|NCT00549848|3553031|FG001|NOT COMPLETED|Overall Study||20
2851023|NCT00549848|3553032|FG002|NOT COMPLETED|Overall Study||51
2851024|NCT00545844|3553048|FG000|STARTED|Overall Study||313
2851025|NCT00545844|3553048|FG000|COMPLETED|Overall Study||301
3313248|NCT03074162|4046697|FG005|COMPLETED|Period 2 Including Washout 2||7
3313249|NCT03074162|4046692|FG000|NOT COMPLETED|Period 2 Including Washout 2||0
3313250|NCT03074162|4046693|FG001|NOT COMPLETED|Period 2 Including Washout 2||0
3313251|NCT03074162|4046694|FG002|NOT COMPLETED|Period 2 Including Washout 2||1
3313252|NCT03074162|4046695|FG003|NOT COMPLETED|Period 2 Including Washout 2||0
3313253|NCT03074162|4046696|FG004|NOT COMPLETED|Period 2 Including Washout 2||0
3313254|NCT03074162|4046697|FG005|NOT COMPLETED|Period 2 Including Washout 2||1
3313255|NCT03074162|4046692|FG000|STARTED|Period 3||8
3313256|NCT03074162|4046693|FG001|STARTED|Period 3||8
3313257|NCT03074162|4046694|FG002|STARTED|Period 3||6
3313258|NCT03074162|4046695|FG003|STARTED|Period 3||8
3313259|NCT03074162|4046696|FG004|STARTED|Period 3||8
3313260|NCT03074162|4046697|FG005|STARTED|Period 3||7
3313261|NCT03074162|4046692|FG000|COMPLETED|Period 3||7
3313262|NCT03074162|4046693|FG001|COMPLETED|Period 3||8
3313263|NCT03074162|4046694|FG002|COMPLETED|Period 3||6
3313264|NCT03074162|4046695|FG003|COMPLETED|Period 3||8
3313265|NCT03074162|4046696|FG004|COMPLETED|Period 3||7
3313266|NCT03074162|4046697|FG005|COMPLETED|Period 3||7
3313267|NCT03074162|4046692|FG000|NOT COMPLETED|Period 3||1
3313268|NCT03074162|4046693|FG001|NOT COMPLETED|Period 3||0
3313269|NCT03074162|4046694|FG002|NOT COMPLETED|Period 3||0
3313270|NCT03074162|4046695|FG003|NOT COMPLETED|Period 3||0
3313271|NCT03074162|4046696|FG004|NOT COMPLETED|Period 3||1
3313272|NCT03074162|4046697|FG005|NOT COMPLETED|Period 3||0
3313273|NCT03074331|4046705|FG000|STARTED|Overall Study||130
3313274|NCT03074331|4046705|FG000|COMPLETED|Overall Study||123
3313275|NCT03074331|4046705|FG000|NOT COMPLETED|Overall Study||7
3313276|NCT03074409|4046711|FG000|STARTED|Overall Study||41
3313277|NCT03074409|4046712|FG001|STARTED|Overall Study||42
3313278|NCT03074409|4046711|FG000|COMPLETED|Overall Study||37
3313279|NCT03074409|4046712|FG001|COMPLETED|Overall Study||38
3313280|NCT03074409|4046711|FG000|NOT COMPLETED|Overall Study||4
3313281|NCT03074409|4046712|FG001|NOT COMPLETED|Overall Study||4
3313282|NCT03074500|4046721|FG000|STARTED|Overall Study||11
3313283|NCT03074500|4046722|FG001|STARTED|Overall Study||11
3313284|NCT03074500|4046723|FG002|STARTED|Overall Study||11
3313285|NCT03074500|4046721|FG000|COMPLETED|Overall Study||10
3313286|NCT03074500|4046722|FG001|COMPLETED|Overall Study||10
3313287|NCT03074500|4046723|FG002|COMPLETED|Overall Study||10
3313288|NCT03074500|4046721|FG000|NOT COMPLETED|Overall Study||1
3313289|NCT03074500|4046722|FG001|NOT COMPLETED|Overall Study||1
3313290|NCT03074500|4046723|FG002|NOT COMPLETED|Overall Study||1
3313291|NCT03074630|4046733|FG000|STARTED|Overall Study||12
3313292|NCT03074630|4046733|FG000|COMPLETED|Overall Study||11
3313293|NCT03074630|4046733|FG000|NOT COMPLETED|Overall Study||1
3313294|NCT03074682|4046741|FG000|STARTED|Overall Study||18
3313295|NCT03074682|4046742|FG001|STARTED|Overall Study||18
3313296|NCT03074682|4046743|FG002|STARTED|Overall Study||18
3313297|NCT03074682|4046741|FG000|COMPLETED|Overall Study||18
3313298|NCT03074682|4046742|FG001|COMPLETED|Overall Study||18
3313299|NCT03074682|4046743|FG002|COMPLETED|Overall Study||18
3313300|NCT03074682|4046741|FG000|NOT COMPLETED|Overall Study||0
3313301|NCT03074682|4046742|FG001|NOT COMPLETED|Overall Study||0
3313302|NCT03074682|4046743|FG002|NOT COMPLETED|Overall Study||0
3313303|NCT03075085|4046753|FG000|STARTED|Overall Study||352
3313304|NCT03075085|4046754|FG001|STARTED|Overall Study||344
3313305|NCT03075085|4046753|FG000|COMPLETED|Overall Study||247
3313306|NCT03075085|4046754|FG001|COMPLETED|Overall Study||232
3313307|NCT03075085|4046753|FG000|NOT COMPLETED|Overall Study||105
3313308|NCT03075085|4046754|FG001|NOT COMPLETED|Overall Study||112
3313309|NCT03075163|4046762|FG000|STARTED|Overall Study||150
3313310|NCT03075163|4046763|FG001|STARTED|Overall Study||150
3313311|NCT03075163|4046762|FG000|COMPLETED|Overall Study||12
3313312|NCT03075163|4046763|FG001|COMPLETED|Overall Study||12
3313313|NCT03075163|4046762|FG000|NOT COMPLETED|Overall Study||138
3313314|NCT03075163|4046763|FG001|NOT COMPLETED|Overall Study||138
3313315|NCT03075267|4046772|FG000|STARTED|Overall Study||32
3313316|NCT03075267|4046773|FG001|STARTED|Overall Study||32
3313317|NCT03075267|4046774|FG002|STARTED|Overall Study||32
3313318|NCT03075267|4046772|FG000|COMPLETED|Overall Study||31
3313319|NCT03075267|4046773|FG001|COMPLETED|Overall Study||32
3313320|NCT03075267|4046774|FG002|COMPLETED|Overall Study||32
3313321|NCT03075267|4046772|FG000|NOT COMPLETED|Overall Study||1
3313322|NCT03075267|4046773|FG001|NOT COMPLETED|Overall Study||0
3313323|NCT03075267|4046774|FG002|NOT COMPLETED|Overall Study||0
3313324|NCT03075410|4046791|FG000|STARTED|Part A-Period 1 (14 Days)||2
3313325|NCT03075410|4046792|FG001|STARTED|Part A-Period 1 (14 Days)||1
3313326|NCT03075410|4046793|FG002|STARTED|Part A-Period 1 (14 Days)||2
3313327|NCT03075410|4046794|FG003|STARTED|Part A-Period 1 (14 Days)||1
3313328|NCT03075410|4046795|FG004|STARTED|Part A-Period 1 (14 Days)||2
2851026|NCT00545844|3553048|FG000|NOT COMPLETED|Overall Study||12
3313329|NCT03075410|4046796|FG005|STARTED|Part A-Period 1 (14 Days)||1
3313330|NCT03075410|4046797|FG006|STARTED|Part A-Period 1 (14 Days)||0
3313331|NCT03075410|4046798|FG007|STARTED|Part A-Period 1 (14 Days)||0
3313332|NCT03075410|4046799|FG008|STARTED|Part A-Period 1 (14 Days)||0
3313333|NCT03075410|4046791|FG000|COMPLETED|Part A-Period 1 (14 Days)||2
2851027|NCT00511433|3553056|FG000|STARTED|Overall Study||32
2851028|NCT00511433|3553057|FG001|STARTED|Overall Study||16
2851029|NCT00511433|3553056|FG000|COMPLETED|Overall Study||26
2851030|NCT00511433|3553057|FG001|COMPLETED|Overall Study||15
2851031|NCT00511433|3553056|FG000|NOT COMPLETED|Overall Study||6
3168461|NCT01919112|3895745|FG002|NOT COMPLETED|Secondary Analysis-day 30||1
3168462|NCT01919164|3895758|FG000|STARTED|Overall Study||108
2851032|NCT00511433|3553057|FG001|NOT COMPLETED|Overall Study||1
2851033|NCT00511355|3553067|FG000|STARTED|Overall Study||60
2851034|NCT00511355|3553068|FG001|STARTED|Overall Study||61
2851035|NCT00511355|3553067|FG000|COMPLETED|Overall Study||53
2851036|NCT00511355|3553068|FG001|COMPLETED|Overall Study||52
2851037|NCT00511355|3553067|FG000|NOT COMPLETED|Overall Study||7
2851038|NCT00511355|3553068|FG001|NOT COMPLETED|Overall Study||9
2851039|NCT00511342|3553078|FG000|STARTED|Overall Study||56
2851040|NCT00511342|3553079|FG001|STARTED|Overall Study||54
2851041|NCT00511342|3553078|FG000|COMPLETED|Overall Study||43
2851042|NCT00511342|3553079|FG001|COMPLETED|Overall Study||32
2851043|NCT00511342|3553078|FG000|NOT COMPLETED|Overall Study||13
2851044|NCT00511342|3553079|FG001|NOT COMPLETED|Overall Study||22
2851045|NCT00511199|3553087|FG000|STARTED|Overall Study||1591
2851046|NCT00511199|3553088|FG001|STARTED|Overall Study||535
2851047|NCT00511199|3553087|FG000|COMPLETED|Overall Study||1142
2851048|NCT00511199|3553088|FG001|COMPLETED|Overall Study||410
2851049|NCT00511199|3553087|FG000|NOT COMPLETED|Overall Study||449
2851050|NCT00511199|3553088|FG001|NOT COMPLETED|Overall Study||125
2851051|NCT00491504|3553100|FG000|STARTED|Overall Study|All subjects who received MFNS only on Day 1|77
2851052|NCT00491504|3553101|FG001|STARTED|Overall Study|All subjects who received placebo only on Day 1|78
2851053|NCT00491504|3553102|FG002|STARTED|Overall Study|All subjects who received MFNS on Day 1 through Day 7|78
2851054|NCT00491504|3553103|FG003|STARTED|Overall Study|All subjects who received placebo on Day 1 through Day 7|77
2851055|NCT00491504|3553100|FG000|COMPLETED|Overall Study||77
2851056|NCT00491504|3553101|FG001|COMPLETED|Overall Study||77
2851057|NCT00491504|3553102|FG002|COMPLETED|Overall Study||74
2851058|NCT00491504|3553103|FG003|COMPLETED|Overall Study||73
2851059|NCT00491504|3553100|FG000|NOT COMPLETED|Overall Study||0
2851060|NCT00491504|3553101|FG001|NOT COMPLETED|Overall Study||1
2851061|NCT00491504|3553102|FG002|NOT COMPLETED|Overall Study||4
2851062|NCT00491504|3553103|FG003|NOT COMPLETED|Overall Study||4
2851063|NCT00468312|3553113|FG000|STARTED|Overall Study||220
2851064|NCT00468312|3553114|FG001|STARTED|Overall Study||209
2851065|NCT00468312|3553113|FG000|COMPLETED|Overall Study||216
2851066|NCT00468312|3553114|FG001|COMPLETED|Overall Study||204
2851067|NCT00468312|3553113|FG000|NOT COMPLETED|Overall Study||4
2851068|NCT00468312|3553114|FG001|NOT COMPLETED|Overall Study||5
2851069|NCT00453063|3553122|FG000|STARTED|Overall Study||211
2851070|NCT00453063|3553123|FG001|STARTED|Overall Study||215
2851071|NCT00453063|3553122|FG000|COMPLETED|Overall Study||208
2851072|NCT00453063|3553123|FG001|COMPLETED|Overall Study||212
2851073|NCT00453063|3553122|FG000|NOT COMPLETED|Overall Study||3
2851074|NCT00453063|3553123|FG001|NOT COMPLETED|Overall Study||3
2851075|NCT00447603|3553129|FG000|STARTED|Screening||40
2851076|NCT00447603|3553130|FG001|STARTED|Screening||0
2851077|NCT00447603|3553131|FG002|STARTED|Screening||0
2851078|NCT00447603|3553129|FG000|COMPLETED|Screening||19
2851079|NCT00447603|3553130|FG001|COMPLETED|Screening||0
2851080|NCT00447603|3553131|FG002|COMPLETED|Screening||0
2851081|NCT00447603|3553129|FG000|NOT COMPLETED|Screening||21
2851082|NCT00447603|3553130|FG001|NOT COMPLETED|Screening||0
2851083|NCT00447603|3553131|FG002|NOT COMPLETED|Screening||0
2851084|NCT00447603|3553129|FG000|STARTED|Filter Period||0
2851085|NCT00447603|3553130|FG001|STARTED|Filter Period|The study was discontinued early; no participant entered treatment period|4
2851086|NCT00447603|3553131|FG002|STARTED|Filter Period|The study was discontinued early; no participant entered treatment period|15
2851087|NCT00447603|3553129|FG000|COMPLETED|Filter Period||0
2851088|NCT00447603|3553130|FG001|COMPLETED|Filter Period||0
2851089|NCT00447603|3553131|FG002|COMPLETED|Filter Period||0
2851090|NCT00447603|3553129|FG000|NOT COMPLETED|Filter Period||0
2851091|NCT00447603|3553130|FG001|NOT COMPLETED|Filter Period||4
2851092|NCT00447603|3553131|FG002|NOT COMPLETED|Filter Period||15
2851093|NCT00442351|3553141|FG000|STARTED|Overall Study|Due to poor enrollment and a high screening failure rate, this study was terminated early.|17
2851094|NCT00442351|3553142|FG001|STARTED|Overall Study||9
2851095|NCT00442351|3553141|FG000|COMPLETED|Overall Study||10
2851096|NCT00442351|3553142|FG001|COMPLETED|Overall Study||3
2851097|NCT00442351|3553141|FG000|NOT COMPLETED|Overall Study||7
2851098|NCT00442351|3553142|FG001|NOT COMPLETED|Overall Study||6
2851099|NCT00423488|3553150|FG000|STARTED|Overall Study||42
2851100|NCT00423488|3553151|FG001|STARTED|Overall Study||51
2851101|NCT00423488|3553150|FG000|COMPLETED|Overall Study||37
2851102|NCT00423488|3553151|FG001|COMPLETED|Overall Study||50
2851103|NCT00423488|3553150|FG000|NOT COMPLETED|Overall Study||5
2851104|NCT00423488|3553151|FG001|NOT COMPLETED|Overall Study||1
2851105|NCT00413972|3553161|FG000|STARTED|Overall Study|1 of the 98 randomized subjects was not treated and was excluded from the ITT data set.|98
2851106|NCT00413972|3553162|FG001|STARTED|Overall Study|1 of the 98 randomized subjects was not treated and was excluded from the ITT data set.|98
2851107|NCT00413972|3553163|FG002|STARTED|Overall Study||98
2851108|NCT00413972|3553164|FG003|STARTED|Overall Study|1 of the 98 randomized subjects was not treated and was excluded from the ITT data set.|98
2851109|NCT00413972|3553161|FG000|COMPLETED|Overall Study||91
2851110|NCT00413972|3553162|FG001|COMPLETED|Overall Study||90
2851111|NCT00413972|3553163|FG002|COMPLETED|Overall Study||88
2851112|NCT00413972|3553164|FG003|COMPLETED|Overall Study||95
2851113|NCT00413972|3553161|FG000|NOT COMPLETED|Overall Study||7
2851114|NCT00413972|3553162|FG001|NOT COMPLETED|Overall Study||8
2851115|NCT00413972|3553163|FG002|NOT COMPLETED|Overall Study||10
2851116|NCT00413972|3553164|FG003|NOT COMPLETED|Overall Study||3
2851117|NCT00413062|3553176|FG000|STARTED|Overall Study||1666
2851118|NCT00413062|3553177|FG001|STARTED|Overall Study||554
2851119|NCT00413062|3553176|FG000|COMPLETED|Overall Study||988
2851120|NCT00413062|3553177|FG001|COMPLETED|Overall Study||344
2851121|NCT00413062|3553176|FG000|NOT COMPLETED|Overall Study||678
2851122|NCT00413062|3553177|FG001|NOT COMPLETED|Overall Study||210
2851123|NCT00391170|3553187|FG000|STARTED|Overall Study||27
2851124|NCT00391170|3553188|FG001|STARTED|Overall Study||27
2851125|NCT00391170|3553187|FG000|COMPLETED|Overall Study||21
2851126|NCT00391170|3553188|FG001|COMPLETED|Overall Study||23
2851127|NCT00391170|3553187|FG000|NOT COMPLETED|Overall Study||6
2851128|NCT00391170|3553188|FG001|NOT COMPLETED|Overall Study||4
2851129|NCT00359138|3553197|FG000|STARTED|Overall Study||12
2851130|NCT00359138|3553198|FG001|STARTED|Overall Study||12
2851131|NCT00359138|3553199|FG002|STARTED|Overall Study||12
2851132|NCT00359138|3553197|FG000|COMPLETED|Overall Study||12
2851133|NCT00359138|3553198|FG001|COMPLETED|Overall Study||12
2851134|NCT00359138|3553199|FG002|COMPLETED|Overall Study||12
2851135|NCT00359138|3553197|FG000|NOT COMPLETED|Overall Study||0
2851136|NCT00359138|3553198|FG001|NOT COMPLETED|Overall Study||0
2851137|NCT00359138|3553199|FG002|NOT COMPLETED|Overall Study||0
2851138|NCT00350701|3553210|FG000|STARTED|Overall Study||17
2851139|NCT00350701|3553211|FG001|STARTED|Overall Study||17
2851140|NCT00350701|3553212|FG002|STARTED|Overall Study||15
2851141|NCT00350701|3553210|FG000|COMPLETED|Overall Study||17
2851142|NCT00350701|3553211|FG001|COMPLETED|Overall Study||17
2851143|NCT00350701|3553212|FG002|COMPLETED|Overall Study||15
2851144|NCT00350701|3553210|FG000|NOT COMPLETED|Overall Study||0
2851145|NCT00350701|3553211|FG001|NOT COMPLETED|Overall Study||0
2851146|NCT00350701|3553212|FG002|NOT COMPLETED|Overall Study||0
2851147|NCT00319449|3553222|FG000|STARTED|Overall Study||10
2851148|NCT00319449|3553223|FG001|STARTED|Overall Study||12
2851149|NCT00319449|3553222|FG000|COMPLETED|Overall Study||8
2851150|NCT00319449|3553223|FG001|COMPLETED|Overall Study||12
2851151|NCT00319449|3553222|FG000|NOT COMPLETED|Overall Study||2
2851152|NCT00319449|3553223|FG001|NOT COMPLETED|Overall Study||0
2851153|NCT00305344|3553229|FG000|STARTED|Overall Study||23
2851154|NCT00305344|3553229|FG000|COMPLETED|Overall Study||23
2851155|NCT00305344|3553229|FG000|NOT COMPLETED|Overall Study||0
2851156|NCT00289887|3553235|FG000|STARTED|Overall Study||127
2851157|NCT00289887|3553236|FG001|STARTED|Overall Study||134
2851158|NCT00289887|3553235|FG000|COMPLETED|Overall Study||105
2851159|NCT00289887|3553236|FG001|COMPLETED|Overall Study||105
2851160|NCT00289887|3553235|FG000|NOT COMPLETED|Overall Study||22
2851161|NCT00289887|3553236|FG001|NOT COMPLETED|Overall Study||29
2851162|NCT00281320|3553244|FG000|STARTED|Overall Study||61
2851163|NCT00281320|3553245|FG001|STARTED|Overall Study||61
2851164|NCT00281320|3553244|FG000|COMPLETED|Overall Study||36
2851165|NCT00281320|3553245|FG001|COMPLETED|Overall Study||40
2851166|NCT00281320|3553244|FG000|NOT COMPLETED|Overall Study||25
2851167|NCT00281320|3553245|FG001|NOT COMPLETED|Overall Study||21
2851168|NCT00276016|3553263|FG000|STARTED|Intervention 1||7
2851169|NCT00276016|3553264|FG001|STARTED|Intervention 1||7
2851170|NCT00276016|3553265|FG002|STARTED|Intervention 1||7
2851171|NCT00276016|3553266|FG003|STARTED|Intervention 1||6
2851172|NCT00276016|3553267|FG004|STARTED|Intervention 1||6
2851173|NCT00276016|3553268|FG005|STARTED|Intervention 1||6
2851174|NCT00276016|3553263|FG000|COMPLETED|Intervention 1||7
2851175|NCT00276016|3553264|FG001|COMPLETED|Intervention 1||6
2851176|NCT00276016|3553265|FG002|COMPLETED|Intervention 1||7
2851177|NCT00276016|3553266|FG003|COMPLETED|Intervention 1||6
2851178|NCT00276016|3553267|FG004|COMPLETED|Intervention 1||6
2851179|NCT00276016|3553268|FG005|COMPLETED|Intervention 1||6
2851180|NCT00276016|3553263|FG000|NOT COMPLETED|Intervention 1||0
2851181|NCT00276016|3553264|FG001|NOT COMPLETED|Intervention 1||1
2851182|NCT00276016|3553265|FG002|NOT COMPLETED|Intervention 1||0
2851183|NCT00276016|3553266|FG003|NOT COMPLETED|Intervention 1||0
2851184|NCT00276016|3553267|FG004|NOT COMPLETED|Intervention 1||0
2851185|NCT00276016|3553268|FG005|NOT COMPLETED|Intervention 1||0
2851186|NCT00276016|3553263|FG000|STARTED|Wash Out 1||7
2851187|NCT00276016|3553264|FG001|STARTED|Wash Out 1||6
2851188|NCT00276016|3553265|FG002|STARTED|Wash Out 1||7
2851189|NCT00276016|3553266|FG003|STARTED|Wash Out 1||6
2851190|NCT00276016|3553267|FG004|STARTED|Wash Out 1||6
2851191|NCT00276016|3553268|FG005|STARTED|Wash Out 1||6
2851192|NCT00276016|3553263|FG000|COMPLETED|Wash Out 1||7
2851193|NCT00276016|3553264|FG001|COMPLETED|Wash Out 1||6
2851194|NCT00276016|3553265|FG002|COMPLETED|Wash Out 1||7
2851195|NCT00276016|3553266|FG003|COMPLETED|Wash Out 1||6
2851196|NCT00276016|3553267|FG004|COMPLETED|Wash Out 1||6
2851197|NCT00276016|3553268|FG005|COMPLETED|Wash Out 1||6
2851198|NCT00276016|3553263|FG000|NOT COMPLETED|Wash Out 1||0
2851199|NCT00276016|3553264|FG001|NOT COMPLETED|Wash Out 1||0
2851200|NCT00276016|3553265|FG002|NOT COMPLETED|Wash Out 1||0
2851201|NCT00276016|3553266|FG003|NOT COMPLETED|Wash Out 1||0
2851202|NCT00276016|3553267|FG004|NOT COMPLETED|Wash Out 1||0
2851203|NCT00276016|3553268|FG005|NOT COMPLETED|Wash Out 1||0
2851204|NCT00276016|3553263|FG000|STARTED|Intervention 2||7
2851205|NCT00276016|3553264|FG001|STARTED|Intervention 2||6
2851206|NCT00276016|3553265|FG002|STARTED|Intervention 2||7
2851207|NCT00276016|3553266|FG003|STARTED|Intervention 2||6
2851208|NCT00276016|3553267|FG004|STARTED|Intervention 2||6
2851209|NCT00276016|3553268|FG005|STARTED|Intervention 2||6
2851210|NCT00276016|3553263|FG000|COMPLETED|Intervention 2||7
2851211|NCT00276016|3553264|FG001|COMPLETED|Intervention 2||6
2851212|NCT00276016|3553265|FG002|COMPLETED|Intervention 2||7
2851213|NCT00276016|3553266|FG003|COMPLETED|Intervention 2||6
2851214|NCT00276016|3553267|FG004|COMPLETED|Intervention 2||6
2851215|NCT00276016|3553268|FG005|COMPLETED|Intervention 2||6
2851216|NCT00276016|3553263|FG000|NOT COMPLETED|Intervention 2||0
2851217|NCT00276016|3553264|FG001|NOT COMPLETED|Intervention 2||0
2851218|NCT00276016|3553265|FG002|NOT COMPLETED|Intervention 2||0
2851219|NCT00276016|3553266|FG003|NOT COMPLETED|Intervention 2||0
2851220|NCT00276016|3553267|FG004|NOT COMPLETED|Intervention 2||0
2851221|NCT00276016|3553268|FG005|NOT COMPLETED|Intervention 2||0
2851222|NCT00276016|3553263|FG000|STARTED|Wash Out 2||7
2851223|NCT00276016|3553264|FG001|STARTED|Wash Out 2||6
2851224|NCT00276016|3553265|FG002|STARTED|Wash Out 2||7
2851225|NCT00276016|3553266|FG003|STARTED|Wash Out 2||6
2851226|NCT00276016|3553267|FG004|STARTED|Wash Out 2||6
2851227|NCT00276016|3553268|FG005|STARTED|Wash Out 2||6
2851228|NCT00276016|3553263|FG000|COMPLETED|Wash Out 2||7
2851229|NCT00276016|3553264|FG001|COMPLETED|Wash Out 2||6
2851230|NCT00276016|3553265|FG002|COMPLETED|Wash Out 2||7
2851231|NCT00276016|3553266|FG003|COMPLETED|Wash Out 2||6
2851232|NCT00276016|3553267|FG004|COMPLETED|Wash Out 2||6
2851233|NCT00276016|3553268|FG005|COMPLETED|Wash Out 2||6
2851234|NCT00276016|3553263|FG000|NOT COMPLETED|Wash Out 2||0
2851235|NCT00276016|3553264|FG001|NOT COMPLETED|Wash Out 2||0
2851236|NCT00276016|3553265|FG002|NOT COMPLETED|Wash Out 2||0
2851237|NCT00276016|3553266|FG003|NOT COMPLETED|Wash Out 2||0
2851238|NCT00276016|3553267|FG004|NOT COMPLETED|Wash Out 2||0
2851239|NCT00276016|3553268|FG005|NOT COMPLETED|Wash Out 2||0
2851240|NCT00276016|3553263|FG000|STARTED|Intervention 3||7
2851241|NCT00276016|3553264|FG001|STARTED|Intervention 3||6
2851242|NCT00276016|3553265|FG002|STARTED|Intervention 3||7
2851243|NCT00276016|3553266|FG003|STARTED|Intervention 3||6
2851244|NCT00276016|3553267|FG004|STARTED|Intervention 3||6
2851245|NCT00276016|3553268|FG005|STARTED|Intervention 3||6
2851246|NCT00276016|3553263|FG000|COMPLETED|Intervention 3||7
2851247|NCT00276016|3553264|FG001|COMPLETED|Intervention 3||6
2851248|NCT00276016|3553265|FG002|COMPLETED|Intervention 3||7
2851249|NCT00276016|3553266|FG003|COMPLETED|Intervention 3||6
2851250|NCT00276016|3553267|FG004|COMPLETED|Intervention 3||6
2851251|NCT00276016|3553268|FG005|COMPLETED|Intervention 3||6
2851252|NCT00276016|3553263|FG000|NOT COMPLETED|Intervention 3||0
2851253|NCT00276016|3553264|FG001|NOT COMPLETED|Intervention 3||0
2851254|NCT00276016|3553265|FG002|NOT COMPLETED|Intervention 3||0
2851255|NCT00276016|3553266|FG003|NOT COMPLETED|Intervention 3||0
2851256|NCT00276016|3553267|FG004|NOT COMPLETED|Intervention 3||0
2851257|NCT00276016|3553268|FG005|NOT COMPLETED|Intervention 3||0
2851258|NCT00265343|3553279|FG000|STARTED|Overall Study||134
2851259|NCT00265343|3553280|FG001|STARTED|Overall Study||172
2851260|NCT00265343|3553279|FG000|COMPLETED|Overall Study||113
2851261|NCT00265343|3553280|FG001|COMPLETED|Overall Study||153
2851262|NCT00265343|3553279|FG000|NOT COMPLETED|Overall Study||21
2851263|NCT00265343|3553280|FG001|NOT COMPLETED|Overall Study||19
2851264|NCT00264147|3553291|FG000|STARTED|Treatment I Period||161
2851265|NCT00264147|3553292|FG001|STARTED|Treatment I Period||154
2851266|NCT00264147|3553293|FG002|STARTED|Treatment I Period||151
2851267|NCT00264147|3553294|FG003|STARTED|Treatment I Period||140
2851268|NCT00264147|3553295|FG004|STARTED|Treatment I Period||155
2851269|NCT00264147|3553296|FG005|STARTED|Treatment I Period||0
2851270|NCT00264147|3553291|FG000|COMPLETED|Treatment I Period|Randomized to Treatment I period and remained on Treatment I period during course of study|63
2851271|NCT00264147|3553292|FG001|COMPLETED|Treatment I Period|Randomized to Treatment I period and remained on Treatment I period during course of study|71
2851272|NCT00264147|3553293|FG002|COMPLETED|Treatment I Period|Randomized to Treatment I period and remained on Treatment I period during course of study|74
2851273|NCT00264147|3553294|FG003|COMPLETED|Treatment I Period|Randomized to Treatment I period and remained on Treatment I period during course of study|68
2851274|NCT00264147|3553295|FG004|COMPLETED|Treatment I Period|Randomized to Treatment I period and remained on Treatment I period during course of study|99
2851275|NCT00264147|3553296|FG005|COMPLETED|Treatment I Period||0
2851276|NCT00264147|3553291|FG000|NOT COMPLETED|Treatment I Period||98
2851277|NCT00264147|3553292|FG001|NOT COMPLETED|Treatment I Period||83
2851278|NCT00264147|3553293|FG002|NOT COMPLETED|Treatment I Period||77
2851279|NCT00264147|3553294|FG003|NOT COMPLETED|Treatment I Period||72
2851280|NCT00264147|3553295|FG004|NOT COMPLETED|Treatment I Period||56
2851281|NCT00264147|3553296|FG005|NOT COMPLETED|Treatment I Period||0
2851282|NCT00264147|3553291|FG000|STARTED|Treatment II Period||0
2851283|NCT00264147|3553292|FG001|STARTED|Treatment II Period||0
2851284|NCT00264147|3553293|FG002|STARTED|Treatment II Period||0
2851285|NCT00264147|3553294|FG003|STARTED|Treatment II Period||0
2851286|NCT00264147|3553295|FG004|STARTED|Treatment II Period|Etoricoxib 10 mg (38), 30 mg (28), 60 mg (33), 90 mg (45) and placebo (36) reassigned to 90 mg (180)|180
2851287|NCT00264147|3553296|FG005|STARTED|Treatment II Period|Etoricoxib 10 mg (34), 30 mg (37), 60 mg (29), and placebo (49) reassigned to diclofenac (149)|149
2851288|NCT00264147|3553291|FG000|COMPLETED|Treatment II Period||0
2851289|NCT00264147|3553292|FG001|COMPLETED|Treatment II Period||0
2851290|NCT00264147|3553293|FG002|COMPLETED|Treatment II Period||0
2851291|NCT00264147|3553294|FG003|COMPLETED|Treatment II Period||0
2851292|NCT00264147|3553295|FG004|COMPLETED|Treatment II Period||147
2851293|NCT00264147|3553296|FG005|COMPLETED|Treatment II Period||116
2851294|NCT00264147|3553291|FG000|NOT COMPLETED|Treatment II Period||0
2851295|NCT00264147|3553292|FG001|NOT COMPLETED|Treatment II Period||0
2851296|NCT00264147|3553293|FG002|NOT COMPLETED|Treatment II Period||0
2851297|NCT00264147|3553294|FG003|NOT COMPLETED|Treatment II Period||0
2851298|NCT00264147|3553295|FG004|NOT COMPLETED|Treatment II Period||33
2851299|NCT00264147|3553296|FG005|NOT COMPLETED|Treatment II Period||33
2851300|NCT00202878|3553312|FG000|STARTED|Overall Study||9067
2851301|NCT00202878|3553313|FG001|STARTED|Overall Study||9077
2851302|NCT00202878|3553312|FG000|COMPLETED|Overall Study||6868
2851303|NCT00202878|3553313|FG001|COMPLETED|Overall Study||6860
2851304|NCT00202878|3553312|FG000|NOT COMPLETED|Overall Study||2199
2851305|NCT00202878|3553313|FG001|NOT COMPLETED|Overall Study||2217
2851306|NCT00174265|3553321|FG000|STARTED|Overall Study|85 participants received randomized treatment assignment and at least one dose of study medication.|86
2851307|NCT00174265|3553322|FG001|STARTED|Overall Study||110
2851308|NCT00174265|3553321|FG000|COMPLETED|Overall Study||57
2851309|NCT00174265|3553322|FG001|COMPLETED|Overall Study||89
2851310|NCT00174265|3553321|FG000|NOT COMPLETED|Overall Study||29
2851311|NCT00174265|3553322|FG001|NOT COMPLETED|Overall Study||21
2851312|NCT00159783|3553331|FG000|STARTED|Overall Study||32
2851313|NCT00159783|3553332|FG001|STARTED|Overall Study||79
2851314|NCT00159783|3553333|FG002|STARTED|Overall Study||107
2851315|NCT00159783|3553331|FG000|COMPLETED|Overall Study||13
2851316|NCT00159783|3553332|FG001|COMPLETED|Overall Study||52
2851317|NCT00159783|3553333|FG002|COMPLETED|Overall Study||68
2851318|NCT00159783|3553331|FG000|NOT COMPLETED|Overall Study||19
2851319|NCT00159783|3553332|FG001|NOT COMPLETED|Overall Study||27
2851320|NCT00159783|3553333|FG002|NOT COMPLETED|Overall Study||39
2851321|NCT00114101|3553344|FG000|STARTED|Overall Study||231
2851322|NCT00114101|3553345|FG001|STARTED|Overall Study||229
2851323|NCT00114101|3553344|FG000|COMPLETED|Overall Study||231
2851324|NCT00114101|3553345|FG001|COMPLETED|Overall Study||229
2851325|NCT00114101|3553344|FG000|NOT COMPLETED|Overall Study||0
2851326|NCT00114101|3553345|FG001|NOT COMPLETED|Overall Study||0
2851327|NCT00092677|3553355|FG000|STARTED|Overall Study||944
2851328|NCT00092677|3553356|FG001|STARTED|Overall Study||929
2851329|NCT00092677|3553355|FG000|COMPLETED|Overall Study|EZ/Simva: 694 (on drug), 140 (after drug discon), 105 (at death)|939
2851330|NCT00092677|3553356|FG001|COMPLETED|Overall Study|Placebo: 698 (on drug), 120 (after drug discon), 100 (at death)|918
2851331|NCT00092677|3553355|FG000|NOT COMPLETED|Overall Study||5
2851332|NCT00092677|3553356|FG001|NOT COMPLETED|Overall Study||11
2851333|NCT00090259|3553364|FG000|STARTED|Overall Study||1913
2851334|NCT00090259|3553365|FG001|STARTED|Overall Study||1921
2851335|NCT00090259|3553364|FG000|COMPLETED|Overall Study|Completed follow-up: 963 on drug, 223 off drug, & 665 at death (death was considered an endpoint)|1851
2851336|NCT00090259|3553365|FG001|COMPLETED|Overall Study|Completed follow-up: 1005 on drug, 233 off drug,& 635 at death (death was considered an endpoint)|1873
2851337|NCT00090259|3553364|FG000|NOT COMPLETED|Overall Study||62
2851338|NCT00090259|3553365|FG001|NOT COMPLETED|Overall Study||48
2851339|NCT00003298|3553371|FG000|STARTED|Step 1 (Neoadjuvant Therapy)||39
2851340|NCT00003298|3553371|FG000|Eligible and Treated|Step 1 (Neoadjuvant Therapy)||38
2851341|NCT00003298|3553371|FG000|Complete 3 Cycles of Neoadjuvant Therapy|Step 1 (Neoadjuvant Therapy)||35
2851342|NCT00003298|3553371|FG000|COMPLETED|Step 1 (Neoadjuvant Therapy)||35
2851343|NCT00003298|3553371|FG000|NOT COMPLETED|Step 1 (Neoadjuvant Therapy)||4
2851344|NCT00003298|3553371|FG000|STARTED|Surgery||35
2851345|NCT00003298|3553371|FG000|COMPLETED|Surgery|1 patient did not complete neoadjuvant therapy but went to surgery anyway, not included here.|28
2851346|NCT00003298|3553371|FG000|NOT COMPLETED|Surgery||7
2851347|NCT00003298|3553371|FG000|STARTED|Re-register to Step 2 After Surgery||28
2851348|NCT00003298|3553371|FG000|COMPLETED|Re-register to Step 2 After Surgery||10
2851349|NCT00003298|3553371|FG000|NOT COMPLETED|Re-register to Step 2 After Surgery||18
2851350|NCT00003298|3553371|FG000|STARTED|Step 2 (Adjuvant Therapy)||10
2851351|NCT00003298|3553371|FG000|Eligible and Treated on Step 2|Step 2 (Adjuvant Therapy)||7
2851352|NCT00003298|3553371|FG000|COMPLETED|Step 2 (Adjuvant Therapy)||4
2851353|NCT00003298|3553371|FG000|NOT COMPLETED|Step 2 (Adjuvant Therapy)||6
2851354|NCT00003377|3553381|FG000|STARTED|Period I||3
2851355|NCT00003377|3553382|FG001|STARTED|Period I||3
2851356|NCT00003377|3553383|FG002|STARTED|Period I||3
2851357|NCT00003377|3553384|FG003|STARTED|Period I||3
2851358|NCT00003377|3553385|FG004|STARTED|Period I||0
2851359|NCT00003377|3553381|FG000|COMPLETED|Period I||3
2851360|NCT00003377|3553382|FG001|COMPLETED|Period I||3
2851361|NCT00003377|3553383|FG002|COMPLETED|Period I||2
2851362|NCT00003377|3553384|FG003|COMPLETED|Period I||2
2851363|NCT00003377|3553385|FG004|COMPLETED|Period I||0
2851364|NCT00003377|3553381|FG000|NOT COMPLETED|Period I||0
2851365|NCT00003377|3553382|FG001|NOT COMPLETED|Period I||0
2851366|NCT00003377|3553383|FG002|NOT COMPLETED|Period I||1
2851367|NCT00003377|3553384|FG003|NOT COMPLETED|Period I||1
2851368|NCT00003377|3553385|FG004|NOT COMPLETED|Period I||0
2851369|NCT00003377|3553381|FG000|STARTED|Period II|Patients participated at this dose level only in Period I.|0
2851370|NCT00003377|3553382|FG001|STARTED|Period II|Patients participated at this dose level only in Period I.|0
2851371|NCT00003377|3553383|FG002|STARTED|Period II|Patients participated at this dose level only in Period I.|0
2851372|NCT00003377|3553384|FG003|STARTED|Period II|Patients participated at this dose level only in Period I.|0
2851373|NCT00003377|3553385|FG004|STARTED|Period II|All pts enrolled on Per II received cisplatin 40 mg/m2 & paclitaxel 40 mg/m2 concurrent w/ radiation|17
2851374|NCT00003377|3553381|FG000|COMPLETED|Period II||0
2851375|NCT00003377|3553382|FG001|COMPLETED|Period II||0
2851376|NCT00003377|3553383|FG002|COMPLETED|Period II||0
2851377|NCT00003377|3553384|FG003|COMPLETED|Period II||0
2851378|NCT00003377|3553385|FG004|COMPLETED|Period II||16
2851379|NCT00003377|3553381|FG000|NOT COMPLETED|Period II||0
2851380|NCT00003377|3553382|FG001|NOT COMPLETED|Period II||0
2851381|NCT00003377|3553383|FG002|NOT COMPLETED|Period II||0
2851382|NCT00003377|3553384|FG003|NOT COMPLETED|Period II||0
2851383|NCT00003377|3553385|FG004|NOT COMPLETED|Period II||1
2851384|NCT00003389|3553400|FG000|STARTED|Overall Study||428
2851385|NCT00003389|3553401|FG001|STARTED|Overall Study||426
2851386|NCT00003389|3553400|FG000|Treated Pts w/ Toxicity Data Available|Overall Study||414
2851387|NCT00003389|3553401|FG001|Treated Pts w/ Toxicity Data Available|Overall Study||422
2851388|NCT00003389|3553400|FG000|Eligible Patients|Overall Study||395
2851389|NCT00003389|3553401|FG001|Eligible Patients|Overall Study||399
2851390|NCT00003389|3553400|FG000|COMPLETED|Overall Study||330
2851391|NCT00003389|3553401|FG001|COMPLETED|Overall Study||366
2851392|NCT00003389|3553400|FG000|NOT COMPLETED|Overall Study||98
2851393|NCT00003389|3553401|FG001|NOT COMPLETED|Overall Study||60
2851394|NCT00003404|3553407|FG000|STARTED|Overall Study||46
2851395|NCT00003404|3553407|FG000|COMPLETED|Overall Study||46
2851396|NCT00003404|3553407|FG000|NOT COMPLETED|Overall Study||0
2851397|NCT00003453|3553412|FG000|STARTED|Overall Study||6
2851398|NCT00003453|3553412|FG000|COMPLETED|Overall Study|One patient was not evaluable|5
2851399|NCT00003453|3553412|FG000|NOT COMPLETED|Overall Study||1
2851400|NCT00003456|3553416|FG000|STARTED|Overall Study||40
2851401|NCT00003456|3553416|FG000|COMPLETED|Overall Study||32
2851402|NCT00003456|3553416|FG000|NOT COMPLETED|Overall Study||8
2851403|NCT00003457|3553420|FG000|STARTED|Overall Study||40
2851404|NCT00003457|3553420|FG000|COMPLETED|Overall Study||31
2851405|NCT00003457|3553420|FG000|NOT COMPLETED|Overall Study||9
2851406|NCT00003459|3553424|FG000|STARTED|Overall Study||40
2851407|NCT00003459|3553424|FG000|COMPLETED|Overall Study|Nine patients were not evaluable.|31
2851408|NCT00003459|3553424|FG000|NOT COMPLETED|Overall Study||9
2851409|NCT00003460|3553428|FG000|STARTED|Overall Study||13
2851410|NCT00003460|3553428|FG000|COMPLETED|Overall Study|One patient was not evaluable.|12
2851411|NCT00003460|3553428|FG000|NOT COMPLETED|Overall Study||1
2851412|NCT00003468|3553432|FG000|STARTED|Overall Study||11
2851413|NCT00003468|3553432|FG000|COMPLETED|Overall Study|Two patients were not evaluable.|9
2851414|NCT00003468|3553432|FG000|NOT COMPLETED|Overall Study||2
2851415|NCT00003469|3553436|FG000|STARTED|Overall Study||4
2851416|NCT00003469|3553436|FG000|COMPLETED|Overall Study||4
2851417|NCT00003469|3553436|FG000|NOT COMPLETED|Overall Study||0
2851418|NCT00003470|3553440|FG000|STARTED|Overall Study||27
2851419|NCT00003470|3553440|FG000|COMPLETED|Overall Study||21
2851420|NCT00003470|3553440|FG000|NOT COMPLETED|Overall Study||6
2851421|NCT00003471|3553444|FG000|STARTED|Overall Study||7
2851422|NCT00003471|3553444|FG000|COMPLETED|Overall Study||3
2851423|NCT00003471|3553444|FG000|NOT COMPLETED|Overall Study||4
2851424|NCT00003472|3553448|FG000|STARTED|Overall Study||13
2851425|NCT00003472|3553448|FG000|COMPLETED|Overall Study||10
2851426|NCT00003472|3553448|FG000|NOT COMPLETED|Overall Study||3
2851427|NCT00003473|3553452|FG000|STARTED|Overall Study||20
2851428|NCT00003473|3553452|FG000|COMPLETED|Overall Study||17
2851429|NCT00003473|3553452|FG000|NOT COMPLETED|Overall Study||3
2851430|NCT00003474|3553456|FG000|STARTED|Overall Study||40
2851431|NCT00003474|3553456|FG000|COMPLETED|Overall Study||26
2851432|NCT00003474|3553456|FG000|NOT COMPLETED|Overall Study||14
2851433|NCT00003475|3553460|FG000|STARTED|Overall Study||40
2851434|NCT00003475|3553460|FG000|COMPLETED|Overall Study||27
2851435|NCT00003475|3553460|FG000|NOT COMPLETED|Overall Study||13
2851436|NCT00003476|3553465|FG000|STARTED|Overall Study||8
2851437|NCT00003476|3553465|FG000|COMPLETED|Overall Study||7
2851438|NCT00003476|3553465|FG000|NOT COMPLETED|Overall Study||1
2851439|NCT00003477|3553469|FG000|STARTED|Overall Study||12
2851440|NCT00003477|3553469|FG000|COMPLETED|Overall Study||8
2851441|NCT00003477|3553469|FG000|NOT COMPLETED|Overall Study||4
2851442|NCT00003483|3553473|FG000|STARTED|Overall Study||3
2851443|NCT00003483|3553473|FG000|COMPLETED|Overall Study||2
2851444|NCT00003483|3553473|FG000|NOT COMPLETED|Overall Study||1
2851445|NCT00003487|3553477|FG000|STARTED|Overall Study||8
2851446|NCT00003487|3553477|FG000|COMPLETED|Overall Study||6
2851447|NCT00003487|3553477|FG000|NOT COMPLETED|Overall Study||2
2851448|NCT00003492|3553481|FG000|STARTED|Overall Study||9
2851449|NCT00003492|3553481|FG000|COMPLETED|Overall Study||3
2851450|NCT00003492|3553481|FG000|NOT COMPLETED|Overall Study||6
2851451|NCT00003498|3553485|FG000|STARTED|Overall Study||5
2851452|NCT00003498|3553485|FG000|COMPLETED|Overall Study||1
2851453|NCT00003498|3553485|FG000|NOT COMPLETED|Overall Study||4
2851454|NCT00003499|3553489|FG000|STARTED|Overall Study||31
2851455|NCT00003499|3553489|FG000|COMPLETED|Overall Study||23
2851456|NCT00003499|3553489|FG000|NOT COMPLETED|Overall Study||8
2851457|NCT00003508|3553493|FG000|STARTED|Overall Study||8
2851458|NCT00003508|3553493|FG000|COMPLETED|Overall Study||3
2851459|NCT00003508|3553493|FG000|NOT COMPLETED|Overall Study||5
2851460|NCT00003509|3553497|FG000|STARTED|Overall Study||13
2851461|NCT00003509|3553497|FG000|COMPLETED|Overall Study||8
2851462|NCT00003509|3553497|FG000|NOT COMPLETED|Overall Study||5
2851463|NCT00003511|3553501|FG000|STARTED|Overall Study||5
2851464|NCT00003511|3553501|FG000|COMPLETED|Overall Study||1
2851465|NCT00003511|3553501|FG000|NOT COMPLETED|Overall Study||4
2851466|NCT00003526|3553505|FG000|STARTED|Overall Study||8
2851467|NCT00003526|3553505|FG000|COMPLETED|Overall Study||2
2851468|NCT00003526|3553505|FG000|NOT COMPLETED|Overall Study||6
2851469|NCT00003531|3553509|FG000|STARTED|Overall Study||15
2851470|NCT00003531|3553509|FG000|COMPLETED|Overall Study||5
2851471|NCT00003531|3553509|FG000|NOT COMPLETED|Overall Study||10
2851472|NCT00003535|3553513|FG000|STARTED|Overall Study||9
2851473|NCT00003535|3553513|FG000|COMPLETED|Overall Study||4
2851474|NCT00003535|3553513|FG000|NOT COMPLETED|Overall Study||5
2851475|NCT00003537|3553517|FG000|STARTED|Overall Study||19
2851476|NCT00003537|3553517|FG000|COMPLETED|Overall Study||18
2851477|NCT00003537|3553517|FG000|NOT COMPLETED|Overall Study||1
2851478|NCT00003590|3553521|FG000|STARTED|Overall Study||29
2851479|NCT00003590|3553521|FG000|Eligible|Overall Study||28
2851480|NCT00003590|3553521|FG000|Eligible and Began Protocol Therapy|Overall Study||28
2851481|NCT00003590|3553521|FG000|COMPLETED|Overall Study|Patients were to receive Hydroxyurea up to 2 years in absence of progressive disease.|7
2851482|NCT00003590|3553521|FG000|NOT COMPLETED|Overall Study||22
2851483|NCT00003631|3553528|FG000|STARTED|Overall Study||50
2851484|NCT00003631|3553529|FG001|STARTED|Overall Study||44
2851485|NCT00003631|3553530|FG002|STARTED|Overall Study||24
2851486|NCT00003631|3553528|FG000|COMPLETED|Overall Study||47
2851487|NCT00003631|3553529|FG001|COMPLETED|Overall Study||43
2851488|NCT00003631|3553530|FG002|COMPLETED|Overall Study||15
2851489|NCT00003631|3553528|FG000|NOT COMPLETED|Overall Study||3
2851490|NCT00003631|3553529|FG001|NOT COMPLETED|Overall Study||1
2851491|NCT00003631|3553530|FG002|NOT COMPLETED|Overall Study||9
2851492|NCT00003641|3553540|FG000|STARTED|Overall Study||569
2851493|NCT00003641|3553541|FG001|STARTED|Overall Study||581
2851494|NCT00003641|3553540|FG000|Treated|Overall Study|Patients on arm I should undergo observation, but 2 patients received interferon therapy|2
2851495|NCT00003641|3553541|FG001|Treated|Overall Study||569
2851496|NCT00003641|3553540|FG000|Toxicity Assessed|Overall Study|439 patients on arm I had their toxicity assessed even though they did not receive any treatment|439
2851497|NCT00003641|3553541|FG001|Toxicity Assessed|Overall Study||568
2851498|NCT00003641|3553540|FG000|COMPLETED|Overall Study||0
2851499|NCT00003641|3553541|FG001|COMPLETED|Overall Study||407
2851500|NCT00003641|3553540|FG000|NOT COMPLETED|Overall Study||569
2851501|NCT00003641|3553541|FG001|NOT COMPLETED|Overall Study||174
2851502|NCT00003644|3553549|FG000|STARTED|Overall Study||289
2851503|NCT00003644|3553550|FG001|STARTED|Overall Study||282
2851504|NCT00003644|3553549|FG000|COMPLETED|Overall Study||274
2851505|NCT00003644|3553550|FG001|COMPLETED|Overall Study||268
2851506|NCT00003644|3553549|FG000|NOT COMPLETED|Overall Study||15
2851507|NCT00003644|3553550|FG001|NOT COMPLETED|Overall Study||14
2851508|NCT00003645|3553560|FG000|STARTED|Overall Study||30
2851509|NCT00003645|3553561|FG001|STARTED|Overall Study||34
2851510|NCT00003645|3553560|FG000|COMPLETED|Overall Study||18
2851511|NCT00003645|3553561|FG001|COMPLETED|Overall Study||22
2851512|NCT00003645|3553560|FG000|NOT COMPLETED|Overall Study||12
2851513|NCT00003645|3553561|FG001|NOT COMPLETED|Overall Study||12
2851514|NCT00003659|3553569|FG000|STARTED|Overall Study||39
2851515|NCT00003659|3553569|FG000|COMPLETED|Overall Study||36
2851516|NCT00003659|3553569|FG000|NOT COMPLETED|Overall Study||3
2851517|NCT00003702|3553575|FG000|STARTED|Overall Study||120
2851518|NCT00003702|3553576|FG001|STARTED|Overall Study||120
2851519|NCT00003702|3553575|FG000|COMPLETED|Overall Study||107
2851520|NCT00003702|3553576|FG001|COMPLETED|Overall Study||109
2851521|NCT00003702|3553575|FG000|NOT COMPLETED|Overall Study||13
2851522|NCT00003702|3553576|FG001|NOT COMPLETED|Overall Study||11
3168463|NCT01919164|3895759|FG001|STARTED|Overall Study||110
3168464|NCT01919164|3895760|FG002|STARTED|Overall Study||111
2851523|NCT00003782|3553586|FG000|STARTED|Overall Study||1783
2851524|NCT00003782|3553587|FG001|STARTED|Overall Study||1784
2851525|NCT00003782|3553588|FG002|STARTED|Overall Study||1784
2851526|NCT00003782|3553586|FG000|COMPLETED|Overall Study||1753
2851527|NCT00003782|3553587|FG001|COMPLETED|Overall Study||1753
2851528|NCT00003782|3553588|FG002|COMPLETED|Overall Study||1758
2851529|NCT00003782|3553586|FG000|NOT COMPLETED|Overall Study||30
2851530|NCT00003782|3553587|FG001|NOT COMPLETED|Overall Study||31
2851531|NCT00003782|3553588|FG002|NOT COMPLETED|Overall Study||26
2851532|NCT00003816|3553601|FG000|STARTED|Overall Study||55
2851533|NCT00003816|3553602|FG001|STARTED|Overall Study||69
2851534|NCT00003816|3553603|FG002|STARTED|Overall Study||199
2851535|NCT00003816|3553604|FG003|STARTED|Overall Study||23
2851536|NCT00003816|3553605|FG004|STARTED|Overall Study||15
2851537|NCT00003816|3553601|FG000|COMPLETED|Overall Study||55
2851538|NCT00003816|3553602|FG001|COMPLETED|Overall Study||69
2851539|NCT00003816|3553603|FG002|COMPLETED|Overall Study||199
2851540|NCT00003816|3553604|FG003|COMPLETED|Overall Study||23
2851541|NCT00003816|3553605|FG004|COMPLETED|Overall Study||15
2851542|NCT00003816|3553601|FG000|NOT COMPLETED|Overall Study||0
2851543|NCT00003816|3553602|FG001|NOT COMPLETED|Overall Study||0
2851544|NCT00003816|3553603|FG002|NOT COMPLETED|Overall Study||0
2851545|NCT00003816|3553604|FG003|NOT COMPLETED|Overall Study||0
2851546|NCT00003816|3553605|FG004|NOT COMPLETED|Overall Study||0
2851547|NCT00003820|3553617|FG000|STARTED|Cycle 1 (Initial Treatment)||23
2851548|NCT00003820|3553618|FG001|STARTED|Cycle 1 (Initial Treatment)||16
2851549|NCT00003820|3553617|FG000|COMPLETED|Cycle 1 (Initial Treatment)||23
2851550|NCT00003820|3553618|FG001|COMPLETED|Cycle 1 (Initial Treatment)||16
2851551|NCT00003820|3553617|FG000|NOT COMPLETED|Cycle 1 (Initial Treatment)||0
2851552|NCT00003820|3553618|FG001|NOT COMPLETED|Cycle 1 (Initial Treatment)||0
2851553|NCT00003820|3553617|FG000|STARTED|Cycle 2 (Maintenance Treatment)|Initial Group of participants only received 1 cycle of treatment|0
2851554|NCT00003820|3553618|FG001|STARTED|Cycle 2 (Maintenance Treatment)|Pts with treatment response/stable disease at 6 mos, & eligible to continue.|16
2851555|NCT00003820|3553617|FG000|COMPLETED|Cycle 2 (Maintenance Treatment)||0
2851556|NCT00003820|3553618|FG001|COMPLETED|Cycle 2 (Maintenance Treatment)|Patients with treatment assessment at 12 months|16
2851557|NCT00003820|3553617|FG000|NOT COMPLETED|Cycle 2 (Maintenance Treatment)||0
2851558|NCT00003820|3553618|FG001|NOT COMPLETED|Cycle 2 (Maintenance Treatment)||0
2851559|NCT00003820|3553617|FG000|STARTED|Cycle 3 (Maintenance Treatment)|Initial Group of participants only received 1 cycle of treatment|0
2851560|NCT00003820|3553618|FG001|STARTED|Cycle 3 (Maintenance Treatment)|Patients with treatment response/stable disease at 12 months|16
2851561|NCT00003820|3553617|FG000|COMPLETED|Cycle 3 (Maintenance Treatment)||0
2851562|NCT00003820|3553618|FG001|COMPLETED|Cycle 3 (Maintenance Treatment)|Patients with treatment assessment at 18 months|16
2851563|NCT00003820|3553617|FG000|NOT COMPLETED|Cycle 3 (Maintenance Treatment)||0
2851564|NCT00003820|3553618|FG001|NOT COMPLETED|Cycle 3 (Maintenance Treatment)||0
2851565|NCT00003820|3553617|FG000|STARTED|Cycle 4 (Maintenance Treatment)|Initial Group of participants only received 1 cycle of treatment|0
2851566|NCT00003820|3553618|FG001|STARTED|Cycle 4 (Maintenance Treatment)|Patients with treatment response/stable disease at 18 months|16
2851567|NCT00003820|3553617|FG000|COMPLETED|Cycle 4 (Maintenance Treatment)||0
2851568|NCT00003820|3553618|FG001|COMPLETED|Cycle 4 (Maintenance Treatment)|Patients with treatment assessment at 24 months|16
2851569|NCT00003820|3553617|FG000|NOT COMPLETED|Cycle 4 (Maintenance Treatment)||0
2851570|NCT00003820|3553618|FG001|NOT COMPLETED|Cycle 4 (Maintenance Treatment)||0
2851571|NCT00003830|3553626|FG000|STARTED|Overall Study||2807
2851572|NCT00003830|3553627|FG001|STARTED|Overall Study||2804
2851573|NCT00003830|3553626|FG000|COMPLETED|Overall Study||1975
2851574|NCT00003830|3553627|FG001|COMPLETED|Overall Study||2011
3168465|NCT01919164|3895761|FG003|STARTED|Overall Study||110
3168466|NCT01919164|3895762|FG004|STARTED|Overall Study||110
3168467|NCT01919164|3895758|FG000|Safety Analysis Set|Overall Study||107
3168468|NCT01919164|3895759|FG001|Safety Analysis Set|Overall Study|1 participant assigned to Placebo arm who inadvertently received 30 mcg was included in this arm.|109
2851575|NCT00003830|3553626|FG000|NOT COMPLETED|Overall Study||832
2851576|NCT00003830|3553627|FG001|NOT COMPLETED|Overall Study||793
2851577|NCT00003869|3553637|FG000|STARTED|Overall Study||94
2851578|NCT00003869|3553638|FG001|STARTED|Overall Study||92
2851579|NCT00003869|3553637|FG000|COMPLETED|Overall Study||53
2851580|NCT00003869|3553638|FG001|COMPLETED|Overall Study||80
2851581|NCT00003869|3553637|FG000|NOT COMPLETED|Overall Study||41
2851582|NCT00003869|3553638|FG001|NOT COMPLETED|Overall Study||12
2851583|NCT00003875|3553644|FG000|STARTED|Overall Study||30
2851584|NCT00003875|3553644|FG000|COMPLETED|Overall Study||29
2851585|NCT00003875|3553644|FG000|NOT COMPLETED|Overall Study||1
2851586|NCT00003895|3553650|FG000|STARTED|Overall Study||18
2851587|NCT00003895|3553651|FG001|STARTED|Overall Study||18
2851588|NCT00003895|3553650|FG000|COMPLETED|Overall Study||11
2851589|NCT00003895|3553651|FG001|COMPLETED|Overall Study||14
2851590|NCT00003895|3553650|FG000|NOT COMPLETED|Overall Study||7
2851591|NCT00003895|3553651|FG001|NOT COMPLETED|Overall Study||4
2851592|NCT00003896|3553657|FG000|STARTED|Overall Study||68
2851593|NCT00003896|3553657|FG000|Eligible|Overall Study|2 eligible patients did not have any toxicity assessments reported.|63
2851594|NCT00003896|3553657|FG000|COMPLETED|Overall Study||39
2851595|NCT00003896|3553657|FG000|NOT COMPLETED|Overall Study||29
2851596|NCT00003901|3553662|FG000|STARTED|Overall Study||1047
2851597|NCT00003901|3553662|FG000|COMPLETED|Overall Study||1030
2851598|NCT00003901|3553662|FG000|NOT COMPLETED|Overall Study||17
2851599|NCT00003907|3553671|FG000|STARTED|Overall Study||19
2851600|NCT00003907|3553672|FG001|STARTED|Overall Study||31
2851601|NCT00003907|3553671|FG000|Eligible|Overall Study||18
2851602|NCT00003907|3553672|FG001|Eligible|Overall Study||29
2851603|NCT00003907|3553671|FG000|Received Protocol Therapy (Treated)|Overall Study||18
2851604|NCT00003907|3553672|FG001|Received Protocol Therapy (Treated)|Overall Study||31
2851605|NCT00003907|3553671|FG000|Eligible and Treated|Overall Study||17
2851606|NCT00003907|3553672|FG001|Eligible and Treated|Overall Study||29
2851607|NCT00003907|3553671|FG000|COMPLETED|Overall Study||6
2851608|NCT00003907|3553672|FG001|COMPLETED|Overall Study||8
2851609|NCT00003907|3553671|FG000|NOT COMPLETED|Overall Study||13
2851610|NCT00003907|3553672|FG001|NOT COMPLETED|Overall Study||23
2851611|NCT00003910|3553678|FG000|STARTED|Step 1|Of 59 (step 1), 4 pts were ineligible.|55
2851612|NCT00003910|3553679|FG001|STARTED|Step 1||0
2851613|NCT00003910|3553678|FG000|COMPLETED|Step 1||55
2851614|NCT00003910|3553679|FG001|COMPLETED|Step 1||0
2851615|NCT00003910|3553678|FG000|NOT COMPLETED|Step 1||0
2851616|NCT00003910|3553679|FG001|NOT COMPLETED|Step 1||0
2851617|NCT00003910|3553678|FG000|STARTED|Step 2||0
2851618|NCT00003910|3553679|FG001|STARTED|Step 2|The 16 includes 2 ineligible pts.|16
2851619|NCT00003910|3553678|FG000|COMPLETED|Step 2||0
2851620|NCT00003910|3553679|FG001|COMPLETED|Step 2||16
2851621|NCT00003910|3553678|FG000|NOT COMPLETED|Step 2||0
2851622|NCT00003910|3553679|FG001|NOT COMPLETED|Step 2||0
2851623|NCT00004031|3553687|FG000|STARTED|Overall Study||128
2851624|NCT00004031|3553688|FG001|STARTED|Overall Study||125
2851625|NCT00004031|3553687|FG000|Assessed for Adverse Events|Overall Study||123
2851626|NCT00004031|3553688|FG001|Assessed for Adverse Events|Overall Study||113
2851627|NCT00004031|3553687|FG000|COMPLETED|Overall Study||103
2851628|NCT00004031|3553688|FG001|COMPLETED|Overall Study||104
2851629|NCT00004031|3553687|FG000|NOT COMPLETED|Overall Study||25
2851630|NCT00004031|3553688|FG001|NOT COMPLETED|Overall Study||21
2851631|NCT00004054|3553698|FG000|STARTED|Overall Study||197
2851632|NCT00004054|3553699|FG001|STARTED|Overall Study||200
2851633|NCT00004054|3553698|FG000|COMPLETED|Overall Study||197
2851634|NCT00004054|3553699|FG001|COMPLETED|Overall Study||200
2851635|NCT00004054|3553698|FG000|NOT COMPLETED|Overall Study||0
2851636|NCT00004054|3553699|FG001|NOT COMPLETED|Overall Study||0
2851637|NCT00004088|3553705|FG000|STARTED|Overall Study||77
2851638|NCT00004088|3553705|FG000|COMPLETED|Overall Study||68
2851639|NCT00004088|3553705|FG000|NOT COMPLETED|Overall Study||9
2918019|NCT00523991|3628095|FG000|NOT COMPLETED|Overall Study||21
2918020|NCT00523991|3628096|FG001|NOT COMPLETED|Overall Study||27
2918021|NCT00524017|3628104|FG000|STARTED|Overall Study||13
2918022|NCT00524017|3628105|FG001|STARTED|Overall Study||6
2918023|NCT00524017|3628104|FG000|COMPLETED|Overall Study||13
2918024|NCT00524017|3628105|FG001|COMPLETED|Overall Study||5
2918025|NCT00524017|3628104|FG000|NOT COMPLETED|Overall Study||0
2918026|NCT00524017|3628105|FG001|NOT COMPLETED|Overall Study||1
2918027|NCT00524030|3628113|FG000|STARTED|Overall Study||32
2918028|NCT00524030|3628114|FG001|STARTED|Overall Study||129
2918029|NCT00524030|3628113|FG000|Completed Double-Blind Treatment Phase|Overall Study||15
2918030|NCT00524030|3628114|FG001|Completed Double-Blind Treatment Phase|Overall Study||70
2918031|NCT00524030|3628113|FG000|Completed Taper/Titration Phase|Overall Study||15
2918032|NCT00524030|3628114|FG001|Completed Taper/Titration Phase|Overall Study||70
2918033|NCT00524030|3628113|FG000|COMPLETED|Overall Study||15
2918034|NCT00524030|3628114|FG001|COMPLETED|Overall Study||70
2918035|NCT00524030|3628113|FG000|NOT COMPLETED|Overall Study||17
2918036|NCT00524030|3628114|FG001|NOT COMPLETED|Overall Study||59
2918037|NCT00524043|3628124|FG000|STARTED|Overall Study|One patient was randomly assigned to treatment but did not receive placebo.|64
2918038|NCT00524043|3628125|FG001|STARTED|Overall Study||70
2918039|NCT00524043|3628126|FG002|STARTED|Overall Study||66
2918040|NCT00524043|3628124|FG000|COMPLETED|Overall Study||34
2918041|NCT00524043|3628125|FG001|COMPLETED|Overall Study||42
2918042|NCT00524043|3628126|FG002|COMPLETED|Overall Study||35
2918043|NCT00524043|3628124|FG000|NOT COMPLETED|Overall Study||30
2918044|NCT00524043|3628125|FG001|NOT COMPLETED|Overall Study||28
2918045|NCT00524043|3628126|FG002|NOT COMPLETED|Overall Study||31
2918046|NCT00524121|3628134|FG000|STARTED|Overall Study||22
2918047|NCT00524121|3628134|FG000|COMPLETED|Overall Study||3
2918048|NCT00524121|3628134|FG000|NOT COMPLETED|Overall Study||19
2918049|NCT00524173|3628151|FG000|STARTED|Overall Study||17
2918050|NCT00524173|3628152|FG001|STARTED|Overall Study||15
2918051|NCT00524173|3628151|FG000|COMPLETED|Overall Study||12
2918052|NCT00524173|3628152|FG001|COMPLETED|Overall Study||13
2918053|NCT00524173|3628151|FG000|NOT COMPLETED|Overall Study||5
2918054|NCT00524173|3628152|FG001|NOT COMPLETED|Overall Study||2
2918055|NCT00524225|3628158|FG000|STARTED|Overall Study||3
2918056|NCT00524225|3628158|FG000|COMPLETED|Overall Study||3
2918057|NCT00524225|3628158|FG000|NOT COMPLETED|Overall Study||0
2918058|NCT00524264|3628165|FG000|STARTED|Overall Study||164
2918059|NCT00524264|3628166|FG001|STARTED|Overall Study||84
2918060|NCT00524264|3628165|FG000|COMPLETED|Overall Study||144
2918061|NCT00524264|3628166|FG001|COMPLETED|Overall Study||57
2918062|NCT00524264|3628165|FG000|NOT COMPLETED|Overall Study||20
2918063|NCT00524264|3628166|FG001|NOT COMPLETED|Overall Study||27
2918064|NCT00524303|3628175|FG000|STARTED|Overall Study||33
2918065|NCT00524303|3628176|FG001|STARTED|Overall Study||34
2918066|NCT00524303|3628177|FG002|STARTED|Overall Study||33
2918067|NCT00524303|3628175|FG000|COMPLETED|Overall Study||21
2918068|NCT00524303|3628176|FG001|COMPLETED|Overall Study||24
2918069|NCT00524303|3628177|FG002|COMPLETED|Overall Study||15
2918070|NCT00524303|3628175|FG000|NOT COMPLETED|Overall Study||12
2918071|NCT00524303|3628176|FG001|NOT COMPLETED|Overall Study||10
2918072|NCT00524303|3628177|FG002|NOT COMPLETED|Overall Study||18
2918073|NCT00524316|3628188|FG000|STARTED|Overall Study||16
2918074|NCT00524316|3628188|FG000|COMPLETED|Overall Study||0
2918075|NCT00524316|3628188|FG000|NOT COMPLETED|Overall Study||16
2918076|NCT00524342|3628192|FG000|STARTED|Overall Study||7
2918077|NCT00524342|3628192|FG000|COMPLETED|Overall Study||7
2918078|NCT00524342|3628192|FG000|NOT COMPLETED|Overall Study||0
2918079|NCT00524368|3628198|FG000|STARTED|Overall Study||294
2918080|NCT00524368|3628199|FG001|STARTED|Overall Study||296
2918081|NCT00524368|3628198|FG000|COMPLETED|Overall Study||253
2918082|NCT00524368|3628199|FG001|COMPLETED|Overall Study||248
2918083|NCT00524368|3628198|FG000|NOT COMPLETED|Overall Study||41
2918084|NCT00524368|3628199|FG001|NOT COMPLETED|Overall Study||48
2918085|NCT00524420|3628207|FG000|STARTED|Overall Study|One was incorrectly randomized;she did not have a BIRS of >7. Was excluded from efficacy analysis.|8
2918086|NCT00524420|3628208|FG001|STARTED|Overall Study||11
2918087|NCT00524420|3628207|FG000|COMPLETED|Overall Study|1 dropped out after treatment 10 because of poor response and was included in the efficacy analyses.|7
2918088|NCT00524420|3628208|FG001|COMPLETED|Overall Study||11
2918089|NCT00524420|3628207|FG000|NOT COMPLETED|Overall Study||1
2918090|NCT00524420|3628208|FG001|NOT COMPLETED|Overall Study||0
2918091|NCT00524472|3628218|FG000|STARTED|Overall Study||709
2918092|NCT00524472|3628219|FG001|STARTED|Overall Study||730
2918093|NCT00524472|3628218|FG000|COMPLETED|Overall Study||709
2918094|NCT00524472|3628219|FG001|COMPLETED|Overall Study||730
2851640|NCT00004092|3553711|FG000|STARTED|Overall Study||21
2851641|NCT00004092|3553712|FG001|STARTED|Overall Study||51
2851642|NCT00004092|3553711|FG000|COMPLETED|Overall Study||21
2851643|NCT00004092|3553712|FG001|COMPLETED|Overall Study||51
2851644|NCT00004092|3553711|FG000|NOT COMPLETED|Overall Study||0
2851645|NCT00004092|3553712|FG001|NOT COMPLETED|Overall Study||0
2851646|NCT00004124|3553720|FG000|STARTED|Overall Study||481
2851647|NCT00004124|3553721|FG001|STARTED|Overall Study||480
2851648|NCT00004124|3553720|FG000|COMPLETED|Overall Study||469
2851649|NCT00004124|3553721|FG001|COMPLETED|Overall Study||460
2851650|NCT00004124|3553720|FG000|NOT COMPLETED|Overall Study||12
2851651|NCT00004124|3553721|FG001|NOT COMPLETED|Overall Study||20
2851652|NCT00004143|3553727|FG000|STARTED|Overall Study||2
2851653|NCT00004143|3553727|FG000|COMPLETED|Overall Study||2
2851654|NCT00004143|3553727|FG000|NOT COMPLETED|Overall Study||0
2851655|NCT00004146|3553731|FG000|STARTED|Overall Study||55
2851656|NCT00004146|3553731|FG000|COMPLETED|Overall Study||55
2851657|NCT00004146|3553731|FG000|NOT COMPLETED|Overall Study||0
2851658|NCT00004228|3553744|FG000|STARTED|Overall Study||60
2851659|NCT00004228|3553745|FG001|STARTED|Overall Study||66
2851660|NCT00004228|3553746|FG002|STARTED|Overall Study||65
2851661|NCT00004228|3553747|FG003|STARTED|Overall Study||13
2851662|NCT00004228|3553748|FG004|STARTED|Overall Study||67
2851663|NCT00004228|3553749|FG005|STARTED|Overall Study||65
2851664|NCT00004228|3553750|FG006|STARTED|Overall Study||57
2851665|NCT00004228|3553744|FG000|COMPLETED|Overall Study||51
2851666|NCT00004228|3553745|FG001|COMPLETED|Overall Study||51
2851667|NCT00004228|3553746|FG002|COMPLETED|Overall Study||46
2851668|NCT00004228|3553747|FG003|COMPLETED|Overall Study||6
2851669|NCT00004228|3553748|FG004|COMPLETED|Overall Study||51
2851670|NCT00004228|3553749|FG005|COMPLETED|Overall Study||51
2851671|NCT00004228|3553750|FG006|COMPLETED|Overall Study||45
2851672|NCT00004228|3553744|FG000|NOT COMPLETED|Overall Study||9
2851673|NCT00004228|3553745|FG001|NOT COMPLETED|Overall Study||15
2851674|NCT00004228|3553746|FG002|NOT COMPLETED|Overall Study||19
2851675|NCT00004228|3553747|FG003|NOT COMPLETED|Overall Study||7
2851676|NCT00004228|3553748|FG004|NOT COMPLETED|Overall Study||16
2851677|NCT00004228|3553749|FG005|NOT COMPLETED|Overall Study||14
2851678|NCT00004228|3553750|FG006|NOT COMPLETED|Overall Study||12
2851679|NCT00004259|3553771|FG000|STARTED|Overall Study||98
2851680|NCT00004259|3553772|FG001|STARTED|Overall Study||103
2851681|NCT00004259|3553773|FG002|STARTED|Overall Study||15
2851682|NCT00004259|3553774|FG003|STARTED|Overall Study||14
2851683|NCT00004259|3553771|FG000|COMPLETED|Overall Study||97
2851684|NCT00004259|3553772|FG001|COMPLETED|Overall Study||99
2851685|NCT00004259|3553773|FG002|COMPLETED|Overall Study||15
2851686|NCT00004259|3553774|FG003|COMPLETED|Overall Study||14
2851687|NCT00004259|3553771|FG000|NOT COMPLETED|Overall Study||1
2851688|NCT00004259|3553772|FG001|NOT COMPLETED|Overall Study||4
2851689|NCT00004259|3553773|FG002|NOT COMPLETED|Overall Study||0
2851690|NCT00004259|3553774|FG003|NOT COMPLETED|Overall Study||0
2851691|NCT00004412|3553790|FG000|STARTED|Randomized Period||11
2851692|NCT00004412|3553791|FG001|STARTED|Randomized Period||12
2851693|NCT00004412|3553792|FG002|STARTED|Randomized Period||0
2851694|NCT00004412|3553790|FG000|COMPLETED|Randomized Period||8
2851695|NCT00004412|3553791|FG001|COMPLETED|Randomized Period||12
2851696|NCT00004412|3553792|FG002|COMPLETED|Randomized Period||0
2851697|NCT00004412|3553790|FG000|NOT COMPLETED|Randomized Period||3
2851698|NCT00004412|3553791|FG001|NOT COMPLETED|Randomized Period||0
2851699|NCT00004412|3553792|FG002|NOT COMPLETED|Randomized Period||0
2851700|NCT00004412|3553790|FG000|STARTED|Crossover Period|Eight subjects were randomized to Standard of Care dressing Arm|8
2851701|NCT00004412|3553791|FG001|STARTED|Crossover Period|Twelve patients were randomized to the Arginine Butyrate plus Standard local care dressing Arm|12
3168469|NCT01919164|3895760|FG002|Safety Analysis Set|Overall Study||111
3168470|NCT01919164|3895761|FG003|Safety Analysis Set|Overall Study|1 participant in Sprifermin2 Cycles arm who inadvertently received 100 mcg was included in this arm.|111
3313334|NCT03075410|4046792|FG001|COMPLETED|Part A-Period 1 (14 Days)||1
2851702|NCT00004412|3553792|FG002|STARTED|Crossover Period|Three of Randomized Period's Arm I elected to move to Crossover Period's Crossover Arm.|3
2851703|NCT00004412|3553790|FG000|COMPLETED|Crossover Period|Eight subjects in this arm completed study without crossing over.|8
2851704|NCT00004412|3553791|FG001|COMPLETED|Crossover Period|Twelve subjects in this arm completed the study.|12
3313335|NCT03075410|4046793|FG002|COMPLETED|Part A-Period 1 (14 Days)||2
3313336|NCT03075410|4046794|FG003|COMPLETED|Part A-Period 1 (14 Days)||1
3313337|NCT03075410|4046795|FG004|COMPLETED|Part A-Period 1 (14 Days)||2
3313338|NCT03075410|4046796|FG005|COMPLETED|Part A-Period 1 (14 Days)||1
3313339|NCT03075410|4046797|FG006|COMPLETED|Part A-Period 1 (14 Days)||0
2851705|NCT00004412|3553792|FG002|COMPLETED|Crossover Period|Three subjects, from Arm I, who crossed- over to Arm II completed the study.|3
2851706|NCT00004412|3553790|FG000|NOT COMPLETED|Crossover Period||0
2851707|NCT00004412|3553791|FG001|NOT COMPLETED|Crossover Period||0
2851708|NCT00004412|3553792|FG002|NOT COMPLETED|Crossover Period||0
2851709|NCT00004418|3553798|FG000|STARTED|Overall Study||126
2851710|NCT00004418|3553798|FG000|COMPLETED|Overall Study|The definition of completed is until the subject wished to stop taking the oil.|126
2851711|NCT00004418|3553798|FG000|NOT COMPLETED|Overall Study||0
2851712|NCT00004445|3553802|FG000|STARTED|Overall Study||18
2851713|NCT00004445|3553802|FG000|COMPLETED|Overall Study||15
2851714|NCT00004445|3553802|FG000|NOT COMPLETED|Overall Study||3
2851715|NCT00004500|3553808|FG000|STARTED|Overall Study||38
3313340|NCT03075410|4046798|FG007|COMPLETED|Part A-Period 1 (14 Days)||0
3313341|NCT03075410|4046799|FG008|COMPLETED|Part A-Period 1 (14 Days)||0
3313342|NCT03075410|4046791|FG000|NOT COMPLETED|Part A-Period 1 (14 Days)||0
3313343|NCT03075410|4046792|FG001|NOT COMPLETED|Part A-Period 1 (14 Days)||0
3313344|NCT03075410|4046793|FG002|NOT COMPLETED|Part A-Period 1 (14 Days)||0
3313345|NCT03075410|4046794|FG003|NOT COMPLETED|Part A-Period 1 (14 Days)||0
3313346|NCT03075410|4046795|FG004|NOT COMPLETED|Part A-Period 1 (14 Days)||0
3313347|NCT03075410|4046796|FG005|NOT COMPLETED|Part A-Period 1 (14 Days)||0
3313348|NCT03075410|4046797|FG006|NOT COMPLETED|Part A-Period 1 (14 Days)||0
3313349|NCT03075410|4046798|FG007|NOT COMPLETED|Part A-Period 1 (14 Days)||0
3313350|NCT03075410|4046799|FG008|NOT COMPLETED|Part A-Period 1 (14 Days)||0
3313351|NCT03075410|4046791|FG000|STARTED|Part A-Washout Period 1 (14 Days)||2
3313352|NCT03075410|4046792|FG001|STARTED|Part A-Washout Period 1 (14 Days)||1
3313353|NCT03075410|4046793|FG002|STARTED|Part A-Washout Period 1 (14 Days)||2
3313354|NCT03075410|4046794|FG003|STARTED|Part A-Washout Period 1 (14 Days)||1
3313355|NCT03075410|4046795|FG004|STARTED|Part A-Washout Period 1 (14 Days)||2
2851716|NCT00004500|3553809|FG001|STARTED|Overall Study||31
2851717|NCT00004500|3553808|FG000|1 Year Follow-Up|Overall Study||24
2851718|NCT00004500|3553809|FG001|1 Year Follow-Up|Overall Study||24
2851719|NCT00004500|3553808|FG000|COMPLETED|Overall Study||38
2851720|NCT00004500|3553809|FG001|COMPLETED|Overall Study||31
2851721|NCT00004500|3553808|FG000|NOT COMPLETED|Overall Study||0
2851722|NCT00004500|3553809|FG001|NOT COMPLETED|Overall Study||0
2851723|NCT00004547|3553818|FG000|STARTED|Overall Study||83
2851724|NCT00004547|3553819|FG001|STARTED|Overall Study||48
2851725|NCT00004547|3553820|FG002|STARTED|Overall Study||57
2851726|NCT00004547|3553818|FG000|Not Evaluable|Overall Study||21
3168471|NCT01919164|3895762|FG004|Safety Analysis Set|Overall Study||109
3168472|NCT01919164|3895758|FG000|COMPLETED|Overall Study||65
2851727|NCT00004547|3553819|FG001|Not Evaluable|Overall Study||9
2851728|NCT00004547|3553820|FG002|Not Evaluable|Overall Study||23
2851729|NCT00004547|3553818|FG000|COMPLETED|Overall Study||61
2851730|NCT00004547|3553819|FG001|COMPLETED|Overall Study||39
2851731|NCT00004547|3553820|FG002|COMPLETED|Overall Study||35
2851732|NCT00004547|3553818|FG000|NOT COMPLETED|Overall Study||22
2851733|NCT00004547|3553819|FG001|NOT COMPLETED|Overall Study||9
2851734|NCT00004547|3553820|FG002|NOT COMPLETED|Overall Study||22
2851735|NCT00004562|3553831|FG000|STARTED|Overall Study||1101
2851736|NCT00004562|3553832|FG001|STARTED|Overall Study||1100
2851737|NCT00004562|3553831|FG000|COMPLETED|Overall Study||999
2851738|NCT00004562|3553832|FG001|COMPLETED|Overall Study||1009
2851739|NCT00004562|3553831|FG000|NOT COMPLETED|Overall Study||102
2851740|NCT00004562|3553832|FG001|NOT COMPLETED|Overall Study||91
2851741|NCT00004563|3553840|FG000|STARTED|Overall Study||79
2851742|NCT00004563|3553841|FG001|STARTED|Overall Study||79
2851743|NCT00004563|3553840|FG000|COMPLETED|Overall Study||54
2851744|NCT00004563|3553841|FG001|COMPLETED|Overall Study||55
2851745|NCT00004563|3553840|FG000|NOT COMPLETED|Overall Study||25
2851746|NCT00004563|3553841|FG001|NOT COMPLETED|Overall Study||24
2851747|NCT00004635|3553849|FG000|STARTED|Period One||79
2851748|NCT00004635|3553850|FG001|STARTED|Period One||80
2851749|NCT00004635|3553849|FG000|Received Treatment|Period One||73
2851750|NCT00004635|3553850|FG001|Received Treatment|Period One||75
2851751|NCT00004635|3553849|FG000|COMPLETED|Period One||73
2851752|NCT00004635|3553850|FG001|COMPLETED|Period One||74
2851753|NCT00004635|3553849|FG000|NOT COMPLETED|Period One||6
2851754|NCT00004635|3553850|FG001|NOT COMPLETED|Period One||6
2851755|NCT00004635|3553849|FG000|STARTED|Period Two||44
2851756|NCT00004635|3553850|FG001|STARTED|Period Two||59
2851757|NCT00004635|3553849|FG000|COMPLETED|Period Two||38
2851758|NCT00004635|3553850|FG001|COMPLETED|Period Two||50
2851759|NCT00004635|3553849|FG000|NOT COMPLETED|Period Two||6
2851760|NCT00004635|3553850|FG001|NOT COMPLETED|Period Two||9
2851761|NCT00004732|3553861|FG000|STARTED|Overall Study||1262
2851762|NCT00004732|3553862|FG001|STARTED|Overall Study||1240
2851763|NCT00004732|3553861|FG000|COMPLETED|Overall Study||1193
2851764|NCT00004732|3553862|FG001|COMPLETED|Overall Study||1129
2851765|NCT00004732|3553861|FG000|NOT COMPLETED|Overall Study||69
2851766|NCT00004732|3553862|FG001|NOT COMPLETED|Overall Study||111
2851767|NCT00004859|3553872|FG000|STARTED|Overall Study||295
2851768|NCT00004859|3553873|FG001|STARTED|Overall Study||294
2851769|NCT00004859|3553872|FG000|Eligible|Overall Study||275
2851770|NCT00004859|3553873|FG001|Eligible|Overall Study||271
2851771|NCT00004859|3553872|FG000|Treated|Overall Study||289
2851772|NCT00004859|3553873|FG001|Treated|Overall Study||289
2851773|NCT00004859|3553872|FG000|Treated and Having Toxicity Data|Overall Study||289
2851774|NCT00004859|3553873|FG001|Treated and Having Toxicity Data|Overall Study|1 patient had missing record for toxicity|288
2851775|NCT00004859|3553872|FG000|COMPLETED|Overall Study||177
2851776|NCT00004859|3553873|FG001|COMPLETED|Overall Study||12
2851777|NCT00004859|3553872|FG000|NOT COMPLETED|Overall Study||118
2851778|NCT00004859|3553873|FG001|NOT COMPLETED|Overall Study||282
2851779|NCT00004888|3553883|FG000|STARTED|Overall Study|Of the 41 pts, 3 were ineligible.|38
2851780|NCT00004888|3553884|FG001|STARTED|Overall Study|Of the 48 pts, 2 were ineligible.|46
2851781|NCT00004888|3553883|FG000|COMPLETED|Overall Study||27
2851782|NCT00004888|3553884|FG001|COMPLETED|Overall Study||22
2851783|NCT00004888|3553883|FG000|NOT COMPLETED|Overall Study||11
2851784|NCT00004888|3553884|FG001|NOT COMPLETED|Overall Study||24
2918095|NCT00524472|3628218|FG000|NOT COMPLETED|Overall Study||0
3168473|NCT01919164|3895759|FG001|COMPLETED|Overall Study||80
2851785|NCT00004978|3553892|FG000|STARTED|Overall Study|includes patients participating in Vanguard studies from the sites which participated in ESPRIT|2090
2851786|NCT00004978|3553893|FG001|STARTED|Overall Study|includes patients participating in Vanguard studies from the sites which participated in ESPRIT|2060
2851787|NCT00004978|3553892|FG000|COMPLETED|Overall Study||1846
2851788|NCT00004978|3553893|FG001|COMPLETED|Overall Study||1790
2851789|NCT00004978|3553892|FG000|NOT COMPLETED|Overall Study||244
2851790|NCT00004978|3553893|FG001|NOT COMPLETED|Overall Study||270
2851791|NCT00004980|3553901|FG000|STARTED|Overall Study||27
2851792|NCT00004980|3553902|FG001|STARTED|Overall Study||23
2851793|NCT00004980|3553901|FG000|COMPLETED|Overall Study||25
2851794|NCT00004980|3553902|FG001|COMPLETED|Overall Study||21
2851795|NCT00004980|3553901|FG000|NOT COMPLETED|Overall Study||2
2851796|NCT00004980|3553902|FG001|NOT COMPLETED|Overall Study||2
2851797|NCT00005044|3553910|FG000|STARTED|Overall Study||790
2851798|NCT00005044|3553911|FG001|STARTED|Overall Study||789
2851799|NCT00005044|3553910|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|752
2851800|NCT00005044|3553911|FG001|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|737
2851801|NCT00005044|3553910|FG000|NOT COMPLETED|Overall Study||38
2851802|NCT00005044|3553911|FG001|NOT COMPLETED|Overall Study||52
2851803|NCT00005047|3553921|FG000|STARTED|Overall Study||58
2851804|NCT00005047|3553922|FG001|STARTED|Overall Study||56
2851805|NCT00005047|3553923|FG002|STARTED|Overall Study||227
2851806|NCT00005047|3553924|FG003|STARTED|Overall Study||158
2851807|NCT00005047|3553921|FG000|COMPLETED|Overall Study||39
2851808|NCT00005047|3553922|FG001|COMPLETED|Overall Study||56
2851809|NCT00005047|3553923|FG002|COMPLETED|Overall Study||227
2851810|NCT00005047|3553924|FG003|COMPLETED|Overall Study||158
2851811|NCT00005047|3553921|FG000|NOT COMPLETED|Overall Study||19
2851812|NCT00005047|3553922|FG001|NOT COMPLETED|Overall Study||0
2851813|NCT00005047|3553923|FG002|NOT COMPLETED|Overall Study||0
2851814|NCT00005047|3553924|FG003|NOT COMPLETED|Overall Study||0
2851815|NCT00005669|3553936|FG000|STARTED|Overall Study||53
2851816|NCT00005669|3553937|FG001|STARTED|Overall Study||47
2851817|NCT00005669|3553936|FG000|COMPLETED|Overall Study||45
2851818|NCT00005669|3553937|FG001|COMPLETED|Overall Study||40
2851819|NCT00005669|3553936|FG000|NOT COMPLETED|Overall Study||8
2851820|NCT00005669|3553937|FG001|NOT COMPLETED|Overall Study||7
2851821|NCT00005803|3553943|FG000|STARTED|Overall Study||76
2851822|NCT00005803|3553943|FG000|COMPLETED|Overall Study||54
2851823|NCT00005803|3553943|FG000|NOT COMPLETED|Overall Study||22
2851824|NCT00005879|3553952|FG000|STARTED|Overall Study||101
2851825|NCT00005879|3553953|FG001|STARTED|Overall Study||98
2851826|NCT00005879|3553952|FG000|COMPLETED|Overall Study||93
2851827|NCT00005879|3553953|FG001|COMPLETED|Overall Study||88
2851828|NCT00005879|3553952|FG000|NOT COMPLETED|Overall Study||8
2851829|NCT00005879|3553953|FG001|NOT COMPLETED|Overall Study||10
2851830|NCT00005901|3553961|FG000|STARTED|Overall Study||19
2851831|NCT00005901|3553962|FG001|STARTED|Overall Study||15
2851832|NCT00005901|3553961|FG000|COMPLETED|Overall Study||19
2851833|NCT00005901|3553962|FG001|COMPLETED|Overall Study||15
2851834|NCT00005901|3553961|FG000|NOT COMPLETED|Overall Study||0
2851835|NCT00005901|3553962|FG001|NOT COMPLETED|Overall Study||0
2851836|NCT00005906|3553968|FG000|STARTED|Overall Study||4
2851837|NCT00005906|3553968|FG000|COMPLETED|Overall Study||1
2851838|NCT00005906|3553968|FG000|NOT COMPLETED|Overall Study||3
2851839|NCT00005908|3553972|FG000|STARTED|Overall Study||10
2851840|NCT00005908|3553973|FG001|STARTED|Overall Study||20
2851841|NCT00005908|3553972|FG000|COMPLETED|Overall Study||9
2851842|NCT00005908|3553973|FG001|COMPLETED|Overall Study||20
2851843|NCT00005908|3553972|FG000|NOT COMPLETED|Overall Study||1
2851844|NCT00005908|3553973|FG001|NOT COMPLETED|Overall Study||0
2851845|NCT00005937|3553982|FG000|STARTED|Overall Study||42
2851846|NCT00005937|3553982|FG000|COMPLETED|Overall Study||37
2851847|NCT00005937|3553982|FG000|NOT COMPLETED|Overall Study||5
2851848|NCT00005947|3553988|FG000|STARTED|Overall Study||82
2851849|NCT00005947|3553989|FG001|STARTED|Overall Study||45
2851850|NCT00005947|3553988|FG000|COMPLETED|Overall Study||25
2851851|NCT00005947|3553989|FG001|COMPLETED|Overall Study||4
2851852|NCT00005947|3553988|FG000|NOT COMPLETED|Overall Study||57
2851853|NCT00005947|3553989|FG001|NOT COMPLETED|Overall Study||41
2851854|NCT00005957|3553999|FG000|STARTED|Overall Study||916
2851855|NCT00005957|3554000|FG001|STARTED|Overall Study||916
2851856|NCT00005957|3553999|FG000|COMPLETED|Overall Study||908
2851857|NCT00005957|3554000|FG001|COMPLETED|Overall Study||888
2851858|NCT00005957|3553999|FG000|NOT COMPLETED|Overall Study||8
2851859|NCT00005957|3554000|FG001|NOT COMPLETED|Overall Study||28
2851860|NCT00006011|3554009|FG000|STARTED|Overall Study|total number of participants enrolled, that received random treatment assignment to Arm 1 of study.|288
2851861|NCT00006011|3554010|FG001|STARTED|Overall Study|total number of participants enrolled, that received random treatment assignment to Arm 2 of study.|298
2851862|NCT00006011|3554011|FG002|STARTED|Overall Study|total number of participants enrolled, that only received radiation treatment.|73
2851863|NCT00006011|3554009|FG000|COMPLETED|Overall Study|total number of partipants that completed 6 cycles of chemotherapy.|223
2851864|NCT00006011|3554010|FG001|COMPLETED|Overall Study|total number of partipants that completed 6 cycles of chemotherapy.|221
2851865|NCT00006011|3554011|FG002|COMPLETED|Overall Study|total number of partipants that completed 6 cycles of chemotherapy.|0
2851866|NCT00006011|3554009|FG000|NOT COMPLETED|Overall Study||65
2851867|NCT00006011|3554010|FG001|NOT COMPLETED|Overall Study||77
2851868|NCT00006011|3554011|FG002|NOT COMPLETED|Overall Study||73
2851869|NCT00006046|3554022|FG000|STARTED|Overall Study||7
2851870|NCT00006046|3554023|FG001|STARTED|Overall Study||0
2851871|NCT00006046|3554024|FG002|STARTED|Overall Study||0
2851872|NCT00006046|3554025|FG003|STARTED|Overall Study||0
2851873|NCT00006046|3554026|FG004|STARTED|Overall Study||0
2851874|NCT00006046|3554022|FG000|COMPLETED|Overall Study||2
2851875|NCT00006046|3554023|FG001|COMPLETED|Overall Study||0
2851876|NCT00006046|3554024|FG002|COMPLETED|Overall Study||0
2851877|NCT00006046|3554025|FG003|COMPLETED|Overall Study||0
2851878|NCT00006046|3554026|FG004|COMPLETED|Overall Study||0
2851879|NCT00006046|3554022|FG000|NOT COMPLETED|Overall Study||5
2851880|NCT00006046|3554023|FG001|NOT COMPLETED|Overall Study||0
2851881|NCT00006046|3554024|FG002|NOT COMPLETED|Overall Study||0
2851882|NCT00006046|3554025|FG003|NOT COMPLETED|Overall Study||0
2851883|NCT00006046|3554026|FG004|NOT COMPLETED|Overall Study||0
2851884|NCT00006099|3554040|FG000|STARTED|Overall Study||1
2851885|NCT00006099|3554041|FG001|STARTED|Overall Study||0
2851886|NCT00006099|3554040|FG000|COMPLETED|Overall Study||1
2851887|NCT00006099|3554041|FG001|COMPLETED|Overall Study||0
2851888|NCT00006099|3554040|FG000|NOT COMPLETED|Overall Study||0
2851889|NCT00006099|3554041|FG001|NOT COMPLETED|Overall Study||0
2851890|NCT00006101|3554049|FG000|STARTED|Overall Study||38
2851891|NCT00006101|3554050|FG001|STARTED|Overall Study||38
2851892|NCT00006101|3554049|FG000|COMPLETED|Overall Study||33
2851893|NCT00006101|3554050|FG001|COMPLETED|Overall Study||33
2851894|NCT00006101|3554049|FG000|NOT COMPLETED|Overall Study||5
2851895|NCT00006101|3554050|FG001|NOT COMPLETED|Overall Study||5
2851896|NCT00006110|3554058|FG000|STARTED|Overall Study||52
2851897|NCT00006110|3554059|FG001|STARTED|Overall Study||30
2851898|NCT00006110|3554058|FG000|COMPLETED|Overall Study||52
2851899|NCT00006110|3554059|FG001|COMPLETED|Overall Study||30
2851900|NCT00006110|3554058|FG000|NOT COMPLETED|Overall Study||0
2851901|NCT00006110|3554059|FG001|NOT COMPLETED|Overall Study||0
2851902|NCT00006151|3554073|FG000|STARTED|Overall Study||30
2851903|NCT00006151|3554074|FG001|STARTED|Overall Study||30
2851904|NCT00006151|3554073|FG000|COMPLETED|Overall Study||17
2851905|NCT00006151|3554074|FG001|COMPLETED|Overall Study||16
2851906|NCT00006151|3554073|FG000|NOT COMPLETED|Overall Study||13
2851907|NCT00006151|3554074|FG001|NOT COMPLETED|Overall Study||14
2851908|NCT00006156|3554082|FG000|STARTED|Overall Study||42
2851909|NCT00006156|3554083|FG001|STARTED|Overall Study||7
2851910|NCT00006156|3554082|FG000|COMPLETED|Overall Study||42
2851911|NCT00006156|3554083|FG001|COMPLETED|Overall Study||7
2851912|NCT00006156|3554082|FG000|NOT COMPLETED|Overall Study||0
2851913|NCT00006156|3554083|FG001|NOT COMPLETED|Overall Study||0
2851914|NCT00006164|3554090|FG000|STARTED|Overall Study||517
2851915|NCT00006164|3554091|FG001|STARTED|Overall Study||533
2851916|NCT00006164|3554090|FG000|COMPLETED|Overall Study|70 Withdrew or were lost to followup; 158 Discontinued peginterferon but were followed|447
2851917|NCT00006164|3554091|FG001|COMPLETED|Overall Study|81 Withdrew or were lost to followup; 9 took peginterferon outside of protocol|452
2851918|NCT00006164|3554090|FG000|NOT COMPLETED|Overall Study||70
2851919|NCT00006164|3554091|FG001|NOT COMPLETED|Overall Study||81
2851920|NCT00006170|3554101|FG000|STARTED|Overall Study||106
2851921|NCT00006170|3554102|FG001|STARTED|Overall Study||87
2851922|NCT00006170|3554103|FG002|STARTED|Overall Study||89
2851923|NCT00006170|3554104|FG003|STARTED|Overall Study||67
2851924|NCT00006170|3554101|FG000|COMPLETED|Overall Study||57
2851925|NCT00006170|3554102|FG001|COMPLETED|Overall Study||37
2851926|NCT00006170|3554103|FG002|COMPLETED|Overall Study||46
2851927|NCT00006170|3554104|FG003|COMPLETED|Overall Study||28
2851928|NCT00006170|3554101|FG000|NOT COMPLETED|Overall Study||49
2851929|NCT00006170|3554102|FG001|NOT COMPLETED|Overall Study||50
2851930|NCT00006170|3554103|FG002|NOT COMPLETED|Overall Study||43
2851931|NCT00006170|3554104|FG003|NOT COMPLETED|Overall Study||39
2851932|NCT00006178|3554114|FG000|STARTED|Overall Study||12
2851933|NCT00006178|3554114|FG000|COMPLETED|Overall Study||12
2851934|NCT00006178|3554114|FG000|NOT COMPLETED|Overall Study||0
2851935|NCT00006184|3554120|FG000|STARTED|Overall Study||10
2851936|NCT00006184|3554121|FG001|STARTED|Overall Study||10
2851937|NCT00006184|3554120|FG000|COMPLETED|Overall Study||9
2851938|NCT00006184|3554121|FG001|COMPLETED|Overall Study||10
2851939|NCT00006184|3554120|FG000|NOT COMPLETED|Overall Study||1
2851940|NCT00006184|3554121|FG001|NOT COMPLETED|Overall Study||0
2851941|NCT00006227|3554127|FG000|STARTED|Overall Study||31
2851942|NCT00006227|3554127|FG000|COMPLETED|Overall Study||31
2851943|NCT00006227|3554127|FG000|NOT COMPLETED|Overall Study||0
2851944|NCT00006237|3554133|FG000|STARTED|Overall Study||212
2851945|NCT00006237|3554134|FG001|STARTED|Overall Study||220
2851946|NCT00006237|3554133|FG000|Eligible|Overall Study||203
2851947|NCT00006237|3554134|FG001|Eligible|Overall Study||200
2851948|NCT00006237|3554133|FG000|Eligible and Treated|Overall Study||203
2851949|NCT00006237|3554134|FG001|Eligible and Treated|Overall Study||199
2851950|NCT00006237|3554133|FG000|COMPLETED|Overall Study||87
2851951|NCT00006237|3554134|FG001|COMPLETED|Overall Study||159
2851952|NCT00006237|3554133|FG000|NOT COMPLETED|Overall Study||125
2851953|NCT00006237|3554134|FG001|NOT COMPLETED|Overall Study||61
2851954|NCT00006244|3554143|FG000|STARTED|Overall Study||36
2851955|NCT00006244|3554143|FG000|COMPLETED|Overall Study||36
2851956|NCT00006244|3554143|FG000|NOT COMPLETED|Overall Study||0
2851957|NCT00006289|3554149|FG000|STARTED|First Intervention (5 Weeks)||11
2851958|NCT00006289|3554150|FG001|STARTED|First Intervention (5 Weeks)||10
2851959|NCT00006289|3554149|FG000|COMPLETED|First Intervention (5 Weeks)||10
2851960|NCT00006289|3554150|FG001|COMPLETED|First Intervention (5 Weeks)||10
2851961|NCT00006289|3554149|FG000|NOT COMPLETED|First Intervention (5 Weeks)||1
2851962|NCT00006289|3554150|FG001|NOT COMPLETED|First Intervention (5 Weeks)||0
2851963|NCT00006289|3554149|FG000|STARTED|Washout (>= 1 Week)||10
2851964|NCT00006289|3554150|FG001|STARTED|Washout (>= 1 Week)||10
2851965|NCT00006289|3554149|FG000|COMPLETED|Washout (>= 1 Week)||10
2851966|NCT00006289|3554150|FG001|COMPLETED|Washout (>= 1 Week)||10
2851967|NCT00006289|3554149|FG000|NOT COMPLETED|Washout (>= 1 Week)||0
2851968|NCT00006289|3554150|FG001|NOT COMPLETED|Washout (>= 1 Week)||0
2851969|NCT00006289|3554149|FG000|STARTED|Second Intervention (5 Weeks)||10
2851970|NCT00006289|3554150|FG001|STARTED|Second Intervention (5 Weeks)||10
2851971|NCT00006289|3554149|FG000|COMPLETED|Second Intervention (5 Weeks)||9
2851972|NCT00006289|3554150|FG001|COMPLETED|Second Intervention (5 Weeks)||9
2851973|NCT00006289|3554149|FG000|NOT COMPLETED|Second Intervention (5 Weeks)||1
2851974|NCT00006289|3554150|FG001|NOT COMPLETED|Second Intervention (5 Weeks)||1
2851975|NCT00006305|3554170|FG000|STARTED|Overall Study||592
2851976|NCT00006305|3554171|FG001|STARTED|Overall Study||584
2851977|NCT00006305|3554172|FG002|STARTED|Overall Study||593
2851978|NCT00006305|3554173|FG003|STARTED|Overall Study||599
2851979|NCT00006305|3554170|FG000|COMPLETED|Overall Study||575
2851980|NCT00006305|3554171|FG001|COMPLETED|Overall Study||574
2851981|NCT00006305|3554172|FG002|COMPLETED|Overall Study||578
2851982|NCT00006305|3554173|FG003|COMPLETED|Overall Study||585
2851983|NCT00006305|3554170|FG000|NOT COMPLETED|Overall Study||17
2851984|NCT00006305|3554171|FG001|NOT COMPLETED|Overall Study||10
2851985|NCT00006305|3554172|FG002|NOT COMPLETED|Overall Study||15
2851986|NCT00006305|3554173|FG003|NOT COMPLETED|Overall Study||14
2851987|NCT00006389|3554183|FG000|STARTED|Overall Study||12
2851988|NCT00006389|3554183|FG000|COMPLETED|Overall Study||11
2851989|NCT00006389|3554183|FG000|NOT COMPLETED|Overall Study||1
2851990|NCT00006392|3554192|FG000|STARTED|Overall Study||8904
2851991|NCT00006392|3554193|FG001|STARTED|Overall Study||8910
2851992|NCT00006392|3554194|FG002|STARTED|Overall Study||8863
2851993|NCT00006392|3554195|FG003|STARTED|Overall Study||8856
2851994|NCT00006392|3554192|FG000|COMPLETED|Overall Study||8737
2851995|NCT00006392|3554193|FG001|COMPLETED|Overall Study||8752
2851996|NCT00006392|3554194|FG002|COMPLETED|Overall Study||8703
2851997|NCT00006392|3554195|FG003|COMPLETED|Overall Study||8696
2851998|NCT00006392|3554192|FG000|NOT COMPLETED|Overall Study||167
2851999|NCT00006392|3554193|FG001|NOT COMPLETED|Overall Study||158
2852000|NCT00006392|3554194|FG002|NOT COMPLETED|Overall Study||160
2852001|NCT00006392|3554195|FG003|NOT COMPLETED|Overall Study||160
2852002|NCT00006400|3554207|FG000|STARTED|Overall Study||96
2852003|NCT00006400|3554208|FG001|STARTED|Overall Study||97
2852004|NCT00006400|3554207|FG000|COMPLETED|Overall Study||83
2852005|NCT00006400|3554208|FG001|COMPLETED|Overall Study||84
2852006|NCT00006400|3554207|FG000|NOT COMPLETED|Overall Study||13
2852007|NCT00006400|3554208|FG001|NOT COMPLETED|Overall Study||13
2852008|NCT00006409|3554220|FG000|STARTED|Baseline||865
2852009|NCT00006409|3554221|FG001|STARTED|Baseline||856
2852010|NCT00006409|3554222|FG002|STARTED|Baseline||0
2852011|NCT00006409|3554223|FG003|STARTED|Baseline||0
2852012|NCT00006409|3554224|FG004|STARTED|Baseline||0
2852013|NCT00006409|3554225|FG005|STARTED|Baseline||0
2852014|NCT00006409|3554220|FG000|COMPLETED|Baseline||817
2852015|NCT00006409|3554221|FG001|COMPLETED|Baseline||786
2852016|NCT00006409|3554222|FG002|COMPLETED|Baseline||0
2852017|NCT00006409|3554223|FG003|COMPLETED|Baseline||0
2852018|NCT00006409|3554224|FG004|COMPLETED|Baseline||0
2852019|NCT00006409|3554225|FG005|COMPLETED|Baseline||0
2852020|NCT00006409|3554220|FG000|NOT COMPLETED|Baseline||48
2852021|NCT00006409|3554221|FG001|NOT COMPLETED|Baseline||70
2852022|NCT00006409|3554222|FG002|NOT COMPLETED|Baseline||0
2852023|NCT00006409|3554223|FG003|NOT COMPLETED|Baseline||0
2852024|NCT00006409|3554224|FG004|NOT COMPLETED|Baseline||0
2852025|NCT00006409|3554225|FG005|NOT COMPLETED|Baseline||0
2852026|NCT00006409|3554220|FG000|STARTED|Post-2 Year Intervention|6th grade/2003 sample was not followed over time|0
2852027|NCT00006409|3554221|FG001|STARTED|Post-2 Year Intervention|6th grade/2003 sample was not followed over time|0
2852028|NCT00006409|3554222|FG002|STARTED|Post-2 Year Intervention|Sample is independent of 6th-grade/2003 sample that was measured at baseline|1791
2852029|NCT00006409|3554223|FG003|STARTED|Post-2 Year Intervention|Sample is independent of 6th-grade/2003 sample that was measured at baseline|1713
2852030|NCT00006409|3554224|FG004|STARTED|Post-2 Year Intervention||0
2852031|NCT00006409|3554225|FG005|STARTED|Post-2 Year Intervention||0
2852032|NCT00006409|3554220|FG000|COMPLETED|Post-2 Year Intervention||0
2852033|NCT00006409|3554221|FG001|COMPLETED|Post-2 Year Intervention||0
2852034|NCT00006409|3554222|FG002|COMPLETED|Post-2 Year Intervention||1540
2852035|NCT00006409|3554223|FG003|COMPLETED|Post-2 Year Intervention||1545
2852036|NCT00006409|3554224|FG004|COMPLETED|Post-2 Year Intervention||0
2852037|NCT00006409|3554225|FG005|COMPLETED|Post-2 Year Intervention||0
2852038|NCT00006409|3554220|FG000|NOT COMPLETED|Post-2 Year Intervention||0
2852039|NCT00006409|3554221|FG001|NOT COMPLETED|Post-2 Year Intervention||0
2852040|NCT00006409|3554222|FG002|NOT COMPLETED|Post-2 Year Intervention||251
2852041|NCT00006409|3554223|FG003|NOT COMPLETED|Post-2 Year Intervention||168
2852042|NCT00006409|3554224|FG004|NOT COMPLETED|Post-2 Year Intervention||0
2852043|NCT00006409|3554225|FG005|NOT COMPLETED|Post-2 Year Intervention||0
2852044|NCT00006409|3554220|FG000|STARTED|Post-3 Year Intervention||0
2852045|NCT00006409|3554221|FG001|STARTED|Post-3 Year Intervention||0
2852046|NCT00006409|3554222|FG002|STARTED|Post-3 Year Intervention|8th-grade/2005 sample was not followed over time|0
2852047|NCT00006409|3554223|FG003|STARTED|Post-3 Year Intervention|8th-grade/2005 sample was not followed over time|0
2852048|NCT00006409|3554224|FG004|STARTED|Post-3 Year Intervention|Sample is independent of 8th-grade/2005 sample that was measured post-2 year intervention|1726
2852049|NCT00006409|3554225|FG005|STARTED|Post-3 Year Intervention|Sample is independent of 8th-grade/2005 sample that was measured post-2 year intervention|1776
2852050|NCT00006409|3554220|FG000|COMPLETED|Post-3 Year Intervention||0
2852051|NCT00006409|3554221|FG001|COMPLETED|Post-3 Year Intervention||0
2852052|NCT00006409|3554222|FG002|COMPLETED|Post-3 Year Intervention||0
2852053|NCT00006409|3554223|FG003|COMPLETED|Post-3 Year Intervention||0
2852054|NCT00006409|3554224|FG004|COMPLETED|Post-3 Year Intervention||1664
2852055|NCT00006409|3554225|FG005|COMPLETED|Post-3 Year Intervention||1714
2852056|NCT00006409|3554220|FG000|NOT COMPLETED|Post-3 Year Intervention||0
2852057|NCT00006409|3554221|FG001|NOT COMPLETED|Post-3 Year Intervention||0
2852058|NCT00006409|3554222|FG002|NOT COMPLETED|Post-3 Year Intervention||0
2852059|NCT00006409|3554223|FG003|NOT COMPLETED|Post-3 Year Intervention||0
2852060|NCT00006409|3554224|FG004|NOT COMPLETED|Post-3 Year Intervention||62
2852061|NCT00006409|3554225|FG005|NOT COMPLETED|Post-3 Year Intervention||62
2852062|NCT00006411|3554241|FG000|STARTED|Overall Study||707
2852063|NCT00006411|3554242|FG001|STARTED|Overall Study||383
2852064|NCT00006411|3554241|FG000|COMPLETED|Overall Study||707
2852065|NCT00006411|3554242|FG001|COMPLETED|Overall Study||383
2852066|NCT00006411|3554241|FG000|NOT COMPLETED|Overall Study||0
2852067|NCT00006411|3554242|FG001|NOT COMPLETED|Overall Study||0
2852068|NCT00006489|3554252|FG000|STARTED|Overall Study||42
2852069|NCT00006489|3554253|FG001|STARTED|Overall Study||40
2852070|NCT00006489|3554254|FG002|STARTED|Overall Study||40
2852071|NCT00006489|3554255|FG003|STARTED|Overall Study||43
2852072|NCT00006489|3554252|FG000|COMPLETED|Overall Study||29
2852073|NCT00006489|3554253|FG001|COMPLETED|Overall Study||26
2852074|NCT00006489|3554254|FG002|COMPLETED|Overall Study||25
2852075|NCT00006489|3554255|FG003|COMPLETED|Overall Study||32
2852076|NCT00006489|3554252|FG000|NOT COMPLETED|Overall Study||13
2852077|NCT00006489|3554253|FG001|NOT COMPLETED|Overall Study||14
2852078|NCT00006489|3554254|FG002|NOT COMPLETED|Overall Study||15
2852079|NCT00006489|3554255|FG003|NOT COMPLETED|Overall Study||11
2852080|NCT00006604|3554272|FG000|STARTED|Overall Study||6
2852081|NCT00006604|3554273|FG001|STARTED|Overall Study||2
2852082|NCT00006604|3554274|FG002|STARTED|Overall Study||5
2852083|NCT00006604|3554275|FG003|STARTED|Overall Study||6
2852084|NCT00006604|3554276|FG004|STARTED|Overall Study||5
2852085|NCT00006604|3554277|FG005|STARTED|Overall Study||5
2852086|NCT00006604|3554278|FG006|STARTED|Overall Study||21
2852087|NCT00006604|3554279|FG007|STARTED|Overall Study||5
2852088|NCT00006604|3554280|FG008|STARTED|Overall Study||5
2852089|NCT00006604|3554281|FG009|STARTED|Overall Study||25
2852090|NCT00006604|3554282|FG010|STARTED|Overall Study||21
2852091|NCT00006604|3554283|FG011|STARTED|Overall Study||12
2852092|NCT00006604|3554284|FG012|STARTED|Overall Study||26
2852093|NCT00006604|3554285|FG013|STARTED|Overall Study||6
2852094|NCT00006604|3554286|FG014|STARTED|Overall Study||24
2852095|NCT00006604|3554287|FG015|STARTED|Overall Study||6
2852096|NCT00006604|3554288|FG016|STARTED|Overall Study||15
2852097|NCT00006604|3554272|FG000|COMPLETED|Overall Study||4
2852098|NCT00006604|3554273|FG001|COMPLETED|Overall Study||2
2852099|NCT00006604|3554274|FG002|COMPLETED|Overall Study||1
2852100|NCT00006604|3554275|FG003|COMPLETED|Overall Study||1
2852101|NCT00006604|3554276|FG004|COMPLETED|Overall Study||3
2852102|NCT00006604|3554277|FG005|COMPLETED|Overall Study||2
2852103|NCT00006604|3554278|FG006|COMPLETED|Overall Study||12
2852104|NCT00006604|3554279|FG007|COMPLETED|Overall Study||2
2852105|NCT00006604|3554280|FG008|COMPLETED|Overall Study||4
2852106|NCT00006604|3554281|FG009|COMPLETED|Overall Study||6
2852107|NCT00006604|3554282|FG010|COMPLETED|Overall Study||13
2852108|NCT00006604|3554283|FG011|COMPLETED|Overall Study||6
2852109|NCT00006604|3554284|FG012|COMPLETED|Overall Study||22
2852110|NCT00006604|3554285|FG013|COMPLETED|Overall Study||0
2852111|NCT00006604|3554286|FG014|COMPLETED|Overall Study||14
2852112|NCT00006604|3554287|FG015|COMPLETED|Overall Study||1
2852113|NCT00006604|3554288|FG016|COMPLETED|Overall Study||6
2852114|NCT00006604|3554272|FG000|NOT COMPLETED|Overall Study||2
2852115|NCT00006604|3554273|FG001|NOT COMPLETED|Overall Study||0
2852116|NCT00006604|3554274|FG002|NOT COMPLETED|Overall Study||4
2852117|NCT00006604|3554275|FG003|NOT COMPLETED|Overall Study||5
2852118|NCT00006604|3554276|FG004|NOT COMPLETED|Overall Study||2
2852119|NCT00006604|3554277|FG005|NOT COMPLETED|Overall Study||3
2852120|NCT00006604|3554278|FG006|NOT COMPLETED|Overall Study||9
2852121|NCT00006604|3554279|FG007|NOT COMPLETED|Overall Study||3
2852122|NCT00006604|3554280|FG008|NOT COMPLETED|Overall Study||1
2852123|NCT00006604|3554281|FG009|NOT COMPLETED|Overall Study||19
2852124|NCT00006604|3554282|FG010|NOT COMPLETED|Overall Study||8
2852125|NCT00006604|3554283|FG011|NOT COMPLETED|Overall Study||6
2852126|NCT00006604|3554284|FG012|NOT COMPLETED|Overall Study||4
2852127|NCT00006604|3554285|FG013|NOT COMPLETED|Overall Study||6
2852128|NCT00006604|3554286|FG014|NOT COMPLETED|Overall Study||10
2852129|NCT00006604|3554287|FG015|NOT COMPLETED|Overall Study||5
2852130|NCT00006604|3554288|FG016|NOT COMPLETED|Overall Study||9
2852131|NCT00006721|3554314|FG000|STARTED|Overall Study||17
2852132|NCT00006721|3554315|FG001|STARTED|Overall Study||279
2852133|NCT00006721|3554316|FG002|STARTED|Overall Study||275
2852134|NCT00006721|3554314|FG000|Eligible|Overall Study||15
2852135|NCT00006721|3554315|FG001|Eligible|Overall Study||267
2852136|NCT00006721|3554316|FG002|Eligible|Overall Study||265
2852137|NCT00006721|3554314|FG000|Eligible and Began Protocol Therapy|Overall Study||14
2852138|NCT00006721|3554315|FG001|Eligible and Began Protocol Therapy|Overall Study||267
2852139|NCT00006721|3554316|FG002|Eligible and Began Protocol Therapy|Overall Study||265
2852140|NCT00006721|3554314|FG000|COMPLETED|Overall Study||13
2852141|NCT00006721|3554315|FG001|COMPLETED|Overall Study||254
2852142|NCT00006721|3554316|FG002|COMPLETED|Overall Study||242
2852143|NCT00006721|3554314|FG000|NOT COMPLETED|Overall Study||4
2852144|NCT00006721|3554315|FG001|NOT COMPLETED|Overall Study||25
2852145|NCT00006721|3554316|FG002|NOT COMPLETED|Overall Study||33
2852146|NCT00006903|3554328|FG000|STARTED|Overall Study||10
2852147|NCT00006903|3554329|FG001|STARTED|Overall Study||24
2852148|NCT00006903|3554330|FG002|STARTED|Overall Study||33
2852149|NCT00006903|3554328|FG000|COMPLETED|Overall Study||0
2852150|NCT00006903|3554329|FG001|COMPLETED|Overall Study||20
2852151|NCT00006903|3554330|FG002|COMPLETED|Overall Study||27
2852152|NCT00006903|3554328|FG000|NOT COMPLETED|Overall Study||10
2852153|NCT00006903|3554329|FG001|NOT COMPLETED|Overall Study||4
2852154|NCT00006903|3554330|FG002|NOT COMPLETED|Overall Study||6
2852155|NCT00007020|3554338|FG000|STARTED|Overall Study||85
2852156|NCT00007020|3554338|FG000|COMPLETED|Overall Study||41
2852157|NCT00007020|3554338|FG000|NOT COMPLETED|Overall Study||44
2852158|NCT00007345|3554346|FG000|STARTED|Overall Study||47
2852159|NCT00007345|3554347|FG001|STARTED|Overall Study||84
2852160|NCT00007345|3554346|FG000|COMPLETED|Overall Study||45
2852161|NCT00007345|3554347|FG001|COMPLETED|Overall Study||73
2852162|NCT00007345|3554346|FG000|NOT COMPLETED|Overall Study||2
2852163|NCT00007345|3554347|FG001|NOT COMPLETED|Overall Study||11
2852164|NCT00007475|3554356|FG000|STARTED|Overall Study|[ arm reflects un-assayed participants' disposition ]|12
2852165|NCT00007475|3554357|FG001|STARTED|Overall Study|[ arm reflects eventual participant disposition ]|1
2852166|NCT00007475|3554358|FG002|STARTED|Overall Study|[ arm reflects eventual participant disposition ]|2
2852167|NCT00007475|3554359|FG003|STARTED|Overall Study||0
2852168|NCT00007475|3554356|FG000|FSGS Permeability Factor (FPF) Assayed|Overall Study|FSGS Permeability Factor's provisional assay only applied to minority of early enrollees, by design.|0
2852169|NCT00007475|3554357|FG001|FSGS Permeability Factor (FPF) Assayed|Overall Study||1
2852170|NCT00007475|3554358|FG002|FSGS Permeability Factor (FPF) Assayed|Overall Study||2
2852171|NCT00007475|3554359|FG003|FSGS Permeability Factor (FPF) Assayed|Overall Study||0
2852172|NCT00007475|3554356|FG000|Initial Transplant|Overall Study||12
2852173|NCT00007475|3554357|FG001|Initial Transplant|Overall Study||1
2852174|NCT00007475|3554358|FG002|Initial Transplant|Overall Study||2
2852175|NCT00007475|3554359|FG003|Initial Transplant|Overall Study||0
2852176|NCT00007475|3554356|FG000|Post-initial Transplant Proteinuria|Overall Study||12
2852177|NCT00007475|3554357|FG001|Post-initial Transplant Proteinuria|Overall Study||1
2852178|NCT00007475|3554358|FG002|Post-initial Transplant Proteinuria|Overall Study||2
2852179|NCT00007475|3554359|FG003|Post-initial Transplant Proteinuria|Overall Study||0
2852180|NCT00007475|3554356|FG000|Initial Plasma Exchange|Overall Study||12
2852181|NCT00007475|3554357|FG001|Initial Plasma Exchange|Overall Study||1
2852182|NCT00007475|3554358|FG002|Initial Plasma Exchange|Overall Study||2
2852183|NCT00007475|3554359|FG003|Initial Plasma Exchange|Overall Study||0
2852184|NCT00007475|3554356|FG000|Initiate Cyclophosphamide|Overall Study||12
2852185|NCT00007475|3554357|FG001|Initiate Cyclophosphamide|Overall Study||1
2852186|NCT00007475|3554358|FG002|Initiate Cyclophosphamide|Overall Study||2
2852187|NCT00007475|3554359|FG003|Initiate Cyclophosphamide|Overall Study||0
2852188|NCT00007475|3554356|FG000|COMPLETED|Overall Study||8
2852189|NCT00007475|3554357|FG001|COMPLETED|Overall Study||1
2852190|NCT00007475|3554358|FG002|COMPLETED|Overall Study||2
2852191|NCT00007475|3554359|FG003|COMPLETED|Overall Study||0
2852192|NCT00007475|3554356|FG000|NOT COMPLETED|Overall Study||4
2852193|NCT00007475|3554357|FG001|NOT COMPLETED|Overall Study||0
2852194|NCT00007475|3554358|FG002|NOT COMPLETED|Overall Study||0
2852195|NCT00007475|3554359|FG003|NOT COMPLETED|Overall Study||0
2852196|NCT00007644|3554371|FG000|STARTED|Overall Study||364
2852197|NCT00007644|3554372|FG001|STARTED|Overall Study||367
2852198|NCT00007644|3554371|FG000|COMPLETED|Overall Study||364
2852199|NCT00007644|3554372|FG001|COMPLETED|Overall Study||367
2852200|NCT00007644|3554371|FG000|NOT COMPLETED|Overall Study||0
2852201|NCT00007644|3554372|FG001|NOT COMPLETED|Overall Study||0
2852202|NCT00008138|3554378|FG000|STARTED|Neoadjuvant Chemotherapy||58
2852203|NCT00008138|3554378|FG000|Eligible|Neoadjuvant Chemotherapy||58
2852204|NCT00008138|3554378|FG000|COMPLETED|Neoadjuvant Chemotherapy||38
2852205|NCT00008138|3554378|FG000|NOT COMPLETED|Neoadjuvant Chemotherapy||20
2852206|NCT00008138|3554378|FG000|STARTED|Interval Debulking||38
2852207|NCT00008138|3554378|FG000|Received Protocol Surgery|Interval Debulking||36
2852208|NCT00008138|3554378|FG000|COMPLETED|Interval Debulking||36
2852209|NCT00008138|3554378|FG000|NOT COMPLETED|Interval Debulking||2
2852210|NCT00008138|3554378|FG000|STARTED|Post-Cytoreduction Chemotherapy|Among 36 patients from previous period, 5 patients rejected and 5 patients are ineligible.|26
2852211|NCT00008138|3554378|FG000|COMPLETED|Post-Cytoreduction Chemotherapy||18
2852212|NCT00008138|3554378|FG000|NOT COMPLETED|Post-Cytoreduction Chemotherapy||8
2852213|NCT00008385|3554385|FG000|STARTED|Overall Study||521
2852214|NCT00008385|3554386|FG001|STARTED|Overall Study||1040
2852215|NCT00008385|3554385|FG000|Treated|Overall Study||477
2852216|NCT00008385|3554386|FG001|Treated|Overall Study||865
2918096|NCT00524472|3628219|FG001|NOT COMPLETED|Overall Study||0
2852217|NCT00008385|3554385|FG000|Off Treatment Reasons Reported|Overall Study||398
2852218|NCT00008385|3554386|FG001|Off Treatment Reasons Reported|Overall Study||795
2852219|NCT00008385|3554385|FG000|COMPLETED|Overall Study||134
2852220|NCT00008385|3554386|FG001|COMPLETED|Overall Study||238
2852221|NCT00008385|3554385|FG000|NOT COMPLETED|Overall Study||387
2852222|NCT00008385|3554386|FG001|NOT COMPLETED|Overall Study||802
2852223|NCT00009737|3554394|FG000|STARTED|Overall Study||1004
2852224|NCT00009737|3554395|FG001|STARTED|Overall Study||983
2852225|NCT00009737|3554394|FG000|COMPLETED|Overall Study||834
2852226|NCT00009737|3554395|FG001|COMPLETED|Overall Study||860
2852227|NCT00009737|3554394|FG000|NOT COMPLETED|Overall Study||170
2852228|NCT00009737|3554395|FG001|NOT COMPLETED|Overall Study||123
2852229|NCT00009945|3554403|FG000|STARTED|Overall Study||1662
2852230|NCT00009945|3554404|FG001|STARTED|Overall Study||1661
2852231|NCT00009945|3554403|FG000|COMPLETED|Overall Study||1655
2852232|NCT00009945|3554404|FG001|COMPLETED|Overall Study||1656
2852233|NCT00009945|3554403|FG000|NOT COMPLETED|Overall Study||7
2852234|NCT00009945|3554404|FG001|NOT COMPLETED|Overall Study||5
2852235|NCT00010257|3554412|FG000|STARTED|Overall Study||25
2852236|NCT00010257|3554413|FG001|STARTED|Overall Study||21
2852237|NCT00010257|3554412|FG000|COMPLETED|Overall Study||24
2852238|NCT00010257|3554413|FG001|COMPLETED|Overall Study||21
2852239|NCT00010257|3554412|FG000|NOT COMPLETED|Overall Study||1
2852240|NCT00010257|3554413|FG001|NOT COMPLETED|Overall Study||0
2852241|NCT00010374|3554419|FG000|STARTED|Overall Study||54
2852242|NCT00010374|3554419|FG000|COMPLETED|Overall Study|One compassionate use participant was withheld from analysis per FDA instructions|53
2852243|NCT00010374|3554419|FG000|NOT COMPLETED|Overall Study||1
2852244|NCT00010439|3554424|FG000|STARTED|Overall Study||10
2852245|NCT00010439|3554424|FG000|6 Months|Overall Study||10
2852246|NCT00010439|3554424|FG000|COMPLETED|Overall Study||10
2852247|NCT00010439|3554424|FG000|NOT COMPLETED|Overall Study||0
2852248|NCT00010803|3554430|FG000|STARTED|Overall Study|Randomized|1545
2852249|NCT00010803|3554431|FG001|STARTED|Overall Study|Randomized|1524
2852250|NCT00010803|3554430|FG000|COMPLETED|Overall Study|Reached endpoint of dementia, death or completion|1448
2852251|NCT00010803|3554431|FG001|COMPLETED|Overall Study|Reached endpoint of dementia, death or completion|1426
2852252|NCT00010803|3554430|FG000|NOT COMPLETED|Overall Study||97
2852253|NCT00010803|3554431|FG001|NOT COMPLETED|Overall Study||98
2852254|NCT00011986|3554442|FG000|STARTED|Overall Study||864
2852255|NCT00011986|3554443|FG001|STARTED|Overall Study||864
2852256|NCT00011986|3554444|FG002|STARTED|Overall Study||862
2852257|NCT00011986|3554445|FG003|STARTED|Overall Study||861
2852258|NCT00011986|3554446|FG004|STARTED|Overall Study||861
2852259|NCT00011986|3554442|FG000|Initiated Treatment|Overall Study||862
2852260|NCT00011986|3554443|FG001|Initiated Treatment|Overall Study||860
2852261|NCT00011986|3554444|FG002|Initiated Treatment|Overall Study||854
2852262|NCT00011986|3554445|FG003|Initiated Treatment|Overall Study||846
2852263|NCT00011986|3554446|FG004|Initiated Treatment|Overall Study||851
2852264|NCT00011986|3554442|FG000|COMPLETED|Overall Study||864
2852265|NCT00011986|3554443|FG001|COMPLETED|Overall Study||864
2852266|NCT00011986|3554444|FG002|COMPLETED|Overall Study||862
2852267|NCT00011986|3554445|FG003|COMPLETED|Overall Study||861
2852268|NCT00011986|3554446|FG004|COMPLETED|Overall Study||861
2852269|NCT00011986|3554442|FG000|NOT COMPLETED|Overall Study||0
2852270|NCT00011986|3554443|FG001|NOT COMPLETED|Overall Study||0
2852271|NCT00011986|3554444|FG002|NOT COMPLETED|Overall Study||0
2852272|NCT00011986|3554445|FG003|NOT COMPLETED|Overall Study||0
2852273|NCT00011986|3554446|FG004|NOT COMPLETED|Overall Study||0
2852274|NCT00012012|3554465|FG000|STARTED|Overall Study||27
2852275|NCT00012012|3554466|FG001|STARTED|Overall Study||18
2852276|NCT00012012|3554465|FG000|COMPLETED|Overall Study||26
2852277|NCT00012012|3554466|FG001|COMPLETED|Overall Study||15
2852278|NCT00012012|3554465|FG000|NOT COMPLETED|Overall Study||1
2852279|NCT00012012|3554466|FG001|NOT COMPLETED|Overall Study||3
2852280|NCT00012298|3554479|FG000|STARTED|Overall Study||11
2852281|NCT00012298|3554480|FG001|STARTED|Overall Study||7
2852282|NCT00012298|3554481|FG002|STARTED|Overall Study||9
2852283|NCT00012298|3554482|FG003|STARTED|Overall Study||4
2852284|NCT00012298|3554483|FG004|STARTED|Overall Study||5
2852285|NCT00012298|3554484|FG005|STARTED|Overall Study||6
2852286|NCT00012298|3554485|FG006|STARTED|Overall Study||39
2852287|NCT00012298|3554479|FG000|COMPLETED|Overall Study||11
2852288|NCT00012298|3554480|FG001|COMPLETED|Overall Study||7
2852289|NCT00012298|3554481|FG002|COMPLETED|Overall Study||9
2852290|NCT00012298|3554482|FG003|COMPLETED|Overall Study||4
2852291|NCT00012298|3554483|FG004|COMPLETED|Overall Study||5
2852292|NCT00012298|3554484|FG005|COMPLETED|Overall Study||6
2852293|NCT00012298|3554485|FG006|COMPLETED|Overall Study||39
2852294|NCT00012298|3554479|FG000|NOT COMPLETED|Overall Study||0
2852295|NCT00012298|3554480|FG001|NOT COMPLETED|Overall Study||0
2852296|NCT00012298|3554481|FG002|NOT COMPLETED|Overall Study||0
2852297|NCT00012298|3554482|FG003|NOT COMPLETED|Overall Study||0
2852298|NCT00012298|3554483|FG004|NOT COMPLETED|Overall Study||0
2852299|NCT00012298|3554484|FG005|NOT COMPLETED|Overall Study||0
2852300|NCT00012298|3554485|FG006|NOT COMPLETED|Overall Study||0
2852301|NCT00013611|3554505|FG000|STARTED|Overall Study|138 were excluded from sites that did not re-consent 2/3 of patients to the amended protocol in 2003|849
2852302|NCT00013611|3554506|FG001|STARTED|Overall Study|138 were excluded from sites that did not re-consent 2/3 of patients to the amended protocol in 2003|846
2852303|NCT00013611|3554505|FG000|COMPLETED|Overall Study||758
2852304|NCT00013611|3554506|FG001|COMPLETED|Overall Study||746
2852305|NCT00013611|3554505|FG000|NOT COMPLETED|Overall Study||91
2852306|NCT00013611|3554506|FG001|NOT COMPLETED|Overall Study||100
2852307|NCT00014222|3554515|FG000|STARTED|Overall Study||701
2852308|NCT00014222|3554516|FG001|STARTED|Overall Study||701
2852309|NCT00014222|3554517|FG002|STARTED|Overall Study||702
2852310|NCT00014222|3554515|FG000|COMPLETED|Overall Study||680
2852311|NCT00014222|3554516|FG001|COMPLETED|Overall Study||688
2852312|NCT00014222|3554517|FG002|COMPLETED|Overall Study||675
2852313|NCT00014222|3554515|FG000|NOT COMPLETED|Overall Study||21
2852314|NCT00014222|3554516|FG001|NOT COMPLETED|Overall Study||13
2852315|NCT00014222|3554517|FG002|NOT COMPLETED|Overall Study||27
2852316|NCT00014495|3554529|FG000|STARTED|Overall Study||3
2852317|NCT00014495|3554530|FG001|STARTED|Overall Study||3
2852318|NCT00014495|3554531|FG002|STARTED|Overall Study||20
2852319|NCT00014495|3554532|FG003|STARTED|Overall Study||6
2852320|NCT00014495|3554529|FG000|COMPLETED|Overall Study||3
2852321|NCT00014495|3554530|FG001|COMPLETED|Overall Study||3
2852322|NCT00014495|3554531|FG002|COMPLETED|Overall Study||19
2852323|NCT00014495|3554532|FG003|COMPLETED|Overall Study||5
2852324|NCT00014495|3554529|FG000|NOT COMPLETED|Overall Study||0
2852325|NCT00014495|3554530|FG001|NOT COMPLETED|Overall Study||0
2852326|NCT00014495|3554531|FG002|NOT COMPLETED|Overall Study||1
2852327|NCT00014495|3554532|FG003|NOT COMPLETED|Overall Study||1
2852328|NCT00014911|3554539|FG000|STARTED|Overall Study||36
2852329|NCT00014911|3554539|FG000|COMPLETED|Overall Study|One subject experienced pneumonia, myocardial infarction, and acute renal failure|25
2852330|NCT00014911|3554539|FG000|NOT COMPLETED|Overall Study||11
2852331|NCT00015457|3554543|FG000|STARTED|First Intervention||8
2852332|NCT00015457|3554544|FG001|STARTED|First Intervention||8
2852333|NCT00015457|3554543|FG000|COMPLETED|First Intervention||8
2852334|NCT00015457|3554544|FG001|COMPLETED|First Intervention||5
2852335|NCT00015457|3554543|FG000|NOT COMPLETED|First Intervention||0
2852336|NCT00015457|3554544|FG001|NOT COMPLETED|First Intervention||3
2852337|NCT00015457|3554543|FG000|STARTED|Second Intervention||8
2852338|NCT00015457|3554544|FG001|STARTED|Second Intervention||5
2852339|NCT00015457|3554543|FG000|COMPLETED|Second Intervention||7
2852340|NCT00015457|3554544|FG001|COMPLETED|Second Intervention||5
2852341|NCT00015457|3554543|FG000|NOT COMPLETED|Second Intervention||1
2852342|NCT00015457|3554544|FG001|NOT COMPLETED|Second Intervention||0
2852343|NCT00015847|3554550|FG000|STARTED|Overall Study||25
2852344|NCT00015847|3554550|FG000|COMPLETED|Overall Study||25
2852345|NCT00015847|3554550|FG000|NOT COMPLETED|Overall Study||0
2852346|NCT00016354|3554554|FG000|STARTED|Overall Study||1
2852347|NCT00016354|3554555|FG001|STARTED|Overall Study||1
2852348|NCT00016354|3554556|FG002|STARTED|Overall Study||1
2852349|NCT00016354|3554557|FG003|STARTED|Overall Study||1
2852350|NCT00016354|3554558|FG004|STARTED|Overall Study||1
2852351|NCT00016354|3554559|FG005|STARTED|Overall Study||1
2852352|NCT00016354|3554560|FG006|STARTED|Overall Study||6
2852353|NCT00016354|3554561|FG007|STARTED|Overall Study||7
2852354|NCT00016354|3554554|FG000|COMPLETED|Overall Study||1
2852355|NCT00016354|3554555|FG001|COMPLETED|Overall Study||1
2852356|NCT00016354|3554556|FG002|COMPLETED|Overall Study||1
2852357|NCT00016354|3554557|FG003|COMPLETED|Overall Study||1
2852358|NCT00016354|3554558|FG004|COMPLETED|Overall Study||1
2852359|NCT00016354|3554559|FG005|COMPLETED|Overall Study||1
2852360|NCT00016354|3554560|FG006|COMPLETED|Overall Study||6
2852361|NCT00016354|3554561|FG007|COMPLETED|Overall Study||6
2852362|NCT00016354|3554554|FG000|NOT COMPLETED|Overall Study||0
2852363|NCT00016354|3554555|FG001|NOT COMPLETED|Overall Study||0
2852364|NCT00016354|3554556|FG002|NOT COMPLETED|Overall Study||0
2852365|NCT00016354|3554557|FG003|NOT COMPLETED|Overall Study||0
2852366|NCT00016354|3554558|FG004|NOT COMPLETED|Overall Study||0
2852367|NCT00016354|3554559|FG005|NOT COMPLETED|Overall Study||0
2852368|NCT00016354|3554560|FG006|NOT COMPLETED|Overall Study||0
2852369|NCT00016354|3554561|FG007|NOT COMPLETED|Overall Study||1
2852370|NCT00016718|3554568|FG000|STARTED|Overall Study||6
2852371|NCT00016718|3554569|FG001|STARTED|Overall Study||21
2852372|NCT00016718|3554570|FG002|STARTED|Overall Study||16
2852373|NCT00016718|3554568|FG000|COMPLETED|Overall Study||6
2852374|NCT00016718|3554569|FG001|COMPLETED|Overall Study||21
2852375|NCT00016718|3554570|FG002|COMPLETED|Overall Study||16
2852376|NCT00016718|3554568|FG000|NOT COMPLETED|Overall Study||0
2852377|NCT00016718|3554569|FG001|NOT COMPLETED|Overall Study||0
2852378|NCT00016718|3554570|FG002|NOT COMPLETED|Overall Study||0
2852379|NCT00016913|3554578|FG000|STARTED|Overall Study||27
2852380|NCT00016913|3554578|FG000|COMPLETED|Overall Study||27
2852381|NCT00016913|3554578|FG000|NOT COMPLETED|Overall Study||0
2852382|NCT00017563|3554582|FG000|STARTED|Overall Study||57
2852383|NCT00017563|3554582|FG000|COMPLETED|Overall Study||56
2852384|NCT00017563|3554582|FG000|NOT COMPLETED|Overall Study||1
2852385|NCT00018031|3554586|FG000|STARTED|Overall Study||36
2852386|NCT00018031|3554586|FG000|COMPLETED|Overall Study||36
2852387|NCT00018031|3554586|FG000|NOT COMPLETED|Overall Study||0
2852388|NCT00019604|3554590|FG000|STARTED|Overall Study||44
2852389|NCT00019604|3554590|FG000|COMPLETED|Overall Study||5
2852390|NCT00019604|3554590|FG000|NOT COMPLETED|Overall Study||39
2852391|NCT00019682|3554596|FG000|STARTED|Overall Study||94
2852392|NCT00019682|3554597|FG001|STARTED|Overall Study||91
2852393|NCT00019682|3554596|FG000|COMPLETED|Overall Study||93
2852394|NCT00019682|3554597|FG001|COMPLETED|Overall Study||85
2852395|NCT00019682|3554596|FG000|NOT COMPLETED|Overall Study||1
2852396|NCT00019682|3554597|FG001|NOT COMPLETED|Overall Study||6
2852397|NCT00021229|3554606|FG000|STARTED|Overall Study||36
2852398|NCT00021229|3554607|FG001|STARTED|Overall Study||33
2852399|NCT00021229|3554608|FG002|STARTED|Overall Study||16
2852400|NCT00021229|3554606|FG000|Enrolled in Phase I|Overall Study||35
2852401|NCT00021229|3554607|FG001|Enrolled in Phase I|Overall Study||33
2852402|NCT00021229|3554608|FG002|Enrolled in Phase I|Overall Study||16
2852403|NCT00021229|3554606|FG000|Maximum Tolerated Dose (MTD) Estimation|Overall Study|12 participants enrolled in the Phase I part did not complete the 8 week MTD estimation period.|23
2852404|NCT00021229|3554607|FG001|Maximum Tolerated Dose (MTD) Estimation|Overall Study|13 participants enrolled in the Phase I part did not complete the 8 week MTD estimation period.|20
2852405|NCT00021229|3554608|FG002|Maximum Tolerated Dose (MTD) Estimation|Overall Study|4 participants enrolled in the Phase I part did not complete the 8 week MTD estimation period.|12
2852406|NCT00021229|3554606|FG000|Enrolled in Phase II|Overall Study|Thirteen participants treated at the MTD in the phase I were also part of the phase II.|14
2852407|NCT00021229|3554607|FG001|Enrolled in Phase II|Overall Study|Participants from stratum IIA did not participate in the phase II part of the study.|0
2852408|NCT00021229|3554608|FG002|Enrolled in Phase II|Overall Study|Participants from stratum IIB did not participate in the phase II part of the study.|0
2852409|NCT00021229|3554606|FG000|COMPLETED|Overall Study|1 participant completed 13 courses of therapy|1
2852410|NCT00021229|3554607|FG001|COMPLETED|Overall Study||0
2852411|NCT00021229|3554608|FG002|COMPLETED|Overall Study||0
2852412|NCT00021229|3554606|FG000|NOT COMPLETED|Overall Study||35
2852413|NCT00021229|3554607|FG001|NOT COMPLETED|Overall Study||33
2852414|NCT00021229|3554608|FG002|NOT COMPLETED|Overall Study||16
2852415|NCT00021255|3554621|FG000|STARTED|Overall Study|Randomized|1073
2852416|NCT00021255|3554622|FG001|STARTED|Overall Study|Randomized|1074
2852417|NCT00021255|3554623|FG002|STARTED|Overall Study|Randomized|1075
2852418|NCT00021255|3554621|FG000|Treated|Overall Study||1045
2852419|NCT00021255|3554622|FG001|Treated|Overall Study||1072
2852420|NCT00021255|3554623|FG002|Treated|Overall Study||1057
2852421|NCT00021255|3554621|FG000|Safety Population|Overall Study|1018 participants received AC-T (1012 from AC-T arm, 6 from AC-TH arm).|1018
2852422|NCT00021255|3554622|FG001|Safety Population|Overall Study|1100 participants received AC-TH (1066 from AC-TH arm, 33 from AC-T arm and 1 from TCH arm).|1100
2852423|NCT00021255|3554623|FG002|Safety Population|Overall Study|1056 participants received TCH.|1056
2852424|NCT00021255|3554621|FG000|COMPLETED|Overall Study||952
2852425|NCT00021255|3554622|FG001|COMPLETED|Overall Study||804
2852426|NCT00021255|3554623|FG002|COMPLETED|Overall Study||926
2852427|NCT00021255|3554621|FG000|NOT COMPLETED|Overall Study||121
2852428|NCT00021255|3554622|FG001|NOT COMPLETED|Overall Study||270
2852429|NCT00021255|3554623|FG002|NOT COMPLETED|Overall Study||149
2852430|NCT00021541|3554633|FG000|STARTED|Period 1-First Treatment||31
2852431|NCT00021541|3554634|FG001|STARTED|Period 1-First Treatment|These are the patients randomized to receive placebo. Two of these patients were deemed ineligible.|31
2852432|NCT00021541|3554633|FG000|Pts Who Progressed to Second Treatment|Period 1-First Treatment||20
2852433|NCT00021541|3554634|FG001|Pts Who Progressed to Second Treatment|Period 1-First Treatment||23
2852434|NCT00021541|3554633|FG000|Ineligible Patients|Period 1-First Treatment||0
2852435|NCT00021541|3554634|FG001|Ineligible Patients|Period 1-First Treatment||2
2852436|NCT00021541|3554633|FG000|COMPLETED|Period 1-First Treatment||20
2852437|NCT00021541|3554634|FG001|COMPLETED|Period 1-First Treatment||23
2852438|NCT00021541|3554633|FG000|NOT COMPLETED|Period 1-First Treatment||11
2852439|NCT00021541|3554634|FG001|NOT COMPLETED|Period 1-First Treatment||8
2852440|NCT00021541|3554633|FG000|STARTED|Period 2-crossover||20
2852441|NCT00021541|3554634|FG001|STARTED|Period 2-crossover||23
2852442|NCT00021541|3554633|FG000|COMPLETED|Period 2-crossover||10
2852443|NCT00021541|3554634|FG001|COMPLETED|Period 2-crossover||12
2852444|NCT00021541|3554633|FG000|NOT COMPLETED|Period 2-crossover||10
2852445|NCT00021541|3554634|FG001|NOT COMPLETED|Period 2-crossover||11
2852446|NCT00022490|3554642|FG000|STARTED|Overall Study||24
2852447|NCT00022490|3554642|FG000|COMPLETED|Overall Study||24
2852448|NCT00022490|3554642|FG000|NOT COMPLETED|Overall Study||0
2852449|NCT00022516|3554648|FG000|STARTED|Overall Study||542
2852450|NCT00022516|3554649|FG001|STARTED|Overall Study||544
2852451|NCT00022516|3554648|FG000|COMPLETED|Overall Study||539
3168474|NCT01919164|3895760|FG002|COMPLETED|Overall Study||74
3168475|NCT01919164|3895761|FG003|COMPLETED|Overall Study||82
3168476|NCT01919164|3895762|FG004|COMPLETED|Overall Study||77
2852452|NCT00022516|3554649|FG001|COMPLETED|Overall Study||314
2852453|NCT00022516|3554648|FG000|NOT COMPLETED|Overall Study||3
2852454|NCT00022516|3554649|FG001|NOT COMPLETED|Overall Study||230
2852455|NCT00022633|3554657|FG000|STARTED|Overall Study||55
2852456|NCT00022633|3554658|FG001|STARTED|Overall Study||10
2852457|NCT00022633|3554657|FG000|Eligible|Overall Study||51
2852458|NCT00022633|3554658|FG001|Eligible|Overall Study||10
2852459|NCT00022633|3554657|FG000|COMPLETED|Overall Study||23
2852460|NCT00022633|3554658|FG001|COMPLETED|Overall Study||5
2852461|NCT00022633|3554657|FG000|NOT COMPLETED|Overall Study||32
2852462|NCT00022633|3554658|FG001|NOT COMPLETED|Overall Study||5
2852463|NCT00022659|3554663|FG000|STARTED|Overall Study||64
2852464|NCT00022659|3554663|FG000|COMPLETED|Overall Study|Eligible and treated patients.|62
2852465|NCT00022659|3554663|FG000|NOT COMPLETED|Overall Study||2
2852466|NCT00022672|3554673|FG000|STARTED|Main Phase: 24 Months||103
2852467|NCT00022672|3554674|FG001|STARTED|Main Phase: 24 Months||104
2852468|NCT00022672|3554673|FG000|Safety Set: Received Study Drug|Main Phase: 24 Months||103
2852469|NCT00022672|3554674|FG001|Safety Set: Received Study Drug|Main Phase: 24 Months||104
2852470|NCT00022672|3554673|FG000|COMPLETED|Main Phase: 24 Months||16
2852471|NCT00022672|3554674|FG001|COMPLETED|Main Phase: 24 Months||4
2852472|NCT00022672|3554673|FG000|NOT COMPLETED|Main Phase: 24 Months||87
2852473|NCT00022672|3554674|FG001|NOT COMPLETED|Main Phase: 24 Months||100
3168477|NCT01919164|3895758|FG000|NOT COMPLETED|Overall Study||43
3168478|NCT01919164|3895759|FG001|NOT COMPLETED|Overall Study||30
3168479|NCT01919164|3895760|FG002|NOT COMPLETED|Overall Study||37
3168480|NCT01919164|3895761|FG003|NOT COMPLETED|Overall Study||28
3168481|NCT01919164|3895762|FG004|NOT COMPLETED|Overall Study||33
3168482|NCT01919190|3895776|FG000|STARTED|Overall Study|Met eligibility criteria|33
3168483|NCT01919190|3895777|FG001|STARTED|Overall Study|Met eligibility criteria|34
3168484|NCT01919190|3895776|FG000|COMPLETED|Overall Study||30
2852474|NCT00022672|3554673|FG000|STARTED|Extension Phase|2 patients completed Main Phase; but did not enter Extension (1-did not cooperate and 1-withdrew).|14
2852475|NCT00022672|3554674|FG001|STARTED|Extension Phase||58
2852476|NCT00022672|3554673|FG000|Safety Set: Received Study Drug|Extension Phase||14
2852477|NCT00022672|3554674|FG001|Safety Set: Received Study Drug|Extension Phase||58
2852478|NCT00022672|3554673|FG000|COMPLETED|Extension Phase||11
2852479|NCT00022672|3554674|FG001|COMPLETED|Extension Phase||7
2852480|NCT00022672|3554673|FG000|NOT COMPLETED|Extension Phase||3
2852481|NCT00022672|3554674|FG001|NOT COMPLETED|Extension Phase||51
2852482|NCT00022698|3554683|FG000|STARTED|Overall Study||15
2852483|NCT00022698|3554684|FG001|STARTED|Overall Study||52
2852484|NCT00022698|3554683|FG000|COMPLETED|Overall Study||7
2852485|NCT00022698|3554684|FG001|COMPLETED|Overall Study||17
2852486|NCT00022698|3554683|FG000|NOT COMPLETED|Overall Study||8
2852487|NCT00022698|3554684|FG001|NOT COMPLETED|Overall Study||35
2852488|NCT00022763|3554694|FG000|STARTED|Overall Study||24
2852489|NCT00022763|3554695|FG001|STARTED|Overall Study||28
2852490|NCT00022763|3554694|FG000|COMPLETED|Overall Study||15
2852491|NCT00022763|3554695|FG001|COMPLETED|Overall Study||11
2852492|NCT00022763|3554694|FG000|NOT COMPLETED|Overall Study||9
2852493|NCT00022763|3554695|FG001|NOT COMPLETED|Overall Study||17
2852494|NCT00023309|3554702|FG000|STARTED|Overall Study||22
2852495|NCT00023309|3554703|FG001|STARTED|Overall Study||19
2852496|NCT00023309|3554702|FG000|COMPLETED|Overall Study||22
2852497|NCT00023309|3554703|FG001|COMPLETED|Overall Study||19
2852498|NCT00023309|3554702|FG000|NOT COMPLETED|Overall Study||0
2852499|NCT00023309|3554703|FG001|NOT COMPLETED|Overall Study||0
2852500|NCT00023322|3554709|FG000|STARTED|Overall Study||13
2852501|NCT00023322|3554709|FG000|COMPLETED|Overall Study||12
2852502|NCT00023322|3554709|FG000|NOT COMPLETED|Overall Study||1
2852503|NCT00023452|3554715|FG000|STARTED|Overall Study||3908
2852504|NCT00023452|3554716|FG001|STARTED|Overall Study||4145
2852505|NCT00023452|3554715|FG000|Randomized|Overall Study||3190
2852506|NCT00023452|3554716|FG001|Randomized|Overall Study||3174
2852507|NCT00023452|3554715|FG000|Enrolled as Part of a Cluster|Overall Study||718
2852508|NCT00023452|3554716|FG001|Enrolled as Part of a Cluster|Overall Study||971
2852509|NCT00023452|3554715|FG000|Completed Treatment|Overall Study||2585
2852510|NCT00023452|3554716|FG001|Completed Treatment|Overall Study||3273
2852511|NCT00023452|3554715|FG000|Not Treated|Overall Study||149
2852512|NCT00023452|3554716|FG001|Not Treated|Overall Study||105
2852513|NCT00023452|3554715|FG000|Completed Study|Overall Study||3174
2852514|NCT00023452|3554716|FG001|Completed Study|Overall Study||3475
2852515|NCT00023452|3554715|FG000|COMPLETED|Overall Study||2585
2852516|NCT00023452|3554716|FG001|COMPLETED|Overall Study||3273
2852517|NCT00023452|3554715|FG000|NOT COMPLETED|Overall Study||1323
2852518|NCT00023452|3554716|FG001|NOT COMPLETED|Overall Study||872
2852519|NCT00023595|3554731|FG000|STARTED|5 Year Follow up||602
2852520|NCT00023595|3554732|FG001|STARTED|5 Year Follow up||534
2852521|NCT00023595|3554733|FG002|STARTED|5 Year Follow up||76
2852522|NCT00023595|3554734|FG003|STARTED|5 Year Follow up|76 of stratum B pts who were randomized to med therapy + CABG group belong to both H01 and H02.|423
2852523|NCT00023595|3554735|FG004|STARTED|5 Year Follow up||501
2852524|NCT00023595|3554731|FG000|COMPLETED|5 Year Follow up||600
2852525|NCT00023595|3554732|FG001|COMPLETED|5 Year Follow up||532
2852526|NCT00023595|3554733|FG002|COMPLETED|5 Year Follow up||75
2852527|NCT00023595|3554734|FG003|COMPLETED|5 Year Follow up||416
2852528|NCT00023595|3554735|FG004|COMPLETED|5 Year Follow up||498
2852529|NCT00023595|3554731|FG000|NOT COMPLETED|5 Year Follow up||2
2852530|NCT00023595|3554732|FG001|NOT COMPLETED|5 Year Follow up||2
2852531|NCT00023595|3554733|FG002|NOT COMPLETED|5 Year Follow up||1
2852532|NCT00023595|3554734|FG003|NOT COMPLETED|5 Year Follow up||7
2852533|NCT00023595|3554735|FG004|NOT COMPLETED|5 Year Follow up||3
2852534|NCT00023595|3554731|FG000|STARTED|10 Year Follow up|all participants who started H01 were counted as starting the 10 year follow up.|602
2852535|NCT00023595|3554732|FG001|STARTED|10 Year Follow up|all participants who started H01 were counted as starting the 10 year follow up.|534
2852536|NCT00023595|3554733|FG002|STARTED|10 Year Follow up|all participants who started H01 were counted as starting the 10 year follow up.|76
2852537|NCT00023595|3554734|FG003|STARTED|10 Year Follow up|H02 arm was not extended and ended at year 5|0
2852538|NCT00023595|3554735|FG004|STARTED|10 Year Follow up|H02 arm was not extended and ended at year 5|0
2852539|NCT00023595|3554731|FG000|COMPLETED|10 Year Follow up||590
2852540|NCT00023595|3554732|FG001|COMPLETED|10 Year Follow up||524
2852541|NCT00023595|3554733|FG002|COMPLETED|10 Year Follow up||73
2852542|NCT00023595|3554734|FG003|COMPLETED|10 Year Follow up|H02 arm was not extended and ended at year 5|0
2852543|NCT00023595|3554735|FG004|COMPLETED|10 Year Follow up|H02 arm was not extended and ended at year 5|0
2852544|NCT00023595|3554731|FG000|NOT COMPLETED|10 Year Follow up||12
2852545|NCT00023595|3554732|FG001|NOT COMPLETED|10 Year Follow up||10
2852546|NCT00023595|3554733|FG002|NOT COMPLETED|10 Year Follow up||3
2852547|NCT00023595|3554734|FG003|NOT COMPLETED|10 Year Follow up||0
2852548|NCT00023595|3554735|FG004|NOT COMPLETED|10 Year Follow up||0
2852549|NCT00023673|3554761|FG000|STARTED|Overall Study||8
2852550|NCT00023673|3554762|FG001|STARTED|Overall Study||9
2852551|NCT00023673|3554763|FG002|STARTED|Overall Study||0
2852552|NCT00023673|3554764|FG003|STARTED|Overall Study||46
2852553|NCT00023673|3554761|FG000|COMPLETED|Overall Study|Phase I eligible patients starting protocol treatment are considered to have completed the study.|8
2852554|NCT00023673|3554762|FG001|COMPLETED|Overall Study|Phase I eligible patients starting protocol treatment are considered to have completed the study.|9
2852555|NCT00023673|3554763|FG002|COMPLETED|Overall Study|This arm was not used since further de-escalation was not required.|0
2852556|NCT00023673|3554764|FG003|COMPLETED|Overall Study|Phase II subjects contributing data to primary analysis are considered to have completed the study.|44
2852557|NCT00023673|3554761|FG000|NOT COMPLETED|Overall Study||0
2852558|NCT00023673|3554762|FG001|NOT COMPLETED|Overall Study||0
2852559|NCT00023673|3554763|FG002|NOT COMPLETED|Overall Study||0
2852560|NCT00023673|3554764|FG003|NOT COMPLETED|Overall Study||2
2852561|NCT00023712|3554776|FG000|STARTED|Overall Study|total number of participants enrolled on study|28
2852562|NCT00023712|3554777|FG001|STARTED|Overall Study|total number of participants enrolled on study|30
2852563|NCT00023712|3554776|FG000|COMPLETED|Overall Study|total number of participants eligible and evaluable|26
2852564|NCT00023712|3554777|FG001|COMPLETED|Overall Study|total number of participants eligible and evaluable|29
2852565|NCT00023712|3554776|FG000|NOT COMPLETED|Overall Study||2
2852566|NCT00023712|3554777|FG001|NOT COMPLETED|Overall Study||1
2852567|NCT00023764|3554793|FG000|STARTED|Overall Study||103
2852568|NCT00023764|3554793|FG000|COMPLETED|Overall Study||89
2852569|NCT00023764|3554793|FG000|NOT COMPLETED|Overall Study||14
2918097|NCT00524537|3628225|FG000|STARTED|Overall Study|All Treated Population: All participants who received at least 1 injection of Humira in the registry|5025
2918098|NCT00524537|3628225|FG000|Discontinued|Overall Study|Discontinued from study|2811
2918099|NCT00524537|3628225|FG000|Re-enrolled|Overall Study|Discontinued from study and later re-enrolled in study|339
2918100|NCT00524537|3628225|FG000|Discontinued After Re-enrollment|Overall Study|Discontinued from study after re-enrollment|102
2918101|NCT00524537|3628225|FG000|COMPLETED|Overall Study|Still enrolled in study at the end of study|2451
2918102|NCT00524537|3628225|FG000|NOT COMPLETED|Overall Study||2574
2918103|NCT00524576|3628231|FG000|STARTED|Overall Study||97
2918104|NCT00524576|3628232|FG001|STARTED|Overall Study||47
2918105|NCT00524576|3628231|FG000|COMPLETED|Overall Study||97
2918106|NCT00524576|3628232|FG001|COMPLETED|Overall Study||47
2918107|NCT00524576|3628231|FG000|NOT COMPLETED|Overall Study||0
2918108|NCT00524576|3628232|FG001|NOT COMPLETED|Overall Study||0
2918109|NCT00524589|3628238|FG000|STARTED|Overall Study||18
2918110|NCT00524589|3628238|FG000|COMPLETED|Overall Study||0
2918111|NCT00524589|3628238|FG000|NOT COMPLETED|Overall Study||18
2918112|NCT00524680|3628246|FG000|STARTED|Overall Study||37
2918113|NCT00524680|3628247|FG001|STARTED|Overall Study||35
2918114|NCT00524680|3628248|FG002|STARTED|Overall Study||36
2918115|NCT00524680|3628249|FG003|STARTED|Overall Study||40
2918116|NCT00524680|3628246|FG000|COMPLETED|Overall Study||34
2918117|NCT00524680|3628247|FG001|COMPLETED|Overall Study||34
2918118|NCT00524680|3628248|FG002|COMPLETED|Overall Study||33
3168485|NCT01919190|3895777|FG001|COMPLETED|Overall Study||34
3168486|NCT01919190|3895776|FG000|NOT COMPLETED|Overall Study||3
3168487|NCT01919190|3895777|FG001|NOT COMPLETED|Overall Study||0
3168488|NCT01919216|3895787|FG000|STARTED|Overall Study||28
3168489|NCT01919216|3895788|FG001|STARTED|Overall Study||21
3168490|NCT01919216|3895789|FG002|STARTED|Overall Study||5
2918119|NCT00524680|3628249|FG003|COMPLETED|Overall Study||34
2918120|NCT00524680|3628246|FG000|NOT COMPLETED|Overall Study||3
2918121|NCT00524680|3628247|FG001|NOT COMPLETED|Overall Study||1
3168491|NCT01919216|3895787|FG000|COMPLETED|Overall Study||26
3168492|NCT01919216|3895788|FG001|COMPLETED|Overall Study||20
3168493|NCT01919216|3895789|FG002|COMPLETED|Overall Study||4
3168494|NCT01919216|3895787|FG000|NOT COMPLETED|Overall Study||2
3168495|NCT01919216|3895788|FG001|NOT COMPLETED|Overall Study||1
3168496|NCT01919216|3895789|FG002|NOT COMPLETED|Overall Study||1
2918122|NCT00524680|3628248|FG002|NOT COMPLETED|Overall Study||3
2918123|NCT00524680|3628249|FG003|NOT COMPLETED|Overall Study||6
2918124|NCT00524745|3628263|FG000|STARTED|Overall Study||229
2918125|NCT00524745|3628264|FG001|STARTED|Overall Study||206
2918126|NCT00524745|3628265|FG002|STARTED|Overall Study||241
2918127|NCT00524745|3628266|FG003|STARTED|Overall Study||227
2918128|NCT00524745|3628263|FG000|COMPLETED|Overall Study||195
2918129|NCT00524745|3628264|FG001|COMPLETED|Overall Study||193
2918130|NCT00524745|3628265|FG002|COMPLETED|Overall Study||212
2918131|NCT00524745|3628266|FG003|COMPLETED|Overall Study||205
2918132|NCT00524745|3628263|FG000|NOT COMPLETED|Overall Study||34
2918133|NCT00524745|3628264|FG001|NOT COMPLETED|Overall Study||13
2918134|NCT00524745|3628265|FG002|NOT COMPLETED|Overall Study||29
2918135|NCT00524745|3628266|FG003|NOT COMPLETED|Overall Study||22
2918136|NCT00524771|3628278|FG000|STARTED|Overall Study||17084
2918137|NCT00524771|3628279|FG001|STARTED|Overall Study||17016
2918138|NCT00524771|3628278|FG000|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 0.5 and 4.0 years.|16864
3038338|NCT01153724|3757759|FG000|STARTED|Treatment Period 2||34
3168497|NCT01919229|3895800|FG000|STARTED|Overall Study||4
3168498|NCT01919229|3895801|FG001|STARTED|Overall Study||6
3168499|NCT01919229|3895802|FG002|STARTED|Overall Study||4
2852570|NCT00024102|3554800|FG000|STARTED|Overall Study||326
2852571|NCT00024102|3554801|FG001|STARTED|Overall Study||307
2852572|NCT00024102|3554800|FG000|COMPLETED|Overall Study||326
2852573|NCT00024102|3554801|FG001|COMPLETED|Overall Study||307
2852574|NCT00024102|3554800|FG000|NOT COMPLETED|Overall Study||0
2852575|NCT00024102|3554801|FG001|NOT COMPLETED|Overall Study||0
2852576|NCT00024167|3554814|FG000|STARTED|Overall Study||65
2852577|NCT00024167|3554815|FG001|STARTED|Overall Study||62
2852578|NCT00024167|3554814|FG000|Induction Treatment Option 1 Completed|Overall Study||22
2852579|NCT00024167|3554815|FG001|Induction Treatment Option 1 Completed|Overall Study||21
2852580|NCT00024167|3554814|FG000|Induction Treatment Option 2 Completed|Overall Study||43
2852581|NCT00024167|3554815|FG001|Induction Treatment Option 2 Completed|Overall Study||41
2852582|NCT00024167|3554814|FG000|COMPLETED|Overall Study||12
2852583|NCT00024167|3554815|FG001|COMPLETED|Overall Study||15
2852584|NCT00024167|3554814|FG000|NOT COMPLETED|Overall Study||53
2852585|NCT00024167|3554815|FG001|NOT COMPLETED|Overall Study||47
2852586|NCT00024258|3554822|FG000|STARTED|Overall Study||22
2852587|NCT00024258|3554822|FG000|COMPLETED|Overall Study||13
2852588|NCT00024258|3554822|FG000|NOT COMPLETED|Overall Study||9
2852589|NCT00025155|3554826|FG000|STARTED|Overall Study||51
2852590|NCT00025155|3554826|FG000|COMPLETED|Overall Study|Patients who were eligible and received any study treatment.|49
2852591|NCT00025155|3554826|FG000|NOT COMPLETED|Overall Study||2
2852592|NCT00025233|3554835|FG000|STARTED|Overall Study||50
2852593|NCT00025233|3554835|FG000|COMPLETED|Overall Study||46
2852594|NCT00025233|3554835|FG000|NOT COMPLETED|Overall Study||4
2852595|NCT00025259|3554852|FG000|STARTED|Overall Study||52
2852596|NCT00025259|3554853|FG001|STARTED|Overall Study||381
2852597|NCT00025259|3554854|FG002|STARTED|Overall Study||382
2852598|NCT00025259|3554855|FG003|STARTED|Overall Study||571
2852599|NCT00025259|3554856|FG004|STARTED|Overall Study||42
2852600|NCT00025259|3554857|FG005|STARTED|Overall Study||153
2852601|NCT00025259|3554858|FG006|STARTED|Overall Study||153
2852602|NCT00025259|3554852|FG000|COMPLETED|Overall Study||7
2852603|NCT00025259|3554853|FG001|COMPLETED|Overall Study||292
2852604|NCT00025259|3554854|FG002|COMPLETED|Overall Study||301
2852605|NCT00025259|3554855|FG003|COMPLETED|Overall Study||457
2852606|NCT00025259|3554856|FG004|COMPLETED|Overall Study||6
2852607|NCT00025259|3554857|FG005|COMPLETED|Overall Study||101
2852608|NCT00025259|3554858|FG006|COMPLETED|Overall Study||102
2852609|NCT00025259|3554852|FG000|NOT COMPLETED|Overall Study||45
2852610|NCT00025259|3554853|FG001|NOT COMPLETED|Overall Study||89
2852611|NCT00025259|3554854|FG002|NOT COMPLETED|Overall Study||81
2852612|NCT00025259|3554855|FG003|NOT COMPLETED|Overall Study||114
2852613|NCT00025259|3554856|FG004|NOT COMPLETED|Overall Study||36
2852614|NCT00025259|3554857|FG005|NOT COMPLETED|Overall Study||52
2852615|NCT00025259|3554858|FG006|NOT COMPLETED|Overall Study||51
2852616|NCT00025506|3554877|FG000|STARTED|Overall Study||55
2852617|NCT00025506|3554877|FG000|COMPLETED|Overall Study|Eligible and treated patients.|45
2852618|NCT00025506|3554877|FG000|NOT COMPLETED|Overall Study||10
2852619|NCT00025662|3554886|FG000|STARTED|Overall Study||25
2852620|NCT00025662|3554886|FG000|COMPLETED|Overall Study|One patient who received a transplant did not meet eligibility and was a special exemption.|22
2852621|NCT00025662|3554886|FG000|NOT COMPLETED|Overall Study||3
2852622|NCT00025883|3554892|FG000|STARTED|Overall Study||103
2852623|NCT00025883|3554892|FG000|Generalized Lipodystrophy|Overall Study||63
2852624|NCT00025883|3554892|FG000|Partial Lipodystrophy|Overall Study||40
2852625|NCT00025883|3554892|FG000|COMPLETED|Overall Study||86
2852626|NCT00025883|3554892|FG000|NOT COMPLETED|Overall Study||17
2852627|NCT00026208|3554899|FG000|STARTED|Overall Study||72
2852628|NCT00026208|3554900|FG001|STARTED|Overall Study||4
2852629|NCT00026208|3554899|FG000|COMPLETED|Overall Study||71
2852630|NCT00026208|3554900|FG001|COMPLETED|Overall Study||4
2852631|NCT00026208|3554899|FG000|NOT COMPLETED|Overall Study||1
2852632|NCT00026208|3554900|FG001|NOT COMPLETED|Overall Study||0
2852633|NCT00026221|3554909|FG000|STARTED|Overall Study||16
2852634|NCT00026221|3554910|FG001|STARTED|Overall Study||16
2852635|NCT00026221|3554911|FG002|STARTED|Overall Study||25
2852636|NCT00026221|3554909|FG000|COMPLETED|Overall Study||16
2852637|NCT00026221|3554910|FG001|COMPLETED|Overall Study||16
2852638|NCT00026221|3554911|FG002|COMPLETED|Overall Study||25
2852639|NCT00026221|3554909|FG000|NOT COMPLETED|Overall Study||0
2852640|NCT00026221|3554910|FG001|NOT COMPLETED|Overall Study||0
2852641|NCT00026221|3554911|FG002|NOT COMPLETED|Overall Study||0
2852642|NCT00026312|3554921|FG000|STARTED|Overall Study||116
2852643|NCT00026312|3554922|FG001|STARTED|Overall Study||1333
2852644|NCT00026312|3554921|FG000|COMPLETED|Overall Study||82
2852645|NCT00026312|3554922|FG001|COMPLETED|Overall Study||1064
2852646|NCT00026312|3554921|FG000|NOT COMPLETED|Overall Study||34
2852647|NCT00026312|3554922|FG001|NOT COMPLETED|Overall Study||269
2852648|NCT00026494|3554936|FG000|STARTED|Overall Study||7
2852649|NCT00026494|3554937|FG001|STARTED|Overall Study||4
2852650|NCT00026494|3554938|FG002|STARTED|Overall Study||22
2852651|NCT00026494|3554939|FG003|STARTED|Overall Study||16
2852652|NCT00026494|3554936|FG000|COMPLETED|Overall Study||5
2852653|NCT00026494|3554937|FG001|COMPLETED|Overall Study||4
2852654|NCT00026494|3554938|FG002|COMPLETED|Overall Study||16
2852655|NCT00026494|3554939|FG003|COMPLETED|Overall Study||16
2852656|NCT00026494|3554936|FG000|NOT COMPLETED|Overall Study||2
2852657|NCT00026494|3554937|FG001|NOT COMPLETED|Overall Study||0
2852658|NCT00026494|3554938|FG002|NOT COMPLETED|Overall Study||6
2852659|NCT00026494|3554939|FG003|NOT COMPLETED|Overall Study||0
2852660|NCT00026793|3554949|FG000|STARTED|Overall Study||29
2852661|NCT00026793|3554949|FG000|COMPLETED|Overall Study||21
2852662|NCT00026793|3554949|FG000|NOT COMPLETED|Overall Study||8
2852663|NCT00027027|3554958|FG000|STARTED|Overall Study||3
2852664|NCT00027027|3554959|FG001|STARTED|Overall Study||3
2852665|NCT00027027|3554960|FG002|STARTED|Overall Study||4
2852666|NCT00027027|3554961|FG003|STARTED|Overall Study||3
2852667|NCT00027027|3554962|FG004|STARTED|Overall Study||8
2852668|NCT00027027|3554958|FG000|Discontinued Before 2 Treatment Cycles|Overall Study||0
2852669|NCT00027027|3554959|FG001|Discontinued Before 2 Treatment Cycles|Overall Study||0
2852670|NCT00027027|3554960|FG002|Discontinued Before 2 Treatment Cycles|Overall Study||1
2852671|NCT00027027|3554961|FG003|Discontinued Before 2 Treatment Cycles|Overall Study||0
2852672|NCT00027027|3554962|FG004|Discontinued Before 2 Treatment Cycles|Overall Study||1
2852673|NCT00027027|3554958|FG000|Completed 2 Cycles of Treatment|Overall Study||3
2852674|NCT00027027|3554959|FG001|Completed 2 Cycles of Treatment|Overall Study||3
2852675|NCT00027027|3554960|FG002|Completed 2 Cycles of Treatment|Overall Study||3
2852676|NCT00027027|3554961|FG003|Completed 2 Cycles of Treatment|Overall Study||3
2852677|NCT00027027|3554962|FG004|Completed 2 Cycles of Treatment|Overall Study||7
2852678|NCT00027027|3554958|FG000|Discontinued at Cycle 2|Overall Study||2
2852679|NCT00027027|3554959|FG001|Discontinued at Cycle 2|Overall Study||2
2852680|NCT00027027|3554960|FG002|Discontinued at Cycle 2|Overall Study||1
2852681|NCT00027027|3554961|FG003|Discontinued at Cycle 2|Overall Study||1
2852682|NCT00027027|3554962|FG004|Discontinued at Cycle 2|Overall Study||3
2852683|NCT00027027|3554958|FG000|Treated Beyond Cycle 2|Overall Study||1
2852684|NCT00027027|3554959|FG001|Treated Beyond Cycle 2|Overall Study||1
2852685|NCT00027027|3554960|FG002|Treated Beyond Cycle 2|Overall Study||2
2852686|NCT00027027|3554961|FG003|Treated Beyond Cycle 2|Overall Study||2
2852687|NCT00027027|3554962|FG004|Treated Beyond Cycle 2|Overall Study||4
2852688|NCT00027027|3554958|FG000|COMPLETED|Overall Study||0
2852689|NCT00027027|3554959|FG001|COMPLETED|Overall Study||0
2852690|NCT00027027|3554960|FG002|COMPLETED|Overall Study||0
2852691|NCT00027027|3554961|FG003|COMPLETED|Overall Study||0
2852692|NCT00027027|3554962|FG004|COMPLETED|Overall Study||0
2852693|NCT00027027|3554958|FG000|NOT COMPLETED|Overall Study||3
2852694|NCT00027027|3554959|FG001|NOT COMPLETED|Overall Study||3
2852695|NCT00027027|3554960|FG002|NOT COMPLETED|Overall Study||4
2852696|NCT00027027|3554961|FG003|NOT COMPLETED|Overall Study||3
2852697|NCT00027027|3554962|FG004|NOT COMPLETED|Overall Study||8
2852698|NCT00027378|3554980|FG000|STARTED|Overall Study||24
2852699|NCT00027378|3554981|FG001|STARTED|Overall Study||26
2852700|NCT00027378|3554980|FG000|COMPLETED|Overall Study||24
2852701|NCT00027378|3554981|FG001|COMPLETED|Overall Study||23
2852702|NCT00027378|3554980|FG000|NOT COMPLETED|Overall Study||0
2852703|NCT00027378|3554981|FG001|NOT COMPLETED|Overall Study||3
2852704|NCT00027560|3554987|FG000|STARTED|Overall Study||51
2852705|NCT00027560|3554987|FG000|COMPLETED|Overall Study||50
2852706|NCT00027560|3554987|FG000|NOT COMPLETED|Overall Study||1
2852707|NCT00027846|3554996|FG000|STARTED|Overall Study||13
2852708|NCT00027846|3554997|FG001|STARTED|Overall Study||287
2852709|NCT00027846|3554998|FG002|STARTED|Overall Study||78
2852710|NCT00027846|3554996|FG000|COMPLETED|Overall Study||11
2852711|NCT00027846|3554997|FG001|COMPLETED|Overall Study||219
2852712|NCT00027846|3554998|FG002|COMPLETED|Overall Study||41
2852713|NCT00027846|3554996|FG000|NOT COMPLETED|Overall Study||2
2852714|NCT00027846|3554997|FG001|NOT COMPLETED|Overall Study||68
2852715|NCT00027846|3554998|FG002|NOT COMPLETED|Overall Study||37
2852716|NCT00028002|3555008|FG000|STARTED|Overall Study||63
2852717|NCT00028002|3555008|FG000|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|52
2852718|NCT00028002|3555008|FG000|NOT COMPLETED|Overall Study||11
2852719|NCT00028093|3555015|FG000|STARTED|Overall Study||25
2852720|NCT00028093|3555016|FG001|STARTED|Overall Study||25
2852721|NCT00028093|3555015|FG000|COMPLETED|Overall Study||25
2852722|NCT00028093|3555016|FG001|COMPLETED|Overall Study||25
2852723|NCT00028093|3555015|FG000|NOT COMPLETED|Overall Study||0
2852724|NCT00028093|3555016|FG001|NOT COMPLETED|Overall Study||0
2852725|NCT00028262|3555022|FG000|STARTED|Overall Study||10
2852726|NCT00028262|3555022|FG000|COMPLETED|Overall Study||9
2852727|NCT00028262|3555022|FG000|NOT COMPLETED|Overall Study||1
2852728|NCT00028769|3555026|FG000|STARTED|Overall Study||41
2852729|NCT00028769|3555026|FG000|Eligible|Overall Study||36
2852730|NCT00028769|3555026|FG000|Eligible and Began Protocol Therapy|Overall Study|One patient refused all protocol treatment and was not evaluable for the present analysis|35
2852731|NCT00028769|3555026|FG000|COMPLETED|Overall Study|Patients receive protocol treatments until evidence of disease progression|0
2852732|NCT00028769|3555026|FG000|NOT COMPLETED|Overall Study||41
2852733|NCT00029107|3555032|FG000|STARTED|Overall Study||12
2852734|NCT00029107|3555033|FG001|STARTED|Overall Study||12
2852735|NCT00029107|3555032|FG000|COMPLETED|Overall Study||12
2852736|NCT00029107|3555033|FG001|COMPLETED|Overall Study||12
2852737|NCT00029107|3555032|FG000|NOT COMPLETED|Overall Study||0
2852738|NCT00029107|3555033|FG001|NOT COMPLETED|Overall Study||0
2852739|NCT00029146|3555041|FG000|STARTED|Overall Study||97
2852740|NCT00029146|3555042|FG001|STARTED|Overall Study||98
2852741|NCT00029146|3555041|FG000|COMPLETED|Overall Study||95
2852742|NCT00029146|3555042|FG001|COMPLETED|Overall Study||97
2852743|NCT00029146|3555041|FG000|NOT COMPLETED|Overall Study||2
2852744|NCT00029146|3555042|FG001|NOT COMPLETED|Overall Study||1
2852745|NCT00029172|3555048|FG000|STARTED|Overall Study||188
2852746|NCT00029172|3555048|FG000|COMPLETED|Overall Study||182
2852747|NCT00029172|3555048|FG000|NOT COMPLETED|Overall Study||6
3313356|NCT03075410|4046796|FG005|STARTED|Part A-Washout Period 1 (14 Days)||1
3313357|NCT03075410|4046797|FG006|STARTED|Part A-Washout Period 1 (14 Days)||0
3313358|NCT03075410|4046798|FG007|STARTED|Part A-Washout Period 1 (14 Days)||0
3313359|NCT03075410|4046799|FG008|STARTED|Part A-Washout Period 1 (14 Days)||0
3313360|NCT03075410|4046791|FG000|COMPLETED|Part A-Washout Period 1 (14 Days)||2
3313361|NCT03075410|4046792|FG001|COMPLETED|Part A-Washout Period 1 (14 Days)||1
3313362|NCT03075410|4046793|FG002|COMPLETED|Part A-Washout Period 1 (14 Days)||2
3313363|NCT03075410|4046794|FG003|COMPLETED|Part A-Washout Period 1 (14 Days)||1
3313364|NCT03075410|4046795|FG004|COMPLETED|Part A-Washout Period 1 (14 Days)||2
3313365|NCT03075410|4046796|FG005|COMPLETED|Part A-Washout Period 1 (14 Days)||1
3313366|NCT03075410|4046797|FG006|COMPLETED|Part A-Washout Period 1 (14 Days)||0
3313367|NCT03075410|4046798|FG007|COMPLETED|Part A-Washout Period 1 (14 Days)||0
2852748|NCT00029536|3555056|FG000|STARTED|Overall Study||85
2852749|NCT00029536|3555057|FG001|STARTED|Overall Study||45
2852750|NCT00029536|3555058|FG002|STARTED|Overall Study||105
2852751|NCT00029536|3555059|FG003|STARTED|Overall Study||59
2852752|NCT00029536|3555056|FG000|COMPLETED|Overall Study||85
2852753|NCT00029536|3555057|FG001|COMPLETED|Overall Study||45
2852754|NCT00029536|3555058|FG002|COMPLETED|Overall Study||105
2852755|NCT00029536|3555059|FG003|COMPLETED|Overall Study||59
2852756|NCT00029536|3555056|FG000|NOT COMPLETED|Overall Study||0
2852757|NCT00029536|3555057|FG001|NOT COMPLETED|Overall Study||0
2852758|NCT00029536|3555058|FG002|NOT COMPLETED|Overall Study||0
2852759|NCT00029536|3555059|FG003|NOT COMPLETED|Overall Study||0
2852760|NCT00030147|3555075|FG000|STARTED|Overall Study||17
2852761|NCT00030147|3555076|FG001|STARTED|Overall Study||19
2852762|NCT00030147|3555077|FG002|STARTED|Overall Study||16
2852763|NCT00030147|3555078|FG003|STARTED|Overall Study||11
2852764|NCT00030147|3555075|FG000|COMPLETED|Overall Study||17
2852765|NCT00030147|3555076|FG001|COMPLETED|Overall Study||18
2852766|NCT00030147|3555077|FG002|COMPLETED|Overall Study||16
2852767|NCT00030147|3555078|FG003|COMPLETED|Overall Study||11
2852768|NCT00030147|3555075|FG000|NOT COMPLETED|Overall Study||0
2852769|NCT00030147|3555076|FG001|NOT COMPLETED|Overall Study||1
2852770|NCT00030147|3555077|FG002|NOT COMPLETED|Overall Study||0
2852771|NCT00030147|3555078|FG003|NOT COMPLETED|Overall Study||0
2852772|NCT00030264|3555088|FG000|STARTED|Overall Study||23
2852773|NCT00030264|3555088|FG000|COMPLETED|Overall Study||23
2852774|NCT00030264|3555088|FG000|NOT COMPLETED|Overall Study||0
2852775|NCT00030823|3555092|FG000|STARTED|Overall Study||14
2852776|NCT00030823|3555092|FG000|COMPLETED|Overall Study||13
2852777|NCT00030823|3555092|FG000|NOT COMPLETED|Overall Study||1
2852778|NCT00030901|3555098|FG000|STARTED|Initial Registration||619
2852779|NCT00030901|3555099|FG001|STARTED|Initial Registration||0
2852780|NCT00030901|3555100|FG002|STARTED|Initial Registration||0
2852781|NCT00030901|3555098|FG000|COMPLETED|Initial Registration||452
2852782|NCT00030901|3555099|FG001|COMPLETED|Initial Registration||0
2852783|NCT00030901|3555100|FG002|COMPLETED|Initial Registration||0
2852784|NCT00030901|3555098|FG000|NOT COMPLETED|Initial Registration||167
2852785|NCT00030901|3555099|FG001|NOT COMPLETED|Initial Registration||0
2852786|NCT00030901|3555100|FG002|NOT COMPLETED|Initial Registration||0
2852787|NCT00030901|3555098|FG000|STARTED|Randomization||0
2852788|NCT00030901|3555099|FG001|STARTED|Randomization||227
2852789|NCT00030901|3555100|FG002|STARTED|Randomization||225
2852790|NCT00030901|3555098|FG000|Eligible|Randomization||0
2852791|NCT00030901|3555099|FG001|Eligible|Randomization||212
2852792|NCT00030901|3555100|FG002|Eligible|Randomization||211
2852793|NCT00030901|3555098|FG000|COMPLETED|Randomization||0
2852794|NCT00030901|3555099|FG001|COMPLETED|Randomization||126
2852795|NCT00030901|3555100|FG002|COMPLETED|Randomization||137
2852796|NCT00030901|3555098|FG000|NOT COMPLETED|Randomization||0
2852797|NCT00030901|3555099|FG001|NOT COMPLETED|Randomization||101
2852798|NCT00030901|3555100|FG002|NOT COMPLETED|Randomization||88
2852799|NCT00030992|3555106|FG000|STARTED|Overall Study||102
2852800|NCT00030992|3555106|FG000|COMPLETED|Overall Study||102
2852801|NCT00030992|3555106|FG000|NOT COMPLETED|Overall Study||0
2852802|NCT00031447|3555112|FG000|STARTED|Overall Study||14
2852803|NCT00031447|3555113|FG001|STARTED|Overall Study||15
2852804|NCT00031447|3555112|FG000|COMPLETED|Overall Study||4
2852805|NCT00031447|3555113|FG001|COMPLETED|Overall Study||8
2852806|NCT00031447|3555112|FG000|NOT COMPLETED|Overall Study||10
2852807|NCT00031447|3555113|FG001|NOT COMPLETED|Overall Study||7
2852808|NCT00031460|3555121|FG000|STARTED|Overall Study||24
2852809|NCT00031460|3555122|FG001|STARTED|Overall Study||22
2852810|NCT00031460|3555121|FG000|COMPLETED|Overall Study||15
2852811|NCT00031460|3555122|FG001|COMPLETED|Overall Study||8
2852812|NCT00031460|3555121|FG000|NOT COMPLETED|Overall Study||9
2852813|NCT00031460|3555122|FG001|NOT COMPLETED|Overall Study||14
2852814|NCT00031486|3555130|FG000|STARTED|Overall Study||40
2852815|NCT00031486|3555131|FG001|STARTED|Overall Study||47
2852816|NCT00031486|3555130|FG000|COMPLETED|Overall Study||33
2852817|NCT00031486|3555131|FG001|COMPLETED|Overall Study||35
2852818|NCT00031486|3555130|FG000|NOT COMPLETED|Overall Study||7
2852819|NCT00031486|3555131|FG001|NOT COMPLETED|Overall Study||12
2852820|NCT00031551|3555141|FG000|STARTED|Overall Study||2
2852821|NCT00031551|3555142|FG001|STARTED|Overall Study||25
2852822|NCT00031551|3555141|FG000|COMPLETED|Overall Study||0
2852823|NCT00031551|3555142|FG001|COMPLETED|Overall Study||25
2852824|NCT00031551|3555141|FG000|NOT COMPLETED|Overall Study||2
2852825|NCT00031551|3555142|FG001|NOT COMPLETED|Overall Study||0
2852826|NCT00031590|3555152|FG000|STARTED|Overall Study||28
2852827|NCT00031590|3555152|FG000|COMPLETED|Overall Study||25
2852828|NCT00031590|3555152|FG000|NOT COMPLETED|Overall Study||3
2852829|NCT00031694|3555157|FG000|STARTED|Overall Study||19
2852830|NCT00031694|3555157|FG000|COMPLETED|Overall Study||0
2852831|NCT00031694|3555157|FG000|NOT COMPLETED|Overall Study||19
2852832|NCT00032487|3555164|FG000|STARTED|Overall Study||899
2852833|NCT00032487|3555165|FG001|STARTED|Overall Study||892
2852834|NCT00032487|3555164|FG000|COMPLETED|Overall Study||760
2852835|NCT00032487|3555165|FG001|COMPLETED|Overall Study||772
2852836|NCT00032487|3555164|FG000|NOT COMPLETED|Overall Study||139
2852837|NCT00032487|3555165|FG001|NOT COMPLETED|Overall Study||120
2852838|NCT00032591|3555173|FG000|STARTED|Screening|3745 patients provided informed consent and were screened for participation.|1873
2852839|NCT00032591|3555174|FG001|STARTED|Screening|Treatment assigned at randomization; screening counts by arm represent half of the total screened.|1872
2852840|NCT00032591|3555173|FG000|COMPLETED|Screening|823 were excluded from the study|1465
2852841|NCT00032591|3555174|FG001|COMPLETED|Screening||1457
2852842|NCT00032591|3555173|FG000|NOT COMPLETED|Screening||408
2852843|NCT00032591|3555174|FG001|NOT COMPLETED|Screening||415
2852844|NCT00032591|3555173|FG000|STARTED|Randomization|2922 underwent randomization|1465
2852845|NCT00032591|3555174|FG001|STARTED|Randomization||1457
2852846|NCT00032591|3555173|FG000|COMPLETED|Randomization|1465 were assigned to self-testing|1465
2852847|NCT00032591|3555174|FG001|COMPLETED|Randomization|1457 were assigned to clinic testing|1457
2852848|NCT00032591|3555173|FG000|NOT COMPLETED|Randomization||0
2852849|NCT00032591|3555174|FG001|NOT COMPLETED|Randomization||0
2852850|NCT00032591|3555173|FG000|STARTED|Follow-up|2 were lost to follow-up, both with Atrial Fibrillation, no Mechanical Heart Valves|1465
2852851|NCT00032591|3555174|FG001|STARTED|Follow-up|5 were lost to follow-up, all with Atrial Fibrillation, no Mechanical Heart Valves|1457
2852852|NCT00032591|3555173|FG000|COMPLETED|Follow-up|1463 were included in analysis with greater than 1 day of follow-up|1463
2852853|NCT00032591|3555174|FG001|COMPLETED|Follow-up|1452 were included in analysis with greater than 1 day of follow-up|1452
2852854|NCT00032591|3555173|FG000|NOT COMPLETED|Follow-up||2
2852855|NCT00032591|3555174|FG001|NOT COMPLETED|Follow-up||5
2852856|NCT00032630|3555182|FG000|STARTED|Overall Study||1099
2852857|NCT00032630|3555183|FG001|STARTED|Overall Study||1104
2852858|NCT00032630|3555182|FG000|COMPLETED|Overall Study||1050
2852859|NCT00032630|3555183|FG001|COMPLETED|Overall Study||1061
2852860|NCT00032630|3555182|FG000|NOT COMPLETED|Overall Study||49
2852861|NCT00032630|3555183|FG001|NOT COMPLETED|Overall Study||43
2852862|NCT00033371|3555191|FG000|STARTED|Overall Study||55
2852863|NCT00033371|3555192|FG001|STARTED|Overall Study||57
2852864|NCT00033371|3555191|FG000|COMPLETED|Overall Study||49
2852865|NCT00033371|3555192|FG001|COMPLETED|Overall Study||47
2852866|NCT00033371|3555191|FG000|NOT COMPLETED|Overall Study||6
2852867|NCT00033371|3555192|FG001|NOT COMPLETED|Overall Study||10
2852868|NCT00033514|3555204|FG000|STARTED|Overall Study||16
2852869|NCT00033514|3555205|FG001|STARTED|Overall Study||11
2852870|NCT00033514|3555204|FG000|COMPLETED|Overall Study||15
2852871|NCT00033514|3555205|FG001|COMPLETED|Overall Study||7
2852872|NCT00033514|3555204|FG000|NOT COMPLETED|Overall Study||1
2852873|NCT00033514|3555205|FG001|NOT COMPLETED|Overall Study||4
2852874|NCT00033540|3555212|FG000|STARTED|Overall Study||57
2852875|NCT00033540|3555212|FG000|Eligible|Overall Study||54
2852876|NCT00033540|3555212|FG000|Eligible and Began Protocol Therapy|Overall Study|One patient went off study prior to any toxicity assessments and is not evaluable for toxicities.|52
2852877|NCT00033540|3555212|FG000|COMPLETED|Overall Study||0
2852878|NCT00033540|3555212|FG000|NOT COMPLETED|Overall Study||57
2852879|NCT00033631|3555219|FG000|STARTED|Overall Study||769
2852880|NCT00033631|3555220|FG001|STARTED|Overall Study||763
2852881|NCT00033631|3555219|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|751
2852882|NCT00033631|3555220|FG001|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|748
2852883|NCT00033631|3555219|FG000|NOT COMPLETED|Overall Study||18
2852884|NCT00033631|3555220|FG001|NOT COMPLETED|Overall Study||15
2852885|NCT00033657|3555229|FG000|STARTED|Neoadjuvant Chemotherapy||50
2852886|NCT00033657|3555230|FG001|STARTED|Neoadjuvant Chemotherapy||47
2852887|NCT00033657|3555229|FG000|Eligible|Neoadjuvant Chemotherapy||42
2852888|NCT00033657|3555230|FG001|Eligible|Neoadjuvant Chemotherapy||43
2852889|NCT00033657|3555229|FG000|Eligible and Treated|Neoadjuvant Chemotherapy||39
2852890|NCT00033657|3555230|FG001|Eligible and Treated|Neoadjuvant Chemotherapy||42
2852891|NCT00033657|3555229|FG000|COMPLETED|Neoadjuvant Chemotherapy||36
2852892|NCT00033657|3555230|FG001|COMPLETED|Neoadjuvant Chemotherapy||36
2852893|NCT00033657|3555229|FG000|NOT COMPLETED|Neoadjuvant Chemotherapy||14
2852894|NCT00033657|3555230|FG001|NOT COMPLETED|Neoadjuvant Chemotherapy||11
2852895|NCT00033657|3555229|FG000|STARTED|Surgical Resection||36
2852896|NCT00033657|3555230|FG001|STARTED|Surgical Resection||36
2852897|NCT00033657|3555229|FG000|COMPLETED|Surgical Resection||36
2852898|NCT00033657|3555230|FG001|COMPLETED|Surgical Resection||33
3168500|NCT01919229|3895800|FG000|COMPLETED|Overall Study||4
3168501|NCT01919229|3895801|FG001|COMPLETED|Overall Study||6
3168502|NCT01919229|3895802|FG002|COMPLETED|Overall Study||3
3168503|NCT01919229|3895800|FG000|NOT COMPLETED|Overall Study||0
3168504|NCT01919229|3895801|FG001|NOT COMPLETED|Overall Study||0
2852899|NCT00033657|3555229|FG000|NOT COMPLETED|Surgical Resection||0
2852900|NCT00033657|3555230|FG001|NOT COMPLETED|Surgical Resection||3
2852901|NCT00033657|3555229|FG000|STARTED|Adjuvant Chemotherapy||36
2852902|NCT00033657|3555230|FG001|STARTED|Adjuvant Chemotherapy||33
2852903|NCT00033657|3555229|FG000|COMPLETED|Adjuvant Chemotherapy||18
2852904|NCT00033657|3555230|FG001|COMPLETED|Adjuvant Chemotherapy||16
2852905|NCT00033657|3555229|FG000|NOT COMPLETED|Adjuvant Chemotherapy||18
2852906|NCT00033657|3555230|FG001|NOT COMPLETED|Adjuvant Chemotherapy||17
2852907|NCT00033917|3555240|FG000|STARTED|Overall Study||209
2852908|NCT00033917|3555241|FG001|STARTED|Overall Study||222
2852909|NCT00033917|3555240|FG000|COMPLETED|Overall Study||209
2852910|NCT00033917|3555241|FG001|COMPLETED|Overall Study||222
2852911|NCT00033917|3555240|FG000|NOT COMPLETED|Overall Study||0
2852912|NCT00033917|3555241|FG001|NOT COMPLETED|Overall Study||0
2852913|NCT00035555|3555254|FG000|STARTED|Overall Study|Randomized patients|74
2852914|NCT00035555|3555255|FG001|STARTED|Overall Study|Randomized patients|71
2852915|NCT00035555|3555256|FG002|STARTED|Overall Study|Randomized patients|73
2852916|NCT00035555|3555254|FG000|Number Who Had Undergone Transplantation|Overall Study||74
2852917|NCT00035555|3555255|FG001|Number Who Had Undergone Transplantation|Overall Study||71
2852918|NCT00035555|3555256|FG002|Number Who Had Undergone Transplantation|Overall Study||73
2852919|NCT00035555|3555254|FG000|Number Who Received Study Drug|Overall Study||74
2852920|NCT00035555|3555255|FG001|Number Who Received Study Drug|Overall Study||71
2852921|NCT00035555|3555256|FG002|Number Who Received Study Drug|Overall Study||71
2852922|NCT00035555|3555254|FG000|COMPLETED|Overall Study||58
2852923|NCT00035555|3555255|FG001|COMPLETED|Overall Study||55
2852924|NCT00035555|3555256|FG002|COMPLETED|Overall Study||51
2852925|NCT00035555|3555254|FG000|NOT COMPLETED|Overall Study||16
2852926|NCT00035555|3555255|FG001|NOT COMPLETED|Overall Study||16
2852927|NCT00035555|3555256|FG002|NOT COMPLETED|Overall Study||22
2852928|NCT00035815|3555267|FG000|STARTED|Overall Study|Enrollment began June 2003, accrual was for 2 years, follow-up period was 2 years.|167
2852929|NCT00035815|3555268|FG001|STARTED|Overall Study|Enrollment began June 2003, accrual was for 2 years, follow-up period was 2 years.|163
2852930|NCT00035815|3555267|FG000|COMPLETED|Overall Study||150
2852931|NCT00035815|3555268|FG001|COMPLETED|Overall Study||152
2852932|NCT00035815|3555267|FG000|NOT COMPLETED|Overall Study||17
2852933|NCT00035815|3555268|FG001|NOT COMPLETED|Overall Study||11
2852934|NCT00035932|3555277|FG000|STARTED|Overall Study|120 randomized, 119 treated|119
2852935|NCT00035932|3555278|FG001|STARTED|Overall Study|115 randomized, 110 treated|110
2852936|NCT00035932|3555279|FG002|STARTED|Overall Study|123 randomized, 118 treated|118
2852937|NCT00035932|3555277|FG000|Discontinued Prior to Week 48 Visit|Overall Study||26
2852938|NCT00035932|3555278|FG001|Discontinued Prior to Week 48 Visit|Overall Study||29
2852939|NCT00035932|3555279|FG002|Discontinued Prior to Week 48 Visit|Overall Study||13
2852940|NCT00035932|3555277|FG000|Discontinued Between Weeks 48 and 96|Overall Study||26
2852941|NCT00035932|3555278|FG001|Discontinued Between Weeks 48 and 96|Overall Study||27
2852942|NCT00035932|3555279|FG002|Discontinued Between Weeks 48 and 96|Overall Study||30
2852943|NCT00035932|3555277|FG000|Discontinued on or After Week 96|Overall Study||4
2852944|NCT00035932|3555278|FG001|Discontinued on or After Week 96|Overall Study||4
2852945|NCT00035932|3555279|FG002|Discontinued on or After Week 96|Overall Study||6
2852946|NCT00035932|3555277|FG000|COMPLETED|Overall Study|63 remained on treatment, 0 completed at Week 96|63
2852947|NCT00035932|3555278|FG001|COMPLETED|Overall Study|50 remained on treatment, 0 completed at Week 96|50
2852948|NCT00035932|3555279|FG002|COMPLETED|Overall Study|59 remained on treatment, 10 completed at Week 96|69
2852949|NCT00035932|3555277|FG000|NOT COMPLETED|Overall Study||56
2852950|NCT00035932|3555278|FG001|NOT COMPLETED|Overall Study||60
2852951|NCT00035932|3555279|FG002|NOT COMPLETED|Overall Study||49
2852952|NCT00036270|3555294|FG000|STARTED|Randomized to Study Treatment||4904
2852953|NCT00036270|3555295|FG001|STARTED|Randomized to Study Treatment||4875
2852954|NCT00036270|3555294|FG000|COMPLETED|Randomized to Study Treatment||4898
2852955|NCT00036270|3555295|FG001|COMPLETED|Randomized to Study Treatment||4868
2852956|NCT00036270|3555294|FG000|NOT COMPLETED|Randomized to Study Treatment||6
2852957|NCT00036270|3555295|FG001|NOT COMPLETED|Randomized to Study Treatment||7
2852958|NCT00036270|3555294|FG000|STARTED|Study Treatment to 5 Year Report||4898
2852959|NCT00036270|3555295|FG001|STARTED|Study Treatment to 5 Year Report||4868
2852960|NCT00036270|3555294|FG000|Treated|Study Treatment to 5 Year Report||4852
2852961|NCT00036270|3555295|FG001|Treated|Study Treatment to 5 Year Report||4814
3168505|NCT01919229|3895802|FG002|NOT COMPLETED|Overall Study||1
3168506|NCT01919307|3895810|FG000|STARTED|Overall Study||29
3168507|NCT01919307|3895810|FG000|COMPLETED|Overall Study||20
3168508|NCT01919307|3895810|FG000|NOT COMPLETED|Overall Study||9
3168509|NCT01919398|3895817|FG000|STARTED|Overall Study||3
3168510|NCT01919398|3895818|FG001|STARTED|Overall Study||3
2852962|NCT00036270|3555294|FG000|COMPLETED|Study Treatment to 5 Year Report||2333
2852963|NCT00036270|3555295|FG001|COMPLETED|Study Treatment to 5 Year Report||1380
2852964|NCT00036270|3555294|FG000|NOT COMPLETED|Study Treatment to 5 Year Report||2565
2852965|NCT00036270|3555295|FG001|NOT COMPLETED|Study Treatment to 5 Year Report||3488
2852966|NCT00036569|3555301|FG000|STARTED|Overall Study||32
2852967|NCT00036569|3555301|FG000|COMPLETED|Overall Study||32
2852968|NCT00036569|3555301|FG000|NOT COMPLETED|Overall Study||0
2852969|NCT00036738|3555307|FG000|STARTED|Overall Study||28
2852970|NCT00036738|3555307|FG000|COMPLETED|Overall Study||28
2852971|NCT00036738|3555307|FG000|NOT COMPLETED|Overall Study||0
2852972|NCT00037830|3555314|FG000|STARTED|Overall Study||39
2852973|NCT00037830|3555315|FG001|STARTED|Overall Study||38
2852974|NCT00037830|3555316|FG002|STARTED|Overall Study||17
2852975|NCT00037830|3555314|FG000|COMPLETED|Overall Study||29
2852976|NCT00037830|3555315|FG001|COMPLETED|Overall Study||31
2852977|NCT00037830|3555316|FG002|COMPLETED|Overall Study||16
2852978|NCT00037830|3555314|FG000|NOT COMPLETED|Overall Study||10
2852979|NCT00037830|3555315|FG001|NOT COMPLETED|Overall Study||7
2852980|NCT00037830|3555316|FG002|NOT COMPLETED|Overall Study||1
2852981|NCT00038103|3555326|FG000|STARTED|Overall Study||55
2852982|NCT00038103|3555327|FG001|STARTED|Overall Study||56
2852983|NCT00038103|3555326|FG000|End of Treatment|Overall Study|patients remained on treatment until discontinued|53
2852984|NCT00038103|3555327|FG001|End of Treatment|Overall Study|patients remained on treatment until discontinued|56
2852985|NCT00038103|3555326|FG000|COMPLETED|Overall Study||0
2852986|NCT00038103|3555327|FG001|COMPLETED|Overall Study||0
2852987|NCT00038103|3555326|FG000|NOT COMPLETED|Overall Study||55
2852988|NCT00038103|3555327|FG001|NOT COMPLETED|Overall Study||56
2852989|NCT00038467|3555335|FG000|STARTED|Overall Study||2352
2852990|NCT00038467|3555336|FG001|STARTED|Overall Study||2372
2852991|NCT00038467|3555335|FG000|Treated|Overall Study|8 participants randomized to receive exemestane, received tamoxifen. Reported as per randomization.|2321
2852992|NCT00038467|3555336|FG001|Treated|Overall Study|7 participants randomized to receive tamoxifen, received exemestane. Reported as per randomization.|2337
2852993|NCT00038467|3555335|FG000|COMPLETED|Overall Study||1810
2852994|NCT00038467|3555336|FG001|COMPLETED|Overall Study||1830
2852995|NCT00038467|3555335|FG000|NOT COMPLETED|Overall Study||542
2852996|NCT00038467|3555336|FG001|NOT COMPLETED|Overall Study||542
2852997|NCT00038610|3555342|FG000|STARTED|Overall Study||54
2852998|NCT00038610|3555342|FG000|COMPLETED|Overall Study||54
2852999|NCT00038610|3555342|FG000|NOT COMPLETED|Overall Study||0
2853000|NCT00038649|3555346|FG000|STARTED|Overall Study||114
2853001|NCT00038649|3555346|FG000|COMPLETED|Overall Study||105
2853002|NCT00038649|3555346|FG000|NOT COMPLETED|Overall Study||9
2853003|NCT00038857|3555350|FG000|STARTED|Overall Study||29
2853004|NCT00038857|3555350|FG000|COMPLETED|Overall Study||28
2853005|NCT00038857|3555350|FG000|NOT COMPLETED|Overall Study||1
2853006|NCT00038948|3555356|FG000|STARTED|Overall Study||555
2853007|NCT00038948|3555357|FG001|STARTED|Overall Study||275
2853008|NCT00038948|3555356|FG000|COMPLETED|Overall Study||386
2853009|NCT00038948|3555357|FG001|COMPLETED|Overall Study||198
3168511|NCT01919398|3895819|FG002|STARTED|Overall Study||13
3168512|NCT01919398|3895817|FG000|Received at Least One Dose of Study Drug|Overall Study||3
3168513|NCT01919398|3895818|FG001|Received at Least One Dose of Study Drug|Overall Study||3
3168514|NCT01919398|3895819|FG002|Received at Least One Dose of Study Drug|Overall Study||13
3168515|NCT01919398|3895817|FG000|COMPLETED|Overall Study||3
3168516|NCT01919398|3895818|FG001|COMPLETED|Overall Study||3
3168517|NCT01919398|3895819|FG002|COMPLETED|Overall Study||9
3168518|NCT01919398|3895817|FG000|NOT COMPLETED|Overall Study||0
3168519|NCT01919398|3895818|FG001|NOT COMPLETED|Overall Study||0
3168520|NCT01919398|3895819|FG002|NOT COMPLETED|Overall Study||4
3168521|NCT01919411|3895829|FG000|STARTED|Overall Study||43
3168522|NCT01919411|3895830|FG001|STARTED|Overall Study||46
3168523|NCT01919411|3895829|FG000|COMPLETED|Overall Study||38
3168524|NCT01919411|3895830|FG001|COMPLETED|Overall Study||41
3168525|NCT01919411|3895829|FG000|NOT COMPLETED|Overall Study||5
3168526|NCT01919411|3895830|FG001|NOT COMPLETED|Overall Study||5
3168527|NCT01919450|3895840|FG000|STARTED|Overall Study||20
2853010|NCT00038948|3555356|FG000|NOT COMPLETED|Overall Study||169
2853011|NCT00038948|3555357|FG001|NOT COMPLETED|Overall Study||77
2853012|NCT00039130|3555369|FG000|STARTED|Overall Study||105
2853013|NCT00039130|3555369|FG000|COMPLETED|Overall Study||75
2853014|NCT00039130|3555369|FG000|NOT COMPLETED|Overall Study||30
2853015|NCT00039195|3555373|FG000|STARTED|Overall Study||98
2853016|NCT00039195|3555373|FG000|COMPLETED|Overall Study||98
2853017|NCT00039195|3555373|FG000|NOT COMPLETED|Overall Study||0
2853018|NCT00039377|3555377|FG000|STARTED|Initial Registration||57
2853019|NCT00039377|3555378|FG001|STARTED|Initial Registration||0
2853020|NCT00039377|3555379|FG002|STARTED|Initial Registration||0
2853021|NCT00039377|3555380|FG003|STARTED|Initial Registration||0
2853022|NCT00039377|3555377|FG000|COMPLETED|Initial Registration||35
2853023|NCT00039377|3555378|FG001|COMPLETED|Initial Registration||0
2853024|NCT00039377|3555379|FG002|COMPLETED|Initial Registration||0
2853025|NCT00039377|3555380|FG003|COMPLETED|Initial Registration||0
2853026|NCT00039377|3555377|FG000|NOT COMPLETED|Initial Registration||22
2853027|NCT00039377|3555378|FG001|NOT COMPLETED|Initial Registration||0
2853028|NCT00039377|3555379|FG002|NOT COMPLETED|Initial Registration||0
2853029|NCT00039377|3555380|FG003|NOT COMPLETED|Initial Registration||0
2853030|NCT00039377|3555377|FG000|STARTED|Course 5 (Transplant Assignments)|After Course I-IV, participants were grouped into autologous, allogeneic or no transplant arms.|0
2853031|NCT00039377|3555378|FG001|STARTED|Course 5 (Transplant Assignments)||15
2853032|NCT00039377|3555379|FG002|STARTED|Course 5 (Transplant Assignments)||19
2853033|NCT00039377|3555380|FG003|STARTED|Course 5 (Transplant Assignments)||1
2853034|NCT00039377|3555377|FG000|COMPLETED|Course 5 (Transplant Assignments)||0
2853035|NCT00039377|3555378|FG001|COMPLETED|Course 5 (Transplant Assignments)||15
2853036|NCT00039377|3555379|FG002|COMPLETED|Course 5 (Transplant Assignments)||19
2853037|NCT00039377|3555380|FG003|COMPLETED|Course 5 (Transplant Assignments)||1
2853038|NCT00039377|3555377|FG000|NOT COMPLETED|Course 5 (Transplant Assignments)||0
2853039|NCT00039377|3555378|FG001|NOT COMPLETED|Course 5 (Transplant Assignments)||0
2853040|NCT00039377|3555379|FG002|NOT COMPLETED|Course 5 (Transplant Assignments)||0
2853041|NCT00039377|3555380|FG003|NOT COMPLETED|Course 5 (Transplant Assignments)||0
2853042|NCT00039741|3555392|FG000|STARTED|Overall Study||66
2853043|NCT00039741|3555393|FG001|STARTED|Overall Study||68
2853044|NCT00039741|3555394|FG002|STARTED|Overall Study||65
2853045|NCT00039741|3555395|FG003|STARTED|Overall Study||64
2853046|NCT00039741|3555392|FG000|Death|Overall Study||0
2853047|NCT00039741|3555393|FG001|Death|Overall Study||1
2853048|NCT00039741|3555394|FG002|Death|Overall Study||0
2853049|NCT00039741|3555395|FG003|Death|Overall Study||0
2853050|NCT00039741|3555392|FG000|COMPLETED|Overall Study||51
2853051|NCT00039741|3555393|FG001|COMPLETED|Overall Study||56
2853052|NCT00039741|3555394|FG002|COMPLETED|Overall Study||54
2853053|NCT00039741|3555395|FG003|COMPLETED|Overall Study||50
2853054|NCT00039741|3555392|FG000|NOT COMPLETED|Overall Study||15
2853055|NCT00039741|3555393|FG001|NOT COMPLETED|Overall Study||12
2853056|NCT00039741|3555394|FG002|NOT COMPLETED|Overall Study||11
2853057|NCT00039741|3555395|FG003|NOT COMPLETED|Overall Study||14
2853058|NCT00039871|3555405|FG000|STARTED|Overall Study|Enrolled 2333; 21 subjects excluded due to GCP non-compliance|2312
2853059|NCT00039871|3555405|FG000|COMPLETED|Overall Study||928
2853060|NCT00039871|3555405|FG000|NOT COMPLETED|Overall Study||1384
2853061|NCT00040365|3555409|FG000|STARTED|Overall Study||30
2853062|NCT00040365|3555409|FG000|Completed Follow Up Phase|Overall Study||19
2853063|NCT00040365|3555409|FG000|COMPLETED|Overall Study||19
2853064|NCT00040365|3555409|FG000|NOT COMPLETED|Overall Study||11
2853065|NCT00040443|3555415|FG000|STARTED|Overall Study||84
2853066|NCT00040443|3555416|FG001|STARTED|Overall Study||91
2853067|NCT00040443|3555415|FG000|COMPLETED|Overall Study||84
2853068|NCT00040443|3555416|FG001|COMPLETED|Overall Study||91
2853069|NCT00040443|3555415|FG000|NOT COMPLETED|Overall Study||0
2853070|NCT00040443|3555416|FG001|NOT COMPLETED|Overall Study||0
2853071|NCT00040664|3555422|FG000|STARTED|Overall Study|All (69) enrolled on QD; 10 switched to twice daily. Participant flow not collected for this group.|69
2853072|NCT00040664|3555423|FG001|STARTED|Overall Study||17
3168528|NCT01919450|3895841|FG001|STARTED|Overall Study||20
3168529|NCT01919450|3895842|FG002|STARTED|Overall Study||20
3168530|NCT01919450|3895843|FG003|STARTED|Overall Study||20
3168531|NCT01919450|3895840|FG000|COMPLETED|Overall Study||20
3168532|NCT01919450|3895841|FG001|COMPLETED|Overall Study||20
3168533|NCT01919450|3895842|FG002|COMPLETED|Overall Study||20
2853073|NCT00040664|3555424|FG002|STARTED|Overall Study||17
2853074|NCT00040664|3555425|FG003|STARTED|Overall Study||35
2853075|NCT00040664|3555422|FG000|COMPLETED|Overall Study||16
2853076|NCT00040664|3555423|FG001|COMPLETED|Overall Study||4
2853077|NCT00040664|3555424|FG002|COMPLETED|Overall Study||4
2853078|NCT00040664|3555425|FG003|COMPLETED|Overall Study||8
2853079|NCT00040664|3555422|FG000|NOT COMPLETED|Overall Study||53
2853080|NCT00040664|3555423|FG001|NOT COMPLETED|Overall Study||13
2853081|NCT00040664|3555424|FG002|NOT COMPLETED|Overall Study||13
2853082|NCT00040664|3555425|FG003|NOT COMPLETED|Overall Study||27
2853083|NCT00040742|3555447|FG000|STARTED|Overall Study||188
2853084|NCT00040742|3555448|FG001|STARTED|Overall Study||183
2853085|NCT00040742|3555449|FG002|STARTED|Overall Study||187
2853086|NCT00040742|3555450|FG003|STARTED|Overall Study|One subject found to be ineligible after randomization. No baseline data collected.|186
2853087|NCT00040742|3555447|FG000|COMPLETED|Overall Study||149
2853088|NCT00040742|3555448|FG001|COMPLETED|Overall Study||134
2853089|NCT00040742|3555449|FG002|COMPLETED|Overall Study||141
2853090|NCT00040742|3555450|FG003|COMPLETED|Overall Study||152
2853091|NCT00040742|3555447|FG000|NOT COMPLETED|Overall Study||39
2853092|NCT00040742|3555448|FG001|NOT COMPLETED|Overall Study||49
2853093|NCT00040742|3555449|FG002|NOT COMPLETED|Overall Study||46
2853094|NCT00040742|3555450|FG003|NOT COMPLETED|Overall Study||34
2853095|NCT00040846|3555466|FG000|STARTED|Overall Study||60
2853096|NCT00040846|3555467|FG001|STARTED|Overall Study||0
2853097|NCT00040846|3555468|FG002|STARTED|Overall Study||0
2853098|NCT00040846|3555469|FG003|STARTED|Overall Study||0
2853099|NCT00040846|3555470|FG004|STARTED|Overall Study||0
2853100|NCT00040846|3555471|FG005|STARTED|Overall Study||0
2853101|NCT00040846|3555466|FG000|COMPLETED|Overall Study||60
2853102|NCT00040846|3555467|FG001|COMPLETED|Overall Study||0
2853103|NCT00040846|3555468|FG002|COMPLETED|Overall Study||0
2853104|NCT00040846|3555469|FG003|COMPLETED|Overall Study||0
2853105|NCT00040846|3555470|FG004|COMPLETED|Overall Study||0
2853106|NCT00040846|3555471|FG005|COMPLETED|Overall Study||0
2853107|NCT00040846|3555466|FG000|NOT COMPLETED|Overall Study||0
2853108|NCT00040846|3555467|FG001|NOT COMPLETED|Overall Study||0
2853109|NCT00040846|3555468|FG002|NOT COMPLETED|Overall Study||0
2853110|NCT00040846|3555469|FG003|NOT COMPLETED|Overall Study||0
2853111|NCT00040846|3555470|FG004|NOT COMPLETED|Overall Study||0
2853112|NCT00040846|3555471|FG005|NOT COMPLETED|Overall Study||0
2853113|NCT00040937|3555485|FG000|STARTED|Induction/PBSC Mobilization|147 registered to this period; 142 were eligible and analyzable; 140 were assessable for toxicity.|147
2853114|NCT00040937|3555485|FG000|COMPLETED|Induction/PBSC Mobilization||110
2853115|NCT00040937|3555485|FG000|NOT COMPLETED|Induction/PBSC Mobilization||37
2853116|NCT00040937|3555485|FG000|STARTED|Autologous PBSCT|108 registered to this period; 105 were eligible and analyzable; 105 were assessable for toxicity.|108
2853117|NCT00040937|3555485|FG000|COMPLETED|Autologous PBSCT||77
2853118|NCT00040937|3555485|FG000|NOT COMPLETED|Autologous PBSCT||31
2853119|NCT00040937|3555485|FG000|STARTED|Maintenance||76
2853120|NCT00040937|3555485|FG000|COMPLETED|Maintenance|Patients remained on protocol therapy until progression.|76
2853121|NCT00040937|3555485|FG000|NOT COMPLETED|Maintenance||0
2853122|NCT00041067|3555492|FG000|STARTED|Overall Study||76
2853123|NCT00041067|3555492|FG000|Eligible|Overall Study||74
2853124|NCT00041067|3555492|FG000|COMPLETED|Overall Study||0
2853125|NCT00041067|3555492|FG000|NOT COMPLETED|Overall Study||76
2853126|NCT00041080|3555499|FG000|STARTED|Overall Study|number patients enrolled on study|69
2853127|NCT00041080|3555500|FG001|STARTED|Overall Study|number patients enrolled on study|70
2853128|NCT00041080|3555499|FG000|COMPLETED|Overall Study||39
2853129|NCT00041080|3555500|FG001|COMPLETED|Overall Study||60
2853130|NCT00041080|3555499|FG000|NOT COMPLETED|Overall Study||30
2853131|NCT00041080|3555500|FG001|NOT COMPLETED|Overall Study||10
2853132|NCT00041119|3555510|FG000|STARTED|Overall Study||1142
2853133|NCT00041119|3555511|FG001|STARTED|Overall Study||789
2853134|NCT00041119|3555512|FG002|STARTED|Overall Study||1151
2853135|NCT00041119|3555513|FG003|STARTED|Overall Study||789
2853136|NCT00041119|3555510|FG000|COMPLETED|Overall Study||1142
2853137|NCT00041119|3555511|FG001|COMPLETED|Overall Study||789
2853138|NCT00041119|3555512|FG002|COMPLETED|Overall Study||1151
2853139|NCT00041119|3555513|FG003|COMPLETED|Overall Study||789
2853140|NCT00041119|3555510|FG000|NOT COMPLETED|Overall Study||0
2853141|NCT00041119|3555511|FG001|NOT COMPLETED|Overall Study||0
2853142|NCT00041119|3555512|FG002|NOT COMPLETED|Overall Study||0
2853143|NCT00041119|3555513|FG003|NOT COMPLETED|Overall Study||0
2853144|NCT00041132|3555527|FG000|STARTED|Overall Study||56
2853145|NCT00041132|3555527|FG000|Eligible|Overall Study||49
2853146|NCT00041132|3555527|FG000|Eligible and Began Protocol Therapy|Overall Study||49
2853147|NCT00041132|3555527|FG000|COMPLETED|Overall Study||26
2853148|NCT00041132|3555527|FG000|NOT COMPLETED|Overall Study||30
2853149|NCT00041392|3555533|FG000|STARTED|Overall Study||198
2853150|NCT00041392|3555534|FG001|STARTED|Overall Study||191
2853151|NCT00041392|3555533|FG000|COMPLETED|Overall Study||198
2853152|NCT00041392|3555534|FG001|COMPLETED|Overall Study||191
2853153|NCT00041392|3555533|FG000|NOT COMPLETED|Overall Study||0
2853154|NCT00041392|3555534|FG001|NOT COMPLETED|Overall Study||0
2853155|NCT00041470|3555540|FG000|STARTED|Overall Study||38
2853156|NCT00041470|3555540|FG000|COMPLETED|Overall Study||0
2853157|NCT00041470|3555540|FG000|NOT COMPLETED|Overall Study||38
2853158|NCT00041717|3555546|FG000|STARTED|Overall Study||114
2853159|NCT00041717|3555547|FG001|STARTED|Overall Study||98
2853160|NCT00041717|3555546|FG000|COMPLETED|Overall Study||81
2853161|NCT00041717|3555547|FG001|COMPLETED|Overall Study||86
2853162|NCT00041717|3555546|FG000|NOT COMPLETED|Overall Study||33
2853163|NCT00041717|3555547|FG001|NOT COMPLETED|Overall Study||12
2853164|NCT00041756|3555558|FG000|STARTED|Overall Study||77
2853165|NCT00041756|3555559|FG001|STARTED|Overall Study||80
2853166|NCT00041756|3555560|FG002|STARTED|Overall Study||79
2853167|NCT00041756|3555561|FG003|STARTED|Overall Study||80
2853168|NCT00041756|3555562|FG004|STARTED|Overall Study||79
2853169|NCT00041756|3555558|FG000|COMPLETED|Overall Study||69
2853170|NCT00041756|3555559|FG001|COMPLETED|Overall Study||65
2853171|NCT00041756|3555560|FG002|COMPLETED|Overall Study||66
2853172|NCT00041756|3555561|FG003|COMPLETED|Overall Study||64
2853173|NCT00041756|3555562|FG004|COMPLETED|Overall Study||19
2853174|NCT00041756|3555558|FG000|NOT COMPLETED|Overall Study||8
2853175|NCT00041756|3555559|FG001|NOT COMPLETED|Overall Study||15
2853176|NCT00041756|3555560|FG002|NOT COMPLETED|Overall Study||13
2853177|NCT00041756|3555561|FG003|NOT COMPLETED|Overall Study||16
2853178|NCT00041756|3555562|FG004|NOT COMPLETED|Overall Study||60
2853179|NCT00041938|3555576|FG000|STARTED|Overall Study||1163
2853180|NCT00041938|3555577|FG001|STARTED|Overall Study||1142
2853181|NCT00041938|3555576|FG000|Completed Follow-up|Overall Study||761
2853182|NCT00041938|3555577|FG001|Completed Follow-up|Overall Study||745
2853183|NCT00041938|3555576|FG000|Primary Endpoint|Overall Study||320
2853184|NCT00041938|3555577|FG001|Primary Endpoint|Overall Study||302
2853185|NCT00041938|3555576|FG000|Only Vital Status Known|Overall Study||44
2853186|NCT00041938|3555577|FG001|Only Vital Status Known|Overall Study||46
2853187|NCT00041938|3555576|FG000|Lost to Follow-up|Overall Study||18
2853188|NCT00041938|3555577|FG001|Lost to Follow-up|Overall Study||17
2853189|NCT00041938|3555576|FG000|Withdrew Consent|Overall Study||20
2853190|NCT00041938|3555577|FG001|Withdrew Consent|Overall Study||14
2853191|NCT00041938|3555576|FG000|COMPLETED|Overall Study||1125
2853192|NCT00041938|3555577|FG001|COMPLETED|Overall Study||1111
2853193|NCT00041938|3555576|FG000|NOT COMPLETED|Overall Study||38
2853194|NCT00041938|3555577|FG001|NOT COMPLETED|Overall Study||31
2853195|NCT00042224|3555585|FG000|STARTED|Overall Study||20
2853196|NCT00042224|3555586|FG001|STARTED|Overall Study||19
2853197|NCT00042224|3555585|FG000|COMPLETED|Overall Study||17
2853198|NCT00042224|3555586|FG001|COMPLETED|Overall Study||16
2853199|NCT00042224|3555585|FG000|NOT COMPLETED|Overall Study||3
2853200|NCT00042224|3555586|FG001|NOT COMPLETED|Overall Study||3
2853201|NCT00042432|3555594|FG000|STARTED|Overall Study||27
2853202|NCT00042432|3555595|FG001|STARTED|Overall Study||27
2853203|NCT00042432|3555594|FG000|COMPLETED|Overall Study||18
2853204|NCT00042432|3555595|FG001|COMPLETED|Overall Study||20
2853205|NCT00042432|3555594|FG000|NOT COMPLETED|Overall Study||9
2853206|NCT00042432|3555595|FG001|NOT COMPLETED|Overall Study||7
2853207|NCT00042666|3555601|FG000|STARTED|Overall Study||55
2853208|NCT00042666|3555601|FG000|Received at Least 1 Dose of Study Drug|Overall Study||55
2853209|NCT00042666|3555601|FG000|Completed at Least 1 Cycle of Study Drug|Overall Study||42
2853210|NCT00042666|3555601|FG000|COMPLETED|Overall Study||1
2853211|NCT00042666|3555601|FG000|NOT COMPLETED|Overall Study||54
2853212|NCT00042939|3555608|FG000|STARTED|Overall Study||48
2853213|NCT00042939|3555609|FG001|STARTED|Overall Study||46
2853214|NCT00042939|3555608|FG000|Treated|Overall Study||46
2853215|NCT00042939|3555609|FG001|Treated|Overall Study||45
2853216|NCT00042939|3555608|FG000|Eligible and Began Protocol Therapy|Overall Study||44
2853217|NCT00042939|3555609|FG001|Eligible and Began Protocol Therapy|Overall Study||43
2853218|NCT00042939|3555608|FG000|Patients With EGFR Results Available|Overall Study||30
2853219|NCT00042939|3555609|FG001|Patients With EGFR Results Available|Overall Study||31
2853220|NCT00042939|3555608|FG000|COMPLETED|Overall Study||24
2853221|NCT00042939|3555609|FG001|COMPLETED|Overall Study||25
2853222|NCT00042939|3555608|FG000|NOT COMPLETED|Overall Study||24
2853223|NCT00042939|3555609|FG001|NOT COMPLETED|Overall Study||21
2853224|NCT00042991|3555622|FG000|STARTED|Overall Study||6
2853225|NCT00042991|3555623|FG001|STARTED|Overall Study|These 43 patients form the Phase-II cohort, seven contributing from the Phase-I trial.|43
2853226|NCT00042991|3555624|FG002|STARTED|Overall Study||7
2853227|NCT00042991|3555625|FG003|STARTED|Overall Study||2
2853228|NCT00042991|3555626|FG004|STARTED|Overall Study||3
2853229|NCT00042991|3555627|FG005|STARTED|Overall Study||5
2853230|NCT00042991|3555628|FG006|STARTED|Overall Study||3
2853231|NCT00042991|3555622|FG000|Phase-I Trial|Overall Study||6
2853232|NCT00042991|3555623|FG001|Phase-I Trial|Overall Study|These seven patients contributed to both Phase-I and Phase-II objectives.|7
2853233|NCT00042991|3555624|FG002|Phase-I Trial|Overall Study||7
2853234|NCT00042991|3555625|FG003|Phase-I Trial|Overall Study||2
2853235|NCT00042991|3555626|FG004|Phase-I Trial|Overall Study||3
2853236|NCT00042991|3555627|FG005|Phase-I Trial|Overall Study||5
2853237|NCT00042991|3555628|FG006|Phase-I Trial|Overall Study||3
2853238|NCT00042991|3555622|FG000|Phase-II Trial|Overall Study||0
2853239|NCT00042991|3555623|FG001|Phase-II Trial|Overall Study||36
2853240|NCT00042991|3555624|FG002|Phase-II Trial|Overall Study||0
2853241|NCT00042991|3555625|FG003|Phase-II Trial|Overall Study||0
2853242|NCT00042991|3555626|FG004|Phase-II Trial|Overall Study||0
2853243|NCT00042991|3555627|FG005|Phase-II Trial|Overall Study||0
2853244|NCT00042991|3555628|FG006|Phase-II Trial|Overall Study||0
2853245|NCT00042991|3555622|FG000|COMPLETED|Overall Study||0
2853246|NCT00042991|3555623|FG001|COMPLETED|Overall Study||3
3168534|NCT01919450|3895843|FG003|COMPLETED|Overall Study||19
3168535|NCT01919450|3895840|FG000|NOT COMPLETED|Overall Study||0
3168536|NCT01919450|3895841|FG001|NOT COMPLETED|Overall Study||0
3168537|NCT01919450|3895842|FG002|NOT COMPLETED|Overall Study||0
3168538|NCT01919450|3895843|FG003|NOT COMPLETED|Overall Study||1
3168539|NCT01919489|3895855|FG000|STARTED|Overall Study||136
2853247|NCT00042991|3555624|FG002|COMPLETED|Overall Study||1
2853248|NCT00042991|3555625|FG003|COMPLETED|Overall Study||0
2853249|NCT00042991|3555626|FG004|COMPLETED|Overall Study||0
2853250|NCT00042991|3555627|FG005|COMPLETED|Overall Study||0
2853251|NCT00042991|3555628|FG006|COMPLETED|Overall Study||1
2853252|NCT00042991|3555622|FG000|NOT COMPLETED|Overall Study||6
2853253|NCT00042991|3555623|FG001|NOT COMPLETED|Overall Study||40
2853254|NCT00042991|3555624|FG002|NOT COMPLETED|Overall Study||6
2853255|NCT00042991|3555625|FG003|NOT COMPLETED|Overall Study||2
2853256|NCT00042991|3555626|FG004|NOT COMPLETED|Overall Study||3
2853257|NCT00042991|3555627|FG005|NOT COMPLETED|Overall Study||5
2853258|NCT00042991|3555628|FG006|NOT COMPLETED|Overall Study||2
2853259|NCT00043186|3555655|FG000|STARTED|Overall Study||46
2853260|NCT00043186|3555656|FG001|STARTED|Overall Study||44
2853261|NCT00043186|3555657|FG002|STARTED|Overall Study||44
2853262|NCT00043186|3555658|FG003|STARTED|Overall Study||41
2853263|NCT00043186|3555659|FG004|STARTED|Overall Study||54
2853264|NCT00043186|3555660|FG005|STARTED|Overall Study||47
2853265|NCT00043186|3555661|FG006|STARTED|Overall Study||42
2853266|NCT00043186|3555662|FG007|STARTED|Overall Study||47
2853267|NCT00043186|3555663|FG008|STARTED|Overall Study||47
2853268|NCT00043186|3555655|FG000|COMPLETED|Overall Study||29
2853269|NCT00043186|3555656|FG001|COMPLETED|Overall Study||29
2853270|NCT00043186|3555657|FG002|COMPLETED|Overall Study||24
2853271|NCT00043186|3555658|FG003|COMPLETED|Overall Study||19
2853272|NCT00043186|3555659|FG004|COMPLETED|Overall Study||36
2853273|NCT00043186|3555660|FG005|COMPLETED|Overall Study||39
2853274|NCT00043186|3555661|FG006|COMPLETED|Overall Study||25
2853275|NCT00043186|3555662|FG007|COMPLETED|Overall Study||31
2853276|NCT00043186|3555663|FG008|COMPLETED|Overall Study||30
2853277|NCT00043186|3555655|FG000|NOT COMPLETED|Overall Study||17
2853278|NCT00043186|3555656|FG001|NOT COMPLETED|Overall Study||15
2853279|NCT00043186|3555657|FG002|NOT COMPLETED|Overall Study||20
2853280|NCT00043186|3555658|FG003|NOT COMPLETED|Overall Study||22
2853281|NCT00043186|3555659|FG004|NOT COMPLETED|Overall Study||18
2853282|NCT00043186|3555660|FG005|NOT COMPLETED|Overall Study||8
2853283|NCT00043186|3555661|FG006|NOT COMPLETED|Overall Study||17
2853284|NCT00043186|3555662|FG007|NOT COMPLETED|Overall Study||16
2853285|NCT00043186|3555663|FG008|NOT COMPLETED|Overall Study||17
2853286|NCT00043550|3555687|FG000|STARTED|Overall Study||55
2853287|NCT00043550|3555688|FG001|STARTED|Overall Study||51
2853288|NCT00043550|3555689|FG002|STARTED|Overall Study||50
2853289|NCT00043550|3555687|FG000|Week 8 Completed|Overall Study||35
2853290|NCT00043550|3555688|FG001|Week 8 Completed|Overall Study||40
2853291|NCT00043550|3555689|FG002|Week 8 Completed|Overall Study||35
2853292|NCT00043550|3555687|FG000|COMPLETED|Overall Study||33
2853293|NCT00043550|3555688|FG001|COMPLETED|Overall Study||39
2853294|NCT00043550|3555689|FG002|COMPLETED|Overall Study||30
2853295|NCT00043550|3555687|FG000|NOT COMPLETED|Overall Study||22
2853296|NCT00043550|3555688|FG001|NOT COMPLETED|Overall Study||12
2853297|NCT00043550|3555689|FG002|NOT COMPLETED|Overall Study||20
2853298|NCT00043979|3555699|FG000|STARTED|Period 1||30
2853299|NCT00043979|3555700|FG001|STARTED|Period 1||17
2853300|NCT00043979|3555701|FG002|STARTED|Period 1||13
2853301|NCT00043979|3555699|FG000|COMPLETED|Period 1||23
2853302|NCT00043979|3555700|FG001|COMPLETED|Period 1||13
2853303|NCT00043979|3555701|FG002|COMPLETED|Period 1||10
2853304|NCT00043979|3555699|FG000|NOT COMPLETED|Period 1||7
2853305|NCT00043979|3555700|FG001|NOT COMPLETED|Period 1||4
2853306|NCT00043979|3555701|FG002|NOT COMPLETED|Period 1||3
2853307|NCT00043979|3555699|FG000|STARTED|Period 2||0
2853308|NCT00043979|3555700|FG001|STARTED|Period 2||13
2853309|NCT00043979|3555701|FG002|STARTED|Period 2||10
2853310|NCT00043979|3555699|FG000|COMPLETED|Period 2||0
2853311|NCT00043979|3555700|FG001|COMPLETED|Period 2||13
2853312|NCT00043979|3555701|FG002|COMPLETED|Period 2||10
2853313|NCT00043979|3555699|FG000|NOT COMPLETED|Period 2||0
2853314|NCT00043979|3555700|FG001|NOT COMPLETED|Period 2||0
2853315|NCT00043979|3555701|FG002|NOT COMPLETED|Period 2||0
2853316|NCT00044005|3555710|FG000|STARTED|Overall Study||32
2853317|NCT00044005|3555711|FG001|STARTED|Overall Study||33
2853318|NCT00044005|3555712|FG002|STARTED|Overall Study||33
2853319|NCT00044005|3555710|FG000|COMPLETED|Overall Study||13
2853320|NCT00044005|3555711|FG001|COMPLETED|Overall Study||19
2853321|NCT00044005|3555712|FG002|COMPLETED|Overall Study||11
2853322|NCT00044005|3555710|FG000|NOT COMPLETED|Overall Study||19
2853323|NCT00044005|3555711|FG001|NOT COMPLETED|Overall Study||14
2853324|NCT00044005|3555712|FG002|NOT COMPLETED|Overall Study||22
2853325|NCT00044044|3555725|FG000|STARTED|Overall Study||71
2853326|NCT00044044|3555726|FG001|STARTED|Overall Study||69
2853327|NCT00044044|3555727|FG002|STARTED|Overall Study||71
2853328|NCT00044044|3555728|FG003|STARTED|Overall Study||73
2853329|NCT00044044|3555729|FG004|STARTED|Overall Study||72
2853330|NCT00044044|3555725|FG000|COMPLETED|Overall Study||27
2853331|NCT00044044|3555726|FG001|COMPLETED|Overall Study||28
2853332|NCT00044044|3555727|FG002|COMPLETED|Overall Study||31
2853333|NCT00044044|3555728|FG003|COMPLETED|Overall Study||29
2853334|NCT00044044|3555729|FG004|COMPLETED|Overall Study||36
2853335|NCT00044044|3555725|FG000|NOT COMPLETED|Overall Study||44
2853336|NCT00044044|3555726|FG001|NOT COMPLETED|Overall Study||41
2853337|NCT00044044|3555727|FG002|NOT COMPLETED|Overall Study||40
2853338|NCT00044044|3555728|FG003|NOT COMPLETED|Overall Study||44
2853339|NCT00044044|3555729|FG004|NOT COMPLETED|Overall Study||36
2853340|NCT00044083|3555743|FG000|STARTED|First Intervention (One Week)- HV's||74
2853341|NCT00044083|3555744|FG001|STARTED|First Intervention (One Week)- HV's||73
2853342|NCT00044083|3555743|FG000|COMPLETED|First Intervention (One Week)- HV's||64
2853343|NCT00044083|3555744|FG001|COMPLETED|First Intervention (One Week)- HV's||66
2853344|NCT00044083|3555743|FG000|NOT COMPLETED|First Intervention (One Week)- HV's||10
2853345|NCT00044083|3555744|FG001|NOT COMPLETED|First Intervention (One Week)- HV's||7
2853346|NCT00044083|3555743|FG000|STARTED|Second Intervention (One Week) HV's||64
2853347|NCT00044083|3555744|FG001|STARTED|Second Intervention (One Week) HV's||66
2853348|NCT00044083|3555743|FG000|COMPLETED|Second Intervention (One Week) HV's||64
2853349|NCT00044083|3555744|FG001|COMPLETED|Second Intervention (One Week) HV's||66
2853350|NCT00044083|3555743|FG000|NOT COMPLETED|Second Intervention (One Week) HV's||0
2853351|NCT00044083|3555744|FG001|NOT COMPLETED|Second Intervention (One Week) HV's||0
2853352|NCT00044083|3555743|FG000|STARTED|First Intervention (One Week) Patients||31
2853353|NCT00044083|3555744|FG001|STARTED|First Intervention (One Week) Patients||32
2853354|NCT00044083|3555743|FG000|COMPLETED|First Intervention (One Week) Patients||30
2853355|NCT00044083|3555744|FG001|COMPLETED|First Intervention (One Week) Patients||30
2853356|NCT00044083|3555743|FG000|NOT COMPLETED|First Intervention (One Week) Patients||1
2853357|NCT00044083|3555744|FG001|NOT COMPLETED|First Intervention (One Week) Patients||2
2853358|NCT00044083|3555743|FG000|STARTED|Second Intervention (One Week) Patients||30
2853359|NCT00044083|3555744|FG001|STARTED|Second Intervention (One Week) Patients||30
2853360|NCT00044083|3555743|FG000|COMPLETED|Second Intervention (One Week) Patients||30
2853361|NCT00044083|3555744|FG001|COMPLETED|Second Intervention (One Week) Patients||29
2853362|NCT00044083|3555743|FG000|NOT COMPLETED|Second Intervention (One Week) Patients||0
2853363|NCT00044083|3555744|FG001|NOT COMPLETED|Second Intervention (One Week) Patients||1
2853364|NCT00044213|3555781|FG000|STARTED|Overall Study||421
2853365|NCT00044213|3555782|FG001|STARTED|Overall Study||418
2853366|NCT00044213|3555783|FG002|STARTED|Overall Study||432
2853367|NCT00044213|3555784|FG003|STARTED|Overall Study||437
2853368|NCT00044213|3555781|FG000|COMPLETED|Overall Study||321
2853369|NCT00044213|3555782|FG001|COMPLETED|Overall Study||306
2853370|NCT00044213|3555783|FG002|COMPLETED|Overall Study||294
2853371|NCT00044213|3555784|FG003|COMPLETED|Overall Study||301
2853372|NCT00044213|3555781|FG000|NOT COMPLETED|Overall Study||100
2853373|NCT00044213|3555782|FG001|NOT COMPLETED|Overall Study||112
2853374|NCT00044213|3555783|FG002|NOT COMPLETED|Overall Study||138
2853375|NCT00044213|3555784|FG003|NOT COMPLETED|Overall Study||136
2853376|NCT00044512|3555794|FG000|STARTED|Treatment||137
2853377|NCT00044512|3555794|FG000|COMPLETED|Treatment||137
2853378|NCT00044512|3555794|FG000|NOT COMPLETED|Treatment||0
2853379|NCT00044512|3555794|FG000|STARTED|Follow Up||137
2853380|NCT00044512|3555794|FG000|COMPLETED|Follow Up||135
2853381|NCT00044512|3555794|FG000|NOT COMPLETED|Follow Up||2
2853382|NCT00044655|3555800|FG000|STARTED|Overall Study||102
2853383|NCT00044655|3555801|FG001|STARTED|Overall Study||117
2853384|NCT00044655|3555800|FG000|COMPLETED|Overall Study||82
2853385|NCT00044655|3555801|FG001|COMPLETED|Overall Study||79
2853386|NCT00044655|3555800|FG000|NOT COMPLETED|Overall Study||20
2853387|NCT00044655|3555801|FG001|NOT COMPLETED|Overall Study||38
2853388|NCT00045032|3555810|FG000|STARTED|Overall Study|Included all participants with available signed Informed Consent Form.|1697
2853389|NCT00045032|3555811|FG001|STARTED|Overall Study|Included all participants with available signed Informed Consent Form.|1702
2853390|NCT00045032|3555812|FG002|STARTED|Overall Study|Included all participants with available signed Informed Consent Form.|1700
2853391|NCT00045032|3555810|FG000|Crossover to Adjuvant Herceptin|Overall Study||888
2853392|NCT00045032|3555811|FG001|Crossover to Adjuvant Herceptin|Overall Study|This milestone is not applicable to participants who were already randomized to Herceptin.|0
2853393|NCT00045032|3555812|FG002|Crossover to Adjuvant Herceptin|Overall Study|This milestone is not applicable to participants who were already randomized to Herceptin.|0
2853394|NCT00045032|3555810|FG000|COMPLETED|Overall Study||834
2853395|NCT00045032|3555811|FG001|COMPLETED|Overall Study||994
2853396|NCT00045032|3555812|FG002|COMPLETED|Overall Study||974
2853397|NCT00045032|3555810|FG000|NOT COMPLETED|Overall Study||863
2853398|NCT00045032|3555811|FG001|NOT COMPLETED|Overall Study||708
2853399|NCT00045032|3555812|FG002|NOT COMPLETED|Overall Study||726
2853400|NCT00045110|3555825|FG000|STARTED|100mg Phase 1 Dose Escalalation||6
2853401|NCT00045110|3555826|FG001|STARTED|100mg Phase 1 Dose Escalalation||59
2853402|NCT00045110|3555827|FG002|STARTED|100mg Phase 1 Dose Escalalation||45
2853403|NCT00045110|3555825|FG000|COMPLETED|100mg Phase 1 Dose Escalalation||6
2853404|NCT00045110|3555826|FG001|COMPLETED|100mg Phase 1 Dose Escalalation||53
2853405|NCT00045110|3555827|FG002|COMPLETED|100mg Phase 1 Dose Escalalation||43
2853406|NCT00045110|3555825|FG000|NOT COMPLETED|100mg Phase 1 Dose Escalalation||0
2853407|NCT00045110|3555826|FG001|NOT COMPLETED|100mg Phase 1 Dose Escalalation||6
2853408|NCT00045110|3555827|FG002|NOT COMPLETED|100mg Phase 1 Dose Escalalation||2
2853409|NCT00045110|3555825|FG000|STARTED|200mg Phase 1 Dose Escalation||4
2853410|NCT00045110|3555826|FG001|STARTED|200mg Phase 1 Dose Escalation||0
2853411|NCT00045110|3555827|FG002|STARTED|200mg Phase 1 Dose Escalation||0
2853412|NCT00045110|3555825|FG000|COMPLETED|200mg Phase 1 Dose Escalation||4
2853413|NCT00045110|3555826|FG001|COMPLETED|200mg Phase 1 Dose Escalation||0
2853414|NCT00045110|3555827|FG002|COMPLETED|200mg Phase 1 Dose Escalation||0
2853415|NCT00045110|3555825|FG000|NOT COMPLETED|200mg Phase 1 Dose Escalation||0
2853416|NCT00045110|3555826|FG001|NOT COMPLETED|200mg Phase 1 Dose Escalation||0
2853417|NCT00045110|3555827|FG002|NOT COMPLETED|200mg Phase 1 Dose Escalation||0
2853418|NCT00045110|3555825|FG000|STARTED|275mg Phase 1 Dose Escalation||3
2853419|NCT00045110|3555826|FG001|STARTED|275mg Phase 1 Dose Escalation||0
2853420|NCT00045110|3555827|FG002|STARTED|275mg Phase 1 Dose Escalation||0
2853421|NCT00045110|3555825|FG000|COMPLETED|275mg Phase 1 Dose Escalation||3
2853422|NCT00045110|3555826|FG001|COMPLETED|275mg Phase 1 Dose Escalation||0
2853423|NCT00045110|3555827|FG002|COMPLETED|275mg Phase 1 Dose Escalation||0
2853424|NCT00045110|3555825|FG000|NOT COMPLETED|275mg Phase 1 Dose Escalation||0
2853425|NCT00045110|3555826|FG001|NOT COMPLETED|275mg Phase 1 Dose Escalation||0
2853426|NCT00045110|3555827|FG002|NOT COMPLETED|275mg Phase 1 Dose Escalation||0
2853427|NCT00045110|3555825|FG000|STARTED|400mg Phase 1 Dose Escalation||3
2853428|NCT00045110|3555826|FG001|STARTED|400mg Phase 1 Dose Escalation||0
2853429|NCT00045110|3555827|FG002|STARTED|400mg Phase 1 Dose Escalation||0
2853430|NCT00045110|3555825|FG000|COMPLETED|400mg Phase 1 Dose Escalation||3
2853431|NCT00045110|3555826|FG001|COMPLETED|400mg Phase 1 Dose Escalation||0
2853432|NCT00045110|3555827|FG002|COMPLETED|400mg Phase 1 Dose Escalation||0
2853433|NCT00045110|3555825|FG000|NOT COMPLETED|400mg Phase 1 Dose Escalation||0
2853434|NCT00045110|3555826|FG001|NOT COMPLETED|400mg Phase 1 Dose Escalation||0
3168540|NCT01919489|3895856|FG001|STARTED|Overall Study||137
3168541|NCT01919489|3895855|FG000|COMPLETED|Overall Study||80
2853435|NCT00045110|3555827|FG002|NOT COMPLETED|400mg Phase 1 Dose Escalation||0
2853436|NCT00045110|3555825|FG000|STARTED|525mg Phase 1 Dose Escalation||3
2853437|NCT00045110|3555826|FG001|STARTED|525mg Phase 1 Dose Escalation||0
2853438|NCT00045110|3555827|FG002|STARTED|525mg Phase 1 Dose Escalation||0
2853439|NCT00045110|3555825|FG000|COMPLETED|525mg Phase 1 Dose Escalation||3
2853440|NCT00045110|3555826|FG001|COMPLETED|525mg Phase 1 Dose Escalation||0
2853441|NCT00045110|3555827|FG002|COMPLETED|525mg Phase 1 Dose Escalation||0
2853442|NCT00045110|3555825|FG000|NOT COMPLETED|525mg Phase 1 Dose Escalation||0
2853443|NCT00045110|3555826|FG001|NOT COMPLETED|525mg Phase 1 Dose Escalation||0
2853444|NCT00045110|3555827|FG002|NOT COMPLETED|525mg Phase 1 Dose Escalation||0
2853445|NCT00045110|3555825|FG000|STARTED|650mg Phase 1 Dose Escalation||6
2853446|NCT00045110|3555826|FG001|STARTED|650mg Phase 1 Dose Escalation||0
2853447|NCT00045110|3555827|FG002|STARTED|650mg Phase 1 Dose Escalation||0
2853448|NCT00045110|3555825|FG000|COMPLETED|650mg Phase 1 Dose Escalation||6
2853449|NCT00045110|3555826|FG001|COMPLETED|650mg Phase 1 Dose Escalation||0
2853450|NCT00045110|3555827|FG002|COMPLETED|650mg Phase 1 Dose Escalation||0
2853451|NCT00045110|3555825|FG000|NOT COMPLETED|650mg Phase 1 Dose Escalation||0
2853452|NCT00045110|3555826|FG001|NOT COMPLETED|650mg Phase 1 Dose Escalation||0
2853453|NCT00045110|3555827|FG002|NOT COMPLETED|650mg Phase 1 Dose Escalation||0
2853454|NCT00045110|3555825|FG000|STARTED|775mg Dose Escalation||7
2853455|NCT00045110|3555826|FG001|STARTED|775mg Dose Escalation||0
2853456|NCT00045110|3555827|FG002|STARTED|775mg Dose Escalation||0
2853457|NCT00045110|3555825|FG000|COMPLETED|775mg Dose Escalation||7
2853458|NCT00045110|3555826|FG001|COMPLETED|775mg Dose Escalation||0
2853459|NCT00045110|3555827|FG002|COMPLETED|775mg Dose Escalation||0
3168542|NCT01919489|3895856|FG001|COMPLETED|Overall Study||93
2853460|NCT00045110|3555825|FG000|NOT COMPLETED|775mg Dose Escalation||0
2853461|NCT00045110|3555826|FG001|NOT COMPLETED|775mg Dose Escalation||0
2853462|NCT00045110|3555827|FG002|NOT COMPLETED|775mg Dose Escalation||0
2853463|NCT00045162|3555846|FG000|STARTED|Overall Study||336
2853464|NCT00045162|3555847|FG001|STARTED|Overall Study||335
2853465|NCT00045162|3555846|FG000|COMPLETED|Overall Study||194
2853466|NCT00045162|3555847|FG001|COMPLETED|Overall Study||217
2853467|NCT00045162|3555846|FG000|NOT COMPLETED|Overall Study||142
2853468|NCT00045162|3555847|FG001|NOT COMPLETED|Overall Study||118
2853469|NCT00045305|3555853|FG000|STARTED|Overall Study||17
2853470|NCT00045305|3555853|FG000|Eligible and Treated|Overall Study||17
2853471|NCT00045305|3555853|FG000|COMPLETED|Overall Study||3
2853472|NCT00045305|3555853|FG000|NOT COMPLETED|Overall Study||14
2853473|NCT00045435|3555857|FG000|STARTED|Overall Study||17
2853474|NCT00045435|3555857|FG000|COMPLETED|Overall Study||17
2853475|NCT00045435|3555857|FG000|NOT COMPLETED|Overall Study||0
2853476|NCT00045487|3555861|FG000|STARTED|Overall Study||41
2853477|NCT00045487|3555861|FG000|COMPLETED|Overall Study||30
2853478|NCT00045487|3555861|FG000|NOT COMPLETED|Overall Study||11
2853479|NCT00045630|3555865|FG000|STARTED|Overall Study||77
2853480|NCT00045630|3555865|FG000|Eligible|Overall Study||75
2853481|NCT00045630|3555865|FG000|Eligible and Began Protocol Therapy|Overall Study||74
2853482|NCT00045630|3555865|FG000|COMPLETED|Overall Study||71
2853483|NCT00045630|3555865|FG000|NOT COMPLETED|Overall Study||6
2918139|NCT00524771|3628279|FG001|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 0.5 and 4.0 years.|16431
2918140|NCT00524771|3628278|FG000|NOT COMPLETED|Overall Study||220
2918141|NCT00524771|3628279|FG001|NOT COMPLETED|Overall Study||585
2918142|NCT00524940|3628286|FG000|STARTED|Overall Study||124
2918143|NCT00524940|3628286|FG000|COMPLETED|Overall Study||124
2918144|NCT00524940|3628286|FG000|NOT COMPLETED|Overall Study||0
2918145|NCT00525031|3628292|FG000|STARTED|Overall Study||27
2918146|NCT00525031|3628293|FG001|STARTED|Overall Study||25
2918147|NCT00525031|3628292|FG000|COMPLETED|Overall Study||26
2918148|NCT00525031|3628293|FG001|COMPLETED|Overall Study||24
2918149|NCT00525031|3628292|FG000|NOT COMPLETED|Overall Study||1
2918150|NCT00525031|3628293|FG001|NOT COMPLETED|Overall Study||1
2918151|NCT00525044|3628302|FG000|STARTED|Overall Study||124
2918152|NCT00525044|3628303|FG001|STARTED|Overall Study||125
2918153|NCT00525044|3628302|FG000|COMPLETED|Overall Study||124
2918154|NCT00525044|3628303|FG001|COMPLETED|Overall Study||124
2918155|NCT00525044|3628302|FG000|NOT COMPLETED|Overall Study||0
2918156|NCT00525044|3628303|FG001|NOT COMPLETED|Overall Study||1
2918157|NCT00525057|3628311|FG000|STARTED|Overall Study||25
2918158|NCT00525057|3628312|FG001|STARTED|Overall Study||25
2918159|NCT00525057|3628311|FG000|COMPLETED|Overall Study||25
2918160|NCT00525057|3628312|FG001|COMPLETED|Overall Study||25
2918161|NCT00525057|3628311|FG000|NOT COMPLETED|Overall Study||0
2918162|NCT00525057|3628312|FG001|NOT COMPLETED|Overall Study||0
2918163|NCT00525135|3628318|FG000|STARTED|Overall Study||5
2918164|NCT00525135|3628318|FG000|COMPLETED|Overall Study||5
2918165|NCT00525135|3628318|FG000|NOT COMPLETED|Overall Study||0
2918166|NCT00525148|3628326|FG000|STARTED|Overall Study|entered and treated|23
2918167|NCT00525148|3628327|FG001|STARTED|Overall Study|entered and treated|38
2918168|NCT00525148|3628328|FG002|STARTED|Overall Study|entered and treated|7
2918169|NCT00525148|3628329|FG003|STARTED|Overall Study|entered and treated|61
2918170|NCT00525148|3628326|FG000|COMPLETED|Overall Study||0
2918171|NCT00525148|3628327|FG001|COMPLETED|Overall Study||0
2918172|NCT00525148|3628328|FG002|COMPLETED|Overall Study||0
2918173|NCT00525148|3628329|FG003|COMPLETED|Overall Study||0
2918174|NCT00525148|3628326|FG000|NOT COMPLETED|Overall Study||23
2918175|NCT00525148|3628327|FG001|NOT COMPLETED|Overall Study||38
2918176|NCT00525148|3628328|FG002|NOT COMPLETED|Overall Study||7
2918177|NCT00525148|3628329|FG003|NOT COMPLETED|Overall Study||61
2918178|NCT00525161|3628339|FG000|STARTED|Overall Study||11
2918179|NCT00525161|3628339|FG000|COMPLETED|Overall Study||10
2918180|NCT00525161|3628339|FG000|NOT COMPLETED|Overall Study||1
2918181|NCT00525174|3628345|FG000|STARTED|Overall Study||97
2918182|NCT00525174|3628346|FG001|STARTED|Overall Study||89
2918183|NCT00525174|3628345|FG000|COMPLETED|Overall Study||88
2918184|NCT00525174|3628346|FG001|COMPLETED|Overall Study||81
2918185|NCT00525174|3628345|FG000|NOT COMPLETED|Overall Study||9
2918186|NCT00525174|3628346|FG001|NOT COMPLETED|Overall Study||8
2918187|NCT00525265|3628354|FG000|STARTED|Overall Study||10
2918188|NCT00525265|3628355|FG001|STARTED|Overall Study||10
2918189|NCT00525265|3628354|FG000|COMPLETED|Overall Study||9
2918190|NCT00525265|3628355|FG001|COMPLETED|Overall Study||10
2918191|NCT00525265|3628354|FG000|NOT COMPLETED|Overall Study||1
2918192|NCT00525265|3628355|FG001|NOT COMPLETED|Overall Study||0
2918193|NCT00525421|3628363|FG000|STARTED|Overall Study|Enrollment started october 2007|10
2918194|NCT00525421|3628364|FG001|STARTED|Overall Study||10
2918195|NCT00525421|3628363|FG000|COMPLETED|Overall Study||10
2918196|NCT00525421|3628364|FG001|COMPLETED|Overall Study||10
2918197|NCT00525421|3628363|FG000|NOT COMPLETED|Overall Study||0
2918198|NCT00525421|3628364|FG001|NOT COMPLETED|Overall Study||0
2918199|NCT00525499|3628374|FG000|STARTED|Overall Study||47
2918200|NCT00525499|3628375|FG001|STARTED|Overall Study||46
2918201|NCT00525499|3628376|FG002|STARTED|Overall Study||47
2918202|NCT00525499|3628377|FG003|STARTED|Overall Study||46
2918203|NCT00525499|3628374|FG000|COMPLETED|Overall Study||40
2918204|NCT00525499|3628375|FG001|COMPLETED|Overall Study||39
2853484|NCT00045708|3555872|FG000|STARTED|Phase 1||21
2853485|NCT00045708|3555873|FG001|STARTED|Phase 1||17
2853486|NCT00045708|3555874|FG002|STARTED|Phase 1||0
2853487|NCT00045708|3555872|FG000|COMPLETED|Phase 1||21
2853488|NCT00045708|3555873|FG001|COMPLETED|Phase 1||16
2853489|NCT00045708|3555874|FG002|COMPLETED|Phase 1||0
2853490|NCT00045708|3555872|FG000|NOT COMPLETED|Phase 1||0
2853491|NCT00045708|3555873|FG001|NOT COMPLETED|Phase 1||1
2853492|NCT00045708|3555874|FG002|NOT COMPLETED|Phase 1||0
2853493|NCT00045708|3555872|FG000|STARTED|Phase 2||0
2853494|NCT00045708|3555873|FG001|STARTED|Phase 2||0
2853495|NCT00045708|3555874|FG002|STARTED|Phase 2||19
2853496|NCT00045708|3555872|FG000|COMPLETED|Phase 2||0
2853497|NCT00045708|3555873|FG001|COMPLETED|Phase 2||0
2853498|NCT00045708|3555874|FG002|COMPLETED|Phase 2||19
2853499|NCT00045708|3555872|FG000|NOT COMPLETED|Phase 2||0
2853500|NCT00045708|3555873|FG001|NOT COMPLETED|Phase 2||0
2853501|NCT00045708|3555874|FG002|NOT COMPLETED|Phase 2||0
2853502|NCT00045734|3555891|FG000|STARTED|Overall Study||23
2853503|NCT00045734|3555891|FG000|COMPLETED|Overall Study||22
2853504|NCT00045734|3555891|FG000|NOT COMPLETED|Overall Study||1
2853505|NCT00045942|3555904|FG000|STARTED|PKC412A2104 (Core)||20
2853506|NCT00045942|3555905|FG001|STARTED|PKC412A2104 (Core)||0
2853507|NCT00045942|3555906|FG002|STARTED|PKC412A2104 (Core)||0
2853508|NCT00045942|3555907|FG003|STARTED|PKC412A2104 (Core)||0
2853509|NCT00045942|3555908|FG004|STARTED|PKC412A2104 (Core)||0
2853510|NCT00045942|3555909|FG005|STARTED|PKC412A2104 (Core)||0
2853511|NCT00045942|3555910|FG006|STARTED|PKC412A2104 (Core)||0
2853512|NCT00045942|3555911|FG007|STARTED|PKC412A2104 (Core)||0
2853513|NCT00045942|3555912|FG008|STARTED|PKC412A2104 (Core)||0
2853514|NCT00045942|3555904|FG000|Core Primary Efficacy|PKC412A2104 (Core)||20
2853515|NCT00045942|3555905|FG001|Core Primary Efficacy|PKC412A2104 (Core)||0
2853516|NCT00045942|3555906|FG002|Core Primary Efficacy|PKC412A2104 (Core)||0
2853517|NCT00045942|3555907|FG003|Core Primary Efficacy|PKC412A2104 (Core)||0
2853518|NCT00045942|3555908|FG004|Core Primary Efficacy|PKC412A2104 (Core)||0
2853519|NCT00045942|3555909|FG005|Core Primary Efficacy|PKC412A2104 (Core)||0
2853520|NCT00045942|3555910|FG006|Core Primary Efficacy|PKC412A2104 (Core)||0
2853521|NCT00045942|3555911|FG007|Core Primary Efficacy|PKC412A2104 (Core)||0
2853522|NCT00045942|3555912|FG008|Core Primary Efficacy|PKC412A2104 (Core)||0
2853523|NCT00045942|3555904|FG000|COMPLETED|PKC412A2104 (Core)||0
2853524|NCT00045942|3555905|FG001|COMPLETED|PKC412A2104 (Core)||0
2853525|NCT00045942|3555906|FG002|COMPLETED|PKC412A2104 (Core)||0
2853526|NCT00045942|3555907|FG003|COMPLETED|PKC412A2104 (Core)||0
2853527|NCT00045942|3555908|FG004|COMPLETED|PKC412A2104 (Core)||0
2853528|NCT00045942|3555909|FG005|COMPLETED|PKC412A2104 (Core)||0
2853529|NCT00045942|3555910|FG006|COMPLETED|PKC412A2104 (Core)||0
2853530|NCT00045942|3555911|FG007|COMPLETED|PKC412A2104 (Core)||0
2853531|NCT00045942|3555912|FG008|COMPLETED|PKC412A2104 (Core)||0
2853532|NCT00045942|3555904|FG000|NOT COMPLETED|PKC412A2104 (Core)||20
2853533|NCT00045942|3555905|FG001|NOT COMPLETED|PKC412A2104 (Core)||0
2853534|NCT00045942|3555906|FG002|NOT COMPLETED|PKC412A2104 (Core)||0
2853535|NCT00045942|3555907|FG003|NOT COMPLETED|PKC412A2104 (Core)||0
2853536|NCT00045942|3555908|FG004|NOT COMPLETED|PKC412A2104 (Core)||0
2853537|NCT00045942|3555909|FG005|NOT COMPLETED|PKC412A2104 (Core)||0
2853538|NCT00045942|3555910|FG006|NOT COMPLETED|PKC412A2104 (Core)||0
2853539|NCT00045942|3555911|FG007|NOT COMPLETED|PKC412A2104 (Core)||0
2853540|NCT00045942|3555912|FG008|NOT COMPLETED|PKC412A2104 (Core)||0
2853541|NCT00045942|3555904|FG000|STARTED|PKC412A2104E1||0
2853542|NCT00045942|3555905|FG001|STARTED|PKC412A2104E1||18
2853543|NCT00045942|3555906|FG002|STARTED|PKC412A2104E1||17
2853544|NCT00045942|3555907|FG003|STARTED|PKC412A2104E1||33
3168543|NCT01919489|3895855|FG000|NOT COMPLETED|Overall Study||56
3168544|NCT01919489|3895856|FG001|NOT COMPLETED|Overall Study||44
3168545|NCT01919606|3895864|FG000|STARTED|Overall Study||1
2853545|NCT00045942|3555908|FG004|STARTED|PKC412A2104E1||27
2853546|NCT00045942|3555909|FG005|STARTED|PKC412A2104E1||0
2853547|NCT00045942|3555910|FG006|STARTED|PKC412A2104E1||0
2853548|NCT00045942|3555911|FG007|STARTED|PKC412A2104E1||0
2853549|NCT00045942|3555912|FG008|STARTED|PKC412A2104E1||0
2853550|NCT00045942|3555904|FG000|Primary Efficacy|PKC412A2104E1||0
2853551|NCT00045942|3555905|FG001|Primary Efficacy|PKC412A2104E1||18
2853552|NCT00045942|3555906|FG002|Primary Efficacy|PKC412A2104E1||17
2853553|NCT00045942|3555907|FG003|Primary Efficacy|PKC412A2104E1||32
2853554|NCT00045942|3555908|FG004|Primary Efficacy|PKC412A2104E1||25
2853555|NCT00045942|3555909|FG005|Primary Efficacy|PKC412A2104E1||0
2853556|NCT00045942|3555910|FG006|Primary Efficacy|PKC412A2104E1||0
3168546|NCT01919606|3895865|FG001|STARTED|Overall Study||0
3168547|NCT01919606|3895864|FG000|COMPLETED|Overall Study||1
3168548|NCT01919606|3895865|FG001|COMPLETED|Overall Study||0
3168549|NCT01919606|3895864|FG000|NOT COMPLETED|Overall Study||0
3168550|NCT01919606|3895865|FG001|NOT COMPLETED|Overall Study||0
3168551|NCT01919697|3895873|FG000|STARTED|Overall Study||224
2853557|NCT00045942|3555911|FG007|Primary Efficacy|PKC412A2104E1||0
2853558|NCT00045942|3555912|FG008|Primary Efficacy|PKC412A2104E1||0
2853559|NCT00045942|3555904|FG000|COMPLETED|PKC412A2104E1||0
2853560|NCT00045942|3555905|FG001|COMPLETED|PKC412A2104E1||0
2853561|NCT00045942|3555906|FG002|COMPLETED|PKC412A2104E1||0
2853562|NCT00045942|3555907|FG003|COMPLETED|PKC412A2104E1||0
2853563|NCT00045942|3555908|FG004|COMPLETED|PKC412A2104E1||0
3168552|NCT01919697|3895874|FG001|STARTED|Overall Study||2146
3168553|NCT01919697|3895873|FG000|COMPLETED|Overall Study||171
3168554|NCT01919697|3895874|FG001|COMPLETED|Overall Study||1761
3168555|NCT01919697|3895873|FG000|NOT COMPLETED|Overall Study||53
3168556|NCT01919697|3895874|FG001|NOT COMPLETED|Overall Study||385
3168557|NCT01919723|3895883|FG000|STARTED|Overall Study||35
3168558|NCT01919723|3895884|FG001|STARTED|Overall Study||35
3168559|NCT01919723|3895883|FG000|COMPLETED|Overall Study||33
3168560|NCT01919723|3895884|FG001|COMPLETED|Overall Study||33
3168561|NCT01919723|3895883|FG000|NOT COMPLETED|Overall Study||2
3168562|NCT01919723|3895884|FG001|NOT COMPLETED|Overall Study||2
3168563|NCT01919801|3895892|FG000|STARTED|Overall Study||61
3168564|NCT01919801|3895893|FG001|STARTED|Overall Study||60
3168565|NCT01919801|3895892|FG000|COMPLETED|Overall Study||60
3168566|NCT01919801|3895893|FG001|COMPLETED|Overall Study||57
3168567|NCT01919801|3895892|FG000|NOT COMPLETED|Overall Study||1
3168568|NCT01919801|3895893|FG001|NOT COMPLETED|Overall Study||3
3168569|NCT01919814|3895899|FG000|STARTED|Overall Study||30
3168570|NCT01919814|3895900|FG001|STARTED|Overall Study||30
3168571|NCT01919814|3895899|FG000|COMPLETED|Overall Study||27
3168572|NCT01919814|3895900|FG001|COMPLETED|Overall Study||30
2853564|NCT00045942|3555909|FG005|COMPLETED|PKC412A2104E1||0
2853565|NCT00045942|3555910|FG006|COMPLETED|PKC412A2104E1||0
2853566|NCT00045942|3555911|FG007|COMPLETED|PKC412A2104E1||0
2853567|NCT00045942|3555912|FG008|COMPLETED|PKC412A2104E1||0
2853568|NCT00045942|3555904|FG000|NOT COMPLETED|PKC412A2104E1||0
2853569|NCT00045942|3555905|FG001|NOT COMPLETED|PKC412A2104E1||18
2853570|NCT00045942|3555906|FG002|NOT COMPLETED|PKC412A2104E1||17
2853571|NCT00045942|3555907|FG003|NOT COMPLETED|PKC412A2104E1||33
2853572|NCT00045942|3555908|FG004|NOT COMPLETED|PKC412A2104E1||27
2853573|NCT00045942|3555909|FG005|NOT COMPLETED|PKC412A2104E1||0
2853574|NCT00045942|3555910|FG006|NOT COMPLETED|PKC412A2104E1||0
2853575|NCT00045942|3555911|FG007|NOT COMPLETED|PKC412A2104E1||0
2853576|NCT00045942|3555912|FG008|NOT COMPLETED|PKC412A2104E1||0
2853577|NCT00045942|3555904|FG000|STARTED|PKC412A2104E2||0
2853578|NCT00045942|3555905|FG001|STARTED|PKC412A2104E2||0
2853579|NCT00045942|3555906|FG002|STARTED|PKC412A2104E2||0
2853580|NCT00045942|3555907|FG003|STARTED|PKC412A2104E2||0
2853581|NCT00045942|3555908|FG004|STARTED|PKC412A2104E2||0
2853582|NCT00045942|3555909|FG005|STARTED|PKC412A2104E2||9
2853583|NCT00045942|3555910|FG006|STARTED|PKC412A2104E2||7
2853584|NCT00045942|3555911|FG007|STARTED|PKC412A2104E2||7
2853585|NCT00045942|3555912|FG008|STARTED|PKC412A2104E2||6
2853586|NCT00045942|3555904|FG000|Primary Efficacy|PKC412A2104E2||0
2853587|NCT00045942|3555905|FG001|Primary Efficacy|PKC412A2104E2||0
2853588|NCT00045942|3555906|FG002|Primary Efficacy|PKC412A2104E2||0
2853589|NCT00045942|3555907|FG003|Primary Efficacy|PKC412A2104E2||0
2853590|NCT00045942|3555908|FG004|Primary Efficacy|PKC412A2104E2||0
2853591|NCT00045942|3555909|FG005|Primary Efficacy|PKC412A2104E2||9
2853592|NCT00045942|3555910|FG006|Primary Efficacy|PKC412A2104E2||7
2853593|NCT00045942|3555911|FG007|Primary Efficacy|PKC412A2104E2||7
2853594|NCT00045942|3555912|FG008|Primary Efficacy|PKC412A2104E2||6
2853595|NCT00045942|3555904|FG000|COMPLETED|PKC412A2104E2||0
2853596|NCT00045942|3555905|FG001|COMPLETED|PKC412A2104E2||0
2853597|NCT00045942|3555906|FG002|COMPLETED|PKC412A2104E2||0
2853598|NCT00045942|3555907|FG003|COMPLETED|PKC412A2104E2||0
2853599|NCT00045942|3555908|FG004|COMPLETED|PKC412A2104E2||0
2853600|NCT00045942|3555909|FG005|COMPLETED|PKC412A2104E2||0
2853601|NCT00045942|3555910|FG006|COMPLETED|PKC412A2104E2||0
2853602|NCT00045942|3555911|FG007|COMPLETED|PKC412A2104E2||0
2853603|NCT00045942|3555912|FG008|COMPLETED|PKC412A2104E2||0
2853604|NCT00045942|3555904|FG000|NOT COMPLETED|PKC412A2104E2||0
2853605|NCT00045942|3555905|FG001|NOT COMPLETED|PKC412A2104E2||0
2853606|NCT00045942|3555906|FG002|NOT COMPLETED|PKC412A2104E2||0
2853607|NCT00045942|3555907|FG003|NOT COMPLETED|PKC412A2104E2||0
2853608|NCT00045942|3555908|FG004|NOT COMPLETED|PKC412A2104E2||0
2853609|NCT00045942|3555909|FG005|NOT COMPLETED|PKC412A2104E2||9
2853610|NCT00045942|3555910|FG006|NOT COMPLETED|PKC412A2104E2||7
2853611|NCT00045942|3555911|FG007|NOT COMPLETED|PKC412A2104E2||7
2853612|NCT00045942|3555912|FG008|NOT COMPLETED|PKC412A2104E2||6
2853613|NCT00046228|3555939|FG000|STARTED|90 Days||806
2853614|NCT00046228|3555940|FG001|STARTED|90 Days||818
2853615|NCT00046228|3555941|FG002|STARTED|90 Days||828
2853616|NCT00046228|3555939|FG000|COMPLETED|90 Days|The number completed includes subjects who died or were seen for a visit within specified window.|793
2853617|NCT00046228|3555940|FG001|COMPLETED|90 Days|The number completed includes subjects who died or were seen for a visit within specified window.|810
2853618|NCT00046228|3555941|FG002|COMPLETED|90 Days|The number completed includes subjects who died or were seen for a visit within specified window.|813
2853619|NCT00046228|3555939|FG000|NOT COMPLETED|90 Days||13
2853620|NCT00046228|3555940|FG001|NOT COMPLETED|90 Days||8
2853621|NCT00046228|3555941|FG002|NOT COMPLETED|90 Days||15
2853622|NCT00046228|3555939|FG000|STARTED|1 Year|This is the number of participants that were originally randomized to the trial.|806
2853623|NCT00046228|3555940|FG001|STARTED|1 Year|This is the number of participants that were originally randomized to the trial.|818
2853624|NCT00046228|3555941|FG002|STARTED|1 Year|This is the number of participants that were originally randomized to the trial.|828
2853625|NCT00046228|3555939|FG000|COMPLETED|1 Year|The number completed includes subjects who died or were seen for a visit within specified window.|787
2853626|NCT00046228|3555940|FG001|COMPLETED|1 Year|The number completed includes subjects who died or were seen for a visit within specified window.|804
2853627|NCT00046228|3555941|FG002|COMPLETED|1 Year|The number completed includes subjects who died or were seen for a visit within specified window|816
3168573|NCT01919814|3895899|FG000|NOT COMPLETED|Overall Study||3
3168574|NCT01919814|3895900|FG001|NOT COMPLETED|Overall Study||0
2853628|NCT00046228|3555939|FG000|NOT COMPLETED|1 Year||19
2853629|NCT00046228|3555940|FG001|NOT COMPLETED|1 Year||14
2853630|NCT00046228|3555941|FG002|NOT COMPLETED|1 Year||12
2853631|NCT00046475|3555951|FG000|STARTED|Screening/Washout Period (Up to 2 Weeks)||140
2853632|NCT00046475|3555952|FG001|STARTED|Screening/Washout Period (Up to 2 Weeks)||0
2853633|NCT00046475|3555953|FG002|STARTED|Screening/Washout Period (Up to 2 Weeks)||0
2853634|NCT00046475|3555951|FG000|COMPLETED|Screening/Washout Period (Up to 2 Weeks)||136
2853635|NCT00046475|3555952|FG001|COMPLETED|Screening/Washout Period (Up to 2 Weeks)||0
2853636|NCT00046475|3555953|FG002|COMPLETED|Screening/Washout Period (Up to 2 Weeks)||0
2853637|NCT00046475|3555951|FG000|NOT COMPLETED|Screening/Washout Period (Up to 2 Weeks)||4
2853638|NCT00046475|3555952|FG001|NOT COMPLETED|Screening/Washout Period (Up to 2 Weeks)||0
2853639|NCT00046475|3555953|FG002|NOT COMPLETED|Screening/Washout Period (Up to 2 Weeks)||0
2853640|NCT00046475|3555951|FG000|STARTED|Titration (1 Week)||136
2853641|NCT00046475|3555952|FG001|STARTED|Titration (1 Week)||0
2853642|NCT00046475|3555953|FG002|STARTED|Titration (1 Week)||0
2853643|NCT00046475|3555951|FG000|COMPLETED|Titration (1 Week)||136
2853644|NCT00046475|3555952|FG001|COMPLETED|Titration (1 Week)||0
2853645|NCT00046475|3555953|FG002|COMPLETED|Titration (1 Week)||0
2853646|NCT00046475|3555951|FG000|NOT COMPLETED|Titration (1 Week)||0
2853647|NCT00046475|3555952|FG001|NOT COMPLETED|Titration (1 Week)||0
2853648|NCT00046475|3555953|FG002|NOT COMPLETED|Titration (1 Week)||0
3168575|NCT01919970|3895908|FG000|STARTED|Overall Study||14
3168576|NCT01919970|3895909|FG001|STARTED|Overall Study||18
3168577|NCT01919970|3895908|FG000|COMPLETED|Overall Study||11
3168578|NCT01919970|3895909|FG001|COMPLETED|Overall Study||18
3168579|NCT01919970|3895908|FG000|NOT COMPLETED|Overall Study||3
3168580|NCT01919970|3895909|FG001|NOT COMPLETED|Overall Study||0
2853649|NCT00046475|3555951|FG000|STARTED|Treatment Period 1 (Up to 2 Weeks)||0
2853650|NCT00046475|3555952|FG001|STARTED|Treatment Period 1 (Up to 2 Weeks)|Patients did not meet the criteria for randomization, had an AE, or withdrew from the study.|45
2853651|NCT00046475|3555953|FG002|STARTED|Treatment Period 1 (Up to 2 Weeks)|Patients did not meet the criteria for randomization, had an AE, or withdrew from the study.|60
2853652|NCT00046475|3555951|FG000|COMPLETED|Treatment Period 1 (Up to 2 Weeks)||0
2853653|NCT00046475|3555952|FG001|COMPLETED|Treatment Period 1 (Up to 2 Weeks)||45
2853654|NCT00046475|3555953|FG002|COMPLETED|Treatment Period 1 (Up to 2 Weeks)||59
2853655|NCT00046475|3555951|FG000|NOT COMPLETED|Treatment Period 1 (Up to 2 Weeks)||0
2853656|NCT00046475|3555952|FG001|NOT COMPLETED|Treatment Period 1 (Up to 2 Weeks)||0
2853657|NCT00046475|3555953|FG002|NOT COMPLETED|Treatment Period 1 (Up to 2 Weeks)||1
2853658|NCT00046475|3555951|FG000|STARTED|Treatment Period 2 (Up to 2 Weeks)||0
2853659|NCT00046475|3555952|FG001|STARTED|Treatment Period 2 (Up to 2 Weeks)||45
2853660|NCT00046475|3555953|FG002|STARTED|Treatment Period 2 (Up to 2 Weeks)||59
2853661|NCT00046475|3555951|FG000|COMPLETED|Treatment Period 2 (Up to 2 Weeks)||0
2853662|NCT00046475|3555952|FG001|COMPLETED|Treatment Period 2 (Up to 2 Weeks)||44
2853663|NCT00046475|3555953|FG002|COMPLETED|Treatment Period 2 (Up to 2 Weeks)||59
2853664|NCT00046475|3555951|FG000|NOT COMPLETED|Treatment Period 2 (Up to 2 Weeks)||0
2853665|NCT00046475|3555952|FG001|NOT COMPLETED|Treatment Period 2 (Up to 2 Weeks)||1
2853666|NCT00046475|3555953|FG002|NOT COMPLETED|Treatment Period 2 (Up to 2 Weeks)||0
2853667|NCT00046566|3555966|FG000|STARTED|Intervention 1 (8 Weeks)|Soy protein 8 weeks|117
2853668|NCT00046566|3555967|FG001|STARTED|Intervention 1 (8 Weeks)|Milk protein 8 weeks|117
2853669|NCT00046566|3555968|FG002|STARTED|Intervention 1 (8 Weeks)|Carbohydrate 8 weeks|118
2853670|NCT00046566|3555966|FG000|COMPLETED|Intervention 1 (8 Weeks)||101
2853671|NCT00046566|3555967|FG001|COMPLETED|Intervention 1 (8 Weeks)||104
2853672|NCT00046566|3555968|FG002|COMPLETED|Intervention 1 (8 Weeks)||101
2853673|NCT00046566|3555966|FG000|NOT COMPLETED|Intervention 1 (8 Weeks)||16
2853674|NCT00046566|3555967|FG001|NOT COMPLETED|Intervention 1 (8 Weeks)||13
2853675|NCT00046566|3555968|FG002|NOT COMPLETED|Intervention 1 (8 Weeks)||17
2853676|NCT00046566|3555966|FG000|STARTED|Intervention 2 (8 Weeks)|Milk protein 8 weeks|101
2853677|NCT00046566|3555967|FG001|STARTED|Intervention 2 (8 Weeks)|Carbohydrate 8 weeks|104
2853678|NCT00046566|3555968|FG002|STARTED|Intervention 2 (8 Weeks)|Soy protein 8 weeks|101
2853679|NCT00046566|3555966|FG000|COMPLETED|Intervention 2 (8 Weeks)||93
2853680|NCT00046566|3555967|FG001|COMPLETED|Intervention 2 (8 Weeks)||92
2853681|NCT00046566|3555968|FG002|COMPLETED|Intervention 2 (8 Weeks)||88
2853682|NCT00046566|3555966|FG000|NOT COMPLETED|Intervention 2 (8 Weeks)||8
2853683|NCT00046566|3555967|FG001|NOT COMPLETED|Intervention 2 (8 Weeks)||12
2853684|NCT00046566|3555968|FG002|NOT COMPLETED|Intervention 2 (8 Weeks)||13
2853685|NCT00046566|3555966|FG000|STARTED|Intervention 3 (8 Weeks)||93
2853686|NCT00046566|3555967|FG001|STARTED|Intervention 3 (8 Weeks)||92
2853687|NCT00046566|3555968|FG002|STARTED|Intervention 3 (8 Weeks)||88
2853688|NCT00046566|3555966|FG000|COMPLETED|Intervention 3 (8 Weeks)||93
2853689|NCT00046566|3555967|FG001|COMPLETED|Intervention 3 (8 Weeks)||92
2853690|NCT00046566|3555968|FG002|COMPLETED|Intervention 3 (8 Weeks)||88
2853691|NCT00046566|3555966|FG000|NOT COMPLETED|Intervention 3 (8 Weeks)||0
2853692|NCT00046566|3555967|FG001|NOT COMPLETED|Intervention 3 (8 Weeks)||0
2853693|NCT00046566|3555968|FG002|NOT COMPLETED|Intervention 3 (8 Weeks)||0
2853694|NCT00046839|3555979|FG000|STARTED|Overall Study||8
2853695|NCT00046839|3555980|FG001|STARTED|Overall Study||13
2853696|NCT00046839|3555979|FG000|COMPLETED|Overall Study|Subjects contributing data to either primary analysis are considered to have completed the study.|7
2918205|NCT00525499|3628376|FG002|COMPLETED|Overall Study||40
3168581|NCT01919996|3895915|FG000|STARTED|Overall Study||8
2853697|NCT00046839|3555980|FG001|COMPLETED|Overall Study|Subjects contributing data to either primary analysis are considered to have completed the study.|11
2853698|NCT00046839|3555979|FG000|NOT COMPLETED|Overall Study||1
2853699|NCT00046839|3555980|FG001|NOT COMPLETED|Overall Study||2
2853700|NCT00046891|3555989|FG000|STARTED|Overall Study||113
2853701|NCT00046891|3555990|FG001|STARTED|Overall Study||113
2853702|NCT00046891|3555989|FG000|COMPLETED|Overall Study||84
2853703|NCT00046891|3555990|FG001|COMPLETED|Overall Study||83
2853704|NCT00046891|3555989|FG000|NOT COMPLETED|Overall Study||29
2853705|NCT00046891|3555990|FG001|NOT COMPLETED|Overall Study||30
2853706|NCT00046930|3556006|FG000|STARTED|Overall Study||224
2853707|NCT00046930|3556007|FG001|STARTED|Overall Study||225
2853708|NCT00046930|3556006|FG000|COMPLETED|Overall Study||212
2853709|NCT00046930|3556007|FG001|COMPLETED|Overall Study||221
2853710|NCT00046930|3556006|FG000|NOT COMPLETED|Overall Study||12
2853711|NCT00046930|3556007|FG001|NOT COMPLETED|Overall Study||4
2853712|NCT00047008|3556018|FG000|STARTED|Overall Study||372
2853713|NCT00047008|3556019|FG001|STARTED|Overall Study||371
2853714|NCT00047008|3556018|FG000|COMPLETED|Overall Study||361
2853715|NCT00047008|3556019|FG001|COMPLETED|Overall Study||360
2853716|NCT00047008|3556018|FG000|NOT COMPLETED|Overall Study||11
2853717|NCT00047008|3556019|FG001|NOT COMPLETED|Overall Study||11
2853718|NCT00047060|3556025|FG000|STARTED|Overall Study||5
2853719|NCT00047060|3556025|FG000|COMPLETED|Overall Study||3
2853720|NCT00047060|3556025|FG000|NOT COMPLETED|Overall Study||2
2853721|NCT00047320|3556029|FG000|STARTED|Overall Study||104
2853722|NCT00047320|3556029|FG000|COMPLETED|Overall Study||76
2853723|NCT00047320|3556029|FG000|NOT COMPLETED|Overall Study||28
2853724|NCT00047385|3556035|FG000|STARTED|Overall Study||26722
2853725|NCT00047385|3556036|FG001|STARTED|Overall Study||26732
2853726|NCT00047385|3556035|FG000|COMPLETED|Overall Study|Had at least one screening exam.|26455
2853727|NCT00047385|3556036|FG001|COMPLETED|Overall Study||26232
2853728|NCT00047385|3556035|FG000|NOT COMPLETED|Overall Study||267
2853729|NCT00047385|3556036|FG001|NOT COMPLETED|Overall Study||500
2853730|NCT00047463|3556044|FG000|STARTED|Overall Study||13
2853731|NCT00047463|3556045|FG001|STARTED|Overall Study||22
2853732|NCT00047463|3556044|FG000|COMPLETED|Overall Study||13
2853733|NCT00047463|3556045|FG001|COMPLETED|Overall Study||19
2853734|NCT00047463|3556044|FG000|NOT COMPLETED|Overall Study||0
2853735|NCT00047463|3556045|FG001|NOT COMPLETED|Overall Study||3
2853736|NCT00047619|3556056|FG000|STARTED|Overall Study||14
2853737|NCT00047619|3556057|FG001|STARTED|Overall Study||14
2853738|NCT00047619|3556056|FG000|COMPLETED|Overall Study||14
2853739|NCT00047619|3556057|FG001|COMPLETED|Overall Study||14
2853740|NCT00047619|3556056|FG000|NOT COMPLETED|Overall Study||0
2853741|NCT00047619|3556057|FG001|NOT COMPLETED|Overall Study||0
2853742|NCT00047697|3556065|FG000|STARTED|Overall Study||18
2853743|NCT00047697|3556066|FG001|STARTED|Overall Study||16
2853744|NCT00047697|3556065|FG000|COMPLETED|Overall Study||18
2853745|NCT00047697|3556066|FG001|COMPLETED|Overall Study||14
2853746|NCT00047697|3556065|FG000|NOT COMPLETED|Overall Study||0
2853747|NCT00047697|3556066|FG001|NOT COMPLETED|Overall Study||2
2853748|NCT00047879|3556075|FG000|STARTED|Overall Study||4
2853749|NCT00047879|3556076|FG001|STARTED|Overall Study||3
2853750|NCT00047879|3556075|FG000|COMPLETED|Overall Study||0
2853751|NCT00047879|3556076|FG001|COMPLETED|Overall Study||0
2853752|NCT00047879|3556075|FG000|NOT COMPLETED|Overall Study||4
2853753|NCT00047879|3556076|FG001|NOT COMPLETED|Overall Study||3
2853754|NCT00048035|3556088|FG000|STARTED|Core Period||15
2853755|NCT00048035|3556089|FG001|STARTED|Core Period||15
2853756|NCT00048035|3556090|FG002|STARTED|Core Period||15
2853757|NCT00048035|3556091|FG003|STARTED|Core Period||15
2853758|NCT00048035|3556092|FG004|STARTED|Core Period||16
2853759|NCT00048035|3556093|FG005|STARTED|Core Period||15
2853760|NCT00048035|3556094|FG006|STARTED|Core Period||0
2853761|NCT00048035|3556095|FG007|STARTED|Core Period||0
2853762|NCT00048035|3556088|FG000|COMPLETED|Core Period||11
2853763|NCT00048035|3556089|FG001|COMPLETED|Core Period||13
2853764|NCT00048035|3556090|FG002|COMPLETED|Core Period||14
2853765|NCT00048035|3556091|FG003|COMPLETED|Core Period||14
2853766|NCT00048035|3556092|FG004|COMPLETED|Core Period||15
2853767|NCT00048035|3556093|FG005|COMPLETED|Core Period||14
2853768|NCT00048035|3556094|FG006|COMPLETED|Core Period||0
2853769|NCT00048035|3556095|FG007|COMPLETED|Core Period||0
2853770|NCT00048035|3556088|FG000|NOT COMPLETED|Core Period||4
2853771|NCT00048035|3556089|FG001|NOT COMPLETED|Core Period||2
2853772|NCT00048035|3556090|FG002|NOT COMPLETED|Core Period||1
2853773|NCT00048035|3556091|FG003|NOT COMPLETED|Core Period||1
2853774|NCT00048035|3556092|FG004|NOT COMPLETED|Core Period||1
2853775|NCT00048035|3556093|FG005|NOT COMPLETED|Core Period||1
2853776|NCT00048035|3556094|FG006|NOT COMPLETED|Core Period||0
2853777|NCT00048035|3556095|FG007|NOT COMPLETED|Core Period||0
2853778|NCT00048035|3556088|FG000|STARTED|Extension Year 1||0
2853779|NCT00048035|3556089|FG001|STARTED|Extension Year 1||0
2853780|NCT00048035|3556090|FG002|STARTED|Extension Year 1||0
2853781|NCT00048035|3556091|FG003|STARTED|Extension Year 1||0
2853782|NCT00048035|3556092|FG004|STARTED|Extension Year 1||0
2853783|NCT00048035|3556093|FG005|STARTED|Extension Year 1||0
2853784|NCT00048035|3556094|FG006|STARTED|Extension Year 1|Participants (Cohorts 1, 3, and 5) who completed core, entered extension period (entry optional).|27
2853785|NCT00048035|3556095|FG007|STARTED|Extension Year 1|Participants (Cohorts 2, 4 and 6) who completed core, entered extension period (entry optional).|26
2853786|NCT00048035|3556088|FG000|COMPLETED|Extension Year 1||0
2853787|NCT00048035|3556089|FG001|COMPLETED|Extension Year 1||0
2853788|NCT00048035|3556090|FG002|COMPLETED|Extension Year 1||0
2853789|NCT00048035|3556091|FG003|COMPLETED|Extension Year 1||0
2853790|NCT00048035|3556092|FG004|COMPLETED|Extension Year 1||0
2853791|NCT00048035|3556093|FG005|COMPLETED|Extension Year 1||0
2853792|NCT00048035|3556094|FG006|COMPLETED|Extension Year 1||16
2853793|NCT00048035|3556095|FG007|COMPLETED|Extension Year 1||15
2853794|NCT00048035|3556088|FG000|NOT COMPLETED|Extension Year 1||0
2853795|NCT00048035|3556089|FG001|NOT COMPLETED|Extension Year 1||0
2853796|NCT00048035|3556090|FG002|NOT COMPLETED|Extension Year 1||0
2853797|NCT00048035|3556091|FG003|NOT COMPLETED|Extension Year 1||0
2853798|NCT00048035|3556092|FG004|NOT COMPLETED|Extension Year 1||0
2853799|NCT00048035|3556093|FG005|NOT COMPLETED|Extension Year 1||0
3168582|NCT01919996|3895915|FG000|COMPLETED|Overall Study||8
3168583|NCT01919996|3895915|FG000|NOT COMPLETED|Overall Study||0
3168584|NCT01920061|3895939|FG000|STARTED|Overall Study||4
2853800|NCT00048035|3556094|FG006|NOT COMPLETED|Extension Year 1||11
2853801|NCT00048035|3556095|FG007|NOT COMPLETED|Extension Year 1||11
2853802|NCT00048035|3556088|FG000|STARTED|Extension Year 2||0
2853803|NCT00048035|3556089|FG001|STARTED|Extension Year 2||0
2853804|NCT00048035|3556090|FG002|STARTED|Extension Year 2||0
2853805|NCT00048035|3556091|FG003|STARTED|Extension Year 2||0
2853806|NCT00048035|3556092|FG004|STARTED|Extension Year 2||0
2853807|NCT00048035|3556093|FG005|STARTED|Extension Year 2||0
2853808|NCT00048035|3556094|FG006|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1, entered Extension Year 2 (entry optional).|14
2853809|NCT00048035|3556095|FG007|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1, entered Extension Year 2 (entry optional).|13
2853810|NCT00048035|3556088|FG000|COMPLETED|Extension Year 2||0
2853811|NCT00048035|3556089|FG001|COMPLETED|Extension Year 2||0
2853812|NCT00048035|3556090|FG002|COMPLETED|Extension Year 2||0
2853813|NCT00048035|3556091|FG003|COMPLETED|Extension Year 2||0
2853814|NCT00048035|3556092|FG004|COMPLETED|Extension Year 2||0
2853815|NCT00048035|3556093|FG005|COMPLETED|Extension Year 2||0
2853816|NCT00048035|3556094|FG006|COMPLETED|Extension Year 2||11
2853817|NCT00048035|3556095|FG007|COMPLETED|Extension Year 2||10
2853818|NCT00048035|3556088|FG000|NOT COMPLETED|Extension Year 2||0
2853819|NCT00048035|3556089|FG001|NOT COMPLETED|Extension Year 2||0
2853820|NCT00048035|3556090|FG002|NOT COMPLETED|Extension Year 2||0
2853821|NCT00048035|3556091|FG003|NOT COMPLETED|Extension Year 2||0
2853822|NCT00048035|3556092|FG004|NOT COMPLETED|Extension Year 2||0
2853823|NCT00048035|3556093|FG005|NOT COMPLETED|Extension Year 2||0
2853824|NCT00048035|3556094|FG006|NOT COMPLETED|Extension Year 2||3
2853825|NCT00048035|3556095|FG007|NOT COMPLETED|Extension Year 2||3
2853826|NCT00048048|3556119|FG000|STARTED|Core Treatment||6
2853827|NCT00048048|3556120|FG001|STARTED|Core Treatment||6
2853828|NCT00048048|3556121|FG002|STARTED|Core Treatment||10
2853829|NCT00048048|3556122|FG003|STARTED|Core Treatment||6
2853830|NCT00048048|3556123|FG004|STARTED|Core Treatment||6
2853831|NCT00048048|3556124|FG005|STARTED|Core Treatment||9
2853832|NCT00048048|3556125|FG006|STARTED|Core Treatment||6
2853833|NCT00048048|3556126|FG007|STARTED|Core Treatment||6
2853834|NCT00048048|3556127|FG008|STARTED|Core Treatment||10
2853835|NCT00048048|3556128|FG009|STARTED|Core Treatment||0
2853836|NCT00048048|3556129|FG010|STARTED|Core Treatment||0
2853837|NCT00048048|3556130|FG011|STARTED|Core Treatment||0
2853838|NCT00048048|3556119|FG000|COMPLETED|Core Treatment||6
2853839|NCT00048048|3556120|FG001|COMPLETED|Core Treatment||6
2853840|NCT00048048|3556121|FG002|COMPLETED|Core Treatment||9
2853841|NCT00048048|3556122|FG003|COMPLETED|Core Treatment||6
2853842|NCT00048048|3556123|FG004|COMPLETED|Core Treatment||6
2853843|NCT00048048|3556124|FG005|COMPLETED|Core Treatment||9
2853844|NCT00048048|3556125|FG006|COMPLETED|Core Treatment||6
2853845|NCT00048048|3556126|FG007|COMPLETED|Core Treatment||5
2853846|NCT00048048|3556127|FG008|COMPLETED|Core Treatment||10
2853847|NCT00048048|3556128|FG009|COMPLETED|Core Treatment||0
3168585|NCT01920061|3895940|FG001|STARTED|Overall Study||5
2853848|NCT00048048|3556129|FG010|COMPLETED|Core Treatment||0
2853849|NCT00048048|3556130|FG011|COMPLETED|Core Treatment||0
2853850|NCT00048048|3556119|FG000|NOT COMPLETED|Core Treatment||0
2853851|NCT00048048|3556120|FG001|NOT COMPLETED|Core Treatment||0
2853852|NCT00048048|3556121|FG002|NOT COMPLETED|Core Treatment||1
2853853|NCT00048048|3556122|FG003|NOT COMPLETED|Core Treatment||0
2853854|NCT00048048|3556123|FG004|NOT COMPLETED|Core Treatment||0
2853855|NCT00048048|3556124|FG005|NOT COMPLETED|Core Treatment||0
2853856|NCT00048048|3556125|FG006|NOT COMPLETED|Core Treatment||0
2853857|NCT00048048|3556126|FG007|NOT COMPLETED|Core Treatment||1
2853858|NCT00048048|3556127|FG008|NOT COMPLETED|Core Treatment||0
2853859|NCT00048048|3556128|FG009|NOT COMPLETED|Core Treatment||0
2853860|NCT00048048|3556129|FG010|NOT COMPLETED|Core Treatment||0
2853861|NCT00048048|3556130|FG011|NOT COMPLETED|Core Treatment||0
2853862|NCT00048048|3556119|FG000|STARTED|Extension Year 1||0
2853863|NCT00048048|3556120|FG001|STARTED|Extension Year 1||0
2853864|NCT00048048|3556121|FG002|STARTED|Extension Year 1||0
2853865|NCT00048048|3556122|FG003|STARTED|Extension Year 1||0
2853866|NCT00048048|3556123|FG004|STARTED|Extension Year 1||0
2853867|NCT00048048|3556124|FG005|STARTED|Extension Year 1||0
2853868|NCT00048048|3556125|FG006|STARTED|Extension Year 1||0
2853869|NCT00048048|3556126|FG007|STARTED|Extension Year 1||0
2853870|NCT00048048|3556127|FG008|STARTED|Extension Year 1||0
2918206|NCT00525499|3628377|FG003|COMPLETED|Overall Study||39
2918207|NCT00525499|3628374|FG000|NOT COMPLETED|Overall Study||7
3168586|NCT01920061|3895941|FG002|STARTED|Overall Study||3
2853871|NCT00048048|3556128|FG009|STARTED|Extension Year 1|Participants (Cohorts 1, 2, and 3) who completed core, entered extension period (entry optional).|16
2853872|NCT00048048|3556129|FG010|STARTED|Extension Year 1|Participants (Cohorts 4, 5, and 6) who completed core, entered extension period (entry optional).|16
2853873|NCT00048048|3556130|FG011|STARTED|Extension Year 1|Participants (Cohorts 7, 8, and 9) who completed core, entered extension period (entry optional).|19
2853874|NCT00048048|3556119|FG000|COMPLETED|Extension Year 1||0
2853875|NCT00048048|3556120|FG001|COMPLETED|Extension Year 1||0
2853876|NCT00048048|3556121|FG002|COMPLETED|Extension Year 1||0
2853877|NCT00048048|3556122|FG003|COMPLETED|Extension Year 1||0
2853878|NCT00048048|3556123|FG004|COMPLETED|Extension Year 1||0
2853879|NCT00048048|3556124|FG005|COMPLETED|Extension Year 1||0
2853880|NCT00048048|3556125|FG006|COMPLETED|Extension Year 1||0
2853881|NCT00048048|3556126|FG007|COMPLETED|Extension Year 1||0
2853882|NCT00048048|3556127|FG008|COMPLETED|Extension Year 1||0
2853883|NCT00048048|3556128|FG009|COMPLETED|Extension Year 1||14
2853884|NCT00048048|3556129|FG010|COMPLETED|Extension Year 1||14
2853885|NCT00048048|3556130|FG011|COMPLETED|Extension Year 1||15
2853886|NCT00048048|3556119|FG000|NOT COMPLETED|Extension Year 1||0
2853887|NCT00048048|3556120|FG001|NOT COMPLETED|Extension Year 1||0
2853888|NCT00048048|3556121|FG002|NOT COMPLETED|Extension Year 1||0
2853889|NCT00048048|3556122|FG003|NOT COMPLETED|Extension Year 1||0
2853890|NCT00048048|3556123|FG004|NOT COMPLETED|Extension Year 1||0
2853891|NCT00048048|3556124|FG005|NOT COMPLETED|Extension Year 1||0
2853892|NCT00048048|3556125|FG006|NOT COMPLETED|Extension Year 1||0
2853893|NCT00048048|3556126|FG007|NOT COMPLETED|Extension Year 1||0
2853894|NCT00048048|3556127|FG008|NOT COMPLETED|Extension Year 1||0
2853895|NCT00048048|3556128|FG009|NOT COMPLETED|Extension Year 1||2
2853896|NCT00048048|3556129|FG010|NOT COMPLETED|Extension Year 1||2
2853897|NCT00048048|3556130|FG011|NOT COMPLETED|Extension Year 1||4
2853898|NCT00048048|3556119|FG000|STARTED|Extension Year 2||0
2853899|NCT00048048|3556120|FG001|STARTED|Extension Year 2||0
2853900|NCT00048048|3556121|FG002|STARTED|Extension Year 2||0
2853901|NCT00048048|3556122|FG003|STARTED|Extension Year 2||0
2853902|NCT00048048|3556123|FG004|STARTED|Extension Year 2||0
2853903|NCT00048048|3556124|FG005|STARTED|Extension Year 2||0
2853904|NCT00048048|3556125|FG006|STARTED|Extension Year 2||0
2853905|NCT00048048|3556126|FG007|STARTED|Extension Year 2||0
2853906|NCT00048048|3556127|FG008|STARTED|Extension Year 2||0
2853907|NCT00048048|3556128|FG009|STARTED|Extension Year 2|Twelve participants who completed Extension Year 1 were switched to RO0503821 (1x/2Week).|2
2853908|NCT00048048|3556129|FG010|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1 + 12 participants from RO0503821 (1X/Week).|23
2853909|NCT00048048|3556130|FG011|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1, entered Extension Year 2 (entry optional).|15
2853910|NCT00048048|3556119|FG000|COMPLETED|Extension Year 2||0
2853911|NCT00048048|3556120|FG001|COMPLETED|Extension Year 2||0
2853912|NCT00048048|3556121|FG002|COMPLETED|Extension Year 2||0
2853913|NCT00048048|3556122|FG003|COMPLETED|Extension Year 2||0
2853914|NCT00048048|3556123|FG004|COMPLETED|Extension Year 2||0
2853915|NCT00048048|3556124|FG005|COMPLETED|Extension Year 2||0
2853916|NCT00048048|3556125|FG006|COMPLETED|Extension Year 2||0
2853917|NCT00048048|3556126|FG007|COMPLETED|Extension Year 2||0
2853918|NCT00048048|3556127|FG008|COMPLETED|Extension Year 2||0
2853919|NCT00048048|3556128|FG009|COMPLETED|Extension Year 2||2
2853920|NCT00048048|3556129|FG010|COMPLETED|Extension Year 2||19
2853921|NCT00048048|3556130|FG011|COMPLETED|Extension Year 2||13
2853922|NCT00048048|3556119|FG000|NOT COMPLETED|Extension Year 2||0
2853923|NCT00048048|3556120|FG001|NOT COMPLETED|Extension Year 2||0
2853924|NCT00048048|3556121|FG002|NOT COMPLETED|Extension Year 2||0
2853925|NCT00048048|3556122|FG003|NOT COMPLETED|Extension Year 2||0
2853926|NCT00048048|3556123|FG004|NOT COMPLETED|Extension Year 2||0
2853927|NCT00048048|3556124|FG005|NOT COMPLETED|Extension Year 2||0
2853928|NCT00048048|3556125|FG006|NOT COMPLETED|Extension Year 2||0
2853929|NCT00048048|3556126|FG007|NOT COMPLETED|Extension Year 2||0
2853930|NCT00048048|3556127|FG008|NOT COMPLETED|Extension Year 2||0
2853931|NCT00048048|3556128|FG009|NOT COMPLETED|Extension Year 2||0
2853932|NCT00048048|3556129|FG010|NOT COMPLETED|Extension Year 2||4
2853933|NCT00048048|3556130|FG011|NOT COMPLETED|Extension Year 2||2
2853934|NCT00048061|3556161|FG000|STARTED|Overall Study||400
2853935|NCT00048061|3556162|FG001|STARTED|Overall Study||401
2853936|NCT00048061|3556163|FG002|STARTED|Overall Study||400
2853937|NCT00048061|3556164|FG003|STARTED|Overall Study||401
2853938|NCT00048061|3556161|FG000|COMPLETED|Overall Study||325
2853939|NCT00048061|3556162|FG001|COMPLETED|Overall Study||328
2853940|NCT00048061|3556163|FG002|COMPLETED|Overall Study||316
2853941|NCT00048061|3556164|FG003|COMPLETED|Overall Study||322
2853942|NCT00048061|3556161|FG000|NOT COMPLETED|Overall Study||75
2853943|NCT00048061|3556162|FG001|NOT COMPLETED|Overall Study||73
2853944|NCT00048061|3556163|FG002|NOT COMPLETED|Overall Study||84
2853945|NCT00048061|3556164|FG003|NOT COMPLETED|Overall Study||79
2853946|NCT00048074|3556177|FG000|STARTED|Overall Study||465
2853947|NCT00048074|3556178|FG001|STARTED|Overall Study||448
2853948|NCT00048074|3556179|FG002|STARTED|Overall Study||469
2853949|NCT00048074|3556177|FG000|COMPLETED|Overall Study||384
2853950|NCT00048074|3556178|FG001|COMPLETED|Overall Study||361
2853951|NCT00048074|3556179|FG002|COMPLETED|Overall Study||372
2853952|NCT00048074|3556177|FG000|NOT COMPLETED|Overall Study||81
2853953|NCT00048074|3556178|FG001|NOT COMPLETED|Overall Study||87
2853954|NCT00048074|3556179|FG002|NOT COMPLETED|Overall Study||97
2853955|NCT00048165|3556189|FG000|STARTED|Completed 6 Months Study||216
2853956|NCT00048165|3556190|FG001|STARTED|Completed 6 Months Study||218
2853957|NCT00048165|3556189|FG000|COMPLETED|Completed 6 Months Study||165
2853958|NCT00048165|3556190|FG001|COMPLETED|Completed 6 Months Study||170
2853959|NCT00048165|3556189|FG000|NOT COMPLETED|Completed 6 Months Study||51
2853960|NCT00048165|3556190|FG001|NOT COMPLETED|Completed 6 Months Study||48
2853961|NCT00048165|3556189|FG000|STARTED|Completed 12 Months Study||165
2853962|NCT00048165|3556190|FG001|STARTED|Completed 12 Months Study||170
2853963|NCT00048165|3556189|FG000|COMPLETED|Completed 12 Months Study||162
2853964|NCT00048165|3556190|FG001|COMPLETED|Completed 12 Months Study||167
2853965|NCT00048165|3556189|FG000|NOT COMPLETED|Completed 12 Months Study||3
2853966|NCT00048165|3556190|FG001|NOT COMPLETED|Completed 12 Months Study||3
2853967|NCT00048347|3556198|FG000|STARTED|Overall Study||18
2853968|NCT00048347|3556198|FG000|COMPLETED|Overall Study||16
2853969|NCT00048347|3556198|FG000|NOT COMPLETED|Overall Study||2
2853970|NCT00048542|3556206|FG000|STARTED|Double-Blind Phase|For all groups, started indicates when the subjects entered the double-blind treatment phase.|38
2853971|NCT00048542|3556207|FG001|STARTED|Double-Blind Phase||37
2853972|NCT00048542|3556208|FG002|STARTED|Double-Blind Phase||30
2853973|NCT00048542|3556209|FG003|STARTED|Double-Blind Phase||28
2853974|NCT00048542|3556210|FG004|STARTED|Double-Blind Phase||0
2853975|NCT00048542|3556211|FG005|STARTED|Double-Blind Phase||0
2853976|NCT00048542|3556212|FG006|STARTED|Double-Blind Phase||0
2853977|NCT00048542|3556213|FG007|STARTED|Double-Blind Phase||0
2853978|NCT00048542|3556206|FG000|COMPLETED|Double-Blind Phase||35
2853979|NCT00048542|3556207|FG001|COMPLETED|Double-Blind Phase||36
2853980|NCT00048542|3556208|FG002|COMPLETED|Double-Blind Phase||29
2853981|NCT00048542|3556209|FG003|COMPLETED|Double-Blind Phase||28
2853982|NCT00048542|3556210|FG004|COMPLETED|Double-Blind Phase||0
2853983|NCT00048542|3556211|FG005|COMPLETED|Double-Blind Phase||0
2853984|NCT00048542|3556212|FG006|COMPLETED|Double-Blind Phase||0
2853985|NCT00048542|3556213|FG007|COMPLETED|Double-Blind Phase||0
2853986|NCT00048542|3556206|FG000|NOT COMPLETED|Double-Blind Phase||3
2853987|NCT00048542|3556207|FG001|NOT COMPLETED|Double-Blind Phase||1
2853988|NCT00048542|3556208|FG002|NOT COMPLETED|Double-Blind Phase||1
2853989|NCT00048542|3556209|FG003|NOT COMPLETED|Double-Blind Phase||0
2853990|NCT00048542|3556210|FG004|NOT COMPLETED|Double-Blind Phase||0
2853991|NCT00048542|3556211|FG005|NOT COMPLETED|Double-Blind Phase||0
2853992|NCT00048542|3556212|FG006|NOT COMPLETED|Double-Blind Phase||0
2853993|NCT00048542|3556213|FG007|NOT COMPLETED|Double-Blind Phase||0
2853994|NCT00048542|3556206|FG000|STARTED|Open-Label Extension BSA Phase||0
2853995|NCT00048542|3556207|FG001|STARTED|Open-Label Extension BSA Phase||0
2853996|NCT00048542|3556208|FG002|STARTED|Open-Label Extension BSA Phase||0
2853997|NCT00048542|3556209|FG003|STARTED|Open-Label Extension BSA Phase||0
2853998|NCT00048542|3556210|FG004|STARTED|Open-Label Extension BSA Phase||71
2853999|NCT00048542|3556211|FG005|STARTED|Open-Label Extension BSA Phase||57
2854000|NCT00048542|3556212|FG006|STARTED|Open-Label Extension BSA Phase||0
2854001|NCT00048542|3556213|FG007|STARTED|Open-Label Extension BSA Phase||0
2854002|NCT00048542|3556206|FG000|COMPLETED|Open-Label Extension BSA Phase||0
2854003|NCT00048542|3556207|FG001|COMPLETED|Open-Label Extension BSA Phase||0
2854004|NCT00048542|3556208|FG002|COMPLETED|Open-Label Extension BSA Phase||0
2854005|NCT00048542|3556209|FG003|COMPLETED|Open-Label Extension BSA Phase||0
2854006|NCT00048542|3556210|FG004|COMPLETED|Open-Label Extension BSA Phase||59
2854007|NCT00048542|3556211|FG005|COMPLETED|Open-Label Extension BSA Phase||47
2854008|NCT00048542|3556212|FG006|COMPLETED|Open-Label Extension BSA Phase||0
2854009|NCT00048542|3556213|FG007|COMPLETED|Open-Label Extension BSA Phase||0
2854010|NCT00048542|3556206|FG000|NOT COMPLETED|Open-Label Extension BSA Phase||0
2854011|NCT00048542|3556207|FG001|NOT COMPLETED|Open-Label Extension BSA Phase||0
2854012|NCT00048542|3556208|FG002|NOT COMPLETED|Open-Label Extension BSA Phase||0
2854013|NCT00048542|3556209|FG003|NOT COMPLETED|Open-Label Extension BSA Phase||0
2854014|NCT00048542|3556210|FG004|NOT COMPLETED|Open-Label Extension BSA Phase||12
2854015|NCT00048542|3556211|FG005|NOT COMPLETED|Open-Label Extension BSA Phase||10
2854016|NCT00048542|3556212|FG006|NOT COMPLETED|Open-Label Extension BSA Phase||0
2854017|NCT00048542|3556213|FG007|NOT COMPLETED|Open-Label Extension BSA Phase||0
2854018|NCT00048542|3556206|FG000|STARTED|Open-Label Extension Fixed Dose Phase||0
2854019|NCT00048542|3556207|FG001|STARTED|Open-Label Extension Fixed Dose Phase||0
2854020|NCT00048542|3556208|FG002|STARTED|Open-Label Extension Fixed Dose Phase||0
2854021|NCT00048542|3556209|FG003|STARTED|Open-Label Extension Fixed Dose Phase||0
2854022|NCT00048542|3556210|FG004|STARTED|Open-Label Extension Fixed Dose Phase||0
2854023|NCT00048542|3556211|FG005|STARTED|Open-Label Extension Fixed Dose Phase||0
2854024|NCT00048542|3556212|FG006|STARTED|Open-Label Extension Fixed Dose Phase||59
2854025|NCT00048542|3556213|FG007|STARTED|Open-Label Extension Fixed Dose Phase||47
2854026|NCT00048542|3556206|FG000|COMPLETED|Open-Label Extension Fixed Dose Phase||0
2854027|NCT00048542|3556207|FG001|COMPLETED|Open-Label Extension Fixed Dose Phase||0
2854028|NCT00048542|3556208|FG002|COMPLETED|Open-Label Extension Fixed Dose Phase||0
2854029|NCT00048542|3556209|FG003|COMPLETED|Open-Label Extension Fixed Dose Phase||0
2854030|NCT00048542|3556210|FG004|COMPLETED|Open-Label Extension Fixed Dose Phase||0
2854031|NCT00048542|3556211|FG005|COMPLETED|Open-Label Extension Fixed Dose Phase||0
2854032|NCT00048542|3556212|FG006|COMPLETED|Open-Label Extension Fixed Dose Phase||37
2854033|NCT00048542|3556213|FG007|COMPLETED|Open-Label Extension Fixed Dose Phase||25
2854034|NCT00048542|3556206|FG000|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
2854035|NCT00048542|3556207|FG001|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
2854036|NCT00048542|3556208|FG002|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
2854037|NCT00048542|3556209|FG003|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
2854038|NCT00048542|3556210|FG004|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
2854039|NCT00048542|3556211|FG005|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
2854040|NCT00048542|3556212|FG006|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||22
2854041|NCT00048542|3556213|FG007|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||22
2854042|NCT00048568|3556244|FG000|STARTED|Double-Blind Period Days 1 to 169||433
2854043|NCT00048568|3556245|FG001|STARTED|Double-Blind Period Days 1 to 169||219
2854044|NCT00048568|3556246|FG002|STARTED|Double-Blind Period Days 1 to 169||0
2854045|NCT00048568|3556244|FG000|COMPLETED|Double-Blind Period Days 1 to 169||401
2854046|NCT00048568|3556245|FG001|COMPLETED|Double-Blind Period Days 1 to 169||174
2854047|NCT00048568|3556246|FG002|COMPLETED|Double-Blind Period Days 1 to 169||0
2854048|NCT00048568|3556244|FG000|NOT COMPLETED|Double-Blind Period Days 1 to 169||32
2854049|NCT00048568|3556245|FG001|NOT COMPLETED|Double-Blind Period Days 1 to 169||45
2854050|NCT00048568|3556246|FG002|NOT COMPLETED|Double-Blind Period Days 1 to 169||0
2854051|NCT00048568|3556244|FG000|STARTED|Double-Blind Period Days 170 to 365||401
2854052|NCT00048568|3556245|FG001|STARTED|Double-Blind Period Days 170 to 365||174
2854053|NCT00048568|3556246|FG002|STARTED|Double-Blind Period Days 170 to 365||0
2854054|NCT00048568|3556244|FG000|COMPLETED|Double-Blind Period Days 170 to 365||385
2854055|NCT00048568|3556245|FG001|COMPLETED|Double-Blind Period Days 170 to 365||162
2854056|NCT00048568|3556246|FG002|COMPLETED|Double-Blind Period Days 170 to 365||0
2854057|NCT00048568|3556244|FG000|NOT COMPLETED|Double-Blind Period Days 170 to 365||16
2854058|NCT00048568|3556245|FG001|NOT COMPLETED|Double-Blind Period Days 170 to 365||12
2854059|NCT00048568|3556246|FG002|NOT COMPLETED|Double-Blind Period Days 170 to 365||0
2854060|NCT00048568|3556244|FG000|STARTED|Open-Label Period||0
3168587|NCT01920061|3895942|FG003|STARTED|Overall Study||4
3168588|NCT01920061|3895943|FG004|STARTED|Overall Study||5
3168589|NCT01920061|3895944|FG005|STARTED|Overall Study||4
3168590|NCT01920061|3895945|FG006|STARTED|Overall Study||3
3168591|NCT01920061|3895946|FG007|STARTED|Overall Study||3
3168592|NCT01920061|3895947|FG008|STARTED|Overall Study||3
3168593|NCT01920061|3895948|FG009|STARTED|Overall Study||3
3168594|NCT01920061|3895949|FG010|STARTED|Overall Study||10
3168595|NCT01920061|3895950|FG011|STARTED|Overall Study||5
3168596|NCT01920061|3895951|FG012|STARTED|Overall Study||3
3168597|NCT01920061|3895952|FG013|STARTED|Overall Study||16
3168598|NCT01920061|3895953|FG014|STARTED|Overall Study||4
3168599|NCT01920061|3895954|FG015|STARTED|Overall Study||7
3168600|NCT01920061|3895955|FG016|STARTED|Overall Study||3
2854061|NCT00048568|3556245|FG001|STARTED|Open-Label Period||0
2854062|NCT00048568|3556246|FG002|STARTED|Open-Label Period||539
2854063|NCT00048568|3556244|FG000|COMPLETED|Open-Label Period||0
2854064|NCT00048568|3556245|FG001|COMPLETED|Open-Label Period||0
2854065|NCT00048568|3556246|FG002|COMPLETED|Open-Label Period||379
2854066|NCT00048568|3556244|FG000|NOT COMPLETED|Open-Label Period||0
2854067|NCT00048568|3556245|FG001|NOT COMPLETED|Open-Label Period||0
2854068|NCT00048568|3556246|FG002|NOT COMPLETED|Open-Label Period||160
2854069|NCT00048581|3556269|FG000|STARTED|Double-Blind Period||258
2854070|NCT00048581|3556270|FG001|STARTED|Double-Blind Period||133
2854071|NCT00048581|3556271|FG002|STARTED|Double-Blind Period||0
2854072|NCT00048581|3556269|FG000|COMPLETED|Double-Blind Period||223
2854073|NCT00048581|3556270|FG001|COMPLETED|Double-Blind Period||99
2854074|NCT00048581|3556271|FG002|COMPLETED|Double-Blind Period||0
2854075|NCT00048581|3556269|FG000|NOT COMPLETED|Double-Blind Period||35
2854076|NCT00048581|3556270|FG001|NOT COMPLETED|Double-Blind Period||34
2854077|NCT00048581|3556271|FG002|NOT COMPLETED|Double-Blind Period||0
2854078|NCT00048581|3556269|FG000|STARTED|Open-Label Period||0
2854079|NCT00048581|3556270|FG001|STARTED|Open-Label Period||0
2854080|NCT00048581|3556271|FG002|STARTED|Open-Label Period||317
2854081|NCT00048581|3556269|FG000|COMPLETED|Open-Label Period||0
2854082|NCT00048581|3556270|FG001|COMPLETED|Open-Label Period||0
2854083|NCT00048581|3556271|FG002|COMPLETED|Open-Label Period||150
2854084|NCT00048581|3556269|FG000|NOT COMPLETED|Open-Label Period||0
2854085|NCT00048581|3556270|FG001|NOT COMPLETED|Open-Label Period||0
2854086|NCT00048581|3556271|FG002|NOT COMPLETED|Open-Label Period||167
2854087|NCT00048724|3556286|FG000|STARTED|Overall Study||311
2854088|NCT00048724|3556287|FG001|STARTED|Overall Study||315
2854089|NCT00048724|3556286|FG000|COMPLETED|Overall Study||195
2854090|NCT00048724|3556287|FG001|COMPLETED|Overall Study||197
2854091|NCT00048724|3556286|FG000|NOT COMPLETED|Overall Study||116
2854092|NCT00048724|3556287|FG001|NOT COMPLETED|Overall Study||118
2854093|NCT00048737|3556293|FG000|STARTED|Overall Study||70
2854094|NCT00048737|3556293|FG000|COMPLETED|Overall Study||70
2854095|NCT00048737|3556293|FG000|NOT COMPLETED|Overall Study||0
2854096|NCT00048815|3556300|FG000|STARTED|Overall Study||24
2854097|NCT00048815|3556301|FG001|STARTED|Overall Study||26
2854098|NCT00048815|3556302|FG002|STARTED|Overall Study||23
2854099|NCT00048815|3556300|FG000|COMPLETED|Overall Study||18
2854100|NCT00048815|3556301|FG001|COMPLETED|Overall Study||22
2854101|NCT00048815|3556302|FG002|COMPLETED|Overall Study||19
2854102|NCT00048815|3556300|FG000|NOT COMPLETED|Overall Study||6
2854103|NCT00048815|3556301|FG001|NOT COMPLETED|Overall Study||4
2854104|NCT00048815|3556302|FG002|NOT COMPLETED|Overall Study||4
2854105|NCT00048893|3556310|FG000|STARTED|Overall Study||37
3168601|NCT01920061|3895956|FG017|STARTED|Overall Study||3
2854106|NCT00048893|3556310|FG000|COMPLETED|Overall Study||37
2854107|NCT00048893|3556310|FG000|NOT COMPLETED|Overall Study||0
2854108|NCT00048932|3556316|FG000|STARTED|Double Blind Period (DB)|Number Treated|959
2854109|NCT00048932|3556317|FG001|STARTED|Double Blind Period (DB)|Number Treated|482
2854110|NCT00048932|3556318|FG002|STARTED|Double Blind Period (DB)||0
2854111|NCT00048932|3556316|FG000|COMPLETED|Double Blind Period (DB)||836
2854112|NCT00048932|3556317|FG001|COMPLETED|Double Blind Period (DB)||395
2854113|NCT00048932|3556318|FG002|COMPLETED|Double Blind Period (DB)||0
2854114|NCT00048932|3556316|FG000|NOT COMPLETED|Double Blind Period (DB)||123
2854115|NCT00048932|3556317|FG001|NOT COMPLETED|Double Blind Period (DB)||87
2854116|NCT00048932|3556318|FG002|NOT COMPLETED|Double Blind Period (DB)||0
2854117|NCT00048932|3556316|FG000|STARTED|Open Label Period (OL)||0
2854118|NCT00048932|3556317|FG001|STARTED|Open Label Period (OL)||0
2854119|NCT00048932|3556318|FG002|STARTED|Open Label Period (OL)|47 participants who completed the double-blind did not enter the open-label|1184
2854120|NCT00048932|3556316|FG000|COMPLETED|Open Label Period (OL)||0
2854121|NCT00048932|3556317|FG001|COMPLETED|Open Label Period (OL)||0
2854122|NCT00048932|3556318|FG002|COMPLETED|Open Label Period (OL)||743
2854123|NCT00048932|3556316|FG000|NOT COMPLETED|Open Label Period (OL)||0
2854124|NCT00048932|3556317|FG001|NOT COMPLETED|Open Label Period (OL)||0
2854125|NCT00048932|3556318|FG002|NOT COMPLETED|Open Label Period (OL)||441
2854126|NCT00048997|3556329|FG000|STARTED|Overall Study||176
2854127|NCT00048997|3556330|FG001|STARTED|Overall Study||180
2854128|NCT00048997|3556329|FG000|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|163
2854129|NCT00048997|3556330|FG001|COMPLETED|Overall Study||177
2854130|NCT00048997|3556329|FG000|NOT COMPLETED|Overall Study||13
2854131|NCT00048997|3556330|FG001|NOT COMPLETED|Overall Study||3
2854132|NCT00049036|3556337|FG000|STARTED|Overall Study||51
2854133|NCT00049036|3556338|FG001|STARTED|Overall Study||55
2854134|NCT00049036|3556337|FG000|COMPLETED|Overall Study||51
2854135|NCT00049036|3556338|FG001|COMPLETED|Overall Study||55
2854136|NCT00049036|3556337|FG000|NOT COMPLETED|Overall Study||0
2854137|NCT00049036|3556338|FG001|NOT COMPLETED|Overall Study||0
2854138|NCT00049127|3556349|FG000|STARTED|Overall Study||12
2854139|NCT00049127|3556350|FG001|STARTED|Overall Study||0
2854140|NCT00049127|3556351|FG002|STARTED|Overall Study||40
2854141|NCT00049127|3556352|FG003|STARTED|Overall Study||0
2854142|NCT00049127|3556353|FG004|STARTED|Overall Study||12
2854143|NCT00049127|3556349|FG000|COMPLETED|Overall Study||12
2854144|NCT00049127|3556350|FG001|COMPLETED|Overall Study||0
2854145|NCT00049127|3556351|FG002|COMPLETED|Overall Study||39
2854146|NCT00049127|3556352|FG003|COMPLETED|Overall Study||0
2854147|NCT00049127|3556353|FG004|COMPLETED|Overall Study||12
2854148|NCT00049127|3556349|FG000|NOT COMPLETED|Overall Study||0
2854149|NCT00049127|3556350|FG001|NOT COMPLETED|Overall Study||0
2854150|NCT00049127|3556351|FG002|NOT COMPLETED|Overall Study||1
2854151|NCT00049127|3556352|FG003|NOT COMPLETED|Overall Study||0
2854152|NCT00049127|3556353|FG004|NOT COMPLETED|Overall Study||0
2854153|NCT00049257|3556365|FG000|STARTED|Carboplatin, Paclitaxel||58
2854154|NCT00049257|3556365|FG000|COMPLETED|Carboplatin, Paclitaxel|13 participants did not complete treatment|45
2854155|NCT00049257|3556365|FG000|NOT COMPLETED|Carboplatin, Paclitaxel||13
2854156|NCT00049257|3556365|FG000|STARTED|Follow-up Period for Survival Status||45
2854157|NCT00049257|3556365|FG000|COMPLETED|Follow-up Period for Survival Status||41
2854158|NCT00049257|3556365|FG000|NOT COMPLETED|Follow-up Period for Survival Status||4
2854159|NCT00049322|3556371|FG000|STARTED|Overall Study||15
2854160|NCT00049322|3556372|FG001|STARTED|Overall Study||15
2854161|NCT00049322|3556371|FG000|COMPLETED|Overall Study||14
2854162|NCT00049322|3556372|FG001|COMPLETED|Overall Study||9
2854163|NCT00049322|3556371|FG000|NOT COMPLETED|Overall Study||1
2854164|NCT00049322|3556372|FG001|NOT COMPLETED|Overall Study||6
2854165|NCT00049504|3556380|FG000|STARTED|Overall Study||55
2854166|NCT00049504|3556380|FG000|COMPLETED|Overall Study||55
2854167|NCT00049504|3556380|FG000|NOT COMPLETED|Overall Study||0
2854168|NCT00049517|3556386|FG000|STARTED|Induction||79
2854169|NCT00049517|3556387|FG001|STARTED|Induction||90
2854170|NCT00049517|3556388|FG002|STARTED|Induction||63
2854171|NCT00049517|3556389|FG003|STARTED|Induction||75
2854172|NCT00049517|3556390|FG004|STARTED|Induction||188
2854173|NCT00049517|3556391|FG005|STARTED|Induction||162
2854174|NCT00049517|3556386|FG000|Treated|Induction||79
2854175|NCT00049517|3556387|FG001|Treated|Induction||90
2854176|NCT00049517|3556388|FG002|Treated|Induction||63
2854177|NCT00049517|3556389|FG003|Treated|Induction||75
2854178|NCT00049517|3556390|FG004|Treated|Induction||186
2854179|NCT00049517|3556391|FG005|Treated|Induction||160
2854180|NCT00049517|3556386|FG000|COMPLETED|Induction||79
2854181|NCT00049517|3556387|FG001|COMPLETED|Induction||90
2854182|NCT00049517|3556388|FG002|COMPLETED|Induction||63
2854183|NCT00049517|3556389|FG003|COMPLETED|Induction||75
2854184|NCT00049517|3556390|FG004|COMPLETED|Induction||128
2854185|NCT00049517|3556391|FG005|COMPLETED|Induction||108
2854186|NCT00049517|3556386|FG000|NOT COMPLETED|Induction||0
2854187|NCT00049517|3556387|FG001|NOT COMPLETED|Induction||0
2854188|NCT00049517|3556388|FG002|NOT COMPLETED|Induction||0
2854189|NCT00049517|3556389|FG003|NOT COMPLETED|Induction||0
2854190|NCT00049517|3556390|FG004|NOT COMPLETED|Induction||60
2854191|NCT00049517|3556391|FG005|NOT COMPLETED|Induction||54
2854192|NCT00049517|3556386|FG000|STARTED|Conditioning/Transplant||79
2854193|NCT00049517|3556387|FG001|STARTED|Conditioning/Transplant||90
2854194|NCT00049517|3556388|FG002|STARTED|Conditioning/Transplant||63
2854195|NCT00049517|3556389|FG003|STARTED|Conditioning/Transplant||75
2854196|NCT00049517|3556390|FG004|STARTED|Conditioning/Transplant||21
2854197|NCT00049517|3556391|FG005|STARTED|Conditioning/Transplant||24
2854198|NCT00049517|3556386|FG000|Randomized to Autologous HCT +/- GO|Conditioning/Transplant|Additional 20 patients received Autologous HCT without randomization.|59
2854199|NCT00049517|3556387|FG001|Randomized to Autologous HCT +/- GO|Conditioning/Transplant|Additional 17 patients received Autologous HCT without randomization.|73
2854200|NCT00049517|3556388|FG002|Randomized to Autologous HCT +/- GO|Conditioning/Transplant||63
2854201|NCT00049517|3556389|FG003|Randomized to Autologous HCT +/- GO|Conditioning/Transplant||75
2854202|NCT00049517|3556390|FG004|Randomized to Autologous HCT +/- GO|Conditioning/Transplant|These 21 patients received Allogeneic HCT without randomization.|0
2854203|NCT00049517|3556391|FG005|Randomized to Autologous HCT +/- GO|Conditioning/Transplant|These 24 patients received Allogeneic HCT without randomization.|0
2854204|NCT00049517|3556386|FG000|COMPLETED|Conditioning/Transplant||27
2854205|NCT00049517|3556387|FG001|COMPLETED|Conditioning/Transplant||40
2854206|NCT00049517|3556388|FG002|COMPLETED|Conditioning/Transplant||25
2854207|NCT00049517|3556389|FG003|COMPLETED|Conditioning/Transplant||32
2854208|NCT00049517|3556390|FG004|COMPLETED|Conditioning/Transplant||15
2854209|NCT00049517|3556391|FG005|COMPLETED|Conditioning/Transplant||18
2854210|NCT00049517|3556386|FG000|NOT COMPLETED|Conditioning/Transplant||52
2854211|NCT00049517|3556387|FG001|NOT COMPLETED|Conditioning/Transplant||50
2854212|NCT00049517|3556388|FG002|NOT COMPLETED|Conditioning/Transplant||38
2854213|NCT00049517|3556389|FG003|NOT COMPLETED|Conditioning/Transplant||43
2854214|NCT00049517|3556390|FG004|NOT COMPLETED|Conditioning/Transplant||6
2854215|NCT00049517|3556391|FG005|NOT COMPLETED|Conditioning/Transplant||6
2854216|NCT00049530|3556399|FG000|STARTED|Overall Study||32
2854217|NCT00049530|3556399|FG000|Eligible and Treated|Overall Study||29
2854218|NCT00049530|3556399|FG000|COMPLETED|Overall Study||0
2854219|NCT00049530|3556399|FG000|NOT COMPLETED|Overall Study||32
2854220|NCT00049543|3556405|FG000|STARTED|Overall Study||251
2854221|NCT00049543|3556406|FG001|STARTED|Overall Study||252
2854222|NCT00049543|3556405|FG000|COMPLETED|Overall Study||249
2854223|NCT00049543|3556406|FG001|COMPLETED|Overall Study||243
2854224|NCT00049543|3556405|FG000|NOT COMPLETED|Overall Study||2
2854225|NCT00049543|3556406|FG001|NOT COMPLETED|Overall Study||9
2854226|NCT00049673|3556414|FG000|STARTED|Overall Study||166
2854227|NCT00049673|3556415|FG001|STARTED|Overall Study||166
2854228|NCT00049673|3556414|FG000|COMPLETED|Overall Study||165
2854229|NCT00049673|3556415|FG001|COMPLETED|Overall Study||163
2854230|NCT00049673|3556414|FG000|NOT COMPLETED|Overall Study||1
2854231|NCT00049673|3556415|FG001|NOT COMPLETED|Overall Study||3
2854232|NCT00049842|3556423|FG000|STARTED|Treatment Phase||270
2854233|NCT00049842|3556424|FG001|STARTED|Treatment Phase||270
2854234|NCT00049842|3556423|FG000|COMPLETED|Treatment Phase||177
2854235|NCT00049842|3556424|FG001|COMPLETED|Treatment Phase||192
2854236|NCT00049842|3556423|FG000|NOT COMPLETED|Treatment Phase||93
2854237|NCT00049842|3556424|FG001|NOT COMPLETED|Treatment Phase||78
2854238|NCT00049842|3556423|FG000|STARTED|Follow-up Phase|Population is all treatment phase completers plus some who discontinued the treatment phase.|218
2854239|NCT00049842|3556424|FG001|STARTED|Follow-up Phase|Population is all treatment phase completers plus some who discontinued the treatment phase.|194
2854240|NCT00049842|3556423|FG000|COMPLETED|Follow-up Phase||211
2854241|NCT00049842|3556424|FG001|COMPLETED|Follow-up Phase||189
2854242|NCT00049842|3556423|FG000|NOT COMPLETED|Follow-up Phase||7
2854243|NCT00049842|3556424|FG001|NOT COMPLETED|Follow-up Phase||5
2854244|NCT00050011|3556432|FG000|STARTED|Overall Study||301
2854245|NCT00050011|3556433|FG001|STARTED|Overall Study||301
2854246|NCT00050011|3556432|FG000|Intent-to-treat Population|Overall Study||300
2854247|NCT00050011|3556433|FG001|Intent-to-treat Population|Overall Study||300
2854248|NCT00050011|3556432|FG000|COMPLETED|Overall Study||180
2854249|NCT00050011|3556433|FG001|COMPLETED|Overall Study||175
2854250|NCT00050011|3556432|FG000|NOT COMPLETED|Overall Study||121
2854251|NCT00050011|3556433|FG001|NOT COMPLETED|Overall Study||126
2854252|NCT00050089|3556444|FG000|STARTED|Overall Study||106
2854253|NCT00050089|3556445|FG001|STARTED|Overall Study||98
2854254|NCT00050089|3556446|FG002|STARTED|Overall Study||86
2854255|NCT00050089|3556447|FG003|STARTED|Overall Study||78
2854256|NCT00050089|3556444|FG000|Baseline|Overall Study|15 participants randomized in the UK Option scheme (not displayed in the 2X2 baseline data)|91
2854257|NCT00050089|3556445|FG001|Baseline|Overall Study|14 participants randomized in the UK Option scheme (not shown in 2X2 baseline data)|84
3168602|NCT01920061|3895957|FG018|STARTED|Overall Study||10
3168603|NCT01920061|3895958|FG019|STARTED|Overall Study||12
3168604|NCT01920061|3895939|FG000|Received Treatment|Overall Study||4
3168605|NCT01920061|3895940|FG001|Received Treatment|Overall Study||5
3168606|NCT01920061|3895941|FG002|Received Treatment|Overall Study||3
3168607|NCT01920061|3895942|FG003|Received Treatment|Overall Study||3
3168608|NCT01920061|3895943|FG004|Received Treatment|Overall Study||5
3168609|NCT01920061|3895944|FG005|Received Treatment|Overall Study||4
2854258|NCT00050089|3556446|FG002|Baseline|Overall Study||86
2854259|NCT00050089|3556447|FG003|Baseline|Overall Study||78
2854260|NCT00050089|3556444|FG000|COMPLETED|Overall Study|For primary outcome assessment|106
2854261|NCT00050089|3556445|FG001|COMPLETED|Overall Study|For primary outcome assessment|98
2854262|NCT00050089|3556446|FG002|COMPLETED|Overall Study|For primary outcome assessment|86
2854263|NCT00050089|3556447|FG003|COMPLETED|Overall Study|For primary outcome assessment|78
2854264|NCT00050089|3556444|FG000|NOT COMPLETED|Overall Study||0
2854265|NCT00050089|3556445|FG001|NOT COMPLETED|Overall Study||0
2854266|NCT00050089|3556446|FG002|NOT COMPLETED|Overall Study||0
2854267|NCT00050089|3556447|FG003|NOT COMPLETED|Overall Study||0
2854268|NCT00050167|3556463|FG000|STARTED|Overall Study||302
2854269|NCT00050167|3556464|FG001|STARTED|Overall Study||301
2854270|NCT00050167|3556463|FG000|COMPLETED|Overall Study||301
2854271|NCT00050167|3556464|FG001|COMPLETED|Overall Study||300
2854272|NCT00050167|3556463|FG000|NOT COMPLETED|Overall Study||1
2854273|NCT00050167|3556464|FG001|NOT COMPLETED|Overall Study||1
2854274|NCT00050622|3556470|FG000|STARTED|Overall Study||154
2854275|NCT00050622|3556470|FG000|COMPLETED|Overall Study||153
2854276|NCT00050622|3556470|FG000|NOT COMPLETED|Overall Study||1
2854277|NCT00050778|3556497|FG000|STARTED|Overall Study|Randomized.|111
2854278|NCT00050778|3556498|FG001|STARTED|Overall Study||113
2854279|NCT00050778|3556499|FG002|STARTED|Overall Study||110
3168610|NCT01920061|3895945|FG006|Received Treatment|Overall Study||3
3168611|NCT01920061|3895946|FG007|Received Treatment|Overall Study||3
3168612|NCT01920061|3895947|FG008|Received Treatment|Overall Study||3
3168613|NCT01920061|3895948|FG009|Received Treatment|Overall Study||3
3168614|NCT01920061|3895949|FG010|Received Treatment|Overall Study||10
3168615|NCT01920061|3895950|FG011|Received Treatment|Overall Study||5
2854280|NCT00050778|3556497|FG000|Treated|Overall Study||107
2854281|NCT00050778|3556498|FG001|Treated|Overall Study||108
2854282|NCT00050778|3556499|FG002|Treated|Overall Study||108
2854283|NCT00050778|3556497|FG000|COMPLETED|Overall Study||66
2854284|NCT00050778|3556498|FG001|COMPLETED|Overall Study||92
2854285|NCT00050778|3556499|FG002|COMPLETED|Overall Study||92
3168616|NCT01920061|3895951|FG012|Received Treatment|Overall Study||2
3168617|NCT01920061|3895952|FG013|Received Treatment|Overall Study||15
3168618|NCT01920061|3895953|FG014|Received Treatment|Overall Study||4
3168619|NCT01920061|3895954|FG015|Received Treatment|Overall Study||7
3168620|NCT01920061|3895955|FG016|Received Treatment|Overall Study||3
3168621|NCT01920061|3895956|FG017|Received Treatment|Overall Study||3
3168622|NCT01920061|3895957|FG018|Received Treatment|Overall Study||10
3168623|NCT01920061|3895958|FG019|Received Treatment|Overall Study||12
3168624|NCT01920061|3895939|FG000|COMPLETED|Overall Study||2
3168625|NCT01920061|3895940|FG001|COMPLETED|Overall Study||1
3168626|NCT01920061|3895941|FG002|COMPLETED|Overall Study||1
3168627|NCT01920061|3895942|FG003|COMPLETED|Overall Study||2
2854286|NCT00050778|3556497|FG000|NOT COMPLETED|Overall Study||45
2854287|NCT00050778|3556498|FG001|NOT COMPLETED|Overall Study||21
2854288|NCT00050778|3556499|FG002|NOT COMPLETED|Overall Study||18
2854289|NCT00050960|3556511|FG000|STARTED|Overall Study||306
2854290|NCT00050960|3556512|FG001|STARTED|Overall Study||306
2854291|NCT00050960|3556511|FG000|COMPLETED|Overall Study|Represents number of patients with no primary reason for termination|4
2854292|NCT00050960|3556512|FG001|COMPLETED|Overall Study|Represents number of patients with no primary reason for termination|2
2854293|NCT00050960|3556511|FG000|NOT COMPLETED|Overall Study||302
2854294|NCT00050960|3556512|FG001|NOT COMPLETED|Overall Study||304
2854295|NCT00050986|3556518|FG000|STARTED|Overall Study||55
2854296|NCT00050986|3556518|FG000|COMPLETED|Overall Study|Two participants had withdrawn consents before the study treatment was initiated.|53
2854297|NCT00050986|3556518|FG000|NOT COMPLETED|Overall Study||2
2854298|NCT00051025|3556524|FG000|STARTED|Overall Study||5
2854299|NCT00051025|3556525|FG001|STARTED|Overall Study||4
2854300|NCT00051025|3556524|FG000|COMPLETED|Overall Study||3
2854301|NCT00051025|3556525|FG001|COMPLETED|Overall Study||0
2854302|NCT00051025|3556524|FG000|NOT COMPLETED|Overall Study||2
2854303|NCT00051025|3556525|FG001|NOT COMPLETED|Overall Study||4
2854304|NCT00051168|3556531|FG000|STARTED|Overall Study||502
2854305|NCT00051168|3556531|FG000|COMPLETED|Overall Study||367
2854306|NCT00051168|3556531|FG000|NOT COMPLETED|Overall Study||135
2854307|NCT00051311|3556537|FG000|STARTED|Overall Study||31
2854308|NCT00051311|3556538|FG001|STARTED|Overall Study||31
2854309|NCT00051311|3556537|FG000|COMPLETED|Overall Study||19
2854310|NCT00051311|3556538|FG001|COMPLETED|Overall Study||17
2854311|NCT00051311|3556537|FG000|NOT COMPLETED|Overall Study||12
2854312|NCT00051311|3556538|FG001|NOT COMPLETED|Overall Study||14
2854313|NCT00051363|3556544|FG000|STARTED|Overall Study||558
2854314|NCT00051363|3556545|FG001|STARTED|Overall Study||547
2854315|NCT00051363|3556544|FG000|Randomized & Analyzed|Overall Study||556
2854316|NCT00051363|3556545|FG001|Randomized & Analyzed|Overall Study||542
2854317|NCT00051363|3556544|FG000|Completed 2M Visit On-Treatment|Overall Study||456
2854318|NCT00051363|3556545|FG001|Completed 2M Visit On-Treatment|Overall Study||417
2854319|NCT00051363|3556544|FG000|Completed 2M Visit On-Study|Overall Study||468
2854320|NCT00051363|3556545|FG001|Completed 2M Visit On-Study|Overall Study||432
2854321|NCT00051363|3556544|FG000|Completed 6M Visit On-Treatment|Overall Study||427
2854322|NCT00051363|3556545|FG001|Completed 6M Visit On-Treatment|Overall Study||372
2854323|NCT00051363|3556544|FG000|Completed 6M Vist On-Study|Overall Study||443
2854324|NCT00051363|3556545|FG001|Completed 6M Vist On-Study|Overall Study||403
2854325|NCT00051363|3556544|FG000|COMPLETED|Overall Study||443
2854326|NCT00051363|3556545|FG001|COMPLETED|Overall Study||403
2854327|NCT00051363|3556544|FG000|NOT COMPLETED|Overall Study||115
2854328|NCT00051363|3556545|FG001|NOT COMPLETED|Overall Study||144
2854329|NCT00051558|3556553|FG000|STARTED|Overall Study||214
2854330|NCT00051558|3556554|FG001|STARTED|Overall Study||214
2854331|NCT00051558|3556553|FG000|COMPLETED|Overall Study||123
2854332|NCT00051558|3556554|FG001|COMPLETED|Overall Study||118
2854333|NCT00051558|3556553|FG000|NOT COMPLETED|Overall Study||91
2854334|NCT00051558|3556554|FG001|NOT COMPLETED|Overall Study||96
2854335|NCT00051636|3556562|FG000|STARTED|Period 1 - Core||90
2854336|NCT00051636|3556563|FG001|STARTED|Period 1 - Core||82
2854337|NCT00051636|3556562|FG000|COMPLETED|Period 1 - Core||86
2854338|NCT00051636|3556563|FG001|COMPLETED|Period 1 - Core||76
2854339|NCT00051636|3556562|FG000|NOT COMPLETED|Period 1 - Core||4
2854340|NCT00051636|3556563|FG001|NOT COMPLETED|Period 1 - Core||6
3168628|NCT01920061|3895943|FG004|COMPLETED|Overall Study||3
3168629|NCT01920061|3895944|FG005|COMPLETED|Overall Study||2
3168630|NCT01920061|3895945|FG006|COMPLETED|Overall Study||2
3168631|NCT01920061|3895946|FG007|COMPLETED|Overall Study||2
3168632|NCT01920061|3895947|FG008|COMPLETED|Overall Study||2
3168633|NCT01920061|3895948|FG009|COMPLETED|Overall Study||1
2854341|NCT00051636|3556562|FG000|STARTED|Period 2- Extended Observation Period||75
2854342|NCT00051636|3556563|FG001|STARTED|Period 2- Extended Observation Period||52
2854343|NCT00051636|3556562|FG000|COMPLETED|Period 2- Extended Observation Period|Includes patients retreated for Paget's disease and patients discontinued when sponsor ended study|5
2854344|NCT00051636|3556563|FG001|COMPLETED|Period 2- Extended Observation Period|Includes patients retreated for Paget's disease|22
2854345|NCT00051636|3556562|FG000|NOT COMPLETED|Period 2- Extended Observation Period||70
2854346|NCT00051636|3556563|FG001|NOT COMPLETED|Period 2- Extended Observation Period||30
2854347|NCT00052078|3556573|FG000|STARTED|Overall Study||133
2854348|NCT00052078|3556574|FG001|STARTED|Overall Study||139
2854349|NCT00052078|3556575|FG002|STARTED|Overall Study||140
2854350|NCT00052078|3556576|FG003|STARTED|Overall Study||76
2854351|NCT00052078|3556573|FG000|COMPLETED|Overall Study||110
2854352|NCT00052078|3556574|FG001|COMPLETED|Overall Study||133
3168634|NCT01920061|3895949|FG010|COMPLETED|Overall Study||5
3168635|NCT01920061|3895950|FG011|COMPLETED|Overall Study||2
3168636|NCT01920061|3895951|FG012|COMPLETED|Overall Study||1
3168637|NCT01920061|3895952|FG013|COMPLETED|Overall Study||10
3168638|NCT01920061|3895953|FG014|COMPLETED|Overall Study||3
2854353|NCT00052078|3556575|FG002|COMPLETED|Overall Study||127
2854354|NCT00052078|3556576|FG003|COMPLETED|Overall Study||61
2854355|NCT00052078|3556573|FG000|NOT COMPLETED|Overall Study||23
2854356|NCT00052078|3556574|FG001|NOT COMPLETED|Overall Study||6
2854357|NCT00052078|3556575|FG002|NOT COMPLETED|Overall Study||13
2854358|NCT00052078|3556576|FG003|NOT COMPLETED|Overall Study||15
2854359|NCT00052429|3556586|FG000|STARTED|Overall Study||25
2854360|NCT00052429|3556586|FG000|COMPLETED|Overall Study||25
2854361|NCT00052429|3556586|FG000|NOT COMPLETED|Overall Study||0
2854362|NCT00052442|3556595|FG000|STARTED|Overall Study||16
2854363|NCT00052442|3556596|FG001|STARTED|Overall Study||3
2854364|NCT00052442|3556597|FG002|STARTED|Overall Study||27
2854365|NCT00052442|3556598|FG003|STARTED|Overall Study||11
2854366|NCT00052442|3556599|FG004|STARTED|Overall Study||15
2854367|NCT00052442|3556595|FG000|COMPLETED|Overall Study||16
2854368|NCT00052442|3556596|FG001|COMPLETED|Overall Study||3
2854369|NCT00052442|3556597|FG002|COMPLETED|Overall Study||27
2854370|NCT00052442|3556598|FG003|COMPLETED|Overall Study||11
2854371|NCT00052442|3556599|FG004|COMPLETED|Overall Study||15
2854372|NCT00052442|3556595|FG000|NOT COMPLETED|Overall Study||0
2854373|NCT00052442|3556596|FG001|NOT COMPLETED|Overall Study||0
2854374|NCT00052442|3556597|FG002|NOT COMPLETED|Overall Study||0
2854375|NCT00052442|3556598|FG003|NOT COMPLETED|Overall Study||0
2854376|NCT00052442|3556599|FG004|NOT COMPLETED|Overall Study||0
2854377|NCT00052715|3556611|FG000|STARTED|Overall Study||31
2854378|NCT00052715|3556611|FG000|COMPLETED|Overall Study||30
2854379|NCT00052715|3556611|FG000|NOT COMPLETED|Overall Study||1
2854380|NCT00052910|3556617|FG000|STARTED|Overall Study||280
2854381|NCT00052910|3556618|FG001|STARTED|Overall Study||266
2854382|NCT00052910|3556617|FG000|COMPLETED|Overall Study||280
2854383|NCT00052910|3556618|FG001|COMPLETED|Overall Study||266
2854384|NCT00052910|3556617|FG000|NOT COMPLETED|Overall Study||0
2854385|NCT00052910|3556618|FG001|NOT COMPLETED|Overall Study||0
2854386|NCT00052962|3556626|FG000|STARTED|Overall Study||13
2854387|NCT00052962|3556627|FG001|STARTED|Overall Study||17
2854388|NCT00052962|3556626|FG000|COMPLETED|Overall Study||12
2854389|NCT00052962|3556627|FG001|COMPLETED|Overall Study||15
2854390|NCT00052962|3556626|FG000|NOT COMPLETED|Overall Study||1
2854391|NCT00052962|3556627|FG001|NOT COMPLETED|Overall Study||2
2854392|NCT00053014|3556633|FG000|STARTED|Overall Study||5
2854393|NCT00053014|3556633|FG000|COMPLETED|Overall Study||5
2854394|NCT00053014|3556633|FG000|NOT COMPLETED|Overall Study||0
2854395|NCT00053352|3556639|FG000|STARTED|Overall Study||190
2854396|NCT00053352|3556640|FG001|STARTED|Overall Study||112
2854397|NCT00053352|3556639|FG000|COMPLETED|Overall Study||169
2854398|NCT00053352|3556640|FG001|COMPLETED|Overall Study||102
2854399|NCT00053352|3556639|FG000|NOT COMPLETED|Overall Study||21
2854400|NCT00053352|3556640|FG001|NOT COMPLETED|Overall Study||10
2854401|NCT00053365|3556647|FG000|STARTED|Overall Study||61
2854402|NCT00053365|3556647|FG000|COMPLETED|Overall Study||55
2854403|NCT00053365|3556647|FG000|NOT COMPLETED|Overall Study||6
2854404|NCT00053417|3556657|FG000|STARTED|Overall Study||47
2854405|NCT00053417|3556658|FG001|STARTED|Overall Study||52
2854406|NCT00053417|3556659|FG002|STARTED|Overall Study||50
2854407|NCT00053417|3556660|FG003|STARTED|Overall Study||57
3168639|NCT01920061|3895954|FG015|COMPLETED|Overall Study||4
3168640|NCT01920061|3895955|FG016|COMPLETED|Overall Study||1
3168641|NCT01920061|3895956|FG017|COMPLETED|Overall Study||1
2854408|NCT00053417|3556657|FG000|COMPLETED|Overall Study||45
2854409|NCT00053417|3556658|FG001|COMPLETED|Overall Study||50
2854410|NCT00053417|3556659|FG002|COMPLETED|Overall Study||49
2854411|NCT00053417|3556660|FG003|COMPLETED|Overall Study||51
2854412|NCT00053417|3556657|FG000|NOT COMPLETED|Overall Study||2
2854413|NCT00053417|3556658|FG001|NOT COMPLETED|Overall Study||2
2854414|NCT00053417|3556659|FG002|NOT COMPLETED|Overall Study||1
2854415|NCT00053417|3556660|FG003|NOT COMPLETED|Overall Study||6
2854416|NCT00053482|3556675|FG000|STARTED|Overall Study||51
2854417|NCT00053482|3556676|FG001|STARTED|Overall Study||102
2854418|NCT00053482|3556677|FG002|STARTED|Overall Study||102
2854419|NCT00053482|3556678|FG003|STARTED|Overall Study||50
2854420|NCT00053482|3556679|FG004|STARTED|Overall Study||52
2854421|NCT00053482|3556675|FG000|COMPLETED|Overall Study||51
2854422|NCT00053482|3556676|FG001|COMPLETED|Overall Study||102
2854423|NCT00053482|3556677|FG002|COMPLETED|Overall Study||102
2854424|NCT00053482|3556678|FG003|COMPLETED|Overall Study||50
2854425|NCT00053482|3556679|FG004|COMPLETED|Overall Study||52
2854426|NCT00053482|3556675|FG000|NOT COMPLETED|Overall Study||0
2854427|NCT00053482|3556676|FG001|NOT COMPLETED|Overall Study||0
2854428|NCT00053482|3556677|FG002|NOT COMPLETED|Overall Study||0
2854429|NCT00053482|3556678|FG003|NOT COMPLETED|Overall Study||0
2854430|NCT00053482|3556679|FG004|NOT COMPLETED|Overall Study||0
2854431|NCT00053495|3556696|FG000|STARTED|Overall Study||51
2854432|NCT00053495|3556697|FG001|STARTED|Overall Study||101
2854433|NCT00053495|3556698|FG002|STARTED|Overall Study||101
2854434|NCT00053495|3556699|FG003|STARTED|Overall Study||51
2854435|NCT00053495|3556700|FG004|STARTED|Overall Study||49
2854436|NCT00053495|3556696|FG000|COMPLETED|Overall Study||51
2854437|NCT00053495|3556697|FG001|COMPLETED|Overall Study||101
2854438|NCT00053495|3556698|FG002|COMPLETED|Overall Study||101
2854439|NCT00053495|3556699|FG003|COMPLETED|Overall Study||51
2854440|NCT00053495|3556700|FG004|COMPLETED|Overall Study||49
2854441|NCT00053495|3556696|FG000|NOT COMPLETED|Overall Study||0
2854442|NCT00053495|3556697|FG001|NOT COMPLETED|Overall Study||0
2854443|NCT00053495|3556698|FG002|NOT COMPLETED|Overall Study||0
2854444|NCT00053495|3556699|FG003|NOT COMPLETED|Overall Study||0
2854445|NCT00053495|3556700|FG004|NOT COMPLETED|Overall Study||0
2854446|NCT00053677|3556714|FG000|STARTED|Overall Study||58
2854447|NCT00053677|3556715|FG001|STARTED|Overall Study||19
2854448|NCT00053677|3556714|FG000|COMPLETED|Overall Study||36
2854449|NCT00053677|3556715|FG001|COMPLETED|Overall Study||13
2854450|NCT00053677|3556714|FG000|NOT COMPLETED|Overall Study||22
2854451|NCT00053677|3556715|FG001|NOT COMPLETED|Overall Study||6
2854452|NCT00053703|3556724|FG000|STARTED|Overall Study||35
2854453|NCT00053703|3556725|FG001|STARTED|Overall Study||41
2854454|NCT00053703|3556726|FG002|STARTED|Overall Study||40
2854455|NCT00053703|3556724|FG000|COMPLETED|Overall Study||17
2854456|NCT00053703|3556725|FG001|COMPLETED|Overall Study||28
2854457|NCT00053703|3556726|FG002|COMPLETED|Overall Study||25
2854458|NCT00053703|3556724|FG000|NOT COMPLETED|Overall Study||18
2854459|NCT00053703|3556725|FG001|NOT COMPLETED|Overall Study||13
2854460|NCT00053703|3556726|FG002|NOT COMPLETED|Overall Study||15
2854461|NCT00053846|3556736|FG000|STARTED|Overall Study||213
2854462|NCT00053846|3556737|FG001|STARTED|Overall Study||219
2854463|NCT00053846|3556736|FG000|COMPLETED|Overall Study||187
2854464|NCT00053846|3556737|FG001|COMPLETED|Overall Study||192
2854465|NCT00053846|3556736|FG000|NOT COMPLETED|Overall Study||26
2854466|NCT00053846|3556737|FG001|NOT COMPLETED|Overall Study||27
2854467|NCT00053898|3556745|FG000|STARTED|Overall Study||1552
2854468|NCT00053898|3556746|FG001|STARTED|Overall Study||1552
2854469|NCT00053898|3556745|FG000|COMPLETED|Overall Study||1538
2854470|NCT00053898|3556746|FG001|COMPLETED|Overall Study||1539
2854471|NCT00053898|3556745|FG000|NOT COMPLETED|Overall Study||14
2854472|NCT00053898|3556746|FG001|NOT COMPLETED|Overall Study||13
2854473|NCT00053989|3556752|FG000|STARTED|Overall Study||41
2854474|NCT00053989|3556752|FG000|COMPLETED|Overall Study||41
2854475|NCT00053989|3556752|FG000|NOT COMPLETED|Overall Study||0
2854476|NCT00054028|3556758|FG000|STARTED|Overall Study||31
2854477|NCT00054028|3556758|FG000|Phase I|Overall Study||9
2854478|NCT00054028|3556758|FG000|Phase II|Overall Study||22
2854479|NCT00054028|3556758|FG000|COMPLETED|Overall Study||31
2854480|NCT00054028|3556758|FG000|NOT COMPLETED|Overall Study||0
2854481|NCT00054132|3556763|FG000|STARTED|Overall Study||38
2854482|NCT00054132|3556763|FG000|COMPLETED|Overall Study||37
2854483|NCT00054132|3556763|FG000|NOT COMPLETED|Overall Study||1
2854484|NCT00054275|3556768|FG000|STARTED|Overall Study||39
2854485|NCT00054275|3556768|FG000|COMPLETED|Overall Study||28
2854486|NCT00054275|3556768|FG000|NOT COMPLETED|Overall Study||11
2854487|NCT00054327|3556778|FG000|STARTED|Overall Study||11
2854488|NCT00054327|3556779|FG001|STARTED|Overall Study||4
2854489|NCT00054327|3556780|FG002|STARTED|Overall Study||3
2854490|NCT00054327|3556781|FG003|STARTED|Overall Study||4
2854491|NCT00054327|3556782|FG004|STARTED|Overall Study||10
2854492|NCT00054327|3556783|FG005|STARTED|Overall Study||2
2854493|NCT00054327|3556778|FG000|COMPLETED|Overall Study||10
2854494|NCT00054327|3556779|FG001|COMPLETED|Overall Study||4
2854495|NCT00054327|3556780|FG002|COMPLETED|Overall Study||3
2854496|NCT00054327|3556781|FG003|COMPLETED|Overall Study||4
2854497|NCT00054327|3556782|FG004|COMPLETED|Overall Study||10
2854498|NCT00054327|3556783|FG005|COMPLETED|Overall Study||2
2854499|NCT00054327|3556778|FG000|NOT COMPLETED|Overall Study||1
2854500|NCT00054327|3556779|FG001|NOT COMPLETED|Overall Study||0
2854501|NCT00054327|3556780|FG002|NOT COMPLETED|Overall Study||0
2854502|NCT00054327|3556781|FG003|NOT COMPLETED|Overall Study||0
2854503|NCT00054327|3556782|FG004|NOT COMPLETED|Overall Study||0
2854504|NCT00054327|3556783|FG005|NOT COMPLETED|Overall Study||0
2854505|NCT00054353|3556799|FG000|STARTED|Overall Study||12
2854506|NCT00054353|3556800|FG001|STARTED|Overall Study||4
2854507|NCT00054353|3556799|FG000|COMPLETED|Overall Study||12
2854508|NCT00054353|3556800|FG001|COMPLETED|Overall Study||4
2854509|NCT00054353|3556799|FG000|NOT COMPLETED|Overall Study||0
2854510|NCT00054353|3556800|FG001|NOT COMPLETED|Overall Study||0
2854511|NCT00054639|3556810|FG000|STARTED|Overall Study||48
2854512|NCT00054639|3556810|FG000|COMPLETED|Overall Study||46
2854513|NCT00054639|3556810|FG000|NOT COMPLETED|Overall Study||2
2854514|NCT00054665|3556814|FG000|STARTED|Part A|5 participants only received Part A and 18 participants received Part B after Part A.|23
2854515|NCT00054665|3556815|FG001|STARTED|Part A||0
2854516|NCT00054665|3556814|FG000|COMPLETED|Part A||23
2854517|NCT00054665|3556815|FG001|COMPLETED|Part A||0
2854518|NCT00054665|3556814|FG000|NOT COMPLETED|Part A||0
2854519|NCT00054665|3556815|FG001|NOT COMPLETED|Part A||0
2854520|NCT00054665|3556814|FG000|STARTED|Part B||0
2854521|NCT00054665|3556815|FG001|STARTED|Part B|26 participants received only Part B|44
2854522|NCT00054665|3556814|FG000|COMPLETED|Part B||0
2854523|NCT00054665|3556815|FG001|COMPLETED|Part B||44
2854524|NCT00054665|3556814|FG000|NOT COMPLETED|Part B||0
2854525|NCT00054665|3556815|FG001|NOT COMPLETED|Part B||0
2854526|NCT00054691|3556823|FG000|STARTED|Overall Study||40
2854527|NCT00054691|3556823|FG000|COMPLETED|Overall Study||37
2854528|NCT00054691|3556823|FG000|NOT COMPLETED|Overall Study||3
2854529|NCT00054704|3556829|FG000|STARTED|Overall Study||8
2854530|NCT00054704|3556830|FG001|STARTED|Overall Study||11
2854531|NCT00054704|3556829|FG000|COMPLETED|Overall Study||3
2854532|NCT00054704|3556830|FG001|COMPLETED|Overall Study||6
2854533|NCT00054704|3556829|FG000|NOT COMPLETED|Overall Study||5
2854534|NCT00054704|3556830|FG001|NOT COMPLETED|Overall Study||5
2854535|NCT00054717|3556838|FG000|STARTED|Overall Study||313
2854536|NCT00054717|3556839|FG001|STARTED|Overall Study||317
2854537|NCT00054717|3556838|FG000|COMPLETED|Overall Study||51
2854538|NCT00054717|3556839|FG001|COMPLETED|Overall Study||18
2854539|NCT00054717|3556838|FG000|NOT COMPLETED|Overall Study||262
2854540|NCT00054717|3556839|FG001|NOT COMPLETED|Overall Study||299
2854541|NCT00054756|3556845|FG000|STARTED|Overall Study||96
2854542|NCT00054756|3556845|FG000|COMPLETED|Overall Study||94
2854543|NCT00054756|3556845|FG000|NOT COMPLETED|Overall Study||2
2854544|NCT00054847|3556851|FG000|STARTED|Overall Study||367
2854545|NCT00054847|3556852|FG001|STARTED|Overall Study||366
2854546|NCT00054847|3556851|FG000|COMPLETED|Overall Study||269
2854547|NCT00054847|3556852|FG001|COMPLETED|Overall Study||266
2854548|NCT00054847|3556851|FG000|NOT COMPLETED|Overall Study||98
2854549|NCT00054847|3556852|FG001|NOT COMPLETED|Overall Study||100
2854550|NCT00055237|3556864|FG000|STARTED|Overall Study||17
2854551|NCT00055237|3556865|FG001|STARTED|Overall Study||2
2854552|NCT00055237|3556864|FG000|COMPLETED|Overall Study||17
2854553|NCT00055237|3556865|FG001|COMPLETED|Overall Study||2
2854554|NCT00055237|3556864|FG000|NOT COMPLETED|Overall Study||0
2854555|NCT00055237|3556865|FG001|NOT COMPLETED|Overall Study||0
2854556|NCT00055471|3556873|FG000|STARTED|Period 1: Dose Escalation Period||3
2854557|NCT00055471|3556874|FG001|STARTED|Period 1: Dose Escalation Period|Dose level given only after lower dose was successfully administered.|10
2854558|NCT00055471|3556875|FG002|STARTED|Period 1: Dose Escalation Period|Dose level given only after lower dose was successfully administered.|3
2854559|NCT00055471|3556873|FG000|COMPLETED|Period 1: Dose Escalation Period||3
2854560|NCT00055471|3556874|FG001|COMPLETED|Period 1: Dose Escalation Period||8
2854561|NCT00055471|3556875|FG002|COMPLETED|Period 1: Dose Escalation Period||0
2854562|NCT00055471|3556873|FG000|NOT COMPLETED|Period 1: Dose Escalation Period||0
2854563|NCT00055471|3556874|FG001|NOT COMPLETED|Period 1: Dose Escalation Period||2
2854564|NCT00055471|3556875|FG002|NOT COMPLETED|Period 1: Dose Escalation Period||3
2854565|NCT00055471|3556873|FG000|STARTED|Period 2: Extension Period|Period 2 - attend Pts who,in the opinion of the Investigator,show benefit from treatment with ZD4054|3
2854566|NCT00055471|3556874|FG001|STARTED|Period 2: Extension Period|2 pts discontinued after completion of Period1,therefore 9 pts proceeded to participate in Period2|6
2854567|NCT00055471|3556875|FG002|STARTED|Period 2: Extension Period||0
2854568|NCT00055471|3556873|FG000|COMPLETED|Period 2: Extension Period||3
2854569|NCT00055471|3556874|FG001|COMPLETED|Period 2: Extension Period||6
2854570|NCT00055471|3556875|FG002|COMPLETED|Period 2: Extension Period||0
2854571|NCT00055471|3556873|FG000|NOT COMPLETED|Period 2: Extension Period||0
2854572|NCT00055471|3556874|FG001|NOT COMPLETED|Period 2: Extension Period||0
2854573|NCT00055471|3556875|FG002|NOT COMPLETED|Period 2: Extension Period||0
2854574|NCT00055497|3556887|FG000|STARTED|Overall Study||18
2854575|NCT00055497|3556888|FG001|STARTED|Overall Study||19
2854576|NCT00055497|3556889|FG002|STARTED|Overall Study||18
2854577|NCT00055497|3556890|FG003|STARTED|Overall Study|17 participants who discontinued at/before Week 4 are counted here because they were not randomized.|221
2854578|NCT00055497|3556887|FG000|COMPLETED|Overall Study|Participants may have continued to the open-label extension study. See NCT01070303.|13
2854579|NCT00055497|3556888|FG001|COMPLETED|Overall Study|Participants may have continued to the open-label extension study. See NCT01070303.|16
2854580|NCT00055497|3556889|FG002|COMPLETED|Overall Study|Participants may have continued to the open-label extension study. See NCT01070303.|16
2854581|NCT00055497|3556890|FG003|COMPLETED|Overall Study|Participants may have continued to the open-label extension study. See NCT01070303.|131
2854582|NCT00055497|3556887|FG000|NOT COMPLETED|Overall Study||5
2854583|NCT00055497|3556888|FG001|NOT COMPLETED|Overall Study||3
2854584|NCT00055497|3556889|FG002|NOT COMPLETED|Overall Study||2
2854585|NCT00055497|3556890|FG003|NOT COMPLETED|Overall Study||90
2854586|NCT00055601|3556907|FG000|STARTED|Overall Study||48
2854587|NCT00055601|3556908|FG001|STARTED|Overall Study||49
2854588|NCT00055601|3556907|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|46
2854589|NCT00055601|3556908|FG001|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|47
2854590|NCT00055601|3556907|FG000|NOT COMPLETED|Overall Study||2
2854591|NCT00055601|3556908|FG001|NOT COMPLETED|Overall Study||2
2854592|NCT00055692|3556914|FG000|STARTED|Overall Study||46
2854593|NCT00055692|3556914|FG000|COMPLETED|Overall Study||46
2854594|NCT00055692|3556914|FG000|NOT COMPLETED|Overall Study||0
2854595|NCT00056160|3556922|FG000|STARTED|Up to Unblinding (07 Jun 2005)||177
2854596|NCT00056160|3556923|FG001|STARTED|Up to Unblinding (07 Jun 2005)||176
2854597|NCT00056160|3556922|FG000|COMPLETED|Up to Unblinding (07 Jun 2005)||64
2854598|NCT00056160|3556923|FG001|COMPLETED|Up to Unblinding (07 Jun 2005)||13
2854599|NCT00056160|3556922|FG000|NOT COMPLETED|Up to Unblinding (07 Jun 2005)||113
2854600|NCT00056160|3556923|FG001|NOT COMPLETED|Up to Unblinding (07 Jun 2005)||163
2854601|NCT00056160|3556922|FG000|STARTED|Extended Follow-up Cutoff (23 Jul 2008)||177
2854602|NCT00056160|3556923|FG001|STARTED|Extended Follow-up Cutoff (23 Jul 2008)||0
2854603|NCT00056160|3556922|FG000|COMPLETED|Extended Follow-up Cutoff (23 Jul 2008)||6
2854604|NCT00056160|3556923|FG001|COMPLETED|Extended Follow-up Cutoff (23 Jul 2008)||0
2854605|NCT00056160|3556922|FG000|NOT COMPLETED|Extended Follow-up Cutoff (23 Jul 2008)||171
2854606|NCT00056160|3556923|FG001|NOT COMPLETED|Extended Follow-up Cutoff (23 Jul 2008)||0
2854607|NCT00056160|3556922|FG000|STARTED|Final Follow-up||6
2854608|NCT00056160|3556923|FG001|STARTED|Final Follow-up||0
2854609|NCT00056160|3556922|FG000|COMPLETED|Final Follow-up||0
2854610|NCT00056160|3556923|FG001|COMPLETED|Final Follow-up||0
2854611|NCT00056160|3556922|FG000|NOT COMPLETED|Final Follow-up||6
2854612|NCT00056160|3556923|FG001|NOT COMPLETED|Final Follow-up||0
2854613|NCT00056316|3556931|FG000|STARTED|Overall Study||33
2854614|NCT00056316|3556932|FG001|STARTED|Overall Study|over-enrolled due to potential higher rates of drop-out.|41
2854615|NCT00056316|3556931|FG000|COMPLETED|Overall Study||30
2854616|NCT00056316|3556932|FG001|COMPLETED|Overall Study||38
2854617|NCT00056316|3556931|FG000|NOT COMPLETED|Overall Study||3
2854618|NCT00056316|3556932|FG001|NOT COMPLETED|Overall Study||3
2854619|NCT00056407|3556940|FG000|STARTED|Overall Study||4126
2854620|NCT00056407|3556941|FG001|STARTED|Overall Study||4105
2854621|NCT00056407|3556940|FG000|COMPLETED|Overall Study||2915
2854622|NCT00056407|3556941|FG001|COMPLETED|Overall Study||2912
2854623|NCT00056407|3556940|FG000|NOT COMPLETED|Overall Study||1211
2854624|NCT00056407|3556941|FG001|NOT COMPLETED|Overall Study||1193
2854625|NCT00056472|3556949|FG000|STARTED|Overall Study||129
2854626|NCT00056472|3556950|FG001|STARTED|Overall Study||130
2854627|NCT00056472|3556949|FG000|COMPLETED|Overall Study||81
2854628|NCT00056472|3556950|FG001|COMPLETED|Overall Study||61
2854629|NCT00056472|3556949|FG000|NOT COMPLETED|Overall Study||48
2854630|NCT00056472|3556950|FG001|NOT COMPLETED|Overall Study||69
2854631|NCT00056498|3556958|FG000|STARTED|Overall Study||30
2854632|NCT00056498|3556959|FG001|STARTED|Overall Study||35
2854633|NCT00056498|3556958|FG000|COMPLETED|Overall Study||25
2854634|NCT00056498|3556959|FG001|COMPLETED|Overall Study||28
2854635|NCT00056498|3556958|FG000|NOT COMPLETED|Overall Study||5
2854636|NCT00056498|3556959|FG001|NOT COMPLETED|Overall Study||7
2854637|NCT00056550|3556965|FG000|STARTED|Overall Study||14
2854638|NCT00056550|3556965|FG000|COMPLETED|Overall Study||14
2854639|NCT00056550|3556965|FG000|NOT COMPLETED|Overall Study||0
2854640|NCT00056563|3556972|FG000|STARTED|Overall Study||121
2854641|NCT00056563|3556973|FG001|STARTED|Overall Study||134
2854642|NCT00056563|3556972|FG000|COMPLETED|Overall Study||121
2854643|NCT00056563|3556973|FG001|COMPLETED|Overall Study||134
2854644|NCT00056563|3556972|FG000|NOT COMPLETED|Overall Study||0
2854645|NCT00056563|3556973|FG001|NOT COMPLETED|Overall Study||0
2854646|NCT00056862|3556981|FG000|STARTED|Overall Study||31
2854647|NCT00056862|3556982|FG001|STARTED|Overall Study||27
2854648|NCT00056862|3556981|FG000|COMPLETED|Overall Study||30
2854649|NCT00056862|3556982|FG001|COMPLETED|Overall Study||27
2854650|NCT00056862|3556981|FG000|NOT COMPLETED|Overall Study||1
2854651|NCT00056862|3556982|FG001|NOT COMPLETED|Overall Study||0
2854652|NCT00057330|3556990|FG000|STARTED|Overall Study||4577
2854653|NCT00057330|3556991|FG001|STARTED|Overall Study||3746
2854654|NCT00057330|3556990|FG000|COMPLETED|Overall Study||3445
2854655|NCT00057330|3556991|FG001|COMPLETED|Overall Study||2826
2854656|NCT00057330|3556990|FG000|NOT COMPLETED|Overall Study||1132
2854657|NCT00057330|3556991|FG001|NOT COMPLETED|Overall Study||920
2854658|NCT00057551|3557000|FG000|STARTED|Overall Study||200
2854659|NCT00057551|3557001|FG001|STARTED|Overall Study||195
2854660|NCT00057551|3557002|FG002|STARTED|Overall Study||96
2854661|NCT00057551|3557000|FG000|COMPLETED|Overall Study||175
2854662|NCT00057551|3557001|FG001|COMPLETED|Overall Study||168
2854663|NCT00057551|3557002|FG002|COMPLETED|Overall Study||80
2854664|NCT00057551|3557000|FG000|NOT COMPLETED|Overall Study||25
2854665|NCT00057551|3557001|FG001|NOT COMPLETED|Overall Study||27
2854666|NCT00057551|3557002|FG002|NOT COMPLETED|Overall Study||16
2854667|NCT00057577|3557012|FG000|STARTED|Overall Study||227
2854668|NCT00057577|3557013|FG001|STARTED|Overall Study||225
2854669|NCT00057577|3557012|FG000|COMPLETED|Overall Study||227
2854670|NCT00057577|3557013|FG001|COMPLETED|Overall Study||225
2854671|NCT00057577|3557012|FG000|NOT COMPLETED|Overall Study||0
2854672|NCT00057577|3557013|FG001|NOT COMPLETED|Overall Study||0
2918208|NCT00525499|3628375|FG001|NOT COMPLETED|Overall Study||7
2918209|NCT00525499|3628376|FG002|NOT COMPLETED|Overall Study||7
2854673|NCT00057681|3557027|FG000|STARTED|Overall Study||137
2854674|NCT00057681|3557028|FG001|STARTED|Overall Study||139
2854675|NCT00057681|3557029|FG002|STARTED|Overall Study||103
2854676|NCT00057681|3557027|FG000|COMPLETED|Overall Study||72
2854677|NCT00057681|3557028|FG001|COMPLETED|Overall Study||67
2854678|NCT00057681|3557029|FG002|COMPLETED|Overall Study||69
2854679|NCT00057681|3557027|FG000|NOT COMPLETED|Overall Study||65
2854680|NCT00057681|3557028|FG001|NOT COMPLETED|Overall Study||72
2854681|NCT00057681|3557029|FG002|NOT COMPLETED|Overall Study||34
2854682|NCT00057746|3557040|FG000|STARTED|Overall Study||131
2854683|NCT00057746|3557041|FG001|STARTED|Overall Study||67
2854684|NCT00057746|3557042|FG002|STARTED|Overall Study||67
2854685|NCT00057746|3557040|FG000|COMPLETED|Overall Study||131
2854686|NCT00057746|3557041|FG001|COMPLETED|Overall Study||67
2854687|NCT00057746|3557042|FG002|COMPLETED|Overall Study||66
2854688|NCT00057746|3557040|FG000|NOT COMPLETED|Overall Study||0
2854689|NCT00057746|3557041|FG001|NOT COMPLETED|Overall Study||0
2854690|NCT00057746|3557042|FG002|NOT COMPLETED|Overall Study||1
2854691|NCT00057785|3557050|FG000|STARTED|Overall Study||68
2854692|NCT00057785|3557050|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|68
2854693|NCT00057785|3557050|FG000|NOT COMPLETED|Overall Study||0
2854694|NCT00057811|3557056|FG000|STARTED|Overall Study||51
2854695|NCT00057811|3557057|FG001|STARTED|Overall Study||46
2854696|NCT00057811|3557056|FG000|COMPLETED|Overall Study||41
2854697|NCT00057811|3557057|FG001|COMPLETED|Overall Study||34
2854698|NCT00057811|3557056|FG000|NOT COMPLETED|Overall Study||10
2854699|NCT00057811|3557057|FG001|NOT COMPLETED|Overall Study||12
2854700|NCT00057837|3557065|FG000|STARTED|Overall Study||70
2854701|NCT00057837|3557066|FG001|STARTED|Overall Study||70
2854702|NCT00057837|3557065|FG000|Treated|Overall Study||69
2854703|NCT00057837|3557066|FG001|Treated|Overall Study||68
2854704|NCT00057837|3557065|FG000|Eligible and Treated|Overall Study||66
2854705|NCT00057837|3557066|FG001|Eligible and Treated|Overall Study||66
2854706|NCT00057837|3557065|FG000|Patients With Response|Overall Study||46
2854707|NCT00057837|3557066|FG001|Patients With Response|Overall Study||38
2854708|NCT00057837|3557065|FG000|COMPLETED|Overall Study||39
2854709|NCT00057837|3557066|FG001|COMPLETED|Overall Study||31
2854710|NCT00057837|3557065|FG000|NOT COMPLETED|Overall Study||31
2854711|NCT00057837|3557066|FG001|NOT COMPLETED|Overall Study||39
2854712|NCT00057863|3557072|FG000|STARTED|Overall Study||35
2854713|NCT00057863|3557072|FG000|COMPLETED|Overall Study||32
2854714|NCT00057863|3557072|FG000|NOT COMPLETED|Overall Study||3
2854715|NCT00057876|3557078|FG000|STARTED|Overall Study||38
2854716|NCT00057876|3557079|FG001|STARTED|Overall Study||36
2854717|NCT00057876|3557078|FG000|Eligible|Overall Study||37
2854718|NCT00057876|3557079|FG001|Eligible|Overall Study||34
2854719|NCT00057876|3557078|FG000|Began Protocol Therapy|Overall Study||35
2854720|NCT00057876|3557079|FG001|Began Protocol Therapy|Overall Study||34
2854721|NCT00057876|3557078|FG000|Eligible and Treated|Overall Study||34
2854722|NCT00057876|3557079|FG001|Eligible and Treated|Overall Study||34
2854723|NCT00057876|3557078|FG000|COMPLETED|Overall Study||9
2854724|NCT00057876|3557079|FG001|COMPLETED|Overall Study||9
2854725|NCT00057876|3557078|FG000|NOT COMPLETED|Overall Study||29
2854726|NCT00057876|3557079|FG001|NOT COMPLETED|Overall Study||27
2854727|NCT00057941|3557087|FG000|STARTED|Overall Study||74
2854728|NCT00057941|3557088|FG001|STARTED|Overall Study||74
2854729|NCT00057941|3557087|FG000|Treated|Overall Study||74
2854730|NCT00057941|3557088|FG001|Treated|Overall Study||74
2854731|NCT00057941|3557087|FG000|Eligible|Overall Study||72
2854732|NCT00057941|3557088|FG001|Eligible|Overall Study||69
2854733|NCT00057941|3557087|FG000|COMPLETED|Overall Study||0
2854734|NCT00057941|3557088|FG001|COMPLETED|Overall Study||0
2854735|NCT00057941|3557087|FG000|NOT COMPLETED|Overall Study||74
2854736|NCT00057941|3557088|FG001|NOT COMPLETED|Overall Study||74
2854737|NCT00057954|3557094|FG000|STARTED|Overall Study||6
2854738|NCT00057954|3557094|FG000|COMPLETED|Overall Study||4
2854739|NCT00057954|3557094|FG000|NOT COMPLETED|Overall Study||2
2854740|NCT00058019|3557100|FG000|STARTED|Overall Study||39
2854741|NCT00058019|3557101|FG001|STARTED|Overall Study||12
2854742|NCT00058019|3557100|FG000|COMPLETED|Overall Study||39
2854743|NCT00058019|3557101|FG001|COMPLETED|Overall Study||12
2854744|NCT00058019|3557100|FG000|NOT COMPLETED|Overall Study||0
2854745|NCT00058019|3557101|FG001|NOT COMPLETED|Overall Study||0
2854746|NCT00058058|3557106|FG000|STARTED|Overall Study||1007
2854747|NCT00058058|3557106|FG000|COMPLETED|Overall Study||969
3168642|NCT01920061|3895957|FG018|COMPLETED|Overall Study||4
3168643|NCT01920061|3895958|FG019|COMPLETED|Overall Study||8
3168644|NCT01920061|3895939|FG000|NOT COMPLETED|Overall Study||2
3168645|NCT01920061|3895940|FG001|NOT COMPLETED|Overall Study||4
3168646|NCT01920061|3895941|FG002|NOT COMPLETED|Overall Study||2
3168647|NCT01920061|3895942|FG003|NOT COMPLETED|Overall Study||2
2854748|NCT00058058|3557106|FG000|NOT COMPLETED|Overall Study||38
2854749|NCT00058123|3557111|FG000|STARTED|Overall Study||55
2854750|NCT00058123|3557111|FG000|COMPLETED|Overall Study||45
2854751|NCT00058123|3557111|FG000|NOT COMPLETED|Overall Study||10
2854752|NCT00058214|3557116|FG000|STARTED|Overall Study||25
2854753|NCT00058214|3557116|FG000|COMPLETED|Overall Study||24
2854754|NCT00058214|3557116|FG000|NOT COMPLETED|Overall Study||1
2854755|NCT00058240|3557124|FG000|STARTED|First Dose Level||20
2854756|NCT00058240|3557125|FG001|STARTED|First Dose Level||3
2854757|NCT00058240|3557126|FG002|STARTED|First Dose Level||17
2854758|NCT00058240|3557127|FG003|STARTED|First Dose Level||12
2854759|NCT00058240|3557124|FG000|Treated|First Dose Level||20
2854760|NCT00058240|3557125|FG001|Treated|First Dose Level||3
2854761|NCT00058240|3557126|FG002|Treated|First Dose Level||17
2854762|NCT00058240|3557127|FG003|Treated|First Dose Level||12
2854763|NCT00058240|3557124|FG000|COMPLETED|First Dose Level||20
2854764|NCT00058240|3557125|FG001|COMPLETED|First Dose Level||3
2854765|NCT00058240|3557126|FG002|COMPLETED|First Dose Level||17
2854766|NCT00058240|3557127|FG003|COMPLETED|First Dose Level||12
2854767|NCT00058240|3557124|FG000|NOT COMPLETED|First Dose Level||0
2854768|NCT00058240|3557125|FG001|NOT COMPLETED|First Dose Level||0
2854769|NCT00058240|3557126|FG002|NOT COMPLETED|First Dose Level||0
2854770|NCT00058240|3557127|FG003|NOT COMPLETED|First Dose Level||0
2854771|NCT00058240|3557124|FG000|STARTED|Second Dose Level||0
2854772|NCT00058240|3557125|FG001|STARTED|Second Dose Level||0
2854773|NCT00058240|3557126|FG002|STARTED|Second Dose Level|2 patients were previously treated at Dose level 1, relapsed, and retreated at Dose level 3.|2
2854774|NCT00058240|3557127|FG003|STARTED|Second Dose Level|4 patients previously relapsed on a different Dose level and were retreated at Dose level 4.|4
2854775|NCT00058240|3557124|FG000|COMPLETED|Second Dose Level||0
2854776|NCT00058240|3557125|FG001|COMPLETED|Second Dose Level||0
2854777|NCT00058240|3557126|FG002|COMPLETED|Second Dose Level||2
2854778|NCT00058240|3557127|FG003|COMPLETED|Second Dose Level||4
2854779|NCT00058240|3557124|FG000|NOT COMPLETED|Second Dose Level||0
2854780|NCT00058240|3557125|FG001|NOT COMPLETED|Second Dose Level||0
2854781|NCT00058240|3557126|FG002|NOT COMPLETED|Second Dose Level||0
2854782|NCT00058240|3557127|FG003|NOT COMPLETED|Second Dose Level||0
2854783|NCT00058370|3557137|FG000|STARTED|Overall Study||6
2854784|NCT00058370|3557137|FG000|COMPLETED|Overall Study||6
2854785|NCT00058370|3557137|FG000|NOT COMPLETED|Overall Study||0
2854786|NCT00058422|3557141|FG000|STARTED|Overall Study||65
2854787|NCT00058422|3557141|FG000|COMPLETED|Overall Study||63
2854788|NCT00058422|3557141|FG000|NOT COMPLETED|Overall Study||2
2854789|NCT00058539|3557145|FG000|STARTED|Overall Study||42
2854790|NCT00058539|3557145|FG000|COMPLETED|Overall Study||0
2854791|NCT00058539|3557145|FG000|NOT COMPLETED|Overall Study||42
2854792|NCT00058552|3557151|FG000|STARTED|Overall Study||65
2854793|NCT00058552|3557152|FG001|STARTED|Overall Study||64
2854794|NCT00058552|3557151|FG000|COMPLETED|Overall Study||0
2854795|NCT00058552|3557152|FG001|COMPLETED|Overall Study||2
2854796|NCT00058552|3557151|FG000|NOT COMPLETED|Overall Study||65
2854797|NCT00058552|3557152|FG001|NOT COMPLETED|Overall Study||62
2854798|NCT00058825|3557160|FG000|STARTED|Overall Study||27
2854799|NCT00058825|3557160|FG000|COMPLETED|Overall Study||5
2854800|NCT00058825|3557160|FG000|NOT COMPLETED|Overall Study||22
2854801|NCT00059202|3557168|FG000|STARTED|Overall Study||76
2854802|NCT00059202|3557169|FG001|STARTED|Overall Study||74
2854803|NCT00059202|3557168|FG000|COMPLETED|Overall Study||70
2854804|NCT00059202|3557169|FG001|COMPLETED|Overall Study||59
2854805|NCT00059202|3557168|FG000|NOT COMPLETED|Overall Study||6
2854806|NCT00059202|3557169|FG001|NOT COMPLETED|Overall Study||15
2854807|NCT00059215|3557182|FG000|STARTED|Overall Study||200
2854808|NCT00059215|3557183|FG001|STARTED|Overall Study||200
2854809|NCT00059215|3557184|FG002|STARTED|Overall Study||251
2854810|NCT00059215|3557185|FG003|STARTED|Overall Study||254
2854811|NCT00059215|3557182|FG000|COMPLETED|Overall Study|One subject discontinued before receiving treatment and is not included in the evaluable set.|187
2854812|NCT00059215|3557183|FG001|COMPLETED|Overall Study||186
2854813|NCT00059215|3557184|FG002|COMPLETED|Overall Study||236
2854814|NCT00059215|3557185|FG003|COMPLETED|Overall Study||239
2854815|NCT00059215|3557182|FG000|NOT COMPLETED|Overall Study||13
2854816|NCT00059215|3557183|FG001|NOT COMPLETED|Overall Study||14
2854817|NCT00059215|3557184|FG002|NOT COMPLETED|Overall Study||15
2854818|NCT00059215|3557185|FG003|NOT COMPLETED|Overall Study||15
2854819|NCT00059228|3557198|FG000|STARTED|Overall Study||6
2854820|NCT00059228|3557199|FG001|STARTED|Overall Study||6
2854821|NCT00059228|3557198|FG000|COMPLETED|Overall Study||6
2854822|NCT00059228|3557199|FG001|COMPLETED|Overall Study||5
2854823|NCT00059228|3557198|FG000|NOT COMPLETED|Overall Study||0
2854824|NCT00059228|3557199|FG001|NOT COMPLETED|Overall Study||1
2854825|NCT00059332|3557207|FG000|STARTED|Overall Study||843
2854826|NCT00059332|3557208|FG001|STARTED|Overall Study||857
2854827|NCT00059332|3557207|FG000|COMPLETED|Overall Study||840
2854828|NCT00059332|3557208|FG001|COMPLETED|Overall Study||855
2854829|NCT00059332|3557207|FG000|NOT COMPLETED|Overall Study||3
2854830|NCT00059332|3557208|FG001|NOT COMPLETED|Overall Study||2
2854831|NCT00059475|3557222|FG000|STARTED|Overall Study||33
2854832|NCT00059475|3557223|FG001|STARTED|Overall Study||2
2854833|NCT00059475|3557224|FG002|STARTED|Overall Study||24
2854834|NCT00059475|3557225|FG003|STARTED|Overall Study||3
2854835|NCT00059475|3557226|FG004|STARTED|Overall Study||33
2854836|NCT00059475|3557227|FG005|STARTED|Overall Study||2
2854837|NCT00059475|3557228|FG006|STARTED|Overall Study||34
2854838|NCT00059475|3557229|FG007|STARTED|Overall Study||7
2854839|NCT00059475|3557222|FG000|COMPLETED|Overall Study||33
2854840|NCT00059475|3557223|FG001|COMPLETED|Overall Study||2
2854841|NCT00059475|3557224|FG002|COMPLETED|Overall Study||24
2854842|NCT00059475|3557225|FG003|COMPLETED|Overall Study||3
2854843|NCT00059475|3557226|FG004|COMPLETED|Overall Study||33
2854844|NCT00059475|3557227|FG005|COMPLETED|Overall Study||2
2854845|NCT00059475|3557228|FG006|COMPLETED|Overall Study||34
2854846|NCT00059475|3557229|FG007|COMPLETED|Overall Study||7
2854847|NCT00059475|3557222|FG000|NOT COMPLETED|Overall Study||0
2854848|NCT00059475|3557223|FG001|NOT COMPLETED|Overall Study||0
2854849|NCT00059475|3557224|FG002|NOT COMPLETED|Overall Study||0
2854850|NCT00059475|3557225|FG003|NOT COMPLETED|Overall Study||0
2854851|NCT00059475|3557226|FG004|NOT COMPLETED|Overall Study||0
2854852|NCT00059475|3557227|FG005|NOT COMPLETED|Overall Study||0
2854853|NCT00059475|3557228|FG006|NOT COMPLETED|Overall Study||0
2854854|NCT00059475|3557229|FG007|NOT COMPLETED|Overall Study||0
2854855|NCT00059787|3557254|FG000|STARTED|Overall Study||56
2854856|NCT00059787|3557254|FG000|COMPLETED|Overall Study||36
2854857|NCT00059787|3557254|FG000|NOT COMPLETED|Overall Study||20
2854858|NCT00059839|3557261|FG000|STARTED|Overall Study||65
2854859|NCT00059839|3557262|FG001|STARTED|Overall Study||64
2854860|NCT00059839|3557261|FG000|COMPLETED|Overall Study||53
2854861|NCT00059839|3557262|FG001|COMPLETED|Overall Study||47
2854862|NCT00059839|3557261|FG000|NOT COMPLETED|Overall Study||12
2854863|NCT00059839|3557262|FG001|NOT COMPLETED|Overall Study||17
2854864|NCT00060008|3557268|FG000|STARTED|Overall Study||18
2854865|NCT00060008|3557268|FG000|COMPLETED|Overall Study||18
2854866|NCT00060008|3557268|FG000|NOT COMPLETED|Overall Study||0
2854867|NCT00060333|3557273|FG000|STARTED|Overall Study||20
2854868|NCT00060333|3557273|FG000|COMPLETED|Overall Study||20
2854869|NCT00060333|3557273|FG000|NOT COMPLETED|Overall Study||0
2854870|NCT00060346|3557280|FG000|STARTED|Overall Study||16
2854871|NCT00060346|3557280|FG000|Eligible and Treated|Overall Study||16
2854872|NCT00060346|3557280|FG000|COMPLETED|Overall Study||16
2854873|NCT00060346|3557280|FG000|NOT COMPLETED|Overall Study||0
2854874|NCT00060424|3557284|FG000|STARTED|Overall Study||21
2854875|NCT00060424|3557284|FG000|COMPLETED|Overall Study||21
2854876|NCT00060424|3557284|FG000|NOT COMPLETED|Overall Study||0
2854877|NCT00060528|3557288|FG000|STARTED|Overall Study|32 participants are reported for the phase II portion.|8
2854878|NCT00060528|3557289|FG001|STARTED|Overall Study||9
2854879|NCT00060528|3557290|FG002|STARTED|Overall Study||7
2854880|NCT00060528|3557291|FG003|STARTED|Overall Study||8
2854881|NCT00060528|3557288|FG000|COMPLETED|Overall Study||8
2854882|NCT00060528|3557289|FG001|COMPLETED|Overall Study||9
2854883|NCT00060528|3557290|FG002|COMPLETED|Overall Study||7
2854884|NCT00060528|3557291|FG003|COMPLETED|Overall Study||8
2854885|NCT00060528|3557288|FG000|NOT COMPLETED|Overall Study||0
2854886|NCT00060528|3557289|FG001|NOT COMPLETED|Overall Study||0
2854887|NCT00060528|3557290|FG002|NOT COMPLETED|Overall Study||0
2854888|NCT00060528|3557291|FG003|NOT COMPLETED|Overall Study||0
2854889|NCT00060606|3557306|FG000|STARTED|Overall Study||91
2854890|NCT00060606|3557307|FG001|STARTED|Overall Study||92
2854891|NCT00060606|3557306|FG000|First Primary Outcome - Shunt at 12 Mont|Overall Study||91
2854892|NCT00060606|3557307|FG001|First Primary Outcome - Shunt at 12 Mont|Overall Study||92
2854893|NCT00060606|3557306|FG000|COMPLETED|Overall Study||91
2854894|NCT00060606|3557307|FG001|COMPLETED|Overall Study||91
2854895|NCT00060606|3557306|FG000|NOT COMPLETED|Overall Study||0
2854896|NCT00060606|3557307|FG001|NOT COMPLETED|Overall Study||1
2854897|NCT00060840|3557315|FG000|STARTED|Overall Study||73
2854898|NCT00060840|3557316|FG001|STARTED|Overall Study||77
2854899|NCT00060840|3557315|FG000|COMPLETED|Overall Study||69
2854900|NCT00060840|3557316|FG001|COMPLETED|Overall Study||68
2854901|NCT00060840|3557315|FG000|NOT COMPLETED|Overall Study||4
2854902|NCT00060840|3557316|FG001|NOT COMPLETED|Overall Study||9
2854903|NCT00060944|3557324|FG000|STARTED|Overall Study||136
2854904|NCT00060944|3557325|FG001|STARTED|Overall Study||134
2854905|NCT00060944|3557324|FG000|Treated|Overall Study||130
2854906|NCT00060944|3557325|FG001|Treated|Overall Study||130
2854907|NCT00060944|3557324|FG000|COMPLETED|Overall Study||0
2854908|NCT00060944|3557325|FG001|COMPLETED|Overall Study||0
2854909|NCT00060944|3557324|FG000|NOT COMPLETED|Overall Study||136
2854910|NCT00060944|3557325|FG001|NOT COMPLETED|Overall Study||134
2854911|NCT00061048|3557331|FG000|STARTED|Overall Study||29
2854912|NCT00061048|3557331|FG000|COMPLETED|Overall Study|Began protocol specified follow-up period.|7
2854913|NCT00061048|3557331|FG000|NOT COMPLETED|Overall Study||22
2854914|NCT00061373|3557337|FG000|STARTED|Overall Study||15
2854915|NCT00061373|3557338|FG001|STARTED|Overall Study||3
2854916|NCT00061373|3557337|FG000|Aspirin and Tinzaparin|Overall Study||15
2854917|NCT00061373|3557338|FG001|Aspirin and Tinzaparin|Overall Study||3
2854918|NCT00061373|3557337|FG000|COMPLETED|Overall Study||15
2854919|NCT00061373|3557338|FG001|COMPLETED|Overall Study||3
2854920|NCT00061373|3557337|FG000|NOT COMPLETED|Overall Study||0
2854921|NCT00061373|3557338|FG001|NOT COMPLETED|Overall Study||0
2854922|NCT00061633|3557346|FG000|STARTED|Overall Study||84
2854923|NCT00061633|3557347|FG001|STARTED|Overall Study||85
2854924|NCT00061633|3557346|FG000|COMPLETED|Overall Study||79
2854925|NCT00061633|3557347|FG001|COMPLETED|Overall Study||74
2854926|NCT00061633|3557346|FG000|NOT COMPLETED|Overall Study||5
2854927|NCT00061633|3557347|FG001|NOT COMPLETED|Overall Study||11
2854928|NCT00061893|3557353|FG000|STARTED|Overall Study||38
2854929|NCT00061893|3557353|FG000|COMPLETED|Overall Study||20
2854930|NCT00061893|3557353|FG000|NOT COMPLETED|Overall Study||18
2854931|NCT00061932|3557359|FG000|STARTED|Overall Study||29
2854932|NCT00061932|3557360|FG001|STARTED|Overall Study||12
2854933|NCT00061932|3557359|FG000|COMPLETED|Overall Study||16
2854934|NCT00061932|3557360|FG001|COMPLETED|Overall Study||8
2854935|NCT00061932|3557359|FG000|NOT COMPLETED|Overall Study||13
2854936|NCT00061932|3557360|FG001|NOT COMPLETED|Overall Study||4
2854937|NCT00061945|3557369|FG000|STARTED|Registration Through Course 3||119
2854938|NCT00061945|3557370|FG001|STARTED|Registration Through Course 3||181
2854939|NCT00061945|3557369|FG000|COMPLETED|Registration Through Course 3||25
2854940|NCT00061945|3557370|FG001|COMPLETED|Registration Through Course 3||66
2854941|NCT00061945|3557369|FG000|NOT COMPLETED|Registration Through Course 3||94
2854942|NCT00061945|3557370|FG001|NOT COMPLETED|Registration Through Course 3||115
2854943|NCT00061945|3557369|FG000|STARTED|Course IV: Alemtuzumab||25
2854944|NCT00061945|3557370|FG001|STARTED|Course IV: Alemtuzumab||66
2854945|NCT00061945|3557369|FG000|COMPLETED|Course IV: Alemtuzumab||18
2854946|NCT00061945|3557370|FG001|COMPLETED|Course IV: Alemtuzumab||50
2854947|NCT00061945|3557369|FG000|NOT COMPLETED|Course IV: Alemtuzumab||7
2854948|NCT00061945|3557370|FG001|NOT COMPLETED|Course IV: Alemtuzumab||16
2854949|NCT00062010|3557378|FG000|STARTED|Overall Study||37
2854950|NCT00062010|3557378|FG000|Eligible and Treated|Overall Study||34
2854951|NCT00062010|3557378|FG000|COMPLETED|Overall Study||34
2854952|NCT00062010|3557378|FG000|NOT COMPLETED|Overall Study||3
2854953|NCT00062166|3557382|FG000|STARTED|Overall Study||340
2854954|NCT00062166|3557382|FG000|COMPLETED|Overall Study||334
2854955|NCT00062166|3557382|FG000|NOT COMPLETED|Overall Study||6
2854956|NCT00062374|3557387|FG000|STARTED|Overall Study||55
2854957|NCT00062374|3557387|FG000|COMPLETED|Overall Study||43
2854958|NCT00062374|3557387|FG000|NOT COMPLETED|Overall Study||12
2854959|NCT00062439|3557391|FG000|STARTED|Induction Chemotherapy + Radiotherapy||46
2854960|NCT00062439|3557391|FG000|COMPLETED|Induction Chemotherapy + Radiotherapy||38
2854961|NCT00062439|3557391|FG000|NOT COMPLETED|Induction Chemotherapy + Radiotherapy||8
2854962|NCT00062439|3557391|FG000|STARTED|Post Chemoradiation Assessment||38
2854963|NCT00062439|3557391|FG000|COMPLETED|Post Chemoradiation Assessment||29
2854964|NCT00062439|3557391|FG000|NOT COMPLETED|Post Chemoradiation Assessment||9
2854965|NCT00062439|3557391|FG000|STARTED|Surgery||29
2854966|NCT00062439|3557391|FG000|COMPLETED|Surgery||22
2854967|NCT00062439|3557391|FG000|NOT COMPLETED|Surgery||7
2854968|NCT00062439|3557391|FG000|STARTED|Consolidation Chemotherapy||22
2854969|NCT00062439|3557391|FG000|COMPLETED|Consolidation Chemotherapy||20
2854970|NCT00062439|3557391|FG000|NOT COMPLETED|Consolidation Chemotherapy||2
2854971|NCT00062647|3557402|FG000|STARTED|Overall Study||30
2854972|NCT00062647|3557403|FG001|STARTED|Overall Study||30
2854973|NCT00062647|3557402|FG000|COMPLETED|Overall Study||14
2854974|NCT00062647|3557403|FG001|COMPLETED|Overall Study||17
2854975|NCT00062647|3557402|FG000|NOT COMPLETED|Overall Study||16
2854976|NCT00062647|3557403|FG001|NOT COMPLETED|Overall Study||13
2854977|NCT00062738|3557412|FG000|STARTED|Overall Study||17
2854978|NCT00062738|3557413|FG001|STARTED|Overall Study||18
2854979|NCT00062738|3557414|FG002|STARTED|Overall Study||17
2854980|NCT00062738|3557412|FG000|COMPLETED|Overall Study||17
2854981|NCT00062738|3557413|FG001|COMPLETED|Overall Study||18
2854982|NCT00062738|3557414|FG002|COMPLETED|Overall Study||17
2854983|NCT00062738|3557412|FG000|NOT COMPLETED|Overall Study||0
2854984|NCT00062738|3557413|FG001|NOT COMPLETED|Overall Study||0
2854985|NCT00062738|3557414|FG002|NOT COMPLETED|Overall Study||0
2854986|NCT00062764|3557425|FG000|STARTED|Overall Study||18
2854987|NCT00062764|3557425|FG000|COMPLETED|Overall Study||18
2854988|NCT00062764|3557425|FG000|NOT COMPLETED|Overall Study||0
2854989|NCT00062868|3557450|FG000|STARTED|Dose Level 1||3
2854990|NCT00062868|3557451|FG001|STARTED|Dose Level 1||0
2854991|NCT00062868|3557452|FG002|STARTED|Dose Level 1||0
2854992|NCT00062868|3557453|FG003|STARTED|Dose Level 1||3
2854993|NCT00062868|3557454|FG004|STARTED|Dose Level 1||0
2854994|NCT00062868|3557455|FG005|STARTED|Dose Level 1||0
2854995|NCT00062868|3557456|FG006|STARTED|Dose Level 1||4
2854996|NCT00062868|3557457|FG007|STARTED|Dose Level 1||0
2854997|NCT00062868|3557458|FG008|STARTED|Dose Level 1||0
2854998|NCT00062868|3557459|FG009|STARTED|Dose Level 1||3
2854999|NCT00062868|3557460|FG010|STARTED|Dose Level 1||0
2855000|NCT00062868|3557461|FG011|STARTED|Dose Level 1||0
2855001|NCT00062868|3557462|FG012|STARTED|Dose Level 1||3
2855002|NCT00062868|3557463|FG013|STARTED|Dose Level 1||0
2855003|NCT00062868|3557464|FG014|STARTED|Dose Level 1||0
2855004|NCT00062868|3557465|FG015|STARTED|Dose Level 1||3
2855005|NCT00062868|3557466|FG016|STARTED|Dose Level 1||0
2855006|NCT00062868|3557467|FG017|STARTED|Dose Level 1||0
2855007|NCT00062868|3557468|FG018|STARTED|Dose Level 1||16
2855008|NCT00062868|3557469|FG019|STARTED|Dose Level 1||2
2855009|NCT00062868|3557470|FG020|STARTED|Dose Level 1||3
2855010|NCT00062868|3557450|FG000|COMPLETED|Dose Level 1||1
2855011|NCT00062868|3557451|FG001|COMPLETED|Dose Level 1||0
2855012|NCT00062868|3557452|FG002|COMPLETED|Dose Level 1||0
2855013|NCT00062868|3557453|FG003|COMPLETED|Dose Level 1||1
2855014|NCT00062868|3557454|FG004|COMPLETED|Dose Level 1||0
2855015|NCT00062868|3557455|FG005|COMPLETED|Dose Level 1||0
2855016|NCT00062868|3557456|FG006|COMPLETED|Dose Level 1||1
2855017|NCT00062868|3557457|FG007|COMPLETED|Dose Level 1||0
2855018|NCT00062868|3557458|FG008|COMPLETED|Dose Level 1||0
2855019|NCT00062868|3557459|FG009|COMPLETED|Dose Level 1||3
2855020|NCT00062868|3557460|FG010|COMPLETED|Dose Level 1||0
2855021|NCT00062868|3557461|FG011|COMPLETED|Dose Level 1||0
2855022|NCT00062868|3557462|FG012|COMPLETED|Dose Level 1||2
2855023|NCT00062868|3557463|FG013|COMPLETED|Dose Level 1||0
2855024|NCT00062868|3557464|FG014|COMPLETED|Dose Level 1||0
2855025|NCT00062868|3557465|FG015|COMPLETED|Dose Level 1||3
2855026|NCT00062868|3557466|FG016|COMPLETED|Dose Level 1||0
2855027|NCT00062868|3557467|FG017|COMPLETED|Dose Level 1||0
2855028|NCT00062868|3557468|FG018|COMPLETED|Dose Level 1||7
2855029|NCT00062868|3557469|FG019|COMPLETED|Dose Level 1||2
2855030|NCT00062868|3557470|FG020|COMPLETED|Dose Level 1||1
2855031|NCT00062868|3557450|FG000|NOT COMPLETED|Dose Level 1||2
2855032|NCT00062868|3557451|FG001|NOT COMPLETED|Dose Level 1||0
2855033|NCT00062868|3557452|FG002|NOT COMPLETED|Dose Level 1||0
2855034|NCT00062868|3557453|FG003|NOT COMPLETED|Dose Level 1||2
2855035|NCT00062868|3557454|FG004|NOT COMPLETED|Dose Level 1||0
2855036|NCT00062868|3557455|FG005|NOT COMPLETED|Dose Level 1||0
2855037|NCT00062868|3557456|FG006|NOT COMPLETED|Dose Level 1||3
2855038|NCT00062868|3557457|FG007|NOT COMPLETED|Dose Level 1||0
2855039|NCT00062868|3557458|FG008|NOT COMPLETED|Dose Level 1||0
2855040|NCT00062868|3557459|FG009|NOT COMPLETED|Dose Level 1||0
2855041|NCT00062868|3557460|FG010|NOT COMPLETED|Dose Level 1||0
2855042|NCT00062868|3557461|FG011|NOT COMPLETED|Dose Level 1||0
2855043|NCT00062868|3557462|FG012|NOT COMPLETED|Dose Level 1||1
2855044|NCT00062868|3557463|FG013|NOT COMPLETED|Dose Level 1||0
2855045|NCT00062868|3557464|FG014|NOT COMPLETED|Dose Level 1||0
2855046|NCT00062868|3557465|FG015|NOT COMPLETED|Dose Level 1||0
2855047|NCT00062868|3557466|FG016|NOT COMPLETED|Dose Level 1||0
2855048|NCT00062868|3557467|FG017|NOT COMPLETED|Dose Level 1||0
2855049|NCT00062868|3557468|FG018|NOT COMPLETED|Dose Level 1||9
2855050|NCT00062868|3557469|FG019|NOT COMPLETED|Dose Level 1||0
2855051|NCT00062868|3557470|FG020|NOT COMPLETED|Dose Level 1||2
2855052|NCT00062868|3557450|FG000|STARTED|Dose Level 2||0
2855053|NCT00062868|3557451|FG001|STARTED|Dose Level 2||6
2855054|NCT00062868|3557452|FG002|STARTED|Dose Level 2||0
2855055|NCT00062868|3557453|FG003|STARTED|Dose Level 2||0
2855056|NCT00062868|3557454|FG004|STARTED|Dose Level 2||3
2855057|NCT00062868|3557455|FG005|STARTED|Dose Level 2||0
2855058|NCT00062868|3557456|FG006|STARTED|Dose Level 2||0
2855059|NCT00062868|3557457|FG007|STARTED|Dose Level 2||0
2855060|NCT00062868|3557458|FG008|STARTED|Dose Level 2||0
2855061|NCT00062868|3557459|FG009|STARTED|Dose Level 2||0
2855062|NCT00062868|3557460|FG010|STARTED|Dose Level 2||4
2855063|NCT00062868|3557461|FG011|STARTED|Dose Level 2||0
2855064|NCT00062868|3557462|FG012|STARTED|Dose Level 2||0
2855065|NCT00062868|3557463|FG013|STARTED|Dose Level 2||3
2855066|NCT00062868|3557464|FG014|STARTED|Dose Level 2||0
3313368|NCT03075410|4046799|FG008|COMPLETED|Part A-Washout Period 1 (14 Days)||0
3313369|NCT03075410|4046791|FG000|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
3313370|NCT03075410|4046792|FG001|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
3313371|NCT03075410|4046793|FG002|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
3313372|NCT03075410|4046794|FG003|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
3313373|NCT03075410|4046795|FG004|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
3313374|NCT03075410|4046796|FG005|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
3313375|NCT03075410|4046797|FG006|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
3133711|NCT01696981|3858634|FG001|NOT COMPLETED|Overall Study||10374
3133712|NCT01696994|3858642|FG000|STARTED|Overall Study||39111
3133713|NCT01696994|3858643|FG001|STARTED|Overall Study||39105
3133714|NCT01696994|3858642|FG000|COMPLETED|Overall Study||33919
3133715|NCT01696994|3858643|FG001|COMPLETED|Overall Study||30668
3133716|NCT01696994|3858642|FG000|NOT COMPLETED|Overall Study||5192
3313376|NCT03075410|4046798|FG007|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
3313377|NCT03075410|4046799|FG008|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
3313378|NCT03075410|4046791|FG000|STARTED|Part A-Period 2 (14 Days)||2
3313379|NCT03075410|4046792|FG001|STARTED|Part A-Period 2 (14 Days)||1
3313380|NCT03075410|4046793|FG002|STARTED|Part A-Period 2 (14 Days)||2
3313381|NCT03075410|4046794|FG003|STARTED|Part A-Period 2 (14 Days)||1
3313382|NCT03075410|4046795|FG004|STARTED|Part A-Period 2 (14 Days)||2
2855067|NCT00062868|3557465|FG015|STARTED|Dose Level 2||0
2855068|NCT00062868|3557466|FG016|STARTED|Dose Level 2||3
2855069|NCT00062868|3557467|FG017|STARTED|Dose Level 2||0
2855070|NCT00062868|3557468|FG018|STARTED|Dose Level 2||0
2855071|NCT00062868|3557469|FG019|STARTED|Dose Level 2||0
2855072|NCT00062868|3557470|FG020|STARTED|Dose Level 2||0
2855073|NCT00062868|3557450|FG000|COMPLETED|Dose Level 2||0
2855074|NCT00062868|3557451|FG001|COMPLETED|Dose Level 2||3
2855075|NCT00062868|3557452|FG002|COMPLETED|Dose Level 2||0
2855076|NCT00062868|3557453|FG003|COMPLETED|Dose Level 2||0
2855077|NCT00062868|3557454|FG004|COMPLETED|Dose Level 2||1
2855078|NCT00062868|3557455|FG005|COMPLETED|Dose Level 2||0
2855079|NCT00062868|3557456|FG006|COMPLETED|Dose Level 2||0
2855080|NCT00062868|3557457|FG007|COMPLETED|Dose Level 2||0
2855081|NCT00062868|3557458|FG008|COMPLETED|Dose Level 2||0
2855082|NCT00062868|3557459|FG009|COMPLETED|Dose Level 2||0
2855083|NCT00062868|3557460|FG010|COMPLETED|Dose Level 2||3
2855084|NCT00062868|3557461|FG011|COMPLETED|Dose Level 2||0
2855085|NCT00062868|3557462|FG012|COMPLETED|Dose Level 2||0
2855086|NCT00062868|3557463|FG013|COMPLETED|Dose Level 2||2
2855087|NCT00062868|3557464|FG014|COMPLETED|Dose Level 2||0
2855088|NCT00062868|3557465|FG015|COMPLETED|Dose Level 2||0
2855089|NCT00062868|3557466|FG016|COMPLETED|Dose Level 2||0
2855090|NCT00062868|3557467|FG017|COMPLETED|Dose Level 2||0
2855091|NCT00062868|3557468|FG018|COMPLETED|Dose Level 2||0
2855092|NCT00062868|3557469|FG019|COMPLETED|Dose Level 2||0
2855093|NCT00062868|3557470|FG020|COMPLETED|Dose Level 2||0
3133717|NCT01696994|3858643|FG001|NOT COMPLETED|Overall Study||8437
3133718|NCT01697319|3858651|FG000|STARTED|Primary Phase|One subject enrolled but did not receive a single dose of study drug|16
3133719|NCT01697319|3858651|FG000|COMPLETED|Primary Phase||15
3133720|NCT01697319|3858651|FG000|NOT COMPLETED|Primary Phase||1
3313383|NCT03075410|4046796|FG005|STARTED|Part A-Period 2 (14 Days)||1
3313384|NCT03075410|4046797|FG006|STARTED|Part A-Period 2 (14 Days)||0
3313385|NCT03075410|4046798|FG007|STARTED|Part A-Period 2 (14 Days)||0
2855094|NCT00062868|3557450|FG000|NOT COMPLETED|Dose Level 2||0
2855095|NCT00062868|3557451|FG001|NOT COMPLETED|Dose Level 2||3
2855096|NCT00062868|3557452|FG002|NOT COMPLETED|Dose Level 2||0
2855097|NCT00062868|3557453|FG003|NOT COMPLETED|Dose Level 2||0
2855098|NCT00062868|3557454|FG004|NOT COMPLETED|Dose Level 2||2
2855099|NCT00062868|3557455|FG005|NOT COMPLETED|Dose Level 2||0
2855100|NCT00062868|3557456|FG006|NOT COMPLETED|Dose Level 2||0
2855101|NCT00062868|3557457|FG007|NOT COMPLETED|Dose Level 2||0
2855102|NCT00062868|3557458|FG008|NOT COMPLETED|Dose Level 2||0
2855103|NCT00062868|3557459|FG009|NOT COMPLETED|Dose Level 2||0
2855104|NCT00062868|3557460|FG010|NOT COMPLETED|Dose Level 2||1
2855105|NCT00062868|3557461|FG011|NOT COMPLETED|Dose Level 2||0
2855106|NCT00062868|3557462|FG012|NOT COMPLETED|Dose Level 2||0
2855107|NCT00062868|3557463|FG013|NOT COMPLETED|Dose Level 2||1
2855108|NCT00062868|3557464|FG014|NOT COMPLETED|Dose Level 2||0
2855109|NCT00062868|3557465|FG015|NOT COMPLETED|Dose Level 2||0
2855110|NCT00062868|3557466|FG016|NOT COMPLETED|Dose Level 2||3
2855111|NCT00062868|3557467|FG017|NOT COMPLETED|Dose Level 2||0
2855112|NCT00062868|3557468|FG018|NOT COMPLETED|Dose Level 2||0
2855113|NCT00062868|3557469|FG019|NOT COMPLETED|Dose Level 2||0
2855114|NCT00062868|3557470|FG020|NOT COMPLETED|Dose Level 2||0
2855115|NCT00062868|3557450|FG000|STARTED|Dose Level 3||0
2855116|NCT00062868|3557451|FG001|STARTED|Dose Level 3||0
2855117|NCT00062868|3557452|FG002|STARTED|Dose Level 3||3
2855118|NCT00062868|3557453|FG003|STARTED|Dose Level 3||0
2855119|NCT00062868|3557454|FG004|STARTED|Dose Level 3||0
2855120|NCT00062868|3557455|FG005|STARTED|Dose Level 3||0
2855121|NCT00062868|3557456|FG006|STARTED|Dose Level 3||0
2855122|NCT00062868|3557457|FG007|STARTED|Dose Level 3||0
2855123|NCT00062868|3557458|FG008|STARTED|Dose Level 3||0
2855124|NCT00062868|3557459|FG009|STARTED|Dose Level 3||0
2855125|NCT00062868|3557460|FG010|STARTED|Dose Level 3||0
2855126|NCT00062868|3557461|FG011|STARTED|Dose Level 3||5
2855127|NCT00062868|3557462|FG012|STARTED|Dose Level 3||0
2855128|NCT00062868|3557463|FG013|STARTED|Dose Level 3||0
2855129|NCT00062868|3557464|FG014|STARTED|Dose Level 3||3
2855130|NCT00062868|3557465|FG015|STARTED|Dose Level 3||0
2855131|NCT00062868|3557466|FG016|STARTED|Dose Level 3||0
2855132|NCT00062868|3557467|FG017|STARTED|Dose Level 3||4
2855133|NCT00062868|3557468|FG018|STARTED|Dose Level 3||0
2855134|NCT00062868|3557469|FG019|STARTED|Dose Level 3||0
2855135|NCT00062868|3557470|FG020|STARTED|Dose Level 3||0
2855136|NCT00062868|3557450|FG000|COMPLETED|Dose Level 3||0
2855137|NCT00062868|3557451|FG001|COMPLETED|Dose Level 3||0
2855138|NCT00062868|3557452|FG002|COMPLETED|Dose Level 3||1
2855139|NCT00062868|3557453|FG003|COMPLETED|Dose Level 3||0
2855140|NCT00062868|3557454|FG004|COMPLETED|Dose Level 3||0
2855141|NCT00062868|3557455|FG005|COMPLETED|Dose Level 3||0
2855142|NCT00062868|3557456|FG006|COMPLETED|Dose Level 3||0
2855143|NCT00062868|3557457|FG007|COMPLETED|Dose Level 3||0
2855144|NCT00062868|3557458|FG008|COMPLETED|Dose Level 3||0
2855145|NCT00062868|3557459|FG009|COMPLETED|Dose Level 3||0
2855146|NCT00062868|3557460|FG010|COMPLETED|Dose Level 3||0
2855147|NCT00062868|3557461|FG011|COMPLETED|Dose Level 3||4
2855148|NCT00062868|3557462|FG012|COMPLETED|Dose Level 3||0
2855149|NCT00062868|3557463|FG013|COMPLETED|Dose Level 3||0
2855150|NCT00062868|3557464|FG014|COMPLETED|Dose Level 3||2
2855151|NCT00062868|3557465|FG015|COMPLETED|Dose Level 3||0
2855152|NCT00062868|3557466|FG016|COMPLETED|Dose Level 3||0
2855153|NCT00062868|3557467|FG017|COMPLETED|Dose Level 3||3
2855154|NCT00062868|3557468|FG018|COMPLETED|Dose Level 3||0
2855155|NCT00062868|3557469|FG019|COMPLETED|Dose Level 3||0
2855156|NCT00062868|3557470|FG020|COMPLETED|Dose Level 3||0
2855157|NCT00062868|3557450|FG000|NOT COMPLETED|Dose Level 3||0
2855158|NCT00062868|3557451|FG001|NOT COMPLETED|Dose Level 3||0
2855159|NCT00062868|3557452|FG002|NOT COMPLETED|Dose Level 3||2
2855160|NCT00062868|3557453|FG003|NOT COMPLETED|Dose Level 3||0
2855161|NCT00062868|3557454|FG004|NOT COMPLETED|Dose Level 3||0
2855162|NCT00062868|3557455|FG005|NOT COMPLETED|Dose Level 3||0
2855163|NCT00062868|3557456|FG006|NOT COMPLETED|Dose Level 3||0
2855164|NCT00062868|3557457|FG007|NOT COMPLETED|Dose Level 3||0
2855165|NCT00062868|3557458|FG008|NOT COMPLETED|Dose Level 3||0
2855166|NCT00062868|3557459|FG009|NOT COMPLETED|Dose Level 3||0
2855167|NCT00062868|3557460|FG010|NOT COMPLETED|Dose Level 3||0
2855168|NCT00062868|3557461|FG011|NOT COMPLETED|Dose Level 3||1
2855169|NCT00062868|3557462|FG012|NOT COMPLETED|Dose Level 3||0
2855170|NCT00062868|3557463|FG013|NOT COMPLETED|Dose Level 3||0
2855171|NCT00062868|3557464|FG014|NOT COMPLETED|Dose Level 3||1
2855172|NCT00062868|3557465|FG015|NOT COMPLETED|Dose Level 3||0
2855173|NCT00062868|3557466|FG016|NOT COMPLETED|Dose Level 3||0
3313386|NCT03075410|4046799|FG008|STARTED|Part A-Period 2 (14 Days)||0
3313387|NCT03075410|4046791|FG000|COMPLETED|Part A-Period 2 (14 Days)||1
3313388|NCT03075410|4046792|FG001|COMPLETED|Part A-Period 2 (14 Days)||1
3313389|NCT03075410|4046793|FG002|COMPLETED|Part A-Period 2 (14 Days)||1
3313390|NCT03075410|4046794|FG003|COMPLETED|Part A-Period 2 (14 Days)||1
2855174|NCT00062868|3557467|FG017|NOT COMPLETED|Dose Level 3||1
2855175|NCT00062868|3557468|FG018|NOT COMPLETED|Dose Level 3||0
2855176|NCT00062868|3557469|FG019|NOT COMPLETED|Dose Level 3||0
2855177|NCT00062868|3557470|FG020|NOT COMPLETED|Dose Level 3||0
2855178|NCT00063154|3557514|FG000|STARTED|Overall Study||51
3313391|NCT03075410|4046795|FG004|COMPLETED|Part A-Period 2 (14 Days)||2
2855179|NCT00063154|3557514|FG000|COMPLETED|Overall Study||0
2855180|NCT00063154|3557514|FG000|NOT COMPLETED|Overall Study||51
2855181|NCT00063232|3557518|FG000|STARTED|Overall Study||26
2855182|NCT00063232|3557518|FG000|COMPLETED|Overall Study||26
2855183|NCT00063232|3557518|FG000|NOT COMPLETED|Overall Study||0
2855184|NCT00063258|3557524|FG000|STARTED|Overall Study||5
2855185|NCT00063258|3557525|FG001|STARTED|Overall Study||0
2855186|NCT00063258|3557524|FG000|COMPLETED|Overall Study||1
2855187|NCT00063258|3557525|FG001|COMPLETED|Overall Study||0
2855188|NCT00063258|3557524|FG000|NOT COMPLETED|Overall Study||4
2855189|NCT00063258|3557525|FG001|NOT COMPLETED|Overall Study||0
2855190|NCT00063362|3557533|FG000|STARTED|Overall Study||23
2855191|NCT00063362|3557534|FG001|STARTED|Overall Study||26
2855192|NCT00063362|3557533|FG000|COMPLETED|Overall Study||19
2855193|NCT00063362|3557534|FG001|COMPLETED|Overall Study||22
2855194|NCT00063362|3557533|FG000|NOT COMPLETED|Overall Study||4
2855195|NCT00063362|3557534|FG001|NOT COMPLETED|Overall Study||4
2855196|NCT00063570|3557542|FG000|STARTED|Overall Study||52
2855197|NCT00063570|3557543|FG001|STARTED|Overall Study||21
2855198|NCT00063570|3557542|FG000|COMPLETED|Overall Study|Completed for this study means patient received study drug and was eligible for efficacy analysis.|52
2855199|NCT00063570|3557543|FG001|COMPLETED|Overall Study|Completed for this study means patient received study drug and was eligible for efficacy analysis.|21
2855200|NCT00063570|3557542|FG000|NOT COMPLETED|Overall Study||0
2855201|NCT00063570|3557543|FG001|NOT COMPLETED|Overall Study||0
2855202|NCT00063622|3557552|FG000|STARTED|Overall Study||80
2855203|NCT00063622|3557553|FG001|STARTED|Overall Study||84
2855204|NCT00063622|3557554|FG002|STARTED|Overall Study||83
2855205|NCT00063622|3557552|FG000|COMPLETED|Overall Study|All randomized patients were included in analysis of primary outcome|70
2855206|NCT00063622|3557553|FG001|COMPLETED|Overall Study|All randomized patients were included in analysis of primary outcome|80
2855207|NCT00063622|3557554|FG002|COMPLETED|Overall Study|All randomized patients were included in analysis of primary outcome|72
2855208|NCT00063622|3557552|FG000|NOT COMPLETED|Overall Study||10
2855209|NCT00063622|3557553|FG001|NOT COMPLETED|Overall Study||4
2855210|NCT00063622|3557554|FG002|NOT COMPLETED|Overall Study||11
2855211|NCT00063635|3557565|FG000|STARTED|Overall Study||57
2855212|NCT00063635|3557566|FG001|STARTED|Overall Study||58
2855213|NCT00063635|3557567|FG002|STARTED|Overall Study||58
2855214|NCT00063635|3557565|FG000|COMPLETED|Overall Study||51
2855215|NCT00063635|3557566|FG001|COMPLETED|Overall Study||50
2855216|NCT00063635|3557567|FG002|COMPLETED|Overall Study||49
2855217|NCT00063635|3557565|FG000|NOT COMPLETED|Overall Study||6
2855218|NCT00063635|3557566|FG001|NOT COMPLETED|Overall Study||8
2855219|NCT00063635|3557567|FG002|NOT COMPLETED|Overall Study||9
2855220|NCT00063882|3557577|FG000|STARTED|Overall Study||292
2855221|NCT00063882|3557578|FG001|STARTED|Overall Study||296
2855222|NCT00063882|3557577|FG000|Has Acute Adverse Event Data|Overall Study||282
2855223|NCT00063882|3557578|FG001|Has Acute Adverse Event Data|Overall Study||288
2855224|NCT00063882|3557577|FG000|Has Late Adverse Event Data|Overall Study||282
2855225|NCT00063882|3557578|FG001|Has Late Adverse Event Data|Overall Study||287
2855226|NCT00063882|3557577|FG000|Has Baseline/4-month EPIC Data|Overall Study||222
2855227|NCT00063882|3557578|FG001|Has Baseline/4-month EPIC Data|Overall Study||241
2855228|NCT00063882|3557577|FG000|Has Baseline/24-month EPIC Data|Overall Study||201
2855229|NCT00063882|3557578|FG001|Has Baseline/24-month EPIC Data|Overall Study||219
2855230|NCT00063882|3557577|FG000|Eligible Patients|Overall Study||287
2855231|NCT00063882|3557578|FG001|Eligible Patients|Overall Study||292
2855232|NCT00063882|3557577|FG000|COMPLETED|Overall Study||287
2855233|NCT00063882|3557578|FG001|COMPLETED|Overall Study||292
2855234|NCT00063882|3557577|FG000|NOT COMPLETED|Overall Study||5
2855235|NCT00063882|3557578|FG001|NOT COMPLETED|Overall Study||4
2855236|NCT00063934|3557584|FG000|STARTED|Overall Study||31
2855237|NCT00063934|3557584|FG000|COMPLETED|Overall Study||30
2855238|NCT00063934|3557584|FG000|NOT COMPLETED|Overall Study||1
2855239|NCT00063986|3557588|FG000|STARTED|Overall Study||110
2855240|NCT00063986|3557588|FG000|Treated|Overall Study||105
2855241|NCT00063986|3557588|FG000|Eligible and Treated|Overall Study||104
2855242|NCT00063986|3557588|FG000|COMPLETED|Overall Study||104
2855243|NCT00063986|3557588|FG000|NOT COMPLETED|Overall Study||6
2855244|NCT00063999|3557594|FG000|STARTED|Overall Study||692
2855245|NCT00063999|3557595|FG001|STARTED|Overall Study||689
2855246|NCT00063999|3557594|FG000|COMPLETED|Overall Study||647
2855247|NCT00063999|3557595|FG001|COMPLETED|Overall Study||665
2855248|NCT00063999|3557594|FG000|NOT COMPLETED|Overall Study||45
2855249|NCT00063999|3557595|FG001|NOT COMPLETED|Overall Study||24
2855250|NCT00064025|3557608|FG000|STARTED|Overall Study||75
3168648|NCT01920061|3895943|FG004|NOT COMPLETED|Overall Study||2
3168649|NCT01920061|3895944|FG005|NOT COMPLETED|Overall Study||2
3168650|NCT01920061|3895945|FG006|NOT COMPLETED|Overall Study||1
3168651|NCT01920061|3895946|FG007|NOT COMPLETED|Overall Study||1
3168652|NCT01920061|3895947|FG008|NOT COMPLETED|Overall Study||1
2855251|NCT00064025|3557608|FG000|COMPLETED|Overall Study||68
2855252|NCT00064025|3557608|FG000|NOT COMPLETED|Overall Study||7
2855253|NCT00064038|3557616|FG000|STARTED|Initial Randomization||100
2855254|NCT00064038|3557617|FG001|STARTED|Initial Randomization||98
2855255|NCT00064038|3557618|FG002|STARTED|Initial Randomization||0
2855256|NCT00064038|3557616|FG000|Eligible and Analyzable|Initial Randomization||97
2855257|NCT00064038|3557617|FG001|Eligible and Analyzable|Initial Randomization||95
3168653|NCT01920061|3895948|FG009|NOT COMPLETED|Overall Study||2
2855258|NCT00064038|3557618|FG002|Eligible and Analyzable|Initial Randomization||0
2855259|NCT00064038|3557616|FG000|Safety Population|Initial Randomization||96
2855260|NCT00064038|3557617|FG001|Safety Population|Initial Randomization||94
2855261|NCT00064038|3557618|FG002|Safety Population|Initial Randomization||0
2855262|NCT00064038|3557616|FG000|COMPLETED|Initial Randomization|The study was closed early per recommedation of the Data Safety Monitoring Committee.|0
2855263|NCT00064038|3557617|FG001|COMPLETED|Initial Randomization|The study was closed early per recommedation of the Data Safety Monitoring Committee.|0
2855264|NCT00064038|3557618|FG002|COMPLETED|Initial Randomization||0
2855265|NCT00064038|3557616|FG000|NOT COMPLETED|Initial Randomization||100
2855266|NCT00064038|3557617|FG001|NOT COMPLETED|Initial Randomization||98
2855267|NCT00064038|3557618|FG002|NOT COMPLETED|Initial Randomization||0
2855268|NCT00064038|3557616|FG000|STARTED|Crossover to Lenalidomide+Dexamethasone||0
2855269|NCT00064038|3557617|FG001|STARTED|Crossover to Lenalidomide+Dexamethasone|See Crossover to Lenalidomide+Dexamethasone Arm.|0
2855270|NCT00064038|3557618|FG002|STARTED|Crossover to Lenalidomide+Dexamethasone||42
2855271|NCT00064038|3557616|FG000|Eligible and Analyzable|Crossover to Lenalidomide+Dexamethasone||0
2855272|NCT00064038|3557617|FG001|Eligible and Analyzable|Crossover to Lenalidomide+Dexamethasone|See Crossover to Lenalidomide+Dexamethasone Arm.|0
2855273|NCT00064038|3557618|FG002|Eligible and Analyzable|Crossover to Lenalidomide+Dexamethasone||40
2855274|NCT00064038|3557616|FG000|Safety Population|Crossover to Lenalidomide+Dexamethasone||0
2855275|NCT00064038|3557617|FG001|Safety Population|Crossover to Lenalidomide+Dexamethasone|See Crossover to Lenalidomide+Dexamethasone Arm.|0
2855276|NCT00064038|3557618|FG002|Safety Population|Crossover to Lenalidomide+Dexamethasone||40
2855277|NCT00064038|3557616|FG000|COMPLETED|Crossover to Lenalidomide+Dexamethasone||0
2855278|NCT00064038|3557617|FG001|COMPLETED|Crossover to Lenalidomide+Dexamethasone|See Crossover to Lenalidomide+Dexamethasone Arm.|0
2855279|NCT00064038|3557618|FG002|COMPLETED|Crossover to Lenalidomide+Dexamethasone||40
2855280|NCT00064038|3557616|FG000|NOT COMPLETED|Crossover to Lenalidomide+Dexamethasone||0
2855281|NCT00064038|3557617|FG001|NOT COMPLETED|Crossover to Lenalidomide+Dexamethasone||0
2855282|NCT00064038|3557618|FG002|NOT COMPLETED|Crossover to Lenalidomide+Dexamethasone||2
2855283|NCT00064077|3557631|FG000|STARTED|Overall Study||118
2855284|NCT00064077|3557632|FG001|STARTED|Overall Study||117
2855285|NCT00064077|3557633|FG002|STARTED|Overall Study||119
2855286|NCT00064077|3557634|FG003|STARTED|Overall Study||118
2855287|NCT00064077|3557631|FG000|COMPLETED|Overall Study|Evaluable (treatment)|103
2855288|NCT00064077|3557632|FG001|COMPLETED|Overall Study|Evaluable (treatment)|108
2855289|NCT00064077|3557633|FG002|COMPLETED|Overall Study|Evaluable (treatment)|112
2855290|NCT00064077|3557634|FG003|COMPLETED|Overall Study|Evaluable (treatment)|111
2855291|NCT00064077|3557631|FG000|NOT COMPLETED|Overall Study||15
2855292|NCT00064077|3557632|FG001|NOT COMPLETED|Overall Study||9
2855293|NCT00064077|3557633|FG002|NOT COMPLETED|Overall Study||7
2855294|NCT00064077|3557634|FG003|NOT COMPLETED|Overall Study||7
2855295|NCT00064259|3557644|FG000|STARTED|Overall Study||4
2855296|NCT00064259|3557645|FG001|STARTED|Overall Study||4
2855297|NCT00064259|3557646|FG002|STARTED|Overall Study||6
2855298|NCT00064259|3557647|FG003|STARTED|Overall Study||1
2855299|NCT00064259|3557644|FG000|COMPLETED|Overall Study||3
2855300|NCT00064259|3557645|FG001|COMPLETED|Overall Study||4
2855301|NCT00064259|3557646|FG002|COMPLETED|Overall Study||6
2855302|NCT00064259|3557647|FG003|COMPLETED|Overall Study||0
2855303|NCT00064259|3557644|FG000|NOT COMPLETED|Overall Study||1
2855304|NCT00064259|3557645|FG001|NOT COMPLETED|Overall Study||0
2855305|NCT00064259|3557646|FG002|NOT COMPLETED|Overall Study||0
2855306|NCT00064259|3557647|FG003|NOT COMPLETED|Overall Study||1
2855307|NCT00064298|3557654|FG000|STARTED|Overall Study||72
2855308|NCT00064298|3557655|FG001|STARTED|Overall Study||62
2855309|NCT00064298|3557654|FG000|COMPLETED|Overall Study||66
2855310|NCT00064298|3557655|FG001|COMPLETED|Overall Study||57
2855311|NCT00064298|3557654|FG000|NOT COMPLETED|Overall Study||6
2855312|NCT00064298|3557655|FG001|NOT COMPLETED|Overall Study||5
2855313|NCT00064337|3557661|FG000|STARTED|PBSCC or Induction/PBSCC|104 patients were registered, 93 of whom were eligible and analyzable.|93
2855314|NCT00064337|3557661|FG000|COMPLETED|PBSCC or Induction/PBSCC||73
2855315|NCT00064337|3557661|FG000|NOT COMPLETED|PBSCC or Induction/PBSCC||20
2855316|NCT00064337|3557661|FG000|STARTED|Transplant|6 patients who completed PBSCC or Induction/PBSCC did not begin Transplant|67
2855317|NCT00064337|3557661|FG000|COMPLETED|Transplant||46
2855318|NCT00064337|3557661|FG000|NOT COMPLETED|Transplant||21
2855319|NCT00064337|3557661|FG000|STARTED|Maintenance|Only patients with High Risk MM or AL + MM were allowed to enroll to Maintenance treatment.|13
2855320|NCT00064337|3557661|FG000|COMPLETED|Maintenance||3
2855321|NCT00064337|3557661|FG000|NOT COMPLETED|Maintenance||10
2855322|NCT00064350|3557671|FG000|STARTED|Induction Treatment||59
2855323|NCT00064350|3557672|FG001|STARTED|Induction Treatment||46
2855324|NCT00064350|3557673|FG002|STARTED|Induction Treatment||237
2855325|NCT00064350|3557671|FG000|Treated|Induction Treatment||59
2855326|NCT00064350|3557672|FG001|Treated|Induction Treatment||46
2855327|NCT00064350|3557673|FG002|Treated|Induction Treatment||228
2855328|NCT00064350|3557671|FG000|Eligible and Treated|Induction Treatment||59
2855329|NCT00064350|3557672|FG001|Eligible and Treated|Induction Treatment||46
2855330|NCT00064350|3557673|FG002|Eligible and Treated|Induction Treatment||194
2855331|NCT00064350|3557671|FG000|COMPLETED|Induction Treatment||51
2855332|NCT00064350|3557672|FG001|COMPLETED|Induction Treatment||37
2855333|NCT00064350|3557673|FG002|COMPLETED|Induction Treatment||1
2855334|NCT00064350|3557671|FG000|NOT COMPLETED|Induction Treatment||8
2855335|NCT00064350|3557672|FG001|NOT COMPLETED|Induction Treatment||9
2855336|NCT00064350|3557673|FG002|NOT COMPLETED|Induction Treatment||236
2855337|NCT00064350|3557671|FG000|STARTED|Randomization||59
2855338|NCT00064350|3557672|FG001|STARTED|Randomization||46
2855339|NCT00064350|3557673|FG002|STARTED|Randomization||0
2855340|NCT00064350|3557671|FG000|Treated|Randomization||55
2855341|NCT00064350|3557672|FG001|Treated|Randomization||40
2855342|NCT00064350|3557673|FG002|Treated|Randomization||0
2855343|NCT00064350|3557671|FG000|Eligible and Treated|Randomization||50
2855344|NCT00064350|3557672|FG001|Eligible and Treated|Randomization||31
2855345|NCT00064350|3557673|FG002|Eligible and Treated|Randomization||0
2855346|NCT00064350|3557671|FG000|COMPLETED|Randomization||33
2855347|NCT00064350|3557672|FG001|COMPLETED|Randomization||28
2855348|NCT00064350|3557673|FG002|COMPLETED|Randomization||0
2855349|NCT00064350|3557671|FG000|NOT COMPLETED|Randomization||26
2855350|NCT00064350|3557672|FG001|NOT COMPLETED|Randomization||18
2855351|NCT00064350|3557673|FG002|NOT COMPLETED|Randomization||0
2855352|NCT00064350|3557671|FG000|STARTED|Cross-Over||10
2855353|NCT00064350|3557672|FG001|STARTED|Cross-Over||27
2855354|NCT00064350|3557673|FG002|STARTED|Cross-Over||0
2855355|NCT00064350|3557671|FG000|Treated|Cross-Over||9
2855356|NCT00064350|3557672|FG001|Treated|Cross-Over||26
2855357|NCT00064350|3557673|FG002|Treated|Cross-Over||0
2855358|NCT00064350|3557671|FG000|Eligible and Treated|Cross-Over||7
2855359|NCT00064350|3557672|FG001|Eligible and Treated|Cross-Over||21
2855360|NCT00064350|3557673|FG002|Eligible and Treated|Cross-Over||0
2855361|NCT00064350|3557671|FG000|COMPLETED|Cross-Over||4
2855362|NCT00064350|3557672|FG001|COMPLETED|Cross-Over||13
2855363|NCT00064350|3557673|FG002|COMPLETED|Cross-Over||0
2855364|NCT00064350|3557671|FG000|NOT COMPLETED|Cross-Over||6
2855365|NCT00064350|3557672|FG001|NOT COMPLETED|Cross-Over||14
2855366|NCT00064350|3557673|FG002|NOT COMPLETED|Cross-Over||0
2855367|NCT00064662|3557684|FG000|STARTED|Overall Study||329
2855368|NCT00064662|3557685|FG001|STARTED|Overall Study||326
2855369|NCT00064662|3557684|FG000|COMPLETED|Overall Study||255
2855370|NCT00064662|3557685|FG001|COMPLETED|Overall Study||265
2855371|NCT00064662|3557684|FG000|NOT COMPLETED|Overall Study||74
2855372|NCT00064662|3557685|FG001|NOT COMPLETED|Overall Study||61
2855373|NCT00064701|3557694|FG000|STARTED|One Year Post-transplant||219
2855374|NCT00064701|3557695|FG001|STARTED|One Year Post-transplant||226
2855375|NCT00064701|3557696|FG002|STARTED|One Year Post-transplant||223
2855376|NCT00064701|3557694|FG000|Received Study Drug|One Year Post-transplant||212
2855377|NCT00064701|3557695|FG001|Received Study Drug|One Year Post-transplant||214
2855378|NCT00064701|3557696|FG002|Received Study Drug|One Year Post-transplant||212
2855379|NCT00064701|3557694|FG000|COMPLETED|One Year Post-transplant||179
2855380|NCT00064701|3557695|FG001|COMPLETED|One Year Post-transplant||183
2855381|NCT00064701|3557696|FG002|COMPLETED|One Year Post-transplant||151
2855382|NCT00064701|3557694|FG000|NOT COMPLETED|One Year Post-transplant||40
2855383|NCT00064701|3557695|FG001|NOT COMPLETED|One Year Post-transplant||43
2855384|NCT00064701|3557696|FG002|NOT COMPLETED|One Year Post-transplant||72
2855385|NCT00064701|3557694|FG000|STARTED|Clinical Continuation Phase||179
2855386|NCT00064701|3557695|FG001|STARTED|Clinical Continuation Phase|One participant did not enter the Clinical Continuation phase|182
2855387|NCT00064701|3557696|FG002|STARTED|Clinical Continuation Phase||151
2855388|NCT00064701|3557694|FG000|COMPLETED|Clinical Continuation Phase||9
2855389|NCT00064701|3557695|FG001|COMPLETED|Clinical Continuation Phase||4
2855390|NCT00064701|3557696|FG002|COMPLETED|Clinical Continuation Phase||11
2855391|NCT00064701|3557694|FG000|NOT COMPLETED|Clinical Continuation Phase||170
2855392|NCT00064701|3557695|FG001|NOT COMPLETED|Clinical Continuation Phase||178
2855393|NCT00064701|3557696|FG002|NOT COMPLETED|Clinical Continuation Phase||140
2855394|NCT00064753|3557706|FG000|STARTED|Overall Study||2056
2855395|NCT00064753|3557707|FG001|STARTED|Overall Study||2054
2855396|NCT00064753|3557706|FG000|COMPLETED|Overall Study||1382
2855397|NCT00064753|3557707|FG001|COMPLETED|Overall Study||1406
2855398|NCT00064753|3557706|FG000|NOT COMPLETED|Overall Study||674
2855399|NCT00064753|3557707|FG001|NOT COMPLETED|Overall Study||648
2855400|NCT00064792|3557715|FG000|STARTED|Overall Study||13
2855401|NCT00064792|3557716|FG001|STARTED|Overall Study||10
2855402|NCT00064792|3557715|FG000|COMPLETED|Overall Study||8
2855403|NCT00064792|3557716|FG001|COMPLETED|Overall Study||10
2855404|NCT00064792|3557715|FG000|NOT COMPLETED|Overall Study||5
2855405|NCT00064792|3557716|FG001|NOT COMPLETED|Overall Study||0
2855406|NCT00064844|3557724|FG000|STARTED|Overall Study||45
2855407|NCT00064844|3557725|FG001|STARTED|Overall Study||51
2855408|NCT00064844|3557724|FG000|2 Week Follow-up|Overall Study||45
2855409|NCT00064844|3557725|FG001|2 Week Follow-up|Overall Study||51
2855410|NCT00064844|3557724|FG000|3 Month Follow-up|Overall Study||40
2855411|NCT00064844|3557725|FG001|3 Month Follow-up|Overall Study||47
2855412|NCT00064844|3557724|FG000|6 Month Follow-up|Overall Study||39
2855413|NCT00064844|3557725|FG001|6 Month Follow-up|Overall Study||40
2855414|NCT00064844|3557724|FG000|12 Month Follow-up|Overall Study||37
2855415|NCT00064844|3557725|FG001|12 Month Follow-up|Overall Study||32
2855416|NCT00064844|3557724|FG000|COMPLETED|Overall Study||37
2855417|NCT00064844|3557725|FG001|COMPLETED|Overall Study||32
2855418|NCT00064844|3557724|FG000|NOT COMPLETED|Overall Study||8
2855419|NCT00064844|3557725|FG001|NOT COMPLETED|Overall Study||19
2855420|NCT00064987|3557733|FG000|STARTED|Overall Study||10
2855421|NCT00064987|3557734|FG001|STARTED|Overall Study||6
2855422|NCT00064987|3557733|FG000|COMPLETED|Overall Study||7
2855423|NCT00064987|3557734|FG001|COMPLETED|Overall Study||6
2855424|NCT00064987|3557733|FG000|NOT COMPLETED|Overall Study||3
2855425|NCT00064987|3557734|FG001|NOT COMPLETED|Overall Study||0
2855426|NCT00065065|3557742|FG000|STARTED|Overall Study||52
2855427|NCT00065065|3557743|FG001|STARTED|Overall Study||53
2855428|NCT00065065|3557742|FG000|COMPLETED|Overall Study||42
2855429|NCT00065065|3557743|FG001|COMPLETED|Overall Study||33
2855430|NCT00065065|3557742|FG000|NOT COMPLETED|Overall Study||10
2855431|NCT00065065|3557743|FG001|NOT COMPLETED|Overall Study||20
2855432|NCT00065156|3557751|FG000|STARTED|Overall Study||148
2855433|NCT00065156|3557751|FG000|Modified Intent to Treat Population|Overall Study||94
2855434|NCT00065156|3557751|FG000|COMPLETED|Overall Study|24 patients rolled over to free drug due to sponsor closure of study.|24
2855435|NCT00065156|3557751|FG000|NOT COMPLETED|Overall Study||124
2855436|NCT00065182|3557757|FG000|STARTED|Overall Study||202
2855437|NCT00065182|3557758|FG001|STARTED|Overall Study||197
2855438|NCT00065182|3557757|FG000|COMPLETED|Overall Study||154
2855439|NCT00065182|3557758|FG001|COMPLETED|Overall Study||160
2855440|NCT00065182|3557757|FG000|NOT COMPLETED|Overall Study||48
2855441|NCT00065182|3557758|FG001|NOT COMPLETED|Overall Study||37
2855442|NCT00065260|3557766|FG000|STARTED|Overall Study||27
2855443|NCT00065260|3557767|FG001|STARTED|Overall Study||27
2855444|NCT00065260|3557766|FG000|COMPLETED|Overall Study||27
2855445|NCT00065260|3557767|FG001|COMPLETED|Overall Study||26
2855446|NCT00065260|3557766|FG000|NOT COMPLETED|Overall Study||0
2855447|NCT00065260|3557767|FG001|NOT COMPLETED|Overall Study||1
2855448|NCT00065429|3557780|FG000|STARTED|Phase I - May 2001 - Oct 2002||4
2855449|NCT00065429|3557781|FG001|STARTED|Phase I - May 2001 - Oct 2002||3
2855450|NCT00065429|3557782|FG002|STARTED|Phase I - May 2001 - Oct 2002||4
2855451|NCT00065429|3557783|FG003|STARTED|Phase I - May 2001 - Oct 2002||4
2855452|NCT00065429|3557784|FG004|STARTED|Phase I - May 2001 - Oct 2002||9
2855453|NCT00065429|3557785|FG005|STARTED|Phase I - May 2001 - Oct 2002||4
2855454|NCT00065429|3557786|FG006|STARTED|Phase I - May 2001 - Oct 2002||4
2855455|NCT00065429|3557780|FG000|COMPLETED|Phase I - May 2001 - Oct 2002||3
2855456|NCT00065429|3557781|FG001|COMPLETED|Phase I - May 2001 - Oct 2002||3
2855457|NCT00065429|3557782|FG002|COMPLETED|Phase I - May 2001 - Oct 2002||3
2855458|NCT00065429|3557783|FG003|COMPLETED|Phase I - May 2001 - Oct 2002||3
2855459|NCT00065429|3557784|FG004|COMPLETED|Phase I - May 2001 - Oct 2002||8
2855460|NCT00065429|3557785|FG005|COMPLETED|Phase I - May 2001 - Oct 2002||2
2855461|NCT00065429|3557786|FG006|COMPLETED|Phase I - May 2001 - Oct 2002||2
2855462|NCT00065429|3557780|FG000|NOT COMPLETED|Phase I - May 2001 - Oct 2002||1
2855463|NCT00065429|3557781|FG001|NOT COMPLETED|Phase I - May 2001 - Oct 2002||0
2855464|NCT00065429|3557782|FG002|NOT COMPLETED|Phase I - May 2001 - Oct 2002||1
2855465|NCT00065429|3557783|FG003|NOT COMPLETED|Phase I - May 2001 - Oct 2002||1
2855466|NCT00065429|3557784|FG004|NOT COMPLETED|Phase I - May 2001 - Oct 2002||1
2855467|NCT00065429|3557785|FG005|NOT COMPLETED|Phase I - May 2001 - Oct 2002||2
2855468|NCT00065429|3557786|FG006|NOT COMPLETED|Phase I - May 2001 - Oct 2002||2
2855469|NCT00065429|3557780|FG000|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
2855470|NCT00065429|3557781|FG001|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
2855471|NCT00065429|3557782|FG002|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
2855472|NCT00065429|3557783|FG003|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
2855473|NCT00065429|3557784|FG004|STARTED|Phase II - Apr 2003 - Aug 2008|All 32 patients enrolled in Phase 2 were at 60 mg/m2.|32
2855474|NCT00065429|3557785|FG005|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
2855475|NCT00065429|3557786|FG006|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
2855476|NCT00065429|3557780|FG000|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
2855477|NCT00065429|3557781|FG001|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
2855478|NCT00065429|3557782|FG002|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
2855479|NCT00065429|3557783|FG003|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
2855480|NCT00065429|3557784|FG004|COMPLETED|Phase II - Apr 2003 - Aug 2008||26
2855481|NCT00065429|3557785|FG005|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
2855482|NCT00065429|3557786|FG006|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
2855483|NCT00065429|3557780|FG000|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
2855484|NCT00065429|3557781|FG001|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
2855485|NCT00065429|3557782|FG002|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
2855486|NCT00065429|3557783|FG003|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
2855487|NCT00065429|3557784|FG004|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||6
2855488|NCT00065429|3557785|FG005|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
2855489|NCT00065429|3557786|FG006|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
2855490|NCT00065442|3557799|FG000|STARTED|Overall Study||171
2855491|NCT00065442|3557800|FG001|STARTED|Overall Study||341
2855492|NCT00065442|3557799|FG000|COMPLETED|Overall Study||46
2855493|NCT00065442|3557800|FG001|COMPLETED|Overall Study||121
2855494|NCT00065442|3557799|FG000|NOT COMPLETED|Overall Study||125
2855495|NCT00065442|3557800|FG001|NOT COMPLETED|Overall Study||220
2855496|NCT00065468|3557809|FG000|STARTED|Overall Study||207
2855497|NCT00065468|3557810|FG001|STARTED|Overall Study||209
2855498|NCT00065468|3557811|FG002|STARTED|Overall Study||210
2855499|NCT00065468|3557809|FG000|Received Treatment|Overall Study||200
2855500|NCT00065468|3557810|FG001|Received Treatment|Overall Study||208
2855501|NCT00065468|3557811|FG002|Received Treatment|Overall Study||208
2855502|NCT00065468|3557809|FG000|COMPLETED|Overall Study||0
2855503|NCT00065468|3557810|FG001|COMPLETED|Overall Study||0
2855504|NCT00065468|3557811|FG002|COMPLETED|Overall Study||0
2855505|NCT00065468|3557809|FG000|NOT COMPLETED|Overall Study||207
2855506|NCT00065468|3557810|FG001|NOT COMPLETED|Overall Study||209
2855507|NCT00065468|3557811|FG002|NOT COMPLETED|Overall Study||210
2855508|NCT00065507|3557821|FG000|STARTED|Overall Study|101 participants were randomized; 1 never treated.|100
2855509|NCT00065507|3557822|FG001|STARTED|Overall Study|94 participants were randomized; 3 never treated.|91
2855510|NCT00065507|3557821|FG000|Treated (As-Randomized Population)|Overall Study|As-randomized population was used in efficacy analyses, unless otherwise noted.|100
2855511|NCT00065507|3557822|FG001|Treated (As-Randomized Population)|Overall Study|As-randomized population was used in efficacy analyses, unless otherwise noted.|91
2855512|NCT00065507|3557821|FG000|Treated (As-Treated Population)|Overall Study|2 subjects randomized to ADV were treated with ETV for the entire dosing period and included in ETV.|102
2855513|NCT00065507|3557822|FG001|Treated (As-Treated Population)|Overall Study|2 subjects randomized to ADV were treated with ETV for the entire dosing period and included in ETV.|89
2855514|NCT00065507|3557821|FG000|Treated, Wk 48 (As-Treated Population)|Overall Study|2 subjects randomized to ADV were treated with ETV for the entire dosing period and included in ETV.|102
2855515|NCT00065507|3557822|FG001|Treated, Wk 48 (As-Treated Population)|Overall Study|2 subjects randomized to ADV were treated with ETV for the entire dosing period and included in ETV.|89
2855516|NCT00065507|3557821|FG000|Treated, 24-Week Follow-Up Population|Overall Study||25
2855517|NCT00065507|3557822|FG001|Treated, 24-Week Follow-Up Population|Overall Study||28
2855518|NCT00065507|3557821|FG000|COMPLETED|Overall Study|Completed first 48 weeks of treatment|71
2855519|NCT00065507|3557822|FG001|COMPLETED|Overall Study|Completed first 48 weeks of treatment|62
2855520|NCT00065507|3557821|FG000|NOT COMPLETED|Overall Study||29
2855521|NCT00065507|3557822|FG001|NOT COMPLETED|Overall Study||29
2855522|NCT00065611|3557834|FG000|STARTED|Overall Study||4
2855523|NCT00065611|3557835|FG001|STARTED|Overall Study||4
2855524|NCT00065611|3557834|FG000|COMPLETED|Overall Study||4
2855525|NCT00065611|3557835|FG001|COMPLETED|Overall Study||3
2855526|NCT00065611|3557834|FG000|NOT COMPLETED|Overall Study||0
2855527|NCT00065611|3557835|FG001|NOT COMPLETED|Overall Study||1
2855528|NCT00065806|3557843|FG000|STARTED|Overall Study||113
2855529|NCT00065806|3557844|FG001|STARTED|Overall Study||108
2855530|NCT00065806|3557843|FG000|COMPLETED|Overall Study||93
2855531|NCT00065806|3557844|FG001|COMPLETED|Overall Study||89
2855532|NCT00065806|3557843|FG000|NOT COMPLETED|Overall Study||20
2855533|NCT00065806|3557844|FG001|NOT COMPLETED|Overall Study||19
2855534|NCT00066066|3557853|FG000|STARTED|Overall Study||27
2855535|NCT00066066|3557854|FG001|STARTED|Overall Study||22
2855536|NCT00066066|3557855|FG002|STARTED|Overall Study||30
2855537|NCT00066066|3557856|FG003|STARTED|Overall Study||20
2855538|NCT00066066|3557857|FG004|STARTED|Overall Study||27
2855539|NCT00066066|3557858|FG005|STARTED|Overall Study||20
2855540|NCT00066066|3557853|FG000|Baseline|Overall Study||27
2855541|NCT00066066|3557854|FG001|Baseline|Overall Study||22
2855542|NCT00066066|3557855|FG002|Baseline|Overall Study||30
2855543|NCT00066066|3557856|FG003|Baseline|Overall Study||20
2855544|NCT00066066|3557857|FG004|Baseline|Overall Study||27
2855545|NCT00066066|3557858|FG005|Baseline|Overall Study||20
2855546|NCT00066066|3557853|FG000|3 Month|Overall Study||21
2855547|NCT00066066|3557854|FG001|3 Month|Overall Study||17
2855548|NCT00066066|3557855|FG002|3 Month|Overall Study||23
2855549|NCT00066066|3557856|FG003|3 Month|Overall Study||16
2855550|NCT00066066|3557857|FG004|3 Month|Overall Study||22
2855551|NCT00066066|3557858|FG005|3 Month|Overall Study||15
2855552|NCT00066066|3557853|FG000|6 Month|Overall Study||19
2855553|NCT00066066|3557854|FG001|6 Month|Overall Study||13
2855554|NCT00066066|3557855|FG002|6 Month|Overall Study||23
2855555|NCT00066066|3557856|FG003|6 Month|Overall Study||13
2855556|NCT00066066|3557857|FG004|6 Month|Overall Study||21
2855557|NCT00066066|3557858|FG005|6 Month|Overall Study||14
2855558|NCT00066066|3557853|FG000|12 Month|Overall Study||18
2855559|NCT00066066|3557854|FG001|12 Month|Overall Study||11
2855560|NCT00066066|3557855|FG002|12 Month|Overall Study||21
2855561|NCT00066066|3557856|FG003|12 Month|Overall Study||11
2855562|NCT00066066|3557857|FG004|12 Month|Overall Study||19
2855563|NCT00066066|3557858|FG005|12 Month|Overall Study||9
2855564|NCT00066066|3557853|FG000|COMPLETED|Overall Study|27 enrolled, 21 analyzed,18 subjects had complete data,3 subjects had data carried forward.|21
2855565|NCT00066066|3557854|FG001|COMPLETED|Overall Study|22 enrolled, 18 analyzed,11 subjects had complete data,7 subjects had data carried forward.|18
2855566|NCT00066066|3557855|FG002|COMPLETED|Overall Study|30 enrolled, 23 analyzed,21 subjects had complete data,2 subjects had data carried forward.|23
2855567|NCT00066066|3557856|FG003|COMPLETED|Overall Study|20 enrolled, 16 analyzed,11 subjects had complete data,5 subjects had data carried forward.|16
2855568|NCT00066066|3557857|FG004|COMPLETED|Overall Study|27 enrolled, 24 analyzed,19 subjects had complete data,5 subjects had data carried forward.|24
2855569|NCT00066066|3557858|FG005|COMPLETED|Overall Study|20 enrolled, 15 analyzed,9 subjects had complete data,6 subjects had data carried forward.|15
2855570|NCT00066066|3557853|FG000|NOT COMPLETED|Overall Study||6
2855571|NCT00066066|3557854|FG001|NOT COMPLETED|Overall Study||4
2855572|NCT00066066|3557855|FG002|NOT COMPLETED|Overall Study||7
2855573|NCT00066066|3557856|FG003|NOT COMPLETED|Overall Study||4
2855574|NCT00066066|3557857|FG004|NOT COMPLETED|Overall Study||3
2855575|NCT00066066|3557858|FG005|NOT COMPLETED|Overall Study||5
2855576|NCT00066170|3557876|FG000|STARTED|Overall Study||56
2855577|NCT00066170|3557877|FG001|STARTED|Overall Study||55
2855578|NCT00066170|3557878|FG002|STARTED|Overall Study||63
2855579|NCT00066170|3557879|FG003|STARTED|Overall Study||57
2855580|NCT00066170|3557876|FG000|Intent to Treat|Overall Study||55
2855581|NCT00066170|3557877|FG001|Intent to Treat|Overall Study||50
2855582|NCT00066170|3557878|FG002|Intent to Treat|Overall Study||63
2855583|NCT00066170|3557879|FG003|Intent to Treat|Overall Study||54
2855584|NCT00066170|3557876|FG000|COMPLETED|Overall Study||49
2855585|NCT00066170|3557877|FG001|COMPLETED|Overall Study||45
2855586|NCT00066170|3557878|FG002|COMPLETED|Overall Study||59
2855587|NCT00066170|3557879|FG003|COMPLETED|Overall Study||48
2855588|NCT00066170|3557876|FG000|NOT COMPLETED|Overall Study||7
2855589|NCT00066170|3557877|FG001|NOT COMPLETED|Overall Study||10
2855590|NCT00066170|3557878|FG002|NOT COMPLETED|Overall Study||4
2855591|NCT00066170|3557879|FG003|NOT COMPLETED|Overall Study||9
2855592|NCT00066222|3557889|FG000|STARTED|Overall Study||72
2855593|NCT00066222|3557889|FG000|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|71
2855594|NCT00066222|3557889|FG000|NOT COMPLETED|Overall Study||1
2855595|NCT00066365|3557895|FG000|STARTED|Overall Study||31
2855596|NCT00066365|3557896|FG001|STARTED|Overall Study||18
2855597|NCT00066365|3557895|FG000|COMPLETED|Overall Study||8
2855598|NCT00066365|3557896|FG001|COMPLETED|Overall Study||4
2855599|NCT00066365|3557895|FG000|NOT COMPLETED|Overall Study||23
2855600|NCT00066365|3557896|FG001|NOT COMPLETED|Overall Study||14
2855601|NCT00066469|3557904|FG000|STARTED|Overall Study||55
2855602|NCT00066469|3557904|FG000|COMPLETED|Overall Study||39
2855603|NCT00066469|3557904|FG000|NOT COMPLETED|Overall Study||16
2855604|NCT00066573|3557910|FG000|STARTED|Overall Study||3789
2855605|NCT00066573|3557911|FG001|STARTED|Overall Study||3787
2855606|NCT00066573|3557910|FG000|COMPLETED|Overall Study||3761
2855607|NCT00066573|3557911|FG001|COMPLETED|Overall Study||3759
2855608|NCT00066573|3557910|FG000|NOT COMPLETED|Overall Study||28
2855609|NCT00066573|3557911|FG001|NOT COMPLETED|Overall Study||28
2855610|NCT00066677|3557919|FG000|STARTED|Overall Study||16
2855611|NCT00066677|3557920|FG001|STARTED|Overall Study||16
2855612|NCT00066677|3557919|FG000|COMPLETED|Overall Study||16
2855613|NCT00066677|3557920|FG001|COMPLETED|Overall Study||16
2855614|NCT00066677|3557919|FG000|NOT COMPLETED|Overall Study||0
2855615|NCT00066677|3557920|FG001|NOT COMPLETED|Overall Study||0
2855616|NCT00066690|3557929|FG000|STARTED|Overall Study||1021
2855617|NCT00066690|3557930|FG001|STARTED|Overall Study||1024
2855618|NCT00066690|3557931|FG002|STARTED|Overall Study||1021
2855619|NCT00066690|3557929|FG000|COMPLETED|Overall Study||423
2855620|NCT00066690|3557930|FG001|COMPLETED|Overall Study||502
2855621|NCT00066690|3557931|FG002|COMPLETED|Overall Study||457
2855622|NCT00066690|3557929|FG000|NOT COMPLETED|Overall Study||598
2855623|NCT00066690|3557930|FG001|NOT COMPLETED|Overall Study||522
2855624|NCT00066690|3557931|FG002|NOT COMPLETED|Overall Study||564
2855625|NCT00066703|3557944|FG000|STARTED|Overall Study||1334
2855626|NCT00066703|3557945|FG001|STARTED|Overall Study||1338
2855627|NCT00066703|3557944|FG000|COMPLETED|Overall Study||722
2855628|NCT00066703|3557945|FG001|COMPLETED|Overall Study||756
2855629|NCT00066703|3557944|FG000|NOT COMPLETED|Overall Study||612
2855630|NCT00066703|3557945|FG001|NOT COMPLETED|Overall Study||582
2855631|NCT00066729|3557951|FG000|STARTED|Overall Study||9
2855632|NCT00066729|3557951|FG000|COMPLETED|Overall Study||7
2855633|NCT00066729|3557951|FG000|NOT COMPLETED|Overall Study||2
2855634|NCT00066742|3557955|FG000|STARTED|Induction Chemoradiotherapy||72
2855635|NCT00066742|3557955|FG000|Eligible|Induction Chemoradiotherapy||69
2855636|NCT00066742|3557955|FG000|Began Protocol Treatment|Induction Chemoradiotherapy||68
2855637|NCT00066742|3557955|FG000|COMPLETED|Induction Chemoradiotherapy||43
2855638|NCT00066742|3557955|FG000|NOT COMPLETED|Induction Chemoradiotherapy||29
2855639|NCT00066742|3557955|FG000|STARTED|Consolidation Chemotherapy||42
2855640|NCT00066742|3557955|FG000|Eligible|Consolidation Chemotherapy||40
2855641|NCT00066742|3557955|FG000|COMPLETED|Consolidation Chemotherapy||39
2855642|NCT00066742|3557955|FG000|NOT COMPLETED|Consolidation Chemotherapy||3
2855643|NCT00066781|3557963|FG000|STARTED|Overall Study||14
2855644|NCT00066781|3557964|FG001|STARTED|Overall Study||17
2855645|NCT00066781|3557963|FG000|COMPLETED|Overall Study||14
2855646|NCT00066781|3557964|FG001|COMPLETED|Overall Study||17
2855647|NCT00066781|3557963|FG000|NOT COMPLETED|Overall Study||0
2855648|NCT00066781|3557964|FG001|NOT COMPLETED|Overall Study||0
2855649|NCT00066937|3557974|FG000|STARTED|Treatment Phase||41
2855650|NCT00066937|3557975|FG001|STARTED|Treatment Phase||38
2855651|NCT00066937|3557976|FG002|STARTED|Treatment Phase||37
2855652|NCT00066937|3557977|FG003|STARTED|Treatment Phase||24
2855653|NCT00066937|3557974|FG000|COMPLETED|Treatment Phase||38
2855654|NCT00066937|3557975|FG001|COMPLETED|Treatment Phase||33
2855655|NCT00066937|3557976|FG002|COMPLETED|Treatment Phase||26
2855656|NCT00066937|3557977|FG003|COMPLETED|Treatment Phase||19
2855657|NCT00066937|3557974|FG000|NOT COMPLETED|Treatment Phase||3
2855658|NCT00066937|3557975|FG001|NOT COMPLETED|Treatment Phase||5
2855659|NCT00066937|3557976|FG002|NOT COMPLETED|Treatment Phase||11
2855660|NCT00066937|3557977|FG003|NOT COMPLETED|Treatment Phase||5
2855661|NCT00066937|3557974|FG000|STARTED|3 Month Follow-up||38
2855662|NCT00066937|3557975|FG001|STARTED|3 Month Follow-up||33
2855663|NCT00066937|3557976|FG002|STARTED|3 Month Follow-up||26
2855664|NCT00066937|3557977|FG003|STARTED|3 Month Follow-up||19
2855665|NCT00066937|3557974|FG000|COMPLETED|3 Month Follow-up||33
2855666|NCT00066937|3557975|FG001|COMPLETED|3 Month Follow-up||32
2855667|NCT00066937|3557976|FG002|COMPLETED|3 Month Follow-up||25
2855668|NCT00066937|3557977|FG003|COMPLETED|3 Month Follow-up||15
2855669|NCT00066937|3557974|FG000|NOT COMPLETED|3 Month Follow-up||5
2855670|NCT00066937|3557975|FG001|NOT COMPLETED|3 Month Follow-up||1
2855671|NCT00066937|3557976|FG002|NOT COMPLETED|3 Month Follow-up||1
2855672|NCT00066937|3557977|FG003|NOT COMPLETED|3 Month Follow-up||4
2855673|NCT00066937|3557974|FG000|STARTED|6 Month Follow-up||33
2855674|NCT00066937|3557975|FG001|STARTED|6 Month Follow-up||32
2855675|NCT00066937|3557976|FG002|STARTED|6 Month Follow-up||25
2855676|NCT00066937|3557977|FG003|STARTED|6 Month Follow-up||15
2855677|NCT00066937|3557974|FG000|COMPLETED|6 Month Follow-up||26
2855678|NCT00066937|3557975|FG001|COMPLETED|6 Month Follow-up||29
2855679|NCT00066937|3557976|FG002|COMPLETED|6 Month Follow-up||22
2855680|NCT00066937|3557977|FG003|COMPLETED|6 Month Follow-up||14
2855681|NCT00066937|3557974|FG000|NOT COMPLETED|6 Month Follow-up||7
2855682|NCT00066937|3557975|FG001|NOT COMPLETED|6 Month Follow-up||3
2855683|NCT00066937|3557976|FG002|NOT COMPLETED|6 Month Follow-up||3
2855684|NCT00066937|3557977|FG003|NOT COMPLETED|6 Month Follow-up||1
2855685|NCT00066963|3557990|FG000|STARTED|Overall Study||126
2855686|NCT00066963|3557991|FG001|STARTED|Overall Study||124
2855687|NCT00066963|3557992|FG002|STARTED|Overall Study||126
2855688|NCT00066963|3557990|FG000|COMPLETED|Overall Study|any follow-up|100
2855689|NCT00066963|3557991|FG001|COMPLETED|Overall Study||93
2855690|NCT00066963|3557992|FG002|COMPLETED|Overall Study||87
2855691|NCT00066963|3557990|FG000|NOT COMPLETED|Overall Study||26
2855692|NCT00066963|3557991|FG001|NOT COMPLETED|Overall Study||31
2855693|NCT00066963|3557992|FG002|NOT COMPLETED|Overall Study||39
2855694|NCT00067002|3558002|FG000|STARTED|Overall Study||52
2855695|NCT00067002|3558003|FG001|STARTED|Overall Study||53
2855696|NCT00067002|3558002|FG000|COMPLETED|Overall Study||45
2855697|NCT00067002|3558003|FG001|COMPLETED|Overall Study||44
2855698|NCT00067002|3558002|FG000|NOT COMPLETED|Overall Study||7
2855699|NCT00067002|3558003|FG001|NOT COMPLETED|Overall Study||9
2855700|NCT00067028|3558012|FG000|STARTED|Overall Study||17
2855701|NCT00067028|3558013|FG001|STARTED|Overall Study||36
2855702|NCT00067028|3558014|FG002|STARTED|Overall Study||63
2855703|NCT00067028|3558012|FG000|COMPLETED|Overall Study||17
2855704|NCT00067028|3558013|FG001|COMPLETED|Overall Study||36
2855705|NCT00067028|3558014|FG002|COMPLETED|Overall Study||63
2855706|NCT00067028|3558012|FG000|NOT COMPLETED|Overall Study||0
2855707|NCT00067028|3558013|FG001|NOT COMPLETED|Overall Study||0
2855708|NCT00067028|3558014|FG002|NOT COMPLETED|Overall Study||0
2855709|NCT00067236|3558026|FG000|STARTED|Overall Study||128
2855710|NCT00067236|3558027|FG001|STARTED|Overall Study||125
2855711|NCT00067236|3558026|FG000|COMPLETED|Overall Study||108
2855712|NCT00067236|3558027|FG001|COMPLETED|Overall Study||99
2855713|NCT00067236|3558026|FG000|NOT COMPLETED|Overall Study||20
2855714|NCT00067236|3558027|FG001|NOT COMPLETED|Overall Study||26
2855715|NCT00067470|3558035|FG000|STARTED|Overall Study||19
2855716|NCT00067470|3558036|FG001|STARTED|Overall Study||20
2855717|NCT00067470|3558035|FG000|COMPLETED|Overall Study||19
2855718|NCT00067470|3558036|FG001|COMPLETED|Overall Study||19
2855719|NCT00067470|3558035|FG000|NOT COMPLETED|Overall Study||0
2855720|NCT00067470|3558036|FG001|NOT COMPLETED|Overall Study||1
2918210|NCT00525499|3628377|FG003|NOT COMPLETED|Overall Study||7
2918211|NCT00525512|3628389|FG000|STARTED|Double-Blind Phase||259
2918212|NCT00525512|3628390|FG001|STARTED|Double-Blind Phase||260
2918213|NCT00525512|3628391|FG002|STARTED|Double-Blind Phase||0
2918214|NCT00525512|3628392|FG003|STARTED|Double-Blind Phase||0
2918215|NCT00525512|3628389|FG000|COMPLETED|Double-Blind Phase||163
2918216|NCT00525512|3628390|FG001|COMPLETED|Double-Blind Phase||194
2918217|NCT00525512|3628391|FG002|COMPLETED|Double-Blind Phase||0
2918218|NCT00525512|3628392|FG003|COMPLETED|Double-Blind Phase||0
2918219|NCT00525512|3628389|FG000|NOT COMPLETED|Double-Blind Phase||96
2918220|NCT00525512|3628390|FG001|NOT COMPLETED|Double-Blind Phase||66
2918221|NCT00525512|3628391|FG002|NOT COMPLETED|Double-Blind Phase||0
2918222|NCT00525512|3628392|FG003|NOT COMPLETED|Double-Blind Phase||0
2918223|NCT00525512|3628389|FG000|STARTED|Open-Label Phase||0
2918224|NCT00525512|3628390|FG001|STARTED|Open-Label Phase||0
2918225|NCT00525512|3628391|FG002|STARTED|Open-Label Phase||164
2918226|NCT00525512|3628392|FG003|STARTED|Open-Label Phase||194
2918227|NCT00525512|3628389|FG000|COMPLETED|Open-Label Phase||0
2918228|NCT00525512|3628390|FG001|COMPLETED|Open-Label Phase||0
2918229|NCT00525512|3628391|FG002|COMPLETED|Open-Label Phase||158
2918230|NCT00525512|3628392|FG003|COMPLETED|Open-Label Phase||189
2918231|NCT00525512|3628389|FG000|NOT COMPLETED|Open-Label Phase||0
2918232|NCT00525512|3628390|FG001|NOT COMPLETED|Open-Label Phase||0
2918233|NCT00525512|3628391|FG002|NOT COMPLETED|Open-Label Phase||6
2918234|NCT00525512|3628392|FG003|NOT COMPLETED|Open-Label Phase||5
2918235|NCT00525525|3628406|FG000|STARTED|Overall Study||59
2918236|NCT00525525|3628407|FG001|STARTED|Overall Study||15
2918237|NCT00525525|3628406|FG000|COMPLETED|Overall Study||59
2918238|NCT00525525|3628407|FG001|COMPLETED|Overall Study||15
2918239|NCT00525525|3628406|FG000|NOT COMPLETED|Overall Study||0
2918240|NCT00525525|3628407|FG001|NOT COMPLETED|Overall Study||0
2918241|NCT00525590|3628413|FG000|STARTED|Overall Study||59
2918242|NCT00525590|3628413|FG000|COMPLETED|Overall Study||14
2918243|NCT00525590|3628413|FG000|NOT COMPLETED|Overall Study||45
2918244|NCT00525603|3628417|FG000|STARTED|Overall Study||60
2918245|NCT00525603|3628417|FG000|COMPLETED|Overall Study||60
2918246|NCT00525603|3628417|FG000|NOT COMPLETED|Overall Study||0
2918247|NCT00525629|3628421|FG000|STARTED|First Intervention||20
2918248|NCT00525629|3628422|FG001|STARTED|First Intervention||20
2918249|NCT00525629|3628421|FG000|COMPLETED|First Intervention||15
2918250|NCT00525629|3628422|FG001|COMPLETED|First Intervention||15
2855721|NCT00067808|3558045|FG000|STARTED|Overall Study||17
2855722|NCT00067808|3558046|FG001|STARTED|Overall Study||93
2855723|NCT00067808|3558047|FG002|STARTED|Overall Study||14
2855724|NCT00067808|3558045|FG000|COMPLETED|Overall Study||17
2855725|NCT00067808|3558046|FG001|COMPLETED|Overall Study||93
2855726|NCT00067808|3558047|FG002|COMPLETED|Overall Study||14
2855727|NCT00067808|3558045|FG000|NOT COMPLETED|Overall Study||0
2855728|NCT00067808|3558046|FG001|NOT COMPLETED|Overall Study||0
2855729|NCT00067808|3558047|FG002|NOT COMPLETED|Overall Study||0
2855730|NCT00067990|3558057|FG000|STARTED|Overall Study||77
2855731|NCT00067990|3558058|FG001|STARTED|Overall Study||76
2855732|NCT00067990|3558057|FG000|COMPLETED|Overall Study||67
2855733|NCT00067990|3558058|FG001|COMPLETED|Overall Study||54
2855734|NCT00067990|3558057|FG000|NOT COMPLETED|Overall Study||10
2855735|NCT00067990|3558058|FG001|NOT COMPLETED|Overall Study||22
2855736|NCT00068107|3558064|FG000|STARTED|Overall Study||12
2855737|NCT00068107|3558064|FG000|COMPLETED|Overall Study||3
2855738|NCT00068107|3558064|FG000|NOT COMPLETED|Overall Study||9
2855739|NCT00068237|3558071|FG000|STARTED|Overall Study||49
2855740|NCT00068237|3558071|FG000|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|44
2855741|NCT00068237|3558071|FG000|NOT COMPLETED|Overall Study||5
2855742|NCT00068250|3558078|FG000|STARTED|Phase I: Dose Level 1||6
2855743|NCT00068250|3558079|FG001|STARTED|Phase I: Dose Level 1||0
2855744|NCT00068250|3558080|FG002|STARTED|Phase I: Dose Level 1||0
2855745|NCT00068250|3558081|FG003|STARTED|Phase I: Dose Level 1||0
2855746|NCT00068250|3558078|FG000|COMPLETED|Phase I: Dose Level 1|Subjects with data available for the primary analysis are considered to have completed the study.|6
2855747|NCT00068250|3558079|FG001|COMPLETED|Phase I: Dose Level 1||0
2855748|NCT00068250|3558080|FG002|COMPLETED|Phase I: Dose Level 1||0
2855749|NCT00068250|3558081|FG003|COMPLETED|Phase I: Dose Level 1||0
2855750|NCT00068250|3558078|FG000|NOT COMPLETED|Phase I: Dose Level 1||0
2855751|NCT00068250|3558079|FG001|NOT COMPLETED|Phase I: Dose Level 1||0
2855752|NCT00068250|3558080|FG002|NOT COMPLETED|Phase I: Dose Level 1||0
2855753|NCT00068250|3558081|FG003|NOT COMPLETED|Phase I: Dose Level 1||0
2855754|NCT00068250|3558078|FG000|STARTED|Phase I: Dose Level 2||0
2855755|NCT00068250|3558079|FG001|STARTED|Phase I: Dose Level 2||7
2855756|NCT00068250|3558080|FG002|STARTED|Phase I: Dose Level 2||0
2855757|NCT00068250|3558081|FG003|STARTED|Phase I: Dose Level 2||0
2855758|NCT00068250|3558078|FG000|COMPLETED|Phase I: Dose Level 2||0
2855759|NCT00068250|3558079|FG001|COMPLETED|Phase I: Dose Level 2|Subjects with data available for the primary analysis are considered to have completed the study.|6
2855760|NCT00068250|3558080|FG002|COMPLETED|Phase I: Dose Level 2||0
2855761|NCT00068250|3558081|FG003|COMPLETED|Phase I: Dose Level 2||0
2855762|NCT00068250|3558078|FG000|NOT COMPLETED|Phase I: Dose Level 2||0
2855763|NCT00068250|3558079|FG001|NOT COMPLETED|Phase I: Dose Level 2||1
2855764|NCT00068250|3558080|FG002|NOT COMPLETED|Phase I: Dose Level 2||0
2855765|NCT00068250|3558081|FG003|NOT COMPLETED|Phase I: Dose Level 2||0
2855766|NCT00068250|3558078|FG000|STARTED|Phase II: Dose Level 2||0
2855767|NCT00068250|3558079|FG001|STARTED|Phase II: Dose Level 2||0
2855768|NCT00068250|3558080|FG002|STARTED|Phase II: Dose Level 2||0
2855769|NCT00068250|3558081|FG003|STARTED|Phase II: Dose Level 2||47
2855770|NCT00068250|3558078|FG000|COMPLETED|Phase II: Dose Level 2||0
2855771|NCT00068250|3558079|FG001|COMPLETED|Phase II: Dose Level 2||0
2855772|NCT00068250|3558080|FG002|COMPLETED|Phase II: Dose Level 2||0
2855773|NCT00068250|3558081|FG003|COMPLETED|Phase II: Dose Level 2|Subjects with data available for the primary analysis are considered to have completed the study.|47
2855774|NCT00068250|3558078|FG000|NOT COMPLETED|Phase II: Dose Level 2||0
2855775|NCT00068250|3558079|FG001|NOT COMPLETED|Phase II: Dose Level 2||0
2855776|NCT00068250|3558080|FG002|NOT COMPLETED|Phase II: Dose Level 2||0
2855777|NCT00068250|3558081|FG003|NOT COMPLETED|Phase II: Dose Level 2||0
2855778|NCT00068341|3558092|FG000|STARTED|Overall Study||15
2855779|NCT00068341|3558093|FG001|STARTED|Overall Study||15
2855780|NCT00068341|3558094|FG002|STARTED|Overall Study||44
2855781|NCT00068341|3558092|FG000|COMPLETED|Overall Study||15
2855782|NCT00068341|3558093|FG001|COMPLETED|Overall Study||15
2855783|NCT00068341|3558094|FG002|COMPLETED|Overall Study||44
2855784|NCT00068341|3558092|FG000|NOT COMPLETED|Overall Study||0
2855785|NCT00068341|3558093|FG001|NOT COMPLETED|Overall Study||0
2855786|NCT00068341|3558094|FG002|NOT COMPLETED|Overall Study||0
2855787|NCT00068367|3558115|FG000|STARTED|Overall Study||20
2855788|NCT00068367|3558115|FG000|COMPLETED|Overall Study||20
2855789|NCT00068367|3558115|FG000|NOT COMPLETED|Overall Study||0
2855790|NCT00068380|3558119|FG000|STARTED|Overall Study||17
2855791|NCT00068380|3558119|FG000|COMPLETED|Overall Study||12
2855792|NCT00068380|3558119|FG000|NOT COMPLETED|Overall Study||5
2855793|NCT00068393|3558123|FG000|STARTED|Overall Study||39
2855794|NCT00068393|3558123|FG000|Eligible and Treated|Overall Study||38
2855795|NCT00068393|3558123|FG000|COMPLETED|Overall Study||29
2855796|NCT00068393|3558123|FG000|NOT COMPLETED|Overall Study||10
2855797|NCT00068406|3558127|FG000|STARTED|Overall Study||61
2855798|NCT00068406|3558127|FG000|COMPLETED|Overall Study||58
2855799|NCT00068406|3558127|FG000|NOT COMPLETED|Overall Study||3
2855800|NCT00068419|3558131|FG000|STARTED|Overall Study||70
2855801|NCT00068419|3558131|FG000|COMPLETED|Overall Study|Participant flow data reported here are for the period of protocol therapy.|10
2855802|NCT00068419|3558131|FG000|NOT COMPLETED|Overall Study||60
2855803|NCT00068445|3558137|FG000|STARTED|Randomization||65
2855804|NCT00068445|3558138|FG001|STARTED|Randomization||66
2855805|NCT00068445|3558137|FG000|COMPLETED|Randomization||63
2855806|NCT00068445|3558138|FG001|COMPLETED|Randomization||62
2855807|NCT00068445|3558137|FG000|NOT COMPLETED|Randomization||2
2855808|NCT00068445|3558138|FG001|NOT COMPLETED|Randomization||4
2855809|NCT00068445|3558137|FG000|STARTED|Treatment||63
2855810|NCT00068445|3558138|FG001|STARTED|Treatment||62
2855811|NCT00068445|3558137|FG000|COMPLETED|Treatment||34
2855812|NCT00068445|3558138|FG001|COMPLETED|Treatment||46
2855813|NCT00068445|3558137|FG000|NOT COMPLETED|Treatment||29
2855814|NCT00068445|3558138|FG001|NOT COMPLETED|Treatment||16
2855815|NCT00068575|3558144|FG000|STARTED|Overall Study||28
2855816|NCT00068575|3558144|FG000|COMPLETED|Overall Study||28
2855817|NCT00068575|3558144|FG000|NOT COMPLETED|Overall Study||0
2855818|NCT00068588|3558151|FG000|STARTED|Overall Study||0
2855819|NCT00068588|3558152|FG001|STARTED|Overall Study||3
2855820|NCT00068588|3558153|FG002|STARTED|Overall Study||21
2855821|NCT00068588|3558151|FG000|COMPLETED|Overall Study||0
2855822|NCT00068588|3558152|FG001|COMPLETED|Overall Study||3
2855823|NCT00068588|3558153|FG002|COMPLETED|Overall Study||17
2855824|NCT00068588|3558151|FG000|NOT COMPLETED|Overall Study||0
2855825|NCT00068588|3558152|FG001|NOT COMPLETED|Overall Study||0
2855826|NCT00068588|3558153|FG002|NOT COMPLETED|Overall Study||4
2855827|NCT00068601|3558162|FG000|STARTED|Overall Study||131
2855828|NCT00068601|3558163|FG001|STARTED|Overall Study||126
2855829|NCT00068601|3558162|FG000|COMPLETED|Overall Study||69
2855830|NCT00068601|3558163|FG001|COMPLETED|Overall Study||66
2855831|NCT00068601|3558162|FG000|NOT COMPLETED|Overall Study||62
2855832|NCT00068601|3558163|FG001|NOT COMPLETED|Overall Study||60
2855833|NCT00068692|3558172|FG000|STARTED|Step 1: Registration||128
2855834|NCT00068692|3558173|FG001|STARTED|Step 1: Registration|Group II patients were registered and randomized at the same time, and were reported in Step 2.|97
2855835|NCT00068692|3558174|FG002|STARTED|Step 1: Registration||0
2855836|NCT00068692|3558175|FG003|STARTED|Step 1: Registration||0
2855837|NCT00068692|3558176|FG004|STARTED|Step 1: Registration||0
2855838|NCT00068692|3558177|FG005|STARTED|Step 1: Registration|Group II patients was registered and randomized at the same time, and reported in step 2|0
2855839|NCT00068692|3558178|FG006|STARTED|Step 1: Registration|Group II patients was registered and randomized at the same time, and reported in step 2|0
2855840|NCT00068692|3558179|FG007|STARTED|Step 1: Registration|Group II patients was registered and randomized at the same time, and reported in step 2|0
2855841|NCT00068692|3558172|FG000|Started Concurrent Chemo/Radiation|Step 1: Registration||125
2855842|NCT00068692|3558173|FG001|Started Concurrent Chemo/Radiation|Step 1: Registration|Group II patients receive protocol therapy in Step 2 after randomization|0
2855843|NCT00068692|3558174|FG002|Started Concurrent Chemo/Radiation|Step 1: Registration||0
2855844|NCT00068692|3558175|FG003|Started Concurrent Chemo/Radiation|Step 1: Registration||0
2855845|NCT00068692|3558176|FG004|Started Concurrent Chemo/Radiation|Step 1: Registration||0
2855846|NCT00068692|3558177|FG005|Started Concurrent Chemo/Radiation|Step 1: Registration||0
2855847|NCT00068692|3558178|FG006|Started Concurrent Chemo/Radiation|Step 1: Registration||0
2855848|NCT00068692|3558179|FG007|Started Concurrent Chemo/Radiation|Step 1: Registration||0
2855849|NCT00068692|3558172|FG000|Reported AE Data|Step 1: Registration||123
2855850|NCT00068692|3558173|FG001|Reported AE Data|Step 1: Registration||0
2855851|NCT00068692|3558174|FG002|Reported AE Data|Step 1: Registration||0
2855852|NCT00068692|3558175|FG003|Reported AE Data|Step 1: Registration||0
2855853|NCT00068692|3558176|FG004|Reported AE Data|Step 1: Registration||0
2855854|NCT00068692|3558177|FG005|Reported AE Data|Step 1: Registration||0
2855855|NCT00068692|3558178|FG006|Reported AE Data|Step 1: Registration||0
2855856|NCT00068692|3558179|FG007|Reported AE Data|Step 1: Registration||0
2855857|NCT00068692|3558172|FG000|COMPLETED|Step 1: Registration||88
2855858|NCT00068692|3558173|FG001|COMPLETED|Step 1: Registration|Case 32191 entered the study as Group II patient but was never randomized.|96
2855859|NCT00068692|3558174|FG002|COMPLETED|Step 1: Registration||0
2855860|NCT00068692|3558175|FG003|COMPLETED|Step 1: Registration||0
2855861|NCT00068692|3558176|FG004|COMPLETED|Step 1: Registration||0
2855862|NCT00068692|3558177|FG005|COMPLETED|Step 1: Registration||0
2855863|NCT00068692|3558178|FG006|COMPLETED|Step 1: Registration||0
2855864|NCT00068692|3558179|FG007|COMPLETED|Step 1: Registration||0
3168654|NCT01920061|3895949|FG010|NOT COMPLETED|Overall Study||5
3168655|NCT01920061|3895950|FG011|NOT COMPLETED|Overall Study||3
3168656|NCT01920061|3895951|FG012|NOT COMPLETED|Overall Study||2
2855865|NCT00068692|3558172|FG000|NOT COMPLETED|Step 1: Registration||40
2855866|NCT00068692|3558173|FG001|NOT COMPLETED|Step 1: Registration||1
2855867|NCT00068692|3558174|FG002|NOT COMPLETED|Step 1: Registration||0
2855868|NCT00068692|3558175|FG003|NOT COMPLETED|Step 1: Registration||0
2855869|NCT00068692|3558176|FG004|NOT COMPLETED|Step 1: Registration||0
2855870|NCT00068692|3558177|FG005|NOT COMPLETED|Step 1: Registration||0
2855871|NCT00068692|3558178|FG006|NOT COMPLETED|Step 1: Registration||0
2855872|NCT00068692|3558179|FG007|NOT COMPLETED|Step 1: Registration||0
2855873|NCT00068692|3558172|FG000|STARTED|Step 2: Randomization|Patients on arm S completing step 1 treatment were randomized to step 2 (Arms I-III).|0
2855874|NCT00068692|3558173|FG001|STARTED|Step 2: Randomization|Group II patients were registered and randomized at the same time, reported as arms I,II,III here.|0
2855875|NCT00068692|3558174|FG002|STARTED|Step 2: Randomization|Of the 128 patients registered to step 1in group 1, 83 were randomized to step 2(arms I-III).|28
2855876|NCT00068692|3558175|FG003|STARTED|Step 2: Randomization|Of the 128 patients registered to step 1in group 1, 83 were randomized to step 2(arms I-III).|25
2855877|NCT00068692|3558176|FG004|STARTED|Step 2: Randomization|Of the 128 patients registered to step 1in group 1, 83 were randomized to step 2(arms I-III).|30
2855878|NCT00068692|3558177|FG005|STARTED|Step 2: Randomization|Group 2 patients were registered and randomized at the same time.|31
2855879|NCT00068692|3558178|FG006|STARTED|Step 2: Randomization|Group 2 patients were registered and randomized at the same time.|33
2855880|NCT00068692|3558179|FG007|STARTED|Step 2: Randomization|Group 2 patients were registered and randomized at the same time.|32
2855881|NCT00068692|3558172|FG000|Treated|Step 2: Randomization||0
2855882|NCT00068692|3558173|FG001|Treated|Step 2: Randomization||0
2855883|NCT00068692|3558174|FG002|Treated|Step 2: Randomization||27
2855884|NCT00068692|3558175|FG003|Treated|Step 2: Randomization||25
2855885|NCT00068692|3558176|FG004|Treated|Step 2: Randomization||29
2855886|NCT00068692|3558177|FG005|Treated|Step 2: Randomization||31
2855887|NCT00068692|3558178|FG006|Treated|Step 2: Randomization||33
2855888|NCT00068692|3558179|FG007|Treated|Step 2: Randomization||32
2855889|NCT00068692|3558172|FG000|Had Sphincter Preservation|Step 2: Randomization||0
2855890|NCT00068692|3558173|FG001|Had Sphincter Preservation|Step 2: Randomization||0
2855891|NCT00068692|3558174|FG002|Had Sphincter Preservation|Step 2: Randomization||28
2855892|NCT00068692|3558175|FG003|Had Sphincter Preservation|Step 2: Randomization||25
2855893|NCT00068692|3558176|FG004|Had Sphincter Preservation|Step 2: Randomization||28
2855894|NCT00068692|3558177|FG005|Had Sphincter Preservation|Step 2: Randomization||31
2855895|NCT00068692|3558178|FG006|Had Sphincter Preservation|Step 2: Randomization||33
2855896|NCT00068692|3558179|FG007|Had Sphincter Preservation|Step 2: Randomization||30
2855897|NCT00068692|3558172|FG000|Reported AE Data|Step 2: Randomization||0
2855898|NCT00068692|3558173|FG001|Reported AE Data|Step 2: Randomization||0
2855899|NCT00068692|3558174|FG002|Reported AE Data|Step 2: Randomization||27
2855900|NCT00068692|3558175|FG003|Reported AE Data|Step 2: Randomization||22
2855901|NCT00068692|3558176|FG004|Reported AE Data|Step 2: Randomization||28
2855902|NCT00068692|3558177|FG005|Reported AE Data|Step 2: Randomization||31
2855903|NCT00068692|3558178|FG006|Reported AE Data|Step 2: Randomization||33
2855904|NCT00068692|3558179|FG007|Reported AE Data|Step 2: Randomization||32
2855905|NCT00068692|3558172|FG000|COMPLETED|Step 2: Randomization||0
2855906|NCT00068692|3558173|FG001|COMPLETED|Step 2: Randomization||0
2855907|NCT00068692|3558174|FG002|COMPLETED|Step 2: Randomization||18
2855908|NCT00068692|3558175|FG003|COMPLETED|Step 2: Randomization||13
2855909|NCT00068692|3558176|FG004|COMPLETED|Step 2: Randomization||21
2855910|NCT00068692|3558177|FG005|COMPLETED|Step 2: Randomization||25
2855911|NCT00068692|3558178|FG006|COMPLETED|Step 2: Randomization||29
2855912|NCT00068692|3558179|FG007|COMPLETED|Step 2: Randomization||24
2855913|NCT00068692|3558172|FG000|NOT COMPLETED|Step 2: Randomization||0
2855914|NCT00068692|3558173|FG001|NOT COMPLETED|Step 2: Randomization||0
2855915|NCT00068692|3558174|FG002|NOT COMPLETED|Step 2: Randomization||10
2855916|NCT00068692|3558175|FG003|NOT COMPLETED|Step 2: Randomization||12
2855917|NCT00068692|3558176|FG004|NOT COMPLETED|Step 2: Randomization||9
2855918|NCT00068692|3558177|FG005|NOT COMPLETED|Step 2: Randomization||6
2855919|NCT00068692|3558178|FG006|NOT COMPLETED|Step 2: Randomization||4
2855920|NCT00068692|3558179|FG007|NOT COMPLETED|Step 2: Randomization||8
2855921|NCT00068718|3558192|FG000|STARTED|Overall Study||35
2855922|NCT00068718|3558192|FG000|COMPLETED|Overall Study||35
2855923|NCT00068718|3558192|FG000|NOT COMPLETED|Overall Study||0
2855924|NCT00068770|3558198|FG000|STARTED|Overall Study||13
2855925|NCT00068770|3558199|FG001|STARTED|Overall Study||22
2855926|NCT00068770|3558198|FG000|COMPLETED|Overall Study||13
2855927|NCT00068770|3558199|FG001|COMPLETED|Overall Study||22
2855928|NCT00068770|3558198|FG000|NOT COMPLETED|Overall Study||0
2855929|NCT00068770|3558199|FG001|NOT COMPLETED|Overall Study||0
2855930|NCT00068822|3558209|FG000|STARTED|First Randomized Intervention||68
2855931|NCT00068822|3558210|FG001|STARTED|First Randomized Intervention||63
2855932|NCT00068822|3558209|FG000|COMPLETED|First Randomized Intervention||67
2855933|NCT00068822|3558210|FG001|COMPLETED|First Randomized Intervention||61
2855934|NCT00068822|3558209|FG000|NOT COMPLETED|First Randomized Intervention||1
2855935|NCT00068822|3558210|FG001|NOT COMPLETED|First Randomized Intervention||2
2855936|NCT00068822|3558209|FG000|STARTED|Optional Crossover Intervention||9
2855937|NCT00068822|3558210|FG001|STARTED|Optional Crossover Intervention||29
2855938|NCT00068822|3558209|FG000|Crossover at Month 1|Optional Crossover Intervention||1
2855939|NCT00068822|3558210|FG001|Crossover at Month 1|Optional Crossover Intervention||2
2855940|NCT00068822|3558209|FG000|Crossover at Month 3|Optional Crossover Intervention||8
2855941|NCT00068822|3558210|FG001|Crossover at Month 3|Optional Crossover Intervention||27
2855942|NCT00068822|3558209|FG000|COMPLETED|Optional Crossover Intervention||9
2855943|NCT00068822|3558210|FG001|COMPLETED|Optional Crossover Intervention||29
2855944|NCT00068822|3558209|FG000|NOT COMPLETED|Optional Crossover Intervention||0
2855945|NCT00068822|3558210|FG001|NOT COMPLETED|Optional Crossover Intervention||0
2855946|NCT00069095|3558222|FG000|STARTED|Primary Treatment Phase||317
2855947|NCT00069095|3558223|FG001|STARTED|Primary Treatment Phase||317
2855948|NCT00069095|3558224|FG002|STARTED|Primary Treatment Phase||350
2855949|NCT00069095|3558225|FG003|STARTED|Primary Treatment Phase||351
2855950|NCT00069095|3558226|FG004|STARTED|Primary Treatment Phase||350
2855951|NCT00069095|3558227|FG005|STARTED|Primary Treatment Phase||349
2855952|NCT00069095|3558222|FG000|COMPLETED|Primary Treatment Phase||22
2855953|NCT00069095|3558223|FG001|COMPLETED|Primary Treatment Phase||15
2855954|NCT00069095|3558224|FG002|COMPLETED|Primary Treatment Phase||36
2855955|NCT00069095|3558225|FG003|COMPLETED|Primary Treatment Phase||31
2855956|NCT00069095|3558226|FG004|COMPLETED|Primary Treatment Phase||48
2855957|NCT00069095|3558227|FG005|COMPLETED|Primary Treatment Phase||48
2855958|NCT00069095|3558222|FG000|NOT COMPLETED|Primary Treatment Phase||295
2855959|NCT00069095|3558223|FG001|NOT COMPLETED|Primary Treatment Phase||302
2855960|NCT00069095|3558224|FG002|NOT COMPLETED|Primary Treatment Phase||314
2855961|NCT00069095|3558225|FG003|NOT COMPLETED|Primary Treatment Phase||320
2855962|NCT00069095|3558226|FG004|NOT COMPLETED|Primary Treatment Phase||302
2855963|NCT00069095|3558227|FG005|NOT COMPLETED|Primary Treatment Phase||301
2855964|NCT00069095|3558222|FG000|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|8
2855965|NCT00069095|3558223|FG001|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|13
2855966|NCT00069095|3558224|FG002|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|21
2855967|NCT00069095|3558225|FG003|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|17
2855968|NCT00069095|3558226|FG004|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|36
2855969|NCT00069095|3558227|FG005|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|29
2855970|NCT00069095|3558222|FG000|COMPLETED|Post-study Treatment Phase||0
2855971|NCT00069095|3558223|FG001|COMPLETED|Post-study Treatment Phase||0
2855972|NCT00069095|3558224|FG002|COMPLETED|Post-study Treatment Phase||0
2855973|NCT00069095|3558225|FG003|COMPLETED|Post-study Treatment Phase||0
2855974|NCT00069095|3558226|FG004|COMPLETED|Post-study Treatment Phase||0
2855975|NCT00069095|3558227|FG005|COMPLETED|Post-study Treatment Phase||0
2855976|NCT00069095|3558222|FG000|NOT COMPLETED|Post-study Treatment Phase||8
2855977|NCT00069095|3558223|FG001|NOT COMPLETED|Post-study Treatment Phase||13
2855978|NCT00069095|3558224|FG002|NOT COMPLETED|Post-study Treatment Phase||21
2855979|NCT00069095|3558225|FG003|NOT COMPLETED|Post-study Treatment Phase||17
2855980|NCT00069095|3558226|FG004|NOT COMPLETED|Post-study Treatment Phase||36
2855981|NCT00069095|3558227|FG005|NOT COMPLETED|Post-study Treatment Phase||29
2855982|NCT00069095|3558222|FG000|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|284
2855983|NCT00069095|3558223|FG001|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|299
2855984|NCT00069095|3558224|FG002|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|298
2855985|NCT00069095|3558225|FG003|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|299
2855986|NCT00069095|3558226|FG004|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|278
2855987|NCT00069095|3558227|FG005|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|272
2855988|NCT00069095|3558222|FG000|COMPLETED|Follow-up Phase||110
2855989|NCT00069095|3558223|FG001|COMPLETED|Follow-up Phase||93
2855990|NCT00069095|3558224|FG002|COMPLETED|Follow-up Phase||178
2855991|NCT00069095|3558225|FG003|COMPLETED|Follow-up Phase||187
2855992|NCT00069095|3558226|FG004|COMPLETED|Follow-up Phase||186
2855993|NCT00069095|3558227|FG005|COMPLETED|Follow-up Phase||171
2855994|NCT00069095|3558222|FG000|NOT COMPLETED|Follow-up Phase||174
2855995|NCT00069095|3558223|FG001|NOT COMPLETED|Follow-up Phase||206
2855996|NCT00069095|3558224|FG002|NOT COMPLETED|Follow-up Phase||120
2855997|NCT00069095|3558225|FG003|NOT COMPLETED|Follow-up Phase||112
2855998|NCT00069095|3558226|FG004|NOT COMPLETED|Follow-up Phase||92
2855999|NCT00069095|3558227|FG005|NOT COMPLETED|Follow-up Phase||101
2856000|NCT00069108|3558241|FG000|STARTED|Overall Study||313
2856001|NCT00069108|3558242|FG001|STARTED|Overall Study||314
2856002|NCT00069108|3558241|FG000|COMPLETED|Overall Study||100
2856003|NCT00069108|3558242|FG001|COMPLETED|Overall Study||95
2856004|NCT00069108|3558241|FG000|NOT COMPLETED|Overall Study||213
2856005|NCT00069108|3558242|FG001|NOT COMPLETED|Overall Study||219
2856006|NCT00069121|3558251|FG000|STARTED|Overall Study||942
2856007|NCT00069121|3558252|FG001|STARTED|Overall Study||944
2856008|NCT00069121|3558251|FG000|Received Treatment|Overall Study|Safety Population|926
2856009|NCT00069121|3558252|FG001|Received Treatment|Overall Study|Safety Population|938
2856010|NCT00069121|3558251|FG000|COMPLETED|Overall Study|total includes Completed and Alive in follow-up|575
2856011|NCT00069121|3558252|FG001|COMPLETED|Overall Study|total includes Completed and Alive in follow-up|619
2856012|NCT00069121|3558251|FG000|NOT COMPLETED|Overall Study||367
2856013|NCT00069121|3558252|FG001|NOT COMPLETED|Overall Study||325
2856014|NCT00069160|3558264|FG000|STARTED|Overall Study||23
2856015|NCT00069160|3558265|FG001|STARTED|Overall Study||25
2856016|NCT00069160|3558264|FG000|COMPLETED|Overall Study||23
2856017|NCT00069160|3558265|FG001|COMPLETED|Overall Study||25
2856018|NCT00069160|3558264|FG000|NOT COMPLETED|Overall Study||0
2856019|NCT00069160|3558265|FG001|NOT COMPLETED|Overall Study||0
2856020|NCT00069264|3558274|FG000|STARTED|Overall Study||32
2856021|NCT00069264|3558274|FG000|COMPLETED|Overall Study||0
2856022|NCT00069264|3558274|FG000|NOT COMPLETED|Overall Study||32
2856023|NCT00069277|3558278|FG000|STARTED|Overall Study||21
2856024|NCT00069277|3558278|FG000|COMPLETED|Overall Study||0
2856025|NCT00069277|3558278|FG000|NOT COMPLETED|Overall Study||21
2856026|NCT00069329|3558282|FG000|STARTED|Overall Study||43
2856027|NCT00069329|3558282|FG000|COMPLETED|Overall Study||41
2856028|NCT00069329|3558282|FG000|NOT COMPLETED|Overall Study||2
2856029|NCT00069576|3558288|FG000|STARTED|Original Trial||485
2856030|NCT00069576|3558289|FG001|STARTED|Original Trial||473
2856031|NCT00069576|3558288|FG000|COMPLETED|Original Trial||460
2856032|NCT00069576|3558289|FG001|COMPLETED|Original Trial||440
2856033|NCT00069576|3558288|FG000|NOT COMPLETED|Original Trial||25
2856034|NCT00069576|3558289|FG001|NOT COMPLETED|Original Trial||33
2856035|NCT00069576|3558288|FG000|STARTED|Follow-up Study at 5-10 Years||460
2856036|NCT00069576|3558289|FG001|STARTED|Follow-up Study at 5-10 Years||440
2856037|NCT00069576|3558288|FG000|COMPLETED|Follow-up Study at 5-10 Years||264
2856038|NCT00069576|3558289|FG001|COMPLETED|Follow-up Study at 5-10 Years||236
2856039|NCT00069576|3558288|FG000|NOT COMPLETED|Follow-up Study at 5-10 Years||196
2856040|NCT00069576|3558289|FG001|NOT COMPLETED|Follow-up Study at 5-10 Years||204
2856041|NCT00069641|3558298|FG000|STARTED|Overall Study||32
2856042|NCT00069641|3558299|FG001|STARTED|Overall Study||32
2856043|NCT00069641|3558300|FG002|STARTED|Overall Study||32
2856044|NCT00069641|3558298|FG000|COMPLETED|Overall Study||31
2856045|NCT00069641|3558299|FG001|COMPLETED|Overall Study||32
2856046|NCT00069641|3558300|FG002|COMPLETED|Overall Study||31
2856047|NCT00069641|3558298|FG000|NOT COMPLETED|Overall Study||1
2856048|NCT00069641|3558299|FG001|NOT COMPLETED|Overall Study||0
2856049|NCT00069641|3558300|FG002|NOT COMPLETED|Overall Study||1
2856050|NCT00069784|3558311|FG000|STARTED|Overall Study|randomized participants = intent-to-treat (ITT) population|6264
2856051|NCT00069784|3558312|FG001|STARTED|Overall Study|randomized participants = intent-to-treat (ITT) population|6273
2856052|NCT00069784|3558311|FG000|Safety Population (Treated)|Overall Study|randomized patients who received at least one dose of insulin glargine|6231
2856053|NCT00069784|3558312|FG001|Safety Population (Treated)|Overall Study|patients randomized to standard care arm|6273
2856054|NCT00069784|3558311|FG000|COMPLETED|Overall Study|completed study treatment|5052
2856055|NCT00069784|3558312|FG001|COMPLETED|Overall Study|not applicable (no treatment)|6273
2856056|NCT00069784|3558311|FG000|NOT COMPLETED|Overall Study||1212
2856057|NCT00069784|3558312|FG001|NOT COMPLETED|Overall Study||0
2856058|NCT00069823|3558320|FG000|STARTED|Overall Study|The design was for 200 participants per group, the study did not exactly meet the design.|199
2856059|NCT00069823|3558321|FG001|STARTED|Overall Study|The design was for 200 participants per group, the study did not exactly meet the design.|203
2856060|NCT00069823|3558320|FG000|COMPLETED|Overall Study||193
2856061|NCT00069823|3558321|FG001|COMPLETED|Overall Study||200
2856062|NCT00069823|3558320|FG000|NOT COMPLETED|Overall Study||6
2856063|NCT00069823|3558321|FG001|NOT COMPLETED|Overall Study||3
2856064|NCT00069953|3558327|FG000|STARTED|Overall Study||43
2856065|NCT00069953|3558327|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study|41
2856066|NCT00069953|3558327|FG000|NOT COMPLETED|Overall Study||2
2856067|NCT00070070|3558335|FG000|STARTED|Overall Study||1
2856068|NCT00070070|3558336|FG001|STARTED|Overall Study||0
2856069|NCT00070070|3558337|FG002|STARTED|Overall Study||0
2856070|NCT00070070|3558338|FG003|STARTED|Overall Study||5
2856071|NCT00070070|3558335|FG000|COMPLETED|Overall Study||1
2856072|NCT00070070|3558336|FG001|COMPLETED|Overall Study||0
2856073|NCT00070070|3558337|FG002|COMPLETED|Overall Study||0
2856074|NCT00070070|3558338|FG003|COMPLETED|Overall Study||5
2856075|NCT00070070|3558335|FG000|NOT COMPLETED|Overall Study||0
2856076|NCT00070070|3558336|FG001|NOT COMPLETED|Overall Study||0
2856077|NCT00070070|3558337|FG002|NOT COMPLETED|Overall Study||0
2856078|NCT00070070|3558338|FG003|NOT COMPLETED|Overall Study||0
2856079|NCT00070109|3558353|FG000|STARTED|Overall Study||8
2856080|NCT00070109|3558354|FG001|STARTED|Overall Study||6
2856081|NCT00070109|3558355|FG002|STARTED|Overall Study||8
2856082|NCT00070109|3558356|FG003|STARTED|Overall Study||20
2856083|NCT00070109|3558357|FG004|STARTED|Overall Study||8
2856084|NCT00070109|3558353|FG000|COMPLETED|Overall Study||0
2856085|NCT00070109|3558354|FG001|COMPLETED|Overall Study||0
2856086|NCT00070109|3558355|FG002|COMPLETED|Overall Study||0
2856087|NCT00070109|3558356|FG003|COMPLETED|Overall Study||0
2856088|NCT00070109|3558357|FG004|COMPLETED|Overall Study||0
2856089|NCT00070109|3558353|FG000|NOT COMPLETED|Overall Study||8
2856090|NCT00070109|3558354|FG001|NOT COMPLETED|Overall Study||6
2856091|NCT00070109|3558355|FG002|NOT COMPLETED|Overall Study||8
2856092|NCT00070109|3558356|FG003|NOT COMPLETED|Overall Study||20
2856093|NCT00070109|3558357|FG004|NOT COMPLETED|Overall Study||8
2856094|NCT00070135|3558376|FG000|STARTED|Overall Study||114
2856095|NCT00070135|3558376|FG000|COMPLETED|Overall Study||114
2856096|NCT00070135|3558376|FG000|NOT COMPLETED|Overall Study||0
2856097|NCT00070291|3558380|FG000|STARTED|Step 1||4
2856098|NCT00070291|3558380|FG000|Treated|Step 1||3
2856099|NCT00070291|3558380|FG000|COMPLETED|Step 1||2
2856100|NCT00070291|3558380|FG000|NOT COMPLETED|Step 1||2
2856101|NCT00070291|3558380|FG000|STARTED|Step 2|One patient completed step 1, but opted to get alternative therapy. One patient entered step 2.|1
2856102|NCT00070291|3558380|FG000|COMPLETED|Step 2||0
2856103|NCT00070291|3558380|FG000|NOT COMPLETED|Step 2||1
2856104|NCT00070317|3558384|FG000|STARTED|Overall Study||102
2856105|NCT00070317|3558384|FG000|COMPLETED|Overall Study||89
2856106|NCT00070317|3558384|FG000|NOT COMPLETED|Overall Study||13
2856107|NCT00070941|3558391|FG000|STARTED|Overall Study||12
2856108|NCT00070941|3558392|FG001|STARTED|Overall Study||11
2856109|NCT00070941|3558393|FG002|STARTED|Overall Study||6
2856110|NCT00070941|3558391|FG000|COMPLETED|Overall Study||2
2856111|NCT00070941|3558392|FG001|COMPLETED|Overall Study||3
2856112|NCT00070941|3558393|FG002|COMPLETED|Overall Study||2
2856113|NCT00070941|3558391|FG000|NOT COMPLETED|Overall Study||10
2856114|NCT00070941|3558392|FG001|NOT COMPLETED|Overall Study||8
2856115|NCT00070941|3558393|FG002|NOT COMPLETED|Overall Study||4
2856116|NCT00071006|3558401|FG000|STARTED|Overall Study||12
2856117|NCT00071006|3558401|FG000|COMPLETED|Overall Study||0
2856118|NCT00071006|3558401|FG000|NOT COMPLETED|Overall Study||12
2856119|NCT00071032|3558407|FG000|STARTED|Overall Study||1007
2856120|NCT00071032|3558408|FG001|STARTED|Overall Study||1009
2856121|NCT00071032|3558407|FG000|COMPLETED|Overall Study||998
2856122|NCT00071032|3558408|FG001|COMPLETED|Overall Study||1001
2856123|NCT00071032|3558407|FG000|NOT COMPLETED|Overall Study||9
2856124|NCT00071032|3558408|FG001|NOT COMPLETED|Overall Study||8
2856125|NCT00071058|3558415|FG000|STARTED|Overall Study||50
2856126|NCT00071058|3558415|FG000|COMPLETED|Overall Study||49
2856127|NCT00071058|3558415|FG000|NOT COMPLETED|Overall Study||1
2856128|NCT00071110|3558422|FG000|STARTED|Overall Study||28
2856129|NCT00071110|3558423|FG001|STARTED|Overall Study||29
2856130|NCT00071110|3558422|FG000|COMPLETED|Overall Study||28
2856131|NCT00071110|3558423|FG001|COMPLETED|Overall Study||25
2856132|NCT00071110|3558422|FG000|NOT COMPLETED|Overall Study||0
2856133|NCT00071110|3558423|FG001|NOT COMPLETED|Overall Study||4
2856134|NCT00071396|3558429|FG000|STARTED|Overall Study||44
2856135|NCT00071396|3558429|FG000|COMPLETED|Overall Study|Evaluable for response.|41
2856136|NCT00071396|3558429|FG000|NOT COMPLETED|Overall Study||3
2856137|NCT00071487|3558437|FG000|STARTED|52-Week Double-Blind Period||113
2856138|NCT00071487|3558438|FG001|STARTED|52-Week Double-Blind Period||114
2856139|NCT00071487|3558439|FG002|STARTED|52-Week Double-Blind Period||111
2856140|NCT00071487|3558440|FG003|STARTED|52-Week Double-Blind Period||111
2856141|NCT00071487|3558437|FG000|COMPLETED|52-Week Double-Blind Period||93
2856142|NCT00071487|3558438|FG001|COMPLETED|52-Week Double-Blind Period||87
2856143|NCT00071487|3558439|FG002|COMPLETED|52-Week Double-Blind Period||94
2856144|NCT00071487|3558440|FG003|COMPLETED|52-Week Double-Blind Period||90
2856145|NCT00071487|3558437|FG000|NOT COMPLETED|52-Week Double-Blind Period||20
2856146|NCT00071487|3558438|FG001|NOT COMPLETED|52-Week Double-Blind Period||27
2856147|NCT00071487|3558439|FG002|NOT COMPLETED|52-Week Double-Blind Period||17
2856148|NCT00071487|3558440|FG003|NOT COMPLETED|52-Week Double-Blind Period||21
2856149|NCT00071487|3558437|FG000|STARTED|24-Week Open-Label Extension Period|Of 93: 88 switched to 10 mg/kg; 5 elected not to continue in the open-label extension period.|0
2856150|NCT00071487|3558438|FG001|STARTED|24-Week Open-Label Extension Period|Of 87: 65 switched to 10 mg/kg; 3 elected not to continue in the open-label extension period.|19
2856151|NCT00071487|3558439|FG002|STARTED|24-Week Open-Label Extension Period|Of 94: 64 switched to 10 mg/kg; 6 elected not to continue in the open-label extension period.|24
2856152|NCT00071487|3558440|FG003|STARTED|24-Week Open-Label Extension Period|Of 90: 85 continued with 10 mg/kg; 5 elected not to continue in the open-label extension period.|302
2856153|NCT00071487|3558437|FG000|COMPLETED|24-Week Open-Label Extension Period||0
2856154|NCT00071487|3558438|FG001|COMPLETED|24-Week Open-Label Extension Period||19
2856155|NCT00071487|3558439|FG002|COMPLETED|24-Week Open-Label Extension Period||23
2856156|NCT00071487|3558440|FG003|COMPLETED|24-Week Open-Label Extension Period||279
2856157|NCT00071487|3558437|FG000|NOT COMPLETED|24-Week Open-Label Extension Period||0
2856158|NCT00071487|3558438|FG001|NOT COMPLETED|24-Week Open-Label Extension Period||0
2856159|NCT00071487|3558439|FG002|NOT COMPLETED|24-Week Open-Label Extension Period||1
2856160|NCT00071487|3558440|FG003|NOT COMPLETED|24-Week Open-Label Extension Period||23
2856161|NCT00071513|3558454|FG000|STARTED|Intervention Component||241
2856162|NCT00071513|3558455|FG001|STARTED|Intervention Component||256
3168657|NCT01920061|3895952|FG013|NOT COMPLETED|Overall Study||6
3168658|NCT01920061|3895953|FG014|NOT COMPLETED|Overall Study||1
2856163|NCT00071513|3558454|FG000|COMPLETED|Intervention Component||239
2856164|NCT00071513|3558455|FG001|COMPLETED|Intervention Component||253
2856165|NCT00071513|3558454|FG000|NOT COMPLETED|Intervention Component||2
2856166|NCT00071513|3558455|FG001|NOT COMPLETED|Intervention Component||3
2856167|NCT00071513|3558454|FG000|STARTED|Follow-up Assessment||239
2856168|NCT00071513|3558455|FG001|STARTED|Follow-up Assessment||253
2856169|NCT00071513|3558454|FG000|COMPLETED|Follow-up Assessment||233
2856170|NCT00071513|3558455|FG001|COMPLETED|Follow-up Assessment||247
2856171|NCT00071513|3558454|FG000|NOT COMPLETED|Follow-up Assessment||6
2856172|NCT00071513|3558455|FG001|NOT COMPLETED|Follow-up Assessment||6
2856173|NCT00071721|3558465|FG000|STARTED|Overall Study||153
2856174|NCT00071721|3558466|FG001|STARTED|Overall Study||160
2856175|NCT00071721|3558465|FG000|COMPLETED|Overall Study||81
2856176|NCT00071721|3558466|FG001|COMPLETED|Overall Study||69
2856177|NCT00071721|3558465|FG000|NOT COMPLETED|Overall Study||72
2856178|NCT00071721|3558466|FG001|NOT COMPLETED|Overall Study||91
2856179|NCT00071760|3558472|FG000|STARTED|Overall Study||54
2856180|NCT00071760|3558472|FG000|Ongoing|Overall Study||25
2856181|NCT00071760|3558472|FG000|COMPLETED|Overall Study||0
2856182|NCT00071760|3558472|FG000|NOT COMPLETED|Overall Study||54
2856183|NCT00071799|3558484|FG000|STARTED|Overall Study||179
2856184|NCT00071799|3558485|FG001|STARTED|Overall Study|Best supportive care: 105, Low-dose cytarabine: 49, Standard chemotherapy: 25 patients|179
2856185|NCT00071799|3558484|FG000|COMPLETED|Overall Study|Includes those who died or transformed to AML, or receiving drug + eligible for extension period.|109
2856186|NCT00071799|3558485|FG001|COMPLETED|Overall Study|Includes patients who died or transformed to AML during treatment, or were still receiving drug.|81
2856187|NCT00071799|3558484|FG000|NOT COMPLETED|Overall Study||70
2856188|NCT00071799|3558485|FG001|NOT COMPLETED|Overall Study||98
2856189|NCT00071812|3558501|FG000|STARTED|24-Week Double-Blind Period||69
2856190|NCT00071812|3558502|FG001|STARTED|24-Week Double-Blind Period||72
2856191|NCT00071812|3558503|FG002|STARTED|24-Week Double-Blind Period||71
2856192|NCT00071812|3558504|FG003|STARTED|24-Week Double-Blind Period||71
2856193|NCT00071812|3558501|FG000|COMPLETED|24-Week Double-Blind Period||59
2856194|NCT00071812|3558502|FG001|COMPLETED|24-Week Double-Blind Period||66
2856195|NCT00071812|3558503|FG002|COMPLETED|24-Week Double-Blind Period||63
2856196|NCT00071812|3558504|FG003|COMPLETED|24-Week Double-Blind Period||60
2856197|NCT00071812|3558501|FG000|NOT COMPLETED|24-Week Double-Blind Period||10
2856198|NCT00071812|3558502|FG001|NOT COMPLETED|24-Week Double-Blind Period||6
2856199|NCT00071812|3558503|FG002|NOT COMPLETED|24-Week Double-Blind Period||8
2856200|NCT00071812|3558504|FG003|NOT COMPLETED|24-Week Double-Blind Period||11
2856201|NCT00071812|3558501|FG000|STARTED|24-Week Open-Label Extension Period|Of 59: 56 switched to 10 mg/kg; 3 elected not to continue in the open-label extension.|0
2856202|NCT00071812|3558502|FG001|STARTED|24-Week Open-Label Extension Period|Of 66: 53 switched to 10 mg/kg; 2 elected not continue in the open-label extension.|11
2856203|NCT00071812|3558503|FG002|STARTED|24-Week Open-Label Extension Period|Of 63: 53 switched to 10 mg/kg; 2 elected not continue in the open-label extension.|8
2856204|NCT00071812|3558504|FG003|STARTED|24-Week Open-Label Extension Period|Of 60: 56 continued with 10 mg/kg; 4 elected not to continue in the open-label extension.|218
2856205|NCT00071812|3558501|FG000|COMPLETED|24-Week Open-Label Extension Period||0
2856206|NCT00071812|3558502|FG001|COMPLETED|24-Week Open-Label Extension Period||11
2856207|NCT00071812|3558503|FG002|COMPLETED|24-Week Open-Label Extension Period||7
2856208|NCT00071812|3558504|FG003|COMPLETED|24-Week Open-Label Extension Period||178
2856209|NCT00071812|3558501|FG000|NOT COMPLETED|24-Week Open-Label Extension Period||0
2856210|NCT00071812|3558502|FG001|NOT COMPLETED|24-Week Open-Label Extension Period||0
2856211|NCT00071812|3558503|FG002|NOT COMPLETED|24-Week Open-Label Extension Period||1
2856212|NCT00071812|3558504|FG003|NOT COMPLETED|24-Week Open-Label Extension Period||40
2856213|NCT00071890|3558518|FG000|STARTED|Overall Study|3 patients did not received Interleukin-2|81
2856214|NCT00071890|3558519|FG001|STARTED|Overall Study|1 patients stopped HAART at week 0|67
2856215|NCT00071890|3558518|FG000|COMPLETED|Overall Study|"1 withdrawal~1 death 81 patients analysed"|81
2856216|NCT00071890|3558519|FG001|COMPLETED|Overall Study|"1 withdrawal~1 lost of follow-up~1 death 67 patients analysed"|67
2856217|NCT00071890|3558518|FG000|NOT COMPLETED|Overall Study||0
2856218|NCT00071890|3558519|FG001|NOT COMPLETED|Overall Study||0
2856219|NCT00071981|3558529|FG000|STARTED|Overall Study||47
2856220|NCT00071981|3558530|FG001|STARTED|Overall Study||43
2856221|NCT00071981|3558531|FG002|STARTED|Overall Study||37
2856222|NCT00071981|3558532|FG003|STARTED|Overall Study||48
2856223|NCT00071981|3558529|FG000|Eligible|Overall Study||43
2856224|NCT00071981|3558530|FG001|Eligible|Overall Study||36
2856225|NCT00071981|3558531|FG002|Eligible|Overall Study||33
2856226|NCT00071981|3558532|FG003|Eligible|Overall Study||42
2856227|NCT00071981|3558529|FG000|Treated|Overall Study||45
2856228|NCT00071981|3558530|FG001|Treated|Overall Study||38
2856229|NCT00071981|3558531|FG002|Treated|Overall Study||36
2856230|NCT00071981|3558532|FG003|Treated|Overall Study||48
2856231|NCT00071981|3558529|FG000|Eligible and Treated|Overall Study||41
2856232|NCT00071981|3558530|FG001|Eligible and Treated|Overall Study||33
2856233|NCT00071981|3558531|FG002|Eligible and Treated|Overall Study||32
2856234|NCT00071981|3558532|FG003|Eligible and Treated|Overall Study||42
2856235|NCT00071981|3558529|FG000|Have CTL Response Data|Overall Study||40
2856236|NCT00071981|3558530|FG001|Have CTL Response Data|Overall Study||30
2856237|NCT00071981|3558531|FG002|Have CTL Response Data|Overall Study||29
2856238|NCT00071981|3558532|FG003|Have CTL Response Data|Overall Study||41
2856239|NCT00071981|3558529|FG000|Have Helper T Cell Response Data|Overall Study||37
2856240|NCT00071981|3558530|FG001|Have Helper T Cell Response Data|Overall Study||27
2856241|NCT00071981|3558531|FG002|Have Helper T Cell Response Data|Overall Study||25
2856242|NCT00071981|3558532|FG003|Have Helper T Cell Response Data|Overall Study||39
2856243|NCT00071981|3558529|FG000|COMPLETED|Overall Study||1
2856244|NCT00071981|3558530|FG001|COMPLETED|Overall Study||2
2856245|NCT00071981|3558531|FG002|COMPLETED|Overall Study||0
2856246|NCT00071981|3558532|FG003|COMPLETED|Overall Study||3
2856247|NCT00071981|3558529|FG000|NOT COMPLETED|Overall Study||46
2856248|NCT00071981|3558530|FG001|NOT COMPLETED|Overall Study||41
2856249|NCT00071981|3558531|FG002|NOT COMPLETED|Overall Study||37
2856250|NCT00071981|3558532|FG003|NOT COMPLETED|Overall Study||45
2856251|NCT00072176|3558544|FG000|STARTED|Overall Study||34
2856252|NCT00072176|3558545|FG001|STARTED|Overall Study||28
2856253|NCT00072176|3558544|FG000|COMPLETED|Overall Study||33
2856254|NCT00072176|3558545|FG001|COMPLETED|Overall Study||27
2856255|NCT00072176|3558544|FG000|NOT COMPLETED|Overall Study||1
2856256|NCT00072176|3558545|FG001|NOT COMPLETED|Overall Study||1
2856257|NCT00072189|3558551|FG000|STARTED|Overall Study||17
2856258|NCT00072189|3558551|FG000|COMPLETED|Overall Study||16
2856259|NCT00072189|3558551|FG000|NOT COMPLETED|Overall Study||1
2856260|NCT00072280|3558557|FG000|STARTED|Treatment||3
2856261|NCT00072280|3558558|FG001|STARTED|Treatment||4
2856262|NCT00072280|3558557|FG000|COMPLETED|Treatment||2
2856263|NCT00072280|3558558|FG001|COMPLETED|Treatment||2
2856264|NCT00072280|3558557|FG000|NOT COMPLETED|Treatment||1
2856265|NCT00072280|3558558|FG001|NOT COMPLETED|Treatment||2
2856266|NCT00072280|3558557|FG000|STARTED|Follow-up||2
2856267|NCT00072280|3558558|FG001|STARTED|Follow-up||2
2856268|NCT00072280|3558557|FG000|COMPLETED|Follow-up||0
2856269|NCT00072280|3558558|FG001|COMPLETED|Follow-up||0
2856270|NCT00072280|3558557|FG000|NOT COMPLETED|Follow-up||2
2856271|NCT00072280|3558558|FG001|NOT COMPLETED|Follow-up||2
2856272|NCT00072293|3558565|FG000|STARTED|Overall Study||465
2856273|NCT00072293|3558566|FG001|STARTED|Overall Study||469
2856274|NCT00072293|3558565|FG000|COMPLETED|Overall Study||464
2856275|NCT00072293|3558566|FG001|COMPLETED|Overall Study||467
3313392|NCT03075410|4046796|FG005|COMPLETED|Part A-Period 2 (14 Days)||1
3313393|NCT03075410|4046797|FG006|COMPLETED|Part A-Period 2 (14 Days)||0
3313394|NCT03075410|4046798|FG007|COMPLETED|Part A-Period 2 (14 Days)||0
3313395|NCT03075410|4046799|FG008|COMPLETED|Part A-Period 2 (14 Days)||0
3313396|NCT03075410|4046791|FG000|NOT COMPLETED|Part A-Period 2 (14 Days)||1
3313397|NCT03075410|4046792|FG001|NOT COMPLETED|Part A-Period 2 (14 Days)||0
2856276|NCT00072293|3558565|FG000|NOT COMPLETED|Overall Study||1
2856277|NCT00072293|3558566|FG001|NOT COMPLETED|Overall Study||2
2856278|NCT00072384|3558572|FG000|STARTED|Overall Study||30
2856279|NCT00072384|3558572|FG000|COMPLETED|Overall Study||21
2856280|NCT00072384|3558572|FG000|NOT COMPLETED|Overall Study||9
2856281|NCT00072449|3558578|FG000|STARTED|Overall Study||12
2856282|NCT00072449|3558578|FG000|COMPLETED|Overall Study||12
2856283|NCT00072449|3558578|FG000|NOT COMPLETED|Overall Study||0
2856284|NCT00072475|3558582|FG000|STARTED|Overall Study||142
2856285|NCT00072475|3558582|FG000|COMPLETED|Overall Study||45
2856286|NCT00072475|3558582|FG000|NOT COMPLETED|Overall Study||97
2856287|NCT00072514|3558586|FG000|STARTED|Overall Study||55
2856288|NCT00072514|3558586|FG000|COMPLETED|Overall Study||51
2856289|NCT00072514|3558586|FG000|NOT COMPLETED|Overall Study||4
2856290|NCT00072566|3558590|FG000|STARTED|Overall Study||70
2856291|NCT00072566|3558590|FG000|COMPLETED|Overall Study||70
2856292|NCT00072566|3558590|FG000|NOT COMPLETED|Overall Study||0
2856293|NCT00072761|3558596|FG000|STARTED|Overall Study||99
2856294|NCT00072761|3558597|FG001|STARTED|Overall Study||97
2856295|NCT00072761|3558596|FG000|COMPLETED|Overall Study||90
2856296|NCT00072761|3558597|FG001|COMPLETED|Overall Study||95
2856297|NCT00072761|3558596|FG000|NOT COMPLETED|Overall Study||9
2856298|NCT00072761|3558597|FG001|NOT COMPLETED|Overall Study||2
2856299|NCT00073008|3558605|FG000|STARTED|Overall Study||65
2856300|NCT00073008|3558606|FG001|STARTED|Overall Study||66
2856301|NCT00073008|3558605|FG000|COMPLETED|Overall Study||3
2856302|NCT00073008|3558606|FG001|COMPLETED|Overall Study||3
2856303|NCT00073008|3558605|FG000|NOT COMPLETED|Overall Study||62
2856304|NCT00073008|3558606|FG001|NOT COMPLETED|Overall Study||63
2856305|NCT00073021|3558614|FG000|STARTED|Overall Study|Subjects with Moderate Disease [PGA = 2] at Baseline|139
2856306|NCT00073021|3558615|FG001|STARTED|Overall Study|Subjects with Moderate Disease [PGA = 2] at Baseline|129
2856307|NCT00073021|3558614|FG000|COMPLETED|Overall Study||113
2856308|NCT00073021|3558615|FG001|COMPLETED|Overall Study||113
2856309|NCT00073021|3558614|FG000|NOT COMPLETED|Overall Study||26
2856310|NCT00073021|3558615|FG001|NOT COMPLETED|Overall Study||16
2856311|NCT00073073|3558621|FG000|STARTED|Overall Study||46
2856312|NCT00073073|3558621|FG000|COMPLETED|Overall Study||42
2856313|NCT00073073|3558621|FG000|NOT COMPLETED|Overall Study||4
2856314|NCT00073307|3558627|FG000|STARTED|Double-Blind (DB, as of ~31May2005)||451
2856315|NCT00073307|3558628|FG001|STARTED|Double-Blind (DB, as of ~31May2005)||452
2856316|NCT00073307|3558629|FG002|STARTED|Double-Blind (DB, as of ~31May2005)||0
2856317|NCT00073307|3558627|FG000|Participants Received Treatment|Double-Blind (DB, as of ~31May2005)||451
2856318|NCT00073307|3558628|FG001|Participants Received Treatment|Double-Blind (DB, as of ~31May2005)||451
2856319|NCT00073307|3558629|FG002|Participants Received Treatment|Double-Blind (DB, as of ~31May2005)||0
2856320|NCT00073307|3558627|FG000|COMPLETED|Double-Blind (DB, as of ~31May2005)||254
2856321|NCT00073307|3558628|FG001|COMPLETED|Double-Blind (DB, as of ~31May2005)||299
2856322|NCT00073307|3558629|FG002|COMPLETED|Double-Blind (DB, as of ~31May2005)||0
2856323|NCT00073307|3558627|FG000|NOT COMPLETED|Double-Blind (DB, as of ~31May2005)||197
2856324|NCT00073307|3558628|FG001|NOT COMPLETED|Double-Blind (DB, as of ~31May2005)||153
2856325|NCT00073307|3558629|FG002|NOT COMPLETED|Double-Blind (DB, as of ~31May2005)||0
2856326|NCT00073307|3558627|FG000|STARTED|Open Label-Sorafenib Only [30Jun2008]||254
2856327|NCT00073307|3558628|FG001|STARTED|Open Label-Sorafenib Only [30Jun2008]|Placebo treatment ended ~ 31May2005. Those who continued, switched to receive Sorafenib.|0
2856328|NCT00073307|3558629|FG002|STARTED|Open Label-Sorafenib Only [30Jun2008]||299
2856329|NCT00073307|3558627|FG000|Entered OL With Sorafenib Only Phase|Open Label-Sorafenib Only [30Jun2008]||219
2856330|NCT00073307|3558628|FG001|Entered OL With Sorafenib Only Phase|Open Label-Sorafenib Only [30Jun2008]||0
2856331|NCT00073307|3558629|FG002|Entered OL With Sorafenib Only Phase|Open Label-Sorafenib Only [30Jun2008]||216
2856332|NCT00073307|3558627|FG000|COMPLETED|Open Label-Sorafenib Only [30Jun2008]||120
2856333|NCT00073307|3558628|FG001|COMPLETED|Open Label-Sorafenib Only [30Jun2008]||0
2856334|NCT00073307|3558629|FG002|COMPLETED|Open Label-Sorafenib Only [30Jun2008]||143
2856335|NCT00073307|3558627|FG000|NOT COMPLETED|Open Label-Sorafenib Only [30Jun2008]||134
2856336|NCT00073307|3558628|FG001|NOT COMPLETED|Open Label-Sorafenib Only [30Jun2008]||0
2856337|NCT00073307|3558629|FG002|NOT COMPLETED|Open Label-Sorafenib Only [30Jun2008]||156
2856338|NCT00073333|3558641|FG000|STARTED|Overall Study||46
2856339|NCT00073333|3558642|FG001|STARTED|Overall Study||41
2856340|NCT00073333|3558643|FG002|STARTED|Overall Study||19
2856341|NCT00073333|3558641|FG000|COMPLETED|Overall Study||32
2856342|NCT00073333|3558642|FG001|COMPLETED|Overall Study||27
2856343|NCT00073333|3558643|FG002|COMPLETED|Overall Study||19
2856344|NCT00073333|3558641|FG000|NOT COMPLETED|Overall Study||14
2856345|NCT00073333|3558642|FG001|NOT COMPLETED|Overall Study||14
2856346|NCT00073333|3558643|FG002|NOT COMPLETED|Overall Study||0
2856347|NCT00073528|3558653|FG000|STARTED|Overall Study||644
2856348|NCT00073528|3558654|FG001|STARTED|Overall Study||642
2856349|NCT00073528|3558653|FG000|COMPLETED|Overall Study||14
2856350|NCT00073528|3558654|FG001|COMPLETED|Overall Study||14
3313398|NCT03075410|4046793|FG002|NOT COMPLETED|Part A-Period 2 (14 Days)||1
2856351|NCT00073528|3558653|FG000|NOT COMPLETED|Overall Study||630
2856352|NCT00073528|3558654|FG001|NOT COMPLETED|Overall Study||628
2856353|NCT00073749|3558667|FG000|STARTED|Overall Study||2
2856354|NCT00073749|3558668|FG001|STARTED|Overall Study||5
2856355|NCT00073749|3558669|FG002|STARTED|Overall Study||11
2856356|NCT00073749|3558670|FG003|STARTED|Overall Study||6
2856357|NCT00073749|3558671|FG004|STARTED|Overall Study||6
2856358|NCT00073749|3558672|FG005|STARTED|Overall Study||6
2856359|NCT00073749|3558673|FG006|STARTED|Overall Study||43
2856360|NCT00073749|3558667|FG000|COMPLETED|Overall Study||0
2856361|NCT00073749|3558668|FG001|COMPLETED|Overall Study||0
2856362|NCT00073749|3558669|FG002|COMPLETED|Overall Study||0
2856363|NCT00073749|3558670|FG003|COMPLETED|Overall Study||0
2856364|NCT00073749|3558671|FG004|COMPLETED|Overall Study||0
2856365|NCT00073749|3558672|FG005|COMPLETED|Overall Study||0
2856366|NCT00073749|3558673|FG006|COMPLETED|Overall Study||3
2856367|NCT00073749|3558667|FG000|NOT COMPLETED|Overall Study||2
2856368|NCT00073749|3558668|FG001|NOT COMPLETED|Overall Study||5
2856369|NCT00073749|3558669|FG002|NOT COMPLETED|Overall Study||11
2856370|NCT00073749|3558670|FG003|NOT COMPLETED|Overall Study||6
2856371|NCT00073749|3558671|FG004|NOT COMPLETED|Overall Study||6
2856372|NCT00073749|3558672|FG005|NOT COMPLETED|Overall Study||6
2856373|NCT00073749|3558673|FG006|NOT COMPLETED|Overall Study||40
2856374|NCT00073918|3558692|FG000|STARTED|Overall Study||111
2856375|NCT00073918|3558692|FG000|COMPLETED|Overall Study||107
2856376|NCT00073918|3558692|FG000|NOT COMPLETED|Overall Study||4
2856377|NCT00073957|3558696|FG000|STARTED|Overall Study||25
2856378|NCT00073957|3558696|FG000|COMPLETED|Overall Study||25
2856379|NCT00073957|3558696|FG000|NOT COMPLETED|Overall Study||0
2856380|NCT00073983|3558702|FG000|STARTED|Overall Study||54
2856381|NCT00073983|3558702|FG000|COMPLETED|Overall Study|One patient in the chondrosarcoma subtype was not evaluable.|53
2856382|NCT00073983|3558702|FG000|NOT COMPLETED|Overall Study||1
2856383|NCT00074035|3558708|FG000|STARTED|Overall Study||38
2856384|NCT00074035|3558708|FG000|COMPLETED|Overall Study||38
2856385|NCT00074035|3558708|FG000|NOT COMPLETED|Overall Study||0
2856386|NCT00074152|3558714|FG000|STARTED|Overall Study||77
2856387|NCT00074152|3558715|FG001|STARTED|Overall Study||85
2856388|NCT00074152|3558714|FG000|COMPLETED|Overall Study||22
2856389|NCT00074152|3558715|FG001|COMPLETED|Overall Study||52
2856390|NCT00074152|3558714|FG000|NOT COMPLETED|Overall Study||55
2856391|NCT00074152|3558715|FG001|NOT COMPLETED|Overall Study||33
2856392|NCT00074165|3558722|FG000|STARTED|Overall Study||17
2856393|NCT00074165|3558722|FG000|COMPLETED|Overall Study||17
2856394|NCT00074165|3558722|FG000|NOT COMPLETED|Overall Study||0
2856395|NCT00074269|3558726|FG000|STARTED|Overall Study||5
2856396|NCT00074269|3558726|FG000|COMPLETED|Overall Study||5
2856397|NCT00074269|3558726|FG000|NOT COMPLETED|Overall Study||0
2856398|NCT00074282|3558734|FG000|STARTED|Step 1||102
2856399|NCT00074282|3558735|FG001|STARTED|Step 1||0
2856400|NCT00074282|3558736|FG002|STARTED|Step 1||0
2856401|NCT00074282|3558734|FG000|Eligible|Step 1||98
2856402|NCT00074282|3558735|FG001|Eligible|Step 1||0
2856403|NCT00074282|3558736|FG002|Eligible|Step 1||0
2856404|NCT00074282|3558734|FG000|Started Treatment|Step 1||96
2856405|NCT00074282|3558735|FG001|Started Treatment|Step 1||0
2856406|NCT00074282|3558736|FG002|Started Treatment|Step 1||0
2856407|NCT00074282|3558734|FG000|COMPLETED|Step 1||44
2856408|NCT00074282|3558735|FG001|COMPLETED|Step 1||0
2856409|NCT00074282|3558736|FG002|COMPLETED|Step 1||0
2856410|NCT00074282|3558734|FG000|NOT COMPLETED|Step 1||58
2856411|NCT00074282|3558735|FG001|NOT COMPLETED|Step 1||0
2856412|NCT00074282|3558736|FG002|NOT COMPLETED|Step 1||0
2856413|NCT00074282|3558734|FG000|STARTED|Step 2||0
2856414|NCT00074282|3558735|FG001|STARTED|Step 2||9
2856415|NCT00074282|3558736|FG002|STARTED|Step 2||31
2856416|NCT00074282|3558734|FG000|COMPLETED|Step 2||0
2856417|NCT00074282|3558735|FG001|COMPLETED|Step 2||7
2856418|NCT00074282|3558736|FG002|COMPLETED|Step 2||7
2856419|NCT00074282|3558734|FG000|NOT COMPLETED|Step 2||0
2856420|NCT00074282|3558735|FG001|NOT COMPLETED|Step 2||2
2856421|NCT00074282|3558736|FG002|NOT COMPLETED|Step 2||24
2856422|NCT00074308|3558746|FG000|STARTED|Overall Study||3
2856423|NCT00074308|3558747|FG001|STARTED|Overall Study||3
2856424|NCT00074308|3558748|FG002|STARTED|Overall Study||3
2856425|NCT00074308|3558749|FG003|STARTED|Overall Study||8
2856426|NCT00074308|3558750|FG004|STARTED|Overall Study||23
2856427|NCT00074308|3558746|FG000|COMPLETED|Overall Study||3
2856428|NCT00074308|3558747|FG001|COMPLETED|Overall Study||3
2856429|NCT00074308|3558748|FG002|COMPLETED|Overall Study||3
2856430|NCT00074308|3558749|FG003|COMPLETED|Overall Study||8
3168659|NCT01920061|3895954|FG015|NOT COMPLETED|Overall Study||3
2856431|NCT00074308|3558750|FG004|COMPLETED|Overall Study||23
2856432|NCT00074308|3558746|FG000|NOT COMPLETED|Overall Study||0
2856433|NCT00074308|3558747|FG001|NOT COMPLETED|Overall Study||0
2856434|NCT00074308|3558748|FG002|NOT COMPLETED|Overall Study||0
2856435|NCT00074308|3558749|FG003|NOT COMPLETED|Overall Study||0
2856436|NCT00074308|3558750|FG004|NOT COMPLETED|Overall Study||0
2856437|NCT00074412|3558762|FG000|STARTED|Overall Study|Number of infants randomized at 6 weeks.|763
3168660|NCT01920061|3895955|FG016|NOT COMPLETED|Overall Study||2
2856438|NCT00074412|3558763|FG001|STARTED|Overall Study|Number of infants randomized at 6 weeks.|759
2856439|NCT00074412|3558762|FG000|Week 8 Visit|Overall Study||759
2856440|NCT00074412|3558763|FG001|Week 8 Visit|Overall Study||759
2856441|NCT00074412|3558762|FG000|Month 3 Visit|Overall Study||759
2856442|NCT00074412|3558763|FG001|Month 3 Visit|Overall Study||755
2856443|NCT00074412|3558762|FG000|Month 4 Visit|Overall Study||758
2856444|NCT00074412|3558763|FG001|Month 4 Visit|Overall Study||752
2856445|NCT00074412|3558762|FG000|Month 5 Visit|Overall Study||756
2856446|NCT00074412|3558763|FG001|Month 5 Visit|Overall Study||750
2856447|NCT00074412|3558762|FG000|Month 6 Visit|Overall Study||748
2856448|NCT00074412|3558763|FG001|Month 6 Visit|Overall Study||748
2856449|NCT00074412|3558762|FG000|Month 9 Visit|Overall Study||741
2856450|NCT00074412|3558763|FG001|Month 9 Visit|Overall Study||741
2856451|NCT00074412|3558762|FG000|Month 12 Visit|Overall Study||733
2856452|NCT00074412|3558763|FG001|Month 12 Visit|Overall Study||735
2856453|NCT00074412|3558762|FG000|COMPLETED|Overall Study|Number of infants who completed final 18 month visit: out of 733 infants who were expected.|681
2856454|NCT00074412|3558763|FG001|COMPLETED|Overall Study|Number of infants who completed final 18 month visit: out of 733 infants who were expected.|675
2856455|NCT00074412|3558762|FG000|NOT COMPLETED|Overall Study||82
2856456|NCT00074412|3558763|FG001|NOT COMPLETED|Overall Study||84
2856457|NCT00074490|3558775|FG000|STARTED|Overall Study||1
2856458|NCT00074490|3558776|FG001|STARTED|Overall Study||34
2856459|NCT00074490|3558777|FG002|STARTED|Overall Study||40
2856460|NCT00074490|3558778|FG003|STARTED|Overall Study||44
2856461|NCT00074490|3558779|FG004|STARTED|Overall Study||45
2856462|NCT00074490|3558780|FG005|STARTED|Overall Study||221
2856463|NCT00074490|3558775|FG000|COMPLETED|Overall Study||1
2856464|NCT00074490|3558776|FG001|COMPLETED|Overall Study||27
2856465|NCT00074490|3558777|FG002|COMPLETED|Overall Study||40
2856466|NCT00074490|3558778|FG003|COMPLETED|Overall Study||44
2856467|NCT00074490|3558779|FG004|COMPLETED|Overall Study||42
2856468|NCT00074490|3558780|FG005|COMPLETED|Overall Study||221
2856469|NCT00074490|3558775|FG000|NOT COMPLETED|Overall Study||0
2856470|NCT00074490|3558776|FG001|NOT COMPLETED|Overall Study||7
2856471|NCT00074490|3558777|FG002|NOT COMPLETED|Overall Study||0
2856472|NCT00074490|3558778|FG003|NOT COMPLETED|Overall Study||0
2856473|NCT00074490|3558779|FG004|NOT COMPLETED|Overall Study||3
2856474|NCT00074490|3558780|FG005|NOT COMPLETED|Overall Study||0
2856475|NCT00074581|3558795|FG000|STARTED|Overall Study|886 HIV-infected index cases and 903 HIV-uninfected partners|1789
2856476|NCT00074581|3558796|FG001|STARTED|Overall Study|877 HIV-infected index cases and 890 HIV-uninfected partners|1767
2856477|NCT00074581|3558795|FG000|COMPLETED|Overall Study||1545
2856478|NCT00074581|3558796|FG001|COMPLETED|Overall Study||1541
2856479|NCT00074581|3558795|FG000|NOT COMPLETED|Overall Study||244
2856480|NCT00074581|3558796|FG001|NOT COMPLETED|Overall Study||226
2856481|NCT00074711|3558804|FG000|STARTED|Overall Study||120
2856482|NCT00074711|3558805|FG001|STARTED|Overall Study||121
2856483|NCT00074711|3558804|FG000|COMPLETED|Overall Study||105
2856484|NCT00074711|3558805|FG001|COMPLETED|Overall Study||106
2856485|NCT00074711|3558804|FG000|NOT COMPLETED|Overall Study||15
2856486|NCT00074711|3558805|FG001|NOT COMPLETED|Overall Study||15
2856487|NCT00074802|3558813|FG000|STARTED|Overall Study||29
2856488|NCT00074802|3558814|FG001|STARTED|Overall Study||32
2856489|NCT00074802|3558813|FG000|COMPLETED|Overall Study||20
2856490|NCT00074802|3558814|FG001|COMPLETED|Overall Study||25
2856491|NCT00074802|3558813|FG000|NOT COMPLETED|Overall Study||9
2856492|NCT00074802|3558814|FG001|NOT COMPLETED|Overall Study||7
2856493|NCT00074815|3558823|FG000|STARTED|Overall Study||42
2856494|NCT00074815|3558824|FG001|STARTED|Overall Study||40
2856495|NCT00074815|3558825|FG002|STARTED|Overall Study||42
2856496|NCT00074815|3558823|FG000|COMPLETED|Overall Study||37
2856497|NCT00074815|3558824|FG001|COMPLETED|Overall Study||34
2856498|NCT00074815|3558825|FG002|COMPLETED|Overall Study||30
2856499|NCT00074815|3558823|FG000|NOT COMPLETED|Overall Study||5
2856500|NCT00074815|3558824|FG001|NOT COMPLETED|Overall Study||6
2856501|NCT00074815|3558825|FG002|NOT COMPLETED|Overall Study||12
2856502|NCT00074958|3558833|FG000|STARTED|Overall Study||16
2856503|NCT00074958|3558833|FG000|COMPLETED|Overall Study||15
2856504|NCT00074958|3558833|FG000|NOT COMPLETED|Overall Study||1
2856505|NCT00074984|3558839|FG000|STARTED|Overall Study||31
2856506|NCT00074984|3558840|FG001|STARTED|Overall Study||51
2856507|NCT00074984|3558839|FG000|COMPLETED|Overall Study||28
2856508|NCT00074984|3558840|FG001|COMPLETED|Overall Study||43
2856509|NCT00074984|3558839|FG000|NOT COMPLETED|Overall Study||3
2856510|NCT00074984|3558840|FG001|NOT COMPLETED|Overall Study||8
2856511|NCT00075023|3558849|FG000|STARTED|Pilot Study||5
2856512|NCT00075023|3558850|FG001|STARTED|Pilot Study||5
2856513|NCT00075023|3558849|FG000|COMPLETED|Pilot Study||3
2856514|NCT00075023|3558850|FG001|COMPLETED|Pilot Study||3
2856515|NCT00075023|3558849|FG000|NOT COMPLETED|Pilot Study||2
2856516|NCT00075023|3558850|FG001|NOT COMPLETED|Pilot Study||2
2856517|NCT00075023|3558849|FG000|STARTED|Part Two|Study was terminated after the pilot study. No participants entered Part Two.|0
2856518|NCT00075023|3558850|FG001|STARTED|Part Two|Study was terminated after the pilot study. No participants entered Part Two.|0
2856519|NCT00075023|3558849|FG000|COMPLETED|Part Two||0
2856520|NCT00075023|3558850|FG001|COMPLETED|Part Two||0
2856521|NCT00075023|3558849|FG000|NOT COMPLETED|Part Two||0
2856522|NCT00075023|3558850|FG001|NOT COMPLETED|Part Two||0
2856523|NCT00075088|3558859|FG000|STARTED|Overall Study||403
2856524|NCT00075088|3558860|FG001|STARTED|Overall Study||391
2856525|NCT00075088|3558859|FG000|COMPLETED|Overall Study||403
2856526|NCT00075088|3558860|FG001|COMPLETED|Overall Study||391
2856527|NCT00075088|3558859|FG000|NOT COMPLETED|Overall Study||0
2856528|NCT00075088|3558860|FG001|NOT COMPLETED|Overall Study||0
2856529|NCT00075218|3558869|FG000|STARTED|Double-Blind Treatment|Intent To Treat Population (ITT)|243
2918251|NCT00525629|3628421|FG000|NOT COMPLETED|First Intervention||5
2856530|NCT00075218|3558870|FG001|STARTED|Double-Blind Treatment|Intent To Treat Population (ITT)|118
2856531|NCT00075218|3558871|FG002|STARTED|Double-Blind Treatment||0
2856532|NCT00075218|3558869|FG000|Received Double-Blind Treatment|Double-Blind Treatment|As Treated Population (AT)|228
2856533|NCT00075218|3558870|FG001|Received Double-Blind Treatment|Double-Blind Treatment|As Treated Population (AT)|114
2856534|NCT00075218|3558871|FG002|Received Double-Blind Treatment|Double-Blind Treatment||0
2856535|NCT00075218|3558869|FG000|Crossed Over to Open-Label Treatment|Double-Blind Treatment||152
2856536|NCT00075218|3558870|FG001|Crossed Over to Open-Label Treatment|Double-Blind Treatment||103
2856537|NCT00075218|3558871|FG002|Crossed Over to Open-Label Treatment|Double-Blind Treatment||0
2856538|NCT00075218|3558869|FG000|COMPLETED|Double-Blind Treatment|Defined:subjects completed double-blind treatment phase and/or entered open-label treatment phase.|152
2856539|NCT00075218|3558870|FG001|COMPLETED|Double-Blind Treatment|Defined:subjects completed double-blind treatment phase and/or entered open-label treatment phase.|103
2856540|NCT00075218|3558871|FG002|COMPLETED|Double-Blind Treatment||0
2856541|NCT00075218|3558869|FG000|NOT COMPLETED|Double-Blind Treatment||91
2856542|NCT00075218|3558870|FG001|NOT COMPLETED|Double-Blind Treatment||15
2856543|NCT00075218|3558871|FG002|NOT COMPLETED|Double-Blind Treatment||0
2856544|NCT00075218|3558869|FG000|STARTED|Open-Label Treatment||0
2856545|NCT00075218|3558870|FG001|STARTED|Open-Label Treatment||0
2856546|NCT00075218|3558871|FG002|STARTED|Open-Label Treatment||255
2856547|NCT00075218|3558869|FG000|COMPLETED|Open-Label Treatment||0
2856548|NCT00075218|3558870|FG001|COMPLETED|Open-Label Treatment||0
2856549|NCT00075218|3558871|FG002|COMPLETED|Open-Label Treatment||0
2856550|NCT00075218|3558869|FG000|NOT COMPLETED|Open-Label Treatment||0
2856551|NCT00075218|3558870|FG001|NOT COMPLETED|Open-Label Treatment||0
2856552|NCT00075218|3558871|FG002|NOT COMPLETED|Open-Label Treatment||255
2856553|NCT00075270|3558880|FG000|STARTED|Overall Study||291
2856554|NCT00075270|3558881|FG001|STARTED|Overall Study||288
2856555|NCT00075270|3558880|FG000|Missing|Overall Study|These participants have no completion status information recorded on the case report forms.|26
2856556|NCT00075270|3558881|FG001|Missing|Overall Study|These participants have no completion status information recorded on the case report forms.|13
3168661|NCT01920061|3895956|FG017|NOT COMPLETED|Overall Study||2
3168662|NCT01920061|3895957|FG018|NOT COMPLETED|Overall Study||6
3168663|NCT01920061|3895958|FG019|NOT COMPLETED|Overall Study||4
3168664|NCT01920152|3896023|FG000|STARTED|Overall Study||19
3168665|NCT01920152|3896024|FG001|STARTED|Overall Study||15
3168666|NCT01920152|3896023|FG000|COMPLETED|Overall Study||18
3168667|NCT01920152|3896024|FG001|COMPLETED|Overall Study||13
3168668|NCT01920152|3896023|FG000|NOT COMPLETED|Overall Study||1
3168669|NCT01920152|3896024|FG001|NOT COMPLETED|Overall Study||2
3168670|NCT01920178|3896032|FG000|STARTED|Overall Study||5
3168671|NCT01920178|3896033|FG001|STARTED|Overall Study||2
2856557|NCT00075270|3558880|FG000|COMPLETED|Overall Study||5
2856558|NCT00075270|3558881|FG001|COMPLETED|Overall Study||4
2856559|NCT00075270|3558880|FG000|NOT COMPLETED|Overall Study||286
2856560|NCT00075270|3558881|FG001|NOT COMPLETED|Overall Study||284
2856561|NCT00075335|3558888|FG000|STARTED|Overall Study||8
2856562|NCT00075335|3558888|FG000|COMPLETED|Overall Study||8
2856563|NCT00075335|3558888|FG000|NOT COMPLETED|Overall Study||0
2856564|NCT00075400|3558892|FG000|STARTED|Overall Study||26
2856565|NCT00075400|3558892|FG000|COMPLETED|Overall Study|Eligible and treated patients.|23
2856566|NCT00075400|3558892|FG000|NOT COMPLETED|Overall Study||3
2856567|NCT00075478|3558903|FG000|STARTED|Overall Study||42
2856568|NCT00075478|3558904|FG001|STARTED|Overall Study||45
2856569|NCT00075478|3558903|FG000|COMPLETED|Overall Study||41
2856570|NCT00075478|3558904|FG001|COMPLETED|Overall Study||44
2856571|NCT00075478|3558903|FG000|NOT COMPLETED|Overall Study||1
2856572|NCT00075478|3558904|FG001|NOT COMPLETED|Overall Study||1
2856573|NCT00075504|3558912|FG000|STARTED|Overall Study||23
2856574|NCT00075504|3558913|FG001|STARTED|Overall Study||10
2856575|NCT00075504|3558912|FG000|COMPLETED|Overall Study||14
2856576|NCT00075504|3558913|FG001|COMPLETED|Overall Study||3
2856577|NCT00075504|3558912|FG000|NOT COMPLETED|Overall Study||9
2856578|NCT00075504|3558913|FG001|NOT COMPLETED|Overall Study||7
2856579|NCT00075582|3558921|FG000|STARTED|Overall Study||305
2856580|NCT00075582|3558922|FG001|STARTED|Overall Study||85
2856581|NCT00075582|3558921|FG000|COMPLETED|Overall Study||255
2856582|NCT00075582|3558922|FG001|COMPLETED|Overall Study||50
2856583|NCT00075582|3558921|FG000|NOT COMPLETED|Overall Study||50
2856584|NCT00075582|3558922|FG001|NOT COMPLETED|Overall Study||35
2856585|NCT00075725|3558944|FG000|STARTED|Overall Study||246
2856586|NCT00075725|3558945|FG001|STARTED|Overall Study||106
2856587|NCT00075725|3558946|FG002|STARTED|Overall Study||296
2856588|NCT00075725|3558947|FG003|STARTED|Overall Study||246
2856589|NCT00075725|3558948|FG004|STARTED|Overall Study||232
2856590|NCT00075725|3558949|FG005|STARTED|Overall Study||710
2856591|NCT00075725|3558950|FG006|STARTED|Overall Study||246
2856592|NCT00075725|3558951|FG007|STARTED|Overall Study||696
2856593|NCT00075725|3558952|FG008|STARTED|Overall Study||302
2856594|NCT00075725|3558953|FG009|STARTED|Overall Study||34
2856595|NCT00075725|3558954|FG010|STARTED|Overall Study||12
2856596|NCT00075725|3558955|FG011|STARTED|Overall Study||28
2856597|NCT00075725|3558944|FG000|COMPLETED|Overall Study||172
2856598|NCT00075725|3558945|FG001|COMPLETED|Overall Study||57
2856599|NCT00075725|3558946|FG002|COMPLETED|Overall Study||175
2856600|NCT00075725|3558947|FG003|COMPLETED|Overall Study||168
2856601|NCT00075725|3558948|FG004|COMPLETED|Overall Study||166
3168672|NCT01920178|3896032|FG000|COMPLETED|Overall Study||3
3168673|NCT01920178|3896033|FG001|COMPLETED|Overall Study||1
2856602|NCT00075725|3558949|FG005|COMPLETED|Overall Study||397
2856603|NCT00075725|3558950|FG006|COMPLETED|Overall Study||171
2856604|NCT00075725|3558951|FG007|COMPLETED|Overall Study||401
2856605|NCT00075725|3558952|FG008|COMPLETED|Overall Study||185
2856606|NCT00075725|3558953|FG009|COMPLETED|Overall Study||16
2856607|NCT00075725|3558954|FG010|COMPLETED|Overall Study||3
2856608|NCT00075725|3558955|FG011|COMPLETED|Overall Study||10
2856609|NCT00075725|3558944|FG000|NOT COMPLETED|Overall Study||74
2856610|NCT00075725|3558945|FG001|NOT COMPLETED|Overall Study||49
2856611|NCT00075725|3558946|FG002|NOT COMPLETED|Overall Study||121
2856612|NCT00075725|3558947|FG003|NOT COMPLETED|Overall Study||78
2856613|NCT00075725|3558948|FG004|NOT COMPLETED|Overall Study||66
2856614|NCT00075725|3558949|FG005|NOT COMPLETED|Overall Study||313
2856615|NCT00075725|3558950|FG006|NOT COMPLETED|Overall Study||75
2856616|NCT00075725|3558951|FG007|NOT COMPLETED|Overall Study||295
2856617|NCT00075725|3558952|FG008|NOT COMPLETED|Overall Study||117
2856618|NCT00075725|3558953|FG009|NOT COMPLETED|Overall Study||18
2856619|NCT00075725|3558954|FG010|NOT COMPLETED|Overall Study||9
2856620|NCT00075725|3558955|FG011|NOT COMPLETED|Overall Study||18
2856621|NCT00075764|3558988|FG000|STARTED|Overall Study||345
2856622|NCT00075764|3558989|FG001|STARTED|Overall Study||349
2856623|NCT00075764|3558988|FG000|COMPLETED|Overall Study||0
2856624|NCT00075764|3558989|FG001|COMPLETED|Overall Study||0
2856625|NCT00075764|3558988|FG000|NOT COMPLETED|Overall Study||345
2856626|NCT00075764|3558989|FG001|NOT COMPLETED|Overall Study||349
2856627|NCT00075803|3558999|FG000|STARTED|Overall Study||295
2856628|NCT00075803|3559000|FG001|STARTED|Overall Study||305
2856629|NCT00075803|3558999|FG000|COMPLETED|Overall Study||295
2856630|NCT00075803|3559000|FG001|COMPLETED|Overall Study||305
2856631|NCT00075803|3558999|FG000|NOT COMPLETED|Overall Study||0
3168674|NCT01920178|3896032|FG000|NOT COMPLETED|Overall Study||2
3168675|NCT01920178|3896033|FG001|NOT COMPLETED|Overall Study||1
3168676|NCT01920282|3896042|FG000|STARTED|Overall Study||15
3168677|NCT01920282|3896043|FG001|STARTED|Overall Study||15
3168678|NCT01920282|3896044|FG002|STARTED|Overall Study||15
3168679|NCT01920282|3896042|FG000|COMPLETED|Overall Study||15
3168680|NCT01920282|3896043|FG001|COMPLETED|Overall Study||15
2856632|NCT00075803|3559000|FG001|NOT COMPLETED|Overall Study||0
2856633|NCT00075816|3559008|FG000|STARTED|Overall Study||278
2856634|NCT00075816|3559009|FG001|STARTED|Overall Study||273
2856635|NCT00075816|3559008|FG000|COMPLETED|Overall Study||264
2856636|NCT00075816|3559009|FG001|COMPLETED|Overall Study||262
2856637|NCT00075816|3559008|FG000|NOT COMPLETED|Overall Study||14
2856638|NCT00075816|3559009|FG001|NOT COMPLETED|Overall Study||11
2856639|NCT00075829|3559021|FG000|STARTED|Overall Study||436
2856640|NCT00075829|3559022|FG001|STARTED|Overall Study||189
2856641|NCT00075829|3559023|FG002|STARTED|Overall Study||48
2856642|NCT00075829|3559024|FG003|STARTED|Overall Study||37
2856643|NCT00075829|3559021|FG000|COMPLETED|Overall Study|Participants that were alive and free of disease progression at the end of follow-up (3 years)|178
2856644|NCT00075829|3559022|FG001|COMPLETED|Overall Study|Participants that were alive and free of disease progression at the end of follow-up (3 years)|71
2856645|NCT00075829|3559023|FG002|COMPLETED|Overall Study|Participants that were alive and free of disease progression at the end of follow-up (3 years)|14
2856646|NCT00075829|3559024|FG003|COMPLETED|Overall Study|Participants that were alive and free of disease progression at the end of follow-up (3 years)|13
2856647|NCT00075829|3559021|FG000|NOT COMPLETED|Overall Study||258
2856648|NCT00075829|3559022|FG001|NOT COMPLETED|Overall Study||118
2856649|NCT00075829|3559023|FG002|NOT COMPLETED|Overall Study||34
2856650|NCT00075829|3559024|FG003|NOT COMPLETED|Overall Study||24
2856651|NCT00075881|3559037|FG000|STARTED|Overall Study||44
2856652|NCT00075881|3559037|FG000|Eligible|Overall Study||43
2856653|NCT00075881|3559037|FG000|Treated|Overall Study||42
2856654|NCT00075881|3559037|FG000|Induction Treatment|Overall Study||42
2856655|NCT00075881|3559037|FG000|Maintenance Treatment|Overall Study||15
2856656|NCT00075881|3559037|FG000|Reinduction Treatment|Overall Study||7
2856657|NCT00075881|3559037|FG000|COMPLETED|Overall Study||1
2856658|NCT00075881|3559037|FG000|NOT COMPLETED|Overall Study||43
2856659|NCT00075946|3559047|FG000|STARTED|Overall Study||148
2856660|NCT00075946|3559048|FG001|STARTED|Overall Study||151
2856661|NCT00075946|3559049|FG002|STARTED|Overall Study||28
2856662|NCT00075946|3559050|FG003|STARTED|Overall Study||30
2856663|NCT00075946|3559051|FG004|STARTED|Overall Study||188
2856664|NCT00075946|3559047|FG000|Treated and With Toxicity Data Available|Overall Study||142
2856665|NCT00075946|3559048|FG001|Treated and With Toxicity Data Available|Overall Study||148
2856666|NCT00075946|3559049|FG002|Treated and With Toxicity Data Available|Overall Study||27
2856667|NCT00075946|3559050|FG003|Treated and With Toxicity Data Available|Overall Study||29
2856668|NCT00075946|3559051|FG004|Treated and With Toxicity Data Available|Overall Study||154
2856669|NCT00075946|3559047|FG000|Included in Primary Analysis|Overall Study||143
2856670|NCT00075946|3559048|FG001|Included in Primary Analysis|Overall Study||146
2856671|NCT00075946|3559049|FG002|Included in Primary Analysis|Overall Study||23
2856672|NCT00075946|3559050|FG003|Included in Primary Analysis|Overall Study||29
2856673|NCT00075946|3559051|FG004|Included in Primary Analysis|Overall Study||0
2856674|NCT00075946|3559047|FG000|COMPLETED|Overall Study||0
2856675|NCT00075946|3559048|FG001|COMPLETED|Overall Study||0
2856676|NCT00075946|3559049|FG002|COMPLETED|Overall Study||0
3168681|NCT01920282|3896044|FG002|COMPLETED|Overall Study||15
3168682|NCT01920282|3896042|FG000|NOT COMPLETED|Overall Study||0
2856677|NCT00075946|3559050|FG003|COMPLETED|Overall Study||0
2856678|NCT00075946|3559051|FG004|COMPLETED|Overall Study||0
2856679|NCT00075946|3559047|FG000|NOT COMPLETED|Overall Study||148
2856680|NCT00075946|3559048|FG001|NOT COMPLETED|Overall Study||151
2856681|NCT00075946|3559049|FG002|NOT COMPLETED|Overall Study||28
2856682|NCT00075946|3559050|FG003|NOT COMPLETED|Overall Study||30
2856683|NCT00075946|3559051|FG004|NOT COMPLETED|Overall Study||188
2918252|NCT00525629|3628422|FG001|NOT COMPLETED|First Intervention||5
2918253|NCT00525629|3628421|FG000|STARTED|Washout||15
2918254|NCT00525629|3628422|FG001|STARTED|Washout||15
2918255|NCT00525629|3628421|FG000|COMPLETED|Washout||15
2918256|NCT00525629|3628422|FG001|COMPLETED|Washout||15
2918257|NCT00525629|3628421|FG000|NOT COMPLETED|Washout||0
2918258|NCT00525629|3628422|FG001|NOT COMPLETED|Washout||0
2918259|NCT00525629|3628421|FG000|STARTED|Second Intervention||15
2918260|NCT00525629|3628422|FG001|STARTED|Second Intervention||15
2918261|NCT00525629|3628421|FG000|COMPLETED|Second Intervention||0
2918262|NCT00525629|3628422|FG001|COMPLETED|Second Intervention||0
2918263|NCT00525629|3628421|FG000|NOT COMPLETED|Second Intervention||15
2918264|NCT00525629|3628422|FG001|NOT COMPLETED|Second Intervention||15
2918265|NCT00525733|3628430|FG000|STARTED|Overall Study||14
2918266|NCT00525733|3628431|FG001|STARTED|Overall Study||26
2918267|NCT00525733|3628430|FG000|COMPLETED|Overall Study||11
2918268|NCT00525733|3628431|FG001|COMPLETED|Overall Study||23
2918269|NCT00525733|3628430|FG000|NOT COMPLETED|Overall Study||3
2918270|NCT00525733|3628431|FG001|NOT COMPLETED|Overall Study||3
2918271|NCT00525785|3628437|FG000|STARTED|Overall Study||58
2918272|NCT00525785|3628437|FG000|COMPLETED|Overall Study||55
2918273|NCT00525785|3628437|FG000|NOT COMPLETED|Overall Study||3
2918274|NCT00525798|3628443|FG000|STARTED|Overall Study||2334
2918275|NCT00525798|3628444|FG001|STARTED|Overall Study||2331
2918276|NCT00525798|3628443|FG000|COMPLETED|Overall Study||1578
2918277|NCT00525798|3628444|FG001|COMPLETED|Overall Study||1732
3168683|NCT01920282|3896043|FG001|NOT COMPLETED|Overall Study||0
3168684|NCT01920282|3896044|FG002|NOT COMPLETED|Overall Study||0
2918278|NCT00525798|3628443|FG000|NOT COMPLETED|Overall Study||756
2918279|NCT00525798|3628444|FG001|NOT COMPLETED|Overall Study||599
2918280|NCT00525824|3628454|FG000|STARTED|Overall Study|Randomized population|214
2918281|NCT00525824|3628455|FG001|STARTED|Overall Study|Randomized population|214
2918282|NCT00525824|3628456|FG002|STARTED|Overall Study|Randomized population|202
2918283|NCT00525824|3628457|FG003|STARTED|Overall Study|Randomized population|203
2918284|NCT00525824|3628454|FG000|COMPLETED|Overall Study||195
2918285|NCT00525824|3628455|FG001|COMPLETED|Overall Study||186
2918286|NCT00525824|3628456|FG002|COMPLETED|Overall Study||183
2918287|NCT00525824|3628457|FG003|COMPLETED|Overall Study||188
2918288|NCT00525824|3628454|FG000|NOT COMPLETED|Overall Study||19
2918289|NCT00525824|3628455|FG001|NOT COMPLETED|Overall Study||28
2918290|NCT00525824|3628456|FG002|NOT COMPLETED|Overall Study||19
2918291|NCT00525824|3628457|FG003|NOT COMPLETED|Overall Study||15
2918292|NCT00525837|3628471|FG000|STARTED|Overall Study||18
2918293|NCT00525837|3628471|FG000|COMPLETED|Overall Study||14
2918294|NCT00525837|3628471|FG000|NOT COMPLETED|Overall Study||4
2918295|NCT00525876|3628478|FG000|STARTED|Overall Study||16
2918296|NCT00525876|3628479|FG001|STARTED|Overall Study||20
2918297|NCT00525876|3628478|FG000|COMPLETED|Overall Study||16
2918298|NCT00525876|3628479|FG001|COMPLETED|Overall Study||20
2918299|NCT00525876|3628478|FG000|NOT COMPLETED|Overall Study||0
2918300|NCT00525876|3628479|FG001|NOT COMPLETED|Overall Study||0
2918301|NCT00525902|3628485|FG000|STARTED|Overall Study||31
2918302|NCT00525902|3628485|FG000|10 Weeks|Overall Study||30
2918303|NCT00525902|3628485|FG000|50 Weeks|Overall Study||12
2918304|NCT00525902|3628485|FG000|COMPLETED|Overall Study||30
2918305|NCT00525902|3628485|FG000|NOT COMPLETED|Overall Study||1
2918306|NCT00525915|3628491|FG000|STARTED|Overall Study||63
2918307|NCT00525915|3628492|FG001|STARTED|Overall Study||63
2918308|NCT00525915|3628491|FG000|COMPLETED|Overall Study|Participants who underwent surgery.|55
2918309|NCT00525915|3628492|FG001|COMPLETED|Overall Study||54
2918310|NCT00525915|3628491|FG000|NOT COMPLETED|Overall Study||8
2918311|NCT00525915|3628492|FG001|NOT COMPLETED|Overall Study||9
2918312|NCT00526058|3628500|FG000|STARTED|Period: First Intervention||9
2918313|NCT00526058|3628501|FG001|STARTED|Period: First Intervention||9
2918314|NCT00526058|3628500|FG000|COMPLETED|Period: First Intervention||9
2918315|NCT00526058|3628501|FG001|COMPLETED|Period: First Intervention||9
2918316|NCT00526058|3628500|FG000|NOT COMPLETED|Period: First Intervention||0
2918317|NCT00526058|3628501|FG001|NOT COMPLETED|Period: First Intervention||0
2918318|NCT00526058|3628500|FG000|STARTED|Period: Second Intervention||9
2918319|NCT00526058|3628501|FG001|STARTED|Period: Second Intervention||9
2918320|NCT00526058|3628500|FG000|COMPLETED|Period: Second Intervention||9
2918321|NCT00526058|3628501|FG001|COMPLETED|Period: Second Intervention||9
2918322|NCT00526058|3628500|FG000|NOT COMPLETED|Period: Second Intervention||0
2918323|NCT00526058|3628501|FG001|NOT COMPLETED|Period: Second Intervention||0
2918324|NCT00526071|3628507|FG000|STARTED|Overall Study||23
2918325|NCT00526071|3628507|FG000|Safety Population|Overall Study||23
2918326|NCT00526071|3628507|FG000|Pharmacodynamic (PD) Population|Overall Study||23
2918327|NCT00526071|3628507|FG000|Amenable Population; Men|Overall Study||11
2918328|NCT00526071|3628507|FG000|Amenable Population; Women|Overall Study||5
2918329|NCT00526071|3628507|FG000|Non-amenable Population; Men|Overall Study||3
2918330|NCT00526071|3628507|FG000|Non-amenable Population; Women|Overall Study||4
3168685|NCT01920477|3896054|FG000|STARTED|Overall Study||17
2856684|NCT00076011|3559062|FG000|STARTED|Overall Study||52
2856685|NCT00076011|3559062|FG000|COMPLETED|Overall Study||0
2856686|NCT00076011|3559062|FG000|NOT COMPLETED|Overall Study||52
2856687|NCT00076024|3559069|FG000|STARTED|Phase 1, Lead-in||6
2856688|NCT00076024|3559070|FG001|STARTED|Phase 1, Lead-in||0
2856689|NCT00076024|3559071|FG002|STARTED|Phase 1, Lead-in||0
2856690|NCT00076024|3559072|FG003|STARTED|Phase 1, Lead-in||0
2856691|NCT00076024|3559069|FG000|COMPLETED|Phase 1, Lead-in||0
2856692|NCT00076024|3559070|FG001|COMPLETED|Phase 1, Lead-in||0
2856693|NCT00076024|3559071|FG002|COMPLETED|Phase 1, Lead-in||0
2856694|NCT00076024|3559072|FG003|COMPLETED|Phase 1, Lead-in||0
2856695|NCT00076024|3559069|FG000|NOT COMPLETED|Phase 1, Lead-in||6
2856696|NCT00076024|3559070|FG001|NOT COMPLETED|Phase 1, Lead-in||0
2856697|NCT00076024|3559071|FG002|NOT COMPLETED|Phase 1, Lead-in||0
2856698|NCT00076024|3559072|FG003|NOT COMPLETED|Phase 1, Lead-in||0
2856699|NCT00076024|3559069|FG000|STARTED|Phase 2, Double-blind||0
2856700|NCT00076024|3559070|FG001|STARTED|Phase 2, Double-blind||112
2856701|NCT00076024|3559071|FG002|STARTED|Phase 2, Double-blind||56
2856702|NCT00076024|3559072|FG003|STARTED|Phase 2, Double-blind||0
2856703|NCT00076024|3559069|FG000|Treated|Phase 2, Double-blind||0
2856704|NCT00076024|3559070|FG001|Treated|Phase 2, Double-blind||111
2856705|NCT00076024|3559071|FG002|Treated|Phase 2, Double-blind||56
2856706|NCT00076024|3559072|FG003|Treated|Phase 2, Double-blind||0
2856707|NCT00076024|3559069|FG000|COMPLETED|Phase 2, Double-blind||0
2856708|NCT00076024|3559070|FG001|COMPLETED|Phase 2, Double-blind||0
2856709|NCT00076024|3559071|FG002|COMPLETED|Phase 2, Double-blind||0
2856710|NCT00076024|3559072|FG003|COMPLETED|Phase 2, Double-blind||0
2856711|NCT00076024|3559069|FG000|NOT COMPLETED|Phase 2, Double-blind||0
2856712|NCT00076024|3559070|FG001|NOT COMPLETED|Phase 2, Double-blind||112
2856713|NCT00076024|3559071|FG002|NOT COMPLETED|Phase 2, Double-blind||56
2856714|NCT00076024|3559072|FG003|NOT COMPLETED|Phase 2, Double-blind||0
2856715|NCT00076024|3559069|FG000|STARTED|Phase 2, Open-label||0
2856716|NCT00076024|3559070|FG001|STARTED|Phase 2, Open-label||0
2856717|NCT00076024|3559071|FG002|STARTED|Phase 2, Open-label||0
2856718|NCT00076024|3559072|FG003|STARTED|Phase 2, Open-label||16
2856719|NCT00076024|3559069|FG000|COMPLETED|Phase 2, Open-label||0
2856720|NCT00076024|3559070|FG001|COMPLETED|Phase 2, Open-label||0
2856721|NCT00076024|3559071|FG002|COMPLETED|Phase 2, Open-label||0
2856722|NCT00076024|3559072|FG003|COMPLETED|Phase 2, Open-label||0
2856723|NCT00076024|3559069|FG000|NOT COMPLETED|Phase 2, Open-label||0
2856724|NCT00076024|3559070|FG001|NOT COMPLETED|Phase 2, Open-label||0
2856725|NCT00076024|3559071|FG002|NOT COMPLETED|Phase 2, Open-label||0
2856726|NCT00076024|3559072|FG003|NOT COMPLETED|Phase 2, Open-label||16
2856727|NCT00076050|3559083|FG000|STARTED|Overall Study||122
2856728|NCT00076050|3559084|FG001|STARTED|Overall Study||126
2856729|NCT00076050|3559083|FG000|COMPLETED|Overall Study||99
2856730|NCT00076050|3559084|FG001|COMPLETED|Overall Study||83
2856731|NCT00076050|3559083|FG000|NOT COMPLETED|Overall Study||23
2856732|NCT00076050|3559084|FG001|NOT COMPLETED|Overall Study||43
2856733|NCT00076102|3559090|FG000|STARTED|Overall Study||36
2856734|NCT00076102|3559090|FG000|COMPLETED|Overall Study||31
2856735|NCT00076102|3559090|FG000|NOT COMPLETED|Overall Study||5
2856736|NCT00076219|3559098|FG000|STARTED|Overall Study||563
2856737|NCT00076219|3559099|FG001|STARTED|Overall Study||561
2856738|NCT00076219|3559098|FG000|COMPLETED|Overall Study||545
2856739|NCT00076219|3559099|FG001|COMPLETED|Overall Study||550
2856740|NCT00076219|3559098|FG000|NOT COMPLETED|Overall Study||18
2856741|NCT00076219|3559099|FG001|NOT COMPLETED|Overall Study||11
2856742|NCT00076245|3559109|FG000|STARTED|Overall Study||16
2856743|NCT00076245|3559110|FG001|STARTED|Overall Study||15
2856744|NCT00076245|3559111|FG002|STARTED|Overall Study||15
2856745|NCT00076245|3559112|FG003|STARTED|Overall Study||15
2856746|NCT00076245|3559109|FG000|COMPLETED|Overall Study||16
2856747|NCT00076245|3559110|FG001|COMPLETED|Overall Study||15
2856748|NCT00076245|3559111|FG002|COMPLETED|Overall Study||15
2856749|NCT00076245|3559112|FG003|COMPLETED|Overall Study||14
2856750|NCT00076245|3559109|FG000|NOT COMPLETED|Overall Study||0
2856751|NCT00076245|3559110|FG001|NOT COMPLETED|Overall Study||0
2856752|NCT00076245|3559111|FG002|NOT COMPLETED|Overall Study||0
2856753|NCT00076245|3559112|FG003|NOT COMPLETED|Overall Study||1
2856754|NCT00076258|3559124|FG000|STARTED|Overall Study||62
2856755|NCT00076258|3559125|FG001|STARTED|Overall Study||64
2856756|NCT00076258|3559124|FG000|COMPLETED|Overall Study||61
2856757|NCT00076258|3559125|FG001|COMPLETED|Overall Study||61
2856758|NCT00076258|3559124|FG000|NOT COMPLETED|Overall Study||1
2856759|NCT00076258|3559125|FG001|NOT COMPLETED|Overall Study||3
2856760|NCT00076336|3559133|FG000|STARTED|Overall Study||116
2856761|NCT00076336|3559134|FG001|STARTED|Overall Study||116
2856762|NCT00076336|3559133|FG000|Safety Population|Overall Study|1 patient was randomized but never received study drug and not included in safety population.|115
2856763|NCT00076336|3559134|FG001|Safety Population|Overall Study||116
2856764|NCT00076336|3559133|FG000|Intent to Treat (ITT) Population|Overall Study|1 patient had no HBV DNA assessments after baseline and was excluded from ITT population.|114
2856765|NCT00076336|3559134|FG001|Intent to Treat (ITT) Population|Overall Study|2 patients had no HBV DNA assessments after baseline and were excluded from ITT population.|114
2856766|NCT00076336|3559133|FG000|Completed Week 52|Overall Study||97
2856767|NCT00076336|3559134|FG001|Completed Week 52|Overall Study||94
2856768|NCT00076336|3559133|FG000|Completed Week 104|Overall Study||70
2856769|NCT00076336|3559134|FG001|Completed Week 104|Overall Study||62
2856770|NCT00076336|3559133|FG000|COMPLETED|Overall Study||64
2856771|NCT00076336|3559134|FG001|COMPLETED|Overall Study||60
2856772|NCT00076336|3559133|FG000|NOT COMPLETED|Overall Study||52
2856773|NCT00076336|3559134|FG001|NOT COMPLETED|Overall Study||56
2856774|NCT00076570|3559142|FG000|STARTED|Overall Study||15
2856775|NCT00076570|3559143|FG001|STARTED|Overall Study||16
2856776|NCT00076570|3559142|FG000|COMPLETED|Overall Study||7
2856777|NCT00076570|3559143|FG001|COMPLETED|Overall Study||8
2856778|NCT00076570|3559142|FG000|NOT COMPLETED|Overall Study||8
2856779|NCT00076570|3559143|FG001|NOT COMPLETED|Overall Study||8
2856780|NCT00076622|3559153|FG000|STARTED|Overall Study||23
2856781|NCT00076622|3559154|FG001|STARTED|Overall Study||13
2856782|NCT00076622|3559155|FG002|STARTED|Overall Study||40
2856783|NCT00076622|3559156|FG003|STARTED|Overall Study||18
2856784|NCT00076622|3559153|FG000|COMPLETED|Overall Study||23
2856785|NCT00076622|3559154|FG001|COMPLETED|Overall Study||13
2856786|NCT00076622|3559155|FG002|COMPLETED|Overall Study||40
2856787|NCT00076622|3559156|FG003|COMPLETED|Overall Study||18
2856788|NCT00076622|3559153|FG000|NOT COMPLETED|Overall Study||0
2856789|NCT00076622|3559154|FG001|NOT COMPLETED|Overall Study||0
2856790|NCT00076622|3559155|FG002|NOT COMPLETED|Overall Study||0
2856791|NCT00076622|3559156|FG003|NOT COMPLETED|Overall Study||0
2856792|NCT00076687|3559173|FG000|STARTED|Overall Study||48
2856793|NCT00076687|3559174|FG001|STARTED|Overall Study||52
2856794|NCT00076687|3559175|FG002|STARTED|Overall Study||55
2856795|NCT00076687|3559173|FG000|COMPLETED|Overall Study||42
2856796|NCT00076687|3559174|FG001|COMPLETED|Overall Study||47
2856797|NCT00076687|3559175|FG002|COMPLETED|Overall Study||51
2856798|NCT00076687|3559173|FG000|NOT COMPLETED|Overall Study||6
2856799|NCT00076687|3559174|FG001|NOT COMPLETED|Overall Study||5
3168686|NCT01920477|3896055|FG001|STARTED|Overall Study||18
3168687|NCT01920477|3896054|FG000|Requiried Individualized Follow-up|Overall Study||1
3168688|NCT01920477|3896055|FG001|Requiried Individualized Follow-up|Overall Study||0
3168689|NCT01920477|3896054|FG000|COMPLETED|Overall Study||2
3168690|NCT01920477|3896055|FG001|COMPLETED|Overall Study||1
2856800|NCT00076687|3559175|FG002|NOT COMPLETED|Overall Study||4
2856801|NCT00076752|3559183|FG000|STARTED|Overall Study||9
2856802|NCT00076752|3559183|FG000|COMPLETED|Overall Study||6
2856803|NCT00076752|3559183|FG000|NOT COMPLETED|Overall Study||3
2856804|NCT00076804|3559190|FG000|STARTED|Overall Study||137
2856805|NCT00076804|3559191|FG001|STARTED|Overall Study||137
2856806|NCT00076804|3559190|FG000|COMPLETED|Overall Study|111 completed week 48, 77 completed week 96.|77
2856807|NCT00076804|3559191|FG001|COMPLETED|Overall Study|102 completed week 48, 68 completed week 96|68
2856808|NCT00076804|3559190|FG000|NOT COMPLETED|Overall Study||60
2856809|NCT00076804|3559191|FG001|NOT COMPLETED|Overall Study||69
2856810|NCT00076999|3559201|FG000|STARTED|Overall Study||25
2856811|NCT00076999|3559202|FG001|STARTED|Overall Study||31
2856812|NCT00076999|3559203|FG002|STARTED|Overall Study||19
2856813|NCT00076999|3559204|FG003|STARTED|Overall Study||6
2856814|NCT00076999|3559205|FG004|STARTED|Overall Study||34
2856815|NCT00076999|3559201|FG000|COMPLETED|Overall Study||13
2856816|NCT00076999|3559202|FG001|COMPLETED|Overall Study||7
2856817|NCT00076999|3559203|FG002|COMPLETED|Overall Study||2
2856818|NCT00076999|3559204|FG003|COMPLETED|Overall Study||5
2856819|NCT00076999|3559205|FG004|COMPLETED|Overall Study||9
2856820|NCT00076999|3559201|FG000|NOT COMPLETED|Overall Study||12
2856821|NCT00076999|3559202|FG001|NOT COMPLETED|Overall Study||24
2856822|NCT00076999|3559203|FG002|NOT COMPLETED|Overall Study||17
2856823|NCT00076999|3559204|FG003|NOT COMPLETED|Overall Study||1
2856824|NCT00076999|3559205|FG004|NOT COMPLETED|Overall Study||25
2856825|NCT00077064|3559220|FG000|STARTED|Overall Study||17
2856826|NCT00077064|3559221|FG001|STARTED|Overall Study||16
2856827|NCT00077064|3559220|FG000|COMPLETED|Overall Study|Randomized eligible subjects are considered to have completed the study.|17
2856828|NCT00077064|3559221|FG001|COMPLETED|Overall Study|Randomized eligible subjects are considered to have completed the study.|10
2856829|NCT00077064|3559220|FG000|NOT COMPLETED|Overall Study||0
2856830|NCT00077064|3559221|FG001|NOT COMPLETED|Overall Study||6
2856831|NCT00077207|3559228|FG000|STARTED|Overall Study||66
2856832|NCT00077207|3559228|FG000|COMPLETED|Overall Study||36
2856833|NCT00077207|3559228|FG000|NOT COMPLETED|Overall Study||30
2856834|NCT00077376|3559233|FG000|STARTED|Overall Study||61
2856835|NCT00077376|3559233|FG000|Treated|Overall Study||59
2856836|NCT00077376|3559233|FG000|HER2+ in Central Testing|Overall Study||39
2856837|NCT00077376|3559233|FG000|COMPLETED|Overall Study||39
2856838|NCT00077376|3559233|FG000|NOT COMPLETED|Overall Study||22
2856839|NCT00077610|3559240|FG000|STARTED|Overall Study||223
2856840|NCT00077610|3559241|FG001|STARTED|Overall Study||224
2856841|NCT00077610|3559242|FG002|STARTED|Overall Study||226
2856842|NCT00077610|3559240|FG000|Started Treatment|Overall Study||221
2856843|NCT00077610|3559241|FG001|Started Treatment|Overall Study||220
2856844|NCT00077610|3559242|FG002|Started Treatment|Overall Study||225
2856845|NCT00077610|3559240|FG000|COMPLETED|Overall Study||169
2856846|NCT00077610|3559241|FG001|COMPLETED|Overall Study||168
2856847|NCT00077610|3559242|FG002|COMPLETED|Overall Study||180
2856848|NCT00077610|3559240|FG000|NOT COMPLETED|Overall Study||54
2856849|NCT00077610|3559241|FG001|NOT COMPLETED|Overall Study||56
2856850|NCT00077610|3559242|FG002|NOT COMPLETED|Overall Study||46
2856851|NCT00077623|3559258|FG000|STARTED|Overall Study||190
2856852|NCT00077623|3559259|FG001|STARTED|Overall Study||191
2856853|NCT00077623|3559260|FG002|STARTED|Overall Study||191
2856854|NCT00077623|3559258|FG000|COMPLETED|Overall Study||154
3168691|NCT01920477|3896054|FG000|NOT COMPLETED|Overall Study||15
2856855|NCT00077623|3559259|FG001|COMPLETED|Overall Study||148
2856856|NCT00077623|3559260|FG002|COMPLETED|Overall Study||159
2856857|NCT00077623|3559258|FG000|NOT COMPLETED|Overall Study||36
2856858|NCT00077623|3559259|FG001|NOT COMPLETED|Overall Study||43
2856859|NCT00077623|3559260|FG002|NOT COMPLETED|Overall Study||32
2856860|NCT00077636|3559270|FG000|STARTED|Overall Study||736
2856861|NCT00077636|3559271|FG001|STARTED|Overall Study||733
2856862|NCT00077636|3559270|FG000|COMPLETED|Overall Study||692
2856863|NCT00077636|3559271|FG001|COMPLETED|Overall Study||641
2856864|NCT00077636|3559270|FG000|NOT COMPLETED|Overall Study||44
2856865|NCT00077636|3559271|FG001|NOT COMPLETED|Overall Study||92
2856866|NCT00077649|3559282|FG000|STARTED|Overall Study||47
2856867|NCT00077649|3559283|FG001|STARTED|Overall Study||47
2856868|NCT00077649|3559284|FG002|STARTED|Overall Study||47
2856869|NCT00077649|3559285|FG003|STARTED|Overall Study||47
2856870|NCT00077649|3559282|FG000|Completed 24 Weeks of Follow-up|Overall Study||36
2856871|NCT00077649|3559283|FG001|Completed 24 Weeks of Follow-up|Overall Study||40
2856872|NCT00077649|3559284|FG002|Completed 24 Weeks of Follow-up|Overall Study||36
2856873|NCT00077649|3559285|FG003|Completed 24 Weeks of Follow-up|Overall Study||31
2856874|NCT00077649|3559282|FG000|COMPLETED|Overall Study||33
2856875|NCT00077649|3559283|FG001|COMPLETED|Overall Study||38
2856876|NCT00077649|3559284|FG002|COMPLETED|Overall Study||32
2856877|NCT00077649|3559285|FG003|COMPLETED|Overall Study||30
2856878|NCT00077649|3559282|FG000|NOT COMPLETED|Overall Study||14
2856879|NCT00077649|3559283|FG001|NOT COMPLETED|Overall Study||9
2856880|NCT00077649|3559284|FG002|NOT COMPLETED|Overall Study||15
2856881|NCT00077649|3559285|FG003|NOT COMPLETED|Overall Study||17
2856882|NCT00077675|3559301|FG000|STARTED|Overall Study||103
2856883|NCT00077675|3559302|FG001|STARTED|Overall Study||98
2856884|NCT00077675|3559301|FG000|COMPLETED|Overall Study||92
2856885|NCT00077675|3559302|FG001|COMPLETED|Overall Study||89
2856886|NCT00077675|3559301|FG000|NOT COMPLETED|Overall Study||11
2856887|NCT00077675|3559302|FG001|NOT COMPLETED|Overall Study||9
2856888|NCT00077766|3559310|FG000|STARTED|Overall Study||157
2856889|NCT00077766|3559311|FG001|STARTED|Overall Study||156
2856890|NCT00077766|3559310|FG000|COMPLETED|Overall Study||118
2856891|NCT00077766|3559311|FG001|COMPLETED|Overall Study||131
2856892|NCT00077766|3559310|FG000|NOT COMPLETED|Overall Study||39
2856893|NCT00077766|3559311|FG001|NOT COMPLETED|Overall Study||25
2856894|NCT00077857|3559320|FG000|STARTED|Overall Study||235
2856895|NCT00077857|3559321|FG001|STARTED|Overall Study||235
2856896|NCT00077857|3559320|FG000|Received Study Drug|Overall Study||231
2856897|NCT00077857|3559321|FG001|Received Study Drug|Overall Study||234
2856898|NCT00077857|3559320|FG000|Safety Population: Actual Dose Received|Overall Study|14 patients in the 1250 dose arm received a lower dose and were included in the 825 arm for Safety.|217
2856899|NCT00077857|3559321|FG001|Safety Population: Actual Dose Received|Overall Study||248
2856900|NCT00077857|3559320|FG000|COMPLETED|Overall Study||34
2856901|NCT00077857|3559321|FG001|COMPLETED|Overall Study||31
2856902|NCT00077857|3559320|FG000|NOT COMPLETED|Overall Study||201
2856903|NCT00077857|3559321|FG001|NOT COMPLETED|Overall Study||204
2856904|NCT00077922|3559327|FG000|STARTED|Overall Study||15
2856905|NCT00077922|3559327|FG000|COMPLETED|Overall Study||15
2856906|NCT00077922|3559327|FG000|NOT COMPLETED|Overall Study||0
2856907|NCT00077974|3559331|FG000|STARTED|Overall Study||106
2856908|NCT00077974|3559331|FG000|COMPLETED|Overall Study||2
2856909|NCT00077974|3559331|FG000|NOT COMPLETED|Overall Study||104
2856910|NCT00078286|3559337|FG000|STARTED|Overall Study||234
2856911|NCT00078286|3559338|FG001|STARTED|Overall Study||235
2856912|NCT00078286|3559337|FG000|COMPLETED|Overall Study||138
2856913|NCT00078286|3559338|FG001|COMPLETED|Overall Study||152
2856914|NCT00078286|3559337|FG000|NOT COMPLETED|Overall Study||96
2856915|NCT00078286|3559338|FG001|NOT COMPLETED|Overall Study||83
2856916|NCT00078312|3559344|FG000|STARTED|Overall Study||328
2856917|NCT00078312|3559344|FG000|COMPLETED|Overall Study||151
2856918|NCT00078312|3559344|FG000|NOT COMPLETED|Overall Study||177
2856919|NCT00078325|3559351|FG000|STARTED|Overall Study||131
2856920|NCT00078325|3559352|FG001|STARTED|Overall Study||133
2856921|NCT00078325|3559353|FG002|STARTED|Overall Study||131
2856922|NCT00078325|3559351|FG000|COMPLETED|Overall Study||110
2856923|NCT00078325|3559352|FG001|COMPLETED|Overall Study||114
2856924|NCT00078325|3559353|FG002|COMPLETED|Overall Study||120
2856925|NCT00078325|3559351|FG000|NOT COMPLETED|Overall Study||21
2856926|NCT00078325|3559352|FG001|NOT COMPLETED|Overall Study||19
2856927|NCT00078325|3559353|FG002|NOT COMPLETED|Overall Study||11
2856928|NCT00078338|3559363|FG000|STARTED|Overall Study||386
2856929|NCT00078338|3559364|FG001|STARTED|Overall Study||378
2856930|NCT00078338|3559363|FG000|Safety Population|Overall Study|Safety population=subjects who received at least 1 dose of treatment and had followup safety data.|381
2856931|NCT00078338|3559364|FG001|Safety Population|Overall Study|Safety population=subjects who received at least 1 dose of treatment and had followup safety data.|375
2856932|NCT00078338|3559363|FG000|COMPLETED|Overall Study||301
2856933|NCT00078338|3559364|FG001|COMPLETED|Overall Study||324
2856934|NCT00078338|3559363|FG000|NOT COMPLETED|Overall Study||85
2856935|NCT00078338|3559364|FG001|NOT COMPLETED|Overall Study||54
2856936|NCT00078377|3559373|FG000|STARTED|Overall Study||67
2856937|NCT00078377|3559374|FG001|STARTED|Overall Study||65
2856938|NCT00078377|3559375|FG002|STARTED|Overall Study||64
2856939|NCT00078377|3559373|FG000|COMPLETED|Overall Study||56
2856940|NCT00078377|3559374|FG001|COMPLETED|Overall Study||49
2856941|NCT00078377|3559375|FG002|COMPLETED|Overall Study||55
2856942|NCT00078377|3559373|FG000|NOT COMPLETED|Overall Study||11
2856943|NCT00078377|3559374|FG001|NOT COMPLETED|Overall Study||16
2856944|NCT00078377|3559375|FG002|NOT COMPLETED|Overall Study||9
2856945|NCT00078403|3559387|FG000|STARTED|Overall Study|Eligible at pre-assignment (40), direct (2), Arm C week 36 non-response (1), EVR inadvertently (1).|44
2856946|NCT00078403|3559388|FG001|STARTED|Overall Study|Eligible at pre-assignment (40), direct (1), Arm C week 36 non-response (1).|42
2856947|NCT00078403|3559389|FG002|STARTED|Overall Study||169
2856948|NCT00078403|3559387|FG000|COMPLETED|Overall Study||26
2856949|NCT00078403|3559388|FG001|COMPLETED|Overall Study||26
2856950|NCT00078403|3559389|FG002|COMPLETED|Overall Study||141
2856951|NCT00078403|3559387|FG000|NOT COMPLETED|Overall Study||18
2856952|NCT00078403|3559388|FG001|NOT COMPLETED|Overall Study||16
2856953|NCT00078403|3559389|FG002|NOT COMPLETED|Overall Study||28
2856954|NCT00078559|3559398|FG000|STARTED|Overall Study||10
2856955|NCT00078559|3559398|FG000|COMPLETED|Overall Study|1 subject stopped study drug due to a severe but non-serious AE, and completed the trial|10
2856956|NCT00078559|3559398|FG000|NOT COMPLETED|Overall Study||0
2856957|NCT00078715|3559405|FG000|STARTED|First Intervention||2
2856958|NCT00078715|3559406|FG001|STARTED|First Intervention||4
2856959|NCT00078715|3559405|FG000|COMPLETED|First Intervention||2
2856960|NCT00078715|3559406|FG001|COMPLETED|First Intervention||4
2856961|NCT00078715|3559405|FG000|NOT COMPLETED|First Intervention||0
2856962|NCT00078715|3559406|FG001|NOT COMPLETED|First Intervention||0
2856963|NCT00078715|3559405|FG000|STARTED|Second Intervention||2
2856964|NCT00078715|3559406|FG001|STARTED|Second Intervention||4
2856965|NCT00078715|3559405|FG000|COMPLETED|Second Intervention||2
2856966|NCT00078715|3559406|FG001|COMPLETED|Second Intervention||4
2856967|NCT00078715|3559405|FG000|NOT COMPLETED|Second Intervention||0
2856968|NCT00078715|3559406|FG001|NOT COMPLETED|Second Intervention||0
2856969|NCT00078728|3559414|FG000|STARTED|Overall Study||20
2856970|NCT00078728|3559415|FG001|STARTED|Overall Study||20
2856971|NCT00078728|3559414|FG000|COMPLETED|Overall Study||16
2856972|NCT00078728|3559415|FG001|COMPLETED|Overall Study||17
2856973|NCT00078728|3559414|FG000|NOT COMPLETED|Overall Study||4
2856974|NCT00078728|3559415|FG001|NOT COMPLETED|Overall Study||3
2856975|NCT00078754|3559425|FG000|STARTED|Overall Study||29
2856976|NCT00078754|3559426|FG001|STARTED|Overall Study||30
2856977|NCT00078754|3559427|FG002|STARTED|Overall Study||31
2856978|NCT00078754|3559425|FG000|COMPLETED|Overall Study||14
2856979|NCT00078754|3559426|FG001|COMPLETED|Overall Study||11
2856980|NCT00078754|3559427|FG002|COMPLETED|Overall Study||16
2856981|NCT00078754|3559425|FG000|NOT COMPLETED|Overall Study||15
2856982|NCT00078754|3559426|FG001|NOT COMPLETED|Overall Study||19
2856983|NCT00078754|3559427|FG002|NOT COMPLETED|Overall Study||15
2856984|NCT00078767|3559440|FG000|STARTED|Overall Study||12
2856985|NCT00078767|3559441|FG001|STARTED|Overall Study||12
2856986|NCT00078767|3559440|FG000|COMPLETED|Overall Study||11
2856987|NCT00078767|3559441|FG001|COMPLETED|Overall Study||11
2856988|NCT00078767|3559440|FG000|NOT COMPLETED|Overall Study||1
2856989|NCT00078767|3559441|FG001|NOT COMPLETED|Overall Study||1
2856990|NCT00078819|3559449|FG000|STARTED|Double-blind Treatment Period: Week 1-12||105
2856991|NCT00078819|3559450|FG001|STARTED|Double-blind Treatment Period: Week 1-12||106
2856992|NCT00078819|3559451|FG002|STARTED|Double-blind Treatment Period: Week 1-12||0
2856993|NCT00078819|3559452|FG003|STARTED|Double-blind Treatment Period: Week 1-12||0
3168692|NCT01920477|3896055|FG001|NOT COMPLETED|Overall Study||17
3168693|NCT01920555|3896066|FG000|STARTED|Overall Study||18
3168694|NCT01920555|3896067|FG001|STARTED|Overall Study||20
2856994|NCT00078819|3559449|FG000|Entered Escape|Double-blind Treatment Period: Week 1-12||27
2856995|NCT00078819|3559450|FG001|Entered Escape|Double-blind Treatment Period: Week 1-12||5
2856996|NCT00078819|3559451|FG002|Entered Escape|Double-blind Treatment Period: Week 1-12||0
2856997|NCT00078819|3559452|FG003|Entered Escape|Double-blind Treatment Period: Week 1-12||0
2856998|NCT00078819|3559449|FG000|COMPLETED|Double-blind Treatment Period: Week 1-12||104
2856999|NCT00078819|3559450|FG001|COMPLETED|Double-blind Treatment Period: Week 1-12||105
3168695|NCT01920555|3896068|FG002|STARTED|Overall Study||22
3168696|NCT01920555|3896069|FG003|STARTED|Overall Study||20
3168697|NCT01920555|3896070|FG004|STARTED|Overall Study||19
3168698|NCT01920555|3896066|FG000|COMPLETED|Overall Study||14
3168699|NCT01920555|3896067|FG001|COMPLETED|Overall Study||16
3168700|NCT01920555|3896068|FG002|COMPLETED|Overall Study||21
3168701|NCT01920555|3896069|FG003|COMPLETED|Overall Study||17
3168702|NCT01920555|3896070|FG004|COMPLETED|Overall Study||18
2857000|NCT00078819|3559451|FG002|COMPLETED|Double-blind Treatment Period: Week 1-12||0
2857001|NCT00078819|3559452|FG003|COMPLETED|Double-blind Treatment Period: Week 1-12||0
2857002|NCT00078819|3559449|FG000|NOT COMPLETED|Double-blind Treatment Period: Week 1-12||1
2857003|NCT00078819|3559450|FG001|NOT COMPLETED|Double-blind Treatment Period: Week 1-12||1
2857004|NCT00078819|3559451|FG002|NOT COMPLETED|Double-blind Treatment Period: Week 1-12||0
2857005|NCT00078819|3559452|FG003|NOT COMPLETED|Double-blind Treatment Period: Week 1-12||0
2857006|NCT00078819|3559449|FG000|STARTED|Open-label Treatment Period: Weeks 13-36|One participant discontinued before starting the open-label period|103
2857007|NCT00078819|3559450|FG001|STARTED|Open-label Treatment Period: Weeks 13-36||105
2857008|NCT00078819|3559451|FG002|STARTED|Open-label Treatment Period: Weeks 13-36||0
3168703|NCT01920555|3896066|FG000|NOT COMPLETED|Overall Study||4
3168704|NCT01920555|3896067|FG001|NOT COMPLETED|Overall Study||4
3168705|NCT01920555|3896068|FG002|NOT COMPLETED|Overall Study||1
3168706|NCT01920555|3896069|FG003|NOT COMPLETED|Overall Study||3
3168707|NCT01920555|3896070|FG004|NOT COMPLETED|Overall Study||1
3168708|NCT01920568|3896084|FG000|STARTED|Overall Study||326
3313399|NCT03075410|4046794|FG003|NOT COMPLETED|Part A-Period 2 (14 Days)||0
3313400|NCT03075410|4046795|FG004|NOT COMPLETED|Part A-Period 2 (14 Days)||0
3313401|NCT03075410|4046796|FG005|NOT COMPLETED|Part A-Period 2 (14 Days)||0
3168709|NCT01920568|3896085|FG001|STARTED|Overall Study||159
3168710|NCT01920568|3896084|FG000|COMPLETED|Overall Study||175
3168711|NCT01920568|3896085|FG001|COMPLETED|Overall Study||75
3168712|NCT01920568|3896084|FG000|NOT COMPLETED|Overall Study||151
3168713|NCT01920568|3896085|FG001|NOT COMPLETED|Overall Study||84
3168714|NCT01920594|3896094|FG000|STARTED|Overall Study||27
3168715|NCT01920594|3896095|FG001|STARTED|Overall Study||28
3168716|NCT01920594|3896094|FG000|COMPLETED|Overall Study||20
2857009|NCT00078819|3559452|FG003|STARTED|Open-label Treatment Period: Weeks 13-36||0
2857010|NCT00078819|3559449|FG000|COMPLETED|Open-label Treatment Period: Weeks 13-36||63
2857011|NCT00078819|3559450|FG001|COMPLETED|Open-label Treatment Period: Weeks 13-36||75
2857012|NCT00078819|3559451|FG002|COMPLETED|Open-label Treatment Period: Weeks 13-36||0
2857013|NCT00078819|3559452|FG003|COMPLETED|Open-label Treatment Period: Weeks 13-36||0
2857014|NCT00078819|3559449|FG000|NOT COMPLETED|Open-label Treatment Period: Weeks 13-36||40
2857015|NCT00078819|3559450|FG001|NOT COMPLETED|Open-label Treatment Period: Weeks 13-36||30
2857016|NCT00078819|3559451|FG002|NOT COMPLETED|Open-label Treatment Period: Weeks 13-36||0
2857017|NCT00078819|3559452|FG003|NOT COMPLETED|Open-label Treatment Period: Weeks 13-36||0
2857018|NCT00078819|3559449|FG000|STARTED|Withdrawal Period: Weeks 37-48||0
2857019|NCT00078819|3559450|FG001|STARTED|Withdrawal Period: Weeks 37-48||0
2857020|NCT00078819|3559451|FG002|STARTED|Withdrawal Period: Weeks 37-48|Participants who completed week 36 with a PASI response|69
2857021|NCT00078819|3559452|FG003|STARTED|Withdrawal Period: Weeks 37-48|Participants who completed week 36 with a PASI response|69
2857022|NCT00078819|3559449|FG000|Received Study Drug|Withdrawal Period: Weeks 37-48||0
2857023|NCT00078819|3559450|FG001|Received Study Drug|Withdrawal Period: Weeks 37-48||0
2857024|NCT00078819|3559451|FG002|Received Study Drug|Withdrawal Period: Weeks 37-48||69
2857025|NCT00078819|3559452|FG003|Received Study Drug|Withdrawal Period: Weeks 37-48||68
2857026|NCT00078819|3559449|FG000|COMPLETED|Withdrawal Period: Weeks 37-48||0
2857027|NCT00078819|3559450|FG001|COMPLETED|Withdrawal Period: Weeks 37-48||0
2857028|NCT00078819|3559451|FG002|COMPLETED|Withdrawal Period: Weeks 37-48|Defined as continuing to receive blinded study drug through week 48|40
2857029|NCT00078819|3559452|FG003|COMPLETED|Withdrawal Period: Weeks 37-48|Defined as continuing to receive blinded study drug through week 48|55
2857030|NCT00078819|3559449|FG000|NOT COMPLETED|Withdrawal Period: Weeks 37-48||0
2857031|NCT00078819|3559450|FG001|NOT COMPLETED|Withdrawal Period: Weeks 37-48||0
2857032|NCT00078819|3559451|FG002|NOT COMPLETED|Withdrawal Period: Weeks 37-48||29
2857033|NCT00078819|3559452|FG003|NOT COMPLETED|Withdrawal Period: Weeks 37-48||14
2857034|NCT00078819|3559449|FG000|STARTED|Re-treatment Period||0
2857035|NCT00078819|3559450|FG001|STARTED|Re-treatment Period||0
2857036|NCT00078819|3559451|FG002|STARTED|Re-treatment Period||29
2857037|NCT00078819|3559452|FG003|STARTED|Re-treatment Period||13
2857038|NCT00078819|3559449|FG000|Received Study Drug|Re-treatment Period||0
2857039|NCT00078819|3559450|FG001|Received Study Drug|Re-treatment Period||0
2857040|NCT00078819|3559451|FG002|Received Study Drug|Re-treatment Period|One additional participant received re-treatment without having disease relapse|30
2857041|NCT00078819|3559452|FG003|Received Study Drug|Re-treatment Period||12
2857042|NCT00078819|3559449|FG000|COMPLETED|Re-treatment Period||0
2857043|NCT00078819|3559450|FG001|COMPLETED|Re-treatment Period||0
2857044|NCT00078819|3559451|FG002|COMPLETED|Re-treatment Period||29
2857045|NCT00078819|3559452|FG003|COMPLETED|Re-treatment Period||13
2857046|NCT00078819|3559449|FG000|NOT COMPLETED|Re-treatment Period||0
2857047|NCT00078819|3559450|FG001|NOT COMPLETED|Re-treatment Period||0
2857048|NCT00078819|3559451|FG002|NOT COMPLETED|Re-treatment Period||0
2857049|NCT00078819|3559452|FG003|NOT COMPLETED|Re-treatment Period||0
2857050|NCT00078897|3559471|FG000|STARTED|Overall Study||809
2857051|NCT00078897|3559472|FG001|STARTED|Overall Study||812
2857052|NCT00078897|3559471|FG000|COMPLETED|Overall Study||685
2857053|NCT00078897|3559472|FG001|COMPLETED|Overall Study||689
2857054|NCT00078897|3559471|FG000|NOT COMPLETED|Overall Study||124
2857055|NCT00078897|3559472|FG001|NOT COMPLETED|Overall Study||123
2857056|NCT00078949|3559482|FG000|STARTED|Overall Study||310
2857057|NCT00078949|3559483|FG001|STARTED|Overall Study||309
2857058|NCT00078949|3559484|FG002|STARTED|Overall Study||115
2857059|NCT00078949|3559485|FG003|STARTED|Overall Study||115
2857060|NCT00078949|3559482|FG000|COMPLETED|Overall Study||306
2857061|NCT00078949|3559483|FG001|COMPLETED|Overall Study||304
2857062|NCT00078949|3559484|FG002|COMPLETED|Overall Study||112
2857063|NCT00078949|3559485|FG003|COMPLETED|Overall Study||112
2857064|NCT00078949|3559482|FG000|NOT COMPLETED|Overall Study||4
2857065|NCT00078949|3559483|FG001|NOT COMPLETED|Overall Study||5
2857066|NCT00078949|3559484|FG002|NOT COMPLETED|Overall Study||3
2857067|NCT00078949|3559485|FG003|NOT COMPLETED|Overall Study||3
2857068|NCT00079001|3559499|FG000|STARTED|Overall Study||323
2857069|NCT00079001|3559500|FG001|STARTED|Overall Study||322
2857070|NCT00079001|3559499|FG000|COMPLETED|Overall Study||323
2857071|NCT00079001|3559500|FG001|COMPLETED|Overall Study||322
2857072|NCT00079001|3559499|FG000|NOT COMPLETED|Overall Study||0
2857073|NCT00079001|3559500|FG001|NOT COMPLETED|Overall Study||0
2857074|NCT00079040|3559506|FG000|STARTED|Overall Study||65
2857075|NCT00079040|3559506|FG000|COMPLETED|Overall Study||63
2857076|NCT00079040|3559506|FG000|NOT COMPLETED|Overall Study||2
2857077|NCT00079183|3559510|FG000|STARTED|Overall Study||44
2857078|NCT00079183|3559510|FG000|Drop Outs|Overall Study||7
2857079|NCT00079183|3559510|FG000|COMPLETED|Overall Study||37
2857080|NCT00079183|3559510|FG000|NOT COMPLETED|Overall Study||7
2857081|NCT00079274|3559522|FG000|STARTED|Overall Study||1402
2857082|NCT00079274|3559523|FG001|STARTED|Overall Study||111
2857083|NCT00079274|3559524|FG002|STARTED|Overall Study||111
2857084|NCT00079274|3559525|FG003|STARTED|Overall Study||1350
2857085|NCT00079274|3559526|FG004|STARTED|Overall Study||45
2857086|NCT00079274|3559527|FG005|STARTED|Overall Study||46
2857087|NCT00079274|3559528|FG006|STARTED|Overall Study||332
2857088|NCT00079274|3559522|FG000|COMPLETED|Overall Study||1081
2857089|NCT00079274|3559523|FG001|COMPLETED|Overall Study||84
2857090|NCT00079274|3559524|FG002|COMPLETED|Overall Study||84
3168717|NCT01920594|3896095|FG001|COMPLETED|Overall Study||25
3168718|NCT01920594|3896094|FG000|NOT COMPLETED|Overall Study||7
3168719|NCT01920594|3896095|FG001|NOT COMPLETED|Overall Study||3
3168720|NCT01920711|3896103|FG000|STARTED|Overall Study||2419
3168721|NCT01920711|3896104|FG001|STARTED|Overall Study||2403
3168722|NCT01920711|3896103|FG000|COMPLETED|Overall Study||2055
3168723|NCT01920711|3896104|FG001|COMPLETED|Overall Study||2030
3168724|NCT01920711|3896103|FG000|NOT COMPLETED|Overall Study||364
3168725|NCT01920711|3896104|FG001|NOT COMPLETED|Overall Study||373
3168726|NCT01920802|3896114|FG000|STARTED|Overall Study||11
3168727|NCT01920802|3896115|FG001|STARTED|Overall Study||9
3168728|NCT01920802|3896116|FG002|STARTED|Overall Study||11
3168729|NCT01920802|3896114|FG000|COMPLETED|Overall Study||7
3168730|NCT01920802|3896115|FG001|COMPLETED|Overall Study||7
2857091|NCT00079274|3559525|FG003|COMPLETED|Overall Study||906
2857092|NCT00079274|3559526|FG004|COMPLETED|Overall Study||30
2857093|NCT00079274|3559527|FG005|COMPLETED|Overall Study||26
2857094|NCT00079274|3559528|FG006|COMPLETED|Overall Study||332
2857095|NCT00079274|3559522|FG000|NOT COMPLETED|Overall Study||321
2857096|NCT00079274|3559523|FG001|NOT COMPLETED|Overall Study||27
2857097|NCT00079274|3559524|FG002|NOT COMPLETED|Overall Study||27
2857098|NCT00079274|3559525|FG003|NOT COMPLETED|Overall Study||444
2857099|NCT00079274|3559526|FG004|NOT COMPLETED|Overall Study||15
2857100|NCT00079274|3559527|FG005|NOT COMPLETED|Overall Study||20
2857101|NCT00079274|3559528|FG006|NOT COMPLETED|Overall Study||0
2857102|NCT00079326|3559543|FG000|STARTED|Overall Study||15
2857103|NCT00079326|3559544|FG001|STARTED|Overall Study||24
2857104|NCT00079326|3559543|FG000|COMPLETED|Overall Study||15
2857105|NCT00079326|3559544|FG001|COMPLETED|Overall Study||24
2857106|NCT00079326|3559543|FG000|NOT COMPLETED|Overall Study||0
2857107|NCT00079326|3559544|FG001|NOT COMPLETED|Overall Study||0
2857108|NCT00079339|3559552|FG000|STARTED|Overall Study||5
2857109|NCT00079339|3559553|FG001|STARTED|Overall Study||40
2857110|NCT00079339|3559554|FG002|STARTED|Overall Study||6
2857111|NCT00079339|3559552|FG000|Enrolled in Phase I|Overall Study||5
2857112|NCT00079339|3559553|FG001|Enrolled in Phase I|Overall Study||6
2857113|NCT00079339|3559554|FG002|Enrolled in Phase I|Overall Study||6
2857114|NCT00079339|3559552|FG000|Maximum Tolerated Dose (MTD) Estimation|Overall Study|2 participants enrolled in the phase I part did not complete the 8 week MTD estimation period.|3
2857115|NCT00079339|3559553|FG001|Maximum Tolerated Dose (MTD) Estimation|Overall Study||6
2857116|NCT00079339|3559554|FG002|Maximum Tolerated Dose (MTD) Estimation|Overall Study|One participant enrolled in the phase I part did not complete the 8 week MTD estimation period.|5
2857117|NCT00079339|3559552|FG000|Enrolled in Phase II|Overall Study|Participants treated at the 100 mg/m2 dose level did not participate in the phase II part.|0
2857118|NCT00079339|3559553|FG001|Enrolled in Phase II|Overall Study|This number includes the 6 patients enrolled on the phase I part.|40
2857119|NCT00079339|3559554|FG002|Enrolled in Phase II|Overall Study|Participants treated at the 150 mg/m2 dose level did not participate in the phase II part.|0
2857120|NCT00079339|3559552|FG000|COMPLETED|Overall Study||0
2857121|NCT00079339|3559553|FG001|COMPLETED|Overall Study||1
2857122|NCT00079339|3559554|FG002|COMPLETED|Overall Study||0
2857123|NCT00079339|3559552|FG000|NOT COMPLETED|Overall Study||5
2857124|NCT00079339|3559553|FG001|NOT COMPLETED|Overall Study||39
2857125|NCT00079339|3559554|FG002|NOT COMPLETED|Overall Study||6
2857126|NCT00079391|3559567|FG000|STARTED|Overall Study|1 of these withdrew after consent.|50
2857127|NCT00079391|3559567|FG000|COMPLETED|Overall Study||49
2857128|NCT00079391|3559567|FG000|NOT COMPLETED|Overall Study||1
2857129|NCT00079417|3559573|FG000|STARTED|Overall Study||28
2857130|NCT00079417|3559573|FG000|COMPLETED|Overall Study||19
2857131|NCT00079417|3559573|FG000|NOT COMPLETED|Overall Study||9
2857132|NCT00079677|3559579|FG000|STARTED|Overall Study||131
2857133|NCT00079677|3559580|FG001|STARTED|Overall Study||132
2857134|NCT00079677|3559579|FG000|COMPLETED|Overall Study||111
2857135|NCT00079677|3559580|FG001|COMPLETED|Overall Study||118
2857136|NCT00079677|3559579|FG000|NOT COMPLETED|Overall Study||20
2857137|NCT00079677|3559580|FG001|NOT COMPLETED|Overall Study||14
2857138|NCT00079781|3559589|FG000|STARTED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|45
2857139|NCT00079781|3559590|FG001|STARTED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|10
2857140|NCT00079781|3559591|FG002|STARTED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|15
2857141|NCT00079781|3559589|FG000|COMPLETED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|42
2857142|NCT00079781|3559590|FG001|COMPLETED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|9
2857143|NCT00079781|3559591|FG002|COMPLETED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|14
2857144|NCT00079781|3559589|FG000|NOT COMPLETED|Pre-implant Period||3
2857145|NCT00079781|3559590|FG001|NOT COMPLETED|Pre-implant Period||1
2857146|NCT00079781|3559591|FG002|NOT COMPLETED|Pre-implant Period||1
2857147|NCT00079781|3559589|FG000|STARTED|Evaluation Period||42
2857148|NCT00079781|3559590|FG001|STARTED|Evaluation Period||9
2857149|NCT00079781|3559591|FG002|STARTED|Evaluation Period||14
2857150|NCT00079781|3559589|FG000|COMPLETED|Evaluation Period||42
2857151|NCT00079781|3559590|FG001|COMPLETED|Evaluation Period||9
2857152|NCT00079781|3559591|FG002|COMPLETED|Evaluation Period||14
2857153|NCT00079781|3559589|FG000|NOT COMPLETED|Evaluation Period||0
2857154|NCT00079781|3559590|FG001|NOT COMPLETED|Evaluation Period||0
2857155|NCT00079781|3559591|FG002|NOT COMPLETED|Evaluation Period||0
2857156|NCT00079781|3559589|FG000|STARTED|Follow-up Period||42
2857157|NCT00079781|3559590|FG001|STARTED|Follow-up Period||9
2857158|NCT00079781|3559591|FG002|STARTED|Follow-up Period||14
2857159|NCT00079781|3559589|FG000|COMPLETED|Follow-up Period||38
2857160|NCT00079781|3559590|FG001|COMPLETED|Follow-up Period||9
2857161|NCT00079781|3559591|FG002|COMPLETED|Follow-up Period||12
2857162|NCT00079781|3559589|FG000|NOT COMPLETED|Follow-up Period||4
2857163|NCT00079781|3559590|FG001|NOT COMPLETED|Follow-up Period||0
2857164|NCT00079781|3559591|FG002|NOT COMPLETED|Follow-up Period||2
2857165|NCT00079937|3559599|FG000|STARTED|Overall Study||421
2857166|NCT00079937|3559600|FG001|STARTED|Overall Study||207
2857167|NCT00079937|3559599|FG000|COMPLETED|Overall Study||352
2857168|NCT00079937|3559600|FG001|COMPLETED|Overall Study||175
2857169|NCT00079937|3559599|FG000|NOT COMPLETED|Overall Study||69
2857170|NCT00079937|3559600|FG001|NOT COMPLETED|Overall Study||32
2857171|NCT00080119|3559610|FG000|STARTED|Overall Study||403
2857172|NCT00080119|3559611|FG001|STARTED|Overall Study||401
2857173|NCT00080119|3559612|FG002|STARTED|Overall Study||273
2857174|NCT00080119|3559613|FG003|STARTED|Overall Study||274
2857175|NCT00080119|3559610|FG000|COMPLETED|Overall Study||347
2857176|NCT00080119|3559611|FG001|COMPLETED|Overall Study||339
2857177|NCT00080119|3559612|FG002|COMPLETED|Overall Study||108
2857178|NCT00080119|3559613|FG003|COMPLETED|Overall Study||111
2857179|NCT00080119|3559610|FG000|NOT COMPLETED|Overall Study||56
2857180|NCT00080119|3559611|FG001|NOT COMPLETED|Overall Study||62
2857181|NCT00080119|3559612|FG002|NOT COMPLETED|Overall Study||165
2857182|NCT00080119|3559613|FG003|NOT COMPLETED|Overall Study||163
2857183|NCT00080223|3559625|FG000|STARTED|Overall Study||83
2857184|NCT00080223|3559625|FG000|COMPLETED|Overall Study||7
2857185|NCT00080223|3559625|FG000|NOT COMPLETED|Overall Study||76
2857186|NCT00080288|3559631|FG000|STARTED|Overall Study||127
3168731|NCT01920802|3896116|FG002|COMPLETED|Overall Study||10
3168732|NCT01920802|3896114|FG000|NOT COMPLETED|Overall Study||4
3168733|NCT01920802|3896115|FG001|NOT COMPLETED|Overall Study||2
3168734|NCT01920802|3896116|FG002|NOT COMPLETED|Overall Study||1
3168735|NCT01920854|3896131|FG000|STARTED|Overall Study||12
3168736|NCT01920854|3896132|FG001|STARTED|Overall Study||6
2857187|NCT00080288|3559632|FG001|STARTED|Overall Study||127
2857188|NCT00080288|3559631|FG000|COMPLETED|Overall Study||97
2857189|NCT00080288|3559632|FG001|COMPLETED|Overall Study||89
2857190|NCT00080288|3559631|FG000|NOT COMPLETED|Overall Study||30
2857191|NCT00080288|3559632|FG001|NOT COMPLETED|Overall Study||38
2857192|NCT00080301|3559640|FG000|STARTED|Overall Study||375
2857193|NCT00080301|3559641|FG001|STARTED|Overall Study||377
2857194|NCT00080301|3559640|FG000|Never Treated|Overall Study||5
2857195|NCT00080301|3559641|FG001|Never Treated|Overall Study||10
2857196|NCT00080301|3559640|FG000|Still on Treatment|Overall Study||0
2857197|NCT00080301|3559641|FG001|Still on Treatment|Overall Study||1
2857198|NCT00080301|3559640|FG000|COMPLETED|Overall Study|Participants who are off treatment|370
2857199|NCT00080301|3559641|FG001|COMPLETED|Overall Study|Participants who are off treatment|366
2857200|NCT00080301|3559640|FG000|NOT COMPLETED|Overall Study||5
2857201|NCT00080301|3559641|FG001|NOT COMPLETED|Overall Study||11
2857202|NCT00080470|3559650|FG000|STARTED|Overall Study||45
2857203|NCT00080470|3559651|FG001|STARTED|Overall Study||42
2857204|NCT00080470|3559650|FG000|COMPLETED|Overall Study||11
2857205|NCT00080470|3559651|FG001|COMPLETED|Overall Study||14
2857206|NCT00080470|3559650|FG000|NOT COMPLETED|Overall Study||34
2857207|NCT00080470|3559651|FG001|NOT COMPLETED|Overall Study||28
2857208|NCT00080483|3559661|FG000|STARTED|Overall Study||17
2857209|NCT00080483|3559662|FG001|STARTED|Overall Study||18
2857210|NCT00080483|3559661|FG000|COMPLETED|Overall Study||15
2857211|NCT00080483|3559662|FG001|COMPLETED|Overall Study||16
2857212|NCT00080483|3559661|FG000|NOT COMPLETED|Overall Study||2
2857213|NCT00080483|3559662|FG001|NOT COMPLETED|Overall Study||2
2857214|NCT00080535|3559668|FG000|STARTED|Overall Study||10
2857215|NCT00080535|3559668|FG000|COMPLETED|Overall Study||10
2857216|NCT00080535|3559668|FG000|NOT COMPLETED|Overall Study||0
2857217|NCT00080899|3559672|FG000|STARTED|Overall Study||23
2857218|NCT00080899|3559672|FG000|COMPLETED|Overall Study||22
3168737|NCT01920854|3896133|FG002|STARTED|Overall Study||6
2857219|NCT00080899|3559672|FG000|NOT COMPLETED|Overall Study||1
2857220|NCT00080912|3559678|FG000|STARTED|Overall Study||425
2857221|NCT00080912|3559679|FG001|STARTED|Overall Study||425
2857222|NCT00080912|3559678|FG000|COMPLETED|Overall Study||425
2857223|NCT00080912|3559679|FG001|COMPLETED|Overall Study||425
2857224|NCT00080912|3559678|FG000|NOT COMPLETED|Overall Study||0
2857225|NCT00080912|3559679|FG001|NOT COMPLETED|Overall Study||0
2857226|NCT00080938|3559685|FG000|STARTED|Overall Study||26
2857227|NCT00080938|3559685|FG000|Began Protocol Therapy|Overall Study||25
2857228|NCT00080938|3559685|FG000|Eligible and Treated|Overall Study||21
2857229|NCT00080938|3559685|FG000|COMPLETED|Overall Study||2
2857230|NCT00080938|3559685|FG000|NOT COMPLETED|Overall Study||24
2857231|NCT00081159|3559691|FG000|STARTED|Overall Study||39
2857232|NCT00081159|3559692|FG001|STARTED|Overall Study||40
2857233|NCT00081159|3559691|FG000|COMPLETED|Overall Study||37
2857234|NCT00081159|3559692|FG001|COMPLETED|Overall Study||35
2857235|NCT00081159|3559691|FG000|NOT COMPLETED|Overall Study||2
2857236|NCT00081159|3559692|FG001|NOT COMPLETED|Overall Study||5
2857237|NCT00081263|3559700|FG000|STARTED|Overall Study||67
2857238|NCT00081263|3559701|FG001|STARTED|Overall Study||63
2857239|NCT00081263|3559700|FG000|COMPLETED|Overall Study||50
2857240|NCT00081263|3559701|FG001|COMPLETED|Overall Study||41
2857241|NCT00081263|3559700|FG000|NOT COMPLETED|Overall Study||17
2857242|NCT00081263|3559701|FG001|NOT COMPLETED|Overall Study||22
2857243|NCT00081289|3559709|FG000|STARTED|Overall Study||73
2857244|NCT00081289|3559710|FG001|STARTED|Overall Study||73
2857245|NCT00081289|3559709|FG000|Primary Endpoint Population|Overall Study||48
2857246|NCT00081289|3559710|FG001|Primary Endpoint Population|Overall Study||48
2857247|NCT00081289|3559709|FG000|General Analysis Population|Overall Study||52
2857248|NCT00081289|3559710|FG001|General Analysis Population|Overall Study||52
2857249|NCT00081289|3559709|FG000|Full AE Population|Overall Study||70
2857250|NCT00081289|3559710|FG001|Full AE Population|Overall Study||68
2857251|NCT00081289|3559709|FG000|Surgery|Overall Study||47
2857252|NCT00081289|3559710|FG001|Surgery|Overall Study||51
2857253|NCT00081289|3559709|FG000|Global Health Status Score at End of CR|Overall Study|European Organization for Research & Treatment of Cancer Quality of Life Questionnaire [EORTC QLQ]|34
2857254|NCT00081289|3559710|FG001|Global Health Status Score at End of CR|Overall Study||32
2857255|NCT00081289|3559709|FG000|GHS at End of Post-op CT|Overall Study||20
2857256|NCT00081289|3559710|FG001|GHS at End of Post-op CT|Overall Study||28
2857257|NCT00081289|3559709|FG000|GHS at Two Years|Overall Study||21
2857258|NCT00081289|3559710|FG001|GHS at Two Years|Overall Study||20
2857259|NCT00081289|3559709|FG000|GI Symptom Score at End of CR|Overall Study||34
2857260|NCT00081289|3559710|FG001|GI Symptom Score at End of CR|Overall Study||33
2857261|NCT00081289|3559709|FG000|GI Symptom Score at End of Post-op CT|Overall Study||22
2857262|NCT00081289|3559710|FG001|GI Symptom Score at End of Post-op CT|Overall Study||27
2857263|NCT00081289|3559709|FG000|GI Symptom Score at Two Years|Overall Study||21
2857264|NCT00081289|3559710|FG001|GI Symptom Score at Two Years|Overall Study||20
2857265|NCT00081289|3559709|FG000|Defecation Symptom Score at End of CR|Overall Study||32
2857266|NCT00081289|3559710|FG001|Defecation Symptom Score at End of CR|Overall Study||32
2857267|NCT00081289|3559709|FG000|DS Score at End of Post-op CT|Overall Study||12
2857268|NCT00081289|3559710|FG001|DS Score at End of Post-op CT|Overall Study||14
2857269|NCT00081289|3559709|FG000|Defecation Symptom Score at Two Years|Overall Study||13
2857270|NCT00081289|3559710|FG001|Defecation Symptom Score at Two Years|Overall Study||15
2857271|NCT00081289|3559709|FG000|COMPLETED|Overall Study||52
2857272|NCT00081289|3559710|FG001|COMPLETED|Overall Study||52
2857273|NCT00081289|3559709|FG000|NOT COMPLETED|Overall Study||21
2857274|NCT00081289|3559710|FG001|NOT COMPLETED|Overall Study||21
2857275|NCT00081328|3559720|FG000|STARTED|Overall Study||232
2857276|NCT00081328|3559721|FG001|STARTED|Overall Study||233
2857277|NCT00081328|3559722|FG002|STARTED|Overall Study||234
2857278|NCT00081328|3559720|FG000|COMPLETED|Overall Study||232
2857279|NCT00081328|3559721|FG001|COMPLETED|Overall Study||233
2857280|NCT00081328|3559722|FG002|COMPLETED|Overall Study||234
2857281|NCT00081328|3559720|FG000|NOT COMPLETED|Overall Study||0
2857282|NCT00081328|3559721|FG001|NOT COMPLETED|Overall Study||0
2857283|NCT00081328|3559722|FG002|NOT COMPLETED|Overall Study||0
2857284|NCT00081458|3559734|FG000|STARTED|Overall Study||16
2857285|NCT00081458|3559735|FG001|STARTED|Overall Study||35
2857286|NCT00081458|3559736|FG002|STARTED|Overall Study||33
2857287|NCT00081458|3559734|FG000|Received Treatment|Overall Study||16
2857288|NCT00081458|3559735|FG001|Received Treatment|Overall Study||35
2857289|NCT00081458|3559736|FG002|Received Treatment|Overall Study|1 subject was randomized but did not receive the study drug|32
2857290|NCT00081458|3559734|FG000|COMPLETED|Overall Study||15
2857291|NCT00081458|3559735|FG001|COMPLETED|Overall Study||27
2857292|NCT00081458|3559736|FG002|COMPLETED|Overall Study||29
2857293|NCT00081458|3559734|FG000|NOT COMPLETED|Overall Study||1
2857294|NCT00081458|3559735|FG001|NOT COMPLETED|Overall Study||8
2857295|NCT00081458|3559736|FG002|NOT COMPLETED|Overall Study||4
2857296|NCT00081497|3559747|FG000|STARTED|Overall Study|Patients who were randomized to placebo in AGAL-008-00 (NCT00074984).|28
2857297|NCT00081497|3559748|FG001|STARTED|Overall Study|Patients who were randomized to Fabrazyme in AGAL-008-00 (NCT00074984).|39
2857298|NCT00081497|3559747|FG000|COMPLETED|Overall Study||25
2857299|NCT00081497|3559748|FG001|COMPLETED|Overall Study||37
2857300|NCT00081497|3559747|FG000|NOT COMPLETED|Overall Study||3
2857301|NCT00081497|3559748|FG001|NOT COMPLETED|Overall Study||2
2857302|NCT00081653|3559762|FG000|STARTED|Overall Study|Patients entering Study MA17903 from Study BM16549|358
2857303|NCT00081653|3559763|FG001|STARTED|Overall Study|Patients entering Study MA17903 from Study BM16549|361
2857304|NCT00081653|3559762|FG000|COMPLETED|Overall Study|Completed 3 years of treatment|311
2857305|NCT00081653|3559763|FG001|COMPLETED|Overall Study|Completed 3 years of treatment|324
2857306|NCT00081653|3559762|FG000|NOT COMPLETED|Overall Study||47
2857307|NCT00081653|3559763|FG001|NOT COMPLETED|Overall Study||37
2857308|NCT00081731|3559772|FG000|STARTED|Overall Study||480
2857309|NCT00081731|3559773|FG001|STARTED|Overall Study||467
2857310|NCT00081731|3559772|FG000|COMPLETED|Overall Study||472
2857311|NCT00081731|3559773|FG001|COMPLETED|Overall Study||459
2857312|NCT00081731|3559772|FG000|NOT COMPLETED|Overall Study||8
2857313|NCT00081731|3559773|FG001|NOT COMPLETED|Overall Study||8
2857314|NCT00081770|3559782|FG000|STARTED|Overall Study||1019
2857315|NCT00081770|3559783|FG001|STARTED|Overall Study||1016
2857316|NCT00081770|3559784|FG002|STARTED|Overall Study||1035
2857317|NCT00081770|3559782|FG000|COMPLETED|Overall Study|Patients who discontinued treatment but continued in study are considered Not Completed|517
2857318|NCT00081770|3559783|FG001|COMPLETED|Overall Study|Patients who discontinued treatment but continued in study are considered Not Completed|470
2857319|NCT00081770|3559784|FG002|COMPLETED|Overall Study|Patients who discontinued treatment but continued in study are considered Not Completed|579
2857320|NCT00081770|3559782|FG000|NOT COMPLETED|Overall Study||502
2857321|NCT00081770|3559783|FG001|NOT COMPLETED|Overall Study||546
2857322|NCT00081770|3559784|FG002|NOT COMPLETED|Overall Study||456
2857323|NCT00081861|3559792|FG000|STARTED|Overall Study||13
2857324|NCT00081861|3559792|FG000|COMPLETED|Overall Study||13
2857325|NCT00081861|3559792|FG000|NOT COMPLETED|Overall Study||0
2857326|NCT00081939|3559796|FG000|STARTED|Overall Study||303
2857327|NCT00081939|3559796|FG000|COMPLETED|Overall Study||303
2857328|NCT00081939|3559796|FG000|NOT COMPLETED|Overall Study||0
2857329|NCT00082017|3559800|FG000|STARTED|Overall Study||11
2857330|NCT00082017|3559801|FG001|STARTED|Overall Study||9
2857331|NCT00082017|3559800|FG000|COMPLETED|Overall Study||11
2857332|NCT00082017|3559801|FG001|COMPLETED|Overall Study||9
2857333|NCT00082017|3559800|FG000|NOT COMPLETED|Overall Study||0
2857334|NCT00082017|3559801|FG001|NOT COMPLETED|Overall Study||0
2857335|NCT00082173|3559809|FG000|STARTED|Overall Study||74
2857336|NCT00082173|3559810|FG001|STARTED|Overall Study||72
2857337|NCT00082173|3559809|FG000|COMPLETED|Overall Study||64
2857338|NCT00082173|3559810|FG001|COMPLETED|Overall Study||61
2857339|NCT00082173|3559809|FG000|NOT COMPLETED|Overall Study||10
2857340|NCT00082173|3559810|FG001|NOT COMPLETED|Overall Study||11
2857341|NCT00082329|3559816|FG000|STARTED|Overall Study||9
2857342|NCT00082329|3559816|FG000|COMPLETED|Overall Study||9
2857343|NCT00082329|3559816|FG000|NOT COMPLETED|Overall Study||0
2857344|NCT00082342|3559822|FG000|STARTED|Overall Study||13
2857345|NCT00082342|3559823|FG001|STARTED|Overall Study||12
2857346|NCT00082342|3559822|FG000|COMPLETED|Overall Study||13
2857347|NCT00082342|3559823|FG001|COMPLETED|Overall Study||12
2857348|NCT00082342|3559822|FG000|NOT COMPLETED|Overall Study||0
2857349|NCT00082342|3559823|FG001|NOT COMPLETED|Overall Study||0
2857350|NCT00082355|3559843|FG000|STARTED|Initial Results of Thrombolytic Therapy||30
2857351|NCT00082355|3559843|FG000|COMPLETED|Initial Results of Thrombolytic Therapy||28
2857352|NCT00082355|3559843|FG000|NOT COMPLETED|Initial Results of Thrombolytic Therapy||2
2857353|NCT00082355|3559843|FG000|STARTED|5 Year Recurrent Thromboembolism Rate||28
2857354|NCT00082355|3559843|FG000|COMPLETED|5 Year Recurrent Thromboembolism Rate|data will not be complied until 2014|0
2857355|NCT00082355|3559843|FG000|NOT COMPLETED|5 Year Recurrent Thromboembolism Rate||28
2857356|NCT00082368|3559847|FG000|STARTED|Overall Study||12
2857357|NCT00082368|3559847|FG000|COMPLETED|Overall Study||11
2857358|NCT00082368|3559847|FG000|NOT COMPLETED|Overall Study||1
2857359|NCT00082381|3559853|FG000|STARTED|Overall Study||283
2857360|NCT00082381|3559854|FG001|STARTED|Overall Study||268
2857361|NCT00082381|3559853|FG000|Received Treatment (Intent to Treat)|Overall Study||282
2857362|NCT00082381|3559854|FG001|Received Treatment (Intent to Treat)|Overall Study||267
2857363|NCT00082381|3559853|FG000|COMPLETED|Overall Study||228
2857364|NCT00082381|3559854|FG001|COMPLETED|Overall Study||242
2857365|NCT00082381|3559853|FG000|NOT COMPLETED|Overall Study||55
2857366|NCT00082381|3559854|FG001|NOT COMPLETED|Overall Study||26
2857367|NCT00082407|3559862|FG000|STARTED|Overall Study||255
2857368|NCT00082407|3559863|FG001|STARTED|Overall Study||250
2857369|NCT00082407|3559862|FG000|Received Treatment (Intent to Treat)|Overall Study||253
2857370|NCT00082407|3559863|FG001|Received Treatment (Intent to Treat)|Overall Study||248
2857371|NCT00082407|3559862|FG000|COMPLETED|Overall Study||199
2857372|NCT00082407|3559863|FG001|COMPLETED|Overall Study||223
2857373|NCT00082407|3559862|FG000|NOT COMPLETED|Overall Study||56
2857374|NCT00082407|3559863|FG001|NOT COMPLETED|Overall Study||27
2857375|NCT00082433|3559871|FG000|STARTED|Overall Study||609
2857376|NCT00082433|3559872|FG001|STARTED|Overall Study||612
2857377|NCT00082433|3559871|FG000|COMPLETED|Overall Study|Participants who received 18 or more cycles of treatment.|15
2857378|NCT00082433|3559872|FG001|COMPLETED|Overall Study|Participants who received 18 or more cycles of treatment.|15
2857379|NCT00082433|3559871|FG000|NOT COMPLETED|Overall Study||594
2857380|NCT00082433|3559872|FG001|NOT COMPLETED|Overall Study||597
2857381|NCT00082628|3559880|FG000|STARTED|Treatment Period I (Week 1 to Week 12)||81
2857382|NCT00082628|3559881|FG001|STARTED|Treatment Period I (Week 1 to Week 12)||245
2857383|NCT00082628|3559882|FG002|STARTED|Treatment Period I (Week 1 to Week 12)||0
2857384|NCT00082628|3559883|FG003|STARTED|Treatment Period I (Week 1 to Week 12)||0
2857385|NCT00082628|3559884|FG004|STARTED|Treatment Period I (Week 1 to Week 12)||0
2857386|NCT00082628|3559880|FG000|COMPLETED|Treatment Period I (Week 1 to Week 12)||73
2857387|NCT00082628|3559881|FG001|COMPLETED|Treatment Period I (Week 1 to Week 12)||185
2857388|NCT00082628|3559882|FG002|COMPLETED|Treatment Period I (Week 1 to Week 12)||0
2857389|NCT00082628|3559883|FG003|COMPLETED|Treatment Period I (Week 1 to Week 12)||0
2857390|NCT00082628|3559884|FG004|COMPLETED|Treatment Period I (Week 1 to Week 12)||0
2857391|NCT00082628|3559880|FG000|NOT COMPLETED|Treatment Period I (Week 1 to Week 12)||8
2857392|NCT00082628|3559881|FG001|NOT COMPLETED|Treatment Period I (Week 1 to Week 12)||60
2857393|NCT00082628|3559882|FG002|NOT COMPLETED|Treatment Period I (Week 1 to Week 12)||0
2857394|NCT00082628|3559883|FG003|NOT COMPLETED|Treatment Period I (Week 1 to Week 12)||0
2857395|NCT00082628|3559884|FG004|NOT COMPLETED|Treatment Period I (Week 1 to Week 12)||0
2857396|NCT00082628|3559880|FG000|STARTED|Treatment Period II: Week 12 to Week 36||0
2857397|NCT00082628|3559881|FG001|STARTED|Treatment Period II: Week 12 to Week 36||0
2857398|NCT00082628|3559882|FG002|STARTED|Treatment Period II: Week 12 to Week 36||93
2857399|NCT00082628|3559883|FG003|STARTED|Treatment Period II: Week 12 to Week 36||92
2857400|NCT00082628|3559884|FG004|STARTED|Treatment Period II: Week 12 to Week 36||73
2857401|NCT00082628|3559880|FG000|COMPLETED|Treatment Period II: Week 12 to Week 36||0
2857402|NCT00082628|3559881|FG001|COMPLETED|Treatment Period II: Week 12 to Week 36||0
2857403|NCT00082628|3559882|FG002|COMPLETED|Treatment Period II: Week 12 to Week 36||78
2857404|NCT00082628|3559883|FG003|COMPLETED|Treatment Period II: Week 12 to Week 36||76
2857405|NCT00082628|3559884|FG004|COMPLETED|Treatment Period II: Week 12 to Week 36||55
2857406|NCT00082628|3559880|FG000|NOT COMPLETED|Treatment Period II: Week 12 to Week 36||0
2857407|NCT00082628|3559881|FG001|NOT COMPLETED|Treatment Period II: Week 12 to Week 36||0
2857408|NCT00082628|3559882|FG002|NOT COMPLETED|Treatment Period II: Week 12 to Week 36||15
2857409|NCT00082628|3559883|FG003|NOT COMPLETED|Treatment Period II: Week 12 to Week 36||16
2857410|NCT00082628|3559884|FG004|NOT COMPLETED|Treatment Period II: Week 12 to Week 36||18
2857411|NCT00082641|3559898|FG000|STARTED|Overall Study||11
2857412|NCT00082641|3559899|FG001|STARTED|Overall Study||12
2857413|NCT00082641|3559898|FG000|COMPLETED|Overall Study||11
2857414|NCT00082641|3559899|FG001|COMPLETED|Overall Study||12
2857415|NCT00082641|3559898|FG000|NOT COMPLETED|Overall Study||0
2857416|NCT00082641|3559899|FG001|NOT COMPLETED|Overall Study||0
2857417|NCT00082758|3559909|FG000|STARTED|Overall Study||15
2857418|NCT00082758|3559910|FG001|STARTED|Overall Study||24
2857419|NCT00082758|3559911|FG002|STARTED|Overall Study||0
2857420|NCT00082758|3559909|FG000|COMPLETED|Overall Study||0
2857421|NCT00082758|3559910|FG001|COMPLETED|Overall Study||7
2857422|NCT00082758|3559911|FG002|COMPLETED|Overall Study||0
2857423|NCT00082758|3559909|FG000|NOT COMPLETED|Overall Study||15
2857424|NCT00082758|3559910|FG001|NOT COMPLETED|Overall Study||17
2857425|NCT00082758|3559911|FG002|NOT COMPLETED|Overall Study||0
2857426|NCT00082810|3559919|FG000|STARTED|Overall Study||33
2857427|NCT00082810|3559919|FG000|COMPLETED|Overall Study||2
2857428|NCT00082810|3559919|FG000|NOT COMPLETED|Overall Study||31
2857429|NCT00082888|3559927|FG000|STARTED|Overall Study||42
2857430|NCT00082888|3559928|FG001|STARTED|Overall Study||15
2857431|NCT00082888|3559929|FG002|STARTED|Overall Study||36
2857432|NCT00082888|3559927|FG000|COMPLETED|Overall Study||41
2857433|NCT00082888|3559928|FG001|COMPLETED|Overall Study||15
2857434|NCT00082888|3559929|FG002|COMPLETED|Overall Study||36
2857435|NCT00082888|3559927|FG000|NOT COMPLETED|Overall Study||1
2857436|NCT00082888|3559928|FG001|NOT COMPLETED|Overall Study||0
2857437|NCT00082888|3559929|FG002|NOT COMPLETED|Overall Study||0
2857438|NCT00083122|3559940|FG000|STARTED|Overall Study||40
2857439|NCT00083122|3559941|FG001|STARTED|Overall Study||5
2857440|NCT00083122|3559940|FG000|COMPLETED|Overall Study||40
2857441|NCT00083122|3559941|FG001|COMPLETED|Overall Study||5
2857442|NCT00083122|3559940|FG000|NOT COMPLETED|Overall Study||0
2857443|NCT00083122|3559941|FG001|NOT COMPLETED|Overall Study||0
2857444|NCT00083174|3559949|FG000|STARTED|Randomization Period||2285
2857445|NCT00083174|3559950|FG001|STARTED|Randomization Period||2275
2857446|NCT00083174|3559951|FG002|STARTED|Randomization Period||0
2857447|NCT00083174|3559949|FG000|COMPLETED|Randomization Period|All women randomized were included in the analysis based on intent-to-treat principle.|2285
2857448|NCT00083174|3559950|FG001|COMPLETED|Randomization Period|All women randomized were included in the analysis based on intent-to-treat principle.|2275
2857449|NCT00083174|3559951|FG002|COMPLETED|Randomization Period||0
2857450|NCT00083174|3559949|FG000|NOT COMPLETED|Randomization Period||0
2857451|NCT00083174|3559950|FG001|NOT COMPLETED|Randomization Period||0
2857452|NCT00083174|3559951|FG002|NOT COMPLETED|Randomization Period||0
2857453|NCT00083174|3559949|FG000|STARTED|Open-label Extension||0
2857454|NCT00083174|3559950|FG001|STARTED|Open-label Extension||0
2857455|NCT00083174|3559951|FG002|STARTED|Open-label Extension||2831
2857456|NCT00083174|3559949|FG000|COMPLETED|Open-label Extension||0
2857457|NCT00083174|3559950|FG001|COMPLETED|Open-label Extension||0
2857458|NCT00083174|3559951|FG002|COMPLETED|Open-label Extension||2831
2857459|NCT00083174|3559949|FG000|NOT COMPLETED|Open-label Extension||0
2857460|NCT00083174|3559950|FG001|NOT COMPLETED|Open-label Extension||0
2857461|NCT00083174|3559951|FG002|NOT COMPLETED|Open-label Extension||0
2857462|NCT00083226|3559961|FG000|STARTED|Overall Study||42
2857463|NCT00083226|3559961|FG000|COMPLETED|Overall Study||0
2857464|NCT00083226|3559961|FG000|NOT COMPLETED|Overall Study||42
2857465|NCT00083382|3559965|FG000|STARTED|Overall Study||83
2857466|NCT00083382|3559965|FG000|COMPLETED|Overall Study||83
2857467|NCT00083382|3559965|FG000|NOT COMPLETED|Overall Study||0
2857468|NCT00083551|3559971|FG000|STARTED|Overall Study||323
2857469|NCT00083551|3559972|FG001|STARTED|Overall Study||345
2857470|NCT00083551|3559971|FG000|COMPLETED|Overall Study||323
2857471|NCT00083551|3559972|FG001|COMPLETED|Overall Study||345
2857472|NCT00083551|3559971|FG000|NOT COMPLETED|Overall Study||0
2857473|NCT00083551|3559972|FG001|NOT COMPLETED|Overall Study||0
2857474|NCT00083616|3559978|FG000|STARTED|Overall Study||185
2857475|NCT00083616|3559978|FG000|Received Study Medication|Overall Study||182
2857476|NCT00083616|3559978|FG000|COMPLETED|Overall Study|Completed safety followup or died on study as of the data cut-off date of 22 December 2006|154
2857477|NCT00083616|3559978|FG000|NOT COMPLETED|Overall Study||31
2857478|NCT00083720|3559982|FG000|STARTED|Overall Study|Patients analyzed for efficacy who met the epidermal growth factor receptor (EGFR) negative criteria|85
2857479|NCT00083720|3559982|FG000|COMPLETED|Overall Study|Two patients died prior to receiving cetuximab.|85
2857480|NCT00083720|3559982|FG000|NOT COMPLETED|Overall Study||0
2857481|NCT00083889|3559988|FG000|STARTED|Overall Study||375
2857482|NCT00083889|3559989|FG001|STARTED|Overall Study||375
2857483|NCT00083889|3559988|FG000|Received Treatment|Overall Study||375
2857484|NCT00083889|3559989|FG001|Received Treatment|Overall Study|15 subjects randomized to IFN-α discontinued before receiving their first dose of study medication.|360
2857485|NCT00083889|3559988|FG000|COMPLETED|Overall Study||0
2857486|NCT00083889|3559989|FG001|COMPLETED|Overall Study|Discontinuation crossover subjects: AEs 5,consent withdrawn 2, lack efficacy 13, sponsor decision 5.|0
2857487|NCT00083889|3559988|FG000|NOT COMPLETED|Overall Study||375
2857488|NCT00083889|3559989|FG001|NOT COMPLETED|Overall Study||375
2857489|NCT00084084|3559998|FG000|STARTED|Phase 1 (Treatment With Replagal RB)||17
2857490|NCT00084084|3559998|FG000|COMPLETED|Phase 1 (Treatment With Replagal RB)||16
2857491|NCT00084084|3559998|FG000|NOT COMPLETED|Phase 1 (Treatment With Replagal RB)||1
2857492|NCT00084084|3559998|FG000|STARTED|Phase 2 (Transition to Replagal AF)|The 11 patients remaining in TKT029 at the time Replagal AF was made available continued to Phase 2.|11
2857493|NCT00084084|3559998|FG000|COMPLETED|Phase 2 (Transition to Replagal AF)||10
2857494|NCT00084084|3559998|FG000|NOT COMPLETED|Phase 2 (Transition to Replagal AF)||1
2857495|NCT00084136|3560006|FG000|STARTED|PI Comparison||519
2857496|NCT00084136|3560007|FG001|STARTED|PI Comparison||526
2857497|NCT00084136|3560008|FG002|STARTED|PI Comparison||0
2857498|NCT00084136|3560006|FG000|COMPLETED|PI Comparison|Follow-up was until ddI+FTC+ATV arm was closed per DSMB recommendation on May 23, 2008.|464
2857499|NCT00084136|3560007|FG001|COMPLETED|PI Comparison|Follow-up was until ddI+FTC+ATV arm was closed per DSMB recommendation on May 23, 2008.|479
2857500|NCT00084136|3560008|FG002|COMPLETED|PI Comparison||0
2857501|NCT00084136|3560006|FG000|NOT COMPLETED|PI Comparison||55
2857502|NCT00084136|3560007|FG001|NOT COMPLETED|PI Comparison||47
2857503|NCT00084136|3560008|FG002|NOT COMPLETED|PI Comparison||0
2857504|NCT00084136|3560006|FG000|STARTED|NRTI Comparison||519
2857505|NCT00084136|3560007|FG001|STARTED|NRTI Comparison||0
2857506|NCT00084136|3560008|FG002|STARTED|NRTI Comparison||526
2857507|NCT00084136|3560006|FG000|COMPLETED|NRTI Comparison|Follow-up though study closeout period (final visit between April 1 and May 31, 2010).|418
2857508|NCT00084136|3560007|FG001|COMPLETED|NRTI Comparison||0
2857509|NCT00084136|3560008|FG002|COMPLETED|NRTI Comparison|Follow-up though study closeout period (final visit between April 1 and May 31, 2010).|444
2857510|NCT00084136|3560006|FG000|NOT COMPLETED|NRTI Comparison||101
2857511|NCT00084136|3560007|FG001|NOT COMPLETED|NRTI Comparison||0
2857512|NCT00084136|3560008|FG002|NOT COMPLETED|NRTI Comparison||82
2857513|NCT00084149|3560019|FG000|STARTED|Overall Study||36
2857514|NCT00084149|3560020|FG001|STARTED|Overall Study||18
2857515|NCT00084149|3560019|FG000|COMPLETED|Overall Study||28
2857516|NCT00084149|3560020|FG001|COMPLETED|Overall Study||13
2857517|NCT00084149|3560019|FG000|NOT COMPLETED|Overall Study||8
2857518|NCT00084149|3560020|FG001|NOT COMPLETED|Overall Study||5
2857519|NCT00084266|3560032|FG000|STARTED|Overall Study||618
2857520|NCT00084266|3560033|FG001|STARTED|Overall Study||607
2857521|NCT00084266|3560032|FG000|Treated|Overall Study||597
2857522|NCT00084266|3560033|FG001|Treated|Overall Study||587
2857523|NCT00084266|3560032|FG000|COMPLETED|Overall Study||177
2857524|NCT00084266|3560033|FG001|COMPLETED|Overall Study||184
2857525|NCT00084266|3560032|FG000|NOT COMPLETED|Overall Study||441
2857526|NCT00084266|3560033|FG001|NOT COMPLETED|Overall Study||423
2857527|NCT00084318|3560041|FG000|STARTED|Overall Study||119
2857528|NCT00084318|3560042|FG001|STARTED|Overall Study||119
2857529|NCT00084318|3560041|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|97
2857530|NCT00084318|3560042|FG001|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|106
2857531|NCT00084318|3560041|FG000|NOT COMPLETED|Overall Study||22
2857532|NCT00084318|3560042|FG001|NOT COMPLETED|Overall Study||13
2857533|NCT00084383|3560050|FG000|STARTED|Overall Study||60
2857534|NCT00084383|3560050|FG000|COMPLETED|Overall Study||13
2857535|NCT00084383|3560050|FG000|NOT COMPLETED|Overall Study||47
2918331|NCT00526071|3628507|FG000|COMPLETED|Overall Study||17
2918332|NCT00526071|3628507|FG000|NOT COMPLETED|Overall Study||6
2918333|NCT00526097|3628517|FG000|STARTED|Overall Study|Started: Participant was randomised and took at least one dose of randomised study medication|121
2918334|NCT00526097|3628518|FG001|STARTED|Overall Study|Started: Participant was randomised and took at least one dose of randomised study medication|247
2918335|NCT00526097|3628517|FG000|COMPLETED|Overall Study|Completed: Participant without premature discontinuation in the randomised treatment period|106
2918336|NCT00526097|3628518|FG001|COMPLETED|Overall Study|Completed: Participant without premature discontinuation in the randomised treatment period|191
2918337|NCT00526097|3628517|FG000|NOT COMPLETED|Overall Study||15
2918338|NCT00526097|3628518|FG001|NOT COMPLETED|Overall Study||56
2918339|NCT00526110|3628526|FG000|STARTED|Overall Study||53
2918340|NCT00526110|3628527|FG001|STARTED|Overall Study||45
2918341|NCT00526110|3628526|FG000|COMPLETED|Overall Study||51
2918342|NCT00526110|3628527|FG001|COMPLETED|Overall Study||4
2918343|NCT00526110|3628526|FG000|NOT COMPLETED|Overall Study||2
2918344|NCT00526110|3628527|FG001|NOT COMPLETED|Overall Study||41
2918345|NCT00526123|3628535|FG000|STARTED|Overall Study|Intent-to-Treat population|303
2918346|NCT00526123|3628536|FG001|STARTED|Overall Study|Intent-to-Treat population|296
2918347|NCT00526123|3628535|FG000|COMPLETED|Overall Study||39
2918348|NCT00526123|3628536|FG001|COMPLETED|Overall Study||50
2918349|NCT00526123|3628535|FG000|NOT COMPLETED|Overall Study||264
2857536|NCT00084409|3560056|FG000|STARTED|Overall Study|40 Current, 35 former|75
2857537|NCT00084409|3560057|FG001|STARTED|Overall Study|41 current, 36 former|77
2857538|NCT00084409|3560056|FG000|COMPLETED|Overall Study|9 current, 6 former|60
2857539|NCT00084409|3560057|FG001|COMPLETED|Overall Study|4 Current, 8 former|65
2857540|NCT00084409|3560056|FG000|NOT COMPLETED|Overall Study||15
2857541|NCT00084409|3560057|FG001|NOT COMPLETED|Overall Study||12
2857542|NCT00084487|3560065|FG000|STARTED|Overall Study||21
2857543|NCT00084487|3560065|FG000|COMPLETED|Overall Study||20
2857544|NCT00084487|3560065|FG000|NOT COMPLETED|Overall Study||1
2857545|NCT00084552|3560071|FG000|STARTED|Overall Study||54
2857546|NCT00084552|3560072|FG001|STARTED|Overall Study||62
2857547|NCT00084552|3560071|FG000|COMPLETED|Overall Study||54
2857548|NCT00084552|3560072|FG001|COMPLETED|Overall Study||62
2857549|NCT00084552|3560071|FG000|NOT COMPLETED|Overall Study||0
2857550|NCT00084552|3560072|FG001|NOT COMPLETED|Overall Study||0
2857551|NCT00084617|3560078|FG000|STARTED|Overall Study||39
2857552|NCT00084617|3560078|FG000|COMPLETED|Overall Study||30
2857553|NCT00084617|3560078|FG000|NOT COMPLETED|Overall Study||9
2857554|NCT00084682|3560082|FG000|STARTED|Overall Study||14
2857555|NCT00084682|3560082|FG000|COMPLETED|Overall Study||13
2857556|NCT00084682|3560082|FG000|NOT COMPLETED|Overall Study||1
2857557|NCT00084747|3560087|FG000|STARTED|Overall Study||30
2857558|NCT00084747|3560087|FG000|COMPLETED|Overall Study||17
2857559|NCT00084747|3560087|FG000|NOT COMPLETED|Overall Study||13
2857560|NCT00084838|3560092|FG000|STARTED|Overall Study||25
2857561|NCT00084838|3560092|FG000|Eligible and Treated|Overall Study|4 ineligible pts upon central path review (n=3) and per DFCI IRB (n=1); 1 pt withdrew before rcv trt|20
2857562|NCT00084838|3560092|FG000|COMPLETED|Overall Study||12
2857563|NCT00084838|3560092|FG000|NOT COMPLETED|Overall Study||13
2857564|NCT00084864|3560102|FG000|STARTED|Overall Study||10
2857565|NCT00084864|3560103|FG001|STARTED|Overall Study||7
2857566|NCT00084864|3560104|FG002|STARTED|Overall Study||4
2857567|NCT00084864|3560105|FG003|STARTED|Overall Study||4
2857568|NCT00084864|3560102|FG000|COMPLETED|Overall Study||9
2857569|NCT00084864|3560103|FG001|COMPLETED|Overall Study||7
2857570|NCT00084864|3560104|FG002|COMPLETED|Overall Study||4
2857571|NCT00084864|3560105|FG003|COMPLETED|Overall Study||4
2857572|NCT00084864|3560102|FG000|NOT COMPLETED|Overall Study||1
2857573|NCT00084864|3560103|FG001|NOT COMPLETED|Overall Study||0
2857574|NCT00084864|3560104|FG002|NOT COMPLETED|Overall Study||0
2857575|NCT00084864|3560105|FG003|NOT COMPLETED|Overall Study||0
2857576|NCT00084929|3560115|FG000|STARTED|Overall Study||2600
2857577|NCT00084929|3560115|FG000|COMPLETED|Overall Study||2531
2857578|NCT00084929|3560115|FG000|NOT COMPLETED|Overall Study||69
2857579|NCT00085098|3560125|FG000|STARTED|Overall Study||11
2857580|NCT00085098|3560126|FG001|STARTED|Overall Study||13
2857581|NCT00085098|3560125|FG000|COMPLETED|Overall Study||10
2857582|NCT00085098|3560126|FG001|COMPLETED|Overall Study||11
2857583|NCT00085098|3560125|FG000|NOT COMPLETED|Overall Study||1
2857584|NCT00085098|3560126|FG001|NOT COMPLETED|Overall Study||2
2857585|NCT00085254|3560138|FG000|STARTED|Overall Study||18
2857586|NCT00085254|3560139|FG001|STARTED|Overall Study||46
2857587|NCT00085254|3560140|FG002|STARTED|Overall Study||48
2857588|NCT00085254|3560138|FG000|COMPLETED|Overall Study||18
2857589|NCT00085254|3560139|FG001|COMPLETED|Overall Study||46
2857590|NCT00085254|3560140|FG002|COMPLETED|Overall Study||48
2857591|NCT00085254|3560138|FG000|NOT COMPLETED|Overall Study||0
2857592|NCT00085254|3560139|FG001|NOT COMPLETED|Overall Study||0
2857593|NCT00085254|3560140|FG002|NOT COMPLETED|Overall Study||0
2857594|NCT00085293|3560154|FG000|STARTED|Overall Study||12
2857595|NCT00085293|3560154|FG000|COMPLETED|Overall Study||12
2857596|NCT00085293|3560154|FG000|NOT COMPLETED|Overall Study||0
2857597|NCT00085410|3560158|FG000|STARTED|Overall Study||20
2857598|NCT00085410|3560158|FG000|COMPLETED|Overall Study||20
2857599|NCT00085410|3560158|FG000|NOT COMPLETED|Overall Study||0
2857600|NCT00085423|3560163|FG000|STARTED|Overall Study||20
2857601|NCT00085423|3560163|FG000|COMPLETED|Overall Study||18
2857602|NCT00085423|3560163|FG000|NOT COMPLETED|Overall Study||2
2857603|NCT00085436|3560167|FG000|STARTED|Overall Study||18
2857604|NCT00085436|3560167|FG000|COMPLETED|Overall Study||18
2857605|NCT00085436|3560167|FG000|NOT COMPLETED|Overall Study||0
2857606|NCT00085540|3560174|FG000|STARTED|Overall Study||8
2857607|NCT00085540|3560175|FG001|STARTED|Overall Study||42
2857608|NCT00085540|3560174|FG000|COMPLETED|Overall Study||8
2857609|NCT00085540|3560175|FG001|COMPLETED|Overall Study||40
2857610|NCT00085540|3560174|FG000|NOT COMPLETED|Overall Study||0
2857611|NCT00085540|3560175|FG001|NOT COMPLETED|Overall Study||2
3168738|NCT01920854|3896134|FG003|STARTED|Overall Study||6
3168739|NCT01920854|3896135|FG004|STARTED|Overall Study||6
3168740|NCT01920854|3896136|FG005|STARTED|Overall Study||6
3168741|NCT01920854|3896137|FG006|STARTED|Overall Study||6
3168742|NCT01920854|3896131|FG000|COMPLETED|Overall Study||11
2857612|NCT00085566|3560184|FG000|STARTED|Overall Study||3
2857613|NCT00085566|3560185|FG001|STARTED|Overall Study||3
2857614|NCT00085566|3560186|FG002|STARTED|Overall Study||57
2857615|NCT00085566|3560184|FG000|COMPLETED|Overall Study||3
2857616|NCT00085566|3560185|FG001|COMPLETED|Overall Study||3
2857617|NCT00085566|3560186|FG002|COMPLETED|Overall Study||43
2857618|NCT00085566|3560184|FG000|NOT COMPLETED|Overall Study||0
2857619|NCT00085566|3560185|FG001|NOT COMPLETED|Overall Study||0
2857620|NCT00085566|3560186|FG002|NOT COMPLETED|Overall Study||14
2857621|NCT00085644|3560196|FG000|STARTED|Double-Blind Period||208
2857622|NCT00085644|3560197|FG001|STARTED|Double-Blind Period||107
2857623|NCT00085644|3560198|FG002|STARTED|Double-Blind Period|This treatment group is not applicable to the Double-Blind Period.|0
2857624|NCT00085644|3560196|FG000|COMPLETED|Double-Blind Period||195
2857625|NCT00085644|3560197|FG001|COMPLETED|Double-Blind Period||101
2857626|NCT00085644|3560198|FG002|COMPLETED|Double-Blind Period||0
2857627|NCT00085644|3560196|FG000|NOT COMPLETED|Double-Blind Period||13
2857628|NCT00085644|3560197|FG001|NOT COMPLETED|Double-Blind Period||6
2857629|NCT00085644|3560198|FG002|NOT COMPLETED|Double-Blind Period||0
2857630|NCT00085644|3560196|FG000|STARTED|Open-Label Period|This treatment group is not applicable to the Open-Label Period.|0
2857631|NCT00085644|3560197|FG001|STARTED|Open-Label Period|This treatment group is not applicable to the Open-Label Period.|0
2857632|NCT00085644|3560198|FG002|STARTED|Open-Label Period|1 subject who discontinued for personal reasons subsequently died 450 days after last dose.|311
2857633|NCT00085644|3560196|FG000|COMPLETED|Open-Label Period||0
2857634|NCT00085644|3560197|FG001|COMPLETED|Open-Label Period||0
2857635|NCT00085644|3560198|FG002|COMPLETED|Open-Label Period||202
2857636|NCT00085644|3560196|FG000|NOT COMPLETED|Open-Label Period||0
2857637|NCT00085644|3560197|FG001|NOT COMPLETED|Open-Label Period||0
2857638|NCT00085644|3560198|FG002|NOT COMPLETED|Open-Label Period||109
2857639|NCT00085709|3560207|FG000|STARTED|Overall Study||317
2857640|NCT00085709|3560208|FG001|STARTED|Overall Study||320
2857641|NCT00085709|3560207|FG000|Eligible|Overall Study||298
2857642|NCT00085709|3560208|FG001|Eligible|Overall Study||301
2857643|NCT00085709|3560207|FG000|Eligible and Did Not Withdraw Consent|Overall Study||296
2857644|NCT00085709|3560208|FG001|Eligible and Did Not Withdraw Consent|Overall Study||300
2857645|NCT00085709|3560207|FG000|COMPLETED|Overall Study||264
2857646|NCT00085709|3560208|FG001|COMPLETED|Overall Study||270
2857647|NCT00085709|3560207|FG000|NOT COMPLETED|Overall Study||53
2857648|NCT00085709|3560208|FG001|NOT COMPLETED|Overall Study||50
2857649|NCT00085735|3560228|FG000|STARTED|Overall Study||64
2857650|NCT00085735|3560229|FG001|STARTED|Overall Study||64
2857651|NCT00085735|3560230|FG002|STARTED|Overall Study||63
2857652|NCT00085735|3560231|FG003|STARTED|Overall Study||65
2857653|NCT00085735|3560232|FG004|STARTED|Overall Study||147
2857654|NCT00085735|3560233|FG005|STARTED|Overall Study||146
2857655|NCT00085735|3560228|FG000|COMPLETED|Overall Study||52
2857656|NCT00085735|3560229|FG001|COMPLETED|Overall Study||54
2857657|NCT00085735|3560230|FG002|COMPLETED|Overall Study||46
2857658|NCT00085735|3560231|FG003|COMPLETED|Overall Study||46
2857659|NCT00085735|3560232|FG004|COMPLETED|Overall Study||105
2857660|NCT00085735|3560233|FG005|COMPLETED|Overall Study||115
2857661|NCT00085735|3560228|FG000|NOT COMPLETED|Overall Study||12
2857662|NCT00085735|3560229|FG001|NOT COMPLETED|Overall Study||10
2857663|NCT00085735|3560230|FG002|NOT COMPLETED|Overall Study||17
2857664|NCT00085735|3560231|FG003|NOT COMPLETED|Overall Study||19
2857665|NCT00085735|3560232|FG004|NOT COMPLETED|Overall Study||42
2857666|NCT00085735|3560233|FG005|NOT COMPLETED|Overall Study||31
2857667|NCT00085839|3560262|FG000|STARTED|Overall Study||52
2857668|NCT00085839|3560263|FG001|STARTED|Overall Study||51
2857669|NCT00085839|3560262|FG000|COMPLETED|Overall Study||52
2857670|NCT00085839|3560263|FG001|COMPLETED|Overall Study||51
2857671|NCT00085839|3560262|FG000|NOT COMPLETED|Overall Study||0
2857672|NCT00085839|3560263|FG001|NOT COMPLETED|Overall Study||0
2857673|NCT00085917|3560271|FG000|STARTED|Overall Study||15
2857674|NCT00085917|3560272|FG001|STARTED|Overall Study||14
2857675|NCT00085917|3560271|FG000|COMPLETED|Overall Study||11
2857676|NCT00085917|3560272|FG001|COMPLETED|Overall Study||11
2857677|NCT00085917|3560271|FG000|NOT COMPLETED|Overall Study||4
2857678|NCT00085917|3560272|FG001|NOT COMPLETED|Overall Study||3
2857679|NCT00086047|3560280|FG000|STARTED|Overall Study||57
2857680|NCT00086047|3560281|FG001|STARTED|Overall Study||57
2857681|NCT00086047|3560280|FG000|COMPLETED|Overall Study||50
2857682|NCT00086047|3560281|FG001|COMPLETED|Overall Study||50
2857683|NCT00086047|3560280|FG000|NOT COMPLETED|Overall Study||7
2857684|NCT00086047|3560281|FG001|NOT COMPLETED|Overall Study||7
2857685|NCT00086138|3560289|FG000|STARTED|Overall Study||64
2857686|NCT00086138|3560290|FG001|STARTED|Overall Study||67
2857687|NCT00086138|3560289|FG000|COMPLETED|Overall Study||60
2857688|NCT00086138|3560290|FG001|COMPLETED|Overall Study||64
2857689|NCT00086138|3560289|FG000|NOT COMPLETED|Overall Study||4
2857690|NCT00086138|3560290|FG001|NOT COMPLETED|Overall Study||3
2857691|NCT00086190|3560299|FG000|STARTED|Overall Study||42
2857692|NCT00086190|3560300|FG001|STARTED|Overall Study||34
2857693|NCT00086190|3560301|FG002|STARTED|Overall Study||39
2857694|NCT00086190|3560299|FG000|COMPLETED|Overall Study||34
2857695|NCT00086190|3560300|FG001|COMPLETED|Overall Study||30
2857696|NCT00086190|3560301|FG002|COMPLETED|Overall Study||33
2857697|NCT00086190|3560299|FG000|NOT COMPLETED|Overall Study||8
2857698|NCT00086190|3560300|FG001|NOT COMPLETED|Overall Study||4
2857699|NCT00086190|3560301|FG002|NOT COMPLETED|Overall Study||6
2857700|NCT00086281|3560324|FG000|STARTED|Phase 1||11
2857701|NCT00086281|3560325|FG001|STARTED|Phase 1||12
2857702|NCT00086281|3560326|FG002|STARTED|Phase 1||8
2857703|NCT00086281|3560327|FG003|STARTED|Phase 1||11
2857704|NCT00086281|3560328|FG004|STARTED|Phase 1||1
2857705|NCT00086281|3560329|FG005|STARTED|Phase 1||3
2857706|NCT00086281|3560330|FG006|STARTED|Phase 1||1
2857707|NCT00086281|3560331|FG007|STARTED|Phase 1||1
2857708|NCT00086281|3560332|FG008|STARTED|Phase 1||2
2857709|NCT00086281|3560333|FG009|STARTED|Phase 1||1
2857710|NCT00086281|3560334|FG010|STARTED|Phase 1||3
2857711|NCT00086281|3560335|FG011|STARTED|Phase 1||1
2857712|NCT00086281|3560336|FG012|STARTED|Phase 1||1
2857713|NCT00086281|3560337|FG013|STARTED|Phase 1||1
2857714|NCT00086281|3560338|FG014|STARTED|Phase 1||3
2857715|NCT00086281|3560324|FG000|COMPLETED|Phase 1||11
2857716|NCT00086281|3560325|FG001|COMPLETED|Phase 1||12
2857717|NCT00086281|3560326|FG002|COMPLETED|Phase 1||8
2857718|NCT00086281|3560327|FG003|COMPLETED|Phase 1||11
2857719|NCT00086281|3560328|FG004|COMPLETED|Phase 1||1
2857720|NCT00086281|3560329|FG005|COMPLETED|Phase 1||3
2857721|NCT00086281|3560330|FG006|COMPLETED|Phase 1||1
2857722|NCT00086281|3560331|FG007|COMPLETED|Phase 1||1
2857723|NCT00086281|3560332|FG008|COMPLETED|Phase 1||2
2857724|NCT00086281|3560333|FG009|COMPLETED|Phase 1||0
2857725|NCT00086281|3560334|FG010|COMPLETED|Phase 1||0
2857726|NCT00086281|3560335|FG011|COMPLETED|Phase 1||0
2857727|NCT00086281|3560336|FG012|COMPLETED|Phase 1||0
2857728|NCT00086281|3560337|FG013|COMPLETED|Phase 1||0
2857729|NCT00086281|3560338|FG014|COMPLETED|Phase 1||0
2857730|NCT00086281|3560324|FG000|NOT COMPLETED|Phase 1||0
2857731|NCT00086281|3560325|FG001|NOT COMPLETED|Phase 1||0
2857732|NCT00086281|3560326|FG002|NOT COMPLETED|Phase 1||0
2857733|NCT00086281|3560327|FG003|NOT COMPLETED|Phase 1||0
2857734|NCT00086281|3560328|FG004|NOT COMPLETED|Phase 1||0
2857735|NCT00086281|3560329|FG005|NOT COMPLETED|Phase 1||0
2857736|NCT00086281|3560330|FG006|NOT COMPLETED|Phase 1||0
2857737|NCT00086281|3560331|FG007|NOT COMPLETED|Phase 1||0
2857738|NCT00086281|3560332|FG008|NOT COMPLETED|Phase 1||0
2857739|NCT00086281|3560333|FG009|NOT COMPLETED|Phase 1||1
2857740|NCT00086281|3560334|FG010|NOT COMPLETED|Phase 1||3
2857741|NCT00086281|3560335|FG011|NOT COMPLETED|Phase 1||1
2857742|NCT00086281|3560336|FG012|NOT COMPLETED|Phase 1||1
2857743|NCT00086281|3560337|FG013|NOT COMPLETED|Phase 1||1
2857744|NCT00086281|3560338|FG014|NOT COMPLETED|Phase 1||3
2857745|NCT00086281|3560324|FG000|STARTED|Phase 2||0
2857746|NCT00086281|3560325|FG001|STARTED|Phase 2||0
2857747|NCT00086281|3560326|FG002|STARTED|Phase 2||0
2857748|NCT00086281|3560327|FG003|STARTED|Phase 2||0
2857749|NCT00086281|3560328|FG004|STARTED|Phase 2||0
2857750|NCT00086281|3560329|FG005|STARTED|Phase 2||0
2857751|NCT00086281|3560330|FG006|STARTED|Phase 2||0
2857752|NCT00086281|3560331|FG007|STARTED|Phase 2||0
2857753|NCT00086281|3560332|FG008|STARTED|Phase 2||0
2857754|NCT00086281|3560333|FG009|STARTED|Phase 2||0
2857755|NCT00086281|3560334|FG010|STARTED|Phase 2||0
2857756|NCT00086281|3560335|FG011|STARTED|Phase 2||0
2857757|NCT00086281|3560336|FG012|STARTED|Phase 2||23
2857758|NCT00086281|3560337|FG013|STARTED|Phase 2||27
2857759|NCT00086281|3560338|FG014|STARTED|Phase 2||0
2857760|NCT00086281|3560324|FG000|COMPLETED|Phase 2||0
2857761|NCT00086281|3560325|FG001|COMPLETED|Phase 2||0
2857762|NCT00086281|3560326|FG002|COMPLETED|Phase 2||0
2857763|NCT00086281|3560327|FG003|COMPLETED|Phase 2||0
2857764|NCT00086281|3560328|FG004|COMPLETED|Phase 2||0
2857765|NCT00086281|3560329|FG005|COMPLETED|Phase 2||0
2857766|NCT00086281|3560330|FG006|COMPLETED|Phase 2||0
2857767|NCT00086281|3560331|FG007|COMPLETED|Phase 2||0
2857768|NCT00086281|3560332|FG008|COMPLETED|Phase 2||0
2857769|NCT00086281|3560333|FG009|COMPLETED|Phase 2||0
2857770|NCT00086281|3560334|FG010|COMPLETED|Phase 2||0
2857771|NCT00086281|3560335|FG011|COMPLETED|Phase 2||0
2857772|NCT00086281|3560336|FG012|COMPLETED|Phase 2||22
2857773|NCT00086281|3560337|FG013|COMPLETED|Phase 2||26
2857774|NCT00086281|3560338|FG014|COMPLETED|Phase 2||0
2857775|NCT00086281|3560324|FG000|NOT COMPLETED|Phase 2||0
2857776|NCT00086281|3560325|FG001|NOT COMPLETED|Phase 2||0
2857777|NCT00086281|3560326|FG002|NOT COMPLETED|Phase 2||0
2857778|NCT00086281|3560327|FG003|NOT COMPLETED|Phase 2||0
2857779|NCT00086281|3560328|FG004|NOT COMPLETED|Phase 2||0
2857780|NCT00086281|3560329|FG005|NOT COMPLETED|Phase 2||0
2857781|NCT00086281|3560330|FG006|NOT COMPLETED|Phase 2||0
2857782|NCT00086281|3560331|FG007|NOT COMPLETED|Phase 2||0
2857783|NCT00086281|3560332|FG008|NOT COMPLETED|Phase 2||0
2857784|NCT00086281|3560333|FG009|NOT COMPLETED|Phase 2||0
2857785|NCT00086281|3560334|FG010|NOT COMPLETED|Phase 2||0
2857786|NCT00086281|3560335|FG011|NOT COMPLETED|Phase 2||0
2857787|NCT00086281|3560336|FG012|NOT COMPLETED|Phase 2||1
2857788|NCT00086281|3560337|FG013|NOT COMPLETED|Phase 2||1
2857789|NCT00086281|3560338|FG014|NOT COMPLETED|Phase 2||0
2857790|NCT00086307|3560351|FG000|STARTED|Overall Study||13
2857791|NCT00086307|3560352|FG001|STARTED|Overall Study||13
2857792|NCT00086307|3560353|FG002|STARTED|Overall Study||13
2857793|NCT00086307|3560351|FG000|COMPLETED|Overall Study||11
2857794|NCT00086307|3560352|FG001|COMPLETED|Overall Study||12
2857795|NCT00086307|3560353|FG002|COMPLETED|Overall Study||5
2857796|NCT00086307|3560351|FG000|NOT COMPLETED|Overall Study||2
2857797|NCT00086307|3560352|FG001|NOT COMPLETED|Overall Study||1
2857798|NCT00086307|3560353|FG002|NOT COMPLETED|Overall Study||8
2857799|NCT00086346|3560363|FG000|STARTED|Randomization||393
2857800|NCT00086346|3560364|FG001|STARTED|Randomization||214
2857801|NCT00086346|3560363|FG000|COMPLETED|Randomization||389
2857802|NCT00086346|3560364|FG001|COMPLETED|Randomization||210
2857803|NCT00086346|3560363|FG000|NOT COMPLETED|Randomization||4
2857804|NCT00086346|3560364|FG001|NOT COMPLETED|Randomization||4
2857805|NCT00086346|3560363|FG000|STARTED|Patients Dosed With Test Article||389
2857806|NCT00086346|3560364|FG001|STARTED|Patients Dosed With Test Article||210
2857807|NCT00086346|3560363|FG000|COMPLETED|Patients Dosed With Test Article||249
2857808|NCT00086346|3560364|FG001|COMPLETED|Patients Dosed With Test Article||187
2857809|NCT00086346|3560363|FG000|NOT COMPLETED|Patients Dosed With Test Article||140
2857810|NCT00086346|3560364|FG001|NOT COMPLETED|Patients Dosed With Test Article||23
2857811|NCT00086385|3560374|FG000|STARTED|Overall Study||100
2857812|NCT00086385|3560375|FG001|STARTED|Overall Study||99
2857813|NCT00086385|3560376|FG002|STARTED|Overall Study||104
2857814|NCT00086385|3560377|FG003|STARTED|Overall Study||99
2857815|NCT00086385|3560374|FG000|COMPLETED|Overall Study||98
2857816|NCT00086385|3560375|FG001|COMPLETED|Overall Study||97
2857817|NCT00086385|3560376|FG002|COMPLETED|Overall Study||103
2857818|NCT00086385|3560377|FG003|COMPLETED|Overall Study||98
2857819|NCT00086385|3560374|FG000|NOT COMPLETED|Overall Study||2
2857820|NCT00086385|3560375|FG001|NOT COMPLETED|Overall Study||2
2857821|NCT00086385|3560376|FG002|NOT COMPLETED|Overall Study||1
2857822|NCT00086385|3560377|FG003|NOT COMPLETED|Overall Study||1
2857823|NCT00086411|3560391|FG000|STARTED|Overall Study||70
2857824|NCT00086411|3560392|FG001|STARTED|Overall Study||63
2857825|NCT00086411|3560393|FG002|STARTED|Overall Study||62
2857826|NCT00086411|3560394|FG003|STARTED|Overall Study||65
2857827|NCT00086411|3560391|FG000|COMPLETED|Overall Study||59
2857828|NCT00086411|3560392|FG001|COMPLETED|Overall Study||52
2857829|NCT00086411|3560393|FG002|COMPLETED|Overall Study||49
2857830|NCT00086411|3560394|FG003|COMPLETED|Overall Study||53
2857831|NCT00086411|3560391|FG000|NOT COMPLETED|Overall Study||11
2857832|NCT00086411|3560392|FG001|NOT COMPLETED|Overall Study||11
2857833|NCT00086411|3560393|FG002|NOT COMPLETED|Overall Study||13
2857834|NCT00086411|3560394|FG003|NOT COMPLETED|Overall Study||12
2857835|NCT00086450|3560407|FG000|STARTED|Overall Study||953
2857836|NCT00086450|3560408|FG001|STARTED|Overall Study||947
2857837|NCT00086450|3560407|FG000|COMPLETED|Overall Study||953
2857838|NCT00086450|3560408|FG001|COMPLETED|Overall Study||947
2857839|NCT00086450|3560407|FG000|NOT COMPLETED|Overall Study||0
3168743|NCT01920854|3896132|FG001|COMPLETED|Overall Study||6
3168744|NCT01920854|3896133|FG002|COMPLETED|Overall Study||6
3168745|NCT01920854|3896134|FG003|COMPLETED|Overall Study||6
3168746|NCT01920854|3896135|FG004|COMPLETED|Overall Study||5
3168747|NCT01920854|3896136|FG005|COMPLETED|Overall Study||6
2857840|NCT00086450|3560408|FG001|NOT COMPLETED|Overall Study||0
2857841|NCT00086502|3560416|FG000|STARTED|Overall Study||175
2857842|NCT00086502|3560417|FG001|STARTED|Overall Study||178
2857843|NCT00086502|3560416|FG000|COMPLETED|Overall Study||149
2857844|NCT00086502|3560417|FG001|COMPLETED|Overall Study||158
2857845|NCT00086502|3560416|FG000|NOT COMPLETED|Overall Study||26
2857846|NCT00086502|3560417|FG001|NOT COMPLETED|Overall Study||20
2857847|NCT00086515|3560425|FG000|STARTED|Phase A (Weeks 0-24)||464
2857848|NCT00086515|3560426|FG001|STARTED|Phase A (Weeks 0-24)||237
2857849|NCT00086515|3560425|FG000|COMPLETED|Phase A (Weeks 0-24)||415
2857850|NCT00086515|3560426|FG001|COMPLETED|Phase A (Weeks 0-24)||192
2857851|NCT00086515|3560425|FG000|NOT COMPLETED|Phase A (Weeks 0-24)||49
2857852|NCT00086515|3560426|FG001|NOT COMPLETED|Phase A (Weeks 0-24)||45
2857853|NCT00086515|3560425|FG000|STARTED|Phase A to Phase B Transition Period||415
2857854|NCT00086515|3560426|FG001|STARTED|Phase A to Phase B Transition Period||192
2857855|NCT00086515|3560425|FG000|COMPLETED|Phase A to Phase B Transition Period||391
2857856|NCT00086515|3560426|FG001|COMPLETED|Phase A to Phase B Transition Period||164
2857857|NCT00086515|3560425|FG000|NOT COMPLETED|Phase A to Phase B Transition Period||24
2857858|NCT00086515|3560426|FG001|NOT COMPLETED|Phase A to Phase B Transition Period||28
2857859|NCT00086515|3560425|FG000|STARTED|Phase B (Weeks 24-104)||391
2857860|NCT00086515|3560426|FG001|STARTED|Phase B (Weeks 24-104)||164
2857861|NCT00086515|3560425|FG000|COMPLETED|Phase B (Weeks 24-104)||201
2857862|NCT00086515|3560426|FG001|COMPLETED|Phase B (Weeks 24-104)||109
2857863|NCT00086515|3560425|FG000|NOT COMPLETED|Phase B (Weeks 24-104)||190
2857864|NCT00086515|3560426|FG001|NOT COMPLETED|Phase B (Weeks 24-104)||55
2857865|NCT00086580|3560434|FG000|STARTED|Treatment Period||168
2857866|NCT00086580|3560435|FG001|STARTED|Treatment Period||167
2857867|NCT00086580|3560434|FG000|Safety Population|Treatment Period|Four participants did not receive treatment|164
2857868|NCT00086580|3560435|FG001|Safety Population|Treatment Period|Two participants did not receive treatment|165
2857869|NCT00086580|3560434|FG000|COMPLETED|Treatment Period|Finished 6 cycles of study drugs|103
2857870|NCT00086580|3560435|FG001|COMPLETED|Treatment Period|Finished 6 cycles of study drug|107
2857871|NCT00086580|3560434|FG000|NOT COMPLETED|Treatment Period||65
2857872|NCT00086580|3560435|FG001|NOT COMPLETED|Treatment Period||60
2857873|NCT00086580|3560434|FG000|STARTED|Follow-up Period||141
2857874|NCT00086580|3560435|FG001|STARTED|Follow-up Period||137
2857875|NCT00086580|3560434|FG000|COMPLETED|Follow-up Period||37
2857876|NCT00086580|3560435|FG001|COMPLETED|Follow-up Period||18
2857877|NCT00086580|3560434|FG000|NOT COMPLETED|Follow-up Period||104
2857878|NCT00086580|3560435|FG001|NOT COMPLETED|Follow-up Period||119
2857879|NCT00086580|3560434|FG000|STARTED|Observation Period||95
2857880|NCT00086580|3560435|FG001|STARTED|Observation Period||121
2857881|NCT00086580|3560434|FG000|COMPLETED|Observation Period||49
2857882|NCT00086580|3560435|FG001|COMPLETED|Observation Period||56
2857883|NCT00086580|3560434|FG000|NOT COMPLETED|Observation Period||46
2857884|NCT00086580|3560435|FG001|NOT COMPLETED|Observation Period||65
2857885|NCT00086619|3560443|FG000|STARTED|Overall Study||40
2857886|NCT00086619|3560444|FG001|STARTED|Overall Study||40
2857887|NCT00086619|3560443|FG000|Completed Baseline Visit|Overall Study||34
2857888|NCT00086619|3560444|FG001|Completed Baseline Visit|Overall Study||36
2857889|NCT00086619|3560443|FG000|Completed 12 Month Visit|Overall Study||26
2857890|NCT00086619|3560444|FG001|Completed 12 Month Visit|Overall Study||26
2857891|NCT00086619|3560443|FG000|COMPLETED|Overall Study||25
3168748|NCT01920854|3896137|FG006|COMPLETED|Overall Study||5
2857892|NCT00086619|3560444|FG001|COMPLETED|Overall Study||23
2857893|NCT00086619|3560443|FG000|NOT COMPLETED|Overall Study||15
2857894|NCT00086619|3560444|FG001|NOT COMPLETED|Overall Study||17
2857895|NCT00086684|3560453|FG000|STARTED|Overall Study||118
2857896|NCT00086684|3560454|FG001|STARTED|Overall Study||129
2857897|NCT00086684|3560455|FG002|STARTED|Overall Study||122
2857898|NCT00086684|3560453|FG000|COMPLETED|Overall Study||63
2857899|NCT00086684|3560454|FG001|COMPLETED|Overall Study||74
2857900|NCT00086684|3560455|FG002|COMPLETED|Overall Study||69
2857901|NCT00086684|3560453|FG000|NOT COMPLETED|Overall Study||55
2857902|NCT00086684|3560454|FG001|NOT COMPLETED|Overall Study||55
2857903|NCT00086684|3560455|FG002|NOT COMPLETED|Overall Study||53
2857904|NCT00086957|3560463|FG000|STARTED|Overall Study||2
2857905|NCT00086957|3560464|FG001|STARTED|Overall Study||7
2857906|NCT00086957|3560465|FG002|STARTED|Overall Study||22
2857907|NCT00086957|3560463|FG000|COMPLETED|Overall Study||2
2857908|NCT00086957|3560464|FG001|COMPLETED|Overall Study||7
2857909|NCT00086957|3560465|FG002|COMPLETED|Overall Study||22
2857910|NCT00086957|3560463|FG000|NOT COMPLETED|Overall Study||0
2857911|NCT00086957|3560464|FG001|NOT COMPLETED|Overall Study||0
2857912|NCT00086957|3560465|FG002|NOT COMPLETED|Overall Study||0
2857913|NCT00086996|3560474|FG000|STARTED|Overall Study||98
2857914|NCT00086996|3560474|FG000|Eligible|Overall Study||93
2857915|NCT00086996|3560474|FG000|Eligible and Began Protocol Therapy|Overall Study||93
2857916|NCT00086996|3560474|FG000|COMPLETED|Overall Study||34
2857917|NCT00086996|3560474|FG000|NOT COMPLETED|Overall Study||64
2857918|NCT00087022|3560480|FG000|STARTED|Overall Study||433
2857919|NCT00087022|3560481|FG001|STARTED|Overall Study||431
2857920|NCT00087022|3560480|FG000|Treated (Safety Population)|Overall Study||431
2857921|NCT00087022|3560481|FG001|Treated (Safety Population)|Overall Study||424
2857922|NCT00087022|3560480|FG000|COMPLETED|Overall Study||379
2857923|NCT00087022|3560481|FG001|COMPLETED|Overall Study||376
2857924|NCT00087022|3560480|FG000|NOT COMPLETED|Overall Study||54
2857925|NCT00087022|3560481|FG001|NOT COMPLETED|Overall Study||55
2857926|NCT00087126|3560487|FG000|STARTED|Overall Study||27
2857927|NCT00087126|3560487|FG000|COMPLETED|Overall Study||25
2857928|NCT00087126|3560487|FG000|NOT COMPLETED|Overall Study||2
2857929|NCT00087139|3560499|FG000|STARTED|Overall Study||39
2857930|NCT00087139|3560500|FG001|STARTED|Overall Study||49
2857931|NCT00087139|3560501|FG002|STARTED|Overall Study||36
2857932|NCT00087139|3560499|FG000|Treated|Overall Study||39
2857933|NCT00087139|3560500|FG001|Treated|Overall Study||48
2857934|NCT00087139|3560501|FG002|Treated|Overall Study||36
2857935|NCT00087139|3560499|FG000|Eligible and Treated|Overall Study||35
2857936|NCT00087139|3560500|FG001|Eligible and Treated|Overall Study||42
2857937|NCT00087139|3560501|FG002|Eligible and Treated|Overall Study||32
2857938|NCT00087139|3560499|FG000|Patients for the Analysis of PSA Respons|Overall Study||30
2857939|NCT00087139|3560500|FG001|Patients for the Analysis of PSA Respons|Overall Study||34
2857940|NCT00087139|3560501|FG002|Patients for the Analysis of PSA Respons|Overall Study||22
2857941|NCT00087139|3560499|FG000|Patients With Measurable Disease|Overall Study||22
2857942|NCT00087139|3560500|FG001|Patients With Measurable Disease|Overall Study||25
2857943|NCT00087139|3560501|FG002|Patients With Measurable Disease|Overall Study||24
2857944|NCT00087139|3560499|FG000|Patients With PSA Response|Overall Study||10
2857945|NCT00087139|3560500|FG001|Patients With PSA Response|Overall Study||8
2857946|NCT00087139|3560501|FG002|Patients With PSA Response|Overall Study||4
2857947|NCT00087139|3560499|FG000|Patients w/ Measurable Disease Response|Overall Study||5
2857948|NCT00087139|3560500|FG001|Patients w/ Measurable Disease Response|Overall Study||2
2857949|NCT00087139|3560501|FG002|Patients w/ Measurable Disease Response|Overall Study||0
2857950|NCT00087139|3560499|FG000|COMPLETED|Overall Study||0
2857951|NCT00087139|3560500|FG001|COMPLETED|Overall Study||0
2857952|NCT00087139|3560501|FG002|COMPLETED|Overall Study||0
2857953|NCT00087139|3560499|FG000|NOT COMPLETED|Overall Study||39
2857954|NCT00087139|3560500|FG001|NOT COMPLETED|Overall Study||49
2857955|NCT00087139|3560501|FG002|NOT COMPLETED|Overall Study||36
2857956|NCT00087152|3560507|FG000|STARTED|Overall Study||27
2857957|NCT00087152|3560507|FG000|COMPLETED|Overall Study||21
2857958|NCT00087152|3560507|FG000|NOT COMPLETED|Overall Study||6
2857959|NCT00087438|3560512|FG000|STARTED|Overall Study||59
2857960|NCT00087438|3560512|FG000|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|55
2857961|NCT00087438|3560512|FG000|NOT COMPLETED|Overall Study||4
2857962|NCT00087490|3560520|FG000|STARTED|Overall Study||544
2857963|NCT00087490|3560521|FG001|STARTED|Overall Study||533
2857964|NCT00087490|3560520|FG000|Treated|Overall Study||537
2857965|NCT00087490|3560521|FG001|Treated|Overall Study||515
2857966|NCT00087490|3560520|FG000|COMPLETED|Overall Study||286
2857967|NCT00087490|3560521|FG001|COMPLETED|Overall Study||264
2857968|NCT00087490|3560520|FG000|NOT COMPLETED|Overall Study||258
2857969|NCT00087490|3560521|FG001|NOT COMPLETED|Overall Study||269
2857970|NCT00087516|3560530|FG000|STARTED|Overall Study||238
2857971|NCT00087516|3560531|FG001|STARTED|Overall Study||250
2857972|NCT00087516|3560532|FG002|STARTED|Overall Study||130
2857973|NCT00087516|3560533|FG003|STARTED|Overall Study||123
2857974|NCT00087516|3560530|FG000|COMPLETED|Overall Study||77
2857975|NCT00087516|3560531|FG001|COMPLETED|Overall Study||81
2857976|NCT00087516|3560532|FG002|COMPLETED|Overall Study||33
2857977|NCT00087516|3560533|FG003|COMPLETED|Overall Study||38
2857978|NCT00087516|3560530|FG000|NOT COMPLETED|Overall Study||161
2857979|NCT00087516|3560531|FG001|NOT COMPLETED|Overall Study||169
2857980|NCT00087516|3560532|FG002|NOT COMPLETED|Overall Study||97
2857981|NCT00087516|3560533|FG003|NOT COMPLETED|Overall Study||85
2857982|NCT00087529|3560549|FG000|STARTED|Overall Study||147
2857983|NCT00087529|3560550|FG001|STARTED|Overall Study||292
2857984|NCT00087529|3560549|FG000|COMPLETED|Overall Study||116
3168749|NCT01920854|3896131|FG000|NOT COMPLETED|Overall Study||1
3168750|NCT01920854|3896132|FG001|NOT COMPLETED|Overall Study||0
3168751|NCT01920854|3896133|FG002|NOT COMPLETED|Overall Study||0
3168752|NCT01920854|3896134|FG003|NOT COMPLETED|Overall Study||0
3168753|NCT01920854|3896135|FG004|NOT COMPLETED|Overall Study||1
3168754|NCT01920854|3896136|FG005|NOT COMPLETED|Overall Study||0
3168755|NCT01920854|3896137|FG006|NOT COMPLETED|Overall Study||1
3168756|NCT01920893|3896174|FG000|STARTED|Overall Study||30
2857985|NCT00087529|3560550|FG001|COMPLETED|Overall Study||224
2857986|NCT00087529|3560549|FG000|NOT COMPLETED|Overall Study||31
2857987|NCT00087529|3560550|FG001|NOT COMPLETED|Overall Study||68
2857988|NCT00087555|3560559|FG000|STARTED|Overall Study||66
2857989|NCT00087555|3560560|FG001|STARTED|Overall Study||62
2857990|NCT00087555|3560561|FG002|STARTED|Overall Study||67
2857991|NCT00087555|3560559|FG000|Treated|Overall Study||65
2857992|NCT00087555|3560560|FG001|Treated|Overall Study||60
2857993|NCT00087555|3560561|FG002|Treated|Overall Study||67
2857994|NCT00087555|3560559|FG000|COMPLETED|Overall Study||54
2857995|NCT00087555|3560560|FG001|COMPLETED|Overall Study||51
2857996|NCT00087555|3560561|FG002|COMPLETED|Overall Study||46
2857997|NCT00087555|3560559|FG000|NOT COMPLETED|Overall Study||12
2857998|NCT00087555|3560560|FG001|NOT COMPLETED|Overall Study||11
2857999|NCT00087555|3560561|FG002|NOT COMPLETED|Overall Study||21
2858000|NCT00087568|3560571|FG000|STARTED|Overall Study||32
2858001|NCT00087568|3560572|FG001|STARTED|Overall Study||25
2858002|NCT00087568|3560571|FG000|COMPLETED|Overall Study||2
2858003|NCT00087568|3560572|FG001|COMPLETED|Overall Study||23
2858004|NCT00087568|3560571|FG000|NOT COMPLETED|Overall Study||30
2858005|NCT00087568|3560572|FG001|NOT COMPLETED|Overall Study||2
2858006|NCT00087594|3560580|FG000|STARTED|Overall Study||24
2858007|NCT00087594|3560581|FG001|STARTED|Overall Study||24
2858008|NCT00087594|3560580|FG000|COMPLETED|Overall Study||16
2858009|NCT00087594|3560581|FG001|COMPLETED|Overall Study||12
2858010|NCT00087594|3560580|FG000|NOT COMPLETED|Overall Study||8
2858011|NCT00087594|3560581|FG001|NOT COMPLETED|Overall Study||12
2858012|NCT00087607|3560589|FG000|STARTED|Overall Study||192
2858013|NCT00087607|3560590|FG001|STARTED|Overall Study||193
2858014|NCT00087607|3560589|FG000|COMPLETED|Overall Study||70
2858015|NCT00087607|3560590|FG001|COMPLETED|Overall Study||71
2858016|NCT00087607|3560589|FG000|NOT COMPLETED|Overall Study||122
2858017|NCT00087607|3560590|FG001|NOT COMPLETED|Overall Study||122
2858018|NCT00087633|3560602|FG000|STARTED|Overall Study|Randomized|55
2858019|NCT00087633|3560603|FG001|STARTED|Overall Study|Randomized|60
2858020|NCT00087633|3560602|FG000|COMPLETED|Overall Study|Completed 48 weeks of treatment/observation|31
2858021|NCT00087633|3560603|FG001|COMPLETED|Overall Study|Completed 48 weeks of treatment/observation|43
2858022|NCT00087633|3560602|FG000|NOT COMPLETED|Overall Study||24
2858023|NCT00087633|3560603|FG001|NOT COMPLETED|Overall Study||17
2858024|NCT00087646|3560613|FG000|STARTED|Overall Study||317
2858025|NCT00087646|3560614|FG001|STARTED|Overall Study||156
2858026|NCT00087646|3560615|FG002|STARTED|Overall Study||156
2858027|NCT00087646|3560616|FG003|STARTED|Overall Study||313
2858028|NCT00087646|3560613|FG000|COMPLETED|Overall Study||182
2858029|NCT00087646|3560614|FG001|COMPLETED|Overall Study||114
2858030|NCT00087646|3560615|FG002|COMPLETED|Overall Study||91
2858031|NCT00087646|3560616|FG003|COMPLETED|Overall Study||229
2858032|NCT00087646|3560613|FG000|NOT COMPLETED|Overall Study||135
2858033|NCT00087646|3560614|FG001|NOT COMPLETED|Overall Study||42
2858034|NCT00087646|3560615|FG002|NOT COMPLETED|Overall Study||65
2858035|NCT00087646|3560616|FG003|NOT COMPLETED|Overall Study||84
2858036|NCT00087672|3560631|FG000|STARTED|Overall Study||41
2858037|NCT00087672|3560631|FG000|COMPLETED|Overall Study||41
2858038|NCT00087672|3560631|FG000|NOT COMPLETED|Overall Study||0
2858039|NCT00087685|3560635|FG000|STARTED|Overall Study||35
2858040|NCT00087685|3560635|FG000|COMPLETED|Overall Study||21
2858041|NCT00087685|3560635|FG000|NOT COMPLETED|Overall Study||14
2858042|NCT00087698|3560639|FG000|STARTED|Overall Study||77
2858043|NCT00087698|3560639|FG000|COMPLETED|Overall Study||41
2858044|NCT00087698|3560639|FG000|NOT COMPLETED|Overall Study||36
2858045|NCT00088153|3560645|FG000|STARTED|Overall Study||55
2858046|NCT00088153|3560646|FG001|STARTED|Overall Study||55
2858047|NCT00088153|3560645|FG000|COMPLETED|Overall Study||31
2858048|NCT00088153|3560646|FG001|COMPLETED|Overall Study||30
2858049|NCT00088153|3560645|FG000|NOT COMPLETED|Overall Study||24
2858050|NCT00088153|3560646|FG001|NOT COMPLETED|Overall Study||25
2858051|NCT00088166|3560654|FG000|STARTED|Overall Study||100
2858052|NCT00088166|3560655|FG001|STARTED|Overall Study||100
2858053|NCT00088166|3560654|FG000|COMPLETED|Overall Study||47
2858054|NCT00088166|3560655|FG001|COMPLETED|Overall Study||39
2858055|NCT00088166|3560654|FG000|NOT COMPLETED|Overall Study||53
2858056|NCT00088166|3560655|FG001|NOT COMPLETED|Overall Study||61
2858057|NCT00088205|3560661|FG000|STARTED|Overall Study||60
2858058|NCT00088205|3560661|FG000|Received at Least 1 Dose of Study Drug|Overall Study||60
2858059|NCT00088205|3560661|FG000|Efficacy Population|Overall Study|Participants with diagnosis of relapsed mantle cell lymphoma.|59
2858060|NCT00088205|3560661|FG000|COMPLETED|Overall Study||0
2858061|NCT00088205|3560661|FG000|NOT COMPLETED|Overall Study||60
2858062|NCT00088218|3560667|FG000|STARTED|Overall Study||16
2858063|NCT00088218|3560668|FG001|STARTED|Overall Study||79
2858064|NCT00088218|3560667|FG000|COMPLETED|Overall Study||16
2858065|NCT00088218|3560668|FG001|COMPLETED|Overall Study||79
2858066|NCT00088218|3560667|FG000|NOT COMPLETED|Overall Study||0
2858067|NCT00088218|3560668|FG001|NOT COMPLETED|Overall Study||0
2858068|NCT00088374|3560674|FG000|STARTED|Overall Study||9
2858069|NCT00088374|3560674|FG000|COMPLETED|Overall Study||7
2858070|NCT00088374|3560674|FG000|NOT COMPLETED|Overall Study||2
2858071|NCT00088413|3560682|FG000|STARTED|Overall Study||10
2858072|NCT00088413|3560683|FG001|STARTED|Overall Study||15
2858073|NCT00088413|3560684|FG002|STARTED|Overall Study||12
2858074|NCT00088413|3560685|FG003|STARTED|Overall Study||14
2858075|NCT00088413|3560682|FG000|COMPLETED|Overall Study||0
2858076|NCT00088413|3560683|FG001|COMPLETED|Overall Study||0
2858077|NCT00088413|3560684|FG002|COMPLETED|Overall Study||0
2858078|NCT00088413|3560685|FG003|COMPLETED|Overall Study||0
2858079|NCT00088413|3560682|FG000|NOT COMPLETED|Overall Study||10
2858080|NCT00088413|3560683|FG001|NOT COMPLETED|Overall Study||15
2858081|NCT00088413|3560684|FG002|NOT COMPLETED|Overall Study||12
2858082|NCT00088413|3560685|FG003|NOT COMPLETED|Overall Study||14
2858083|NCT00088452|3560700|FG000|STARTED|Overall Study||156
2858084|NCT00088452|3560701|FG001|STARTED|Overall Study||149
2858085|NCT00088452|3560702|FG002|STARTED|Overall Study||148
2858086|NCT00088452|3560700|FG000|COMPLETED|Overall Study||155
2858087|NCT00088452|3560701|FG001|COMPLETED|Overall Study||149
2858088|NCT00088452|3560702|FG002|COMPLETED|Overall Study||147
2858089|NCT00088452|3560700|FG000|NOT COMPLETED|Overall Study||1
2858090|NCT00088452|3560701|FG001|NOT COMPLETED|Overall Study||0
2858091|NCT00088452|3560702|FG002|NOT COMPLETED|Overall Study||1
2858092|NCT00088465|3560710|FG000|STARTED|Overall Study||931
2858093|NCT00088465|3560710|FG000|COMPLETED|Overall Study||370
2858094|NCT00088465|3560710|FG000|NOT COMPLETED|Overall Study||561
2858095|NCT00088530|3560716|FG000|STARTED|Overall Study||70
2858096|NCT00088530|3560717|FG001|STARTED|Overall Study||70
2858097|NCT00088530|3560716|FG000|COMPLETED|Overall Study||20
2858098|NCT00088530|3560717|FG001|COMPLETED|Overall Study||16
2858099|NCT00088530|3560716|FG000|NOT COMPLETED|Overall Study||50
2858100|NCT00088530|3560717|FG001|NOT COMPLETED|Overall Study||54
2858101|NCT00088595|3560723|FG000|STARTED|Overall Study||45
2858102|NCT00088595|3560723|FG000|COMPLETED|Overall Study||17
2858103|NCT00088595|3560723|FG000|NOT COMPLETED|Overall Study||28
2858104|NCT00088621|3560737|FG000|STARTED|Overall Study||61
2858105|NCT00088621|3560737|FG000|COMPLETED|Overall Study||7
2858106|NCT00088621|3560737|FG000|NOT COMPLETED|Overall Study||54
2858107|NCT00088634|3560743|FG000|STARTED|Overall Study||90
2858108|NCT00088634|3560744|FG001|STARTED|Overall Study||90
2858109|NCT00088634|3560743|FG000|COMPLETED|Overall Study||52
2858110|NCT00088634|3560744|FG001|COMPLETED|Overall Study||47
2858111|NCT00088634|3560743|FG000|NOT COMPLETED|Overall Study||38
2858112|NCT00088634|3560744|FG001|NOT COMPLETED|Overall Study||43
2858113|NCT00088699|3560752|FG000|STARTED|Infusion 1||23
2858114|NCT00088699|3560753|FG001|STARTED|Infusion 1||19
2858115|NCT00088699|3560754|FG002|STARTED|Infusion 1||13
2858116|NCT00088699|3560755|FG003|STARTED|Infusion 1||12
2858117|NCT00088699|3560752|FG000|COMPLETED|Infusion 1||22
2858118|NCT00088699|3560753|FG001|COMPLETED|Infusion 1||19
2858119|NCT00088699|3560754|FG002|COMPLETED|Infusion 1||12
2858120|NCT00088699|3560755|FG003|COMPLETED|Infusion 1||10
2858121|NCT00088699|3560752|FG000|NOT COMPLETED|Infusion 1||1
2858122|NCT00088699|3560753|FG001|NOT COMPLETED|Infusion 1||0
2858123|NCT00088699|3560754|FG002|NOT COMPLETED|Infusion 1||1
2858124|NCT00088699|3560755|FG003|NOT COMPLETED|Infusion 1||2
2858125|NCT00088699|3560752|FG000|STARTED|Infusion 2||19
2858126|NCT00088699|3560753|FG001|STARTED|Infusion 2||18
2858127|NCT00088699|3560754|FG002|STARTED|Infusion 2||11
2858128|NCT00088699|3560755|FG003|STARTED|Infusion 2||11
2858129|NCT00088699|3560752|FG000|COMPLETED|Infusion 2||19
2858130|NCT00088699|3560753|FG001|COMPLETED|Infusion 2||18
2858131|NCT00088699|3560754|FG002|COMPLETED|Infusion 2||11
2858132|NCT00088699|3560755|FG003|COMPLETED|Infusion 2||10
2858133|NCT00088699|3560752|FG000|NOT COMPLETED|Infusion 2||0
2858134|NCT00088699|3560753|FG001|NOT COMPLETED|Infusion 2||0
2858135|NCT00088699|3560754|FG002|NOT COMPLETED|Infusion 2||0
2858136|NCT00088699|3560755|FG003|NOT COMPLETED|Infusion 2||1
2858137|NCT00088881|3560765|FG000|STARTED|Step 1 - R-CHOP||62
2858138|NCT00088881|3560765|FG000|Eligible and Treated|Step 1 - R-CHOP||53
2858139|NCT00088881|3560765|FG000|COMPLETED|Step 1 - R-CHOP||48
2858140|NCT00088881|3560765|FG000|NOT COMPLETED|Step 1 - R-CHOP||14
2858141|NCT00088881|3560765|FG000|STARTED|Step 2 - Zevalin™ Radioimmunotherapy|This includes all patients who received step 2 treatment regardless of eligibility.|56
2858142|NCT00088881|3560765|FG000|Eligible and Treated|Step 2 - Zevalin™ Radioimmunotherapy||48
2858143|NCT00088881|3560765|FG000|COMPLETED|Step 2 - Zevalin™ Radioimmunotherapy||45
2858144|NCT00088881|3560765|FG000|NOT COMPLETED|Step 2 - Zevalin™ Radioimmunotherapy||11
2858145|NCT00088881|3560765|FG000|STARTED|Step 3 - Radiation Therapy||1
2858146|NCT00088881|3560765|FG000|COMPLETED|Step 3 - Radiation Therapy||1
2858147|NCT00088881|3560765|FG000|NOT COMPLETED|Step 3 - Radiation Therapy||0
2858148|NCT00088907|3560773|FG000|STARTED|Randomized Study (Step 1)||136
2858149|NCT00088907|3560774|FG001|STARTED|Randomized Study (Step 1)||134
2858150|NCT00088907|3560773|FG000|Treated|Randomized Study (Step 1)||129
2858151|NCT00088907|3560774|FG001|Treated|Randomized Study (Step 1)||124
2858152|NCT00088907|3560773|FG000|Eligible|Randomized Study (Step 1)||117
2858153|NCT00088907|3560774|FG001|Eligible|Randomized Study (Step 1)||122
2858154|NCT00088907|3560773|FG000|Eligible and Treated|Randomized Study (Step 1)||117
2858155|NCT00088907|3560774|FG001|Eligible and Treated|Randomized Study (Step 1)||122
2858156|NCT00088907|3560773|FG000|COMPLETED|Randomized Study (Step 1)|Treatment would continue until disease progression, no certain fixed number of cycles.|0
2858157|NCT00088907|3560774|FG001|COMPLETED|Randomized Study (Step 1)|Treatment would continue until disease progression, no certain fixed number of cycles|0
2858158|NCT00088907|3560773|FG000|NOT COMPLETED|Randomized Study (Step 1)||136
2858159|NCT00088907|3560774|FG001|NOT COMPLETED|Randomized Study (Step 1)||134
2858160|NCT00088907|3560773|FG000|STARTED|Single Gefitinib Treatment (Step 2)|Patients on Arm I could cross over to gefitinib after disease progression on step 1.|24
2858161|NCT00088907|3560774|FG001|STARTED|Single Gefitinib Treatment (Step 2)|Cross over to single gefitinib therapy at progression was allowed for patients on Arm I only.|0
2858162|NCT00088907|3560773|FG000|Treated|Single Gefitinib Treatment (Step 2)||19
2858163|NCT00088907|3560774|FG001|Treated|Single Gefitinib Treatment (Step 2)||0
2858164|NCT00088907|3560773|FG000|COMPLETED|Single Gefitinib Treatment (Step 2)||0
2858165|NCT00088907|3560774|FG001|COMPLETED|Single Gefitinib Treatment (Step 2)||0
2858166|NCT00088907|3560773|FG000|NOT COMPLETED|Single Gefitinib Treatment (Step 2)||24
2858167|NCT00088907|3560774|FG001|NOT COMPLETED|Single Gefitinib Treatment (Step 2)||0
2858168|NCT00088985|3560781|FG000|STARTED|Overall Study||7
2858169|NCT00088985|3560781|FG000|COMPLETED|Overall Study||4
2858170|NCT00088985|3560781|FG000|NOT COMPLETED|Overall Study||3
2858171|NCT00089011|3560787|FG000|STARTED|Overall Study||100
2858172|NCT00089011|3560788|FG001|STARTED|Overall Study||50
2858173|NCT00089011|3560787|FG000|COMPLETED|Overall Study||100
2858174|NCT00089011|3560788|FG001|COMPLETED|Overall Study||50
2858175|NCT00089011|3560787|FG000|NOT COMPLETED|Overall Study||0
2858176|NCT00089011|3560788|FG001|NOT COMPLETED|Overall Study||0
2858177|NCT00089024|3560794|FG000|STARTED|Overall Study||29
2858178|NCT00089024|3560794|FG000|Treated Subjects|Overall Study||29
2858179|NCT00089024|3560794|FG000|COMPLETED|Overall Study||24
2858180|NCT00089024|3560794|FG000|NOT COMPLETED|Overall Study||5
2858181|NCT00089076|3560798|FG000|STARTED|Overall Study||18
2858182|NCT00089076|3560798|FG000|COMPLETED|Overall Study||8
2858183|NCT00089076|3560798|FG000|NOT COMPLETED|Overall Study||10
2858184|NCT00089102|3560802|FG000|STARTED|Overall Study||9
2858185|NCT00089102|3560802|FG000|COMPLETED|Overall Study||9
2858186|NCT00089102|3560802|FG000|NOT COMPLETED|Overall Study||0
2858187|NCT00089284|3560811|FG000|STARTED|Overall Study||7
2858188|NCT00089284|3560812|FG001|STARTED|Overall Study||3
2858189|NCT00089284|3560813|FG002|STARTED|Overall Study||6
2858190|NCT00089284|3560814|FG003|STARTED|Overall Study||6
2858191|NCT00089284|3560815|FG004|STARTED|Overall Study|No patients were accrued to this cohort of 6-24% involvement due to lack of eligible patients.|0
2858192|NCT00089284|3560816|FG005|STARTED|Overall Study|No patients were accrued to this cohort of 6-24% involvement due to lack of eligible patients.|0
2858193|NCT00089284|3560817|FG006|STARTED|Overall Study||8
2858194|NCT00089284|3560811|FG000|COMPLETED|Overall Study||7
2858195|NCT00089284|3560812|FG001|COMPLETED|Overall Study||3
2858196|NCT00089284|3560813|FG002|COMPLETED|Overall Study||6
2858197|NCT00089284|3560814|FG003|COMPLETED|Overall Study||6
2858198|NCT00089284|3560815|FG004|COMPLETED|Overall Study||0
2858199|NCT00089284|3560816|FG005|COMPLETED|Overall Study||0
2858200|NCT00089284|3560817|FG006|COMPLETED|Overall Study||7
2858201|NCT00089284|3560811|FG000|NOT COMPLETED|Overall Study||0
2858202|NCT00089284|3560812|FG001|NOT COMPLETED|Overall Study||0
2858203|NCT00089284|3560813|FG002|NOT COMPLETED|Overall Study||0
2858204|NCT00089284|3560814|FG003|NOT COMPLETED|Overall Study||0
2858205|NCT00089284|3560815|FG004|NOT COMPLETED|Overall Study||0
2858206|NCT00089284|3560816|FG005|NOT COMPLETED|Overall Study||0
2858207|NCT00089284|3560817|FG006|NOT COMPLETED|Overall Study||1
2858208|NCT00089297|3560839|FG000|STARTED|Overall Study||74
2858209|NCT00089297|3560839|FG000|Treated|Overall Study||70
2858210|NCT00089297|3560839|FG000|Eligible|Overall Study||63
2858211|NCT00089297|3560839|FG000|COMPLETED|Overall Study||36
2858212|NCT00089297|3560839|FG000|NOT COMPLETED|Overall Study||38
2858213|NCT00089479|3560845|FG000|STARTED|Overall Study||1304
2858214|NCT00089479|3560846|FG001|STARTED|Overall Study||1307
2858215|NCT00089479|3560845|FG000|Received Treatment|Overall Study|Safety Population (includes 19 patients randomized to ACXT, who received ACT)|1305
2858216|NCT00089479|3560846|FG001|Received Treatment|Overall Study|Safety Population (includes 5 patients randomized to ACT, who received ACXT)|1283
2858217|NCT00089479|3560845|FG000|COMPLETED|Overall Study|total includes Completed and Alive in follow-up|973
2858218|NCT00089479|3560846|FG001|COMPLETED|Overall Study|total includes Completed and Alive in follow-up|1018
2858219|NCT00089479|3560845|FG000|NOT COMPLETED|Overall Study||331
2858220|NCT00089479|3560846|FG001|NOT COMPLETED|Overall Study||289
2858221|NCT00089505|3560856|FG000|STARTED|Overall Study|2 women never started treatment and per protocol, were not followed and not included in analysis.|121
2858222|NCT00089505|3560857|FG001|STARTED|Overall Study||120
2858223|NCT00089505|3560858|FG002|STARTED|Overall Study|2 women never started treatment and per protocol, were not followed and not included in analysis.|249
2858224|NCT00089505|3560859|FG003|STARTED|Overall Study||251
2858225|NCT00089505|3560856|FG000|COMPLETED|Overall Study|The results for NVP/NVP were through database cutoff for DSMB review (by 6 October 2008).|112
2858226|NCT00089505|3560857|FG001|COMPLETED|Overall Study|The results for NVP/LPV_r were through database cutoff for DSMB review (by 6 October 2008).|118
2858227|NCT00089505|3560858|FG002|COMPLETED|Overall Study||228
2858228|NCT00089505|3560859|FG003|COMPLETED|Overall Study||230
2858229|NCT00089505|3560856|FG000|NOT COMPLETED|Overall Study||9
2858230|NCT00089505|3560857|FG001|NOT COMPLETED|Overall Study||2
2858231|NCT00089505|3560858|FG002|NOT COMPLETED|Overall Study||21
2858232|NCT00089505|3560859|FG003|NOT COMPLETED|Overall Study||21
2858233|NCT00089544|3560871|FG000|STARTED|Overall Study||16
2858234|NCT00089544|3560872|FG001|STARTED|Overall Study||7
2858235|NCT00089544|3560871|FG000|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|15
3168757|NCT01920893|3896175|FG001|STARTED|Overall Study||30
3168758|NCT01920893|3896174|FG000|Treated (Safety Population)|Overall Study||30
3168759|NCT01920893|3896175|FG001|Treated (Safety Population)|Overall Study||30
3168760|NCT01920893|3896174|FG000|COMPLETED|Overall Study||23
3168761|NCT01920893|3896175|FG001|COMPLETED|Overall Study||28
3168762|NCT01920893|3896174|FG000|NOT COMPLETED|Overall Study||7
3168763|NCT01920893|3896175|FG001|NOT COMPLETED|Overall Study||2
3168764|NCT01920958|3896182|FG000|STARTED|Overall Study||233
3168765|NCT01920958|3896182|FG000|COMPLETED|Overall Study|Intent-to-Treat (ITT) Population|228
3168766|NCT01920958|3896182|FG000|NOT COMPLETED|Overall Study||5
3168767|NCT01921101|3896188|FG000|STARTED|Overall Study||40
3168768|NCT01921101|3896189|FG001|STARTED|Overall Study||38
3168769|NCT01921101|3896188|FG000|COMPLETED|Overall Study||24
3168770|NCT01921101|3896189|FG001|COMPLETED|Overall Study||32
3168771|NCT01921101|3896188|FG000|NOT COMPLETED|Overall Study||16
3168772|NCT01921101|3896189|FG001|NOT COMPLETED|Overall Study||6
3168773|NCT01921166|3896197|FG000|STARTED|Overall Study||8
3168774|NCT01921166|3896198|FG001|STARTED|Overall Study||15
3168775|NCT01921166|3896197|FG000|COMPLETED|Overall Study||8
3168776|NCT01921166|3896198|FG001|COMPLETED|Overall Study||15
3168777|NCT01921166|3896197|FG000|NOT COMPLETED|Overall Study||0
3168778|NCT01921166|3896198|FG001|NOT COMPLETED|Overall Study||0
3168779|NCT01921179|3896206|FG000|STARTED|5 Week Randomized GOALS vs EDU Training||24
3168780|NCT01921179|3896207|FG001|STARTED|5 Week Randomized GOALS vs EDU Training||22
3168781|NCT01921179|3896206|FG000|COMPLETED|5 Week Randomized GOALS vs EDU Training||21
3168782|NCT01921179|3896207|FG001|COMPLETED|5 Week Randomized GOALS vs EDU Training||19
3168783|NCT01921179|3896206|FG000|NOT COMPLETED|5 Week Randomized GOALS vs EDU Training||3
3168784|NCT01921179|3896207|FG001|NOT COMPLETED|5 Week Randomized GOALS vs EDU Training||3
3168785|NCT01921179|3896206|FG000|STARTED|Long Term Follow-up After GOALS Training||34
3168786|NCT01921179|3896207|FG001|STARTED|Long Term Follow-up After GOALS Training|13 out of 19 participants who completed EDU, also completed GOALS training|0
3168787|NCT01921179|3896206|FG000|COMPLETED|Long Term Follow-up After GOALS Training||32
3168788|NCT01921179|3896207|FG001|COMPLETED|Long Term Follow-up After GOALS Training||0
3168789|NCT01921179|3896206|FG000|NOT COMPLETED|Long Term Follow-up After GOALS Training||2
3168790|NCT01921179|3896207|FG001|NOT COMPLETED|Long Term Follow-up After GOALS Training||0
3168791|NCT01921205|3896216|FG000|STARTED|Overall Study||172
3168792|NCT01921205|3896217|FG001|STARTED|Overall Study||171
3168793|NCT01921205|3896216|FG000|COMPLETED|Overall Study||151
3168794|NCT01921205|3896217|FG001|COMPLETED|Overall Study||151
3168795|NCT01921205|3896216|FG000|NOT COMPLETED|Overall Study||21
3168796|NCT01921205|3896217|FG001|NOT COMPLETED|Overall Study||20
3168797|NCT01921257|3896223|FG000|STARTED|Overall Study||16
3168798|NCT01921257|3896223|FG000|Placebo run-in|Overall Study||16
3168799|NCT01921257|3896223|FG000|Active Treatment|Overall Study||13
3168800|NCT01921257|3896223|FG000|COMPLETED|Overall Study||13
3168801|NCT01921257|3896223|FG000|NOT COMPLETED|Overall Study||3
3168802|NCT01921270|3896228|FG000|STARTED|Overall Study||18
3168803|NCT01921270|3896228|FG000|COMPLETED|Overall Study||17
3168804|NCT01921270|3896228|FG000|NOT COMPLETED|Overall Study||1
3168805|NCT01921296|3896232|FG000|STARTED|Overall Study||2
3168806|NCT01921296|3896232|FG000|COMPLETED|Overall Study||2
3168807|NCT01921296|3896232|FG000|NOT COMPLETED|Overall Study||0
3168808|NCT01921322|3896238|FG000|STARTED|Overall Study||57
3168809|NCT01921322|3896239|FG001|STARTED|Overall Study||61
3168810|NCT01921322|3896238|FG000|COMPLETED|Overall Study||42
3168811|NCT01921322|3896239|FG001|COMPLETED|Overall Study||44
3168812|NCT01921322|3896238|FG000|NOT COMPLETED|Overall Study||15
3168813|NCT01921322|3896239|FG001|NOT COMPLETED|Overall Study||17
3168814|NCT01921348|3896247|FG000|STARTED|Overall Study||9
3168815|NCT01921348|3896248|FG001|STARTED|Overall Study||9
3168816|NCT01921348|3896247|FG000|COMPLETED|Overall Study||8
2858236|NCT00089544|3560872|FG001|COMPLETED|Overall Study||7
2858237|NCT00089544|3560871|FG000|NOT COMPLETED|Overall Study||1
2858238|NCT00089544|3560872|FG001|NOT COMPLETED|Overall Study||0
2858239|NCT00089583|3560880|FG000|STARTED|Overall Study||20
2858240|NCT00089583|3560881|FG001|STARTED|Overall Study||89
2858241|NCT00089583|3560880|FG000|COMPLETED|Overall Study||13
2858242|NCT00089583|3560881|FG001|COMPLETED|Overall Study||51
2858243|NCT00089583|3560880|FG000|NOT COMPLETED|Overall Study||7
2858244|NCT00089583|3560881|FG001|NOT COMPLETED|Overall Study||38
2858245|NCT00089609|3560895|FG000|STARTED|Overall Study||60
3168817|NCT01921348|3896248|FG001|COMPLETED|Overall Study||7
3168818|NCT01921348|3896247|FG000|NOT COMPLETED|Overall Study||1
3168819|NCT01921348|3896248|FG001|NOT COMPLETED|Overall Study||2
3168820|NCT01921387|3896254|FG000|STARTED|Overall Study||20
3168821|NCT01921387|3896254|FG000|COMPLETED|Overall Study||19
3168822|NCT01921387|3896254|FG000|NOT COMPLETED|Overall Study||1
3168823|NCT01921452|3896258|FG000|STARTED|Overall Study||283
3168824|NCT01921452|3896258|FG000|COMPLETED|Overall Study||283
3168825|NCT01921452|3896258|FG000|NOT COMPLETED|Overall Study||0
3168826|NCT01921517|3896265|FG000|STARTED|Overall Study||42
3168827|NCT01921517|3896266|FG001|STARTED|Overall Study||38
3168828|NCT01921517|3896265|FG000|COMPLETED|Overall Study||27
2858246|NCT00089609|3560896|FG001|STARTED|Overall Study||13
2858247|NCT00089609|3560895|FG000|COMPLETED|Overall Study||57
2858248|NCT00089609|3560896|FG001|COMPLETED|Overall Study||12
2858249|NCT00089609|3560895|FG000|NOT COMPLETED|Overall Study||3
2858250|NCT00089609|3560896|FG001|NOT COMPLETED|Overall Study||1
2858251|NCT00089635|3560905|FG000|STARTED|Overall Study||203
2858252|NCT00089635|3560905|FG000|COMPLETED|Overall Study||160
2858253|NCT00089635|3560905|FG000|NOT COMPLETED|Overall Study||43
2858254|NCT00089648|3560909|FG000|STARTED|Overall Study||61
2858255|NCT00089648|3560909|FG000|COMPLETED|Overall Study||20
2858256|NCT00089648|3560909|FG000|NOT COMPLETED|Overall Study||41
2858257|NCT00089661|3560915|FG000|STARTED|Overall Study||127
2858258|NCT00089661|3560916|FG001|STARTED|Overall Study||125
2858259|NCT00089661|3560915|FG000|COMPLETED|Overall Study||106
2858260|NCT00089661|3560916|FG001|COMPLETED|Overall Study||99
2858261|NCT00089661|3560915|FG000|NOT COMPLETED|Overall Study||21
2858262|NCT00089661|3560916|FG001|NOT COMPLETED|Overall Study||26
2858263|NCT00089674|3560924|FG000|STARTED|Overall Study||734
2858264|NCT00089674|3560925|FG001|STARTED|Overall Study||734
2858265|NCT00089674|3560924|FG000|Received Study Drug|Overall Study||730
2858266|NCT00089674|3560925|FG001|Received Study Drug|Overall Study||726
2858267|NCT00089674|3560924|FG000|COMPLETED|Overall Study||445
2858268|NCT00089674|3560925|FG001|COMPLETED|Overall Study||467
2858269|NCT00089674|3560924|FG000|NOT COMPLETED|Overall Study||289
2858270|NCT00089674|3560925|FG001|NOT COMPLETED|Overall Study||267
2858271|NCT00089752|3560933|FG000|STARTED|Overall Study||141
2858272|NCT00089752|3560934|FG001|STARTED|Overall Study||140
2858273|NCT00089752|3560933|FG000|COMPLETED|Overall Study||121
2858274|NCT00089752|3560934|FG001|COMPLETED|Overall Study||118
2858275|NCT00089752|3560933|FG000|NOT COMPLETED|Overall Study||20
2858276|NCT00089752|3560934|FG001|NOT COMPLETED|Overall Study||22
2858277|NCT00089778|3560945|FG000|STARTED|Overall Study||2
2858278|NCT00089778|3560946|FG001|STARTED|Overall Study||1
2858279|NCT00089778|3560947|FG002|STARTED|Overall Study||8
2858280|NCT00089778|3560945|FG000|COMPLETED|Overall Study||2
2858281|NCT00089778|3560946|FG001|COMPLETED|Overall Study||1
2858282|NCT00089778|3560947|FG002|COMPLETED|Overall Study||7
2858283|NCT00089778|3560945|FG000|NOT COMPLETED|Overall Study||0
2858284|NCT00089778|3560946|FG001|NOT COMPLETED|Overall Study||0
2858285|NCT00089778|3560947|FG002|NOT COMPLETED|Overall Study||1
2858286|NCT00089791|3560959|FG000|STARTED|Overall Study||3906
2858287|NCT00089791|3560960|FG001|STARTED|Overall Study||3902
2858288|NCT00089791|3560959|FG000|Received Study Medication|Overall Study||3883
2858289|NCT00089791|3560960|FG001|Received Study Medication|Overall Study||3879
2858290|NCT00089791|3560959|FG000|Safety Analysis Set|Overall Study|7 participants in the placebo arm received ≥1 dose of denosumab & were analyzed in the denosumab arm|3876
2858291|NCT00089791|3560960|FG001|Safety Analysis Set|Overall Study||3886
2858292|NCT00089791|3560959|FG000|COMPLETED|Overall Study||3206
2858293|NCT00089791|3560960|FG001|COMPLETED|Overall Study||3272
2858294|NCT00089791|3560959|FG000|NOT COMPLETED|Overall Study||700
2858295|NCT00089791|3560960|FG001|NOT COMPLETED|Overall Study||630
2858296|NCT00089843|3560970|FG000|STARTED|Overall Study||19
2858297|NCT00089843|3560971|FG001|STARTED|Overall Study||20
2858298|NCT00089843|3560972|FG002|STARTED|Overall Study||20
2858299|NCT00089843|3560973|FG003|STARTED|Overall Study||18
2858300|NCT00089843|3560970|FG000|COMPLETED|Overall Study||17
2858301|NCT00089843|3560971|FG001|COMPLETED|Overall Study||16
2858302|NCT00089843|3560972|FG002|COMPLETED|Overall Study||15
2858303|NCT00089843|3560973|FG003|COMPLETED|Overall Study||11
2858304|NCT00089843|3560970|FG000|NOT COMPLETED|Overall Study||2
2858305|NCT00089843|3560971|FG001|NOT COMPLETED|Overall Study||4
2858306|NCT00089843|3560972|FG002|NOT COMPLETED|Overall Study||5
2858307|NCT00089843|3560973|FG003|NOT COMPLETED|Overall Study||7
2858308|NCT00089973|3560983|FG000|STARTED|Overall Study||50
2858309|NCT00089973|3560983|FG000|COMPLETED|Overall Study||0
2858310|NCT00089973|3560983|FG000|NOT COMPLETED|Overall Study||50
2858311|NCT00089986|3560990|FG000|STARTED|Overall Study||599
2858312|NCT00089986|3560991|FG001|STARTED|Overall Study||598
2858313|NCT00089986|3560992|FG002|STARTED|Overall Study||182
2858314|NCT00089986|3560990|FG000|COMPLETED|Overall Study||584
2858315|NCT00089986|3560991|FG001|COMPLETED|Overall Study||574
2858316|NCT00089986|3560992|FG002|COMPLETED|Overall Study||172
2858317|NCT00089986|3560990|FG000|NOT COMPLETED|Overall Study||15
2858318|NCT00089986|3560991|FG001|NOT COMPLETED|Overall Study||24
2858319|NCT00089986|3560992|FG002|NOT COMPLETED|Overall Study||10
2858320|NCT00089999|3561002|FG000|STARTED|Overall Study||69
2858321|NCT00089999|3561003|FG001|STARTED|Overall Study||69
2858322|NCT00089999|3561002|FG000|COMPLETED|Overall Study||0
2858323|NCT00089999|3561003|FG001|COMPLETED|Overall Study||0
2858324|NCT00089999|3561002|FG000|NOT COMPLETED|Overall Study||69
2858325|NCT00089999|3561003|FG001|NOT COMPLETED|Overall Study||69
2858326|NCT00090051|3561012|FG000|STARTED|Overall Study||276
2858327|NCT00090051|3561013|FG001|STARTED|Overall Study||276
2858328|NCT00090051|3561012|FG000|Safety Population; Received Study Drug|Overall Study||272
2858329|NCT00090051|3561013|FG001|Safety Population; Received Study Drug|Overall Study||274
2858330|NCT00090051|3561012|FG000|COMPLETED|Overall Study|Completed 6 Cycles of Treatment|167
2858331|NCT00090051|3561013|FG001|COMPLETED|Overall Study|Completed 6 Cycles of Treatment|181
2858332|NCT00090051|3561012|FG000|NOT COMPLETED|Overall Study||109
2858333|NCT00090051|3561013|FG001|NOT COMPLETED|Overall Study||95
2858334|NCT00090064|3561021|FG000|STARTED|Overall Study||15
2858335|NCT00090064|3561022|FG001|STARTED|Overall Study||8
2858336|NCT00090064|3561021|FG000|COMPLETED|Overall Study||12
2858337|NCT00090064|3561022|FG001|COMPLETED|Overall Study||8
2858338|NCT00090064|3561021|FG000|NOT COMPLETED|Overall Study||3
2858339|NCT00090064|3561022|FG001|NOT COMPLETED|Overall Study||0
2858340|NCT00090103|3561034|FG000|STARTED|Four-Year Double-Blind Treatment Period||1610
2858341|NCT00090103|3561035|FG001|STARTED|Four-Year Double-Blind Treatment Period||1623
2858342|NCT00090103|3561036|FG002|STARTED|Four-Year Double-Blind Treatment Period||1611
2858343|NCT00090103|3561034|FG000|COMPLETED|Four-Year Double-Blind Treatment Period||1113
2858344|NCT00090103|3561035|FG001|COMPLETED|Four-Year Double-Blind Treatment Period||1093
2858345|NCT00090103|3561036|FG002|COMPLETED|Four-Year Double-Blind Treatment Period||989
2858346|NCT00090103|3561034|FG000|NOT COMPLETED|Four-Year Double-Blind Treatment Period||497
2858347|NCT00090103|3561035|FG001|NOT COMPLETED|Four-Year Double-Blind Treatment Period||530
2858348|NCT00090103|3561036|FG002|NOT COMPLETED|Four-Year Double-Blind Treatment Period||622
2858349|NCT00090103|3561034|FG000|STARTED|16-Week Safety Follow-up Period|Some par. didn't enter the Follow-up phase or dropped out before completing the treatment phase.|1598
2858350|NCT00090103|3561035|FG001|STARTED|16-Week Safety Follow-up Period|Some par. didn't enter the Follow-up phase or dropped out before completing the treatment phase.|1615
2858351|NCT00090103|3561036|FG002|STARTED|16-Week Safety Follow-up Period|Some par. didn't enter the Follow-up phase or dropped out before completing the treatment phase.|1600
2858352|NCT00090103|3561034|FG000|COMPLETED|16-Week Safety Follow-up Period||1224
2858353|NCT00090103|3561035|FG001|COMPLETED|16-Week Safety Follow-up Period||1205
2858354|NCT00090103|3561036|FG002|COMPLETED|16-Week Safety Follow-up Period||1143
2858355|NCT00090103|3561034|FG000|NOT COMPLETED|16-Week Safety Follow-up Period||374
2858356|NCT00090103|3561035|FG001|NOT COMPLETED|16-Week Safety Follow-up Period||410
2858357|NCT00090103|3561036|FG002|NOT COMPLETED|16-Week Safety Follow-up Period||457
2858358|NCT00090220|3561046|FG000|STARTED|Base Study Vaccination Period||1911
2858359|NCT00090220|3561047|FG001|STARTED|Base Study Vaccination Period||1908
2858360|NCT00090220|3561048|FG002|STARTED|Base Study Vaccination Period||0
2858361|NCT00090220|3561049|FG003|STARTED|Base Study Vaccination Period||0
2858362|NCT00090220|3561050|FG004|STARTED|Base Study Vaccination Period||0
2858363|NCT00090220|3561051|FG005|STARTED|Base Study Vaccination Period||0
2858364|NCT00090220|3561046|FG000|Vaccinated|Base Study Vaccination Period||1910
2858365|NCT00090220|3561047|FG001|Vaccinated|Base Study Vaccination Period||1907
2858366|NCT00090220|3561048|FG002|Vaccinated|Base Study Vaccination Period||0
2858367|NCT00090220|3561049|FG003|Vaccinated|Base Study Vaccination Period||0
2858368|NCT00090220|3561050|FG004|Vaccinated|Base Study Vaccination Period||0
2858369|NCT00090220|3561051|FG005|Vaccinated|Base Study Vaccination Period||0
2858370|NCT00090220|3561046|FG000|COMPLETED|Base Study Vaccination Period||1847
2858371|NCT00090220|3561047|FG001|COMPLETED|Base Study Vaccination Period||1845
2858372|NCT00090220|3561048|FG002|COMPLETED|Base Study Vaccination Period||0
2858373|NCT00090220|3561049|FG003|COMPLETED|Base Study Vaccination Period||0
2858374|NCT00090220|3561050|FG004|COMPLETED|Base Study Vaccination Period||0
2858375|NCT00090220|3561051|FG005|COMPLETED|Base Study Vaccination Period||0
2858376|NCT00090220|3561046|FG000|NOT COMPLETED|Base Study Vaccination Period||64
2858377|NCT00090220|3561047|FG001|NOT COMPLETED|Base Study Vaccination Period||63
2858378|NCT00090220|3561048|FG002|NOT COMPLETED|Base Study Vaccination Period||0
2858379|NCT00090220|3561049|FG003|NOT COMPLETED|Base Study Vaccination Period||0
3168829|NCT01921517|3896266|FG001|COMPLETED|Overall Study||29
3168830|NCT01921517|3896265|FG000|NOT COMPLETED|Overall Study||15
3168831|NCT01921517|3896266|FG001|NOT COMPLETED|Overall Study||9
3168832|NCT01921634|3896272|FG000|STARTED|Overall Study||300
3168833|NCT01921634|3896272|FG000|COMPLETED|Overall Study||300
2858380|NCT00090220|3561050|FG004|NOT COMPLETED|Base Study Vaccination Period||0
2858381|NCT00090220|3561051|FG005|NOT COMPLETED|Base Study Vaccination Period||0
2858382|NCT00090220|3561046|FG000|STARTED|Base Study Follow-up Period|8 participants did not complete the Vaccination Period but entered the Follow-up Period.|1855
2858383|NCT00090220|3561047|FG001|STARTED|Base Study Follow-up Period|5 participants did not complete the Vaccination Period but entered the Follow-up Period.|1851
2858384|NCT00090220|3561048|FG002|STARTED|Base Study Follow-up Period||0
2858385|NCT00090220|3561049|FG003|STARTED|Base Study Follow-up Period||0
2858386|NCT00090220|3561050|FG004|STARTED|Base Study Follow-up Period||0
2858387|NCT00090220|3561051|FG005|STARTED|Base Study Follow-up Period||0
2858388|NCT00090220|3561046|FG000|COMPLETED|Base Study Follow-up Period||1695
2858389|NCT00090220|3561047|FG001|COMPLETED|Base Study Follow-up Period||1687
2858390|NCT00090220|3561048|FG002|COMPLETED|Base Study Follow-up Period||0
2858391|NCT00090220|3561049|FG003|COMPLETED|Base Study Follow-up Period||0
2858392|NCT00090220|3561050|FG004|COMPLETED|Base Study Follow-up Period||0
2858393|NCT00090220|3561051|FG005|COMPLETED|Base Study Follow-up Period||0
2858394|NCT00090220|3561046|FG000|NOT COMPLETED|Base Study Follow-up Period||160
2858395|NCT00090220|3561047|FG001|NOT COMPLETED|Base Study Follow-up Period||164
2858396|NCT00090220|3561048|FG002|NOT COMPLETED|Base Study Follow-up Period||0
2858397|NCT00090220|3561049|FG003|NOT COMPLETED|Base Study Follow-up Period||0
2858398|NCT00090220|3561050|FG004|NOT COMPLETED|Base Study Follow-up Period||0
2858399|NCT00090220|3561051|FG005|NOT COMPLETED|Base Study Follow-up Period||0
2858400|NCT00090220|3561046|FG000|STARTED|Extension 1 (EXT1)||0
2858401|NCT00090220|3561047|FG001|STARTED|Extension 1 (EXT1)||0
2858402|NCT00090220|3561048|FG002|STARTED|Extension 1 (EXT1)|Participation in EXT1 was voluntary; not all participants eligible for EXT1 enrolled.|1322
2858403|NCT00090220|3561049|FG003|STARTED|Extension 1 (EXT1)|Participation in EXT1 was voluntary; not all participants eligible for EXT1 enrolled.|7
3168834|NCT01921634|3896272|FG000|NOT COMPLETED|Overall Study||0
2858404|NCT00090220|3561050|FG004|STARTED|Extension 1 (EXT1)||0
2858405|NCT00090220|3561051|FG005|STARTED|Extension 1 (EXT1)||0
2858406|NCT00090220|3561046|FG000|Vaccinated|Extension 1 (EXT1)||0
2858407|NCT00090220|3561047|FG001|Vaccinated|Extension 1 (EXT1)||0
2858408|NCT00090220|3561048|FG002|Vaccinated|Extension 1 (EXT1)||1321
2858409|NCT00090220|3561049|FG003|Vaccinated|Extension 1 (EXT1)||7
2858410|NCT00090220|3561050|FG004|Vaccinated|Extension 1 (EXT1)||0
2858411|NCT00090220|3561051|FG005|Vaccinated|Extension 1 (EXT1)||0
2858412|NCT00090220|3561046|FG000|COMPLETED|Extension 1 (EXT1)||0
2858413|NCT00090220|3561047|FG001|COMPLETED|Extension 1 (EXT1)||0
2858414|NCT00090220|3561048|FG002|COMPLETED|Extension 1 (EXT1)||1267
2858415|NCT00090220|3561049|FG003|COMPLETED|Extension 1 (EXT1)||5
2858416|NCT00090220|3561050|FG004|COMPLETED|Extension 1 (EXT1)||0
2858417|NCT00090220|3561051|FG005|COMPLETED|Extension 1 (EXT1)||0
2858418|NCT00090220|3561046|FG000|NOT COMPLETED|Extension 1 (EXT1)||0
2858419|NCT00090220|3561047|FG001|NOT COMPLETED|Extension 1 (EXT1)||0
2858420|NCT00090220|3561048|FG002|NOT COMPLETED|Extension 1 (EXT1)||55
2858421|NCT00090220|3561049|FG003|NOT COMPLETED|Extension 1 (EXT1)||2
2858422|NCT00090220|3561050|FG004|NOT COMPLETED|Extension 1 (EXT1)||0
2858423|NCT00090220|3561051|FG005|NOT COMPLETED|Extension 1 (EXT1)||0
2858424|NCT00090220|3561046|FG000|STARTED|Long-term Follow-up (EXT2)||0
2858425|NCT00090220|3561047|FG001|STARTED|Long-term Follow-up (EXT2)||0
2858426|NCT00090220|3561048|FG002|STARTED|Long-term Follow-up (EXT2)||0
2858427|NCT00090220|3561049|FG003|STARTED|Long-term Follow-up (EXT2)||0
2858428|NCT00090220|3561050|FG004|STARTED|Long-term Follow-up (EXT2)|Participation in LTFU was voluntary; not all participants eligible for LTFU enrolled.|685
2858429|NCT00090220|3561051|FG005|STARTED|Long-term Follow-up (EXT2)|Participation in LTFU was voluntary; not all participants eligible for LTFU enrolled.|651
2858430|NCT00090220|3561046|FG000|COMPLETED|Long-term Follow-up (EXT2)||0
2858431|NCT00090220|3561047|FG001|COMPLETED|Long-term Follow-up (EXT2)||0
2858432|NCT00090220|3561048|FG002|COMPLETED|Long-term Follow-up (EXT2)||0
2858433|NCT00090220|3561049|FG003|COMPLETED|Long-term Follow-up (EXT2)||0
2858434|NCT00090220|3561050|FG004|COMPLETED|Long-term Follow-up (EXT2)||641
2858435|NCT00090220|3561051|FG005|COMPLETED|Long-term Follow-up (EXT2)||623
2858436|NCT00090220|3561046|FG000|NOT COMPLETED|Long-term Follow-up (EXT2)||0
2858437|NCT00090220|3561047|FG001|NOT COMPLETED|Long-term Follow-up (EXT2)||0
2858438|NCT00090220|3561048|FG002|NOT COMPLETED|Long-term Follow-up (EXT2)||0
2858439|NCT00090220|3561049|FG003|NOT COMPLETED|Long-term Follow-up (EXT2)||0
2858440|NCT00090220|3561050|FG004|NOT COMPLETED|Long-term Follow-up (EXT2)||44
2858441|NCT00090220|3561051|FG005|NOT COMPLETED|Long-term Follow-up (EXT2)||28
2858442|NCT00090233|3561070|FG000|STARTED|Overall Study|Evaluated by data safety monitoring board (DSMB) when they recommended stopping enrollment|34644
2858443|NCT00090233|3561071|FG001|STARTED|Overall Study|Evaluated by data safety monitoring board when they recommended stopping enrollment|34630
2858444|NCT00090233|3561070|FG000|Vaccinated at Visit 1|Overall Study|Randomized Not vaccinated 609|34035
2858445|NCT00090233|3561071|FG001|Vaccinated at Visit 1|Overall Study|Randomized Not vaccinated 627|34003
2858446|NCT00090233|3561070|FG000|Vaccinated at Visit 2|Overall Study||31052
2858447|NCT00090233|3561071|FG001|Vaccinated at Visit 2|Overall Study||31066
2858448|NCT00090233|3561070|FG000|Vaccinated at Visit 3|Overall Study||29667
2858449|NCT00090233|3561071|FG001|Vaccinated at Visit 3|Overall Study||29598
2858450|NCT00090233|3561070|FG000|COMPLETED|Overall Study|Does not include participants who discontinued prior to the 42 day safety follow-up|29645
2858451|NCT00090233|3561071|FG001|COMPLETED|Overall Study|Does not include participants who discontinued prior to the 42 day safety follow-up|29565
2858452|NCT00090233|3561070|FG000|NOT COMPLETED|Overall Study||4999
2858453|NCT00090233|3561071|FG001|NOT COMPLETED|Overall Study||5065
2858454|NCT00090285|3561083|FG000|STARTED|Base Study Vaccination Period||2032
2858455|NCT00090285|3561084|FG001|STARTED|Base Study Vaccination Period||2033
2858456|NCT00090285|3561085|FG002|STARTED|Base Study Vaccination Period||0
2858457|NCT00090285|3561086|FG003|STARTED|Base Study Vaccination Period||0
3168835|NCT01921751|3896280|FG000|STARTED|Overall Study||4
3168836|NCT01921751|3896281|FG001|STARTED|Overall Study||4
3168837|NCT01921751|3896282|FG002|STARTED|Overall Study||5
3168838|NCT01921751|3896280|FG000|COMPLETED|Overall Study|All randomized patients are reported here.|4
3168839|NCT01921751|3896281|FG001|COMPLETED|Overall Study|All randomized patients are reported here.|4
2858458|NCT00090285|3561087|FG004|STARTED|Base Study Vaccination Period||0
2858459|NCT00090285|3561088|FG005|STARTED|Base Study Vaccination Period||0
2858460|NCT00090285|3561083|FG000|Vaccinated|Base Study Vaccination Period||2025
2858461|NCT00090285|3561084|FG001|Vaccinated|Base Study Vaccination Period||2030
2858462|NCT00090285|3561085|FG002|Vaccinated|Base Study Vaccination Period||0
2858463|NCT00090285|3561086|FG003|Vaccinated|Base Study Vaccination Period||0
2858464|NCT00090285|3561087|FG004|Vaccinated|Base Study Vaccination Period||0
2858465|NCT00090285|3561088|FG005|Vaccinated|Base Study Vaccination Period||0
2858466|NCT00090285|3561083|FG000|COMPLETED|Base Study Vaccination Period||1818
2858467|NCT00090285|3561084|FG001|COMPLETED|Base Study Vaccination Period||1814
2858468|NCT00090285|3561085|FG002|COMPLETED|Base Study Vaccination Period||0
2858469|NCT00090285|3561086|FG003|COMPLETED|Base Study Vaccination Period||0
2858470|NCT00090285|3561087|FG004|COMPLETED|Base Study Vaccination Period||0
2858471|NCT00090285|3561088|FG005|COMPLETED|Base Study Vaccination Period||0
2858472|NCT00090285|3561083|FG000|NOT COMPLETED|Base Study Vaccination Period||214
2858473|NCT00090285|3561084|FG001|NOT COMPLETED|Base Study Vaccination Period||219
2858474|NCT00090285|3561085|FG002|NOT COMPLETED|Base Study Vaccination Period||0
2858475|NCT00090285|3561086|FG003|NOT COMPLETED|Base Study Vaccination Period||0
2858476|NCT00090285|3561087|FG004|NOT COMPLETED|Base Study Vaccination Period||0
2858477|NCT00090285|3561088|FG005|NOT COMPLETED|Base Study Vaccination Period||0
2858478|NCT00090285|3561083|FG000|STARTED|Base Study Follow-up Period|4 subjects who did not receive 3 doses of vaccine in base study continued into the Follow-up Period|1822
2858479|NCT00090285|3561084|FG001|STARTED|Base Study Follow-up Period|7 subjects who did not receive 3 doses of placebo in base study continued into the Follow-up Period|1821
2858480|NCT00090285|3561085|FG002|STARTED|Base Study Follow-up Period||0
2858481|NCT00090285|3561086|FG003|STARTED|Base Study Follow-up Period||0
2858482|NCT00090285|3561087|FG004|STARTED|Base Study Follow-up Period||0
2858483|NCT00090285|3561088|FG005|STARTED|Base Study Follow-up Period||0
2858484|NCT00090285|3561083|FG000|COMPLETED|Base Study Follow-up Period||1487
2858485|NCT00090285|3561084|FG001|COMPLETED|Base Study Follow-up Period||1479
2858486|NCT00090285|3561085|FG002|COMPLETED|Base Study Follow-up Period||0
2858487|NCT00090285|3561086|FG003|COMPLETED|Base Study Follow-up Period||0
2858488|NCT00090285|3561087|FG004|COMPLETED|Base Study Follow-up Period||0
2858489|NCT00090285|3561088|FG005|COMPLETED|Base Study Follow-up Period||0
2858490|NCT00090285|3561083|FG000|NOT COMPLETED|Base Study Follow-up Period||335
2858491|NCT00090285|3561084|FG001|NOT COMPLETED|Base Study Follow-up Period||342
3313402|NCT03075410|4046797|FG006|NOT COMPLETED|Part A-Period 2 (14 Days)||0
3313403|NCT03075410|4046798|FG007|NOT COMPLETED|Part A-Period 2 (14 Days)||0
3313404|NCT03075410|4046799|FG008|NOT COMPLETED|Part A-Period 2 (14 Days)||0
3313405|NCT03075410|4046791|FG000|STARTED|Part A-Washout Period 2 (14 Days)||1
3313406|NCT03075410|4046792|FG001|STARTED|Part A-Washout Period 2 (14 Days)||1
3313407|NCT03075410|4046793|FG002|STARTED|Part A-Washout Period 2 (14 Days)||1
3313408|NCT03075410|4046794|FG003|STARTED|Part A-Washout Period 2 (14 Days)||1
3313409|NCT03075410|4046795|FG004|STARTED|Part A-Washout Period 2 (14 Days)||2
2858492|NCT00090285|3561085|FG002|NOT COMPLETED|Base Study Follow-up Period||0
2858493|NCT00090285|3561086|FG003|NOT COMPLETED|Base Study Follow-up Period||0
2858494|NCT00090285|3561087|FG004|NOT COMPLETED|Base Study Follow-up Period||0
2858495|NCT00090285|3561088|FG005|NOT COMPLETED|Base Study Follow-up Period||0
2858496|NCT00090285|3561083|FG000|STARTED|Extension 1||0
2858497|NCT00090285|3561084|FG001|STARTED|Extension 1||0
2858498|NCT00090285|3561085|FG002|STARTED|Extension 1|Participation in EXT1 was voluntary; not all participants eligible for EXT1 enrolled.|1098
2858499|NCT00090285|3561086|FG003|STARTED|Extension 1|Participation in EXT1 was voluntary; not all participants eligible for EXT1 enrolled.|16
2858500|NCT00090285|3561087|FG004|STARTED|Extension 1||0
2858501|NCT00090285|3561088|FG005|STARTED|Extension 1||0
2858502|NCT00090285|3561083|FG000|COMPLETED|Extension 1||0
2858503|NCT00090285|3561084|FG001|COMPLETED|Extension 1||0
2858504|NCT00090285|3561085|FG002|COMPLETED|Extension 1||1041
2858505|NCT00090285|3561086|FG003|COMPLETED|Extension 1||15
2858506|NCT00090285|3561087|FG004|COMPLETED|Extension 1||0
2858507|NCT00090285|3561088|FG005|COMPLETED|Extension 1||0
2858508|NCT00090285|3561083|FG000|NOT COMPLETED|Extension 1||0
2858509|NCT00090285|3561084|FG001|NOT COMPLETED|Extension 1||0
2858510|NCT00090285|3561085|FG002|NOT COMPLETED|Extension 1||57
2858511|NCT00090285|3561086|FG003|NOT COMPLETED|Extension 1||1
2858512|NCT00090285|3561087|FG004|NOT COMPLETED|Extension 1||0
2858513|NCT00090285|3561088|FG005|NOT COMPLETED|Extension 1||0
2858514|NCT00090285|3561083|FG000|STARTED|Long-term Follow-up (EXT2)||0
2858515|NCT00090285|3561084|FG001|STARTED|Long-term Follow-up (EXT2)||0
2858516|NCT00090285|3561085|FG002|STARTED|Long-term Follow-up (EXT2)||0
2858517|NCT00090285|3561086|FG003|STARTED|Long-term Follow-up (EXT2)||0
2858518|NCT00090285|3561087|FG004|STARTED|Long-term Follow-up (EXT2)|Not all eligible participants enrolled in LTFU (EXT2)|936
2858519|NCT00090285|3561088|FG005|STARTED|Long-term Follow-up (EXT2)|Not all eligible participants enrolled in LTFU (EXT2)|867
2858520|NCT00090285|3561083|FG000|COMPLETED|Long-term Follow-up (EXT2)||0
2858521|NCT00090285|3561084|FG001|COMPLETED|Long-term Follow-up (EXT2)||0
2858522|NCT00090285|3561085|FG002|COMPLETED|Long-term Follow-up (EXT2)||0
2858523|NCT00090285|3561086|FG003|COMPLETED|Long-term Follow-up (EXT2)||0
2858524|NCT00090285|3561087|FG004|COMPLETED|Long-term Follow-up (EXT2)||709
2858525|NCT00090285|3561088|FG005|COMPLETED|Long-term Follow-up (EXT2)||664
2858526|NCT00090285|3561083|FG000|NOT COMPLETED|Long-term Follow-up (EXT2)||0
2858527|NCT00090285|3561084|FG001|NOT COMPLETED|Long-term Follow-up (EXT2)||0
2858528|NCT00090285|3561085|FG002|NOT COMPLETED|Long-term Follow-up (EXT2)||0
2858529|NCT00090285|3561086|FG003|NOT COMPLETED|Long-term Follow-up (EXT2)||0
2858530|NCT00090285|3561087|FG004|NOT COMPLETED|Long-term Follow-up (EXT2)||227
2858531|NCT00090285|3561088|FG005|NOT COMPLETED|Long-term Follow-up (EXT2)||203
2858532|NCT00090363|3561106|FG000|STARTED|Overall Study||107
2858533|NCT00090363|3561107|FG001|STARTED|Overall Study||107
2858534|NCT00090363|3561108|FG002|STARTED|Overall Study||98
2858535|NCT00090363|3561106|FG000|Received Study Treatment.|Overall Study||107
2858536|NCT00090363|3561107|FG001|Received Study Treatment.|Overall Study||107
2858537|NCT00090363|3561108|FG002|Received Study Treatment.|Overall Study||98
2858538|NCT00090363|3561106|FG000|COMPLETED|Overall Study|Number of patients receiving study treatment at data cut-off (18th December 2008).|1
2858539|NCT00090363|3561107|FG001|COMPLETED|Overall Study|Number of patients receiving study treatment at data cut-off (18th December 2008).|0
2858540|NCT00090363|3561108|FG002|COMPLETED|Overall Study|Number of patients receiving study treatment at data cut-off (18th December 2008).|2
2858541|NCT00090363|3561106|FG000|NOT COMPLETED|Overall Study||106
2858542|NCT00090363|3561107|FG001|NOT COMPLETED|Overall Study||107
3168840|NCT01921751|3896282|FG002|COMPLETED|Overall Study|All randomized patients are reported here.|5
3313410|NCT03075410|4046796|FG005|STARTED|Part A-Washout Period 2 (14 Days)||1
3168841|NCT01921751|3896280|FG000|NOT COMPLETED|Overall Study||0
3168842|NCT01921751|3896281|FG001|NOT COMPLETED|Overall Study||0
3168843|NCT01921751|3896282|FG002|NOT COMPLETED|Overall Study||0
3168844|NCT01921829|3896293|FG000|STARTED|Overall Study||10
2858543|NCT00090363|3561108|FG002|NOT COMPLETED|Overall Study||96
2918350|NCT00526123|3628536|FG001|NOT COMPLETED|Overall Study||246
2918351|NCT00526162|3628542|FG000|STARTED|Overall Study||83
2918352|NCT00526162|3628542|FG000|COMPLETED|Overall Study||80
2918353|NCT00526162|3628542|FG000|NOT COMPLETED|Overall Study||3
2918354|NCT00526188|3628550|FG000|STARTED|Overall Study||234
2918355|NCT00526188|3628550|FG000|COMPLETED|Overall Study||234
2918356|NCT00526188|3628550|FG000|NOT COMPLETED|Overall Study||0
2918357|NCT00526292|3628554|FG000|STARTED|Overall Study||6
2918358|NCT00526292|3628554|FG000|COMPLETED|Overall Study||6
2918359|NCT00526292|3628554|FG000|NOT COMPLETED|Overall Study||0
2918360|NCT00526474|3628560|FG000|STARTED|Overall Study||13224
2918361|NCT00526474|3628561|FG001|STARTED|Overall Study||13225
2918362|NCT00526474|3628560|FG000|Received Study Drug|Overall Study||13166
2918363|NCT00526474|3628561|FG001|Received Study Drug|Overall Study||13186
2918364|NCT00526474|3628560|FG000|COMPLETED|Overall Study||12932
2918365|NCT00526474|3628561|FG001|COMPLETED|Overall Study||12953
2918366|NCT00526474|3628560|FG000|NOT COMPLETED|Overall Study||292
2918367|NCT00526474|3628561|FG001|NOT COMPLETED|Overall Study||272
2918368|NCT00526591|3628569|FG000|STARTED|Overall Study||8
2918369|NCT00526591|3628570|FG001|STARTED|Overall Study||9
2918370|NCT00526591|3628569|FG000|COMPLETED|Overall Study||8
2918371|NCT00526591|3628570|FG001|COMPLETED|Overall Study||9
2918372|NCT00526591|3628569|FG000|NOT COMPLETED|Overall Study||0
2918373|NCT00526591|3628570|FG001|NOT COMPLETED|Overall Study||0
2918374|NCT00526630|3628578|FG000|STARTED|First Intervention Period - 12 Weeks||12
2918375|NCT00526630|3628579|FG001|STARTED|First Intervention Period - 12 Weeks||11
2918376|NCT00526630|3628578|FG000|COMPLETED|First Intervention Period - 12 Weeks||12
2918377|NCT00526630|3628579|FG001|COMPLETED|First Intervention Period - 12 Weeks||8
2918378|NCT00526630|3628578|FG000|NOT COMPLETED|First Intervention Period - 12 Weeks||0
2918379|NCT00526630|3628579|FG001|NOT COMPLETED|First Intervention Period - 12 Weeks||3
2918380|NCT00526630|3628578|FG000|STARTED|Second Intervention Period - 12 Weeks||12
2918381|NCT00526630|3628579|FG001|STARTED|Second Intervention Period - 12 Weeks||8
2918382|NCT00526630|3628578|FG000|COMPLETED|Second Intervention Period - 12 Weeks||10
2918383|NCT00526630|3628579|FG001|COMPLETED|Second Intervention Period - 12 Weeks||7
2918384|NCT00526630|3628578|FG000|NOT COMPLETED|Second Intervention Period - 12 Weeks||2
2918385|NCT00526630|3628579|FG001|NOT COMPLETED|Second Intervention Period - 12 Weeks||1
2918386|NCT00526656|3628587|FG000|STARTED|Overall Study||9
2918387|NCT00526656|3628587|FG000|COMPLETED|Overall Study||7
2918388|NCT00526656|3628587|FG000|NOT COMPLETED|Overall Study||2
2918389|NCT00526669|3628592|FG000|STARTED|7-Day Run-in Monotherapy Treatment Phase||67
2918390|NCT00526669|3628593|FG001|STARTED|7-Day Run-in Monotherapy Treatment Phase||0
2918391|NCT00526669|3628592|FG000|COMPLETED|7-Day Run-in Monotherapy Treatment Phase||67
2918392|NCT00526669|3628593|FG001|COMPLETED|7-Day Run-in Monotherapy Treatment Phase||0
2918393|NCT00526669|3628592|FG000|NOT COMPLETED|7-Day Run-in Monotherapy Treatment Phase||0
2918394|NCT00526669|3628593|FG001|NOT COMPLETED|7-Day Run-in Monotherapy Treatment Phase||0
2918395|NCT00526669|3628592|FG000|STARTED|Combined Treatment Phase||0
2918396|NCT00526669|3628593|FG001|STARTED|Combined Treatment Phase||67
2918397|NCT00526669|3628592|FG000|COMPLETED|Combined Treatment Phase||0
2918398|NCT00526669|3628593|FG001|COMPLETED|Combined Treatment Phase||59
2918399|NCT00526669|3628592|FG000|NOT COMPLETED|Combined Treatment Phase||0
2918400|NCT00526669|3628593|FG001|NOT COMPLETED|Combined Treatment Phase||8
2918401|NCT00526799|3628601|FG000|STARTED|Overall Study||16
2918402|NCT00526799|3628602|FG001|STARTED|Overall Study||14
2918403|NCT00526799|3628601|FG000|COMPLETED|Overall Study||15
2918404|NCT00526799|3628602|FG001|COMPLETED|Overall Study||13
2918405|NCT00526799|3628601|FG000|NOT COMPLETED|Overall Study||1
2918406|NCT00526799|3628602|FG001|NOT COMPLETED|Overall Study||1
2918407|NCT00526890|3628608|FG000|STARTED|Overall Study||16
2918408|NCT00526890|3628608|FG000|COMPLETED|Overall Study||14
2918409|NCT00526890|3628608|FG000|NOT COMPLETED|Overall Study||2
2918410|NCT00526994|3628615|FG000|STARTED|Overall Study||909
2918411|NCT00526994|3628616|FG001|STARTED|Overall Study||893
2918412|NCT00526994|3628617|FG002|STARTED|Overall Study||898
2918413|NCT00526994|3628615|FG000|COMPLETED|Overall Study||801
2918414|NCT00526994|3628616|FG001|COMPLETED|Overall Study||772
2918415|NCT00526994|3628617|FG002|COMPLETED|Overall Study||791
2918416|NCT00526994|3628615|FG000|NOT COMPLETED|Overall Study||108
2918417|NCT00526994|3628616|FG001|NOT COMPLETED|Overall Study||121
2918418|NCT00526994|3628617|FG002|NOT COMPLETED|Overall Study||107
2918419|NCT00527072|3628625|FG000|STARTED|Overall Study||215
2918420|NCT00527072|3628625|FG000|COMPLETED|Overall Study||179
2918421|NCT00527072|3628625|FG000|NOT COMPLETED|Overall Study||36
2918422|NCT00527098|3628632|FG000|STARTED|Overall Study||36
2918423|NCT00527098|3628633|FG001|STARTED|Overall Study||83
2918424|NCT00527098|3628632|FG000|COMPLETED|Overall Study||36
2918425|NCT00527098|3628633|FG001|COMPLETED|Overall Study||83
2918426|NCT00527098|3628632|FG000|NOT COMPLETED|Overall Study||0
2918427|NCT00527098|3628633|FG001|NOT COMPLETED|Overall Study||0
2918428|NCT00527111|3628640|FG000|STARTED|Overall Study||70
2918429|NCT00527111|3628641|FG001|STARTED|Overall Study||69
3168845|NCT01921829|3896294|FG001|STARTED|Overall Study||9
3168846|NCT01921829|3896293|FG000|COMPLETED|Overall Study||10
2858544|NCT00090402|3561119|FG000|STARTED|Overall Study||13
2858545|NCT00090402|3561120|FG001|STARTED|Overall Study||13
2858546|NCT00090402|3561121|FG002|STARTED|Overall Study||13
2858547|NCT00090402|3561119|FG000|COMPLETED|Overall Study||11
2858548|NCT00090402|3561120|FG001|COMPLETED|Overall Study||11
2858549|NCT00090402|3561121|FG002|COMPLETED|Overall Study||12
2858550|NCT00090402|3561119|FG000|NOT COMPLETED|Overall Study||2
2858551|NCT00090402|3561120|FG001|NOT COMPLETED|Overall Study||2
2858552|NCT00090402|3561121|FG002|NOT COMPLETED|Overall Study||1
2858553|NCT00090493|3561132|FG000|STARTED|Overall Study||4
2858554|NCT00090493|3561132|FG000|COMPLETED|Overall Study||2
2858555|NCT00090493|3561132|FG000|NOT COMPLETED|Overall Study||2
2858556|NCT00090519|3561138|FG000|STARTED|Overall Study||371
2858557|NCT00090519|3561139|FG001|STARTED|Overall Study||360
2858558|NCT00090519|3561138|FG000|COMPLETED|Overall Study||298
2858559|NCT00090519|3561139|FG001|COMPLETED|Overall Study||285
2858560|NCT00090519|3561138|FG000|NOT COMPLETED|Overall Study||73
2858561|NCT00090519|3561139|FG001|NOT COMPLETED|Overall Study||75
3168847|NCT01921829|3896294|FG001|COMPLETED|Overall Study||8
3168848|NCT01921829|3896293|FG000|NOT COMPLETED|Overall Study||0
3168849|NCT01921829|3896294|FG001|NOT COMPLETED|Overall Study||1
3168850|NCT01921894|3896303|FG000|STARTED|Overall Study||8
2858562|NCT00090545|3561147|FG000|STARTED|Overall Study||22
2858563|NCT00090545|3561148|FG001|STARTED|Overall Study||24
2858564|NCT00090545|3561147|FG000|COMPLETED|Overall Study||0
2858565|NCT00090545|3561148|FG001|COMPLETED|Overall Study||0
2858566|NCT00090545|3561147|FG000|NOT COMPLETED|Overall Study||22
2858567|NCT00090545|3561148|FG001|NOT COMPLETED|Overall Study||24
2858568|NCT00090584|3561158|FG000|STARTED|Baseline to 10 Weeks||154
2858569|NCT00090584|3561159|FG001|STARTED|Baseline to 10 Weeks||153
2858570|NCT00090584|3561158|FG000|COMPLETED|Baseline to 10 Weeks||139
2858571|NCT00090584|3561159|FG001|COMPLETED|Baseline to 10 Weeks||141
2858572|NCT00090584|3561158|FG000|NOT COMPLETED|Baseline to 10 Weeks||15
2858573|NCT00090584|3561159|FG001|NOT COMPLETED|Baseline to 10 Weeks||12
2858574|NCT00090584|3561158|FG000|STARTED|Baseline to 8 Months||154
2858575|NCT00090584|3561159|FG001|STARTED|Baseline to 8 Months||153
2858576|NCT00090584|3561158|FG000|COMPLETED|Baseline to 8 Months||110
2858577|NCT00090584|3561159|FG001|COMPLETED|Baseline to 8 Months||112
2858578|NCT00090584|3561158|FG000|NOT COMPLETED|Baseline to 8 Months||44
2858579|NCT00090584|3561159|FG001|NOT COMPLETED|Baseline to 8 Months||41
2858580|NCT00090610|3561175|FG000|STARTED|Overall Study||75
2858581|NCT00090610|3561176|FG001|STARTED|Overall Study||75
2858582|NCT00090610|3561175|FG000|COMPLETED|Overall Study||74
2858583|NCT00090610|3561176|FG001|COMPLETED|Overall Study||74
2858584|NCT00090610|3561175|FG000|NOT COMPLETED|Overall Study||1
2858585|NCT00090610|3561176|FG001|NOT COMPLETED|Overall Study||1
2858586|NCT00090753|3561184|FG000|STARTED|First Treatment Period||748
2858587|NCT00090753|3561185|FG001|STARTED|First Treatment Period||480
2858588|NCT00090753|3561184|FG000|COMPLETED|First Treatment Period||492
2858589|NCT00090753|3561185|FG001|COMPLETED|First Treatment Period||302
2858590|NCT00090753|3561184|FG000|NOT COMPLETED|First Treatment Period||256
2858591|NCT00090753|3561185|FG001|NOT COMPLETED|First Treatment Period||178
2858592|NCT00090753|3561184|FG000|STARTED|Extended Treatment Period|39 patients who completed the first treatment period refused to enter the extended treatment period.|453
2858593|NCT00090753|3561185|FG001|STARTED|Extended Treatment Period|52 patients who completed the first treatment period refused to enter the extended treatment period.|250
2858594|NCT00090753|3561184|FG000|COMPLETED|Extended Treatment Period||94
2858595|NCT00090753|3561185|FG001|COMPLETED|Extended Treatment Period||59
2858596|NCT00090753|3561184|FG000|NOT COMPLETED|Extended Treatment Period||359
2858597|NCT00090753|3561185|FG001|NOT COMPLETED|Extended Treatment Period||191
2858598|NCT00090766|3561194|FG000|STARTED|Overall Study||17
2858599|NCT00090766|3561195|FG001|STARTED|Overall Study||21
2858600|NCT00090766|3561196|FG002|STARTED|Overall Study||25
2858601|NCT00090766|3561194|FG000|COMPLETED|Overall Study||14
2858602|NCT00090766|3561195|FG001|COMPLETED|Overall Study||19
2858603|NCT00090766|3561196|FG002|COMPLETED|Overall Study||22
2858604|NCT00090766|3561194|FG000|NOT COMPLETED|Overall Study||3
2858605|NCT00090766|3561195|FG001|NOT COMPLETED|Overall Study||2
2858606|NCT00090766|3561196|FG002|NOT COMPLETED|Overall Study||3
2858607|NCT00090779|3561208|FG000|STARTED|Step 1||66
2858608|NCT00090779|3561209|FG001|STARTED|Step 1||64
2858609|NCT00090779|3561208|FG000|COMPLETED|Step 1|Results are based on the database frozen on July 2, 2009 per DSMB recommendation of study closure.|55
2858610|NCT00090779|3561209|FG001|COMPLETED|Step 1|Results are based on the database frozen on July 2, 2009 per DSMB recommendation of study closure.|49
2858611|NCT00090779|3561208|FG000|NOT COMPLETED|Step 1||11
2858612|NCT00090779|3561209|FG001|NOT COMPLETED|Step 1||15
2858613|NCT00090779|3561208|FG000|STARTED|Step 2|One subject who had two consecutive CD4<350cells/mm^3 did not enter step 2.|6
2858614|NCT00090779|3561209|FG001|STARTED|Step 2|Three with two consecutive CD4<350cells/mm^3 and one with CDC category B event didn't enter step 2.|19
2858615|NCT00090779|3561208|FG000|COMPLETED|Step 2||0
2858616|NCT00090779|3561209|FG001|COMPLETED|Step 2||1
2858617|NCT00090779|3561208|FG000|NOT COMPLETED|Step 2||6
2858618|NCT00090779|3561209|FG001|NOT COMPLETED|Step 2||18
2858619|NCT00090779|3561208|FG000|STARTED|Step 3||7
2858620|NCT00090779|3561209|FG001|STARTED|Step 3||5
2858621|NCT00090779|3561208|FG000|COMPLETED|Step 3||0
2858622|NCT00090779|3561209|FG001|COMPLETED|Step 3||0
2858623|NCT00090779|3561208|FG000|NOT COMPLETED|Step 3||7
2858624|NCT00090779|3561209|FG001|NOT COMPLETED|Step 3||5
3168851|NCT01921894|3896304|FG001|STARTED|Overall Study||8
2858625|NCT00090844|3561217|FG000|STARTED|Overall Study||27
2858626|NCT00090844|3561218|FG001|STARTED|Overall Study||22
2858627|NCT00090844|3561217|FG000|COMPLETED|Overall Study||26
2858628|NCT00090844|3561218|FG001|COMPLETED|Overall Study||21
2858629|NCT00090844|3561217|FG000|NOT COMPLETED|Overall Study||1
2858630|NCT00090844|3561218|FG001|NOT COMPLETED|Overall Study||1
2858631|NCT00090857|3561227|FG000|STARTED|Overall Study||33
2858632|NCT00090857|3561228|FG001|STARTED|Overall Study||16
2858633|NCT00090857|3561227|FG000|COMPLETED|Overall Study||29
2858634|NCT00090857|3561228|FG001|COMPLETED|Overall Study||13
2858635|NCT00090857|3561227|FG000|NOT COMPLETED|Overall Study||4
2858636|NCT00090857|3561228|FG001|NOT COMPLETED|Overall Study||3
2858637|NCT00090987|3561234|FG000|STARTED|Overall Study||30
2858638|NCT00090987|3561234|FG000|COMPLETED|Overall Study||9
2858639|NCT00090987|3561234|FG000|NOT COMPLETED|Overall Study||21
2858640|NCT00091026|3561240|FG000|STARTED|Overall Study||72
2858641|NCT00091026|3561241|FG001|STARTED|Overall Study||71
2858642|NCT00091026|3561240|FG000|COMPLETED|Overall Study||71
2858643|NCT00091026|3561241|FG001|COMPLETED|Overall Study||68
2858644|NCT00091026|3561240|FG000|NOT COMPLETED|Overall Study||1
2858645|NCT00091026|3561241|FG001|NOT COMPLETED|Overall Study||3
2858646|NCT00091169|3561249|FG000|STARTED|Overall Study||189
2858647|NCT00091169|3561250|FG001|STARTED|Overall Study||187
2858648|NCT00091169|3561249|FG000|Treated|Overall Study||163
2858649|NCT00091169|3561250|FG001|Treated|Overall Study||170
2858650|NCT00091169|3561249|FG000|COMPLETED|Overall Study||132
2858651|NCT00091169|3561250|FG001|COMPLETED|Overall Study||134
2858652|NCT00091169|3561249|FG000|NOT COMPLETED|Overall Study||57
2858653|NCT00091169|3561250|FG001|NOT COMPLETED|Overall Study||53
2858654|NCT00091260|3561258|FG000|STARTED|Overall Study||82
2858655|NCT00091260|3561258|FG000|COMPLETED|Overall Study||82
2858656|NCT00091260|3561258|FG000|NOT COMPLETED|Overall Study||0
2858657|NCT00091273|3561263|FG000|STARTED|Overall Study||9
2858658|NCT00091273|3561263|FG000|COMPLETED|Overall Study||9
2858659|NCT00091273|3561263|FG000|NOT COMPLETED|Overall Study||0
2858660|NCT00091390|3561267|FG000|STARTED|Overall Study||129
2858661|NCT00091390|3561267|FG000|Eligible and Started Study Treatment|Overall Study||125
2858662|NCT00091390|3561267|FG000|Eligible, Started Treatment, Has AE Data|Overall Study||115
2858663|NCT00091390|3561267|FG000|COMPLETED|Overall Study|Subjects contributing data to results are considered to have completed the study.|125
2858664|NCT00091390|3561267|FG000|NOT COMPLETED|Overall Study||4
2858665|NCT00091442|3561273|FG000|STARTED|Overall Study||373
2858666|NCT00091442|3561274|FG001|STARTED|Overall Study||378
2858667|NCT00091442|3561273|FG000|COMPLETED|Overall Study|Indicates number of participants on study treatment at time of the primary objective|4
2858668|NCT00091442|3561274|FG001|COMPLETED|Overall Study|Indicates number of participants on study treatment at time of the primary objective|5
2858669|NCT00091442|3561273|FG000|NOT COMPLETED|Overall Study||369
2858670|NCT00091442|3561274|FG001|NOT COMPLETED|Overall Study||373
2858671|NCT00091507|3561282|FG000|STARTED|Overall Study||432
2858672|NCT00091507|3561283|FG001|STARTED|Overall Study||479
2858673|NCT00091507|3561282|FG000|COMPLETED|Overall Study||411
2858674|NCT00091507|3561283|FG001|COMPLETED|Overall Study||460
2858675|NCT00091507|3561282|FG000|NOT COMPLETED|Overall Study||21
2858676|NCT00091507|3561283|FG001|NOT COMPLETED|Overall Study||19
2858677|NCT00091572|3561291|FG000|STARTED|Overall Study|10 subjects in temozolomide group not treated.|429
2858678|NCT00091572|3561292|FG001|STARTED|Overall Study|9 subjects in dacarbazine group not treated.|430
2858679|NCT00091572|3561291|FG000|COMPLETED|Overall Study|Progressive disease/relapse/death due to progressive disease|334
2858680|NCT00091572|3561292|FG001|COMPLETED|Overall Study|Progressive disease/relapse/death due to progressive disease|348
2858681|NCT00091572|3561291|FG000|NOT COMPLETED|Overall Study||95
2858682|NCT00091572|3561292|FG001|NOT COMPLETED|Overall Study||82
2858683|NCT00091793|3561300|FG000|STARTED|Overall Study||166
2858684|NCT00091793|3561301|FG001|STARTED|Overall Study||166
2858685|NCT00091793|3561300|FG000|COMPLETED|Overall Study||142
2858686|NCT00091793|3561301|FG001|COMPLETED|Overall Study||144
2858687|NCT00091793|3561300|FG000|NOT COMPLETED|Overall Study||24
2858688|NCT00091793|3561301|FG001|NOT COMPLETED|Overall Study||22
2858689|NCT00091819|3561309|FG000|STARTED|Overall Study||429
2858690|NCT00091819|3561310|FG001|STARTED|Overall Study||433
2858691|NCT00091819|3561309|FG000|COMPLETED|Overall Study||387
2858692|NCT00091819|3561310|FG001|COMPLETED|Overall Study||387
2858693|NCT00091819|3561309|FG000|NOT COMPLETED|Overall Study||42
2858694|NCT00091819|3561310|FG001|NOT COMPLETED|Overall Study||46
2858695|NCT00091832|3561322|FG000|STARTED|Overall Study||43
2858696|NCT00091832|3561323|FG001|STARTED|Overall Study||42
2858697|NCT00091832|3561324|FG002|STARTED|Overall Study||42
2858698|NCT00091832|3561325|FG003|STARTED|Overall Study||43
2858699|NCT00091832|3561326|FG004|STARTED|Overall Study||42
2858700|NCT00091832|3561327|FG005|STARTED|Overall Study||43
2858701|NCT00091832|3561322|FG000|Received Study Medication|Overall Study||43
2858702|NCT00091832|3561323|FG001|Received Study Medication|Overall Study||42
2858703|NCT00091832|3561324|FG002|Received Study Medication|Overall Study||41
2858704|NCT00091832|3561325|FG003|Received Study Medication|Overall Study||43
2858705|NCT00091832|3561326|FG004|Received Study Medication|Overall Study||42
2858706|NCT00091832|3561327|FG005|Received Study Medication|Overall Study||43
2858707|NCT00091832|3561322|FG000|COMPLETED|Overall Study||29
2858708|NCT00091832|3561323|FG001|COMPLETED|Overall Study||31
2858709|NCT00091832|3561324|FG002|COMPLETED|Overall Study||30
2858710|NCT00091832|3561325|FG003|COMPLETED|Overall Study||29
2858711|NCT00091832|3561326|FG004|COMPLETED|Overall Study||27
2858712|NCT00091832|3561327|FG005|COMPLETED|Overall Study||32
2858713|NCT00091832|3561322|FG000|NOT COMPLETED|Overall Study||14
2858714|NCT00091832|3561323|FG001|NOT COMPLETED|Overall Study||11
2858715|NCT00091832|3561324|FG002|NOT COMPLETED|Overall Study||12
2858716|NCT00091832|3561325|FG003|NOT COMPLETED|Overall Study||14
2858717|NCT00091832|3561326|FG004|NOT COMPLETED|Overall Study||15
2858718|NCT00091832|3561327|FG005|NOT COMPLETED|Overall Study||11
2858719|NCT00091949|3561343|FG000|STARTED|Overall Study||1939
2858720|NCT00091949|3561344|FG001|STARTED|Overall Study||1937
2858721|NCT00091949|3561343|FG000|COMPLETED|Overall Study||1764
2858722|NCT00091949|3561344|FG001|COMPLETED|Overall Study||1786
2858723|NCT00091949|3561343|FG000|NOT COMPLETED|Overall Study||175
2858724|NCT00091949|3561344|FG001|NOT COMPLETED|Overall Study||151
2858725|NCT00091962|3561353|FG000|STARTED|Overall Study||150
2858726|NCT00091962|3561354|FG001|STARTED|Overall Study||152
2858727|NCT00091962|3561355|FG002|STARTED|Overall Study||151
2858728|NCT00091962|3561353|FG000|COMPLETED|Overall Study||150
2858729|NCT00091962|3561354|FG001|COMPLETED|Overall Study||152
2858730|NCT00091962|3561355|FG002|COMPLETED|Overall Study||151
2858731|NCT00091962|3561353|FG000|NOT COMPLETED|Overall Study||0
2858732|NCT00091962|3561354|FG001|NOT COMPLETED|Overall Study||0
2858733|NCT00091962|3561355|FG002|NOT COMPLETED|Overall Study||0
2858734|NCT00092417|3561368|FG000|STARTED|Overall Study|Started Period Group 1|464
2858735|NCT00092417|3561369|FG001|STARTED|Overall Study|Started Period Group 2|234
2858736|NCT00092417|3561368|FG000|Vaccinated|Overall Study|3 participants were allocated,not vaccinated; they are not reported in the Baseline Characteristics|461
2858737|NCT00092417|3561369|FG001|Vaccinated|Overall Study||234
2858738|NCT00092417|3561368|FG000|COMPLETED|Overall Study|Received the higher potency zoster vaccine & completed 42 days of safety follow-up post vaccination|459
2858739|NCT00092417|3561369|FG001|COMPLETED|Overall Study|Received the lower potency zoster vaccine & completed 42 days of safety follow-up post vaccination|233
2858740|NCT00092417|3561368|FG000|NOT COMPLETED|Overall Study||5
2858741|NCT00092417|3561369|FG001|NOT COMPLETED|Overall Study||1
2858742|NCT00092443|3561377|FG000|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|651
2858743|NCT00092443|3561378|FG001|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|661
2858744|NCT00092443|3561377|FG000|Vaccinated at Visit 1|Overall Study||650
2858745|NCT00092443|3561378|FG001|Vaccinated at Visit 1|Overall Study||660
2858746|NCT00092443|3561377|FG000|Vaccinated at Visit 2|Overall Study||618
2858747|NCT00092443|3561378|FG001|Vaccinated at Visit 2|Overall Study||627
2858748|NCT00092443|3561377|FG000|Vaccinated at Visit 3|Overall Study||593
3168852|NCT01921894|3896305|FG002|STARTED|Overall Study||8
3168853|NCT01921894|3896303|FG000|COMPLETED|Overall Study||8
3168854|NCT01921894|3896304|FG001|COMPLETED|Overall Study||8
3168855|NCT01921894|3896305|FG002|COMPLETED|Overall Study||8
3168856|NCT01921894|3896303|FG000|NOT COMPLETED|Overall Study||0
3168857|NCT01921894|3896304|FG001|NOT COMPLETED|Overall Study||0
3168858|NCT01921894|3896305|FG002|NOT COMPLETED|Overall Study||0
3168859|NCT01922011|3896327|FG000|STARTED|Overall Study|Randomized participants|75
3168860|NCT01922011|3896328|FG001|STARTED|Overall Study|Randomized participants|74
3168861|NCT01922011|3896327|FG000|Treated|Overall Study|Treated Participants|73
3168862|NCT01922011|3896328|FG001|Treated|Overall Study|Treated Participants|73
3168863|NCT01922011|3896327|FG000|Treatment Actually Received|Overall Study|One participant intended for treatment with Vancomycin or Nafcillin was treated with Daptomycin|74
2858749|NCT00092443|3561378|FG001|Vaccinated at Visit 3|Overall Study||608
2858750|NCT00092443|3561377|FG000|COMPLETED|Overall Study|Subjects vaccinated and followed up 42 days after each dose, thru 1st rotavirus season post study|593
2858751|NCT00092443|3561378|FG001|COMPLETED|Overall Study|Subjects vaccinated and followed up 42 days after each dose, thru 1st rotavirus season post study|607
2858752|NCT00092443|3561377|FG000|NOT COMPLETED|Overall Study||58
2858753|NCT00092443|3561378|FG001|NOT COMPLETED|Overall Study||54
2858754|NCT00092456|3561398|FG000|STARTED|Overall Study|Subject assigned to ~8.81 X 10^7 IU/Dose of RotaTeq™ - Lot 1|226
2858755|NCT00092456|3561399|FG001|STARTED|Overall Study|Subject assigned to ~8.01 X 10^7 IU/Dose of RotaTeq™ - Lot 2|225
2858756|NCT00092456|3561400|FG002|STARTED|Overall Study|Subject assigned to ~6.91 X 10^7 IU/Dose of RotaTeq™ - Lot 3|229
2858757|NCT00092456|3561401|FG003|STARTED|Overall Study|Subjects assigned to Placebo-matching RotaTeq™|113
2858758|NCT00092456|3561398|FG000|Vaccinated at Visit 1|Overall Study||226
2858759|NCT00092456|3561399|FG001|Vaccinated at Visit 1|Overall Study||225
2858760|NCT00092456|3561400|FG002|Vaccinated at Visit 1|Overall Study||229
2858761|NCT00092456|3561401|FG003|Vaccinated at Visit 1|Overall Study||113
2858762|NCT00092456|3561398|FG000|Vaccinated at Visit 2|Overall Study||208
2858763|NCT00092456|3561399|FG001|Vaccinated at Visit 2|Overall Study||217
2858764|NCT00092456|3561400|FG002|Vaccinated at Visit 2|Overall Study||210
2858765|NCT00092456|3561401|FG003|Vaccinated at Visit 2|Overall Study||104
2858766|NCT00092456|3561398|FG000|Vaccinated at Visit 3|Overall Study||202
2858767|NCT00092456|3561399|FG001|Vaccinated at Visit 3|Overall Study||210
2858768|NCT00092456|3561400|FG002|Vaccinated at Visit 3|Overall Study||200
2858769|NCT00092456|3561401|FG003|Vaccinated at Visit 3|Overall Study||98
2858770|NCT00092456|3561398|FG000|COMPLETED|Overall Study|Subjects who received 3 scheduled vaccinations; with up to 42 days safety follow-up after each dose|201
2858771|NCT00092456|3561399|FG001|COMPLETED|Overall Study|Subjects who received 3 scheduled vaccinations; with up to 42 days safety follow-up after each dose|208
2918430|NCT00527111|3628640|FG000|COMPLETED|Overall Study||50
2918431|NCT00527111|3628641|FG001|COMPLETED|Overall Study||47
2858772|NCT00092456|3561400|FG002|COMPLETED|Overall Study|Subjects who received 3 scheduled vaccinations; with up to 42 days safety follow-up after each dose|200
2858773|NCT00092456|3561401|FG003|COMPLETED|Overall Study|Subjects who received 3 scheduled vaccinations; with up to 42 days safety follow-up after each dose|97
2858774|NCT00092456|3561398|FG000|NOT COMPLETED|Overall Study||25
2858775|NCT00092456|3561399|FG001|NOT COMPLETED|Overall Study||17
2858776|NCT00092456|3561400|FG002|NOT COMPLETED|Overall Study||29
2858777|NCT00092456|3561401|FG003|NOT COMPLETED|Overall Study||16
2858778|NCT00092495|3561415|FG000|STARTED|Base Study Vaccination Period||504
2858779|NCT00092495|3561416|FG001|STARTED|Base Study Vaccination Period||514
2858780|NCT00092495|3561417|FG002|STARTED|Base Study Vaccination Period||508
2858781|NCT00092495|3561418|FG003|STARTED|Base Study Vaccination Period||1529
2858782|NCT00092495|3561419|FG004|STARTED|Base Study Vaccination Period||0
2858783|NCT00092495|3561415|FG000|With Long-term Follow-up *|Base Study Vaccination Period|Subjects received fewer than 3 doses of vaccinations and entered the long-term follow-up period|2
2858784|NCT00092495|3561416|FG001|With Long-term Follow-up *|Base Study Vaccination Period|Subjects received fewer than 3 doses of vaccinations and entered the long-term follow-up period|2
2858785|NCT00092495|3561417|FG002|With Long-term Follow-up *|Base Study Vaccination Period|Subjects received fewer than 3 doses of vaccinations and entered the long-term follow-up period|6
2858786|NCT00092495|3561418|FG003|With Long-term Follow-up *|Base Study Vaccination Period|Subjects received fewer than 3 doses of vaccinations and entered the long-term follow-up period|10
2858787|NCT00092495|3561419|FG004|With Long-term Follow-up *|Base Study Vaccination Period||0
2858788|NCT00092495|3561415|FG000|Without Long-term Follow-up|Base Study Vaccination Period|Subjects discontinued on or before Month 7 and did not enter the long-term follow-up period|34
2858789|NCT00092495|3561416|FG001|Without Long-term Follow-up|Base Study Vaccination Period|Subjects discontinued on or before Month 7 and did not enter the long-term follow-up period|20
2858790|NCT00092495|3561417|FG002|Without Long-term Follow-up|Base Study Vaccination Period|Subjects discontinued on or before Month 7 and did not enter the long-term follow-up period|28
2858791|NCT00092495|3561418|FG003|Without Long-term Follow-up|Base Study Vaccination Period|Subjects discontinued on or before Month 7 and did not enter the long-term follow-up period|73
2858792|NCT00092495|3561419|FG004|Without Long-term Follow-up|Base Study Vaccination Period||0
2858793|NCT00092495|3561415|FG000|COMPLETED|Base Study Vaccination Period|Completed 3 vaccinations; entered the long-term follow-up or completed the study per-protocol|467
2858794|NCT00092495|3561416|FG001|COMPLETED|Base Study Vaccination Period|Completed 3 vaccinations; entered the long-term follow-up or completed the study per-protocol|492
2858795|NCT00092495|3561417|FG002|COMPLETED|Base Study Vaccination Period|Completed 3 vaccinations; entered the long-term follow-up or completed the study per-protocol|474
2858796|NCT00092495|3561418|FG003|COMPLETED|Base Study Vaccination Period|Completed 3 vaccinations; entered the long-term follow-up or completed the study per-protocol|1441
2858797|NCT00092495|3561419|FG004|COMPLETED|Base Study Vaccination Period||0
2858798|NCT00092495|3561415|FG000|NOT COMPLETED|Base Study Vaccination Period||37
2858799|NCT00092495|3561416|FG001|NOT COMPLETED|Base Study Vaccination Period||22
2858800|NCT00092495|3561417|FG002|NOT COMPLETED|Base Study Vaccination Period||34
2858801|NCT00092495|3561418|FG003|NOT COMPLETED|Base Study Vaccination Period||88
2858802|NCT00092495|3561419|FG004|NOT COMPLETED|Base Study Vaccination Period||0
2858803|NCT00092495|3561415|FG000|STARTED|Base Study Follow-up Period|Protocol amended to extend follow-up for 10-15 year old subjects to Month 12 (6 months Postdose 3)|115
2858804|NCT00092495|3561416|FG001|STARTED|Base Study Follow-up Period|Protocol amended to extend follow-up for 10-15 year old subjects to Month 12 (6 months Postdose 3)|125
2858805|NCT00092495|3561417|FG002|STARTED|Base Study Follow-up Period|Protocol amended to extend follow-up for 10-15 year old subjects to Month 12 (6 months Postdose 3)|130
2858806|NCT00092495|3561418|FG003|STARTED|Base Study Follow-up Period|Protocol amended to extend follow-up for 10-15 year old subjects to Month 12 (6 months Postdose 3)|460
2858807|NCT00092495|3561419|FG004|STARTED|Base Study Follow-up Period||0
2858808|NCT00092495|3561415|FG000|COMPLETED|Base Study Follow-up Period||112
2858809|NCT00092495|3561416|FG001|COMPLETED|Base Study Follow-up Period||122
2858810|NCT00092495|3561417|FG002|COMPLETED|Base Study Follow-up Period||126
2858811|NCT00092495|3561418|FG003|COMPLETED|Base Study Follow-up Period||446
2858812|NCT00092495|3561419|FG004|COMPLETED|Base Study Follow-up Period||0
2858813|NCT00092495|3561415|FG000|NOT COMPLETED|Base Study Follow-up Period||3
2858814|NCT00092495|3561416|FG001|NOT COMPLETED|Base Study Follow-up Period||3
2858815|NCT00092495|3561417|FG002|NOT COMPLETED|Base Study Follow-up Period||4
2858816|NCT00092495|3561418|FG003|NOT COMPLETED|Base Study Follow-up Period||14
2858817|NCT00092495|3561419|FG004|NOT COMPLETED|Base Study Follow-up Period||0
2858818|NCT00092495|3561415|FG000|STARTED|Extension Study||0
2858819|NCT00092495|3561416|FG001|STARTED|Extension Study||0
2858820|NCT00092495|3561417|FG002|STARTED|Extension Study||0
2858821|NCT00092495|3561418|FG003|STARTED|Extension Study||0
2858822|NCT00092495|3561419|FG004|STARTED|Extension Study||12
2858823|NCT00092495|3561415|FG000|COMPLETED|Extension Study||0
2858824|NCT00092495|3561416|FG001|COMPLETED|Extension Study||0
2858825|NCT00092495|3561417|FG002|COMPLETED|Extension Study||0
2858826|NCT00092495|3561418|FG003|COMPLETED|Extension Study||0
2858827|NCT00092495|3561419|FG004|COMPLETED|Extension Study||12
2858828|NCT00092495|3561415|FG000|NOT COMPLETED|Extension Study||0
2858829|NCT00092495|3561416|FG001|NOT COMPLETED|Extension Study||0
2858830|NCT00092495|3561417|FG002|NOT COMPLETED|Extension Study||0
2858831|NCT00092495|3561418|FG003|NOT COMPLETED|Extension Study||0
2858832|NCT00092495|3561419|FG004|NOT COMPLETED|Extension Study||0
2858833|NCT00092521|3561435|FG000|STARTED|Vaccination (Day 1 Through Month 7)||2723
2858834|NCT00092521|3561436|FG001|STARTED|Vaccination (Day 1 Through Month 7)||304
3313411|NCT03075410|4046797|FG006|STARTED|Part A-Washout Period 2 (14 Days)||0
3313412|NCT03075410|4046798|FG007|STARTED|Part A-Washout Period 2 (14 Days)||0
3313413|NCT03075410|4046799|FG008|STARTED|Part A-Washout Period 2 (14 Days)||0
2858835|NCT00092521|3561437|FG002|STARTED|Vaccination (Day 1 Through Month 7)||2732
2858836|NCT00092521|3561438|FG003|STARTED|Vaccination (Day 1 Through Month 7)||0
2858837|NCT00092521|3561435|FG000|COMPLETED|Vaccination (Day 1 Through Month 7)||2583
2858838|NCT00092521|3561436|FG001|COMPLETED|Vaccination (Day 1 Through Month 7)||290
2858839|NCT00092521|3561437|FG002|COMPLETED|Vaccination (Day 1 Through Month 7)||2586
2858840|NCT00092521|3561438|FG003|COMPLETED|Vaccination (Day 1 Through Month 7)||0
2858841|NCT00092521|3561435|FG000|NOT COMPLETED|Vaccination (Day 1 Through Month 7)||140
2858842|NCT00092521|3561436|FG001|NOT COMPLETED|Vaccination (Day 1 Through Month 7)||14
2858843|NCT00092521|3561437|FG002|NOT COMPLETED|Vaccination (Day 1 Through Month 7)||146
2858844|NCT00092521|3561438|FG003|NOT COMPLETED|Vaccination (Day 1 Through Month 7)||0
2858845|NCT00092521|3561435|FG000|STARTED|Follow-Up (After Month 7)|Includes subjects who did not receive 3 doses of vaccine/placebo but continued into the follow-up|2599
2858846|NCT00092521|3561436|FG001|STARTED|Follow-Up (After Month 7)|Includes subjects who did not receive 3 doses of vaccine/placebo but continued into the follow-up|291
2858847|NCT00092521|3561437|FG002|STARTED|Follow-Up (After Month 7)|Includes subjects who did not receive 3 doses of vaccine/placebo but continued into the follow-up|2607
2858848|NCT00092521|3561438|FG003|STARTED|Follow-Up (After Month 7)||0
2858849|NCT00092521|3561435|FG000|COMPLETED|Follow-Up (After Month 7)||2353
2858850|NCT00092521|3561436|FG001|COMPLETED|Follow-Up (After Month 7)||155
2858851|NCT00092521|3561437|FG002|COMPLETED|Follow-Up (After Month 7)||1959
2858852|NCT00092521|3561438|FG003|COMPLETED|Follow-Up (After Month 7)||0
2858853|NCT00092521|3561435|FG000|NOT COMPLETED|Follow-Up (After Month 7)||246
2858854|NCT00092521|3561436|FG001|NOT COMPLETED|Follow-Up (After Month 7)||136
2858855|NCT00092521|3561437|FG002|NOT COMPLETED|Follow-Up (After Month 7)||648
2858856|NCT00092521|3561438|FG003|NOT COMPLETED|Follow-Up (After Month 7)||0
2858857|NCT00092521|3561435|FG000|STARTED|Extension Study (Group 4)||0
2858858|NCT00092521|3561436|FG001|STARTED|Extension Study (Group 4)||0
2858859|NCT00092521|3561437|FG002|STARTED|Extension Study (Group 4)||0
2858860|NCT00092521|3561438|FG003|STARTED|Extension Study (Group 4)||844
2858861|NCT00092521|3561435|FG000|Initiated Extension Study|Extension Study (Group 4)||0
2858862|NCT00092521|3561436|FG001|Initiated Extension Study|Extension Study (Group 4)||0
2858863|NCT00092521|3561437|FG002|Initiated Extension Study|Extension Study (Group 4)||0
2858864|NCT00092521|3561438|FG003|Initiated Extension Study|Extension Study (Group 4)||829
2858865|NCT00092521|3561435|FG000|Received >=1 Dose in Extension Study|Extension Study (Group 4)||0
2858866|NCT00092521|3561436|FG001|Received >=1 Dose in Extension Study|Extension Study (Group 4)||0
2858867|NCT00092521|3561437|FG002|Received >=1 Dose in Extension Study|Extension Study (Group 4)||0
2858868|NCT00092521|3561438|FG003|Received >=1 Dose in Extension Study|Extension Study (Group 4)||801
2858869|NCT00092521|3561435|FG000|COMPLETED|Extension Study (Group 4)||0
2858870|NCT00092521|3561436|FG001|COMPLETED|Extension Study (Group 4)||0
2858871|NCT00092521|3561437|FG002|COMPLETED|Extension Study (Group 4)||0
2858872|NCT00092521|3561438|FG003|COMPLETED|Extension Study (Group 4)||635
2858873|NCT00092521|3561435|FG000|NOT COMPLETED|Extension Study (Group 4)||0
2858874|NCT00092521|3561436|FG001|NOT COMPLETED|Extension Study (Group 4)||0
2858875|NCT00092521|3561437|FG002|NOT COMPLETED|Extension Study (Group 4)||0
2858876|NCT00092521|3561438|FG003|NOT COMPLETED|Extension Study (Group 4)||209
2858877|NCT00092534|3561448|FG000|STARTED|Base Study Vaccination Period||6087
2858878|NCT00092534|3561449|FG001|STARTED|Base Study Vaccination Period||6080
2858879|NCT00092534|3561450|FG002|STARTED|Base Study Vaccination Period||0
2858880|NCT00092534|3561451|FG003|STARTED|Base Study Vaccination Period||0
2858881|NCT00092534|3561452|FG004|STARTED|Base Study Vaccination Period||0
2858882|NCT00092534|3561448|FG000|COMPLETED|Base Study Vaccination Period||5916
2858883|NCT00092534|3561449|FG001|COMPLETED|Base Study Vaccination Period||5954
2858884|NCT00092534|3561450|FG002|COMPLETED|Base Study Vaccination Period||0
2858885|NCT00092534|3561451|FG003|COMPLETED|Base Study Vaccination Period||0
2858886|NCT00092534|3561452|FG004|COMPLETED|Base Study Vaccination Period||0
2858887|NCT00092534|3561448|FG000|NOT COMPLETED|Base Study Vaccination Period||171
2858888|NCT00092534|3561449|FG001|NOT COMPLETED|Base Study Vaccination Period||126
2858889|NCT00092534|3561450|FG002|NOT COMPLETED|Base Study Vaccination Period||0
2858890|NCT00092534|3561451|FG003|NOT COMPLETED|Base Study Vaccination Period||0
2858891|NCT00092534|3561452|FG004|NOT COMPLETED|Base Study Vaccination Period||0
2858892|NCT00092534|3561448|FG000|STARTED|Base Study Follow-Up Period|Includes subjects who did not receive 3 doses of vaccine/placebo but continued into the follow-up.|5942
2858893|NCT00092534|3561449|FG001|STARTED|Base Study Follow-Up Period|Includes subjects who did not receive 3 doses of vaccine/placebo but continued into the follow-up.|5971
2858894|NCT00092534|3561450|FG002|STARTED|Base Study Follow-Up Period||0
2858895|NCT00092534|3561451|FG003|STARTED|Base Study Follow-Up Period||0
2858896|NCT00092534|3561452|FG004|STARTED|Base Study Follow-Up Period||0
2858897|NCT00092534|3561448|FG000|COMPLETED|Base Study Follow-Up Period||5626
2858898|NCT00092534|3561449|FG001|COMPLETED|Base Study Follow-Up Period||5277
2858899|NCT00092534|3561450|FG002|COMPLETED|Base Study Follow-Up Period||0
2858900|NCT00092534|3561451|FG003|COMPLETED|Base Study Follow-Up Period||0
2858901|NCT00092534|3561452|FG004|COMPLETED|Base Study Follow-Up Period||0
2858902|NCT00092534|3561448|FG000|NOT COMPLETED|Base Study Follow-Up Period||316
2858903|NCT00092534|3561449|FG001|NOT COMPLETED|Base Study Follow-Up Period||694
2858904|NCT00092534|3561450|FG002|NOT COMPLETED|Base Study Follow-Up Period||0
2858905|NCT00092534|3561451|FG003|NOT COMPLETED|Base Study Follow-Up Period||0
2858906|NCT00092534|3561452|FG004|NOT COMPLETED|Base Study Follow-Up Period||0
2858907|NCT00092534|3561448|FG000|STARTED|Base Study EXT||0
2858908|NCT00092534|3561449|FG001|STARTED|Base Study EXT||0
2858909|NCT00092534|3561450|FG002|STARTED|Base Study EXT||594
2858910|NCT00092534|3561451|FG003|STARTED|Base Study EXT||0
2858911|NCT00092534|3561452|FG004|STARTED|Base Study EXT||0
2858912|NCT00092534|3561448|FG000|COMPLETED|Base Study EXT||0
2858913|NCT00092534|3561449|FG001|COMPLETED|Base Study EXT||0
2858914|NCT00092534|3561450|FG002|COMPLETED|Base Study EXT||449
2858915|NCT00092534|3561451|FG003|COMPLETED|Base Study EXT||0
2858916|NCT00092534|3561452|FG004|COMPLETED|Base Study EXT||0
2858917|NCT00092534|3561448|FG000|NOT COMPLETED|Base Study EXT||0
2858918|NCT00092534|3561449|FG001|NOT COMPLETED|Base Study EXT||0
2858919|NCT00092534|3561450|FG002|NOT COMPLETED|Base Study EXT||145
2858920|NCT00092534|3561451|FG003|NOT COMPLETED|Base Study EXT||0
2858921|NCT00092534|3561452|FG004|NOT COMPLETED|Base Study EXT||0
2858922|NCT00092534|3561448|FG000|STARTED|Long-Term Follow-Up (LTFU) Study||0
2858923|NCT00092534|3561449|FG001|STARTED|Long-Term Follow-Up (LTFU) Study||0
2858924|NCT00092534|3561450|FG002|STARTED|Long-Term Follow-Up (LTFU) Study||0
2858925|NCT00092534|3561451|FG003|STARTED|Long-Term Follow-Up (LTFU) Study|Some Base Study participants did not consent for inclusion in the LTFU.|2750
2858926|NCT00092534|3561452|FG004|STARTED|Long-Term Follow-Up (LTFU) Study|Some Base Study participants did not consent for inclusion in the LTFU.|2097
2858927|NCT00092534|3561448|FG000|Started: Registry-based Effectiveness|Long-Term Follow-Up (LTFU) Study||0
2858928|NCT00092534|3561449|FG001|Started: Registry-based Effectiveness|Long-Term Follow-Up (LTFU) Study||0
2858929|NCT00092534|3561450|FG002|Started: Registry-based Effectiveness|Long-Term Follow-Up (LTFU) Study||0
2858930|NCT00092534|3561451|FG003|Started: Registry-based Effectiveness|Long-Term Follow-Up (LTFU) Study||2650
2858931|NCT00092534|3561452|FG004|Started: Registry-based Effectiveness|Long-Term Follow-Up (LTFU) Study||2050
2858932|NCT00092534|3561448|FG000|Started: Immunogenicity Analysis|Long-Term Follow-Up (LTFU) Study||0
2858933|NCT00092534|3561449|FG001|Started: Immunogenicity Analysis|Long-Term Follow-Up (LTFU) Study||0
2858934|NCT00092534|3561450|FG002|Started: Immunogenicity Analysis|Long-Term Follow-Up (LTFU) Study||0
2858935|NCT00092534|3561451|FG003|Started: Immunogenicity Analysis|Long-Term Follow-Up (LTFU) Study||2385
2858936|NCT00092534|3561452|FG004|Started: Immunogenicity Analysis|Long-Term Follow-Up (LTFU) Study||1849
2858937|NCT00092534|3561448|FG000|Started: Registry-based Safety|Long-Term Follow-Up (LTFU) Study||0
2858938|NCT00092534|3561449|FG001|Started: Registry-based Safety|Long-Term Follow-Up (LTFU) Study||0
2858939|NCT00092534|3561450|FG002|Started: Registry-based Safety|Long-Term Follow-Up (LTFU) Study||0
2858940|NCT00092534|3561451|FG003|Started: Registry-based Safety|Long-Term Follow-Up (LTFU) Study||2448
2858941|NCT00092534|3561452|FG004|Started: Registry-based Safety|Long-Term Follow-Up (LTFU) Study||1888
2858942|NCT00092534|3561448|FG000|COMPLETED|Long-Term Follow-Up (LTFU) Study||0
2858943|NCT00092534|3561449|FG001|COMPLETED|Long-Term Follow-Up (LTFU) Study||0
2858944|NCT00092534|3561450|FG002|COMPLETED|Long-Term Follow-Up (LTFU) Study||0
2858945|NCT00092534|3561451|FG003|COMPLETED|Long-Term Follow-Up (LTFU) Study||2749
2858946|NCT00092534|3561452|FG004|COMPLETED|Long-Term Follow-Up (LTFU) Study||2097
2858947|NCT00092534|3561448|FG000|NOT COMPLETED|Long-Term Follow-Up (LTFU) Study||0
2858948|NCT00092534|3561449|FG001|NOT COMPLETED|Long-Term Follow-Up (LTFU) Study||0
2858949|NCT00092534|3561450|FG002|NOT COMPLETED|Long-Term Follow-Up (LTFU) Study||0
2858950|NCT00092534|3561451|FG003|NOT COMPLETED|Long-Term Follow-Up (LTFU) Study||1
2858951|NCT00092534|3561452|FG004|NOT COMPLETED|Long-Term Follow-Up (LTFU) Study||0
2858952|NCT00092547|3561464|FG000|STARTED|Base Vaccine Phase (Day 1 to Month 7)||1184
2858953|NCT00092547|3561465|FG001|STARTED|Base Vaccine Phase (Day 1 to Month 7)||597
2858954|NCT00092547|3561466|FG002|STARTED|Base Vaccine Phase (Day 1 to Month 7)||0
2858955|NCT00092547|3561464|FG000|Vaccinated|Base Vaccine Phase (Day 1 to Month 7)||1179
2858956|NCT00092547|3561465|FG001|Vaccinated|Base Vaccine Phase (Day 1 to Month 7)||596
2858957|NCT00092547|3561466|FG002|Vaccinated|Base Vaccine Phase (Day 1 to Month 7)||0
2858958|NCT00092547|3561464|FG000|COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||1121
2858959|NCT00092547|3561465|FG001|COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||561
2858960|NCT00092547|3561466|FG002|COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||0
2858961|NCT00092547|3561464|FG000|NOT COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||63
2858962|NCT00092547|3561465|FG001|NOT COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||36
2858963|NCT00092547|3561466|FG002|NOT COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||0
2858964|NCT00092547|3561464|FG000|STARTED|Base Follow-up Phase (Month 7 to 18)|Includes participants continuing and who previously discontinued who re-entered the study|1128
2858965|NCT00092547|3561465|FG001|STARTED|Base Follow-up Phase (Month 7 to 18)|Includes participants continuing and who previously discontinued who re-entered the study|565
2858966|NCT00092547|3561466|FG002|STARTED|Base Follow-up Phase (Month 7 to 18)||0
2858967|NCT00092547|3561464|FG000|COMPLETED|Base Follow-up Phase (Month 7 to 18)||1108
2858968|NCT00092547|3561465|FG001|COMPLETED|Base Follow-up Phase (Month 7 to 18)||551
2858969|NCT00092547|3561466|FG002|COMPLETED|Base Follow-up Phase (Month 7 to 18)||0
2858970|NCT00092547|3561464|FG000|NOT COMPLETED|Base Follow-up Phase (Month 7 to 18)||20
2858971|NCT00092547|3561465|FG001|NOT COMPLETED|Base Follow-up Phase (Month 7 to 18)||14
2858972|NCT00092547|3561466|FG002|NOT COMPLETED|Base Follow-up Phase (Month 7 to 18)||0
2918432|NCT00527111|3628640|FG000|NOT COMPLETED|Overall Study||20
3168864|NCT01922011|3896328|FG001|Treatment Actually Received|Overall Study|One participant intended for treatment with Vancomycin or Nafcillin was treated with Daptomycin|72
2918433|NCT00527111|3628641|FG001|NOT COMPLETED|Overall Study||22
2858973|NCT00092547|3561464|FG000|STARTED|Base Follow-up Phase (Month 18 to 30)|Includes participants continuing and who previously discontinued who re-entered the study|964
2858974|NCT00092547|3561465|FG001|STARTED|Base Follow-up Phase (Month 18 to 30)|Includes participants continuing and who previously discontinued who re-entered the study|490
2858975|NCT00092547|3561466|FG002|STARTED|Base Follow-up Phase (Month 18 to 30)||0
2858976|NCT00092547|3561464|FG000|COMPLETED|Base Follow-up Phase (Month 18 to 30)||956
2858977|NCT00092547|3561465|FG001|COMPLETED|Base Follow-up Phase (Month 18 to 30)||485
2858978|NCT00092547|3561466|FG002|COMPLETED|Base Follow-up Phase (Month 18 to 30)||0
2858979|NCT00092547|3561464|FG000|NOT COMPLETED|Base Follow-up Phase (Month 18 to 30)||8
2858980|NCT00092547|3561465|FG001|NOT COMPLETED|Base Follow-up Phase (Month 18 to 30)||5
2858981|NCT00092547|3561466|FG002|NOT COMPLETED|Base Follow-up Phase (Month 18 to 30)||0
2858982|NCT00092547|3561464|FG000|STARTED|Extension Vaccine Phase (Month 30 to 37)|Includes participants continuing and who previously discontinued who re-entered the study|956
2858983|NCT00092547|3561465|FG001|STARTED|Extension Vaccine Phase (Month 30 to 37)||0
2858984|NCT00092547|3561466|FG002|STARTED|Extension Vaccine Phase (Month 30 to 37)|Includes participants continuing and who previously discontinued who re-entered the study|485
2858985|NCT00092547|3561464|FG000|Vaccinated in Extension Study|Extension Vaccine Phase (Month 30 to 37)||0
2858986|NCT00092547|3561465|FG001|Vaccinated in Extension Study|Extension Vaccine Phase (Month 30 to 37)||0
2858987|NCT00092547|3561466|FG002|Vaccinated in Extension Study|Extension Vaccine Phase (Month 30 to 37)||482
2858988|NCT00092547|3561464|FG000|COMPLETED|Extension Vaccine Phase (Month 30 to 37)||933
2858989|NCT00092547|3561465|FG001|COMPLETED|Extension Vaccine Phase (Month 30 to 37)||0
2858990|NCT00092547|3561466|FG002|COMPLETED|Extension Vaccine Phase (Month 30 to 37)||469
2858991|NCT00092547|3561464|FG000|NOT COMPLETED|Extension Vaccine Phase (Month 30 to 37)||23
2858992|NCT00092547|3561465|FG001|NOT COMPLETED|Extension Vaccine Phase (Month 30 to 37)||0
2858993|NCT00092547|3561466|FG002|NOT COMPLETED|Extension Vaccine Phase (Month 30 to 37)||16
2858994|NCT00092547|3561464|FG000|STARTED|Long-term Follow-up (Month 42 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|612
2858995|NCT00092547|3561465|FG001|STARTED|Long-term Follow-up (Month 42 Visit)||0
2858996|NCT00092547|3561466|FG002|STARTED|Long-term Follow-up (Month 42 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|308
2858997|NCT00092547|3561464|FG000|COMPLETED|Long-term Follow-up (Month 42 Visit)||611
2858998|NCT00092547|3561465|FG001|COMPLETED|Long-term Follow-up (Month 42 Visit)||0
2858999|NCT00092547|3561466|FG002|COMPLETED|Long-term Follow-up (Month 42 Visit)||308
2859000|NCT00092547|3561464|FG000|NOT COMPLETED|Long-term Follow-up (Month 42 Visit)||1
2859001|NCT00092547|3561465|FG001|NOT COMPLETED|Long-term Follow-up (Month 42 Visit)||0
2859002|NCT00092547|3561466|FG002|NOT COMPLETED|Long-term Follow-up (Month 42 Visit)||0
2859003|NCT00092547|3561464|FG000|STARTED|Long-term Follow-up (Month 72 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|550
2859004|NCT00092547|3561465|FG001|STARTED|Long-term Follow-up (Month 72 Visit)||0
2859005|NCT00092547|3561466|FG002|STARTED|Long-term Follow-up (Month 72 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|276
2859006|NCT00092547|3561464|FG000|COMPLETED|Long-term Follow-up (Month 72 Visit)||550
2859007|NCT00092547|3561465|FG001|COMPLETED|Long-term Follow-up (Month 72 Visit)||0
2859008|NCT00092547|3561466|FG002|COMPLETED|Long-term Follow-up (Month 72 Visit)||276
2859009|NCT00092547|3561464|FG000|NOT COMPLETED|Long-term Follow-up (Month 72 Visit)||0
2859010|NCT00092547|3561465|FG001|NOT COMPLETED|Long-term Follow-up (Month 72 Visit)||0
2859011|NCT00092547|3561466|FG002|NOT COMPLETED|Long-term Follow-up (Month 72 Visit)||0
2859012|NCT00092547|3561464|FG000|STARTED|Long-term Follow-up (Month 96 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|508
2859013|NCT00092547|3561465|FG001|STARTED|Long-term Follow-up (Month 96 Visit)||0
2859014|NCT00092547|3561466|FG002|STARTED|Long-term Follow-up (Month 96 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|267
2859015|NCT00092547|3561464|FG000|COMPLETED|Long-term Follow-up (Month 96 Visit)||508
2859016|NCT00092547|3561465|FG001|COMPLETED|Long-term Follow-up (Month 96 Visit)||0
2859017|NCT00092547|3561466|FG002|COMPLETED|Long-term Follow-up (Month 96 Visit)||267
2859018|NCT00092547|3561464|FG000|NOT COMPLETED|Long-term Follow-up (Month 96 Visit)||0
2859019|NCT00092547|3561465|FG001|NOT COMPLETED|Long-term Follow-up (Month 96 Visit)||0
2859020|NCT00092547|3561466|FG002|NOT COMPLETED|Long-term Follow-up (Month 96 Visit)||0
2859021|NCT00092547|3561464|FG000|STARTED|Long-term Follow-up (Month 126 Visit)||454
2859022|NCT00092547|3561465|FG001|STARTED|Long-term Follow-up (Month 126 Visit)||0
2859023|NCT00092547|3561466|FG002|STARTED|Long-term Follow-up (Month 126 Visit)||211
2859024|NCT00092547|3561464|FG000|COMPLETED|Long-term Follow-up (Month 126 Visit)||454
2859025|NCT00092547|3561465|FG001|COMPLETED|Long-term Follow-up (Month 126 Visit)||0
2859026|NCT00092547|3561466|FG002|COMPLETED|Long-term Follow-up (Month 126 Visit)||211
2859027|NCT00092547|3561464|FG000|NOT COMPLETED|Long-term Follow-up (Month 126 Visit)||0
2859028|NCT00092547|3561465|FG001|NOT COMPLETED|Long-term Follow-up (Month 126 Visit)||0
2859029|NCT00092547|3561466|FG002|NOT COMPLETED|Long-term Follow-up (Month 126 Visit)||0
2859030|NCT00093015|3561479|FG000|STARTED|Overall Study||2026
2859031|NCT00093015|3561480|FG001|STARTED|Overall Study||2012
2859032|NCT00093015|3561479|FG000|Received Study Medication|Overall Study||2019
2859033|NCT00093015|3561480|FG001|Received Study Medication|Overall Study||2004
2859034|NCT00093015|3561479|FG000|COMPLETED|Overall Study||1361
2859035|NCT00093015|3561480|FG001|COMPLETED|Overall Study||1348
2859036|NCT00093015|3561479|FG000|NOT COMPLETED|Overall Study||665
2859037|NCT00093015|3561480|FG001|NOT COMPLETED|Overall Study||664
2859038|NCT00093041|3561492|FG000|STARTED|Overall Study||4
2859039|NCT00093041|3561493|FG001|STARTED|Overall Study||4
2859040|NCT00093041|3561494|FG002|STARTED|Overall Study||5
2859041|NCT00093041|3561495|FG003|STARTED|Overall Study||4
2859042|NCT00093041|3561496|FG004|STARTED|Overall Study||4
2859043|NCT00093041|3561497|FG005|STARTED|Overall Study||7
2859044|NCT00093041|3561492|FG000|COMPLETED|Overall Study|One discontinued during single dose period and one during multiple dose period|2
2859045|NCT00093041|3561493|FG001|COMPLETED|Overall Study|Three discontinued during single dose period|1
2859046|NCT00093041|3561494|FG002|COMPLETED|Overall Study|Two discontinued during single dose period|3
2859047|NCT00093041|3561495|FG003|COMPLETED|Overall Study|One discontinued during single dose period|3
2859048|NCT00093041|3561496|FG004|COMPLETED|Overall Study|One discontinued during multiple dose period|3
2859049|NCT00093041|3561497|FG005|COMPLETED|Overall Study|Three discontinued during multiple dose period|4
2859050|NCT00093041|3561492|FG000|NOT COMPLETED|Overall Study||2
2859051|NCT00093041|3561493|FG001|NOT COMPLETED|Overall Study||3
2859052|NCT00093041|3561494|FG002|NOT COMPLETED|Overall Study||2
2859053|NCT00093041|3561495|FG003|NOT COMPLETED|Overall Study||1
2859054|NCT00093041|3561496|FG004|NOT COMPLETED|Overall Study||1
2859055|NCT00093041|3561497|FG005|NOT COMPLETED|Overall Study||3
2859056|NCT00093145|3561511|FG000|STARTED|Overall Study||32
2859057|NCT00093145|3561511|FG000|At Least One Response Assessment|Overall Study||31
2859058|NCT00093145|3561511|FG000|COMPLETED|Overall Study|Treatment completed upon progressive disease|15
2859059|NCT00093145|3561511|FG000|NOT COMPLETED|Overall Study||17
2859060|NCT00093379|3561515|FG000|STARTED|Overall Study||20
2859061|NCT00093379|3561515|FG000|COMPLETED|Overall Study||20
2859062|NCT00093379|3561515|FG000|NOT COMPLETED|Overall Study||0
2859063|NCT00093470|3561521|FG000|STARTED|Overall Study||73
2859064|NCT00093470|3561522|FG001|STARTED|Overall Study||71
2859065|NCT00093470|3561521|FG000|Treated|Overall Study||72
2859066|NCT00093470|3561522|FG001|Treated|Overall Study||71
2859067|NCT00093470|3561521|FG000|Patients With Toxicity Assessment|Overall Study||72
2859068|NCT00093470|3561522|FG001|Patients With Toxicity Assessment|Overall Study||69
2859069|NCT00093470|3561521|FG000|COMPLETED|Overall Study|Treatment continued until disease progression or unacceptable toxicities.|0
2859070|NCT00093470|3561522|FG001|COMPLETED|Overall Study|Patients underwent observation only.|71
2859071|NCT00093470|3561521|FG000|NOT COMPLETED|Overall Study||73
2859072|NCT00093470|3561522|FG001|NOT COMPLETED|Overall Study||0
2859073|NCT00093496|3561530|FG000|STARTED|Overall Study||15
2859074|NCT00093496|3561531|FG001|STARTED|Overall Study||14
2859075|NCT00093496|3561530|FG000|COMPLETED|Overall Study||14
2859076|NCT00093496|3561531|FG001|COMPLETED|Overall Study||11
2859077|NCT00093496|3561530|FG000|NOT COMPLETED|Overall Study||1
2859078|NCT00093496|3561531|FG001|NOT COMPLETED|Overall Study||3
2859079|NCT00093756|3561538|FG000|STARTED|Overall Study||27
2859080|NCT00093756|3561539|FG001|STARTED|Overall Study||21
2859081|NCT00093756|3561538|FG000|COMPLETED|Overall Study||27
2859082|NCT00093756|3561539|FG001|COMPLETED|Overall Study||21
2859083|NCT00093756|3561538|FG000|NOT COMPLETED|Overall Study||0
2859084|NCT00093756|3561539|FG001|NOT COMPLETED|Overall Study||0
2859085|NCT00093782|3561547|FG000|STARTED|Overall Study||36
2859086|NCT00093782|3561547|FG000|COMPLETED|Overall Study||36
2859087|NCT00093782|3561547|FG000|NOT COMPLETED|Overall Study||0
2859088|NCT00093795|3561554|FG000|STARTED|Overall Study||1630
2859089|NCT00093795|3561555|FG001|STARTED|Overall Study||1634
2859090|NCT00093795|3561556|FG002|STARTED|Overall Study||1630
2859091|NCT00093795|3561554|FG000|COMPLETED|Overall Study||1610
2859092|NCT00093795|3561555|FG001|COMPLETED|Overall Study||1618
2859093|NCT00093795|3561556|FG002|COMPLETED|Overall Study||1613
2859094|NCT00093795|3561554|FG000|NOT COMPLETED|Overall Study||20
2859095|NCT00093795|3561555|FG001|NOT COMPLETED|Overall Study||16
2859096|NCT00093795|3561556|FG002|NOT COMPLETED|Overall Study||17
2859097|NCT00093808|3561564|FG000|STARTED|Overall Study||47
2859098|NCT00093808|3561564|FG000|COMPLETED|Overall Study||45
2859099|NCT00093808|3561564|FG000|NOT COMPLETED|Overall Study||2
2859100|NCT00093847|3561570|FG000|STARTED|Overall Study||39
2859101|NCT00093847|3561571|FG001|STARTED|Overall Study||34
2859102|NCT00093847|3561570|FG000|COMPLETED|Overall Study||31
2859103|NCT00093847|3561571|FG001|COMPLETED|Overall Study||24
2859104|NCT00093847|3561570|FG000|NOT COMPLETED|Overall Study||8
2859105|NCT00093847|3561571|FG001|NOT COMPLETED|Overall Study||10
2859106|NCT00093964|3561579|FG000|STARTED|Overall Study||41
2859107|NCT00093964|3561580|FG001|STARTED|Overall Study||40
2859108|NCT00093964|3561579|FG000|COMPLETED|Overall Study||41
2859109|NCT00093964|3561580|FG001|COMPLETED|Overall Study||40
2859110|NCT00093964|3561579|FG000|NOT COMPLETED|Overall Study||0
2859111|NCT00093964|3561580|FG001|NOT COMPLETED|Overall Study||0
2859112|NCT00094055|3561588|FG000|STARTED|Overall Study||60
2859113|NCT00094055|3561588|FG000|COMPLETED|Overall Study||0
2859114|NCT00094055|3561588|FG000|NOT COMPLETED|Overall Study||60
2859115|NCT00094094|3561592|FG000|STARTED|Overall Study||32
2859116|NCT00094094|3561592|FG000|COMPLETED|Overall Study||0
2859117|NCT00094094|3561592|FG000|NOT COMPLETED|Overall Study||32
2859118|NCT00094107|3561596|FG000|STARTED|Overall Study||32
2859119|NCT00094107|3561596|FG000|COMPLETED|Overall Study||0
2859120|NCT00094107|3561596|FG000|NOT COMPLETED|Overall Study||32
2859121|NCT00094172|3561602|FG000|STARTED|Overall Study|Safety Sample: 49; Intent-to-Treat Sample: 49; Per Protocol Sample: 39|50
2859122|NCT00094172|3561603|FG001|STARTED|Overall Study|Safety Sample: 32; Intent-to-Treat Sample: 32; Per Protocol Sample: 28|32
2859123|NCT00094172|3561602|FG000|COMPLETED|Overall Study||36
2859124|NCT00094172|3561603|FG001|COMPLETED|Overall Study||25
2859125|NCT00094172|3561602|FG000|NOT COMPLETED|Overall Study||14
2859126|NCT00094172|3561603|FG001|NOT COMPLETED|Overall Study||7
2859127|NCT00094211|3561613|FG000|STARTED|Overall Study||221
2859128|NCT00094211|3561614|FG001|STARTED|Overall Study||259
2859129|NCT00094211|3561615|FG002|STARTED|Overall Study||230
2859130|NCT00094211|3561616|FG003|STARTED|Overall Study||186
2859131|NCT00094211|3561613|FG000|COMPLETED|Overall Study||212
2859132|NCT00094211|3561614|FG001|COMPLETED|Overall Study||251
2859133|NCT00094211|3561615|FG002|COMPLETED|Overall Study||220
2859134|NCT00094211|3561616|FG003|COMPLETED|Overall Study||179
2859135|NCT00094211|3561613|FG000|NOT COMPLETED|Overall Study||9
2859136|NCT00094211|3561614|FG001|NOT COMPLETED|Overall Study||8
2859137|NCT00094211|3561615|FG002|NOT COMPLETED|Overall Study||10
2859138|NCT00094211|3561616|FG003|NOT COMPLETED|Overall Study||7
2859139|NCT00094302|3561632|FG000|STARTED|Overall Study||1723
2859140|NCT00094302|3561633|FG001|STARTED|Overall Study||1722
2859141|NCT00094302|3561632|FG000|COMPLETED|Overall Study||1306
2859142|NCT00094302|3561633|FG001|COMPLETED|Overall Study||1316
2859143|NCT00094302|3561632|FG000|NOT COMPLETED|Overall Study||417
2859144|NCT00094302|3561633|FG001|NOT COMPLETED|Overall Study||406
2859145|NCT00094328|3561639|FG000|STARTED|Overall Study|Received treatment|14
2859146|NCT00094328|3561639|FG000|COMPLETED|Overall Study|Completed 12 months on treatment|13
2859147|NCT00094328|3561639|FG000|NOT COMPLETED|Overall Study||1
2859148|NCT00094445|3561643|FG000|STARTED|Overall Study||50
2859149|NCT00094445|3561643|FG000|COMPLETED|Overall Study||44
2859150|NCT00094445|3561643|FG000|NOT COMPLETED|Overall Study||6
2859151|NCT00094458|3561650|FG000|STARTED|Main Study: Through Week 30||170
2859152|NCT00094458|3561651|FG001|STARTED|Main Study: Through Week 30||169
2859153|NCT00094458|3561652|FG002|STARTED|Main Study: Through Week 30||169
2859154|NCT00094458|3561653|FG003|STARTED|Main Study: Through Week 30||0
2859155|NCT00094458|3561654|FG004|STARTED|Main Study: Through Week 30||0
2859156|NCT00094458|3561655|FG005|STARTED|Main Study: Through Week 30||0
2859157|NCT00094458|3561650|FG000|COMPLETED|Main Study: Through Week 30||86
2859158|NCT00094458|3561651|FG001|COMPLETED|Main Study: Through Week 30||111
2859159|NCT00094458|3561652|FG002|COMPLETED|Main Study: Through Week 30||121
2859160|NCT00094458|3561653|FG003|COMPLETED|Main Study: Through Week 30||0
2859161|NCT00094458|3561654|FG004|COMPLETED|Main Study: Through Week 30||0
2859162|NCT00094458|3561655|FG005|COMPLETED|Main Study: Through Week 30||0
2859163|NCT00094458|3561650|FG000|NOT COMPLETED|Main Study: Through Week 30||84
2859164|NCT00094458|3561651|FG001|NOT COMPLETED|Main Study: Through Week 30||58
2859165|NCT00094458|3561652|FG002|NOT COMPLETED|Main Study: Through Week 30||48
2859166|NCT00094458|3561653|FG003|NOT COMPLETED|Main Study: Through Week 30||0
2859167|NCT00094458|3561654|FG004|NOT COMPLETED|Main Study: Through Week 30||0
2859168|NCT00094458|3561655|FG005|NOT COMPLETED|Main Study: Through Week 30||0
2859169|NCT00094458|3561650|FG000|STARTED|Study Extension: Week 30 Through Week 50||75
2859170|NCT00094458|3561651|FG001|STARTED|Study Extension: Week 30 Through Week 50||97
2859171|NCT00094458|3561652|FG002|STARTED|Study Extension: Week 30 Through Week 50||108
2859172|NCT00094458|3561653|FG003|STARTED|Study Extension: Week 30 Through Week 50||0
2859173|NCT00094458|3561654|FG004|STARTED|Study Extension: Week 30 Through Week 50||0
2859174|NCT00094458|3561655|FG005|STARTED|Study Extension: Week 30 Through Week 50||0
2859175|NCT00094458|3561650|FG000|COMPLETED|Study Extension: Week 30 Through Week 50||67
2859176|NCT00094458|3561651|FG001|COMPLETED|Study Extension: Week 30 Through Week 50||85
2859177|NCT00094458|3561652|FG002|COMPLETED|Study Extension: Week 30 Through Week 50||90
2859178|NCT00094458|3561653|FG003|COMPLETED|Study Extension: Week 30 Through Week 50||0
2859179|NCT00094458|3561654|FG004|COMPLETED|Study Extension: Week 30 Through Week 50||0
2859180|NCT00094458|3561655|FG005|COMPLETED|Study Extension: Week 30 Through Week 50||0
2859181|NCT00094458|3561650|FG000|NOT COMPLETED|Study Extension: Week 30 Through Week 50||8
2859182|NCT00094458|3561651|FG001|NOT COMPLETED|Study Extension: Week 30 Through Week 50||12
2859183|NCT00094458|3561652|FG002|NOT COMPLETED|Study Extension: Week 30 Through Week 50||18
2859184|NCT00094458|3561653|FG003|NOT COMPLETED|Study Extension: Week 30 Through Week 50||0
2859185|NCT00094458|3561654|FG004|NOT COMPLETED|Study Extension: Week 30 Through Week 50||0
2859186|NCT00094458|3561655|FG005|NOT COMPLETED|Study Extension: Week 30 Through Week 50||0
2859187|NCT00094458|3561650|FG000|STARTED|OLE: Open-Label Extension||0
2859188|NCT00094458|3561651|FG001|STARTED|OLE: Open-Label Extension||0
2859189|NCT00094458|3561652|FG002|STARTED|OLE: Open-Label Extension||0
2859190|NCT00094458|3561653|FG003|STARTED|OLE: Open-Label Extension||8
2859191|NCT00094458|3561654|FG004|STARTED|OLE: Open-Label Extension||18
2859192|NCT00094458|3561655|FG005|STARTED|OLE: Open-Label Extension||17
2859193|NCT00094458|3561650|FG000|COMPLETED|OLE: Open-Label Extension||0
2859194|NCT00094458|3561651|FG001|COMPLETED|OLE: Open-Label Extension||0
2859195|NCT00094458|3561652|FG002|COMPLETED|OLE: Open-Label Extension||0
2859196|NCT00094458|3561653|FG003|COMPLETED|OLE: Open-Label Extension||7
2859197|NCT00094458|3561654|FG004|COMPLETED|OLE: Open-Label Extension||13
2859198|NCT00094458|3561655|FG005|COMPLETED|OLE: Open-Label Extension||13
2859199|NCT00094458|3561650|FG000|NOT COMPLETED|OLE: Open-Label Extension||0
2859200|NCT00094458|3561651|FG001|NOT COMPLETED|OLE: Open-Label Extension||0
2859201|NCT00094458|3561652|FG002|NOT COMPLETED|OLE: Open-Label Extension||0
2859202|NCT00094458|3561653|FG003|NOT COMPLETED|OLE: Open-Label Extension||1
2859203|NCT00094458|3561654|FG004|NOT COMPLETED|OLE: Open-Label Extension||5
2859204|NCT00094458|3561655|FG005|NOT COMPLETED|OLE: Open-Label Extension||4
2859205|NCT00094497|3561671|FG000|STARTED|Overall Study||151
2859206|NCT00094497|3561672|FG001|STARTED|Overall Study||153
2859207|NCT00094497|3561671|FG000|Treated|Overall Study||148
2859208|NCT00094497|3561672|FG001|Treated|Overall Study||149
2859209|NCT00094497|3561671|FG000|Received Second Line Therapy|Overall Study||84
2859210|NCT00094497|3561672|FG001|Received Second Line Therapy|Overall Study||101
2859211|NCT00094497|3561671|FG000|COMPLETED|Overall Study||151
2859212|NCT00094497|3561672|FG001|COMPLETED|Overall Study||153
2859213|NCT00094497|3561671|FG000|NOT COMPLETED|Overall Study||0
2859214|NCT00094497|3561672|FG001|NOT COMPLETED|Overall Study||0
2859215|NCT00094536|3561678|FG000|STARTED|Inclusion Exclusion Evaluation||106
2859216|NCT00094536|3561678|FG000|COMPLETED|Inclusion Exclusion Evaluation||82
2859217|NCT00094536|3561678|FG000|NOT COMPLETED|Inclusion Exclusion Evaluation||24
2859218|NCT00094536|3561678|FG000|STARTED|Treatment and Follow-up|82 subjects qualified for and underwent the study treatment.|82
2859219|NCT00094536|3561678|FG000|12 Month Follow-up|Treatment and Follow-up|69 subjects were evaluated at 1-year post-treatment for the primary endpoint of success.|69
2859220|NCT00094536|3561678|FG000|24 Month Follow-up|Treatment and Follow-up||53
2859221|NCT00094536|3561678|FG000|36 Month Follow-up|Treatment and Follow-up||51
2859222|NCT00094536|3561678|FG000|COMPLETED|Treatment and Follow-up|51 subjects successfully completed the study.|51
2859223|NCT00094536|3561678|FG000|NOT COMPLETED|Treatment and Follow-up||31
2859224|NCT00094575|3561684|FG000|STARTED|Overall Study||444
2859225|NCT00094575|3561685|FG001|STARTED|Overall Study||437
2859226|NCT00094575|3561684|FG000|COMPLETED|Overall Study||298
2859227|NCT00094575|3561685|FG001|COMPLETED|Overall Study||291
2859228|NCT00094575|3561684|FG000|NOT COMPLETED|Overall Study||146
2859229|NCT00094575|3561685|FG001|NOT COMPLETED|Overall Study||146
2859230|NCT00094653|3561696|FG000|STARTED|Overall Study||403
2859231|NCT00094653|3561697|FG001|STARTED|Overall Study||137
2859232|NCT00094653|3561698|FG002|STARTED|Overall Study||136
2859233|NCT00094653|3561696|FG000|Treated|Overall Study||381
2859234|NCT00094653|3561697|FG001|Treated|Overall Study||131
2859235|NCT00094653|3561698|FG002|Treated|Overall Study||131
2859236|NCT00094653|3561696|FG000|COMPLETED|Overall Study||82
2859237|NCT00094653|3561697|FG001|COMPLETED|Overall Study||31
2859238|NCT00094653|3561698|FG002|COMPLETED|Overall Study||10
2859239|NCT00094653|3561696|FG000|NOT COMPLETED|Overall Study||321
2859240|NCT00094653|3561697|FG001|NOT COMPLETED|Overall Study||106
2859241|NCT00094653|3561698|FG002|NOT COMPLETED|Overall Study||126
2859242|NCT00094757|3561710|FG000|STARTED|Overall Study||205
2859243|NCT00094757|3561711|FG001|STARTED|Overall Study||206
2859244|NCT00094757|3561712|FG002|STARTED|Overall Study||110
2859245|NCT00094757|3561710|FG000|COMPLETED|Overall Study||152
2859246|NCT00094757|3561711|FG001|COMPLETED|Overall Study||144
2859247|NCT00094757|3561712|FG002|COMPLETED|Overall Study||80
2859248|NCT00094757|3561710|FG000|NOT COMPLETED|Overall Study||53
2859249|NCT00094757|3561711|FG001|NOT COMPLETED|Overall Study||62
2859250|NCT00094757|3561712|FG002|NOT COMPLETED|Overall Study||30
2859251|NCT00094770|3561722|FG000|STARTED|Year 1 ( Week 0 to Week 52)||588
2859252|NCT00094770|3561723|FG001|STARTED|Year 1 ( Week 0 to Week 52)||584
2859253|NCT00094770|3561722|FG000|COMPLETED|Year 1 ( Week 0 to Week 52)|4 Participants who Completed Week 52, Did NOT Enter second year|386
2859254|NCT00094770|3561723|FG001|COMPLETED|Year 1 ( Week 0 to Week 52)|11 Participants who Completed Week 52, Did NOT Enter second year|412
2859255|NCT00094770|3561722|FG000|NOT COMPLETED|Year 1 ( Week 0 to Week 52)||202
2859256|NCT00094770|3561723|FG001|NOT COMPLETED|Year 1 ( Week 0 to Week 52)||172
2859257|NCT00094770|3561722|FG000|STARTED|Year 2 (Week 0 to Week 104)||588
2859258|NCT00094770|3561723|FG001|STARTED|Year 2 (Week 0 to Week 104)||584
2859259|NCT00094770|3561722|FG000|COMPLETED|Year 2 (Week 0 to Week 104)||255
2859260|NCT00094770|3561723|FG001|COMPLETED|Year 2 (Week 0 to Week 104)||264
2859261|NCT00094770|3561722|FG000|NOT COMPLETED|Year 2 (Week 0 to Week 104)||333
2859262|NCT00094770|3561723|FG001|NOT COMPLETED|Year 2 (Week 0 to Week 104)||320
2859263|NCT00094809|3561731|FG000|STARTED|Overall Study||126
2859264|NCT00094809|3561732|FG001|STARTED|Overall Study||126
2859265|NCT00094809|3561731|FG000|Received Study Drug|Overall Study||124
2859266|NCT00094809|3561732|FG001|Received Study Drug|Overall Study||118
2859267|NCT00094809|3561731|FG000|Properly Consented; Received Study Drug|Overall Study||123
2859268|NCT00094809|3561732|FG001|Properly Consented; Received Study Drug|Overall Study||118
2859269|NCT00094809|3561731|FG000|Completed All 4 Cycles of Treatment|Overall Study||98
2859270|NCT00094809|3561732|FG001|Completed All 4 Cycles of Treatment|Overall Study||90
2859271|NCT00094809|3561731|FG000|COMPLETED|Overall Study|Subjects who completed treatment and Long term follow up (LTFU)|74
2859272|NCT00094809|3561732|FG001|COMPLETED|Overall Study|Subjects who completed treatment and LTFU|61
2859273|NCT00094809|3561731|FG000|NOT COMPLETED|Overall Study||52
2859274|NCT00094809|3561732|FG001|NOT COMPLETED|Overall Study||65
2859275|NCT00094835|3561745|FG000|STARTED|Overall Study||9
2859276|NCT00094835|3561746|FG001|STARTED|Overall Study||11
2859277|NCT00094835|3561747|FG002|STARTED|Overall Study||7
2859278|NCT00094835|3561748|FG003|STARTED|Overall Study||5
2859279|NCT00094835|3561749|FG004|STARTED|Overall Study||7
2859280|NCT00094835|3561750|FG005|STARTED|Overall Study||6
2859281|NCT00094835|3561751|FG006|STARTED|Overall Study||6
2859282|NCT00094835|3561745|FG000|Treated With Motesanib|Overall Study||6
2859283|NCT00094835|3561746|FG001|Treated With Motesanib|Overall Study||11
2859284|NCT00094835|3561747|FG002|Treated With Motesanib|Overall Study||6
2859285|NCT00094835|3561748|FG003|Treated With Motesanib|Overall Study||4
2859286|NCT00094835|3561749|FG004|Treated With Motesanib|Overall Study||7
2859287|NCT00094835|3561750|FG005|Treated With Motesanib|Overall Study||5
2859288|NCT00094835|3561751|FG006|Treated With Motesanib|Overall Study||6
2859289|NCT00094835|3561745|FG000|COMPLETED|Overall Study||5
2859290|NCT00094835|3561746|FG001|COMPLETED|Overall Study||8
2859291|NCT00094835|3561747|FG002|COMPLETED|Overall Study||4
2859292|NCT00094835|3561748|FG003|COMPLETED|Overall Study||4
2859293|NCT00094835|3561749|FG004|COMPLETED|Overall Study||3
2859294|NCT00094835|3561750|FG005|COMPLETED|Overall Study||3
2859295|NCT00094835|3561751|FG006|COMPLETED|Overall Study||4
2859296|NCT00094835|3561745|FG000|NOT COMPLETED|Overall Study||4
2859297|NCT00094835|3561746|FG001|NOT COMPLETED|Overall Study||3
2859298|NCT00094835|3561747|FG002|NOT COMPLETED|Overall Study||3
2859299|NCT00094835|3561748|FG003|NOT COMPLETED|Overall Study||1
2859300|NCT00094835|3561749|FG004|NOT COMPLETED|Overall Study||4
2859301|NCT00094835|3561750|FG005|NOT COMPLETED|Overall Study||3
2859302|NCT00094835|3561751|FG006|NOT COMPLETED|Overall Study||2
2859303|NCT00094861|3561774|FG000|STARTED|Overall Study||46
2859304|NCT00094861|3561775|FG001|STARTED|Overall Study||49
2859305|NCT00094861|3561774|FG000|Participants Treated|Overall Study||46
2859306|NCT00094861|3561775|FG001|Participants Treated|Overall Study||48
2859307|NCT00094861|3561774|FG000|COMPLETED|Overall Study|Participants who completed the acute dysphagia evaluation phase|28
2859308|NCT00094861|3561775|FG001|COMPLETED|Overall Study|Participants who completed the acute dysphagia evaluation phase|40
2859309|NCT00094861|3561774|FG000|NOT COMPLETED|Overall Study||18
2859310|NCT00094861|3561775|FG001|NOT COMPLETED|Overall Study||9
2859311|NCT00094887|3561783|FG000|STARTED|Overall Study||75
2859312|NCT00094887|3561784|FG001|STARTED|Overall Study||75
2859313|NCT00094887|3561783|FG000|Safety Population|Overall Study||75
2859314|NCT00094887|3561784|FG001|Safety Population|Overall Study||75
2859315|NCT00094887|3561783|FG000|Intent to Treat Population|Overall Study||75
2859316|NCT00094887|3561784|FG001|Intent to Treat Population|Overall Study||75
2859317|NCT00094887|3561783|FG000|Per Protocol Analysis Set|Overall Study||71
2859318|NCT00094887|3561784|FG001|Per Protocol Analysis Set|Overall Study||71
2859319|NCT00094887|3561783|FG000|Primary Efficacy Population|Overall Study||65
2859320|NCT00094887|3561784|FG001|Primary Efficacy Population|Overall Study||64
2859321|NCT00094887|3561783|FG000|COMPLETED|Overall Study||71
2859322|NCT00094887|3561784|FG001|COMPLETED|Overall Study||71
2859323|NCT00094887|3561783|FG000|NOT COMPLETED|Overall Study||4
2859324|NCT00094887|3561784|FG001|NOT COMPLETED|Overall Study||4
2859325|NCT00094900|3561790|FG000|STARTED|Overall Study||11
2859326|NCT00094900|3561790|FG000|COMPLETED|Overall Study||10
2859327|NCT00094900|3561790|FG000|NOT COMPLETED|Overall Study||1
2859328|NCT00095056|3561796|FG000|STARTED|Phase A (Weeks 0-12)||65
2859329|NCT00095056|3561797|FG001|STARTED|Phase A (Weeks 0-12)||26
2859330|NCT00095056|3561796|FG000|COMPLETED|Phase A (Weeks 0-12)||58
2859331|NCT00095056|3561797|FG001|COMPLETED|Phase A (Weeks 0-12)||25
2859332|NCT00095056|3561796|FG000|NOT COMPLETED|Phase A (Weeks 0-12)||7
2859333|NCT00095056|3561797|FG001|NOT COMPLETED|Phase A (Weeks 0-12)||1
2859334|NCT00095056|3561796|FG000|STARTED|Phase B (Weeks 12-54)|2 randomized patients completed Period 1 but did not enter Period 2.|56
2859335|NCT00095056|3561797|FG001|STARTED|Phase B (Weeks 12-54)||25
2859336|NCT00095056|3561796|FG000|COMPLETED|Phase B (Weeks 12-54)||46
2859337|NCT00095056|3561797|FG001|COMPLETED|Phase B (Weeks 12-54)||20
2859338|NCT00095056|3561796|FG000|NOT COMPLETED|Phase B (Weeks 12-54)||10
2859339|NCT00095056|3561797|FG001|NOT COMPLETED|Phase B (Weeks 12-54)||5
2859340|NCT00095121|3561805|FG000|STARTED|Double-Blind (Study Weeks 0 Through 48)||115
2859341|NCT00095121|3561806|FG001|STARTED|Double-Blind (Study Weeks 0 Through 48)||58
2859342|NCT00095121|3561805|FG000|COMPLETED|Double-Blind (Study Weeks 0 Through 48)||112
2859343|NCT00095121|3561806|FG001|COMPLETED|Double-Blind (Study Weeks 0 Through 48)||58
2859344|NCT00095121|3561805|FG000|NOT COMPLETED|Double-Blind (Study Weeks 0 Through 48)||3
2859345|NCT00095121|3561806|FG001|NOT COMPLETED|Double-Blind (Study Weeks 0 Through 48)||0
2859346|NCT00095121|3561805|FG000|STARTED|Open-Label (Study Weeks 49 Through 240)||108
2859347|NCT00095121|3561806|FG001|STARTED|Open-Label (Study Weeks 49 Through 240)||54
2859348|NCT00095121|3561805|FG000|Received Lamivudine (LAM) After Week 96|Open-Label (Study Weeks 49 Through 240)||21
2859349|NCT00095121|3561806|FG001|Received Lamivudine (LAM) After Week 96|Open-Label (Study Weeks 49 Through 240)||11
2859350|NCT00095121|3561805|FG000|COMPLETED|Open-Label (Study Weeks 49 Through 240)|Completed the 240-week study period either on or off treatment at Week 240.|46
2859351|NCT00095121|3561806|FG001|COMPLETED|Open-Label (Study Weeks 49 Through 240)|Completed the 240-week study period either on or off treatment at Week 240.|35
2859352|NCT00095121|3561805|FG000|NOT COMPLETED|Open-Label (Study Weeks 49 Through 240)||62
2859353|NCT00095121|3561806|FG001|NOT COMPLETED|Open-Label (Study Weeks 49 Through 240)||19
2859354|NCT00095147|3561825|FG000|STARTED|Double-blind Period 1 (Days 1-197)||156
2859355|NCT00095147|3561826|FG001|STARTED|Double-blind Period 1 (Days 1-197)||165
2859356|NCT00095147|3561827|FG002|STARTED|Double-blind Period 1 (Days 1-197)||110
2859357|NCT00095147|3561828|FG003|STARTED|Double-blind Period 1 (Days 1-197)||0
2859358|NCT00095147|3561829|FG004|STARTED|Double-blind Period 1 (Days 1-197)||0
2859359|NCT00095147|3561825|FG000|COMPLETED|Double-blind Period 1 (Days 1-197)||147
2859360|NCT00095147|3561826|FG001|COMPLETED|Double-blind Period 1 (Days 1-197)||152
2859361|NCT00095147|3561827|FG002|COMPLETED|Double-blind Period 1 (Days 1-197)||107
2859362|NCT00095147|3561828|FG003|COMPLETED|Double-blind Period 1 (Days 1-197)||0
2859363|NCT00095147|3561829|FG004|COMPLETED|Double-blind Period 1 (Days 1-197)||0
2859364|NCT00095147|3561825|FG000|NOT COMPLETED|Double-blind Period 1 (Days 1-197)||9
2859365|NCT00095147|3561826|FG001|NOT COMPLETED|Double-blind Period 1 (Days 1-197)||13
2859366|NCT00095147|3561827|FG002|NOT COMPLETED|Double-blind Period 1 (Days 1-197)||3
2859367|NCT00095147|3561828|FG003|NOT COMPLETED|Double-blind Period 1 (Days 1-197)||0
2859368|NCT00095147|3561829|FG004|NOT COMPLETED|Double-blind Period 1 (Days 1-197)||0
2859369|NCT00095147|3561825|FG000|STARTED|Double-blind Period 2 (Days 198-365)||147
2859370|NCT00095147|3561826|FG001|STARTED|Double-blind Period 2 (Days 198-365)||152
2859371|NCT00095147|3561827|FG002|STARTED|Double-blind Period 2 (Days 198-365)||0
2859372|NCT00095147|3561828|FG003|STARTED|Double-blind Period 2 (Days 198-365)||107
2859373|NCT00095147|3561829|FG004|STARTED|Double-blind Period 2 (Days 198-365)||0
2859374|NCT00095147|3561825|FG000|COMPLETED|Double-blind Period 2 (Days 198-365)||139
2859375|NCT00095147|3561826|FG001|COMPLETED|Double-blind Period 2 (Days 198-365)||141
2859376|NCT00095147|3561827|FG002|COMPLETED|Double-blind Period 2 (Days 198-365)||0
2859377|NCT00095147|3561828|FG003|COMPLETED|Double-blind Period 2 (Days 198-365)||104
2859378|NCT00095147|3561829|FG004|COMPLETED|Double-blind Period 2 (Days 198-365)||0
2859379|NCT00095147|3561825|FG000|NOT COMPLETED|Double-blind Period 2 (Days 198-365)||8
2859380|NCT00095147|3561826|FG001|NOT COMPLETED|Double-blind Period 2 (Days 198-365)||11
2859381|NCT00095147|3561827|FG002|NOT COMPLETED|Double-blind Period 2 (Days 198-365)||0
2859382|NCT00095147|3561828|FG003|NOT COMPLETED|Double-blind Period 2 (Days 198-365)||3
2859383|NCT00095147|3561829|FG004|NOT COMPLETED|Double-blind Period 2 (Days 198-365)||0
2859384|NCT00095147|3561825|FG000|STARTED|Long-term Extension Period||0
2859385|NCT00095147|3561826|FG001|STARTED|Long-term Extension Period||0
2859386|NCT00095147|3561827|FG002|STARTED|Long-term Extension Period||0
2859387|NCT00095147|3561828|FG003|STARTED|Long-term Extension Period||0
2859388|NCT00095147|3561829|FG004|STARTED|Long-term Extension Period||372
2859389|NCT00095147|3561825|FG000|COMPLETED|Long-term Extension Period||0
2859390|NCT00095147|3561826|FG001|COMPLETED|Long-term Extension Period||0
2859391|NCT00095147|3561827|FG002|COMPLETED|Long-term Extension Period||0
2859392|NCT00095147|3561828|FG003|COMPLETED|Long-term Extension Period||0
2859393|NCT00095147|3561829|FG004|COMPLETED|Long-term Extension Period||327
2859394|NCT00095147|3561825|FG000|NOT COMPLETED|Long-term Extension Period||0
2859395|NCT00095147|3561826|FG001|NOT COMPLETED|Long-term Extension Period||0
2859396|NCT00095147|3561827|FG002|NOT COMPLETED|Long-term Extension Period||0
2859397|NCT00095147|3561828|FG003|NOT COMPLETED|Long-term Extension Period||0
2859398|NCT00095147|3561829|FG004|NOT COMPLETED|Long-term Extension Period||45
2859399|NCT00095173|3561847|FG000|STARTED|Open-Label Lead-In Phase (Period A)||190
2859400|NCT00095173|3561848|FG001|STARTED|Open-Label Lead-In Phase (Period A)||0
2859401|NCT00095173|3561849|FG002|STARTED|Open-Label Lead-In Phase (Period A)||0
2859402|NCT00095173|3561850|FG003|STARTED|Open-Label Lead-In Phase (Period A)||0
2859403|NCT00095173|3561851|FG004|STARTED|Open-Label Lead-In Phase (Period A)||0
2859404|NCT00095173|3561852|FG005|STARTED|Open-Label Lead-In Phase (Period A)||0
2859405|NCT00095173|3561847|FG000|COMPLETED|Open-Label Lead-In Phase (Period A)||170
2859406|NCT00095173|3561848|FG001|COMPLETED|Open-Label Lead-In Phase (Period A)||0
2859407|NCT00095173|3561849|FG002|COMPLETED|Open-Label Lead-In Phase (Period A)||0
2859408|NCT00095173|3561850|FG003|COMPLETED|Open-Label Lead-In Phase (Period A)||0
2859409|NCT00095173|3561851|FG004|COMPLETED|Open-Label Lead-In Phase (Period A)||0
2859410|NCT00095173|3561852|FG005|COMPLETED|Open-Label Lead-In Phase (Period A)||0
2859411|NCT00095173|3561847|FG000|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||20
2859412|NCT00095173|3561848|FG001|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||0
2859413|NCT00095173|3561849|FG002|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||0
2859414|NCT00095173|3561850|FG003|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||0
2859415|NCT00095173|3561851|FG004|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||0
2859416|NCT00095173|3561852|FG005|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||0
2859417|NCT00095173|3561847|FG000|STARTED|Double-Blind Phase (Period B)|All participants did not continue; responders entered Period B; non-responders re-entered Period C.|0
2859418|NCT00095173|3561848|FG001|STARTED|Double-Blind Phase (Period B)|123 responders from Period A qualified;122 entered and were randomized to abatacept and placebo.|60
2859419|NCT00095173|3561849|FG002|STARTED|Double-Blind Phase (Period B)|123 responders from Period A qualified;122 entered and were randomized to abatacept and placebo.|62
2859420|NCT00095173|3561850|FG003|STARTED|Double-Blind Phase (Period B)||0
2859421|NCT00095173|3561851|FG004|STARTED|Double-Blind Phase (Period B)||0
2859422|NCT00095173|3561852|FG005|STARTED|Double-Blind Phase (Period B)||0
2859423|NCT00095173|3561847|FG000|COMPLETED|Double-Blind Phase (Period B)||0
2859424|NCT00095173|3561848|FG001|COMPLETED|Double-Blind Phase (Period B)||49
2859425|NCT00095173|3561849|FG002|COMPLETED|Double-Blind Phase (Period B)||31
2859426|NCT00095173|3561850|FG003|COMPLETED|Double-Blind Phase (Period B)||0
2859427|NCT00095173|3561851|FG004|COMPLETED|Double-Blind Phase (Period B)||0
2859428|NCT00095173|3561852|FG005|COMPLETED|Double-Blind Phase (Period B)||0
2859429|NCT00095173|3561847|FG000|NOT COMPLETED|Double-Blind Phase (Period B)||0
2859430|NCT00095173|3561848|FG001|NOT COMPLETED|Double-Blind Phase (Period B)||11
2859431|NCT00095173|3561849|FG002|NOT COMPLETED|Double-Blind Phase (Period B)||31
2859432|NCT00095173|3561850|FG003|NOT COMPLETED|Double-Blind Phase (Period B)||0
2859433|NCT00095173|3561851|FG004|NOT COMPLETED|Double-Blind Phase (Period B)||0
2859434|NCT00095173|3561852|FG005|NOT COMPLETED|Double-Blind Phase (Period B)||0
2859435|NCT00095173|3561847|FG000|STARTED|Open-Label Extension Phase (Period C)||0
2859436|NCT00095173|3561848|FG001|STARTED|Open-Label Extension Phase (Period C)||0
2859437|NCT00095173|3561849|FG002|STARTED|Open-Label Extension Phase (Period C)||0
2859438|NCT00095173|3561850|FG003|STARTED|Open-Label Extension Phase (Period C)|Participants were non-responders from Period A who re-entered in Period C.|36
2859439|NCT00095173|3561851|FG004|STARTED|Open-Label Extension Phase (Period C)|Includes 47 who completed Period B with no flare and 11 who discontinued Period B due to a flare|58
2859440|NCT00095173|3561852|FG005|STARTED|Open-Label Extension Phase (Period C)|Includes 33 who discontinued Period B due to a flare and 26 who completed Period B with no flare|59
2859441|NCT00095173|3561847|FG000|COMPLETED|Open-Label Extension Phase (Period C)||0
2859442|NCT00095173|3561848|FG001|COMPLETED|Open-Label Extension Phase (Period C)||0
2859443|NCT00095173|3561849|FG002|COMPLETED|Open-Label Extension Phase (Period C)||0
2859444|NCT00095173|3561850|FG003|COMPLETED|Open-Label Extension Phase (Period C)||13
2859445|NCT00095173|3561851|FG004|COMPLETED|Open-Label Extension Phase (Period C)||29
2859446|NCT00095173|3561852|FG005|COMPLETED|Open-Label Extension Phase (Period C)||27
2859447|NCT00095173|3561847|FG000|NOT COMPLETED|Open-Label Extension Phase (Period C)||0
2859448|NCT00095173|3561848|FG001|NOT COMPLETED|Open-Label Extension Phase (Period C)||0
2859449|NCT00095173|3561849|FG002|NOT COMPLETED|Open-Label Extension Phase (Period C)||0
2859450|NCT00095173|3561850|FG003|NOT COMPLETED|Open-Label Extension Phase (Period C)||23
2859451|NCT00095173|3561851|FG004|NOT COMPLETED|Open-Label Extension Phase (Period C)||29
2859452|NCT00095173|3561852|FG005|NOT COMPLETED|Open-Label Extension Phase (Period C)||32
2859453|NCT00095199|3561870|FG000|STARTED|Overall Study|1 participant has no data in database; not included in analyses. Data was lost/destroyed at site.|302
2859454|NCT00095199|3561871|FG001|STARTED|Overall Study||304
2859455|NCT00095199|3561872|FG002|STARTED|Overall Study||167
2859456|NCT00095199|3561873|FG003|STARTED|Overall Study||166
2859457|NCT00095199|3561870|FG000|COMPLETED|Overall Study||6
2859458|NCT00095199|3561871|FG001|COMPLETED|Overall Study||62
2859459|NCT00095199|3561872|FG002|COMPLETED|Overall Study||7
2859460|NCT00095199|3561873|FG003|COMPLETED|Overall Study||23
2859461|NCT00095199|3561870|FG000|NOT COMPLETED|Overall Study||296
2859462|NCT00095199|3561871|FG001|NOT COMPLETED|Overall Study||242
2859463|NCT00095199|3561872|FG002|NOT COMPLETED|Overall Study||160
2859464|NCT00095199|3561873|FG003|NOT COMPLETED|Overall Study||143
2859465|NCT00095212|3561890|FG000|STARTED|Overall Study||13
2859466|NCT00095212|3561891|FG001|STARTED|Overall Study||12
2859467|NCT00095212|3561890|FG000|COMPLETED|Overall Study||12
2859468|NCT00095212|3561891|FG001|COMPLETED|Overall Study||9
2859469|NCT00095212|3561890|FG000|NOT COMPLETED|Overall Study||1
2859470|NCT00095212|3561891|FG001|NOT COMPLETED|Overall Study||3
2859471|NCT00095238|3561899|FG000|STARTED|Overall Study|number randomized|2067
2859472|NCT00095238|3561900|FG001|STARTED|Overall Study|number randomized|2061
2859473|NCT00095238|3561899|FG000|Safety (Treated) Population|Overall Study|Two participants were randomized but not treated; 1 randomized to irbesartan received placebo|2064
2859474|NCT00095238|3561900|FG001|Safety (Treated) Population|Overall Study|One participant randomized to irbesartan received placebo.|2062
2859475|NCT00095238|3561899|FG000|COMPLETED|Overall Study|completed double-blind therapy|1210
2859476|NCT00095238|3561900|FG001|COMPLETED|Overall Study|completed double-blind therapy|1209
2859477|NCT00095238|3561899|FG000|NOT COMPLETED|Overall Study||857
2859478|NCT00095238|3561900|FG001|NOT COMPLETED|Overall Study||852
2859479|NCT00095303|3561940|FG000|STARTED|Main Study||245
2859480|NCT00095303|3561941|FG001|STARTED|Main Study||235
2859481|NCT00095303|3561940|FG000|COMPLETED|Main Study||154
2859482|NCT00095303|3561941|FG001|COMPLETED|Main Study||148
2859483|NCT00095303|3561940|FG000|NOT COMPLETED|Main Study||91
2859484|NCT00095303|3561941|FG001|NOT COMPLETED|Main Study||87
2859485|NCT00095303|3561940|FG000|STARTED|Follow Up Study|199 (BSFT) gave permission for future contact; not a requirement to finish Main to start Follow up|199
2859486|NCT00095303|3561941|FG001|STARTED|Follow Up Study|179 (TAU) gave permission for future contact; not a requirement to finish Main to start Follow up|179
2859487|NCT00095303|3561940|FG000|COMPLETED|Follow Up Study||140
2859488|NCT00095303|3561941|FG001|COMPLETED|Follow Up Study||121
2859489|NCT00095303|3561940|FG000|NOT COMPLETED|Follow Up Study||59
2859490|NCT00095303|3561941|FG001|NOT COMPLETED|Follow Up Study||58
2859491|NCT00095498|3561950|FG000|STARTED|Overall Study||76
2859492|NCT00095498|3561951|FG001|STARTED|Overall Study||73
2859493|NCT00095498|3561952|FG002|STARTED|Overall Study||78
2859494|NCT00095498|3561950|FG000|Received Investigational Product|Overall Study||72
2859495|NCT00095498|3561951|FG001|Received Investigational Product|Overall Study||71
2859496|NCT00095498|3561952|FG002|Received Investigational Product|Overall Study||75
2859497|NCT00095498|3561950|FG000|COMPLETED|Overall Study||39
2859498|NCT00095498|3561951|FG001|COMPLETED|Overall Study||38
2859499|NCT00095498|3561952|FG002|COMPLETED|Overall Study||39
2859500|NCT00095498|3561950|FG000|NOT COMPLETED|Overall Study||37
2859501|NCT00095498|3561951|FG001|NOT COMPLETED|Overall Study||35
2859502|NCT00095498|3561952|FG002|NOT COMPLETED|Overall Study||39
2859503|NCT00095563|3561960|FG000|STARTED|Overall Study||39
2859504|NCT00095563|3561960|FG000|COMPLETED|Overall Study||39
2859505|NCT00095563|3561960|FG000|NOT COMPLETED|Overall Study||0
2859506|NCT00095576|3561966|FG000|STARTED|Overall Study||1484
2859507|NCT00095576|3561967|FG001|STARTED|Overall Study||1495
2859508|NCT00095576|3561966|FG000|VACCINATED AT VISIT 2 (Dose 1)|Overall Study||1484
2859509|NCT00095576|3561967|FG001|VACCINATED AT VISIT 2 (Dose 1)|Overall Study||1495
2859510|NCT00095576|3561966|FG000|VACCINATED AT VISIT 4 (Dose 2)|Overall Study||1426
2859511|NCT00095576|3561967|FG001|VACCINATED AT VISIT 4 (Dose 2)|Overall Study||1443
2859512|NCT00095576|3561966|FG000|VACCINATED AT VISIT 7 (Dose 3)|Overall Study||1328
2859513|NCT00095576|3561967|FG001|VACCINATED AT VISIT 7 (Dose 3)|Overall Study||1361
2918434|NCT00527124|3628649|FG000|STARTED|Overall Study||29
2859514|NCT00095576|3561966|FG000|COMPLETED|Overall Study|Subjects not completing entire study were eligible for observational long term follow up in V520-030|9
2859515|NCT00095576|3561967|FG001|COMPLETED|Overall Study|Subjects not completing entire study were eligible for observational long term follow up in V520-030|14
2859516|NCT00095576|3561966|FG000|NOT COMPLETED|Overall Study||1475
2859517|NCT00095576|3561967|FG001|NOT COMPLETED|Overall Study||1481
2859518|NCT00095628|3561973|FG000|STARTED|Overall Study||21
2859519|NCT00095628|3561973|FG000|COMPLETED|Overall Study||20
2859520|NCT00095628|3561973|FG000|NOT COMPLETED|Overall Study||1
2859521|NCT00095836|3561977|FG000|STARTED|Overall Study||27
2859522|NCT00095836|3561977|FG000|COMPLETED|Overall Study||23
2859523|NCT00095836|3561977|FG000|NOT COMPLETED|Overall Study||4
2859524|NCT00095875|3561983|FG000|STARTED|Overall Study||70
2859525|NCT00095875|3561984|FG001|STARTED|Overall Study||75
2859526|NCT00095875|3561983|FG000|COMPLETED|Overall Study||56
2859527|NCT00095875|3561984|FG001|COMPLETED|Overall Study||66
2859528|NCT00095875|3561983|FG000|NOT COMPLETED|Overall Study||14
2859529|NCT00095875|3561984|FG001|NOT COMPLETED|Overall Study||9
2859530|NCT00095940|3561997|FG000|STARTED|Molecular Biology Phase||2
2859531|NCT00095940|3561998|FG001|STARTED|Molecular Biology Phase||2
2859532|NCT00095940|3561999|FG002|STARTED|Molecular Biology Phase|No surgery prior to study enrollment; not eligible for the molecular biology phase|0
2859533|NCT00095940|3562000|FG003|STARTED|Molecular Biology Phase||0
2859534|NCT00095940|3562001|FG004|STARTED|Molecular Biology Phase||0
2859535|NCT00095940|3562002|FG005|STARTED|Molecular Biology Phase|No surgery prior to study enrollment; not eligible for the molecular biology phase|0
2859536|NCT00095940|3562003|FG006|STARTED|Molecular Biology Phase||2
2859537|NCT00095940|3562004|FG007|STARTED|Molecular Biology Phase||2
2859538|NCT00095940|3562005|FG008|STARTED|Molecular Biology Phase|No surgery prior to study enrollment; not eligible for the molecular biology phase|0
2859539|NCT00095940|3561997|FG000|COMPLETED|Molecular Biology Phase||2
2859540|NCT00095940|3561998|FG001|COMPLETED|Molecular Biology Phase||2
2859541|NCT00095940|3561999|FG002|COMPLETED|Molecular Biology Phase||0
2859542|NCT00095940|3562000|FG003|COMPLETED|Molecular Biology Phase||0
2859543|NCT00095940|3562001|FG004|COMPLETED|Molecular Biology Phase||0
2859544|NCT00095940|3562002|FG005|COMPLETED|Molecular Biology Phase||0
2859545|NCT00095940|3562003|FG006|COMPLETED|Molecular Biology Phase||2
2859546|NCT00095940|3562004|FG007|COMPLETED|Molecular Biology Phase||2
2859547|NCT00095940|3562005|FG008|COMPLETED|Molecular Biology Phase||0
2859548|NCT00095940|3561997|FG000|NOT COMPLETED|Molecular Biology Phase||0
2859549|NCT00095940|3561998|FG001|NOT COMPLETED|Molecular Biology Phase||0
2859550|NCT00095940|3561999|FG002|NOT COMPLETED|Molecular Biology Phase||0
2859551|NCT00095940|3562000|FG003|NOT COMPLETED|Molecular Biology Phase||0
2859552|NCT00095940|3562001|FG004|NOT COMPLETED|Molecular Biology Phase||0
2859553|NCT00095940|3562002|FG005|NOT COMPLETED|Molecular Biology Phase||0
2859554|NCT00095940|3562003|FG006|NOT COMPLETED|Molecular Biology Phase||0
2859555|NCT00095940|3562004|FG007|NOT COMPLETED|Molecular Biology Phase||0
2859556|NCT00095940|3562005|FG008|NOT COMPLETED|Molecular Biology Phase||0
2859557|NCT00095940|3561997|FG000|STARTED|Lapatinib Continuation/Phase II|Continued to receive lapatinib but were ineligible for the phase II.|2
2859558|NCT00095940|3561998|FG001|STARTED|Lapatinib Continuation/Phase II|No measurable disease post surgery - ineligible for the phase II. Continued to receive lapatinib.|2
2859559|NCT00095940|3561999|FG002|STARTED|Lapatinib Continuation/Phase II||17
2859560|NCT00095940|3562000|FG003|STARTED|Lapatinib Continuation/Phase II||0
2859561|NCT00095940|3562001|FG004|STARTED|Lapatinib Continuation/Phase II||0
2859562|NCT00095940|3562002|FG005|STARTED|Lapatinib Continuation/Phase II||13
3168865|NCT01922011|3896327|FG000|COMPLETED|Overall Study||69
3168866|NCT01922011|3896328|FG001|COMPLETED|Overall Study||69
3168867|NCT01922011|3896327|FG000|NOT COMPLETED|Overall Study||6
2859563|NCT00095940|3562003|FG006|STARTED|Lapatinib Continuation/Phase II|Continued to receive lapatinib but were ineligible for the phase II.|2
2859564|NCT00095940|3562004|FG007|STARTED|Lapatinib Continuation/Phase II|No measurable disease post surgery - ineligible for the phase II. Continued to receive lapatinib.|2
2859565|NCT00095940|3562005|FG008|STARTED|Lapatinib Continuation/Phase II||14
2859566|NCT00095940|3561997|FG000|COMPLETED|Lapatinib Continuation/Phase II||0
2859567|NCT00095940|3561998|FG001|COMPLETED|Lapatinib Continuation/Phase II||0
2859568|NCT00095940|3561999|FG002|COMPLETED|Lapatinib Continuation/Phase II||1
2859569|NCT00095940|3562000|FG003|COMPLETED|Lapatinib Continuation/Phase II||0
2859570|NCT00095940|3562001|FG004|COMPLETED|Lapatinib Continuation/Phase II||0
2859571|NCT00095940|3562002|FG005|COMPLETED|Lapatinib Continuation/Phase II||0
2859572|NCT00095940|3562003|FG006|COMPLETED|Lapatinib Continuation/Phase II||0
2859573|NCT00095940|3562004|FG007|COMPLETED|Lapatinib Continuation/Phase II||0
2859574|NCT00095940|3562005|FG008|COMPLETED|Lapatinib Continuation/Phase II||1
2859575|NCT00095940|3561997|FG000|NOT COMPLETED|Lapatinib Continuation/Phase II||2
2859576|NCT00095940|3561998|FG001|NOT COMPLETED|Lapatinib Continuation/Phase II||2
2859577|NCT00095940|3561999|FG002|NOT COMPLETED|Lapatinib Continuation/Phase II||16
2859578|NCT00095940|3562000|FG003|NOT COMPLETED|Lapatinib Continuation/Phase II||0
2859579|NCT00095940|3562001|FG004|NOT COMPLETED|Lapatinib Continuation/Phase II||0
2859580|NCT00095940|3562002|FG005|NOT COMPLETED|Lapatinib Continuation/Phase II||13
2859581|NCT00095940|3562003|FG006|NOT COMPLETED|Lapatinib Continuation/Phase II||2
2859582|NCT00095940|3562004|FG007|NOT COMPLETED|Lapatinib Continuation/Phase II||2
2859583|NCT00095940|3562005|FG008|NOT COMPLETED|Lapatinib Continuation/Phase II||13
2859584|NCT00095979|3562023|FG000|STARTED|Overall Study||52
2859585|NCT00095979|3562023|FG000|COMPLETED|Overall Study||50
2859586|NCT00095979|3562023|FG000|NOT COMPLETED|Overall Study||2
2859587|NCT00096018|3562034|FG000|STARTED|Overall Study||13
2859588|NCT00096018|3562035|FG001|STARTED|Overall Study||30
2859589|NCT00096018|3562034|FG000|Treated With Study Therapy|Overall Study||13
2859590|NCT00096018|3562035|FG001|Treated With Study Therapy|Overall Study||25
2859591|NCT00096018|3562034|FG000|COMPLETED|Overall Study||11
2859592|NCT00096018|3562035|FG001|COMPLETED|Overall Study||16
2859593|NCT00096018|3562034|FG000|NOT COMPLETED|Overall Study||2
2859594|NCT00096018|3562035|FG001|NOT COMPLETED|Overall Study||14
2859595|NCT00096031|3562041|FG000|STARTED|Overall Study||63
2859596|NCT00096031|3562041|FG000|Eligible|Overall Study||57
2859597|NCT00096031|3562041|FG000|Eligible and Began Protocol Therapy|Overall Study||55
2859598|NCT00096031|3562041|FG000|COMPLETED|Overall Study||0
2859599|NCT00096031|3562041|FG000|NOT COMPLETED|Overall Study||63
2859600|NCT00096044|3562045|FG000|STARTED|Overall Study||45
2859601|NCT00096044|3562045|FG000|COMPLETED|Overall Study||11
2859602|NCT00096044|3562045|FG000|NOT COMPLETED|Overall Study||34
2859603|NCT00096109|3562049|FG000|STARTED|Overall Study||11
2859604|NCT00096109|3562049|FG000|COMPLETED|Overall Study||11
2859605|NCT00096109|3562049|FG000|NOT COMPLETED|Overall Study||0
2859606|NCT00096122|3562053|FG000|STARTED|Overall Study||95
2859607|NCT00096122|3562053|FG000|COMPLETED|Overall Study||95
2859608|NCT00096122|3562053|FG000|NOT COMPLETED|Overall Study||0
2859609|NCT00096135|3562059|FG000|STARTED|Overall Study||126
2859610|NCT00096135|3562060|FG001|STARTED|Overall Study||42
2859611|NCT00096135|3562059|FG000|COMPLETED|Overall Study||63
2859612|NCT00096135|3562060|FG001|COMPLETED|Overall Study||27
2859613|NCT00096135|3562059|FG000|NOT COMPLETED|Overall Study||63
2859614|NCT00096135|3562060|FG001|NOT COMPLETED|Overall Study||15
2859615|NCT00096161|3562070|FG000|STARTED|Overall Study||20
2859616|NCT00096161|3562071|FG001|STARTED|Overall Study||10
2859617|NCT00096161|3562072|FG002|STARTED|Overall Study||6
2859618|NCT00096161|3562073|FG003|STARTED|Overall Study||0
2859619|NCT00096161|3562070|FG000|COMPLETED|Overall Study||20
2859620|NCT00096161|3562071|FG001|COMPLETED|Overall Study||10
2859621|NCT00096161|3562072|FG002|COMPLETED|Overall Study||6
2859622|NCT00096161|3562073|FG003|COMPLETED|Overall Study||0
2859623|NCT00096161|3562070|FG000|NOT COMPLETED|Overall Study||0
2859624|NCT00096161|3562071|FG001|NOT COMPLETED|Overall Study||0
2859625|NCT00096161|3562072|FG002|NOT COMPLETED|Overall Study||0
2859626|NCT00096161|3562073|FG003|NOT COMPLETED|Overall Study||0
2859627|NCT00096174|3562083|FG000|STARTED|Overall Study||69
2859628|NCT00096174|3562083|FG000|Began Protocol Therapy|Overall Study|3 patients never started treatment|66
2859629|NCT00096174|3562083|FG000|Eligible and Treated|Overall Study|6 treated patients were ineligible|60
2859630|NCT00096174|3562083|FG000|COMPLETED|Overall Study||7
2859631|NCT00096174|3562083|FG000|NOT COMPLETED|Overall Study||62
2859632|NCT00096226|3562087|FG000|STARTED|Overall Study||60
2859633|NCT00096226|3562087|FG000|Eligible|Overall Study||57
2859634|NCT00096226|3562087|FG000|Eligible and Underwent Surgery|Overall Study||37
2859635|NCT00096226|3562087|FG000|COMPLETED|Overall Study|Subjects contributing any data to analysis are considered to have completed the study|57
2859636|NCT00096226|3562087|FG000|NOT COMPLETED|Overall Study||3
2859637|NCT00096265|3562094|FG000|STARTED|Overall Study||45
2859638|NCT00096265|3562095|FG001|STARTED|Overall Study||40
2859639|NCT00096265|3562096|FG002|STARTED|Overall Study||41
2859640|NCT00096265|3562094|FG000|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|44
2859641|NCT00096265|3562095|FG001|COMPLETED|Overall Study||40
2859642|NCT00096265|3562096|FG002|COMPLETED|Overall Study||41
2859643|NCT00096265|3562094|FG000|NOT COMPLETED|Overall Study||1
2859644|NCT00096265|3562095|FG001|NOT COMPLETED|Overall Study||0
2859645|NCT00096265|3562096|FG002|NOT COMPLETED|Overall Study||0
3168868|NCT01922011|3896328|FG001|NOT COMPLETED|Overall Study||5
3168869|NCT01922024|3896342|FG000|STARTED|Overall Study||1653
3168870|NCT01922024|3896343|FG001|STARTED|Overall Study||471
3168871|NCT01922024|3896342|FG000|COMPLETED|Overall Study||1653
3168872|NCT01922024|3896343|FG001|COMPLETED|Overall Study||471
3168873|NCT01922024|3896342|FG000|NOT COMPLETED|Overall Study||0
3168874|NCT01922024|3896343|FG001|NOT COMPLETED|Overall Study||0
3168875|NCT01922037|3896351|FG000|STARTED|Overall Study||69
3168876|NCT01922037|3896352|FG001|STARTED|Overall Study||737
2859646|NCT00096278|3562107|FG000|STARTED|Overall Study||1356
2859647|NCT00096278|3562108|FG001|STARTED|Overall Study||1354
2859648|NCT00096278|3562107|FG000|COMPLETED|Overall Study||1338
2859649|NCT00096278|3562108|FG001|COMPLETED|Overall Study||1334
2859650|NCT00096278|3562107|FG000|NOT COMPLETED|Overall Study||18
3168877|NCT01922037|3896351|FG000|Treated|Overall Study||69
3168878|NCT01922037|3896352|FG001|Treated|Overall Study||732
3168879|NCT01922037|3896351|FG000|COMPLETED|Overall Study||59
2859651|NCT00096278|3562108|FG001|NOT COMPLETED|Overall Study||20
2859652|NCT00096356|3562118|FG000|STARTED|Overall Study||122
2859653|NCT00096356|3562119|FG001|STARTED|Overall Study||114
2859654|NCT00096356|3562118|FG000|COMPLETED|Overall Study||78
2859655|NCT00096356|3562119|FG001|COMPLETED|Overall Study||61
2859656|NCT00096356|3562118|FG000|NOT COMPLETED|Overall Study||44
2859657|NCT00096356|3562119|FG001|NOT COMPLETED|Overall Study||53
2859658|NCT00096382|3562128|FG000|STARTED|Overall Study||23
2859659|NCT00096382|3562129|FG001|STARTED|Overall Study||3
3168880|NCT01922037|3896352|FG001|COMPLETED|Overall Study||563
3168881|NCT01922037|3896351|FG000|NOT COMPLETED|Overall Study||10
2859660|NCT00096382|3562128|FG000|COMPLETED|Overall Study||21
2859661|NCT00096382|3562129|FG001|COMPLETED|Overall Study||3
2859662|NCT00096382|3562128|FG000|NOT COMPLETED|Overall Study||2
2859663|NCT00096382|3562129|FG001|NOT COMPLETED|Overall Study||0
2859664|NCT00096447|3562135|FG000|STARTED|Overall Study||31
2859665|NCT00096447|3562135|FG000|COMPLETED|Overall Study|Eligible and treated patients.|30
2859666|NCT00096447|3562135|FG000|NOT COMPLETED|Overall Study||1
2859667|NCT00096460|3562146|FG000|STARTED|Overall Study||22
2859668|NCT00096460|3562147|FG001|STARTED|Overall Study||8
2859669|NCT00096460|3562146|FG000|COMPLETED|Overall Study||15
2859670|NCT00096460|3562147|FG001|COMPLETED|Overall Study||7
2859671|NCT00096460|3562146|FG000|NOT COMPLETED|Overall Study||7
2859672|NCT00096460|3562147|FG001|NOT COMPLETED|Overall Study||1
2859673|NCT00096486|3562157|FG000|STARTED|Overall Study||4
2859674|NCT00096486|3562158|FG001|STARTED|Overall Study||6
2859675|NCT00096486|3562159|FG002|STARTED|Overall Study||26
2859676|NCT00096486|3562160|FG003|STARTED|Overall Study||38
2859677|NCT00096486|3562157|FG000|COMPLETED|Overall Study||4
2859678|NCT00096486|3562158|FG001|COMPLETED|Overall Study||6
2859679|NCT00096486|3562159|FG002|COMPLETED|Overall Study||24
2859680|NCT00096486|3562160|FG003|COMPLETED|Overall Study||36
2859681|NCT00096486|3562157|FG000|NOT COMPLETED|Overall Study||0
2859682|NCT00096486|3562158|FG001|NOT COMPLETED|Overall Study||0
2859683|NCT00096486|3562159|FG002|NOT COMPLETED|Overall Study||2
2859684|NCT00096486|3562160|FG003|NOT COMPLETED|Overall Study||2
2859685|NCT00096538|3562170|FG000|STARTED|Overall Study||6
2859686|NCT00096538|3562170|FG000|COMPLETED|Overall Study||5
2859687|NCT00096538|3562170|FG000|NOT COMPLETED|Overall Study||1
2859688|NCT00096681|3562174|FG000|STARTED|Overall Study||762
2859689|NCT00096681|3562174|FG000|COMPLETED|Overall Study||762
2859690|NCT00096681|3562174|FG000|NOT COMPLETED|Overall Study||0
2859691|NCT00096785|3562180|FG000|STARTED|Overall Study|1 participant randomized to ADV, treated with ETV. (As randomized= 35; as treated=36)|35
2859692|NCT00096785|3562181|FG001|STARTED|Overall Study|1 participant randomized to ADV, treated with ETV. (As randomized= 34; as treated=33)|34
2859693|NCT00096785|3562180|FG000|As-Randomized Population|Overall Study||35
2859694|NCT00096785|3562181|FG001|As-Randomized Population|Overall Study||34
2859695|NCT00096785|3562180|FG000|As-Treated Population|Overall Study||36
2859696|NCT00096785|3562181|FG001|As-Treated Population|Overall Study||33
2859697|NCT00096785|3562180|FG000|COMPLETED|Overall Study|As randomized cohort|33
2859698|NCT00096785|3562181|FG001|COMPLETED|Overall Study|As randomized cohort|33
2859699|NCT00096785|3562180|FG000|NOT COMPLETED|Overall Study||2
2859700|NCT00096785|3562181|FG001|NOT COMPLETED|Overall Study||1
2859701|NCT00096941|3562187|FG000|STARTED|Overall Study||3
2859702|NCT00096941|3562187|FG000|COMPLETED|Overall Study||0
2859703|NCT00096941|3562187|FG000|NOT COMPLETED|Overall Study||3
2918435|NCT00527124|3628650|FG001|STARTED|Overall Study||28
2918436|NCT00527124|3628649|FG000|COMPLETED|Overall Study||29
2918437|NCT00527124|3628650|FG001|COMPLETED|Overall Study||28
2918438|NCT00527124|3628649|FG000|NOT COMPLETED|Overall Study||0
2918439|NCT00527124|3628650|FG001|NOT COMPLETED|Overall Study||0
2918440|NCT00527319|3628659|FG000|STARTED|Overall Study||12
2918441|NCT00527319|3628660|FG001|STARTED|Overall Study||12
2918442|NCT00527319|3628661|FG002|STARTED|Overall Study||13
2918443|NCT00527319|3628659|FG000|COMPLETED|Overall Study||6
2918444|NCT00527319|3628660|FG001|COMPLETED|Overall Study||8
2918445|NCT00527319|3628661|FG002|COMPLETED|Overall Study||7
2918446|NCT00527319|3628659|FG000|NOT COMPLETED|Overall Study||6
2918447|NCT00527319|3628660|FG001|NOT COMPLETED|Overall Study||4
2918448|NCT00527319|3628661|FG002|NOT COMPLETED|Overall Study||6
2918449|NCT00527332|3628671|FG000|STARTED|Overall Study||91
2918450|NCT00527332|3628672|FG001|STARTED|Overall Study||89
2918451|NCT00527332|3628671|FG000|COMPLETED|Overall Study||82
2918452|NCT00527332|3628672|FG001|COMPLETED|Overall Study||80
2918453|NCT00527332|3628671|FG000|NOT COMPLETED|Overall Study||9
2918454|NCT00527332|3628672|FG001|NOT COMPLETED|Overall Study||9
2920761|NCT00538681|3631332|FG003|STARTED|Overall Study|One (1) participant received pemetrexed and cisplatin only before the study was closed.|11
2920762|NCT00538681|3631329|FG000|Received ≥1 Dose of Any Study Drug|Overall Study||9
2920763|NCT00538681|3631330|FG001|Received ≥1 Dose of Any Study Drug|Overall Study||4
2920764|NCT00538681|3631331|FG002|Received ≥1 Dose of Any Study Drug|Overall Study||11
2920765|NCT00538681|3631332|FG003|Received ≥1 Dose of Any Study Drug|Overall Study||11
2920766|NCT00538681|3631329|FG000|COMPLETED|Overall Study||0
2920767|NCT00538681|3631330|FG001|COMPLETED|Overall Study||0
2920768|NCT00538681|3631331|FG002|COMPLETED|Overall Study||0
2920769|NCT00538681|3631332|FG003|COMPLETED|Overall Study||0
2920770|NCT00538681|3631329|FG000|NOT COMPLETED|Overall Study||9
2920771|NCT00538681|3631330|FG001|NOT COMPLETED|Overall Study||4
2920772|NCT00538681|3631331|FG002|NOT COMPLETED|Overall Study||11
2920773|NCT00538681|3631332|FG003|NOT COMPLETED|Overall Study||11
2920774|NCT00538733|3631343|FG000|STARTED|Overall Study||26
2920775|NCT00538733|3631343|FG000|Removed Due to Progression of Disease|Overall Study||1
2920776|NCT00538733|3631343|FG000|Removed to Pursue a Stem Cell Transplant|Overall Study||11
2920777|NCT00538733|3631343|FG000|Removed to Pursue Alternative Theray|Overall Study||2
3168882|NCT01922037|3896352|FG001|NOT COMPLETED|Overall Study||174
3168883|NCT01922050|3896374|FG000|STARTED|Part 1 Open-label, Dose-escalation Phase||3
3168884|NCT01922050|3896375|FG001|STARTED|Part 1 Open-label, Dose-escalation Phase||3
3168885|NCT01922050|3896376|FG002|STARTED|Part 1 Open-label, Dose-escalation Phase||6
2920778|NCT00538733|3631343|FG000|COMPLETED|Overall Study||14
2920779|NCT00538733|3631343|FG000|NOT COMPLETED|Overall Study||12
2920780|NCT00538759|3631352|FG000|STARTED|Overall Study||13
2859704|NCT00096954|3562193|FG000|STARTED|Overall Study||159
2859705|NCT00096954|3562194|FG001|STARTED|Overall Study||174
2859706|NCT00096954|3562193|FG000|Received Study Drug|Overall Study||157
2859707|NCT00096954|3562194|FG001|Received Study Drug|Overall Study||171
2859708|NCT00096954|3562193|FG000|COMPLETED|Overall Study||135
2859709|NCT00096954|3562194|FG001|COMPLETED|Overall Study||154
2859710|NCT00096954|3562193|FG000|NOT COMPLETED|Overall Study||24
2859711|NCT00096954|3562194|FG001|NOT COMPLETED|Overall Study||20
2859712|NCT00096993|3562202|FG000|STARTED|Overall Study||66
2859713|NCT00096993|3562203|FG001|STARTED|Overall Study||65
2859714|NCT00096993|3562202|FG000|COMPLETED|Overall Study||1
2859715|NCT00096993|3562203|FG001|COMPLETED|Overall Study||0
2859716|NCT00096993|3562202|FG000|NOT COMPLETED|Overall Study||65
2859717|NCT00096993|3562203|FG001|NOT COMPLETED|Overall Study||65
2859718|NCT00097253|3562209|FG000|STARTED|Lavender||56
2859719|NCT00097253|3562209|FG000|COMPLETED|Lavender||56
2859720|NCT00097253|3562209|FG000|NOT COMPLETED|Lavender||0
2859721|NCT00097253|3562209|FG000|STARTED|Lemon||56
2859722|NCT00097253|3562209|FG000|COMPLETED|Lemon||56
2859723|NCT00097253|3562209|FG000|NOT COMPLETED|Lemon||0
2859724|NCT00097253|3562209|FG000|STARTED|Water (Control)||56
2859725|NCT00097253|3562209|FG000|COMPLETED|Water (Control)||56
2859726|NCT00097253|3562209|FG000|NOT COMPLETED|Water (Control)||0
2859727|NCT00097370|3562217|FG000|STARTED|Stage 1|Participants entered from study MHE100185.|37
2859728|NCT00097370|3562217|FG000|COMPLETED|Stage 1||31
2859729|NCT00097370|3562217|FG000|NOT COMPLETED|Stage 1||6
2859730|NCT00097370|3562217|FG000|STARTED|Stage 2|41 participants entered from study MHE100185 and 31 participants continued from Stage 1.|72
2859731|NCT00097370|3562217|FG000|COMPLETED|Stage 2||59
2859732|NCT00097370|3562217|FG000|NOT COMPLETED|Stage 2||13
2859733|NCT00097370|3562217|FG000|STARTED|Stage 3|Participants continued from Stage 2.|59
2859734|NCT00097370|3562217|FG000|COMPLETED|Stage 3||0
2859735|NCT00097370|3562217|FG000|NOT COMPLETED|Stage 3||59
2859736|NCT00097448|3562223|FG000|STARTED|Overall Study||125
2859737|NCT00097448|3562224|FG001|STARTED|Overall Study||130
2859738|NCT00097448|3562223|FG000|COMPLETED|Overall Study||121
2859739|NCT00097448|3562224|FG001|COMPLETED|Overall Study||129
2859740|NCT00097448|3562223|FG000|NOT COMPLETED|Overall Study||4
2859741|NCT00097448|3562224|FG001|NOT COMPLETED|Overall Study||1
2859742|NCT00097500|3562232|FG000|STARTED|On-drug Period (Week 0 to Week 52)||36
2859743|NCT00097500|3562233|FG001|STARTED|On-drug Period (Week 0 to Week 52)||33
2859744|NCT00097500|3562232|FG000|COMPLETED|On-drug Period (Week 0 to Week 52)|Subjects experiencing loss of glucose control after Week 52 are considered to have completed study.|30
2859745|NCT00097500|3562233|FG001|COMPLETED|On-drug Period (Week 0 to Week 52)|Subjects experiencing loss of glucose control after Week 52 are considered to have completed study.|30
2859746|NCT00097500|3562232|FG000|NOT COMPLETED|On-drug Period (Week 0 to Week 52)||6
2859747|NCT00097500|3562233|FG001|NOT COMPLETED|On-drug Period (Week 0 to Week 52)||3
2859748|NCT00097500|3562232|FG000|STARTED|Off-drug Period (Week 52 to Week 64)|Exenatide is discontinued, metformin is continued|30
2859749|NCT00097500|3562233|FG001|STARTED|Off-drug Period (Week 52 to Week 64)|Insulin Glargine is discontinued, metformin is continued|30
2859750|NCT00097500|3562232|FG000|COMPLETED|Off-drug Period (Week 52 to Week 64)||25
2859751|NCT00097500|3562233|FG001|COMPLETED|Off-drug Period (Week 52 to Week 64)||26
2859752|NCT00097500|3562232|FG000|NOT COMPLETED|Off-drug Period (Week 52 to Week 64)||5
2859753|NCT00097500|3562233|FG001|NOT COMPLETED|Off-drug Period (Week 52 to Week 64)||4
2859754|NCT00097539|3562246|FG000|STARTED|Overall Study||27286
2859755|NCT00097539|3562247|FG001|STARTED|Overall Study||9356
2859756|NCT00097539|3562248|FG002|STARTED|Overall Study||12519
2859757|NCT00097539|3562249|FG003|STARTED|Overall Study||5651
2859758|NCT00097539|3562250|FG004|STARTED|Overall Study||2144
2859759|NCT00097539|3562251|FG005|STARTED|Overall Study||8010
2859760|NCT00097539|3562252|FG006|STARTED|Overall Study||239
2859761|NCT00097539|3562246|FG000|COMPLETED|Overall Study||8220
2859762|NCT00097539|3562247|FG001|COMPLETED|Overall Study||2825
2859763|NCT00097539|3562248|FG002|COMPLETED|Overall Study||3411
2859764|NCT00097539|3562249|FG003|COMPLETED|Overall Study||2066
2859765|NCT00097539|3562250|FG004|COMPLETED|Overall Study||386
2859766|NCT00097539|3562251|FG005|COMPLETED|Overall Study||2118
2859767|NCT00097539|3562252|FG006|COMPLETED|Overall Study||68
2859768|NCT00097539|3562246|FG000|NOT COMPLETED|Overall Study||19066
2859769|NCT00097539|3562247|FG001|NOT COMPLETED|Overall Study||6531
2859770|NCT00097539|3562248|FG002|NOT COMPLETED|Overall Study||9108
2859771|NCT00097539|3562249|FG003|NOT COMPLETED|Overall Study||3585
2859772|NCT00097539|3562250|FG004|NOT COMPLETED|Overall Study||1758
2859773|NCT00097539|3562251|FG005|NOT COMPLETED|Overall Study||5892
2859774|NCT00097539|3562252|FG006|NOT COMPLETED|Overall Study||171
2859775|NCT00097591|3562270|FG000|STARTED|Overall Study|7 subjects randomized but not analyzed due to an incomplete informed consent document|6813
2859776|NCT00097591|3562271|FG001|STARTED|Overall Study|4 subjects randomized but not analyzed due to an incomplete informed consent document|6795
2859777|NCT00097591|3562270|FG000|COMPLETED|Overall Study||6403
2859778|NCT00097591|3562271|FG001|COMPLETED|Overall Study||6401
2859779|NCT00097591|3562270|FG000|NOT COMPLETED|Overall Study||410
2859780|NCT00097591|3562271|FG001|NOT COMPLETED|Overall Study||394
2859781|NCT00097669|3562279|FG000|STARTED|Overall Study||4089
2859782|NCT00097669|3562280|FG001|STARTED|Overall Study||4075
2859783|NCT00097669|3562279|FG000|COMPLETED|Overall Study||4089
2859784|NCT00097669|3562280|FG001|COMPLETED|Overall Study||4075
2859785|NCT00097669|3562279|FG000|NOT COMPLETED|Overall Study||0
2859786|NCT00097669|3562280|FG001|NOT COMPLETED|Overall Study||0
2859787|NCT00097695|3562290|FG000|STARTED|The Controlled Phase||27
2859788|NCT00097695|3562291|FG001|STARTED|The Controlled Phase||29
2859789|NCT00097695|3562292|FG002|STARTED|The Controlled Phase||8
2859790|NCT00097695|3562293|FG003|STARTED|The Controlled Phase||20
2859791|NCT00097695|3562290|FG000|COMPLETED|The Controlled Phase||23
2859792|NCT00097695|3562291|FG001|COMPLETED|The Controlled Phase||26
2859793|NCT00097695|3562292|FG002|COMPLETED|The Controlled Phase||3
2859794|NCT00097695|3562293|FG003|COMPLETED|The Controlled Phase|Patients screened and found eligible but did not have HAE attack or attack was not severe enough|0
2859795|NCT00097695|3562290|FG000|NOT COMPLETED|The Controlled Phase||4
2859796|NCT00097695|3562291|FG001|NOT COMPLETED|The Controlled Phase||3
2859797|NCT00097695|3562292|FG002|NOT COMPLETED|The Controlled Phase||5
2859798|NCT00097695|3562293|FG003|NOT COMPLETED|The Controlled Phase||20
2859799|NCT00097695|3562290|FG000|STARTED|The Open Label Extension (OLE) Phase||23
2859800|NCT00097695|3562291|FG001|STARTED|The Open Label Extension (OLE) Phase||26
2859801|NCT00097695|3562292|FG002|STARTED|The Open Label Extension (OLE) Phase||3
2859802|NCT00097695|3562293|FG003|STARTED|The Open Label Extension (OLE) Phase||20
2859803|NCT00097695|3562290|FG000|COMPLETED|The Open Label Extension (OLE) Phase||10
2859804|NCT00097695|3562291|FG001|COMPLETED|The Open Label Extension (OLE) Phase||11
2859805|NCT00097695|3562292|FG002|COMPLETED|The Open Label Extension (OLE) Phase||1
2859806|NCT00097695|3562293|FG003|COMPLETED|The Open Label Extension (OLE) Phase||15
2859807|NCT00097695|3562290|FG000|NOT COMPLETED|The Open Label Extension (OLE) Phase||13
2859808|NCT00097695|3562291|FG001|NOT COMPLETED|The Open Label Extension (OLE) Phase||15
2859809|NCT00097695|3562292|FG002|NOT COMPLETED|The Open Label Extension (OLE) Phase||2
2859810|NCT00097695|3562293|FG003|NOT COMPLETED|The Open Label Extension (OLE) Phase||5
2859811|NCT00097708|3562308|FG000|STARTED|Overall Study||173
2859812|NCT00097708|3562309|FG001|STARTED|Overall Study||176
3168886|NCT01922050|3896377|FG003|STARTED|Part 1 Open-label, Dose-escalation Phase||6
3168887|NCT01922050|3896378|FG004|STARTED|Part 1 Open-label, Dose-escalation Phase||17
3168888|NCT01922050|3896379|FG005|STARTED|Part 1 Open-label, Dose-escalation Phase||18
3168889|NCT01922050|3896380|FG006|STARTED|Part 1 Open-label, Dose-escalation Phase||3
3313414|NCT03075410|4046791|FG000|COMPLETED|Part A-Washout Period 2 (14 Days)||1
3313415|NCT03075410|4046792|FG001|COMPLETED|Part A-Washout Period 2 (14 Days)||1
2859813|NCT00097708|3562310|FG002|STARTED|Overall Study||162
2859814|NCT00097708|3562308|FG000|Intent-to-Treat (ITT)|Overall Study||165
2859815|NCT00097708|3562309|FG001|Intent-to-Treat (ITT)|Overall Study||169
2859816|NCT00097708|3562310|FG002|Intent-to-Treat (ITT)|Overall Study||149
2859817|NCT00097708|3562308|FG000|Treated|Overall Study||171
2859818|NCT00097708|3562309|FG001|Treated|Overall Study||176
2859819|NCT00097708|3562310|FG002|Treated|Overall Study||160
2859820|NCT00097708|3562308|FG000|COMPLETED|Overall Study||109
2859821|NCT00097708|3562309|FG001|COMPLETED|Overall Study||120
2859822|NCT00097708|3562310|FG002|COMPLETED|Overall Study||97
2859823|NCT00097708|3562308|FG000|NOT COMPLETED|Overall Study||64
2859824|NCT00097708|3562309|FG001|NOT COMPLETED|Overall Study||56
2859825|NCT00097708|3562310|FG002|NOT COMPLETED|Overall Study||65
2859826|NCT00097721|3562320|FG000|STARTED|Overall Study|The number started is all enrolled subjects.BL Characteristics consists of Safety Population.|71
2859827|NCT00097721|3562321|FG001|STARTED|Overall Study||33
2859828|NCT00097721|3562320|FG000|COMPLETED|Overall Study||0
2859829|NCT00097721|3562321|FG001|COMPLETED|Overall Study||0
2859830|NCT00097721|3562320|FG000|NOT COMPLETED|Overall Study||71
2859831|NCT00097721|3562321|FG001|NOT COMPLETED|Overall Study||33
2859832|NCT00097773|3562331|FG000|STARTED|Overall Study||76
2859833|NCT00097773|3562332|FG001|STARTED|Overall Study||76
2859834|NCT00097773|3562333|FG002|STARTED|Overall Study||76
2859835|NCT00097773|3562334|FG003|STARTED|Overall Study||76
2859836|NCT00097773|3562331|FG000|COMPLETED|Overall Study||68
2859837|NCT00097773|3562332|FG001|COMPLETED|Overall Study||68
2859838|NCT00097773|3562333|FG002|COMPLETED|Overall Study||68
2859839|NCT00097773|3562334|FG003|COMPLETED|Overall Study||73
2859840|NCT00097773|3562331|FG000|NOT COMPLETED|Overall Study||8
2859841|NCT00097773|3562332|FG001|NOT COMPLETED|Overall Study||8
2859842|NCT00097773|3562333|FG002|NOT COMPLETED|Overall Study||8
2859843|NCT00097773|3562334|FG003|NOT COMPLETED|Overall Study||3
2859844|NCT00097786|3562353|FG000|STARTED|Overall Study|"Started indicates Full Analysis Set (FAS) population. Initially enrolled 9518, 212 excluded."|2316
2859845|NCT00097786|3562354|FG001|STARTED|Overall Study||2315
2859846|NCT00097786|3562355|FG002|STARTED|Overall Study||2329
2859847|NCT00097786|3562356|FG003|STARTED|Overall Study||2346
2859848|NCT00097786|3562353|FG000|Complete FU for Progression to Diabetes|Overall Study||1709
2859849|NCT00097786|3562354|FG001|Complete FU for Progression to Diabetes|Overall Study||1712
2859850|NCT00097786|3562355|FG002|Complete FU for Progression to Diabetes|Overall Study||1734
2859851|NCT00097786|3562356|FG003|Complete FU for Progression to Diabetes|Overall Study||1762
2859852|NCT00097786|3562353|FG000|Complete Follow-up for Extended CV EPs|Overall Study||1969
2859853|NCT00097786|3562354|FG001|Complete Follow-up for Extended CV EPs|Overall Study||1985
2859854|NCT00097786|3562355|FG002|Complete Follow-up for Extended CV EPs|Overall Study||1987
2859855|NCT00097786|3562356|FG003|Complete Follow-up for Extended CV EPs|Overall Study||2015
2859856|NCT00097786|3562353|FG000|Complete Follow-up for Core CV EPs|Overall Study||1948
2859857|NCT00097786|3562354|FG001|Complete Follow-up for Core CV EPs|Overall Study||1963
2859858|NCT00097786|3562355|FG002|Complete Follow-up for Core CV EPs|Overall Study||1966
2859859|NCT00097786|3562356|FG003|Complete Follow-up for Core CV EPs|Overall Study||1988
3168890|NCT01922050|3896381|FG007|STARTED|Part 1 Open-label, Dose-escalation Phase||3
2859860|NCT00097786|3562353|FG000|COMPLETED|Overall Study|"Completed means completed follow up for all cause death."|2020
2859861|NCT00097786|3562354|FG001|COMPLETED|Overall Study||2023
2859862|NCT00097786|3562355|FG002|COMPLETED|Overall Study||2016
2859863|NCT00097786|3562356|FG003|COMPLETED|Overall Study||2036
2859864|NCT00097786|3562353|FG000|NOT COMPLETED|Overall Study||296
2859865|NCT00097786|3562354|FG001|NOT COMPLETED|Overall Study||292
2859866|NCT00097786|3562355|FG002|NOT COMPLETED|Overall Study||313
2859867|NCT00097786|3562356|FG003|NOT COMPLETED|Overall Study||310
2859868|NCT00097981|3562368|FG000|STARTED|Overall Study|Enrollment at randomization|113
2859869|NCT00097981|3562369|FG001|STARTED|Overall Study|Enrollment at randomization|112
2859870|NCT00097981|3562368|FG000|Received Study Medication|Overall Study||110
2859871|NCT00097981|3562369|FG001|Received Study Medication|Overall Study||106
2859872|NCT00097981|3562368|FG000|COMPLETED|Overall Study|Completion of 2 or more cycles after CR or nCR, or completion of 12 cycles.|7
2859873|NCT00097981|3562369|FG001|COMPLETED|Overall Study|Completion of 2 or more cycles after CR or nCR, or completion of 12 cycles.|12
2859874|NCT00097981|3562368|FG000|NOT COMPLETED|Overall Study||106
2859875|NCT00097981|3562369|FG001|NOT COMPLETED|Overall Study||100
2859876|NCT00098020|3562375|FG000|STARTED|Overall Study||12
2859877|NCT00098020|3562375|FG000|Started Isotretinoin|Overall Study||8
2859878|NCT00098020|3562375|FG000|COMPLETED|Overall Study||6
2859879|NCT00098020|3562375|FG000|NOT COMPLETED|Overall Study||6
2859880|NCT00098059|3562381|FG000|STARTED|Overall Study||27
2859881|NCT00098059|3562382|FG001|STARTED|Overall Study||47
2859882|NCT00098059|3562381|FG000|COMPLETED|Overall Study||27
2859883|NCT00098059|3562382|FG001|COMPLETED|Overall Study||46
2859884|NCT00098059|3562381|FG000|NOT COMPLETED|Overall Study||0
2859885|NCT00098059|3562382|FG001|NOT COMPLETED|Overall Study||1
2859886|NCT00098254|3562393|FG000|STARTED|Overall Study||37
2859887|NCT00098254|3562393|FG000|COMPLETED|Overall Study||34
2859888|NCT00098254|3562393|FG000|NOT COMPLETED|Overall Study||3
2859889|NCT00098293|3562400|FG000|STARTED|Double-blind (DB) Phase||177
2859890|NCT00098293|3562401|FG001|STARTED|Double-blind (DB) Phase||368
2859891|NCT00098293|3562402|FG002|STARTED|Double-blind (DB) Phase||372
2859892|NCT00098293|3562403|FG003|STARTED|Double-blind (DB) Phase||0
2859893|NCT00098293|3562404|FG004|STARTED|Double-blind (DB) Phase||0
2859894|NCT00098293|3562400|FG000|Treated|Double-blind (DB) Phase||174
2859895|NCT00098293|3562401|FG001|Treated|Double-blind (DB) Phase||360
2859896|NCT00098293|3562402|FG002|Treated|Double-blind (DB) Phase||361
2859897|NCT00098293|3562403|FG003|Treated|Double-blind (DB) Phase||0
2859898|NCT00098293|3562404|FG004|Treated|Double-blind (DB) Phase||0
2859899|NCT00098293|3562400|FG000|COMPLETED|Double-blind (DB) Phase||0
2859900|NCT00098293|3562401|FG001|COMPLETED|Double-blind (DB) Phase||202
2859901|NCT00098293|3562402|FG002|COMPLETED|Double-blind (DB) Phase||202
2859902|NCT00098293|3562403|FG003|COMPLETED|Double-blind (DB) Phase||0
2859903|NCT00098293|3562404|FG004|COMPLETED|Double-blind (DB) Phase||0
2859904|NCT00098293|3562400|FG000|NOT COMPLETED|Double-blind (DB) Phase||177
2859905|NCT00098293|3562401|FG001|NOT COMPLETED|Double-blind (DB) Phase||166
2859906|NCT00098293|3562402|FG002|NOT COMPLETED|Double-blind (DB) Phase||170
2859907|NCT00098293|3562403|FG003|NOT COMPLETED|Double-blind (DB) Phase||0
2859908|NCT00098293|3562404|FG004|NOT COMPLETED|Double-blind (DB) Phase||0
2859909|NCT00098293|3562400|FG000|STARTED|Between DB and OL Phase||0
2859910|NCT00098293|3562401|FG001|STARTED|Between DB and OL Phase||202
2859911|NCT00098293|3562402|FG002|STARTED|Between DB and OL Phase||202
2859912|NCT00098293|3562403|FG003|STARTED|Between DB and OL Phase||0
2859913|NCT00098293|3562404|FG004|STARTED|Between DB and OL Phase||0
2859914|NCT00098293|3562400|FG000|COMPLETED|Between DB and OL Phase||0
2859915|NCT00098293|3562401|FG001|COMPLETED|Between DB and OL Phase||202
2859916|NCT00098293|3562402|FG002|COMPLETED|Between DB and OL Phase||199
2859917|NCT00098293|3562403|FG003|COMPLETED|Between DB and OL Phase||0
2859918|NCT00098293|3562404|FG004|COMPLETED|Between DB and OL Phase||0
2859919|NCT00098293|3562400|FG000|NOT COMPLETED|Between DB and OL Phase||0
2859920|NCT00098293|3562401|FG001|NOT COMPLETED|Between DB and OL Phase||0
2859921|NCT00098293|3562402|FG002|NOT COMPLETED|Between DB and OL Phase||3
2859922|NCT00098293|3562403|FG003|NOT COMPLETED|Between DB and OL Phase||0
2859923|NCT00098293|3562404|FG004|NOT COMPLETED|Between DB and OL Phase||0
2859924|NCT00098293|3562400|FG000|STARTED|Open-label (OL) Phase||0
2859925|NCT00098293|3562401|FG001|STARTED|Open-label (OL) Phase||202
2859926|NCT00098293|3562402|FG002|STARTED|Open-label (OL) Phase||199
2859927|NCT00098293|3562403|FG003|STARTED|Open-label (OL) Phase||130
2859928|NCT00098293|3562404|FG004|STARTED|Open-label (OL) Phase||0
2859929|NCT00098293|3562400|FG000|COMPLETED|Open-label (OL) Phase||0
2859930|NCT00098293|3562401|FG001|COMPLETED|Open-label (OL) Phase||177
2859931|NCT00098293|3562402|FG002|COMPLETED|Open-label (OL) Phase||158
2859932|NCT00098293|3562403|FG003|COMPLETED|Open-label (OL) Phase||65
2859933|NCT00098293|3562404|FG004|COMPLETED|Open-label (OL) Phase||0
2859934|NCT00098293|3562400|FG000|NOT COMPLETED|Open-label (OL) Phase||0
2859935|NCT00098293|3562401|FG001|NOT COMPLETED|Open-label (OL) Phase||25
2859936|NCT00098293|3562402|FG002|NOT COMPLETED|Open-label (OL) Phase||41
2859937|NCT00098293|3562403|FG003|NOT COMPLETED|Open-label (OL) Phase||65
2859938|NCT00098293|3562404|FG004|NOT COMPLETED|Open-label (OL) Phase||0
2859939|NCT00098293|3562400|FG000|STARTED|Supplemental Phase (SP)||0
2859940|NCT00098293|3562401|FG001|STARTED|Supplemental Phase (SP)||0
2859941|NCT00098293|3562402|FG002|STARTED|Supplemental Phase (SP)||0
2859942|NCT00098293|3562403|FG003|STARTED|Supplemental Phase (SP)||0
2859943|NCT00098293|3562404|FG004|STARTED|Supplemental Phase (SP)||127
2859944|NCT00098293|3562400|FG000|COMPLETED|Supplemental Phase (SP)||0
2859945|NCT00098293|3562401|FG001|COMPLETED|Supplemental Phase (SP)||0
2859946|NCT00098293|3562402|FG002|COMPLETED|Supplemental Phase (SP)||0
2859947|NCT00098293|3562403|FG003|COMPLETED|Supplemental Phase (SP)||0
2859948|NCT00098293|3562404|FG004|COMPLETED|Supplemental Phase (SP)||94
2859949|NCT00098293|3562400|FG000|NOT COMPLETED|Supplemental Phase (SP)||0
2859950|NCT00098293|3562401|FG001|NOT COMPLETED|Supplemental Phase (SP)||0
2859951|NCT00098293|3562402|FG002|NOT COMPLETED|Supplemental Phase (SP)||0
2859952|NCT00098293|3562403|FG003|NOT COMPLETED|Supplemental Phase (SP)||0
2859953|NCT00098293|3562404|FG004|NOT COMPLETED|Supplemental Phase (SP)||33
2859954|NCT00098306|3562418|FG000|STARTED|Double Blind||241
2859955|NCT00098306|3562419|FG001|STARTED|Double Blind||240
2859956|NCT00098306|3562420|FG002|STARTED|Double Blind||120
2859957|NCT00098306|3562421|FG003|STARTED|Double Blind||0
2859958|NCT00098306|3562422|FG004|STARTED|Double Blind||0
2859959|NCT00098306|3562423|FG005|STARTED|Double Blind||0
2859960|NCT00098306|3562424|FG006|STARTED|Double Blind||0
2859961|NCT00098306|3562418|FG000|Treated|Double Blind||232
2859962|NCT00098306|3562419|FG001|Treated|Double Blind||235
2859963|NCT00098306|3562420|FG002|Treated|Double Blind||118
2859964|NCT00098306|3562421|FG003|Treated|Double Blind||0
2859965|NCT00098306|3562422|FG004|Treated|Double Blind||0
2859966|NCT00098306|3562423|FG005|Treated|Double Blind||0
2859967|NCT00098306|3562424|FG006|Treated|Double Blind||0
2859968|NCT00098306|3562418|FG000|COMPLETED|Double Blind||0
2859969|NCT00098306|3562419|FG001|COMPLETED|Double Blind||0
2859970|NCT00098306|3562420|FG002|COMPLETED|Double Blind||0
2859971|NCT00098306|3562421|FG003|COMPLETED|Double Blind||0
2859972|NCT00098306|3562422|FG004|COMPLETED|Double Blind||0
2859973|NCT00098306|3562423|FG005|COMPLETED|Double Blind||0
2859974|NCT00098306|3562424|FG006|COMPLETED|Double Blind||0
2859975|NCT00098306|3562418|FG000|NOT COMPLETED|Double Blind||241
2859976|NCT00098306|3562419|FG001|NOT COMPLETED|Double Blind||240
2859977|NCT00098306|3562420|FG002|NOT COMPLETED|Double Blind||120
2859978|NCT00098306|3562421|FG003|NOT COMPLETED|Double Blind||0
2859979|NCT00098306|3562422|FG004|NOT COMPLETED|Double Blind||0
2859980|NCT00098306|3562423|FG005|NOT COMPLETED|Double Blind||0
2859981|NCT00098306|3562424|FG006|NOT COMPLETED|Double Blind||0
2859982|NCT00098306|3562418|FG000|STARTED|Open Label||0
2859983|NCT00098306|3562419|FG001|STARTED|Open Label||0
2859984|NCT00098306|3562420|FG002|STARTED|Open Label||0
2859985|NCT00098306|3562421|FG003|STARTED|Open Label||327
2859986|NCT00098306|3562422|FG004|STARTED|Open Label||62
2859987|NCT00098306|3562423|FG005|STARTED|Open Label||0
2859988|NCT00098306|3562424|FG006|STARTED|Open Label||0
2859989|NCT00098306|3562418|FG000|COMPLETED|Open Label||0
2859990|NCT00098306|3562419|FG001|COMPLETED|Open Label||0
2859991|NCT00098306|3562420|FG002|COMPLETED|Open Label||0
2859992|NCT00098306|3562421|FG003|COMPLETED|Open Label||0
2859993|NCT00098306|3562422|FG004|COMPLETED|Open Label||0
2859994|NCT00098306|3562423|FG005|COMPLETED|Open Label||0
2859995|NCT00098306|3562424|FG006|COMPLETED|Open Label||0
2859996|NCT00098306|3562418|FG000|NOT COMPLETED|Open Label||0
2859997|NCT00098306|3562419|FG001|NOT COMPLETED|Open Label||0
2859998|NCT00098306|3562420|FG002|NOT COMPLETED|Open Label||0
2859999|NCT00098306|3562421|FG003|NOT COMPLETED|Open Label||327
2860000|NCT00098306|3562422|FG004|NOT COMPLETED|Open Label||62
2860001|NCT00098306|3562423|FG005|NOT COMPLETED|Open Label||0
2860002|NCT00098306|3562424|FG006|NOT COMPLETED|Open Label||0
2860003|NCT00098306|3562418|FG000|STARTED|Observational Phase||0
2860004|NCT00098306|3562419|FG001|STARTED|Observational Phase||0
2860005|NCT00098306|3562420|FG002|STARTED|Observational Phase||0
2860006|NCT00098306|3562421|FG003|STARTED|Observational Phase||0
2860007|NCT00098306|3562422|FG004|STARTED|Observational Phase||0
2860008|NCT00098306|3562423|FG005|STARTED|Observational Phase||250
2860009|NCT00098306|3562424|FG006|STARTED|Observational Phase||81
2860010|NCT00098306|3562418|FG000|COMPLETED|Observational Phase||0
2860011|NCT00098306|3562419|FG001|COMPLETED|Observational Phase||0
2860012|NCT00098306|3562420|FG002|COMPLETED|Observational Phase||0
2860013|NCT00098306|3562421|FG003|COMPLETED|Observational Phase||0
2860014|NCT00098306|3562422|FG004|COMPLETED|Observational Phase||0
2860015|NCT00098306|3562423|FG005|COMPLETED|Observational Phase||204
2860016|NCT00098306|3562424|FG006|COMPLETED|Observational Phase||55
2860017|NCT00098306|3562418|FG000|NOT COMPLETED|Observational Phase||0
2860018|NCT00098306|3562419|FG001|NOT COMPLETED|Observational Phase||0
2860019|NCT00098306|3562420|FG002|NOT COMPLETED|Observational Phase||0
2860020|NCT00098306|3562421|FG003|NOT COMPLETED|Observational Phase||0
2860021|NCT00098306|3562422|FG004|NOT COMPLETED|Observational Phase||0
2860022|NCT00098306|3562423|FG005|NOT COMPLETED|Observational Phase||46
2860023|NCT00098306|3562424|FG006|NOT COMPLETED|Observational Phase||26
2860024|NCT00098345|3562437|FG000|STARTED|Overall Study||30
2860025|NCT00098345|3562437|FG000|COMPLETED|Overall Study|ongoing study treatment at data cut-off|17
2860026|NCT00098345|3562437|FG000|NOT COMPLETED|Overall Study||13
2860027|NCT00098371|3562441|FG000|STARTED|Overall Study||64
2860028|NCT00098371|3562441|FG000|COMPLETED|Overall Study||64
2860029|NCT00098371|3562441|FG000|NOT COMPLETED|Overall Study||0
2860030|NCT00098475|3562458|FG000|STARTED|Step 1||223
2860031|NCT00098475|3562459|FG001|STARTED|Step 1||222
2860032|NCT00098475|3562460|FG002|STARTED|Step 1||4
2860033|NCT00098475|3562461|FG003|STARTED|Step 1||3
2860034|NCT00098475|3562458|FG000|Treated|Step 1||223
2860035|NCT00098475|3562459|FG001|Treated|Step 1||220
2860036|NCT00098475|3562460|FG002|Treated|Step 1||4
2860037|NCT00098475|3562461|FG003|Treated|Step 1||3
2860038|NCT00098475|3562458|FG000|Eligible|Step 1|Some patients were considered eligible at registration but found ineligible in the analysis.|214
2860039|NCT00098475|3562459|FG001|Eligible|Step 1|Some patients were considered eligible at registration but found ineligible in the analysis.|208
2860040|NCT00098475|3562460|FG002|Eligible|Step 1||4
2860041|NCT00098475|3562461|FG003|Eligible|Step 1||3
2860042|NCT00098475|3562458|FG000|COMPLETED|Step 1||52
2860043|NCT00098475|3562459|FG001|COMPLETED|Step 1||49
2860044|NCT00098475|3562460|FG002|COMPLETED|Step 1||0
2860045|NCT00098475|3562461|FG003|COMPLETED|Step 1||0
2860046|NCT00098475|3562458|FG000|NOT COMPLETED|Step 1||171
2860047|NCT00098475|3562459|FG001|NOT COMPLETED|Step 1||173
2860048|NCT00098475|3562460|FG002|NOT COMPLETED|Step 1||4
2860049|NCT00098475|3562461|FG003|NOT COMPLETED|Step 1||3
2860050|NCT00098475|3562458|FG000|STARTED|Step 2|Step 2 treatment was an option but not required for patients who ended step 1 treatment.|5
2860051|NCT00098475|3562459|FG001|STARTED|Step 2|Step 2 treatment was an option but not required for patients who ended step 1 treatment.|15
2860052|NCT00098475|3562460|FG002|STARTED|Step 2||0
2860053|NCT00098475|3562461|FG003|STARTED|Step 2||0
2860054|NCT00098475|3562458|FG000|Treated|Step 2||4
2860055|NCT00098475|3562459|FG001|Treated|Step 2||14
2860056|NCT00098475|3562460|FG002|Treated|Step 2||0
2860057|NCT00098475|3562461|FG003|Treated|Step 2||0
2860058|NCT00098475|3562458|FG000|Eligible|Step 2|Some patients were considered eligible at registration but found ineligible in the analysis.|2
2860059|NCT00098475|3562459|FG001|Eligible|Step 2|Some patients were considered eligible at registration but found ineligible in the analysis.|9
2860060|NCT00098475|3562460|FG002|Eligible|Step 2||0
2860061|NCT00098475|3562461|FG003|Eligible|Step 2||0
2860062|NCT00098475|3562458|FG000|COMPLETED|Step 2||0
2860063|NCT00098475|3562459|FG001|COMPLETED|Step 2||5
2860064|NCT00098475|3562460|FG002|COMPLETED|Step 2||0
2860065|NCT00098475|3562461|FG003|COMPLETED|Step 2||0
2860066|NCT00098475|3562458|FG000|NOT COMPLETED|Step 2||5
2860067|NCT00098475|3562459|FG001|NOT COMPLETED|Step 2||10
2860068|NCT00098475|3562460|FG002|NOT COMPLETED|Step 2||0
2860069|NCT00098475|3562461|FG003|NOT COMPLETED|Step 2||0
2860070|NCT00098670|3562471|FG000|STARTED|Overall Study||102
2860071|NCT00098670|3562471|FG000|COMPLETED|Overall Study||102
2860072|NCT00098670|3562471|FG000|NOT COMPLETED|Overall Study||0
2860073|NCT00098722|3562479|FG000|STARTED|Double Blind Phase||186
2860074|NCT00098722|3562480|FG001|STARTED|Double Blind Phase||194
2860075|NCT00098722|3562481|FG002|STARTED|Double Blind Phase||94
2860076|NCT00098722|3562482|FG003|STARTED|Double Blind Phase||0
2860077|NCT00098722|3562483|FG004|STARTED|Double Blind Phase||0
2860078|NCT00098722|3562484|FG005|STARTED|Double Blind Phase||0
2860079|NCT00098722|3562485|FG006|STARTED|Double Blind Phase||0
2860080|NCT00098722|3562479|FG000|Treated|Double Blind Phase||182
2860081|NCT00098722|3562480|FG001|Treated|Double Blind Phase||191
2860082|NCT00098722|3562481|FG002|Treated|Double Blind Phase||91
2860083|NCT00098722|3562482|FG003|Treated|Double Blind Phase||0
2860084|NCT00098722|3562483|FG004|Treated|Double Blind Phase||0
2860085|NCT00098722|3562484|FG005|Treated|Double Blind Phase||0
2860086|NCT00098722|3562485|FG006|Treated|Double Blind Phase||0
2860087|NCT00098722|3562479|FG000|COMPLETED|Double Blind Phase||0
2860088|NCT00098722|3562480|FG001|COMPLETED|Double Blind Phase||0
2860089|NCT00098722|3562481|FG002|COMPLETED|Double Blind Phase||0
2860090|NCT00098722|3562482|FG003|COMPLETED|Double Blind Phase||0
2860091|NCT00098722|3562483|FG004|COMPLETED|Double Blind Phase||0
2860092|NCT00098722|3562484|FG005|COMPLETED|Double Blind Phase||0
2860093|NCT00098722|3562485|FG006|COMPLETED|Double Blind Phase||0
2860094|NCT00098722|3562479|FG000|NOT COMPLETED|Double Blind Phase||186
2860095|NCT00098722|3562480|FG001|NOT COMPLETED|Double Blind Phase||194
2860096|NCT00098722|3562481|FG002|NOT COMPLETED|Double Blind Phase||94
2860097|NCT00098722|3562482|FG003|NOT COMPLETED|Double Blind Phase||0
2860098|NCT00098722|3562483|FG004|NOT COMPLETED|Double Blind Phase||0
2860099|NCT00098722|3562484|FG005|NOT COMPLETED|Double Blind Phase||0
2860100|NCT00098722|3562485|FG006|NOT COMPLETED|Double Blind Phase||0
2860101|NCT00098722|3562479|FG000|STARTED|Open Label Phase||0
2860102|NCT00098722|3562480|FG001|STARTED|Open Label Phase||0
2860103|NCT00098722|3562481|FG002|STARTED|Open Label Phase||0
2860104|NCT00098722|3562482|FG003|STARTED|Open Label Phase||272
2860105|NCT00098722|3562483|FG004|STARTED|Open Label Phase||50
2860106|NCT00098722|3562484|FG005|STARTED|Open Label Phase||0
2860107|NCT00098722|3562485|FG006|STARTED|Open Label Phase||0
2860108|NCT00098722|3562479|FG000|COMPLETED|Open Label Phase||0
2860109|NCT00098722|3562480|FG001|COMPLETED|Open Label Phase||0
2860110|NCT00098722|3562481|FG002|COMPLETED|Open Label Phase||0
2860111|NCT00098722|3562482|FG003|COMPLETED|Open Label Phase||0
2860112|NCT00098722|3562483|FG004|COMPLETED|Open Label Phase||0
3168891|NCT01922050|3896382|FG008|STARTED|Part 1 Open-label, Dose-escalation Phase||6
3168892|NCT01922050|3896383|FG009|STARTED|Part 1 Open-label, Dose-escalation Phase||12
3168893|NCT01922050|3896384|FG010|STARTED|Part 1 Open-label, Dose-escalation Phase||0
2860113|NCT00098722|3562484|FG005|COMPLETED|Open Label Phase||0
2860114|NCT00098722|3562485|FG006|COMPLETED|Open Label Phase||0
2860115|NCT00098722|3562479|FG000|NOT COMPLETED|Open Label Phase||0
2860116|NCT00098722|3562480|FG001|NOT COMPLETED|Open Label Phase||0
2860117|NCT00098722|3562481|FG002|NOT COMPLETED|Open Label Phase||0
2860118|NCT00098722|3562482|FG003|NOT COMPLETED|Open Label Phase||272
2860119|NCT00098722|3562483|FG004|NOT COMPLETED|Open Label Phase||50
2860120|NCT00098722|3562484|FG005|NOT COMPLETED|Open Label Phase||0
2860121|NCT00098722|3562485|FG006|NOT COMPLETED|Open Label Phase||0
2860122|NCT00098722|3562479|FG000|STARTED|Observation Phase||0
2860123|NCT00098722|3562480|FG001|STARTED|Observation Phase||0
2860124|NCT00098722|3562481|FG002|STARTED|Observation Phase||0
2860125|NCT00098722|3562482|FG003|STARTED|Observation Phase||0
2860126|NCT00098722|3562483|FG004|STARTED|Observation Phase||0
2860127|NCT00098722|3562484|FG005|STARTED|Observation Phase||205
2860128|NCT00098722|3562485|FG006|STARTED|Observation Phase||65
2860129|NCT00098722|3562479|FG000|COMPLETED|Observation Phase||0
2860130|NCT00098722|3562480|FG001|COMPLETED|Observation Phase||0
2860131|NCT00098722|3562481|FG002|COMPLETED|Observation Phase||0
2860132|NCT00098722|3562482|FG003|COMPLETED|Observation Phase||0
2860133|NCT00098722|3562483|FG004|COMPLETED|Observation Phase||0
2860134|NCT00098722|3562484|FG005|COMPLETED|Observation Phase||160
2860135|NCT00098722|3562485|FG006|COMPLETED|Observation Phase||48
2860136|NCT00098722|3562479|FG000|NOT COMPLETED|Observation Phase||0
2860137|NCT00098722|3562480|FG001|NOT COMPLETED|Observation Phase||0
2860138|NCT00098722|3562481|FG002|NOT COMPLETED|Observation Phase||0
2860139|NCT00098722|3562482|FG003|NOT COMPLETED|Observation Phase||0
2860140|NCT00098722|3562483|FG004|NOT COMPLETED|Observation Phase||0
2860141|NCT00098722|3562484|FG005|NOT COMPLETED|Observation Phase||45
2860142|NCT00098722|3562485|FG006|NOT COMPLETED|Observation Phase||17
2860143|NCT00098748|3562500|FG000|STARTED|Assigned to Study Treatment||63
2860144|NCT00098748|3562501|FG001|STARTED|Assigned to Study Treatment||63
2860145|NCT00098748|3562502|FG002|STARTED|Assigned to Study Treatment||64
2860146|NCT00098748|3562500|FG000|COMPLETED|Assigned to Study Treatment||63
2860147|NCT00098748|3562501|FG001|COMPLETED|Assigned to Study Treatment||61
2860148|NCT00098748|3562502|FG002|COMPLETED|Assigned to Study Treatment||62
2860149|NCT00098748|3562500|FG000|NOT COMPLETED|Assigned to Study Treatment||0
2860150|NCT00098748|3562501|FG001|NOT COMPLETED|Assigned to Study Treatment||2
2860151|NCT00098748|3562502|FG002|NOT COMPLETED|Assigned to Study Treatment||2
2860152|NCT00098748|3562500|FG000|STARTED|Received Study Treatment||63
2860153|NCT00098748|3562501|FG001|STARTED|Received Study Treatment|Due to 1 placebo subject switched to maraviroc BID, BID = 62 subjects in Adverse event tables.|61
2860154|NCT00098748|3562502|FG002|STARTED|Received Study Treatment|Due to 1 placebo subject switched to maraviroc BID, Placebo = 61 subjects in Adverse event tables.|62
2860155|NCT00098748|3562500|FG000|Dual-tropic Subjects by Phenotype Assay|Received Study Treatment|Dual-tropic: Virus capable of using both CCR5 and CXCR4 coreceptors for cell entry.|57
2860156|NCT00098748|3562501|FG001|Dual-tropic Subjects by Phenotype Assay|Received Study Treatment||52
2860157|NCT00098748|3562502|FG002|Dual-tropic Subjects by Phenotype Assay|Received Study Treatment||58
2860158|NCT00098748|3562500|FG000|COMPLETED|Received Study Treatment||15
2860159|NCT00098748|3562501|FG001|COMPLETED|Received Study Treatment||25
2860160|NCT00098748|3562502|FG002|COMPLETED|Received Study Treatment||18
2860161|NCT00098748|3562500|FG000|NOT COMPLETED|Received Study Treatment||48
2860162|NCT00098748|3562501|FG001|NOT COMPLETED|Received Study Treatment||36
2860163|NCT00098748|3562502|FG002|NOT COMPLETED|Received Study Treatment||44
2860164|NCT00098748|3562500|FG000|STARTED|Continued on Open-Label Treatment||15
2860165|NCT00098748|3562501|FG001|STARTED|Continued on Open-Label Treatment||25
2860166|NCT00098748|3562502|FG002|STARTED|Continued on Open-Label Treatment|Placebo group not offered open-label maraviroc due to study not reaching primary endpoint at Week 24|0
2860167|NCT00098748|3562500|FG000|COMPLETED|Continued on Open-Label Treatment||7
2860168|NCT00098748|3562501|FG001|COMPLETED|Continued on Open-Label Treatment||10
2860169|NCT00098748|3562502|FG002|COMPLETED|Continued on Open-Label Treatment||0
2860170|NCT00098748|3562500|FG000|NOT COMPLETED|Continued on Open-Label Treatment||8
2860171|NCT00098748|3562501|FG001|NOT COMPLETED|Continued on Open-Label Treatment||15
2860172|NCT00098748|3562502|FG002|NOT COMPLETED|Continued on Open-Label Treatment||0
2860173|NCT00098774|3562510|FG000|STARTED|Overall Study||44
2860174|NCT00098774|3562510|FG000|COMPLETED|Overall Study||26
2860175|NCT00098774|3562510|FG000|NOT COMPLETED|Overall Study||18
3168894|NCT01922050|3896385|FG011|STARTED|Part 1 Open-label, Dose-escalation Phase||0
3168895|NCT01922050|3896386|FG012|STARTED|Part 1 Open-label, Dose-escalation Phase||0
3168896|NCT01922050|3896387|FG013|STARTED|Part 1 Open-label, Dose-escalation Phase||0
3168897|NCT01922050|3896374|FG000|COMPLETED|Part 1 Open-label, Dose-escalation Phase||3
3168898|NCT01922050|3896375|FG001|COMPLETED|Part 1 Open-label, Dose-escalation Phase||3
3168899|NCT01922050|3896376|FG002|COMPLETED|Part 1 Open-label, Dose-escalation Phase||6
2860176|NCT00098787|3562517|FG000|STARTED|Overall Study||73
2860177|NCT00098787|3562518|FG001|STARTED|Overall Study||75
2860178|NCT00098787|3562519|FG002|STARTED|Overall Study||63
2860179|NCT00098787|3562517|FG000|Treated|Overall Study||70
2860180|NCT00098787|3562518|FG001|Treated|Overall Study||73
2860181|NCT00098787|3562519|FG002|Treated|Overall Study||62
3168900|NCT01922050|3896377|FG003|COMPLETED|Part 1 Open-label, Dose-escalation Phase||6
2860182|NCT00098787|3562517|FG000|Eligible and Treated|Overall Study||61
2860183|NCT00098787|3562518|FG001|Eligible and Treated|Overall Study||66
2860184|NCT00098787|3562519|FG002|Eligible and Treated|Overall Study||59
2860185|NCT00098787|3562517|FG000|COMPLETED|Overall Study||0
2860186|NCT00098787|3562518|FG001|COMPLETED|Overall Study||0
2860187|NCT00098787|3562519|FG002|COMPLETED|Overall Study||0
2860188|NCT00098787|3562517|FG000|NOT COMPLETED|Overall Study||73
2860189|NCT00098787|3562518|FG001|NOT COMPLETED|Overall Study||75
2860190|NCT00098787|3562519|FG002|NOT COMPLETED|Overall Study||63
2860191|NCT00098813|3562527|FG000|STARTED|Overall Study||20
2860192|NCT00098813|3562527|FG000|COMPLETED|Overall Study||1
2860193|NCT00098813|3562527|FG000|NOT COMPLETED|Overall Study||19
2860194|NCT00098839|3562533|FG000|STARTED|Overall Study||56
2860195|NCT00098839|3562534|FG001|STARTED|Overall Study||60
2860196|NCT00098839|3562533|FG000|COMPLETED|Overall Study||24
2860197|NCT00098839|3562534|FG001|COMPLETED|Overall Study||27
2860198|NCT00098839|3562533|FG000|NOT COMPLETED|Overall Study||32
2860199|NCT00098839|3562534|FG001|NOT COMPLETED|Overall Study||33
2860200|NCT00098865|3562541|FG000|STARTED|Overall Study||15
2860201|NCT00098865|3562541|FG000|COMPLETED|Overall Study||6
2860202|NCT00098865|3562541|FG000|NOT COMPLETED|Overall Study||9
2860203|NCT00098956|3562545|FG000|STARTED|Overall Study||19
2860204|NCT00098956|3562545|FG000|COMPLETED|Overall Study||19
2860205|NCT00098956|3562545|FG000|NOT COMPLETED|Overall Study||0
2860206|NCT00099021|3562549|FG000|STARTED|Overall Study||21
2860207|NCT00099021|3562549|FG000|COMPLETED|Overall Study||21
2860208|NCT00099021|3562549|FG000|NOT COMPLETED|Overall Study||0
2860209|NCT00099047|3562555|FG000|STARTED|Overall Study||11
2860210|NCT00099047|3562556|FG001|STARTED|Overall Study||12
2860211|NCT00099047|3562555|FG000|COMPLETED|Overall Study||11
2860212|NCT00099047|3562556|FG001|COMPLETED|Overall Study||12
2860213|NCT00099047|3562555|FG000|NOT COMPLETED|Overall Study||0
2860214|NCT00099047|3562556|FG001|NOT COMPLETED|Overall Study||0
2860215|NCT00099268|3562564|FG000|STARTED|Overall Study||374
2860216|NCT00099268|3562565|FG001|STARTED|Overall Study||373
2860217|NCT00099268|3562564|FG000|Intent-to-Treat|Overall Study|One patient from each group discontinued without receiving a single dose of study drug.|373
2860218|NCT00099268|3562565|FG001|Intent-to-Treat|Overall Study||372
2860219|NCT00099268|3562564|FG000|COMPLETED|Overall Study|Plus 1 death in the carbidopa/levodopa/entacapone group within 30 days of treatment discontinuation|282
2860220|NCT00099268|3562565|FG001|COMPLETED|Overall Study|Plus 1 death in the carbidopa/levodopa group within 30 days of treatment discontinuation|291
2860221|NCT00099268|3562564|FG000|NOT COMPLETED|Overall Study||92
2860222|NCT00099268|3562565|FG001|NOT COMPLETED|Overall Study||82
2860223|NCT00099359|3562574|FG000|STARTED|Overall Study||581
2860224|NCT00099359|3562575|FG001|STARTED|Overall Study||580
2860225|NCT00099359|3562576|FG002|STARTED|Overall Study||574
2860226|NCT00099359|3562574|FG000|COMPLETED|Overall Study||527
2860227|NCT00099359|3562575|FG001|COMPLETED|Overall Study||515
2860228|NCT00099359|3562576|FG002|COMPLETED|Overall Study||506
2860229|NCT00099359|3562574|FG000|NOT COMPLETED|Overall Study||54
2860230|NCT00099359|3562575|FG001|NOT COMPLETED|Overall Study||65
2860231|NCT00099359|3562576|FG002|NOT COMPLETED|Overall Study||68
2860232|NCT00099372|3562596|FG000|STARTED|Enrolled in Extended CARE Trial||104
2860233|NCT00099372|3562597|FG001|STARTED|Enrolled in Extended CARE Trial||111
2860234|NCT00099372|3562596|FG000|COMPLETED|Enrolled in Extended CARE Trial||104
2860235|NCT00099372|3562597|FG001|COMPLETED|Enrolled in Extended CARE Trial||111
2860236|NCT00099372|3562596|FG000|NOT COMPLETED|Enrolled in Extended CARE Trial||0
2860237|NCT00099372|3562597|FG001|NOT COMPLETED|Enrolled in Extended CARE Trial||0
2860238|NCT00099372|3562596|FG000|STARTED|Followed up 5 Years After Index Surgery||104
2860239|NCT00099372|3562597|FG001|STARTED|Followed up 5 Years After Index Surgery||111
2860240|NCT00099372|3562596|FG000|COMPLETED|Followed up 5 Years After Index Surgery||89
2860241|NCT00099372|3562597|FG001|COMPLETED|Followed up 5 Years After Index Surgery||92
2860242|NCT00099372|3562596|FG000|NOT COMPLETED|Followed up 5 Years After Index Surgery||15
2860243|NCT00099372|3562597|FG001|NOT COMPLETED|Followed up 5 Years After Index Surgery||19
2860244|NCT00099372|3562596|FG000|STARTED|Followed up 7 Years After Index Surgery||89
2860245|NCT00099372|3562597|FG001|STARTED|Followed up 7 Years After Index Surgery||92
2860246|NCT00099372|3562596|FG000|COMPLETED|Followed up 7 Years After Index Surgery||66
2860247|NCT00099372|3562597|FG001|COMPLETED|Followed up 7 Years After Index Surgery||60
2860248|NCT00099372|3562596|FG000|NOT COMPLETED|Followed up 7 Years After Index Surgery||23
2860249|NCT00099372|3562597|FG001|NOT COMPLETED|Followed up 7 Years After Index Surgery||32
2860250|NCT00099632|3562611|FG000|STARTED|Overall Study||73
2860251|NCT00099632|3562612|FG001|STARTED|Overall Study||68
2860252|NCT00099632|3562613|FG002|STARTED|Overall Study||75
2860253|NCT00099632|3562614|FG003|STARTED|Overall Study||67
2860254|NCT00099632|3562615|FG004|STARTED|Overall Study||71
2860255|NCT00099632|3562616|FG005|STARTED|Overall Study||68
2860256|NCT00099632|3562611|FG000|COMPLETED|Overall Study||72
2860257|NCT00099632|3562612|FG001|COMPLETED|Overall Study||67
2860258|NCT00099632|3562613|FG002|COMPLETED|Overall Study||72
2860259|NCT00099632|3562614|FG003|COMPLETED|Overall Study||66
2860260|NCT00099632|3562615|FG004|COMPLETED|Overall Study||70
2860261|NCT00099632|3562616|FG005|COMPLETED|Overall Study||66
2860262|NCT00099632|3562611|FG000|NOT COMPLETED|Overall Study||1
2860263|NCT00099632|3562612|FG001|NOT COMPLETED|Overall Study||1
2860264|NCT00099632|3562613|FG002|NOT COMPLETED|Overall Study||3
2860265|NCT00099632|3562614|FG003|NOT COMPLETED|Overall Study||1
3168901|NCT01922050|3896378|FG004|COMPLETED|Part 1 Open-label, Dose-escalation Phase||17
2860266|NCT00099632|3562615|FG004|NOT COMPLETED|Overall Study||1
2860267|NCT00099632|3562616|FG005|NOT COMPLETED|Overall Study||2
2860268|NCT00099983|3562632|FG000|STARTED|Overall Study||147
2860269|NCT00099983|3562633|FG001|STARTED|Overall Study||149
2860270|NCT00099983|3562632|FG000|COMPLETED|Overall Study||123
2860271|NCT00099983|3562633|FG001|COMPLETED|Overall Study||124
2860272|NCT00099983|3562632|FG000|NOT COMPLETED|Overall Study||24
2860273|NCT00099983|3562633|FG001|NOT COMPLETED|Overall Study||25
2860274|NCT00100048|3562644|FG000|STARTED|Cohort I-Monotherapy Phase 10 Days||7
2860275|NCT00100048|3562645|FG001|STARTED|Cohort I-Monotherapy Phase 10 Days||7
2860276|NCT00100048|3562646|FG002|STARTED|Cohort I-Monotherapy Phase 10 Days||6
2860277|NCT00100048|3562647|FG003|STARTED|Cohort I-Monotherapy Phase 10 Days||8
2860278|NCT00100048|3562648|FG004|STARTED|Cohort I-Monotherapy Phase 10 Days||7
2860279|NCT00100048|3562649|FG005|STARTED|Cohort I-Monotherapy Phase 10 Days|participants only assigned Efavirenz 600 mg q.h.s in Cohort II Combined-Combination Therapy Phase|0
2860280|NCT00100048|3562644|FG000|Treated|Cohort I-Monotherapy Phase 10 Days||7
2860281|NCT00100048|3562645|FG001|Treated|Cohort I-Monotherapy Phase 10 Days||7
2860282|NCT00100048|3562646|FG002|Treated|Cohort I-Monotherapy Phase 10 Days||6
2860283|NCT00100048|3562647|FG003|Treated|Cohort I-Monotherapy Phase 10 Days||8
2860284|NCT00100048|3562648|FG004|Treated|Cohort I-Monotherapy Phase 10 Days||7
2860285|NCT00100048|3562649|FG005|Treated|Cohort I-Monotherapy Phase 10 Days||0
2860286|NCT00100048|3562644|FG000|COMPLETED|Cohort I-Monotherapy Phase 10 Days|7 Subjects Continued to Cohort II Combined-Combination Therapy Phase (48 Weeks)|7
2860287|NCT00100048|3562645|FG001|COMPLETED|Cohort I-Monotherapy Phase 10 Days|7 Subjects Continued to Cohort II Combined-Combination Therapy Phase (48 Weeks)|7
2860288|NCT00100048|3562646|FG002|COMPLETED|Cohort I-Monotherapy Phase 10 Days|6 Subjects Continued to Cohort II Combined-Combination Therapy Phase (48 Weeks)|6
2860289|NCT00100048|3562647|FG003|COMPLETED|Cohort I-Monotherapy Phase 10 Days|6 Subjects Continued to Cohort II Combined-Combination Therapy Phase (48 Weeks)|8
2860290|NCT00100048|3562648|FG004|COMPLETED|Cohort I-Monotherapy Phase 10 Days|4 Subjects Continued to Cohort II, as part of the Efavirenz 600 mg q.d. arm|7
2860291|NCT00100048|3562649|FG005|COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
2860292|NCT00100048|3562644|FG000|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
2860293|NCT00100048|3562645|FG001|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
2860294|NCT00100048|3562646|FG002|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
2860295|NCT00100048|3562647|FG003|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
2860296|NCT00100048|3562648|FG004|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
2860297|NCT00100048|3562649|FG005|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
2860298|NCT00100048|3562644|FG000|STARTED|Cohort I & II-Combination Therapy Phase|7 subjects from the Monotherapy Phase and 34 new subjects|41
2860299|NCT00100048|3562645|FG001|STARTED|Cohort I & II-Combination Therapy Phase|7 subjects from the Monotherapy Phase and 33 new subjects|40
2860300|NCT00100048|3562646|FG002|STARTED|Cohort I & II-Combination Therapy Phase|6 subjects from the Monotherapy Phase and 35 new subjects|41
2860301|NCT00100048|3562647|FG003|STARTED|Cohort I & II-Combination Therapy Phase|8 subjects from the Monotherapy Phase and 32 new subjects|40
2860302|NCT00100048|3562648|FG004|STARTED|Cohort I & II-Combination Therapy Phase|participants only assigned Placebo in Cohort I-Monotherapy Phase.|0
2860303|NCT00100048|3562649|FG005|STARTED|Cohort I & II-Combination Therapy Phase|4 subjects from the Monotherapy Phase (Placebo)and 35 new subjects|39
2860304|NCT00100048|3562644|FG000|Treated|Cohort I & II-Combination Therapy Phase||39
2860305|NCT00100048|3562645|FG001|Treated|Cohort I & II-Combination Therapy Phase||40
2860306|NCT00100048|3562646|FG002|Treated|Cohort I & II-Combination Therapy Phase||41
2860307|NCT00100048|3562647|FG003|Treated|Cohort I & II-Combination Therapy Phase||40
2860308|NCT00100048|3562648|FG004|Treated|Cohort I & II-Combination Therapy Phase||0
2860309|NCT00100048|3562649|FG005|Treated|Cohort I & II-Combination Therapy Phase||38
2860310|NCT00100048|3562644|FG000|Never Treated|Cohort I & II-Combination Therapy Phase|Randomised in Cohort II did not start Period|2
2860311|NCT00100048|3562645|FG001|Never Treated|Cohort I & II-Combination Therapy Phase||0
2860312|NCT00100048|3562646|FG002|Never Treated|Cohort I & II-Combination Therapy Phase||0
2860313|NCT00100048|3562647|FG003|Never Treated|Cohort I & II-Combination Therapy Phase||0
2860314|NCT00100048|3562648|FG004|Never Treated|Cohort I & II-Combination Therapy Phase||0
2860315|NCT00100048|3562649|FG005|Never Treated|Cohort I & II-Combination Therapy Phase|Randomised in Cohort II did not start Period|1
2860316|NCT00100048|3562644|FG000|COMPLETED|Cohort I & II-Combination Therapy Phase||27
2860317|NCT00100048|3562645|FG001|COMPLETED|Cohort I & II-Combination Therapy Phase||31
2860318|NCT00100048|3562646|FG002|COMPLETED|Cohort I & II-Combination Therapy Phase||28
2860319|NCT00100048|3562647|FG003|COMPLETED|Cohort I & II-Combination Therapy Phase||30
2860320|NCT00100048|3562648|FG004|COMPLETED|Cohort I & II-Combination Therapy Phase||0
2860321|NCT00100048|3562649|FG005|COMPLETED|Cohort I & II-Combination Therapy Phase||26
2860322|NCT00100048|3562644|FG000|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||14
2860323|NCT00100048|3562645|FG001|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||9
2860324|NCT00100048|3562646|FG002|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||13
2860325|NCT00100048|3562647|FG003|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||10
2860326|NCT00100048|3562648|FG004|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||0
2860327|NCT00100048|3562649|FG005|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||13
2860328|NCT00100165|3562677|FG000|STARTED|Baseline||10
2860329|NCT00100165|3562678|FG001|STARTED|Baseline||10
2860330|NCT00100165|3562679|FG002|STARTED|Baseline||9
2860331|NCT00100165|3562677|FG000|COMPLETED|Baseline||10
2860332|NCT00100165|3562678|FG001|COMPLETED|Baseline||10
2860333|NCT00100165|3562679|FG002|COMPLETED|Baseline||9
2860334|NCT00100165|3562677|FG000|NOT COMPLETED|Baseline||0
2860335|NCT00100165|3562678|FG001|NOT COMPLETED|Baseline||0
2860336|NCT00100165|3562679|FG002|NOT COMPLETED|Baseline||0
2860337|NCT00100165|3562677|FG000|STARTED|First Intervention (4 Weeks)||10
2860338|NCT00100165|3562678|FG001|STARTED|First Intervention (4 Weeks)||10
2860339|NCT00100165|3562679|FG002|STARTED|First Intervention (4 Weeks)||9
2860340|NCT00100165|3562677|FG000|COMPLETED|First Intervention (4 Weeks)||10
2860341|NCT00100165|3562678|FG001|COMPLETED|First Intervention (4 Weeks)||10
2860342|NCT00100165|3562679|FG002|COMPLETED|First Intervention (4 Weeks)||9
2860343|NCT00100165|3562677|FG000|NOT COMPLETED|First Intervention (4 Weeks)||0
2860344|NCT00100165|3562678|FG001|NOT COMPLETED|First Intervention (4 Weeks)||0
2860345|NCT00100165|3562679|FG002|NOT COMPLETED|First Intervention (4 Weeks)||0
2860346|NCT00100165|3562677|FG000|STARTED|Washout (1 Week)||10
2860347|NCT00100165|3562678|FG001|STARTED|Washout (1 Week)||10
2860348|NCT00100165|3562679|FG002|STARTED|Washout (1 Week)||9
2860349|NCT00100165|3562677|FG000|COMPLETED|Washout (1 Week)||10
2860350|NCT00100165|3562678|FG001|COMPLETED|Washout (1 Week)||10
2860351|NCT00100165|3562679|FG002|COMPLETED|Washout (1 Week)||9
2860352|NCT00100165|3562677|FG000|NOT COMPLETED|Washout (1 Week)||0
2860353|NCT00100165|3562678|FG001|NOT COMPLETED|Washout (1 Week)||0
2860354|NCT00100165|3562679|FG002|NOT COMPLETED|Washout (1 Week)||0
2860355|NCT00100165|3562677|FG000|STARTED|Second Intervention (4 Weeks)||10
2860356|NCT00100165|3562678|FG001|STARTED|Second Intervention (4 Weeks)||10
2860357|NCT00100165|3562679|FG002|STARTED|Second Intervention (4 Weeks)||9
2860358|NCT00100165|3562677|FG000|COMPLETED|Second Intervention (4 Weeks)||10
2860359|NCT00100165|3562678|FG001|COMPLETED|Second Intervention (4 Weeks)||10
2860360|NCT00100165|3562679|FG002|COMPLETED|Second Intervention (4 Weeks)||9
2860361|NCT00100165|3562677|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||0
2860362|NCT00100165|3562678|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||0
2860363|NCT00100165|3562679|FG002|NOT COMPLETED|Second Intervention (4 Weeks)||0
2860364|NCT00100165|3562677|FG000|STARTED|Washout (1 Week)||10
2860365|NCT00100165|3562678|FG001|STARTED|Washout (1 Week)||10
2860366|NCT00100165|3562679|FG002|STARTED|Washout (1 Week)||9
2860367|NCT00100165|3562677|FG000|COMPLETED|Washout (1 Week)||10
2860368|NCT00100165|3562678|FG001|COMPLETED|Washout (1 Week)||10
2860369|NCT00100165|3562679|FG002|COMPLETED|Washout (1 Week)||9
2860370|NCT00100165|3562677|FG000|NOT COMPLETED|Washout (1 Week)||0
2860371|NCT00100165|3562678|FG001|NOT COMPLETED|Washout (1 Week)||0
2860372|NCT00100165|3562679|FG002|NOT COMPLETED|Washout (1 Week)||0
2860373|NCT00100165|3562677|FG000|STARTED|Third Intervention (4 Weeks)||10
2860374|NCT00100165|3562678|FG001|STARTED|Third Intervention (4 Weeks)||10
2860375|NCT00100165|3562679|FG002|STARTED|Third Intervention (4 Weeks)||9
2860376|NCT00100165|3562677|FG000|COMPLETED|Third Intervention (4 Weeks)||10
2860377|NCT00100165|3562678|FG001|COMPLETED|Third Intervention (4 Weeks)||10
2860378|NCT00100165|3562679|FG002|COMPLETED|Third Intervention (4 Weeks)||9
2860379|NCT00100165|3562677|FG000|NOT COMPLETED|Third Intervention (4 Weeks)||0
2860380|NCT00100165|3562678|FG001|NOT COMPLETED|Third Intervention (4 Weeks)||0
2860381|NCT00100165|3562679|FG002|NOT COMPLETED|Third Intervention (4 Weeks)||0
2860382|NCT00100178|3562693|FG000|STARTED|Overall Study||41
2860383|NCT00100178|3562694|FG001|STARTED|Overall Study|12 subjects randomized to the MMF alone group were excluded from analysis due to randomization error|31
2860384|NCT00100178|3562695|FG002|STARTED|Overall Study||42
2860385|NCT00100178|3562693|FG000|COMPLETED|Overall Study||32
2860386|NCT00100178|3562694|FG001|COMPLETED|Overall Study||21
2860387|NCT00100178|3562695|FG002|COMPLETED|Overall Study||32
2860388|NCT00100178|3562693|FG000|NOT COMPLETED|Overall Study||9
2860389|NCT00100178|3562694|FG001|NOT COMPLETED|Overall Study||10
2860390|NCT00100178|3562695|FG002|NOT COMPLETED|Overall Study||10
2860391|NCT00100230|3562705|FG000|STARTED|Overall Study||41
2860392|NCT00100230|3562706|FG001|STARTED|Overall Study||37
2860393|NCT00100230|3562705|FG000|COMPLETED|Overall Study||29
2860394|NCT00100230|3562706|FG001|COMPLETED|Overall Study||22
2860395|NCT00100230|3562705|FG000|NOT COMPLETED|Overall Study||12
2860396|NCT00100230|3562706|FG001|NOT COMPLETED|Overall Study||15
2860397|NCT00100659|3562716|FG000|STARTED|Overall Study||55
2860398|NCT00100659|3562717|FG001|STARTED|Overall Study||59
2860399|NCT00100659|3562716|FG000|COMPLETED|Overall Study||52
2860400|NCT00100659|3562717|FG001|COMPLETED|Overall Study||57
2860401|NCT00100659|3562716|FG000|NOT COMPLETED|Overall Study||3
2860402|NCT00100659|3562717|FG001|NOT COMPLETED|Overall Study||2
2860403|NCT00100698|3562727|FG000|STARTED|Overall Study||27
2860404|NCT00100698|3562728|FG001|STARTED|Overall Study||29
2860405|NCT00100698|3562727|FG000|COMPLETED|Overall Study||21
2860406|NCT00100698|3562728|FG001|COMPLETED|Overall Study||27
2860407|NCT00100698|3562727|FG000|NOT COMPLETED|Overall Study||6
2860408|NCT00100698|3562728|FG001|NOT COMPLETED|Overall Study||2
2860409|NCT00100789|3562734|FG000|STARTED|Overall Study||67
2860410|NCT00100789|3562734|FG000|Eligible|Overall Study||64
2860411|NCT00100789|3562734|FG000|Eligible and Began Protocol Therapy|Overall Study||63
2860412|NCT00100789|3562734|FG000|COMPLETED|Overall Study||3
2860413|NCT00100789|3562734|FG000|NOT COMPLETED|Overall Study||64
2860414|NCT00100802|3562739|FG000|STARTED|Overall Study||118
2860415|NCT00100802|3562739|FG000|COMPLETED|Overall Study||38
2860416|NCT00100802|3562739|FG000|NOT COMPLETED|Overall Study||80
2860417|NCT00100815|3562743|FG000|STARTED|Overall Study||50
2860418|NCT00100815|3562743|FG000|COMPLETED|Overall Study||1
2860419|NCT00100815|3562743|FG000|NOT COMPLETED|Overall Study||49
2860420|NCT00100841|3562747|FG000|STARTED|Overall Study||66
2860421|NCT00100841|3562747|FG000|COMPLETED|Overall Study||66
2860422|NCT00100841|3562747|FG000|NOT COMPLETED|Overall Study||0
2860423|NCT00100932|3562753|FG000|STARTED|Overall Study|Represents all enrolled pts; counts in demographic section represents ITT/Safety Population.|78
2860424|NCT00100932|3562754|FG001|STARTED|Overall Study|Represents all enrolled pts; counts in demographic section represents ITT/Safety Population.|28
2860425|NCT00100932|3562753|FG000|COMPLETED|Overall Study||5
2860426|NCT00100932|3562754|FG001|COMPLETED|Overall Study||1
2860427|NCT00100932|3562753|FG000|NOT COMPLETED|Overall Study||73
2860428|NCT00100932|3562754|FG001|NOT COMPLETED|Overall Study||27
2860429|NCT00101010|3562760|FG000|STARTED|Overall Study||80
2860430|NCT00101010|3562760|FG000|COMPLETED|Overall Study||79
2860431|NCT00101010|3562760|FG000|NOT COMPLETED|Overall Study||1
2860432|NCT00101036|3562766|FG000|STARTED|Overall Study||17
2860433|NCT00101036|3562767|FG001|STARTED|Overall Study||40
2860434|NCT00101036|3562766|FG000|COMPLETED|Overall Study||17
2860435|NCT00101036|3562767|FG001|COMPLETED|Overall Study||40
2860436|NCT00101036|3562766|FG000|NOT COMPLETED|Overall Study||0
2860437|NCT00101036|3562767|FG001|NOT COMPLETED|Overall Study||0
2860438|NCT00101101|3562773|FG000|STARTED|Overall Study||43
2860439|NCT00101101|3562773|FG000|COMPLETED|Overall Study|Participants who received at least one vaccine injection.|23
2860440|NCT00101101|3562773|FG000|NOT COMPLETED|Overall Study||20
2860441|NCT00101166|3562777|FG000|STARTED|Overall Study||28
2860442|NCT00101166|3562777|FG000|COMPLETED|Overall Study||18
2860443|NCT00101166|3562777|FG000|NOT COMPLETED|Overall Study||10
2860444|NCT00101192|3562781|FG000|STARTED|Overall Study||76
2860445|NCT00101192|3562781|FG000|COMPLETED|Overall Study||69
2860446|NCT00101192|3562781|FG000|NOT COMPLETED|Overall Study||7
2860447|NCT00101283|3562787|FG000|STARTED|Overall Study||16
2860448|NCT00101283|3562788|FG001|STARTED|Overall Study||16
2860449|NCT00101283|3562787|FG000|Began Treatment|Overall Study||16
2860450|NCT00101283|3562788|FG001|Began Treatment|Overall Study||13
2860451|NCT00101283|3562787|FG000|COMPLETED|Overall Study||16
2860452|NCT00101283|3562788|FG001|COMPLETED|Overall Study||13
2860453|NCT00101283|3562787|FG000|NOT COMPLETED|Overall Study||0
2860454|NCT00101283|3562788|FG001|NOT COMPLETED|Overall Study||3
2860455|NCT00101361|3562796|FG000|STARTED|Overall Study||108
2860456|NCT00101361|3562797|FG001|STARTED|Overall Study||104
2860457|NCT00101361|3562796|FG000|COMPLETED|Overall Study||108
2860458|NCT00101361|3562797|FG001|COMPLETED|Overall Study||104
2860459|NCT00101361|3562796|FG000|NOT COMPLETED|Overall Study||0
2860460|NCT00101361|3562797|FG001|NOT COMPLETED|Overall Study||0
2860461|NCT00101400|3562803|FG000|STARTED|Treatment|Treated until disease progression, unacceptable sorafenib-related toxicity or withdrawal of consent.|54
2860462|NCT00101400|3562803|FG000|COMPLETED|Treatment|Reasons for treatment termination: 4 Adverse Events, 3 Deaths, 46 Progression, 1 Withdrawal.|54
2860463|NCT00101400|3562803|FG000|NOT COMPLETED|Treatment||0
2860464|NCT00101400|3562803|FG000|STARTED|Survival Follow-Up|3 subjects died during previous period (completion as defined in protocol)|51
2860465|NCT00101400|3562803|FG000|COMPLETED|Survival Follow-Up|44 subjects reached endpoint (death); 7 subjects were still alive|44
2860466|NCT00101400|3562803|FG000|NOT COMPLETED|Survival Follow-Up||7
2860467|NCT00101413|3562807|FG000|STARTED|Overall Study||52
2860468|NCT00101413|3562807|FG000|COMPLETED|Overall Study|Safety data collected for 4 subjects after 30 Jun 2005 until 11 Apr 2008.|52
2860469|NCT00101413|3562807|FG000|NOT COMPLETED|Overall Study||0
2860470|NCT00101452|3562814|FG000|STARTED|Overall Study||65
2860471|NCT00101452|3562815|FG001|STARTED|Overall Study||69
2860472|NCT00101452|3562816|FG002|STARTED|Overall Study||65
2860473|NCT00101452|3562814|FG000|COMPLETED|Overall Study||21
2860474|NCT00101452|3562815|FG001|COMPLETED|Overall Study||26
2860475|NCT00101452|3562816|FG002|COMPLETED|Overall Study||22
2860476|NCT00101452|3562814|FG000|NOT COMPLETED|Overall Study||44
2860477|NCT00101452|3562815|FG001|NOT COMPLETED|Overall Study||43
2860478|NCT00101452|3562816|FG002|NOT COMPLETED|Overall Study||43
2860479|NCT00101582|3562830|FG000|STARTED|Overall Study||94
2860480|NCT00101582|3562831|FG001|STARTED|Overall Study||94
2860481|NCT00101582|3562830|FG000|Received Study Drug|Overall Study||91
2860482|NCT00101582|3562831|FG001|Received Study Drug|Overall Study||94
2860483|NCT00101582|3562830|FG000|COMPLETED|Overall Study|Participants who completed the acute oral mucositis evaluation phase|83
2860484|NCT00101582|3562831|FG001|COMPLETED|Overall Study|Participants who completed the acute oral mucositis evaluation phase|79
2860485|NCT00101582|3562830|FG000|NOT COMPLETED|Overall Study||11
2860486|NCT00101582|3562831|FG001|NOT COMPLETED|Overall Study||15
2860487|NCT00101647|3562839|FG000|STARTED|Overall Study|Randomized|13
2860488|NCT00101647|3562840|FG001|STARTED|Overall Study|Randomized|161
2860489|NCT00101647|3562839|FG000|COMPLETED|Overall Study||13
2860490|NCT00101647|3562840|FG001|COMPLETED|Overall Study||161
2860491|NCT00101647|3562839|FG000|NOT COMPLETED|Overall Study||0
2860492|NCT00101647|3562840|FG001|NOT COMPLETED|Overall Study||0
2860493|NCT00101660|3562858|FG000|STARTED|Overall Study||99
2860494|NCT00101660|3562859|FG001|STARTED|Overall Study||288
2860495|NCT00101660|3562858|FG000|COMPLETED|Overall Study||99
2860496|NCT00101660|3562859|FG001|COMPLETED|Overall Study||288
2860497|NCT00101660|3562858|FG000|NOT COMPLETED|Overall Study||0
2860498|NCT00101660|3562859|FG001|NOT COMPLETED|Overall Study||0
2860499|NCT00101686|3562881|FG000|STARTED|Overall Study||71
2860500|NCT00101686|3562882|FG001|STARTED|Overall Study||73
2860501|NCT00101686|3562883|FG002|STARTED|Overall Study||69
2860502|NCT00101686|3562884|FG003|STARTED|Overall Study||72
2860503|NCT00101686|3562885|FG004|STARTED|Overall Study||73
2860504|NCT00101686|3562886|FG005|STARTED|Overall Study||72
2860505|NCT00101686|3562887|FG006|STARTED|Overall Study||27
2860506|NCT00101686|3562888|FG007|STARTED|Overall Study||30
2860507|NCT00101686|3562889|FG008|STARTED|Overall Study||30
2860508|NCT00101686|3562890|FG009|STARTED|Overall Study||30
2860509|NCT00101686|3562881|FG000|Received Treatment|Overall Study||70
2860510|NCT00101686|3562882|FG001|Received Treatment|Overall Study||67
2860511|NCT00101686|3562883|FG002|Received Treatment|Overall Study||67
2860512|NCT00101686|3562884|FG003|Received Treatment|Overall Study||70
2860513|NCT00101686|3562885|FG004|Received Treatment|Overall Study||71
2860514|NCT00101686|3562886|FG005|Received Treatment|Overall Study||70
2860515|NCT00101686|3562887|FG006|Received Treatment|Overall Study||27
2860516|NCT00101686|3562888|FG007|Received Treatment|Overall Study||29
2860517|NCT00101686|3562889|FG008|Received Treatment|Overall Study||30
2860518|NCT00101686|3562890|FG009|Received Treatment|Overall Study||29
2860519|NCT00101686|3562881|FG000|COMPLETED|Overall Study|Patients treated until disease progression.|0
2860520|NCT00101686|3562882|FG001|COMPLETED|Overall Study|Patients treated until disease progression.|0
2860521|NCT00101686|3562883|FG002|COMPLETED|Overall Study|Patients treated until disease progression.|0
2860522|NCT00101686|3562884|FG003|COMPLETED|Overall Study|Patients treated until disease progression.|0
2860523|NCT00101686|3562885|FG004|COMPLETED|Overall Study|Patients treated until disease progression.|0
2860524|NCT00101686|3562886|FG005|COMPLETED|Overall Study|Patients treated until disease progression.|0
2860525|NCT00101686|3562887|FG006|COMPLETED|Overall Study|Patients treated until disease progression.|0
2860526|NCT00101686|3562888|FG007|COMPLETED|Overall Study|Patients treated until disease progression.|0
2860527|NCT00101686|3562889|FG008|COMPLETED|Overall Study|Patients treated until disease progression.|0
2860528|NCT00101686|3562890|FG009|COMPLETED|Overall Study|Patients treated until disease progression.|0
2860529|NCT00101686|3562881|FG000|NOT COMPLETED|Overall Study||71
2860530|NCT00101686|3562882|FG001|NOT COMPLETED|Overall Study||73
2860531|NCT00101686|3562883|FG002|NOT COMPLETED|Overall Study||69
2860532|NCT00101686|3562884|FG003|NOT COMPLETED|Overall Study||72
2860533|NCT00101686|3562885|FG004|NOT COMPLETED|Overall Study||73
2860534|NCT00101686|3562886|FG005|NOT COMPLETED|Overall Study||72
2860535|NCT00101686|3562887|FG006|NOT COMPLETED|Overall Study||27
2860536|NCT00101686|3562888|FG007|NOT COMPLETED|Overall Study||30
2860537|NCT00101686|3562889|FG008|NOT COMPLETED|Overall Study||30
2860538|NCT00101686|3562890|FG009|NOT COMPLETED|Overall Study||30
2860539|NCT00101816|3562909|FG000|STARTED|Overall Study||10
2860540|NCT00101816|3562910|FG001|STARTED|Overall Study||99
2860541|NCT00101816|3562909|FG000|COMPLETED|Overall Study||10
2860542|NCT00101816|3562910|FG001|COMPLETED|Overall Study||99
2860543|NCT00101816|3562909|FG000|NOT COMPLETED|Overall Study||0
2860544|NCT00101816|3562910|FG001|NOT COMPLETED|Overall Study||0
2860545|NCT00101868|3562926|FG000|STARTED|Overall Study|35 hospital physicians allocated to discharge software|316
2860546|NCT00101868|3562927|FG001|STARTED|Overall Study|35 hospital physicians allocated to usual care discharge|315
2860547|NCT00101868|3562926|FG000|COMPLETED|Overall Study|1 hospital physician with zero patients lost to follow up|287
2860548|NCT00101868|3562927|FG001|COMPLETED|Overall Study|zero hospital physician with zero patients lost to follow up|283
2860549|NCT00101868|3562926|FG000|NOT COMPLETED|Overall Study||29
2860550|NCT00101868|3562927|FG001|NOT COMPLETED|Overall Study||32
2860551|NCT00101907|3562941|FG000|STARTED|Overall Study||8
2860552|NCT00101907|3562942|FG001|STARTED|Overall Study||8
2860553|NCT00101907|3562943|FG002|STARTED|Overall Study||6
2860554|NCT00101907|3562944|FG003|STARTED|Overall Study||6
2860555|NCT00101907|3562945|FG004|STARTED|Overall Study||11
2860556|NCT00101907|3562946|FG005|STARTED|Overall Study||2
2860557|NCT00101907|3562941|FG000|COMPLETED|Overall Study||6
2860558|NCT00101907|3562942|FG001|COMPLETED|Overall Study||7
2860559|NCT00101907|3562943|FG002|COMPLETED|Overall Study||5
2860560|NCT00101907|3562944|FG003|COMPLETED|Overall Study||5
2860561|NCT00101907|3562945|FG004|COMPLETED|Overall Study||6
2860562|NCT00101907|3562946|FG005|COMPLETED|Overall Study||2
2860563|NCT00101907|3562941|FG000|NOT COMPLETED|Overall Study||2
2860564|NCT00101907|3562942|FG001|NOT COMPLETED|Overall Study||1
2860565|NCT00101907|3562943|FG002|NOT COMPLETED|Overall Study||1
2860566|NCT00101907|3562944|FG003|NOT COMPLETED|Overall Study||1
2860567|NCT00101907|3562945|FG004|NOT COMPLETED|Overall Study||5
2860568|NCT00101907|3562946|FG005|NOT COMPLETED|Overall Study||0
2860569|NCT00101933|3562969|FG000|STARTED|Overall Study||54
2860570|NCT00101933|3562970|FG001|STARTED|Overall Study||55
2860571|NCT00101933|3562969|FG000|COMPLETED|Overall Study||54
2860572|NCT00101933|3562970|FG001|COMPLETED|Overall Study||55
2860573|NCT00101933|3562969|FG000|NOT COMPLETED|Overall Study||0
2860574|NCT00101933|3562970|FG001|NOT COMPLETED|Overall Study||0
2860575|NCT00102063|3562980|FG000|STARTED|Overall Study||100
2860576|NCT00102063|3562981|FG001|STARTED|Overall Study||102
2860577|NCT00102063|3562982|FG002|STARTED|Overall Study||100
2860578|NCT00102063|3562980|FG000|COMPLETED|Overall Study||84
2860579|NCT00102063|3562981|FG001|COMPLETED|Overall Study||84
2860580|NCT00102063|3562982|FG002|COMPLETED|Overall Study||90
2860581|NCT00102063|3562980|FG000|NOT COMPLETED|Overall Study||16
2860582|NCT00102063|3562981|FG001|NOT COMPLETED|Overall Study||18
2860583|NCT00102063|3562982|FG002|NOT COMPLETED|Overall Study||10
2860584|NCT00102440|3562993|FG000|STARTED|Overall Study||256
2860585|NCT00102440|3562994|FG001|STARTED|Overall Study||251
2860586|NCT00102440|3562995|FG002|STARTED|Overall Study||253
2860587|NCT00102440|3562993|FG000|COMPLETED|Overall Study||168
2860588|NCT00102440|3562994|FG001|COMPLETED|Overall Study||153
2860589|NCT00102440|3562995|FG002|COMPLETED|Overall Study||187
2860590|NCT00102440|3562993|FG000|NOT COMPLETED|Overall Study||88
2860591|NCT00102440|3562994|FG001|NOT COMPLETED|Overall Study||98
2860592|NCT00102440|3562995|FG002|NOT COMPLETED|Overall Study||66
2860593|NCT00102518|3563003|FG000|STARTED|Overall Study||325
2860594|NCT00102518|3563003|FG000|COMPLETED|Overall Study||238
2860595|NCT00102518|3563003|FG000|NOT COMPLETED|Overall Study||87
2860596|NCT00102531|3563009|FG000|STARTED|Overall Study||7
2860597|NCT00102531|3563010|FG001|STARTED|Overall Study||12
2860598|NCT00102531|3563009|FG000|COMPLETED|Overall Study||2
2860599|NCT00102531|3563010|FG001|COMPLETED|Overall Study||1
2860600|NCT00102531|3563009|FG000|NOT COMPLETED|Overall Study||5
2860601|NCT00102531|3563010|FG001|NOT COMPLETED|Overall Study||11
2860602|NCT00102596|3563016|FG000|STARTED|Part A||11
2860603|NCT00102596|3563017|FG001|STARTED|Part A||0
2860604|NCT00102596|3563016|FG000|Participants Assigned Treatment|Part A||5
2860605|NCT00102596|3563017|FG001|Participants Assigned Treatment|Part A||0
2860606|NCT00102596|3563016|FG000|COMPLETED|Part A||4
2860607|NCT00102596|3563017|FG001|COMPLETED|Part A||0
2860608|NCT00102596|3563016|FG000|NOT COMPLETED|Part A||7
2860609|NCT00102596|3563017|FG001|NOT COMPLETED|Part A||0
2860610|NCT00102596|3563016|FG000|STARTED|Part B|Participants from Part A did not continue to Part B|0
2860611|NCT00102596|3563017|FG001|STARTED|Part B||10
3313416|NCT03075410|4046793|FG002|COMPLETED|Part A-Washout Period 2 (14 Days)||1
3313417|NCT03075410|4046794|FG003|COMPLETED|Part A-Washout Period 2 (14 Days)||1
3313418|NCT03075410|4046795|FG004|COMPLETED|Part A-Washout Period 2 (14 Days)||2
3313419|NCT03075410|4046796|FG005|COMPLETED|Part A-Washout Period 2 (14 Days)||1
2860612|NCT00102596|3563016|FG000|COMPLETED|Part B||0
2860613|NCT00102596|3563017|FG001|COMPLETED|Part B||10
2860614|NCT00102596|3563016|FG000|NOT COMPLETED|Part B||0
2860615|NCT00102596|3563017|FG001|NOT COMPLETED|Part B||0
2860616|NCT00102596|3563016|FG000|STARTED|Part C||0
2860617|NCT00102596|3563017|FG001|STARTED|Part C|Only 2 patients participated in Part C|2
2860618|NCT00102596|3563016|FG000|COMPLETED|Part C||0
2860619|NCT00102596|3563017|FG001|COMPLETED|Part C||2
2860620|NCT00102596|3563016|FG000|NOT COMPLETED|Part C||0
2860621|NCT00102596|3563017|FG001|NOT COMPLETED|Part C||0
2860622|NCT00102687|3563027|FG000|STARTED|Initial Period||50
2860623|NCT00102687|3563028|FG001|STARTED|Initial Period||50
2860624|NCT00102687|3563029|FG002|STARTED|Initial Period|3 randomized participants did not receive treatment.|51
2860625|NCT00102687|3563030|FG003|STARTED|Initial Period||0
2860626|NCT00102687|3563031|FG004|STARTED|Initial Period||0
2860627|NCT00102687|3563027|FG000|COMPLETED|Initial Period||32
2860628|NCT00102687|3563028|FG001|COMPLETED|Initial Period||22
2860629|NCT00102687|3563029|FG002|COMPLETED|Initial Period||25
2860630|NCT00102687|3563030|FG003|COMPLETED|Initial Period||0
2860631|NCT00102687|3563031|FG004|COMPLETED|Initial Period||0
2860632|NCT00102687|3563027|FG000|NOT COMPLETED|Initial Period||18
2860633|NCT00102687|3563028|FG001|NOT COMPLETED|Initial Period||28
2860634|NCT00102687|3563029|FG002|NOT COMPLETED|Initial Period||26
2860635|NCT00102687|3563030|FG003|NOT COMPLETED|Initial Period||0
2860636|NCT00102687|3563031|FG004|NOT COMPLETED|Initial Period||0
2860637|NCT00102687|3563027|FG000|STARTED|Maintenance Period|Remained on initial treatment in the maintenance period.|13
2860638|NCT00102687|3563028|FG001|STARTED|Maintenance Period|Remained on initial treatment in the maintenance period.|6
2860639|NCT00102687|3563029|FG002|STARTED|Maintenance Period|Remained on initial treatment in the maintenance period.|8
2860640|NCT00102687|3563030|FG003|STARTED|Maintenance Period|Second randomization to one of two maintenance regimens|22
2860641|NCT00102687|3563031|FG004|STARTED|Maintenance Period|Second randomization to one of two maintenance regimens|21
2860642|NCT00102687|3563027|FG000|COMPLETED|Maintenance Period||6
2860643|NCT00102687|3563028|FG001|COMPLETED|Maintenance Period||2
2860644|NCT00102687|3563029|FG002|COMPLETED|Maintenance Period||2
2860645|NCT00102687|3563030|FG003|COMPLETED|Maintenance Period||12
2860646|NCT00102687|3563031|FG004|COMPLETED|Maintenance Period||8
2860647|NCT00102687|3563027|FG000|NOT COMPLETED|Maintenance Period||7
2860648|NCT00102687|3563028|FG001|NOT COMPLETED|Maintenance Period||4
2860649|NCT00102687|3563029|FG002|NOT COMPLETED|Maintenance Period||6
2860650|NCT00102687|3563030|FG003|NOT COMPLETED|Maintenance Period||10
2860651|NCT00102687|3563031|FG004|NOT COMPLETED|Maintenance Period||13
2860652|NCT00102804|3563049|FG000|STARTED|Overall Study||441
2860653|NCT00102804|3563050|FG001|STARTED|Overall Study||222
2860654|NCT00102804|3563049|FG000|Received at Least 1 Dose of Study Drug|Overall Study||434
2860655|NCT00102804|3563050|FG001|Received at Least 1 Dose of Study Drug|Overall Study|Four participants randomized to placebo received pemetrexed.|222
2860656|NCT00102804|3563049|FG000|COMPLETED|Overall Study||0
2860657|NCT00102804|3563050|FG001|COMPLETED|Overall Study||0
3168902|NCT01922050|3896379|FG005|COMPLETED|Part 1 Open-label, Dose-escalation Phase||18
3168903|NCT01922050|3896380|FG006|COMPLETED|Part 1 Open-label, Dose-escalation Phase||3
3168904|NCT01922050|3896381|FG007|COMPLETED|Part 1 Open-label, Dose-escalation Phase||3
3168905|NCT01922050|3896382|FG008|COMPLETED|Part 1 Open-label, Dose-escalation Phase||6
2860658|NCT00102804|3563049|FG000|NOT COMPLETED|Overall Study||441
2860659|NCT00102804|3563050|FG001|NOT COMPLETED|Overall Study||222
2860660|NCT00102960|3563059|FG000|STARTED|Overall Study||125
2860661|NCT00102960|3563060|FG001|STARTED|Overall Study||126
2860662|NCT00102960|3563061|FG002|STARTED|Overall Study||126
2860663|NCT00102960|3563059|FG000|COMPLETED|Overall Study||95
2860664|NCT00102960|3563060|FG001|COMPLETED|Overall Study||103
2860665|NCT00102960|3563061|FG002|COMPLETED|Overall Study||98
2860666|NCT00102960|3563059|FG000|NOT COMPLETED|Overall Study||30
2860667|NCT00102960|3563060|FG001|NOT COMPLETED|Overall Study||23
2860668|NCT00102960|3563061|FG002|NOT COMPLETED|Overall Study||28
2860669|NCT00103012|3563076|FG000|STARTED|Overall Study||17
2860670|NCT00103012|3563077|FG001|STARTED|Overall Study||14
2860671|NCT00103012|3563078|FG002|STARTED|Overall Study||16
2860672|NCT00103012|3563076|FG000|COMPLETED|Overall Study||14
2860673|NCT00103012|3563077|FG001|COMPLETED|Overall Study||13
2860674|NCT00103012|3563078|FG002|COMPLETED|Overall Study||12
2860675|NCT00103012|3563076|FG000|NOT COMPLETED|Overall Study||3
2860676|NCT00103012|3563077|FG001|NOT COMPLETED|Overall Study||1
2860677|NCT00103012|3563078|FG002|NOT COMPLETED|Overall Study||4
2860678|NCT00103116|3563086|FG000|STARTED|Overall Study||32
2860679|NCT00103116|3563086|FG000|COMPLETED|Overall Study||32
2860680|NCT00103116|3563086|FG000|NOT COMPLETED|Overall Study||0
2860681|NCT00103142|3563092|FG000|STARTED|Overall Study||36
2860682|NCT00103142|3563093|FG001|STARTED|Overall Study||37
2860683|NCT00103142|3563092|FG000|COMPLETED|Overall Study||33
2860684|NCT00103142|3563093|FG001|COMPLETED|Overall Study||36
2860685|NCT00103142|3563092|FG000|NOT COMPLETED|Overall Study||3
2860686|NCT00103142|3563093|FG001|NOT COMPLETED|Overall Study||1
2860687|NCT00103194|3563101|FG000|STARTED|Overall Study||49
2860688|NCT00103194|3563101|FG000|Treated|Overall Study||49
2860689|NCT00103194|3563101|FG000|Eligible|Overall Study||35
2860690|NCT00103194|3563101|FG000|Eligible and Treated|Overall Study||35
2860691|NCT00103194|3563101|FG000|COMPLETED|Overall Study||18
2860692|NCT00103194|3563101|FG000|NOT COMPLETED|Overall Study||31
2860693|NCT00103207|3563105|FG000|STARTED|Overall Study||72
2860694|NCT00103207|3563105|FG000|Eligible Patients w/ Confirmed Diagnosis|Overall Study||41
2860695|NCT00103207|3563105|FG000|Eligible Patients w/ Smoking Status Data|Overall Study||37
2860696|NCT00103207|3563105|FG000|COMPLETED|Overall Study||34
2860697|NCT00103207|3563105|FG000|NOT COMPLETED|Overall Study||38
2860698|NCT00103259|3563113|FG000|STARTED|Overall Study||27
2860699|NCT00103259|3563114|FG001|STARTED|Overall Study||44
2860700|NCT00103259|3563113|FG000|Eligible|Overall Study||27
2860701|NCT00103259|3563114|FG001|Eligible|Overall Study||41
2860702|NCT00103259|3563113|FG000|Treated|Overall Study||23
2860703|NCT00103259|3563114|FG001|Treated|Overall Study||41
2860704|NCT00103259|3563113|FG000|Eligible and Treated|Overall Study||23
2860705|NCT00103259|3563114|FG001|Eligible and Treated|Overall Study||38
3168906|NCT01922050|3896383|FG009|COMPLETED|Part 1 Open-label, Dose-escalation Phase||12
3168907|NCT01922050|3896384|FG010|COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
3168908|NCT01922050|3896385|FG011|COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
2860706|NCT00103259|3563113|FG000|Cross Over to the Other Arm|Overall Study||0
2860707|NCT00103259|3563114|FG001|Cross Over to the Other Arm|Overall Study|11 patients who progressed on bortezomib crossed over to Arm I. 10 of them were eligible|11
2860708|NCT00103259|3563113|FG000|Eligible Patients Who Cross Over|Overall Study||0
2860709|NCT00103259|3563114|FG001|Eligible Patients Who Cross Over|Overall Study||10
2860710|NCT00103259|3563113|FG000|COMPLETED|Overall Study|Treatment continued until disease progression or intolerable toxicity.|15
2860711|NCT00103259|3563114|FG001|COMPLETED|Overall Study|Treatment continued until disease progression or intolerable toxicity.This number is for stage I.|32
2860712|NCT00103259|3563113|FG000|NOT COMPLETED|Overall Study||12
2860713|NCT00103259|3563114|FG001|NOT COMPLETED|Overall Study||12
2860714|NCT00103285|3563122|FG000|STARTED|Induction||5377
2860715|NCT00103285|3563123|FG001|STARTED|Induction||0
2860716|NCT00103285|3563124|FG002|STARTED|Induction||0
2860717|NCT00103285|3563125|FG003|STARTED|Induction||0
2860718|NCT00103285|3563126|FG004|STARTED|Induction||0
2860719|NCT00103285|3563127|FG005|STARTED|Induction||0
2860720|NCT00103285|3563128|FG006|STARTED|Induction||0
2860721|NCT00103285|3563129|FG007|STARTED|Induction||0
2860722|NCT00103285|3563122|FG000|COMPLETED|Induction||4028
2860723|NCT00103285|3563123|FG001|COMPLETED|Induction||0
3168909|NCT01922050|3896386|FG012|COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
3168910|NCT01922050|3896387|FG013|COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
3168911|NCT01922050|3896374|FG000|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
3168912|NCT01922050|3896375|FG001|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
3168913|NCT01922050|3896376|FG002|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
3168914|NCT01922050|3896377|FG003|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
3168915|NCT01922050|3896378|FG004|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
3168916|NCT01922050|3896379|FG005|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
3168917|NCT01922050|3896380|FG006|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
3168918|NCT01922050|3896381|FG007|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
3168919|NCT01922050|3896382|FG008|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
3168920|NCT01922050|3896383|FG009|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
3168921|NCT01922050|3896384|FG010|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
3168922|NCT01922050|3896385|FG011|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
3168923|NCT01922050|3896386|FG012|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
3168924|NCT01922050|3896387|FG013|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
3168925|NCT01922050|3896374|FG000|STARTED|Part 2 Double-blind Phase||0
2860724|NCT00103285|3563124|FG002|COMPLETED|Induction||0
2860725|NCT00103285|3563125|FG003|COMPLETED|Induction||0
2860726|NCT00103285|3563126|FG004|COMPLETED|Induction||0
2860727|NCT00103285|3563127|FG005|COMPLETED|Induction||0
2860728|NCT00103285|3563128|FG006|COMPLETED|Induction||0
2860729|NCT00103285|3563129|FG007|COMPLETED|Induction||0
2860730|NCT00103285|3563122|FG000|NOT COMPLETED|Induction||1349
2860731|NCT00103285|3563123|FG001|NOT COMPLETED|Induction||0
2860732|NCT00103285|3563124|FG002|NOT COMPLETED|Induction||0
2860733|NCT00103285|3563125|FG003|NOT COMPLETED|Induction||0
2860734|NCT00103285|3563126|FG004|NOT COMPLETED|Induction||0
2860735|NCT00103285|3563127|FG005|NOT COMPLETED|Induction||0
2860736|NCT00103285|3563128|FG006|NOT COMPLETED|Induction||0
2860737|NCT00103285|3563129|FG007|NOT COMPLETED|Induction||0
2860738|NCT00103285|3563122|FG000|STARTED|Response Assignment||0
2860739|NCT00103285|3563123|FG001|STARTED|Response Assignment||939
2860740|NCT00103285|3563124|FG002|STARTED|Response Assignment||937
2860741|NCT00103285|3563125|FG003|STARTED|Response Assignment||503
2860742|NCT00103285|3563126|FG004|STARTED|Response Assignment||509
2860743|NCT00103285|3563127|FG005|STARTED|Response Assignment||249
2860744|NCT00103285|3563128|FG006|STARTED|Response Assignment||248
2860745|NCT00103285|3563129|FG007|STARTED|Response Assignment||643
2860746|NCT00103285|3563122|FG000|COMPLETED|Response Assignment||0
2860747|NCT00103285|3563123|FG001|COMPLETED|Response Assignment||807
2860748|NCT00103285|3563124|FG002|COMPLETED|Response Assignment||853
2860749|NCT00103285|3563125|FG003|COMPLETED|Response Assignment||441
2860750|NCT00103285|3563126|FG004|COMPLETED|Response Assignment||425
2860751|NCT00103285|3563127|FG005|COMPLETED|Response Assignment||201
2860752|NCT00103285|3563128|FG006|COMPLETED|Response Assignment||199
2860753|NCT00103285|3563129|FG007|COMPLETED|Response Assignment||523
2860754|NCT00103285|3563122|FG000|NOT COMPLETED|Response Assignment||0
2860755|NCT00103285|3563123|FG001|NOT COMPLETED|Response Assignment||132
2860756|NCT00103285|3563124|FG002|NOT COMPLETED|Response Assignment||84
2860757|NCT00103285|3563125|FG003|NOT COMPLETED|Response Assignment||62
2860758|NCT00103285|3563126|FG004|NOT COMPLETED|Response Assignment||84
2860759|NCT00103285|3563127|FG005|NOT COMPLETED|Response Assignment||48
2860760|NCT00103285|3563128|FG006|NOT COMPLETED|Response Assignment||49
2860761|NCT00103285|3563129|FG007|NOT COMPLETED|Response Assignment||120
2860762|NCT00103311|3563156|FG000|STARTED|Overall Study||33
2860763|NCT00103311|3563157|FG001|STARTED|Overall Study||31
2860764|NCT00103311|3563156|FG000|COMPLETED|Overall Study||29
2860765|NCT00103311|3563157|FG001|COMPLETED|Overall Study||30
2860766|NCT00103311|3563156|FG000|NOT COMPLETED|Overall Study||4
2860767|NCT00103311|3563157|FG001|NOT COMPLETED|Overall Study||1
2860768|NCT00103376|3563166|FG000|STARTED|Overall Study||8
2860769|NCT00103376|3563167|FG001|STARTED|Overall Study||7
2860770|NCT00103376|3563168|FG002|STARTED|Overall Study||8
2860771|NCT00103376|3563166|FG000|COMPLETED|Overall Study||8
2860772|NCT00103376|3563167|FG001|COMPLETED|Overall Study||7
2860773|NCT00103376|3563168|FG002|COMPLETED|Overall Study||8
2860774|NCT00103376|3563166|FG000|NOT COMPLETED|Overall Study||0
2860775|NCT00103376|3563167|FG001|NOT COMPLETED|Overall Study||0
2860776|NCT00103376|3563168|FG002|NOT COMPLETED|Overall Study||0
2860777|NCT00103402|3563184|FG000|STARTED|Overall Study||138
2860778|NCT00103402|3563185|FG001|STARTED|Overall Study||134
2860779|NCT00103402|3563184|FG000|COMPLETED|Overall Study||116
2860780|NCT00103402|3563185|FG001|COMPLETED|Overall Study||117
2860781|NCT00103402|3563184|FG000|NOT COMPLETED|Overall Study||22
2860782|NCT00103402|3563185|FG001|NOT COMPLETED|Overall Study||17
2860783|NCT00103506|3563193|FG000|STARTED|Overall Study||322
2860784|NCT00103506|3563194|FG001|STARTED|Overall Study||324
2860785|NCT00103506|3563193|FG000|COMPLETED|Overall Study||0
2860786|NCT00103506|3563194|FG001|COMPLETED|Overall Study||0
2860787|NCT00103506|3563193|FG000|NOT COMPLETED|Overall Study||322
2860788|NCT00103506|3563194|FG001|NOT COMPLETED|Overall Study||324
2860789|NCT00103610|3563202|FG000|STARTED|Overall Study||150
2860790|NCT00103610|3563203|FG001|STARTED|Overall Study||148
2860791|NCT00103610|3563202|FG000|COMPLETED|Overall Study||112
2860792|NCT00103610|3563203|FG001|COMPLETED|Overall Study||68
2860793|NCT00103610|3563202|FG000|NOT COMPLETED|Overall Study||38
2860794|NCT00103610|3563203|FG001|NOT COMPLETED|Overall Study||80
2860795|NCT00103662|3563212|FG000|STARTED|Overall Study||148
2860796|NCT00103662|3563213|FG001|STARTED|Overall Study||154
2860797|NCT00103662|3563212|FG000|COMPLETED|Overall Study|1 participant was wrongly terminated due to 'other'; the participant stayed on study until death.|129
2860798|NCT00103662|3563213|FG001|COMPLETED|Overall Study|1 participant was wrongly terminated due to 'other'; the participant stayed on study until death.|121
2860799|NCT00103662|3563212|FG000|NOT COMPLETED|Overall Study||19
2860800|NCT00103662|3563213|FG001|NOT COMPLETED|Overall Study||33
2860801|NCT00103740|3563221|FG000|STARTED|Period 1 - Core||92
2860802|NCT00103740|3563222|FG001|STARTED|Period 1 - Core||93
2860803|NCT00103740|3563221|FG000|COMPLETED|Period 1 - Core||85
2860804|NCT00103740|3563222|FG001|COMPLETED|Period 1 - Core||89
2860805|NCT00103740|3563221|FG000|NOT COMPLETED|Period 1 - Core||7
2860806|NCT00103740|3563222|FG001|NOT COMPLETED|Period 1 - Core||4
2860807|NCT00103740|3563221|FG000|STARTED|Period 2 - Extended Observation Period||78
2860808|NCT00103740|3563222|FG001|STARTED|Period 2 - Extended Observation Period||63
2860809|NCT00103740|3563221|FG000|COMPLETED|Period 2 - Extended Observation Period|Includes patients retreated for Paget's disease and patients discontinued when sponsor ended study|9
2860810|NCT00103740|3563222|FG001|COMPLETED|Period 2 - Extended Observation Period|Includes patients retreated for Paget's disease and patients discontinued when sponsor ended study|27
2860811|NCT00103740|3563221|FG000|NOT COMPLETED|Period 2 - Extended Observation Period||69
2860812|NCT00103740|3563222|FG001|NOT COMPLETED|Period 2 - Extended Observation Period||36
2860813|NCT00103844|3563230|FG000|STARTED|Overall Study||101
2860814|NCT00103844|3563231|FG001|STARTED|Overall Study||49
2860815|NCT00103844|3563230|FG000|Crossed Over|Overall Study|22 participants from the dasatinib arm crossed over to imatinib|22
2860816|NCT00103844|3563231|FG001|Crossed Over|Overall Study|40 participants from the imatinib arm crossed over the dasatinib|40
2860817|NCT00103844|3563230|FG000|COMPLETED|Overall Study|Completed=no longer on treatment.Treatment continued until disease progression/intolerable toxicity.|101
2860818|NCT00103844|3563231|FG001|COMPLETED|Overall Study|Completed=no longer on treatment.Treatment continued until disease progression/intolerable toxicity.|49
2860819|NCT00103844|3563230|FG000|NOT COMPLETED|Overall Study||0
2860820|NCT00103844|3563231|FG001|NOT COMPLETED|Overall Study||0
2860821|NCT00103857|3563244|FG000|STARTED|54-Week Base Study||179
2860822|NCT00103857|3563245|FG001|STARTED|54-Week Base Study||182
2860823|NCT00103857|3563246|FG002|STARTED|54-Week Base Study||182
2860824|NCT00103857|3563247|FG003|STARTED|54-Week Base Study||190
2860825|NCT00103857|3563248|FG004|STARTED|54-Week Base Study||182
2860826|NCT00103857|3563249|FG005|STARTED|54-Week Base Study||176
2860827|NCT00103857|3563250|FG006|STARTED|54-Week Base Study|Results for the OLC are through Week 24. Results for the 6 randomized groups are through Week 54.|117
2860828|NCT00103857|3563244|FG000|COMPLETED|54-Week Base Study||122
2860829|NCT00103857|3563245|FG001|COMPLETED|54-Week Base Study||126
2860830|NCT00103857|3563246|FG002|COMPLETED|54-Week Base Study||135
2860831|NCT00103857|3563247|FG003|COMPLETED|54-Week Base Study||148
2860832|NCT00103857|3563248|FG004|COMPLETED|54-Week Base Study||141
2860833|NCT00103857|3563249|FG005|COMPLETED|54-Week Base Study||115
2860834|NCT00103857|3563250|FG006|COMPLETED|54-Week Base Study||79
2860835|NCT00103857|3563244|FG000|NOT COMPLETED|54-Week Base Study||57
2860836|NCT00103857|3563245|FG001|NOT COMPLETED|54-Week Base Study||56
2860837|NCT00103857|3563246|FG002|NOT COMPLETED|54-Week Base Study||47
2860838|NCT00103857|3563247|FG003|NOT COMPLETED|54-Week Base Study||42
2860839|NCT00103857|3563248|FG004|NOT COMPLETED|54-Week Base Study||41
2860840|NCT00103857|3563249|FG005|NOT COMPLETED|54-Week Base Study||61
2860841|NCT00103857|3563250|FG006|NOT COMPLETED|54-Week Base Study||38
2860842|NCT00103857|3563244|FG000|STARTED|50-Week Extension Study|19 randomized patients completed Period 1 but did not enter Period 2.|103
2860843|NCT00103857|3563245|FG001|STARTED|50-Week Extension Study|19 randomized patients completed Period 1 but did not enter Period 2.|107
2860844|NCT00103857|3563246|FG002|STARTED|50-Week Extension Study|14 randomized patients completed Period 1 but did not enter Period 2.|121
2860845|NCT00103857|3563247|FG003|STARTED|50-Week Extension Study|14 randomized patients completed Period 1 but did not enter Period 2.|134
2860846|NCT00103857|3563248|FG004|STARTED|50-Week Extension Study|19 randomized patients completed Period 1 but did not enter Period 2.|122
2860847|NCT00103857|3563249|FG005|STARTED|50-Week Extension Study|17 randomized patients completed Period 1 but did not enter Period 2.|98
2860848|NCT00103857|3563250|FG006|STARTED|50-Week Extension Study||0
2860849|NCT00103857|3563244|FG000|COMPLETED|50-Week Extension Study||65
2860850|NCT00103857|3563245|FG001|COMPLETED|50-Week Extension Study||80
2860851|NCT00103857|3563246|FG002|COMPLETED|50-Week Extension Study||95
2860852|NCT00103857|3563247|FG003|COMPLETED|50-Week Extension Study||98
2860853|NCT00103857|3563248|FG004|COMPLETED|50-Week Extension Study||101
2860854|NCT00103857|3563249|FG005|COMPLETED|50-Week Extension Study||78
2860855|NCT00103857|3563250|FG006|COMPLETED|50-Week Extension Study||0
3168926|NCT01922050|3896375|FG001|STARTED|Part 2 Double-blind Phase||0
3168927|NCT01922050|3896376|FG002|STARTED|Part 2 Double-blind Phase||0
3168928|NCT01922050|3896377|FG003|STARTED|Part 2 Double-blind Phase||0
3168929|NCT01922050|3896378|FG004|STARTED|Part 2 Double-blind Phase||0
3168930|NCT01922050|3896379|FG005|STARTED|Part 2 Double-blind Phase||0
3168931|NCT01922050|3896380|FG006|STARTED|Part 2 Double-blind Phase||0
3168932|NCT01922050|3896381|FG007|STARTED|Part 2 Double-blind Phase||0
3168933|NCT01922050|3896382|FG008|STARTED|Part 2 Double-blind Phase||0
3168934|NCT01922050|3896383|FG009|STARTED|Part 2 Double-blind Phase||0
3168935|NCT01922050|3896384|FG010|STARTED|Part 2 Double-blind Phase||62
3168936|NCT01922050|3896385|FG011|STARTED|Part 2 Double-blind Phase||60
3168937|NCT01922050|3896386|FG012|STARTED|Part 2 Double-blind Phase||62
2860856|NCT00103857|3563244|FG000|NOT COMPLETED|50-Week Extension Study||38
2860857|NCT00103857|3563245|FG001|NOT COMPLETED|50-Week Extension Study||27
2860858|NCT00103857|3563246|FG002|NOT COMPLETED|50-Week Extension Study||26
2860859|NCT00103857|3563247|FG003|NOT COMPLETED|50-Week Extension Study||36
2860860|NCT00103857|3563248|FG004|NOT COMPLETED|50-Week Extension Study||21
2860861|NCT00103857|3563249|FG005|NOT COMPLETED|50-Week Extension Study||20
2860862|NCT00103857|3563250|FG006|NOT COMPLETED|50-Week Extension Study||0
2860863|NCT00104052|3563265|FG000|STARTED|Overall Study||107
2860864|NCT00104052|3563265|FG000|COMPLETED|Overall Study||78
2860865|NCT00104052|3563265|FG000|NOT COMPLETED|Overall Study||29
2860866|NCT00104104|3563271|FG000|STARTED|Overall Study|2 Participants in the 15-minute infusion group did not receive study drug.|90
2860867|NCT00104104|3563272|FG001|STARTED|Overall Study|1 Participants in the 30-minute infusion group did not receive study drug.|89
2860868|NCT00104104|3563271|FG000|Safety Population (Including Site 74)|Overall Study||88
2860869|NCT00104104|3563272|FG001|Safety Population (Including Site 74)|Overall Study||88
2860870|NCT00104104|3563271|FG000|Safety Population (Excluding Site 74)|Overall Study|Because of GCP violations at Site 74, post-baseline data for 3 patients in this arm were excluded.|85
2860871|NCT00104104|3563272|FG001|Safety Population (Excluding Site 74)|Overall Study|Because of GCP violations at Site 74, post-baseline data for 4 patients in this arm were excluded.|84
2860872|NCT00104104|3563271|FG000|COMPLETED|Overall Study||15
2860873|NCT00104104|3563272|FG001|COMPLETED|Overall Study||17
2860874|NCT00104104|3563271|FG000|NOT COMPLETED|Overall Study||75
2860875|NCT00104104|3563272|FG001|NOT COMPLETED|Overall Study||72
2860876|NCT00104234|3563280|FG000|STARTED|Overall Study||19
2860877|NCT00104234|3563281|FG001|STARTED|Overall Study||20
2860878|NCT00104234|3563280|FG000|COMPLETED|Overall Study||19
2860879|NCT00104234|3563281|FG001|COMPLETED|Overall Study||19
2860880|NCT00104234|3563280|FG000|NOT COMPLETED|Overall Study||0
2860881|NCT00104234|3563281|FG001|NOT COMPLETED|Overall Study||1
2860882|NCT00104247|3563289|FG000|STARTED|Overall Study||42
2860883|NCT00104247|3563290|FG001|STARTED|Overall Study||47
2860884|NCT00104247|3563289|FG000|COMPLETED|Overall Study|Subject withdrew prior to dosing|41
2860885|NCT00104247|3563290|FG001|COMPLETED|Overall Study|One subject withdrew at Week 4, but is included in the data analysis|46
2860886|NCT00104247|3563289|FG000|NOT COMPLETED|Overall Study||1
2860887|NCT00104247|3563290|FG001|NOT COMPLETED|Overall Study||1
2860888|NCT00104299|3563298|FG000|STARTED|Overall Study||99
2860889|NCT00104299|3563299|FG001|STARTED|Overall Study||98
2860890|NCT00104299|3563298|FG000|COMPLETED|Overall Study|Number of participants who completed 18 months post-randomization|90
2860891|NCT00104299|3563299|FG001|COMPLETED|Overall Study|Number of participants who completed 18 months post-randomization|88
2860892|NCT00104299|3563298|FG000|NOT COMPLETED|Overall Study||9
2860893|NCT00104299|3563299|FG001|NOT COMPLETED|Overall Study||10
2860894|NCT00104416|3563307|FG000|STARTED|Double-Blind Phase||77
2860895|NCT00104416|3563308|FG001|STARTED|Double-Blind Phase||76
2860896|NCT00104416|3563309|FG002|STARTED|Double-Blind Phase||0
2860897|NCT00104416|3563310|FG003|STARTED|Double-Blind Phase||0
2860898|NCT00104416|3563311|FG004|STARTED|Double-Blind Phase||0
2860899|NCT00104416|3563307|FG000|COMPLETED|Double-Blind Phase||69
2860900|NCT00104416|3563308|FG001|COMPLETED|Double-Blind Phase||66
2860901|NCT00104416|3563309|FG002|COMPLETED|Double-Blind Phase||0
2860902|NCT00104416|3563310|FG003|COMPLETED|Double-Blind Phase||0
2860903|NCT00104416|3563311|FG004|COMPLETED|Double-Blind Phase||0
2860904|NCT00104416|3563307|FG000|NOT COMPLETED|Double-Blind Phase||8
2860905|NCT00104416|3563308|FG001|NOT COMPLETED|Double-Blind Phase||10
2860906|NCT00104416|3563309|FG002|NOT COMPLETED|Double-Blind Phase||0
2860907|NCT00104416|3563310|FG003|NOT COMPLETED|Double-Blind Phase||0
2860908|NCT00104416|3563311|FG004|NOT COMPLETED|Double-Blind Phase||0
2860909|NCT00104416|3563307|FG000|STARTED|Continuation Phase||0
2860910|NCT00104416|3563308|FG001|STARTED|Continuation Phase||0
2860911|NCT00104416|3563309|FG002|STARTED|Continuation Phase||69
2860912|NCT00104416|3563310|FG003|STARTED|Continuation Phase|One participant did not complete the Double-Blind Phase but was enrolled in the Continuation Phase.|67
2860913|NCT00104416|3563311|FG004|STARTED|Continuation Phase||32
2860914|NCT00104416|3563307|FG000|COMPLETED|Continuation Phase||0
2860915|NCT00104416|3563308|FG001|COMPLETED|Continuation Phase||0
2860916|NCT00104416|3563309|FG002|COMPLETED|Continuation Phase||63
2860917|NCT00104416|3563310|FG003|COMPLETED|Continuation Phase||65
2860918|NCT00104416|3563311|FG004|COMPLETED|Continuation Phase||27
2860919|NCT00104416|3563307|FG000|NOT COMPLETED|Continuation Phase||0
2860920|NCT00104416|3563308|FG001|NOT COMPLETED|Continuation Phase||0
2860921|NCT00104416|3563309|FG002|NOT COMPLETED|Continuation Phase||6
2860922|NCT00104416|3563310|FG003|NOT COMPLETED|Continuation Phase||2
2860923|NCT00104416|3563311|FG004|NOT COMPLETED|Continuation Phase||5
2860924|NCT00104520|3563325|FG000|STARTED|Overall Study||76
2860925|NCT00104520|3563326|FG001|STARTED|Overall Study||135
2860926|NCT00104520|3563325|FG000|COMPLETED|Overall Study||26
2860927|NCT00104520|3563326|FG001|COMPLETED|Overall Study||64
2860928|NCT00104520|3563325|FG000|NOT COMPLETED|Overall Study||50
2860929|NCT00104520|3563326|FG001|NOT COMPLETED|Overall Study||71
2860930|NCT00104572|3563335|FG000|STARTED|Overall Study|These are the analysed subjects|13
2860931|NCT00104572|3563336|FG001|STARTED|Overall Study|These are the analysed subjects|13
2860932|NCT00104572|3563337|FG002|STARTED|Overall Study|(N=11) in placebo, physician removed 2 men due to total testosterone>450 ng/DL, N=9 analysed.|9
2860933|NCT00104572|3563335|FG000|COMPLETED|Overall Study||10
2860934|NCT00104572|3563336|FG001|COMPLETED|Overall Study||10
2860935|NCT00104572|3563337|FG002|COMPLETED|Overall Study||9
2860936|NCT00104572|3563335|FG000|NOT COMPLETED|Overall Study||3
2860937|NCT00104572|3563336|FG001|NOT COMPLETED|Overall Study||3
2860938|NCT00104572|3563337|FG002|NOT COMPLETED|Overall Study||0
2918455|NCT00527397|3628678|FG000|STARTED|Overall Study||24
2918456|NCT00527397|3628678|FG000|COMPLETED|Overall Study||0
2918457|NCT00527397|3628678|FG000|NOT COMPLETED|Overall Study||24
2918458|NCT00527423|3628685|FG000|STARTED|Overall Study||157
2918459|NCT00527423|3628685|FG000|COMPLETED|Overall Study||120
2918460|NCT00527423|3628685|FG000|NOT COMPLETED|Overall Study||37
2918461|NCT00527475|3628693|FG000|STARTED|Overall Study||30
2918462|NCT00527475|3628694|FG001|STARTED|Overall Study||30
2918463|NCT00527475|3628693|FG000|COMPLETED|Overall Study||27
2918464|NCT00527475|3628694|FG001|COMPLETED|Overall Study||29
2918465|NCT00527475|3628693|FG000|NOT COMPLETED|Overall Study||3
2918466|NCT00527475|3628694|FG001|NOT COMPLETED|Overall Study||1
2918467|NCT00527488|3628704|FG000|STARTED|Overall Study||13
2918468|NCT00527488|3628705|FG001|STARTED|Overall Study||13
2918469|NCT00527488|3628706|FG002|STARTED|Overall Study||13
2918470|NCT00527488|3628707|FG003|STARTED|Overall Study||13
2918471|NCT00527488|3628704|FG000|COMPLETED|Overall Study||13
2918472|NCT00527488|3628705|FG001|COMPLETED|Overall Study||12
2918473|NCT00527488|3628706|FG002|COMPLETED|Overall Study||12
2918474|NCT00527488|3628707|FG003|COMPLETED|Overall Study||13
2918475|NCT00527488|3628704|FG000|NOT COMPLETED|Overall Study||0
2918476|NCT00527488|3628705|FG001|NOT COMPLETED|Overall Study||1
2918477|NCT00527488|3628706|FG002|NOT COMPLETED|Overall Study||1
2918478|NCT00527488|3628707|FG003|NOT COMPLETED|Overall Study||0
2918479|NCT00527514|3628717|FG000|STARTED|Weeks 1-3: Amlodipine (Aml) 5mg||185
2918480|NCT00527514|3628717|FG000|COMPLETED|Weeks 1-3: Amlodipine (Aml) 5mg|1 participant dropped out. 2 participants were subsequently mis-titrated to the third regimen.|184
2918481|NCT00527514|3628717|FG000|NOT COMPLETED|Weeks 1-3: Amlodipine (Aml) 5mg||1
2918482|NCT00527514|3628717|FG000|STARTED|Weeks 4-6: Aml 5mg+Olmesartan 20 mg|184 -2 who were mis-titrated -2 who met blood pressure goal = 180|180
2918483|NCT00527514|3628717|FG000|COMPLETED|Weeks 4-6: Aml 5mg+Olmesartan 20 mg||178
2918484|NCT00527514|3628717|FG000|NOT COMPLETED|Weeks 4-6: Aml 5mg+Olmesartan 20 mg||2
2920781|NCT00538759|3631353|FG001|STARTED|Overall Study||8
2920782|NCT00538759|3631352|FG000|COMPLETED|Overall Study||13
2860939|NCT00104637|3563345|FG000|STARTED|Period 1: ( TREATMENT: 4 Weeks)||6
2860940|NCT00104637|3563346|FG001|STARTED|Period 1: ( TREATMENT: 4 Weeks)||4
2860941|NCT00104637|3563345|FG000|COMPLETED|Period 1: ( TREATMENT: 4 Weeks)||5
2860942|NCT00104637|3563346|FG001|COMPLETED|Period 1: ( TREATMENT: 4 Weeks)||4
2860943|NCT00104637|3563345|FG000|NOT COMPLETED|Period 1: ( TREATMENT: 4 Weeks)||1
2860944|NCT00104637|3563346|FG001|NOT COMPLETED|Period 1: ( TREATMENT: 4 Weeks)||0
2860945|NCT00104637|3563345|FG000|STARTED|Period 2 (WASHOUT: 1 Week)||5
2860946|NCT00104637|3563346|FG001|STARTED|Period 2 (WASHOUT: 1 Week)||4
2860947|NCT00104637|3563345|FG000|COMPLETED|Period 2 (WASHOUT: 1 Week)||5
2860948|NCT00104637|3563346|FG001|COMPLETED|Period 2 (WASHOUT: 1 Week)||4
2860949|NCT00104637|3563345|FG000|NOT COMPLETED|Period 2 (WASHOUT: 1 Week)||0
2860950|NCT00104637|3563346|FG001|NOT COMPLETED|Period 2 (WASHOUT: 1 Week)||0
2860951|NCT00104637|3563345|FG000|STARTED|Period 3 ( TREATMENT: 4 Weeks)||5
2860952|NCT00104637|3563346|FG001|STARTED|Period 3 ( TREATMENT: 4 Weeks)||4
2860953|NCT00104637|3563345|FG000|COMPLETED|Period 3 ( TREATMENT: 4 Weeks)||5
2860954|NCT00104637|3563346|FG001|COMPLETED|Period 3 ( TREATMENT: 4 Weeks)||4
2860955|NCT00104637|3563345|FG000|NOT COMPLETED|Period 3 ( TREATMENT: 4 Weeks)||0
2860956|NCT00104637|3563346|FG001|NOT COMPLETED|Period 3 ( TREATMENT: 4 Weeks)||0
2860957|NCT00104650|3563358|FG000|STARTED|Treatment Period (25 Weeks)||37
2860958|NCT00104650|3563359|FG001|STARTED|Treatment Period (25 Weeks)||36
2860959|NCT00104650|3563360|FG002|STARTED|Treatment Period (25 Weeks)||38
2860960|NCT00104650|3563358|FG000|Received Investigational Product|Treatment Period (25 Weeks)||35
2860961|NCT00104650|3563359|FG001|Received Investigational Product|Treatment Period (25 Weeks)||35
2860962|NCT00104650|3563360|FG002|Received Investigational Product|Treatment Period (25 Weeks)||38
2860963|NCT00104650|3563358|FG000|COMPLETED|Treatment Period (25 Weeks)||25
2860964|NCT00104650|3563359|FG001|COMPLETED|Treatment Period (25 Weeks)||25
2860965|NCT00104650|3563360|FG002|COMPLETED|Treatment Period (25 Weeks)||28
2860966|NCT00104650|3563358|FG000|NOT COMPLETED|Treatment Period (25 Weeks)||12
2860967|NCT00104650|3563359|FG001|NOT COMPLETED|Treatment Period (25 Weeks)||11
2860968|NCT00104650|3563360|FG002|NOT COMPLETED|Treatment Period (25 Weeks)||10
2860969|NCT00104650|3563358|FG000|STARTED|Follow-up Period||25
2860970|NCT00104650|3563359|FG001|STARTED|Follow-up Period||25
2860971|NCT00104650|3563360|FG002|STARTED|Follow-up Period||28
2860972|NCT00104650|3563358|FG000|COMPLETED|Follow-up Period||14
2860973|NCT00104650|3563359|FG001|COMPLETED|Follow-up Period||12
2860974|NCT00104650|3563360|FG002|COMPLETED|Follow-up Period||18
2860975|NCT00104650|3563358|FG000|NOT COMPLETED|Follow-up Period||11
2860976|NCT00104650|3563359|FG001|NOT COMPLETED|Follow-up Period||13
2860977|NCT00104650|3563360|FG002|NOT COMPLETED|Follow-up Period||10
2860978|NCT00104676|3563370|FG000|STARTED|Overall Study||98
2860979|NCT00104676|3563371|FG001|STARTED|Overall Study||105
2860980|NCT00104676|3563370|FG000|COMPLETED|Overall Study||91
2860981|NCT00104676|3563371|FG001|COMPLETED|Overall Study||91
2860982|NCT00104676|3563370|FG000|NOT COMPLETED|Overall Study||7
2860983|NCT00104676|3563371|FG001|NOT COMPLETED|Overall Study||14
2860984|NCT00104858|3563377|FG000|STARTED|Overall Study||52
2860985|NCT00104858|3563377|FG000|COMPLETED|Overall Study||52
2860986|NCT00104858|3563377|FG000|NOT COMPLETED|Overall Study||0
2860987|NCT00104871|3563383|FG000|STARTED|Overall Study||22
2860988|NCT00104871|3563383|FG000|COMPLETED|Overall Study||21
2860989|NCT00104871|3563383|FG000|NOT COMPLETED|Overall Study||1
2860990|NCT00104884|3563387|FG000|STARTED|Overall Study||4
2860991|NCT00104884|3563387|FG000|COMPLETED|Overall Study||0
2860992|NCT00104884|3563387|FG000|NOT COMPLETED|Overall Study||4
2860993|NCT00105001|3563394|FG000|STARTED|Overall Study||70
2860994|NCT00105001|3563395|FG001|STARTED|Overall Study||71
2860995|NCT00105001|3563396|FG002|STARTED|Overall Study||69
3168938|NCT01922050|3896387|FG013|STARTED|Part 2 Double-blind Phase||59
3168939|NCT01922050|3896374|FG000|COMPLETED|Part 2 Double-blind Phase||0
3168940|NCT01922050|3896375|FG001|COMPLETED|Part 2 Double-blind Phase||0
3168941|NCT01922050|3896376|FG002|COMPLETED|Part 2 Double-blind Phase||0
3168942|NCT01922050|3896377|FG003|COMPLETED|Part 2 Double-blind Phase||0
2860996|NCT00105001|3563394|FG000|COMPLETED|Overall Study||70
2860997|NCT00105001|3563395|FG001|COMPLETED|Overall Study||71
2860998|NCT00105001|3563396|FG002|COMPLETED|Overall Study||69
2860999|NCT00105001|3563394|FG000|NOT COMPLETED|Overall Study||0
2861000|NCT00105001|3563395|FG001|NOT COMPLETED|Overall Study||0
2861001|NCT00105001|3563396|FG002|NOT COMPLETED|Overall Study||0
2861002|NCT00105027|3563410|FG000|STARTED|Overall Study||88
2861003|NCT00105027|3563411|FG001|STARTED|Overall Study||92
2861004|NCT00105027|3563412|FG002|STARTED|Overall Study||91
2861005|NCT00105027|3563413|FG003|STARTED|Overall Study||137
2861006|NCT00105027|3563414|FG004|STARTED|Overall Study||136
2861007|NCT00105027|3563415|FG005|STARTED|Overall Study||138
2861008|NCT00105027|3563410|FG000|COMPLETED|Overall Study||73
2861009|NCT00105027|3563411|FG001|COMPLETED|Overall Study||83
2861010|NCT00105027|3563412|FG002|COMPLETED|Overall Study||82
2861011|NCT00105027|3563413|FG003|COMPLETED|Overall Study||121
2861012|NCT00105027|3563414|FG004|COMPLETED|Overall Study||121
2861013|NCT00105027|3563415|FG005|COMPLETED|Overall Study||125
2861014|NCT00105027|3563410|FG000|NOT COMPLETED|Overall Study||15
2861015|NCT00105027|3563411|FG001|NOT COMPLETED|Overall Study||9
2861016|NCT00105027|3563412|FG002|NOT COMPLETED|Overall Study||9
2861017|NCT00105027|3563413|FG003|NOT COMPLETED|Overall Study||16
2861018|NCT00105027|3563414|FG004|NOT COMPLETED|Overall Study||15
2861019|NCT00105027|3563415|FG005|NOT COMPLETED|Overall Study||13
2861020|NCT00105066|3563431|FG000|STARTED|Overall Study||27
2861021|NCT00105066|3563432|FG001|STARTED|Overall Study||50
2861022|NCT00105066|3563431|FG000|COMPLETED|Overall Study||25
2861023|NCT00105066|3563432|FG001|COMPLETED|Overall Study||45
2861024|NCT00105066|3563431|FG000|NOT COMPLETED|Overall Study||2
2861025|NCT00105066|3563432|FG001|NOT COMPLETED|Overall Study||5
3168943|NCT01922050|3896378|FG004|COMPLETED|Part 2 Double-blind Phase||0
3168944|NCT01922050|3896379|FG005|COMPLETED|Part 2 Double-blind Phase||0
3168945|NCT01922050|3896380|FG006|COMPLETED|Part 2 Double-blind Phase||0
3168946|NCT01922050|3896381|FG007|COMPLETED|Part 2 Double-blind Phase||0
3168947|NCT01922050|3896382|FG008|COMPLETED|Part 2 Double-blind Phase||0
3168948|NCT01922050|3896383|FG009|COMPLETED|Part 2 Double-blind Phase||0
3168949|NCT01922050|3896384|FG010|COMPLETED|Part 2 Double-blind Phase||61
3168950|NCT01922050|3896385|FG011|COMPLETED|Part 2 Double-blind Phase||58
3168951|NCT01922050|3896386|FG012|COMPLETED|Part 2 Double-blind Phase||62
2861026|NCT00105079|3563440|FG000|STARTED|Overall Study||167
2861027|NCT00105079|3563441|FG001|STARTED|Overall Study||170
2861028|NCT00105079|3563440|FG000|Safety Population|Overall Study||163
2861029|NCT00105079|3563441|FG001|Safety Population|Overall Study||168
2861030|NCT00105079|3563440|FG000|COMPLETED|Overall Study||128
2861031|NCT00105079|3563441|FG001|COMPLETED|Overall Study||135
2861032|NCT00105079|3563440|FG000|NOT COMPLETED|Overall Study||39
2861033|NCT00105079|3563441|FG001|NOT COMPLETED|Overall Study||35
2861034|NCT00105157|3563451|FG000|STARTED|Double-Blind (DB)||44
2861035|NCT00105157|3563452|FG001|STARTED|Double-Blind (DB)||45
2861036|NCT00105157|3563453|FG002|STARTED|Double-Blind (DB)||45
2861037|NCT00105157|3563454|FG003|STARTED|Double-Blind (DB)||45
2861038|NCT00105157|3563451|FG000|Treated|Double-Blind (DB)||43
2861039|NCT00105157|3563452|FG001|Treated|Double-Blind (DB)||45
2861040|NCT00105157|3563453|FG002|Treated|Double-Blind (DB)||45
2861041|NCT00105157|3563454|FG003|Treated|Double-Blind (DB)||45
2861042|NCT00105157|3563451|FG000|COMPLETED|Double-Blind (DB)||30
2861043|NCT00105157|3563452|FG001|COMPLETED|Double-Blind (DB)||31
2861044|NCT00105157|3563453|FG002|COMPLETED|Double-Blind (DB)||33
2861045|NCT00105157|3563454|FG003|COMPLETED|Double-Blind (DB)||6
2861046|NCT00105157|3563451|FG000|NOT COMPLETED|Double-Blind (DB)||14
2861047|NCT00105157|3563452|FG001|NOT COMPLETED|Double-Blind (DB)||14
2861048|NCT00105157|3563453|FG002|NOT COMPLETED|Double-Blind (DB)||12
2861049|NCT00105157|3563454|FG003|NOT COMPLETED|Double-Blind (DB)||39
2861050|NCT00105157|3563451|FG000|STARTED|Open-Label Continuation of DB||30
2861051|NCT00105157|3563452|FG001|STARTED|Open-Label Continuation of DB||31
2861052|NCT00105157|3563453|FG002|STARTED|Open-Label Continuation of DB||33
2861053|NCT00105157|3563454|FG003|STARTED|Open-Label Continuation of DB||6
2861054|NCT00105157|3563451|FG000|COMPLETED|Open-Label Continuation of DB||23
2861055|NCT00105157|3563452|FG001|COMPLETED|Open-Label Continuation of DB||21
2861056|NCT00105157|3563453|FG002|COMPLETED|Open-Label Continuation of DB||24
2861057|NCT00105157|3563454|FG003|COMPLETED|Open-Label Continuation of DB||5
2861058|NCT00105157|3563451|FG000|NOT COMPLETED|Open-Label Continuation of DB||7
2861059|NCT00105157|3563452|FG001|NOT COMPLETED|Open-Label Continuation of DB||10
2861060|NCT00105157|3563453|FG002|NOT COMPLETED|Open-Label Continuation of DB||9
2861061|NCT00105157|3563454|FG003|NOT COMPLETED|Open-Label Continuation of DB||1
2861062|NCT00105157|3563451|FG000|STARTED|Open-Label Post Virologic Failure(OLPVF)|Number of Patients appropriate for and who consented to enter the OLPVF|11
2861063|NCT00105157|3563452|FG001|STARTED|Open-Label Post Virologic Failure(OLPVF)|Number of Patients appropriate for and who consented to enter the OLPVF|13
2861064|NCT00105157|3563453|FG002|STARTED|Open-Label Post Virologic Failure(OLPVF)|Number of Patients appropriate for and who consented to enter the OLPVF|11
2861065|NCT00105157|3563454|FG003|STARTED|Open-Label Post Virologic Failure(OLPVF)|Number of Patients appropriate for and who consented to enter the OLPVF|37
2861066|NCT00105157|3563451|FG000|COMPLETED|Open-Label Post Virologic Failure(OLPVF)||2
2861067|NCT00105157|3563452|FG001|COMPLETED|Open-Label Post Virologic Failure(OLPVF)||7
2861068|NCT00105157|3563453|FG002|COMPLETED|Open-Label Post Virologic Failure(OLPVF)||5
2861069|NCT00105157|3563454|FG003|COMPLETED|Open-Label Post Virologic Failure(OLPVF)||19
2861070|NCT00105157|3563451|FG000|NOT COMPLETED|Open-Label Post Virologic Failure(OLPVF)||9
2861071|NCT00105157|3563452|FG001|NOT COMPLETED|Open-Label Post Virologic Failure(OLPVF)||6
2861072|NCT00105157|3563453|FG002|NOT COMPLETED|Open-Label Post Virologic Failure(OLPVF)||6
2861073|NCT00105157|3563454|FG003|NOT COMPLETED|Open-Label Post Virologic Failure(OLPVF)||18
2861074|NCT00105183|3563465|FG000|STARTED|Overall Study|Randomized|82
2861075|NCT00105183|3563466|FG001|STARTED|Overall Study|Randomized|79
2861076|NCT00105183|3563467|FG002|STARTED|Overall Study|Randomized|62
2861077|NCT00105183|3563465|FG000|COMPLETED|Overall Study|Completed at least 12 months follow up|60
2861078|NCT00105183|3563466|FG001|COMPLETED|Overall Study|Completed at least 12 months follow up|60
2861079|NCT00105183|3563467|FG002|COMPLETED|Overall Study|Completed at least 12 months follow up|39
2861080|NCT00105183|3563465|FG000|NOT COMPLETED|Overall Study||22
2861081|NCT00105183|3563466|FG001|NOT COMPLETED|Overall Study||19
2861082|NCT00105183|3563467|FG002|NOT COMPLETED|Overall Study||23
2861083|NCT00105196|3563477|FG000|STARTED|Overall Study||177
2861084|NCT00105196|3563478|FG001|STARTED|Overall Study||172
2861085|NCT00105196|3563477|FG000|COMPLETED|Overall Study||147
2861086|NCT00105196|3563478|FG001|COMPLETED|Overall Study||149
2861087|NCT00105196|3563477|FG000|NOT COMPLETED|Overall Study||30
2861088|NCT00105196|3563478|FG001|NOT COMPLETED|Overall Study||23
2861089|NCT00105235|3563484|FG000|STARTED|Overall Study||27
2861090|NCT00105235|3563484|FG000|COMPLETED|Overall Study||20
2861091|NCT00105235|3563484|FG000|NOT COMPLETED|Overall Study||7
2861092|NCT00105443|3563494|FG000|STARTED|Double-Blind Treatment||242
2861093|NCT00105443|3563495|FG001|STARTED|Double-Blind Treatment||57
2861094|NCT00105443|3563496|FG002|STARTED|Double-Blind Treatment||256
2861095|NCT00105443|3563497|FG003|STARTED|Double-Blind Treatment||47
2861096|NCT00105443|3563494|FG000|Received Treatment|Double-Blind Treatment|Subjects at Risk/Safety Population - partly in RG1 and RG3 (RG = Reporting Group for Safety Data)|240
2861097|NCT00105443|3563495|FG001|Received Treatment|Double-Blind Treatment|Subjects at Risk/Safety Population - partly in RG1 and RG3|57
2861098|NCT00105443|3563496|FG002|Received Treatment|Double-Blind Treatment|Subjects at Risk/Safety Population - partly in RG2 and RG4|255
2861099|NCT00105443|3563497|FG003|Received Treatment|Double-Blind Treatment|Subjects at Risk/Safety Population - partly in RG2 and RG4 as well as RG5|47
2861100|NCT00105443|3563494|FG000|COMPLETED|Double-Blind Treatment|228 participants directly switched to the Follow-up (FU) phase only|228
2861101|NCT00105443|3563495|FG001|COMPLETED|Double-Blind Treatment|47 participants continued with Sorafenib Open Label (OL); 10 first to FU prior to also switch to OL|57
2861102|NCT00105443|3563496|FG002|COMPLETED|Double-Blind Treatment|245 participants directly switched to the Follow-up (FU) phase|245
2861103|NCT00105443|3563497|FG003|COMPLETED|Double-Blind Treatment|36 participants switched to Sorafenib Open Label (OL); 11 first to FU prior to also switch to OL|47
2861104|NCT00105443|3563494|FG000|NOT COMPLETED|Double-Blind Treatment||14
2861105|NCT00105443|3563495|FG001|NOT COMPLETED|Double-Blind Treatment||0
2861106|NCT00105443|3563496|FG002|NOT COMPLETED|Double-Blind Treatment||11
2861107|NCT00105443|3563497|FG003|NOT COMPLETED|Double-Blind Treatment||0
2861108|NCT00105443|3563494|FG000|STARTED|Follow-up and/or Open Label Nexavar|At start of period, 228 participants directly switched to Follow-up (FU)|228
2861109|NCT00105443|3563495|FG001|STARTED|Follow-up and/or Open Label Nexavar|At start of period, 47 participants directly switched to Open Label (OL) Sorafenib treatment|57
2861110|NCT00105443|3563496|FG002|STARTED|Follow-up and/or Open Label Nexavar|At start of period, 245 participants directly switched to Follow-up (FU)|245
2861111|NCT00105443|3563497|FG003|STARTED|Follow-up and/or Open Label Nexavar|At start of period, 36 participants directly switched to Open Label (OL) Sorafenib treatment|47
2861112|NCT00105443|3563494|FG000|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Nexavar|"In parallel to Open Label treatment only phase"|228
2861113|NCT00105443|3563495|FG001|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Nexavar||0
2861114|NCT00105443|3563496|FG002|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Nexavar|"In parallel to Open Label treatment only phase"|245
2861115|NCT00105443|3563497|FG003|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Nexavar||0
2861116|NCT00105443|3563494|FG000|Open Label Treatment Only (no Follow-up)|Follow-up and/or Open Label Nexavar||0
2861117|NCT00105443|3563495|FG001|Open Label Treatment Only (no Follow-up)|Follow-up and/or Open Label Nexavar|"In parallel to Follow-up only phase; participants received Sorafenib 400 mg bid"|47
2861118|NCT00105443|3563496|FG002|Open Label Treatment Only (no Follow-up)|Follow-up and/or Open Label Nexavar||0
2861119|NCT00105443|3563497|FG003|Open Label Treatment Only (no Follow-up)|Follow-up and/or Open Label Nexavar|"In parallel to Follow-up only phase; participants received Sorafenib 400 mg bid"|36
2861120|NCT00105443|3563494|FG000|Follow-up First, Then Open Label|Follow-up and/or Open Label Nexavar||0
2861121|NCT00105443|3563495|FG001|Follow-up First, Then Open Label|Follow-up and/or Open Label Nexavar||10
2861122|NCT00105443|3563496|FG002|Follow-up First, Then Open Label|Follow-up and/or Open Label Nexavar||0
2861123|NCT00105443|3563497|FG003|Follow-up First, Then Open Label|Follow-up and/or Open Label Nexavar||11
2861124|NCT00105443|3563494|FG000|COMPLETED|Follow-up and/or Open Label Nexavar||0
2861125|NCT00105443|3563495|FG001|COMPLETED|Follow-up and/or Open Label Nexavar|57 participants in total (47 + 10) received Open Label Sorafenib treatment (Subjects at Risk)|0
2861126|NCT00105443|3563496|FG002|COMPLETED|Follow-up and/or Open Label Nexavar||0
2861127|NCT00105443|3563497|FG003|COMPLETED|Follow-up and/or Open Label Nexavar|47 participants in total (36 + 11) received Open Label Sorafenib treatment (Subjects at Risk)|0
2861128|NCT00105443|3563494|FG000|NOT COMPLETED|Follow-up and/or Open Label Nexavar||228
2861129|NCT00105443|3563495|FG001|NOT COMPLETED|Follow-up and/or Open Label Nexavar||57
2861130|NCT00105443|3563496|FG002|NOT COMPLETED|Follow-up and/or Open Label Nexavar||245
2861131|NCT00105443|3563497|FG003|NOT COMPLETED|Follow-up and/or Open Label Nexavar||47
2861132|NCT00105469|3563508|FG000|STARTED|Overall Study||365
2861133|NCT00105469|3563509|FG001|STARTED|Overall Study||378
2861134|NCT00105469|3563508|FG000|COMPLETED|Overall Study||343
2861135|NCT00105469|3563509|FG001|COMPLETED|Overall Study||367
2861136|NCT00105469|3563508|FG000|NOT COMPLETED|Overall Study||22
2861137|NCT00105469|3563509|FG001|NOT COMPLETED|Overall Study||11
3168952|NCT01922050|3896387|FG013|COMPLETED|Part 2 Double-blind Phase||56
3313420|NCT03075410|4046797|FG006|COMPLETED|Part A-Washout Period 2 (14 Days)||0
3313421|NCT03075410|4046798|FG007|COMPLETED|Part A-Washout Period 2 (14 Days)||0
2861138|NCT00105482|3563517|FG000|STARTED|Overall Study||87
2861139|NCT00105482|3563518|FG001|STARTED|Overall Study||85
2861140|NCT00105482|3563517|FG000|COMPLETED|Overall Study||28
2861141|NCT00105482|3563518|FG001|COMPLETED|Overall Study||30
2861142|NCT00105482|3563517|FG000|NOT COMPLETED|Overall Study||59
2861143|NCT00105482|3563518|FG001|NOT COMPLETED|Overall Study||55
2861144|NCT00105508|3563526|FG000|STARTED|Overall Study||253
2861145|NCT00105508|3563527|FG001|STARTED|Overall Study||253
2861146|NCT00105508|3563526|FG000|COMPLETED|Overall Study||213
2861147|NCT00105508|3563527|FG001|COMPLETED|Overall Study||217
2861148|NCT00105508|3563526|FG000|NOT COMPLETED|Overall Study||40
2861149|NCT00105508|3563527|FG001|NOT COMPLETED|Overall Study||36
2861150|NCT00105521|3563537|FG000|STARTED|Overall Study||98
2861151|NCT00105521|3563538|FG001|STARTED|Overall Study||101
2861152|NCT00105521|3563539|FG002|STARTED|Overall Study||97
2861153|NCT00105521|3563540|FG003|STARTED|Overall Study||102
2861154|NCT00105521|3563537|FG000|COMPLETED|Overall Study||83
2861155|NCT00105521|3563538|FG001|COMPLETED|Overall Study||90
2861156|NCT00105521|3563539|FG002|COMPLETED|Overall Study||80
2861157|NCT00105521|3563540|FG003|COMPLETED|Overall Study||85
2861158|NCT00105521|3563537|FG000|NOT COMPLETED|Overall Study||15
2861159|NCT00105521|3563538|FG001|NOT COMPLETED|Overall Study||11
2861160|NCT00105521|3563539|FG002|NOT COMPLETED|Overall Study||17
2861161|NCT00105521|3563540|FG003|NOT COMPLETED|Overall Study||17
2861162|NCT00105534|3563552|FG000|STARTED|Overall Study||335
2861163|NCT00105534|3563553|FG001|STARTED|Overall Study||350
2861164|NCT00105534|3563552|FG000|COMPLETED|Overall Study||313
2861165|NCT00105534|3563553|FG001|COMPLETED|Overall Study||317
2861166|NCT00105534|3563552|FG000|NOT COMPLETED|Overall Study||22
2861167|NCT00105534|3563553|FG001|NOT COMPLETED|Overall Study||33
2861168|NCT00105586|3563561|FG000|STARTED|Overall Study||92
2861169|NCT00105586|3563562|FG001|STARTED|Overall Study||85
2861170|NCT00105586|3563561|FG000|COMPLETED|Overall Study||75
2861171|NCT00105586|3563562|FG001|COMPLETED|Overall Study||69
2861172|NCT00105586|3563561|FG000|NOT COMPLETED|Overall Study||17
2861173|NCT00105586|3563562|FG001|NOT COMPLETED|Overall Study||16
2861174|NCT00105989|3563570|FG000|STARTED|Acute - Open Label: Week 0-10||514
2861175|NCT00105989|3563571|FG001|STARTED|Acute - Open Label: Week 0-10||0
2861176|NCT00105989|3563570|FG000|COMPLETED|Acute - Open Label: Week 0-10||413
2861177|NCT00105989|3563571|FG001|COMPLETED|Acute - Open Label: Week 0-10||0
2861178|NCT00105989|3563570|FG000|NOT COMPLETED|Acute - Open Label: Week 0-10||101
2861179|NCT00105989|3563571|FG001|NOT COMPLETED|Acute - Open Label: Week 0-10||0
2861180|NCT00105989|3563570|FG000|STARTED|Continuation - Open Label:Week 10-34||413
2861181|NCT00105989|3563571|FG001|STARTED|Continuation - Open Label:Week 10-34||0
2861182|NCT00105989|3563570|FG000|COMPLETED|Continuation - Open Label:Week 10-34||288
2861183|NCT00105989|3563571|FG001|COMPLETED|Continuation - Open Label:Week 10-34||0
2861184|NCT00105989|3563570|FG000|NOT COMPLETED|Continuation - Open Label:Week 10-34||125
2861185|NCT00105989|3563571|FG001|NOT COMPLETED|Continuation - Open Label:Week 10-34||0
2861186|NCT00105989|3563570|FG000|STARTED|Maintenance - Double-Blind:Week 34-86||146
2861187|NCT00105989|3563571|FG001|STARTED|Maintenance - Double-Blind:Week 34-86||142
2861188|NCT00105989|3563570|FG000|COMPLETED|Maintenance - Double-Blind:Week 34-86||96
2861189|NCT00105989|3563571|FG001|COMPLETED|Maintenance - Double-Blind:Week 34-86||73
2861190|NCT00105989|3563570|FG000|NOT COMPLETED|Maintenance - Double-Blind:Week 34-86||50
2861191|NCT00105989|3563571|FG001|NOT COMPLETED|Maintenance - Double-Blind:Week 34-86||69
2861192|NCT00106002|3563587|FG000|STARTED|Overall Study||37
2861193|NCT00106002|3563587|FG000|COMPLETED|Overall Study|Completed means that the patient was evaluable for response.|35
2861194|NCT00106002|3563587|FG000|NOT COMPLETED|Overall Study||2
2861195|NCT00106028|3563593|FG000|STARTED|Overall Study|ITT Population: Patients Randomized and Received at least 1 Dose of Study Drug|49
2861196|NCT00106028|3563594|FG001|STARTED|Overall Study|ITT Population: Patients Randomized and Received at least 1 Dose of Study Drug|94
2861197|NCT00106028|3563593|FG000|Month 12 Completed/Started Open Label|Overall Study||49
2861198|NCT00106028|3563594|FG001|Month 12 Completed/Started Open Label|Overall Study||87
2861199|NCT00106028|3563593|FG000|COMPLETED|Overall Study|Completed Month 36|43
2861200|NCT00106028|3563594|FG001|COMPLETED|Overall Study|Completed Month 36|82
2861201|NCT00106028|3563593|FG000|NOT COMPLETED|Overall Study||6
2861202|NCT00106028|3563594|FG001|NOT COMPLETED|Overall Study||12
2861203|NCT00106080|3563604|FG000|STARTED|Overall Study||194
2861204|NCT00106080|3563605|FG001|STARTED|Overall Study||182
2861205|NCT00106080|3563604|FG000|COMPLETED|Overall Study||151
2861206|NCT00106080|3563605|FG001|COMPLETED|Overall Study||155
2861207|NCT00106080|3563604|FG000|NOT COMPLETED|Overall Study||43
2861208|NCT00106080|3563605|FG001|NOT COMPLETED|Overall Study||27
2861209|NCT00106106|3563613|FG000|STARTED|Overall Study||26
2861210|NCT00106106|3563614|FG001|STARTED|Overall Study||23
2861211|NCT00106106|3563613|FG000|Completed Both MRS Scans|Overall Study||18
2861212|NCT00106106|3563614|FG001|Completed Both MRS Scans|Overall Study||15
2861213|NCT00106106|3563613|FG000|COMPLETED|Overall Study|Although 22 subjects completed all other assessments for the study, only 18 completed both MRS scans|22
2861214|NCT00106106|3563614|FG001|COMPLETED|Overall Study|Although 19 subjects completed all other assessments for the study, only 15 completed both MRS scans|19
2861215|NCT00106106|3563613|FG000|NOT COMPLETED|Overall Study||4
2861216|NCT00106106|3563614|FG001|NOT COMPLETED|Overall Study||4
2861217|NCT00106119|3563620|FG000|STARTED|First Intervention||7
2861218|NCT00106119|3563621|FG001|STARTED|First Intervention||7
2861219|NCT00106119|3563620|FG000|COMPLETED|First Intervention||7
2861220|NCT00106119|3563621|FG001|COMPLETED|First Intervention||7
2861221|NCT00106119|3563620|FG000|NOT COMPLETED|First Intervention||0
2861222|NCT00106119|3563621|FG001|NOT COMPLETED|First Intervention||0
2861223|NCT00106119|3563620|FG000|STARTED|Washout Period of 30 Days||7
2861224|NCT00106119|3563621|FG001|STARTED|Washout Period of 30 Days||7
2861225|NCT00106119|3563620|FG000|COMPLETED|Washout Period of 30 Days||7
2861226|NCT00106119|3563621|FG001|COMPLETED|Washout Period of 30 Days||7
2861227|NCT00106119|3563620|FG000|NOT COMPLETED|Washout Period of 30 Days||0
2861228|NCT00106119|3563621|FG001|NOT COMPLETED|Washout Period of 30 Days||0
2861229|NCT00106119|3563620|FG000|STARTED|Second Intervention||7
2861230|NCT00106119|3563621|FG001|STARTED|Second Intervention||7
2861231|NCT00106119|3563620|FG000|COMPLETED|Second Intervention||7
2861232|NCT00106119|3563621|FG001|COMPLETED|Second Intervention||7
2861233|NCT00106119|3563620|FG000|NOT COMPLETED|Second Intervention||0
2861234|NCT00106119|3563621|FG001|NOT COMPLETED|Second Intervention||0
2861235|NCT00106184|3563629|FG000|STARTED|Overall Study||96
2861236|NCT00106184|3563630|FG001|STARTED|Overall Study||104
2861237|NCT00106184|3563629|FG000|Treated|Overall Study|96 subjects were randomized.|93
2861238|NCT00106184|3563630|FG001|Treated|Overall Study|104 subjects were randomized.|102
2861239|NCT00106184|3563629|FG000|COMPLETED|Overall Study||93
2861240|NCT00106184|3563630|FG001|COMPLETED|Overall Study||102
2861241|NCT00106184|3563629|FG000|NOT COMPLETED|Overall Study||3
2861242|NCT00106184|3563630|FG001|NOT COMPLETED|Overall Study||2
2861243|NCT00106249|3563640|FG000|STARTED|Overall Study||14
2861244|NCT00106249|3563641|FG001|STARTED|Overall Study||13
2861245|NCT00106249|3563640|FG000|COMPLETED|Overall Study||11
2861246|NCT00106249|3563641|FG001|COMPLETED|Overall Study||11
2861247|NCT00106249|3563640|FG000|NOT COMPLETED|Overall Study||3
2861248|NCT00106249|3563641|FG001|NOT COMPLETED|Overall Study||2
2861249|NCT00106353|3563649|FG000|STARTED|Part 1||4
2861250|NCT00106353|3563650|FG001|STARTED|Part 1||5
2861251|NCT00106353|3563651|FG002|STARTED|Part 1||3
2861252|NCT00106353|3563652|FG003|STARTED|Part 1||7
2861253|NCT00106353|3563653|FG004|STARTED|Part 1||0
2861254|NCT00106353|3563654|FG005|STARTED|Part 1||0
2861255|NCT00106353|3563655|FG006|STARTED|Part 1||0
2861256|NCT00106353|3563649|FG000|COMPLETED|Part 1||0
2861257|NCT00106353|3563650|FG001|COMPLETED|Part 1||0
2861258|NCT00106353|3563651|FG002|COMPLETED|Part 1||0
2861259|NCT00106353|3563652|FG003|COMPLETED|Part 1||0
2861260|NCT00106353|3563653|FG004|COMPLETED|Part 1||0
2861261|NCT00106353|3563654|FG005|COMPLETED|Part 1||0
2861262|NCT00106353|3563655|FG006|COMPLETED|Part 1||0
2861263|NCT00106353|3563649|FG000|NOT COMPLETED|Part 1||4
2861264|NCT00106353|3563650|FG001|NOT COMPLETED|Part 1||5
2861265|NCT00106353|3563651|FG002|NOT COMPLETED|Part 1||3
2861266|NCT00106353|3563652|FG003|NOT COMPLETED|Part 1||7
2861267|NCT00106353|3563653|FG004|NOT COMPLETED|Part 1||0
2861268|NCT00106353|3563654|FG005|NOT COMPLETED|Part 1||0
2861269|NCT00106353|3563655|FG006|NOT COMPLETED|Part 1||0
2861270|NCT00106353|3563649|FG000|STARTED|Part 2||0
2861271|NCT00106353|3563650|FG001|STARTED|Part 2||0
2861272|NCT00106353|3563651|FG002|STARTED|Part 2||0
2861273|NCT00106353|3563652|FG003|STARTED|Part 2||0
2861274|NCT00106353|3563653|FG004|STARTED|Part 2||17
2861275|NCT00106353|3563654|FG005|STARTED|Part 2||19
2861276|NCT00106353|3563655|FG006|STARTED|Part 2||16
2861277|NCT00106353|3563649|FG000|COMPLETED|Part 2||0
2861278|NCT00106353|3563650|FG001|COMPLETED|Part 2||0
2861279|NCT00106353|3563651|FG002|COMPLETED|Part 2||0
2861280|NCT00106353|3563652|FG003|COMPLETED|Part 2||0
2861281|NCT00106353|3563653|FG004|COMPLETED|Part 2||1
2861282|NCT00106353|3563654|FG005|COMPLETED|Part 2||1
2861283|NCT00106353|3563655|FG006|COMPLETED|Part 2||0
2861284|NCT00106353|3563649|FG000|NOT COMPLETED|Part 2||0
2861285|NCT00106353|3563650|FG001|NOT COMPLETED|Part 2||0
2861286|NCT00106353|3563651|FG002|NOT COMPLETED|Part 2||0
2861287|NCT00106353|3563652|FG003|NOT COMPLETED|Part 2||0
2861288|NCT00106353|3563653|FG004|NOT COMPLETED|Part 2||16
2861289|NCT00106353|3563654|FG005|NOT COMPLETED|Part 2||18
2861290|NCT00106353|3563655|FG006|NOT COMPLETED|Part 2||16
2861291|NCT00106392|3563678|FG000|STARTED|Overall Study||62
2861292|NCT00106392|3563679|FG001|STARTED|Overall Study||69
2861293|NCT00106392|3563678|FG000|Baseline Participants|Overall Study|3 patients withdrew: 2 prior to surgery and study drug; 1 took study drug but did not have surgery|59
2861294|NCT00106392|3563679|FG001|Baseline Participants|Overall Study|4 patients withdrew: all prior to surgery and study drug|65
2861295|NCT00106392|3563678|FG000|Full Analysis Set (FAS)|Overall Study||53
2861296|NCT00106392|3563679|FG001|Full Analysis Set (FAS)|Overall Study||61
2861297|NCT00106392|3563678|FG000|COMPLETED|Overall Study||36
2861298|NCT00106392|3563679|FG001|COMPLETED|Overall Study||42
2861299|NCT00106392|3563678|FG000|NOT COMPLETED|Overall Study||26
2861300|NCT00106392|3563679|FG001|NOT COMPLETED|Overall Study||27
2861301|NCT00106431|3563685|FG000|STARTED|Overall Study||102
2861302|NCT00106431|3563685|FG000|COMPLETED|Overall Study|37 represents the number of patients who reached at least 6 months treatment|37
2861303|NCT00106431|3563685|FG000|NOT COMPLETED|Overall Study||65
2861304|NCT00106535|3563692|FG000|STARTED|2-year Placebo Controlled Period||394
2861305|NCT00106535|3563693|FG001|STARTED|2-year Placebo Controlled Period||401
2861306|NCT00106535|3563694|FG002|STARTED|2-year Placebo Controlled Period||401
2861307|NCT00106535|3563695|FG003|STARTED|2-year Placebo Controlled Period||0
2861308|NCT00106535|3563692|FG000|Intent-to-treat: Received Study Drug|2-year Placebo Controlled Period||393
2861309|NCT00106535|3563693|FG001|Intent-to-treat: Received Study Drug|2-year Placebo Controlled Period||399
2861310|NCT00106535|3563694|FG002|Intent-to-treat: Received Study Drug|2-year Placebo Controlled Period||398
2861311|NCT00106535|3563695|FG003|Intent-to-treat: Received Study Drug|2-year Placebo Controlled Period||0
2861312|NCT00106535|3563692|FG000|Safety: Actual Treatment Received|2-year Placebo Controlled Period||392
2861313|NCT00106535|3563693|FG001|Safety: Actual Treatment Received|2-year Placebo Controlled Period||399
2861314|NCT00106535|3563694|FG002|Safety: Actual Treatment Received|2-year Placebo Controlled Period||399
2861315|NCT00106535|3563695|FG003|Safety: Actual Treatment Received|2-year Placebo Controlled Period||0
2861316|NCT00106535|3563692|FG000|Completed Week 24|2-year Placebo Controlled Period||356
2861317|NCT00106535|3563693|FG001|Completed Week 24|2-year Placebo Controlled Period||373
2861318|NCT00106535|3563694|FG002|Completed Week 24|2-year Placebo Controlled Period||366
2861319|NCT00106535|3563695|FG003|Completed Week 24|2-year Placebo Controlled Period||0
2861320|NCT00106535|3563692|FG000|Completed Week 52|2-year Placebo Controlled Period||326
2861321|NCT00106535|3563693|FG001|Completed Week 52|2-year Placebo Controlled Period||342
2861322|NCT00106535|3563694|FG002|Completed Week 52|2-year Placebo Controlled Period||338
2861323|NCT00106535|3563695|FG003|Completed Week 52|2-year Placebo Controlled Period||0
2861324|NCT00106535|3563692|FG000|COMPLETED|2-year Placebo Controlled Period|Completed Week 104 (Year 2). 284 participants randomized to the Placebo arm entered the LTE period.|287
2861325|NCT00106535|3563693|FG001|COMPLETED|2-year Placebo Controlled Period|Completed Week 104. 304 participants randomized to the TCZ 4 mg/kg arm entered the LTE period.|309
2861326|NCT00106535|3563694|FG002|COMPLETED|2-year Placebo Controlled Period|Completed Week 104. 306 participants randomized to the TCZ 8 mg/kg arm entered the LTE period.|310
2861327|NCT00106535|3563695|FG003|COMPLETED|2-year Placebo Controlled Period||0
2861328|NCT00106535|3563692|FG000|NOT COMPLETED|2-year Placebo Controlled Period||107
2861329|NCT00106535|3563693|FG001|NOT COMPLETED|2-year Placebo Controlled Period||92
2861330|NCT00106535|3563694|FG002|NOT COMPLETED|2-year Placebo Controlled Period||91
2861331|NCT00106535|3563695|FG003|NOT COMPLETED|2-year Placebo Controlled Period||0
2861332|NCT00106535|3563692|FG000|STARTED|Long-term Extension Period (Year 3 to 5)||0
2861333|NCT00106535|3563693|FG001|STARTED|Long-term Extension Period (Year 3 to 5)||0
2861334|NCT00106535|3563694|FG002|STARTED|Long-term Extension Period (Year 3 to 5)||0
2861335|NCT00106535|3563695|FG003|STARTED|Long-term Extension Period (Year 3 to 5)|Entered the Long-term Extension.|894
2861336|NCT00106535|3563692|FG000|COMPLETED|Long-term Extension Period (Year 3 to 5)||0
2861337|NCT00106535|3563693|FG001|COMPLETED|Long-term Extension Period (Year 3 to 5)||0
2861338|NCT00106535|3563694|FG002|COMPLETED|Long-term Extension Period (Year 3 to 5)||0
2861339|NCT00106535|3563695|FG003|COMPLETED|Long-term Extension Period (Year 3 to 5)|Completed the study.|704
2861340|NCT00106535|3563692|FG000|NOT COMPLETED|Long-term Extension Period (Year 3 to 5)||0
2861341|NCT00106535|3563693|FG001|NOT COMPLETED|Long-term Extension Period (Year 3 to 5)||0
2861342|NCT00106535|3563694|FG002|NOT COMPLETED|Long-term Extension Period (Year 3 to 5)||0
2861343|NCT00106535|3563695|FG003|NOT COMPLETED|Long-term Extension Period (Year 3 to 5)||190
2861344|NCT00106639|3563710|FG000|STARTED|Overall Study||20
2861345|NCT00106639|3563711|FG001|STARTED|Overall Study||20
2861346|NCT00106639|3563712|FG002|STARTED|Overall Study||21
2861347|NCT00106639|3563710|FG000|COMPLETED|Overall Study||17
2861348|NCT00106639|3563711|FG001|COMPLETED|Overall Study||13
2861349|NCT00106639|3563712|FG002|COMPLETED|Overall Study||19
2861350|NCT00106639|3563710|FG000|NOT COMPLETED|Overall Study||3
2861351|NCT00106639|3563711|FG001|NOT COMPLETED|Overall Study||7
2861352|NCT00106639|3563712|FG002|NOT COMPLETED|Overall Study||2
2861353|NCT00106704|3563723|FG000|STARTED|Overall Study||222
2861354|NCT00106704|3563724|FG001|STARTED|Overall Study||219
2861355|NCT00106704|3563723|FG000|COMPLETED|Overall Study||91
2861356|NCT00106704|3563724|FG001|COMPLETED|Overall Study||68
2861357|NCT00106704|3563723|FG000|NOT COMPLETED|Overall Study||131
2861358|NCT00106704|3563724|FG001|NOT COMPLETED|Overall Study||151
2861359|NCT00106938|3563732|FG000|STARTED|Overall Study||1089
2861360|NCT00106938|3563733|FG001|STARTED|Overall Study||364
2861361|NCT00106938|3563732|FG000|COMPLETED|Overall Study||913
2861362|NCT00106938|3563733|FG001|COMPLETED|Overall Study||293
2861363|NCT00106938|3563732|FG000|NOT COMPLETED|Overall Study||176
2861364|NCT00106938|3563733|FG001|NOT COMPLETED|Overall Study||71
2861365|NCT00106964|3563742|FG000|STARTED|Overall Study||118
2861366|NCT00106964|3563743|FG001|STARTED|Overall Study||126
2861367|NCT00106964|3563744|FG002|STARTED|Overall Study||127
2861368|NCT00106964|3563742|FG000|COMPLETED|Overall Study|The number of those those who completed the vaccine series was 105.|105
2861369|NCT00106964|3563743|FG001|COMPLETED|Overall Study|The number of those who completed the vaccine series was 111.|111
2861370|NCT00106964|3563744|FG002|COMPLETED|Overall Study|The number of those who completed the vaccine series was 120.|120
2861371|NCT00106964|3563742|FG000|NOT COMPLETED|Overall Study||13
2861372|NCT00106964|3563743|FG001|NOT COMPLETED|Overall Study||15
2861373|NCT00106964|3563744|FG002|NOT COMPLETED|Overall Study||7
2861374|NCT00107042|3563763|FG000|STARTED|Overall Study||60
2861375|NCT00107042|3563764|FG001|STARTED|Overall Study||63
2861376|NCT00107042|3563763|FG000|COMPLETED|Overall Study||38
2861377|NCT00107042|3563764|FG001|COMPLETED|Overall Study||47
2861378|NCT00107042|3563763|FG000|NOT COMPLETED|Overall Study||22
2861379|NCT00107042|3563764|FG001|NOT COMPLETED|Overall Study||16
2861380|NCT00107120|3563814|FG000|STARTED|Overall Study|Safety Population defined as all patients who took at least one dose of double-blind study drug|155
2861381|NCT00107120|3563815|FG001|STARTED|Overall Study|Safety Population defined as all patients who took at least one dose of double-blind study drug|157
2861382|NCT00107120|3563814|FG000|COMPLETED|Overall Study||126
2861383|NCT00107120|3563815|FG001|COMPLETED|Overall Study||133
2861384|NCT00107120|3563814|FG000|NOT COMPLETED|Overall Study||29
2861385|NCT00107120|3563815|FG001|NOT COMPLETED|Overall Study||24
2861386|NCT00107172|3563823|FG000|STARTED|Overall Study||114
2861387|NCT00107172|3563824|FG001|STARTED|Overall Study||108
2861388|NCT00107172|3563823|FG000|COMPLETED|Overall Study||109
2861389|NCT00107172|3563824|FG001|COMPLETED|Overall Study||103
2861390|NCT00107172|3563823|FG000|NOT COMPLETED|Overall Study||5
2861391|NCT00107172|3563824|FG001|NOT COMPLETED|Overall Study||5
2861392|NCT00107198|3563830|FG000|STARTED|Overall Study||188
2861393|NCT00107198|3563830|FG000|COMPLETED|Overall Study||136
2861394|NCT00107198|3563830|FG000|NOT COMPLETED|Overall Study||52
2861395|NCT00107276|3563834|FG000|STARTED|Overall Study||112
2861396|NCT00107276|3563834|FG000|Eligible|Overall Study||96
2861397|NCT00107276|3563834|FG000|COMPLETED|Overall Study||40
2861398|NCT00107276|3563834|FG000|NOT COMPLETED|Overall Study||72
2861399|NCT00107380|3563839|FG000|STARTED|Overall Study||86
2861400|NCT00107380|3563839|FG000|Eligible|Overall Study||84
2861401|NCT00107380|3563839|FG000|COMPLETED|Overall Study||56
2861402|NCT00107380|3563839|FG000|NOT COMPLETED|Overall Study||30
2861403|NCT00107536|3563844|FG000|STARTED|Overall Study||26
2861404|NCT00107536|3563844|FG000|COMPLETED|Overall Study||26
2861405|NCT00107536|3563844|FG000|NOT COMPLETED|Overall Study||0
2861406|NCT00107575|3563850|FG000|STARTED|Overall Study||119
2861407|NCT00107575|3563851|FG001|STARTED|Overall Study||117
2861408|NCT00107575|3563850|FG000|COMPLETED|Overall Study||108
2861409|NCT00107575|3563851|FG001|COMPLETED|Overall Study||107
2861410|NCT00107575|3563850|FG000|NOT COMPLETED|Overall Study||11
2861411|NCT00107575|3563851|FG001|NOT COMPLETED|Overall Study||10
2861412|NCT00107653|3563859|FG000|STARTED|Overall Study||269
2861413|NCT00107653|3563860|FG001|STARTED|Overall Study||300
2861414|NCT00107653|3563859|FG000|COMPLETED|Overall Study||190
2861415|NCT00107653|3563860|FG001|COMPLETED|Overall Study||224
2861416|NCT00107653|3563859|FG000|NOT COMPLETED|Overall Study||79
2861417|NCT00107653|3563860|FG001|NOT COMPLETED|Overall Study||76
2861418|NCT00107744|3563869|FG000|STARTED|Intervention 1 (8 Weeks)||117
2861419|NCT00107744|3563870|FG001|STARTED|Intervention 1 (8 Weeks)||117
2861420|NCT00107744|3563871|FG002|STARTED|Intervention 1 (8 Weeks)||118
2861421|NCT00107744|3563869|FG000|COMPLETED|Intervention 1 (8 Weeks)||101
2861422|NCT00107744|3563870|FG001|COMPLETED|Intervention 1 (8 Weeks)||104
2861423|NCT00107744|3563871|FG002|COMPLETED|Intervention 1 (8 Weeks)||101
2861424|NCT00107744|3563869|FG000|NOT COMPLETED|Intervention 1 (8 Weeks)||16
2861425|NCT00107744|3563870|FG001|NOT COMPLETED|Intervention 1 (8 Weeks)||13
2861426|NCT00107744|3563871|FG002|NOT COMPLETED|Intervention 1 (8 Weeks)||17
2861427|NCT00107744|3563869|FG000|STARTED|Intervention 2 (8 Weeks)||101
2861428|NCT00107744|3563870|FG001|STARTED|Intervention 2 (8 Weeks)||104
2861429|NCT00107744|3563871|FG002|STARTED|Intervention 2 (8 Weeks)||101
2861430|NCT00107744|3563869|FG000|COMPLETED|Intervention 2 (8 Weeks)||93
2861431|NCT00107744|3563870|FG001|COMPLETED|Intervention 2 (8 Weeks)||92
2861432|NCT00107744|3563871|FG002|COMPLETED|Intervention 2 (8 Weeks)||88
2861433|NCT00107744|3563869|FG000|NOT COMPLETED|Intervention 2 (8 Weeks)||8
2861434|NCT00107744|3563870|FG001|NOT COMPLETED|Intervention 2 (8 Weeks)||12
2861435|NCT00107744|3563871|FG002|NOT COMPLETED|Intervention 2 (8 Weeks)||13
2861436|NCT00107744|3563869|FG000|STARTED|Intervention 3 (8 Weeks)||93
2861437|NCT00107744|3563870|FG001|STARTED|Intervention 3 (8 Weeks)||92
2861438|NCT00107744|3563871|FG002|STARTED|Intervention 3 (8 Weeks)||88
2861439|NCT00107744|3563869|FG000|COMPLETED|Intervention 3 (8 Weeks)||93
2861440|NCT00107744|3563870|FG001|COMPLETED|Intervention 3 (8 Weeks)||92
2861441|NCT00107744|3563871|FG002|COMPLETED|Intervention 3 (8 Weeks)||88
2861442|NCT00107744|3563869|FG000|NOT COMPLETED|Intervention 3 (8 Weeks)||0
2861443|NCT00107744|3563870|FG001|NOT COMPLETED|Intervention 3 (8 Weeks)||0
2861444|NCT00107744|3563871|FG002|NOT COMPLETED|Intervention 3 (8 Weeks)||0
2861445|NCT00107783|3563881|FG000|STARTED|Overall Study||20
2861446|NCT00107783|3563882|FG001|STARTED|Overall Study||20
2861447|NCT00107783|3563881|FG000|COMPLETED|Overall Study||17
2861448|NCT00107783|3563882|FG001|COMPLETED|Overall Study||16
2861449|NCT00107783|3563881|FG000|NOT COMPLETED|Overall Study||3
2861450|NCT00107783|3563882|FG001|NOT COMPLETED|Overall Study||4
2861451|NCT00107900|3563894|FG000|STARTED|Overall Study||85
2861452|NCT00107900|3563895|FG001|STARTED|Overall Study||75
2861453|NCT00107900|3563896|FG002|STARTED|Overall Study||129
2861454|NCT00107900|3563897|FG003|STARTED|Overall Study||99
2861455|NCT00107900|3563898|FG004|STARTED|Overall Study||115
2861456|NCT00107900|3563899|FG005|STARTED|Overall Study||103
2861457|NCT00107900|3563894|FG000|COMPLETED|Overall Study||75
2861458|NCT00107900|3563895|FG001|COMPLETED|Overall Study||72
2861459|NCT00107900|3563896|FG002|COMPLETED|Overall Study||104
2861460|NCT00107900|3563897|FG003|COMPLETED|Overall Study||87
2861461|NCT00107900|3563898|FG004|COMPLETED|Overall Study||94
2861462|NCT00107900|3563899|FG005|COMPLETED|Overall Study||94
2861463|NCT00107900|3563894|FG000|NOT COMPLETED|Overall Study||10
2861464|NCT00107900|3563895|FG001|NOT COMPLETED|Overall Study||3
2861465|NCT00107900|3563896|FG002|NOT COMPLETED|Overall Study||25
2861466|NCT00107900|3563897|FG003|NOT COMPLETED|Overall Study||12
2861467|NCT00107900|3563898|FG004|NOT COMPLETED|Overall Study||21
3168953|NCT01922050|3896374|FG000|NOT COMPLETED|Part 2 Double-blind Phase||0
2861468|NCT00107900|3563899|FG005|NOT COMPLETED|Overall Study||9
2861469|NCT00107952|3563915|FG000|STARTED|Overall Study||381
2861470|NCT00107952|3563916|FG001|STARTED|Overall Study||380
2861471|NCT00107952|3563915|FG000|COMPLETED|Overall Study||286
2861472|NCT00107952|3563916|FG001|COMPLETED|Overall Study||299
2861473|NCT00107952|3563915|FG000|NOT COMPLETED|Overall Study||95
2861474|NCT00107952|3563916|FG001|NOT COMPLETED|Overall Study||81
2861475|NCT00107978|3563924|FG000|STARTED|Overall Study||458
2861476|NCT00107978|3563925|FG001|STARTED|Overall Study||481
2861477|NCT00107978|3563924|FG000|COMPLETED|Overall Study||425
2861478|NCT00107978|3563925|FG001|COMPLETED|Overall Study||431
2861479|NCT00107978|3563924|FG000|NOT COMPLETED|Overall Study||33
2861480|NCT00107978|3563925|FG001|NOT COMPLETED|Overall Study||50
2861481|NCT00107991|3563931|FG000|STARTED|Eligibility Assessment||38
2861482|NCT00107991|3563931|FG000|COMPLETED|Eligibility Assessment||15
2861483|NCT00107991|3563931|FG000|NOT COMPLETED|Eligibility Assessment||23
2861484|NCT00107991|3563931|FG000|STARTED|12 Week Treatment Period||15
2861485|NCT00107991|3563931|FG000|COMPLETED|12 Week Treatment Period||10
3168954|NCT01922050|3896375|FG001|NOT COMPLETED|Part 2 Double-blind Phase||0
2861486|NCT00107991|3563931|FG000|NOT COMPLETED|12 Week Treatment Period||5
2861487|NCT00107991|3563931|FG000|STARTED|18-Week Post Treatment Assessment||10
2861488|NCT00107991|3563931|FG000|COMPLETED|18-Week Post Treatment Assessment||8
2861489|NCT00107991|3563931|FG000|NOT COMPLETED|18-Week Post Treatment Assessment||2
2861490|NCT00108069|3563937|FG000|STARTED|Overall Study||30
2861491|NCT00108069|3563938|FG001|STARTED|Overall Study||13
2861492|NCT00108069|3563937|FG000|COMPLETED|Overall Study||0
2861493|NCT00108069|3563938|FG001|COMPLETED|Overall Study||0
2861494|NCT00108069|3563937|FG000|NOT COMPLETED|Overall Study||30
2861495|NCT00108069|3563938|FG001|NOT COMPLETED|Overall Study||13
2861496|NCT00108082|3563953|FG000|STARTED|Overall Study||91
2861497|NCT00108082|3563954|FG001|STARTED|Overall Study||100
2861498|NCT00108082|3563955|FG002|STARTED|Overall Study||96
2861499|NCT00108082|3563953|FG000|COMPLETED|Overall Study|Per protocol Amendment 4, participants who had completed Month 12 prior to amendment were withdrawn.|53
2861500|NCT00108082|3563954|FG001|COMPLETED|Overall Study|Per protocol Amendment 4, participants who had completed Month 12 prior to amendment were withdrawn.|68
2861501|NCT00108082|3563955|FG002|COMPLETED|Overall Study|Per protocol Amendment 4, participants who had completed Month 12 prior to amendment were withdrawn.|53
2861502|NCT00108082|3563953|FG000|NOT COMPLETED|Overall Study||38
2861503|NCT00108082|3563954|FG001|NOT COMPLETED|Overall Study||32
2861504|NCT00108082|3563955|FG002|NOT COMPLETED|Overall Study||43
2861505|NCT00108160|3563965|FG000|STARTED|Overall Study||83
2861506|NCT00108160|3563966|FG001|STARTED|Overall Study||63
2861507|NCT00108160|3563965|FG000|Completed Visit 0 (Baseline)|Overall Study|4 patients who signed consent and were randomized did not complete the initial visit to start drug|79
2861508|NCT00108160|3563966|FG001|Completed Visit 0 (Baseline)|Overall Study|3 patients who signed a consent and were randomized did not complete the initial visit to start drug|60
2861509|NCT00108160|3563965|FG000|Completed Visit 1 (2 Wks)|Overall Study||72
2861510|NCT00108160|3563966|FG001|Completed Visit 1 (2 Wks)|Overall Study||54
2861511|NCT00108160|3563965|FG000|Completed Visit 2 (3 mo)|Overall Study||54
2861512|NCT00108160|3563966|FG001|Completed Visit 2 (3 mo)|Overall Study||46
2861513|NCT00108160|3563965|FG000|Completed Visit 3 (6 mo)|Overall Study||44
2861514|NCT00108160|3563966|FG001|Completed Visit 3 (6 mo)|Overall Study||38
2861515|NCT00108160|3563965|FG000|Completed Visit 4 (9 mo)|Overall Study||38
2861516|NCT00108160|3563966|FG001|Completed Visit 4 (9 mo)|Overall Study||37
2861517|NCT00108160|3563965|FG000|Completed Visit 5 (12 mo)|Overall Study||37
2861518|NCT00108160|3563966|FG001|Completed Visit 5 (12 mo)|Overall Study||37
2861519|NCT00108160|3563965|FG000|Completed Visit 6 (15 mo)|Overall Study||36
2861520|NCT00108160|3563966|FG001|Completed Visit 6 (15 mo)|Overall Study||33
2861521|NCT00108160|3563965|FG000|Completed Visit 7 (18 mo)|Overall Study||34
2861522|NCT00108160|3563966|FG001|Completed Visit 7 (18 mo)|Overall Study||31
2861523|NCT00108160|3563965|FG000|COMPLETED|Overall Study|Patients who completed 18 months of mupirocin or developed new (recurrent) S. aureus infection.|44
2861524|NCT00108160|3563966|FG001|COMPLETED|Overall Study|Participants who completed 18 months of placebo or developed new (recurrent) S. aureus infection.|42
2861525|NCT00108160|3563965|FG000|NOT COMPLETED|Overall Study||39
2861526|NCT00108160|3563966|FG001|NOT COMPLETED|Overall Study||21
2861527|NCT00108277|3563977|FG000|STARTED|Overall Study||29
2861528|NCT00108277|3563978|FG001|STARTED|Overall Study||28
2861529|NCT00108277|3563979|FG002|STARTED|Overall Study||35
2861530|NCT00108277|3563977|FG000|COMPLETED|Overall Study||19
2861531|NCT00108277|3563978|FG001|COMPLETED|Overall Study||16
2861532|NCT00108277|3563979|FG002|COMPLETED|Overall Study||19
2861533|NCT00108277|3563977|FG000|NOT COMPLETED|Overall Study||10
2861534|NCT00108277|3563978|FG001|NOT COMPLETED|Overall Study||12
2861535|NCT00108277|3563979|FG002|NOT COMPLETED|Overall Study||16
2861536|NCT00108303|3563990|FG000|STARTED|Overall Study||179
2861537|NCT00108303|3563991|FG001|STARTED|Overall Study||179
2861538|NCT00108303|3563992|FG002|STARTED|Overall Study||180
2861539|NCT00108303|3563990|FG000|COMPLETED|Overall Study||179
2861540|NCT00108303|3563991|FG001|COMPLETED|Overall Study||179
2861541|NCT00108303|3563992|FG002|COMPLETED|Overall Study||180
2861542|NCT00108303|3563990|FG000|NOT COMPLETED|Overall Study||0
2861543|NCT00108303|3563991|FG001|NOT COMPLETED|Overall Study||0
2861544|NCT00108303|3563992|FG002|NOT COMPLETED|Overall Study||0
2861545|NCT00108355|3564006|FG000|STARTED|Overall Study|Two patients met inclusion criteria not randomized, one had peritonitis , other loculated ascites.|15
2861546|NCT00108355|3564007|FG001|STARTED|Overall Study|Two patients met inclusion criteria not randomized, one had peritonitis, other loculated ascites.|14
2861547|NCT00108355|3564006|FG000|COMPLETED|Overall Study||13
2861548|NCT00108355|3564007|FG001|COMPLETED|Overall Study||12
2861549|NCT00108355|3564006|FG000|NOT COMPLETED|Overall Study||2
2861550|NCT00108355|3564007|FG001|NOT COMPLETED|Overall Study||2
2861551|NCT00108485|3564015|FG000|STARTED|Overall Study||5
2861552|NCT00108485|3564016|FG001|STARTED|Overall Study||4
2861553|NCT00108485|3564015|FG000|COMPLETED|Overall Study||2
2861554|NCT00108485|3564016|FG001|COMPLETED|Overall Study||2
2861555|NCT00108485|3564015|FG000|NOT COMPLETED|Overall Study||3
2861556|NCT00108485|3564016|FG001|NOT COMPLETED|Overall Study||2
2861557|NCT00108524|3564024|FG000|STARTED|Overall Study||81
2861558|NCT00108524|3564025|FG001|STARTED|Overall Study||79
2861559|NCT00108524|3564024|FG000|COMPLETED|Overall Study||52
2861560|NCT00108524|3564025|FG001|COMPLETED|Overall Study||61
2861561|NCT00108524|3564024|FG000|NOT COMPLETED|Overall Study||29
2861562|NCT00108524|3564025|FG001|NOT COMPLETED|Overall Study||18
2861563|NCT00108550|3564033|FG000|STARTED|Overall Study||55
2861564|NCT00108550|3564034|FG001|STARTED|Overall Study||53
2861565|NCT00108550|3564033|FG000|COMPLETED|Overall Study||39
2861566|NCT00108550|3564034|FG001|COMPLETED|Overall Study||37
2861567|NCT00108550|3564033|FG000|NOT COMPLETED|Overall Study||16
2861568|NCT00108550|3564034|FG001|NOT COMPLETED|Overall Study||16
2861569|NCT00108628|3564042|FG000|STARTED|Overall Study||61
2861570|NCT00108628|3564043|FG001|STARTED|Overall Study||63
2861571|NCT00108628|3564042|FG000|Received One or More Sessions|Overall Study||53
2861572|NCT00108628|3564043|FG001|Received One or More Sessions|Overall Study||58
2861573|NCT00108628|3564042|FG000|Completed Treatment|Overall Study||42
2861574|NCT00108628|3564043|FG001|Completed Treatment|Overall Study||57
2861575|NCT00108628|3564042|FG000|COMPLETED|Overall Study||41
2861576|NCT00108628|3564043|FG001|COMPLETED|Overall Study||53
2861577|NCT00108628|3564042|FG000|NOT COMPLETED|Overall Study||20
2861578|NCT00108628|3564043|FG001|NOT COMPLETED|Overall Study||10
2861579|NCT00108732|3564049|FG000|STARTED|Step 1 (Vaccinia/Fowlpox/GM-CSF)||50
2861580|NCT00108732|3564049|FG000|Eligible and Treated|Step 1 (Vaccinia/Fowlpox/GM-CSF)||40
2861581|NCT00108732|3564049|FG000|COMPLETED|Step 1 (Vaccinia/Fowlpox/GM-CSF)||36
2861582|NCT00108732|3564049|FG000|NOT COMPLETED|Step 1 (Vaccinia/Fowlpox/GM-CSF)||14
2861583|NCT00108732|3564049|FG000|STARTED|Step 2 (Androgen Ablation and Vaccine)||31
2861584|NCT00108732|3564049|FG000|COMPLETED|Step 2 (Androgen Ablation and Vaccine)||26
2861585|NCT00108732|3564049|FG000|NOT COMPLETED|Step 2 (Androgen Ablation and Vaccine)||5
2861586|NCT00108745|3564056|FG000|STARTED|Overall Study||387
2861587|NCT00108745|3564057|FG001|STARTED|Overall Study||384
2861588|NCT00108745|3564058|FG002|STARTED|Overall Study||386
2861589|NCT00108745|3564056|FG000|COMPLETED|Overall Study||353
2861590|NCT00108745|3564057|FG001|COMPLETED|Overall Study||349
2861591|NCT00108745|3564058|FG002|COMPLETED|Overall Study||349
2861592|NCT00108745|3564056|FG000|NOT COMPLETED|Overall Study||34
2861593|NCT00108745|3564057|FG001|NOT COMPLETED|Overall Study||35
2861594|NCT00108745|3564058|FG002|NOT COMPLETED|Overall Study||37
2861595|NCT00108862|3564068|FG000|STARTED|Overall Study||405
2861596|NCT00108862|3564069|FG001|STARTED|Overall Study|Three participants who were deemed clinically ineligible and taken off study were omitted.|401
2861597|NCT00108862|3564068|FG000|COMPLETED|Overall Study||337
2861598|NCT00108862|3564069|FG001|COMPLETED|Overall Study||339
2861599|NCT00108862|3564068|FG000|NOT COMPLETED|Overall Study||68
2861600|NCT00108862|3564069|FG001|NOT COMPLETED|Overall Study||62
2861601|NCT00108953|3564077|FG000|STARTED|Treatment Period|ITT population|47
2861602|NCT00108953|3564078|FG001|STARTED|Treatment Period|ITT population|49
2861603|NCT00108953|3564077|FG000|COMPLETED|Treatment Period|No patient under study medication anymore|47
2861604|NCT00108953|3564078|FG001|COMPLETED|Treatment Period|No patient under study medication anymore|49
2861605|NCT00108953|3564077|FG000|NOT COMPLETED|Treatment Period||0
2861606|NCT00108953|3564078|FG001|NOT COMPLETED|Treatment Period||0
2861607|NCT00108953|3564077|FG000|STARTED|Follow-up|40 out of 47 patients were followed after end of double blind treatment|40
2861608|NCT00108953|3564078|FG001|STARTED|Follow-up|45 out of 49 patients were followed after end of double blind treatment|45
2861609|NCT00108953|3564077|FG000|COMPLETED|Follow-up||11
2861610|NCT00108953|3564078|FG001|COMPLETED|Follow-up||12
2861611|NCT00108953|3564077|FG000|NOT COMPLETED|Follow-up||29
2861612|NCT00108953|3564078|FG001|NOT COMPLETED|Follow-up||33
2861613|NCT00109005|3564088|FG000|STARTED|Overall Study||8
2861614|NCT00109005|3564089|FG001|STARTED|Overall Study||9
2861615|NCT00109005|3564088|FG000|COMPLETED|Overall Study||8
2861616|NCT00109005|3564089|FG001|COMPLETED|Overall Study||9
2861617|NCT00109005|3564088|FG000|NOT COMPLETED|Overall Study||0
2861618|NCT00109005|3564089|FG001|NOT COMPLETED|Overall Study||0
2861619|NCT00109031|3564100|FG000|STARTED|Overall Study||11
2861620|NCT00109031|3564101|FG001|STARTED|Overall Study||10
2861621|NCT00109031|3564102|FG002|STARTED|Overall Study||14
2861622|NCT00109031|3564103|FG003|STARTED|Overall Study||12
2861623|NCT00109031|3564100|FG000|COMPLETED|Overall Study||11
2861624|NCT00109031|3564101|FG001|COMPLETED|Overall Study||8
2861625|NCT00109031|3564102|FG002|COMPLETED|Overall Study||12
2861626|NCT00109031|3564103|FG003|COMPLETED|Overall Study||12
2861627|NCT00109031|3564100|FG000|NOT COMPLETED|Overall Study||0
2861628|NCT00109031|3564101|FG001|NOT COMPLETED|Overall Study||2
2861629|NCT00109031|3564102|FG002|NOT COMPLETED|Overall Study||2
2861630|NCT00109031|3564103|FG003|NOT COMPLETED|Overall Study||0
2861631|NCT00109343|3564116|FG000|STARTED|Overall Study||510
2861632|NCT00109343|3564117|FG001|STARTED|Overall Study||258
2861633|NCT00109343|3564118|FG002|STARTED|Overall Study||259
2861634|NCT00109343|3564116|FG000|Vaccinated at Visit 1|Overall Study||510
2861635|NCT00109343|3564117|FG001|Vaccinated at Visit 1|Overall Study||258
2861636|NCT00109343|3564118|FG002|Vaccinated at Visit 1|Overall Study||259
2861637|NCT00109343|3564116|FG000|Vaccinated at Visit 2|Overall Study|Per-protocol, subjects in Group 1 were not vaccinated at Visit 2|0
2861638|NCT00109343|3564117|FG001|Vaccinated at Visit 2|Overall Study||246
2861639|NCT00109343|3564118|FG002|Vaccinated at Visit 2|Overall Study||246
2861640|NCT00109343|3564116|FG000|Vaccinated at Visit 4|Overall Study||466
2861641|NCT00109343|3564117|FG001|Vaccinated at Visit 4|Overall Study||235
2861642|NCT00109343|3564118|FG002|Vaccinated at Visit 4|Overall Study||240
2861643|NCT00109343|3564116|FG000|COMPLETED|Overall Study||446
2861644|NCT00109343|3564117|FG001|COMPLETED|Overall Study||221
2861645|NCT00109343|3564118|FG002|COMPLETED|Overall Study||229
2861646|NCT00109343|3564116|FG000|NOT COMPLETED|Overall Study||64
2861647|NCT00109343|3564117|FG001|NOT COMPLETED|Overall Study||37
2861648|NCT00109343|3564118|FG002|NOT COMPLETED|Overall Study||30
2920783|NCT00538759|3631353|FG001|COMPLETED|Overall Study||8
2861649|NCT00109473|3564128|FG000|STARTED|Baseline (0 Through 12 Weeks)|11 subjects allocated to Group A; one withdrew consent, only 10 receieved intervention.|10
2861650|NCT00109473|3564129|FG001|STARTED|Baseline (0 Through 12 Weeks)||10
2861651|NCT00109473|3564128|FG000|Analyzed|Baseline (0 Through 12 Weeks)||10
2861652|NCT00109473|3564129|FG001|Analyzed|Baseline (0 Through 12 Weeks)||10
2861653|NCT00109473|3564128|FG000|COMPLETED|Baseline (0 Through 12 Weeks)||10
2861654|NCT00109473|3564129|FG001|COMPLETED|Baseline (0 Through 12 Weeks)|One subject discontinued intervention because of active disease requiring imfliximab|9
2861655|NCT00109473|3564128|FG000|NOT COMPLETED|Baseline (0 Through 12 Weeks)||0
2861656|NCT00109473|3564129|FG001|NOT COMPLETED|Baseline (0 Through 12 Weeks)||1
2861657|NCT00109473|3564128|FG000|STARTED|Week 12 to Week 24||10
2861658|NCT00109473|3564129|FG001|STARTED|Week 12 to Week 24||9
2861659|NCT00109473|3564128|FG000|Analyzed|Week 12 to Week 24||9
2861660|NCT00109473|3564129|FG001|Analyzed|Week 12 to Week 24||9
2861661|NCT00109473|3564128|FG000|COMPLETED|Week 12 to Week 24|One subject withdrew consent|9
2861662|NCT00109473|3564129|FG001|COMPLETED|Week 12 to Week 24|one subject discontinued intervention due to active disease requiring surgery|9
2861663|NCT00109473|3564128|FG000|NOT COMPLETED|Week 12 to Week 24||1
2861664|NCT00109473|3564129|FG001|NOT COMPLETED|Week 12 to Week 24||0
2861665|NCT00109473|3564128|FG000|STARTED|52 Week Extension Phase||9
2861666|NCT00109473|3564129|FG001|STARTED|52 Week Extension Phase||8
2861667|NCT00109473|3564128|FG000|Analyzed|52 Week Extension Phase||9
2861668|NCT00109473|3564129|FG001|Analyzed|52 Week Extension Phase||8
2861669|NCT00109473|3564128|FG000|COMPLETED|52 Week Extension Phase|Extension phase ends when subjects discontinue intervention due to active disease or reaches week 64|5
2861670|NCT00109473|3564129|FG001|COMPLETED|52 Week Extension Phase|Extension phase ends when subjects discontinue intervention due to active disease or reaches week 64|3
2861671|NCT00109473|3564128|FG000|NOT COMPLETED|52 Week Extension Phase||4
2861672|NCT00109473|3564129|FG001|NOT COMPLETED|52 Week Extension Phase||5
2861673|NCT00109577|3564140|FG000|STARTED|Overall Study||20
2861674|NCT00109577|3564141|FG001|STARTED|Overall Study||20
2861675|NCT00109577|3564140|FG000|COMPLETED|Overall Study||17
2861676|NCT00109577|3564141|FG001|COMPLETED|Overall Study||17
2861677|NCT00109577|3564140|FG000|NOT COMPLETED|Overall Study||3
2861678|NCT00109577|3564141|FG001|NOT COMPLETED|Overall Study||3
2861679|NCT00109590|3564150|FG000|STARTED|Overall Study||57
2861680|NCT00109590|3564151|FG001|STARTED|Overall Study||58
2861681|NCT00109590|3564152|FG002|STARTED|Overall Study||60
2861682|NCT00109590|3564150|FG000|RECEIVED TREATMENT|Overall Study||56
2861683|NCT00109590|3564151|FG001|RECEIVED TREATMENT|Overall Study||56
2861684|NCT00109590|3564152|FG002|RECEIVED TREATMENT|Overall Study||57
2861685|NCT00109590|3564150|FG000|COMPLETED|Overall Study||55
2861686|NCT00109590|3564151|FG001|COMPLETED|Overall Study||56
2861687|NCT00109590|3564152|FG002|COMPLETED|Overall Study||56
2861688|NCT00109590|3564150|FG000|NOT COMPLETED|Overall Study||2
2861689|NCT00109590|3564151|FG001|NOT COMPLETED|Overall Study||2
2861690|NCT00109590|3564152|FG002|NOT COMPLETED|Overall Study||4
2861691|NCT00109707|3564177|FG000|STARTED|Overall Study||321
2861692|NCT00109707|3564178|FG001|STARTED|Overall Study||137
2861693|NCT00109707|3564179|FG002|STARTED|Overall Study||49
2861694|NCT00109707|3564177|FG000|Entered Extension Study|Overall Study||106
2861695|NCT00109707|3564178|FG001|Entered Extension Study|Overall Study||15
2861696|NCT00109707|3564179|FG002|Entered Extension Study|Overall Study||15
2861697|NCT00109707|3564177|FG000|COMPLETED|Overall Study||67
2861698|NCT00109707|3564178|FG001|COMPLETED|Overall Study||8
2861699|NCT00109707|3564179|FG002|COMPLETED|Overall Study||8
2861700|NCT00109707|3564177|FG000|NOT COMPLETED|Overall Study||254
2861701|NCT00109707|3564178|FG001|NOT COMPLETED|Overall Study||129
2861702|NCT00109707|3564179|FG002|NOT COMPLETED|Overall Study||41
2861703|NCT00109733|3564193|FG000|STARTED|Overall Study||15
2861704|NCT00109733|3564194|FG001|STARTED|Overall Study||16
2861705|NCT00109733|3564193|FG000|COMPLETED|Overall Study||13
2861706|NCT00109733|3564194|FG001|COMPLETED|Overall Study||12
2861707|NCT00109733|3564193|FG000|NOT COMPLETED|Overall Study||2
2861708|NCT00109733|3564194|FG001|NOT COMPLETED|Overall Study||4
2861709|NCT00109772|3564202|FG000|STARTED|Double-blind Treatment||90
2861710|NCT00109772|3564203|FG001|STARTED|Double-blind Treatment||94
2861711|NCT00109772|3564202|FG000|Safety and ITT Population|Double-blind Treatment|Safety: at least one dose of study drug ITT: treated and at least one post dose diary measurement|87
2861712|NCT00109772|3564203|FG001|Safety and ITT Population|Double-blind Treatment|Safety: at least one dose of study drug ITT: treated and at least one post dose diary measurement|93
2861713|NCT00109772|3564202|FG000|COMPLETED|Double-blind Treatment||68
2861714|NCT00109772|3564203|FG001|COMPLETED|Double-blind Treatment||79
2861715|NCT00109772|3564202|FG000|NOT COMPLETED|Double-blind Treatment||22
2861716|NCT00109772|3564203|FG001|NOT COMPLETED|Double-blind Treatment||15
2861717|NCT00109772|3564202|FG000|STARTED|Open-label Extension|Four double-blind participants did not continue into the open-label extension|64
2861718|NCT00109772|3564203|FG001|STARTED|Open-label Extension|One double-blind participant did not continue into the open-label extension|78
2861719|NCT00109772|3564202|FG000|COMPLETED|Open-label Extension|Participants who were active in extension period when the sponsor terminated the study.|19
2861720|NCT00109772|3564203|FG001|COMPLETED|Open-label Extension|Participants who were active in extension period when the sponsor terminated the study.|29
2861721|NCT00109772|3564202|FG000|NOT COMPLETED|Open-label Extension||45
2861722|NCT00109772|3564203|FG001|NOT COMPLETED|Open-label Extension||49
2861723|NCT00109837|3564209|FG000|STARTED|Overall Study||79
2861724|NCT00109837|3564209|FG000|Eligible|Overall Study||78
2861725|NCT00109837|3564209|FG000|Eligible and Ph-|Overall Study||61
2861726|NCT00109837|3564209|FG000|Eligible and Ph- and Treated|Overall Study||60
2861727|NCT00109837|3564209|FG000|COMPLETED|Overall Study||56
2861728|NCT00109837|3564209|FG000|NOT COMPLETED|Overall Study||23
2861729|NCT00109850|3564217|FG000|STARTED|Overall Study||22
2861730|NCT00109850|3564217|FG000|Eligible|Overall Study||21
2861731|NCT00109850|3564217|FG000|Eligible and Began Protocol Therapy|Overall Study||21
2861732|NCT00109850|3564217|FG000|COMPLETED|Overall Study||18
2861733|NCT00109850|3564217|FG000|NOT COMPLETED|Overall Study||4
2861734|NCT00109876|3564221|FG000|STARTED|Overall Study||51
2861735|NCT00109876|3564221|FG000|COMPLETED|Overall Study||51
2861736|NCT00109876|3564221|FG000|NOT COMPLETED|Overall Study||0
2861737|NCT00109928|3564225|FG000|STARTED|Overall Study||34
2861738|NCT00109928|3564225|FG000|Eligible|Overall Study||33
2861739|NCT00109928|3564225|FG000|Eligible and Began Protocol Therapy|Overall Study||33
2861740|NCT00109928|3564225|FG000|COMPLETED|Overall Study||21
2861741|NCT00109928|3564225|FG000|NOT COMPLETED|Overall Study||13
2861742|NCT00109967|3564232|FG000|STARTED|Overall Study||50
2861743|NCT00109967|3564233|FG001|STARTED|Overall Study||21
2861744|NCT00109967|3564232|FG000|COMPLETED|Overall Study||30
2861745|NCT00109967|3564233|FG001|COMPLETED|Overall Study||15
2861746|NCT00109967|3564232|FG000|NOT COMPLETED|Overall Study||20
2861747|NCT00109967|3564233|FG001|NOT COMPLETED|Overall Study||6
2861748|NCT00110019|3564241|FG000|STARTED|Overall Study||410
2861749|NCT00110019|3564242|FG001|STARTED|Overall Study||413
2861750|NCT00110019|3564241|FG000|Eligible|Overall Study||395
2861751|NCT00110019|3564242|FG001|Eligible|Overall Study||398
2861752|NCT00110019|3564241|FG000|Treated|Overall Study||393
2861753|NCT00110019|3564242|FG001|Treated|Overall Study||397
2861754|NCT00110019|3564241|FG000|COMPLETED|Overall Study||4
2861755|NCT00110019|3564242|FG001|COMPLETED|Overall Study||0
2861756|NCT00110019|3564241|FG000|NOT COMPLETED|Overall Study||406
2861757|NCT00110019|3564242|FG001|NOT COMPLETED|Overall Study||413
2861758|NCT00110084|3564248|FG000|STARTED|Overall Study||50
2861759|NCT00110084|3564248|FG000|COMPLETED|Overall Study||22
2861760|NCT00110084|3564248|FG000|NOT COMPLETED|Overall Study||28
2861761|NCT00110136|3564252|FG000|STARTED|Overall Study||9
2861762|NCT00110136|3564252|FG000|COMPLETED|Overall Study||9
2861763|NCT00110136|3564252|FG000|NOT COMPLETED|Overall Study||0
2861764|NCT00110149|3564257|FG000|STARTED|Overall Study|total number that signed consent to be screened.|12
2861765|NCT00110149|3564257|FG000|Received Treatment|Overall Study|total number of patient that passed screening and received treatment.|9
2861766|NCT00110149|3564257|FG000|COMPLETED|Overall Study||9
2861767|NCT00110149|3564257|FG000|NOT COMPLETED|Overall Study||3
2861768|NCT00110214|3564264|FG000|STARTED|Overall Study||526
2861769|NCT00110214|3564265|FG001|STARTED|Overall Study||524
2861770|NCT00110214|3564264|FG000|COMPLETED|Overall Study||17
2861771|NCT00110214|3564265|FG001|COMPLETED|Overall Study||21
2861772|NCT00110214|3564264|FG000|NOT COMPLETED|Overall Study||509
2861773|NCT00110214|3564265|FG001|NOT COMPLETED|Overall Study||503
2861774|NCT00110266|3564271|FG000|STARTED|Overall Study||173
2861775|NCT00110266|3564271|FG000|COMPLETED|Overall Study||95
2861776|NCT00110266|3564271|FG000|NOT COMPLETED|Overall Study||78
2861777|NCT00110305|3564280|FG000|STARTED|Overall Study||279
2861778|NCT00110305|3564281|FG001|STARTED|Overall Study||89
2861779|NCT00110305|3564280|FG000|COMPLETED|Overall Study||165
2861780|NCT00110305|3564281|FG001|COMPLETED|Overall Study||57
2861781|NCT00110305|3564280|FG000|NOT COMPLETED|Overall Study||114
2861782|NCT00110305|3564281|FG001|NOT COMPLETED|Overall Study||32
2861783|NCT00110357|3564300|FG000|STARTED|Overall Study||27
2861784|NCT00110357|3564301|FG001|STARTED|Overall Study||19
2861785|NCT00110357|3564300|FG000|COMPLETED|Overall Study|Number Still on Study|0
2861786|NCT00110357|3564301|FG001|COMPLETED|Overall Study|Number Still on Study|0
2861787|NCT00110357|3564300|FG000|NOT COMPLETED|Overall Study||27
2861788|NCT00110357|3564301|FG001|NOT COMPLETED|Overall Study||19
2861789|NCT00110396|3564334|FG000|STARTED|Overall Study||260
2861790|NCT00110396|3564334|FG000|COMPLETED|Overall Study|260 participants included in the Safety Population.207 completed treatment. 224 completed the trial|224
2861791|NCT00110396|3564334|FG000|NOT COMPLETED|Overall Study||36
2861792|NCT00110461|3564341|FG000|STARTED|30-Week, Double-blind Treatment Phase||98
2861793|NCT00110461|3564342|FG001|STARTED|30-Week, Double-blind Treatment Phase||99
2861794|NCT00110461|3564343|FG002|STARTED|30-Week, Double-blind Treatment Phase||99
2861795|NCT00110461|3564341|FG000|COMPLETED|30-Week, Double-blind Treatment Phase||34
2861796|NCT00110461|3564342|FG001|COMPLETED|30-Week, Double-blind Treatment Phase||22
2861797|NCT00110461|3564343|FG002|COMPLETED|30-Week, Double-blind Treatment Phase||12
2861798|NCT00110461|3564341|FG000|NOT COMPLETED|30-Week, Double-blind Treatment Phase||64
2861799|NCT00110461|3564342|FG001|NOT COMPLETED|30-Week, Double-blind Treatment Phase||77
2861800|NCT00110461|3564343|FG002|NOT COMPLETED|30-Week, Double-blind Treatment Phase||87
2861801|NCT00110461|3564341|FG000|STARTED|Acute Phase||98
2861802|NCT00110461|3564342|FG001|STARTED|Acute Phase||99
2861803|NCT00110461|3564343|FG002|STARTED|Acute Phase||99
2861804|NCT00110461|3564341|FG000|COMPLETED|Acute Phase||84
2861805|NCT00110461|3564342|FG001|COMPLETED|Acute Phase||77
2861806|NCT00110461|3564343|FG002|COMPLETED|Acute Phase||76
2861807|NCT00110461|3564341|FG000|NOT COMPLETED|Acute Phase||14
2861808|NCT00110461|3564342|FG001|NOT COMPLETED|Acute Phase||22
2861809|NCT00110461|3564343|FG002|NOT COMPLETED|Acute Phase||23
2861810|NCT00110513|3564351|FG000|STARTED|Overall Study||18
2861811|NCT00110513|3564351|FG000|COMPLETED|Overall Study||18
2861812|NCT00110513|3564351|FG000|NOT COMPLETED|Overall Study||0
2861813|NCT00110617|3564357|FG000|STARTED|Overall Study||135
2861814|NCT00110617|3564358|FG001|STARTED|Overall Study|Full Analysis Set 1 does not include 9 participants who were excluded due to GCP violations.|68
2861815|NCT00110617|3564357|FG000|Safety Set 1; Received Study Drug|Overall Study||135
2861816|NCT00110617|3564358|FG001|Safety Set 1; Received Study Drug|Overall Study||56
2861817|NCT00110617|3564357|FG000|Full Analysis 2; Received ICL670|Overall Study||135
2861818|NCT00110617|3564358|FG001|Full Analysis 2; Received ICL670|Overall Study||53
2861819|NCT00110617|3564357|FG000|On Going at Week 24|Overall Study||126
2861820|NCT00110617|3564358|FG001|On Going at Week 24|Overall Study||53
2861821|NCT00110617|3564357|FG000|COMPLETED|Overall Study||96
2861822|NCT00110617|3564358|FG001|COMPLETED|Overall Study||39
2861823|NCT00110617|3564357|FG000|NOT COMPLETED|Overall Study||39
2861824|NCT00110617|3564358|FG001|NOT COMPLETED|Overall Study||29
2861825|NCT00110812|3564369|FG000|STARTED|Main Study||91
2861826|NCT00110812|3564370|FG001|STARTED|Main Study||89
2861827|NCT00110812|3564371|FG002|STARTED|Main Study||87
2861828|NCT00110812|3564369|FG000|COMPLETED|Main Study||83
2861829|NCT00110812|3564370|FG001|COMPLETED|Main Study||78
2861830|NCT00110812|3564371|FG002|COMPLETED|Main Study||74
2861831|NCT00110812|3564369|FG000|NOT COMPLETED|Main Study||8
2861832|NCT00110812|3564370|FG001|NOT COMPLETED|Main Study||11
2861833|NCT00110812|3564371|FG002|NOT COMPLETED|Main Study||13
2861834|NCT00110812|3564369|FG000|STARTED|Extended Follow-up||80
2861835|NCT00110812|3564370|FG001|STARTED|Extended Follow-up||69
2861836|NCT00110812|3564371|FG002|STARTED|Extended Follow-up||73
2861837|NCT00110812|3564369|FG000|COMPLETED|Extended Follow-up||78
2861838|NCT00110812|3564370|FG001|COMPLETED|Extended Follow-up||65
2861839|NCT00110812|3564371|FG002|COMPLETED|Extended Follow-up||69
2861840|NCT00110812|3564369|FG000|NOT COMPLETED|Extended Follow-up||2
2861841|NCT00110812|3564370|FG001|NOT COMPLETED|Extended Follow-up||4
2861842|NCT00110812|3564371|FG002|NOT COMPLETED|Extended Follow-up||4
2861843|NCT00110890|3564386|FG000|STARTED|Overall Study||368
2861844|NCT00110890|3564387|FG001|STARTED|Overall Study||184
2861845|NCT00110890|3564386|FG000|End of Dose Optimization Phase|Overall Study|Weeks 1 to 16|316
2861846|NCT00110890|3564387|FG001|End of Dose Optimization Phase|Overall Study|Weeks 1 to 16|170
2861847|NCT00110890|3564386|FG000|End of Efficacy Assessment Phase|Overall Study|Weeks 17 to 23|280
2861848|NCT00110890|3564387|FG001|End of Efficacy Assessment Phase|Overall Study|Weeks 17 to 23|150
2861849|NCT00110890|3564386|FG000|COMPLETED|Overall Study|Follow-up Phase|7
2861850|NCT00110890|3564387|FG001|COMPLETED|Overall Study|Follow-up Phase|5
2861851|NCT00110890|3564386|FG000|NOT COMPLETED|Overall Study||361
2861852|NCT00110890|3564387|FG001|NOT COMPLETED|Overall Study||179
2861853|NCT00110994|3564395|FG000|STARTED|Double-blind (DB) Treatment|ITT population|51
2861854|NCT00110994|3564396|FG001|STARTED|Double-blind (DB) Treatment|ITT population|50
2861855|NCT00110994|3564395|FG000|Received Treatment|Double-blind (DB) Treatment|Safety population|51
2861856|NCT00110994|3564396|FG001|Received Treatment|Double-blind (DB) Treatment|Safety population|50
2861857|NCT00110994|3564395|FG000|COMPLETED|Double-blind (DB) Treatment||9
2861858|NCT00110994|3564396|FG001|COMPLETED|Double-blind (DB) Treatment||3
2861859|NCT00110994|3564395|FG000|NOT COMPLETED|Double-blind (DB) Treatment||42
2861860|NCT00110994|3564396|FG001|NOT COMPLETED|Double-blind (DB) Treatment||47
2861861|NCT00110994|3564395|FG000|STARTED|Active Follow-up|Subjects discontinued DB treatment with CR, PR and SD entered this period.|1
2861862|NCT00110994|3564396|FG001|STARTED|Active Follow-up|Subjects discontinued DB treatment with CR, PR and SD entered this period.|2
2861863|NCT00110994|3564395|FG000|COMPLETED|Active Follow-up||0
2861864|NCT00110994|3564396|FG001|COMPLETED|Active Follow-up||0
2861865|NCT00110994|3564395|FG000|NOT COMPLETED|Active Follow-up||1
3313422|NCT03075410|4046799|FG008|COMPLETED|Part A-Washout Period 2 (14 Days)||0
3313423|NCT03075410|4046791|FG000|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
3168955|NCT01922050|3896376|FG002|NOT COMPLETED|Part 2 Double-blind Phase||0
3313424|NCT03075410|4046792|FG001|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
3313425|NCT03075410|4046793|FG002|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
3313426|NCT03075410|4046794|FG003|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
3313427|NCT03075410|4046795|FG004|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
3313428|NCT03075410|4046796|FG005|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
3313429|NCT03075410|4046797|FG006|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
3313430|NCT03075410|4046798|FG007|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
3313431|NCT03075410|4046799|FG008|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
3313432|NCT03075410|4046791|FG000|STARTED|Part A-Period 3 (14 Days)|Participants who withdrew in Period 2 were replaced (2 new participants entered Part A period 3).|2
3313433|NCT03075410|4046792|FG001|STARTED|Part A-Period 3 (14 Days)||1
3313434|NCT03075410|4046793|FG002|STARTED|Part A-Period 3 (14 Days)|Participants who withdrew in Period 2 were replaced (2 new participants entered Part A period 3).|2
3313435|NCT03075410|4046794|FG003|STARTED|Part A-Period 3 (14 Days)||1
2861866|NCT00110994|3564396|FG001|NOT COMPLETED|Active Follow-up||2
2861867|NCT00110994|3564395|FG000|STARTED|Long Term Follow-up|Subjects discontinued DB treatment with DP entered this period.|41
2861868|NCT00110994|3564396|FG001|STARTED|Long Term Follow-up|Subjects discontinued DB treatment with DP entered this period.|47
2861869|NCT00110994|3564395|FG000|COMPLETED|Long Term Follow-up||22
2861870|NCT00110994|3564396|FG001|COMPLETED|Long Term Follow-up||30
2861871|NCT00110994|3564395|FG000|NOT COMPLETED|Long Term Follow-up||19
2861872|NCT00110994|3564396|FG001|NOT COMPLETED|Long Term Follow-up||17
2861873|NCT00111007|3564404|FG000|STARTED|Double-blind (DB) Treatment|ITT population|135
2861874|NCT00111007|3564405|FG001|STARTED|Double-blind (DB) Treatment|ITT population|135
2861875|NCT00111007|3564404|FG000|Received Treatment|Double-blind (DB) Treatment|Safety population|134
2861876|NCT00111007|3564405|FG001|Received Treatment|Double-blind (DB) Treatment|Safety population|134
2861877|NCT00111007|3564404|FG000|COMPLETED|Double-blind (DB) Treatment||27
2861878|NCT00111007|3564405|FG001|COMPLETED|Double-blind (DB) Treatment||24
2861879|NCT00111007|3564404|FG000|NOT COMPLETED|Double-blind (DB) Treatment||108
2861880|NCT00111007|3564405|FG001|NOT COMPLETED|Double-blind (DB) Treatment||111
2861881|NCT00111007|3564404|FG000|STARTED|Active Follow-up|Subjects discontinued DB treatment with CR, PR and SD entered this period.|6
2861882|NCT00111007|3564405|FG001|STARTED|Active Follow-up|Subjects discontinued DB treatment with CR, PR and SD entered this period.|4
2861883|NCT00111007|3564404|FG000|COMPLETED|Active Follow-up||0
2861884|NCT00111007|3564405|FG001|COMPLETED|Active Follow-up||2
2861885|NCT00111007|3564404|FG000|NOT COMPLETED|Active Follow-up||6
2861886|NCT00111007|3564405|FG001|NOT COMPLETED|Active Follow-up||2
2861887|NCT00111007|3564404|FG000|STARTED|Long Term Follow-up|Subjects discontinued DB treatment with DP entered this period.|101
2861888|NCT00111007|3564405|FG001|STARTED|Long Term Follow-up|Subjects discontinued DB treatment with DP entered this period.|107
2861889|NCT00111007|3564404|FG000|COMPLETED|Long Term Follow-up||54
2861890|NCT00111007|3564405|FG001|COMPLETED|Long Term Follow-up||62
2861891|NCT00111007|3564404|FG000|NOT COMPLETED|Long Term Follow-up||47
2861892|NCT00111007|3564405|FG001|NOT COMPLETED|Long Term Follow-up||45
2861893|NCT00111228|3564414|FG000|STARTED|Overall Study||54
2861894|NCT00111228|3564415|FG001|STARTED|Overall Study||54
2861895|NCT00111228|3564416|FG002|STARTED|Overall Study||54
2861896|NCT00111228|3564414|FG000|COMPLETED|Overall Study||49
2861897|NCT00111228|3564415|FG001|COMPLETED|Overall Study||53
2861898|NCT00111228|3564416|FG002|COMPLETED|Overall Study||54
2861899|NCT00111228|3564414|FG000|NOT COMPLETED|Overall Study||5
2861900|NCT00111228|3564415|FG001|NOT COMPLETED|Overall Study||1
2861901|NCT00111228|3564416|FG002|NOT COMPLETED|Overall Study||0
2861902|NCT00111241|3564426|FG000|STARTED|Overall Study||45
3168956|NCT01922050|3896377|FG003|NOT COMPLETED|Part 2 Double-blind Phase||0
3168957|NCT01922050|3896378|FG004|NOT COMPLETED|Part 2 Double-blind Phase||0
3168958|NCT01922050|3896379|FG005|NOT COMPLETED|Part 2 Double-blind Phase||0
3168959|NCT01922050|3896380|FG006|NOT COMPLETED|Part 2 Double-blind Phase||0
2861903|NCT00111241|3564427|FG001|STARTED|Overall Study||70
2861904|NCT00111241|3564426|FG000|COMPLETED|Overall Study||30
2861905|NCT00111241|3564427|FG001|COMPLETED|Overall Study||62
2861906|NCT00111241|3564426|FG000|NOT COMPLETED|Overall Study||15
2861907|NCT00111241|3564427|FG001|NOT COMPLETED|Overall Study||8
2861908|NCT00111475|3564445|FG000|STARTED|Overall Study||4
2861909|NCT00111475|3564446|FG001|STARTED|Overall Study||4
2861910|NCT00111475|3564447|FG002|STARTED|Overall Study||4
2861911|NCT00111475|3564448|FG003|STARTED|Overall Study||4
2861912|NCT00111475|3564449|FG004|STARTED|Overall Study||4
2861913|NCT00111475|3564450|FG005|STARTED|Overall Study||4
2861914|NCT00111475|3564451|FG006|STARTED|Overall Study||4
2861915|NCT00111475|3564452|FG007|STARTED|Overall Study||8
2861916|NCT00111475|3564453|FG008|STARTED|Overall Study||8
2861917|NCT00111475|3564454|FG009|STARTED|Overall Study||1
2861918|NCT00111475|3564445|FG000|COMPLETED|Overall Study||4
2861919|NCT00111475|3564446|FG001|COMPLETED|Overall Study||4
2861920|NCT00111475|3564447|FG002|COMPLETED|Overall Study||4
2861921|NCT00111475|3564448|FG003|COMPLETED|Overall Study||4
2861922|NCT00111475|3564449|FG004|COMPLETED|Overall Study||4
2861923|NCT00111475|3564450|FG005|COMPLETED|Overall Study||3
2861924|NCT00111475|3564451|FG006|COMPLETED|Overall Study||4
2861925|NCT00111475|3564452|FG007|COMPLETED|Overall Study||8
2861926|NCT00111475|3564453|FG008|COMPLETED|Overall Study||8
2861927|NCT00111475|3564454|FG009|COMPLETED|Overall Study||1
2861928|NCT00111475|3564445|FG000|NOT COMPLETED|Overall Study||0
2861929|NCT00111475|3564446|FG001|NOT COMPLETED|Overall Study||0
2861930|NCT00111475|3564447|FG002|NOT COMPLETED|Overall Study||0
2861931|NCT00111475|3564448|FG003|NOT COMPLETED|Overall Study||0
2861932|NCT00111475|3564449|FG004|NOT COMPLETED|Overall Study||0
2861933|NCT00111475|3564450|FG005|NOT COMPLETED|Overall Study||1
2861934|NCT00111475|3564451|FG006|NOT COMPLETED|Overall Study||0
2861935|NCT00111475|3564452|FG007|NOT COMPLETED|Overall Study||0
2861936|NCT00111475|3564453|FG008|NOT COMPLETED|Overall Study||0
2861937|NCT00111475|3564454|FG009|NOT COMPLETED|Overall Study||0
2861938|NCT00111657|3564481|FG000|STARTED|Overall Study|37 consented. 30 initiated treatment. 29 completed at least 1 dose.|37
2861939|NCT00111657|3564481|FG000|COMPLETED|Overall Study|Completed all intended doses.|21
2861940|NCT00111657|3564481|FG000|NOT COMPLETED|Overall Study||16
2918485|NCT00527514|3628717|FG000|STARTED|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|178 -19 who met blood pressure goal + 2 who were mis-titrated = 161|161
2918486|NCT00527514|3628717|FG000|COMPLETED|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg||158
2918487|NCT00527514|3628717|FG000|NOT COMPLETED|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg||3
2918488|NCT00527514|3628717|FG000|STARTED|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|158 -24 who met blood pressure goal = 134|134
2918489|NCT00527514|3628717|FG000|COMPLETED|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg||132
2918490|NCT00527514|3628717|FG000|NOT COMPLETED|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg||2
2918491|NCT00527566|3628728|FG000|STARTED|Overall Study||10
2918492|NCT00527566|3628728|FG000|COMPLETED|Overall Study||10
2918493|NCT00527566|3628728|FG000|NOT COMPLETED|Overall Study||0
2918494|NCT00527592|3628734|FG000|STARTED|Overall Study||54
3168960|NCT01922050|3896381|FG007|NOT COMPLETED|Part 2 Double-blind Phase||0
3168961|NCT01922050|3896382|FG008|NOT COMPLETED|Part 2 Double-blind Phase||0
2861941|NCT00111761|3564489|FG000|STARTED|Part 1|This treatment group was not initiated until Part 2|0
2861942|NCT00111761|3564490|FG001|STARTED|Part 1||19
2861943|NCT00111761|3564489|FG000|COMPLETED|Part 1||0
2861944|NCT00111761|3564490|FG001|COMPLETED|Part 1|Completed through safety followup|14
2861945|NCT00111761|3564489|FG000|NOT COMPLETED|Part 1||0
2861946|NCT00111761|3564490|FG001|NOT COMPLETED|Part 1||5
2861947|NCT00111761|3564489|FG000|STARTED|Part 2||24
2861948|NCT00111761|3564490|FG001|STARTED|Part 2|This treatment group was used in Part 1 only|0
2861949|NCT00111761|3564489|FG000|COMPLETED|Part 2||16
2861950|NCT00111761|3564490|FG001|COMPLETED|Part 2||0
2861951|NCT00111761|3564489|FG000|NOT COMPLETED|Part 2||8
2861952|NCT00111761|3564490|FG001|NOT COMPLETED|Part 2||0
2861953|NCT00111800|3564502|FG000|STARTED|Period 1: Main Phase (12 Weeks)||64
2861954|NCT00111800|3564503|FG001|STARTED|Period 1: Main Phase (12 Weeks)||61
2861955|NCT00111800|3564504|FG002|STARTED|Period 1: Main Phase (12 Weeks)||63
2861956|NCT00111800|3564505|FG003|STARTED|Period 1: Main Phase (12 Weeks)||66
2861957|NCT00111800|3564506|FG004|STARTED|Period 1: Main Phase (12 Weeks)||60
2861958|NCT00111800|3564507|FG005|STARTED|Period 1: Main Phase (12 Weeks)||61
2861959|NCT00111800|3564502|FG000|COMPLETED|Period 1: Main Phase (12 Weeks)||49
2861960|NCT00111800|3564503|FG001|COMPLETED|Period 1: Main Phase (12 Weeks)||47
2861961|NCT00111800|3564504|FG002|COMPLETED|Period 1: Main Phase (12 Weeks)||54
2861962|NCT00111800|3564505|FG003|COMPLETED|Period 1: Main Phase (12 Weeks)||60
2861963|NCT00111800|3564506|FG004|COMPLETED|Period 1: Main Phase (12 Weeks)||55
2861964|NCT00111800|3564507|FG005|COMPLETED|Period 1: Main Phase (12 Weeks)||56
2861965|NCT00111800|3564502|FG000|NOT COMPLETED|Period 1: Main Phase (12 Weeks)||15
2861966|NCT00111800|3564503|FG001|NOT COMPLETED|Period 1: Main Phase (12 Weeks)||14
2861967|NCT00111800|3564504|FG002|NOT COMPLETED|Period 1: Main Phase (12 Weeks)||9
2861968|NCT00111800|3564505|FG003|NOT COMPLETED|Period 1: Main Phase (12 Weeks)||6
2861969|NCT00111800|3564506|FG004|NOT COMPLETED|Period 1: Main Phase (12 Weeks)||5
2861970|NCT00111800|3564507|FG005|NOT COMPLETED|Period 1: Main Phase (12 Weeks)||5
2861971|NCT00111800|3564502|FG000|STARTED|Period 2: Extension Phase (12 Weeks)||48
2861972|NCT00111800|3564503|FG001|STARTED|Period 2: Extension Phase (12 Weeks)||47
2861973|NCT00111800|3564504|FG002|STARTED|Period 2: Extension Phase (12 Weeks)||54
2861974|NCT00111800|3564505|FG003|STARTED|Period 2: Extension Phase (12 Weeks)||59
2861975|NCT00111800|3564506|FG004|STARTED|Period 2: Extension Phase (12 Weeks)||55
2861976|NCT00111800|3564507|FG005|STARTED|Period 2: Extension Phase (12 Weeks)||55
2861977|NCT00111800|3564502|FG000|COMPLETED|Period 2: Extension Phase (12 Weeks)||46
2861978|NCT00111800|3564503|FG001|COMPLETED|Period 2: Extension Phase (12 Weeks)||40
2861979|NCT00111800|3564504|FG002|COMPLETED|Period 2: Extension Phase (12 Weeks)||47
2861980|NCT00111800|3564505|FG003|COMPLETED|Period 2: Extension Phase (12 Weeks)||54
2861981|NCT00111800|3564506|FG004|COMPLETED|Period 2: Extension Phase (12 Weeks)||51
2861982|NCT00111800|3564507|FG005|COMPLETED|Period 2: Extension Phase (12 Weeks)||53
2861983|NCT00111800|3564502|FG000|NOT COMPLETED|Period 2: Extension Phase (12 Weeks)||2
2861984|NCT00111800|3564503|FG001|NOT COMPLETED|Period 2: Extension Phase (12 Weeks)||7
2861985|NCT00111800|3564504|FG002|NOT COMPLETED|Period 2: Extension Phase (12 Weeks)||7
2861986|NCT00111800|3564505|FG003|NOT COMPLETED|Period 2: Extension Phase (12 Weeks)||5
2861987|NCT00111800|3564506|FG004|NOT COMPLETED|Period 2: Extension Phase (12 Weeks)||4
2861988|NCT00111800|3564507|FG005|NOT COMPLETED|Period 2: Extension Phase (12 Weeks)||2
2861989|NCT00111813|3564530|FG000|STARTED|Overall Study||3
2861990|NCT00111813|3564531|FG001|STARTED|Overall Study||3
2861991|NCT00111813|3564532|FG002|STARTED|Overall Study||10
2861992|NCT00111813|3564533|FG003|STARTED|Overall Study||6
2861993|NCT00111813|3564534|FG004|STARTED|Overall Study||6
2861994|NCT00111813|3564535|FG005|STARTED|Overall Study||6
2861995|NCT00111813|3564530|FG000|COMPLETED|Overall Study||0
2861996|NCT00111813|3564531|FG001|COMPLETED|Overall Study||0
2861997|NCT00111813|3564532|FG002|COMPLETED|Overall Study||0
2861998|NCT00111813|3564533|FG003|COMPLETED|Overall Study||1
2861999|NCT00111813|3564534|FG004|COMPLETED|Overall Study||0
2862000|NCT00111813|3564535|FG005|COMPLETED|Overall Study||0
2862001|NCT00111813|3564530|FG000|NOT COMPLETED|Overall Study||3
2862002|NCT00111813|3564531|FG001|NOT COMPLETED|Overall Study||3
2862003|NCT00111813|3564532|FG002|NOT COMPLETED|Overall Study||10
2862004|NCT00111813|3564533|FG003|NOT COMPLETED|Overall Study||5
2862005|NCT00111813|3564534|FG004|NOT COMPLETED|Overall Study||6
2862006|NCT00111813|3564535|FG005|NOT COMPLETED|Overall Study||6
2862007|NCT00111839|3564553|FG000|STARTED|Overall Study||50
2862008|NCT00111839|3564554|FG001|STARTED|Overall Study||51
2862009|NCT00111839|3564555|FG002|STARTED|Overall Study||49
2862010|NCT00111839|3564553|FG000|Treated|Overall Study||50
2862011|NCT00111839|3564554|FG001|Treated|Overall Study||51
2862012|NCT00111839|3564555|FG002|Treated|Overall Study||47
2862013|NCT00111839|3564553|FG000|COMPLETED|Overall Study||2
2862014|NCT00111839|3564554|FG001|COMPLETED|Overall Study||5
2862015|NCT00111839|3564555|FG002|COMPLETED|Overall Study||0
2862016|NCT00111839|3564553|FG000|NOT COMPLETED|Overall Study||48
2862017|NCT00111839|3564554|FG001|NOT COMPLETED|Overall Study||46
2862018|NCT00111839|3564555|FG002|NOT COMPLETED|Overall Study||49
2862019|NCT00111917|3564565|FG000|STARTED|Overall Study||9
2862020|NCT00111917|3564566|FG001|STARTED|Overall Study||4
2862021|NCT00111917|3564565|FG000|COMPLETED|Overall Study||8
2862022|NCT00111917|3564566|FG001|COMPLETED|Overall Study||3
2862023|NCT00111917|3564565|FG000|NOT COMPLETED|Overall Study||1
2862024|NCT00111917|3564566|FG001|NOT COMPLETED|Overall Study||1
2862025|NCT00112047|3564578|FG000|STARTED|Randomized Phase|Intention to treat (ITT) population N=255 (2 participants had received prior antiretroviral therapy)|257
2862026|NCT00112047|3564579|FG001|STARTED|Randomized Phase|ITT analysis population|254
2862027|NCT00112047|3564578|FG000|COMPLETED|Randomized Phase||187
2862028|NCT00112047|3564579|FG001|COMPLETED|Randomized Phase||166
2862029|NCT00112047|3564578|FG000|NOT COMPLETED|Randomized Phase||70
2862030|NCT00112047|3564579|FG001|NOT COMPLETED|Randomized Phase||88
2862031|NCT00112047|3564578|FG000|STARTED|Atripla Phase|Number of participants who completed randomized phase and opted to roll over to Atripla at Week 144|160
2862032|NCT00112047|3564579|FG001|STARTED|Atripla Phase|Number of participants who completed randomized phase and opted to roll over to Atripla at Week 144|126
2862033|NCT00112047|3564578|FG000|COMPLETED|Atripla Phase||142
2862034|NCT00112047|3564579|FG001|COMPLETED|Atripla Phase||106
2862035|NCT00112047|3564578|FG000|NOT COMPLETED|Atripla Phase||18
2862036|NCT00112047|3564579|FG001|NOT COMPLETED|Atripla Phase||20
2862037|NCT00112112|3564592|FG000|STARTED|Overall Study||10
2862038|NCT00112112|3564593|FG001|STARTED|Overall Study||10
2862039|NCT00112112|3564592|FG000|COMPLETED|Overall Study||10
2862040|NCT00112112|3564593|FG001|COMPLETED|Overall Study||10
2862041|NCT00112112|3564592|FG000|NOT COMPLETED|Overall Study||0
2862042|NCT00112112|3564593|FG001|NOT COMPLETED|Overall Study||0
2862043|NCT00112125|3564601|FG000|STARTED|Overall Study||213
2862044|NCT00112125|3564602|FG001|STARTED|Overall Study||215
2862045|NCT00112125|3564601|FG000|COMPLETED|Overall Study||189
2862046|NCT00112125|3564602|FG001|COMPLETED|Overall Study||193
2862047|NCT00112125|3564601|FG000|NOT COMPLETED|Overall Study||24
2862048|NCT00112125|3564602|FG001|NOT COMPLETED|Overall Study||22
2862049|NCT00112151|3564614|FG000|STARTED|Overall Study||28
2862050|NCT00112151|3564615|FG001|STARTED|Overall Study||28
2862051|NCT00112151|3564616|FG002|STARTED|Overall Study||28
2862052|NCT00112151|3564617|FG003|STARTED|Overall Study||27
2862053|NCT00112151|3564618|FG004|STARTED|Overall Study||28
2862054|NCT00112151|3564619|FG005|STARTED|Overall Study||28
2862055|NCT00112151|3564614|FG000|COMPLETED|Overall Study||24
2862056|NCT00112151|3564615|FG001|COMPLETED|Overall Study||23
2862057|NCT00112151|3564616|FG002|COMPLETED|Overall Study||25
2862058|NCT00112151|3564617|FG003|COMPLETED|Overall Study||24
2862059|NCT00112151|3564618|FG004|COMPLETED|Overall Study||22
2862060|NCT00112151|3564619|FG005|COMPLETED|Overall Study||25
2862061|NCT00112151|3564614|FG000|NOT COMPLETED|Overall Study||4
2862062|NCT00112151|3564615|FG001|NOT COMPLETED|Overall Study||5
2862063|NCT00112151|3564616|FG002|NOT COMPLETED|Overall Study||3
2862064|NCT00112151|3564617|FG003|NOT COMPLETED|Overall Study||3
2862065|NCT00112151|3564618|FG004|NOT COMPLETED|Overall Study||6
2862066|NCT00112151|3564619|FG005|NOT COMPLETED|Overall Study||3
2862067|NCT00112242|3564635|FG000|STARTED|Overall Study||10
2862068|NCT00112242|3564636|FG001|STARTED|Overall Study||5
2862069|NCT00112242|3564637|FG002|STARTED|Overall Study||5
2862070|NCT00112242|3564638|FG003|STARTED|Overall Study||10
2862071|NCT00112242|3564639|FG004|STARTED|Overall Study|One patient received only 1 vaccine however this minimum dose allowed the safety evaluation|9
2862072|NCT00112242|3564635|FG000|Cycle 1 Completed|Overall Study||10
2862073|NCT00112242|3564636|FG001|Cycle 1 Completed|Overall Study||5
2862074|NCT00112242|3564637|FG002|Cycle 1 Completed|Overall Study||5
2862075|NCT00112242|3564638|FG003|Cycle 1 Completed|Overall Study||9
2862076|NCT00112242|3564639|FG004|Cycle 1 Completed|Overall Study||7
2862077|NCT00112242|3564635|FG000|Cycle 2 Completed|Overall Study||8
2862078|NCT00112242|3564636|FG001|Cycle 2 Completed|Overall Study||3
2862079|NCT00112242|3564637|FG002|Cycle 2 Completed|Overall Study||4
2862080|NCT00112242|3564638|FG003|Cycle 2 Completed|Overall Study||8
2862081|NCT00112242|3564639|FG004|Cycle 2 Completed|Overall Study||4
2862082|NCT00112242|3564635|FG000|Cycle 3 Completed|Overall Study||5
2862083|NCT00112242|3564636|FG001|Cycle 3 Completed|Overall Study||3
2862084|NCT00112242|3564637|FG002|Cycle 3 Completed|Overall Study||4
2862085|NCT00112242|3564638|FG003|Cycle 3 Completed|Overall Study||4
2862086|NCT00112242|3564639|FG004|Cycle 3 Completed|Overall Study||2
3168962|NCT01922050|3896383|FG009|NOT COMPLETED|Part 2 Double-blind Phase||0
3168963|NCT01922050|3896384|FG010|NOT COMPLETED|Part 2 Double-blind Phase||1
2862087|NCT00112242|3564635|FG000|COMPLETED|Overall Study||5
2862088|NCT00112242|3564636|FG001|COMPLETED|Overall Study||3
2862089|NCT00112242|3564637|FG002|COMPLETED|Overall Study||4
2862090|NCT00112242|3564638|FG003|COMPLETED|Overall Study||4
2862091|NCT00112242|3564639|FG004|COMPLETED|Overall Study||2
2862092|NCT00112242|3564635|FG000|NOT COMPLETED|Overall Study||5
2862093|NCT00112242|3564636|FG001|NOT COMPLETED|Overall Study||2
2862094|NCT00112242|3564637|FG002|NOT COMPLETED|Overall Study||1
2862095|NCT00112242|3564638|FG003|NOT COMPLETED|Overall Study||6
2862096|NCT00112242|3564639|FG004|NOT COMPLETED|Overall Study||7
2862097|NCT00112294|3564661|FG000|STARTED|Overall Study|338 randomized and 325 treated.|325
2862098|NCT00112294|3564662|FG001|STARTED|Overall Study|338 randomized and 320 treated.|320
2862099|NCT00112294|3564661|FG000|Never Treated|Overall Study|Number by randomized group = 11, but 2 participants received C/T/C instead of T/C.|13
2862100|NCT00112294|3564662|FG001|Never Treated|Overall Study|Number by randomized group = 20, but 2 participants received C/T/C instead of T/C.|18
2862101|NCT00112294|3564661|FG000|COMPLETED|Overall Study|Off all study therapies.|320
2862102|NCT00112294|3564662|FG001|COMPLETED|Overall Study|Off all study therapies.|320
2862103|NCT00112294|3564661|FG000|NOT COMPLETED|Overall Study||5
2862104|NCT00112294|3564662|FG001|NOT COMPLETED|Overall Study||0
2862105|NCT00112359|3564670|FG000|STARTED|Overall Study||84
2862106|NCT00112359|3564671|FG001|STARTED|Overall Study||80
2862107|NCT00112359|3564670|FG000|COMPLETED|Overall Study||57
2862108|NCT00112359|3564671|FG001|COMPLETED|Overall Study||67
2862109|NCT00112359|3564670|FG000|NOT COMPLETED|Overall Study||27
2862110|NCT00112359|3564671|FG001|NOT COMPLETED|Overall Study||13
2862111|NCT00112385|3564679|FG000|STARTED|Overall Study||11
2862112|NCT00112385|3564680|FG001|STARTED|Overall Study||5
2862113|NCT00112385|3564679|FG000|COMPLETED|Overall Study||10
2862114|NCT00112385|3564680|FG001|COMPLETED|Overall Study||4
2862115|NCT00112385|3564679|FG000|NOT COMPLETED|Overall Study||1
2862116|NCT00112385|3564680|FG001|NOT COMPLETED|Overall Study||1
2862117|NCT00112437|3564691|FG000|STARTED|Year 1 (12-Month Base Study)||83
2862118|NCT00112437|3564692|FG001|STARTED|Year 1 (12-Month Base Study)||82
2862119|NCT00112437|3564693|FG002|STARTED|Year 1 (12-Month Base Study)||77
2862120|NCT00112437|3564694|FG003|STARTED|Year 1 (12-Month Base Study)||79
2862121|NCT00112437|3564695|FG004|STARTED|Year 1 (12-Month Base Study)||78
2862122|NCT00112437|3564696|FG005|STARTED|Year 1 (12-Month Base Study)||0
2862123|NCT00112437|3564697|FG006|STARTED|Year 1 (12-Month Base Study)||0
2862124|NCT00112437|3564698|FG007|STARTED|Year 1 (12-Month Base Study)||0
2862125|NCT00112437|3564699|FG008|STARTED|Year 1 (12-Month Base Study)||0
2862126|NCT00112437|3564700|FG009|STARTED|Year 1 (12-Month Base Study)||0
2862127|NCT00112437|3564701|FG010|STARTED|Year 1 (12-Month Base Study)||0
2862128|NCT00112437|3564702|FG011|STARTED|Year 1 (12-Month Base Study)||0
2862129|NCT00112437|3564703|FG012|STARTED|Year 1 (12-Month Base Study)||0
2862130|NCT00112437|3564704|FG013|STARTED|Year 1 (12-Month Base Study)||0
2862131|NCT00112437|3564705|FG014|STARTED|Year 1 (12-Month Base Study)||0
2862132|NCT00112437|3564706|FG015|STARTED|Year 1 (12-Month Base Study)||0
2862133|NCT00112437|3564707|FG016|STARTED|Year 1 (12-Month Base Study)||0
2862134|NCT00112437|3564708|FG017|STARTED|Year 1 (12-Month Base Study)||0
2862135|NCT00112437|3564709|FG018|STARTED|Year 1 (12-Month Base Study)||0
2862136|NCT00112437|3564710|FG019|STARTED|Year 1 (12-Month Base Study)||0
2862137|NCT00112437|3564711|FG020|STARTED|Year 1 (12-Month Base Study)||0
2862138|NCT00112437|3564712|FG021|STARTED|Year 1 (12-Month Base Study)||0
2862139|NCT00112437|3564713|FG022|STARTED|Year 1 (12-Month Base Study)||0
2862140|NCT00112437|3564714|FG023|STARTED|Year 1 (12-Month Base Study)||0
2862141|NCT00112437|3564715|FG024|STARTED|Year 1 (12-Month Base Study)||0
2862142|NCT00112437|3564716|FG025|STARTED|Year 1 (12-Month Base Study)||0
2862143|NCT00112437|3564691|FG000|COMPLETED|Year 1 (12-Month Base Study)|1 patient completed base study after December 19, 2006 and is not included in completed total.|68
2862144|NCT00112437|3564692|FG001|COMPLETED|Year 1 (12-Month Base Study)|1 patient completed base study after December 19, 2006 and is not included in completed total.|64
2862145|NCT00112437|3564693|FG002|COMPLETED|Year 1 (12-Month Base Study)||65
2862146|NCT00112437|3564694|FG003|COMPLETED|Year 1 (12-Month Base Study)||71
2862147|NCT00112437|3564695|FG004|COMPLETED|Year 1 (12-Month Base Study)|1 patient completed base study after December 19, 2006 and is not included in the completed total.|66
2862148|NCT00112437|3564696|FG005|COMPLETED|Year 1 (12-Month Base Study)||0
2862149|NCT00112437|3564697|FG006|COMPLETED|Year 1 (12-Month Base Study)||0
2862150|NCT00112437|3564698|FG007|COMPLETED|Year 1 (12-Month Base Study)||0
2862151|NCT00112437|3564699|FG008|COMPLETED|Year 1 (12-Month Base Study)||0
2862152|NCT00112437|3564700|FG009|COMPLETED|Year 1 (12-Month Base Study)||0
2862153|NCT00112437|3564701|FG010|COMPLETED|Year 1 (12-Month Base Study)||0
2862154|NCT00112437|3564702|FG011|COMPLETED|Year 1 (12-Month Base Study)||0
2862155|NCT00112437|3564703|FG012|COMPLETED|Year 1 (12-Month Base Study)||0
2862156|NCT00112437|3564704|FG013|COMPLETED|Year 1 (12-Month Base Study)||0
2862157|NCT00112437|3564705|FG014|COMPLETED|Year 1 (12-Month Base Study)||0
2862158|NCT00112437|3564706|FG015|COMPLETED|Year 1 (12-Month Base Study)||0
2862159|NCT00112437|3564707|FG016|COMPLETED|Year 1 (12-Month Base Study)||0
2862160|NCT00112437|3564708|FG017|COMPLETED|Year 1 (12-Month Base Study)||0
2862161|NCT00112437|3564709|FG018|COMPLETED|Year 1 (12-Month Base Study)||0
2862162|NCT00112437|3564710|FG019|COMPLETED|Year 1 (12-Month Base Study)||0
2862163|NCT00112437|3564711|FG020|COMPLETED|Year 1 (12-Month Base Study)||0
2862164|NCT00112437|3564712|FG021|COMPLETED|Year 1 (12-Month Base Study)||0
2862165|NCT00112437|3564713|FG022|COMPLETED|Year 1 (12-Month Base Study)||0
2862166|NCT00112437|3564714|FG023|COMPLETED|Year 1 (12-Month Base Study)||0
2862167|NCT00112437|3564715|FG024|COMPLETED|Year 1 (12-Month Base Study)||0
2862168|NCT00112437|3564716|FG025|COMPLETED|Year 1 (12-Month Base Study)||0
2862169|NCT00112437|3564691|FG000|NOT COMPLETED|Year 1 (12-Month Base Study)||15
2862170|NCT00112437|3564692|FG001|NOT COMPLETED|Year 1 (12-Month Base Study)||18
2862171|NCT00112437|3564693|FG002|NOT COMPLETED|Year 1 (12-Month Base Study)||12
2862172|NCT00112437|3564694|FG003|NOT COMPLETED|Year 1 (12-Month Base Study)||8
2862173|NCT00112437|3564695|FG004|NOT COMPLETED|Year 1 (12-Month Base Study)||12
2862174|NCT00112437|3564696|FG005|NOT COMPLETED|Year 1 (12-Month Base Study)||0
2862175|NCT00112437|3564697|FG006|NOT COMPLETED|Year 1 (12-Month Base Study)||0
2862176|NCT00112437|3564698|FG007|NOT COMPLETED|Year 1 (12-Month Base Study)||0
2862177|NCT00112437|3564699|FG008|NOT COMPLETED|Year 1 (12-Month Base Study)||0
2862178|NCT00112437|3564700|FG009|NOT COMPLETED|Year 1 (12-Month Base Study)||0
2862179|NCT00112437|3564701|FG010|NOT COMPLETED|Year 1 (12-Month Base Study)||0
2862180|NCT00112437|3564702|FG011|NOT COMPLETED|Year 1 (12-Month Base Study)||0
2862181|NCT00112437|3564703|FG012|NOT COMPLETED|Year 1 (12-Month Base Study)||0
2862182|NCT00112437|3564704|FG013|NOT COMPLETED|Year 1 (12-Month Base Study)||0
2862183|NCT00112437|3564705|FG014|NOT COMPLETED|Year 1 (12-Month Base Study)||0
2918495|NCT00527592|3628734|FG000|COMPLETED|Overall Study||54
2862184|NCT00112437|3564706|FG015|NOT COMPLETED|Year 1 (12-Month Base Study)||0
2862185|NCT00112437|3564707|FG016|NOT COMPLETED|Year 1 (12-Month Base Study)||0
2862186|NCT00112437|3564708|FG017|NOT COMPLETED|Year 1 (12-Month Base Study)||0
2862187|NCT00112437|3564709|FG018|NOT COMPLETED|Year 1 (12-Month Base Study)||0
2862188|NCT00112437|3564710|FG019|NOT COMPLETED|Year 1 (12-Month Base Study)||0
3168964|NCT01922050|3896385|FG011|NOT COMPLETED|Part 2 Double-blind Phase||2
3168965|NCT01922050|3896386|FG012|NOT COMPLETED|Part 2 Double-blind Phase||0
3168966|NCT01922050|3896387|FG013|NOT COMPLETED|Part 2 Double-blind Phase||3
3168967|NCT01922089|3896419|FG000|STARTED|Overall Study||247
3168968|NCT01922089|3896420|FG001|STARTED|Overall Study||251
3168969|NCT01922089|3896419|FG000|Safety Set|Overall Study||246
3168970|NCT01922089|3896420|FG001|Safety Set|Overall Study||251
3168971|NCT01922089|3896419|FG000|COMPLETED|Overall Study||208
3168972|NCT01922089|3896420|FG001|COMPLETED|Overall Study||221
2862189|NCT00112437|3564711|FG020|NOT COMPLETED|Year 1 (12-Month Base Study)||0
2862190|NCT00112437|3564712|FG021|NOT COMPLETED|Year 1 (12-Month Base Study)||0
2862191|NCT00112437|3564713|FG022|NOT COMPLETED|Year 1 (12-Month Base Study)||0
2862192|NCT00112437|3564714|FG023|NOT COMPLETED|Year 1 (12-Month Base Study)||0
2862193|NCT00112437|3564715|FG024|NOT COMPLETED|Year 1 (12-Month Base Study)||0
2862194|NCT00112437|3564716|FG025|NOT COMPLETED|Year 1 (12-Month Base Study)||0
2862195|NCT00112437|3564691|FG000|STARTED|Year 2 (12-Month Extension)||0
2862196|NCT00112437|3564692|FG001|STARTED|Year 2 (12-Month Extension)||0
2862197|NCT00112437|3564693|FG002|STARTED|Year 2 (12-Month Extension)||0
2862198|NCT00112437|3564694|FG003|STARTED|Year 2 (12-Month Extension)||0
2862199|NCT00112437|3564695|FG004|STARTED|Year 2 (12-Month Extension)||0
2862200|NCT00112437|3564696|FG005|STARTED|Year 2 (12-Month Extension)||63
2862201|NCT00112437|3564697|FG006|STARTED|Year 2 (12-Month Extension)||62
2862202|NCT00112437|3564698|FG007|STARTED|Year 2 (12-Month Extension)||63
2862203|NCT00112437|3564699|FG008|STARTED|Year 2 (12-Month Extension)||69
3168973|NCT01922089|3896419|FG000|NOT COMPLETED|Overall Study||39
3168974|NCT01922089|3896420|FG001|NOT COMPLETED|Overall Study||30
3168975|NCT01922102|3896429|FG000|STARTED|Overall Study||182
3168976|NCT01922102|3896430|FG001|STARTED|Overall Study||184
2862204|NCT00112437|3564700|FG009|STARTED|Year 2 (12-Month Extension)||63
2862205|NCT00112437|3564701|FG010|STARTED|Year 2 (12-Month Extension)||0
2862206|NCT00112437|3564702|FG011|STARTED|Year 2 (12-Month Extension)||0
2862207|NCT00112437|3564703|FG012|STARTED|Year 2 (12-Month Extension)||0
2862208|NCT00112437|3564704|FG013|STARTED|Year 2 (12-Month Extension)||0
2862209|NCT00112437|3564705|FG014|STARTED|Year 2 (12-Month Extension)||0
2862210|NCT00112437|3564706|FG015|STARTED|Year 2 (12-Month Extension)||0
2862211|NCT00112437|3564707|FG016|STARTED|Year 2 (12-Month Extension)||0
2862212|NCT00112437|3564708|FG017|STARTED|Year 2 (12-Month Extension)||0
2862213|NCT00112437|3564709|FG018|STARTED|Year 2 (12-Month Extension)||0
2862214|NCT00112437|3564710|FG019|STARTED|Year 2 (12-Month Extension)||0
2862215|NCT00112437|3564711|FG020|STARTED|Year 2 (12-Month Extension)||0
2862216|NCT00112437|3564712|FG021|STARTED|Year 2 (12-Month Extension)||0
2862217|NCT00112437|3564713|FG022|STARTED|Year 2 (12-Month Extension)||0
2862218|NCT00112437|3564714|FG023|STARTED|Year 2 (12-Month Extension)||0
2862219|NCT00112437|3564715|FG024|STARTED|Year 2 (12-Month Extension)||0
2862220|NCT00112437|3564716|FG025|STARTED|Year 2 (12-Month Extension)||0
2862221|NCT00112437|3564691|FG000|COMPLETED|Year 2 (12-Month Extension)||0
2862222|NCT00112437|3564692|FG001|COMPLETED|Year 2 (12-Month Extension)||0
2862223|NCT00112437|3564693|FG002|COMPLETED|Year 2 (12-Month Extension)||0
2862224|NCT00112437|3564694|FG003|COMPLETED|Year 2 (12-Month Extension)||0
2862225|NCT00112437|3564695|FG004|COMPLETED|Year 2 (12-Month Extension)||0
2862226|NCT00112437|3564696|FG005|COMPLETED|Year 2 (12-Month Extension)||60
2862227|NCT00112437|3564697|FG006|COMPLETED|Year 2 (12-Month Extension)||53
2862228|NCT00112437|3564698|FG007|COMPLETED|Year 2 (12-Month Extension)||55
2862229|NCT00112437|3564699|FG008|COMPLETED|Year 2 (12-Month Extension)||62
2862230|NCT00112437|3564700|FG009|COMPLETED|Year 2 (12-Month Extension)||50
2862231|NCT00112437|3564701|FG010|COMPLETED|Year 2 (12-Month Extension)||0
2862232|NCT00112437|3564702|FG011|COMPLETED|Year 2 (12-Month Extension)||0
2862233|NCT00112437|3564703|FG012|COMPLETED|Year 2 (12-Month Extension)||0
2862234|NCT00112437|3564704|FG013|COMPLETED|Year 2 (12-Month Extension)||0
2862235|NCT00112437|3564705|FG014|COMPLETED|Year 2 (12-Month Extension)||0
2862236|NCT00112437|3564706|FG015|COMPLETED|Year 2 (12-Month Extension)||0
2862237|NCT00112437|3564707|FG016|COMPLETED|Year 2 (12-Month Extension)||0
2862238|NCT00112437|3564708|FG017|COMPLETED|Year 2 (12-Month Extension)||0
2862239|NCT00112437|3564709|FG018|COMPLETED|Year 2 (12-Month Extension)||0
2862240|NCT00112437|3564710|FG019|COMPLETED|Year 2 (12-Month Extension)||0
2862241|NCT00112437|3564711|FG020|COMPLETED|Year 2 (12-Month Extension)||0
2862242|NCT00112437|3564712|FG021|COMPLETED|Year 2 (12-Month Extension)||0
2862243|NCT00112437|3564713|FG022|COMPLETED|Year 2 (12-Month Extension)||0
2862244|NCT00112437|3564714|FG023|COMPLETED|Year 2 (12-Month Extension)||0
2862245|NCT00112437|3564715|FG024|COMPLETED|Year 2 (12-Month Extension)||0
2862246|NCT00112437|3564716|FG025|COMPLETED|Year 2 (12-Month Extension)||0
2862247|NCT00112437|3564691|FG000|NOT COMPLETED|Year 2 (12-Month Extension)||0
2862248|NCT00112437|3564692|FG001|NOT COMPLETED|Year 2 (12-Month Extension)||0
3168977|NCT01922102|3896431|FG002|STARTED|Overall Study||91
3168978|NCT01922102|3896429|FG000|COMPLETED|Overall Study||173
3168979|NCT01922102|3896430|FG001|COMPLETED|Overall Study||175
3168980|NCT01922102|3896431|FG002|COMPLETED|Overall Study||83
2862249|NCT00112437|3564693|FG002|NOT COMPLETED|Year 2 (12-Month Extension)||0
2862250|NCT00112437|3564694|FG003|NOT COMPLETED|Year 2 (12-Month Extension)||0
2862251|NCT00112437|3564695|FG004|NOT COMPLETED|Year 2 (12-Month Extension)||0
2862252|NCT00112437|3564696|FG005|NOT COMPLETED|Year 2 (12-Month Extension)||3
2862253|NCT00112437|3564697|FG006|NOT COMPLETED|Year 2 (12-Month Extension)||9
2862254|NCT00112437|3564698|FG007|NOT COMPLETED|Year 2 (12-Month Extension)||8
2862255|NCT00112437|3564699|FG008|NOT COMPLETED|Year 2 (12-Month Extension)||7
2862256|NCT00112437|3564700|FG009|NOT COMPLETED|Year 2 (12-Month Extension)||13
2862257|NCT00112437|3564701|FG010|NOT COMPLETED|Year 2 (12-Month Extension)||0
2862258|NCT00112437|3564702|FG011|NOT COMPLETED|Year 2 (12-Month Extension)||0
2862259|NCT00112437|3564703|FG012|NOT COMPLETED|Year 2 (12-Month Extension)||0
2862260|NCT00112437|3564704|FG013|NOT COMPLETED|Year 2 (12-Month Extension)||0
2862261|NCT00112437|3564705|FG014|NOT COMPLETED|Year 2 (12-Month Extension)||0
2862262|NCT00112437|3564706|FG015|NOT COMPLETED|Year 2 (12-Month Extension)||0
2862263|NCT00112437|3564707|FG016|NOT COMPLETED|Year 2 (12-Month Extension)||0
2862264|NCT00112437|3564708|FG017|NOT COMPLETED|Year 2 (12-Month Extension)||0
2862265|NCT00112437|3564709|FG018|NOT COMPLETED|Year 2 (12-Month Extension)||0
2862266|NCT00112437|3564710|FG019|NOT COMPLETED|Year 2 (12-Month Extension)||0
2862267|NCT00112437|3564711|FG020|NOT COMPLETED|Year 2 (12-Month Extension)||0
2862268|NCT00112437|3564712|FG021|NOT COMPLETED|Year 2 (12-Month Extension)||0
2862269|NCT00112437|3564713|FG022|NOT COMPLETED|Year 2 (12-Month Extension)||0
2862270|NCT00112437|3564714|FG023|NOT COMPLETED|Year 2 (12-Month Extension)||0
2862271|NCT00112437|3564715|FG024|NOT COMPLETED|Year 2 (12-Month Extension)||0
2862272|NCT00112437|3564716|FG025|NOT COMPLETED|Year 2 (12-Month Extension)||0
2862273|NCT00112437|3564691|FG000|STARTED|Year 3 (12-Month Extension)||0
2862274|NCT00112437|3564692|FG001|STARTED|Year 3 (12-Month Extension)||0
2862275|NCT00112437|3564693|FG002|STARTED|Year 3 (12-Month Extension)||0
2862276|NCT00112437|3564694|FG003|STARTED|Year 3 (12-Month Extension)||0
2862277|NCT00112437|3564695|FG004|STARTED|Year 3 (12-Month Extension)||0
2862278|NCT00112437|3564696|FG005|STARTED|Year 3 (12-Month Extension)||0
2862279|NCT00112437|3564697|FG006|STARTED|Year 3 (12-Month Extension)||0
2862280|NCT00112437|3564698|FG007|STARTED|Year 3 (12-Month Extension)||0
2862281|NCT00112437|3564699|FG008|STARTED|Year 3 (12-Month Extension)||0
2862282|NCT00112437|3564700|FG009|STARTED|Year 3 (12-Month Extension)||0
2862283|NCT00112437|3564701|FG010|STARTED|Year 3 (12-Month Extension)||19
2862284|NCT00112437|3564702|FG011|STARTED|Year 3 (12-Month Extension)||22
2862285|NCT00112437|3564703|FG012|STARTED|Year 3 (12-Month Extension)||18
2862286|NCT00112437|3564704|FG013|STARTED|Year 3 (12-Month Extension)||17
2862287|NCT00112437|3564705|FG014|STARTED|Year 3 (12-Month Extension)||18
2862288|NCT00112437|3564706|FG015|STARTED|Year 3 (12-Month Extension)||17
2862289|NCT00112437|3564707|FG016|STARTED|Year 3 (12-Month Extension)||19
2862290|NCT00112437|3564708|FG017|STARTED|Year 3 (12-Month Extension)||21
2862291|NCT00112437|3564709|FG018|STARTED|Year 3 (12-Month Extension)||18
2862292|NCT00112437|3564710|FG019|STARTED|Year 3 (12-Month Extension)||20
2862293|NCT00112437|3564711|FG020|STARTED|Year 3 (12-Month Extension)||0
2862294|NCT00112437|3564712|FG021|STARTED|Year 3 (12-Month Extension)||0
2862295|NCT00112437|3564713|FG022|STARTED|Year 3 (12-Month Extension)||0
2862296|NCT00112437|3564714|FG023|STARTED|Year 3 (12-Month Extension)||0
2862297|NCT00112437|3564715|FG024|STARTED|Year 3 (12-Month Extension)||0
2862298|NCT00112437|3564716|FG025|STARTED|Year 3 (12-Month Extension)||0
2862299|NCT00112437|3564691|FG000|COMPLETED|Year 3 (12-Month Extension)||0
2862300|NCT00112437|3564692|FG001|COMPLETED|Year 3 (12-Month Extension)||0
2862301|NCT00112437|3564693|FG002|COMPLETED|Year 3 (12-Month Extension)||0
2862302|NCT00112437|3564694|FG003|COMPLETED|Year 3 (12-Month Extension)||0
2862303|NCT00112437|3564695|FG004|COMPLETED|Year 3 (12-Month Extension)||0
2862304|NCT00112437|3564696|FG005|COMPLETED|Year 3 (12-Month Extension)||0
2862305|NCT00112437|3564697|FG006|COMPLETED|Year 3 (12-Month Extension)||0
2862306|NCT00112437|3564698|FG007|COMPLETED|Year 3 (12-Month Extension)||0
2862307|NCT00112437|3564699|FG008|COMPLETED|Year 3 (12-Month Extension)||0
2862308|NCT00112437|3564700|FG009|COMPLETED|Year 3 (12-Month Extension)||0
2862309|NCT00112437|3564701|FG010|COMPLETED|Year 3 (12-Month Extension)||17
2862310|NCT00112437|3564702|FG011|COMPLETED|Year 3 (12-Month Extension)||17
2862311|NCT00112437|3564703|FG012|COMPLETED|Year 3 (12-Month Extension)||18
2862312|NCT00112437|3564704|FG013|COMPLETED|Year 3 (12-Month Extension)||16
2862313|NCT00112437|3564705|FG014|COMPLETED|Year 3 (12-Month Extension)||17
2862314|NCT00112437|3564706|FG015|COMPLETED|Year 3 (12-Month Extension)||13
2862315|NCT00112437|3564707|FG016|COMPLETED|Year 3 (12-Month Extension)||16
3168981|NCT01922102|3896429|FG000|NOT COMPLETED|Overall Study||9
3168982|NCT01922102|3896430|FG001|NOT COMPLETED|Overall Study||9
3168983|NCT01922102|3896431|FG002|NOT COMPLETED|Overall Study||8
2862316|NCT00112437|3564708|FG017|COMPLETED|Year 3 (12-Month Extension)||20
2862317|NCT00112437|3564709|FG018|COMPLETED|Year 3 (12-Month Extension)||16
2862318|NCT00112437|3564710|FG019|COMPLETED|Year 3 (12-Month Extension)||19
2862319|NCT00112437|3564711|FG020|COMPLETED|Year 3 (12-Month Extension)||0
2862320|NCT00112437|3564712|FG021|COMPLETED|Year 3 (12-Month Extension)||0
2862321|NCT00112437|3564713|FG022|COMPLETED|Year 3 (12-Month Extension)||0
2862322|NCT00112437|3564714|FG023|COMPLETED|Year 3 (12-Month Extension)||0
2862323|NCT00112437|3564715|FG024|COMPLETED|Year 3 (12-Month Extension)||0
2862324|NCT00112437|3564716|FG025|COMPLETED|Year 3 (12-Month Extension)||0
2862325|NCT00112437|3564691|FG000|NOT COMPLETED|Year 3 (12-Month Extension)||0
2862326|NCT00112437|3564692|FG001|NOT COMPLETED|Year 3 (12-Month Extension)||0
2862327|NCT00112437|3564693|FG002|NOT COMPLETED|Year 3 (12-Month Extension)||0
2862328|NCT00112437|3564694|FG003|NOT COMPLETED|Year 3 (12-Month Extension)||0
2862329|NCT00112437|3564695|FG004|NOT COMPLETED|Year 3 (12-Month Extension)||0
2862330|NCT00112437|3564696|FG005|NOT COMPLETED|Year 3 (12-Month Extension)||0
2862331|NCT00112437|3564697|FG006|NOT COMPLETED|Year 3 (12-Month Extension)||0
2862332|NCT00112437|3564698|FG007|NOT COMPLETED|Year 3 (12-Month Extension)||0
2862333|NCT00112437|3564699|FG008|NOT COMPLETED|Year 3 (12-Month Extension)||0
2862334|NCT00112437|3564700|FG009|NOT COMPLETED|Year 3 (12-Month Extension)||0
2862335|NCT00112437|3564701|FG010|NOT COMPLETED|Year 3 (12-Month Extension)||2
2862336|NCT00112437|3564702|FG011|NOT COMPLETED|Year 3 (12-Month Extension)||5
2862337|NCT00112437|3564703|FG012|NOT COMPLETED|Year 3 (12-Month Extension)||0
2862338|NCT00112437|3564704|FG013|NOT COMPLETED|Year 3 (12-Month Extension)||1
2862339|NCT00112437|3564705|FG014|NOT COMPLETED|Year 3 (12-Month Extension)||1
2862340|NCT00112437|3564706|FG015|NOT COMPLETED|Year 3 (12-Month Extension)||4
2862341|NCT00112437|3564707|FG016|NOT COMPLETED|Year 3 (12-Month Extension)||3
2862342|NCT00112437|3564708|FG017|NOT COMPLETED|Year 3 (12-Month Extension)||1
2862343|NCT00112437|3564709|FG018|NOT COMPLETED|Year 3 (12-Month Extension)||2
2862344|NCT00112437|3564710|FG019|NOT COMPLETED|Year 3 (12-Month Extension)||1
2862345|NCT00112437|3564711|FG020|NOT COMPLETED|Year 3 (12-Month Extension)||0
2862346|NCT00112437|3564712|FG021|NOT COMPLETED|Year 3 (12-Month Extension)||0
2862347|NCT00112437|3564713|FG022|NOT COMPLETED|Year 3 (12-Month Extension)||0
2862348|NCT00112437|3564714|FG023|NOT COMPLETED|Year 3 (12-Month Extension)||0
2862349|NCT00112437|3564715|FG024|NOT COMPLETED|Year 3 (12-Month Extension)||0
2862350|NCT00112437|3564716|FG025|NOT COMPLETED|Year 3 (12-Month Extension)||0
2862351|NCT00112437|3564691|FG000|STARTED|Years 4-5 (24-Month Extension)||0
2862352|NCT00112437|3564692|FG001|STARTED|Years 4-5 (24-Month Extension)||0
2862353|NCT00112437|3564693|FG002|STARTED|Years 4-5 (24-Month Extension)||0
2862354|NCT00112437|3564694|FG003|STARTED|Years 4-5 (24-Month Extension)||0
2862355|NCT00112437|3564695|FG004|STARTED|Years 4-5 (24-Month Extension)||0
2862356|NCT00112437|3564696|FG005|STARTED|Years 4-5 (24-Month Extension)||0
2862357|NCT00112437|3564697|FG006|STARTED|Years 4-5 (24-Month Extension)||0
2862358|NCT00112437|3564698|FG007|STARTED|Years 4-5 (24-Month Extension)||0
2862359|NCT00112437|3564699|FG008|STARTED|Years 4-5 (24-Month Extension)||0
2862360|NCT00112437|3564700|FG009|STARTED|Years 4-5 (24-Month Extension)||0
2862361|NCT00112437|3564701|FG010|STARTED|Years 4-5 (24-Month Extension)||0
2862362|NCT00112437|3564702|FG011|STARTED|Years 4-5 (24-Month Extension)||0
2862363|NCT00112437|3564703|FG012|STARTED|Years 4-5 (24-Month Extension)||0
2862364|NCT00112437|3564704|FG013|STARTED|Years 4-5 (24-Month Extension)||0
2862365|NCT00112437|3564705|FG014|STARTED|Years 4-5 (24-Month Extension)||0
2862366|NCT00112437|3564706|FG015|STARTED|Years 4-5 (24-Month Extension)||0
2862367|NCT00112437|3564707|FG016|STARTED|Years 4-5 (24-Month Extension)||0
2862368|NCT00112437|3564708|FG017|STARTED|Years 4-5 (24-Month Extension)||0
2862369|NCT00112437|3564709|FG018|STARTED|Years 4-5 (24-Month Extension)||0
2862370|NCT00112437|3564710|FG019|STARTED|Years 4-5 (24-Month Extension)||0
2862371|NCT00112437|3564711|FG020|STARTED|Years 4-5 (24-Month Extension)||41
2862372|NCT00112437|3564712|FG021|STARTED|Years 4-5 (24-Month Extension)||100
2862373|NCT00112437|3564713|FG022|STARTED|Years 4-5 (24-Month Extension)||0
2862374|NCT00112437|3564714|FG023|STARTED|Years 4-5 (24-Month Extension)||0
2862375|NCT00112437|3564715|FG024|STARTED|Years 4-5 (24-Month Extension)||0
2862376|NCT00112437|3564716|FG025|STARTED|Years 4-5 (24-Month Extension)||0
2862377|NCT00112437|3564691|FG000|COMPLETED|Years 4-5 (24-Month Extension)||0
2862378|NCT00112437|3564692|FG001|COMPLETED|Years 4-5 (24-Month Extension)||0
2862379|NCT00112437|3564693|FG002|COMPLETED|Years 4-5 (24-Month Extension)||0
2862380|NCT00112437|3564694|FG003|COMPLETED|Years 4-5 (24-Month Extension)||0
2862381|NCT00112437|3564695|FG004|COMPLETED|Years 4-5 (24-Month Extension)||0
2862382|NCT00112437|3564696|FG005|COMPLETED|Years 4-5 (24-Month Extension)||0
2862383|NCT00112437|3564697|FG006|COMPLETED|Years 4-5 (24-Month Extension)||0
2862384|NCT00112437|3564698|FG007|COMPLETED|Years 4-5 (24-Month Extension)||0
2862385|NCT00112437|3564699|FG008|COMPLETED|Years 4-5 (24-Month Extension)||0
2862386|NCT00112437|3564700|FG009|COMPLETED|Years 4-5 (24-Month Extension)||0
2862387|NCT00112437|3564701|FG010|COMPLETED|Years 4-5 (24-Month Extension)||0
2862388|NCT00112437|3564702|FG011|COMPLETED|Years 4-5 (24-Month Extension)||0
2862389|NCT00112437|3564703|FG012|COMPLETED|Years 4-5 (24-Month Extension)||0
2862390|NCT00112437|3564704|FG013|COMPLETED|Years 4-5 (24-Month Extension)||0
2862391|NCT00112437|3564705|FG014|COMPLETED|Years 4-5 (24-Month Extension)||0
2862392|NCT00112437|3564706|FG015|COMPLETED|Years 4-5 (24-Month Extension)||0
2862393|NCT00112437|3564707|FG016|COMPLETED|Years 4-5 (24-Month Extension)||0
2862394|NCT00112437|3564708|FG017|COMPLETED|Years 4-5 (24-Month Extension)||0
2862395|NCT00112437|3564709|FG018|COMPLETED|Years 4-5 (24-Month Extension)||0
2862396|NCT00112437|3564710|FG019|COMPLETED|Years 4-5 (24-Month Extension)||0
2862397|NCT00112437|3564711|FG020|COMPLETED|Years 4-5 (24-Month Extension)||37
2862398|NCT00112437|3564712|FG021|COMPLETED|Years 4-5 (24-Month Extension)||92
2862399|NCT00112437|3564713|FG022|COMPLETED|Years 4-5 (24-Month Extension)||0
2862400|NCT00112437|3564714|FG023|COMPLETED|Years 4-5 (24-Month Extension)||0
2862401|NCT00112437|3564715|FG024|COMPLETED|Years 4-5 (24-Month Extension)||0
2862402|NCT00112437|3564716|FG025|COMPLETED|Years 4-5 (24-Month Extension)||0
2862403|NCT00112437|3564691|FG000|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
2862404|NCT00112437|3564692|FG001|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
2862405|NCT00112437|3564693|FG002|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
2862406|NCT00112437|3564694|FG003|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
2862407|NCT00112437|3564695|FG004|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
2862408|NCT00112437|3564696|FG005|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
2862409|NCT00112437|3564697|FG006|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
2862410|NCT00112437|3564698|FG007|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
2862411|NCT00112437|3564699|FG008|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
2862412|NCT00112437|3564700|FG009|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
2862413|NCT00112437|3564701|FG010|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
2862414|NCT00112437|3564702|FG011|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
2862415|NCT00112437|3564703|FG012|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
2862416|NCT00112437|3564704|FG013|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
2862417|NCT00112437|3564705|FG014|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
2862418|NCT00112437|3564706|FG015|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
2862419|NCT00112437|3564707|FG016|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
2862420|NCT00112437|3564708|FG017|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
2862421|NCT00112437|3564709|FG018|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
2862422|NCT00112437|3564710|FG019|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
2862423|NCT00112437|3564711|FG020|NOT COMPLETED|Years 4-5 (24-Month Extension)||4
2862424|NCT00112437|3564712|FG021|NOT COMPLETED|Years 4-5 (24-Month Extension)||8
2862425|NCT00112437|3564713|FG022|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
2862426|NCT00112437|3564714|FG023|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
2862427|NCT00112437|3564715|FG024|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
2862428|NCT00112437|3564716|FG025|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
2862429|NCT00112437|3564691|FG000|STARTED|Years 6-10 (60-Month Extension)||0
2862430|NCT00112437|3564692|FG001|STARTED|Years 6-10 (60-Month Extension)||0
2862431|NCT00112437|3564693|FG002|STARTED|Years 6-10 (60-Month Extension)||0
2862432|NCT00112437|3564694|FG003|STARTED|Years 6-10 (60-Month Extension)||0
2862433|NCT00112437|3564695|FG004|STARTED|Years 6-10 (60-Month Extension)||0
2862434|NCT00112437|3564696|FG005|STARTED|Years 6-10 (60-Month Extension)||0
2862435|NCT00112437|3564697|FG006|STARTED|Years 6-10 (60-Month Extension)||0
2862436|NCT00112437|3564698|FG007|STARTED|Years 6-10 (60-Month Extension)||0
2862437|NCT00112437|3564699|FG008|STARTED|Years 6-10 (60-Month Extension)||0
2862438|NCT00112437|3564700|FG009|STARTED|Years 6-10 (60-Month Extension)||0
2862439|NCT00112437|3564701|FG010|STARTED|Years 6-10 (60-Month Extension)||0
2862440|NCT00112437|3564702|FG011|STARTED|Years 6-10 (60-Month Extension)||0
2862441|NCT00112437|3564703|FG012|STARTED|Years 6-10 (60-Month Extension)||0
2862442|NCT00112437|3564704|FG013|STARTED|Years 6-10 (60-Month Extension)||0
2862443|NCT00112437|3564705|FG014|STARTED|Years 6-10 (60-Month Extension)||0
2862444|NCT00112437|3564706|FG015|STARTED|Years 6-10 (60-Month Extension)||0
2862445|NCT00112437|3564707|FG016|STARTED|Years 6-10 (60-Month Extension)||0
2862446|NCT00112437|3564708|FG017|STARTED|Years 6-10 (60-Month Extension)||0
2862447|NCT00112437|3564709|FG018|STARTED|Years 6-10 (60-Month Extension)||0
2862448|NCT00112437|3564710|FG019|STARTED|Years 6-10 (60-Month Extension)||0
2862449|NCT00112437|3564711|FG020|STARTED|Years 6-10 (60-Month Extension)||0
2862450|NCT00112437|3564712|FG021|STARTED|Years 6-10 (60-Month Extension)||0
2862451|NCT00112437|3564713|FG022|STARTED|Years 6-10 (60-Month Extension)||28
2862452|NCT00112437|3564714|FG023|STARTED|Years 6-10 (60-Month Extension)||34
2862453|NCT00112437|3564715|FG024|STARTED|Years 6-10 (60-Month Extension)||23
2862454|NCT00112437|3564716|FG025|STARTED|Years 6-10 (60-Month Extension)||32
2862455|NCT00112437|3564691|FG000|COMPLETED|Years 6-10 (60-Month Extension)||0
2862456|NCT00112437|3564692|FG001|COMPLETED|Years 6-10 (60-Month Extension)||0
2862457|NCT00112437|3564693|FG002|COMPLETED|Years 6-10 (60-Month Extension)||0
2862458|NCT00112437|3564694|FG003|COMPLETED|Years 6-10 (60-Month Extension)||0
2862459|NCT00112437|3564695|FG004|COMPLETED|Years 6-10 (60-Month Extension)||0
2862460|NCT00112437|3564696|FG005|COMPLETED|Years 6-10 (60-Month Extension)||0
2862461|NCT00112437|3564697|FG006|COMPLETED|Years 6-10 (60-Month Extension)||0
2862462|NCT00112437|3564698|FG007|COMPLETED|Years 6-10 (60-Month Extension)||0
2862463|NCT00112437|3564699|FG008|COMPLETED|Years 6-10 (60-Month Extension)||0
2862464|NCT00112437|3564700|FG009|COMPLETED|Years 6-10 (60-Month Extension)||0
2862465|NCT00112437|3564701|FG010|COMPLETED|Years 6-10 (60-Month Extension)||0
2862466|NCT00112437|3564702|FG011|COMPLETED|Years 6-10 (60-Month Extension)||0
2862467|NCT00112437|3564703|FG012|COMPLETED|Years 6-10 (60-Month Extension)||0
2862468|NCT00112437|3564704|FG013|COMPLETED|Years 6-10 (60-Month Extension)||0
2862469|NCT00112437|3564705|FG014|COMPLETED|Years 6-10 (60-Month Extension)||0
2862470|NCT00112437|3564706|FG015|COMPLETED|Years 6-10 (60-Month Extension)||0
2862471|NCT00112437|3564707|FG016|COMPLETED|Years 6-10 (60-Month Extension)||0
2862472|NCT00112437|3564708|FG017|COMPLETED|Years 6-10 (60-Month Extension)||0
2862473|NCT00112437|3564709|FG018|COMPLETED|Years 6-10 (60-Month Extension)||0
2862474|NCT00112437|3564710|FG019|COMPLETED|Years 6-10 (60-Month Extension)||0
2862475|NCT00112437|3564711|FG020|COMPLETED|Years 6-10 (60-Month Extension)||0
2862476|NCT00112437|3564712|FG021|COMPLETED|Years 6-10 (60-Month Extension)||0
2862477|NCT00112437|3564713|FG022|COMPLETED|Years 6-10 (60-Month Extension)||23
2862478|NCT00112437|3564714|FG023|COMPLETED|Years 6-10 (60-Month Extension)||22
2862479|NCT00112437|3564715|FG024|COMPLETED|Years 6-10 (60-Month Extension)||22
2862480|NCT00112437|3564716|FG025|COMPLETED|Years 6-10 (60-Month Extension)||27
2862481|NCT00112437|3564691|FG000|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
2862482|NCT00112437|3564692|FG001|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
2862483|NCT00112437|3564693|FG002|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
2862484|NCT00112437|3564694|FG003|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
2918496|NCT00527592|3628734|FG000|NOT COMPLETED|Overall Study||0
2862485|NCT00112437|3564695|FG004|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
2862486|NCT00112437|3564696|FG005|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
2862487|NCT00112437|3564697|FG006|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
2862488|NCT00112437|3564698|FG007|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
2862489|NCT00112437|3564699|FG008|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
2862490|NCT00112437|3564700|FG009|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
2862491|NCT00112437|3564701|FG010|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
2862492|NCT00112437|3564702|FG011|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
2862493|NCT00112437|3564703|FG012|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
2862494|NCT00112437|3564704|FG013|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
2862495|NCT00112437|3564705|FG014|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
2862496|NCT00112437|3564706|FG015|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
2862497|NCT00112437|3564707|FG016|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
3168984|NCT01922115|3896445|FG000|STARTED|Overall Study||28
3168985|NCT01922115|3896446|FG001|STARTED|Overall Study||31
3168986|NCT01922115|3896445|FG000|COMPLETED|Overall Study||21
3168987|NCT01922115|3896446|FG001|COMPLETED|Overall Study||24
3168988|NCT01922115|3896445|FG000|NOT COMPLETED|Overall Study||7
3168989|NCT01922115|3896446|FG001|NOT COMPLETED|Overall Study||7
3168990|NCT01922219|3896452|FG000|STARTED|Overall Study||37
3168991|NCT01922219|3896452|FG000|COMPLETED|Overall Study||28
3168992|NCT01922219|3896452|FG000|NOT COMPLETED|Overall Study||9
3168993|NCT01922258|3896458|FG000|STARTED|Overall Study||133
3168994|NCT01922258|3896459|FG001|STARTED|Overall Study||137
3168995|NCT01922258|3896458|FG000|COMPLETED|Overall Study||117
3168996|NCT01922258|3896459|FG001|COMPLETED|Overall Study||121
3168997|NCT01922258|3896458|FG000|NOT COMPLETED|Overall Study||16
3168998|NCT01922258|3896459|FG001|NOT COMPLETED|Overall Study||16
3168999|NCT01922271|3896467|FG000|STARTED|PERIOD 1||76
3169000|NCT01922271|3896468|FG001|STARTED|PERIOD 1||76
3169001|NCT01922271|3896467|FG000|COMPLETED|PERIOD 1||76
3169002|NCT01922271|3896468|FG001|COMPLETED|PERIOD 1||76
3169003|NCT01922271|3896467|FG000|NOT COMPLETED|PERIOD 1||0
3169004|NCT01922271|3896468|FG001|NOT COMPLETED|PERIOD 1||0
3169005|NCT01922271|3896467|FG000|STARTED|WASHOUT Period||76
3169006|NCT01922271|3896468|FG001|STARTED|WASHOUT Period||76
3169007|NCT01922271|3896467|FG000|COMPLETED|WASHOUT Period||75
3169008|NCT01922271|3896468|FG001|COMPLETED|WASHOUT Period||76
3169009|NCT01922271|3896467|FG000|NOT COMPLETED|WASHOUT Period||1
3169010|NCT01922271|3896468|FG001|NOT COMPLETED|WASHOUT Period||0
3169011|NCT01922271|3896467|FG000|STARTED|PERIOD 2||75
3169012|NCT01922271|3896468|FG001|STARTED|PERIOD 2||76
3169013|NCT01922271|3896467|FG000|COMPLETED|PERIOD 2||75
3169014|NCT01922271|3896468|FG001|COMPLETED|PERIOD 2||76
3169015|NCT01922271|3896467|FG000|NOT COMPLETED|PERIOD 2||0
3169016|NCT01922271|3896468|FG001|NOT COMPLETED|PERIOD 2||0
3169017|NCT01922336|3896477|FG000|STARTED|Overall Study||53
3169018|NCT01922336|3896478|FG001|STARTED|Overall Study||53
3169019|NCT01922336|3896479|FG002|STARTED|Overall Study||53
3169020|NCT01922336|3896477|FG000|COMPLETED|Overall Study||53
3169021|NCT01922336|3896478|FG001|COMPLETED|Overall Study||53
3169022|NCT01922336|3896479|FG002|COMPLETED|Overall Study||53
3169023|NCT01922336|3896477|FG000|NOT COMPLETED|Overall Study||0
3169024|NCT01922336|3896478|FG001|NOT COMPLETED|Overall Study||0
2862498|NCT00112437|3564708|FG017|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
2862499|NCT00112437|3564709|FG018|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
2862500|NCT00112437|3564710|FG019|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
2862501|NCT00112437|3564711|FG020|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
2862502|NCT00112437|3564712|FG021|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
2862503|NCT00112437|3564713|FG022|NOT COMPLETED|Years 6-10 (60-Month Extension)||5
2862504|NCT00112437|3564714|FG023|NOT COMPLETED|Years 6-10 (60-Month Extension)||12
2862505|NCT00112437|3564715|FG024|NOT COMPLETED|Years 6-10 (60-Month Extension)||1
2862506|NCT00112437|3564716|FG025|NOT COMPLETED|Years 6-10 (60-Month Extension)||5
2862507|NCT00112463|3564770|FG000|STARTED|Overall Study||40
2862508|NCT00112463|3564770|FG000|COMPLETED|Overall Study||1
2862509|NCT00112463|3564770|FG000|NOT COMPLETED|Overall Study||39
2862510|NCT00112489|3564775|FG000|STARTED|Overall Study|All patients enrolled on study|55
2862511|NCT00112489|3564775|FG000|COMPLETED|Overall Study|Completed regimen due to progression|15
2862512|NCT00112489|3564775|FG000|NOT COMPLETED|Overall Study||40
2862513|NCT00112502|3564793|FG000|STARTED|Overall Study||22
2862514|NCT00112502|3564794|FG001|STARTED|Overall Study||22
2862515|NCT00112502|3564795|FG002|STARTED|Overall Study||22
2862516|NCT00112502|3564796|FG003|STARTED|Overall Study||22
2862517|NCT00112502|3564797|FG004|STARTED|Overall Study||23
2862518|NCT00112502|3564798|FG005|STARTED|Overall Study||22
2862519|NCT00112502|3564799|FG006|STARTED|Overall Study||23
2862520|NCT00112502|3564800|FG007|STARTED|Overall Study||22
2862521|NCT00112502|3564793|FG000|COMPLETED|Overall Study||22
2862522|NCT00112502|3564794|FG001|COMPLETED|Overall Study||21
2862523|NCT00112502|3564795|FG002|COMPLETED|Overall Study||21
2862524|NCT00112502|3564796|FG003|COMPLETED|Overall Study||18
3169025|NCT01922336|3896479|FG002|NOT COMPLETED|Overall Study||0
3169026|NCT01922349|3896491|FG000|STARTED|Single Rising Dose (SRD) Period||25
3169027|NCT01922349|3896492|FG001|STARTED|Single Rising Dose (SRD) Period||27
3169028|NCT01922349|3896493|FG002|STARTED|Single Rising Dose (SRD) Period||18
3169029|NCT01922349|3896494|FG003|STARTED|Single Rising Dose (SRD) Period||27
3169030|NCT01922349|3896491|FG000|COMPLETED|Single Rising Dose (SRD) Period||25
3169031|NCT01922349|3896492|FG001|COMPLETED|Single Rising Dose (SRD) Period||27
2862525|NCT00112502|3564797|FG004|COMPLETED|Overall Study||21
2862526|NCT00112502|3564798|FG005|COMPLETED|Overall Study||17
2862527|NCT00112502|3564799|FG006|COMPLETED|Overall Study||20
2862528|NCT00112502|3564800|FG007|COMPLETED|Overall Study||15
2862529|NCT00112502|3564793|FG000|NOT COMPLETED|Overall Study||0
2862530|NCT00112502|3564794|FG001|NOT COMPLETED|Overall Study||1
2862531|NCT00112502|3564795|FG002|NOT COMPLETED|Overall Study||1
2862532|NCT00112502|3564796|FG003|NOT COMPLETED|Overall Study||4
2862533|NCT00112502|3564797|FG004|NOT COMPLETED|Overall Study||2
3169032|NCT01922349|3896493|FG002|COMPLETED|Single Rising Dose (SRD) Period||18
3169033|NCT01922349|3896494|FG003|COMPLETED|Single Rising Dose (SRD) Period||27
3169034|NCT01922349|3896491|FG000|NOT COMPLETED|Single Rising Dose (SRD) Period||0
3169035|NCT01922349|3896492|FG001|NOT COMPLETED|Single Rising Dose (SRD) Period||0
3169036|NCT01922349|3896493|FG002|NOT COMPLETED|Single Rising Dose (SRD) Period||0
3169037|NCT01922349|3896494|FG003|NOT COMPLETED|Single Rising Dose (SRD) Period||0
3169038|NCT01922349|3896491|FG000|STARTED|Multiple Rising Dose (MRD) Period|One subject discontinued the trial after the SRD period due to non-compliance with the protocol.|24
3169039|NCT01922349|3896492|FG001|STARTED|Multiple Rising Dose (MRD) Period||27
3169040|NCT01922349|3896493|FG002|STARTED|Multiple Rising Dose (MRD) Period||18
3169041|NCT01922349|3896494|FG003|STARTED|Multiple Rising Dose (MRD) Period||27
3169042|NCT01922349|3896491|FG000|COMPLETED|Multiple Rising Dose (MRD) Period||24
3169043|NCT01922349|3896492|FG001|COMPLETED|Multiple Rising Dose (MRD) Period||27
2862534|NCT00112502|3564798|FG005|NOT COMPLETED|Overall Study||5
2862535|NCT00112502|3564799|FG006|NOT COMPLETED|Overall Study||3
2862536|NCT00112502|3564800|FG007|NOT COMPLETED|Overall Study||7
2862537|NCT00112580|3564830|FG000|STARTED|Overall Study||8
2862538|NCT00112580|3564831|FG001|STARTED|Overall Study||19
2862539|NCT00112580|3564830|FG000|COMPLETED|Overall Study||0
2862540|NCT00112580|3564831|FG001|COMPLETED|Overall Study||0
2862541|NCT00112580|3564830|FG000|NOT COMPLETED|Overall Study||8
2862542|NCT00112580|3564831|FG001|NOT COMPLETED|Overall Study||19
2862543|NCT00112593|3564836|FG000|STARTED|Overall Study||5
2862544|NCT00112593|3564836|FG000|COMPLETED|Overall Study||5
2862545|NCT00112593|3564836|FG000|NOT COMPLETED|Overall Study||0
2862546|NCT00112671|3564840|FG000|STARTED|Overall Study||17
2862547|NCT00112671|3564840|FG000|COMPLETED|Overall Study||17
2862548|NCT00112671|3564840|FG000|NOT COMPLETED|Overall Study||0
2862549|NCT00112723|3564844|FG000|STARTED|Overall Study||13
2862550|NCT00112723|3564845|FG001|STARTED|Overall Study||19
2862551|NCT00112723|3564846|FG002|STARTED|Overall Study||14
2862552|NCT00112723|3564844|FG000|Patients Evaluable for Toxicity|Overall Study||11
2862553|NCT00112723|3564845|FG001|Patients Evaluable for Toxicity|Overall Study||12
2862554|NCT00112723|3564846|FG002|Patients Evaluable for Toxicity|Overall Study||12
2862555|NCT00112723|3564844|FG000|COMPLETED|Overall Study||11
2862556|NCT00112723|3564845|FG001|COMPLETED|Overall Study||12
2862557|NCT00112723|3564846|FG002|COMPLETED|Overall Study||12
2862558|NCT00112723|3564844|FG000|NOT COMPLETED|Overall Study||2
2862559|NCT00112723|3564845|FG001|NOT COMPLETED|Overall Study||7
2862560|NCT00112723|3564846|FG002|NOT COMPLETED|Overall Study||2
2862561|NCT00112736|3564870|FG000|STARTED|Overall Study||22
2862562|NCT00112736|3564871|FG001|STARTED|Overall Study||47
2862563|NCT00112736|3564870|FG000|COMPLETED|Overall Study|12 of Phase I pts treated at MTD and hence considered part of the Phase II analysis|21
2862564|NCT00112736|3564871|FG001|COMPLETED|Overall Study|12 additional pts from phase 1 study were used in analysis for Phase 2 as they were treated at MTD|47
2862565|NCT00112736|3564870|FG000|NOT COMPLETED|Overall Study||1
2862566|NCT00112736|3564871|FG001|NOT COMPLETED|Overall Study||0
2862567|NCT00112827|3564888|FG000|STARTED|Overall Study||3
2862568|NCT00112827|3564889|FG001|STARTED|Overall Study||4
2862569|NCT00112827|3564890|FG002|STARTED|Overall Study||4
2862570|NCT00112827|3564891|FG003|STARTED|Overall Study||36
2862571|NCT00112827|3564892|FG004|STARTED|Overall Study||7
2862572|NCT00112827|3564888|FG000|COMPLETED|Overall Study||3
2862573|NCT00112827|3564889|FG001|COMPLETED|Overall Study||4
2862574|NCT00112827|3564890|FG002|COMPLETED|Overall Study||4
2862575|NCT00112827|3564891|FG003|COMPLETED|Overall Study||36
2862576|NCT00112827|3564892|FG004|COMPLETED|Overall Study||7
2862577|NCT00112827|3564888|FG000|NOT COMPLETED|Overall Study||0
2862578|NCT00112827|3564889|FG001|NOT COMPLETED|Overall Study||0
2862579|NCT00112827|3564890|FG002|NOT COMPLETED|Overall Study||0
2862580|NCT00112827|3564891|FG003|NOT COMPLETED|Overall Study||0
2862581|NCT00112827|3564892|FG004|NOT COMPLETED|Overall Study||0
2862582|NCT00112866|3564907|FG000|STARTED|Overall Study||15
2862583|NCT00112866|3564908|FG001|STARTED|Overall Study||15
2862584|NCT00112866|3564907|FG000|COMPLETED|Overall Study||13
2862585|NCT00112866|3564908|FG001|COMPLETED|Overall Study||13
2862586|NCT00112866|3564907|FG000|NOT COMPLETED|Overall Study||2
2862587|NCT00112866|3564908|FG001|NOT COMPLETED|Overall Study||2
2862588|NCT00112905|3564922|FG000|STARTED|Overall Study||27
2862589|NCT00112905|3564922|FG000|Eligible and Treated|Overall Study||22
2862590|NCT00112905|3564922|FG000|COMPLETED|Overall Study||15
2862591|NCT00112905|3564922|FG000|NOT COMPLETED|Overall Study||12
2862592|NCT00112918|3564929|FG000|STARTED|Overall Study||1151
2862593|NCT00112918|3564930|FG001|STARTED|Overall Study||1155
2862594|NCT00112918|3564931|FG002|STARTED|Overall Study||1145
2862595|NCT00112918|3564929|FG000|Received Treatment|Overall Study||1126
2862596|NCT00112918|3564930|FG001|Received Treatment|Overall Study|Includes two patients from FOLFOX4 who received Bv and were assigned to FOLFOX4+Bv safety analysis|1145
2862597|NCT00112918|3564931|FG002|Received Treatment|Overall Study||1135
2862598|NCT00112918|3564929|FG000|Stage III Disease Population|Overall Study||955
2862599|NCT00112918|3564930|FG001|Stage III Disease Population|Overall Study||960
2862600|NCT00112918|3564931|FG002|Stage III Disease Population|Overall Study||952
2862601|NCT00112918|3564929|FG000|COMPLETED|Overall Study|Represents patients alive in follow-up at the time of final data cut-off (30 June 2012)|854
2862602|NCT00112918|3564930|FG001|COMPLETED|Overall Study|Represents patients alive in follow-up at the time of final data cut-off (30 June 2012)|810
2862603|NCT00112918|3564931|FG002|COMPLETED|Overall Study|Represents patients alive in follow-up at the time of final data cut-off (30 June 2012)|846
2862604|NCT00112918|3564929|FG000|NOT COMPLETED|Overall Study||297
2862605|NCT00112918|3564930|FG001|NOT COMPLETED|Overall Study||345
2862606|NCT00112918|3564931|FG002|NOT COMPLETED|Overall Study||299
2862607|NCT00112957|3564939|FG000|STARTED|Overall Study||23
2862608|NCT00112957|3564939|FG000|COMPLETED|Overall Study||4
2862609|NCT00112957|3564939|FG000|NOT COMPLETED|Overall Study||19
2862610|NCT00113022|3564945|FG000|STARTED|Overall Study||5
2862611|NCT00113022|3564946|FG001|STARTED|Overall Study||4
2862612|NCT00113022|3564945|FG000|COMPLETED|Overall Study||2
2862613|NCT00113022|3564946|FG001|COMPLETED|Overall Study||2
2862614|NCT00113022|3564945|FG000|NOT COMPLETED|Overall Study||3
2862615|NCT00113022|3564946|FG001|NOT COMPLETED|Overall Study||2
2862616|NCT00113087|3564954|FG000|STARTED|Overall Study||115
2862617|NCT00113087|3564955|FG001|STARTED|Overall Study||115
2862618|NCT00113087|3564954|FG000|COMPLETED|Overall Study||91
2862619|NCT00113087|3564955|FG001|COMPLETED|Overall Study||94
2862620|NCT00113087|3564954|FG000|NOT COMPLETED|Overall Study||24
2862621|NCT00113087|3564955|FG001|NOT COMPLETED|Overall Study||21
2862622|NCT00113217|3564961|FG000|STARTED|Overall Study||50
2862623|NCT00113217|3564961|FG000|COMPLETED|Overall Study||50
2862624|NCT00113217|3564961|FG000|NOT COMPLETED|Overall Study||0
2862625|NCT00113230|3564965|FG000|STARTED|Overall Study||25
2862626|NCT00113230|3564965|FG000|COMPLETED|Overall Study||25
2862627|NCT00113230|3564965|FG000|NOT COMPLETED|Overall Study||0
2862628|NCT00113269|3564973|FG000|STARTED|Overall Study||76
2862629|NCT00113269|3564974|FG001|STARTED|Overall Study||70
2862630|NCT00113269|3564975|FG002|STARTED|Overall Study||175
2862631|NCT00113269|3564976|FG003|STARTED|Overall Study||180
2862632|NCT00113269|3564973|FG000|Received Treatment|Overall Study||70
2862633|NCT00113269|3564974|FG001|Received Treatment|Overall Study||69
2862634|NCT00113269|3564975|FG002|Received Treatment|Overall Study||164
2862635|NCT00113269|3564976|FG003|Received Treatment|Overall Study||171
2862636|NCT00113269|3564973|FG000|COMPLETED|Overall Study||51
2862637|NCT00113269|3564974|FG001|COMPLETED|Overall Study||48
2862638|NCT00113269|3564975|FG002|COMPLETED|Overall Study||134
2862639|NCT00113269|3564976|FG003|COMPLETED|Overall Study||140
2862640|NCT00113269|3564973|FG000|NOT COMPLETED|Overall Study||25
2862641|NCT00113269|3564974|FG001|NOT COMPLETED|Overall Study||22
2862642|NCT00113269|3564975|FG002|NOT COMPLETED|Overall Study||41
2862643|NCT00113269|3564976|FG003|NOT COMPLETED|Overall Study||40
2862644|NCT00113295|3564988|FG000|STARTED|Overall Study||11
2862645|NCT00113295|3564989|FG001|STARTED|Overall Study||11
2862646|NCT00113295|3564988|FG000|COMPLETED|Overall Study||6
2862647|NCT00113295|3564989|FG001|COMPLETED|Overall Study||10
2862648|NCT00113295|3564988|FG000|NOT COMPLETED|Overall Study||5
2862649|NCT00113295|3564989|FG001|NOT COMPLETED|Overall Study||1
2862650|NCT00113321|3564997|FG000|STARTED|Overall Study||16
2862651|NCT00113321|3564997|FG000|COMPLETED|Overall Study||16
2862652|NCT00113321|3564997|FG000|NOT COMPLETED|Overall Study||0
2862653|NCT00113334|3565001|FG000|STARTED|Overall Study||6
2862654|NCT00113334|3565001|FG000|COMPLETED|Overall Study||6
2862655|NCT00113334|3565001|FG000|NOT COMPLETED|Overall Study||0
2862656|NCT00113360|3565005|FG000|STARTED|Overall Study|67 participants were enrolled for screening.|67
2862657|NCT00113360|3565005|FG000|COMPLETED|Overall Study||60
2862658|NCT00113360|3565005|FG000|NOT COMPLETED|Overall Study||7
2862659|NCT00113373|3565009|FG000|STARTED|Overall Study||28
2862660|NCT00113373|3565009|FG000|COMPLETED|Overall Study|Eligible and treated patients.|25
2862661|NCT00113373|3565009|FG000|NOT COMPLETED|Overall Study||3
2862662|NCT00113425|3565018|FG000|STARTED|Overall Study||44
2862663|NCT00113425|3565018|FG000|COMPLETED|Overall Study||29
2862664|NCT00113425|3565018|FG000|NOT COMPLETED|Overall Study||15
2862665|NCT00113490|3565025|FG000|STARTED|Overall Study||66
2862666|NCT00113490|3565026|FG001|STARTED|Overall Study||70
2862667|NCT00113490|3565025|FG000|COMPLETED|Overall Study||64
2862668|NCT00113490|3565026|FG001|COMPLETED|Overall Study||67
2862669|NCT00113490|3565025|FG000|NOT COMPLETED|Overall Study||2
2862670|NCT00113490|3565026|FG001|NOT COMPLETED|Overall Study||3
2862671|NCT00113516|3565032|FG000|STARTED|Part 1||84
2862672|NCT00113516|3565033|FG001|STARTED|Part 1||0
2862673|NCT00113516|3565032|FG000|COMPLETED|Part 1|66 subjects continued into Part 2 of the study.|0
2862674|NCT00113516|3565033|FG001|COMPLETED|Part 1||0
2862675|NCT00113516|3565032|FG000|NOT COMPLETED|Part 1||84
2862676|NCT00113516|3565033|FG001|NOT COMPLETED|Part 1||0
2862677|NCT00113516|3565032|FG000|STARTED|Part 2||0
2862678|NCT00113516|3565033|FG001|STARTED|Part 2||66
2862679|NCT00113516|3565032|FG000|COMPLETED|Part 2||0
2862680|NCT00113516|3565033|FG001|COMPLETED|Part 2||0
2862681|NCT00113516|3565032|FG000|NOT COMPLETED|Part 2||0
2862682|NCT00113516|3565033|FG001|NOT COMPLETED|Part 2||66
2862683|NCT00113529|3565039|FG000|STARTED|Overall Study|Phase 2 included 4 subjects from Phase 1 and 31 from Phase 2, for a total of 35 subjects.|35
2862684|NCT00113529|3565039|FG000|COMPLETED|Overall Study|Subject discontinued from the study and continued treatment on commercially available sunitinib.|1
2862685|NCT00113529|3565039|FG000|NOT COMPLETED|Overall Study||34
2862686|NCT00113555|3565043|FG000|STARTED|Overall Study||221
2862687|NCT00113555|3565043|FG000|TREATED|Overall Study|1 Additional Patient was treated on a compassionate use basis.|162
2862688|NCT00113555|3565043|FG000|COMPLETED|Overall Study|All treated patients were considered in the Intent to Treat analysis.|142
2862689|NCT00113555|3565043|FG000|NOT COMPLETED|Overall Study||79
2862690|NCT00113568|3565048|FG000|STARTED|Overall Study||784
2862691|NCT00113568|3565048|FG000|Intent to Treat Population|Overall Study||723
2862692|NCT00113568|3565048|FG000|COMPLETED|Overall Study||239
3313436|NCT03075410|4046795|FG004|STARTED|Part A-Period 3 (14 Days)||2
3313437|NCT03075410|4046796|FG005|STARTED|Part A-Period 3 (14 Days)||1
3313438|NCT03075410|4046797|FG006|STARTED|Part A-Period 3 (14 Days)||0
3313439|NCT03075410|4046798|FG007|STARTED|Part A-Period 3 (14 Days)||0
2862693|NCT00113568|3565048|FG000|NOT COMPLETED|Overall Study||545
2862694|NCT00113607|3565054|FG000|STARTED|Overall Study|Number of randomized participants|335
2862695|NCT00113607|3565055|FG001|STARTED|Overall Study|Number of randomized participants|337
2862696|NCT00113607|3565054|FG000|COMPLETED|Overall Study||0
2862697|NCT00113607|3565055|FG001|COMPLETED|Overall Study||0
2862698|NCT00113607|3565054|FG000|NOT COMPLETED|Overall Study||335
2862699|NCT00113607|3565055|FG001|NOT COMPLETED|Overall Study||337
2862700|NCT00113763|3565064|FG000|STARTED|Overall Study||231
2862701|NCT00113763|3565065|FG001|STARTED|Overall Study||232
2862702|NCT00113763|3565064|FG000|Received Study Drug|Overall Study||229
3169044|NCT01922349|3896493|FG002|COMPLETED|Multiple Rising Dose (MRD) Period||18
3169045|NCT01922349|3896494|FG003|COMPLETED|Multiple Rising Dose (MRD) Period||26
3169046|NCT01922349|3896491|FG000|NOT COMPLETED|Multiple Rising Dose (MRD) Period||0
3169047|NCT01922349|3896492|FG001|NOT COMPLETED|Multiple Rising Dose (MRD) Period||0
3313440|NCT03075410|4046799|FG008|STARTED|Part A-Period 3 (14 Days)||0
2862703|NCT00113763|3565065|FG001|Received Study Drug|Overall Study||0
2862704|NCT00113763|3565064|FG000|COMPLETED|Overall Study|Defined as participants who completed safety follow-up visit or who died.|158
2862705|NCT00113763|3565065|FG001|COMPLETED|Overall Study|Defined as participants who completed safety follow-up visit or who died.|206
2862706|NCT00113763|3565064|FG000|NOT COMPLETED|Overall Study||73
2862707|NCT00113763|3565065|FG001|NOT COMPLETED|Overall Study||26
2862708|NCT00113841|3565074|FG000|STARTED|Overall Study||16
2862709|NCT00113841|3565075|FG001|STARTED|Overall Study||17
2862710|NCT00113841|3565074|FG000|COMPLETED|Overall Study||15
2862711|NCT00113841|3565075|FG001|COMPLETED|Overall Study||15
2862712|NCT00113841|3565074|FG000|NOT COMPLETED|Overall Study||1
2862713|NCT00113841|3565075|FG001|NOT COMPLETED|Overall Study||2
2862714|NCT00113880|3565084|FG000|STARTED|Overall Study||63061
2862715|NCT00113880|3565085|FG001|STARTED|Overall Study||71949
2862716|NCT00113880|3565086|FG002|STARTED|Overall Study||62492
2862717|NCT00113880|3565084|FG000|COMPLETED|Overall Study||63061
2862718|NCT00113880|3565085|FG001|COMPLETED|Overall Study||71949
2862719|NCT00113880|3565086|FG002|COMPLETED|Overall Study||62492
2862720|NCT00113880|3565084|FG000|NOT COMPLETED|Overall Study||0
2862721|NCT00113880|3565085|FG001|NOT COMPLETED|Overall Study||0
2862722|NCT00113880|3565086|FG002|NOT COMPLETED|Overall Study||0
2862723|NCT00114114|3565107|FG000|STARTED|Overall Study||26
2862724|NCT00114114|3565108|FG001|STARTED|Overall Study||25
2862725|NCT00114114|3565109|FG002|STARTED|Overall Study||31
2862726|NCT00114114|3565110|FG003|STARTED|Overall Study||35
2862727|NCT00114114|3565111|FG004|STARTED|Overall Study||29
2862728|NCT00114114|3565112|FG005|STARTED|Overall Study||31
2862729|NCT00114114|3565107|FG000|COMPLETED|Overall Study||21
2862730|NCT00114114|3565108|FG001|COMPLETED|Overall Study||24
2862731|NCT00114114|3565109|FG002|COMPLETED|Overall Study||30
2862732|NCT00114114|3565110|FG003|COMPLETED|Overall Study||31
2862733|NCT00114114|3565111|FG004|COMPLETED|Overall Study||27
2862734|NCT00114114|3565112|FG005|COMPLETED|Overall Study||30
2862735|NCT00114114|3565107|FG000|NOT COMPLETED|Overall Study||5
2862736|NCT00114114|3565108|FG001|NOT COMPLETED|Overall Study||1
2862737|NCT00114114|3565109|FG002|NOT COMPLETED|Overall Study||1
2862738|NCT00114114|3565110|FG003|NOT COMPLETED|Overall Study||4
2862739|NCT00114114|3565111|FG004|NOT COMPLETED|Overall Study||2
2862740|NCT00114114|3565112|FG005|NOT COMPLETED|Overall Study||1
2862741|NCT00114127|3565130|FG000|STARTED|Overall Study||13
2862742|NCT00114127|3565131|FG001|STARTED|Overall Study||15
2862743|NCT00114127|3565130|FG000|COMPLETED|Overall Study||9
2862744|NCT00114127|3565131|FG001|COMPLETED|Overall Study||11
2862745|NCT00114127|3565130|FG000|NOT COMPLETED|Overall Study||4
2862746|NCT00114127|3565131|FG001|NOT COMPLETED|Overall Study||4
2862747|NCT00114140|3565137|FG000|STARTED|Overall Study||136
2862748|NCT00114140|3565137|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|129
2862749|NCT00114140|3565137|FG000|NOT COMPLETED|Overall Study||7
2862750|NCT00114166|3565150|FG000|STARTED|Overall Study||15
2862751|NCT00114166|3565151|FG001|STARTED|Overall Study||66
2862752|NCT00114166|3565150|FG000|COMPLETED|Overall Study||15
2862753|NCT00114166|3565151|FG001|COMPLETED|Overall Study||65
2862754|NCT00114166|3565150|FG000|NOT COMPLETED|Overall Study||0
2862755|NCT00114166|3565151|FG001|NOT COMPLETED|Overall Study||1
2862756|NCT00114218|3565159|FG000|STARTED|Overall Study||28
2862757|NCT00114218|3565159|FG000|COMPLETED|Overall Study||24
2862758|NCT00114218|3565159|FG000|NOT COMPLETED|Overall Study||4
2862759|NCT00114231|3565165|FG000|STARTED|Overall Study||62
2862760|NCT00114231|3565166|FG001|STARTED|Overall Study||28
3169048|NCT01922349|3896493|FG002|NOT COMPLETED|Multiple Rising Dose (MRD) Period||0
2862761|NCT00114231|3565165|FG000|COMPLETED|Overall Study||53
2862762|NCT00114231|3565166|FG001|COMPLETED|Overall Study||26
2862763|NCT00114231|3565165|FG000|NOT COMPLETED|Overall Study||9
2862764|NCT00114231|3565166|FG001|NOT COMPLETED|Overall Study||2
2862765|NCT00114244|3565173|FG000|STARTED|Overall Study||15
2862766|NCT00114244|3565174|FG001|STARTED|Overall Study||37
2862767|NCT00114244|3565173|FG000|COMPLETED|Overall Study||13
2862768|NCT00114244|3565174|FG001|COMPLETED|Overall Study||30
2862769|NCT00114244|3565173|FG000|NOT COMPLETED|Overall Study||2
2862770|NCT00114244|3565174|FG001|NOT COMPLETED|Overall Study||7
2862771|NCT00114504|3565182|FG000|STARTED|Overall Study||21
2862772|NCT00114504|3565183|FG001|STARTED|Overall Study||22
2862773|NCT00114504|3565182|FG000|COMPLETED|Overall Study||21
2862774|NCT00114504|3565183|FG001|COMPLETED|Overall Study||22
2862775|NCT00114504|3565182|FG000|NOT COMPLETED|Overall Study||0
2862776|NCT00114504|3565183|FG001|NOT COMPLETED|Overall Study||0
2862777|NCT00114517|3565197|FG000|STARTED|Overall Study||137
2862778|NCT00114517|3565198|FG001|STARTED|Overall Study||134
2862779|NCT00114517|3565199|FG002|STARTED|Overall Study||186
2862780|NCT00114517|3565200|FG003|STARTED|Overall Study||186
2862781|NCT00114517|3565197|FG000|COMPLETED|Overall Study||125
2862782|NCT00114517|3565198|FG001|COMPLETED|Overall Study||123
2862783|NCT00114517|3565199|FG002|COMPLETED|Overall Study||172
2862784|NCT00114517|3565200|FG003|COMPLETED|Overall Study||176
2862785|NCT00114517|3565197|FG000|NOT COMPLETED|Overall Study||12
2862786|NCT00114517|3565198|FG001|NOT COMPLETED|Overall Study||11
2862787|NCT00114517|3565199|FG002|NOT COMPLETED|Overall Study||14
2862788|NCT00114517|3565200|FG003|NOT COMPLETED|Overall Study||10
2862789|NCT00114530|3565208|FG000|STARTED|Overall Study||36
2862790|NCT00114530|3565209|FG001|STARTED|Overall Study||39
2862791|NCT00114530|3565208|FG000|COMPLETED|Overall Study|Completed 72 mo, 54 mo after failure, or at least 54 mo at study end (last patient's 54 mo visit)|27
2862792|NCT00114530|3565209|FG001|COMPLETED|Overall Study|Completed 72 mo, 54 mo after failure, or at least 54 mo at study end (last patient's 54 mo visit)|19
2862793|NCT00114530|3565208|FG000|NOT COMPLETED|Overall Study||9
2862794|NCT00114530|3565209|FG001|NOT COMPLETED|Overall Study||20
2862795|NCT00114634|3565219|FG000|STARTED|Overall Study||13
2862796|NCT00114634|3565219|FG000|COMPLETED|Overall Study|Assessment forms lost by one failure to complete and return forms by two|10
2862797|NCT00114634|3565219|FG000|NOT COMPLETED|Overall Study||3
2862798|NCT00114738|3565225|FG000|STARTED|Bortezomib Then Bortezomib + Induction||53
2862799|NCT00114738|3565226|FG001|STARTED|Bortezomib Then Bortezomib + Induction||0
2862800|NCT00114738|3565227|FG002|STARTED|Bortezomib Then Bortezomib + Induction||0
2862801|NCT00114738|3565225|FG000|Started With Bortezomib Alone|Bortezomib Then Bortezomib + Induction||47
2862802|NCT00114738|3565226|FG001|Started With Bortezomib Alone|Bortezomib Then Bortezomib + Induction||0
2862803|NCT00114738|3565227|FG002|Started With Bortezomib Alone|Bortezomib Then Bortezomib + Induction||0
2862804|NCT00114738|3565225|FG000|Skipped Bortezomib Alone|Bortezomib Then Bortezomib + Induction||6
2862805|NCT00114738|3565226|FG001|Skipped Bortezomib Alone|Bortezomib Then Bortezomib + Induction||0
2862806|NCT00114738|3565227|FG002|Skipped Bortezomib Alone|Bortezomib Then Bortezomib + Induction||0
2862807|NCT00114738|3565225|FG000|COMPLETED|Bortezomib Then Bortezomib + Induction||51
2862808|NCT00114738|3565226|FG001|COMPLETED|Bortezomib Then Bortezomib + Induction||0
2862809|NCT00114738|3565227|FG002|COMPLETED|Bortezomib Then Bortezomib + Induction||0
2862810|NCT00114738|3565225|FG000|NOT COMPLETED|Bortezomib Then Bortezomib + Induction||2
2862811|NCT00114738|3565226|FG001|NOT COMPLETED|Bortezomib Then Bortezomib + Induction||0
2862812|NCT00114738|3565227|FG002|NOT COMPLETED|Bortezomib Then Bortezomib + Induction||0
2862813|NCT00114738|3565225|FG000|STARTED|Screening for Randomization||51
2862814|NCT00114738|3565226|FG001|STARTED|Screening for Randomization||0
2862815|NCT00114738|3565227|FG002|STARTED|Screening for Randomization||0
2862816|NCT00114738|3565225|FG000|COMPLETED|Screening for Randomization||30
2862817|NCT00114738|3565226|FG001|COMPLETED|Screening for Randomization||0
2862818|NCT00114738|3565227|FG002|COMPLETED|Screening for Randomization||0
2862819|NCT00114738|3565225|FG000|NOT COMPLETED|Screening for Randomization||21
2862820|NCT00114738|3565226|FG001|NOT COMPLETED|Screening for Randomization||0
2862821|NCT00114738|3565227|FG002|NOT COMPLETED|Screening for Randomization||0
2862822|NCT00114738|3565225|FG000|STARTED|Randomization||0
2862823|NCT00114738|3565226|FG001|STARTED|Randomization||14
2862824|NCT00114738|3565227|FG002|STARTED|Randomization||16
2862825|NCT00114738|3565225|FG000|COMPLETED|Randomization||0
2862826|NCT00114738|3565226|FG001|COMPLETED|Randomization||14
2862827|NCT00114738|3565227|FG002|COMPLETED|Randomization||16
2862828|NCT00114738|3565225|FG000|NOT COMPLETED|Randomization||0
2862829|NCT00114738|3565226|FG001|NOT COMPLETED|Randomization||0
2862830|NCT00114738|3565227|FG002|NOT COMPLETED|Randomization||0
2862831|NCT00114777|3565237|FG000|STARTED|Randomization to Month 36||184
2862832|NCT00114777|3565238|FG001|STARTED|Randomization to Month 36||175
2862833|NCT00114777|3565239|FG002|STARTED|Randomization to Month 36||184
2862834|NCT00114777|3565237|FG000|COMPLETED|Randomization to Month 36||109
2862835|NCT00114777|3565238|FG001|COMPLETED|Randomization to Month 36||114
2862836|NCT00114777|3565239|FG002|COMPLETED|Randomization to Month 36||100
2862837|NCT00114777|3565237|FG000|NOT COMPLETED|Randomization to Month 36||75
2862838|NCT00114777|3565238|FG001|NOT COMPLETED|Randomization to Month 36||61
2862839|NCT00114777|3565239|FG002|NOT COMPLETED|Randomization to Month 36||84
2862840|NCT00114777|3565237|FG000|STARTED|Long-Term Extension to Month 84||104
2862841|NCT00114777|3565238|FG001|STARTED|Long-Term Extension to Month 84||113
2862842|NCT00114777|3565239|FG002|STARTED|Long-Term Extension to Month 84||87
3169049|NCT01922349|3896494|FG003|NOT COMPLETED|Multiple Rising Dose (MRD) Period||1
3169050|NCT01922739|3896530|FG000|STARTED|Titration/Adjustment Period||182
2862843|NCT00114777|3565237|FG000|COMPLETED|Long-Term Extension to Month 84||74
2862844|NCT00114777|3565238|FG001|COMPLETED|Long-Term Extension to Month 84||84
2862845|NCT00114777|3565239|FG002|COMPLETED|Long-Term Extension to Month 84||57
2862846|NCT00114777|3565237|FG000|NOT COMPLETED|Long-Term Extension to Month 84||30
2862847|NCT00114777|3565238|FG001|NOT COMPLETED|Long-Term Extension to Month 84||29
2862848|NCT00114777|3565239|FG002|NOT COMPLETED|Long-Term Extension to Month 84||30
2862849|NCT00114959|3565248|FG000|STARTED|Overall Study||15
2862850|NCT00114959|3565248|FG000|COMPLETED|Overall Study|protocol definition of completed study is having received >= 4 cycles of treatment|7
2862851|NCT00114959|3565248|FG000|NOT COMPLETED|Overall Study||8
2862852|NCT00114972|3565254|FG000|STARTED|Overall Study||897
2862853|NCT00114972|3565255|FG001|STARTED|Overall Study||903
2862854|NCT00114972|3565254|FG000|COMPLETED|Overall Study||849
2862855|NCT00114972|3565255|FG001|COMPLETED|Overall Study||891
2862856|NCT00114972|3565254|FG000|NOT COMPLETED|Overall Study||48
2862857|NCT00114972|3565255|FG001|NOT COMPLETED|Overall Study||12
2862858|NCT00115037|3565263|FG000|STARTED|Phase1||152
2862859|NCT00115037|3565264|FG001|STARTED|Phase1||150
2862860|NCT00115037|3565265|FG002|STARTED|Phase1||0
2862861|NCT00115037|3565266|FG003|STARTED|Phase1||0
2862862|NCT00115037|3565267|FG004|STARTED|Phase1||0
2862863|NCT00115037|3565268|FG005|STARTED|Phase1||0
2862864|NCT00115037|3565263|FG000|COMPLETED|Phase1||127
2862865|NCT00115037|3565264|FG001|COMPLETED|Phase1||123
2862866|NCT00115037|3565265|FG002|COMPLETED|Phase1||0
2862867|NCT00115037|3565266|FG003|COMPLETED|Phase1||0
2862868|NCT00115037|3565267|FG004|COMPLETED|Phase1||0
2862869|NCT00115037|3565268|FG005|COMPLETED|Phase1||0
2862870|NCT00115037|3565263|FG000|NOT COMPLETED|Phase1||25
2862871|NCT00115037|3565264|FG001|NOT COMPLETED|Phase1||27
2862872|NCT00115037|3565265|FG002|NOT COMPLETED|Phase1||0
2862873|NCT00115037|3565266|FG003|NOT COMPLETED|Phase1||0
2862874|NCT00115037|3565267|FG004|NOT COMPLETED|Phase1||0
2862875|NCT00115037|3565268|FG005|NOT COMPLETED|Phase1||0
2862876|NCT00115037|3565263|FG000|STARTED|Phase2||0
2862877|NCT00115037|3565264|FG001|STARTED|Phase2||0
2862878|NCT00115037|3565265|FG002|STARTED|Phase2||91
2862879|NCT00115037|3565266|FG003|STARTED|Phase2||92
2862880|NCT00115037|3565267|FG004|STARTED|Phase2||34
2862881|NCT00115037|3565268|FG005|STARTED|Phase2||33
2862882|NCT00115037|3565263|FG000|COMPLETED|Phase2||0
2862883|NCT00115037|3565264|FG001|COMPLETED|Phase2||0
2862884|NCT00115037|3565265|FG002|COMPLETED|Phase2||76
2862885|NCT00115037|3565266|FG003|COMPLETED|Phase2||77
2862886|NCT00115037|3565267|FG004|COMPLETED|Phase2||28
2862887|NCT00115037|3565268|FG005|COMPLETED|Phase2||21
2862888|NCT00115037|3565263|FG000|NOT COMPLETED|Phase2||0
2862889|NCT00115037|3565264|FG001|NOT COMPLETED|Phase2||0
2862890|NCT00115037|3565265|FG002|NOT COMPLETED|Phase2||15
2862891|NCT00115037|3565266|FG003|NOT COMPLETED|Phase2||15
2862892|NCT00115037|3565267|FG004|NOT COMPLETED|Phase2||6
2862893|NCT00115037|3565268|FG005|NOT COMPLETED|Phase2||12
2862894|NCT00115063|3565284|FG000|STARTED|Overall Study||200
2862895|NCT00115063|3565285|FG001|STARTED|Overall Study||190
2862896|NCT00115063|3565284|FG000|COMPLETED|Overall Study||101
2862897|NCT00115063|3565285|FG001|COMPLETED|Overall Study||86
2862898|NCT00115063|3565284|FG000|NOT COMPLETED|Overall Study||99
2862899|NCT00115063|3565285|FG001|NOT COMPLETED|Overall Study||104
2862900|NCT00115076|3565291|FG000|STARTED|Overall Study||30
2862901|NCT00115076|3565291|FG000|COMPLETED|Overall Study||30
2862902|NCT00115076|3565291|FG000|NOT COMPLETED|Overall Study||0
2862903|NCT00115297|3565297|FG000|STARTED|Overall Study||30
2862904|NCT00115297|3565298|FG001|STARTED|Overall Study||32
2862905|NCT00115297|3565297|FG000|COMPLETED|Overall Study||30
2862906|NCT00115297|3565298|FG001|COMPLETED|Overall Study||32
2862907|NCT00115297|3565297|FG000|NOT COMPLETED|Overall Study||0
2862908|NCT00115297|3565298|FG001|NOT COMPLETED|Overall Study||0
2862909|NCT00115336|3565309|FG000|STARTED|Overall Study||6
2862910|NCT00115336|3565310|FG001|STARTED|Overall Study||4
2862911|NCT00115336|3565309|FG000|COMPLETED|Overall Study||6
2862912|NCT00115336|3565310|FG001|COMPLETED|Overall Study||3
2862913|NCT00115336|3565309|FG000|NOT COMPLETED|Overall Study||0
2862914|NCT00115336|3565310|FG001|NOT COMPLETED|Overall Study||1
2862915|NCT00115349|3565320|FG000|STARTED|Overall Study|Target was 43 subjects in this arm.|11
3169051|NCT01922739|3896530|FG000|Safety Analysis Set|Titration/Adjustment Period||182
2862916|NCT00115349|3565321|FG001|STARTED|Overall Study|Target was 43 subjects in this arm.|9
2862917|NCT00115349|3565320|FG000|COMPLETED|Overall Study|Study closed due to low enrollment.|0
2862918|NCT00115349|3565321|FG001|COMPLETED|Overall Study|study closed due to low enrollment.|0
2862919|NCT00115349|3565320|FG000|NOT COMPLETED|Overall Study||11
2862920|NCT00115349|3565321|FG001|NOT COMPLETED|Overall Study||9
2862921|NCT00115739|3565327|FG000|STARTED|Overall Study||11
2862922|NCT00115739|3565327|FG000|COMPLETED|Overall Study||8
2862923|NCT00115739|3565327|FG000|NOT COMPLETED|Overall Study||3
2862924|NCT00115765|3565337|FG000|STARTED|Overall Study||115
2862925|NCT00115765|3565338|FG001|STARTED|Overall Study||413
2862926|NCT00115765|3565339|FG002|STARTED|Overall Study||410
2862927|NCT00115765|3565340|FG003|STARTED|Overall Study||115
2862928|NCT00115765|3565337|FG000|COMPLETED|Overall Study|Participants who were on study at closure or died|80
2862929|NCT00115765|3565338|FG001|COMPLETED|Overall Study|Participants who were on study at closure or died|313
2862930|NCT00115765|3565339|FG002|COMPLETED|Overall Study|Participants who were on study at closure or died|289
2862931|NCT00115765|3565340|FG003|COMPLETED|Overall Study|Participants who were on study at closure or died|84
2862932|NCT00115765|3565337|FG000|NOT COMPLETED|Overall Study||35
2862933|NCT00115765|3565338|FG001|NOT COMPLETED|Overall Study||100
2862934|NCT00115765|3565339|FG002|NOT COMPLETED|Overall Study||121
2862935|NCT00115765|3565340|FG003|NOT COMPLETED|Overall Study||31
2862936|NCT00115778|3565348|FG000|STARTED|Overall Study||6
2862937|NCT00115778|3565349|FG001|STARTED|Overall Study||5
2862938|NCT00115778|3565348|FG000|COMPLETED|Overall Study||6
2862939|NCT00115778|3565349|FG001|COMPLETED|Overall Study||4
2862940|NCT00115778|3565348|FG000|NOT COMPLETED|Overall Study||0
2862941|NCT00115778|3565349|FG001|NOT COMPLETED|Overall Study||1
2862942|NCT00115804|3565355|FG000|STARTED|Overall Study||6
2862943|NCT00115804|3565355|FG000|COMPLETED|Overall Study||4
2862944|NCT00115804|3565355|FG000|NOT COMPLETED|Overall Study||2
2862945|NCT00115869|3565363|FG000|STARTED|Overall Study||4211
2862946|NCT00115869|3565364|FG001|STARTED|Overall Study||4177
2862947|NCT00115869|3565363|FG000|Completed Data Collection at 12th Grade|Overall Study||3876
2862948|NCT00115869|3565364|FG001|Completed Data Collection at 12th Grade|Overall Study||3847
2862949|NCT00115869|3565363|FG000|COMPLETED|Overall Study||3894
2862950|NCT00115869|3565364|FG001|COMPLETED|Overall Study|Follow-up at two years post high school.|3881
2862951|NCT00115869|3565363|FG000|NOT COMPLETED|Overall Study||317
2862952|NCT00115869|3565364|FG001|NOT COMPLETED|Overall Study||296
2862953|NCT00115934|3565374|FG000|STARTED|Overall Study|279 randomized to MBTS, but 3 did not have a Norwood surgery; one was withdrawn-with limited data.|279
2862954|NCT00115934|3565375|FG001|STARTED|Overall Study|276 randomized to RVPAS, but 2 did not have a Norwood surgery and were excluded from analyses.|276
2862955|NCT00115934|3565374|FG000|COMPLETED|Overall Study||275
2862956|NCT00115934|3565375|FG001|COMPLETED|Overall Study||274
2862957|NCT00115934|3565374|FG000|NOT COMPLETED|Overall Study||4
2862958|NCT00115934|3565375|FG001|NOT COMPLETED|Overall Study||2
2862959|NCT00116168|3565385|FG000|STARTED|Overall Study||6
2862960|NCT00116168|3565386|FG001|STARTED|Overall Study||11
2862961|NCT00116168|3565387|FG002|STARTED|Overall Study||6
2862962|NCT00116168|3565388|FG003|STARTED|Overall Study||6
2862963|NCT00116168|3565385|FG000|COMPLETED|Overall Study||0
2862964|NCT00116168|3565386|FG001|COMPLETED|Overall Study||6
2862965|NCT00116168|3565387|FG002|COMPLETED|Overall Study||6
2862966|NCT00116168|3565388|FG003|COMPLETED|Overall Study||6
2862967|NCT00116168|3565385|FG000|NOT COMPLETED|Overall Study||6
2862968|NCT00116168|3565386|FG001|NOT COMPLETED|Overall Study||5
2862969|NCT00116168|3565387|FG002|NOT COMPLETED|Overall Study||0
2862970|NCT00116168|3565388|FG003|NOT COMPLETED|Overall Study||0
2862971|NCT00116207|3565400|FG000|STARTED|Overall Study||22
2862972|NCT00116207|3565401|FG001|STARTED|Overall Study||22
2862973|NCT00116207|3565400|FG000|COMPLETED|Overall Study||13
2862974|NCT00116207|3565401|FG001|COMPLETED|Overall Study||18
2862975|NCT00116207|3565400|FG000|NOT COMPLETED|Overall Study||9
2862976|NCT00116207|3565401|FG001|NOT COMPLETED|Overall Study||4
2862977|NCT00116272|3565409|FG000|STARTED|Overall Study||370
2862978|NCT00116272|3565410|FG001|STARTED|Overall Study||164
2862979|NCT00116272|3565409|FG000|COMPLETED|Overall Study|Indicates participants with a known outcome of pregnancy|359
2862980|NCT00116272|3565410|FG001|COMPLETED|Overall Study|Indicates participants with a known outcome of pregnancy|158
2862981|NCT00116272|3565409|FG000|NOT COMPLETED|Overall Study||11
2862982|NCT00116272|3565410|FG001|NOT COMPLETED|Overall Study||6
2862983|NCT00116337|3565418|FG000|STARTED|Overall Study||17
2862984|NCT00116337|3565418|FG000|COMPLETED|Overall Study||17
2862985|NCT00116337|3565418|FG000|NOT COMPLETED|Overall Study||0
2862986|NCT00116428|3565431|FG000|STARTED|Overall Study||106
2862987|NCT00116428|3565432|FG001|STARTED|Overall Study||61
2862988|NCT00116428|3565431|FG000|Underwent Study Ablation Procedure|Overall Study||103
2862989|NCT00116428|3565432|FG001|Underwent Study Ablation Procedure|Overall Study||36
2862990|NCT00116428|3565431|FG000|COMPLETED|Overall Study||103
2862991|NCT00116428|3565432|FG001|COMPLETED|Overall Study||56
2862992|NCT00116428|3565431|FG000|NOT COMPLETED|Overall Study||3
2862993|NCT00116428|3565432|FG001|NOT COMPLETED|Overall Study||5
2862994|NCT00116558|3565444|FG000|STARTED|Overall Study||80
2862995|NCT00116558|3565445|FG001|STARTED|Overall Study||26
2862996|NCT00116558|3565446|FG002|STARTED|Overall Study||47
2862997|NCT00116558|3565444|FG000|COMPLETED|Overall Study||49
2862998|NCT00116558|3565445|FG001|COMPLETED|Overall Study||11
2862999|NCT00116558|3565446|FG002|COMPLETED|Overall Study||14
2863000|NCT00116558|3565444|FG000|NOT COMPLETED|Overall Study||31
2863001|NCT00116558|3565445|FG001|NOT COMPLETED|Overall Study||15
2863002|NCT00116558|3565446|FG002|NOT COMPLETED|Overall Study||33
2863003|NCT00116584|3565455|FG000|STARTED|Overall Study||36
2863004|NCT00116584|3565456|FG001|STARTED|Overall Study||36
2863005|NCT00116584|3565455|FG000|COMPLETED|Overall Study||34
2863006|NCT00116584|3565456|FG001|COMPLETED|Overall Study||35
2863007|NCT00116584|3565455|FG000|NOT COMPLETED|Overall Study||2
2863008|NCT00116584|3565456|FG001|NOT COMPLETED|Overall Study||1
2863009|NCT00116649|3565462|FG000|STARTED|Overall Study|586 screened (34 not eligible) 552 enrolled 551 study population (1 subject not treated)|551
2863010|NCT00116649|3565462|FG000|COMPLETED|Overall Study||396
2863011|NCT00116649|3565462|FG000|NOT COMPLETED|Overall Study||155
2863012|NCT00116688|3565468|FG000|STARTED|Overall Study||292
2863013|NCT00116688|3565469|FG001|STARTED|Overall Study||21
2863014|NCT00116688|3565468|FG000|Received Study Medication|Overall Study||291
2863015|NCT00116688|3565469|FG001|Received Study Medication|Overall Study||20
2863016|NCT00116688|3565468|FG000|COMPLETED|Overall Study||200
2863017|NCT00116688|3565469|FG001|COMPLETED|Overall Study||17
2863018|NCT00116688|3565468|FG000|NOT COMPLETED|Overall Study||92
2863019|NCT00116688|3565469|FG001|NOT COMPLETED|Overall Study||4
2863020|NCT00116753|3565478|FG000|STARTED|Overall Study|Randomised.|153
2863021|NCT00116753|3565479|FG001|STARTED|Overall Study||155
2863022|NCT00116753|3565480|FG002|STARTED|Overall Study||152
2863023|NCT00116753|3565478|FG000|ITT Population|Overall Study||150
2863024|NCT00116753|3565479|FG001|ITT Population|Overall Study||150
2863025|NCT00116753|3565480|FG002|ITT Population|Overall Study||147
2863026|NCT00116753|3565478|FG000|COMPLETED|Overall Study||121
2863027|NCT00116753|3565479|FG001|COMPLETED|Overall Study||125
2863028|NCT00116753|3565480|FG002|COMPLETED|Overall Study||128
2863029|NCT00116753|3565478|FG000|NOT COMPLETED|Overall Study||32
2863030|NCT00116753|3565479|FG001|NOT COMPLETED|Overall Study||30
2863031|NCT00116753|3565480|FG002|NOT COMPLETED|Overall Study||24
2863032|NCT00116779|3565490|FG000|STARTED|Overall Study|Randomized and treated; Intent-to-treat population|63
2863033|NCT00116779|3565491|FG001|STARTED|Overall Study|Randomized and treated; intent-to-treat population|64
2863034|NCT00116779|3565490|FG000|COMPLETED|Overall Study||42
2863035|NCT00116779|3565491|FG001|COMPLETED|Overall Study||45
2863036|NCT00116779|3565490|FG000|NOT COMPLETED|Overall Study||21
2863037|NCT00116779|3565491|FG001|NOT COMPLETED|Overall Study||19
2863038|NCT00116805|3565499|FG000|STARTED|Double-blind Period Through Week 48||176
2863039|NCT00116805|3565500|FG001|STARTED|Double-blind Period Through Week 48||90
2863040|NCT00116805|3565499|FG000|COMPLETED|Double-blind Period Through Week 48||165
2863041|NCT00116805|3565500|FG001|COMPLETED|Double-blind Period Through Week 48||85
2863042|NCT00116805|3565499|FG000|NOT COMPLETED|Double-blind Period Through Week 48||11
2863043|NCT00116805|3565500|FG001|NOT COMPLETED|Double-blind Period Through Week 48||5
2863044|NCT00116805|3565499|FG000|STARTED|Open-label Period Weeks 49 - 96|11 participants completed 48 weeks but did not continue on study.|154
2863045|NCT00116805|3565500|FG001|STARTED|Open-label Period Weeks 49 - 96|1 participant completed 48 weeks but did not continue on study.|84
2863046|NCT00116805|3565499|FG000|COMPLETED|Open-label Period Weeks 49 - 96||144
2863047|NCT00116805|3565500|FG001|COMPLETED|Open-label Period Weeks 49 - 96||83
2863048|NCT00116805|3565499|FG000|NOT COMPLETED|Open-label Period Weeks 49 - 96||10
2863049|NCT00116805|3565500|FG001|NOT COMPLETED|Open-label Period Weeks 49 - 96||1
2863050|NCT00116805|3565499|FG000|STARTED|Open-label Period Weeks 97 - 144||144
2863051|NCT00116805|3565500|FG001|STARTED|Open-label Period Weeks 97 - 144||83
2863052|NCT00116805|3565499|FG000|COMPLETED|Open-label Period Weeks 97 - 144||133
2863053|NCT00116805|3565500|FG001|COMPLETED|Open-label Period Weeks 97 - 144||74
2863054|NCT00116805|3565499|FG000|NOT COMPLETED|Open-label Period Weeks 97 - 144||11
2863055|NCT00116805|3565500|FG001|NOT COMPLETED|Open-label Period Weeks 97 - 144||9
2863056|NCT00116805|3565499|FG000|STARTED|Open-label Period Weeks 145 - 192||133
2863057|NCT00116805|3565500|FG001|STARTED|Open-label Period Weeks 145 - 192||74
2863058|NCT00116805|3565499|FG000|COMPLETED|Open-label Period Weeks 145 - 192||123
2863059|NCT00116805|3565500|FG001|COMPLETED|Open-label Period Weeks 145 - 192||68
2863060|NCT00116805|3565499|FG000|NOT COMPLETED|Open-label Period Weeks 145 - 192||10
2863061|NCT00116805|3565500|FG001|NOT COMPLETED|Open-label Period Weeks 145 - 192||6
2863062|NCT00116805|3565499|FG000|STARTED|Open-label Period Weeks 193 - 240||123
2863063|NCT00116805|3565500|FG001|STARTED|Open-label Period Weeks 193 - 240||68
2863064|NCT00116805|3565499|FG000|COMPLETED|Open-label Period Weeks 193 - 240||110
2863065|NCT00116805|3565500|FG001|COMPLETED|Open-label Period Weeks 193 - 240||64
2863066|NCT00116805|3565499|FG000|NOT COMPLETED|Open-label Period Weeks 193 - 240||13
2863067|NCT00116805|3565500|FG001|NOT COMPLETED|Open-label Period Weeks 193 - 240||4
2863068|NCT00116805|3565499|FG000|STARTED|Open-label Period Weeks 241 - 288||110
2863069|NCT00116805|3565500|FG001|STARTED|Open-label Period Weeks 241 - 288||64
2863070|NCT00116805|3565499|FG000|COMPLETED|Open-label Period Weeks 241 - 288||104
2863071|NCT00116805|3565500|FG001|COMPLETED|Open-label Period Weeks 241 - 288||64
2863072|NCT00116805|3565499|FG000|NOT COMPLETED|Open-label Period Weeks 241 - 288||6
2863073|NCT00116805|3565500|FG001|NOT COMPLETED|Open-label Period Weeks 241 - 288||0
2863074|NCT00116805|3565499|FG000|STARTED|Open-label Period Weeks 289 - 336||104
2863075|NCT00116805|3565500|FG001|STARTED|Open-label Period Weeks 289 - 336||64
2863076|NCT00116805|3565499|FG000|COMPLETED|Open-label Period Weeks 289 - 336||98
2863077|NCT00116805|3565500|FG001|COMPLETED|Open-label Period Weeks 289 - 336||57
2863078|NCT00116805|3565499|FG000|NOT COMPLETED|Open-label Period Weeks 289 - 336||6
2863079|NCT00116805|3565500|FG001|NOT COMPLETED|Open-label Period Weeks 289 - 336||7
2863080|NCT00116805|3565499|FG000|STARTED|Open-label Period Weeks 337 - 384||98
2863081|NCT00116805|3565500|FG001|STARTED|Open-label Period Weeks 337 - 384||57
2863082|NCT00116805|3565499|FG000|COMPLETED|Open-label Period Weeks 337 - 384||90
3169052|NCT01922739|3896530|FG000|COMPLETED|Titration/Adjustment Period||170
3169053|NCT01922739|3896530|FG000|NOT COMPLETED|Titration/Adjustment Period||12
3169054|NCT01922739|3896530|FG000|STARTED|Open-label Treatment Period||170
3169055|NCT01922739|3896530|FG000|Treatment SAS and FAS|Open-label Treatment Period|SAS = safety analysis set FAS = full analysis set|170
2863083|NCT00116805|3565500|FG001|COMPLETED|Open-label Period Weeks 337 - 384||56
2863084|NCT00116805|3565499|FG000|NOT COMPLETED|Open-label Period Weeks 337 - 384||8
2863085|NCT00116805|3565500|FG001|NOT COMPLETED|Open-label Period Weeks 337 - 384||1
2863086|NCT00116805|3565499|FG000|STARTED|Open-label Period Weeks 385 - 432|31 participants completed 384 weeks but did not continue on study.|59
2863087|NCT00116805|3565500|FG001|STARTED|Open-label Period Weeks 385 - 432|26 participants completed 384 weeks but did not continue on study.|30
2863088|NCT00116805|3565499|FG000|COMPLETED|Open-label Period Weeks 385 - 432||57
2863089|NCT00116805|3565500|FG001|COMPLETED|Open-label Period Weeks 385 - 432||30
2863090|NCT00116805|3565499|FG000|NOT COMPLETED|Open-label Period Weeks 385 - 432||2
2863091|NCT00116805|3565500|FG001|NOT COMPLETED|Open-label Period Weeks 385 - 432||0
2863092|NCT00116805|3565499|FG000|STARTED|Open-label Period Weeks 433 - 480||57
2863093|NCT00116805|3565500|FG001|STARTED|Open-label Period Weeks 433 - 480|1 participant completed 432 weeks but did not continue on study.|29
2863094|NCT00116805|3565499|FG000|COMPLETED|Open-label Period Weeks 433 - 480||53
2863095|NCT00116805|3565500|FG001|COMPLETED|Open-label Period Weeks 433 - 480||29
2863096|NCT00116805|3565499|FG000|NOT COMPLETED|Open-label Period Weeks 433 - 480||4
2863097|NCT00116805|3565500|FG001|NOT COMPLETED|Open-label Period Weeks 433 - 480||0
2863098|NCT00116831|3565517|FG000|STARTED|Overall Study||337
2863099|NCT00116831|3565518|FG001|STARTED|Overall Study||331
2863100|NCT00116831|3565517|FG000|COMPLETED|Overall Study||264
2863101|NCT00116831|3565518|FG001|COMPLETED|Overall Study||259
2863102|NCT00116831|3565517|FG000|NOT COMPLETED|Overall Study||73
2863103|NCT00116831|3565518|FG001|NOT COMPLETED|Overall Study||72
2863104|NCT00116844|3565526|FG000|STARTED|Period 1: Treatment Period 1 (60 Days)||35
2863105|NCT00116844|3565527|FG001|STARTED|Period 1: Treatment Period 1 (60 Days)||36
2863106|NCT00116844|3565526|FG000|COMPLETED|Period 1: Treatment Period 1 (60 Days)||28
3169056|NCT01922739|3896530|FG000|COMPLETED|Open-label Treatment Period||136
3169057|NCT01922739|3896530|FG000|NOT COMPLETED|Open-label Treatment Period||34
3169058|NCT01922934|3896548|FG000|STARTED|Eligible Patients||428
3169059|NCT01922934|3896549|FG001|STARTED|Eligible Patients||4302
3169060|NCT01922934|3896548|FG000|COMPLETED|Eligible Patients|375 patients determined eligible after original random selection from DHHA data warehouse.|375
3169061|NCT01922934|3896549|FG001|COMPLETED|Eligible Patients|81 patients did not meet inclusion criteria as they were 80 years or older. 7 patients had died.|4214
2863107|NCT00116844|3565527|FG001|COMPLETED|Period 1: Treatment Period 1 (60 Days)||33
2863108|NCT00116844|3565526|FG000|NOT COMPLETED|Period 1: Treatment Period 1 (60 Days)||7
2863109|NCT00116844|3565527|FG001|NOT COMPLETED|Period 1: Treatment Period 1 (60 Days)||3
2863110|NCT00116844|3565526|FG000|STARTED|Period 2: Washout Period (7 Days)||28
2863111|NCT00116844|3565527|FG001|STARTED|Period 2: Washout Period (7 Days)||33
2863112|NCT00116844|3565526|FG000|COMPLETED|Period 2: Washout Period (7 Days)||28
2863113|NCT00116844|3565527|FG001|COMPLETED|Period 2: Washout Period (7 Days)||33
2863114|NCT00116844|3565526|FG000|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
2863115|NCT00116844|3565527|FG001|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
2863116|NCT00116844|3565526|FG000|STARTED|Period 1: Treatment Period 2 (60 Days)||28
2863117|NCT00116844|3565527|FG001|STARTED|Period 1: Treatment Period 2 (60 Days)||33
2863118|NCT00116844|3565526|FG000|COMPLETED|Period 1: Treatment Period 2 (60 Days)||24
2863119|NCT00116844|3565527|FG001|COMPLETED|Period 1: Treatment Period 2 (60 Days)||28
2863120|NCT00116844|3565526|FG000|NOT COMPLETED|Period 1: Treatment Period 2 (60 Days)||4
2863121|NCT00116844|3565527|FG001|NOT COMPLETED|Period 1: Treatment Period 2 (60 Days)||5
2863122|NCT00116857|3565535|FG000|STARTED|Overall Study||62
2863123|NCT00116857|3565536|FG001|STARTED|Overall Study||60
2863124|NCT00116857|3565535|FG000|COMPLETED|Overall Study||59
2863125|NCT00116857|3565536|FG001|COMPLETED|Overall Study||56
2863126|NCT00116857|3565535|FG000|NOT COMPLETED|Overall Study||3
2863127|NCT00116857|3565536|FG001|NOT COMPLETED|Overall Study||4
2863128|NCT00117143|3565546|FG000|STARTED|Overall Study||4
2863129|NCT00117143|3565547|FG001|STARTED|Overall Study||4
2863130|NCT00117143|3565548|FG002|STARTED|Overall Study||7
2863131|NCT00117143|3565549|FG003|STARTED|Overall Study||1
2863132|NCT00117143|3565546|FG000|Received First Dose|Overall Study||4
2863133|NCT00117143|3565547|FG001|Received First Dose|Overall Study||4
2863134|NCT00117143|3565548|FG002|Received First Dose|Overall Study||7
2863135|NCT00117143|3565549|FG003|Received First Dose|Overall Study||1
2863136|NCT00117143|3565546|FG000|Received Second Dose|Overall Study||4
2863137|NCT00117143|3565547|FG001|Received Second Dose|Overall Study||4
2863138|NCT00117143|3565548|FG002|Received Second Dose|Overall Study||6
2863139|NCT00117143|3565549|FG003|Received Second Dose|Overall Study||0
2863140|NCT00117143|3565546|FG000|COMPLETED|Overall Study||4
2863141|NCT00117143|3565547|FG001|COMPLETED|Overall Study||4
2863142|NCT00117143|3565548|FG002|COMPLETED|Overall Study||7
2863143|NCT00117143|3565549|FG003|COMPLETED|Overall Study||1
2863144|NCT00117143|3565546|FG000|NOT COMPLETED|Overall Study||0
2863145|NCT00117143|3565547|FG001|NOT COMPLETED|Overall Study||0
2863146|NCT00117143|3565548|FG002|NOT COMPLETED|Overall Study||0
2863147|NCT00117143|3565549|FG003|NOT COMPLETED|Overall Study||0
2863148|NCT00117156|3565559|FG000|STARTED|Overall Study||26
2863149|NCT00117156|3565559|FG000|COMPLETED|Overall Study||15
2863150|NCT00117156|3565559|FG000|NOT COMPLETED|Overall Study||11
2863151|NCT00117286|3565565|FG000|STARTED|Overall Study|Safety analysis set|30
2863152|NCT00117286|3565566|FG001|STARTED|Overall Study||27
2863153|NCT00117286|3565565|FG000|Switched to Higher Dose|Overall Study|A protocol amendment changed the dosage to 160 mg (40 mg/mL)|17
2863154|NCT00117286|3565566|FG001|Switched to Higher Dose|Overall Study||17
2863155|NCT00117286|3565565|FG000|COMPLETED|Overall Study|Participants ongoing at the time of study closure were considered to have completed the study|2
2863156|NCT00117286|3565566|FG001|COMPLETED|Overall Study||6
2863157|NCT00117286|3565565|FG000|NOT COMPLETED|Overall Study||28
2863158|NCT00117286|3565566|FG001|NOT COMPLETED|Overall Study||21
2863159|NCT00117312|3565576|FG000|STARTED|Overall Study||10
2863160|NCT00117312|3565577|FG001|STARTED|Overall Study||24
2863161|NCT00117312|3565578|FG002|STARTED|Overall Study||24
2863162|NCT00117312|3565579|FG003|STARTED|Overall Study||24
2863163|NCT00117312|3565576|FG000|Started FE200486 CS06A|Overall Study||1
2863164|NCT00117312|3565577|FG001|Started FE200486 CS06A|Overall Study||11
2863165|NCT00117312|3565578|FG002|Started FE200486 CS06A|Overall Study||16
2863166|NCT00117312|3565579|FG003|Started FE200486 CS06A|Overall Study||9
2863167|NCT00117312|3565576|FG000|COMPLETED|Overall Study||0
2863168|NCT00117312|3565577|FG001|COMPLETED|Overall Study|Defined as those patients ongoing when the extension study was terminated|4
2863169|NCT00117312|3565578|FG002|COMPLETED|Overall Study||0
2863170|NCT00117312|3565579|FG003|COMPLETED|Overall Study||3
2863171|NCT00117312|3565576|FG000|NOT COMPLETED|Overall Study||10
2863172|NCT00117312|3565577|FG001|NOT COMPLETED|Overall Study||20
2863173|NCT00117312|3565578|FG002|NOT COMPLETED|Overall Study||24
2863174|NCT00117312|3565579|FG003|NOT COMPLETED|Overall Study||21
2863175|NCT00117325|3565591|FG000|STARTED|Overall Study||173
2863176|NCT00117325|3565592|FG001|STARTED|Overall Study||179
2863177|NCT00117325|3565591|FG000|COMPLETED|Overall Study||160
2863178|NCT00117325|3565592|FG001|COMPLETED|Overall Study||167
2863179|NCT00117325|3565591|FG000|NOT COMPLETED|Overall Study||13
2863180|NCT00117325|3565592|FG001|NOT COMPLETED|Overall Study||12
2863181|NCT00117507|3565599|FG000|STARTED|Overall Study||24
2863182|NCT00117507|3565599|FG000|COMPLETED|Overall Study||9
2863183|NCT00117507|3565599|FG000|NOT COMPLETED|Overall Study||15
2863184|NCT00117559|3565606|FG000|STARTED|Overall Study||9
2863185|NCT00117559|3565607|FG001|STARTED|Overall Study||10
2863186|NCT00117559|3565606|FG000|COMPLETED|Overall Study||8
2863187|NCT00117559|3565607|FG001|COMPLETED|Overall Study||9
2863188|NCT00117559|3565606|FG000|NOT COMPLETED|Overall Study||1
2863189|NCT00117559|3565607|FG001|NOT COMPLETED|Overall Study||1
2863190|NCT00117572|3565615|FG000|STARTED|Overall Study||144
2863191|NCT00117572|3565616|FG001|STARTED|Overall Study||141
2863192|NCT00117572|3565615|FG000|COMPLETED|Overall Study||138
2863193|NCT00117572|3565616|FG001|COMPLETED|Overall Study||135
2863194|NCT00117572|3565615|FG000|NOT COMPLETED|Overall Study||6
2863195|NCT00117572|3565616|FG001|NOT COMPLETED|Overall Study||6
2863196|NCT00117585|3565622|FG000|STARTED|Overall Study||341
2863197|NCT00117585|3565622|FG000|COMPLETED|Overall Study||341
2863198|NCT00117585|3565622|FG000|NOT COMPLETED|Overall Study||0
2863199|NCT00117598|3565629|FG000|STARTED|Prior to Treatment Cross Over||57
2863200|NCT00117598|3565630|FG001|STARTED|Prior to Treatment Cross Over||56
2863201|NCT00117598|3565631|FG002|STARTED|Prior to Treatment Cross Over||56
2863202|NCT00117598|3565632|FG003|STARTED|Prior to Treatment Cross Over||0
2863203|NCT00117598|3565633|FG004|STARTED|Prior to Treatment Cross Over||0
2863204|NCT00117598|3565629|FG000|COMPLETED|Prior to Treatment Cross Over||0
2863205|NCT00117598|3565630|FG001|COMPLETED|Prior to Treatment Cross Over||3
2863206|NCT00117598|3565631|FG002|COMPLETED|Prior to Treatment Cross Over||4
2863207|NCT00117598|3565632|FG003|COMPLETED|Prior to Treatment Cross Over||0
2863208|NCT00117598|3565633|FG004|COMPLETED|Prior to Treatment Cross Over||0
2863209|NCT00117598|3565629|FG000|NOT COMPLETED|Prior to Treatment Cross Over||57
2863210|NCT00117598|3565630|FG001|NOT COMPLETED|Prior to Treatment Cross Over||53
2863211|NCT00117598|3565631|FG002|NOT COMPLETED|Prior to Treatment Cross Over||52
2863212|NCT00117598|3565632|FG003|NOT COMPLETED|Prior to Treatment Cross Over||0
2863213|NCT00117598|3565633|FG004|NOT COMPLETED|Prior to Treatment Cross Over||0
2863214|NCT00117598|3565629|FG000|STARTED|After Treament Cross Over||0
2863215|NCT00117598|3565630|FG001|STARTED|After Treament Cross Over||0
2863216|NCT00117598|3565631|FG002|STARTED|After Treament Cross Over||0
2863217|NCT00117598|3565632|FG003|STARTED|After Treament Cross Over||3
3169062|NCT01922934|3896548|FG000|NOT COMPLETED|Eligible Patients||53
3169063|NCT01922934|3896549|FG001|NOT COMPLETED|Eligible Patients||88
3169064|NCT01922934|3896548|FG000|STARTED|Visit 0 - Patient Contacted & Consented||375
3169065|NCT01922934|3896549|FG001|STARTED|Visit 0 - Patient Contacted & Consented|Control group patients were not contacted or offered intervention|4214
2863218|NCT00117598|3565633|FG004|STARTED|After Treament Cross Over||4
2863219|NCT00117598|3565629|FG000|COMPLETED|After Treament Cross Over||0
2863220|NCT00117598|3565630|FG001|COMPLETED|After Treament Cross Over||0
2863221|NCT00117598|3565631|FG002|COMPLETED|After Treament Cross Over||0
2863222|NCT00117598|3565632|FG003|COMPLETED|After Treament Cross Over||0
2863223|NCT00117598|3565633|FG004|COMPLETED|After Treament Cross Over||0
2863224|NCT00117598|3565629|FG000|NOT COMPLETED|After Treament Cross Over||0
2863225|NCT00117598|3565630|FG001|NOT COMPLETED|After Treament Cross Over||0
2863226|NCT00117598|3565631|FG002|NOT COMPLETED|After Treament Cross Over||0
2863227|NCT00117598|3565632|FG003|NOT COMPLETED|After Treament Cross Over||3
2863228|NCT00117598|3565633|FG004|NOT COMPLETED|After Treament Cross Over||4
2863229|NCT00117637|3565645|FG000|STARTED|First Intervention (Period 1)||97
2863230|NCT00117637|3565646|FG001|STARTED|First Intervention (Period 1)||92
2863231|NCT00117637|3565645|FG000|Subjects Received Treatment|First Intervention (Period 1)||97
2863232|NCT00117637|3565646|FG001|Subjects Received Treatment|First Intervention (Period 1)||90
2863233|NCT00117637|3565645|FG000|COMPLETED|First Intervention (Period 1)||79
2863234|NCT00117637|3565646|FG001|COMPLETED|First Intervention (Period 1)||67
2863235|NCT00117637|3565645|FG000|NOT COMPLETED|First Intervention (Period 1)||18
2863236|NCT00117637|3565646|FG001|NOT COMPLETED|First Intervention (Period 1)||25
2863237|NCT00117637|3565645|FG000|STARTED|Second Intervention (Period 2)|Not all patients who completed Period 1 (first progression) enter into Period 2|49
2863238|NCT00117637|3565646|FG001|STARTED|Second Intervention (Period 2)|Not all patients who completed Period 1 (first progression) enter into Period 2|61
2863239|NCT00117637|3565645|FG000|Subjects Received Treatment|Second Intervention (Period 2)||49
2863240|NCT00117637|3565646|FG001|Subjects Received Treatment|Second Intervention (Period 2)||61
2863241|NCT00117637|3565645|FG000|COMPLETED|Second Intervention (Period 2)||39
2863242|NCT00117637|3565646|FG001|COMPLETED|Second Intervention (Period 2)||39
2863243|NCT00117637|3565645|FG000|NOT COMPLETED|Second Intervention (Period 2)||10
2863244|NCT00117637|3565646|FG001|NOT COMPLETED|Second Intervention (Period 2)||22
2918497|NCT00527605|3628742|FG000|STARTED|Overall Study||126
2918498|NCT00527605|3628743|FG001|STARTED|Overall Study||127
2918499|NCT00527605|3628742|FG000|COMPLETED|Overall Study||113
2918500|NCT00527605|3628743|FG001|COMPLETED|Overall Study||116
2918501|NCT00527605|3628742|FG000|NOT COMPLETED|Overall Study||13
2918502|NCT00527605|3628743|FG001|NOT COMPLETED|Overall Study||11
2918503|NCT00527618|3628749|FG000|STARTED|Week 1-12 (First Intervention)|Acyclovir|16
2918504|NCT00527618|3628750|FG001|STARTED|Week 1-12 (First Intervention)|Valacyclovir; one participant was removed from the study due to urticaria after 2.5 weeks|18
2918505|NCT00527618|3628749|FG000|COMPLETED|Week 1-12 (First Intervention)|Acyclovir|13
2918506|NCT00527618|3628750|FG001|COMPLETED|Week 1-12 (First Intervention)|Valacyclovir|16
2918507|NCT00527618|3628749|FG000|NOT COMPLETED|Week 1-12 (First Intervention)||3
2918508|NCT00527618|3628750|FG001|NOT COMPLETED|Week 1-12 (First Intervention)||2
3169066|NCT01922934|3896548|FG000|COMPLETED|Visit 0 - Patient Contacted & Consented|reflects number of patients that were contacted and agreed to attend Visit 0|140
3169067|NCT01922934|3896549|FG001|COMPLETED|Visit 0 - Patient Contacted & Consented||4214
3169068|NCT01922934|3896548|FG000|NOT COMPLETED|Visit 0 - Patient Contacted & Consented||235
3169069|NCT01922934|3896549|FG001|NOT COMPLETED|Visit 0 - Patient Contacted & Consented||0
3169070|NCT01922934|3896548|FG000|STARTED|Visit 1- Weight Measured|21 patients did not return for Visit 1 to receive tool or have weight measured.|140
3169071|NCT01922934|3896549|FG001|STARTED|Visit 1- Weight Measured||4214
3169072|NCT01922934|3896548|FG000|COMPLETED|Visit 1- Weight Measured|Patients first received tool and were weighed at Visit 1|119
3169073|NCT01922934|3896549|FG001|COMPLETED|Visit 1- Weight Measured|1284 patients did not have any weights recorded in EMR during study timeframe|2930
3169074|NCT01922934|3896548|FG000|NOT COMPLETED|Visit 1- Weight Measured||21
3169075|NCT01922934|3896549|FG001|NOT COMPLETED|Visit 1- Weight Measured||1284
3169076|NCT01922934|3896548|FG000|STARTED|Visit 12 / Final Visits||119
3169077|NCT01922934|3896549|FG001|STARTED|Visit 12 / Final Visits||2930
3169078|NCT01922934|3896548|FG000|COMPLETED|Visit 12 / Final Visits|6 patients did not return for final visit and weight measure|113
3169079|NCT01922934|3896549|FG001|COMPLETED|Visit 12 / Final Visits|290 patients did not have a second weight recorded at one year (+/- 6months) of first weight|2640
3169080|NCT01922934|3896548|FG000|NOT COMPLETED|Visit 12 / Final Visits||6
3169081|NCT01922934|3896549|FG001|NOT COMPLETED|Visit 12 / Final Visits||290
3169082|NCT01922986|3896559|FG000|STARTED|Overall Study||2
3169083|NCT01922986|3896560|FG001|STARTED|Overall Study||2
3169084|NCT01922986|3896559|FG000|COMPLETED|Overall Study||2
3169085|NCT01922986|3896560|FG001|COMPLETED|Overall Study||2
3169086|NCT01922986|3896559|FG000|NOT COMPLETED|Overall Study||0
3169087|NCT01922986|3896560|FG001|NOT COMPLETED|Overall Study||0
3169088|NCT01923129|3896568|FG000|STARTED|Overall Study||71
3169089|NCT01923129|3896569|FG001|STARTED|Overall Study||71
3169090|NCT01923129|3896568|FG000|COMPLETED|Overall Study||71
3169091|NCT01923129|3896569|FG001|COMPLETED|Overall Study||71
3169092|NCT01923129|3896568|FG000|NOT COMPLETED|Overall Study||0
3169093|NCT01923129|3896569|FG001|NOT COMPLETED|Overall Study||0
3169094|NCT01923181|3896584|FG000|STARTED|Overall Study||70
2918509|NCT00527618|3628749|FG000|STARTED|Week 13-14 (Washout)||13
2918510|NCT00527618|3628750|FG001|STARTED|Week 13-14 (Washout)||16
2918511|NCT00527618|3628749|FG000|COMPLETED|Week 13-14 (Washout)||12
2918512|NCT00527618|3628750|FG001|COMPLETED|Week 13-14 (Washout)||16
2918513|NCT00527618|3628749|FG000|NOT COMPLETED|Week 13-14 (Washout)||1
2918514|NCT00527618|3628750|FG001|NOT COMPLETED|Week 13-14 (Washout)||0
2918515|NCT00527618|3628749|FG000|STARTED|Week 15-18 (Second Intervention)|Valacyclovir|12
2918516|NCT00527618|3628750|FG001|STARTED|Week 15-18 (Second Intervention)|Acyclovir|16
2918517|NCT00527618|3628749|FG000|COMPLETED|Week 15-18 (Second Intervention)|Valacyclovir|12
2918518|NCT00527618|3628750|FG001|COMPLETED|Week 15-18 (Second Intervention)|Acyclovir|13
2918519|NCT00527618|3628749|FG000|NOT COMPLETED|Week 15-18 (Second Intervention)||0
2918520|NCT00527618|3628750|FG001|NOT COMPLETED|Week 15-18 (Second Intervention)||3
2918521|NCT00527644|3628757|FG000|STARTED|Overall Study||14
2918522|NCT00527644|3628757|FG000|COMPLETED|Overall Study||14
2918523|NCT00527644|3628757|FG000|NOT COMPLETED|Overall Study||0
2918524|NCT00527722|3628763|FG000|STARTED|Overall Study||22
2918525|NCT00527722|3628764|FG001|STARTED|Overall Study||25
2918526|NCT00527722|3628763|FG000|COMPLETED|Overall Study||22
2918527|NCT00527722|3628764|FG001|COMPLETED|Overall Study||25
2918528|NCT00527722|3628763|FG000|NOT COMPLETED|Overall Study||0
2918529|NCT00527722|3628764|FG001|NOT COMPLETED|Overall Study||0
2918530|NCT00527735|3628773|FG000|STARTED|Overall Study|Treated|113
2918531|NCT00527735|3628774|FG001|STARTED|Overall Study|Treated|109
2918532|NCT00527735|3628775|FG002|STARTED|Overall Study|Treated|109
2918533|NCT00527735|3628773|FG000|COMPLETED|Overall Study|Still on treatment|5
2918534|NCT00527735|3628774|FG001|COMPLETED|Overall Study|Still on treatment|2
2918535|NCT00527735|3628775|FG002|COMPLETED|Overall Study|Still on treatment|2
2918536|NCT00527735|3628773|FG000|NOT COMPLETED|Overall Study||108
2918537|NCT00527735|3628774|FG001|NOT COMPLETED|Overall Study||107
2918538|NCT00527735|3628775|FG002|NOT COMPLETED|Overall Study||107
2918539|NCT00527787|3628797|FG000|STARTED|Overall Study||218
2920784|NCT00538759|3631352|FG000|NOT COMPLETED|Overall Study||0
2863245|NCT00117676|3565661|FG000|STARTED|Double-blind Period Through Week 48||254
2863246|NCT00117676|3565662|FG001|STARTED|Double-blind Period Through Week 48||128
2863247|NCT00117676|3565661|FG000|COMPLETED|Double-blind Period Through Week 48||244
2863248|NCT00117676|3565662|FG001|COMPLETED|Double-blind Period Through Week 48||121
2863249|NCT00117676|3565661|FG000|NOT COMPLETED|Double-blind Period Through Week 48||10
2863250|NCT00117676|3565662|FG001|NOT COMPLETED|Double-blind Period Through Week 48||7
2863251|NCT00117676|3565661|FG000|STARTED|Open-label Period: Weeks 49 - 96|9 participants completed 48 weeks but did not continue on study.|235
2863252|NCT00117676|3565662|FG001|STARTED|Open-label Period: Weeks 49 - 96|9 participants completed 48 weeks but did not continue on study.|112
2863253|NCT00117676|3565661|FG000|COMPLETED|Open-label Period: Weeks 49 - 96||225
2863254|NCT00117676|3565662|FG001|COMPLETED|Open-label Period: Weeks 49 - 96||110
2863255|NCT00117676|3565661|FG000|NOT COMPLETED|Open-label Period: Weeks 49 - 96||10
2863256|NCT00117676|3565662|FG001|NOT COMPLETED|Open-label Period: Weeks 49 - 96||2
2863257|NCT00117676|3565661|FG000|STARTED|Open-label Period: Weeks 97 - 144||225
2863258|NCT00117676|3565662|FG001|STARTED|Open-label Period: Weeks 97 - 144||110
2863259|NCT00117676|3565661|FG000|COMPLETED|Open-label Period: Weeks 97 - 144||219
2863260|NCT00117676|3565662|FG001|COMPLETED|Open-label Period: Weeks 97 - 144||109
2863261|NCT00117676|3565661|FG000|NOT COMPLETED|Open-label Period: Weeks 97 - 144||6
2863262|NCT00117676|3565662|FG001|NOT COMPLETED|Open-label Period: Weeks 97 - 144||1
2863263|NCT00117676|3565661|FG000|STARTED|Open-label Period: Weeks 145 - 192||219
2863264|NCT00117676|3565662|FG001|STARTED|Open-label Period: Weeks 145 - 192||109
2863265|NCT00117676|3565661|FG000|COMPLETED|Open-label Period: Weeks 145 - 192||209
2863266|NCT00117676|3565662|FG001|COMPLETED|Open-label Period: Weeks 145 - 192||106
2863267|NCT00117676|3565661|FG000|NOT COMPLETED|Open-label Period: Weeks 145 - 192||10
2863268|NCT00117676|3565662|FG001|NOT COMPLETED|Open-label Period: Weeks 145 - 192||3
2863269|NCT00117676|3565661|FG000|STARTED|Open-label Period: Weeks 193 - 240||209
2863270|NCT00117676|3565662|FG001|STARTED|Open-label Period: Weeks 193 - 240||106
2863271|NCT00117676|3565661|FG000|COMPLETED|Open-label Period: Weeks 193 - 240||202
2863272|NCT00117676|3565662|FG001|COMPLETED|Open-label Period: Weeks 193 - 240||103
2863273|NCT00117676|3565661|FG000|NOT COMPLETED|Open-label Period: Weeks 193 - 240||7
2863274|NCT00117676|3565662|FG001|NOT COMPLETED|Open-label Period: Weeks 193 - 240||3
2863275|NCT00117676|3565661|FG000|STARTED|Open-label Period: Weeks 241 - 288||202
2863276|NCT00117676|3565662|FG001|STARTED|Open-label Period: Weeks 241 - 288||103
2863277|NCT00117676|3565661|FG000|COMPLETED|Open-label Period: Weeks 241 - 288||192
2863278|NCT00117676|3565662|FG001|COMPLETED|Open-label Period: Weeks 241 - 288||100
2863279|NCT00117676|3565661|FG000|NOT COMPLETED|Open-label Period: Weeks 241 - 288||10
2863280|NCT00117676|3565662|FG001|NOT COMPLETED|Open-label Period: Weeks 241 - 288||3
2863281|NCT00117676|3565661|FG000|STARTED|Open-label Period: Weeks 289 - 336||192
2863282|NCT00117676|3565662|FG001|STARTED|Open-label Period: Weeks 289 - 336||100
2863283|NCT00117676|3565661|FG000|COMPLETED|Open-label Period: Weeks 289 - 336||183
2863284|NCT00117676|3565662|FG001|COMPLETED|Open-label Period: Weeks 289 - 336||93
2863285|NCT00117676|3565661|FG000|NOT COMPLETED|Open-label Period: Weeks 289 - 336||9
2863286|NCT00117676|3565662|FG001|NOT COMPLETED|Open-label Period: Weeks 289 - 336||7
2863287|NCT00117676|3565661|FG000|STARTED|Open-label Period: Weeks 337 - 384||183
2863288|NCT00117676|3565662|FG001|STARTED|Open-label Period: Weeks 337 - 384||93
2863289|NCT00117676|3565661|FG000|COMPLETED|Open-label Period: Weeks 337 - 384||176
2863290|NCT00117676|3565662|FG001|COMPLETED|Open-label Period: Weeks 337 - 384||90
2863291|NCT00117676|3565661|FG000|NOT COMPLETED|Open-label Period: Weeks 337 - 384||7
2863292|NCT00117676|3565662|FG001|NOT COMPLETED|Open-label Period: Weeks 337 - 384||3
2863293|NCT00117676|3565661|FG000|STARTED|Open-label Period: Weeks 385 - 432|94 participants completed 384 weeks but did not continue on study.|82
2863294|NCT00117676|3565662|FG001|STARTED|Open-label Period: Weeks 385 - 432|44 participants completed 384 weeks but did not continue on study.|46
2863295|NCT00117676|3565661|FG000|COMPLETED|Open-label Period: Weeks 385 - 432||82
2863296|NCT00117676|3565662|FG001|COMPLETED|Open-label Period: Weeks 385 - 432||44
2863297|NCT00117676|3565661|FG000|NOT COMPLETED|Open-label Period: Weeks 385 - 432||0
2863298|NCT00117676|3565662|FG001|NOT COMPLETED|Open-label Period: Weeks 385 - 432||2
2863299|NCT00117676|3565661|FG000|STARTED|Open-label Period: Weeks 433 - 480||82
2863300|NCT00117676|3565662|FG001|STARTED|Open-label Period: Weeks 433 - 480|1 participant completed 432 weeks but did not continue on study.|43
2863301|NCT00117676|3565661|FG000|COMPLETED|Open-label Period: Weeks 433 - 480||80
2863302|NCT00117676|3565662|FG001|COMPLETED|Open-label Period: Weeks 433 - 480||41
2863303|NCT00117676|3565661|FG000|NOT COMPLETED|Open-label Period: Weeks 433 - 480||2
2863304|NCT00117676|3565662|FG001|NOT COMPLETED|Open-label Period: Weeks 433 - 480||2
2863305|NCT00117715|3565673|FG000|STARTED|Overall Study||121
2863306|NCT00117715|3565673|FG000|1 Year|Overall Study||88
2863307|NCT00117715|3565673|FG000|1.5 Year|Overall Study||85
2863308|NCT00117715|3565673|FG000|2 Year|Overall Study||76
2863309|NCT00117715|3565673|FG000|2.5 Year|Overall Study||70
2863310|NCT00117715|3565673|FG000|3 Year|Overall Study||61
2863311|NCT00117715|3565673|FG000|3.5 Year|Overall Study||60
2863312|NCT00117715|3565673|FG000|4 Year|Overall Study||58
2863313|NCT00117715|3565673|FG000|4.5 Year|Overall Study||55
2863314|NCT00117715|3565673|FG000|5 Year|Overall Study||49
2863315|NCT00117715|3565673|FG000|COMPLETED|Overall Study||49
2863316|NCT00117715|3565673|FG000|NOT COMPLETED|Overall Study||72
2863317|NCT00117793|3565677|FG000|STARTED|Overall Study||17
2863318|NCT00117793|3565677|FG000|COMPLETED|Overall Study||5
2863319|NCT00117793|3565677|FG000|NOT COMPLETED|Overall Study||12
2863320|NCT00117806|3565684|FG000|STARTED|Overall Study||81
2863321|NCT00117806|3565685|FG001|STARTED|Overall Study||76
2863322|NCT00117806|3565684|FG000|COMPLETED|Overall Study||43
2863323|NCT00117806|3565685|FG001|COMPLETED|Overall Study||60
2863324|NCT00117806|3565684|FG000|NOT COMPLETED|Overall Study||38
2863325|NCT00117806|3565685|FG001|NOT COMPLETED|Overall Study||16
2863326|NCT00117845|3565694|FG000|STARTED|Overall Study||17
2863327|NCT00117845|3565694|FG000|COMPLETED|Overall Study||16
2863328|NCT00117845|3565694|FG000|NOT COMPLETED|Overall Study||1
2863329|NCT00117949|3565702|FG000|STARTED|Overall Study|Dose level terminated prematurely due to inadequate testosterone response|10
2863330|NCT00117949|3565703|FG001|STARTED|Overall Study||24
2863331|NCT00117949|3565704|FG002|STARTED|Overall Study||24
2863332|NCT00117949|3565705|FG003|STARTED|Overall Study||24
2863333|NCT00117949|3565702|FG000|COMPLETED|Overall Study||0
2863334|NCT00117949|3565703|FG001|COMPLETED|Overall Study||0
2863335|NCT00117949|3565704|FG002|COMPLETED|Overall Study||0
2863336|NCT00117949|3565705|FG003|COMPLETED|Overall Study||0
2863337|NCT00117949|3565702|FG000|NOT COMPLETED|Overall Study||10
2863338|NCT00117949|3565703|FG001|NOT COMPLETED|Overall Study||24
2863339|NCT00117949|3565704|FG002|NOT COMPLETED|Overall Study||24
2863340|NCT00117949|3565705|FG003|NOT COMPLETED|Overall Study||24
2863341|NCT00117962|3565717|FG000|STARTED|Overall Study||48
2863342|NCT00117962|3565718|FG001|STARTED|Overall Study||53
2863343|NCT00117962|3565717|FG000|COMPLETED|Overall Study||26
2863344|NCT00117962|3565718|FG001|COMPLETED|Overall Study||28
2863345|NCT00117962|3565717|FG000|NOT COMPLETED|Overall Study||22
2863346|NCT00117962|3565718|FG001|NOT COMPLETED|Overall Study||25
2863347|NCT00117988|3565724|FG000|STARTED|Overall Study||22
2863348|NCT00117988|3565724|FG000|COMPLETED|Overall Study||18
2863349|NCT00117988|3565724|FG000|NOT COMPLETED|Overall Study||4
2863350|NCT00118040|3565731|FG000|STARTED|Overall Study||20
2863351|NCT00118040|3565732|FG001|STARTED|Overall Study||20
2863352|NCT00118040|3565733|FG002|STARTED|Overall Study||20
2863353|NCT00118040|3565731|FG000|COMPLETED|Overall Study||19
2863354|NCT00118040|3565732|FG001|COMPLETED|Overall Study||18
2863355|NCT00118040|3565733|FG002|COMPLETED|Overall Study||14
2863356|NCT00118040|3565731|FG000|NOT COMPLETED|Overall Study||1
2863357|NCT00118040|3565732|FG001|NOT COMPLETED|Overall Study||2
2863358|NCT00118040|3565733|FG002|NOT COMPLETED|Overall Study||6
2863359|NCT00118092|3565746|FG000|STARTED|Overall Study||17
2863360|NCT00118092|3565746|FG000|COMPLETED|Overall Study||15
2863361|NCT00118092|3565746|FG000|NOT COMPLETED|Overall Study||2
2863362|NCT00118131|3565751|FG000|STARTED|Overall Study||49
2863363|NCT00118131|3565751|FG000|COMPLETED|Overall Study||49
2863364|NCT00118131|3565751|FG000|NOT COMPLETED|Overall Study||0
2863365|NCT00118144|3565755|FG000|STARTED|Overall Study||42
2863366|NCT00118144|3565755|FG000|COMPLETED|Overall Study||41
2863367|NCT00118144|3565755|FG000|NOT COMPLETED|Overall Study||1
2863368|NCT00118157|3565760|FG000|STARTED|Overall Study||19
2863369|NCT00118157|3565760|FG000|COMPLETED|Overall Study||7
2863370|NCT00118157|3565760|FG000|NOT COMPLETED|Overall Study||12
2863371|NCT00118209|3565767|FG000|STARTED|Overall Study||262
2863372|NCT00118209|3565768|FG001|STARTED|Overall Study||262
2863373|NCT00118209|3565767|FG000|Evaluable for Primary Endpoint|Overall Study||250
2863374|NCT00118209|3565768|FG001|Evaluable for Primary Endpoint|Overall Study||241
2863375|NCT00118209|3565767|FG000|Evaluable for Safety Analysis|Overall Study||243
2863376|NCT00118209|3565768|FG001|Evaluable for Safety Analysis|Overall Study||237
2863377|NCT00118209|3565767|FG000|COMPLETED|Overall Study||250
2863378|NCT00118209|3565768|FG001|COMPLETED|Overall Study||241
2863379|NCT00118209|3565767|FG000|NOT COMPLETED|Overall Study||12
2863380|NCT00118209|3565768|FG001|NOT COMPLETED|Overall Study||21
2863381|NCT00118248|3565776|FG000|STARTED|Overall Study||17
2863382|NCT00118248|3565777|FG001|STARTED|Overall Study||24
2863383|NCT00118248|3565776|FG000|COMPLETED|Overall Study||17
2863384|NCT00118248|3565777|FG001|COMPLETED|Overall Study||24
2863385|NCT00118248|3565776|FG000|NOT COMPLETED|Overall Study||0
2863386|NCT00118248|3565777|FG001|NOT COMPLETED|Overall Study||0
2863387|NCT00118274|3565786|FG000|STARTED|Overall Study||41
2863388|NCT00118274|3565787|FG001|STARTED|Overall Study||43
2863389|NCT00118274|3565788|FG002|STARTED|Overall Study||42
2863390|NCT00118274|3565789|FG003|STARTED|Overall Study||44
3169095|NCT01923181|3896585|FG001|STARTED|Overall Study||70
3169096|NCT01923181|3896586|FG002|STARTED|Overall Study||69
3169097|NCT01923181|3896587|FG003|STARTED|Overall Study||70
3169098|NCT01923181|3896588|FG004|STARTED|Overall Study||71
3169099|NCT01923181|3896589|FG005|STARTED|Overall Study||70
2863391|NCT00118274|3565786|FG000|COMPLETED|Overall Study||21
2863392|NCT00118274|3565787|FG001|COMPLETED|Overall Study||21
2863393|NCT00118274|3565788|FG002|COMPLETED|Overall Study||25
2863394|NCT00118274|3565789|FG003|COMPLETED|Overall Study||29
2863395|NCT00118274|3565786|FG000|NOT COMPLETED|Overall Study||20
2863396|NCT00118274|3565787|FG001|NOT COMPLETED|Overall Study||22
2863397|NCT00118274|3565788|FG002|NOT COMPLETED|Overall Study||17
2863398|NCT00118274|3565789|FG003|NOT COMPLETED|Overall Study||15
2863399|NCT00118287|3565799|FG000|STARTED|Overall Study||32
2863400|NCT00118287|3565799|FG000|COMPLETED|Overall Study||30
2863401|NCT00118287|3565799|FG000|NOT COMPLETED|Overall Study||2
2863402|NCT00118352|3565806|FG000|STARTED|Overall Study||12
2863403|NCT00118352|3565807|FG001|STARTED|Overall Study||0
2863404|NCT00118352|3565808|FG002|STARTED|Overall Study||0
3169100|NCT01923181|3896590|FG006|STARTED|Overall Study||70
3169101|NCT01923181|3896591|FG007|STARTED|Overall Study||69
2863405|NCT00118352|3565806|FG000|COMPLETED|Overall Study||12
2863406|NCT00118352|3565807|FG001|COMPLETED|Overall Study||0
2863407|NCT00118352|3565808|FG002|COMPLETED|Overall Study||0
2863408|NCT00118352|3565806|FG000|NOT COMPLETED|Overall Study||0
2863409|NCT00118352|3565807|FG001|NOT COMPLETED|Overall Study||0
2863410|NCT00118352|3565808|FG002|NOT COMPLETED|Overall Study||0
2863411|NCT00118365|3565818|FG000|STARTED|Overall Study||191
2863412|NCT00118365|3565819|FG001|STARTED|Overall Study||184
2863413|NCT00118365|3565818|FG000|COMPLETED|Overall Study||132
2863414|NCT00118365|3565819|FG001|COMPLETED|Overall Study||124
2863415|NCT00118365|3565818|FG000|NOT COMPLETED|Overall Study||59
2863416|NCT00118365|3565819|FG001|NOT COMPLETED|Overall Study||60
2863417|NCT00118378|3565857|FG000|STARTED|Overall Study||62
2863418|NCT00118378|3565858|FG001|STARTED|Overall Study||53
2863419|NCT00118378|3565857|FG000|COMPLETED|Overall Study||60
2863420|NCT00118378|3565858|FG001|COMPLETED|Overall Study||45
2863421|NCT00118378|3565857|FG000|NOT COMPLETED|Overall Study||2
2863422|NCT00118378|3565858|FG001|NOT COMPLETED|Overall Study||8
2863423|NCT00118404|3565869|FG000|STARTED|Overall Study||86
2863424|NCT00118404|3565870|FG001|STARTED|Overall Study||86
2863425|NCT00118404|3565871|FG002|STARTED|Overall Study||69
2863426|NCT00118404|3565869|FG000|COMPLETED|Overall Study||62
2863427|NCT00118404|3565870|FG001|COMPLETED|Overall Study||70
2863428|NCT00118404|3565871|FG002|COMPLETED|Overall Study||49
2863429|NCT00118404|3565869|FG000|NOT COMPLETED|Overall Study||24
2863430|NCT00118404|3565870|FG001|NOT COMPLETED|Overall Study||16
2863431|NCT00118404|3565871|FG002|NOT COMPLETED|Overall Study||20
2863432|NCT00118417|3565879|FG000|STARTED|Phase I (Weeks 0 to 6)||39
2863433|NCT00118417|3565880|FG001|STARTED|Phase I (Weeks 0 to 6)|In Phase 1, all participants received open label SSRI - no second treatment arm.|0
2863434|NCT00118417|3565879|FG000|COMPLETED|Phase I (Weeks 0 to 6)||21
2863435|NCT00118417|3565880|FG001|COMPLETED|Phase I (Weeks 0 to 6)||0
2863436|NCT00118417|3565879|FG000|NOT COMPLETED|Phase I (Weeks 0 to 6)||18
2863437|NCT00118417|3565880|FG001|NOT COMPLETED|Phase I (Weeks 0 to 6)||0
2863438|NCT00118417|3565879|FG000|STARTED|Phase II (Weeks 6 to 12)|Three new participants on Phase 1 endpoint doses of SSRIs entered at Phase 2.|11
2863439|NCT00118417|3565880|FG001|STARTED|Phase II (Weeks 6 to 12)||13
2863440|NCT00118417|3565879|FG000|COMPLETED|Phase II (Weeks 6 to 12)||9
2863441|NCT00118417|3565880|FG001|COMPLETED|Phase II (Weeks 6 to 12)||10
2863442|NCT00118417|3565879|FG000|NOT COMPLETED|Phase II (Weeks 6 to 12)||2
2863443|NCT00118417|3565880|FG001|NOT COMPLETED|Phase II (Weeks 6 to 12)||3
2863444|NCT00118417|3565879|FG000|STARTED|Phase III (Weeks 12 to 24)||9
2863445|NCT00118417|3565880|FG001|STARTED|Phase III (Weeks 12 to 24)||10
2863446|NCT00118417|3565879|FG000|COMPLETED|Phase III (Weeks 12 to 24)||8
2863447|NCT00118417|3565880|FG001|COMPLETED|Phase III (Weeks 12 to 24)||9
2863448|NCT00118417|3565879|FG000|NOT COMPLETED|Phase III (Weeks 12 to 24)||1
2863449|NCT00118417|3565880|FG001|NOT COMPLETED|Phase III (Weeks 12 to 24)||1
2863450|NCT00118430|3565893|FG000|STARTED|Overall Study||123
2863451|NCT00118430|3565894|FG001|STARTED|Overall Study||127
2863452|NCT00118430|3565895|FG002|STARTED|Overall Study||250
2863453|NCT00118430|3565893|FG000|COMPLETED|Overall Study|123 included in primary analysis due to repeated measures and interim 1,3 and 6 month assessments|102
2863454|NCT00118430|3565894|FG001|COMPLETED|Overall Study|127 included in primary analysis due to repeated measures and interim 1,3 and 6 month assessments|103
2863455|NCT00118430|3565895|FG002|COMPLETED|Overall Study||222
2863456|NCT00118430|3565893|FG000|NOT COMPLETED|Overall Study||21
2863457|NCT00118430|3565894|FG001|NOT COMPLETED|Overall Study||24
2863458|NCT00118430|3565895|FG002|NOT COMPLETED|Overall Study||28
2863459|NCT00118482|3565904|FG000|STARTED|Overall Study|3 patients signed the consent but did not take the study medication.|105
2863460|NCT00118482|3565905|FG001|STARTED|Overall Study||105
2863461|NCT00118482|3565904|FG000|COMPLETED|Overall Study|210 in the Intention To Treat analysis|75
2863462|NCT00118482|3565905|FG001|COMPLETED|Overall Study||76
2863463|NCT00118482|3565904|FG000|NOT COMPLETED|Overall Study||30
2863464|NCT00118482|3565905|FG001|NOT COMPLETED|Overall Study||29
2863465|NCT00118534|3565913|FG000|STARTED|Overall Study||472
2863466|NCT00118534|3565914|FG001|STARTED|Overall Study||471
2863467|NCT00118534|3565913|FG000|COMPLETED|Overall Study||472
2863468|NCT00118534|3565914|FG001|COMPLETED|Overall Study||471
2863469|NCT00118534|3565913|FG000|NOT COMPLETED|Overall Study||0
2863470|NCT00118534|3565914|FG001|NOT COMPLETED|Overall Study||0
2863471|NCT00118703|3565923|FG000|STARTED|Overall Study||173
2863472|NCT00118703|3565924|FG001|STARTED|Overall Study||174
2863473|NCT00118703|3565923|FG000|COMPLETED|Overall Study||168
2863474|NCT00118703|3565924|FG001|COMPLETED|Overall Study||165
2863475|NCT00118703|3565923|FG000|NOT COMPLETED|Overall Study||5
2863476|NCT00118703|3565924|FG001|NOT COMPLETED|Overall Study||9
2863477|NCT00118716|3565932|FG000|STARTED|Overall Study||124
2863478|NCT00118716|3565933|FG001|STARTED|Overall Study||124
2863479|NCT00118716|3565932|FG000|COMPLETED|Overall Study||111
2863480|NCT00118716|3565933|FG001|COMPLETED|Overall Study||102
2863481|NCT00118716|3565932|FG000|NOT COMPLETED|Overall Study||13
2863482|NCT00118716|3565933|FG001|NOT COMPLETED|Overall Study||22
2863483|NCT00118742|3565941|FG000|STARTED|Overall Study||145
2863484|NCT00118742|3565942|FG001|STARTED|Overall Study||148
2863485|NCT00118742|3565941|FG000|COMPLETED|Overall Study||96
2863486|NCT00118742|3565942|FG001|COMPLETED|Overall Study||82
2863487|NCT00118742|3565941|FG000|NOT COMPLETED|Overall Study||49
2863488|NCT00118742|3565942|FG001|NOT COMPLETED|Overall Study||66
2863489|NCT00118755|3565950|FG000|STARTED|Overall Study||217
2863490|NCT00118755|3565951|FG001|STARTED|Overall Study||218
2863491|NCT00118755|3565950|FG000|Safety Population|Overall Study||208
2863492|NCT00118755|3565951|FG001|Safety Population|Overall Study||211
2863493|NCT00118755|3565950|FG000|COMPLETED|Overall Study||7
2863494|NCT00118755|3565951|FG001|COMPLETED|Overall Study||3
2863495|NCT00118755|3565950|FG000|NOT COMPLETED|Overall Study||210
2863496|NCT00118755|3565951|FG001|NOT COMPLETED|Overall Study||215
2863497|NCT00118898|3565961|FG000|STARTED|Overall Study||464
2863498|NCT00118898|3565962|FG001|STARTED|Overall Study||465
2863499|NCT00118898|3565963|FG002|STARTED|Overall Study||465
2863500|NCT00118898|3565964|FG003|STARTED|Overall Study||463
2863501|NCT00118898|3565961|FG000|Initiated Treatment|Overall Study||461
2863502|NCT00118898|3565962|FG001|Initiated Treatment|Overall Study||461
2863503|NCT00118898|3565963|FG002|Initiated Treatment|Overall Study||464
2863504|NCT00118898|3565964|FG003|Initiated Treatment|Overall Study||462
2863505|NCT00118898|3565961|FG000|COMPLETED|Overall Study||343
2863506|NCT00118898|3565962|FG001|COMPLETED|Overall Study||324
2863507|NCT00118898|3565963|FG002|COMPLETED|Overall Study||342
2863508|NCT00118898|3565964|FG003|COMPLETED|Overall Study||322
2863509|NCT00118898|3565961|FG000|NOT COMPLETED|Overall Study||121
2863510|NCT00118898|3565962|FG001|NOT COMPLETED|Overall Study||141
2863511|NCT00118898|3565963|FG002|NOT COMPLETED|Overall Study||123
2863512|NCT00118898|3565964|FG003|NOT COMPLETED|Overall Study||141
2863513|NCT00118911|3565976|FG000|STARTED|Overall Study||43
2863514|NCT00118911|3565977|FG001|STARTED|Overall Study||43
2863515|NCT00118911|3565976|FG000|Received Intervention as Assigned|Overall Study||41
2863516|NCT00118911|3565977|FG001|Received Intervention as Assigned|Overall Study||38
2863517|NCT00118911|3565976|FG000|Completed Post-Treatment Assessment|Overall Study||41
2863518|NCT00118911|3565977|FG001|Completed Post-Treatment Assessment|Overall Study||37
2863519|NCT00118911|3565976|FG000|6 Month Follow-up|Overall Study||37
2863520|NCT00118911|3565977|FG001|6 Month Follow-up|Overall Study||30
2863521|NCT00118911|3565976|FG000|12 Month Follow-up|Overall Study|1 participant did not complete the 6 month follow-up but did complete the 12 month follow-up|38
2863522|NCT00118911|3565977|FG001|12 Month Follow-up|Overall Study|2 participants did not complete the 6 month follow-up but did complete the 12 month follow-up|32
2863523|NCT00118911|3565976|FG000|COMPLETED|Overall Study||41
2863524|NCT00118911|3565977|FG001|COMPLETED|Overall Study||38
2863525|NCT00118911|3565976|FG000|NOT COMPLETED|Overall Study||2
2863526|NCT00118911|3565977|FG001|NOT COMPLETED|Overall Study||5
2863527|NCT00119015|3565985|FG000|STARTED|Open-Label Phase (2 Weeks)||102
2863528|NCT00119015|3565986|FG001|STARTED|Open-Label Phase (2 Weeks)||0
2863529|NCT00119015|3565987|FG002|STARTED|Open-Label Phase (2 Weeks)||0
2863530|NCT00119015|3565985|FG000|COMPLETED|Open-Label Phase (2 Weeks)||54
2863531|NCT00119015|3565986|FG001|COMPLETED|Open-Label Phase (2 Weeks)||0
2863532|NCT00119015|3565987|FG002|COMPLETED|Open-Label Phase (2 Weeks)||0
2863533|NCT00119015|3565985|FG000|NOT COMPLETED|Open-Label Phase (2 Weeks)||48
2863534|NCT00119015|3565986|FG001|NOT COMPLETED|Open-Label Phase (2 Weeks)||0
2863535|NCT00119015|3565987|FG002|NOT COMPLETED|Open-Label Phase (2 Weeks)||0
2863536|NCT00119015|3565985|FG000|STARTED|Double-Blind, Randomized Phase (2 Weeks)||0
2863537|NCT00119015|3565986|FG001|STARTED|Double-Blind, Randomized Phase (2 Weeks)|Baseline Analysis Population|28
2863538|NCT00119015|3565987|FG002|STARTED|Double-Blind, Randomized Phase (2 Weeks)|Baseline Analysis Population|26
2863539|NCT00119015|3565985|FG000|COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||0
2863540|NCT00119015|3565986|FG001|COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||28
2863541|NCT00119015|3565987|FG002|COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||26
2863542|NCT00119015|3565985|FG000|NOT COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||0
2863543|NCT00119015|3565986|FG001|NOT COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||0
2863544|NCT00119015|3565987|FG002|NOT COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||0
2863545|NCT00119041|3565996|FG000|STARTED|Overall Study||199
2863546|NCT00119041|3565997|FG001|STARTED|Overall Study||83
2863547|NCT00119041|3565998|FG002|STARTED|Overall Study||22
2863548|NCT00119041|3565996|FG000|COMPLETED|Overall Study||199
2863549|NCT00119041|3565997|FG001|COMPLETED|Overall Study||83
2863550|NCT00119041|3565998|FG002|COMPLETED|Overall Study||22
2863551|NCT00119041|3565996|FG000|NOT COMPLETED|Overall Study||0
2863552|NCT00119041|3565997|FG001|NOT COMPLETED|Overall Study||0
2863553|NCT00119041|3565998|FG002|NOT COMPLETED|Overall Study||0
2863554|NCT00119106|3566009|FG000|STARTED|Overall Study||1204
2863555|NCT00119106|3566010|FG001|STARTED|Overall Study|2 participants later found to be HIV infected at baseline. Therefore 1207 in mITT analysis|1209
2863556|NCT00119106|3566009|FG000|COMPLETED|Overall Study||1025
2863557|NCT00119106|3566010|FG001|COMPLETED|Overall Study||1031
2863558|NCT00119106|3566009|FG000|NOT COMPLETED|Overall Study||179
2863559|NCT00119106|3566010|FG001|NOT COMPLETED|Overall Study||178
2863560|NCT00119158|3566026|FG000|STARTED|Active Treatment|patients are self controls|45
2863561|NCT00119158|3566027|FG001|STARTED|Active Treatment||45
2863562|NCT00119158|3566026|FG000|COMPLETED|Active Treatment||45
2863563|NCT00119158|3566027|FG001|COMPLETED|Active Treatment||45
2863564|NCT00119158|3566026|FG000|NOT COMPLETED|Active Treatment||0
2863565|NCT00119158|3566027|FG001|NOT COMPLETED|Active Treatment||0
2863566|NCT00119158|3566026|FG000|STARTED|Placebo Treatment||45
2863567|NCT00119158|3566027|FG001|STARTED|Placebo Treatment||45
2863568|NCT00119158|3566026|FG000|COMPLETED|Placebo Treatment||45
2863569|NCT00119158|3566027|FG001|COMPLETED|Placebo Treatment||45
2863570|NCT00119158|3566026|FG000|NOT COMPLETED|Placebo Treatment||0
2863571|NCT00119158|3566027|FG001|NOT COMPLETED|Placebo Treatment||0
2863572|NCT00119262|3566035|FG000|STARTED|Overall Study||104
2863573|NCT00119262|3566036|FG001|STARTED|Overall Study||122
2863574|NCT00119262|3566035|FG000|Eligible|Overall Study||103
2863575|NCT00119262|3566036|FG001|Eligible|Overall Study||120
2863576|NCT00119262|3566035|FG000|Treated|Overall Study||103
2863577|NCT00119262|3566036|FG001|Treated|Overall Study||120
2863578|NCT00119262|3566035|FG000|Eligible and Treated|Overall Study||102
2863579|NCT00119262|3566036|FG001|Eligible and Treated|Overall Study||119
2863580|NCT00119262|3566035|FG000|COMPLETED|Overall Study||58
2863581|NCT00119262|3566036|FG001|COMPLETED|Overall Study||64
2863582|NCT00119262|3566035|FG000|NOT COMPLETED|Overall Study||46
2863583|NCT00119262|3566036|FG001|NOT COMPLETED|Overall Study||58
2863584|NCT00119379|3566044|FG000|STARTED|Overall Study||26
2863585|NCT00119379|3566045|FG001|STARTED|Overall Study||24
2863586|NCT00119379|3566044|FG000|COMPLETED|Overall Study||22
2863587|NCT00119379|3566045|FG001|COMPLETED|Overall Study||23
2863588|NCT00119379|3566044|FG000|NOT COMPLETED|Overall Study||4
2863589|NCT00119379|3566045|FG001|NOT COMPLETED|Overall Study||1
2863590|NCT00119392|3566051|FG000|STARTED|Overall Study||45
2863591|NCT00119392|3566051|FG000|COMPLETED|Overall Study||40
2863592|NCT00119392|3566051|FG000|NOT COMPLETED|Overall Study||5
2863593|NCT00119405|3566055|FG000|STARTED|Overall Study||18
2863594|NCT00119405|3566055|FG000|COMPLETED|Overall Study||17
2863595|NCT00119405|3566055|FG000|NOT COMPLETED|Overall Study||1
2863596|NCT00119678|3566061|FG000|STARTED|Double-blind Treatment Period||122
2863597|NCT00119678|3566062|FG001|STARTED|Double-blind Treatment Period||61
2863598|NCT00119678|3566061|FG000|RANDOMIZED AND TREATED|Double-blind Treatment Period||121
2863599|NCT00119678|3566062|FG001|RANDOMIZED AND TREATED|Double-blind Treatment Period||59
2863600|NCT00119678|3566061|FG000|RANDOMIZED,TREATED, AND ANALYZED|Double-blind Treatment Period||118
2863601|NCT00119678|3566062|FG001|RANDOMIZED,TREATED, AND ANALYZED|Double-blind Treatment Period||57
2863602|NCT00119678|3566061|FG000|COMPLETED|Double-blind Treatment Period||81
2863603|NCT00119678|3566062|FG001|COMPLETED|Double-blind Treatment Period||35
2863604|NCT00119678|3566061|FG000|NOT COMPLETED|Double-blind Treatment Period||41
2863605|NCT00119678|3566062|FG001|NOT COMPLETED|Double-blind Treatment Period||26
2863606|NCT00119678|3566061|FG000|STARTED|Open-label Treatment Period|Number of participants treated|110
2863607|NCT00119678|3566062|FG001|STARTED|Open-label Treatment Period||0
2863608|NCT00119678|3566061|FG000|COMPLETED|Open-label Treatment Period||0
2863609|NCT00119678|3566062|FG001|COMPLETED|Open-label Treatment Period||0
2863610|NCT00119678|3566061|FG000|NOT COMPLETED|Open-label Treatment Period||110
2863611|NCT00119678|3566062|FG001|NOT COMPLETED|Open-label Treatment Period||0
2863612|NCT00119847|3566072|FG000|STARTED|Overall Study||149
2863613|NCT00119847|3566073|FG001|STARTED|Overall Study||151
2863614|NCT00119847|3566072|FG000|COMPLETED|Overall Study||118
2863615|NCT00119847|3566073|FG001|COMPLETED|Overall Study||119
2863616|NCT00119847|3566072|FG000|NOT COMPLETED|Overall Study||31
2863617|NCT00119847|3566073|FG001|NOT COMPLETED|Overall Study||32
2863618|NCT00120250|3566079|FG000|STARTED|Overall Study||13
2863619|NCT00120250|3566080|FG001|STARTED|Overall Study||14
2863620|NCT00120250|3566079|FG000|COMPLETED|Overall Study||12
2863621|NCT00120250|3566080|FG001|COMPLETED|Overall Study||12
2863622|NCT00120250|3566079|FG000|NOT COMPLETED|Overall Study||1
2863623|NCT00120250|3566080|FG001|NOT COMPLETED|Overall Study||2
2863624|NCT00120289|3566089|FG000|STARTED|Overall Study||1718
2863625|NCT00120289|3566090|FG001|STARTED|Overall Study||1696
2863626|NCT00120289|3566089|FG000|COMPLETED|Overall Study||1597
2863627|NCT00120289|3566090|FG001|COMPLETED|Overall Study||1587
2863628|NCT00120289|3566089|FG000|NOT COMPLETED|Overall Study||121
2863629|NCT00120289|3566090|FG001|NOT COMPLETED|Overall Study||109
2863630|NCT00120406|3566098|FG000|STARTED|Overall Study||236
2863631|NCT00120406|3566099|FG001|STARTED|Overall Study||238
2863632|NCT00120406|3566098|FG000|COMPLETED|Overall Study||217
2863633|NCT00120406|3566099|FG001|COMPLETED|Overall Study||222
2863634|NCT00120406|3566098|FG000|NOT COMPLETED|Overall Study||19
2863635|NCT00120406|3566099|FG001|NOT COMPLETED|Overall Study||16
2863636|NCT00120523|3566107|FG000|STARTED|Treatment Period||1205
2863637|NCT00120523|3566108|FG001|STARTED|Treatment Period||1213
2863638|NCT00120523|3566107|FG000|COMPLETED|Treatment Period||836
2863639|NCT00120523|3566108|FG001|COMPLETED|Treatment Period||874
2863640|NCT00120523|3566107|FG000|NOT COMPLETED|Treatment Period||369
2863641|NCT00120523|3566108|FG001|NOT COMPLETED|Treatment Period||339
2863642|NCT00120523|3566107|FG000|STARTED|Follow-Up Period|Patients discontinued due to lost to follow-up or who withdrew consent were not part of this period.|120
2863643|NCT00120523|3566108|FG001|STARTED|Follow-Up Period|Patients discontinued due to lost to follow-up or who withdrew consent were not part of this period.|70
2863644|NCT00120523|3566107|FG000|COMPLETED|Follow-Up Period||90
2863645|NCT00120523|3566108|FG001|COMPLETED|Follow-Up Period||46
2863646|NCT00120523|3566107|FG000|NOT COMPLETED|Follow-Up Period||30
2863647|NCT00120523|3566108|FG001|NOT COMPLETED|Follow-Up Period||24
2863648|NCT00120627|3566117|FG000|STARTED|Overall Study|This is the number who enrolled and was randomly assigned to receive the Mantram Repetition Program.|71
2863649|NCT00120627|3566118|FG001|STARTED|Overall Study|This was the number that enrolled and was randomly assigned to receive the control condition.|75
2863650|NCT00120627|3566117|FG000|Began Interventions|Overall Study|Two people dropped due to scheduling conflict and illness.|69
2863651|NCT00120627|3566118|FG001|Began Interventions|Overall Study|Two people dropped due to scheduling conflict and an unknown reason.|73
2863652|NCT00120627|3566117|FG000|Did Not Complete Post-tx Assessments|Overall Study|One person had a scheduling conflict and two people were incarcerated.|3
2863653|NCT00120627|3566118|FG001|Did Not Complete Post-tx Assessments|Overall Study|Three people dropped out but no reason given.|3
2863654|NCT00120627|3566117|FG000|COMPLETED|Overall Study||66
2863655|NCT00120627|3566118|FG001|COMPLETED|Overall Study|Three people refused the post-assessments CAPS interview only.|70
2863656|NCT00120627|3566117|FG000|NOT COMPLETED|Overall Study||5
2863657|NCT00120627|3566118|FG001|NOT COMPLETED|Overall Study||5
2863658|NCT00120874|3566135|FG000|STARTED|Overall Study||10
2863659|NCT00120874|3566136|FG001|STARTED|Overall Study||10
2863660|NCT00120874|3566135|FG000|Completed Study; Started Extension Study|Overall Study||10
2863661|NCT00120874|3566136|FG001|Completed Study; Started Extension Study|Overall Study||10
2863662|NCT00120874|3566135|FG000|COMPLETED|Overall Study||10
2863663|NCT00120874|3566136|FG001|COMPLETED|Overall Study||9
2863664|NCT00120874|3566135|FG000|NOT COMPLETED|Overall Study||0
2863665|NCT00120874|3566136|FG001|NOT COMPLETED|Overall Study||1
2863666|NCT00121134|3566146|FG000|STARTED|Overall Study||40
2863667|NCT00121134|3566147|FG001|STARTED|Overall Study||41
2863668|NCT00121134|3566148|FG002|STARTED|Overall Study||41
2863669|NCT00121134|3566149|FG003|STARTED|Overall Study||40
2863670|NCT00121134|3566146|FG000|COMPLETED|Overall Study||24
3169102|NCT01923181|3896592|FG008|STARTED|Overall Study||71
3169103|NCT01923181|3896584|FG000|Full Analysis Set (FAS)|Overall Study||70
3169104|NCT01923181|3896585|FG001|Full Analysis Set (FAS)|Overall Study||70
3169105|NCT01923181|3896586|FG002|Full Analysis Set (FAS)|Overall Study||69
3169106|NCT01923181|3896587|FG003|Full Analysis Set (FAS)|Overall Study||70
3169107|NCT01923181|3896588|FG004|Full Analysis Set (FAS)|Overall Study||71
3169108|NCT01923181|3896589|FG005|Full Analysis Set (FAS)|Overall Study||70
3169109|NCT01923181|3896590|FG006|Full Analysis Set (FAS)|Overall Study||70
3169110|NCT01923181|3896591|FG007|Full Analysis Set (FAS)|Overall Study||69
3169111|NCT01923181|3896592|FG008|Full Analysis Set (FAS)|Overall Study||71
3169112|NCT01923181|3896584|FG000|Safety Analysis Set (SAS)|Overall Study||70
3169113|NCT01923181|3896585|FG001|Safety Analysis Set (SAS)|Overall Study||70
3169114|NCT01923181|3896586|FG002|Safety Analysis Set (SAS)|Overall Study||69
3169115|NCT01923181|3896587|FG003|Safety Analysis Set (SAS)|Overall Study||70
3169116|NCT01923181|3896588|FG004|Safety Analysis Set (SAS)|Overall Study||71
2863671|NCT00121134|3566147|FG001|COMPLETED|Overall Study||26
2863672|NCT00121134|3566148|FG002|COMPLETED|Overall Study||20
2863673|NCT00121134|3566149|FG003|COMPLETED|Overall Study||31
2863674|NCT00121134|3566146|FG000|NOT COMPLETED|Overall Study||16
2863675|NCT00121134|3566147|FG001|NOT COMPLETED|Overall Study||15
2863676|NCT00121134|3566148|FG002|NOT COMPLETED|Overall Study||21
2863677|NCT00121134|3566149|FG003|NOT COMPLETED|Overall Study||9
2863678|NCT00121173|3566162|FG000|STARTED|Overall Study||4
2863679|NCT00121173|3566163|FG001|STARTED|Overall Study||3
2863680|NCT00121173|3566164|FG002|STARTED|Overall Study||9
2863681|NCT00121173|3566162|FG000|COMPLETED|Overall Study||3
2863682|NCT00121173|3566163|FG001|COMPLETED|Overall Study||3
2863683|NCT00121173|3566164|FG002|COMPLETED|Overall Study||9
2863684|NCT00121173|3566162|FG000|NOT COMPLETED|Overall Study||1
2863685|NCT00121173|3566163|FG001|NOT COMPLETED|Overall Study||0
2863686|NCT00121173|3566164|FG002|NOT COMPLETED|Overall Study||0
2863687|NCT00121186|3566175|FG000|STARTED|Overall Study||1
2863688|NCT00121186|3566175|FG000|COMPLETED|Overall Study||1
2863689|NCT00121186|3566175|FG000|NOT COMPLETED|Overall Study||0
2863690|NCT00121199|3566179|FG000|STARTED|Overall Study||73
2863691|NCT00121199|3566179|FG000|Eligible|Overall Study||64
2863692|NCT00121199|3566179|FG000|Eligible and Began Protocol Therapy|Overall Study||64
2863693|NCT00121199|3566179|FG000|COMPLETED|Overall Study||45
2863694|NCT00121199|3566179|FG000|NOT COMPLETED|Overall Study||28
2863695|NCT00121225|3566183|FG000|STARTED|Overall Study||32
2863696|NCT00121225|3566183|FG000|COMPLETED|Overall Study||32
2863697|NCT00121225|3566183|FG000|NOT COMPLETED|Overall Study||0
2863698|NCT00121238|3566188|FG000|STARTED|Overall Study||16
2863699|NCT00121238|3566188|FG000|COMPLETED|Overall Study|2 were later deemed ineligible (PSA rise), censored from efficacy but included for toxicity analysis|13
2863700|NCT00121238|3566188|FG000|NOT COMPLETED|Overall Study||3
2863701|NCT00121251|3566192|FG000|STARTED|Overall Study||17
2863702|NCT00121251|3566192|FG000|COMPLETED|Overall Study||17
2863703|NCT00121251|3566192|FG000|NOT COMPLETED|Overall Study||0
2863704|NCT00121472|3566196|FG000|STARTED|Overall Study||194
2863705|NCT00121472|3566196|FG000|COMPLETED|Overall Study|Followed for at least 1 year after implantation of HM II LVAS.|194
2863706|NCT00121472|3566196|FG000|NOT COMPLETED|Overall Study||0
2863707|NCT00121485|3566206|FG000|STARTED|Overall Study||134
2863708|NCT00121485|3566207|FG001|STARTED|Overall Study||66
2863709|NCT00121485|3566206|FG000|COMPLETED|Overall Study||133
2863710|NCT00121485|3566207|FG001|COMPLETED|Overall Study||59
2863711|NCT00121485|3566206|FG000|NOT COMPLETED|Overall Study||1
2863712|NCT00121485|3566207|FG001|NOT COMPLETED|Overall Study||7
2863713|NCT00121641|3566218|FG000|STARTED|24-week Short-term Treatment Period||102
2863714|NCT00121641|3566219|FG001|STARTED|24-week Short-term Treatment Period||106
2863715|NCT00121641|3566220|FG002|STARTED|24-week Short-term Treatment Period||98
2863716|NCT00121641|3566221|FG003|STARTED|24-week Short-term Treatment Period||95
2863717|NCT00121641|3566222|FG004|STARTED|24-week Short-term Treatment Period||66
2863718|NCT00121641|3566218|FG000|COMPLETED|24-week Short-term Treatment Period||73
2863719|NCT00121641|3566219|FG001|COMPLETED|24-week Short-term Treatment Period||68
2863720|NCT00121641|3566220|FG002|COMPLETED|24-week Short-term Treatment Period||69
2863721|NCT00121641|3566221|FG003|COMPLETED|24-week Short-term Treatment Period||55
3169117|NCT01923181|3896589|FG005|Safety Analysis Set (SAS)|Overall Study||70
3169118|NCT01923181|3896590|FG006|Safety Analysis Set (SAS)|Overall Study||70
2863722|NCT00121641|3566222|FG004|COMPLETED|24-week Short-term Treatment Period||25
2863723|NCT00121641|3566218|FG000|NOT COMPLETED|24-week Short-term Treatment Period||29
2863724|NCT00121641|3566219|FG001|NOT COMPLETED|24-week Short-term Treatment Period||38
2863725|NCT00121641|3566220|FG002|NOT COMPLETED|24-week Short-term Treatment Period||29
2863726|NCT00121641|3566221|FG003|NOT COMPLETED|24-week Short-term Treatment Period||40
2863727|NCT00121641|3566222|FG004|NOT COMPLETED|24-week Short-term Treatment Period||41
2863728|NCT00121641|3566218|FG000|STARTED|48-month Short Term + Long Term Period||102
2863729|NCT00121641|3566219|FG001|STARTED|48-month Short Term + Long Term Period||106
2863730|NCT00121641|3566220|FG002|STARTED|48-month Short Term + Long Term Period||98
2863731|NCT00121641|3566221|FG003|STARTED|48-month Short Term + Long Term Period||95
2863732|NCT00121641|3566222|FG004|STARTED|48-month Short Term + Long Term Period||66
2863733|NCT00121641|3566218|FG000|COMPLETED|48-month Short Term + Long Term Period||23
2863734|NCT00121641|3566219|FG001|COMPLETED|48-month Short Term + Long Term Period||24
2863735|NCT00121641|3566220|FG002|COMPLETED|48-month Short Term + Long Term Period||28
2863736|NCT00121641|3566221|FG003|COMPLETED|48-month Short Term + Long Term Period||24
2863737|NCT00121641|3566222|FG004|COMPLETED|48-month Short Term + Long Term Period||8
2863738|NCT00121641|3566218|FG000|NOT COMPLETED|48-month Short Term + Long Term Period||79
2863739|NCT00121641|3566219|FG001|NOT COMPLETED|48-month Short Term + Long Term Period||82
2863740|NCT00121641|3566220|FG002|NOT COMPLETED|48-month Short Term + Long Term Period||70
2863741|NCT00121641|3566221|FG003|NOT COMPLETED|48-month Short Term + Long Term Period||71
2863742|NCT00121641|3566222|FG004|NOT COMPLETED|48-month Short Term + Long Term Period||58
2863743|NCT00121667|3566240|FG000|STARTED|Short Term (ST) Period||192
2863744|NCT00121667|3566241|FG001|STARTED|Short Term (ST) Period||191
2863745|NCT00121667|3566242|FG002|STARTED|Short Term (ST) Period||181
2863746|NCT00121667|3566243|FG003|STARTED|Short Term (ST) Period||179
2863747|NCT00121667|3566240|FG000|COMPLETED|Short Term (ST) Period||148
2863748|NCT00121667|3566241|FG001|COMPLETED|Short Term (ST) Period||143
2863749|NCT00121667|3566242|FG002|COMPLETED|Short Term (ST) Period||140
2863750|NCT00121667|3566243|FG003|COMPLETED|Short Term (ST) Period||112
2863751|NCT00121667|3566240|FG000|NOT COMPLETED|Short Term (ST) Period||44
2863752|NCT00121667|3566241|FG001|NOT COMPLETED|Short Term (ST) Period||48
2863753|NCT00121667|3566242|FG002|NOT COMPLETED|Short Term (ST) Period||41
2863754|NCT00121667|3566243|FG003|NOT COMPLETED|Short Term (ST) Period||67
2863755|NCT00121667|3566240|FG000|STARTED|Short Term (ST) + Long Term (LT) Period||192
2863756|NCT00121667|3566241|FG001|STARTED|Short Term (ST) + Long Term (LT) Period||191
2863757|NCT00121667|3566242|FG002|STARTED|Short Term (ST) + Long Term (LT) Period||181
2863758|NCT00121667|3566243|FG003|STARTED|Short Term (ST) + Long Term (LT) Period||179
2863759|NCT00121667|3566240|FG000|Completed Study Without Being Rescued|Short Term (ST) + Long Term (LT) Period||14
2863760|NCT00121667|3566241|FG001|Completed Study Without Being Rescued|Short Term (ST) + Long Term (LT) Period||18
2863761|NCT00121667|3566242|FG002|Completed Study Without Being Rescued|Short Term (ST) + Long Term (LT) Period||23
2863762|NCT00121667|3566243|FG003|Completed Study Without Being Rescued|Short Term (ST) + Long Term (LT) Period||7
2863763|NCT00121667|3566240|FG000|COMPLETED|Short Term (ST) + Long Term (LT) Period||64
2863764|NCT00121667|3566241|FG001|COMPLETED|Short Term (ST) + Long Term (LT) Period||58
2863765|NCT00121667|3566242|FG002|COMPLETED|Short Term (ST) + Long Term (LT) Period||68
2863766|NCT00121667|3566243|FG003|COMPLETED|Short Term (ST) + Long Term (LT) Period||39
2863767|NCT00121667|3566240|FG000|NOT COMPLETED|Short Term (ST) + Long Term (LT) Period||128
2863768|NCT00121667|3566241|FG001|NOT COMPLETED|Short Term (ST) + Long Term (LT) Period||133
2863769|NCT00121667|3566242|FG002|NOT COMPLETED|Short Term (ST) + Long Term (LT) Period||113
2863770|NCT00121667|3566243|FG003|NOT COMPLETED|Short Term (ST) + Long Term (LT) Period||140
2863771|NCT00121719|3566265|FG000|STARTED|Dose Escalation (4 Weeks)||4
2863772|NCT00121719|3566266|FG001|STARTED|Dose Escalation (4 Weeks)||4
2863773|NCT00121719|3566267|FG002|STARTED|Dose Escalation (4 Weeks)||4
2863774|NCT00121719|3566268|FG003|STARTED|Dose Escalation (4 Weeks)||3
2863775|NCT00121719|3566269|FG004|STARTED|Dose Escalation (4 Weeks)||3
2863776|NCT00121719|3566270|FG005|STARTED|Dose Escalation (4 Weeks)||3
2863777|NCT00121719|3566271|FG006|STARTED|Dose Escalation (4 Weeks)||12
2863778|NCT00121719|3566272|FG007|STARTED|Dose Escalation (4 Weeks)||9
2863779|NCT00121719|3566273|FG008|STARTED|Dose Escalation (4 Weeks)||6
2863780|NCT00121719|3566274|FG009|STARTED|Dose Escalation (4 Weeks)||3
2863781|NCT00121719|3566275|FG010|STARTED|Dose Escalation (4 Weeks)||0
2863782|NCT00121719|3566276|FG011|STARTED|Dose Escalation (4 Weeks)||0
2863783|NCT00121719|3566277|FG012|STARTED|Dose Escalation (4 Weeks)||24
2863784|NCT00121719|3566278|FG013|STARTED|Dose Escalation (4 Weeks)||7
2863785|NCT00121719|3566265|FG000|COMPLETED|Dose Escalation (4 Weeks)||4
2863786|NCT00121719|3566266|FG001|COMPLETED|Dose Escalation (4 Weeks)||4
2863787|NCT00121719|3566267|FG002|COMPLETED|Dose Escalation (4 Weeks)||4
2863788|NCT00121719|3566268|FG003|COMPLETED|Dose Escalation (4 Weeks)||3
2863789|NCT00121719|3566269|FG004|COMPLETED|Dose Escalation (4 Weeks)||3
2863790|NCT00121719|3566270|FG005|COMPLETED|Dose Escalation (4 Weeks)||3
2863791|NCT00121719|3566271|FG006|COMPLETED|Dose Escalation (4 Weeks)||12
3313441|NCT03075410|4046791|FG000|COMPLETED|Part A-Period 3 (14 Days)||1
3313442|NCT03075410|4046792|FG001|COMPLETED|Part A-Period 3 (14 Days)||1
3313443|NCT03075410|4046793|FG002|COMPLETED|Part A-Period 3 (14 Days)||2
3313444|NCT03075410|4046794|FG003|COMPLETED|Part A-Period 3 (14 Days)||1
3313445|NCT03075410|4046795|FG004|COMPLETED|Part A-Period 3 (14 Days)||2
3313446|NCT03075410|4046796|FG005|COMPLETED|Part A-Period 3 (14 Days)||1
3313447|NCT03075410|4046797|FG006|COMPLETED|Part A-Period 3 (14 Days)||0
2863792|NCT00121719|3566272|FG007|COMPLETED|Dose Escalation (4 Weeks)||9
2863793|NCT00121719|3566273|FG008|COMPLETED|Dose Escalation (4 Weeks)||6
2863794|NCT00121719|3566274|FG009|COMPLETED|Dose Escalation (4 Weeks)||3
2863795|NCT00121719|3566275|FG010|COMPLETED|Dose Escalation (4 Weeks)||0
2863796|NCT00121719|3566276|FG011|COMPLETED|Dose Escalation (4 Weeks)||0
2863797|NCT00121719|3566277|FG012|COMPLETED|Dose Escalation (4 Weeks)||24
2863798|NCT00121719|3566278|FG013|COMPLETED|Dose Escalation (4 Weeks)||7
2863799|NCT00121719|3566265|FG000|NOT COMPLETED|Dose Escalation (4 Weeks)||0
2863800|NCT00121719|3566266|FG001|NOT COMPLETED|Dose Escalation (4 Weeks)||0
2863801|NCT00121719|3566267|FG002|NOT COMPLETED|Dose Escalation (4 Weeks)||0
2863802|NCT00121719|3566268|FG003|NOT COMPLETED|Dose Escalation (4 Weeks)||0
2863803|NCT00121719|3566269|FG004|NOT COMPLETED|Dose Escalation (4 Weeks)||0
2863804|NCT00121719|3566270|FG005|NOT COMPLETED|Dose Escalation (4 Weeks)||0
2863805|NCT00121719|3566271|FG006|NOT COMPLETED|Dose Escalation (4 Weeks)||0
2863806|NCT00121719|3566272|FG007|NOT COMPLETED|Dose Escalation (4 Weeks)||0
2863807|NCT00121719|3566273|FG008|NOT COMPLETED|Dose Escalation (4 Weeks)||0
2863808|NCT00121719|3566274|FG009|NOT COMPLETED|Dose Escalation (4 Weeks)||0
2863809|NCT00121719|3566275|FG010|NOT COMPLETED|Dose Escalation (4 Weeks)||0
2863810|NCT00121719|3566276|FG011|NOT COMPLETED|Dose Escalation (4 Weeks)||0
2863811|NCT00121719|3566277|FG012|NOT COMPLETED|Dose Escalation (4 Weeks)||0
2863812|NCT00121719|3566278|FG013|NOT COMPLETED|Dose Escalation (4 Weeks)||0
2863813|NCT00121719|3566265|FG000|STARTED|Food-Effect Pilot Study (4 Weeks)||0
2863814|NCT00121719|3566266|FG001|STARTED|Food-Effect Pilot Study (4 Weeks)||0
2863815|NCT00121719|3566267|FG002|STARTED|Food-Effect Pilot Study (4 Weeks)||0
2863816|NCT00121719|3566268|FG003|STARTED|Food-Effect Pilot Study (4 Weeks)||0
2863817|NCT00121719|3566269|FG004|STARTED|Food-Effect Pilot Study (4 Weeks)||0
2863818|NCT00121719|3566270|FG005|STARTED|Food-Effect Pilot Study (4 Weeks)||0
2863819|NCT00121719|3566271|FG006|STARTED|Food-Effect Pilot Study (4 Weeks)||0
2863820|NCT00121719|3566272|FG007|STARTED|Food-Effect Pilot Study (4 Weeks)||0
2863821|NCT00121719|3566273|FG008|STARTED|Food-Effect Pilot Study (4 Weeks)||0
2863822|NCT00121719|3566274|FG009|STARTED|Food-Effect Pilot Study (4 Weeks)||0
2863823|NCT00121719|3566275|FG010|STARTED|Food-Effect Pilot Study (4 Weeks)||6
2863824|NCT00121719|3566276|FG011|STARTED|Food-Effect Pilot Study (4 Weeks)||5
2863825|NCT00121719|3566277|FG012|STARTED|Food-Effect Pilot Study (4 Weeks)||0
2863826|NCT00121719|3566278|FG013|STARTED|Food-Effect Pilot Study (4 Weeks)||0
2863827|NCT00121719|3566265|FG000|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
2863828|NCT00121719|3566266|FG001|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
2863829|NCT00121719|3566267|FG002|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
2863830|NCT00121719|3566268|FG003|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
2863831|NCT00121719|3566269|FG004|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
2863832|NCT00121719|3566270|FG005|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
2863833|NCT00121719|3566271|FG006|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
2863834|NCT00121719|3566272|FG007|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
2863835|NCT00121719|3566273|FG008|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
2863836|NCT00121719|3566274|FG009|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
2863837|NCT00121719|3566275|FG010|COMPLETED|Food-Effect Pilot Study (4 Weeks)||6
2863838|NCT00121719|3566276|FG011|COMPLETED|Food-Effect Pilot Study (4 Weeks)||5
2863839|NCT00121719|3566277|FG012|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
2863840|NCT00121719|3566278|FG013|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
2863841|NCT00121719|3566265|FG000|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
2863842|NCT00121719|3566266|FG001|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
2863843|NCT00121719|3566267|FG002|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
2863844|NCT00121719|3566268|FG003|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
2863845|NCT00121719|3566269|FG004|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
2863846|NCT00121719|3566270|FG005|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
2863847|NCT00121719|3566271|FG006|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
2863848|NCT00121719|3566272|FG007|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
2863849|NCT00121719|3566273|FG008|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
2863850|NCT00121719|3566274|FG009|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
2863851|NCT00121719|3566275|FG010|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
2863852|NCT00121719|3566276|FG011|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
2863853|NCT00121719|3566277|FG012|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
2863854|NCT00121719|3566278|FG013|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
2863855|NCT00121810|3566322|FG000|STARTED|Overall Study||151
2863856|NCT00121810|3566323|FG001|STARTED|Overall Study||154
2863857|NCT00121810|3566322|FG000|Safety Population|Overall Study||148
2863858|NCT00121810|3566323|FG001|Safety Population|Overall Study||153
2863859|NCT00121810|3566322|FG000|Intent-to-Treat (ITT) Population|Overall Study||148
2863860|NCT00121810|3566323|FG001|Intent-to-Treat (ITT) Population|Overall Study||151
2863861|NCT00121810|3566322|FG000|COMPLETED|Overall Study||121
2863862|NCT00121810|3566323|FG001|COMPLETED|Overall Study||115
2863863|NCT00121810|3566322|FG000|NOT COMPLETED|Overall Study||30
2863864|NCT00121810|3566323|FG001|NOT COMPLETED|Overall Study||39
2863865|NCT00121836|3566329|FG000|STARTED|Overall Study||109
2863866|NCT00121836|3566329|FG000|COMPLETED|Overall Study||54
2863867|NCT00121836|3566329|FG000|NOT COMPLETED|Overall Study||55
2863868|NCT00121992|3566336|FG000|STARTED|Overall Study||521
2863869|NCT00121992|3566337|FG001|STARTED|Overall Study||539
2863870|NCT00121992|3566336|FG000|Hormone-receptor Positive and HER2 Positive Status Subjects|Overall Study||28
2920785|NCT00538759|3631353|FG001|NOT COMPLETED|Overall Study||0
2863871|NCT00121992|3566337|FG001|Hormone-receptor Positive and HER2 Positive Status Subjects|Overall Study||30
2863872|NCT00121992|3566336|FG000|Hormone-receptor Negative and HER2 Positive Status Subjects|Overall Study||24
2863873|NCT00121992|3566337|FG001|Hormone-receptor Negative and HER2 Positive Status Subjects|Overall Study||22
2863874|NCT00121992|3566336|FG000|Hormone-receptor Positive and HER2 Negative Status Subjects|Overall Study||209
2863875|NCT00121992|3566337|FG001|Hormone-receptor Positive and HER2 Negative Status Subjects|Overall Study||220
2863876|NCT00121992|3566336|FG000|Hormone-receptor Negative and HER2 Negative Status Subjects|Overall Study||92
2863877|NCT00121992|3566337|FG001|Hormone-receptor Negative and HER2 Negative Status Subjects|Overall Study||103
2863878|NCT00121992|3566336|FG000|COMPLETED|Overall Study||519
2863879|NCT00121992|3566337|FG001|COMPLETED|Overall Study||528
2863880|NCT00121992|3566336|FG000|NOT COMPLETED|Overall Study||2
2863881|NCT00121992|3566337|FG001|NOT COMPLETED|Overall Study||11
2863882|NCT00122109|3566345|FG000|STARTED|Overall Study|ITT|61
2863883|NCT00122109|3566346|FG001|STARTED|Overall Study|ITT|64
2863884|NCT00122109|3566345|FG000|COMPLETED|Overall Study||55
2863885|NCT00122109|3566346|FG001|COMPLETED|Overall Study||57
2863886|NCT00122109|3566345|FG000|NOT COMPLETED|Overall Study||6
2863887|NCT00122109|3566346|FG001|NOT COMPLETED|Overall Study||7
2863888|NCT00122135|3566357|FG000|STARTED|Overall Study||60
2863889|NCT00122135|3566358|FG001|STARTED|Overall Study||60
2863890|NCT00122135|3566357|FG000|COMPLETED|Overall Study||57
2863891|NCT00122135|3566358|FG001|COMPLETED|Overall Study||60
2863892|NCT00122135|3566357|FG000|NOT COMPLETED|Overall Study||3
2863893|NCT00122135|3566358|FG001|NOT COMPLETED|Overall Study||0
2863894|NCT00122187|3566366|FG000|STARTED|Overall Study||4
2863895|NCT00122187|3566367|FG001|STARTED|Overall Study||4
2863896|NCT00122187|3566366|FG000|Matched by Colonoscopy Volume|Overall Study||4
2863897|NCT00122187|3566367|FG001|Matched by Colonoscopy Volume|Overall Study||4
2863898|NCT00122187|3566366|FG000|Randomized to Intervention or Usual Care|Overall Study||4
2863899|NCT00122187|3566367|FG001|Randomized to Intervention or Usual Care|Overall Study||4
2863900|NCT00122187|3566366|FG000|Intervention Implemented|Overall Study||3
2863901|NCT00122187|3566367|FG001|Intervention Implemented|Overall Study||4
2863902|NCT00122187|3566366|FG000|Post-intervention Data Collection|Overall Study||2
2863903|NCT00122187|3566367|FG001|Post-intervention Data Collection|Overall Study||2
2863904|NCT00122187|3566366|FG000|COMPLETED|Overall Study||2
2863905|NCT00122187|3566367|FG001|COMPLETED|Overall Study||2
2863906|NCT00122187|3566366|FG000|NOT COMPLETED|Overall Study||2
2863907|NCT00122187|3566367|FG001|NOT COMPLETED|Overall Study||2
2863908|NCT00122278|3566377|FG000|STARTED|Overall Study||106
2863909|NCT00122278|3566378|FG001|STARTED|Overall Study||99
2863910|NCT00122278|3566377|FG000|COMPLETED|Overall Study||104
2863911|NCT00122278|3566378|FG001|COMPLETED|Overall Study||99
2863912|NCT00122278|3566377|FG000|NOT COMPLETED|Overall Study||2
2863913|NCT00122278|3566378|FG001|NOT COMPLETED|Overall Study||0
3169119|NCT01923181|3896591|FG007|Safety Analysis Set (SAS)|Overall Study||69
3169120|NCT01923181|3896592|FG008|Safety Analysis Set (SAS)|Overall Study||71
3169121|NCT01923181|3896584|FG000|COMPLETED|Overall Study||67
3169122|NCT01923181|3896585|FG001|COMPLETED|Overall Study||64
2863914|NCT00122317|3566384|FG000|STARTED|Overall Study||187
2863915|NCT00122317|3566384|FG000|COMPLETED|Overall Study||176
2863916|NCT00122317|3566384|FG000|NOT COMPLETED|Overall Study||11
2863917|NCT00122369|3566391|FG000|STARTED|Overall Study||76
2863918|NCT00122369|3566392|FG001|STARTED|Overall Study||82
2863919|NCT00122369|3566393|FG002|STARTED|Overall Study||78
2863920|NCT00122369|3566391|FG000|COMPLETED|Overall Study||76
2863921|NCT00122369|3566392|FG001|COMPLETED|Overall Study||82
2863922|NCT00122369|3566393|FG002|COMPLETED|Overall Study||78
2863923|NCT00122369|3566391|FG000|NOT COMPLETED|Overall Study||0
2863924|NCT00122369|3566392|FG001|NOT COMPLETED|Overall Study||0
2863925|NCT00122369|3566393|FG002|NOT COMPLETED|Overall Study||0
2863926|NCT00122382|3566406|FG000|STARTED|Double-Blind Study|participants randomized|256
2863927|NCT00122382|3566407|FG001|STARTED|Double-Blind Study|participants randomized|255
2863928|NCT00122382|3566408|FG002|STARTED|Double-Blind Study||0
2863929|NCT00122382|3566406|FG000|Treated|Double-Blind Study||256
2863930|NCT00122382|3566407|FG001|Treated|Double-Blind Study||253
2863931|NCT00122382|3566408|FG002|Treated|Double-Blind Study||0
2863932|NCT00122382|3566406|FG000|COMPLETED|Double-Blind Study||232
2863933|NCT00122382|3566407|FG001|COMPLETED|Double-Blind Study||227
2863934|NCT00122382|3566408|FG002|COMPLETED|Double-Blind Study||0
2863935|NCT00122382|3566406|FG000|NOT COMPLETED|Double-Blind Study||24
2863936|NCT00122382|3566407|FG001|NOT COMPLETED|Double-Blind Study||28
2863937|NCT00122382|3566408|FG002|NOT COMPLETED|Double-Blind Study||0
2863938|NCT00122382|3566406|FG000|STARTED|Open-Label Study||0
2863939|NCT00122382|3566407|FG001|STARTED|Open-Label Study||0
2863940|NCT00122382|3566408|FG002|STARTED|Open-Label Study||459
2863941|NCT00122382|3566406|FG000|COMPLETED|Open-Label Study||0
2863942|NCT00122382|3566407|FG001|COMPLETED|Open-Label Study||0
2863943|NCT00122382|3566408|FG002|COMPLETED|Open-Label Study||433
2863944|NCT00122382|3566406|FG000|NOT COMPLETED|Open-Label Study||0
2863945|NCT00122382|3566407|FG001|NOT COMPLETED|Open-Label Study||0
2863946|NCT00122382|3566408|FG002|NOT COMPLETED|Open-Label Study||26
2863947|NCT00122447|3566430|FG000|STARTED|Overall Study||18
2863948|NCT00122447|3566431|FG001|STARTED|Overall Study||18
2863949|NCT00122447|3566432|FG002|STARTED|Overall Study||17
2863950|NCT00122447|3566433|FG003|STARTED|Overall Study||17
2863951|NCT00122447|3566430|FG000|COMPLETED|Overall Study||17
3169123|NCT01923181|3896586|FG002|COMPLETED|Overall Study||67
2863952|NCT00122447|3566431|FG001|COMPLETED|Overall Study||13
2863953|NCT00122447|3566432|FG002|COMPLETED|Overall Study||16
2863954|NCT00122447|3566433|FG003|COMPLETED|Overall Study||14
2863955|NCT00122447|3566430|FG000|NOT COMPLETED|Overall Study||1
2863956|NCT00122447|3566431|FG001|NOT COMPLETED|Overall Study||5
2863957|NCT00122447|3566432|FG002|NOT COMPLETED|Overall Study||1
2863958|NCT00122447|3566433|FG003|NOT COMPLETED|Overall Study||3
2863959|NCT00122460|3566449|FG000|STARTED|Overall Study|Intention To Treat population, treatment group as randomized|222
2863960|NCT00122460|3566450|FG001|STARTED|Overall Study|Intention To Treat population, treatment group as randomized|220
2863961|NCT00122460|3566449|FG000|COMPLETED|Overall Study||215
2863962|NCT00122460|3566450|FG001|COMPLETED|Overall Study||219
2863963|NCT00122460|3566449|FG000|NOT COMPLETED|Overall Study||7
2863964|NCT00122460|3566450|FG001|NOT COMPLETED|Overall Study||1
2863965|NCT00122681|3566458|FG000|STARTED|Overall Study||9325
2863966|NCT00122681|3566459|FG001|STARTED|Overall Study||9319
2863967|NCT00122681|3566458|FG000|COMPLETED|Overall Study||7811
2863968|NCT00122681|3566459|FG001|COMPLETED|Overall Study||7798
2863969|NCT00122681|3566458|FG000|NOT COMPLETED|Overall Study||1514
2863970|NCT00122681|3566459|FG001|NOT COMPLETED|Overall Study||1521
2863971|NCT00122954|3566475|FG000|STARTED|Overall Study||18
2863972|NCT00122954|3566476|FG001|STARTED|Overall Study||21
2863973|NCT00122954|3566475|FG000|COMPLETED|Overall Study||16
2863974|NCT00122954|3566476|FG001|COMPLETED|Overall Study||18
2863975|NCT00122954|3566475|FG000|NOT COMPLETED|Overall Study||2
2863976|NCT00122954|3566476|FG001|NOT COMPLETED|Overall Study||3
2863977|NCT00122980|3566484|FG000|STARTED|Overall Study|Randomized sample: 67; Intent-to-treat sample: 67|67
2863978|NCT00122980|3566485|FG001|STARTED|Overall Study|Randomized sample: 67; Intent-to-treat sample: 66|66
2863979|NCT00122980|3566484|FG000|COMPLETED|Overall Study|Study terminated early|24
2863980|NCT00122980|3566485|FG001|COMPLETED|Overall Study|Study terminated early|26
2863981|NCT00122980|3566484|FG000|NOT COMPLETED|Overall Study||43
2863982|NCT00122980|3566485|FG001|NOT COMPLETED|Overall Study||40
2863983|NCT00123110|3566494|FG000|STARTED|Overall Study||12
2863984|NCT00123110|3566495|FG001|STARTED|Overall Study||12
2863985|NCT00123110|3566496|FG002|STARTED|Overall Study||11
2863986|NCT00123110|3566494|FG000|COMPLETED|Overall Study||12
2863987|NCT00123110|3566495|FG001|COMPLETED|Overall Study||12
2863988|NCT00123110|3566496|FG002|COMPLETED|Overall Study||11
2863989|NCT00123110|3566494|FG000|NOT COMPLETED|Overall Study||0
2863990|NCT00123110|3566495|FG001|NOT COMPLETED|Overall Study||0
2863991|NCT00123110|3566496|FG002|NOT COMPLETED|Overall Study||0
2863992|NCT00123123|3566507|FG000|STARTED|Overall Study||59
2863993|NCT00123123|3566508|FG001|STARTED|Overall Study||58
2863994|NCT00123123|3566509|FG002|STARTED|Overall Study||58
2863995|NCT00123123|3566507|FG000|COMPLETED|Overall Study||59
2863996|NCT00123123|3566508|FG001|COMPLETED|Overall Study||58
2863997|NCT00123123|3566509|FG002|COMPLETED|Overall Study||58
2863998|NCT00123123|3566507|FG000|NOT COMPLETED|Overall Study||0
2863999|NCT00123123|3566508|FG001|NOT COMPLETED|Overall Study||0
2864000|NCT00123123|3566509|FG002|NOT COMPLETED|Overall Study||0
2864001|NCT00123162|3566519|FG000|STARTED|Overall Study||13
2864002|NCT00123162|3566520|FG001|STARTED|Overall Study||12
2864003|NCT00123162|3566519|FG000|COMPLETED|Overall Study||13
2864004|NCT00123162|3566520|FG001|COMPLETED|Overall Study||12
2864005|NCT00123162|3566519|FG000|NOT COMPLETED|Overall Study||0
2864006|NCT00123162|3566520|FG001|NOT COMPLETED|Overall Study||0
2864007|NCT00123409|3566528|FG000|STARTED|Overall Study||72
2864008|NCT00123409|3566529|FG001|STARTED|Overall Study||74
2864009|NCT00123409|3566528|FG000|COMPLETED|Overall Study||68
2864010|NCT00123409|3566529|FG001|COMPLETED|Overall Study||71
2864011|NCT00123409|3566528|FG000|NOT COMPLETED|Overall Study||4
2864012|NCT00123409|3566529|FG001|NOT COMPLETED|Overall Study||3
2864013|NCT00123422|3566540|FG000|STARTED|Overall Study||35
2864014|NCT00123422|3566541|FG001|STARTED|Overall Study||33
2864015|NCT00123422|3566542|FG002|STARTED|Overall Study||35
2864016|NCT00123422|3566540|FG000|8-week Testing|Overall Study||32
2864017|NCT00123422|3566541|FG001|8-week Testing|Overall Study||30
2864018|NCT00123422|3566542|FG002|8-week Testing|Overall Study||27
2864019|NCT00123422|3566540|FG000|COMPLETED|Overall Study||31
2864020|NCT00123422|3566541|FG001|COMPLETED|Overall Study||27
2864021|NCT00123422|3566542|FG002|COMPLETED|Overall Study||25
2864022|NCT00123422|3566540|FG000|NOT COMPLETED|Overall Study||4
2864023|NCT00123422|3566541|FG001|NOT COMPLETED|Overall Study||6
2864024|NCT00123422|3566542|FG002|NOT COMPLETED|Overall Study||10
2864025|NCT00123474|3566554|FG000|STARTED|Randomized to Treatment||167
2864026|NCT00123474|3566555|FG001|STARTED|Randomized to Treatment||167
2864027|NCT00123474|3566556|FG002|STARTED|Randomized to Treatment||168
2864028|NCT00123474|3566557|FG003|STARTED|Randomized to Treatment||168
2864029|NCT00123474|3566554|FG000|COMPLETED|Randomized to Treatment||166
2864030|NCT00123474|3566555|FG001|COMPLETED|Randomized to Treatment||163
3169124|NCT01923181|3896587|FG003|COMPLETED|Overall Study||65
3169125|NCT01923181|3896588|FG004|COMPLETED|Overall Study||63
2864031|NCT00123474|3566556|FG002|COMPLETED|Randomized to Treatment||166
2864032|NCT00123474|3566557|FG003|COMPLETED|Randomized to Treatment||167
2864033|NCT00123474|3566554|FG000|NOT COMPLETED|Randomized to Treatment||1
2864034|NCT00123474|3566555|FG001|NOT COMPLETED|Randomized to Treatment||4
2864035|NCT00123474|3566556|FG002|NOT COMPLETED|Randomized to Treatment||2
2864036|NCT00123474|3566557|FG003|NOT COMPLETED|Randomized to Treatment||1
2864037|NCT00123474|3566554|FG000|STARTED|As Treated at Study Closure|Randomized to 50 mg BID but received 100 mg QD.|165
2864038|NCT00123474|3566555|FG001|STARTED|As Treated at Study Closure||163
2864039|NCT00123474|3566556|FG002|STARTED|As Treated at Study Closure||167
2864040|NCT00123474|3566557|FG003|STARTED|As Treated at Study Closure||167
2864041|NCT00123474|3566554|FG000|COMPLETED|As Treated at Study Closure||0
2864042|NCT00123474|3566555|FG001|COMPLETED|As Treated at Study Closure||0
2864043|NCT00123474|3566556|FG002|COMPLETED|As Treated at Study Closure|Randomized to 100 mg QD but received 50 mg BID.|0
2864044|NCT00123474|3566557|FG003|COMPLETED|As Treated at Study Closure||0
2864045|NCT00123474|3566554|FG000|NOT COMPLETED|As Treated at Study Closure||165
2864046|NCT00123474|3566555|FG001|NOT COMPLETED|As Treated at Study Closure||163
2864047|NCT00123474|3566556|FG002|NOT COMPLETED|As Treated at Study Closure||167
2864048|NCT00123474|3566557|FG003|NOT COMPLETED|As Treated at Study Closure||167
2864049|NCT00123487|3566590|FG000|STARTED|Randomized||306
2864050|NCT00123487|3566591|FG001|STARTED|Randomized||305
2864051|NCT00123487|3566590|FG000|COMPLETED|Randomized||305
2864052|NCT00123487|3566591|FG001|COMPLETED|Randomized||304
2864053|NCT00123487|3566590|FG000|NOT COMPLETED|Randomized||1
2864054|NCT00123487|3566591|FG001|NOT COMPLETED|Randomized||1
2864055|NCT00123487|3566590|FG000|STARTED|Treated With Study Drug|1 participant randomized to QD but received BID in error. 304 represents actual QD treatment.|304
2864056|NCT00123487|3566591|FG001|STARTED|Treated With Study Drug|1 participant randomized to QD but received BID in error. 305 represents actual BID treatment.|305
2864057|NCT00123487|3566590|FG000|COMPLETED|Treated With Study Drug||0
2864058|NCT00123487|3566591|FG001|COMPLETED|Treated With Study Drug||0
2864059|NCT00123487|3566590|FG000|NOT COMPLETED|Treated With Study Drug||304
2864060|NCT00123487|3566591|FG001|NOT COMPLETED|Treated With Study Drug||305
2864061|NCT00123604|3566600|FG000|STARTED|Overall Study||19
2864062|NCT00123604|3566601|FG001|STARTED|Overall Study||17
2864063|NCT00123604|3566600|FG000|COMPLETED|Overall Study||18
2864064|NCT00123604|3566601|FG001|COMPLETED|Overall Study||16
2864065|NCT00123604|3566600|FG000|NOT COMPLETED|Overall Study||1
2864066|NCT00123604|3566601|FG001|NOT COMPLETED|Overall Study||1
2864067|NCT00123630|3566609|FG000|STARTED|Overall Study||15
2864068|NCT00123630|3566610|FG001|STARTED|Overall Study||15
2864069|NCT00123630|3566609|FG000|COMPLETED|Overall Study||15
2864070|NCT00123630|3566610|FG001|COMPLETED|Overall Study||15
2864071|NCT00123630|3566609|FG000|NOT COMPLETED|Overall Study||0
2864072|NCT00123630|3566610|FG001|NOT COMPLETED|Overall Study||0
2864073|NCT00123643|3566618|FG000|STARTED|Overall Study||20
2864074|NCT00123643|3566619|FG001|STARTED|Overall Study||16
2864075|NCT00123643|3566618|FG000|COMPLETED|Overall Study||20
2864076|NCT00123643|3566619|FG001|COMPLETED|Overall Study||16
2864077|NCT00123643|3566618|FG000|NOT COMPLETED|Overall Study||0
2864078|NCT00123643|3566619|FG001|NOT COMPLETED|Overall Study||0
2864079|NCT00123682|3566629|FG000|STARTED|Overall Study||1069
2864080|NCT00123682|3566630|FG001|STARTED|Overall Study||934
2864081|NCT00123682|3566631|FG002|STARTED|Overall Study||592
2864082|NCT00123682|3566632|FG003|STARTED|Overall Study||525
2864083|NCT00123682|3566629|FG000|COMPLETED|Overall Study||749
3169126|NCT01923181|3896589|FG005|COMPLETED|Overall Study||66
3169127|NCT01923181|3896590|FG006|COMPLETED|Overall Study||62
3169128|NCT01923181|3896591|FG007|COMPLETED|Overall Study||61
3169129|NCT01923181|3896592|FG008|COMPLETED|Overall Study||68
3169130|NCT01923181|3896584|FG000|NOT COMPLETED|Overall Study||3
3169131|NCT01923181|3896585|FG001|NOT COMPLETED|Overall Study||6
3169132|NCT01923181|3896586|FG002|NOT COMPLETED|Overall Study||2
3169133|NCT01923181|3896587|FG003|NOT COMPLETED|Overall Study||5
2864084|NCT00123682|3566630|FG001|COMPLETED|Overall Study||731
2864085|NCT00123682|3566631|FG002|COMPLETED|Overall Study||438
2864086|NCT00123682|3566632|FG003|COMPLETED|Overall Study||430
2864087|NCT00123682|3566629|FG000|NOT COMPLETED|Overall Study||320
2864088|NCT00123682|3566630|FG001|NOT COMPLETED|Overall Study||203
2864089|NCT00123682|3566631|FG002|NOT COMPLETED|Overall Study||154
2864090|NCT00123682|3566632|FG003|NOT COMPLETED|Overall Study||95
2864091|NCT00123734|3566646|FG000|STARTED|Overall Study||82
2864092|NCT00123734|3566646|FG000|COMPLETED|Overall Study||74
2864093|NCT00123734|3566646|FG000|NOT COMPLETED|Overall Study||8
2864094|NCT00123955|3566655|FG000|STARTED|Overall Study||42
2864095|NCT00123955|3566656|FG001|STARTED|Overall Study||38
2864096|NCT00123955|3566655|FG000|COMPLETED|Overall Study||37
2864097|NCT00123955|3566656|FG001|COMPLETED|Overall Study||34
2864098|NCT00123955|3566655|FG000|NOT COMPLETED|Overall Study||5
2864099|NCT00123955|3566656|FG001|NOT COMPLETED|Overall Study||4
2864100|NCT00124020|3566664|FG000|STARTED|Overall Study||377
2864101|NCT00124020|3566665|FG001|STARTED|Overall Study||380
2864102|NCT00124020|3566664|FG000|COMPLETED|Overall Study||289
2864103|NCT00124020|3566665|FG001|COMPLETED|Overall Study||289
2864104|NCT00124020|3566664|FG000|NOT COMPLETED|Overall Study||88
2864105|NCT00124020|3566665|FG001|NOT COMPLETED|Overall Study||91
2864106|NCT00124072|3566675|FG000|STARTED|Overall Study||3017
2864107|NCT00124072|3566676|FG001|STARTED|Overall Study||3016
2864108|NCT00124072|3566677|FG002|STARTED|Overall Study||3016
2864109|NCT00124072|3566678|FG003|STARTED|Overall Study||3015
2864110|NCT00124072|3566675|FG000|COMPLETED|Overall Study||2503
2864111|NCT00124072|3566676|FG001|COMPLETED|Overall Study||2504
3169134|NCT01923181|3896588|FG004|NOT COMPLETED|Overall Study||8
3169135|NCT01923181|3896589|FG005|NOT COMPLETED|Overall Study||4
3169136|NCT01923181|3896590|FG006|NOT COMPLETED|Overall Study||8
3169137|NCT01923181|3896591|FG007|NOT COMPLETED|Overall Study||8
2864112|NCT00124072|3566677|FG002|COMPLETED|Overall Study||2524
3169138|NCT01923181|3896592|FG008|NOT COMPLETED|Overall Study||3
3169139|NCT01923285|3896617|FG000|STARTED|Overall Study||76
2864113|NCT00124072|3566678|FG003|COMPLETED|Overall Study||2515
2864114|NCT00124072|3566675|FG000|NOT COMPLETED|Overall Study||514
2864115|NCT00124072|3566676|FG001|NOT COMPLETED|Overall Study||512
2864116|NCT00124072|3566677|FG002|NOT COMPLETED|Overall Study||492
2864117|NCT00124072|3566678|FG003|NOT COMPLETED|Overall Study||500
2864118|NCT00124176|3566690|FG000|STARTED|Overall Study||40
2864119|NCT00124176|3566691|FG001|STARTED|Overall Study||41
2864120|NCT00124176|3566690|FG000|Received Study Drug|Overall Study|3 never started on drug due to improvement but were kept in the study by intention to treat.|37
2864121|NCT00124176|3566691|FG001|Received Study Drug|Overall Study||41
2864122|NCT00124176|3566690|FG000|COMPLETED|Overall Study||40
2864123|NCT00124176|3566691|FG001|COMPLETED|Overall Study||41
2864124|NCT00124176|3566690|FG000|NOT COMPLETED|Overall Study||0
2864125|NCT00124176|3566691|FG001|NOT COMPLETED|Overall Study||0
2864126|NCT00124449|3566699|FG000|STARTED|6-month Double-Blind Treatment Period||28
2864127|NCT00124449|3566700|FG001|STARTED|6-month Double-Blind Treatment Period||28
2864128|NCT00124449|3566699|FG000|COMPLETED|6-month Double-Blind Treatment Period||22
2864129|NCT00124449|3566700|FG001|COMPLETED|6-month Double-Blind Treatment Period||17
2864130|NCT00124449|3566699|FG000|NOT COMPLETED|6-month Double-Blind Treatment Period||6
2864131|NCT00124449|3566700|FG001|NOT COMPLETED|6-month Double-Blind Treatment Period||11
2864132|NCT00124449|3566699|FG000|STARTED|18-Month Untreated Observation Period||22
2864133|NCT00124449|3566700|FG001|STARTED|18-Month Untreated Observation Period||17
2864134|NCT00124449|3566699|FG000|Completed Year 1 of Study|18-Month Untreated Observation Period||14
2864135|NCT00124449|3566700|FG001|Completed Year 1 of Study|18-Month Untreated Observation Period||9
2864136|NCT00124449|3566699|FG000|COMPLETED|18-Month Untreated Observation Period||7
2864137|NCT00124449|3566700|FG001|COMPLETED|18-Month Untreated Observation Period||4
2864138|NCT00124449|3566699|FG000|NOT COMPLETED|18-Month Untreated Observation Period||15
2864139|NCT00124449|3566700|FG001|NOT COMPLETED|18-Month Untreated Observation Period||13
2864140|NCT00124462|3566709|FG000|STARTED|Overall Study||40
2864141|NCT00124462|3566710|FG001|STARTED|Overall Study||40
2864142|NCT00124462|3566709|FG000|COMPLETED|Overall Study||29
2864143|NCT00124462|3566710|FG001|COMPLETED|Overall Study||27
2864144|NCT00124462|3566709|FG000|NOT COMPLETED|Overall Study||11
2864145|NCT00124462|3566710|FG001|NOT COMPLETED|Overall Study||13
2864146|NCT00124514|3566721|FG000|STARTED|Overall Study||6
2864147|NCT00124514|3566722|FG001|STARTED|Overall Study||9
2864148|NCT00124514|3566723|FG002|STARTED|Overall Study||8
2864149|NCT00124514|3566724|FG003|STARTED|Overall Study||6
2864150|NCT00124514|3566725|FG004|STARTED|Overall Study||2
2864151|NCT00124514|3566721|FG000|COMPLETED|Overall Study||2
2864152|NCT00124514|3566722|FG001|COMPLETED|Overall Study||7
2864153|NCT00124514|3566723|FG002|COMPLETED|Overall Study||7
2864154|NCT00124514|3566724|FG003|COMPLETED|Overall Study||5
2864155|NCT00124514|3566725|FG004|COMPLETED|Overall Study||1
2864156|NCT00124514|3566721|FG000|NOT COMPLETED|Overall Study||4
2864157|NCT00124514|3566722|FG001|NOT COMPLETED|Overall Study||2
2864158|NCT00124514|3566723|FG002|NOT COMPLETED|Overall Study||1
2864159|NCT00124514|3566724|FG003|NOT COMPLETED|Overall Study||1
2864160|NCT00124514|3566725|FG004|NOT COMPLETED|Overall Study||1
2864161|NCT00124579|3566732|FG000|STARTED|Induction||7
2864162|NCT00124579|3566732|FG000|COMPLETED|Induction||2
2864163|NCT00124579|3566732|FG000|NOT COMPLETED|Induction||5
2864164|NCT00124579|3566732|FG000|STARTED|Maintenance||2
2864165|NCT00124579|3566732|FG000|COMPLETED|Maintenance||0
2864166|NCT00124579|3566732|FG000|NOT COMPLETED|Maintenance||2
2864167|NCT00124618|3566737|FG000|STARTED|Overall Study||58
2864168|NCT00124618|3566737|FG000|COMPLETED|Overall Study||57
2864169|NCT00124618|3566737|FG000|NOT COMPLETED|Overall Study||1
2864170|NCT00124657|3566744|FG000|STARTED|Overall Study||18
2864171|NCT00124657|3566745|FG001|STARTED|Overall Study||5
2864172|NCT00124657|3566746|FG002|STARTED|Overall Study||39
2864173|NCT00124657|3566744|FG000|COMPLETED|Overall Study||2
2864174|NCT00124657|3566745|FG001|COMPLETED|Overall Study||0
2864175|NCT00124657|3566746|FG002|COMPLETED|Overall Study||7
2864176|NCT00124657|3566744|FG000|NOT COMPLETED|Overall Study||16
2864177|NCT00124657|3566745|FG001|NOT COMPLETED|Overall Study||5
2864178|NCT00124657|3566746|FG002|NOT COMPLETED|Overall Study||32
2864179|NCT00124709|3566769|FG000|STARTED|Overall Study||546
2864180|NCT00124709|3566770|FG001|STARTED|Overall Study||545
2864181|NCT00124709|3566769|FG000|Patients Who Received Study Medication|Overall Study||543
2864182|NCT00124709|3566770|FG001|Patients Who Received Study Medication|Overall Study||544
2864183|NCT00124709|3566769|FG000|COMPLETED|Overall Study|232 Participants entered the OL phase of the study.|291
2864184|NCT00124709|3566770|FG001|COMPLETED|Overall Study|232 Participants entered the OL phase of the study.|273
2864185|NCT00124709|3566769|FG000|NOT COMPLETED|Overall Study||255
2864186|NCT00124709|3566770|FG001|NOT COMPLETED|Overall Study||272
2864187|NCT00124735|3566786|FG000|STARTED|Overall Study||5
2864188|NCT00124735|3566787|FG001|STARTED|Overall Study||8
2864189|NCT00124735|3566788|FG002|STARTED|Overall Study||18
2864190|NCT00124735|3566789|FG003|STARTED|Overall Study||21
2864191|NCT00124735|3566790|FG004|STARTED|Overall Study||19
2864192|NCT00124735|3566791|FG005|STARTED|Overall Study||7
2864193|NCT00124735|3566792|FG006|STARTED|Overall Study||6
2864194|NCT00124735|3566793|FG007|STARTED|Overall Study||20
2864195|NCT00124735|3566794|FG008|STARTED|Overall Study||25
2864196|NCT00124735|3566795|FG009|STARTED|Overall Study||20
2864197|NCT00124735|3566786|FG000|COMPLETED|Overall Study||4
2864198|NCT00124735|3566787|FG001|COMPLETED|Overall Study||6
2864199|NCT00124735|3566788|FG002|COMPLETED|Overall Study||18
2864200|NCT00124735|3566789|FG003|COMPLETED|Overall Study||18
2864201|NCT00124735|3566790|FG004|COMPLETED|Overall Study||17
3169140|NCT01923285|3896618|FG001|STARTED|Overall Study||76
3169141|NCT01923285|3896617|FG000|Modified Intent-to-treat|Overall Study||73
3169142|NCT01923285|3896618|FG001|Modified Intent-to-treat|Overall Study||73
2864202|NCT00124735|3566791|FG005|COMPLETED|Overall Study||5
2864203|NCT00124735|3566792|FG006|COMPLETED|Overall Study||6
2864204|NCT00124735|3566793|FG007|COMPLETED|Overall Study||19
2864205|NCT00124735|3566794|FG008|COMPLETED|Overall Study||22
2864206|NCT00124735|3566795|FG009|COMPLETED|Overall Study||18
2864207|NCT00124735|3566786|FG000|NOT COMPLETED|Overall Study||1
2864208|NCT00124735|3566787|FG001|NOT COMPLETED|Overall Study||2
2864209|NCT00124735|3566788|FG002|NOT COMPLETED|Overall Study||0
2864210|NCT00124735|3566789|FG003|NOT COMPLETED|Overall Study||3
2864211|NCT00124735|3566790|FG004|NOT COMPLETED|Overall Study||2
2864212|NCT00124735|3566791|FG005|NOT COMPLETED|Overall Study||2
2864213|NCT00124735|3566792|FG006|NOT COMPLETED|Overall Study||0
2864214|NCT00124735|3566793|FG007|NOT COMPLETED|Overall Study||1
2864215|NCT00124735|3566794|FG008|NOT COMPLETED|Overall Study||3
2864216|NCT00124735|3566795|FG009|NOT COMPLETED|Overall Study||2
2864217|NCT00124748|3566811|FG000|STARTED|Overall Study||157
2864218|NCT00124748|3566812|FG001|STARTED|Overall Study||319
2864219|NCT00124748|3566811|FG000|Safety Population|Overall Study||157
2864220|NCT00124748|3566812|FG001|Safety Population|Overall Study||316
2864221|NCT00124748|3566811|FG000|COMPLETED|Overall Study||14
2864222|NCT00124748|3566812|FG001|COMPLETED|Overall Study||35
2864223|NCT00124748|3566811|FG000|NOT COMPLETED|Overall Study||143
2864224|NCT00124748|3566812|FG001|NOT COMPLETED|Overall Study||284
2864225|NCT00124917|3566818|FG000|STARTED|Overall Study||6
2864226|NCT00124917|3566818|FG000|COMPLETED|Overall Study||3
2864227|NCT00124917|3566818|FG000|NOT COMPLETED|Overall Study||3
2918540|NCT00527787|3628798|FG001|STARTED|Overall Study|Safety and Intent-to-treat population (>=1 dose drug + no baseline ulcer) N=216|216
2918541|NCT00527787|3628797|FG000|COMPLETED|Overall Study||180
2918542|NCT00527787|3628798|FG001|COMPLETED|Overall Study||153
2918543|NCT00527787|3628797|FG000|NOT COMPLETED|Overall Study||38
2918544|NCT00527787|3628798|FG001|NOT COMPLETED|Overall Study||63
2918545|NCT00527826|3628806|FG000|STARTED|Overall Study|All Patients Population was used for Participant Flow section.|108
2918546|NCT00527826|3628807|FG001|STARTED|Overall Study||106
2918547|NCT00527826|3628806|FG000|COMPLETED|Overall Study||87
2918548|NCT00527826|3628807|FG001|COMPLETED|Overall Study||80
2918549|NCT00527826|3628806|FG000|NOT COMPLETED|Overall Study||21
2918550|NCT00527826|3628807|FG001|NOT COMPLETED|Overall Study||26
2918551|NCT00527878|3628816|FG000|STARTED|Intervention 1||7
2918552|NCT00527878|3628817|FG001|STARTED|Intervention 1||7
2918553|NCT00527878|3628816|FG000|COMPLETED|Intervention 1||5
2918554|NCT00527878|3628817|FG001|COMPLETED|Intervention 1||4
2918555|NCT00527878|3628816|FG000|NOT COMPLETED|Intervention 1||2
2918556|NCT00527878|3628817|FG001|NOT COMPLETED|Intervention 1||3
2918557|NCT00527878|3628816|FG000|STARTED|Intervention 2||5
2918558|NCT00527878|3628817|FG001|STARTED|Intervention 2||4
2918559|NCT00527878|3628816|FG000|COMPLETED|Intervention 2||5
2918560|NCT00527878|3628817|FG001|COMPLETED|Intervention 2||4
2918561|NCT00527878|3628816|FG000|NOT COMPLETED|Intervention 2||0
2918562|NCT00527878|3628817|FG001|NOT COMPLETED|Intervention 2||0
2918563|NCT00527904|3628823|FG000|STARTED|Overall Study||239
2918564|NCT00527904|3628823|FG000|COMPLETED|Overall Study||143
2918565|NCT00527904|3628823|FG000|NOT COMPLETED|Overall Study||96
2918566|NCT00527943|3628829|FG000|STARTED|Overall Study||6471
2918567|NCT00527943|3628830|FG001|STARTED|Overall Study||6473
2918568|NCT00527943|3628829|FG000|Received Treatment|Overall Study||6441
2918569|NCT00527943|3628830|FG001|Received Treatment|Overall Study||6446
2918570|NCT00527943|3628829|FG000|COMPLETED|Overall Study||6311
2918571|NCT00527943|3628830|FG001|COMPLETED|Overall Study||6327
2918572|NCT00527943|3628829|FG000|NOT COMPLETED|Overall Study||160
2918573|NCT00527943|3628830|FG001|NOT COMPLETED|Overall Study||146
2918574|NCT00528021|3628840|FG000|STARTED|Overall Study||59
2918575|NCT00528021|3628841|FG001|STARTED|Overall Study||59
2918576|NCT00528021|3628842|FG002|STARTED|Overall Study||56
2918577|NCT00528021|3628843|FG003|STARTED|Overall Study||56
2918578|NCT00528021|3628840|FG000|COMPLETED|Overall Study||42
2918579|NCT00528021|3628841|FG001|COMPLETED|Overall Study||46
2918580|NCT00528021|3628842|FG002|COMPLETED|Overall Study||49
2918581|NCT00528021|3628843|FG003|COMPLETED|Overall Study||47
2918582|NCT00528021|3628840|FG000|NOT COMPLETED|Overall Study||17
2918583|NCT00528021|3628841|FG001|NOT COMPLETED|Overall Study||13
2918584|NCT00528021|3628842|FG002|NOT COMPLETED|Overall Study||7
2918585|NCT00528021|3628843|FG003|NOT COMPLETED|Overall Study||9
2918586|NCT00528112|3628855|FG000|STARTED|Treatment up to 3 Years||1432
2918587|NCT00528112|3628856|FG001|STARTED|Treatment up to 3 Years||1453
2918588|NCT00528112|3628855|FG000|Participants Received Treatment|Treatment up to 3 Years|Full analysis set/Safety population|1432
2918589|NCT00528112|3628856|FG001|Participants Received Treatment|Treatment up to 3 Years|Full analysis set/Safety population|1452
2918590|NCT00528112|3628855|FG000|COMPLETED|Treatment up to 3 Years||819
2918591|NCT00528112|3628856|FG001|COMPLETED|Treatment up to 3 Years||870
2918592|NCT00528112|3628855|FG000|NOT COMPLETED|Treatment up to 3 Years||613
2918593|NCT00528112|3628856|FG001|NOT COMPLETED|Treatment up to 3 Years||583
2918594|NCT00528112|3628855|FG000|STARTED|Extension Phase|Only subjects in the LCS16 groups could participate in the extension phase|0
3169143|NCT01923285|3896617|FG000|COMPLETED|Overall Study||69
2864228|NCT00124943|3566827|FG000|STARTED|Phase I||3
2864229|NCT00124943|3566828|FG001|STARTED|Phase I||3
2864230|NCT00124943|3566829|FG002|STARTED|Phase I||3
2864231|NCT00124943|3566830|FG003|STARTED|Phase I||3
2864232|NCT00124943|3566827|FG000|COMPLETED|Phase I||3
2864233|NCT00124943|3566828|FG001|COMPLETED|Phase I||3
2864234|NCT00124943|3566829|FG002|COMPLETED|Phase I||3
2864235|NCT00124943|3566830|FG003|COMPLETED|Phase I||3
2864236|NCT00124943|3566827|FG000|NOT COMPLETED|Phase I||0
2864237|NCT00124943|3566828|FG001|NOT COMPLETED|Phase I||0
2864238|NCT00124943|3566829|FG002|NOT COMPLETED|Phase I||0
2864239|NCT00124943|3566830|FG003|NOT COMPLETED|Phase I||0
2864240|NCT00124943|3566827|FG000|STARTED|Phase II|Includes participants from Phase I who were followed for efficacy but not retreated in Phase II.|3
2864241|NCT00124943|3566828|FG001|STARTED|Phase II|Includes participants from Phase I who were followed for efficacy but not retreated in Phase II.|51
2864242|NCT00124943|3566829|FG002|STARTED|Phase II|Includes participants from Phase I who were followed for efficacy but not retreated in Phase II.|3
2864243|NCT00124943|3566830|FG003|STARTED|Phase II|Includes participants from Phase I who were followed for efficacy but not retreated in Phase II.|55
2864244|NCT00124943|3566827|FG000|COMPLETED|Phase II||3
2864245|NCT00124943|3566828|FG001|COMPLETED|Phase II||49
2864246|NCT00124943|3566829|FG002|COMPLETED|Phase II||3
2864247|NCT00124943|3566830|FG003|COMPLETED|Phase II||50
2864248|NCT00124943|3566827|FG000|NOT COMPLETED|Phase II||0
2864249|NCT00124943|3566828|FG001|NOT COMPLETED|Phase II||2
2864250|NCT00124943|3566829|FG002|NOT COMPLETED|Phase II||0
2864251|NCT00124943|3566830|FG003|NOT COMPLETED|Phase II||5
2864252|NCT00124982|3566842|FG000|STARTED|Short-term Period||449
2864253|NCT00124982|3566843|FG001|STARTED|Short-term Period||597
2864254|NCT00124982|3566844|FG002|STARTED|Short-term Period||0
2864255|NCT00124982|3566842|FG000|COMPLETED|Short-term Period||377
2864256|NCT00124982|3566843|FG001|COMPLETED|Short-term Period||483
2864257|NCT00124982|3566844|FG002|COMPLETED|Short-term Period||0
2864258|NCT00124982|3566842|FG000|NOT COMPLETED|Short-term Period||72
2864259|NCT00124982|3566843|FG001|NOT COMPLETED|Short-term Period||114
2864260|NCT00124982|3566844|FG002|NOT COMPLETED|Short-term Period||0
2864261|NCT00124982|3566842|FG000|STARTED|Long-term Period||0
2864262|NCT00124982|3566843|FG001|STARTED|Long-term Period||0
2864263|NCT00124982|3566844|FG002|STARTED|Long-term Period|A large number did not continue due to a rollover from study drug to commercially available drug.|530
2864264|NCT00124982|3566842|FG000|COMPLETED|Long-term Period||0
2864265|NCT00124982|3566843|FG001|COMPLETED|Long-term Period||0
2864266|NCT00124982|3566844|FG002|COMPLETED|Long-term Period||441
2864267|NCT00124982|3566842|FG000|NOT COMPLETED|Long-term Period||0
2864268|NCT00124982|3566843|FG001|NOT COMPLETED|Long-term Period||0
2864269|NCT00124982|3566844|FG002|NOT COMPLETED|Long-term Period||89
2864270|NCT00125034|3566855|FG000|STARTED|Overall Study|Randomized & treated. 1 subject was not randomized correctly and was excluded in the ITT population.|170
2864271|NCT00125034|3566856|FG001|STARTED|Overall Study|Randomized & treated|168
2864272|NCT00125034|3566855|FG000|COMPLETED|Overall Study||170
2864273|NCT00125034|3566856|FG001|COMPLETED|Overall Study||168
2864274|NCT00125034|3566855|FG000|NOT COMPLETED|Overall Study||0
2864275|NCT00125034|3566856|FG001|NOT COMPLETED|Overall Study||0
2864276|NCT00125138|3566866|FG000|STARTED|Overall Study||15
2864277|NCT00125138|3566867|FG001|STARTED|Overall Study|One subject requested withdrawal prior to treatment; data for the subject are excluded from results.|20
2864278|NCT00125138|3566868|FG002|STARTED|Overall Study||25
2864279|NCT00125138|3566869|FG003|STARTED|Overall Study||30
2864280|NCT00125138|3566866|FG000|COMPLETED|Overall Study||12
2864281|NCT00125138|3566867|FG001|COMPLETED|Overall Study||17
2864282|NCT00125138|3566868|FG002|COMPLETED|Overall Study||21
2864283|NCT00125138|3566869|FG003|COMPLETED|Overall Study||25
2864284|NCT00125138|3566866|FG000|NOT COMPLETED|Overall Study||3
2864285|NCT00125138|3566867|FG001|NOT COMPLETED|Overall Study||3
2864286|NCT00125138|3566868|FG002|NOT COMPLETED|Overall Study||4
2864287|NCT00125138|3566869|FG003|NOT COMPLETED|Overall Study||5
2864288|NCT00125164|3566883|FG000|STARTED|Overall Study||25
2864289|NCT00125164|3566884|FG001|STARTED|Overall Study||16
2864290|NCT00125164|3566885|FG002|STARTED|Overall Study||44
2864291|NCT00125164|3566886|FG003|STARTED|Overall Study||51
2864292|NCT00125164|3566883|FG000|COMPLETED|Overall Study||23
2864293|NCT00125164|3566884|FG001|COMPLETED|Overall Study||16
2864294|NCT00125164|3566885|FG002|COMPLETED|Overall Study||40
2864295|NCT00125164|3566886|FG003|COMPLETED|Overall Study||45
2864296|NCT00125164|3566883|FG000|NOT COMPLETED|Overall Study||2
2864297|NCT00125164|3566884|FG001|NOT COMPLETED|Overall Study||0
2864298|NCT00125164|3566885|FG002|NOT COMPLETED|Overall Study||4
2864299|NCT00125164|3566886|FG003|NOT COMPLETED|Overall Study||6
2864300|NCT00125190|3566896|FG000|STARTED|Overall Study||45
2864301|NCT00125190|3566896|FG000|Completed 34 Weeks of Study|Overall Study||43
2864302|NCT00125190|3566896|FG000|COMPLETED|Overall Study||30
2864303|NCT00125190|3566896|FG000|NOT COMPLETED|Overall Study||15
2864304|NCT00125242|3566903|FG000|STARTED|Overall Study||94
2864305|NCT00125242|3566904|FG001|STARTED|Overall Study||16
2864306|NCT00125242|3566903|FG000|COMPLETED|Overall Study||87
2864307|NCT00125242|3566904|FG001|COMPLETED|Overall Study||14
2864308|NCT00125242|3566903|FG000|NOT COMPLETED|Overall Study||7
2864309|NCT00125242|3566904|FG001|NOT COMPLETED|Overall Study||2
2864310|NCT00125359|3566909|FG000|STARTED|Overall Study||42
2864311|NCT00125359|3566909|FG000|COMPLETED|Overall Study||19
2864312|NCT00125359|3566909|FG000|NOT COMPLETED|Overall Study||23
2864313|NCT00125372|3566913|FG000|STARTED|Overall Study||12
2864314|NCT00125372|3566913|FG000|COMPLETED|Overall Study||10
2864315|NCT00125372|3566913|FG000|NOT COMPLETED|Overall Study||2
2864316|NCT00125515|3566920|FG000|STARTED|Overall Study||27
2864317|NCT00125515|3566921|FG001|STARTED|Overall Study||27
2864318|NCT00125515|3566922|FG002|STARTED|Overall Study||27
2864319|NCT00125515|3566920|FG000|COMPLETED|Overall Study||7
2864320|NCT00125515|3566921|FG001|COMPLETED|Overall Study||7
2864321|NCT00125515|3566922|FG002|COMPLETED|Overall Study||6
2864322|NCT00125515|3566920|FG000|NOT COMPLETED|Overall Study||20
2864323|NCT00125515|3566921|FG001|NOT COMPLETED|Overall Study||20
2864324|NCT00125515|3566922|FG002|NOT COMPLETED|Overall Study||21
2864325|NCT00125528|3566932|FG000|STARTED|Overall Study||20
2864326|NCT00125528|3566933|FG001|STARTED|Overall Study||21
2864327|NCT00125528|3566932|FG000|COMPLETED|Overall Study||18
2864328|NCT00125528|3566933|FG001|COMPLETED|Overall Study||20
2864329|NCT00125528|3566932|FG000|NOT COMPLETED|Overall Study||2
2864330|NCT00125528|3566933|FG001|NOT COMPLETED|Overall Study||1
2864331|NCT00125593|3566941|FG000|STARTED|Overall Study||4650
2864332|NCT00125593|3566942|FG001|STARTED|Overall Study||4620
2864333|NCT00125593|3566941|FG000|COMPLETED|Overall Study||4549
2864334|NCT00125593|3566942|FG001|COMPLETED|Overall Study||4517
2864335|NCT00125593|3566941|FG000|NOT COMPLETED|Overall Study||101
2864336|NCT00125593|3566942|FG001|NOT COMPLETED|Overall Study||103
2864337|NCT00125619|3566950|FG000|STARTED|Overall Study||8
2864338|NCT00125619|3566951|FG001|STARTED|Overall Study||8
2864339|NCT00125619|3566950|FG000|COMPLETED|Overall Study||8
2864340|NCT00125619|3566951|FG001|COMPLETED|Overall Study||8
2864341|NCT00125619|3566950|FG000|NOT COMPLETED|Overall Study||0
2864342|NCT00125619|3566951|FG001|NOT COMPLETED|Overall Study||0
2864343|NCT00125658|3566960|FG000|STARTED|Overall Study||8
2864344|NCT00125658|3566961|FG001|STARTED|Overall Study||6
2864345|NCT00125658|3566960|FG000|COMPLETED|Overall Study||8
2864346|NCT00125658|3566961|FG001|COMPLETED|Overall Study||6
2864347|NCT00125658|3566960|FG000|NOT COMPLETED|Overall Study||0
2864348|NCT00125658|3566961|FG001|NOT COMPLETED|Overall Study||0
2864349|NCT00125762|3566969|FG000|STARTED|Overall Study||907
2864350|NCT00125762|3566969|FG000|COMPLETED|Overall Study||748
2864351|NCT00125762|3566969|FG000|NOT COMPLETED|Overall Study||159
2864352|NCT00125788|3566975|FG000|STARTED|Overall Study||37
2864353|NCT00125788|3566976|FG001|STARTED|Overall Study||33
2864354|NCT00125788|3566975|FG000|COMPLETED|Overall Study||33
2864355|NCT00125788|3566976|FG001|COMPLETED|Overall Study||29
2864356|NCT00125788|3566975|FG000|NOT COMPLETED|Overall Study||4
2864357|NCT00125788|3566976|FG001|NOT COMPLETED|Overall Study||4
2864358|NCT00125853|3566982|FG000|STARTED|Wash-out (4 Weeks)||27
2864359|NCT00125853|3566983|FG001|STARTED|Wash-out (4 Weeks)||27
2864360|NCT00125853|3566982|FG000|COMPLETED|Wash-out (4 Weeks)||27
2864361|NCT00125853|3566983|FG001|COMPLETED|Wash-out (4 Weeks)||27
2864362|NCT00125853|3566982|FG000|NOT COMPLETED|Wash-out (4 Weeks)||0
2864363|NCT00125853|3566983|FG001|NOT COMPLETED|Wash-out (4 Weeks)||0
2864364|NCT00125853|3566982|FG000|STARTED|First Intervention (8 Weeks)||27
2864365|NCT00125853|3566983|FG001|STARTED|First Intervention (8 Weeks)||27
2864366|NCT00125853|3566982|FG000|COMPLETED|First Intervention (8 Weeks)||27
2864367|NCT00125853|3566983|FG001|COMPLETED|First Intervention (8 Weeks)||27
2864368|NCT00125853|3566982|FG000|NOT COMPLETED|First Intervention (8 Weeks)||0
2864369|NCT00125853|3566983|FG001|NOT COMPLETED|First Intervention (8 Weeks)||0
2864370|NCT00125853|3566982|FG000|STARTED|Wash-out (4 Weeks)||27
2864371|NCT00125853|3566983|FG001|STARTED|Wash-out (4 Weeks)||27
2864372|NCT00125853|3566982|FG000|COMPLETED|Wash-out (4 Weeks)||24
2864373|NCT00125853|3566983|FG001|COMPLETED|Wash-out (4 Weeks)||20
2864374|NCT00125853|3566982|FG000|NOT COMPLETED|Wash-out (4 Weeks)||3
2864375|NCT00125853|3566983|FG001|NOT COMPLETED|Wash-out (4 Weeks)||7
2864376|NCT00125853|3566982|FG000|STARTED|Second Intervention (8 Weeks)||24
2864377|NCT00125853|3566983|FG001|STARTED|Second Intervention (8 Weeks)||20
2864378|NCT00125853|3566982|FG000|COMPLETED|Second Intervention (8 Weeks)||24
2864379|NCT00125853|3566983|FG001|COMPLETED|Second Intervention (8 Weeks)||20
2864380|NCT00125853|3566982|FG000|NOT COMPLETED|Second Intervention (8 Weeks)||0
2864381|NCT00125853|3566983|FG001|NOT COMPLETED|Second Intervention (8 Weeks)||0
2864382|NCT00125931|3566989|FG000|STARTED|Overall Study||10
2864383|NCT00125931|3566989|FG000|COMPLETED|Overall Study||10
2864384|NCT00125931|3566989|FG000|NOT COMPLETED|Overall Study||0
2864385|NCT00125957|3566995|FG000|STARTED|First Intervention (3 Weeks)||15
2864386|NCT00125957|3566996|FG001|STARTED|First Intervention (3 Weeks)||17
2864387|NCT00125957|3566995|FG000|COMPLETED|First Intervention (3 Weeks)||15
2864388|NCT00125957|3566996|FG001|COMPLETED|First Intervention (3 Weeks)||17
2864389|NCT00125957|3566995|FG000|NOT COMPLETED|First Intervention (3 Weeks)||0
2864390|NCT00125957|3566996|FG001|NOT COMPLETED|First Intervention (3 Weeks)||0
2864391|NCT00125957|3566995|FG000|STARTED|Second Intervention (3 Weeks)||15
2864392|NCT00125957|3566996|FG001|STARTED|Second Intervention (3 Weeks)||17
2864393|NCT00125957|3566995|FG000|COMPLETED|Second Intervention (3 Weeks)||15
2864394|NCT00125957|3566996|FG001|COMPLETED|Second Intervention (3 Weeks)||17
2864395|NCT00125957|3566995|FG000|NOT COMPLETED|Second Intervention (3 Weeks)||0
2864396|NCT00125957|3566996|FG001|NOT COMPLETED|Second Intervention (3 Weeks)||0
2864397|NCT00126113|3567004|FG000|STARTED|Overall Study||37
2864398|NCT00126113|3567005|FG001|STARTED|Overall Study||37
2864399|NCT00126113|3567004|FG000|COMPLETED|Overall Study||34
2864400|NCT00126113|3567005|FG001|COMPLETED|Overall Study||35
2864401|NCT00126113|3567004|FG000|NOT COMPLETED|Overall Study||3
2864402|NCT00126113|3567005|FG001|NOT COMPLETED|Overall Study||2
2864403|NCT00126126|3567013|FG000|STARTED|Overall Study||9
2864404|NCT00126126|3567014|FG001|STARTED|Overall Study||9
2864405|NCT00126126|3567013|FG000|COMPLETED|Overall Study||9
2864406|NCT00126126|3567014|FG001|COMPLETED|Overall Study||7
2864407|NCT00126126|3567013|FG000|NOT COMPLETED|Overall Study||0
2864408|NCT00126126|3567014|FG001|NOT COMPLETED|Overall Study||2
2864409|NCT00126191|3567022|FG000|STARTED|Overall Study||2
2864410|NCT00126191|3567023|FG001|STARTED|Overall Study||8
2864411|NCT00126191|3567022|FG000|COMPLETED|Overall Study||2
2864412|NCT00126191|3567023|FG001|COMPLETED|Overall Study|1 pt off study during cycle 1 due to toxicity|6
2864413|NCT00126191|3567022|FG000|NOT COMPLETED|Overall Study||0
2864414|NCT00126191|3567023|FG001|NOT COMPLETED|Overall Study||2
2864415|NCT00126425|3567031|FG000|STARTED|Overall Study||539
2864416|NCT00126425|3567032|FG001|STARTED|Overall Study||48
2864417|NCT00126425|3567031|FG000|COMPLETED|Overall Study||498
2864418|NCT00126425|3567032|FG001|COMPLETED|Overall Study||37
2864419|NCT00126425|3567031|FG000|NOT COMPLETED|Overall Study||41
2864420|NCT00126425|3567032|FG001|NOT COMPLETED|Overall Study||11
2864421|NCT00126438|3567040|FG000|STARTED|Overall Study||453
2864422|NCT00126438|3567041|FG001|STARTED|Overall Study||62
2864423|NCT00126438|3567040|FG000|COMPLETED|Overall Study||419
2864424|NCT00126438|3567041|FG001|COMPLETED|Overall Study||52
2864425|NCT00126438|3567040|FG000|NOT COMPLETED|Overall Study||34
2864426|NCT00126438|3567041|FG001|NOT COMPLETED|Overall Study||10
2864427|NCT00126490|3567047|FG000|STARTED|Overall Study||19
2864428|NCT00126490|3567047|FG000|COMPLETED|Overall Study||18
3169144|NCT01923285|3896618|FG001|COMPLETED|Overall Study||70
3169145|NCT01923285|3896617|FG000|NOT COMPLETED|Overall Study||7
3169146|NCT01923285|3896618|FG001|NOT COMPLETED|Overall Study||6
3169147|NCT01923311|3896626|FG000|STARTED|Overall Study||17
3169148|NCT01923311|3896627|FG001|STARTED|Overall Study||14
3169149|NCT01923311|3896626|FG000|COMPLETED|Overall Study||0
3169150|NCT01923311|3896627|FG001|COMPLETED|Overall Study||13
3169151|NCT01923311|3896626|FG000|NOT COMPLETED|Overall Study||17
3169152|NCT01923311|3896627|FG001|NOT COMPLETED|Overall Study||1
2864429|NCT00126490|3567047|FG000|NOT COMPLETED|Overall Study||1
2864430|NCT00126503|3567053|FG000|STARTED|Overall Study||48
2864431|NCT00126503|3567054|FG001|STARTED|Overall Study||21
2864432|NCT00126503|3567053|FG000|COMPLETED|Overall Study||1
2864433|NCT00126503|3567054|FG001|COMPLETED|Overall Study||0
2864434|NCT00126503|3567053|FG000|NOT COMPLETED|Overall Study||47
2864435|NCT00126503|3567054|FG001|NOT COMPLETED|Overall Study||21
2864436|NCT00126555|3567064|FG000|STARTED|Overall Study||23
2864437|NCT00126555|3567064|FG000|Stratum 1- Resectable|Overall Study|1 participant did not participate|18
2864438|NCT00126555|3567064|FG000|Stratum 2- Unresectable|Overall Study||4
2864439|NCT00126555|3567064|FG000|COMPLETED|Overall Study||17
2864440|NCT00126555|3567064|FG000|NOT COMPLETED|Overall Study||6
2864441|NCT00126568|3567080|FG000|STARTED|Overall Study||20
2864442|NCT00126568|3567080|FG000|COMPLETED|Overall Study|Disease progression at beginning of study, not evaluable|18
2864443|NCT00126568|3567080|FG000|NOT COMPLETED|Overall Study||2
2864444|NCT00126581|3567087|FG000|STARTED|Overall Study||81
2864445|NCT00126581|3567088|FG001|STARTED|Overall Study||100
2864446|NCT00126581|3567087|FG000|COMPLETED|Overall Study||68
2864447|NCT00126581|3567088|FG001|COMPLETED|Overall Study||80
2864448|NCT00126581|3567087|FG000|NOT COMPLETED|Overall Study||13
2864449|NCT00126581|3567088|FG001|NOT COMPLETED|Overall Study||20
2864450|NCT00126594|3567098|FG000|STARTED|Overall Study||40
2864451|NCT00126594|3567099|FG001|STARTED|Overall Study||40
2864452|NCT00126594|3567098|FG000|COMPLETED|Overall Study||1
2864453|NCT00126594|3567099|FG001|COMPLETED|Overall Study||3
2864454|NCT00126594|3567098|FG000|NOT COMPLETED|Overall Study||39
2864455|NCT00126594|3567099|FG001|NOT COMPLETED|Overall Study||37
2864456|NCT00126737|3567110|FG000|STARTED|Overall Study||28
2864457|NCT00126737|3567111|FG001|STARTED|Overall Study||27
2864458|NCT00126737|3567112|FG002|STARTED|Overall Study||30
2864459|NCT00126737|3567113|FG003|STARTED|Overall Study||25
2864460|NCT00126737|3567110|FG000|COMPLETED|Overall Study||22
2864461|NCT00126737|3567111|FG001|COMPLETED|Overall Study||24
2864462|NCT00126737|3567112|FG002|COMPLETED|Overall Study||24
2864463|NCT00126737|3567113|FG003|COMPLETED|Overall Study||18
2864464|NCT00126737|3567110|FG000|NOT COMPLETED|Overall Study||6
2864465|NCT00126737|3567111|FG001|NOT COMPLETED|Overall Study||3
2864466|NCT00126737|3567112|FG002|NOT COMPLETED|Overall Study||6
2864467|NCT00126737|3567113|FG003|NOT COMPLETED|Overall Study||7
2864468|NCT00126750|3567128|FG000|STARTED|Overall Study|Number of providers from 84 clinics|385
2864469|NCT00126750|3567129|FG001|STARTED|Overall Study|Number of providers from 84 clinics|462
2864470|NCT00126750|3567128|FG000|COMPLETED|Overall Study|Total providers at participating clinic locations were given the option to 'enroll'.|205
2864471|NCT00126750|3567129|FG001|COMPLETED|Overall Study|Total providers at clinic locations were given the option to 'enroll'.|196
2864472|NCT00126750|3567128|FG000|NOT COMPLETED|Overall Study||180
3169153|NCT01923363|3896634|FG000|STARTED|Overall Study||29
3169154|NCT01923363|3896634|FG000|COMPLETED|Overall Study||28
3169155|NCT01923363|3896634|FG000|NOT COMPLETED|Overall Study||1
2864473|NCT00126750|3567129|FG001|NOT COMPLETED|Overall Study||266
2864474|NCT00127036|3567137|FG000|STARTED|Overall Study||34
2864475|NCT00127036|3567138|FG001|STARTED|Overall Study||31
2918595|NCT00528112|3628856|FG001|STARTED|Extension Phase||707
3171786|NCT01937130|3898981|FG002|COMPLETED|Overall Study||2
3171787|NCT01937130|3898982|FG003|COMPLETED|Overall Study||2
3169156|NCT01923389|3896640|FG000|STARTED|Overall Study||2
3169157|NCT01923389|3896641|FG001|STARTED|Overall Study||2
3169158|NCT01923389|3896640|FG000|COMPLETED|Overall Study||1
3169159|NCT01923389|3896641|FG001|COMPLETED|Overall Study||2
3169160|NCT01923389|3896640|FG000|NOT COMPLETED|Overall Study||1
3169161|NCT01923389|3896641|FG001|NOT COMPLETED|Overall Study||0
3169162|NCT01923428|3896652|FG000|STARTED|Overall Study||88
3169163|NCT01923428|3896653|FG001|STARTED|Overall Study||89
3169164|NCT01923428|3896654|FG002|STARTED|Overall Study||89
3169165|NCT01923428|3896655|FG003|STARTED|Overall Study||90
3169166|NCT01923428|3896652|FG000|COMPLETED|Overall Study||69
3169167|NCT01923428|3896653|FG001|COMPLETED|Overall Study||77
3169168|NCT01923428|3896654|FG002|COMPLETED|Overall Study||78
3169169|NCT01923428|3896655|FG003|COMPLETED|Overall Study||80
3169170|NCT01923428|3896652|FG000|NOT COMPLETED|Overall Study||19
3169171|NCT01923428|3896653|FG001|NOT COMPLETED|Overall Study||12
3169172|NCT01923428|3896654|FG002|NOT COMPLETED|Overall Study||11
3169173|NCT01923428|3896655|FG003|NOT COMPLETED|Overall Study||10
3169174|NCT01923467|3896665|FG000|STARTED|Overall Study|Offered stop smoking program|767
3169175|NCT01923467|3896665|FG000|Baseline Completed, Enrolled|Overall Study||288
3169176|NCT01923467|3896665|FG000|COMPLETED|Overall Study|Completed 3-month follow up survey|226
3169177|NCT01923467|3896665|FG000|NOT COMPLETED|Overall Study||541
3169178|NCT01923740|3896671|FG000|STARTED|Overall Study||227
3169179|NCT01923740|3896672|FG001|STARTED|Overall Study||232
3169180|NCT01923740|3896671|FG000|COMPLETED|Overall Study||221
3169181|NCT01923740|3896672|FG001|COMPLETED|Overall Study||223
3169182|NCT01923740|3896671|FG000|NOT COMPLETED|Overall Study||6
3169183|NCT01923740|3896672|FG001|NOT COMPLETED|Overall Study||9
2864476|NCT00127036|3567137|FG000|COMPLETED|Overall Study|26 Participants were evaluable.|26
2864477|NCT00127036|3567138|FG001|COMPLETED|Overall Study|20 Participants were evaluable.|20
2864478|NCT00127036|3567137|FG000|NOT COMPLETED|Overall Study||8
2864479|NCT00127036|3567138|FG001|NOT COMPLETED|Overall Study||11
2864480|NCT00127062|3567146|FG000|STARTED|First intervention_Oxford Street||31
2864481|NCT00127062|3567147|FG001|STARTED|First intervention_Oxford Street||29
2864482|NCT00127062|3567146|FG000|COMPLETED|First intervention_Oxford Street||31
2864483|NCT00127062|3567147|FG001|COMPLETED|First intervention_Oxford Street||29
2864484|NCT00127062|3567146|FG000|NOT COMPLETED|First intervention_Oxford Street||0
2864485|NCT00127062|3567147|FG001|NOT COMPLETED|First intervention_Oxford Street||0
2864486|NCT00127062|3567146|FG000|STARTED|Second intervention_Hyde Park||31
2864487|NCT00127062|3567147|FG001|STARTED|Second intervention_Hyde Park||29
2864488|NCT00127062|3567146|FG000|COMPLETED|Second intervention_Hyde Park||31
2864489|NCT00127062|3567147|FG001|COMPLETED|Second intervention_Hyde Park||29
2864490|NCT00127062|3567146|FG000|NOT COMPLETED|Second intervention_Hyde Park||0
2864491|NCT00127062|3567147|FG001|NOT COMPLETED|Second intervention_Hyde Park||0
2864492|NCT00127101|3567163|FG000|STARTED|Base Protocol||3
2864493|NCT00127101|3567164|FG001|STARTED|Base Protocol||5
2864494|NCT00127101|3567165|FG002|STARTED|Base Protocol||3
2864495|NCT00127101|3567166|FG003|STARTED|Base Protocol||3
2864496|NCT00127101|3567167|FG004|STARTED|Base Protocol||5
2864497|NCT00127101|3567168|FG005|STARTED|Base Protocol||4
2864498|NCT00127101|3567163|FG000|COMPLETED|Base Protocol||1
2864499|NCT00127101|3567164|FG001|COMPLETED|Base Protocol||1
2864500|NCT00127101|3567165|FG002|COMPLETED|Base Protocol||1
2864501|NCT00127101|3567166|FG003|COMPLETED|Base Protocol||3
2864502|NCT00127101|3567167|FG004|COMPLETED|Base Protocol||3
2864503|NCT00127101|3567168|FG005|COMPLETED|Base Protocol||3
3169184|NCT01923805|3896680|FG000|STARTED|Overall Study|early termination|3
3169185|NCT01923805|3896681|FG001|STARTED|Overall Study|early termination|5
3169186|NCT01923805|3896680|FG000|COMPLETED|Overall Study||0
3169187|NCT01923805|3896681|FG001|COMPLETED|Overall Study||0
3169188|NCT01923805|3896680|FG000|NOT COMPLETED|Overall Study||3
3169189|NCT01923805|3896681|FG001|NOT COMPLETED|Overall Study||5
3169190|NCT01923896|3896689|FG000|STARTED|Overall Study||8
3169191|NCT01923896|3896690|FG001|STARTED|Overall Study||8
3169192|NCT01923896|3896689|FG000|COMPLETED|Overall Study||7
2864504|NCT00127101|3567163|FG000|NOT COMPLETED|Base Protocol||2
2864505|NCT00127101|3567164|FG001|NOT COMPLETED|Base Protocol||4
2864506|NCT00127101|3567165|FG002|NOT COMPLETED|Base Protocol||2
2864507|NCT00127101|3567166|FG003|NOT COMPLETED|Base Protocol||0
2864508|NCT00127101|3567167|FG004|NOT COMPLETED|Base Protocol||2
2864509|NCT00127101|3567168|FG005|NOT COMPLETED|Base Protocol||1
2864510|NCT00127101|3567163|FG000|STARTED|Continuation Phase||0
2864511|NCT00127101|3567164|FG001|STARTED|Continuation Phase||0
2864512|NCT00127101|3567165|FG002|STARTED|Continuation Phase||1
2864513|NCT00127101|3567166|FG003|STARTED|Continuation Phase|No patients from the 2b Cohort entered into the extension phase|0
2864514|NCT00127101|3567167|FG004|STARTED|Continuation Phase||3
3169193|NCT01923896|3896690|FG001|COMPLETED|Overall Study||8
3169194|NCT01923896|3896689|FG000|NOT COMPLETED|Overall Study||1
3169195|NCT01923896|3896690|FG001|NOT COMPLETED|Overall Study||0
3169196|NCT01923961|3896699|FG000|STARTED|First Intervention||3
3169197|NCT01923961|3896700|FG001|STARTED|First Intervention||3
3169198|NCT01923961|3896701|FG002|STARTED|First Intervention||2
3169199|NCT01923961|3896699|FG000|COMPLETED|First Intervention||3
3169200|NCT01923961|3896700|FG001|COMPLETED|First Intervention||3
3169201|NCT01923961|3896701|FG002|COMPLETED|First Intervention||2
3169202|NCT01923961|3896699|FG000|NOT COMPLETED|First Intervention||0
3169203|NCT01923961|3896700|FG001|NOT COMPLETED|First Intervention||0
2864515|NCT00127101|3567168|FG005|STARTED|Continuation Phase||3
2864516|NCT00127101|3567163|FG000|COMPLETED|Continuation Phase||0
2864517|NCT00127101|3567164|FG001|COMPLETED|Continuation Phase||0
2864518|NCT00127101|3567165|FG002|COMPLETED|Continuation Phase||0
2864519|NCT00127101|3567166|FG003|COMPLETED|Continuation Phase||0
2864520|NCT00127101|3567167|FG004|COMPLETED|Continuation Phase||0
2864521|NCT00127101|3567168|FG005|COMPLETED|Continuation Phase||0
2864522|NCT00127101|3567163|FG000|NOT COMPLETED|Continuation Phase||0
2864523|NCT00127101|3567164|FG001|NOT COMPLETED|Continuation Phase||0
2864524|NCT00127101|3567165|FG002|NOT COMPLETED|Continuation Phase||1
2864525|NCT00127101|3567166|FG003|NOT COMPLETED|Continuation Phase||0
2864526|NCT00127101|3567167|FG004|NOT COMPLETED|Continuation Phase||3
2864527|NCT00127101|3567168|FG005|NOT COMPLETED|Continuation Phase||3
2864528|NCT00127166|3567184|FG000|STARTED|Period I||78
2864529|NCT00127166|3567185|FG001|STARTED|Period I||76
2864530|NCT00127166|3567184|FG000|COMPLETED|Period I||75
2864531|NCT00127166|3567185|FG001|COMPLETED|Period I||74
2864532|NCT00127166|3567184|FG000|NOT COMPLETED|Period I||3
2864533|NCT00127166|3567185|FG001|NOT COMPLETED|Period I||2
2864534|NCT00127166|3567184|FG000|STARTED|Washout Period||75
2864535|NCT00127166|3567185|FG001|STARTED|Washout Period||74
2864536|NCT00127166|3567184|FG000|COMPLETED|Washout Period||75
2864537|NCT00127166|3567185|FG001|COMPLETED|Washout Period||73
2864538|NCT00127166|3567184|FG000|NOT COMPLETED|Washout Period||0
2864539|NCT00127166|3567185|FG001|NOT COMPLETED|Washout Period||1
2864540|NCT00127166|3567184|FG000|STARTED|Period II||75
2864541|NCT00127166|3567185|FG001|STARTED|Period II||73
2864542|NCT00127166|3567184|FG000|COMPLETED|Period II||72
2864543|NCT00127166|3567185|FG001|COMPLETED|Period II||73
2864544|NCT00127166|3567184|FG000|NOT COMPLETED|Period II||3
2864545|NCT00127166|3567185|FG001|NOT COMPLETED|Period II||0
2864546|NCT00127192|3567196|FG000|STARTED|Overall Study|Study enrolled slightly more than the target of N=70|80
2864547|NCT00127192|3567197|FG001|STARTED|Overall Study|Study enrolled slightly more than the target of N=70|72
2864548|NCT00127192|3567198|FG002|STARTED|Overall Study|Study enrolled as per the target of N=70|70
2864549|NCT00127192|3567199|FG003|STARTED|Overall Study|Study enrolled slightly less than the target of N=70|68
2864550|NCT00127192|3567200|FG004|STARTED|Overall Study|Study enrolled slightly more than the target of N=70|73
2864551|NCT00127192|3567196|FG000|COMPLETED|Overall Study||77
2864552|NCT00127192|3567197|FG001|COMPLETED|Overall Study||71
2864553|NCT00127192|3567198|FG002|COMPLETED|Overall Study||68
2864554|NCT00127192|3567199|FG003|COMPLETED|Overall Study||67
2864555|NCT00127192|3567200|FG004|COMPLETED|Overall Study||68
2864556|NCT00127192|3567196|FG000|NOT COMPLETED|Overall Study||3
2864557|NCT00127192|3567197|FG001|NOT COMPLETED|Overall Study||1
2864558|NCT00127192|3567198|FG002|NOT COMPLETED|Overall Study||2
2864559|NCT00127192|3567199|FG003|NOT COMPLETED|Overall Study||1
2864560|NCT00127192|3567200|FG004|NOT COMPLETED|Overall Study||5
2864561|NCT00127205|3567215|FG000|STARTED|Overall Study||2262
2864562|NCT00127205|3567216|FG001|STARTED|Overall Study||2268
2864563|NCT00127205|3567217|FG002|STARTED|Overall Study||1567
2864564|NCT00127205|3567215|FG000|COMPLETED|Overall Study||1433
2864565|NCT00127205|3567216|FG001|COMPLETED|Overall Study||1295
2864566|NCT00127205|3567217|FG002|COMPLETED|Overall Study||955
2864567|NCT00127205|3567215|FG000|NOT COMPLETED|Overall Study||829
2864568|NCT00127205|3567216|FG001|NOT COMPLETED|Overall Study||973
2864569|NCT00127205|3567217|FG002|NOT COMPLETED|Overall Study||612
2864570|NCT00127218|3567229|FG000|STARTED|Overall Study||72
2864571|NCT00127218|3567230|FG001|STARTED|Overall Study||73
2864572|NCT00127218|3567229|FG000|COMPLETED|Overall Study||59
2864573|NCT00127218|3567230|FG001|COMPLETED|Overall Study||58
2864574|NCT00127218|3567229|FG000|NOT COMPLETED|Overall Study||13
2864575|NCT00127218|3567230|FG001|NOT COMPLETED|Overall Study||15
2864576|NCT00127231|3567240|FG000|STARTED|Overall Study||74
2864577|NCT00127231|3567241|FG001|STARTED|Overall Study||74
2864578|NCT00127231|3567240|FG000|COMPLETED|Overall Study||68
2864579|NCT00127231|3567241|FG001|COMPLETED|Overall Study||68
2864580|NCT00127231|3567240|FG000|NOT COMPLETED|Overall Study||6
2864581|NCT00127231|3567241|FG001|NOT COMPLETED|Overall Study||6
2864582|NCT00127413|3567251|FG000|STARTED|Overall Study||12
2864583|NCT00127413|3567252|FG001|STARTED|Overall Study||10
2864584|NCT00127413|3567253|FG002|STARTED|Overall Study||13
2864585|NCT00127413|3567254|FG003|STARTED|Overall Study||7
2864586|NCT00127413|3567251|FG000|COMPLETED|Overall Study||6
2864587|NCT00127413|3567252|FG001|COMPLETED|Overall Study||6
2864588|NCT00127413|3567253|FG002|COMPLETED|Overall Study||5
2864589|NCT00127413|3567254|FG003|COMPLETED|Overall Study||5
2864590|NCT00127413|3567251|FG000|NOT COMPLETED|Overall Study||6
2864591|NCT00127413|3567252|FG001|NOT COMPLETED|Overall Study||4
2864592|NCT00127413|3567253|FG002|NOT COMPLETED|Overall Study||8
2864593|NCT00127413|3567254|FG003|NOT COMPLETED|Overall Study||2
2864594|NCT00127439|3567266|FG000|STARTED|Overall Study||9
2864595|NCT00127439|3567267|FG001|STARTED|Overall Study||10
2864596|NCT00127439|3567266|FG000|COMPLETED|Overall Study||9
2864597|NCT00127439|3567267|FG001|COMPLETED|Overall Study||10
2864598|NCT00127439|3567266|FG000|NOT COMPLETED|Overall Study||0
2864599|NCT00127439|3567267|FG001|NOT COMPLETED|Overall Study||0
2864600|NCT00127530|3567278|FG000|STARTED|Overall Study||72
2864601|NCT00127530|3567279|FG001|STARTED|Overall Study||228
2864602|NCT00127530|3567278|FG000|COMPLETED|Overall Study||71
2864603|NCT00127530|3567279|FG001|COMPLETED|Overall Study||207
2864604|NCT00127530|3567278|FG000|NOT COMPLETED|Overall Study||1
3313448|NCT03075410|4046798|FG007|COMPLETED|Part A-Period 3 (14 Days)||0
3313449|NCT03075410|4046799|FG008|COMPLETED|Part A-Period 3 (14 Days)||0
3313450|NCT03075410|4046791|FG000|NOT COMPLETED|Part A-Period 3 (14 Days)||1
3313451|NCT03075410|4046792|FG001|NOT COMPLETED|Part A-Period 3 (14 Days)||0
2864605|NCT00127530|3567279|FG001|NOT COMPLETED|Overall Study||21
2864606|NCT00127608|3567285|FG000|STARTED|Overall Study||36
2864607|NCT00127608|3567285|FG000|COMPLETED|Overall Study||35
2864608|NCT00127608|3567285|FG000|NOT COMPLETED|Overall Study||1
2864609|NCT00127660|3567293|FG000|STARTED|Overall Study||153
2864610|NCT00127660|3567294|FG001|STARTED|Overall Study||154
2864611|NCT00127660|3567295|FG002|STARTED|Overall Study||148
2864612|NCT00127660|3567296|FG003|STARTED|Overall Study||150
2864613|NCT00127660|3567293|FG000|COMPLETED|Overall Study||150
2864614|NCT00127660|3567294|FG001|COMPLETED|Overall Study||151
2864615|NCT00127660|3567295|FG002|COMPLETED|Overall Study||143
2864616|NCT00127660|3567296|FG003|COMPLETED|Overall Study||150
2864617|NCT00127660|3567293|FG000|NOT COMPLETED|Overall Study||3
2864618|NCT00127660|3567294|FG001|NOT COMPLETED|Overall Study||3
2864619|NCT00127660|3567295|FG002|NOT COMPLETED|Overall Study||5
2864620|NCT00127660|3567296|FG003|NOT COMPLETED|Overall Study||0
2864621|NCT00127712|3567308|FG000|STARTED|Overall Study||65
2864622|NCT00127712|3567309|FG001|STARTED|Overall Study||65
2864623|NCT00127712|3567308|FG000|COMPLETED|Overall Study||60
2864624|NCT00127712|3567309|FG001|COMPLETED|Overall Study||65
2864625|NCT00127712|3567308|FG000|NOT COMPLETED|Overall Study||5
2864626|NCT00127712|3567309|FG001|NOT COMPLETED|Overall Study||0
2864627|NCT00127790|3567319|FG000|STARTED|Pre-Treatment|7 enrolled subjects were withdrawn prior to randomization; 21 of 28 enrolled were randomized.|6
2864628|NCT00127790|3567320|FG001|STARTED|Pre-Treatment||5
2864629|NCT00127790|3567321|FG002|STARTED|Pre-Treatment||6
2864630|NCT00127790|3567322|FG003|STARTED|Pre-Treatment||4
2864631|NCT00127790|3567319|FG000|COMPLETED|Pre-Treatment||6
2864632|NCT00127790|3567320|FG001|COMPLETED|Pre-Treatment||5
2864633|NCT00127790|3567321|FG002|COMPLETED|Pre-Treatment||6
2864634|NCT00127790|3567322|FG003|COMPLETED|Pre-Treatment||4
2864635|NCT00127790|3567319|FG000|NOT COMPLETED|Pre-Treatment||0
2864636|NCT00127790|3567320|FG001|NOT COMPLETED|Pre-Treatment||0
2864637|NCT00127790|3567321|FG002|NOT COMPLETED|Pre-Treatment||0
3169204|NCT01923961|3896701|FG002|NOT COMPLETED|First Intervention||0
3169205|NCT01923961|3896699|FG000|STARTED|Washout (1 Week)||3
3169206|NCT01923961|3896700|FG001|STARTED|Washout (1 Week)||3
3169207|NCT01923961|3896701|FG002|STARTED|Washout (1 Week)||2
3169208|NCT01923961|3896699|FG000|COMPLETED|Washout (1 Week)||3
3169209|NCT01923961|3896700|FG001|COMPLETED|Washout (1 Week)||3
3169210|NCT01923961|3896701|FG002|COMPLETED|Washout (1 Week)||2
3169211|NCT01923961|3896699|FG000|NOT COMPLETED|Washout (1 Week)||0
3169212|NCT01923961|3896700|FG001|NOT COMPLETED|Washout (1 Week)||0
3169213|NCT01923961|3896701|FG002|NOT COMPLETED|Washout (1 Week)||0
3169214|NCT01923961|3896699|FG000|STARTED|Second Intervention||3
3169215|NCT01923961|3896700|FG001|STARTED|Second Intervention||3
3169216|NCT01923961|3896701|FG002|STARTED|Second Intervention||2
3169217|NCT01923961|3896699|FG000|COMPLETED|Second Intervention||3
2864638|NCT00127790|3567322|FG003|NOT COMPLETED|Pre-Treatment||0
2864639|NCT00127790|3567319|FG000|STARTED|Post-Treatment||6
2864640|NCT00127790|3567320|FG001|STARTED|Post-Treatment||5
2864641|NCT00127790|3567321|FG002|STARTED|Post-Treatment||6
2864642|NCT00127790|3567322|FG003|STARTED|Post-Treatment||4
2864643|NCT00127790|3567319|FG000|COMPLETED|Post-Treatment||6
2864644|NCT00127790|3567320|FG001|COMPLETED|Post-Treatment||5
2864645|NCT00127790|3567321|FG002|COMPLETED|Post-Treatment||6
2864646|NCT00127790|3567322|FG003|COMPLETED|Post-Treatment||4
2864647|NCT00127790|3567319|FG000|NOT COMPLETED|Post-Treatment||0
2864648|NCT00127790|3567320|FG001|NOT COMPLETED|Post-Treatment||0
2864649|NCT00127790|3567321|FG002|NOT COMPLETED|Post-Treatment||0
2864650|NCT00127790|3567322|FG003|NOT COMPLETED|Post-Treatment||0
2864651|NCT00127803|3567336|FG000|STARTED|Overall Study||13
2864652|NCT00127803|3567337|FG001|STARTED|Overall Study||13
2864653|NCT00127803|3567338|FG002|STARTED|Overall Study||12
2864654|NCT00127803|3567339|FG003|STARTED|Overall Study||12
2864655|NCT00127803|3567336|FG000|COMPLETED|Overall Study||10
2864656|NCT00127803|3567337|FG001|COMPLETED|Overall Study||13
2864657|NCT00127803|3567338|FG002|COMPLETED|Overall Study||12
2864658|NCT00127803|3567339|FG003|COMPLETED|Overall Study||11
2864659|NCT00127803|3567336|FG000|NOT COMPLETED|Overall Study||3
2864660|NCT00127803|3567337|FG001|NOT COMPLETED|Overall Study||0
2864661|NCT00127803|3567338|FG002|NOT COMPLETED|Overall Study||0
2864662|NCT00127803|3567339|FG003|NOT COMPLETED|Overall Study||1
2864663|NCT00127842|3567349|FG000|STARTED|Overall Study||110
2864664|NCT00127842|3567349|FG000|COMPLETED|Overall Study||71
2864665|NCT00127842|3567349|FG000|NOT COMPLETED|Overall Study||39
2864666|NCT00127855|3567358|FG000|STARTED|Primary Vaccination Course||82
3169218|NCT01923961|3896700|FG001|COMPLETED|Second Intervention||3
3169219|NCT01923961|3896701|FG002|COMPLETED|Second Intervention||2
3313452|NCT03075410|4046793|FG002|NOT COMPLETED|Part A-Period 3 (14 Days)||0
3169220|NCT01923961|3896699|FG000|NOT COMPLETED|Second Intervention||0
3169221|NCT01923961|3896700|FG001|NOT COMPLETED|Second Intervention||0
3169222|NCT01923961|3896701|FG002|NOT COMPLETED|Second Intervention||0
2864667|NCT00127855|3567359|FG001|STARTED|Primary Vaccination Course||82
2864668|NCT00127855|3567360|FG002|STARTED|Primary Vaccination Course||80
2864669|NCT00127855|3567361|FG003|STARTED|Primary Vaccination Course||81
2864670|NCT00127855|3567362|FG004|STARTED|Primary Vaccination Course||82
3169223|NCT01923961|3896699|FG000|STARTED|Washout (1 Week)||3
3169224|NCT01923961|3896700|FG001|STARTED|Washout (1 Week)||3
2864671|NCT00127855|3567358|FG000|COMPLETED|Primary Vaccination Course||80
2864672|NCT00127855|3567359|FG001|COMPLETED|Primary Vaccination Course||81
2864673|NCT00127855|3567360|FG002|COMPLETED|Primary Vaccination Course||78
2864674|NCT00127855|3567361|FG003|COMPLETED|Primary Vaccination Course||81
2864675|NCT00127855|3567362|FG004|COMPLETED|Primary Vaccination Course||78
2864676|NCT00127855|3567358|FG000|NOT COMPLETED|Primary Vaccination Course||2
2864677|NCT00127855|3567359|FG001|NOT COMPLETED|Primary Vaccination Course||1
2864678|NCT00127855|3567360|FG002|NOT COMPLETED|Primary Vaccination Course||2
2864679|NCT00127855|3567361|FG003|NOT COMPLETED|Primary Vaccination Course||0
2864680|NCT00127855|3567362|FG004|NOT COMPLETED|Primary Vaccination Course||4
2864681|NCT00127855|3567358|FG000|STARTED|Polysaccharide Challenge Dose||80
2864682|NCT00127855|3567359|FG001|STARTED|Polysaccharide Challenge Dose||79
2864683|NCT00127855|3567360|FG002|STARTED|Polysaccharide Challenge Dose||77
2864684|NCT00127855|3567361|FG003|STARTED|Polysaccharide Challenge Dose||81
2864685|NCT00127855|3567362|FG004|STARTED|Polysaccharide Challenge Dose||77
2864686|NCT00127855|3567358|FG000|COMPLETED|Polysaccharide Challenge Dose||80
2864687|NCT00127855|3567359|FG001|COMPLETED|Polysaccharide Challenge Dose||79
2864688|NCT00127855|3567360|FG002|COMPLETED|Polysaccharide Challenge Dose||77
2864689|NCT00127855|3567361|FG003|COMPLETED|Polysaccharide Challenge Dose||81
2864690|NCT00127855|3567362|FG004|COMPLETED|Polysaccharide Challenge Dose||77
2864691|NCT00127855|3567358|FG000|NOT COMPLETED|Polysaccharide Challenge Dose||0
2864692|NCT00127855|3567359|FG001|NOT COMPLETED|Polysaccharide Challenge Dose||0
2864693|NCT00127855|3567360|FG002|NOT COMPLETED|Polysaccharide Challenge Dose||0
2864694|NCT00127855|3567361|FG003|NOT COMPLETED|Polysaccharide Challenge Dose||0
2864695|NCT00127855|3567362|FG004|NOT COMPLETED|Polysaccharide Challenge Dose||0
2864696|NCT00127933|3567376|FG000|STARTED|Overall Study||123
2864697|NCT00127933|3567377|FG001|STARTED|Overall Study||34
2864698|NCT00127933|3567376|FG000|Pathological Response|Overall Study||101
2864699|NCT00127933|3567377|FG001|Pathological Response|Overall Study||28
2864700|NCT00127933|3567376|FG000|Clinical Response|Overall Study||122
2864701|NCT00127933|3567377|FG001|Clinical Response|Overall Study||34
2864702|NCT00127933|3567376|FG000|Safety Population|Overall Study||122
2864703|NCT00127933|3567377|FG001|Safety Population|Overall Study||34
2864704|NCT00127933|3567376|FG000|Quality of Life Population|Overall Study||118
2864705|NCT00127933|3567377|FG001|Quality of Life Population|Overall Study||33
2864706|NCT00127933|3567376|FG000|Postoperative|Overall Study||98
2864707|NCT00127933|3567377|FG001|Postoperative|Overall Study||27
2864708|NCT00127933|3567376|FG000|COMPLETED|Overall Study||122
2864709|NCT00127933|3567377|FG001|COMPLETED|Overall Study||34
2864710|NCT00127933|3567376|FG000|NOT COMPLETED|Overall Study||1
2864711|NCT00127933|3567377|FG001|NOT COMPLETED|Overall Study||0
2864712|NCT00128102|3567385|FG000|STARTED|Overall Study||329
3313453|NCT03075410|4046794|FG003|NOT COMPLETED|Part A-Period 3 (14 Days)||0
3313454|NCT03075410|4046795|FG004|NOT COMPLETED|Part A-Period 3 (14 Days)||0
3313455|NCT03075410|4046796|FG005|NOT COMPLETED|Part A-Period 3 (14 Days)||0
3313456|NCT03075410|4046797|FG006|NOT COMPLETED|Part A-Period 3 (14 Days)||0
3313457|NCT03075410|4046798|FG007|NOT COMPLETED|Part A-Period 3 (14 Days)||0
3313458|NCT03075410|4046799|FG008|NOT COMPLETED|Part A-Period 3 (14 Days)||0
3313459|NCT03075410|4046791|FG000|STARTED|Part A-Washout Period 3 (14 Days)||1
2864713|NCT00128102|3567386|FG001|STARTED|Overall Study||332
2864714|NCT00128102|3567385|FG000|Treated|Overall Study||329
2864715|NCT00128102|3567386|FG001|Treated|Overall Study||329
2864716|NCT00128102|3567385|FG000|COMPLETED|Overall Study||1
2864717|NCT00128102|3567386|FG001|COMPLETED|Overall Study||0
3169225|NCT01923961|3896701|FG002|STARTED|Washout (1 Week)||2
3169226|NCT01923961|3896699|FG000|COMPLETED|Washout (1 Week)||3
3169227|NCT01923961|3896700|FG001|COMPLETED|Washout (1 Week)||3
3169228|NCT01923961|3896701|FG002|COMPLETED|Washout (1 Week)||2
3313460|NCT03075410|4046792|FG001|STARTED|Part A-Washout Period 3 (14 Days)||1
2864718|NCT00128102|3567385|FG000|NOT COMPLETED|Overall Study||328
2864719|NCT00128102|3567386|FG001|NOT COMPLETED|Overall Study||332
2864720|NCT00128180|3567394|FG000|STARTED|Overall Study||32
2864721|NCT00128180|3567395|FG001|STARTED|Overall Study||34
2864722|NCT00128180|3567394|FG000|COMPLETED|Overall Study||32
2864723|NCT00128180|3567395|FG001|COMPLETED|Overall Study||34
2864724|NCT00128180|3567394|FG000|NOT COMPLETED|Overall Study||0
2864725|NCT00128180|3567395|FG001|NOT COMPLETED|Overall Study||0
2864726|NCT00128193|3567413|FG000|STARTED|Overall Study||5
2864727|NCT00128193|3567414|FG001|STARTED|Overall Study||5
2864728|NCT00128193|3567415|FG002|STARTED|Overall Study||45
2864729|NCT00128193|3567416|FG003|STARTED|Overall Study||45
2864730|NCT00128193|3567417|FG004|STARTED|Overall Study||20
2864731|NCT00128193|3567418|FG005|STARTED|Overall Study||20
2864732|NCT00128193|3567419|FG006|STARTED|Overall Study||20
2864733|NCT00128193|3567420|FG007|STARTED|Overall Study||20
2864734|NCT00128193|3567421|FG008|STARTED|Overall Study||20
2864735|NCT00128193|3567422|FG009|STARTED|Overall Study||20
2864736|NCT00128193|3567423|FG010|STARTED|Overall Study||20
2864737|NCT00128193|3567424|FG011|STARTED|Overall Study||20
2864738|NCT00128193|3567413|FG000|COMPLETED|Overall Study||5
2864739|NCT00128193|3567414|FG001|COMPLETED|Overall Study||5
2864740|NCT00128193|3567415|FG002|COMPLETED|Overall Study||42
2864741|NCT00128193|3567416|FG003|COMPLETED|Overall Study||44
2864742|NCT00128193|3567417|FG004|COMPLETED|Overall Study||18
3169229|NCT01923961|3896699|FG000|NOT COMPLETED|Washout (1 Week)||0
2864743|NCT00128193|3567418|FG005|COMPLETED|Overall Study||17
2864744|NCT00128193|3567419|FG006|COMPLETED|Overall Study||16
2864745|NCT00128193|3567420|FG007|COMPLETED|Overall Study||20
2864746|NCT00128193|3567421|FG008|COMPLETED|Overall Study||18
2864747|NCT00128193|3567422|FG009|COMPLETED|Overall Study||18
2864748|NCT00128193|3567423|FG010|COMPLETED|Overall Study||17
2864749|NCT00128193|3567424|FG011|COMPLETED|Overall Study||18
2864750|NCT00128193|3567413|FG000|NOT COMPLETED|Overall Study||0
2864751|NCT00128193|3567414|FG001|NOT COMPLETED|Overall Study||0
2864752|NCT00128193|3567415|FG002|NOT COMPLETED|Overall Study||3
2864753|NCT00128193|3567416|FG003|NOT COMPLETED|Overall Study||1
2864754|NCT00128193|3567417|FG004|NOT COMPLETED|Overall Study||2
2864755|NCT00128193|3567418|FG005|NOT COMPLETED|Overall Study||3
2864756|NCT00128193|3567419|FG006|NOT COMPLETED|Overall Study||4
3313461|NCT03075410|4046793|FG002|STARTED|Part A-Washout Period 3 (14 Days)||2
3313462|NCT03075410|4046794|FG003|STARTED|Part A-Washout Period 3 (14 Days)||1
3313463|NCT03075410|4046795|FG004|STARTED|Part A-Washout Period 3 (14 Days)||2
3313464|NCT03075410|4046796|FG005|STARTED|Part A-Washout Period 3 (14 Days)||1
3313465|NCT03075410|4046797|FG006|STARTED|Part A-Washout Period 3 (14 Days)||0
3313466|NCT03075410|4046798|FG007|STARTED|Part A-Washout Period 3 (14 Days)||0
3313467|NCT03075410|4046799|FG008|STARTED|Part A-Washout Period 3 (14 Days)||0
2864757|NCT00128193|3567420|FG007|NOT COMPLETED|Overall Study||0
2864758|NCT00128193|3567421|FG008|NOT COMPLETED|Overall Study||2
2864759|NCT00128193|3567422|FG009|NOT COMPLETED|Overall Study||2
2864760|NCT00128193|3567423|FG010|NOT COMPLETED|Overall Study||3
2864761|NCT00128193|3567424|FG011|NOT COMPLETED|Overall Study||2
2864762|NCT00128206|3567506|FG000|STARTED|Overall Study||184
2864763|NCT00128206|3567507|FG001|STARTED|Overall Study||180
2864764|NCT00128206|3567506|FG000|COMPLETED|Overall Study||47
2864765|NCT00128206|3567507|FG001|COMPLETED|Overall Study||60
2864766|NCT00128206|3567506|FG000|NOT COMPLETED|Overall Study||137
2864767|NCT00128206|3567507|FG001|NOT COMPLETED|Overall Study||120
2864768|NCT00128219|3567515|FG000|STARTED|Overall Study||333
2864769|NCT00128219|3567516|FG001|STARTED|Overall Study||334
2864770|NCT00128219|3567515|FG000|COMPLETED|Overall Study||264
2864771|NCT00128219|3567516|FG001|COMPLETED|Overall Study||263
2864772|NCT00128219|3567515|FG000|NOT COMPLETED|Overall Study||69
2864773|NCT00128219|3567516|FG001|NOT COMPLETED|Overall Study||71
2864774|NCT00128401|3567524|FG000|STARTED|Overall Study||20
2864775|NCT00128401|3567525|FG001|STARTED|Overall Study||19
2864776|NCT00128401|3567524|FG000|COMPLETED|Overall Study||14
2864777|NCT00128401|3567525|FG001|COMPLETED|Overall Study||15
2864778|NCT00128401|3567524|FG000|NOT COMPLETED|Overall Study||6
2864779|NCT00128401|3567525|FG001|NOT COMPLETED|Overall Study||4
2864780|NCT00128492|3567534|FG000|STARTED|Overall Study||85
2864781|NCT00128492|3567535|FG001|STARTED|Overall Study||189
2864782|NCT00128492|3567534|FG000|COMPLETED|Overall Study||65
2864783|NCT00128492|3567535|FG001|COMPLETED|Overall Study||130
2864784|NCT00128492|3567534|FG000|NOT COMPLETED|Overall Study||20
2864785|NCT00128492|3567535|FG001|NOT COMPLETED|Overall Study||59
2864786|NCT00128661|3567543|FG000|STARTED|Overall Study||3727
2864787|NCT00128661|3567544|FG001|STARTED|Overall Study||3739
2864788|NCT00128661|3567543|FG000|COMPLETED|Overall Study||3453
2864789|NCT00128661|3567544|FG001|COMPLETED|Overall Study||3481
2864790|NCT00128661|3567543|FG000|NOT COMPLETED|Overall Study||274
2864791|NCT00128661|3567544|FG001|NOT COMPLETED|Overall Study||258
2864792|NCT00128713|3567553|FG000|STARTED|Overall Study||453
2864793|NCT00128713|3567554|FG001|STARTED|Overall Study||449
2864794|NCT00128713|3567555|FG002|STARTED|Overall Study||449
2864795|NCT00128713|3567553|FG000|COMPLETED|Overall Study||453
2864796|NCT00128713|3567554|FG001|COMPLETED|Overall Study||449
2864797|NCT00128713|3567555|FG002|COMPLETED|Overall Study||449
2864798|NCT00128713|3567553|FG000|NOT COMPLETED|Overall Study||0
2864799|NCT00128713|3567554|FG001|NOT COMPLETED|Overall Study||0
2864800|NCT00128713|3567555|FG002|NOT COMPLETED|Overall Study||0
2864801|NCT00128830|3567563|FG000|STARTED|Overall Study||211
2864802|NCT00128830|3567563|FG000|COMPLETED|Overall Study||139
2864803|NCT00128830|3567563|FG000|NOT COMPLETED|Overall Study||72
2864804|NCT00128921|3567572|FG000|STARTED|Overall Study||10
2864805|NCT00128921|3567573|FG001|STARTED|Overall Study||8
2864806|NCT00128921|3567574|FG002|STARTED|Overall Study||0
2864807|NCT00128921|3567572|FG000|Received Bortezomib|Overall Study||10
2864808|NCT00128921|3567573|FG001|Received Bortezomib|Overall Study||6
2864809|NCT00128921|3567574|FG002|Received Bortezomib|Overall Study||0
2864810|NCT00128921|3567572|FG000|COMPLETED|Overall Study||5
2864811|NCT00128921|3567573|FG001|COMPLETED|Overall Study||3
2864812|NCT00128921|3567574|FG002|COMPLETED|Overall Study||0
2864813|NCT00128921|3567572|FG000|NOT COMPLETED|Overall Study||5
2864814|NCT00128921|3567573|FG001|NOT COMPLETED|Overall Study||5
2864815|NCT00128921|3567574|FG002|NOT COMPLETED|Overall Study||0
3169230|NCT01923961|3896700|FG001|NOT COMPLETED|Washout (1 Week)||0
3169231|NCT01923961|3896701|FG002|NOT COMPLETED|Washout (1 Week)||0
3169232|NCT01923961|3896699|FG000|STARTED|Third Intervention||3
3169233|NCT01923961|3896700|FG001|STARTED|Third Intervention||3
3169234|NCT01923961|3896701|FG002|STARTED|Third Intervention||2
3169235|NCT01923961|3896699|FG000|COMPLETED|Third Intervention||3
3169236|NCT01923961|3896700|FG001|COMPLETED|Third Intervention||3
3169237|NCT01923961|3896701|FG002|COMPLETED|Third Intervention||2
3169238|NCT01923961|3896699|FG000|NOT COMPLETED|Third Intervention||0
3313468|NCT03075410|4046791|FG000|COMPLETED|Part A-Washout Period 3 (14 Days)||1
3169239|NCT01923961|3896700|FG001|NOT COMPLETED|Third Intervention||0
3169240|NCT01923961|3896701|FG002|NOT COMPLETED|Third Intervention||0
2864816|NCT00129116|3567589|FG000|STARTED|Primary Phase||78
2864817|NCT00129116|3567590|FG001|STARTED|Primary Phase||77
3169241|NCT01924169|3896709|FG000|STARTED|Overall Study||3
3169242|NCT01924169|3896709|FG000|COMPLETED|Overall Study||3
3169243|NCT01924169|3896709|FG000|NOT COMPLETED|Overall Study||0
2864818|NCT00129116|3567591|FG002|STARTED|Primary Phase||78
2864819|NCT00129116|3567592|FG003|STARTED|Primary Phase||78
2864820|NCT00129116|3567593|FG004|STARTED|Primary Phase||77
2864821|NCT00129116|3567589|FG000|COMPLETED|Primary Phase||76
2864822|NCT00129116|3567590|FG001|COMPLETED|Primary Phase||73
2864823|NCT00129116|3567591|FG002|COMPLETED|Primary Phase||77
2864824|NCT00129116|3567592|FG003|COMPLETED|Primary Phase||77
2864825|NCT00129116|3567593|FG004|COMPLETED|Primary Phase||76
2864826|NCT00129116|3567589|FG000|NOT COMPLETED|Primary Phase||2
2864827|NCT00129116|3567590|FG001|NOT COMPLETED|Primary Phase||4
2864828|NCT00129116|3567591|FG002|NOT COMPLETED|Primary Phase||1
2864829|NCT00129116|3567592|FG003|NOT COMPLETED|Primary Phase||1
2864830|NCT00129116|3567593|FG004|NOT COMPLETED|Primary Phase||1
2864831|NCT00129116|3567589|FG000|STARTED|Booster Phase||47
2864832|NCT00129116|3567590|FG001|STARTED|Booster Phase||42
2864833|NCT00129116|3567591|FG002|STARTED|Booster Phase||44
2864834|NCT00129116|3567592|FG003|STARTED|Booster Phase||44
2864835|NCT00129116|3567593|FG004|STARTED|Booster Phase||44
2864836|NCT00129116|3567589|FG000|COMPLETED|Booster Phase||45
2864837|NCT00129116|3567590|FG001|COMPLETED|Booster Phase||42
2864838|NCT00129116|3567591|FG002|COMPLETED|Booster Phase||44
2864839|NCT00129116|3567592|FG003|COMPLETED|Booster Phase||44
2864840|NCT00129116|3567593|FG004|COMPLETED|Booster Phase||43
2864841|NCT00129116|3567589|FG000|NOT COMPLETED|Booster Phase||2
2864842|NCT00129116|3567590|FG001|NOT COMPLETED|Booster Phase||0
2864843|NCT00129116|3567591|FG002|NOT COMPLETED|Booster Phase||0
2864844|NCT00129116|3567592|FG003|NOT COMPLETED|Booster Phase||0
2864845|NCT00129116|3567593|FG004|NOT COMPLETED|Booster Phase||1
2864846|NCT00129129|3567608|FG000|STARTED|Primary Phase||287
2864847|NCT00129129|3567609|FG001|STARTED|Primary Phase||319
2864848|NCT00129129|3567610|FG002|STARTED|Primary Phase||150
2864849|NCT00129129|3567611|FG003|STARTED|Primary Phase||0
2864850|NCT00129129|3567612|FG004|STARTED|Primary Phase||0
2864851|NCT00129129|3567608|FG000|COMPLETED|Primary Phase||262
2864852|NCT00129129|3567609|FG001|COMPLETED|Primary Phase||294
2864853|NCT00129129|3567610|FG002|COMPLETED|Primary Phase||150
2864854|NCT00129129|3567611|FG003|COMPLETED|Primary Phase||0
2864855|NCT00129129|3567612|FG004|COMPLETED|Primary Phase||0
2864856|NCT00129129|3567608|FG000|NOT COMPLETED|Primary Phase||25
2864857|NCT00129129|3567609|FG001|NOT COMPLETED|Primary Phase||25
2864858|NCT00129129|3567610|FG002|NOT COMPLETED|Primary Phase||0
2864859|NCT00129129|3567611|FG003|NOT COMPLETED|Primary Phase||0
2864860|NCT00129129|3567612|FG004|NOT COMPLETED|Primary Phase||0
2864861|NCT00129129|3567608|FG000|STARTED|Fourth Dose Phase||236
2864862|NCT00129129|3567609|FG001|STARTED|Fourth Dose Phase||0
2864863|NCT00129129|3567610|FG002|STARTED|Fourth Dose Phase||0
2864864|NCT00129129|3567611|FG003|STARTED|Fourth Dose Phase||132
2864865|NCT00129129|3567612|FG004|STARTED|Fourth Dose Phase||130
2864866|NCT00129129|3567608|FG000|COMPLETED|Fourth Dose Phase||232
2864867|NCT00129129|3567609|FG001|COMPLETED|Fourth Dose Phase||0
2864868|NCT00129129|3567610|FG002|COMPLETED|Fourth Dose Phase||0
2864869|NCT00129129|3567611|FG003|COMPLETED|Fourth Dose Phase||128
2864870|NCT00129129|3567612|FG004|COMPLETED|Fourth Dose Phase||124
2864871|NCT00129129|3567608|FG000|NOT COMPLETED|Fourth Dose Phase||4
2864872|NCT00129129|3567609|FG001|NOT COMPLETED|Fourth Dose Phase||0
2864873|NCT00129129|3567610|FG002|NOT COMPLETED|Fourth Dose Phase||0
2864874|NCT00129129|3567611|FG003|NOT COMPLETED|Fourth Dose Phase||4
2864875|NCT00129129|3567612|FG004|NOT COMPLETED|Fourth Dose Phase||6
2864876|NCT00129220|3567635|FG000|STARTED|Study Period II||105
2864877|NCT00129220|3567636|FG001|STARTED|Study Period II||20
2864878|NCT00129220|3567637|FG002|STARTED|Study Period II||99
2864879|NCT00129220|3567635|FG000|Received at Least One Dose of Study Drug|Study Period II||104
2864880|NCT00129220|3567636|FG001|Received at Least One Dose of Study Drug|Study Period II||20
2864881|NCT00129220|3567637|FG002|Received at Least One Dose of Study Drug|Study Period II||97
2864882|NCT00129220|3567635|FG000|COMPLETED|Study Period II||72
2864883|NCT00129220|3567636|FG001|COMPLETED|Study Period II||8
2864884|NCT00129220|3567637|FG002|COMPLETED|Study Period II||52
2864885|NCT00129220|3567635|FG000|NOT COMPLETED|Study Period II||33
2864886|NCT00129220|3567636|FG001|NOT COMPLETED|Study Period II||12
2864887|NCT00129220|3567637|FG002|NOT COMPLETED|Study Period II||47
2864888|NCT00129220|3567635|FG000|STARTED|Study Period III||72
2864889|NCT00129220|3567636|FG001|STARTED|Study Period III||8
2864890|NCT00129220|3567637|FG002|STARTED|Study Period III||52
2864891|NCT00129220|3567635|FG000|COMPLETED|Study Period III||59
2864892|NCT00129220|3567636|FG001|COMPLETED|Study Period III||7
2864893|NCT00129220|3567637|FG002|COMPLETED|Study Period III||42
3169244|NCT01924182|3896715|FG000|STARTED|Overall Study||3
2864894|NCT00129220|3567635|FG000|NOT COMPLETED|Study Period III||13
2864895|NCT00129220|3567636|FG001|NOT COMPLETED|Study Period III||1
2864896|NCT00129220|3567637|FG002|NOT COMPLETED|Study Period III||10
2864897|NCT00129246|3567649|FG000|STARTED|Overall Study||20
2864898|NCT00129246|3567650|FG001|STARTED|Overall Study||20
2864899|NCT00129246|3567649|FG000|COMPLETED|Overall Study||20
3169245|NCT01924182|3896716|FG001|STARTED|Overall Study||0
2864900|NCT00129246|3567650|FG001|COMPLETED|Overall Study||20
2864901|NCT00129246|3567649|FG000|NOT COMPLETED|Overall Study||0
2864902|NCT00129246|3567650|FG001|NOT COMPLETED|Overall Study||0
2864903|NCT00129259|3567658|FG000|STARTED|Overall Study|Subjects not in the Intent-to-treat group did not have a baseline visit and are not included here|52
2864904|NCT00129259|3567659|FG001|STARTED|Overall Study|Subjects not in the Intent-to-treat group did not have a baseline visit and are not included here|25
3169246|NCT01924182|3896715|FG000|COMPLETED|Overall Study||2
3169247|NCT01924182|3896716|FG001|COMPLETED|Overall Study||0
3169248|NCT01924182|3896715|FG000|NOT COMPLETED|Overall Study||1
3169249|NCT01924182|3896716|FG001|NOT COMPLETED|Overall Study||0
3169250|NCT01924299|3896724|FG000|STARTED|Period 1||18
3169251|NCT01924299|3896725|FG001|STARTED|Period 1||18
3169252|NCT01924299|3896724|FG000|Received Baricitinib|Period 1||18
3169253|NCT01924299|3896725|FG001|Received Baricitinib|Period 1||18
2864905|NCT00129259|3567658|FG000|Received All or Part of Cycle 1|Overall Study||52
2864906|NCT00129259|3567659|FG001|Received All or Part of Cycle 1|Overall Study||0
2864907|NCT00129259|3567658|FG000|Received All or Part of Cycle 2|Overall Study||40
2864908|NCT00129259|3567659|FG001|Received All or Part of Cycle 2|Overall Study||0
2864909|NCT00129259|3567658|FG000|COMPLETED|Overall Study||49
2864910|NCT00129259|3567659|FG001|COMPLETED|Overall Study||22
3169254|NCT01924299|3896724|FG000|COMPLETED|Period 1||18
3169255|NCT01924299|3896725|FG001|COMPLETED|Period 1||18
3169256|NCT01924299|3896724|FG000|NOT COMPLETED|Period 1||0
3169257|NCT01924299|3896725|FG001|NOT COMPLETED|Period 1||0
3169258|NCT01924299|3896724|FG000|STARTED|Period 2||18
2864911|NCT00129259|3567658|FG000|NOT COMPLETED|Overall Study||3
2864912|NCT00129259|3567659|FG001|NOT COMPLETED|Overall Study||3
2864913|NCT00129272|3567667|FG000|STARTED|Overall Study||71
2864914|NCT00129272|3567668|FG001|STARTED|Overall Study||73
2864915|NCT00129272|3567667|FG000|COMPLETED|Overall Study||54
2864916|NCT00129272|3567668|FG001|COMPLETED|Overall Study||51
2864917|NCT00129272|3567667|FG000|NOT COMPLETED|Overall Study||17
2864918|NCT00129272|3567668|FG001|NOT COMPLETED|Overall Study||22
2864919|NCT00129285|3567677|FG000|STARTED|Overall Study||65
2864920|NCT00129285|3567678|FG001|STARTED|Overall Study||70
2864921|NCT00129285|3567679|FG002|STARTED|Overall Study||75
2864922|NCT00129285|3567677|FG000|COMPLETED|Overall Study||40
2864923|NCT00129285|3567678|FG001|COMPLETED|Overall Study||43
2864924|NCT00129285|3567679|FG002|COMPLETED|Overall Study||37
2864925|NCT00129285|3567677|FG000|NOT COMPLETED|Overall Study||25
2864926|NCT00129285|3567678|FG001|NOT COMPLETED|Overall Study||27
2864927|NCT00129285|3567679|FG002|NOT COMPLETED|Overall Study||38
2864928|NCT00129311|3567693|FG000|STARTED|Overall Study||51
2864929|NCT00129311|3567694|FG001|STARTED|Overall Study||50
2864930|NCT00129311|3567693|FG000|COMPLETED|Overall Study||39
2864931|NCT00129311|3567694|FG001|COMPLETED|Overall Study||31
2864932|NCT00129311|3567693|FG000|NOT COMPLETED|Overall Study||12
2864933|NCT00129311|3567694|FG001|NOT COMPLETED|Overall Study||19
2864934|NCT00129376|3567700|FG000|STARTED|Overall Study||63
2864935|NCT00129376|3567700|FG000|COMPLETED|Overall Study||61
2864936|NCT00129376|3567700|FG000|NOT COMPLETED|Overall Study||2
2864937|NCT00129389|3567706|FG000|STARTED|Overall Study||974
2864938|NCT00129389|3567707|FG001|STARTED|Overall Study||951
2864939|NCT00129389|3567706|FG000|COMPLETED|Overall Study|1 patient was crossed from arm A to B by error. 16 patients were crossed from arm B, to A by error.|941
2864940|NCT00129389|3567707|FG001|COMPLETED|Overall Study|16 patients were crossed from arm B to A by error. 1 patient was crossed from arm A to B by error.|811
2864941|NCT00129389|3567706|FG000|NOT COMPLETED|Overall Study||33
2864942|NCT00129389|3567707|FG001|NOT COMPLETED|Overall Study||140
2864943|NCT00129441|3567715|FG000|STARTED|Overall Study||9
2864944|NCT00129441|3567716|FG001|STARTED|Overall Study||6
2864945|NCT00129441|3567715|FG000|Baseline, Visit 1|Overall Study|Baseline # only includes those who completed 4-week trial (one L-830982 subject did not complete).|9
2864946|NCT00129441|3567716|FG001|Baseline, Visit 1|Overall Study||6
2864947|NCT00129441|3567715|FG000|Week 1, Visit 2|Overall Study||9
2864948|NCT00129441|3567716|FG001|Week 1, Visit 2|Overall Study||6
2864949|NCT00129441|3567715|FG000|Week 2, Visit 3|Overall Study||9
2864950|NCT00129441|3567716|FG001|Week 2, Visit 3|Overall Study||6
2864951|NCT00129441|3567715|FG000|Week 3, Visit 4|Overall Study||9
2864952|NCT00129441|3567716|FG001|Week 3, Visit 4|Overall Study||6
2864953|NCT00129441|3567715|FG000|Week 4, Visit 5|Overall Study||9
2864954|NCT00129441|3567716|FG001|Week 4, Visit 5|Overall Study||6
2864955|NCT00129441|3567715|FG000|Week 5, Visit 6|Overall Study||9
2864956|NCT00129441|3567716|FG001|Week 5, Visit 6|Overall Study||6
2864957|NCT00129441|3567715|FG000|Week 26, Visit 7|Overall Study||9
2864958|NCT00129441|3567716|FG001|Week 26, Visit 7|Overall Study||6
2864959|NCT00129441|3567715|FG000|Year 1, Visit 8|Overall Study||9
2864960|NCT00129441|3567716|FG001|Year 1, Visit 8|Overall Study||6
2864961|NCT00129441|3567715|FG000|COMPLETED|Overall Study||9
2864962|NCT00129441|3567716|FG001|COMPLETED|Overall Study||6
2864963|NCT00129441|3567715|FG000|NOT COMPLETED|Overall Study||0
2864964|NCT00129441|3567716|FG001|NOT COMPLETED|Overall Study||0
2864965|NCT00129467|3567724|FG000|STARTED|Received Intervention||15
2864966|NCT00129467|3567725|FG001|STARTED|Received Intervention||17
2864967|NCT00129467|3567724|FG000|COMPLETED|Received Intervention||9
2864968|NCT00129467|3567725|FG001|COMPLETED|Received Intervention||13
2864969|NCT00129467|3567724|FG000|NOT COMPLETED|Received Intervention||6
3169259|NCT01924299|3896725|FG001|STARTED|Period 2||18
3169260|NCT01924299|3896724|FG000|Received at Least 1 Dose of Study Drug|Period 2||18
3169261|NCT01924299|3896725|FG001|Received at Least 1 Dose of Study Drug|Period 2||18
3169262|NCT01924299|3896724|FG000|Received Baricitinib|Period 2||17
2864970|NCT00129467|3567725|FG001|NOT COMPLETED|Received Intervention||4
2864971|NCT00129467|3567724|FG000|STARTED|Open Label for SSRI+Methylphenidate Arm|Eligible if in methylphenidate arm & had 50% reduction in Montgomery-Asberg Depression Rating score|4
2864972|NCT00129467|3567725|FG001|STARTED|Open Label for SSRI+Methylphenidate Arm||0
2864973|NCT00129467|3567724|FG000|COMPLETED|Open Label for SSRI+Methylphenidate Arm||2
2864974|NCT00129467|3567725|FG001|COMPLETED|Open Label for SSRI+Methylphenidate Arm||0
2864975|NCT00129467|3567724|FG000|NOT COMPLETED|Open Label for SSRI+Methylphenidate Arm||2
2864976|NCT00129467|3567725|FG001|NOT COMPLETED|Open Label for SSRI+Methylphenidate Arm||0
2864977|NCT00129480|3567733|FG000|STARTED|Overall Study||187
2864978|NCT00129480|3567734|FG001|STARTED|Overall Study||214
2864979|NCT00129480|3567733|FG000|COMPLETED|Overall Study||187
2864980|NCT00129480|3567734|FG001|COMPLETED|Overall Study||214
2864981|NCT00129480|3567733|FG000|NOT COMPLETED|Overall Study||0
2864982|NCT00129480|3567734|FG001|NOT COMPLETED|Overall Study||0
2864983|NCT00129545|3567743|FG000|STARTED|Overall Study||93
2864984|NCT00129545|3567744|FG001|STARTED|Overall Study|2:1 randomization WATCHMAN to warfarin|463
2864985|NCT00129545|3567745|FG002|STARTED|Overall Study||244
2864986|NCT00129545|3567743|FG000|COMPLETED|Overall Study||67
2864987|NCT00129545|3567744|FG001|COMPLETED|Overall Study||299
2864988|NCT00129545|3567745|FG002|COMPLETED|Overall Study||133
2864989|NCT00129545|3567743|FG000|NOT COMPLETED|Overall Study||26
2864990|NCT00129545|3567744|FG001|NOT COMPLETED|Overall Study||164
2864991|NCT00129545|3567745|FG002|NOT COMPLETED|Overall Study||111
2864992|NCT00129623|3567755|FG000|STARTED|Overall Study||83
2864993|NCT00129623|3567756|FG001|STARTED|Overall Study||77
2864994|NCT00129623|3567755|FG000|Intent-to-treat (ITT)/ Safety Population|Overall Study||83
2864995|NCT00129623|3567756|FG001|Intent-to-treat (ITT)/ Safety Population|Overall Study||77
2864996|NCT00129623|3567755|FG000|COMPLETED|Overall Study||73
2864997|NCT00129623|3567756|FG001|COMPLETED|Overall Study||65
2864998|NCT00129623|3567755|FG000|NOT COMPLETED|Overall Study||10
2864999|NCT00129623|3567756|FG001|NOT COMPLETED|Overall Study||12
2865000|NCT00129649|3567766|FG000|STARTED|Overall Study||258
2865001|NCT00129649|3567767|FG001|STARTED|Overall Study||246
2865002|NCT00129649|3567766|FG000|COMPLETED|Overall Study||182
2865003|NCT00129649|3567767|FG001|COMPLETED|Overall Study||181
2865004|NCT00129649|3567766|FG000|NOT COMPLETED|Overall Study||76
3169263|NCT01924299|3896725|FG001|Received Baricitinib|Period 2||17
3169264|NCT01924299|3896724|FG000|COMPLETED|Period 2||17
3169265|NCT01924299|3896725|FG001|COMPLETED|Period 2||17
3169266|NCT01924299|3896724|FG000|NOT COMPLETED|Period 2||1
3169267|NCT01924299|3896725|FG001|NOT COMPLETED|Period 2||1
3169268|NCT01924364|3896737|FG000|STARTED|Overall Study||7
2865005|NCT00129649|3567767|FG001|NOT COMPLETED|Overall Study||65
2865006|NCT00129701|3567773|FG000|STARTED|Overall Study||104
2865007|NCT00129701|3567773|FG000|COMPLETED|Overall Study||71
2865008|NCT00129701|3567773|FG000|NOT COMPLETED|Overall Study||33
2865009|NCT00129727|3567780|FG000|STARTED|Overall Study||62
2865010|NCT00129727|3567780|FG000|COMPLETED|Overall Study||57
2865011|NCT00129727|3567780|FG000|NOT COMPLETED|Overall Study||5
2865012|NCT00129740|3567784|FG000|STARTED|Overall Study||148
2865013|NCT00129740|3567784|FG000|COMPLETED|Overall Study||148
3169269|NCT01924364|3896737|FG000|COMPLETED|Overall Study||4
3169270|NCT01924364|3896737|FG000|NOT COMPLETED|Overall Study||3
3169271|NCT01924390|3896754|FG000|STARTED|Overall Study||22
3169272|NCT01924390|3896755|FG001|STARTED|Overall Study||22
3169273|NCT01924390|3896754|FG000|COMPLETED|Overall Study||21
3169274|NCT01924390|3896755|FG001|COMPLETED|Overall Study||21
3169275|NCT01924390|3896754|FG000|NOT COMPLETED|Overall Study||1
3169276|NCT01924390|3896755|FG001|NOT COMPLETED|Overall Study||1
3169277|NCT01924429|3896763|FG000|STARTED|Period 1 - First Intervention (4 Weeks)||17
3169278|NCT01924429|3896764|FG001|STARTED|Period 1 - First Intervention (4 Weeks)||13
2865014|NCT00129740|3567784|FG000|NOT COMPLETED|Overall Study||0
2865015|NCT00129766|3567790|FG000|STARTED|Overall Study||3306
2865016|NCT00129766|3567791|FG001|STARTED|Overall Study||3329
2865017|NCT00129766|3567790|FG000|COMPLETED|Overall Study||3246
2865018|NCT00129766|3567791|FG001|COMPLETED|Overall Study||3270
2865019|NCT00129766|3567790|FG000|NOT COMPLETED|Overall Study||60
2865020|NCT00129766|3567791|FG001|NOT COMPLETED|Overall Study||59
2865021|NCT00129935|3567800|FG000|STARTED|Overall Study||669
2865022|NCT00129935|3567801|FG001|STARTED|Overall Study||715
2865023|NCT00129935|3567800|FG000|COMPLETED|Overall Study|2 patients crossed from arm A to B by error, and 1 patient received other treatment by error.|633
2865024|NCT00129935|3567801|FG001|COMPLETED|Overall Study|1 patient crossed from arm B to A by error.|623
2865025|NCT00129935|3567800|FG000|NOT COMPLETED|Overall Study||36
2865026|NCT00129935|3567801|FG001|NOT COMPLETED|Overall Study||92
2865027|NCT00129961|3567809|FG000|STARTED|Overall Study||39
2865028|NCT00129961|3567810|FG001|STARTED|Overall Study||47
2865029|NCT00129961|3567809|FG000|COMPLETED|Overall Study||20
2865030|NCT00129961|3567810|FG001|COMPLETED|Overall Study||24
2865031|NCT00129961|3567809|FG000|NOT COMPLETED|Overall Study||19
2865032|NCT00129961|3567810|FG001|NOT COMPLETED|Overall Study||23
2865033|NCT00129987|3567818|FG000|STARTED|1st Educational Session||287
2865034|NCT00129987|3567819|FG001|STARTED|1st Educational Session||280
2865035|NCT00129987|3567818|FG000|COMPLETED|1st Educational Session||146
2865036|NCT00129987|3567819|FG001|COMPLETED|1st Educational Session||171
2865037|NCT00129987|3567818|FG000|NOT COMPLETED|1st Educational Session||141
3169279|NCT01924429|3896763|FG000|COMPLETED|Period 1 - First Intervention (4 Weeks)||17
3169280|NCT01924429|3896764|FG001|COMPLETED|Period 1 - First Intervention (4 Weeks)||13
2865038|NCT00129987|3567819|FG001|NOT COMPLETED|1st Educational Session||109
2865039|NCT00129987|3567818|FG000|STARTED|1 Year||146
2865040|NCT00129987|3567819|FG001|STARTED|1 Year||171
2865041|NCT00129987|3567818|FG000|COMPLETED|1 Year||114
2865042|NCT00129987|3567819|FG001|COMPLETED|1 Year||150
2865043|NCT00129987|3567818|FG000|NOT COMPLETED|1 Year||32
2865044|NCT00129987|3567819|FG001|NOT COMPLETED|1 Year||21
2865045|NCT00130039|3567827|FG000|STARTED|Overall Study||232
2865046|NCT00130039|3567828|FG001|STARTED|Overall Study||225
2865047|NCT00130039|3567827|FG000|COMPLETED|Overall Study|full analysis set|202
2865048|NCT00130039|3567828|FG001|COMPLETED|Overall Study|full analysis set|207
2865049|NCT00130039|3567827|FG000|NOT COMPLETED|Overall Study||30
2865050|NCT00130039|3567828|FG001|NOT COMPLETED|Overall Study||18
2865051|NCT00130117|3567836|FG000|STARTED|Overall Study||11
2865052|NCT00130117|3567837|FG001|STARTED|Overall Study||9
2865053|NCT00130117|3567836|FG000|COMPLETED|Overall Study||7
2865054|NCT00130117|3567837|FG001|COMPLETED|Overall Study||6
2865055|NCT00130117|3567836|FG000|NOT COMPLETED|Overall Study||4
2865056|NCT00130117|3567837|FG001|NOT COMPLETED|Overall Study||3
2865057|NCT00130208|3567846|FG000|STARTED|Maintenance Period (26 Weeks)||524
2865058|NCT00130208|3567847|FG001|STARTED|Maintenance Period (26 Weeks)||532
2865059|NCT00130208|3567846|FG000|Valid Albumin Creatinine Ratio|Maintenance Period (26 Weeks)||492
2865060|NCT00130208|3567847|FG001|Valid Albumin Creatinine Ratio|Maintenance Period (26 Weeks)||494
2865061|NCT00130208|3567846|FG000|COMPLETED|Maintenance Period (26 Weeks)||500
2865062|NCT00130208|3567847|FG001|COMPLETED|Maintenance Period (26 Weeks)||502
2865063|NCT00130208|3567846|FG000|NOT COMPLETED|Maintenance Period (26 Weeks)||24
2865064|NCT00130208|3567847|FG001|NOT COMPLETED|Maintenance Period (26 Weeks)||30
2865065|NCT00130208|3567846|FG000|STARTED|Washout Period (8 Weeks)||500
2865066|NCT00130208|3567847|FG001|STARTED|Washout Period (8 Weeks)||502
2865067|NCT00130208|3567846|FG000|COMPLETED|Washout Period (8 Weeks)||494
2865068|NCT00130208|3567847|FG001|COMPLETED|Washout Period (8 Weeks)||490
2865069|NCT00130208|3567846|FG000|NOT COMPLETED|Washout Period (8 Weeks)||6
2865070|NCT00130208|3567847|FG001|NOT COMPLETED|Washout Period (8 Weeks)||12
2865071|NCT00130247|3567855|FG000|STARTED|Overall Study||196
2865072|NCT00130247|3567856|FG001|STARTED|Overall Study||198
2865073|NCT00130247|3567855|FG000|COMPLETED|Overall Study||194
2865074|NCT00130247|3567856|FG001|COMPLETED|Overall Study||194
2865075|NCT00130247|3567855|FG000|NOT COMPLETED|Overall Study||2
2865076|NCT00130247|3567856|FG001|NOT COMPLETED|Overall Study||4
2865077|NCT00130286|3567866|FG000|STARTED|Overall Study||22
2865078|NCT00130286|3567867|FG001|STARTED|Overall Study||19
2865079|NCT00130286|3567868|FG002|STARTED|Overall Study||17
2865080|NCT00130286|3567869|FG003|STARTED|Overall Study||19
2865081|NCT00130286|3567866|FG000|COMPLETED|Overall Study||22
2865082|NCT00130286|3567867|FG001|COMPLETED|Overall Study||16
2865083|NCT00130286|3567868|FG002|COMPLETED|Overall Study||13
2865084|NCT00130286|3567869|FG003|COMPLETED|Overall Study||17
2865085|NCT00130286|3567866|FG000|NOT COMPLETED|Overall Study||0
2865086|NCT00130286|3567867|FG001|NOT COMPLETED|Overall Study||3
2865087|NCT00130286|3567868|FG002|NOT COMPLETED|Overall Study||4
2865088|NCT00130286|3567869|FG003|NOT COMPLETED|Overall Study||2
2865089|NCT00130442|3567881|FG000|STARTED|Overall Study||66
2865090|NCT00130442|3567882|FG001|STARTED|Overall Study||68
2865091|NCT00130442|3567881|FG000|COMPLETED|Overall Study||65
2865092|NCT00130442|3567882|FG001|COMPLETED|Overall Study||66
2865093|NCT00130442|3567881|FG000|NOT COMPLETED|Overall Study||1
2865094|NCT00130442|3567882|FG001|NOT COMPLETED|Overall Study||2
2865095|NCT00130520|3567890|FG000|STARTED|Overall Study|85 women were screened for eligibility, 56 consented, 40 treated.|40
2865096|NCT00130520|3567890|FG000|Completion of at Least One Cycle|Overall Study||39
2865097|NCT00130520|3567890|FG000|COMPLETED|Overall Study||1
2865098|NCT00130520|3567890|FG000|NOT COMPLETED|Overall Study||39
2865099|NCT00130533|3567896|FG000|STARTED|Overall Study||448
2865100|NCT00130533|3567897|FG001|STARTED|Overall Study||428
2865101|NCT00130533|3567896|FG000|COMPLETED|Overall Study||337
2865102|NCT00130533|3567897|FG001|COMPLETED|Overall Study||398
2865103|NCT00130533|3567896|FG000|NOT COMPLETED|Overall Study||111
2865104|NCT00130533|3567897|FG001|NOT COMPLETED|Overall Study||30
2865105|NCT00130637|3567903|FG000|STARTED|Overall Study||6
2865106|NCT00130637|3567903|FG000|COMPLETED|Overall Study||3
2865107|NCT00130637|3567903|FG000|NOT COMPLETED|Overall Study||3
2865108|NCT00130689|3567907|FG000|STARTED|Overall Study||43
2865109|NCT00130689|3567907|FG000|Eligible|Overall Study||37
2865110|NCT00130689|3567907|FG000|Treated|Overall Study||35
2865111|NCT00130689|3567907|FG000|COMPLETED|Overall Study|Since treatment duration was not fixed, patients were not considered to have completed treatment.|0
2865112|NCT00130689|3567907|FG000|NOT COMPLETED|Overall Study||43
2865113|NCT00130728|3567913|FG000|STARTED|Overall Study||319
2865114|NCT00130728|3567914|FG001|STARTED|Overall Study||317
2865115|NCT00130728|3567913|FG000|Received Study Drug (Safety Population)|Overall Study||313
2865116|NCT00130728|3567914|FG001|Received Study Drug (Safety Population)|Overall Study||313
2865117|NCT00130728|3567913|FG000|COMPLETED|Overall Study||57
2865118|NCT00130728|3567914|FG001|COMPLETED|Overall Study||57
2865119|NCT00130728|3567913|FG000|NOT COMPLETED|Overall Study||262
2865120|NCT00130728|3567914|FG001|NOT COMPLETED|Overall Study||260
2865121|NCT00130780|3567922|FG000|STARTED|Overall Study||51
2865122|NCT00130780|3567923|FG001|STARTED|Overall Study||20
2865123|NCT00130780|3567922|FG000|COMPLETED|Overall Study||51
2865124|NCT00130780|3567923|FG001|COMPLETED|Overall Study||20
2865125|NCT00130780|3567922|FG000|NOT COMPLETED|Overall Study||0
2865126|NCT00130780|3567923|FG001|NOT COMPLETED|Overall Study||0
2865127|NCT00130793|3567931|FG000|STARTED|Overall Study||183
2865128|NCT00130793|3567932|FG001|STARTED|Overall Study||185
2865129|NCT00130793|3567931|FG000|Vaccinated|Overall Study|One subject was allocated but not vaccinated.|182
2865130|NCT00130793|3567932|FG001|Vaccinated|Overall Study||185
2865131|NCT00130793|3567931|FG000|COMPLETED|Overall Study|Subject received vaccine, completed blood draws, returned vaccination report card (VRC) at Week 4|180
2865132|NCT00130793|3567932|FG001|COMPLETED|Overall Study|Subject received vaccine, completed blood draws, returned VRC at Week 4|181
2865133|NCT00130793|3567931|FG000|NOT COMPLETED|Overall Study||3
2865134|NCT00130793|3567932|FG001|NOT COMPLETED|Overall Study||4
2865135|NCT00130832|3567941|FG000|STARTED|Overall Study||372
2865136|NCT00130832|3567942|FG001|STARTED|Overall Study||363
2865137|NCT00130832|3567941|FG000|COMPLETED|Overall Study|Those who received all 3 doses of concomitant RotaTeq™/ OPV with blood draw ~42 days postdose 3|356
2865138|NCT00130832|3567942|FG001|COMPLETED|Overall Study|Those who received all 3 doses; last 2 blood draws ~42 days postdose 3 of RotaTeq™ and postdose OPV|346
2865139|NCT00130832|3567941|FG000|NOT COMPLETED|Overall Study||16
2865140|NCT00130832|3567942|FG001|NOT COMPLETED|Overall Study||17
2865141|NCT00130923|3567950|FG000|STARTED|Overall Study||49
2865142|NCT00130923|3567951|FG001|STARTED|Overall Study||46
2865143|NCT00130923|3567950|FG000|COMPLETED|Overall Study||36
2865144|NCT00130923|3567951|FG001|COMPLETED|Overall Study||32
2865145|NCT00130923|3567950|FG000|NOT COMPLETED|Overall Study||13
2865146|NCT00130923|3567951|FG001|NOT COMPLETED|Overall Study||14
2918596|NCT00528112|3628855|FG000|COMPLETED|Extension Phase||0
2918597|NCT00528112|3628856|FG001|COMPLETED|Extension Phase||550
2918598|NCT00528112|3628855|FG000|NOT COMPLETED|Extension Phase||0
2918599|NCT00528112|3628856|FG001|NOT COMPLETED|Extension Phase||157
2918600|NCT00528190|3628866|FG000|STARTED|Overall Study||18
2918601|NCT00528190|3628867|FG001|STARTED|Overall Study||17
2918602|NCT00528190|3628866|FG000|COMPLETED|Overall Study||18
2918603|NCT00528190|3628867|FG001|COMPLETED|Overall Study||16
2918604|NCT00528190|3628866|FG000|NOT COMPLETED|Overall Study||0
2918605|NCT00528190|3628867|FG001|NOT COMPLETED|Overall Study||1
2918606|NCT00528268|3628875|FG000|STARTED|Overall Study||6
2918607|NCT00528268|3628876|FG001|STARTED|Overall Study||8
2918608|NCT00528268|3628875|FG000|COMPLETED|Overall Study||5
2918609|NCT00528268|3628876|FG001|COMPLETED|Overall Study||7
2918610|NCT00528268|3628875|FG000|NOT COMPLETED|Overall Study||1
2918611|NCT00528268|3628876|FG001|NOT COMPLETED|Overall Study||1
2918612|NCT00528372|3628891|FG000|STARTED|Short-term (ST) Period (Day 1-Week 24)||75
2918613|NCT00528372|3628892|FG001|STARTED|Short-term (ST) Period (Day 1-Week 24)||65
2918614|NCT00528372|3628893|FG002|STARTED|Short-term (ST) Period (Day 1-Week 24)||64
2918615|NCT00528372|3628894|FG003|STARTED|Short-term (ST) Period (Day 1-Week 24)||70
2918616|NCT00528372|3628895|FG004|STARTED|Short-term (ST) Period (Day 1-Week 24)||67
2918617|NCT00528372|3628896|FG005|STARTED|Short-term (ST) Period (Day 1-Week 24)||68
2918618|NCT00528372|3628897|FG006|STARTED|Short-term (ST) Period (Day 1-Week 24)||76
2918619|NCT00528372|3628898|FG007|STARTED|Short-term (ST) Period (Day 1-Week 24)||34
2918620|NCT00528372|3628899|FG008|STARTED|Short-term (ST) Period (Day 1-Week 24)||39
2918621|NCT00528372|3628891|FG000|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||63
2918622|NCT00528372|3628892|FG001|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||60
2918623|NCT00528372|3628893|FG002|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||52
2918624|NCT00528372|3628894|FG003|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||57
2918625|NCT00528372|3628895|FG004|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||58
2918626|NCT00528372|3628896|FG005|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||57
2918627|NCT00528372|3628897|FG006|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||65
2918628|NCT00528372|3628898|FG007|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||28
2918629|NCT00528372|3628899|FG008|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||34
2918630|NCT00528372|3628891|FG000|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||12
2918631|NCT00528372|3628892|FG001|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||5
2918632|NCT00528372|3628893|FG002|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||12
2918633|NCT00528372|3628894|FG003|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||13
2918634|NCT00528372|3628895|FG004|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||9
2918635|NCT00528372|3628896|FG005|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||11
2918636|NCT00528372|3628897|FG006|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||11
2918637|NCT00528372|3628898|FG007|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||6
2918638|NCT00528372|3628899|FG008|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||5
2918639|NCT00528372|3628891|FG000|STARTED|Long-term (LT) Period (Weeks 24-102)||62
2918640|NCT00528372|3628892|FG001|STARTED|Long-term (LT) Period (Weeks 24-102)||59
2918641|NCT00528372|3628893|FG002|STARTED|Long-term (LT) Period (Weeks 24-102)||51
2918642|NCT00528372|3628894|FG003|STARTED|Long-term (LT) Period (Weeks 24-102)||56
2918643|NCT00528372|3628895|FG004|STARTED|Long-term (LT) Period (Weeks 24-102)||58
2918644|NCT00528372|3628896|FG005|STARTED|Long-term (LT) Period (Weeks 24-102)||57
2918645|NCT00528372|3628897|FG006|STARTED|Long-term (LT) Period (Weeks 24-102)||65
2918646|NCT00528372|3628898|FG007|STARTED|Long-term (LT) Period (Weeks 24-102)||28
2918647|NCT00528372|3628899|FG008|STARTED|Long-term (LT) Period (Weeks 24-102)|1 patient completed ST phase but withdrew for sponsor administrative reason before start of LT phase|33
2918648|NCT00528372|3628891|FG000|COMPLETED|Long-term (LT) Period (Weeks 24-102)||42
2918649|NCT00528372|3628892|FG001|COMPLETED|Long-term (LT) Period (Weeks 24-102)||40
2918650|NCT00528372|3628893|FG002|COMPLETED|Long-term (LT) Period (Weeks 24-102)||43
2865147|NCT00131248|3567958|FG000|STARTED|Intervention 1 (3-day Course)||9
2865148|NCT00131248|3567959|FG001|STARTED|Intervention 1 (3-day Course)||9
2865149|NCT00131248|3567958|FG000|COMPLETED|Intervention 1 (3-day Course)||8
2865150|NCT00131248|3567959|FG001|COMPLETED|Intervention 1 (3-day Course)||9
2865151|NCT00131248|3567958|FG000|NOT COMPLETED|Intervention 1 (3-day Course)||1
2865152|NCT00131248|3567959|FG001|NOT COMPLETED|Intervention 1 (3-day Course)||0
2865153|NCT00131248|3567958|FG000|STARTED|Washout (24 Hour)||8
2865154|NCT00131248|3567959|FG001|STARTED|Washout (24 Hour)||9
2865155|NCT00131248|3567958|FG000|COMPLETED|Washout (24 Hour)||8
2865156|NCT00131248|3567959|FG001|COMPLETED|Washout (24 Hour)||9
2865157|NCT00131248|3567958|FG000|NOT COMPLETED|Washout (24 Hour)||0
2865158|NCT00131248|3567959|FG001|NOT COMPLETED|Washout (24 Hour)||0
2865159|NCT00131248|3567958|FG000|STARTED|Intervention 2 (7-day Course)||8
2865160|NCT00131248|3567959|FG001|STARTED|Intervention 2 (7-day Course)||9
2865161|NCT00131248|3567958|FG000|COMPLETED|Intervention 2 (7-day Course)||8
2865162|NCT00131248|3567959|FG001|COMPLETED|Intervention 2 (7-day Course)||9
2865163|NCT00131248|3567958|FG000|NOT COMPLETED|Intervention 2 (7-day Course)||0
2865164|NCT00131248|3567959|FG001|NOT COMPLETED|Intervention 2 (7-day Course)||0
2865165|NCT00131248|3567958|FG000|STARTED|Washout 2 (24 Hours)||8
2865166|NCT00131248|3567959|FG001|STARTED|Washout 2 (24 Hours)||9
2865167|NCT00131248|3567958|FG000|COMPLETED|Washout 2 (24 Hours)||8
2865168|NCT00131248|3567959|FG001|COMPLETED|Washout 2 (24 Hours)||9
2865169|NCT00131248|3567958|FG000|NOT COMPLETED|Washout 2 (24 Hours)||0
2865170|NCT00131248|3567959|FG001|NOT COMPLETED|Washout 2 (24 Hours)||0
2865171|NCT00131248|3567958|FG000|STARTED|Intervention 3 (4-day Course)||8
2865172|NCT00131248|3567959|FG001|STARTED|Intervention 3 (4-day Course)||9
2865173|NCT00131248|3567958|FG000|COMPLETED|Intervention 3 (4-day Course)||8
2865174|NCT00131248|3567959|FG001|COMPLETED|Intervention 3 (4-day Course)||9
2865175|NCT00131248|3567958|FG000|NOT COMPLETED|Intervention 3 (4-day Course)||0
2865176|NCT00131248|3567959|FG001|NOT COMPLETED|Intervention 3 (4-day Course)||0
2865177|NCT00131352|3567967|FG000|STARTED|Initial Treatment Period|Safety population|123
2865178|NCT00131352|3567968|FG001|STARTED|Initial Treatment Period|Safety population|130
2865179|NCT00131352|3567967|FG000|Intent to Treat Population|Initial Treatment Period||124
2865180|NCT00131352|3567968|FG001|Intent to Treat Population|Initial Treatment Period||129
2865181|NCT00131352|3567967|FG000|COMPLETED|Initial Treatment Period||114
2865182|NCT00131352|3567968|FG001|COMPLETED|Initial Treatment Period||118
2865183|NCT00131352|3567967|FG000|NOT COMPLETED|Initial Treatment Period||9
2865184|NCT00131352|3567968|FG001|NOT COMPLETED|Initial Treatment Period||12
2865185|NCT00131352|3567967|FG000|STARTED|Repeat Treatment Period|Safety population: 77 Synvisc + 83 Saline Control participants from the Initial Treatment period.|160
2865186|NCT00131352|3567968|FG001|STARTED|Repeat Treatment Period||0
2865187|NCT00131352|3567967|FG000|COMPLETED|Repeat Treatment Period||158
2865188|NCT00131352|3567968|FG001|COMPLETED|Repeat Treatment Period||0
2865189|NCT00131352|3567967|FG000|NOT COMPLETED|Repeat Treatment Period||2
2865190|NCT00131352|3567968|FG001|NOT COMPLETED|Repeat Treatment Period||0
2865191|NCT00131365|3567976|FG000|STARTED|Overall Study|Only safety data was reported due to early closure of the study due to device obsolescence.|9
2865192|NCT00131365|3567976|FG000|COMPLETED|Overall Study||5
2865193|NCT00131365|3567976|FG000|NOT COMPLETED|Overall Study||4
2865194|NCT00131378|3567985|FG000|STARTED|Overall Study||40
2865195|NCT00131378|3567986|FG001|STARTED|Overall Study||40
2865196|NCT00131378|3567987|FG002|STARTED|Overall Study||32
2865197|NCT00131378|3567988|FG003|STARTED|Overall Study||30
2865198|NCT00131378|3567985|FG000|COMPLETED|Overall Study||29
2865199|NCT00131378|3567986|FG001|COMPLETED|Overall Study||22
2865200|NCT00131378|3567987|FG002|COMPLETED|Overall Study||22
2865201|NCT00131378|3567988|FG003|COMPLETED|Overall Study||21
2865202|NCT00131378|3567985|FG000|NOT COMPLETED|Overall Study||11
2865203|NCT00131378|3567986|FG001|NOT COMPLETED|Overall Study||18
2865204|NCT00131378|3567987|FG002|NOT COMPLETED|Overall Study||10
2865205|NCT00131378|3567988|FG003|NOT COMPLETED|Overall Study||9
2865206|NCT00131456|3568002|FG000|STARTED|Overall Study||52
2865207|NCT00131456|3568003|FG001|STARTED|Overall Study||51
2865208|NCT00131456|3568002|FG000|COMPLETED|Overall Study||33
2865209|NCT00131456|3568003|FG001|COMPLETED|Overall Study||31
2865210|NCT00131456|3568002|FG000|NOT COMPLETED|Overall Study||19
2865211|NCT00131456|3568003|FG001|NOT COMPLETED|Overall Study||20
2865212|NCT00131469|3568011|FG000|STARTED|Overall Study||38
2865213|NCT00131469|3568012|FG001|STARTED|Overall Study||40
2865214|NCT00131469|3568011|FG000|COMPLETED|Overall Study||29
2865215|NCT00131469|3568012|FG001|COMPLETED|Overall Study||27
2865216|NCT00131469|3568011|FG000|NOT COMPLETED|Overall Study||9
2865217|NCT00131469|3568012|FG001|NOT COMPLETED|Overall Study||13
2865218|NCT00131508|3568020|FG000|STARTED|Overall Study||12
2865219|NCT00131508|3568021|FG001|STARTED|Overall Study||13
2865220|NCT00131508|3568020|FG000|COMPLETED|Overall Study||9
2865221|NCT00131508|3568021|FG001|COMPLETED|Overall Study||5
2865222|NCT00131508|3568020|FG000|NOT COMPLETED|Overall Study||3
2865223|NCT00131508|3568021|FG001|NOT COMPLETED|Overall Study||8
2865224|NCT00131573|3568029|FG000|STARTED|Overall Study||46
2865225|NCT00131573|3568030|FG001|STARTED|Overall Study||39
2865226|NCT00131573|3568029|FG000|COMPLETED|Overall Study||13
2865227|NCT00131573|3568030|FG001|COMPLETED|Overall Study||13
2865228|NCT00131573|3568029|FG000|NOT COMPLETED|Overall Study||33
2865229|NCT00131573|3568030|FG001|NOT COMPLETED|Overall Study||26
2865230|NCT00131664|3568040|FG000|STARTED|First Period (First 6 Months)||136
2865231|NCT00131664|3568041|FG001|STARTED|First Period (First 6 Months)||135
2865232|NCT00131664|3568042|FG002|STARTED|First Period (First 6 Months)||120
2865233|NCT00131664|3568043|FG003|STARTED|First Period (First 6 Months)||0
2865234|NCT00131664|3568044|FG004|STARTED|First Period (First 6 Months)||0
2865235|NCT00131664|3568045|FG005|STARTED|First Period (First 6 Months)||0
2865236|NCT00131664|3568040|FG000|COMPLETED|First Period (First 6 Months)||111
2865237|NCT00131664|3568041|FG001|COMPLETED|First Period (First 6 Months)||117
2865238|NCT00131664|3568042|FG002|COMPLETED|First Period (First 6 Months)||104
2865239|NCT00131664|3568043|FG003|COMPLETED|First Period (First 6 Months)||0
2865240|NCT00131664|3568044|FG004|COMPLETED|First Period (First 6 Months)||0
2865241|NCT00131664|3568045|FG005|COMPLETED|First Period (First 6 Months)||0
2865242|NCT00131664|3568040|FG000|NOT COMPLETED|First Period (First 6 Months)||25
2865243|NCT00131664|3568041|FG001|NOT COMPLETED|First Period (First 6 Months)||18
2865244|NCT00131664|3568042|FG002|NOT COMPLETED|First Period (First 6 Months)||16
2865245|NCT00131664|3568043|FG003|NOT COMPLETED|First Period (First 6 Months)||0
2865246|NCT00131664|3568044|FG004|NOT COMPLETED|First Period (First 6 Months)||0
2865247|NCT00131664|3568045|FG005|NOT COMPLETED|First Period (First 6 Months)||0
2865248|NCT00131664|3568040|FG000|STARTED|Second Period (Additional Drug Added)|21 had added Metformin at Month 6|90
2865249|NCT00131664|3568041|FG001|STARTED|Second Period (Additional Drug Added)|16 had added Amaryl at Month 6|101
2865250|NCT00131664|3568042|FG002|STARTED|Second Period (Additional Drug Added)|25 had added Amaryl at Month 6|79
2865251|NCT00131664|3568043|FG003|STARTED|Second Period (Additional Drug Added)||21
2865252|NCT00131664|3568044|FG004|STARTED|Second Period (Additional Drug Added)||16
2865253|NCT00131664|3568045|FG005|STARTED|Second Period (Additional Drug Added)||25
2865254|NCT00131664|3568040|FG000|COMPLETED|Second Period (Additional Drug Added)||81
2865255|NCT00131664|3568041|FG001|COMPLETED|Second Period (Additional Drug Added)||97
2865256|NCT00131664|3568042|FG002|COMPLETED|Second Period (Additional Drug Added)||76
2865257|NCT00131664|3568043|FG003|COMPLETED|Second Period (Additional Drug Added)||19
2865258|NCT00131664|3568044|FG004|COMPLETED|Second Period (Additional Drug Added)||15
2865259|NCT00131664|3568045|FG005|COMPLETED|Second Period (Additional Drug Added)||22
2865260|NCT00131664|3568040|FG000|NOT COMPLETED|Second Period (Additional Drug Added)||9
2865261|NCT00131664|3568041|FG001|NOT COMPLETED|Second Period (Additional Drug Added)||4
2865262|NCT00131664|3568042|FG002|NOT COMPLETED|Second Period (Additional Drug Added)||3
2865263|NCT00131664|3568043|FG003|NOT COMPLETED|Second Period (Additional Drug Added)||2
2865264|NCT00131664|3568044|FG004|NOT COMPLETED|Second Period (Additional Drug Added)||1
2865265|NCT00131664|3568045|FG005|NOT COMPLETED|Second Period (Additional Drug Added)||3
2865266|NCT00131677|3568058|FG000|STARTED|Overall Study|201 randomized to active drug; 101 to start immediately and 100 after a 9 month delay.|201
2865267|NCT00131677|3568059|FG001|STARTED|Overall Study|199 randomized to placebo; 99 to start immediately and 100 after a 9 month delay.|199
2865268|NCT00131677|3568058|FG000|COMPLETED|Overall Study||171
2865269|NCT00131677|3568059|FG001|COMPLETED|Overall Study||160
2865270|NCT00131677|3568058|FG000|NOT COMPLETED|Overall Study||30
2865271|NCT00131677|3568059|FG001|NOT COMPLETED|Overall Study||39
2865272|NCT00131885|3568074|FG000|STARTED|Time 1: First Intervention||9
2865273|NCT00131885|3568075|FG001|STARTED|Time 1: First Intervention||9
2865274|NCT00131885|3568076|FG002|STARTED|Time 1: First Intervention||9
2865275|NCT00131885|3568077|FG003|STARTED|Time 1: First Intervention||9
2865276|NCT00131885|3568074|FG000|COMPLETED|Time 1: First Intervention||9
2865277|NCT00131885|3568075|FG001|COMPLETED|Time 1: First Intervention||9
2865278|NCT00131885|3568076|FG002|COMPLETED|Time 1: First Intervention||9
2865279|NCT00131885|3568077|FG003|COMPLETED|Time 1: First Intervention||9
2865280|NCT00131885|3568074|FG000|NOT COMPLETED|Time 1: First Intervention||0
2865281|NCT00131885|3568075|FG001|NOT COMPLETED|Time 1: First Intervention||0
2865282|NCT00131885|3568076|FG002|NOT COMPLETED|Time 1: First Intervention||0
2865283|NCT00131885|3568077|FG003|NOT COMPLETED|Time 1: First Intervention||0
2865284|NCT00131885|3568074|FG000|STARTED|Time 2: Second Intervention||9
2865285|NCT00131885|3568075|FG001|STARTED|Time 2: Second Intervention||9
2865286|NCT00131885|3568076|FG002|STARTED|Time 2: Second Intervention||9
2865287|NCT00131885|3568077|FG003|STARTED|Time 2: Second Intervention||9
2865288|NCT00131885|3568074|FG000|COMPLETED|Time 2: Second Intervention||9
2865289|NCT00131885|3568075|FG001|COMPLETED|Time 2: Second Intervention||9
2865290|NCT00131885|3568076|FG002|COMPLETED|Time 2: Second Intervention||9
2865291|NCT00131885|3568077|FG003|COMPLETED|Time 2: Second Intervention||9
2865292|NCT00131885|3568074|FG000|NOT COMPLETED|Time 2: Second Intervention||0
2865293|NCT00131885|3568075|FG001|NOT COMPLETED|Time 2: Second Intervention||0
2865294|NCT00131885|3568076|FG002|NOT COMPLETED|Time 2: Second Intervention||0
2865295|NCT00131885|3568077|FG003|NOT COMPLETED|Time 2: Second Intervention||0
2865296|NCT00131911|3568089|FG000|STARTED|Overall Study||51
2865297|NCT00131911|3568090|FG001|STARTED|Overall Study||42
2865298|NCT00131911|3568089|FG000|COMPLETED|Overall Study||50
2865299|NCT00131911|3568090|FG001|COMPLETED|Overall Study||42
2865300|NCT00131911|3568089|FG000|NOT COMPLETED|Overall Study||1
2865301|NCT00131911|3568090|FG001|NOT COMPLETED|Overall Study||0
2865302|NCT00131937|3568095|FG000|STARTED|Overall Study||14
2865303|NCT00131937|3568095|FG000|COMPLETED|Overall Study||0
2865304|NCT00131937|3568095|FG000|NOT COMPLETED|Overall Study||14
2865305|NCT00132002|3568099|FG000|STARTED|Overall Study||14
2865306|NCT00132002|3568099|FG000|COMPLETED|Overall Study||14
2865307|NCT00132002|3568099|FG000|NOT COMPLETED|Overall Study||0
2865308|NCT00132028|3568103|FG000|STARTED|Overall Study||27
3169281|NCT01924429|3896763|FG000|NOT COMPLETED|Period 1 - First Intervention (4 Weeks)||0
3169282|NCT01924429|3896764|FG001|NOT COMPLETED|Period 1 - First Intervention (4 Weeks)||0
3313469|NCT03075410|4046792|FG001|COMPLETED|Part A-Washout Period 3 (14 Days)||1
3313470|NCT03075410|4046793|FG002|COMPLETED|Part A-Washout Period 3 (14 Days)||2
2865309|NCT00132028|3568103|FG000|Eligible|Overall Study||25
2865310|NCT00132028|3568103|FG000|Eligible and Began Protocol Therapy|Overall Study||25
2865311|NCT00132028|3568103|FG000|COMPLETED|Overall Study|"Since there was no maximum number of cycles, patients could not complete treatment."|0
2865312|NCT00132028|3568103|FG000|NOT COMPLETED|Overall Study||27
2865313|NCT00132041|3568107|FG000|STARTED|Baseline||51
2865314|NCT00132041|3568107|FG000|Eligible|Baseline||45
2865315|NCT00132041|3568107|FG000|COMPLETED|Baseline||45
2865316|NCT00132041|3568107|FG000|NOT COMPLETED|Baseline||6
2865317|NCT00132041|3568107|FG000|STARTED|3 Months Post Ablation||45
2865318|NCT00132041|3568107|FG000|COMPLETED|3 Months Post Ablation||42
2865319|NCT00132041|3568107|FG000|NOT COMPLETED|3 Months Post Ablation||3
2865320|NCT00132041|3568107|FG000|STARTED|6 Months Post Ablation||42
2865321|NCT00132041|3568107|FG000|COMPLETED|6 Months Post Ablation||32
2865322|NCT00132041|3568107|FG000|NOT COMPLETED|6 Months Post Ablation||10
2865323|NCT00132041|3568107|FG000|STARTED|9 Months Post Ablation||32
2865324|NCT00132041|3568107|FG000|COMPLETED|9 Months Post Ablation||30
2865325|NCT00132041|3568107|FG000|NOT COMPLETED|9 Months Post Ablation||2
2865326|NCT00132041|3568107|FG000|STARTED|12 Months Post Ablation||30
2865327|NCT00132041|3568107|FG000|COMPLETED|12 Months Post Ablation||26
2865328|NCT00132041|3568107|FG000|NOT COMPLETED|12 Months Post Ablation||4
2865329|NCT00132041|3568107|FG000|STARTED|15 Months Post Ablation||26
2865330|NCT00132041|3568107|FG000|COMPLETED|15 Months Post Ablation||18
2865331|NCT00132041|3568107|FG000|NOT COMPLETED|15 Months Post Ablation||8
2865332|NCT00132041|3568107|FG000|STARTED|18 Months Post Ablation||18
2865333|NCT00132041|3568107|FG000|COMPLETED|18 Months Post Ablation||12
2865334|NCT00132041|3568107|FG000|NOT COMPLETED|18 Months Post Ablation||6
2865335|NCT00132132|3568119|FG000|STARTED|Overall Study||15
2865336|NCT00132132|3568120|FG001|STARTED|Overall Study||15
2865337|NCT00132132|3568119|FG000|COMPLETED|Overall Study||8
2865338|NCT00132132|3568120|FG001|COMPLETED|Overall Study||13
2865339|NCT00132132|3568119|FG000|NOT COMPLETED|Overall Study||7
2865340|NCT00132132|3568120|FG001|NOT COMPLETED|Overall Study||2
2865341|NCT00132301|3568128|FG000|STARTED|Overall Study||141
2865342|NCT00132301|3568129|FG001|STARTED|Overall Study||157
2865343|NCT00132301|3568128|FG000|COMPLETED|Overall Study||121
2865344|NCT00132301|3568129|FG001|COMPLETED|Overall Study||144
2865345|NCT00132301|3568128|FG000|NOT COMPLETED|Overall Study||20
2865346|NCT00132301|3568129|FG001|NOT COMPLETED|Overall Study||13
2865347|NCT00132314|3568137|FG000|STARTED|Overall Study||190
2865348|NCT00132314|3568138|FG001|STARTED|Overall Study||192
2865349|NCT00132314|3568137|FG000|Received Treatment|Overall Study||188
2865350|NCT00132314|3568138|FG001|Received Treatment|Overall Study||185
2865351|NCT00132314|3568137|FG000|Completed Baseline Visit, Provided SSN|Overall Study|This is the ITT cohort|187
2865352|NCT00132314|3568138|FG001|Completed Baseline Visit, Provided SSN|Overall Study|This is the ITT cohort.|182
2865353|NCT00132314|3568137|FG000|COMPLETED|Overall Study||117
2865354|NCT00132314|3568138|FG001|COMPLETED|Overall Study||120
2865355|NCT00132314|3568137|FG000|NOT COMPLETED|Overall Study||73
2865356|NCT00132314|3568138|FG001|NOT COMPLETED|Overall Study||72
2865357|NCT00132496|3568146|FG000|STARTED|Overall Study||54
2865358|NCT00132496|3568147|FG001|STARTED|Overall Study||57
2865359|NCT00132496|3568146|FG000|COMPLETED|Overall Study||52
2865360|NCT00132496|3568147|FG001|COMPLETED|Overall Study||55
2865361|NCT00132496|3568146|FG000|NOT COMPLETED|Overall Study||2
2865362|NCT00132496|3568147|FG001|NOT COMPLETED|Overall Study||2
2865363|NCT00132678|3568155|FG000|STARTED|Period II (Open-Label Oral Risperidone)||0
2865364|NCT00132678|3568156|FG001|STARTED|Period II (Open-Label Oral Risperidone)||0
2865365|NCT00132678|3568157|FG002|STARTED|Period II (Open-Label Oral Risperidone)||440
2865366|NCT00132678|3568155|FG000|COMPLETED|Period II (Open-Label Oral Risperidone)||0
2865367|NCT00132678|3568156|FG001|COMPLETED|Period II (Open-Label Oral Risperidone)||0
2865368|NCT00132678|3568157|FG002|COMPLETED|Period II (Open-Label Oral Risperidone)||382
2865369|NCT00132678|3568155|FG000|NOT COMPLETED|Period II (Open-Label Oral Risperidone)||0
2865370|NCT00132678|3568156|FG001|NOT COMPLETED|Period II (Open-Label Oral Risperidone)||0
2865371|NCT00132678|3568157|FG002|NOT COMPLETED|Period II (Open-Label Oral Risperidone)||58
2865372|NCT00132678|3568155|FG000|STARTED|Period III (Open-Label Stabilization)||501
2865373|NCT00132678|3568156|FG001|STARTED|Period III (Open-Label Stabilization)||0
2865374|NCT00132678|3568157|FG002|STARTED|Period III (Open-Label Stabilization)||0
2865375|NCT00132678|3568155|FG000|COMPLETED|Period III (Open-Label Stabilization)||303
2865376|NCT00132678|3568156|FG001|COMPLETED|Period III (Open-Label Stabilization)||0
3313471|NCT03075410|4046794|FG003|COMPLETED|Part A-Washout Period 3 (14 Days)||1
3313472|NCT03075410|4046795|FG004|COMPLETED|Part A-Washout Period 3 (14 Days)||2
3313473|NCT03075410|4046796|FG005|COMPLETED|Part A-Washout Period 3 (14 Days)||1
3313474|NCT03075410|4046797|FG006|COMPLETED|Part A-Washout Period 3 (14 Days)||0
3313475|NCT03075410|4046798|FG007|COMPLETED|Part A-Washout Period 3 (14 Days)||0
3313476|NCT03075410|4046799|FG008|COMPLETED|Part A-Washout Period 3 (14 Days)||0
2865377|NCT00132678|3568157|FG002|COMPLETED|Period III (Open-Label Stabilization)||0
2865378|NCT00132678|3568155|FG000|NOT COMPLETED|Period III (Open-Label Stabilization)||198
2865379|NCT00132678|3568156|FG001|NOT COMPLETED|Period III (Open-Label Stabilization)||0
2865380|NCT00132678|3568157|FG002|NOT COMPLETED|Period III (Open-Label Stabilization)||0
2865381|NCT00132678|3568155|FG000|STARTED|Period IV (Double-Blind Treatment)||154
2865382|NCT00132678|3568156|FG001|STARTED|Period IV (Double-Blind Treatment)||149
2865383|NCT00132678|3568157|FG002|STARTED|Period IV (Double-Blind Treatment)||0
2865384|NCT00132678|3568155|FG000|COMPLETED|Period IV (Double-Blind Treatment)||117
2865385|NCT00132678|3568156|FG001|COMPLETED|Period IV (Double-Blind Treatment)||109
2865386|NCT00132678|3568157|FG002|COMPLETED|Period IV (Double-Blind Treatment)||0
2865387|NCT00132678|3568155|FG000|NOT COMPLETED|Period IV (Double-Blind Treatment)||37
2865388|NCT00132678|3568156|FG001|NOT COMPLETED|Period IV (Double-Blind Treatment)||40
2865389|NCT00132678|3568157|FG002|NOT COMPLETED|Period IV (Double-Blind Treatment)||0
2865390|NCT00132691|3568167|FG000|STARTED|Overall Study|129 participants were assigned to implant; 122 received implant|129
2865391|NCT00132691|3568168|FG001|STARTED|Overall Study|126 participants were assigned to systemic treatment; 121 received systemic therapy|126
2865392|NCT00132691|3568167|FG000|COMPLETED|Overall Study|118 participants completed the 2-year anniversary visit|118
2865393|NCT00132691|3568168|FG001|COMPLETED|Overall Study|114 participants completed the 2-year anniversary visit|114
2865394|NCT00132691|3568167|FG000|NOT COMPLETED|Overall Study||11
2865395|NCT00132691|3568168|FG001|NOT COMPLETED|Overall Study||12
2865396|NCT00132730|3568183|FG000|STARTED|Period I - Placebo Run-in (Base)||150
2865397|NCT00132730|3568184|FG001|STARTED|Period I - Placebo Run-in (Base)||148
2865398|NCT00132730|3568185|FG002|STARTED|Period I - Placebo Run-in (Base)||153
2865399|NCT00132730|3568186|FG003|STARTED|Period I - Placebo Run-in (Base)||153
2865400|NCT00132730|3568187|FG004|STARTED|Period I - Placebo Run-in (Base)||0
2865401|NCT00132730|3568188|FG005|STARTED|Period I - Placebo Run-in (Base)||0
2865402|NCT00132730|3568183|FG000|COMPLETED|Period I - Placebo Run-in (Base)||150
2865403|NCT00132730|3568184|FG001|COMPLETED|Period I - Placebo Run-in (Base)||148
2865404|NCT00132730|3568185|FG002|COMPLETED|Period I - Placebo Run-in (Base)||153
2865405|NCT00132730|3568186|FG003|COMPLETED|Period I - Placebo Run-in (Base)||153
2865406|NCT00132730|3568187|FG004|COMPLETED|Period I - Placebo Run-in (Base)||0
2865407|NCT00132730|3568188|FG005|COMPLETED|Period I - Placebo Run-in (Base)||0
2865408|NCT00132730|3568183|FG000|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
2865409|NCT00132730|3568184|FG001|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
2865410|NCT00132730|3568185|FG002|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
2865411|NCT00132730|3568186|FG003|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
2865412|NCT00132730|3568187|FG004|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
2865413|NCT00132730|3568188|FG005|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
2865414|NCT00132730|3568183|FG000|STARTED|Period II - 12-week Treatment (Base)||150
2865415|NCT00132730|3568184|FG001|STARTED|Period II - 12-week Treatment (Base)||148
2865416|NCT00132730|3568185|FG002|STARTED|Period II - 12-week Treatment (Base)||153
2865417|NCT00132730|3568186|FG003|STARTED|Period II - 12-week Treatment (Base)||153
2865418|NCT00132730|3568187|FG004|STARTED|Period II - 12-week Treatment (Base)||0
2865419|NCT00132730|3568188|FG005|STARTED|Period II - 12-week Treatment (Base)||0
2865420|NCT00132730|3568183|FG000|COMPLETED|Period II - 12-week Treatment (Base)||127
2865421|NCT00132730|3568184|FG001|COMPLETED|Period II - 12-week Treatment (Base)||133
2865422|NCT00132730|3568185|FG002|COMPLETED|Period II - 12-week Treatment (Base)||135
2865423|NCT00132730|3568186|FG003|COMPLETED|Period II - 12-week Treatment (Base)||131
2865424|NCT00132730|3568187|FG004|COMPLETED|Period II - 12-week Treatment (Base)||0
2865425|NCT00132730|3568188|FG005|COMPLETED|Period II - 12-week Treatment (Base)||0
2865426|NCT00132730|3568183|FG000|NOT COMPLETED|Period II - 12-week Treatment (Base)||23
2865427|NCT00132730|3568184|FG001|NOT COMPLETED|Period II - 12-week Treatment (Base)||15
2865428|NCT00132730|3568185|FG002|NOT COMPLETED|Period II - 12-week Treatment (Base)||18
2865429|NCT00132730|3568186|FG003|NOT COMPLETED|Period II - 12-week Treatment (Base)||22
2865430|NCT00132730|3568187|FG004|NOT COMPLETED|Period II - 12-week Treatment (Base)||0
2865431|NCT00132730|3568188|FG005|NOT COMPLETED|Period II - 12-week Treatment (Base)||0
2865432|NCT00132730|3568183|FG000|STARTED|Period III - Blinded Extension (EXT1)||0
2865433|NCT00132730|3568184|FG001|STARTED|Period III - Blinded Extension (EXT1)||0
2865434|NCT00132730|3568185|FG002|STARTED|Period III - Blinded Extension (EXT1)|Includes all MK-0873 participants from Period II. Not all eligible participants entered EXT1|317
3313477|NCT03075410|4046791|FG000|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
3313478|NCT03075410|4046792|FG001|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
3313479|NCT03075410|4046793|FG002|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
3313480|NCT03075410|4046794|FG003|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
3313481|NCT03075410|4046795|FG004|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
3313482|NCT03075410|4046796|FG005|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
3313483|NCT03075410|4046797|FG006|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
2865435|NCT00132730|3568186|FG003|STARTED|Period III - Blinded Extension (EXT1)|Not all eligible participants entered EXT1|107
2865436|NCT00132730|3568187|FG004|STARTED|Period III - Blinded Extension (EXT1)||0
2865437|NCT00132730|3568188|FG005|STARTED|Period III - Blinded Extension (EXT1)||0
2865438|NCT00132730|3568183|FG000|COMPLETED|Period III - Blinded Extension (EXT1)||0
2865439|NCT00132730|3568184|FG001|COMPLETED|Period III - Blinded Extension (EXT1)||0
2865440|NCT00132730|3568185|FG002|COMPLETED|Period III - Blinded Extension (EXT1)||235
2865441|NCT00132730|3568186|FG003|COMPLETED|Period III - Blinded Extension (EXT1)||82
2865442|NCT00132730|3568187|FG004|COMPLETED|Period III - Blinded Extension (EXT1)||0
2865443|NCT00132730|3568188|FG005|COMPLETED|Period III - Blinded Extension (EXT1)||0
2865444|NCT00132730|3568183|FG000|NOT COMPLETED|Period III - Blinded Extension (EXT1)||0
2865445|NCT00132730|3568184|FG001|NOT COMPLETED|Period III - Blinded Extension (EXT1)||0
2865446|NCT00132730|3568185|FG002|NOT COMPLETED|Period III - Blinded Extension (EXT1)||82
2865447|NCT00132730|3568186|FG003|NOT COMPLETED|Period III - Blinded Extension (EXT1)||25
2865448|NCT00132730|3568187|FG004|NOT COMPLETED|Period III - Blinded Extension (EXT1)||0
2865449|NCT00132730|3568188|FG005|NOT COMPLETED|Period III - Blinded Extension (EXT1)||0
2865450|NCT00132730|3568183|FG000|STARTED|Period IV - Open-label Extension (EXT2)||0
2865451|NCT00132730|3568184|FG001|STARTED|Period IV - Open-label Extension (EXT2)||0
2865452|NCT00132730|3568185|FG002|STARTED|Period IV - Open-label Extension (EXT2)||0
2865453|NCT00132730|3568186|FG003|STARTED|Period IV - Open-label Extension (EXT2)||0
2865454|NCT00132730|3568187|FG004|STARTED|Period IV - Open-label Extension (EXT2)|Includes participants from Period III. Not all eligible participants entered EXT2|187
2865455|NCT00132730|3568188|FG005|STARTED|Period IV - Open-label Extension (EXT2)|Includes paricipants from Period III. Not all eligible participants entered EXT2|71
2865456|NCT00132730|3568183|FG000|COMPLETED|Period IV - Open-label Extension (EXT2)||0
2865457|NCT00132730|3568184|FG001|COMPLETED|Period IV - Open-label Extension (EXT2)||0
2865458|NCT00132730|3568185|FG002|COMPLETED|Period IV - Open-label Extension (EXT2)||0
2865459|NCT00132730|3568186|FG003|COMPLETED|Period IV - Open-label Extension (EXT2)||0
2865460|NCT00132730|3568187|FG004|COMPLETED|Period IV - Open-label Extension (EXT2)||8
2865461|NCT00132730|3568188|FG005|COMPLETED|Period IV - Open-label Extension (EXT2)||3
2865462|NCT00132730|3568183|FG000|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||0
2865463|NCT00132730|3568184|FG001|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||0
2865464|NCT00132730|3568185|FG002|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||0
2865465|NCT00132730|3568186|FG003|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||0
2865466|NCT00132730|3568187|FG004|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||179
2865467|NCT00132730|3568188|FG005|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||68
2865468|NCT00132730|3568183|FG000|STARTED|Period V - Open-label Extension (EXT2)||0
2865469|NCT00132730|3568184|FG001|STARTED|Period V - Open-label Extension (EXT2)||0
2865470|NCT00132730|3568185|FG002|STARTED|Period V - Open-label Extension (EXT2)||0
2865471|NCT00132730|3568186|FG003|STARTED|Period V - Open-label Extension (EXT2)||0
2865472|NCT00132730|3568187|FG004|STARTED|Period V - Open-label Extension (EXT2)|Not all participants who completed Period IV entered Period V|7
2865473|NCT00132730|3568188|FG005|STARTED|Period V - Open-label Extension (EXT2)|Not all participants who completed Period IV entered Period V|2
2865474|NCT00132730|3568183|FG000|COMPLETED|Period V - Open-label Extension (EXT2)||0
2865475|NCT00132730|3568184|FG001|COMPLETED|Period V - Open-label Extension (EXT2)||0
2865476|NCT00132730|3568185|FG002|COMPLETED|Period V - Open-label Extension (EXT2)||0
2865477|NCT00132730|3568186|FG003|COMPLETED|Period V - Open-label Extension (EXT2)||0
2865478|NCT00132730|3568187|FG004|COMPLETED|Period V - Open-label Extension (EXT2)||0
2865479|NCT00132730|3568188|FG005|COMPLETED|Period V - Open-label Extension (EXT2)||0
2865480|NCT00132730|3568183|FG000|NOT COMPLETED|Period V - Open-label Extension (EXT2)||0
2865481|NCT00132730|3568184|FG001|NOT COMPLETED|Period V - Open-label Extension (EXT2)||0
2865482|NCT00132730|3568185|FG002|NOT COMPLETED|Period V - Open-label Extension (EXT2)||0
2865483|NCT00132730|3568186|FG003|NOT COMPLETED|Period V - Open-label Extension (EXT2)||0
2865484|NCT00132730|3568187|FG004|NOT COMPLETED|Period V - Open-label Extension (EXT2)||7
2865485|NCT00132730|3568188|FG005|NOT COMPLETED|Period V - Open-label Extension (EXT2)||2
2865486|NCT00132769|3568204|FG000|STARTED|Overall Study||53
2865487|NCT00132769|3568205|FG001|STARTED|Overall Study||53
2865488|NCT00132769|3568204|FG000|COMPLETED|Overall Study||42
2865489|NCT00132769|3568205|FG001|COMPLETED|Overall Study||42
2865490|NCT00132769|3568204|FG000|NOT COMPLETED|Overall Study||11
2865491|NCT00132769|3568205|FG001|NOT COMPLETED|Overall Study||11
2865492|NCT00132808|3568214|FG000|STARTED|Stratum I||77
2865493|NCT00132808|3568215|FG001|STARTED|Stratum I||70
2865494|NCT00132808|3568216|FG002|STARTED|Stratum I||77
2865495|NCT00132808|3568214|FG000|COMPLETED|Stratum I||68
2865496|NCT00132808|3568215|FG001|COMPLETED|Stratum I||58
2865497|NCT00132808|3568216|FG002|COMPLETED|Stratum I||72
2865498|NCT00132808|3568214|FG000|NOT COMPLETED|Stratum I||9
2865499|NCT00132808|3568215|FG001|NOT COMPLETED|Stratum I||12
2865500|NCT00132808|3568216|FG002|NOT COMPLETED|Stratum I||5
2865501|NCT00132808|3568214|FG000|STARTED|Stratum II||121
2865502|NCT00132808|3568215|FG001|STARTED|Stratum II||111
2865503|NCT00132808|3568216|FG002|STARTED|Stratum II||125
2865504|NCT00132808|3568214|FG000|COMPLETED|Stratum II||113
2865505|NCT00132808|3568215|FG001|COMPLETED|Stratum II||96
2865506|NCT00132808|3568216|FG002|COMPLETED|Stratum II||116
2865507|NCT00132808|3568214|FG000|NOT COMPLETED|Stratum II||8
2865508|NCT00132808|3568215|FG001|NOT COMPLETED|Stratum II||15
2865509|NCT00132808|3568216|FG002|NOT COMPLETED|Stratum II||9
2865510|NCT00132873|3568224|FG000|STARTED|Overall Study||59
2865511|NCT00132873|3568224|FG000|COMPLETED|Overall Study||50
2865512|NCT00132873|3568224|FG000|NOT COMPLETED|Overall Study||9
2865513|NCT00132964|3568230|FG000|STARTED|Overall Study||54
2865514|NCT00132964|3568231|FG001|STARTED|Overall Study||57
2865515|NCT00132964|3568230|FG000|COMPLETED|Overall Study||50
2865516|NCT00132964|3568231|FG001|COMPLETED|Overall Study||54
2865517|NCT00132964|3568230|FG000|NOT COMPLETED|Overall Study||4
2865518|NCT00132964|3568231|FG001|NOT COMPLETED|Overall Study||3
2865519|NCT00133575|3568244|FG000|STARTED|Overall Study||10
2865520|NCT00133575|3568245|FG001|STARTED|Overall Study||10
2865521|NCT00133575|3568246|FG002|STARTED|Overall Study||10
2865522|NCT00133575|3568247|FG003|STARTED|Overall Study||10
2865523|NCT00133575|3568248|FG004|STARTED|Overall Study||10
2865524|NCT00133575|3568249|FG005|STARTED|Overall Study||10
2865525|NCT00133575|3568250|FG006|STARTED|Overall Study||12
2865526|NCT00133575|3568244|FG000|COMPLETED|Overall Study||10
2865527|NCT00133575|3568245|FG001|COMPLETED|Overall Study||10
2865528|NCT00133575|3568246|FG002|COMPLETED|Overall Study||8
3169283|NCT01924429|3896763|FG000|STARTED|Washout Period (2 Weeks)||17
3169284|NCT01924429|3896764|FG001|STARTED|Washout Period (2 Weeks)||13
3169285|NCT01924429|3896763|FG000|COMPLETED|Washout Period (2 Weeks)||14
3169286|NCT01924429|3896764|FG001|COMPLETED|Washout Period (2 Weeks)||11
3169287|NCT01924429|3896763|FG000|NOT COMPLETED|Washout Period (2 Weeks)||3
2865529|NCT00133575|3568247|FG003|COMPLETED|Overall Study||9
2865530|NCT00133575|3568248|FG004|COMPLETED|Overall Study||6
2865531|NCT00133575|3568249|FG005|COMPLETED|Overall Study||9
2865532|NCT00133575|3568250|FG006|COMPLETED|Overall Study||9
2865533|NCT00133575|3568244|FG000|NOT COMPLETED|Overall Study||0
2865534|NCT00133575|3568245|FG001|NOT COMPLETED|Overall Study||0
2865535|NCT00133575|3568246|FG002|NOT COMPLETED|Overall Study||2
2865536|NCT00133575|3568247|FG003|NOT COMPLETED|Overall Study||1
2865537|NCT00133575|3568248|FG004|NOT COMPLETED|Overall Study||4
2865538|NCT00133575|3568249|FG005|NOT COMPLETED|Overall Study||1
2865539|NCT00133575|3568250|FG006|NOT COMPLETED|Overall Study||3
2865540|NCT00133705|3568268|FG000|STARTED|Overall Study||22
2865541|NCT00133705|3568269|FG001|STARTED|Overall Study||20
2865542|NCT00133705|3568268|FG000|COMPLETED|Overall Study||20
2865543|NCT00133705|3568269|FG001|COMPLETED|Overall Study||17
2865544|NCT00133705|3568268|FG000|NOT COMPLETED|Overall Study||2
2865545|NCT00133705|3568269|FG001|NOT COMPLETED|Overall Study||3
2865546|NCT00133809|3568275|FG000|STARTED|Overall Study||8
2865547|NCT00133809|3568275|FG000|COMPLETED|Overall Study||8
2865548|NCT00133809|3568275|FG000|NOT COMPLETED|Overall Study||0
2865549|NCT00133952|3568281|FG000|STARTED|Overall Study||157
2865550|NCT00133952|3568282|FG001|STARTED|Overall Study||152
2865551|NCT00133952|3568281|FG000|Received at Least One Dose of Study Drug|Overall Study||153
2865552|NCT00133952|3568282|FG001|Received at Least One Dose of Study Drug|Overall Study||149
2865553|NCT00133952|3568281|FG000|COMPLETED|Overall Study||115
2865554|NCT00133952|3568282|FG001|COMPLETED|Overall Study||124
2865555|NCT00133952|3568281|FG000|NOT COMPLETED|Overall Study||42
2865556|NCT00133952|3568282|FG001|NOT COMPLETED|Overall Study||28
2865557|NCT00133978|3568292|FG000|STARTED|Overall Study||303
2865558|NCT00133978|3568293|FG001|STARTED|Overall Study||308
2865559|NCT00133978|3568294|FG002|STARTED|Overall Study||310
2865560|NCT00133978|3568295|FG003|STARTED|Overall Study||302
2865561|NCT00133978|3568292|FG000|COMPLETED|Overall Study||301
2865562|NCT00133978|3568293|FG001|COMPLETED|Overall Study||307
2865563|NCT00133978|3568294|FG002|COMPLETED|Overall Study||310
2865564|NCT00133978|3568295|FG003|COMPLETED|Overall Study||300
2865565|NCT00133978|3568292|FG000|NOT COMPLETED|Overall Study||2
2865566|NCT00133978|3568293|FG001|NOT COMPLETED|Overall Study||1
2865567|NCT00133978|3568294|FG002|NOT COMPLETED|Overall Study||0
2865568|NCT00133978|3568295|FG003|NOT COMPLETED|Overall Study||2
2865569|NCT00133991|3568309|FG000|STARTED|Overall Study||21
2865570|NCT00133991|3568309|FG000|COMPLETED|Overall Study||17
2865571|NCT00133991|3568309|FG000|NOT COMPLETED|Overall Study||4
2865572|NCT00134004|3568313|FG000|STARTED|Overall Study||210
2865573|NCT00134004|3568313|FG000|COMPLETED|Overall Study||210
2865574|NCT00134004|3568313|FG000|NOT COMPLETED|Overall Study||0
2865575|NCT00134017|3568317|FG000|STARTED|Overall Study||142
2865576|NCT00134017|3568317|FG000|COMPLETED|Overall Study||142
2865577|NCT00134017|3568317|FG000|NOT COMPLETED|Overall Study||0
2865578|NCT00134043|3568323|FG000|STARTED|Overall Study||16
2865579|NCT00134043|3568324|FG001|STARTED|Overall Study||3
2865580|NCT00134043|3568323|FG000|COMPLETED|Overall Study||16
2865581|NCT00134043|3568324|FG001|COMPLETED|Overall Study||3
2865582|NCT00134043|3568323|FG000|NOT COMPLETED|Overall Study||0
2865583|NCT00134043|3568324|FG001|NOT COMPLETED|Overall Study||0
2865584|NCT00134056|3568331|FG000|STARTED|Randomization||518
2865585|NCT00134056|3568332|FG001|STARTED|Randomization||520
2865586|NCT00134056|3568331|FG000|COMPLETED|Randomization||496
2865587|NCT00134056|3568332|FG001|COMPLETED|Randomization||500
2865588|NCT00134056|3568331|FG000|NOT COMPLETED|Randomization||22
2865589|NCT00134056|3568332|FG001|NOT COMPLETED|Randomization||20
2865590|NCT00134056|3568331|FG000|STARTED|Eligible for Protocol Assigned Treatment||496
2865591|NCT00134056|3568332|FG001|STARTED|Eligible for Protocol Assigned Treatment||500
2865592|NCT00134056|3568331|FG000|COMPLETED|Eligible for Protocol Assigned Treatment||169
2865593|NCT00134056|3568332|FG001|COMPLETED|Eligible for Protocol Assigned Treatment||185
2865594|NCT00134056|3568331|FG000|NOT COMPLETED|Eligible for Protocol Assigned Treatment||327
2865595|NCT00134056|3568332|FG001|NOT COMPLETED|Eligible for Protocol Assigned Treatment||315
2865596|NCT00134082|3568341|FG000|STARTED|Overall Study||30
2865597|NCT00134082|3568341|FG000|COMPLETED|Overall Study||27
2865598|NCT00134082|3568341|FG000|NOT COMPLETED|Overall Study||3
2865599|NCT00134381|3568345|FG000|STARTED|Overall Study||1
2865600|NCT00134381|3568346|FG001|STARTED|Overall Study||2
2865601|NCT00134381|3568347|FG002|STARTED|Overall Study||1
2865602|NCT00134381|3568348|FG003|STARTED|Overall Study||2
2865603|NCT00134381|3568349|FG004|STARTED|Overall Study||31
2865604|NCT00134381|3568350|FG005|STARTED|Overall Study||31
2865605|NCT00134381|3568345|FG000|COMPLETED|Overall Study||1
2865606|NCT00134381|3568346|FG001|COMPLETED|Overall Study||2
2865607|NCT00134381|3568347|FG002|COMPLETED|Overall Study||1
2865608|NCT00134381|3568348|FG003|COMPLETED|Overall Study||2
2865609|NCT00134381|3568349|FG004|COMPLETED|Overall Study||31
2865610|NCT00134381|3568350|FG005|COMPLETED|Overall Study||29
2865611|NCT00134381|3568345|FG000|NOT COMPLETED|Overall Study||0
2865612|NCT00134381|3568346|FG001|NOT COMPLETED|Overall Study||0
2865613|NCT00134381|3568347|FG002|NOT COMPLETED|Overall Study||0
2865614|NCT00134381|3568348|FG003|NOT COMPLETED|Overall Study||0
2865615|NCT00134381|3568349|FG004|NOT COMPLETED|Overall Study||0
2865616|NCT00134381|3568350|FG005|NOT COMPLETED|Overall Study||2
2865617|NCT00134563|3568370|FG000|STARTED|Overall Study|Randomized|363
2865618|NCT00134563|3568371|FG001|STARTED|Overall Study|Randomized|366
2865619|NCT00134563|3568372|FG002|STARTED|Overall Study|Randomized|359
2865620|NCT00134563|3568370|FG000|Treated|Overall Study|Two participants received doses of Teriflunomide 7 mg, one participant doses of Teriflunomide 14 mg|363
2865621|NCT00134563|3568371|FG001|Treated|Overall Study||365
2865622|NCT00134563|3568372|FG002|Treated|Overall Study|one participant received doses of Teriflunomide 7 mg|358
2865623|NCT00134563|3568370|FG000|COMPLETED|Overall Study|completed treatment period|259
2865624|NCT00134563|3568371|FG001|COMPLETED|Overall Study|completed treatment period|274
2865625|NCT00134563|3568372|FG002|COMPLETED|Overall Study|completed treatment period|263
2865626|NCT00134563|3568370|FG000|NOT COMPLETED|Overall Study||104
2865627|NCT00134563|3568371|FG001|NOT COMPLETED|Overall Study||92
2865628|NCT00134563|3568372|FG002|NOT COMPLETED|Overall Study||96
2865629|NCT00134719|3568383|FG000|STARTED|Primary Vaccination Phase||661
2865630|NCT00134719|3568384|FG001|STARTED|Primary Vaccination Phase||221
2865631|NCT00134719|3568385|FG002|STARTED|Primary Vaccination Phase||221
2865632|NCT00134719|3568383|FG000|COMPLETED|Primary Vaccination Phase||647
2865633|NCT00134719|3568384|FG001|COMPLETED|Primary Vaccination Phase||215
2865634|NCT00134719|3568385|FG002|COMPLETED|Primary Vaccination Phase||216
2865635|NCT00134719|3568383|FG000|NOT COMPLETED|Primary Vaccination Phase||14
2865636|NCT00134719|3568384|FG001|NOT COMPLETED|Primary Vaccination Phase||6
2865637|NCT00134719|3568385|FG002|NOT COMPLETED|Primary Vaccination Phase||5
2865638|NCT00134719|3568383|FG000|STARTED|Fourth Dose Vaccination Phase||625
2865639|NCT00134719|3568384|FG001|STARTED|Fourth Dose Vaccination Phase||206
2865640|NCT00134719|3568385|FG002|STARTED|Fourth Dose Vaccination Phase||204
2865641|NCT00134719|3568383|FG000|COMPLETED|Fourth Dose Vaccination Phase||623
2865642|NCT00134719|3568384|FG001|COMPLETED|Fourth Dose Vaccination Phase||203
2865643|NCT00134719|3568385|FG002|COMPLETED|Fourth Dose Vaccination Phase||203
2865644|NCT00134719|3568383|FG000|NOT COMPLETED|Fourth Dose Vaccination Phase||2
2865645|NCT00134719|3568384|FG001|NOT COMPLETED|Fourth Dose Vaccination Phase||3
2865646|NCT00134719|3568385|FG002|NOT COMPLETED|Fourth Dose Vaccination Phase||1
2865647|NCT00134784|3568397|FG000|STARTED|Overall Study||29
2865648|NCT00134784|3568398|FG001|STARTED|Overall Study||38
2865649|NCT00134784|3568399|FG002|STARTED|Overall Study||37
2865650|NCT00134784|3568400|FG003|STARTED|Overall Study||38
2865651|NCT00134784|3568397|FG000|COMPLETED|Overall Study||27
2865652|NCT00134784|3568398|FG001|COMPLETED|Overall Study||36
2865653|NCT00134784|3568399|FG002|COMPLETED|Overall Study||35
2865654|NCT00134784|3568400|FG003|COMPLETED|Overall Study||37
2865655|NCT00134784|3568397|FG000|NOT COMPLETED|Overall Study||2
2865656|NCT00134784|3568398|FG001|NOT COMPLETED|Overall Study||2
2865657|NCT00134784|3568399|FG002|NOT COMPLETED|Overall Study||2
2865658|NCT00134784|3568400|FG003|NOT COMPLETED|Overall Study||1
2865659|NCT00134901|3568409|FG000|STARTED|Overall Study||39
2865660|NCT00134901|3568410|FG001|STARTED|Overall Study||42
2865661|NCT00134901|3568409|FG000|COMPLETED|Overall Study||22
2865662|NCT00134901|3568410|FG001|COMPLETED|Overall Study||27
2865663|NCT00134901|3568409|FG000|NOT COMPLETED|Overall Study||17
2865664|NCT00134901|3568410|FG001|NOT COMPLETED|Overall Study||15
2865665|NCT00135200|3568418|FG000|STARTED|Overall Study||16
2865666|NCT00135200|3568418|FG000|COMPLETED|Overall Study||16
2865667|NCT00135200|3568418|FG000|NOT COMPLETED|Overall Study||0
2865668|NCT00135226|3568426|FG000|STARTED|Overall Study||3870
2865669|NCT00135226|3568427|FG001|STARTED|Overall Study||3870
2865670|NCT00135226|3568428|FG002|STARTED|Overall Study||3870
2865671|NCT00135226|3568429|FG003|STARTED|Overall Study||3870
2865672|NCT00135226|3568426|FG000|COMPLETED|Overall Study||3836
2865673|NCT00135226|3568427|FG001|COMPLETED|Overall Study||3835
2865674|NCT00135226|3568428|FG002|COMPLETED|Overall Study||3836
2865675|NCT00135226|3568429|FG003|COMPLETED|Overall Study||3834
2865676|NCT00135226|3568426|FG000|NOT COMPLETED|Overall Study||34
2865677|NCT00135226|3568427|FG001|NOT COMPLETED|Overall Study||35
2865678|NCT00135226|3568428|FG002|NOT COMPLETED|Overall Study||34
2865679|NCT00135226|3568429|FG003|NOT COMPLETED|Overall Study||36
2865680|NCT00135330|3568444|FG000|STARTED|Overall Study||45
2865681|NCT00135330|3568445|FG001|STARTED|Overall Study||47
2865682|NCT00135330|3568446|FG002|STARTED|Overall Study||45
2865683|NCT00135330|3568444|FG000|COMPLETED|Overall Study||33
2865684|NCT00135330|3568445|FG001|COMPLETED|Overall Study||34
2865685|NCT00135330|3568446|FG002|COMPLETED|Overall Study||34
2865686|NCT00135330|3568444|FG000|NOT COMPLETED|Overall Study||12
2865687|NCT00135330|3568445|FG001|NOT COMPLETED|Overall Study||13
2865688|NCT00135330|3568446|FG002|NOT COMPLETED|Overall Study||11
2865689|NCT00135356|3568456|FG000|STARTED|Overall Study|Number randomized and treated|131
2865690|NCT00135356|3568457|FG001|STARTED|Overall Study|Number randomized and treated(1 randomized and never treated subject not included in this number.)|69
2865691|NCT00135356|3568456|FG000|Discontinued Prior to Week 96 Visit|Overall Study||16
2865692|NCT00135356|3568457|FG001|Discontinued Prior to Week 96 Visit|Overall Study||9
2865693|NCT00135356|3568456|FG000|Discontinued on or After Week 96 Visit|Overall Study||1
2865694|NCT00135356|3568457|FG001|Discontinued on or After Week 96 Visit|Overall Study||0
2865695|NCT00135356|3568456|FG000|COMPLETED|Overall Study||114
2865696|NCT00135356|3568457|FG001|COMPLETED|Overall Study||60
2865697|NCT00135356|3568456|FG000|NOT COMPLETED|Overall Study||17
2865698|NCT00135356|3568457|FG001|NOT COMPLETED|Overall Study||9
2865699|NCT00135512|3568463|FG000|STARTED|Overall Study||234
2865700|NCT00135512|3568463|FG000|COMPLETED|Overall Study||111
2865701|NCT00135512|3568463|FG000|NOT COMPLETED|Overall Study||123
2865702|NCT00135694|3568470|FG000|STARTED|Overall Study||180
2865703|NCT00135694|3568471|FG001|STARTED|Overall Study||77
2865704|NCT00135694|3568472|FG002|STARTED|Overall Study||18
2865705|NCT00135694|3568470|FG000|COMPLETED|Overall Study|Subjects were assessed as ineligible for random assignment and subsequently terminated per protocol.|0
2865706|NCT00135694|3568471|FG001|COMPLETED|Overall Study||56
2865707|NCT00135694|3568472|FG002|COMPLETED|Overall Study||11
2865708|NCT00135694|3568470|FG000|NOT COMPLETED|Overall Study||180
2865709|NCT00135694|3568471|FG001|NOT COMPLETED|Overall Study||21
2865710|NCT00135694|3568472|FG002|NOT COMPLETED|Overall Study||7
2865711|NCT00135707|3568482|FG000|STARTED|Overall Study||5088
2865712|NCT00135707|3568483|FG001|STARTED|Overall Study||5066
2865713|NCT00135707|3568482|FG000|COMPLETED|Overall Study||4993
2865714|NCT00135707|3568483|FG001|COMPLETED|Overall Study||4976
2865715|NCT00135707|3568482|FG000|NOT COMPLETED|Overall Study||95
2865716|NCT00135707|3568483|FG001|NOT COMPLETED|Overall Study||90
2865717|NCT00135798|3568496|FG000|STARTED|Overall Study||16
2865718|NCT00135798|3568497|FG001|STARTED|Overall Study||31
2865719|NCT00135798|3568498|FG002|STARTED|Overall Study||32
2865720|NCT00135798|3568496|FG000|COMPLETED|Overall Study||16
2865721|NCT00135798|3568497|FG001|COMPLETED|Overall Study||31
2865722|NCT00135798|3568498|FG002|COMPLETED|Overall Study||32
2865723|NCT00135798|3568496|FG000|NOT COMPLETED|Overall Study||0
2865724|NCT00135798|3568497|FG001|NOT COMPLETED|Overall Study||0
2865725|NCT00135798|3568498|FG002|NOT COMPLETED|Overall Study||0
2865726|NCT00136084|3568507|FG000|STARTED|Overall Study||109
2865727|NCT00136084|3568508|FG001|STARTED|Overall Study||114
2865728|NCT00136084|3568507|FG000|COMPLETED|Overall Study||61
2865729|NCT00136084|3568508|FG001|COMPLETED|Overall Study||72
2865730|NCT00136084|3568507|FG000|NOT COMPLETED|Overall Study||48
2865731|NCT00136084|3568508|FG001|NOT COMPLETED|Overall Study||42
2865732|NCT00136214|3568522|FG000|STARTED|Overall Study||15
2865733|NCT00136214|3568523|FG001|STARTED|Overall Study||7
2865734|NCT00136214|3568522|FG000|COMPLETED|Overall Study||15
2865735|NCT00136214|3568523|FG001|COMPLETED|Overall Study||7
2865736|NCT00136214|3568522|FG000|NOT COMPLETED|Overall Study||0
2865737|NCT00136214|3568523|FG001|NOT COMPLETED|Overall Study||0
2865738|NCT00136318|3568533|FG000|STARTED|Overall Study|Took first dose of study medication|90
2865739|NCT00136318|3568534|FG001|STARTED|Overall Study|Took first dose of study medication|91
2865740|NCT00136318|3568533|FG000|COMPLETED|Overall Study|reached end-point of antiviral treatment|83
2865741|NCT00136318|3568534|FG001|COMPLETED|Overall Study||84
2865742|NCT00136318|3568533|FG000|NOT COMPLETED|Overall Study||7
2865743|NCT00136318|3568534|FG001|NOT COMPLETED|Overall Study||7
2865744|NCT00136357|3568543|FG000|STARTED|Overall Study||41
2865745|NCT00136357|3568544|FG001|STARTED|Overall Study||41
2865746|NCT00136357|3568543|FG000|COMPLETED|Overall Study||38
2865747|NCT00136357|3568544|FG001|COMPLETED|Overall Study||39
2865748|NCT00136357|3568543|FG000|NOT COMPLETED|Overall Study||3
2865749|NCT00136357|3568544|FG001|NOT COMPLETED|Overall Study||2
2865750|NCT00136604|3568555|FG000|STARTED|Overall Study||249
2865751|NCT00136604|3568556|FG001|STARTED|Overall Study||123
2865752|NCT00136604|3568557|FG002|STARTED|Overall Study||79
2865753|NCT00136604|3568558|FG003|STARTED|Overall Study||41
2865754|NCT00136604|3568559|FG004|STARTED|Overall Study||125
2865755|NCT00136604|3568555|FG000|COMPLETED|Overall Study||248
2865756|NCT00136604|3568556|FG001|COMPLETED|Overall Study||122
2865757|NCT00136604|3568557|FG002|COMPLETED|Overall Study||79
2865758|NCT00136604|3568558|FG003|COMPLETED|Overall Study||41
2865759|NCT00136604|3568559|FG004|COMPLETED|Overall Study||124
2865760|NCT00136604|3568555|FG000|NOT COMPLETED|Overall Study||1
2865761|NCT00136604|3568556|FG001|NOT COMPLETED|Overall Study||1
2865762|NCT00136604|3568557|FG002|NOT COMPLETED|Overall Study||0
2865763|NCT00136604|3568558|FG003|NOT COMPLETED|Overall Study||0
2865764|NCT00136604|3568559|FG004|NOT COMPLETED|Overall Study||1
2865765|NCT00136695|3568577|FG000|STARTED|Overall Study||45
2865766|NCT00136695|3568578|FG001|STARTED|Overall Study||43
2865767|NCT00136695|3568577|FG000|COMPLETED|Overall Study||34
2865768|NCT00136695|3568578|FG001|COMPLETED|Overall Study||35
2865769|NCT00136695|3568577|FG000|NOT COMPLETED|Overall Study||11
2865770|NCT00136695|3568578|FG001|NOT COMPLETED|Overall Study||8
2865771|NCT00136760|3568588|FG000|STARTED|Overall Study||12
2865772|NCT00136760|3568589|FG001|STARTED|Overall Study||16
2865773|NCT00136760|3568590|FG002|STARTED|Overall Study||11
2865774|NCT00136760|3568591|FG003|STARTED|Overall Study||13
2865775|NCT00136760|3568588|FG000|COMPLETED|Overall Study||12
2865776|NCT00136760|3568589|FG001|COMPLETED|Overall Study||16
2865777|NCT00136760|3568590|FG002|COMPLETED|Overall Study||11
2865778|NCT00136760|3568591|FG003|COMPLETED|Overall Study||13
2865779|NCT00136760|3568588|FG000|NOT COMPLETED|Overall Study||0
2865780|NCT00136760|3568589|FG001|NOT COMPLETED|Overall Study||0
2865781|NCT00136760|3568590|FG002|NOT COMPLETED|Overall Study||0
2865782|NCT00136760|3568591|FG003|NOT COMPLETED|Overall Study||0
2865783|NCT00136812|3568603|FG000|STARTED|Overall Study||111
2865784|NCT00136812|3568604|FG001|STARTED|Overall Study||113
2865785|NCT00136812|3568603|FG000|COMPLETED|Overall Study||111
2865786|NCT00136812|3568604|FG001|COMPLETED|Overall Study||113
2865787|NCT00136812|3568603|FG000|NOT COMPLETED|Overall Study||0
2865788|NCT00136812|3568604|FG001|NOT COMPLETED|Overall Study||0
2865789|NCT00136838|3568610|FG000|STARTED|First Intervention ( 5 Days)||6
2865790|NCT00136838|3568611|FG001|STARTED|First Intervention ( 5 Days)||6
2865791|NCT00136838|3568610|FG000|COMPLETED|First Intervention ( 5 Days)||6
2865792|NCT00136838|3568611|FG001|COMPLETED|First Intervention ( 5 Days)||6
2865793|NCT00136838|3568610|FG000|NOT COMPLETED|First Intervention ( 5 Days)||0
2865794|NCT00136838|3568611|FG001|NOT COMPLETED|First Intervention ( 5 Days)||0
2865795|NCT00136838|3568610|FG000|STARTED|Second Intervention ( 5 Days)||6
2865796|NCT00136838|3568611|FG001|STARTED|Second Intervention ( 5 Days)||6
2865797|NCT00136838|3568610|FG000|COMPLETED|Second Intervention ( 5 Days)||6
2865798|NCT00136838|3568611|FG001|COMPLETED|Second Intervention ( 5 Days)||6
2865799|NCT00136838|3568610|FG000|NOT COMPLETED|Second Intervention ( 5 Days)||0
2865800|NCT00136838|3568611|FG001|NOT COMPLETED|Second Intervention ( 5 Days)||0
2865801|NCT00136916|3568621|FG000|STARTED|Overall Study||319
2865802|NCT00136916|3568622|FG001|STARTED|Overall Study||316
2865803|NCT00136916|3568621|FG000|Received Treatment|Overall Study||316
2865804|NCT00136916|3568622|FG001|Received Treatment|Overall Study||311
2865805|NCT00136916|3568621|FG000|COMPLETED|Overall Study|At study termination, active subjects completed end-of-study assessment and 3-month follow-up visit|194
2865806|NCT00136916|3568622|FG001|COMPLETED|Overall Study|At study termination, active subjects completed end-of-study assessment and 3-month follow-up visit|212
2865807|NCT00136916|3568621|FG000|NOT COMPLETED|Overall Study||125
2865808|NCT00136916|3568622|FG001|NOT COMPLETED|Overall Study||104
2865809|NCT00136955|3568630|FG000|STARTED|Overall Study||41
2865810|NCT00136955|3568630|FG000|COMPLETED|Overall Study||18
2865811|NCT00136955|3568630|FG000|NOT COMPLETED|Overall Study||23
2865812|NCT00137046|3568636|FG000|STARTED|Overall Study|One subject was randomized to inhaled insulin but never received treatment.|291
2865813|NCT00137046|3568637|FG001|STARTED|Overall Study|One subject was randomized to subcutaneous insulin but never received treatment.|291
2865814|NCT00137046|3568636|FG000|Received Study Treatment|Overall Study||290
2865815|NCT00137046|3568637|FG001|Received Study Treatment|Overall Study||290
2865816|NCT00137046|3568636|FG000|COMPLETED|Overall Study|Completed subjects were those subjects who did not discontinue while on active drug.|192
2865817|NCT00137046|3568637|FG001|COMPLETED|Overall Study||198
2865818|NCT00137046|3568636|FG000|NOT COMPLETED|Overall Study||99
2865819|NCT00137046|3568637|FG001|NOT COMPLETED|Overall Study||93
2865820|NCT00137111|3568651|FG000|STARTED|Window Therapy||0
2865821|NCT00137111|3568652|FG001|STARTED|Window Therapy||176
2865822|NCT00137111|3568653|FG002|STARTED|Window Therapy||180
2865823|NCT00137111|3568654|FG003|STARTED|Window Therapy||142
2865824|NCT00137111|3568651|FG000|COMPLETED|Window Therapy||0
2865825|NCT00137111|3568652|FG001|COMPLETED|Window Therapy||176
2865826|NCT00137111|3568653|FG002|COMPLETED|Window Therapy||180
2865827|NCT00137111|3568654|FG003|COMPLETED|Window Therapy||142
2865828|NCT00137111|3568651|FG000|NOT COMPLETED|Window Therapy||0
2865829|NCT00137111|3568652|FG001|NOT COMPLETED|Window Therapy||0
2865830|NCT00137111|3568653|FG002|NOT COMPLETED|Window Therapy||0
2865831|NCT00137111|3568654|FG003|NOT COMPLETED|Window Therapy||0
2865832|NCT00137111|3568651|FG000|STARTED|Total Therapy||498
2865833|NCT00137111|3568652|FG001|STARTED|Total Therapy||0
2865834|NCT00137111|3568653|FG002|STARTED|Total Therapy||0
2865835|NCT00137111|3568654|FG003|STARTED|Total Therapy||0
2865836|NCT00137111|3568651|FG000|COMPLETED|Total Therapy||458
2865837|NCT00137111|3568652|FG001|COMPLETED|Total Therapy||0
2865838|NCT00137111|3568653|FG002|COMPLETED|Total Therapy||0
2865839|NCT00137111|3568654|FG003|COMPLETED|Total Therapy||0
2865840|NCT00137111|3568651|FG000|NOT COMPLETED|Total Therapy||40
2865841|NCT00137111|3568652|FG001|NOT COMPLETED|Total Therapy||0
2865842|NCT00137111|3568653|FG002|NOT COMPLETED|Total Therapy||0
2865843|NCT00137111|3568654|FG003|NOT COMPLETED|Total Therapy||0
2865844|NCT00137267|3568663|FG000|STARTED|Overall Study||55
2865845|NCT00137267|3568664|FG001|STARTED|Overall Study||47
2865846|NCT00137267|3568663|FG000|COMPLETED|Overall Study||40
2865847|NCT00137267|3568664|FG001|COMPLETED|Overall Study||26
2865848|NCT00137267|3568663|FG000|NOT COMPLETED|Overall Study||15
2865849|NCT00137267|3568664|FG001|NOT COMPLETED|Overall Study||21
2865850|NCT00137280|3568672|FG000|STARTED|Overall Study||389
2865851|NCT00137280|3568673|FG001|STARTED|Overall Study||412
2865852|NCT00137280|3568672|FG000|COMPLETED|Overall Study||305
2865853|NCT00137280|3568673|FG001|COMPLETED|Overall Study||357
2865854|NCT00137280|3568672|FG000|NOT COMPLETED|Overall Study||84
2865855|NCT00137280|3568673|FG001|NOT COMPLETED|Overall Study||55
2865856|NCT00137423|3568681|FG000|STARTED|Overall Study||54
2865857|NCT00137423|3568682|FG001|STARTED|Overall Study||53
2865858|NCT00137423|3568681|FG000|COMPLETED|Overall Study||15
2865859|NCT00137423|3568682|FG001|COMPLETED|Overall Study||9
2865860|NCT00137423|3568681|FG000|NOT COMPLETED|Overall Study||39
2865861|NCT00137423|3568682|FG001|NOT COMPLETED|Overall Study||44
2865862|NCT00137436|3568692|FG000|STARTED|Overall Study|Phase 2 did not include 38 participants from Phase 1.|55
2865863|NCT00137436|3568692|FG000|COMPLETED|Overall Study||12
2865864|NCT00137436|3568692|FG000|NOT COMPLETED|Overall Study||43
2865865|NCT00137449|3568698|FG000|STARTED|Overall Study||30
2865866|NCT00137449|3568699|FG001|STARTED|Overall Study||30
2865867|NCT00137449|3568698|FG000|COMPLETED|Overall Study||14
2865868|NCT00137449|3568699|FG001|COMPLETED|Overall Study||12
2865869|NCT00137449|3568698|FG000|NOT COMPLETED|Overall Study||16
2865870|NCT00137449|3568699|FG001|NOT COMPLETED|Overall Study||18
2865871|NCT00137631|3568708|FG000|STARTED|Overall Study||164
2865872|NCT00137631|3568709|FG001|STARTED|Overall Study||174
2865873|NCT00137631|3568708|FG000|Complete 3-month Follow-up|Overall Study||120
2865874|NCT00137631|3568709|FG001|Complete 3-month Follow-up|Overall Study||125
2865875|NCT00137631|3568708|FG000|Completed 6-month Follow-up|Overall Study|7 participants who were lost to follow-up at 3-months were retained at 6-months|127
2865876|NCT00137631|3568709|FG001|Completed 6-month Follow-up|Overall Study|8 participants who were lost to follow-up at 3-months were retained at 6-months|133
2865877|NCT00137631|3568708|FG000|COMPLETED|Overall Study||127
2865878|NCT00137631|3568709|FG001|COMPLETED|Overall Study||133
2865879|NCT00137631|3568708|FG000|NOT COMPLETED|Overall Study||37
2865880|NCT00137631|3568709|FG001|NOT COMPLETED|Overall Study||41
2865881|NCT00137839|3568715|FG000|STARTED|Overall Study||84
2865882|NCT00137839|3568715|FG000|Treated|Overall Study||83
2865883|NCT00137839|3568715|FG000|COMPLETED|Overall Study|Data on Reason Not Completed reflects Reason Off-Study|0
2865884|NCT00137839|3568715|FG000|NOT COMPLETED|Overall Study||84
2865885|NCT00137969|3568724|FG000|STARTED|Overall Study||174
2865886|NCT00137969|3568725|FG001|STARTED|Overall Study||88
2865887|NCT00137969|3568724|FG000|Received Study Drug|Overall Study||169
2865888|NCT00137969|3568725|FG001|Received Study Drug|Overall Study||88
2865889|NCT00137969|3568724|FG000|COMPLETED|Overall Study||107
2865890|NCT00137969|3568725|FG001|COMPLETED|Overall Study||67
2865891|NCT00137969|3568724|FG000|NOT COMPLETED|Overall Study||67
2865892|NCT00137969|3568725|FG001|NOT COMPLETED|Overall Study||21
2865893|NCT00138034|3568733|FG000|STARTED|Overall Study||26
2865894|NCT00138034|3568734|FG001|STARTED|Overall Study||23
2865895|NCT00138034|3568733|FG000|COMPLETED|Overall Study||23
2865896|NCT00138034|3568734|FG001|COMPLETED|Overall Study||20
2865897|NCT00138034|3568733|FG000|NOT COMPLETED|Overall Study||3
2865898|NCT00138034|3568734|FG001|NOT COMPLETED|Overall Study||3
2865899|NCT00138125|3568740|FG000|STARTED|Overall Study||2
2865900|NCT00138125|3568740|FG000|COMPLETED|Overall Study||2
2865901|NCT00138125|3568740|FG000|NOT COMPLETED|Overall Study||0
2865902|NCT00138203|3568745|FG000|STARTED|Overall Study||16
2865903|NCT00138203|3568745|FG000|COMPLETED|Overall Study||16
2865904|NCT00138203|3568745|FG000|NOT COMPLETED|Overall Study||0
2865905|NCT00138294|3568750|FG000|STARTED|Overall Study||29255
2865906|NCT00138294|3568750|FG000|COMPLETED|Overall Study||29255
2865907|NCT00138294|3568750|FG000|NOT COMPLETED|Overall Study||0
2865908|NCT00138424|3568760|FG000|STARTED|Overall Study||9
2865909|NCT00138424|3568761|FG001|STARTED|Overall Study||5
2865910|NCT00138424|3568762|FG002|STARTED|Overall Study||5
2865911|NCT00138424|3568763|FG003|STARTED|Overall Study||3
2865912|NCT00138424|3568760|FG000|COMPLETED|Overall Study||9
2865913|NCT00138424|3568761|FG001|COMPLETED|Overall Study||4
2865914|NCT00138424|3568762|FG002|COMPLETED|Overall Study||5
2865915|NCT00138424|3568763|FG003|COMPLETED|Overall Study||3
2865916|NCT00138424|3568760|FG000|NOT COMPLETED|Overall Study||0
2865917|NCT00138424|3568761|FG001|NOT COMPLETED|Overall Study||1
2865918|NCT00138424|3568762|FG002|NOT COMPLETED|Overall Study||0
2865919|NCT00138424|3568763|FG003|NOT COMPLETED|Overall Study||0
2865920|NCT00138645|3568777|FG000|STARTED|Overall Study||30
2865921|NCT00138645|3568778|FG001|STARTED|Overall Study||30
2865922|NCT00138645|3568777|FG000|COMPLETED|Overall Study||24
2865923|NCT00138645|3568778|FG001|COMPLETED|Overall Study||23
2865924|NCT00138645|3568777|FG000|NOT COMPLETED|Overall Study||6
2865925|NCT00138645|3568778|FG001|NOT COMPLETED|Overall Study||7
2865926|NCT00138658|3568784|FG000|STARTED|Overall Study||81
2865927|NCT00138658|3568784|FG000|COMPLETED|Overall Study||20
2865928|NCT00138658|3568784|FG000|NOT COMPLETED|Overall Study||61
2865929|NCT00138671|3568792|FG000|STARTED|Overall Study||59
2865930|NCT00138671|3568793|FG001|STARTED|Overall Study||46
2865931|NCT00138671|3568792|FG000|COMPLETED|Overall Study||46
2865932|NCT00138671|3568793|FG001|COMPLETED|Overall Study||30
2865933|NCT00138671|3568792|FG000|NOT COMPLETED|Overall Study||13
2865934|NCT00138671|3568793|FG001|NOT COMPLETED|Overall Study||16
2865935|NCT00139399|3568803|FG000|STARTED|Overall Study||60
2865936|NCT00139399|3568804|FG001|STARTED|Overall Study||82
2865937|NCT00139399|3568803|FG000|COMPLETED|Overall Study||44
2865938|NCT00139399|3568804|FG001|COMPLETED|Overall Study||59
2865939|NCT00139399|3568803|FG000|NOT COMPLETED|Overall Study||16
2865940|NCT00139399|3568804|FG001|NOT COMPLETED|Overall Study||23
2865941|NCT00139477|3568812|FG000|STARTED|First Intervention -Baseline to 6Months||31
2865942|NCT00139477|3568813|FG001|STARTED|First Intervention -Baseline to 6Months||35
2865943|NCT00139477|3568812|FG000|COMPLETED|First Intervention -Baseline to 6Months||19
2865944|NCT00139477|3568813|FG001|COMPLETED|First Intervention -Baseline to 6Months||23
2865945|NCT00139477|3568812|FG000|NOT COMPLETED|First Intervention -Baseline to 6Months||12
2865946|NCT00139477|3568813|FG001|NOT COMPLETED|First Intervention -Baseline to 6Months||12
2865947|NCT00139477|3568812|FG000|STARTED|Second Intervention -6Months to 12Months||19
2865948|NCT00139477|3568813|FG001|STARTED|Second Intervention -6Months to 12Months||23
2865949|NCT00139477|3568812|FG000|COMPLETED|Second Intervention -6Months to 12Months||14
2865950|NCT00139477|3568813|FG001|COMPLETED|Second Intervention -6Months to 12Months||18
2865951|NCT00139477|3568812|FG000|NOT COMPLETED|Second Intervention -6Months to 12Months||5
2865952|NCT00139477|3568813|FG001|NOT COMPLETED|Second Intervention -6Months to 12Months||5
2865953|NCT00139659|3568823|FG000|STARTED|Overall Study|1 subject randomized was DC'd prior to receiving inhaled insulin but received subcutaneous insulin|146
2865954|NCT00139659|3568824|FG001|STARTED|Overall Study|1 subject randomized DC'd before receiving subcutaneous insulin and is not included in # of subjects|141
2865955|NCT00139659|3568823|FG000|COMPLETED|Overall Study||106
2865956|NCT00139659|3568824|FG001|COMPLETED|Overall Study||123
2865957|NCT00139659|3568823|FG000|NOT COMPLETED|Overall Study||40
2865958|NCT00139659|3568824|FG001|NOT COMPLETED|Overall Study||18
2865959|NCT00139737|3568834|FG000|STARTED|Overall Study||344
2865960|NCT00139737|3568834|FG000|Received Treatment|Overall Study||331
2865961|NCT00139737|3568834|FG000|COMPLETED|Overall Study||3
2865962|NCT00139737|3568834|FG000|NOT COMPLETED|Overall Study||341
2865963|NCT00139776|3568840|FG000|STARTED|Period I||1772
2865964|NCT00139776|3568841|FG001|STARTED|Period I||0
2865965|NCT00139776|3568842|FG002|STARTED|Period I||0
2865966|NCT00139776|3568843|FG003|STARTED|Period I||0
2865967|NCT00139776|3568840|FG000|COMPLETED|Period I||1197
2865968|NCT00139776|3568841|FG001|COMPLETED|Period I||0
2865969|NCT00139776|3568842|FG002|COMPLETED|Period I||0
2865970|NCT00139776|3568843|FG003|COMPLETED|Period I||0
2865971|NCT00139776|3568840|FG000|NOT COMPLETED|Period I||575
2865972|NCT00139776|3568841|FG001|NOT COMPLETED|Period I||0
2865973|NCT00139776|3568842|FG002|NOT COMPLETED|Period I||0
2865974|NCT00139776|3568843|FG003|NOT COMPLETED|Period I||0
2865975|NCT00139776|3568840|FG000|STARTED|Period II||0
2865976|NCT00139776|3568841|FG001|STARTED|Period II||1197
2865977|NCT00139776|3568842|FG002|STARTED|Period II||0
2865978|NCT00139776|3568843|FG003|STARTED|Period II||0
2865979|NCT00139776|3568840|FG000|COMPLETED|Period II||0
2865980|NCT00139776|3568841|FG001|COMPLETED|Period II||875
2865981|NCT00139776|3568842|FG002|COMPLETED|Period II||0
2865982|NCT00139776|3568843|FG003|COMPLETED|Period II||0
2865983|NCT00139776|3568840|FG000|NOT COMPLETED|Period II||0
2865984|NCT00139776|3568841|FG001|NOT COMPLETED|Period II||322
2865985|NCT00139776|3568842|FG002|NOT COMPLETED|Period II||0
2865986|NCT00139776|3568843|FG003|NOT COMPLETED|Period II||0
2865987|NCT00139776|3568840|FG000|STARTED|Period III||0
2865988|NCT00139776|3568841|FG001|STARTED|Period III||0
2865989|NCT00139776|3568842|FG002|STARTED|Period III|Randomized 440: 9 participants not treated|431
2865990|NCT00139776|3568843|FG003|STARTED|Period III|Randomized 435: 8 participants not treated|427
2865991|NCT00139776|3568840|FG000|COMPLETED|Period III||0
2865992|NCT00139776|3568841|FG001|COMPLETED|Period III||0
2865993|NCT00139776|3568842|FG002|COMPLETED|Period III||355
2865994|NCT00139776|3568843|FG003|COMPLETED|Period III||321
2865995|NCT00139776|3568840|FG000|NOT COMPLETED|Period III||0
2865996|NCT00139776|3568841|FG001|NOT COMPLETED|Period III||0
2865997|NCT00139776|3568842|FG002|NOT COMPLETED|Period III||76
2865998|NCT00139776|3568843|FG003|NOT COMPLETED|Period III||106
2865999|NCT00139997|3568852|FG000|STARTED|Overall Study||15
2866000|NCT00139997|3568853|FG001|STARTED|Overall Study||11
2866001|NCT00139997|3568852|FG000|COMPLETED|Overall Study||14
2866002|NCT00139997|3568853|FG001|COMPLETED|Overall Study||9
2866003|NCT00139997|3568852|FG000|NOT COMPLETED|Overall Study||1
2866004|NCT00139997|3568853|FG001|NOT COMPLETED|Overall Study||2
2866005|NCT00140140|3568862|FG000|STARTED|Overall Study||4
2866006|NCT00140140|3568863|FG001|STARTED|Overall Study||6
2866007|NCT00140140|3568864|FG002|STARTED|Overall Study||6
2866008|NCT00140140|3568862|FG000|COMPLETED|Overall Study|Progressive disease|2
2866009|NCT00140140|3568863|FG001|COMPLETED|Overall Study|Progressive disease|4
2866010|NCT00140140|3568864|FG002|COMPLETED|Overall Study|Progressive disease|4
2866011|NCT00140140|3568862|FG000|NOT COMPLETED|Overall Study||2
2866012|NCT00140140|3568863|FG001|NOT COMPLETED|Overall Study||2
2866013|NCT00140140|3568864|FG002|NOT COMPLETED|Overall Study||2
2866014|NCT00140205|3568874|FG000|STARTED|Overall Study||5
2866015|NCT00140205|3568875|FG001|STARTED|Overall Study||5
2866016|NCT00140205|3568876|FG002|STARTED|Overall Study||5
2866017|NCT00140205|3568874|FG000|COMPLETED|Overall Study||5
2866018|NCT00140205|3568875|FG001|COMPLETED|Overall Study||5
2866019|NCT00140205|3568876|FG002|COMPLETED|Overall Study||5
2866020|NCT00140205|3568874|FG000|NOT COMPLETED|Overall Study||0
2866021|NCT00140205|3568875|FG001|NOT COMPLETED|Overall Study||0
2866022|NCT00140205|3568876|FG002|NOT COMPLETED|Overall Study||0
2866023|NCT00140231|3568907|FG000|STARTED|Fed State 1 Day- day5||7
2866024|NCT00140231|3568908|FG001|STARTED|Fed State 1 Day- day5||6
2866025|NCT00140231|3568907|FG000|COMPLETED|Fed State 1 Day- day5||7
2866026|NCT00140231|3568908|FG001|COMPLETED|Fed State 1 Day- day5||6
2866027|NCT00140231|3568907|FG000|NOT COMPLETED|Fed State 1 Day- day5||0
2866028|NCT00140231|3568908|FG001|NOT COMPLETED|Fed State 1 Day- day5||0
2866029|NCT00140231|3568907|FG000|STARTED|Washout 8weeks||7
2866030|NCT00140231|3568908|FG001|STARTED|Washout 8weeks||6
2866031|NCT00140231|3568907|FG000|COMPLETED|Washout 8weeks||7
2866032|NCT00140231|3568908|FG001|COMPLETED|Washout 8weeks||6
2866033|NCT00140231|3568907|FG000|NOT COMPLETED|Washout 8weeks||0
2866034|NCT00140231|3568908|FG001|NOT COMPLETED|Washout 8weeks||0
2866035|NCT00140231|3568907|FG000|STARTED|First Fasting State 3 Days With Placebo||7
2866036|NCT00140231|3568908|FG001|STARTED|First Fasting State 3 Days With Placebo||6
2866037|NCT00140231|3568907|FG000|COMPLETED|First Fasting State 3 Days With Placebo||7
2866038|NCT00140231|3568908|FG001|COMPLETED|First Fasting State 3 Days With Placebo||6
2866039|NCT00140231|3568907|FG000|NOT COMPLETED|First Fasting State 3 Days With Placebo||0
2866040|NCT00140231|3568908|FG001|NOT COMPLETED|First Fasting State 3 Days With Placebo||0
2866041|NCT00140231|3568907|FG000|STARTED|Washout 8 Weeks||7
2866042|NCT00140231|3568908|FG001|STARTED|Washout 8 Weeks||6
2866043|NCT00140231|3568907|FG000|COMPLETED|Washout 8 Weeks||7
2866044|NCT00140231|3568908|FG001|COMPLETED|Washout 8 Weeks||6
2866045|NCT00140231|3568907|FG000|NOT COMPLETED|Washout 8 Weeks||0
2866046|NCT00140231|3568908|FG001|NOT COMPLETED|Washout 8 Weeks||0
2866047|NCT00140231|3568907|FG000|STARTED|Fasting State With Leptin and Crossover||7
2866048|NCT00140231|3568908|FG001|STARTED|Fasting State With Leptin and Crossover||6
2866049|NCT00140231|3568907|FG000|COMPLETED|Fasting State With Leptin and Crossover||7
2866050|NCT00140231|3568908|FG001|COMPLETED|Fasting State With Leptin and Crossover||6
2866051|NCT00140231|3568907|FG000|NOT COMPLETED|Fasting State With Leptin and Crossover||0
2866052|NCT00140231|3568908|FG001|NOT COMPLETED|Fasting State With Leptin and Crossover||0
2866053|NCT00140244|3568914|FG000|STARTED|Intervention 1||3
2866054|NCT00140244|3568915|FG001|STARTED|Intervention 1||4
2866055|NCT00140244|3568914|FG000|COMPLETED|Intervention 1||3
2866056|NCT00140244|3568915|FG001|COMPLETED|Intervention 1||4
2866057|NCT00140244|3568914|FG000|NOT COMPLETED|Intervention 1||0
2866058|NCT00140244|3568915|FG001|NOT COMPLETED|Intervention 1||0
2866059|NCT00140244|3568914|FG000|STARTED|Washout||3
2866060|NCT00140244|3568915|FG001|STARTED|Washout||4
2866061|NCT00140244|3568914|FG000|COMPLETED|Washout||3
2866062|NCT00140244|3568915|FG001|COMPLETED|Washout||4
2866063|NCT00140244|3568914|FG000|NOT COMPLETED|Washout||0
2866064|NCT00140244|3568915|FG001|NOT COMPLETED|Washout||0
2866065|NCT00140244|3568914|FG000|STARTED|Intervention 2||3
2866066|NCT00140244|3568915|FG001|STARTED|Intervention 2||4
2866067|NCT00140244|3568914|FG000|COMPLETED|Intervention 2||3
2866068|NCT00140244|3568915|FG001|COMPLETED|Intervention 2||2
2866069|NCT00140244|3568914|FG000|NOT COMPLETED|Intervention 2||0
2866070|NCT00140244|3568915|FG001|NOT COMPLETED|Intervention 2||2
2866071|NCT00140413|3568925|FG000|STARTED|Overall Study||13
2866072|NCT00140413|3568926|FG001|STARTED|Overall Study||7
2866073|NCT00140413|3568925|FG000|Received at Least One Dose of GH|Overall Study||13
2866074|NCT00140413|3568926|FG001|Received at Least One Dose of GH|Overall Study|Controls were crossed over to GH if they met criteria for growth deceleration during the study.|3
2866075|NCT00140413|3568925|FG000|COMPLETED|Overall Study||10
2866076|NCT00140413|3568926|FG001|COMPLETED|Overall Study|Crossed over subjects were treated as controls for purpose of intent to treat analysis.|7
2866077|NCT00140413|3568925|FG000|NOT COMPLETED|Overall Study||3
2866078|NCT00140413|3568926|FG001|NOT COMPLETED|Overall Study||0
2866079|NCT00140426|3568935|FG000|STARTED|Overall Study||22
2866080|NCT00140426|3568936|FG001|STARTED|Overall Study||19
2866081|NCT00140426|3568935|FG000|COMPLETED|Overall Study||22
2866082|NCT00140426|3568936|FG001|COMPLETED|Overall Study||16
2866083|NCT00140426|3568935|FG000|NOT COMPLETED|Overall Study||0
2866084|NCT00140426|3568936|FG001|NOT COMPLETED|Overall Study||3
2866085|NCT00140556|3568947|FG000|STARTED|Pre Radiation Period: Avastin / Tarceva||28
2866086|NCT00140556|3568947|FG000|COMPLETED|Pre Radiation Period: Avastin / Tarceva||28
2866087|NCT00140556|3568947|FG000|NOT COMPLETED|Pre Radiation Period: Avastin / Tarceva||0
2866088|NCT00140556|3568947|FG000|STARTED|Chemoradiotherapy Period||28
2866089|NCT00140556|3568947|FG000|COMPLETED|Chemoradiotherapy Period||28
2866090|NCT00140556|3568947|FG000|NOT COMPLETED|Chemoradiotherapy Period||0
2866091|NCT00140621|3568951|FG000|STARTED|Overall Study||6
2866092|NCT00140621|3568951|FG000|COMPLETED|Overall Study||6
2866093|NCT00140621|3568951|FG000|NOT COMPLETED|Overall Study||0
2866094|NCT00140842|3568957|FG000|STARTED|Overall Study||15
2866095|NCT00140842|3568958|FG001|STARTED|Overall Study||15
2866096|NCT00140842|3568957|FG000|COMPLETED|Overall Study||15
2866097|NCT00140842|3568958|FG001|COMPLETED|Overall Study||15
2866098|NCT00140842|3568957|FG000|NOT COMPLETED|Overall Study||0
2866099|NCT00140842|3568958|FG001|NOT COMPLETED|Overall Study||0
2866100|NCT00140855|3568964|FG000|STARTED|Overall Study||6
2866101|NCT00140855|3568964|FG000|COMPLETED|Overall Study||4
2866102|NCT00140855|3568964|FG000|NOT COMPLETED|Overall Study||2
2866103|NCT00141037|3568970|FG000|STARTED|Overall Study||60
2866104|NCT00141037|3568971|FG001|STARTED|Overall Study||70
2866105|NCT00141037|3568970|FG000|COMPLETED|Overall Study|16 subjects had reduced follow-up|50
2866106|NCT00141037|3568971|FG001|COMPLETED|Overall Study|8 subjects had reduced follow-up|52
2866107|NCT00141037|3568970|FG000|NOT COMPLETED|Overall Study||10
2866108|NCT00141037|3568971|FG001|NOT COMPLETED|Overall Study||18
2866109|NCT00141102|3568979|FG000|STARTED|Overall Study||2238
2866110|NCT00141102|3568980|FG001|STARTED|Overall Study||2246
2866111|NCT00141102|3568979|FG000|Received Treatment|Overall Study||2223
2866112|NCT00141102|3568980|FG001|Received Treatment|Overall Study||2237
2866113|NCT00141102|3568979|FG000|COMPLETED|Overall Study||1730
2866114|NCT00141102|3568980|FG001|COMPLETED|Overall Study||1621
2866115|NCT00141102|3568979|FG000|NOT COMPLETED|Overall Study||508
2866116|NCT00141102|3568980|FG001|NOT COMPLETED|Overall Study||625
2866117|NCT00141115|3568987|FG000|STARTED|Overall Study||3
2866118|NCT00141115|3568987|FG000|COMPLETED|Overall Study||2
2866119|NCT00141115|3568987|FG000|NOT COMPLETED|Overall Study||1
2866120|NCT00141219|3568994|FG000|STARTED|Overall Study||162
2866121|NCT00141219|3568995|FG001|STARTED|Overall Study||78
2866122|NCT00141219|3568994|FG000|COMPLETED|Overall Study||138
2866123|NCT00141219|3568995|FG001|COMPLETED|Overall Study||62
2866124|NCT00141219|3568994|FG000|NOT COMPLETED|Overall Study||24
2866125|NCT00141219|3568995|FG001|NOT COMPLETED|Overall Study||16
2918651|NCT00528372|3628894|FG003|COMPLETED|Long-term (LT) Period (Weeks 24-102)||42
2918652|NCT00528372|3628895|FG004|COMPLETED|Long-term (LT) Period (Weeks 24-102)||37
2918653|NCT00528372|3628896|FG005|COMPLETED|Long-term (LT) Period (Weeks 24-102)||42
2918654|NCT00528372|3628897|FG006|COMPLETED|Long-term (LT) Period (Weeks 24-102)||48
2918655|NCT00528372|3628898|FG007|COMPLETED|Long-term (LT) Period (Weeks 24-102)||22
2918656|NCT00528372|3628899|FG008|COMPLETED|Long-term (LT) Period (Weeks 24-102)||27
2918657|NCT00528372|3628891|FG000|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||20
2918658|NCT00528372|3628892|FG001|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||19
2866126|NCT00141271|3569004|FG000|STARTED|Overall Study||171
2866127|NCT00141271|3569005|FG001|STARTED|Overall Study||165
2866128|NCT00141271|3569006|FG002|STARTED|Overall Study||168
2866129|NCT00141271|3569004|FG000|COMPLETED|Overall Study||91
2866130|NCT00141271|3569005|FG001|COMPLETED|Overall Study||102
2866131|NCT00141271|3569006|FG002|COMPLETED|Overall Study||111
2866132|NCT00141271|3569004|FG000|NOT COMPLETED|Overall Study||80
2866133|NCT00141271|3569005|FG001|NOT COMPLETED|Overall Study||63
2866134|NCT00141271|3569006|FG002|NOT COMPLETED|Overall Study||57
2866135|NCT00141297|3569016|FG000|STARTED|Overall Study||3
2866136|NCT00141297|3569017|FG001|STARTED|Overall Study||3
2866137|NCT00141297|3569018|FG002|STARTED|Overall Study||7
2866138|NCT00141297|3569019|FG003|STARTED|Overall Study||3
2866139|NCT00141297|3569020|FG004|STARTED|Overall Study||22
2866140|NCT00141297|3569021|FG005|STARTED|Overall Study||3
2866141|NCT00141297|3569022|FG006|STARTED|Overall Study||3
2866142|NCT00141297|3569023|FG007|STARTED|Overall Study||4
2866143|NCT00141297|3569024|FG008|STARTED|Overall Study||20
2866144|NCT00141297|3569025|FG009|STARTED|Overall Study||6
2866145|NCT00141297|3569016|FG000|COMPLETED|Overall Study||0
2866146|NCT00141297|3569017|FG001|COMPLETED|Overall Study||0
2866147|NCT00141297|3569018|FG002|COMPLETED|Overall Study||0
2866148|NCT00141297|3569019|FG003|COMPLETED|Overall Study||0
2866149|NCT00141297|3569020|FG004|COMPLETED|Overall Study||0
2866150|NCT00141297|3569021|FG005|COMPLETED|Overall Study||0
2866151|NCT00141297|3569022|FG006|COMPLETED|Overall Study||0
2866152|NCT00141297|3569023|FG007|COMPLETED|Overall Study||0
2866153|NCT00141297|3569024|FG008|COMPLETED|Overall Study||0
2866154|NCT00141297|3569025|FG009|COMPLETED|Overall Study||0
2866155|NCT00141297|3569016|FG000|NOT COMPLETED|Overall Study||3
2866156|NCT00141297|3569017|FG001|NOT COMPLETED|Overall Study||3
2866157|NCT00141297|3569018|FG002|NOT COMPLETED|Overall Study||7
2866158|NCT00141297|3569019|FG003|NOT COMPLETED|Overall Study||3
2866159|NCT00141297|3569020|FG004|NOT COMPLETED|Overall Study||22
2866160|NCT00141297|3569021|FG005|NOT COMPLETED|Overall Study||3
2866161|NCT00141297|3569022|FG006|NOT COMPLETED|Overall Study||3
2866162|NCT00141297|3569023|FG007|NOT COMPLETED|Overall Study||4
2866163|NCT00141297|3569024|FG008|NOT COMPLETED|Overall Study||20
2866164|NCT00141297|3569025|FG009|NOT COMPLETED|Overall Study||6
2866165|NCT00141453|3569060|FG000|STARTED|Overall Study||288
2866166|NCT00141453|3569061|FG001|STARTED|Overall Study||289
2866167|NCT00141453|3569060|FG000|COMPLETED|Overall Study||282
2866168|NCT00141453|3569061|FG001|COMPLETED|Overall Study||284
2866169|NCT00141453|3569060|FG000|NOT COMPLETED|Overall Study||6
2866170|NCT00141453|3569061|FG001|NOT COMPLETED|Overall Study||5
2866171|NCT00141518|3569070|FG000|STARTED|Overall Study||37
2866172|NCT00141518|3569071|FG001|STARTED|Overall Study||22
2866173|NCT00141518|3569072|FG002|STARTED|Overall Study||18
2866174|NCT00141518|3569070|FG000|Safety Sample|Overall Study||36
2866175|NCT00141518|3569071|FG001|Safety Sample|Overall Study||22
2866176|NCT00141518|3569072|FG002|Safety Sample|Overall Study||18
2866177|NCT00141518|3569070|FG000|Full Analysis Sample|Overall Study||27
2866178|NCT00141518|3569071|FG001|Full Analysis Sample|Overall Study||22
2866179|NCT00141518|3569072|FG002|Full Analysis Sample|Overall Study||18
2866180|NCT00141518|3569070|FG000|COMPLETED|Overall Study||21
2866181|NCT00141518|3569071|FG001|COMPLETED|Overall Study||16
2866182|NCT00141518|3569072|FG002|COMPLETED|Overall Study||12
2866183|NCT00141518|3569070|FG000|NOT COMPLETED|Overall Study||16
2866184|NCT00141518|3569071|FG001|NOT COMPLETED|Overall Study||6
2866185|NCT00141518|3569072|FG002|NOT COMPLETED|Overall Study||6
2866186|NCT00141726|3569082|FG000|STARTED|Overall Study||34
2866187|NCT00141726|3569082|FG000|COMPLETED|Overall Study||31
2866188|NCT00141726|3569082|FG000|NOT COMPLETED|Overall Study||3
2866189|NCT00141739|3569086|FG000|STARTED|Overall Study|Number of evaluable patients|100
2866190|NCT00141739|3569086|FG000|COMPLETED|Overall Study||100
2866191|NCT00141739|3569086|FG000|NOT COMPLETED|Overall Study||0
2866192|NCT00141765|3569092|FG000|STARTED|Overall Study||25
2866193|NCT00141765|3569092|FG000|COMPLETED|Overall Study||25
2866194|NCT00141765|3569092|FG000|NOT COMPLETED|Overall Study||0
2866195|NCT00141778|3569099|FG000|STARTED|Randomization Prior to Study Med||152
2866196|NCT00141778|3569100|FG001|STARTED|Randomization Prior to Study Med||153
2866197|NCT00141778|3569101|FG002|STARTED|Randomization Prior to Study Med||153
2866198|NCT00141778|3569099|FG000|COMPLETED|Randomization Prior to Study Med||147
2866199|NCT00141778|3569100|FG001|COMPLETED|Randomization Prior to Study Med||151
2866200|NCT00141778|3569101|FG002|COMPLETED|Randomization Prior to Study Med||147
2866201|NCT00141778|3569099|FG000|NOT COMPLETED|Randomization Prior to Study Med||5
2866202|NCT00141778|3569100|FG001|NOT COMPLETED|Randomization Prior to Study Med||2
2866203|NCT00141778|3569101|FG002|NOT COMPLETED|Randomization Prior to Study Med||6
2866204|NCT00141778|3569099|FG000|STARTED|Started Study Medication||147
2866205|NCT00141778|3569100|FG001|STARTED|Started Study Medication||151
2866206|NCT00141778|3569101|FG002|STARTED|Started Study Medication||147
2866207|NCT00141778|3569099|FG000|COMPLETED|Started Study Medication||145
2866208|NCT00141778|3569100|FG001|COMPLETED|Started Study Medication||144
2866209|NCT00141778|3569101|FG002|COMPLETED|Started Study Medication||143
2866210|NCT00141778|3569099|FG000|NOT COMPLETED|Started Study Medication||2
2866211|NCT00141778|3569100|FG001|NOT COMPLETED|Started Study Medication||7
2866212|NCT00141778|3569101|FG002|NOT COMPLETED|Started Study Medication||4
2866213|NCT00141817|3569113|FG000|STARTED|Overall Study||7
2866214|NCT00141817|3569114|FG001|STARTED|Overall Study||10
2866215|NCT00141817|3569115|FG002|STARTED|Overall Study||11
2866216|NCT00141817|3569116|FG003|STARTED|Overall Study||13
2866217|NCT00141817|3569113|FG000|COMPLETED|Overall Study||6
2866218|NCT00141817|3569114|FG001|COMPLETED|Overall Study||10
2866219|NCT00141817|3569115|FG002|COMPLETED|Overall Study||10
2866220|NCT00141817|3569116|FG003|COMPLETED|Overall Study||13
2866221|NCT00141817|3569113|FG000|NOT COMPLETED|Overall Study||1
2866222|NCT00141817|3569114|FG001|NOT COMPLETED|Overall Study||0
2866223|NCT00141817|3569115|FG002|NOT COMPLETED|Overall Study||1
2866224|NCT00141817|3569116|FG003|NOT COMPLETED|Overall Study||0
2866225|NCT00141921|3569126|FG000|STARTED|Overall Study||182
2866226|NCT00141921|3569126|FG000|Received Treatment|Overall Study||181
2866227|NCT00141921|3569126|FG000|COMPLETED|Overall Study||41
2866228|NCT00141921|3569126|FG000|NOT COMPLETED|Overall Study||141
2866229|NCT00142116|3569130|FG000|STARTED|Overall Study||25
2866230|NCT00142116|3569130|FG000|COMPLETED|Overall Study||25
2866231|NCT00142116|3569130|FG000|NOT COMPLETED|Overall Study||0
2866232|NCT00142168|3569135|FG000|STARTED|Overall Study||16
2866233|NCT00142168|3569135|FG000|COMPLETED|Overall Study||16
2866234|NCT00142168|3569135|FG000|NOT COMPLETED|Overall Study||0
2866235|NCT00142298|3569149|FG000|STARTED|Overall Study||667
2866236|NCT00142298|3569150|FG001|STARTED|Overall Study||632
2866237|NCT00142298|3569151|FG002|STARTED|Overall Study||123
2866238|NCT00142298|3569152|FG003|STARTED|Overall Study||206
2866239|NCT00142298|3569153|FG004|STARTED|Overall Study||56
2866240|NCT00142298|3569154|FG005|STARTED|Overall Study||26
2866241|NCT00142298|3569155|FG006|STARTED|Overall Study||23
2866242|NCT00142298|3569156|FG007|STARTED|Overall Study||66
2866243|NCT00142298|3569157|FG008|STARTED|Overall Study||57
2866244|NCT00142298|3569158|FG009|STARTED|Overall Study||13
2866245|NCT00142298|3569149|FG000|Safety Population|Overall Study||655
2866246|NCT00142298|3569150|FG001|Safety Population|Overall Study||626
2866247|NCT00142298|3569151|FG002|Safety Population|Overall Study||122
2866248|NCT00142298|3569152|FG003|Safety Population|Overall Study||206
2866249|NCT00142298|3569153|FG004|Safety Population|Overall Study||50
2866250|NCT00142298|3569154|FG005|Safety Population|Overall Study||26
2866251|NCT00142298|3569155|FG006|Safety Population|Overall Study||23
2866252|NCT00142298|3569156|FG007|Safety Population|Overall Study||66
2866253|NCT00142298|3569157|FG008|Safety Population|Overall Study||57
2866254|NCT00142298|3569158|FG009|Safety Population|Overall Study||13
2866255|NCT00142298|3569149|FG000|Per Protocol Population|Overall Study||635
2866256|NCT00142298|3569150|FG001|Per Protocol Population|Overall Study||606
2866257|NCT00142298|3569151|FG002|Per Protocol Population|Overall Study||120
2866258|NCT00142298|3569152|FG003|Per Protocol Population|Overall Study||202
2866259|NCT00142298|3569153|FG004|Per Protocol Population|Overall Study||50
2866260|NCT00142298|3569154|FG005|Per Protocol Population|Overall Study||25
2866261|NCT00142298|3569155|FG006|Per Protocol Population|Overall Study||19
2866262|NCT00142298|3569156|FG007|Per Protocol Population|Overall Study||64
2866263|NCT00142298|3569157|FG008|Per Protocol Population|Overall Study||56
2866264|NCT00142298|3569158|FG009|Per Protocol Population|Overall Study||13
2866265|NCT00142298|3569149|FG000|COMPLETED|Overall Study|Completed week 104/week 208.|507
2866266|NCT00142298|3569150|FG001|COMPLETED|Overall Study||456
2866267|NCT00142298|3569151|FG002|COMPLETED|Overall Study||90
2866268|NCT00142298|3569152|FG003|COMPLETED|Overall Study||121
2866269|NCT00142298|3569153|FG004|COMPLETED|Overall Study||46
2866270|NCT00142298|3569154|FG005|COMPLETED|Overall Study||10
2866271|NCT00142298|3569155|FG006|COMPLETED|Overall Study||15
2866272|NCT00142298|3569156|FG007|COMPLETED|Overall Study||58
2866273|NCT00142298|3569157|FG008|COMPLETED|Overall Study||52
2866274|NCT00142298|3569158|FG009|COMPLETED|Overall Study||13
2866275|NCT00142298|3569149|FG000|NOT COMPLETED|Overall Study||160
2866276|NCT00142298|3569150|FG001|NOT COMPLETED|Overall Study||176
2866277|NCT00142298|3569151|FG002|NOT COMPLETED|Overall Study||33
2866278|NCT00142298|3569152|FG003|NOT COMPLETED|Overall Study||85
2866279|NCT00142298|3569153|FG004|NOT COMPLETED|Overall Study||10
2866280|NCT00142298|3569154|FG005|NOT COMPLETED|Overall Study||16
2866281|NCT00142298|3569155|FG006|NOT COMPLETED|Overall Study||8
2866282|NCT00142298|3569156|FG007|NOT COMPLETED|Overall Study||8
2866283|NCT00142298|3569157|FG008|NOT COMPLETED|Overall Study||5
2866284|NCT00142298|3569158|FG009|NOT COMPLETED|Overall Study||0
2866285|NCT00142415|3569186|FG000|STARTED|Overall Study||3
2866286|NCT00142415|3569187|FG001|STARTED|Overall Study||3
2866287|NCT00142415|3569188|FG002|STARTED|Overall Study||6
2866288|NCT00142415|3569189|FG003|STARTED|Overall Study||3
2866289|NCT00142415|3569190|FG004|STARTED|Overall Study||3
2866290|NCT00142415|3569191|FG005|STARTED|Overall Study||8
2866291|NCT00142415|3569186|FG000|COMPLETED|Overall Study||3
2866292|NCT00142415|3569187|FG001|COMPLETED|Overall Study||3
2866293|NCT00142415|3569188|FG002|COMPLETED|Overall Study||6
2866294|NCT00142415|3569189|FG003|COMPLETED|Overall Study||3
2866295|NCT00142415|3569190|FG004|COMPLETED|Overall Study||2
2866296|NCT00142415|3569191|FG005|COMPLETED|Overall Study||6
2866297|NCT00142415|3569186|FG000|NOT COMPLETED|Overall Study||0
2866298|NCT00142415|3569187|FG001|NOT COMPLETED|Overall Study||0
2866299|NCT00142415|3569188|FG002|NOT COMPLETED|Overall Study||0
2866300|NCT00142415|3569189|FG003|NOT COMPLETED|Overall Study||0
2866301|NCT00142415|3569190|FG004|NOT COMPLETED|Overall Study||1
2866302|NCT00142415|3569191|FG005|NOT COMPLETED|Overall Study||2
2866303|NCT00142454|3569207|FG000|STARTED|Overall Study||9
2866304|NCT00142454|3569207|FG000|COMPLETED|Overall Study||9
2866305|NCT00142454|3569207|FG000|NOT COMPLETED|Overall Study||0
2866306|NCT00142506|3569213|FG000|STARTED|Overall Study||184
2866307|NCT00142506|3569214|FG001|STARTED|Overall Study||106
2866308|NCT00142506|3569213|FG000|COMPLETED|Overall Study||112
2866309|NCT00142506|3569214|FG001|COMPLETED|Overall Study||77
2866310|NCT00142506|3569213|FG000|NOT COMPLETED|Overall Study||72
2866311|NCT00142506|3569214|FG001|NOT COMPLETED|Overall Study||29
2866312|NCT00142597|3569222|FG000|STARTED|Overall Study|N=10 underwent PET imaging|23
2866313|NCT00142597|3569223|FG001|STARTED|Overall Study|N=10 underwent PET imaging|23
2866314|NCT00142597|3569222|FG000|COMPLETED|Overall Study|N=10 completed PET imaging|20
2866315|NCT00142597|3569223|FG001|COMPLETED|Overall Study|N=10 completed PET imaging|22
2866316|NCT00142597|3569222|FG000|NOT COMPLETED|Overall Study||3
2866317|NCT00142597|3569223|FG001|NOT COMPLETED|Overall Study||1
2866318|NCT00142792|3569232|FG000|STARTED|Overall Study||39
2866319|NCT00142792|3569233|FG001|STARTED|Overall Study||41
2866320|NCT00142792|3569234|FG002|STARTED|Overall Study||42
2866321|NCT00142792|3569232|FG000|Completed Intervention|Overall Study||35
2866322|NCT00142792|3569233|FG001|Completed Intervention|Overall Study||37
2866323|NCT00142792|3569234|FG002|Completed Intervention|Overall Study||37
2866324|NCT00142792|3569232|FG000|COMPLETED|Overall Study||27
2866325|NCT00142792|3569233|FG001|COMPLETED|Overall Study||26
2866326|NCT00142792|3569234|FG002|COMPLETED|Overall Study||30
2866327|NCT00142792|3569232|FG000|NOT COMPLETED|Overall Study||12
2866328|NCT00142792|3569233|FG001|NOT COMPLETED|Overall Study||15
2866329|NCT00142792|3569234|FG002|NOT COMPLETED|Overall Study||12
2866330|NCT00142818|3569246|FG000|STARTED|Overall Study||45
2866331|NCT00142818|3569247|FG001|STARTED|Overall Study||40
2866332|NCT00142818|3569248|FG002|STARTED|Overall Study||37
2866333|NCT00142818|3569249|FG003|STARTED|Overall Study||42
2866334|NCT00142818|3569246|FG000|COMPLETED|Overall Study||28
2866335|NCT00142818|3569247|FG001|COMPLETED|Overall Study||19
2866336|NCT00142818|3569248|FG002|COMPLETED|Overall Study||24
2866337|NCT00142818|3569249|FG003|COMPLETED|Overall Study||20
2866338|NCT00142818|3569246|FG000|NOT COMPLETED|Overall Study||17
2866339|NCT00142818|3569247|FG001|NOT COMPLETED|Overall Study||21
2866340|NCT00142818|3569248|FG002|NOT COMPLETED|Overall Study||13
2866341|NCT00142818|3569249|FG003|NOT COMPLETED|Overall Study||22
2866342|NCT00142909|3569265|FG000|STARTED|Randomization||42
2866343|NCT00142909|3569266|FG001|STARTED|Randomization||44
2866344|NCT00142909|3569265|FG000|COMPLETED|Randomization||35
2866345|NCT00142909|3569266|FG001|COMPLETED|Randomization||34
2866346|NCT00142909|3569265|FG000|NOT COMPLETED|Randomization||7
2866347|NCT00142909|3569266|FG001|NOT COMPLETED|Randomization||10
2866348|NCT00142909|3569265|FG000|STARTED|Medications Begin||35
2866349|NCT00142909|3569266|FG001|STARTED|Medications Begin||34
2866350|NCT00142909|3569265|FG000|COMPLETED|Medications Begin||26
2866351|NCT00142909|3569266|FG001|COMPLETED|Medications Begin||31
2866352|NCT00142909|3569265|FG000|NOT COMPLETED|Medications Begin||9
2866353|NCT00142909|3569266|FG001|NOT COMPLETED|Medications Begin||3
2866354|NCT00142935|3569275|FG000|STARTED|Overall Study||29
2866355|NCT00142935|3569276|FG001|STARTED|Overall Study||28
2866356|NCT00142935|3569277|FG002|STARTED|Overall Study||30
2866357|NCT00142935|3569275|FG000|COMPLETED|Overall Study||26
2866358|NCT00142935|3569276|FG001|COMPLETED|Overall Study||20
2866359|NCT00142935|3569277|FG002|COMPLETED|Overall Study||23
2866360|NCT00142935|3569275|FG000|NOT COMPLETED|Overall Study||3
2866361|NCT00142935|3569276|FG001|NOT COMPLETED|Overall Study||8
2866362|NCT00142935|3569277|FG002|NOT COMPLETED|Overall Study||7
2866363|NCT00143247|3569289|FG000|STARTED|Overall Study|173=total subjects of current + 3 previous protocols|173
2866364|NCT00143247|3569289|FG000|COMPLETED|Overall Study||17
2866365|NCT00143247|3569289|FG000|NOT COMPLETED|Overall Study||156
2866366|NCT00143312|3569293|FG000|STARTED|Overall Study||45
2866367|NCT00143312|3569293|FG000|COMPLETED|Overall Study||29
2866368|NCT00143312|3569293|FG000|NOT COMPLETED|Overall Study||16
2866369|NCT00143390|3569299|FG000|STARTED|Overall Study||149
2866370|NCT00143390|3569300|FG001|STARTED|Overall Study||149
2866371|NCT00143390|3569299|FG000|COMPLETED|Overall Study||0
2866372|NCT00143390|3569300|FG001|COMPLETED|Overall Study||0
2866373|NCT00143390|3569299|FG000|NOT COMPLETED|Overall Study||149
2866374|NCT00143390|3569300|FG001|NOT COMPLETED|Overall Study||149
3169288|NCT01924429|3896764|FG001|NOT COMPLETED|Washout Period (2 Weeks)||2
3169289|NCT01924429|3896763|FG000|STARTED|Period 2 - Second Intervention (4 Weeks)||14
3169290|NCT01924429|3896764|FG001|STARTED|Period 2 - Second Intervention (4 Weeks)||11
3169291|NCT01924429|3896763|FG000|COMPLETED|Period 2 - Second Intervention (4 Weeks)||14
3169292|NCT01924429|3896764|FG001|COMPLETED|Period 2 - Second Intervention (4 Weeks)||11
3169293|NCT01924429|3896763|FG000|NOT COMPLETED|Period 2 - Second Intervention (4 Weeks)||0
3171788|NCT01937130|3898979|FG000|NOT COMPLETED|Overall Study||5
2866375|NCT00143403|3569308|FG000|STARTED|Overall Study||160
2866376|NCT00143403|3569309|FG001|STARTED|Overall Study||161
2866377|NCT00143403|3569308|FG000|Treated|Overall Study||153
2866378|NCT00143403|3569309|FG001|Treated|Overall Study||153
2866379|NCT00143403|3569308|FG000|COMPLETED|Overall Study|Received maximum number of cycles.|125
2866380|NCT00143403|3569309|FG001|COMPLETED|Overall Study|Received maximum number of cycles.|115
2866381|NCT00143403|3569308|FG000|NOT COMPLETED|Overall Study||35
2866382|NCT00143403|3569309|FG001|NOT COMPLETED|Overall Study||46
2866383|NCT00143455|3569319|FG000|STARTED|Cohort 1||39
2866384|NCT00143455|3569320|FG001|STARTED|Cohort 1||39
2866385|NCT00143455|3569321|FG002|STARTED|Cohort 1||0
2866386|NCT00143455|3569322|FG003|STARTED|Cohort 1||0
2866387|NCT00143455|3569319|FG000|Received Treatment|Cohort 1||39
2866388|NCT00143455|3569320|FG001|Received Treatment|Cohort 1||38
2866389|NCT00143455|3569321|FG002|Received Treatment|Cohort 1||0
2866390|NCT00143455|3569322|FG003|Received Treatment|Cohort 1||0
2866391|NCT00143455|3569319|FG000|COMPLETED|Cohort 1||25
2866392|NCT00143455|3569320|FG001|COMPLETED|Cohort 1||22
2866393|NCT00143455|3569321|FG002|COMPLETED|Cohort 1||0
2866394|NCT00143455|3569322|FG003|COMPLETED|Cohort 1||0
2866395|NCT00143455|3569319|FG000|NOT COMPLETED|Cohort 1||14
2866396|NCT00143455|3569320|FG001|NOT COMPLETED|Cohort 1||17
2866397|NCT00143455|3569321|FG002|NOT COMPLETED|Cohort 1||0
2866398|NCT00143455|3569322|FG003|NOT COMPLETED|Cohort 1||0
2866399|NCT00143455|3569319|FG000|STARTED|Cohort 2||0
2866400|NCT00143455|3569320|FG001|STARTED|Cohort 2||0
2866401|NCT00143455|3569321|FG002|STARTED|Cohort 2||203
2866402|NCT00143455|3569322|FG003|STARTED|Cohort 2||204
2866403|NCT00143455|3569319|FG000|Received Treatment|Cohort 2||0
2866404|NCT00143455|3569320|FG001|Received Treatment|Cohort 2||0
2866405|NCT00143455|3569321|FG002|Received Treatment|Cohort 2||202
2866406|NCT00143455|3569322|FG003|Received Treatment|Cohort 2||203
2866407|NCT00143455|3569319|FG000|COMPLETED|Cohort 2||0
2866408|NCT00143455|3569320|FG001|COMPLETED|Cohort 2||0
2866409|NCT00143455|3569321|FG002|COMPLETED|Cohort 2||97
2866410|NCT00143455|3569322|FG003|COMPLETED|Cohort 2||111
2866411|NCT00143455|3569319|FG000|NOT COMPLETED|Cohort 2||0
2866412|NCT00143455|3569320|FG001|NOT COMPLETED|Cohort 2||0
2866413|NCT00143455|3569321|FG002|NOT COMPLETED|Cohort 2||106
2866414|NCT00143455|3569322|FG003|NOT COMPLETED|Cohort 2||93
2866415|NCT00143507|3569336|FG000|STARTED|Overall Study||5479
2866416|NCT00143507|3569337|FG001|STARTED|Overall Study||5438
2866417|NCT00143507|3569336|FG000|COMPLETED|Overall Study||4792
2866418|NCT00143507|3569337|FG001|COMPLETED|Overall Study||4786
2866419|NCT00143507|3569336|FG000|NOT COMPLETED|Overall Study||687
2866420|NCT00143507|3569337|FG001|NOT COMPLETED|Overall Study||652
2866421|NCT00143598|3569345|FG000|STARTED|Overall Study||410
2866422|NCT00143598|3569346|FG001|STARTED|Overall Study||396
2866423|NCT00143598|3569345|FG000|COMPLETED|Overall Study||318
2866424|NCT00143598|3569346|FG001|COMPLETED|Overall Study||302
2866425|NCT00143598|3569345|FG000|NOT COMPLETED|Overall Study||92
2866426|NCT00143598|3569346|FG001|NOT COMPLETED|Overall Study||94
2866427|NCT00143819|3569354|FG000|STARTED|Overall Study||5
2866428|NCT00143819|3569355|FG001|STARTED|Overall Study||8
2866429|NCT00143819|3569354|FG000|COMPLETED|Overall Study||3
2866430|NCT00143819|3569355|FG001|COMPLETED|Overall Study||5
2866431|NCT00143819|3569354|FG000|NOT COMPLETED|Overall Study||2
2866432|NCT00143819|3569355|FG001|NOT COMPLETED|Overall Study||3
2866433|NCT00143845|3569365|FG000|STARTED|Overall Study||54
2866434|NCT00143845|3569365|FG000|COMPLETED|Overall Study||54
2866435|NCT00143845|3569365|FG000|NOT COMPLETED|Overall Study||0
2866436|NCT00144027|3569371|FG000|STARTED|Overall Study|participants who consented|39
2866437|NCT00144027|3569372|FG001|STARTED|Overall Study|participants who consented|36
2866438|NCT00144027|3569371|FG000|Completed Baseline Assessment|Overall Study||39
2866439|NCT00144027|3569372|FG001|Completed Baseline Assessment|Overall Study||29
2866440|NCT00144027|3569371|FG000|Completed 6 Month Assessment|Overall Study||37
2866441|NCT00144027|3569372|FG001|Completed 6 Month Assessment|Overall Study||24
3169294|NCT01924429|3896764|FG001|NOT COMPLETED|Period 2 - Second Intervention (4 Weeks)||0
3169295|NCT01924442|3896774|FG000|STARTED|Overall Study||1099
3169296|NCT01924442|3896775|FG001|STARTED|Overall Study||1104
2866442|NCT00144027|3569371|FG000|COMPLETED|Overall Study|participants who completed 12-month follow-up|36
2866443|NCT00144027|3569372|FG001|COMPLETED|Overall Study|participants who completed 12-month follow-up|25
2866444|NCT00144027|3569371|FG000|NOT COMPLETED|Overall Study||3
2866445|NCT00144027|3569372|FG001|NOT COMPLETED|Overall Study||11
2866446|NCT00144170|3569380|FG000|STARTED|Overall Study||438
2866447|NCT00144170|3569381|FG001|STARTED|Overall Study||428
2866448|NCT00144170|3569380|FG000|COMPLETED|Overall Study||86
2866449|NCT00144170|3569381|FG001|COMPLETED|Overall Study||32
2866450|NCT00144170|3569380|FG000|NOT COMPLETED|Overall Study||352
2866451|NCT00144170|3569381|FG001|NOT COMPLETED|Overall Study||396
2866452|NCT00144300|3569389|FG000|STARTED|Overall Study||121
2866453|NCT00144300|3569390|FG001|STARTED|Overall Study||125
2866454|NCT00144300|3569389|FG000|COMPLETED|Overall Study||92
2866455|NCT00144300|3569390|FG001|COMPLETED|Overall Study||97
2866456|NCT00144300|3569389|FG000|NOT COMPLETED|Overall Study||29
2866457|NCT00144300|3569390|FG001|NOT COMPLETED|Overall Study||28
2866458|NCT00144339|3569398|FG000|STARTED|Overall Study||3006
2866459|NCT00144339|3569399|FG001|STARTED|Overall Study||2986
2866460|NCT00144339|3569398|FG000|COMPLETED|Overall Study||1648
2866461|NCT00144339|3569399|FG001|COMPLETED|Overall Study||1887
2866462|NCT00144339|3569398|FG000|NOT COMPLETED|Overall Study||1358
2866463|NCT00144339|3569399|FG001|NOT COMPLETED|Overall Study||1099
2866464|NCT00144391|3569407|FG000|STARTED|Overall Study||11
2866465|NCT00144391|3569408|FG001|STARTED|Overall Study||9
2866466|NCT00144391|3569407|FG000|COMPLETED|Overall Study||11
2866467|NCT00144391|3569408|FG001|COMPLETED|Overall Study||9
2866468|NCT00144391|3569407|FG000|NOT COMPLETED|Overall Study||0
2866469|NCT00144391|3569408|FG001|NOT COMPLETED|Overall Study||0
2866470|NCT00144781|3569418|FG000|STARTED|Overall Study||8
2866471|NCT00144781|3569419|FG001|STARTED|Overall Study||9
2866472|NCT00144781|3569420|FG002|STARTED|Overall Study||8
2866473|NCT00144781|3569421|FG003|STARTED|Overall Study||9
2866474|NCT00144781|3569418|FG000|COMPLETED|Overall Study||8
2866475|NCT00144781|3569419|FG001|COMPLETED|Overall Study||7
2866476|NCT00144781|3569420|FG002|COMPLETED|Overall Study||8
3169297|NCT01924442|3896774|FG000|COMPLETED|Overall Study||1059
2866477|NCT00144781|3569421|FG003|COMPLETED|Overall Study||9
2866478|NCT00144781|3569418|FG000|NOT COMPLETED|Overall Study||0
2866479|NCT00144781|3569419|FG001|NOT COMPLETED|Overall Study||2
2866480|NCT00144781|3569420|FG002|NOT COMPLETED|Overall Study||0
2866481|NCT00144781|3569421|FG003|NOT COMPLETED|Overall Study||0
2866482|NCT00144963|3569431|FG000|STARTED|Overall Study||36
2866483|NCT00144963|3569431|FG000|COMPLETED|Overall Study||36
2866484|NCT00144963|3569431|FG000|NOT COMPLETED|Overall Study||0
2866485|NCT00145041|3569435|FG000|STARTED|Overall Study||7
2866486|NCT00145041|3569435|FG000|COMPLETED|Overall Study||7
2866487|NCT00145041|3569435|FG000|NOT COMPLETED|Overall Study||0
2866488|NCT00145119|3569439|FG000|STARTED|Overall Study||312
2866489|NCT00145119|3569439|FG000|COMPLETED|Overall Study||267
2866490|NCT00145119|3569439|FG000|NOT COMPLETED|Overall Study||45
2866491|NCT00145145|3569443|FG000|STARTED|Overall Study||1
2866492|NCT00145145|3569443|FG000|COMPLETED|Overall Study||1
2866493|NCT00145145|3569443|FG000|NOT COMPLETED|Overall Study||0
2866494|NCT00145249|3569450|FG000|STARTED|Overall Study|47 subjects randomized; 45 subjects treated|47
2866495|NCT00145249|3569451|FG001|STARTED|Overall Study|48 subjects randomized; 47 subjects treated-2 subjects randomized to AmphoB rec'd AmphoB+Fluc400|48
2866496|NCT00145249|3569452|FG002|STARTED|Overall Study|48 subjects randomized; 49 treated-3 subjects randomized to AmphoB+Fluc400 rec'd AmphoB+Fluc800|48
2866497|NCT00145249|3569450|FG000|COMPLETED|Overall Study||36
2866498|NCT00145249|3569451|FG001|COMPLETED|Overall Study||33
2866499|NCT00145249|3569452|FG002|COMPLETED|Overall Study||31
2866500|NCT00145249|3569450|FG000|NOT COMPLETED|Overall Study||11
2866501|NCT00145249|3569451|FG001|NOT COMPLETED|Overall Study||15
2866502|NCT00145249|3569452|FG002|NOT COMPLETED|Overall Study||17
2866503|NCT00145327|3569463|FG000|STARTED|Overall Study|Group Z6 and Group Z3P3 have randomized participants.|616
2866504|NCT00145327|3569464|FG001|STARTED|Overall Study||617
2866505|NCT00145327|3569465|FG002|STARTED|Overall Study|Group P3Z3 have non-randomized participants|1223
2866506|NCT00145327|3569463|FG000|COMPLETED|Overall Study||474
2866507|NCT00145327|3569464|FG001|COMPLETED|Overall Study||493
2866508|NCT00145327|3569465|FG002|COMPLETED|Overall Study||975
2866509|NCT00145327|3569463|FG000|NOT COMPLETED|Overall Study||142
2866510|NCT00145327|3569464|FG001|NOT COMPLETED|Overall Study||124
2866511|NCT00145327|3569465|FG002|NOT COMPLETED|Overall Study||248
2866512|NCT00145418|3569473|FG000|STARTED|Overall Study||15
2866513|NCT00145418|3569473|FG000|COMPLETED|Overall Study||15
2866514|NCT00145418|3569473|FG000|NOT COMPLETED|Overall Study||0
2866515|NCT00145574|3569480|FG000|STARTED|Double Blind||65
2866516|NCT00145574|3569481|FG001|STARTED|Double Blind||65
2866517|NCT00145574|3569482|FG002|STARTED|Double Blind||64
2866518|NCT00145574|3569480|FG000|COMPLETED|Double Blind||64
2866519|NCT00145574|3569481|FG001|COMPLETED|Double Blind||60
2866520|NCT00145574|3569482|FG002|COMPLETED|Double Blind||62
2866521|NCT00145574|3569480|FG000|NOT COMPLETED|Double Blind||1
2866522|NCT00145574|3569481|FG001|NOT COMPLETED|Double Blind||5
2866523|NCT00145574|3569482|FG002|NOT COMPLETED|Double Blind||2
2866524|NCT00145574|3569480|FG000|STARTED|Open Label Long-term Extension||0
2866525|NCT00145574|3569481|FG001|STARTED|Open Label Long-term Extension||0
2866526|NCT00145574|3569482|FG002|STARTED|Open Label Long-term Extension|2 participants discontinued after completing double-blind but before starting open label.|184
2866527|NCT00145574|3569480|FG000|COMPLETED|Open Label Long-term Extension||0
2866528|NCT00145574|3569481|FG001|COMPLETED|Open Label Long-term Extension||0
2866529|NCT00145574|3569482|FG002|COMPLETED|Open Label Long-term Extension||173
2866530|NCT00145574|3569480|FG000|NOT COMPLETED|Open Label Long-term Extension||0
2866531|NCT00145574|3569481|FG001|NOT COMPLETED|Open Label Long-term Extension||0
2866532|NCT00145574|3569482|FG002|NOT COMPLETED|Open Label Long-term Extension||11
2866533|NCT00145587|3569497|FG000|STARTED|Overall Study||5
2866534|NCT00145587|3569498|FG001|STARTED|Overall Study||1
2866535|NCT00145587|3569497|FG000|COMPLETED|Overall Study||5
2866536|NCT00145587|3569498|FG001|COMPLETED|Overall Study||1
2866537|NCT00145587|3569497|FG000|NOT COMPLETED|Overall Study||0
2866538|NCT00145587|3569498|FG001|NOT COMPLETED|Overall Study||0
2866539|NCT00145600|3569508|FG000|STARTED|Overall Study||91
2866540|NCT00145600|3569509|FG001|STARTED|Overall Study||46
2866541|NCT00145600|3569510|FG002|STARTED|Overall Study||13
2866542|NCT00145600|3569511|FG003|STARTED|Overall Study||146
2866543|NCT00145600|3569508|FG000|COMPLETED|Overall Study||83
2866544|NCT00145600|3569509|FG001|COMPLETED|Overall Study||36
2866545|NCT00145600|3569510|FG002|COMPLETED|Overall Study||8
2866546|NCT00145600|3569511|FG003|COMPLETED|Overall Study||130
2866547|NCT00145600|3569508|FG000|NOT COMPLETED|Overall Study||8
2866548|NCT00145600|3569509|FG001|NOT COMPLETED|Overall Study||10
2866549|NCT00145600|3569510|FG002|NOT COMPLETED|Overall Study||5
2866550|NCT00145600|3569511|FG003|NOT COMPLETED|Overall Study||16
2866551|NCT00145626|3569537|FG000|STARTED|Overall Study||19
2866552|NCT00145626|3569537|FG000|COMPLETED|Overall Study||14
2866553|NCT00145626|3569537|FG000|NOT COMPLETED|Overall Study||5
2866554|NCT00145795|3569559|FG000|STARTED|Overall Study||10
2866555|NCT00145795|3569560|FG001|STARTED|Overall Study||10
2866556|NCT00145795|3569559|FG000|COMPLETED|Overall Study|1 patient discontinued early due to grade II gastrointestinal symptoms.|9
2866557|NCT00145795|3569560|FG001|COMPLETED|Overall Study||10
3169298|NCT01924442|3896775|FG001|COMPLETED|Overall Study||967
3169299|NCT01924442|3896774|FG000|NOT COMPLETED|Overall Study||40
3169300|NCT01924442|3896775|FG001|NOT COMPLETED|Overall Study||137
3169301|NCT01924533|3896783|FG000|STARTED|Overall Study||263
3169302|NCT01924533|3896784|FG001|STARTED|Overall Study||262
3169303|NCT01924533|3896783|FG000|COMPLETED|Overall Study||74
3169304|NCT01924533|3896784|FG001|COMPLETED|Overall Study||57
3169305|NCT01924533|3896783|FG000|NOT COMPLETED|Overall Study||189
3169306|NCT01924533|3896784|FG001|NOT COMPLETED|Overall Study||205
3169307|NCT01924559|3896790|FG000|STARTED|Overall Study|All 37 participants were scored under the same six scenarios, resulting in 222 observations.|37
3169308|NCT01924559|3896790|FG000|COMPLETED|Overall Study|The order in which subjects started scenarios (in biohazard gear vs street clothing) was randomized|37
3169309|NCT01924559|3896790|FG000|NOT COMPLETED|Overall Study||0
3169310|NCT01924689|3896810|FG000|STARTED|Overall Study||3
3169311|NCT01924689|3896811|FG001|STARTED|Overall Study||3
3169312|NCT01924689|3896812|FG002|STARTED|Overall Study||4
3169313|NCT01924689|3896813|FG003|STARTED|Overall Study||6
3169314|NCT01924689|3896814|FG004|STARTED|Overall Study||6
3169315|NCT01924689|3896815|FG005|STARTED|Overall Study||2
3169316|NCT01924689|3896810|FG000|COMPLETED|Overall Study||0
3169317|NCT01924689|3896811|FG001|COMPLETED|Overall Study||0
3169318|NCT01924689|3896812|FG002|COMPLETED|Overall Study||0
3169319|NCT01924689|3896813|FG003|COMPLETED|Overall Study||0
3169320|NCT01924689|3896814|FG004|COMPLETED|Overall Study||0
3169321|NCT01924689|3896815|FG005|COMPLETED|Overall Study||0
3169322|NCT01924689|3896810|FG000|NOT COMPLETED|Overall Study||3
3169323|NCT01924689|3896811|FG001|NOT COMPLETED|Overall Study||3
3169324|NCT01924689|3896812|FG002|NOT COMPLETED|Overall Study||4
3169325|NCT01924689|3896813|FG003|NOT COMPLETED|Overall Study||6
3169326|NCT01924689|3896814|FG004|NOT COMPLETED|Overall Study||6
3169327|NCT01924689|3896815|FG005|NOT COMPLETED|Overall Study||2
3169328|NCT01924754|3896836|FG000|STARTED|Overall Study||50
2866558|NCT00145795|3569559|FG000|NOT COMPLETED|Overall Study||1
2866559|NCT00145795|3569560|FG001|NOT COMPLETED|Overall Study||0
2866560|NCT00145977|3569568|FG000|STARTED|Overall Study||19
3169329|NCT01924754|3896837|FG001|STARTED|Overall Study||50
3169330|NCT01924754|3896838|FG002|STARTED|Overall Study||50
3169331|NCT01924754|3896836|FG000|COMPLETED|Overall Study||49
3169332|NCT01924754|3896837|FG001|COMPLETED|Overall Study||47
3169333|NCT01924754|3896838|FG002|COMPLETED|Overall Study||47
3169334|NCT01924754|3896836|FG000|NOT COMPLETED|Overall Study||1
3169335|NCT01924754|3896837|FG001|NOT COMPLETED|Overall Study||3
3169336|NCT01924754|3896838|FG002|NOT COMPLETED|Overall Study||3
3169337|NCT01924767|3896854|FG000|STARTED|Overall Study||12
2866561|NCT00145977|3569569|FG001|STARTED|Overall Study||17
2866562|NCT00145977|3569568|FG000|COMPLETED|Overall Study||17
2866563|NCT00145977|3569569|FG001|COMPLETED|Overall Study||13
2866564|NCT00145977|3569568|FG000|NOT COMPLETED|Overall Study||2
2866565|NCT00145977|3569569|FG001|NOT COMPLETED|Overall Study||4
2866566|NCT00146172|3569583|FG000|STARTED|Overall Study||3
2866567|NCT00146172|3569584|FG001|STARTED|Overall Study||4
2866568|NCT00146172|3569585|FG002|STARTED|Overall Study||4
2866569|NCT00146172|3569586|FG003|STARTED|Overall Study||6
2866570|NCT00146172|3569587|FG004|STARTED|Overall Study||3
2866571|NCT00146172|3569588|FG005|STARTED|Overall Study||7
2866572|NCT00146172|3569589|FG006|STARTED|Overall Study||6
2866573|NCT00146172|3569590|FG007|STARTED|Overall Study||40
2866574|NCT00146172|3569583|FG000|Received Drug|Overall Study||3
2866575|NCT00146172|3569584|FG001|Received Drug|Overall Study||4
2866576|NCT00146172|3569585|FG002|Received Drug|Overall Study||4
2866577|NCT00146172|3569586|FG003|Received Drug|Overall Study||6
2866578|NCT00146172|3569587|FG004|Received Drug|Overall Study||3
2866579|NCT00146172|3569588|FG005|Received Drug|Overall Study||7
2866580|NCT00146172|3569589|FG006|Received Drug|Overall Study||6
2866581|NCT00146172|3569590|FG007|Received Drug|Overall Study||39
2866582|NCT00146172|3569583|FG000|COMPLETED|Overall Study||0
2866583|NCT00146172|3569584|FG001|COMPLETED|Overall Study||0
2866584|NCT00146172|3569585|FG002|COMPLETED|Overall Study||0
2866585|NCT00146172|3569586|FG003|COMPLETED|Overall Study||0
2866586|NCT00146172|3569587|FG004|COMPLETED|Overall Study||0
2866587|NCT00146172|3569588|FG005|COMPLETED|Overall Study||0
2866588|NCT00146172|3569589|FG006|COMPLETED|Overall Study||0
2866589|NCT00146172|3569590|FG007|COMPLETED|Overall Study||0
2866590|NCT00146172|3569583|FG000|NOT COMPLETED|Overall Study||3
2866591|NCT00146172|3569584|FG001|NOT COMPLETED|Overall Study||4
2866592|NCT00146172|3569585|FG002|NOT COMPLETED|Overall Study||4
2866593|NCT00146172|3569586|FG003|NOT COMPLETED|Overall Study||6
2866594|NCT00146172|3569587|FG004|NOT COMPLETED|Overall Study||3
2866595|NCT00146172|3569588|FG005|NOT COMPLETED|Overall Study||7
2866596|NCT00146172|3569589|FG006|NOT COMPLETED|Overall Study||6
2866597|NCT00146172|3569590|FG007|NOT COMPLETED|Overall Study||40
2866598|NCT00146328|3569619|FG000|STARTED|Overall Study||291
2866599|NCT00146328|3569620|FG001|STARTED|Overall Study||255
2866600|NCT00146328|3569621|FG002|STARTED|Overall Study||449
2866601|NCT00146328|3569619|FG000|COMPLETED|Overall Study||150
2866602|NCT00146328|3569620|FG001|COMPLETED|Overall Study||101
2866603|NCT00146328|3569621|FG002|COMPLETED|Overall Study||158
2866604|NCT00146328|3569619|FG000|NOT COMPLETED|Overall Study||141
3169338|NCT01924767|3896855|FG001|STARTED|Overall Study||9
3169339|NCT01924767|3896856|FG002|STARTED|Overall Study||9
2866605|NCT00146328|3569620|FG001|NOT COMPLETED|Overall Study||154
3169340|NCT01924767|3896857|FG003|STARTED|Overall Study||9
3169341|NCT01924767|3896858|FG004|STARTED|Overall Study||9
3169342|NCT01924767|3896854|FG000|COMPLETED|Overall Study||11
3169343|NCT01924767|3896855|FG001|COMPLETED|Overall Study||9
3169344|NCT01924767|3896856|FG002|COMPLETED|Overall Study||8
2866606|NCT00146328|3569621|FG002|NOT COMPLETED|Overall Study||291
2866607|NCT00146640|3569631|FG000|STARTED|Overall Study||144
2866608|NCT00146640|3569632|FG001|STARTED|Overall Study||144
2866609|NCT00146640|3569631|FG000|COMPLETED|Overall Study||121
2866610|NCT00146640|3569632|FG001|COMPLETED|Overall Study||130
2866611|NCT00146640|3569631|FG000|NOT COMPLETED|Overall Study||23
2866612|NCT00146640|3569632|FG001|NOT COMPLETED|Overall Study||14
2866613|NCT00146757|3569638|FG000|STARTED|Overall Study||16
2866614|NCT00146757|3569639|FG001|STARTED|Overall Study||4
2866615|NCT00146757|3569638|FG000|COMPLETED|Overall Study||14
2866616|NCT00146757|3569639|FG001|COMPLETED|Overall Study||4
2866617|NCT00146757|3569638|FG000|NOT COMPLETED|Overall Study||2
2866618|NCT00146757|3569639|FG001|NOT COMPLETED|Overall Study||0
2866619|NCT00146770|3569647|FG000|STARTED|Overall Study||23
2866620|NCT00146770|3569648|FG001|STARTED|Overall Study||22
2866621|NCT00146770|3569647|FG000|COMPLETED|Overall Study||18
2866622|NCT00146770|3569648|FG001|COMPLETED|Overall Study||22
2866623|NCT00146770|3569647|FG000|NOT COMPLETED|Overall Study||5
2866624|NCT00146770|3569648|FG001|NOT COMPLETED|Overall Study||0
2866625|NCT00146848|3569657|FG000|STARTED|Pre-randomization|Registered|1742
2866626|NCT00146848|3569658|FG001|STARTED|Pre-randomization||0
2866627|NCT00146848|3569659|FG002|STARTED|Pre-randomization||0
2866628|NCT00146848|3569657|FG000|COMPLETED|Pre-randomization|Reached 6-week visit and were randomized|1433
2866629|NCT00146848|3569658|FG001|COMPLETED|Pre-randomization||0
2866630|NCT00146848|3569659|FG002|COMPLETED|Pre-randomization||0
2866631|NCT00146848|3569657|FG000|NOT COMPLETED|Pre-randomization||309
2866632|NCT00146848|3569658|FG001|NOT COMPLETED|Pre-randomization||0
2866633|NCT00146848|3569659|FG002|NOT COMPLETED|Pre-randomization||0
2866634|NCT00146848|3569657|FG000|STARTED|Post-randomization||475
2866635|NCT00146848|3569658|FG001|STARTED|Post-randomization||488
2866636|NCT00146848|3569659|FG002|STARTED|Post-randomization||470
2866637|NCT00146848|3569657|FG000|COMPLETED|Post-randomization||437
2866638|NCT00146848|3569658|FG001|COMPLETED|Post-randomization||441
2866639|NCT00146848|3569659|FG002|COMPLETED|Post-randomization||431
2866640|NCT00146848|3569657|FG000|NOT COMPLETED|Post-randomization||38
2866641|NCT00146848|3569658|FG001|NOT COMPLETED|Post-randomization||47
2866642|NCT00146848|3569659|FG002|NOT COMPLETED|Post-randomization||39
2866643|NCT00147017|3569670|FG000|STARTED|Overall Study||6
2866644|NCT00147017|3569671|FG001|STARTED|Overall Study||7
2866645|NCT00147017|3569672|FG002|STARTED|Overall Study||4
2866646|NCT00147017|3569670|FG000|COMPLETED|Overall Study||6
2866647|NCT00147017|3569671|FG001|COMPLETED|Overall Study||7
2866648|NCT00147017|3569672|FG002|COMPLETED|Overall Study||4
2866649|NCT00147017|3569670|FG000|NOT COMPLETED|Overall Study||0
2866650|NCT00147017|3569671|FG001|NOT COMPLETED|Overall Study||0
2866651|NCT00147017|3569672|FG002|NOT COMPLETED|Overall Study||0
2866652|NCT00147030|3569682|FG000|STARTED|Overall Study||163
2866653|NCT00147030|3569683|FG001|STARTED|Overall Study||162
2866654|NCT00147030|3569682|FG000|COMPLETED|Overall Study||163
2866655|NCT00147030|3569683|FG001|COMPLETED|Overall Study||162
2866656|NCT00147030|3569682|FG000|NOT COMPLETED|Overall Study||0
2866657|NCT00147030|3569683|FG001|NOT COMPLETED|Overall Study||0
2866658|NCT00147043|3569691|FG000|STARTED|Overall Study||5
2866659|NCT00147043|3569691|FG000|COMPLETED|Overall Study||5
2866660|NCT00147043|3569691|FG000|NOT COMPLETED|Overall Study||0
2866661|NCT00147069|3569700|FG000|STARTED|Overall Study||15
2866662|NCT00147069|3569701|FG001|STARTED|Overall Study||15
2866663|NCT00147069|3569702|FG002|STARTED|Overall Study||15
2866664|NCT00147069|3569703|FG003|STARTED|Overall Study||15
2866665|NCT00147069|3569700|FG000|COMPLETED|Overall Study||15
2866666|NCT00147069|3569701|FG001|COMPLETED|Overall Study||15
2866667|NCT00147069|3569702|FG002|COMPLETED|Overall Study||15
2866668|NCT00147069|3569703|FG003|COMPLETED|Overall Study||15
2866669|NCT00147069|3569700|FG000|NOT COMPLETED|Overall Study||0
2866670|NCT00147069|3569701|FG001|NOT COMPLETED|Overall Study||0
2866671|NCT00147069|3569702|FG002|NOT COMPLETED|Overall Study||0
2866672|NCT00147069|3569703|FG003|NOT COMPLETED|Overall Study||0
2866673|NCT00147082|3569716|FG000|STARTED|Overall Study||37
2866674|NCT00147082|3569717|FG001|STARTED|Overall Study||33
2866675|NCT00147082|3569718|FG002|STARTED|Overall Study||30
2866676|NCT00147082|3569716|FG000|COMPLETED|Overall Study||37
2866677|NCT00147082|3569717|FG001|COMPLETED|Overall Study||33
2866678|NCT00147082|3569718|FG002|COMPLETED|Overall Study||30
2866679|NCT00147082|3569716|FG000|NOT COMPLETED|Overall Study||0
2866680|NCT00147082|3569717|FG001|NOT COMPLETED|Overall Study||0
2866681|NCT00147082|3569718|FG002|NOT COMPLETED|Overall Study||0
2866682|NCT00147199|3569728|FG000|STARTED|Overall Study||115
2866683|NCT00147199|3569729|FG001|STARTED|Overall Study||120
2866684|NCT00147199|3569728|FG000|COMPLETED|Overall Study||102
2866685|NCT00147199|3569729|FG001|COMPLETED|Overall Study||110
2866686|NCT00147199|3569728|FG000|NOT COMPLETED|Overall Study||13
2866687|NCT00147199|3569729|FG001|NOT COMPLETED|Overall Study||10
2866688|NCT00147212|3569735|FG000|STARTED|Overall Study||50
2866689|NCT00147212|3569735|FG000|COMPLETED|Overall Study||50
2866690|NCT00147212|3569735|FG000|NOT COMPLETED|Overall Study||0
2866691|NCT00147225|3569745|FG000|STARTED|Overall Study||7
2866692|NCT00147225|3569746|FG001|STARTED|Overall Study||6
2866693|NCT00147225|3569747|FG002|STARTED|Overall Study||8
2866694|NCT00147225|3569748|FG003|STARTED|Overall Study||11
2866695|NCT00147225|3569749|FG004|STARTED|Overall Study||11
2866696|NCT00147225|3569750|FG005|STARTED|Overall Study||12
2866697|NCT00147225|3569745|FG000|COMPLETED|Overall Study||6
2866698|NCT00147225|3569746|FG001|COMPLETED|Overall Study||6
2866699|NCT00147225|3569747|FG002|COMPLETED|Overall Study||6
2866700|NCT00147225|3569748|FG003|COMPLETED|Overall Study||10
2866701|NCT00147225|3569749|FG004|COMPLETED|Overall Study||10
2866702|NCT00147225|3569750|FG005|COMPLETED|Overall Study||10
2866703|NCT00147225|3569745|FG000|NOT COMPLETED|Overall Study||1
2866704|NCT00147225|3569746|FG001|NOT COMPLETED|Overall Study||0
2866705|NCT00147225|3569747|FG002|NOT COMPLETED|Overall Study||2
2866706|NCT00147225|3569748|FG003|NOT COMPLETED|Overall Study||1
2866707|NCT00147225|3569749|FG004|NOT COMPLETED|Overall Study||1
2866708|NCT00147225|3569750|FG005|NOT COMPLETED|Overall Study||2
2866709|NCT00147251|3569766|FG000|STARTED|Recruitment and Enrollment||271
2866710|NCT00147251|3569767|FG001|STARTED|Recruitment and Enrollment||277
2866711|NCT00147251|3569766|FG000|COMPLETED|Recruitment and Enrollment||247
2866712|NCT00147251|3569767|FG001|COMPLETED|Recruitment and Enrollment||252
2866713|NCT00147251|3569766|FG000|NOT COMPLETED|Recruitment and Enrollment||24
2866714|NCT00147251|3569767|FG001|NOT COMPLETED|Recruitment and Enrollment||25
2866715|NCT00147251|3569766|FG000|STARTED|Follow up||247
2866716|NCT00147251|3569767|FG001|STARTED|Follow up||252
2866717|NCT00147251|3569766|FG000|COMPLETED|Follow up||247
2866718|NCT00147251|3569767|FG001|COMPLETED|Follow up||252
2866719|NCT00147251|3569766|FG000|NOT COMPLETED|Follow up||0
2866720|NCT00147251|3569767|FG001|NOT COMPLETED|Follow up||0
2866721|NCT00147316|3569775|FG000|STARTED|Overall Study||103
2866722|NCT00147316|3569775|FG000|COMPLETED|Overall Study||103
2866723|NCT00147316|3569775|FG000|NOT COMPLETED|Overall Study||0
2866724|NCT00147446|3569781|FG000|STARTED|Overall Study||60
2866725|NCT00147446|3569782|FG001|STARTED|Overall Study||61
2866726|NCT00147446|3569781|FG000|COMPLETED|Overall Study||60
2866727|NCT00147446|3569782|FG001|COMPLETED|Overall Study||61
2866728|NCT00147446|3569781|FG000|NOT COMPLETED|Overall Study||0
2866729|NCT00147446|3569782|FG001|NOT COMPLETED|Overall Study||0
2866730|NCT00147498|3569794|FG000|STARTED|Overall Study||61
2866731|NCT00147498|3569795|FG001|STARTED|Overall Study||69
2866732|NCT00147498|3569796|FG002|STARTED|Overall Study||69
2866733|NCT00147498|3569797|FG003|STARTED|Overall Study||65
2866734|NCT00147498|3569794|FG000|COMPLETED|Overall Study||58
2866735|NCT00147498|3569795|FG001|COMPLETED|Overall Study||60
2866736|NCT00147498|3569796|FG002|COMPLETED|Overall Study||52
2866737|NCT00147498|3569797|FG003|COMPLETED|Overall Study||48
2866738|NCT00147498|3569794|FG000|NOT COMPLETED|Overall Study||3
2866739|NCT00147498|3569795|FG001|NOT COMPLETED|Overall Study||9
2866740|NCT00147498|3569796|FG002|NOT COMPLETED|Overall Study||17
2866741|NCT00147498|3569797|FG003|NOT COMPLETED|Overall Study||17
2866742|NCT00147537|3569811|FG000|STARTED|Phase 1b||3
2866743|NCT00147537|3569812|FG001|STARTED|Phase 1b||2
2866744|NCT00147537|3569813|FG002|STARTED|Phase 1b||4
2866745|NCT00147537|3569814|FG003|STARTED|Phase 1b||3
2866746|NCT00147537|3569815|FG004|STARTED|Phase 1b||3
2866747|NCT00147537|3569816|FG005|STARTED|Phase 1b||3
2866748|NCT00147537|3569817|FG006|STARTED|Phase 1b|18 participants randomized; 17 participants treated|18
2866749|NCT00147537|3569818|FG007|STARTED|Phase 1b||7
2866750|NCT00147537|3569819|FG008|STARTED|Phase 1b|18 participants randomized; 17 participants treated|18
2866751|NCT00147537|3569820|FG009|STARTED|Phase 1b||0
2866752|NCT00147537|3569821|FG010|STARTED|Phase 1b||0
2866753|NCT00147537|3569811|FG000|COMPLETED|Phase 1b||1
2866754|NCT00147537|3569812|FG001|COMPLETED|Phase 1b||0
2866755|NCT00147537|3569813|FG002|COMPLETED|Phase 1b||0
2866756|NCT00147537|3569814|FG003|COMPLETED|Phase 1b||1
2866757|NCT00147537|3569815|FG004|COMPLETED|Phase 1b||0
2866758|NCT00147537|3569816|FG005|COMPLETED|Phase 1b||0
2866759|NCT00147537|3569817|FG006|COMPLETED|Phase 1b||0
2866760|NCT00147537|3569818|FG007|COMPLETED|Phase 1b||0
2866761|NCT00147537|3569819|FG008|COMPLETED|Phase 1b||1
2866762|NCT00147537|3569820|FG009|COMPLETED|Phase 1b||0
2866763|NCT00147537|3569821|FG010|COMPLETED|Phase 1b||0
2866764|NCT00147537|3569811|FG000|NOT COMPLETED|Phase 1b||2
2866765|NCT00147537|3569812|FG001|NOT COMPLETED|Phase 1b||2
2866766|NCT00147537|3569813|FG002|NOT COMPLETED|Phase 1b||4
2866767|NCT00147537|3569814|FG003|NOT COMPLETED|Phase 1b||2
2866768|NCT00147537|3569815|FG004|NOT COMPLETED|Phase 1b||3
2866769|NCT00147537|3569816|FG005|NOT COMPLETED|Phase 1b||3
2866770|NCT00147537|3569817|FG006|NOT COMPLETED|Phase 1b||18
2866771|NCT00147537|3569818|FG007|NOT COMPLETED|Phase 1b||7
2866772|NCT00147537|3569819|FG008|NOT COMPLETED|Phase 1b||17
2866773|NCT00147537|3569820|FG009|NOT COMPLETED|Phase 1b||0
2866774|NCT00147537|3569821|FG010|NOT COMPLETED|Phase 1b||0
2866775|NCT00147537|3569811|FG000|STARTED|Phase 2||0
2866776|NCT00147537|3569812|FG001|STARTED|Phase 2||0
2866777|NCT00147537|3569813|FG002|STARTED|Phase 2||0
2866778|NCT00147537|3569814|FG003|STARTED|Phase 2||0
2866779|NCT00147537|3569815|FG004|STARTED|Phase 2||0
2866780|NCT00147537|3569816|FG005|STARTED|Phase 2||0
2866781|NCT00147537|3569817|FG006|STARTED|Phase 2||0
2866782|NCT00147537|3569818|FG007|STARTED|Phase 2||0
2866783|NCT00147537|3569819|FG008|STARTED|Phase 2||0
2866784|NCT00147537|3569820|FG009|STARTED|Phase 2|166 particpants randomized; 163 participants treated|166
2866785|NCT00147537|3569821|FG010|STARTED|Phase 2|55 randomized; 56 treated-1 randomized but not treated, 2 randomized to F+P+C rec'd P+C|55
2866786|NCT00147537|3569811|FG000|COMPLETED|Phase 2||0
2866787|NCT00147537|3569812|FG001|COMPLETED|Phase 2||0
2866788|NCT00147537|3569813|FG002|COMPLETED|Phase 2||0
2866789|NCT00147537|3569814|FG003|COMPLETED|Phase 2||0
2866790|NCT00147537|3569815|FG004|COMPLETED|Phase 2||0
2866791|NCT00147537|3569816|FG005|COMPLETED|Phase 2||0
2866792|NCT00147537|3569817|FG006|COMPLETED|Phase 2||0
2866793|NCT00147537|3569818|FG007|COMPLETED|Phase 2||0
2866794|NCT00147537|3569819|FG008|COMPLETED|Phase 2||0
2866795|NCT00147537|3569820|FG009|COMPLETED|Phase 2||5
2866796|NCT00147537|3569821|FG010|COMPLETED|Phase 2||3
2866797|NCT00147537|3569811|FG000|NOT COMPLETED|Phase 2||0
2866798|NCT00147537|3569812|FG001|NOT COMPLETED|Phase 2||0
2866799|NCT00147537|3569813|FG002|NOT COMPLETED|Phase 2||0
2866800|NCT00147537|3569814|FG003|NOT COMPLETED|Phase 2||0
2866801|NCT00147537|3569815|FG004|NOT COMPLETED|Phase 2||0
2866802|NCT00147537|3569816|FG005|NOT COMPLETED|Phase 2||0
2866803|NCT00147537|3569817|FG006|NOT COMPLETED|Phase 2||0
2866804|NCT00147537|3569818|FG007|NOT COMPLETED|Phase 2||0
2866805|NCT00147537|3569819|FG008|NOT COMPLETED|Phase 2||0
2866806|NCT00147537|3569820|FG009|NOT COMPLETED|Phase 2||161
2866807|NCT00147537|3569821|FG010|NOT COMPLETED|Phase 2||52
2866808|NCT00147745|3569869|FG000|STARTED|Overall Study||16
2866809|NCT00147745|3569870|FG001|STARTED|Overall Study||14
2866810|NCT00147745|3569871|FG002|STARTED|Overall Study||6
2866811|NCT00147745|3569869|FG000|COMPLETED|Overall Study||15
2866812|NCT00147745|3569870|FG001|COMPLETED|Overall Study||14
2866813|NCT00147745|3569871|FG002|COMPLETED|Overall Study||6
2866814|NCT00147745|3569869|FG000|NOT COMPLETED|Overall Study||1
2866815|NCT00147745|3569870|FG001|NOT COMPLETED|Overall Study||0
2866816|NCT00147745|3569871|FG002|NOT COMPLETED|Overall Study||0
2866817|NCT00147823|3569881|FG000|STARTED|Overall Study||32
2866818|NCT00147823|3569882|FG001|STARTED|Overall Study||31
2866819|NCT00147823|3569881|FG000|Week 6 Visit|Overall Study||26
2866820|NCT00147823|3569882|FG001|Week 6 Visit|Overall Study||28
2866821|NCT00147823|3569881|FG000|Month 3 Visit|Overall Study||25
2866822|NCT00147823|3569882|FG001|Month 3 Visit|Overall Study||24
2866823|NCT00147823|3569881|FG000|Month 6 Visit|Overall Study||25
2866824|NCT00147823|3569882|FG001|Month 6 Visit|Overall Study||21
2866825|NCT00147823|3569881|FG000|Month 12 Visit|Overall Study||21
2866826|NCT00147823|3569882|FG001|Month 12 Visit|Overall Study|Subjects are counted at each milestone as that is when data is collectec|25
2866827|NCT00147823|3569881|FG000|Month 12 CT Scan|Overall Study||20
2866828|NCT00147823|3569882|FG001|Month 12 CT Scan|Overall Study||25
2866829|NCT00147823|3569881|FG000|Month 18 Visit|Overall Study|As stated previously ea. subject is counted at each milestone, as data is collected at ea. timepoint|21
2866830|NCT00147823|3569882|FG001|Month 18 Visit|Overall Study||20
2866831|NCT00147823|3569881|FG000|Month 24 Visit|Overall Study||21
2866832|NCT00147823|3569882|FG001|Month 24 Visit|Overall Study||18
2866833|NCT00147823|3569881|FG000|COMPLETED|Overall Study||19
2866834|NCT00147823|3569882|FG001|COMPLETED|Overall Study||16
2866835|NCT00147823|3569881|FG000|NOT COMPLETED|Overall Study||13
2866836|NCT00147823|3569882|FG001|NOT COMPLETED|Overall Study||15
2866837|NCT00147966|3569888|FG000|STARTED|Overall Study||24
2866838|NCT00147966|3569888|FG000|COMPLETED|Overall Study||24
2866839|NCT00147966|3569888|FG000|NOT COMPLETED|Overall Study||0
2866840|NCT00148109|3569894|FG000|STARTED|Overall Study||15
2866841|NCT00148109|3569895|FG001|STARTED|Overall Study||21
2866842|NCT00148109|3569894|FG000|COMPLETED|Overall Study||3
2866843|NCT00148109|3569895|FG001|COMPLETED|Overall Study||1
2866844|NCT00148109|3569894|FG000|NOT COMPLETED|Overall Study||12
2866845|NCT00148109|3569895|FG001|NOT COMPLETED|Overall Study||20
2866846|NCT00148122|3569901|FG000|STARTED|Overall Study||40
2866847|NCT00148122|3569901|FG000|COMPLETED|Overall Study||38
2866848|NCT00148122|3569901|FG000|NOT COMPLETED|Overall Study||2
2866849|NCT00148317|3569905|FG000|STARTED|Consolidation (VEL + DEX)||38
2866850|NCT00148317|3569905|FG000|DOXIL Added at Cycle 3|Consolidation (VEL + DEX)||16
2866851|NCT00148317|3569905|FG000|DOXIL Added at Cycle 5|Consolidation (VEL + DEX)||12
2866852|NCT00148317|3569905|FG000|no DOXIL Added|Consolidation (VEL + DEX)||10
2866853|NCT00148317|3569905|FG000|COMPLETED|Consolidation (VEL + DEX)||38
2866854|NCT00148317|3569905|FG000|NOT COMPLETED|Consolidation (VEL + DEX)||0
2866855|NCT00148317|3569905|FG000|STARTED|Mobilization (VEL+CYTOXAN+FILGRASTIM)||38
2866856|NCT00148317|3569905|FG000|COMPLETED|Mobilization (VEL+CYTOXAN+FILGRASTIM)||27
2866857|NCT00148317|3569905|FG000|NOT COMPLETED|Mobilization (VEL+CYTOXAN+FILGRASTIM)||11
2866858|NCT00148343|3569914|FG000|STARTED|Overall Study||54
2866859|NCT00148343|3569915|FG001|STARTED|Overall Study||56
2866860|NCT00148343|3569914|FG000|COMPLETED|Overall Study||39
2866861|NCT00148343|3569915|FG001|COMPLETED|Overall Study||45
2866862|NCT00148343|3569914|FG000|NOT COMPLETED|Overall Study||15
2866863|NCT00148343|3569915|FG001|NOT COMPLETED|Overall Study||11
2866864|NCT00148668|3569923|FG000|STARTED|Overall Study||41
2866865|NCT00148668|3569924|FG001|STARTED|Overall Study||40
2866866|NCT00148668|3569923|FG000|COMPLETED|Overall Study||41
2866867|NCT00148668|3569924|FG001|COMPLETED|Overall Study||40
2866868|NCT00148668|3569923|FG000|NOT COMPLETED|Overall Study||0
2866869|NCT00148668|3569924|FG001|NOT COMPLETED|Overall Study||0
2866870|NCT00148733|3569932|FG000|STARTED|Overall Study||1314
2866871|NCT00148733|3569933|FG001|STARTED|Overall Study||1314
2866872|NCT00148733|3569932|FG000|COMPLETED|Overall Study||1300
2866873|NCT00148733|3569933|FG001|COMPLETED|Overall Study||1299
2866874|NCT00148733|3569932|FG000|NOT COMPLETED|Overall Study||14
2866875|NCT00148733|3569933|FG001|NOT COMPLETED|Overall Study||15
2866876|NCT00148759|3569941|FG000|STARTED|Overall Study||11
2866877|NCT00148759|3569942|FG001|STARTED|Overall Study||12
2866878|NCT00148759|3569941|FG000|24-hr PK Sampling|Overall Study||9
2866879|NCT00148759|3569942|FG001|24-hr PK Sampling|Overall Study||11
2866880|NCT00148759|3569941|FG000|COMPLETED|Overall Study||9
2866881|NCT00148759|3569942|FG001|COMPLETED|Overall Study||11
2866882|NCT00148759|3569941|FG000|NOT COMPLETED|Overall Study||2
2866883|NCT00148759|3569942|FG001|NOT COMPLETED|Overall Study||1
2866884|NCT00148798|3569950|FG000|STARTED|Overall Study|Intent To Treat (ITT) Population|557
2866885|NCT00148798|3569951|FG001|STARTED|Overall Study|ITT Population|568
2866886|NCT00148798|3569950|FG000|COMPLETED|Overall Study||557
2866887|NCT00148798|3569951|FG001|COMPLETED|Overall Study||568
2866888|NCT00148798|3569950|FG000|NOT COMPLETED|Overall Study||0
2866889|NCT00148798|3569951|FG001|NOT COMPLETED|Overall Study||0
2866890|NCT00148941|3569963|FG000|STARTED|Overall Study||1053
2866891|NCT00148941|3569964|FG001|STARTED|Overall Study||1051
2866892|NCT00148941|3569965|FG002|STARTED|Overall Study||1052
2866893|NCT00148941|3569966|FG003|STARTED|Overall Study||1053
2866894|NCT00148941|3569963|FG000|COMPLETED|Overall Study||1035
2866895|NCT00148941|3569964|FG001|COMPLETED|Overall Study||1027
2866896|NCT00148941|3569965|FG002|COMPLETED|Overall Study||1032
2866897|NCT00148941|3569966|FG003|COMPLETED|Overall Study||1029
2866898|NCT00148941|3569963|FG000|NOT COMPLETED|Overall Study||18
2866899|NCT00148941|3569964|FG001|NOT COMPLETED|Overall Study||24
2866900|NCT00148941|3569965|FG002|NOT COMPLETED|Overall Study||20
2866901|NCT00148941|3569966|FG003|NOT COMPLETED|Overall Study||24
2866902|NCT00148954|3569978|FG000|STARTED|Overall Study||985
2866903|NCT00148954|3569979|FG001|STARTED|Overall Study||977
2866904|NCT00148954|3569978|FG000|COMPLETED|Overall Study||678
2866905|NCT00148954|3569979|FG001|COMPLETED|Overall Study||677
2866906|NCT00148954|3569978|FG000|NOT COMPLETED|Overall Study||307
2866907|NCT00148954|3569979|FG001|NOT COMPLETED|Overall Study||300
2866908|NCT00149214|3569987|FG000|STARTED|Overall Study|One patient randomized to Pemetrexed (P) was treated with Cyclophosphamide (C).|135
2866909|NCT00149214|3569988|FG001|STARTED|Overall Study||122
2866910|NCT00149214|3569987|FG000|COMPLETED|Overall Study|The patient treated with Cyclophosphamide (C) was included in that arm (C) for safety analysis.|109
2866911|NCT00149214|3569988|FG001|COMPLETED|Overall Study||105
2866912|NCT00149214|3569987|FG000|NOT COMPLETED|Overall Study||26
2866913|NCT00149214|3569988|FG001|NOT COMPLETED|Overall Study||17
2866914|NCT00149227|3569996|FG000|STARTED|Overall Study||1517
2866915|NCT00149227|3569997|FG001|STARTED|Overall Study||1514
2866916|NCT00149227|3569996|FG000|COMPLETED|Overall Study||1517
2866917|NCT00149227|3569997|FG001|COMPLETED|Overall Study||1514
2866918|NCT00149227|3569996|FG000|NOT COMPLETED|Overall Study||0
2866919|NCT00149227|3569997|FG001|NOT COMPLETED|Overall Study||0
2866920|NCT00149396|3570003|FG000|STARTED|Overall Study||32
2866921|NCT00149396|3570003|FG000|Completed NV1020 Therapy|Overall Study||29
2866922|NCT00149396|3570003|FG000|Completed NV1020 and Chemotherapy|Overall Study||9
2866923|NCT00149396|3570003|FG000|COMPLETED|Overall Study||9
2866924|NCT00149396|3570003|FG000|NOT COMPLETED|Overall Study||23
2866925|NCT00149630|3570016|FG000|STARTED|Overall Study||34
2866926|NCT00149630|3570017|FG001|STARTED|Overall Study||40
2866927|NCT00149630|3570016|FG000|COMPLETED|Overall Study||26
2866928|NCT00149630|3570017|FG001|COMPLETED|Overall Study||35
2866929|NCT00149630|3570016|FG000|NOT COMPLETED|Overall Study||8
2866930|NCT00149630|3570017|FG001|NOT COMPLETED|Overall Study||5
2866931|NCT00149643|3570029|FG000|STARTED|Overall Study||34
2866932|NCT00149643|3570030|FG001|STARTED|Overall Study||36
2866933|NCT00149643|3570029|FG000|COMPLETED|Overall Study||0
2866934|NCT00149643|3570030|FG001|COMPLETED|Overall Study||0
2866935|NCT00149643|3570029|FG000|NOT COMPLETED|Overall Study||34
2866936|NCT00149643|3570030|FG001|NOT COMPLETED|Overall Study||36
2866937|NCT00149669|3570038|FG000|STARTED|Overall Study||32
2866938|NCT00149669|3570039|FG001|STARTED|Overall Study||35
2866939|NCT00149669|3570038|FG000|COMPLETED|Overall Study||29
2866940|NCT00149669|3570039|FG001|COMPLETED|Overall Study||30
2866941|NCT00149669|3570038|FG000|NOT COMPLETED|Overall Study||3
2866942|NCT00149669|3570039|FG001|NOT COMPLETED|Overall Study||5
2866943|NCT00149734|3570047|FG000|STARTED|Overall Study||4
2866944|NCT00149734|3570048|FG001|STARTED|Overall Study||4
2866945|NCT00149734|3570047|FG000|Started Intervention 2|Overall Study||4
2866946|NCT00149734|3570048|FG001|Started Intervention 2|Overall Study||4
2866947|NCT00149734|3570047|FG000|COMPLETED|Overall Study||4
2866948|NCT00149734|3570048|FG001|COMPLETED|Overall Study||4
2866949|NCT00149734|3570047|FG000|NOT COMPLETED|Overall Study||0
2866950|NCT00149734|3570048|FG001|NOT COMPLETED|Overall Study||0
2866951|NCT00149747|3570056|FG000|STARTED|Overall Study||36
2866952|NCT00149747|3570057|FG001|STARTED|Overall Study||30
2866953|NCT00149747|3570056|FG000|COMPLETED|Overall Study||32
2866954|NCT00149747|3570057|FG001|COMPLETED|Overall Study||27
2866955|NCT00149747|3570056|FG000|NOT COMPLETED|Overall Study||4
2866956|NCT00149747|3570057|FG001|NOT COMPLETED|Overall Study||3
2866957|NCT00149799|3570065|FG000|STARTED|Open Label Escitalopram (Phase I)||100
2866958|NCT00149799|3570066|FG001|STARTED|Open Label Escitalopram (Phase I)||0
2866959|NCT00149799|3570067|FG002|STARTED|Open Label Escitalopram (Phase I)||0
2866960|NCT00149799|3570065|FG000|COMPLETED|Open Label Escitalopram (Phase I)|14 completers were non-responders and 2 responders terminated the study after completing Phase I|74
2866961|NCT00149799|3570066|FG001|COMPLETED|Open Label Escitalopram (Phase I)||0
2866962|NCT00149799|3570067|FG002|COMPLETED|Open Label Escitalopram (Phase I)||0
2866963|NCT00149799|3570065|FG000|NOT COMPLETED|Open Label Escitalopram (Phase I)||26
2866964|NCT00149799|3570066|FG001|NOT COMPLETED|Open Label Escitalopram (Phase I)||0
2866965|NCT00149799|3570067|FG002|NOT COMPLETED|Open Label Escitalopram (Phase I)||0
2866966|NCT00149799|3570065|FG000|STARTED|Discontinuation (Phase II)||0
2866967|NCT00149799|3570066|FG001|STARTED|Discontinuation (Phase II)|Only responders who completed Phase I and were willing to continue were randomized in Phase II|28
2866968|NCT00149799|3570067|FG002|STARTED|Discontinuation (Phase II)|Only responders who completed Phase I and were willing to continue were randomized in Phase II|30
2866969|NCT00149799|3570065|FG000|COMPLETED|Discontinuation (Phase II)||0
3169345|NCT01924767|3896857|FG003|COMPLETED|Overall Study||9
3169346|NCT01924767|3896858|FG004|COMPLETED|Overall Study||9
3169347|NCT01924767|3896854|FG000|NOT COMPLETED|Overall Study||1
3169348|NCT01924767|3896855|FG001|NOT COMPLETED|Overall Study||0
2866970|NCT00149799|3570066|FG001|COMPLETED|Discontinuation (Phase II)||25
2866971|NCT00149799|3570067|FG002|COMPLETED|Discontinuation (Phase II)||21
2866972|NCT00149799|3570065|FG000|NOT COMPLETED|Discontinuation (Phase II)||0
2866973|NCT00149799|3570066|FG001|NOT COMPLETED|Discontinuation (Phase II)||3
2866974|NCT00149799|3570067|FG002|NOT COMPLETED|Discontinuation (Phase II)||9
2866975|NCT00149825|3570077|FG000|STARTED|Overall Study||15
2866976|NCT00149825|3570078|FG001|STARTED|Overall Study||15
2866977|NCT00149825|3570077|FG000|COMPLETED|Overall Study||10
2866978|NCT00149825|3570078|FG001|COMPLETED|Overall Study||12
2866979|NCT00149825|3570077|FG000|NOT COMPLETED|Overall Study||5
2866980|NCT00149825|3570078|FG001|NOT COMPLETED|Overall Study||3
2866981|NCT00149838|3570086|FG000|STARTED|Phase I||92
2866982|NCT00149838|3570087|FG001|STARTED|Phase I||98
2866983|NCT00149838|3570088|FG002|STARTED|Phase I||0
2866984|NCT00149838|3570089|FG003|STARTED|Phase I||0
2866985|NCT00149838|3570086|FG000|COMPLETED|Phase I||72
2866986|NCT00149838|3570087|FG001|COMPLETED|Phase I||82
2866987|NCT00149838|3570088|FG002|COMPLETED|Phase I||0
2866988|NCT00149838|3570089|FG003|COMPLETED|Phase I||0
2866989|NCT00149838|3570086|FG000|NOT COMPLETED|Phase I||20
2866990|NCT00149838|3570087|FG001|NOT COMPLETED|Phase I||16
2866991|NCT00149838|3570088|FG002|NOT COMPLETED|Phase I||0
2866992|NCT00149838|3570089|FG003|NOT COMPLETED|Phase I||0
2866993|NCT00149838|3570086|FG000|STARTED|Phase II||0
2866994|NCT00149838|3570087|FG001|STARTED|Phase II||0
2866995|NCT00149838|3570088|FG002|STARTED|Phase II||144
2866996|NCT00149838|3570089|FG003|STARTED|Phase II||0
2866997|NCT00149838|3570086|FG000|COMPLETED|Phase II||0
2866998|NCT00149838|3570087|FG001|COMPLETED|Phase II||0
2866999|NCT00149838|3570088|FG002|COMPLETED|Phase II||144
2867000|NCT00149838|3570089|FG003|COMPLETED|Phase II||0
2867001|NCT00149838|3570086|FG000|NOT COMPLETED|Phase II||0
2867002|NCT00149838|3570087|FG001|NOT COMPLETED|Phase II||0
2867003|NCT00149838|3570088|FG002|NOT COMPLETED|Phase II||0
2867004|NCT00149838|3570089|FG003|NOT COMPLETED|Phase II||0
2867005|NCT00149838|3570086|FG000|STARTED|Phase III||0
2867006|NCT00149838|3570087|FG001|STARTED|Phase III||0
2867007|NCT00149838|3570088|FG002|STARTED|Phase III||0
2867008|NCT00149838|3570089|FG003|STARTED|Phase III||61
2867009|NCT00149838|3570086|FG000|COMPLETED|Phase III||0
2867010|NCT00149838|3570087|FG001|COMPLETED|Phase III||0
2867011|NCT00149838|3570088|FG002|COMPLETED|Phase III||0
2867012|NCT00149838|3570089|FG003|COMPLETED|Phase III||37
2867013|NCT00149838|3570086|FG000|NOT COMPLETED|Phase III||0
2867014|NCT00149838|3570087|FG001|NOT COMPLETED|Phase III||0
2867015|NCT00149838|3570088|FG002|NOT COMPLETED|Phase III||0
2867016|NCT00149838|3570089|FG003|NOT COMPLETED|Phase III||24
2867017|NCT00149890|3570101|FG000|STARTED|Overall Study|"Started indicates all screened and treated participants."|39
2867018|NCT00149890|3570102|FG001|STARTED|Overall Study||38
2867019|NCT00149890|3570101|FG000|COMPLETED|Overall Study||26
2867020|NCT00149890|3570102|FG001|COMPLETED|Overall Study||20
2867021|NCT00149890|3570101|FG000|NOT COMPLETED|Overall Study||13
2867022|NCT00149890|3570102|FG001|NOT COMPLETED|Overall Study||18
2867023|NCT00149994|3570110|FG000|STARTED|Overall Study|"Started indicates Safety population."|85
2867024|NCT00149994|3570111|FG001|STARTED|Overall Study||86
2867025|NCT00149994|3570110|FG000|COMPLETED|Overall Study|"Completed indicates intention to treat (ITT) population."|84
2867026|NCT00149994|3570111|FG001|COMPLETED|Overall Study||85
2867027|NCT00149994|3570110|FG000|NOT COMPLETED|Overall Study||1
2867028|NCT00149994|3570111|FG001|NOT COMPLETED|Overall Study||1
2867029|NCT00150345|3570119|FG000|STARTED|Overall Study||81
2867030|NCT00150345|3570120|FG001|STARTED|Overall Study||66
2867031|NCT00150345|3570119|FG000|COMPLETED|Overall Study||47
2867032|NCT00150345|3570120|FG001|COMPLETED|Overall Study||34
2867033|NCT00150345|3570119|FG000|NOT COMPLETED|Overall Study||34
2867034|NCT00150345|3570120|FG001|NOT COMPLETED|Overall Study||32
2867035|NCT00150462|3570138|FG000|STARTED|Overall Study||3
2867036|NCT00150462|3570139|FG001|STARTED|Overall Study||3
2867037|NCT00150462|3570140|FG002|STARTED|Overall Study||4
2867038|NCT00150462|3570141|FG003|STARTED|Overall Study||3
2867039|NCT00150462|3570142|FG004|STARTED|Overall Study||3
2867040|NCT00150462|3570143|FG005|STARTED|Overall Study||4
2867041|NCT00150462|3570144|FG006|STARTED|Overall Study||3
2867042|NCT00150462|3570145|FG007|STARTED|Overall Study||8
2867043|NCT00150462|3570146|FG008|STARTED|Overall Study||6
2867044|NCT00150462|3570147|FG009|STARTED|Overall Study||7
2867045|NCT00150462|3570148|FG010|STARTED|Overall Study||4
2867046|NCT00150462|3570138|FG000|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
2867047|NCT00150462|3570139|FG001|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
2867048|NCT00150462|3570140|FG002|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
2867049|NCT00150462|3570141|FG003|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
2867050|NCT00150462|3570142|FG004|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
2867051|NCT00150462|3570143|FG005|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
3169349|NCT01924767|3896856|FG002|NOT COMPLETED|Overall Study||1
2867052|NCT00150462|3570144|FG006|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
2867053|NCT00150462|3570145|FG007|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
2867054|NCT00150462|3570146|FG008|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
2867055|NCT00150462|3570147|FG009|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of treatment.|1
2867056|NCT00150462|3570148|FG010|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of treatment.|1
2867057|NCT00150462|3570138|FG000|NOT COMPLETED|Overall Study||3
2867058|NCT00150462|3570139|FG001|NOT COMPLETED|Overall Study||3
2867059|NCT00150462|3570140|FG002|NOT COMPLETED|Overall Study||4
2867060|NCT00150462|3570141|FG003|NOT COMPLETED|Overall Study||3
2867061|NCT00150462|3570142|FG004|NOT COMPLETED|Overall Study||3
2867062|NCT00150462|3570143|FG005|NOT COMPLETED|Overall Study||4
2867063|NCT00150462|3570144|FG006|NOT COMPLETED|Overall Study||3
2867064|NCT00150462|3570145|FG007|NOT COMPLETED|Overall Study||8
2867065|NCT00150462|3570146|FG008|NOT COMPLETED|Overall Study||6
2867066|NCT00150462|3570147|FG009|NOT COMPLETED|Overall Study||6
2867067|NCT00150462|3570148|FG010|NOT COMPLETED|Overall Study||3
2867068|NCT00150592|3570177|FG000|STARTED|Overall Study||121
2867069|NCT00150592|3570178|FG001|STARTED|Overall Study||57
2867070|NCT00150592|3570177|FG000|COMPLETED|Overall Study||114
2867071|NCT00150592|3570178|FG001|COMPLETED|Overall Study||54
2867072|NCT00150592|3570177|FG000|NOT COMPLETED|Overall Study||7
2867073|NCT00150592|3570178|FG001|NOT COMPLETED|Overall Study||3
2867074|NCT00150618|3570189|FG000|STARTED|Overall Study||62
2867075|NCT00150618|3570190|FG001|STARTED|Overall Study||65
2867076|NCT00150618|3570191|FG002|STARTED|Overall Study||65
2867077|NCT00150618|3570192|FG003|STARTED|Overall Study||66
2867078|NCT00150618|3570193|FG004|STARTED|Overall Study||66
2867079|NCT00150618|3570189|FG000|COMPLETED|Overall Study||45
2867080|NCT00150618|3570190|FG001|COMPLETED|Overall Study||47
2867081|NCT00150618|3570191|FG002|COMPLETED|Overall Study||38
2867082|NCT00150618|3570192|FG003|COMPLETED|Overall Study||40
2867083|NCT00150618|3570193|FG004|COMPLETED|Overall Study||41
2867084|NCT00150618|3570189|FG000|NOT COMPLETED|Overall Study||17
3313484|NCT03075410|4046798|FG007|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
3313485|NCT03075410|4046799|FG008|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
3313486|NCT03075410|4046791|FG000|STARTED|Part A-Period 4 (14 Days)||1
3313487|NCT03075410|4046792|FG001|STARTED|Part A-Period 4 (14 Days)||1
3313488|NCT03075410|4046793|FG002|STARTED|Part A-Period 4 (14 Days)||2
2867085|NCT00150618|3570190|FG001|NOT COMPLETED|Overall Study||18
2867086|NCT00150618|3570191|FG002|NOT COMPLETED|Overall Study||27
2867087|NCT00150618|3570192|FG003|NOT COMPLETED|Overall Study||26
2867088|NCT00150618|3570193|FG004|NOT COMPLETED|Overall Study||25
2867089|NCT00150800|3570205|FG000|STARTED|Overall Study||667
2867090|NCT00150800|3570205|FG000|COMPLETED|Overall Study||171
2867091|NCT00150800|3570205|FG000|NOT COMPLETED|Overall Study||496
2867092|NCT00150813|3570210|FG000|STARTED|Overall Study||66
2867093|NCT00150813|3570210|FG000|COMPLETED|Overall Study||48
2867094|NCT00150813|3570210|FG000|NOT COMPLETED|Overall Study||18
2918659|NCT00528372|3628893|FG002|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||8
2918660|NCT00528372|3628894|FG003|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||14
2918661|NCT00528372|3628895|FG004|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||21
2918662|NCT00528372|3628896|FG005|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||15
2918663|NCT00528372|3628897|FG006|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||17
2918664|NCT00528372|3628898|FG007|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||6
2918665|NCT00528372|3628899|FG008|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||6
3169350|NCT01924767|3896857|FG003|NOT COMPLETED|Overall Study||0
3169351|NCT01924767|3896858|FG004|NOT COMPLETED|Overall Study||0
3169352|NCT01924806|3896877|FG000|STARTED|Overall Study||5
3169353|NCT01924806|3896878|FG001|STARTED|Overall Study||4
3169354|NCT01924806|3896877|FG000|COMPLETED|Overall Study||3
2918666|NCT00528398|3628945|FG000|STARTED|Overall Study||111
2918667|NCT00528398|3628945|FG000|COMPLETED|Overall Study||111
2918668|NCT00528398|3628945|FG000|NOT COMPLETED|Overall Study||0
2918669|NCT00528411|3628952|FG000|STARTED|Overall Study||57
2918670|NCT00528411|3628953|FG001|STARTED|Overall Study||54
2918671|NCT00528411|3628954|FG002|STARTED|Overall Study||12
2918672|NCT00528411|3628952|FG000|COMPLETED|Overall Study||52
2918673|NCT00528411|3628953|FG001|COMPLETED|Overall Study||51
2918674|NCT00528411|3628954|FG002|COMPLETED|Overall Study||11
2918675|NCT00528411|3628952|FG000|NOT COMPLETED|Overall Study||5
2918676|NCT00528411|3628953|FG001|NOT COMPLETED|Overall Study||3
2918677|NCT00528411|3628954|FG002|NOT COMPLETED|Overall Study||1
2918678|NCT00528424|3628962|FG000|STARTED|Overall Study||286
2918679|NCT00528424|3628962|FG000|COMPLETED|Overall Study||257
2918680|NCT00528424|3628962|FG000|NOT COMPLETED|Overall Study||29
2918681|NCT00528450|3628966|FG000|STARTED|Overall Study||1
2918682|NCT00528450|3628966|FG000|COMPLETED|Overall Study||1
2918683|NCT00528450|3628966|FG000|NOT COMPLETED|Overall Study||0
2918684|NCT00528528|3628974|FG000|STARTED|Overall Study||40
2918685|NCT00528528|3628975|FG001|STARTED|Overall Study||42
2918686|NCT00528528|3628976|FG002|STARTED|Overall Study||40
2918687|NCT00528528|3628977|FG003|STARTED|Overall Study||39
2918688|NCT00528528|3628974|FG000|Ongoing at Time of Cut-off|Overall Study||0
2918689|NCT00528528|3628975|FG001|Ongoing at Time of Cut-off|Overall Study||0
2918690|NCT00528528|3628976|FG002|Ongoing at Time of Cut-off|Overall Study||1
3169355|NCT01924806|3896878|FG001|COMPLETED|Overall Study||3
2867095|NCT00150969|3570216|FG000|STARTED|24 Month Main Study||217
2867096|NCT00150969|3570217|FG001|STARTED|24 Month Main Study||223
2867097|NCT00150969|3570216|FG000|COMPLETED|24 Month Main Study||198
2867098|NCT00150969|3570217|FG001|COMPLETED|24 Month Main Study||202
2867099|NCT00150969|3570216|FG000|NOT COMPLETED|24 Month Main Study||19
2867100|NCT00150969|3570217|FG001|NOT COMPLETED|24 Month Main Study||21
2867101|NCT00150969|3570216|FG000|STARTED|24-48 Month Extension||121
2867102|NCT00150969|3570217|FG001|STARTED|24-48 Month Extension||140
2867103|NCT00150969|3570216|FG000|COMPLETED|24-48 Month Extension||33
2867104|NCT00150969|3570217|FG001|COMPLETED|24-48 Month Extension||40
2867105|NCT00150969|3570216|FG000|NOT COMPLETED|24-48 Month Extension||88
2867106|NCT00150969|3570217|FG001|NOT COMPLETED|24-48 Month Extension||100
2867107|NCT00151281|3570224|FG000|STARTED|Overall Study||25
2867108|NCT00151281|3570224|FG000|COMPLETED|Overall Study||22
2867109|NCT00151281|3570224|FG000|NOT COMPLETED|Overall Study||3
2867110|NCT00151320|3570231|FG000|STARTED|Overall Study||76
2867111|NCT00151320|3570231|FG000|COMPLETED|Overall Study||76
2867112|NCT00151320|3570231|FG000|NOT COMPLETED|Overall Study||0
2867113|NCT00151372|3570238|FG000|STARTED|Overall Study||67
2867114|NCT00151372|3570239|FG001|STARTED|Overall Study||74
2867115|NCT00151372|3570238|FG000|COMPLETED|Overall Study||38
2867116|NCT00151372|3570239|FG001|COMPLETED|Overall Study||45
2867117|NCT00151372|3570238|FG000|NOT COMPLETED|Overall Study||29
2867118|NCT00151372|3570239|FG001|NOT COMPLETED|Overall Study||29
2867119|NCT00151411|3570247|FG000|STARTED|Overall Study||55
2867120|NCT00151411|3570248|FG001|STARTED|Overall Study||59
2867121|NCT00151411|3570247|FG000|COMPLETED|Overall Study||22
2867122|NCT00151411|3570248|FG001|COMPLETED|Overall Study||16
2867123|NCT00151411|3570247|FG000|NOT COMPLETED|Overall Study||33
2867124|NCT00151411|3570248|FG001|NOT COMPLETED|Overall Study||43
2867125|NCT00151476|3570257|FG000|STARTED|FAP Identified Subjects||13
2867126|NCT00151476|3570258|FG001|STARTED|FAP Identified Subjects||55
2867127|NCT00151476|3570257|FG000|COMPLETED|FAP Identified Subjects||13
2867128|NCT00151476|3570258|FG001|COMPLETED|FAP Identified Subjects||54
2867129|NCT00151476|3570257|FG000|NOT COMPLETED|FAP Identified Subjects||0
3169356|NCT01924806|3896877|FG000|NOT COMPLETED|Overall Study||2
3169357|NCT01924806|3896878|FG001|NOT COMPLETED|Overall Study||1
3169358|NCT01924845|3896884|FG000|STARTED|Overall Study||24
3169359|NCT01924845|3896884|FG000|COMPLETED|Overall Study||18
3169360|NCT01924845|3896884|FG000|NOT COMPLETED|Overall Study||6
3169361|NCT01924871|3896890|FG000|STARTED|Overall Study||31
3169362|NCT01924871|3896891|FG001|STARTED|Overall Study||31
3169363|NCT01924871|3896890|FG000|COMPLETED|Overall Study||25
2867130|NCT00151476|3570258|FG001|NOT COMPLETED|FAP Identified Subjects||1
2867131|NCT00151476|3570257|FG000|STARTED|FAP Analyzed Subjects||13
2867132|NCT00151476|3570258|FG001|STARTED|FAP Analyzed Subjects||54
2867133|NCT00151476|3570257|FG000|COMPLETED|FAP Analyzed Subjects||13
2867134|NCT00151476|3570258|FG001|COMPLETED|FAP Analyzed Subjects||51
2867135|NCT00151476|3570257|FG000|NOT COMPLETED|FAP Analyzed Subjects||0
2867136|NCT00151476|3570258|FG001|NOT COMPLETED|FAP Analyzed Subjects||3
2867137|NCT00151775|3570270|FG000|STARTED|Period 2 - Double-Blind Dose Response||95
2867138|NCT00151775|3570271|FG001|STARTED|Period 2 - Double-Blind Dose Response||95
2867139|NCT00151775|3570272|FG002|STARTED|Period 2 - Double-Blind Dose Response||0
2867140|NCT00151775|3570273|FG003|STARTED|Period 2 - Double-Blind Dose Response||0
2867141|NCT00151775|3570274|FG004|STARTED|Period 2 - Double-Blind Dose Response||0
2867142|NCT00151775|3570275|FG005|STARTED|Period 2 - Double-Blind Dose Response||56
2867143|NCT00151775|3570276|FG006|STARTED|Period 2 - Double-Blind Dose Response||56
2867144|NCT00151775|3570277|FG007|STARTED|Period 2 - Double-Blind Dose Response||0
3169364|NCT01924871|3896891|FG001|COMPLETED|Overall Study||29
3169365|NCT01924871|3896890|FG000|NOT COMPLETED|Overall Study||6
3169366|NCT01924871|3896891|FG001|NOT COMPLETED|Overall Study||2
3169367|NCT01924949|3896897|FG000|STARTED|Overall Study||5
3169368|NCT01924949|3896897|FG000|COMPLETED|Overall Study||5
3169369|NCT01924949|3896897|FG000|NOT COMPLETED|Overall Study||0
3169370|NCT01924975|3896903|FG000|STARTED|Overall Study||51
3169371|NCT01924975|3896904|FG001|STARTED|Overall Study||51
3169372|NCT01924975|3896903|FG000|COMPLETED|Overall Study||51
3169373|NCT01924975|3896904|FG001|COMPLETED|Overall Study||51
3169374|NCT01924975|3896903|FG000|NOT COMPLETED|Overall Study||0
2867145|NCT00151775|3570278|FG008|STARTED|Period 2 - Double-Blind Dose Response||0
2867146|NCT00151775|3570279|FG009|STARTED|Period 2 - Double-Blind Dose Response||0
2867147|NCT00151775|3570280|FG010|STARTED|Period 2 - Double-Blind Dose Response||60
2867148|NCT00151775|3570281|FG011|STARTED|Period 2 - Double-Blind Dose Response||0
2867149|NCT00151775|3570270|FG000|COMPLETED|Period 2 - Double-Blind Dose Response||93
2867150|NCT00151775|3570271|FG001|COMPLETED|Period 2 - Double-Blind Dose Response||89
2867151|NCT00151775|3570272|FG002|COMPLETED|Period 2 - Double-Blind Dose Response||0
2867152|NCT00151775|3570273|FG003|COMPLETED|Period 2 - Double-Blind Dose Response||0
2867153|NCT00151775|3570274|FG004|COMPLETED|Period 2 - Double-Blind Dose Response||0
2867154|NCT00151775|3570275|FG005|COMPLETED|Period 2 - Double-Blind Dose Response||54
2867155|NCT00151775|3570276|FG006|COMPLETED|Period 2 - Double-Blind Dose Response||53
2867156|NCT00151775|3570277|FG007|COMPLETED|Period 2 - Double-Blind Dose Response||0
2867157|NCT00151775|3570278|FG008|COMPLETED|Period 2 - Double-Blind Dose Response||0
2867158|NCT00151775|3570279|FG009|COMPLETED|Period 2 - Double-Blind Dose Response||0
2867159|NCT00151775|3570280|FG010|COMPLETED|Period 2 - Double-Blind Dose Response||59
3169375|NCT01924975|3896904|FG001|NOT COMPLETED|Overall Study||0
3169376|NCT01924988|3896910|FG000|STARTED|Overall Study||15
2867160|NCT00151775|3570281|FG011|COMPLETED|Period 2 - Double-Blind Dose Response||0
2867161|NCT00151775|3570270|FG000|NOT COMPLETED|Period 2 - Double-Blind Dose Response||2
2867162|NCT00151775|3570271|FG001|NOT COMPLETED|Period 2 - Double-Blind Dose Response||6
2867163|NCT00151775|3570272|FG002|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
2867164|NCT00151775|3570273|FG003|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
2867165|NCT00151775|3570274|FG004|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
2867166|NCT00151775|3570275|FG005|NOT COMPLETED|Period 2 - Double-Blind Dose Response||2
2867167|NCT00151775|3570276|FG006|NOT COMPLETED|Period 2 - Double-Blind Dose Response||3
2867168|NCT00151775|3570277|FG007|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
2867169|NCT00151775|3570278|FG008|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
2867170|NCT00151775|3570279|FG009|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
2867171|NCT00151775|3570280|FG010|NOT COMPLETED|Period 2 - Double-Blind Dose Response||1
2867172|NCT00151775|3570281|FG011|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
2867173|NCT00151775|3570270|FG000|STARTED|Period 3: Double-blind, Withdrawal||48
2867174|NCT00151775|3570271|FG001|STARTED|Period 3: Double-blind, Withdrawal||45
2867175|NCT00151775|3570272|FG002|STARTED|Period 3: Double-blind, Withdrawal||45
2867176|NCT00151775|3570273|FG003|STARTED|Period 3: Double-blind, Withdrawal||44
2867177|NCT00151775|3570274|FG004|STARTED|Period 3: Double-blind, Withdrawal||0
2867178|NCT00151775|3570275|FG005|STARTED|Period 3: Double-blind, Withdrawal||26
2867179|NCT00151775|3570276|FG006|STARTED|Period 3: Double-blind, Withdrawal||27
2867180|NCT00151775|3570277|FG007|STARTED|Period 3: Double-blind, Withdrawal||28
2867181|NCT00151775|3570278|FG008|STARTED|Period 3: Double-blind, Withdrawal||26
2867182|NCT00151775|3570279|FG009|STARTED|Period 3: Double-blind, Withdrawal||0
2867183|NCT00151775|3570280|FG010|STARTED|Period 3: Double-blind, Withdrawal||29
2867184|NCT00151775|3570281|FG011|STARTED|Period 3: Double-blind, Withdrawal||29
2867185|NCT00151775|3570270|FG000|COMPLETED|Period 3: Double-blind, Withdrawal||48
2867186|NCT00151775|3570271|FG001|COMPLETED|Period 3: Double-blind, Withdrawal||45
2867187|NCT00151775|3570272|FG002|COMPLETED|Period 3: Double-blind, Withdrawal||42
2867188|NCT00151775|3570273|FG003|COMPLETED|Period 3: Double-blind, Withdrawal||44
2867189|NCT00151775|3570274|FG004|COMPLETED|Period 3: Double-blind, Withdrawal||0
2867190|NCT00151775|3570275|FG005|COMPLETED|Period 3: Double-blind, Withdrawal||25
2867191|NCT00151775|3570276|FG006|COMPLETED|Period 3: Double-blind, Withdrawal||26
2867192|NCT00151775|3570277|FG007|COMPLETED|Period 3: Double-blind, Withdrawal||27
2867193|NCT00151775|3570278|FG008|COMPLETED|Period 3: Double-blind, Withdrawal||26
2867194|NCT00151775|3570279|FG009|COMPLETED|Period 3: Double-blind, Withdrawal||0
2867195|NCT00151775|3570280|FG010|COMPLETED|Period 3: Double-blind, Withdrawal||29
2867196|NCT00151775|3570281|FG011|COMPLETED|Period 3: Double-blind, Withdrawal||28
2867197|NCT00151775|3570270|FG000|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
2867198|NCT00151775|3570271|FG001|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
2867199|NCT00151775|3570272|FG002|NOT COMPLETED|Period 3: Double-blind, Withdrawal||3
2867200|NCT00151775|3570273|FG003|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
2867201|NCT00151775|3570274|FG004|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
2867202|NCT00151775|3570275|FG005|NOT COMPLETED|Period 3: Double-blind, Withdrawal||1
2867203|NCT00151775|3570276|FG006|NOT COMPLETED|Period 3: Double-blind, Withdrawal||1
2867204|NCT00151775|3570277|FG007|NOT COMPLETED|Period 3: Double-blind, Withdrawal||1
2867205|NCT00151775|3570278|FG008|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
2867206|NCT00151775|3570279|FG009|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
2867207|NCT00151775|3570280|FG010|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
2867208|NCT00151775|3570281|FG011|NOT COMPLETED|Period 3: Double-blind, Withdrawal||1
2867209|NCT00151775|3570270|FG000|STARTED|Period 4: Open Label||0
2867210|NCT00151775|3570271|FG001|STARTED|Period 4: Open Label||0
2867211|NCT00151775|3570272|FG002|STARTED|Period 4: Open Label||0
2867212|NCT00151775|3570273|FG003|STARTED|Period 4: Open Label||0
2867213|NCT00151775|3570274|FG004|STARTED|Period 4: Open Label||179
2867214|NCT00151775|3570275|FG005|STARTED|Period 4: Open Label||0
2867215|NCT00151775|3570276|FG006|STARTED|Period 4: Open Label||0
2867216|NCT00151775|3570277|FG007|STARTED|Period 4: Open Label||0
2867217|NCT00151775|3570278|FG008|STARTED|Period 4: Open Label||0
2867218|NCT00151775|3570279|FG009|STARTED|Period 4: Open Label||104
2867219|NCT00151775|3570280|FG010|STARTED|Period 4: Open Label||57
2867220|NCT00151775|3570281|FG011|STARTED|Period 4: Open Label||0
2867221|NCT00151775|3570270|FG000|COMPLETED|Period 4: Open Label||0
2867222|NCT00151775|3570271|FG001|COMPLETED|Period 4: Open Label||0
2867223|NCT00151775|3570272|FG002|COMPLETED|Period 4: Open Label||0
2867224|NCT00151775|3570273|FG003|COMPLETED|Period 4: Open Label||0
2867225|NCT00151775|3570274|FG004|COMPLETED|Period 4: Open Label||149
2867226|NCT00151775|3570275|FG005|COMPLETED|Period 4: Open Label||0
2867227|NCT00151775|3570276|FG006|COMPLETED|Period 4: Open Label||0
2867228|NCT00151775|3570277|FG007|COMPLETED|Period 4: Open Label||0
2867229|NCT00151775|3570278|FG008|COMPLETED|Period 4: Open Label||0
2867230|NCT00151775|3570279|FG009|COMPLETED|Period 4: Open Label||83
2867231|NCT00151775|3570280|FG010|COMPLETED|Period 4: Open Label||57
2867232|NCT00151775|3570281|FG011|COMPLETED|Period 4: Open Label||0
2867233|NCT00151775|3570270|FG000|NOT COMPLETED|Period 4: Open Label||0
2867234|NCT00151775|3570271|FG001|NOT COMPLETED|Period 4: Open Label||0
2867235|NCT00151775|3570272|FG002|NOT COMPLETED|Period 4: Open Label||0
2867236|NCT00151775|3570273|FG003|NOT COMPLETED|Period 4: Open Label||0
2867237|NCT00151775|3570274|FG004|NOT COMPLETED|Period 4: Open Label||30
2867238|NCT00151775|3570275|FG005|NOT COMPLETED|Period 4: Open Label||0
2867239|NCT00151775|3570276|FG006|NOT COMPLETED|Period 4: Open Label||0
2867240|NCT00151775|3570277|FG007|NOT COMPLETED|Period 4: Open Label||0
2867241|NCT00151775|3570278|FG008|NOT COMPLETED|Period 4: Open Label||0
2867242|NCT00151775|3570279|FG009|NOT COMPLETED|Period 4: Open Label||21
2867243|NCT00151775|3570280|FG010|NOT COMPLETED|Period 4: Open Label||0
2867244|NCT00151775|3570281|FG011|NOT COMPLETED|Period 4: Open Label||0
2867245|NCT00151814|3570325|FG000|STARTED|Overall Study||4
2867246|NCT00151814|3570326|FG001|STARTED|Overall Study||10
2867247|NCT00151814|3570327|FG002|STARTED|Overall Study||10
2867248|NCT00151814|3570325|FG000|COMPLETED|Overall Study||4
2867249|NCT00151814|3570326|FG001|COMPLETED|Overall Study||10
2867250|NCT00151814|3570327|FG002|COMPLETED|Overall Study||10
2867251|NCT00151814|3570325|FG000|NOT COMPLETED|Overall Study||0
2867252|NCT00151814|3570326|FG001|NOT COMPLETED|Overall Study||0
2867253|NCT00151814|3570327|FG002|NOT COMPLETED|Overall Study||0
2867254|NCT00151892|3570336|FG000|STARTED|Overall Study||416
2867255|NCT00151892|3570337|FG001|STARTED|Overall Study||413
2867256|NCT00151892|3570336|FG000|COMPLETED|Overall Study||340
2867257|NCT00151892|3570337|FG001|COMPLETED|Overall Study||330
2867258|NCT00151892|3570336|FG000|NOT COMPLETED|Overall Study||76
2867259|NCT00151892|3570337|FG001|NOT COMPLETED|Overall Study||83
2867260|NCT00151996|3570345|FG000|STARTED|Overall Study||42
2867261|NCT00151996|3570346|FG001|STARTED|Overall Study||33
2867262|NCT00151996|3570345|FG000|COMPLETED|Overall Study||37
2867263|NCT00151996|3570346|FG001|COMPLETED|Overall Study||26
2867264|NCT00151996|3570345|FG000|NOT COMPLETED|Overall Study||5
2867265|NCT00151996|3570346|FG001|NOT COMPLETED|Overall Study||7
2867266|NCT00152009|3570356|FG000|STARTED|Overall Study||87
2867267|NCT00152009|3570357|FG001|STARTED|Overall Study||86
2867268|NCT00152009|3570358|FG002|STARTED|Overall Study||86
2867269|NCT00152009|3570359|FG003|STARTED|Overall Study||86
2867270|NCT00152009|3570356|FG000|COMPLETED|Overall Study||58
2867271|NCT00152009|3570357|FG001|COMPLETED|Overall Study||55
2867272|NCT00152009|3570358|FG002|COMPLETED|Overall Study||49
2867273|NCT00152009|3570359|FG003|COMPLETED|Overall Study||53
2867274|NCT00152009|3570356|FG000|NOT COMPLETED|Overall Study||29
2867275|NCT00152009|3570357|FG001|NOT COMPLETED|Overall Study||31
2867276|NCT00152009|3570358|FG002|NOT COMPLETED|Overall Study||37
2867277|NCT00152009|3570359|FG003|NOT COMPLETED|Overall Study||33
2867278|NCT00152464|3570371|FG000|STARTED|Overall Study||255
2867279|NCT00152464|3570372|FG001|STARTED|Overall Study||255
2867280|NCT00152464|3570371|FG000|COMPLETED|Overall Study||215
2867281|NCT00152464|3570372|FG001|COMPLETED|Overall Study||219
2867282|NCT00152464|3570371|FG000|NOT COMPLETED|Overall Study||40
2867283|NCT00152464|3570372|FG001|NOT COMPLETED|Overall Study||36
2867284|NCT00152516|3570378|FG000|STARTED|Overall Study|Subjects that were dispensed at least 1 dose of study medication|255
2867285|NCT00152516|3570378|FG000|COMPLETED|Overall Study|Subjects ongoing until study close-out|180
2867286|NCT00152516|3570378|FG000|NOT COMPLETED|Overall Study||75
2867287|NCT00152763|3570386|FG000|STARTED|Overall Study||77
2867288|NCT00152763|3570387|FG001|STARTED|Overall Study||19
2867289|NCT00152763|3570388|FG002|STARTED|Overall Study||20
2867290|NCT00152763|3570389|FG003|STARTED|Overall Study||77
2867291|NCT00152763|3570386|FG000|COMPLETED|Overall Study||67
2867292|NCT00152763|3570387|FG001|COMPLETED|Overall Study||14
2867293|NCT00152763|3570388|FG002|COMPLETED|Overall Study||16
2867294|NCT00152763|3570389|FG003|COMPLETED|Overall Study||63
2867295|NCT00152763|3570386|FG000|NOT COMPLETED|Overall Study||10
2867296|NCT00152763|3570387|FG001|NOT COMPLETED|Overall Study||5
2867297|NCT00152763|3570388|FG002|NOT COMPLETED|Overall Study||4
2867298|NCT00152763|3570389|FG003|NOT COMPLETED|Overall Study||14
2867299|NCT00152971|3570404|FG000|STARTED|Overall Study||857
2867300|NCT00152971|3570405|FG001|STARTED|Overall Study||871
2867301|NCT00152971|3570406|FG002|STARTED|Overall Study||868
2867302|NCT00152971|3570404|FG000|COMPLETED|Overall Study|Non-completers in 'overall study' table may have completed treatment but not study, and vice versa|806
2867303|NCT00152971|3570405|FG001|COMPLETED|Overall Study|Non-completers in 'overall study' table may have completed treatment but not study, and vice versa|823
2867304|NCT00152971|3570406|FG002|COMPLETED|Overall Study|Non-completers in 'overall study' table may have completed treatment but not study, and vice versa|819
2867305|NCT00152971|3570404|FG000|NOT COMPLETED|Overall Study||51
2867306|NCT00152971|3570405|FG001|NOT COMPLETED|Overall Study||48
2867307|NCT00152971|3570406|FG002|NOT COMPLETED|Overall Study||49
2867308|NCT00152971|3570404|FG000|STARTED|Treatment||857
2867309|NCT00152971|3570405|FG001|STARTED|Treatment||871
2867310|NCT00152971|3570406|FG002|STARTED|Treatment||868
2867311|NCT00152971|3570404|FG000|COMPLETED|Treatment|Non-completers in 'treatment' table may have completed study but not treatment, and vice versa|786
2867312|NCT00152971|3570405|FG001|COMPLETED|Treatment|Non-completers in 'treatment' table may have completed study but not treatment, and vice versa|808
2867313|NCT00152971|3570406|FG002|COMPLETED|Treatment|Non-completers in 'treatment' table may have completed study but not treatment, and vice versa|788
2867314|NCT00152971|3570404|FG000|NOT COMPLETED|Treatment||71
2867315|NCT00152971|3570405|FG001|NOT COMPLETED|Treatment||63
2867316|NCT00152971|3570406|FG002|NOT COMPLETED|Treatment||80
2867317|NCT00153062|3570418|FG000|STARTED|Overall Study||5086
2867318|NCT00153062|3570419|FG001|STARTED|Overall Study||5095
2867319|NCT00153062|3570420|FG002|STARTED|Overall Study||5060
2867320|NCT00153062|3570421|FG003|STARTED|Overall Study||5091
2867321|NCT00153062|3570418|FG000|COMPLETED|Overall Study||4699
2867322|NCT00153062|3570419|FG001|COMPLETED|Overall Study||4689
2867323|NCT00153062|3570420|FG002|COMPLETED|Overall Study||4645
2867324|NCT00153062|3570421|FG003|COMPLETED|Overall Study||4680
2867325|NCT00153062|3570418|FG000|NOT COMPLETED|Overall Study||387
2867326|NCT00153062|3570419|FG001|NOT COMPLETED|Overall Study||406
2867327|NCT00153062|3570420|FG002|NOT COMPLETED|Overall Study||415
2867328|NCT00153062|3570421|FG003|NOT COMPLETED|Overall Study||411
2867329|NCT00153101|3570436|FG000|STARTED|Overall Study||8502
2867330|NCT00153101|3570437|FG001|STARTED|Overall Study||8542
2867331|NCT00153101|3570438|FG002|STARTED|Overall Study||8576
2867332|NCT00153101|3570439|FG003|STARTED|Overall Study||2954
2867333|NCT00153101|3570440|FG004|STARTED|Overall Study||2972
2867334|NCT00153101|3570436|FG000|COMPLETED|Overall Study||8485
2867335|NCT00153101|3570437|FG001|COMPLETED|Overall Study||8524
2867336|NCT00153101|3570438|FG002|COMPLETED|Overall Study||8561
2867337|NCT00153101|3570439|FG003|COMPLETED|Overall Study||2946
2867338|NCT00153101|3570440|FG004|COMPLETED|Overall Study||2962
2867339|NCT00153101|3570436|FG000|NOT COMPLETED|Overall Study||17
2867340|NCT00153101|3570437|FG001|NOT COMPLETED|Overall Study||18
2867341|NCT00153101|3570438|FG002|NOT COMPLETED|Overall Study||15
2867342|NCT00153101|3570439|FG003|NOT COMPLETED|Overall Study||8
2867343|NCT00153101|3570440|FG004|NOT COMPLETED|Overall Study||10
2867344|NCT00153166|3570457|FG000|STARTED|Overall Study||11
2867345|NCT00153166|3570458|FG001|STARTED|Overall Study||37
2867346|NCT00153166|3570459|FG002|STARTED|Overall Study||28
2867347|NCT00153166|3570457|FG000|Received Atorvastatin and Pioglitazone|Overall Study||3
2867348|NCT00153166|3570458|FG001|Received Atorvastatin and Pioglitazone|Overall Study||9
2867349|NCT00153166|3570459|FG002|Received Atorvastatin and Pioglitazone|Overall Study||7
2867350|NCT00153166|3570457|FG000|Received Atorvastatin and Placebo|Overall Study||2
2867351|NCT00153166|3570458|FG001|Received Atorvastatin and Placebo|Overall Study||9
2867352|NCT00153166|3570459|FG002|Received Atorvastatin and Placebo|Overall Study||7
2867353|NCT00153166|3570457|FG000|Received Placebo and Pioglitazone|Overall Study||3
2867354|NCT00153166|3570458|FG001|Received Placebo and Pioglitazone|Overall Study||10
2867355|NCT00153166|3570459|FG002|Received Placebo and Pioglitazone|Overall Study||7
2867356|NCT00153166|3570457|FG000|Received Placebo and Placebo|Overall Study||3
2867357|NCT00153166|3570458|FG001|Received Placebo and Placebo|Overall Study||9
2867358|NCT00153166|3570459|FG002|Received Placebo and Placebo|Overall Study||7
2867359|NCT00153166|3570457|FG000|COMPLETED|Overall Study||11
2867360|NCT00153166|3570458|FG001|COMPLETED|Overall Study||37
2867361|NCT00153166|3570459|FG002|COMPLETED|Overall Study||28
2867362|NCT00153166|3570457|FG000|NOT COMPLETED|Overall Study||0
2867363|NCT00153166|3570458|FG001|NOT COMPLETED|Overall Study||0
2867364|NCT00153166|3570459|FG002|NOT COMPLETED|Overall Study||0
2867365|NCT00153179|3570470|FG000|STARTED|Study Visit Day 1||10
2867366|NCT00153179|3570471|FG001|STARTED|Study Visit Day 1||8
2867367|NCT00153179|3570472|FG002|STARTED|Study Visit Day 1||13
2867368|NCT00153179|3570473|FG003|STARTED|Study Visit Day 1||9
2867369|NCT00153179|3570470|FG000|COMPLETED|Study Visit Day 1||10
2867370|NCT00153179|3570471|FG001|COMPLETED|Study Visit Day 1||8
2867371|NCT00153179|3570472|FG002|COMPLETED|Study Visit Day 1||13
2867372|NCT00153179|3570473|FG003|COMPLETED|Study Visit Day 1||9
2867373|NCT00153179|3570470|FG000|NOT COMPLETED|Study Visit Day 1||0
2867374|NCT00153179|3570471|FG001|NOT COMPLETED|Study Visit Day 1||0
2867375|NCT00153179|3570472|FG002|NOT COMPLETED|Study Visit Day 1||0
2867376|NCT00153179|3570473|FG003|NOT COMPLETED|Study Visit Day 1||0
2867377|NCT00153179|3570470|FG000|STARTED|Study Visit Day 2||10
2867378|NCT00153179|3570471|FG001|STARTED|Study Visit Day 2||8
2867379|NCT00153179|3570472|FG002|STARTED|Study Visit Day 2||13
2867380|NCT00153179|3570473|FG003|STARTED|Study Visit Day 2||9
2867381|NCT00153179|3570470|FG000|COMPLETED|Study Visit Day 2||9
2867382|NCT00153179|3570471|FG001|COMPLETED|Study Visit Day 2||8
2867383|NCT00153179|3570472|FG002|COMPLETED|Study Visit Day 2||11
2867384|NCT00153179|3570473|FG003|COMPLETED|Study Visit Day 2||7
2867385|NCT00153179|3570470|FG000|NOT COMPLETED|Study Visit Day 2||1
2867386|NCT00153179|3570471|FG001|NOT COMPLETED|Study Visit Day 2||0
2867387|NCT00153179|3570472|FG002|NOT COMPLETED|Study Visit Day 2||2
2867388|NCT00153179|3570473|FG003|NOT COMPLETED|Study Visit Day 2||2
2867389|NCT00153803|3570483|FG000|STARTED|Concurrent Chemoradiation||123
2867390|NCT00153803|3570484|FG001|STARTED|Concurrent Chemoradiation||122
2867391|NCT00153803|3570483|FG000|Received Chemoradiation|Concurrent Chemoradiation||118
2867392|NCT00153803|3570484|FG001|Received Chemoradiation|Concurrent Chemoradiation||117
2867393|NCT00153803|3570483|FG000|COMPLETED|Concurrent Chemoradiation||118
2867394|NCT00153803|3570484|FG001|COMPLETED|Concurrent Chemoradiation||117
2867395|NCT00153803|3570483|FG000|NOT COMPLETED|Concurrent Chemoradiation||5
2867396|NCT00153803|3570484|FG001|NOT COMPLETED|Concurrent Chemoradiation||5
2867397|NCT00153803|3570483|FG000|STARTED|Investigational Drug||118
2867398|NCT00153803|3570484|FG001|STARTED|Investigational Drug||117
2867399|NCT00153803|3570483|FG000|Investigational Drug Dispensed|Investigational Drug||77
2867400|NCT00153803|3570484|FG001|Investigational Drug Dispensed|Investigational Drug||75
2867401|NCT00153803|3570483|FG000|COMPLETED|Investigational Drug||77
2867402|NCT00153803|3570484|FG001|COMPLETED|Investigational Drug||75
2867403|NCT00153803|3570483|FG000|NOT COMPLETED|Investigational Drug||41
2867404|NCT00153803|3570484|FG001|NOT COMPLETED|Investigational Drug||42
2867405|NCT00153816|3570499|FG000|STARTED|Overall Study||415
2867406|NCT00153816|3570500|FG001|STARTED|Overall Study||419
2867407|NCT00153816|3570501|FG002|STARTED|Overall Study||420
2867408|NCT00153816|3570502|FG003|STARTED|Overall Study||421
2867409|NCT00153816|3570503|FG004|STARTED|Overall Study||295
2867410|NCT00153816|3570504|FG005|STARTED|Overall Study||289
2867411|NCT00153816|3570499|FG000|COMPLETED|Overall Study||383
2867412|NCT00153816|3570500|FG001|COMPLETED|Overall Study||387
2867413|NCT00153816|3570501|FG002|COMPLETED|Overall Study||388
2867414|NCT00153816|3570502|FG003|COMPLETED|Overall Study||390
2867415|NCT00153816|3570503|FG004|COMPLETED|Overall Study||278
2867416|NCT00153816|3570504|FG005|COMPLETED|Overall Study||262
2867417|NCT00153816|3570499|FG000|NOT COMPLETED|Overall Study||32
2867418|NCT00153816|3570500|FG001|NOT COMPLETED|Overall Study||32
2867419|NCT00153816|3570501|FG002|NOT COMPLETED|Overall Study||32
2867420|NCT00153816|3570502|FG003|NOT COMPLETED|Overall Study||31
2867421|NCT00153816|3570503|FG004|NOT COMPLETED|Overall Study||17
2867422|NCT00153816|3570504|FG005|NOT COMPLETED|Overall Study||27
2867423|NCT00153842|3570520|FG000|STARTED|Overall Study||26
2867424|NCT00153842|3570521|FG001|STARTED|Overall Study||7
2867425|NCT00153842|3570520|FG000|COMPLETED|Overall Study||26
2867426|NCT00153842|3570521|FG001|COMPLETED|Overall Study||7
2867427|NCT00153842|3570520|FG000|NOT COMPLETED|Overall Study||0
2867428|NCT00153842|3570521|FG001|NOT COMPLETED|Overall Study||0
2867429|NCT00153920|3570529|FG000|STARTED|Overall Study||66
2867430|NCT00153920|3570529|FG000|Eligible and Treated|Overall Study||64
2867431|NCT00153920|3570529|FG000|COMPLETED|Overall Study||36
2867432|NCT00153920|3570529|FG000|NOT COMPLETED|Overall Study||30
2867433|NCT00153985|3570533|FG000|STARTED|Overall Study||2
2867434|NCT00153985|3570533|FG000|COMPLETED|Overall Study||2
2867435|NCT00153985|3570533|FG000|NOT COMPLETED|Overall Study||0
2867436|NCT00154063|3570539|FG000|STARTED|Overall Study||104
2867437|NCT00154063|3570540|FG001|STARTED|Overall Study||102
2867438|NCT00154063|3570539|FG000|COMPLETED|Overall Study||92
2867439|NCT00154063|3570540|FG001|COMPLETED|Overall Study||80
2867440|NCT00154063|3570539|FG000|NOT COMPLETED|Overall Study||12
2867441|NCT00154063|3570540|FG001|NOT COMPLETED|Overall Study||22
2867442|NCT00154102|3570552|FG000|STARTED|Overall Study|Randomized and treated subjects; 1 additional subject was treated but not randomised|599
2867443|NCT00154102|3570553|FG001|STARTED|Overall Study|Randomized and treated subjects; 3 additional subjects were treated but not randomised|599
2867444|NCT00154102|3570552|FG000|COMPLETED|Overall Study||592
2867445|NCT00154102|3570553|FG001|COMPLETED|Overall Study||597
2867446|NCT00154102|3570552|FG000|NOT COMPLETED|Overall Study||7
2867447|NCT00154102|3570553|FG001|NOT COMPLETED|Overall Study||2
2867448|NCT00154284|3570561|FG000|STARTED|Overall Study|"Started indicates Safety Population (randomized patients and treated after randomization.)"|59
2867449|NCT00154284|3570562|FG001|STARTED|Overall Study||55
2867450|NCT00154284|3570561|FG000|Intent to Treat (ITT) Population|Overall Study||57
2867451|NCT00154284|3570562|FG001|Intent to Treat (ITT) Population|Overall Study||53
2867452|NCT00154284|3570561|FG000|COMPLETED|Overall Study|"Completed means patients completed on study medication.All patients of both arms completed study."|52
2867453|NCT00154284|3570562|FG001|COMPLETED|Overall Study||42
2867454|NCT00154284|3570561|FG000|NOT COMPLETED|Overall Study||7
2867455|NCT00154284|3570562|FG001|NOT COMPLETED|Overall Study||13
2867456|NCT00154297|3570572|FG000|STARTED|Overall Study|Randomized population.|65
2867457|NCT00154297|3570573|FG001|STARTED|Overall Study|Randomized population.|74
2867458|NCT00154297|3570572|FG000|COMPLETED|Overall Study|Completed study by 12 month.|57
3169377|NCT01924988|3896910|FG000|COMPLETED|Overall Study||15
3169378|NCT01924988|3896910|FG000|NOT COMPLETED|Overall Study||0
3169379|NCT01925014|3896919|FG000|STARTED|Overall Study||1535
2867459|NCT00154297|3570573|FG001|COMPLETED|Overall Study|Completed study by 12 month.|67
2867460|NCT00154297|3570572|FG000|NOT COMPLETED|Overall Study||8
2867461|NCT00154297|3570573|FG001|NOT COMPLETED|Overall Study||7
2867462|NCT00154310|3570581|FG000|STARTED|Overall Study|"Started indicates enrolled participants. Randomized participants for two arms are 154 and 146."|155
2867463|NCT00154310|3570582|FG001|STARTED|Overall Study||145
2867464|NCT00154310|3570581|FG000|COMPLETED|Overall Study||118
2867465|NCT00154310|3570582|FG001|COMPLETED|Overall Study||117
2867466|NCT00154310|3570581|FG000|NOT COMPLETED|Overall Study||37
2867467|NCT00154310|3570582|FG001|NOT COMPLETED|Overall Study||28
2867468|NCT00154375|3570590|FG000|STARTED|Overall Study||120
2867469|NCT00154375|3570591|FG001|STARTED|Overall Study||120
2867470|NCT00154375|3570590|FG000|Discontinued Study Treatment|Overall Study||111
2867471|NCT00154375|3570591|FG001|Discontinued Study Treatment|Overall Study||104
2867472|NCT00154375|3570590|FG000|Not Exposed to Study Treatment|Overall Study|4 randomized patients didn't receive study treatment were excluded from the safety analyses.|2
2867473|NCT00154375|3570591|FG001|Not Exposed to Study Treatment|Overall Study||2
2867474|NCT00154375|3570590|FG000|COMPLETED|Overall Study||7
2867475|NCT00154375|3570591|FG001|COMPLETED|Overall Study||14
2867476|NCT00154375|3570590|FG000|NOT COMPLETED|Overall Study||113
2867477|NCT00154375|3570591|FG001|NOT COMPLETED|Overall Study||106
2867478|NCT00154466|3570601|FG000|STARTED|Overall Study||20
2867479|NCT00154466|3570602|FG001|STARTED|Overall Study||19
2867480|NCT00154466|3570603|FG002|STARTED|Overall Study|Healthy controls underwent the test of myocardial perfusion only at baseline.|19
2867481|NCT00154466|3570601|FG000|COMPLETED|Overall Study||20
3169380|NCT01925014|3896920|FG001|STARTED|Overall Study||1539
3169381|NCT01925014|3896919|FG000|COMPLETED|Overall Study||1526
3169382|NCT01925014|3896920|FG001|COMPLETED|Overall Study||1520
3169383|NCT01925014|3896919|FG000|NOT COMPLETED|Overall Study||9
3169384|NCT01925014|3896920|FG001|NOT COMPLETED|Overall Study||19
3169385|NCT01925144|3896926|FG000|STARTED|Period 1 (Day 1 Through Predose Day 3)||30
3171789|NCT01937130|3898980|FG001|NOT COMPLETED|Overall Study||4
2867482|NCT00154466|3570602|FG001|COMPLETED|Overall Study||19
2867483|NCT00154466|3570603|FG002|COMPLETED|Overall Study||19
2867484|NCT00154466|3570601|FG000|NOT COMPLETED|Overall Study||0
2867485|NCT00154466|3570602|FG001|NOT COMPLETED|Overall Study||0
2867486|NCT00154466|3570603|FG002|NOT COMPLETED|Overall Study||0
3169386|NCT01925144|3896926|FG000|Received Baricitinib|Period 1 (Day 1 Through Predose Day 3)||30
3169387|NCT01925144|3896926|FG000|COMPLETED|Period 1 (Day 1 Through Predose Day 3)||30
2867487|NCT00156013|3570613|FG000|STARTED|Overall Study||33
2867488|NCT00156013|3570613|FG000|COMPLETED|Overall Study||31
2867489|NCT00156013|3570613|FG000|NOT COMPLETED|Overall Study||2
2867490|NCT00156247|3570619|FG000|STARTED|Overall Study||9
2867491|NCT00156247|3570619|FG000|COMPLETED|Overall Study||5
2867492|NCT00156247|3570619|FG000|NOT COMPLETED|Overall Study||4
2867493|NCT00156390|3570625|FG000|STARTED|Overall Study||110
2867494|NCT00156390|3570626|FG001|STARTED|Overall Study||77
2867495|NCT00156390|3570625|FG000|COMPLETED|Overall Study||96
2867496|NCT00156390|3570626|FG001|COMPLETED|Overall Study||69
2867497|NCT00156390|3570625|FG000|NOT COMPLETED|Overall Study||14
2867498|NCT00156390|3570626|FG001|NOT COMPLETED|Overall Study||8
2867499|NCT00156533|3570637|FG000|STARTED|Overall Study||5
2867500|NCT00156533|3570638|FG001|STARTED|Overall Study||5
2867501|NCT00156533|3570639|FG002|STARTED|Overall Study||5
2867502|NCT00156533|3570640|FG003|STARTED|Overall Study||5
2867503|NCT00156533|3570637|FG000|COMPLETED|Overall Study||3
2867504|NCT00156533|3570638|FG001|COMPLETED|Overall Study||3
2867505|NCT00156533|3570639|FG002|COMPLETED|Overall Study||3
2867506|NCT00156533|3570640|FG003|COMPLETED|Overall Study||3
2867507|NCT00156533|3570637|FG000|NOT COMPLETED|Overall Study||2
2867508|NCT00156533|3570638|FG001|NOT COMPLETED|Overall Study||2
2867509|NCT00156533|3570639|FG002|NOT COMPLETED|Overall Study||2
2867510|NCT00156533|3570640|FG003|NOT COMPLETED|Overall Study||2
2867511|NCT00156715|3570652|FG000|STARTED|Overall Study||23
2867512|NCT00156715|3570652|FG000|COMPLETED|Overall Study||16
2867513|NCT00156715|3570652|FG000|NOT COMPLETED|Overall Study||7
2867514|NCT00156819|3570659|FG000|STARTED|Overall Study||169
2867515|NCT00156819|3570660|FG001|STARTED|Overall Study||166
2867516|NCT00156819|3570661|FG002|STARTED|Overall Study||165
2867517|NCT00156819|3570659|FG000|COMPLETED|Overall Study||168
2867518|NCT00156819|3570660|FG001|COMPLETED|Overall Study||165
2867519|NCT00156819|3570661|FG002|COMPLETED|Overall Study||162
2867520|NCT00156819|3570659|FG000|NOT COMPLETED|Overall Study||1
2867521|NCT00156819|3570660|FG001|NOT COMPLETED|Overall Study||1
2867522|NCT00156819|3570661|FG002|NOT COMPLETED|Overall Study||3
2867523|NCT00156910|3570671|FG000|STARTED|Double-Blind Phase (DB)||341
2867524|NCT00156910|3570672|FG001|STARTED|Double-Blind Phase (DB)||338
2867525|NCT00156910|3570671|FG000|COMPLETED|Double-Blind Phase (DB)|Completed Week 24|296
2867526|NCT00156910|3570672|FG001|COMPLETED|Double-Blind Phase (DB)|Completed Week 24|295
2867527|NCT00156910|3570671|FG000|NOT COMPLETED|Double-Blind Phase (DB)||45
2867528|NCT00156910|3570672|FG001|NOT COMPLETED|Double-Blind Phase (DB)||43
2867529|NCT00156910|3570671|FG000|STARTED|Open-Label Phase (OL)|Number of DB Botulinum toxin type A patients who rolled into OL phase|285
2867530|NCT00156910|3570672|FG001|STARTED|Open-Label Phase (OL)|Number of DB Placebo patients who rolled into OL Phase|286
2867531|NCT00156910|3570671|FG000|COMPLETED|Open-Label Phase (OL)||252
2867532|NCT00156910|3570672|FG001|COMPLETED|Open-Label Phase (OL)||231
2867533|NCT00156910|3570671|FG000|NOT COMPLETED|Open-Label Phase (OL)||33
2867534|NCT00156910|3570672|FG001|NOT COMPLETED|Open-Label Phase (OL)||55
2867535|NCT00156923|3570680|FG000|STARTED|Overall Study||56
2867536|NCT00156923|3570681|FG001|STARTED|Overall Study||52
2867537|NCT00156923|3570680|FG000|COMPLETED|Overall Study||22
2867538|NCT00156923|3570681|FG001|COMPLETED|Overall Study||20
2867539|NCT00156923|3570680|FG000|NOT COMPLETED|Overall Study||34
2867540|NCT00156923|3570681|FG001|NOT COMPLETED|Overall Study||32
2867541|NCT00156936|3570689|FG000|STARTED|Overall Study||92
2867542|NCT00156936|3570690|FG001|STARTED|Overall Study||16
2867543|NCT00156936|3570689|FG000|COMPLETED|Overall Study||20
2867544|NCT00156936|3570690|FG001|COMPLETED|Overall Study||5
2867545|NCT00156936|3570689|FG000|NOT COMPLETED|Overall Study||72
2867546|NCT00156936|3570690|FG001|NOT COMPLETED|Overall Study||11
2867547|NCT00157014|3570700|FG000|STARTED|Overall Study||52
2867548|NCT00157014|3570701|FG001|STARTED|Overall Study||46
2867549|NCT00157014|3570702|FG002|STARTED|Overall Study||5
2867550|NCT00157014|3570703|FG003|STARTED|Overall Study||6
2867551|NCT00157014|3570700|FG000|COMPLETED|Overall Study||45
2867552|NCT00157014|3570701|FG001|COMPLETED|Overall Study||41
2867553|NCT00157014|3570702|FG002|COMPLETED|Overall Study||4
2867554|NCT00157014|3570703|FG003|COMPLETED|Overall Study||5
2867555|NCT00157014|3570700|FG000|NOT COMPLETED|Overall Study||7
2867556|NCT00157014|3570701|FG001|NOT COMPLETED|Overall Study||5
2867557|NCT00157014|3570702|FG002|NOT COMPLETED|Overall Study||1
2867558|NCT00157014|3570703|FG003|NOT COMPLETED|Overall Study||1
2867559|NCT00157157|3570713|FG000|STARTED|Overall Study||55
2867560|NCT00157157|3570713|FG000|COMPLETED|Overall Study||44
2867561|NCT00157157|3570713|FG000|NOT COMPLETED|Overall Study||11
2867562|NCT00157196|3570724|FG000|STARTED|Overall Study||22
2867563|NCT00157196|3570724|FG000|COMPLETED|Overall Study||13
2867564|NCT00157196|3570724|FG000|NOT COMPLETED|Overall Study||9
2867565|NCT00157209|3570730|FG000|STARTED|Overall Study||88
2867566|NCT00157209|3570731|FG001|STARTED|Overall Study||83
2867567|NCT00157209|3570730|FG000|COMPLETED|Overall Study||78
2867568|NCT00157209|3570731|FG001|COMPLETED|Overall Study||83
3171790|NCT01937130|3898981|FG002|NOT COMPLETED|Overall Study||3
2867569|NCT00157209|3570730|FG000|NOT COMPLETED|Overall Study||10
2867570|NCT00157209|3570731|FG001|NOT COMPLETED|Overall Study||0
2867571|NCT00157248|3570741|FG000|STARTED|Overall Study|Started: Participant completed previous trial on Dabigatran and took study drug of present trial.|98
2867572|NCT00157248|3570742|FG001|STARTED|Overall Study||89
2867573|NCT00157248|3570743|FG002|STARTED|Overall Study||50
2867574|NCT00157248|3570744|FG003|STARTED|Overall Study||124
2867575|NCT00157248|3570741|FG000|COMPLETED|Overall Study|Completed: Participant without premature discontinuation of study medication.|50
2867576|NCT00157248|3570742|FG001|COMPLETED|Overall Study||52
2867577|NCT00157248|3570743|FG002|COMPLETED|Overall Study||29
2867578|NCT00157248|3570744|FG003|COMPLETED|Overall Study||77
2867579|NCT00157248|3570741|FG000|NOT COMPLETED|Overall Study||48
2867580|NCT00157248|3570742|FG001|NOT COMPLETED|Overall Study||37
3169388|NCT01925144|3896926|FG000|NOT COMPLETED|Period 1 (Day 1 Through Predose Day 3)||0
3169389|NCT01925144|3896926|FG000|STARTED|Period 2 (At Dosing Day 3 Through Day12)||30
3169390|NCT01925144|3896926|FG000|Received Baricitinib|Period 2 (At Dosing Day 3 Through Day12)||30
3169391|NCT01925144|3896926|FG000|Received 8 Doses of Omeprazole|Period 2 (At Dosing Day 3 Through Day12)||30
2867581|NCT00157248|3570743|FG002|NOT COMPLETED|Overall Study||21
2867582|NCT00157248|3570744|FG003|NOT COMPLETED|Overall Study||47
2867583|NCT00157573|3570758|FG000|STARTED|Overall Study||35
2867584|NCT00157573|3570759|FG001|STARTED|Overall Study||37
2867585|NCT00157573|3570758|FG000|COMPLETED|Overall Study||35
2867586|NCT00157573|3570759|FG001|COMPLETED|Overall Study||37
2867587|NCT00157573|3570758|FG000|NOT COMPLETED|Overall Study||0
2867588|NCT00157573|3570759|FG001|NOT COMPLETED|Overall Study||0
2867589|NCT00157755|3570766|FG000|STARTED|Overall Study||26
2867590|NCT00157755|3570767|FG001|STARTED|Overall Study||19
2867591|NCT00157755|3570768|FG002|STARTED|Overall Study||10
2867592|NCT00157755|3570769|FG003|STARTED|Overall Study||15
2867593|NCT00157755|3570770|FG004|STARTED|Overall Study||12
2867594|NCT00157755|3570771|FG005|STARTED|Overall Study||5
2867595|NCT00157755|3570766|FG000|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|24
2867596|NCT00157755|3570767|FG001|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|15
2867597|NCT00157755|3570768|FG002|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|3
2867598|NCT00157755|3570769|FG003|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|11
2867599|NCT00157755|3570770|FG004|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|10
2867600|NCT00157755|3570771|FG005|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|0
2867601|NCT00157755|3570766|FG000|NOT COMPLETED|Overall Study||2
2867602|NCT00157755|3570767|FG001|NOT COMPLETED|Overall Study||4
2867603|NCT00157755|3570768|FG002|NOT COMPLETED|Overall Study||7
2867604|NCT00157755|3570769|FG003|NOT COMPLETED|Overall Study||4
2867605|NCT00157755|3570770|FG004|NOT COMPLETED|Overall Study||2
2867606|NCT00157755|3570771|FG005|NOT COMPLETED|Overall Study||5
2867607|NCT00157820|3570780|FG000|STARTED|Randomized||118
2867608|NCT00157820|3570781|FG001|STARTED|Randomized||116
2867609|NCT00157820|3570782|FG002|STARTED|Randomized||120
2867610|NCT00157820|3570780|FG000|COMPLETED|Randomized||111
2867611|NCT00157820|3570781|FG001|COMPLETED|Randomized||111
2867612|NCT00157820|3570782|FG002|COMPLETED|Randomized||112
2867613|NCT00157820|3570780|FG000|NOT COMPLETED|Randomized||7
2867614|NCT00157820|3570781|FG001|NOT COMPLETED|Randomized||5
2867615|NCT00157820|3570782|FG002|NOT COMPLETED|Randomized||8
2867616|NCT00157820|3570780|FG000|STARTED|1st 8 Month||111
2867617|NCT00157820|3570781|FG001|STARTED|1st 8 Month||111
2867618|NCT00157820|3570782|FG002|STARTED|1st 8 Month||112
2867619|NCT00157820|3570780|FG000|COMPLETED|1st 8 Month||103
2867620|NCT00157820|3570781|FG001|COMPLETED|1st 8 Month||99
2867621|NCT00157820|3570782|FG002|COMPLETED|1st 8 Month||106
2867622|NCT00157820|3570780|FG000|NOT COMPLETED|1st 8 Month||8
2867623|NCT00157820|3570781|FG001|NOT COMPLETED|1st 8 Month||12
2867624|NCT00157820|3570782|FG002|NOT COMPLETED|1st 8 Month||6
2867625|NCT00157820|3570780|FG000|STARTED|1 Month Wash Out Period||103
2867626|NCT00157820|3570781|FG001|STARTED|1 Month Wash Out Period|2 patients had crossed over prematurely in SC sim period, that are now carried to DC true period|101
2867627|NCT00157820|3570782|FG002|STARTED|1 Month Wash Out Period|2 patients had crossed over prematurely in DC true period, that are now carried to SC sim period|108
2867628|NCT00157820|3570780|FG000|COMPLETED|1 Month Wash Out Period||103
2867629|NCT00157820|3570781|FG001|COMPLETED|1 Month Wash Out Period||101
2867630|NCT00157820|3570782|FG002|COMPLETED|1 Month Wash Out Period||108
2867631|NCT00157820|3570780|FG000|NOT COMPLETED|1 Month Wash Out Period||0
2867632|NCT00157820|3570781|FG001|NOT COMPLETED|1 Month Wash Out Period||0
2867633|NCT00157820|3570782|FG002|NOT COMPLETED|1 Month Wash Out Period||0
2867634|NCT00157820|3570780|FG000|STARTED|2nd 8 Months||103
2867635|NCT00157820|3570781|FG001|STARTED|2nd 8 Months||101
2867636|NCT00157820|3570782|FG002|STARTED|2nd 8 Months||108
2867637|NCT00157820|3570780|FG000|COMPLETED|2nd 8 Months||98
2867638|NCT00157820|3570781|FG001|COMPLETED|2nd 8 Months||88
2867639|NCT00157820|3570782|FG002|COMPLETED|2nd 8 Months||94
2867640|NCT00157820|3570780|FG000|NOT COMPLETED|2nd 8 Months||5
2867641|NCT00157820|3570781|FG001|NOT COMPLETED|2nd 8 Months||13
2867642|NCT00157820|3570782|FG002|NOT COMPLETED|2nd 8 Months||14
2867643|NCT00157950|3570793|FG000|STARTED|Overall Study||117
2867644|NCT00157950|3570794|FG001|STARTED|Overall Study||59
2867645|NCT00157950|3570793|FG000|Vaccinated at Dose 1|Overall Study||117
2867646|NCT00157950|3570794|FG001|Vaccinated at Dose 1|Overall Study||59
2867647|NCT00157950|3570793|FG000|Vaccinated at Dose 2|Overall Study||117
2867648|NCT00157950|3570794|FG001|Vaccinated at Dose 2|Overall Study||59
2867649|NCT00157950|3570793|FG000|Vaccinated at Dose 3|Overall Study||116
2867650|NCT00157950|3570794|FG001|Vaccinated at Dose 3|Overall Study||59
2867651|NCT00157950|3570793|FG000|COMPLETED|Overall Study||116
2867652|NCT00157950|3570794|FG001|COMPLETED|Overall Study||59
2867653|NCT00157950|3570793|FG000|NOT COMPLETED|Overall Study||1
2867654|NCT00157950|3570794|FG001|NOT COMPLETED|Overall Study||0
2867655|NCT00158054|3570802|FG000|STARTED|Overall Study||80
2867656|NCT00158054|3570803|FG001|STARTED|Overall Study||77
2867657|NCT00158054|3570802|FG000|COMPLETED|Overall Study||70
3169392|NCT01925144|3896926|FG000|COMPLETED|Period 2 (At Dosing Day 3 Through Day12)||30
3169393|NCT01925144|3896926|FG000|NOT COMPLETED|Period 2 (At Dosing Day 3 Through Day12)||0
3169394|NCT01925170|3896933|FG000|STARTED|Overall Study||1638
2867658|NCT00158054|3570803|FG001|COMPLETED|Overall Study||74
2867659|NCT00158054|3570802|FG000|NOT COMPLETED|Overall Study||10
2867660|NCT00158054|3570803|FG001|NOT COMPLETED|Overall Study||3
2867661|NCT00158184|3570811|FG000|STARTED|Overall Study||16
2867662|NCT00158184|3570812|FG001|STARTED|Overall Study||11
2867663|NCT00158184|3570811|FG000|COMPLETED|Overall Study||10
2867664|NCT00158184|3570812|FG001|COMPLETED|Overall Study||9
2867665|NCT00158184|3570811|FG000|NOT COMPLETED|Overall Study||6
2867666|NCT00158184|3570812|FG001|NOT COMPLETED|Overall Study||2
2867667|NCT00158197|3570824|FG000|STARTED|Overall Study||32
2867668|NCT00158197|3570825|FG001|STARTED|Overall Study||30
2867669|NCT00158197|3570826|FG002|STARTED|Overall Study||28
2867670|NCT00158197|3570827|FG003|STARTED|Overall Study||29
2867671|NCT00158197|3570824|FG000|COMPLETED|Overall Study||32
2867672|NCT00158197|3570825|FG001|COMPLETED|Overall Study||30
2867673|NCT00158197|3570826|FG002|COMPLETED|Overall Study||28
2867674|NCT00158197|3570827|FG003|COMPLETED|Overall Study||29
2867675|NCT00158197|3570824|FG000|NOT COMPLETED|Overall Study||0
2867676|NCT00158197|3570825|FG001|NOT COMPLETED|Overall Study||0
2867677|NCT00158197|3570826|FG002|NOT COMPLETED|Overall Study||0
2867678|NCT00158197|3570827|FG003|NOT COMPLETED|Overall Study||0
2867679|NCT00158223|3570839|FG000|STARTED|Overall Study||28
2867680|NCT00158223|3570840|FG001|STARTED|Overall Study||25
2867681|NCT00158223|3570839|FG000|COMPLETED|Overall Study||23
2867682|NCT00158223|3570840|FG001|COMPLETED|Overall Study||22
2867683|NCT00158223|3570839|FG000|NOT COMPLETED|Overall Study||5
2867684|NCT00158223|3570840|FG001|NOT COMPLETED|Overall Study||3
2867685|NCT00158249|3570848|FG000|STARTED|Overall Study||11
2867686|NCT00158249|3570849|FG001|STARTED|Overall Study||10
2867687|NCT00158249|3570848|FG000|COMPLETED|Overall Study||9
2867688|NCT00158249|3570849|FG001|COMPLETED|Overall Study||10
2867689|NCT00158249|3570848|FG000|NOT COMPLETED|Overall Study||2
2867690|NCT00158249|3570849|FG001|NOT COMPLETED|Overall Study||0
2867691|NCT00158262|3570857|FG000|STARTED|Overall Study||21
2867692|NCT00158262|3570858|FG001|STARTED|Overall Study||22
2867693|NCT00158262|3570857|FG000|COMPLETED|Overall Study||20
2867694|NCT00158262|3570858|FG001|COMPLETED|Overall Study||21
2867695|NCT00158262|3570857|FG000|NOT COMPLETED|Overall Study||1
2867696|NCT00158262|3570858|FG001|NOT COMPLETED|Overall Study||1
2867697|NCT00158379|3570864|FG000|STARTED|Overall Study||105
2867698|NCT00158379|3570864|FG000|COMPLETED|Overall Study||105
2867699|NCT00158379|3570864|FG000|NOT COMPLETED|Overall Study||0
2867700|NCT00158600|3570870|FG000|STARTED|Overall Study||60
2867701|NCT00158600|3570871|FG001|STARTED|Overall Study||30
2867702|NCT00158600|3570870|FG000|COMPLETED|Overall Study||55
2867703|NCT00158600|3570871|FG001|COMPLETED|Overall Study||26
2867704|NCT00158600|3570870|FG000|NOT COMPLETED|Overall Study||5
2867705|NCT00158600|3570871|FG001|NOT COMPLETED|Overall Study||4
2867706|NCT00158743|3570880|FG000|STARTED|Overall Study||24
2867707|NCT00158743|3570881|FG001|STARTED|Overall Study||27
2867708|NCT00158743|3570880|FG000|COMPLETED|Overall Study||15
2867709|NCT00158743|3570881|FG001|COMPLETED|Overall Study||20
2867710|NCT00158743|3570880|FG000|NOT COMPLETED|Overall Study||9
2867711|NCT00158743|3570881|FG001|NOT COMPLETED|Overall Study||7
2867712|NCT00158756|3570892|FG000|STARTED|Overall Study||80
2867713|NCT00158756|3570893|FG001|STARTED|Overall Study||25
2867714|NCT00158756|3570894|FG002|STARTED|Overall Study||81
2867715|NCT00158756|3570895|FG003|STARTED|Overall Study||23
2867716|NCT00158756|3570896|FG004|STARTED|Overall Study||99
2867717|NCT00158756|3570892|FG000|COMPLETED|Overall Study||75
2867718|NCT00158756|3570893|FG001|COMPLETED|Overall Study||25
2867719|NCT00158756|3570894|FG002|COMPLETED|Overall Study||73
2867720|NCT00158756|3570895|FG003|COMPLETED|Overall Study||22
2867721|NCT00158756|3570896|FG004|COMPLETED|Overall Study||96
2867722|NCT00158756|3570892|FG000|NOT COMPLETED|Overall Study||5
2867723|NCT00158756|3570893|FG001|NOT COMPLETED|Overall Study||0
2867724|NCT00158756|3570894|FG002|NOT COMPLETED|Overall Study||8
2867725|NCT00158756|3570895|FG003|NOT COMPLETED|Overall Study||1
2867726|NCT00158756|3570896|FG004|NOT COMPLETED|Overall Study||3
2867727|NCT00158860|3570910|FG000|STARTED|Overall Study||128
2867728|NCT00158860|3570911|FG001|STARTED|Overall Study||255
2867729|NCT00158860|3570910|FG000|COMPLETED|Overall Study||93
2867730|NCT00158860|3570911|FG001|COMPLETED|Overall Study||184
2867731|NCT00158860|3570910|FG000|NOT COMPLETED|Overall Study||35
2867732|NCT00158860|3570911|FG001|NOT COMPLETED|Overall Study||71
2867733|NCT00158925|3570918|FG000|STARTED|Overall Study|96 subjects were implanted or attempted with the study lead|96
2867734|NCT00158925|3570918|FG000|COMPLETED|Overall Study||84
2867735|NCT00158925|3570918|FG000|NOT COMPLETED|Overall Study||12
2867736|NCT00159250|3570924|FG000|STARTED|Overall Study||2
2867737|NCT00159250|3570925|FG001|STARTED|Overall Study||5
2867738|NCT00159250|3570924|FG000|COMPLETED|Overall Study||2
2867739|NCT00159250|3570925|FG001|COMPLETED|Overall Study||5
2867740|NCT00159250|3570924|FG000|NOT COMPLETED|Overall Study||0
2867741|NCT00159250|3570925|FG001|NOT COMPLETED|Overall Study||0
2867742|NCT00159263|3570931|FG000|STARTED|First Intervention||1
2867743|NCT00159263|3570932|FG001|STARTED|First Intervention||1
2867744|NCT00159263|3570933|FG002|STARTED|First Intervention||2
2867745|NCT00159263|3570934|FG003|STARTED|First Intervention||2
2867746|NCT00159263|3570935|FG004|STARTED|First Intervention||2
2867747|NCT00159263|3570936|FG005|STARTED|First Intervention||2
2867748|NCT00159263|3570931|FG000|COMPLETED|First Intervention||1
2867749|NCT00159263|3570932|FG001|COMPLETED|First Intervention||1
2867750|NCT00159263|3570933|FG002|COMPLETED|First Intervention||2
2867751|NCT00159263|3570934|FG003|COMPLETED|First Intervention||2
2867752|NCT00159263|3570935|FG004|COMPLETED|First Intervention||2
2867753|NCT00159263|3570936|FG005|COMPLETED|First Intervention||2
2867754|NCT00159263|3570931|FG000|NOT COMPLETED|First Intervention||0
2867755|NCT00159263|3570932|FG001|NOT COMPLETED|First Intervention||0
2867756|NCT00159263|3570933|FG002|NOT COMPLETED|First Intervention||0
2867757|NCT00159263|3570934|FG003|NOT COMPLETED|First Intervention||0
2867758|NCT00159263|3570935|FG004|NOT COMPLETED|First Intervention||0
2867759|NCT00159263|3570936|FG005|NOT COMPLETED|First Intervention||0
2867760|NCT00159263|3570931|FG000|STARTED|Washout||1
2867761|NCT00159263|3570932|FG001|STARTED|Washout||1
2867762|NCT00159263|3570933|FG002|STARTED|Washout||2
2867763|NCT00159263|3570934|FG003|STARTED|Washout||2
2867764|NCT00159263|3570935|FG004|STARTED|Washout||2
2867765|NCT00159263|3570936|FG005|STARTED|Washout||2
2867766|NCT00159263|3570931|FG000|COMPLETED|Washout||1
2867767|NCT00159263|3570932|FG001|COMPLETED|Washout||1
2867768|NCT00159263|3570933|FG002|COMPLETED|Washout||2
2867769|NCT00159263|3570934|FG003|COMPLETED|Washout||2
2867770|NCT00159263|3570935|FG004|COMPLETED|Washout||2
2867771|NCT00159263|3570936|FG005|COMPLETED|Washout||2
2867772|NCT00159263|3570931|FG000|NOT COMPLETED|Washout||0
2867773|NCT00159263|3570932|FG001|NOT COMPLETED|Washout||0
2867774|NCT00159263|3570933|FG002|NOT COMPLETED|Washout||0
2867775|NCT00159263|3570934|FG003|NOT COMPLETED|Washout||0
2867776|NCT00159263|3570935|FG004|NOT COMPLETED|Washout||0
2867777|NCT00159263|3570936|FG005|NOT COMPLETED|Washout||0
2867778|NCT00159263|3570931|FG000|STARTED|Second Intervention||1
2867779|NCT00159263|3570932|FG001|STARTED|Second Intervention||1
2867780|NCT00159263|3570933|FG002|STARTED|Second Intervention||2
2867781|NCT00159263|3570934|FG003|STARTED|Second Intervention||2
2867782|NCT00159263|3570935|FG004|STARTED|Second Intervention||2
2867783|NCT00159263|3570936|FG005|STARTED|Second Intervention||2
2867784|NCT00159263|3570931|FG000|COMPLETED|Second Intervention||1
2867785|NCT00159263|3570932|FG001|COMPLETED|Second Intervention||1
2867786|NCT00159263|3570933|FG002|COMPLETED|Second Intervention||2
2867787|NCT00159263|3570934|FG003|COMPLETED|Second Intervention||2
2867788|NCT00159263|3570935|FG004|COMPLETED|Second Intervention||2
2867789|NCT00159263|3570936|FG005|COMPLETED|Second Intervention||2
2867790|NCT00159263|3570931|FG000|NOT COMPLETED|Second Intervention||0
2867791|NCT00159263|3570932|FG001|NOT COMPLETED|Second Intervention||0
2867792|NCT00159263|3570933|FG002|NOT COMPLETED|Second Intervention||0
2867793|NCT00159263|3570934|FG003|NOT COMPLETED|Second Intervention||0
2867794|NCT00159263|3570935|FG004|NOT COMPLETED|Second Intervention||0
2867795|NCT00159263|3570936|FG005|NOT COMPLETED|Second Intervention||0
2867796|NCT00159263|3570931|FG000|STARTED|Washout||1
2867797|NCT00159263|3570932|FG001|STARTED|Washout||1
2867798|NCT00159263|3570933|FG002|STARTED|Washout||2
2867799|NCT00159263|3570934|FG003|STARTED|Washout||2
2867800|NCT00159263|3570935|FG004|STARTED|Washout||2
2867801|NCT00159263|3570936|FG005|STARTED|Washout||2
2867802|NCT00159263|3570931|FG000|COMPLETED|Washout||1
2867803|NCT00159263|3570932|FG001|COMPLETED|Washout||1
2867804|NCT00159263|3570933|FG002|COMPLETED|Washout||2
2867805|NCT00159263|3570934|FG003|COMPLETED|Washout||2
2867806|NCT00159263|3570935|FG004|COMPLETED|Washout||2
2867807|NCT00159263|3570936|FG005|COMPLETED|Washout||2
2867808|NCT00159263|3570931|FG000|NOT COMPLETED|Washout||0
2867809|NCT00159263|3570932|FG001|NOT COMPLETED|Washout||0
2867810|NCT00159263|3570933|FG002|NOT COMPLETED|Washout||0
2867811|NCT00159263|3570934|FG003|NOT COMPLETED|Washout||0
2867812|NCT00159263|3570935|FG004|NOT COMPLETED|Washout||0
2867813|NCT00159263|3570936|FG005|NOT COMPLETED|Washout||0
2867814|NCT00159263|3570931|FG000|STARTED|Third Intervention||1
2867815|NCT00159263|3570932|FG001|STARTED|Third Intervention||1
2867816|NCT00159263|3570933|FG002|STARTED|Third Intervention||2
2867817|NCT00159263|3570934|FG003|STARTED|Third Intervention||2
2867818|NCT00159263|3570935|FG004|STARTED|Third Intervention||2
2867819|NCT00159263|3570936|FG005|STARTED|Third Intervention||2
2867820|NCT00159263|3570931|FG000|COMPLETED|Third Intervention||1
2867821|NCT00159263|3570932|FG001|COMPLETED|Third Intervention||1
2867822|NCT00159263|3570933|FG002|COMPLETED|Third Intervention||2
2867823|NCT00159263|3570934|FG003|COMPLETED|Third Intervention||2
2867824|NCT00159263|3570935|FG004|COMPLETED|Third Intervention||2
2867825|NCT00159263|3570936|FG005|COMPLETED|Third Intervention||2
2867826|NCT00159263|3570931|FG000|NOT COMPLETED|Third Intervention||0
2867827|NCT00159263|3570932|FG001|NOT COMPLETED|Third Intervention||0
2867828|NCT00159263|3570933|FG002|NOT COMPLETED|Third Intervention||0
2867829|NCT00159263|3570934|FG003|NOT COMPLETED|Third Intervention||0
2867830|NCT00159263|3570935|FG004|NOT COMPLETED|Third Intervention||0
2867831|NCT00159263|3570936|FG005|NOT COMPLETED|Third Intervention||0
2867832|NCT00159263|3570931|FG000|STARTED|Washout||1
2867833|NCT00159263|3570932|FG001|STARTED|Washout||1
2867834|NCT00159263|3570933|FG002|STARTED|Washout||2
2867835|NCT00159263|3570934|FG003|STARTED|Washout||2
2867836|NCT00159263|3570935|FG004|STARTED|Washout||2
2867837|NCT00159263|3570936|FG005|STARTED|Washout||2
2867838|NCT00159263|3570931|FG000|COMPLETED|Washout||1
2867839|NCT00159263|3570932|FG001|COMPLETED|Washout||1
2867840|NCT00159263|3570933|FG002|COMPLETED|Washout||2
2867841|NCT00159263|3570934|FG003|COMPLETED|Washout||2
2867842|NCT00159263|3570935|FG004|COMPLETED|Washout||2
2867843|NCT00159263|3570936|FG005|COMPLETED|Washout||2
2867844|NCT00159263|3570931|FG000|NOT COMPLETED|Washout||0
2867845|NCT00159263|3570932|FG001|NOT COMPLETED|Washout||0
2867846|NCT00159263|3570933|FG002|NOT COMPLETED|Washout||0
2867847|NCT00159263|3570934|FG003|NOT COMPLETED|Washout||0
2867848|NCT00159263|3570935|FG004|NOT COMPLETED|Washout||0
2867849|NCT00159263|3570936|FG005|NOT COMPLETED|Washout||0
3169395|NCT01925170|3896933|FG000|COMPLETED|Overall Study||1585
3169396|NCT01925170|3896933|FG000|NOT COMPLETED|Overall Study||53
3169397|NCT01925183|3896941|FG000|STARTED|Overall Study||3
2867850|NCT00159263|3570931|FG000|STARTED|Fourth Intervention||1
2867851|NCT00159263|3570932|FG001|STARTED|Fourth Intervention||1
2867852|NCT00159263|3570933|FG002|STARTED|Fourth Intervention||2
2867853|NCT00159263|3570934|FG003|STARTED|Fourth Intervention||2
2867854|NCT00159263|3570935|FG004|STARTED|Fourth Intervention||2
2867855|NCT00159263|3570936|FG005|STARTED|Fourth Intervention||2
2867856|NCT00159263|3570931|FG000|COMPLETED|Fourth Intervention||1
2867857|NCT00159263|3570932|FG001|COMPLETED|Fourth Intervention||1
2867858|NCT00159263|3570933|FG002|COMPLETED|Fourth Intervention||2
2867859|NCT00159263|3570934|FG003|COMPLETED|Fourth Intervention||2
2867860|NCT00159263|3570935|FG004|COMPLETED|Fourth Intervention||2
2867861|NCT00159263|3570936|FG005|COMPLETED|Fourth Intervention||2
2867862|NCT00159263|3570931|FG000|NOT COMPLETED|Fourth Intervention||0
2867863|NCT00159263|3570932|FG001|NOT COMPLETED|Fourth Intervention||0
2867864|NCT00159263|3570933|FG002|NOT COMPLETED|Fourth Intervention||0
2867865|NCT00159263|3570934|FG003|NOT COMPLETED|Fourth Intervention||0
2867866|NCT00159263|3570935|FG004|NOT COMPLETED|Fourth Intervention||0
3313489|NCT03075410|4046794|FG003|STARTED|Part A-Period 4 (14 Days)||1
3313490|NCT03075410|4046795|FG004|STARTED|Part A-Period 4 (14 Days)||2
3313491|NCT03075410|4046796|FG005|STARTED|Part A-Period 4 (14 Days)||1
3313492|NCT03075410|4046797|FG006|STARTED|Part A-Period 4 (14 Days)||0
3313493|NCT03075410|4046798|FG007|STARTED|Part A-Period 4 (14 Days)||0
3313494|NCT03075410|4046799|FG008|STARTED|Part A-Period 4 (14 Days)||0
3313495|NCT03075410|4046791|FG000|COMPLETED|Part A-Period 4 (14 Days)||1
3313496|NCT03075410|4046792|FG001|COMPLETED|Part A-Period 4 (14 Days)||1
3313497|NCT03075410|4046793|FG002|COMPLETED|Part A-Period 4 (14 Days)||2
3313498|NCT03075410|4046794|FG003|COMPLETED|Part A-Period 4 (14 Days)||1
3313499|NCT03075410|4046795|FG004|COMPLETED|Part A-Period 4 (14 Days)||2
3313500|NCT03075410|4046796|FG005|COMPLETED|Part A-Period 4 (14 Days)||1
3313501|NCT03075410|4046797|FG006|COMPLETED|Part A-Period 4 (14 Days)||0
3313502|NCT03075410|4046798|FG007|COMPLETED|Part A-Period 4 (14 Days)||0
3313503|NCT03075410|4046799|FG008|COMPLETED|Part A-Period 4 (14 Days)||0
3313504|NCT03075410|4046791|FG000|NOT COMPLETED|Part A-Period 4 (14 Days)||0
3313505|NCT03075410|4046792|FG001|NOT COMPLETED|Part A-Period 4 (14 Days)||0
3313506|NCT03075410|4046793|FG002|NOT COMPLETED|Part A-Period 4 (14 Days)||0
3313507|NCT03075410|4046794|FG003|NOT COMPLETED|Part A-Period 4 (14 Days)||0
3313508|NCT03075410|4046795|FG004|NOT COMPLETED|Part A-Period 4 (14 Days)||0
3313509|NCT03075410|4046796|FG005|NOT COMPLETED|Part A-Period 4 (14 Days)||0
3313510|NCT03075410|4046797|FG006|NOT COMPLETED|Part A-Period 4 (14 Days)||0
3313511|NCT03075410|4046798|FG007|NOT COMPLETED|Part A-Period 4 (14 Days)||0
3313512|NCT03075410|4046799|FG008|NOT COMPLETED|Part A-Period 4 (14 Days)||0
2867867|NCT00159263|3570936|FG005|NOT COMPLETED|Fourth Intervention||0
2867868|NCT00159263|3570931|FG000|STARTED|Washout||1
2867869|NCT00159263|3570932|FG001|STARTED|Washout||1
2867870|NCT00159263|3570933|FG002|STARTED|Washout||2
2867871|NCT00159263|3570934|FG003|STARTED|Washout||2
2867872|NCT00159263|3570935|FG004|STARTED|Washout||2
2867873|NCT00159263|3570936|FG005|STARTED|Washout||2
2867874|NCT00159263|3570931|FG000|COMPLETED|Washout||1
2867875|NCT00159263|3570932|FG001|COMPLETED|Washout||1
2867876|NCT00159263|3570933|FG002|COMPLETED|Washout||2
2867877|NCT00159263|3570934|FG003|COMPLETED|Washout||2
2867878|NCT00159263|3570935|FG004|COMPLETED|Washout||2
2867879|NCT00159263|3570936|FG005|COMPLETED|Washout||2
2867880|NCT00159263|3570931|FG000|NOT COMPLETED|Washout||0
2867881|NCT00159263|3570932|FG001|NOT COMPLETED|Washout||0
2867882|NCT00159263|3570933|FG002|NOT COMPLETED|Washout||0
2867883|NCT00159263|3570934|FG003|NOT COMPLETED|Washout||0
2867884|NCT00159263|3570935|FG004|NOT COMPLETED|Washout||0
2867885|NCT00159263|3570936|FG005|NOT COMPLETED|Washout||0
2867886|NCT00159263|3570931|FG000|STARTED|Fifth Intervention||1
2867887|NCT00159263|3570932|FG001|STARTED|Fifth Intervention||1
2867888|NCT00159263|3570933|FG002|STARTED|Fifth Intervention||2
2867889|NCT00159263|3570934|FG003|STARTED|Fifth Intervention||2
2867890|NCT00159263|3570935|FG004|STARTED|Fifth Intervention||2
2867891|NCT00159263|3570936|FG005|STARTED|Fifth Intervention||2
2867892|NCT00159263|3570931|FG000|COMPLETED|Fifth Intervention||1
2867893|NCT00159263|3570932|FG001|COMPLETED|Fifth Intervention||1
2867894|NCT00159263|3570933|FG002|COMPLETED|Fifth Intervention||2
2867895|NCT00159263|3570934|FG003|COMPLETED|Fifth Intervention||2
2867896|NCT00159263|3570935|FG004|COMPLETED|Fifth Intervention||2
2867897|NCT00159263|3570936|FG005|COMPLETED|Fifth Intervention||2
2867898|NCT00159263|3570931|FG000|NOT COMPLETED|Fifth Intervention||0
2867899|NCT00159263|3570932|FG001|NOT COMPLETED|Fifth Intervention||0
2867900|NCT00159263|3570933|FG002|NOT COMPLETED|Fifth Intervention||0
2867901|NCT00159263|3570934|FG003|NOT COMPLETED|Fifth Intervention||0
2867902|NCT00159263|3570935|FG004|NOT COMPLETED|Fifth Intervention||0
2867903|NCT00159263|3570936|FG005|NOT COMPLETED|Fifth Intervention||0
2867904|NCT00159263|3570931|FG000|STARTED|Washout||1
2867905|NCT00159263|3570932|FG001|STARTED|Washout||1
2867906|NCT00159263|3570933|FG002|STARTED|Washout||2
2867907|NCT00159263|3570934|FG003|STARTED|Washout||2
2867908|NCT00159263|3570935|FG004|STARTED|Washout||2
2867909|NCT00159263|3570936|FG005|STARTED|Washout||2
2867910|NCT00159263|3570931|FG000|COMPLETED|Washout||1
2867911|NCT00159263|3570932|FG001|COMPLETED|Washout||1
2867912|NCT00159263|3570933|FG002|COMPLETED|Washout||2
2867913|NCT00159263|3570934|FG003|COMPLETED|Washout||2
2867914|NCT00159263|3570935|FG004|COMPLETED|Washout||2
2867915|NCT00159263|3570936|FG005|COMPLETED|Washout||2
2867916|NCT00159263|3570931|FG000|NOT COMPLETED|Washout||0
2867917|NCT00159263|3570932|FG001|NOT COMPLETED|Washout||0
2867918|NCT00159263|3570933|FG002|NOT COMPLETED|Washout||0
2867919|NCT00159263|3570934|FG003|NOT COMPLETED|Washout||0
2867920|NCT00159263|3570935|FG004|NOT COMPLETED|Washout||0
2867921|NCT00159263|3570936|FG005|NOT COMPLETED|Washout||0
2867922|NCT00159263|3570931|FG000|STARTED|Sixth Intervention||1
2867923|NCT00159263|3570932|FG001|STARTED|Sixth Intervention||1
2867924|NCT00159263|3570933|FG002|STARTED|Sixth Intervention||2
2867925|NCT00159263|3570934|FG003|STARTED|Sixth Intervention||2
2867926|NCT00159263|3570935|FG004|STARTED|Sixth Intervention||2
2867927|NCT00159263|3570936|FG005|STARTED|Sixth Intervention||2
2867928|NCT00159263|3570931|FG000|COMPLETED|Sixth Intervention||1
2867929|NCT00159263|3570932|FG001|COMPLETED|Sixth Intervention||1
2867930|NCT00159263|3570933|FG002|COMPLETED|Sixth Intervention||2
2867931|NCT00159263|3570934|FG003|COMPLETED|Sixth Intervention||2
2867932|NCT00159263|3570935|FG004|COMPLETED|Sixth Intervention||2
2867933|NCT00159263|3570936|FG005|COMPLETED|Sixth Intervention||2
2867934|NCT00159263|3570931|FG000|NOT COMPLETED|Sixth Intervention||0
2867935|NCT00159263|3570932|FG001|NOT COMPLETED|Sixth Intervention||0
2867936|NCT00159263|3570933|FG002|NOT COMPLETED|Sixth Intervention||0
2867937|NCT00159263|3570934|FG003|NOT COMPLETED|Sixth Intervention||0
2867938|NCT00159263|3570935|FG004|NOT COMPLETED|Sixth Intervention||0
2867939|NCT00159263|3570936|FG005|NOT COMPLETED|Sixth Intervention||0
2867940|NCT00159419|3570952|FG000|STARTED|Overall Study||9
2867941|NCT00159419|3570953|FG001|STARTED|Overall Study||9
2867942|NCT00159419|3570952|FG000|COMPLETED|Overall Study||9
2867943|NCT00159419|3570953|FG001|COMPLETED|Overall Study||9
2867944|NCT00159419|3570952|FG000|NOT COMPLETED|Overall Study||0
2867945|NCT00159419|3570953|FG001|NOT COMPLETED|Overall Study||0
2867946|NCT00159432|3570959|FG000|STARTED|Overall Study||63
2867947|NCT00159432|3570959|FG000|COMPLETED|Overall Study||53
2867948|NCT00159432|3570959|FG000|NOT COMPLETED|Overall Study||10
2867949|NCT00159822|3570963|FG000|STARTED|Voriconazole Treatment Period||48
2867950|NCT00159822|3570963|FG000|COMPLETED|Voriconazole Treatment Period|Number of subjects completed treatment: 36 up to month 6 (M6); 26 after M6.|26
2867951|NCT00159822|3570963|FG000|NOT COMPLETED|Voriconazole Treatment Period||22
2867952|NCT00159822|3570963|FG000|STARTED|Post-treatment Follow-up Period||26
2867953|NCT00159822|3570963|FG000|COMPLETED|Post-treatment Follow-up Period||23
2867954|NCT00159822|3570963|FG000|NOT COMPLETED|Post-treatment Follow-up Period||3
2867955|NCT00159861|3570969|FG000|STARTED|Core Study - 16 Weeks||133
2867956|NCT00159861|3570970|FG001|STARTED|Core Study - 16 Weeks||134
2867957|NCT00159861|3570969|FG000|Treated|Core Study - 16 Weeks||131
2867958|NCT00159861|3570970|FG001|Treated|Core Study - 16 Weeks||134
2867959|NCT00159861|3570969|FG000|COMPLETED|Core Study - 16 Weeks|Entered A1481153: 115; Did not enter A1481153: 16|108
2867960|NCT00159861|3570970|FG001|COMPLETED|Core Study - 16 Weeks|Entered A1481153: 127; Did not enter A1481153: 7|122
2867961|NCT00159861|3570969|FG000|NOT COMPLETED|Core Study - 16 Weeks||25
2867962|NCT00159861|3570970|FG001|NOT COMPLETED|Core Study - 16 Weeks||12
2867963|NCT00159861|3570969|FG000|STARTED|Extension Study - up to 3 Years|Subjects may have entered extension study after 4 weeks in core study (prior to completion).|115
2867964|NCT00159861|3570970|FG001|STARTED|Extension Study - up to 3 Years|Subjects may have entered extension study after 4 weeks in core study (prior to completion).|127
2867965|NCT00159861|3570969|FG000|Treated|Extension Study - up to 3 Years||115
2867966|NCT00159861|3570970|FG001|Treated|Extension Study - up to 3 Years||127
2867967|NCT00159861|3570969|FG000|COMPLETED|Extension Study - up to 3 Years||53
2867968|NCT00159861|3570970|FG001|COMPLETED|Extension Study - up to 3 Years||56
2867969|NCT00159861|3570969|FG000|NOT COMPLETED|Extension Study - up to 3 Years||62
2867970|NCT00159861|3570970|FG001|NOT COMPLETED|Extension Study - up to 3 Years||71
2867971|NCT00159874|3570988|FG000|STARTED|Overall Study||42
2867972|NCT00159874|3570989|FG001|STARTED|Overall Study||55
2867973|NCT00159874|3570990|FG002|STARTED|Overall Study||77
2867974|NCT00159874|3570991|FG003|STARTED|Overall Study||13
2867975|NCT00159874|3570992|FG004|STARTED|Overall Study||19
2867976|NCT00159874|3570993|FG005|STARTED|Overall Study||23
2867977|NCT00159874|3570994|FG006|STARTED|Overall Study||5
2867978|NCT00159874|3570988|FG000|Treated|Overall Study||42
2867979|NCT00159874|3570989|FG001|Treated|Overall Study||55
2867980|NCT00159874|3570990|FG002|Treated|Overall Study||77
2867981|NCT00159874|3570991|FG003|Treated|Overall Study||13
2867982|NCT00159874|3570992|FG004|Treated|Overall Study||19
2867983|NCT00159874|3570993|FG005|Treated|Overall Study||23
2867984|NCT00159874|3570994|FG006|Treated|Overall Study||5
2867985|NCT00159874|3570988|FG000|COMPLETED|Overall Study||22
2867986|NCT00159874|3570989|FG001|COMPLETED|Overall Study||25
2867987|NCT00159874|3570990|FG002|COMPLETED|Overall Study||34
2867988|NCT00159874|3570991|FG003|COMPLETED|Overall Study||7
2867989|NCT00159874|3570992|FG004|COMPLETED|Overall Study||11
2867990|NCT00159874|3570993|FG005|COMPLETED|Overall Study||11
2867991|NCT00159874|3570994|FG006|COMPLETED|Overall Study||0
2867992|NCT00159874|3570988|FG000|NOT COMPLETED|Overall Study||20
2867993|NCT00159874|3570989|FG001|NOT COMPLETED|Overall Study||30
2867994|NCT00159874|3570990|FG002|NOT COMPLETED|Overall Study||43
2867995|NCT00159874|3570991|FG003|NOT COMPLETED|Overall Study||6
3169398|NCT01925183|3896942|FG001|STARTED|Overall Study||3
3169399|NCT01925183|3896941|FG000|COMPLETED|Overall Study||2
3169400|NCT01925183|3896942|FG001|COMPLETED|Overall Study||3
3169401|NCT01925183|3896941|FG000|NOT COMPLETED|Overall Study||1
3169402|NCT01925183|3896942|FG001|NOT COMPLETED|Overall Study||0
3169403|NCT01925209|3896952|FG000|STARTED|Treatment Epoch||63
3169404|NCT01925209|3896953|FG001|STARTED|Treatment Epoch||63
3169405|NCT01925209|3896954|FG002|STARTED|Treatment Epoch||63
3169406|NCT01925209|3896955|FG003|STARTED|Treatment Epoch||62
3169407|NCT01925209|3896952|FG000|Full Analysis Set|Treatment Epoch||63
3169408|NCT01925209|3896953|FG001|Full Analysis Set|Treatment Epoch||63
3169409|NCT01925209|3896954|FG002|Full Analysis Set|Treatment Epoch||63
3169410|NCT01925209|3896955|FG003|Full Analysis Set|Treatment Epoch||62
3169411|NCT01925209|3896952|FG000|COMPLETED|Treatment Epoch||54
3169412|NCT01925209|3896953|FG001|COMPLETED|Treatment Epoch||55
2867996|NCT00159874|3570992|FG004|NOT COMPLETED|Overall Study||8
2867997|NCT00159874|3570993|FG005|NOT COMPLETED|Overall Study||12
2867998|NCT00159874|3570994|FG006|NOT COMPLETED|Overall Study||5
2867999|NCT00159913|3571014|FG000|STARTED|Overall Study||42
2868000|NCT00159913|3571015|FG001|STARTED|Overall Study||55
2868001|NCT00159913|3571016|FG002|STARTED|Overall Study||77
2868002|NCT00159913|3571017|FG003|STARTED|Overall Study||60
2868003|NCT00159913|3571014|FG000|COMPLETED|Overall Study||40
2868004|NCT00159913|3571015|FG001|COMPLETED|Overall Study||55
2868005|NCT00159913|3571016|FG002|COMPLETED|Overall Study||75
2868006|NCT00159913|3571017|FG003|COMPLETED|Overall Study||58
2868007|NCT00159913|3571014|FG000|NOT COMPLETED|Overall Study||2
2868008|NCT00159913|3571015|FG001|NOT COMPLETED|Overall Study||0
2868009|NCT00159913|3571016|FG002|NOT COMPLETED|Overall Study||2
2868010|NCT00159913|3571017|FG003|NOT COMPLETED|Overall Study||2
2868011|NCT00159965|3571031|FG000|STARTED|Overall Study||19
2868012|NCT00159965|3571032|FG001|STARTED|Overall Study||19
2868013|NCT00159965|3571031|FG000|COMPLETED|Overall Study||12
2868014|NCT00159965|3571032|FG001|COMPLETED|Overall Study||14
2868015|NCT00159965|3571031|FG000|NOT COMPLETED|Overall Study||7
2868016|NCT00159965|3571032|FG001|NOT COMPLETED|Overall Study||5
2868017|NCT00160199|3571040|FG000|STARTED|Overall Study||122
2868018|NCT00160199|3571041|FG001|STARTED|Overall Study||118
2868019|NCT00160199|3571040|FG000|COMPLETED|Overall Study||98
2868020|NCT00160199|3571041|FG001|COMPLETED|Overall Study||81
2868021|NCT00160199|3571040|FG000|NOT COMPLETED|Overall Study||24
2868022|NCT00160199|3571041|FG001|NOT COMPLETED|Overall Study||37
2868023|NCT00160251|3571053|FG000|STARTED|Prior to Amendment 2||15
2868024|NCT00160251|3571054|FG001|STARTED|Prior to Amendment 2||34
2868025|NCT00160251|3571055|FG002|STARTED|Prior to Amendment 2||48
2868026|NCT00160251|3571056|FG003|STARTED|Prior to Amendment 2||49
2868027|NCT00160251|3571057|FG004|STARTED|Prior to Amendment 2||49
2868028|NCT00160251|3571058|FG005|STARTED|Prior to Amendment 2||97
2868029|NCT00160251|3571059|FG006|STARTED|Prior to Amendment 2||65
2868030|NCT00160251|3571060|FG007|STARTED|Prior to Amendment 2||0
2868031|NCT00160251|3571053|FG000|COMPLETED|Prior to Amendment 2||6
2868032|NCT00160251|3571054|FG001|COMPLETED|Prior to Amendment 2||28
2868033|NCT00160251|3571055|FG002|COMPLETED|Prior to Amendment 2||4
2868034|NCT00160251|3571056|FG003|COMPLETED|Prior to Amendment 2||9
2868035|NCT00160251|3571057|FG004|COMPLETED|Prior to Amendment 2||21
2868036|NCT00160251|3571058|FG005|COMPLETED|Prior to Amendment 2||14
2868037|NCT00160251|3571059|FG006|COMPLETED|Prior to Amendment 2||61
2868038|NCT00160251|3571060|FG007|COMPLETED|Prior to Amendment 2||0
2868039|NCT00160251|3571053|FG000|NOT COMPLETED|Prior to Amendment 2||9
2868040|NCT00160251|3571054|FG001|NOT COMPLETED|Prior to Amendment 2||6
2868041|NCT00160251|3571055|FG002|NOT COMPLETED|Prior to Amendment 2||44
2868042|NCT00160251|3571056|FG003|NOT COMPLETED|Prior to Amendment 2||40
2868043|NCT00160251|3571057|FG004|NOT COMPLETED|Prior to Amendment 2||28
2868044|NCT00160251|3571058|FG005|NOT COMPLETED|Prior to Amendment 2||83
2868045|NCT00160251|3571059|FG006|NOT COMPLETED|Prior to Amendment 2||4
2868046|NCT00160251|3571060|FG007|NOT COMPLETED|Prior to Amendment 2||0
2868047|NCT00160251|3571053|FG000|STARTED|Post-amendment 2||0
2868048|NCT00160251|3571054|FG001|STARTED|Post-amendment 2||0
2868049|NCT00160251|3571055|FG002|STARTED|Post-amendment 2||0
2868050|NCT00160251|3571056|FG003|STARTED|Post-amendment 2||0
2868051|NCT00160251|3571057|FG004|STARTED|Post-amendment 2||0
2868052|NCT00160251|3571058|FG005|STARTED|Post-amendment 2||0
2868053|NCT00160251|3571059|FG006|STARTED|Post-amendment 2||0
2868054|NCT00160251|3571060|FG007|STARTED|Post-amendment 2||143
2868055|NCT00160251|3571053|FG000|COMPLETED|Post-amendment 2||0
2868056|NCT00160251|3571054|FG001|COMPLETED|Post-amendment 2||0
2868057|NCT00160251|3571055|FG002|COMPLETED|Post-amendment 2||0
2868058|NCT00160251|3571056|FG003|COMPLETED|Post-amendment 2||0
2868059|NCT00160251|3571057|FG004|COMPLETED|Post-amendment 2||0
2868060|NCT00160251|3571058|FG005|COMPLETED|Post-amendment 2||0
2868061|NCT00160251|3571059|FG006|COMPLETED|Post-amendment 2||0
2868062|NCT00160251|3571060|FG007|COMPLETED|Post-amendment 2||88
2868063|NCT00160251|3571053|FG000|NOT COMPLETED|Post-amendment 2||0
2868064|NCT00160251|3571054|FG001|NOT COMPLETED|Post-amendment 2||0
2868065|NCT00160251|3571055|FG002|NOT COMPLETED|Post-amendment 2||0
2868066|NCT00160251|3571056|FG003|NOT COMPLETED|Post-amendment 2||0
2868067|NCT00160251|3571057|FG004|NOT COMPLETED|Post-amendment 2||0
2868068|NCT00160251|3571058|FG005|NOT COMPLETED|Post-amendment 2||0
2868069|NCT00160251|3571059|FG006|NOT COMPLETED|Post-amendment 2||0
2868070|NCT00160251|3571060|FG007|NOT COMPLETED|Post-amendment 2||55
2868071|NCT00160524|3571117|FG000|STARTED|Overall Study|One subject was enrolled erroneously and has no data in the database.|595
2868072|NCT00160524|3571117|FG000|COMPLETED|Overall Study||117
2868073|NCT00160524|3571117|FG000|NOT COMPLETED|Overall Study||478
2868074|NCT00160615|3571123|FG000|STARTED|Overall Study||50
2868075|NCT00160615|3571124|FG001|STARTED|Overall Study||101
2868076|NCT00160615|3571123|FG000|COMPLETED|Overall Study||32
2868077|NCT00160615|3571124|FG001|COMPLETED|Overall Study||56
2868078|NCT00160615|3571123|FG000|NOT COMPLETED|Overall Study||18
2868079|NCT00160615|3571124|FG001|NOT COMPLETED|Overall Study||45
2868080|NCT00160641|3571132|FG000|STARTED|Overall Study||567
2868081|NCT00160641|3571132|FG000|COMPLETED|Overall Study||346
2868082|NCT00160641|3571132|FG000|NOT COMPLETED|Overall Study||221
2868083|NCT00160654|3571136|FG000|STARTED|Overall Study||251
2868084|NCT00160654|3571136|FG000|COMPLETED|Overall Study||218
2868085|NCT00160654|3571136|FG000|NOT COMPLETED|Overall Study||33
2868086|NCT00160667|3571143|FG000|STARTED|Overall Study||50
2868087|NCT00160667|3571144|FG001|STARTED|Overall Study||51
2868088|NCT00160667|3571145|FG002|STARTED|Overall Study||51
2868089|NCT00160667|3571143|FG000|COMPLETED|Overall Study||45
2868090|NCT00160667|3571144|FG001|COMPLETED|Overall Study||48
2868091|NCT00160667|3571145|FG002|COMPLETED|Overall Study||45
2868092|NCT00160667|3571143|FG000|NOT COMPLETED|Overall Study||5
2868093|NCT00160667|3571144|FG001|NOT COMPLETED|Overall Study||3
2868094|NCT00160667|3571145|FG002|NOT COMPLETED|Overall Study||6
2868095|NCT00160680|3571156|FG000|STARTED|Overall Study||31
2868096|NCT00160680|3571157|FG001|STARTED|Overall Study||31
2868097|NCT00160680|3571156|FG000|COMPLETED|Overall Study||22
2868098|NCT00160680|3571157|FG001|COMPLETED|Overall Study||18
3169413|NCT01925209|3896954|FG002|COMPLETED|Treatment Epoch||56
3169414|NCT01925209|3896955|FG003|COMPLETED|Treatment Epoch||57
2868099|NCT00160680|3571156|FG000|NOT COMPLETED|Overall Study||9
2868100|NCT00160680|3571157|FG001|NOT COMPLETED|Overall Study||13
2868101|NCT00160693|3571163|FG000|STARTED|Overall Study||402
2868102|NCT00160693|3571163|FG000|COMPLETED|Overall Study||167
2868103|NCT00160693|3571163|FG000|NOT COMPLETED|Overall Study||235
2868104|NCT00160706|3571167|FG000|STARTED|Overall Study||310
2868105|NCT00160706|3571167|FG000|COMPLETED|Overall Study||24
2868106|NCT00160706|3571167|FG000|NOT COMPLETED|Overall Study||286
2868107|NCT00161213|3571171|FG000|STARTED|Overall Study||44
2868108|NCT00161213|3571171|FG000|COMPLETED|Overall Study||42
2868109|NCT00161213|3571171|FG000|NOT COMPLETED|Overall Study||2
2868110|NCT00161382|3571177|FG000|STARTED|Overall Study|Number of students allocated to intervention group|598
2868111|NCT00161382|3571178|FG001|STARTED|Overall Study|Number of students allocated to comparison group|847
2868112|NCT00161382|3571177|FG000|COMPLETED|Overall Study|Number of intervention students included in the analyzed cohort (i.e., completed 9th-grade survey)|349
2868113|NCT00161382|3571178|FG001|COMPLETED|Overall Study|Number of control students included in the analyzed cohort (i.e., completed 9th-grade survey)|558
2868114|NCT00161382|3571177|FG000|NOT COMPLETED|Overall Study||249
2868115|NCT00161382|3571178|FG001|NOT COMPLETED|Overall Study||289
2868116|NCT00161473|3571186|FG000|STARTED|Overall Study||12
2868117|NCT00161473|3571187|FG001|STARTED|Overall Study||12
2868118|NCT00161473|3571186|FG000|COMPLETED|Overall Study||7
2868119|NCT00161473|3571187|FG001|COMPLETED|Overall Study||6
2868120|NCT00161473|3571186|FG000|NOT COMPLETED|Overall Study||5
2868121|NCT00161473|3571187|FG001|NOT COMPLETED|Overall Study||6
2868122|NCT00161616|3571195|FG000|STARTED|Overall Study||139
2868123|NCT00161616|3571196|FG001|STARTED|Overall Study||138
2868124|NCT00161616|3571195|FG000|COMPLETED|Overall Study||113
2868125|NCT00161616|3571196|FG001|COMPLETED|Overall Study||119
2868126|NCT00161616|3571195|FG000|NOT COMPLETED|Overall Study||26
2868127|NCT00161616|3571196|FG001|NOT COMPLETED|Overall Study||19
2868128|NCT00162032|3571204|FG000|STARTED|Overall Study||329
2868129|NCT00162032|3571205|FG001|STARTED|Overall Study||116
2868130|NCT00162032|3571204|FG000|COMPLETED|Overall Study|Completed is all subjects who completed 3 yr FU whether or not they were seen in the previous year.|324
2868131|NCT00162032|3571205|FG001|COMPLETED|Overall Study|Completed is all subjects who completed 3 yr FU whether or not they were seen in the previous year.|114
2868132|NCT00162032|3571204|FG000|NOT COMPLETED|Overall Study||5
2868133|NCT00162032|3571205|FG001|NOT COMPLETED|Overall Study||2
2868134|NCT00162097|3571220|FG000|STARTED|Overall Study|Treated on Day 1|6
2868135|NCT00162097|3571221|FG001|STARTED|Overall Study|Treated on Day 1|2
2868136|NCT00162097|3571222|FG002|STARTED|Overall Study|Treated on Day 1|1
2868137|NCT00162097|3571223|FG003|STARTED|Overall Study|Treated on Day 1. One participant enrolled twice in the study and is hence counted twice|7
2868138|NCT00162097|3571220|FG000|COMPLETED|Overall Study||6
2868139|NCT00162097|3571221|FG001|COMPLETED|Overall Study||2
2868140|NCT00162097|3571222|FG002|COMPLETED|Overall Study||1
2868141|NCT00162097|3571223|FG003|COMPLETED|Overall Study||6
2868142|NCT00162097|3571220|FG000|NOT COMPLETED|Overall Study||0
2868143|NCT00162097|3571221|FG001|NOT COMPLETED|Overall Study||0
2868144|NCT00162097|3571222|FG002|NOT COMPLETED|Overall Study||0
2868145|NCT00162097|3571223|FG003|NOT COMPLETED|Overall Study||1
2868146|NCT00162123|3571247|FG000|STARTED|Overall Study|Enrolled|53
2868147|NCT00162123|3571248|FG001|STARTED|Overall Study|Enrolled|34
2868148|NCT00162123|3571249|FG002|STARTED|Overall Study|Enrolled|24
2868149|NCT00162123|3571250|FG003|STARTED|Overall Study|Enrolled|11
2868150|NCT00162123|3571251|FG004|STARTED|Overall Study|Enrolled|45
2868151|NCT00162123|3571252|FG005|STARTED|Overall Study|Enrolled|13
2868152|NCT00162123|3571253|FG006|STARTED|Overall Study|Enrolled|4
2868153|NCT00162123|3571254|FG007|STARTED|Overall Study|Enrolled|58
2868154|NCT00162123|3571247|FG000|Received Treatment|Overall Study||53
2868155|NCT00162123|3571248|FG001|Received Treatment|Overall Study||34
2868156|NCT00162123|3571249|FG002|Received Treatment|Overall Study||24
2868157|NCT00162123|3571250|FG003|Received Treatment|Overall Study||11
2868158|NCT00162123|3571251|FG004|Received Treatment|Overall Study||33
2868159|NCT00162123|3571252|FG005|Received Treatment|Overall Study||12
2868160|NCT00162123|3571253|FG006|Received Treatment|Overall Study||4
2868161|NCT00162123|3571254|FG007|Received Treatment|Overall Study||0
2868162|NCT00162123|3571247|FG000|COMPLETED|Overall Study|Still on treatment|9
2868163|NCT00162123|3571248|FG001|COMPLETED|Overall Study|Still on treatment|5
2868164|NCT00162123|3571249|FG002|COMPLETED|Overall Study|Still on treatment|3
2868165|NCT00162123|3571250|FG003|COMPLETED|Overall Study|Still on treatment|3
2868166|NCT00162123|3571251|FG004|COMPLETED|Overall Study|Still on treatment|14
2868167|NCT00162123|3571252|FG005|COMPLETED|Overall Study|Still on treatment|4
2868168|NCT00162123|3571253|FG006|COMPLETED|Overall Study|Still on treatment|0
2868169|NCT00162123|3571254|FG007|COMPLETED|Overall Study|Still on treatment|0
2868170|NCT00162123|3571247|FG000|NOT COMPLETED|Overall Study||44
2868171|NCT00162123|3571248|FG001|NOT COMPLETED|Overall Study||29
2868172|NCT00162123|3571249|FG002|NOT COMPLETED|Overall Study||21
2868173|NCT00162123|3571250|FG003|NOT COMPLETED|Overall Study||8
2868174|NCT00162123|3571251|FG004|NOT COMPLETED|Overall Study||31
2868175|NCT00162123|3571252|FG005|NOT COMPLETED|Overall Study||9
2868176|NCT00162123|3571253|FG006|NOT COMPLETED|Overall Study||4
2868177|NCT00162123|3571254|FG007|NOT COMPLETED|Overall Study||58
2868178|NCT00162136|3571279|FG000|STARTED|Overall Study||35
2868179|NCT00162136|3571279|FG000|COMPLETED|Overall Study|Number of Participants still on treatment at study termination|0
2868180|NCT00162136|3571279|FG000|NOT COMPLETED|Overall Study||35
2868181|NCT00162266|3571306|FG000|STARTED|Double-Blind Period||115
2868182|NCT00162266|3571307|FG001|STARTED|Double-Blind Period||105
2868183|NCT00162266|3571308|FG002|STARTED|Double-Blind Period||119
2868184|NCT00162266|3571309|FG003|STARTED|Double-Blind Period||0
2868185|NCT00162266|3571306|FG000|Completed Day 1 to Day 181|Double-Blind Period||98
2868186|NCT00162266|3571307|FG001|Completed Day 1 to Day 181|Double-Blind Period||80
2868187|NCT00162266|3571308|FG002|Completed Day 1 to Day 181|Double-Blind Period||78
2868188|NCT00162266|3571309|FG003|Completed Day 1 to Day 181|Double-Blind Period||0
2868189|NCT00162266|3571306|FG000|COMPLETED|Double-Blind Period||90
2868190|NCT00162266|3571307|FG001|COMPLETED|Double-Blind Period||74
2868191|NCT00162266|3571308|FG002|COMPLETED|Double-Blind Period||71
2868192|NCT00162266|3571309|FG003|COMPLETED|Double-Blind Period||0
2868193|NCT00162266|3571306|FG000|NOT COMPLETED|Double-Blind Period||25
2868194|NCT00162266|3571307|FG001|NOT COMPLETED|Double-Blind Period||31
2868195|NCT00162266|3571308|FG002|NOT COMPLETED|Double-Blind Period||48
2868196|NCT00162266|3571309|FG003|NOT COMPLETED|Double-Blind Period||0
2868197|NCT00162266|3571306|FG000|STARTED|Open-Label Period||0
2868198|NCT00162266|3571307|FG001|STARTED|Open-Label Period||0
2868199|NCT00162266|3571308|FG002|STARTED|Open-Label Period||0
2868200|NCT00162266|3571309|FG003|STARTED|Open-Label Period||219
2868201|NCT00162266|3571306|FG000|COMPLETED|Open-Label Period||0
2868202|NCT00162266|3571307|FG001|COMPLETED|Open-Label Period||0
2868203|NCT00162266|3571308|FG002|COMPLETED|Open-Label Period||0
2868204|NCT00162266|3571309|FG003|COMPLETED|Open-Label Period||82
2868205|NCT00162266|3571306|FG000|NOT COMPLETED|Open-Label Period||0
2868206|NCT00162266|3571307|FG001|NOT COMPLETED|Open-Label Period||0
2868207|NCT00162266|3571308|FG002|NOT COMPLETED|Open-Label Period||0
2868208|NCT00162266|3571309|FG003|NOT COMPLETED|Open-Label Period||137
2868209|NCT00162981|3571363|FG000|STARTED|Overall Study||32
2868210|NCT00162981|3571364|FG001|STARTED|Overall Study||36
2868211|NCT00162981|3571363|FG000|COMPLETED|Overall Study||28
2868212|NCT00162981|3571364|FG001|COMPLETED|Overall Study||30
2868213|NCT00162981|3571363|FG000|NOT COMPLETED|Overall Study||4
2868214|NCT00162981|3571364|FG001|NOT COMPLETED|Overall Study||6
2868215|NCT00163020|3571372|FG000|STARTED|Overall Study|Twins = 160 Triplets = 56|216
2868216|NCT00163020|3571373|FG001|STARTED|Overall Study|Twins = 80 Triplets = 25|105
2868217|NCT00163020|3571372|FG000|COMPLETED|Overall Study|Twins = 160 Triplets = 56|216
2868218|NCT00163020|3571373|FG001|COMPLETED|Overall Study|Twins = 78 Triplets = 25|103
2868219|NCT00163020|3571372|FG000|NOT COMPLETED|Overall Study||0
2868220|NCT00163020|3571373|FG001|NOT COMPLETED|Overall Study||2
2868221|NCT00163189|3571381|FG000|STARTED|Overall Study||98
2868222|NCT00163189|3571381|FG000|COMPLETED|Overall Study||35
2868223|NCT00163189|3571381|FG000|NOT COMPLETED|Overall Study||63
2868224|NCT00163215|3571385|FG000|STARTED|Overall Study||46
2868225|NCT00163215|3571385|FG000|COMPLETED|Overall Study||31
2868226|NCT00163215|3571385|FG000|NOT COMPLETED|Overall Study||15
2868227|NCT00163293|3571392|FG000|STARTED|Overall Study||79
2868228|NCT00163293|3571393|FG001|STARTED|Overall Study||76
2868229|NCT00163293|3571394|FG002|STARTED|Overall Study||85
2868230|NCT00163293|3571392|FG000|COMPLETED|Overall Study||66
2868231|NCT00163293|3571393|FG001|COMPLETED|Overall Study||69
2868232|NCT00163293|3571394|FG002|COMPLETED|Overall Study||66
2868233|NCT00163293|3571392|FG000|NOT COMPLETED|Overall Study||13
2868234|NCT00163293|3571393|FG001|NOT COMPLETED|Overall Study||7
2868235|NCT00163293|3571394|FG002|NOT COMPLETED|Overall Study||19
2868236|NCT00163657|3571405|FG000|STARTED|Overall Study||80
2868237|NCT00163657|3571406|FG001|STARTED|Overall Study||79
2868238|NCT00163657|3571407|FG002|STARTED|Overall Study||153
2868239|NCT00163657|3571405|FG000|COMPLETED|Overall Study||60
2868240|NCT00163657|3571406|FG001|COMPLETED|Overall Study||56
2868241|NCT00163657|3571407|FG002|COMPLETED|Overall Study||116
2868242|NCT00163657|3571405|FG000|NOT COMPLETED|Overall Study||20
2868243|NCT00163657|3571406|FG001|NOT COMPLETED|Overall Study||23
2868244|NCT00163657|3571407|FG002|NOT COMPLETED|Overall Study||37
2868245|NCT00165646|3571418|FG000|STARTED|Overall Study||93
2868246|NCT00165646|3571419|FG001|STARTED|Overall Study||93
2868247|NCT00165646|3571420|FG002|STARTED|Overall Study||102
2868248|NCT00165646|3571418|FG000|COMPLETED|Overall Study||88
2868249|NCT00165646|3571419|FG001|COMPLETED|Overall Study||88
2868250|NCT00165646|3571420|FG002|COMPLETED|Overall Study||98
2868251|NCT00165646|3571418|FG000|NOT COMPLETED|Overall Study||5
2868252|NCT00165646|3571419|FG001|NOT COMPLETED|Overall Study||5
2868253|NCT00165646|3571420|FG002|NOT COMPLETED|Overall Study||4
2868254|NCT00165672|3571430|FG000|STARTED|Overall Study||13
2868255|NCT00165672|3571431|FG001|STARTED|Overall Study||13
2868256|NCT00165672|3571430|FG000|COMPLETED|Overall Study||13
2868257|NCT00165672|3571431|FG001|COMPLETED|Overall Study||12
2868258|NCT00165672|3571430|FG000|NOT COMPLETED|Overall Study||0
2868259|NCT00165672|3571431|FG001|NOT COMPLETED|Overall Study||1
2868260|NCT00165698|3571439|FG000|STARTED|Overall Study||120
2868261|NCT00165698|3571440|FG001|STARTED|Overall Study||120
2868262|NCT00165698|3571439|FG000|COMPLETED|Overall Study||112
2868263|NCT00165698|3571440|FG001|COMPLETED|Overall Study||105
2868264|NCT00165698|3571439|FG000|NOT COMPLETED|Overall Study||8
2868265|NCT00165698|3571440|FG001|NOT COMPLETED|Overall Study||15
3313513|NCT03075410|4046791|FG000|STARTED|Part B (up to 28 Days)||0
3313514|NCT03075410|4046792|FG001|STARTED|Part B (up to 28 Days)||0
3313515|NCT03075410|4046793|FG002|STARTED|Part B (up to 28 Days)||0
3313516|NCT03075410|4046794|FG003|STARTED|Part B (up to 28 Days)||0
3313517|NCT03075410|4046795|FG004|STARTED|Part B (up to 28 Days)||0
2868266|NCT00165776|3571450|FG000|STARTED|Overall Study||35
2868267|NCT00165776|3571451|FG001|STARTED|Overall Study||34
2868268|NCT00165776|3571452|FG002|STARTED|Overall Study||33
2868269|NCT00165776|3571453|FG003|STARTED|Overall Study||31
2868270|NCT00165776|3571450|FG000|COMPLETED|Overall Study||31
2868271|NCT00165776|3571451|FG001|COMPLETED|Overall Study||33
2868272|NCT00165776|3571452|FG002|COMPLETED|Overall Study||31
2868273|NCT00165776|3571453|FG003|COMPLETED|Overall Study||29
2868274|NCT00165776|3571450|FG000|NOT COMPLETED|Overall Study||4
2868275|NCT00165776|3571451|FG001|NOT COMPLETED|Overall Study||1
2868276|NCT00165776|3571452|FG002|NOT COMPLETED|Overall Study||2
2868277|NCT00165776|3571453|FG003|NOT COMPLETED|Overall Study||2
2868278|NCT00165789|3571467|FG000|STARTED|Overall Study||8
2868279|NCT00165789|3571468|FG001|STARTED|Overall Study||20
2868280|NCT00165789|3571469|FG002|STARTED|Overall Study||12
2868281|NCT00165789|3571470|FG003|STARTED|Overall Study||35
2868282|NCT00165789|3571467|FG000|COMPLETED|Overall Study||8
2868283|NCT00165789|3571468|FG001|COMPLETED|Overall Study||16
2868284|NCT00165789|3571469|FG002|COMPLETED|Overall Study||11
2868285|NCT00165789|3571470|FG003|COMPLETED|Overall Study||21
2868286|NCT00165789|3571467|FG000|NOT COMPLETED|Overall Study||0
2868287|NCT00165789|3571468|FG001|NOT COMPLETED|Overall Study||4
2868288|NCT00165789|3571469|FG002|NOT COMPLETED|Overall Study||1
2868289|NCT00165789|3571470|FG003|NOT COMPLETED|Overall Study||14
2918691|NCT00528528|3628977|FG003|Ongoing at Time of Cut-off|Overall Study||0
2918692|NCT00528528|3628974|FG000|COMPLETED|Overall Study||37
2918693|NCT00528528|3628975|FG001|COMPLETED|Overall Study||39
2918694|NCT00528528|3628976|FG002|COMPLETED|Overall Study||37
2918695|NCT00528528|3628977|FG003|COMPLETED|Overall Study||36
2918696|NCT00528528|3628974|FG000|NOT COMPLETED|Overall Study||3
2918697|NCT00528528|3628975|FG001|NOT COMPLETED|Overall Study||3
2918698|NCT00528528|3628976|FG002|NOT COMPLETED|Overall Study||3
2918699|NCT00528528|3628977|FG003|NOT COMPLETED|Overall Study||3
2918700|NCT00528541|3628991|FG000|STARTED|Overall Study||75
2918701|NCT00528541|3628992|FG001|STARTED|Overall Study||70
2918702|NCT00528541|3628991|FG000|COMPLETED|Overall Study||73
2918703|NCT00528541|3628992|FG001|COMPLETED|Overall Study||69
2918704|NCT00528541|3628991|FG000|NOT COMPLETED|Overall Study||2
2918705|NCT00528541|3628992|FG001|NOT COMPLETED|Overall Study||1
2918706|NCT00528567|3629000|FG000|STARTED|Overall Study||1301
2918707|NCT00528567|3629001|FG001|STARTED|Overall Study||1290
2918708|NCT00528567|3629000|FG000|Intention to Treat|Overall Study||1301
2918709|NCT00528567|3629001|FG001|Intention to Treat|Overall Study||1290
2918710|NCT00528567|3629000|FG000|Safety Population|Overall Study||1288
2918711|NCT00528567|3629001|FG001|Safety Population|Overall Study||1271
2918712|NCT00528567|3629000|FG000|COMPLETED|Overall Study||870
2918713|NCT00528567|3629001|FG001|COMPLETED|Overall Study||982
2918714|NCT00528567|3629000|FG000|NOT COMPLETED|Overall Study||431
2918715|NCT00528567|3629001|FG001|NOT COMPLETED|Overall Study||308
2918716|NCT00528580|3629016|FG000|STARTED|Overall Study||34
2868290|NCT00165841|3571482|FG000|STARTED|Overall Study||103
2868291|NCT00165841|3571483|FG001|STARTED|Overall Study||97
2868292|NCT00165841|3571482|FG000|COMPLETED|Overall Study||73
2868293|NCT00165841|3571483|FG001|COMPLETED|Overall Study||35
2868294|NCT00165841|3571482|FG000|NOT COMPLETED|Overall Study||30
2868295|NCT00165841|3571483|FG001|NOT COMPLETED|Overall Study||62
2868296|NCT00165958|3571491|FG000|STARTED|Overall Study||19
2868297|NCT00165958|3571492|FG001|STARTED|Overall Study||21
2868298|NCT00165958|3571491|FG000|COMPLETED|Overall Study||18
2868299|NCT00165958|3571492|FG001|COMPLETED|Overall Study||19
2868300|NCT00165958|3571491|FG000|NOT COMPLETED|Overall Study||1
2868301|NCT00165958|3571492|FG001|NOT COMPLETED|Overall Study||2
2868302|NCT00165984|3571498|FG000|STARTED|Overall Study||165
2868303|NCT00165984|3571498|FG000|COMPLETED|Overall Study||150
2868304|NCT00165984|3571498|FG000|NOT COMPLETED|Overall Study||15
2868305|NCT00166036|3571507|FG000|STARTED|Overall Study||17
2868306|NCT00166036|3571508|FG001|STARTED|Overall Study||19
2868307|NCT00166036|3571507|FG000|COMPLETED|Overall Study||17
2868308|NCT00166036|3571508|FG001|COMPLETED|Overall Study||19
2868309|NCT00166036|3571507|FG000|NOT COMPLETED|Overall Study||0
2868310|NCT00166036|3571508|FG001|NOT COMPLETED|Overall Study||0
2868311|NCT00166114|3571517|FG000|STARTED|Overall Study||21
2868312|NCT00166114|3571518|FG001|STARTED|Overall Study||19
2868313|NCT00166114|3571517|FG000|COMPLETED|Overall Study||7
2868314|NCT00166114|3571518|FG001|COMPLETED|Overall Study||13
2868315|NCT00166114|3571517|FG000|NOT COMPLETED|Overall Study||14
2868316|NCT00166114|3571518|FG001|NOT COMPLETED|Overall Study||6
2868317|NCT00166166|3571526|FG000|STARTED|Overall Study||103
2868318|NCT00166166|3571527|FG001|STARTED|Overall Study||71
2868319|NCT00166166|3571526|FG000|COMPLETED|Overall Study||103
2868320|NCT00166166|3571527|FG001|COMPLETED|Overall Study||71
2868321|NCT00166166|3571526|FG000|NOT COMPLETED|Overall Study||0
2868322|NCT00166166|3571527|FG001|NOT COMPLETED|Overall Study||0
2868323|NCT00166205|3571546|FG000|STARTED|Overall Study||276
2868324|NCT00166205|3571546|FG000|Intervention - SAGB Surgery|Overall Study||276
2868325|NCT00166205|3571546|FG000|COMPLETED|Overall Study||228
2868326|NCT00166205|3571546|FG000|NOT COMPLETED|Overall Study||48
2868327|NCT00166296|3571552|FG000|STARTED|Overall Study|Randomized patients|67
2868328|NCT00166296|3571553|FG001|STARTED|Overall Study|Randomized patients|66
2868329|NCT00166296|3571552|FG000|ANALYZED|Overall Study|Patients who did receive at least the first dose of study medications, included in the analysis|66
2868330|NCT00166296|3571553|FG001|ANALYZED|Overall Study|Patients who did receive at least the first dose of study medications, included in the analysis|63
2868331|NCT00166296|3571552|FG000|COMPLETED|Overall Study|Patients who completed both trial medication and interferon+ribavirin treatment for 12 weeks|60
2868332|NCT00166296|3571553|FG001|COMPLETED|Overall Study|Patients who completed both trial medication and interferon+ribavirin treatment for 12 weeks|57
2868333|NCT00166296|3571552|FG000|NOT COMPLETED|Overall Study||7
2868334|NCT00166296|3571553|FG001|NOT COMPLETED|Overall Study||9
2868335|NCT00166361|3571561|FG000|STARTED|Overall Study||14
2868336|NCT00166361|3571562|FG001|STARTED|Overall Study||10
2868337|NCT00166361|3571561|FG000|COMPLETED|Overall Study||14
2868338|NCT00166361|3571562|FG001|COMPLETED|Overall Study||10
2868339|NCT00166361|3571561|FG000|NOT COMPLETED|Overall Study||0
3313518|NCT03075410|4046796|FG005|STARTED|Part B (up to 28 Days)||0
3313519|NCT03075410|4046797|FG006|STARTED|Part B (up to 28 Days)||4
3313520|NCT03075410|4046798|FG007|STARTED|Part B (up to 28 Days)||7
3313521|NCT03075410|4046799|FG008|STARTED|Part B (up to 28 Days)||8
3313522|NCT03075410|4046791|FG000|COMPLETED|Part B (up to 28 Days)||0
3313523|NCT03075410|4046792|FG001|COMPLETED|Part B (up to 28 Days)||0
3313524|NCT03075410|4046793|FG002|COMPLETED|Part B (up to 28 Days)||0
3313525|NCT03075410|4046794|FG003|COMPLETED|Part B (up to 28 Days)||0
3313526|NCT03075410|4046795|FG004|COMPLETED|Part B (up to 28 Days)||0
3313527|NCT03075410|4046796|FG005|COMPLETED|Part B (up to 28 Days)||0
2868340|NCT00166361|3571562|FG001|NOT COMPLETED|Overall Study||0
2868341|NCT00166439|3571568|FG000|STARTED|Overall Study||50
2868342|NCT00166439|3571568|FG000|COMPLETED|Overall Study||45
2868343|NCT00166439|3571568|FG000|NOT COMPLETED|Overall Study||5
2868344|NCT00166517|3571574|FG000|STARTED|Overall Study||115
2868345|NCT00166517|3571575|FG001|STARTED|Overall Study||63
2868346|NCT00166517|3571574|FG000|Vaccinated at Visit 1|Overall Study||115
2868347|NCT00166517|3571575|FG001|Vaccinated at Visit 1|Overall Study||63
2868348|NCT00166517|3571574|FG000|Vaccinated at Visit 2|Overall Study||112
2868349|NCT00166517|3571575|FG001|Vaccinated at Visit 2|Overall Study||61
2868350|NCT00166517|3571574|FG000|Vaccinated at Visit 3|Overall Study||110
2868351|NCT00166517|3571575|FG001|Vaccinated at Visit 3|Overall Study||61
2868352|NCT00166517|3571574|FG000|COMPLETED|Overall Study||110
2868353|NCT00166517|3571575|FG001|COMPLETED|Overall Study||61
2868354|NCT00166517|3571574|FG000|NOT COMPLETED|Overall Study||5
2868355|NCT00166517|3571575|FG001|NOT COMPLETED|Overall Study||2
2868356|NCT00166712|3571583|FG000|STARTED|Overall Study|Consented:Randomized-Group 1. Given MMF prior to surgery, Alemtuzumab & TAC (Prograf) day of surgery|24
2868357|NCT00166712|3571584|FG001|STARTED|Overall Study|Consented: Randomized-Group 2. Given Sirolimus & MMF prior to surgery, Alemtuzumab day of surgery.|16
2868358|NCT00166712|3571583|FG000|Phase 1|Overall Study|Evaluated for rejection at 6months post-transplant|22
3313528|NCT03075410|4046797|FG006|COMPLETED|Part B (up to 28 Days)||4
3313529|NCT03075410|4046798|FG007|COMPLETED|Part B (up to 28 Days)||7
3313530|NCT03075410|4046799|FG008|COMPLETED|Part B (up to 28 Days)||8
2868359|NCT00166712|3571584|FG001|Phase 1|Overall Study|Evaluated at 6 month post-transplant to potentially be weaned off Sirolimus.|12
2868360|NCT00166712|3571583|FG000|Phase 2a|Overall Study|Subjects who remained on Prograf at 6mo post-transplant.|19
2868361|NCT00166712|3571584|FG001|Phase 2a|Overall Study|Subject who remained on Sirolimus at 6 months post-transplant.|12
2868362|NCT00166712|3571583|FG000|Phase 2b|Overall Study|Subjects converted to Sirolimus post-transplant.|3
2868363|NCT00166712|3571584|FG001|Phase 2b|Overall Study|Subjects weaned off Sirolimus|0
2868364|NCT00166712|3571583|FG000|Phase 3|Overall Study|Subjects from Phase 2b who were weaned off Sirolimus @ 12 months post-transplant.|0
2868365|NCT00166712|3571584|FG001|Phase 3|Overall Study|# weaned off Sirolimus at 12 months post-transplant.|0
2868366|NCT00166712|3571583|FG000|COMPLETED|Overall Study|Completed study participation.|22
2868367|NCT00166712|3571584|FG001|COMPLETED|Overall Study|Completed study participation.|11
2868368|NCT00166712|3571583|FG000|NOT COMPLETED|Overall Study||2
2868369|NCT00166712|3571584|FG001|NOT COMPLETED|Overall Study||5
2868370|NCT00167102|3571596|FG000|STARTED|Overall Study||23
2868371|NCT00167102|3571597|FG001|STARTED|Overall Study||22
2868372|NCT00167102|3571596|FG000|COMPLETED|Overall Study||23
2868373|NCT00167102|3571597|FG001|COMPLETED|Overall Study||22
2868374|NCT00167102|3571596|FG000|NOT COMPLETED|Overall Study||0
2868375|NCT00167102|3571597|FG001|NOT COMPLETED|Overall Study||0
2868376|NCT00167180|3571607|FG000|STARTED|Overall Study||0
2868377|NCT00167180|3571608|FG001|STARTED|Overall Study||57
2868378|NCT00167180|3571607|FG000|COMPLETED|Overall Study||0
2868379|NCT00167180|3571608|FG001|COMPLETED|Overall Study||57
2868380|NCT00167180|3571607|FG000|NOT COMPLETED|Overall Study||0
2868381|NCT00167180|3571608|FG001|NOT COMPLETED|Overall Study||0
2868382|NCT00167206|3571614|FG000|STARTED|Overall Study||16
2868383|NCT00167206|3571614|FG000|COMPLETED|Overall Study||16
2868384|NCT00167206|3571614|FG000|NOT COMPLETED|Overall Study||0
2868385|NCT00167245|3571620|FG000|STARTED|Overall Study||83
3313531|NCT03075410|4046791|FG000|NOT COMPLETED|Part B (up to 28 Days)||0
3313532|NCT03075410|4046792|FG001|NOT COMPLETED|Part B (up to 28 Days)||0
3313533|NCT03075410|4046793|FG002|NOT COMPLETED|Part B (up to 28 Days)||0
3313534|NCT03075410|4046794|FG003|NOT COMPLETED|Part B (up to 28 Days)||0
3313535|NCT03075410|4046795|FG004|NOT COMPLETED|Part B (up to 28 Days)||0
3313536|NCT03075410|4046796|FG005|NOT COMPLETED|Part B (up to 28 Days)||0
3313537|NCT03075410|4046797|FG006|NOT COMPLETED|Part B (up to 28 Days)||0
3313538|NCT03075410|4046798|FG007|NOT COMPLETED|Part B (up to 28 Days)||0
3313539|NCT03075410|4046799|FG008|NOT COMPLETED|Part B (up to 28 Days)||0
3313540|NCT03075449|4046823|FG000|STARTED|Overall Study||170
2868386|NCT00167245|3571621|FG001|STARTED|Overall Study||87
2868387|NCT00167245|3571620|FG000|COMPLETED|Overall Study||54
2868388|NCT00167245|3571621|FG001|COMPLETED|Overall Study||46
2868389|NCT00167245|3571620|FG000|NOT COMPLETED|Overall Study||29
2868390|NCT00167245|3571621|FG001|NOT COMPLETED|Overall Study||41
2868391|NCT00167310|3571632|FG000|STARTED|Overall Study||29
2868392|NCT00167310|3571633|FG001|STARTED|Overall Study||28
2868393|NCT00167310|3571632|FG000|COMPLETED|Overall Study||21
2868394|NCT00167310|3571633|FG001|COMPLETED|Overall Study||18
2868395|NCT00167310|3571632|FG000|NOT COMPLETED|Overall Study||8
2868396|NCT00167310|3571633|FG001|NOT COMPLETED|Overall Study||10
2868397|NCT00167388|3571643|FG000|STARTED|Overall Study||5
2868398|NCT00167388|3571644|FG001|STARTED|Overall Study||5
2868399|NCT00167388|3571645|FG002|STARTED|Overall Study||6
2868400|NCT00167388|3571646|FG003|STARTED|Overall Study||6
2868401|NCT00167388|3571643|FG000|Completed Doppler Study|Overall Study||5
2868402|NCT00167388|3571644|FG001|Completed Doppler Study|Overall Study||5
2868403|NCT00167388|3571645|FG002|Completed Doppler Study|Overall Study||6
2868404|NCT00167388|3571646|FG003|Completed Doppler Study|Overall Study||6
2868405|NCT00167388|3571643|FG000|COMPLETED|Overall Study||5
2868406|NCT00167388|3571644|FG001|COMPLETED|Overall Study||5
2868407|NCT00167388|3571645|FG002|COMPLETED|Overall Study||6
2868408|NCT00167388|3571646|FG003|COMPLETED|Overall Study||6
2868409|NCT00167388|3571643|FG000|NOT COMPLETED|Overall Study||0
2868410|NCT00167388|3571644|FG001|NOT COMPLETED|Overall Study||0
2868411|NCT00167388|3571645|FG002|NOT COMPLETED|Overall Study||0
2868412|NCT00167388|3571646|FG003|NOT COMPLETED|Overall Study||0
2868413|NCT00167414|3571654|FG000|STARTED|Overall Study||49
2868414|NCT00167414|3571654|FG000|COMPLETED|Overall Study||39
2868415|NCT00167414|3571654|FG000|NOT COMPLETED|Overall Study||10
2868416|NCT00167544|3571660|FG000|STARTED|Overall Study||31
2868417|NCT00167544|3571661|FG001|STARTED|Overall Study||33
2868418|NCT00167544|3571660|FG000|COMPLETED|Overall Study||30
2868419|NCT00167544|3571661|FG001|COMPLETED|Overall Study||33
2868420|NCT00167544|3571660|FG000|NOT COMPLETED|Overall Study||1
2868421|NCT00167544|3571661|FG001|NOT COMPLETED|Overall Study||0
2868422|NCT00167661|3571667|FG000|STARTED|Overall Study||33
2868423|NCT00167661|3571667|FG000|COMPLETED|Overall Study||33
2868424|NCT00167661|3571667|FG000|NOT COMPLETED|Overall Study||0
2868425|NCT00167778|3571671|FG000|STARTED|Overall Study||11
2868426|NCT00167778|3571671|FG000|COMPLETED|Overall Study||10
2868427|NCT00167778|3571671|FG000|NOT COMPLETED|Overall Study||1
2868428|NCT00167934|3571678|FG000|STARTED|Overall Study||82
2868429|NCT00167934|3571679|FG001|STARTED|Overall Study||82
2868430|NCT00167934|3571678|FG000|COMPLETED|Overall Study||82
2868431|NCT00167934|3571679|FG001|COMPLETED|Overall Study||82
2868432|NCT00167934|3571678|FG000|NOT COMPLETED|Overall Study||0
2868433|NCT00167934|3571679|FG001|NOT COMPLETED|Overall Study||0
2868434|NCT00168038|3571685|FG000|STARTED|Overall Study||57
2868435|NCT00168038|3571685|FG000|COMPLETED|Overall Study||55
2868436|NCT00168038|3571685|FG000|NOT COMPLETED|Overall Study||2
2868437|NCT00168064|3571691|FG000|STARTED|Overall Study|128 participants received PG formulation|130
2868438|NCT00168064|3571692|FG001|STARTED|Overall Study|127 participants received AP formulation|130
2868439|NCT00168064|3571691|FG000|COMPLETED|Overall Study||81
2868440|NCT00168064|3571692|FG001|COMPLETED|Overall Study||86
2868441|NCT00168064|3571691|FG000|NOT COMPLETED|Overall Study||49
2868442|NCT00168064|3571692|FG001|NOT COMPLETED|Overall Study||44
2868443|NCT00168103|3571703|FG000|STARTED|Overall Study||40
2868444|NCT00168103|3571704|FG001|STARTED|Overall Study||43
2868445|NCT00168103|3571705|FG002|STARTED|Overall Study||42
2868446|NCT00168103|3571706|FG003|STARTED|Overall Study||1
2868447|NCT00168103|3571703|FG000|COMPLETED|Overall Study|1 randomized subject received open-label rescue medication before receiving randomized treatment.|38
2868448|NCT00168103|3571704|FG001|COMPLETED|Overall Study||38
2868449|NCT00168103|3571705|FG002|COMPLETED|Overall Study||41
2868450|NCT00168103|3571706|FG003|COMPLETED|Overall Study||1
2868451|NCT00168103|3571703|FG000|NOT COMPLETED|Overall Study||2
2868452|NCT00168103|3571704|FG001|NOT COMPLETED|Overall Study||5
2868453|NCT00168103|3571705|FG002|NOT COMPLETED|Overall Study||1
2868454|NCT00168103|3571706|FG003|NOT COMPLETED|Overall Study||0
2868455|NCT00168298|3571717|FG000|STARTED|Double-Blind Period||226
2868456|NCT00168298|3571718|FG001|STARTED|Double-Blind Period||218
2868457|NCT00168298|3571719|FG002|STARTED|Double-Blind Period||224
2868458|NCT00168298|3571717|FG000|COMPLETED|Double-Blind Period||214
2868459|NCT00168298|3571718|FG001|COMPLETED|Double-Blind Period||206
2868460|NCT00168298|3571719|FG002|COMPLETED|Double-Blind Period||209
2868461|NCT00168298|3571717|FG000|NOT COMPLETED|Double-Blind Period||12
2868462|NCT00168298|3571718|FG001|NOT COMPLETED|Double-Blind Period||12
2868463|NCT00168298|3571719|FG002|NOT COMPLETED|Double-Blind Period||15
2868464|NCT00168298|3571717|FG000|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|179
2868465|NCT00168298|3571718|FG001|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|173
2868466|NCT00168298|3571719|FG002|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|168
2868467|NCT00168298|3571717|FG000|COMPLETED|Open-Label Period||172
2868468|NCT00168298|3571718|FG001|COMPLETED|Open-Label Period||168
2868469|NCT00168298|3571719|FG002|COMPLETED|Open-Label Period||160
2868470|NCT00168298|3571717|FG000|NOT COMPLETED|Open-Label Period||7
2868471|NCT00168298|3571718|FG001|NOT COMPLETED|Open-Label Period||5
2868472|NCT00168298|3571719|FG002|NOT COMPLETED|Open-Label Period||8
2868473|NCT00168311|3571729|FG000|STARTED|Overall Study||12
2868474|NCT00168311|3571730|FG001|STARTED|Overall Study||10
2868475|NCT00168311|3571729|FG000|COMPLETED|Overall Study||12
2868476|NCT00168311|3571730|FG001|COMPLETED|Overall Study||8
2868477|NCT00168311|3571729|FG000|NOT COMPLETED|Overall Study||0
2868478|NCT00168311|3571730|FG001|NOT COMPLETED|Overall Study||2
2868479|NCT00168324|3571739|FG000|STARTED|Double-Blind Period||201
2868480|NCT00168324|3571740|FG001|STARTED|Double-Blind Period||196
2868481|NCT00168324|3571741|FG002|STARTED|Double-Blind Period||202
2868482|NCT00168324|3571739|FG000|COMPLETED|Double-Blind Period||189
2868483|NCT00168324|3571740|FG001|COMPLETED|Double-Blind Period||189
2868484|NCT00168324|3571741|FG002|COMPLETED|Double-Blind Period||189
2868485|NCT00168324|3571739|FG000|NOT COMPLETED|Double-Blind Period||12
2868486|NCT00168324|3571740|FG001|NOT COMPLETED|Double-Blind Period||7
2868487|NCT00168324|3571741|FG002|NOT COMPLETED|Double-Blind Period||13
2868488|NCT00168324|3571739|FG000|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|164
2868489|NCT00168324|3571740|FG001|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|155
2868490|NCT00168324|3571741|FG002|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|158
2868491|NCT00168324|3571739|FG000|COMPLETED|Open-Label Period||160
2868492|NCT00168324|3571740|FG001|COMPLETED|Open-Label Period||147
3169415|NCT01925209|3896952|FG000|NOT COMPLETED|Treatment Epoch||9
3169416|NCT01925209|3896953|FG001|NOT COMPLETED|Treatment Epoch||8
3169417|NCT01925209|3896954|FG002|NOT COMPLETED|Treatment Epoch||7
2868493|NCT00168324|3571741|FG002|COMPLETED|Open-Label Period||152
2868494|NCT00168324|3571739|FG000|NOT COMPLETED|Open-Label Period||4
2868495|NCT00168324|3571740|FG001|NOT COMPLETED|Open-Label Period||8
2868496|NCT00168324|3571741|FG002|NOT COMPLETED|Open-Label Period||6
2868497|NCT00168337|3571752|FG000|STARTED|Overall Study||188
2868498|NCT00168337|3571753|FG001|STARTED|Overall Study||181
3169418|NCT01925209|3896955|FG003|NOT COMPLETED|Treatment Epoch||5
3169419|NCT01925209|3896952|FG000|STARTED|Maintenance Treatment Epoch||49
3169420|NCT01925209|3896953|FG001|STARTED|Maintenance Treatment Epoch||46
3169421|NCT01925209|3896954|FG002|STARTED|Maintenance Treatment Epoch||52
3169422|NCT01925209|3896955|FG003|STARTED|Maintenance Treatment Epoch||50
2868499|NCT00168337|3571754|FG002|STARTED|Overall Study||185
2868500|NCT00168337|3571752|FG000|COMPLETED|Overall Study||118
2868501|NCT00168337|3571753|FG001|COMPLETED|Overall Study||112
2868502|NCT00168337|3571754|FG002|COMPLETED|Overall Study||82
2868503|NCT00168337|3571752|FG000|NOT COMPLETED|Overall Study||70
2868504|NCT00168337|3571753|FG001|NOT COMPLETED|Overall Study||69
2868505|NCT00168337|3571754|FG002|NOT COMPLETED|Overall Study||103
2868506|NCT00168389|3571765|FG000|STARTED|Overall Study||163
2868507|NCT00168389|3571766|FG001|STARTED|Overall Study||166
2868508|NCT00168389|3571767|FG002|STARTED|Overall Study||165
2868509|NCT00168389|3571765|FG000|COMPLETED|Overall Study||107
2868510|NCT00168389|3571766|FG001|COMPLETED|Overall Study||118
2868511|NCT00168389|3571767|FG002|COMPLETED|Overall Study||70
2868512|NCT00168389|3571765|FG000|NOT COMPLETED|Overall Study||56
2868513|NCT00168389|3571766|FG001|NOT COMPLETED|Overall Study||48
2868514|NCT00168389|3571767|FG002|NOT COMPLETED|Overall Study||95
2868515|NCT00168428|3571777|FG000|STARTED|Double-Blind Phase (DB)||347
2868516|NCT00168428|3571778|FG001|STARTED|Double-Blind Phase (DB)||358
2868517|NCT00168428|3571777|FG000|COMPLETED|Double-Blind Phase (DB)|Completed Week 24|311
2868518|NCT00168428|3571778|FG001|COMPLETED|Double-Blind Phase (DB)|Completed Week 24|334
2868519|NCT00168428|3571777|FG000|NOT COMPLETED|Double-Blind Phase (DB)||36
2868520|NCT00168428|3571778|FG001|NOT COMPLETED|Double-Blind Phase (DB)||24
2868521|NCT00168428|3571777|FG000|STARTED|Open-Label Phase (OL)|Number of DB Botulinum toxin type A patients who rolled into OL phase|305
2868522|NCT00168428|3571778|FG001|STARTED|Open-Label Phase (OL)|Number of DB Placebo patients who rolled into OL phase|329
2868523|NCT00168428|3571777|FG000|COMPLETED|Open-Label Phase (OL)||261
2868524|NCT00168428|3571778|FG001|COMPLETED|Open-Label Phase (OL)||261
2868525|NCT00168428|3571777|FG000|NOT COMPLETED|Open-Label Phase (OL)||44
2868526|NCT00168428|3571778|FG001|NOT COMPLETED|Open-Label Phase (OL)||68
2868527|NCT00168454|3571790|FG000|STARTED|Overall Study||44
2868528|NCT00168454|3571791|FG001|STARTED|Overall Study||57
2868529|NCT00168454|3571792|FG002|STARTED|Overall Study||54
2868530|NCT00168454|3571793|FG003|STARTED|Overall Study||49
2868531|NCT00168454|3571794|FG004|STARTED|Overall Study||53
2868532|NCT00168454|3571795|FG005|STARTED|Overall Study||56
2868533|NCT00168454|3571790|FG000|COMPLETED|Overall Study||37
2868534|NCT00168454|3571791|FG001|COMPLETED|Overall Study||50
2868535|NCT00168454|3571792|FG002|COMPLETED|Overall Study||48
2868536|NCT00168454|3571793|FG003|COMPLETED|Overall Study||40
2868537|NCT00168454|3571794|FG004|COMPLETED|Overall Study||47
2868538|NCT00168454|3571795|FG005|COMPLETED|Overall Study||50
2868539|NCT00168454|3571790|FG000|NOT COMPLETED|Overall Study||7
2868540|NCT00168454|3571791|FG001|NOT COMPLETED|Overall Study||7
2868541|NCT00168454|3571792|FG002|NOT COMPLETED|Overall Study||6
2868542|NCT00168454|3571793|FG003|NOT COMPLETED|Overall Study||9
2868543|NCT00168454|3571794|FG004|NOT COMPLETED|Overall Study||6
2868544|NCT00168454|3571795|FG005|NOT COMPLETED|Overall Study||6
2868545|NCT00168805|3571812|FG000|STARTED|Overall Study||679
2868546|NCT00168805|3571813|FG001|STARTED|Overall Study||703
2868547|NCT00168805|3571814|FG002|STARTED|Overall Study||694
2868548|NCT00168805|3571812|FG000|COMPLETED|Overall Study||608
2868549|NCT00168805|3571813|FG001|COMPLETED|Overall Study||625
2868550|NCT00168805|3571814|FG002|COMPLETED|Overall Study||616
2868551|NCT00168805|3571812|FG000|NOT COMPLETED|Overall Study||71
2868552|NCT00168805|3571813|FG001|NOT COMPLETED|Overall Study||78
2868553|NCT00168805|3571814|FG002|NOT COMPLETED|Overall Study||78
2868554|NCT00168805|3571812|FG000|STARTED|Treatment||679
2868555|NCT00168805|3571813|FG001|STARTED|Treatment||703
2868556|NCT00168805|3571814|FG002|STARTED|Treatment||694
2868557|NCT00168805|3571812|FG000|COMPLETED|Treatment||630
2868558|NCT00168805|3571813|FG001|COMPLETED|Treatment||647
2868559|NCT00168805|3571814|FG002|COMPLETED|Treatment||632
2868560|NCT00168805|3571812|FG000|NOT COMPLETED|Treatment||49
2868561|NCT00168805|3571813|FG001|NOT COMPLETED|Treatment||56
2868562|NCT00168805|3571814|FG002|NOT COMPLETED|Treatment||62
2868563|NCT00168818|3571825|FG000|STARTED|Overall Study||1146
2868564|NCT00168818|3571826|FG001|STARTED|Overall Study||1163
2868565|NCT00168818|3571827|FG002|STARTED|Overall Study||1154
2868566|NCT00168818|3571825|FG000|COMPLETED|Overall Study||1029
2868567|NCT00168818|3571826|FG001|COMPLETED|Overall Study||1054
2868568|NCT00168818|3571827|FG002|COMPLETED|Overall Study||1030
2868569|NCT00168818|3571825|FG000|NOT COMPLETED|Overall Study||117
2868570|NCT00168818|3571826|FG001|NOT COMPLETED|Overall Study||109
2868571|NCT00168818|3571827|FG002|NOT COMPLETED|Overall Study||124
2868572|NCT00168818|3571825|FG000|STARTED|Treatment||1146
2868573|NCT00168818|3571826|FG001|STARTED|Treatment||1163
2868574|NCT00168818|3571827|FG002|STARTED|Treatment||1154
2868575|NCT00168818|3571825|FG000|COMPLETED|Treatment||1013
2868576|NCT00168818|3571826|FG001|COMPLETED|Treatment||1012
2868577|NCT00168818|3571827|FG002|COMPLETED|Treatment||1021
2868578|NCT00168818|3571825|FG000|NOT COMPLETED|Treatment||133
2868579|NCT00168818|3571826|FG001|NOT COMPLETED|Treatment||151
2868580|NCT00168818|3571827|FG002|NOT COMPLETED|Treatment||133
2868581|NCT00168831|3571838|FG000|STARTED|Overall Study||338
2868582|NCT00168831|3571839|FG001|STARTED|Overall Study||335
2868583|NCT00168831|3571840|FG002|STARTED|Overall Study||334
2868584|NCT00168831|3571838|FG000|COMPLETED|Overall Study||278
2868585|NCT00168831|3571839|FG001|COMPLETED|Overall Study||254
2868586|NCT00168831|3571840|FG002|COMPLETED|Overall Study||220
2868587|NCT00168831|3571838|FG000|NOT COMPLETED|Overall Study||60
3169423|NCT01925209|3896952|FG000|COMPLETED|Maintenance Treatment Epoch||49
3169424|NCT01925209|3896953|FG001|COMPLETED|Maintenance Treatment Epoch||45
3169425|NCT01925209|3896954|FG002|COMPLETED|Maintenance Treatment Epoch||50
2868588|NCT00168831|3571839|FG001|NOT COMPLETED|Overall Study||81
2868589|NCT00168831|3571840|FG002|NOT COMPLETED|Overall Study||114
2868590|NCT00168844|3571851|FG000|STARTED|Overall Study||332
2868591|NCT00168844|3571852|FG001|STARTED|Overall Study||332
2868592|NCT00168844|3571853|FG002|STARTED|Overall Study||319
2868593|NCT00168844|3571851|FG000|COMPLETED|Overall Study||277
2868594|NCT00168844|3571852|FG001|COMPLETED|Overall Study||277
2868595|NCT00168844|3571853|FG002|COMPLETED|Overall Study||228
2868596|NCT00168844|3571851|FG000|NOT COMPLETED|Overall Study||55
2868597|NCT00168844|3571852|FG001|NOT COMPLETED|Overall Study||55
2868598|NCT00168844|3571853|FG002|NOT COMPLETED|Overall Study||91
2868599|NCT00169104|3571863|FG000|STARTED|Overall Study||13
2868600|NCT00169104|3571864|FG001|STARTED|Overall Study||10
2868601|NCT00169104|3571863|FG000|COMPLETED|Overall Study||11
2868602|NCT00169104|3571864|FG001|COMPLETED|Overall Study||8
2868603|NCT00169104|3571863|FG000|NOT COMPLETED|Overall Study||2
2868604|NCT00169104|3571864|FG001|NOT COMPLETED|Overall Study||2
2868605|NCT00169442|3571877|FG000|STARTED|Overall Study||119
2868606|NCT00169442|3571878|FG001|STARTED|Overall Study||124
2868607|NCT00169442|3571879|FG002|STARTED|Overall Study||167
2868608|NCT00169442|3571880|FG003|STARTED|Overall Study||250
3313541|NCT03075449|4046823|FG000|COMPLETED|Overall Study||170
3313542|NCT03075449|4046823|FG000|NOT COMPLETED|Overall Study||0
3313543|NCT03075501|4046829|FG000|STARTED|Overall Study||89
3313544|NCT03075501|4046830|FG001|STARTED|Overall Study||44
3313545|NCT03075501|4046829|FG000|COMPLETED|Overall Study||74
3313546|NCT03075501|4046830|FG001|COMPLETED|Overall Study||35
2868609|NCT00169442|3571881|FG004|STARTED|Overall Study||42
2868610|NCT00169442|3571882|FG005|STARTED|Overall Study||43
2868611|NCT00169442|3571877|FG000|COMPLETED|Overall Study||119
2868612|NCT00169442|3571878|FG001|COMPLETED|Overall Study||123
2868613|NCT00169442|3571879|FG002|COMPLETED|Overall Study||166
2868614|NCT00169442|3571880|FG003|COMPLETED|Overall Study||250
2868615|NCT00169442|3571881|FG004|COMPLETED|Overall Study||41
2868616|NCT00169442|3571882|FG005|COMPLETED|Overall Study||41
2868617|NCT00169442|3571877|FG000|NOT COMPLETED|Overall Study||0
2868618|NCT00169442|3571878|FG001|NOT COMPLETED|Overall Study||1
2868619|NCT00169442|3571879|FG002|NOT COMPLETED|Overall Study||1
2868620|NCT00169442|3571880|FG003|NOT COMPLETED|Overall Study||0
2868621|NCT00169442|3571881|FG004|NOT COMPLETED|Overall Study||1
2868622|NCT00169442|3571882|FG005|NOT COMPLETED|Overall Study||2
2868623|NCT00170157|3571898|FG000|STARTED|Treatment Period 1 Initial Randomization||54
2868624|NCT00170157|3571899|FG001|STARTED|Treatment Period 1 Initial Randomization||58
2868625|NCT00170157|3571898|FG000|COMPLETED|Treatment Period 1 Initial Randomization||54
2868626|NCT00170157|3571899|FG001|COMPLETED|Treatment Period 1 Initial Randomization||58
2868627|NCT00170157|3571898|FG000|NOT COMPLETED|Treatment Period 1 Initial Randomization||0
2868628|NCT00170157|3571899|FG001|NOT COMPLETED|Treatment Period 1 Initial Randomization||0
2868629|NCT00170157|3571898|FG000|STARTED|Washout Period of 14 Days|Participants initially randomized to this arm were not eligible for crossover.|0
2868630|NCT00170157|3571899|FG001|STARTED|Washout Period of 14 Days||58
2868631|NCT00170157|3571898|FG000|COMPLETED|Washout Period of 14 Days||0
3169426|NCT01925209|3896955|FG003|COMPLETED|Maintenance Treatment Epoch||48
3169427|NCT01925209|3896952|FG000|NOT COMPLETED|Maintenance Treatment Epoch||0
3169428|NCT01925209|3896953|FG001|NOT COMPLETED|Maintenance Treatment Epoch||1
3169429|NCT01925209|3896954|FG002|NOT COMPLETED|Maintenance Treatment Epoch||2
3169430|NCT01925209|3896955|FG003|NOT COMPLETED|Maintenance Treatment Epoch||2
3169431|NCT01925209|3896952|FG000|STARTED|Follow-up||57
3169432|NCT01925209|3896953|FG001|STARTED|Follow-up||61
3169433|NCT01925209|3896954|FG002|STARTED|Follow-up||56
3169434|NCT01925209|3896955|FG003|STARTED|Follow-up||58
3169435|NCT01925209|3896952|FG000|COMPLETED|Follow-up||56
3169436|NCT01925209|3896953|FG001|COMPLETED|Follow-up||55
3169437|NCT01925209|3896954|FG002|COMPLETED|Follow-up||55
3169438|NCT01925209|3896955|FG003|COMPLETED|Follow-up||54
3169439|NCT01925209|3896952|FG000|NOT COMPLETED|Follow-up||1
3169440|NCT01925209|3896953|FG001|NOT COMPLETED|Follow-up||6
3169441|NCT01925209|3896954|FG002|NOT COMPLETED|Follow-up||1
3169442|NCT01925209|3896955|FG003|NOT COMPLETED|Follow-up||4
3169443|NCT01925274|3896968|FG000|STARTED|Overall Study||7
3169444|NCT01925274|3896969|FG001|STARTED|Overall Study||6
3169445|NCT01925274|3896970|FG002|STARTED|Overall Study||6
3169446|NCT01925274|3896968|FG000|COMPLETED|Overall Study||0
3169447|NCT01925274|3896969|FG001|COMPLETED|Overall Study||0
3169448|NCT01925274|3896970|FG002|COMPLETED|Overall Study||0
3169449|NCT01925274|3896968|FG000|NOT COMPLETED|Overall Study||7
2868632|NCT00170157|3571899|FG001|COMPLETED|Washout Period of 14 Days||41
2868633|NCT00170157|3571898|FG000|NOT COMPLETED|Washout Period of 14 Days||0
2868634|NCT00170157|3571899|FG001|NOT COMPLETED|Washout Period of 14 Days||17
2868635|NCT00170157|3571898|FG000|STARTED|Treatment Period 2 Crossover|Participants initially randomized to this arm were not eligible for crossover.|0
2868636|NCT00170157|3571899|FG001|STARTED|Treatment Period 2 Crossover||41
2868637|NCT00170157|3571898|FG000|COMPLETED|Treatment Period 2 Crossover||0
2868638|NCT00170157|3571899|FG001|COMPLETED|Treatment Period 2 Crossover||41
2868639|NCT00170157|3571898|FG000|NOT COMPLETED|Treatment Period 2 Crossover||0
2868640|NCT00170157|3571899|FG001|NOT COMPLETED|Treatment Period 2 Crossover||0
2868641|NCT00170625|3571905|FG000|STARTED|Overall Study||26
2868642|NCT00170625|3571905|FG000|COMPLETED|Overall Study||26
2868643|NCT00170625|3571905|FG000|NOT COMPLETED|Overall Study||0
2868644|NCT00170846|3571912|FG000|STARTED|Overall Study||123
2868645|NCT00170846|3571913|FG001|STARTED|Overall Study||127
2868646|NCT00170846|3571914|FG002|STARTED|Overall Study||144
3169450|NCT01925274|3896969|FG001|NOT COMPLETED|Overall Study||6
3169451|NCT01925274|3896970|FG002|NOT COMPLETED|Overall Study||6
3169452|NCT01925339|3896982|FG000|STARTED|Overall Study||20
3313547|NCT03075501|4046829|FG000|NOT COMPLETED|Overall Study||15
3313548|NCT03075501|4046830|FG001|NOT COMPLETED|Overall Study||9
3313549|NCT03075527|4046837|FG000|STARTED|Overall Study||19
3313550|NCT03075527|4046837|FG000|COMPLETED|Overall Study||17
3169453|NCT01925339|3896983|FG001|STARTED|Overall Study||20
3169454|NCT01925339|3896982|FG000|COMPLETED|Overall Study||18
3169455|NCT01925339|3896983|FG001|COMPLETED|Overall Study||20
3169456|NCT01925339|3896982|FG000|NOT COMPLETED|Overall Study||2
2868647|NCT00170846|3571912|FG000|COMPLETED|Overall Study||112
2868648|NCT00170846|3571913|FG001|COMPLETED|Overall Study||108
2868649|NCT00170846|3571914|FG002|COMPLETED|Overall Study||131
2868650|NCT00170846|3571912|FG000|NOT COMPLETED|Overall Study||11
2868651|NCT00170846|3571913|FG001|NOT COMPLETED|Overall Study||19
2868652|NCT00170846|3571914|FG002|NOT COMPLETED|Overall Study||13
2868653|NCT00170950|3571924|FG000|STARTED|Overall Study||5744
2868654|NCT00170950|3571925|FG001|STARTED|Overall Study||5762
2868655|NCT00170950|3571924|FG000|COMPLETED|Overall Study||4859
2868656|NCT00170950|3571925|FG001|COMPLETED|Overall Study||4852
2868657|NCT00170950|3571924|FG000|NOT COMPLETED|Overall Study||885
2868658|NCT00170950|3571925|FG001|NOT COMPLETED|Overall Study||910
2868659|NCT00171054|3571933|FG000|STARTED|Overall Study||63
2868660|NCT00171054|3571934|FG001|STARTED|Overall Study||62
2868661|NCT00171054|3571933|FG000|COMPLETED|Overall Study||53
2868662|NCT00171054|3571934|FG001|COMPLETED|Overall Study||50
2868663|NCT00171054|3571933|FG000|NOT COMPLETED|Overall Study||10
2868664|NCT00171054|3571934|FG001|NOT COMPLETED|Overall Study||12
2868665|NCT00171158|3571940|FG000|STARTED|Core Study||260
2868666|NCT00171158|3571940|FG000|COMPLETED|Core Study||21
2868667|NCT00171158|3571940|FG000|NOT COMPLETED|Core Study||239
2868668|NCT00171158|3571940|FG000|STARTED|E2 Extension||8
2868669|NCT00171158|3571940|FG000|COMPLETED|E2 Extension||1
2868670|NCT00171158|3571940|FG000|NOT COMPLETED|E2 Extension||7
2868671|NCT00171210|3571946|FG000|STARTED|Overall Study||259
2868672|NCT00171210|3571947|FG001|STARTED|Overall Study||296
2868673|NCT00171210|3571946|FG000|STARTED EXTENSION STUDY|Overall Study||259
2868674|NCT00171210|3571947|FG001|STARTED EXTENSION STUDY|Overall Study||247
2868675|NCT00171210|3571946|FG000|COMPLETED|Overall Study||190
2868676|NCT00171210|3571947|FG001|COMPLETED|Overall Study||181
2868677|NCT00171210|3571946|FG000|NOT COMPLETED|Overall Study||69
2868678|NCT00171210|3571947|FG001|NOT COMPLETED|Overall Study||115
2868679|NCT00171223|3571956|FG000|STARTED|Overall Study||152
2868680|NCT00171223|3571957|FG001|STARTED|Overall Study||188
2868681|NCT00171223|3571958|FG002|STARTED|Overall Study||192
2868682|NCT00171223|3571956|FG000|COMPLETED|Overall Study||12
2868683|NCT00171223|3571957|FG001|COMPLETED|Overall Study||47
2868684|NCT00171223|3571958|FG002|COMPLETED|Overall Study||22
2868685|NCT00171223|3571956|FG000|NOT COMPLETED|Overall Study||140
2868686|NCT00171223|3571957|FG001|NOT COMPLETED|Overall Study||141
2868687|NCT00171223|3571958|FG002|NOT COMPLETED|Overall Study||170
2868688|NCT00171249|3571964|FG000|STARTED|Overall Study||77
2868689|NCT00171249|3571965|FG001|STARTED|Overall Study||5
2868690|NCT00171249|3571966|FG002|STARTED|Overall Study||5
2868691|NCT00171249|3571967|FG003|STARTED|Overall Study||158
2868692|NCT00171249|3571968|FG004|STARTED|Overall Study||3
2868693|NCT00171249|3571969|FG005|STARTED|Overall Study||43
2868694|NCT00171249|3571970|FG006|STARTED|Overall Study||2
2868695|NCT00171249|3571964|FG000|Completed Part 1|Overall Study||50
2868696|NCT00171249|3571965|FG001|Completed Part 1|Overall Study||0
2868697|NCT00171249|3571966|FG002|Completed Part 1|Overall Study||1
2868698|NCT00171249|3571967|FG003|Completed Part 1|Overall Study||125
2868699|NCT00171249|3571968|FG004|Completed Part 1|Overall Study||2
2868700|NCT00171249|3571969|FG005|Completed Part 1|Overall Study||6
2868701|NCT00171249|3571970|FG006|Completed Part 1|Overall Study||0
2868702|NCT00171249|3571964|FG000|COMPLETED|Overall Study||1
2868703|NCT00171249|3571965|FG001|COMPLETED|Overall Study||0
2868704|NCT00171249|3571966|FG002|COMPLETED|Overall Study||0
2868705|NCT00171249|3571967|FG003|COMPLETED|Overall Study||6
2868706|NCT00171249|3571968|FG004|COMPLETED|Overall Study||0
2868707|NCT00171249|3571969|FG005|COMPLETED|Overall Study||0
2868708|NCT00171249|3571970|FG006|COMPLETED|Overall Study||0
2868709|NCT00171249|3571964|FG000|NOT COMPLETED|Overall Study||76
2868710|NCT00171249|3571965|FG001|NOT COMPLETED|Overall Study||5
2868711|NCT00171249|3571966|FG002|NOT COMPLETED|Overall Study||5
2868712|NCT00171249|3571967|FG003|NOT COMPLETED|Overall Study||152
2868713|NCT00171249|3571968|FG004|NOT COMPLETED|Overall Study||3
2868714|NCT00171249|3571969|FG005|NOT COMPLETED|Overall Study||43
2868715|NCT00171249|3571970|FG006|NOT COMPLETED|Overall Study||2
2868716|NCT00171301|3571981|FG000|STARTED|Overall Study||162
2868717|NCT00171301|3571982|FG001|STARTED|Overall Study|2 participants in this group never received deferasirox.|71
2868718|NCT00171301|3571981|FG000|Received Deferasirox|Overall Study||162
2868719|NCT00171301|3571982|FG001|Received Deferasirox|Overall Study||69
2868720|NCT00171301|3571981|FG000|COMPLETED|Overall Study||154
2868721|NCT00171301|3571982|FG001|COMPLETED|Overall Study||62
2868722|NCT00171301|3571981|FG000|NOT COMPLETED|Overall Study||8
2868723|NCT00171301|3571982|FG001|NOT COMPLETED|Overall Study||9
2868724|NCT00171314|3571991|FG000|STARTED|Overall Study|2 patients in each arm were randomized but not treated.|263
2868725|NCT00171314|3571992|FG001|STARTED|Overall Study||264
2868726|NCT00171314|3571991|FG000|Safety Population|Overall Study|"Treatment Actually Received = 251 from upfront Arm and 3 from delayed Arm"|254
2868727|NCT00171314|3571992|FG001|Safety Population|Overall Study|"Treatment Actually Received = 10 from upfront Arm and 259 from delayed Arm"|269
2868728|NCT00171314|3571991|FG000|COMPLETED|Overall Study||172
2868729|NCT00171314|3571992|FG001|COMPLETED|Overall Study||186
2868730|NCT00171314|3571991|FG000|NOT COMPLETED|Overall Study||91
2868731|NCT00171314|3571992|FG001|NOT COMPLETED|Overall Study||78
2868732|NCT00171340|3572000|FG000|STARTED|Overall Study||532
2868733|NCT00171340|3572001|FG001|STARTED|Overall Study||533
2868734|NCT00171340|3572000|FG000|COMPLETED|Overall Study||408
2868735|NCT00171340|3572001|FG001|COMPLETED|Overall Study||398
2868736|NCT00171340|3572000|FG000|NOT COMPLETED|Overall Study||124
2868737|NCT00171340|3572001|FG001|NOT COMPLETED|Overall Study||135
2868738|NCT00171704|3572011|FG000|STARTED|Overall Study||133
2868739|NCT00171704|3572012|FG001|STARTED|Overall Study||130
2868740|NCT00171704|3572011|FG000|COMPLETED|Overall Study||89
2868741|NCT00171704|3572012|FG001|COMPLETED|Overall Study||81
2868742|NCT00171704|3572011|FG000|NOT COMPLETED|Overall Study||44
2868743|NCT00171704|3572012|FG001|NOT COMPLETED|Overall Study||49
2868744|NCT00171730|3572018|FG000|STARTED|Overall Study||30
2868745|NCT00171730|3572018|FG000|COMPLETED|Overall Study||15
2868746|NCT00171730|3572018|FG000|NOT COMPLETED|Overall Study||15
2868747|NCT00171834|3572035|FG000|STARTED|Overall Study||6
2868748|NCT00171834|3572036|FG001|STARTED|Overall Study||12
3313551|NCT03075527|4046837|FG000|NOT COMPLETED|Overall Study||2
2868749|NCT00171834|3572037|FG002|STARTED|Overall Study||12
2868750|NCT00171834|3572038|FG003|STARTED|Overall Study||12
2868751|NCT00171834|3572039|FG004|STARTED|Overall Study||8
2868752|NCT00171834|3572040|FG005|STARTED|Overall Study||35
2868753|NCT00171834|3572041|FG006|STARTED|Overall Study||4
2868754|NCT00171834|3572035|FG000|Completed 6 Cycles of Treatment|Overall Study||0
2868755|NCT00171834|3572036|FG001|Completed 6 Cycles of Treatment|Overall Study||0
2868756|NCT00171834|3572037|FG002|Completed 6 Cycles of Treatment|Overall Study||1
2868757|NCT00171834|3572038|FG003|Completed 6 Cycles of Treatment|Overall Study||0
2868758|NCT00171834|3572039|FG004|Completed 6 Cycles of Treatment|Overall Study||2
2868759|NCT00171834|3572040|FG005|Completed 6 Cycles of Treatment|Overall Study||1
2868760|NCT00171834|3572041|FG006|Completed 6 Cycles of Treatment|Overall Study||0
2868761|NCT00171834|3572035|FG000|COMPLETED|Overall Study||0
2868762|NCT00171834|3572036|FG001|COMPLETED|Overall Study||0
3169457|NCT01925339|3896983|FG001|NOT COMPLETED|Overall Study||0
3169458|NCT01925404|3896993|FG000|STARTED|Overall Study|"The primary outcome of this study is at the level of a park.~The park is the unit of analysis. We did not recruit participants, but had measure of park use by counting observed users"|
3169459|NCT01925404|3896994|FG001|STARTED|Overall Study|The park is the unit of analysis. We did not recruit participants, but had measure of park use by counting observed users|
3169460|NCT01925404|3896995|FG002|STARTED|Overall Study|The park is the unit of analysis. We did not recruit participants, but had measure of park use by counting observed users|
3169461|NCT01925404|3896996|FG003|STARTED|Overall Study|The park is the unit of analysis. We did not recruit participants, but had measure of park use by counting observed users|
3169462|NCT01925404|3896993|FG000|COMPLETED|Overall Study|We did not recruit participants or follow the same park users over time. The follow up numbers of users are greater than at baseline, and this generates an error message.|
3169463|NCT01925404|3896994|FG001|COMPLETED|Overall Study|We did not recruit participants or follow the same park users over time. The follow up numbers of users are greater than at baseline, and this generates an error message.|
3169464|NCT01925404|3896995|FG002|COMPLETED|Overall Study|We did not recruit participants or follow the same park users over time. The follow up numbers of users are greater than at baseline, and this generates an error message.|
3169465|NCT01925404|3896996|FG003|COMPLETED|Overall Study|We did not recruit participants or follow the same park users over time. The follow up numbers of users are greater than at baseline, and this generates an error message.|
3169466|NCT01925404|3896993|FG000|NOT COMPLETED|Overall Study||
3169467|NCT01925404|3896994|FG001|NOT COMPLETED|Overall Study||
3169468|NCT01925404|3896995|FG002|NOT COMPLETED|Overall Study||
3169469|NCT01925404|3896996|FG003|NOT COMPLETED|Overall Study||
3313552|NCT03075553|4046841|FG000|STARTED|Overall Study||12
2868763|NCT00171834|3572037|FG002|COMPLETED|Overall Study||0
2868764|NCT00171834|3572038|FG003|COMPLETED|Overall Study||0
2868765|NCT00171834|3572039|FG004|COMPLETED|Overall Study||0
2868766|NCT00171834|3572040|FG005|COMPLETED|Overall Study||0
2868767|NCT00171834|3572041|FG006|COMPLETED|Overall Study||0
2868768|NCT00171834|3572035|FG000|NOT COMPLETED|Overall Study||6
2868769|NCT00171834|3572036|FG001|NOT COMPLETED|Overall Study||12
2868770|NCT00171834|3572037|FG002|NOT COMPLETED|Overall Study||12
2868771|NCT00171834|3572038|FG003|NOT COMPLETED|Overall Study||12
2868772|NCT00171834|3572039|FG004|NOT COMPLETED|Overall Study||8
2868773|NCT00171834|3572040|FG005|NOT COMPLETED|Overall Study||35
2868774|NCT00171834|3572041|FG006|NOT COMPLETED|Overall Study||4
2868775|NCT00171873|3572073|FG000|STARTED|Overall Study||42
2868776|NCT00171873|3572074|FG001|STARTED|Overall Study||43
2868777|NCT00171873|3572073|FG000|COMPLETED|Overall Study||33
2868778|NCT00171873|3572074|FG001|COMPLETED|Overall Study||40
2868779|NCT00171873|3572073|FG000|NOT COMPLETED|Overall Study||9
2868780|NCT00171873|3572074|FG001|NOT COMPLETED|Overall Study||3
2868781|NCT00171925|3572082|FG000|STARTED|Overall Study||72
2868782|NCT00171925|3572083|FG001|STARTED|Overall Study||71
2868783|NCT00171925|3572082|FG000|COMPLETED|Overall Study||42
2868784|NCT00171925|3572083|FG001|COMPLETED|Overall Study||40
2868785|NCT00171925|3572082|FG000|NOT COMPLETED|Overall Study||30
2868786|NCT00171925|3572083|FG001|NOT COMPLETED|Overall Study||31
2868787|NCT00171951|3572089|FG000|STARTED|Overall Study||19
2868788|NCT00171951|3572089|FG000|COMPLETED|Overall Study||3
2868789|NCT00171951|3572089|FG000|NOT COMPLETED|Overall Study||16
2868790|NCT00172042|3572098|FG000|STARTED|Overall Study||226
2868791|NCT00172042|3572099|FG001|STARTED|Overall Study||211
2868792|NCT00172042|3572098|FG000|COMPLETED|Overall Study||68
2868793|NCT00172042|3572099|FG001|COMPLETED|Overall Study||86
2868794|NCT00172042|3572098|FG000|NOT COMPLETED|Overall Study||158
2868795|NCT00172042|3572099|FG001|NOT COMPLETED|Overall Study||125
2868796|NCT00172185|3572109|FG000|STARTED|Overall Study||6
2868797|NCT00172185|3572110|FG001|STARTED|Overall Study||7
2868798|NCT00172185|3572111|FG002|STARTED|Overall Study||25
2868799|NCT00172185|3572112|FG003|STARTED|Overall Study||27
2868800|NCT00172185|3572109|FG000|COMPLETED|Overall Study||6
2868801|NCT00172185|3572110|FG001|COMPLETED|Overall Study||5
2868802|NCT00172185|3572111|FG002|COMPLETED|Overall Study||20
2868803|NCT00172185|3572112|FG003|COMPLETED|Overall Study||23
2868804|NCT00172185|3572109|FG000|NOT COMPLETED|Overall Study||0
2868805|NCT00172185|3572110|FG001|NOT COMPLETED|Overall Study||2
2868806|NCT00172185|3572111|FG002|NOT COMPLETED|Overall Study||5
2868807|NCT00172185|3572112|FG003|NOT COMPLETED|Overall Study||4
2868808|NCT00174187|3572128|FG000|STARTED|Period 1 (up to 3 Years)||15
2868809|NCT00174187|3572129|FG001|STARTED|Period 1 (up to 3 Years)||15
2868810|NCT00174187|3572130|FG002|STARTED|Period 1 (up to 3 Years)||0
2868811|NCT00174187|3572128|FG000|COMPLETED|Period 1 (up to 3 Years)||15
2868812|NCT00174187|3572129|FG001|COMPLETED|Period 1 (up to 3 Years)||11
2868813|NCT00174187|3572130|FG002|COMPLETED|Period 1 (up to 3 Years)||0
2868814|NCT00174187|3572128|FG000|NOT COMPLETED|Period 1 (up to 3 Years)||0
2868815|NCT00174187|3572129|FG001|NOT COMPLETED|Period 1 (up to 3 Years)||4
2868816|NCT00174187|3572130|FG002|NOT COMPLETED|Period 1 (up to 3 Years)||0
2868817|NCT00174187|3572128|FG000|STARTED|Between Period 1 and Period 2||0
2868818|NCT00174187|3572129|FG001|STARTED|Between Period 1 and Period 2||0
2868819|NCT00174187|3572130|FG002|STARTED|Between Period 1 and Period 2||26
2868820|NCT00174187|3572128|FG000|Consented|Between Period 1 and Period 2||0
2868821|NCT00174187|3572129|FG001|Consented|Between Period 1 and Period 2||0
2868822|NCT00174187|3572130|FG002|Consented|Between Period 1 and Period 2||24
2868823|NCT00174187|3572128|FG000|COMPLETED|Between Period 1 and Period 2||0
2868824|NCT00174187|3572129|FG001|COMPLETED|Between Period 1 and Period 2||0
2868825|NCT00174187|3572130|FG002|COMPLETED|Between Period 1 and Period 2||21
2868826|NCT00174187|3572128|FG000|NOT COMPLETED|Between Period 1 and Period 2||0
2868827|NCT00174187|3572129|FG001|NOT COMPLETED|Between Period 1 and Period 2||0
2868828|NCT00174187|3572130|FG002|NOT COMPLETED|Between Period 1 and Period 2||5
2868829|NCT00174187|3572128|FG000|STARTED|Period 2 (After 3 Years)||0
2868830|NCT00174187|3572129|FG001|STARTED|Period 2 (After 3 Years)||0
2868831|NCT00174187|3572130|FG002|STARTED|Period 2 (After 3 Years)||21
2868832|NCT00174187|3572128|FG000|COMPLETED|Period 2 (After 3 Years)||0
2868833|NCT00174187|3572129|FG001|COMPLETED|Period 2 (After 3 Years)||0
2868834|NCT00174187|3572130|FG002|COMPLETED|Period 2 (After 3 Years)||13
2868835|NCT00174187|3572128|FG000|NOT COMPLETED|Period 2 (After 3 Years)||0
2868836|NCT00174187|3572129|FG001|NOT COMPLETED|Period 2 (After 3 Years)||0
2868837|NCT00174187|3572130|FG002|NOT COMPLETED|Period 2 (After 3 Years)||8
2868838|NCT00174252|3572138|FG000|STARTED|Overall Study||57
2868839|NCT00174252|3572138|FG000|COMPLETED|Overall Study||55
2868840|NCT00174252|3572138|FG000|NOT COMPLETED|Overall Study||2
2868841|NCT00174291|3572146|FG000|STARTED|Overall Study||11
2868842|NCT00174291|3572147|FG001|STARTED|Overall Study||10
2868843|NCT00174291|3572146|FG000|COMPLETED|Overall Study||6
2868844|NCT00174291|3572147|FG001|COMPLETED|Overall Study||4
2868845|NCT00174291|3572146|FG000|NOT COMPLETED|Overall Study||5
2868846|NCT00174291|3572147|FG001|NOT COMPLETED|Overall Study||6
2868847|NCT00174382|3572153|FG000|STARTED|Overall Study|148 are summarized below: 1 subject entered the study but was lost to follow up.|149
2868848|NCT00174382|3572153|FG000|COMPLETED|Overall Study||116
2868849|NCT00174382|3572153|FG000|NOT COMPLETED|Overall Study||33
2868850|NCT00174447|3572157|FG000|STARTED|Overall Study||43
2868851|NCT00174447|3572157|FG000|COMPLETED|Overall Study||5
2868852|NCT00174447|3572157|FG000|NOT COMPLETED|Overall Study||38
2868853|NCT00174460|3572163|FG000|STARTED|Overall Study||18
2868854|NCT00174460|3572164|FG001|STARTED|Overall Study||15
2868855|NCT00174460|3572163|FG000|Received Study Treatment|Overall Study||18
2868856|NCT00174460|3572164|FG001|Received Study Treatment|Overall Study||14
2868857|NCT00174460|3572163|FG000|COMPLETED|Overall Study||18
2868858|NCT00174460|3572164|FG001|COMPLETED|Overall Study||14
2868859|NCT00174460|3572163|FG000|NOT COMPLETED|Overall Study||0
2868860|NCT00174460|3572164|FG001|NOT COMPLETED|Overall Study||1
2868861|NCT00174785|3572173|FG000|STARTED|Overall Study|randomized patients; among them, 10 patients did not receive any study drug in the dronedarone group|2301
2868862|NCT00174785|3572174|FG001|STARTED|Overall Study|randomized patients; among them, 14 patients did not receive any study drug in the placebo group|2327
2868863|NCT00174785|3572173|FG000|COMPLETED|Overall Study|completed study drug|1605
2868864|NCT00174785|3572174|FG001|COMPLETED|Overall Study|completed study drug|1611
2868865|NCT00174785|3572173|FG000|NOT COMPLETED|Overall Study||696
2868866|NCT00174785|3572174|FG001|NOT COMPLETED|Overall Study||716
2868867|NCT00174915|3572185|FG000|STARTED|Overall Study||267
2868868|NCT00174915|3572186|FG001|STARTED|Overall Study||269
2868869|NCT00174915|3572187|FG002|STARTED|Overall Study||134
2868870|NCT00174915|3572188|FG003|STARTED|Overall Study||268
2868871|NCT00174915|3572189|FG004|STARTED|Overall Study||134
2868872|NCT00174915|3572185|FG000|COMPLETED|Overall Study||174
2868873|NCT00174915|3572186|FG001|COMPLETED|Overall Study||200
2868874|NCT00174915|3572187|FG002|COMPLETED|Overall Study||86
2868875|NCT00174915|3572188|FG003|COMPLETED|Overall Study||211
2868876|NCT00174915|3572189|FG004|COMPLETED|Overall Study||101
2868877|NCT00174915|3572185|FG000|NOT COMPLETED|Overall Study||93
2868878|NCT00174915|3572186|FG001|NOT COMPLETED|Overall Study||69
2868879|NCT00174915|3572187|FG002|NOT COMPLETED|Overall Study||48
2868880|NCT00174915|3572188|FG003|NOT COMPLETED|Overall Study||57
2868881|NCT00174915|3572189|FG004|NOT COMPLETED|Overall Study||33
2918717|NCT00528580|3629017|FG001|STARTED|Overall Study||34
2868882|NCT00174941|3572204|FG000|STARTED|Overall Study|Subjects started on febuxostat 80mg. Number of subjects based on Final Stable Dose after titration.|8
2868883|NCT00174941|3572205|FG001|STARTED|Overall Study|Subjects started on febuxostat 80mg. Number of subjects based on Final Stable Dose after titration.|79
2868884|NCT00174941|3572206|FG002|STARTED|Overall Study|Subjects started on febuxostat 80mg. Number of subjects based on Final Stable Dose after titration.|29
2868885|NCT00174941|3572207|FG003|STARTED|Overall Study||116
2868886|NCT00174941|3572204|FG000|COMPLETED|Overall Study||6
2868887|NCT00174941|3572205|FG001|COMPLETED|Overall Study||41
2868888|NCT00174941|3572206|FG002|COMPLETED|Overall Study||11
2868889|NCT00174941|3572207|FG003|COMPLETED|Overall Study||58
2868890|NCT00174941|3572204|FG000|NOT COMPLETED|Overall Study||2
2868891|NCT00174941|3572205|FG001|NOT COMPLETED|Overall Study||38
2868892|NCT00174941|3572206|FG002|NOT COMPLETED|Overall Study||18
2868893|NCT00174941|3572207|FG003|NOT COMPLETED|Overall Study||58
2868894|NCT00174954|3572217|FG000|STARTED|Overall Study||32
2868895|NCT00174954|3572217|FG000|COMPLETED|Overall Study||28
2868896|NCT00174954|3572217|FG000|NOT COMPLETED|Overall Study||4
2868897|NCT00174967|3572225|FG000|STARTED|Overall Study||37
2868898|NCT00174967|3572226|FG001|STARTED|Overall Study||40
2868899|NCT00174967|3572227|FG002|STARTED|Overall Study||38
2868900|NCT00174967|3572228|FG003|STARTED|Overall Study||38
2868901|NCT00174967|3572225|FG000|COMPLETED|Overall Study||36
2868902|NCT00174967|3572226|FG001|COMPLETED|Overall Study||37
2868903|NCT00174967|3572227|FG002|COMPLETED|Overall Study||36
2868904|NCT00174967|3572228|FG003|COMPLETED|Overall Study||36
2868905|NCT00174967|3572225|FG000|NOT COMPLETED|Overall Study||1
2868906|NCT00174967|3572226|FG001|NOT COMPLETED|Overall Study||3
2868907|NCT00174967|3572227|FG002|NOT COMPLETED|Overall Study||2
2868908|NCT00174967|3572228|FG003|NOT COMPLETED|Overall Study||2
2868909|NCT00175006|3572238|FG000|STARTED|Overall Study||13
2868910|NCT00175006|3572238|FG000|COMPLETED|Overall Study||13
2868911|NCT00175006|3572238|FG000|NOT COMPLETED|Overall Study||0
2868912|NCT00175019|3572245|FG000|STARTED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|606
2868913|NCT00175019|3572246|FG001|STARTED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|388
2868914|NCT00175019|3572247|FG002|STARTED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|92
2868915|NCT00175019|3572245|FG000|COMPLETED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|412
2868916|NCT00175019|3572246|FG001|COMPLETED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|217
2868917|NCT00175019|3572247|FG002|COMPLETED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|35
2868918|NCT00175019|3572245|FG000|NOT COMPLETED|Overall Study||194
2868919|NCT00175019|3572246|FG001|NOT COMPLETED|Overall Study||171
2868920|NCT00175019|3572247|FG002|NOT COMPLETED|Overall Study||57
2868921|NCT00175825|3572259|FG000|STARTED|Overall Study||54
2868922|NCT00175825|3572260|FG001|STARTED|Overall Study||50
2868923|NCT00175825|3572261|FG002|STARTED|Overall Study||52
2868924|NCT00175825|3572262|FG003|STARTED|Overall Study||52
2868925|NCT00175825|3572259|FG000|COMPLETED|Overall Study||49
2868926|NCT00175825|3572260|FG001|COMPLETED|Overall Study||46
2868927|NCT00175825|3572261|FG002|COMPLETED|Overall Study||51
2868928|NCT00175825|3572262|FG003|COMPLETED|Overall Study||51
2868929|NCT00175825|3572259|FG000|NOT COMPLETED|Overall Study||5
2868930|NCT00175825|3572260|FG001|NOT COMPLETED|Overall Study||4
2868931|NCT00175825|3572261|FG002|NOT COMPLETED|Overall Study||1
2868932|NCT00175825|3572262|FG003|NOT COMPLETED|Overall Study||1
2868933|NCT00175877|3572272|FG000|STARTED|Overall Study||846
2868934|NCT00175877|3572272|FG000|COMPLETED|Overall Study||497
2868935|NCT00175877|3572272|FG000|NOT COMPLETED|Overall Study||349
2868936|NCT00175916|3572276|FG000|STARTED|Overall Study||853
2868937|NCT00175916|3572276|FG000|COMPLETED|Overall Study||234
2868938|NCT00175916|3572276|FG000|NOT COMPLETED|Overall Study||619
2868939|NCT00176202|3572283|FG000|STARTED|Overall Study||32
2868940|NCT00176202|3572284|FG001|STARTED|Overall Study||33
2868941|NCT00176202|3572283|FG000|COMPLETED|Overall Study||27
2868942|NCT00176202|3572284|FG001|COMPLETED|Overall Study||17
2868943|NCT00176202|3572283|FG000|NOT COMPLETED|Overall Study||5
2868944|NCT00176202|3572284|FG001|NOT COMPLETED|Overall Study||16
2868945|NCT00176228|3572292|FG000|STARTED|Overall Study|When study began|48
2868946|NCT00176228|3572292|FG000|COMPLETED|Overall Study|Study ended|46
2868947|NCT00176228|3572292|FG000|NOT COMPLETED|Overall Study||2
2868948|NCT00176254|3572297|FG000|STARTED|Overall Study||40
2868949|NCT00176254|3572297|FG000|COMPLETED|Overall Study|1 patient only received 1 cycle and refused further induction, another progressed in neck nodes|39
2868950|NCT00176254|3572297|FG000|NOT COMPLETED|Overall Study||1
2868951|NCT00176306|3572301|FG000|STARTED|Overall Study||15
2868952|NCT00176306|3572301|FG000|COMPLETED|Overall Study||15
2868953|NCT00176306|3572301|FG000|NOT COMPLETED|Overall Study||0
2868954|NCT00176423|3572307|FG000|STARTED|Overall Study||42
2868955|NCT00176423|3572308|FG001|STARTED|Overall Study||44
2868956|NCT00176423|3572307|FG000|COMPLETED|Overall Study||35
2868957|NCT00176423|3572308|FG001|COMPLETED|Overall Study||38
2868958|NCT00176423|3572307|FG000|NOT COMPLETED|Overall Study||7
2868959|NCT00176423|3572308|FG001|NOT COMPLETED|Overall Study||6
2868960|NCT00176436|3572316|FG000|STARTED|Overall Study||20
2868961|NCT00176436|3572317|FG001|STARTED|Overall Study||17
2868962|NCT00176436|3572316|FG000|COMPLETED|Overall Study||14
2868963|NCT00176436|3572317|FG001|COMPLETED|Overall Study||12
2868964|NCT00176436|3572316|FG000|NOT COMPLETED|Overall Study||6
2868965|NCT00176436|3572317|FG001|NOT COMPLETED|Overall Study||5
2868966|NCT00176462|3572325|FG000|STARTED|Induction (4 Weeks)||21
2868967|NCT00176462|3572326|FG001|STARTED|Induction (4 Weeks)||39
2868968|NCT00176462|3572325|FG000|COMPLETED|Induction (4 Weeks)||20
2868969|NCT00176462|3572326|FG001|COMPLETED|Induction (4 Weeks)||34
2868970|NCT00176462|3572325|FG000|NOT COMPLETED|Induction (4 Weeks)||1
2868971|NCT00176462|3572326|FG001|NOT COMPLETED|Induction (4 Weeks)||5
2868972|NCT00176462|3572325|FG000|STARTED|Consolidation (12 Weeks)||20
2868973|NCT00176462|3572326|FG001|STARTED|Consolidation (12 Weeks)||34
2868974|NCT00176462|3572325|FG000|COMPLETED|Consolidation (12 Weeks)||20
2868975|NCT00176462|3572326|FG001|COMPLETED|Consolidation (12 Weeks)||29
2868976|NCT00176462|3572325|FG000|NOT COMPLETED|Consolidation (12 Weeks)||0
2868977|NCT00176462|3572326|FG001|NOT COMPLETED|Consolidation (12 Weeks)||5
2868978|NCT00176462|3572325|FG000|STARTED|Delayed Intensification (8 Weeks)||20
2868979|NCT00176462|3572326|FG001|STARTED|Delayed Intensification (8 Weeks)||29
2868980|NCT00176462|3572325|FG000|COMPLETED|Delayed Intensification (8 Weeks)||20
2868981|NCT00176462|3572326|FG001|COMPLETED|Delayed Intensification (8 Weeks)||29
2868982|NCT00176462|3572325|FG000|NOT COMPLETED|Delayed Intensification (8 Weeks)||0
2868983|NCT00176462|3572326|FG001|NOT COMPLETED|Delayed Intensification (8 Weeks)||0
2868984|NCT00176462|3572325|FG000|STARTED|Intensive Continuation (8X8-week Cycles)||20
2868985|NCT00176462|3572326|FG001|STARTED|Intensive Continuation (8X8-week Cycles)||29
2868986|NCT00176462|3572325|FG000|COMPLETED|Intensive Continuation (8X8-week Cycles)||19
2868987|NCT00176462|3572326|FG001|COMPLETED|Intensive Continuation (8X8-week Cycles)||26
2868988|NCT00176462|3572325|FG000|NOT COMPLETED|Intensive Continuation (8X8-week Cycles)||1
2868989|NCT00176462|3572326|FG001|NOT COMPLETED|Intensive Continuation (8X8-week Cycles)||3
2868990|NCT00176462|3572325|FG000|STARTED|Continuation -up to 30mos Post Remission||19
2868991|NCT00176462|3572326|FG001|STARTED|Continuation -up to 30mos Post Remission||26
2868992|NCT00176462|3572325|FG000|COMPLETED|Continuation -up to 30mos Post Remission||19
2868993|NCT00176462|3572326|FG001|COMPLETED|Continuation -up to 30mos Post Remission||26
2868994|NCT00176462|3572325|FG000|NOT COMPLETED|Continuation -up to 30mos Post Remission||0
2868995|NCT00176462|3572326|FG001|NOT COMPLETED|Continuation -up to 30mos Post Remission||0
2868996|NCT00176592|3572335|FG000|STARTED|Overall Study||36
2868997|NCT00176592|3572336|FG001|STARTED|Overall Study||39
2868998|NCT00176592|3572335|FG000|Followed for 1 Year|Overall Study||35
2868999|NCT00176592|3572336|FG001|Followed for 1 Year|Overall Study||35
2869000|NCT00176592|3572335|FG000|Followed for 2 Years|Overall Study||29
2869001|NCT00176592|3572336|FG001|Followed for 2 Years|Overall Study||35
2869002|NCT00176592|3572335|FG000|COMPLETED|Overall Study||36
2869003|NCT00176592|3572336|FG001|COMPLETED|Overall Study||39
2869004|NCT00176592|3572335|FG000|NOT COMPLETED|Overall Study||0
2869005|NCT00176592|3572336|FG001|NOT COMPLETED|Overall Study||0
2869006|NCT00176605|3572342|FG000|STARTED|Overall Study||15
2869007|NCT00176605|3572342|FG000|COMPLETED|Overall Study||13
2869008|NCT00176605|3572342|FG000|NOT COMPLETED|Overall Study||2
2869009|NCT00176644|3572346|FG000|STARTED|Overall Study||23
2869010|NCT00176644|3572346|FG000|COMPLETED|Overall Study||22
2869011|NCT00176644|3572346|FG000|NOT COMPLETED|Overall Study||1
2869012|NCT00176800|3572350|FG000|STARTED|Overall Study||69
2869013|NCT00176800|3572350|FG000|COMPLETED|Overall Study||69
2869014|NCT00176800|3572350|FG000|NOT COMPLETED|Overall Study||0
2869015|NCT00176826|3572354|FG000|STARTED|Overall Study||22
2869016|NCT00176826|3572354|FG000|COMPLETED|Overall Study||22
2869017|NCT00176826|3572354|FG000|NOT COMPLETED|Overall Study||0
2869018|NCT00176839|3572358|FG000|STARTED|Overall Study||11
2869019|NCT00176839|3572358|FG000|COMPLETED|Overall Study||11
2869020|NCT00176839|3572358|FG000|NOT COMPLETED|Overall Study||0
2869021|NCT00176852|3572365|FG000|STARTED|Overall Study||3
2869022|NCT00176852|3572366|FG001|STARTED|Overall Study||5
2869023|NCT00176852|3572367|FG002|STARTED|Overall Study||14
2869024|NCT00176852|3572365|FG000|COMPLETED|Overall Study||3
2869025|NCT00176852|3572366|FG001|COMPLETED|Overall Study||5
2869026|NCT00176852|3572367|FG002|COMPLETED|Overall Study||14
2869027|NCT00176852|3572365|FG000|NOT COMPLETED|Overall Study||0
2869028|NCT00176852|3572366|FG001|NOT COMPLETED|Overall Study||0
2869029|NCT00176852|3572367|FG002|NOT COMPLETED|Overall Study||0
2869030|NCT00176865|3572378|FG000|STARTED|Overall Study||3
2869031|NCT00176865|3572379|FG001|STARTED|Overall Study||10
2869032|NCT00176865|3572380|FG002|STARTED|Overall Study||6
2869033|NCT00176865|3572378|FG000|COMPLETED|Overall Study||3
2869034|NCT00176865|3572379|FG001|COMPLETED|Overall Study||10
2869035|NCT00176865|3572380|FG002|COMPLETED|Overall Study||6
2869036|NCT00176865|3572378|FG000|NOT COMPLETED|Overall Study||0
2869037|NCT00176865|3572379|FG001|NOT COMPLETED|Overall Study||0
2869038|NCT00176865|3572380|FG002|NOT COMPLETED|Overall Study||0
2869039|NCT00176878|3572388|FG000|STARTED|Overall Study||10
2869040|NCT00176878|3572388|FG000|COMPLETED|Overall Study||10
2869041|NCT00176878|3572388|FG000|NOT COMPLETED|Overall Study||0
2869042|NCT00176891|3572392|FG000|STARTED|Overall Study||25
2869043|NCT00176891|3572392|FG000|COMPLETED|Overall Study||22
2869044|NCT00176891|3572392|FG000|NOT COMPLETED|Overall Study||3
2869045|NCT00176904|3572396|FG000|STARTED|Overall Study||135
2869046|NCT00176904|3572396|FG000|COMPLETED|Overall Study||135
2869047|NCT00176904|3572396|FG000|NOT COMPLETED|Overall Study||0
2869048|NCT00176917|3572400|FG000|STARTED|Overall Study||41
2869049|NCT00176917|3572400|FG000|COMPLETED|Overall Study||41
2869050|NCT00176917|3572400|FG000|NOT COMPLETED|Overall Study||0
2869051|NCT00176930|3572412|FG000|STARTED|Overall Study||12
2869052|NCT00176930|3572413|FG001|STARTED|Overall Study||13
2869053|NCT00176930|3572414|FG002|STARTED|Overall Study||1
2869054|NCT00176930|3572415|FG003|STARTED|Overall Study||1
2869055|NCT00176930|3572416|FG004|STARTED|Overall Study||213
2869056|NCT00176930|3572417|FG005|STARTED|Overall Study||85
2869057|NCT00176930|3572418|FG006|STARTED|Overall Study||2
2869058|NCT00176930|3572419|FG007|STARTED|Overall Study||2
2869059|NCT00176930|3572412|FG000|COMPLETED|Overall Study||12
2869060|NCT00176930|3572413|FG001|COMPLETED|Overall Study||13
2869061|NCT00176930|3572414|FG002|COMPLETED|Overall Study||1
2869062|NCT00176930|3572415|FG003|COMPLETED|Overall Study||1
2869063|NCT00176930|3572416|FG004|COMPLETED|Overall Study||213
2869064|NCT00176930|3572417|FG005|COMPLETED|Overall Study||85
2869065|NCT00176930|3572418|FG006|COMPLETED|Overall Study||2
2869066|NCT00176930|3572419|FG007|COMPLETED|Overall Study||2
2869067|NCT00176930|3572412|FG000|NOT COMPLETED|Overall Study||0
2869068|NCT00176930|3572413|FG001|NOT COMPLETED|Overall Study||0
2869069|NCT00176930|3572414|FG002|NOT COMPLETED|Overall Study||0
2869070|NCT00176930|3572415|FG003|NOT COMPLETED|Overall Study||0
3313553|NCT03075553|4046841|FG000|COMPLETED|Overall Study||12
3313554|NCT03075553|4046841|FG000|NOT COMPLETED|Overall Study||0
2869071|NCT00176930|3572416|FG004|NOT COMPLETED|Overall Study||0
2869072|NCT00176930|3572417|FG005|NOT COMPLETED|Overall Study||0
2869073|NCT00176930|3572418|FG006|NOT COMPLETED|Overall Study||0
2869074|NCT00176930|3572419|FG007|NOT COMPLETED|Overall Study||0
2869075|NCT00177047|3572437|FG000|STARTED|Overall Study||363
2869076|NCT00177047|3572437|FG000|COMPLETED|Overall Study||363
2869077|NCT00177047|3572437|FG000|NOT COMPLETED|Overall Study||0
2869078|NCT00177164|3572443|FG000|STARTED|Overall Study||23
2869079|NCT00177164|3572444|FG001|STARTED|Overall Study||25
2869080|NCT00177164|3572443|FG000|COMPLETED|Overall Study||14
2869081|NCT00177164|3572444|FG001|COMPLETED|Overall Study||9
2869082|NCT00177164|3572443|FG000|NOT COMPLETED|Overall Study||9
2869083|NCT00177164|3572444|FG001|NOT COMPLETED|Overall Study||16
2869084|NCT00177216|3572453|FG000|STARTED|Overall Study||26
2869085|NCT00177216|3572454|FG001|STARTED|Overall Study||23
2869086|NCT00177216|3572455|FG002|STARTED|Overall Study||20
2869087|NCT00177216|3572453|FG000|COMPLETED|Overall Study||20
2869088|NCT00177216|3572454|FG001|COMPLETED|Overall Study||20
2869089|NCT00177216|3572455|FG002|COMPLETED|Overall Study||19
2869090|NCT00177216|3572453|FG000|NOT COMPLETED|Overall Study||6
2869091|NCT00177216|3572454|FG001|NOT COMPLETED|Overall Study||3
2869092|NCT00177216|3572455|FG002|NOT COMPLETED|Overall Study||1
2869093|NCT00177255|3572467|FG000|STARTED|Overall Study||39
2869094|NCT00177255|3572467|FG000|COMPLETED|Overall Study||39
2869095|NCT00177255|3572467|FG000|NOT COMPLETED|Overall Study||0
2869096|NCT00177294|3572473|FG000|STARTED|Overall Study||60
2869097|NCT00177294|3572474|FG001|STARTED|Overall Study||64
2869098|NCT00177294|3572473|FG000|COMPLETED|Overall Study||53
2869099|NCT00177294|3572474|FG001|COMPLETED|Overall Study||59
2869100|NCT00177294|3572473|FG000|NOT COMPLETED|Overall Study||7
2869101|NCT00177294|3572474|FG001|NOT COMPLETED|Overall Study||5
2918718|NCT00528580|3629016|FG000|COMPLETED|Overall Study||34
2918719|NCT00528580|3629017|FG001|COMPLETED|Overall Study||34
2918720|NCT00528580|3629016|FG000|NOT COMPLETED|Overall Study||0
2918721|NCT00528580|3629017|FG001|NOT COMPLETED|Overall Study||0
2918722|NCT00528606|3629025|FG000|STARTED|Overall Study||204
2918723|NCT00528606|3629026|FG001|STARTED|Overall Study||104
2918724|NCT00528606|3629025|FG000|COMPLETED|Overall Study||191
2918725|NCT00528606|3629026|FG001|COMPLETED|Overall Study||100
2918726|NCT00528606|3629025|FG000|NOT COMPLETED|Overall Study||13
2918727|NCT00528606|3629026|FG001|NOT COMPLETED|Overall Study||4
2918728|NCT00528645|3629032|FG000|STARTED|Overall Study||23
2918729|NCT00528645|3629032|FG000|COMPLETED|Overall Study||20
2918730|NCT00528645|3629032|FG000|NOT COMPLETED|Overall Study||3
2918731|NCT00528788|3629037|FG000|STARTED|Overall Study||24
2918732|NCT00528788|3629037|FG000|COMPLETED|Overall Study||20
2918733|NCT00528788|3629037|FG000|NOT COMPLETED|Overall Study||4
2918734|NCT00528801|3629043|FG000|STARTED|Overall Study||160
2918735|NCT00528801|3629044|FG001|STARTED|Overall Study||52
2918736|NCT00528801|3629043|FG000|COMPLETED|Overall Study||133
2918737|NCT00528801|3629044|FG001|COMPLETED|Overall Study||41
2918738|NCT00528801|3629043|FG000|NOT COMPLETED|Overall Study||27
3313555|NCT03075644|4046847|FG000|STARTED|Overall Study||16
3313556|NCT03075644|4046848|FG001|STARTED|Overall Study||46
2918739|NCT00528801|3629044|FG001|NOT COMPLETED|Overall Study||11
2918740|NCT00528840|3629050|FG000|STARTED|Overall Study||201
2918741|NCT00528840|3629050|FG000|COMPLETED|Overall Study||168
2918742|NCT00528840|3629050|FG000|NOT COMPLETED|Overall Study||33
2918743|NCT00528866|3629054|FG000|STARTED|Overall Study||80
2918744|NCT00528866|3629054|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|74
2918745|NCT00528866|3629054|FG000|NOT COMPLETED|Overall Study||6
2918746|NCT00528879|3629063|FG000|STARTED|Short-term Period (Day 1 to Week 24)||137
2918747|NCT00528879|3629064|FG001|STARTED|Short-term Period (Day 1 to Week 24)||137
2918748|NCT00528879|3629065|FG002|STARTED|Short-term Period (Day 1 to Week 24)||137
2918749|NCT00528879|3629066|FG003|STARTED|Short-term Period (Day 1 to Week 24)||135
2918750|NCT00528879|3629063|FG000|Completed the Period|Short-term Period (Day 1 to Week 24)||119
2918751|NCT00528879|3629064|FG001|Completed the Period|Short-term Period (Day 1 to Week 24)||121
2918752|NCT00528879|3629065|FG002|Completed the Period|Short-term Period (Day 1 to Week 24)||122
2869102|NCT00177307|3572480|FG000|STARTED|Overall Study||40
2869103|NCT00177307|3572480|FG000|COMPLETED|Overall Study||39
2869104|NCT00177307|3572480|FG000|NOT COMPLETED|Overall Study||1
2869105|NCT00177671|3572486|FG000|STARTED|Overall Study||67
2869106|NCT00177671|3572487|FG001|STARTED|Overall Study||63
2869107|NCT00177671|3572486|FG000|Month 12|Overall Study||45
2869108|NCT00177671|3572487|FG001|Month 12|Overall Study||57
2869109|NCT00177671|3572486|FG000|Month 24|Overall Study||42
2869110|NCT00177671|3572487|FG001|Month 24|Overall Study||49
2869111|NCT00177671|3572486|FG000|COMPLETED|Overall Study||42
2869112|NCT00177671|3572487|FG001|COMPLETED|Overall Study||49
2869113|NCT00177671|3572486|FG000|NOT COMPLETED|Overall Study||25
2869114|NCT00177671|3572487|FG001|NOT COMPLETED|Overall Study||14
2869115|NCT00178126|3572495|FG000|STARTED|Overall Study||119
2869116|NCT00178126|3572496|FG001|STARTED|Overall Study||113
2869117|NCT00178126|3572495|FG000|COMPLETED|Overall Study||94
2869118|NCT00178126|3572496|FG001|COMPLETED|Overall Study||86
2869119|NCT00178126|3572495|FG000|NOT COMPLETED|Overall Study||25
2869120|NCT00178126|3572496|FG001|NOT COMPLETED|Overall Study||27
2869121|NCT00178178|3572506|FG000|STARTED|Overall Study||24
2869122|NCT00178178|3572507|FG001|STARTED|Overall Study||24
2869123|NCT00178178|3572508|FG002|STARTED|Overall Study||24
2869124|NCT00178178|3572509|FG003|STARTED|Overall Study||24
2869125|NCT00178178|3572506|FG000|COMPLETED|Overall Study||24
2869126|NCT00178178|3572507|FG001|COMPLETED|Overall Study||24
2869127|NCT00178178|3572508|FG002|COMPLETED|Overall Study||24
2869128|NCT00178178|3572509|FG003|COMPLETED|Overall Study||24
2869129|NCT00178178|3572506|FG000|NOT COMPLETED|Overall Study||0
2869130|NCT00178178|3572507|FG001|NOT COMPLETED|Overall Study||0
2869131|NCT00178178|3572508|FG002|NOT COMPLETED|Overall Study||0
2869132|NCT00178178|3572509|FG003|NOT COMPLETED|Overall Study||0
2869133|NCT00178191|3572522|FG000|STARTED|Overall Study||11
2869134|NCT00178191|3572523|FG001|STARTED|Overall Study||10
2869135|NCT00178191|3572524|FG002|STARTED|Overall Study||7
2869136|NCT00178191|3572522|FG000|COMPLETED|Overall Study||11
2869137|NCT00178191|3572523|FG001|COMPLETED|Overall Study||10
2869138|NCT00178191|3572524|FG002|COMPLETED|Overall Study||7
2869139|NCT00178191|3572522|FG000|NOT COMPLETED|Overall Study||0
2869140|NCT00178191|3572523|FG001|NOT COMPLETED|Overall Study||0
2869141|NCT00178191|3572524|FG002|NOT COMPLETED|Overall Study||0
2869142|NCT00178256|3572532|FG000|STARTED|Overall Study||10
2869143|NCT00178256|3572533|FG001|STARTED|Overall Study||7
2869144|NCT00178256|3572534|FG002|STARTED|Overall Study||6
2869145|NCT00178256|3572535|FG003|STARTED|Overall Study||18
2869146|NCT00178256|3572532|FG000|COMPLETED|Overall Study||6
2869147|NCT00178256|3572533|FG001|COMPLETED|Overall Study||6
2869148|NCT00178256|3572534|FG002|COMPLETED|Overall Study||6
2869149|NCT00178256|3572535|FG003|COMPLETED|Overall Study||16
2869150|NCT00178256|3572532|FG000|NOT COMPLETED|Overall Study||4
2869151|NCT00178256|3572533|FG001|NOT COMPLETED|Overall Study||1
2869152|NCT00178256|3572534|FG002|NOT COMPLETED|Overall Study||0
2869153|NCT00178256|3572535|FG003|NOT COMPLETED|Overall Study||2
2869154|NCT00178399|3572542|FG000|STARTED|Overall Study||128
2869155|NCT00178399|3572542|FG000|COMPLETED|Overall Study||115
2869156|NCT00178399|3572542|FG000|NOT COMPLETED|Overall Study||13
2869157|NCT00178464|3572547|FG000|STARTED|Overall Study||11
2869158|NCT00178464|3572547|FG000|COMPLETED|Overall Study||9
2869159|NCT00178464|3572547|FG000|NOT COMPLETED|Overall Study||2
2869160|NCT00178503|3572551|FG000|STARTED|MPH Trial: Placebo||24
2869161|NCT00178503|3572551|FG000|COMPLETED|MPH Trial: Placebo||24
2869162|NCT00178503|3572551|FG000|NOT COMPLETED|MPH Trial: Placebo||0
2869163|NCT00178503|3572551|FG000|STARTED|MPH Trial: Low Dose||24
2869164|NCT00178503|3572551|FG000|COMPLETED|MPH Trial: Low Dose||24
2869165|NCT00178503|3572551|FG000|NOT COMPLETED|MPH Trial: Low Dose||0
2869166|NCT00178503|3572551|FG000|STARTED|MPH Trial: Med Dose||24
2869167|NCT00178503|3572551|FG000|COMPLETED|MPH Trial: Med Dose||24
3169470|NCT01925417|3897006|FG000|STARTED|Overall Study||34
3169471|NCT01925417|3897006|FG000|COMPLETED|Overall Study||31
3169472|NCT01925417|3897006|FG000|NOT COMPLETED|Overall Study||3
3169473|NCT01925469|3897013|FG000|STARTED|Overall Study||15
3169474|NCT01925469|3897014|FG001|STARTED|Overall Study||15
3169475|NCT01925469|3897013|FG000|COMPLETED|Overall Study||14
3169476|NCT01925469|3897014|FG001|COMPLETED|Overall Study||15
3169477|NCT01925469|3897013|FG000|NOT COMPLETED|Overall Study||1
3169478|NCT01925469|3897014|FG001|NOT COMPLETED|Overall Study||0
3169479|NCT01925612|3897025|FG000|STARTED|Overall Study||29
3169480|NCT01925612|3897026|FG001|STARTED|Overall Study||22
3169481|NCT01925612|3897027|FG002|STARTED|Overall Study||11
3169482|NCT01925612|3897028|FG003|STARTED|Overall Study||11
3169483|NCT01925612|3897029|FG004|STARTED|Overall Study||12
3169484|NCT01925612|3897025|FG000|COMPLETED|Overall Study||25
3169485|NCT01925612|3897026|FG001|COMPLETED|Overall Study||18
3169486|NCT01925612|3897027|FG002|COMPLETED|Overall Study||10
3169487|NCT01925612|3897028|FG003|COMPLETED|Overall Study||10
2869168|NCT00178503|3572551|FG000|NOT COMPLETED|MPH Trial: Med Dose||0
2869169|NCT00178503|3572551|FG000|STARTED|MPH Trial: High Dose||24
2869170|NCT00178503|3572551|FG000|COMPLETED|MPH Trial: High Dose||24
2869171|NCT00178503|3572551|FG000|NOT COMPLETED|MPH Trial: High Dose||0
3169488|NCT01925612|3897029|FG004|COMPLETED|Overall Study||10
3169489|NCT01925612|3897025|FG000|NOT COMPLETED|Overall Study||4
3169490|NCT01925612|3897026|FG001|NOT COMPLETED|Overall Study||4
3169491|NCT01925612|3897027|FG002|NOT COMPLETED|Overall Study||1
3169492|NCT01925612|3897028|FG003|NOT COMPLETED|Overall Study||1
3169493|NCT01925612|3897029|FG004|NOT COMPLETED|Overall Study||2
3169494|NCT01925677|3897041|FG000|STARTED|Overall Study||3
3169495|NCT01925677|3897041|FG000|COMPLETED|Overall Study||3
3169496|NCT01925677|3897041|FG000|NOT COMPLETED|Overall Study||0
3169497|NCT01925703|3897045|FG000|STARTED|Overall Study||13
3169498|NCT01925703|3897045|FG000|Dosing Regimen Completed|Overall Study||12
3169499|NCT01925703|3897045|FG000|Full Iron Repletion Achieved|Overall Study||11
2869172|NCT00178633|3572566|FG000|STARTED|Overall Study||43
2869173|NCT00178633|3572566|FG000|COMPLETED|Overall Study||37
2869174|NCT00178633|3572566|FG000|NOT COMPLETED|Overall Study||6
2869175|NCT00178646|3572574|FG000|STARTED|Overall Study||12
2869176|NCT00178646|3572575|FG001|STARTED|Overall Study||9
2869177|NCT00178646|3572576|FG002|STARTED|Overall Study||11
2869178|NCT00178646|3572574|FG000|COMPLETED|Overall Study||12
2869179|NCT00178646|3572575|FG001|COMPLETED|Overall Study||8
2869180|NCT00178646|3572576|FG002|COMPLETED|Overall Study||10
2869181|NCT00178646|3572574|FG000|NOT COMPLETED|Overall Study||0
2869182|NCT00178646|3572575|FG001|NOT COMPLETED|Overall Study||1
2869183|NCT00178646|3572576|FG002|NOT COMPLETED|Overall Study||1
3169500|NCT01925703|3897045|FG000|Follow-up Completed|Overall Study||9
3169501|NCT01925703|3897045|FG000|COMPLETED|Overall Study||9
3169502|NCT01925703|3897045|FG000|NOT COMPLETED|Overall Study||4
3169503|NCT01925768|3897051|FG000|STARTED|Placebo-controlled Phase (Week 0 - 24)||109
3169504|NCT01925768|3897052|FG001|STARTED|Placebo-controlled Phase (Week 0 - 24)||110
2869184|NCT00178685|3572590|FG000|STARTED|Overall Study||172
2869185|NCT00178685|3572591|FG001|STARTED|Overall Study||324
2869186|NCT00178685|3572592|FG002|STARTED|Overall Study||324
2869187|NCT00178685|3572590|FG000|COMPLETED|Overall Study||61
2869188|NCT00178685|3572591|FG001|COMPLETED|Overall Study||120
2869189|NCT00178685|3572592|FG002|COMPLETED|Overall Study||128
2869190|NCT00178685|3572590|FG000|NOT COMPLETED|Overall Study||111
2869191|NCT00178685|3572591|FG001|NOT COMPLETED|Overall Study||204
2869192|NCT00178685|3572592|FG002|NOT COMPLETED|Overall Study||196
2869193|NCT00178711|3572602|FG000|STARTED|Overall Study||52
2869194|NCT00178711|3572603|FG001|STARTED|Overall Study||45
2869195|NCT00178711|3572602|FG000|COMPLETED|Overall Study||52
2869196|NCT00178711|3572603|FG001|COMPLETED|Overall Study||45
2869197|NCT00178711|3572602|FG000|NOT COMPLETED|Overall Study||0
2869198|NCT00178711|3572603|FG001|NOT COMPLETED|Overall Study||0
2869199|NCT00178841|3572611|FG000|STARTED|Overall Study||4
2869200|NCT00178841|3572611|FG000|COMPLETED|Overall Study||4
2869201|NCT00178841|3572611|FG000|NOT COMPLETED|Overall Study||0
2869202|NCT00178919|3572618|FG000|STARTED|Overall Study||19
2869203|NCT00178919|3572619|FG001|STARTED|Overall Study||93
2869204|NCT00178919|3572618|FG000|COMPLETED|Overall Study||19
2869205|NCT00178919|3572619|FG001|COMPLETED|Overall Study||68
2869206|NCT00178919|3572618|FG000|NOT COMPLETED|Overall Study||0
2869207|NCT00178919|3572619|FG001|NOT COMPLETED|Overall Study||25
2869208|NCT00179010|3572627|FG000|STARTED|Overall Study||6
2869209|NCT00179010|3572628|FG001|STARTED|Overall Study||7
2869210|NCT00179010|3572627|FG000|COMPLETED|Overall Study||5
2869211|NCT00179010|3572628|FG001|COMPLETED|Overall Study||5
2869212|NCT00179010|3572627|FG000|NOT COMPLETED|Overall Study||1
2869213|NCT00179010|3572628|FG001|NOT COMPLETED|Overall Study||2
2869214|NCT00179309|3572637|FG000|STARTED|Treatment||25
2869215|NCT00179309|3572638|FG001|STARTED|Treatment||23
2869216|NCT00179309|3572637|FG000|COMPLETED|Treatment||21
2869217|NCT00179309|3572638|FG001|COMPLETED|Treatment||18
2869218|NCT00179309|3572637|FG000|NOT COMPLETED|Treatment||4
2869219|NCT00179309|3572638|FG001|NOT COMPLETED|Treatment||5
2869220|NCT00179309|3572637|FG000|STARTED|Crossover||0
2869221|NCT00179309|3572638|FG001|STARTED|Crossover|Crossover was allowed so that patients randomized to B could receive the vaccine upon progression.|3
2869222|NCT00179309|3572637|FG000|COMPLETED|Crossover||0
2869223|NCT00179309|3572638|FG001|COMPLETED|Crossover||3
2869224|NCT00179309|3572637|FG000|NOT COMPLETED|Crossover||0
2869225|NCT00179309|3572638|FG001|NOT COMPLETED|Crossover||0
2869226|NCT00179413|3572646|FG000|STARTED|Overall Study||282
2869227|NCT00179413|3572647|FG001|STARTED|Overall Study||267
2869228|NCT00179413|3572646|FG000|COMPLETED|Overall Study||157
2869229|NCT00179413|3572647|FG001|COMPLETED|Overall Study||152
2869230|NCT00179413|3572646|FG000|NOT COMPLETED|Overall Study||125
2869231|NCT00179413|3572647|FG001|NOT COMPLETED|Overall Study||115
2869232|NCT00179478|3572655|FG000|STARTED|Overall Study||81
2869233|NCT00179478|3572656|FG001|STARTED|Overall Study||74
2869234|NCT00179478|3572655|FG000|COMPLETED|Overall Study||68
2869235|NCT00179478|3572656|FG001|COMPLETED|Overall Study||59
2869236|NCT00179478|3572655|FG000|NOT COMPLETED|Overall Study||13
2869237|NCT00179478|3572656|FG001|NOT COMPLETED|Overall Study||15
2869238|NCT00179517|3572663|FG000|STARTED|Overall Study||20
2869239|NCT00179517|3572664|FG001|STARTED|Overall Study||20
2869240|NCT00179517|3572663|FG000|COMPLETED|Overall Study||18
2869241|NCT00179517|3572664|FG001|COMPLETED|Overall Study||19
2869242|NCT00179517|3572663|FG000|NOT COMPLETED|Overall Study||2
2869243|NCT00179517|3572664|FG001|NOT COMPLETED|Overall Study||1
2869244|NCT00179621|3572673|FG000|STARTED|Double-Blind Period||67
2869245|NCT00179621|3572674|FG001|STARTED|Double-Blind Period||69
2869246|NCT00179621|3572675|FG002|STARTED|Double-Blind Period||69
2869247|NCT00179621|3572676|FG003|STARTED|Double-Blind Period||0
2869248|NCT00179621|3572673|FG000|COMPLETED|Double-Blind Period||3
2869249|NCT00179621|3572674|FG001|COMPLETED|Double-Blind Period||23
2869250|NCT00179621|3572675|FG002|COMPLETED|Double-Blind Period||39
2869251|NCT00179621|3572676|FG003|COMPLETED|Double-Blind Period||0
2869252|NCT00179621|3572673|FG000|NOT COMPLETED|Double-Blind Period||64
2869253|NCT00179621|3572674|FG001|NOT COMPLETED|Double-Blind Period||46
2869254|NCT00179621|3572675|FG002|NOT COMPLETED|Double-Blind Period||30
2869255|NCT00179621|3572676|FG003|NOT COMPLETED|Double-Blind Period||0
2869256|NCT00179621|3572673|FG000|STARTED|Open-Label Period||0
2869257|NCT00179621|3572674|FG001|STARTED|Open-Label Period|'Started' includes 23 participants who completed double-blind and 19 who discontinued double-blind.|42
2869258|NCT00179621|3572675|FG002|STARTED|Open-Label Period|'Started' includes 39 participants who completed double-blind and 8 who discontinued double-blind.|47
2869259|NCT00179621|3572676|FG003|STARTED|Open-Label Period|'Started' includes 1 participant who completed double-blind and 55 who discontinued double-blind.|56
2869260|NCT00179621|3572673|FG000|COMPLETED|Open-Label Period||0
2869261|NCT00179621|3572674|FG001|COMPLETED|Open-Label Period||14
2869262|NCT00179621|3572675|FG002|COMPLETED|Open-Label Period||19
2869263|NCT00179621|3572676|FG003|COMPLETED|Open-Label Period||13
2869264|NCT00179621|3572673|FG000|NOT COMPLETED|Open-Label Period||0
2869265|NCT00179621|3572674|FG001|NOT COMPLETED|Open-Label Period||28
2869266|NCT00179621|3572675|FG002|NOT COMPLETED|Open-Label Period||28
2869267|NCT00179621|3572676|FG003|NOT COMPLETED|Open-Label Period||43
2869268|NCT00179647|3572685|FG000|STARTED|Overall Study||1913
2869269|NCT00179647|3572685|FG000|COMPLETED|Overall Study|Subjects participated in study until they presented with reason for discontinuation.|0
2869270|NCT00179647|3572685|FG000|NOT COMPLETED|Overall Study||1913
2869271|NCT00179660|3572689|FG000|STARTED|Overall Study||50
2869272|NCT00179660|3572689|FG000|Received Study Drug|Overall Study||49
2869273|NCT00179660|3572689|FG000|Completed 12 Cycles of Treatment|Overall Study||12
2869274|NCT00179660|3572689|FG000|COMPLETED|Overall Study|Completed refers to participants ongoing in the study at the time of analysis.|0
2869275|NCT00179660|3572689|FG000|NOT COMPLETED|Overall Study||50
2869276|NCT00179673|3572693|FG000|STARTED|Overall Study||43
2869277|NCT00179673|3572693|FG000|Received Study Drug|Overall Study||43
2869278|NCT00179673|3572693|FG000|COMPLETED|Overall Study|Completed refers to participants ongoing in the study at the time of analysis.|0
2869279|NCT00179673|3572693|FG000|NOT COMPLETED|Overall Study||43
2869280|NCT00179777|3572699|FG000|STARTED|Overall Study||2613
2869281|NCT00179777|3572700|FG001|STARTED|Overall Study||2543
2869282|NCT00179777|3572699|FG000|COMPLETED|Overall Study||1081
2869283|NCT00179777|3572700|FG001|COMPLETED|Overall Study||1078
2869284|NCT00179777|3572699|FG000|NOT COMPLETED|Overall Study||1532
2869285|NCT00179777|3572700|FG001|NOT COMPLETED|Overall Study||1465
2869286|NCT00179959|3572710|FG000|STARTED|Overall Study||15
2869287|NCT00179959|3572711|FG001|STARTED|Overall Study||16
2869288|NCT00179959|3572710|FG000|COMPLETED|Overall Study||9
2869289|NCT00179959|3572711|FG001|COMPLETED|Overall Study||13
2869290|NCT00179959|3572710|FG000|NOT COMPLETED|Overall Study||6
2869291|NCT00179959|3572711|FG001|NOT COMPLETED|Overall Study||3
2869292|NCT00179998|3572719|FG000|STARTED|Initial Period - 6 Months||12
2869293|NCT00179998|3572720|FG001|STARTED|Initial Period - 6 Months||12
2869294|NCT00179998|3572719|FG000|COMPLETED|Initial Period - 6 Months||12
2869295|NCT00179998|3572720|FG001|COMPLETED|Initial Period - 6 Months||12
2869296|NCT00179998|3572719|FG000|NOT COMPLETED|Initial Period - 6 Months||0
2869297|NCT00179998|3572720|FG001|NOT COMPLETED|Initial Period - 6 Months||0
2869298|NCT00179998|3572719|FG000|STARTED|Crossover Period - 6 Months||12
2869299|NCT00179998|3572720|FG001|STARTED|Crossover Period - 6 Months||12
2869300|NCT00179998|3572719|FG000|COMPLETED|Crossover Period - 6 Months||12
2869301|NCT00179998|3572720|FG001|COMPLETED|Crossover Period - 6 Months||10
2869302|NCT00179998|3572719|FG000|NOT COMPLETED|Crossover Period - 6 Months||0
2869303|NCT00179998|3572720|FG001|NOT COMPLETED|Crossover Period - 6 Months||2
2869304|NCT00180271|3572732|FG000|STARTED|Overall Study||1089
2869305|NCT00180271|3572733|FG001|STARTED|Overall Study||731
2869306|NCT00180271|3572732|FG000|COMPLETED|Overall Study||1089
2869307|NCT00180271|3572733|FG001|COMPLETED|Overall Study||731
2869308|NCT00180271|3572732|FG000|NOT COMPLETED|Overall Study||0
2869309|NCT00180271|3572733|FG001|NOT COMPLETED|Overall Study||0
2869310|NCT00180297|3572743|FG000|STARTED|Overall Study||107
2869311|NCT00180297|3572744|FG001|STARTED|Overall Study||108
2869312|NCT00180297|3572743|FG000|COMPLETED|Overall Study||61
2869313|NCT00180297|3572744|FG001|COMPLETED|Overall Study||67
2869314|NCT00180297|3572743|FG000|NOT COMPLETED|Overall Study||46
2869315|NCT00180297|3572744|FG001|NOT COMPLETED|Overall Study||41
2869316|NCT00180323|3572750|FG000|STARTED|Overall Study||43
2869317|NCT00180323|3572750|FG000|COMPLETED|Overall Study||43
2869318|NCT00180323|3572750|FG000|NOT COMPLETED|Overall Study||0
2869319|NCT00180479|3572758|FG000|STARTED|Overall Study||669
2869320|NCT00180479|3572759|FG001|STARTED|Overall Study|1 patient randomized never signed consent, therefore no data collected. Analysis group = 332.|333
2869321|NCT00180479|3572758|FG000|COMPLETED|Overall Study||653
2869322|NCT00180479|3572759|FG001|COMPLETED|Overall Study||320
2869323|NCT00180479|3572758|FG000|NOT COMPLETED|Overall Study||16
2869324|NCT00180479|3572759|FG001|NOT COMPLETED|Overall Study||13
2869325|NCT00180661|3572767|FG000|STARTED|Overall Study||19
2869326|NCT00180661|3572768|FG001|STARTED|Overall Study||20
2869327|NCT00180661|3572767|FG000|COMPLETED|Overall Study||19
2869328|NCT00180661|3572768|FG001|COMPLETED|Overall Study||20
2869329|NCT00180661|3572767|FG000|NOT COMPLETED|Overall Study||0
2869330|NCT00180661|3572768|FG001|NOT COMPLETED|Overall Study||0
2869331|NCT00180674|3572774|FG000|STARTED|Phase 1, Observation Period||14
2869332|NCT00180674|3572774|FG000|COMPLETED|Phase 1, Observation Period||10
2869333|NCT00180674|3572774|FG000|NOT COMPLETED|Phase 1, Observation Period||4
2869334|NCT00180674|3572774|FG000|STARTED|Phase 2, Warfarin Treatment Period||10
2869335|NCT00180674|3572774|FG000|COMPLETED|Phase 2, Warfarin Treatment Period||9
2869336|NCT00180674|3572774|FG000|NOT COMPLETED|Phase 2, Warfarin Treatment Period||1
2869337|NCT00180687|3572786|FG000|STARTED|Overall Study||20
2869338|NCT00180687|3572787|FG001|STARTED|Overall Study||20
2869339|NCT00180687|3572788|FG002|STARTED|Overall Study||20
2869340|NCT00180687|3572789|FG003|STARTED|Overall Study||20
2869341|NCT00180687|3572786|FG000|COMPLETED|Overall Study||20
2869342|NCT00180687|3572787|FG001|COMPLETED|Overall Study||20
2869343|NCT00180687|3572788|FG002|COMPLETED|Overall Study||20
2869344|NCT00180687|3572789|FG003|COMPLETED|Overall Study||20
2869345|NCT00180687|3572786|FG000|NOT COMPLETED|Overall Study||0
2869346|NCT00180687|3572787|FG001|NOT COMPLETED|Overall Study||0
2869347|NCT00180687|3572788|FG002|NOT COMPLETED|Overall Study||0
2869348|NCT00180687|3572789|FG003|NOT COMPLETED|Overall Study||0
2869349|NCT00180713|3572801|FG000|STARTED|Overall Study||23
2869350|NCT00180713|3572802|FG001|STARTED|Overall Study||19
2869351|NCT00180713|3572801|FG000|COMPLETED|Overall Study||18
2869352|NCT00180713|3572802|FG001|COMPLETED|Overall Study||16
2869353|NCT00180713|3572801|FG000|NOT COMPLETED|Overall Study||5
2869354|NCT00180713|3572802|FG001|NOT COMPLETED|Overall Study||3
2869355|NCT00181155|3572808|FG000|STARTED|Overall Study||15
2869356|NCT00181155|3572809|FG001|STARTED|Overall Study||3
2869357|NCT00181155|3572808|FG000|COMPLETED|Overall Study||13
2869358|NCT00181155|3572809|FG001|COMPLETED|Overall Study||3
2869359|NCT00181155|3572808|FG000|NOT COMPLETED|Overall Study||2
2869360|NCT00181155|3572809|FG001|NOT COMPLETED|Overall Study||0
2869361|NCT00181168|3572818|FG000|STARTED|Overall Study||30
2869362|NCT00181168|3572819|FG001|STARTED|Overall Study||33
2869363|NCT00181168|3572818|FG000|COMPLETED|Overall Study||30
2869364|NCT00181168|3572819|FG001|COMPLETED|Overall Study||33
2869365|NCT00181168|3572818|FG000|NOT COMPLETED|Overall Study||0
2869366|NCT00181168|3572819|FG001|NOT COMPLETED|Overall Study||0
2869367|NCT00181207|3572827|FG000|STARTED|Overall Study||24
2869368|NCT00181207|3572828|FG001|STARTED|Overall Study||26
2869369|NCT00181207|3572827|FG000|COMPLETED|Overall Study||24
2869370|NCT00181207|3572828|FG001|COMPLETED|Overall Study||26
2869371|NCT00181207|3572827|FG000|NOT COMPLETED|Overall Study||0
2869372|NCT00181207|3572828|FG001|NOT COMPLETED|Overall Study||0
2869373|NCT00181285|3572836|FG000|STARTED|Overall Study||27
2869374|NCT00181285|3572837|FG001|STARTED|Overall Study||25
2869375|NCT00181285|3572836|FG000|COMPLETED|Overall Study||27
2869376|NCT00181285|3572837|FG001|COMPLETED|Overall Study||25
2869377|NCT00181285|3572836|FG000|NOT COMPLETED|Overall Study||0
2869378|NCT00181285|3572837|FG001|NOT COMPLETED|Overall Study||0
2869379|NCT00181363|3572843|FG000|STARTED|Overall Study|10|10
2869380|NCT00181363|3572843|FG000|COMPLETED|Overall Study||10
2869381|NCT00181363|3572843|FG000|NOT COMPLETED|Overall Study||0
2869382|NCT00181610|3572853|FG000|STARTED|Overall Study||4
2869383|NCT00181610|3572854|FG001|STARTED|Overall Study||4
2869384|NCT00181610|3572855|FG002|STARTED|Overall Study||3
2869385|NCT00181610|3572853|FG000|COMPLETED|Overall Study||4
2869386|NCT00181610|3572854|FG001|COMPLETED|Overall Study||3
2869387|NCT00181610|3572855|FG002|COMPLETED|Overall Study||3
2869388|NCT00181610|3572853|FG000|NOT COMPLETED|Overall Study||0
2869389|NCT00181610|3572854|FG001|NOT COMPLETED|Overall Study||1
2869390|NCT00181610|3572855|FG002|NOT COMPLETED|Overall Study||0
2869391|NCT00181623|3572864|FG000|STARTED|Overall Study||6
2869392|NCT00181623|3572864|FG000|COMPLETED|Overall Study||5
2869393|NCT00181623|3572864|FG000|NOT COMPLETED|Overall Study||1
2869394|NCT00181714|3572869|FG000|STARTED|Signed Consent/Enrolled||203
2869395|NCT00181714|3572869|FG000|COMPLETED|Signed Consent/Enrolled||154
2869396|NCT00181714|3572869|FG000|NOT COMPLETED|Signed Consent/Enrolled||49
2869397|NCT00181714|3572869|FG000|STARTED|Began Treatment With OROS-MPH||154
2869398|NCT00181714|3572869|FG000|COMPLETED|Began Treatment With OROS-MPH||30
2869399|NCT00181714|3572869|FG000|NOT COMPLETED|Began Treatment With OROS-MPH||124
2869400|NCT00181766|3572873|FG000|STARTED|Overall Study|Number of subjects enrolled and treated with Atomoxetine.|45
2869401|NCT00181766|3572873|FG000|COMPLETED|Overall Study|Completed the trial.|33
2869402|NCT00181766|3572873|FG000|NOT COMPLETED|Overall Study||12
2869403|NCT00181844|3572877|FG000|STARTED|Signed Consent||51
2869404|NCT00181844|3572877|FG000|COMPLETED|Signed Consent||39
2869405|NCT00181844|3572877|FG000|NOT COMPLETED|Signed Consent||12
2869406|NCT00181844|3572877|FG000|STARTED|Exposed to Study Medication||39
2869407|NCT00181844|3572877|FG000|COMPLETED|Exposed to Study Medication||22
2869408|NCT00181844|3572877|FG000|NOT COMPLETED|Exposed to Study Medication||17
2869409|NCT00181883|3572881|FG000|STARTED|Overall Study||30
2869410|NCT00181883|3572881|FG000|COMPLETED|Overall Study||20
2869411|NCT00181883|3572881|FG000|NOT COMPLETED|Overall Study||10
2869412|NCT00181961|3572887|FG000|STARTED|Overall Study||7
2869413|NCT00181961|3572888|FG001|STARTED|Overall Study||9
2869414|NCT00181961|3572887|FG000|COMPLETED|Overall Study||6
2869415|NCT00181961|3572888|FG001|COMPLETED|Overall Study||4
2869416|NCT00181961|3572887|FG000|NOT COMPLETED|Overall Study||1
2869417|NCT00181961|3572888|FG001|NOT COMPLETED|Overall Study||5
2869418|NCT00182000|3572896|FG000|STARTED|Overall Study||14
2869419|NCT00182000|3572897|FG001|STARTED|Overall Study||15
2869420|NCT00182000|3572896|FG000|COMPLETED|Overall Study||9
2869421|NCT00182000|3572897|FG001|COMPLETED|Overall Study||13
2869422|NCT00182000|3572896|FG000|NOT COMPLETED|Overall Study||5
2869423|NCT00182000|3572897|FG001|NOT COMPLETED|Overall Study||2
2869424|NCT00182078|3572905|FG000|STARTED|Overall Study||9
2869425|NCT00182078|3572906|FG001|STARTED|Overall Study||17
2869426|NCT00182078|3572905|FG000|COMPLETED|Overall Study||8
2869427|NCT00182078|3572906|FG001|COMPLETED|Overall Study||17
2869428|NCT00182078|3572905|FG000|NOT COMPLETED|Overall Study||1
2869429|NCT00182078|3572906|FG001|NOT COMPLETED|Overall Study||0
2869430|NCT00182091|3572916|FG000|STARTED|Overall Study||15
2869431|NCT00182091|3572917|FG001|STARTED|Overall Study||15
2869432|NCT00182091|3572918|FG002|STARTED|Overall Study||25
2869433|NCT00182091|3572919|FG003|STARTED|Overall Study||20
2869434|NCT00182091|3572916|FG000|COMPLETED|Overall Study||14
2869435|NCT00182091|3572917|FG001|COMPLETED|Overall Study||15
2869436|NCT00182091|3572918|FG002|COMPLETED|Overall Study||25
2869437|NCT00182091|3572919|FG003|COMPLETED|Overall Study||20
2869438|NCT00182091|3572916|FG000|NOT COMPLETED|Overall Study||1
2869439|NCT00182091|3572917|FG001|NOT COMPLETED|Overall Study||0
2869440|NCT00182091|3572918|FG002|NOT COMPLETED|Overall Study||0
2869441|NCT00182091|3572919|FG003|NOT COMPLETED|Overall Study||0
2869442|NCT00182325|3572929|FG000|STARTED|Overall Study||97
2869443|NCT00182325|3572930|FG001|STARTED|Overall Study||96
2869444|NCT00182325|3572929|FG000|COMPLETED|Overall Study|63 completed survey, 85 included in intention-to-treat analysis|63
2869445|NCT00182325|3572930|FG001|COMPLETED|Overall Study|43 completed survey, 89 included in intention-to-treat analysis|43
2869446|NCT00182325|3572929|FG000|NOT COMPLETED|Overall Study||34
2869447|NCT00182325|3572930|FG001|NOT COMPLETED|Overall Study||53
2869448|NCT00182689|3572938|FG000|STARTED|Overall Study||40
2869449|NCT00182689|3572939|FG001|STARTED|Overall Study||49
2869450|NCT00182689|3572938|FG000|Eligible|Overall Study||39
2869451|NCT00182689|3572939|FG001|Eligible|Overall Study||45
2869452|NCT00182689|3572938|FG000|Eligible and Began Protocol Therapy|Overall Study||38
2869453|NCT00182689|3572939|FG001|Eligible and Began Protocol Therapy|Overall Study||45
2869454|NCT00182689|3572938|FG000|COMPLETED|Overall Study||0
2869455|NCT00182689|3572939|FG001|COMPLETED|Overall Study||0
2869456|NCT00182689|3572938|FG000|NOT COMPLETED|Overall Study||40
2869457|NCT00182689|3572939|FG001|NOT COMPLETED|Overall Study||49
2869458|NCT00182754|3572951|FG000|STARTED|Overall Study||16
2869459|NCT00182754|3572952|FG001|STARTED|Overall Study||17
2869460|NCT00182754|3572951|FG000|COMPLETED|Overall Study||16
2869461|NCT00182754|3572952|FG001|COMPLETED|Overall Study||17
2869462|NCT00182754|3572951|FG000|NOT COMPLETED|Overall Study||0
2869463|NCT00182754|3572952|FG001|NOT COMPLETED|Overall Study||0
2869464|NCT00182767|3572958|FG000|STARTED|Overall Study||6
2869465|NCT00182767|3572959|FG001|STARTED|Overall Study||6
2869466|NCT00182767|3572960|FG002|STARTED|Overall Study||6
2869467|NCT00182767|3572961|FG003|STARTED|Overall Study||3
2869468|NCT00182767|3572962|FG004|STARTED|Overall Study||24
2869469|NCT00182767|3572958|FG000|COMPLETED|Overall Study||6
2869470|NCT00182767|3572959|FG001|COMPLETED|Overall Study||6
2869471|NCT00182767|3572960|FG002|COMPLETED|Overall Study||6
2869472|NCT00182767|3572961|FG003|COMPLETED|Overall Study||3
2869473|NCT00182767|3572962|FG004|COMPLETED|Overall Study||24
2869474|NCT00182767|3572958|FG000|NOT COMPLETED|Overall Study||0
2869475|NCT00182767|3572959|FG001|NOT COMPLETED|Overall Study||0
2869476|NCT00182767|3572960|FG002|NOT COMPLETED|Overall Study||0
2869477|NCT00182767|3572961|FG003|NOT COMPLETED|Overall Study||0
2869478|NCT00182767|3572962|FG004|NOT COMPLETED|Overall Study||0
2869479|NCT00182793|3572976|FG000|STARTED|Overall Study||32
2869480|NCT00182793|3572976|FG000|COMPLETED|Overall Study||32
2869481|NCT00182793|3572976|FG000|NOT COMPLETED|Overall Study||0
2869482|NCT00183092|3572982|FG000|STARTED|Double-blind (Baseline - Month 2)||23
2869483|NCT00183092|3572983|FG001|STARTED|Double-blind (Baseline - Month 2)||28
2869484|NCT00183092|3572984|FG002|STARTED|Double-blind (Baseline - Month 2)||0
2869485|NCT00183092|3572985|FG003|STARTED|Double-blind (Baseline - Month 2)||0
2869486|NCT00183092|3572982|FG000|Alive at Month 2|Double-blind (Baseline - Month 2)||13
2869487|NCT00183092|3572983|FG001|Alive at Month 2|Double-blind (Baseline - Month 2)||19
2869488|NCT00183092|3572984|FG002|Alive at Month 2|Double-blind (Baseline - Month 2)||0
2869489|NCT00183092|3572985|FG003|Alive at Month 2|Double-blind (Baseline - Month 2)||0
2869490|NCT00183092|3572982|FG000|Came in for Month 2 Visit|Double-blind (Baseline - Month 2)||10
2869491|NCT00183092|3572983|FG001|Came in for Month 2 Visit|Double-blind (Baseline - Month 2)||16
2869492|NCT00183092|3572984|FG002|Came in for Month 2 Visit|Double-blind (Baseline - Month 2)||0
2869493|NCT00183092|3572985|FG003|Came in for Month 2 Visit|Double-blind (Baseline - Month 2)||0
2869494|NCT00183092|3572982|FG000|COMPLETED|Double-blind (Baseline - Month 2)||11
2869495|NCT00183092|3572983|FG001|COMPLETED|Double-blind (Baseline - Month 2)||16
2869496|NCT00183092|3572984|FG002|COMPLETED|Double-blind (Baseline - Month 2)||0
2869497|NCT00183092|3572985|FG003|COMPLETED|Double-blind (Baseline - Month 2)||0
2869498|NCT00183092|3572982|FG000|NOT COMPLETED|Double-blind (Baseline - Month 2)||12
2869499|NCT00183092|3572983|FG001|NOT COMPLETED|Double-blind (Baseline - Month 2)||12
2869500|NCT00183092|3572984|FG002|NOT COMPLETED|Double-blind (Baseline - Month 2)||0
2869501|NCT00183092|3572985|FG003|NOT COMPLETED|Double-blind (Baseline - Month 2)||0
2869502|NCT00183092|3572982|FG000|STARTED|Open-label Period (Month 2 Until Death)|Participants initially assigned to Quinacrine opted to begin open-label Quinacrine at Month 2|10
2869503|NCT00183092|3572983|FG001|STARTED|Open-label Period (Month 2 Until Death)|Participants initially assigned to Placebo opted to begin open-label Quinacrine at Month 2|14
2869504|NCT00183092|3572984|FG002|STARTED|Open-label Period (Month 2 Until Death)|Participants assigned to Quinacrine opted to continue assigned drug during open-label period|1
2918753|NCT00528879|3629066|FG003|Completed the Period|Short-term Period (Day 1 to Week 24)||121
2869505|NCT00183092|3572985|FG003|STARTED|Open-label Period (Month 2 Until Death)|Participants assigned to Placebo opted to continue assigned drug during open-label period|1
2869506|NCT00183092|3572982|FG000|COMPLETED|Open-label Period (Month 2 Until Death)||0
2869507|NCT00183092|3572983|FG001|COMPLETED|Open-label Period (Month 2 Until Death)||0
2869508|NCT00183092|3572984|FG002|COMPLETED|Open-label Period (Month 2 Until Death)||0
2869509|NCT00183092|3572985|FG003|COMPLETED|Open-label Period (Month 2 Until Death)||0
2869510|NCT00183092|3572982|FG000|NOT COMPLETED|Open-label Period (Month 2 Until Death)||10
2869511|NCT00183092|3572983|FG001|NOT COMPLETED|Open-label Period (Month 2 Until Death)||14
2869512|NCT00183092|3572984|FG002|NOT COMPLETED|Open-label Period (Month 2 Until Death)||1
2869513|NCT00183092|3572985|FG003|NOT COMPLETED|Open-label Period (Month 2 Until Death)||1
2869514|NCT00183170|3572994|FG000|STARTED|First Intervention||103
2869515|NCT00183170|3572995|FG001|STARTED|First Intervention||109
2869516|NCT00183170|3572994|FG000|COMPLETED|First Intervention||101
2869517|NCT00183170|3572995|FG001|COMPLETED|First Intervention||109
2869518|NCT00183170|3572994|FG000|NOT COMPLETED|First Intervention||2
2869519|NCT00183170|3572995|FG001|NOT COMPLETED|First Intervention||0
2869520|NCT00183170|3572994|FG000|STARTED|Washout 1 Week||101
2869521|NCT00183170|3572995|FG001|STARTED|Washout 1 Week||109
2869522|NCT00183170|3572994|FG000|COMPLETED|Washout 1 Week||95
2869523|NCT00183170|3572995|FG001|COMPLETED|Washout 1 Week||101
2869524|NCT00183170|3572994|FG000|NOT COMPLETED|Washout 1 Week||6
2869525|NCT00183170|3572995|FG001|NOT COMPLETED|Washout 1 Week||8
2869526|NCT00183170|3572994|FG000|STARTED|Second Intervention||95
2869527|NCT00183170|3572995|FG001|STARTED|Second Intervention||101
2869528|NCT00183170|3572994|FG000|COMPLETED|Second Intervention||94
2869529|NCT00183170|3572995|FG001|COMPLETED|Second Intervention||99
2869530|NCT00183170|3572994|FG000|NOT COMPLETED|Second Intervention||1
2869531|NCT00183170|3572995|FG001|NOT COMPLETED|Second Intervention||2
2869532|NCT00183196|3573004|FG000|STARTED|Overall Study|2 subjects had no post-randomization data|50
2869533|NCT00183196|3573005|FG001|STARTED|Overall Study|1 subject had no post-randomization data|50
2869534|NCT00183196|3573006|FG002|STARTED|Overall Study|1 subject had no post-randomization data|50
2869535|NCT00183196|3573004|FG000|COMPLETED|Overall Study||30
2869536|NCT00183196|3573005|FG001|COMPLETED|Overall Study||35
2869537|NCT00183196|3573006|FG002|COMPLETED|Overall Study||32
2869538|NCT00183196|3573004|FG000|NOT COMPLETED|Overall Study||20
2869539|NCT00183196|3573005|FG001|NOT COMPLETED|Overall Study||15
2869540|NCT00183196|3573006|FG002|NOT COMPLETED|Overall Study||18
2869541|NCT00183248|3573016|FG000|STARTED|Overall Study||4
2869542|NCT00183248|3573017|FG001|STARTED|Overall Study||5
2869543|NCT00183248|3573016|FG000|COMPLETED|Overall Study||3
2869544|NCT00183248|3573017|FG001|COMPLETED|Overall Study||4
2869545|NCT00183248|3573016|FG000|NOT COMPLETED|Overall Study||1
2869546|NCT00183248|3573017|FG001|NOT COMPLETED|Overall Study||1
2869547|NCT00183274|3573023|FG000|STARTED|Phase 1: Open-Label||268
2869548|NCT00183274|3573024|FG001|STARTED|Phase 1: Open-Label||0
2869549|NCT00183274|3573025|FG002|STARTED|Phase 1: Open-Label||0
2869550|NCT00183274|3573026|FG003|STARTED|Phase 1: Open-Label||0
2869551|NCT00183274|3573027|FG004|STARTED|Phase 1: Open-Label||0
2869552|NCT00183274|3573028|FG005|STARTED|Phase 1: Open-Label||0
2869553|NCT00183274|3573023|FG000|COMPLETED|Phase 1: Open-Label|110 dropouts during phase 1|158
2869554|NCT00183274|3573024|FG001|COMPLETED|Phase 1: Open-Label||0
2869555|NCT00183274|3573025|FG002|COMPLETED|Phase 1: Open-Label||0
2869556|NCT00183274|3573026|FG003|COMPLETED|Phase 1: Open-Label||0
2869557|NCT00183274|3573027|FG004|COMPLETED|Phase 1: Open-Label||0
2869558|NCT00183274|3573028|FG005|COMPLETED|Phase 1: Open-Label||0
2869559|NCT00183274|3573023|FG000|NOT COMPLETED|Phase 1: Open-Label||110
2869560|NCT00183274|3573024|FG001|NOT COMPLETED|Phase 1: Open-Label||0
2869561|NCT00183274|3573025|FG002|NOT COMPLETED|Phase 1: Open-Label||0
2869562|NCT00183274|3573026|FG003|NOT COMPLETED|Phase 1: Open-Label||0
2869563|NCT00183274|3573027|FG004|NOT COMPLETED|Phase 1: Open-Label||0
2869564|NCT00183274|3573028|FG005|NOT COMPLETED|Phase 1: Open-Label||0
2869565|NCT00183274|3573023|FG000|STARTED|Phase 2: Double-Blind|This phase ended after 6 months. There were no longer participants in this phase.|0
2869566|NCT00183274|3573024|FG001|STARTED|Phase 2: Double-Blind|22 did not enter phase 2 due to lack of efficacy and withdrawal of consent|82
2869567|NCT00183274|3573025|FG002|STARTED|Phase 2: Double-Blind|22 did not enter phase 2 due to lack of efficacy and withdrawal of consent|54
2869568|NCT00183274|3573026|FG003|STARTED|Phase 2: Double-Blind||0
2869569|NCT00183274|3573027|FG004|STARTED|Phase 2: Double-Blind||0
2869570|NCT00183274|3573028|FG005|STARTED|Phase 2: Double-Blind||0
2869571|NCT00183274|3573023|FG000|COMPLETED|Phase 2: Double-Blind||0
2869572|NCT00183274|3573024|FG001|COMPLETED|Phase 2: Double-Blind|8 lost to relapse, 18 lost to dropout|56
2869573|NCT00183274|3573025|FG002|COMPLETED|Phase 2: Double-Blind|29 lost to relapse, 14 lost to dropout|11
2869574|NCT00183274|3573026|FG003|COMPLETED|Phase 2: Double-Blind||0
2869575|NCT00183274|3573027|FG004|COMPLETED|Phase 2: Double-Blind||0
2869576|NCT00183274|3573028|FG005|COMPLETED|Phase 2: Double-Blind||0
2869577|NCT00183274|3573023|FG000|NOT COMPLETED|Phase 2: Double-Blind||0
2869578|NCT00183274|3573024|FG001|NOT COMPLETED|Phase 2: Double-Blind||26
2869579|NCT00183274|3573025|FG002|NOT COMPLETED|Phase 2: Double-Blind||43
2869580|NCT00183274|3573026|FG003|NOT COMPLETED|Phase 2: Double-Blind||0
2869581|NCT00183274|3573027|FG004|NOT COMPLETED|Phase 2: Double-Blind||0
2869582|NCT00183274|3573028|FG005|NOT COMPLETED|Phase 2: Double-Blind||0
2869583|NCT00183274|3573023|FG000|STARTED|Phase 3: Double-Blind||0
2869584|NCT00183274|3573024|FG001|STARTED|Phase 3: Double-Blind|Phase 2 ended at the end of 12 months of study.|0
2869585|NCT00183274|3573025|FG002|STARTED|Phase 3: Double-Blind|Phase 2 ended at the end of 12 months of study.|0
2869586|NCT00183274|3573026|FG003|STARTED|Phase 3: Double-Blind|8 completed Phase 2 but did not enter phase 3|15
2869587|NCT00183274|3573027|FG004|STARTED|Phase 3: Double-Blind|8 completed Phase 2 but did not enter phase 3|34
2869588|NCT00183274|3573028|FG005|STARTED|Phase 3: Double-Blind|8 completed Phase 2 but did not enter phase 3|10
2869589|NCT00183274|3573023|FG000|COMPLETED|Phase 3: Double-Blind||0
2869590|NCT00183274|3573024|FG001|COMPLETED|Phase 3: Double-Blind||0
2869591|NCT00183274|3573025|FG002|COMPLETED|Phase 3: Double-Blind||0
2869592|NCT00183274|3573026|FG003|COMPLETED|Phase 3: Double-Blind|1 lost to relapse and 1 lost to dropout|13
2869593|NCT00183274|3573027|FG004|COMPLETED|Phase 3: Double-Blind|11 lost to relapse and 9 lost to dropout|14
2869594|NCT00183274|3573028|FG005|COMPLETED|Phase 3: Double-Blind|2 lost to relapse and 2 lost to dropout|6
2869595|NCT00183274|3573023|FG000|NOT COMPLETED|Phase 3: Double-Blind||0
2869596|NCT00183274|3573024|FG001|NOT COMPLETED|Phase 3: Double-Blind||0
2869597|NCT00183274|3573025|FG002|NOT COMPLETED|Phase 3: Double-Blind||0
2869598|NCT00183274|3573026|FG003|NOT COMPLETED|Phase 3: Double-Blind||2
2869599|NCT00183274|3573027|FG004|NOT COMPLETED|Phase 3: Double-Blind||20
2869600|NCT00183274|3573028|FG005|NOT COMPLETED|Phase 3: Double-Blind||4
2869601|NCT00183339|3573045|FG000|STARTED|Overall Study||10
2869602|NCT00183339|3573046|FG001|STARTED|Overall Study||8
2869603|NCT00183339|3573045|FG000|COMPLETED|Overall Study||4
2869604|NCT00183339|3573046|FG001|COMPLETED|Overall Study||4
2869605|NCT00183339|3573045|FG000|NOT COMPLETED|Overall Study||6
2869606|NCT00183339|3573046|FG001|NOT COMPLETED|Overall Study||4
2869607|NCT00183391|3573057|FG000|STARTED|Block 1 - 5 Weeks||108
2869608|NCT00183391|3573058|FG001|STARTED|Block 1 - 5 Weeks||124
2869609|NCT00183391|3573057|FG000|COMPLETED|Block 1 - 5 Weeks||95
2869610|NCT00183391|3573058|FG001|COMPLETED|Block 1 - 5 Weeks||110
2869611|NCT00183391|3573057|FG000|NOT COMPLETED|Block 1 - 5 Weeks||13
2869612|NCT00183391|3573058|FG001|NOT COMPLETED|Block 1 - 5 Weeks||14
2869613|NCT00183391|3573057|FG000|STARTED|Crossover Placebo - 2 Weeks||95
2869614|NCT00183391|3573058|FG001|STARTED|Crossover Placebo - 2 Weeks||110
2869615|NCT00183391|3573057|FG000|COMPLETED|Crossover Placebo - 2 Weeks||95
2869616|NCT00183391|3573058|FG001|COMPLETED|Crossover Placebo - 2 Weeks||110
2869617|NCT00183391|3573057|FG000|NOT COMPLETED|Crossover Placebo - 2 Weeks||0
2869618|NCT00183391|3573058|FG001|NOT COMPLETED|Crossover Placebo - 2 Weeks||0
2869619|NCT00183391|3573057|FG000|STARTED|Block 2 - 5 Weeks||95
2869620|NCT00183391|3573058|FG001|STARTED|Block 2 - 5 Weeks||110
2869621|NCT00183391|3573057|FG000|COMPLETED|Block 2 - 5 Weeks||91
2869622|NCT00183391|3573058|FG001|COMPLETED|Block 2 - 5 Weeks||108
2869623|NCT00183391|3573057|FG000|NOT COMPLETED|Block 2 - 5 Weeks||4
2869624|NCT00183391|3573058|FG001|NOT COMPLETED|Block 2 - 5 Weeks||2
2869625|NCT00183430|3573068|FG000|STARTED|Overall Study||9
2869626|NCT00183430|3573069|FG001|STARTED|Overall Study||11
2869627|NCT00183430|3573068|FG000|COMPLETED|Overall Study||3
2869628|NCT00183430|3573069|FG001|COMPLETED|Overall Study||11
2869629|NCT00183430|3573068|FG000|NOT COMPLETED|Overall Study||6
2869630|NCT00183430|3573069|FG001|NOT COMPLETED|Overall Study||0
2869631|NCT00183443|3573078|FG000|STARTED|Overall Study||24
2869632|NCT00183443|3573079|FG001|STARTED|Overall Study||26
2869633|NCT00183443|3573080|FG002|STARTED|Overall Study||25
2869634|NCT00183443|3573078|FG000|COMPLETED|Overall Study|13 eligible participants were offered enrollment in the continuation phase|24
2869635|NCT00183443|3573079|FG001|COMPLETED|Overall Study|8 eligible participants were offered enrollment in the continuation phase|26
2869636|NCT00183443|3573080|FG002|COMPLETED|Overall Study|4 eligible participants were offered enrollment in the continuation phase|25
2869637|NCT00183443|3573078|FG000|NOT COMPLETED|Overall Study||0
2869638|NCT00183443|3573079|FG001|NOT COMPLETED|Overall Study||0
2869639|NCT00183443|3573080|FG002|NOT COMPLETED|Overall Study||0
2869640|NCT00183456|3573092|FG000|STARTED|Overall Study||85
2869641|NCT00183456|3573093|FG001|STARTED|Overall Study||84
2869642|NCT00183456|3573094|FG002|STARTED|Overall Study||329
2869643|NCT00183456|3573095|FG003|STARTED|Overall Study||248
2869644|NCT00183456|3573092|FG000|6 Month Follow-up|Overall Study||74
2869645|NCT00183456|3573093|FG001|6 Month Follow-up|Overall Study||77
2869646|NCT00183456|3573094|FG002|6 Month Follow-up|Overall Study||278
2869647|NCT00183456|3573095|FG003|6 Month Follow-up|Overall Study||175
2869648|NCT00183456|3573092|FG000|12 Month Follow-up|Overall Study||76
2869649|NCT00183456|3573093|FG001|12 Month Follow-up|Overall Study||74
2869650|NCT00183456|3573094|FG002|12 Month Follow-up|Overall Study||267
2869651|NCT00183456|3573095|FG003|12 Month Follow-up|Overall Study||186
2869652|NCT00183456|3573092|FG000|18 Month Follow-up|Overall Study||80
2869653|NCT00183456|3573093|FG001|18 Month Follow-up|Overall Study||81
2869654|NCT00183456|3573094|FG002|18 Month Follow-up|Overall Study||303
2869655|NCT00183456|3573095|FG003|18 Month Follow-up|Overall Study||207
2869656|NCT00183456|3573092|FG000|COMPLETED|Overall Study|total # of intervention participants that completed any follow-up (6, 12, or 18 month Follow-up)|82
2869657|NCT00183456|3573093|FG001|COMPLETED|Overall Study|total # of comparison condition participants that completed any follow-up|83
2869658|NCT00183456|3573094|FG002|COMPLETED|Overall Study|total # of network participants that completed any follow-up|313
2869659|NCT00183456|3573095|FG003|COMPLETED|Overall Study|total # of non-randomized index participants that completed any follow-up|220
2869660|NCT00183456|3573092|FG000|NOT COMPLETED|Overall Study||3
2869661|NCT00183456|3573093|FG001|NOT COMPLETED|Overall Study||1
2869662|NCT00183456|3573094|FG002|NOT COMPLETED|Overall Study||16
2869663|NCT00183456|3573095|FG003|NOT COMPLETED|Overall Study||28
2869664|NCT00183469|3573107|FG000|STARTED|Overall Study||41
2869665|NCT00183469|3573108|FG001|STARTED|Overall Study||45
2869666|NCT00183469|3573107|FG000|COMPLETED|Overall Study||13
2869667|NCT00183469|3573108|FG001|COMPLETED|Overall Study||16
2869668|NCT00183469|3573107|FG000|NOT COMPLETED|Overall Study||28
2869669|NCT00183469|3573108|FG001|NOT COMPLETED|Overall Study||29
2869670|NCT00183625|3573116|FG000|STARTED|Overall Study||27
2869671|NCT00183625|3573117|FG001|STARTED|Overall Study||28
2869672|NCT00183625|3573118|FG002|STARTED|Overall Study||28
2869673|NCT00183625|3573119|FG003|STARTED|Overall Study||24
2869674|NCT00183625|3573116|FG000|Obtained Employment|Overall Study||21
2869675|NCT00183625|3573117|FG001|Obtained Employment|Overall Study||18
2869676|NCT00183625|3573118|FG002|Obtained Employment|Overall Study||14
2869677|NCT00183625|3573119|FG003|Obtained Employment|Overall Study||14
2869678|NCT00183625|3573116|FG000|COMPLETED|Overall Study||9
2869679|NCT00183625|3573117|FG001|COMPLETED|Overall Study||10
2869680|NCT00183625|3573118|FG002|COMPLETED|Overall Study||9
2869681|NCT00183625|3573119|FG003|COMPLETED|Overall Study||10
2869682|NCT00183625|3573116|FG000|NOT COMPLETED|Overall Study||18
2869683|NCT00183625|3573117|FG001|NOT COMPLETED|Overall Study||18
2869684|NCT00183625|3573118|FG002|NOT COMPLETED|Overall Study||19
2869685|NCT00183625|3573119|FG003|NOT COMPLETED|Overall Study||14
2869686|NCT00183677|3573127|FG000|STARTED|Overall Study||97
2869687|NCT00183677|3573127|FG000|COMPLETED|Overall Study||53
2869688|NCT00183677|3573127|FG000|NOT COMPLETED|Overall Study||44
2869689|NCT00183729|3573133|FG000|STARTED|Overall Study||17
2869690|NCT00183729|3573134|FG001|STARTED|Overall Study||18
2869691|NCT00183729|3573133|FG000|COMPLETED|Overall Study||14
2869692|NCT00183729|3573134|FG001|COMPLETED|Overall Study||13
2869693|NCT00183729|3573133|FG000|NOT COMPLETED|Overall Study||3
2869694|NCT00183729|3573134|FG001|NOT COMPLETED|Overall Study||5
2869695|NCT00183794|3573140|FG000|STARTED|Overall Study||20
2869696|NCT00183794|3573140|FG000|COMPLETED|Overall Study||20
2869697|NCT00183794|3573140|FG000|NOT COMPLETED|Overall Study||0
2869698|NCT00183872|3573144|FG000|STARTED|Overall Study||40
2869699|NCT00183872|3573144|FG000|COMPLETED|Overall Study||24
2869700|NCT00183872|3573144|FG000|NOT COMPLETED|Overall Study||16
2869701|NCT00184002|3573148|FG000|STARTED|Overall Study||68
2869702|NCT00184002|3573148|FG000|COMPLETED|Overall Study||51
2869703|NCT00184002|3573148|FG000|NOT COMPLETED|Overall Study||17
2869704|NCT00184028|3573152|FG000|STARTED|Overall Study||12
2869705|NCT00184028|3573152|FG000|COMPLETED|Overall Study||2
2869706|NCT00184028|3573152|FG000|NOT COMPLETED|Overall Study||10
2869707|NCT00184054|3573157|FG000|STARTED|Overall Study||11
2869708|NCT00184054|3573157|FG000|COMPLETED|Overall Study||10
2869709|NCT00184054|3573157|FG000|NOT COMPLETED|Overall Study||1
2869710|NCT00184093|3573161|FG000|STARTED|Overall Study|Phase 1 participants = 6 Phase 2 participants = 29|35
2869711|NCT00184093|3573161|FG000|COMPLETED|Overall Study||26
2869712|NCT00184093|3573161|FG000|NOT COMPLETED|Overall Study||9
2869713|NCT00184548|3573169|FG000|STARTED|Overall Study||226
2869714|NCT00184548|3573170|FG001|STARTED|Overall Study||255
2869715|NCT00184548|3573171|FG002|STARTED|Overall Study||47
2869716|NCT00184548|3573172|FG003|STARTED|Overall Study||45
2869717|NCT00184548|3573169|FG000|Exposed|Overall Study|Two subjects withdrew due to ineligibility. Excluded from safety analysis set|224
2869718|NCT00184548|3573170|FG001|Exposed|Overall Study|Three subjects withdrew due to ineligibility, two subjects died. Excluded from safety analysis set|250
2869719|NCT00184548|3573171|FG002|Exposed|Overall Study|One subject withdrew due to ineligibility. Excluded from safety analysis set|46
2869720|NCT00184548|3573172|FG003|Exposed|Overall Study|Four subjects withdrew due to ineligibility, one subject died. Excluded from safety analysis set|40
2869721|NCT00184548|3573169|FG000|COMPLETED|Overall Study||218
2869722|NCT00184548|3573170|FG001|COMPLETED|Overall Study||242
2869723|NCT00184548|3573171|FG002|COMPLETED|Overall Study||44
2869724|NCT00184548|3573172|FG003|COMPLETED|Overall Study||38
2869725|NCT00184548|3573169|FG000|NOT COMPLETED|Overall Study||8
2869726|NCT00184548|3573170|FG001|NOT COMPLETED|Overall Study||13
2869727|NCT00184548|3573171|FG002|NOT COMPLETED|Overall Study||3
2869728|NCT00184548|3573172|FG003|NOT COMPLETED|Overall Study||7
2869729|NCT00184600|3573185|FG000|STARTED|Overall Study||234
2869730|NCT00184600|3573186|FG001|STARTED|Overall Study||239
2869731|NCT00184600|3573187|FG002|STARTED|Overall Study||235
2869732|NCT00184600|3573185|FG000|COMPLETED|Overall Study||189
2869733|NCT00184600|3573186|FG001|COMPLETED|Overall Study||188
2869734|NCT00184600|3573187|FG002|COMPLETED|Overall Study||201
2869735|NCT00184600|3573185|FG000|NOT COMPLETED|Overall Study||45
2869736|NCT00184600|3573186|FG001|NOT COMPLETED|Overall Study||51
2869737|NCT00184600|3573187|FG002|NOT COMPLETED|Overall Study||34
2869738|NCT00184717|3573198|FG000|STARTED|Main Period (GHLIQUID-1516)||39
2869739|NCT00184717|3573199|FG001|STARTED|Main Period (GHLIQUID-1516)||38
2869740|NCT00184717|3573200|FG002|STARTED|Main Period (GHLIQUID-1516)||21
2869741|NCT00184717|3573201|FG003|STARTED|Main Period (GHLIQUID-1516)||0
2869742|NCT00184717|3573202|FG004|STARTED|Main Period (GHLIQUID-1516)||0
2869743|NCT00184717|3573198|FG000|Exposed to Trial Drug|Main Period (GHLIQUID-1516)||38
2869744|NCT00184717|3573199|FG001|Exposed to Trial Drug|Main Period (GHLIQUID-1516)||38
2869745|NCT00184717|3573200|FG002|Exposed to Trial Drug|Main Period (GHLIQUID-1516)||21
2869746|NCT00184717|3573201|FG003|Exposed to Trial Drug|Main Period (GHLIQUID-1516)||0
2869747|NCT00184717|3573202|FG004|Exposed to Trial Drug|Main Period (GHLIQUID-1516)||0
2869748|NCT00184717|3573198|FG000|COMPLETED|Main Period (GHLIQUID-1516)||36
2869749|NCT00184717|3573199|FG001|COMPLETED|Main Period (GHLIQUID-1516)||36
2869750|NCT00184717|3573200|FG002|COMPLETED|Main Period (GHLIQUID-1516)||20
2869751|NCT00184717|3573201|FG003|COMPLETED|Main Period (GHLIQUID-1516)||0
2869752|NCT00184717|3573202|FG004|COMPLETED|Main Period (GHLIQUID-1516)||0
2869753|NCT00184717|3573198|FG000|NOT COMPLETED|Main Period (GHLIQUID-1516)||3
2869754|NCT00184717|3573199|FG001|NOT COMPLETED|Main Period (GHLIQUID-1516)||2
2869755|NCT00184717|3573200|FG002|NOT COMPLETED|Main Period (GHLIQUID-1516)||1
2869756|NCT00184717|3573201|FG003|NOT COMPLETED|Main Period (GHLIQUID-1516)||0
2869757|NCT00184717|3573202|FG004|NOT COMPLETED|Main Period (GHLIQUID-1516)||0
2869758|NCT00184717|3573198|FG000|STARTED|Extension Period (GHLIQUID-1517)|Three subjects did not continue in extension period|33
2869759|NCT00184717|3573199|FG001|STARTED|Extension Period (GHLIQUID-1517)|Three subjects did not continue in extension period|33
2869760|NCT00184717|3573200|FG002|STARTED|Extension Period (GHLIQUID-1517)|Re-randomised to receive 0.033 or 0.067 mg|0
2869761|NCT00184717|3573201|FG003|STARTED|Extension Period (GHLIQUID-1517)|Re-randomised from No treatment group|10
2869762|NCT00184717|3573202|FG004|STARTED|Extension Period (GHLIQUID-1517)|Re-randomised from No treatment group|10
2869763|NCT00184717|3573198|FG000|COMPLETED|Extension Period (GHLIQUID-1517)||23
2869764|NCT00184717|3573199|FG001|COMPLETED|Extension Period (GHLIQUID-1517)||27
2869765|NCT00184717|3573200|FG002|COMPLETED|Extension Period (GHLIQUID-1517)||0
2869766|NCT00184717|3573201|FG003|COMPLETED|Extension Period (GHLIQUID-1517)||7
2869767|NCT00184717|3573202|FG004|COMPLETED|Extension Period (GHLIQUID-1517)||5
2869768|NCT00184717|3573198|FG000|NOT COMPLETED|Extension Period (GHLIQUID-1517)||10
2869769|NCT00184717|3573199|FG001|NOT COMPLETED|Extension Period (GHLIQUID-1517)||6
2869770|NCT00184717|3573200|FG002|NOT COMPLETED|Extension Period (GHLIQUID-1517)||0
2869771|NCT00184717|3573201|FG003|NOT COMPLETED|Extension Period (GHLIQUID-1517)||3
2869772|NCT00184717|3573202|FG004|NOT COMPLETED|Extension Period (GHLIQUID-1517)||5
2869773|NCT00185211|3573214|FG000|STARTED|Placebo-controlled Study (92012)||292
2869774|NCT00185211|3573215|FG001|STARTED|Placebo-controlled Study (92012)||176
2869775|NCT00185211|3573214|FG000|COMPLETED|Placebo-controlled Study (92012)||271
2869776|NCT00185211|3573215|FG001|COMPLETED|Placebo-controlled Study (92012)||166
2869777|NCT00185211|3573214|FG000|NOT COMPLETED|Placebo-controlled Study (92012)||21
2869778|NCT00185211|3573215|FG001|NOT COMPLETED|Placebo-controlled Study (92012)||10
2869779|NCT00185211|3573214|FG000|STARTED|Follow-up Study (91031 - This Study)|10 of the 271 subjects completing the placebo-controlled study did not consent to the Follow-up.|261
2869780|NCT00185211|3573215|FG001|STARTED|Follow-up Study (91031 - This Study)|9 of the 166 subjects completing the placebo-controlled study did not consent to the Follow-up.|157
2869781|NCT00185211|3573214|FG000|COMPLETED|Follow-up Study (91031 - This Study)||235
2869782|NCT00185211|3573215|FG001|COMPLETED|Follow-up Study (91031 - This Study)||123
2869783|NCT00185211|3573214|FG000|NOT COMPLETED|Follow-up Study (91031 - This Study)||26
2869784|NCT00185211|3573215|FG001|NOT COMPLETED|Follow-up Study (91031 - This Study)||34
2869785|NCT00185380|3573225|FG000|STARTED|Overall Study||240
2869786|NCT00185380|3573226|FG001|STARTED|Overall Study||246
2869787|NCT00185380|3573227|FG002|STARTED|Overall Study||256
2869788|NCT00185380|3573225|FG000|Subjects Received Treatment|Overall Study||239
2869789|NCT00185380|3573226|FG001|Subjects Received Treatment|Overall Study||245
2869790|NCT00185380|3573227|FG002|Subjects Received Treatment|Overall Study||254
2869791|NCT00185380|3573225|FG000|COMPLETED|Overall Study||174
2869792|NCT00185380|3573226|FG001|COMPLETED|Overall Study||174
2869793|NCT00185380|3573227|FG002|COMPLETED|Overall Study||182
2869794|NCT00185380|3573225|FG000|NOT COMPLETED|Overall Study||66
2869795|NCT00185380|3573226|FG001|NOT COMPLETED|Overall Study||72
2869796|NCT00185380|3573227|FG002|NOT COMPLETED|Overall Study||74
2869797|NCT00185458|3573235|FG000|STARTED|Contraception Phase||394
2869798|NCT00185458|3573235|FG000|COMPLETED|Contraception Phase||336
2869799|NCT00185458|3573235|FG000|NOT COMPLETED|Contraception Phase||58
2869800|NCT00185458|3573235|FG000|STARTED|HRT Phase|168 subjects were eligible for the HRT phase out 336 who completed contraception phase.|168
2869801|NCT00185458|3573235|FG000|COMPLETED|HRT Phase||141
2869802|NCT00185458|3573235|FG000|NOT COMPLETED|HRT Phase||27
2869803|NCT00185588|3573251|FG000|STARTED|Overall Study||6
2869804|NCT00185588|3573252|FG001|STARTED|Overall Study||4
2869805|NCT00185588|3573253|FG002|STARTED|Overall Study||6
2869806|NCT00185588|3573254|FG003|STARTED|Overall Study||17
2869807|NCT00185588|3573251|FG000|COMPLETED|Overall Study||3
2869808|NCT00185588|3573252|FG001|COMPLETED|Overall Study||2
3313557|NCT03075644|4046847|FG000|Full Analysis Set (FAS)|Overall Study||16
3313558|NCT03075644|4046848|FG001|Full Analysis Set (FAS)|Overall Study||46
3313559|NCT03075644|4046847|FG000|Safety Analysis Set (SAS)|Overall Study||16
3313560|NCT03075644|4046848|FG001|Safety Analysis Set (SAS)|Overall Study||46
3313561|NCT03075644|4046847|FG000|COMPLETED|Overall Study||15
3313562|NCT03075644|4046848|FG001|COMPLETED|Overall Study||45
3313563|NCT03075644|4046847|FG000|NOT COMPLETED|Overall Study||1
3313564|NCT03075644|4046848|FG001|NOT COMPLETED|Overall Study||1
3313565|NCT03075761|4046857|FG000|STARTED|Overall Study||11
3313566|NCT03075761|4046858|FG001|STARTED|Overall Study||12
3313567|NCT03075761|4046857|FG000|COMPLETED|Overall Study||10
3313568|NCT03075761|4046858|FG001|COMPLETED|Overall Study||6
3313569|NCT03075761|4046857|FG000|NOT COMPLETED|Overall Study||1
3313570|NCT03075761|4046858|FG001|NOT COMPLETED|Overall Study||6
3313571|NCT03075839|4046869|FG000|STARTED|Overall Study||33
3313572|NCT03075839|4046869|FG000|COMPLETED|Overall Study||29
3313573|NCT03075839|4046869|FG000|NOT COMPLETED|Overall Study||4
3313574|NCT03075878|4046873|FG000|STARTED|Overall Study||8
3313575|NCT03075878|4046873|FG000|Received at Least 1 Dose of Study Drug|Overall Study||8
3313576|NCT03075878|4046873|FG000|COMPLETED|Overall Study||7
3313577|NCT03075878|4046873|FG000|NOT COMPLETED|Overall Study||1
2869809|NCT00185588|3573253|FG002|COMPLETED|Overall Study||0
2869810|NCT00185588|3573254|FG003|COMPLETED|Overall Study||13
2869811|NCT00185588|3573251|FG000|NOT COMPLETED|Overall Study||3
2869812|NCT00185588|3573252|FG001|NOT COMPLETED|Overall Study||2
2869813|NCT00185588|3573253|FG002|NOT COMPLETED|Overall Study||6
2869814|NCT00185588|3573254|FG003|NOT COMPLETED|Overall Study||4
2869815|NCT00185614|3573264|FG000|STARTED|Autologous HCT (Auto-HCT)||63
2869816|NCT00185614|3573264|FG000|COMPLETED|Autologous HCT (Auto-HCT)||63
2869817|NCT00185614|3573264|FG000|NOT COMPLETED|Autologous HCT (Auto-HCT)||0
2869818|NCT00185614|3573264|FG000|STARTED|Inter-treatment Period|Not all participants who received autologous transplant continued to receive allogeneic transplant.|63
2869819|NCT00185614|3573264|FG000|COMPLETED|Inter-treatment Period||59
3313578|NCT03075891|4046879|FG000|STARTED|Overall Study||135
3313579|NCT03075891|4046880|FG001|STARTED|Overall Study||138
3313580|NCT03075891|4046879|FG000|COMPLETED|Overall Study||126
3313581|NCT03075891|4046880|FG001|COMPLETED|Overall Study||125
3313582|NCT03075891|4046879|FG000|NOT COMPLETED|Overall Study||9
3313583|NCT03075891|4046880|FG001|NOT COMPLETED|Overall Study||13
2869820|NCT00185614|3573264|FG000|NOT COMPLETED|Inter-treatment Period||4
2869821|NCT00185614|3573264|FG000|STARTED|Allogenic HCT (Allo-HCT)||59
2869822|NCT00185614|3573264|FG000|COMPLETED|Allogenic HCT (Allo-HCT)||59
2869823|NCT00185614|3573264|FG000|NOT COMPLETED|Allogenic HCT (Allo-HCT)||0
2869824|NCT00185640|3573268|FG000|STARTED|Overall Study||303
2869825|NCT00185640|3573268|FG000|Transplanted|Overall Study||296
2869826|NCT00185640|3573268|FG000|90 Days Post-transplant|Overall Study||161
2869827|NCT00185640|3573268|FG000|COMPLETED|Overall Study||158
2869828|NCT00185640|3573268|FG000|NOT COMPLETED|Overall Study||145
2869829|NCT00185679|3573272|FG000|STARTED|Overall Study||13
2869830|NCT00185679|3573272|FG000|COMPLETED|Overall Study||13
2869831|NCT00185679|3573272|FG000|NOT COMPLETED|Overall Study||0
2869832|NCT00185692|3573276|FG000|STARTED|Overall Study||16
2869833|NCT00185692|3573276|FG000|COMPLETED|Overall Study||0
2869834|NCT00185692|3573276|FG000|NOT COMPLETED|Overall Study||16
2869835|NCT00185731|3573280|FG000|STARTED|Overall Study||25
2869836|NCT00185731|3573280|FG000|COMPLETED|Overall Study||23
2869837|NCT00185731|3573280|FG000|NOT COMPLETED|Overall Study||2
2869838|NCT00185900|3573288|FG000|STARTED|Overall Study||92
2869839|NCT00185900|3573289|FG001|STARTED|Overall Study||100
2869840|NCT00185900|3573288|FG000|COMPLETED|Overall Study||92
2869841|NCT00185900|3573289|FG001|COMPLETED|Overall Study||100
2869842|NCT00185900|3573288|FG000|NOT COMPLETED|Overall Study||0
2869843|NCT00185900|3573289|FG001|NOT COMPLETED|Overall Study||0
2869844|NCT00185965|3573297|FG000|STARTED|Overall Study||15
2869845|NCT00185965|3573298|FG001|STARTED|Overall Study||15
2869846|NCT00185965|3573297|FG000|COMPLETED|Overall Study||15
2869847|NCT00185965|3573298|FG001|COMPLETED|Overall Study||14
2869848|NCT00185965|3573297|FG000|NOT COMPLETED|Overall Study||0
2869849|NCT00185965|3573298|FG001|NOT COMPLETED|Overall Study||1
2869850|NCT00186017|3573306|FG000|STARTED|Overall Study||25
2869851|NCT00186017|3573307|FG001|STARTED|Overall Study||25
2869852|NCT00186017|3573306|FG000|COMPLETED|Overall Study||23
2869853|NCT00186017|3573307|FG001|COMPLETED|Overall Study||22
2869854|NCT00186017|3573306|FG000|NOT COMPLETED|Overall Study||2
2869855|NCT00186017|3573307|FG001|NOT COMPLETED|Overall Study||3
2869856|NCT00186043|3573316|FG000|STARTED|Overall Study||30
2869857|NCT00186043|3573317|FG001|STARTED|Overall Study||25
2869858|NCT00186043|3573316|FG000|COMPLETED|Overall Study||15
2869859|NCT00186043|3573317|FG001|COMPLETED|Overall Study||12
2869860|NCT00186043|3573316|FG000|NOT COMPLETED|Overall Study||15
2869861|NCT00186043|3573317|FG001|NOT COMPLETED|Overall Study||13
2869862|NCT00186056|3573325|FG000|STARTED|Overall Study||14
2869863|NCT00186056|3573326|FG001|STARTED|Overall Study||17
2869864|NCT00186056|3573325|FG000|COMPLETED|Overall Study||12
2869865|NCT00186056|3573326|FG001|COMPLETED|Overall Study||16
2869866|NCT00186056|3573325|FG000|NOT COMPLETED|Overall Study||2
2869867|NCT00186056|3573326|FG001|NOT COMPLETED|Overall Study||1
2869868|NCT00186069|3573334|FG000|STARTED|Overall Study|Enrollment goal was not reached due to the introduction of magnesium sulfate for neuroprotection|15
2869869|NCT00186069|3573335|FG001|STARTED|Overall Study|Enrollment goal was not reached due to the introduction of magnesium sulfate for neuroprotection|15
2869870|NCT00186069|3573334|FG000|COMPLETED|Overall Study||15
2869871|NCT00186069|3573335|FG001|COMPLETED|Overall Study||15
2869872|NCT00186069|3573334|FG000|NOT COMPLETED|Overall Study||0
2869873|NCT00186069|3573335|FG001|NOT COMPLETED|Overall Study||0
2869874|NCT00186121|3573341|FG000|STARTED|Overall Study||35
2869875|NCT00186121|3573341|FG000|COMPLETED|Overall Study||32
2869876|NCT00186121|3573341|FG000|NOT COMPLETED|Overall Study||3
2869877|NCT00186186|3573345|FG000|STARTED|Overall Study||28
2869878|NCT00186186|3573345|FG000|COMPLETED|Overall Study||20
3313584|NCT03075904|4046888|FG000|STARTED|Overall Study||8
3313585|NCT03075904|4046888|FG000|Received at Least 1 Dose of Study Drug|Overall Study||8
3313586|NCT03075904|4046888|FG000|COMPLETED|Overall Study||4
3313587|NCT03075904|4046888|FG000|NOT COMPLETED|Overall Study||4
3313588|NCT03076190|4046894|FG000|STARTED|Overall Study||50
3313589|NCT03076190|4046895|FG001|STARTED|Overall Study||77
3313590|NCT03076190|4046894|FG000|COMPLETED|Overall Study||32
3313591|NCT03076190|4046895|FG001|COMPLETED|Overall Study||36
3313592|NCT03076190|4046894|FG000|NOT COMPLETED|Overall Study||18
3313593|NCT03076190|4046895|FG001|NOT COMPLETED|Overall Study||41
3313594|NCT03076333|4046904|FG000|STARTED|Overall Study||3
3313595|NCT03076333|4046904|FG000|COMPLETED|Overall Study||3
2869879|NCT00186186|3573345|FG000|NOT COMPLETED|Overall Study||8
2869880|NCT00186446|3573350|FG000|STARTED|Overall Study||20
2869881|NCT00186446|3573350|FG000|COMPLETED|Overall Study||11
2869882|NCT00186446|3573350|FG000|NOT COMPLETED|Overall Study||9
2869883|NCT00186485|3573356|FG000|STARTED|Overall Study||28
2869884|NCT00186485|3573356|FG000|COMPLETED|Overall Study||25
2869885|NCT00186485|3573356|FG000|NOT COMPLETED|Overall Study||3
2869886|NCT00186498|3573362|FG000|STARTED|Overall Study||6
2869887|NCT00186498|3573363|FG001|STARTED|Overall Study||5
2869888|NCT00186498|3573362|FG000|COMPLETED|Overall Study||4
2869889|NCT00186498|3573363|FG001|COMPLETED|Overall Study||3
2869890|NCT00186498|3573362|FG000|NOT COMPLETED|Overall Study||2
2869891|NCT00186498|3573363|FG001|NOT COMPLETED|Overall Study||2
2869892|NCT00186537|3573372|FG000|STARTED|Overall Study||19
2869893|NCT00186537|3573373|FG001|STARTED|Overall Study||12
2869894|NCT00186537|3573374|FG002|STARTED|Overall Study||16
2869895|NCT00186537|3573372|FG000|COMPLETED|Overall Study||12
2869896|NCT00186537|3573373|FG001|COMPLETED|Overall Study||12
2869897|NCT00186537|3573374|FG002|COMPLETED|Overall Study||13
2869898|NCT00186537|3573372|FG000|NOT COMPLETED|Overall Study||7
2869899|NCT00186537|3573373|FG001|NOT COMPLETED|Overall Study||0
2869900|NCT00186537|3573374|FG002|NOT COMPLETED|Overall Study||3
2869901|NCT00186628|3573382|FG000|STARTED|Overall Study||36
2869902|NCT00186628|3573382|FG000|COMPLETED|Overall Study||33
2869903|NCT00186628|3573382|FG000|NOT COMPLETED|Overall Study||3
2918754|NCT00528879|3629063|FG000|COMPLETED|Short-term Period (Day 1 to Week 24)|Completed=entered Long-term Period|115
2918755|NCT00528879|3629064|FG001|COMPLETED|Short-term Period (Day 1 to Week 24)|Completed=entered Long-term Period|120
2918756|NCT00528879|3629065|FG002|COMPLETED|Short-term Period (Day 1 to Week 24)|Completed=entered Long-term Period|122
2918757|NCT00528879|3629066|FG003|COMPLETED|Short-term Period (Day 1 to Week 24)|Completed=entered Long-term Period|119
2918758|NCT00528879|3629063|FG000|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||22
2918759|NCT00528879|3629064|FG001|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||17
2918760|NCT00528879|3629065|FG002|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||15
2918761|NCT00528879|3629066|FG003|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||16
2918762|NCT00528879|3629063|FG000|STARTED|Long-term Period (Weeks 24 to 102)||115
2918763|NCT00528879|3629064|FG001|STARTED|Long-term Period (Weeks 24 to 102)||120
2918764|NCT00528879|3629065|FG002|STARTED|Long-term Period (Weeks 24 to 102)||122
2918765|NCT00528879|3629066|FG003|STARTED|Long-term Period (Weeks 24 to 102)||119
2918766|NCT00528879|3629063|FG000|COMPLETED|Long-term Period (Weeks 24 to 102)||73
2918767|NCT00528879|3629064|FG001|COMPLETED|Long-term Period (Weeks 24 to 102)||82
2918768|NCT00528879|3629065|FG002|COMPLETED|Long-term Period (Weeks 24 to 102)||89
2918769|NCT00528879|3629066|FG003|COMPLETED|Long-term Period (Weeks 24 to 102)||95
2918770|NCT00528879|3629063|FG000|NOT COMPLETED|Long-term Period (Weeks 24 to 102)||42
2918771|NCT00528879|3629064|FG001|NOT COMPLETED|Long-term Period (Weeks 24 to 102)||38
2918772|NCT00528879|3629065|FG002|NOT COMPLETED|Long-term Period (Weeks 24 to 102)||33
2918773|NCT00528879|3629066|FG003|NOT COMPLETED|Long-term Period (Weeks 24 to 102)||24
2918774|NCT00528931|3629076|FG000|STARTED|Overall Study||16
2918775|NCT00528931|3629076|FG000|COMPLETED|Overall Study||15
2918776|NCT00528931|3629076|FG000|NOT COMPLETED|Overall Study||1
2918777|NCT00528957|3629083|FG000|STARTED|Randomized Phase (Baseline to Week 48)||48
2918778|NCT00528957|3629084|FG001|STARTED|Randomized Phase (Baseline to Week 48)||49
2918779|NCT00528957|3629083|FG000|COMPLETED|Randomized Phase (Baseline to Week 48)||44
2918780|NCT00528957|3629084|FG001|COMPLETED|Randomized Phase (Baseline to Week 48)||48
2918781|NCT00528957|3629083|FG000|NOT COMPLETED|Randomized Phase (Baseline to Week 48)||4
2918782|NCT00528957|3629084|FG001|NOT COMPLETED|Randomized Phase (Baseline to Week 48)||1
2918783|NCT00528957|3629083|FG000|STARTED|First Extension (Week 48 to Week 144)|Six participants completed the 48-week randomized phase and did not enroll in the first extension.|38
2918784|NCT00528957|3629084|FG001|STARTED|First Extension (Week 48 to Week 144)|Seven participants completed the 48-week randomized phase and did not enroll in the first extension.|41
2918785|NCT00528957|3629083|FG000|COMPLETED|First Extension (Week 48 to Week 144)||35
2918786|NCT00528957|3629084|FG001|COMPLETED|First Extension (Week 48 to Week 144)||40
2918787|NCT00528957|3629083|FG000|NOT COMPLETED|First Extension (Week 48 to Week 144)||3
2918788|NCT00528957|3629084|FG001|NOT COMPLETED|First Extension (Week 48 to Week 144)||1
2918789|NCT00528957|3629083|FG000|STARTED|Second Extension (Week 144 to Week 240)|One participant completed the first extension and did not enroll in the second extension.|34
2918790|NCT00528957|3629084|FG001|STARTED|Second Extension (Week 144 to Week 240)||40
2918791|NCT00528957|3629083|FG000|COMPLETED|Second Extension (Week 144 to Week 240)||27
2918792|NCT00528957|3629084|FG001|COMPLETED|Second Extension (Week 144 to Week 240)||37
2918793|NCT00528957|3629083|FG000|NOT COMPLETED|Second Extension (Week 144 to Week 240)||7
2918794|NCT00528957|3629084|FG001|NOT COMPLETED|Second Extension (Week 144 to Week 240)||3
2918795|NCT00528957|3629083|FG000|STARTED|Third Extension (Week 240 to Week 336)||27
2918796|NCT00528957|3629084|FG001|STARTED|Third Extension (Week 240 to Week 336)||37
2918797|NCT00528957|3629083|FG000|COMPLETED|Third Extension (Week 240 to Week 336)||21
2918798|NCT00528957|3629084|FG001|COMPLETED|Third Extension (Week 240 to Week 336)||27
2918799|NCT00528957|3629083|FG000|NOT COMPLETED|Third Extension (Week 240 to Week 336)||6
2918800|NCT00528957|3629084|FG001|NOT COMPLETED|Third Extension (Week 240 to Week 336)||10
2918801|NCT00528957|3629083|FG000|STARTED|Long-Term Extension (Week 336 and On)|Two participants completed the third extension and did not enroll in the long-term extension.|19
3034284|NCT01131676|3753343|FG000|Final Vital Status (VS) Available|Discontinuation From Study (Treated Set)||2316
2869904|NCT00186875|3573390|FG000|STARTED|Overall Study||26
2869905|NCT00186875|3573391|FG001|STARTED|Overall Study||14
2869906|NCT00186875|3573390|FG000|COMPLETED|Overall Study||26
2869907|NCT00186875|3573391|FG001|COMPLETED|Overall Study||14
2869908|NCT00186875|3573390|FG000|NOT COMPLETED|Overall Study||0
2869909|NCT00186875|3573391|FG001|NOT COMPLETED|Overall Study||0
2869910|NCT00186901|3573401|FG000|STARTED|Overall Study||134
2869911|NCT00186901|3573402|FG001|STARTED|Overall Study||141
2869912|NCT00186901|3573403|FG002|STARTED|Overall Study||149
2869913|NCT00186901|3573401|FG000|Baseline|Overall Study||134
2869914|NCT00186901|3573402|FG001|Baseline|Overall Study||141
2869915|NCT00186901|3573403|FG002|Baseline|Overall Study||0
2869916|NCT00186901|3573401|FG000|12 Month Follow-up|Overall Study||117
2869917|NCT00186901|3573402|FG001|12 Month Follow-up|Overall Study||122
2869918|NCT00186901|3573403|FG002|12 Month Follow-up|Overall Study||0
2869919|NCT00186901|3573401|FG000|24 Month Follow-up|Overall Study||106
2869920|NCT00186901|3573402|FG001|24 Month Follow-up|Overall Study||107
2869921|NCT00186901|3573403|FG002|24 Month Follow-up|Overall Study||0
2869922|NCT00186901|3573401|FG000|COMPLETED|Overall Study||85
2869923|NCT00186901|3573402|FG001|COMPLETED|Overall Study||96
2869924|NCT00186901|3573403|FG002|COMPLETED|Overall Study||0
2869925|NCT00186901|3573401|FG000|NOT COMPLETED|Overall Study||49
2869926|NCT00186901|3573402|FG001|NOT COMPLETED|Overall Study||45
2869927|NCT00186901|3573403|FG002|NOT COMPLETED|Overall Study||149
2869928|NCT00187096|3573443|FG000|STARTED|Overall Study||10
2869929|NCT00187096|3573444|FG001|STARTED|Overall Study||3
2869930|NCT00187096|3573445|FG002|STARTED|Overall Study||12
2869931|NCT00187096|3573443|FG000|COMPLETED|Overall Study||10
2869932|NCT00187096|3573444|FG001|COMPLETED|Overall Study||3
2869933|NCT00187096|3573445|FG002|COMPLETED|Overall Study||11
2869934|NCT00187096|3573443|FG000|NOT COMPLETED|Overall Study||0
2869935|NCT00187096|3573444|FG001|NOT COMPLETED|Overall Study||0
2869936|NCT00187096|3573445|FG002|NOT COMPLETED|Overall Study||1
2869937|NCT00187135|3573459|FG000|STARTED|Visit One||30
2869938|NCT00187135|3573460|FG001|STARTED|Visit One||28
2869939|NCT00187135|3573461|FG002|STARTED|Visit One||25
2869940|NCT00187135|3573462|FG003|STARTED|Visit One||26
2869941|NCT00187135|3573463|FG004|STARTED|Visit One||25
2869942|NCT00187135|3573464|FG005|STARTED|Visit One||28
2869943|NCT00187135|3573459|FG000|COMPLETED|Visit One||26
2869944|NCT00187135|3573460|FG001|COMPLETED|Visit One||27
2869945|NCT00187135|3573461|FG002|COMPLETED|Visit One||25
2869946|NCT00187135|3573462|FG003|COMPLETED|Visit One||26
2869947|NCT00187135|3573463|FG004|COMPLETED|Visit One||25
2869948|NCT00187135|3573464|FG005|COMPLETED|Visit One||26
2869949|NCT00187135|3573459|FG000|NOT COMPLETED|Visit One||4
2869950|NCT00187135|3573460|FG001|NOT COMPLETED|Visit One||1
2869951|NCT00187135|3573461|FG002|NOT COMPLETED|Visit One||0
2869952|NCT00187135|3573462|FG003|NOT COMPLETED|Visit One||0
2869953|NCT00187135|3573463|FG004|NOT COMPLETED|Visit One||0
2869954|NCT00187135|3573464|FG005|NOT COMPLETED|Visit One||2
2869955|NCT00187135|3573459|FG000|STARTED|Visit Two||26
2869956|NCT00187135|3573460|FG001|STARTED|Visit Two||27
2869957|NCT00187135|3573461|FG002|STARTED|Visit Two||25
2869958|NCT00187135|3573462|FG003|STARTED|Visit Two||26
2869959|NCT00187135|3573463|FG004|STARTED|Visit Two||25
2869960|NCT00187135|3573464|FG005|STARTED|Visit Two||26
2869961|NCT00187135|3573459|FG000|COMPLETED|Visit Two||21
2869962|NCT00187135|3573460|FG001|COMPLETED|Visit Two||24
2869963|NCT00187135|3573461|FG002|COMPLETED|Visit Two||23
2869964|NCT00187135|3573462|FG003|COMPLETED|Visit Two||18
2869965|NCT00187135|3573463|FG004|COMPLETED|Visit Two||19
2869966|NCT00187135|3573464|FG005|COMPLETED|Visit Two||18
2869967|NCT00187135|3573459|FG000|NOT COMPLETED|Visit Two||5
2869968|NCT00187135|3573460|FG001|NOT COMPLETED|Visit Two||3
2869969|NCT00187135|3573461|FG002|NOT COMPLETED|Visit Two||2
2869970|NCT00187135|3573462|FG003|NOT COMPLETED|Visit Two||8
2869971|NCT00187135|3573463|FG004|NOT COMPLETED|Visit Two||6
2869972|NCT00187135|3573464|FG005|NOT COMPLETED|Visit Two||8
2869973|NCT00187135|3573459|FG000|STARTED|Visit Three||21
2869974|NCT00187135|3573460|FG001|STARTED|Visit Three||24
2869975|NCT00187135|3573461|FG002|STARTED|Visit Three||23
2869976|NCT00187135|3573462|FG003|STARTED|Visit Three||18
2869977|NCT00187135|3573463|FG004|STARTED|Visit Three||19
2869978|NCT00187135|3573464|FG005|STARTED|Visit Three||18
2869979|NCT00187135|3573459|FG000|COMPLETED|Visit Three||14
2869980|NCT00187135|3573460|FG001|COMPLETED|Visit Three||17
2869981|NCT00187135|3573461|FG002|COMPLETED|Visit Three||14
2869982|NCT00187135|3573462|FG003|COMPLETED|Visit Three||9
2869983|NCT00187135|3573463|FG004|COMPLETED|Visit Three||11
2869984|NCT00187135|3573464|FG005|COMPLETED|Visit Three||12
2869985|NCT00187135|3573459|FG000|NOT COMPLETED|Visit Three||7
2869986|NCT00187135|3573460|FG001|NOT COMPLETED|Visit Three||7
2869987|NCT00187135|3573461|FG002|NOT COMPLETED|Visit Three||9
2869988|NCT00187135|3573462|FG003|NOT COMPLETED|Visit Three||9
2869989|NCT00187135|3573463|FG004|NOT COMPLETED|Visit Three||8
2869990|NCT00187135|3573464|FG005|NOT COMPLETED|Visit Three||6
2869991|NCT00187200|3573478|FG000|STARTED|Overall Study||49
2869992|NCT00187200|3573479|FG001|STARTED|Overall Study||44
2869993|NCT00187200|3573478|FG000|COMPLETED|Overall Study||31
2869994|NCT00187200|3573479|FG001|COMPLETED|Overall Study||26
2869995|NCT00187200|3573478|FG000|NOT COMPLETED|Overall Study||18
2869996|NCT00187200|3573479|FG001|NOT COMPLETED|Overall Study||18
2869997|NCT00187226|3573493|FG000|STARTED|Overall Study||88
2869998|NCT00187226|3573494|FG001|STARTED|Overall Study||49
2869999|NCT00187226|3573495|FG002|STARTED|Overall Study||28
2870000|NCT00187226|3573496|FG003|STARTED|Overall Study||2
2870001|NCT00187226|3573497|FG004|STARTED|Overall Study||34
2870002|NCT00187226|3573498|FG005|STARTED|Overall Study||1
2870003|NCT00187226|3573493|FG000|COMPLETED|Overall Study||88
2870004|NCT00187226|3573494|FG001|COMPLETED|Overall Study||49
2870005|NCT00187226|3573495|FG002|COMPLETED|Overall Study||28
2870006|NCT00187226|3573496|FG003|COMPLETED|Overall Study||2
2870007|NCT00187226|3573497|FG004|COMPLETED|Overall Study||34
2870008|NCT00187226|3573498|FG005|COMPLETED|Overall Study||1
2870009|NCT00187226|3573493|FG000|NOT COMPLETED|Overall Study||0
2870010|NCT00187226|3573494|FG001|NOT COMPLETED|Overall Study||0
2870011|NCT00187226|3573495|FG002|NOT COMPLETED|Overall Study||0
2870012|NCT00187226|3573496|FG003|NOT COMPLETED|Overall Study||0
2870013|NCT00187226|3573497|FG004|NOT COMPLETED|Overall Study||0
2870014|NCT00187226|3573498|FG005|NOT COMPLETED|Overall Study||0
2870015|NCT00187278|3573514|FG000|STARTED|Overall Study||918
2870016|NCT00187278|3573515|FG001|STARTED|Overall Study||915
2870017|NCT00187278|3573514|FG000|COMPLETED|Overall Study||908
2870018|NCT00187278|3573515|FG001|COMPLETED|Overall Study||902
2870019|NCT00187278|3573514|FG000|NOT COMPLETED|Overall Study||10
2870020|NCT00187278|3573515|FG001|NOT COMPLETED|Overall Study||13
2870021|NCT00187369|3573525|FG000|STARTED|Mothers||1398
2870022|NCT00187369|3573526|FG001|STARTED|Mothers||1406
2870023|NCT00187369|3573525|FG000|Included in the Study|Mothers||1393
2870024|NCT00187369|3573526|FG001|Included in the Study|Mothers||1393
2870025|NCT00187369|3573525|FG000|COMPLETED|Mothers||1392
2870026|NCT00187369|3573526|FG001|COMPLETED|Mothers||1392
2870027|NCT00187369|3573525|FG000|NOT COMPLETED|Mothers||6
2870028|NCT00187369|3573526|FG001|NOT COMPLETED|Mothers||14
2870029|NCT00187369|3573525|FG000|STARTED|Fetuses or Infants||2795
2870030|NCT00187369|3573526|FG001|STARTED|Fetuses or Infants||2812
2870031|NCT00187369|3573525|FG000|Included in the Study|Fetuses or Infants||2785
2870032|NCT00187369|3573526|FG001|Included in the Study|Fetuses or Infants||2786
2870033|NCT00187369|3573525|FG000|COMPLETED|Fetuses or Infants||2783
2870034|NCT00187369|3573526|FG001|COMPLETED|Fetuses or Infants||2782
2870035|NCT00187369|3573525|FG000|NOT COMPLETED|Fetuses or Infants||12
2870036|NCT00187369|3573526|FG001|NOT COMPLETED|Fetuses or Infants||30
2870037|NCT00187486|3573538|FG000|STARTED|Overall Study||66
3169505|NCT01925768|3897051|FG000|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||109
3169506|NCT01925768|3897052|FG001|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||109
3169507|NCT01925768|3897051|FG000|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||101
3169508|NCT01925768|3897052|FG001|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||91
2870038|NCT00187486|3573538|FG000|COMPLETED|Overall Study||65
2870039|NCT00187486|3573538|FG000|NOT COMPLETED|Overall Study||1
2870040|NCT00187655|3573542|FG000|STARTED|Overall Study||24
2870041|NCT00187655|3573542|FG000|COMPLETED|Overall Study||24
2870042|NCT00187655|3573542|FG000|NOT COMPLETED|Overall Study||0
2870043|NCT00187681|3573549|FG000|STARTED|Overall Study||12
2870044|NCT00187681|3573550|FG001|STARTED|Overall Study||8
2870045|NCT00187681|3573549|FG000|COMPLETED|Overall Study||12
2870046|NCT00187681|3573550|FG001|COMPLETED|Overall Study||8
2870047|NCT00187681|3573549|FG000|NOT COMPLETED|Overall Study||0
2870048|NCT00187681|3573550|FG001|NOT COMPLETED|Overall Study||0
2870049|NCT00187720|3573560|FG000|STARTED|Overall Study||9
2870050|NCT00187720|3573561|FG001|STARTED|Overall Study||14
2870051|NCT00187720|3573560|FG000|COMPLETED|Overall Study||9
2870052|NCT00187720|3573561|FG001|COMPLETED|Overall Study||14
2870053|NCT00187720|3573560|FG000|NOT COMPLETED|Overall Study||0
2870054|NCT00187720|3573561|FG001|NOT COMPLETED|Overall Study||0
2870055|NCT00187876|3573569|FG000|STARTED|Overall Study||24
2870056|NCT00187876|3573570|FG001|STARTED|Overall Study||43
2870057|NCT00187876|3573569|FG000|COMPLETED|Overall Study||24
2870058|NCT00187876|3573570|FG001|COMPLETED|Overall Study||43
2870059|NCT00187876|3573569|FG000|NOT COMPLETED|Overall Study||0
2870060|NCT00187876|3573570|FG001|NOT COMPLETED|Overall Study||0
2870061|NCT00187889|3573578|FG000|STARTED|Overall Study||25
2870062|NCT00187889|3573579|FG001|STARTED|Overall Study||26
2870063|NCT00187889|3573578|FG000|COMPLETED|Overall Study||19
2870064|NCT00187889|3573579|FG001|COMPLETED|Overall Study||22
2870065|NCT00187889|3573578|FG000|NOT COMPLETED|Overall Study||6
2870066|NCT00187889|3573579|FG001|NOT COMPLETED|Overall Study||4
2870067|NCT00189098|3573588|FG000|STARTED|Overall Study||51
2870068|NCT00189098|3573589|FG001|STARTED|Overall Study||50
2870069|NCT00189098|3573588|FG000|COMPLETED|Overall Study||46
2870070|NCT00189098|3573589|FG001|COMPLETED|Overall Study||44
2870071|NCT00189098|3573588|FG000|NOT COMPLETED|Overall Study||5
2870072|NCT00189098|3573589|FG001|NOT COMPLETED|Overall Study||6
2870073|NCT00189137|3573599|FG000|STARTED|Overall Study||37
2870074|NCT00189137|3573600|FG001|STARTED|Overall Study||43
2870075|NCT00189137|3573599|FG000|COMPLETED|Overall Study||37
2870076|NCT00189137|3573600|FG001|COMPLETED|Overall Study||43
2870077|NCT00189137|3573599|FG000|NOT COMPLETED|Overall Study||0
2870078|NCT00189137|3573600|FG001|NOT COMPLETED|Overall Study||0
2870079|NCT00189202|3573606|FG000|STARTED|Overall Study||49
2870080|NCT00189202|3573606|FG000|COMPLETED|Overall Study||44
2870081|NCT00189202|3573606|FG000|NOT COMPLETED|Overall Study||5
2870082|NCT00189228|3573610|FG000|STARTED|Overall Study||18
2870083|NCT00189228|3573610|FG000|COMPLETED|Overall Study||18
2870084|NCT00189228|3573610|FG000|NOT COMPLETED|Overall Study||0
2870085|NCT00189306|3573614|FG000|STARTED|Treatment Period||169
3034285|NCT01131676|3753344|FG001|Final Vital Status (VS) Available|Discontinuation From Study (Treated Set)||2324
2870086|NCT00189306|3573614|FG000|COMPLETED|Treatment Period|5 subjects discontinued during treatment - 4 subjects returned for the Posttreatment Period|164
2870087|NCT00189306|3573614|FG000|NOT COMPLETED|Treatment Period||5
2870088|NCT00189306|3573614|FG000|STARTED|Posttreatment Period|5 of the 169 discontinued, but 4 returned for the Posttreatment Period|169
2870089|NCT00189306|3573614|FG000|COMPLETED|Posttreatment Period|11 subjects discontinued during the 12-week Posttreatment Period|157
2870090|NCT00189306|3573614|FG000|NOT COMPLETED|Posttreatment Period||12
2870091|NCT00189306|3573614|FG000|STARTED|Long-Term Follow-up||157
2870092|NCT00189306|3573614|FG000|COMPLETED|Long-Term Follow-up||119
2870093|NCT00189306|3573614|FG000|NOT COMPLETED|Long-Term Follow-up||38
2870094|NCT00189423|3573620|FG000|STARTED|Overall Study||813
2870095|NCT00189423|3573621|FG001|STARTED|Overall Study||840
2870096|NCT00189423|3573620|FG000|COMPLETED|Overall Study||48
2870097|NCT00189423|3573621|FG001|COMPLETED|Overall Study||74
2870098|NCT00189423|3573620|FG000|NOT COMPLETED|Overall Study||765
2870099|NCT00189423|3573621|FG001|NOT COMPLETED|Overall Study||766
2870100|NCT00189436|3573629|FG000|STARTED|Overall Study||31
2870101|NCT00189436|3573630|FG001|STARTED|Overall Study||30
2870102|NCT00189436|3573629|FG000|COMPLETED|Overall Study||23
2870103|NCT00189436|3573630|FG001|COMPLETED|Overall Study||25
2870104|NCT00189436|3573629|FG000|NOT COMPLETED|Overall Study||8
2870105|NCT00189436|3573630|FG001|NOT COMPLETED|Overall Study||5
2870106|NCT00189462|3573638|FG000|STARTED|Overall Study||50
2870107|NCT00189462|3573639|FG001|STARTED|Overall Study||49
2870108|NCT00189462|3573638|FG000|COMPLETED|Overall Study||27
2870109|NCT00189462|3573639|FG001|COMPLETED|Overall Study||28
2870110|NCT00189462|3573638|FG000|NOT COMPLETED|Overall Study||23
2870111|NCT00189462|3573639|FG001|NOT COMPLETED|Overall Study||21
2870112|NCT00189475|3573647|FG000|STARTED|Overall Study||42
2870113|NCT00189475|3573648|FG001|STARTED|Overall Study||42
2870114|NCT00189475|3573647|FG000|COMPLETED|Overall Study||42
2870115|NCT00189475|3573648|FG001|COMPLETED|Overall Study||42
2870116|NCT00189475|3573647|FG000|NOT COMPLETED|Overall Study||0
2870117|NCT00189475|3573648|FG001|NOT COMPLETED|Overall Study||0
2870118|NCT00189488|3573656|FG000|STARTED|Overall Study||78
2870119|NCT00189488|3573657|FG001|STARTED|Overall Study||77
2870120|NCT00189488|3573656|FG000|Received Palifermin/Placebo|Overall Study||75
2870121|NCT00189488|3573657|FG001|Received Palifermin/Placebo|Overall Study||76
2870122|NCT00189488|3573656|FG000|COMPLETED|Overall Study||63
2870123|NCT00189488|3573657|FG001|COMPLETED|Overall Study||55
2870124|NCT00189488|3573656|FG000|NOT COMPLETED|Overall Study||15
2870125|NCT00189488|3573657|FG001|NOT COMPLETED|Overall Study||22
2870126|NCT00189540|3573666|FG000|STARTED|Overall Study||21
2870127|NCT00189540|3573667|FG001|STARTED|Overall Study||6
2870128|NCT00189540|3573666|FG000|COMPLETED|Overall Study||14
2870129|NCT00189540|3573667|FG001|COMPLETED|Overall Study||5
2870130|NCT00189540|3573666|FG000|NOT COMPLETED|Overall Study||7
2870131|NCT00189540|3573667|FG001|NOT COMPLETED|Overall Study||1
2870132|NCT00190671|3573675|FG000|STARTED|Overall Study||42
2870133|NCT00190671|3573676|FG001|STARTED|Overall Study||61
2870134|NCT00190671|3573675|FG000|COMPLETED|Overall Study||15
2870135|NCT00190671|3573676|FG001|COMPLETED|Overall Study||19
2870136|NCT00190671|3573675|FG000|NOT COMPLETED|Overall Study||27
2870137|NCT00190671|3573676|FG001|NOT COMPLETED|Overall Study||42
2870138|NCT00190684|3573683|FG000|STARTED|Overall Study||1553
2870139|NCT00190684|3573683|FG000|Received at Least 1 Dose of Study Drug|Overall Study|1553 patients entered the study; 1551 were enrolled and received study drug.|1551
2870140|NCT00190684|3573683|FG000|COMPLETED|Overall Study|Number of patients that completed overall study (through Period VI)|64
2870141|NCT00190684|3573683|FG000|NOT COMPLETED|Overall Study||1489
2870142|NCT00190749|3573689|FG000|STARTED|Overall Study||68
2870143|NCT00190749|3573690|FG001|STARTED|Overall Study||62
2870144|NCT00190749|3573689|FG000|COMPLETED|Overall Study||42
2870145|NCT00190749|3573690|FG001|COMPLETED|Overall Study||31
2870146|NCT00190749|3573689|FG000|NOT COMPLETED|Overall Study||26
2870147|NCT00190749|3573690|FG001|NOT COMPLETED|Overall Study||31
2870148|NCT00190775|3573698|FG000|STARTED|Overall Study||268
2870149|NCT00190775|3573699|FG001|STARTED|Overall Study||234
2870150|NCT00190775|3573698|FG000|Received Study Drug|Overall Study||266
2870151|NCT00190775|3573699|FG001|Received Study Drug|Overall Study||234
2870152|NCT00190775|3573698|FG000|COMPLETED|Overall Study||119
2870153|NCT00190775|3573699|FG001|COMPLETED|Overall Study||134
2870154|NCT00190775|3573698|FG000|NOT COMPLETED|Overall Study||149
2870155|NCT00190775|3573699|FG001|NOT COMPLETED|Overall Study||100
2870156|NCT00190983|3573712|FG000|STARTED|Overall Study||29
2870157|NCT00190983|3573712|FG000|COMPLETED|Overall Study|Completed means patient received treatment and was evaluable for response.|27
2870158|NCT00190983|3573712|FG000|NOT COMPLETED|Overall Study||2
2870159|NCT00191100|3573718|FG000|STARTED|Overall Study||259
2870160|NCT00191100|3573719|FG001|STARTED|Overall Study||256
2870161|NCT00191100|3573718|FG000|COMPLETED|Overall Study||217
2870162|NCT00191100|3573719|FG001|COMPLETED|Overall Study||244
2870163|NCT00191100|3573718|FG000|NOT COMPLETED|Overall Study||42
2870164|NCT00191100|3573719|FG001|NOT COMPLETED|Overall Study||12
2870165|NCT00191113|3573727|FG000|STARTED|Core Study||78
2870166|NCT00191113|3573728|FG001|STARTED|Core Study||76
3169509|NCT01925768|3897051|FG000|Escaped Early (EE)|Placebo-controlled Phase (Week 0 - 24)||35
2870167|NCT00191113|3573727|FG000|COMPLETED|Core Study||43
2870168|NCT00191113|3573728|FG001|COMPLETED|Core Study||61
2870169|NCT00191113|3573727|FG000|NOT COMPLETED|Core Study||35
2870170|NCT00191113|3573728|FG001|NOT COMPLETED|Core Study||15
2870171|NCT00191113|3573727|FG000|STARTED|Addendum 1||2
3169510|NCT01925768|3897052|FG001|Escaped Early (EE)|Placebo-controlled Phase (Week 0 - 24)||13
3169511|NCT01925768|3897051|FG000|COMPLETED|Placebo-controlled Phase (Week 0 - 24)|3 participants who completed Week 24 did not enter the active treatment phase|98
3169512|NCT01925768|3897052|FG001|COMPLETED|Placebo-controlled Phase (Week 0 - 24)|2 participants who completed Week 24 did not enter the active treatment phase|87
3169513|NCT01925768|3897051|FG000|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||11
2870172|NCT00191113|3573728|FG001|STARTED|Addendum 1|Not Applicable -- only Control patients were eligible for Addendum 1|0
2870173|NCT00191113|3573727|FG000|COMPLETED|Addendum 1||2
2870174|NCT00191113|3573728|FG001|COMPLETED|Addendum 1|Not Applicable -- only Control patients were eligible for Addendum 1|0
2870175|NCT00191113|3573727|FG000|NOT COMPLETED|Addendum 1||0
2870176|NCT00191113|3573728|FG001|NOT COMPLETED|Addendum 1||0
2870177|NCT00191113|3573727|FG000|STARTED|Addendum 2||28
2870178|NCT00191113|3573728|FG001|STARTED|Addendum 2||48
2870179|NCT00191113|3573727|FG000|COMPLETED|Addendum 2||18
2870180|NCT00191113|3573728|FG001|COMPLETED|Addendum 2||31
2870181|NCT00191113|3573727|FG000|NOT COMPLETED|Addendum 2||10
2870182|NCT00191113|3573728|FG001|NOT COMPLETED|Addendum 2||17
2870183|NCT00191113|3573727|FG000|STARTED|Addendum 3||20
2870184|NCT00191113|3573728|FG001|STARTED|Addendum 3||37
2870185|NCT00191113|3573727|FG000|COMPLETED|Addendum 3||20
2870186|NCT00191113|3573728|FG001|COMPLETED|Addendum 3||37
2870187|NCT00191113|3573727|FG000|NOT COMPLETED|Addendum 3||0
2870188|NCT00191113|3573728|FG001|NOT COMPLETED|Addendum 3||0
2870189|NCT00191139|3573742|FG000|STARTED|Overall Study||32
2870190|NCT00191139|3573743|FG001|STARTED|Overall Study||32
2870191|NCT00191139|3573742|FG000|COMPLETED|Overall Study||27
2870192|NCT00191139|3573743|FG001|COMPLETED|Overall Study||20
2870193|NCT00191139|3573742|FG000|NOT COMPLETED|Overall Study||5
2870194|NCT00191139|3573743|FG001|NOT COMPLETED|Overall Study||12
2870195|NCT00191152|3573751|FG000|STARTED|Initial Treatment||239
2870196|NCT00191152|3573752|FG001|STARTED|Initial Treatment||236
2870197|NCT00191152|3573751|FG000|Received Initial Treatment|Initial Treatment||236
2870198|NCT00191152|3573752|FG001|Received Initial Treatment|Initial Treatment||227
2870199|NCT00191152|3573751|FG000|COMPLETED|Initial Treatment||98
2870200|NCT00191152|3573752|FG001|COMPLETED|Initial Treatment||83
2870201|NCT00191152|3573751|FG000|NOT COMPLETED|Initial Treatment||141
2870202|NCT00191152|3573752|FG001|NOT COMPLETED|Initial Treatment||153
2870203|NCT00191152|3573751|FG000|STARTED|Crossover Treatment||77
2870204|NCT00191152|3573752|FG001|STARTED|Crossover Treatment||81
2870205|NCT00191152|3573751|FG000|Received Treatment|Crossover Treatment||76
2870206|NCT00191152|3573752|FG001|Received Treatment|Crossover Treatment||80
2870207|NCT00191152|3573751|FG000|COMPLETED|Crossover Treatment||50
2870208|NCT00191152|3573752|FG001|COMPLETED|Crossover Treatment||53
2870209|NCT00191152|3573751|FG000|NOT COMPLETED|Crossover Treatment||27
2870210|NCT00191152|3573752|FG001|NOT COMPLETED|Crossover Treatment||28
2870211|NCT00191165|3573772|FG000|STARTED|Overall Study||14
2870212|NCT00191165|3573773|FG001|STARTED|Overall Study||13
2870213|NCT00191165|3573772|FG000|COMPLETED|Overall Study||12
2870214|NCT00191165|3573773|FG001|COMPLETED|Overall Study||11
2870215|NCT00191165|3573772|FG000|NOT COMPLETED|Overall Study||2
2870216|NCT00191165|3573773|FG001|NOT COMPLETED|Overall Study||2
2870217|NCT00191191|3573781|FG000|STARTED|Overall Study||114
2870218|NCT00191191|3573782|FG001|STARTED|Overall Study||112
2870219|NCT00191191|3573781|FG000|Safety Analysis Population|Overall Study||114
2870220|NCT00191191|3573782|FG001|Safety Analysis Population|Overall Study||111
2870221|NCT00191191|3573781|FG000|Full Analysis Set Population|Overall Study||108
2870222|NCT00191191|3573782|FG001|Full Analysis Set Population|Overall Study||108
2870223|NCT00191191|3573781|FG000|COMPLETED|Overall Study||0
2870224|NCT00191191|3573782|FG001|COMPLETED|Overall Study||0
2870225|NCT00191191|3573781|FG000|NOT COMPLETED|Overall Study||114
2870226|NCT00191191|3573782|FG001|NOT COMPLETED|Overall Study||112
2870227|NCT00191269|3573790|FG000|STARTED|Overall Study||6
2870228|NCT00191269|3573791|FG001|STARTED|Overall Study||62
2870229|NCT00191269|3573790|FG000|COMPLETED|Overall Study||0
2870230|NCT00191269|3573791|FG001|COMPLETED|Overall Study||4
2870231|NCT00191269|3573790|FG000|NOT COMPLETED|Overall Study||6
2870232|NCT00191269|3573791|FG001|NOT COMPLETED|Overall Study||58
2870233|NCT00191282|3573800|FG000|STARTED|Overall Study||558
2870234|NCT00191282|3573801|FG001|STARTED|Overall Study||558
2870235|NCT00191282|3573800|FG000|COMPLETED|Overall Study||338
2870236|NCT00191282|3573801|FG001|COMPLETED|Overall Study||346
2870237|NCT00191282|3573800|FG000|NOT COMPLETED|Overall Study||220
2870238|NCT00191282|3573801|FG001|NOT COMPLETED|Overall Study||212
2870239|NCT00191308|3573807|FG000|STARTED|Overall Study||30
2870240|NCT00191308|3573807|FG000|COMPLETED|Overall Study||29
2870241|NCT00191308|3573807|FG000|NOT COMPLETED|Overall Study||1
2870242|NCT00191334|3573811|FG000|STARTED|Overall Study||50
2870243|NCT00191334|3573811|FG000|COMPLETED|Overall Study||33
2870244|NCT00191334|3573811|FG000|NOT COMPLETED|Overall Study||17
2870245|NCT00191386|3573815|FG000|STARTED|Overall Study||228
2870246|NCT00191386|3573815|FG000|6 Months|Overall Study||183
2870247|NCT00191386|3573815|FG000|12 Months|Overall Study||149
2870248|NCT00191386|3573815|FG000|2 Years|Overall Study||105
2870249|NCT00191386|3573815|FG000|3 Years|Overall Study||65
2870250|NCT00191386|3573815|FG000|COMPLETED|Overall Study||68
2870251|NCT00191386|3573815|FG000|NOT COMPLETED|Overall Study||160
3171791|NCT01937130|3898982|FG003|NOT COMPLETED|Overall Study||2
2870252|NCT00191451|3573822|FG000|STARTED|Overall Study||50
2870253|NCT00191451|3573823|FG001|STARTED|Overall Study||51
2870254|NCT00191451|3573824|FG002|STARTED|Overall Study||49
2870255|NCT00191451|3573822|FG000|Received at Least One Dose of Study Drug|Overall Study||50
2870256|NCT00191451|3573823|FG001|Received at Least One Dose of Study Drug|Overall Study||48
2870257|NCT00191451|3573824|FG002|Received at Least One Dose of Study Drug|Overall Study||47
2870258|NCT00191451|3573822|FG000|COMPLETED|Overall Study||43
2870259|NCT00191451|3573823|FG001|COMPLETED|Overall Study||37
2870260|NCT00191451|3573824|FG002|COMPLETED|Overall Study||35
2870261|NCT00191451|3573822|FG000|NOT COMPLETED|Overall Study||7
2870262|NCT00191451|3573823|FG001|NOT COMPLETED|Overall Study||14
2870263|NCT00191451|3573824|FG002|NOT COMPLETED|Overall Study||14
2870264|NCT00191477|3573834|FG000|STARTED|Overall Study||179
2870265|NCT00191477|3573835|FG001|STARTED|Overall Study||176
2870266|NCT00191477|3573834|FG000|Received Study Drug|Overall Study||166
2870267|NCT00191477|3573835|FG001|Received Study Drug|Overall Study||162
2870268|NCT00191477|3573834|FG000|COMPLETED|Overall Study||41
2870269|NCT00191477|3573835|FG001|COMPLETED|Overall Study||47
2870270|NCT00191477|3573834|FG000|NOT COMPLETED|Overall Study||138
2870271|NCT00191477|3573835|FG001|NOT COMPLETED|Overall Study||129
2870272|NCT00191646|3573843|FG000|STARTED|Overall Study||417
2870273|NCT00191646|3573844|FG001|STARTED|Overall Study||414
2870274|NCT00191646|3573843|FG000|Received Induction Therapy|Overall Study||411
2870275|NCT00191646|3573844|FG001|Received Induction Therapy|Overall Study||409
2870276|NCT00191646|3573843|FG000|Received Consolidation Therapy|Overall Study||169
2870277|NCT00191646|3573844|FG001|Received Consolidation Therapy|Overall Study||183
2870278|NCT00191646|3573843|FG000|Received Crossover Therapy|Overall Study||77
2870279|NCT00191646|3573844|FG001|Received Crossover Therapy|Overall Study||78
2870280|NCT00191646|3573843|FG000|COMPLETED|Overall Study|Completed was defined as the patients treated in either consolidation therapy or crossover therapy.|246
2870281|NCT00191646|3573844|FG001|COMPLETED|Overall Study|Completed was defined as the patients treated in either consolidation therapy or crossover therapy.|261
2870282|NCT00191646|3573843|FG000|NOT COMPLETED|Overall Study||171
2870283|NCT00191646|3573844|FG001|NOT COMPLETED|Overall Study||153
2870284|NCT00191724|3573863|FG000|STARTED|Overall Study||6
2870285|NCT00191724|3573864|FG001|STARTED|Overall Study||9
2870286|NCT00191724|3573865|FG002|STARTED|Overall Study||9
2870287|NCT00191724|3573866|FG003|STARTED|Overall Study||8
2870288|NCT00191724|3573867|FG004|STARTED|Overall Study||15
2870289|NCT00191724|3573863|FG000|COMPLETED|Overall Study||5
2870290|NCT00191724|3573864|FG001|COMPLETED|Overall Study||8
2870291|NCT00191724|3573865|FG002|COMPLETED|Overall Study||8
2870292|NCT00191724|3573866|FG003|COMPLETED|Overall Study||5
2870293|NCT00191724|3573867|FG004|COMPLETED|Overall Study||12
2870294|NCT00191724|3573863|FG000|NOT COMPLETED|Overall Study||1
2870295|NCT00191724|3573864|FG001|NOT COMPLETED|Overall Study||1
2870296|NCT00191724|3573865|FG002|NOT COMPLETED|Overall Study||1
2870297|NCT00191724|3573866|FG003|NOT COMPLETED|Overall Study||3
2870298|NCT00191724|3573867|FG004|NOT COMPLETED|Overall Study||3
2870299|NCT00191789|3573879|FG000|STARTED|Overall Study||65
2870300|NCT00191789|3573879|FG000|COMPLETED|Overall Study||40
2870301|NCT00191789|3573879|FG000|NOT COMPLETED|Overall Study||25
2870302|NCT00191815|3573883|FG000|STARTED|Overall Study||70
2870303|NCT00191815|3573883|FG000|Treated|Overall Study||67
2870304|NCT00191815|3573883|FG000|COMPLETED|Overall Study||30
2870305|NCT00191815|3573883|FG000|NOT COMPLETED|Overall Study||40
2870306|NCT00191854|3573890|FG000|STARTED|Overall Study||49
2870307|NCT00191854|3573891|FG001|STARTED|Overall Study||47
2870308|NCT00191854|3573892|FG002|STARTED|Overall Study||51
2870309|NCT00191854|3573890|FG000|Received at Least One Dose of Study Drug|Overall Study||49
2870310|NCT00191854|3573891|FG001|Received at Least One Dose of Study Drug|Overall Study||47
2870311|NCT00191854|3573892|FG002|Received at Least One Dose of Study Drug|Overall Study|Screen failure: discontinued prior to receiving study drug.|50
2870312|NCT00191854|3573890|FG000|COMPLETED|Overall Study||12
2870313|NCT00191854|3573891|FG001|COMPLETED|Overall Study||17
2870314|NCT00191854|3573892|FG002|COMPLETED|Overall Study||12
2870315|NCT00191854|3573890|FG000|NOT COMPLETED|Overall Study||37
2870316|NCT00191854|3573891|FG001|NOT COMPLETED|Overall Study||30
2870317|NCT00191854|3573892|FG002|NOT COMPLETED|Overall Study||39
2870318|NCT00191906|3573904|FG000|STARTED|Study Period II||39
2870319|NCT00191906|3573905|FG001|STARTED|Study Period II||37
2870320|NCT00191906|3573906|FG002|STARTED|Study Period II||27
2870321|NCT00191906|3573907|FG003|STARTED|Study Period II||18
2870322|NCT00191906|3573904|FG000|COMPLETED|Study Period II||39
2870323|NCT00191906|3573905|FG001|COMPLETED|Study Period II||32
2870324|NCT00191906|3573906|FG002|COMPLETED|Study Period II||26
2870325|NCT00191906|3573907|FG003|COMPLETED|Study Period II||18
2870326|NCT00191906|3573904|FG000|NOT COMPLETED|Study Period II||0
2870327|NCT00191906|3573905|FG001|NOT COMPLETED|Study Period II||5
2870328|NCT00191906|3573906|FG002|NOT COMPLETED|Study Period II||1
2870329|NCT00191906|3573907|FG003|NOT COMPLETED|Study Period II||0
2870330|NCT00191906|3573904|FG000|STARTED|Study Period III|These are patients who continued in optional open-label period (1 country). All received atomoxetine|14
2870331|NCT00191906|3573905|FG001|STARTED|Study Period III|These are patients who continued in optional open-label period (1 country). All received atomoxetine|11
2870332|NCT00191906|3573906|FG002|STARTED|Study Period III||0
2870333|NCT00191906|3573907|FG003|STARTED|Study Period III||0
2870334|NCT00191906|3573904|FG000|COMPLETED|Study Period III||9
2870335|NCT00191906|3573905|FG001|COMPLETED|Study Period III||7
3169514|NCT01925768|3897052|FG001|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||23
3169515|NCT01925768|3897051|FG000|STARTED|ActiveTreatment/Extension (Weeks 24-104)||95
3169516|NCT01925768|3897052|FG001|STARTED|ActiveTreatment/Extension (Weeks 24-104)||85
3169517|NCT01925768|3897051|FG000|COMPLETED|ActiveTreatment/Extension (Weeks 24-104)||75
3169518|NCT01925768|3897052|FG001|COMPLETED|ActiveTreatment/Extension (Weeks 24-104)|Completed Apremilast treatment at Week 104|67
3169519|NCT01925768|3897051|FG000|NOT COMPLETED|ActiveTreatment/Extension (Weeks 24-104)||20
3169520|NCT01925768|3897052|FG001|NOT COMPLETED|ActiveTreatment/Extension (Weeks 24-104)||18
2870336|NCT00191906|3573906|FG002|COMPLETED|Study Period III||0
2870337|NCT00191906|3573907|FG003|COMPLETED|Study Period III||0
2870338|NCT00191906|3573904|FG000|NOT COMPLETED|Study Period III||5
2870339|NCT00191906|3573905|FG001|NOT COMPLETED|Study Period III||4
2870340|NCT00191906|3573906|FG002|NOT COMPLETED|Study Period III||0
2870341|NCT00191906|3573907|FG003|NOT COMPLETED|Study Period III||0
2870342|NCT00191945|3573925|FG000|STARTED|Double-Blind Acute Treatment||100
2870343|NCT00191945|3573926|FG001|STARTED|Double-Blind Acute Treatment||51
2870344|NCT00191945|3573925|FG000|COMPLETED|Double-Blind Acute Treatment||94
2870345|NCT00191945|3573926|FG001|COMPLETED|Double-Blind Acute Treatment||48
3313596|NCT03076333|4046904|FG000|NOT COMPLETED|Overall Study||0
3313597|NCT03076359|4046910|FG000|STARTED|Overall Study||170
3313598|NCT03076359|4046911|FG001|STARTED|Overall Study||150
3313599|NCT03076359|4046910|FG000|COMPLETED|Overall Study||170
3313600|NCT03076359|4046911|FG001|COMPLETED|Overall Study||150
3313601|NCT03076359|4046910|FG000|NOT COMPLETED|Overall Study||0
2870346|NCT00191945|3573925|FG000|NOT COMPLETED|Double-Blind Acute Treatment||6
2870347|NCT00191945|3573926|FG001|NOT COMPLETED|Double-Blind Acute Treatment||3
2870348|NCT00191945|3573925|FG000|STARTED|Open-Label Treatment Extension||94
2870349|NCT00191945|3573926|FG001|STARTED|Open-Label Treatment Extension||48
2870350|NCT00191945|3573925|FG000|COMPLETED|Open-Label Treatment Extension||94
2870351|NCT00191945|3573926|FG001|COMPLETED|Open-Label Treatment Extension||48
2870352|NCT00191945|3573925|FG000|NOT COMPLETED|Open-Label Treatment Extension||0
2870353|NCT00191945|3573926|FG001|NOT COMPLETED|Open-Label Treatment Extension||0
2870354|NCT00191984|3573933|FG000|STARTED|Overall Study||46
2870355|NCT00191984|3573933|FG000|COMPLETED|Overall Study||7
2870356|NCT00191984|3573933|FG000|NOT COMPLETED|Overall Study||39
2870357|NCT00192023|3573939|FG000|STARTED|Period III - Double-Blind||107
2870358|NCT00192023|3573940|FG001|STARTED|Period III - Double-Blind||32
2870359|NCT00192023|3573939|FG000|COMPLETED|Period III - Double-Blind|6 patients who completed the protocol did not enter optional open-label period.|100
2870360|NCT00192023|3573940|FG001|COMPLETED|Period III - Double-Blind|2 patients who completed the protocol did not enter the optional open-label period.|32
2870361|NCT00192023|3573939|FG000|NOT COMPLETED|Period III - Double-Blind||7
2870362|NCT00192023|3573940|FG001|NOT COMPLETED|Period III - Double-Blind||0
2870363|NCT00192023|3573939|FG000|STARTED|Period IV - Optional Open-Label||124
2870364|NCT00192023|3573940|FG001|STARTED|Period IV - Optional Open-Label|Placebo patients received atomoxetine during the optional open-label period.|0
2870365|NCT00192023|3573939|FG000|COMPLETED|Period IV - Optional Open-Label||49
2870366|NCT00192023|3573940|FG001|COMPLETED|Period IV - Optional Open-Label||0
3169521|NCT01925781|3897064|FG000|STARTED|Overall Study||5
3169522|NCT01925781|3897065|FG001|STARTED|Overall Study||5
3169523|NCT01925781|3897064|FG000|COMPLETED|Overall Study||3
3169524|NCT01925781|3897065|FG001|COMPLETED|Overall Study||1
3313602|NCT03076359|4046911|FG001|NOT COMPLETED|Overall Study||0
3313603|NCT03076515|4046921|FG000|STARTED|Overall Study||58
2870367|NCT00192023|3573939|FG000|NOT COMPLETED|Period IV - Optional Open-Label||75
2870368|NCT00192023|3573940|FG001|NOT COMPLETED|Period IV - Optional Open-Label||0
2870369|NCT00192036|3573946|FG000|STARTED|Overall Study||49
2870370|NCT00192036|3573946|FG000|COMPLETED|Overall Study||28
2870371|NCT00192036|3573946|FG000|NOT COMPLETED|Overall Study||21
2870372|NCT00192075|3573952|FG000|STARTED|Overall Study||42
3313604|NCT03076515|4046922|FG001|STARTED|Overall Study||62
3313605|NCT03076515|4046921|FG000|COMPLETED|Overall Study||33
3313606|NCT03076515|4046922|FG001|COMPLETED|Overall Study||33
3313607|NCT03076515|4046921|FG000|NOT COMPLETED|Overall Study||25
3313608|NCT03076515|4046922|FG001|NOT COMPLETED|Overall Study||29
3313609|NCT03076970|4046928|FG000|STARTED|Period 1||7
3313610|NCT03076970|4046929|FG001|STARTED|Period 1||7
3313611|NCT03076970|4046930|FG002|STARTED|Period 1||7
3313612|NCT03076970|4046931|FG003|STARTED|Period 1||7
3313613|NCT03076970|4046932|FG004|STARTED|Period 1||7
3313614|NCT03076970|4046933|FG005|STARTED|Period 1||7
3313615|NCT03076970|4046928|FG000|Received at Least 1 Dose of Study Drug|Period 1||7
3313616|NCT03076970|4046929|FG001|Received at Least 1 Dose of Study Drug|Period 1||7
2870373|NCT00192075|3573953|FG001|STARTED|Overall Study||42
2870374|NCT00192075|3573952|FG000|COMPLETED|Overall Study||3
2870375|NCT00192075|3573953|FG001|COMPLETED|Overall Study||23
2870376|NCT00192075|3573952|FG000|NOT COMPLETED|Overall Study||39
2870377|NCT00192075|3573953|FG001|NOT COMPLETED|Overall Study||19
2870378|NCT00192114|3573964|FG000|STARTED|Overall Study||28
2870379|NCT00192114|3573964|FG000|Received at Least 1 Dose of Study Drug|Overall Study||28
2870380|NCT00192114|3573964|FG000|COMPLETED|Overall Study||4
2870381|NCT00192114|3573964|FG000|NOT COMPLETED|Overall Study||24
2870382|NCT00192296|3573972|FG000|STARTED|Overall Study||6
2870383|NCT00192296|3573973|FG001|STARTED|Overall Study||6
2870384|NCT00192296|3573974|FG002|STARTED|Overall Study||6
2870385|NCT00192296|3573975|FG003|STARTED|Overall Study||6
2870386|NCT00192296|3573972|FG000|COMPLETED|Overall Study||6
2870387|NCT00192296|3573973|FG001|COMPLETED|Overall Study||5
2870388|NCT00192296|3573974|FG002|COMPLETED|Overall Study||6
3313617|NCT03076970|4046930|FG002|Received at Least 1 Dose of Study Drug|Period 1||7
2870389|NCT00192296|3573975|FG003|COMPLETED|Overall Study||6
2870390|NCT00192296|3573972|FG000|NOT COMPLETED|Overall Study||0
2870391|NCT00192296|3573973|FG001|NOT COMPLETED|Overall Study||1
2870392|NCT00192296|3573974|FG002|NOT COMPLETED|Overall Study||0
2870393|NCT00192296|3573975|FG003|NOT COMPLETED|Overall Study||0
2870394|NCT00192504|3573989|FG000|STARTED|Overall Study||5
2870395|NCT00192504|3573990|FG001|STARTED|Overall Study||5
2870396|NCT00192504|3573991|FG002|STARTED|Overall Study|Baseline demographics are not available on one patient who did not receive study drug.|6
2870397|NCT00192504|3573992|FG003|STARTED|Overall Study||15
2870398|NCT00192504|3573989|FG000|COMPLETED|Overall Study||4
2870399|NCT00192504|3573990|FG001|COMPLETED|Overall Study||5
2870400|NCT00192504|3573991|FG002|COMPLETED|Overall Study||5
2870401|NCT00192504|3573992|FG003|COMPLETED|Overall Study||15
2870402|NCT00192504|3573989|FG000|NOT COMPLETED|Overall Study||1
2870403|NCT00192504|3573990|FG001|NOT COMPLETED|Overall Study||0
2870404|NCT00192504|3573991|FG002|NOT COMPLETED|Overall Study||1
2870405|NCT00192504|3573992|FG003|NOT COMPLETED|Overall Study||0
2870406|NCT00192647|3574004|FG000|STARTED|Overall Study||448
2870407|NCT00192647|3574005|FG001|STARTED|Overall Study||448
2870408|NCT00192647|3574004|FG000|Treated|Overall Study||433
2870409|NCT00192647|3574005|FG001|Treated|Overall Study||438
2870410|NCT00192647|3574004|FG000|COMPLETED|Overall Study||320
2870411|NCT00192647|3574005|FG001|COMPLETED|Overall Study||302
2870412|NCT00192647|3574004|FG000|NOT COMPLETED|Overall Study||128
2870413|NCT00192647|3574005|FG001|NOT COMPLETED|Overall Study||146
2870414|NCT00193037|3574013|FG000|STARTED|Randomized Treatment||50
2870415|NCT00193037|3574014|FG001|STARTED|Randomized Treatment||52
2870416|NCT00193037|3574013|FG000|COMPLETED|Randomized Treatment||32
2870417|NCT00193037|3574014|FG001|COMPLETED|Randomized Treatment||24
2870418|NCT00193037|3574013|FG000|NOT COMPLETED|Randomized Treatment||18
2870419|NCT00193037|3574014|FG001|NOT COMPLETED|Randomized Treatment||28
2870420|NCT00193037|3574013|FG000|STARTED|Crossover Treatment||32
2870421|NCT00193037|3574014|FG001|STARTED|Crossover Treatment||24
2870422|NCT00193037|3574013|FG000|COMPLETED|Crossover Treatment||32
2870423|NCT00193037|3574014|FG001|COMPLETED|Crossover Treatment||24
2870424|NCT00193037|3574013|FG000|NOT COMPLETED|Crossover Treatment||0
2870425|NCT00193037|3574014|FG001|NOT COMPLETED|Crossover Treatment||0
2870426|NCT00193050|3574020|FG000|STARTED|Neoadjuvant Treatment||110
2870427|NCT00193050|3574020|FG000|COMPLETED|Neoadjuvant Treatment||101
2870428|NCT00193050|3574020|FG000|NOT COMPLETED|Neoadjuvant Treatment||9
2870429|NCT00193050|3574020|FG000|STARTED|Surgery|2 patients had surgery after 2 cycles of neoadjuvant treatment|103
2870430|NCT00193050|3574020|FG000|COMPLETED|Surgery||103
2870431|NCT00193050|3574020|FG000|NOT COMPLETED|Surgery||0
2870432|NCT00193050|3574020|FG000|STARTED|Adjuvant|16 patients never initiated postoperative adjuvant therapy|87
2870433|NCT00193050|3574020|FG000|COMPLETED|Adjuvant||77
2870434|NCT00193050|3574020|FG000|NOT COMPLETED|Adjuvant||10
2870435|NCT00193063|3574025|FG000|STARTED|Overall Study||41
2870436|NCT00193063|3574025|FG000|COMPLETED|Overall Study||37
2870437|NCT00193063|3574025|FG000|NOT COMPLETED|Overall Study||4
2870438|NCT00193128|3574031|FG000|STARTED|Overall Study||10
2870439|NCT00193128|3574032|FG001|STARTED|Overall Study||49
2870440|NCT00193128|3574031|FG000|COMPLETED|Overall Study||10
2870441|NCT00193128|3574032|FG001|COMPLETED|Overall Study||39
2870442|NCT00193128|3574031|FG000|NOT COMPLETED|Overall Study||0
2870443|NCT00193128|3574032|FG001|NOT COMPLETED|Overall Study||10
2870444|NCT00193180|3574040|FG000|STARTED|Overall Study||37
2870445|NCT00193180|3574040|FG000|COMPLETED|Overall Study||27
2870446|NCT00193180|3574040|FG000|NOT COMPLETED|Overall Study||10
2870447|NCT00193206|3574045|FG000|STARTED|Preoperative Therapy||123
2870448|NCT00193206|3574045|FG000|COMPLETED|Preoperative Therapy||116
2870449|NCT00193206|3574045|FG000|NOT COMPLETED|Preoperative Therapy||7
2870450|NCT00193206|3574045|FG000|STARTED|Surgery||116
2870451|NCT00193206|3574045|FG000|COMPLETED|Surgery||116
2870452|NCT00193206|3574045|FG000|NOT COMPLETED|Surgery||0
2870453|NCT00193206|3574045|FG000|STARTED|Postoperative Therapy||116
2870454|NCT00193206|3574045|FG000|COMPLETED|Postoperative Therapy||102
2870455|NCT00193206|3574045|FG000|NOT COMPLETED|Postoperative Therapy||14
2870456|NCT00193258|3574049|FG000|STARTED|Overall Study||94
2870457|NCT00193258|3574049|FG000|COMPLETED|Overall Study||94
2870458|NCT00193258|3574049|FG000|NOT COMPLETED|Overall Study||0
2870459|NCT00193375|3574053|FG000|STARTED|Overall Study||60
2870460|NCT00193375|3574053|FG000|COMPLETED|Overall Study||41
2870461|NCT00193375|3574053|FG000|NOT COMPLETED|Overall Study||19
2870462|NCT00193414|3574057|FG000|STARTED|Overall Study||72
2870463|NCT00193414|3574057|FG000|COMPLETED|Overall Study||14
2870464|NCT00193414|3574057|FG000|NOT COMPLETED|Overall Study||58
2870465|NCT00193427|3574061|FG000|STARTED|Overall Study||75
2870466|NCT00193427|3574061|FG000|COMPLETED|Overall Study||26
2870467|NCT00193427|3574061|FG000|NOT COMPLETED|Overall Study||49
2870468|NCT00193453|3574066|FG000|STARTED|Overall Study||69
2870469|NCT00193453|3574066|FG000|COMPLETED|Overall Study||21
2870470|NCT00193453|3574066|FG000|NOT COMPLETED|Overall Study||48
2870471|NCT00193479|3574070|FG000|STARTED|Induction Chemotherapy||51
2870472|NCT00193479|3574070|FG000|COMPLETED|Induction Chemotherapy||48
2870473|NCT00193479|3574070|FG000|NOT COMPLETED|Induction Chemotherapy||3
2870474|NCT00193479|3574070|FG000|STARTED|Maintenance Rituximab||44
2870475|NCT00193479|3574070|FG000|COMPLETED|Maintenance Rituximab||44
2870476|NCT00193479|3574070|FG000|NOT COMPLETED|Maintenance Rituximab||0
2870477|NCT00193492|3574076|FG000|STARTED|Overall Study||31
2870478|NCT00193492|3574077|FG001|STARTED|Overall Study||29
2870479|NCT00193492|3574076|FG000|COMPLETED|Overall Study||14
2870480|NCT00193492|3574077|FG001|COMPLETED|Overall Study||14
2870481|NCT00193492|3574076|FG000|NOT COMPLETED|Overall Study||17
2870482|NCT00193492|3574077|FG001|NOT COMPLETED|Overall Study||15
2870483|NCT00193596|3574085|FG000|STARTED|Overall Study||93
2870484|NCT00193596|3574086|FG001|STARTED|Overall Study||105
2870485|NCT00193596|3574085|FG000|COMPLETED|Overall Study||37
2870486|NCT00193596|3574086|FG001|COMPLETED|Overall Study||39
2870487|NCT00193596|3574085|FG000|NOT COMPLETED|Overall Study||56
2870488|NCT00193596|3574086|FG001|NOT COMPLETED|Overall Study||66
2870489|NCT00193609|3574092|FG000|STARTED|Overall Study||48
2870490|NCT00193609|3574092|FG000|COMPLETED|Overall Study||44
2870491|NCT00193609|3574092|FG000|NOT COMPLETED|Overall Study||4
2870492|NCT00194012|3574098|FG000|STARTED|Randomized Phase||31
2870493|NCT00194012|3574099|FG001|STARTED|Randomized Phase||31
2870494|NCT00194012|3574098|FG000|Received More Than One Dose|Randomized Phase||30
2870495|NCT00194012|3574099|FG001|Received More Than One Dose|Randomized Phase||29
2870496|NCT00194012|3574098|FG000|COMPLETED|Randomized Phase||15
2870497|NCT00194012|3574099|FG001|COMPLETED|Randomized Phase||6
2870498|NCT00194012|3574098|FG000|NOT COMPLETED|Randomized Phase||16
2870499|NCT00194012|3574099|FG001|NOT COMPLETED|Randomized Phase||25
2870500|NCT00194012|3574098|FG000|STARTED|Open Label Extension (OLE)|Participants from aripiprazole group started OLE (eligible even if randomized period not completed).|22
2870501|NCT00194012|3574099|FG001|STARTED|Open Label Extension (OLE)|Participants from placebo group started OLE (eligible even if randomized period not completed).|21
2870502|NCT00194012|3574098|FG000|COMPLETED|Open Label Extension (OLE)||17
2870503|NCT00194012|3574099|FG001|COMPLETED|Open Label Extension (OLE)||15
2870504|NCT00194012|3574098|FG000|NOT COMPLETED|Open Label Extension (OLE)||5
2870505|NCT00194012|3574099|FG001|NOT COMPLETED|Open Label Extension (OLE)||6
2870506|NCT00194025|3574111|FG000|STARTED|Overall Study|The intent-to-treat population received at least one dose of valproate semisodium.|20
2870507|NCT00194025|3574111|FG000|COMPLETED|Overall Study|5 participants withdrew prematurely|15
2870508|NCT00194025|3574111|FG000|NOT COMPLETED|Overall Study||5
2870509|NCT00194077|3574117|FG000|STARTED|Overall Study||30
2870510|NCT00194077|3574118|FG001|STARTED|Overall Study||30
2870511|NCT00194077|3574117|FG000|COMPLETED|Overall Study|"Lack of efficacy:~Hypomania n=12 Cycling n=5 Mixed state=4 Mania n=1"|6
2870512|NCT00194077|3574118|FG001|COMPLETED|Overall Study|"Lack of efficacy:~hypomania n=17 Cycling n=6 Mania n=5 Mixed state n=1 Concern regarding tx n=1"|0
2870513|NCT00194077|3574117|FG000|NOT COMPLETED|Overall Study||24
2870514|NCT00194077|3574118|FG001|NOT COMPLETED|Overall Study||30
2870515|NCT00194116|3574126|FG000|STARTED|Overall Study||26
2870516|NCT00194116|3574127|FG001|STARTED|Overall Study||28
2870517|NCT00194116|3574126|FG000|COMPLETED|Overall Study||13
2870518|NCT00194116|3574127|FG001|COMPLETED|Overall Study||13
2870519|NCT00194116|3574126|FG000|NOT COMPLETED|Overall Study||13
2870520|NCT00194116|3574127|FG001|NOT COMPLETED|Overall Study||15
2870521|NCT00194129|3574135|FG000|STARTED|Overall Study||15
2870522|NCT00194129|3574136|FG001|STARTED|Overall Study||16
2870523|NCT00194129|3574135|FG000|COMPLETED|Overall Study||5
2870524|NCT00194129|3574136|FG001|COMPLETED|Overall Study||3
2870525|NCT00194129|3574135|FG000|NOT COMPLETED|Overall Study||10
2870526|NCT00194129|3574136|FG001|NOT COMPLETED|Overall Study||13
2870527|NCT00194532|3574151|FG000|STARTED|Overall Study||150
2870528|NCT00194532|3574152|FG001|STARTED|Overall Study||150
2870529|NCT00194532|3574151|FG000|COMPLETED|Overall Study||150
2870530|NCT00194532|3574152|FG001|COMPLETED|Overall Study||150
2870531|NCT00194532|3574151|FG000|NOT COMPLETED|Overall Study||0
2870532|NCT00194532|3574152|FG001|NOT COMPLETED|Overall Study||0
2870533|NCT00194610|3574160|FG000|STARTED|Overall Study||11
2870534|NCT00194610|3574161|FG001|STARTED|Overall Study||9
2870535|NCT00194610|3574160|FG000|COMPLETED|Overall Study||11
2870536|NCT00194610|3574161|FG001|COMPLETED|Overall Study||9
2870537|NCT00194610|3574160|FG000|NOT COMPLETED|Overall Study||0
2870538|NCT00194610|3574161|FG001|NOT COMPLETED|Overall Study||0
2870539|NCT00194675|3574169|FG000|STARTED|Overall Study||27
2870540|NCT00194675|3574170|FG001|STARTED|Overall Study||26
2870541|NCT00194675|3574169|FG000|COMPLETED|Overall Study||22
2870542|NCT00194675|3574170|FG001|COMPLETED|Overall Study||24
2870543|NCT00194675|3574169|FG000|NOT COMPLETED|Overall Study||5
2870544|NCT00194675|3574170|FG001|NOT COMPLETED|Overall Study||2
2870545|NCT00194779|3574178|FG000|STARTED|Overall Study||50
2870546|NCT00194779|3574178|FG000|COMPLETED|Overall Study||50
2870547|NCT00194779|3574178|FG000|NOT COMPLETED|Overall Study||0
2870548|NCT00194792|3574182|FG000|STARTED|Overall Study||28
2870549|NCT00194792|3574182|FG000|COMPLETED|Overall Study||27
2870550|NCT00194792|3574182|FG000|NOT COMPLETED|Overall Study||1
2870551|NCT00194896|3574190|FG000|STARTED|Overall Study||15
2870552|NCT00194896|3574191|FG001|STARTED|Overall Study||15
2870553|NCT00194896|3574192|FG002|STARTED|Overall Study||13
2870554|NCT00194896|3574193|FG003|STARTED|Overall Study||21
2870555|NCT00194896|3574190|FG000|COMPLETED|Overall Study||4
2870556|NCT00194896|3574191|FG001|COMPLETED|Overall Study||10
2870557|NCT00194896|3574192|FG002|COMPLETED|Overall Study||7
2870558|NCT00194896|3574193|FG003|COMPLETED|Overall Study||9
2870559|NCT00194896|3574190|FG000|NOT COMPLETED|Overall Study||11
2870560|NCT00194896|3574191|FG001|NOT COMPLETED|Overall Study||5
2870561|NCT00194896|3574192|FG002|NOT COMPLETED|Overall Study||6
3313618|NCT03076970|4046931|FG003|Received at Least 1 Dose of Study Drug|Period 1||7
3317212|NCT03124537|4050741|FG001|STARTED|Overall Study||45
2870562|NCT00194896|3574193|FG003|NOT COMPLETED|Overall Study||12
2870563|NCT00194987|3574205|FG000|STARTED|Overall Study||51
2870564|NCT00194987|3574206|FG001|STARTED|Overall Study||51
2870565|NCT00194987|3574205|FG000|COMPLETED|Overall Study||51
2870566|NCT00194987|3574206|FG001|COMPLETED|Overall Study|"3 women chose to withdraw because they felt the study was too inconvenient."|48
2870567|NCT00194987|3574205|FG000|NOT COMPLETED|Overall Study||0
2870568|NCT00194987|3574206|FG001|NOT COMPLETED|Overall Study||3
2870569|NCT00195013|3574216|FG000|STARTED|Overall Study||14
2870570|NCT00195013|3574217|FG001|STARTED|Overall Study||16
2870571|NCT00195013|3574216|FG000|COMPLETED|Overall Study||12
2870572|NCT00195013|3574217|FG001|COMPLETED|Overall Study||15
2870573|NCT00195013|3574216|FG000|NOT COMPLETED|Overall Study||2
2870574|NCT00195013|3574217|FG001|NOT COMPLETED|Overall Study||1
2870575|NCT00195039|3574223|FG000|STARTED|Overall Study||47
3169525|NCT01925781|3897064|FG000|NOT COMPLETED|Overall Study||2
3169526|NCT01925781|3897065|FG001|NOT COMPLETED|Overall Study||4
3169527|NCT01925950|3897073|FG000|STARTED|Part 1||1
3169528|NCT01925950|3897074|FG001|STARTED|Part 1||1
3169529|NCT01925950|3897073|FG000|COMPLETED|Part 1||1
3169530|NCT01925950|3897074|FG001|COMPLETED|Part 1||1
3169531|NCT01925950|3897073|FG000|NOT COMPLETED|Part 1||0
2870576|NCT00195039|3574223|FG000|COMPLETED|Overall Study||47
2870577|NCT00195039|3574223|FG000|NOT COMPLETED|Overall Study||0
2870578|NCT00195260|3574229|FG000|STARTED|Part 1: Dose Escalation||4
2870579|NCT00195260|3574230|FG001|STARTED|Part 1: Dose Escalation||4
2870580|NCT00195260|3574231|FG002|STARTED|Part 1: Dose Escalation||6
2870581|NCT00195260|3574232|FG003|STARTED|Part 1: Dose Escalation||7
2870582|NCT00195260|3574233|FG004|STARTED|Part 1: Dose Escalation||7
2870583|NCT00195260|3574234|FG005|STARTED|Part 1: Dose Escalation||7
2870584|NCT00195260|3574235|FG006|STARTED|Part 1: Dose Escalation||10
2870585|NCT00195260|3574236|FG007|STARTED|Part 1: Dose Escalation||6
2870586|NCT00195260|3574237|FG008|STARTED|Part 1: Dose Escalation||0
2870587|NCT00195260|3574238|FG009|STARTED|Part 1: Dose Escalation||0
2870588|NCT00195260|3574239|FG010|STARTED|Part 1: Dose Escalation||0
2870589|NCT00195260|3574229|FG000|COMPLETED|Part 1: Dose Escalation||0
2870590|NCT00195260|3574230|FG001|COMPLETED|Part 1: Dose Escalation||0
2870591|NCT00195260|3574231|FG002|COMPLETED|Part 1: Dose Escalation||0
2870592|NCT00195260|3574232|FG003|COMPLETED|Part 1: Dose Escalation||0
2870593|NCT00195260|3574233|FG004|COMPLETED|Part 1: Dose Escalation||0
2870594|NCT00195260|3574234|FG005|COMPLETED|Part 1: Dose Escalation||0
2870595|NCT00195260|3574235|FG006|COMPLETED|Part 1: Dose Escalation||0
2870596|NCT00195260|3574236|FG007|COMPLETED|Part 1: Dose Escalation||0
2870597|NCT00195260|3574237|FG008|COMPLETED|Part 1: Dose Escalation||0
2870598|NCT00195260|3574238|FG009|COMPLETED|Part 1: Dose Escalation||0
2870599|NCT00195260|3574239|FG010|COMPLETED|Part 1: Dose Escalation||0
2870600|NCT00195260|3574229|FG000|NOT COMPLETED|Part 1: Dose Escalation||4
2870601|NCT00195260|3574230|FG001|NOT COMPLETED|Part 1: Dose Escalation||4
2870602|NCT00195260|3574231|FG002|NOT COMPLETED|Part 1: Dose Escalation||6
2870603|NCT00195260|3574232|FG003|NOT COMPLETED|Part 1: Dose Escalation||7
2870604|NCT00195260|3574233|FG004|NOT COMPLETED|Part 1: Dose Escalation||7
2870605|NCT00195260|3574234|FG005|NOT COMPLETED|Part 1: Dose Escalation||7
2870606|NCT00195260|3574235|FG006|NOT COMPLETED|Part 1: Dose Escalation||10
2870607|NCT00195260|3574236|FG007|NOT COMPLETED|Part 1: Dose Escalation||6
2870608|NCT00195260|3574237|FG008|NOT COMPLETED|Part 1: Dose Escalation||0
2870609|NCT00195260|3574238|FG009|NOT COMPLETED|Part 1: Dose Escalation||0
2870610|NCT00195260|3574239|FG010|NOT COMPLETED|Part 1: Dose Escalation||0
2870611|NCT00195260|3574229|FG000|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
2870612|NCT00195260|3574230|FG001|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
2870613|NCT00195260|3574231|FG002|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
2870614|NCT00195260|3574232|FG003|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
2870615|NCT00195260|3574233|FG004|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
2870616|NCT00195260|3574234|FG005|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
2870617|NCT00195260|3574235|FG006|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
2870618|NCT00195260|3574236|FG007|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
2870619|NCT00195260|3574237|FG008|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||37
2870620|NCT00195260|3574238|FG009|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||38
2870621|NCT00195260|3574239|FG010|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||25
2870622|NCT00195260|3574229|FG000|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
2870623|NCT00195260|3574230|FG001|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
2870624|NCT00195260|3574231|FG002|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
2870625|NCT00195260|3574232|FG003|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
2870626|NCT00195260|3574233|FG004|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
2870627|NCT00195260|3574234|FG005|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
2870628|NCT00195260|3574235|FG006|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
2870629|NCT00195260|3574236|FG007|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
2870630|NCT00195260|3574237|FG008|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||4
2870631|NCT00195260|3574238|FG009|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
2870632|NCT00195260|3574239|FG010|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||2
2870633|NCT00195260|3574229|FG000|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
2870634|NCT00195260|3574230|FG001|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
2870635|NCT00195260|3574231|FG002|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
3169532|NCT01925950|3897074|FG001|NOT COMPLETED|Part 1||0
3169533|NCT01925950|3897073|FG000|STARTED|Part 2||1
2870636|NCT00195260|3574232|FG003|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
2870637|NCT00195260|3574233|FG004|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
2870638|NCT00195260|3574234|FG005|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
2870639|NCT00195260|3574235|FG006|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
2870640|NCT00195260|3574236|FG007|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
2870641|NCT00195260|3574237|FG008|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||33
2870642|NCT00195260|3574238|FG009|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||38
2870643|NCT00195260|3574239|FG010|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||23
2870644|NCT00195273|3574269|FG000|STARTED|Overall Study||31
2870645|NCT00195273|3574270|FG001|STARTED|Overall Study||30
2870646|NCT00195273|3574269|FG000|COMPLETED|Overall Study||10
2870647|NCT00195273|3574270|FG001|COMPLETED|Overall Study||16
2870648|NCT00195273|3574269|FG000|NOT COMPLETED|Overall Study||21
2870649|NCT00195273|3574270|FG001|NOT COMPLETED|Overall Study||14
2870650|NCT00195338|3574276|FG000|STARTED|Overall Study||25
2870651|NCT00195338|3574276|FG000|COMPLETED|Overall Study||13
2870652|NCT00195338|3574276|FG000|NOT COMPLETED|Overall Study||12
2870653|NCT00195351|3574282|FG000|STARTED|Overall Study||236
2870654|NCT00195351|3574283|FG001|STARTED|Overall Study||231
2870655|NCT00195351|3574282|FG000|COMPLETED|Overall Study||215
2870656|NCT00195351|3574283|FG001|COMPLETED|Overall Study||215
2870657|NCT00195351|3574282|FG000|NOT COMPLETED|Overall Study||21
2870658|NCT00195351|3574283|FG001|NOT COMPLETED|Overall Study||16
2870659|NCT00195403|3574289|FG000|STARTED|Overall Study||1014
2870660|NCT00195403|3574289|FG000|COMPLETED|Overall Study||1014
2870661|NCT00195403|3574289|FG000|NOT COMPLETED|Overall Study||0
2870662|NCT00195429|3574295|FG000|STARTED|Overall Study||24
2870663|NCT00195429|3574296|FG001|STARTED|Overall Study||23
2870664|NCT00195429|3574295|FG000|COMPLETED|Overall Study||19
2870665|NCT00195429|3574296|FG001|COMPLETED|Overall Study||18
2870666|NCT00195429|3574295|FG000|NOT COMPLETED|Overall Study||5
2870667|NCT00195429|3574296|FG001|NOT COMPLETED|Overall Study||5
2870668|NCT00195442|3574302|FG000|STARTED|Overall Study||288
2870669|NCT00195442|3574302|FG000|COMPLETED|Overall Study||152
2870670|NCT00195442|3574302|FG000|NOT COMPLETED|Overall Study||136
2870671|NCT00195494|3574308|FG000|STARTED|Year 1||0
2870672|NCT00195494|3574309|FG001|STARTED|Year 1||0
2870673|NCT00195494|3574310|FG002|STARTED|Year 1||0
2870674|NCT00195494|3574311|FG003|STARTED|Year 1||0
2870675|NCT00195494|3574312|FG004|STARTED|Year 1||268
2870676|NCT00195494|3574313|FG005|STARTED|Year 1||274
2870677|NCT00195494|3574308|FG000|COMPLETED|Year 1||0
2870678|NCT00195494|3574309|FG001|COMPLETED|Year 1||0
2870679|NCT00195494|3574310|FG002|COMPLETED|Year 1||0
2870680|NCT00195494|3574311|FG003|COMPLETED|Year 1||0
2870681|NCT00195494|3574312|FG004|COMPLETED|Year 1||189
2870682|NCT00195494|3574313|FG005|COMPLETED|Year 1||221
2870683|NCT00195494|3574308|FG000|NOT COMPLETED|Year 1||0
2870684|NCT00195494|3574309|FG001|NOT COMPLETED|Year 1||0
2870685|NCT00195494|3574310|FG002|NOT COMPLETED|Year 1||0
2870686|NCT00195494|3574311|FG003|NOT COMPLETED|Year 1||0
2870687|NCT00195494|3574312|FG004|NOT COMPLETED|Year 1||79
2870688|NCT00195494|3574313|FG005|NOT COMPLETED|Year 1||53
2870689|NCT00195494|3574308|FG000|STARTED|Year 2|A patient with Year 1 termination had taken drug briefly during Year 2 and thus counted in the data.|111
2870690|NCT00195494|3574309|FG001|STARTED|Year 2||90
2870691|NCT00195494|3574310|FG002|STARTED|Year 2|A patient with Year 1 termination had taken drug briefly during Year 2 and thus counted in the data.|111
2870692|NCT00195494|3574311|FG003|STARTED|Year 2||99
2870693|NCT00195494|3574312|FG004|STARTED|Year 2||0
2870694|NCT00195494|3574313|FG005|STARTED|Year 2||0
2870695|NCT00195494|3574308|FG000|COMPLETED|Year 2||104
2870696|NCT00195494|3574309|FG001|COMPLETED|Year 2||74
2870697|NCT00195494|3574310|FG002|COMPLETED|Year 2||93
2870698|NCT00195494|3574311|FG003|COMPLETED|Year 2||76
2870699|NCT00195494|3574312|FG004|COMPLETED|Year 2||0
2870700|NCT00195494|3574313|FG005|COMPLETED|Year 2||0
2870701|NCT00195494|3574308|FG000|NOT COMPLETED|Year 2||7
2870702|NCT00195494|3574309|FG001|NOT COMPLETED|Year 2||16
2870703|NCT00195494|3574310|FG002|NOT COMPLETED|Year 2||18
2870704|NCT00195494|3574311|FG003|NOT COMPLETED|Year 2||23
2870705|NCT00195494|3574312|FG004|NOT COMPLETED|Year 2||0
2870706|NCT00195494|3574313|FG005|NOT COMPLETED|Year 2||0
2870707|NCT00195507|3574331|FG000|STARTED|Overall Study||357
2870708|NCT00195507|3574332|FG001|STARTED|Overall Study||363
2870709|NCT00195507|3574331|FG000|COMPLETED|Overall Study||258
2870710|NCT00195507|3574332|FG001|COMPLETED|Overall Study||245
2870711|NCT00195507|3574331|FG000|NOT COMPLETED|Overall Study||99
2870712|NCT00195507|3574332|FG001|NOT COMPLETED|Overall Study||118
2870713|NCT00195624|3574340|FG000|STARTED|Overall Study||5
2870714|NCT00195624|3574341|FG001|STARTED|Overall Study||42
2870715|NCT00195624|3574340|FG000|COMPLETED|Overall Study||5
2870716|NCT00195624|3574341|FG001|COMPLETED|Overall Study||42
2870717|NCT00195624|3574340|FG000|NOT COMPLETED|Overall Study||0
2870718|NCT00195624|3574341|FG001|NOT COMPLETED|Overall Study||0
2870719|NCT00195650|3574347|FG000|STARTED|Overall Study|Participants who received at least 1 adalimumab dose in study;3 enrolled did not receive adalimumab.|846
2870720|NCT00195650|3574347|FG000|COMPLETED|Overall Study||321
2870721|NCT00195650|3574347|FG000|NOT COMPLETED|Overall Study||525
2870722|NCT00195663|3574354|FG000|STARTED|2-year Double-blind Treatment Period||257
2870723|NCT00195663|3574355|FG001|STARTED|2-year Double-blind Treatment Period||274
2870724|NCT00195663|3574356|FG002|STARTED|2-year Double-blind Treatment Period||268
2870725|NCT00195663|3574354|FG000|COMPLETED|2-year Double-blind Treatment Period||164
2870726|NCT00195663|3574355|FG001|COMPLETED|2-year Double-blind Treatment Period||166
2870727|NCT00195663|3574356|FG002|COMPLETED|2-year Double-blind Treatment Period||196
2870728|NCT00195663|3574354|FG000|NOT COMPLETED|2-year Double-blind Treatment Period||93
2870729|NCT00195663|3574355|FG001|NOT COMPLETED|2-year Double-blind Treatment Period||108
2870730|NCT00195663|3574356|FG002|NOT COMPLETED|2-year Double-blind Treatment Period||72
2870731|NCT00195663|3574354|FG000|STARTED|Open-Label Extension Period||155
2870732|NCT00195663|3574355|FG001|STARTED|Open-Label Extension Period||159
2870733|NCT00195663|3574356|FG002|STARTED|Open-Label Extension Period||183
2870734|NCT00195663|3574354|FG000|COMPLETED|Open-Label Extension Period||79
2870735|NCT00195663|3574355|FG001|COMPLETED|Open-Label Extension Period||85
2870736|NCT00195663|3574356|FG002|COMPLETED|Open-Label Extension Period||86
2870737|NCT00195663|3574354|FG000|NOT COMPLETED|Open-Label Extension Period||76
2870738|NCT00195663|3574355|FG001|NOT COMPLETED|Open-Label Extension Period||74
2870739|NCT00195663|3574356|FG002|NOT COMPLETED|Open-Label Extension Period||97
2870740|NCT00195676|3574374|FG000|STARTED|Period O - Open-label Treatment|Number receiving adalimumab in Period O (1 additional participant enrolled but did not receive drug)|1468
2870741|NCT00195676|3574374|FG000|COMPLETED|Period O - Open-label Treatment|254 Period O completers did not consent or were not eligible to continue into Period W and Period R.|862
2870742|NCT00195676|3574374|FG000|NOT COMPLETED|Period O - Open-label Treatment||606
2870743|NCT00195676|3574374|FG000|STARTED|Period W (Withdrawal) - No Treatment|Period O completers with a Physician's Global Assessment =<2 who continued into Periods W and R.|608
2870744|NCT00195676|3574374|FG000|COMPLETED|Period W (Withdrawal) - No Treatment|Non-completers may have entered Period R, whether or not they relapsed (PGA >= 3).|0
2870745|NCT00195676|3574374|FG000|NOT COMPLETED|Period W (Withdrawal) - No Treatment||608
2870746|NCT00195676|3574374|FG000|STARTED|Period R - Retreatment 16 Weeks|Number who entered from Period W, including those who did and did not relapse in that period.|525
2870747|NCT00195676|3574374|FG000|COMPLETED|Period R - Retreatment 16 Weeks||490
2870748|NCT00195676|3574374|FG000|NOT COMPLETED|Period R - Retreatment 16 Weeks||35
2918802|NCT00528957|3629084|FG001|STARTED|Long-Term Extension (Week 336 and On)|Two participants completed the third extension and did not enroll in the long-term extension.|25
2918803|NCT00528957|3629083|FG000|COMPLETED|Long-Term Extension (Week 336 and On)||9
2918804|NCT00528957|3629084|FG001|COMPLETED|Long-Term Extension (Week 336 and On)||8
2918805|NCT00528957|3629083|FG000|NOT COMPLETED|Long-Term Extension (Week 336 and On)||10
2918806|NCT00528957|3629084|FG001|NOT COMPLETED|Long-Term Extension (Week 336 and On)||17
2918807|NCT00528970|3629103|FG000|STARTED|Overall Study||124
2918808|NCT00528970|3629104|FG001|STARTED|Overall Study||125
2918809|NCT00528970|3629105|FG002|STARTED|Overall Study||125
2918810|NCT00528970|3629103|FG000|Received at Least 1 Dose of Study Drug|Overall Study||124
2918811|NCT00528970|3629104|FG001|Received at Least 1 Dose of Study Drug|Overall Study||125
2918812|NCT00528970|3629105|FG002|Received at Least 1 Dose of Study Drug|Overall Study||124
2918813|NCT00528970|3629103|FG000|COMPLETED|Overall Study||110
2918814|NCT00528970|3629104|FG001|COMPLETED|Overall Study||110
2918815|NCT00528970|3629105|FG002|COMPLETED|Overall Study||105
2918816|NCT00528970|3629103|FG000|NOT COMPLETED|Overall Study||14
2918817|NCT00528970|3629104|FG001|NOT COMPLETED|Overall Study||15
2918818|NCT00528970|3629105|FG002|NOT COMPLETED|Overall Study||20
2918819|NCT00528996|3629118|FG000|STARTED|Overall Study||429
2918820|NCT00528996|3629119|FG001|STARTED|Overall Study||419
2918821|NCT00528996|3629120|FG002|STARTED|Overall Study||415
2918822|NCT00528996|3629121|FG003|STARTED|Overall Study||390
2918823|NCT00528996|3629122|FG004|STARTED|Overall Study||427
2918824|NCT00528996|3629118|FG000|COMPLETED|Overall Study||365
2918825|NCT00528996|3629119|FG001|COMPLETED|Overall Study||395
2918826|NCT00528996|3629120|FG002|COMPLETED|Overall Study||372
2918827|NCT00528996|3629121|FG003|COMPLETED|Overall Study||340
2918828|NCT00528996|3629122|FG004|COMPLETED|Overall Study||390
2918829|NCT00528996|3629118|FG000|NOT COMPLETED|Overall Study||64
2918830|NCT00528996|3629119|FG001|NOT COMPLETED|Overall Study||24
2918831|NCT00528996|3629120|FG002|NOT COMPLETED|Overall Study||43
2918832|NCT00528996|3629121|FG003|NOT COMPLETED|Overall Study||50
2918833|NCT00528996|3629122|FG004|NOT COMPLETED|Overall Study||37
2918834|NCT00529035|3629137|FG000|STARTED|Overall Study|29 enrolled|29
2918835|NCT00529035|3629137|FG000|COMPLETED|Overall Study|28 evaluable, 1 patient withdrew participation and was not evaluable|28
3169534|NCT01925950|3897074|FG001|STARTED|Part 2|The 1 orBec subject completed Part 1 but did not meet the criteria of a CR to continue to Part 2|0
3169535|NCT01925950|3897073|FG000|COMPLETED|Part 2||0
3169536|NCT01925950|3897074|FG001|COMPLETED|Part 2||0
2918836|NCT00529035|3629137|FG000|NOT COMPLETED|Overall Study||1
2918837|NCT00529087|3629151|FG000|STARTED|Overall Study||150
2918838|NCT00529087|3629152|FG001|STARTED|Overall Study||148
3169537|NCT01925950|3897073|FG000|NOT COMPLETED|Part 2||1
3169538|NCT01925950|3897074|FG001|NOT COMPLETED|Part 2||0
3169539|NCT01925989|3897082|FG000|STARTED|Period 1||7
3169540|NCT01925989|3897083|FG001|STARTED|Period 1||8
3169541|NCT01925989|3897084|FG002|STARTED|Period 1||12
3169542|NCT01925989|3897082|FG000|Received at Least 1 Dose of Study Drug|Period 1||7
3169543|NCT01925989|3897083|FG001|Received at Least 1 Dose of Study Drug|Period 1||8
3169544|NCT01925989|3897084|FG002|Received at Least 1 Dose of Study Drug|Period 1||0
3169545|NCT01925989|3897082|FG000|COMPLETED|Period 1||6
3169546|NCT01925989|3897083|FG001|COMPLETED|Period 1||6
3169547|NCT01925989|3897084|FG002|COMPLETED|Period 1||12
2918839|NCT00529087|3629153|FG002|STARTED|Overall Study||162
2918840|NCT00529087|3629151|FG000|COMPLETED|Overall Study||122
2918841|NCT00529087|3629152|FG001|COMPLETED|Overall Study||120
3169548|NCT01925989|3897082|FG000|NOT COMPLETED|Period 1||1
3169549|NCT01925989|3897083|FG001|NOT COMPLETED|Period 1||2
3169550|NCT01925989|3897084|FG002|NOT COMPLETED|Period 1||0
3169551|NCT01925989|3897082|FG000|STARTED|Period 2||6
3169552|NCT01925989|3897083|FG001|STARTED|Period 2||6
3169553|NCT01925989|3897084|FG002|STARTED|Period 2||12
3169554|NCT01925989|3897082|FG000|COMPLETED|Period 2||6
3169555|NCT01925989|3897083|FG001|COMPLETED|Period 2||6
3169556|NCT01925989|3897084|FG002|COMPLETED|Period 2||12
3169557|NCT01925989|3897082|FG000|NOT COMPLETED|Period 2||0
2870749|NCT00195702|3574385|FG000|STARTED|Double-blind Phase|For all groups, started indicates when the subjects entered the 52-week double-blind phase.|212
2870750|NCT00195702|3574386|FG001|STARTED|Double-blind Phase||207
2870751|NCT00195702|3574387|FG002|STARTED|Double-blind Phase||200
2870752|NCT00195702|3574388|FG003|STARTED|Double-blind Phase||0
2870753|NCT00195702|3574389|FG004|STARTED|Double-blind Phase||0
2870754|NCT00195702|3574390|FG005|STARTED|Double-blind Phase||0
2870755|NCT00195702|3574385|FG000|COMPLETED|Double-blind Phase||168
2870756|NCT00195702|3574386|FG001|COMPLETED|Double-blind Phase||159
2870757|NCT00195702|3574387|FG002|COMPLETED|Double-blind Phase||140
2870758|NCT00195702|3574388|FG003|COMPLETED|Double-blind Phase||0
2870759|NCT00195702|3574389|FG004|COMPLETED|Double-blind Phase||0
2870760|NCT00195702|3574390|FG005|COMPLETED|Double-blind Phase||0
2870761|NCT00195702|3574385|FG000|NOT COMPLETED|Double-blind Phase||44
2870762|NCT00195702|3574386|FG001|NOT COMPLETED|Double-blind Phase||48
2870763|NCT00195702|3574387|FG002|NOT COMPLETED|Double-blind Phase||60
2870764|NCT00195702|3574388|FG003|NOT COMPLETED|Double-blind Phase||0
2870765|NCT00195702|3574389|FG004|NOT COMPLETED|Double-blind Phase||0
2870766|NCT00195702|3574390|FG005|NOT COMPLETED|Double-blind Phase||0
2870767|NCT00195702|3574385|FG000|STARTED|Open-label Extension Phase||0
2870768|NCT00195702|3574386|FG001|STARTED|Open-label Extension Phase||0
2870769|NCT00195702|3574387|FG002|STARTED|Open-label Extension Phase||0
2870770|NCT00195702|3574388|FG003|STARTED|Open-label Extension Phase|3 subjects completed the double-blind phase but did not enter the open-label extension phase.|165
2870771|NCT00195702|3574389|FG004|STARTED|Open-label Extension Phase|1 subject completed the double-blind phase but did not enter the open-label extension phase.|158
2870772|NCT00195702|3574390|FG005|STARTED|Open-label Extension Phase|6 subjects completed the double-blind phase but did not enter the open-label extension phase.|134
2870773|NCT00195702|3574385|FG000|COMPLETED|Open-label Extension Phase||0
2870774|NCT00195702|3574386|FG001|COMPLETED|Open-label Extension Phase||0
2870775|NCT00195702|3574387|FG002|COMPLETED|Open-label Extension Phase||0
2870776|NCT00195702|3574388|FG003|COMPLETED|Open-label Extension Phase||66
2870777|NCT00195702|3574389|FG004|COMPLETED|Open-label Extension Phase||80
2870778|NCT00195702|3574390|FG005|COMPLETED|Open-label Extension Phase||56
2870779|NCT00195702|3574385|FG000|NOT COMPLETED|Open-label Extension Phase||0
2870780|NCT00195702|3574386|FG001|NOT COMPLETED|Open-label Extension Phase||0
2870781|NCT00195702|3574387|FG002|NOT COMPLETED|Open-label Extension Phase||0
2870782|NCT00195702|3574388|FG003|NOT COMPLETED|Open-label Extension Phase||99
2870783|NCT00195702|3574389|FG004|NOT COMPLETED|Open-label Extension Phase||78
2870784|NCT00195702|3574390|FG005|NOT COMPLETED|Open-label Extension Phase||78
2870785|NCT00195715|3574403|FG000|STARTED|Overall Study||777
2870786|NCT00195715|3574403|FG000|COMPLETED|Overall Study||400
2870787|NCT00195715|3574403|FG000|NOT COMPLETED|Overall Study||377
2870788|NCT00195819|3574407|FG000|STARTED|Double-Blind||44
2870789|NCT00195819|3574408|FG001|STARTED|Double-Blind||38
2870790|NCT00195819|3574407|FG000|COMPLETED|Double-Blind||42
2870791|NCT00195819|3574408|FG001|COMPLETED|Double-Blind||38
2870792|NCT00195819|3574407|FG000|NOT COMPLETED|Double-Blind||2
2870793|NCT00195819|3574408|FG001|NOT COMPLETED|Double-Blind||0
2870794|NCT00195819|3574407|FG000|STARTED|Open-label||0
2870795|NCT00195819|3574408|FG001|STARTED|Open-label||82
2870796|NCT00195819|3574407|FG000|COMPLETED|Open-label||0
2870797|NCT00195819|3574408|FG001|COMPLETED|Open-label||62
2870798|NCT00195819|3574407|FG000|NOT COMPLETED|Open-label||0
2870799|NCT00195819|3574408|FG001|NOT COMPLETED|Open-label||20
2870800|NCT00196105|3574423|FG000|STARTED|Overall Study||64
2870801|NCT00196105|3574424|FG001|STARTED|Overall Study||88
2870802|NCT00196105|3574425|FG002|STARTED|Overall Study||89
2870803|NCT00196105|3574423|FG000|COMPLETED|Overall Study||60
2870804|NCT00196105|3574424|FG001|COMPLETED|Overall Study||83
2870805|NCT00196105|3574425|FG002|COMPLETED|Overall Study||82
2870806|NCT00196105|3574423|FG000|NOT COMPLETED|Overall Study||4
2870807|NCT00196105|3574424|FG001|NOT COMPLETED|Overall Study||5
2870808|NCT00196105|3574425|FG002|NOT COMPLETED|Overall Study||7
2870809|NCT00196196|3574433|FG000|STARTED|Overall Study||274
2870810|NCT00196196|3574433|FG000|COMPLETED|Overall Study||267
2870811|NCT00196196|3574433|FG000|NOT COMPLETED|Overall Study||7
2870812|NCT00196313|3574439|FG000|STARTED|Overall Study||47
2870813|NCT00196313|3574440|FG001|STARTED|Overall Study||48
2870814|NCT00196313|3574439|FG000|COMPLETED|Overall Study||36
2870815|NCT00196313|3574440|FG001|COMPLETED|Overall Study||40
2870816|NCT00196313|3574439|FG000|NOT COMPLETED|Overall Study||11
2870817|NCT00196313|3574440|FG001|NOT COMPLETED|Overall Study||8
2870818|NCT00196326|3574447|FG000|STARTED|Overall Study|Took at least one dose of study medication|2235
2870819|NCT00196326|3574447|FG000|Safety Population|Overall Study|Treated participants|2185
2870820|NCT00196326|3574447|FG000|Pregnancy Intent-to-treat Cohort (PITT)|Overall Study|Completed one cycle and 18-35 years old|1735
2870821|NCT00196326|3574447|FG000|COMPLETED|Overall Study||1249
2870822|NCT00196326|3574447|FG000|NOT COMPLETED|Overall Study||986
3169558|NCT01925989|3897083|FG001|NOT COMPLETED|Period 2||0
2870823|NCT00196716|3574451|FG000|STARTED|1.0 mg/kg Period||21
2870824|NCT00196716|3574451|FG000|COMPLETED|1.0 mg/kg Period||21
2870825|NCT00196716|3574451|FG000|NOT COMPLETED|1.0 mg/kg Period||0
2870826|NCT00196716|3574451|FG000|STARTED|0.3 mg/kg Period||21
2870827|NCT00196716|3574451|FG000|COMPLETED|0.3 mg/kg Period||21
2870828|NCT00196716|3574451|FG000|NOT COMPLETED|0.3 mg/kg Period||0
2870829|NCT00196937|3574460|FG000|STARTED|Overall Study||229
2870830|NCT00196937|3574461|FG001|STARTED|Overall Study||226
2870831|NCT00196937|3574462|FG002|STARTED|Overall Study||211
2870832|NCT00196937|3574460|FG000|COMPLETED|Overall Study||220
2870833|NCT00196937|3574461|FG001|COMPLETED|Overall Study||221
2870834|NCT00196937|3574462|FG002|COMPLETED|Overall Study||204
2870835|NCT00196937|3574460|FG000|NOT COMPLETED|Overall Study||9
2870836|NCT00196937|3574461|FG001|NOT COMPLETED|Overall Study||5
2870837|NCT00196937|3574462|FG002|NOT COMPLETED|Overall Study||7
2870838|NCT00196976|3574485|FG000|STARTED|Primary Study||39
2870839|NCT00196976|3574486|FG001|STARTED|Primary Study||41
2870840|NCT00196976|3574487|FG002|STARTED|Primary Study||41
2870841|NCT00196976|3574488|FG003|STARTED|Primary Study||40
2870842|NCT00196976|3574489|FG004|STARTED|Primary Study||40
2870843|NCT00196976|3574490|FG005|STARTED|Primary Study||54
2870844|NCT00196976|3574491|FG006|STARTED|Primary Study||50
2870845|NCT00196976|3574492|FG007|STARTED|Primary Study||52
2870846|NCT00196976|3574493|FG008|STARTED|Primary Study||52
2870847|NCT00196976|3574494|FG009|STARTED|Primary Study||52
2870848|NCT00196976|3574495|FG010|STARTED|Primary Study||0
2870849|NCT00196976|3574496|FG011|STARTED|Primary Study||0
2870850|NCT00196976|3574497|FG012|STARTED|Primary Study||0
2870851|NCT00196976|3574498|FG013|STARTED|Primary Study||0
2870852|NCT00196976|3574485|FG000|COMPLETED|Primary Study||38
2870853|NCT00196976|3574486|FG001|COMPLETED|Primary Study||40
2870854|NCT00196976|3574487|FG002|COMPLETED|Primary Study||37
2870855|NCT00196976|3574488|FG003|COMPLETED|Primary Study||39
2870856|NCT00196976|3574489|FG004|COMPLETED|Primary Study||37
2870857|NCT00196976|3574490|FG005|COMPLETED|Primary Study||52
2870858|NCT00196976|3574491|FG006|COMPLETED|Primary Study||50
2870859|NCT00196976|3574492|FG007|COMPLETED|Primary Study||49
2870860|NCT00196976|3574493|FG008|COMPLETED|Primary Study||52
2870861|NCT00196976|3574494|FG009|COMPLETED|Primary Study||51
2870862|NCT00196976|3574495|FG010|COMPLETED|Primary Study||0
2870863|NCT00196976|3574496|FG011|COMPLETED|Primary Study||0
2870864|NCT00196976|3574497|FG012|COMPLETED|Primary Study||0
2870865|NCT00196976|3574498|FG013|COMPLETED|Primary Study||0
2870866|NCT00196976|3574485|FG000|NOT COMPLETED|Primary Study||1
2870867|NCT00196976|3574486|FG001|NOT COMPLETED|Primary Study||1
2870868|NCT00196976|3574487|FG002|NOT COMPLETED|Primary Study||4
2870869|NCT00196976|3574488|FG003|NOT COMPLETED|Primary Study||1
2870870|NCT00196976|3574489|FG004|NOT COMPLETED|Primary Study||3
2870871|NCT00196976|3574490|FG005|NOT COMPLETED|Primary Study||2
2870872|NCT00196976|3574491|FG006|NOT COMPLETED|Primary Study||0
2870873|NCT00196976|3574492|FG007|NOT COMPLETED|Primary Study||3
2870874|NCT00196976|3574493|FG008|NOT COMPLETED|Primary Study||0
2870875|NCT00196976|3574494|FG009|NOT COMPLETED|Primary Study||1
2870876|NCT00196976|3574495|FG010|NOT COMPLETED|Primary Study||0
2870877|NCT00196976|3574496|FG011|NOT COMPLETED|Primary Study||0
2870878|NCT00196976|3574497|FG012|NOT COMPLETED|Primary Study||0
2870879|NCT00196976|3574498|FG013|NOT COMPLETED|Primary Study||0
2870880|NCT00196976|3574485|FG000|STARTED|Booster Study||0
2870881|NCT00196976|3574486|FG001|STARTED|Booster Study||0
2870882|NCT00196976|3574487|FG002|STARTED|Booster Study||0
2870883|NCT00196976|3574488|FG003|STARTED|Booster Study||0
2870884|NCT00196976|3574489|FG004|STARTED|Booster Study||0
2870885|NCT00196976|3574490|FG005|STARTED|Booster Study||0
2870886|NCT00196976|3574491|FG006|STARTED|Booster Study||0
2870887|NCT00196976|3574492|FG007|STARTED|Booster Study||0
2870888|NCT00196976|3574493|FG008|STARTED|Booster Study||0
2870889|NCT00196976|3574494|FG009|STARTED|Booster Study||0
2870890|NCT00196976|3574495|FG010|STARTED|Booster Study||33
2870891|NCT00196976|3574496|FG011|STARTED|Booster Study||32
2870892|NCT00196976|3574497|FG012|STARTED|Booster Study||45
2870893|NCT00196976|3574498|FG013|STARTED|Booster Study||43
2870894|NCT00196976|3574485|FG000|COMPLETED|Booster Study||0
2870895|NCT00196976|3574486|FG001|COMPLETED|Booster Study||0
2870896|NCT00196976|3574487|FG002|COMPLETED|Booster Study||0
2870897|NCT00196976|3574488|FG003|COMPLETED|Booster Study||0
2870898|NCT00196976|3574489|FG004|COMPLETED|Booster Study||0
2870899|NCT00196976|3574490|FG005|COMPLETED|Booster Study||0
2870900|NCT00196976|3574491|FG006|COMPLETED|Booster Study||0
2870901|NCT00196976|3574492|FG007|COMPLETED|Booster Study||0
2870902|NCT00196976|3574493|FG008|COMPLETED|Booster Study||0
2870903|NCT00196976|3574494|FG009|COMPLETED|Booster Study||0
2870904|NCT00196976|3574495|FG010|COMPLETED|Booster Study||31
2870905|NCT00196976|3574496|FG011|COMPLETED|Booster Study||30
2870906|NCT00196976|3574497|FG012|COMPLETED|Booster Study||45
2870907|NCT00196976|3574498|FG013|COMPLETED|Booster Study||43
2870908|NCT00196976|3574485|FG000|NOT COMPLETED|Booster Study||0
2870909|NCT00196976|3574486|FG001|NOT COMPLETED|Booster Study||0
2870910|NCT00196976|3574487|FG002|NOT COMPLETED|Booster Study||0
2870911|NCT00196976|3574488|FG003|NOT COMPLETED|Booster Study||0
2870912|NCT00196976|3574489|FG004|NOT COMPLETED|Booster Study||0
2870913|NCT00196976|3574490|FG005|NOT COMPLETED|Booster Study||0
2870914|NCT00196976|3574491|FG006|NOT COMPLETED|Booster Study||0
2870915|NCT00196976|3574492|FG007|NOT COMPLETED|Booster Study||0
2870916|NCT00196976|3574493|FG008|NOT COMPLETED|Booster Study||0
2870917|NCT00196976|3574494|FG009|NOT COMPLETED|Booster Study||0
2870918|NCT00196976|3574495|FG010|NOT COMPLETED|Booster Study||2
2870919|NCT00196976|3574496|FG011|NOT COMPLETED|Booster Study||2
2870920|NCT00196976|3574497|FG012|NOT COMPLETED|Booster Study||0
2870921|NCT00196976|3574498|FG013|NOT COMPLETED|Booster Study||0
2870922|NCT00197002|3574541|FG000|STARTED|Overall Study||147
2870923|NCT00197002|3574542|FG001|STARTED|Overall Study||137
2870924|NCT00197002|3574543|FG002|STARTED|Overall Study||149
2870925|NCT00197002|3574541|FG000|COMPLETED|Overall Study||125
2870926|NCT00197002|3574542|FG001|COMPLETED|Overall Study||119
2870927|NCT00197002|3574543|FG002|COMPLETED|Overall Study||132
2870928|NCT00197002|3574541|FG000|NOT COMPLETED|Overall Study||22
2870929|NCT00197002|3574542|FG001|NOT COMPLETED|Overall Study||18
2870930|NCT00197002|3574543|FG002|NOT COMPLETED|Overall Study||17
2870931|NCT00197015|3574557|FG000|STARTED|Overall Study||324
2870932|NCT00197015|3574558|FG001|STARTED|Overall Study||455
2870933|NCT00197015|3574559|FG002|STARTED|Overall Study||462
2870934|NCT00197015|3574557|FG000|COMPLETED|Overall Study||274
2870935|NCT00197015|3574558|FG001|COMPLETED|Overall Study||366
2870936|NCT00197015|3574559|FG002|COMPLETED|Overall Study||385
2870937|NCT00197015|3574557|FG000|NOT COMPLETED|Overall Study||50
2870938|NCT00197015|3574558|FG001|NOT COMPLETED|Overall Study||89
2870939|NCT00197015|3574559|FG002|NOT COMPLETED|Overall Study||77
2870940|NCT00197028|3574569|FG000|STARTED|Overall Study||107
2870941|NCT00197028|3574570|FG001|STARTED|Overall Study||107
2870942|NCT00197028|3574569|FG000|COMPLETED|Overall Study||91
2870943|NCT00197028|3574570|FG001|COMPLETED|Overall Study||86
2870944|NCT00197028|3574569|FG000|NOT COMPLETED|Overall Study||16
2870945|NCT00197028|3574570|FG001|NOT COMPLETED|Overall Study||21
2870946|NCT00197054|3574579|FG000|STARTED|Overall Study||85
2870947|NCT00197054|3574580|FG001|STARTED|Overall Study||85
2870948|NCT00197054|3574581|FG002|STARTED|Overall Study||85
2870949|NCT00197054|3574579|FG000|COMPLETED|Overall Study||68
2870950|NCT00197054|3574580|FG001|COMPLETED|Overall Study||64
2870951|NCT00197054|3574581|FG002|COMPLETED|Overall Study||73
2870952|NCT00197054|3574579|FG000|NOT COMPLETED|Overall Study||17
2870953|NCT00197054|3574580|FG001|NOT COMPLETED|Overall Study||21
2870954|NCT00197054|3574581|FG002|NOT COMPLETED|Overall Study||12
2870955|NCT00197106|3574601|FG000|STARTED|4-Week Run-In Period||257
2870956|NCT00197106|3574602|FG001|STARTED|4-Week Run-In Period||0
2870957|NCT00197106|3574603|FG002|STARTED|4-Week Run-In Period||0
2870958|NCT00197106|3574601|FG000|COMPLETED|4-Week Run-In Period||158
2870959|NCT00197106|3574602|FG001|COMPLETED|4-Week Run-In Period||0
2870960|NCT00197106|3574603|FG002|COMPLETED|4-Week Run-In Period||0
2870961|NCT00197106|3574601|FG000|NOT COMPLETED|4-Week Run-In Period||99
2870962|NCT00197106|3574602|FG001|NOT COMPLETED|4-Week Run-In Period||0
2870963|NCT00197106|3574603|FG002|NOT COMPLETED|4-Week Run-In Period||0
2870964|NCT00197106|3574601|FG000|STARTED|Overall Treatment Period||0
2870965|NCT00197106|3574602|FG001|STARTED|Overall Treatment Period||78
2870966|NCT00197106|3574603|FG002|STARTED|Overall Treatment Period||80
2870967|NCT00197106|3574601|FG000|COMPLETED|Overall Treatment Period||0
2870968|NCT00197106|3574602|FG001|COMPLETED|Overall Treatment Period||77
2870969|NCT00197106|3574603|FG002|COMPLETED|Overall Treatment Period||74
2870970|NCT00197106|3574601|FG000|NOT COMPLETED|Overall Treatment Period||0
2870971|NCT00197106|3574602|FG001|NOT COMPLETED|Overall Treatment Period||1
2870972|NCT00197106|3574603|FG002|NOT COMPLETED|Overall Treatment Period||6
2870973|NCT00197119|3574611|FG000|STARTED|Year 6||126
2870974|NCT00197119|3574612|FG001|STARTED|Year 6||118
2870975|NCT00197119|3574611|FG000|COMPLETED|Year 6||126
2870976|NCT00197119|3574612|FG001|COMPLETED|Year 6||118
3169559|NCT01925989|3897084|FG002|NOT COMPLETED|Period 2||0
3169560|NCT01926015|3897098|FG000|STARTED|Overall Study|Participants who passed all entry criteria and who were randomized into the study|96
3169561|NCT01926015|3897099|FG001|STARTED|Overall Study|Participants who passed all entry criteria and who were randomized into the study|96
3169562|NCT01926015|3897098|FG000|Received >=1 Vaccination|Overall Study||94
3169563|NCT01926015|3897099|FG001|Received >=1 Vaccination|Overall Study||96
3169564|NCT01926015|3897098|FG000|COMPLETED|Overall Study||94
3169565|NCT01926015|3897099|FG001|COMPLETED|Overall Study||95
2870977|NCT00197119|3574611|FG000|NOT COMPLETED|Year 6||0
2870978|NCT00197119|3574612|FG001|NOT COMPLETED|Year 6||0
2870979|NCT00197119|3574611|FG000|STARTED|Year 7|4 subjects who participated in the Year 6 follow-up time point did not return for this time point.|122
2870980|NCT00197119|3574612|FG001|STARTED|Year 7|4 subjects who participated in the Year 6 follow-up time point did not return for this time point.|114
2870981|NCT00197119|3574611|FG000|COMPLETED|Year 7||122
2870982|NCT00197119|3574612|FG001|COMPLETED|Year 7||114
2870983|NCT00197119|3574611|FG000|NOT COMPLETED|Year 7||0
2870984|NCT00197119|3574612|FG001|NOT COMPLETED|Year 7||0
2870985|NCT00197119|3574611|FG000|STARTED|Year 8||122
2870986|NCT00197119|3574612|FG001|STARTED|Year 8|One additional subject (compared to Year 7) participated in the current follow-up time point.|115
2870987|NCT00197119|3574611|FG000|COMPLETED|Year 8||122
2870988|NCT00197119|3574612|FG001|COMPLETED|Year 8||115
2870989|NCT00197119|3574611|FG000|NOT COMPLETED|Year 8||0
2870990|NCT00197119|3574612|FG001|NOT COMPLETED|Year 8||0
2870991|NCT00197119|3574611|FG000|STARTED|Year 9|One subject participating in the Year 8 time point did not return for the current time point.|121
2870992|NCT00197119|3574612|FG001|STARTED|Year 9|One subject participating in the Year 8 time point did not return for the current time point.|114
2870993|NCT00197119|3574611|FG000|COMPLETED|Year 9||121
2870994|NCT00197119|3574612|FG001|COMPLETED|Year 9||114
2870995|NCT00197119|3574611|FG000|NOT COMPLETED|Year 9||0
2870996|NCT00197119|3574612|FG001|NOT COMPLETED|Year 9||0
2870997|NCT00197119|3574611|FG000|STARTED|Year 10|One subject participating in the Year 9 time point did not return for the current time point.|120
2870998|NCT00197119|3574612|FG001|STARTED|Year 10|Six subjects participating in the Year 9 time point did not return for the current time point.|108
2870999|NCT00197119|3574611|FG000|COMPLETED|Year 10||120
2871000|NCT00197119|3574612|FG001|COMPLETED|Year 10||108
2871001|NCT00197119|3574611|FG000|NOT COMPLETED|Year 10||0
2871002|NCT00197119|3574612|FG001|NOT COMPLETED|Year 10||0
2871003|NCT00197145|3574620|FG000|STARTED|Period 1: Randomized Treatment Phase||13
2871004|NCT00197145|3574621|FG001|STARTED|Period 1: Randomized Treatment Phase||11
2871005|NCT00197145|3574620|FG000|COMPLETED|Period 1: Randomized Treatment Phase||0
2871006|NCT00197145|3574621|FG001|COMPLETED|Period 1: Randomized Treatment Phase||0
2871007|NCT00197145|3574620|FG000|NOT COMPLETED|Period 1: Randomized Treatment Phase||13
2871008|NCT00197145|3574621|FG001|NOT COMPLETED|Period 1: Randomized Treatment Phase||11
2871009|NCT00197145|3574620|FG000|STARTED|Period 2 : Open Label Phase||10
2871010|NCT00197145|3574621|FG001|STARTED|Period 2 : Open Label Phase||0
2871011|NCT00197145|3574620|FG000|COMPLETED|Period 2 : Open Label Phase||0
2871012|NCT00197145|3574621|FG001|COMPLETED|Period 2 : Open Label Phase||0
2871013|NCT00197145|3574620|FG000|NOT COMPLETED|Period 2 : Open Label Phase||10
2871014|NCT00197145|3574621|FG001|NOT COMPLETED|Period 2 : Open Label Phase||0
2871015|NCT00197184|3574630|FG000|STARTED|Overall Study||139
2871016|NCT00197184|3574631|FG001|STARTED|Overall Study||137
2871017|NCT00197184|3574630|FG000|COMPLETED|Overall Study||139
2871018|NCT00197184|3574631|FG001|COMPLETED|Overall Study||137
2871019|NCT00197184|3574630|FG000|NOT COMPLETED|Overall Study||0
2871020|NCT00197184|3574631|FG001|NOT COMPLETED|Overall Study||0
2871021|NCT00197236|3574640|FG000|STARTED|Overall Study||135
2871022|NCT00197236|3574641|FG001|STARTED|Overall Study||127
2871023|NCT00197236|3574642|FG002|STARTED|Overall Study||132
2871024|NCT00197236|3574640|FG000|COMPLETED|Overall Study||121
2871025|NCT00197236|3574641|FG001|COMPLETED|Overall Study||110
2871026|NCT00197236|3574642|FG002|COMPLETED|Overall Study||109
2871027|NCT00197236|3574640|FG000|NOT COMPLETED|Overall Study||14
2871028|NCT00197236|3574641|FG001|NOT COMPLETED|Overall Study||17
2871029|NCT00197236|3574642|FG002|NOT COMPLETED|Overall Study||23
2871030|NCT00197392|3574655|FG000|STARTED|Overall Study||214
2871031|NCT00197392|3574656|FG001|STARTED|Overall Study||220
2871032|NCT00197392|3574655|FG000|Safety Population|Overall Study||214
2871033|NCT00197392|3574656|FG001|Safety Population|Overall Study||220
2871034|NCT00197392|3574655|FG000|Modified Intent to Treat|Overall Study||209
2871035|NCT00197392|3574656|FG001|Modified Intent to Treat|Overall Study||210
2871036|NCT00197392|3574655|FG000|Evaluable|Overall Study||176
2871037|NCT00197392|3574656|FG001|Evaluable|Overall Study||181
2871038|NCT00197392|3574655|FG000|Per Protocol|Overall Study||126
2871039|NCT00197392|3574656|FG001|Per Protocol|Overall Study||134
2871040|NCT00197392|3574655|FG000|COMPLETED|Overall Study||126
2871041|NCT00197392|3574656|FG001|COMPLETED|Overall Study||134
2871042|NCT00197392|3574655|FG000|NOT COMPLETED|Overall Study||88
2871043|NCT00197392|3574656|FG001|NOT COMPLETED|Overall Study||86
2871044|NCT00197496|3574680|FG000|STARTED|Baseline to Discharge||14
2871045|NCT00197496|3574681|FG001|STARTED|Baseline to Discharge||7
2871046|NCT00197496|3574680|FG000|COMPLETED|Baseline to Discharge||12
2871047|NCT00197496|3574681|FG001|COMPLETED|Baseline to Discharge||5
2871048|NCT00197496|3574680|FG000|NOT COMPLETED|Baseline to Discharge||2
2871049|NCT00197496|3574681|FG001|NOT COMPLETED|Baseline to Discharge||2
2871050|NCT00197496|3574680|FG000|STARTED|Follow-up||12
2871051|NCT00197496|3574681|FG001|STARTED|Follow-up||5
2871052|NCT00197496|3574680|FG000|COMPLETED|Follow-up||10
2871053|NCT00197496|3574681|FG001|COMPLETED|Follow-up||4
2871054|NCT00197496|3574680|FG000|NOT COMPLETED|Follow-up||2
2871055|NCT00197496|3574681|FG001|NOT COMPLETED|Follow-up||1
2871056|NCT00198029|3574687|FG000|STARTED|Overall Study||32
2871057|NCT00198029|3574687|FG000|COMPLETED|Overall Study||28
2871058|NCT00198029|3574687|FG000|NOT COMPLETED|Overall Study||4
2871059|NCT00198042|3574691|FG000|STARTED|Overall Study||18
2871060|NCT00198042|3574691|FG000|COMPLETED|Overall Study||18
2871061|NCT00198042|3574691|FG000|NOT COMPLETED|Overall Study||0
2871062|NCT00198081|3574697|FG000|STARTED|Overall Study|Eight (8) persons consented to participate but 3 withdrew prior to beginning protocol treatment.|5
2871063|NCT00198081|3574698|FG001|STARTED|Overall Study|No enrollment on this arm.|0
2871064|NCT00198081|3574697|FG000|COMPLETED|Overall Study||4
2871065|NCT00198081|3574698|FG001|COMPLETED|Overall Study|No enrollment on this arm.|0
2871066|NCT00198081|3574697|FG000|NOT COMPLETED|Overall Study||1
2871067|NCT00198081|3574698|FG001|NOT COMPLETED|Overall Study||0
2871068|NCT00198107|3574711|FG000|STARTED|Double-Blind Period||41
2871069|NCT00198107|3574712|FG001|STARTED|Double-Blind Period||40
2871070|NCT00198107|3574713|FG002|STARTED|Double-Blind Period||0
2871071|NCT00198107|3574711|FG000|1 or More Follow-up Visits|Double-Blind Period||40
2871072|NCT00198107|3574712|FG001|1 or More Follow-up Visits|Double-Blind Period||38
2871073|NCT00198107|3574713|FG002|1 or More Follow-up Visits|Double-Blind Period||0
2871074|NCT00198107|3574711|FG000|COMPLETED|Double-Blind Period||35
2871075|NCT00198107|3574712|FG001|COMPLETED|Double-Blind Period||37
2871076|NCT00198107|3574713|FG002|COMPLETED|Double-Blind Period||0
2871077|NCT00198107|3574711|FG000|NOT COMPLETED|Double-Blind Period||6
2871078|NCT00198107|3574712|FG001|NOT COMPLETED|Double-Blind Period||3
2871079|NCT00198107|3574713|FG002|NOT COMPLETED|Double-Blind Period||0
2871080|NCT00198107|3574711|FG000|STARTED|Pilot Add-On Aripiprazole +D-cycloserine||0
2871081|NCT00198107|3574712|FG001|STARTED|Pilot Add-On Aripiprazole +D-cycloserine||0
2871082|NCT00198107|3574713|FG002|STARTED|Pilot Add-On Aripiprazole +D-cycloserine||10
2871083|NCT00198107|3574711|FG000|COMPLETED|Pilot Add-On Aripiprazole +D-cycloserine||0
2871084|NCT00198107|3574712|FG001|COMPLETED|Pilot Add-On Aripiprazole +D-cycloserine||0
2871085|NCT00198107|3574713|FG002|COMPLETED|Pilot Add-On Aripiprazole +D-cycloserine||8
2871086|NCT00198107|3574711|FG000|NOT COMPLETED|Pilot Add-On Aripiprazole +D-cycloserine||0
2871087|NCT00198107|3574712|FG001|NOT COMPLETED|Pilot Add-On Aripiprazole +D-cycloserine||0
2871088|NCT00198107|3574713|FG002|NOT COMPLETED|Pilot Add-On Aripiprazole +D-cycloserine||2
2871089|NCT00198133|3574723|FG000|STARTED|Overall Study||16
2871090|NCT00198133|3574724|FG001|STARTED|Overall Study||11
2871091|NCT00198133|3574723|FG000|COMPLETED|Overall Study||11
2871092|NCT00198133|3574724|FG001|COMPLETED|Overall Study||3
3169566|NCT01926015|3897098|FG000|NOT COMPLETED|Overall Study||2
3169567|NCT01926015|3897099|FG001|NOT COMPLETED|Overall Study||1
3169568|NCT01926028|3897108|FG000|STARTED|Overall Study||85
3169569|NCT01926028|3897109|FG001|STARTED|Overall Study||89
3169570|NCT01926028|3897110|FG002|STARTED|Overall Study||14
3169571|NCT01926028|3897108|FG000|COMPLETED|Overall Study||64
3169572|NCT01926028|3897109|FG001|COMPLETED|Overall Study||67
3169573|NCT01926028|3897110|FG002|COMPLETED|Overall Study||12
3169574|NCT01926028|3897108|FG000|NOT COMPLETED|Overall Study||21
3169575|NCT01926028|3897109|FG001|NOT COMPLETED|Overall Study||22
3169576|NCT01926028|3897110|FG002|NOT COMPLETED|Overall Study||2
3169577|NCT01926119|3897119|FG000|STARTED|Overall Study||4
3169578|NCT01926119|3897119|FG000|COMPLETED|Overall Study||3
3169579|NCT01926119|3897119|FG000|NOT COMPLETED|Overall Study||1
3169580|NCT01926444|3897127|FG000|STARTED|Overall Study||56
3169581|NCT01926444|3897128|FG001|STARTED|Overall Study||52
3169582|NCT01926444|3897129|FG002|STARTED|Overall Study||57
3169583|NCT01926444|3897130|FG003|STARTED|Overall Study||103
2871093|NCT00198133|3574723|FG000|NOT COMPLETED|Overall Study||5
2871094|NCT00198133|3574724|FG001|NOT COMPLETED|Overall Study||8
2871095|NCT00198822|3574733|FG000|STARTED|Overall Study|No. of consenting pregnant women in the placebo arm of trial cohort|19876
2871096|NCT00198822|3574734|FG001|STARTED|Overall Study|No. of consenting pregnant women in the vitamin A arm of trial cohort|19826
2871097|NCT00198822|3574735|FG002|STARTED|Overall Study|No. of consenting pregnant women in the beta-catorene arm of trial cohort|20019
2871098|NCT00198822|3574733|FG000|COMPLETED|Overall Study|No. of consented pregnant women in placebo arm with vital status known at 12 weeks postpartum|19862
2871099|NCT00198822|3574734|FG001|COMPLETED|Overall Study|No. of consented pregnant women in vitamin A arm with vital status known at 12 weeks postpartum|19806
2871100|NCT00198822|3574735|FG002|COMPLETED|Overall Study|No. of consented pregnant women in beta-catorene arm with vital status known at 12 weeks postpartum|19998
2871101|NCT00198822|3574733|FG000|NOT COMPLETED|Overall Study||14
2871102|NCT00198822|3574734|FG001|NOT COMPLETED|Overall Study||20
2871103|NCT00198822|3574735|FG002|NOT COMPLETED|Overall Study||21
2871104|NCT00199381|3574743|FG000|STARTED|Overall Study||504
2871105|NCT00199381|3574743|FG000|COMPLETED|Overall Study|Premature study termination by the Sponsor.|0
2871106|NCT00199381|3574743|FG000|NOT COMPLETED|Overall Study||504
2871107|NCT00199797|3574747|FG000|STARTED|Overall Study||20
2871108|NCT00199797|3574747|FG000|COMPLETED|Overall Study||17
2871109|NCT00199797|3574747|FG000|NOT COMPLETED|Overall Study||3
2871110|NCT00199836|3574752|FG000|STARTED|Overall Study||14
2871111|NCT00199836|3574752|FG000|COMPLETED|Overall Study||8
2871112|NCT00199836|3574752|FG000|NOT COMPLETED|Overall Study||6
2871113|NCT00199849|3574760|FG000|STARTED|Overall Study||3
2871114|NCT00199849|3574761|FG001|STARTED|Overall Study||7
2871115|NCT00199849|3574762|FG002|STARTED|Overall Study||8
2871116|NCT00199849|3574760|FG000|COMPLETED|Overall Study||3
2871117|NCT00199849|3574761|FG001|COMPLETED|Overall Study||6
2871118|NCT00199849|3574762|FG002|COMPLETED|Overall Study||6
2871119|NCT00199849|3574760|FG000|NOT COMPLETED|Overall Study||0
2871120|NCT00199849|3574761|FG001|NOT COMPLETED|Overall Study||1
2871121|NCT00199849|3574762|FG002|NOT COMPLETED|Overall Study||2
2871122|NCT00199875|3574775|FG000|STARTED|Overall Study||3
2871123|NCT00199875|3574776|FG001|STARTED|Overall Study||3
2871124|NCT00199875|3574777|FG002|STARTED|Overall Study||6
2871125|NCT00199875|3574778|FG003|STARTED|Overall Study||3
2871126|NCT00199875|3574779|FG004|STARTED|Overall Study||3
2871127|NCT00199875|3574775|FG000|COMPLETED|Overall Study||3
2871128|NCT00199875|3574776|FG001|COMPLETED|Overall Study||3
2871129|NCT00199875|3574777|FG002|COMPLETED|Overall Study||6
2871130|NCT00199875|3574778|FG003|COMPLETED|Overall Study||3
2871131|NCT00199875|3574779|FG004|COMPLETED|Overall Study||2
2871132|NCT00199875|3574775|FG000|NOT COMPLETED|Overall Study||0
2871133|NCT00199875|3574776|FG001|NOT COMPLETED|Overall Study||0
2871134|NCT00199875|3574777|FG002|NOT COMPLETED|Overall Study||0
2871135|NCT00199875|3574778|FG003|NOT COMPLETED|Overall Study||0
2871136|NCT00199875|3574779|FG004|NOT COMPLETED|Overall Study||1
2871137|NCT00199888|3574791|FG000|STARTED|Overall Study||26
2871138|NCT00199888|3574791|FG000|COMPLETED|Overall Study||25
2871139|NCT00199888|3574791|FG000|NOT COMPLETED|Overall Study||1
2871140|NCT00199901|3574797|FG000|STARTED|Overall Study||56
2871141|NCT00199901|3574798|FG001|STARTED|Overall Study||54
2871142|NCT00199901|3574797|FG000|COMPLETED|Overall Study||29
3169584|NCT01926444|3897127|FG000|COMPLETED|Overall Study||56
3313619|NCT03076970|4046932|FG004|Received at Least 1 Dose of Study Drug|Period 1||7
3313620|NCT03076970|4046933|FG005|Received at Least 1 Dose of Study Drug|Period 1||7
3313621|NCT03076970|4046928|FG000|COMPLETED|Period 1||7
2871143|NCT00199901|3574798|FG001|COMPLETED|Overall Study||30
2871144|NCT00199901|3574797|FG000|NOT COMPLETED|Overall Study||27
2871145|NCT00199901|3574798|FG001|NOT COMPLETED|Overall Study||24
2871146|NCT00199914|3574808|FG000|STARTED|Overall Study||53
2871147|NCT00199914|3574809|FG001|STARTED|Overall Study||60
2871148|NCT00199914|3574808|FG000|COMPLETED|Overall Study||50
2871149|NCT00199914|3574809|FG001|COMPLETED|Overall Study||54
2871150|NCT00199914|3574808|FG000|NOT COMPLETED|Overall Study||3
2871151|NCT00199914|3574809|FG001|NOT COMPLETED|Overall Study||6
2871152|NCT00200057|3574815|FG000|STARTED|Overall Study||120
2871153|NCT00200057|3574815|FG000|1 Month Follow-up|Overall Study||117
2871154|NCT00200057|3574815|FG000|3 Month Follow-up|Overall Study||116
2871155|NCT00200057|3574815|FG000|6 Month Follow-up|Overall Study||114
2871156|NCT00200057|3574815|FG000|12 Month Follow-up|Overall Study||111
2871157|NCT00200057|3574815|FG000|COMPLETED|Overall Study||111
2871158|NCT00200057|3574815|FG000|NOT COMPLETED|Overall Study||9
2871159|NCT00200161|3574821|FG000|STARTED|Overall Study||43
2871160|NCT00200161|3574822|FG001|STARTED|Overall Study||42
2871161|NCT00200161|3574821|FG000|COMPLETED|Overall Study||43
2871162|NCT00200161|3574822|FG001|COMPLETED|Overall Study||42
2871163|NCT00200161|3574821|FG000|NOT COMPLETED|Overall Study||0
2871164|NCT00200161|3574822|FG001|NOT COMPLETED|Overall Study||0
2871165|NCT00200343|3574831|FG000|STARTED|Overall Study||199
2871166|NCT00200343|3574832|FG001|STARTED|Overall Study||200
2871167|NCT00200343|3574833|FG002|STARTED|Overall Study||197
2871168|NCT00200343|3574831|FG000|COMPLETED|Overall Study||183
2871169|NCT00200343|3574832|FG001|COMPLETED|Overall Study||192
2871170|NCT00200343|3574833|FG002|COMPLETED|Overall Study||184
2871171|NCT00200343|3574831|FG000|NOT COMPLETED|Overall Study||16
2871172|NCT00200343|3574832|FG001|NOT COMPLETED|Overall Study||8
2871173|NCT00200343|3574833|FG002|NOT COMPLETED|Overall Study||13
2871174|NCT00200356|3574843|FG000|STARTED|Overall Study||199
2871175|NCT00200356|3574844|FG001|STARTED|Overall Study||202
2871176|NCT00200356|3574843|FG000|Safety Analysis Set|Overall Study||194
2871177|NCT00200356|3574844|FG001|Safety Analysis Set|Overall Study||198
2871178|NCT00200356|3574843|FG000|COMPLETED|Overall Study||191
2871179|NCT00200356|3574844|FG001|COMPLETED|Overall Study||195
2871180|NCT00200356|3574843|FG000|NOT COMPLETED|Overall Study||8
2871181|NCT00200356|3574844|FG001|NOT COMPLETED|Overall Study||7
2871182|NCT00200785|3574852|FG000|STARTED|First Intervention||9
2871183|NCT00200785|3574853|FG001|STARTED|First Intervention||6
2871184|NCT00200785|3574852|FG000|COMPLETED|First Intervention||9
2871185|NCT00200785|3574853|FG001|COMPLETED|First Intervention||6
2871186|NCT00200785|3574852|FG000|NOT COMPLETED|First Intervention||0
2871187|NCT00200785|3574853|FG001|NOT COMPLETED|First Intervention||0
2871188|NCT00200785|3574852|FG000|STARTED|Washout Period of 1 Week||9
2871189|NCT00200785|3574853|FG001|STARTED|Washout Period of 1 Week||6
2871190|NCT00200785|3574852|FG000|COMPLETED|Washout Period of 1 Week||9
2871191|NCT00200785|3574853|FG001|COMPLETED|Washout Period of 1 Week||6
2871192|NCT00200785|3574852|FG000|NOT COMPLETED|Washout Period of 1 Week||0
2871193|NCT00200785|3574853|FG001|NOT COMPLETED|Washout Period of 1 Week||0
2871194|NCT00200785|3574852|FG000|STARTED|Second Intervention||9
2871195|NCT00200785|3574853|FG001|STARTED|Second Intervention||6
2871196|NCT00200785|3574852|FG000|COMPLETED|Second Intervention||9
2871197|NCT00200785|3574853|FG001|COMPLETED|Second Intervention||6
2871198|NCT00200785|3574852|FG000|NOT COMPLETED|Second Intervention||0
2871199|NCT00200785|3574853|FG001|NOT COMPLETED|Second Intervention||0
2871200|NCT00200850|3574862|FG000|STARTED|Overall Study||10
2871201|NCT00200850|3574863|FG001|STARTED|Overall Study||10
2871202|NCT00200850|3574864|FG002|STARTED|Overall Study||11
2871203|NCT00200850|3574862|FG000|COMPLETED|Overall Study||7
2871204|NCT00200850|3574863|FG001|COMPLETED|Overall Study||9
2871205|NCT00200850|3574864|FG002|COMPLETED|Overall Study||5
2871206|NCT00200850|3574862|FG000|NOT COMPLETED|Overall Study||3
2871207|NCT00200850|3574863|FG001|NOT COMPLETED|Overall Study||1
2871208|NCT00200850|3574864|FG002|NOT COMPLETED|Overall Study||6
2871209|NCT00200902|3574875|FG000|STARTED|Overall Study||39
3313622|NCT03076970|4046929|FG001|COMPLETED|Period 1||7
3313623|NCT03076970|4046930|FG002|COMPLETED|Period 1||7
3313624|NCT03076970|4046931|FG003|COMPLETED|Period 1||7
3313625|NCT03076970|4046932|FG004|COMPLETED|Period 1||7
2871210|NCT00200902|3574876|FG001|STARTED|Overall Study||29
2871211|NCT00200902|3574877|FG002|STARTED|Overall Study||20
2871212|NCT00200902|3574875|FG000|COMPLETED|Overall Study||29
2871213|NCT00200902|3574876|FG001|COMPLETED|Overall Study||26
2871214|NCT00200902|3574877|FG002|COMPLETED|Overall Study||12
2871215|NCT00200902|3574875|FG000|NOT COMPLETED|Overall Study||10
2871216|NCT00200902|3574876|FG001|NOT COMPLETED|Overall Study||3
2871217|NCT00200902|3574877|FG002|NOT COMPLETED|Overall Study||8
2871218|NCT00200967|3574893|FG000|STARTED|First Treatment Period||42
2871219|NCT00200967|3574894|FG001|STARTED|First Treatment Period||45
2871220|NCT00200967|3574893|FG000|First Treatment Period|First Treatment Period||42
2871221|NCT00200967|3574894|FG001|First Treatment Period|First Treatment Period||45
2871222|NCT00200967|3574893|FG000|COMPLETED|First Treatment Period||36
2871223|NCT00200967|3574894|FG001|COMPLETED|First Treatment Period||44
2871224|NCT00200967|3574893|FG000|NOT COMPLETED|First Treatment Period||6
2871225|NCT00200967|3574894|FG001|NOT COMPLETED|First Treatment Period||1
2871226|NCT00200967|3574893|FG000|STARTED|Wash-out Period||36
2871227|NCT00200967|3574894|FG001|STARTED|Wash-out Period||44
2871228|NCT00200967|3574893|FG000|COMPLETED|Wash-out Period||36
2871229|NCT00200967|3574894|FG001|COMPLETED|Wash-out Period||43
2871230|NCT00200967|3574893|FG000|NOT COMPLETED|Wash-out Period||0
2871231|NCT00200967|3574894|FG001|NOT COMPLETED|Wash-out Period||1
2871232|NCT00200967|3574893|FG000|STARTED|Second Treatment Period||36
2871233|NCT00200967|3574894|FG001|STARTED|Second Treatment Period||43
2871234|NCT00200967|3574893|FG000|COMPLETED|Second Treatment Period||35
2871235|NCT00200967|3574894|FG001|COMPLETED|Second Treatment Period||41
2871236|NCT00200967|3574893|FG000|NOT COMPLETED|Second Treatment Period||1
2871237|NCT00200967|3574894|FG001|NOT COMPLETED|Second Treatment Period||2
2871238|NCT00200967|3574893|FG000|STARTED|Run-out Period||35
2871239|NCT00200967|3574894|FG001|STARTED|Run-out Period||41
2871240|NCT00200967|3574893|FG000|COMPLETED|Run-out Period||34
2871241|NCT00200967|3574894|FG001|COMPLETED|Run-out Period||41
2871242|NCT00200967|3574893|FG000|NOT COMPLETED|Run-out Period||1
2871243|NCT00200967|3574894|FG001|NOT COMPLETED|Run-out Period||0
2871244|NCT00201006|3574903|FG000|STARTED|Overall Study||83
2871245|NCT00201006|3574904|FG001|STARTED|Overall Study||72
2871246|NCT00201006|3574905|FG002|STARTED|Overall Study||79
2871247|NCT00201006|3574903|FG000|COMPLETED|Overall Study||75
2871248|NCT00201006|3574904|FG001|COMPLETED|Overall Study||70
2871249|NCT00201006|3574905|FG002|COMPLETED|Overall Study||75
2871250|NCT00201006|3574903|FG000|NOT COMPLETED|Overall Study||8
2871251|NCT00201006|3574904|FG001|NOT COMPLETED|Overall Study||2
2871252|NCT00201006|3574905|FG002|NOT COMPLETED|Overall Study||4
2871253|NCT00201123|3574916|FG000|STARTED|Overall Study||32
2871254|NCT00201123|3574917|FG001|STARTED|Overall Study||32
2871255|NCT00201123|3574918|FG002|STARTED|Overall Study||32
2871256|NCT00201123|3574916|FG000|Did Not Meet Continuation Criteria|Overall Study||2
2871257|NCT00201123|3574917|FG001|Did Not Meet Continuation Criteria|Overall Study||0
2871258|NCT00201123|3574918|FG002|Did Not Meet Continuation Criteria|Overall Study||5
2871259|NCT00201123|3574916|FG000|COMPLETED|Overall Study||26
2871260|NCT00201123|3574917|FG001|COMPLETED|Overall Study||28
2871261|NCT00201123|3574918|FG002|COMPLETED|Overall Study||23
2871262|NCT00201123|3574916|FG000|NOT COMPLETED|Overall Study||6
2871263|NCT00201123|3574917|FG001|NOT COMPLETED|Overall Study||4
2871264|NCT00201123|3574918|FG002|NOT COMPLETED|Overall Study||9
2871265|NCT00201201|3574932|FG000|STARTED|Overall Study||87
2871266|NCT00201201|3574933|FG001|STARTED|Overall Study||73
2871267|NCT00201201|3574932|FG000|COMPLETED|Overall Study||82
2871268|NCT00201201|3574933|FG001|COMPLETED|Overall Study||66
2871269|NCT00201201|3574932|FG000|NOT COMPLETED|Overall Study||5
2871270|NCT00201201|3574933|FG001|NOT COMPLETED|Overall Study||7
2871271|NCT00201240|3574939|FG000|STARTED|Overall Study||47
2871272|NCT00201240|3574939|FG000|COMPLETED|Overall Study||44
2871273|NCT00201240|3574939|FG000|NOT COMPLETED|Overall Study||3
2871274|NCT00201409|3574946|FG000|STARTED|Overall Study||65
2871275|NCT00201409|3574947|FG001|STARTED|Overall Study||67
2871276|NCT00201409|3574946|FG000|COMPLETED|Overall Study||64
2871277|NCT00201409|3574947|FG001|COMPLETED|Overall Study||66
3313626|NCT03076970|4046933|FG005|COMPLETED|Period 1||7
3313627|NCT03076970|4046928|FG000|NOT COMPLETED|Period 1||0
3313628|NCT03076970|4046929|FG001|NOT COMPLETED|Period 1||0
3313629|NCT03076970|4046930|FG002|NOT COMPLETED|Period 1||0
3313630|NCT03076970|4046931|FG003|NOT COMPLETED|Period 1||0
3313631|NCT03076970|4046932|FG004|NOT COMPLETED|Period 1||0
3313632|NCT03076970|4046933|FG005|NOT COMPLETED|Period 1||0
3313633|NCT03076970|4046928|FG000|STARTED|Washout Period 1||7
3313634|NCT03076970|4046929|FG001|STARTED|Washout Period 1||7
3313635|NCT03076970|4046930|FG002|STARTED|Washout Period 1||7
3313636|NCT03076970|4046931|FG003|STARTED|Washout Period 1||7
3313637|NCT03076970|4046932|FG004|STARTED|Washout Period 1||7
3313638|NCT03076970|4046933|FG005|STARTED|Washout Period 1||7
3313639|NCT03076970|4046928|FG000|COMPLETED|Washout Period 1||7
3313640|NCT03076970|4046929|FG001|COMPLETED|Washout Period 1||7
3313641|NCT03076970|4046930|FG002|COMPLETED|Washout Period 1||7
3313642|NCT03076970|4046931|FG003|COMPLETED|Washout Period 1||7
3313643|NCT03076970|4046932|FG004|COMPLETED|Washout Period 1||7
3313644|NCT03076970|4046933|FG005|COMPLETED|Washout Period 1||7
3313645|NCT03076970|4046928|FG000|NOT COMPLETED|Washout Period 1||0
3313646|NCT03076970|4046929|FG001|NOT COMPLETED|Washout Period 1||0
3313647|NCT03076970|4046930|FG002|NOT COMPLETED|Washout Period 1||0
3313648|NCT03076970|4046931|FG003|NOT COMPLETED|Washout Period 1||0
3313649|NCT03076970|4046932|FG004|NOT COMPLETED|Washout Period 1||0
3313650|NCT03076970|4046933|FG005|NOT COMPLETED|Washout Period 1||0
3313651|NCT03076970|4046928|FG000|STARTED|Period 2||7
3313652|NCT03076970|4046929|FG001|STARTED|Period 2||7
3313653|NCT03076970|4046930|FG002|STARTED|Period 2||7
3313654|NCT03076970|4046931|FG003|STARTED|Period 2||7
3313655|NCT03076970|4046932|FG004|STARTED|Period 2||7
2871278|NCT00201409|3574946|FG000|NOT COMPLETED|Overall Study||1
2871279|NCT00201409|3574947|FG001|NOT COMPLETED|Overall Study||1
2871280|NCT00201448|3574955|FG000|STARTED|Overall Study||42
2871281|NCT00201448|3574956|FG001|STARTED|Overall Study||40
2871282|NCT00201448|3574955|FG000|COMPLETED|Overall Study||42
2871283|NCT00201448|3574956|FG001|COMPLETED|Overall Study||40
2871284|NCT00201448|3574955|FG000|NOT COMPLETED|Overall Study||0
2871285|NCT00201448|3574956|FG001|NOT COMPLETED|Overall Study||0
2871286|NCT00201643|3574966|FG000|STARTED|Overall Study||223
2871287|NCT00201643|3574967|FG001|STARTED|Overall Study||214
2871288|NCT00201643|3574966|FG000|COMPLETED|Overall Study||218
3313656|NCT03076970|4046933|FG005|STARTED|Period 2||7
3313657|NCT03076970|4046928|FG000|COMPLETED|Period 2||7
3313658|NCT03076970|4046929|FG001|COMPLETED|Period 2||7
3313659|NCT03076970|4046930|FG002|COMPLETED|Period 2||7
2871289|NCT00201643|3574967|FG001|COMPLETED|Overall Study||210
2871290|NCT00201643|3574966|FG000|NOT COMPLETED|Overall Study||5
2871291|NCT00201643|3574967|FG001|NOT COMPLETED|Overall Study||4
2871292|NCT00201734|3574975|FG000|STARTED|Overall Study||32
2871293|NCT00201734|3574976|FG001|STARTED|Overall Study||25
2871294|NCT00201734|3574975|FG000|Patients Not Evaluable|Overall Study||3
2871295|NCT00201734|3574976|FG001|Patients Not Evaluable|Overall Study||0
2871296|NCT00201734|3574975|FG000|COMPLETED|Overall Study||29
2871297|NCT00201734|3574976|FG001|COMPLETED|Overall Study||25
2871298|NCT00201734|3574975|FG000|NOT COMPLETED|Overall Study||3
2871299|NCT00201734|3574976|FG001|NOT COMPLETED|Overall Study||0
2871300|NCT00201760|3574985|FG000|STARTED|Overall Study||5
2871301|NCT00201760|3574986|FG001|STARTED|Overall Study||5
2871302|NCT00201760|3574985|FG000|COMPLETED|Overall Study||5
2871303|NCT00201760|3574986|FG001|COMPLETED|Overall Study||5
2871304|NCT00201760|3574985|FG000|NOT COMPLETED|Overall Study||0
2871305|NCT00201760|3574986|FG001|NOT COMPLETED|Overall Study||0
2871306|NCT00201773|3574992|FG000|STARTED|Overall Study||22
2871307|NCT00201773|3574992|FG000|Completed 8 Weeks of Planned Therapy|Overall Study||16
2871308|NCT00201773|3574992|FG000|Received All Exemestane Therapy|Overall Study||5
2871309|NCT00201773|3574992|FG000|Stopped Exemestane After 4 Weeks|Overall Study||1
2871310|NCT00201773|3574992|FG000|COMPLETED|Overall Study||16
2871311|NCT00201773|3574992|FG000|NOT COMPLETED|Overall Study||6
2871312|NCT00201825|3574999|FG000|STARTED|Overall Study||29
2871313|NCT00201825|3574999|FG000|COMPLETED|Overall Study||29
2871314|NCT00201825|3574999|FG000|NOT COMPLETED|Overall Study||0
2871315|NCT00201838|3575005|FG000|STARTED|Overall Study||30
2871316|NCT00201838|3575006|FG001|STARTED|Overall Study||8
2871317|NCT00201838|3575005|FG000|Treatment Cohort|Overall Study||30
2871318|NCT00201838|3575006|FG001|Treatment Cohort|Overall Study||8
2871319|NCT00201838|3575005|FG000|COMPLETED|Overall Study||30
2871320|NCT00201838|3575006|FG001|COMPLETED|Overall Study||8
2871321|NCT00201838|3575005|FG000|NOT COMPLETED|Overall Study||0
2871322|NCT00201838|3575006|FG001|NOT COMPLETED|Overall Study||0
2871323|NCT00201851|3575021|FG000|STARTED|Overall Study||252
2871324|NCT00201851|3575022|FG001|STARTED|Overall Study||257
2871325|NCT00201851|3575023|FG002|STARTED|Overall Study||231
2871326|NCT00201851|3575021|FG000|COMPLETED|Overall Study||244
2871327|NCT00201851|3575022|FG001|COMPLETED|Overall Study||255
2871328|NCT00201851|3575023|FG002|COMPLETED|Overall Study||230
2871329|NCT00201851|3575021|FG000|NOT COMPLETED|Overall Study||8
2871330|NCT00201851|3575022|FG001|NOT COMPLETED|Overall Study||2
2871331|NCT00201851|3575023|FG002|NOT COMPLETED|Overall Study||1
2871332|NCT00201864|3575031|FG000|STARTED|Overall Study||40
2871333|NCT00201864|3575031|FG000|COMPLETED|Overall Study||40
2871334|NCT00201864|3575031|FG000|NOT COMPLETED|Overall Study||0
2871335|NCT00201877|3575037|FG000|STARTED|Overall Study||25
2871336|NCT00201877|3575037|FG000|COMPLETED|Overall Study||25
2871337|NCT00201877|3575037|FG000|NOT COMPLETED|Overall Study||0
2871338|NCT00202449|3575045|FG000|STARTED|Overall Study||18
2871339|NCT00202449|3575046|FG001|STARTED|Overall Study||20
2871340|NCT00202449|3575047|FG002|STARTED|Overall Study||21
2871341|NCT00202449|3575045|FG000|COMPLETED|Overall Study||7
2871342|NCT00202449|3575046|FG001|COMPLETED|Overall Study||9
2871343|NCT00202449|3575047|FG002|COMPLETED|Overall Study||9
2871344|NCT00202449|3575045|FG000|NOT COMPLETED|Overall Study||11
2871345|NCT00202449|3575046|FG001|NOT COMPLETED|Overall Study||11
2871346|NCT00202449|3575047|FG002|NOT COMPLETED|Overall Study||12
2871347|NCT00202644|3575057|FG000|STARTED|Overall Study|One participant not randomized but treated.|76
2871348|NCT00202644|3575058|FG001|STARTED|Overall Study||70
2871349|NCT00202644|3575057|FG000|COMPLETED|Overall Study||41
2871350|NCT00202644|3575058|FG001|COMPLETED|Overall Study||43
2871351|NCT00202644|3575057|FG000|NOT COMPLETED|Overall Study||35
2871352|NCT00202644|3575058|FG001|NOT COMPLETED|Overall Study||27
2871353|NCT00202722|3575064|FG000|STARTED|Overall Study||41
2871354|NCT00202722|3575064|FG000|COMPLETED|Overall Study||41
2871355|NCT00202722|3575064|FG000|NOT COMPLETED|Overall Study||0
2871356|NCT00202839|3575071|FG000|STARTED|Overall Study||78
2871357|NCT00202839|3575072|FG001|STARTED|Overall Study||82
2871358|NCT00202839|3575071|FG000|COMPLETED|Overall Study||54
2871359|NCT00202839|3575072|FG001|COMPLETED|Overall Study||72
2871360|NCT00202839|3575071|FG000|NOT COMPLETED|Overall Study||24
2871361|NCT00202839|3575072|FG001|NOT COMPLETED|Overall Study||10
2871362|NCT00202930|3575078|FG000|STARTED|Overall Study||4
2871363|NCT00202930|3575078|FG000|COMPLETED|Overall Study||4
2871364|NCT00202930|3575078|FG000|NOT COMPLETED|Overall Study||0
2871365|NCT00203021|3575084|FG000|STARTED|Overall Study||107
2871366|NCT00203021|3575085|FG001|STARTED|Overall Study||101
2871367|NCT00203021|3575084|FG000|Received at Least 1 Dose of Study Drug|Overall Study||107
2871368|NCT00203021|3575085|FG001|Received at Least 1 Dose of Study Drug|Overall Study||101
2871369|NCT00203021|3575084|FG000|COMPLETED|Overall Study||28
2871370|NCT00203021|3575085|FG001|COMPLETED|Overall Study||24
2871371|NCT00203021|3575084|FG000|NOT COMPLETED|Overall Study||79
2871372|NCT00203021|3575085|FG001|NOT COMPLETED|Overall Study||77
2871373|NCT00203047|3575093|FG000|STARTED|Overall Study||204
2871374|NCT00203047|3575094|FG001|STARTED|Overall Study||210
2871375|NCT00203047|3575093|FG000|In Database as of January 29, 2009|Overall Study||199
2871376|NCT00203047|3575094|FG001|In Database as of January 29, 2009|Overall Study||209
2871377|NCT00203047|3575093|FG000|COMPLETED|Overall Study||13
2871378|NCT00203047|3575094|FG001|COMPLETED|Overall Study||7
2871379|NCT00203047|3575093|FG000|NOT COMPLETED|Overall Study||191
2871380|NCT00203047|3575094|FG001|NOT COMPLETED|Overall Study||203
2871381|NCT00203203|3575102|FG000|STARTED|Overall Study||10
2871382|NCT00203203|3575103|FG001|STARTED|Overall Study||20
2871383|NCT00203203|3575102|FG000|COMPLETED|Overall Study||9
2871384|NCT00203203|3575103|FG001|COMPLETED|Overall Study||20
2871385|NCT00203203|3575102|FG000|NOT COMPLETED|Overall Study||1
2871386|NCT00203203|3575103|FG001|NOT COMPLETED|Overall Study||0
2871387|NCT00203216|3575109|FG000|STARTED|Overall Study||31
2871388|NCT00203216|3575109|FG000|COMPLETED|Overall Study||27
2871389|NCT00203216|3575109|FG000|NOT COMPLETED|Overall Study||4
2871390|NCT00203229|3575115|FG000|STARTED|Overall Study||10
2871391|NCT00203229|3575116|FG001|STARTED|Overall Study||10
2871392|NCT00203229|3575115|FG000|COMPLETED|Overall Study||7
2871393|NCT00203229|3575116|FG001|COMPLETED|Overall Study||7
2871394|NCT00203229|3575115|FG000|NOT COMPLETED|Overall Study||3
2871395|NCT00203229|3575116|FG001|NOT COMPLETED|Overall Study||3
2871396|NCT00203242|3575122|FG000|STARTED|Overall Study||15
2871397|NCT00203242|3575122|FG000|COMPLETED|Overall Study||14
2871398|NCT00203242|3575122|FG000|NOT COMPLETED|Overall Study||1
2871399|NCT00203268|3575126|FG000|STARTED|Early Treatment||13
2871400|NCT00203268|3575126|FG000|COMPLETED|Early Treatment||9
2871401|NCT00203268|3575126|FG000|NOT COMPLETED|Early Treatment||4
2871402|NCT00203268|3575126|FG000|STARTED|Late Treatment||9
2871403|NCT00203268|3575126|FG000|COMPLETED|Late Treatment||9
2871404|NCT00203268|3575126|FG000|NOT COMPLETED|Late Treatment||0
2871405|NCT00203294|3575134|FG000|STARTED|Overall Study||22
2871406|NCT00203294|3575135|FG001|STARTED|Overall Study||23
2871407|NCT00203294|3575134|FG000|COMPLETED|Overall Study||14
2871408|NCT00203294|3575135|FG001|COMPLETED|Overall Study||10
2871409|NCT00203294|3575134|FG000|NOT COMPLETED|Overall Study||8
2871410|NCT00203294|3575135|FG001|NOT COMPLETED|Overall Study||13
2871411|NCT00203307|3575143|FG000|STARTED|First Intervention|Double-blind cross-over design. Study terminated early. Results not analyzed.|3
2871412|NCT00203307|3575144|FG001|STARTED|First Intervention||0
2871413|NCT00203307|3575143|FG000|COMPLETED|First Intervention||1
2871414|NCT00203307|3575144|FG001|COMPLETED|First Intervention||0
2871415|NCT00203307|3575143|FG000|NOT COMPLETED|First Intervention||2
2871416|NCT00203307|3575144|FG001|NOT COMPLETED|First Intervention||0
2871417|NCT00203307|3575143|FG000|STARTED|Second Intervention|2 subjects dropped out of the 1st intervention period, due to fatugue.|1
2871418|NCT00203307|3575144|FG001|STARTED|Second Intervention||0
2871419|NCT00203307|3575143|FG000|COMPLETED|Second Intervention||1
2871420|NCT00203307|3575144|FG001|COMPLETED|Second Intervention||0
2871421|NCT00203307|3575143|FG000|NOT COMPLETED|Second Intervention||0
2871422|NCT00203307|3575144|FG001|NOT COMPLETED|Second Intervention||0
2871423|NCT00203411|3575150|FG000|STARTED|Treatment Period||45
2871424|NCT00203411|3575150|FG000|COMPLETED|Treatment Period||45
2871425|NCT00203411|3575150|FG000|NOT COMPLETED|Treatment Period||0
2871426|NCT00203411|3575150|FG000|STARTED|Follow-up||45
2871427|NCT00203411|3575150|FG000|COMPLETED|Follow-up||41
2871428|NCT00203411|3575150|FG000|NOT COMPLETED|Follow-up||4
2871429|NCT00203424|3575155|FG000|STARTED|Treatment Period|23 subjects registered for treatment, 1 withdrew consent after registration,22 received treatment.|22
2871430|NCT00203424|3575155|FG000|COMPLETED|Treatment Period|Of 11 pts that did not complete treatment,5 stopped due to adverse event and entered followup period|11
2871431|NCT00203424|3575155|FG000|NOT COMPLETED|Treatment Period||11
2871432|NCT00203424|3575155|FG000|STARTED|Follow-up Period|followup includes 11 pts that completed treatment + 5 pts who stopped treatment due to adverse event|16
2871433|NCT00203424|3575155|FG000|COMPLETED|Follow-up Period||10
2871434|NCT00203424|3575155|FG000|NOT COMPLETED|Follow-up Period||6
2871435|NCT00203476|3575162|FG000|STARTED|Overall Study||10
3169585|NCT01926444|3897128|FG001|COMPLETED|Overall Study||52
3169586|NCT01926444|3897129|FG002|COMPLETED|Overall Study||53
3169587|NCT01926444|3897130|FG003|COMPLETED|Overall Study||101
3169588|NCT01926444|3897127|FG000|NOT COMPLETED|Overall Study||0
3169589|NCT01926444|3897128|FG001|NOT COMPLETED|Overall Study||0
3169590|NCT01926444|3897129|FG002|NOT COMPLETED|Overall Study||4
3169591|NCT01926444|3897130|FG003|NOT COMPLETED|Overall Study||2
3169592|NCT01926496|3897142|FG000|STARTED|Overall Study||240
3169593|NCT01926496|3897143|FG001|STARTED|Overall Study||245
3169594|NCT01926496|3897142|FG000|COMPLETED|Overall Study||203
3169595|NCT01926496|3897143|FG001|COMPLETED|Overall Study||197
3169596|NCT01926496|3897142|FG000|NOT COMPLETED|Overall Study||37
3169597|NCT01926496|3897143|FG001|NOT COMPLETED|Overall Study||48
3169598|NCT01926509|3897157|FG000|STARTED|Overall Study||6
3169599|NCT01926509|3897158|FG001|STARTED|Overall Study||6
3169600|NCT01926509|3897159|FG002|STARTED|Overall Study||5
3169601|NCT01926509|3897160|FG003|STARTED|Overall Study||6
2871436|NCT00203476|3575163|FG001|STARTED|Overall Study||10
2871437|NCT00203476|3575164|FG002|STARTED|Overall Study||10
2871438|NCT00203476|3575162|FG000|COMPLETED|Overall Study||9
2871439|NCT00203476|3575163|FG001|COMPLETED|Overall Study||9
2871440|NCT00203476|3575164|FG002|COMPLETED|Overall Study||10
2871441|NCT00203476|3575162|FG000|NOT COMPLETED|Overall Study||1
2871442|NCT00203476|3575163|FG001|NOT COMPLETED|Overall Study||1
2871443|NCT00203476|3575164|FG002|NOT COMPLETED|Overall Study||0
2871444|NCT00203502|3575172|FG000|STARTED|Overall Study||40
2871445|NCT00203502|3575172|FG000|COMPLETED|Overall Study||39
2871446|NCT00203502|3575172|FG000|NOT COMPLETED|Overall Study||1
3169602|NCT01926509|3897157|FG000|COMPLETED|Overall Study||5
3169603|NCT01926509|3897158|FG001|COMPLETED|Overall Study||6
3169604|NCT01926509|3897159|FG002|COMPLETED|Overall Study||5
3169605|NCT01926509|3897160|FG003|COMPLETED|Overall Study||6
2871447|NCT00203892|3575179|FG000|STARTED|Overall Study||7
2871448|NCT00203892|3575180|FG001|STARTED|Overall Study||10
2871449|NCT00203892|3575181|FG002|STARTED|Overall Study||6
2871450|NCT00203892|3575179|FG000|Received at Least 3 Doses of CEA Vaccine|Overall Study|This group of patients were evaluable for the primary outcome.|5
2871451|NCT00203892|3575180|FG001|Received at Least 3 Doses of CEA Vaccine|Overall Study|This group of patients were evaluable for the primary outcome.|5
2871452|NCT00203892|3575181|FG002|Received at Least 3 Doses of CEA Vaccine|Overall Study|This group of patients were evaluable for the primary outcome.|4
2871453|NCT00203892|3575179|FG000|COMPLETED|Overall Study|2 patients not completing study were randomized but never treated|5
2871454|NCT00203892|3575180|FG001|COMPLETED|Overall Study|2 patients not completing study were randomized but never treated|8
2871455|NCT00203892|3575181|FG002|COMPLETED|Overall Study||6
2871456|NCT00203892|3575179|FG000|NOT COMPLETED|Overall Study||2
2871457|NCT00203892|3575180|FG001|NOT COMPLETED|Overall Study||2
2871458|NCT00203892|3575181|FG002|NOT COMPLETED|Overall Study||0
2871459|NCT00203931|3575191|FG000|STARTED|Overall Study||27
2871460|NCT00203931|3575192|FG001|STARTED|Overall Study||28
2871461|NCT00203931|3575191|FG000|COMPLETED|Overall Study|These are the evaluable patients who received at least 3 doses of cetuximab.|20
2871462|NCT00203931|3575192|FG001|COMPLETED|Overall Study|These are the evaluable patients who received at least 3 doses of cetuximab.|23
2871463|NCT00203931|3575191|FG000|NOT COMPLETED|Overall Study||7
2871464|NCT00203931|3575192|FG001|NOT COMPLETED|Overall Study||5
2871465|NCT00203996|3575208|FG000|STARTED|Overall Study||0
2871466|NCT00203996|3575209|FG001|STARTED|Overall Study||0
2871467|NCT00203996|3575210|FG002|STARTED|Overall Study||0
2871468|NCT00203996|3575211|FG003|STARTED|Overall Study||19
2871469|NCT00203996|3575212|FG004|STARTED|Overall Study||4
2871470|NCT00203996|3575213|FG005|STARTED|Overall Study||3
2871471|NCT00203996|3575214|FG006|STARTED|Overall Study||2
2871472|NCT00203996|3575215|FG007|STARTED|Overall Study||4
2871473|NCT00203996|3575216|FG008|STARTED|Overall Study||2
2871474|NCT00203996|3575217|FG009|STARTED|Overall Study||3
2871475|NCT00203996|3575208|FG000|Aim 3 Only: First Intervention|Overall Study||0
2871476|NCT00203996|3575209|FG001|Aim 3 Only: First Intervention|Overall Study||0
2871477|NCT00203996|3575210|FG002|Aim 3 Only: First Intervention|Overall Study||0
2871478|NCT00203996|3575211|FG003|Aim 3 Only: First Intervention|Overall Study||0
2871479|NCT00203996|3575212|FG004|Aim 3 Only: First Intervention|Overall Study||0
2871480|NCT00203996|3575213|FG005|Aim 3 Only: First Intervention|Overall Study||3
2871481|NCT00203996|3575214|FG006|Aim 3 Only: First Intervention|Overall Study||2
2871482|NCT00203996|3575215|FG007|Aim 3 Only: First Intervention|Overall Study||4
2871483|NCT00203996|3575216|FG008|Aim 3 Only: First Intervention|Overall Study||2
2871484|NCT00203996|3575217|FG009|Aim 3 Only: First Intervention|Overall Study||3
2871485|NCT00203996|3575208|FG000|Aim 3 Only: Washout|Overall Study||0
2871486|NCT00203996|3575209|FG001|Aim 3 Only: Washout|Overall Study||0
2871487|NCT00203996|3575210|FG002|Aim 3 Only: Washout|Overall Study||0
2871488|NCT00203996|3575211|FG003|Aim 3 Only: Washout|Overall Study||0
2871489|NCT00203996|3575212|FG004|Aim 3 Only: Washout|Overall Study||0
2871490|NCT00203996|3575213|FG005|Aim 3 Only: Washout|Overall Study||3
2871491|NCT00203996|3575214|FG006|Aim 3 Only: Washout|Overall Study||2
2871492|NCT00203996|3575215|FG007|Aim 3 Only: Washout|Overall Study||2
2871493|NCT00203996|3575216|FG008|Aim 3 Only: Washout|Overall Study||2
2871494|NCT00203996|3575217|FG009|Aim 3 Only: Washout|Overall Study||2
2871495|NCT00203996|3575208|FG000|Aim 3 Only: Second Intervention|Overall Study||0
2871496|NCT00203996|3575209|FG001|Aim 3 Only: Second Intervention|Overall Study||0
2871497|NCT00203996|3575210|FG002|Aim 3 Only: Second Intervention|Overall Study||0
2871498|NCT00203996|3575211|FG003|Aim 3 Only: Second Intervention|Overall Study||0
2871499|NCT00203996|3575212|FG004|Aim 3 Only: Second Intervention|Overall Study||0
2871500|NCT00203996|3575213|FG005|Aim 3 Only: Second Intervention|Overall Study||3
2871501|NCT00203996|3575214|FG006|Aim 3 Only: Second Intervention|Overall Study||2
2871502|NCT00203996|3575215|FG007|Aim 3 Only: Second Intervention|Overall Study||2
2871503|NCT00203996|3575216|FG008|Aim 3 Only: Second Intervention|Overall Study||2
2871504|NCT00203996|3575217|FG009|Aim 3 Only: Second Intervention|Overall Study||2
2871505|NCT00203996|3575208|FG000|Aim 3 Only: Second Washout|Overall Study||0
2871506|NCT00203996|3575209|FG001|Aim 3 Only: Second Washout|Overall Study||0
2871507|NCT00203996|3575210|FG002|Aim 3 Only: Second Washout|Overall Study||0
2871508|NCT00203996|3575211|FG003|Aim 3 Only: Second Washout|Overall Study||0
2871509|NCT00203996|3575212|FG004|Aim 3 Only: Second Washout|Overall Study||0
2871510|NCT00203996|3575213|FG005|Aim 3 Only: Second Washout|Overall Study||3
2871511|NCT00203996|3575214|FG006|Aim 3 Only: Second Washout|Overall Study||2
2871512|NCT00203996|3575215|FG007|Aim 3 Only: Second Washout|Overall Study||2
2871513|NCT00203996|3575216|FG008|Aim 3 Only: Second Washout|Overall Study||2
2871514|NCT00203996|3575217|FG009|Aim 3 Only: Second Washout|Overall Study||2
2871515|NCT00203996|3575208|FG000|Aim 3 Only: Third Intervention|Overall Study||0
2871516|NCT00203996|3575209|FG001|Aim 3 Only: Third Intervention|Overall Study||0
2871517|NCT00203996|3575210|FG002|Aim 3 Only: Third Intervention|Overall Study||0
2871518|NCT00203996|3575211|FG003|Aim 3 Only: Third Intervention|Overall Study||0
2871519|NCT00203996|3575212|FG004|Aim 3 Only: Third Intervention|Overall Study||0
2871520|NCT00203996|3575213|FG005|Aim 3 Only: Third Intervention|Overall Study||3
2871521|NCT00203996|3575214|FG006|Aim 3 Only: Third Intervention|Overall Study||2
2871522|NCT00203996|3575215|FG007|Aim 3 Only: Third Intervention|Overall Study||2
2871523|NCT00203996|3575216|FG008|Aim 3 Only: Third Intervention|Overall Study||2
2871524|NCT00203996|3575217|FG009|Aim 3 Only: Third Intervention|Overall Study||2
2871525|NCT00203996|3575208|FG000|COMPLETED|Overall Study||0
3169606|NCT01926509|3897157|FG000|NOT COMPLETED|Overall Study||1
3169607|NCT01926509|3897158|FG001|NOT COMPLETED|Overall Study||0
3169608|NCT01926509|3897159|FG002|NOT COMPLETED|Overall Study||0
2871526|NCT00203996|3575209|FG001|COMPLETED|Overall Study||0
2871527|NCT00203996|3575210|FG002|COMPLETED|Overall Study||0
2871528|NCT00203996|3575211|FG003|COMPLETED|Overall Study||9
2871529|NCT00203996|3575212|FG004|COMPLETED|Overall Study||3
2871530|NCT00203996|3575213|FG005|COMPLETED|Overall Study||3
2871531|NCT00203996|3575214|FG006|COMPLETED|Overall Study||2
2871532|NCT00203996|3575215|FG007|COMPLETED|Overall Study||2
2871533|NCT00203996|3575216|FG008|COMPLETED|Overall Study||2
2871534|NCT00203996|3575217|FG009|COMPLETED|Overall Study||2
2871535|NCT00203996|3575208|FG000|NOT COMPLETED|Overall Study||0
2871536|NCT00203996|3575209|FG001|NOT COMPLETED|Overall Study||0
2871537|NCT00203996|3575210|FG002|NOT COMPLETED|Overall Study||0
2871538|NCT00203996|3575211|FG003|NOT COMPLETED|Overall Study||10
2871539|NCT00203996|3575212|FG004|NOT COMPLETED|Overall Study||1
2871540|NCT00203996|3575213|FG005|NOT COMPLETED|Overall Study||0
2871541|NCT00203996|3575214|FG006|NOT COMPLETED|Overall Study||0
2871542|NCT00203996|3575215|FG007|NOT COMPLETED|Overall Study||2
2871543|NCT00203996|3575216|FG008|NOT COMPLETED|Overall Study||0
2871544|NCT00203996|3575217|FG009|NOT COMPLETED|Overall Study||1
2871545|NCT00204373|3575233|FG000|STARTED|Overall Study||72
2871546|NCT00204373|3575233|FG000|COMPLETED|Overall Study||72
2871547|NCT00204373|3575233|FG000|NOT COMPLETED|Overall Study||0
2871548|NCT00204932|3575239|FG000|STARTED|Overall Study||24
2871549|NCT00204932|3575240|FG001|STARTED|Overall Study||24
2871550|NCT00204932|3575239|FG000|COMPLETED|Overall Study||22
2871551|NCT00204932|3575240|FG001|COMPLETED|Overall Study||18
2871552|NCT00204932|3575239|FG000|NOT COMPLETED|Overall Study||2
2871553|NCT00204932|3575240|FG001|NOT COMPLETED|Overall Study||6
2871554|NCT00205179|3575248|FG000|STARTED|Overall Study||32
2871555|NCT00205179|3575249|FG001|STARTED|Overall Study||33
3169609|NCT01926509|3897160|FG003|NOT COMPLETED|Overall Study||0
3169610|NCT01926626|3897170|FG000|STARTED|Overall Study||38
3169611|NCT01926626|3897170|FG000|Received Moclobemide|Overall Study||37
3169612|NCT01926626|3897170|FG000|COMPLETED|Overall Study||16
3169613|NCT01926626|3897170|FG000|NOT COMPLETED|Overall Study||22
3169614|NCT01926782|3897180|FG000|STARTED|Overall Study||157
3169615|NCT01926782|3897181|FG001|STARTED|Overall Study||78
3169616|NCT01926782|3897182|FG002|STARTED|Overall Study||312
3169617|NCT01926782|3897183|FG003|STARTED|Overall Study||73
3169618|NCT01926782|3897184|FG004|STARTED|Overall Study||37
3169619|NCT01926782|3897185|FG005|STARTED|Overall Study||146
3169620|NCT01926782|3897180|FG000|Treated|Overall Study||157
3169621|NCT01926782|3897181|FG001|Treated|Overall Study||78
3169622|NCT01926782|3897182|FG002|Treated|Overall Study||312
3169623|NCT01926782|3897183|FG003|Treated|Overall Study||72
3169624|NCT01926782|3897184|FG004|Treated|Overall Study||37
3313660|NCT03076970|4046931|FG003|COMPLETED|Period 2||7
3313661|NCT03076970|4046932|FG004|COMPLETED|Period 2||7
2871556|NCT00205179|3575248|FG000|COMPLETED|Overall Study||30
2871557|NCT00205179|3575249|FG001|COMPLETED|Overall Study||29
2871558|NCT00205179|3575248|FG000|NOT COMPLETED|Overall Study||2
2871559|NCT00205179|3575249|FG001|NOT COMPLETED|Overall Study||4
2871560|NCT00205348|3575256|FG000|STARTED|Overall Study||146
2871561|NCT00205348|3575256|FG000|COMPLETED|Overall Study||116
2871562|NCT00205348|3575256|FG000|NOT COMPLETED|Overall Study||30
2871563|NCT00205374|3575262|FG000|STARTED|Overall Study||10
2871564|NCT00205374|3575263|FG001|STARTED|Overall Study||9
2871565|NCT00205374|3575262|FG000|COMPLETED|Overall Study||10
3313662|NCT03076970|4046933|FG005|COMPLETED|Period 2||7
3313663|NCT03076970|4046928|FG000|NOT COMPLETED|Period 2||0
3313664|NCT03076970|4046929|FG001|NOT COMPLETED|Period 2||0
3313665|NCT03076970|4046930|FG002|NOT COMPLETED|Period 2||0
3313666|NCT03076970|4046931|FG003|NOT COMPLETED|Period 2||0
3313667|NCT03076970|4046932|FG004|NOT COMPLETED|Period 2||0
3313668|NCT03076970|4046933|FG005|NOT COMPLETED|Period 2||0
3313669|NCT03076970|4046928|FG000|STARTED|Washout Period 2||7
3313670|NCT03076970|4046929|FG001|STARTED|Washout Period 2||7
3313671|NCT03076970|4046930|FG002|STARTED|Washout Period 2||7
3313672|NCT03076970|4046931|FG003|STARTED|Washout Period 2||7
3313673|NCT03076970|4046932|FG004|STARTED|Washout Period 2||7
3313674|NCT03076970|4046933|FG005|STARTED|Washout Period 2||7
3313675|NCT03076970|4046928|FG000|COMPLETED|Washout Period 2||7
3313676|NCT03076970|4046929|FG001|COMPLETED|Washout Period 2||7
3313677|NCT03076970|4046930|FG002|COMPLETED|Washout Period 2||7
3313678|NCT03076970|4046931|FG003|COMPLETED|Washout Period 2||7
3313679|NCT03076970|4046932|FG004|COMPLETED|Washout Period 2||6
3313680|NCT03076970|4046933|FG005|COMPLETED|Washout Period 2||7
3313681|NCT03076970|4046928|FG000|NOT COMPLETED|Washout Period 2||0
3313682|NCT03076970|4046929|FG001|NOT COMPLETED|Washout Period 2||0
3313683|NCT03076970|4046930|FG002|NOT COMPLETED|Washout Period 2||0
3313684|NCT03076970|4046931|FG003|NOT COMPLETED|Washout Period 2||0
3313685|NCT03076970|4046932|FG004|NOT COMPLETED|Washout Period 2||1
3313686|NCT03076970|4046933|FG005|NOT COMPLETED|Washout Period 2||0
2871566|NCT00205374|3575263|FG001|COMPLETED|Overall Study||9
2871567|NCT00205374|3575262|FG000|NOT COMPLETED|Overall Study||0
2871568|NCT00205374|3575263|FG001|NOT COMPLETED|Overall Study||0
2871569|NCT00205504|3575271|FG000|STARTED|Overall Study||21
3169625|NCT01926782|3897185|FG005|Treated|Overall Study||146
2871570|NCT00205504|3575272|FG001|STARTED|Overall Study||15
2871571|NCT00205504|3575271|FG000|COMPLETED|Overall Study||14
2871572|NCT00205504|3575272|FG001|COMPLETED|Overall Study||15
2871573|NCT00205504|3575271|FG000|NOT COMPLETED|Overall Study||7
2871574|NCT00205504|3575272|FG001|NOT COMPLETED|Overall Study||0
2871575|NCT00205660|3575284|FG000|STARTED|Overall Study||14
3169626|NCT01926782|3897180|FG000|Completed 24 Weeks Treatment Period|Overall Study||137
2871576|NCT00205660|3575285|FG001|STARTED|Overall Study||37
2871577|NCT00205660|3575284|FG000|COMPLETED|Overall Study||12
2871578|NCT00205660|3575285|FG001|COMPLETED|Overall Study||35
2871579|NCT00205660|3575284|FG000|NOT COMPLETED|Overall Study||2
2871580|NCT00205660|3575285|FG001|NOT COMPLETED|Overall Study||2
2871581|NCT00205699|3575295|FG000|STARTED|Overall Study||49
2871582|NCT00205699|3575296|FG001|STARTED|Overall Study||46
2871583|NCT00205699|3575297|FG002|STARTED|Overall Study||49
2871584|NCT00205699|3575295|FG000|COMPLETED|Overall Study||46
2871585|NCT00205699|3575296|FG001|COMPLETED|Overall Study||40
2871586|NCT00205699|3575297|FG002|COMPLETED|Overall Study||43
2871587|NCT00205699|3575295|FG000|NOT COMPLETED|Overall Study||3
2871588|NCT00205699|3575296|FG001|NOT COMPLETED|Overall Study||6
2871589|NCT00205699|3575297|FG002|NOT COMPLETED|Overall Study||6
2871590|NCT00205712|3575310|FG000|STARTED|Overall Study||20
2871591|NCT00205712|3575311|FG001|STARTED|Overall Study||20
2871592|NCT00205712|3575310|FG000|COMPLETED|Overall Study||20
2871593|NCT00205712|3575311|FG001|COMPLETED|Overall Study||19
2871594|NCT00205712|3575310|FG000|NOT COMPLETED|Overall Study||0
2871595|NCT00205712|3575311|FG001|NOT COMPLETED|Overall Study||1
2871596|NCT00205777|3575323|FG000|STARTED|Core Study (Up to 3 Years)||1907
2871597|NCT00205777|3575324|FG001|STARTED|Core Study (Up to 3 Years)||1904
2871598|NCT00205777|3575325|FG002|STARTED|Core Study (Up to 3 Years)||1884
2871599|NCT00205777|3575326|FG003|STARTED|Core Study (Up to 3 Years)||1914
2871600|NCT00205777|3575327|FG004|STARTED|Core Study (Up to 3 Years)||0
2871601|NCT00205777|3575328|FG005|STARTED|Core Study (Up to 3 Years)||0
2871602|NCT00205777|3575323|FG000|TREATED|Core Study (Up to 3 Years)||1886
2871603|NCT00205777|3575324|FG001|TREATED|Core Study (Up to 3 Years)||1872
2871604|NCT00205777|3575325|FG002|TREATED|Core Study (Up to 3 Years)||1849
2871605|NCT00205777|3575326|FG003|TREATED|Core Study (Up to 3 Years)||1885
2871606|NCT00205777|3575327|FG004|TREATED|Core Study (Up to 3 Years)||0
2871607|NCT00205777|3575328|FG005|TREATED|Core Study (Up to 3 Years)||0
2871608|NCT00205777|3575323|FG000|COMPLETED|Core Study (Up to 3 Years)||1279
2871609|NCT00205777|3575324|FG001|COMPLETED|Core Study (Up to 3 Years)||1245
2871610|NCT00205777|3575325|FG002|COMPLETED|Core Study (Up to 3 Years)||1277
2871611|NCT00205777|3575326|FG003|COMPLETED|Core Study (Up to 3 Years)||1282
2871612|NCT00205777|3575327|FG004|COMPLETED|Core Study (Up to 3 Years)||0
2871613|NCT00205777|3575328|FG005|COMPLETED|Core Study (Up to 3 Years)||0
2871614|NCT00205777|3575323|FG000|NOT COMPLETED|Core Study (Up to 3 Years)||628
2871615|NCT00205777|3575324|FG001|NOT COMPLETED|Core Study (Up to 3 Years)||659
2871616|NCT00205777|3575325|FG002|NOT COMPLETED|Core Study (Up to 3 Years)||607
2871617|NCT00205777|3575326|FG003|NOT COMPLETED|Core Study (Up to 3 Years)||632
2871618|NCT00205777|3575327|FG004|NOT COMPLETED|Core Study (Up to 3 Years)||0
2871619|NCT00205777|3575328|FG005|NOT COMPLETED|Core Study (Up to 3 Years)||0
2871620|NCT00205777|3575323|FG000|STARTED|Completed Core Study, Entered SE I||1279
2871621|NCT00205777|3575324|FG001|STARTED|Completed Core Study, Entered SE I||1245
2871622|NCT00205777|3575325|FG002|STARTED|Completed Core Study, Entered SE I||1277
2871623|NCT00205777|3575326|FG003|STARTED|Completed Core Study, Entered SE I||1282
2871624|NCT00205777|3575327|FG004|STARTED|Completed Core Study, Entered SE I||0
2871625|NCT00205777|3575328|FG005|STARTED|Completed Core Study, Entered SE I||0
2871626|NCT00205777|3575323|FG000|COMPLETED|Completed Core Study, Entered SE I||1047
2871627|NCT00205777|3575324|FG001|COMPLETED|Completed Core Study, Entered SE I||1041
2871628|NCT00205777|3575325|FG002|COMPLETED|Completed Core Study, Entered SE I||1070
2871629|NCT00205777|3575326|FG003|COMPLETED|Completed Core Study, Entered SE I||1058
2871630|NCT00205777|3575327|FG004|COMPLETED|Completed Core Study, Entered SE I||0
2871631|NCT00205777|3575328|FG005|COMPLETED|Completed Core Study, Entered SE I||0
2871632|NCT00205777|3575323|FG000|NOT COMPLETED|Completed Core Study, Entered SE I||232
2871633|NCT00205777|3575324|FG001|NOT COMPLETED|Completed Core Study, Entered SE I||204
2871634|NCT00205777|3575325|FG002|NOT COMPLETED|Completed Core Study, Entered SE I||207
2871635|NCT00205777|3575326|FG003|NOT COMPLETED|Completed Core Study, Entered SE I||224
2871636|NCT00205777|3575327|FG004|NOT COMPLETED|Completed Core Study, Entered SE I||0
2871637|NCT00205777|3575328|FG005|NOT COMPLETED|Completed Core Study, Entered SE I||0
2871638|NCT00205777|3575323|FG000|STARTED|Study Extension I||1047
2871639|NCT00205777|3575324|FG001|STARTED|Study Extension I||0
2871640|NCT00205777|3575325|FG002|STARTED|Study Extension I||1070
2871641|NCT00205777|3575326|FG003|STARTED|Study Extension I||1058
2871642|NCT00205777|3575327|FG004|STARTED|Study Extension I||1041
2871643|NCT00205777|3575328|FG005|STARTED|Study Extension I||0
2871644|NCT00205777|3575323|FG000|COMPLETED|Study Extension I||833
2871645|NCT00205777|3575324|FG001|COMPLETED|Study Extension I||0
2871646|NCT00205777|3575325|FG002|COMPLETED|Study Extension I||0
2871647|NCT00205777|3575326|FG003|COMPLETED|Study Extension I||830
2871648|NCT00205777|3575327|FG004|COMPLETED|Study Extension I||840
2871649|NCT00205777|3575328|FG005|COMPLETED|Study Extension I||0
2871650|NCT00205777|3575323|FG000|NOT COMPLETED|Study Extension I||214
2871651|NCT00205777|3575324|FG001|NOT COMPLETED|Study Extension I||0
2871652|NCT00205777|3575325|FG002|NOT COMPLETED|Study Extension I||1070
2871653|NCT00205777|3575326|FG003|NOT COMPLETED|Study Extension I||228
2871654|NCT00205777|3575327|FG004|NOT COMPLETED|Study Extension I||201
2871655|NCT00205777|3575328|FG005|NOT COMPLETED|Study Extension I||0
2871656|NCT00205777|3575323|FG000|STARTED|Completed SE I, Entered Extension SE II||833
2871657|NCT00205777|3575324|FG001|STARTED|Completed SE I, Entered Extension SE II||0
2871658|NCT00205777|3575325|FG002|STARTED|Completed SE I, Entered Extension SE II||0
2871659|NCT00205777|3575326|FG003|STARTED|Completed SE I, Entered Extension SE II||830
2871660|NCT00205777|3575327|FG004|STARTED|Completed SE I, Entered Extension SE II||840
2871661|NCT00205777|3575328|FG005|STARTED|Completed SE I, Entered Extension SE II||0
2871662|NCT00205777|3575323|FG000|COMPLETED|Completed SE I, Entered Extension SE II||560
2871663|NCT00205777|3575324|FG001|COMPLETED|Completed SE I, Entered Extension SE II||0
2871664|NCT00205777|3575325|FG002|COMPLETED|Completed SE I, Entered Extension SE II||0
2871665|NCT00205777|3575326|FG003|COMPLETED|Completed SE I, Entered Extension SE II||590
2871666|NCT00205777|3575327|FG004|COMPLETED|Completed SE I, Entered Extension SE II||582
2871667|NCT00205777|3575328|FG005|COMPLETED|Completed SE I, Entered Extension SE II||0
2871668|NCT00205777|3575323|FG000|NOT COMPLETED|Completed SE I, Entered Extension SE II||273
2871669|NCT00205777|3575324|FG001|NOT COMPLETED|Completed SE I, Entered Extension SE II||0
2871670|NCT00205777|3575325|FG002|NOT COMPLETED|Completed SE I, Entered Extension SE II||0
2871671|NCT00205777|3575326|FG003|NOT COMPLETED|Completed SE I, Entered Extension SE II||240
2871672|NCT00205777|3575327|FG004|NOT COMPLETED|Completed SE I, Entered Extension SE II||258
2871673|NCT00205777|3575328|FG005|NOT COMPLETED|Completed SE I, Entered Extension SE II||0
2871674|NCT00205777|3575323|FG000|STARTED|Study Extension II||0
2871675|NCT00205777|3575324|FG001|STARTED|Study Extension II||0
2871676|NCT00205777|3575325|FG002|STARTED|Study Extension II||0
2871677|NCT00205777|3575326|FG003|STARTED|Study Extension II||590
2871678|NCT00205777|3575327|FG004|STARTED|Study Extension II||0
2871679|NCT00205777|3575328|FG005|STARTED|Study Extension II||1142
2871680|NCT00205777|3575323|FG000|TREATED|Study Extension II||0
2871681|NCT00205777|3575324|FG001|TREATED|Study Extension II||0
2871682|NCT00205777|3575325|FG002|TREATED|Study Extension II||0
2871683|NCT00205777|3575326|FG003|TREATED|Study Extension II||519
2871684|NCT00205777|3575327|FG004|TREATED|Study Extension II||0
2871685|NCT00205777|3575328|FG005|TREATED|Study Extension II||1011
2871686|NCT00205777|3575323|FG000|COMPLETED|Study Extension II||0
2871687|NCT00205777|3575324|FG001|COMPLETED|Study Extension II||0
2871688|NCT00205777|3575325|FG002|COMPLETED|Study Extension II||0
2871689|NCT00205777|3575326|FG003|COMPLETED|Study Extension II||441
2871690|NCT00205777|3575327|FG004|COMPLETED|Study Extension II||0
2871691|NCT00205777|3575328|FG005|COMPLETED|Study Extension II||860
2871692|NCT00205777|3575323|FG000|NOT COMPLETED|Study Extension II||0
2871693|NCT00205777|3575324|FG001|NOT COMPLETED|Study Extension II||0
2871694|NCT00205777|3575325|FG002|NOT COMPLETED|Study Extension II||0
2871695|NCT00205777|3575326|FG003|NOT COMPLETED|Study Extension II||149
2871696|NCT00205777|3575327|FG004|NOT COMPLETED|Study Extension II||0
2871697|NCT00205777|3575328|FG005|NOT COMPLETED|Study Extension II||282
2871698|NCT00205803|3575345|FG000|STARTED|Infant Series||122
3169627|NCT01926782|3897181|FG001|Completed 24 Weeks Treatment Period|Overall Study||68
3169628|NCT01926782|3897182|FG002|Completed 24 Weeks Treatment Period|Overall Study||285
3169629|NCT01926782|3897183|FG003|Completed 24 Weeks Treatment Period|Overall Study||58
3169630|NCT01926782|3897184|FG004|Completed 24 Weeks Treatment Period|Overall Study||31
3169631|NCT01926782|3897185|FG005|Completed 24 Weeks Treatment Period|Overall Study||120
3169632|NCT01926782|3897180|FG000|COMPLETED|Overall Study||129
3169633|NCT01926782|3897181|FG001|COMPLETED|Overall Study||65
3169634|NCT01926782|3897182|FG002|COMPLETED|Overall Study||272
3169635|NCT01926782|3897183|FG003|COMPLETED|Overall Study||53
3169636|NCT01926782|3897184|FG004|COMPLETED|Overall Study||29
3169637|NCT01926782|3897185|FG005|COMPLETED|Overall Study||105
3169638|NCT01926782|3897180|FG000|NOT COMPLETED|Overall Study||28
3169639|NCT01926782|3897181|FG001|NOT COMPLETED|Overall Study||13
3169640|NCT01926782|3897182|FG002|NOT COMPLETED|Overall Study||40
3169641|NCT01926782|3897183|FG003|NOT COMPLETED|Overall Study||20
3169642|NCT01926782|3897184|FG004|NOT COMPLETED|Overall Study||8
3169643|NCT01926782|3897185|FG005|NOT COMPLETED|Overall Study||41
3169644|NCT01926886|3897200|FG000|STARTED|Overall Study||102
3169645|NCT01926886|3897201|FG001|STARTED|Overall Study|HCPs were not enrolled in the study. No baseline data were collected for these participants.|21
3169646|NCT01926886|3897200|FG000|Received at Least 1 Dose of Study Drug|Overall Study||101
3169647|NCT01926886|3897201|FG001|Received at Least 1 Dose of Study Drug|Overall Study|Partcipants were HCPs included for polling purposes. HCPs were not enrolled in the study.|0
3313687|NCT03076970|4046928|FG000|STARTED|Period 3||7
3313688|NCT03076970|4046929|FG001|STARTED|Period 3||7
3313689|NCT03076970|4046930|FG002|STARTED|Period 3||7
3313690|NCT03076970|4046931|FG003|STARTED|Period 3||7
3313691|NCT03076970|4046932|FG004|STARTED|Period 3||6
3313692|NCT03076970|4046933|FG005|STARTED|Period 3||7
3313693|NCT03076970|4046928|FG000|COMPLETED|Period 3||7
3313694|NCT03076970|4046929|FG001|COMPLETED|Period 3||7
3313695|NCT03076970|4046930|FG002|COMPLETED|Period 3||7
3313696|NCT03076970|4046931|FG003|COMPLETED|Period 3||7
3313697|NCT03076970|4046932|FG004|COMPLETED|Period 3||5
3313698|NCT03076970|4046933|FG005|COMPLETED|Period 3||6
3313699|NCT03076970|4046928|FG000|NOT COMPLETED|Period 3||0
3313700|NCT03076970|4046929|FG001|NOT COMPLETED|Period 3||0
3313701|NCT03076970|4046930|FG002|NOT COMPLETED|Period 3||0
3313702|NCT03076970|4046931|FG003|NOT COMPLETED|Period 3||0
2871699|NCT00205803|3575346|FG001|STARTED|Infant Series||127
2871700|NCT00205803|3575345|FG000|Vaccinated Dose 1|Infant Series||121
2871701|NCT00205803|3575346|FG001|Vaccinated Dose 1|Infant Series||126
2871702|NCT00205803|3575345|FG000|Vaccinated Dose 2|Infant Series||115
2871703|NCT00205803|3575346|FG001|Vaccinated Dose 2|Infant Series||122
2871704|NCT00205803|3575345|FG000|Vaccinated Dose 3|Infant Series||110
2871705|NCT00205803|3575346|FG001|Vaccinated Dose 3|Infant Series||118
2871706|NCT00205803|3575345|FG000|COMPLETED|Infant Series||104
2871707|NCT00205803|3575346|FG001|COMPLETED|Infant Series||116
2871708|NCT00205803|3575345|FG000|NOT COMPLETED|Infant Series||18
2871709|NCT00205803|3575346|FG001|NOT COMPLETED|Infant Series||11
2871710|NCT00205803|3575345|FG000|STARTED|After Infant Series||104
2871711|NCT00205803|3575346|FG001|STARTED|After Infant Series||116
2871712|NCT00205803|3575345|FG000|COMPLETED|After Infant Series||86
2871713|NCT00205803|3575346|FG001|COMPLETED|After Infant Series||103
2871714|NCT00205803|3575345|FG000|NOT COMPLETED|After Infant Series||18
2871715|NCT00205803|3575346|FG001|NOT COMPLETED|After Infant Series||13
2871716|NCT00205803|3575345|FG000|STARTED|Toddler Dose||86
2871717|NCT00205803|3575346|FG001|STARTED|Toddler Dose||103
2871718|NCT00205803|3575345|FG000|COMPLETED|Toddler Dose||84
2871719|NCT00205803|3575346|FG001|COMPLETED|Toddler Dose||100
2871720|NCT00205803|3575345|FG000|NOT COMPLETED|Toddler Dose||2
2871721|NCT00205803|3575346|FG001|NOT COMPLETED|Toddler Dose||3
2871722|NCT00205855|3575370|FG000|STARTED|Overall Study||65
2871723|NCT00205855|3575370|FG000|COMPLETED|Overall Study||44
2871724|NCT00205855|3575370|FG000|NOT COMPLETED|Overall Study||21
2871725|NCT00205881|3575374|FG000|STARTED|Overall Study||32
2871726|NCT00205881|3575374|FG000|COMPLETED|Overall Study|32 enrolled. 1 unilateral. 25 bilateral for data analysis at 8 months. 16 completed study.|16
2871727|NCT00205881|3575374|FG000|NOT COMPLETED|Overall Study||16
2871728|NCT00206076|3575381|FG000|STARTED|Overall Study||9
2871729|NCT00206076|3575382|FG001|STARTED|Overall Study||10
2871730|NCT00206076|3575381|FG000|COMPLETED|Overall Study||6
2871731|NCT00206076|3575382|FG001|COMPLETED|Overall Study||9
2871732|NCT00206076|3575381|FG000|NOT COMPLETED|Overall Study||3
2871733|NCT00206076|3575382|FG001|NOT COMPLETED|Overall Study||1
2871734|NCT00206102|3575392|FG000|STARTED|Overall Study||596
2871735|NCT00206102|3575393|FG001|STARTED|Overall Study||502
2871736|NCT00206102|3575392|FG000|COMPLETED|Overall Study||188
2871737|NCT00206102|3575393|FG001|COMPLETED|Overall Study||187
2871738|NCT00206102|3575392|FG000|NOT COMPLETED|Overall Study||408
2871739|NCT00206102|3575393|FG001|NOT COMPLETED|Overall Study||315
2871740|NCT00206323|3575401|FG000|STARTED|Overall Study||14
2871741|NCT00206323|3575402|FG001|STARTED|Overall Study||15
2871742|NCT00206323|3575401|FG000|COMPLETED|Overall Study||8
2871743|NCT00206323|3575402|FG001|COMPLETED|Overall Study||12
2871744|NCT00206323|3575401|FG000|NOT COMPLETED|Overall Study||6
2871745|NCT00206323|3575402|FG001|NOT COMPLETED|Overall Study||3
2871746|NCT00206336|3575408|FG000|STARTED|Overall Study||20
2871747|NCT00206336|3575408|FG000|COMPLETED|Overall Study||20
2871748|NCT00206336|3575408|FG000|NOT COMPLETED|Overall Study||0
2871749|NCT00206427|3575412|FG000|STARTED|Overall Study|Received First Dose|49
2871750|NCT00206427|3575412|FG000|COMPLETED|Overall Study|Complete 6-week therapy|47
2871751|NCT00206427|3575412|FG000|NOT COMPLETED|Overall Study||2
2871752|NCT00206440|3575418|FG000|STARTED|Overall Study||21
2871753|NCT00206440|3575419|FG001|STARTED|Overall Study||22
2871754|NCT00206440|3575418|FG000|COMPLETED|Overall Study||16
2871755|NCT00206440|3575419|FG001|COMPLETED|Overall Study||18
2871756|NCT00206440|3575418|FG000|NOT COMPLETED|Overall Study||5
2871757|NCT00206440|3575419|FG001|NOT COMPLETED|Overall Study||4
2871758|NCT00206518|3575427|FG000|STARTED|Overall Study||83
2871759|NCT00206518|3575428|FG001|STARTED|Overall Study||84
2871760|NCT00206518|3575427|FG000|COMPLETED|Overall Study||73
2871761|NCT00206518|3575428|FG001|COMPLETED|Overall Study||78
2871762|NCT00206518|3575427|FG000|NOT COMPLETED|Overall Study||10
2871763|NCT00206518|3575428|FG001|NOT COMPLETED|Overall Study||6
2871764|NCT00206726|3575434|FG000|STARTED|Overall Study||60
2871765|NCT00206726|3575434|FG000|Treatment Started|Overall Study|Safety population (3 withdrew consent prior to receiving study drug)|57
2871766|NCT00206726|3575434|FG000|4 Cycles Completed|Overall Study|per protocol population|41
2871767|NCT00206726|3575434|FG000|COMPLETED|Overall Study|4-6 cycles of treatment with assessments at 2, 6, and 9 months post last dose|9
2871768|NCT00206726|3575434|FG000|NOT COMPLETED|Overall Study||51
2918842|NCT00529087|3629153|FG002|COMPLETED|Overall Study||146
2918843|NCT00529087|3629151|FG000|NOT COMPLETED|Overall Study||28
2918844|NCT00529087|3629152|FG001|NOT COMPLETED|Overall Study||28
2918845|NCT00529087|3629153|FG002|NOT COMPLETED|Overall Study||16
2918846|NCT00529100|3629174|FG000|STARTED|Overall Study||16
2918847|NCT00529100|3629175|FG001|STARTED|Overall Study||33
2918848|NCT00529100|3629174|FG000|Received at Least 1 Dose of Study Drug|Overall Study||16
2918849|NCT00529100|3629175|FG001|Received at Least 1 Dose of Study Drug|Overall Study||33
2918850|NCT00529100|3629174|FG000|COMPLETED|Overall Study||16
2918851|NCT00529100|3629175|FG001|COMPLETED|Overall Study||24
2918852|NCT00529100|3629174|FG000|NOT COMPLETED|Overall Study||0
2918853|NCT00529100|3629175|FG001|NOT COMPLETED|Overall Study||9
2918854|NCT00529126|3629189|FG000|STARTED|Overall Study||25
2918855|NCT00529126|3629190|FG001|STARTED|Overall Study||25
2918856|NCT00529126|3629191|FG002|STARTED|Overall Study||24
2918857|NCT00529126|3629192|FG003|STARTED|Overall Study||26
2918858|NCT00529126|3629189|FG000|COMPLETED|Overall Study||25
2918859|NCT00529126|3629190|FG001|COMPLETED|Overall Study||25
2918860|NCT00529126|3629191|FG002|COMPLETED|Overall Study||24
2871769|NCT00207090|3575438|FG000|STARTED|Overall Study|Number of participants treated|15
2871770|NCT00207090|3575438|FG000|COMPLETED|Overall Study||8
2871771|NCT00207090|3575438|FG000|NOT COMPLETED|Overall Study||7
2871772|NCT00207142|3575450|FG000|STARTED|Induction Phase||252
2871773|NCT00207142|3575451|FG001|STARTED|Induction Phase||0
2871774|NCT00207142|3575452|FG002|STARTED|Induction Phase||0
2871775|NCT00207142|3575453|FG003|STARTED|Induction Phase||0
2871776|NCT00207142|3575450|FG000|COMPLETED|Induction Phase|Subjects randomized into Maintenance Phase=172 (87 ATV +85 ATV/RTV); Rescue Phase subjects=50|222
2871777|NCT00207142|3575451|FG001|COMPLETED|Induction Phase||0
2871778|NCT00207142|3575452|FG002|COMPLETED|Induction Phase||0
2871779|NCT00207142|3575453|FG003|COMPLETED|Induction Phase||0
2871780|NCT00207142|3575450|FG000|NOT COMPLETED|Induction Phase||30
2871781|NCT00207142|3575451|FG001|NOT COMPLETED|Induction Phase||0
2871782|NCT00207142|3575452|FG002|NOT COMPLETED|Induction Phase||0
2871783|NCT00207142|3575453|FG003|NOT COMPLETED|Induction Phase||0
2871784|NCT00207142|3575450|FG000|STARTED|Maintenance Phase/Rescue Phase||0
2871785|NCT00207142|3575451|FG001|STARTED|Maintenance Phase/Rescue Phase||87
2871786|NCT00207142|3575452|FG002|STARTED|Maintenance Phase/Rescue Phase||85
2871787|NCT00207142|3575453|FG003|STARTED|Maintenance Phase/Rescue Phase||50
2871788|NCT00207142|3575450|FG000|COMPLETED|Maintenance Phase/Rescue Phase||0
2871789|NCT00207142|3575451|FG001|COMPLETED|Maintenance Phase/Rescue Phase||78
2871790|NCT00207142|3575452|FG002|COMPLETED|Maintenance Phase/Rescue Phase||72
2871791|NCT00207142|3575453|FG003|COMPLETED|Maintenance Phase/Rescue Phase||41
2871792|NCT00207142|3575450|FG000|NOT COMPLETED|Maintenance Phase/Rescue Phase||0
2871793|NCT00207142|3575451|FG001|NOT COMPLETED|Maintenance Phase/Rescue Phase||9
2871794|NCT00207142|3575452|FG002|NOT COMPLETED|Maintenance Phase/Rescue Phase||13
2871795|NCT00207142|3575453|FG003|NOT COMPLETED|Maintenance Phase/Rescue Phase||9
2871796|NCT00207714|3575473|FG000|STARTED|Overall Study||35
2871797|NCT00207714|3575474|FG001|STARTED|Overall Study||35
2871798|NCT00207714|3575475|FG002|STARTED|Overall Study||34
2871799|NCT00207714|3575476|FG003|STARTED|Overall Study||34
2871800|NCT00207714|3575477|FG004|STARTED|Overall Study||34
2871801|NCT00207714|3575473|FG000|COMPLETED|Overall Study|Indicates number of participants who continued subcutaneous study agent at Wk 16|21
2871802|NCT00207714|3575474|FG001|COMPLETED|Overall Study|Indicates number of participants who continued subcutaneous study agent at Wk 16|28
2871803|NCT00207714|3575475|FG002|COMPLETED|Overall Study|Indicates number of participants who continued subcutaneous study agent at Wk 16|24
2871804|NCT00207714|3575476|FG003|COMPLETED|Overall Study|Indicates number of participants who continued subcutaneous study agent at Wk 16|26
2871805|NCT00207714|3575477|FG004|COMPLETED|Overall Study|Indicates number of participants who continued subcutaneous study agent at Wk 16|29
2871806|NCT00207714|3575473|FG000|NOT COMPLETED|Overall Study||14
2871807|NCT00207714|3575474|FG001|NOT COMPLETED|Overall Study||7
2871808|NCT00207714|3575475|FG002|NOT COMPLETED|Overall Study||10
2871809|NCT00207714|3575476|FG003|NOT COMPLETED|Overall Study||8
2871810|NCT00207714|3575477|FG004|NOT COMPLETED|Overall Study||5
2871811|NCT00207727|3575501|FG000|STARTED|Overall Study||49
2871812|NCT00207727|3575502|FG001|STARTED|Overall Study||50
2871813|NCT00207727|3575503|FG002|STARTED|Overall Study||50
2871814|NCT00207727|3575504|FG003|STARTED|Overall Study||50
2871815|NCT00207727|3575505|FG004|STARTED|Overall Study||50
2871816|NCT00207727|3575501|FG000|COMPLETED|Overall Study||11
2871817|NCT00207727|3575502|FG001|COMPLETED|Overall Study||8
2871818|NCT00207727|3575503|FG002|COMPLETED|Overall Study||9
2871819|NCT00207727|3575504|FG003|COMPLETED|Overall Study||13
2871820|NCT00207727|3575505|FG004|COMPLETED|Overall Study||16
2871821|NCT00207727|3575501|FG000|NOT COMPLETED|Overall Study||38
2871822|NCT00207727|3575502|FG001|NOT COMPLETED|Overall Study||42
2871823|NCT00207727|3575503|FG002|NOT COMPLETED|Overall Study||41
2871824|NCT00207727|3575504|FG003|NOT COMPLETED|Overall Study||37
2871825|NCT00207727|3575505|FG004|NOT COMPLETED|Overall Study||34
2871826|NCT00207740|3575521|FG000|STARTED|Overall Study||78
2871827|NCT00207740|3575522|FG001|STARTED|Overall Study||77
2871828|NCT00207740|3575523|FG002|STARTED|Overall Study||76
2871829|NCT00207740|3575524|FG003|STARTED|Overall Study||78
2871830|NCT00207740|3575521|FG000|COMPLETED|Overall Study|Indicates number of patients who received subcutaneous study medication through Week 52|49
2871831|NCT00207740|3575522|FG001|COMPLETED|Overall Study|Indicates number of patients who received subcutaneous study medication through Week 52|36
2871832|NCT00207740|3575523|FG002|COMPLETED|Overall Study|Indicates number of patients who received subcutaneous study medication through Week 52|36
2871833|NCT00207740|3575524|FG003|COMPLETED|Overall Study|Indicates number of patients who received subcutaneous study medication through Week 52|35
2871834|NCT00207740|3575521|FG000|NOT COMPLETED|Overall Study||29
2871835|NCT00207740|3575522|FG001|NOT COMPLETED|Overall Study||41
2871836|NCT00207740|3575523|FG002|NOT COMPLETED|Overall Study||40
2871837|NCT00207740|3575524|FG003|NOT COMPLETED|Overall Study||43
2871838|NCT00207883|3575540|FG000|STARTED|Overall Study||93
2871839|NCT00207883|3575541|FG001|STARTED|Overall Study||119
2871840|NCT00207883|3575540|FG000|COMPLETED|Overall Study||93
2871841|NCT00207883|3575541|FG001|COMPLETED|Overall Study||119
2871842|NCT00207883|3575540|FG000|NOT COMPLETED|Overall Study||0
2871843|NCT00207883|3575541|FG001|NOT COMPLETED|Overall Study||0
2871844|NCT00208026|3575547|FG000|STARTED|Overall Study||3
2871845|NCT00208026|3575547|FG000|COMPLETED|Overall Study||3
2871846|NCT00208026|3575547|FG000|NOT COMPLETED|Overall Study||0
2871847|NCT00208091|3575553|FG000|STARTED|Overall Study||16
2871848|NCT00208091|3575553|FG000|COMPLETED|Overall Study||16
2871849|NCT00208091|3575553|FG000|NOT COMPLETED|Overall Study||0
2871850|NCT00208325|3575565|FG000|STARTED|Overall Study||193
2871851|NCT00208325|3575566|FG001|STARTED|Overall Study||196
2871852|NCT00208325|3575567|FG002|STARTED|Overall Study||170
2871853|NCT00208325|3575568|FG003|STARTED|Overall Study||161
2871854|NCT00208325|3575565|FG000|COMPLETED|Overall Study||142
2871855|NCT00208325|3575566|FG001|COMPLETED|Overall Study||142
2871856|NCT00208325|3575567|FG002|COMPLETED|Overall Study||156
2871857|NCT00208325|3575568|FG003|COMPLETED|Overall Study||147
2871858|NCT00208325|3575565|FG000|NOT COMPLETED|Overall Study||51
2871859|NCT00208325|3575566|FG001|NOT COMPLETED|Overall Study||54
2871860|NCT00208325|3575567|FG002|NOT COMPLETED|Overall Study||14
2871861|NCT00208325|3575568|FG003|NOT COMPLETED|Overall Study||14
2871862|NCT00208494|3575580|FG000|STARTED|Overall Study||194
2871863|NCT00208494|3575581|FG001|STARTED|Overall Study||196
2871864|NCT00208494|3575580|FG000|COMPLETED|Overall Study||164
2871865|NCT00208494|3575581|FG001|COMPLETED|Overall Study||162
2871866|NCT00208494|3575580|FG000|NOT COMPLETED|Overall Study||30
2871867|NCT00208494|3575581|FG001|NOT COMPLETED|Overall Study||34
2871868|NCT00208507|3575589|FG000|STARTED|Overall Study||177
2871869|NCT00208507|3575590|FG001|STARTED|Overall Study||87
2871870|NCT00208507|3575589|FG000|COMPLETED|Overall Study||163
2871871|NCT00208507|3575590|FG001|COMPLETED|Overall Study||79
2871872|NCT00208507|3575589|FG000|NOT COMPLETED|Overall Study||14
2871873|NCT00208507|3575590|FG001|NOT COMPLETED|Overall Study||8
2871874|NCT00208767|3575598|FG000|STARTED|Overall Study||80
2871875|NCT00208767|3575599|FG001|STARTED|Overall Study||40
2871876|NCT00208767|3575598|FG000|COMPLETED|Overall Study||53
2871877|NCT00208767|3575599|FG001|COMPLETED|Overall Study||33
2871878|NCT00208767|3575598|FG000|NOT COMPLETED|Overall Study||27
2871879|NCT00208767|3575599|FG001|NOT COMPLETED|Overall Study||7
2871880|NCT00208949|3575607|FG000|STARTED|Overall Study||25
2871881|NCT00208949|3575608|FG001|STARTED|Overall Study||25
2871882|NCT00208949|3575607|FG000|COMPLETED|Overall Study||25
2871883|NCT00208949|3575608|FG001|COMPLETED|Overall Study||25
2871884|NCT00208949|3575607|FG000|NOT COMPLETED|Overall Study||0
2871885|NCT00208949|3575608|FG001|NOT COMPLETED|Overall Study||0
2871886|NCT00208975|3575614|FG000|STARTED|Overall Study||15
2871887|NCT00208975|3575614|FG000|COMPLETED|Overall Study||15
2871888|NCT00208975|3575614|FG000|NOT COMPLETED|Overall Study||0
2871889|NCT00209092|3575621|FG000|STARTED|Overall Study||25
2871890|NCT00209092|3575622|FG001|STARTED|Overall Study||26
2871891|NCT00209092|3575621|FG000|COMPLETED|Overall Study||17
2871892|NCT00209092|3575622|FG001|COMPLETED|Overall Study||24
2871893|NCT00209092|3575621|FG000|NOT COMPLETED|Overall Study||8
2871894|NCT00209092|3575622|FG001|NOT COMPLETED|Overall Study||2
2871895|NCT00209170|3575630|FG000|STARTED|Overall Study||7
2871896|NCT00209170|3575631|FG001|STARTED|Overall Study||7
2871897|NCT00209170|3575630|FG000|COMPLETED|Overall Study||5
2871898|NCT00209170|3575631|FG001|COMPLETED|Overall Study||4
2871899|NCT00209170|3575630|FG000|NOT COMPLETED|Overall Study||2
3169648|NCT01926886|3897200|FG000|COMPLETED|Overall Study||70
3169649|NCT01926886|3897201|FG001|COMPLETED|Overall Study|Partcipants were HCPs included for polling purposes. HCPs were not enrolled in the study.|21
3169650|NCT01926886|3897200|FG000|NOT COMPLETED|Overall Study||32
3169651|NCT01926886|3897201|FG001|NOT COMPLETED|Overall Study||0
3169652|NCT01926977|3897209|FG000|STARTED|Overall Study||47
3169653|NCT01926977|3897210|FG001|STARTED|Overall Study||53
3169654|NCT01926977|3897209|FG000|COMPLETED|Overall Study||47
3169655|NCT01926977|3897210|FG001|COMPLETED|Overall Study||53
3169656|NCT01926977|3897209|FG000|NOT COMPLETED|Overall Study||0
3169657|NCT01926977|3897210|FG001|NOT COMPLETED|Overall Study||0
3169658|NCT01927055|3897219|FG000|STARTED|Open-label||61
3313703|NCT03076970|4046932|FG004|NOT COMPLETED|Period 3||1
3313704|NCT03076970|4046933|FG005|NOT COMPLETED|Period 3||1
3313705|NCT03076970|4046928|FG000|STARTED|Washout Period 3||7
3313706|NCT03076970|4046929|FG001|STARTED|Washout Period 3||7
3313707|NCT03076970|4046930|FG002|STARTED|Washout Period 3||7
3313708|NCT03076970|4046931|FG003|STARTED|Washout Period 3||7
3313709|NCT03076970|4046932|FG004|STARTED|Washout Period 3||5
3313710|NCT03076970|4046933|FG005|STARTED|Washout Period 3||6
3313711|NCT03076970|4046928|FG000|COMPLETED|Washout Period 3||7
3313712|NCT03076970|4046929|FG001|COMPLETED|Washout Period 3||7
3313713|NCT03076970|4046930|FG002|COMPLETED|Washout Period 3||7
3313714|NCT03076970|4046931|FG003|COMPLETED|Washout Period 3||7
3313715|NCT03076970|4046932|FG004|COMPLETED|Washout Period 3||5
3313716|NCT03076970|4046933|FG005|COMPLETED|Washout Period 3||6
3313717|NCT03076970|4046928|FG000|NOT COMPLETED|Washout Period 3||0
3313718|NCT03076970|4046929|FG001|NOT COMPLETED|Washout Period 3||0
3313719|NCT03076970|4046930|FG002|NOT COMPLETED|Washout Period 3||0
3313720|NCT03076970|4046931|FG003|NOT COMPLETED|Washout Period 3||0
3313721|NCT03076970|4046932|FG004|NOT COMPLETED|Washout Period 3||0
2871900|NCT00209170|3575631|FG001|NOT COMPLETED|Overall Study||3
2871901|NCT00209274|3575639|FG000|STARTED|Overall Study||184
2871902|NCT00209274|3575640|FG001|STARTED|Overall Study||95
2871903|NCT00209274|3575639|FG000|COMPLETED|Overall Study||113
2871904|NCT00209274|3575640|FG001|COMPLETED|Overall Study||48
2871905|NCT00209274|3575639|FG000|NOT COMPLETED|Overall Study||71
2871906|NCT00209274|3575640|FG001|NOT COMPLETED|Overall Study||47
2871907|NCT00209339|3575646|FG000|STARTED|At 12 Months Follow-up||55
2871908|NCT00209339|3575646|FG000|COMPLETED|At 12 Months Follow-up||40
2871909|NCT00209339|3575646|FG000|NOT COMPLETED|At 12 Months Follow-up||15
2871910|NCT00209339|3575646|FG000|STARTED|At 24 Months Follow-up||40
2871911|NCT00209339|3575646|FG000|COMPLETED|At 24 Months Follow-up||29
2871912|NCT00209339|3575646|FG000|NOT COMPLETED|At 24 Months Follow-up||11
2871913|NCT00209339|3575646|FG000|STARTED|At 3 Years Follow-up||29
2871914|NCT00209339|3575646|FG000|COMPLETED|At 3 Years Follow-up||28
2871915|NCT00209339|3575646|FG000|NOT COMPLETED|At 3 Years Follow-up||1
2871916|NCT00209339|3575646|FG000|STARTED|At 4 Years Follow-up||28
2871917|NCT00209339|3575646|FG000|COMPLETED|At 4 Years Follow-up||23
2871918|NCT00209339|3575646|FG000|NOT COMPLETED|At 4 Years Follow-up||5
2871919|NCT00209339|3575646|FG000|STARTED|At 5 Years Follow-up||23
2871920|NCT00209339|3575646|FG000|COMPLETED|At 5 Years Follow-up||15
2871921|NCT00209339|3575646|FG000|NOT COMPLETED|At 5 Years Follow-up||8
2871922|NCT00209417|3575652|FG000|STARTED|Overall Study||321
2871923|NCT00209417|3575653|FG001|STARTED|Overall Study||327
2871924|NCT00209417|3575652|FG000|COMPLETED|Overall Study||321
2871925|NCT00209417|3575653|FG001|COMPLETED|Overall Study||327
2871926|NCT00209417|3575652|FG000|NOT COMPLETED|Overall Study||0
2871927|NCT00209417|3575653|FG001|NOT COMPLETED|Overall Study||0
2871928|NCT00209560|3575661|FG000|STARTED|Overall Study||121
2871929|NCT00209560|3575662|FG001|STARTED|Overall Study||42
2871930|NCT00209560|3575661|FG000|COMPLETED|Overall Study||120
2871931|NCT00209560|3575662|FG001|COMPLETED|Overall Study||42
2871932|NCT00209560|3575661|FG000|NOT COMPLETED|Overall Study||1
2871933|NCT00209560|3575662|FG001|NOT COMPLETED|Overall Study||0
2871934|NCT00210106|3575668|FG000|STARTED|Overall Study||52
2871935|NCT00210106|3575668|FG000|Safety Population|Overall Study||49
2871936|NCT00210106|3575668|FG000|COMPLETED|Overall Study||38
2871937|NCT00210106|3575668|FG000|NOT COMPLETED|Overall Study||14
2871938|NCT00210119|3575673|FG000|STARTED|Overall Study||19
2871939|NCT00210119|3575673|FG000|COMPLETED|Overall Study||17
2871940|NCT00210119|3575673|FG000|NOT COMPLETED|Overall Study||2
2871941|NCT00210184|3575677|FG000|STARTED|Overall Study||42
2871942|NCT00210184|3575677|FG000|COMPLETED|Overall Study||40
2871943|NCT00210184|3575677|FG000|NOT COMPLETED|Overall Study||2
2871944|NCT00210353|3575684|FG000|STARTED|Overall Study||151
2871945|NCT00210353|3575685|FG001|STARTED|Overall Study||152
2871946|NCT00210353|3575686|FG002|STARTED|Overall Study||151
2871947|NCT00210353|3575684|FG000|COMPLETED|Overall Study||113
2871948|NCT00210353|3575685|FG001|COMPLETED|Overall Study||107
2871949|NCT00210353|3575686|FG002|COMPLETED|Overall Study||125
2871950|NCT00210353|3575684|FG000|NOT COMPLETED|Overall Study||38
2871951|NCT00210353|3575685|FG001|NOT COMPLETED|Overall Study||45
2871952|NCT00210353|3575686|FG002|NOT COMPLETED|Overall Study||26
2871953|NCT00210470|3575699|FG000|STARTED|Overall Study||27
2871954|NCT00210470|3575699|FG000|COMPLETED|Overall Study||27
2871955|NCT00210470|3575699|FG000|NOT COMPLETED|Overall Study||0
2871956|NCT00210626|3575708|FG000|STARTED|Overall Study||97
2871957|NCT00210626|3575709|FG001|STARTED|Overall Study||95
2871958|NCT00210626|3575708|FG000|COMPLETED|Overall Study||49
2871959|NCT00210626|3575709|FG001|COMPLETED|Overall Study||50
2871960|NCT00210626|3575708|FG000|NOT COMPLETED|Overall Study||48
2871961|NCT00210626|3575709|FG001|NOT COMPLETED|Overall Study||45
2871962|NCT00210639|3575717|FG000|STARTED|Overall Study||124
2871963|NCT00210639|3575718|FG001|STARTED|Overall Study||83
2871964|NCT00210639|3575717|FG000|COMPLETED|Overall Study||61
2871965|NCT00210639|3575718|FG001|COMPLETED|Overall Study||41
2871966|NCT00210639|3575717|FG000|NOT COMPLETED|Overall Study||63
2871967|NCT00210639|3575718|FG001|NOT COMPLETED|Overall Study||42
2871968|NCT00211081|3575724|FG000|STARTED|Overall Study||12
2871969|NCT00211081|3575724|FG000|COMPLETED|Overall Study||10
2871970|NCT00211081|3575724|FG000|NOT COMPLETED|Overall Study||2
2871971|NCT00211172|3575730|FG000|STARTED|Overall Study||449
3313722|NCT03076970|4046933|FG005|NOT COMPLETED|Washout Period 3||0
3313723|NCT03076983|4046946|FG000|STARTED|Overall Study||55
3313724|NCT03076983|4046947|FG001|STARTED|Overall Study||25
3313725|NCT03076983|4046946|FG000|COMPLETED|Overall Study||55
3313726|NCT03076983|4046947|FG001|COMPLETED|Overall Study||25
3313727|NCT03076983|4046946|FG000|NOT COMPLETED|Overall Study||0
3313728|NCT03076983|4046947|FG001|NOT COMPLETED|Overall Study||0
3313729|NCT03076996|4046953|FG000|STARTED|Overall Study||41
3313730|NCT03076996|4046953|FG000|COMPLETED|Overall Study||35
3313731|NCT03076996|4046953|FG000|NOT COMPLETED|Overall Study||6
3313732|NCT03077165|4046963|FG000|STARTED|Overall Study||21
3313733|NCT03077165|4046964|FG001|STARTED|Overall Study||22
3313734|NCT03077165|4046965|FG002|STARTED|Overall Study||20
3313735|NCT03077165|4046966|FG003|STARTED|Overall Study||19
3313736|NCT03077165|4046967|FG004|STARTED|Overall Study||19
3313737|NCT03077165|4046968|FG005|STARTED|Overall Study||20
3313738|NCT03077165|4046963|FG000|COMPLETED|Overall Study||20
3313739|NCT03077165|4046964|FG001|COMPLETED|Overall Study||22
3313740|NCT03077165|4046965|FG002|COMPLETED|Overall Study||20
3313741|NCT03077165|4046966|FG003|COMPLETED|Overall Study||19
3313742|NCT03077165|4046967|FG004|COMPLETED|Overall Study||16
3313743|NCT03077165|4046968|FG005|COMPLETED|Overall Study||20
3313744|NCT03077165|4046963|FG000|NOT COMPLETED|Overall Study||1
3313745|NCT03077165|4046964|FG001|NOT COMPLETED|Overall Study||0
3313746|NCT03077165|4046965|FG002|NOT COMPLETED|Overall Study||0
3313747|NCT03077165|4046966|FG003|NOT COMPLETED|Overall Study||0
3313748|NCT03077165|4046967|FG004|NOT COMPLETED|Overall Study||3
3313749|NCT03077165|4046968|FG005|NOT COMPLETED|Overall Study||0
2871972|NCT00211172|3575731|FG001|STARTED|Overall Study||458
3313750|NCT03077438|4046984|FG000|STARTED|Overall Study||499
3313751|NCT03077438|4046985|FG001|STARTED|Overall Study||501
3313752|NCT03077438|4046984|FG000|Safety Analysis Set (SafAS)|Overall Study||498
2871973|NCT00211172|3575730|FG000|COMPLETED|Overall Study|39 patients died or lost health plan eligibility|410
2871974|NCT00211172|3575731|FG001|COMPLETED|Overall Study|32 patients died or lost health plan eligibility|426
2871975|NCT00211172|3575730|FG000|NOT COMPLETED|Overall Study||39
2871976|NCT00211172|3575731|FG001|NOT COMPLETED|Overall Study||32
2871977|NCT00211185|3575737|FG000|STARTED|Overall Study||49
2871978|NCT00211185|3575737|FG000|COMPLETED|Overall Study||29
2871979|NCT00211185|3575737|FG000|NOT COMPLETED|Overall Study||20
2871980|NCT00211237|3575743|FG000|STARTED|Baseline||70
2871981|NCT00211237|3575744|FG001|STARTED|Baseline||64
2871982|NCT00211237|3575745|FG002|STARTED|Baseline||0
2871983|NCT00211237|3575743|FG000|COMPLETED|Baseline||68
2871984|NCT00211237|3575744|FG001|COMPLETED|Baseline||61
2871985|NCT00211237|3575745|FG002|COMPLETED|Baseline||0
2871986|NCT00211237|3575743|FG000|NOT COMPLETED|Baseline||2
2871987|NCT00211237|3575744|FG001|NOT COMPLETED|Baseline||3
2871988|NCT00211237|3575745|FG002|NOT COMPLETED|Baseline||0
2871989|NCT00211237|3575743|FG000|STARTED|1 Month||68
2871990|NCT00211237|3575744|FG001|STARTED|1 Month||61
2871991|NCT00211237|3575745|FG002|STARTED|1 Month||0
2871992|NCT00211237|3575743|FG000|COMPLETED|1 Month||65
2871993|NCT00211237|3575744|FG001|COMPLETED|1 Month||52
2871994|NCT00211237|3575745|FG002|COMPLETED|1 Month||0
2871995|NCT00211237|3575743|FG000|NOT COMPLETED|1 Month||3
2871996|NCT00211237|3575744|FG001|NOT COMPLETED|1 Month||9
2871997|NCT00211237|3575745|FG002|NOT COMPLETED|1 Month||0
2871998|NCT00211237|3575743|FG000|STARTED|3 Months||65
2871999|NCT00211237|3575744|FG001|STARTED|3 Months|34 patients crossed over to Balloon Kyphoplasty.|18
2872000|NCT00211237|3575745|FG002|STARTED|3 Months||34
2872001|NCT00211237|3575743|FG000|COMPLETED|3 Months||57
2872002|NCT00211237|3575744|FG001|COMPLETED|3 Months||14
2872003|NCT00211237|3575745|FG002|COMPLETED|3 Months||33
2872004|NCT00211237|3575743|FG000|NOT COMPLETED|3 Months||8
2872005|NCT00211237|3575744|FG001|NOT COMPLETED|3 Months||4
2872006|NCT00211237|3575745|FG002|NOT COMPLETED|3 Months||1
2872007|NCT00211237|3575743|FG000|STARTED|6 Months||57
2872008|NCT00211237|3575744|FG001|STARTED|6 Months|3 patients crossed over Balloon Kyphoplasty|11
2872009|NCT00211237|3575745|FG002|STARTED|6 Months||36
2872010|NCT00211237|3575743|FG000|COMPLETED|6 Months||49
2872011|NCT00211237|3575744|FG001|COMPLETED|6 Months||9
2872012|NCT00211237|3575745|FG002|COMPLETED|6 Months||33
2872013|NCT00211237|3575743|FG000|NOT COMPLETED|6 Months||8
2872014|NCT00211237|3575744|FG001|NOT COMPLETED|6 Months||2
2872015|NCT00211237|3575745|FG002|NOT COMPLETED|6 Months||3
2872016|NCT00211237|3575743|FG000|STARTED|12 Months||49
2872017|NCT00211237|3575744|FG001|STARTED|12 Months|1 patient crossed over Balloon Kyphoplasty|8
2872018|NCT00211237|3575745|FG002|STARTED|12 Months||34
2872019|NCT00211237|3575743|FG000|COMPLETED|12 Months||40
2872020|NCT00211237|3575744|FG001|COMPLETED|12 Months||6
2872021|NCT00211237|3575745|FG002|COMPLETED|12 Months||28
2872022|NCT00211237|3575743|FG000|NOT COMPLETED|12 Months||9
2872023|NCT00211237|3575744|FG001|NOT COMPLETED|12 Months||2
2872024|NCT00211237|3575745|FG002|NOT COMPLETED|12 Months||6
2872025|NCT00211510|3575764|FG000|STARTED|Overall Study||72
2872026|NCT00211510|3575765|FG001|STARTED|Overall Study||74
2872027|NCT00211510|3575764|FG000|COMPLETED|Overall Study||66
2872028|NCT00211510|3575765|FG001|COMPLETED|Overall Study||72
2872029|NCT00211510|3575764|FG000|NOT COMPLETED|Overall Study||6
2872030|NCT00211510|3575765|FG001|NOT COMPLETED|Overall Study||2
2872031|NCT00211536|3575776|FG000|STARTED|Overall Study||53
2872032|NCT00211536|3575777|FG001|STARTED|Overall Study||54
2872033|NCT00211536|3575776|FG000|As Treated Data Analysis Set|Overall Study|This set includes all subjects followed to Visit 5 (90 days, first insulin refill for MIP group).|52
2872034|NCT00211536|3575777|FG001|As Treated Data Analysis Set|Overall Study||48
2872035|NCT00211536|3575776|FG000|COMPLETED|Overall Study||49
2872036|NCT00211536|3575777|FG001|COMPLETED|Overall Study|This set includes all subjects followed to Visit 5 (90 days, first insulin refill for MIP group).|47
2872037|NCT00211536|3575776|FG000|NOT COMPLETED|Overall Study||4
2872038|NCT00211536|3575777|FG001|NOT COMPLETED|Overall Study||7
2872039|NCT00211692|3575785|FG000|STARTED|Overall Study||33
2872040|NCT00211692|3575786|FG001|STARTED|Overall Study||31
2872041|NCT00211692|3575785|FG000|COMPLETED|Overall Study||33
2872042|NCT00211692|3575786|FG001|COMPLETED|Overall Study||31
2872043|NCT00211692|3575785|FG000|NOT COMPLETED|Overall Study||0
2872044|NCT00211692|3575786|FG001|NOT COMPLETED|Overall Study||0
2872045|NCT00211757|3575794|FG000|STARTED|Overall Study||11
2872046|NCT00211757|3575795|FG001|STARTED|Overall Study||16
2872047|NCT00211757|3575794|FG000|COMPLETED|Overall Study||10
2872048|NCT00211757|3575795|FG001|COMPLETED|Overall Study||14
2872049|NCT00211757|3575794|FG000|NOT COMPLETED|Overall Study||1
2872050|NCT00211757|3575795|FG001|NOT COMPLETED|Overall Study||2
2872051|NCT00211809|3575803|FG000|STARTED|Overall Study||17
2872052|NCT00211809|3575803|FG000|COMPLETED|Overall Study||11
2872053|NCT00211809|3575803|FG000|NOT COMPLETED|Overall Study||6
3313753|NCT03077438|4046985|FG001|Safety Analysis Set (SafAS)|Overall Study||494
3313754|NCT03077438|4046984|FG000|COMPLETED|Overall Study||487
3313755|NCT03077438|4046985|FG001|COMPLETED|Overall Study||487
3313756|NCT03077438|4046984|FG000|NOT COMPLETED|Overall Study||12
3313757|NCT03077438|4046985|FG001|NOT COMPLETED|Overall Study||14
3313758|NCT03077607|4046997|FG000|STARTED|Period 1 (15 Days)||19
2872054|NCT00211887|3575812|FG000|STARTED|Overall Study||499
2872055|NCT00211887|3575813|FG001|STARTED|Overall Study||250
2872056|NCT00211887|3575814|FG002|STARTED|Overall Study||259
3313759|NCT03077607|4046998|FG001|STARTED|Period 1 (15 Days)||17
2872057|NCT00211887|3575812|FG000|COMPLETED|Overall Study||397
2872058|NCT00211887|3575813|FG001|COMPLETED|Overall Study||194
2872059|NCT00211887|3575814|FG002|COMPLETED|Overall Study||223
2872060|NCT00211887|3575812|FG000|NOT COMPLETED|Overall Study||102
2872061|NCT00211887|3575813|FG001|NOT COMPLETED|Overall Study||56
2872062|NCT00211887|3575814|FG002|NOT COMPLETED|Overall Study||36
2872063|NCT00212134|3575824|FG000|STARTED|Phase 1 (to Age 1 Year)||57
2872064|NCT00212134|3575825|FG001|STARTED|Phase 1 (to Age 1 Year)||57
2872065|NCT00212134|3575824|FG000|Complete First Endpoint at 1 Year|Phase 1 (to Age 1 Year)||57
2872066|NCT00212134|3575825|FG001|Complete First Endpoint at 1 Year|Phase 1 (to Age 1 Year)||57
2872067|NCT00212134|3575824|FG000|COMPLETED|Phase 1 (to Age 1 Year)|Age 1 data collection visit|57
2872068|NCT00212134|3575825|FG001|COMPLETED|Phase 1 (to Age 1 Year)|Age 1 data collection visit|57
2872069|NCT00212134|3575824|FG000|NOT COMPLETED|Phase 1 (to Age 1 Year)||0
2872070|NCT00212134|3575825|FG001|NOT COMPLETED|Phase 1 (to Age 1 Year)||0
2872071|NCT00212134|3575824|FG000|STARTED|Phase 2 (Age 1 Year to Age 5 Years)|Visual acuity assessment at Age 4.5 Years and final visit at Age 5 Years.|57
2872072|NCT00212134|3575825|FG001|STARTED|Phase 2 (Age 1 Year to Age 5 Years)|Visual acuity assessment at Age 4.5 Years and final visit at Age 5 Years.|57
2872073|NCT00212134|3575824|FG000|COMPLETED|Phase 2 (Age 1 Year to Age 5 Years)||57
2872074|NCT00212134|3575825|FG001|COMPLETED|Phase 2 (Age 1 Year to Age 5 Years)|Patient lost to follow-up.|56
2872075|NCT00212134|3575824|FG000|NOT COMPLETED|Phase 2 (Age 1 Year to Age 5 Years)||0
2872076|NCT00212134|3575825|FG001|NOT COMPLETED|Phase 2 (Age 1 Year to Age 5 Years)||1
2872077|NCT00212134|3575824|FG000|STARTED|Phase 3 (Age 10 Years)||57
2872078|NCT00212134|3575825|FG001|STARTED|Phase 3 (Age 10 Years)||56
2872079|NCT00212134|3575824|FG000|COMPLETED|Phase 3 (Age 10 Years)||55
2872080|NCT00212134|3575825|FG001|COMPLETED|Phase 3 (Age 10 Years)||55
2872081|NCT00212134|3575824|FG000|NOT COMPLETED|Phase 3 (Age 10 Years)||2
2872082|NCT00212134|3575825|FG001|NOT COMPLETED|Phase 3 (Age 10 Years)||1
2872083|NCT00212264|3575838|FG000|STARTED|Overall Study||70
2872084|NCT00212264|3575839|FG001|STARTED|Overall Study||70
2872085|NCT00212264|3575840|FG002|STARTED|Overall Study||68
2872086|NCT00212264|3575838|FG000|COMPLETED|Overall Study||58
2872087|NCT00212264|3575839|FG001|COMPLETED|Overall Study||54
2872088|NCT00212264|3575840|FG002|COMPLETED|Overall Study||64
2872089|NCT00212264|3575838|FG000|NOT COMPLETED|Overall Study||12
2872090|NCT00212264|3575839|FG001|NOT COMPLETED|Overall Study||16
2872091|NCT00212264|3575840|FG002|NOT COMPLETED|Overall Study||4
2872092|NCT00212355|3575848|FG000|STARTED|Overall Study||37
2872093|NCT00212355|3575848|FG000|COMPLETED|Overall Study||34
2872094|NCT00212355|3575848|FG000|NOT COMPLETED|Overall Study||3
2872095|NCT00212446|3575852|FG000|STARTED|Overall Study||8
2872096|NCT00212446|3575852|FG000|COMPLETED|Overall Study||8
2872097|NCT00212446|3575852|FG000|NOT COMPLETED|Overall Study||0
2872098|NCT00212758|3575856|FG000|STARTED|First Intervention (7 Days)||8
2872099|NCT00212758|3575857|FG001|STARTED|First Intervention (7 Days)||9
2872100|NCT00212758|3575856|FG000|COMPLETED|First Intervention (7 Days)||8
2872101|NCT00212758|3575857|FG001|COMPLETED|First Intervention (7 Days)||9
2872102|NCT00212758|3575856|FG000|NOT COMPLETED|First Intervention (7 Days)||0
2872103|NCT00212758|3575857|FG001|NOT COMPLETED|First Intervention (7 Days)||0
2872104|NCT00212758|3575856|FG000|STARTED|Wash Out Period (2 Weeks)||8
2872105|NCT00212758|3575857|FG001|STARTED|Wash Out Period (2 Weeks)||9
2872106|NCT00212758|3575856|FG000|COMPLETED|Wash Out Period (2 Weeks)||8
2872107|NCT00212758|3575857|FG001|COMPLETED|Wash Out Period (2 Weeks)||9
2872108|NCT00212758|3575856|FG000|NOT COMPLETED|Wash Out Period (2 Weeks)||0
2872109|NCT00212758|3575857|FG001|NOT COMPLETED|Wash Out Period (2 Weeks)||0
2872110|NCT00212758|3575856|FG000|STARTED|Second Intervention (7 Days)||8
2872111|NCT00212758|3575857|FG001|STARTED|Second Intervention (7 Days)||9
2872112|NCT00212758|3575856|FG000|COMPLETED|Second Intervention (7 Days)||8
2872113|NCT00212758|3575857|FG001|COMPLETED|Second Intervention (7 Days)||9
2872114|NCT00212758|3575856|FG000|NOT COMPLETED|Second Intervention (7 Days)||0
2872115|NCT00212758|3575857|FG001|NOT COMPLETED|Second Intervention (7 Days)||0
2872116|NCT00212758|3575856|FG000|STARTED|Standard Therapy of GH (12 Months)||8
2872117|NCT00212758|3575857|FG001|STARTED|Standard Therapy of GH (12 Months)||9
2872118|NCT00212758|3575856|FG000|COMPLETED|Standard Therapy of GH (12 Months)||6
2872119|NCT00212758|3575857|FG001|COMPLETED|Standard Therapy of GH (12 Months)||8
2872120|NCT00212758|3575856|FG000|NOT COMPLETED|Standard Therapy of GH (12 Months)||2
2872121|NCT00212758|3575857|FG001|NOT COMPLETED|Standard Therapy of GH (12 Months)||1
2872122|NCT00212888|3575866|FG000|STARTED|Overall Study||19
2872123|NCT00212888|3575867|FG001|STARTED|Overall Study||18
2872124|NCT00212888|3575868|FG002|STARTED|Overall Study||15
2872125|NCT00212888|3575866|FG000|COMPLETED|Overall Study||16
2872126|NCT00212888|3575867|FG001|COMPLETED|Overall Study||18
2872127|NCT00212888|3575868|FG002|COMPLETED|Overall Study||14
2872128|NCT00212888|3575866|FG000|NOT COMPLETED|Overall Study||3
2872129|NCT00212888|3575867|FG001|NOT COMPLETED|Overall Study||0
2872130|NCT00212888|3575868|FG002|NOT COMPLETED|Overall Study||1
2872131|NCT00213135|3575881|FG000|STARTED|Overall Study||456
2872132|NCT00213135|3575882|FG001|STARTED|Overall Study||433
2872133|NCT00213135|3575883|FG002|STARTED|Overall Study||437
2872134|NCT00213135|3575881|FG000|COMPLETED|Overall Study||406
2872135|NCT00213135|3575882|FG001|COMPLETED|Overall Study||398
2872136|NCT00213135|3575883|FG002|COMPLETED|Overall Study||380
2872137|NCT00213135|3575881|FG000|NOT COMPLETED|Overall Study||50
2872138|NCT00213135|3575882|FG001|NOT COMPLETED|Overall Study||35
2872139|NCT00213135|3575883|FG002|NOT COMPLETED|Overall Study||57
2872140|NCT00213148|3575895|FG000|STARTED|Cycle 1 (1 Month)||77
2872141|NCT00213148|3575896|FG001|STARTED|Cycle 1 (1 Month)||0
2872142|NCT00213148|3575897|FG002|STARTED|Cycle 1 (1 Month)||79
2872143|NCT00213148|3575898|FG003|STARTED|Cycle 1 (1 Month)||76
2872144|NCT00213148|3575899|FG004|STARTED|Cycle 1 (1 Month)||39
2872145|NCT00213148|3575895|FG000|COMPLETED|Cycle 1 (1 Month)||53
2872146|NCT00213148|3575896|FG001|COMPLETED|Cycle 1 (1 Month)||0
2872147|NCT00213148|3575897|FG002|COMPLETED|Cycle 1 (1 Month)||60
2872148|NCT00213148|3575898|FG003|COMPLETED|Cycle 1 (1 Month)||58
2872149|NCT00213148|3575899|FG004|COMPLETED|Cycle 1 (1 Month)||17
2872150|NCT00213148|3575895|FG000|NOT COMPLETED|Cycle 1 (1 Month)||24
2872151|NCT00213148|3575896|FG001|NOT COMPLETED|Cycle 1 (1 Month)||0
2872152|NCT00213148|3575897|FG002|NOT COMPLETED|Cycle 1 (1 Month)||19
2872153|NCT00213148|3575898|FG003|NOT COMPLETED|Cycle 1 (1 Month)||18
2872154|NCT00213148|3575899|FG004|NOT COMPLETED|Cycle 1 (1 Month)||22
2872155|NCT00213148|3575895|FG000|STARTED|Cycle 2 (1 Month)||43
2872156|NCT00213148|3575896|FG001|STARTED|Cycle 2 (1 Month)||10
2872157|NCT00213148|3575897|FG002|STARTED|Cycle 2 (1 Month)||42
2872158|NCT00213148|3575898|FG003|STARTED|Cycle 2 (1 Month)||52
2872159|NCT00213148|3575899|FG004|STARTED|Cycle 2 (1 Month)||41
2872160|NCT00213148|3575895|FG000|COMPLETED|Cycle 2 (1 Month)||29
2872161|NCT00213148|3575896|FG001|COMPLETED|Cycle 2 (1 Month)||4
2872162|NCT00213148|3575897|FG002|COMPLETED|Cycle 2 (1 Month)||28
2872163|NCT00213148|3575898|FG003|COMPLETED|Cycle 2 (1 Month)||33
2872164|NCT00213148|3575899|FG004|COMPLETED|Cycle 2 (1 Month)||11
2872165|NCT00213148|3575895|FG000|NOT COMPLETED|Cycle 2 (1 Month)||14
2872166|NCT00213148|3575896|FG001|NOT COMPLETED|Cycle 2 (1 Month)||6
2872167|NCT00213148|3575897|FG002|NOT COMPLETED|Cycle 2 (1 Month)||14
2872168|NCT00213148|3575898|FG003|NOT COMPLETED|Cycle 2 (1 Month)||19
2872169|NCT00213148|3575899|FG004|NOT COMPLETED|Cycle 2 (1 Month)||30
2872170|NCT00213148|3575895|FG000|STARTED|Cycle 3 (1 Month)||23
2872171|NCT00213148|3575896|FG001|STARTED|Cycle 3 (1 Month)||10
2872172|NCT00213148|3575897|FG002|STARTED|Cycle 3 (1 Month)||26
2872173|NCT00213148|3575898|FG003|STARTED|Cycle 3 (1 Month)||24
2872174|NCT00213148|3575899|FG004|STARTED|Cycle 3 (1 Month)||22
2872175|NCT00213148|3575895|FG000|COMPLETED|Cycle 3 (1 Month)||23
2872176|NCT00213148|3575896|FG001|COMPLETED|Cycle 3 (1 Month)||8
2872177|NCT00213148|3575897|FG002|COMPLETED|Cycle 3 (1 Month)||25
2872178|NCT00213148|3575898|FG003|COMPLETED|Cycle 3 (1 Month)||23
2872179|NCT00213148|3575899|FG004|COMPLETED|Cycle 3 (1 Month)||21
2872180|NCT00213148|3575895|FG000|NOT COMPLETED|Cycle 3 (1 Month)||0
2872181|NCT00213148|3575896|FG001|NOT COMPLETED|Cycle 3 (1 Month)||2
2872182|NCT00213148|3575897|FG002|NOT COMPLETED|Cycle 3 (1 Month)||1
2872183|NCT00213148|3575898|FG003|NOT COMPLETED|Cycle 3 (1 Month)||1
2872184|NCT00213148|3575899|FG004|NOT COMPLETED|Cycle 3 (1 Month)||1
2872185|NCT00213239|3575921|FG000|STARTED|Overall Study||32
2872186|NCT00213239|3575922|FG001|STARTED|Overall Study||32
2872187|NCT00213239|3575921|FG000|COMPLETED|Overall Study||32
2872188|NCT00213239|3575922|FG001|COMPLETED|Overall Study||32
2872189|NCT00213239|3575921|FG000|NOT COMPLETED|Overall Study||0
3313760|NCT03077607|4046997|FG000|Treated (With Any Study Drug)|Period 1 (15 Days)||19
3313761|NCT03077607|4046998|FG001|Treated (With Any Study Drug)|Period 1 (15 Days)||17
3313762|NCT03077607|4046997|FG000|Received Talazoparib|Period 1 (15 Days)||19
3313763|NCT03077607|4046998|FG001|Received Talazoparib|Period 1 (15 Days)||17
3313764|NCT03077607|4046997|FG000|COMPLETED|Period 1 (15 Days)||17
3313765|NCT03077607|4046998|FG001|COMPLETED|Period 1 (15 Days)||17
3313766|NCT03077607|4046997|FG000|NOT COMPLETED|Period 1 (15 Days)||2
3313767|NCT03077607|4046998|FG001|NOT COMPLETED|Period 1 (15 Days)||0
3313768|NCT03077607|4046997|FG000|STARTED|Period 2 (Arm A:21 Days; Arm B:23 Days)||17
3313769|NCT03077607|4046998|FG001|STARTED|Period 2 (Arm A:21 Days; Arm B:23 Days)||17
3313770|NCT03077607|4046997|FG000|Treated (With Any Study Drug)|Period 2 (Arm A:21 Days; Arm B:23 Days)||17
3313771|NCT03077607|4046998|FG001|Treated (With Any Study Drug)|Period 2 (Arm A:21 Days; Arm B:23 Days)||17
3313772|NCT03077607|4046997|FG000|Received Talazoparib|Period 2 (Arm A:21 Days; Arm B:23 Days)||15
3313773|NCT03077607|4046998|FG001|Received Talazoparib|Period 2 (Arm A:21 Days; Arm B:23 Days)||15
3313774|NCT03077607|4046997|FG000|COMPLETED|Period 2 (Arm A:21 Days; Arm B:23 Days)||14
3313775|NCT03077607|4046998|FG001|COMPLETED|Period 2 (Arm A:21 Days; Arm B:23 Days)||15
3313776|NCT03077607|4046997|FG000|NOT COMPLETED|Period 2 (Arm A:21 Days; Arm B:23 Days)||3
3313777|NCT03077607|4046998|FG001|NOT COMPLETED|Period 2 (Arm A:21 Days; Arm B:23 Days)||2
3313778|NCT03077646|4047018|FG000|STARTED|Overall Study||76
3313779|NCT03077646|4047019|FG001|STARTED|Overall Study||75
3313780|NCT03077646|4047020|FG002|STARTED|Overall Study||74
3313781|NCT03077646|4047018|FG000|COMPLETED|Overall Study|Of these 47, there were 25 paired samples for primary outcome|47
3313782|NCT03077646|4047019|FG001|COMPLETED|Overall Study|Of these 45, there were 27 paired samples for primary outcome|45
3313783|NCT03077646|4047020|FG002|COMPLETED|Overall Study|Of these 43, there were 20 paired samples for primary outcome|43
3313784|NCT03077646|4047018|FG000|NOT COMPLETED|Overall Study||29
3313785|NCT03077646|4047019|FG001|NOT COMPLETED|Overall Study||30
3313786|NCT03077646|4047020|FG002|NOT COMPLETED|Overall Study||31
3313787|NCT03077659|4047031|FG000|STARTED|Overall Study||3
3313788|NCT03077659|4047032|FG001|STARTED|Overall Study||3
3313789|NCT03077659|4047033|FG002|STARTED|Overall Study||10
3313790|NCT03077659|4047031|FG000|COMPLETED|Overall Study||3
3313791|NCT03077659|4047032|FG001|COMPLETED|Overall Study||3
2872190|NCT00213239|3575922|FG001|NOT COMPLETED|Overall Study||0
2872191|NCT00213980|3575930|FG000|STARTED|Overall Study||32
2872192|NCT00213980|3575931|FG001|STARTED|Overall Study||36
2872193|NCT00213980|3575930|FG000|COMPLETED|Overall Study||26
2872194|NCT00213980|3575931|FG001|COMPLETED|Overall Study||29
2872195|NCT00213980|3575930|FG000|NOT COMPLETED|Overall Study||6
2872196|NCT00213980|3575931|FG001|NOT COMPLETED|Overall Study||7
2872197|NCT00214019|3575937|FG000|STARTED|Overall Study||36
2872198|NCT00214019|3575937|FG000|Placebo/Placebo Arm|Overall Study||6
2872199|NCT00214019|3575937|FG000|Placebo/Salmeterol Arm|Overall Study||6
2872200|NCT00214019|3575937|FG000|Fluticasone/Placebo Arm|Overall Study||6
2872201|NCT00214019|3575937|FG000|Fluticason/Salmeterol Arm|Overall Study||6
2872202|NCT00214019|3575937|FG000|COMPLETED|Overall Study||6
2872203|NCT00214019|3575937|FG000|NOT COMPLETED|Overall Study||30
2872204|NCT00214045|3575946|FG000|STARTED|Overall Study||18
2872205|NCT00214045|3575947|FG001|STARTED|Overall Study||18
2872206|NCT00214045|3575946|FG000|COMPLETED|Overall Study||18
2872207|NCT00214045|3575947|FG001|COMPLETED|Overall Study||18
2872208|NCT00214045|3575946|FG000|NOT COMPLETED|Overall Study||0
2872209|NCT00214045|3575947|FG001|NOT COMPLETED|Overall Study||0
2872210|NCT00214097|3575956|FG000|STARTED|Overall Study|Escalation to the next higher level will occur when > 20 pt yrs of F/U and > 5 pts followed >1 yr|101
2872211|NCT00214097|3575957|FG001|STARTED|Overall Study|Escalation to the next higher level will occur when > 20 pt yrs of F/U and > 5 pts followed >1 yr|111
2872212|NCT00214097|3575958|FG002|STARTED|Overall Study||135
2872213|NCT00214097|3575956|FG000|COMPLETED|Overall Study||101
2872214|NCT00214097|3575957|FG001|COMPLETED|Overall Study||111
2872215|NCT00214097|3575958|FG002|COMPLETED|Overall Study||135
2872216|NCT00214097|3575956|FG000|NOT COMPLETED|Overall Study||0
2872217|NCT00214097|3575957|FG001|NOT COMPLETED|Overall Study||0
2872218|NCT00214097|3575958|FG002|NOT COMPLETED|Overall Study||0
3169659|NCT01927055|3897220|FG001|STARTED|Open-label||0
3169660|NCT01927055|3897221|FG002|STARTED|Open-label||0
3169661|NCT01927055|3897219|FG000|COMPLETED|Open-label||45
3169662|NCT01927055|3897220|FG001|COMPLETED|Open-label||0
3169663|NCT01927055|3897221|FG002|COMPLETED|Open-label||0
3169664|NCT01927055|3897219|FG000|NOT COMPLETED|Open-label||16
2872219|NCT00214136|3575972|FG000|STARTED|Overall Study||30
2872220|NCT00214136|3575972|FG000|COMPLETED|Overall Study||25
2872221|NCT00214136|3575972|FG000|NOT COMPLETED|Overall Study||5
2872222|NCT00214201|3575978|FG000|STARTED|Overall Study||20
2872223|NCT00214201|3575979|FG001|STARTED|Overall Study||20
2872224|NCT00214201|3575978|FG000|COMPLETED|Overall Study||18
2872225|NCT00214201|3575979|FG001|COMPLETED|Overall Study||18
2872226|NCT00214201|3575978|FG000|NOT COMPLETED|Overall Study||2
2872227|NCT00214201|3575979|FG001|NOT COMPLETED|Overall Study||2
2872228|NCT00214383|3575988|FG000|STARTED|Overall Study||148
2872229|NCT00214383|3575989|FG001|STARTED|Overall Study||153
2872230|NCT00214383|3575988|FG000|COMPLETED|Overall Study||132
2872231|NCT00214383|3575989|FG001|COMPLETED|Overall Study||127
2872232|NCT00214383|3575988|FG000|NOT COMPLETED|Overall Study||16
2872233|NCT00214383|3575989|FG001|NOT COMPLETED|Overall Study||26
2872234|NCT00214422|3575998|FG000|STARTED|Overall Study||12
2872235|NCT00214422|3575999|FG001|STARTED|Overall Study||3
2872236|NCT00214422|3576000|FG002|STARTED|Overall Study||4
2872237|NCT00214422|3575998|FG000|COMPLETED|Overall Study||7
2872238|NCT00214422|3575999|FG001|COMPLETED|Overall Study||2
2872239|NCT00214422|3576000|FG002|COMPLETED|Overall Study||3
2872240|NCT00214422|3575998|FG000|NOT COMPLETED|Overall Study||5
2872241|NCT00214422|3575999|FG001|NOT COMPLETED|Overall Study||1
2872242|NCT00214422|3576000|FG002|NOT COMPLETED|Overall Study||1
2872243|NCT00214461|3576016|FG000|STARTED|Overall Study||12
2872244|NCT00214461|3576017|FG001|STARTED|Overall Study||12
2872245|NCT00214461|3576018|FG002|STARTED|Overall Study||12
2872246|NCT00214461|3576019|FG003|STARTED|Overall Study||12
2872247|NCT00214461|3576016|FG000|COMPLETED|Overall Study||12
2872248|NCT00214461|3576017|FG001|COMPLETED|Overall Study||12
2872249|NCT00214461|3576018|FG002|COMPLETED|Overall Study||10
2872250|NCT00214461|3576019|FG003|COMPLETED|Overall Study||11
2872251|NCT00214461|3576016|FG000|NOT COMPLETED|Overall Study||0
3313792|NCT03077659|4047033|FG002|COMPLETED|Overall Study||9
3313793|NCT03077659|4047031|FG000|NOT COMPLETED|Overall Study||0
3313794|NCT03077659|4047032|FG001|NOT COMPLETED|Overall Study||0
2872252|NCT00214461|3576017|FG001|NOT COMPLETED|Overall Study||0
2872253|NCT00214461|3576018|FG002|NOT COMPLETED|Overall Study||2
2872254|NCT00214461|3576019|FG003|NOT COMPLETED|Overall Study||1
3169665|NCT01927055|3897220|FG001|NOT COMPLETED|Open-label||0
3169666|NCT01927055|3897221|FG002|NOT COMPLETED|Open-label||0
3169667|NCT01927055|3897219|FG000|STARTED|Double-Blind||0
3169668|NCT01927055|3897220|FG001|STARTED|Double-Blind||22
3169669|NCT01927055|3897221|FG002|STARTED|Double-Blind||23
3169670|NCT01927055|3897219|FG000|COMPLETED|Double-Blind||0
3169671|NCT01927055|3897220|FG001|COMPLETED|Double-Blind||11
3169672|NCT01927055|3897221|FG002|COMPLETED|Double-Blind||10
3313795|NCT03077659|4047033|FG002|NOT COMPLETED|Overall Study||1
2872255|NCT00214487|3576031|FG000|STARTED|Overall Study||43
3313796|NCT03077711|4047046|FG000|STARTED|Overall Study||47
3313797|NCT03077711|4047047|FG001|STARTED|Overall Study||45
3313798|NCT03077711|4047046|FG000|COMPLETED|Overall Study||43
3313799|NCT03077711|4047047|FG001|COMPLETED|Overall Study||43
3313800|NCT03077711|4047046|FG000|NOT COMPLETED|Overall Study||4
3313801|NCT03077711|4047047|FG001|NOT COMPLETED|Overall Study||2
3313802|NCT03077724|4047057|FG000|STARTED|Overall Study||14
3169673|NCT01927055|3897219|FG000|NOT COMPLETED|Double-Blind||0
3313803|NCT03077724|4047058|FG001|STARTED|Overall Study||14
3313804|NCT03077724|4047057|FG000|COMPLETED|Overall Study||6
3313805|NCT03077724|4047058|FG001|COMPLETED|Overall Study||12
2872256|NCT00214487|3576032|FG001|STARTED|Overall Study||43
2872257|NCT00214487|3576031|FG000|COMPLETED|Overall Study||38
2872258|NCT00214487|3576032|FG001|COMPLETED|Overall Study||40
2872259|NCT00214487|3576031|FG000|NOT COMPLETED|Overall Study||5
2872260|NCT00214487|3576032|FG001|NOT COMPLETED|Overall Study||3
2872261|NCT00214526|3576040|FG000|STARTED|Randomized||56
2872262|NCT00214526|3576041|FG001|STARTED|Randomized||56
2872263|NCT00214526|3576040|FG000|COMPLETED|Randomized||55
2872264|NCT00214526|3576041|FG001|COMPLETED|Randomized||54
2872265|NCT00214526|3576040|FG000|NOT COMPLETED|Randomized||1
2872266|NCT00214526|3576041|FG001|NOT COMPLETED|Randomized||2
2872267|NCT00214526|3576040|FG000|STARTED|Treatment Period||55
2872268|NCT00214526|3576041|FG001|STARTED|Treatment Period||54
2872269|NCT00214526|3576040|FG000|COMPLETED|Treatment Period||53
2872270|NCT00214526|3576041|FG001|COMPLETED|Treatment Period||49
2872271|NCT00214526|3576040|FG000|NOT COMPLETED|Treatment Period||2
2872272|NCT00214526|3576041|FG001|NOT COMPLETED|Treatment Period||5
2872273|NCT00214526|3576040|FG000|STARTED|Post-Treatment Period||53
2872274|NCT00214526|3576041|FG001|STARTED|Post-Treatment Period||49
2872275|NCT00214526|3576040|FG000|COMPLETED|Post-Treatment Period||52
2872276|NCT00214526|3576041|FG001|COMPLETED|Post-Treatment Period||49
2872277|NCT00214526|3576040|FG000|NOT COMPLETED|Post-Treatment Period||1
2872278|NCT00214526|3576041|FG001|NOT COMPLETED|Post-Treatment Period||0
2872279|NCT00214539|3576051|FG000|STARTED|Randomized||17
2872280|NCT00214539|3576052|FG001|STARTED|Randomized||17
2872281|NCT00214539|3576051|FG000|COMPLETED|Randomized||15
2872282|NCT00214539|3576052|FG001|COMPLETED|Randomized||17
2872283|NCT00214539|3576051|FG000|NOT COMPLETED|Randomized||2
2872284|NCT00214539|3576052|FG001|NOT COMPLETED|Randomized||0
2872285|NCT00214539|3576051|FG000|STARTED|Treatment Period||15
2872286|NCT00214539|3576052|FG001|STARTED|Treatment Period||17
2872287|NCT00214539|3576051|FG000|COMPLETED|Treatment Period||15
2872288|NCT00214539|3576052|FG001|COMPLETED|Treatment Period||17
2872289|NCT00214539|3576051|FG000|NOT COMPLETED|Treatment Period||0
2872290|NCT00214539|3576052|FG001|NOT COMPLETED|Treatment Period||0
2872291|NCT00214539|3576051|FG000|STARTED|Steroid Stable (Post-Tx to 22-Weeks)||15
2872292|NCT00214539|3576052|FG001|STARTED|Steroid Stable (Post-Tx to 22-Weeks)||17
2872293|NCT00214539|3576051|FG000|COMPLETED|Steroid Stable (Post-Tx to 22-Weeks)||15
2872294|NCT00214539|3576052|FG001|COMPLETED|Steroid Stable (Post-Tx to 22-Weeks)||17
2872295|NCT00214539|3576051|FG000|NOT COMPLETED|Steroid Stable (Post-Tx to 22-Weeks)||0
2872296|NCT00214539|3576052|FG001|NOT COMPLETED|Steroid Stable (Post-Tx to 22-Weeks)||0
2872297|NCT00214539|3576051|FG000|STARTED|Reduced Steroid (Post-SS to 52-Weeks)||15
2872298|NCT00214539|3576052|FG001|STARTED|Reduced Steroid (Post-SS to 52-Weeks)||17
2872299|NCT00214539|3576051|FG000|COMPLETED|Reduced Steroid (Post-SS to 52-Weeks)||15
2872300|NCT00214539|3576052|FG001|COMPLETED|Reduced Steroid (Post-SS to 52-Weeks)||17
2872301|NCT00214539|3576051|FG000|NOT COMPLETED|Reduced Steroid (Post-SS to 52-Weeks)||0
2872302|NCT00214539|3576052|FG001|NOT COMPLETED|Reduced Steroid (Post-SS to 52-Weeks)||0
2872303|NCT00214786|3576062|FG000|STARTED|Overall Study||4
2872304|NCT00214786|3576062|FG000|COMPLETED|Overall Study||1
2872305|NCT00214786|3576062|FG000|NOT COMPLETED|Overall Study||3
2872306|NCT00214890|3576068|FG000|STARTED|Overall Study||10
2872307|NCT00214890|3576069|FG001|STARTED|Overall Study||11
2872308|NCT00214890|3576068|FG000|COMPLETED|Overall Study||10
2872309|NCT00214890|3576069|FG001|COMPLETED|Overall Study||11
2872310|NCT00214890|3576068|FG000|NOT COMPLETED|Overall Study||0
2872311|NCT00214890|3576069|FG001|NOT COMPLETED|Overall Study||0
2872312|NCT00214903|3576079|FG000|STARTED|Overall Study||10043
2872313|NCT00214903|3576080|FG001|STARTED|Overall Study||13384
2872314|NCT00214903|3576081|FG002|STARTED|Overall Study||4113
2872315|NCT00214903|3576082|FG003|STARTED|Overall Study||3057
2872316|NCT00214903|3576079|FG000|COMPLETED|Overall Study||10043
2872317|NCT00214903|3576080|FG001|COMPLETED|Overall Study||13384
2872318|NCT00214903|3576081|FG002|COMPLETED|Overall Study||4113
2872319|NCT00214903|3576082|FG003|COMPLETED|Overall Study||3057
2872320|NCT00214903|3576079|FG000|NOT COMPLETED|Overall Study||0
2872321|NCT00214903|3576080|FG001|NOT COMPLETED|Overall Study||0
2872322|NCT00214903|3576081|FG002|NOT COMPLETED|Overall Study||0
2872323|NCT00214903|3576082|FG003|NOT COMPLETED|Overall Study||0
2872324|NCT00215137|3576092|FG000|STARTED|Open Label Escitalopram||14
2872325|NCT00215137|3576093|FG001|STARTED|Open Label Escitalopram||0
2872326|NCT00215137|3576094|FG002|STARTED|Open Label Escitalopram||0
2872327|NCT00215137|3576092|FG000|COMPLETED|Open Label Escitalopram||13
2872328|NCT00215137|3576093|FG001|COMPLETED|Open Label Escitalopram||0
2872329|NCT00215137|3576094|FG002|COMPLETED|Open Label Escitalopram||0
2872330|NCT00215137|3576092|FG000|NOT COMPLETED|Open Label Escitalopram||1
2872331|NCT00215137|3576093|FG001|NOT COMPLETED|Open Label Escitalopram||0
2872332|NCT00215137|3576094|FG002|NOT COMPLETED|Open Label Escitalopram||0
2872333|NCT00215137|3576092|FG000|STARTED|Randomization Period||0
2872334|NCT00215137|3576093|FG001|STARTED|Randomization Period||7
2872335|NCT00215137|3576094|FG002|STARTED|Randomization Period||5
2872336|NCT00215137|3576092|FG000|COMPLETED|Randomization Period||0
2872337|NCT00215137|3576093|FG001|COMPLETED|Randomization Period||5
2872338|NCT00215137|3576094|FG002|COMPLETED|Randomization Period||5
2872339|NCT00215137|3576092|FG000|NOT COMPLETED|Randomization Period||0
2872340|NCT00215137|3576093|FG001|NOT COMPLETED|Randomization Period||2
2872341|NCT00215137|3576094|FG002|NOT COMPLETED|Randomization Period||0
2872342|NCT00215150|3576102|FG000|STARTED|Open Label Phase|Number of subjects consented|51
2872343|NCT00215150|3576102|FG000|COMPLETED|Open Label Phase||21
2872344|NCT00215150|3576102|FG000|NOT COMPLETED|Open Label Phase||30
2872345|NCT00215150|3576102|FG000|STARTED|Randomization Phase Ziprasidone||10
2872346|NCT00215150|3576102|FG000|COMPLETED|Randomization Phase Ziprasidone||7
2872347|NCT00215150|3576102|FG000|NOT COMPLETED|Randomization Phase Ziprasidone||3
2872348|NCT00215150|3576102|FG000|STARTED|Randomization Phase Placebo||11
2872349|NCT00215150|3576102|FG000|COMPLETED|Randomization Phase Placebo||10
2872350|NCT00215150|3576102|FG000|NOT COMPLETED|Randomization Phase Placebo||1
2872351|NCT00215540|3576113|FG000|STARTED|Overall Study||45
2872352|NCT00215540|3576114|FG001|STARTED|Overall Study||47
2872353|NCT00215540|3576115|FG002|STARTED|Overall Study||44
2872354|NCT00215540|3576113|FG000|COMPLETED|Overall Study||44
2872355|NCT00215540|3576114|FG001|COMPLETED|Overall Study||47
2872356|NCT00215540|3576115|FG002|COMPLETED|Overall Study||44
2872357|NCT00215540|3576113|FG000|NOT COMPLETED|Overall Study||1
2872358|NCT00215540|3576114|FG001|NOT COMPLETED|Overall Study||0
2872359|NCT00215540|3576115|FG002|NOT COMPLETED|Overall Study||0
2872360|NCT00215553|3576130|FG000|STARTED|Overall Study||5
2872361|NCT00215553|3576131|FG001|STARTED|Overall Study||6
2872362|NCT00215553|3576132|FG002|STARTED|Overall Study||6
2872363|NCT00215553|3576133|FG003|STARTED|Overall Study||5
2872364|NCT00215553|3576134|FG004|STARTED|Overall Study||28
2872365|NCT00215553|3576135|FG005|STARTED|Overall Study||38
2872366|NCT00215553|3576136|FG006|STARTED|Overall Study||36
2872367|NCT00215553|3576130|FG000|COMPLETED|Overall Study||5
2872368|NCT00215553|3576131|FG001|COMPLETED|Overall Study||5
2872369|NCT00215553|3576132|FG002|COMPLETED|Overall Study||4
2872370|NCT00215553|3576133|FG003|COMPLETED|Overall Study||4
2872371|NCT00215553|3576134|FG004|COMPLETED|Overall Study||26
2872372|NCT00215553|3576135|FG005|COMPLETED|Overall Study||32
2872373|NCT00215553|3576136|FG006|COMPLETED|Overall Study||36
2872374|NCT00215553|3576130|FG000|NOT COMPLETED|Overall Study||0
2872375|NCT00215553|3576131|FG001|NOT COMPLETED|Overall Study||1
2872376|NCT00215553|3576132|FG002|NOT COMPLETED|Overall Study||2
2872377|NCT00215553|3576133|FG003|NOT COMPLETED|Overall Study||1
2872378|NCT00215553|3576134|FG004|NOT COMPLETED|Overall Study||2
2872379|NCT00215553|3576135|FG005|NOT COMPLETED|Overall Study||6
2872380|NCT00215553|3576136|FG006|NOT COMPLETED|Overall Study||0
2872381|NCT00215644|3576154|FG000|STARTED|Overall Study||36
2872382|NCT00215644|3576155|FG001|STARTED|Overall Study||36
2872383|NCT00215644|3576154|FG000|Treated|Overall Study||35
2872384|NCT00215644|3576155|FG001|Treated|Overall Study||36
2872385|NCT00215644|3576154|FG000|COMPLETED|Overall Study||0
2872386|NCT00215644|3576155|FG001|COMPLETED|Overall Study||0
2872387|NCT00215644|3576154|FG000|NOT COMPLETED|Overall Study||36
2872388|NCT00215644|3576155|FG001|NOT COMPLETED|Overall Study||36
2872389|NCT00215657|3576169|FG000|STARTED|Overall Study||26
2872390|NCT00215657|3576170|FG001|STARTED|Overall Study||12
2872391|NCT00215657|3576171|FG002|STARTED|Overall Study||13
2872392|NCT00215657|3576172|FG003|STARTED|Overall Study||24
2872393|NCT00215657|3576173|FG004|STARTED|Overall Study||27
2872394|NCT00215657|3576174|FG005|STARTED|Overall Study||24
2872395|NCT00215657|3576175|FG006|STARTED|Overall Study||27
2872396|NCT00215657|3576176|FG007|STARTED|Overall Study||27
2872397|NCT00215657|3576169|FG000|Intention-to-treat Population|Overall Study||25
2872398|NCT00215657|3576170|FG001|Intention-to-treat Population|Overall Study||12
2872399|NCT00215657|3576171|FG002|Intention-to-treat Population|Overall Study||12
2872400|NCT00215657|3576172|FG003|Intention-to-treat Population|Overall Study||24
2872401|NCT00215657|3576173|FG004|Intention-to-treat Population|Overall Study||24
2872402|NCT00215657|3576174|FG005|Intention-to-treat Population|Overall Study||24
2872403|NCT00215657|3576175|FG006|Intention-to-treat Population|Overall Study||24
2872404|NCT00215657|3576176|FG007|Intention-to-treat Population|Overall Study||27
2872405|NCT00215657|3576169|FG000|Started FE200486 CS07A|Overall Study||20
2872406|NCT00215657|3576170|FG001|Started FE200486 CS07A|Overall Study||6
2872407|NCT00215657|3576171|FG002|Started FE200486 CS07A|Overall Study||7
2872408|NCT00215657|3576172|FG003|Started FE200486 CS07A|Overall Study||24
2872409|NCT00215657|3576173|FG004|Started FE200486 CS07A|Overall Study||17
2872410|NCT00215657|3576174|FG005|Started FE200486 CS07A|Overall Study||20
2872411|NCT00215657|3576175|FG006|Started FE200486 CS07A|Overall Study||14
2872412|NCT00215657|3576176|FG007|Started FE200486 CS07A|Overall Study||23
2872413|NCT00215657|3576169|FG000|COMPLETED|Overall Study|Participants ongoing at the time of study closure were considered to have completed the study.|4
2872414|NCT00215657|3576170|FG001|COMPLETED|Overall Study||1
2872415|NCT00215657|3576171|FG002|COMPLETED|Overall Study||2
2872416|NCT00215657|3576172|FG003|COMPLETED|Overall Study||6
2872417|NCT00215657|3576173|FG004|COMPLETED|Overall Study||4
2872418|NCT00215657|3576174|FG005|COMPLETED|Overall Study||4
2872419|NCT00215657|3576175|FG006|COMPLETED|Overall Study||4
2872420|NCT00215657|3576176|FG007|COMPLETED|Overall Study||11
2872421|NCT00215657|3576169|FG000|NOT COMPLETED|Overall Study||22
2872422|NCT00215657|3576170|FG001|NOT COMPLETED|Overall Study||11
2872423|NCT00215657|3576171|FG002|NOT COMPLETED|Overall Study||11
2872424|NCT00215657|3576172|FG003|NOT COMPLETED|Overall Study||18
2872425|NCT00215657|3576173|FG004|NOT COMPLETED|Overall Study||23
2872426|NCT00215657|3576174|FG005|NOT COMPLETED|Overall Study||20
2872427|NCT00215657|3576175|FG006|NOT COMPLETED|Overall Study||23
2872428|NCT00215657|3576176|FG007|NOT COMPLETED|Overall Study||16
2872429|NCT00215683|3576197|FG000|STARTED|Overall Study|Safety analysis set|45
2872430|NCT00215683|3576198|FG001|STARTED|Overall Study||48
2872431|NCT00215683|3576199|FG002|STARTED|Overall Study||44
2872432|NCT00215683|3576197|FG000|Switched to 160 mg|Overall Study|A protocol amendment changed the dosage to 160 mg (40 mg/mL) for all participants|32
2872433|NCT00215683|3576198|FG001|Switched to 160 mg|Overall Study||41
2872434|NCT00215683|3576199|FG002|Switched to 160 mg|Overall Study||36
2872435|NCT00215683|3576197|FG000|COMPLETED|Overall Study|Participants ongoing at the time of study closure were considered to have completed the study|16
2872436|NCT00215683|3576198|FG001|COMPLETED|Overall Study||22
2872437|NCT00215683|3576199|FG002|COMPLETED|Overall Study||12
2872438|NCT00215683|3576197|FG000|NOT COMPLETED|Overall Study||29
2872439|NCT00215683|3576198|FG001|NOT COMPLETED|Overall Study||26
2872440|NCT00215683|3576199|FG002|NOT COMPLETED|Overall Study||32
2872441|NCT00215787|3576207|FG000|STARTED|Overall Study||20
2872442|NCT00215787|3576207|FG000|COMPLETED|Overall Study||20
2872443|NCT00215787|3576207|FG000|NOT COMPLETED|Overall Study||0
2872444|NCT00215930|3576211|FG000|STARTED|Overall Study||53
2872445|NCT00215930|3576211|FG000|COMPLETED|Overall Study||53
2872446|NCT00215930|3576211|FG000|NOT COMPLETED|Overall Study||0
2872447|NCT00215943|3576218|FG000|STARTED|Overall Study||36
2872448|NCT00215943|3576219|FG001|STARTED|Overall Study||37
2872449|NCT00215943|3576218|FG000|COMPLETED|Overall Study||27
2872450|NCT00215943|3576219|FG001|COMPLETED|Overall Study||23
2872451|NCT00215943|3576218|FG000|NOT COMPLETED|Overall Study||9
2872452|NCT00215943|3576219|FG001|NOT COMPLETED|Overall Study||14
2872453|NCT00216060|3576227|FG000|STARTED|Overall Study||32
2872454|NCT00216060|3576228|FG001|STARTED|Overall Study||31
2872455|NCT00216060|3576227|FG000|COMPLETED|Overall Study||32
2872456|NCT00216060|3576228|FG001|COMPLETED|Overall Study||31
2872457|NCT00216060|3576227|FG000|NOT COMPLETED|Overall Study||0
2872458|NCT00216060|3576228|FG001|NOT COMPLETED|Overall Study||0
2872459|NCT00216086|3576236|FG000|STARTED|Overall Study||22
2872460|NCT00216086|3576236|FG000|COMPLETED|Overall Study||18
2872461|NCT00216086|3576236|FG000|NOT COMPLETED|Overall Study||4
2872462|NCT00216099|3576240|FG000|STARTED|Overall Study||49
2872463|NCT00216099|3576240|FG000|Toxicity Analysis|Overall Study||49
2872464|NCT00216099|3576240|FG000|Response Analysis|Overall Study||48
2872465|NCT00216099|3576240|FG000|COMPLETED|Overall Study||48
2872466|NCT00216099|3576240|FG000|NOT COMPLETED|Overall Study||1
2872467|NCT00216125|3576244|FG000|STARTED|Pre-Randomization Phase||243
2872468|NCT00216125|3576245|FG001|STARTED|Pre-Randomization Phase||0
2872469|NCT00216125|3576246|FG002|STARTED|Pre-Randomization Phase||0
2872470|NCT00216125|3576244|FG000|DSMB Cohort for Futility|Pre-Randomization Phase||203
2872471|NCT00216125|3576245|FG001|DSMB Cohort for Futility|Pre-Randomization Phase||0
2872472|NCT00216125|3576246|FG002|DSMB Cohort for Futility|Pre-Randomization Phase||0
2872473|NCT00216125|3576244|FG000|COMPLETED|Pre-Randomization Phase||166
2872474|NCT00216125|3576245|FG001|COMPLETED|Pre-Randomization Phase||0
2872475|NCT00216125|3576246|FG002|COMPLETED|Pre-Randomization Phase||0
2872476|NCT00216125|3576244|FG000|NOT COMPLETED|Pre-Randomization Phase||77
2872477|NCT00216125|3576245|FG001|NOT COMPLETED|Pre-Randomization Phase||0
2872478|NCT00216125|3576246|FG002|NOT COMPLETED|Pre-Randomization Phase||0
2872479|NCT00216125|3576244|FG000|STARTED|Randomization Phase||0
2872480|NCT00216125|3576245|FG001|STARTED|Randomization Phase||84
2872481|NCT00216125|3576246|FG002|STARTED|Randomization Phase||82
2872482|NCT00216125|3576244|FG000|DSMB Cohort for Futility|Randomization Phase||0
2872483|NCT00216125|3576245|FG001|DSMB Cohort for Futility|Randomization Phase||73
2872484|NCT00216125|3576246|FG002|DSMB Cohort for Futility|Randomization Phase||74
2872485|NCT00216125|3576244|FG000|COMPLETED|Randomization Phase||0
2872486|NCT00216125|3576245|FG001|COMPLETED|Randomization Phase||73
2872487|NCT00216125|3576246|FG002|COMPLETED|Randomization Phase||74
2872488|NCT00216125|3576244|FG000|NOT COMPLETED|Randomization Phase||0
2872489|NCT00216125|3576245|FG001|NOT COMPLETED|Randomization Phase||11
2872490|NCT00216125|3576246|FG002|NOT COMPLETED|Randomization Phase||8
2872491|NCT00216203|3576253|FG000|STARTED|Overall Study||36
2872492|NCT00216203|3576253|FG000|COMPLETED|Overall Study||34
2872493|NCT00216203|3576253|FG000|NOT COMPLETED|Overall Study||2
2872494|NCT00216320|3576261|FG000|STARTED|Phase 1 (Weeks 0 - 6)||43
2872495|NCT00216320|3576262|FG001|STARTED|Phase 1 (Weeks 0 - 6)||39
2872496|NCT00216320|3576263|FG002|STARTED|Phase 1 (Weeks 0 - 6)||30
2872497|NCT00216320|3576261|FG000|COMPLETED|Phase 1 (Weeks 0 - 6)||43
2872498|NCT00216320|3576262|FG001|COMPLETED|Phase 1 (Weeks 0 - 6)||35
2872499|NCT00216320|3576263|FG002|COMPLETED|Phase 1 (Weeks 0 - 6)||25
2872500|NCT00216320|3576261|FG000|NOT COMPLETED|Phase 1 (Weeks 0 - 6)||0
2872501|NCT00216320|3576262|FG001|NOT COMPLETED|Phase 1 (Weeks 0 - 6)||4
2872502|NCT00216320|3576263|FG002|NOT COMPLETED|Phase 1 (Weeks 0 - 6)||5
2872503|NCT00216320|3576261|FG000|STARTED|Phase 2 (Weeks 6 -12)||43
2872504|NCT00216320|3576262|FG001|STARTED|Phase 2 (Weeks 6 -12)||35
2872505|NCT00216320|3576263|FG002|STARTED|Phase 2 (Weeks 6 -12)||25
2872506|NCT00216320|3576261|FG000|COMPLETED|Phase 2 (Weeks 6 -12)||38
2872507|NCT00216320|3576262|FG001|COMPLETED|Phase 2 (Weeks 6 -12)||31
2872508|NCT00216320|3576263|FG002|COMPLETED|Phase 2 (Weeks 6 -12)||24
2872509|NCT00216320|3576261|FG000|NOT COMPLETED|Phase 2 (Weeks 6 -12)||5
2872510|NCT00216320|3576262|FG001|NOT COMPLETED|Phase 2 (Weeks 6 -12)||4
2872511|NCT00216320|3576263|FG002|NOT COMPLETED|Phase 2 (Weeks 6 -12)||1
2872512|NCT00216476|3576274|FG000|STARTED|Overall Study||329
2872513|NCT00216476|3576275|FG001|STARTED|Overall Study||337
2872514|NCT00216476|3576276|FG002|STARTED|Overall Study||45
2872515|NCT00216476|3576274|FG000|COMPLETED|Overall Study||224
2872516|NCT00216476|3576275|FG001|COMPLETED|Overall Study||230
2872517|NCT00216476|3576276|FG002|COMPLETED|Overall Study||28
2872518|NCT00216476|3576274|FG000|NOT COMPLETED|Overall Study||105
2872519|NCT00216476|3576275|FG001|NOT COMPLETED|Overall Study||107
2872520|NCT00216476|3576276|FG002|NOT COMPLETED|Overall Study||17
2872521|NCT00216671|3576289|FG000|STARTED|Overall Study||110
2872522|NCT00216671|3576290|FG001|STARTED|Overall Study||110
2872523|NCT00216671|3576289|FG000|COMPLETED|Overall Study||75
2872524|NCT00216671|3576290|FG001|COMPLETED|Overall Study||60
2872525|NCT00216671|3576289|FG000|NOT COMPLETED|Overall Study||35
2872526|NCT00216671|3576290|FG001|NOT COMPLETED|Overall Study||50
2872527|NCT00216736|3576298|FG000|STARTED|Overall Study||32
2872528|NCT00216736|3576299|FG001|STARTED|Overall Study||31
2872529|NCT00216736|3576298|FG000|COMPLETED|Overall Study||31
2872530|NCT00216736|3576299|FG001|COMPLETED|Overall Study||30
2872531|NCT00216736|3576298|FG000|NOT COMPLETED|Overall Study||1
2872532|NCT00216736|3576299|FG001|NOT COMPLETED|Overall Study||1
2872533|NCT00217022|3576307|FG000|STARTED|Overall Study||12
2872534|NCT00217022|3576308|FG001|STARTED|Overall Study||4
2872535|NCT00217022|3576307|FG000|COMPLETED|Overall Study||11
2872536|NCT00217022|3576308|FG001|COMPLETED|Overall Study||3
2872537|NCT00217022|3576307|FG000|NOT COMPLETED|Overall Study||1
2872538|NCT00217022|3576308|FG001|NOT COMPLETED|Overall Study||1
2872539|NCT00217087|3576316|FG000|STARTED|Overall Study||36
2872540|NCT00217087|3576317|FG001|STARTED|Overall Study||37
2872541|NCT00217087|3576316|FG000|COMPLETED|Overall Study||25
2872542|NCT00217087|3576317|FG001|COMPLETED|Overall Study||17
2872543|NCT00217087|3576316|FG000|NOT COMPLETED|Overall Study||11
2872544|NCT00217087|3576317|FG001|NOT COMPLETED|Overall Study||20
2872545|NCT00217399|3576329|FG000|STARTED|Overall Study||35
2872546|NCT00217399|3576329|FG000|COMPLETED|Overall Study||35
2872547|NCT00217399|3576329|FG000|NOT COMPLETED|Overall Study||0
2872548|NCT00217425|3576335|FG000|STARTED|Overall Study||46
2872549|NCT00217425|3576335|FG000|Treated|Overall Study||44
2872550|NCT00217425|3576335|FG000|Eligible and Treated|Overall Study||39
2872551|NCT00217425|3576335|FG000|COMPLETED|Overall Study||9
2872552|NCT00217425|3576335|FG000|NOT COMPLETED|Overall Study||37
2872553|NCT00217438|3576341|FG000|STARTED|Overall Study||66
2872554|NCT00217438|3576342|FG001|STARTED|Overall Study||64
2872555|NCT00217438|3576341|FG000|COMPLETED|Overall Study||66
2872556|NCT00217438|3576342|FG001|COMPLETED|Overall Study|One patient did not complete Day 80-120 evaluation tests after returning to referring physician.|63
2872557|NCT00217438|3576341|FG000|NOT COMPLETED|Overall Study||0
2872558|NCT00217438|3576342|FG001|NOT COMPLETED|Overall Study||1
2872559|NCT00217464|3576348|FG000|STARTED|Overall Study||17
2872560|NCT00217464|3576348|FG000|COMPLETED|Overall Study||0
2872561|NCT00217464|3576348|FG000|NOT COMPLETED|Overall Study||17
2872562|NCT00217490|3576356|FG000|STARTED|Overall Study||154
2872563|NCT00217490|3576357|FG001|STARTED|Overall Study||153
2872564|NCT00217490|3576358|FG002|STARTED|Overall Study||155
2872565|NCT00217490|3576359|FG003|STARTED|Overall Study||153
2872566|NCT00217490|3576356|FG000|COMPLETED|Overall Study||137
2872567|NCT00217490|3576357|FG001|COMPLETED|Overall Study||128
2872568|NCT00217490|3576358|FG002|COMPLETED|Overall Study||131
2872569|NCT00217490|3576359|FG003|COMPLETED|Overall Study||130
2872570|NCT00217490|3576356|FG000|NOT COMPLETED|Overall Study||17
2872571|NCT00217490|3576357|FG001|NOT COMPLETED|Overall Study||25
2872572|NCT00217490|3576358|FG002|NOT COMPLETED|Overall Study||24
2872573|NCT00217490|3576359|FG003|NOT COMPLETED|Overall Study||23
2872574|NCT00217581|3576373|FG000|STARTED|Overall Study||39
2872575|NCT00217581|3576373|FG000|COMPLETED|Overall Study||38
3313806|NCT03077724|4047057|FG000|NOT COMPLETED|Overall Study||8
3313807|NCT03077724|4047058|FG001|NOT COMPLETED|Overall Study||2
3313808|NCT03077893|4047066|FG000|STARTED|Overall Study||18
3313809|NCT03077893|4047067|FG001|STARTED|Overall Study||19
3313810|NCT03077893|4047066|FG000|COMPLETED|Overall Study||14
3313811|NCT03077893|4047067|FG001|COMPLETED|Overall Study||16
3313812|NCT03077893|4047066|FG000|NOT COMPLETED|Overall Study||4
3313813|NCT03077893|4047067|FG001|NOT COMPLETED|Overall Study||3
3317213|NCT03124537|4050740|FG000|COMPLETED|Overall Study||31
3317214|NCT03124537|4050741|FG001|COMPLETED|Overall Study||32
3317215|NCT03124537|4050740|FG000|NOT COMPLETED|Overall Study||10
3317216|NCT03124537|4050741|FG001|NOT COMPLETED|Overall Study||13
3317217|NCT03124550|4050747|FG000|STARTED|Overall Study||18
3317218|NCT03124550|4050747|FG000|COMPLETED|Overall Study||18
3317219|NCT03124550|4050747|FG000|NOT COMPLETED|Overall Study||0
3317220|NCT03124563|4050753|FG000|STARTED|Overall Study||32
3317221|NCT03124563|4050754|FG001|STARTED|Overall Study||31
3317222|NCT03124563|4050753|FG000|Pre-test|Overall Study||30
3317223|NCT03124563|4050754|FG001|Pre-test|Overall Study||30
3317224|NCT03124563|4050753|FG000|COMPLETED|Overall Study||30
2872576|NCT00217581|3576373|FG000|NOT COMPLETED|Overall Study||1
2872577|NCT00217594|3576378|FG000|STARTED|Overall Study||31
2872578|NCT00217594|3576378|FG000|COMPLETED|Overall Study||31
2872579|NCT00217594|3576378|FG000|NOT COMPLETED|Overall Study||0
2872580|NCT00217620|3576382|FG000|STARTED|Overall Study||51
2872581|NCT00217620|3576382|FG000|Eligible|Overall Study||38
2872582|NCT00217620|3576382|FG000|Eligible and Began Protocol Therapy|Overall Study||37
2872583|NCT00217620|3576382|FG000|COMPLETED|Overall Study||0
2872584|NCT00217620|3576382|FG000|NOT COMPLETED|Overall Study||51
2872585|NCT00217672|3576390|FG000|STARTED|Allocation||69
2872586|NCT00217672|3576391|FG001|STARTED|Allocation|When bevacizumab became available, study converted to a 1-arm open-label trial with just bevacizumab|7
2872587|NCT00217672|3576390|FG000|COMPLETED|Allocation||67
3317225|NCT03124563|4050754|FG001|COMPLETED|Overall Study||29
3317226|NCT03124563|4050753|FG000|NOT COMPLETED|Overall Study||2
2872588|NCT00217672|3576391|FG001|COMPLETED|Allocation||7
2872589|NCT00217672|3576390|FG000|NOT COMPLETED|Allocation||2
2872590|NCT00217672|3576391|FG001|NOT COMPLETED|Allocation||0
2872591|NCT00217672|3576390|FG000|STARTED|Treatment||67
2872592|NCT00217672|3576391|FG001|STARTED|Treatment|When bevacizumab became available, study converted to a 1-arm open-label trial with just bevacizumab|7
2872593|NCT00217672|3576390|FG000|COMPLETED|Treatment||0
2872594|NCT00217672|3576391|FG001|COMPLETED|Treatment||0
2872595|NCT00217672|3576390|FG000|NOT COMPLETED|Treatment||67
2872596|NCT00217672|3576391|FG001|NOT COMPLETED|Treatment||7
2872597|NCT00217672|3576390|FG000|STARTED|Follow-up|when bevacizumab became available, converted to a 1-arm open-label trial (67+7=74)|74
2872598|NCT00217672|3576391|FG001|STARTED|Follow-up||0
2872599|NCT00217672|3576390|FG000|COMPLETED|Follow-up||69
2872600|NCT00217672|3576391|FG001|COMPLETED|Follow-up||0
2872601|NCT00217672|3576390|FG000|NOT COMPLETED|Follow-up||5
2872602|NCT00217672|3576391|FG001|NOT COMPLETED|Follow-up||0
2872603|NCT00217724|3576395|FG000|STARTED|Course 1, (Glutamine/Placebo Arms)||8
2872604|NCT00217724|3576396|FG001|STARTED|Course 1, (Glutamine/Placebo Arms)||10
2872605|NCT00217724|3576395|FG000|COMPLETED|Course 1, (Glutamine/Placebo Arms)||5
2872606|NCT00217724|3576396|FG001|COMPLETED|Course 1, (Glutamine/Placebo Arms)||9
2872607|NCT00217724|3576395|FG000|NOT COMPLETED|Course 1, (Glutamine/Placebo Arms)||3
2872608|NCT00217724|3576396|FG001|NOT COMPLETED|Course 1, (Glutamine/Placebo Arms)||1
2872609|NCT00217724|3576395|FG000|STARTED|Course 2, (Glutamine/Placebo Crossover)||9
2872610|NCT00217724|3576396|FG001|STARTED|Course 2, (Glutamine/Placebo Crossover)||5
2872611|NCT00217724|3576395|FG000|COMPLETED|Course 2, (Glutamine/Placebo Crossover)||8
2872612|NCT00217724|3576396|FG001|COMPLETED|Course 2, (Glutamine/Placebo Crossover)||5
2872613|NCT00217724|3576395|FG000|NOT COMPLETED|Course 2, (Glutamine/Placebo Crossover)||1
2872614|NCT00217724|3576396|FG001|NOT COMPLETED|Course 2, (Glutamine/Placebo Crossover)||0
2872615|NCT00217971|3576404|FG000|STARTED|Overall Study||79
2872616|NCT00217971|3576405|FG001|STARTED|Overall Study||77
2872617|NCT00217971|3576404|FG000|COMPLETED|Overall Study||55
2872618|NCT00217971|3576405|FG001|COMPLETED|Overall Study||44
2872619|NCT00217971|3576404|FG000|NOT COMPLETED|Overall Study||24
2872620|NCT00217971|3576405|FG001|NOT COMPLETED|Overall Study||33
2872621|NCT00218023|3576415|FG000|STARTED|Overall Study||22
2872622|NCT00218023|3576416|FG001|STARTED|Overall Study||25
2872623|NCT00218023|3576417|FG002|STARTED|Overall Study||16
2872624|NCT00218023|3576418|FG003|STARTED|Overall Study||18
2872625|NCT00218023|3576415|FG000|Received Drug or Placebo in Phase II|Overall Study||18
2872626|NCT00218023|3576416|FG001|Received Drug or Placebo in Phase II|Overall Study||24
2872627|NCT00218023|3576417|FG002|Received Drug or Placebo in Phase II|Overall Study||15
2872628|NCT00218023|3576418|FG003|Received Drug or Placebo in Phase II|Overall Study||18
2872629|NCT00218023|3576415|FG000|COMPLETED|Overall Study||9
2872630|NCT00218023|3576416|FG001|COMPLETED|Overall Study||10
2872631|NCT00218023|3576417|FG002|COMPLETED|Overall Study||6
2872632|NCT00218023|3576418|FG003|COMPLETED|Overall Study||11
2872633|NCT00218023|3576415|FG000|NOT COMPLETED|Overall Study||13
2872634|NCT00218023|3576416|FG001|NOT COMPLETED|Overall Study||15
2872635|NCT00218023|3576417|FG002|NOT COMPLETED|Overall Study||10
2872636|NCT00218023|3576418|FG003|NOT COMPLETED|Overall Study||7
2872637|NCT00218062|3576432|FG000|STARTED|Overall Study||22
2872638|NCT00218062|3576433|FG001|STARTED|Overall Study||20
2872639|NCT00218062|3576434|FG002|STARTED|Overall Study||15
2872640|NCT00218062|3576435|FG003|STARTED|Overall Study||16
2872641|NCT00218062|3576432|FG000|Received First Dose of Study Medication|Overall Study||16
2872642|NCT00218062|3576433|FG001|Received First Dose of Study Medication|Overall Study||11
2872643|NCT00218062|3576434|FG002|Received First Dose of Study Medication|Overall Study||10
2872644|NCT00218062|3576435|FG003|Received First Dose of Study Medication|Overall Study||12
2872645|NCT00218062|3576432|FG000|COMPLETED|Overall Study||7
2872646|NCT00218062|3576433|FG001|COMPLETED|Overall Study||4
2872647|NCT00218062|3576434|FG002|COMPLETED|Overall Study||3
2872648|NCT00218062|3576435|FG003|COMPLETED|Overall Study||3
2872649|NCT00218062|3576432|FG000|NOT COMPLETED|Overall Study||15
2872650|NCT00218062|3576433|FG001|NOT COMPLETED|Overall Study||16
2872651|NCT00218062|3576434|FG002|NOT COMPLETED|Overall Study||12
2872652|NCT00218062|3576435|FG003|NOT COMPLETED|Overall Study||13
2872653|NCT00218257|3576445|FG000|STARTED|Intervention 1||23
2872654|NCT00218257|3576446|FG001|STARTED|Intervention 1||22
2872655|NCT00218257|3576445|FG000|COMPLETED|Intervention 1||23
2872656|NCT00218257|3576446|FG001|COMPLETED|Intervention 1||22
2872657|NCT00218257|3576445|FG000|NOT COMPLETED|Intervention 1||0
2872658|NCT00218257|3576446|FG001|NOT COMPLETED|Intervention 1||0
2872659|NCT00218257|3576445|FG000|STARTED|Period Between Visit 1 and 2||23
2872660|NCT00218257|3576446|FG001|STARTED|Period Between Visit 1 and 2||22
2872661|NCT00218257|3576445|FG000|COMPLETED|Period Between Visit 1 and 2||19
2872662|NCT00218257|3576446|FG001|COMPLETED|Period Between Visit 1 and 2||19
2872663|NCT00218257|3576445|FG000|NOT COMPLETED|Period Between Visit 1 and 2||4
2872664|NCT00218257|3576446|FG001|NOT COMPLETED|Period Between Visit 1 and 2||3
2872665|NCT00218257|3576445|FG000|STARTED|Intervention 2||19
2872666|NCT00218257|3576446|FG001|STARTED|Intervention 2||19
2872667|NCT00218257|3576445|FG000|COMPLETED|Intervention 2||19
2872668|NCT00218257|3576446|FG001|COMPLETED|Intervention 2||19
2872669|NCT00218257|3576445|FG000|NOT COMPLETED|Intervention 2||0
2872670|NCT00218257|3576446|FG001|NOT COMPLETED|Intervention 2||0
2872671|NCT00218296|3576457|FG000|STARTED|Overall Study||163
2872672|NCT00218296|3576458|FG001|STARTED|Overall Study||169
2872673|NCT00218296|3576457|FG000|Attended Visti|Overall Study||97
2872674|NCT00218296|3576458|FG001|Attended Visti|Overall Study||102
2872675|NCT00218296|3576457|FG000|COMPLETED|Overall Study||52
2872676|NCT00218296|3576458|FG001|COMPLETED|Overall Study||48
2872677|NCT00218296|3576457|FG000|NOT COMPLETED|Overall Study||111
2872678|NCT00218296|3576458|FG001|NOT COMPLETED|Overall Study||121
2872679|NCT00218335|3576470|FG000|STARTED|Overall Study||114
2872680|NCT00218335|3576471|FG001|STARTED|Overall Study||113
2872681|NCT00218335|3576472|FG002|STARTED|Overall Study||373
2872682|NCT00218335|3576473|FG003|STARTED|Overall Study||424
2872683|NCT00218335|3576470|FG000|6 Month Follow-up|Overall Study||103
2872684|NCT00218335|3576471|FG001|6 Month Follow-up|Overall Study||99
2872685|NCT00218335|3576472|FG002|6 Month Follow-up|Overall Study||219
2872686|NCT00218335|3576473|FG003|6 Month Follow-up|Overall Study||301
2872687|NCT00218335|3576470|FG000|12 Month Follow-up|Overall Study||95
2872688|NCT00218335|3576471|FG001|12 Month Follow-up|Overall Study||102
2872689|NCT00218335|3576472|FG002|12 Month Follow-up|Overall Study||244
2872690|NCT00218335|3576473|FG003|12 Month Follow-up|Overall Study||303
2872691|NCT00218335|3576470|FG000|18 Month Follow-up|Overall Study||101
2872692|NCT00218335|3576471|FG001|18 Month Follow-up|Overall Study||108
2872693|NCT00218335|3576472|FG002|18 Month Follow-up|Overall Study||296
2872694|NCT00218335|3576473|FG003|18 Month Follow-up|Overall Study||368
2872695|NCT00218335|3576470|FG000|COMPLETED|Overall Study||108
2872696|NCT00218335|3576471|FG001|COMPLETED|Overall Study||110
2872697|NCT00218335|3576472|FG002|COMPLETED|Overall Study||319
2872698|NCT00218335|3576473|FG003|COMPLETED|Overall Study||388
2872699|NCT00218335|3576470|FG000|NOT COMPLETED|Overall Study||6
2872700|NCT00218335|3576471|FG001|NOT COMPLETED|Overall Study||3
2872701|NCT00218335|3576472|FG002|NOT COMPLETED|Overall Study||54
2872702|NCT00218335|3576473|FG003|NOT COMPLETED|Overall Study||36
2872703|NCT00218387|3576488|FG000|STARTED|Overall Study||40
2872704|NCT00218387|3576489|FG001|STARTED|Overall Study||43
2872705|NCT00218387|3576490|FG002|STARTED|Overall Study||40
2872706|NCT00218387|3576488|FG000|COMPLETED|Overall Study||25
2872707|NCT00218387|3576489|FG001|COMPLETED|Overall Study||25
2872708|NCT00218387|3576490|FG002|COMPLETED|Overall Study||17
2872709|NCT00218387|3576488|FG000|NOT COMPLETED|Overall Study||15
2872710|NCT00218387|3576489|FG001|NOT COMPLETED|Overall Study||18
2872711|NCT00218387|3576490|FG002|NOT COMPLETED|Overall Study||23
2872712|NCT00218426|3576501|FG000|STARTED|Overall Study||102
2872713|NCT00218426|3576502|FG001|STARTED|Overall Study||102
2872714|NCT00218426|3576503|FG002|STARTED|Overall Study||102
2872715|NCT00218426|3576501|FG000|COMPLETED|Overall Study||54
2872716|NCT00218426|3576502|FG001|COMPLETED|Overall Study||16
2872717|NCT00218426|3576503|FG002|COMPLETED|Overall Study||11
2872718|NCT00218426|3576501|FG000|NOT COMPLETED|Overall Study||48
2872719|NCT00218426|3576502|FG001|NOT COMPLETED|Overall Study||86
2872720|NCT00218426|3576503|FG002|NOT COMPLETED|Overall Study||91
2918861|NCT00529126|3629192|FG003|COMPLETED|Overall Study||26
2918862|NCT00529126|3629189|FG000|NOT COMPLETED|Overall Study||0
2918863|NCT00529126|3629190|FG001|NOT COMPLETED|Overall Study||0
2918864|NCT00529126|3629191|FG002|NOT COMPLETED|Overall Study||0
2918865|NCT00529126|3629192|FG003|NOT COMPLETED|Overall Study||0
2918866|NCT00529191|3629204|FG000|STARTED|Overall Study||27
2918867|NCT00529191|3629205|FG001|STARTED|Overall Study||13
2918868|NCT00529191|3629204|FG000|COMPLETED|Overall Study||24
2918869|NCT00529191|3629205|FG001|COMPLETED|Overall Study||13
2918870|NCT00529191|3629204|FG000|NOT COMPLETED|Overall Study||3
2918871|NCT00529191|3629205|FG001|NOT COMPLETED|Overall Study||0
3313814|NCT03077919|4047076|FG000|STARTED|Overall Study||74
3313815|NCT03077919|4047077|FG001|STARTED|Overall Study||39
3313816|NCT03077919|4047076|FG000|Week 2 Visit|Overall Study||74
3313817|NCT03077919|4047077|FG001|Week 2 Visit|Overall Study||39
3313818|NCT03077919|4047076|FG000|Week 4 Visit|Overall Study||73
3313819|NCT03077919|4047077|FG001|Week 4 Visit|Overall Study||38
3313820|NCT03077919|4047076|FG000|Week 6 Visit|Overall Study||73
3313821|NCT03077919|4047077|FG001|Week 6 Visit|Overall Study||38
3313822|NCT03077919|4047076|FG000|Week 8 Visit|Overall Study||71
3313823|NCT03077919|4047077|FG001|Week 8 Visit|Overall Study||38
3313824|NCT03077919|4047076|FG000|Final CAPS|Overall Study||70
3313825|NCT03077919|4047077|FG001|Final CAPS|Overall Study||38
3313826|NCT03077919|4047076|FG000|COMPLETED|Overall Study||70
3313827|NCT03077919|4047077|FG001|COMPLETED|Overall Study||38
3313828|NCT03077919|4047076|FG000|NOT COMPLETED|Overall Study||4
3313829|NCT03077919|4047077|FG001|NOT COMPLETED|Overall Study||1
3313830|NCT03078075|4047085|FG000|STARTED|Overall Study||111
3313831|NCT03078075|4047086|FG001|STARTED|Overall Study||114
3313832|NCT03078075|4047087|FG002|STARTED|Overall Study||59
3313833|NCT03078075|4047088|FG003|STARTED|Overall Study||10
3313834|NCT03078075|4047089|FG004|STARTED|Overall Study||109
3313835|NCT03078075|4047085|FG000|COMPLETED|Overall Study||106
3313836|NCT03078075|4047086|FG001|COMPLETED|Overall Study||103
3313837|NCT03078075|4047087|FG002|COMPLETED|Overall Study||19
3313838|NCT03078075|4047088|FG003|COMPLETED|Overall Study||9
3313839|NCT03078075|4047089|FG004|COMPLETED|Overall Study||78
3313840|NCT03078075|4047085|FG000|NOT COMPLETED|Overall Study||5
3313841|NCT03078075|4047086|FG001|NOT COMPLETED|Overall Study||11
3313842|NCT03078075|4047087|FG002|NOT COMPLETED|Overall Study||40
3313843|NCT03078075|4047088|FG003|NOT COMPLETED|Overall Study||1
3313844|NCT03078075|4047089|FG004|NOT COMPLETED|Overall Study||31
2918872|NCT00529204|3629220|FG000|STARTED|Overall Study||1
2918873|NCT00529204|3629220|FG000|COMPLETED|Overall Study||1
2872721|NCT00218439|3576516|FG000|STARTED|First Intervention (4 Weeks)||58
2872722|NCT00218439|3576517|FG001|STARTED|First Intervention (4 Weeks)||47
2872723|NCT00218439|3576516|FG000|COMPLETED|First Intervention (4 Weeks)||40
2872724|NCT00218439|3576517|FG001|COMPLETED|First Intervention (4 Weeks)||35
2872725|NCT00218439|3576516|FG000|NOT COMPLETED|First Intervention (4 Weeks)||18
2872726|NCT00218439|3576517|FG001|NOT COMPLETED|First Intervention (4 Weeks)||12
2872727|NCT00218439|3576516|FG000|STARTED|Second Intervention (4 Weeks)||40
2872728|NCT00218439|3576517|FG001|STARTED|Second Intervention (4 Weeks)||35
2872729|NCT00218439|3576516|FG000|COMPLETED|Second Intervention (4 Weeks)||33
2872730|NCT00218439|3576517|FG001|COMPLETED|Second Intervention (4 Weeks)||30
2872731|NCT00218439|3576516|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||7
2872732|NCT00218439|3576517|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||5
2872733|NCT00218465|3576533|FG000|STARTED|Overall Study||50
2872734|NCT00218465|3576534|FG001|STARTED|Overall Study||48
2872735|NCT00218465|3576533|FG000|COMPLETED|Overall Study||33
2872736|NCT00218465|3576534|FG001|COMPLETED|Overall Study||30
2872737|NCT00218465|3576533|FG000|NOT COMPLETED|Overall Study||17
2872738|NCT00218465|3576534|FG001|NOT COMPLETED|Overall Study||18
2872739|NCT00218491|3576543|FG000|STARTED|Overall Study||40
2872740|NCT00218491|3576544|FG001|STARTED|Overall Study||33
2872741|NCT00218491|3576545|FG002|STARTED|Overall Study||38
2872742|NCT00218491|3576543|FG000|COMPLETED|Overall Study||40
2872743|NCT00218491|3576544|FG001|COMPLETED|Overall Study||33
2872744|NCT00218491|3576545|FG002|COMPLETED|Overall Study||38
2872745|NCT00218491|3576543|FG000|NOT COMPLETED|Overall Study||0
2872746|NCT00218491|3576544|FG001|NOT COMPLETED|Overall Study||0
2872747|NCT00218491|3576545|FG002|NOT COMPLETED|Overall Study||0
2872748|NCT00218543|3576553|FG000|STARTED|Overall Study||20
2872749|NCT00218543|3576553|FG000|COMPLETED|Overall Study|13 reached the maintenance dose phase of treatment; 9 completed at least six weeks of treatment.|5
2872750|NCT00218543|3576553|FG000|NOT COMPLETED|Overall Study||15
2872751|NCT00218634|3576559|FG000|STARTED|Overall Study||44
2872752|NCT00218634|3576560|FG001|STARTED|Overall Study||45
2872753|NCT00218634|3576559|FG000|COMPLETED|Overall Study||36
2872754|NCT00218634|3576560|FG001|COMPLETED|Overall Study||30
2872755|NCT00218634|3576559|FG000|NOT COMPLETED|Overall Study||8
2872756|NCT00218634|3576560|FG001|NOT COMPLETED|Overall Study||15
2872757|NCT00219141|3576572|FG000|STARTED|Overall Study||154
2872758|NCT00219141|3576573|FG001|STARTED|Overall Study||152
2872759|NCT00219141|3576574|FG002|STARTED|Overall Study||154
2872760|NCT00219141|3576572|FG000|COMPLETED|Overall Study||140
2872761|NCT00219141|3576573|FG001|COMPLETED|Overall Study||131
2872762|NCT00219141|3576574|FG002|COMPLETED|Overall Study||142
2872763|NCT00219141|3576572|FG000|NOT COMPLETED|Overall Study||14
2872764|NCT00219141|3576573|FG001|NOT COMPLETED|Overall Study||21
2872765|NCT00219141|3576574|FG002|NOT COMPLETED|Overall Study||12
2872766|NCT00219284|3576584|FG000|STARTED|Treatment Phase - 16 Weeks||180
2872767|NCT00219284|3576585|FG001|STARTED|Treatment Phase - 16 Weeks||179
2872768|NCT00219284|3576584|FG000|COMPLETED|Treatment Phase - 16 Weeks||136
2872769|NCT00219284|3576585|FG001|COMPLETED|Treatment Phase - 16 Weeks||128
2872770|NCT00219284|3576584|FG000|NOT COMPLETED|Treatment Phase - 16 Weeks||44
2872771|NCT00219284|3576585|FG001|NOT COMPLETED|Treatment Phase - 16 Weeks||51
2872772|NCT00219284|3576584|FG000|STARTED|Extension Phase - 8 Weeks|Not all subjects who completed the treatment phase chose to enter this optional extension phase.|114
2872773|NCT00219284|3576585|FG001|STARTED|Extension Phase - 8 Weeks|Not all subjects who completed the treatment phase chose to enter this optional extension phase.|106
2872774|NCT00219284|3576584|FG000|COMPLETED|Extension Phase - 8 Weeks||112
2872775|NCT00219284|3576585|FG001|COMPLETED|Extension Phase - 8 Weeks||99
2872776|NCT00219284|3576584|FG000|NOT COMPLETED|Extension Phase - 8 Weeks||2
2872777|NCT00219284|3576585|FG001|NOT COMPLETED|Extension Phase - 8 Weeks||7
2872778|NCT00219349|3576591|FG000|STARTED|Cognitive Behavioral Therapy Phase||25
2872779|NCT00219349|3576591|FG000|COMPLETED|Cognitive Behavioral Therapy Phase||15
2872780|NCT00219349|3576591|FG000|NOT COMPLETED|Cognitive Behavioral Therapy Phase||10
2872781|NCT00219349|3576591|FG000|STARTED|Escitalopram Phase|7 responders to CBT were ineligible to start and 1 declined, leaving 7 who started escitalopram|7
3169674|NCT01927055|3897220|FG001|NOT COMPLETED|Double-Blind||11
3169675|NCT01927055|3897221|FG002|NOT COMPLETED|Double-Blind||13
3313845|NCT03078127|4047115|FG000|STARTED|First Intervention||4
2872782|NCT00219349|3576591|FG000|COMPLETED|Escitalopram Phase||4
2872783|NCT00219349|3576591|FG000|NOT COMPLETED|Escitalopram Phase||3
2918874|NCT00529204|3629220|FG000|NOT COMPLETED|Overall Study||0
2918875|NCT00529217|3629224|FG000|STARTED|Overall Study||12
2918876|NCT00529217|3629224|FG000|COMPLETED|Overall Study||8
2918877|NCT00529217|3629224|FG000|NOT COMPLETED|Overall Study||4
2918878|NCT00529243|3629229|FG000|STARTED|Overall Study||52
2918879|NCT00529243|3629229|FG000|COMPLETED|Overall Study||49
2918880|NCT00529243|3629229|FG000|NOT COMPLETED|Overall Study||3
2918881|NCT00529308|3629235|FG000|STARTED|Overall Study||9
2918882|NCT00529308|3629236|FG001|STARTED|Overall Study||11
2918883|NCT00529308|3629235|FG000|COMPLETED|Overall Study||8
3169676|NCT01927120|3897228|FG000|STARTED|Overall Study||20
3313846|NCT03078127|4047116|FG001|STARTED|First Intervention||3
3313847|NCT03078127|4047117|FG002|STARTED|First Intervention||3
3313848|NCT03078127|4047115|FG000|COMPLETED|First Intervention||4
3313849|NCT03078127|4047116|FG001|COMPLETED|First Intervention||3
3313850|NCT03078127|4047117|FG002|COMPLETED|First Intervention||3
3313851|NCT03078127|4047115|FG000|NOT COMPLETED|First Intervention||0
2872784|NCT00219544|3576595|FG000|STARTED|Single Blind Treatment Period||256
2872785|NCT00219544|3576596|FG001|STARTED|Single Blind Treatment Period||0
2872786|NCT00219544|3576595|FG000|COMPLETED|Single Blind Treatment Period||234
2872787|NCT00219544|3576596|FG001|COMPLETED|Single Blind Treatment Period||0
2872788|NCT00219544|3576595|FG000|NOT COMPLETED|Single Blind Treatment Period||22
2872789|NCT00219544|3576596|FG001|NOT COMPLETED|Single Blind Treatment Period||0
2872790|NCT00219544|3576595|FG000|STARTED|Double Blind Treatment Period||80
2872791|NCT00219544|3576596|FG001|STARTED|Double Blind Treatment Period||77
2872792|NCT00219544|3576595|FG000|COMPLETED|Double Blind Treatment Period||80
2872793|NCT00219544|3576596|FG001|COMPLETED|Double Blind Treatment Period||77
2872794|NCT00219544|3576595|FG000|NOT COMPLETED|Double Blind Treatment Period||0
2872795|NCT00219544|3576596|FG001|NOT COMPLETED|Double Blind Treatment Period||0
2872796|NCT00219557|3576607|FG000|STARTED|Phase 1||8
2872797|NCT00219557|3576608|FG001|STARTED|Phase 1||0
2872798|NCT00219557|3576609|FG002|STARTED|Phase 1||0
2872799|NCT00219557|3576607|FG000|COMPLETED|Phase 1||1
2872800|NCT00219557|3576608|FG001|COMPLETED|Phase 1||0
2872801|NCT00219557|3576609|FG002|COMPLETED|Phase 1||0
2872802|NCT00219557|3576607|FG000|NOT COMPLETED|Phase 1||7
2872803|NCT00219557|3576608|FG001|NOT COMPLETED|Phase 1||0
2872804|NCT00219557|3576609|FG002|NOT COMPLETED|Phase 1||0
2872805|NCT00219557|3576607|FG000|STARTED|Phase 2||0
2872806|NCT00219557|3576608|FG001|STARTED|Phase 2||69
2872807|NCT00219557|3576609|FG002|STARTED|Phase 2||34
2872808|NCT00219557|3576607|FG000|Treated|Phase 2||0
2872809|NCT00219557|3576608|FG001|Treated|Phase 2||68
2872810|NCT00219557|3576609|FG002|Treated|Phase 2||31
2872811|NCT00219557|3576607|FG000|COMPLETED|Phase 2||0
2872812|NCT00219557|3576608|FG001|COMPLETED|Phase 2||0
2872813|NCT00219557|3576609|FG002|COMPLETED|Phase 2||1
2872814|NCT00219557|3576607|FG000|NOT COMPLETED|Phase 2||0
2872815|NCT00219557|3576608|FG001|NOT COMPLETED|Phase 2||69
2872816|NCT00219557|3576609|FG002|NOT COMPLETED|Phase 2||33
2872817|NCT00220636|3576618|FG000|STARTED|Overall Study||15
2872818|NCT00220636|3576618|FG000|COMPLETED|Overall Study||11
2872819|NCT00220636|3576618|FG000|NOT COMPLETED|Overall Study||4
2872820|NCT00220701|3576625|FG000|STARTED|Overall Study||17
2872821|NCT00220701|3576626|FG001|STARTED|Overall Study||17
2872822|NCT00220701|3576625|FG000|COMPLETED|Overall Study||12
2872823|NCT00220701|3576626|FG001|COMPLETED|Overall Study||13
2872824|NCT00220701|3576625|FG000|NOT COMPLETED|Overall Study||5
2872825|NCT00220701|3576626|FG001|NOT COMPLETED|Overall Study||4
2872826|NCT00220727|3576634|FG000|STARTED|First Infusion (Week 0)||4
2872827|NCT00220727|3576635|FG001|STARTED|First Infusion (Week 0)||4
2872828|NCT00220727|3576634|FG000|COMPLETED|First Infusion (Week 0)||4
2872829|NCT00220727|3576635|FG001|COMPLETED|First Infusion (Week 0)||4
2872830|NCT00220727|3576634|FG000|NOT COMPLETED|First Infusion (Week 0)||0
2872831|NCT00220727|3576635|FG001|NOT COMPLETED|First Infusion (Week 0)||0
2872832|NCT00220727|3576634|FG000|STARTED|Second Infusion (Week <6)||4
2872833|NCT00220727|3576635|FG001|STARTED|Second Infusion (Week <6)||4
2872834|NCT00220727|3576634|FG000|COMPLETED|Second Infusion (Week <6)||3
2872835|NCT00220727|3576635|FG001|COMPLETED|Second Infusion (Week <6)||4
2872836|NCT00220727|3576634|FG000|NOT COMPLETED|Second Infusion (Week <6)||1
2872837|NCT00220727|3576635|FG001|NOT COMPLETED|Second Infusion (Week <6)||0
2872838|NCT00220740|3576645|FG000|STARTED|Efficacy Period||59
2872839|NCT00220740|3576646|FG001|STARTED|Efficacy Period||58
2872840|NCT00220740|3576645|FG000|COMPLETED|Efficacy Period||33
2872841|NCT00220740|3576646|FG001|COMPLETED|Efficacy Period||12
2872842|NCT00220740|3576645|FG000|NOT COMPLETED|Efficacy Period||26
2872843|NCT00220740|3576646|FG001|NOT COMPLETED|Efficacy Period||46
2872844|NCT00220740|3576645|FG000|STARTED|Rescue Treatment|Only the subjects who failed the treatment in the Efficacy period entered the Rescue period.|45
2872845|NCT00220740|3576646|FG001|STARTED|Rescue Treatment|Only the subjects who failed the treatment in the Efficacy period entered the Rescue period.|23
2872846|NCT00220740|3576645|FG000|COMPLETED|Rescue Treatment||26
2872847|NCT00220740|3576646|FG001|COMPLETED|Rescue Treatment||5
2872848|NCT00220740|3576645|FG000|NOT COMPLETED|Rescue Treatment||19
2872849|NCT00220740|3576646|FG001|NOT COMPLETED|Rescue Treatment||18
2872850|NCT00220740|3576645|FG000|STARTED|Withdrawal Period|The subjects who were success in Efficacy or Rescue Period were re-randomized to Withdrawal period.|43
2872851|NCT00220740|3576646|FG001|STARTED|Withdrawal Period|The subjects who were success in Efficacy or Rescue Period were re-randomized to Withdrawal period.|31
2872852|NCT00220740|3576645|FG000|COMPLETED|Withdrawal Period||37
2872853|NCT00220740|3576646|FG001|COMPLETED|Withdrawal Period||16
2872854|NCT00220740|3576645|FG000|NOT COMPLETED|Withdrawal Period||6
2872855|NCT00220740|3576646|FG001|NOT COMPLETED|Withdrawal Period||15
2872856|NCT00220779|3576657|FG000|STARTED|Overall Study||45
3313852|NCT03078127|4047116|FG001|NOT COMPLETED|First Intervention||0
3313853|NCT03078127|4047117|FG002|NOT COMPLETED|First Intervention||0
3313854|NCT03078127|4047115|FG000|STARTED|Washout (3-21 Days)||4
3313855|NCT03078127|4047116|FG001|STARTED|Washout (3-21 Days)||3
2872857|NCT00220779|3576658|FG001|STARTED|Overall Study||42
2872858|NCT00220779|3576659|FG002|STARTED|Overall Study||41
2872859|NCT00220779|3576657|FG000|COMPLETED|Overall Study||38
2872860|NCT00220779|3576658|FG001|COMPLETED|Overall Study||38
2872861|NCT00220779|3576659|FG002|COMPLETED|Overall Study||37
2872862|NCT00220779|3576657|FG000|NOT COMPLETED|Overall Study||7
2872863|NCT00220779|3576658|FG001|NOT COMPLETED|Overall Study||4
2872864|NCT00220779|3576659|FG002|NOT COMPLETED|Overall Study||4
2872865|NCT00220805|3576669|FG000|STARTED|Overall Study||30
2872866|NCT00220805|3576670|FG001|STARTED|Overall Study||27
2872867|NCT00220805|3576669|FG000|COMPLETED|Overall Study||22
2872868|NCT00220805|3576670|FG001|COMPLETED|Overall Study||16
2872869|NCT00220805|3576669|FG000|NOT COMPLETED|Overall Study||8
2872870|NCT00220805|3576670|FG001|NOT COMPLETED|Overall Study||11
2872871|NCT00220961|3576678|FG000|STARTED|Overall Study||299
2872872|NCT00220961|3576679|FG001|STARTED|Overall Study||303
2872873|NCT00220961|3576678|FG000|COMPLETED|Overall Study||228
2872874|NCT00220961|3576679|FG001|COMPLETED|Overall Study||213
2872875|NCT00220961|3576678|FG000|NOT COMPLETED|Overall Study||71
2872876|NCT00220961|3576679|FG001|NOT COMPLETED|Overall Study||90
2872877|NCT00221104|3576687|FG000|STARTED|Overall Study||793
2872878|NCT00221104|3576688|FG001|STARTED|Overall Study||785
2872879|NCT00221104|3576687|FG000|COMPLETED|Overall Study||710
2872880|NCT00221104|3576688|FG001|COMPLETED|Overall Study||709
2872881|NCT00221104|3576687|FG000|NOT COMPLETED|Overall Study||83
2872882|NCT00221104|3576688|FG001|NOT COMPLETED|Overall Study||76
2872883|NCT00221117|3576698|FG000|STARTED|Overall Study||12
2872884|NCT00221117|3576699|FG001|STARTED|Overall Study|One participant dropped out of the study after signing consent but prior to baseline assessments.|9
2872885|NCT00221117|3576698|FG000|COMPLETED|Overall Study||12
2872886|NCT00221117|3576699|FG001|COMPLETED|Overall Study||9
2872887|NCT00221117|3576698|FG000|NOT COMPLETED|Overall Study||0
2872888|NCT00221117|3576699|FG001|NOT COMPLETED|Overall Study||0
2872889|NCT00221195|3576709|FG000|STARTED|Therapy 1 (Months 1-6)||17
2872890|NCT00221195|3576710|FG001|STARTED|Therapy 1 (Months 1-6)||17
2872891|NCT00221195|3576709|FG000|COMPLETED|Therapy 1 (Months 1-6)||14
2872892|NCT00221195|3576710|FG001|COMPLETED|Therapy 1 (Months 1-6)||15
2872893|NCT00221195|3576709|FG000|NOT COMPLETED|Therapy 1 (Months 1-6)||3
2872894|NCT00221195|3576710|FG001|NOT COMPLETED|Therapy 1 (Months 1-6)||2
2872895|NCT00221195|3576709|FG000|STARTED|Washout Period (Months 7-9)||14
2872896|NCT00221195|3576710|FG001|STARTED|Washout Period (Months 7-9)||15
2872897|NCT00221195|3576709|FG000|COMPLETED|Washout Period (Months 7-9)||14
2872898|NCT00221195|3576710|FG001|COMPLETED|Washout Period (Months 7-9)||14
2872899|NCT00221195|3576709|FG000|NOT COMPLETED|Washout Period (Months 7-9)||0
2872900|NCT00221195|3576710|FG001|NOT COMPLETED|Washout Period (Months 7-9)||1
2872901|NCT00221195|3576709|FG000|STARTED|Therapy 2 (Months 10-15)||14
2872902|NCT00221195|3576710|FG001|STARTED|Therapy 2 (Months 10-15)||14
2872903|NCT00221195|3576709|FG000|COMPLETED|Therapy 2 (Months 10-15)||12
2872904|NCT00221195|3576710|FG001|COMPLETED|Therapy 2 (Months 10-15)||14
2872905|NCT00221195|3576709|FG000|NOT COMPLETED|Therapy 2 (Months 10-15)||2
2872906|NCT00221195|3576710|FG001|NOT COMPLETED|Therapy 2 (Months 10-15)||0
2872907|NCT00221299|3576720|FG000|STARTED|Overall Study||11
2872908|NCT00221299|3576721|FG001|STARTED|Overall Study||13
2872909|NCT00221299|3576722|FG002|STARTED|Overall Study||14
2872910|NCT00221299|3576723|FG003|STARTED|Overall Study||11
2872911|NCT00221299|3576720|FG000|COMPLETED|Overall Study||10
2872912|NCT00221299|3576721|FG001|COMPLETED|Overall Study||11
2872913|NCT00221299|3576722|FG002|COMPLETED|Overall Study||14
2872914|NCT00221299|3576723|FG003|COMPLETED|Overall Study||10
2872915|NCT00221299|3576720|FG000|NOT COMPLETED|Overall Study||1
2872916|NCT00221299|3576721|FG001|NOT COMPLETED|Overall Study||2
2872917|NCT00221299|3576722|FG002|NOT COMPLETED|Overall Study||0
2872918|NCT00221299|3576723|FG003|NOT COMPLETED|Overall Study||1
2872919|NCT00221338|3576733|FG000|STARTED|Overall Study||374
2872920|NCT00221338|3576734|FG001|STARTED|Overall Study||376
2872921|NCT00221338|3576733|FG000|COMPLETED|Overall Study||350
2872922|NCT00221338|3576734|FG001|COMPLETED|Overall Study||347
2872923|NCT00221338|3576733|FG000|NOT COMPLETED|Overall Study||24
2872924|NCT00221338|3576734|FG001|NOT COMPLETED|Overall Study||29
2872925|NCT00221403|3576743|FG000|STARTED|Overall Study||18
2872926|NCT00221403|3576744|FG001|STARTED|Overall Study||21
2872927|NCT00221403|3576745|FG002|STARTED|Overall Study||7
2872928|NCT00221403|3576743|FG000|COMPLETED|Overall Study||16
2872929|NCT00221403|3576744|FG001|COMPLETED|Overall Study||16
2872930|NCT00221403|3576745|FG002|COMPLETED|Overall Study||7
2872931|NCT00221403|3576743|FG000|NOT COMPLETED|Overall Study||2
2872932|NCT00221403|3576744|FG001|NOT COMPLETED|Overall Study||5
2872933|NCT00221403|3576745|FG002|NOT COMPLETED|Overall Study||0
2872934|NCT00222105|3576753|FG000|STARTED|Overall Study||25
2872935|NCT00222105|3576753|FG000|COMPLETED|Overall Study||11
2872936|NCT00222105|3576753|FG000|NOT COMPLETED|Overall Study||14
2872937|NCT00222131|3576759|FG000|STARTED|Overall Study||38
2872938|NCT00222131|3576760|FG001|STARTED|Overall Study||35
2872939|NCT00222131|3576759|FG000|COMPLETED|Overall Study||38
2872940|NCT00222131|3576760|FG001|COMPLETED|Overall Study||35
2872941|NCT00222131|3576759|FG000|NOT COMPLETED|Overall Study||0
2872942|NCT00222131|3576760|FG001|NOT COMPLETED|Overall Study||0
2872943|NCT00222729|3576766|FG000|STARTED|Overall Study||40
2872944|NCT00222729|3576766|FG000|COMPLETED|Overall Study||37
2872945|NCT00222729|3576766|FG000|NOT COMPLETED|Overall Study||3
2872946|NCT00223080|3576772|FG000|STARTED|Overall Study||8197
2872947|NCT00223080|3576773|FG001|STARTED|Overall Study||8198
2872948|NCT00223080|3576772|FG000|COMPLETED|Overall Study||7401
2872949|NCT00223080|3576773|FG001|COMPLETED|Overall Study||7401
2872950|NCT00223080|3576772|FG000|NOT COMPLETED|Overall Study||796
2872951|NCT00223080|3576773|FG001|NOT COMPLETED|Overall Study||797
2872952|NCT00223236|3576781|FG000|STARTED|Overall Study|23 completed baseline assessment but 16 completed at least one treatment visit.|16
2872953|NCT00223236|3576782|FG001|STARTED|Overall Study|21 completed baseline assessment but 18 completed at least one treatment visit.|18
2872954|NCT00223236|3576781|FG000|COMPLETED|Overall Study|9 completed 12 week trial.|9
2872955|NCT00223236|3576782|FG001|COMPLETED|Overall Study|4 completed 12 week trial.|4
2872956|NCT00223236|3576781|FG000|NOT COMPLETED|Overall Study||7
2872957|NCT00223236|3576782|FG001|NOT COMPLETED|Overall Study||14
2872958|NCT00223262|3576790|FG000|STARTED|Overall Study||16
2872959|NCT00223262|3576791|FG001|STARTED|Overall Study||12
2872960|NCT00223262|3576790|FG000|COMPLETED|Overall Study||8
2872961|NCT00223262|3576791|FG001|COMPLETED|Overall Study||11
2872962|NCT00223262|3576790|FG000|NOT COMPLETED|Overall Study||8
2872963|NCT00223262|3576791|FG001|NOT COMPLETED|Overall Study||1
2872964|NCT00223496|3576797|FG000|STARTED|Overall Study|32 people consented, 19 were baselined|32
2872965|NCT00223496|3576797|FG000|COMPLETED|Overall Study||10
2872966|NCT00223496|3576797|FG000|NOT COMPLETED|Overall Study||22
2872967|NCT00223652|3576803|FG000|STARTED|T-CBT 12 Weeks, TAU 20 Weeks||41
3313856|NCT03078127|4047117|FG002|STARTED|Washout (3-21 Days)||3
3313857|NCT03078127|4047115|FG000|COMPLETED|Washout (3-21 Days)||4
3313858|NCT03078127|4047116|FG001|COMPLETED|Washout (3-21 Days)||3
3313859|NCT03078127|4047117|FG002|COMPLETED|Washout (3-21 Days)||3
3313860|NCT03078127|4047115|FG000|NOT COMPLETED|Washout (3-21 Days)||0
3313861|NCT03078127|4047116|FG001|NOT COMPLETED|Washout (3-21 Days)||0
2872968|NCT00223652|3576804|FG001|STARTED|T-CBT 12 Weeks, TAU 20 Weeks||44
2872969|NCT00223652|3576803|FG000|COMPLETED|T-CBT 12 Weeks, TAU 20 Weeks||40
2872970|NCT00223652|3576804|FG001|COMPLETED|T-CBT 12 Weeks, TAU 20 Weeks||41
2872971|NCT00223652|3576803|FG000|NOT COMPLETED|T-CBT 12 Weeks, TAU 20 Weeks||1
2872972|NCT00223652|3576804|FG001|NOT COMPLETED|T-CBT 12 Weeks, TAU 20 Weeks||3
2872973|NCT00223652|3576803|FG000|STARTED|T-CBT 20 Weeks, TAU 20 Weeks||40
2872974|NCT00223652|3576804|FG001|STARTED|T-CBT 20 Weeks, TAU 20 Weeks||41
2872975|NCT00223652|3576803|FG000|COMPLETED|T-CBT 20 Weeks, TAU 20 Weeks||40
2872976|NCT00223652|3576804|FG001|COMPLETED|T-CBT 20 Weeks, TAU 20 Weeks||41
2872977|NCT00223652|3576803|FG000|NOT COMPLETED|T-CBT 20 Weeks, TAU 20 Weeks||0
2872978|NCT00223652|3576804|FG001|NOT COMPLETED|T-CBT 20 Weeks, TAU 20 Weeks||0
2872979|NCT00223652|3576803|FG000|STARTED|T-CBT and TAU 6 Month Follow-up||40
2872980|NCT00223652|3576804|FG001|STARTED|T-CBT and TAU 6 Month Follow-up||41
3169677|NCT01927120|3897228|FG000|COMPLETED|Overall Study||10
3169678|NCT01927120|3897228|FG000|NOT COMPLETED|Overall Study||10
3313862|NCT03078127|4047117|FG002|NOT COMPLETED|Washout (3-21 Days)||0
3313863|NCT03078127|4047115|FG000|STARTED|Second Intervention||4
3313864|NCT03078127|4047116|FG001|STARTED|Second Intervention||3
3313865|NCT03078127|4047117|FG002|STARTED|Second Intervention||3
3313866|NCT03078127|4047115|FG000|COMPLETED|Second Intervention||4
3313867|NCT03078127|4047116|FG001|COMPLETED|Second Intervention||3
3313868|NCT03078127|4047117|FG002|COMPLETED|Second Intervention||3
3313869|NCT03078127|4047115|FG000|NOT COMPLETED|Second Intervention||0
3313870|NCT03078127|4047116|FG001|NOT COMPLETED|Second Intervention||0
3313871|NCT03078127|4047117|FG002|NOT COMPLETED|Second Intervention||0
3313872|NCT03078127|4047115|FG000|STARTED|Washout (3-21 Days)||4
3313873|NCT03078127|4047116|FG001|STARTED|Washout (3-21 Days)||3
3313874|NCT03078127|4047117|FG002|STARTED|Washout (3-21 Days)||3
3313875|NCT03078127|4047115|FG000|COMPLETED|Washout (3-21 Days)||4
3313876|NCT03078127|4047116|FG001|COMPLETED|Washout (3-21 Days)||3
3313877|NCT03078127|4047117|FG002|COMPLETED|Washout (3-21 Days)||3
3313878|NCT03078127|4047115|FG000|NOT COMPLETED|Washout (3-21 Days)||0
3313879|NCT03078127|4047116|FG001|NOT COMPLETED|Washout (3-21 Days)||0
3313880|NCT03078127|4047117|FG002|NOT COMPLETED|Washout (3-21 Days)||0
3313881|NCT03078127|4047115|FG000|STARTED|Third Intervention||4
3313882|NCT03078127|4047116|FG001|STARTED|Third Intervention||3
3313883|NCT03078127|4047117|FG002|STARTED|Third Intervention||3
3313884|NCT03078127|4047115|FG000|COMPLETED|Third Intervention||4
3313885|NCT03078127|4047116|FG001|COMPLETED|Third Intervention||3
3313886|NCT03078127|4047117|FG002|COMPLETED|Third Intervention||3
3313887|NCT03078127|4047115|FG000|NOT COMPLETED|Third Intervention||0
3313888|NCT03078127|4047116|FG001|NOT COMPLETED|Third Intervention||0
3313889|NCT03078127|4047117|FG002|NOT COMPLETED|Third Intervention||0
3313890|NCT03078504|4047128|FG000|STARTED|Overall Study||6
3313891|NCT03078504|4047128|FG000|COMPLETED|Overall Study||6
3313892|NCT03078504|4047128|FG000|NOT COMPLETED|Overall Study||0
3313893|NCT03078556|4047134|FG000|STARTED|Treatment Period 1 (4 Days)||39
3313894|NCT03078556|4047135|FG001|STARTED|Treatment Period 1 (4 Days)||39
3313895|NCT03078556|4047136|FG002|STARTED|Treatment Period 1 (4 Days)||38
3313896|NCT03078556|4047137|FG003|STARTED|Treatment Period 1 (4 Days)||38
3313897|NCT03078556|4047134|FG000|COMPLETED|Treatment Period 1 (4 Days)||39
3313898|NCT03078556|4047135|FG001|COMPLETED|Treatment Period 1 (4 Days)||38
3313899|NCT03078556|4047136|FG002|COMPLETED|Treatment Period 1 (4 Days)||38
3313900|NCT03078556|4047137|FG003|COMPLETED|Treatment Period 1 (4 Days)||38
3313901|NCT03078556|4047134|FG000|NOT COMPLETED|Treatment Period 1 (4 Days)||0
3313902|NCT03078556|4047135|FG001|NOT COMPLETED|Treatment Period 1 (4 Days)||1
3313903|NCT03078556|4047136|FG002|NOT COMPLETED|Treatment Period 1 (4 Days)||0
3313904|NCT03078556|4047137|FG003|NOT COMPLETED|Treatment Period 1 (4 Days)||0
3313905|NCT03078556|4047134|FG000|STARTED|Washout Period 1 (7 Days)||39
3313906|NCT03078556|4047135|FG001|STARTED|Washout Period 1 (7 Days)||38
3313907|NCT03078556|4047136|FG002|STARTED|Washout Period 1 (7 Days)||38
3313908|NCT03078556|4047137|FG003|STARTED|Washout Period 1 (7 Days)||38
3313909|NCT03078556|4047134|FG000|COMPLETED|Washout Period 1 (7 Days)||37
3313910|NCT03078556|4047135|FG001|COMPLETED|Washout Period 1 (7 Days)||36
3313911|NCT03078556|4047136|FG002|COMPLETED|Washout Period 1 (7 Days)||37
3313912|NCT03078556|4047137|FG003|COMPLETED|Washout Period 1 (7 Days)||37
2872981|NCT00223652|3576803|FG000|COMPLETED|T-CBT and TAU 6 Month Follow-up||39
2872982|NCT00223652|3576804|FG001|COMPLETED|T-CBT and TAU 6 Month Follow-up||37
2872983|NCT00223652|3576803|FG000|NOT COMPLETED|T-CBT and TAU 6 Month Follow-up||1
2872984|NCT00223652|3576804|FG001|NOT COMPLETED|T-CBT and TAU 6 Month Follow-up||4
2872985|NCT00223665|3576811|FG000|STARTED|Overall Study||102
2872986|NCT00223665|3576811|FG000|COMPLETED|Overall Study||102
2872987|NCT00223665|3576811|FG000|NOT COMPLETED|Overall Study||0
2872988|NCT00223678|3576818|FG000|STARTED|Overall Study||13
2872989|NCT00223678|3576819|FG001|STARTED|Overall Study||7
2872990|NCT00223678|3576818|FG000|COMPLETED|Overall Study||13
2872991|NCT00223678|3576819|FG001|COMPLETED|Overall Study||7
2872992|NCT00223678|3576818|FG000|NOT COMPLETED|Overall Study||0
2872993|NCT00223678|3576819|FG001|NOT COMPLETED|Overall Study||0
2872994|NCT00223704|3576828|FG000|STARTED|Overall Study||38
2872995|NCT00223704|3576829|FG001|STARTED|Overall Study||37
2872996|NCT00223704|3576830|FG002|STARTED|Overall Study||40
2872997|NCT00223704|3576828|FG000|COMPLETED|Overall Study||38
2872998|NCT00223704|3576829|FG001|COMPLETED|Overall Study||37
2872999|NCT00223704|3576830|FG002|COMPLETED|Overall Study||40
2873000|NCT00223704|3576828|FG000|NOT COMPLETED|Overall Study||0
2873001|NCT00223704|3576829|FG001|NOT COMPLETED|Overall Study||0
2873002|NCT00223704|3576830|FG002|NOT COMPLETED|Overall Study||0
2873003|NCT00223795|3576838|FG000|STARTED|First Intervention - Eight Weeks||26
2873004|NCT00223795|3576839|FG001|STARTED|First Intervention - Eight Weeks||27
2873005|NCT00223795|3576838|FG000|COMPLETED|First Intervention - Eight Weeks||19
2873006|NCT00223795|3576839|FG001|COMPLETED|First Intervention - Eight Weeks||18
2873007|NCT00223795|3576838|FG000|NOT COMPLETED|First Intervention - Eight Weeks||7
2873008|NCT00223795|3576839|FG001|NOT COMPLETED|First Intervention - Eight Weeks||9
2873009|NCT00223795|3576838|FG000|STARTED|Second Intervention - All Use Canes 4 mo||19
2873010|NCT00223795|3576839|FG001|STARTED|Second Intervention - All Use Canes 4 mo||18
2873011|NCT00223795|3576838|FG000|COMPLETED|Second Intervention - All Use Canes 4 mo||18
2873012|NCT00223795|3576839|FG001|COMPLETED|Second Intervention - All Use Canes 4 mo||17
2873013|NCT00223795|3576838|FG000|NOT COMPLETED|Second Intervention - All Use Canes 4 mo||1
2873014|NCT00223795|3576839|FG001|NOT COMPLETED|Second Intervention - All Use Canes 4 mo||1
3169679|NCT01927341|3897237|FG000|STARTED|Phase 1b||10
3169680|NCT01927341|3897238|FG001|STARTED|Phase 1b||0
3169681|NCT01927341|3897239|FG002|STARTED|Phase 1b||0
3169682|NCT01927341|3897240|FG003|STARTED|Phase 1b||0
3169683|NCT01927341|3897241|FG004|STARTED|Phase 1b||0
3169684|NCT01927341|3897237|FG000|COMPLETED|Phase 1b||0
3169685|NCT01927341|3897238|FG001|COMPLETED|Phase 1b||0
2873015|NCT00223808|3576849|FG000|STARTED|Overall Study||22
2873016|NCT00223808|3576850|FG001|STARTED|Overall Study||22
2873017|NCT00223808|3576851|FG002|STARTED|Overall Study||23
2873018|NCT00223808|3576849|FG000|COMPLETED|Overall Study|Completed at least the immediate post-treatment testing with 5 or more hours of treatment.|19
2873019|NCT00223808|3576850|FG001|COMPLETED|Overall Study|Completed at least the immediate post-treatment testing with 5 or more hours of treatment.|17
2873020|NCT00223808|3576851|FG002|COMPLETED|Overall Study|Completed at least the immediate post-treatment testing with 5 or more hours of treatment.|18
2873021|NCT00223808|3576849|FG000|NOT COMPLETED|Overall Study||3
2873022|NCT00223808|3576850|FG001|NOT COMPLETED|Overall Study||5
2873023|NCT00223808|3576851|FG002|NOT COMPLETED|Overall Study||5
2873024|NCT00223821|3576861|FG000|STARTED|Overall Study||32
2873025|NCT00223821|3576862|FG001|STARTED|Overall Study||32
2873026|NCT00223821|3576861|FG000|Completed Therapy|Overall Study||31
2873027|NCT00223821|3576862|FG001|Completed Therapy|Overall Study||28
2873028|NCT00223821|3576861|FG000|Completed Post-treatment Assessment|Overall Study||31
2873029|NCT00223821|3576862|FG001|Completed Post-treatment Assessment|Overall Study||27
2873030|NCT00223821|3576861|FG000|Completed 6-month Follow-up|Overall Study||28
2873031|NCT00223821|3576862|FG001|Completed 6-month Follow-up|Overall Study||25
2873032|NCT00223821|3576861|FG000|COMPLETED|Overall Study||28
2873033|NCT00223821|3576862|FG001|COMPLETED|Overall Study||22
2873034|NCT00223821|3576861|FG000|NOT COMPLETED|Overall Study||4
2873035|NCT00223821|3576862|FG001|NOT COMPLETED|Overall Study||10
2873036|NCT00223977|3576871|FG000|STARTED|Overall Study||46
2873037|NCT00223977|3576872|FG001|STARTED|Overall Study||58
2873038|NCT00223977|3576873|FG002|STARTED|Overall Study||42
2873039|NCT00223977|3576871|FG000|COMPLETED|Overall Study||37
2873040|NCT00223977|3576872|FG001|COMPLETED|Overall Study||47
2873041|NCT00223977|3576873|FG002|COMPLETED|Overall Study||39
2873042|NCT00223977|3576871|FG000|NOT COMPLETED|Overall Study||9
2873043|NCT00223977|3576872|FG001|NOT COMPLETED|Overall Study||11
2873044|NCT00223977|3576873|FG002|NOT COMPLETED|Overall Study||3
2873045|NCT00223990|3576883|FG000|STARTED|Overall Study||200
2873046|NCT00223990|3576884|FG001|STARTED|Overall Study||200
2873047|NCT00223990|3576883|FG000|COMPLETED|Overall Study||193
2873048|NCT00223990|3576884|FG001|COMPLETED|Overall Study||191
2873049|NCT00223990|3576883|FG000|NOT COMPLETED|Overall Study||7
2873050|NCT00223990|3576884|FG001|NOT COMPLETED|Overall Study||9
2873051|NCT00224016|3576892|FG000|STARTED|Titration Period||39
2873052|NCT00224016|3576893|FG001|STARTED|Titration Period||16
2873053|NCT00224016|3576892|FG000|COMPLETED|Titration Period||38
2873054|NCT00224016|3576893|FG001|COMPLETED|Titration Period||15
2873055|NCT00224016|3576892|FG000|NOT COMPLETED|Titration Period||1
2873056|NCT00224016|3576893|FG001|NOT COMPLETED|Titration Period||1
2873057|NCT00224016|3576892|FG000|STARTED|Maintenance Period||38
2873058|NCT00224016|3576893|FG001|STARTED|Maintenance Period||15
2873059|NCT00224016|3576892|FG000|COMPLETED|Maintenance Period||36
2873060|NCT00224016|3576893|FG001|COMPLETED|Maintenance Period||14
2873061|NCT00224016|3576892|FG000|NOT COMPLETED|Maintenance Period||2
2873062|NCT00224016|3576893|FG001|NOT COMPLETED|Maintenance Period||1
2873063|NCT00224016|3576892|FG000|STARTED|Follow-Up Period||35
2873064|NCT00224016|3576893|FG001|STARTED|Follow-Up Period|This group of subjects did not proceed to follow-up period.|0
2873065|NCT00224016|3576892|FG000|COMPLETED|Follow-Up Period||35
2873066|NCT00224016|3576893|FG001|COMPLETED|Follow-Up Period||0
2873067|NCT00224016|3576892|FG000|NOT COMPLETED|Follow-Up Period||0
2873068|NCT00224016|3576893|FG001|NOT COMPLETED|Follow-Up Period||0
2873069|NCT00224029|3576899|FG000|STARTED|Overall Study||24
2873070|NCT00224029|3576899|FG000|COMPLETED|Overall Study||18
2873071|NCT00224029|3576899|FG000|NOT COMPLETED|Overall Study||6
2873072|NCT00224042|3576905|FG000|STARTED|Overall Study||26
2873073|NCT00224042|3576906|FG001|STARTED|Overall Study||26
2873074|NCT00224042|3576905|FG000|COMPLETED|Overall Study||20
2873075|NCT00224042|3576906|FG001|COMPLETED|Overall Study||20
2873076|NCT00224042|3576905|FG000|NOT COMPLETED|Overall Study||6
2873077|NCT00224042|3576906|FG001|NOT COMPLETED|Overall Study||6
2873078|NCT00224055|3576914|FG000|STARTED|Overall Study||44
2873079|NCT00224055|3576915|FG001|STARTED|Overall Study||45
2873080|NCT00224055|3576914|FG000|COMPLETED|Overall Study||29
2873081|NCT00224055|3576915|FG001|COMPLETED|Overall Study||31
2873082|NCT00224055|3576914|FG000|NOT COMPLETED|Overall Study||15
2873083|NCT00224055|3576915|FG001|NOT COMPLETED|Overall Study||14
2873084|NCT00224107|3576923|FG000|STARTED|Overall Study||233
2873085|NCT00224107|3576924|FG001|STARTED|Overall Study||228
2873086|NCT00224107|3576923|FG000|COMPLETED|Overall Study||202
2873087|NCT00224107|3576924|FG001|COMPLETED|Overall Study||214
2873088|NCT00224107|3576923|FG000|NOT COMPLETED|Overall Study||31
2873089|NCT00224107|3576924|FG001|NOT COMPLETED|Overall Study||14
2873090|NCT00224120|3576932|FG000|STARTED|Overall Study||233
2873091|NCT00224120|3576933|FG001|STARTED|Overall Study||229
2873092|NCT00224120|3576932|FG000|COMPLETED|Overall Study||211
2873093|NCT00224120|3576933|FG001|COMPLETED|Overall Study||205
2873094|NCT00224120|3576932|FG000|NOT COMPLETED|Overall Study||22
2873095|NCT00224120|3576933|FG001|NOT COMPLETED|Overall Study||24
2873096|NCT00224133|3576939|FG000|STARTED|Overall Study||661
2873097|NCT00224133|3576939|FG000|COMPLETED|Overall Study||435
2873098|NCT00224133|3576939|FG000|NOT COMPLETED|Overall Study||226
3313913|NCT03078556|4047134|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||2
3313914|NCT03078556|4047135|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||2
3313915|NCT03078556|4047136|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||1
3313916|NCT03078556|4047137|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||1
3313917|NCT03078556|4047134|FG000|STARTED|Treatment Period 2 (4 Days)||37
3313918|NCT03078556|4047135|FG001|STARTED|Treatment Period 2 (4 Days)||36
3313919|NCT03078556|4047136|FG002|STARTED|Treatment Period 2 (4 Days)||37
3313920|NCT03078556|4047137|FG003|STARTED|Treatment Period 2 (4 Days)||37
3313921|NCT03078556|4047134|FG000|COMPLETED|Treatment Period 2 (4 Days)||37
3313922|NCT03078556|4047135|FG001|COMPLETED|Treatment Period 2 (4 Days)||36
3313923|NCT03078556|4047136|FG002|COMPLETED|Treatment Period 2 (4 Days)||37
3313924|NCT03078556|4047137|FG003|COMPLETED|Treatment Period 2 (4 Days)||37
3313925|NCT03078556|4047134|FG000|NOT COMPLETED|Treatment Period 2 (4 Days)||0
3313926|NCT03078556|4047135|FG001|NOT COMPLETED|Treatment Period 2 (4 Days)||0
3313927|NCT03078556|4047136|FG002|NOT COMPLETED|Treatment Period 2 (4 Days)||0
3313928|NCT03078556|4047137|FG003|NOT COMPLETED|Treatment Period 2 (4 Days)||0
3313929|NCT03078556|4047134|FG000|STARTED|Washout Period 2 (7 Days)||9
3313930|NCT03078556|4047135|FG001|STARTED|Washout Period 2 (7 Days)||7
3313931|NCT03078556|4047136|FG002|STARTED|Washout Period 2 (7 Days)||7
3313932|NCT03078556|4047137|FG003|STARTED|Washout Period 2 (7 Days)||9
3313933|NCT03078556|4047134|FG000|COMPLETED|Washout Period 2 (7 Days)||9
3313934|NCT03078556|4047135|FG001|COMPLETED|Washout Period 2 (7 Days)||7
3313935|NCT03078556|4047136|FG002|COMPLETED|Washout Period 2 (7 Days)||7
3313936|NCT03078556|4047137|FG003|COMPLETED|Washout Period 2 (7 Days)||9
3313937|NCT03078556|4047134|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||0
3313938|NCT03078556|4047135|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0
3313939|NCT03078556|4047136|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0
3313940|NCT03078556|4047137|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||0
3313941|NCT03078556|4047134|FG000|STARTED|Treatment Period 3 (4 Days)||9
3313942|NCT03078556|4047135|FG001|STARTED|Treatment Period 3 (4 Days)||7
3313943|NCT03078556|4047136|FG002|STARTED|Treatment Period 3 (4 Days)||7
3313944|NCT03078556|4047137|FG003|STARTED|Treatment Period 3 (4 Days)||9
3313945|NCT03078556|4047134|FG000|COMPLETED|Treatment Period 3 (4 Days)||9
3313946|NCT03078556|4047135|FG001|COMPLETED|Treatment Period 3 (4 Days)||7
3313947|NCT03078556|4047136|FG002|COMPLETED|Treatment Period 3 (4 Days)||7
3313948|NCT03078556|4047137|FG003|COMPLETED|Treatment Period 3 (4 Days)||9
3313949|NCT03078556|4047134|FG000|NOT COMPLETED|Treatment Period 3 (4 Days)||0
3313950|NCT03078556|4047135|FG001|NOT COMPLETED|Treatment Period 3 (4 Days)||0
3313951|NCT03078556|4047136|FG002|NOT COMPLETED|Treatment Period 3 (4 Days)||0
3313952|NCT03078556|4047137|FG003|NOT COMPLETED|Treatment Period 3 (4 Days)||0
3313953|NCT03078582|4047164|FG000|STARTED|Overall Study||10
2873099|NCT00224289|3576943|FG000|STARTED|Overall Study||17
2873100|NCT00224289|3576943|FG000|COMPLETED|Overall Study||17
2873101|NCT00224289|3576943|FG000|NOT COMPLETED|Overall Study||0
2873102|NCT00224484|3576950|FG000|STARTED|Overall Study||2977
2873103|NCT00224484|3576951|FG001|STARTED|Overall Study||1491
2873104|NCT00224484|3576952|FG002|STARTED|Overall Study||1487
2873105|NCT00224484|3576950|FG000|COMPLETED|Overall Study||2831
2873106|NCT00224484|3576951|FG001|COMPLETED|Overall Study||1426
2873107|NCT00224484|3576952|FG002|COMPLETED|Overall Study||1425
2873108|NCT00224484|3576950|FG000|NOT COMPLETED|Overall Study||146
2873109|NCT00224484|3576951|FG001|NOT COMPLETED|Overall Study||65
2873110|NCT00224484|3576952|FG002|NOT COMPLETED|Overall Study||62
2873111|NCT00224770|3576966|FG000|STARTED|Overall Study||42
2873112|NCT00224770|3576967|FG001|STARTED|Overall Study||54
2873113|NCT00224770|3576968|FG002|STARTED|Overall Study||14
2873114|NCT00224770|3576966|FG000|COMPLETED|Overall Study||38
2873115|NCT00224770|3576967|FG001|COMPLETED|Overall Study||52
2873116|NCT00224770|3576968|FG002|COMPLETED|Overall Study||14
2873117|NCT00224770|3576966|FG000|NOT COMPLETED|Overall Study||4
2873118|NCT00224770|3576967|FG001|NOT COMPLETED|Overall Study||2
2873119|NCT00224770|3576968|FG002|NOT COMPLETED|Overall Study||0
2873120|NCT00224874|3576981|FG000|STARTED|Overall Study||46
2873121|NCT00224874|3576982|FG001|STARTED|Overall Study||45
3169686|NCT01927341|3897239|FG002|COMPLETED|Phase 1b||0
3169687|NCT01927341|3897240|FG003|COMPLETED|Phase 1b||0
3169688|NCT01927341|3897241|FG004|COMPLETED|Phase 1b||0
3169689|NCT01927341|3897237|FG000|NOT COMPLETED|Phase 1b||10
3169690|NCT01927341|3897238|FG001|NOT COMPLETED|Phase 1b||0
3169691|NCT01927341|3897239|FG002|NOT COMPLETED|Phase 1b||0
2873122|NCT00224874|3576983|FG002|STARTED|Overall Study||47
2873123|NCT00224874|3576984|FG003|STARTED|Overall Study||42
2873124|NCT00224874|3576981|FG000|COMPLETED|Overall Study||46
2873125|NCT00224874|3576982|FG001|COMPLETED|Overall Study||45
2873126|NCT00224874|3576983|FG002|COMPLETED|Overall Study||46
2873127|NCT00224874|3576984|FG003|COMPLETED|Overall Study||42
2873128|NCT00224874|3576981|FG000|NOT COMPLETED|Overall Study||0
2873129|NCT00224874|3576982|FG001|NOT COMPLETED|Overall Study||0
2873130|NCT00224874|3576983|FG002|NOT COMPLETED|Overall Study||1
2873131|NCT00224874|3576984|FG003|NOT COMPLETED|Overall Study||0
2873132|NCT00224887|3576996|FG000|STARTED|Overall Study||154
2873133|NCT00224887|3576997|FG001|STARTED|Overall Study||153
2873134|NCT00224887|3576996|FG000|COMPLETED|Overall Study||148
2873135|NCT00224887|3576997|FG001|COMPLETED|Overall Study||147
2873136|NCT00224887|3576996|FG000|NOT COMPLETED|Overall Study||6
2873137|NCT00224887|3576997|FG001|NOT COMPLETED|Overall Study||6
2873138|NCT00224952|3577006|FG000|STARTED|Overall Study||53
2873139|NCT00224952|3577007|FG001|STARTED|Overall Study||87
2873140|NCT00224952|3577008|FG002|STARTED|Overall Study||134
2873141|NCT00224952|3577006|FG000|COMPLETED|Overall Study||53
2873142|NCT00224952|3577007|FG001|COMPLETED|Overall Study||87
2873143|NCT00224952|3577008|FG002|COMPLETED|Overall Study||134
2873144|NCT00224952|3577006|FG000|NOT COMPLETED|Overall Study||0
2873145|NCT00224952|3577007|FG001|NOT COMPLETED|Overall Study||0
2873146|NCT00224952|3577008|FG002|NOT COMPLETED|Overall Study||0
2873147|NCT00225017|3577019|FG000|STARTED|Overall Study||26
2873148|NCT00225017|3577020|FG001|STARTED|Overall Study||24
2873149|NCT00225017|3577019|FG000|COMPLETED|Overall Study||26
3313954|NCT03078582|4047165|FG001|STARTED|Overall Study||16
3313955|NCT03078582|4047164|FG000|COMPLETED|Overall Study||10
3313956|NCT03078582|4047165|FG001|COMPLETED|Overall Study||8
3313957|NCT03078582|4047164|FG000|NOT COMPLETED|Overall Study||0
3313958|NCT03078582|4047165|FG001|NOT COMPLETED|Overall Study||8
3313959|NCT03078595|4047173|FG000|STARTED|Overall Study||24
3313960|NCT03078595|4047174|FG001|STARTED|Overall Study||24
3313961|NCT03078595|4047173|FG000|COMPLETED|Overall Study||24
3313962|NCT03078595|4047174|FG001|COMPLETED|Overall Study||24
3313963|NCT03078595|4047173|FG000|NOT COMPLETED|Overall Study||0
3313964|NCT03078595|4047174|FG001|NOT COMPLETED|Overall Study||0
3313965|NCT03078647|4047183|FG000|STARTED|Overall Study||17
3313966|NCT03078647|4047184|FG001|STARTED|Overall Study||11
3313967|NCT03078647|4047185|FG002|STARTED|Overall Study||3
3313968|NCT03078647|4047183|FG000|COMPLETED|Overall Study||17
3313969|NCT03078647|4047184|FG001|COMPLETED|Overall Study||10
3313970|NCT03078647|4047185|FG002|COMPLETED|Overall Study||3
3313971|NCT03078647|4047183|FG000|NOT COMPLETED|Overall Study||0
3313972|NCT03078647|4047184|FG001|NOT COMPLETED|Overall Study||1
3313973|NCT03078647|4047185|FG002|NOT COMPLETED|Overall Study||0
3313974|NCT03078751|4047195|FG000|STARTED|Overall Study||26
3313975|NCT03078751|4047196|FG001|STARTED|Overall Study||28
3313976|NCT03078751|4047195|FG000|Untreated Participants|Overall Study||0
3313977|NCT03078751|4047196|FG001|Untreated Participants|Overall Study||4
3313978|NCT03078751|4047195|FG000|Safety Set|Overall Study||26
3313979|NCT03078751|4047196|FG001|Safety Set|Overall Study||24
3313980|NCT03078751|4047195|FG000|COMPLETED|Overall Study||13
3313981|NCT03078751|4047196|FG001|COMPLETED|Overall Study||0
3313982|NCT03078751|4047195|FG000|NOT COMPLETED|Overall Study||13
3313983|NCT03078751|4047196|FG001|NOT COMPLETED|Overall Study||28
2873150|NCT00225017|3577020|FG001|COMPLETED|Overall Study|1 subject did not complete week 24 assessments|23
2873151|NCT00225017|3577019|FG000|NOT COMPLETED|Overall Study||0
2873152|NCT00225017|3577020|FG001|NOT COMPLETED|Overall Study||1
3169692|NCT01927341|3897240|FG003|NOT COMPLETED|Phase 1b||0
3313984|NCT03078816|4047202|FG000|STARTED|Overall Study||5
3313985|NCT03078816|4047202|FG000|COMPLETED|Overall Study||4
3313986|NCT03078816|4047202|FG000|NOT COMPLETED|Overall Study||1
3313987|NCT03078907|4047208|FG000|STARTED|Overall Study||53
3313988|NCT03078907|4047209|FG001|STARTED|Overall Study||55
3313989|NCT03078907|4047208|FG000|COMPLETED|Overall Study||50
3313990|NCT03078907|4047209|FG001|COMPLETED|Overall Study||54
3313991|NCT03078907|4047208|FG000|NOT COMPLETED|Overall Study||3
2873153|NCT00225147|3577030|FG000|STARTED|Double-blind Phase||13
2873154|NCT00225147|3577031|FG001|STARTED|Double-blind Phase||12
2873155|NCT00225147|3577032|FG002|STARTED|Double-blind Phase||13
2873156|NCT00225147|3577033|FG003|STARTED|Double-blind Phase||0
2873157|NCT00225147|3577030|FG000|COMPLETED|Double-blind Phase||13
2873158|NCT00225147|3577031|FG001|COMPLETED|Double-blind Phase||12
2873159|NCT00225147|3577032|FG002|COMPLETED|Double-blind Phase||13
2873160|NCT00225147|3577033|FG003|COMPLETED|Double-blind Phase||0
2873161|NCT00225147|3577030|FG000|NOT COMPLETED|Double-blind Phase||0
2873162|NCT00225147|3577031|FG001|NOT COMPLETED|Double-blind Phase||0
2873163|NCT00225147|3577032|FG002|NOT COMPLETED|Double-blind Phase||0
2873164|NCT00225147|3577033|FG003|NOT COMPLETED|Double-blind Phase||0
2873165|NCT00225147|3577030|FG000|STARTED|Open-label Phase||0
2873166|NCT00225147|3577031|FG001|STARTED|Open-label Phase||0
2873167|NCT00225147|3577032|FG002|STARTED|Open-label Phase||0
2873168|NCT00225147|3577033|FG003|STARTED|Open-label Phase||62
2873169|NCT00225147|3577030|FG000|COMPLETED|Open-label Phase||0
2873170|NCT00225147|3577031|FG001|COMPLETED|Open-label Phase||0
2873171|NCT00225147|3577032|FG002|COMPLETED|Open-label Phase||0
2873172|NCT00225147|3577033|FG003|COMPLETED|Open-label Phase||52
2873173|NCT00225147|3577030|FG000|NOT COMPLETED|Open-label Phase||0
2873174|NCT00225147|3577031|FG001|NOT COMPLETED|Open-label Phase||0
2873175|NCT00225147|3577032|FG002|NOT COMPLETED|Open-label Phase||0
2873176|NCT00225147|3577033|FG003|NOT COMPLETED|Open-label Phase||10
2873177|NCT00225212|3577045|FG000|STARTED|Overall Study||35
2873178|NCT00225212|3577045|FG000|COMPLETED|Overall Study||29
2873179|NCT00225212|3577045|FG000|NOT COMPLETED|Overall Study||6
2873180|NCT00225251|3577051|FG000|STARTED|Overall Study||11
2873181|NCT00225251|3577052|FG001|STARTED|Overall Study||7
2873182|NCT00225251|3577051|FG000|COMPLETED|Overall Study||10
2873183|NCT00225251|3577052|FG001|COMPLETED|Overall Study||6
2873184|NCT00225251|3577051|FG000|NOT COMPLETED|Overall Study||1
2873185|NCT00225251|3577052|FG001|NOT COMPLETED|Overall Study||1
2873186|NCT00225277|3577060|FG000|STARTED|Overall Study|274 subjects randomized, but four subjects did not receive drug.|274
2873187|NCT00225277|3577061|FG001|STARTED|Overall Study|Mean treatment durations were 56.3 weeks (glimepiride) and 56.5 weeks (pioglitazone).|273
2873188|NCT00225277|3577060|FG000|COMPLETED|Overall Study||177
2873189|NCT00225277|3577061|FG001|COMPLETED|Overall Study||178
2873190|NCT00225277|3577060|FG000|NOT COMPLETED|Overall Study||97
2873191|NCT00225277|3577061|FG001|NOT COMPLETED|Overall Study||95
2873192|NCT00225420|3577067|FG000|STARTED|Overall Study||9
2873193|NCT00225420|3577068|FG001|STARTED|Overall Study||6
2873194|NCT00225420|3577069|FG002|STARTED|Overall Study||3
2873195|NCT00225420|3577067|FG000|COMPLETED|Overall Study||9
2873196|NCT00225420|3577068|FG001|COMPLETED|Overall Study||6
2873197|NCT00225420|3577069|FG002|COMPLETED|Overall Study||3
2873198|NCT00225420|3577067|FG000|NOT COMPLETED|Overall Study||0
2873199|NCT00225420|3577068|FG001|NOT COMPLETED|Overall Study||0
2873200|NCT00225420|3577069|FG002|NOT COMPLETED|Overall Study||0
2873201|NCT00225498|3577076|FG000|STARTED|Overall Study||10
2873202|NCT00225498|3577076|FG000|COMPLETED|Overall Study|The only analyses with adequate statistical power were of the 10 ziprasidone nonresponders.|10
2873203|NCT00225498|3577076|FG000|NOT COMPLETED|Overall Study||0
2873204|NCT00225732|3577082|FG000|STARTED|Overall Study||153
2873205|NCT00225732|3577083|FG001|STARTED|Overall Study||166
2873206|NCT00225732|3577082|FG000|COMPLETED|Overall Study||153
2873207|NCT00225732|3577083|FG001|COMPLETED|Overall Study||166
2873208|NCT00225732|3577082|FG000|NOT COMPLETED|Overall Study||0
2873209|NCT00225732|3577083|FG001|NOT COMPLETED|Overall Study||0
2873210|NCT00225758|3577089|FG000|STARTED|Overall Study||27
2873211|NCT00225758|3577089|FG000|COMPLETED|Overall Study||23
2873212|NCT00225758|3577089|FG000|NOT COMPLETED|Overall Study||4
2873213|NCT00225784|3577095|FG000|STARTED|Overall Study||37
2873214|NCT00225784|3577095|FG000|COMPLETED|Overall Study||33
2873215|NCT00225784|3577095|FG000|NOT COMPLETED|Overall Study||4
2873216|NCT00226239|3577102|FG000|STARTED|TPE, Induction Therapy||39
2873217|NCT00226239|3577102|FG000|COMPLETED|TPE, Induction Therapy||37
2873218|NCT00226239|3577102|FG000|NOT COMPLETED|TPE, Induction Therapy||2
2873219|NCT00226239|3577102|FG000|STARTED|XPE, Definitive Therapy||37
2873220|NCT00226239|3577102|FG000|COMPLETED|XPE, Definitive Therapy||33
2873221|NCT00226239|3577102|FG000|NOT COMPLETED|XPE, Definitive Therapy||4
2873222|NCT00226239|3577102|FG000|STARTED|Maintenance Cetuximab||31
2873223|NCT00226239|3577102|FG000|COMPLETED|Maintenance Cetuximab||17
2873224|NCT00226239|3577102|FG000|NOT COMPLETED|Maintenance Cetuximab||14
2873225|NCT00226499|3577110|FG000|STARTED|Overall Study||2489
2873226|NCT00226499|3577111|FG001|STARTED|Overall Study||2487
3313992|NCT03078907|4047209|FG001|NOT COMPLETED|Overall Study||1
3313993|NCT03078946|4047217|FG000|STARTED|Overall Study||30
3313994|NCT03078946|4047218|FG001|STARTED|Overall Study||30
3313995|NCT03078946|4047217|FG000|COMPLETED|Overall Study||30
3313996|NCT03078946|4047218|FG001|COMPLETED|Overall Study||30
3313997|NCT03078946|4047217|FG000|NOT COMPLETED|Overall Study||0
3313998|NCT03078946|4047218|FG001|NOT COMPLETED|Overall Study||0
2873227|NCT00226499|3577112|FG002|STARTED|Overall Study||827
2873228|NCT00226499|3577110|FG000|COMPLETED|Overall Study||1415
2873229|NCT00226499|3577111|FG001|COMPLETED|Overall Study||1415
2873230|NCT00226499|3577112|FG002|COMPLETED|Overall Study||468
2873231|NCT00226499|3577110|FG000|NOT COMPLETED|Overall Study||1074
2873232|NCT00226499|3577111|FG001|NOT COMPLETED|Overall Study||1072
2873233|NCT00226499|3577112|FG002|NOT COMPLETED|Overall Study||359
3313999|NCT03079375|4047227|FG000|STARTED|Overall Study||503
2873234|NCT00226577|3577122|FG000|STARTED|Overall Study||52
2873235|NCT00226577|3577122|FG000|COMPLETED|Overall Study||52
2873236|NCT00226577|3577122|FG000|NOT COMPLETED|Overall Study||0
2873237|NCT00226590|3577126|FG000|STARTED|Overall Study||39
2873238|NCT00226590|3577126|FG000|COMPLETED|Overall Study||39
2873239|NCT00226590|3577126|FG000|NOT COMPLETED|Overall Study||0
2873240|NCT00226655|3577131|FG000|STARTED|Overall Study||112
2873241|NCT00226655|3577131|FG000|COMPLETED|Overall Study||33
2873242|NCT00226655|3577131|FG000|NOT COMPLETED|Overall Study||79
2873243|NCT00226811|3577135|FG000|STARTED|Overall Study||78
2873244|NCT00226811|3577135|FG000|COMPLETED|Overall Study||2
2873245|NCT00226811|3577135|FG000|NOT COMPLETED|Overall Study||76
2873246|NCT00226941|3577143|FG000|STARTED|Overall Study||6
2873247|NCT00226941|3577144|FG001|STARTED|Overall Study||6
2873248|NCT00226941|3577145|FG002|STARTED|Overall Study||4
2873249|NCT00226941|3577146|FG003|STARTED|Overall Study||7
2873250|NCT00226941|3577143|FG000|COMPLETED|Overall Study||6
2873251|NCT00226941|3577144|FG001|COMPLETED|Overall Study||6
2873252|NCT00226941|3577145|FG002|COMPLETED|Overall Study||4
2873253|NCT00226941|3577146|FG003|COMPLETED|Overall Study||5
2873254|NCT00226941|3577143|FG000|NOT COMPLETED|Overall Study||0
2873255|NCT00226941|3577144|FG001|NOT COMPLETED|Overall Study||0
2873256|NCT00226941|3577145|FG002|NOT COMPLETED|Overall Study||0
2873257|NCT00226941|3577146|FG003|NOT COMPLETED|Overall Study||2
2873258|NCT00227019|3577162|FG000|STARTED|Overall Study||16
2873259|NCT00227019|3577162|FG000|COMPLETED|Overall Study||16
2873260|NCT00227019|3577162|FG000|NOT COMPLETED|Overall Study||0
2873261|NCT00227266|3577170|FG000|STARTED|Overall Study||31
2873262|NCT00227266|3577171|FG001|STARTED|Overall Study||30
2873263|NCT00227266|3577172|FG002|STARTED|Overall Study||33
2873264|NCT00227266|3577170|FG000|COMPLETED|Overall Study||30
2873265|NCT00227266|3577171|FG001|COMPLETED|Overall Study||30
2873266|NCT00227266|3577172|FG002|COMPLETED|Overall Study||29
2873267|NCT00227266|3577170|FG000|NOT COMPLETED|Overall Study||1
2873268|NCT00227266|3577171|FG001|NOT COMPLETED|Overall Study||0
2873269|NCT00227266|3577172|FG002|NOT COMPLETED|Overall Study||4
2873270|NCT00227305|3577183|FG000|STARTED|Overall Study|enrolled|381
2873271|NCT00227305|3577183|FG000|Drug Received|Overall Study|safety population|380
2873272|NCT00227305|3577183|FG000|COMPLETED|Overall Study|Completed 26 weeks|237
2873273|NCT00227305|3577183|FG000|NOT COMPLETED|Overall Study||144
2873274|NCT00227344|3577189|FG000|STARTED|Overall Study||87
2873275|NCT00227344|3577190|FG001|STARTED|Overall Study||42
2873276|NCT00227344|3577189|FG000|COMPLETED|Overall Study||75
2873277|NCT00227344|3577190|FG001|COMPLETED|Overall Study||37
2873278|NCT00227344|3577189|FG000|NOT COMPLETED|Overall Study||12
2873279|NCT00227344|3577190|FG001|NOT COMPLETED|Overall Study||5
2873280|NCT00227370|3577198|FG000|STARTED|Overall Study|Placebo Group|66
2873281|NCT00227370|3577199|FG001|STARTED|Overall Study|Treatment Group|70
2873282|NCT00227370|3577198|FG000|COMPLETED|Overall Study||45
2873283|NCT00227370|3577199|FG001|COMPLETED|Overall Study||46
3384503|NCT02180217|4119613|FG001|Discontinued at/Prior to Week 12 (W12)|Overall Study||0
3384504|NCT02180217|4119614|FG002|Discontinued at/Prior to Week 12 (W12)|Overall Study||7
3384505|NCT02180217|4119612|FG000|Discont. at/Prior to W26 But After W12|Overall Study||0
3384506|NCT02180217|4119613|FG001|Discont. at/Prior to W26 But After W12|Overall Study||0
3314000|NCT03079375|4047228|FG001|STARTED|Overall Study||499
3314001|NCT03079375|4047229|FG002|STARTED|Overall Study||497
3314002|NCT03079375|4047227|FG000|COMPLETED|Overall Study||498
3314003|NCT03079375|4047228|FG001|COMPLETED|Overall Study||493
3314004|NCT03079375|4047229|FG002|COMPLETED|Overall Study||476
3314005|NCT03079375|4047227|FG000|NOT COMPLETED|Overall Study||5
3314006|NCT03079375|4047228|FG001|NOT COMPLETED|Overall Study||6
3314007|NCT03079375|4047229|FG002|NOT COMPLETED|Overall Study||21
3314008|NCT03079531|4047241|FG000|STARTED|Overall Study||24
3314009|NCT03079531|4047241|FG000|Attended ≥1 Post-baseline Visit|Overall Study||23
3314010|NCT03079531|4047241|FG000|COMPLETED|Overall Study||17
3314011|NCT03079531|4047241|FG000|NOT COMPLETED|Overall Study||7
3314012|NCT03080142|4047247|FG000|STARTED|Overall Study||42
3314013|NCT03080142|4047248|FG001|STARTED|Overall Study||44
3314014|NCT03080142|4047247|FG000|COMPLETED|Overall Study||42
3314015|NCT03080142|4047248|FG001|COMPLETED|Overall Study||44
3314016|NCT03080142|4047247|FG000|NOT COMPLETED|Overall Study||0
3314017|NCT03080142|4047248|FG001|NOT COMPLETED|Overall Study||0
3314018|NCT03080454|4047254|FG000|STARTED|Baseline||26
3314019|NCT03080454|4047254|FG000|COMPLETED|Baseline|Two participants (pts) dropped out after consent due to hospitalizations unrelated to the study.|24
3314020|NCT03080454|4047254|FG000|NOT COMPLETED|Baseline||2
3314021|NCT03080454|4047254|FG000|STARTED|Sham Doublestim (5days)||24
3314022|NCT03080454|4047254|FG000|COMPLETED|Sham Doublestim (5days)||24
3314023|NCT03080454|4047254|FG000|NOT COMPLETED|Sham Doublestim (5days)||0
3314024|NCT03080454|4047254|FG000|STARTED|Sham FU (7days)||24
3314025|NCT03080454|4047254|FG000|COMPLETED|Sham FU (7days)||24
2873284|NCT00227370|3577198|FG000|NOT COMPLETED|Overall Study||21
2873285|NCT00227370|3577199|FG001|NOT COMPLETED|Overall Study||24
2873286|NCT00227539|3577205|FG000|STARTED|Overall Study||25
2873287|NCT00227539|3577205|FG000|COMPLETED|Overall Study||24
2873288|NCT00227539|3577205|FG000|NOT COMPLETED|Overall Study||1
2873289|NCT00227591|3577209|FG000|STARTED|Overall Study|48 pts registered to the study|48
2873290|NCT00227591|3577209|FG000|Began Treatment|Overall Study||47
3314026|NCT03080454|4047254|FG000|NOT COMPLETED|Sham FU (7days)||0
3314027|NCT03080454|4047254|FG000|STARTED|Anodal Doublestim (5 Days)||24
2873291|NCT00227591|3577209|FG000|COMPLETED|Overall Study||47
2873292|NCT00227591|3577209|FG000|NOT COMPLETED|Overall Study||1
2873293|NCT00227617|3577213|FG000|STARTED|Stage 1||22
2873294|NCT00227617|3577214|FG001|STARTED|Stage 1||12
2873295|NCT00227617|3577215|FG002|STARTED|Stage 1||2
2873296|NCT00227617|3577213|FG000|COMPLETED|Stage 1||22
2873297|NCT00227617|3577214|FG001|COMPLETED|Stage 1||12
2873298|NCT00227617|3577215|FG002|COMPLETED|Stage 1||2
2873299|NCT00227617|3577213|FG000|NOT COMPLETED|Stage 1||0
2873300|NCT00227617|3577214|FG001|NOT COMPLETED|Stage 1||0
2873301|NCT00227617|3577215|FG002|NOT COMPLETED|Stage 1||0
2873302|NCT00227617|3577213|FG000|STARTED|Stage 2||0
2873303|NCT00227617|3577214|FG001|STARTED|Stage 2||0
2873304|NCT00227617|3577215|FG002|STARTED|Stage 2||0
2873305|NCT00227617|3577213|FG000|COMPLETED|Stage 2||0
2873306|NCT00227617|3577214|FG001|COMPLETED|Stage 2||0
2873307|NCT00227617|3577215|FG002|COMPLETED|Stage 2||0
2873308|NCT00227617|3577213|FG000|NOT COMPLETED|Stage 2||0
2873309|NCT00227617|3577214|FG001|NOT COMPLETED|Stage 2||0
2873310|NCT00227617|3577215|FG002|NOT COMPLETED|Stage 2||0
2873311|NCT00227721|3577227|FG000|STARTED|Overall Study||30
2873312|NCT00227721|3577227|FG000|COMPLETED|Overall Study||29
2873313|NCT00227721|3577227|FG000|NOT COMPLETED|Overall Study||1
2873314|NCT00227760|3577231|FG000|STARTED|Overall Study||44
2873315|NCT00227760|3577231|FG000|COMPLETED|Overall Study||44
2873316|NCT00227760|3577231|FG000|NOT COMPLETED|Overall Study||0
2873317|NCT00227877|3577239|FG000|STARTED|Pre-visit Assessment||1075
2873318|NCT00227877|3577240|FG001|STARTED|Pre-visit Assessment||1031
2873319|NCT00227877|3577241|FG002|STARTED|Pre-visit Assessment||297
2873320|NCT00227877|3577242|FG003|STARTED|Pre-visit Assessment||292
2873321|NCT00227877|3577239|FG000|COMPLETED|Pre-visit Assessment|Final analysis sample|1068
2873322|NCT00227877|3577240|FG001|COMPLETED|Pre-visit Assessment|Final analysis sample|1028
2873323|NCT00227877|3577241|FG002|COMPLETED|Pre-visit Assessment|Final analysis sample|297
2873324|NCT00227877|3577242|FG003|COMPLETED|Pre-visit Assessment|Final analysis sample|292
2873325|NCT00227877|3577239|FG000|NOT COMPLETED|Pre-visit Assessment||7
2873326|NCT00227877|3577240|FG001|NOT COMPLETED|Pre-visit Assessment||3
2873327|NCT00227877|3577241|FG002|NOT COMPLETED|Pre-visit Assessment||0
2873328|NCT00227877|3577242|FG003|NOT COMPLETED|Pre-visit Assessment||0
2873329|NCT00227877|3577239|FG000|STARTED|Post-visit Checklist||1068
2873330|NCT00227877|3577240|FG001|STARTED|Post-visit Checklist||1028
2873331|NCT00227877|3577241|FG002|STARTED|Post-visit Checklist||297
2873332|NCT00227877|3577242|FG003|STARTED|Post-visit Checklist||292
2873333|NCT00227877|3577239|FG000|COMPLETED|Post-visit Checklist||1044
2873334|NCT00227877|3577240|FG001|COMPLETED|Post-visit Checklist||1015
2873335|NCT00227877|3577241|FG002|COMPLETED|Post-visit Checklist||296
2873336|NCT00227877|3577242|FG003|COMPLETED|Post-visit Checklist||292
2873337|NCT00227877|3577239|FG000|NOT COMPLETED|Post-visit Checklist||24
2873338|NCT00227877|3577240|FG001|NOT COMPLETED|Post-visit Checklist||13
2873339|NCT00227877|3577241|FG002|NOT COMPLETED|Post-visit Checklist||1
2873340|NCT00227877|3577242|FG003|NOT COMPLETED|Post-visit Checklist||0
3314028|NCT03080454|4047254|FG000|COMPLETED|Anodal Doublestim (5 Days)||23
3314029|NCT03080454|4047254|FG000|NOT COMPLETED|Anodal Doublestim (5 Days)||1
3314030|NCT03080454|4047254|FG000|STARTED|Anodal FU (7 Days)||23
3314031|NCT03080454|4047254|FG000|COMPLETED|Anodal FU (7 Days)||19
3314032|NCT03080454|4047254|FG000|NOT COMPLETED|Anodal FU (7 Days)||4
3314033|NCT03080493|4047263|FG000|STARTED|Overall Study||61
3314034|NCT03080493|4047264|FG001|STARTED|Overall Study||60
3314035|NCT03080493|4047263|FG000|COMPLETED|Overall Study||60
3314036|NCT03080493|4047264|FG001|COMPLETED|Overall Study||58
3314037|NCT03080493|4047263|FG000|NOT COMPLETED|Overall Study||1
3314038|NCT03080493|4047264|FG001|NOT COMPLETED|Overall Study||2
3314039|NCT03080961|4047270|FG000|STARTED|Overall Study||46
3314040|NCT03080961|4047270|FG000|COMPLETED|Overall Study||43
3314041|NCT03080961|4047270|FG000|NOT COMPLETED|Overall Study||3
3314042|NCT03081117|4047281|FG000|STARTED|Overall Study||10
3314043|NCT03081117|4047282|FG001|STARTED|Overall Study||11
3314044|NCT03081117|4047281|FG000|Primary Outcome 1 (SAE)|Overall Study||10
3314045|NCT03081117|4047282|FG001|Primary Outcome 1 (SAE)|Overall Study||11
3314046|NCT03081117|4047281|FG000|Secondary Measures Collected at Week 24|Overall Study||8
3314047|NCT03081117|4047282|FG001|Secondary Measures Collected at Week 24|Overall Study||9
3314048|NCT03081117|4047281|FG000|Completed (ITT): Primary Outcome 2 (GDS)|Overall Study||7
3314049|NCT03081117|4047282|FG001|Completed (ITT): Primary Outcome 2 (GDS)|Overall Study||9
3314050|NCT03081117|4047281|FG000|COMPLETED|Overall Study||6
3314051|NCT03081117|4047282|FG001|COMPLETED|Overall Study||8
3314052|NCT03081117|4047281|FG000|NOT COMPLETED|Overall Study||4
3314053|NCT03081117|4047282|FG001|NOT COMPLETED|Overall Study||3
3314054|NCT03081884|4047288|FG000|STARTED|Overall Study||61
3314055|NCT03081884|4047288|FG000|COMPLETED|Overall Study||57
3314056|NCT03081884|4047288|FG000|NOT COMPLETED|Overall Study||4
3314057|NCT03082196|4047295|FG000|STARTED|Overall Study||142
2873341|NCT00227877|3577239|FG000|STARTED|3-months Follow-up||1068
2873342|NCT00227877|3577240|FG001|STARTED|3-months Follow-up||1028
2873343|NCT00227877|3577241|FG002|STARTED|3-months Follow-up||297
2873344|NCT00227877|3577242|FG003|STARTED|3-months Follow-up||292
2873345|NCT00227877|3577239|FG000|COMPLETED|3-months Follow-up||755
2873346|NCT00227877|3577240|FG001|COMPLETED|3-months Follow-up||761
2873347|NCT00227877|3577241|FG002|COMPLETED|3-months Follow-up||245
2873348|NCT00227877|3577242|FG003|COMPLETED|3-months Follow-up||271
3314058|NCT03082196|4047296|FG001|STARTED|Overall Study||142
3314059|NCT03082196|4047295|FG000|COMPLETED|Overall Study||133
2873349|NCT00227877|3577239|FG000|NOT COMPLETED|3-months Follow-up||313
2873350|NCT00227877|3577240|FG001|NOT COMPLETED|3-months Follow-up||267
3169693|NCT01927341|3897241|FG004|NOT COMPLETED|Phase 1b||0
3169694|NCT01927341|3897237|FG000|STARTED|Phase 2||0
3171792|NCT01937195|3898992|FG000|STARTED|Overall Study||95
2873351|NCT00227877|3577241|FG002|NOT COMPLETED|3-months Follow-up||52
2873352|NCT00227877|3577242|FG003|NOT COMPLETED|3-months Follow-up||21
2873353|NCT00227877|3577239|FG000|STARTED|12-months Follow-up||1068
2873354|NCT00227877|3577240|FG001|STARTED|12-months Follow-up||1028
2873355|NCT00227877|3577241|FG002|STARTED|12-months Follow-up||297
2873356|NCT00227877|3577242|FG003|STARTED|12-months Follow-up||292
2873357|NCT00227877|3577239|FG000|COMPLETED|12-months Follow-up||758
2873358|NCT00227877|3577240|FG001|COMPLETED|12-months Follow-up||765
2873359|NCT00227877|3577241|FG002|COMPLETED|12-months Follow-up||266
2873360|NCT00227877|3577242|FG003|COMPLETED|12-months Follow-up||266
2873361|NCT00227877|3577239|FG000|NOT COMPLETED|12-months Follow-up||310
2873362|NCT00227877|3577240|FG001|NOT COMPLETED|12-months Follow-up||263
2873363|NCT00227877|3577241|FG002|NOT COMPLETED|12-months Follow-up||31
2873364|NCT00227877|3577242|FG003|NOT COMPLETED|12-months Follow-up||26
2873365|NCT00227903|3577256|FG000|STARTED|Overall Study||91
2873366|NCT00227903|3577257|FG001|STARTED|Overall Study||92
2873367|NCT00227903|3577256|FG000|Received ≥ 1 Follow-up Assessment|Overall Study|1 participant did not receive any treatment sessions.|86
2873368|NCT00227903|3577257|FG001|Received ≥ 1 Follow-up Assessment|Overall Study|4 participants did not receive any treatment sessions.|82
2873369|NCT00227903|3577256|FG000|COMPLETED|Overall Study|Participants with at least 1 follow-up assessment were analyzed|86
2873370|NCT00227903|3577257|FG001|COMPLETED|Overall Study|Participants with at least 1 follow-up assessment were analyzed|82
2873371|NCT00227903|3577256|FG000|NOT COMPLETED|Overall Study||5
2873372|NCT00227903|3577257|FG001|NOT COMPLETED|Overall Study||10
2873373|NCT00227994|3577265|FG000|STARTED|Overall Study||20
2873374|NCT00227994|3577266|FG001|STARTED|Overall Study||20
2873375|NCT00227994|3577265|FG000|COMPLETED|Overall Study||13
2873376|NCT00227994|3577266|FG001|COMPLETED|Overall Study||13
2873377|NCT00227994|3577265|FG000|NOT COMPLETED|Overall Study||7
2873378|NCT00227994|3577266|FG001|NOT COMPLETED|Overall Study||7
2873379|NCT00228384|3577274|FG000|STARTED|Overall Study||72
2873380|NCT00228384|3577275|FG001|STARTED|Overall Study||76
2873381|NCT00228384|3577274|FG000|Baseline|Overall Study||72
2873382|NCT00228384|3577275|FG001|Baseline|Overall Study||76
2873383|NCT00228384|3577274|FG000|30-Day Follow-up (Safety Outcome)|Overall Study||69
2873384|NCT00228384|3577275|FG001|30-Day Follow-up (Safety Outcome)|Overall Study||72
2873385|NCT00228384|3577274|FG000|Three Year Follow-up (Final)|Overall Study||43
2873386|NCT00228384|3577275|FG001|Three Year Follow-up (Final)|Overall Study||47
2873387|NCT00228384|3577274|FG000|COMPLETED|Overall Study||43
2873388|NCT00228384|3577275|FG001|COMPLETED|Overall Study||47
2873389|NCT00228384|3577274|FG000|NOT COMPLETED|Overall Study||29
2873390|NCT00228384|3577275|FG001|NOT COMPLETED|Overall Study||29
2873391|NCT00228423|3577283|FG000|STARTED|Overall Study||56
2873392|NCT00228423|3577284|FG001|STARTED|Overall Study||57
2873393|NCT00228423|3577283|FG000|COMPLETED|Overall Study||46
2873394|NCT00228423|3577284|FG001|COMPLETED|Overall Study||45
2873395|NCT00228423|3577283|FG000|NOT COMPLETED|Overall Study||10
2873396|NCT00228423|3577284|FG001|NOT COMPLETED|Overall Study||12
2873397|NCT00228553|3577290|FG000|STARTED|Overall Study||743
2873398|NCT00228553|3577290|FG000|COMPLETED|Overall Study||313
2873399|NCT00228553|3577290|FG000|NOT COMPLETED|Overall Study||430
2873400|NCT00228566|3577294|FG000|STARTED|Overall Study||247
2873401|NCT00228566|3577294|FG000|COMPLETED|Overall Study||176
2873402|NCT00228566|3577294|FG000|NOT COMPLETED|Overall Study||71
2873403|NCT00228813|3577298|FG000|STARTED|Overall Study||8
2873404|NCT00228813|3577298|FG000|COMPLETED|Overall Study||4
2873405|NCT00228813|3577298|FG000|NOT COMPLETED|Overall Study||4
2873406|NCT00228917|3577310|FG000|STARTED|Overall Study||193
2873407|NCT00228917|3577311|FG001|STARTED|Overall Study||96
2873408|NCT00228917|3577312|FG002|STARTED|Overall Study||65
2873409|NCT00228917|3577313|FG003|STARTED|Overall Study||33
2873410|NCT00228917|3577314|FG004|STARTED|Overall Study||205
2873411|NCT00228917|3577315|FG005|STARTED|Overall Study||104
2873412|NCT00228917|3577316|FG006|STARTED|Overall Study||69
2873413|NCT00228917|3577317|FG007|STARTED|Overall Study||33
2873414|NCT00228917|3577310|FG000|COMPLETED|Overall Study||193
2873415|NCT00228917|3577311|FG001|COMPLETED|Overall Study||96
2873416|NCT00228917|3577312|FG002|COMPLETED|Overall Study||65
2873417|NCT00228917|3577313|FG003|COMPLETED|Overall Study||33
2873418|NCT00228917|3577314|FG004|COMPLETED|Overall Study||205
2873419|NCT00228917|3577315|FG005|COMPLETED|Overall Study||102
2873420|NCT00228917|3577316|FG006|COMPLETED|Overall Study||69
2873421|NCT00228917|3577317|FG007|COMPLETED|Overall Study||33
2873422|NCT00228917|3577310|FG000|NOT COMPLETED|Overall Study||0
2873423|NCT00228917|3577311|FG001|NOT COMPLETED|Overall Study||0
2873424|NCT00228917|3577312|FG002|NOT COMPLETED|Overall Study||0
2873425|NCT00228917|3577313|FG003|NOT COMPLETED|Overall Study||0
2873426|NCT00228917|3577314|FG004|NOT COMPLETED|Overall Study||0
2873427|NCT00228917|3577315|FG005|NOT COMPLETED|Overall Study||2
2873428|NCT00228917|3577316|FG006|NOT COMPLETED|Overall Study||0
2873429|NCT00228917|3577317|FG007|NOT COMPLETED|Overall Study||0
2873430|NCT00228943|3577331|FG000|STARTED|Week 1||28
2873431|NCT00228943|3577331|FG000|COMPLETED|Week 1||28
2873432|NCT00228943|3577331|FG000|NOT COMPLETED|Week 1||0
2873433|NCT00228943|3577331|FG000|STARTED|Week 2||28
2873434|NCT00228943|3577331|FG000|COMPLETED|Week 2||27
2873435|NCT00228943|3577331|FG000|NOT COMPLETED|Week 2||1
2873436|NCT00229203|3577339|FG000|STARTED|Overall Study||32
2873437|NCT00229203|3577340|FG001|STARTED|Overall Study||19
2873438|NCT00229203|3577339|FG000|COMPLETED|Overall Study||0
2873439|NCT00229203|3577340|FG001|COMPLETED|Overall Study||0
2873440|NCT00229203|3577339|FG000|NOT COMPLETED|Overall Study||32
2873441|NCT00229203|3577340|FG001|NOT COMPLETED|Overall Study||19
2873442|NCT00229619|3577346|FG000|STARTED|Overall Study||11
2873443|NCT00229619|3577346|FG000|COMPLETED|Overall Study||11
2873444|NCT00229619|3577346|FG000|NOT COMPLETED|Overall Study||0
2873445|NCT00229658|3577354|FG000|STARTED|Overall Study||766
2873446|NCT00229658|3577355|FG001|STARTED|Overall Study||531
2873447|NCT00229658|3577354|FG000|COMPLETED|Overall Study||541
2873448|NCT00229658|3577355|FG001|COMPLETED|Overall Study||364
2873449|NCT00229658|3577354|FG000|NOT COMPLETED|Overall Study||225
2873450|NCT00229658|3577355|FG001|NOT COMPLETED|Overall Study||167
2873451|NCT00229723|3577368|FG000|STARTED|Concomitant Phase|Received randomized treatment|60
2873452|NCT00229723|3577369|FG001|STARTED|Concomitant Phase|Received randomized treatment|24
2873453|NCT00229723|3577370|FG002|STARTED|Concomitant Phase|Received randomized treatment|31
2873454|NCT00229723|3577371|FG003|STARTED|Concomitant Phase|Received randomized treatment|31
2873455|NCT00229723|3577372|FG004|STARTED|Concomitant Phase|Received randomized treatment|24
2873456|NCT00229723|3577373|FG005|STARTED|Concomitant Phase|Received randomized treatment|34
2873457|NCT00229723|3577374|FG006|STARTED|Concomitant Phase|Received randomized treatment|22
2873458|NCT00229723|3577368|FG000|COMPLETED|Concomitant Phase||50
2873459|NCT00229723|3577369|FG001|COMPLETED|Concomitant Phase||19
2873460|NCT00229723|3577370|FG002|COMPLETED|Concomitant Phase||25
2873461|NCT00229723|3577371|FG003|COMPLETED|Concomitant Phase||26
2873462|NCT00229723|3577372|FG004|COMPLETED|Concomitant Phase||22
2873463|NCT00229723|3577373|FG005|COMPLETED|Concomitant Phase||31
2873464|NCT00229723|3577374|FG006|COMPLETED|Concomitant Phase||19
2873465|NCT00229723|3577368|FG000|NOT COMPLETED|Concomitant Phase||10
2873466|NCT00229723|3577369|FG001|NOT COMPLETED|Concomitant Phase||5
2873467|NCT00229723|3577370|FG002|NOT COMPLETED|Concomitant Phase||6
2873468|NCT00229723|3577371|FG003|NOT COMPLETED|Concomitant Phase||5
2873469|NCT00229723|3577372|FG004|NOT COMPLETED|Concomitant Phase||2
2873470|NCT00229723|3577373|FG005|NOT COMPLETED|Concomitant Phase||3
2873471|NCT00229723|3577374|FG006|NOT COMPLETED|Concomitant Phase||3
2873472|NCT00229723|3577368|FG000|STARTED|Maintenance Phase||50
2873473|NCT00229723|3577369|FG001|STARTED|Maintenance Phase||19
2873474|NCT00229723|3577370|FG002|STARTED|Maintenance Phase||25
2873475|NCT00229723|3577371|FG003|STARTED|Maintenance Phase||26
3314060|NCT03082196|4047296|FG001|COMPLETED|Overall Study||129
3314061|NCT03082196|4047295|FG000|NOT COMPLETED|Overall Study||9
3314062|NCT03082196|4047296|FG001|NOT COMPLETED|Overall Study||13
3314063|NCT03082261|4047302|FG000|STARTED|Overall Study||269
3314064|NCT03082261|4047302|FG000|COMPLETED|Overall Study||149
3314065|NCT03082261|4047302|FG000|NOT COMPLETED|Overall Study||120
3314066|NCT03082586|4047312|FG000|STARTED|Overall Study|the patients received a total radiation dose of 57.2 Gy in this group|3
3314067|NCT03082586|4047313|FG001|STARTED|Overall Study|the patients received a total radiation dose of 64.4 Gy in this group|3
3314068|NCT03082586|4047314|FG002|STARTED|Overall Study|the patients received a total radiation dose of 71.6 Gy in this group|3
3314069|NCT03082586|4047315|FG003|STARTED|Overall Study|the patients received a total radiation dose of 78.8 Gy in this group|6
3314070|NCT03082586|4047316|FG004|STARTED|Overall Study|the patients received a total radiation dose of 86 Gy in this group|13
3314071|NCT03082586|4047317|FG005|STARTED|Overall Study|the patients received a total radiation dose of 93.2 Gy in this group|3
3314072|NCT03082586|4047312|FG000|COMPLETED|Overall Study|the patients received a total radiation dose of 57.2 Gy in this group|3
3314073|NCT03082586|4047313|FG001|COMPLETED|Overall Study|the patients received a total radiation dose of 64.4 Gy in this group|3
3314074|NCT03082586|4047314|FG002|COMPLETED|Overall Study|the patients received a total radiation dose of 71.6 Gy in this group|3
3314075|NCT03082586|4047315|FG003|COMPLETED|Overall Study|the patients received a total radiation dose of 78.8 Gy in this group|6
3314076|NCT03082586|4047316|FG004|COMPLETED|Overall Study|the patients received a total radiation dose of 86 Gy in this group|13
3314077|NCT03082586|4047317|FG005|COMPLETED|Overall Study|the patients received a total radiation dose of 93.2 Gy in this group|3
3314078|NCT03082586|4047312|FG000|NOT COMPLETED|Overall Study||0
3314079|NCT03082586|4047313|FG001|NOT COMPLETED|Overall Study||0
3314080|NCT03082586|4047314|FG002|NOT COMPLETED|Overall Study||0
3314081|NCT03082586|4047315|FG003|NOT COMPLETED|Overall Study||0
3314082|NCT03082586|4047316|FG004|NOT COMPLETED|Overall Study||0
3314083|NCT03082586|4047317|FG005|NOT COMPLETED|Overall Study||0
3314084|NCT03082599|4047339|FG000|STARTED|Overall Study||40
3314085|NCT03082599|4047340|FG001|STARTED|Overall Study||39
3314086|NCT03082599|4047339|FG000|COMPLETED|Overall Study||39
3314087|NCT03082599|4047340|FG001|COMPLETED|Overall Study||39
3314088|NCT03082599|4047339|FG000|NOT COMPLETED|Overall Study||1
3314089|NCT03082599|4047340|FG001|NOT COMPLETED|Overall Study||0
3314090|NCT03083093|4047348|FG000|STARTED|Overall Study||50
3314091|NCT03083093|4047349|FG001|STARTED|Overall Study||50
3314092|NCT03083093|4047348|FG000|COMPLETED|Overall Study||50
3314093|NCT03083093|4047349|FG001|COMPLETED|Overall Study||50
2873476|NCT00229723|3577372|FG004|STARTED|Maintenance Phase||22
2873477|NCT00229723|3577373|FG005|STARTED|Maintenance Phase||31
2873478|NCT00229723|3577374|FG006|STARTED|Maintenance Phase||19
2873479|NCT00229723|3577368|FG000|COMPLETED|Maintenance Phase|Completed study on randomized treatment|25
2918884|NCT00529308|3629236|FG001|COMPLETED|Overall Study||10
2873480|NCT00229723|3577369|FG001|COMPLETED|Maintenance Phase|Completed study on randomized treatment|5
2873481|NCT00229723|3577370|FG002|COMPLETED|Maintenance Phase|Completed study on randomized treatment|16
2873482|NCT00229723|3577371|FG003|COMPLETED|Maintenance Phase|Completed study on randomized treatment|9
2873483|NCT00229723|3577372|FG004|COMPLETED|Maintenance Phase|Completed study on randomized treatment|7
2873484|NCT00229723|3577373|FG005|COMPLETED|Maintenance Phase|Completed study on randomized treatment|12
2873485|NCT00229723|3577374|FG006|COMPLETED|Maintenance Phase|Completed study on randomized treatment|9
2873486|NCT00229723|3577368|FG000|NOT COMPLETED|Maintenance Phase||25
2873487|NCT00229723|3577369|FG001|NOT COMPLETED|Maintenance Phase||14
2873488|NCT00229723|3577370|FG002|NOT COMPLETED|Maintenance Phase||9
2873489|NCT00229723|3577371|FG003|NOT COMPLETED|Maintenance Phase||17
2873490|NCT00229723|3577372|FG004|NOT COMPLETED|Maintenance Phase||15
2873491|NCT00229723|3577373|FG005|NOT COMPLETED|Maintenance Phase||19
2873492|NCT00229723|3577374|FG006|NOT COMPLETED|Maintenance Phase||10
2873493|NCT00229957|3577392|FG000|STARTED|Overall Study||152
2873494|NCT00229957|3577393|FG001|STARTED|Overall Study||151
2873495|NCT00229957|3577392|FG000|COMPLETED|Overall Study||132
2873496|NCT00229957|3577393|FG001|COMPLETED|Overall Study||139
2873497|NCT00229957|3577392|FG000|NOT COMPLETED|Overall Study||20
2873498|NCT00229957|3577393|FG001|NOT COMPLETED|Overall Study||12
2873499|NCT00230009|3577401|FG000|STARTED|Single Session Intervention/Control||50
2873500|NCT00230009|3577402|FG001|STARTED|Single Session Intervention/Control||50
2873501|NCT00230009|3577401|FG000|COMPLETED|Single Session Intervention/Control||50
2873502|NCT00230009|3577402|FG001|COMPLETED|Single Session Intervention/Control||50
3314094|NCT03083093|4047348|FG000|NOT COMPLETED|Overall Study||0
3314095|NCT03083093|4047349|FG001|NOT COMPLETED|Overall Study||0
3314096|NCT03083132|4047357|FG000|STARTED|First 12 Weeks (Placebo vs Modafinil)||12
3314097|NCT03083132|4047358|FG001|STARTED|First 12 Weeks (Placebo vs Modafinil)||9
3314098|NCT03083132|4047357|FG000|COMPLETED|First 12 Weeks (Placebo vs Modafinil)||12
3314099|NCT03083132|4047358|FG001|COMPLETED|First 12 Weeks (Placebo vs Modafinil)||7
3314100|NCT03083132|4047357|FG000|NOT COMPLETED|First 12 Weeks (Placebo vs Modafinil)||0
3314101|NCT03083132|4047358|FG001|NOT COMPLETED|First 12 Weeks (Placebo vs Modafinil)||2
3314102|NCT03083132|4047357|FG000|STARTED|Last 12 Weeks (Drug for All Subjects)||12
3314103|NCT03083132|4047358|FG001|STARTED|Last 12 Weeks (Drug for All Subjects)||7
3314104|NCT03083132|4047357|FG000|COMPLETED|Last 12 Weeks (Drug for All Subjects)||11
3314105|NCT03083132|4047358|FG001|COMPLETED|Last 12 Weeks (Drug for All Subjects)||6
3314106|NCT03083132|4047357|FG000|NOT COMPLETED|Last 12 Weeks (Drug for All Subjects)||1
3314107|NCT03083132|4047358|FG001|NOT COMPLETED|Last 12 Weeks (Drug for All Subjects)||1
3314108|NCT03083379|4047366|FG000|STARTED|Overall Study||15
3314109|NCT03083379|4047367|FG001|STARTED|Overall Study||15
3314110|NCT03083379|4047366|FG000|COMPLETED|Overall Study||15
3314111|NCT03083379|4047367|FG001|COMPLETED|Overall Study||15
3314112|NCT03083379|4047366|FG000|NOT COMPLETED|Overall Study||0
3314113|NCT03083379|4047367|FG001|NOT COMPLETED|Overall Study||0
3314114|NCT03083470|4047378|FG000|STARTED|Overall Study||6
3314115|NCT03083470|4047379|FG001|STARTED|Overall Study||6
3314116|NCT03083470|4047380|FG002|STARTED|Overall Study||6
3314117|NCT03083470|4047381|FG003|STARTED|Overall Study||6
3314118|NCT03083470|4047382|FG004|STARTED|Overall Study||9
3314119|NCT03083470|4047378|FG000|COMPLETED|Overall Study||6
3314120|NCT03083470|4047379|FG001|COMPLETED|Overall Study||6
3314121|NCT03083470|4047380|FG002|COMPLETED|Overall Study||6
3314122|NCT03083470|4047381|FG003|COMPLETED|Overall Study||6
3314123|NCT03083470|4047382|FG004|COMPLETED|Overall Study||7
3314124|NCT03083470|4047378|FG000|NOT COMPLETED|Overall Study||0
3314125|NCT03083470|4047379|FG001|NOT COMPLETED|Overall Study||0
3314126|NCT03083470|4047380|FG002|NOT COMPLETED|Overall Study||0
3314127|NCT03083470|4047381|FG003|NOT COMPLETED|Overall Study||0
3314128|NCT03083470|4047382|FG004|NOT COMPLETED|Overall Study||2
3314129|NCT03083483|4047397|FG000|STARTED|Overall Study||24
3314130|NCT03083483|4047398|FG001|STARTED|Overall Study||22
3314131|NCT03083483|4047399|FG002|STARTED|Overall Study||23
3314132|NCT03083483|4047397|FG000|COMPLETED|Overall Study||20
3314133|NCT03083483|4047398|FG001|COMPLETED|Overall Study||20
3314134|NCT03083483|4047399|FG002|COMPLETED|Overall Study||20
3314135|NCT03083483|4047397|FG000|NOT COMPLETED|Overall Study||4
3314136|NCT03083483|4047398|FG001|NOT COMPLETED|Overall Study||2
3314137|NCT03083483|4047399|FG002|NOT COMPLETED|Overall Study||3
3314138|NCT03083639|4047409|FG000|STARTED|Intervention Period 1 (1 Day)||26
3314139|NCT03083639|4047410|FG001|STARTED|Intervention Period 1 (1 Day)||26
3314140|NCT03083639|4047409|FG000|COMPLETED|Intervention Period 1 (1 Day)||26
3314141|NCT03083639|4047410|FG001|COMPLETED|Intervention Period 1 (1 Day)||26
3314142|NCT03083639|4047409|FG000|NOT COMPLETED|Intervention Period 1 (1 Day)||0
3314143|NCT03083639|4047410|FG001|NOT COMPLETED|Intervention Period 1 (1 Day)||0
3314144|NCT03083639|4047409|FG000|STARTED|Washout Period (at Least 6 Days)||26
3314145|NCT03083639|4047410|FG001|STARTED|Washout Period (at Least 6 Days)||26
3314146|NCT03083639|4047409|FG000|COMPLETED|Washout Period (at Least 6 Days)||25
3314147|NCT03083639|4047410|FG001|COMPLETED|Washout Period (at Least 6 Days)||25
3314148|NCT03083639|4047409|FG000|NOT COMPLETED|Washout Period (at Least 6 Days)||1
3314149|NCT03083639|4047410|FG001|NOT COMPLETED|Washout Period (at Least 6 Days)||1
3314150|NCT03083639|4047409|FG000|STARTED|Intervention Period 2 (1 Day)||25
3314151|NCT03083639|4047410|FG001|STARTED|Intervention Period 2 (1 Day)||25
3314152|NCT03083639|4047409|FG000|COMPLETED|Intervention Period 2 (1 Day)||25
2873503|NCT00230009|3577401|FG000|NOT COMPLETED|Single Session Intervention/Control||0
2873504|NCT00230009|3577402|FG001|NOT COMPLETED|Single Session Intervention/Control||0
2873505|NCT00230009|3577401|FG000|STARTED|Follow-up||50
2873506|NCT00230009|3577402|FG001|STARTED|Follow-up||50
2873507|NCT00230009|3577401|FG000|COMPLETED|Follow-up||19
2873508|NCT00230009|3577402|FG001|COMPLETED|Follow-up||24
2873509|NCT00230009|3577401|FG000|NOT COMPLETED|Follow-up||31
2873510|NCT00230009|3577402|FG001|NOT COMPLETED|Follow-up||26
2873511|NCT00230022|3577410|FG000|STARTED|Overall Study||15
2873512|NCT00230022|3577411|FG001|STARTED|Overall Study||15
2873513|NCT00230022|3577410|FG000|COMPLETED|Overall Study||15
2873514|NCT00230022|3577411|FG001|COMPLETED|Overall Study||15
2873515|NCT00230022|3577410|FG000|NOT COMPLETED|Overall Study||0
2873516|NCT00230022|3577411|FG001|NOT COMPLETED|Overall Study||0
2873517|NCT00230048|3577419|FG000|STARTED|Overall Study||52
2873518|NCT00230048|3577420|FG001|STARTED|Overall Study||55
2873519|NCT00230048|3577419|FG000|Completed Intervention/Control Session|Overall Study||52
2873520|NCT00230048|3577420|FG001|Completed Intervention/Control Session|Overall Study||55
2873521|NCT00230048|3577419|FG000|COMPLETED|Overall Study||39
2873522|NCT00230048|3577420|FG001|COMPLETED|Overall Study||37
2873523|NCT00230048|3577419|FG000|NOT COMPLETED|Overall Study||13
3314153|NCT03083639|4047410|FG001|COMPLETED|Intervention Period 2 (1 Day)||25
3314154|NCT03083639|4047409|FG000|NOT COMPLETED|Intervention Period 2 (1 Day)||0
3314155|NCT03083639|4047410|FG001|NOT COMPLETED|Intervention Period 2 (1 Day)||0
3314156|NCT03083769|4047418|FG000|STARTED|Overall Study||839
3314157|NCT03083769|4047419|FG001|STARTED|Overall Study||663
3314158|NCT03083769|4047418|FG000|COMPLETED|Overall Study||819
3314159|NCT03083769|4047419|FG001|COMPLETED|Overall Study||631
3314160|NCT03083769|4047418|FG000|NOT COMPLETED|Overall Study||20
3314161|NCT03083769|4047419|FG001|NOT COMPLETED|Overall Study||32
3314162|NCT03083847|4047435|FG000|STARTED|Pilot 1a||2
3314163|NCT03083847|4047436|FG001|STARTED|Pilot 1a||0
3314164|NCT03083847|4047437|FG002|STARTED|Pilot 1a||0
3314165|NCT03083847|4047438|FG003|STARTED|Pilot 1a||0
3314166|NCT03083847|4047439|FG004|STARTED|Pilot 1a||0
3314167|NCT03083847|4047440|FG005|STARTED|Pilot 1a||0
3314168|NCT03083847|4047441|FG006|STARTED|Pilot 1a||0
3314169|NCT03083847|4047442|FG007|STARTED|Pilot 1a||0
3314170|NCT03083847|4047443|FG008|STARTED|Pilot 1a||0
3314171|NCT03083847|4047444|FG009|STARTED|Pilot 1a||0
3314172|NCT03083847|4047435|FG000|COMPLETED|Pilot 1a||2
3314173|NCT03083847|4047436|FG001|COMPLETED|Pilot 1a||0
3314174|NCT03083847|4047437|FG002|COMPLETED|Pilot 1a||0
3314175|NCT03083847|4047438|FG003|COMPLETED|Pilot 1a||0
3314176|NCT03083847|4047439|FG004|COMPLETED|Pilot 1a||0
3314177|NCT03083847|4047440|FG005|COMPLETED|Pilot 1a||0
3314178|NCT03083847|4047441|FG006|COMPLETED|Pilot 1a||0
3314179|NCT03083847|4047442|FG007|COMPLETED|Pilot 1a||0
3314180|NCT03083847|4047443|FG008|COMPLETED|Pilot 1a||0
3314181|NCT03083847|4047444|FG009|COMPLETED|Pilot 1a||0
3314182|NCT03083847|4047435|FG000|NOT COMPLETED|Pilot 1a||0
3314183|NCT03083847|4047436|FG001|NOT COMPLETED|Pilot 1a||0
3314184|NCT03083847|4047437|FG002|NOT COMPLETED|Pilot 1a||0
3314185|NCT03083847|4047438|FG003|NOT COMPLETED|Pilot 1a||0
3314186|NCT03083847|4047439|FG004|NOT COMPLETED|Pilot 1a||0
3314187|NCT03083847|4047440|FG005|NOT COMPLETED|Pilot 1a||0
3314188|NCT03083847|4047441|FG006|NOT COMPLETED|Pilot 1a||0
3314189|NCT03083847|4047442|FG007|NOT COMPLETED|Pilot 1a||0
3314190|NCT03083847|4047443|FG008|NOT COMPLETED|Pilot 1a||0
3314191|NCT03083847|4047444|FG009|NOT COMPLETED|Pilot 1a||0
3314192|NCT03083847|4047435|FG000|STARTED|Pilot Ib & 5a||0
3314193|NCT03083847|4047436|FG001|STARTED|Pilot Ib & 5a||2
3314194|NCT03083847|4047437|FG002|STARTED|Pilot Ib & 5a||2
3314195|NCT03083847|4047438|FG003|STARTED|Pilot Ib & 5a||0
3314196|NCT03083847|4047439|FG004|STARTED|Pilot Ib & 5a||0
3314197|NCT03083847|4047440|FG005|STARTED|Pilot Ib & 5a||0
3314198|NCT03083847|4047441|FG006|STARTED|Pilot Ib & 5a||0
3314199|NCT03083847|4047442|FG007|STARTED|Pilot Ib & 5a||0
3314200|NCT03083847|4047443|FG008|STARTED|Pilot Ib & 5a||0
3314201|NCT03083847|4047444|FG009|STARTED|Pilot Ib & 5a||0
3314202|NCT03083847|4047435|FG000|COMPLETED|Pilot Ib & 5a||0
3314203|NCT03083847|4047436|FG001|COMPLETED|Pilot Ib & 5a||2
3314204|NCT03083847|4047437|FG002|COMPLETED|Pilot Ib & 5a||2
3314205|NCT03083847|4047438|FG003|COMPLETED|Pilot Ib & 5a||0
3314206|NCT03083847|4047439|FG004|COMPLETED|Pilot Ib & 5a||0
3314207|NCT03083847|4047440|FG005|COMPLETED|Pilot Ib & 5a||0
3314208|NCT03083847|4047441|FG006|COMPLETED|Pilot Ib & 5a||0
3314209|NCT03083847|4047442|FG007|COMPLETED|Pilot Ib & 5a||0
3314210|NCT03083847|4047443|FG008|COMPLETED|Pilot Ib & 5a||0
3314211|NCT03083847|4047444|FG009|COMPLETED|Pilot Ib & 5a||0
3314212|NCT03083847|4047435|FG000|NOT COMPLETED|Pilot Ib & 5a||0
3314213|NCT03083847|4047436|FG001|NOT COMPLETED|Pilot Ib & 5a||0
3314214|NCT03083847|4047437|FG002|NOT COMPLETED|Pilot Ib & 5a||0
3314215|NCT03083847|4047438|FG003|NOT COMPLETED|Pilot Ib & 5a||0
3314216|NCT03083847|4047439|FG004|NOT COMPLETED|Pilot Ib & 5a||0
2873524|NCT00230048|3577420|FG001|NOT COMPLETED|Overall Study||18
2873525|NCT00230100|3577430|FG000|STARTED|Overall Study||29
2873526|NCT00230100|3577431|FG001|STARTED|Overall Study||17
3314217|NCT03083847|4047440|FG005|NOT COMPLETED|Pilot Ib & 5a||0
3314218|NCT03083847|4047441|FG006|NOT COMPLETED|Pilot Ib & 5a||0
3314219|NCT03083847|4047442|FG007|NOT COMPLETED|Pilot Ib & 5a||0
3314220|NCT03083847|4047443|FG008|NOT COMPLETED|Pilot Ib & 5a||0
3314221|NCT03083847|4047444|FG009|NOT COMPLETED|Pilot Ib & 5a||0
3314222|NCT03083847|4047435|FG000|STARTED|Pilot 1d & 5b||0
2873527|NCT00230100|3577430|FG000|COMPLETED|Overall Study||29
2873528|NCT00230100|3577431|FG001|COMPLETED|Overall Study||17
2873529|NCT00230100|3577430|FG000|NOT COMPLETED|Overall Study||0
2873530|NCT00230100|3577431|FG001|NOT COMPLETED|Overall Study||0
2873531|NCT00230126|3577439|FG000|STARTED|Overall Study||30
2873532|NCT00230126|3577440|FG001|STARTED|Overall Study||28
2873533|NCT00230126|3577439|FG000|COMPLETED|Overall Study||28
2873534|NCT00230126|3577440|FG001|COMPLETED|Overall Study||27
2873535|NCT00230126|3577439|FG000|NOT COMPLETED|Overall Study||2
2873536|NCT00230126|3577440|FG001|NOT COMPLETED|Overall Study||1
2873537|NCT00230178|3577451|FG000|STARTED|Overall Study|Intent-to-treat (ITT)population: randomized patients|94
2873538|NCT00230178|3577452|FG001|STARTED|Overall Study||93
2873539|NCT00230178|3577453|FG002|STARTED|Overall Study||93
2873540|NCT00230178|3577451|FG000|Treated|Overall Study|Modified ITT population: ITT patients with at least 1 dose of study drug|92
2873541|NCT00230178|3577452|FG001|Treated|Overall Study||92
2873542|NCT00230178|3577453|FG002|Treated|Overall Study||91
2873543|NCT00230178|3577451|FG000|COMPLETED|Overall Study||90
2873544|NCT00230178|3577452|FG001|COMPLETED|Overall Study||86
2873545|NCT00230178|3577453|FG002|COMPLETED|Overall Study||86
2873546|NCT00230178|3577451|FG000|NOT COMPLETED|Overall Study||4
2873547|NCT00230178|3577452|FG001|NOT COMPLETED|Overall Study||7
2873548|NCT00230178|3577453|FG002|NOT COMPLETED|Overall Study||7
2918885|NCT00529308|3629235|FG000|NOT COMPLETED|Overall Study||1
2918886|NCT00529308|3629236|FG001|NOT COMPLETED|Overall Study||1
2918887|NCT00529373|3629244|FG000|STARTED|Base Study||8043
2918888|NCT00529373|3629245|FG001|STARTED|Base Study||8028
2918889|NCT00529373|3629244|FG000|COMPLETED|Base Study||4297
2918890|NCT00529373|3629245|FG001|COMPLETED|Base Study||3960
2918891|NCT00529373|3629244|FG000|NOT COMPLETED|Base Study||3746
2918892|NCT00529373|3629245|FG001|NOT COMPLETED|Base Study||4068
2918893|NCT00529373|3629244|FG000|STARTED|First Extension Study||4297
2918894|NCT00529373|3629245|FG001|STARTED|First Extension Study||3960
2918895|NCT00529373|3629244|FG000|COMPLETED|First Extension Study||3144
2918896|NCT00529373|3629245|FG001|COMPLETED|First Extension Study||2309
2918897|NCT00529373|3629244|FG000|NOT COMPLETED|First Extension Study||1153
2918898|NCT00529373|3629245|FG001|NOT COMPLETED|First Extension Study||1651
2918899|NCT00529373|3629244|FG000|STARTED|Second Extension Study||3144
2918900|NCT00529373|3629245|FG001|STARTED|Second Extension Study||2309
2918901|NCT00529373|3629244|FG000|COMPLETED|Second Extension Study||2844
2918902|NCT00529373|3629245|FG001|COMPLETED|Second Extension Study||2112
2918903|NCT00529373|3629244|FG000|NOT COMPLETED|Second Extension Study||300
2918904|NCT00529373|3629245|FG001|NOT COMPLETED|Second Extension Study||197
2918905|NCT00529386|3629259|FG000|STARTED|Overall Study|Study has been discontinued|7
2918906|NCT00529386|3629259|FG000|COMPLETED|Overall Study|Study discontinued after 7 patients enrolled and analyzed|6
3314223|NCT03083847|4047436|FG001|STARTED|Pilot 1d & 5b||0
3314224|NCT03083847|4047437|FG002|STARTED|Pilot 1d & 5b||0
3314225|NCT03083847|4047438|FG003|STARTED|Pilot 1d & 5b||4
3314226|NCT03083847|4047439|FG004|STARTED|Pilot 1d & 5b||4
3314227|NCT03083847|4047440|FG005|STARTED|Pilot 1d & 5b||0
3314228|NCT03083847|4047441|FG006|STARTED|Pilot 1d & 5b||0
3314229|NCT03083847|4047442|FG007|STARTED|Pilot 1d & 5b||0
3314230|NCT03083847|4047443|FG008|STARTED|Pilot 1d & 5b||0
3314231|NCT03083847|4047444|FG009|STARTED|Pilot 1d & 5b||0
3314232|NCT03083847|4047435|FG000|COMPLETED|Pilot 1d & 5b||0
3314233|NCT03083847|4047436|FG001|COMPLETED|Pilot 1d & 5b||0
3314234|NCT03083847|4047437|FG002|COMPLETED|Pilot 1d & 5b||0
3314235|NCT03083847|4047438|FG003|COMPLETED|Pilot 1d & 5b||4
3314236|NCT03083847|4047439|FG004|COMPLETED|Pilot 1d & 5b||4
3314237|NCT03083847|4047440|FG005|COMPLETED|Pilot 1d & 5b||0
3314238|NCT03083847|4047441|FG006|COMPLETED|Pilot 1d & 5b||0
3314239|NCT03083847|4047442|FG007|COMPLETED|Pilot 1d & 5b||0
3314240|NCT03083847|4047443|FG008|COMPLETED|Pilot 1d & 5b||0
3314241|NCT03083847|4047444|FG009|COMPLETED|Pilot 1d & 5b||0
3314242|NCT03083847|4047435|FG000|NOT COMPLETED|Pilot 1d & 5b||0
3314243|NCT03083847|4047436|FG001|NOT COMPLETED|Pilot 1d & 5b||0
3314244|NCT03083847|4047437|FG002|NOT COMPLETED|Pilot 1d & 5b||0
3314245|NCT03083847|4047438|FG003|NOT COMPLETED|Pilot 1d & 5b||0
3314246|NCT03083847|4047439|FG004|NOT COMPLETED|Pilot 1d & 5b||0
3314247|NCT03083847|4047440|FG005|NOT COMPLETED|Pilot 1d & 5b||0
3314248|NCT03083847|4047441|FG006|NOT COMPLETED|Pilot 1d & 5b||0
3314249|NCT03083847|4047442|FG007|NOT COMPLETED|Pilot 1d & 5b||0
3314250|NCT03083847|4047443|FG008|NOT COMPLETED|Pilot 1d & 5b||0
3314251|NCT03083847|4047444|FG009|NOT COMPLETED|Pilot 1d & 5b||0
3314252|NCT03083847|4047435|FG000|STARTED|Main||0
3314253|NCT03083847|4047436|FG001|STARTED|Main||0
3314254|NCT03083847|4047437|FG002|STARTED|Main||0
3314255|NCT03083847|4047438|FG003|STARTED|Main||0
3314256|NCT03083847|4047439|FG004|STARTED|Main||0
3314257|NCT03083847|4047440|FG005|STARTED|Main||9
3314258|NCT03083847|4047441|FG006|STARTED|Main||10
2918907|NCT00529386|3629259|FG000|NOT COMPLETED|Overall Study||1
2918908|NCT00529399|3629266|FG000|STARTED|Overall Study||48
2918909|NCT00529399|3629267|FG001|STARTED|Overall Study||49
2918910|NCT00529399|3629268|FG002|STARTED|Overall Study||48
2918911|NCT00529399|3629266|FG000|COMPLETED|Overall Study||46
2918912|NCT00529399|3629267|FG001|COMPLETED|Overall Study||48
3314259|NCT03083847|4047442|FG007|STARTED|Main||10
3314260|NCT03083847|4047443|FG008|STARTED|Main||4
3314261|NCT03083847|4047444|FG009|STARTED|Main||8
3314262|NCT03083847|4047435|FG000|COMPLETED|Main||0
3314263|NCT03083847|4047436|FG001|COMPLETED|Main||0
3314264|NCT03083847|4047437|FG002|COMPLETED|Main||0
2873549|NCT00230282|3577461|FG000|STARTED|Fludarabine + Cyclophosphamide||25
2873550|NCT00230282|3577461|FG000|COMPLETED|Fludarabine + Cyclophosphamide||17
2873551|NCT00230282|3577461|FG000|NOT COMPLETED|Fludarabine + Cyclophosphamide||8
2873552|NCT00230282|3577461|FG000|STARTED|Maintanence Therapy With Alemtuzumab||17
2873553|NCT00230282|3577461|FG000|COMPLETED|Maintanence Therapy With Alemtuzumab||17
2873554|NCT00230282|3577461|FG000|NOT COMPLETED|Maintanence Therapy With Alemtuzumab||0
2873555|NCT00230737|3577468|FG000|STARTED|Overall Study||9
2873556|NCT00230737|3577469|FG001|STARTED|Overall Study||10
3314265|NCT03083847|4047438|FG003|COMPLETED|Main||0
3314266|NCT03083847|4047439|FG004|COMPLETED|Main||0
3314267|NCT03083847|4047440|FG005|COMPLETED|Main||8
3314268|NCT03083847|4047441|FG006|COMPLETED|Main||9
3314269|NCT03083847|4047442|FG007|COMPLETED|Main||6
3314270|NCT03083847|4047443|FG008|COMPLETED|Main||4
3314271|NCT03083847|4047444|FG009|COMPLETED|Main||8
3314272|NCT03083847|4047435|FG000|NOT COMPLETED|Main||0
3314273|NCT03083847|4047436|FG001|NOT COMPLETED|Main||0
3314274|NCT03083847|4047437|FG002|NOT COMPLETED|Main||0
3314275|NCT03083847|4047438|FG003|NOT COMPLETED|Main||0
3314276|NCT03083847|4047439|FG004|NOT COMPLETED|Main||0
3314277|NCT03083847|4047440|FG005|NOT COMPLETED|Main||1
3314278|NCT03083847|4047441|FG006|NOT COMPLETED|Main||1
3314279|NCT03083847|4047442|FG007|NOT COMPLETED|Main||4
3314280|NCT03083847|4047443|FG008|NOT COMPLETED|Main||0
3314281|NCT03083847|4047444|FG009|NOT COMPLETED|Main||0
3314282|NCT03083990|4047474|FG000|STARTED|Overall Study||50
3314283|NCT03083990|4047475|FG001|STARTED|Overall Study||50
3314284|NCT03083990|4047474|FG000|COMPLETED|Overall Study||49
3314285|NCT03083990|4047475|FG001|COMPLETED|Overall Study||50
3314286|NCT03083990|4047474|FG000|NOT COMPLETED|Overall Study||1
3314287|NCT03083990|4047475|FG001|NOT COMPLETED|Overall Study||0
3314288|NCT03084302|4047481|FG000|STARTED|Overall Study||120
3314289|NCT03084302|4047481|FG000|COMPLETED|Overall Study||105
3314290|NCT03084302|4047481|FG000|NOT COMPLETED|Overall Study||15
3314291|NCT03084315|4047488|FG000|STARTED|Overall Study||116
3314292|NCT03084315|4047489|FG001|STARTED|Overall Study||118
3314293|NCT03084315|4047488|FG000|COMPLETED|Overall Study||106
3314294|NCT03084315|4047489|FG001|COMPLETED|Overall Study||109
3314295|NCT03084315|4047488|FG000|NOT COMPLETED|Overall Study||10
3314296|NCT03084315|4047489|FG001|NOT COMPLETED|Overall Study||9
3314297|NCT03084796|4047501|FG000|STARTED|Overall Study||121
3314298|NCT03084796|4047502|FG001|STARTED|Overall Study||123
3314299|NCT03084796|4047503|FG002|STARTED|Overall Study||122
3314300|NCT03084796|4047504|FG003|STARTED|Overall Study||123
3314301|NCT03084796|4047505|FG004|STARTED|Overall Study||121
3314302|NCT03084796|4047506|FG005|STARTED|Overall Study||123
3314303|NCT03084796|4047501|FG000|COMPLETED|Overall Study||114
3314304|NCT03084796|4047502|FG001|COMPLETED|Overall Study||113
3314305|NCT03084796|4047503|FG002|COMPLETED|Overall Study||110
3314306|NCT03084796|4047504|FG003|COMPLETED|Overall Study||119
3314307|NCT03084796|4047505|FG004|COMPLETED|Overall Study||110
3314308|NCT03084796|4047506|FG005|COMPLETED|Overall Study||116
3314309|NCT03084796|4047501|FG000|NOT COMPLETED|Overall Study||7
3314310|NCT03084796|4047502|FG001|NOT COMPLETED|Overall Study||10
3314311|NCT03084796|4047503|FG002|NOT COMPLETED|Overall Study||12
3314312|NCT03084796|4047504|FG003|NOT COMPLETED|Overall Study||4
3314313|NCT03084796|4047505|FG004|NOT COMPLETED|Overall Study||11
3314314|NCT03084796|4047506|FG005|NOT COMPLETED|Overall Study||7
3314315|NCT03085017|4047522|FG000|STARTED|Overall Study||30
3314316|NCT03085017|4047523|FG001|STARTED|Overall Study||27
3314317|NCT03085017|4047522|FG000|COMPLETED|Overall Study||30
3314318|NCT03085017|4047523|FG001|COMPLETED|Overall Study||24
3314319|NCT03085017|4047522|FG000|NOT COMPLETED|Overall Study||0
3314320|NCT03085017|4047523|FG001|NOT COMPLETED|Overall Study||3
3314321|NCT03085238|4047529|FG000|STARTED|Overall Study||23
3314322|NCT03085238|4047529|FG000|1 Month|Overall Study||23
3314323|NCT03085238|4047529|FG000|3 Months|Overall Study||22
3314324|NCT03085238|4047529|FG000|6 Months|Overall Study||19
3314325|NCT03085238|4047529|FG000|9 Months|Overall Study||16
3314326|NCT03085238|4047529|FG000|12 Months|Overall Study||14
3314327|NCT03085238|4047529|FG000|15 Months|Overall Study||11
3314328|NCT03085238|4047529|FG000|18 Months|Overall Study||7
3314329|NCT03085238|4047529|FG000|COMPLETED|Overall Study||19
3314330|NCT03085238|4047529|FG000|NOT COMPLETED|Overall Study||4
3314331|NCT03085758|4047545|FG000|STARTED|Overall Study||72
3314332|NCT03085758|4047546|FG001|STARTED|Overall Study||77
3314333|NCT03085758|4047547|FG002|STARTED|Overall Study||152
3314334|NCT03085758|4047545|FG000|COMPLETED|Overall Study||43
3314335|NCT03085758|4047546|FG001|COMPLETED|Overall Study||49
3314336|NCT03085758|4047547|FG002|COMPLETED|Overall Study||96
3314337|NCT03085758|4047545|FG000|NOT COMPLETED|Overall Study||29
3314338|NCT03085758|4047546|FG001|NOT COMPLETED|Overall Study||28
3314339|NCT03085758|4047547|FG002|NOT COMPLETED|Overall Study||56
3314340|NCT03085797|4047561|FG000|STARTED|Treatment Period (TP) (52 Weeks)||201
3314341|NCT03085797|4047562|FG001|STARTED|Treatment Period (TP) (52 Weeks)||206
3314342|NCT03085797|4047561|FG000|Completed Investigational Product (IP)|Treatment Period (TP) (52 Weeks)||167
3314343|NCT03085797|4047562|FG001|Completed Investigational Product (IP)|Treatment Period (TP) (52 Weeks)||183
3314344|NCT03085797|4047561|FG000|Not Completed IP|Treatment Period (TP) (52 Weeks)||34
3314345|NCT03085797|4047562|FG001|Not Completed IP|Treatment Period (TP) (52 Weeks)||23
3314346|NCT03085797|4047561|FG000|Withdrew IP Due to: Adverse Event|Treatment Period (TP) (52 Weeks)||4
2873557|NCT00230737|3577470|FG002|STARTED|Overall Study||8
2873558|NCT00230737|3577468|FG000|COMPLETED|Overall Study||9
2873559|NCT00230737|3577469|FG001|COMPLETED|Overall Study||10
2873560|NCT00230737|3577470|FG002|COMPLETED|Overall Study||8
2873561|NCT00230737|3577468|FG000|NOT COMPLETED|Overall Study||0
2873562|NCT00230737|3577469|FG001|NOT COMPLETED|Overall Study||0
2873563|NCT00230737|3577470|FG002|NOT COMPLETED|Overall Study||0
2873564|NCT00230802|3577480|FG000|STARTED|Overall Study||25
2873565|NCT00230802|3577481|FG001|STARTED|Overall Study||23
3314347|NCT03085797|4047562|FG001|Withdrew IP Due to: Adverse Event|Treatment Period (TP) (52 Weeks)||4
3314348|NCT03085797|4047561|FG000|Withdrew IP Due to: Lack of Efficacy|Treatment Period (TP) (52 Weeks)||11
3314349|NCT03085797|4047562|FG001|Withdrew IP Due to: Lack of Efficacy|Treatment Period (TP) (52 Weeks)||5
3314350|NCT03085797|4047561|FG000|Withdrew IP Due to: Protocol Deviation|Treatment Period (TP) (52 Weeks)||1
3314351|NCT03085797|4047562|FG001|Withdrew IP Due to: Protocol Deviation|Treatment Period (TP) (52 Weeks)||0
3314352|NCT03085797|4047561|FG000|Withdrew IP Due to: Stopping Criteria|Treatment Period (TP) (52 Weeks)||1
3314353|NCT03085797|4047562|FG001|Withdrew IP Due to: Stopping Criteria|Treatment Period (TP) (52 Weeks)||1
3314354|NCT03085797|4047561|FG000|Withdrew IP Due to: Physician Decision|Treatment Period (TP) (52 Weeks)||2
3314355|NCT03085797|4047562|FG001|Withdrew IP Due to: Physician Decision|Treatment Period (TP) (52 Weeks)||1
3314356|NCT03085797|4047561|FG000|Withdrew IP Due to: Withdrawal by Par.|Treatment Period (TP) (52 Weeks)||15
3314357|NCT03085797|4047562|FG001|Withdrew IP Due to: Withdrawal by Par.|Treatment Period (TP) (52 Weeks)||12
3314358|NCT03085797|4047561|FG000|COMPLETED|Treatment Period (TP) (52 Weeks)||184
3314359|NCT03085797|4047562|FG001|COMPLETED|Treatment Period (TP) (52 Weeks)||189
3314360|NCT03085797|4047561|FG000|NOT COMPLETED|Treatment Period (TP) (52 Weeks)||17
3314361|NCT03085797|4047562|FG001|NOT COMPLETED|Treatment Period (TP) (52 Weeks)||17
3314362|NCT03085797|4047561|FG000|STARTED|No-treatment Follow-up Period (6 Months)|Only 65 Par. continued in FU to check maintenance of response after stopping treatment per protocol|65
3314363|NCT03085797|4047562|FG001|STARTED|No-treatment Follow-up Period (6 Months)|Only 69 Par. continued in FU to check maintenance of response after stopping treatment per protocol|69
3314364|NCT03085797|4047561|FG000|COMPLETED|No-treatment Follow-up Period (6 Months)||65
3314365|NCT03085797|4047562|FG001|COMPLETED|No-treatment Follow-up Period (6 Months)||68
3314366|NCT03085797|4047561|FG000|NOT COMPLETED|No-treatment Follow-up Period (6 Months)||0
3314367|NCT03085797|4047562|FG001|NOT COMPLETED|No-treatment Follow-up Period (6 Months)||1
3314368|NCT03085836|4047573|FG000|STARTED|Overall Study||12
3314369|NCT03085836|4047574|FG001|STARTED|Overall Study||11
3314370|NCT03085836|4047575|FG002|STARTED|Overall Study||10
3314371|NCT03085836|4047573|FG000|COMPLETED|Overall Study||12
3314372|NCT03085836|4047574|FG001|COMPLETED|Overall Study||11
3314373|NCT03085836|4047575|FG002|COMPLETED|Overall Study||10
3314374|NCT03085836|4047573|FG000|NOT COMPLETED|Overall Study||0
3314375|NCT03085836|4047574|FG001|NOT COMPLETED|Overall Study||0
3314376|NCT03085836|4047575|FG002|NOT COMPLETED|Overall Study||0
3314377|NCT03085914|4047590|FG000|STARTED|Overall Study||9
3314378|NCT03085914|4047591|FG001|STARTED|Overall Study||9
3314379|NCT03085914|4047592|FG002|STARTED|Overall Study||11
3314380|NCT03085914|4047593|FG003|STARTED|Overall Study||9
3314381|NCT03085914|4047594|FG004|STARTED|Overall Study||13
3314382|NCT03085914|4047595|FG005|STARTED|Overall Study||8
3314383|NCT03085914|4047596|FG006|STARTED|Overall Study||11
3314384|NCT03085914|4047590|FG000|COMPLETED|Overall Study||0
3314385|NCT03085914|4047591|FG001|COMPLETED|Overall Study||0
3314386|NCT03085914|4047592|FG002|COMPLETED|Overall Study||0
3314387|NCT03085914|4047593|FG003|COMPLETED|Overall Study||0
3314388|NCT03085914|4047594|FG004|COMPLETED|Overall Study||0
3314389|NCT03085914|4047595|FG005|COMPLETED|Overall Study||0
3314390|NCT03085914|4047596|FG006|COMPLETED|Overall Study||0
3314391|NCT03085914|4047590|FG000|NOT COMPLETED|Overall Study||9
3314392|NCT03085914|4047591|FG001|NOT COMPLETED|Overall Study||9
3314393|NCT03085914|4047592|FG002|NOT COMPLETED|Overall Study||11
3314394|NCT03085914|4047593|FG003|NOT COMPLETED|Overall Study||9
3314395|NCT03085914|4047594|FG004|NOT COMPLETED|Overall Study||13
3314396|NCT03085914|4047595|FG005|NOT COMPLETED|Overall Study||8
3314397|NCT03085914|4047596|FG006|NOT COMPLETED|Overall Study||11
3314398|NCT03085927|4047617|FG000|STARTED|Overall Study||69
3314399|NCT03085927|4047618|FG001|STARTED|Overall Study||67
3314400|NCT03085927|4047617|FG000|Study Sessions|Overall Study|"Off Study reasons:~Child toxicity/side effects (n=1) Dyad withdrew (n=1) Dyad lost to follow-up (n=2)"|65
3314401|NCT03085927|4047618|FG001|Study Sessions|Overall Study|"Off Study reasons:~Dyad withdrew (n=3) Dyad became ineligible (n=1)"|63
3314402|NCT03085927|4047617|FG000|Time 2 Measures|Overall Study||65
3314403|NCT03085927|4047618|FG001|Time 2 Measures|Overall Study|"Off Study reasons:~Dyad withdrew (n=1)"|62
3314404|NCT03085927|4047617|FG000|COMPLETED|Overall Study|"Off Study reasons:~Death of child (n=1) Dyad lost to follow up (n=1)"|63
3314405|NCT03085927|4047618|FG001|COMPLETED|Overall Study|"Off Study reason:~Dyad lost to follow up (n=1)"|61
3314406|NCT03085927|4047617|FG000|NOT COMPLETED|Overall Study||6
3314407|NCT03085927|4047618|FG001|NOT COMPLETED|Overall Study||6
3314408|NCT03086018|4047626|FG000|STARTED|Field Testing||30
3314409|NCT03086018|4047626|FG000|COMPLETED|Field Testing||30
3314410|NCT03086018|4047626|FG000|NOT COMPLETED|Field Testing||0
3314411|NCT03086018|4047626|FG000|STARTED|Final Testing for End of Trial||30
3314412|NCT03086018|4047626|FG000|COMPLETED|Final Testing for End of Trial||28
3314413|NCT03086018|4047626|FG000|NOT COMPLETED|Final Testing for End of Trial||2
3314414|NCT03086057|4047636|FG000|STARTED|Stage 1: PrEP Uptake||55
3314415|NCT03086057|4047637|FG001|STARTED|Stage 1: PrEP Uptake||55
2873566|NCT00230802|3577480|FG000|COMPLETED|Overall Study||25
2873567|NCT00230802|3577481|FG001|COMPLETED|Overall Study||23
2873568|NCT00230802|3577480|FG000|NOT COMPLETED|Overall Study||0
2873569|NCT00230802|3577481|FG001|NOT COMPLETED|Overall Study||0
2873570|NCT00230971|3577491|FG000|STARTED|Randomization||235
2873571|NCT00230971|3577492|FG001|STARTED|Randomization||238
2873572|NCT00230971|3577491|FG000|COMPLETED|Randomization||232
2873573|NCT00230971|3577492|FG001|COMPLETED|Randomization||235
2873574|NCT00230971|3577491|FG000|NOT COMPLETED|Randomization||3
2873575|NCT00230971|3577492|FG001|NOT COMPLETED|Randomization||3
2873576|NCT00230971|3577491|FG000|STARTED|Baseline Participants||232
2873577|NCT00230971|3577492|FG001|STARTED|Baseline Participants||235
2873578|NCT00230971|3577491|FG000|COMPLETED|Baseline Participants||210
2873579|NCT00230971|3577492|FG001|COMPLETED|Baseline Participants||216
2873580|NCT00230971|3577491|FG000|NOT COMPLETED|Baseline Participants||22
2873581|NCT00230971|3577492|FG001|NOT COMPLETED|Baseline Participants||19
2873582|NCT00231062|3577498|FG000|STARTED|Overall Study||115
3314416|NCT03086057|4047638|FG002|STARTED|Stage 1: PrEP Uptake|This intervention was not provided until Stage 2|0
3314417|NCT03086057|4047639|FG003|STARTED|Stage 1: PrEP Uptake|This intervention was not provided until Stage 2|0
3314418|NCT03086057|4047636|FG000|COMPLETED|Stage 1: PrEP Uptake||44
3314419|NCT03086057|4047637|FG001|COMPLETED|Stage 1: PrEP Uptake||45
3314420|NCT03086057|4047638|FG002|COMPLETED|Stage 1: PrEP Uptake||0
3314421|NCT03086057|4047639|FG003|COMPLETED|Stage 1: PrEP Uptake||0
3314422|NCT03086057|4047636|FG000|NOT COMPLETED|Stage 1: PrEP Uptake||11
3314423|NCT03086057|4047637|FG001|NOT COMPLETED|Stage 1: PrEP Uptake||10
3314424|NCT03086057|4047638|FG002|NOT COMPLETED|Stage 1: PrEP Uptake||0
3314425|NCT03086057|4047639|FG003|NOT COMPLETED|Stage 1: PrEP Uptake||0
3314426|NCT03086057|4047636|FG000|STARTED|Stage 2: PrEP Adherence|This was only provided in Stage 1|0
3314427|NCT03086057|4047637|FG001|STARTED|Stage 2: PrEP Adherence|This was only provided in Stage 1|0
3314428|NCT03086057|4047638|FG002|STARTED|Stage 2: PrEP Adherence|Only individuals who completed Stage 1 AND initiated PrEP were randomized in Stage 2.|17
3314429|NCT03086057|4047639|FG003|STARTED|Stage 2: PrEP Adherence|Only individuals who completed Stage 1 AND initiated PrEP were randomized in Stage 2.|18
3314430|NCT03086057|4047636|FG000|COMPLETED|Stage 2: PrEP Adherence||0
3314431|NCT03086057|4047637|FG001|COMPLETED|Stage 2: PrEP Adherence||0
3314432|NCT03086057|4047638|FG002|COMPLETED|Stage 2: PrEP Adherence||11
3314433|NCT03086057|4047639|FG003|COMPLETED|Stage 2: PrEP Adherence||16
3314434|NCT03086057|4047636|FG000|NOT COMPLETED|Stage 2: PrEP Adherence||0
3314435|NCT03086057|4047637|FG001|NOT COMPLETED|Stage 2: PrEP Adherence||0
3314436|NCT03086057|4047638|FG002|NOT COMPLETED|Stage 2: PrEP Adherence||6
3314437|NCT03086057|4047639|FG003|NOT COMPLETED|Stage 2: PrEP Adherence||2
3314438|NCT03086135|4047649|FG000|STARTED|Overall Study||51
3314439|NCT03086135|4047649|FG000|COMPLETED|Overall Study||48
3314440|NCT03086135|4047649|FG000|NOT COMPLETED|Overall Study||3
3314441|NCT03086213|4047653|FG000|STARTED|Overall Study||24
3314442|NCT03086213|4047654|FG001|STARTED|Overall Study||24
3314443|NCT03086213|4047653|FG000|COMPLETED|Overall Study||24
3314444|NCT03086213|4047654|FG001|COMPLETED|Overall Study||24
3314445|NCT03086213|4047653|FG000|NOT COMPLETED|Overall Study||0
3314446|NCT03086213|4047654|FG001|NOT COMPLETED|Overall Study||0
3314447|NCT03086265|4047662|FG000|STARTED|Overall Study||10
3314448|NCT03086265|4047663|FG001|STARTED|Overall Study||10
3314449|NCT03086265|4047662|FG000|COMPLETED|Overall Study||10
3314450|NCT03086265|4047663|FG001|COMPLETED|Overall Study||10
3314451|NCT03086265|4047662|FG000|NOT COMPLETED|Overall Study||0
3314452|NCT03086265|4047663|FG001|NOT COMPLETED|Overall Study||0
3314453|NCT03086330|4047671|FG000|STARTED|Overall Study||151
3314454|NCT03086330|4047672|FG001|STARTED|Overall Study||151
3314455|NCT03086330|4047671|FG000|Exposed|Overall Study||150
3314456|NCT03086330|4047672|FG001|Exposed|Overall Study||151
3314457|NCT03086330|4047671|FG000|COMPLETED|Overall Study||147
3314458|NCT03086330|4047672|FG001|COMPLETED|Overall Study||147
3314459|NCT03086330|4047671|FG000|NOT COMPLETED|Overall Study||4
3314460|NCT03086330|4047672|FG001|NOT COMPLETED|Overall Study||4
3314461|NCT03086343|4047680|FG000|STARTED|Overall Study||309
3314462|NCT03086343|4047681|FG001|STARTED|Overall Study||303
3314463|NCT03086343|4047680|FG000|COMPLETED|Overall Study||277
3314464|NCT03086343|4047681|FG001|COMPLETED|Overall Study||278
3314465|NCT03086343|4047680|FG000|NOT COMPLETED|Overall Study||32
3314466|NCT03086343|4047681|FG001|NOT COMPLETED|Overall Study||25
3314467|NCT03086356|4047687|FG000|STARTED|Overall Study||12
3314468|NCT03086356|4047687|FG000|COMPLETED|Overall Study||12
3314469|NCT03086356|4047687|FG000|NOT COMPLETED|Overall Study||0
3314470|NCT03086408|4047693|FG000|STARTED|Overall Study||10
3314471|NCT03086408|4047694|FG001|STARTED|Overall Study||10
3314472|NCT03086408|4047693|FG000|COMPLETED|Overall Study||10
3314473|NCT03086408|4047694|FG001|COMPLETED|Overall Study||10
3314474|NCT03086408|4047693|FG000|NOT COMPLETED|Overall Study||0
3314475|NCT03086408|4047694|FG001|NOT COMPLETED|Overall Study||0
3314476|NCT03086447|4047702|FG000|STARTED|Overall Study||132
3314477|NCT03086447|4047703|FG001|STARTED|Overall Study||130
3314478|NCT03086447|4047702|FG000|COMPLETED|Overall Study||121
3314479|NCT03086447|4047703|FG001|COMPLETED|Overall Study||110
2873583|NCT00231062|3577498|FG000|COMPLETED|Overall Study||109
2873584|NCT00231062|3577498|FG000|NOT COMPLETED|Overall Study||6
2873585|NCT00231114|3577504|FG000|STARTED|Randomized||196
2873586|NCT00231114|3577505|FG001|STARTED|Randomized||101
3314480|NCT03086447|4047702|FG000|NOT COMPLETED|Overall Study||11
3314481|NCT03086447|4047703|FG001|NOT COMPLETED|Overall Study||20
3314482|NCT03086460|4047709|FG000|STARTED|Study Participants||67
2873587|NCT00231114|3577504|FG000|COMPLETED|Randomized||190
2873588|NCT00231114|3577505|FG001|COMPLETED|Randomized||98
3314483|NCT03086460|4047709|FG000|Treatment A|Study Participants||39
3314484|NCT03086460|4047709|FG000|Treatment B|Study Participants||35
3314485|NCT03086460|4047709|FG000|Treatment C|Study Participants||37
3314486|NCT03086460|4047709|FG000|Treatment D|Study Participants||40
3314487|NCT03086460|4047709|FG000|Treatment E|Study Participants||40
3314488|NCT03086460|4047709|FG000|Treatment F|Study Participants||41
3314489|NCT03086460|4047709|FG000|COMPLETED|Study Participants||58
3314490|NCT03086460|4047709|FG000|NOT COMPLETED|Study Participants||9
3314491|NCT03086460|4047709|FG000|STARTED|Treatment A||39
3314492|NCT03086460|4047709|FG000|COMPLETED|Treatment A||35
3314493|NCT03086460|4047709|FG000|NOT COMPLETED|Treatment A||4
3314494|NCT03086460|4047709|FG000|STARTED|Treatment B||35
3314495|NCT03086460|4047709|FG000|COMPLETED|Treatment B||35
3314496|NCT03086460|4047709|FG000|NOT COMPLETED|Treatment B||0
3314497|NCT03086460|4047709|FG000|STARTED|Treatment C||37
3314498|NCT03086460|4047709|FG000|COMPLETED|Treatment C||35
3314499|NCT03086460|4047709|FG000|NOT COMPLETED|Treatment C||2
3314500|NCT03086460|4047709|FG000|STARTED|Treatment D||40
3314501|NCT03086460|4047709|FG000|COMPLETED|Treatment D||40
3314502|NCT03086460|4047709|FG000|NOT COMPLETED|Treatment D||0
3314503|NCT03086460|4047709|FG000|STARTED|Treatment E||40
3314504|NCT03086460|4047709|FG000|COMPLETED|Treatment E||36
3314505|NCT03086460|4047709|FG000|NOT COMPLETED|Treatment E||4
3314506|NCT03086460|4047709|FG000|STARTED|Treatment F||41
3314507|NCT03086460|4047709|FG000|COMPLETED|Treatment F||41
3314508|NCT03086460|4047709|FG000|NOT COMPLETED|Treatment F||0
3314509|NCT03086551|4047726|FG000|STARTED|First Intervention||5
3314510|NCT03086551|4047727|FG001|STARTED|First Intervention||5
3314511|NCT03086551|4047726|FG000|COMPLETED|First Intervention||4
3314512|NCT03086551|4047727|FG001|COMPLETED|First Intervention||4
3314513|NCT03086551|4047726|FG000|NOT COMPLETED|First Intervention||1
3314514|NCT03086551|4047727|FG001|NOT COMPLETED|First Intervention||1
3314515|NCT03086551|4047726|FG000|STARTED|Washout||4
3314516|NCT03086551|4047727|FG001|STARTED|Washout||4
3314517|NCT03086551|4047726|FG000|COMPLETED|Washout||1
3314518|NCT03086551|4047727|FG001|COMPLETED|Washout||1
3314519|NCT03086551|4047726|FG000|NOT COMPLETED|Washout||3
3314520|NCT03086551|4047727|FG001|NOT COMPLETED|Washout||3
3314521|NCT03086551|4047726|FG000|STARTED|Second Intervention||1
3314522|NCT03086551|4047727|FG001|STARTED|Second Intervention||1
3314523|NCT03086551|4047726|FG000|COMPLETED|Second Intervention||1
3314524|NCT03086551|4047727|FG001|COMPLETED|Second Intervention||1
3314525|NCT03086551|4047726|FG000|NOT COMPLETED|Second Intervention||0
3314526|NCT03086551|4047727|FG001|NOT COMPLETED|Second Intervention||0
3314527|NCT03086707|4047735|FG000|STARTED|Overall Study||7
3314528|NCT03086707|4047736|FG001|STARTED|Overall Study||7
3314529|NCT03086707|4047735|FG000|COMPLETED|Overall Study||7
3314530|NCT03086707|4047736|FG001|COMPLETED|Overall Study||7
3314531|NCT03086707|4047735|FG000|NOT COMPLETED|Overall Study||0
3314532|NCT03086707|4047736|FG001|NOT COMPLETED|Overall Study||0
3314533|NCT03087019|4047746|FG000|STARTED|Overall Study||11
3314534|NCT03087019|4047747|FG001|STARTED|Overall Study||10
3314535|NCT03087019|4047746|FG000|COMPLETED|Overall Study||10
3314536|NCT03087019|4047747|FG001|COMPLETED|Overall Study||10
3314537|NCT03087019|4047746|FG000|NOT COMPLETED|Overall Study||1
3314538|NCT03087019|4047747|FG001|NOT COMPLETED|Overall Study||0
3314539|NCT03087513|4047753|FG000|STARTED|First Intervention||40
3314540|NCT03087513|4047753|FG000|COMPLETED|First Intervention||40
3314541|NCT03087513|4047753|FG000|NOT COMPLETED|First Intervention||0
3314542|NCT03087513|4047753|FG000|STARTED|Second Intervention After 3 hr Washout||40
3314543|NCT03087513|4047753|FG000|COMPLETED|Second Intervention After 3 hr Washout||38
3314544|NCT03087513|4047753|FG000|NOT COMPLETED|Second Intervention After 3 hr Washout||2
3314545|NCT03087604|4047768|FG000|STARTED|Overall Study||50
3314546|NCT03087604|4047769|FG001|STARTED|Overall Study||50
3314547|NCT03087604|4047768|FG000|COMPLETED|Overall Study||50
3314548|NCT03087604|4047769|FG001|COMPLETED|Overall Study||50
3314549|NCT03087604|4047768|FG000|NOT COMPLETED|Overall Study||0
3314550|NCT03087604|4047769|FG001|NOT COMPLETED|Overall Study||0
3314551|NCT03087643|4047777|FG000|STARTED|Overall Study||26
3314552|NCT03087643|4047778|FG001|STARTED|Overall Study||25
3314553|NCT03087643|4047777|FG000|COMPLETED|Overall Study||22
3314554|NCT03087643|4047778|FG001|COMPLETED|Overall Study||19
3314555|NCT03087643|4047777|FG000|NOT COMPLETED|Overall Study||4
3314556|NCT03087643|4047778|FG001|NOT COMPLETED|Overall Study||6
3314557|NCT03087786|4047786|FG000|STARTED|Overall Study||50
3314558|NCT03087786|4047787|FG001|STARTED|Overall Study||50
3314559|NCT03087786|4047786|FG000|COMPLETED|Overall Study||48
3314560|NCT03087786|4047787|FG001|COMPLETED|Overall Study||50
3314561|NCT03087786|4047786|FG000|NOT COMPLETED|Overall Study||2
3314562|NCT03087786|4047787|FG001|NOT COMPLETED|Overall Study||0
3314563|NCT03087851|4047796|FG000|STARTED|Overall Study||20
3314564|NCT03087851|4047797|FG001|STARTED|Overall Study||20
3314565|NCT03087851|4047798|FG002|STARTED|Overall Study||21
3314566|NCT03087851|4047796|FG000|COMPLETED|Overall Study||20
3314567|NCT03087851|4047797|FG001|COMPLETED|Overall Study||19
3314568|NCT03087851|4047798|FG002|COMPLETED|Overall Study||19
3314569|NCT03087851|4047796|FG000|NOT COMPLETED|Overall Study||0
3314570|NCT03087851|4047797|FG001|NOT COMPLETED|Overall Study||1
3314571|NCT03087851|4047798|FG002|NOT COMPLETED|Overall Study||2
3314572|NCT03088137|4047808|FG000|STARTED|Overall Study||55
3314573|NCT03088137|4047809|FG001|STARTED|Overall Study||55
2873589|NCT00231114|3577504|FG000|NOT COMPLETED|Randomized||6
2873590|NCT00231114|3577505|FG001|NOT COMPLETED|Randomized||3
2873591|NCT00231114|3577504|FG000|STARTED|Treatment Period||190
2873592|NCT00231114|3577505|FG001|STARTED|Treatment Period||98
2873593|NCT00231114|3577504|FG000|COMPLETED|Treatment Period||189
2873594|NCT00231114|3577505|FG001|COMPLETED|Treatment Period||98
2873595|NCT00231114|3577504|FG000|NOT COMPLETED|Treatment Period||1
2873596|NCT00231114|3577505|FG001|NOT COMPLETED|Treatment Period||0
2873597|NCT00231114|3577504|FG000|STARTED|Post-Treatment Period||189
2873598|NCT00231114|3577505|FG001|STARTED|Post-Treatment Period||98
2873599|NCT00231114|3577504|FG000|COMPLETED|Post-Treatment Period||181
2873600|NCT00231114|3577505|FG001|COMPLETED|Post-Treatment Period||97
2873601|NCT00231114|3577504|FG000|NOT COMPLETED|Post-Treatment Period||8
2873602|NCT00231114|3577505|FG001|NOT COMPLETED|Post-Treatment Period||1
2873603|NCT00231179|3577515|FG000|STARTED|Overall Study||152
2873604|NCT00231179|3577516|FG001|STARTED|Overall Study||150
2873605|NCT00231179|3577515|FG000|COMPLETED|Overall Study|128 (95%) in intervention group completed the five year follow-up visit.|128
2873606|NCT00231179|3577516|FG001|COMPLETED|Overall Study|126 (93%) in the control group completed the five year follow-up visit.|126
2873607|NCT00231179|3577515|FG000|NOT COMPLETED|Overall Study||24
2873608|NCT00231179|3577516|FG001|NOT COMPLETED|Overall Study||24
2873609|NCT00231283|3577522|FG000|STARTED|Overall Study||100
2873610|NCT00231283|3577522|FG000|COMPLETED|Overall Study||95
2873611|NCT00231283|3577522|FG000|NOT COMPLETED|Overall Study||5
2873612|NCT00231309|3577526|FG000|STARTED|Overall Study||10
2873613|NCT00231309|3577526|FG000|COMPLETED|Overall Study||10
3169695|NCT01927341|3897238|FG001|STARTED|Phase 2|Participants of phase 2 enrolled after enrollment of participants of phase 1b.|15
3169696|NCT01927341|3897239|FG002|STARTED|Phase 2|Participants of phase 2 enrolled after enrollment of participants of phase 1b.|5
3169697|NCT01927341|3897240|FG003|STARTED|Phase 2|Participants of phase 2 enrolled after enrollment of participants of phase 1b.|15
2873614|NCT00231309|3577526|FG000|NOT COMPLETED|Overall Study||0
2873615|NCT00231413|3577538|FG000|STARTED|Overall Study||88
2873616|NCT00231413|3577539|FG001|STARTED|Overall Study||50
2873617|NCT00231413|3577540|FG002|STARTED|Overall Study||49
2873618|NCT00231413|3577541|FG003|STARTED|Overall Study||48
2873619|NCT00231413|3577542|FG004|STARTED|Overall Study||48
2873620|NCT00231413|3577543|FG005|STARTED|Overall Study||50
2873621|NCT00231413|3577544|FG006|STARTED|Overall Study||50
2873622|NCT00231413|3577538|FG000|COMPLETED|Overall Study||80
2873623|NCT00231413|3577539|FG001|COMPLETED|Overall Study||45
2873624|NCT00231413|3577540|FG002|COMPLETED|Overall Study||42
2873625|NCT00231413|3577541|FG003|COMPLETED|Overall Study||45
2873626|NCT00231413|3577542|FG004|COMPLETED|Overall Study||45
2873627|NCT00231413|3577543|FG005|COMPLETED|Overall Study||45
2873628|NCT00231413|3577544|FG006|COMPLETED|Overall Study||46
2873629|NCT00231413|3577538|FG000|NOT COMPLETED|Overall Study||8
2873630|NCT00231413|3577539|FG001|NOT COMPLETED|Overall Study||5
2873631|NCT00231413|3577540|FG002|NOT COMPLETED|Overall Study||7
2873632|NCT00231413|3577541|FG003|NOT COMPLETED|Overall Study||3
2873633|NCT00231413|3577542|FG004|NOT COMPLETED|Overall Study||3
2873634|NCT00231413|3577543|FG005|NOT COMPLETED|Overall Study||5
2873635|NCT00231413|3577544|FG006|NOT COMPLETED|Overall Study||4
2873636|NCT00231465|3577560|FG000|STARTED|Overall Study||44
2873637|NCT00231465|3577560|FG000|COMPLETED|Overall Study||42
2873638|NCT00231465|3577560|FG000|NOT COMPLETED|Overall Study||2
2873639|NCT00231478|3577566|FG000|STARTED|Overall Study||87
2873640|NCT00231478|3577567|FG001|STARTED|Overall Study||84
2873641|NCT00231478|3577566|FG000|COMPLETED|Overall Study||79
2873642|NCT00231478|3577567|FG001|COMPLETED|Overall Study||78
2873643|NCT00231478|3577566|FG000|NOT COMPLETED|Overall Study||8
2873644|NCT00231478|3577567|FG001|NOT COMPLETED|Overall Study||6
2873645|NCT00231777|3577575|FG000|STARTED|Overall Study||170
2873646|NCT00231777|3577576|FG001|STARTED|Overall Study||46
2873647|NCT00231777|3577575|FG000|COMPLETED|Overall Study||164
2873648|NCT00231777|3577576|FG001|COMPLETED|Overall Study||44
2873649|NCT00231777|3577575|FG000|NOT COMPLETED|Overall Study||6
2873650|NCT00231777|3577576|FG001|NOT COMPLETED|Overall Study||2
2873651|NCT00231816|3577584|FG000|STARTED|Overall Study||382
2873652|NCT00231816|3577585|FG001|STARTED|Overall Study||381
2873653|NCT00231816|3577584|FG000|Vaccinated at Visit 1|Overall Study||382
2873654|NCT00231816|3577585|FG001|Vaccinated at Visit 1|Overall Study|One participant was randomized but not vaccinated|380
2873655|NCT00231816|3577584|FG000|Vaccinated at Visit 2|Overall Study||369
2873656|NCT00231816|3577585|FG001|Vaccinated at Visit 2|Overall Study||371
2873657|NCT00231816|3577584|FG000|COMPLETED|Overall Study|Participant received required vaccines and returned completed vaccination report cards at Visits 2&3|366
2873658|NCT00231816|3577585|FG001|COMPLETED|Overall Study|Participant received required vaccines and returned completed vaccination report cards at Visits 2&3|369
2873659|NCT00231816|3577584|FG000|NOT COMPLETED|Overall Study||16
2873660|NCT00231816|3577585|FG001|NOT COMPLETED|Overall Study||12
2873661|NCT00231842|3577592|FG000|STARTED|Overall Study||30
2873662|NCT00231842|3577592|FG000|Initiated Therapy|Overall Study||27
2873663|NCT00231842|3577592|FG000|Completed First 3 Cycles|Overall Study||27
2873664|NCT00231842|3577592|FG000|Completed Prescribed RT|Overall Study||27
2873665|NCT00231842|3577592|FG000|Completed Full Prescribed Therapy|Overall Study||19
2873666|NCT00231842|3577592|FG000|COMPLETED|Overall Study||19
2873667|NCT00231842|3577592|FG000|NOT COMPLETED|Overall Study||11
2873668|NCT00231868|3577597|FG000|STARTED|Overall Study||81
2873669|NCT00231868|3577597|FG000|COMPLETED|Overall Study||65
2873670|NCT00231868|3577597|FG000|NOT COMPLETED|Overall Study||16
2873671|NCT00231894|3577603|FG000|STARTED|Overall Study||31
2873672|NCT00231894|3577604|FG001|STARTED|Overall Study||25
2873673|NCT00231894|3577603|FG000|COMPLETED|Overall Study||30
2873674|NCT00231894|3577604|FG001|COMPLETED|Overall Study||24
2873675|NCT00231894|3577603|FG000|NOT COMPLETED|Overall Study||1
2873676|NCT00231894|3577604|FG001|NOT COMPLETED|Overall Study||1
2873677|NCT00232180|3577618|FG000|STARTED|Double-blind (DB) Phase|Three participants in each arm were enrolled after data cut-off.|1367
2873678|NCT00232180|3577619|FG001|STARTED|Double-blind (DB) Phase|Three participants in each arm were enrolled after data cut-off.|1376
2873679|NCT00232180|3577620|FG002|STARTED|Double-blind (DB) Phase||0
2873680|NCT00232180|3577618|FG000|Treated|Double-blind (DB) Phase||1364
2873681|NCT00232180|3577619|FG001|Treated|Double-blind (DB) Phase||1372
2873682|NCT00232180|3577620|FG002|Treated|Double-blind (DB) Phase||0
2873683|NCT00232180|3577618|FG000|COMPLETED|Double-blind (DB) Phase||826
2873684|NCT00232180|3577619|FG001|COMPLETED|Double-blind (DB) Phase||771
2873685|NCT00232180|3577620|FG002|COMPLETED|Double-blind (DB) Phase||0
2873686|NCT00232180|3577618|FG000|NOT COMPLETED|Double-blind (DB) Phase||541
2873687|NCT00232180|3577619|FG001|NOT COMPLETED|Double-blind (DB) Phase||605
2873688|NCT00232180|3577620|FG002|NOT COMPLETED|Double-blind (DB) Phase||0
2873689|NCT00232180|3577618|FG000|STARTED|Open Label Phase||0
2873690|NCT00232180|3577619|FG001|STARTED|Open Label Phase||0
2873691|NCT00232180|3577620|FG002|STARTED|Open Label Phase||1246
2873692|NCT00232180|3577618|FG000|Treated|Open Label Phase||0
2873693|NCT00232180|3577619|FG001|Treated|Open Label Phase||0
2873694|NCT00232180|3577620|FG002|Treated|Open Label Phase||1245
2873695|NCT00232180|3577618|FG000|COMPLETED|Open Label Phase||0
2873696|NCT00232180|3577619|FG001|COMPLETED|Open Label Phase||0
2873697|NCT00232180|3577620|FG002|COMPLETED|Open Label Phase||1098
2873698|NCT00232180|3577618|FG000|NOT COMPLETED|Open Label Phase||0
2873699|NCT00232180|3577619|FG001|NOT COMPLETED|Open Label Phase||0
2873700|NCT00232180|3577620|FG002|NOT COMPLETED|Open Label Phase||148
2873701|NCT00232479|3577629|FG000|STARTED|Overall Study||44
2873702|NCT00232479|3577629|FG000|COMPLETED|Overall Study||44
2873703|NCT00232479|3577629|FG000|NOT COMPLETED|Overall Study||0
2873704|NCT00232505|3577636|FG000|STARTED|Overall Study||31
2873705|NCT00232505|3577637|FG001|STARTED|Overall Study||71
2873706|NCT00232505|3577636|FG000|Not Evaluable|Overall Study||0
2873707|NCT00232505|3577637|FG001|Not Evaluable|Overall Study||6
2873708|NCT00232505|3577636|FG000|Early Progressors|Overall Study||2
2873709|NCT00232505|3577637|FG001|Early Progressors|Overall Study||5
3314574|NCT03088137|4047808|FG000|COMPLETED|Overall Study||55
3314575|NCT03088137|4047809|FG001|COMPLETED|Overall Study||55
3314576|NCT03088137|4047808|FG000|NOT COMPLETED|Overall Study||0
3314577|NCT03088137|4047809|FG001|NOT COMPLETED|Overall Study||0
3314578|NCT03088267|4047815|FG000|STARTED|Overall Study||9
3314579|NCT03088267|4047816|FG001|STARTED|Overall Study||9
3314580|NCT03088267|4047815|FG000|COMPLETED|Overall Study||9
3314581|NCT03088267|4047816|FG001|COMPLETED|Overall Study||9
3314582|NCT03088267|4047815|FG000|NOT COMPLETED|Overall Study||0
3314583|NCT03088267|4047816|FG001|NOT COMPLETED|Overall Study||0
3314584|NCT03088345|4047825|FG000|STARTED|Overall Study||10
3314585|NCT03088345|4047826|FG001|STARTED|Overall Study||10
3314586|NCT03088345|4047825|FG000|COMPLETED|Overall Study||10
3314587|NCT03088345|4047826|FG001|COMPLETED|Overall Study||10
3314588|NCT03088345|4047825|FG000|NOT COMPLETED|Overall Study||0
3314589|NCT03088345|4047826|FG001|NOT COMPLETED|Overall Study||0
3314590|NCT03088748|4047834|FG000|STARTED|Overall Study||40
3314591|NCT03088748|4047835|FG001|STARTED|Overall Study||10
3314592|NCT03088748|4047834|FG000|COMPLETED|Overall Study||40
3314593|NCT03088748|4047835|FG001|COMPLETED|Overall Study||10
3314594|NCT03088748|4047834|FG000|NOT COMPLETED|Overall Study||0
3314595|NCT03088748|4047835|FG001|NOT COMPLETED|Overall Study||0
3314596|NCT03088800|4047844|FG000|STARTED|Overall Study||30
3314597|NCT03088800|4047845|FG001|STARTED|Overall Study||30
3314598|NCT03088800|4047846|FG002|STARTED|Overall Study||30
3314599|NCT03088800|4047844|FG000|COMPLETED|Overall Study||30
3314600|NCT03088800|4047845|FG001|COMPLETED|Overall Study||30
3314601|NCT03088800|4047846|FG002|COMPLETED|Overall Study||30
3314602|NCT03088800|4047844|FG000|NOT COMPLETED|Overall Study||0
3314603|NCT03088800|4047845|FG001|NOT COMPLETED|Overall Study||0
3314604|NCT03088800|4047846|FG002|NOT COMPLETED|Overall Study||0
3314605|NCT03088917|4047854|FG000|STARTED|Overall Study||106
3314606|NCT03088917|4047854|FG000|COMPLETED|Overall Study||10
3314607|NCT03088917|4047854|FG000|NOT COMPLETED|Overall Study||96
3314608|NCT03089047|4047862|FG000|STARTED|Overall Study||2
3314609|NCT03089047|4047863|FG001|STARTED|Overall Study||2
3314610|NCT03089047|4047862|FG000|COMPLETED|Overall Study||1
3314611|NCT03089047|4047863|FG001|COMPLETED|Overall Study||2
3314612|NCT03089047|4047862|FG000|NOT COMPLETED|Overall Study||1
3314613|NCT03089047|4047863|FG001|NOT COMPLETED|Overall Study||0
3314614|NCT03089216|4047873|FG000|STARTED|Overall Study||27
3314615|NCT03089216|4047874|FG001|STARTED|Overall Study||27
3314616|NCT03089216|4047875|FG002|STARTED|Overall Study||27
2873710|NCT00232505|3577636|FG000|Off Protocol|Overall Study||5
2873711|NCT00232505|3577637|FG001|Off Protocol|Overall Study||0
2873712|NCT00232505|3577636|FG000|COMPLETED|Overall Study||26
2873713|NCT00232505|3577637|FG001|COMPLETED|Overall Study||60
2873714|NCT00232505|3577636|FG000|NOT COMPLETED|Overall Study||5
2873715|NCT00232505|3577637|FG001|NOT COMPLETED|Overall Study||11
2873716|NCT00232544|3577649|FG000|STARTED|Overall Study||124
3314617|NCT03089216|4047876|FG003|STARTED|Overall Study||27
2873717|NCT00232544|3577650|FG001|STARTED|Overall Study||126
2873718|NCT00232544|3577649|FG000|COMPLETED|Overall Study||104
2873719|NCT00232544|3577650|FG001|COMPLETED|Overall Study||111
2873720|NCT00232544|3577649|FG000|NOT COMPLETED|Overall Study||20
2873721|NCT00232544|3577650|FG001|NOT COMPLETED|Overall Study||15
2873722|NCT00232557|3577658|FG000|STARTED|Overall Study||71
2873723|NCT00232557|3577659|FG001|STARTED|Overall Study||65
2873724|NCT00232557|3577658|FG000|COMPLETED|Overall Study||68
2873725|NCT00232557|3577659|FG001|COMPLETED|Overall Study||60
2873726|NCT00232557|3577658|FG000|NOT COMPLETED|Overall Study||3
2873727|NCT00232557|3577659|FG001|NOT COMPLETED|Overall Study||5
2873728|NCT00232583|3577667|FG000|STARTED|Overall Study||29
2873729|NCT00232583|3577668|FG001|STARTED|Overall Study||29
2873730|NCT00232583|3577667|FG000|COMPLETED|Overall Study||19
2873731|NCT00232583|3577668|FG001|COMPLETED|Overall Study||16
2873732|NCT00232583|3577667|FG000|NOT COMPLETED|Overall Study||10
2873733|NCT00232583|3577668|FG001|NOT COMPLETED|Overall Study||13
2873734|NCT00232596|3577680|FG000|STARTED|6-Week Titration Phase||152
2873735|NCT00232596|3577681|FG001|STARTED|6-Week Titration Phase||154
2873736|NCT00232596|3577680|FG000|COMPLETED|6-Week Titration Phase||138
2873737|NCT00232596|3577681|FG001|COMPLETED|6-Week Titration Phase||125
2873738|NCT00232596|3577680|FG000|NOT COMPLETED|6-Week Titration Phase||14
2873739|NCT00232596|3577681|FG001|NOT COMPLETED|6-Week Titration Phase||29
2873740|NCT00232596|3577680|FG000|STARTED|12-Week Maintenance Phase||138
2873741|NCT00232596|3577681|FG001|STARTED|12-Week Maintenance Phase||125
2873742|NCT00232596|3577680|FG000|COMPLETED|12-Week Maintenance Phase|"One participant withdrew after being considered a completer and is listed as an early withdraw."|126
2873743|NCT00232596|3577681|FG001|COMPLETED|12-Week Maintenance Phase||97
2873744|NCT00232596|3577680|FG000|NOT COMPLETED|12-Week Maintenance Phase||12
2873745|NCT00232596|3577681|FG001|NOT COMPLETED|12-Week Maintenance Phase||28
2873746|NCT00232739|3577699|FG000|STARTED|Overall Study||100
2873747|NCT00232739|3577699|FG000|COMPLETED|Overall Study||91
2873748|NCT00232739|3577699|FG000|NOT COMPLETED|Overall Study||9
2873749|NCT00233064|3577705|FG000|STARTED|Overall Study||211
2873750|NCT00233064|3577706|FG001|STARTED|Overall Study||202
2873751|NCT00233064|3577705|FG000|COMPLETED|Overall Study||197
2873752|NCT00233064|3577706|FG001|COMPLETED|Overall Study||190
2873753|NCT00233064|3577705|FG000|NOT COMPLETED|Overall Study||14
2873754|NCT00233064|3577706|FG001|NOT COMPLETED|Overall Study||12
2873755|NCT00233103|3577715|FG000|STARTED|Overall Study||27
2873756|NCT00233103|3577716|FG001|STARTED|Overall Study||25
2873757|NCT00233103|3577715|FG000|COMPLETED|Overall Study||22
2873758|NCT00233103|3577716|FG001|COMPLETED|Overall Study||19
2873759|NCT00233103|3577715|FG000|NOT COMPLETED|Overall Study||5
2873760|NCT00233103|3577716|FG001|NOT COMPLETED|Overall Study||6
2873761|NCT00233324|3577726|FG000|STARTED|Main Study||318
2873762|NCT00233324|3577727|FG001|STARTED|Main Study||335
2873763|NCT00233324|3577728|FG002|STARTED|Main Study||336
2873764|NCT00233324|3577729|FG003|STARTED|Main Study||327
2873765|NCT00233324|3577726|FG000|COMPLETED|Main Study||250
2873766|NCT00233324|3577727|FG001|COMPLETED|Main Study||275
2873767|NCT00233324|3577728|FG002|COMPLETED|Main Study||274
2873768|NCT00233324|3577729|FG003|COMPLETED|Main Study||280
2873769|NCT00233324|3577726|FG000|NOT COMPLETED|Main Study||68
2873770|NCT00233324|3577727|FG001|NOT COMPLETED|Main Study||60
2873771|NCT00233324|3577728|FG002|NOT COMPLETED|Main Study||62
2873772|NCT00233324|3577729|FG003|NOT COMPLETED|Main Study||47
2873773|NCT00233324|3577726|FG000|STARTED|Follow up at 18-22 Months Corrected Age||250
2873774|NCT00233324|3577727|FG001|STARTED|Follow up at 18-22 Months Corrected Age||275
2873775|NCT00233324|3577728|FG002|STARTED|Follow up at 18-22 Months Corrected Age||274
2873776|NCT00233324|3577729|FG003|STARTED|Follow up at 18-22 Months Corrected Age||280
2873777|NCT00233324|3577726|FG000|COMPLETED|Follow up at 18-22 Months Corrected Age||237
2873778|NCT00233324|3577727|FG001|COMPLETED|Follow up at 18-22 Months Corrected Age||261
2873779|NCT00233324|3577728|FG002|COMPLETED|Follow up at 18-22 Months Corrected Age||256
2873780|NCT00233324|3577729|FG003|COMPLETED|Follow up at 18-22 Months Corrected Age||269
2873781|NCT00233324|3577726|FG000|NOT COMPLETED|Follow up at 18-22 Months Corrected Age||13
2873782|NCT00233324|3577727|FG001|NOT COMPLETED|Follow up at 18-22 Months Corrected Age||14
2873783|NCT00233324|3577728|FG002|NOT COMPLETED|Follow up at 18-22 Months Corrected Age||18
2873784|NCT00233324|3577729|FG003|NOT COMPLETED|Follow up at 18-22 Months Corrected Age||11
2873785|NCT00233363|3577748|FG000|STARTED|Overall Study||53
2873786|NCT00233363|3577749|FG001|STARTED|Overall Study||51
2873787|NCT00233363|3577748|FG000|COMPLETED|Overall Study||50
2873788|NCT00233363|3577749|FG001|COMPLETED|Overall Study||46
2873789|NCT00233363|3577748|FG000|NOT COMPLETED|Overall Study||3
2873790|NCT00233363|3577749|FG001|NOT COMPLETED|Overall Study||5
2873791|NCT00233389|3577757|FG000|STARTED|Overall Study||154
2873792|NCT00233389|3577758|FG001|STARTED|Overall Study||147
2873793|NCT00233389|3577757|FG000|COMPLETED|Overall Study||136
2873794|NCT00233389|3577758|FG001|COMPLETED|Overall Study||131
2873795|NCT00233389|3577757|FG000|NOT COMPLETED|Overall Study||18
2873796|NCT00233389|3577758|FG001|NOT COMPLETED|Overall Study||16
2873797|NCT00233402|3577766|FG000|STARTED|Overall Study||384
2873798|NCT00233402|3577767|FG001|STARTED|Overall Study||395
2873799|NCT00233402|3577766|FG000|COMPLETED|Overall Study||280
2873800|NCT00233402|3577767|FG001|COMPLETED|Overall Study||271
2873801|NCT00233402|3577766|FG000|NOT COMPLETED|Overall Study||104
2873802|NCT00233402|3577767|FG001|NOT COMPLETED|Overall Study||124
2873803|NCT00233454|3577775|FG000|STARTED|Overall Study||26
2873804|NCT00233454|3577775|FG000|2 Months (for Response Rate)|Overall Study||26
2873805|NCT00233454|3577775|FG000|COMPLETED|Overall Study||20
2873806|NCT00233454|3577775|FG000|NOT COMPLETED|Overall Study||6
2873807|NCT00233480|3577781|FG000|STARTED|Overall Study||14
2873808|NCT00233480|3577782|FG001|STARTED|Overall Study||13
2873809|NCT00233480|3577781|FG000|COMPLETED|Overall Study||14
2873810|NCT00233480|3577782|FG001|COMPLETED|Overall Study||12
2873811|NCT00233480|3577781|FG000|NOT COMPLETED|Overall Study||0
2873812|NCT00233480|3577782|FG001|NOT COMPLETED|Overall Study||1
2873813|NCT00233519|3577792|FG000|STARTED|Overall Study||7
2873814|NCT00233519|3577793|FG001|STARTED|Overall Study||10
2873815|NCT00233519|3577792|FG000|COMPLETED|Overall Study||6
2873816|NCT00233519|3577793|FG001|COMPLETED|Overall Study||9
2873817|NCT00233519|3577792|FG000|NOT COMPLETED|Overall Study||1
2873818|NCT00233519|3577793|FG001|NOT COMPLETED|Overall Study||1
2873819|NCT00233948|3577801|FG000|STARTED|Overall Study||4
2873820|NCT00233948|3577802|FG001|STARTED|Overall Study||3
2873821|NCT00233948|3577803|FG002|STARTED|Overall Study||3
2873822|NCT00233948|3577804|FG003|STARTED|Overall Study||3
2873823|NCT00233948|3577805|FG004|STARTED|Overall Study||4
2873824|NCT00233948|3577806|FG005|STARTED|Overall Study||12
2873825|NCT00233948|3577801|FG000|COMPLETED|Overall Study||3
2873826|NCT00233948|3577802|FG001|COMPLETED|Overall Study||3
2873827|NCT00233948|3577803|FG002|COMPLETED|Overall Study||3
2873828|NCT00233948|3577804|FG003|COMPLETED|Overall Study||3
2873829|NCT00233948|3577805|FG004|COMPLETED|Overall Study||4
2873830|NCT00233948|3577806|FG005|COMPLETED|Overall Study||12
2873831|NCT00233948|3577801|FG000|NOT COMPLETED|Overall Study||1
2873832|NCT00233948|3577802|FG001|NOT COMPLETED|Overall Study||0
2873833|NCT00233948|3577803|FG002|NOT COMPLETED|Overall Study||0
2873834|NCT00233948|3577804|FG003|NOT COMPLETED|Overall Study||0
2873835|NCT00233948|3577805|FG004|NOT COMPLETED|Overall Study||0
2873836|NCT00233948|3577806|FG005|NOT COMPLETED|Overall Study||0
2873837|NCT00233987|3577821|FG000|STARTED|Overall Study||98
2873838|NCT00233987|3577821|FG000|Eligible|Overall Study||94
2873839|NCT00233987|3577821|FG000|Eligible and Treated|Overall Study||92
2873840|NCT00233987|3577821|FG000|COMPLETED|Overall Study||83
2873841|NCT00233987|3577821|FG000|NOT COMPLETED|Overall Study||15
2873842|NCT00234039|3577825|FG000|STARTED|Overall Study||58
2873843|NCT00234039|3577825|FG000|Eligible|Overall Study||49
2873844|NCT00234039|3577825|FG000|Eligible and Began Protocol Therapy|Overall Study||47
2873845|NCT00234039|3577825|FG000|COMPLETED|Overall Study||8
2873846|NCT00234039|3577825|FG000|NOT COMPLETED|Overall Study||50
2873847|NCT00234052|3577829|FG000|STARTED|Treatment||51
2873848|NCT00234052|3577829|FG000|Started Treatment|Treatment||50
2873849|NCT00234052|3577829|FG000|Completed 6 Cycles|Treatment||33
2873850|NCT00234052|3577829|FG000|Went Into Maintenance Phase|Treatment||30
2873851|NCT00234052|3577829|FG000|COMPLETED|Treatment||30
2873852|NCT00234052|3577829|FG000|NOT COMPLETED|Treatment||21
2873853|NCT00234052|3577829|FG000|STARTED|Follow-up for 5 Years|All patients that are treated on study go into the follow up period.|50
2873854|NCT00234052|3577829|FG000|COMPLETED|Follow-up for 5 Years||1
2873855|NCT00234052|3577829|FG000|NOT COMPLETED|Follow-up for 5 Years||49
2873856|NCT00234065|3577835|FG000|STARTED|Overall Study||1356
2873857|NCT00234065|3577836|FG001|STARTED|Overall Study||1360
2873858|NCT00234065|3577835|FG000|COMPLETED|Overall Study||881
2873859|NCT00234065|3577836|FG001|COMPLETED|Overall Study||1004
2873860|NCT00234065|3577835|FG000|NOT COMPLETED|Overall Study||475
2873861|NCT00234065|3577836|FG001|NOT COMPLETED|Overall Study||356
2873862|NCT00234078|3577846|FG000|STARTED|Overall Study||72
2873863|NCT00234078|3577847|FG001|STARTED|Overall Study||72
2873864|NCT00234078|3577848|FG002|STARTED|Overall Study||74
2873865|NCT00234078|3577849|FG003|STARTED|Overall Study||72
2873866|NCT00234078|3577846|FG000|COMPLETED|Overall Study||66
2873867|NCT00234078|3577847|FG001|COMPLETED|Overall Study||63
2873868|NCT00234078|3577848|FG002|COMPLETED|Overall Study||64
2873869|NCT00234078|3577849|FG003|COMPLETED|Overall Study||68
2873870|NCT00234078|3577846|FG000|NOT COMPLETED|Overall Study||6
2873871|NCT00234078|3577847|FG001|NOT COMPLETED|Overall Study||9
2873872|NCT00234078|3577848|FG002|NOT COMPLETED|Overall Study||10
2873873|NCT00234078|3577849|FG003|NOT COMPLETED|Overall Study||4
2873874|NCT00234104|3577863|FG000|STARTED|Overall Study||30
2873875|NCT00234104|3577864|FG001|STARTED|Overall Study||29
2873876|NCT00234104|3577865|FG002|STARTED|Overall Study||34
2873877|NCT00234104|3577866|FG003|STARTED|Overall Study||29
2873878|NCT00234104|3577863|FG000|COMPLETED|Overall Study||26
2873879|NCT00234104|3577864|FG001|COMPLETED|Overall Study||28
2873880|NCT00234104|3577865|FG002|COMPLETED|Overall Study||29
2873881|NCT00234104|3577866|FG003|COMPLETED|Overall Study||21
2873882|NCT00234104|3577863|FG000|NOT COMPLETED|Overall Study||4
2873883|NCT00234104|3577864|FG001|NOT COMPLETED|Overall Study||1
2873884|NCT00234104|3577865|FG002|NOT COMPLETED|Overall Study||5
2873885|NCT00234104|3577866|FG003|NOT COMPLETED|Overall Study||8
2873886|NCT00234286|3577876|FG000|STARTED|Overall Study|We reviewed eletronic health records for 6066 deceased individuals within 6 VA Hospitals|6066
2873887|NCT00234286|3577876|FG000|COMPLETED|Overall Study|We reviewed eletronic health records for 6066 deceased individuals within 6 VA Hospitals|6066
2873888|NCT00234286|3577876|FG000|NOT COMPLETED|Overall Study||0
2873889|NCT00234494|3577909|FG000|STARTED|Overall Study||45
2873890|NCT00234494|3577909|FG000|COMPLETED|Overall Study||43
2873891|NCT00234494|3577909|FG000|NOT COMPLETED|Overall Study||2
2873892|NCT00234533|3577913|FG000|STARTED|Overall Study||251
2873893|NCT00234533|3577913|FG000|COMPLETED|Overall Study||240
2873894|NCT00234533|3577913|FG000|NOT COMPLETED|Overall Study||11
2873895|NCT00234832|3577920|FG000|STARTED|Overall Study|Subjects completed the 6-week Lead-in Period and were dispensed randomized study drug.|4906
2873896|NCT00234832|3577921|FG001|STARTED|Overall Study|Subjects completed the 6-week Lead-in Period and were dispensed randomized study drug.|4898
2873897|NCT00234832|3577920|FG000|COMPLETED|Overall Study|Subjects completed the Randomization Phase.|3890
2873898|NCT00234832|3577921|FG001|COMPLETED|Overall Study|Subjects completed the Randomization Phase.|3902
2873899|NCT00234832|3577920|FG000|NOT COMPLETED|Overall Study||1016
2873900|NCT00234832|3577921|FG001|NOT COMPLETED|Overall Study||996
2873901|NCT00234884|3577934|FG000|STARTED|Overall Study||3435
2873902|NCT00234884|3577934|FG000|COMPLETED|Overall Study||1805
2873903|NCT00234884|3577934|FG000|NOT COMPLETED|Overall Study||1630
2873904|NCT00235391|3577944|FG000|STARTED|Overall Study||97
2873905|NCT00235391|3577945|FG001|STARTED|Overall Study||200
2873906|NCT00235391|3577946|FG002|STARTED|Overall Study||172
2873907|NCT00235391|3577947|FG003|STARTED|Overall Study||1164
2873908|NCT00235391|3577948|FG004|STARTED|Overall Study||43
2873909|NCT00235391|3577949|FG005|STARTED|Overall Study||7
2873910|NCT00235391|3577944|FG000|Deferasirox Treatment|Overall Study||97
2873911|NCT00235391|3577945|FG001|Deferasirox Treatment|Overall Study||200
2873912|NCT00235391|3577946|FG002|Deferasirox Treatment|Overall Study||172
2873913|NCT00235391|3577947|FG003|Deferasirox Treatment|Overall Study||1164
2873914|NCT00235391|3577948|FG004|Deferasirox Treatment|Overall Study||43
2873915|NCT00235391|3577949|FG005|Deferasirox Treatment|Overall Study||7
2873916|NCT00235391|3577944|FG000|COMPLETED|Overall Study||85
2873917|NCT00235391|3577945|FG001|COMPLETED|Overall Study||182
2873918|NCT00235391|3577946|FG002|COMPLETED|Overall Study||148
2873919|NCT00235391|3577947|FG003|COMPLETED|Overall Study||944
2873920|NCT00235391|3577948|FG004|COMPLETED|Overall Study||31
2873921|NCT00235391|3577949|FG005|COMPLETED|Overall Study||3
2873922|NCT00235391|3577944|FG000|NOT COMPLETED|Overall Study||12
2873923|NCT00235391|3577945|FG001|NOT COMPLETED|Overall Study||18
2873924|NCT00235391|3577946|FG002|NOT COMPLETED|Overall Study||24
2873925|NCT00235391|3577947|FG003|NOT COMPLETED|Overall Study||220
2873926|NCT00235391|3577948|FG004|NOT COMPLETED|Overall Study||12
2873927|NCT00235391|3577949|FG005|NOT COMPLETED|Overall Study||4
2873928|NCT00235443|3577964|FG000|STARTED|Overall Study||11
2873929|NCT00235443|3577965|FG001|STARTED|Overall Study||57
2873930|NCT00235443|3577966|FG002|STARTED|Overall Study||85
2873931|NCT00235443|3577967|FG003|STARTED|Overall Study||205
2873932|NCT00235443|3577968|FG004|STARTED|Overall Study||39
2873933|NCT00235443|3577969|FG005|STARTED|Overall Study||54
2873934|NCT00235443|3577964|FG000|COMPLETED|Overall Study||3
2873935|NCT00235443|3577965|FG001|COMPLETED|Overall Study||19
2873936|NCT00235443|3577966|FG002|COMPLETED|Overall Study||23
2873937|NCT00235443|3577967|FG003|COMPLETED|Overall Study||108
2873938|NCT00235443|3577968|FG004|COMPLETED|Overall Study||9
2873939|NCT00235443|3577969|FG005|COMPLETED|Overall Study||9
2873940|NCT00235443|3577964|FG000|NOT COMPLETED|Overall Study||8
2873941|NCT00235443|3577965|FG001|NOT COMPLETED|Overall Study||38
2873942|NCT00235443|3577966|FG002|NOT COMPLETED|Overall Study||62
2873943|NCT00235443|3577967|FG003|NOT COMPLETED|Overall Study||97
2873944|NCT00235443|3577968|FG004|NOT COMPLETED|Overall Study||30
2873945|NCT00235443|3577969|FG005|NOT COMPLETED|Overall Study||45
2873946|NCT00235456|3577987|FG000|STARTED|Overall Study||150
2873947|NCT00235456|3577988|FG001|STARTED|Overall Study||150
2873948|NCT00235456|3577987|FG000|COMPLETED|Overall Study||148
2873949|NCT00235456|3577988|FG001|COMPLETED|Overall Study||143
2873950|NCT00235456|3577987|FG000|NOT COMPLETED|Overall Study||2
2873951|NCT00235456|3577988|FG001|NOT COMPLETED|Overall Study||7
2873952|NCT00235495|3577996|FG000|STARTED|Overall Study||422
2873953|NCT00235495|3577997|FG001|STARTED|Overall Study||419
2873954|NCT00235495|3577996|FG000|COMPLETED|Overall Study||354
2873955|NCT00235495|3577997|FG001|COMPLETED|Overall Study||351
2873956|NCT00235495|3577996|FG000|NOT COMPLETED|Overall Study||68
2873957|NCT00235495|3577997|FG001|NOT COMPLETED|Overall Study||68
2873958|NCT00235547|3578005|FG000|STARTED|2 Month Follow-up Survey||154
3169698|NCT01927341|3897241|FG004|STARTED|Phase 2|Participants of phase 2 enrolled after enrollment of participants of phase 1b.|8
3169699|NCT01927341|3897237|FG000|COMPLETED|Phase 2||0
3169700|NCT01927341|3897238|FG001|COMPLETED|Phase 2||0
3169701|NCT01927341|3897239|FG002|COMPLETED|Phase 2||0
3169702|NCT01927341|3897240|FG003|COMPLETED|Phase 2||0
3169703|NCT01927341|3897241|FG004|COMPLETED|Phase 2||0
3169704|NCT01927341|3897237|FG000|NOT COMPLETED|Phase 2||0
3169705|NCT01927341|3897238|FG001|NOT COMPLETED|Phase 2||15
3169706|NCT01927341|3897239|FG002|NOT COMPLETED|Phase 2||5
3169707|NCT01927341|3897240|FG003|NOT COMPLETED|Phase 2||15
3169708|NCT01927341|3897241|FG004|NOT COMPLETED|Phase 2||8
2873959|NCT00235547|3578006|FG001|STARTED|2 Month Follow-up Survey||144
2873960|NCT00235547|3578005|FG000|COMPLETED|2 Month Follow-up Survey||108
2873961|NCT00235547|3578006|FG001|COMPLETED|2 Month Follow-up Survey||104
2873962|NCT00235547|3578005|FG000|NOT COMPLETED|2 Month Follow-up Survey||46
2873963|NCT00235547|3578006|FG001|NOT COMPLETED|2 Month Follow-up Survey||40
2873964|NCT00235547|3578005|FG000|STARTED|6 Month Follow-up Survey||154
2873965|NCT00235547|3578006|FG001|STARTED|6 Month Follow-up Survey||144
2873966|NCT00235547|3578005|FG000|COMPLETED|6 Month Follow-up Survey||83
2873967|NCT00235547|3578006|FG001|COMPLETED|6 Month Follow-up Survey||76
2873968|NCT00235547|3578005|FG000|NOT COMPLETED|6 Month Follow-up Survey||71
2873969|NCT00235547|3578006|FG001|NOT COMPLETED|6 Month Follow-up Survey||68
2918913|NCT00529399|3629268|FG002|COMPLETED|Overall Study||46
3169709|NCT01927367|3897259|FG000|STARTED|Overall Study||597
2873970|NCT00235573|3578012|FG000|STARTED|Overall Study|35 subjects screened; 14 not eligible; 21 started and completed study|21
2873971|NCT00235573|3578012|FG000|COMPLETED|Overall Study||21
2873972|NCT00235573|3578012|FG000|NOT COMPLETED|Overall Study||0
2873973|NCT00235716|3578020|FG000|STARTED|Overall Study||152
2873974|NCT00235716|3578021|FG001|STARTED|Overall Study||155
2873975|NCT00235716|3578022|FG002|STARTED|Overall Study||154
2873976|NCT00235716|3578023|FG003|STARTED|Overall Study||152
2873977|NCT00235716|3578020|FG000|COMPLETED|Overall Study||90
2873978|NCT00235716|3578021|FG001|COMPLETED|Overall Study||88
2873979|NCT00235716|3578022|FG002|COMPLETED|Overall Study||89
2873980|NCT00235716|3578023|FG003|COMPLETED|Overall Study||90
2873981|NCT00235716|3578020|FG000|NOT COMPLETED|Overall Study||62
2873982|NCT00235716|3578021|FG001|NOT COMPLETED|Overall Study||67
2873983|NCT00235716|3578022|FG002|NOT COMPLETED|Overall Study||65
2873984|NCT00235716|3578023|FG003|NOT COMPLETED|Overall Study||62
2873985|NCT00235755|3578036|FG000|STARTED|4-Week Titration Phase||179
2873986|NCT00235755|3578037|FG001|STARTED|4-Week Titration Phase||181
2873987|NCT00235755|3578038|FG002|STARTED|4-Week Titration Phase||179
2873988|NCT00235755|3578036|FG000|COMPLETED|4-Week Titration Phase||168
2873989|NCT00235755|3578037|FG001|COMPLETED|4-Week Titration Phase||162
2873990|NCT00235755|3578038|FG002|COMPLETED|4-Week Titration Phase||153
2873991|NCT00235755|3578036|FG000|NOT COMPLETED|4-Week Titration Phase||11
2873992|NCT00235755|3578037|FG001|NOT COMPLETED|4-Week Titration Phase||19
2873993|NCT00235755|3578038|FG002|NOT COMPLETED|4-Week Titration Phase||26
2873994|NCT00235755|3578036|FG000|STARTED|12-Week Maintenance Phase||168
2873995|NCT00235755|3578037|FG001|STARTED|12-Week Maintenance Phase||162
2873996|NCT00235755|3578038|FG002|STARTED|12-Week Maintenance Phase||153
2873997|NCT00235755|3578036|FG000|COMPLETED|12-Week Maintenance Phase||152
2873998|NCT00235755|3578037|FG001|COMPLETED|12-Week Maintenance Phase||135
2873999|NCT00235755|3578038|FG002|COMPLETED|12-Week Maintenance Phase||122
2874000|NCT00235755|3578036|FG000|NOT COMPLETED|12-Week Maintenance Phase||16
2874001|NCT00235755|3578037|FG001|NOT COMPLETED|12-Week Maintenance Phase||27
2874002|NCT00235755|3578038|FG002|NOT COMPLETED|12-Week Maintenance Phase||31
2874003|NCT00235833|3578061|FG000|STARTED|Overall Study||25
2874004|NCT00235833|3578061|FG000|COMPLETED|Overall Study||9
3169710|NCT01927367|3897260|FG001|STARTED|Overall Study||548
3169711|NCT01927367|3897259|FG000|COMPLETED|Overall Study||590
2874005|NCT00235833|3578061|FG000|NOT COMPLETED|Overall Study||16
2874006|NCT00235872|3578065|FG000|STARTED|Overall Study||309
2874007|NCT00235872|3578065|FG000|COMPLETED|Overall Study||162
2874008|NCT00235872|3578065|FG000|NOT COMPLETED|Overall Study||147
2874009|NCT00235989|3578073|FG000|STARTED|Core Treatment Period (CT)||0
2874010|NCT00235989|3578074|FG001|STARTED|Core Treatment Period (CT)||0
2874011|NCT00235989|3578075|FG002|STARTED|Core Treatment Period (CT)||0
2874012|NCT00235989|3578076|FG003|STARTED|Core Treatment Period (CT)||0
2874013|NCT00235989|3578077|FG004|STARTED|Core Treatment Period (CT)||36
2874014|NCT00235989|3578078|FG005|STARTED|Core Treatment Period (CT)||27
2874015|NCT00235989|3578073|FG000|COMPLETED|Core Treatment Period (CT)||0
2874016|NCT00235989|3578074|FG001|COMPLETED|Core Treatment Period (CT)||0
2874017|NCT00235989|3578075|FG002|COMPLETED|Core Treatment Period (CT)||0
2874018|NCT00235989|3578076|FG003|COMPLETED|Core Treatment Period (CT)||0
2874019|NCT00235989|3578077|FG004|COMPLETED|Core Treatment Period (CT)||36
2874020|NCT00235989|3578078|FG005|COMPLETED|Core Treatment Period (CT)||25
2874021|NCT00235989|3578073|FG000|NOT COMPLETED|Core Treatment Period (CT)||0
2874022|NCT00235989|3578074|FG001|NOT COMPLETED|Core Treatment Period (CT)||0
2874023|NCT00235989|3578075|FG002|NOT COMPLETED|Core Treatment Period (CT)||0
2874024|NCT00235989|3578076|FG003|NOT COMPLETED|Core Treatment Period (CT)||0
2874025|NCT00235989|3578077|FG004|NOT COMPLETED|Core Treatment Period (CT)||0
2874026|NCT00235989|3578078|FG005|NOT COMPLETED|Core Treatment Period (CT)||2
2874027|NCT00235989|3578073|FG000|STARTED|Extension Treatment Period (ET)||16
2874028|NCT00235989|3578074|FG001|STARTED|Extension Treatment Period (ET)||6
2874029|NCT00235989|3578075|FG002|STARTED|Extension Treatment Period (ET)||19
2874030|NCT00235989|3578076|FG003|STARTED|Extension Treatment Period (ET)||20
2874031|NCT00235989|3578077|FG004|STARTED|Extension Treatment Period (ET)||0
2874032|NCT00235989|3578078|FG005|STARTED|Extension Treatment Period (ET)||0
2874033|NCT00235989|3578073|FG000|COMPLETED|Extension Treatment Period (ET)||8
2874034|NCT00235989|3578074|FG001|COMPLETED|Extension Treatment Period (ET)||2
2874035|NCT00235989|3578075|FG002|COMPLETED|Extension Treatment Period (ET)||14
2874036|NCT00235989|3578076|FG003|COMPLETED|Extension Treatment Period (ET)||14
2874037|NCT00235989|3578077|FG004|COMPLETED|Extension Treatment Period (ET)||0
2874038|NCT00235989|3578078|FG005|COMPLETED|Extension Treatment Period (ET)||0
2874039|NCT00235989|3578073|FG000|NOT COMPLETED|Extension Treatment Period (ET)||8
2874040|NCT00235989|3578074|FG001|NOT COMPLETED|Extension Treatment Period (ET)||4
2874041|NCT00235989|3578075|FG002|NOT COMPLETED|Extension Treatment Period (ET)||5
2874042|NCT00235989|3578076|FG003|NOT COMPLETED|Extension Treatment Period (ET)||6
2874043|NCT00235989|3578077|FG004|NOT COMPLETED|Extension Treatment Period (ET)||0
2874044|NCT00235989|3578078|FG005|NOT COMPLETED|Extension Treatment Period (ET)||0
2874045|NCT00236080|3578093|FG000|STARTED|Overall Study||29
2874046|NCT00236080|3578094|FG001|STARTED|Overall Study||28
2874047|NCT00236080|3578095|FG002|STARTED|Overall Study||27
2874048|NCT00236080|3578096|FG003|STARTED|Overall Study||25
2874049|NCT00236080|3578097|FG004|STARTED|Overall Study||27
2874050|NCT00236080|3578093|FG000|COMPLETED|Overall Study||27
2874051|NCT00236080|3578094|FG001|COMPLETED|Overall Study||27
3169712|NCT01927367|3897260|FG001|COMPLETED|Overall Study||543
2874052|NCT00236080|3578095|FG002|COMPLETED|Overall Study||22
2874053|NCT00236080|3578096|FG003|COMPLETED|Overall Study||23
2874054|NCT00236080|3578097|FG004|COMPLETED|Overall Study||26
2874055|NCT00236080|3578093|FG000|NOT COMPLETED|Overall Study||2
2874056|NCT00236080|3578094|FG001|NOT COMPLETED|Overall Study||1
3169713|NCT01927367|3897259|FG000|NOT COMPLETED|Overall Study||7
3169714|NCT01927367|3897260|FG001|NOT COMPLETED|Overall Study||5
3169715|NCT01927497|3897268|FG000|STARTED|Overall Study||50
3169716|NCT01927497|3897269|FG001|STARTED|Overall Study||54
3169717|NCT01927497|3897268|FG000|COMPLETED|Overall Study||48
3169718|NCT01927497|3897269|FG001|COMPLETED|Overall Study||53
2874057|NCT00236080|3578095|FG002|NOT COMPLETED|Overall Study||5
3169719|NCT01927497|3897268|FG000|NOT COMPLETED|Overall Study||2
3169720|NCT01927497|3897269|FG001|NOT COMPLETED|Overall Study||1
3169721|NCT01927562|3897275|FG000|STARTED|Overall Study||57
2874058|NCT00236080|3578096|FG003|NOT COMPLETED|Overall Study||2
2874059|NCT00236080|3578097|FG004|NOT COMPLETED|Overall Study||1
2874060|NCT00236184|3578111|FG000|STARTED|Overall Study||310
2874061|NCT00236184|3578112|FG001|STARTED|Overall Study||319
2874062|NCT00236184|3578111|FG000|COMPLETED|Overall Study||292
2874063|NCT00236184|3578112|FG001|COMPLETED|Overall Study||308
2874064|NCT00236184|3578111|FG000|NOT COMPLETED|Overall Study||18
2874065|NCT00236184|3578112|FG001|NOT COMPLETED|Overall Study||11
2874066|NCT00236197|3578120|FG000|STARTED|Overall Study||312
2874067|NCT00236197|3578121|FG001|STARTED|Overall Study||307
2874068|NCT00236197|3578120|FG000|COMPLETED|Overall Study||307
2874069|NCT00236197|3578121|FG001|COMPLETED|Overall Study||293
2874070|NCT00236197|3578120|FG000|NOT COMPLETED|Overall Study||5
2874071|NCT00236197|3578121|FG001|NOT COMPLETED|Overall Study||14
2874072|NCT00236899|3578131|FG000|STARTED|Overall Study||60
2874073|NCT00236899|3578132|FG001|STARTED|Overall Study||64
2874074|NCT00236899|3578133|FG002|STARTED|Overall Study||58
2874075|NCT00236899|3578134|FG003|STARTED|Overall Study||59
2874076|NCT00236899|3578131|FG000|COMPLETED|Overall Study||18
2874077|NCT00236899|3578132|FG001|COMPLETED|Overall Study||24
2874078|NCT00236899|3578133|FG002|COMPLETED|Overall Study||14
2874079|NCT00236899|3578134|FG003|COMPLETED|Overall Study||19
2874080|NCT00236899|3578131|FG000|NOT COMPLETED|Overall Study||42
2874081|NCT00236899|3578132|FG001|NOT COMPLETED|Overall Study||40
2874082|NCT00236899|3578133|FG002|NOT COMPLETED|Overall Study||44
2874083|NCT00236899|3578134|FG003|NOT COMPLETED|Overall Study||40
2874084|NCT00236938|3578153|FG000|STARTED|Overall Study||75
2874085|NCT00236938|3578154|FG001|STARTED|Overall Study||46
2874086|NCT00236938|3578153|FG000|COMPLETED|Overall Study||62
2874087|NCT00236938|3578154|FG001|COMPLETED|Overall Study||26
2874088|NCT00236938|3578153|FG000|NOT COMPLETED|Overall Study||13
2874089|NCT00236938|3578154|FG001|NOT COMPLETED|Overall Study||20
2874090|NCT00236951|3578164|FG000|STARTED|Overall Study||59
2874091|NCT00236951|3578165|FG001|STARTED|Overall Study||77
2874092|NCT00236951|3578166|FG002|STARTED|Overall Study||40
2874093|NCT00236951|3578167|FG003|STARTED|Overall Study||48
2874094|NCT00236951|3578164|FG000|COMPLETED|Overall Study||33
2874095|NCT00236951|3578165|FG001|COMPLETED|Overall Study||46
2874096|NCT00236951|3578166|FG002|COMPLETED|Overall Study||21
2874097|NCT00236951|3578167|FG003|COMPLETED|Overall Study||17
2874098|NCT00236951|3578164|FG000|NOT COMPLETED|Overall Study||26
3169722|NCT01927562|3897275|FG000|COMPLETED|Overall Study|5 at M24, 2 at M30,12 at M36 due to two protocol changes moving followups from M24 to M30 to M36|19
3169723|NCT01927562|3897275|FG000|NOT COMPLETED|Overall Study||38
3169724|NCT01927575|3897279|FG000|STARTED|Overall Study||1
3169725|NCT01927575|3897279|FG000|COMPLETED|Overall Study||1
3169726|NCT01927575|3897279|FG000|NOT COMPLETED|Overall Study||0
3169727|NCT01927627|3897287|FG000|STARTED|Overall Study||42
3169728|NCT01927627|3897287|FG000|COMPLETED|Overall Study||37
3169729|NCT01927627|3897287|FG000|NOT COMPLETED|Overall Study||5
3169730|NCT01927718|3897291|FG000|STARTED|Overall Study||10
2874099|NCT00236951|3578165|FG001|NOT COMPLETED|Overall Study||31
2874100|NCT00236951|3578166|FG002|NOT COMPLETED|Overall Study||19
2874101|NCT00236951|3578167|FG003|NOT COMPLETED|Overall Study||31
2874102|NCT00236977|3578179|FG000|STARTED|Overall Study||91
2874103|NCT00236977|3578180|FG001|STARTED|Overall Study||91
2874104|NCT00236977|3578179|FG000|COMPLETED|Overall Study||70
3169731|NCT01927718|3897291|FG000|COMPLETED|Overall Study||10
3169732|NCT01927718|3897291|FG000|NOT COMPLETED|Overall Study||0
3169733|NCT01927757|3897295|FG000|STARTED|Overall Study||90
2874105|NCT00236977|3578180|FG001|COMPLETED|Overall Study||72
2874106|NCT00236977|3578179|FG000|NOT COMPLETED|Overall Study||21
2874107|NCT00236977|3578180|FG001|NOT COMPLETED|Overall Study||19
2874108|NCT00237042|3578189|FG000|STARTED|Treatment||60
2874109|NCT00237042|3578190|FG001|STARTED|Treatment||57
2874110|NCT00237042|3578191|FG002|STARTED|Treatment||74
2874111|NCT00237042|3578189|FG000|COMPLETED|Treatment||54
2874112|NCT00237042|3578190|FG001|COMPLETED|Treatment||50
2874113|NCT00237042|3578191|FG002|COMPLETED|Treatment||36
2874114|NCT00237042|3578189|FG000|NOT COMPLETED|Treatment||6
2874115|NCT00237042|3578190|FG001|NOT COMPLETED|Treatment||7
2874116|NCT00237042|3578191|FG002|NOT COMPLETED|Treatment||38
2874117|NCT00237042|3578189|FG000|STARTED|Short Term (6 Month) Follow up|Greater than number completing treatment: intent to treat analysis|59
2874118|NCT00237042|3578190|FG001|STARTED|Short Term (6 Month) Follow up|Greater than number completing treatment: intent to treat analysis|55
2874119|NCT00237042|3578191|FG002|STARTED|Short Term (6 Month) Follow up|Greater than number completing treatment: intent to treat analysis|57
2874120|NCT00237042|3578189|FG000|COMPLETED|Short Term (6 Month) Follow up||50
2874121|NCT00237042|3578190|FG001|COMPLETED|Short Term (6 Month) Follow up||47
2874122|NCT00237042|3578191|FG002|COMPLETED|Short Term (6 Month) Follow up||46
2874123|NCT00237042|3578189|FG000|NOT COMPLETED|Short Term (6 Month) Follow up||9
2874124|NCT00237042|3578190|FG001|NOT COMPLETED|Short Term (6 Month) Follow up||8
2874125|NCT00237042|3578191|FG002|NOT COMPLETED|Short Term (6 Month) Follow up||11
2874126|NCT00237042|3578189|FG000|STARTED|Long Term (12 Month) Follow up|Greater than number completing treatment: intent to treat analysis|59
2874127|NCT00237042|3578190|FG001|STARTED|Long Term (12 Month) Follow up|Greater than number completing treatment: intent to treat analysis|55
2874128|NCT00237042|3578191|FG002|STARTED|Long Term (12 Month) Follow up|Greater than number completing treatment: intent to treat analysis|57
2874129|NCT00237042|3578189|FG000|COMPLETED|Long Term (12 Month) Follow up||48
2874130|NCT00237042|3578190|FG001|COMPLETED|Long Term (12 Month) Follow up||46
2874131|NCT00237042|3578191|FG002|COMPLETED|Long Term (12 Month) Follow up||48
2874132|NCT00237042|3578189|FG000|NOT COMPLETED|Long Term (12 Month) Follow up||11
2874133|NCT00237042|3578190|FG001|NOT COMPLETED|Long Term (12 Month) Follow up||9
2874134|NCT00237042|3578191|FG002|NOT COMPLETED|Long Term (12 Month) Follow up||9
2874135|NCT00237185|3578201|FG000|STARTED|Core||74
2874136|NCT00237185|3578202|FG001|STARTED|Core||74
2874137|NCT00237185|3578201|FG000|Treated Participants|Core||73
2874138|NCT00237185|3578202|FG001|Treated Participants|Core||74
2874139|NCT00237185|3578201|FG000|COMPLETED|Core||30
2874140|NCT00237185|3578202|FG001|COMPLETED|Core||37
2874141|NCT00237185|3578201|FG000|NOT COMPLETED|Core||44
2874142|NCT00237185|3578202|FG001|NOT COMPLETED|Core||37
2874143|NCT00237185|3578201|FG000|STARTED|Extension|A portion of the participants, who completed the core, entered the extension.|24
2874144|NCT00237185|3578202|FG001|STARTED|Extension|A portion of the participants, who completed the core, entered the extension.|32
2874145|NCT00237185|3578201|FG000|COMPLETED|Extension||8
2874146|NCT00237185|3578202|FG001|COMPLETED|Extension||13
2874147|NCT00237185|3578201|FG000|NOT COMPLETED|Extension||16
2874148|NCT00237185|3578202|FG001|NOT COMPLETED|Extension||19
2874149|NCT00237458|3578208|FG000|STARTED|Overall Study||7
2874150|NCT00237458|3578208|FG000|COMPLETED|Overall Study||4
2874151|NCT00237458|3578208|FG000|NOT COMPLETED|Overall Study||3
2874152|NCT00237666|3578212|FG000|STARTED|Overall Study||30
2874153|NCT00237666|3578212|FG000|COMPLETED|Overall Study||24
2874154|NCT00237666|3578212|FG000|NOT COMPLETED|Overall Study||6
2874155|NCT00237692|3578220|FG000|STARTED|Overall Study||147
2874156|NCT00237692|3578221|FG001|STARTED|Overall Study||148
2874157|NCT00237692|3578222|FG002|STARTED|Overall Study||149
2874158|NCT00237692|3578223|FG003|STARTED|Overall Study||147
2874159|NCT00237692|3578220|FG000|6 Month f/u|Overall Study||132
2874160|NCT00237692|3578221|FG001|6 Month f/u|Overall Study||134
2874161|NCT00237692|3578222|FG002|6 Month f/u|Overall Study||135
2874162|NCT00237692|3578223|FG003|6 Month f/u|Overall Study||134
2874163|NCT00237692|3578220|FG000|12 Month f/u|Overall Study||137
2874164|NCT00237692|3578221|FG001|12 Month f/u|Overall Study||127
2874165|NCT00237692|3578222|FG002|12 Month f/u|Overall Study||132
2874166|NCT00237692|3578223|FG003|12 Month f/u|Overall Study||127
2874167|NCT00237692|3578220|FG000|18 Month f/u|Overall Study||124
2874168|NCT00237692|3578221|FG001|18 Month f/u|Overall Study||131
2874169|NCT00237692|3578222|FG002|18 Month f/u|Overall Study||126
2874170|NCT00237692|3578223|FG003|18 Month f/u|Overall Study||122
2874171|NCT00237692|3578220|FG000|COMPLETED|Overall Study||129
2874172|NCT00237692|3578221|FG001|COMPLETED|Overall Study||134
2874173|NCT00237692|3578222|FG002|COMPLETED|Overall Study||127
2874174|NCT00237692|3578223|FG003|COMPLETED|Overall Study||128
2874175|NCT00237692|3578220|FG000|NOT COMPLETED|Overall Study||18
2874176|NCT00237692|3578221|FG001|NOT COMPLETED|Overall Study||14
2874177|NCT00237692|3578222|FG002|NOT COMPLETED|Overall Study||22
2874178|NCT00237692|3578223|FG003|NOT COMPLETED|Overall Study||19
3169734|NCT01927757|3897295|FG000|Received Etanercept|Overall Study||88
3169735|NCT01927757|3897295|FG000|COMPLETED|Overall Study||67
3169736|NCT01927757|3897295|FG000|NOT COMPLETED|Overall Study||23
3169737|NCT01927861|3897305|FG000|STARTED|Pivotal Phase (104 Weeks)||25
2874179|NCT00237718|3578235|FG000|STARTED|Overall Study||160
2874180|NCT00237718|3578236|FG001|STARTED|Overall Study||165
2874181|NCT00237718|3578235|FG000|COMPLETED|Overall Study||114
2874182|NCT00237718|3578236|FG001|COMPLETED|Overall Study||124
2874183|NCT00237718|3578235|FG000|NOT COMPLETED|Overall Study||46
2874184|NCT00237718|3578236|FG001|NOT COMPLETED|Overall Study||41
2874185|NCT00237744|3578245|FG000|STARTED|Overall Study||11
2874186|NCT00237744|3578246|FG001|STARTED|Overall Study||11
2874187|NCT00237744|3578247|FG002|STARTED|Overall Study||18
2874188|NCT00237744|3578245|FG000|COMPLETED|Overall Study||8
2874189|NCT00237744|3578246|FG001|COMPLETED|Overall Study||10
2874190|NCT00237744|3578247|FG002|COMPLETED|Overall Study||18
2874191|NCT00237744|3578245|FG000|NOT COMPLETED|Overall Study||3
2874192|NCT00237744|3578246|FG001|NOT COMPLETED|Overall Study||1
2874193|NCT00237744|3578247|FG002|NOT COMPLETED|Overall Study||0
2874194|NCT00237770|3578260|FG000|STARTED|Overall Study||9
2874195|NCT00237770|3578261|FG001|STARTED|Overall Study||7
2874196|NCT00237770|3578260|FG000|COMPLETED|Overall Study||9
2874197|NCT00237770|3578261|FG001|COMPLETED|Overall Study||7
2874198|NCT00237770|3578260|FG000|NOT COMPLETED|Overall Study||0
2874199|NCT00237770|3578261|FG001|NOT COMPLETED|Overall Study||0
2874200|NCT00237796|3578273|FG000|STARTED|Overall Study||41
2874201|NCT00237796|3578274|FG001|STARTED|Overall Study||38
2874202|NCT00237796|3578273|FG000|COMPLETED|Overall Study||31
3169738|NCT01927861|3897306|FG001|STARTED|Pivotal Phase (104 Weeks)||26
2874203|NCT00237796|3578274|FG001|COMPLETED|Overall Study||33
2874204|NCT00237796|3578273|FG000|NOT COMPLETED|Overall Study||10
2874205|NCT00237796|3578274|FG001|NOT COMPLETED|Overall Study||5
2874206|NCT00237809|3578285|FG000|STARTED|Overall Study||27
2874207|NCT00237809|3578286|FG001|STARTED|Overall Study||27
2874208|NCT00237809|3578287|FG002|STARTED|Overall Study||24
2874209|NCT00237809|3578288|FG003|STARTED|Overall Study||26
2874210|NCT00237809|3578285|FG000|COMPLETED|Overall Study||16
2874211|NCT00237809|3578286|FG001|COMPLETED|Overall Study||17
2874212|NCT00237809|3578287|FG002|COMPLETED|Overall Study||15
2874213|NCT00237809|3578288|FG003|COMPLETED|Overall Study||17
2874214|NCT00237809|3578285|FG000|NOT COMPLETED|Overall Study||11
2874215|NCT00237809|3578286|FG001|NOT COMPLETED|Overall Study||10
2874216|NCT00237809|3578287|FG002|NOT COMPLETED|Overall Study||9
2874217|NCT00237809|3578288|FG003|NOT COMPLETED|Overall Study||9
2874218|NCT00238108|3578300|FG000|STARTED|Overall Study||8
2874219|NCT00238108|3578301|FG001|STARTED|Overall Study||8
2874220|NCT00238108|3578300|FG000|COMPLETED|Overall Study||8
2874221|NCT00238108|3578301|FG001|COMPLETED|Overall Study||8
2874222|NCT00238108|3578300|FG000|NOT COMPLETED|Overall Study||0
2874223|NCT00238108|3578301|FG001|NOT COMPLETED|Overall Study||0
2874224|NCT00238121|3578309|FG000|STARTED|Overall Study||40
2874225|NCT00238121|3578310|FG001|STARTED|Overall Study||16
2874226|NCT00238121|3578309|FG000|COMPLETED|Overall Study||37
2874227|NCT00238121|3578310|FG001|COMPLETED|Overall Study||14
2874228|NCT00238121|3578309|FG000|NOT COMPLETED|Overall Study||3
2874229|NCT00238121|3578310|FG001|NOT COMPLETED|Overall Study||2
2874230|NCT00238238|3578318|FG000|STARTED|Overall Study||3
2874231|NCT00238238|3578319|FG001|STARTED|Overall Study||48
2874232|NCT00238238|3578320|FG002|STARTED|Overall Study||46
2874233|NCT00238238|3578318|FG000|COMPLETED|Overall Study||3
2874234|NCT00238238|3578319|FG001|COMPLETED|Overall Study||45
2874235|NCT00238238|3578320|FG002|COMPLETED|Overall Study||46
2874236|NCT00238238|3578318|FG000|NOT COMPLETED|Overall Study||0
2874237|NCT00238238|3578319|FG001|NOT COMPLETED|Overall Study||3
2874238|NCT00238238|3578320|FG002|NOT COMPLETED|Overall Study||0
2874239|NCT00238264|3578328|FG000|STARTED|Overall Study||92
2874240|NCT00238264|3578328|FG000|COMPLETED|Overall Study||56
2874241|NCT00238264|3578328|FG000|NOT COMPLETED|Overall Study||36
2874242|NCT00238303|3578335|FG000|STARTED|Overall Study||68
2874243|NCT00238303|3578336|FG001|STARTED|Overall Study||15
2874244|NCT00238303|3578337|FG002|STARTED|Overall Study||20
2874245|NCT00238303|3578335|FG000|COMPLETED|Overall Study||53
2874246|NCT00238303|3578336|FG001|COMPLETED|Overall Study||13
2874247|NCT00238303|3578337|FG002|COMPLETED|Overall Study||11
2874248|NCT00238303|3578335|FG000|NOT COMPLETED|Overall Study||15
2874249|NCT00238303|3578336|FG001|NOT COMPLETED|Overall Study||2
2874250|NCT00238303|3578337|FG002|NOT COMPLETED|Overall Study||9
2874251|NCT00238355|3578346|FG000|STARTED|Overall Study||13
2874252|NCT00238355|3578346|FG000|COMPLETED|Overall Study||10
2874253|NCT00238355|3578346|FG000|NOT COMPLETED|Overall Study||3
2874254|NCT00238433|3578350|FG000|STARTED|Overall Study||37
2874255|NCT00238433|3578350|FG000|COMPLETED|Overall Study||34
2874256|NCT00238433|3578350|FG000|NOT COMPLETED|Overall Study||3
2874257|NCT00238615|3578355|FG000|STARTED|Overall Study||13
2874258|NCT00238615|3578355|FG000|COMPLETED|Overall Study||13
2874259|NCT00238615|3578355|FG000|NOT COMPLETED|Overall Study||0
2874260|NCT00239005|3578363|FG000|STARTED|Overall Study||69
2874261|NCT00239005|3578364|FG001|STARTED|Overall Study||65
2874262|NCT00239005|3578363|FG000|Intention-to-treat Population (ITT)|Overall Study||68
2874263|NCT00239005|3578364|FG001|Intention-to-treat Population (ITT)|Overall Study||61
2874264|NCT00239005|3578363|FG000|COMPLETED|Overall Study||57
2874265|NCT00239005|3578364|FG001|COMPLETED|Overall Study||53
2874266|NCT00239005|3578363|FG000|NOT COMPLETED|Overall Study||12
2874267|NCT00239005|3578364|FG001|NOT COMPLETED|Overall Study||12
2874268|NCT00239226|3578374|FG000|STARTED|Overall Study||30
2874269|NCT00239226|3578375|FG001|STARTED|Overall Study||18
2874270|NCT00239226|3578376|FG002|STARTED|Overall Study||37
2874271|NCT00239226|3578377|FG003|STARTED|Overall Study||17
2874272|NCT00239226|3578374|FG000|COMPLETED|Overall Study||29
2874273|NCT00239226|3578375|FG001|COMPLETED|Overall Study||18
2874274|NCT00239226|3578376|FG002|COMPLETED|Overall Study||36
2874275|NCT00239226|3578377|FG003|COMPLETED|Overall Study||14
2874276|NCT00239226|3578374|FG000|NOT COMPLETED|Overall Study||1
2874277|NCT00239226|3578375|FG001|NOT COMPLETED|Overall Study||0
2874278|NCT00239226|3578376|FG002|NOT COMPLETED|Overall Study||1
2874279|NCT00239226|3578377|FG003|NOT COMPLETED|Overall Study||3
2874280|NCT00239356|3578389|FG000|STARTED|Overall Study||97
2874281|NCT00239356|3578390|FG001|STARTED|Overall Study||20
2874282|NCT00239356|3578389|FG000|COMPLETED|Overall Study||58
2874283|NCT00239356|3578390|FG001|COMPLETED|Overall Study||11
2874284|NCT00239356|3578389|FG000|NOT COMPLETED|Overall Study||39
2874285|NCT00239356|3578390|FG001|NOT COMPLETED|Overall Study||9
2874286|NCT00239577|3578400|FG000|STARTED|Primary Phase||22
2874287|NCT00239577|3578401|FG001|STARTED|Primary Phase||22
2874288|NCT00239577|3578402|FG002|STARTED|Primary Phase||21
2874289|NCT00239577|3578403|FG003|STARTED|Primary Phase||21
2874290|NCT00239577|3578400|FG000|COMPLETED|Primary Phase||17
2874291|NCT00239577|3578401|FG001|COMPLETED|Primary Phase||19
2874292|NCT00239577|3578402|FG002|COMPLETED|Primary Phase||18
2874293|NCT00239577|3578403|FG003|COMPLETED|Primary Phase||21
2874294|NCT00239577|3578400|FG000|NOT COMPLETED|Primary Phase||5
2874295|NCT00239577|3578401|FG001|NOT COMPLETED|Primary Phase||3
2874296|NCT00239577|3578402|FG002|NOT COMPLETED|Primary Phase||3
2874297|NCT00239577|3578403|FG003|NOT COMPLETED|Primary Phase||0
2874298|NCT00239577|3578400|FG000|STARTED|Booster Phase|The subjects belonging to this group did not receive a booster dose of Dengue vaccine.|0
2874299|NCT00239577|3578401|FG001|STARTED|Booster Phase||9
2874300|NCT00239577|3578402|FG002|STARTED|Booster Phase||12
2874301|NCT00239577|3578403|FG003|STARTED|Booster Phase|The subjects belonging to this group did not receive an additional dose of Placebo.|0
2874302|NCT00239577|3578400|FG000|COMPLETED|Booster Phase|The subjects belonging to this group did not receive a booster dose of Dengue vaccine.|0
2874303|NCT00239577|3578401|FG001|COMPLETED|Booster Phase||9
2874304|NCT00239577|3578402|FG002|COMPLETED|Booster Phase||12
2874305|NCT00239577|3578403|FG003|COMPLETED|Booster Phase|The subjects belonging to this group did not receive an additional dose of Placebo.|0
2874306|NCT00239577|3578400|FG000|NOT COMPLETED|Booster Phase||0
2874307|NCT00239577|3578401|FG001|NOT COMPLETED|Booster Phase||0
2874308|NCT00239577|3578402|FG002|NOT COMPLETED|Booster Phase||0
2874309|NCT00239577|3578403|FG003|NOT COMPLETED|Booster Phase||0
2874310|NCT00239590|3578415|FG000|STARTED|Randomized||14
2874311|NCT00239590|3578416|FG001|STARTED|Randomized||14
2874312|NCT00239590|3578415|FG000|COMPLETED|Randomized||14
2874313|NCT00239590|3578416|FG001|COMPLETED|Randomized||12
2874314|NCT00239590|3578415|FG000|NOT COMPLETED|Randomized||0
2874315|NCT00239590|3578416|FG001|NOT COMPLETED|Randomized||2
2874316|NCT00239590|3578415|FG000|STARTED|Started Intervention After Randomization||14
2874317|NCT00239590|3578416|FG001|STARTED|Started Intervention After Randomization||12
2874318|NCT00239590|3578415|FG000|COMPLETED|Started Intervention After Randomization||14
2874319|NCT00239590|3578416|FG001|COMPLETED|Started Intervention After Randomization||12
2874320|NCT00239590|3578415|FG000|NOT COMPLETED|Started Intervention After Randomization||0
2874321|NCT00239590|3578416|FG001|NOT COMPLETED|Started Intervention After Randomization||0
2874322|NCT00239590|3578415|FG000|STARTED|Completed Study Protocol||14
2874323|NCT00239590|3578416|FG001|STARTED|Completed Study Protocol||12
2874324|NCT00239590|3578415|FG000|COMPLETED|Completed Study Protocol||13
2874325|NCT00239590|3578416|FG001|COMPLETED|Completed Study Protocol||10
2874326|NCT00239590|3578415|FG000|NOT COMPLETED|Completed Study Protocol||1
2874327|NCT00239590|3578416|FG001|NOT COMPLETED|Completed Study Protocol||2
2874328|NCT00239642|3578427|FG000|STARTED|Overall Study||49
2874329|NCT00239642|3578428|FG001|STARTED|Overall Study||47
2874330|NCT00239642|3578429|FG002|STARTED|Overall Study||49
2874331|NCT00239642|3578427|FG000|COMPLETED|Overall Study||47
2874332|NCT00239642|3578428|FG001|COMPLETED|Overall Study||47
2874333|NCT00239642|3578429|FG002|COMPLETED|Overall Study||47
2874334|NCT00239642|3578427|FG000|NOT COMPLETED|Overall Study||2
2874335|NCT00239642|3578428|FG001|NOT COMPLETED|Overall Study||0
2874336|NCT00239642|3578429|FG002|NOT COMPLETED|Overall Study||2
2874337|NCT00239681|3578439|FG000|STARTED|Overall Study||8901
2874338|NCT00239681|3578440|FG001|STARTED|Overall Study||8901
2874339|NCT00239681|3578439|FG000|Randomized and Treated (Safety Pop)|Overall Study||8869
2874340|NCT00239681|3578440|FG001|Randomized and Treated (Safety Pop)|Overall Study||8864
2874341|NCT00239681|3578439|FG000|COMPLETED|Overall Study||8208
2874342|NCT00239681|3578440|FG001|COMPLETED|Overall Study||8186
2874343|NCT00239681|3578439|FG000|NOT COMPLETED|Overall Study||693
2874344|NCT00239681|3578440|FG001|NOT COMPLETED|Overall Study||715
2874345|NCT00239733|3578446|FG000|STARTED|Overall Study||6
2874346|NCT00239733|3578446|FG000|COMPLETED|Overall Study||6
2874347|NCT00239733|3578446|FG000|NOT COMPLETED|Overall Study||0
2874348|NCT00239837|3578452|FG000|STARTED|Overall Study||48
2874349|NCT00239837|3578453|FG001|STARTED|Overall Study||52
2874350|NCT00239837|3578452|FG000|6 Months|Overall Study||48
2874351|NCT00239837|3578453|FG001|6 Months|Overall Study||50
2874352|NCT00239837|3578452|FG000|COMPLETED|Overall Study|3-year follow-up|45
2874353|NCT00239837|3578453|FG001|COMPLETED|Overall Study|3-year follow-up|45
2874354|NCT00239837|3578452|FG000|NOT COMPLETED|Overall Study||3
2874355|NCT00239837|3578453|FG001|NOT COMPLETED|Overall Study||7
2874356|NCT00239928|3578461|FG000|STARTED|Overall Study||61
2874357|NCT00239928|3578461|FG000|COMPLETED|Overall Study||51
2874358|NCT00239928|3578461|FG000|NOT COMPLETED|Overall Study||10
2874359|NCT00240071|3578465|FG000|STARTED|Overall Study||30
2874360|NCT00240071|3578465|FG000|COMPLETED|Overall Study|3 patients withdrew consent after 29, 5 and 3 1/2 months on study.|27
2874361|NCT00240071|3578465|FG000|NOT COMPLETED|Overall Study||3
2874362|NCT00240097|3578470|FG000|STARTED|Part I||30
2874363|NCT00240097|3578470|FG000|COMPLETED|Part I||26
2874364|NCT00240097|3578470|FG000|NOT COMPLETED|Part I||4
2874365|NCT00240097|3578470|FG000|STARTED|Part II||26
2874366|NCT00240097|3578470|FG000|COMPLETED|Part II||3
2874367|NCT00240097|3578470|FG000|NOT COMPLETED|Part II||23
2874368|NCT00240110|3578480|FG000|STARTED|Overall Study||13
2874369|NCT00240110|3578481|FG001|STARTED|Overall Study||13
2874370|NCT00240110|3578480|FG000|COMPLETED|Overall Study||7
2874371|NCT00240110|3578481|FG001|COMPLETED|Overall Study||6
2874372|NCT00240110|3578480|FG000|NOT COMPLETED|Overall Study||6
2874373|NCT00240110|3578481|FG001|NOT COMPLETED|Overall Study||7
2874374|NCT00240162|3578489|FG000|STARTED|Overall Study||21
2874375|NCT00240162|3578489|FG000|COMPLETED|Overall Study||21
2874376|NCT00240162|3578489|FG000|NOT COMPLETED|Overall Study||0
2874377|NCT00240331|3578495|FG000|STARTED|Overall Study|Two patients were incorrectly randomised and not included in the analyses.|1389
2874378|NCT00240331|3578496|FG001|STARTED|Overall Study|One patient was incorrectly randomised and not included in the analyses|1384
2918914|NCT00529399|3629266|FG000|NOT COMPLETED|Overall Study||2
2874379|NCT00240331|3578495|FG000|COMPLETED|Overall Study|Vital status was obtained for all randomised patients at the end of the study|1263
2874380|NCT00240331|3578496|FG001|COMPLETED|Overall Study|Vital status was obtained for all randomised patients at the end of the study|1250
2874381|NCT00240331|3578495|FG000|NOT COMPLETED|Overall Study||126
2874382|NCT00240331|3578496|FG001|NOT COMPLETED|Overall Study||134
2874383|NCT00240487|3578504|FG000|STARTED|Overall Study||24
2874384|NCT00240487|3578505|FG001|STARTED|Overall Study||28
2874385|NCT00240487|3578504|FG000|COMPLETED|Overall Study||24
2874386|NCT00240487|3578505|FG001|COMPLETED|Overall Study||28
2874387|NCT00240487|3578504|FG000|NOT COMPLETED|Overall Study||0
2874388|NCT00240487|3578505|FG001|NOT COMPLETED|Overall Study||0
2874389|NCT00240526|3578515|FG000|STARTED|Year 15|Number of subjects who come back at Year 15 (Month 180) time-point|19
2874390|NCT00240526|3578516|FG001|STARTED|Year 15|Number of subjects who come back at Year 15 (Month 180) time-point|19
2874391|NCT00240526|3578517|FG002|STARTED|Year 15|Number of subjects who come back at Year 15 (Month 180) time-point|14
2874392|NCT00240526|3578518|FG003|STARTED|Year 15|Number of subjects who come back at Year 15 (Month 180) time-point|21
2874393|NCT00240526|3578515|FG000|COMPLETED|Year 15||19
2874394|NCT00240526|3578516|FG001|COMPLETED|Year 15||19
2874395|NCT00240526|3578517|FG002|COMPLETED|Year 15||14
2874396|NCT00240526|3578518|FG003|COMPLETED|Year 15||21
2874397|NCT00240526|3578515|FG000|NOT COMPLETED|Year 15||0
2874398|NCT00240526|3578516|FG001|NOT COMPLETED|Year 15||0
2874399|NCT00240526|3578517|FG002|NOT COMPLETED|Year 15||0
2874400|NCT00240526|3578518|FG003|NOT COMPLETED|Year 15||0
2874401|NCT00240526|3578515|FG000|STARTED|Year 16|Number of subjects who come back at Year 16 (Month 192) time-point|17
2874402|NCT00240526|3578516|FG001|STARTED|Year 16|Number of subjects who come back at Year 16 (Month 192) time-point|19
2874403|NCT00240526|3578517|FG002|STARTED|Year 16|Number of subjects who come back at Year 16 (Month 192) time-point|16
2874404|NCT00240526|3578518|FG003|STARTED|Year 16|Number of subjects who come back at Year 16 (Month 192) time-point|22
2874405|NCT00240526|3578515|FG000|COMPLETED|Year 16||17
2874406|NCT00240526|3578516|FG001|COMPLETED|Year 16||19
2874407|NCT00240526|3578517|FG002|COMPLETED|Year 16||16
2874408|NCT00240526|3578518|FG003|COMPLETED|Year 16||22
2874409|NCT00240526|3578515|FG000|NOT COMPLETED|Year 16||0
2874410|NCT00240526|3578516|FG001|NOT COMPLETED|Year 16||0
2874411|NCT00240526|3578517|FG002|NOT COMPLETED|Year 16||0
2874412|NCT00240526|3578518|FG003|NOT COMPLETED|Year 16||0
2874413|NCT00240526|3578515|FG000|STARTED|Year 17|Number of subjects who come back at Year 17 (Month 204) time-point|19
2874414|NCT00240526|3578516|FG001|STARTED|Year 17|Number of subjects who come back at Year 17 (Month 204) time-point|17
2874415|NCT00240526|3578517|FG002|STARTED|Year 17|Number of subjects who come back at Year 17 (Month 204) time-point|13
2874416|NCT00240526|3578518|FG003|STARTED|Year 17|Number of subjects who come back at Year 17 (Month 204) time-point|20
2874417|NCT00240526|3578515|FG000|COMPLETED|Year 17||19
2874418|NCT00240526|3578516|FG001|COMPLETED|Year 17||17
2874419|NCT00240526|3578517|FG002|COMPLETED|Year 17||13
2874420|NCT00240526|3578518|FG003|COMPLETED|Year 17||20
2874421|NCT00240526|3578515|FG000|NOT COMPLETED|Year 17||0
2874422|NCT00240526|3578516|FG001|NOT COMPLETED|Year 17||0
2874423|NCT00240526|3578517|FG002|NOT COMPLETED|Year 17||0
2874424|NCT00240526|3578518|FG003|NOT COMPLETED|Year 17||0
2874425|NCT00240526|3578515|FG000|STARTED|Year 18|Number of subjects who come back at Year 18 (Month 216) time-point|16
2874426|NCT00240526|3578516|FG001|STARTED|Year 18|Number of subjects who come back at Year 18 (Month 216) time-point|17
2874427|NCT00240526|3578517|FG002|STARTED|Year 18|Number of subjects who come back at Year 18 (Month 216) time-point|14
2874428|NCT00240526|3578518|FG003|STARTED|Year 18|Number of subjects who come back at Year 18 (Month 216) time-point|20
2874429|NCT00240526|3578515|FG000|COMPLETED|Year 18||16
2874430|NCT00240526|3578516|FG001|COMPLETED|Year 18||17
2874431|NCT00240526|3578517|FG002|COMPLETED|Year 18||14
2874432|NCT00240526|3578518|FG003|COMPLETED|Year 18||20
2874433|NCT00240526|3578515|FG000|NOT COMPLETED|Year 18||0
2874434|NCT00240526|3578516|FG001|NOT COMPLETED|Year 18||0
2874435|NCT00240526|3578517|FG002|NOT COMPLETED|Year 18||0
2874436|NCT00240526|3578518|FG003|NOT COMPLETED|Year 18||0
2874437|NCT00240526|3578515|FG000|STARTED|Year 19|Number of subjects who come back at Year 19 (Month 228) time-point|17
2874438|NCT00240526|3578516|FG001|STARTED|Year 19|Number of subjects who come back at Year 19 (Month 228) time-point|16
2874439|NCT00240526|3578517|FG002|STARTED|Year 19|Number of subjects who come back at Year 19 (Month 228) time-point|12
2874440|NCT00240526|3578518|FG003|STARTED|Year 19|Number of subjects who come back at Year 19 (Month 228) time-point|18
2874441|NCT00240526|3578515|FG000|COMPLETED|Year 19||17
2874442|NCT00240526|3578516|FG001|COMPLETED|Year 19||16
2874443|NCT00240526|3578517|FG002|COMPLETED|Year 19||12
2874444|NCT00240526|3578518|FG003|COMPLETED|Year 19||18
2874445|NCT00240526|3578515|FG000|NOT COMPLETED|Year 19||0
2874446|NCT00240526|3578516|FG001|NOT COMPLETED|Year 19||0
2874447|NCT00240526|3578517|FG002|NOT COMPLETED|Year 19||0
2874448|NCT00240526|3578518|FG003|NOT COMPLETED|Year 19||0
2874449|NCT00240526|3578515|FG000|STARTED|Year 20|Number of subjects who come back at Year 20 (Month 240) time-point|19
2874450|NCT00240526|3578516|FG001|STARTED|Year 20|Number of subjects who come back at Year 20 (Month 240) time-point|17
2874451|NCT00240526|3578517|FG002|STARTED|Year 20|Number of subjects who come back at Year 20 (Month 240) time-point|13
2874452|NCT00240526|3578518|FG003|STARTED|Year 20|Number of subjects who come back at Year 20 (Month 240) time-point|20
2874453|NCT00240526|3578515|FG000|COMPLETED|Year 20||19
2874454|NCT00240526|3578516|FG001|COMPLETED|Year 20||17
2874455|NCT00240526|3578517|FG002|COMPLETED|Year 20||13
2874456|NCT00240526|3578518|FG003|COMPLETED|Year 20||20
2874457|NCT00240526|3578515|FG000|NOT COMPLETED|Year 20||0
2874458|NCT00240526|3578516|FG001|NOT COMPLETED|Year 20||0
2874459|NCT00240526|3578517|FG002|NOT COMPLETED|Year 20||0
2874460|NCT00240526|3578518|FG003|NOT COMPLETED|Year 20||0
2874461|NCT00240539|3578536|FG000|STARTED|Overall Study||2
2874462|NCT00240539|3578537|FG001|STARTED|Overall Study||2
2874463|NCT00240539|3578538|FG002|STARTED|Overall Study||31
2874464|NCT00240539|3578539|FG003|STARTED|Overall Study||1
2874465|NCT00240539|3578536|FG000|COMPLETED|Overall Study||2
2874466|NCT00240539|3578537|FG001|COMPLETED|Overall Study||2
2874467|NCT00240539|3578538|FG002|COMPLETED|Overall Study||31
2874468|NCT00240539|3578539|FG003|COMPLETED|Overall Study||1
2874469|NCT00240539|3578536|FG000|NOT COMPLETED|Overall Study||0
2874470|NCT00240539|3578537|FG001|NOT COMPLETED|Overall Study||0
2874471|NCT00240539|3578538|FG002|NOT COMPLETED|Overall Study||0
2874472|NCT00240539|3578539|FG003|NOT COMPLETED|Overall Study||0
2918915|NCT00529399|3629267|FG001|NOT COMPLETED|Overall Study||1
2918916|NCT00529399|3629268|FG002|NOT COMPLETED|Overall Study||2
2918917|NCT00529451|3629280|FG000|STARTED|Overall Study||331
2918918|NCT00529451|3629281|FG001|STARTED|Overall Study||323
2918919|NCT00529451|3629282|FG002|STARTED|Overall Study||332
2918920|NCT00529451|3629283|FG003|STARTED|Overall Study||330
2918921|NCT00529451|3629280|FG000|COMPLETED|Overall Study||294
2918922|NCT00529451|3629281|FG001|COMPLETED|Overall Study||275
2918923|NCT00529451|3629282|FG002|COMPLETED|Overall Study||292
2918924|NCT00529451|3629283|FG003|COMPLETED|Overall Study||299
2918925|NCT00529451|3629280|FG000|NOT COMPLETED|Overall Study||37
2918926|NCT00529451|3629281|FG001|NOT COMPLETED|Overall Study||48
2918927|NCT00529451|3629282|FG002|NOT COMPLETED|Overall Study||40
2918928|NCT00529451|3629283|FG003|NOT COMPLETED|Overall Study||31
2918929|NCT00529516|3629299|FG000|STARTED|Overall Study||475
2918930|NCT00529516|3629300|FG001|STARTED|Overall Study||488
2918931|NCT00529516|3629301|FG002|STARTED|Overall Study||289
2918932|NCT00529516|3629299|FG000|COMPLETED|Overall Study||472
2918933|NCT00529516|3629300|FG001|COMPLETED|Overall Study||486
2918934|NCT00529516|3629301|FG002|COMPLETED|Overall Study||288
2918935|NCT00529516|3629299|FG000|NOT COMPLETED|Overall Study||3
2918936|NCT00529516|3629300|FG001|NOT COMPLETED|Overall Study||2
2918937|NCT00529516|3629301|FG002|NOT COMPLETED|Overall Study||1
2918938|NCT00529529|3629312|FG000|STARTED|Overall Study||268
2918939|NCT00529529|3629313|FG001|STARTED|Overall Study||268
2918940|NCT00529529|3629314|FG002|STARTED|Overall Study||269
2918941|NCT00529529|3629312|FG000|COMPLETED|Overall Study||225
2918942|NCT00529529|3629313|FG001|COMPLETED|Overall Study||225
2918943|NCT00529529|3629314|FG002|COMPLETED|Overall Study||238
2918944|NCT00529529|3629312|FG000|NOT COMPLETED|Overall Study||43
2918945|NCT00529529|3629313|FG001|NOT COMPLETED|Overall Study||43
2918946|NCT00529529|3629314|FG002|NOT COMPLETED|Overall Study||31
2918947|NCT00529542|3629324|FG000|STARTED|Overall Study||9
2918948|NCT00529542|3629325|FG001|STARTED|Overall Study||11
2918949|NCT00529542|3629324|FG000|COMPLETED|Overall Study||8
2918950|NCT00529542|3629325|FG001|COMPLETED|Overall Study||10
2918951|NCT00529542|3629324|FG000|NOT COMPLETED|Overall Study||1
2918952|NCT00529542|3629325|FG001|NOT COMPLETED|Overall Study||1
2918953|NCT00529555|3629334|FG000|STARTED|Overall Study||200
2918954|NCT00529555|3629335|FG001|STARTED|Overall Study||202
2918955|NCT00529555|3629336|FG002|STARTED|Overall Study||200
2918956|NCT00529555|3629334|FG000|COMPLETED|Overall Study||171
2918957|NCT00529555|3629335|FG001|COMPLETED|Overall Study||172
2918958|NCT00529555|3629336|FG002|COMPLETED|Overall Study||174
2918959|NCT00529555|3629334|FG000|NOT COMPLETED|Overall Study||29
2918960|NCT00529555|3629335|FG001|NOT COMPLETED|Overall Study||30
2918961|NCT00529555|3629336|FG002|NOT COMPLETED|Overall Study||26
2918962|NCT00529568|3629346|FG000|STARTED|Open-label Pre-Antiviral Treatment Phase||805
2918963|NCT00529568|3629347|FG001|STARTED|Open-label Pre-Antiviral Treatment Phase||0
2918964|NCT00529568|3629348|FG002|STARTED|Open-label Pre-Antiviral Treatment Phase||0
2918965|NCT00529568|3629346|FG000|COMPLETED|Open-label Pre-Antiviral Treatment Phase||759
2918966|NCT00529568|3629347|FG001|COMPLETED|Open-label Pre-Antiviral Treatment Phase||0
2918967|NCT00529568|3629348|FG002|COMPLETED|Open-label Pre-Antiviral Treatment Phase||0
2918968|NCT00529568|3629346|FG000|NOT COMPLETED|Open-label Pre-Antiviral Treatment Phase||46
2918969|NCT00529568|3629347|FG001|NOT COMPLETED|Open-label Pre-Antiviral Treatment Phase||0
2918970|NCT00529568|3629348|FG002|NOT COMPLETED|Open-label Pre-Antiviral Treatment Phase||0
2918971|NCT00529568|3629346|FG000|STARTED|Double-bilnd Antiviral Treatment Phase||0
2918972|NCT00529568|3629347|FG001|STARTED|Double-bilnd Antiviral Treatment Phase||253
2918973|NCT00529568|3629348|FG002|STARTED|Double-bilnd Antiviral Treatment Phase||506
2918974|NCT00529568|3629346|FG000|COMPLETED|Double-bilnd Antiviral Treatment Phase||0
2918975|NCT00529568|3629347|FG001|COMPLETED|Double-bilnd Antiviral Treatment Phase||205
2918976|NCT00529568|3629348|FG002|COMPLETED|Double-bilnd Antiviral Treatment Phase||404
2918977|NCT00529568|3629346|FG000|NOT COMPLETED|Double-bilnd Antiviral Treatment Phase||0
2918978|NCT00529568|3629347|FG001|NOT COMPLETED|Double-bilnd Antiviral Treatment Phase||48
2918979|NCT00529568|3629348|FG002|NOT COMPLETED|Double-bilnd Antiviral Treatment Phase||102
2918980|NCT00529633|3629359|FG000|STARTED|Overall Study||2
2918981|NCT00529633|3629360|FG001|STARTED|Overall Study||2
2918982|NCT00529633|3629359|FG000|COMPLETED|Overall Study||1
2918983|NCT00529633|3629360|FG001|COMPLETED|Overall Study||1
2918984|NCT00529633|3629359|FG000|NOT COMPLETED|Overall Study||1
2918985|NCT00529633|3629360|FG001|NOT COMPLETED|Overall Study||1
2918986|NCT00529659|3629368|FG000|STARTED|Overall Study||81
2874473|NCT00240981|3578551|FG000|STARTED|Overall Study||106
2874474|NCT00240981|3578552|FG001|STARTED|Overall Study||103
2874475|NCT00240981|3578551|FG000|Intent to Treat Sample|Overall Study||82
2874476|NCT00240981|3578552|FG001|Intent to Treat Sample|Overall Study||83
2874477|NCT00240981|3578551|FG000|COMPLETED|Overall Study||68
2874478|NCT00240981|3578552|FG001|COMPLETED|Overall Study||70
2874479|NCT00240981|3578551|FG000|NOT COMPLETED|Overall Study||38
2874480|NCT00240981|3578552|FG001|NOT COMPLETED|Overall Study||33
2874481|NCT00240994|3578559|FG000|STARTED|Overall Study||35
2874482|NCT00240994|3578559|FG000|COMPLETED|Overall Study||32
2874483|NCT00240994|3578559|FG000|NOT COMPLETED|Overall Study||3
2874484|NCT00241176|3578563|FG000|STARTED|Overall Study||11
2874485|NCT00241176|3578563|FG000|COMPLETED|Overall Study||11
2874486|NCT00241176|3578563|FG000|NOT COMPLETED|Overall Study||0
2874487|NCT00241280|3578570|FG000|STARTED|Overall Study||247
2874488|NCT00241280|3578571|FG001|STARTED|Overall Study||254
2874489|NCT00241280|3578570|FG000|COMPLETED|Overall Study||199
2874490|NCT00241280|3578571|FG001|COMPLETED|Overall Study||186
2874491|NCT00241280|3578570|FG000|NOT COMPLETED|Overall Study||48
2874492|NCT00241280|3578571|FG001|NOT COMPLETED|Overall Study||68
2874493|NCT00241358|3578581|FG000|STARTED|Overall Study||25
2874494|NCT00241358|3578582|FG001|STARTED|Overall Study||46
2874495|NCT00241358|3578583|FG002|STARTED|Overall Study||21
2874496|NCT00241358|3578581|FG000|COMPLETED|Overall Study||25
2874497|NCT00241358|3578582|FG001|COMPLETED|Overall Study||45
2874498|NCT00241358|3578583|FG002|COMPLETED|Overall Study||20
2874499|NCT00241358|3578581|FG000|NOT COMPLETED|Overall Study||0
2874500|NCT00241358|3578582|FG001|NOT COMPLETED|Overall Study||1
2874501|NCT00241358|3578583|FG002|NOT COMPLETED|Overall Study||1
2874502|NCT00241631|3578592|FG000|STARTED|Run in (2 Weeks)||25
2874503|NCT00241631|3578593|FG001|STARTED|Run in (2 Weeks)||24
2874504|NCT00241631|3578592|FG000|COMPLETED|Run in (2 Weeks)||22
2874505|NCT00241631|3578593|FG001|COMPLETED|Run in (2 Weeks)||21
2874506|NCT00241631|3578592|FG000|NOT COMPLETED|Run in (2 Weeks)||3
2874507|NCT00241631|3578593|FG001|NOT COMPLETED|Run in (2 Weeks)||3
2874508|NCT00241631|3578592|FG000|STARTED|Phase 1 (4 Weeks)||22
2874509|NCT00241631|3578593|FG001|STARTED|Phase 1 (4 Weeks)||21
2874510|NCT00241631|3578592|FG000|COMPLETED|Phase 1 (4 Weeks)||14
2874511|NCT00241631|3578593|FG001|COMPLETED|Phase 1 (4 Weeks)||16
2874512|NCT00241631|3578592|FG000|NOT COMPLETED|Phase 1 (4 Weeks)||8
2874513|NCT00241631|3578593|FG001|NOT COMPLETED|Phase 1 (4 Weeks)||5
2874514|NCT00241631|3578592|FG000|STARTED|Wash Out (2 Weeks)||14
2874515|NCT00241631|3578593|FG001|STARTED|Wash Out (2 Weeks)||16
2874516|NCT00241631|3578592|FG000|COMPLETED|Wash Out (2 Weeks)||14
2874517|NCT00241631|3578593|FG001|COMPLETED|Wash Out (2 Weeks)||16
2874518|NCT00241631|3578592|FG000|NOT COMPLETED|Wash Out (2 Weeks)||0
2874519|NCT00241631|3578593|FG001|NOT COMPLETED|Wash Out (2 Weeks)||0
3169739|NCT01927861|3897305|FG000|COMPLETED|Pivotal Phase (104 Weeks)||25
3169740|NCT01927861|3897306|FG001|COMPLETED|Pivotal Phase (104 Weeks)||26
3169741|NCT01927861|3897305|FG000|NOT COMPLETED|Pivotal Phase (104 Weeks)||0
3169742|NCT01927861|3897306|FG001|NOT COMPLETED|Pivotal Phase (104 Weeks)||0
3169743|NCT01927861|3897305|FG000|STARTED|Extension Phase (104 Weeks)||25
3169744|NCT01927861|3897306|FG001|STARTED|Extension Phase (104 Weeks)||26
3169745|NCT01927861|3897305|FG000|COMPLETED|Extension Phase (104 Weeks)||25
3169746|NCT01927861|3897306|FG001|COMPLETED|Extension Phase (104 Weeks)||23
3169747|NCT01927861|3897305|FG000|NOT COMPLETED|Extension Phase (104 Weeks)||0
3169748|NCT01927861|3897306|FG001|NOT COMPLETED|Extension Phase (104 Weeks)||3
3171793|NCT01937195|3898992|FG000|COMPLETED|Overall Study||95
2874520|NCT00241631|3578592|FG000|STARTED|Phase 2 (4 Weeks)||14
2874521|NCT00241631|3578593|FG001|STARTED|Phase 2 (4 Weeks)||16
2874522|NCT00241631|3578592|FG000|COMPLETED|Phase 2 (4 Weeks)||14
2874523|NCT00241631|3578593|FG001|COMPLETED|Phase 2 (4 Weeks)||16
2874524|NCT00241631|3578592|FG000|NOT COMPLETED|Phase 2 (4 Weeks)||0
2874525|NCT00241631|3578593|FG001|NOT COMPLETED|Phase 2 (4 Weeks)||0
2874526|NCT00241644|3578603|FG000|STARTED|First Efficacy Period (Year 1)||1647
2874527|NCT00241644|3578604|FG001|STARTED|First Efficacy Period (Year 1)||1651
2874528|NCT00241644|3578605|FG002|STARTED|First Efficacy Period (Year 1)||1641
2874529|NCT00241644|3578606|FG003|STARTED|First Efficacy Period (Year 1)||3298
2874530|NCT00241644|3578603|FG000|COMPLETED|First Efficacy Period (Year 1)||1420
2874531|NCT00241644|3578604|FG001|COMPLETED|First Efficacy Period (Year 1)||1383
2874532|NCT00241644|3578605|FG002|COMPLETED|First Efficacy Period (Year 1)||1392
2874533|NCT00241644|3578606|FG003|COMPLETED|First Efficacy Period (Year 1)||2803
2874534|NCT00241644|3578603|FG000|NOT COMPLETED|First Efficacy Period (Year 1)||227
2874535|NCT00241644|3578604|FG001|NOT COMPLETED|First Efficacy Period (Year 1)||268
2874536|NCT00241644|3578605|FG002|NOT COMPLETED|First Efficacy Period (Year 1)||249
2874537|NCT00241644|3578606|FG003|NOT COMPLETED|First Efficacy Period (Year 1)||495
2874538|NCT00241644|3578603|FG000|STARTED|Second Efficacy Period (Year 2)||771
2874539|NCT00241644|3578604|FG001|STARTED|Second Efficacy Period (Year 2)||754
2874540|NCT00241644|3578605|FG002|STARTED|Second Efficacy Period (Year 2)||746
2874541|NCT00241644|3578606|FG003|STARTED|Second Efficacy Period (Year 2)||1525
2874542|NCT00241644|3578603|FG000|COMPLETED|Second Efficacy Period (Year 2)||710
2874543|NCT00241644|3578604|FG001|COMPLETED|Second Efficacy Period (Year 2)||697
2874544|NCT00241644|3578605|FG002|COMPLETED|Second Efficacy Period (Year 2)||682
2874545|NCT00241644|3578606|FG003|COMPLETED|Second Efficacy Period (Year 2)||1407
2874546|NCT00241644|3578603|FG000|NOT COMPLETED|Second Efficacy Period (Year 2)||61
2874547|NCT00241644|3578604|FG001|NOT COMPLETED|Second Efficacy Period (Year 2)||57
2874548|NCT00241644|3578605|FG002|NOT COMPLETED|Second Efficacy Period (Year 2)||64
2874549|NCT00241644|3578606|FG003|NOT COMPLETED|Second Efficacy Period (Year 2)||118
2874550|NCT00241839|3578618|FG000|STARTED|Overall Study||71
2874551|NCT00241839|3578619|FG001|STARTED|Overall Study||71
2874552|NCT00241839|3578618|FG000|COMPLETED|Overall Study|N=52 represents number with both baseline and 8-10 week data. N<52 implies missing data.|52
2874553|NCT00241839|3578619|FG001|COMPLETED|Overall Study|N=53 represents number with both baseline and 8-10 week data. N<53 implies missing data.|53
2874554|NCT00241839|3578618|FG000|NOT COMPLETED|Overall Study||19
2874555|NCT00241839|3578619|FG001|NOT COMPLETED|Overall Study||18
2874556|NCT00241904|3578627|FG000|STARTED|Overall Study||261
2874557|NCT00241904|3578628|FG001|STARTED|Overall Study||264
2874558|NCT00241904|3578627|FG000|COMPLETED|Overall Study||227
2874559|NCT00241904|3578628|FG001|COMPLETED|Overall Study||240
2874560|NCT00241904|3578627|FG000|NOT COMPLETED|Overall Study||34
2874561|NCT00241904|3578628|FG001|NOT COMPLETED|Overall Study||24
2874562|NCT00241969|3578637|FG000|STARTED|Overall Study||36
2874563|NCT00241969|3578638|FG001|STARTED|Overall Study||42
2874564|NCT00241969|3578637|FG000|COMPLETED|Overall Study||36
2874565|NCT00241969|3578638|FG001|COMPLETED|Overall Study||42
2874566|NCT00241969|3578637|FG000|NOT COMPLETED|Overall Study||0
2874567|NCT00241969|3578638|FG001|NOT COMPLETED|Overall Study||0
2874568|NCT00242216|3578646|FG000|STARTED|Overall Study||39
2874569|NCT00242216|3578647|FG001|STARTED|Overall Study||37
2874570|NCT00242216|3578646|FG000|COMPLETED|Overall Study||21
2874571|NCT00242216|3578647|FG001|COMPLETED|Overall Study||15
2874572|NCT00242216|3578646|FG000|NOT COMPLETED|Overall Study||18
2874573|NCT00242216|3578647|FG001|NOT COMPLETED|Overall Study||22
2874574|NCT00242385|3578653|FG000|STARTED|Period 1||14
2874575|NCT00242385|3578654|FG001|STARTED|Period 1||11
2874576|NCT00242385|3578653|FG000|COMPLETED|Period 1||14
2874577|NCT00242385|3578654|FG001|COMPLETED|Period 1||11
2874578|NCT00242385|3578653|FG000|NOT COMPLETED|Period 1||0
2874579|NCT00242385|3578654|FG001|NOT COMPLETED|Period 1||0
2874580|NCT00242385|3578653|FG000|STARTED|Period 2||14
2874581|NCT00242385|3578654|FG001|STARTED|Period 2||11
2874582|NCT00242385|3578653|FG000|COMPLETED|Period 2||14
2874583|NCT00242385|3578654|FG001|COMPLETED|Period 2||11
2874584|NCT00242385|3578653|FG000|NOT COMPLETED|Period 2||0
2874585|NCT00242385|3578654|FG001|NOT COMPLETED|Period 2||0
2874586|NCT00242502|3578660|FG000|STARTED|Overall Study||59
2874587|NCT00242502|3578660|FG000|COMPLETED|Overall Study||59
2874588|NCT00242502|3578660|FG000|NOT COMPLETED|Overall Study||0
2874589|NCT00242567|3578666|FG000|STARTED|Overall Study||259
2874590|NCT00242567|3578667|FG001|STARTED|Overall Study||263
2874591|NCT00242567|3578666|FG000|Received at Least 1 Dose of Study Drug|Overall Study||259
2874592|NCT00242567|3578667|FG001|Received at Least 1 Dose of Study Drug|Overall Study||72
2874593|NCT00242567|3578666|FG000|Never Received Study Drug|Overall Study||0
2874594|NCT00242567|3578667|FG001|Never Received Study Drug|Overall Study||191
2874595|NCT00242567|3578666|FG000|COMPLETED|Overall Study||93
2874596|NCT00242567|3578667|FG001|COMPLETED|Overall Study||123
2874597|NCT00242567|3578666|FG000|NOT COMPLETED|Overall Study||166
2874598|NCT00242567|3578667|FG001|NOT COMPLETED|Overall Study||140
2874599|NCT00242580|3578678|FG000|STARTED|Overall Study||32
2874600|NCT00242580|3578679|FG001|STARTED|Overall Study||41
2874601|NCT00242580|3578680|FG002|STARTED|Overall Study||38
2874602|NCT00242580|3578678|FG000|COMPLETED|Overall Study|"Completed indicates 12 month data."|22
2874603|NCT00242580|3578679|FG001|COMPLETED|Overall Study||29
2874604|NCT00242580|3578680|FG002|COMPLETED|Overall Study||24
2874605|NCT00242580|3578678|FG000|NOT COMPLETED|Overall Study||10
2874606|NCT00242580|3578679|FG001|NOT COMPLETED|Overall Study||12
2874607|NCT00242580|3578680|FG002|NOT COMPLETED|Overall Study||14
2874608|NCT00242619|3578690|FG000|STARTED|Overall Study||8
2874609|NCT00242619|3578691|FG001|STARTED|Overall Study||4
2874610|NCT00242619|3578690|FG000|COMPLETED|Overall Study||8
2874611|NCT00242619|3578691|FG001|COMPLETED|Overall Study||4
2874612|NCT00242619|3578690|FG000|NOT COMPLETED|Overall Study||0
2874613|NCT00242619|3578691|FG001|NOT COMPLETED|Overall Study||0
2874614|NCT00242632|3578701|FG000|STARTED|Overall Study||11
2874615|NCT00242632|3578702|FG001|STARTED|Overall Study||11
2874616|NCT00242632|3578701|FG000|COMPLETED|Overall Study||11
2874617|NCT00242632|3578702|FG001|COMPLETED|Overall Study||11
2874618|NCT00242632|3578701|FG000|NOT COMPLETED|Overall Study||0
2874619|NCT00242632|3578702|FG001|NOT COMPLETED|Overall Study||0
2874620|NCT00242658|3578709|FG000|STARTED|Overall Study||187
3169749|NCT01927861|3897305|FG000|STARTED|Extended Treatment Phase (26 Weeks)|15 participants agreed to continue the treatment for 26 weeks in the extended treatment phase.|15
2874621|NCT00242658|3578710|FG001|STARTED|Overall Study||207
2874622|NCT00242658|3578709|FG000|COMPLETED|Overall Study||165
2874623|NCT00242658|3578710|FG001|COMPLETED|Overall Study||188
2874624|NCT00242658|3578709|FG000|NOT COMPLETED|Overall Study||22
2874625|NCT00242658|3578710|FG001|NOT COMPLETED|Overall Study||19
2874626|NCT00242684|3578716|FG000|STARTED|Overall Study||446
2874627|NCT00242684|3578716|FG000|COMPLETED|Overall Study||446
2874628|NCT00242684|3578716|FG000|NOT COMPLETED|Overall Study||0
2874629|NCT00242710|3578724|FG000|STARTED|Core Study (up to Year 1)||373
2874630|NCT00242710|3578725|FG001|STARTED|Core Study (up to Year 1)||353
2874631|NCT00242710|3578726|FG002|STARTED|Core Study (up to Year 1)||183
2874632|NCT00242710|3578727|FG003|STARTED|Core Study (up to Year 1)||174
2874633|NCT00242710|3578724|FG000|Treated|Core Study (up to Year 1)||361
2874634|NCT00242710|3578725|FG001|Treated|Core Study (up to Year 1)||349
2874635|NCT00242710|3578726|FG002|Treated|Core Study (up to Year 1)||179
2874636|NCT00242710|3578727|FG003|Treated|Core Study (up to Year 1)||172
2874637|NCT00242710|3578724|FG000|COMPLETED|Core Study (up to Year 1)||287
2874638|NCT00242710|3578725|FG001|COMPLETED|Core Study (up to Year 1)||289
2874639|NCT00242710|3578726|FG002|COMPLETED|Core Study (up to Year 1)||132
2874640|NCT00242710|3578727|FG003|COMPLETED|Core Study (up to Year 1)||143
2874641|NCT00242710|3578724|FG000|NOT COMPLETED|Core Study (up to Year 1)||86
2874642|NCT00242710|3578725|FG001|NOT COMPLETED|Core Study (up to Year 1)||64
2874643|NCT00242710|3578726|FG002|NOT COMPLETED|Core Study (up to Year 1)||51
2874644|NCT00242710|3578727|FG003|NOT COMPLETED|Core Study (up to Year 1)||31
2874645|NCT00242710|3578724|FG000|STARTED|Period Between Core Study and Extension||287
2874646|NCT00242710|3578725|FG001|STARTED|Period Between Core Study and Extension||289
2874647|NCT00242710|3578726|FG002|STARTED|Period Between Core Study and Extension||132
2874648|NCT00242710|3578727|FG003|STARTED|Period Between Core Study and Extension||143
2874649|NCT00242710|3578724|FG000|COMPLETED|Period Between Core Study and Extension||168
2874650|NCT00242710|3578725|FG001|COMPLETED|Period Between Core Study and Extension||177
2874651|NCT00242710|3578726|FG002|COMPLETED|Period Between Core Study and Extension||84
2874652|NCT00242710|3578727|FG003|COMPLETED|Period Between Core Study and Extension||94
2874653|NCT00242710|3578724|FG000|NOT COMPLETED|Period Between Core Study and Extension||119
2874654|NCT00242710|3578725|FG001|NOT COMPLETED|Period Between Core Study and Extension||112
2874655|NCT00242710|3578726|FG002|NOT COMPLETED|Period Between Core Study and Extension||48
2874656|NCT00242710|3578727|FG003|NOT COMPLETED|Period Between Core Study and Extension||49
2874657|NCT00242710|3578724|FG000|STARTED|Study Extension (up to Year 2)||168
2874658|NCT00242710|3578725|FG001|STARTED|Study Extension (up to Year 2)||177
2874659|NCT00242710|3578726|FG002|STARTED|Study Extension (up to Year 2)||84
2874660|NCT00242710|3578727|FG003|STARTED|Study Extension (up to Year 2)||94
2874661|NCT00242710|3578724|FG000|COMPLETED|Study Extension (up to Year 2)||141
2874662|NCT00242710|3578725|FG001|COMPLETED|Study Extension (up to Year 2)||148
2874663|NCT00242710|3578726|FG002|COMPLETED|Study Extension (up to Year 2)||69
2874664|NCT00242710|3578727|FG003|COMPLETED|Study Extension (up to Year 2)||84
2874665|NCT00242710|3578724|FG000|NOT COMPLETED|Study Extension (up to Year 2)||27
2874666|NCT00242710|3578725|FG001|NOT COMPLETED|Study Extension (up to Year 2)||29
2874667|NCT00242710|3578726|FG002|NOT COMPLETED|Study Extension (up to Year 2)||15
2874668|NCT00242710|3578727|FG003|NOT COMPLETED|Study Extension (up to Year 2)||10
2874669|NCT00243022|3578739|FG000|STARTED|Overall Study||7
2874670|NCT00243022|3578740|FG001|STARTED|Overall Study||5
2874671|NCT00243022|3578739|FG000|COMPLETED|Overall Study||5
2874672|NCT00243022|3578740|FG001|COMPLETED|Overall Study||4
2874673|NCT00243022|3578739|FG000|NOT COMPLETED|Overall Study||2
2874674|NCT00243022|3578740|FG001|NOT COMPLETED|Overall Study||1
2874675|NCT00243061|3578747|FG000|STARTED|Overall Study||24
3169750|NCT01927861|3897306|FG001|STARTED|Extended Treatment Phase (26 Weeks)|14 participants agreed to continue the treatment for 26 weeks in the extended treatment phase.|14
3169751|NCT01927861|3897305|FG000|COMPLETED|Extended Treatment Phase (26 Weeks)||15
3169752|NCT01927861|3897306|FG001|COMPLETED|Extended Treatment Phase (26 Weeks)||14
3169753|NCT01927861|3897305|FG000|NOT COMPLETED|Extended Treatment Phase (26 Weeks)||0
3169754|NCT01927861|3897306|FG001|NOT COMPLETED|Extended Treatment Phase (26 Weeks)||0
3169755|NCT01927887|3897312|FG000|STARTED|Overall Study||12
3169756|NCT01927887|3897312|FG000|COMPLETED|Overall Study||12
3169757|NCT01927887|3897312|FG000|NOT COMPLETED|Overall Study||0
3169758|NCT01928030|3897317|FG000|STARTED|Overall Study||3
3169759|NCT01928030|3897318|FG001|STARTED|Overall Study||0
3169760|NCT01928030|3897319|FG002|STARTED|Overall Study||0
3169761|NCT01928030|3897317|FG000|COMPLETED|Overall Study||3
3169762|NCT01928030|3897318|FG001|COMPLETED|Overall Study||0
3169763|NCT01928030|3897319|FG002|COMPLETED|Overall Study||0
3169764|NCT01928030|3897317|FG000|NOT COMPLETED|Overall Study||0
3169765|NCT01928030|3897318|FG001|NOT COMPLETED|Overall Study||0
3169766|NCT01928030|3897319|FG002|NOT COMPLETED|Overall Study||0
3169767|NCT01928186|3897326|FG000|STARTED|Overall Study||28
3169768|NCT01928186|3897326|FG000|COMPLETED|Overall Study||28
3169769|NCT01928186|3897326|FG000|NOT COMPLETED|Overall Study||0
3169770|NCT01928199|3897332|FG000|STARTED|Overall Study||32
3169771|NCT01928199|3897333|FG001|STARTED|Overall Study||29
3169772|NCT01928199|3897332|FG000|COMPLETED|Overall Study||32
3169773|NCT01928199|3897333|FG001|COMPLETED|Overall Study||29
3169774|NCT01928199|3897332|FG000|NOT COMPLETED|Overall Study||0
3169775|NCT01928199|3897333|FG001|NOT COMPLETED|Overall Study||0
3169776|NCT01928225|3897341|FG000|STARTED|Overall Study||90
3169777|NCT01928225|3897342|FG001|STARTED|Overall Study||90
3169778|NCT01928225|3897341|FG000|COMPLETED|Overall Study||87
3169779|NCT01928225|3897342|FG001|COMPLETED|Overall Study||87
3169780|NCT01928225|3897341|FG000|NOT COMPLETED|Overall Study||3
3169781|NCT01928225|3897342|FG001|NOT COMPLETED|Overall Study||3
3169782|NCT01928290|3897351|FG000|STARTED|Overall Study||41
3169783|NCT01928290|3897352|FG001|STARTED|Overall Study||26
3169784|NCT01928290|3897351|FG000|COMPLETED|Overall Study||41
3169785|NCT01928290|3897352|FG001|COMPLETED|Overall Study||26
3169786|NCT01928290|3897351|FG000|NOT COMPLETED|Overall Study||0
3169787|NCT01928290|3897352|FG001|NOT COMPLETED|Overall Study||0
3169788|NCT01928329|3897360|FG000|STARTED|Overall Study||40
3169789|NCT01928329|3897361|FG001|STARTED|Overall Study||39
3169790|NCT01928329|3897360|FG000|COMPLETED|Overall Study||28
3169791|NCT01928329|3897361|FG001|COMPLETED|Overall Study||25
3169792|NCT01928329|3897360|FG000|NOT COMPLETED|Overall Study||12
3169793|NCT01928329|3897361|FG001|NOT COMPLETED|Overall Study||14
2874676|NCT00243061|3578747|FG000|COMPLETED|Overall Study||24
2874677|NCT00243061|3578747|FG000|NOT COMPLETED|Overall Study||0
2874678|NCT00243074|3578752|FG000|STARTED|Overall Study||54
2874679|NCT00243074|3578752|FG000|COMPLETED|Overall Study||0
2874680|NCT00243074|3578752|FG000|NOT COMPLETED|Overall Study||54
2874681|NCT00243152|3578757|FG000|STARTED|Overall Study||3
2874682|NCT00243152|3578758|FG001|STARTED|Overall Study||3
2874683|NCT00243152|3578757|FG000|Scan 1: Drug or Placebo|Overall Study||3
2874684|NCT00243152|3578758|FG001|Scan 1: Drug or Placebo|Overall Study||3
2874685|NCT00243152|3578757|FG000|Scan 2: Placebo or Drug|Overall Study||3
2874686|NCT00243152|3578758|FG001|Scan 2: Placebo or Drug|Overall Study||3
2874687|NCT00243152|3578757|FG000|COMPLETED|Overall Study||3
2874688|NCT00243152|3578758|FG001|COMPLETED|Overall Study||3
2874689|NCT00243152|3578757|FG000|NOT COMPLETED|Overall Study||0
2874690|NCT00243152|3578758|FG001|NOT COMPLETED|Overall Study||0
2874691|NCT00243191|3578765|FG000|STARTED|Overall Study||18
2874692|NCT00243191|3578765|FG000|COMPLETED|Overall Study||18
2874693|NCT00243191|3578765|FG000|NOT COMPLETED|Overall Study||0
2874694|NCT00243230|3578772|FG000|STARTED|Double-Blind Period||39
2874695|NCT00243230|3578773|FG001|STARTED|Double-Blind Period||40
2874696|NCT00243230|3578774|FG002|STARTED|Double-Blind Period||37
2874697|NCT00243230|3578775|FG003|STARTED|Double-Blind Period||0
2874698|NCT00243230|3578772|FG000|Treated|Double-Blind Period||39
2874699|NCT00243230|3578773|FG001|Treated|Double-Blind Period||40
2874700|NCT00243230|3578774|FG002|Treated|Double-Blind Period||35
2874701|NCT00243230|3578775|FG003|Treated|Double-Blind Period||0
2874702|NCT00243230|3578772|FG000|COMPLETED|Double-Blind Period||33
2874703|NCT00243230|3578773|FG001|COMPLETED|Double-Blind Period||35
2874704|NCT00243230|3578774|FG002|COMPLETED|Double-Blind Period||18
2874705|NCT00243230|3578775|FG003|COMPLETED|Double-Blind Period||0
2874706|NCT00243230|3578772|FG000|NOT COMPLETED|Double-Blind Period||6
2874707|NCT00243230|3578773|FG001|NOT COMPLETED|Double-Blind Period||5
2874708|NCT00243230|3578774|FG002|NOT COMPLETED|Double-Blind Period||19
2874709|NCT00243230|3578775|FG003|NOT COMPLETED|Double-Blind Period||0
2874710|NCT00243230|3578772|FG000|STARTED|Open Label Period||0
2874711|NCT00243230|3578773|FG001|STARTED|Open Label Period||0
2874712|NCT00243230|3578774|FG002|STARTED|Open Label Period||0
2874713|NCT00243230|3578775|FG003|STARTED|Open Label Period||85
2874714|NCT00243230|3578772|FG000|COMPLETED|Open Label Period||0
2874715|NCT00243230|3578773|FG001|COMPLETED|Open Label Period||0
2874716|NCT00243230|3578774|FG002|COMPLETED|Open Label Period||0
2874717|NCT00243230|3578775|FG003|COMPLETED|Open Label Period||0
2874718|NCT00243230|3578772|FG000|NOT COMPLETED|Open Label Period||0
2874719|NCT00243230|3578773|FG001|NOT COMPLETED|Open Label Period||0
2874720|NCT00243230|3578774|FG002|NOT COMPLETED|Open Label Period||0
2874721|NCT00243230|3578775|FG003|NOT COMPLETED|Open Label Period||85
2874722|NCT00243243|3578787|FG000|STARTED|Overall Study||10
2874723|NCT00243243|3578788|FG001|STARTED|Overall Study||10
2874724|NCT00243243|3578787|FG000|COMPLETED|Overall Study||10
2874725|NCT00243243|3578788|FG001|COMPLETED|Overall Study||10
2874726|NCT00243243|3578787|FG000|NOT COMPLETED|Overall Study||0
2874727|NCT00243243|3578788|FG001|NOT COMPLETED|Overall Study||0
2874728|NCT00243269|3578798|FG000|STARTED|Overall Study||31
2874729|NCT00243269|3578799|FG001|STARTED|Overall Study||11
2874730|NCT00243269|3578800|FG002|STARTED|Overall Study||12
2874731|NCT00243269|3578801|FG003|STARTED|Overall Study||29
2874732|NCT00243269|3578798|FG000|COMPLETED|Overall Study||28
2874733|NCT00243269|3578799|FG001|COMPLETED|Overall Study||10
2874734|NCT00243269|3578800|FG002|COMPLETED|Overall Study||11
2874735|NCT00243269|3578801|FG003|COMPLETED|Overall Study||25
2874736|NCT00243269|3578798|FG000|NOT COMPLETED|Overall Study||3
2874737|NCT00243269|3578799|FG001|NOT COMPLETED|Overall Study||1
2874738|NCT00243269|3578800|FG002|NOT COMPLETED|Overall Study||1
2874739|NCT00243269|3578801|FG003|NOT COMPLETED|Overall Study||4
2874740|NCT00243347|3578811|FG000|STARTED|Overall Study|Treated|19
2874741|NCT00243347|3578811|FG000|COMPLETED|Overall Study|Completed study|0
2874742|NCT00243347|3578811|FG000|NOT COMPLETED|Overall Study||19
2874743|NCT00243386|3578815|FG000|STARTED|On-Demand Regimen (Study Part 1)||73
2874744|NCT00243386|3578816|FG001|STARTED|On-Demand Regimen (Study Part 1)|Participants were randomized to PK-Driven or Standard Prophylaxis after Part 1 (On-Demand Regimen)|0
2874745|NCT00243386|3578817|FG002|STARTED|On-Demand Regimen (Study Part 1)|Participants were randomized to PK-Driven or Standard Prophylaxis after Part 1 (On-Demand Regimen)|0
2874746|NCT00243386|3578815|FG000|COMPLETED|On-Demand Regimen (Study Part 1)||69
2874747|NCT00243386|3578816|FG001|COMPLETED|On-Demand Regimen (Study Part 1)||0
2874748|NCT00243386|3578817|FG002|COMPLETED|On-Demand Regimen (Study Part 1)||0
2874749|NCT00243386|3578815|FG000|NOT COMPLETED|On-Demand Regimen (Study Part 1)||4
2874750|NCT00243386|3578816|FG001|NOT COMPLETED|On-Demand Regimen (Study Part 1)||0
2874751|NCT00243386|3578817|FG002|NOT COMPLETED|On-Demand Regimen (Study Part 1)||0
2874752|NCT00243386|3578815|FG000|STARTED|End of Part 1, But Prior to Prophylaxis||69
2874753|NCT00243386|3578816|FG001|STARTED|End of Part 1, But Prior to Prophylaxis|Participants were randomized to PK-Driven or Standard Prophylaxis after Part 1 (On-Demand Regimen)|0
2874754|NCT00243386|3578817|FG002|STARTED|End of Part 1, But Prior to Prophylaxis|Participants were randomized to PK-Driven or Standard Prophylaxis after Part 1 (On-Demand Regimen)|0
3169794|NCT01928381|3897367|FG000|STARTED|Screening for Pain Training||143
3169795|NCT01928381|3897368|FG001|STARTED|Screening for Pain Training||0
3169796|NCT01928381|3897369|FG002|STARTED|Screening for Pain Training||0
3169797|NCT01928381|3897370|FG003|STARTED|Screening for Pain Training||0
2874755|NCT00243386|3578815|FG000|COMPLETED|End of Part 1, But Prior to Prophylaxis||66
2874756|NCT00243386|3578816|FG001|COMPLETED|End of Part 1, But Prior to Prophylaxis||0
2874757|NCT00243386|3578817|FG002|COMPLETED|End of Part 1, But Prior to Prophylaxis||0
2874758|NCT00243386|3578815|FG000|NOT COMPLETED|End of Part 1, But Prior to Prophylaxis||3
2874759|NCT00243386|3578816|FG001|NOT COMPLETED|End of Part 1, But Prior to Prophylaxis||0
2874760|NCT00243386|3578817|FG002|NOT COMPLETED|End of Part 1, But Prior to Prophylaxis||0
2874761|NCT00243386|3578815|FG000|STARTED|PK-Driven or Standard Prophylaxis|Participants were randomized to PK-Driven or Standard Prophylaxis after Part 1 (On-Demand Regimen)|0
2874762|NCT00243386|3578816|FG001|STARTED|PK-Driven or Standard Prophylaxis||34
2874763|NCT00243386|3578817|FG002|STARTED|PK-Driven or Standard Prophylaxis||32
2874764|NCT00243386|3578815|FG000|COMPLETED|PK-Driven or Standard Prophylaxis||0
2874765|NCT00243386|3578816|FG001|COMPLETED|PK-Driven or Standard Prophylaxis||31
2874766|NCT00243386|3578817|FG002|COMPLETED|PK-Driven or Standard Prophylaxis||32
2874767|NCT00243386|3578815|FG000|NOT COMPLETED|PK-Driven or Standard Prophylaxis||0
2874768|NCT00243386|3578816|FG001|NOT COMPLETED|PK-Driven or Standard Prophylaxis||3
2874769|NCT00243386|3578817|FG002|NOT COMPLETED|PK-Driven or Standard Prophylaxis||0
2874770|NCT00243412|3578855|FG000|STARTED|Overall Study|Intent to treat|21
2874771|NCT00243412|3578856|FG001|STARTED|Overall Study|Intent to treat|21
2874772|NCT00243412|3578855|FG000|Safety Evaluable|Overall Study||21
2874773|NCT00243412|3578856|FG001|Safety Evaluable|Overall Study||20
2874774|NCT00243412|3578855|FG000|COMPLETED|Overall Study|Completed Week 104|11
2874775|NCT00243412|3578856|FG001|COMPLETED|Overall Study|Completed Week 104|10
2874776|NCT00243412|3578855|FG000|NOT COMPLETED|Overall Study||10
2874777|NCT00243412|3578856|FG001|NOT COMPLETED|Overall Study||11
2874778|NCT00243503|3578862|FG000|STARTED|Overall Study|3 participants discontinued and only took Trastuzumab.|60
2874779|NCT00243503|3578862|FG000|COMPLETED|Overall Study||2
2874780|NCT00243503|3578862|FG000|NOT COMPLETED|Overall Study||58
2874781|NCT00243659|3578869|FG000|STARTED|Overall Study||22
2874782|NCT00243659|3578870|FG001|STARTED|Overall Study||8
2874783|NCT00243659|3578869|FG000|COMPLETED|Overall Study||20
2874784|NCT00243659|3578870|FG001|COMPLETED|Overall Study||5
2874785|NCT00243659|3578869|FG000|NOT COMPLETED|Overall Study||2
2874786|NCT00243659|3578870|FG001|NOT COMPLETED|Overall Study||3
2874787|NCT00243841|3578879|FG000|STARTED|Overall Study||3
2874788|NCT00243841|3578880|FG001|STARTED|Overall Study||6
2874789|NCT00243841|3578881|FG002|STARTED|Overall Study||5
2874790|NCT00243841|3578882|FG003|STARTED|Overall Study||3
2874791|NCT00243841|3578883|FG004|STARTED|Overall Study||39
2874792|NCT00243841|3578884|FG005|STARTED|Overall Study||21
2874793|NCT00243841|3578879|FG000|COMPLETED|Overall Study||3
2874794|NCT00243841|3578880|FG001|COMPLETED|Overall Study||6
2874795|NCT00243841|3578881|FG002|COMPLETED|Overall Study||4
2874796|NCT00243841|3578882|FG003|COMPLETED|Overall Study||3
3133721|NCT01697319|3858651|FG000|STARTED|Extension Phase||15
3133722|NCT01697319|3858651|FG000|COMPLETED|Extension Phase||0
3133723|NCT01697319|3858651|FG000|NOT COMPLETED|Extension Phase||15
3133724|NCT01697345|3858655|FG000|STARTED|Overall Study||13
3133725|NCT01697345|3858655|FG000|COMPLETED|Overall Study|One patient withdrew due to symptoms of recurrent Gardnerella vaginalis.|12
3133726|NCT01697345|3858655|FG000|NOT COMPLETED|Overall Study||1
3133727|NCT01697358|3858676|FG000|STARTED|Period I: Randomization to 6 Months||110
3133728|NCT01697358|3858677|FG001|STARTED|Period I: Randomization to 6 Months||108
3133729|NCT01697358|3858676|FG000|COMPLETED|Period I: Randomization to 6 Months||97
3133730|NCT01697358|3858677|FG001|COMPLETED|Period I: Randomization to 6 Months||107
3133731|NCT01697358|3858676|FG000|NOT COMPLETED|Period I: Randomization to 6 Months||13
3133732|NCT01697358|3858677|FG001|NOT COMPLETED|Period I: Randomization to 6 Months||1
3133733|NCT01697358|3858676|FG000|STARTED|Period II: 6-24M Long-term Follow-up||97
3133734|NCT01697358|3858677|FG001|STARTED|Period II: 6-24M Long-term Follow-up||107
3133735|NCT01697358|3858676|FG000|COMPLETED|Period II: 6-24M Long-term Follow-up||48
2874797|NCT00243841|3578883|FG004|COMPLETED|Overall Study||39
2874798|NCT00243841|3578884|FG005|COMPLETED|Overall Study||19
2874799|NCT00243841|3578879|FG000|NOT COMPLETED|Overall Study||0
2874800|NCT00243841|3578880|FG001|NOT COMPLETED|Overall Study||0
2874801|NCT00243841|3578881|FG002|NOT COMPLETED|Overall Study||1
2874802|NCT00243841|3578882|FG003|NOT COMPLETED|Overall Study||0
2874803|NCT00243841|3578883|FG004|NOT COMPLETED|Overall Study||0
2874804|NCT00243841|3578884|FG005|NOT COMPLETED|Overall Study||2
2874805|NCT00243919|3578903|FG000|STARTED|Overall Study||139
2874806|NCT00243919|3578904|FG001|STARTED|Overall Study||143
2874807|NCT00243919|3578905|FG002|STARTED|Overall Study||126
2874808|NCT00243919|3578903|FG000|COMPLETED|Overall Study||122
2874809|NCT00243919|3578904|FG001|COMPLETED|Overall Study||125
2874810|NCT00243919|3578905|FG002|COMPLETED|Overall Study||115
2874811|NCT00243919|3578903|FG000|NOT COMPLETED|Overall Study||17
2874812|NCT00243919|3578904|FG001|NOT COMPLETED|Overall Study||18
2874813|NCT00243919|3578905|FG002|NOT COMPLETED|Overall Study||11
2874814|NCT00243932|3578916|FG000|STARTED|Stage 1: Dose Selection||35
2874815|NCT00243932|3578917|FG001|STARTED|Stage 1: Dose Selection||35
2874816|NCT00243932|3578918|FG002|STARTED|Stage 1: Dose Selection||35
2874817|NCT00243932|3578916|FG000|COMPLETED|Stage 1: Dose Selection||33
2874818|NCT00243932|3578917|FG001|COMPLETED|Stage 1: Dose Selection||35
2874819|NCT00243932|3578918|FG002|COMPLETED|Stage 1: Dose Selection||35
2874820|NCT00243932|3578916|FG000|NOT COMPLETED|Stage 1: Dose Selection||2
2874821|NCT00243932|3578917|FG001|NOT COMPLETED|Stage 1: Dose Selection||0
3133736|NCT01697358|3858677|FG001|COMPLETED|Period II: 6-24M Long-term Follow-up||52
2874822|NCT00243932|3578918|FG002|NOT COMPLETED|Stage 1: Dose Selection||0
2874823|NCT00243932|3578916|FG000|STARTED|Stage 2: Efficacy|40 newly randomized pts. Efficacy analysis included Stage 1 + Stage 2 patients|40
2874824|NCT00243932|3578917|FG001|STARTED|Stage 2: Efficacy|40 newly randomized pts. Efficacy analysis included Stage 1 + Stage 2 patients|40
2874825|NCT00243932|3578918|FG002|STARTED|Stage 2: Efficacy|No new pts. randomized because selection procedure in Stage 1 selected the 2,700 mg dose.|0
2874826|NCT00243932|3578916|FG000|COMPLETED|Stage 2: Efficacy||40
2874827|NCT00243932|3578917|FG001|COMPLETED|Stage 2: Efficacy||40
2874828|NCT00243932|3578918|FG002|COMPLETED|Stage 2: Efficacy||0
2874829|NCT00243932|3578916|FG000|NOT COMPLETED|Stage 2: Efficacy||0
2874830|NCT00243932|3578917|FG001|NOT COMPLETED|Stage 2: Efficacy||0
2874831|NCT00243932|3578918|FG002|NOT COMPLETED|Stage 2: Efficacy||0
2874832|NCT00244101|3578929|FG000|STARTED|Overall Study||209
2874833|NCT00244101|3578930|FG001|STARTED|Overall Study||223
2874834|NCT00244101|3578931|FG002|STARTED|Overall Study||216
2874835|NCT00244101|3578929|FG000|COMPLETED|Overall Study||209
2874836|NCT00244101|3578930|FG001|COMPLETED|Overall Study||223
2874837|NCT00244101|3578931|FG002|COMPLETED|Overall Study||216
2874838|NCT00244101|3578929|FG000|NOT COMPLETED|Overall Study||0
2874839|NCT00244101|3578930|FG001|NOT COMPLETED|Overall Study||0
2874840|NCT00244101|3578931|FG002|NOT COMPLETED|Overall Study||0
2874841|NCT00244140|3578941|FG000|STARTED|Overall Study||412
2874842|NCT00244140|3578942|FG001|STARTED|Overall Study||22
2874843|NCT00244140|3578941|FG000|COMPLETED|Overall Study||412
2874844|NCT00244140|3578942|FG001|COMPLETED|Overall Study||22
2874845|NCT00244140|3578941|FG000|NOT COMPLETED|Overall Study||0
2874846|NCT00244140|3578942|FG001|NOT COMPLETED|Overall Study||0
2874847|NCT00244374|3578948|FG000|STARTED|Pre-Randomization Cross-sectional Study||546
2874848|NCT00244374|3578949|FG001|STARTED|Pre-Randomization Cross-sectional Study||0
2874849|NCT00244374|3578950|FG002|STARTED|Pre-Randomization Cross-sectional Study||0
2874850|NCT00244374|3578951|FG003|STARTED|Pre-Randomization Cross-sectional Study||0
2874851|NCT00244374|3578952|FG004|STARTED|Pre-Randomization Cross-sectional Study||0
2874852|NCT00244374|3578948|FG000|COMPLETED|Pre-Randomization Cross-sectional Study||409
2874853|NCT00244374|3578949|FG001|COMPLETED|Pre-Randomization Cross-sectional Study||0
2874854|NCT00244374|3578950|FG002|COMPLETED|Pre-Randomization Cross-sectional Study||0
2874855|NCT00244374|3578951|FG003|COMPLETED|Pre-Randomization Cross-sectional Study||0
2874856|NCT00244374|3578952|FG004|COMPLETED|Pre-Randomization Cross-sectional Study||0
2874857|NCT00244374|3578948|FG000|NOT COMPLETED|Pre-Randomization Cross-sectional Study||137
2874858|NCT00244374|3578949|FG001|NOT COMPLETED|Pre-Randomization Cross-sectional Study||0
2874859|NCT00244374|3578950|FG002|NOT COMPLETED|Pre-Randomization Cross-sectional Study||0
2874860|NCT00244374|3578951|FG003|NOT COMPLETED|Pre-Randomization Cross-sectional Study||0
2874861|NCT00244374|3578952|FG004|NOT COMPLETED|Pre-Randomization Cross-sectional Study||0
2874862|NCT00244374|3578948|FG000|STARTED|Evaluation for Vaccine Adherence Cohort|440 study participants enrolled prior to 3/31/2007 were evaluated for vaccine adherence cohort|440
2874863|NCT00244374|3578949|FG001|STARTED|Evaluation for Vaccine Adherence Cohort||0
2874864|NCT00244374|3578950|FG002|STARTED|Evaluation for Vaccine Adherence Cohort||0
2874865|NCT00244374|3578951|FG003|STARTED|Evaluation for Vaccine Adherence Cohort||0
2874866|NCT00244374|3578952|FG004|STARTED|Evaluation for Vaccine Adherence Cohort||0
2874867|NCT00244374|3578948|FG000|Eligible for Vaccine Adherence Cohort|Evaluation for Vaccine Adherence Cohort||217
2874868|NCT00244374|3578949|FG001|Eligible for Vaccine Adherence Cohort|Evaluation for Vaccine Adherence Cohort||0
2874869|NCT00244374|3578950|FG002|Eligible for Vaccine Adherence Cohort|Evaluation for Vaccine Adherence Cohort||0
2874870|NCT00244374|3578951|FG003|Eligible for Vaccine Adherence Cohort|Evaluation for Vaccine Adherence Cohort||0
2874871|NCT00244374|3578952|FG004|Eligible for Vaccine Adherence Cohort|Evaluation for Vaccine Adherence Cohort||0
2874872|NCT00244374|3578948|FG000|COMPLETED|Evaluation for Vaccine Adherence Cohort||167
2874873|NCT00244374|3578949|FG001|COMPLETED|Evaluation for Vaccine Adherence Cohort||0
2874874|NCT00244374|3578950|FG002|COMPLETED|Evaluation for Vaccine Adherence Cohort||0
3314618|NCT03089216|4047873|FG000|COMPLETED|Overall Study||27
3314619|NCT03089216|4047874|FG001|COMPLETED|Overall Study||27
3314620|NCT03089216|4047875|FG002|COMPLETED|Overall Study||27
3314621|NCT03089216|4047876|FG003|COMPLETED|Overall Study||26
3169798|NCT01928381|3897371|FG004|STARTED|Screening for Pain Training||0
3169799|NCT01928381|3897372|FG005|STARTED|Screening for Pain Training||0
3169800|NCT01928381|3897373|FG006|STARTED|Screening for Pain Training||0
3314622|NCT03089216|4047873|FG000|NOT COMPLETED|Overall Study||0
3314623|NCT03089216|4047874|FG001|NOT COMPLETED|Overall Study||0
3314624|NCT03089216|4047875|FG002|NOT COMPLETED|Overall Study||0
3314625|NCT03089216|4047876|FG003|NOT COMPLETED|Overall Study||1
3314626|NCT03089580|4047890|FG000|STARTED|Overall Study||14
3314627|NCT03089580|4047890|FG000|COMPLETED|Overall Study||12
2874875|NCT00244374|3578951|FG003|COMPLETED|Evaluation for Vaccine Adherence Cohort||0
2874876|NCT00244374|3578952|FG004|COMPLETED|Evaluation for Vaccine Adherence Cohort||0
2874877|NCT00244374|3578948|FG000|NOT COMPLETED|Evaluation for Vaccine Adherence Cohort||273
2874878|NCT00244374|3578949|FG001|NOT COMPLETED|Evaluation for Vaccine Adherence Cohort||0
2874879|NCT00244374|3578950|FG002|NOT COMPLETED|Evaluation for Vaccine Adherence Cohort||0
2874880|NCT00244374|3578951|FG003|NOT COMPLETED|Evaluation for Vaccine Adherence Cohort||0
2874881|NCT00244374|3578952|FG004|NOT COMPLETED|Evaluation for Vaccine Adherence Cohort||0
2874882|NCT00244374|3578948|FG000|STARTED|Vaccine Adherence Cohort|Eligible and willing cross-sectional study participants progressed to adherence cohort randomization|0
3314628|NCT03089580|4047890|FG000|NOT COMPLETED|Overall Study||2
2874883|NCT00244374|3578949|FG001|STARTED|Vaccine Adherence Cohort||47
2874884|NCT00244374|3578950|FG002|STARTED|Vaccine Adherence Cohort||43
2874885|NCT00244374|3578951|FG003|STARTED|Vaccine Adherence Cohort||36
2874886|NCT00244374|3578952|FG004|STARTED|Vaccine Adherence Cohort||41
2874887|NCT00244374|3578948|FG000|COMPLETED|Vaccine Adherence Cohort||0
2874888|NCT00244374|3578949|FG001|COMPLETED|Vaccine Adherence Cohort||47
2874889|NCT00244374|3578950|FG002|COMPLETED|Vaccine Adherence Cohort||43
2874890|NCT00244374|3578951|FG003|COMPLETED|Vaccine Adherence Cohort||36
2874891|NCT00244374|3578952|FG004|COMPLETED|Vaccine Adherence Cohort||41
2874892|NCT00244374|3578948|FG000|NOT COMPLETED|Vaccine Adherence Cohort||0
2874893|NCT00244374|3578949|FG001|NOT COMPLETED|Vaccine Adherence Cohort||0
2874894|NCT00244374|3578950|FG002|NOT COMPLETED|Vaccine Adherence Cohort||0
2874895|NCT00244374|3578951|FG003|NOT COMPLETED|Vaccine Adherence Cohort||0
2874896|NCT00244374|3578952|FG004|NOT COMPLETED|Vaccine Adherence Cohort||0
2874897|NCT00244621|3578971|FG000|STARTED|Double-blind Treatment Period||29
2874898|NCT00244621|3578972|FG001|STARTED|Double-blind Treatment Period||32
2874899|NCT00244621|3578973|FG002|STARTED|Double-blind Treatment Period||32
2874900|NCT00244621|3578971|FG000|COMPLETED|Double-blind Treatment Period||27
2874901|NCT00244621|3578972|FG001|COMPLETED|Double-blind Treatment Period||29
2874902|NCT00244621|3578973|FG002|COMPLETED|Double-blind Treatment Period||30
2874903|NCT00244621|3578971|FG000|NOT COMPLETED|Double-blind Treatment Period||2
2874904|NCT00244621|3578972|FG001|NOT COMPLETED|Double-blind Treatment Period||3
2874905|NCT00244621|3578973|FG002|NOT COMPLETED|Double-blind Treatment Period||2
2874906|NCT00244621|3578971|FG000|STARTED|Open-label Treatment Period|One participant discontinued study due to Adverse Event after completing the double-blind period.|26
2874907|NCT00244621|3578972|FG001|STARTED|Open-label Treatment Period||29
2874908|NCT00244621|3578973|FG002|STARTED|Open-label Treatment Period||30
2874909|NCT00244621|3578971|FG000|COMPLETED|Open-label Treatment Period||25
2874910|NCT00244621|3578972|FG001|COMPLETED|Open-label Treatment Period||28
2874911|NCT00244621|3578973|FG002|COMPLETED|Open-label Treatment Period||28
2874912|NCT00244621|3578971|FG000|NOT COMPLETED|Open-label Treatment Period||1
2874913|NCT00244621|3578972|FG001|NOT COMPLETED|Open-label Treatment Period||1
2874914|NCT00244621|3578973|FG002|NOT COMPLETED|Open-label Treatment Period||2
2874915|NCT00244712|3578983|FG000|STARTED|Overall Study||343
2874916|NCT00244712|3578984|FG001|STARTED|Overall Study||345
2874917|NCT00244712|3578983|FG000|COMPLETED|Overall Study||234
2874918|NCT00244712|3578984|FG001|COMPLETED|Overall Study||221
2874919|NCT00244712|3578983|FG000|NOT COMPLETED|Overall Study||109
2874920|NCT00244712|3578984|FG001|NOT COMPLETED|Overall Study||124
2874921|NCT00244725|3578994|FG000|STARTED|Overall Study||237
2874922|NCT00244725|3578995|FG001|STARTED|Overall Study||245
2874923|NCT00244725|3578996|FG002|STARTED|Overall Study||239
2874924|NCT00244725|3578997|FG003|STARTED|Overall Study||237
2874925|NCT00244725|3578994|FG000|COMPLETED|Overall Study||214
2874926|NCT00244725|3578995|FG001|COMPLETED|Overall Study||226
2874927|NCT00244725|3578996|FG002|COMPLETED|Overall Study||215
2874928|NCT00244725|3578997|FG003|COMPLETED|Overall Study||216
2874929|NCT00244725|3578994|FG000|NOT COMPLETED|Overall Study||23
2874930|NCT00244725|3578995|FG001|NOT COMPLETED|Overall Study||19
2874931|NCT00244725|3578996|FG002|NOT COMPLETED|Overall Study||24
2874932|NCT00244725|3578997|FG003|NOT COMPLETED|Overall Study||21
2874933|NCT00244751|3579010|FG000|STARTED|Overall Study||88
2874934|NCT00244751|3579011|FG001|STARTED|Overall Study||89
2874935|NCT00244751|3579012|FG002|STARTED|Overall Study||88
2874936|NCT00244751|3579010|FG000|COMPLETED|Overall Study||72
2874937|NCT00244751|3579011|FG001|COMPLETED|Overall Study||74
2874938|NCT00244751|3579012|FG002|COMPLETED|Overall Study||78
2874939|NCT00244751|3579010|FG000|NOT COMPLETED|Overall Study||16
2874940|NCT00244751|3579011|FG001|NOT COMPLETED|Overall Study||15
2874941|NCT00244751|3579012|FG002|NOT COMPLETED|Overall Study||10
2874942|NCT00244764|3579029|FG000|STARTED|Overall Study||225
2874943|NCT00244764|3579029|FG000|COMPLETED|Overall Study||129
2874944|NCT00244764|3579029|FG000|NOT COMPLETED|Overall Study||96
2874945|NCT00244855|3579036|FG000|STARTED|Overall Study||7
2874946|NCT00244855|3579037|FG001|STARTED|Overall Study||25
2874947|NCT00244855|3579036|FG000|COMPLETED|Overall Study||7
2874948|NCT00244855|3579037|FG001|COMPLETED|Overall Study||24
2874949|NCT00244855|3579036|FG000|NOT COMPLETED|Overall Study||0
2874950|NCT00244855|3579037|FG001|NOT COMPLETED|Overall Study||1
2874951|NCT00244881|3579045|FG000|STARTED|Overall Study||26
2874952|NCT00244881|3579045|FG000|COMPLETED|Overall Study||23
2874953|NCT00244881|3579045|FG000|NOT COMPLETED|Overall Study||3
2874954|NCT00244933|3579049|FG000|STARTED|Overall Study||19
2874955|NCT00244933|3579049|FG000|COMPLETED|Overall Study||17
2874956|NCT00244933|3579049|FG000|NOT COMPLETED|Overall Study||2
2874957|NCT00244985|3579053|FG000|STARTED|Overall Study||42
2874958|NCT00244985|3579053|FG000|COMPLETED|Overall Study||42
2874959|NCT00244985|3579053|FG000|NOT COMPLETED|Overall Study||0
2874960|NCT00245011|3579057|FG000|STARTED|Overall Study||11
2874961|NCT00245011|3579057|FG000|COMPLETED|Overall Study|Subject had disease progression prior to completing study.|10
2874962|NCT00245011|3579057|FG000|NOT COMPLETED|Overall Study||1
2874963|NCT00245037|3579061|FG000|STARTED|Overall Study||147
2874964|NCT00245037|3579061|FG000|COMPLETED|Overall Study|17 participants died from infectious complications.|130
2874965|NCT00245037|3579061|FG000|NOT COMPLETED|Overall Study||17
2874966|NCT00245050|3579067|FG000|STARTED|Overall Study||18
2874967|NCT00245050|3579068|FG001|STARTED|Overall Study||16
2874968|NCT00245050|3579067|FG000|COMPLETED|Overall Study||15
2874969|NCT00245050|3579068|FG001|COMPLETED|Overall Study||14
2874970|NCT00245050|3579067|FG000|NOT COMPLETED|Overall Study||3
2874971|NCT00245050|3579068|FG001|NOT COMPLETED|Overall Study||2
2874972|NCT00245063|3579076|FG000|STARTED|Overall Study||12
2874973|NCT00245063|3579077|FG001|STARTED|Overall Study||13
2874974|NCT00245063|3579076|FG000|COMPLETED|Overall Study||5
3169801|NCT01928381|3897367|FG000|COMPLETED|Screening for Pain Training||83
3169802|NCT01928381|3897368|FG001|COMPLETED|Screening for Pain Training||0
3169803|NCT01928381|3897369|FG002|COMPLETED|Screening for Pain Training||0
2874975|NCT00245063|3579077|FG001|COMPLETED|Overall Study||8
2874976|NCT00245063|3579076|FG000|NOT COMPLETED|Overall Study||7
2874977|NCT00245063|3579077|FG001|NOT COMPLETED|Overall Study||5
2874978|NCT00245102|3579089|FG000|STARTED|Overall Study||44
2874979|NCT00245102|3579090|FG001|STARTED|Overall Study||16
2874980|NCT00245102|3579091|FG002|STARTED|Overall Study||46
2874981|NCT00245102|3579092|FG003|STARTED|Overall Study||13
2874982|NCT00245102|3579093|FG004|STARTED|Overall Study||5
2874983|NCT00245102|3579094|FG005|STARTED|Overall Study||23
2874984|NCT00245102|3579089|FG000|COMPLETED|Overall Study||37
2874985|NCT00245102|3579090|FG001|COMPLETED|Overall Study||12
2874986|NCT00245102|3579091|FG002|COMPLETED|Overall Study||39
2874987|NCT00245102|3579092|FG003|COMPLETED|Overall Study||10
2874988|NCT00245102|3579093|FG004|COMPLETED|Overall Study||5
2874989|NCT00245102|3579094|FG005|COMPLETED|Overall Study||19
2874990|NCT00245102|3579089|FG000|NOT COMPLETED|Overall Study||7
2874991|NCT00245102|3579090|FG001|NOT COMPLETED|Overall Study||4
2874992|NCT00245102|3579091|FG002|NOT COMPLETED|Overall Study||7
2874993|NCT00245102|3579092|FG003|NOT COMPLETED|Overall Study||3
2874994|NCT00245102|3579093|FG004|NOT COMPLETED|Overall Study||0
2874995|NCT00245102|3579094|FG005|NOT COMPLETED|Overall Study||4
2874996|NCT00245219|3579111|FG000|STARTED|Overall Study||91
2874997|NCT00245219|3579112|FG001|STARTED|Overall Study||94
2874998|NCT00245219|3579113|FG002|STARTED|Overall Study||60
2874999|NCT00245219|3579111|FG000|COMPLETED|Overall Study||85
2875000|NCT00245219|3579112|FG001|COMPLETED|Overall Study||88
2875001|NCT00245219|3579113|FG002|COMPLETED|Overall Study||58
2875002|NCT00245219|3579111|FG000|NOT COMPLETED|Overall Study||6
2875003|NCT00245219|3579112|FG001|NOT COMPLETED|Overall Study||6
2875004|NCT00245219|3579113|FG002|NOT COMPLETED|Overall Study||2
2875005|NCT00245466|3579124|FG000|STARTED|Overall Study||43
2875006|NCT00245466|3579125|FG001|STARTED|Overall Study||46
2875007|NCT00245466|3579126|FG002|STARTED|Overall Study||40
2875008|NCT00245466|3579124|FG000|Started FE200486 CS02A|Overall Study||32
2875009|NCT00245466|3579125|FG001|Started FE200486 CS02A|Overall Study||30
2875010|NCT00245466|3579126|FG002|Started FE200486 CS02A|Overall Study||26
2875011|NCT00245466|3579124|FG000|COMPLETED|Overall Study|Defined as those participants ongoing when the extension study was terminated|7
2875012|NCT00245466|3579125|FG001|COMPLETED|Overall Study||2
2875013|NCT00245466|3579126|FG002|COMPLETED|Overall Study||3
2875014|NCT00245466|3579124|FG000|NOT COMPLETED|Overall Study||36
2875015|NCT00245466|3579125|FG001|NOT COMPLETED|Overall Study||44
2875016|NCT00245466|3579126|FG002|NOT COMPLETED|Overall Study||37
2875017|NCT00245518|3579136|FG000|STARTED|Overall Study||17
2875018|NCT00245518|3579137|FG001|STARTED|Overall Study||16
2875019|NCT00245518|3579136|FG000|COMPLETED|Overall Study||17
2875020|NCT00245518|3579137|FG001|COMPLETED|Overall Study||16
2875021|NCT00245518|3579136|FG000|NOT COMPLETED|Overall Study||0
2875022|NCT00245518|3579137|FG001|NOT COMPLETED|Overall Study||0
2875023|NCT00245557|3579145|FG000|STARTED|Overall Study||17
2875024|NCT00245557|3579146|FG001|STARTED|Overall Study||26
2875025|NCT00245557|3579145|FG000|COMPLETED|Overall Study||11
2875026|NCT00245557|3579146|FG001|COMPLETED|Overall Study||10
2875027|NCT00245557|3579145|FG000|NOT COMPLETED|Overall Study||6
2875028|NCT00245557|3579146|FG001|NOT COMPLETED|Overall Study||16
2875029|NCT00245583|3579155|FG000|STARTED|Overall Study||20
2875030|NCT00245583|3579156|FG001|STARTED|Overall Study||22
2875031|NCT00245583|3579155|FG000|COMPLETED|Overall Study||14
2875032|NCT00245583|3579156|FG001|COMPLETED|Overall Study||13
2875033|NCT00245583|3579155|FG000|NOT COMPLETED|Overall Study||6
2875034|NCT00245583|3579156|FG001|NOT COMPLETED|Overall Study||9
2875035|NCT00245635|3579164|FG000|STARTED|Overall Study||25
2875036|NCT00245635|3579165|FG001|STARTED|Overall Study||18
2875037|NCT00245635|3579164|FG000|COMPLETED|Overall Study||25
2875038|NCT00245635|3579165|FG001|COMPLETED|Overall Study||18
2875039|NCT00245635|3579164|FG000|NOT COMPLETED|Overall Study||0
2875040|NCT00245635|3579165|FG001|NOT COMPLETED|Overall Study||0
2875041|NCT00245765|3579174|FG000|STARTED|Overall Study||59
2875042|NCT00245765|3579175|FG001|STARTED|Overall Study||59
2875043|NCT00245765|3579176|FG002|STARTED|Overall Study||58
2875044|NCT00245765|3579174|FG000|Safety Population|Overall Study|One subject in the Placebo (PBO) group received one injection of CDP870 200 mg on one occasion.|58
2875045|NCT00245765|3579175|FG001|Safety Population|Overall Study|For safety analysis, the PBO group subj. who received CDP870 was considered to be in the 200mg group|60
2875046|NCT00245765|3579176|FG002|Safety Population|Overall Study|One subject in the 400 mg group was randomized by mistake but did not receive study medication.|57
2875047|NCT00245765|3579174|FG000|COMPLETED|Overall Study||27
2875048|NCT00245765|3579175|FG001|COMPLETED|Overall Study||45
2875049|NCT00245765|3579176|FG002|COMPLETED|Overall Study||50
2875050|NCT00245765|3579174|FG000|NOT COMPLETED|Overall Study||32
2875051|NCT00245765|3579175|FG001|NOT COMPLETED|Overall Study||14
2875052|NCT00245765|3579176|FG002|NOT COMPLETED|Overall Study||8
3169804|NCT01928381|3897370|FG003|COMPLETED|Screening for Pain Training||0
2875053|NCT00245856|3579184|FG000|STARTED|Period One||28
2875054|NCT00245856|3579185|FG001|STARTED|Period One||0
2875055|NCT00245856|3579184|FG000|COMPLETED|Period One||28
2875056|NCT00245856|3579185|FG001|COMPLETED|Period One||0
2875057|NCT00245856|3579184|FG000|NOT COMPLETED|Period One||0
2875058|NCT00245856|3579185|FG001|NOT COMPLETED|Period One||0
2875059|NCT00245856|3579184|FG000|STARTED|Period Two||0
2875060|NCT00245856|3579185|FG001|STARTED|Period Two||39
2875061|NCT00245856|3579184|FG000|COMPLETED|Period Two||0
2875062|NCT00245856|3579185|FG001|COMPLETED|Period Two||38
2875063|NCT00245856|3579184|FG000|NOT COMPLETED|Period Two||0
2875064|NCT00245856|3579185|FG001|NOT COMPLETED|Period Two||1
2875065|NCT00246012|3579201|FG000|STARTED|Overall Study||3
2875066|NCT00246012|3579202|FG001|STARTED|Overall Study||3
2875067|NCT00246012|3579203|FG002|STARTED|Overall Study||3
2875068|NCT00246012|3579204|FG003|STARTED|Overall Study||3
2875069|NCT00246012|3579205|FG004|STARTED|Overall Study||3
2875070|NCT00246012|3579206|FG005|STARTED|Overall Study||32
2875071|NCT00246012|3579207|FG006|STARTED|Overall Study||32
2875072|NCT00246012|3579208|FG007|STARTED|Overall Study||33
2875073|NCT00246012|3579209|FG008|STARTED|Overall Study||32
2875074|NCT00246012|3579201|FG000|Treated|Overall Study||3
2875075|NCT00246012|3579202|FG001|Treated|Overall Study||3
2875076|NCT00246012|3579203|FG002|Treated|Overall Study||3
2875077|NCT00246012|3579204|FG003|Treated|Overall Study||3
2875078|NCT00246012|3579205|FG004|Treated|Overall Study||3
2875079|NCT00246012|3579206|FG005|Treated|Overall Study||31
2875080|NCT00246012|3579207|FG006|Treated|Overall Study||31
2875081|NCT00246012|3579208|FG007|Treated|Overall Study||33
2875082|NCT00246012|3579209|FG008|Treated|Overall Study||32
2875083|NCT00246012|3579201|FG000|COMPLETED|Overall Study||0
2875084|NCT00246012|3579202|FG001|COMPLETED|Overall Study||2
2875085|NCT00246012|3579203|FG002|COMPLETED|Overall Study||1
2875086|NCT00246012|3579204|FG003|COMPLETED|Overall Study||0
2875087|NCT00246012|3579205|FG004|COMPLETED|Overall Study||0
2875088|NCT00246012|3579206|FG005|COMPLETED|Overall Study||4
2875089|NCT00246012|3579207|FG006|COMPLETED|Overall Study||1
2875090|NCT00246012|3579208|FG007|COMPLETED|Overall Study||5
2875091|NCT00246012|3579209|FG008|COMPLETED|Overall Study||4
2875092|NCT00246012|3579201|FG000|NOT COMPLETED|Overall Study||3
2875093|NCT00246012|3579202|FG001|NOT COMPLETED|Overall Study||1
2875094|NCT00246012|3579203|FG002|NOT COMPLETED|Overall Study||2
2875095|NCT00246012|3579204|FG003|NOT COMPLETED|Overall Study||3
2875096|NCT00246012|3579205|FG004|NOT COMPLETED|Overall Study||3
2875097|NCT00246012|3579206|FG005|NOT COMPLETED|Overall Study||28
2875098|NCT00246012|3579207|FG006|NOT COMPLETED|Overall Study||31
2875099|NCT00246012|3579208|FG007|NOT COMPLETED|Overall Study||28
2875100|NCT00246012|3579209|FG008|NOT COMPLETED|Overall Study||28
2875101|NCT00246025|3579235|FG000|STARTED|Overall Study||124
2875102|NCT00246025|3579236|FG001|STARTED|Overall Study||133
2875103|NCT00246025|3579237|FG002|STARTED|Overall Study||126
2875104|NCT00246025|3579238|FG003|STARTED|Overall Study||129
2875105|NCT00246025|3579235|FG000|COMPLETED|Overall Study||114
2875106|NCT00246025|3579236|FG001|COMPLETED|Overall Study||124
2875107|NCT00246025|3579237|FG002|COMPLETED|Overall Study||116
2875108|NCT00246025|3579238|FG003|COMPLETED|Overall Study||116
2875109|NCT00246025|3579235|FG000|NOT COMPLETED|Overall Study||10
2875110|NCT00246025|3579236|FG001|NOT COMPLETED|Overall Study||9
2875111|NCT00246025|3579237|FG002|NOT COMPLETED|Overall Study||10
2875112|NCT00246025|3579238|FG003|NOT COMPLETED|Overall Study||13
2875113|NCT00246090|3579248|FG000|STARTED|Overall Study||298
2875114|NCT00246090|3579248|FG000|COMPLETED|Overall Study||3
2875115|NCT00246090|3579248|FG000|NOT COMPLETED|Overall Study||295
2875116|NCT00246129|3579254|FG000|STARTED|Overall Study||82
2875117|NCT00246129|3579255|FG001|STARTED|Overall Study||41
2875118|NCT00246129|3579254|FG000|COMPLETED|Overall Study||75
2875119|NCT00246129|3579255|FG001|COMPLETED|Overall Study||39
2875120|NCT00246129|3579254|FG000|NOT COMPLETED|Overall Study||7
2875121|NCT00246129|3579255|FG001|NOT COMPLETED|Overall Study||2
2875122|NCT00246259|3579266|FG000|STARTED|Overall Study||44
2875123|NCT00246259|3579267|FG001|STARTED|Overall Study||41
2875124|NCT00246259|3579266|FG000|Eligible for Intent-to-treat (ITT)|Overall Study||42
2875125|NCT00246259|3579267|FG001|Eligible for Intent-to-treat (ITT)|Overall Study||35
2875126|NCT00246259|3579266|FG000|COMPLETED|Overall Study||16
2875127|NCT00246259|3579267|FG001|COMPLETED|Overall Study||15
2875128|NCT00246259|3579266|FG000|NOT COMPLETED|Overall Study||28
2875129|NCT00246259|3579267|FG001|NOT COMPLETED|Overall Study||26
2875130|NCT00246324|3579273|FG000|STARTED|Overall Study||16
2875131|NCT00246324|3579273|FG000|COMPLETED|Overall Study||15
2875132|NCT00246324|3579273|FG000|NOT COMPLETED|Overall Study||1
2875133|NCT00246337|3579286|FG000|STARTED|Overall Study||147
2875134|NCT00246337|3579287|FG001|STARTED|Overall Study||16
2875135|NCT00246337|3579288|FG002|STARTED|Overall Study||18
2875136|NCT00246337|3579289|FG003|STARTED|Overall Study||17
2875137|NCT00246337|3579290|FG004|STARTED|Overall Study||16
2875138|NCT00246337|3579291|FG005|STARTED|Overall Study||54
2875139|NCT00246337|3579292|FG006|STARTED|Overall Study||54
2875140|NCT00246337|3579293|FG007|STARTED|Overall Study||53
2875141|NCT00246337|3579294|FG008|STARTED|Overall Study||45
2875142|NCT00246337|3579286|FG000|Completed Period (Initial Dose)|Overall Study||46
2875143|NCT00246337|3579287|FG001|Completed Period (Initial Dose)|Overall Study||4
2875144|NCT00246337|3579288|FG002|Completed Period (Initial Dose)|Overall Study||9
2875145|NCT00246337|3579289|FG003|Completed Period (Initial Dose)|Overall Study||5
2875146|NCT00246337|3579290|FG004|Completed Period (Initial Dose)|Overall Study||8
2875147|NCT00246337|3579291|FG005|Completed Period (Initial Dose)|Overall Study||29
2875148|NCT00246337|3579292|FG006|Completed Period (Initial Dose)|Overall Study||29
2875149|NCT00246337|3579293|FG007|Completed Period (Initial Dose)|Overall Study||27
2875150|NCT00246337|3579294|FG008|Completed Period (Initial Dose)|Overall Study||19
2875151|NCT00246337|3579286|FG000|Completed Period (Both Doses)|Overall Study||69
2875152|NCT00246337|3579287|FG001|Completed Period (Both Doses)|Overall Study||10
2875153|NCT00246337|3579288|FG002|Completed Period (Both Doses)|Overall Study||6
2875154|NCT00246337|3579289|FG003|Completed Period (Both Doses)|Overall Study||11
2875155|NCT00246337|3579290|FG004|Completed Period (Both Doses)|Overall Study||4
2875156|NCT00246337|3579291|FG005|Completed Period (Both Doses)|Overall Study||10
2875157|NCT00246337|3579292|FG006|Completed Period (Both Doses)|Overall Study||16
2875158|NCT00246337|3579293|FG007|Completed Period (Both Doses)|Overall Study||13
2875159|NCT00246337|3579294|FG008|Completed Period (Both Doses)|Overall Study||15
2875160|NCT00246337|3579286|FG000|COMPLETED|Overall Study||115
2875161|NCT00246337|3579287|FG001|COMPLETED|Overall Study||14
2875162|NCT00246337|3579288|FG002|COMPLETED|Overall Study||15
2875163|NCT00246337|3579289|FG003|COMPLETED|Overall Study||16
2875164|NCT00246337|3579290|FG004|COMPLETED|Overall Study||12
2875165|NCT00246337|3579291|FG005|COMPLETED|Overall Study||39
2875166|NCT00246337|3579292|FG006|COMPLETED|Overall Study||45
2875167|NCT00246337|3579293|FG007|COMPLETED|Overall Study||40
2875168|NCT00246337|3579294|FG008|COMPLETED|Overall Study||34
2875169|NCT00246337|3579286|FG000|NOT COMPLETED|Overall Study||32
2875170|NCT00246337|3579287|FG001|NOT COMPLETED|Overall Study||2
2875171|NCT00246337|3579288|FG002|NOT COMPLETED|Overall Study||3
2875172|NCT00246337|3579289|FG003|NOT COMPLETED|Overall Study||1
2875173|NCT00246337|3579290|FG004|NOT COMPLETED|Overall Study||4
2875174|NCT00246337|3579291|FG005|NOT COMPLETED|Overall Study||15
2875175|NCT00246337|3579292|FG006|NOT COMPLETED|Overall Study||9
2875176|NCT00246337|3579293|FG007|NOT COMPLETED|Overall Study||13
2875177|NCT00246337|3579294|FG008|NOT COMPLETED|Overall Study||11
2875178|NCT00246376|3579319|FG000|STARTED|Overall Study||41
2875179|NCT00246376|3579320|FG001|STARTED|Overall Study||43
2875180|NCT00246376|3579321|FG002|STARTED|Overall Study||45
2875181|NCT00246376|3579322|FG003|STARTED|Overall Study||47
2875182|NCT00246376|3579323|FG004|STARTED|Overall Study||45
2875183|NCT00246376|3579319|FG000|After Dietary run-in at Two Weeks|Overall Study||30
2875184|NCT00246376|3579320|FG001|After Dietary run-in at Two Weeks|Overall Study||38
2875185|NCT00246376|3579321|FG002|After Dietary run-in at Two Weeks|Overall Study||41
2875186|NCT00246376|3579322|FG003|After Dietary run-in at Two Weeks|Overall Study||40
2875187|NCT00246376|3579323|FG004|After Dietary run-in at Two Weeks|Overall Study||42
2875188|NCT00246376|3579319|FG000|COMPLETED|Overall Study||26
2875189|NCT00246376|3579320|FG001|COMPLETED|Overall Study||24
2875190|NCT00246376|3579321|FG002|COMPLETED|Overall Study||29
2875191|NCT00246376|3579322|FG003|COMPLETED|Overall Study||21
2875192|NCT00246376|3579323|FG004|COMPLETED|Overall Study||28
2875193|NCT00246376|3579319|FG000|NOT COMPLETED|Overall Study||15
2875194|NCT00246376|3579320|FG001|NOT COMPLETED|Overall Study||19
2875195|NCT00246376|3579321|FG002|NOT COMPLETED|Overall Study||16
2875196|NCT00246376|3579322|FG003|NOT COMPLETED|Overall Study||26
2875197|NCT00246376|3579323|FG004|NOT COMPLETED|Overall Study||17
3169805|NCT01928381|3897371|FG004|COMPLETED|Screening for Pain Training||0
3169806|NCT01928381|3897372|FG005|COMPLETED|Screening for Pain Training||0
3169807|NCT01928381|3897373|FG006|COMPLETED|Screening for Pain Training||0
3169808|NCT01928381|3897367|FG000|NOT COMPLETED|Screening for Pain Training||60
3169809|NCT01928381|3897368|FG001|NOT COMPLETED|Screening for Pain Training||0
2875198|NCT00246441|3579343|FG000|STARTED|Overall Study||20
2875199|NCT00246441|3579344|FG001|STARTED|Overall Study||22
2875200|NCT00246441|3579343|FG000|COMPLETED|Overall Study||19
2875201|NCT00246441|3579344|FG001|COMPLETED|Overall Study||22
2875202|NCT00246441|3579343|FG000|NOT COMPLETED|Overall Study||1
2875203|NCT00246441|3579344|FG001|NOT COMPLETED|Overall Study||0
2875204|NCT00246519|3579352|FG000|STARTED|Overall Study||442
2875205|NCT00246519|3579353|FG001|STARTED|Overall Study||446
2875206|NCT00246519|3579352|FG000|COMPLETED|Overall Study||386
2875207|NCT00246519|3579353|FG001|COMPLETED|Overall Study||382
2875208|NCT00246519|3579352|FG000|NOT COMPLETED|Overall Study||56
2875209|NCT00246519|3579353|FG001|NOT COMPLETED|Overall Study||64
2875210|NCT00246571|3579361|FG000|STARTED|Overall Study||113
2875211|NCT00246571|3579362|FG001|STARTED|Overall Study||104
2875212|NCT00246571|3579361|FG000|Randomized But Not Treated|Overall Study||3
2875213|NCT00246571|3579362|FG001|Randomized But Not Treated|Overall Study||1
2875214|NCT00246571|3579361|FG000|COMPLETED|Overall Study||0
2875215|NCT00246571|3579362|FG001|COMPLETED|Overall Study||0
2875216|NCT00246571|3579361|FG000|NOT COMPLETED|Overall Study||113
2875217|NCT00246571|3579362|FG001|NOT COMPLETED|Overall Study||104
2875218|NCT00246740|3579370|FG000|STARTED|Initial Enrollment||28
2875219|NCT00246740|3579371|FG001|STARTED|Initial Enrollment||28
2875220|NCT00246740|3579370|FG000|COMPLETED|Initial Enrollment||22
2875221|NCT00246740|3579371|FG001|COMPLETED|Initial Enrollment||20
2875222|NCT00246740|3579370|FG000|NOT COMPLETED|Initial Enrollment||6
2875223|NCT00246740|3579371|FG001|NOT COMPLETED|Initial Enrollment||8
2875224|NCT00246740|3579370|FG000|STARTED|Experimental Phase||22
2875225|NCT00246740|3579371|FG001|STARTED|Experimental Phase||20
2875226|NCT00246740|3579370|FG000|COMPLETED|Experimental Phase||22
3169810|NCT01928381|3897369|FG002|NOT COMPLETED|Screening for Pain Training||0
2875227|NCT00246740|3579371|FG001|COMPLETED|Experimental Phase||20
2875228|NCT00246740|3579370|FG000|NOT COMPLETED|Experimental Phase||0
2875229|NCT00246740|3579371|FG001|NOT COMPLETED|Experimental Phase||0
2875230|NCT00246753|3579377|FG000|STARTED|Overall Study||29
2875231|NCT00246753|3579377|FG000|COMPLETED|Overall Study||21
2875232|NCT00246753|3579377|FG000|NOT COMPLETED|Overall Study||8
2875233|NCT00246805|3579383|FG000|STARTED|Phase 1||34
2875234|NCT00246805|3579384|FG001|STARTED|Phase 1||33
2875235|NCT00246805|3579383|FG000|COMPLETED|Phase 1||33
2875236|NCT00246805|3579384|FG001|COMPLETED|Phase 1||33
2875237|NCT00246805|3579383|FG000|NOT COMPLETED|Phase 1||1
2875238|NCT00246805|3579384|FG001|NOT COMPLETED|Phase 1||0
2875239|NCT00246805|3579383|FG000|STARTED|Phase 2||33
2875240|NCT00246805|3579384|FG001|STARTED|Phase 2||33
2875241|NCT00246805|3579383|FG000|COMPLETED|Phase 2||33
2875242|NCT00246805|3579384|FG001|COMPLETED|Phase 2||33
2875243|NCT00246805|3579383|FG000|NOT COMPLETED|Phase 2||0
2875244|NCT00246805|3579384|FG001|NOT COMPLETED|Phase 2||0
2875245|NCT00247273|3579392|FG000|STARTED|Overall Study||644
2875246|NCT00247273|3579393|FG001|STARTED|Overall Study||650
2875247|NCT00247273|3579392|FG000|Intent to Treat Population|Overall Study|Two subjects not included as they did not take any study medication.|642
2875248|NCT00247273|3579393|FG001|Intent to Treat Population|Overall Study||650
2875249|NCT00247273|3579392|FG000|COMPLETED|Overall Study||498
2875250|NCT00247273|3579393|FG001|COMPLETED|Overall Study||513
2875251|NCT00247273|3579392|FG000|NOT COMPLETED|Overall Study||146
2875252|NCT00247273|3579393|FG001|NOT COMPLETED|Overall Study||137
2875253|NCT00247377|3579401|FG000|STARTED|Overall Study||111
2875254|NCT00247377|3579402|FG001|STARTED|Overall Study||86
2875255|NCT00247377|3579401|FG000|COMPLETED|Overall Study||111
2875256|NCT00247377|3579402|FG001|COMPLETED|Overall Study||86
2875257|NCT00247377|3579401|FG000|NOT COMPLETED|Overall Study||0
2875258|NCT00247377|3579402|FG001|NOT COMPLETED|Overall Study||0
2875259|NCT00247416|3579410|FG000|STARTED|Overall Study||26
2875260|NCT00247416|3579411|FG001|STARTED|Overall Study||33
2875261|NCT00247416|3579410|FG000|COMPLETED|Overall Study||25
2875262|NCT00247416|3579411|FG001|COMPLETED|Overall Study||31
2875263|NCT00247416|3579410|FG000|NOT COMPLETED|Overall Study||1
2875264|NCT00247416|3579411|FG001|NOT COMPLETED|Overall Study||2
2875265|NCT00247611|3579421|FG000|STARTED|Baselined|Participants randomized|304
2875266|NCT00247611|3579422|FG001|STARTED|Baselined|Participants randomized|290
2875267|NCT00247611|3579421|FG000|COMPLETED|Baselined|Randomized participants who completed at least 2 adherence assessments/sessions|287
2875268|NCT00247611|3579422|FG001|COMPLETED|Baselined|Randomized participants who completed at least 2 adherence assessments/sessions|277
2875269|NCT00247611|3579421|FG000|NOT COMPLETED|Baselined||17
2875270|NCT00247611|3579422|FG001|NOT COMPLETED|Baselined||13
2875271|NCT00247611|3579421|FG000|STARTED|Intention to Treat Sample|Participants randomized|304
2875272|NCT00247611|3579422|FG001|STARTED|Intention to Treat Sample|Participants randomized|290
2875273|NCT00247611|3579421|FG000|COMPLETED|Intention to Treat Sample|Randomized participants who completed at least 2 adherence assessments/sessions|287
2875274|NCT00247611|3579422|FG001|COMPLETED|Intention to Treat Sample|Randomized participants who completed at least 2 adherence assessments/sessions|277
2875275|NCT00247611|3579421|FG000|NOT COMPLETED|Intention to Treat Sample||17
2875276|NCT00247611|3579422|FG001|NOT COMPLETED|Intention to Treat Sample||13
2875277|NCT00247611|3579421|FG000|STARTED|On Protocol Sample|ITT sample participants|287
2875278|NCT00247611|3579422|FG001|STARTED|On Protocol Sample|ITT sample participants|277
2875279|NCT00247611|3579421|FG000|COMPLETED|On Protocol Sample|Participants with no interruptions in ART receipt and completing 6 or more LifeWindows assessments|176
2875280|NCT00247611|3579422|FG001|COMPLETED|On Protocol Sample|Participants with no interruptions in ART receipt and completing 6 or more LifeWindows assessments|152
2875281|NCT00247611|3579421|FG000|NOT COMPLETED|On Protocol Sample||111
2875282|NCT00247611|3579422|FG001|NOT COMPLETED|On Protocol Sample||125
2875283|NCT00247624|3579436|FG000|STARTED|Overall Study||30
2875284|NCT00247624|3579437|FG001|STARTED|Overall Study||30
2875285|NCT00247624|3579436|FG000|COMPLETED|Overall Study||25
2875286|NCT00247624|3579437|FG001|COMPLETED|Overall Study||26
2875287|NCT00247624|3579436|FG000|NOT COMPLETED|Overall Study||5
2875288|NCT00247624|3579437|FG001|NOT COMPLETED|Overall Study||4
2875289|NCT00247676|3579443|FG000|STARTED|Overall Study||37
2875290|NCT00247676|3579443|FG000|COMPLETED|Overall Study||1
2875291|NCT00247676|3579443|FG000|NOT COMPLETED|Overall Study||36
2875292|NCT00247728|3579450|FG000|STARTED|Overall Study||58
2875293|NCT00247728|3579451|FG001|STARTED|Overall Study||57
2875294|NCT00247728|3579452|FG002|STARTED|Overall Study||57
2875295|NCT00247728|3579450|FG000|COMPLETED|Overall Study||55
2875296|NCT00247728|3579451|FG001|COMPLETED|Overall Study||51
2875297|NCT00247728|3579452|FG002|COMPLETED|Overall Study||43
2875298|NCT00247728|3579450|FG000|NOT COMPLETED|Overall Study||3
2875299|NCT00247728|3579451|FG001|NOT COMPLETED|Overall Study||6
2875300|NCT00247728|3579452|FG002|NOT COMPLETED|Overall Study||14
2875301|NCT00247962|3579464|FG000|STARTED|Overall Study||379
2875302|NCT00247962|3579465|FG001|STARTED|Overall Study||187
2875303|NCT00247962|3579464|FG000|COMPLETED|Overall Study||353
2875304|NCT00247962|3579465|FG001|COMPLETED|Overall Study||168
2875305|NCT00247962|3579464|FG000|NOT COMPLETED|Overall Study||26
2875306|NCT00247962|3579465|FG001|NOT COMPLETED|Overall Study||19
2875307|NCT00248040|3579474|FG000|STARTED|Overall Study||25
2875308|NCT00248040|3579475|FG001|STARTED|Overall Study||23
2875309|NCT00248040|3579476|FG002|STARTED|Overall Study||26
2875310|NCT00248040|3579474|FG000|COMPLETED|Overall Study||22
2875311|NCT00248040|3579475|FG001|COMPLETED|Overall Study||22
2875312|NCT00248040|3579476|FG002|COMPLETED|Overall Study||22
2875313|NCT00248040|3579474|FG000|NOT COMPLETED|Overall Study||3
2875314|NCT00248040|3579475|FG001|NOT COMPLETED|Overall Study||1
2875315|NCT00248040|3579476|FG002|NOT COMPLETED|Overall Study||4
2875316|NCT00248170|3579487|FG000|STARTED|Overall Study||2078
2875317|NCT00248170|3579488|FG001|STARTED|Overall Study||2094
2875318|NCT00248170|3579487|FG000|Intent-to-treat (ITT)|Overall Study||2061
2875319|NCT00248170|3579488|FG001|Intent-to-treat (ITT)|Overall Study||2075
2875320|NCT00248170|3579487|FG000|Safety Set|Overall Study||2049
2875321|NCT00248170|3579488|FG001|Safety Set|Overall Study||2062
2875322|NCT00248170|3579487|FG000|COMPLETED|Overall Study||1317
2875323|NCT00248170|3579488|FG001|COMPLETED|Overall Study||1286
2875324|NCT00248170|3579487|FG000|NOT COMPLETED|Overall Study||761
2875325|NCT00248170|3579488|FG001|NOT COMPLETED|Overall Study||808
2875326|NCT00248495|3579494|FG000|STARTED|Overall Study||38
2875327|NCT00248495|3579494|FG000|COMPLETED|Overall Study||37
2875328|NCT00248495|3579494|FG000|NOT COMPLETED|Overall Study||1
2875329|NCT00248534|3579498|FG000|STARTED|Overall Study||16
2875330|NCT00248534|3579498|FG000|COMPLETED|Overall Study||16
2875331|NCT00248534|3579498|FG000|NOT COMPLETED|Overall Study||0
2875332|NCT00248547|3579504|FG000|STARTED|Overall Study||20
2875333|NCT00248547|3579505|FG001|STARTED|Overall Study||20
2875334|NCT00248547|3579504|FG000|COMPLETED|Overall Study||20
2875335|NCT00248547|3579505|FG001|COMPLETED|Overall Study||20
2875336|NCT00248547|3579504|FG000|NOT COMPLETED|Overall Study||0
2875337|NCT00248547|3579505|FG001|NOT COMPLETED|Overall Study||0
2875338|NCT00248560|3579511|FG000|STARTED|Overall Study||36
2875339|NCT00248560|3579511|FG000|COMPLETED|Overall Study||36
2875340|NCT00248560|3579511|FG000|NOT COMPLETED|Overall Study||0
2875341|NCT00248612|3579520|FG000|STARTED|Overall Study||24
2875342|NCT00248612|3579521|FG001|STARTED|Overall Study||21
2875343|NCT00248612|3579522|FG002|STARTED|Overall Study||14
2875344|NCT00248612|3579523|FG003|STARTED|Overall Study||22
2875345|NCT00248612|3579520|FG000|COMPLETED|Overall Study||24
2875346|NCT00248612|3579521|FG001|COMPLETED|Overall Study||21
2875347|NCT00248612|3579522|FG002|COMPLETED|Overall Study||14
2875348|NCT00248612|3579523|FG003|COMPLETED|Overall Study||22
2875349|NCT00248612|3579520|FG000|NOT COMPLETED|Overall Study||0
2875350|NCT00248612|3579521|FG001|NOT COMPLETED|Overall Study||0
2875351|NCT00248612|3579522|FG002|NOT COMPLETED|Overall Study||0
2875352|NCT00248612|3579523|FG003|NOT COMPLETED|Overall Study||0
2875353|NCT00248625|3579537|FG000|STARTED|Overall Study||92
2875354|NCT00248625|3579538|FG001|STARTED|Overall Study||92
2875355|NCT00248625|3579537|FG000|COMPLETED|Overall Study||92
2875356|NCT00248625|3579538|FG001|COMPLETED|Overall Study||90
2875357|NCT00248625|3579537|FG000|NOT COMPLETED|Overall Study||0
2875358|NCT00248625|3579538|FG001|NOT COMPLETED|Overall Study||2
2875359|NCT00248638|3579546|FG000|STARTED|Overall Study||75
2875360|NCT00248638|3579547|FG001|STARTED|Overall Study||75
2875361|NCT00248638|3579546|FG000|COMPLETED|Overall Study||75
2875362|NCT00248638|3579547|FG001|COMPLETED|Overall Study||75
2875363|NCT00248638|3579546|FG000|NOT COMPLETED|Overall Study||0
2875364|NCT00248638|3579547|FG001|NOT COMPLETED|Overall Study||0
2875365|NCT00248651|3579558|FG000|STARTED|Overall Study||97
2875366|NCT00248651|3579559|FG001|STARTED|Overall Study||98
2875367|NCT00248651|3579560|FG002|STARTED|Overall Study||97
2875368|NCT00248651|3579558|FG000|Completed 12 Weeks of Treatment|Overall Study||78
2875369|NCT00248651|3579559|FG001|Completed 12 Weeks of Treatment|Overall Study||66
2875370|NCT00248651|3579560|FG002|Completed 12 Weeks of Treatment|Overall Study||75
2875371|NCT00248651|3579558|FG000|COMPLETED|Overall Study||69
2875372|NCT00248651|3579559|FG001|COMPLETED|Overall Study||58
2875373|NCT00248651|3579560|FG002|COMPLETED|Overall Study||65
2875374|NCT00248651|3579558|FG000|NOT COMPLETED|Overall Study||28
2875375|NCT00248651|3579559|FG001|NOT COMPLETED|Overall Study||40
2875376|NCT00248651|3579560|FG002|NOT COMPLETED|Overall Study||32
2875377|NCT00248781|3579570|FG000|STARTED|Overall Study||52
2875378|NCT00248781|3579571|FG001|STARTED|Overall Study||51
2875379|NCT00248781|3579570|FG000|COMPLETED|Overall Study||42
2875380|NCT00248781|3579571|FG001|COMPLETED|Overall Study||47
2875381|NCT00248781|3579570|FG000|NOT COMPLETED|Overall Study||10
2875382|NCT00248781|3579571|FG001|NOT COMPLETED|Overall Study||4
2875383|NCT00248794|3579580|FG000|STARTED|Overall Study||25
2875384|NCT00248794|3579581|FG001|STARTED|Overall Study||24
2875385|NCT00248794|3579582|FG002|STARTED|Overall Study||10
2875386|NCT00248794|3579580|FG000|COMPLETED|Overall Study||19
2875387|NCT00248794|3579581|FG001|COMPLETED|Overall Study||16
2875388|NCT00248794|3579582|FG002|COMPLETED|Overall Study||7
2875389|NCT00248794|3579580|FG000|NOT COMPLETED|Overall Study||6
2875390|NCT00248794|3579581|FG001|NOT COMPLETED|Overall Study||8
2875391|NCT00248794|3579582|FG002|NOT COMPLETED|Overall Study||3
2875392|NCT00248807|3579598|FG000|STARTED|Overall Study||19
2875393|NCT00248807|3579599|FG001|STARTED|Overall Study||11
2875394|NCT00248807|3579598|FG000|COMPLETED|Overall Study||19
2875395|NCT00248807|3579599|FG001|COMPLETED|Overall Study||11
2875396|NCT00248807|3579598|FG000|NOT COMPLETED|Overall Study||0
2875397|NCT00248807|3579599|FG001|NOT COMPLETED|Overall Study||0
2875398|NCT00248833|3579614|FG000|STARTED|Overall Study||12
2875399|NCT00248833|3579615|FG001|STARTED|Overall Study||11
2875400|NCT00248833|3579616|FG002|STARTED|Overall Study||11
2875401|NCT00248833|3579614|FG000|COMPLETED|Overall Study||9
2875402|NCT00248833|3579615|FG001|COMPLETED|Overall Study||8
2875403|NCT00248833|3579616|FG002|COMPLETED|Overall Study||9
2875404|NCT00248833|3579614|FG000|NOT COMPLETED|Overall Study||3
2875405|NCT00248833|3579615|FG001|NOT COMPLETED|Overall Study||3
2875406|NCT00248833|3579616|FG002|NOT COMPLETED|Overall Study||2
2875407|NCT00249002|3579626|FG000|STARTED|Overall Study||9
2875408|NCT00249002|3579626|FG000|COMPLETED|Overall Study||2
2875409|NCT00249002|3579626|FG000|NOT COMPLETED|Overall Study||7
2875410|NCT00249249|3579634|FG000|STARTED|Overall Study||321
2875411|NCT00249249|3579635|FG001|STARTED|Overall Study||103
2875412|NCT00249249|3579636|FG002|STARTED|Overall Study||303
2875413|NCT00249249|3579637|FG003|STARTED|Overall Study||103
2875414|NCT00249249|3579634|FG000|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|316
2875415|NCT00249249|3579635|FG001|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|102
2875416|NCT00249249|3579636|FG002|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|300
2875417|NCT00249249|3579637|FG003|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|103
2875418|NCT00249249|3579634|FG000|COMPLETED|Overall Study||301
2875419|NCT00249249|3579635|FG001|COMPLETED|Overall Study||98
2875420|NCT00249249|3579636|FG002|COMPLETED|Overall Study||288
2875421|NCT00249249|3579637|FG003|COMPLETED|Overall Study||100
2875422|NCT00249249|3579634|FG000|NOT COMPLETED|Overall Study||20
2875423|NCT00249249|3579635|FG001|NOT COMPLETED|Overall Study||5
2875424|NCT00249249|3579636|FG002|NOT COMPLETED|Overall Study||15
2875425|NCT00249249|3579637|FG003|NOT COMPLETED|Overall Study||3
2875426|NCT00249288|3579649|FG000|STARTED|Overall Study||19
2875427|NCT00249288|3579650|FG001|STARTED|Overall Study||19
2875428|NCT00249288|3579649|FG000|Initiated Treatment|Overall Study||17
2875429|NCT00249288|3579650|FG001|Initiated Treatment|Overall Study||15
2875430|NCT00249288|3579649|FG000|COMPLETED|Overall Study||14
2875431|NCT00249288|3579650|FG001|COMPLETED|Overall Study||14
2875432|NCT00249288|3579649|FG000|NOT COMPLETED|Overall Study||5
2875433|NCT00249288|3579650|FG001|NOT COMPLETED|Overall Study||5
2918987|NCT00529659|3629369|FG001|STARTED|Overall Study||89
2918988|NCT00529659|3629368|FG000|COMPLETED|Overall Study||70
2918989|NCT00529659|3629369|FG001|COMPLETED|Overall Study||66
2918990|NCT00529659|3629368|FG000|NOT COMPLETED|Overall Study||11
2918991|NCT00529659|3629369|FG001|NOT COMPLETED|Overall Study||23
2918992|NCT00529789|3629375|FG000|STARTED|Study Period II/III||72
2918993|NCT00529789|3629375|FG000|COMPLETED|Study Period II/III||48
2918994|NCT00529789|3629375|FG000|NOT COMPLETED|Study Period II/III||24
2918995|NCT00529789|3629375|FG000|STARTED|Study Period IV||48
2918996|NCT00529789|3629375|FG000|COMPLETED|Study Period IV|Includes 1 patient who withdrew at last visit; didn't enter Taper; however received 30 weeks of drug|42
2918997|NCT00529789|3629375|FG000|NOT COMPLETED|Study Period IV||6
2918998|NCT00529802|3629385|FG000|STARTED|Evaluable for Primary Endpoint|60 patients started trial|60
2918999|NCT00529802|3629385|FG000|COMPLETED|Evaluable for Primary Endpoint|Evaluable for primary endpoint|50
2919000|NCT00529802|3629385|FG000|NOT COMPLETED|Evaluable for Primary Endpoint||10
2919001|NCT00529802|3629385|FG000|STARTED|Evaluable for Secondary Endpoint||50
2919002|NCT00529802|3629385|FG000|COMPLETED|Evaluable for Secondary Endpoint||48
2919003|NCT00529802|3629385|FG000|NOT COMPLETED|Evaluable for Secondary Endpoint||2
2919004|NCT00529958|3629394|FG000|STARTED|2-Year Follow-up||110
2919005|NCT00529958|3629395|FG001|STARTED|2-Year Follow-up|110 randomized to HT, but there was (n=1) cross-over from the DB group|110
2919006|NCT00529958|3629396|FG002|STARTED|2-Year Follow-up|110 randomized to DB, but there was (n=1) cross-over to the HT group|110
2919007|NCT00529958|3629394|FG000|COMPLETED|2-Year Follow-up||106
2919008|NCT00529958|3629395|FG001|COMPLETED|2-Year Follow-up|108 HT patients analyzed excludes n=1 cross-over patient (analyzed on intention-to-treat basis).|108
2919009|NCT00529958|3629396|FG002|COMPLETED|2-Year Follow-up|108 DB patients analyzed include 1 cross-over with HT graft (analyzed on intention-to-treat basis).|108
2919010|NCT00529958|3629394|FG000|NOT COMPLETED|2-Year Follow-up||4
3169811|NCT01928381|3897370|FG003|NOT COMPLETED|Screening for Pain Training||0
3169812|NCT01928381|3897371|FG004|NOT COMPLETED|Screening for Pain Training||0
3169813|NCT01928381|3897372|FG005|NOT COMPLETED|Screening for Pain Training||0
3169814|NCT01928381|3897373|FG006|NOT COMPLETED|Screening for Pain Training||0
3169815|NCT01928381|3897367|FG000|STARTED|Part 1 - Pain Training||83
3169816|NCT01928381|3897368|FG001|STARTED|Part 1 - Pain Training||0
2919011|NCT00529958|3629395|FG001|NOT COMPLETED|2-Year Follow-up||2
2919012|NCT00529958|3629396|FG002|NOT COMPLETED|2-Year Follow-up||2
2919013|NCT00529958|3629394|FG000|STARTED|5-Year Follow-up||106
2919014|NCT00529958|3629395|FG001|STARTED|5-Year Follow-up|108 HT patients available for 5-year follow-up excludes n=1 cross-over patient from the DB group|108
2919015|NCT00529958|3629396|FG002|STARTED|5-Year Follow-up|108 DB patients available for 5-year follow-up includes n=1 cross-over with a single-bundle HT graft|108
2919016|NCT00529958|3629394|FG000|COMPLETED|5-Year Follow-up||103
2919017|NCT00529958|3629395|FG001|COMPLETED|5-Year Follow-up||105
2919018|NCT00529958|3629396|FG002|COMPLETED|5-Year Follow-up||107
2919019|NCT00529958|3629394|FG000|NOT COMPLETED|5-Year Follow-up||3
2919020|NCT00529958|3629395|FG001|NOT COMPLETED|5-Year Follow-up||3
2919021|NCT00529958|3629396|FG002|NOT COMPLETED|5-Year Follow-up||1
2919022|NCT00530023|3629406|FG000|STARTED|Overall Study||14
2919023|NCT00530023|3629407|FG001|STARTED|Overall Study||15
2919024|NCT00530023|3629406|FG000|COMPLETED|Overall Study||14
2919025|NCT00530023|3629407|FG001|COMPLETED|Overall Study||14
2919026|NCT00530023|3629406|FG000|NOT COMPLETED|Overall Study||0
2919027|NCT00530023|3629407|FG001|NOT COMPLETED|Overall Study||1
2919028|NCT00530075|3629413|FG000|STARTED|Overall Study||45
2919029|NCT00530075|3629413|FG000|COMPLETED|Overall Study||38
2875434|NCT00249379|3579666|FG000|STARTED|Overall Study||14
2875435|NCT00249379|3579667|FG001|STARTED|Overall Study||12
2875436|NCT00249379|3579666|FG000|COMPLETED|Overall Study||6
2875437|NCT00249379|3579667|FG001|COMPLETED|Overall Study||4
2875438|NCT00249379|3579666|FG000|NOT COMPLETED|Overall Study||8
2875439|NCT00249379|3579667|FG001|NOT COMPLETED|Overall Study||8
2875440|NCT00249444|3579675|FG000|STARTED|Overall Study||42
2875441|NCT00249444|3579676|FG001|STARTED|Overall Study||44
2875442|NCT00249444|3579675|FG000|COMPLETED|Overall Study||30
2875443|NCT00249444|3579676|FG001|COMPLETED|Overall Study||29
2875444|NCT00249444|3579675|FG000|NOT COMPLETED|Overall Study||12
2875445|NCT00249444|3579676|FG001|NOT COMPLETED|Overall Study||15
2875446|NCT00249470|3579684|FG000|STARTED|Overall Study||28
2875447|NCT00249470|3579685|FG001|STARTED|Overall Study||28
2875448|NCT00249470|3579684|FG000|COMPLETED|Overall Study||28
2875449|NCT00249470|3579685|FG001|COMPLETED|Overall Study||28
2875450|NCT00249470|3579684|FG000|NOT COMPLETED|Overall Study||0
2875451|NCT00249470|3579685|FG001|NOT COMPLETED|Overall Study||0
2875452|NCT00249496|3579693|FG000|STARTED|Overall Study||24
2875453|NCT00249496|3579694|FG001|STARTED|Overall Study||27
2875454|NCT00249496|3579693|FG000|COMPLETED|Overall Study||24
2875455|NCT00249496|3579694|FG001|COMPLETED|Overall Study||26
2875456|NCT00249496|3579693|FG000|NOT COMPLETED|Overall Study||0
2875457|NCT00249496|3579694|FG001|NOT COMPLETED|Overall Study||1
2875458|NCT00249613|3579704|FG000|STARTED|Baseline||152
2875459|NCT00249613|3579705|FG001|STARTED|Baseline||139
2875460|NCT00249613|3579704|FG000|COMPLETED|Baseline||152
2875461|NCT00249613|3579705|FG001|COMPLETED|Baseline||139
2875462|NCT00249613|3579704|FG000|NOT COMPLETED|Baseline||0
2875463|NCT00249613|3579705|FG001|NOT COMPLETED|Baseline||0
2875464|NCT00249613|3579704|FG000|STARTED|12 Month Follow-up||152
2875465|NCT00249613|3579705|FG001|STARTED|12 Month Follow-up||139
2875466|NCT00249613|3579704|FG000|COMPLETED|12 Month Follow-up||135
2875467|NCT00249613|3579705|FG001|COMPLETED|12 Month Follow-up||124
2875468|NCT00249613|3579704|FG000|NOT COMPLETED|12 Month Follow-up||17
2875469|NCT00249613|3579705|FG001|NOT COMPLETED|12 Month Follow-up||15
2875470|NCT00249769|3579717|FG000|STARTED|Overall Study||100
2875471|NCT00249769|3579718|FG001|STARTED|Overall Study||250
2875472|NCT00249769|3579719|FG002|STARTED|Overall Study||250
2875473|NCT00249769|3579717|FG000|Received LJEV|Overall Study||100
2875474|NCT00249769|3579718|FG001|Received LJEV|Overall Study||236
2875475|NCT00249769|3579719|FG002|Received LJEV|Overall Study||224
2875476|NCT00249769|3579717|FG000|Received Measles Vaccine|Overall Study||97
2875477|NCT00249769|3579718|FG001|Received Measles Vaccine|Overall Study||236
2875478|NCT00249769|3579719|FG002|Received Measles Vaccine|Overall Study||235
2875479|NCT00249769|3579717|FG000|COMPLETED|Overall Study||98
2875480|NCT00249769|3579718|FG001|COMPLETED|Overall Study||235
2875481|NCT00249769|3579719|FG002|COMPLETED|Overall Study||222
2875482|NCT00249769|3579717|FG000|NOT COMPLETED|Overall Study||2
2875483|NCT00249769|3579718|FG001|NOT COMPLETED|Overall Study||15
2875484|NCT00249769|3579719|FG002|NOT COMPLETED|Overall Study||28
2875485|NCT00249795|3579729|FG000|STARTED|Overall Study|randomized patients: patients remained in the study whether treated or not until planned study end|4518
2875486|NCT00249795|3579730|FG001|STARTED|Overall Study|randomized patients: patients remained in the study whether treated or not until planned study end|4498
2875487|NCT00249795|3579729|FG000|COMPLETED|Overall Study|started and completed study drug|3124
2875488|NCT00249795|3579730|FG001|COMPLETED|Overall Study|started and completed study drug|3108
2875489|NCT00249795|3579729|FG000|NOT COMPLETED|Overall Study||1394
2875490|NCT00249795|3579730|FG001|NOT COMPLETED|Overall Study||1390
2875491|NCT00249808|3579736|FG000|STARTED|Overall Study||1266
2875492|NCT00249808|3579736|FG000|COMPLETED|Overall Study||1084
2875493|NCT00249808|3579736|FG000|NOT COMPLETED|Overall Study||182
2875494|NCT00249821|3579742|FG000|STARTED|Overall Study||10
2875495|NCT00249821|3579743|FG001|STARTED|Overall Study||12
2875496|NCT00249821|3579742|FG000|COMPLETED|Overall Study||10
2875497|NCT00249821|3579743|FG001|COMPLETED|Overall Study||11
2875498|NCT00249821|3579742|FG000|NOT COMPLETED|Overall Study||0
2875499|NCT00249821|3579743|FG001|NOT COMPLETED|Overall Study||1
2875500|NCT00249834|3579757|FG000|STARTED|Overall Study||1
2875501|NCT00249834|3579758|FG001|STARTED|Overall Study||48
2875502|NCT00249834|3579759|FG002|STARTED|Overall Study||45
2875503|NCT00249834|3579760|FG003|STARTED|Overall Study||34
2875504|NCT00249834|3579761|FG004|STARTED|Overall Study||24
2875505|NCT00249834|3579762|FG005|STARTED|Overall Study||10
2875506|NCT00249834|3579763|FG006|STARTED|Overall Study||2
2875507|NCT00249834|3579764|FG007|STARTED|Overall Study||2
2875508|NCT00249834|3579757|FG000|COMPLETED|Overall Study||0
2875509|NCT00249834|3579758|FG001|COMPLETED|Overall Study||29
2875510|NCT00249834|3579759|FG002|COMPLETED|Overall Study||31
2875511|NCT00249834|3579760|FG003|COMPLETED|Overall Study||26
2875512|NCT00249834|3579761|FG004|COMPLETED|Overall Study||19
2875513|NCT00249834|3579762|FG005|COMPLETED|Overall Study||8
2875514|NCT00249834|3579763|FG006|COMPLETED|Overall Study||1
2875515|NCT00249834|3579764|FG007|COMPLETED|Overall Study||2
2875516|NCT00249834|3579757|FG000|NOT COMPLETED|Overall Study||1
2875517|NCT00249834|3579758|FG001|NOT COMPLETED|Overall Study||19
2875518|NCT00249834|3579759|FG002|NOT COMPLETED|Overall Study||14
2875519|NCT00249834|3579760|FG003|NOT COMPLETED|Overall Study||8
2875520|NCT00249834|3579761|FG004|NOT COMPLETED|Overall Study||5
2875521|NCT00249834|3579762|FG005|NOT COMPLETED|Overall Study||2
2875522|NCT00249834|3579763|FG006|NOT COMPLETED|Overall Study||1
2875523|NCT00249834|3579764|FG007|NOT COMPLETED|Overall Study||0
2875524|NCT00249873|3579778|FG000|STARTED|Overall Study|randomized patients: patients remained in the study whether treated or not until planned study end|3772
2875525|NCT00249873|3579779|FG001|STARTED|Overall Study|randomized patients: patients remained in the study whether treated or not until planned study end|3782
2875526|NCT00249873|3579778|FG000|COMPLETED|Overall Study|started and completed study drug|2442
2875527|NCT00249873|3579779|FG001|COMPLETED|Overall Study|started and completed study drug|2528
2875528|NCT00249873|3579778|FG000|NOT COMPLETED|Overall Study||1330
2875529|NCT00249873|3579779|FG001|NOT COMPLETED|Overall Study||1254
2875530|NCT00250276|3579789|FG000|STARTED|Overall Study||199
2875531|NCT00250276|3579790|FG001|STARTED|Overall Study||198
2875532|NCT00250276|3579791|FG002|STARTED|Overall Study||201
2875533|NCT00250276|3579792|FG003|STARTED|Overall Study||200
2875534|NCT00250276|3579789|FG000|COMPLETED|Overall Study||182
2875535|NCT00250276|3579790|FG001|COMPLETED|Overall Study||177
2875536|NCT00250276|3579791|FG002|COMPLETED|Overall Study||182
2875537|NCT00250276|3579792|FG003|COMPLETED|Overall Study||181
2875538|NCT00250276|3579789|FG000|NOT COMPLETED|Overall Study||17
2875539|NCT00250276|3579790|FG001|NOT COMPLETED|Overall Study||21
2875540|NCT00250276|3579791|FG002|NOT COMPLETED|Overall Study||19
2875541|NCT00250276|3579792|FG003|NOT COMPLETED|Overall Study||19
2875542|NCT00250432|3579809|FG000|STARTED|Overall Study||104
2875543|NCT00250432|3579810|FG001|STARTED|Overall Study||100
2875544|NCT00250432|3579809|FG000|COMPLETED|Overall Study||59
2875545|NCT00250432|3579810|FG001|COMPLETED|Overall Study||53
2875546|NCT00250432|3579809|FG000|NOT COMPLETED|Overall Study||45
2875547|NCT00250432|3579810|FG001|NOT COMPLETED|Overall Study||47
2875548|NCT00250484|3579818|FG000|STARTED|Overall Study||9
2875549|NCT00250484|3579819|FG001|STARTED|Overall Study||8
2875550|NCT00250484|3579818|FG000|COMPLETED|Overall Study||9
2875551|NCT00250484|3579819|FG001|COMPLETED|Overall Study||8
2875552|NCT00250484|3579818|FG000|NOT COMPLETED|Overall Study||0
2875553|NCT00250484|3579819|FG001|NOT COMPLETED|Overall Study||0
2875554|NCT00250497|3579827|FG000|STARTED|Overall Study||182
2875555|NCT00250497|3579828|FG001|STARTED|Overall Study||174
2875556|NCT00250497|3579827|FG000|COMPLETED|Overall Study||177
2875557|NCT00250497|3579828|FG001|COMPLETED|Overall Study||159
2875558|NCT00250497|3579827|FG000|NOT COMPLETED|Overall Study||5
2875559|NCT00250497|3579828|FG001|NOT COMPLETED|Overall Study||15
2875560|NCT00250588|3579837|FG000|STARTED|Overall Study||81
2875561|NCT00250588|3579838|FG001|STARTED|Overall Study||84
2875562|NCT00250588|3579839|FG002|STARTED|Overall Study||87
2875563|NCT00250588|3579837|FG000|COMPLETED|Overall Study||72
2875564|NCT00250588|3579838|FG001|COMPLETED|Overall Study||65
2875565|NCT00250588|3579839|FG002|COMPLETED|Overall Study||74
2875566|NCT00250588|3579837|FG000|NOT COMPLETED|Overall Study||9
2875567|NCT00250588|3579838|FG001|NOT COMPLETED|Overall Study||19
2875568|NCT00250588|3579839|FG002|NOT COMPLETED|Overall Study||13
2875569|NCT00250679|3579850|FG000|STARTED|Overall Study||147
2875570|NCT00250679|3579851|FG001|STARTED|Overall Study||149
2875571|NCT00250679|3579852|FG002|STARTED|Overall Study||147
2875572|NCT00250679|3579850|FG000|COMPLETED|Overall Study||108
2875573|NCT00250679|3579851|FG001|COMPLETED|Overall Study||100
2875574|NCT00250679|3579852|FG002|COMPLETED|Overall Study||103
2875575|NCT00250679|3579850|FG000|NOT COMPLETED|Overall Study||39
2875576|NCT00250679|3579851|FG001|NOT COMPLETED|Overall Study||49
2875577|NCT00250679|3579852|FG002|NOT COMPLETED|Overall Study||44
2875578|NCT00250705|3579860|FG000|STARTED|Overall Study||12
2875579|NCT00250705|3579860|FG000|COMPLETED|Overall Study||10
2875580|NCT00250705|3579860|FG000|NOT COMPLETED|Overall Study||2
2875581|NCT00250835|3579866|FG000|STARTED|Overall Study||38
2875582|NCT00250835|3579866|FG000|COMPLETED|Overall Study||37
2875583|NCT00250835|3579866|FG000|NOT COMPLETED|Overall Study||1
2875584|NCT00250926|3579870|FG000|STARTED|Overall Study||23
2875585|NCT00250926|3579870|FG000|COMPLETED|Overall Study||23
2875586|NCT00250926|3579870|FG000|NOT COMPLETED|Overall Study||0
2875587|NCT00251004|3579878|FG000|STARTED|Overall Study||277
2875588|NCT00251004|3579879|FG001|STARTED|Overall Study||279
2875589|NCT00251004|3579880|FG002|STARTED|Overall Study||277
2875590|NCT00251004|3579878|FG000|12 Month Analysis|Overall Study|Under 12 month analysis under group 1, 179 Completed study medication.|241
2875591|NCT00251004|3579879|FG001|12 Month Analysis|Overall Study|Under 12 month analysis under group 2, 175 Completed study medication.|249
2875592|NCT00251004|3579880|FG002|12 Month Analysis|Overall Study|Under 12 month analysis under group 3, 200 Completed study medication.|253
2875593|NCT00251004|3579878|FG000|24 Month Analysis|Overall Study|Under 24 month analysis under group 1, 167 Completed study medication.|232
2875594|NCT00251004|3579879|FG001|24 Month Analysis|Overall Study|Under 24 month analysis under group 2, 161 Completed study medication.|238
2875595|NCT00251004|3579880|FG002|24 Month Analysis|Overall Study|Under 24 month analysis under group 3, 185 Completed study medication.|246
2875596|NCT00251004|3579878|FG000|COMPLETED|Overall Study||232
2875597|NCT00251004|3579879|FG001|COMPLETED|Overall Study||238
2875598|NCT00251004|3579880|FG002|COMPLETED|Overall Study||246
2875599|NCT00251004|3579878|FG000|NOT COMPLETED|Overall Study||45
2875600|NCT00251004|3579879|FG001|NOT COMPLETED|Overall Study||41
2875601|NCT00251004|3579880|FG002|NOT COMPLETED|Overall Study||31
2875602|NCT00251225|3579888|FG000|STARTED|Overall Study||49
2875603|NCT00251225|3579888|FG000|COMPLETED|Overall Study||49
2875604|NCT00251225|3579888|FG000|NOT COMPLETED|Overall Study||0
2875605|NCT00251238|3579894|FG000|STARTED|Overall Study||21
2875606|NCT00251238|3579895|FG001|STARTED|Overall Study||20
2875607|NCT00251238|3579894|FG000|COMPLETED|Overall Study||21
2875608|NCT00251238|3579895|FG001|COMPLETED|Overall Study||20
2875609|NCT00251238|3579894|FG000|NOT COMPLETED|Overall Study||0
2875610|NCT00251238|3579895|FG001|NOT COMPLETED|Overall Study||0
2875611|NCT00251303|3579903|FG000|STARTED|Overall Study|78 subjects signed any consent. 60 started drug (30 riluzole & 30 placebo).|30
2875612|NCT00251303|3579904|FG001|STARTED|Overall Study||30
2875613|NCT00251303|3579903|FG000|COMPLETED|Overall Study||22
2875614|NCT00251303|3579904|FG001|COMPLETED|Overall Study||29
2875615|NCT00251303|3579903|FG000|NOT COMPLETED|Overall Study||8
2875616|NCT00251303|3579904|FG001|NOT COMPLETED|Overall Study||1
2875617|NCT00251316|3579914|FG000|STARTED|Overall Study||17
2875618|NCT00251316|3579915|FG001|STARTED|Overall Study||17
2875619|NCT00251316|3579914|FG000|COMPLETED|Overall Study||15
2875620|NCT00251316|3579915|FG001|COMPLETED|Overall Study||14
2875621|NCT00251316|3579914|FG000|NOT COMPLETED|Overall Study||2
2875622|NCT00251316|3579915|FG001|NOT COMPLETED|Overall Study||3
2875623|NCT00251589|3579925|FG000|STARTED|Overall Study|4 of the 16 patients participated in Phase I and II portions. 12 participated in Phase II only.|16
2875624|NCT00251589|3579926|FG001|STARTED|Overall Study||3
2875625|NCT00251589|3579927|FG002|STARTED|Overall Study||2
2875626|NCT00251589|3579928|FG003|STARTED|Overall Study||2
2875627|NCT00251589|3579925|FG000|COMPLETED|Overall Study||1
2875628|NCT00251589|3579926|FG001|COMPLETED|Overall Study||0
2875629|NCT00251589|3579927|FG002|COMPLETED|Overall Study||0
2875630|NCT00251589|3579928|FG003|COMPLETED|Overall Study||0
2875631|NCT00251589|3579925|FG000|NOT COMPLETED|Overall Study||15
2875632|NCT00251589|3579926|FG001|NOT COMPLETED|Overall Study||3
2875633|NCT00251589|3579927|FG002|NOT COMPLETED|Overall Study||2
2875634|NCT00251589|3579928|FG003|NOT COMPLETED|Overall Study||2
2875635|NCT00251641|3579940|FG000|STARTED|Overall Study||653
2875636|NCT00251641|3579941|FG001|STARTED|Overall Study||215
2875637|NCT00251641|3579940|FG000|COMPLETED|Overall Study||541
2875638|NCT00251641|3579941|FG001|COMPLETED|Overall Study||127
2875639|NCT00251641|3579940|FG000|NOT COMPLETED|Overall Study||112
2875640|NCT00251641|3579941|FG001|NOT COMPLETED|Overall Study||88
2875641|NCT00251693|3579952|FG000|STARTED|Overall Study||680
2875642|NCT00251693|3579953|FG001|STARTED|Overall Study||668
2875643|NCT00251693|3579954|FG002|STARTED|Overall Study||690
2875644|NCT00251693|3579952|FG000|COMPLETED|Overall Study||629
2875645|NCT00251693|3579953|FG001|COMPLETED|Overall Study||624
2875646|NCT00251693|3579954|FG002|COMPLETED|Overall Study||644
2875647|NCT00251693|3579952|FG000|NOT COMPLETED|Overall Study||51
2875648|NCT00251693|3579953|FG001|NOT COMPLETED|Overall Study||44
2875649|NCT00251693|3579954|FG002|NOT COMPLETED|Overall Study||46
2875650|NCT00251719|3579965|FG000|STARTED|Overall Study||694
2875651|NCT00251719|3579966|FG001|STARTED|Overall Study||687
2875652|NCT00251719|3579967|FG002|STARTED|Overall Study||673
2875653|NCT00251719|3579965|FG000|COMPLETED|Overall Study||641
2875654|NCT00251719|3579966|FG001|COMPLETED|Overall Study||642
2875655|NCT00251719|3579967|FG002|COMPLETED|Overall Study||643
2875656|NCT00251719|3579965|FG000|NOT COMPLETED|Overall Study||53
2875657|NCT00251719|3579966|FG001|NOT COMPLETED|Overall Study||45
2875658|NCT00251719|3579967|FG002|NOT COMPLETED|Overall Study||30
2875659|NCT00251745|3579978|FG000|STARTED|Overall Study||292
2875660|NCT00251745|3579979|FG001|STARTED|Overall Study||312
2875661|NCT00251745|3579980|FG002|STARTED|Overall Study||304
2875662|NCT00251745|3579978|FG000|COMPLETED|Overall Study||264
2875663|NCT00251745|3579979|FG001|COMPLETED|Overall Study||285
2875664|NCT00251745|3579980|FG002|COMPLETED|Overall Study||277
2875665|NCT00251745|3579978|FG000|NOT COMPLETED|Overall Study||28
2875666|NCT00251745|3579979|FG001|NOT COMPLETED|Overall Study||27
2875667|NCT00251745|3579980|FG002|NOT COMPLETED|Overall Study||27
2875668|NCT00251758|3579991|FG000|STARTED|Overall Study||292
2875669|NCT00251758|3579992|FG001|STARTED|Overall Study||312
2875670|NCT00251758|3579993|FG002|STARTED|Overall Study||304
2875671|NCT00251758|3579991|FG000|COMPLETED|Overall Study||264
2875672|NCT00251758|3579992|FG001|COMPLETED|Overall Study||285
2875673|NCT00251758|3579993|FG002|COMPLETED|Overall Study||277
2875674|NCT00251758|3579991|FG000|NOT COMPLETED|Overall Study||28
2875675|NCT00251758|3579992|FG001|NOT COMPLETED|Overall Study||27
2875676|NCT00251758|3579993|FG002|NOT COMPLETED|Overall Study||27
2875677|NCT00251862|3580004|FG000|STARTED|Overall Study||280
2875678|NCT00251862|3580005|FG001|STARTED|Overall Study||269
2875679|NCT00251862|3580006|FG002|STARTED|Overall Study||276
2875680|NCT00251862|3580004|FG000|COMPLETED|Overall Study||280
2875681|NCT00251862|3580005|FG001|COMPLETED|Overall Study||269
2875682|NCT00251862|3580006|FG002|COMPLETED|Overall Study||276
2875683|NCT00251862|3580004|FG000|NOT COMPLETED|Overall Study||0
2875684|NCT00251862|3580005|FG001|NOT COMPLETED|Overall Study||0
2875685|NCT00251862|3580006|FG002|NOT COMPLETED|Overall Study||0
2875686|NCT00251927|3580016|FG000|STARTED|Overall Study|Randomised|288
2875687|NCT00251927|3580017|FG001|STARTED|Overall Study|Randomised|266
2875688|NCT00251927|3580016|FG000|COMPLETED|Overall Study|Completed 5 year visit|180
2875689|NCT00251927|3580017|FG001|COMPLETED|Overall Study|Completed 5 year visit|192
2875690|NCT00251927|3580016|FG000|NOT COMPLETED|Overall Study||108
2875691|NCT00251927|3580017|FG001|NOT COMPLETED|Overall Study||74
2875692|NCT00251979|3580026|FG000|STARTED|Overall Study|ITT population|375
2875693|NCT00251979|3580027|FG001|STARTED|Overall Study|ITT population|389
2875694|NCT00251979|3580026|FG000|COMPLETED|Overall Study||337
2875695|NCT00251979|3580027|FG001|COMPLETED|Overall Study||349
2875696|NCT00251979|3580026|FG000|NOT COMPLETED|Overall Study||38
2875697|NCT00251979|3580027|FG001|NOT COMPLETED|Overall Study||40
2875698|NCT00252057|3580035|FG000|STARTED|Overall Study||373
2875699|NCT00252057|3580036|FG001|STARTED|Overall Study||376
2875700|NCT00252057|3580035|FG000|COMPLETED|Overall Study||370
2875701|NCT00252057|3580036|FG001|COMPLETED|Overall Study||368
2875702|NCT00252057|3580035|FG000|NOT COMPLETED|Overall Study||3
2875703|NCT00252057|3580036|FG001|NOT COMPLETED|Overall Study||8
2875704|NCT00252187|3580044|FG000|STARTED|Overall Study||24
2875705|NCT00252187|3580045|FG001|STARTED|Overall Study||21
2875706|NCT00252187|3580044|FG000|COMPLETED|Overall Study||20
2875707|NCT00252187|3580045|FG001|COMPLETED|Overall Study||20
2875708|NCT00252187|3580044|FG000|NOT COMPLETED|Overall Study||4
2875709|NCT00252187|3580045|FG001|NOT COMPLETED|Overall Study||1
2875710|NCT00252239|3580055|FG000|STARTED|Overall Study||31
2875711|NCT00252239|3580056|FG001|STARTED|Overall Study||31
2875712|NCT00252239|3580057|FG002|STARTED|Overall Study||19
2875713|NCT00252239|3580058|FG003|STARTED|Overall Study||31
2875714|NCT00252239|3580055|FG000|COMPLETED|Overall Study||30
2875715|NCT00252239|3580056|FG001|COMPLETED|Overall Study||31
2875716|NCT00252239|3580057|FG002|COMPLETED|Overall Study||17
2875717|NCT00252239|3580058|FG003|COMPLETED|Overall Study||30
2875718|NCT00252239|3580055|FG000|NOT COMPLETED|Overall Study||1
2875719|NCT00252239|3580056|FG001|NOT COMPLETED|Overall Study||0
2875720|NCT00252239|3580057|FG002|NOT COMPLETED|Overall Study||2
2875721|NCT00252239|3580058|FG003|NOT COMPLETED|Overall Study||1
2875722|NCT00252382|3580068|FG000|STARTED|Overall Study||31
2875723|NCT00252382|3580068|FG000|COMPLETED|Overall Study||5
3169817|NCT01928381|3897369|FG002|STARTED|Part 1 - Pain Training||0
3169818|NCT01928381|3897370|FG003|STARTED|Part 1 - Pain Training||0
3169819|NCT01928381|3897371|FG004|STARTED|Part 1 - Pain Training||0
3169820|NCT01928381|3897372|FG005|STARTED|Part 1 - Pain Training||0
3169821|NCT01928381|3897373|FG006|STARTED|Part 1 - Pain Training||0
3169822|NCT01928381|3897367|FG000|COMPLETED|Part 1 - Pain Training||48
3169823|NCT01928381|3897368|FG001|COMPLETED|Part 1 - Pain Training||0
3169824|NCT01928381|3897369|FG002|COMPLETED|Part 1 - Pain Training||0
2875724|NCT00252382|3580068|FG000|NOT COMPLETED|Overall Study||26
2875725|NCT00252499|3580075|FG000|STARTED|Overall Study||5
2875726|NCT00252499|3580076|FG001|STARTED|Overall Study||2
2875727|NCT00252499|3580077|FG002|STARTED|Overall Study||6
2875728|NCT00252499|3580075|FG000|COMPLETED|Overall Study||4
2875729|NCT00252499|3580076|FG001|COMPLETED|Overall Study||2
2875730|NCT00252499|3580077|FG002|COMPLETED|Overall Study||6
2875731|NCT00252499|3580075|FG000|NOT COMPLETED|Overall Study||1
2875732|NCT00252499|3580076|FG001|NOT COMPLETED|Overall Study||0
2875733|NCT00252499|3580077|FG002|NOT COMPLETED|Overall Study||0
2875734|NCT00252512|3580087|FG000|STARTED|Intervention||165
2875735|NCT00252512|3580088|FG001|STARTED|Intervention||165
2875736|NCT00252512|3580087|FG000|COMPLETED|Intervention||136
2875737|NCT00252512|3580088|FG001|COMPLETED|Intervention||134
2875738|NCT00252512|3580087|FG000|NOT COMPLETED|Intervention||29
2875739|NCT00252512|3580088|FG001|NOT COMPLETED|Intervention||31
2875740|NCT00252512|3580087|FG000|STARTED|Six Month Follow up||136
2875741|NCT00252512|3580088|FG001|STARTED|Six Month Follow up||134
2875742|NCT00252512|3580087|FG000|COMPLETED|Six Month Follow up||132
2875743|NCT00252512|3580088|FG001|COMPLETED|Six Month Follow up||122
2875744|NCT00252512|3580087|FG000|NOT COMPLETED|Six Month Follow up||4
2875745|NCT00252512|3580088|FG001|NOT COMPLETED|Six Month Follow up||12
2875746|NCT00252512|3580087|FG000|STARTED|12 Month Follow up||132
2875747|NCT00252512|3580088|FG001|STARTED|12 Month Follow up||122
2875748|NCT00252512|3580087|FG000|COMPLETED|12 Month Follow up||123
2875749|NCT00252512|3580088|FG001|COMPLETED|12 Month Follow up||121
2875750|NCT00252512|3580087|FG000|NOT COMPLETED|12 Month Follow up||9
2875751|NCT00252512|3580088|FG001|NOT COMPLETED|12 Month Follow up||1
2875752|NCT00252538|3580094|FG000|STARTED|Overall Study||19
2875753|NCT00252538|3580095|FG001|STARTED|Overall Study||114
2875754|NCT00252538|3580094|FG000|COMPLETED|Overall Study||19
2875755|NCT00252538|3580095|FG001|COMPLETED|Overall Study||114
2875756|NCT00252538|3580094|FG000|NOT COMPLETED|Overall Study||0
2875757|NCT00252538|3580095|FG001|NOT COMPLETED|Overall Study||0
2875758|NCT00252564|3580102|FG000|STARTED|Overall Study|From randomization|124
2875759|NCT00252564|3580103|FG001|STARTED|Overall Study|From randomization|123
2875760|NCT00252564|3580102|FG000|COMPLETED|Overall Study|Received 6+ cycles OR had response (RECIST criteria, CR or PR)|85
2875761|NCT00252564|3580103|FG001|COMPLETED|Overall Study|Received 6+ cycles OR had response (RECIST criteria, CR or PR)|79
2875762|NCT00252564|3580102|FG000|NOT COMPLETED|Overall Study||39
2875763|NCT00252564|3580103|FG001|NOT COMPLETED|Overall Study||44
2875764|NCT00252577|3580109|FG000|STARTED|Overall Study||130
2875765|NCT00252577|3580109|FG000|COMPLETED|Overall Study||110
2875766|NCT00252577|3580109|FG000|NOT COMPLETED|Overall Study||20
2875767|NCT00252590|3580116|FG000|STARTED|Overall Study||35
2875768|NCT00252590|3580117|FG001|STARTED|Overall Study||30
2875769|NCT00252590|3580118|FG002|STARTED|Overall Study||34
2875770|NCT00252590|3580116|FG000|COMPLETED|Overall Study||33
2875771|NCT00252590|3580117|FG001|COMPLETED|Overall Study||28
2875772|NCT00252590|3580118|FG002|COMPLETED|Overall Study||31
2875773|NCT00252590|3580116|FG000|NOT COMPLETED|Overall Study||2
2875774|NCT00252590|3580117|FG001|NOT COMPLETED|Overall Study||2
2875775|NCT00252590|3580118|FG002|NOT COMPLETED|Overall Study||3
2875776|NCT00252629|3580129|FG000|STARTED|Overall Study||9
2875777|NCT00252629|3580130|FG001|STARTED|Overall Study||9
2875778|NCT00252629|3580131|FG002|STARTED|Overall Study|We used data from the 18 veterans with GWS in addition to the 11 control|11
3169825|NCT01928381|3897370|FG003|COMPLETED|Part 1 - Pain Training||0
2875779|NCT00252629|3580129|FG000|COMPLETED|Overall Study|One participant assigned to therapeutic CPAP was excluded from the trial before starting treatment.|8
2875780|NCT00252629|3580130|FG001|COMPLETED|Overall Study||9
2875781|NCT00252629|3580131|FG002|COMPLETED|Overall Study|We used data from the 18 veterans with GWS in addition to the 11 control|11
2875782|NCT00252629|3580129|FG000|NOT COMPLETED|Overall Study||1
2875783|NCT00252629|3580130|FG001|NOT COMPLETED|Overall Study||0
2875784|NCT00252629|3580131|FG002|NOT COMPLETED|Overall Study||0
2875785|NCT00252694|3580146|FG000|STARTED|Overall Study||951
2875786|NCT00252694|3580147|FG001|STARTED|Overall Study||954
2875787|NCT00252694|3580146|FG000|COMPLETED|Overall Study||807
2875788|NCT00252694|3580147|FG001|COMPLETED|Overall Study||800
2875789|NCT00252694|3580146|FG000|NOT COMPLETED|Overall Study||144
2875790|NCT00252694|3580147|FG001|NOT COMPLETED|Overall Study||154
2875791|NCT00252720|3580155|FG000|STARTED|Overall Study||951
2875792|NCT00252720|3580156|FG001|STARTED|Overall Study||954
2875793|NCT00252720|3580155|FG000|COMPLETED|Overall Study||819
2875794|NCT00252720|3580156|FG001|COMPLETED|Overall Study||789
2875795|NCT00252720|3580155|FG000|NOT COMPLETED|Overall Study||132
2875796|NCT00252720|3580156|FG001|NOT COMPLETED|Overall Study||165
2875797|NCT00252733|3580164|FG000|STARTED|Overall Study||711
2875798|NCT00252733|3580165|FG001|STARTED|Overall Study||710
2875799|NCT00252733|3580164|FG000|COMPLETED|Overall Study||605
2875800|NCT00252733|3580165|FG001|COMPLETED|Overall Study||618
2875801|NCT00252733|3580164|FG000|NOT COMPLETED|Overall Study||106
2875802|NCT00252733|3580165|FG001|NOT COMPLETED|Overall Study||92
2875803|NCT00252967|3580173|FG000|STARTED|Overall Study||31
2875804|NCT00252967|3580174|FG001|STARTED|Overall Study||33
2875805|NCT00252967|3580173|FG000|COMPLETED|Overall Study||31
2875806|NCT00252967|3580174|FG001|COMPLETED|Overall Study||33
2875807|NCT00252967|3580173|FG000|NOT COMPLETED|Overall Study||0
2875808|NCT00252967|3580174|FG001|NOT COMPLETED|Overall Study||0
2875809|NCT00253019|3580183|FG000|STARTED|Overall Study||111
2875810|NCT00253019|3580184|FG001|STARTED|Overall Study||109
2875811|NCT00253019|3580185|FG002|STARTED|Overall Study||101
2875812|NCT00253019|3580183|FG000|COMPLETED|Overall Study||82
2875813|NCT00253019|3580184|FG001|COMPLETED|Overall Study||78
2875814|NCT00253019|3580185|FG002|COMPLETED|Overall Study||83
2875815|NCT00253019|3580183|FG000|NOT COMPLETED|Overall Study||29
2875816|NCT00253019|3580184|FG001|NOT COMPLETED|Overall Study||31
2875817|NCT00253019|3580185|FG002|NOT COMPLETED|Overall Study||18
2875818|NCT00253370|3580193|FG000|STARTED|Overall Study||44
2875819|NCT00253370|3580193|FG000|COMPLETED|Overall Study||1
2875820|NCT00253370|3580193|FG000|NOT COMPLETED|Overall Study||43
2875821|NCT00253435|3580200|FG000|STARTED|Overall Study|Total number is 42|42
2875822|NCT00253435|3580201|FG001|STARTED|Overall Study|This cohort opened as long as the poor risk group is open to accrual.|8
2875823|NCT00253435|3580200|FG000|1st Interim Analysis|Overall Study|First interim analysis: need 2+ responses in first 15 patients. Goal met study continued.|15
2875824|NCT00253435|3580201|FG001|1st Interim Analysis|Overall Study|Only interim analysis: need 1+ response in first 10 patients.|8
2875825|NCT00253435|3580200|FG000|2nd Interim Analysis|Overall Study|Second interim analysis: need 3+ responses in first 25 patients. Goal met study continued.|10
2875826|NCT00253435|3580201|FG001|2nd Interim Analysis|Overall Study|This cohort opened as long as the poor risk group is open to accrual.|0
2875827|NCT00253435|3580200|FG000|3rd Interim Analysis|Overall Study|Third interim analysis: need 4+ responses in first 35 patients. Goal met study continued.|10
2875828|NCT00253435|3580201|FG001|3rd Interim Analysis|Overall Study|This cohort opened as long as the poor risk group is open to accrual.|0
2875829|NCT00253435|3580200|FG000|COMPLETED|Overall Study|Forty-two evaluable poor risk patients enrolled.|42
2875830|NCT00253435|3580201|FG001|COMPLETED|Overall Study|Eight evaluable patients enrolled.|8
2875831|NCT00253435|3580200|FG000|NOT COMPLETED|Overall Study||0
2875832|NCT00253435|3580201|FG001|NOT COMPLETED|Overall Study||0
2875833|NCT00253448|3580207|FG000|STARTED|Overall Study||35
2875834|NCT00253448|3580207|FG000|COMPLETED|Overall Study||34
2875835|NCT00253448|3580207|FG000|NOT COMPLETED|Overall Study||1
2875836|NCT00253513|3580211|FG000|STARTED|Overall Study||60
2875837|NCT00253513|3580211|FG000|COMPLETED|Overall Study||60
2875838|NCT00253513|3580211|FG000|NOT COMPLETED|Overall Study||0
2875839|NCT00253630|3580215|FG000|STARTED|Overall Study||37
2875840|NCT00253630|3580215|FG000|COMPLETED|Overall Study||35
2875841|NCT00253630|3580215|FG000|NOT COMPLETED|Overall Study||2
2875842|NCT00253643|3580223|FG000|STARTED|Overall Study||14
2875843|NCT00253643|3580224|FG001|STARTED|Overall Study||15
2875844|NCT00253643|3580225|FG002|STARTED|Overall Study||29
2875845|NCT00253643|3580226|FG003|STARTED|Overall Study||31
2875846|NCT00253643|3580223|FG000|COMPLETED|Overall Study||14
2875847|NCT00253643|3580224|FG001|COMPLETED|Overall Study||15
2875848|NCT00253643|3580225|FG002|COMPLETED|Overall Study||28
2875849|NCT00253643|3580226|FG003|COMPLETED|Overall Study||28
2875850|NCT00253643|3580223|FG000|NOT COMPLETED|Overall Study||0
2875851|NCT00253643|3580224|FG001|NOT COMPLETED|Overall Study||0
2875852|NCT00253643|3580225|FG002|NOT COMPLETED|Overall Study||1
2875853|NCT00253643|3580226|FG003|NOT COMPLETED|Overall Study||3
2875854|NCT00253708|3580239|FG000|STARTED|Overall Study||20
2875855|NCT00253708|3580240|FG001|STARTED|Overall Study||10
3169826|NCT01928381|3897371|FG004|COMPLETED|Part 1 - Pain Training||0
3169827|NCT01928381|3897372|FG005|COMPLETED|Part 1 - Pain Training||0
3169828|NCT01928381|3897373|FG006|COMPLETED|Part 1 - Pain Training||0
3169829|NCT01928381|3897367|FG000|NOT COMPLETED|Part 1 - Pain Training||35
3169830|NCT01928381|3897368|FG001|NOT COMPLETED|Part 1 - Pain Training||0
2875856|NCT00253708|3580241|FG002|STARTED|Overall Study||9
2875857|NCT00253708|3580239|FG000|COMPLETED|Overall Study||20
2875858|NCT00253708|3580240|FG001|COMPLETED|Overall Study||10
2875859|NCT00253708|3580241|FG002|COMPLETED|Overall Study||8
2875860|NCT00253708|3580239|FG000|NOT COMPLETED|Overall Study||0
2875861|NCT00253708|3580240|FG001|NOT COMPLETED|Overall Study||0
2875862|NCT00253708|3580241|FG002|NOT COMPLETED|Overall Study||1
2875863|NCT00253747|3580251|FG000|STARTED|Overall Study||127
2875864|NCT00253747|3580252|FG001|STARTED|Overall Study||128
2875865|NCT00253747|3580251|FG000|COMPLETED|Overall Study||103
2875866|NCT00253747|3580252|FG001|COMPLETED|Overall Study||101
2875867|NCT00253747|3580251|FG000|NOT COMPLETED|Overall Study||24
2875868|NCT00253747|3580252|FG001|NOT COMPLETED|Overall Study||27
2875869|NCT00253890|3580270|FG000|STARTED|Overall Study||69
2875870|NCT00253890|3580271|FG001|STARTED|Overall Study||68
2875871|NCT00253890|3580270|FG000|COMPLETED|Overall Study||62
2875872|NCT00253890|3580271|FG001|COMPLETED|Overall Study||61
2875873|NCT00253890|3580270|FG000|NOT COMPLETED|Overall Study||7
2875874|NCT00253890|3580271|FG001|NOT COMPLETED|Overall Study||7
2875875|NCT00254072|3580279|FG000|STARTED|Overall Study||180
2875876|NCT00254072|3580280|FG001|STARTED|Overall Study||175
2875877|NCT00254072|3580279|FG000|COMPLETED|Overall Study||180
2875878|NCT00254072|3580280|FG001|COMPLETED|Overall Study||175
2875879|NCT00254072|3580279|FG000|NOT COMPLETED|Overall Study||0
2875880|NCT00254072|3580280|FG001|NOT COMPLETED|Overall Study||0
2875881|NCT00254163|3580288|FG000|STARTED|Overall Study||92
2875882|NCT00254163|3580289|FG001|STARTED|Overall Study||92
2875883|NCT00254163|3580288|FG000|COMPLETED|Overall Study||47
2875884|NCT00254163|3580289|FG001|COMPLETED|Overall Study||46
2875885|NCT00254163|3580288|FG000|NOT COMPLETED|Overall Study||45
2875886|NCT00254163|3580289|FG001|NOT COMPLETED|Overall Study||46
2875887|NCT00254293|3580301|FG000|STARTED|Short Term (12 Week) Randomized Dosing||7
2875888|NCT00254293|3580302|FG001|STARTED|Short Term (12 Week) Randomized Dosing||4
2875889|NCT00254293|3580303|FG002|STARTED|Short Term (12 Week) Randomized Dosing||29
2875890|NCT00254293|3580304|FG003|STARTED|Short Term (12 Week) Randomized Dosing||6
2875891|NCT00254293|3580305|FG004|STARTED|Short Term (12 Week) Randomized Dosing||5
2875892|NCT00254293|3580306|FG005|STARTED|Short Term (12 Week) Randomized Dosing|2, 2, 9, 2, and 2 were randomized to placebo in body weight Groups 1, 2, 3, 4, 5, respectively.|17
2875893|NCT00254293|3580307|FG006|STARTED|Short Term (12 Week) Randomized Dosing||0
2875894|NCT00254293|3580301|FG000|COMPLETED|Short Term (12 Week) Randomized Dosing||7
2875895|NCT00254293|3580302|FG001|COMPLETED|Short Term (12 Week) Randomized Dosing||3
2875896|NCT00254293|3580303|FG002|COMPLETED|Short Term (12 Week) Randomized Dosing||26
2875897|NCT00254293|3580304|FG003|COMPLETED|Short Term (12 Week) Randomized Dosing||5
2875898|NCT00254293|3580305|FG004|COMPLETED|Short Term (12 Week) Randomized Dosing||5
2875899|NCT00254293|3580306|FG005|COMPLETED|Short Term (12 Week) Randomized Dosing||17
2875900|NCT00254293|3580307|FG006|COMPLETED|Short Term (12 Week) Randomized Dosing||0
2875901|NCT00254293|3580301|FG000|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||0
2875902|NCT00254293|3580302|FG001|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||1
2875903|NCT00254293|3580303|FG002|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||3
2875904|NCT00254293|3580304|FG003|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||1
2875905|NCT00254293|3580305|FG004|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||0
2875906|NCT00254293|3580306|FG005|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||0
2875907|NCT00254293|3580307|FG006|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||0
2875908|NCT00254293|3580301|FG000|STARTED|LTE Open Label Variable SC Dosing|Participants who received ST placebo rolled over to 75mg SC dose group (by body weight, <60kg).|11
2875909|NCT00254293|3580302|FG001|STARTED|LTE Open Label Variable SC Dosing|Participants rolled over to 125mg dose group summarized as one group (body weight <60 to >100 kg).|0
2875910|NCT00254293|3580303|FG002|STARTED|LTE Open Label Variable SC Dosing|Variable SC dose group: 125 mg Weekly, body weight <60 to >100kg (Groups 2, 3, 4 in ST Period).|42
2875911|NCT00254293|3580304|FG003|STARTED|LTE Open Label Variable SC Dosing|Participants rolled over to 125mg dose group summarized as one group (body weight <60 to >100 kg).|0
2875912|NCT00254293|3580305|FG004|STARTED|LTE Open Label Variable SC Dosing|Participants who received ST placebo rolled over to variable SC dose group (by body weight, >100kg).|10
2875913|NCT00254293|3580306|FG005|STARTED|LTE Open Label Variable SC Dosing|Participants rolled over to a variable SC dose group of 75, 125 or 200 mg Weekly by body weight.|0
2875914|NCT00254293|3580307|FG006|STARTED|LTE Open Label Variable SC Dosing|Participant rolled over from LTE (Variable Dose Period) to LTE (Fixed Dose Period).|0
2875915|NCT00254293|3580301|FG000|COMPLETED|LTE Open Label Variable SC Dosing||8
2875916|NCT00254293|3580302|FG001|COMPLETED|LTE Open Label Variable SC Dosing||0
2875917|NCT00254293|3580303|FG002|COMPLETED|LTE Open Label Variable SC Dosing||32
2875918|NCT00254293|3580304|FG003|COMPLETED|LTE Open Label Variable SC Dosing||0
2875919|NCT00254293|3580305|FG004|COMPLETED|LTE Open Label Variable SC Dosing||8
2875920|NCT00254293|3580306|FG005|COMPLETED|LTE Open Label Variable SC Dosing||0
2875921|NCT00254293|3580307|FG006|COMPLETED|LTE Open Label Variable SC Dosing||0
2875922|NCT00254293|3580301|FG000|NOT COMPLETED|LTE Open Label Variable SC Dosing||3
2875923|NCT00254293|3580302|FG001|NOT COMPLETED|LTE Open Label Variable SC Dosing||0
2875924|NCT00254293|3580303|FG002|NOT COMPLETED|LTE Open Label Variable SC Dosing||10
2875925|NCT00254293|3580304|FG003|NOT COMPLETED|LTE Open Label Variable SC Dosing||0
2875926|NCT00254293|3580305|FG004|NOT COMPLETED|LTE Open Label Variable SC Dosing||2
2875927|NCT00254293|3580306|FG005|NOT COMPLETED|LTE Open Label Variable SC Dosing||0
2875928|NCT00254293|3580307|FG006|NOT COMPLETED|LTE Open Label Variable SC Dosing||0
2875929|NCT00254293|3580301|FG000|STARTED|LTE Open Label Fixed Dosing||0
2875930|NCT00254293|3580302|FG001|STARTED|LTE Open Label Fixed Dosing||0
2875931|NCT00254293|3580303|FG002|STARTED|LTE Open Label Fixed Dosing||0
2875932|NCT00254293|3580304|FG003|STARTED|LTE Open Label Fixed Dosing||0
2875933|NCT00254293|3580305|FG004|STARTED|LTE Open Label Fixed Dosing||0
2875934|NCT00254293|3580306|FG005|STARTED|LTE Open Label Fixed Dosing||0
2875935|NCT00254293|3580307|FG006|STARTED|LTE Open Label Fixed Dosing||48
2875936|NCT00254293|3580301|FG000|COMPLETED|LTE Open Label Fixed Dosing||0
2875937|NCT00254293|3580302|FG001|COMPLETED|LTE Open Label Fixed Dosing||0
2875938|NCT00254293|3580303|FG002|COMPLETED|LTE Open Label Fixed Dosing||0
2875939|NCT00254293|3580304|FG003|COMPLETED|LTE Open Label Fixed Dosing||0
2875940|NCT00254293|3580305|FG004|COMPLETED|LTE Open Label Fixed Dosing||0
2875941|NCT00254293|3580306|FG005|COMPLETED|LTE Open Label Fixed Dosing||0
2875942|NCT00254293|3580307|FG006|COMPLETED|LTE Open Label Fixed Dosing||35
2875943|NCT00254293|3580301|FG000|NOT COMPLETED|LTE Open Label Fixed Dosing||0
2875944|NCT00254293|3580302|FG001|NOT COMPLETED|LTE Open Label Fixed Dosing||0
2875945|NCT00254293|3580303|FG002|NOT COMPLETED|LTE Open Label Fixed Dosing||0
2875946|NCT00254293|3580304|FG003|NOT COMPLETED|LTE Open Label Fixed Dosing||0
2875947|NCT00254293|3580305|FG004|NOT COMPLETED|LTE Open Label Fixed Dosing||0
2875948|NCT00254293|3580306|FG005|NOT COMPLETED|LTE Open Label Fixed Dosing||0
2875949|NCT00254293|3580307|FG006|NOT COMPLETED|LTE Open Label Fixed Dosing||13
2875950|NCT00254397|3580354|FG000|STARTED|Overall Study||10
2875951|NCT00254397|3580355|FG001|STARTED|Overall Study||6
2875952|NCT00254397|3580356|FG002|STARTED|Overall Study||37
2875953|NCT00254397|3580357|FG003|STARTED|Overall Study||45
2875954|NCT00254397|3580354|FG000|COMPLETED|Overall Study||4
2875955|NCT00254397|3580355|FG001|COMPLETED|Overall Study||5
2875956|NCT00254397|3580356|FG002|COMPLETED|Overall Study||18
2875957|NCT00254397|3580357|FG003|COMPLETED|Overall Study||20
2875958|NCT00254397|3580354|FG000|NOT COMPLETED|Overall Study||6
2875959|NCT00254397|3580355|FG001|NOT COMPLETED|Overall Study||1
2875960|NCT00254397|3580356|FG002|NOT COMPLETED|Overall Study||19
2875961|NCT00254397|3580357|FG003|NOT COMPLETED|Overall Study||25
2875962|NCT00254410|3580366|FG000|STARTED|Overall Study||30
2875963|NCT00254410|3580366|FG000|COMPLETED|Overall Study||30
2875964|NCT00254410|3580366|FG000|NOT COMPLETED|Overall Study||0
2875965|NCT00254462|3580372|FG000|STARTED|Overall Study||44
2875966|NCT00254462|3580373|FG001|STARTED|Overall Study||49
2875967|NCT00254462|3580372|FG000|COMPLETED|Overall Study||36
2875968|NCT00254462|3580373|FG001|COMPLETED|Overall Study||39
2875969|NCT00254462|3580372|FG000|NOT COMPLETED|Overall Study||8
2875970|NCT00254462|3580373|FG001|NOT COMPLETED|Overall Study||10
2875971|NCT00254488|3580383|FG000|STARTED|Overall Study||112
2875972|NCT00254488|3580384|FG001|STARTED|Overall Study||112
2875973|NCT00254488|3580383|FG000|COMPLETED|Overall Study||55
2875974|NCT00254488|3580384|FG001|COMPLETED|Overall Study||63
2875975|NCT00254488|3580383|FG000|NOT COMPLETED|Overall Study||57
2875976|NCT00254488|3580384|FG001|NOT COMPLETED|Overall Study||49
2875977|NCT00254501|3580392|FG000|STARTED|Overall Study||32
2875978|NCT00254501|3580393|FG001|STARTED|Overall Study||37
2875979|NCT00254501|3580392|FG000|COMPLETED|Overall Study||31
2875980|NCT00254501|3580393|FG001|COMPLETED|Overall Study||36
2875981|NCT00254501|3580392|FG000|NOT COMPLETED|Overall Study||1
2875982|NCT00254501|3580393|FG001|NOT COMPLETED|Overall Study||1
2875983|NCT00254540|3580403|FG000|STARTED|Overall Study|All 25 subjects enrolled were included in Intent-To Treat population.|25
2875984|NCT00254540|3580404|FG001|STARTED|Overall Study|All 26 subjects enrolled were included in Intent-To Treat population.|26
2875985|NCT00254540|3580403|FG000|COMPLETED|Overall Study||6
2875986|NCT00254540|3580404|FG001|COMPLETED|Overall Study||4
2875987|NCT00254540|3580403|FG000|NOT COMPLETED|Overall Study||19
2875988|NCT00254540|3580404|FG001|NOT COMPLETED|Overall Study||22
2875989|NCT00254566|3580413|FG000|STARTED|Overall Study||198
2875990|NCT00254566|3580414|FG001|STARTED|Overall Study||198
2875991|NCT00254566|3580413|FG000|COMPLETED|Overall Study||167
2875992|NCT00254566|3580414|FG001|COMPLETED|Overall Study||172
2875993|NCT00254566|3580413|FG000|NOT COMPLETED|Overall Study||31
2875994|NCT00254566|3580414|FG001|NOT COMPLETED|Overall Study||26
2875995|NCT00254592|3580420|FG000|STARTED|Overall Study||43
2875996|NCT00254592|3580420|FG000|COMPLETED|Overall Study||41
2875997|NCT00254592|3580420|FG000|NOT COMPLETED|Overall Study||2
2875998|NCT00254982|3580426|FG000|STARTED|Overall Study||297
2875999|NCT00254982|3580427|FG001|STARTED|Overall Study||296
2876000|NCT00254982|3580426|FG000|COMPLETED|Overall Study||261
2876001|NCT00254982|3580427|FG001|COMPLETED|Overall Study||265
2876002|NCT00254982|3580426|FG000|NOT COMPLETED|Overall Study||36
2876003|NCT00254982|3580427|FG001|NOT COMPLETED|Overall Study||31
2876004|NCT00254995|3580435|FG000|STARTED|Overall Study||31561
2876005|NCT00254995|3580436|FG001|STARTED|Overall Study||31065
2876006|NCT00254995|3580435|FG000|COMPLETED|Overall Study||31561
2876007|NCT00254995|3580436|FG001|COMPLETED|Overall Study||31065
2876008|NCT00254995|3580435|FG000|NOT COMPLETED|Overall Study||0
2876009|NCT00254995|3580436|FG001|NOT COMPLETED|Overall Study||0
2876010|NCT00255008|3580448|FG000|STARTED|Overall Study||45
2876011|NCT00255008|3580449|FG001|STARTED|Overall Study||9
2876012|NCT00255008|3580450|FG002|STARTED|Overall Study||33
2876013|NCT00255008|3580451|FG003|STARTED|Overall Study||34
2876014|NCT00255008|3580448|FG000|COMPLETED|Overall Study|The study was terminated early and as a result only 42 patients completed the study.|13
2876015|NCT00255008|3580449|FG001|COMPLETED|Overall Study||0
2876016|NCT00255008|3580450|FG002|COMPLETED|Overall Study||17
2876017|NCT00255008|3580451|FG003|COMPLETED|Overall Study||12
2876018|NCT00255008|3580448|FG000|NOT COMPLETED|Overall Study||32
2876019|NCT00255008|3580449|FG001|NOT COMPLETED|Overall Study||9
2876020|NCT00255008|3580450|FG002|NOT COMPLETED|Overall Study||16
2876021|NCT00255008|3580451|FG003|NOT COMPLETED|Overall Study||22
2876022|NCT00255034|3580463|FG000|STARTED|Overall Study||79
2876023|NCT00255034|3580464|FG001|STARTED|Overall Study||64
2876024|NCT00255034|3580463|FG000|COMPLETED|Overall Study||64
2876025|NCT00255034|3580464|FG001|COMPLETED|Overall Study||26
2876026|NCT00255034|3580463|FG000|NOT COMPLETED|Overall Study||15
2876027|NCT00255034|3580464|FG001|NOT COMPLETED|Overall Study||38
2876028|NCT00255047|3580474|FG000|STARTED|Overall Study||538
2876029|NCT00255047|3580475|FG001|STARTED|Overall Study||535
2876030|NCT00255047|3580476|FG002|STARTED|Overall Study||546
2876031|NCT00255047|3580477|FG003|STARTED|Overall Study||548
2876032|NCT00255047|3580474|FG000|COMPLETED|Overall Study||490
2876033|NCT00255047|3580475|FG001|COMPLETED|Overall Study||487
2876034|NCT00255047|3580476|FG002|COMPLETED|Overall Study||496
2876035|NCT00255047|3580477|FG003|COMPLETED|Overall Study||502
2876036|NCT00255047|3580474|FG000|NOT COMPLETED|Overall Study||48
3314629|NCT03089697|4047898|FG000|STARTED|Overall Study||13
3314630|NCT03089697|4047899|FG001|STARTED|Overall Study||12
3314631|NCT03089697|4047898|FG000|COMPLETED|Overall Study||11
3314632|NCT03089697|4047899|FG001|COMPLETED|Overall Study||10
3314633|NCT03089697|4047898|FG000|NOT COMPLETED|Overall Study||2
3314634|NCT03089697|4047899|FG001|NOT COMPLETED|Overall Study||2
3314635|NCT03089853|4047907|FG000|STARTED|Overall Study||4
3314636|NCT03089853|4047908|FG001|STARTED|Overall Study||3
2876037|NCT00255047|3580475|FG001|NOT COMPLETED|Overall Study||48
2876038|NCT00255047|3580476|FG002|NOT COMPLETED|Overall Study||50
2876039|NCT00255047|3580477|FG003|NOT COMPLETED|Overall Study||46
2876040|NCT00255086|3580489|FG000|STARTED|Overall Study||9
2876041|NCT00255086|3580490|FG001|STARTED|Overall Study||8
2876042|NCT00255086|3580489|FG000|COMPLETED|Overall Study||7
2876043|NCT00255086|3580490|FG001|COMPLETED|Overall Study||6
2876044|NCT00255086|3580489|FG000|NOT COMPLETED|Overall Study||2
2876045|NCT00255086|3580490|FG001|NOT COMPLETED|Overall Study||2
2876046|NCT00255125|3580499|FG000|STARTED|Overall Study||42
2876047|NCT00255125|3580500|FG001|STARTED|Overall Study||44
2876048|NCT00255125|3580499|FG000|COMPLETED|Overall Study||42
2876049|NCT00255125|3580500|FG001|COMPLETED|Overall Study||44
2876050|NCT00255125|3580499|FG000|NOT COMPLETED|Overall Study||0
2876051|NCT00255125|3580500|FG001|NOT COMPLETED|Overall Study||0
2876052|NCT00255151|3580511|FG000|STARTED|Overall Study||140
2876053|NCT00255151|3580512|FG001|STARTED|Overall Study||159
2876054|NCT00255151|3580513|FG002|STARTED|Overall Study||152
2876055|NCT00255151|3580511|FG000|COMPLETED|Overall Study||17
2876056|NCT00255151|3580512|FG001|COMPLETED|Overall Study||110
2876057|NCT00255151|3580513|FG002|COMPLETED|Overall Study||103
2876058|NCT00255151|3580511|FG000|NOT COMPLETED|Overall Study||123
2876059|NCT00255151|3580512|FG001|NOT COMPLETED|Overall Study||49
2876060|NCT00255151|3580513|FG002|NOT COMPLETED|Overall Study||49
2876061|NCT00255164|3580524|FG000|STARTED|Overall Study||140
2876062|NCT00255164|3580525|FG001|STARTED|Overall Study||159
2876063|NCT00255164|3580526|FG002|STARTED|Overall Study||152
2876064|NCT00255164|3580524|FG000|COMPLETED|Overall Study||17
2876065|NCT00255164|3580525|FG001|COMPLETED|Overall Study||110
2876066|NCT00255164|3580526|FG002|COMPLETED|Overall Study||103
2876067|NCT00255164|3580524|FG000|NOT COMPLETED|Overall Study||123
2876068|NCT00255164|3580525|FG001|NOT COMPLETED|Overall Study||49
2876069|NCT00255164|3580526|FG002|NOT COMPLETED|Overall Study||49
2876070|NCT00255177|3580538|FG000|STARTED|Overall Study||11
2876071|NCT00255177|3580539|FG001|STARTED|Overall Study||14
2876072|NCT00255177|3580540|FG002|STARTED|Overall Study||13
2876073|NCT00255177|3580541|FG003|STARTED|Overall Study||6
2876074|NCT00255177|3580538|FG000|COMPLETED|Overall Study||9
2876075|NCT00255177|3580539|FG001|COMPLETED|Overall Study||13
2876076|NCT00255177|3580540|FG002|COMPLETED|Overall Study||12
2876077|NCT00255177|3580541|FG003|COMPLETED|Overall Study||4
2876078|NCT00255177|3580538|FG000|NOT COMPLETED|Overall Study||2
2876079|NCT00255177|3580539|FG001|NOT COMPLETED|Overall Study||1
2876080|NCT00255177|3580540|FG002|NOT COMPLETED|Overall Study||1
2876081|NCT00255177|3580541|FG003|NOT COMPLETED|Overall Study||2
2876082|NCT00255190|3580553|FG000|STARTED|Overall Study||153
2876083|NCT00255190|3580554|FG001|STARTED|Overall Study||438
2876084|NCT00255190|3580553|FG000|COMPLETED|Overall Study||103
2876085|NCT00255190|3580554|FG001|COMPLETED|Overall Study||281
2876086|NCT00255190|3580553|FG000|NOT COMPLETED|Overall Study||50
2876087|NCT00255190|3580554|FG001|NOT COMPLETED|Overall Study||157
2876088|NCT00255346|3580565|FG000|STARTED|Overall Study||10
2876089|NCT00255346|3580566|FG001|STARTED|Overall Study||6
2876090|NCT00255346|3580567|FG002|STARTED|Overall Study||8
2876091|NCT00255346|3580568|FG003|STARTED|Overall Study||11
2876092|NCT00255346|3580569|FG004|STARTED|Overall Study||33
2876093|NCT00255346|3580565|FG000|COMPLETED|Overall Study||9
2876094|NCT00255346|3580566|FG001|COMPLETED|Overall Study||6
2876095|NCT00255346|3580567|FG002|COMPLETED|Overall Study||8
2876096|NCT00255346|3580568|FG003|COMPLETED|Overall Study||11
2876097|NCT00255346|3580569|FG004|COMPLETED|Overall Study||33
2876098|NCT00255346|3580565|FG000|NOT COMPLETED|Overall Study||1
2876099|NCT00255346|3580566|FG001|NOT COMPLETED|Overall Study||0
2876100|NCT00255346|3580567|FG002|NOT COMPLETED|Overall Study||0
3314637|NCT03089853|4047907|FG000|COMPLETED|Overall Study||2
3314638|NCT03089853|4047908|FG001|COMPLETED|Overall Study||2
2876101|NCT00255346|3580568|FG003|NOT COMPLETED|Overall Study||0
2876102|NCT00255346|3580569|FG004|NOT COMPLETED|Overall Study||0
2876103|NCT00255684|3580577|FG000|STARTED|Overall Study||16
2876104|NCT00255684|3580577|FG000|COMPLETED|Overall Study||16
2876105|NCT00255684|3580577|FG000|NOT COMPLETED|Overall Study||0
2876106|NCT00255723|3580583|FG000|STARTED|Overall Study||56
2876107|NCT00255723|3580584|FG001|STARTED|Overall Study||41
2876108|NCT00255723|3580583|FG000|COMPLETED|Overall Study||54
2876109|NCT00255723|3580584|FG001|COMPLETED|Overall Study||39
2876110|NCT00255723|3580583|FG000|NOT COMPLETED|Overall Study||2
2876111|NCT00255723|3580584|FG001|NOT COMPLETED|Overall Study||2
2876112|NCT00255801|3580590|FG000|STARTED|Overall Study||37
2876113|NCT00255801|3580590|FG000|COMPLETED|Overall Study||37
2876114|NCT00255801|3580590|FG000|NOT COMPLETED|Overall Study||0
2876115|NCT00255840|3580596|FG000|STARTED|Overall Study||408
2876116|NCT00255840|3580597|FG001|STARTED|Overall Study||404
2876117|NCT00255840|3580596|FG000|COMPLETED|Overall Study||345
2876118|NCT00255840|3580597|FG001|COMPLETED|Overall Study||334
2876119|NCT00255840|3580596|FG000|NOT COMPLETED|Overall Study||63
2876120|NCT00255840|3580597|FG001|NOT COMPLETED|Overall Study||70
2876121|NCT00255944|3580605|FG000|STARTED|Overall Study||1311
2876122|NCT00255944|3580606|FG001|STARTED|Overall Study||1311
2876123|NCT00255944|3580605|FG000|COMPLETED|Overall Study||514
2876124|NCT00255944|3580606|FG001|COMPLETED|Overall Study||477
2876125|NCT00255944|3580605|FG000|NOT COMPLETED|Overall Study||797
2876126|NCT00255944|3580606|FG001|NOT COMPLETED|Overall Study||834
2876127|NCT00255970|3580614|FG000|STARTED|Overall Study||21
2876128|NCT00255970|3580615|FG001|STARTED|Overall Study||19
2876129|NCT00255970|3580614|FG000|Screening Visit|Overall Study||21
2876130|NCT00255970|3580615|FG001|Screening Visit|Overall Study||19
2876131|NCT00255970|3580614|FG000|Final Visit Week 24|Overall Study||21
2876132|NCT00255970|3580615|FG001|Final Visit Week 24|Overall Study||19
2876133|NCT00255970|3580614|FG000|COMPLETED|Overall Study||21
2876134|NCT00255970|3580615|FG001|COMPLETED|Overall Study||19
2876135|NCT00255970|3580614|FG000|NOT COMPLETED|Overall Study||0
2876136|NCT00255970|3580615|FG001|NOT COMPLETED|Overall Study||0
2876137|NCT00256126|3580623|FG000|STARTED|Overall Study||149
2876138|NCT00256126|3580624|FG001|STARTED|Overall Study||169
2876139|NCT00256126|3580623|FG000|COMPLETED|Overall Study||147
2876140|NCT00256126|3580624|FG001|COMPLETED|Overall Study||167
2876141|NCT00256126|3580623|FG000|NOT COMPLETED|Overall Study||2
2876142|NCT00256126|3580624|FG001|NOT COMPLETED|Overall Study||2
2876143|NCT00256204|3580634|FG000|STARTED|Overall Study||298
2876144|NCT00256204|3580635|FG001|STARTED|Overall Study||288
2876145|NCT00256204|3580636|FG002|STARTED|Overall Study||295
2876146|NCT00256204|3580637|FG003|STARTED|Overall Study||293
2876147|NCT00256204|3580634|FG000|COMPLETED|Overall Study||231
2876148|NCT00256204|3580635|FG001|COMPLETED|Overall Study||238
2876149|NCT00256204|3580636|FG002|COMPLETED|Overall Study||241
2876150|NCT00256204|3580637|FG003|COMPLETED|Overall Study||244
2876151|NCT00256204|3580634|FG000|NOT COMPLETED|Overall Study||67
2876152|NCT00256204|3580635|FG001|NOT COMPLETED|Overall Study||50
2876153|NCT00256204|3580636|FG002|NOT COMPLETED|Overall Study||54
2876154|NCT00256204|3580637|FG003|NOT COMPLETED|Overall Study||49
2876155|NCT00256217|3580650|FG000|STARTED|Overall Study||42
2876156|NCT00256217|3580650|FG000|COMPLETED|Overall Study||34
2876157|NCT00256217|3580650|FG000|NOT COMPLETED|Overall Study||8
2876158|NCT00256243|3580654|FG000|STARTED|Overall Study||48
2876159|NCT00256243|3580654|FG000|COMPLETED|Overall Study||38
2876160|NCT00256243|3580654|FG000|NOT COMPLETED|Overall Study||10
2876161|NCT00256282|3580659|FG000|STARTED|Overall Study||52
2876162|NCT00256282|3580659|FG000|COMPLETED|Overall Study||36
2876163|NCT00256282|3580659|FG000|NOT COMPLETED|Overall Study||16
2876164|NCT00256308|3580663|FG000|STARTED|Overall Study||6
2876165|NCT00256308|3580663|FG000|COMPLETED|Overall Study||4
2876166|NCT00256308|3580663|FG000|NOT COMPLETED|Overall Study||2
2876167|NCT00256451|3580667|FG000|STARTED|Session1||10
2876168|NCT00256451|3580668|FG001|STARTED|Session1||11
3169831|NCT01928381|3897369|FG002|NOT COMPLETED|Part 1 - Pain Training||0
3169832|NCT01928381|3897370|FG003|NOT COMPLETED|Part 1 - Pain Training||0
3169833|NCT01928381|3897371|FG004|NOT COMPLETED|Part 1 - Pain Training||0
3169834|NCT01928381|3897372|FG005|NOT COMPLETED|Part 1 - Pain Training||0
3169835|NCT01928381|3897373|FG006|NOT COMPLETED|Part 1 - Pain Training||0
3169836|NCT01928381|3897367|FG000|STARTED|Placebo run-in & Part 2 Eligibility||48
2876169|NCT00256451|3580669|FG002|STARTED|Session1||11
2876170|NCT00256451|3580670|FG003|STARTED|Session1||11
2876171|NCT00256451|3580667|FG000|COMPLETED|Session1||10
2876172|NCT00256451|3580668|FG001|COMPLETED|Session1||11
2876173|NCT00256451|3580669|FG002|COMPLETED|Session1||11
2876174|NCT00256451|3580670|FG003|COMPLETED|Session1||11
2876175|NCT00256451|3580667|FG000|NOT COMPLETED|Session1||0
2876176|NCT00256451|3580668|FG001|NOT COMPLETED|Session1||0
2876177|NCT00256451|3580669|FG002|NOT COMPLETED|Session1||0
2876178|NCT00256451|3580670|FG003|NOT COMPLETED|Session1||0
2876179|NCT00256451|3580667|FG000|STARTED|Session2||9
2876180|NCT00256451|3580668|FG001|STARTED|Session2||11
2876181|NCT00256451|3580669|FG002|STARTED|Session2||10
2876182|NCT00256451|3580670|FG003|STARTED|Session2||10
2876183|NCT00256451|3580667|FG000|COMPLETED|Session2||9
2876184|NCT00256451|3580668|FG001|COMPLETED|Session2||11
2876185|NCT00256451|3580669|FG002|COMPLETED|Session2||10
2876186|NCT00256451|3580670|FG003|COMPLETED|Session2||10
2876187|NCT00256451|3580667|FG000|NOT COMPLETED|Session2||0
2876188|NCT00256451|3580668|FG001|NOT COMPLETED|Session2||0
2876189|NCT00256451|3580669|FG002|NOT COMPLETED|Session2||0
2876190|NCT00256451|3580670|FG003|NOT COMPLETED|Session2||0
2876191|NCT00256451|3580667|FG000|STARTED|Session3||9
2876192|NCT00256451|3580668|FG001|STARTED|Session3||9
2876193|NCT00256451|3580669|FG002|STARTED|Session3||10
2876194|NCT00256451|3580670|FG003|STARTED|Session3||9
2876195|NCT00256451|3580667|FG000|COMPLETED|Session3||9
2876196|NCT00256451|3580668|FG001|COMPLETED|Session3||9
2876197|NCT00256451|3580669|FG002|COMPLETED|Session3||10
2876198|NCT00256451|3580670|FG003|COMPLETED|Session3||9
2876199|NCT00256451|3580667|FG000|NOT COMPLETED|Session3||0
2876200|NCT00256451|3580668|FG001|NOT COMPLETED|Session3||0
2876201|NCT00256451|3580669|FG002|NOT COMPLETED|Session3||0
2876202|NCT00256451|3580670|FG003|NOT COMPLETED|Session3||0
2876203|NCT00256451|3580667|FG000|STARTED|Session4||9
2876204|NCT00256451|3580668|FG001|STARTED|Session4||8
2876205|NCT00256451|3580669|FG002|STARTED|Session4||10
2876206|NCT00256451|3580670|FG003|STARTED|Session4||8
2876207|NCT00256451|3580667|FG000|COMPLETED|Session4||9
2876208|NCT00256451|3580668|FG001|COMPLETED|Session4||8
2876209|NCT00256451|3580669|FG002|COMPLETED|Session4||10
2876210|NCT00256451|3580670|FG003|COMPLETED|Session4||8
2876211|NCT00256451|3580667|FG000|NOT COMPLETED|Session4||0
2876212|NCT00256451|3580668|FG001|NOT COMPLETED|Session4||0
2876213|NCT00256451|3580669|FG002|NOT COMPLETED|Session4||0
2876214|NCT00256451|3580670|FG003|NOT COMPLETED|Session4||0
2876215|NCT00256698|3580682|FG000|STARTED|Overall Study||258
2876216|NCT00256698|3580683|FG001|STARTED|Overall Study||256
2876217|NCT00256698|3580682|FG000|COMPLETED|Overall Study||91
2876218|NCT00256698|3580683|FG001|COMPLETED|Overall Study||84
2876219|NCT00256698|3580682|FG000|NOT COMPLETED|Overall Study||167
2876220|NCT00256698|3580683|FG001|NOT COMPLETED|Overall Study||172
2876221|NCT00256724|3580691|FG000|STARTED|Overall Study||23
2876222|NCT00256724|3580692|FG001|STARTED|Overall Study||24
2876223|NCT00256724|3580691|FG000|COMPLETED|Overall Study||18
2876224|NCT00256724|3580692|FG001|COMPLETED|Overall Study||16
2876225|NCT00256724|3580691|FG000|NOT COMPLETED|Overall Study||5
2876226|NCT00256724|3580692|FG001|NOT COMPLETED|Overall Study||8
2876227|NCT00256750|3580701|FG000|STARTED|Transplanted Pre-Treatment||221
2876228|NCT00256750|3580702|FG001|STARTED|Transplanted Pre-Treatment||226
2876229|NCT00256750|3580703|FG002|STARTED|Transplanted Pre-Treatment||219
2876230|NCT00256750|3580701|FG000|COMPLETED|Transplanted Pre-Treatment||215
2876231|NCT00256750|3580702|FG001|COMPLETED|Transplanted Pre-Treatment||226
2876232|NCT00256750|3580703|FG002|COMPLETED|Transplanted Pre-Treatment||219
2876233|NCT00256750|3580701|FG000|NOT COMPLETED|Transplanted Pre-Treatment||6
2876234|NCT00256750|3580702|FG001|NOT COMPLETED|Transplanted Pre-Treatment||0
2876235|NCT00256750|3580703|FG002|NOT COMPLETED|Transplanted Pre-Treatment||0
2876236|NCT00256750|3580701|FG000|STARTED|Post-Transplant Treated (12 Months)||215
2876237|NCT00256750|3580702|FG001|STARTED|Post-Transplant Treated (12 Months)||226
2876238|NCT00256750|3580703|FG002|STARTED|Post-Transplant Treated (12 Months)||219
2876239|NCT00256750|3580701|FG000|COMPLETED|Post-Transplant Treated (12 Months)||174
2876240|NCT00256750|3580702|FG001|COMPLETED|Post-Transplant Treated (12 Months)||183
2876241|NCT00256750|3580703|FG002|COMPLETED|Post-Transplant Treated (12 Months)||173
2876242|NCT00256750|3580701|FG000|NOT COMPLETED|Post-Transplant Treated (12 Months)||41
2876243|NCT00256750|3580702|FG001|NOT COMPLETED|Post-Transplant Treated (12 Months)||43
2876244|NCT00256750|3580703|FG002|NOT COMPLETED|Post-Transplant Treated (12 Months)||46
2876245|NCT00256750|3580701|FG000|STARTED|Post-Transplant Treated (24 Months)||174
2876246|NCT00256750|3580702|FG001|STARTED|Post-Transplant Treated (24 Months)||183
2876247|NCT00256750|3580703|FG002|STARTED|Post-Transplant Treated (24 Months)||173
2876248|NCT00256750|3580701|FG000|COMPLETED|Post-Transplant Treated (24 Months)||153
2876249|NCT00256750|3580702|FG001|COMPLETED|Post-Transplant Treated (24 Months)||176
2876250|NCT00256750|3580703|FG002|COMPLETED|Post-Transplant Treated (24 Months)||164
2876251|NCT00256750|3580701|FG000|NOT COMPLETED|Post-Transplant Treated (24 Months)||21
2876252|NCT00256750|3580702|FG001|NOT COMPLETED|Post-Transplant Treated (24 Months)||7
2876253|NCT00256750|3580703|FG002|NOT COMPLETED|Post-Transplant Treated (24 Months)||9
2876254|NCT00256750|3580701|FG000|STARTED|Post-Transplant Treated (36 Months)||153
2876255|NCT00256750|3580702|FG001|STARTED|Post-Transplant Treated (36 Months)||176
2876256|NCT00256750|3580703|FG002|STARTED|Post-Transplant Treated (36 Months)||164
2876257|NCT00256750|3580701|FG000|COMPLETED|Post-Transplant Treated (36 Months)||143
2876258|NCT00256750|3580702|FG001|COMPLETED|Post-Transplant Treated (36 Months)||170
2876259|NCT00256750|3580703|FG002|COMPLETED|Post-Transplant Treated (36 Months)||158
2876260|NCT00256750|3580701|FG000|NOT COMPLETED|Post-Transplant Treated (36 Months)||10
2876261|NCT00256750|3580702|FG001|NOT COMPLETED|Post-Transplant Treated (36 Months)||6
2876262|NCT00256750|3580703|FG002|NOT COMPLETED|Post-Transplant Treated (36 Months)||6
2876263|NCT00256750|3580701|FG000|STARTED|Long Term Extension (LTE; 84 Months)|Participants on drug through month 36 eligible to enroll in LTE; 2 ineligible, 5 withdrew or refused|136
2876264|NCT00256750|3580702|FG001|STARTED|Long Term Extension (LTE; 84 Months)|Participants on drug through month 36 were eligible to enroll in LTE; 4 withdrew or refused.|166
2876265|NCT00256750|3580703|FG002|STARTED|Long Term Extension (LTE; 84 Months)|Participants on drug through month 36 were eligible to enroll in LTE; 3 withdrew or refused.|155
2876266|NCT00256750|3580701|FG000|COMPLETED|Long Term Extension (LTE; 84 Months)||89
2876267|NCT00256750|3580702|FG001|COMPLETED|Long Term Extension (LTE; 84 Months)||136
2876268|NCT00256750|3580703|FG002|COMPLETED|Long Term Extension (LTE; 84 Months)||127
2876269|NCT00256750|3580701|FG000|NOT COMPLETED|Long Term Extension (LTE; 84 Months)||47
2876270|NCT00256750|3580702|FG001|NOT COMPLETED|Long Term Extension (LTE; 84 Months)||30
2876271|NCT00256750|3580703|FG002|NOT COMPLETED|Long Term Extension (LTE; 84 Months)||28
2876272|NCT00256776|3580714|FG000|STARTED|Overall Study||135
2876273|NCT00256776|3580715|FG001|STARTED|Overall Study||134
2876274|NCT00256776|3580714|FG000|COMPLETED|Overall Study||52
2876275|NCT00256776|3580715|FG001|COMPLETED|Overall Study||54
2876276|NCT00256776|3580714|FG000|NOT COMPLETED|Overall Study||83
2876277|NCT00256776|3580715|FG001|NOT COMPLETED|Overall Study||80
2876278|NCT00256854|3580729|FG000|STARTED|Overall Study||26
2876279|NCT00256854|3580730|FG001|STARTED|Overall Study||26
2876280|NCT00256854|3580731|FG002|STARTED|Overall Study||26
2876281|NCT00256854|3580732|FG003|STARTED|Overall Study||27
2876282|NCT00256854|3580733|FG004|STARTED|Overall Study||16
2876283|NCT00256854|3580734|FG005|STARTED|Overall Study||14
2876284|NCT00256854|3580729|FG000|COMPLETED|Overall Study||23
2876285|NCT00256854|3580730|FG001|COMPLETED|Overall Study||22
2876286|NCT00256854|3580731|FG002|COMPLETED|Overall Study||23
2876287|NCT00256854|3580732|FG003|COMPLETED|Overall Study||24
2876288|NCT00256854|3580733|FG004|COMPLETED|Overall Study||15
2876289|NCT00256854|3580734|FG005|COMPLETED|Overall Study||13
2876290|NCT00256854|3580729|FG000|NOT COMPLETED|Overall Study||3
2876291|NCT00256854|3580730|FG001|NOT COMPLETED|Overall Study||4
2876292|NCT00256854|3580731|FG002|NOT COMPLETED|Overall Study||3
2876293|NCT00256854|3580732|FG003|NOT COMPLETED|Overall Study||3
2876294|NCT00256854|3580733|FG004|NOT COMPLETED|Overall Study||1
2876295|NCT00256854|3580734|FG005|NOT COMPLETED|Overall Study||1
2919030|NCT00530075|3629413|FG000|NOT COMPLETED|Overall Study||7
2919031|NCT00530088|3629417|FG000|STARTED|Overall Study||30
2919032|NCT00530088|3629417|FG000|COMPLETED|Overall Study||20
2919033|NCT00530088|3629417|FG000|NOT COMPLETED|Overall Study||10
2919034|NCT00530218|3629421|FG000|STARTED|Overall Study||61
2919035|NCT00530218|3629421|FG000|COMPLETED|Overall Study|CMV Reactivation Was Detected|36
2919036|NCT00530218|3629421|FG000|NOT COMPLETED|Overall Study||25
2919037|NCT00530257|3629428|FG000|STARTED|Overall Study||31
2919038|NCT00530257|3629428|FG000|COMPLETED|Overall Study||30
2919039|NCT00530257|3629428|FG000|NOT COMPLETED|Overall Study||1
2919040|NCT00530270|3629437|FG000|STARTED|Overall Study||6
2919041|NCT00530270|3629438|FG001|STARTED|Overall Study||6
2919042|NCT00530270|3629437|FG000|COMPLETED|Overall Study||5
2919043|NCT00530270|3629438|FG001|COMPLETED|Overall Study||6
2919044|NCT00530270|3629437|FG000|NOT COMPLETED|Overall Study||1
2919045|NCT00530270|3629438|FG001|NOT COMPLETED|Overall Study||0
2919046|NCT00530335|3629444|FG000|STARTED|Overall Study||45
2919047|NCT00530335|3629444|FG000|COMPLETED|Overall Study||39
2919048|NCT00530335|3629444|FG000|NOT COMPLETED|Overall Study||6
2919049|NCT00530348|3629450|FG000|STARTED|Overall Study|Randomized.|195
2919050|NCT00530348|3629451|FG001|STARTED|Overall Study|Randomized.|386
2919051|NCT00530348|3629450|FG000|Treated|Overall Study|All randomized participants who received at least 1 dose of study drug.|187
2919052|NCT00530348|3629451|FG001|Treated|Overall Study|All randomized participants who received at least 1 dose of study drug.|376
2919053|NCT00530348|3629450|FG000|COMPLETED|Overall Study||173
2919054|NCT00530348|3629451|FG001|COMPLETED|Overall Study||367
2919055|NCT00530348|3629450|FG000|NOT COMPLETED|Overall Study||22
2919056|NCT00530348|3629451|FG001|NOT COMPLETED|Overall Study||19
2919057|NCT00530439|3629459|FG000|STARTED|Overall Study||180
3314639|NCT03089853|4047907|FG000|NOT COMPLETED|Overall Study||2
3314640|NCT03089853|4047908|FG001|NOT COMPLETED|Overall Study||1
3314641|NCT03089879|4047917|FG000|STARTED|Overall Study||7
3314642|NCT03089879|4047918|FG001|STARTED|Overall Study||2
3314643|NCT03089879|4047919|FG002|STARTED|Overall Study||26
3314644|NCT03089879|4047917|FG000|COMPLETED|Overall Study||7
3314645|NCT03089879|4047918|FG001|COMPLETED|Overall Study||2
3314646|NCT03089879|4047919|FG002|COMPLETED|Overall Study||26
2919058|NCT00530439|3629460|FG001|STARTED|Overall Study||180
2919059|NCT00530439|3629459|FG000|COMPLETED|Overall Study||150
2919060|NCT00530439|3629460|FG001|COMPLETED|Overall Study||154
2919061|NCT00530439|3629459|FG000|NOT COMPLETED|Overall Study||30
2919062|NCT00530439|3629460|FG001|NOT COMPLETED|Overall Study||26
2919063|NCT00530504|3629466|FG000|STARTED|Overall Study||1500
2919064|NCT00530504|3629466|FG000|COMPLETED|Overall Study||1348
2919065|NCT00530504|3629466|FG000|NOT COMPLETED|Overall Study||152
2919066|NCT00530621|3629472|FG000|STARTED|Overall Study||80
2919067|NCT00530621|3629473|FG001|STARTED|Overall Study||80
2919068|NCT00530621|3629472|FG000|Received at Least 1 Dose of Study Drug|Overall Study||79
2919069|NCT00530621|3629473|FG001|Received at Least 1 Dose of Study Drug|Overall Study||80
2919070|NCT00530621|3629472|FG000|COMPLETED|Overall Study||0
2919071|NCT00530621|3629473|FG001|COMPLETED|Overall Study||0
2919072|NCT00530621|3629472|FG000|NOT COMPLETED|Overall Study||80
2919073|NCT00530621|3629473|FG001|NOT COMPLETED|Overall Study||80
2919074|NCT00530634|3629483|FG000|STARTED|Overall Study||3
2919075|NCT00530634|3629483|FG000|COMPLETED|Overall Study||3
2919076|NCT00530634|3629483|FG000|NOT COMPLETED|Overall Study||0
2919077|NCT00530712|3629487|FG000|STARTED|Enrollment|Total Enrolled Subjects|287
2919078|NCT00530712|3629487|FG000|COMPLETED|Enrollment|Subjects Available at Discharge|287
2919079|NCT00530712|3629487|FG000|NOT COMPLETED|Enrollment||0
2919080|NCT00530712|3629487|FG000|STARTED|30 Day Follow-up Visit|Subjects Expected for 30-Day Visit|287
2919081|NCT00530712|3629487|FG000|COMPLETED|30 Day Follow-up Visit|Subjects that Completed 30-Day Follow-up Visit|280
2919082|NCT00530712|3629487|FG000|NOT COMPLETED|30 Day Follow-up Visit||7
3038339|NCT01153724|3757759|FG000|COMPLETED|Treatment Period 2||32
2876296|NCT00256867|3580757|FG000|STARTED|Overall Study||47
2876297|NCT00256867|3580758|FG001|STARTED|Overall Study||44
2876298|NCT00256867|3580759|FG002|STARTED|Overall Study||45
2876299|NCT00256867|3580760|FG003|STARTED|Overall Study||46
2876300|NCT00256867|3580761|FG004|STARTED|Overall Study||48
2876301|NCT00256867|3580762|FG005|STARTED|Overall Study||46
2876302|NCT00256867|3580763|FG006|STARTED|Overall Study||46
2876303|NCT00256867|3580764|FG007|STARTED|Overall Study||47
2876304|NCT00256867|3580757|FG000|COMPLETED|Overall Study||45
2876305|NCT00256867|3580758|FG001|COMPLETED|Overall Study||39
2876306|NCT00256867|3580759|FG002|COMPLETED|Overall Study||40
2876307|NCT00256867|3580760|FG003|COMPLETED|Overall Study||40
2876308|NCT00256867|3580761|FG004|COMPLETED|Overall Study||41
2876309|NCT00256867|3580762|FG005|COMPLETED|Overall Study||40
2876310|NCT00256867|3580763|FG006|COMPLETED|Overall Study||41
2876311|NCT00256867|3580764|FG007|COMPLETED|Overall Study||36
2876312|NCT00256867|3580757|FG000|NOT COMPLETED|Overall Study||2
2876313|NCT00256867|3580758|FG001|NOT COMPLETED|Overall Study||5
2876314|NCT00256867|3580759|FG002|NOT COMPLETED|Overall Study||5
2876315|NCT00256867|3580760|FG003|NOT COMPLETED|Overall Study||6
2876316|NCT00256867|3580761|FG004|NOT COMPLETED|Overall Study||7
2876317|NCT00256867|3580762|FG005|NOT COMPLETED|Overall Study||6
2876318|NCT00256867|3580763|FG006|NOT COMPLETED|Overall Study||5
2876319|NCT00256867|3580764|FG007|NOT COMPLETED|Overall Study||11
2876320|NCT00256984|3580787|FG000|STARTED|Overall Study||75
2876321|NCT00256984|3580787|FG000|COMPLETED|Overall Study||59
2876322|NCT00256984|3580787|FG000|NOT COMPLETED|Overall Study||16
2876323|NCT00256997|3580793|FG000|STARTED|Overall Study||81
2876324|NCT00256997|3580794|FG001|STARTED|Overall Study||86
2876325|NCT00256997|3580793|FG000|Treated|Overall Study||79
2876326|NCT00256997|3580794|FG001|Treated|Overall Study||86
2876327|NCT00256997|3580793|FG000|COMPLETED|Overall Study||33
2876328|NCT00256997|3580794|FG001|COMPLETED|Overall Study||31
2876329|NCT00256997|3580793|FG000|NOT COMPLETED|Overall Study||48
2876330|NCT00256997|3580794|FG001|NOT COMPLETED|Overall Study||55
2876331|NCT00257010|3580801|FG000|STARTED|Overall Study||447
2876332|NCT00257010|3580801|FG000|COMPLETED|Overall Study||319
2876333|NCT00257010|3580801|FG000|NOT COMPLETED|Overall Study||128
2876334|NCT00257166|3580807|FG000|STARTED|Overall Study||150
2876335|NCT00257166|3580808|FG001|STARTED|Overall Study||88
2876336|NCT00257166|3580807|FG000|Treated|Overall Study||149
2876337|NCT00257166|3580808|FG001|Treated|Overall Study||88
2876338|NCT00257166|3580807|FG000|COMPLETED|Overall Study||97
2876339|NCT00257166|3580808|FG001|COMPLETED|Overall Study||51
2876340|NCT00257166|3580807|FG000|NOT COMPLETED|Overall Study||53
2876341|NCT00257166|3580808|FG001|NOT COMPLETED|Overall Study||37
2876342|NCT00257192|3580816|FG000|STARTED|Overall Study||193
2876343|NCT00257192|3580817|FG001|STARTED|Overall Study|Includes 1 subject randomized but not treated|91
2876344|NCT00257192|3580816|FG000|Received Study Treatment|Overall Study||193
2876345|NCT00257192|3580817|FG001|Received Study Treatment|Overall Study||90
2876346|NCT00257192|3580816|FG000|COMPLETED|Overall Study||135
2876347|NCT00257192|3580817|FG001|COMPLETED|Overall Study||52
2876348|NCT00257192|3580816|FG000|NOT COMPLETED|Overall Study||58
2876349|NCT00257192|3580817|FG001|NOT COMPLETED|Overall Study||39
2876350|NCT00257309|3580825|FG000|STARTED|Overall Study||134
2876351|NCT00257309|3580826|FG001|STARTED|Overall Study||132
2876352|NCT00257309|3580825|FG000|COMPLETED|Overall Study||132
2876353|NCT00257309|3580826|FG001|COMPLETED|Overall Study||130
2876354|NCT00257309|3580825|FG000|NOT COMPLETED|Overall Study||2
2876355|NCT00257309|3580826|FG001|NOT COMPLETED|Overall Study||2
2876356|NCT00257322|3580832|FG000|STARTED|Overall Study|20 subjects accrued.|20
2876357|NCT00257322|3580832|FG000|COMPLETED|Overall Study|4 subjects withdrew from this study.|16
2876358|NCT00257322|3580832|FG000|NOT COMPLETED|Overall Study||4
2876359|NCT00257556|3580838|FG000|STARTED|Overall Study||38
2876360|NCT00257556|3580839|FG001|STARTED|Overall Study||42
2876361|NCT00257556|3580838|FG000|All Patients Treated Population|Overall Study|Also the safety population. One randomized patient did not receive study medication.|37
2876362|NCT00257556|3580839|FG001|All Patients Treated Population|Overall Study|Also the safety population. Three randomized patients did not receive study medication.|39
2876363|NCT00257556|3580838|FG000|COMPLETED|Overall Study||24
2876364|NCT00257556|3580839|FG001|COMPLETED|Overall Study||32
2876365|NCT00257556|3580838|FG000|NOT COMPLETED|Overall Study||14
2876366|NCT00257556|3580839|FG001|NOT COMPLETED|Overall Study||10
2876367|NCT00257608|3580847|FG000|STARTED|Chemotherapy Phase||1145
2876368|NCT00257608|3580848|FG001|STARTED|Chemotherapy Phase||0
2876369|NCT00257608|3580849|FG002|STARTED|Chemotherapy Phase||0
2876370|NCT00257608|3580847|FG000|COMPLETED|Chemotherapy Phase||769
2876371|NCT00257608|3580848|FG001|COMPLETED|Chemotherapy Phase||0
2876372|NCT00257608|3580849|FG002|COMPLETED|Chemotherapy Phase||0
2876373|NCT00257608|3580847|FG000|NOT COMPLETED|Chemotherapy Phase||376
2876374|NCT00257608|3580848|FG001|NOT COMPLETED|Chemotherapy Phase||0
2876375|NCT00257608|3580849|FG002|NOT COMPLETED|Chemotherapy Phase||0
2876376|NCT00257608|3580847|FG000|STARTED|Post Chemotherapy Phase||0
2876377|NCT00257608|3580848|FG001|STARTED|Post Chemotherapy Phase||373
2876378|NCT00257608|3580849|FG002|STARTED|Post Chemotherapy Phase||370
2876379|NCT00257608|3580847|FG000|COMPLETED|Post Chemotherapy Phase||0
2876380|NCT00257608|3580848|FG001|COMPLETED|Post Chemotherapy Phase||109
2876381|NCT00257608|3580849|FG002|COMPLETED|Post Chemotherapy Phase||126
2876382|NCT00257608|3580847|FG000|NOT COMPLETED|Post Chemotherapy Phase||0
2876383|NCT00257608|3580848|FG001|NOT COMPLETED|Post Chemotherapy Phase||264
2876384|NCT00257608|3580849|FG002|NOT COMPLETED|Post Chemotherapy Phase||244
2876385|NCT00257660|3580864|FG000|STARTED|Overall Study||55
2876386|NCT00257660|3580865|FG001|STARTED|Overall Study||61
2876387|NCT00257660|3580864|FG000|COMPLETED|Overall Study||45
2876388|NCT00257660|3580865|FG001|COMPLETED|Overall Study||38
2876389|NCT00257660|3580864|FG000|NOT COMPLETED|Overall Study||10
2876390|NCT00257660|3580865|FG001|NOT COMPLETED|Overall Study||23
2876391|NCT00257686|3580877|FG000|STARTED|Overall Study||209
2876392|NCT00257686|3580878|FG001|STARTED|Overall Study||108
2876393|NCT00257686|3580879|FG002|STARTED|Overall Study||226
2876394|NCT00257686|3580880|FG003|STARTED|Overall Study||99
2876395|NCT00257686|3580881|FG004|STARTED|Overall Study||216
2876396|NCT00257686|3580882|FG005|STARTED|Overall Study||104
2876397|NCT00257686|3580877|FG000|Safety Population|Overall Study|Subjects who received at least one dose of study medication|207
2876398|NCT00257686|3580878|FG001|Safety Population|Overall Study|Subjects who received at least one dose of study medication|103
2876399|NCT00257686|3580879|FG002|Safety Population|Overall Study|Subjects who received at least one dose of study medication|224
2876400|NCT00257686|3580880|FG003|Safety Population|Overall Study|Subjects who received at least one dose of study medication|96
2876401|NCT00257686|3580881|FG004|Safety Population|Overall Study|Subjects who received at least one dose of study medication|210
2876402|NCT00257686|3580882|FG005|Safety Population|Overall Study|Subjects who received at least one dose of study medication|102
2876403|NCT00257686|3580877|FG000|COMPLETED|Overall Study||188
2876404|NCT00257686|3580878|FG001|COMPLETED|Overall Study||89
2876405|NCT00257686|3580879|FG002|COMPLETED|Overall Study||208
2876406|NCT00257686|3580880|FG003|COMPLETED|Overall Study||88
2876407|NCT00257686|3580881|FG004|COMPLETED|Overall Study||194
2876408|NCT00257686|3580882|FG005|COMPLETED|Overall Study||95
2876409|NCT00257686|3580877|FG000|NOT COMPLETED|Overall Study||21
2876410|NCT00257686|3580878|FG001|NOT COMPLETED|Overall Study||19
2876411|NCT00257686|3580879|FG002|NOT COMPLETED|Overall Study||18
2876412|NCT00257686|3580880|FG003|NOT COMPLETED|Overall Study||11
2876413|NCT00257686|3580881|FG004|NOT COMPLETED|Overall Study||22
2876414|NCT00257686|3580882|FG005|NOT COMPLETED|Overall Study||9
2876415|NCT00257725|3580896|FG000|STARTED|Overall Study||11
2876416|NCT00257725|3580896|FG000|COMPLETED|Overall Study||8
2876417|NCT00257725|3580896|FG000|NOT COMPLETED|Overall Study||3
2876418|NCT00257894|3580903|FG000|STARTED|Overall Study||21
2876419|NCT00257894|3580904|FG001|STARTED|Overall Study||20
2876420|NCT00257894|3580903|FG000|COMPLETED|Overall Study||17
2876421|NCT00257894|3580904|FG001|COMPLETED|Overall Study||15
2876422|NCT00257894|3580903|FG000|NOT COMPLETED|Overall Study||4
2876423|NCT00257894|3580904|FG001|NOT COMPLETED|Overall Study||5
2876424|NCT00257920|3580912|FG000|STARTED|Period: First Intervention||21
2876425|NCT00257920|3580913|FG001|STARTED|Period: First Intervention||20
2876426|NCT00257920|3580912|FG000|COMPLETED|Period: First Intervention||21
2876427|NCT00257920|3580913|FG001|COMPLETED|Period: First Intervention||20
2876428|NCT00257920|3580912|FG000|NOT COMPLETED|Period: First Intervention||0
2876429|NCT00257920|3580913|FG001|NOT COMPLETED|Period: First Intervention||0
2876430|NCT00257920|3580912|FG000|STARTED|Period: Washout Period of Two Weeks||21
2876431|NCT00257920|3580913|FG001|STARTED|Period: Washout Period of Two Weeks||20
2876432|NCT00257920|3580912|FG000|COMPLETED|Period: Washout Period of Two Weeks||21
2876433|NCT00257920|3580913|FG001|COMPLETED|Period: Washout Period of Two Weeks||19
2876434|NCT00257920|3580912|FG000|NOT COMPLETED|Period: Washout Period of Two Weeks||0
2876435|NCT00257920|3580913|FG001|NOT COMPLETED|Period: Washout Period of Two Weeks||1
2876436|NCT00257920|3580912|FG000|STARTED|Period: Second Intervention||21
2876437|NCT00257920|3580913|FG001|STARTED|Period: Second Intervention||19
2876438|NCT00257920|3580912|FG000|COMPLETED|Period: Second Intervention||19
2876439|NCT00257920|3580913|FG001|COMPLETED|Period: Second Intervention||18
2876440|NCT00257920|3580912|FG000|NOT COMPLETED|Period: Second Intervention||2
2876441|NCT00257920|3580913|FG001|NOT COMPLETED|Period: Second Intervention||1
2876442|NCT00257933|3580922|FG000|STARTED|Overall Study||74
2876443|NCT00257933|3580923|FG001|STARTED|Overall Study||78
2876444|NCT00257933|3580922|FG000|COMPLETED|Overall Study||74
2876445|NCT00257933|3580923|FG001|COMPLETED|Overall Study||78
2876446|NCT00257933|3580922|FG000|NOT COMPLETED|Overall Study||0
2876447|NCT00257933|3580923|FG001|NOT COMPLETED|Overall Study||0
2876448|NCT00258011|3580929|FG000|STARTED|Overall Study||3
2876449|NCT00258011|3580929|FG000|COMPLETED|Overall Study||3
2876450|NCT00258011|3580929|FG000|NOT COMPLETED|Overall Study||0
2876451|NCT00258128|3580935|FG000|STARTED|Overall Study||8
2876452|NCT00258128|3580936|FG001|STARTED|Overall Study||9
2876453|NCT00258128|3580935|FG000|COMPLETED|Overall Study||8
2876454|NCT00258128|3580936|FG001|COMPLETED|Overall Study||9
2876455|NCT00258128|3580935|FG000|NOT COMPLETED|Overall Study||0
2876456|NCT00258128|3580936|FG001|NOT COMPLETED|Overall Study||0
2876457|NCT00258154|3580946|FG000|STARTED|Overall Study|Healthy infants who started in the RotaTeq™ concomitantly with INFANRIX™ hexa group.|201
2876458|NCT00258154|3580947|FG001|STARTED|Overall Study|Healthy infants who started in the Placebo concomitantly with INFANRIX™ hexa group.|202
2876459|NCT00258154|3580946|FG000|Vaccinated at Visit 1|Overall Study||201
2876460|NCT00258154|3580947|FG001|Vaccinated at Visit 1|Overall Study||202
2876461|NCT00258154|3580946|FG000|Vaccinated at Visit 2|Overall Study||198
2876462|NCT00258154|3580947|FG001|Vaccinated at Visit 2|Overall Study||198
2876463|NCT00258154|3580946|FG000|Vaccinated at Visit 3|Overall Study||195
2876464|NCT00258154|3580947|FG001|Vaccinated at Visit 3|Overall Study||197
2876465|NCT00258154|3580946|FG000|COMPLETED|Overall Study|Subjects who completed the study.|192
2876466|NCT00258154|3580947|FG001|COMPLETED|Overall Study|Subjects who completed the study.|195
2876467|NCT00258154|3580946|FG000|NOT COMPLETED|Overall Study||9
2876468|NCT00258154|3580947|FG001|NOT COMPLETED|Overall Study||7
2876469|NCT00258180|3580953|FG000|STARTED|Overall Study||2
2876470|NCT00258180|3580953|FG000|COMPLETED|Overall Study||2
2876471|NCT00258180|3580953|FG000|NOT COMPLETED|Overall Study||0
2876472|NCT00258206|3580958|FG000|STARTED|Overall Study||21
2876473|NCT00258206|3580958|FG000|COMPLETED|Overall Study||21
2876474|NCT00258206|3580958|FG000|NOT COMPLETED|Overall Study||0
2876475|NCT00258310|3580962|FG000|STARTED|Overall Study||35
2876476|NCT00258310|3580962|FG000|COMPLETED|Overall Study||35
2876477|NCT00258310|3580962|FG000|NOT COMPLETED|Overall Study||0
2876478|NCT00258349|3580966|FG000|STARTED|Overall Study||16
2876479|NCT00258349|3580966|FG000|HER2-positive by Central Review|Overall Study||10
2876480|NCT00258349|3580966|FG000|COMPLETED|Overall Study||16
2876481|NCT00258349|3580966|FG000|NOT COMPLETED|Overall Study||0
2876482|NCT00258362|3580972|FG000|STARTED|Overall Study||41
2876483|NCT00258362|3580972|FG000|COMPLETED|Overall Study||41
2876484|NCT00258362|3580972|FG000|NOT COMPLETED|Overall Study||0
2876485|NCT00258440|3580980|FG000|STARTED|Overall Study||1
2876486|NCT00258440|3580981|FG001|STARTED|Overall Study||0
2876487|NCT00258440|3580982|FG002|STARTED|Overall Study||6
2876488|NCT00258440|3580980|FG000|COMPLETED|Overall Study||1
2876489|NCT00258440|3580981|FG001|COMPLETED|Overall Study||0
2876490|NCT00258440|3580982|FG002|COMPLETED|Overall Study||5
2876491|NCT00258440|3580980|FG000|NOT COMPLETED|Overall Study||0
2876492|NCT00258440|3580981|FG001|NOT COMPLETED|Overall Study||0
2876493|NCT00258440|3580982|FG002|NOT COMPLETED|Overall Study||1
2876494|NCT00258674|3580993|FG000|STARTED|Overall Study||597
2876495|NCT00258674|3580994|FG001|STARTED|Overall Study||811
2876496|NCT00258674|3580995|FG002|STARTED|Overall Study||602
2876497|NCT00258674|3580993|FG000|COMPLETED|Overall Study||565
2876498|NCT00258674|3580994|FG001|COMPLETED|Overall Study||758
2876499|NCT00258674|3580995|FG002|COMPLETED|Overall Study||568
2876500|NCT00258674|3580993|FG000|NOT COMPLETED|Overall Study||32
2876501|NCT00258674|3580994|FG001|NOT COMPLETED|Overall Study||53
2876502|NCT00258674|3580995|FG002|NOT COMPLETED|Overall Study||34
2876503|NCT00258817|3581005|FG000|STARTED|Overall Study||15
2876504|NCT00258817|3581006|FG001|STARTED|Overall Study||15
2876505|NCT00258817|3581005|FG000|COMPLETED|Overall Study||15
2876506|NCT00258817|3581006|FG001|COMPLETED|Overall Study||15
2876507|NCT00258817|3581005|FG000|NOT COMPLETED|Overall Study||0
2876508|NCT00258817|3581006|FG001|NOT COMPLETED|Overall Study||0
2876509|NCT00258830|3581014|FG000|STARTED|Overall Study||60
2876510|NCT00258830|3581015|FG001|STARTED|Overall Study||60
2876511|NCT00258830|3581014|FG000|COMPLETED|Overall Study||60
2876512|NCT00258830|3581015|FG001|COMPLETED|Overall Study||60
2876513|NCT00258830|3581014|FG000|NOT COMPLETED|Overall Study||0
2876514|NCT00258830|3581015|FG001|NOT COMPLETED|Overall Study||0
2876515|NCT00258856|3581025|FG000|STARTED|Overall Study||59
2876516|NCT00258856|3581026|FG001|STARTED|Overall Study||58
2876517|NCT00258856|3581027|FG002|STARTED|Overall Study||58
2876518|NCT00258856|3581028|FG003|STARTED|Overall Study||59
2876519|NCT00258856|3581025|FG000|COMPLETED|Overall Study||56
2876520|NCT00258856|3581026|FG001|COMPLETED|Overall Study||58
2876521|NCT00258856|3581027|FG002|COMPLETED|Overall Study||56
2876522|NCT00258856|3581028|FG003|COMPLETED|Overall Study||58
2876523|NCT00258856|3581025|FG000|NOT COMPLETED|Overall Study||3
2876524|NCT00258856|3581026|FG001|NOT COMPLETED|Overall Study||0
2876525|NCT00258856|3581027|FG002|NOT COMPLETED|Overall Study||2
2876526|NCT00258856|3581028|FG003|NOT COMPLETED|Overall Study||1
2876527|NCT00258882|3581040|FG000|STARTED|Adacel Recipients Historic Cohort Method||124139
2876528|NCT00258882|3581041|FG001|STARTED|Adacel Recipients Historic Cohort Method||203154
2876529|NCT00258882|3581040|FG000|COMPLETED|Adacel Recipients Historic Cohort Method||124139
2876530|NCT00258882|3581041|FG001|COMPLETED|Adacel Recipients Historic Cohort Method||203154
2876531|NCT00258882|3581040|FG000|NOT COMPLETED|Adacel Recipients Historic Cohort Method||0
2876532|NCT00258882|3581041|FG001|NOT COMPLETED|Adacel Recipients Historic Cohort Method||0
2876533|NCT00258882|3581040|FG000|STARTED|Adacel Recipients-Risk Interval Method||124139
2876534|NCT00258882|3581041|FG001|STARTED|Adacel Recipients-Risk Interval Method|Study participants served as their own controls for this analysis|0
2876535|NCT00258882|3581040|FG000|COMPLETED|Adacel Recipients-Risk Interval Method||124139
2876536|NCT00258882|3581041|FG001|COMPLETED|Adacel Recipients-Risk Interval Method||0
2876537|NCT00258882|3581040|FG000|NOT COMPLETED|Adacel Recipients-Risk Interval Method||0
2876538|NCT00258882|3581041|FG001|NOT COMPLETED|Adacel Recipients-Risk Interval Method||0
2876539|NCT00258882|3581040|FG000|STARTED|Pregnancy Surveillance|Adacel recipients who were pregnant at the time of vaccination or within 28 days thereafter.|225
2876540|NCT00258882|3581041|FG001|STARTED|Pregnancy Surveillance|Non-vaccinated age-matched subjects with first positive pregnancy test in the same month (± 1 month)|675
2876541|NCT00258882|3581040|FG000|COMPLETED|Pregnancy Surveillance||225
2876542|NCT00258882|3581041|FG001|COMPLETED|Pregnancy Surveillance||675
2876543|NCT00258882|3581040|FG000|NOT COMPLETED|Pregnancy Surveillance||0
2876544|NCT00258882|3581041|FG001|NOT COMPLETED|Pregnancy Surveillance||0
2876545|NCT00258895|3581051|FG000|STARTED|Overall Study||487
2876546|NCT00258895|3581052|FG001|STARTED|Overall Study||162
2876547|NCT00258895|3581051|FG000|COMPLETED|Overall Study||477
2876548|NCT00258895|3581052|FG001|COMPLETED|Overall Study||159
2876549|NCT00258895|3581051|FG000|NOT COMPLETED|Overall Study||10
2876550|NCT00258895|3581052|FG001|NOT COMPLETED|Overall Study||3
2876551|NCT00258908|3581058|FG000|STARTED|Overall Study|3 participants were not vaccinated and were not included in the final analysis and in this report.|112
2876552|NCT00258908|3581058|FG000|COMPLETED|Overall Study||112
2876553|NCT00258908|3581058|FG000|NOT COMPLETED|Overall Study||0
2876554|NCT00258960|3581062|FG000|STARTED|Overall Study|49 patients included but 1 is not considered due to not receive any treatment and died before start|49
2876555|NCT00258960|3581062|FG000|COMPLETED|Overall Study||32
2876556|NCT00258960|3581062|FG000|NOT COMPLETED|Overall Study||17
2876557|NCT00259012|3581068|FG000|STARTED|Overall Study||33
2876558|NCT00259012|3581069|FG001|STARTED|Overall Study||34
2876559|NCT00259012|3581068|FG000|COMPLETED|Overall Study||31
2876560|NCT00259012|3581069|FG001|COMPLETED|Overall Study||30
2876561|NCT00259012|3581068|FG000|NOT COMPLETED|Overall Study||2
2876562|NCT00259012|3581069|FG001|NOT COMPLETED|Overall Study||4
2876563|NCT00259090|3581078|FG000|STARTED|Overall Study|Doesn't include protocol deviators, those who didn't complete the study or had missing tumor samples|35
2876564|NCT00259090|3581079|FG001|STARTED|Overall Study|Doesn't include protocol deviators, those who didn't complete the study or had missing tumor samples|31
2876565|NCT00259090|3581080|FG002|STARTED|Overall Study|Doesn't include protocol deviators, those who didn't complete the study or had missing tumor samples|37
2876566|NCT00259090|3581078|FG000|COMPLETED|Overall Study||35
2876567|NCT00259090|3581079|FG001|COMPLETED|Overall Study||31
2876568|NCT00259090|3581080|FG002|COMPLETED|Overall Study||37
2876569|NCT00259090|3581078|FG000|NOT COMPLETED|Overall Study||0
2876570|NCT00259090|3581079|FG001|NOT COMPLETED|Overall Study||0
2876571|NCT00259090|3581080|FG002|NOT COMPLETED|Overall Study||0
2876572|NCT00259272|3581092|FG000|STARTED|Overall Study||36
2876573|NCT00259272|3581093|FG001|STARTED|Overall Study||31
2876574|NCT00259272|3581094|FG002|STARTED|Overall Study||26
2876575|NCT00259272|3581095|FG003|STARTED|Overall Study||48
2876576|NCT00259272|3581092|FG000|COMPLETED|Overall Study||21
2876577|NCT00259272|3581093|FG001|COMPLETED|Overall Study||24
2876578|NCT00259272|3581094|FG002|COMPLETED|Overall Study||21
2876579|NCT00259272|3581095|FG003|COMPLETED|Overall Study||27
2876580|NCT00259272|3581092|FG000|NOT COMPLETED|Overall Study||15
2876581|NCT00259272|3581093|FG001|NOT COMPLETED|Overall Study||7
2876582|NCT00259272|3581094|FG002|NOT COMPLETED|Overall Study||5
2876583|NCT00259272|3581095|FG003|NOT COMPLETED|Overall Study||21
2876584|NCT00259285|3581110|FG000|STARTED|Overall Study||10
2876585|NCT00259285|3581110|FG000|COMPLETED|Overall Study||10
2876586|NCT00259285|3581110|FG000|NOT COMPLETED|Overall Study||0
2876587|NCT00259298|3581114|FG000|STARTED|Overall Study||12
2876588|NCT00259298|3581114|FG000|Received at Least 1 Dose of Study Drug|Overall Study||10
2876589|NCT00259298|3581114|FG000|COMPLETED|Overall Study||9
2876590|NCT00259298|3581114|FG000|NOT COMPLETED|Overall Study||3
2876591|NCT00259610|3581122|FG000|STARTED|Overall Study||244
2876592|NCT00259610|3581123|FG001|STARTED|Overall Study||132
2876593|NCT00259610|3581124|FG002|STARTED|Overall Study||255
2876594|NCT00259610|3581125|FG003|STARTED|Overall Study||124
2876595|NCT00259610|3581122|FG000|COMPLETED|Overall Study||168
2876596|NCT00259610|3581123|FG001|COMPLETED|Overall Study||86
2876597|NCT00259610|3581124|FG002|COMPLETED|Overall Study||182
2876598|NCT00259610|3581125|FG003|COMPLETED|Overall Study||81
2876599|NCT00259610|3581122|FG000|NOT COMPLETED|Overall Study||76
2876600|NCT00259610|3581123|FG001|NOT COMPLETED|Overall Study||46
2876601|NCT00259610|3581124|FG002|NOT COMPLETED|Overall Study||73
2876602|NCT00259610|3581125|FG003|NOT COMPLETED|Overall Study||43
2876603|NCT00259649|3581135|FG000|STARTED|Overall Study||71
2876604|NCT00259649|3581135|FG000|COMPLETED|Overall Study||61
2876605|NCT00259649|3581135|FG000|NOT COMPLETED|Overall Study||10
2876606|NCT00259740|3581141|FG000|STARTED|Overall Study||43
2876607|NCT00259740|3581142|FG001|STARTED|Overall Study||53
2876608|NCT00259740|3581141|FG000|Received Study Medication|Overall Study||42
2876609|NCT00259740|3581142|FG001|Received Study Medication|Overall Study||53
2876610|NCT00259740|3581141|FG000|COMPLETED|Overall Study||0
2876611|NCT00259740|3581142|FG001|COMPLETED|Overall Study||0
2876612|NCT00259740|3581141|FG000|NOT COMPLETED|Overall Study||43
2876613|NCT00259740|3581142|FG001|NOT COMPLETED|Overall Study||53
2876614|NCT00259857|3581150|FG000|STARTED|12 Months Treatment||11
2876615|NCT00259857|3581151|FG001|STARTED|12 Months Treatment||11
2876616|NCT00259857|3581150|FG000|COMPLETED|12 Months Treatment||10
2876617|NCT00259857|3581151|FG001|COMPLETED|12 Months Treatment||9
2876618|NCT00259857|3581150|FG000|NOT COMPLETED|12 Months Treatment||1
2876619|NCT00259857|3581151|FG001|NOT COMPLETED|12 Months Treatment||2
2876620|NCT00259857|3581150|FG000|STARTED|24 Months Treatment||10
2876621|NCT00259857|3581151|FG001|STARTED|24 Months Treatment||9
2876622|NCT00259857|3581150|FG000|COMPLETED|24 Months Treatment||10
2876623|NCT00259857|3581151|FG001|COMPLETED|24 Months Treatment||6
2876624|NCT00259857|3581150|FG000|NOT COMPLETED|24 Months Treatment||0
2876625|NCT00259857|3581151|FG001|NOT COMPLETED|24 Months Treatment||3
2876626|NCT00260065|3581157|FG000|STARTED|Overall Study||99
2876627|NCT00260065|3581157|FG000|COMPLETED|Overall Study||6
2876628|NCT00260065|3581157|FG000|NOT COMPLETED|Overall Study||93
2876629|NCT00260195|3581163|FG000|STARTED|Overall Study||39
2876630|NCT00260195|3581164|FG001|STARTED|Overall Study||37
2876631|NCT00260195|3581163|FG000|COMPLETED|Overall Study||39
2876632|NCT00260195|3581164|FG001|COMPLETED|Overall Study||37
2876633|NCT00260195|3581163|FG000|NOT COMPLETED|Overall Study||0
2876634|NCT00260195|3581164|FG001|NOT COMPLETED|Overall Study||0
2876635|NCT00260208|3581173|FG000|STARTED|Overall Study|"Started indicates safety population."|184
2876636|NCT00260208|3581174|FG001|STARTED|Overall Study||172
2876637|NCT00260208|3581173|FG000|Intent to Treat (ITT) Population|Overall Study||182
2876638|NCT00260208|3581174|FG001|Intent to Treat (ITT) Population|Overall Study||169
2876639|NCT00260208|3581173|FG000|Modified ITT|Overall Study||101
2876640|NCT00260208|3581174|FG001|Modified ITT|Overall Study||96
2876641|NCT00260208|3581173|FG000|COMPLETED|Overall Study||137
2876642|NCT00260208|3581174|FG001|COMPLETED|Overall Study||138
2876643|NCT00260208|3581173|FG000|NOT COMPLETED|Overall Study||47
2876644|NCT00260208|3581174|FG001|NOT COMPLETED|Overall Study||34
2876645|NCT00260429|3581182|FG000|STARTED|Overall Study||23
2876646|NCT00260429|3581183|FG001|STARTED|Overall Study||12
2876647|NCT00260429|3581182|FG000|COMPLETED|Overall Study||21
2876648|NCT00260429|3581183|FG001|COMPLETED|Overall Study||12
2876649|NCT00260429|3581182|FG000|NOT COMPLETED|Overall Study||2
2876650|NCT00260429|3581183|FG001|NOT COMPLETED|Overall Study||0
2876651|NCT00260533|3581191|FG000|STARTED|Overall Study||14
2876652|NCT00260533|3581192|FG001|STARTED|Overall Study||13
2876653|NCT00260533|3581191|FG000|COMPLETED|Overall Study||11
2876654|NCT00260533|3581192|FG001|COMPLETED|Overall Study||10
2876655|NCT00260533|3581191|FG000|NOT COMPLETED|Overall Study||3
2876656|NCT00260533|3581192|FG001|NOT COMPLETED|Overall Study||3
2876657|NCT00260689|3581201|FG000|STARTED|Overall Study||60
2876658|NCT00260689|3581202|FG001|STARTED|Overall Study||60
2876659|NCT00260689|3581203|FG002|STARTED|Overall Study||16
2876660|NCT00260689|3581201|FG000|COMPLETED|Overall Study||19
2876661|NCT00260689|3581202|FG001|COMPLETED|Overall Study||11
2876662|NCT00260689|3581203|FG002|COMPLETED|Overall Study||1
2876663|NCT00260689|3581201|FG000|NOT COMPLETED|Overall Study||41
2876664|NCT00260689|3581202|FG001|NOT COMPLETED|Overall Study||49
2876665|NCT00260689|3581203|FG002|NOT COMPLETED|Overall Study||15
2876666|NCT00260832|3581213|FG000|STARTED|Overall Study||243
2876667|NCT00260832|3581214|FG001|STARTED|Overall Study||242
2876668|NCT00260832|3581213|FG000|COMPLETED|Overall Study|At study completion, these subjects chose to remain on treatment|15
2876669|NCT00260832|3581214|FG001|COMPLETED|Overall Study|At study completion, these subjects chose to remain on treatment|31
2876670|NCT00260832|3581213|FG000|NOT COMPLETED|Overall Study||228
2876671|NCT00260832|3581214|FG001|NOT COMPLETED|Overall Study||211
2876672|NCT00260962|3581222|FG000|STARTED|Overall Study||18
2876673|NCT00260962|3581223|FG001|STARTED|Overall Study||16
2876674|NCT00260962|3581222|FG000|COMPLETED|Overall Study||14
2876675|NCT00260962|3581223|FG001|COMPLETED|Overall Study||14
2876676|NCT00260962|3581222|FG000|NOT COMPLETED|Overall Study||4
2876677|NCT00260962|3581223|FG001|NOT COMPLETED|Overall Study||2
2876678|NCT00261040|3581231|FG000|STARTED|Overall Study||20
2876679|NCT00261040|3581232|FG001|STARTED|Overall Study||20
2876680|NCT00261040|3581231|FG000|COMPLETED|Overall Study||19
2876681|NCT00261040|3581232|FG001|COMPLETED|Overall Study||20
2876682|NCT00261040|3581231|FG000|NOT COMPLETED|Overall Study||1
2876683|NCT00261040|3581232|FG001|NOT COMPLETED|Overall Study||0
2876684|NCT00261443|3581240|FG000|STARTED|1: Confirmation of Partial Nonresponse||1270
2876685|NCT00261443|3581241|FG001|STARTED|1: Confirmation of Partial Nonresponse||0
2876686|NCT00261443|3581242|FG002|STARTED|1: Confirmation of Partial Nonresponse||0
2876687|NCT00261443|3581240|FG000|COMPLETED|1: Confirmation of Partial Nonresponse||686
2876688|NCT00261443|3581241|FG001|COMPLETED|1: Confirmation of Partial Nonresponse||0
2876689|NCT00261443|3581242|FG002|COMPLETED|1: Confirmation of Partial Nonresponse||0
2876690|NCT00261443|3581240|FG000|NOT COMPLETED|1: Confirmation of Partial Nonresponse||584
2876691|NCT00261443|3581241|FG001|NOT COMPLETED|1: Confirmation of Partial Nonresponse||0
2876692|NCT00261443|3581242|FG002|NOT COMPLETED|1: Confirmation of Partial Nonresponse||0
2876693|NCT00261443|3581240|FG000|STARTED|2: Stability & Maintenance of Stability||686
2876694|NCT00261443|3581241|FG001|STARTED|2: Stability & Maintenance of Stability||0
2876695|NCT00261443|3581242|FG002|STARTED|2: Stability & Maintenance of Stability||0
2876696|NCT00261443|3581240|FG000|COMPLETED|2: Stability & Maintenance of Stability||346
2876697|NCT00261443|3581241|FG001|COMPLETED|2: Stability & Maintenance of Stability||0
2876698|NCT00261443|3581242|FG002|COMPLETED|2: Stability & Maintenance of Stability||0
2876699|NCT00261443|3581240|FG000|NOT COMPLETED|2: Stability & Maintenance of Stability||340
2876700|NCT00261443|3581241|FG001|NOT COMPLETED|2: Stability & Maintenance of Stability||0
2876701|NCT00261443|3581242|FG002|NOT COMPLETED|2: Stability & Maintenance of Stability||0
2876702|NCT00261443|3581240|FG000|STARTED|3: Assessment of Relapse||0
2876703|NCT00261443|3581241|FG001|STARTED|3: Assessment of Relapse||169
2876704|NCT00261443|3581242|FG002|STARTED|3: Assessment of Relapse||168
3169837|NCT01928381|3897368|FG001|STARTED|Placebo run-in & Part 2 Eligibility||0
3169838|NCT01928381|3897369|FG002|STARTED|Placebo run-in & Part 2 Eligibility||0
3169839|NCT01928381|3897370|FG003|STARTED|Placebo run-in & Part 2 Eligibility||0
3169840|NCT01928381|3897371|FG004|STARTED|Placebo run-in & Part 2 Eligibility||0
3169841|NCT01928381|3897372|FG005|STARTED|Placebo run-in & Part 2 Eligibility||0
3169842|NCT01928381|3897373|FG006|STARTED|Placebo run-in & Part 2 Eligibility||0
3169843|NCT01928381|3897367|FG000|COMPLETED|Placebo run-in & Part 2 Eligibility||34
3169844|NCT01928381|3897368|FG001|COMPLETED|Placebo run-in & Part 2 Eligibility||0
3169845|NCT01928381|3897369|FG002|COMPLETED|Placebo run-in & Part 2 Eligibility||0
3169846|NCT01928381|3897370|FG003|COMPLETED|Placebo run-in & Part 2 Eligibility||0
3169847|NCT01928381|3897371|FG004|COMPLETED|Placebo run-in & Part 2 Eligibility||0
2876705|NCT00261443|3581240|FG000|COMPLETED|3: Assessment of Relapse||0
2876706|NCT00261443|3581241|FG001|COMPLETED|3: Assessment of Relapse||89
2876707|NCT00261443|3581242|FG002|COMPLETED|3: Assessment of Relapse||103
2876708|NCT00261443|3581240|FG000|NOT COMPLETED|3: Assessment of Relapse||0
2876709|NCT00261443|3581241|FG001|NOT COMPLETED|3: Assessment of Relapse||80
2876710|NCT00261443|3581242|FG002|NOT COMPLETED|3: Assessment of Relapse||65
2876711|NCT00261443|3581240|FG000|STARTED|4: Extension Phase||0
2876712|NCT00261443|3581241|FG001|STARTED|4: Extension Phase||19
2876713|NCT00261443|3581242|FG002|STARTED|4: Extension Phase||23
2876714|NCT00261443|3581240|FG000|COMPLETED|4: Extension Phase||0
2876715|NCT00261443|3581241|FG001|COMPLETED|4: Extension Phase||16
2876716|NCT00261443|3581242|FG002|COMPLETED|4: Extension Phase||21
2876717|NCT00261443|3581240|FG000|NOT COMPLETED|4: Extension Phase||0
2876718|NCT00261443|3581241|FG001|NOT COMPLETED|4: Extension Phase||3
2876719|NCT00261443|3581242|FG002|NOT COMPLETED|4: Extension Phase||2
2876720|NCT00261495|3581255|FG000|STARTED|Titration Phase (Weeks 0 to 4)||254
2876721|NCT00261495|3581256|FG001|STARTED|Titration Phase (Weeks 0 to 4)||250
2876722|NCT00261495|3581255|FG000|COMPLETED|Titration Phase (Weeks 0 to 4)||206
2876723|NCT00261495|3581256|FG001|COMPLETED|Titration Phase (Weeks 0 to 4)||185
2876724|NCT00261495|3581255|FG000|NOT COMPLETED|Titration Phase (Weeks 0 to 4)||48
2876725|NCT00261495|3581256|FG001|NOT COMPLETED|Titration Phase (Weeks 0 to 4)||65
2876726|NCT00261495|3581255|FG000|STARTED|Maintenance Phase (Weeks 4 to 24)||206
2876727|NCT00261495|3581256|FG001|STARTED|Maintenance Phase (Weeks 4 to 24)||185
2876728|NCT00261495|3581255|FG000|COMPLETED|Maintenance Phase (Weeks 4 to 24)||140
2876729|NCT00261495|3581256|FG001|COMPLETED|Maintenance Phase (Weeks 4 to 24)||137
2876730|NCT00261495|3581255|FG000|NOT COMPLETED|Maintenance Phase (Weeks 4 to 24)||66
2876731|NCT00261495|3581256|FG001|NOT COMPLETED|Maintenance Phase (Weeks 4 to 24)||48
2876732|NCT00261495|3581255|FG000|STARTED|Extension Phase (Weeks 24 to 52)|Number started is different to number completed maintenance phase owing to drop outs (80 subjects).|60
2876733|NCT00261495|3581256|FG001|STARTED|Extension Phase (Weeks 24 to 52)|Number started is different to number completed maintenance phase owing to drop outs (85 subjects).|52
2876734|NCT00261495|3581255|FG000|COMPLETED|Extension Phase (Weeks 24 to 52)||50
2876735|NCT00261495|3581256|FG001|COMPLETED|Extension Phase (Weeks 24 to 52)||47
2876736|NCT00261495|3581255|FG000|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||10
2876737|NCT00261495|3581256|FG001|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||5
2876738|NCT00261716|3581264|FG000|STARTED|Overall Study||17
2876739|NCT00261716|3581265|FG001|STARTED|Overall Study||21
2876740|NCT00261716|3581264|FG000|COMPLETED|Overall Study||11
3169848|NCT01928381|3897372|FG005|COMPLETED|Placebo run-in & Part 2 Eligibility||0
3169849|NCT01928381|3897373|FG006|COMPLETED|Placebo run-in & Part 2 Eligibility||0
3169850|NCT01928381|3897367|FG000|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||14
3169851|NCT01928381|3897368|FG001|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
3169852|NCT01928381|3897369|FG002|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
3169853|NCT01928381|3897370|FG003|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
2876741|NCT00261716|3581265|FG001|COMPLETED|Overall Study||11
2876742|NCT00261716|3581264|FG000|NOT COMPLETED|Overall Study||6
2876743|NCT00261716|3581265|FG001|NOT COMPLETED|Overall Study||10
2876744|NCT00261833|3581277|FG000|STARTED|Overall Study||93
2876745|NCT00261833|3581278|FG001|STARTED|Overall Study||87
2876746|NCT00261833|3581277|FG000|COMPLETED|Overall Study||84
2876747|NCT00261833|3581278|FG001|COMPLETED|Overall Study||69
2876748|NCT00261833|3581277|FG000|NOT COMPLETED|Overall Study||9
2876749|NCT00261833|3581278|FG001|NOT COMPLETED|Overall Study||18
2876750|NCT00261846|3581294|FG000|STARTED|Period 1: Part 1 (Dose Escalation)||3
2876751|NCT00261846|3581295|FG001|STARTED|Period 1: Part 1 (Dose Escalation)||3
2876752|NCT00261846|3581296|FG002|STARTED|Period 1: Part 1 (Dose Escalation)||12
2876753|NCT00261846|3581297|FG003|STARTED|Period 1: Part 1 (Dose Escalation)||0
2876754|NCT00261846|3581298|FG004|STARTED|Period 1: Part 1 (Dose Escalation)||0
2876755|NCT00261846|3581299|FG005|STARTED|Period 1: Part 1 (Dose Escalation)||0
2876756|NCT00261846|3581300|FG006|STARTED|Period 1: Part 1 (Dose Escalation)||0
2876757|NCT00261846|3581301|FG007|STARTED|Period 1: Part 1 (Dose Escalation)||0
2876758|NCT00261846|3581302|FG008|STARTED|Period 1: Part 1 (Dose Escalation)||0
2876759|NCT00261846|3581303|FG009|STARTED|Period 1: Part 1 (Dose Escalation)||0
2876760|NCT00261846|3581304|FG010|STARTED|Period 1: Part 1 (Dose Escalation)||0
2876761|NCT00261846|3581305|FG011|STARTED|Period 1: Part 1 (Dose Escalation)||0
2876762|NCT00261846|3581294|FG000|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
2876763|NCT00261846|3581295|FG001|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
2876764|NCT00261846|3581296|FG002|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
2876765|NCT00261846|3581297|FG003|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
2876766|NCT00261846|3581298|FG004|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
2876767|NCT00261846|3581299|FG005|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
2876768|NCT00261846|3581300|FG006|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
2876769|NCT00261846|3581301|FG007|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
2876770|NCT00261846|3581302|FG008|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
2876771|NCT00261846|3581303|FG009|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
2876772|NCT00261846|3581304|FG010|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
2876773|NCT00261846|3581305|FG011|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
2876774|NCT00261846|3581294|FG000|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||3
2876775|NCT00261846|3581295|FG001|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||3
2876776|NCT00261846|3581296|FG002|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||12
2876777|NCT00261846|3581297|FG003|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
2876778|NCT00261846|3581298|FG004|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
2876779|NCT00261846|3581299|FG005|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
2876780|NCT00261846|3581300|FG006|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
2876781|NCT00261846|3581301|FG007|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
2876782|NCT00261846|3581302|FG008|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
2876783|NCT00261846|3581303|FG009|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
2876784|NCT00261846|3581304|FG010|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
2876785|NCT00261846|3581305|FG011|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
2876786|NCT00261846|3581294|FG000|STARTED|Period 2: Part 2 (Efficacy)||0
2876787|NCT00261846|3581295|FG001|STARTED|Period 2: Part 2 (Efficacy)||0
2876788|NCT00261846|3581296|FG002|STARTED|Period 2: Part 2 (Efficacy)||0
2876789|NCT00261846|3581297|FG003|STARTED|Period 2: Part 2 (Efficacy)|17 participants from Part 1 (Bosutinib 400mg, 500mg, 600mg cohort) continued in Part 2 of the study.|195
2876790|NCT00261846|3581298|FG004|STARTED|Period 2: Part 2 (Efficacy)||89
2876791|NCT00261846|3581299|FG005|STARTED|Period 2: Part 2 (Efficacy)||5
2876792|NCT00261846|3581300|FG006|STARTED|Period 2: Part 2 (Efficacy)||38
2876793|NCT00261846|3581301|FG007|STARTED|Period 2: Part 2 (Efficacy)||50
2876794|NCT00261846|3581302|FG008|STARTED|Period 2: Part 2 (Efficacy)||26
2876795|NCT00261846|3581303|FG009|STARTED|Period 2: Part 2 (Efficacy)|1 participant from Part 1 (Bosutinib 600mg cohort) continued in Part 2 of the study.|79
2876796|NCT00261846|3581304|FG010|STARTED|Period 2: Part 2 (Efficacy)||64
2876797|NCT00261846|3581305|FG011|STARTED|Period 2: Part 2 (Efficacy)||24
2876798|NCT00261846|3581294|FG000|COMPLETED|Period 2: Part 2 (Efficacy)||0
2876799|NCT00261846|3581295|FG001|COMPLETED|Period 2: Part 2 (Efficacy)||0
2876800|NCT00261846|3581296|FG002|COMPLETED|Period 2: Part 2 (Efficacy)||0
2876801|NCT00261846|3581297|FG003|COMPLETED|Period 2: Part 2 (Efficacy)||60
2876802|NCT00261846|3581298|FG004|COMPLETED|Period 2: Part 2 (Efficacy)||39
2876803|NCT00261846|3581299|FG005|COMPLETED|Period 2: Part 2 (Efficacy)||3
2876804|NCT00261846|3581300|FG006|COMPLETED|Period 2: Part 2 (Efficacy)||16
2876805|NCT00261846|3581301|FG007|COMPLETED|Period 2: Part 2 (Efficacy)||21
2876806|NCT00261846|3581302|FG008|COMPLETED|Period 2: Part 2 (Efficacy)||12
2876807|NCT00261846|3581303|FG009|COMPLETED|Period 2: Part 2 (Efficacy)||30
2876808|NCT00261846|3581304|FG010|COMPLETED|Period 2: Part 2 (Efficacy)||15
2876809|NCT00261846|3581305|FG011|COMPLETED|Period 2: Part 2 (Efficacy)||1
2876810|NCT00261846|3581294|FG000|NOT COMPLETED|Period 2: Part 2 (Efficacy)||0
2876811|NCT00261846|3581295|FG001|NOT COMPLETED|Period 2: Part 2 (Efficacy)||0
2876812|NCT00261846|3581296|FG002|NOT COMPLETED|Period 2: Part 2 (Efficacy)||0
2876813|NCT00261846|3581297|FG003|NOT COMPLETED|Period 2: Part 2 (Efficacy)||135
2876814|NCT00261846|3581298|FG004|NOT COMPLETED|Period 2: Part 2 (Efficacy)||50
2876815|NCT00261846|3581299|FG005|NOT COMPLETED|Period 2: Part 2 (Efficacy)||2
2876816|NCT00261846|3581300|FG006|NOT COMPLETED|Period 2: Part 2 (Efficacy)||22
2876817|NCT00261846|3581301|FG007|NOT COMPLETED|Period 2: Part 2 (Efficacy)||29
2876818|NCT00261846|3581302|FG008|NOT COMPLETED|Period 2: Part 2 (Efficacy)||14
2876819|NCT00261846|3581303|FG009|NOT COMPLETED|Period 2: Part 2 (Efficacy)||49
2876820|NCT00261846|3581304|FG010|NOT COMPLETED|Period 2: Part 2 (Efficacy)||49
2876821|NCT00261846|3581305|FG011|NOT COMPLETED|Period 2: Part 2 (Efficacy)||23
2876822|NCT00261950|3581344|FG000|STARTED|Overall Study||110
2876823|NCT00261950|3581344|FG000|COMPLETED|Overall Study||84
2876824|NCT00261950|3581344|FG000|NOT COMPLETED|Overall Study||26
2876825|NCT00262002|3581355|FG000|STARTED|Overall Study||90
2876826|NCT00262002|3581356|FG001|STARTED|Overall Study||90
2876827|NCT00262002|3581357|FG002|STARTED|Overall Study||45
2876828|NCT00262002|3581358|FG003|STARTED|Overall Study||98
2876829|NCT00262002|3581359|FG004|STARTED|Overall Study||98
2876830|NCT00262002|3581360|FG005|STARTED|Overall Study||90
2876831|NCT00262002|3581361|FG006|STARTED|Overall Study||90
2876832|NCT00262002|3581355|FG000|COMPLETED|Overall Study||79
2876833|NCT00262002|3581356|FG001|COMPLETED|Overall Study||84
2876834|NCT00262002|3581357|FG002|COMPLETED|Overall Study||45
2876835|NCT00262002|3581358|FG003|COMPLETED|Overall Study||93
2876836|NCT00262002|3581359|FG004|COMPLETED|Overall Study||91
2876837|NCT00262002|3581360|FG005|COMPLETED|Overall Study||83
2876838|NCT00262002|3581361|FG006|COMPLETED|Overall Study||84
2876839|NCT00262002|3581355|FG000|NOT COMPLETED|Overall Study||11
2876840|NCT00262002|3581356|FG001|NOT COMPLETED|Overall Study||6
2876841|NCT00262002|3581357|FG002|NOT COMPLETED|Overall Study||0
2876842|NCT00262002|3581358|FG003|NOT COMPLETED|Overall Study||5
2876843|NCT00262002|3581359|FG004|NOT COMPLETED|Overall Study||7
2876844|NCT00262002|3581360|FG005|NOT COMPLETED|Overall Study||7
2876845|NCT00262002|3581361|FG006|NOT COMPLETED|Overall Study||6
2876846|NCT00262028|3581435|FG000|STARTED|Overall Study||152
2876847|NCT00262028|3581436|FG001|STARTED|Overall Study||153
2876848|NCT00262028|3581437|FG002|STARTED|Overall Study||157
2876849|NCT00262028|3581438|FG003|STARTED|Overall Study||157
2876850|NCT00262028|3581439|FG004|STARTED|Overall Study||74
2876851|NCT00262028|3581440|FG005|STARTED|Overall Study||73
2876852|NCT00262028|3581441|FG006|STARTED|Overall Study||71
2876853|NCT00262028|3581442|FG007|STARTED|Overall Study||73
2876854|NCT00262028|3581443|FG008|STARTED|Overall Study||100
2876855|NCT00262028|3581435|FG000|COMPLETED|Overall Study||128
2876856|NCT00262028|3581436|FG001|COMPLETED|Overall Study||126
2876857|NCT00262028|3581437|FG002|COMPLETED|Overall Study||137
3133737|NCT01697358|3858676|FG000|NOT COMPLETED|Period II: 6-24M Long-term Follow-up||49
3133738|NCT01697358|3858677|FG001|NOT COMPLETED|Period II: 6-24M Long-term Follow-up||55
3133739|NCT01697449|3858683|FG000|STARTED|Overall Study||191
3133740|NCT01697449|3858683|FG000|COMPLETED|Overall Study||101
3133741|NCT01697449|3858683|FG000|NOT COMPLETED|Overall Study||90
3133742|NCT01697462|3858690|FG000|STARTED|Overall Study||258
2876858|NCT00262028|3581438|FG003|COMPLETED|Overall Study||134
2876859|NCT00262028|3581439|FG004|COMPLETED|Overall Study||62
2876860|NCT00262028|3581440|FG005|COMPLETED|Overall Study||60
2876861|NCT00262028|3581441|FG006|COMPLETED|Overall Study||59
2876862|NCT00262028|3581442|FG007|COMPLETED|Overall Study||55
2876863|NCT00262028|3581443|FG008|COMPLETED|Overall Study||81
2876864|NCT00262028|3581435|FG000|NOT COMPLETED|Overall Study||24
2876865|NCT00262028|3581436|FG001|NOT COMPLETED|Overall Study||27
2876866|NCT00262028|3581437|FG002|NOT COMPLETED|Overall Study||20
2876867|NCT00262028|3581438|FG003|NOT COMPLETED|Overall Study||23
2876868|NCT00262028|3581439|FG004|NOT COMPLETED|Overall Study||12
2876869|NCT00262028|3581440|FG005|NOT COMPLETED|Overall Study||13
2876870|NCT00262028|3581441|FG006|NOT COMPLETED|Overall Study||12
2876871|NCT00262028|3581442|FG007|NOT COMPLETED|Overall Study||18
2876872|NCT00262028|3581443|FG008|NOT COMPLETED|Overall Study||19
2876873|NCT00262041|3581489|FG000|STARTED|Overall Study||164
2876874|NCT00262041|3581490|FG001|STARTED|Overall Study||151
2876875|NCT00262041|3581491|FG002|STARTED|Overall Study||209
2876876|NCT00262041|3581489|FG000|COMPLETED|Overall Study||162
2876877|NCT00262041|3581490|FG001|COMPLETED|Overall Study||147
2876878|NCT00262041|3581491|FG002|COMPLETED|Overall Study||203
2876879|NCT00262041|3581489|FG000|NOT COMPLETED|Overall Study||2
2876880|NCT00262041|3581490|FG001|NOT COMPLETED|Overall Study||4
2876881|NCT00262041|3581491|FG002|NOT COMPLETED|Overall Study||6
2876882|NCT00262067|3581509|FG000|STARTED|Overall Study||415
2876883|NCT00262067|3581510|FG001|STARTED|Overall Study||207
2876884|NCT00262067|3581511|FG002|STARTED|Overall Study||409
2876885|NCT00262067|3581512|FG003|STARTED|Overall Study||206
2876886|NCT00262067|3581509|FG000|COMPLETED|Overall Study||196
2876887|NCT00262067|3581510|FG001|COMPLETED|Overall Study||107
2876888|NCT00262067|3581511|FG002|COMPLETED|Overall Study||193
2876889|NCT00262067|3581512|FG003|COMPLETED|Overall Study||93
2876890|NCT00262067|3581509|FG000|NOT COMPLETED|Overall Study||219
2876891|NCT00262067|3581510|FG001|NOT COMPLETED|Overall Study||100
2876892|NCT00262067|3581511|FG002|NOT COMPLETED|Overall Study||216
2876893|NCT00262067|3581512|FG003|NOT COMPLETED|Overall Study||113
2876894|NCT00262080|3581525|FG000|STARTED|Double Blind Treatment Period|One patient was randomized to receive ecallantide but was treated with placebo.|36
2876895|NCT00262080|3581526|FG001|STARTED|Double Blind Treatment Period|One patient was randomized to receive placebo but was treated with ecallantide.|36
2876896|NCT00262080|3581527|FG002|STARTED|Double Blind Treatment Period||0
2876897|NCT00262080|3581525|FG000|COMPLETED|Double Blind Treatment Period||35
2876898|NCT00262080|3581526|FG001|COMPLETED|Double Blind Treatment Period||36
2876899|NCT00262080|3581527|FG002|COMPLETED|Double Blind Treatment Period||0
2876900|NCT00262080|3581525|FG000|NOT COMPLETED|Double Blind Treatment Period||1
2876901|NCT00262080|3581526|FG001|NOT COMPLETED|Double Blind Treatment Period||0
2876902|NCT00262080|3581527|FG002|NOT COMPLETED|Double Blind Treatment Period||0
2876903|NCT00262080|3581525|FG000|STARTED|Repeat Dose Treatment Period|Not all patients treated in the double-blind part came for treatment in the repeat-dose part.|22
2876904|NCT00262080|3581526|FG001|STARTED|Repeat Dose Treatment Period|Not all patients treated in the double-blind part came for treatment in the repeat-dose part.|26
2876905|NCT00262080|3581527|FG002|STARTED|Repeat Dose Treatment Period|This arm represents new patients, not treated in the double-blind part of the study.|19
2876906|NCT00262080|3581525|FG000|COMPLETED|Repeat Dose Treatment Period|Some patients participated in only the double-blind or the open label phase.|18
2876907|NCT00262080|3581526|FG001|COMPLETED|Repeat Dose Treatment Period||25
2876908|NCT00262080|3581527|FG002|COMPLETED|Repeat Dose Treatment Period||14
2876909|NCT00262080|3581525|FG000|NOT COMPLETED|Repeat Dose Treatment Period||4
2876910|NCT00262080|3581526|FG001|NOT COMPLETED|Repeat Dose Treatment Period||1
2876911|NCT00262080|3581527|FG002|NOT COMPLETED|Repeat Dose Treatment Period||5
2876912|NCT00262119|3581538|FG000|STARTED|Overall Study||385
2876913|NCT00262119|3581539|FG001|STARTED|Overall Study||398
2876914|NCT00262119|3581540|FG002|STARTED|Overall Study||383
2876915|NCT00262119|3581538|FG000|COMPLETED|Overall Study||327
2876916|NCT00262119|3581539|FG001|COMPLETED|Overall Study||328
2876917|NCT00262119|3581540|FG002|COMPLETED|Overall Study||325
2876918|NCT00262119|3581538|FG000|NOT COMPLETED|Overall Study||58
2876919|NCT00262119|3581539|FG001|NOT COMPLETED|Overall Study||70
2876920|NCT00262119|3581540|FG002|NOT COMPLETED|Overall Study||58
2876921|NCT00262223|3581550|FG000|STARTED|Treatment Phase||32
2876922|NCT00262223|3581551|FG001|STARTED|Treatment Phase||37
2876923|NCT00262223|3581550|FG000|COMPLETED|Treatment Phase||28
2876924|NCT00262223|3581551|FG001|COMPLETED|Treatment Phase||29
2876925|NCT00262223|3581550|FG000|NOT COMPLETED|Treatment Phase||4
2876926|NCT00262223|3581551|FG001|NOT COMPLETED|Treatment Phase||8
2876927|NCT00262223|3581550|FG000|STARTED|1-week Post-treatment Follow-up||28
2876928|NCT00262223|3581551|FG001|STARTED|1-week Post-treatment Follow-up||29
2876929|NCT00262223|3581550|FG000|COMPLETED|1-week Post-treatment Follow-up||24
2876930|NCT00262223|3581551|FG001|COMPLETED|1-week Post-treatment Follow-up||25
2876931|NCT00262223|3581550|FG000|NOT COMPLETED|1-week Post-treatment Follow-up||4
2876932|NCT00262223|3581551|FG001|NOT COMPLETED|1-week Post-treatment Follow-up||4
2876933|NCT00262223|3581550|FG000|STARTED|6-month Post-treatment Follow-up|Subjects were included in subsequent follow-ups even if lost to contact during previous follow-up.|28
2876934|NCT00262223|3581551|FG001|STARTED|6-month Post-treatment Follow-up|Subjects were included in subsequent follow-ups even if lost to contact during previous follow-up.|29
2876935|NCT00262223|3581550|FG000|COMPLETED|6-month Post-treatment Follow-up||22
2876936|NCT00262223|3581551|FG001|COMPLETED|6-month Post-treatment Follow-up||28
2876937|NCT00262223|3581550|FG000|NOT COMPLETED|6-month Post-treatment Follow-up||6
2876938|NCT00262223|3581551|FG001|NOT COMPLETED|6-month Post-treatment Follow-up||1
2876939|NCT00262223|3581550|FG000|STARTED|12-month Post-treatment Follow-up|Subjects were included in subsequent follow-ups even if lost to contact during previous follow-up.|28
2876940|NCT00262223|3581551|FG001|STARTED|12-month Post-treatment Follow-up|Subjects were included in subsequent follow-ups even if lost to contact during previous follow-up.|29
2876941|NCT00262223|3581550|FG000|COMPLETED|12-month Post-treatment Follow-up||21
2876942|NCT00262223|3581551|FG001|COMPLETED|12-month Post-treatment Follow-up||22
2876943|NCT00262223|3581550|FG000|NOT COMPLETED|12-month Post-treatment Follow-up||7
2876944|NCT00262223|3581551|FG001|NOT COMPLETED|12-month Post-treatment Follow-up||7
2876945|NCT00262301|3581561|FG000|STARTED|Double-blind Phase||16
2876946|NCT00262301|3581562|FG001|STARTED|Double-blind Phase||16
2876947|NCT00262301|3581563|FG002|STARTED|Double-blind Phase||0
2876948|NCT00262301|3581561|FG000|COMPLETED|Double-blind Phase||15
2876949|NCT00262301|3581562|FG001|COMPLETED|Double-blind Phase||15
2876950|NCT00262301|3581563|FG002|COMPLETED|Double-blind Phase||0
2876951|NCT00262301|3581561|FG000|NOT COMPLETED|Double-blind Phase||1
2876952|NCT00262301|3581562|FG001|NOT COMPLETED|Double-blind Phase||1
2876953|NCT00262301|3581563|FG002|NOT COMPLETED|Double-blind Phase||0
2876954|NCT00262301|3581561|FG000|STARTED|Open-label Phase||0
2876955|NCT00262301|3581562|FG001|STARTED|Open-label Phase||0
2876956|NCT00262301|3581563|FG002|STARTED|Open-label Phase|"14/57 patients crossed over from the double-blind phase (7/14 were treated with 100 U/kg rhC1INH)"|57
2876957|NCT00262301|3581561|FG000|COMPLETED|Open-label Phase||0
2876958|NCT00262301|3581562|FG001|COMPLETED|Open-label Phase||0
2876959|NCT00262301|3581563|FG002|COMPLETED|Open-label Phase||57
2876960|NCT00262301|3581561|FG000|NOT COMPLETED|Open-label Phase||0
2876961|NCT00262301|3581562|FG001|NOT COMPLETED|Open-label Phase||0
2876962|NCT00262301|3581563|FG002|NOT COMPLETED|Open-label Phase||0
2876963|NCT00262314|3581571|FG000|STARTED|Overall Study|Patients with validated data who received at least 1 dose of Novantrone®|509
2876964|NCT00262314|3581571|FG000|COMPLETED|Overall Study|Patients in the study for 5 years +/-3 months are considered to have completed the 5-year study|172
2876965|NCT00262314|3581571|FG000|NOT COMPLETED|Overall Study||337
2876966|NCT00262509|3581577|FG000|STARTED|Overall Study||8
2876967|NCT00262509|3581578|FG001|STARTED|Overall Study||9
2876968|NCT00262509|3581577|FG000|COMPLETED|Overall Study||8
2876969|NCT00262509|3581578|FG001|COMPLETED|Overall Study||9
2876970|NCT00262509|3581577|FG000|NOT COMPLETED|Overall Study||0
2876971|NCT00262509|3581578|FG001|NOT COMPLETED|Overall Study||0
2876972|NCT00262522|3581588|FG000|STARTED|Study Start Through 8 Weeks||167
2876973|NCT00262522|3581589|FG001|STARTED|Study Start Through 8 Weeks||166
2876974|NCT00262522|3581590|FG002|STARTED|Study Start Through 8 Weeks||166
2876975|NCT00262522|3581591|FG003|STARTED|Study Start Through 8 Weeks||165
2876976|NCT00262522|3581588|FG000|COMPLETED|Study Start Through 8 Weeks||163
2876977|NCT00262522|3581589|FG001|COMPLETED|Study Start Through 8 Weeks||161
2876978|NCT00262522|3581590|FG002|COMPLETED|Study Start Through 8 Weeks||155
2876979|NCT00262522|3581591|FG003|COMPLETED|Study Start Through 8 Weeks||160
2876980|NCT00262522|3581588|FG000|NOT COMPLETED|Study Start Through 8 Weeks||4
2876981|NCT00262522|3581589|FG001|NOT COMPLETED|Study Start Through 8 Weeks||5
2876982|NCT00262522|3581590|FG002|NOT COMPLETED|Study Start Through 8 Weeks||11
2876983|NCT00262522|3581591|FG003|NOT COMPLETED|Study Start Through 8 Weeks||5
2876984|NCT00262522|3581588|FG000|STARTED|Study Start Through 48 Weeks|Number of subjects who started the study, not the number who completed the first 8 weeks.|333
2876985|NCT00262522|3581589|FG001|STARTED|Study Start Through 48 Weeks|After Week 8, these subjects received the tablet formulation once daily through the end of study.|0
2876986|NCT00262522|3581590|FG002|STARTED|Study Start Through 48 Weeks|Number of subjects who started the study, not the number who completed the first 8 weeks.|331
2876987|NCT00262522|3581591|FG003|STARTED|Study Start Through 48 Weeks|After Week 8, these subjects received the tablet formulation twice daily through the end of study.|0
2876988|NCT00262522|3581588|FG000|COMPLETED|Study Start Through 48 Weeks||284
2876989|NCT00262522|3581589|FG001|COMPLETED|Study Start Through 48 Weeks||0
2876990|NCT00262522|3581590|FG002|COMPLETED|Study Start Through 48 Weeks||276
3169854|NCT01928381|3897371|FG004|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
3169855|NCT01928381|3897372|FG005|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
3169856|NCT01928381|3897373|FG006|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
3169857|NCT01928381|3897367|FG000|STARTED|Part 2 - First Intervention||0
3169858|NCT01928381|3897368|FG001|STARTED|Part 2 - First Intervention||6
2876991|NCT00262522|3581591|FG003|COMPLETED|Study Start Through 48 Weeks||0
2876992|NCT00262522|3581588|FG000|NOT COMPLETED|Study Start Through 48 Weeks||49
2876993|NCT00262522|3581589|FG001|NOT COMPLETED|Study Start Through 48 Weeks||0
2876994|NCT00262522|3581590|FG002|NOT COMPLETED|Study Start Through 48 Weeks||55
2876995|NCT00262522|3581591|FG003|NOT COMPLETED|Study Start Through 48 Weeks||0
2876996|NCT00262522|3581588|FG000|STARTED|Study Start Through 96 Weeks|Number of subjects who started the study, not the number who completed the first 48 weeks.|333
2876997|NCT00262522|3581589|FG001|STARTED|Study Start Through 96 Weeks|After Week 8, these subjects received the tablet formulation once daily through the end of study.|0
2876998|NCT00262522|3581590|FG002|STARTED|Study Start Through 96 Weeks|Number of subjects who started the study, not the number who completed the first 48 weeks.|331
2876999|NCT00262522|3581591|FG003|STARTED|Study Start Through 96 Weeks|After Week 8, these subjects received the tablet formulation twice daily through the end of study.|0
2877000|NCT00262522|3581588|FG000|COMPLETED|Study Start Through 96 Weeks||256
2877001|NCT00262522|3581589|FG001|COMPLETED|Study Start Through 96 Weeks||0
2877002|NCT00262522|3581590|FG002|COMPLETED|Study Start Through 96 Weeks||254
2877003|NCT00262522|3581591|FG003|COMPLETED|Study Start Through 96 Weeks||0
2877004|NCT00262522|3581588|FG000|NOT COMPLETED|Study Start Through 96 Weeks||77
2877005|NCT00262522|3581589|FG001|NOT COMPLETED|Study Start Through 96 Weeks||0
2877006|NCT00262522|3581590|FG002|NOT COMPLETED|Study Start Through 96 Weeks||77
2877007|NCT00262522|3581591|FG003|NOT COMPLETED|Study Start Through 96 Weeks||0
2877008|NCT00262600|3581602|FG000|STARTED|Overall Study||6015
2877009|NCT00262600|3581603|FG001|STARTED|Overall Study||6076
2877010|NCT00262600|3581604|FG002|STARTED|Overall Study||6022
3133743|NCT01697462|3858690|FG000|COMPLETED|Overall Study||181
3133744|NCT01697462|3858690|FG000|NOT COMPLETED|Overall Study||77
3133745|NCT01697501|3858694|FG000|STARTED|Overall Study||88
3133746|NCT01697501|3858694|FG000|COMPLETED|Overall Study||86
3133747|NCT01697501|3858694|FG000|NOT COMPLETED|Overall Study||2
2877011|NCT00262600|3581602|FG000|COMPLETED|Overall Study||5780
2877012|NCT00262600|3581603|FG001|COMPLETED|Overall Study||5824
2877013|NCT00262600|3581604|FG002|COMPLETED|Overall Study||5756
2877014|NCT00262600|3581602|FG000|NOT COMPLETED|Overall Study||235
2877015|NCT00262600|3581603|FG001|NOT COMPLETED|Overall Study||252
2877016|NCT00262600|3581604|FG002|NOT COMPLETED|Overall Study||266
2877017|NCT00262639|3581616|FG000|STARTED|Overall Study||18
2877018|NCT00262639|3581617|FG001|STARTED|Overall Study||26
2877019|NCT00262639|3581618|FG002|STARTED|Overall Study||9
2877020|NCT00262639|3581619|FG003|STARTED|Overall Study||7
2877021|NCT00262639|3581616|FG000|COMPLETED|Overall Study||18
2877022|NCT00262639|3581617|FG001|COMPLETED|Overall Study||26
2877023|NCT00262639|3581618|FG002|COMPLETED|Overall Study||9
2877024|NCT00262639|3581619|FG003|COMPLETED|Overall Study||7
2877025|NCT00262639|3581616|FG000|NOT COMPLETED|Overall Study||0
2877026|NCT00262639|3581617|FG001|NOT COMPLETED|Overall Study||0
2877027|NCT00262639|3581618|FG002|NOT COMPLETED|Overall Study||0
2877028|NCT00262639|3581619|FG003|NOT COMPLETED|Overall Study||0
2877029|NCT00262730|3581629|FG000|STARTED|Overall Study||97
2877030|NCT00262730|3581629|FG000|COMPLETED|Overall Study||97
2877031|NCT00262730|3581629|FG000|NOT COMPLETED|Overall Study||0
2877032|NCT00262743|3581635|FG000|STARTED|Overall Study||27
2877033|NCT00262743|3581636|FG001|STARTED|Overall Study||42
2877034|NCT00262743|3581635|FG000|COMPLETED|Overall Study||27
2877035|NCT00262743|3581636|FG001|COMPLETED|Overall Study||30
2877036|NCT00262743|3581635|FG000|NOT COMPLETED|Overall Study||0
2877037|NCT00262743|3581636|FG001|NOT COMPLETED|Overall Study||12
2877038|NCT00262821|3581642|FG000|STARTED|Overall Study||198
2877039|NCT00262821|3581643|FG001|STARTED|Overall Study||204
2877040|NCT00262821|3581642|FG000|COMPLETED|Overall Study||194
2877041|NCT00262821|3581643|FG001|COMPLETED|Overall Study||185
2877042|NCT00262821|3581642|FG000|NOT COMPLETED|Overall Study||4
2877043|NCT00262821|3581643|FG001|NOT COMPLETED|Overall Study||19
2877044|NCT00262834|3581651|FG000|STARTED|Overall Study||25
2877045|NCT00262834|3581652|FG001|STARTED|Overall Study||29
2877046|NCT00262834|3581651|FG000|COMPLETED|Overall Study||24
2877047|NCT00262834|3581652|FG001|COMPLETED|Overall Study||25
2877048|NCT00262834|3581651|FG000|NOT COMPLETED|Overall Study||1
2877049|NCT00262834|3581652|FG001|NOT COMPLETED|Overall Study||4
2877050|NCT00262847|3581661|FG000|STARTED|Overall Study|Total enrolled and included in efficacy analysis|625
2877051|NCT00262847|3581662|FG001|STARTED|Overall Study|Total enrolled and included in efficacy analysis|625
2877052|NCT00262847|3581663|FG002|STARTED|Overall Study|Total enrolled and included in efficacy analysis|623
2877053|NCT00262847|3581661|FG000|COMPLETED|Overall Study||107
2877054|NCT00262847|3581662|FG001|COMPLETED|Overall Study||112
2877055|NCT00262847|3581663|FG002|COMPLETED|Overall Study||227
2877056|NCT00262847|3581661|FG000|NOT COMPLETED|Overall Study||518
2877057|NCT00262847|3581662|FG001|NOT COMPLETED|Overall Study||513
2877058|NCT00262847|3581663|FG002|NOT COMPLETED|Overall Study||396
2877059|NCT00262860|3581674|FG000|STARTED|Overall Study||18
2877060|NCT00262860|3581674|FG000|COMPLETED|Overall Study||16
2877061|NCT00262860|3581674|FG000|NOT COMPLETED|Overall Study||2
2877062|NCT00262873|3581678|FG000|STARTED|Overall Study||8
2877063|NCT00262873|3581678|FG000|COMPLETED|Overall Study||0
2877064|NCT00262873|3581678|FG000|NOT COMPLETED|Overall Study||8
2877065|NCT00262925|3581682|FG000|STARTED|Overall Study|7 patients were enrolled to step 1, and 5 patients were enrolled to step 2|12
2877066|NCT00262925|3581682|FG000|COMPLETED|Overall Study||1
2877067|NCT00262925|3581682|FG000|NOT COMPLETED|Overall Study||11
2877068|NCT00262951|3581688|FG000|STARTED|Overall Study||23
2877069|NCT00262951|3581688|FG000|COMPLETED|Overall Study||7
2877070|NCT00262951|3581688|FG000|NOT COMPLETED|Overall Study||16
2877071|NCT00262964|3581694|FG000|STARTED|Overall Study||11
2877072|NCT00262964|3581695|FG001|STARTED|Overall Study||11
2877073|NCT00262964|3581696|FG002|STARTED|Overall Study||17
2877074|NCT00262964|3581697|FG003|STARTED|Overall Study||12
2877075|NCT00262964|3581694|FG000|COMPLETED|Overall Study||11
2877076|NCT00262964|3581695|FG001|COMPLETED|Overall Study||11
2877077|NCT00262964|3581696|FG002|COMPLETED|Overall Study||17
2877078|NCT00262964|3581697|FG003|COMPLETED|Overall Study||12
2877079|NCT00262964|3581694|FG000|NOT COMPLETED|Overall Study||0
2877080|NCT00262964|3581695|FG001|NOT COMPLETED|Overall Study||0
2877081|NCT00262964|3581696|FG002|NOT COMPLETED|Overall Study||0
2877082|NCT00262964|3581697|FG003|NOT COMPLETED|Overall Study||0
2877083|NCT00263211|3581721|FG000|STARTED|Overall Study||24
2877084|NCT00263211|3581722|FG001|STARTED|Overall Study||24
2877085|NCT00263211|3581721|FG000|COMPLETED|Overall Study||19
2877086|NCT00263211|3581722|FG001|COMPLETED|Overall Study||23
2877087|NCT00263211|3581721|FG000|NOT COMPLETED|Overall Study||5
2877088|NCT00263211|3581722|FG001|NOT COMPLETED|Overall Study||1
2877089|NCT00263328|3581734|FG000|STARTED|Overall Study||18
2877090|NCT00263328|3581735|FG001|STARTED|Overall Study||14
2877091|NCT00263328|3581736|FG002|STARTED|Overall Study||13
2877092|NCT00263328|3581734|FG000|COMPLETED|Overall Study||10
2877093|NCT00263328|3581735|FG001|COMPLETED|Overall Study||12
2877094|NCT00263328|3581736|FG002|COMPLETED|Overall Study||6
2877095|NCT00263328|3581734|FG000|NOT COMPLETED|Overall Study||8
2877096|NCT00263328|3581735|FG001|NOT COMPLETED|Overall Study||2
2877097|NCT00263328|3581736|FG002|NOT COMPLETED|Overall Study||7
2877098|NCT00263562|3581748|FG000|STARTED|Overall Study||9
2877099|NCT00263562|3581749|FG001|STARTED|Overall Study||9
2877100|NCT00263562|3581748|FG000|COMPLETED|Overall Study||6
2877101|NCT00263562|3581749|FG001|COMPLETED|Overall Study||9
2877102|NCT00263562|3581748|FG000|NOT COMPLETED|Overall Study||3
2877103|NCT00263562|3581749|FG001|NOT COMPLETED|Overall Study||0
2877104|NCT00263575|3581757|FG000|STARTED|Titration Period||139
2877105|NCT00263575|3581757|FG000|COMPLETED|Titration Period||96
2877106|NCT00263575|3581757|FG000|NOT COMPLETED|Titration Period||43
2877107|NCT00263575|3581757|FG000|STARTED|Maintence Period||96
2877108|NCT00263575|3581757|FG000|COMPLETED|Maintence Period||19
2877109|NCT00263575|3581757|FG000|NOT COMPLETED|Maintence Period||77
2877110|NCT00263588|3581765|FG000|STARTED|Overall Study||95
2877111|NCT00263588|3581766|FG001|STARTED|Overall Study||147
2877112|NCT00263588|3581765|FG000|COMPLETED|Overall Study||14
2877113|NCT00263588|3581766|FG001|COMPLETED|Overall Study||15
2877114|NCT00263588|3581765|FG000|NOT COMPLETED|Overall Study||81
2877115|NCT00263588|3581766|FG001|NOT COMPLETED|Overall Study||132
2877116|NCT00263666|3581775|FG000|STARTED|Overall Study||50
2877117|NCT00263666|3581776|FG001|STARTED|Overall Study||50
3169859|NCT01928381|3897369|FG002|STARTED|Part 2 - First Intervention||6
3169860|NCT01928381|3897370|FG003|STARTED|Part 2 - First Intervention||6
3169861|NCT01928381|3897371|FG004|STARTED|Part 2 - First Intervention||4
2877118|NCT00263666|3581775|FG000|COMPLETED|Overall Study||43
2877119|NCT00263666|3581776|FG001|COMPLETED|Overall Study||39
2877120|NCT00263666|3581775|FG000|NOT COMPLETED|Overall Study||7
2877121|NCT00263666|3581776|FG001|NOT COMPLETED|Overall Study||11
2877122|NCT00263757|3581784|FG000|STARTED|Overall Study||12
2877123|NCT00263757|3581785|FG001|STARTED|Overall Study||13
3169862|NCT01928381|3897372|FG005|STARTED|Part 2 - First Intervention||6
3169863|NCT01928381|3897373|FG006|STARTED|Part 2 - First Intervention||6
3169864|NCT01928381|3897367|FG000|COMPLETED|Part 2 - First Intervention||0
2877124|NCT00263757|3581784|FG000|COMPLETED|Overall Study||4
2877125|NCT00263757|3581785|FG001|COMPLETED|Overall Study||5
2877126|NCT00263757|3581784|FG000|NOT COMPLETED|Overall Study||8
2877127|NCT00263757|3581785|FG001|NOT COMPLETED|Overall Study||8
2877128|NCT00263887|3581793|FG000|STARTED|Overall Study||38
2877129|NCT00263887|3581794|FG001|STARTED|Overall Study||39
2877130|NCT00263887|3581793|FG000|COMPLETED|Overall Study||35
2877131|NCT00263887|3581794|FG001|COMPLETED|Overall Study||32
2877132|NCT00263887|3581793|FG000|NOT COMPLETED|Overall Study||3
2877133|NCT00263887|3581794|FG001|NOT COMPLETED|Overall Study||7
2877134|NCT00264004|3581804|FG000|STARTED|Overall Study|Randomised|30
2877135|NCT00264004|3581805|FG001|STARTED|Overall Study|Randomised|32
2877136|NCT00264004|3581806|FG002|STARTED|Overall Study|Randomised|30
2877137|NCT00264004|3581807|FG003|STARTED|Overall Study|Randomised|34
3169865|NCT01928381|3897368|FG001|COMPLETED|Part 2 - First Intervention||6
3169866|NCT01928381|3897369|FG002|COMPLETED|Part 2 - First Intervention||4
3169867|NCT01928381|3897370|FG003|COMPLETED|Part 2 - First Intervention||5
3169868|NCT01928381|3897371|FG004|COMPLETED|Part 2 - First Intervention||4
2877138|NCT00264004|3581804|FG000|COMPLETED|Overall Study|Completed 12 weeks treatment|13
2877139|NCT00264004|3581805|FG001|COMPLETED|Overall Study|Completed 12 weeks treatment|21
2877140|NCT00264004|3581806|FG002|COMPLETED|Overall Study|Completed 12 weeks treatment|16
2877141|NCT00264004|3581807|FG003|COMPLETED|Overall Study|Completed 12 weeks treatment|19
2877142|NCT00264004|3581804|FG000|NOT COMPLETED|Overall Study||17
2877143|NCT00264004|3581805|FG001|NOT COMPLETED|Overall Study||11
2877144|NCT00264004|3581806|FG002|NOT COMPLETED|Overall Study||14
2877145|NCT00264004|3581807|FG003|NOT COMPLETED|Overall Study||15
2877146|NCT00264238|3581817|FG000|STARTED|Overall Study||15
2877147|NCT00264238|3581817|FG000|COMPLETED|Overall Study||14
2877148|NCT00264238|3581817|FG000|NOT COMPLETED|Overall Study||1
2877149|NCT00264290|3581825|FG000|STARTED|Intervention (8 Weeks)||16
2877150|NCT00264290|3581826|FG001|STARTED|Intervention (8 Weeks)||14
2877151|NCT00264290|3581825|FG000|COMPLETED|Intervention (8 Weeks)||15
2877152|NCT00264290|3581826|FG001|COMPLETED|Intervention (8 Weeks)||14
2877153|NCT00264290|3581825|FG000|NOT COMPLETED|Intervention (8 Weeks)||1
2877154|NCT00264290|3581826|FG001|NOT COMPLETED|Intervention (8 Weeks)||0
2877155|NCT00264290|3581825|FG000|STARTED|Observation (4 Weeks)||15
2877156|NCT00264290|3581826|FG001|STARTED|Observation (4 Weeks)||14
2877157|NCT00264290|3581825|FG000|COMPLETED|Observation (4 Weeks)||15
2877158|NCT00264290|3581826|FG001|COMPLETED|Observation (4 Weeks)||14
2877159|NCT00264290|3581825|FG000|NOT COMPLETED|Observation (4 Weeks)||0
2877160|NCT00264290|3581826|FG001|NOT COMPLETED|Observation (4 Weeks)||0
2877161|NCT00264303|3581838|FG000|STARTED|Overall Study||438
2877162|NCT00264303|3581839|FG001|STARTED|Overall Study||448
2877163|NCT00264303|3581838|FG000|COMPLETED|Overall Study||413
2877164|NCT00264303|3581839|FG001|COMPLETED|Overall Study||419
2877165|NCT00264303|3581838|FG000|NOT COMPLETED|Overall Study||25
2877166|NCT00264303|3581839|FG001|NOT COMPLETED|Overall Study||29
2877167|NCT00264381|3581847|FG000|STARTED|Overall Study||35
2877168|NCT00264381|3581848|FG001|STARTED|Overall Study||37
2877169|NCT00264381|3581847|FG000|COMPLETED|Overall Study||35
2877170|NCT00264381|3581848|FG001|COMPLETED|Overall Study||37
2877171|NCT00264381|3581847|FG000|NOT COMPLETED|Overall Study||0
2877172|NCT00264381|3581848|FG001|NOT COMPLETED|Overall Study||0
2877173|NCT00264498|3581856|FG000|STARTED|Randomized Treatment||17
2877174|NCT00264498|3581857|FG001|STARTED|Randomized Treatment||18
2877175|NCT00264498|3581856|FG000|COMPLETED|Randomized Treatment|Treatment is not for a fixed period and continues until a discontinuation criterion is met.|0
2877176|NCT00264498|3581857|FG001|COMPLETED|Randomized Treatment|Treatment is not for a fixed period and continues until a discontinuation criterion is met.|0
2877177|NCT00264498|3581856|FG000|NOT COMPLETED|Randomized Treatment||17
2877178|NCT00264498|3581857|FG001|NOT COMPLETED|Randomized Treatment||18
2877179|NCT00264498|3581856|FG000|STARTED|Crossover Treatment||6
2877180|NCT00264498|3581857|FG001|STARTED|Crossover Treatment||9
2877181|NCT00264498|3581856|FG000|COMPLETED|Crossover Treatment|Treatment is not for a fixed period and continues until a discontinuation criterion is met.|0
2877182|NCT00264498|3581857|FG001|COMPLETED|Crossover Treatment|Treatment is not for a fixed period and continues until a discontinuation criterion is met.|0
2877183|NCT00264498|3581856|FG000|NOT COMPLETED|Crossover Treatment||6
2877184|NCT00264498|3581857|FG001|NOT COMPLETED|Crossover Treatment||9
2877185|NCT00264537|3581867|FG000|STARTED|Overall Study||160
2877186|NCT00264537|3581868|FG001|STARTED|Overall Study||159
2877187|NCT00264537|3581869|FG002|STARTED|Overall Study||159
2877188|NCT00264537|3581870|FG003|STARTED|Overall Study||159
2877189|NCT00264537|3581867|FG000|COMPLETED|Overall Study||110
2877190|NCT00264537|3581868|FG001|COMPLETED|Overall Study||101
2877191|NCT00264537|3581869|FG002|COMPLETED|Overall Study||109
2877192|NCT00264537|3581870|FG003|COMPLETED|Overall Study||99
2877193|NCT00264537|3581867|FG000|NOT COMPLETED|Overall Study||50
2877194|NCT00264537|3581868|FG001|NOT COMPLETED|Overall Study||58
2877195|NCT00264537|3581869|FG002|NOT COMPLETED|Overall Study||50
2877196|NCT00264537|3581870|FG003|NOT COMPLETED|Overall Study||60
2877197|NCT00264550|3581886|FG000|STARTED|Overall Study||133
2877198|NCT00264550|3581887|FG001|STARTED|Overall Study||133
2877199|NCT00264550|3581888|FG002|STARTED|Overall Study||89
2877200|NCT00264550|3581889|FG003|STARTED|Overall Study||89
2877201|NCT00264550|3581886|FG000|COMPLETED|Overall Study||90
2877202|NCT00264550|3581887|FG001|COMPLETED|Overall Study||92
2877203|NCT00264550|3581888|FG002|COMPLETED|Overall Study||72
2877204|NCT00264550|3581889|FG003|COMPLETED|Overall Study||59
2877205|NCT00264550|3581886|FG000|NOT COMPLETED|Overall Study||43
2877206|NCT00264550|3581887|FG001|NOT COMPLETED|Overall Study||41
2877207|NCT00264550|3581888|FG002|NOT COMPLETED|Overall Study||17
2877208|NCT00264550|3581889|FG003|NOT COMPLETED|Overall Study||30
2877209|NCT00264576|3581901|FG000|STARTED|Overall Study||308
2877210|NCT00264576|3581902|FG001|STARTED|Overall Study||305
2877211|NCT00264576|3581901|FG000|COMPLETED|Overall Study||307
2877212|NCT00264576|3581902|FG001|COMPLETED|Overall Study||304
2877213|NCT00264576|3581901|FG000|NOT COMPLETED|Overall Study||1
2877214|NCT00264576|3581902|FG001|NOT COMPLETED|Overall Study||1
2877215|NCT00264641|3581911|FG000|STARTED|Overall Study||10
2877216|NCT00264641|3581912|FG001|STARTED|Overall Study||10
2877217|NCT00264641|3581911|FG000|Initiation of the Study|Overall Study||10
2877218|NCT00264641|3581912|FG001|Initiation of the Study|Overall Study||10
2877219|NCT00264641|3581911|FG000|COMPLETED|Overall Study||10
2877220|NCT00264641|3581912|FG001|COMPLETED|Overall Study||10
2877221|NCT00264641|3581911|FG000|NOT COMPLETED|Overall Study||0
2877222|NCT00264641|3581912|FG001|NOT COMPLETED|Overall Study||0
2877223|NCT00264797|3581919|FG000|STARTED|Overall Study||151
2877224|NCT00264797|3581920|FG001|STARTED|Overall Study||152
2877225|NCT00264797|3581919|FG000|COMPLETED|Overall Study||118
2877226|NCT00264797|3581920|FG001|COMPLETED|Overall Study||109
2877227|NCT00264797|3581919|FG000|NOT COMPLETED|Overall Study||33
2877228|NCT00264797|3581920|FG001|NOT COMPLETED|Overall Study||43
2877229|NCT00264810|3581928|FG000|STARTED|Baseline|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|120
2877230|NCT00264810|3581929|FG001|STARTED|Baseline|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|120
2877231|NCT00264810|3581928|FG000|COMPLETED|Baseline|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|97
2877232|NCT00264810|3581929|FG001|COMPLETED|Baseline|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|94
2877233|NCT00264810|3581928|FG000|NOT COMPLETED|Baseline||23
2877234|NCT00264810|3581929|FG001|NOT COMPLETED|Baseline||26
2877235|NCT00264810|3581928|FG000|STARTED|Post-Operative Stabilization Period|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|97
2877236|NCT00264810|3581929|FG001|STARTED|Post-Operative Stabilization Period|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|94
2877237|NCT00264810|3581928|FG000|COMPLETED|Post-Operative Stabilization Period||97
2877238|NCT00264810|3581929|FG001|COMPLETED|Post-Operative Stabilization Period||94
2877239|NCT00264810|3581928|FG000|NOT COMPLETED|Post-Operative Stabilization Period||0
2877240|NCT00264810|3581929|FG001|NOT COMPLETED|Post-Operative Stabilization Period||0
2877241|NCT00264810|3581928|FG000|STARTED|Stimulation Optimization Period||97
2877242|NCT00264810|3581929|FG001|STARTED|Stimulation Optimization Period||94
2877243|NCT00264810|3581928|FG000|COMPLETED|Stimulation Optimization Period||96
2877244|NCT00264810|3581929|FG001|COMPLETED|Stimulation Optimization Period||93
2877245|NCT00264810|3581928|FG000|NOT COMPLETED|Stimulation Optimization Period||1
2877246|NCT00264810|3581929|FG001|NOT COMPLETED|Stimulation Optimization Period||1
2877247|NCT00264810|3581928|FG000|STARTED|Blinded Evaluation Period||96
2877248|NCT00264810|3581929|FG001|STARTED|Blinded Evaluation Period||93
2877249|NCT00264810|3581928|FG000|COMPLETED|Blinded Evaluation Period||95
2877250|NCT00264810|3581929|FG001|COMPLETED|Blinded Evaluation Period||92
2877251|NCT00264810|3581928|FG000|NOT COMPLETED|Blinded Evaluation Period||1
2877252|NCT00264810|3581929|FG001|NOT COMPLETED|Blinded Evaluation Period||1
2877253|NCT00264810|3581928|FG000|STARTED|Open Label Evaluation Period||95
2877254|NCT00264810|3581929|FG001|STARTED|Open Label Evaluation Period||92
2877255|NCT00264810|3581928|FG000|1-year Post-implant|Open Label Evaluation Period||92
2877256|NCT00264810|3581929|FG001|1-year Post-implant|Open Label Evaluation Period||90
2877257|NCT00264810|3581928|FG000|COMPLETED|Open Label Evaluation Period||89
2877258|NCT00264810|3581929|FG001|COMPLETED|Open Label Evaluation Period||86
2877259|NCT00264810|3581928|FG000|NOT COMPLETED|Open Label Evaluation Period||6
2877260|NCT00264810|3581929|FG001|NOT COMPLETED|Open Label Evaluation Period||6
2919083|NCT00530712|3629487|FG000|STARTED|6 Month Follow-up Visit|Subjects Expected for 6-Month Visit|287
2919084|NCT00530712|3629487|FG000|COMPLETED|6 Month Follow-up Visit|Subjects that Completed 6-Month Follow-up Visit|275
2919085|NCT00530712|3629487|FG000|NOT COMPLETED|6 Month Follow-up Visit||12
2919086|NCT00530712|3629487|FG000|STARTED|12 Month Follow-up Visit|Subjects Expected for 12 Month Visit|287
2919087|NCT00530712|3629487|FG000|COMPLETED|12 Month Follow-up Visit|Subjects that Completed 12-Month Follow-up Visit|263
2919088|NCT00530712|3629487|FG000|NOT COMPLETED|12 Month Follow-up Visit||24
2919089|NCT00530764|3629496|FG000|STARTED|Overall Study||90
2919090|NCT00530764|3629497|FG001|STARTED|Overall Study||88
2919091|NCT00530764|3629498|FG002|STARTED|Overall Study||91
2919092|NCT00530764|3629499|FG003|STARTED|Overall Study||91
2919093|NCT00530764|3629496|FG000|COMPLETED|Overall Study||59
2919094|NCT00530764|3629497|FG001|COMPLETED|Overall Study||67
2919095|NCT00530764|3629498|FG002|COMPLETED|Overall Study||71
2919096|NCT00530764|3629499|FG003|COMPLETED|Overall Study||66
2919097|NCT00530764|3629496|FG000|NOT COMPLETED|Overall Study||31
2919098|NCT00530764|3629497|FG001|NOT COMPLETED|Overall Study||21
2919099|NCT00530764|3629498|FG002|NOT COMPLETED|Overall Study||20
2919100|NCT00530764|3629499|FG003|NOT COMPLETED|Overall Study||25
2919101|NCT00530777|3629514|FG000|STARTED|Overall Study||74
2919102|NCT00530777|3629515|FG001|STARTED|Overall Study||74
2919103|NCT00530777|3629514|FG000|COMPLETED|Overall Study||67
2919104|NCT00530777|3629515|FG001|COMPLETED|Overall Study||69
2919105|NCT00530777|3629514|FG000|NOT COMPLETED|Overall Study||7
2919106|NCT00530777|3629515|FG001|NOT COMPLETED|Overall Study||5
2919107|NCT00530790|3629521|FG000|STARTED|Overall Study||35
2919108|NCT00530790|3629521|FG000|COMPLETED|Overall Study||30
2919109|NCT00530790|3629521|FG000|NOT COMPLETED|Overall Study||5
2919110|NCT00530803|3629527|FG000|STARTED|Overall Study||50
2919111|NCT00530803|3629528|FG001|STARTED|Overall Study||50
2919112|NCT00530803|3629527|FG000|COMPLETED|Overall Study||50
2919113|NCT00530803|3629528|FG001|COMPLETED|Overall Study||50
2919114|NCT00530803|3629527|FG000|NOT COMPLETED|Overall Study||0
2919115|NCT00530803|3629528|FG001|NOT COMPLETED|Overall Study||0
2919116|NCT00530816|3629537|FG000|STARTED|Overall Study||35
2919117|NCT00530816|3629538|FG001|STARTED|Overall Study||59
2919118|NCT00530816|3629539|FG002|STARTED|Overall Study||70
2919119|NCT00530816|3629537|FG000|COMPLETED|Overall Study||9
2919120|NCT00530816|3629538|FG001|COMPLETED|Overall Study||17
2919121|NCT00530816|3629539|FG002|COMPLETED|Overall Study||29
2919122|NCT00530816|3629537|FG000|NOT COMPLETED|Overall Study||26
2919123|NCT00530816|3629538|FG001|NOT COMPLETED|Overall Study||42
2919124|NCT00530816|3629539|FG002|NOT COMPLETED|Overall Study||41
2919125|NCT00530842|3629549|FG000|STARTED|Overall Study||172
2919126|NCT00530842|3629550|FG001|STARTED|Overall Study||172
2919127|NCT00530842|3629549|FG000|COMPLETED|Overall Study||149
2919128|NCT00530842|3629550|FG001|COMPLETED|Overall Study||151
2919129|NCT00530842|3629549|FG000|NOT COMPLETED|Overall Study||23
2919130|NCT00530842|3629550|FG001|NOT COMPLETED|Overall Study||21
2919131|NCT00530842|3629549|FG000|STARTED|Period 1||172
2919132|NCT00530842|3629550|FG001|STARTED|Period 1||172
2919133|NCT00530842|3629549|FG000|COMPLETED|Period 1||158
2919134|NCT00530842|3629550|FG001|COMPLETED|Period 1||161
2919135|NCT00530842|3629549|FG000|NOT COMPLETED|Period 1||14
2919136|NCT00530842|3629550|FG001|NOT COMPLETED|Period 1||11
2919137|NCT00530842|3629549|FG000|STARTED|Period 2||157
2919138|NCT00530842|3629550|FG001|STARTED|Period 2||160
2919139|NCT00530842|3629549|FG000|COMPLETED|Period 2||149
2919140|NCT00530842|3629550|FG001|COMPLETED|Period 2||151
2919141|NCT00530842|3629549|FG000|NOT COMPLETED|Period 2||8
2919142|NCT00530842|3629550|FG001|NOT COMPLETED|Period 2||9
2919143|NCT00530855|3629558|FG000|STARTED|Overall Study||322
2919144|NCT00530855|3629558|FG000|COMPLETED|Overall Study||210
2919145|NCT00530855|3629558|FG000|NOT COMPLETED|Overall Study||112
2919146|NCT00530894|3629566|FG000|STARTED|Overall Study||348
2919147|NCT00530894|3629567|FG001|STARTED|Overall Study||351
2919148|NCT00530894|3629568|FG002|STARTED|Overall Study||179
2919149|NCT00530894|3629569|FG003|STARTED|Overall Study||179
2919150|NCT00530894|3629566|FG000|COMPLETED|Overall Study||260
2919151|NCT00530894|3629567|FG001|COMPLETED|Overall Study||236
2919152|NCT00530894|3629568|FG002|COMPLETED|Overall Study||124
2919153|NCT00530894|3629569|FG003|COMPLETED|Overall Study||85
2877261|NCT00264849|3581939|FG000|STARTED|Overall Study||275
2877262|NCT00264849|3581940|FG001|STARTED|Overall Study||131
2877263|NCT00264849|3581939|FG000|COMPLETED|Overall Study||253
2877264|NCT00264849|3581940|FG001|COMPLETED|Overall Study||106
2877265|NCT00264849|3581939|FG000|NOT COMPLETED|Overall Study||22
2877266|NCT00264849|3581940|FG001|NOT COMPLETED|Overall Study||25
2877267|NCT00264875|3581946|FG000|STARTED|Overall Study||220
2877268|NCT00264875|3581946|FG000|COMPLETED|Overall Study||190
2877269|NCT00264875|3581946|FG000|NOT COMPLETED|Overall Study||30
2877270|NCT00265083|3581953|FG000|STARTED|Overall Study||78
2877271|NCT00265083|3581954|FG001|STARTED|Overall Study|One patient did not receive study agent.|138
2877272|NCT00265083|3581955|FG002|STARTED|Overall Study||140
2877273|NCT00265083|3581953|FG000|COMPLETED|Overall Study||61
2877274|NCT00265083|3581954|FG001|COMPLETED|Overall Study|One patient did not receive study agent.|96
2877275|NCT00265083|3581955|FG002|COMPLETED|Overall Study||98
2877276|NCT00265083|3581953|FG000|NOT COMPLETED|Overall Study||17
2877277|NCT00265083|3581954|FG001|NOT COMPLETED|Overall Study||42
2877278|NCT00265083|3581955|FG002|NOT COMPLETED|Overall Study||42
2877279|NCT00265096|3581967|FG000|STARTED|Overall Study||113
2877280|NCT00265096|3581968|FG001|STARTED|Overall Study||146
2877281|NCT00265096|3581969|FG002|STARTED|Overall Study||146
2877282|NCT00265096|3581967|FG000|COMPLETED|Overall Study|Indicates number of patients that were continuing SC study agent at Wk 24|77
2877283|NCT00265096|3581968|FG001|COMPLETED|Overall Study|Indicates number of patients that were continuing SC study agent at Wk 24|95
2877284|NCT00265096|3581969|FG002|COMPLETED|Overall Study|Indicates number of patients that were continuing SC study agent at Wk 24|107
2877285|NCT00265096|3581967|FG000|NOT COMPLETED|Overall Study||36
2877286|NCT00265096|3581968|FG001|NOT COMPLETED|Overall Study||51
2877287|NCT00265096|3581969|FG002|NOT COMPLETED|Overall Study||39
2877288|NCT00265109|3581979|FG000|STARTED|Overall Study||17
2877289|NCT00265109|3581979|FG000|COMPLETED|Overall Study||11
2877290|NCT00265109|3581979|FG000|NOT COMPLETED|Overall Study||6
2877291|NCT00265122|3581990|FG000|STARTED|Intervention Period 1 (Weeks 0 to 8):||26
2877292|NCT00265122|3581991|FG001|STARTED|Intervention Period 1 (Weeks 0 to 8):||25
2877293|NCT00265122|3581992|FG002|STARTED|Intervention Period 1 (Weeks 0 to 8):||27
3169869|NCT01928381|3897372|FG005|COMPLETED|Part 2 - First Intervention||5
3169870|NCT01928381|3897373|FG006|COMPLETED|Part 2 - First Intervention||5
3169871|NCT01928381|3897367|FG000|NOT COMPLETED|Part 2 - First Intervention||0
3169872|NCT01928381|3897368|FG001|NOT COMPLETED|Part 2 - First Intervention||0
3169873|NCT01928381|3897369|FG002|NOT COMPLETED|Part 2 - First Intervention||2
2877294|NCT00265122|3581993|FG003|STARTED|Intervention Period 1 (Weeks 0 to 8):||26
2877295|NCT00265122|3581994|FG004|STARTED|Intervention Period 1 (Weeks 0 to 8):||14
2877296|NCT00265122|3581995|FG005|STARTED|Intervention Period 1 (Weeks 0 to 8):||13
2877297|NCT00265122|3581990|FG000|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||24
2877298|NCT00265122|3581991|FG001|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||23
2877299|NCT00265122|3581992|FG002|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||22
2877300|NCT00265122|3581993|FG003|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||24
2877301|NCT00265122|3581994|FG004|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||13
2877302|NCT00265122|3581995|FG005|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||13
2877303|NCT00265122|3581990|FG000|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||2
2877304|NCT00265122|3581991|FG001|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||2
2877305|NCT00265122|3581992|FG002|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||5
2877306|NCT00265122|3581993|FG003|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||2
2877307|NCT00265122|3581994|FG004|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||1
2877308|NCT00265122|3581995|FG005|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||0
2877309|NCT00265122|3581990|FG000|STARTED|Intervention Period 2 (Weeks 8 to 28):||24
2877310|NCT00265122|3581991|FG001|STARTED|Intervention Period 2 (Weeks 8 to 28):||23
2877311|NCT00265122|3581992|FG002|STARTED|Intervention Period 2 (Weeks 8 to 28):||22
2877312|NCT00265122|3581993|FG003|STARTED|Intervention Period 2 (Weeks 8 to 28):||24
2877313|NCT00265122|3581994|FG004|STARTED|Intervention Period 2 (Weeks 8 to 28):||13
2877314|NCT00265122|3581995|FG005|STARTED|Intervention Period 2 (Weeks 8 to 28):||13
2877315|NCT00265122|3581990|FG000|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||17
2877316|NCT00265122|3581991|FG001|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||22
2877317|NCT00265122|3581992|FG002|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||18
2877318|NCT00265122|3581993|FG003|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||20
2877319|NCT00265122|3581994|FG004|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||8
2877320|NCT00265122|3581995|FG005|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||12
2877321|NCT00265122|3581990|FG000|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||7
2877322|NCT00265122|3581991|FG001|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||1
2877323|NCT00265122|3581992|FG002|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||4
2877324|NCT00265122|3581993|FG003|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||4
2877325|NCT00265122|3581994|FG004|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||5
2877326|NCT00265122|3581995|FG005|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||1
2877327|NCT00265148|3582016|FG000|STARTED|Overall Study||40
2877328|NCT00265148|3582017|FG001|STARTED|Overall Study||40
2877329|NCT00265148|3582016|FG000|COMPLETED|Overall Study||31
2877330|NCT00265148|3582017|FG001|COMPLETED|Overall Study||31
2877331|NCT00265148|3582016|FG000|NOT COMPLETED|Overall Study||9
2877332|NCT00265148|3582017|FG001|NOT COMPLETED|Overall Study||9
2877333|NCT00265200|3582024|FG000|STARTED|Overall Study||28
2877334|NCT00265200|3582024|FG000|COMPLETED|Overall Study||24
2877335|NCT00265200|3582024|FG000|NOT COMPLETED|Overall Study||4
2877336|NCT00265239|3582030|FG000|STARTED|Overall Study||52
2877337|NCT00265239|3582031|FG001|STARTED|Overall Study||52
2877338|NCT00265239|3582030|FG000|COMPLETED|Overall Study||50
2877339|NCT00265239|3582031|FG001|COMPLETED|Overall Study||51
2877340|NCT00265239|3582030|FG000|NOT COMPLETED|Overall Study||2
2877341|NCT00265239|3582031|FG001|NOT COMPLETED|Overall Study||1
2877342|NCT00265317|3582041|FG000|STARTED|Lead-In||13
2877343|NCT00265317|3582042|FG001|STARTED|Lead-In||17
2877344|NCT00265317|3582043|FG002|STARTED|Lead-In||0
2877345|NCT00265317|3582044|FG003|STARTED|Lead-In||0
2877346|NCT00265317|3582041|FG000|COMPLETED|Lead-In||1
2877347|NCT00265317|3582042|FG001|COMPLETED|Lead-In||0
2877348|NCT00265317|3582043|FG002|COMPLETED|Lead-In||0
2877349|NCT00265317|3582044|FG003|COMPLETED|Lead-In||0
2877350|NCT00265317|3582041|FG000|NOT COMPLETED|Lead-In||12
2877351|NCT00265317|3582042|FG001|NOT COMPLETED|Lead-In||17
2877352|NCT00265317|3582043|FG002|NOT COMPLETED|Lead-In||0
2877353|NCT00265317|3582044|FG003|NOT COMPLETED|Lead-In||0
2877354|NCT00265317|3582041|FG000|STARTED|Phase 2||0
2877355|NCT00265317|3582042|FG001|STARTED|Phase 2||0
2877356|NCT00265317|3582043|FG002|STARTED|Phase 2||65
2877357|NCT00265317|3582044|FG003|STARTED|Phase 2||67
2877358|NCT00265317|3582041|FG000|COMPLETED|Phase 2||0
2877359|NCT00265317|3582042|FG001|COMPLETED|Phase 2||0
2877360|NCT00265317|3582043|FG002|COMPLETED|Phase 2||1
2877361|NCT00265317|3582044|FG003|COMPLETED|Phase 2||2
2877362|NCT00265317|3582041|FG000|NOT COMPLETED|Phase 2||0
2877363|NCT00265317|3582042|FG001|NOT COMPLETED|Phase 2||0
2877364|NCT00265317|3582043|FG002|NOT COMPLETED|Phase 2||64
2877365|NCT00265317|3582044|FG003|NOT COMPLETED|Phase 2||65
2877366|NCT00265330|3582063|FG000|STARTED|Overall Study||162
2877367|NCT00265330|3582063|FG000|COMPLETED|Overall Study||67
2877368|NCT00265330|3582063|FG000|NOT COMPLETED|Overall Study||95
2877369|NCT00265382|3582067|FG000|STARTED|Overall Study||221
2877370|NCT00265382|3582067|FG000|COMPLETED|Overall Study||76
2877371|NCT00265382|3582067|FG000|NOT COMPLETED|Overall Study||145
2877372|NCT00265395|3582073|FG000|STARTED|Overall Study||86
2877373|NCT00265395|3582074|FG001|STARTED|Overall Study||73
2877374|NCT00265395|3582073|FG000|COMPLETED|Overall Study||78
2877375|NCT00265395|3582074|FG001|COMPLETED|Overall Study||56
2877376|NCT00265395|3582073|FG000|NOT COMPLETED|Overall Study||8
2877377|NCT00265395|3582074|FG001|NOT COMPLETED|Overall Study||17
2877378|NCT00265473|3582079|FG000|STARTED|Overall Study||5
2877379|NCT00265473|3582079|FG000|COMPLETED|Overall Study||5
2877380|NCT00265473|3582079|FG000|NOT COMPLETED|Overall Study||0
2877381|NCT00265512|3582086|FG000|STARTED|Overall Study||213
2877382|NCT00265512|3582087|FG001|STARTED|Overall Study||454
2877383|NCT00265512|3582086|FG000|COMPLETED|Overall Study||168
2877384|NCT00265512|3582087|FG001|COMPLETED|Overall Study||359
2877385|NCT00265512|3582086|FG000|NOT COMPLETED|Overall Study||45
2877386|NCT00265512|3582087|FG001|NOT COMPLETED|Overall Study||95
2877387|NCT00265538|3582095|FG000|STARTED|Overall Study||196
2877388|NCT00265538|3582096|FG001|STARTED|Overall Study||170
2877389|NCT00265538|3582097|FG002|STARTED|Overall Study||182
2877390|NCT00265538|3582098|FG003|STARTED|Overall Study||286
2877391|NCT00265538|3582095|FG000|COMPLETED|Overall Study||186
2877392|NCT00265538|3582096|FG001|COMPLETED|Overall Study||161
2877393|NCT00265538|3582097|FG002|COMPLETED|Overall Study||171
2877394|NCT00265538|3582098|FG003|COMPLETED|Overall Study||267
2877395|NCT00265538|3582095|FG000|NOT COMPLETED|Overall Study||10
2877396|NCT00265538|3582096|FG001|NOT COMPLETED|Overall Study||9
2877397|NCT00265538|3582097|FG002|NOT COMPLETED|Overall Study||11
2877398|NCT00265538|3582098|FG003|NOT COMPLETED|Overall Study||19
2877399|NCT00265564|3582112|FG000|STARTED|Overall Study||59
2877400|NCT00265564|3582113|FG001|STARTED|Overall Study||58
2877401|NCT00265564|3582112|FG000|COMPLETED|Overall Study||49
2877402|NCT00265564|3582113|FG001|COMPLETED|Overall Study||49
2877403|NCT00265564|3582112|FG000|NOT COMPLETED|Overall Study||10
2877404|NCT00265564|3582113|FG001|NOT COMPLETED|Overall Study||9
2877405|NCT00265616|3582121|FG000|STARTED|Overall Study||14
2877406|NCT00265616|3582122|FG001|STARTED|Overall Study||9
2877407|NCT00265616|3582121|FG000|COMPLETED|Overall Study||14
2877408|NCT00265616|3582122|FG001|COMPLETED|Overall Study||9
2877409|NCT00265616|3582121|FG000|NOT COMPLETED|Overall Study||0
2877410|NCT00265616|3582122|FG001|NOT COMPLETED|Overall Study||0
2877411|NCT00265759|3582134|FG000|STARTED|Overall Study||124
2877412|NCT00265759|3582135|FG001|STARTED|Overall Study||128
2877413|NCT00265759|3582136|FG002|STARTED|Overall Study||125
2877414|NCT00265759|3582137|FG003|STARTED|Overall Study||245
2877415|NCT00265759|3582134|FG000|COMPLETED|Overall Study||124
2877416|NCT00265759|3582135|FG001|COMPLETED|Overall Study||127
2877417|NCT00265759|3582136|FG002|COMPLETED|Overall Study||123
2877418|NCT00265759|3582137|FG003|COMPLETED|Overall Study||236
2877419|NCT00265759|3582134|FG000|NOT COMPLETED|Overall Study||0
2877420|NCT00265759|3582135|FG001|NOT COMPLETED|Overall Study||1
2877421|NCT00265759|3582136|FG002|NOT COMPLETED|Overall Study||2
2877422|NCT00265759|3582137|FG003|NOT COMPLETED|Overall Study||9
2877423|NCT00265785|3582148|FG000|STARTED|Overall Study||27
2877424|NCT00265785|3582148|FG000|Eligible|Overall Study||26
2877425|NCT00265785|3582148|FG000|Eligible and Began Protocol Treatment|Overall Study||24
2877426|NCT00265785|3582148|FG000|COMPLETED|Overall Study||0
2877427|NCT00265785|3582148|FG000|NOT COMPLETED|Overall Study||27
2877428|NCT00265798|3582152|FG000|STARTED|Overall Study||38
2877429|NCT00265798|3582152|FG000|COMPLETED|Overall Study||38
2877430|NCT00265798|3582152|FG000|NOT COMPLETED|Overall Study||0
2877431|NCT00265850|3582159|FG000|STARTED|Overall Study||899
2877432|NCT00265850|3582160|FG001|STARTED|Overall Study||902
2877433|NCT00265850|3582161|FG002|STARTED|Overall Study||533
2877434|NCT00265850|3582159|FG000|COMPLETED|Overall Study||899
2877435|NCT00265850|3582160|FG001|COMPLETED|Overall Study||902
2877436|NCT00265850|3582161|FG002|COMPLETED|Overall Study||533
2877437|NCT00265850|3582159|FG000|NOT COMPLETED|Overall Study||0
2877438|NCT00265850|3582160|FG001|NOT COMPLETED|Overall Study||0
2877439|NCT00265850|3582161|FG002|NOT COMPLETED|Overall Study||0
2877440|NCT00265889|3582168|FG000|STARTED|Overall Study||42
2877441|NCT00265889|3582168|FG000|Cycle 1: 1st Regimen/Transplant|Overall Study||37
2877442|NCT00265889|3582168|FG000|Cycle 2: 2nd Regimen/Transplant|Overall Study||37
2877443|NCT00265889|3582168|FG000|COMPLETED|Overall Study||37
2877444|NCT00265889|3582168|FG000|NOT COMPLETED|Overall Study||5
2877445|NCT00265941|3582174|FG000|STARTED|Overall Study||470
2877446|NCT00265941|3582175|FG001|STARTED|Overall Study||470
2877447|NCT00265941|3582174|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|447
2877448|NCT00265941|3582175|FG001|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|444
2877449|NCT00265941|3582174|FG000|NOT COMPLETED|Overall Study||23
2877450|NCT00265941|3582175|FG001|NOT COMPLETED|Overall Study||26
2877451|NCT00265980|3582189|FG000|STARTED|Overall Study||22
2877452|NCT00265980|3582189|FG000|Weight Initial|Overall Study||22
2877453|NCT00265980|3582189|FG000|Weight -10% Placebo|Overall Study||22
2877454|NCT00265980|3582189|FG000|Weight -10% Leptin|Overall Study||22
2877455|NCT00265980|3582189|FG000|COMPLETED|Overall Study||22
2877456|NCT00265980|3582189|FG000|NOT COMPLETED|Overall Study||0
2877457|NCT00266032|3582196|FG000|STARTED|Treatment|all randomized subjects, baseline data for full analysis set (FAS) only|691
2877458|NCT00266032|3582197|FG001|STARTED|Treatment|all randomized subjects, baseline data for full analysis set (FAS) only|236
2877459|NCT00266032|3582198|FG002|STARTED|Treatment|all randomized subjects, baseline data for full analysis set (FAS) only|239
2877460|NCT00266032|3582196|FG000|Patients Treated|Treatment||684
2877461|NCT00266032|3582197|FG001|Patients Treated|Treatment||221
2877462|NCT00266032|3582198|FG002|Patients Treated|Treatment||229
2877463|NCT00266032|3582196|FG000|Patients Treated and in FAS|Treatment|FAS|642
2877464|NCT00266032|3582197|FG001|Patients Treated and in FAS|Treatment|FAS|209
2877465|NCT00266032|3582198|FG002|Patients Treated and in FAS|Treatment|FAS|216
2877466|NCT00266032|3582196|FG000|COMPLETED|Treatment|not all entered period 2 (open-label safety extension)|580
2877467|NCT00266032|3582197|FG001|COMPLETED|Treatment|not all entered period 2 (open-label safety extension)|172
2877468|NCT00266032|3582198|FG002|COMPLETED|Treatment|not all entered period 2 (open-label safety extension)|192
2877469|NCT00266032|3582196|FG000|NOT COMPLETED|Treatment||111
2877470|NCT00266032|3582197|FG001|NOT COMPLETED|Treatment||64
2877471|NCT00266032|3582198|FG002|NOT COMPLETED|Treatment||47
2877472|NCT00266032|3582196|FG000|STARTED|Open-label Safety Extension|treatment for subjects of all 3 treatment groups in 2nd period, except for 28 in subgroups|489
2877473|NCT00266032|3582197|FG001|STARTED|Open-label Safety Extension|7 subjects continued their treatment in second period (safety extension)|129
2877474|NCT00266032|3582198|FG002|STARTED|Open-label Safety Extension|21 subjects continued their treatment in second period (safety extension)|165
2877475|NCT00266032|3582196|FG000|COMPLETED|Open-label Safety Extension||448
2877476|NCT00266032|3582197|FG001|COMPLETED|Open-label Safety Extension||115
2877477|NCT00266032|3582198|FG002|COMPLETED|Open-label Safety Extension||140
2877478|NCT00266032|3582196|FG000|NOT COMPLETED|Open-label Safety Extension||41
2877479|NCT00266032|3582197|FG001|NOT COMPLETED|Open-label Safety Extension||14
2877480|NCT00266032|3582198|FG002|NOT COMPLETED|Open-label Safety Extension||25
2877481|NCT00266110|3582206|FG000|STARTED|Overall Study||17
2877482|NCT00266110|3582206|FG000|COMPLETED|Overall Study||10
2877483|NCT00266110|3582206|FG000|NOT COMPLETED|Overall Study||7
2877484|NCT00266227|3582213|FG000|STARTED|Initial Treatment||0
2877485|NCT00266227|3582214|FG001|STARTED|Initial Treatment||0
2877486|NCT00266227|3582215|FG002|STARTED|Initial Treatment||559
2877487|NCT00266227|3582213|FG000|COMPLETED|Initial Treatment||0
2877488|NCT00266227|3582214|FG001|COMPLETED|Initial Treatment||0
2877489|NCT00266227|3582215|FG002|COMPLETED|Initial Treatment||482
2877490|NCT00266227|3582213|FG000|NOT COMPLETED|Initial Treatment||0
2877491|NCT00266227|3582214|FG001|NOT COMPLETED|Initial Treatment||0
2877492|NCT00266227|3582215|FG002|NOT COMPLETED|Initial Treatment||77
2877493|NCT00266227|3582213|FG000|STARTED|Retreatment: Up to Week 48||318
2877494|NCT00266227|3582214|FG001|STARTED|Retreatment: Up to Week 48||157
2877495|NCT00266227|3582215|FG002|STARTED|Retreatment: Up to Week 48||0
2877496|NCT00266227|3582213|FG000|COMPLETED|Retreatment: Up to Week 48||291
2877497|NCT00266227|3582214|FG001|COMPLETED|Retreatment: Up to Week 48||134
2877498|NCT00266227|3582215|FG002|COMPLETED|Retreatment: Up to Week 48||0
2877499|NCT00266227|3582213|FG000|NOT COMPLETED|Retreatment: Up to Week 48||27
2877500|NCT00266227|3582214|FG001|NOT COMPLETED|Retreatment: Up to Week 48||23
2877501|NCT00266227|3582215|FG002|NOT COMPLETED|Retreatment: Up to Week 48||0
2877502|NCT00266227|3582213|FG000|STARTED|Retreatment: Week 48 to Week 72||291
2877503|NCT00266227|3582214|FG001|STARTED|Retreatment: Week 48 to Week 72||134
2877504|NCT00266227|3582215|FG002|STARTED|Retreatment: Week 48 to Week 72||0
3169874|NCT01928381|3897370|FG003|NOT COMPLETED|Part 2 - First Intervention||1
3169875|NCT01928381|3897371|FG004|NOT COMPLETED|Part 2 - First Intervention||0
3169876|NCT01928381|3897372|FG005|NOT COMPLETED|Part 2 - First Intervention||1
3169877|NCT01928381|3897373|FG006|NOT COMPLETED|Part 2 - First Intervention||1
3169878|NCT01928381|3897367|FG000|STARTED|Washout First Intervention||0
3169879|NCT01928381|3897368|FG001|STARTED|Washout First Intervention||6
3169880|NCT01928381|3897369|FG002|STARTED|Washout First Intervention||4
3169881|NCT01928381|3897370|FG003|STARTED|Washout First Intervention||5
2877505|NCT00266227|3582213|FG000|COMPLETED|Retreatment: Week 48 to Week 72||227
2877506|NCT00266227|3582214|FG001|COMPLETED|Retreatment: Week 48 to Week 72||92
2877507|NCT00266227|3582215|FG002|COMPLETED|Retreatment: Week 48 to Week 72||0
2877508|NCT00266227|3582213|FG000|NOT COMPLETED|Retreatment: Week 48 to Week 72||64
2877509|NCT00266227|3582214|FG001|NOT COMPLETED|Retreatment: Week 48 to Week 72||42
2877510|NCT00266227|3582215|FG002|NOT COMPLETED|Retreatment: Week 48 to Week 72||0
2877511|NCT00266279|3582224|FG000|STARTED|Overall Study||17
2877512|NCT00266279|3582224|FG000|COMPLETED|Overall Study||15
2877513|NCT00266279|3582224|FG000|NOT COMPLETED|Overall Study||2
2877514|NCT00266409|3582233|FG000|STARTED|Overall Study||137
2877515|NCT00266409|3582234|FG001|STARTED|Overall Study||138
2877516|NCT00266409|3582235|FG002|STARTED|Overall Study||72
2877517|NCT00266409|3582236|FG003|STARTED|Overall Study||71
2877518|NCT00266409|3582233|FG000|COMPLETED|Overall Study||92
2877519|NCT00266409|3582234|FG001|COMPLETED|Overall Study||92
2877520|NCT00266409|3582235|FG002|COMPLETED|Overall Study||55
2877521|NCT00266409|3582236|FG003|COMPLETED|Overall Study||49
2877522|NCT00266409|3582233|FG000|NOT COMPLETED|Overall Study||45
2877523|NCT00266409|3582234|FG001|NOT COMPLETED|Overall Study||46
2877524|NCT00266409|3582235|FG002|NOT COMPLETED|Overall Study||17
2877525|NCT00266409|3582236|FG003|NOT COMPLETED|Overall Study||22
2877526|NCT00266630|3582248|FG000|STARTED|Overall Study||100
2877527|NCT00266630|3582249|FG001|STARTED|Overall Study||39
2877528|NCT00266630|3582248|FG000|COMPLETED|Overall Study||58
2877529|NCT00266630|3582249|FG001|COMPLETED|Overall Study||11
2877530|NCT00266630|3582248|FG000|NOT COMPLETED|Overall Study||42
2877531|NCT00266630|3582249|FG001|NOT COMPLETED|Overall Study||28
2877532|NCT00266656|3582259|FG000|STARTED|Overall Study||36
2877533|NCT00266656|3582260|FG001|STARTED|Overall Study||33
2877534|NCT00266656|3582259|FG000|COMPLETED|Overall Study||22
2877535|NCT00266656|3582260|FG001|COMPLETED|Overall Study||20
2877536|NCT00266656|3582259|FG000|NOT COMPLETED|Overall Study||14
2877537|NCT00266656|3582260|FG001|NOT COMPLETED|Overall Study||13
2877538|NCT00266695|3582266|FG000|STARTED|Overall Study||203
2877539|NCT00266695|3582266|FG000|COMPLETED|Overall Study||174
2877540|NCT00266695|3582266|FG000|NOT COMPLETED|Overall Study||29
2877541|NCT00266708|3582272|FG000|STARTED|Overall Study||20
2877542|NCT00266708|3582273|FG001|STARTED|Overall Study||22
2877543|NCT00266708|3582272|FG000|COMPLETED|Overall Study||16
2877544|NCT00266708|3582273|FG001|COMPLETED|Overall Study||13
2877545|NCT00266708|3582272|FG000|NOT COMPLETED|Overall Study||4
2877546|NCT00266708|3582273|FG001|NOT COMPLETED|Overall Study||9
2877547|NCT00266799|3582281|FG000|STARTED|Overall Study||98
2877548|NCT00266799|3582282|FG001|STARTED|Overall Study||102
2877549|NCT00266799|3582281|FG000|COMPLETED|Overall Study||62
2877550|NCT00266799|3582282|FG001|COMPLETED|Overall Study||68
2877551|NCT00266799|3582281|FG000|NOT COMPLETED|Overall Study||36
2877552|NCT00266799|3582282|FG001|NOT COMPLETED|Overall Study||34
2877553|NCT00266812|3582290|FG000|STARTED|Overall Study||22
2877554|NCT00266812|3582291|FG001|STARTED|Overall Study||13
2877555|NCT00266812|3582290|FG000|COMPLETED|Overall Study||1
2877556|NCT00266812|3582291|FG001|COMPLETED|Overall Study||2
2877557|NCT00266812|3582290|FG000|NOT COMPLETED|Overall Study||21
2877558|NCT00266812|3582291|FG001|NOT COMPLETED|Overall Study||11
2877559|NCT00266825|3582299|FG000|STARTED|Enrolled and Allocated Intervention||172
2877560|NCT00266825|3582300|FG001|STARTED|Enrolled and Allocated Intervention||178
2877561|NCT00266825|3582299|FG000|COMPLETED|Enrolled and Allocated Intervention||172
2877562|NCT00266825|3582300|FG001|COMPLETED|Enrolled and Allocated Intervention||178
2877563|NCT00266825|3582299|FG000|NOT COMPLETED|Enrolled and Allocated Intervention||0
2877564|NCT00266825|3582300|FG001|NOT COMPLETED|Enrolled and Allocated Intervention||0
2877565|NCT00266825|3582299|FG000|STARTED|Completed Follow-Up||172
2877566|NCT00266825|3582300|FG001|STARTED|Completed Follow-Up||178
2877567|NCT00266825|3582299|FG000|COMPLETED|Completed Follow-Up||147
2877568|NCT00266825|3582300|FG001|COMPLETED|Completed Follow-Up||154
2877569|NCT00266825|3582299|FG000|NOT COMPLETED|Completed Follow-Up||25
2877570|NCT00266825|3582300|FG001|NOT COMPLETED|Completed Follow-Up||24
2877571|NCT00266851|3582311|FG000|STARTED|Overall Study||37
2877572|NCT00266851|3582312|FG001|STARTED|Overall Study||38
2877573|NCT00266851|3582313|FG002|STARTED|Overall Study||22
2877574|NCT00266851|3582311|FG000|Completed 3 Month Follow up|Overall Study||26
2877575|NCT00266851|3582312|FG001|Completed 3 Month Follow up|Overall Study||22
2877576|NCT00266851|3582313|FG002|Completed 3 Month Follow up|Overall Study||15
2877577|NCT00266851|3582311|FG000|Completed 6 Month Follow up|Overall Study||27
2877578|NCT00266851|3582312|FG001|Completed 6 Month Follow up|Overall Study||22
2877579|NCT00266851|3582313|FG002|Completed 6 Month Follow up|Overall Study||17
2877580|NCT00266851|3582311|FG000|Completed 9 Month Follow up|Overall Study||22
2877581|NCT00266851|3582312|FG001|Completed 9 Month Follow up|Overall Study||23
2877582|NCT00266851|3582313|FG002|Completed 9 Month Follow up|Overall Study||15
2877583|NCT00266851|3582311|FG000|Completed 12 Month Follow up|Overall Study||25
2877584|NCT00266851|3582312|FG001|Completed 12 Month Follow up|Overall Study||19
2877585|NCT00266851|3582313|FG002|Completed 12 Month Follow up|Overall Study||13
2877586|NCT00266851|3582311|FG000|COMPLETED|Overall Study||37
2877587|NCT00266851|3582312|FG001|COMPLETED|Overall Study||38
2877588|NCT00266851|3582313|FG002|COMPLETED|Overall Study||22
2877589|NCT00266851|3582311|FG000|NOT COMPLETED|Overall Study||0
2877590|NCT00266851|3582312|FG001|NOT COMPLETED|Overall Study||0
2877591|NCT00266851|3582313|FG002|NOT COMPLETED|Overall Study||0
2877592|NCT00266864|3582327|FG000|STARTED|Overall Study||18
2877593|NCT00266864|3582328|FG001|STARTED|Overall Study||13
2877594|NCT00266864|3582327|FG000|COMPLETED|Overall Study||13
2877595|NCT00266864|3582328|FG001|COMPLETED|Overall Study||11
2877596|NCT00266864|3582327|FG000|NOT COMPLETED|Overall Study||5
2877597|NCT00266864|3582328|FG001|NOT COMPLETED|Overall Study||2
2877598|NCT00266877|3582337|FG000|STARTED|Overall Study||91
2877599|NCT00266877|3582338|FG001|STARTED|Overall Study||48
2877600|NCT00266877|3582339|FG002|STARTED|Overall Study||28
2877601|NCT00266877|3582337|FG000|COMPLETED|Overall Study||0
2877602|NCT00266877|3582338|FG001|COMPLETED|Overall Study||0
2877603|NCT00266877|3582339|FG002|COMPLETED|Overall Study||0
2877604|NCT00266877|3582337|FG000|NOT COMPLETED|Overall Study||91
2877605|NCT00266877|3582338|FG001|NOT COMPLETED|Overall Study||48
2877606|NCT00266877|3582339|FG002|NOT COMPLETED|Overall Study||28
2877607|NCT00267007|3582349|FG000|STARTED|Overall Study|2 additional patients were randomized but never received study medication and no data were collected|19
2877608|NCT00267007|3582350|FG001|STARTED|Overall Study||11
2877609|NCT00267007|3582349|FG000|COMPLETED|Overall Study||11
2877610|NCT00267007|3582350|FG001|COMPLETED|Overall Study||10
2877611|NCT00267007|3582349|FG000|NOT COMPLETED|Overall Study||8
2877612|NCT00267007|3582350|FG001|NOT COMPLETED|Overall Study||1
2877613|NCT00267020|3582358|FG000|STARTED|Overall Study||86
2877614|NCT00267020|3582359|FG001|STARTED|Overall Study||44
2877615|NCT00267020|3582358|FG000|Received at Least 1 Dose|Overall Study||82
2877616|NCT00267020|3582359|FG001|Received at Least 1 Dose|Overall Study||39
2877617|NCT00267020|3582358|FG000|Per-Protocol Population|Overall Study|With: cancer of the pancreas;no other chemotherapy;disease at baseline;received 1 dose of study drug|81
2877618|NCT00267020|3582359|FG001|Per-Protocol Population|Overall Study|With: cancer of the pancreas;no other chemotherapy;disease at baseline;received 1 dose of study drug|38
2877619|NCT00267020|3582358|FG000|COMPLETED|Overall Study||0
2877620|NCT00267020|3582359|FG001|COMPLETED|Overall Study||1
2877621|NCT00267020|3582358|FG000|NOT COMPLETED|Overall Study||86
2877622|NCT00267020|3582359|FG001|NOT COMPLETED|Overall Study||43
2877623|NCT00267046|3582367|FG000|STARTED|Overall Study||32
2877624|NCT00267046|3582368|FG001|STARTED|Overall Study||16
2877625|NCT00267046|3582367|FG000|COMPLETED|Overall Study||20
2877626|NCT00267046|3582368|FG001|COMPLETED|Overall Study||5
2877627|NCT00267046|3582367|FG000|NOT COMPLETED|Overall Study||12
2877628|NCT00267046|3582368|FG001|NOT COMPLETED|Overall Study||11
2877629|NCT00267059|3582374|FG000|STARTED|Overall Study||44
2877630|NCT00267059|3582374|FG000|COMPLETED|Overall Study||44
2877631|NCT00267059|3582374|FG000|NOT COMPLETED|Overall Study||0
2877632|NCT00267085|3582378|FG000|STARTED|Overall Study||10
2877633|NCT00267085|3582378|FG000|COMPLETED|Overall Study||10
2877634|NCT00267085|3582378|FG000|NOT COMPLETED|Overall Study||0
2877635|NCT00267098|3582390|FG000|STARTED|Overall Study||109
2877636|NCT00267098|3582391|FG001|STARTED|Overall Study||51
2877637|NCT00267098|3582392|FG002|STARTED|Overall Study||243
2877638|NCT00267098|3582393|FG003|STARTED|Overall Study||241
2877639|NCT00267098|3582394|FG004|STARTED|Overall Study||47
2877640|NCT00267098|3582395|FG005|STARTED|Overall Study||106
2877641|NCT00267098|3582396|FG006|STARTED|Overall Study||101
2877642|NCT00267098|3582397|FG007|STARTED|Overall Study||20
2877643|NCT00267098|3582390|FG000|COMPLETED|Overall Study||0
2877644|NCT00267098|3582391|FG001|COMPLETED|Overall Study||0
2877645|NCT00267098|3582392|FG002|COMPLETED|Overall Study||149
3169882|NCT01928381|3897371|FG004|STARTED|Washout First Intervention||4
3169883|NCT01928381|3897372|FG005|STARTED|Washout First Intervention||5
3169884|NCT01928381|3897373|FG006|STARTED|Washout First Intervention||5
3169885|NCT01928381|3897367|FG000|COMPLETED|Washout First Intervention||0
3169886|NCT01928381|3897368|FG001|COMPLETED|Washout First Intervention||6
2877646|NCT00267098|3582393|FG003|COMPLETED|Overall Study||135
2877647|NCT00267098|3582394|FG004|COMPLETED|Overall Study||10
2877648|NCT00267098|3582395|FG005|COMPLETED|Overall Study||66
2877649|NCT00267098|3582396|FG006|COMPLETED|Overall Study||55
2877650|NCT00267098|3582397|FG007|COMPLETED|Overall Study||5
2877651|NCT00267098|3582390|FG000|NOT COMPLETED|Overall Study||109
2877652|NCT00267098|3582391|FG001|NOT COMPLETED|Overall Study||51
2877653|NCT00267098|3582392|FG002|NOT COMPLETED|Overall Study||94
2877654|NCT00267098|3582393|FG003|NOT COMPLETED|Overall Study||106
2877655|NCT00267098|3582394|FG004|NOT COMPLETED|Overall Study||37
2877656|NCT00267098|3582395|FG005|NOT COMPLETED|Overall Study||40
2877657|NCT00267098|3582396|FG006|NOT COMPLETED|Overall Study||46
2877658|NCT00267098|3582397|FG007|NOT COMPLETED|Overall Study||15
2877659|NCT00267111|3582422|FG000|STARTED|Overall Study||55
2877660|NCT00267111|3582423|FG001|STARTED|Overall Study||55
2877661|NCT00267111|3582422|FG000|COMPLETED|Overall Study||55
2877662|NCT00267111|3582423|FG001|COMPLETED|Overall Study||55
2877663|NCT00267111|3582422|FG000|NOT COMPLETED|Overall Study||0
2877664|NCT00267111|3582423|FG001|NOT COMPLETED|Overall Study||0
2877665|NCT00267150|3582430|FG000|STARTED|Overall Study||31
2877666|NCT00267150|3582430|FG000|COMPLETED|Overall Study||30
2877667|NCT00267150|3582430|FG000|NOT COMPLETED|Overall Study||1
2877668|NCT00267189|3582436|FG000|STARTED|Overall Study|Intention to treat (ITT) population.|72
2877669|NCT00267189|3582437|FG001|STARTED|Overall Study||73
2877670|NCT00267189|3582436|FG000|Completed Study Medication|Overall Study||54
2877671|NCT00267189|3582437|FG001|Completed Study Medication|Overall Study||72
2877672|NCT00267189|3582436|FG000|COMPLETED|Overall Study|"Completed indicates completed study."|67
2877673|NCT00267189|3582437|FG001|COMPLETED|Overall Study||72
2877674|NCT00267189|3582436|FG000|NOT COMPLETED|Overall Study||5
2877675|NCT00267189|3582437|FG001|NOT COMPLETED|Overall Study||1
2877676|NCT00267202|3582445|FG000|STARTED|Overall Study||136
2877677|NCT00267202|3582446|FG001|STARTED|Overall Study||139
2877678|NCT00267202|3582445|FG000|COMPLETED|Overall Study||83
2877679|NCT00267202|3582446|FG001|COMPLETED|Overall Study||105
2877680|NCT00267202|3582445|FG000|NOT COMPLETED|Overall Study||53
2877681|NCT00267202|3582446|FG001|NOT COMPLETED|Overall Study||34
2877682|NCT00267293|3582456|FG000|STARTED|Overall Study||20
2877683|NCT00267293|3582457|FG001|STARTED|Overall Study||20
2877684|NCT00267293|3582458|FG002|STARTED|Overall Study||20
2877685|NCT00267293|3582456|FG000|COMPLETED|Overall Study||20
2877686|NCT00267293|3582457|FG001|COMPLETED|Overall Study||20
2877687|NCT00267293|3582458|FG002|COMPLETED|Overall Study||20
2877688|NCT00267293|3582456|FG000|NOT COMPLETED|Overall Study||0
2877689|NCT00267293|3582457|FG001|NOT COMPLETED|Overall Study||0
2877690|NCT00267293|3582458|FG002|NOT COMPLETED|Overall Study||0
2877691|NCT00267488|3582466|FG000|STARTED|Overall Study||37
2877692|NCT00267488|3582466|FG000|COMPLETED|Overall Study||26
2877693|NCT00267488|3582466|FG000|NOT COMPLETED|Overall Study||11
2877694|NCT00267631|3582472|FG000|STARTED|Overall Study||2361
2877695|NCT00267631|3582473|FG001|STARTED|Overall Study||3031
2877696|NCT00267631|3582472|FG000|COMPLETED|Overall Study||2361
2877697|NCT00267631|3582473|FG001|COMPLETED|Overall Study||3031
2877698|NCT00267631|3582472|FG000|NOT COMPLETED|Overall Study||0
2877699|NCT00267631|3582473|FG001|NOT COMPLETED|Overall Study||0
2877700|NCT00267644|3582481|FG000|STARTED|Overall Study||13
2877701|NCT00267644|3582482|FG001|STARTED|Overall Study||63
2877702|NCT00267644|3582481|FG000|COMPLETED|Overall Study||13
2877703|NCT00267644|3582482|FG001|COMPLETED|Overall Study||63
2877704|NCT00267644|3582481|FG000|NOT COMPLETED|Overall Study||0
2877705|NCT00267644|3582482|FG001|NOT COMPLETED|Overall Study||0
2877706|NCT00267670|3582492|FG000|STARTED|Overall Study||19
2877707|NCT00267670|3582493|FG001|STARTED|Overall Study||7
2877708|NCT00267670|3582492|FG000|COMPLETED|Overall Study||15
2877709|NCT00267670|3582493|FG001|COMPLETED|Overall Study||7
2877710|NCT00267670|3582492|FG000|NOT COMPLETED|Overall Study||4
2877711|NCT00267670|3582493|FG001|NOT COMPLETED|Overall Study||0
2877712|NCT00267696|3582500|FG000|STARTED|Overall Study||45
2877713|NCT00267696|3582500|FG000|COMPLETED|Overall Study||45
2877714|NCT00267696|3582500|FG000|NOT COMPLETED|Overall Study||0
2877715|NCT00267748|3582507|FG000|STARTED|Non-randomized Period||25
2877716|NCT00267748|3582508|FG001|STARTED|Non-randomized Period||0
2877717|NCT00267748|3582509|FG002|STARTED|Non-randomized Period||0
2877718|NCT00267748|3582507|FG000|COMPLETED|Non-randomized Period||2
2877719|NCT00267748|3582508|FG001|COMPLETED|Non-randomized Period||0
2877720|NCT00267748|3582509|FG002|COMPLETED|Non-randomized Period||0
2877721|NCT00267748|3582507|FG000|NOT COMPLETED|Non-randomized Period||23
2877722|NCT00267748|3582508|FG001|NOT COMPLETED|Non-randomized Period||0
2877723|NCT00267748|3582509|FG002|NOT COMPLETED|Non-randomized Period||0
2877724|NCT00267748|3582507|FG000|STARTED|Randomized Period||0
2877725|NCT00267748|3582508|FG001|STARTED|Randomized Period||146
2877726|NCT00267748|3582509|FG002|STARTED|Randomized Period||146
2877727|NCT00267748|3582507|FG000|Treated|Randomized Period||0
2877728|NCT00267748|3582508|FG001|Treated|Randomized Period||146
2877729|NCT00267748|3582509|FG002|Treated|Randomized Period||143
2877730|NCT00267748|3582507|FG000|COMPLETED|Randomized Period||0
2877731|NCT00267748|3582508|FG001|COMPLETED|Randomized Period||19
2877732|NCT00267748|3582509|FG002|COMPLETED|Randomized Period||14
2877733|NCT00267748|3582507|FG000|NOT COMPLETED|Randomized Period||0
2877734|NCT00267748|3582508|FG001|NOT COMPLETED|Randomized Period||127
2877735|NCT00267748|3582509|FG002|NOT COMPLETED|Randomized Period||132
2877736|NCT00267774|3582518|FG000|STARTED|Overall Study||509
2877737|NCT00267774|3582519|FG001|STARTED|Overall Study||496
2877738|NCT00267774|3582518|FG000|COMPLETED|Overall Study||509
2877739|NCT00267774|3582519|FG001|COMPLETED|Overall Study||496
2877740|NCT00267774|3582518|FG000|NOT COMPLETED|Overall Study||0
2877741|NCT00267774|3582519|FG001|NOT COMPLETED|Overall Study||0
2877742|NCT00267865|3582525|FG000|STARTED|Induction Treatment||12
2877743|NCT00267865|3582525|FG000|COMPLETED|Induction Treatment||9
2877744|NCT00267865|3582525|FG000|NOT COMPLETED|Induction Treatment||3
2877745|NCT00267865|3582525|FG000|STARTED|Consolidation Treatment||5
2877746|NCT00267865|3582525|FG000|COMPLETED|Consolidation Treatment||5
2877747|NCT00267865|3582525|FG000|NOT COMPLETED|Consolidation Treatment||0
2877748|NCT00267956|3582531|FG000|STARTED|Controlled Period||70
2877749|NCT00267956|3582532|FG001|STARTED|Controlled Period||76
2877750|NCT00267956|3582533|FG002|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
2877751|NCT00267956|3582534|FG003|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
2877752|NCT00267956|3582531|FG000|COMPLETED|Controlled Period||57
2877753|NCT00267956|3582532|FG001|COMPLETED|Controlled Period||72
2877754|NCT00267956|3582533|FG002|COMPLETED|Controlled Period||0
2877755|NCT00267956|3582534|FG003|COMPLETED|Controlled Period||0
2877756|NCT00267956|3582531|FG000|NOT COMPLETED|Controlled Period||13
2877757|NCT00267956|3582532|FG001|NOT COMPLETED|Controlled Period||4
2877758|NCT00267956|3582533|FG002|NOT COMPLETED|Controlled Period||0
2877759|NCT00267956|3582534|FG003|NOT COMPLETED|Controlled Period||0
2877760|NCT00267956|3582531|FG000|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
2877761|NCT00267956|3582532|FG001|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
2877762|NCT00267956|3582533|FG002|STARTED|After Controlled Period||57
2877763|NCT00267956|3582534|FG003|STARTED|After Controlled Period||72
2877764|NCT00267956|3582531|FG000|COMPLETED|After Controlled Period||0
2877765|NCT00267956|3582532|FG001|COMPLETED|After Controlled Period||0
2877766|NCT00267956|3582533|FG002|COMPLETED|After Controlled Period||52
2877767|NCT00267956|3582534|FG003|COMPLETED|After Controlled Period||70
2877768|NCT00267956|3582531|FG000|NOT COMPLETED|After Controlled Period||0
2877769|NCT00267956|3582532|FG001|NOT COMPLETED|After Controlled Period||0
2877770|NCT00267956|3582533|FG002|NOT COMPLETED|After Controlled Period||5
2877771|NCT00267956|3582534|FG003|NOT COMPLETED|After Controlled Period||2
2877772|NCT00267969|3582545|FG000|STARTED|Controlled Period|Number of patients randomized|255
2877773|NCT00267969|3582546|FG001|STARTED|Controlled Period|Number of patients randomized|255
2877774|NCT00267969|3582547|FG002|STARTED|Controlled Period|Number of patients randomized|256
2877775|NCT00267969|3582548|FG003|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
2877776|NCT00267969|3582549|FG004|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
2877777|NCT00267969|3582550|FG005|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
2877778|NCT00267969|3582551|FG006|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
2877779|NCT00267969|3582545|FG000|COMPLETED|Controlled Period||243
2877780|NCT00267969|3582546|FG001|COMPLETED|Controlled Period||254
2877781|NCT00267969|3582547|FG002|COMPLETED|Controlled Period||245
2877782|NCT00267969|3582548|FG003|COMPLETED|Controlled Period||0
2877783|NCT00267969|3582549|FG004|COMPLETED|Controlled Period||0
2877784|NCT00267969|3582550|FG005|COMPLETED|Controlled Period||0
2877785|NCT00267969|3582551|FG006|COMPLETED|Controlled Period||0
2877786|NCT00267969|3582545|FG000|NOT COMPLETED|Controlled Period||12
2877787|NCT00267969|3582546|FG001|NOT COMPLETED|Controlled Period||1
2877788|NCT00267969|3582547|FG002|NOT COMPLETED|Controlled Period||11
2877789|NCT00267969|3582548|FG003|NOT COMPLETED|Controlled Period||0
2877790|NCT00267969|3582549|FG004|NOT COMPLETED|Controlled Period||0
2877791|NCT00267969|3582550|FG005|NOT COMPLETED|Controlled Period||0
2877792|NCT00267969|3582551|FG006|NOT COMPLETED|Controlled Period||0
2877793|NCT00267969|3582545|FG000|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
2877794|NCT00267969|3582546|FG001|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
2877795|NCT00267969|3582547|FG002|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
2877796|NCT00267969|3582548|FG003|STARTED|After Controlled Period||123
2877797|NCT00267969|3582549|FG004|STARTED|After Controlled Period||120
2877798|NCT00267969|3582550|FG005|STARTED|After Controlled Period||254
2877799|NCT00267969|3582551|FG006|STARTED|After Controlled Period||245
2877800|NCT00267969|3582545|FG000|COMPLETED|After Controlled Period||0
2877801|NCT00267969|3582546|FG001|COMPLETED|After Controlled Period||0
2877802|NCT00267969|3582547|FG002|COMPLETED|After Controlled Period||0
2877803|NCT00267969|3582548|FG003|COMPLETED|After Controlled Period||87
2877804|NCT00267969|3582549|FG004|COMPLETED|After Controlled Period||85
2877805|NCT00267969|3582550|FG005|COMPLETED|After Controlled Period||172
2877806|NCT00267969|3582551|FG006|COMPLETED|After Controlled Period||173
2877807|NCT00267969|3582545|FG000|NOT COMPLETED|After Controlled Period||0
2877808|NCT00267969|3582546|FG001|NOT COMPLETED|After Controlled Period||0
2877809|NCT00267969|3582547|FG002|NOT COMPLETED|After Controlled Period||0
2877810|NCT00267969|3582548|FG003|NOT COMPLETED|After Controlled Period||36
2877811|NCT00267969|3582549|FG004|NOT COMPLETED|After Controlled Period||35
2877812|NCT00267969|3582550|FG005|NOT COMPLETED|After Controlled Period||82
2877813|NCT00267969|3582551|FG006|NOT COMPLETED|After Controlled Period||72
2877814|NCT00268203|3582569|FG000|STARTED|Overall Study||765
2877815|NCT00268203|3582569|FG000|Completed 2 Years of Follow-up|Overall Study||62
2877816|NCT00268203|3582569|FG000|COMPLETED|Overall Study|These participants completed 10 years of follow-up.|118
2877817|NCT00268203|3582569|FG000|NOT COMPLETED|Overall Study||647
2877818|NCT00268242|3582573|FG000|STARTED|Overall Study||24
2877819|NCT00268242|3582573|FG000|COMPLETED|Overall Study||23
2877820|NCT00268242|3582573|FG000|NOT COMPLETED|Overall Study||1
2877821|NCT00268346|3582579|FG000|STARTED|Overall Study||18
2877822|NCT00268346|3582580|FG001|STARTED|Overall Study||40
2877823|NCT00268346|3582579|FG000|Started Treatment|Overall Study||18
2877824|NCT00268346|3582580|FG001|Started Treatment|Overall Study||40
2877825|NCT00268346|3582579|FG000|COMPLETED|Overall Study||18
2877826|NCT00268346|3582580|FG001|COMPLETED|Overall Study||37
2877827|NCT00268346|3582579|FG000|NOT COMPLETED|Overall Study||0
2877828|NCT00268346|3582580|FG001|NOT COMPLETED|Overall Study||3
2877829|NCT00268437|3582586|FG000|STARTED|Overall Study||27
2877830|NCT00268437|3582586|FG000|COMPLETED|Overall Study||26
2877831|NCT00268437|3582586|FG000|NOT COMPLETED|Overall Study||1
2877832|NCT00268762|3582591|FG000|STARTED|Overall Study||65
2877833|NCT00268762|3582591|FG000|COMPLETED|Overall Study||65
2877834|NCT00268762|3582591|FG000|NOT COMPLETED|Overall Study||0
2877835|NCT00268892|3582598|FG000|STARTED|Overall Study||90
2877836|NCT00268892|3582599|FG001|STARTED|Overall Study||95
2877837|NCT00268892|3582600|FG002|STARTED|Overall Study||93
2877838|NCT00268892|3582598|FG000|Switched to Higher Dose|Overall Study||59
2877839|NCT00268892|3582599|FG001|Switched to Higher Dose|Overall Study||68
2877840|NCT00268892|3582600|FG002|Switched to Higher Dose|Overall Study||76
2877841|NCT00268892|3582598|FG000|COMPLETED|Overall Study||51
2877842|NCT00268892|3582599|FG001|COMPLETED|Overall Study||53
2877843|NCT00268892|3582600|FG002|COMPLETED|Overall Study||54
2877844|NCT00268892|3582598|FG000|NOT COMPLETED|Overall Study||39
2877845|NCT00268892|3582599|FG001|NOT COMPLETED|Overall Study||42
2877846|NCT00268892|3582600|FG002|NOT COMPLETED|Overall Study||39
2877847|NCT00268905|3582611|FG000|STARTED|Overall Study||43
2877848|NCT00268905|3582612|FG001|STARTED|Overall Study||9
2877849|NCT00268905|3582613|FG002|STARTED|Overall Study||12
2877850|NCT00268905|3582611|FG000|COMPLETED|Overall Study||0
2877851|NCT00268905|3582612|FG001|COMPLETED|Overall Study||0
2877852|NCT00268905|3582613|FG002|COMPLETED|Overall Study||0
2877853|NCT00268905|3582611|FG000|NOT COMPLETED|Overall Study||43
2877854|NCT00268905|3582612|FG001|NOT COMPLETED|Overall Study||9
2877855|NCT00268905|3582613|FG002|NOT COMPLETED|Overall Study||12
2877856|NCT00268983|3582623|FG000|STARTED|Overall Study||6
2877857|NCT00268983|3582624|FG001|STARTED|Overall Study||8
2877858|NCT00268983|3582623|FG000|COMPLETED|Overall Study||3
2877859|NCT00268983|3582624|FG001|COMPLETED|Overall Study||8
2877860|NCT00268983|3582623|FG000|NOT COMPLETED|Overall Study||3
2877861|NCT00268983|3582624|FG001|NOT COMPLETED|Overall Study||0
2877862|NCT00268996|3582632|FG000|STARTED|Overall Study||151
2877863|NCT00268996|3582633|FG001|STARTED|Overall Study||172
2877864|NCT00268996|3582632|FG000|COMPLETED|Overall Study||130
2877865|NCT00268996|3582633|FG001|COMPLETED|Overall Study||152
2877866|NCT00268996|3582632|FG000|NOT COMPLETED|Overall Study||21
2877867|NCT00268996|3582633|FG001|NOT COMPLETED|Overall Study||20
2877868|NCT00269087|3582641|FG000|STARTED|Overall Study||122
2877869|NCT00269087|3582641|FG000|COMPLETED|Overall Study||88
2877870|NCT00269087|3582641|FG000|NOT COMPLETED|Overall Study||34
2877871|NCT00269113|3582647|FG000|STARTED|Overall Study||177
2877872|NCT00269113|3582648|FG001|STARTED|Overall Study||183
2877873|NCT00269113|3582647|FG000|COMPLETED|Overall Study||103
2877874|NCT00269113|3582648|FG001|COMPLETED|Overall Study||146
2877875|NCT00269113|3582647|FG000|NOT COMPLETED|Overall Study||74
2877876|NCT00269113|3582648|FG001|NOT COMPLETED|Overall Study||37
2877877|NCT00269152|3582656|FG000|STARTED|Overall Study|One participant in Pemetrexed+Carboplatin actually received Pemetrexed+Cisplatin|63
2877878|NCT00269152|3582657|FG001|STARTED|Overall Study|4 were randomized without receiving any study drug.|59
2877879|NCT00269152|3582656|FG000|COMPLETED|Overall Study||45
2877880|NCT00269152|3582657|FG001|COMPLETED|Overall Study||49
2877881|NCT00269152|3582656|FG000|NOT COMPLETED|Overall Study||18
2877882|NCT00269152|3582657|FG001|NOT COMPLETED|Overall Study||10
2877883|NCT00269399|3582665|FG000|STARTED|Overall Study||119
2877884|NCT00269399|3582666|FG001|STARTED|Overall Study||118
2877885|NCT00269399|3582665|FG000|COMPLETED|Overall Study||78
2877886|NCT00269399|3582666|FG001|COMPLETED|Overall Study||91
2877887|NCT00269399|3582665|FG000|NOT COMPLETED|Overall Study||41
2877888|NCT00269399|3582666|FG001|NOT COMPLETED|Overall Study||27
2877889|NCT00269477|3582676|FG000|STARTED|Overall Study||9
2877890|NCT00269477|3582677|FG001|STARTED|Overall Study||18
2877891|NCT00269477|3582678|FG002|STARTED|Overall Study||58
2877892|NCT00269477|3582679|FG003|STARTED|Overall Study||60
2877893|NCT00269477|3582676|FG000|COMPLETED|Overall Study||4
2877894|NCT00269477|3582677|FG001|COMPLETED|Overall Study||12
2877895|NCT00269477|3582678|FG002|COMPLETED|Overall Study||57
2877896|NCT00269477|3582679|FG003|COMPLETED|Overall Study||60
2877897|NCT00269477|3582676|FG000|NOT COMPLETED|Overall Study||5
2877898|NCT00269477|3582677|FG001|NOT COMPLETED|Overall Study||6
2877899|NCT00269477|3582678|FG002|NOT COMPLETED|Overall Study||1
2877900|NCT00269477|3582679|FG003|NOT COMPLETED|Overall Study||0
2877901|NCT00269633|3582691|FG000|STARTED|Overall Study||4
2877902|NCT00269633|3582692|FG001|STARTED|Overall Study||5
2877903|NCT00269633|3582691|FG000|COMPLETED|Overall Study||3
2877904|NCT00269633|3582692|FG001|COMPLETED|Overall Study||5
2877905|NCT00269633|3582691|FG000|NOT COMPLETED|Overall Study||1
2877906|NCT00269633|3582692|FG001|NOT COMPLETED|Overall Study||0
2877907|NCT00269919|3582698|FG000|STARTED|Overall Study||40
2877908|NCT00269919|3582698|FG000|Treated|Overall Study||39
2877909|NCT00269919|3582698|FG000|COMPLETED|Overall Study||13
2877910|NCT00269919|3582698|FG000|NOT COMPLETED|Overall Study||27
2877911|NCT00270205|3582707|FG000|STARTED|Overall Study||6
2877912|NCT00270205|3582708|FG001|STARTED|Overall Study|7 participants enrolled. One never started study vaccination and was excluded from all analyses.|6
2877913|NCT00270205|3582709|FG002|STARTED|Overall Study||6
2877914|NCT00270205|3582710|FG003|STARTED|Overall Study||7
2877915|NCT00270205|3582707|FG000|COMPLETED|Overall Study||5
2877916|NCT00270205|3582708|FG001|COMPLETED|Overall Study||6
2877917|NCT00270205|3582709|FG002|COMPLETED|Overall Study||6
2877918|NCT00270205|3582710|FG003|COMPLETED|Overall Study||6
2877919|NCT00270205|3582707|FG000|NOT COMPLETED|Overall Study||1
2877920|NCT00270205|3582708|FG001|NOT COMPLETED|Overall Study||0
2877921|NCT00270205|3582709|FG002|NOT COMPLETED|Overall Study||0
2877922|NCT00270205|3582710|FG003|NOT COMPLETED|Overall Study||1
2877923|NCT00270231|3582720|FG000|STARTED|First Intervention||32
2877924|NCT00270231|3582721|FG001|STARTED|First Intervention||32
2877925|NCT00270231|3582720|FG000|COMPLETED|First Intervention||31
2877926|NCT00270231|3582721|FG001|COMPLETED|First Intervention||31
2877927|NCT00270231|3582720|FG000|NOT COMPLETED|First Intervention||1
2877928|NCT00270231|3582721|FG001|NOT COMPLETED|First Intervention||1
2877929|NCT00270231|3582720|FG000|STARTED|Washout Period||31
2877930|NCT00270231|3582721|FG001|STARTED|Washout Period||31
2877931|NCT00270231|3582720|FG000|COMPLETED|Washout Period||30
2877932|NCT00270231|3582721|FG001|COMPLETED|Washout Period||31
2877933|NCT00270231|3582720|FG000|NOT COMPLETED|Washout Period||1
2877934|NCT00270231|3582721|FG001|NOT COMPLETED|Washout Period||0
2877935|NCT00270231|3582720|FG000|STARTED|Second Intervention||30
2877936|NCT00270231|3582721|FG001|STARTED|Second Intervention||31
2877937|NCT00270231|3582720|FG000|COMPLETED|Second Intervention||30
2877938|NCT00270231|3582721|FG001|COMPLETED|Second Intervention||30
2877939|NCT00270231|3582720|FG000|NOT COMPLETED|Second Intervention||0
2877940|NCT00270231|3582721|FG001|NOT COMPLETED|Second Intervention||1
2877941|NCT00270257|3582729|FG000|STARTED|Overall Study||623
2877942|NCT00270257|3582730|FG001|STARTED|Overall Study|1 excluded from analysis (enrollment date exceeded eligibility window by 13 days)|628
2877943|NCT00270257|3582729|FG000|Week 8|Overall Study||510
2877944|NCT00270257|3582730|FG001|Week 8|Overall Study||443
2877945|NCT00270257|3582729|FG000|Week 26|Overall Study||460
2877946|NCT00270257|3582730|FG001|Week 26|Overall Study||440
2877947|NCT00270257|3582729|FG000|Week 52|Overall Study||362
2877948|NCT00270257|3582730|FG001|Week 52|Overall Study||340
2877949|NCT00270257|3582729|FG000|Week 78|Overall Study||283
2877950|NCT00270257|3582730|FG001|Week 78|Overall Study||285
2877951|NCT00270257|3582729|FG000|Visit 104|Overall Study||211
2877952|NCT00270257|3582730|FG001|Visit 104|Overall Study||204
2877953|NCT00270257|3582729|FG000|COMPLETED|Overall Study||211
2877954|NCT00270257|3582730|FG001|COMPLETED|Overall Study||204
2877955|NCT00270257|3582729|FG000|NOT COMPLETED|Overall Study||412
2877956|NCT00270257|3582730|FG001|NOT COMPLETED|Overall Study||424
2877957|NCT00270296|3582741|FG000|STARTED|Overall Study||285
2877958|NCT00270296|3582742|FG001|STARTED|Overall Study||275
2877959|NCT00270296|3582743|FG002|STARTED|Overall Study||170
2877960|NCT00270296|3582741|FG000|COMPLETED|Overall Study||186
2877961|NCT00270296|3582742|FG001|COMPLETED|Overall Study||185
2877962|NCT00270296|3582743|FG002|COMPLETED|Overall Study||109
2877963|NCT00270296|3582741|FG000|NOT COMPLETED|Overall Study||99
2877964|NCT00270296|3582742|FG001|NOT COMPLETED|Overall Study||90
2877965|NCT00270296|3582743|FG002|NOT COMPLETED|Overall Study||61
2877966|NCT00270634|3582755|FG000|STARTED|Overall Study||87
2877967|NCT00270634|3582756|FG001|STARTED|Overall Study||77
2877968|NCT00270634|3582757|FG002|STARTED|Overall Study||84
2877969|NCT00270634|3582758|FG003|STARTED|Overall Study||86
2877970|NCT00270634|3582755|FG000|COMPLETED|Overall Study||70
2877971|NCT00270634|3582756|FG001|COMPLETED|Overall Study||64
2877972|NCT00270634|3582757|FG002|COMPLETED|Overall Study||62
2877973|NCT00270634|3582758|FG003|COMPLETED|Overall Study||81
2877974|NCT00270634|3582755|FG000|NOT COMPLETED|Overall Study||17
2877975|NCT00270634|3582756|FG001|NOT COMPLETED|Overall Study||13
2877976|NCT00270634|3582757|FG002|NOT COMPLETED|Overall Study||22
2877977|NCT00270634|3582758|FG003|NOT COMPLETED|Overall Study||5
2877978|NCT00270790|3582772|FG000|STARTED|Overall Study||21
2877979|NCT00270790|3582772|FG000|COMPLETED|Overall Study||16
2877980|NCT00270790|3582772|FG000|NOT COMPLETED|Overall Study||5
2877981|NCT00270842|3582779|FG000|STARTED|Overall Study||33
2877982|NCT00270842|3582780|FG001|STARTED|Overall Study||34
2877983|NCT00270842|3582781|FG002|STARTED|Overall Study||34
2877984|NCT00270842|3582779|FG000|COMPLETED|Overall Study||18
2877985|NCT00270842|3582780|FG001|COMPLETED|Overall Study||18
2877986|NCT00270842|3582781|FG002|COMPLETED|Overall Study||18
2877987|NCT00270842|3582779|FG000|NOT COMPLETED|Overall Study||15
2877988|NCT00270842|3582780|FG001|NOT COMPLETED|Overall Study||16
2877989|NCT00270842|3582781|FG002|NOT COMPLETED|Overall Study||16
2877990|NCT00270855|3582791|FG000|STARTED|Overall Study||15
2877991|NCT00270855|3582792|FG001|STARTED|Overall Study||14
2877992|NCT00270855|3582791|FG000|COMPLETED|Overall Study||7
2877993|NCT00270855|3582792|FG001|COMPLETED|Overall Study||6
2877994|NCT00270855|3582791|FG000|NOT COMPLETED|Overall Study||8
2877995|NCT00270855|3582792|FG001|NOT COMPLETED|Overall Study||8
2877996|NCT00270894|3582800|FG000|STARTED|Overall Study||30
2877997|NCT00270894|3582800|FG000|COMPLETED|Overall Study||28
2877998|NCT00270894|3582800|FG000|NOT COMPLETED|Overall Study||2
2877999|NCT00270998|3582807|FG000|STARTED|3 Month Follow-up||149
2878000|NCT00270998|3582808|FG001|STARTED|3 Month Follow-up||146
2878001|NCT00270998|3582809|FG002|STARTED|3 Month Follow-up|1 participant randomized to combined found ineligible at first treatment visit, removed from study.|150
2878002|NCT00270998|3582807|FG000|COMPLETED|3 Month Follow-up||110
2878003|NCT00270998|3582808|FG001|COMPLETED|3 Month Follow-up||124
2878004|NCT00270998|3582809|FG002|COMPLETED|3 Month Follow-up||132
2878005|NCT00270998|3582807|FG000|NOT COMPLETED|3 Month Follow-up||39
2878006|NCT00270998|3582808|FG001|NOT COMPLETED|3 Month Follow-up||22
2878007|NCT00270998|3582809|FG002|NOT COMPLETED|3 Month Follow-up||18
2878008|NCT00270998|3582807|FG000|STARTED|12 Month Follow-up||110
2878009|NCT00270998|3582808|FG001|STARTED|12 Month Follow-up||124
2878010|NCT00270998|3582809|FG002|STARTED|12 Month Follow-up||132
2878011|NCT00270998|3582807|FG000|COMPLETED|12 Month Follow-up||96
2878012|NCT00270998|3582808|FG001|COMPLETED|12 Month Follow-up||99
2878013|NCT00270998|3582809|FG002|COMPLETED|12 Month Follow-up||111
2878014|NCT00270998|3582807|FG000|NOT COMPLETED|12 Month Follow-up||14
2878015|NCT00270998|3582808|FG001|NOT COMPLETED|12 Month Follow-up||25
2878016|NCT00270998|3582809|FG002|NOT COMPLETED|12 Month Follow-up||21
2878017|NCT00271024|3582823|FG000|STARTED|Overall Study||80
2878018|NCT00271024|3582824|FG001|STARTED|Overall Study||77
2878019|NCT00271024|3582825|FG002|STARTED|Overall Study||88
2878020|NCT00271024|3582826|FG003|STARTED|Overall Study||88
2878021|NCT00271024|3582823|FG000|Received Study Treatment|Overall Study|n=4 did not start treatment (3 lost interest, 1 unknown)|76
2878022|NCT00271024|3582824|FG001|Received Study Treatment|Overall Study|n=6 did not start treatment (1 diff treat. desired, 3 lost interest, 1 began psych meds, 1 unknown)|71
2878023|NCT00271024|3582825|FG002|Received Study Treatment|Overall Study|n=3 did not start treatment (2 lost interest, 1 unknown)|85
2878024|NCT00271024|3582826|FG003|Received Study Treatment|Overall Study|n=5 did not start treatment (2 health problems, 1 wanted diff. treatment method, 2 lost interest)|83
2878025|NCT00271024|3582823|FG000|COMPLETED|Overall Study|Discontinued: 1 smoking related, 1 reaction to tablet, 6 time commitment, 2 other, 8 unspecified|58
2878026|NCT00271024|3582824|FG001|COMPLETED|Overall Study|Discontinued: 5 smoking related, 3 reaction to tablet, 2 time commitment, 1 other, 9 unspecified|51
2878027|NCT00271024|3582825|FG002|COMPLETED|Overall Study|Discontinued: 5 smoking related, 4 reaction to tablet, 4 time commitment, 3 other, 4 unspecified|65
2878028|NCT00271024|3582826|FG003|COMPLETED|Overall Study|Discontinued: 9 smoking related, 2 reaction to tablet, 4 time commitment, 1 other, 3 unspecified|64
2878029|NCT00271024|3582823|FG000|NOT COMPLETED|Overall Study||22
2878030|NCT00271024|3582824|FG001|NOT COMPLETED|Overall Study||26
2878031|NCT00271024|3582825|FG002|NOT COMPLETED|Overall Study||23
2878032|NCT00271024|3582826|FG003|NOT COMPLETED|Overall Study||24
2878033|NCT00271154|3582838|FG000|STARTED|Overall Study||191
2878034|NCT00271154|3582839|FG001|STARTED|Overall Study||419
2878035|NCT00271154|3582838|FG000|COMPLETED|Overall Study||191
2878036|NCT00271154|3582839|FG001|COMPLETED|Overall Study||419
2878037|NCT00271154|3582838|FG000|NOT COMPLETED|Overall Study||0
2878038|NCT00271154|3582839|FG001|NOT COMPLETED|Overall Study||0
2878039|NCT00271219|3582848|FG000|STARTED|Overall Study||89
2878040|NCT00271219|3582849|FG001|STARTED|Overall Study||86
2878041|NCT00271219|3582848|FG000|COMPLETED|Overall Study||73
2878042|NCT00271219|3582849|FG001|COMPLETED|Overall Study||58
2878043|NCT00271219|3582848|FG000|NOT COMPLETED|Overall Study||16
2878044|NCT00271219|3582849|FG001|NOT COMPLETED|Overall Study||28
2878045|NCT00271375|3582862|FG000|STARTED|Overall Study||114
2878046|NCT00271375|3582863|FG001|STARTED|Overall Study||83
2878047|NCT00271375|3582864|FG002|STARTED|Overall Study||57
2878048|NCT00271375|3582862|FG000|COMPLETED|Overall Study||114
2878049|NCT00271375|3582863|FG001|COMPLETED|Overall Study||83
2878050|NCT00271375|3582864|FG002|COMPLETED|Overall Study||57
2878051|NCT00271375|3582862|FG000|NOT COMPLETED|Overall Study||0
2878052|NCT00271375|3582863|FG001|NOT COMPLETED|Overall Study||0
2878053|NCT00271375|3582864|FG002|NOT COMPLETED|Overall Study||0
2878054|NCT00271505|3582873|FG000|STARTED|Overall Study||43
2878055|NCT00271505|3582873|FG000|COMPLETED|Overall Study||38
2878056|NCT00271505|3582873|FG000|NOT COMPLETED|Overall Study||5
2878057|NCT00271570|3582880|FG000|STARTED|Overall Study||12
2878058|NCT00271570|3582881|FG001|STARTED|Overall Study||12
2878059|NCT00271570|3582880|FG000|COMPLETED|Overall Study||12
2878060|NCT00271570|3582881|FG001|COMPLETED|Overall Study||12
2878061|NCT00271570|3582880|FG000|NOT COMPLETED|Overall Study||0
2878062|NCT00271570|3582881|FG001|NOT COMPLETED|Overall Study||0
2878063|NCT00271596|3582889|FG000|STARTED|Overall Study||17
2878064|NCT00271596|3582890|FG001|STARTED|Overall Study||16
2878065|NCT00271596|3582889|FG000|COMPLETED|Overall Study||16
2878066|NCT00271596|3582890|FG001|COMPLETED|Overall Study||15
2878067|NCT00271596|3582889|FG000|NOT COMPLETED|Overall Study||1
2878068|NCT00271596|3582890|FG001|NOT COMPLETED|Overall Study||1
2878069|NCT00271609|3582898|FG000|STARTED|Overall Study||56
2878070|NCT00271609|3582899|FG001|STARTED|Overall Study||32
2878071|NCT00271609|3582898|FG000|COMPLETED|Overall Study||43
2878072|NCT00271609|3582899|FG001|COMPLETED|Overall Study||29
2878073|NCT00271609|3582898|FG000|NOT COMPLETED|Overall Study||13
2878074|NCT00271609|3582899|FG001|NOT COMPLETED|Overall Study||3
2878075|NCT00271739|3582907|FG000|STARTED|Overall Study||844
2878076|NCT00271739|3582908|FG001|STARTED|Overall Study||821
2878077|NCT00271739|3582907|FG000|COMPLETED|Overall Study||729
2878078|NCT00271739|3582908|FG001|COMPLETED|Overall Study||716
2878079|NCT00271739|3582907|FG000|NOT COMPLETED|Overall Study||115
2878080|NCT00271739|3582908|FG001|NOT COMPLETED|Overall Study||105
2878081|NCT00271856|3582916|FG000|STARTED|Overall Study||89
2878082|NCT00271856|3582917|FG001|STARTED|Overall Study||88
2878083|NCT00271856|3582916|FG000|COMPLETED|Overall Study||78
2878084|NCT00271856|3582917|FG001|COMPLETED|Overall Study||70
2878085|NCT00271856|3582916|FG000|NOT COMPLETED|Overall Study||11
2878086|NCT00271856|3582917|FG001|NOT COMPLETED|Overall Study||18
2878087|NCT00272038|3582923|FG000|STARTED|Overall Study||29
2878088|NCT00272038|3582923|FG000|COMPLETED|Overall Study||22
2878089|NCT00272038|3582923|FG000|NOT COMPLETED|Overall Study||7
2878090|NCT00272168|3582930|FG000|STARTED|Overall Study||47
2878091|NCT00272168|3582931|FG001|STARTED|Overall Study||41
2878092|NCT00272168|3582930|FG000|COMPLETED|Overall Study||37
2878093|NCT00272168|3582931|FG001|COMPLETED|Overall Study||31
2878094|NCT00272168|3582930|FG000|NOT COMPLETED|Overall Study||10
2878095|NCT00272168|3582931|FG001|NOT COMPLETED|Overall Study||10
2878096|NCT00272311|3582942|FG000|STARTED|Overall Study||14
2878097|NCT00272311|3582943|FG001|STARTED|Overall Study||14
2878098|NCT00272311|3582944|FG002|STARTED|Overall Study||14
2878099|NCT00272311|3582945|FG003|STARTED|Overall Study||14
2878100|NCT00272311|3582946|FG004|STARTED|Overall Study||14
2878101|NCT00272311|3582942|FG000|COMPLETED|Overall Study||14
2878102|NCT00272311|3582943|FG001|COMPLETED|Overall Study||14
2878103|NCT00272311|3582944|FG002|COMPLETED|Overall Study||14
2878104|NCT00272311|3582945|FG003|COMPLETED|Overall Study||14
2878105|NCT00272311|3582946|FG004|COMPLETED|Overall Study||14
2878106|NCT00272311|3582942|FG000|NOT COMPLETED|Overall Study||0
2878107|NCT00272311|3582943|FG001|NOT COMPLETED|Overall Study||0
2878108|NCT00272311|3582944|FG002|NOT COMPLETED|Overall Study||0
2878109|NCT00272311|3582945|FG003|NOT COMPLETED|Overall Study||0
2878110|NCT00272311|3582946|FG004|NOT COMPLETED|Overall Study||0
2919154|NCT00530894|3629566|FG000|NOT COMPLETED|Overall Study||88
2919155|NCT00530894|3629567|FG001|NOT COMPLETED|Overall Study||115
2919156|NCT00530894|3629568|FG002|NOT COMPLETED|Overall Study||55
2919157|NCT00530894|3629569|FG003|NOT COMPLETED|Overall Study||94
2919158|NCT00530920|3629584|FG000|STARTED|Overall Study||30
2919159|NCT00530920|3629585|FG001|STARTED|Overall Study||27
2919160|NCT00530920|3629586|FG002|STARTED|Overall Study||28
2919161|NCT00530920|3629584|FG000|COMPLETED|Overall Study||30
2919162|NCT00530920|3629585|FG001|COMPLETED|Overall Study||25
2919163|NCT00530920|3629586|FG002|COMPLETED|Overall Study||24
2919164|NCT00530920|3629584|FG000|NOT COMPLETED|Overall Study||0
2919165|NCT00530920|3629585|FG001|NOT COMPLETED|Overall Study||2
2919166|NCT00530920|3629586|FG002|NOT COMPLETED|Overall Study||4
2919167|NCT00530946|3629599|FG000|STARTED|Overall Study||43
2919168|NCT00530946|3629600|FG001|STARTED|Overall Study||41
2919169|NCT00530946|3629601|FG002|STARTED|Overall Study||41
2919170|NCT00530946|3629602|FG003|STARTED|Overall Study||40
2919171|NCT00530946|3629599|FG000|COMPLETED|Overall Study||41
2919172|NCT00530946|3629600|FG001|COMPLETED|Overall Study||39
2919173|NCT00530946|3629601|FG002|COMPLETED|Overall Study||40
2919174|NCT00530946|3629602|FG003|COMPLETED|Overall Study||38
2919175|NCT00530946|3629599|FG000|NOT COMPLETED|Overall Study||2
2919176|NCT00530946|3629600|FG001|NOT COMPLETED|Overall Study||2
2919177|NCT00530946|3629601|FG002|NOT COMPLETED|Overall Study||1
2919178|NCT00530946|3629602|FG003|NOT COMPLETED|Overall Study||2
2919179|NCT00531011|3629614|FG000|STARTED|Overall Study||103
2919180|NCT00531011|3629615|FG001|STARTED|Overall Study||97
2919181|NCT00531011|3629614|FG000|COMPLETED|Overall Study||99
2919182|NCT00531011|3629615|FG001|COMPLETED|Overall Study||90
2919183|NCT00531011|3629614|FG000|NOT COMPLETED|Overall Study||4
2919184|NCT00531011|3629615|FG001|NOT COMPLETED|Overall Study||7
2919185|NCT00531050|3629627|FG000|STARTED|Part 1: Period 1||4
2919186|NCT00531050|3629628|FG001|STARTED|Part 1: Period 1||5
2919187|NCT00531050|3629629|FG002|STARTED|Part 1: Period 1||4
2919188|NCT00531050|3629630|FG003|STARTED|Part 1: Period 1||5
2919189|NCT00531050|3629631|FG004|STARTED|Part 1: Period 1||4
2919190|NCT00531050|3629632|FG005|STARTED|Part 1: Period 1||5
2919191|NCT00531050|3629627|FG000|COMPLETED|Part 1: Period 1||4
2919192|NCT00531050|3629628|FG001|COMPLETED|Part 1: Period 1||4
2919193|NCT00531050|3629629|FG002|COMPLETED|Part 1: Period 1||4
2919194|NCT00531050|3629630|FG003|COMPLETED|Part 1: Period 1||4
2919195|NCT00531050|3629631|FG004|COMPLETED|Part 1: Period 1||4
2919196|NCT00531050|3629632|FG005|COMPLETED|Part 1: Period 1||5
2919197|NCT00531050|3629627|FG000|NOT COMPLETED|Part 1: Period 1||0
2919198|NCT00531050|3629628|FG001|NOT COMPLETED|Part 1: Period 1||1
2919199|NCT00531050|3629629|FG002|NOT COMPLETED|Part 1: Period 1||0
2919200|NCT00531050|3629630|FG003|NOT COMPLETED|Part 1: Period 1||1
2919201|NCT00531050|3629631|FG004|NOT COMPLETED|Part 1: Period 1||0
2919202|NCT00531050|3629632|FG005|NOT COMPLETED|Part 1: Period 1||0
2919203|NCT00531050|3629627|FG000|STARTED|Part 1: Period 2||4
2919204|NCT00531050|3629628|FG001|STARTED|Part 1: Period 2||4
2919205|NCT00531050|3629629|FG002|STARTED|Part 1: Period 2||4
2919206|NCT00531050|3629630|FG003|STARTED|Part 1: Period 2||4
2919207|NCT00531050|3629631|FG004|STARTED|Part 1: Period 2||4
2919208|NCT00531050|3629632|FG005|STARTED|Part 1: Period 2||5
2919209|NCT00531050|3629627|FG000|COMPLETED|Part 1: Period 2||4
2919210|NCT00531050|3629628|FG001|COMPLETED|Part 1: Period 2||4
2919211|NCT00531050|3629629|FG002|COMPLETED|Part 1: Period 2||4
2919212|NCT00531050|3629630|FG003|COMPLETED|Part 1: Period 2||4
2919213|NCT00531050|3629631|FG004|COMPLETED|Part 1: Period 2||4
2919214|NCT00531050|3629632|FG005|COMPLETED|Part 1: Period 2||5
2919215|NCT00531050|3629627|FG000|NOT COMPLETED|Part 1: Period 2||0
2919216|NCT00531050|3629628|FG001|NOT COMPLETED|Part 1: Period 2||0
2919217|NCT00531050|3629629|FG002|NOT COMPLETED|Part 1: Period 2||0
2919218|NCT00531050|3629630|FG003|NOT COMPLETED|Part 1: Period 2||0
2919219|NCT00531050|3629631|FG004|NOT COMPLETED|Part 1: Period 2||0
2919220|NCT00531050|3629632|FG005|NOT COMPLETED|Part 1: Period 2||0
2919221|NCT00531050|3629627|FG000|STARTED|Part 1: Period 3||4
2919222|NCT00531050|3629628|FG001|STARTED|Part 1: Period 3||4
2919223|NCT00531050|3629629|FG002|STARTED|Part 1: Period 3||4
2919224|NCT00531050|3629630|FG003|STARTED|Part 1: Period 3||4
2919225|NCT00531050|3629631|FG004|STARTED|Part 1: Period 3||4
2919226|NCT00531050|3629632|FG005|STARTED|Part 1: Period 3||5
2919227|NCT00531050|3629627|FG000|COMPLETED|Part 1: Period 3||3
2919228|NCT00531050|3629628|FG001|COMPLETED|Part 1: Period 3||4
2919229|NCT00531050|3629629|FG002|COMPLETED|Part 1: Period 3||4
2919230|NCT00531050|3629630|FG003|COMPLETED|Part 1: Period 3||4
2919231|NCT00531050|3629631|FG004|COMPLETED|Part 1: Period 3||4
2919232|NCT00531050|3629632|FG005|COMPLETED|Part 1: Period 3||5
2919233|NCT00531050|3629627|FG000|NOT COMPLETED|Part 1: Period 3||1
2919234|NCT00531050|3629628|FG001|NOT COMPLETED|Part 1: Period 3||0
2919235|NCT00531050|3629629|FG002|NOT COMPLETED|Part 1: Period 3||0
2919236|NCT00531050|3629630|FG003|NOT COMPLETED|Part 1: Period 3||0
2919237|NCT00531050|3629631|FG004|NOT COMPLETED|Part 1: Period 3||0
2878111|NCT00272337|3582963|FG000|STARTED|Overall Study||8
2878112|NCT00272337|3582964|FG001|STARTED|Overall Study||7
2878113|NCT00272337|3582965|FG002|STARTED|Overall Study||7
2878114|NCT00272337|3582966|FG003|STARTED|Overall Study||7
2878115|NCT00272337|3582967|FG004|STARTED|Overall Study||8
2878116|NCT00272337|3582963|FG000|COMPLETED|Overall Study||8
2878117|NCT00272337|3582964|FG001|COMPLETED|Overall Study||7
2878118|NCT00272337|3582965|FG002|COMPLETED|Overall Study||7
2878119|NCT00272337|3582966|FG003|COMPLETED|Overall Study||7
2878120|NCT00272337|3582967|FG004|COMPLETED|Overall Study||8
2878121|NCT00272337|3582963|FG000|NOT COMPLETED|Overall Study||0
2878122|NCT00272337|3582964|FG001|NOT COMPLETED|Overall Study||0
2878123|NCT00272337|3582965|FG002|NOT COMPLETED|Overall Study||0
2878124|NCT00272337|3582966|FG003|NOT COMPLETED|Overall Study||0
2878125|NCT00272337|3582967|FG004|NOT COMPLETED|Overall Study||0
2878126|NCT00272779|3582981|FG000|STARTED|Baseline Through Week 48|Number of participants randomized to ATV|440
2878127|NCT00272779|3582982|FG001|STARTED|Baseline Through Week 48|Number of participants randomized to LPV|443
2878128|NCT00272779|3582981|FG000|RECEIVED ANY TREATMENT|Baseline Through Week 48|1 participant randomized to LPV received ATV instead (treatment error)|441
2878129|NCT00272779|3582982|FG001|RECEIVED ANY TREATMENT|Baseline Through Week 48|3 participants received ATV instead of LPV (treatment error), 3 participants never treated with LPV|437
2878130|NCT00272779|3582981|FG000|TREATED AS RANDOMIZED|Baseline Through Week 48||438
2878131|NCT00272779|3582982|FG001|TREATED AS RANDOMIZED|Baseline Through Week 48||440
2878132|NCT00272779|3582981|FG000|Discontinued Before Week 48|Baseline Through Week 48||39
2878133|NCT00272779|3582982|FG001|Discontinued Before Week 48|Baseline Through Week 48||58
2878134|NCT00272779|3582981|FG000|Discontinued on or After Week 48|Baseline Through Week 48||14
2878135|NCT00272779|3582982|FG001|Discontinued on or After Week 48|Baseline Through Week 48||14
2878136|NCT00272779|3582981|FG000|STILL ON TREATMENT|Baseline Through Week 48||385
2878137|NCT00272779|3582982|FG001|STILL ON TREATMENT|Baseline Through Week 48||368
2878138|NCT00272779|3582981|FG000|COMPLETED|Baseline Through Week 48||0
2878139|NCT00272779|3582982|FG001|COMPLETED|Baseline Through Week 48||0
2878140|NCT00272779|3582981|FG000|NOT COMPLETED|Baseline Through Week 48||440
2878141|NCT00272779|3582982|FG001|NOT COMPLETED|Baseline Through Week 48||443
2878142|NCT00272779|3582981|FG000|STARTED|Baseline Through Week 96|Number randomized to ATV|440
2878143|NCT00272779|3582982|FG001|STARTED|Baseline Through Week 96|Number randomized to LPV|443
2878144|NCT00272779|3582981|FG000|RECEIVED ANY TREATMENT|Baseline Through Week 96|1 participant randomized to LPV received ATV instead (treatment error)|441
2878145|NCT00272779|3582982|FG001|RECEIVED ANY TREATMENT|Baseline Through Week 96|3 participants received ATV instead of LPV (treatment error) and 3 participants never treated|437
2878146|NCT00272779|3582981|FG000|COMPLETED|Baseline Through Week 96||301
2878147|NCT00272779|3582982|FG001|COMPLETED|Baseline Through Week 96||307
2878148|NCT00272779|3582981|FG000|NOT COMPLETED|Baseline Through Week 96||139
2878149|NCT00272779|3582982|FG001|NOT COMPLETED|Baseline Through Week 96||136
2878150|NCT00272792|3582991|FG000|STARTED|Part 1: Responsiveness||90
2878151|NCT00272792|3582992|FG001|STARTED|Part 1: Responsiveness||0
2878152|NCT00272792|3582991|FG000|COMPLETED|Part 1: Responsiveness||89
2878153|NCT00272792|3582992|FG001|COMPLETED|Part 1: Responsiveness||0
2878154|NCT00272792|3582991|FG000|NOT COMPLETED|Part 1: Responsiveness||1
2878155|NCT00272792|3582992|FG001|NOT COMPLETED|Part 1: Responsiveness||0
2878156|NCT00272792|3582991|FG000|STARTED|Part 2: Blinded, Placebo Control Period||33
2878157|NCT00272792|3582992|FG001|STARTED|Part 2: Blinded, Placebo Control Period||12
2878158|NCT00272792|3582991|FG000|COMPLETED|Part 2: Blinded, Placebo Control Period||32
2878159|NCT00272792|3582992|FG001|COMPLETED|Part 2: Blinded, Placebo Control Period||9
2878160|NCT00272792|3582991|FG000|NOT COMPLETED|Part 2: Blinded, Placebo Control Period||1
2878161|NCT00272792|3582992|FG001|NOT COMPLETED|Part 2: Blinded, Placebo Control Period||3
2878162|NCT00272844|3582998|FG000|STARTED|Overall Study||23
2878163|NCT00272844|3582998|FG000|COMPLETED|Overall Study||18
2878164|NCT00272844|3582998|FG000|NOT COMPLETED|Overall Study||5
2878165|NCT00272961|3583007|FG000|STARTED|Placebo Run-in Phase: Up to Week 2||60
2878166|NCT00272961|3583008|FG001|STARTED|Placebo Run-in Phase: Up to Week 2||0
2878167|NCT00272961|3583009|FG002|STARTED|Placebo Run-in Phase: Up to Week 2||0
2878168|NCT00272961|3583010|FG003|STARTED|Placebo Run-in Phase: Up to Week 2||0
2878169|NCT00272961|3583011|FG004|STARTED|Placebo Run-in Phase: Up to Week 2||0
2878170|NCT00272961|3583007|FG000|COMPLETED|Placebo Run-in Phase: Up to Week 2||49
2878171|NCT00272961|3583008|FG001|COMPLETED|Placebo Run-in Phase: Up to Week 2||0
2878172|NCT00272961|3583009|FG002|COMPLETED|Placebo Run-in Phase: Up to Week 2||0
2878173|NCT00272961|3583010|FG003|COMPLETED|Placebo Run-in Phase: Up to Week 2||0
2878174|NCT00272961|3583011|FG004|COMPLETED|Placebo Run-in Phase: Up to Week 2||0
2878175|NCT00272961|3583007|FG000|NOT COMPLETED|Placebo Run-in Phase: Up to Week 2||11
2878176|NCT00272961|3583008|FG001|NOT COMPLETED|Placebo Run-in Phase: Up to Week 2||0
2878177|NCT00272961|3583009|FG002|NOT COMPLETED|Placebo Run-in Phase: Up to Week 2||0
2878178|NCT00272961|3583010|FG003|NOT COMPLETED|Placebo Run-in Phase: Up to Week 2||0
2878179|NCT00272961|3583011|FG004|NOT COMPLETED|Placebo Run-in Phase: Up to Week 2||0
2878180|NCT00272961|3583007|FG000|STARTED|Treatment Phase: Week 3 Up to Week 12||10
2878181|NCT00272961|3583008|FG001|STARTED|Treatment Phase: Week 3 Up to Week 12||8
2878182|NCT00272961|3583009|FG002|STARTED|Treatment Phase: Week 3 Up to Week 12||11
2878183|NCT00272961|3583010|FG003|STARTED|Treatment Phase: Week 3 Up to Week 12||10
2878184|NCT00272961|3583011|FG004|STARTED|Treatment Phase: Week 3 Up to Week 12||10
2878185|NCT00272961|3583007|FG000|COMPLETED|Treatment Phase: Week 3 Up to Week 12||8
2878186|NCT00272961|3583008|FG001|COMPLETED|Treatment Phase: Week 3 Up to Week 12||4
2878187|NCT00272961|3583009|FG002|COMPLETED|Treatment Phase: Week 3 Up to Week 12||7
2878188|NCT00272961|3583010|FG003|COMPLETED|Treatment Phase: Week 3 Up to Week 12||7
2878189|NCT00272961|3583011|FG004|COMPLETED|Treatment Phase: Week 3 Up to Week 12||6
2878190|NCT00272961|3583007|FG000|NOT COMPLETED|Treatment Phase: Week 3 Up to Week 12||2
2878191|NCT00272961|3583008|FG001|NOT COMPLETED|Treatment Phase: Week 3 Up to Week 12||4
2878192|NCT00272961|3583009|FG002|NOT COMPLETED|Treatment Phase: Week 3 Up to Week 12||4
2878193|NCT00272961|3583010|FG003|NOT COMPLETED|Treatment Phase: Week 3 Up to Week 12||3
2878194|NCT00272961|3583011|FG004|NOT COMPLETED|Treatment Phase: Week 3 Up to Week 12||4
2878195|NCT00272987|3583026|FG000|STARTED|Overall Study||29
2878196|NCT00272987|3583027|FG001|STARTED|Overall Study||14
2878197|NCT00272987|3583028|FG002|STARTED|Overall Study||20
2878198|NCT00272987|3583026|FG000|COMPLETED|Overall Study||20
2878199|NCT00272987|3583027|FG001|COMPLETED|Overall Study||10
2878200|NCT00272987|3583028|FG002|COMPLETED|Overall Study||9
2878201|NCT00272987|3583026|FG000|NOT COMPLETED|Overall Study||9
2878202|NCT00272987|3583027|FG001|NOT COMPLETED|Overall Study||4
2878203|NCT00272987|3583028|FG002|NOT COMPLETED|Overall Study||11
2878204|NCT00273052|3583038|FG000|STARTED|Overall Study||290
2878205|NCT00273052|3583039|FG001|STARTED|Overall Study||278
2878206|NCT00273052|3583038|FG000|COMPLETED|Overall Study||221
2878207|NCT00273052|3583039|FG001|COMPLETED|Overall Study||190
2878208|NCT00273052|3583038|FG000|NOT COMPLETED|Overall Study||69
2878209|NCT00273052|3583039|FG001|NOT COMPLETED|Overall Study||88
2878210|NCT00273182|3583045|FG000|STARTED|Overall Study||1999
2878211|NCT00273182|3583045|FG000|COMPLETED|Overall Study||1014
2878212|NCT00273182|3583045|FG000|NOT COMPLETED|Overall Study||985
2878213|NCT00273364|3583052|FG000|STARTED|Overall Study||55
2878214|NCT00273364|3583053|FG001|STARTED|Overall Study||55
2878215|NCT00273364|3583052|FG000|COMPLETED|Overall Study||55
2878216|NCT00273364|3583053|FG001|COMPLETED|Overall Study||55
2878217|NCT00273364|3583052|FG000|NOT COMPLETED|Overall Study||0
2878218|NCT00273364|3583053|FG001|NOT COMPLETED|Overall Study||0
2878219|NCT00273754|3583061|FG000|STARTED|Overall Study||36
2878220|NCT00273754|3583062|FG001|STARTED|Overall Study||36
2878221|NCT00273754|3583061|FG000|COMPLETED|Overall Study||36
2878222|NCT00273754|3583062|FG001|COMPLETED|Overall Study||36
2878223|NCT00273754|3583061|FG000|NOT COMPLETED|Overall Study||0
2878224|NCT00273754|3583062|FG001|NOT COMPLETED|Overall Study||0
2878225|NCT00273793|3583074|FG000|STARTED|Overall Study||36
2878226|NCT00273793|3583075|FG001|STARTED|Overall Study||38
2878227|NCT00273793|3583076|FG002|STARTED|Overall Study||18
2878228|NCT00273793|3583077|FG003|STARTED|Overall Study||60
2878229|NCT00273793|3583078|FG004|STARTED|Overall Study||58
2878230|NCT00273793|3583079|FG005|STARTED|Overall Study||29
2878231|NCT00273793|3583074|FG000|COMPLETED|Overall Study||36
2878232|NCT00273793|3583075|FG001|COMPLETED|Overall Study||38
2878233|NCT00273793|3583076|FG002|COMPLETED|Overall Study||18
2878234|NCT00273793|3583077|FG003|COMPLETED|Overall Study||60
2878235|NCT00273793|3583078|FG004|COMPLETED|Overall Study||58
2878236|NCT00273793|3583079|FG005|COMPLETED|Overall Study||29
2878237|NCT00273793|3583074|FG000|NOT COMPLETED|Overall Study||0
2878238|NCT00273793|3583075|FG001|NOT COMPLETED|Overall Study||0
2878239|NCT00273793|3583076|FG002|NOT COMPLETED|Overall Study||0
2878240|NCT00273793|3583077|FG003|NOT COMPLETED|Overall Study||0
2878241|NCT00273793|3583078|FG004|NOT COMPLETED|Overall Study||0
2878242|NCT00273793|3583079|FG005|NOT COMPLETED|Overall Study||0
2878243|NCT00273858|3583093|FG000|STARTED|Overall Study||880
2878244|NCT00273858|3583093|FG000|COMPLETED|Overall Study||343
2878245|NCT00273858|3583093|FG000|NOT COMPLETED|Overall Study||537
2878246|NCT00273910|3583103|FG000|STARTED|Overall Study||19
2878247|NCT00273910|3583104|FG001|STARTED|Overall Study||19
2878248|NCT00273910|3583105|FG002|STARTED|Overall Study||18
2878249|NCT00273910|3583106|FG003|STARTED|Overall Study||19
2878250|NCT00273910|3583107|FG004|STARTED|Overall Study||15
2878251|NCT00273910|3583108|FG005|STARTED|Overall Study||14
2878252|NCT00273910|3583103|FG000|COMPLETED|Overall Study||19
2878253|NCT00273910|3583104|FG001|COMPLETED|Overall Study||19
2878254|NCT00273910|3583105|FG002|COMPLETED|Overall Study||18
2878255|NCT00273910|3583106|FG003|COMPLETED|Overall Study||19
2878256|NCT00273910|3583107|FG004|COMPLETED|Overall Study||15
2878257|NCT00273910|3583108|FG005|COMPLETED|Overall Study||14
2878258|NCT00273910|3583103|FG000|NOT COMPLETED|Overall Study||0
2878259|NCT00273910|3583104|FG001|NOT COMPLETED|Overall Study||0
2878260|NCT00273910|3583105|FG002|NOT COMPLETED|Overall Study||0
2878261|NCT00273910|3583106|FG003|NOT COMPLETED|Overall Study||0
2878262|NCT00273910|3583107|FG004|NOT COMPLETED|Overall Study||0
2878263|NCT00273910|3583108|FG005|NOT COMPLETED|Overall Study||0
2878264|NCT00274261|3583124|FG000|STARTED|Overall Study||932
2878265|NCT00274261|3583125|FG001|STARTED|Overall Study||633
2878266|NCT00274261|3583124|FG000|COMPLETED|Overall Study||443
2878267|NCT00274261|3583125|FG001|COMPLETED|Overall Study||296
2878268|NCT00274261|3583124|FG000|NOT COMPLETED|Overall Study||489
2878269|NCT00274261|3583125|FG001|NOT COMPLETED|Overall Study||337
2878270|NCT00274287|3583133|FG000|STARTED|Overall Study||15
2878271|NCT00274287|3583133|FG000|COMPLETED|Overall Study||13
2878272|NCT00274287|3583133|FG000|NOT COMPLETED|Overall Study||2
2878273|NCT00274456|3583142|FG000|STARTED|Overall Study||76
2878274|NCT00274456|3583143|FG001|STARTED|Overall Study||76
2878275|NCT00274456|3583144|FG002|STARTED|Overall Study||74
2878276|NCT00274456|3583145|FG003|STARTED|Overall Study||74
2878277|NCT00274456|3583142|FG000|At Least One Response Assessment|Overall Study||73
2878278|NCT00274456|3583143|FG001|At Least One Response Assessment|Overall Study||76
2878279|NCT00274456|3583144|FG002|At Least One Response Assessment|Overall Study||73
2878280|NCT00274456|3583145|FG003|At Least One Response Assessment|Overall Study||70
2878281|NCT00274456|3583142|FG000|COMPLETED|Overall Study|Treatment completed upon progressive disease|39
2878282|NCT00274456|3583143|FG001|COMPLETED|Overall Study|Treatment completed upon progressive disease|49
2878283|NCT00274456|3583144|FG002|COMPLETED|Overall Study|Treatment completed upon progressive disease|39
2878284|NCT00274456|3583145|FG003|COMPLETED|Overall Study|Treatment completed upon progressive disease|29
2878285|NCT00274456|3583142|FG000|NOT COMPLETED|Overall Study||37
2878286|NCT00274456|3583143|FG001|NOT COMPLETED|Overall Study||27
2878287|NCT00274456|3583144|FG002|NOT COMPLETED|Overall Study||35
2878288|NCT00274456|3583145|FG003|NOT COMPLETED|Overall Study||45
2878289|NCT00274469|3583157|FG000|STARTED|Overall Study|Number of patients randomized|102
2878290|NCT00274469|3583158|FG001|STARTED|Overall Study|Number of patients randomized|103
2878291|NCT00274469|3583157|FG000|COMPLETED|Overall Study|Number of patients ongoing study treatment at data cut-off|23
2878292|NCT00274469|3583158|FG001|COMPLETED|Overall Study|Number of patients ongoing study treatment at data cut-off|10
2878293|NCT00274469|3583157|FG000|NOT COMPLETED|Overall Study||79
2878294|NCT00274469|3583158|FG001|NOT COMPLETED|Overall Study||93
2878295|NCT00274625|3583166|FG000|STARTED|Overall Study||199
2878296|NCT00274625|3583167|FG001|STARTED|Overall Study||203
2878297|NCT00274625|3583166|FG000|COMPLETED|Overall Study||139
2878298|NCT00274625|3583167|FG001|COMPLETED|Overall Study||141
2878299|NCT00274625|3583166|FG000|NOT COMPLETED|Overall Study||60
2878300|NCT00274625|3583167|FG001|NOT COMPLETED|Overall Study||62
2878301|NCT00274651|3583175|FG000|STARTED|Overall Study||29
2878302|NCT00274651|3583176|FG001|STARTED|Overall Study||24
2878303|NCT00274651|3583175|FG000|COMPLETED|Overall Study||1
2878304|NCT00274651|3583176|FG001|COMPLETED|Overall Study||4
2878305|NCT00274651|3583175|FG000|NOT COMPLETED|Overall Study||28
2878306|NCT00274651|3583176|FG001|NOT COMPLETED|Overall Study||20
2878307|NCT00274716|3583189|FG000|STARTED|Phase A||54
2878308|NCT00274716|3583190|FG001|STARTED|Phase A||54
2878309|NCT00274716|3583191|FG002|STARTED|Phase A||52
2878310|NCT00274716|3583192|FG003|STARTED|Phase A||51
2878311|NCT00274716|3583193|FG004|STARTED|Phase A||19
2878312|NCT00274716|3583194|FG005|STARTED|Phase A||19
2878313|NCT00274716|3583189|FG000|COMPLETED|Phase A||43
2878314|NCT00274716|3583190|FG001|COMPLETED|Phase A||44
2878315|NCT00274716|3583191|FG002|COMPLETED|Phase A||44
2878316|NCT00274716|3583192|FG003|COMPLETED|Phase A||42
2878317|NCT00274716|3583193|FG004|COMPLETED|Phase A||16
2878318|NCT00274716|3583194|FG005|COMPLETED|Phase A||15
2878319|NCT00274716|3583189|FG000|NOT COMPLETED|Phase A||11
2878320|NCT00274716|3583190|FG001|NOT COMPLETED|Phase A||10
2878321|NCT00274716|3583191|FG002|NOT COMPLETED|Phase A||8
2878322|NCT00274716|3583192|FG003|NOT COMPLETED|Phase A||9
2878323|NCT00274716|3583193|FG004|NOT COMPLETED|Phase A||3
2878324|NCT00274716|3583194|FG005|NOT COMPLETED|Phase A||4
2878325|NCT00274716|3583189|FG000|STARTED|Phase B||43
2878326|NCT00274716|3583190|FG001|STARTED|Phase B||44
2878327|NCT00274716|3583191|FG002|STARTED|Phase B||44
2878328|NCT00274716|3583192|FG003|STARTED|Phase B||42
2878329|NCT00274716|3583193|FG004|STARTED|Phase B||16
2878330|NCT00274716|3583194|FG005|STARTED|Phase B||15
2878331|NCT00274716|3583189|FG000|COMPLETED|Phase B||42
2878332|NCT00274716|3583190|FG001|COMPLETED|Phase B||40
2878333|NCT00274716|3583191|FG002|COMPLETED|Phase B||41
2878334|NCT00274716|3583192|FG003|COMPLETED|Phase B||41
2878335|NCT00274716|3583193|FG004|COMPLETED|Phase B||16
2878336|NCT00274716|3583194|FG005|COMPLETED|Phase B||14
2878337|NCT00274716|3583189|FG000|NOT COMPLETED|Phase B||1
2878338|NCT00274716|3583190|FG001|NOT COMPLETED|Phase B||4
2878339|NCT00274716|3583191|FG002|NOT COMPLETED|Phase B||3
2878340|NCT00274716|3583192|FG003|NOT COMPLETED|Phase B||1
2878341|NCT00274716|3583193|FG004|NOT COMPLETED|Phase B||0
2878342|NCT00274716|3583194|FG005|NOT COMPLETED|Phase B||1
2878343|NCT00274742|3583218|FG000|STARTED|Overall Study||12
2878344|NCT00274742|3583219|FG001|STARTED|Overall Study||13
2878345|NCT00274742|3583220|FG002|STARTED|Overall Study||6
2878346|NCT00274742|3583221|FG003|STARTED|Overall Study||9
2878347|NCT00274742|3583222|FG004|STARTED|Overall Study||32
2878348|NCT00274742|3583223|FG005|STARTED|Overall Study||4
2878349|NCT00274742|3583218|FG000|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|12
2878350|NCT00274742|3583219|FG001|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|5
2878351|NCT00274742|3583220|FG002|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|4
2878352|NCT00274742|3583221|FG003|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|4
2878353|NCT00274742|3583222|FG004|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|16
2878354|NCT00274742|3583223|FG005|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|1
2878355|NCT00274742|3583218|FG000|NOT COMPLETED|Overall Study||0
2878356|NCT00274742|3583219|FG001|NOT COMPLETED|Overall Study||8
2878357|NCT00274742|3583220|FG002|NOT COMPLETED|Overall Study||2
2878358|NCT00274742|3583221|FG003|NOT COMPLETED|Overall Study||5
2878359|NCT00274742|3583222|FG004|NOT COMPLETED|Overall Study||16
2878360|NCT00274742|3583223|FG005|NOT COMPLETED|Overall Study||3
2878361|NCT00274768|3583243|FG000|STARTED|Overall Study||26
2878362|NCT00274768|3583243|FG000|COMPLETED|Overall Study||26
2878363|NCT00274768|3583243|FG000|NOT COMPLETED|Overall Study||0
2878364|NCT00274781|3583247|FG000|STARTED|Overall Study||30
2878365|NCT00274781|3583247|FG000|COMPLETED|Overall Study||30
2878366|NCT00274781|3583247|FG000|NOT COMPLETED|Overall Study||0
2878367|NCT00274846|3583252|FG000|STARTED|Overall Study||21
2878368|NCT00274846|3583252|FG000|COMPLETED|Overall Study|Evaluable patients - received adequate natural killer (NK) cells|20
2878369|NCT00274846|3583252|FG000|NOT COMPLETED|Overall Study||1
2878370|NCT00274924|3583260|FG000|STARTED|Step 1 (R-CHOP X 3 Cycles)||17
2878371|NCT00274924|3583261|FG001|STARTED|Step 1 (R-CHOP X 3 Cycles)||77
2878372|NCT00274924|3583262|FG002|STARTED|Step 1 (R-CHOP X 3 Cycles)||6
2878373|NCT00274924|3583260|FG000|Treated|Step 1 (R-CHOP X 3 Cycles)||17
2878374|NCT00274924|3583261|FG001|Treated|Step 1 (R-CHOP X 3 Cycles)||77
2878375|NCT00274924|3583262|FG002|Treated|Step 1 (R-CHOP X 3 Cycles)||5
2878376|NCT00274924|3583260|FG000|Eligible and Treated|Step 1 (R-CHOP X 3 Cycles)||13
2878377|NCT00274924|3583261|FG001|Eligible and Treated|Step 1 (R-CHOP X 3 Cycles)||63
2878378|NCT00274924|3583262|FG002|Eligible and Treated|Step 1 (R-CHOP X 3 Cycles)||4
2878379|NCT00274924|3583260|FG000|COMPLETED|Step 1 (R-CHOP X 3 Cycles)||13
2878380|NCT00274924|3583261|FG001|COMPLETED|Step 1 (R-CHOP X 3 Cycles)||63
2878381|NCT00274924|3583262|FG002|COMPLETED|Step 1 (R-CHOP X 3 Cycles)||0
2878382|NCT00274924|3583260|FG000|NOT COMPLETED|Step 1 (R-CHOP X 3 Cycles)||4
2878383|NCT00274924|3583261|FG001|NOT COMPLETED|Step 1 (R-CHOP X 3 Cycles)||14
2878384|NCT00274924|3583262|FG002|NOT COMPLETED|Step 1 (R-CHOP X 3 Cycles)||6
2878385|NCT00274924|3583260|FG000|STARTED|Step 2 (Tx Based on Mid-treatment PET)|All patients who started step 2 therapy were included regardless of eligibility.|17
2878386|NCT00274924|3583261|FG001|STARTED|Step 2 (Tx Based on Mid-treatment PET)|One patient withdrew from the study after step 1 treatment.|76
2878387|NCT00274924|3583262|FG002|STARTED|Step 2 (Tx Based on Mid-treatment PET)||0
2878388|NCT00274924|3583260|FG000|Eligible and Treated|Step 2 (Tx Based on Mid-treatment PET)||13
2878389|NCT00274924|3583261|FG001|Eligible and Treated|Step 2 (Tx Based on Mid-treatment PET)||61
2878390|NCT00274924|3583262|FG002|Eligible and Treated|Step 2 (Tx Based on Mid-treatment PET)||0
2878391|NCT00274924|3583260|FG000|COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||10
2878392|NCT00274924|3583261|FG001|COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||58
2878393|NCT00274924|3583262|FG002|COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||0
2878394|NCT00274924|3583260|FG000|NOT COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||7
2878395|NCT00274924|3583261|FG001|NOT COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||18
2878396|NCT00274924|3583262|FG002|NOT COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||0
2878397|NCT00274937|3583269|FG000|STARTED|Overall Study||111
2878398|NCT00274937|3583269|FG000|COMPLETED|Overall Study||91
2878399|NCT00274937|3583269|FG000|NOT COMPLETED|Overall Study||20
2878400|NCT00275002|3583275|FG000|STARTED|Overall Study||25
2878401|NCT00275002|3583276|FG001|STARTED|Overall Study||16
2878402|NCT00275002|3583275|FG000|COMPLETED|Overall Study||3
2878403|NCT00275002|3583276|FG001|COMPLETED|Overall Study||0
2878404|NCT00275002|3583275|FG000|NOT COMPLETED|Overall Study||22
2878405|NCT00275002|3583276|FG001|NOT COMPLETED|Overall Study||16
2878406|NCT00275028|3583282|FG000|STARTED|Overall Study||47
2878407|NCT00275028|3583282|FG000|COMPLETED|Overall Study|Participants are treated until one of the below milestones is reached. Completion is N/A.|0
2878408|NCT00275028|3583282|FG000|NOT COMPLETED|Overall Study||47
2878409|NCT00275262|3583288|FG000|STARTED|Overall Study||12
2878410|NCT00275262|3583289|FG001|STARTED|Overall Study||13
2878411|NCT00275262|3583288|FG000|COMPLETED|Overall Study|Patients who completed the entire 12 month study period|6
2878412|NCT00275262|3583289|FG001|COMPLETED|Overall Study|Patients who completed the entire 12 month study period|4
2878413|NCT00275262|3583288|FG000|NOT COMPLETED|Overall Study||6
2878414|NCT00275262|3583289|FG001|NOT COMPLETED|Overall Study||9
2878415|NCT00275275|3583298|FG000|STARTED|Overall Study||20
2878416|NCT00275275|3583299|FG001|STARTED|Overall Study||20
2878417|NCT00275275|3583300|FG002|STARTED|Overall Study|One participant was removed after enrollment and before any data was collected for him.|21
2878418|NCT00275275|3583298|FG000|COMPLETED|Overall Study||14
2878419|NCT00275275|3583299|FG001|COMPLETED|Overall Study||18
2878420|NCT00275275|3583300|FG002|COMPLETED|Overall Study||15
2878421|NCT00275275|3583298|FG000|NOT COMPLETED|Overall Study||6
2878422|NCT00275275|3583299|FG001|NOT COMPLETED|Overall Study||2
2878423|NCT00275275|3583300|FG002|NOT COMPLETED|Overall Study||6
2878424|NCT00275301|3583308|FG000|STARTED|Overall Study||19
2878425|NCT00275301|3583308|FG000|COMPLETED|Overall Study||14
2878426|NCT00275301|3583308|FG000|NOT COMPLETED|Overall Study||5
2878427|NCT00275392|3583314|FG000|STARTED|Overall Study||20
2878428|NCT00275392|3583315|FG001|STARTED|Overall Study||19
2878429|NCT00275392|3583314|FG000|COMPLETED|Overall Study||20
2878430|NCT00275392|3583315|FG001|COMPLETED|Overall Study||17
2878431|NCT00275392|3583314|FG000|NOT COMPLETED|Overall Study||0
2878432|NCT00275392|3583315|FG001|NOT COMPLETED|Overall Study||2
2878433|NCT00275509|3583323|FG000|STARTED|Overall Study||30
2878434|NCT00275509|3583324|FG001|STARTED|Overall Study||26
2878435|NCT00275509|3583323|FG000|COMPLETED|Overall Study||30
2878436|NCT00275509|3583324|FG001|COMPLETED|Overall Study||25
2878437|NCT00275509|3583323|FG000|NOT COMPLETED|Overall Study||0
2878438|NCT00275509|3583324|FG001|NOT COMPLETED|Overall Study||1
2878439|NCT00275561|3583332|FG000|STARTED|Overall Study||21
2878440|NCT00275561|3583333|FG001|STARTED|Overall Study||21
2878441|NCT00275561|3583332|FG000|COMPLETED|Overall Study||19
2878442|NCT00275561|3583333|FG001|COMPLETED|Overall Study||15
2878443|NCT00275561|3583332|FG000|NOT COMPLETED|Overall Study||2
2878444|NCT00275561|3583333|FG001|NOT COMPLETED|Overall Study||6
2878445|NCT00275821|3583342|FG000|STARTED|Overall Study||120
2878446|NCT00275821|3583343|FG001|STARTED|Overall Study||118
2878447|NCT00275821|3583344|FG002|STARTED|Overall Study||115
2878448|NCT00275821|3583342|FG000|COMPLETED|Overall Study||106
2878449|NCT00275821|3583343|FG001|COMPLETED|Overall Study||95
2878450|NCT00275821|3583344|FG002|COMPLETED|Overall Study||103
2878451|NCT00275821|3583342|FG000|NOT COMPLETED|Overall Study||14
2878452|NCT00275821|3583343|FG001|NOT COMPLETED|Overall Study||23
2878453|NCT00275821|3583344|FG002|NOT COMPLETED|Overall Study||12
2878454|NCT00275834|3583355|FG000|STARTED|Overall Study||74
2878455|NCT00275834|3583356|FG001|STARTED|Overall Study||76
2878456|NCT00275834|3583357|FG002|STARTED|Overall Study||75
2878457|NCT00275834|3583355|FG000|Completed Study While on Study Drug|Overall Study||54
2878458|NCT00275834|3583356|FG001|Completed Study While on Study Drug|Overall Study||51
2878459|NCT00275834|3583357|FG002|Completed Study While on Study Drug|Overall Study||62
2878460|NCT00275834|3583355|FG000|COMPLETED|Overall Study||71
2878461|NCT00275834|3583356|FG001|COMPLETED|Overall Study||73
2878462|NCT00275834|3583357|FG002|COMPLETED|Overall Study||74
2878463|NCT00275834|3583355|FG000|NOT COMPLETED|Overall Study||3
2878464|NCT00275834|3583356|FG001|NOT COMPLETED|Overall Study||3
2878465|NCT00275834|3583357|FG002|NOT COMPLETED|Overall Study||1
2878466|NCT00276094|3583370|FG000|STARTED|Overall Study||282
2878467|NCT00276094|3583371|FG001|STARTED|Overall Study||276
2878468|NCT00276094|3583372|FG002|STARTED|Overall Study||268
2878469|NCT00276094|3583370|FG000|COMPLETED|Overall Study||225
2878470|NCT00276094|3583371|FG001|COMPLETED|Overall Study||234
2878471|NCT00276094|3583372|FG002|COMPLETED|Overall Study||230
2878472|NCT00276094|3583370|FG000|NOT COMPLETED|Overall Study||57
2878473|NCT00276094|3583371|FG001|NOT COMPLETED|Overall Study||42
2878474|NCT00276094|3583372|FG002|NOT COMPLETED|Overall Study||38
2878475|NCT00276159|3583380|FG000|STARTED|Overall Study||6
2878476|NCT00276159|3583380|FG000|COMPLETED|Overall Study||0
2878477|NCT00276159|3583380|FG000|NOT COMPLETED|Overall Study||6
2878478|NCT00276250|3583387|FG000|STARTED|Overall Study||4
2878479|NCT00276250|3583388|FG001|STARTED|Overall Study||1
2878480|NCT00276250|3583389|FG002|STARTED|Overall Study||0
2878481|NCT00276250|3583387|FG000|COMPLETED|Overall Study||4
2878482|NCT00276250|3583388|FG001|COMPLETED|Overall Study||1
2878483|NCT00276250|3583389|FG002|COMPLETED|Overall Study||0
2878484|NCT00276250|3583387|FG000|NOT COMPLETED|Overall Study||0
2878485|NCT00276250|3583388|FG001|NOT COMPLETED|Overall Study||0
2878486|NCT00276250|3583389|FG002|NOT COMPLETED|Overall Study||0
2878487|NCT00276380|3583399|FG000|STARTED|Overall Study||102
2878488|NCT00276380|3583400|FG001|STARTED|Overall Study||102
2878489|NCT00276380|3583399|FG000|COMPLETED|Overall Study||88
2878490|NCT00276380|3583400|FG001|COMPLETED|Overall Study||88
2878491|NCT00276380|3583399|FG000|NOT COMPLETED|Overall Study||14
2878492|NCT00276380|3583400|FG001|NOT COMPLETED|Overall Study||14
2878493|NCT00276406|3583409|FG000|STARTED|Overall Study||16
2878494|NCT00276406|3583410|FG001|STARTED|Overall Study||14
2878495|NCT00276406|3583409|FG000|COMPLETED|Overall Study|14 of 16 subjects tolerated 360mg daily, while 2 of 16 tolerated 180mg daily.|16
2878496|NCT00276406|3583410|FG001|COMPLETED|Overall Study||14
2878497|NCT00276406|3583409|FG000|NOT COMPLETED|Overall Study||0
2878498|NCT00276406|3583410|FG001|NOT COMPLETED|Overall Study||0
2878499|NCT00276549|3583416|FG000|STARTED|Overall Study||35
2878500|NCT00276549|3583416|FG000|COMPLETED|Overall Study||35
2878501|NCT00276549|3583416|FG000|NOT COMPLETED|Overall Study||0
2878502|NCT00276614|3583420|FG000|STARTED|Overall Study||4
2878503|NCT00276614|3583420|FG000|COMPLETED|Overall Study||1
2878504|NCT00276614|3583420|FG000|NOT COMPLETED|Overall Study||3
2878505|NCT00276744|3583424|FG000|STARTED|PART A||240
2878506|NCT00276744|3583424|FG000|COMPLETED|PART A||142
2878507|NCT00276744|3583424|FG000|NOT COMPLETED|PART A||98
2878508|NCT00276744|3583424|FG000|STARTED|PART B|This study was terminated before participants could reach this stage of the study.|0
2878509|NCT00276744|3583424|FG000|COMPLETED|PART B||0
2878510|NCT00276744|3583424|FG000|NOT COMPLETED|PART B||0
2878511|NCT00276861|3583428|FG000|STARTED|Overall Study||10
2878512|NCT00276861|3583428|FG000|COMPLETED|Overall Study||10
2878513|NCT00276861|3583428|FG000|NOT COMPLETED|Overall Study||0
2878514|NCT00277095|3583433|FG000|STARTED|Overall Study|Anatomy of 1 patient did not allow ProACT to be implanted, hence only 123 patients were implanted.|124
3169887|NCT01928381|3897369|FG002|COMPLETED|Washout First Intervention||4
3169888|NCT01928381|3897370|FG003|COMPLETED|Washout First Intervention||5
3169889|NCT01928381|3897371|FG004|COMPLETED|Washout First Intervention||3
3169890|NCT01928381|3897372|FG005|COMPLETED|Washout First Intervention||5
3169891|NCT01928381|3897373|FG006|COMPLETED|Washout First Intervention||5
2878515|NCT00277095|3583433|FG000|COMPLETED|Overall Study|Details of patients who did not complete study are given below.|103
2878516|NCT00277095|3583433|FG000|NOT COMPLETED|Overall Study||21
2878517|NCT00277212|3583437|FG000|STARTED|Phase 1 - Single-Blind Treatment||787
2878518|NCT00277212|3583438|FG001|STARTED|Phase 1 - Single-Blind Treatment||0
2878519|NCT00277212|3583439|FG002|STARTED|Phase 1 - Single-Blind Treatment||0
2878520|NCT00277212|3583437|FG000|Phase 1 Safety Sample|Phase 1 - Single-Blind Treatment||787
2878521|NCT00277212|3583438|FG001|Phase 1 Safety Sample|Phase 1 - Single-Blind Treatment||0
2878522|NCT00277212|3583439|FG002|Phase 1 Safety Sample|Phase 1 - Single-Blind Treatment||0
2878523|NCT00277212|3583437|FG000|Phase 1 Efficacy Sample|Phase 1 - Single-Blind Treatment||756
2878524|NCT00277212|3583438|FG001|Phase 1 Efficacy Sample|Phase 1 - Single-Blind Treatment||0
2878525|NCT00277212|3583439|FG002|Phase 1 Efficacy Sample|Phase 1 - Single-Blind Treatment||0
3169892|NCT01928381|3897367|FG000|NOT COMPLETED|Washout First Intervention||0
3169893|NCT01928381|3897368|FG001|NOT COMPLETED|Washout First Intervention||0
3169894|NCT01928381|3897369|FG002|NOT COMPLETED|Washout First Intervention||0
3169895|NCT01928381|3897370|FG003|NOT COMPLETED|Washout First Intervention||0
3169896|NCT01928381|3897371|FG004|NOT COMPLETED|Washout First Intervention||1
2878526|NCT00277212|3583437|FG000|COMPLETED|Phase 1 - Single-Blind Treatment||352
2878527|NCT00277212|3583438|FG001|COMPLETED|Phase 1 - Single-Blind Treatment||0
2878528|NCT00277212|3583439|FG002|COMPLETED|Phase 1 - Single-Blind Treatment||0
2878529|NCT00277212|3583437|FG000|NOT COMPLETED|Phase 1 - Single-Blind Treatment||435
2878530|NCT00277212|3583438|FG001|NOT COMPLETED|Phase 1 - Single-Blind Treatment||0
2878531|NCT00277212|3583439|FG002|NOT COMPLETED|Phase 1 - Single-Blind Treatment||0
2878532|NCT00277212|3583437|FG000|STARTED|Phase 2 - Double-Blind Treatment||0
2878533|NCT00277212|3583438|FG001|STARTED|Phase 2 - Double-Blind Treatment||173
2878534|NCT00277212|3583439|FG002|STARTED|Phase 2 - Double-Blind Treatment|1 participant did not want to continue in the study for personal reasons, and did not enter Phase 2.|178
2878535|NCT00277212|3583437|FG000|Phase 2 Safety Sample|Phase 2 - Double-Blind Treatment||0
2878536|NCT00277212|3583438|FG001|Phase 2 Safety Sample|Phase 2 - Double-Blind Treatment||165
2878537|NCT00277212|3583439|FG002|Phase 2 Safety Sample|Phase 2 - Double-Blind Treatment||176
2878538|NCT00277212|3583437|FG000|Phase 2 Efficacy Sample|Phase 2 - Double-Blind Treatment||0
2878539|NCT00277212|3583438|FG001|Phase 2 Efficacy Sample|Phase 2 - Double-Blind Treatment||164
2878540|NCT00277212|3583439|FG002|Phase 2 Efficacy Sample|Phase 2 - Double-Blind Treatment||174
2878541|NCT00277212|3583437|FG000|COMPLETED|Phase 2 - Double-Blind Treatment||0
2878542|NCT00277212|3583438|FG001|COMPLETED|Phase 2 - Double-Blind Treatment||53
2878543|NCT00277212|3583439|FG002|COMPLETED|Phase 2 - Double-Blind Treatment||65
2878544|NCT00277212|3583437|FG000|NOT COMPLETED|Phase 2 - Double-Blind Treatment||0
2878545|NCT00277212|3583438|FG001|NOT COMPLETED|Phase 2 - Double-Blind Treatment||120
2878546|NCT00277212|3583439|FG002|NOT COMPLETED|Phase 2 - Double-Blind Treatment||113
2878547|NCT00277355|3583449|FG000|STARTED|Overall Study||87
2878548|NCT00277355|3583450|FG001|STARTED|Overall Study||27
2878549|NCT00277355|3583449|FG000|COMPLETED|Overall Study||73
2878550|NCT00277355|3583450|FG001|COMPLETED|Overall Study||22
2878551|NCT00277355|3583449|FG000|NOT COMPLETED|Overall Study||14
2878552|NCT00277355|3583450|FG001|NOT COMPLETED|Overall Study||5
2878553|NCT00277394|3583459|FG000|STARTED|Overall Study||269
2878554|NCT00277394|3583460|FG001|STARTED|Overall Study||270
2878555|NCT00277394|3583459|FG000|COMPLETED|Overall Study||232
2878556|NCT00277394|3583460|FG001|COMPLETED|Overall Study||246
2878557|NCT00277394|3583459|FG000|NOT COMPLETED|Overall Study||37
2878558|NCT00277394|3583460|FG001|NOT COMPLETED|Overall Study||24
2878559|NCT00277446|3583466|FG000|STARTED|Overall Study||13
2878560|NCT00277446|3583466|FG000|COMPLETED|Overall Study||13
2878561|NCT00277446|3583466|FG000|NOT COMPLETED|Overall Study||0
2878562|NCT00277524|3583470|FG000|STARTED|Overall Study||621
2878563|NCT00277524|3583471|FG001|STARTED|Overall Study||324
2878564|NCT00277524|3583472|FG002|STARTED|Overall Study||1088
2878565|NCT00277524|3583473|FG003|STARTED|Overall Study||850
2878566|NCT00277524|3583470|FG000|COMPLETED|Overall Study||621
2878567|NCT00277524|3583471|FG001|COMPLETED|Overall Study||324
2878568|NCT00277524|3583472|FG002|COMPLETED|Overall Study||1088
2878569|NCT00277524|3583473|FG003|COMPLETED|Overall Study||850
2878570|NCT00277524|3583470|FG000|NOT COMPLETED|Overall Study||0
2878571|NCT00277524|3583471|FG001|NOT COMPLETED|Overall Study||0
2878572|NCT00277524|3583472|FG002|NOT COMPLETED|Overall Study||0
2878573|NCT00277524|3583473|FG003|NOT COMPLETED|Overall Study||0
2878574|NCT00278109|3583491|FG000|STARTED|Overall Study||25
2878575|NCT00278109|3583491|FG000|Completed 3 Cycles of Chemotherapy|Overall Study||25
2878576|NCT00278109|3583491|FG000|COMPLETED|Overall Study||21
2878577|NCT00278109|3583491|FG000|NOT COMPLETED|Overall Study||4
2878578|NCT00278148|3583495|FG000|STARTED|Phase I - Dose Escalation||4
2878579|NCT00278148|3583496|FG001|STARTED|Phase I - Dose Escalation||2
2878580|NCT00278148|3583497|FG002|STARTED|Phase I - Dose Escalation||3
2878581|NCT00278148|3583495|FG000|COMPLETED|Phase I - Dose Escalation||4
2878582|NCT00278148|3583496|FG001|COMPLETED|Phase I - Dose Escalation||2
2878583|NCT00278148|3583497|FG002|COMPLETED|Phase I - Dose Escalation||3
2878584|NCT00278148|3583495|FG000|NOT COMPLETED|Phase I - Dose Escalation||0
2878585|NCT00278148|3583496|FG001|NOT COMPLETED|Phase I - Dose Escalation||0
2878586|NCT00278148|3583497|FG002|NOT COMPLETED|Phase I - Dose Escalation||0
2878587|NCT00278148|3583495|FG000|STARTED|Phase II - Expansion Phase||0
2878588|NCT00278148|3583496|FG001|STARTED|Phase II - Expansion Phase||0
2878589|NCT00278148|3583497|FG002|STARTED|Phase II - Expansion Phase|Includes the 3 participants from phase I|26
2878590|NCT00278148|3583495|FG000|COMPLETED|Phase II - Expansion Phase||0
2878591|NCT00278148|3583496|FG001|COMPLETED|Phase II - Expansion Phase||0
2878592|NCT00278148|3583497|FG002|COMPLETED|Phase II - Expansion Phase||20
2878593|NCT00278148|3583495|FG000|NOT COMPLETED|Phase II - Expansion Phase||0
2878594|NCT00278148|3583496|FG001|NOT COMPLETED|Phase II - Expansion Phase||0
2878595|NCT00278148|3583497|FG002|NOT COMPLETED|Phase II - Expansion Phase||6
2878596|NCT00278161|3583504|FG000|STARTED|Overall Study||81
2878597|NCT00278161|3583504|FG000|COMPLETED|Overall Study||70
2878598|NCT00278161|3583504|FG000|NOT COMPLETED|Overall Study||11
2878599|NCT00278200|3583510|FG000|STARTED|Overall Study||2
2878600|NCT00278200|3583511|FG001|STARTED|Overall Study||12
2878601|NCT00278200|3583510|FG000|COMPLETED|Overall Study||1
2878602|NCT00278200|3583511|FG001|COMPLETED|Overall Study||8
3169897|NCT01928381|3897372|FG005|NOT COMPLETED|Washout First Intervention||0
2878603|NCT00278200|3583510|FG000|NOT COMPLETED|Overall Study||1
2878604|NCT00278200|3583511|FG001|NOT COMPLETED|Overall Study||4
2878605|NCT00278395|3583517|FG000|STARTED|Overall Study||14
2878606|NCT00278395|3583517|FG000|COMPLETED|Overall Study||11
2878607|NCT00278395|3583517|FG000|NOT COMPLETED|Overall Study||3
2878608|NCT00278473|3583526|FG000|STARTED|Overall Study||45
2878609|NCT00278473|3583527|FG001|STARTED|Overall Study||43
2878610|NCT00278473|3583526|FG000|COMPLETED|Overall Study||41
2878611|NCT00278473|3583527|FG001|COMPLETED|Overall Study||40
2878612|NCT00278473|3583526|FG000|NOT COMPLETED|Overall Study||4
2878613|NCT00278473|3583527|FG001|NOT COMPLETED|Overall Study||3
2878614|NCT00278512|3583535|FG000|STARTED|Overall Study||7
2878615|NCT00278512|3583536|FG001|STARTED|Overall Study||0
2878616|NCT00278512|3583535|FG000|COMPLETED|Overall Study||6
2878617|NCT00278512|3583536|FG001|COMPLETED|Overall Study||0
2878618|NCT00278512|3583535|FG000|NOT COMPLETED|Overall Study||1
2878619|NCT00278512|3583536|FG001|NOT COMPLETED|Overall Study||0
2878620|NCT00278525|3583544|FG000|STARTED|Overall Study||9
2878621|NCT00278525|3583545|FG001|STARTED|Overall Study||10
2878622|NCT00278525|3583544|FG000|COMPLETED|Overall Study|7 participants crossed to HSCT arm in accordance with the protocol|9
2878623|NCT00278525|3583545|FG001|COMPLETED|Overall Study|7 participant crossed over to the HSCT arm and underwent HSCT, in accordance with the protocol.|10
2878624|NCT00278525|3583544|FG000|NOT COMPLETED|Overall Study||0
2878625|NCT00278525|3583545|FG001|NOT COMPLETED|Overall Study||0
2878626|NCT00278538|3583551|FG000|STARTED|Overall Study||32
2878627|NCT00278538|3583551|FG000|COMPLETED|Overall Study||30
2878628|NCT00278538|3583551|FG000|NOT COMPLETED|Overall Study||2
2878629|NCT00278564|3583555|FG000|STARTED|Overall Study||7
2878630|NCT00278564|3583555|FG000|COMPLETED|Overall Study||3
2878631|NCT00278564|3583555|FG000|NOT COMPLETED|Overall Study||4
2878632|NCT00278629|3583559|FG000|STARTED|Overall Study||80
2878633|NCT00278629|3583559|FG000|COMPLETED|Overall Study||66
2878634|NCT00278629|3583559|FG000|NOT COMPLETED|Overall Study||14
2878635|NCT00278655|3583564|FG000|STARTED|Overall Study||21
2878636|NCT00278655|3583564|FG000|COMPLETED|Overall Study||21
2878637|NCT00278655|3583564|FG000|NOT COMPLETED|Overall Study||0
2878638|NCT00278863|3583571|FG000|STARTED|Overall Study||49
2878639|NCT00278863|3583572|FG001|STARTED|Overall Study||47
2878640|NCT00278863|3583571|FG000|COMPLETED|Overall Study||44
2878641|NCT00278863|3583572|FG001|COMPLETED|Overall Study||45
2878642|NCT00278863|3583571|FG000|NOT COMPLETED|Overall Study||5
2878643|NCT00278863|3583572|FG001|NOT COMPLETED|Overall Study||2
2878644|NCT00278876|3583578|FG000|STARTED|Overall Study||47
2878645|NCT00278876|3583578|FG000|COMPLETED|Overall Study||38
2878646|NCT00278876|3583578|FG000|NOT COMPLETED|Overall Study||9
2878647|NCT00278889|3583585|FG000|STARTED|Overall Study|Randomised|73
2878648|NCT00278889|3583586|FG001|STARTED|Overall Study|Randomised|74
2878649|NCT00278889|3583587|FG002|STARTED|Overall Study|Randomised|68
2878650|NCT00278889|3583585|FG000|Overall Survival Analysis|Overall Study|Ongoing at data cut-off for OS analysis (30 January 2009)|16
2878651|NCT00278889|3583586|FG001|Overall Survival Analysis|Overall Study|Ongoing at data cut-off for OS analysis (30 January 2009)|20
2878652|NCT00278889|3583587|FG002|Overall Survival Analysis|Overall Study|Ongoing at data cut-off for OS analysis (30 January 2009)|19
2878653|NCT00278889|3583585|FG000|COMPLETED|Overall Study|Ongoing at data cut-off for PFS analysis (November 2007)|48
2878654|NCT00278889|3583586|FG001|COMPLETED|Overall Study|Ongoing at data cut-off for PFS analysis (November 2007)|47
2878655|NCT00278889|3583587|FG002|COMPLETED|Overall Study|Ongoing at data cut-off for PFS analysis (November 2007)|48
2878656|NCT00278889|3583585|FG000|NOT COMPLETED|Overall Study||25
2878657|NCT00278889|3583586|FG001|NOT COMPLETED|Overall Study||27
2878658|NCT00278889|3583587|FG002|NOT COMPLETED|Overall Study||20
2878662|NCT00278954|3583599|FG000|STARTED|Overall Study||50
2878663|NCT00278954|3583599|FG000|COMPLETED|Overall Study||45
2878664|NCT00278954|3583599|FG000|NOT COMPLETED|Overall Study||5
2878665|NCT00278993|3583603|FG000|STARTED|Overall Study||108
2878666|NCT00278993|3583603|FG000|COMPLETED|Overall Study||1
2878667|NCT00278993|3583603|FG000|NOT COMPLETED|Overall Study||107
2878668|NCT00279201|3583609|FG000|STARTED|Initiation||1046
2878669|NCT00279201|3583610|FG001|STARTED|Initiation||1045
2878670|NCT00279201|3583611|FG002|STARTED|Initiation||0
2878671|NCT00279201|3583612|FG003|STARTED|Initiation||0
2878672|NCT00279201|3583613|FG004|STARTED|Initiation||0
2878673|NCT00279201|3583614|FG005|STARTED|Initiation||0
2878674|NCT00279201|3583609|FG000|COMPLETED|Initiation||918
2878675|NCT00279201|3583610|FG001|COMPLETED|Initiation||900
2878676|NCT00279201|3583611|FG002|COMPLETED|Initiation||0
2878677|NCT00279201|3583612|FG003|COMPLETED|Initiation||0
2878678|NCT00279201|3583613|FG004|COMPLETED|Initiation||0
2878679|NCT00279201|3583614|FG005|COMPLETED|Initiation||0
2878680|NCT00279201|3583609|FG000|NOT COMPLETED|Initiation||128
2878681|NCT00279201|3583610|FG001|NOT COMPLETED|Initiation||145
2878682|NCT00279201|3583611|FG002|NOT COMPLETED|Initiation||0
2878683|NCT00279201|3583612|FG003|NOT COMPLETED|Initiation||0
2878684|NCT00279201|3583613|FG004|NOT COMPLETED|Initiation||0
2878685|NCT00279201|3583614|FG005|NOT COMPLETED|Initiation||0
2878686|NCT00279201|3583609|FG000|STARTED|Maintenance|100 left the study after initiation. 399 had HbA1c>7% and enrolled in intensification addendum.|419
2919238|NCT00531050|3629632|FG005|NOT COMPLETED|Part 1: Period 3||0
2878687|NCT00279201|3583610|FG001|STARTED|Maintenance|82 left the study after initiation. 345 had HbA1c>7% and enrolled in intensification addendum.|473
2878688|NCT00279201|3583611|FG002|STARTED|Maintenance||0
2878689|NCT00279201|3583612|FG003|STARTED|Maintenance||0
2878690|NCT00279201|3583613|FG004|STARTED|Maintenance||0
2878691|NCT00279201|3583614|FG005|STARTED|Maintenance||0
2878692|NCT00279201|3583609|FG000|COMPLETED|Maintenance||188
2878693|NCT00279201|3583610|FG001|COMPLETED|Maintenance||239
2878694|NCT00279201|3583611|FG002|COMPLETED|Maintenance||0
2878695|NCT00279201|3583612|FG003|COMPLETED|Maintenance||0
2878696|NCT00279201|3583613|FG004|COMPLETED|Maintenance||0
2878697|NCT00279201|3583614|FG005|COMPLETED|Maintenance||0
2878698|NCT00279201|3583609|FG000|NOT COMPLETED|Maintenance||231
2878699|NCT00279201|3583610|FG001|NOT COMPLETED|Maintenance||234
2878700|NCT00279201|3583611|FG002|NOT COMPLETED|Maintenance||0
2878701|NCT00279201|3583612|FG003|NOT COMPLETED|Maintenance||0
2878702|NCT00279201|3583613|FG004|NOT COMPLETED|Maintenance||0
2878703|NCT00279201|3583614|FG005|NOT COMPLETED|Maintenance||0
2878704|NCT00279201|3583609|FG000|STARTED|Intensification Addendum||0
2878705|NCT00279201|3583610|FG001|STARTED|Intensification Addendum||0
2878706|NCT00279201|3583611|FG002|STARTED|Intensification Addendum||174
2878707|NCT00279201|3583612|FG003|STARTED|Intensification Addendum||200
2878708|NCT00279201|3583613|FG004|STARTED|Intensification Addendum||171
2878709|NCT00279201|3583614|FG005|STARTED|Intensification Addendum||199
2878710|NCT00279201|3583609|FG000|COMPLETED|Intensification Addendum||0
2878711|NCT00279201|3583610|FG001|COMPLETED|Intensification Addendum||0
2878712|NCT00279201|3583611|FG002|COMPLETED|Intensification Addendum||151
2878713|NCT00279201|3583612|FG003|COMPLETED|Intensification Addendum||172
2878714|NCT00279201|3583613|FG004|COMPLETED|Intensification Addendum||142
2878715|NCT00279201|3583614|FG005|COMPLETED|Intensification Addendum||162
2878716|NCT00279201|3583609|FG000|NOT COMPLETED|Intensification Addendum||0
2878717|NCT00279201|3583610|FG001|NOT COMPLETED|Intensification Addendum||0
2878718|NCT00279201|3583611|FG002|NOT COMPLETED|Intensification Addendum||23
2878719|NCT00279201|3583612|FG003|NOT COMPLETED|Intensification Addendum||28
2878720|NCT00279201|3583613|FG004|NOT COMPLETED|Intensification Addendum||29
2878721|NCT00279201|3583614|FG005|NOT COMPLETED|Intensification Addendum||37
2878722|NCT00279214|3583649|FG000|STARTED|Overall Study||22
2878723|NCT00279214|3583650|FG001|STARTED|Overall Study||21
2878724|NCT00279214|3583649|FG000|COMPLETED|Overall Study|Completed means the number of per-protocol patients in the study|19
2878725|NCT00279214|3583650|FG001|COMPLETED|Overall Study|Completed means the number of per-protocol patients in the study|19
2878726|NCT00279214|3583649|FG000|NOT COMPLETED|Overall Study||3
2878727|NCT00279214|3583650|FG001|NOT COMPLETED|Overall Study||2
2878728|NCT00279305|3583658|FG000|STARTED|Overall Study||57
2878729|NCT00279305|3583659|FG001|STARTED|Overall Study||30
2878730|NCT00279305|3583658|FG000|COMPLETED|Overall Study||49
2878731|NCT00279305|3583659|FG001|COMPLETED|Overall Study||29
2878732|NCT00279305|3583658|FG000|NOT COMPLETED|Overall Study||8
2878733|NCT00279305|3583659|FG001|NOT COMPLETED|Overall Study||1
2878734|NCT00279500|3583665|FG000|STARTED|Overall Study|6 patients treated|6
2878735|NCT00279500|3583665|FG000|COMPLETED|Overall Study|6 patients treated|6
2878736|NCT00279500|3583665|FG000|NOT COMPLETED|Overall Study||0
2878737|NCT00279591|3583671|FG000|STARTED|Overall Study||48
2878738|NCT00279591|3583672|FG001|STARTED|Overall Study||46
2878739|NCT00279591|3583671|FG000|COMPLETED|Overall Study||48
2878740|NCT00279591|3583672|FG001|COMPLETED|Overall Study||46
2878741|NCT00279591|3583671|FG000|NOT COMPLETED|Overall Study||0
2878742|NCT00279591|3583672|FG001|NOT COMPLETED|Overall Study||0
2878743|NCT00279708|3583682|FG000|STARTED|Overall Study|"Started meaning randomized"|27
2878744|NCT00279708|3583683|FG001|STARTED|Overall Study||28
2878745|NCT00279708|3583682|FG000|COMPLETED|Overall Study||24
2878746|NCT00279708|3583683|FG001|COMPLETED|Overall Study||24
2878747|NCT00279708|3583682|FG000|NOT COMPLETED|Overall Study||3
2878748|NCT00279708|3583683|FG001|NOT COMPLETED|Overall Study||4
2878749|NCT00279812|3583695|FG000|STARTED|Overall Study||21
2878750|NCT00279812|3583696|FG001|STARTED|Overall Study||26
2878751|NCT00279812|3583697|FG002|STARTED|Overall Study||24
2878752|NCT00279812|3583698|FG003|STARTED|Overall Study||23
2878753|NCT00279812|3583699|FG004|STARTED|Overall Study||20
2878754|NCT00279812|3583700|FG005|STARTED|Overall Study||19
2878755|NCT00279812|3583695|FG000|COMPLETED|Overall Study||20
2878756|NCT00279812|3583696|FG001|COMPLETED|Overall Study||20
2878757|NCT00279812|3583697|FG002|COMPLETED|Overall Study||21
2878758|NCT00279812|3583698|FG003|COMPLETED|Overall Study||23
2878759|NCT00279812|3583699|FG004|COMPLETED|Overall Study||17
2878760|NCT00279812|3583700|FG005|COMPLETED|Overall Study||18
2878761|NCT00279812|3583695|FG000|NOT COMPLETED|Overall Study||1
2878762|NCT00279812|3583696|FG001|NOT COMPLETED|Overall Study||6
2878763|NCT00279812|3583697|FG002|NOT COMPLETED|Overall Study||3
2878764|NCT00279812|3583698|FG003|NOT COMPLETED|Overall Study||0
2878765|NCT00279812|3583699|FG004|NOT COMPLETED|Overall Study||3
2878766|NCT00279812|3583700|FG005|NOT COMPLETED|Overall Study||1
2878767|NCT00279916|3583716|FG000|STARTED|Overall Study||45
2878768|NCT00279916|3583717|FG001|STARTED|Overall Study||46
2878769|NCT00279916|3583716|FG000|COMPLETED|Overall Study||38
2878770|NCT00279916|3583717|FG001|COMPLETED|Overall Study||41
2878771|NCT00279916|3583716|FG000|NOT COMPLETED|Overall Study||7
2878772|NCT00279916|3583717|FG001|NOT COMPLETED|Overall Study||5
2878773|NCT00279955|3583726|FG000|STARTED|Overall Study||157
2878774|NCT00279955|3583727|FG001|STARTED|Overall Study||486
2878775|NCT00279955|3583728|FG002|STARTED|Overall Study||358
2878776|NCT00279955|3583726|FG000|COMPLETED|Overall Study||157
2878777|NCT00279955|3583727|FG001|COMPLETED|Overall Study||486
2878778|NCT00279955|3583728|FG002|COMPLETED|Overall Study|They are still counted as completes, though they are never used for the analyses of objectives.|358
2878779|NCT00279955|3583726|FG000|NOT COMPLETED|Overall Study||0
2878780|NCT00279955|3583727|FG001|NOT COMPLETED|Overall Study||0
2878781|NCT00279955|3583728|FG002|NOT COMPLETED|Overall Study||0
2878782|NCT00280059|3583737|FG000|STARTED|Efficacy Assessment Phase||330
2878783|NCT00280059|3583738|FG001|STARTED|Efficacy Assessment Phase||330
2878784|NCT00280059|3583737|FG000|COMPLETED|Efficacy Assessment Phase|Week 56: up to end of efficacy assessment phase (excluding extension phase).|236
2878785|NCT00280059|3583738|FG001|COMPLETED|Efficacy Assessment Phase|Week 56: up to end of efficacy assessment phase (excluding extension phase).|250
2878786|NCT00280059|3583737|FG000|NOT COMPLETED|Efficacy Assessment Phase||94
2878787|NCT00280059|3583738|FG001|NOT COMPLETED|Efficacy Assessment Phase||80
2878788|NCT00280059|3583737|FG000|STARTED|Extension Phase|Optional phase; number entered was less than the number who completed the efficacy assessment phase.|194
2878789|NCT00280059|3583738|FG001|STARTED|Extension Phase|Optional phase; number entered was less than the number who completed the efficacy assessment phase.|215
2878790|NCT00280059|3583737|FG000|COMPLETED|Extension Phase||145
2878791|NCT00280059|3583738|FG001|COMPLETED|Extension Phase||177
2878792|NCT00280059|3583737|FG000|NOT COMPLETED|Extension Phase||49
2878793|NCT00280059|3583738|FG001|NOT COMPLETED|Extension Phase||38
2878794|NCT00280150|3583756|FG000|STARTED|Overall Study||5
2878795|NCT00280150|3583757|FG001|STARTED|Overall Study||5
2878796|NCT00280150|3583758|FG002|STARTED|Overall Study||6
2878797|NCT00280150|3583759|FG003|STARTED|Overall Study||30
2878798|NCT00280150|3583756|FG000|Cohort Induction|Overall Study||5
2878799|NCT00280150|3583757|FG001|Cohort Induction|Overall Study||5
2878800|NCT00280150|3583758|FG002|Cohort Induction|Overall Study||6
2878801|NCT00280150|3583759|FG003|Cohort Induction|Overall Study||30
2878802|NCT00280150|3583756|FG000|Consolidation Therapy|Overall Study||2
2878803|NCT00280150|3583757|FG001|Consolidation Therapy|Overall Study||5
2878804|NCT00280150|3583758|FG002|Consolidation Therapy|Overall Study||3
2878805|NCT00280150|3583759|FG003|Consolidation Therapy|Overall Study|Phase II participants did not receive consolidation therapy.|0
2878806|NCT00280150|3583756|FG000|COMPLETED|Overall Study||2
2878807|NCT00280150|3583757|FG001|COMPLETED|Overall Study||4
2878808|NCT00280150|3583758|FG002|COMPLETED|Overall Study||1
2878809|NCT00280150|3583759|FG003|COMPLETED|Overall Study||20
2878810|NCT00280150|3583756|FG000|NOT COMPLETED|Overall Study||3
2878811|NCT00280150|3583757|FG001|NOT COMPLETED|Overall Study||1
2878812|NCT00280150|3583758|FG002|NOT COMPLETED|Overall Study||5
2878813|NCT00280150|3583759|FG003|NOT COMPLETED|Overall Study||10
2878814|NCT00280241|3583770|FG000|STARTED|Overall Study||65
2878815|NCT00280241|3583770|FG000|COMPLETED|Overall Study||55
2878816|NCT00280241|3583770|FG000|NOT COMPLETED|Overall Study||10
2878817|NCT00280293|3583776|FG000|STARTED|Overall Study||55
2878818|NCT00280293|3583777|FG001|STARTED|Overall Study||57
2878819|NCT00280293|3583776|FG000|COMPLETED|Overall Study||29
2878820|NCT00280293|3583777|FG001|COMPLETED|Overall Study||34
2878821|NCT00280293|3583776|FG000|NOT COMPLETED|Overall Study||26
2878822|NCT00280293|3583777|FG001|NOT COMPLETED|Overall Study||23
2878823|NCT00280384|3583791|FG000|STARTED|Overall Study||6
2878824|NCT00280384|3583792|FG001|STARTED|Overall Study||6
2878825|NCT00280384|3583793|FG002|STARTED|Overall Study||6
3169898|NCT01928381|3897373|FG006|NOT COMPLETED|Washout First Intervention||0
3169899|NCT01928381|3897367|FG000|STARTED|Part 2 - Second Intervention||0
3169900|NCT01928381|3897368|FG001|STARTED|Part 2 - Second Intervention||6
3169901|NCT01928381|3897369|FG002|STARTED|Part 2 - Second Intervention||4
3169902|NCT01928381|3897370|FG003|STARTED|Part 2 - Second Intervention||5
3169903|NCT01928381|3897371|FG004|STARTED|Part 2 - Second Intervention||3
3169904|NCT01928381|3897372|FG005|STARTED|Part 2 - Second Intervention||5
3169905|NCT01928381|3897373|FG006|STARTED|Part 2 - Second Intervention||5
3169906|NCT01928381|3897367|FG000|COMPLETED|Part 2 - Second Intervention||0
3169907|NCT01928381|3897368|FG001|COMPLETED|Part 2 - Second Intervention||5
3169908|NCT01928381|3897369|FG002|COMPLETED|Part 2 - Second Intervention||4
3169909|NCT01928381|3897370|FG003|COMPLETED|Part 2 - Second Intervention||4
3169910|NCT01928381|3897371|FG004|COMPLETED|Part 2 - Second Intervention||3
3169911|NCT01928381|3897372|FG005|COMPLETED|Part 2 - Second Intervention||5
3169912|NCT01928381|3897373|FG006|COMPLETED|Part 2 - Second Intervention||5
3169913|NCT01928381|3897367|FG000|NOT COMPLETED|Part 2 - Second Intervention||0
3169914|NCT01928381|3897368|FG001|NOT COMPLETED|Part 2 - Second Intervention||1
3169915|NCT01928381|3897369|FG002|NOT COMPLETED|Part 2 - Second Intervention||0
3169916|NCT01928381|3897370|FG003|NOT COMPLETED|Part 2 - Second Intervention||1
3169917|NCT01928381|3897371|FG004|NOT COMPLETED|Part 2 - Second Intervention||0
3169918|NCT01928381|3897372|FG005|NOT COMPLETED|Part 2 - Second Intervention||0
3169919|NCT01928381|3897373|FG006|NOT COMPLETED|Part 2 - Second Intervention||0
3169920|NCT01928381|3897367|FG000|STARTED|Washout Second Intervention||0
3169921|NCT01928381|3897368|FG001|STARTED|Washout Second Intervention||5
3169922|NCT01928381|3897369|FG002|STARTED|Washout Second Intervention||4
3169923|NCT01928381|3897370|FG003|STARTED|Washout Second Intervention||4
3169924|NCT01928381|3897371|FG004|STARTED|Washout Second Intervention||3
3169925|NCT01928381|3897372|FG005|STARTED|Washout Second Intervention||5
3169926|NCT01928381|3897373|FG006|STARTED|Washout Second Intervention||5
3169927|NCT01928381|3897367|FG000|COMPLETED|Washout Second Intervention||0
3169928|NCT01928381|3897368|FG001|COMPLETED|Washout Second Intervention||5
3169929|NCT01928381|3897369|FG002|COMPLETED|Washout Second Intervention||4
3169930|NCT01928381|3897370|FG003|COMPLETED|Washout Second Intervention||4
3169931|NCT01928381|3897371|FG004|COMPLETED|Washout Second Intervention||3
3169932|NCT01928381|3897372|FG005|COMPLETED|Washout Second Intervention||5
3169933|NCT01928381|3897373|FG006|COMPLETED|Washout Second Intervention||5
2878826|NCT00280384|3583794|FG003|STARTED|Overall Study||6
2878827|NCT00280384|3583795|FG004|STARTED|Overall Study||6
2878828|NCT00280384|3583796|FG005|STARTED|Overall Study||6
2878829|NCT00280384|3583797|FG006|STARTED|Overall Study||6
2878830|NCT00280384|3583798|FG007|STARTED|Overall Study||6
2878831|NCT00280384|3583791|FG000|COMPLETED|Overall Study||6
2878832|NCT00280384|3583792|FG001|COMPLETED|Overall Study||6
2878833|NCT00280384|3583793|FG002|COMPLETED|Overall Study||6
2878834|NCT00280384|3583794|FG003|COMPLETED|Overall Study||6
2878835|NCT00280384|3583795|FG004|COMPLETED|Overall Study||6
2878836|NCT00280384|3583796|FG005|COMPLETED|Overall Study||6
2878837|NCT00280384|3583797|FG006|COMPLETED|Overall Study||6
2878838|NCT00280384|3583798|FG007|COMPLETED|Overall Study||6
2878839|NCT00280384|3583791|FG000|NOT COMPLETED|Overall Study||0
2878840|NCT00280384|3583792|FG001|NOT COMPLETED|Overall Study||0
2878841|NCT00280384|3583793|FG002|NOT COMPLETED|Overall Study||0
2878842|NCT00280384|3583794|FG003|NOT COMPLETED|Overall Study||0
2878843|NCT00280384|3583795|FG004|NOT COMPLETED|Overall Study||0
2878844|NCT00280384|3583796|FG005|NOT COMPLETED|Overall Study||0
2878845|NCT00280384|3583797|FG006|NOT COMPLETED|Overall Study||0
2878846|NCT00280384|3583798|FG007|NOT COMPLETED|Overall Study||0
2878847|NCT00280397|3583816|FG000|STARTED|Overall Study||27
2878848|NCT00280397|3583816|FG000|COMPLETED|Overall Study||26
2878849|NCT00280397|3583816|FG000|NOT COMPLETED|Overall Study||1
2878850|NCT00280566|3583824|FG000|STARTED|Period 1 Open Label Ziprasidone|1 subject inappropriately randomized into 2 different sites. Data from this subject was excluded.|584
2878851|NCT00280566|3583825|FG001|STARTED|Period 1 Open Label Ziprasidone||0
2878852|NCT00280566|3583826|FG002|STARTED|Period 1 Open Label Ziprasidone||0
2878853|NCT00280566|3583824|FG000|COMPLETED|Period 1 Open Label Ziprasidone|Subject excluded as described above is counted as 2; enrolled in 2 sites (2 identification numbers)|241
2878854|NCT00280566|3583825|FG001|COMPLETED|Period 1 Open Label Ziprasidone||0
2878855|NCT00280566|3583826|FG002|COMPLETED|Period 1 Open Label Ziprasidone||0
2878856|NCT00280566|3583824|FG000|NOT COMPLETED|Period 1 Open Label Ziprasidone||343
2878857|NCT00280566|3583825|FG001|NOT COMPLETED|Period 1 Open Label Ziprasidone||0
2878858|NCT00280566|3583826|FG002|NOT COMPLETED|Period 1 Open Label Ziprasidone||0
2878859|NCT00280566|3583824|FG000|STARTED|Period 2 Double Blind|1 subject in Period 1 did not want to be randomized into Period 2|0
2878860|NCT00280566|3583825|FG001|STARTED|Period 2 Double Blind||127
2878861|NCT00280566|3583826|FG002|STARTED|Period 2 Double Blind||111
2878862|NCT00280566|3583824|FG000|COMPLETED|Period 2 Double Blind||0
2878863|NCT00280566|3583825|FG001|COMPLETED|Period 2 Double Blind||84
2878864|NCT00280566|3583826|FG002|COMPLETED|Period 2 Double Blind||54
2878865|NCT00280566|3583824|FG000|NOT COMPLETED|Period 2 Double Blind||0
2878866|NCT00280566|3583825|FG001|NOT COMPLETED|Period 2 Double Blind||43
2878867|NCT00280566|3583826|FG002|NOT COMPLETED|Period 2 Double Blind||57
2878868|NCT00280683|3583835|FG000|STARTED|Overall Study||10
2878869|NCT00280683|3583836|FG001|STARTED|Overall Study||10
2878870|NCT00280683|3583835|FG000|COMPLETED|Overall Study|Reasons for subjects discontinuing included inability to adhere to the schedule or adverse event.|8
2878871|NCT00280683|3583836|FG001|COMPLETED|Overall Study||7
2878872|NCT00280683|3583835|FG000|NOT COMPLETED|Overall Study||2
2878873|NCT00280683|3583836|FG001|NOT COMPLETED|Overall Study||3
2878874|NCT00280735|3583844|FG000|STARTED|Overall Study||75
2878875|NCT00280735|3583844|FG000|Received Treatment|Overall Study||72
2878876|NCT00280735|3583844|FG000|Received Adequate Exposure|Overall Study||57
2878877|NCT00280735|3583844|FG000|COMPLETED|Overall Study||57
2878878|NCT00280735|3583844|FG000|NOT COMPLETED|Overall Study||18
2878879|NCT00280748|3583852|FG000|STARTED|Overall Study||10
2878880|NCT00280748|3583852|FG000|COMPLETED|Overall Study||6
2878881|NCT00280748|3583852|FG000|NOT COMPLETED|Overall Study||4
2878882|NCT00280826|3583856|FG000|STARTED|Overall Study||6
2878883|NCT00280826|3583856|FG000|COMPLETED|Overall Study||6
2878884|NCT00280826|3583856|FG000|NOT COMPLETED|Overall Study||0
2878885|NCT00280904|3583860|FG000|STARTED|Overall Study||433
2878886|NCT00280904|3583860|FG000|COMPLETED|Overall Study||433
2878887|NCT00280904|3583860|FG000|NOT COMPLETED|Overall Study||0
2878888|NCT00280917|3583869|FG000|STARTED|Overall Study||65
2878889|NCT00280917|3583870|FG001|STARTED|Overall Study||63
2878890|NCT00280917|3583871|FG002|STARTED|Overall Study||63
2878891|NCT00280917|3583872|FG003|STARTED|Overall Study||63
2878892|NCT00280917|3583869|FG000|COMPLETED|Overall Study||63
2878893|NCT00280917|3583870|FG001|COMPLETED|Overall Study||57
2878894|NCT00280917|3583871|FG002|COMPLETED|Overall Study||57
2878895|NCT00280917|3583872|FG003|COMPLETED|Overall Study||61
2878896|NCT00280917|3583869|FG000|NOT COMPLETED|Overall Study||2
2878897|NCT00280917|3583870|FG001|NOT COMPLETED|Overall Study||6
2878898|NCT00280917|3583871|FG002|NOT COMPLETED|Overall Study||6
2878899|NCT00280917|3583872|FG003|NOT COMPLETED|Overall Study||2
2878900|NCT00281021|3583882|FG000|STARTED|Overall Study||26
3169934|NCT01928381|3897367|FG000|NOT COMPLETED|Washout Second Intervention||0
3169935|NCT01928381|3897368|FG001|NOT COMPLETED|Washout Second Intervention||0
2878901|NCT00281021|3583882|FG000|COMPLETED|Overall Study||24
2878902|NCT00281021|3583882|FG000|NOT COMPLETED|Overall Study||2
2878903|NCT00281099|3583888|FG000|STARTED|Overall Study||513
2878904|NCT00281099|3583889|FG001|STARTED|Overall Study||518
2878905|NCT00281099|3583888|FG000|COMPLETED|Overall Study||308
2878906|NCT00281099|3583889|FG001|COMPLETED|Overall Study||296
2878907|NCT00281099|3583888|FG000|NOT COMPLETED|Overall Study||205
2878908|NCT00281099|3583889|FG001|NOT COMPLETED|Overall Study||222
2878909|NCT00281463|3583896|FG000|STARTED|Overall Study||45
2878910|NCT00281463|3583896|FG000|COMPLETED|Overall Study||45
2878911|NCT00281463|3583896|FG000|NOT COMPLETED|Overall Study||0
2878912|NCT00281528|3583903|FG000|STARTED|Overall Study||75
2878913|NCT00281528|3583904|FG001|STARTED|Overall Study||54
2878914|NCT00281528|3583905|FG002|STARTED|Overall Study||79
2878915|NCT00281528|3583903|FG000|COMPLETED|Overall Study|No participants completed because they continued in the study until disease progression|0
2878916|NCT00281528|3583904|FG001|COMPLETED|Overall Study|No participants completed because they continued in the study until disease progression|0
2878917|NCT00281528|3583905|FG002|COMPLETED|Overall Study|No participants completed because they continued in the study until disease progression|0
2878918|NCT00281528|3583903|FG000|NOT COMPLETED|Overall Study||75
2878919|NCT00281528|3583904|FG001|NOT COMPLETED|Overall Study||54
2878920|NCT00281528|3583905|FG002|NOT COMPLETED|Overall Study||79
2878921|NCT00281580|3583929|FG000|STARTED|Overall Study||46
2878922|NCT00281580|3583930|FG001|STARTED|Overall Study||42
2878923|NCT00281580|3583931|FG002|STARTED|Overall Study||130
2878924|NCT00281580|3583932|FG003|STARTED|Overall Study||135
2878925|NCT00281580|3583933|FG004|STARTED|Overall Study||44
2878926|NCT00281580|3583934|FG005|STARTED|Overall Study||46
2878927|NCT00281580|3583935|FG006|STARTED|Overall Study||44
2878928|NCT00281580|3583936|FG007|STARTED|Overall Study||47
2878929|NCT00281580|3583937|FG008|STARTED|Overall Study||143
2878930|NCT00281580|3583938|FG009|STARTED|Overall Study||129
2878931|NCT00281580|3583939|FG010|STARTED|Overall Study||48
2878932|NCT00281580|3583940|FG011|STARTED|Overall Study||146
2878933|NCT00281580|3583941|FG012|STARTED|Overall Study||142
2878934|NCT00281580|3583942|FG013|STARTED|Overall Study||50
2878935|NCT00281580|3583943|FG014|STARTED|Overall Study||140
2878936|NCT00281580|3583944|FG015|STARTED|Overall Study||129
2878937|NCT00281580|3583929|FG000|COMPLETED|Overall Study||39
2878938|NCT00281580|3583930|FG001|COMPLETED|Overall Study||41
2878939|NCT00281580|3583931|FG002|COMPLETED|Overall Study||125
2878940|NCT00281580|3583932|FG003|COMPLETED|Overall Study||118
2878941|NCT00281580|3583933|FG004|COMPLETED|Overall Study||40
2878942|NCT00281580|3583934|FG005|COMPLETED|Overall Study||43
2878943|NCT00281580|3583935|FG006|COMPLETED|Overall Study||39
2878944|NCT00281580|3583936|FG007|COMPLETED|Overall Study||46
2878945|NCT00281580|3583937|FG008|COMPLETED|Overall Study||135
2878946|NCT00281580|3583938|FG009|COMPLETED|Overall Study||117
2878947|NCT00281580|3583939|FG010|COMPLETED|Overall Study||44
2878948|NCT00281580|3583940|FG011|COMPLETED|Overall Study||136
2878949|NCT00281580|3583941|FG012|COMPLETED|Overall Study||129
2878950|NCT00281580|3583942|FG013|COMPLETED|Overall Study||43
2878951|NCT00281580|3583943|FG014|COMPLETED|Overall Study||133
2878952|NCT00281580|3583944|FG015|COMPLETED|Overall Study||116
2878953|NCT00281580|3583929|FG000|NOT COMPLETED|Overall Study||7
2878954|NCT00281580|3583930|FG001|NOT COMPLETED|Overall Study||1
2878955|NCT00281580|3583931|FG002|NOT COMPLETED|Overall Study||5
2878956|NCT00281580|3583932|FG003|NOT COMPLETED|Overall Study||17
2878957|NCT00281580|3583933|FG004|NOT COMPLETED|Overall Study||4
2878958|NCT00281580|3583934|FG005|NOT COMPLETED|Overall Study||3
2878959|NCT00281580|3583935|FG006|NOT COMPLETED|Overall Study||5
2878960|NCT00281580|3583936|FG007|NOT COMPLETED|Overall Study||1
2878961|NCT00281580|3583937|FG008|NOT COMPLETED|Overall Study||8
2878962|NCT00281580|3583938|FG009|NOT COMPLETED|Overall Study||12
2878963|NCT00281580|3583939|FG010|NOT COMPLETED|Overall Study||4
2878964|NCT00281580|3583940|FG011|NOT COMPLETED|Overall Study||10
2878965|NCT00281580|3583941|FG012|NOT COMPLETED|Overall Study||13
2878966|NCT00281580|3583942|FG013|NOT COMPLETED|Overall Study||7
2878967|NCT00281580|3583943|FG014|NOT COMPLETED|Overall Study||7
2878968|NCT00281580|3583944|FG015|NOT COMPLETED|Overall Study||13
2878969|NCT00281632|3584013|FG000|STARTED|Overall Study||36
2878970|NCT00281632|3584013|FG000|COMPLETED|Overall Study|Three participants were ongoing in the study at the time of the data cut-off (30 Apr 2008).|0
2878971|NCT00281632|3584013|FG000|NOT COMPLETED|Overall Study||36
2878972|NCT00281671|3584025|FG000|STARTED|Overall Study||5
2878973|NCT00281671|3584026|FG001|STARTED|Overall Study||4
2878974|NCT00281671|3584025|FG000|COMPLETED|Overall Study||5
2878975|NCT00281671|3584026|FG001|COMPLETED|Overall Study||4
2878976|NCT00281671|3584025|FG000|NOT COMPLETED|Overall Study||0
2878977|NCT00281671|3584026|FG001|NOT COMPLETED|Overall Study||0
2878978|NCT00281684|3584039|FG000|STARTED|Overall Study||37
2878979|NCT00281684|3584040|FG001|STARTED|Overall Study||36
2878980|NCT00281684|3584041|FG002|STARTED|Overall Study||34
2878981|NCT00281684|3584042|FG003|STARTED|Overall Study||38
2878982|NCT00281684|3584039|FG000|COMPLETED|Overall Study||36
2878983|NCT00281684|3584040|FG001|COMPLETED|Overall Study||36
2878984|NCT00281684|3584041|FG002|COMPLETED|Overall Study||33
2878985|NCT00281684|3584042|FG003|COMPLETED|Overall Study||38
2878986|NCT00281684|3584039|FG000|NOT COMPLETED|Overall Study||1
2878987|NCT00281684|3584040|FG001|NOT COMPLETED|Overall Study||0
2878988|NCT00281684|3584041|FG002|NOT COMPLETED|Overall Study||1
2878989|NCT00281684|3584042|FG003|NOT COMPLETED|Overall Study||0
2878990|NCT00281697|3584056|FG000|STARTED|Overall Study||459
2878991|NCT00281697|3584057|FG001|STARTED|Overall Study||225
2878992|NCT00281697|3584056|FG000|COMPLETED|Overall Study||58
2878993|NCT00281697|3584057|FG001|COMPLETED|Overall Study||28
2878994|NCT00281697|3584056|FG000|NOT COMPLETED|Overall Study||401
2878995|NCT00281697|3584057|FG001|NOT COMPLETED|Overall Study||197
2919239|NCT00531050|3629627|FG000|STARTED|Part 2: Period 1||3
2919240|NCT00531050|3629628|FG001|STARTED|Part 2: Period 1||4
2919241|NCT00531050|3629629|FG002|STARTED|Part 2: Period 1||4
2919242|NCT00531050|3629630|FG003|STARTED|Part 2: Period 1||4
2919243|NCT00531050|3629631|FG004|STARTED|Part 2: Period 1||4
2919244|NCT00531050|3629632|FG005|STARTED|Part 2: Period 1||5
2919245|NCT00531050|3629627|FG000|COMPLETED|Part 2: Period 1||3
2919246|NCT00531050|3629628|FG001|COMPLETED|Part 2: Period 1||4
2919247|NCT00531050|3629629|FG002|COMPLETED|Part 2: Period 1||4
2919248|NCT00531050|3629630|FG003|COMPLETED|Part 2: Period 1||4
2919249|NCT00531050|3629631|FG004|COMPLETED|Part 2: Period 1||4
2919250|NCT00531050|3629632|FG005|COMPLETED|Part 2: Period 1||4
2919251|NCT00531050|3629627|FG000|NOT COMPLETED|Part 2: Period 1||0
2919252|NCT00531050|3629628|FG001|NOT COMPLETED|Part 2: Period 1||0
2919253|NCT00531050|3629629|FG002|NOT COMPLETED|Part 2: Period 1||0
2919254|NCT00531050|3629630|FG003|NOT COMPLETED|Part 2: Period 1||0
2919255|NCT00531050|3629631|FG004|NOT COMPLETED|Part 2: Period 1||0
2919256|NCT00531050|3629632|FG005|NOT COMPLETED|Part 2: Period 1||1
2919257|NCT00531050|3629627|FG000|STARTED|Part 2: Period 2||3
2919258|NCT00531050|3629628|FG001|STARTED|Part 2: Period 2||4
2919259|NCT00531050|3629629|FG002|STARTED|Part 2: Period 2||4
2919260|NCT00531050|3629630|FG003|STARTED|Part 2: Period 2||4
2919261|NCT00531050|3629631|FG004|STARTED|Part 2: Period 2||4
2919262|NCT00531050|3629632|FG005|STARTED|Part 2: Period 2||4
3169936|NCT01928381|3897369|FG002|NOT COMPLETED|Washout Second Intervention||0
3169937|NCT01928381|3897370|FG003|NOT COMPLETED|Washout Second Intervention||0
3169938|NCT01928381|3897371|FG004|NOT COMPLETED|Washout Second Intervention||0
3169939|NCT01928381|3897372|FG005|NOT COMPLETED|Washout Second Intervention||0
3169940|NCT01928381|3897373|FG006|NOT COMPLETED|Washout Second Intervention||0
3169941|NCT01928381|3897367|FG000|STARTED|Part 2 - Third Intervention||0
3169942|NCT01928381|3897368|FG001|STARTED|Part 2 - Third Intervention||5
3169943|NCT01928381|3897369|FG002|STARTED|Part 2 - Third Intervention||4
3169944|NCT01928381|3897370|FG003|STARTED|Part 2 - Third Intervention||4
3169945|NCT01928381|3897371|FG004|STARTED|Part 2 - Third Intervention||3
3169946|NCT01928381|3897372|FG005|STARTED|Part 2 - Third Intervention||5
3169947|NCT01928381|3897373|FG006|STARTED|Part 2 - Third Intervention||5
3169948|NCT01928381|3897367|FG000|COMPLETED|Part 2 - Third Intervention||0
3169949|NCT01928381|3897368|FG001|COMPLETED|Part 2 - Third Intervention||5
3169950|NCT01928381|3897369|FG002|COMPLETED|Part 2 - Third Intervention||4
3169951|NCT01928381|3897370|FG003|COMPLETED|Part 2 - Third Intervention||4
3169952|NCT01928381|3897371|FG004|COMPLETED|Part 2 - Third Intervention||3
3169953|NCT01928381|3897372|FG005|COMPLETED|Part 2 - Third Intervention||5
3169954|NCT01928381|3897373|FG006|COMPLETED|Part 2 - Third Intervention||5
3169955|NCT01928381|3897367|FG000|NOT COMPLETED|Part 2 - Third Intervention||0
3169956|NCT01928381|3897368|FG001|NOT COMPLETED|Part 2 - Third Intervention||0
2919263|NCT00531050|3629627|FG000|COMPLETED|Part 2: Period 2||3
2919264|NCT00531050|3629628|FG001|COMPLETED|Part 2: Period 2||4
2919265|NCT00531050|3629629|FG002|COMPLETED|Part 2: Period 2||4
2919266|NCT00531050|3629630|FG003|COMPLETED|Part 2: Period 2||4
2919267|NCT00531050|3629631|FG004|COMPLETED|Part 2: Period 2||4
2919268|NCT00531050|3629632|FG005|COMPLETED|Part 2: Period 2||4
2919269|NCT00531050|3629627|FG000|NOT COMPLETED|Part 2: Period 2||0
2919270|NCT00531050|3629628|FG001|NOT COMPLETED|Part 2: Period 2||0
2919271|NCT00531050|3629629|FG002|NOT COMPLETED|Part 2: Period 2||0
2919272|NCT00531050|3629630|FG003|NOT COMPLETED|Part 2: Period 2||0
2919273|NCT00531050|3629631|FG004|NOT COMPLETED|Part 2: Period 2||0
2919274|NCT00531050|3629632|FG005|NOT COMPLETED|Part 2: Period 2||0
2919275|NCT00531050|3629627|FG000|STARTED|Part 2: Period 3||3
2919276|NCT00531050|3629628|FG001|STARTED|Part 2: Period 3||4
2919277|NCT00531050|3629629|FG002|STARTED|Part 2: Period 3||4
2919278|NCT00531050|3629630|FG003|STARTED|Part 2: Period 3||4
2919279|NCT00531050|3629631|FG004|STARTED|Part 2: Period 3||4
2919280|NCT00531050|3629632|FG005|STARTED|Part 2: Period 3||4
2919281|NCT00531050|3629627|FG000|COMPLETED|Part 2: Period 3||2
2919282|NCT00531050|3629628|FG001|COMPLETED|Part 2: Period 3||4
2919283|NCT00531050|3629629|FG002|COMPLETED|Part 2: Period 3||4
2919284|NCT00531050|3629630|FG003|COMPLETED|Part 2: Period 3||4
2919285|NCT00531050|3629631|FG004|COMPLETED|Part 2: Period 3||4
2919286|NCT00531050|3629632|FG005|COMPLETED|Part 2: Period 3||3
2919287|NCT00531050|3629627|FG000|NOT COMPLETED|Part 2: Period 3||1
2919288|NCT00531050|3629628|FG001|NOT COMPLETED|Part 2: Period 3||0
2919289|NCT00531050|3629629|FG002|NOT COMPLETED|Part 2: Period 3||0
2919290|NCT00531050|3629630|FG003|NOT COMPLETED|Part 2: Period 3||0
2919291|NCT00531050|3629631|FG004|NOT COMPLETED|Part 2: Period 3||0
2919292|NCT00531050|3629632|FG005|NOT COMPLETED|Part 2: Period 3||1
2919293|NCT00531206|3629649|FG000|STARTED|Overall Study||65
2919294|NCT00531206|3629649|FG000|COMPLETED|Overall Study||45
2919295|NCT00531206|3629649|FG000|NOT COMPLETED|Overall Study||20
2919296|NCT00531232|3629656|FG000|STARTED|Overall Study||4
2919297|NCT00531232|3629657|FG001|STARTED|Overall Study||9
2919298|NCT00531232|3629658|FG002|STARTED|Overall Study||25
2919299|NCT00531232|3629656|FG000|Treated|Overall Study||4
2919300|NCT00531232|3629657|FG001|Treated|Overall Study||8
2919301|NCT00531232|3629658|FG002|Treated|Overall Study||24
2919302|NCT00531232|3629656|FG000|COMPLETED|Overall Study||0
2919303|NCT00531232|3629657|FG001|COMPLETED|Overall Study||0
2878996|NCT00281827|3584063|FG000|STARTED|Overall Study||22
2878997|NCT00281827|3584063|FG000|COMPLETED|Overall Study|All patients received 3 cycles of therapy; 2 did not receive all 3 thalidomide cycles|22
2878998|NCT00281827|3584063|FG000|NOT COMPLETED|Overall Study||0
2878999|NCT00281840|3584069|FG000|STARTED|Overall Study||30
2879000|NCT00281840|3584069|FG000|COMPLETED|Overall Study||5
2879001|NCT00281840|3584069|FG000|NOT COMPLETED|Overall Study||25
2879002|NCT00281918|3584076|FG000|STARTED|Overall Study|Informed consent unavailable for 2 patients at time of analysis; intent-to-treat population was 407.|409
2879003|NCT00281918|3584077|FG001|STARTED|Overall Study|Informed consent unavailable for 5 patients at time of analysis; intent-to-treat population was 403.|408
2879004|NCT00281918|3584076|FG000|Safety Population; Received Study Drug|Overall Study||398
2879005|NCT00281918|3584077|FG001|Safety Population; Received Study Drug|Overall Study||402
2879006|NCT00281918|3584076|FG000|COMPLETED|Overall Study|Completed all 6 cycles of study medication.|267
2879007|NCT00281918|3584077|FG001|COMPLETED|Overall Study|Completed all 6 cycles of study medication.|300
2879008|NCT00281918|3584076|FG000|NOT COMPLETED|Overall Study||142
2879009|NCT00281918|3584077|FG001|NOT COMPLETED|Overall Study||108
2879010|NCT00281957|3584085|FG000|STARTED|Overall Study||67
2879011|NCT00281957|3584086|FG001|STARTED|Overall Study||42
2879012|NCT00281957|3584085|FG000|Eligible|Overall Study||66
2879013|NCT00281957|3584086|FG001|Eligible|Overall Study||40
2879014|NCT00281957|3584085|FG000|Eligible and Received Treatment|Overall Study||63
2879015|NCT00281957|3584086|FG001|Eligible and Received Treatment|Overall Study||39
2879016|NCT00281957|3584085|FG000|COMPLETED|Overall Study||0
2879017|NCT00281957|3584086|FG001|COMPLETED|Overall Study||0
2879018|NCT00281957|3584085|FG000|NOT COMPLETED|Overall Study||67
2879019|NCT00281957|3584086|FG001|NOT COMPLETED|Overall Study||42
2879020|NCT00282048|3584094|FG000|STARTED|Overall Study||62
2879021|NCT00282048|3584094|FG000|COMPLETED|Overall Study||0
2879022|NCT00282048|3584094|FG000|NOT COMPLETED|Overall Study||62
2879023|NCT00282087|3584098|FG000|STARTED|Overall Study||47
2879024|NCT00282087|3584098|FG000|COMPLETED|Overall Study|One patient died during cycle 1 of treatment because of infectious complications of AIDS.|46
2879025|NCT00282087|3584098|FG000|NOT COMPLETED|Overall Study||1
2879026|NCT00282113|3584106|FG000|STARTED|Overall Study||31
2879027|NCT00282113|3584107|FG001|STARTED|Overall Study||30
2879028|NCT00282113|3584108|FG002|STARTED|Overall Study||29
2879029|NCT00282113|3584106|FG000|COMPLETED|Overall Study||30
2879030|NCT00282113|3584107|FG001|COMPLETED|Overall Study||30
2879031|NCT00282113|3584108|FG002|COMPLETED|Overall Study||29
2879032|NCT00282113|3584106|FG000|NOT COMPLETED|Overall Study||1
2879033|NCT00282113|3584107|FG001|NOT COMPLETED|Overall Study||0
2879034|NCT00282113|3584108|FG002|NOT COMPLETED|Overall Study||0
2879035|NCT00282152|3584118|FG000|STARTED|Overall Study||15
2879036|NCT00282152|3584119|FG001|STARTED|Overall Study||15
2879037|NCT00282152|3584118|FG000|COMPLETED|Overall Study||14
2879038|NCT00282152|3584119|FG001|COMPLETED|Overall Study||15
2879039|NCT00282152|3584118|FG000|NOT COMPLETED|Overall Study||1
2879040|NCT00282152|3584119|FG001|NOT COMPLETED|Overall Study||0
2879041|NCT00282243|3584126|FG000|STARTED|Pharmacokinetic Treatment Period||70
2879042|NCT00282243|3584126|FG000|Received Tacrolimus|Pharmacokinetic Treatment Period||70
2879043|NCT00282243|3584126|FG000|Received Tacrolimus MR|Pharmacokinetic Treatment Period||69
2879044|NCT00282243|3584126|FG000|COMPLETED|Pharmacokinetic Treatment Period||65
2879045|NCT00282243|3584126|FG000|NOT COMPLETED|Pharmacokinetic Treatment Period||5
2879046|NCT00282243|3584126|FG000|STARTED|Extension Treatment Period||65
2879047|NCT00282243|3584126|FG000|COMPLETED|Extension Treatment Period||43
2879048|NCT00282243|3584126|FG000|NOT COMPLETED|Extension Treatment Period||22
2879049|NCT00282256|3584130|FG000|STARTED|Pharmacokinetic Treatment Period||19
2879050|NCT00282256|3584130|FG000|Received Tacrolimus|Pharmacokinetic Treatment Period||19
2879051|NCT00282256|3584130|FG000|Received Tacrolimus MR|Pharmacokinetic Treatment Period||18
2879052|NCT00282256|3584130|FG000|COMPLETED|Pharmacokinetic Treatment Period||18
2879053|NCT00282256|3584130|FG000|NOT COMPLETED|Pharmacokinetic Treatment Period||1
2879054|NCT00282256|3584130|FG000|STARTED|Extension Treatment Period||18
2879055|NCT00282256|3584130|FG000|COMPLETED|Extension Treatment Period||16
2879056|NCT00282256|3584130|FG000|NOT COMPLETED|Extension Treatment Period||2
2879057|NCT00282282|3584134|FG000|STARTED|Overall Study|31 patients enrolled but 2 patients did not go through with transplant|29
2879058|NCT00282282|3584134|FG000|COMPLETED|Overall Study||29
2879059|NCT00282282|3584134|FG000|NOT COMPLETED|Overall Study||0
2879060|NCT00282295|3584142|FG000|STARTED|Overall Study||446
2879061|NCT00282295|3584143|FG001|STARTED|Overall Study||446
2879062|NCT00282295|3584144|FG002|STARTED|Overall Study||449
2879063|NCT00282295|3584142|FG000|COMPLETED|Overall Study||443
2879064|NCT00282295|3584143|FG001|COMPLETED|Overall Study||429
2879065|NCT00282295|3584144|FG002|COMPLETED|Overall Study||441
2879066|NCT00282295|3584142|FG000|NOT COMPLETED|Overall Study||3
2879067|NCT00282295|3584143|FG001|NOT COMPLETED|Overall Study||17
2879068|NCT00282295|3584144|FG002|NOT COMPLETED|Overall Study||8
2879069|NCT00282308|3584159|FG000|STARTED|Treatment Period||69
2879070|NCT00282308|3584160|FG001|STARTED|Treatment Period||34
2879071|NCT00282308|3584161|FG002|STARTED|Treatment Period|Participant Flow is reported separately for the treatment groups for this Period.|0
2879072|NCT00282308|3584159|FG000|COMPLETED|Treatment Period||65
2879073|NCT00282308|3584160|FG001|COMPLETED|Treatment Period||28
2879074|NCT00282308|3584161|FG002|COMPLETED|Treatment Period||0
2879075|NCT00282308|3584159|FG000|NOT COMPLETED|Treatment Period||4
2879076|NCT00282308|3584160|FG001|NOT COMPLETED|Treatment Period||6
2879077|NCT00282308|3584161|FG002|NOT COMPLETED|Treatment Period||0
2879078|NCT00282308|3584159|FG000|STARTED|Optional Extension Re-treatment Period|Participant Flow is reported for the combined treatment groups for this Period.|0
2879079|NCT00282308|3584160|FG001|STARTED|Optional Extension Re-treatment Period|Participant Flow is reported for the combined treatment groups for this Period.|0
2879080|NCT00282308|3584161|FG002|STARTED|Optional Extension Re-treatment Period|Not all patients who completed the Treatment Period entered this Optional Re-treatment Period.|78
2879081|NCT00282308|3584159|FG000|COMPLETED|Optional Extension Re-treatment Period||0
2879082|NCT00282308|3584160|FG001|COMPLETED|Optional Extension Re-treatment Period||0
2879083|NCT00282308|3584161|FG002|COMPLETED|Optional Extension Re-treatment Period||72
2879084|NCT00282308|3584159|FG000|NOT COMPLETED|Optional Extension Re-treatment Period||0
2879085|NCT00282308|3584160|FG001|NOT COMPLETED|Optional Extension Re-treatment Period||0
2879086|NCT00282308|3584161|FG002|NOT COMPLETED|Optional Extension Re-treatment Period||6
2879087|NCT00282308|3584159|FG000|STARTED|Safety Follow-up Period|Participant Flow is reported for the combined treatment groups for this Period.|0
2879088|NCT00282308|3584160|FG001|STARTED|Safety Follow-up Period|Participant Flow is reported for the combined treatment groups for this Period.|0
2879089|NCT00282308|3584161|FG002|STARTED|Safety Follow-up Period|Some patients entered this Safety Follow-up Period directly from the Treatment Period.|100
2879090|NCT00282308|3584159|FG000|COMPLETED|Safety Follow-up Period||0
2879091|NCT00282308|3584160|FG001|COMPLETED|Safety Follow-up Period||0
2879092|NCT00282308|3584161|FG002|COMPLETED|Safety Follow-up Period||81
2879093|NCT00282308|3584159|FG000|NOT COMPLETED|Safety Follow-up Period||0
2879094|NCT00282308|3584160|FG001|NOT COMPLETED|Safety Follow-up Period||0
2879095|NCT00282308|3584161|FG002|NOT COMPLETED|Safety Follow-up Period||19
2879096|NCT00282334|3584173|FG000|STARTED|Overall Study||113
2879097|NCT00282334|3584174|FG001|STARTED|Overall Study||123
2879098|NCT00282334|3584173|FG000|COMPLETED|Overall Study||105
2879099|NCT00282334|3584174|FG001|COMPLETED|Overall Study||118
2879100|NCT00282334|3584173|FG000|NOT COMPLETED|Overall Study||8
2879101|NCT00282334|3584174|FG001|NOT COMPLETED|Overall Study||5
2879102|NCT00282347|3584182|FG000|STARTED|Treatment Period||72
2879103|NCT00282347|3584183|FG001|STARTED|Treatment Period||72
2879104|NCT00282347|3584182|FG000|COMPLETED|Treatment Period||67
2879105|NCT00282347|3584183|FG001|COMPLETED|Treatment Period||63
2879106|NCT00282347|3584182|FG000|NOT COMPLETED|Treatment Period||5
2879107|NCT00282347|3584183|FG001|NOT COMPLETED|Treatment Period||9
2879108|NCT00282347|3584182|FG000|STARTED|Safety Follow-up Period||67
2879109|NCT00282347|3584183|FG001|STARTED|Safety Follow-up Period||63
2879110|NCT00282347|3584182|FG000|COMPLETED|Safety Follow-up Period||64
2879111|NCT00282347|3584183|FG001|COMPLETED|Safety Follow-up Period||57
2879112|NCT00282347|3584182|FG000|NOT COMPLETED|Safety Follow-up Period||3
2879113|NCT00282347|3584183|FG001|NOT COMPLETED|Safety Follow-up Period||6
2879114|NCT00282347|3584182|FG000|STARTED|B Cell Follow-up Period||20
2879115|NCT00282347|3584183|FG001|STARTED|B Cell Follow-up Period||4
2879116|NCT00282347|3584182|FG000|COMPLETED|B Cell Follow-up Period||15
2879117|NCT00282347|3584183|FG001|COMPLETED|B Cell Follow-up Period||4
2879118|NCT00282347|3584182|FG000|NOT COMPLETED|B Cell Follow-up Period||5
2879119|NCT00282347|3584183|FG001|NOT COMPLETED|B Cell Follow-up Period||0
2879120|NCT00282412|3584191|FG000|STARTED|Overall Study||4
2879121|NCT00282412|3584191|FG000|COMPLETED|Overall Study|Two late deaths non-treatment related. One from pulmonary embolism and one from late leukemia.|2
2879122|NCT00282412|3584191|FG000|NOT COMPLETED|Overall Study||2
2879123|NCT00282438|3584197|FG000|STARTED|Overall Study||1
2879124|NCT00282438|3584198|FG001|STARTED|Overall Study||1
2879125|NCT00282438|3584197|FG000|COMPLETED|Overall Study||0
2879126|NCT00282438|3584198|FG001|COMPLETED|Overall Study||0
2879127|NCT00282438|3584197|FG000|NOT COMPLETED|Overall Study||1
2879128|NCT00282438|3584198|FG001|NOT COMPLETED|Overall Study||1
2879129|NCT00282464|3584206|FG000|STARTED|Overall Study||185
2879130|NCT00282464|3584207|FG001|STARTED|Overall Study||196
2879131|NCT00282464|3584206|FG000|COMPLETED|Overall Study||112
2879132|NCT00282464|3584207|FG001|COMPLETED|Overall Study||134
2879133|NCT00282464|3584206|FG000|NOT COMPLETED|Overall Study||73
2879134|NCT00282464|3584207|FG001|NOT COMPLETED|Overall Study||62
2879135|NCT00282568|3584213|FG000|STARTED|Pharmacokinetic Treatment Period||70
2879136|NCT00282568|3584213|FG000|Received Tacrolimus|Pharmacokinetic Treatment Period||68
2879137|NCT00282568|3584213|FG000|Received Tacrolimus MR|Pharmacokinetic Treatment Period||67
2879138|NCT00282568|3584213|FG000|COMPLETED|Pharmacokinetic Treatment Period||67
2879139|NCT00282568|3584213|FG000|NOT COMPLETED|Pharmacokinetic Treatment Period||3
2879140|NCT00282568|3584213|FG000|STARTED|Extended Treatment Period|One patient who completed the PK period did not enter the extended treatment period.|66
2879141|NCT00282568|3584213|FG000|COMPLETED|Extended Treatment Period||42
2879142|NCT00282568|3584213|FG000|NOT COMPLETED|Extended Treatment Period||24
2879143|NCT00282672|3584221|FG000|STARTED|1 Year||22
2879144|NCT00282672|3584222|FG001|STARTED|1 Year||42
2879145|NCT00282672|3584223|FG002|STARTED|1 Year||21
2879146|NCT00282672|3584224|FG003|STARTED|1 Year||42
2879147|NCT00282672|3584221|FG000|COMPLETED|1 Year||19
2879148|NCT00282672|3584222|FG001|COMPLETED|1 Year||40
2879149|NCT00282672|3584223|FG002|COMPLETED|1 Year||20
2879150|NCT00282672|3584224|FG003|COMPLETED|1 Year||38
2879151|NCT00282672|3584221|FG000|NOT COMPLETED|1 Year||3
2879152|NCT00282672|3584222|FG001|NOT COMPLETED|1 Year||2
2879153|NCT00282672|3584223|FG002|NOT COMPLETED|1 Year||1
2879154|NCT00282672|3584224|FG003|NOT COMPLETED|1 Year||4
2879155|NCT00282672|3584221|FG000|STARTED|2 Year: Sham Crossed Over to RFA|19 crossed over to RFA treatment|19
2879156|NCT00282672|3584222|FG001|STARTED|2 Year: Sham Crossed Over to RFA||40
2879157|NCT00282672|3584223|FG002|STARTED|2 Year: Sham Crossed Over to RFA|16 Crossed over to RFA treatment|16
2879158|NCT00282672|3584224|FG003|STARTED|2 Year: Sham Crossed Over to RFA||38
2879159|NCT00282672|3584221|FG000|COMPLETED|2 Year: Sham Crossed Over to RFA||16
2879160|NCT00282672|3584222|FG001|COMPLETED|2 Year: Sham Crossed Over to RFA||39
2879161|NCT00282672|3584223|FG002|COMPLETED|2 Year: Sham Crossed Over to RFA||15
2879162|NCT00282672|3584224|FG003|COMPLETED|2 Year: Sham Crossed Over to RFA||36
2879163|NCT00282672|3584221|FG000|NOT COMPLETED|2 Year: Sham Crossed Over to RFA||3
2879164|NCT00282672|3584222|FG001|NOT COMPLETED|2 Year: Sham Crossed Over to RFA||1
2879165|NCT00282672|3584223|FG002|NOT COMPLETED|2 Year: Sham Crossed Over to RFA||1
2879166|NCT00282672|3584224|FG003|NOT COMPLETED|2 Year: Sham Crossed Over to RFA||2
2879167|NCT00282672|3584221|FG000|STARTED|5 Year: Follow up|1 withdrew|15
2879168|NCT00282672|3584222|FG001|STARTED|5 Year: Follow up|7 withdrew|32
2879169|NCT00282672|3584223|FG002|STARTED|5 Year: Follow up|3 withdrew|12
2879170|NCT00282672|3584224|FG003|STARTED|5 Year: Follow up|11 withdrew|25
2879171|NCT00282672|3584221|FG000|COMPLETED|5 Year: Follow up||14
2879172|NCT00282672|3584222|FG001|COMPLETED|5 Year: Follow up||27
2879173|NCT00282672|3584223|FG002|COMPLETED|5 Year: Follow up||12
2879174|NCT00282672|3584224|FG003|COMPLETED|5 Year: Follow up||20
2879175|NCT00282672|3584221|FG000|NOT COMPLETED|5 Year: Follow up||1
2879176|NCT00282672|3584222|FG001|NOT COMPLETED|5 Year: Follow up||5
2879177|NCT00282672|3584223|FG002|NOT COMPLETED|5 Year: Follow up||0
2879178|NCT00282672|3584224|FG003|NOT COMPLETED|5 Year: Follow up||5
2879179|NCT00282815|3584260|FG000|STARTED|Overall Study||15
2879180|NCT00282815|3584261|FG001|STARTED|Overall Study||17
2879181|NCT00282815|3584260|FG000|COMPLETED|Overall Study||8
2879182|NCT00282815|3584261|FG001|COMPLETED|Overall Study||11
2879183|NCT00282815|3584260|FG000|NOT COMPLETED|Overall Study||7
2879184|NCT00282815|3584261|FG001|NOT COMPLETED|Overall Study||6
2879185|NCT00282828|3584273|FG000|STARTED|Overall Study||63
2879186|NCT00282828|3584274|FG001|STARTED|Overall Study||59
2879187|NCT00282828|3584275|FG002|STARTED|Overall Study||59
2879188|NCT00282828|3584273|FG000|COMPLETED|Overall Study||57
2879189|NCT00282828|3584274|FG001|COMPLETED|Overall Study||47
2879190|NCT00282828|3584275|FG002|COMPLETED|Overall Study||50
2879191|NCT00282828|3584273|FG000|NOT COMPLETED|Overall Study||6
2879192|NCT00282828|3584274|FG001|NOT COMPLETED|Overall Study||12
2879193|NCT00282828|3584275|FG002|NOT COMPLETED|Overall Study||9
2879194|NCT00282841|3584283|FG000|STARTED|Overall Study|Anticipated recruitment 400; stopped due to funding and poor recruitment.|61
2879195|NCT00282841|3584283|FG000|COMPLETED|Overall Study||61
2879196|NCT00282841|3584283|FG000|NOT COMPLETED|Overall Study||0
2879197|NCT00282919|3584288|FG000|STARTED|Overall Study||110
2879198|NCT00282919|3584288|FG000|COMPLETED|Overall Study||103
2879199|NCT00282919|3584288|FG000|NOT COMPLETED|Overall Study||7
2879200|NCT00282971|3584294|FG000|STARTED|Overall Study||180
2879201|NCT00282971|3584295|FG001|STARTED|Overall Study||171
2879202|NCT00282971|3584294|FG000|COMPLETED|Overall Study||146
3169957|NCT01928381|3897369|FG002|NOT COMPLETED|Part 2 - Third Intervention||0
3169958|NCT01928381|3897370|FG003|NOT COMPLETED|Part 2 - Third Intervention||0
3169959|NCT01928381|3897371|FG004|NOT COMPLETED|Part 2 - Third Intervention||0
2879203|NCT00282971|3584295|FG001|COMPLETED|Overall Study||149
2879204|NCT00282971|3584294|FG000|NOT COMPLETED|Overall Study||34
2879205|NCT00282971|3584295|FG001|NOT COMPLETED|Overall Study||22
2879206|NCT00282984|3584303|FG000|STARTED|Overall Study||353
2879207|NCT00282984|3584304|FG001|STARTED|Overall Study||350
2879208|NCT00282984|3584303|FG000|COMPLETED|Overall Study||302
2879209|NCT00282984|3584304|FG001|COMPLETED|Overall Study||289
2879210|NCT00282984|3584303|FG000|NOT COMPLETED|Overall Study||51
2879211|NCT00282984|3584304|FG001|NOT COMPLETED|Overall Study||61
2879212|NCT00283049|3584313|FG000|STARTED|Overall Study|2 randomized patients did not receive study drug and were not included in the safety population|128
2879213|NCT00283049|3584314|FG001|STARTED|Overall Study|1 randomized patient did not receive study drug and was not included in the safety population|128
2879214|NCT00283049|3584315|FG002|STARTED|Overall Study|1 randomized patient did not receive study drug and was not included in the safety population|130
3169960|NCT01928381|3897372|FG005|NOT COMPLETED|Part 2 - Third Intervention||0
3169961|NCT01928381|3897373|FG006|NOT COMPLETED|Part 2 - Third Intervention||0
3169962|NCT01928381|3897367|FG000|STARTED|Part 2 - Post Third Intervention||0
3169963|NCT01928381|3897368|FG001|STARTED|Part 2 - Post Third Intervention||5
3169964|NCT01928381|3897369|FG002|STARTED|Part 2 - Post Third Intervention||4
3169965|NCT01928381|3897370|FG003|STARTED|Part 2 - Post Third Intervention||4
3169966|NCT01928381|3897371|FG004|STARTED|Part 2 - Post Third Intervention||3
3169967|NCT01928381|3897372|FG005|STARTED|Part 2 - Post Third Intervention||5
3169968|NCT01928381|3897373|FG006|STARTED|Part 2 - Post Third Intervention||5
3169969|NCT01928381|3897367|FG000|COMPLETED|Part 2 - Post Third Intervention||0
3169970|NCT01928381|3897368|FG001|COMPLETED|Part 2 - Post Third Intervention||5
3169971|NCT01928381|3897369|FG002|COMPLETED|Part 2 - Post Third Intervention||3
3169972|NCT01928381|3897370|FG003|COMPLETED|Part 2 - Post Third Intervention||4
3169973|NCT01928381|3897371|FG004|COMPLETED|Part 2 - Post Third Intervention||3
3169974|NCT01928381|3897372|FG005|COMPLETED|Part 2 - Post Third Intervention||5
3169975|NCT01928381|3897373|FG006|COMPLETED|Part 2 - Post Third Intervention||5
3169976|NCT01928381|3897367|FG000|NOT COMPLETED|Part 2 - Post Third Intervention||0
3169977|NCT01928381|3897368|FG001|NOT COMPLETED|Part 2 - Post Third Intervention||0
3169978|NCT01928381|3897369|FG002|NOT COMPLETED|Part 2 - Post Third Intervention||1
2879215|NCT00283049|3584313|FG000|COMPLETED|Overall Study||70
2879216|NCT00283049|3584314|FG001|COMPLETED|Overall Study||83
2879217|NCT00283049|3584315|FG002|COMPLETED|Overall Study||76
2879218|NCT00283049|3584313|FG000|NOT COMPLETED|Overall Study||58
2879219|NCT00283049|3584314|FG001|NOT COMPLETED|Overall Study||45
2879220|NCT00283049|3584315|FG002|NOT COMPLETED|Overall Study||54
2879221|NCT00283062|3584327|FG000|STARTED|Overall Study||55
2879222|NCT00283062|3584328|FG001|STARTED|Overall Study||55
2879223|NCT00283062|3584329|FG002|STARTED|Overall Study||56
2879224|NCT00283062|3584330|FG003|STARTED|Overall Study||62
2879225|NCT00283062|3584327|FG000|ADMINISTERED STUDY TREATMENT|Overall Study||50
2879226|NCT00283062|3584328|FG001|ADMINISTERED STUDY TREATMENT|Overall Study||51
2879227|NCT00283062|3584329|FG002|ADMINISTERED STUDY TREATMENT|Overall Study||20
2879228|NCT00283062|3584330|FG003|ADMINISTERED STUDY TREATMENT|Overall Study||17
2879229|NCT00283062|3584327|FG000|COMPLETED HORMONAL THERAPY (6 Cycles)|Overall Study||44
2879230|NCT00283062|3584328|FG001|COMPLETED HORMONAL THERAPY (6 Cycles)|Overall Study||48
2879231|NCT00283062|3584329|FG002|COMPLETED HORMONAL THERAPY (6 Cycles)|Overall Study||15
2879232|NCT00283062|3584330|FG003|COMPLETED HORMONAL THERAPY (6 Cycles)|Overall Study||13
2879233|NCT00283062|3584327|FG000|COMPLETED CHEMOTHERAPY (6 Cycles)|Overall Study||43
2879234|NCT00283062|3584328|FG001|COMPLETED CHEMOTHERAPY (6 Cycles)|Overall Study|Not applicable, since participants in this arm did not receive chemotherapy.|0
3169979|NCT01928381|3897370|FG003|NOT COMPLETED|Part 2 - Post Third Intervention||0
3169980|NCT01928381|3897371|FG004|NOT COMPLETED|Part 2 - Post Third Intervention||0
3169981|NCT01928381|3897372|FG005|NOT COMPLETED|Part 2 - Post Third Intervention||0
3169982|NCT01928381|3897373|FG006|NOT COMPLETED|Part 2 - Post Third Intervention||0
3169983|NCT01928394|3897406|FG000|STARTED|Treatment Period||18
3169984|NCT01928394|3897407|FG001|STARTED|Treatment Period||3
3169985|NCT01928394|3897408|FG002|STARTED|Treatment Period||18
3169986|NCT01928394|3897409|FG003|STARTED|Treatment Period||59
3169987|NCT01928394|3897410|FG004|STARTED|Treatment Period||3
3169988|NCT01928394|3897411|FG005|STARTED|Treatment Period||49
3169989|NCT01928394|3897412|FG006|STARTED|Treatment Period||52
3169990|NCT01928394|3897413|FG007|STARTED|Treatment Period||18
3169991|NCT01928394|3897414|FG008|STARTED|Treatment Period||3
3169992|NCT01928394|3897415|FG009|STARTED|Treatment Period||18
3169993|NCT01928394|3897416|FG010|STARTED|Treatment Period||30
3169994|NCT01928394|3897417|FG011|STARTED|Treatment Period||98
3169995|NCT01928394|3897418|FG012|STARTED|Treatment Period||61
3169996|NCT01928394|3897419|FG013|STARTED|Treatment Period||147
3169997|NCT01928394|3897420|FG014|STARTED|Treatment Period||96
3169998|NCT01928394|3897421|FG015|STARTED|Treatment Period||3
3169999|NCT01928394|3897422|FG016|STARTED|Treatment Period||55
3170000|NCT01928394|3897423|FG017|STARTED|Treatment Period||78
3170001|NCT01928394|3897424|FG018|STARTED|Treatment Period||92
3170002|NCT01928394|3897425|FG019|STARTED|Treatment Period||104
3170003|NCT01928394|3897426|FG020|STARTED|Treatment Period||41
3170004|NCT01928394|3897427|FG021|STARTED|Treatment Period||43
3170005|NCT01928394|3897428|FG022|STARTED|Treatment Period||42
2879235|NCT00283062|3584329|FG002|COMPLETED CHEMOTHERAPY (6 Cycles)|Overall Study||15
2879236|NCT00283062|3584330|FG003|COMPLETED CHEMOTHERAPY (6 Cycles)|Overall Study|Not applicable, since participants in this arm did not receive chemotherapy.|0
2879237|NCT00283062|3584327|FG000|COMPLETED|Overall Study||43
2879238|NCT00283062|3584328|FG001|COMPLETED|Overall Study||48
2879239|NCT00283062|3584329|FG002|COMPLETED|Overall Study||15
2879240|NCT00283062|3584330|FG003|COMPLETED|Overall Study||13
2879241|NCT00283062|3584327|FG000|NOT COMPLETED|Overall Study||12
2879242|NCT00283062|3584328|FG001|NOT COMPLETED|Overall Study||7
2879243|NCT00283062|3584329|FG002|NOT COMPLETED|Overall Study||41
2879244|NCT00283062|3584330|FG003|NOT COMPLETED|Overall Study||49
2879245|NCT00283075|3584340|FG000|STARTED|Overall Study||25
2879246|NCT00283075|3584341|FG001|STARTED|Overall Study||6
2879247|NCT00283075|3584340|FG000|COMPLETED|Overall Study||25
2879248|NCT00283075|3584341|FG001|COMPLETED|Overall Study||6
2879249|NCT00283075|3584340|FG000|NOT COMPLETED|Overall Study||0
2879250|NCT00283075|3584341|FG001|NOT COMPLETED|Overall Study||0
2879251|NCT00283244|3584355|FG000|STARTED|Overall Study||44
2879252|NCT00283244|3584356|FG001|STARTED|Overall Study||51
2879253|NCT00283244|3584357|FG002|STARTED|Overall Study||51
2879254|NCT00283244|3584355|FG000|COMPLETED|Overall Study|19 patients went on to receive second line Erlotinib|26
2879255|NCT00283244|3584356|FG001|COMPLETED|Overall Study|Patients treated until progression or unacceptable toxicity; 12 patients received 2nd line therapy|0
2879256|NCT00283244|3584357|FG002|COMPLETED|Overall Study|Patients treated until progression or unacceptable toxicity; 9 patients received 2nd line therapy|0
2879257|NCT00283244|3584355|FG000|NOT COMPLETED|Overall Study||18
2879258|NCT00283244|3584356|FG001|NOT COMPLETED|Overall Study||51
2879259|NCT00283244|3584357|FG002|NOT COMPLETED|Overall Study||51
2879260|NCT00283283|3584370|FG000|STARTED|Overall Study||274
2879261|NCT00283283|3584371|FG001|STARTED|Overall Study||284
2879262|NCT00283283|3584372|FG002|STARTED|Overall Study||280
2879263|NCT00283283|3584373|FG003|STARTED|Overall Study||276
2879264|NCT00283283|3584370|FG000|COMPLETED|Overall Study||274
2879265|NCT00283283|3584371|FG001|COMPLETED|Overall Study||284
2879266|NCT00283283|3584372|FG002|COMPLETED|Overall Study||280
2879267|NCT00283283|3584373|FG003|COMPLETED|Overall Study||276
2879268|NCT00283283|3584370|FG000|NOT COMPLETED|Overall Study||0
2879269|NCT00283283|3584371|FG001|NOT COMPLETED|Overall Study||0
2879270|NCT00283283|3584372|FG002|NOT COMPLETED|Overall Study||0
3170006|NCT01928394|3897406|FG000|Transition|Treatment Period||3
3170007|NCT01928394|3897407|FG001|Transition|Treatment Period||0
2879271|NCT00283283|3584373|FG003|NOT COMPLETED|Overall Study||0
2879272|NCT00283296|3584388|FG000|STARTED|Overall Study||14
2879273|NCT00283296|3584388|FG000|COMPLETED|Overall Study|Completed in-lab and in-home trial.|9
2879274|NCT00283296|3584388|FG000|NOT COMPLETED|Overall Study||5
2879275|NCT00283387|3584393|FG000|STARTED|First Intervention||6
2879276|NCT00283387|3584394|FG001|STARTED|First Intervention||7
2879277|NCT00283387|3584393|FG000|COMPLETED|First Intervention||5
2879278|NCT00283387|3584394|FG001|COMPLETED|First Intervention||5
2879279|NCT00283387|3584393|FG000|NOT COMPLETED|First Intervention||1
2879280|NCT00283387|3584394|FG001|NOT COMPLETED|First Intervention||2
2879281|NCT00283387|3584393|FG000|STARTED|Washout Period of 2 Months||5
2879282|NCT00283387|3584394|FG001|STARTED|Washout Period of 2 Months||5
2879283|NCT00283387|3584393|FG000|COMPLETED|Washout Period of 2 Months||5
2879284|NCT00283387|3584394|FG001|COMPLETED|Washout Period of 2 Months||5
2879285|NCT00283387|3584393|FG000|NOT COMPLETED|Washout Period of 2 Months||0
2879286|NCT00283387|3584394|FG001|NOT COMPLETED|Washout Period of 2 Months||0
2879287|NCT00283387|3584393|FG000|STARTED|Second Intervention||5
2879288|NCT00283387|3584394|FG001|STARTED|Second Intervention||5
2879289|NCT00283387|3584393|FG000|COMPLETED|Second Intervention||5
2879290|NCT00283387|3584394|FG001|COMPLETED|Second Intervention||5
2879291|NCT00283387|3584393|FG000|NOT COMPLETED|Second Intervention||0
2879292|NCT00283387|3584394|FG001|NOT COMPLETED|Second Intervention||0
2879293|NCT00283400|3584404|FG000|STARTED|Overall Study||20
2879294|NCT00283400|3584405|FG001|STARTED|Overall Study||20
2879295|NCT00283400|3584406|FG002|STARTED|Overall Study||7
2879296|NCT00283400|3584407|FG003|STARTED|Overall Study||0
2879297|NCT00283400|3584404|FG000|COMPLETED|Overall Study||18
2879298|NCT00283400|3584405|FG001|COMPLETED|Overall Study||19
2879299|NCT00283400|3584406|FG002|COMPLETED|Overall Study||6
2879300|NCT00283400|3584407|FG003|COMPLETED|Overall Study||0
2879301|NCT00283400|3584404|FG000|NOT COMPLETED|Overall Study||2
2879302|NCT00283400|3584405|FG001|NOT COMPLETED|Overall Study||1
2879303|NCT00283400|3584406|FG002|NOT COMPLETED|Overall Study||1
2879304|NCT00283400|3584407|FG003|NOT COMPLETED|Overall Study||0
2879305|NCT00283439|3584421|FG000|STARTED|Overall Study||8
2879306|NCT00283439|3584422|FG001|STARTED|Overall Study||11
2879307|NCT00283439|3584423|FG002|STARTED|Overall Study||11
2879308|NCT00283439|3584424|FG003|STARTED|Overall Study||9
2879309|NCT00283439|3584421|FG000|COMPLETED|Overall Study||0
2879310|NCT00283439|3584422|FG001|COMPLETED|Overall Study||0
2879311|NCT00283439|3584423|FG002|COMPLETED|Overall Study||0
2879312|NCT00283439|3584424|FG003|COMPLETED|Overall Study||0
2879313|NCT00283439|3584421|FG000|NOT COMPLETED|Overall Study||8
2879314|NCT00283439|3584422|FG001|NOT COMPLETED|Overall Study||11
2879315|NCT00283439|3584423|FG002|NOT COMPLETED|Overall Study||11
2879316|NCT00283439|3584424|FG003|NOT COMPLETED|Overall Study||9
2879317|NCT00283504|3584436|FG000|STARTED|Overall Study||7
2879318|NCT00283504|3584437|FG001|STARTED|Overall Study||6
2879319|NCT00283504|3584436|FG000|COMPLETED|Overall Study||7
2879320|NCT00283504|3584437|FG001|COMPLETED|Overall Study||6
2879321|NCT00283504|3584436|FG000|NOT COMPLETED|Overall Study||0
2879322|NCT00283504|3584437|FG001|NOT COMPLETED|Overall Study||0
2879323|NCT00283595|3584447|FG000|STARTED|Overall Study||10
2879324|NCT00283595|3584448|FG001|STARTED|Overall Study||11
2879325|NCT00283595|3584447|FG000|COMPLETED|Overall Study||9
2879326|NCT00283595|3584448|FG001|COMPLETED|Overall Study||9
2879327|NCT00283595|3584447|FG000|NOT COMPLETED|Overall Study||1
2879328|NCT00283595|3584448|FG001|NOT COMPLETED|Overall Study||2
2879329|NCT00283686|3584458|FG000|STARTED|Overall Study||140
2879330|NCT00283686|3584459|FG001|STARTED|Overall Study||133
2879331|NCT00283686|3584460|FG002|STARTED|Overall Study||144
2879332|NCT00283686|3584461|FG003|STARTED|Overall Study||141
2879333|NCT00283686|3584458|FG000|COMPLETED|Overall Study||111
2879334|NCT00283686|3584459|FG001|COMPLETED|Overall Study||92
2879335|NCT00283686|3584460|FG002|COMPLETED|Overall Study||111
2879336|NCT00283686|3584461|FG003|COMPLETED|Overall Study||109
2879337|NCT00283686|3584458|FG000|NOT COMPLETED|Overall Study||29
2879338|NCT00283686|3584459|FG001|NOT COMPLETED|Overall Study||41
2879339|NCT00283686|3584460|FG002|NOT COMPLETED|Overall Study||33
2879340|NCT00283686|3584461|FG003|NOT COMPLETED|Overall Study||32
2879341|NCT00283712|3584473|FG000|STARTED|Overall Study||10
2879342|NCT00283712|3584474|FG001|STARTED|Overall Study||10
2879343|NCT00283712|3584473|FG000|Intent-to-treat Sample|Overall Study||10
2879344|NCT00283712|3584474|FG001|Intent-to-treat Sample|Overall Study||10
2879345|NCT00283712|3584473|FG000|Safety Sample|Overall Study||10
2879346|NCT00283712|3584474|FG001|Safety Sample|Overall Study||10
3170008|NCT01928394|3897408|FG002|Transition|Treatment Period||0
3170009|NCT01928394|3897409|FG003|Transition|Treatment Period||9
3170010|NCT01928394|3897410|FG004|Transition|Treatment Period||0
3170011|NCT01928394|3897411|FG005|Transition|Treatment Period||0
3170012|NCT01928394|3897412|FG006|Transition|Treatment Period||0
3170013|NCT01928394|3897413|FG007|Transition|Treatment Period||2
2879347|NCT00283712|3584473|FG000|Per-Protocol Sample|Overall Study||6
2879348|NCT00283712|3584474|FG001|Per-Protocol Sample|Overall Study||7
2879349|NCT00283712|3584473|FG000|COMPLETED|Overall Study||10
2879350|NCT00283712|3584474|FG001|COMPLETED|Overall Study|One subject in placebo arm died prior to study completion.|9
2879351|NCT00283712|3584473|FG000|NOT COMPLETED|Overall Study||0
2879352|NCT00283712|3584474|FG001|NOT COMPLETED|Overall Study||1
2879353|NCT00283803|3584480|FG000|STARTED|Overall Study||32
2879354|NCT00283803|3584480|FG000|COMPLETED|Overall Study||19
2879355|NCT00283803|3584480|FG000|NOT COMPLETED|Overall Study||13
2879356|NCT00283816|3584486|FG000|STARTED|Overall Study||18
2879357|NCT00283816|3584487|FG001|STARTED|Overall Study||18
2879358|NCT00283816|3584486|FG000|COMPLETED|Overall Study||16
2879359|NCT00283816|3584487|FG001|COMPLETED|Overall Study||16
2879360|NCT00283816|3584486|FG000|NOT COMPLETED|Overall Study||2
2879361|NCT00283816|3584487|FG001|NOT COMPLETED|Overall Study||2
2879362|NCT00283842|3584500|FG000|STARTED|Overall Study||63
2879363|NCT00283842|3584501|FG001|STARTED|Overall Study||87
2879364|NCT00283842|3584502|FG002|STARTED|Overall Study||99
2879365|NCT00283842|3584503|FG003|STARTED|Overall Study||69
2879366|NCT00283842|3584504|FG004|STARTED|Overall Study||90
2879367|NCT00283842|3584500|FG000|COMPLETED|Overall Study||51
2879368|NCT00283842|3584501|FG001|COMPLETED|Overall Study||69
2879369|NCT00283842|3584502|FG002|COMPLETED|Overall Study||68
3170014|NCT01928394|3897414|FG008|Transition|Treatment Period||0
3170015|NCT01928394|3897415|FG009|Transition|Treatment Period||0
3170016|NCT01928394|3897416|FG010|Transition|Treatment Period||0
3170017|NCT01928394|3897417|FG011|Transition|Treatment Period||17
3170018|NCT01928394|3897418|FG012|Transition|Treatment Period||0
3170019|NCT01928394|3897419|FG013|Transition|Treatment Period||2
3170020|NCT01928394|3897420|FG014|Transition|Treatment Period||0
2879370|NCT00283842|3584503|FG003|COMPLETED|Overall Study||42
2879371|NCT00283842|3584504|FG004|COMPLETED|Overall Study||75
2879372|NCT00283842|3584500|FG000|NOT COMPLETED|Overall Study||12
2879373|NCT00283842|3584501|FG001|NOT COMPLETED|Overall Study||18
2879374|NCT00283842|3584502|FG002|NOT COMPLETED|Overall Study||31
2879375|NCT00283842|3584503|FG003|NOT COMPLETED|Overall Study||27
2879376|NCT00283842|3584504|FG004|NOT COMPLETED|Overall Study||15
2879377|NCT00283933|3584516|FG000|STARTED|Treatment Period||5
2879378|NCT00283933|3584516|FG000|Safety Population|Treatment Period||5
2879379|NCT00283933|3584516|FG000|Pharmacodynamic (PD) Population|Treatment Period||5
2879380|NCT00283933|3584516|FG000|COMPLETED|Treatment Period||5
2879381|NCT00283933|3584516|FG000|NOT COMPLETED|Treatment Period||0
2879382|NCT00283933|3584516|FG000|STARTED|Extension Period||5
2879383|NCT00283933|3584516|FG000|COMPLETED|Extension Period||5
2879384|NCT00283933|3584516|FG000|NOT COMPLETED|Extension Period||0
2879385|NCT00284050|3584523|FG000|STARTED|Overall Study||51
2879386|NCT00284050|3584524|FG001|STARTED|Overall Study||51
2879387|NCT00284050|3584525|FG002|STARTED|Overall Study||49
2879388|NCT00284050|3584523|FG000|COMPLETED|Overall Study||46
2879389|NCT00284050|3584524|FG001|COMPLETED|Overall Study||46
2879390|NCT00284050|3584525|FG002|COMPLETED|Overall Study||40
2879391|NCT00284050|3584523|FG000|NOT COMPLETED|Overall Study||5
2879392|NCT00284050|3584524|FG001|NOT COMPLETED|Overall Study||5
2879393|NCT00284050|3584525|FG002|NOT COMPLETED|Overall Study||9
2879394|NCT00284089|3584537|FG000|STARTED|Single Dose Phase||6
2879395|NCT00284089|3584538|FG001|STARTED|Single Dose Phase||6
2879396|NCT00284089|3584539|FG002|STARTED|Single Dose Phase|Group B patients did not participate in the Single Dose Phase of the study.|0
2879397|NCT00284089|3584540|FG003|STARTED|Single Dose Phase|Group B patients did not participate in the Single Dose Phase of the study.|0
2879398|NCT00284089|3584537|FG000|COMPLETED|Single Dose Phase||6
2879399|NCT00284089|3584538|FG001|COMPLETED|Single Dose Phase||6
2879400|NCT00284089|3584539|FG002|COMPLETED|Single Dose Phase||0
2879401|NCT00284089|3584540|FG003|COMPLETED|Single Dose Phase||0
2879402|NCT00284089|3584537|FG000|NOT COMPLETED|Single Dose Phase||0
2879403|NCT00284089|3584538|FG001|NOT COMPLETED|Single Dose Phase||0
2879404|NCT00284089|3584539|FG002|NOT COMPLETED|Single Dose Phase||0
2879405|NCT00284089|3584540|FG003|NOT COMPLETED|Single Dose Phase||0
2879406|NCT00284089|3584537|FG000|STARTED|Multiple Dose Phase|1 subject chose to receive other treatment & discontinued before starting the multiple dose phase.|5
2879407|NCT00284089|3584538|FG001|STARTED|Multiple Dose Phase||6
2879408|NCT00284089|3584539|FG002|STARTED|Multiple Dose Phase||35
2879409|NCT00284089|3584540|FG003|STARTED|Multiple Dose Phase||41
2879410|NCT00284089|3584537|FG000|COMPLETED|Multiple Dose Phase||4
2879411|NCT00284089|3584538|FG001|COMPLETED|Multiple Dose Phase||6
2879412|NCT00284089|3584539|FG002|COMPLETED|Multiple Dose Phase||31
2879413|NCT00284089|3584540|FG003|COMPLETED|Multiple Dose Phase||37
2879414|NCT00284089|3584537|FG000|NOT COMPLETED|Multiple Dose Phase||1
2879415|NCT00284089|3584538|FG001|NOT COMPLETED|Multiple Dose Phase||0
2879416|NCT00284089|3584539|FG002|NOT COMPLETED|Multiple Dose Phase||4
2879417|NCT00284089|3584540|FG003|NOT COMPLETED|Multiple Dose Phase||4
2879418|NCT00284089|3584537|FG000|STARTED|Extension Phase|Patients providing written consent & satisfying eligibility criteria could enter the extension phase|3
2879419|NCT00284089|3584538|FG001|STARTED|Extension Phase|Patients providing written consent & satisfying eligibility criteria could enter the extension phase|6
2879420|NCT00284089|3584539|FG002|STARTED|Extension Phase|Patients providing written consent & satisfying eligibility criteria could enter the extension phase|28
2879421|NCT00284089|3584540|FG003|STARTED|Extension Phase|Patients providing written consent & satisfying eligibility criteria could enter the extension phase|33
2879422|NCT00284089|3584537|FG000|COMPLETED|Extension Phase||1
2879423|NCT00284089|3584538|FG001|COMPLETED|Extension Phase||6
2879424|NCT00284089|3584539|FG002|COMPLETED|Extension Phase||22
2879425|NCT00284089|3584540|FG003|COMPLETED|Extension Phase||21
2879426|NCT00284089|3584537|FG000|NOT COMPLETED|Extension Phase||2
2879427|NCT00284089|3584538|FG001|NOT COMPLETED|Extension Phase||0
2879428|NCT00284089|3584539|FG002|NOT COMPLETED|Extension Phase||6
3170021|NCT01928394|3897421|FG015|Transition|Treatment Period||0
2879429|NCT00284089|3584540|FG003|NOT COMPLETED|Extension Phase||12
2879430|NCT00284141|3584550|FG000|STARTED|Overall Study||98
2879431|NCT00284141|3584550|FG000|TREATED|Overall Study|Participants received at least part of one dose of Aflibercept.|96
2879432|NCT00284141|3584550|FG000|ONGOING TREATMENT|Overall Study|Participants were still on study treatment at the clinical database cut-off date.|2
2879433|NCT00284141|3584550|FG000|COMPLETED|Overall Study|Participants met treatment discontinuation criteria or were still ongoing treatment.|0
2879434|NCT00284141|3584550|FG000|NOT COMPLETED|Overall Study||98
2879435|NCT00284154|3584556|FG000|STARTED|Overall Study||51
2879436|NCT00284154|3584556|FG000|COMPLETED|Overall Study||9
2879437|NCT00284154|3584556|FG000|NOT COMPLETED|Overall Study||42
2879438|NCT00284180|3584562|FG000|STARTED|Overall Study||11
2879439|NCT00284180|3584563|FG001|STARTED|Overall Study||21
2879440|NCT00284180|3584562|FG000|COMPLETED|Overall Study||11
2879441|NCT00284180|3584563|FG001|COMPLETED|Overall Study||17
2879442|NCT00284180|3584562|FG000|NOT COMPLETED|Overall Study||0
2879443|NCT00284180|3584563|FG001|NOT COMPLETED|Overall Study||4
2879444|NCT00284518|3584573|FG000|STARTED|Overall Study||97
2879445|NCT00284518|3584574|FG001|STARTED|Overall Study||94
2879446|NCT00284518|3584575|FG002|STARTED|Overall Study||95
2879447|NCT00284518|3584576|FG003|STARTED|Overall Study||94
2879448|NCT00284518|3584573|FG000|COMPLETED|Overall Study||71
2879449|NCT00284518|3584574|FG001|COMPLETED|Overall Study||66
2879450|NCT00284518|3584575|FG002|COMPLETED|Overall Study||67
2879451|NCT00284518|3584576|FG003|COMPLETED|Overall Study||61
2879452|NCT00284518|3584573|FG000|NOT COMPLETED|Overall Study||26
2879453|NCT00284518|3584574|FG001|NOT COMPLETED|Overall Study||28
2879454|NCT00284518|3584575|FG002|NOT COMPLETED|Overall Study||28
2879455|NCT00284518|3584576|FG003|NOT COMPLETED|Overall Study||33
2879456|NCT00284557|3584588|FG000|STARTED|Overall Study||67
2879457|NCT00284557|3584589|FG001|STARTED|Overall Study||63
2879458|NCT00284557|3584588|FG000|COMPLETED|Overall Study||58
2879459|NCT00284557|3584589|FG001|COMPLETED|Overall Study||50
2879460|NCT00284557|3584588|FG000|NOT COMPLETED|Overall Study||9
2879461|NCT00284557|3584589|FG001|NOT COMPLETED|Overall Study||13
2879462|NCT00284739|3584597|FG000|STARTED|Overall Study||11
2879463|NCT00284739|3584598|FG001|STARTED|Overall Study||9
2879464|NCT00284739|3584597|FG000|COMPLETED|Overall Study||11
2879465|NCT00284739|3584598|FG001|COMPLETED|Overall Study||9
2879466|NCT00284739|3584597|FG000|NOT COMPLETED|Overall Study||0
2879467|NCT00284739|3584598|FG001|NOT COMPLETED|Overall Study||0
2879468|NCT00284934|3584606|FG000|STARTED|Overall Study||48
2879469|NCT00284934|3584607|FG001|STARTED|Overall Study||46
2879470|NCT00284934|3584606|FG000|Intent-to-treat Population (ITT)|Overall Study||47
2879471|NCT00284934|3584607|FG001|Intent-to-treat Population (ITT)|Overall Study||45
2879472|NCT00284934|3584606|FG000|COMPLETED|Overall Study||44
2879473|NCT00284934|3584607|FG001|COMPLETED|Overall Study||43
2879474|NCT00284934|3584606|FG000|NOT COMPLETED|Overall Study||4
2879475|NCT00284934|3584607|FG001|NOT COMPLETED|Overall Study||3
2879476|NCT00285012|3584615|FG000|STARTED|Assigned to Study Treatment (Tx)||250
2879477|NCT00285012|3584616|FG001|STARTED|Assigned to Study Treatment (Tx)||254
2879478|NCT00285012|3584615|FG000|COMPLETED|Assigned to Study Treatment (Tx)||248
2879479|NCT00285012|3584616|FG001|COMPLETED|Assigned to Study Treatment (Tx)||251
2879480|NCT00285012|3584615|FG000|NOT COMPLETED|Assigned to Study Treatment (Tx)||2
2879481|NCT00285012|3584616|FG001|NOT COMPLETED|Assigned to Study Treatment (Tx)||3
2879482|NCT00285012|3584615|FG000|STARTED|Received Study Tx||248
2879483|NCT00285012|3584616|FG001|STARTED|Received Study Tx||251
2879484|NCT00285012|3584615|FG000|Completed Tx (May Continue in Study)|Received Study Tx|After treatment completion at Wk 12, subjects may continue in nontreatment follow-up phase|207
2879485|NCT00285012|3584616|FG001|Completed Tx (May Continue in Study)|Received Study Tx|After treatment completion at Wk 12, subjects may continue in nontreatment follow-up phase|193
2879486|NCT00285012|3584615|FG000|Discontinued Tx (May Continue in Study)|Received Study Tx|Discontinued Tx=12 Adverse Event (AE); 10 Lost to follow up; 13 subject withdrawal; 6 other, unknown|41
2879487|NCT00285012|3584616|FG001|Discontinued Tx (May Continue in Study)|Received Study Tx|Discontinued Tx=14 AE;3 Lack of efficacy;10 Lost to follow up;25 subject withdrawal;6 other, unknown|58
2879488|NCT00285012|3584615|FG000|COMPLETED|Received Study Tx|Completed study through nontreatment follow-up phase Week 13 to Week 52|176
2879489|NCT00285012|3584616|FG001|COMPLETED|Received Study Tx|Completed study through nontreatment follow-up phase Week 13 to Week 52|157
2879490|NCT00285012|3584615|FG000|NOT COMPLETED|Received Study Tx||72
2879491|NCT00285012|3584616|FG001|NOT COMPLETED|Received Study Tx||94
2879492|NCT00285207|3584624|FG000|STARTED|Overall Study||70
2879493|NCT00285207|3584625|FG001|STARTED|Overall Study||77
2879494|NCT00285207|3584624|FG000|Treated|Overall Study||63
2879495|NCT00285207|3584625|FG001|Treated|Overall Study||75
2879496|NCT00285207|3584624|FG000|COMPLETED|Overall Study||61
2879497|NCT00285207|3584625|FG001|COMPLETED|Overall Study||71
2879498|NCT00285207|3584624|FG000|NOT COMPLETED|Overall Study||9
2879499|NCT00285207|3584625|FG001|NOT COMPLETED|Overall Study||6
2879500|NCT00285246|3584631|FG000|STARTED|Overall Study||838
2879501|NCT00285246|3584631|FG000|COMPLETED|Overall Study|Number of participants who were eligible and completed at least one phase of data collection|790
2879502|NCT00285246|3584631|FG000|NOT COMPLETED|Overall Study||48
2879503|NCT00285467|3584637|FG000|STARTED|Overall Study||25
2879504|NCT00285467|3584638|FG001|STARTED|Overall Study||22
2879505|NCT00285467|3584637|FG000|COMPLETED|Overall Study||25
2879506|NCT00285467|3584638|FG001|COMPLETED|Overall Study||22
2879507|NCT00285467|3584637|FG000|NOT COMPLETED|Overall Study||0
2879508|NCT00285467|3584638|FG001|NOT COMPLETED|Overall Study||0
2879509|NCT00285584|3584646|FG000|STARTED|Enrollment (Month 0)||20
2879510|NCT00285584|3584647|FG001|STARTED|Enrollment (Month 0)||21
2879511|NCT00285584|3584646|FG000|COMPLETED|Enrollment (Month 0)||20
2879512|NCT00285584|3584647|FG001|COMPLETED|Enrollment (Month 0)||21
2879513|NCT00285584|3584646|FG000|NOT COMPLETED|Enrollment (Month 0)||0
2879514|NCT00285584|3584647|FG001|NOT COMPLETED|Enrollment (Month 0)||0
2879515|NCT00285584|3584646|FG000|STARTED|Month 3||20
2879516|NCT00285584|3584647|FG001|STARTED|Month 3||21
2879517|NCT00285584|3584646|FG000|COMPLETED|Month 3||16
2879518|NCT00285584|3584647|FG001|COMPLETED|Month 3||18
2879519|NCT00285584|3584646|FG000|NOT COMPLETED|Month 3||4
2879520|NCT00285584|3584647|FG001|NOT COMPLETED|Month 3||3
2879521|NCT00285584|3584646|FG000|STARTED|Month 6||16
2879522|NCT00285584|3584647|FG001|STARTED|Month 6||18
2879523|NCT00285584|3584646|FG000|COMPLETED|Month 6||16
2879524|NCT00285584|3584647|FG001|COMPLETED|Month 6||17
2879525|NCT00285584|3584646|FG000|NOT COMPLETED|Month 6||0
2879526|NCT00285584|3584647|FG001|NOT COMPLETED|Month 6||1
2879527|NCT00285584|3584646|FG000|STARTED|Month 9||16
2879528|NCT00285584|3584647|FG001|STARTED|Month 9||17
2879529|NCT00285584|3584646|FG000|COMPLETED|Month 9||15
2879530|NCT00285584|3584647|FG001|COMPLETED|Month 9||14
2879531|NCT00285584|3584646|FG000|NOT COMPLETED|Month 9||1
2879532|NCT00285584|3584647|FG001|NOT COMPLETED|Month 9||3
2879533|NCT00285649|3584660|FG000|STARTED|Overall Study||72
2879534|NCT00285649|3584661|FG001|STARTED|Overall Study||72
2879535|NCT00285649|3584662|FG002|STARTED|Overall Study||48
2879536|NCT00285649|3584660|FG000|COMPLETED|Overall Study||63
2879537|NCT00285649|3584661|FG001|COMPLETED|Overall Study||66
2879538|NCT00285649|3584662|FG002|COMPLETED|Overall Study||42
2879539|NCT00285649|3584660|FG000|NOT COMPLETED|Overall Study||9
2879540|NCT00285649|3584661|FG001|NOT COMPLETED|Overall Study||6
2879541|NCT00285649|3584662|FG002|NOT COMPLETED|Overall Study||6
2879542|NCT00285779|3584672|FG000|STARTED|Placebo-controlled Period (wk 1-12)||14
2879543|NCT00285779|3584673|FG001|STARTED|Placebo-controlled Period (wk 1-12)||13
2879544|NCT00285779|3584672|FG000|COMPLETED|Placebo-controlled Period (wk 1-12)||11
2879545|NCT00285779|3584673|FG001|COMPLETED|Placebo-controlled Period (wk 1-12)||12
2879546|NCT00285779|3584672|FG000|NOT COMPLETED|Placebo-controlled Period (wk 1-12)||3
2879547|NCT00285779|3584673|FG001|NOT COMPLETED|Placebo-controlled Period (wk 1-12)||1
2879548|NCT00285779|3584672|FG000|STARTED|Open Label Period (wk 12-24)||11
2879549|NCT00285779|3584673|FG001|STARTED|Open Label Period (wk 12-24)||12
2879550|NCT00285779|3584672|FG000|COMPLETED|Open Label Period (wk 12-24)||9
2879551|NCT00285779|3584673|FG001|COMPLETED|Open Label Period (wk 12-24)||10
2879552|NCT00285779|3584672|FG000|NOT COMPLETED|Open Label Period (wk 12-24)||2
2879553|NCT00285779|3584673|FG001|NOT COMPLETED|Open Label Period (wk 12-24)||2
2879554|NCT00285779|3584672|FG000|STARTED|Follow-up Period (wk 24-32)||9
2879555|NCT00285779|3584673|FG001|STARTED|Follow-up Period (wk 24-32)||10
2879556|NCT00285779|3584672|FG000|COMPLETED|Follow-up Period (wk 24-32)||8
2879557|NCT00285779|3584673|FG001|COMPLETED|Follow-up Period (wk 24-32)||10
2879558|NCT00285779|3584672|FG000|NOT COMPLETED|Follow-up Period (wk 24-32)||1
2879559|NCT00285779|3584673|FG001|NOT COMPLETED|Follow-up Period (wk 24-32)||0
2879560|NCT00285818|3584681|FG000|STARTED|Overall Study||6
3170022|NCT01928394|3897422|FG016|Transition|Treatment Period||0
3170023|NCT01928394|3897423|FG017|Transition|Treatment Period||20
3170024|NCT01928394|3897424|FG018|Transition|Treatment Period||0
2879561|NCT00285818|3584682|FG001|STARTED|Overall Study||5
2879562|NCT00285818|3584681|FG000|COMPLETED|Overall Study||2
2879563|NCT00285818|3584682|FG001|COMPLETED|Overall Study||3
2879564|NCT00285818|3584681|FG000|NOT COMPLETED|Overall Study||4
3170025|NCT01928394|3897425|FG019|Transition|Treatment Period||0
3170026|NCT01928394|3897426|FG020|Transition|Treatment Period||0
3170027|NCT01928394|3897427|FG021|Transition|Treatment Period||0
3170028|NCT01928394|3897428|FG022|Transition|Treatment Period||0
3170029|NCT01928394|3897406|FG000|Transition- Continued|Treatment Period||0
3170030|NCT01928394|3897407|FG001|Transition- Continued|Treatment Period||0
3170031|NCT01928394|3897408|FG002|Transition- Continued|Treatment Period||3
3170032|NCT01928394|3897409|FG003|Transition- Continued|Treatment Period||0
2879565|NCT00285818|3584682|FG001|NOT COMPLETED|Overall Study||2
2879566|NCT00285857|3584688|FG000|STARTED|Overall Study||30
2879567|NCT00285857|3584688|FG000|COMPLETED|Overall Study||26
2879568|NCT00285857|3584688|FG000|NOT COMPLETED|Overall Study||4
2879569|NCT00286078|3584699|FG000|STARTED|Overall Study||72
2879570|NCT00286078|3584700|FG001|STARTED|Overall Study||68
2879571|NCT00286078|3584699|FG000|12 Weeks|Overall Study||63
2879572|NCT00286078|3584700|FG001|12 Weeks|Overall Study||62
2879573|NCT00286078|3584699|FG000|COMPLETED|Overall Study||40
2879574|NCT00286078|3584700|FG001|COMPLETED|Overall Study||34
2879575|NCT00286078|3584699|FG000|NOT COMPLETED|Overall Study||32
2879576|NCT00286078|3584700|FG001|NOT COMPLETED|Overall Study||34
2879577|NCT00286091|3584708|FG000|STARTED|Double-blind Treatment Phase||716
2879578|NCT00286091|3584709|FG001|STARTED|Double-blind Treatment Phase||716
2879579|NCT00286091|3584708|FG000|Received Treatment|Double-blind Treatment Phase|4 participants received ≥ 1 dose of denosumab in error|709
2879580|NCT00286091|3584709|FG001|Received Treatment|Double-blind Treatment Phase||716
2879581|NCT00286091|3584708|FG000|On Study at Primary Data Analysis Cutoff|Double-blind Treatment Phase|Primary analysis cut-off date was 30 July 2010|164
2879582|NCT00286091|3584709|FG001|On Study at Primary Data Analysis Cutoff|Double-blind Treatment Phase|Primary analysis cut-off date was 30 July 2010|174
2879583|NCT00286091|3584708|FG000|COMPLETED|Double-blind Treatment Phase|On study through blinded treatment cutoff date of 09 January 2011|132
2879584|NCT00286091|3584709|FG001|COMPLETED|Double-blind Treatment Phase|On study through blinded treatment cutoff date of 09 January 2011|123
2879585|NCT00286091|3584708|FG000|NOT COMPLETED|Double-blind Treatment Phase||584
2879586|NCT00286091|3584709|FG001|NOT COMPLETED|Double-blind Treatment Phase||593
2879587|NCT00286091|3584708|FG000|STARTED|Open-label Treatment Phase|Participants in the Czech Republic and UK are reported separately (Study 20080585; NCT01824342)|110
2879588|NCT00286091|3584709|FG001|STARTED|Open-label Treatment Phase|Participants in the Czech Republic and UK are reported separately (Study 20080585; NCT01824342)|104
2879589|NCT00286091|3584708|FG000|Received Treatment|Open-label Treatment Phase||109
2879590|NCT00286091|3584709|FG001|Received Treatment|Open-label Treatment Phase||101
2879591|NCT00286091|3584708|FG000|COMPLETED|Open-label Treatment Phase|Completed 3 years of open-label treatment|33
2879592|NCT00286091|3584709|FG001|COMPLETED|Open-label Treatment Phase|Completed 3 years of open-label treatment|33
2879593|NCT00286091|3584708|FG000|NOT COMPLETED|Open-label Treatment Phase||77
2879594|NCT00286091|3584709|FG001|NOT COMPLETED|Open-label Treatment Phase||71
2879595|NCT00286156|3584720|FG000|STARTED|Overall Study||10
2879596|NCT00286156|3584721|FG001|STARTED|Overall Study||10
2879597|NCT00286156|3584722|FG002|STARTED|Overall Study||10
2879598|NCT00286156|3584720|FG000|COMPLETED|Overall Study||8
2879599|NCT00286156|3584721|FG001|COMPLETED|Overall Study||9
2879600|NCT00286156|3584722|FG002|COMPLETED|Overall Study||9
2879601|NCT00286156|3584720|FG000|NOT COMPLETED|Overall Study||2
2879602|NCT00286156|3584721|FG001|NOT COMPLETED|Overall Study||1
2879603|NCT00286156|3584722|FG002|NOT COMPLETED|Overall Study||1
2879604|NCT00286182|3584732|FG000|STARTED|Overall Study||28
2879605|NCT00286182|3584733|FG001|STARTED|Overall Study||28
2879606|NCT00286182|3584732|FG000|COMPLETED|Overall Study||23
2879607|NCT00286182|3584733|FG001|COMPLETED|Overall Study||25
2879608|NCT00286182|3584732|FG000|NOT COMPLETED|Overall Study||5
2879609|NCT00286182|3584733|FG001|NOT COMPLETED|Overall Study||3
2879610|NCT00286221|3584743|FG000|STARTED|Overall Study||39
2879611|NCT00286221|3584744|FG001|STARTED|Overall Study||40
2879612|NCT00286221|3584745|FG002|STARTED|Overall Study||40
2879613|NCT00286221|3584746|FG003|STARTED|Overall Study||40
2879614|NCT00286221|3584743|FG000|COMPLETED|Overall Study||29
2879615|NCT00286221|3584744|FG001|COMPLETED|Overall Study||35
2879616|NCT00286221|3584745|FG002|COMPLETED|Overall Study||31
2879617|NCT00286221|3584746|FG003|COMPLETED|Overall Study||34
2879618|NCT00286221|3584743|FG000|NOT COMPLETED|Overall Study||10
2879619|NCT00286221|3584744|FG001|NOT COMPLETED|Overall Study||5
2879620|NCT00286221|3584745|FG002|NOT COMPLETED|Overall Study||9
2879621|NCT00286221|3584746|FG003|NOT COMPLETED|Overall Study||6
2879622|NCT00286234|3584760|FG000|STARTED|Overall Study||17
2879623|NCT00286234|3584761|FG001|STARTED|Overall Study||17
2879624|NCT00286234|3584762|FG002|STARTED|Overall Study||17
2879625|NCT00286234|3584763|FG003|STARTED|Overall Study||17
2879626|NCT00286234|3584760|FG000|COMPLETED|Overall Study||15
2879627|NCT00286234|3584761|FG001|COMPLETED|Overall Study||15
2879628|NCT00286234|3584762|FG002|COMPLETED|Overall Study||17
2879629|NCT00286234|3584763|FG003|COMPLETED|Overall Study||13
2879630|NCT00286234|3584760|FG000|NOT COMPLETED|Overall Study||2
2879631|NCT00286234|3584761|FG001|NOT COMPLETED|Overall Study||2
2879632|NCT00286234|3584762|FG002|NOT COMPLETED|Overall Study||0
2879633|NCT00286234|3584763|FG003|NOT COMPLETED|Overall Study||4
2879634|NCT00286325|3584773|FG000|STARTED|Overall Study||8
2879635|NCT00286325|3584773|FG000|COMPLETED|Overall Study||8
2879636|NCT00286325|3584773|FG000|NOT COMPLETED|Overall Study||0
2879637|NCT00286429|3584780|FG000|STARTED|Overall Study||130
2879638|NCT00286429|3584781|FG001|STARTED|Overall Study||131
2879639|NCT00286429|3584782|FG002|STARTED|Overall Study||129
2879640|NCT00286429|3584780|FG000|COMPLETED|Overall Study||55
2879641|NCT00286429|3584781|FG001|COMPLETED|Overall Study||83
2879642|NCT00286429|3584782|FG002|COMPLETED|Overall Study||77
2879643|NCT00286429|3584780|FG000|NOT COMPLETED|Overall Study||75
2879644|NCT00286429|3584781|FG001|NOT COMPLETED|Overall Study||48
2879645|NCT00286429|3584782|FG002|NOT COMPLETED|Overall Study||52
2879646|NCT00286442|3584793|FG000|STARTED|Overall Study||213
2879647|NCT00286442|3584794|FG001|STARTED|Overall Study||210
2879648|NCT00286442|3584795|FG002|STARTED|Overall Study||104
2879649|NCT00286442|3584793|FG000|COMPLETED|Overall Study||176
2879650|NCT00286442|3584794|FG001|COMPLETED|Overall Study||165
2879651|NCT00286442|3584795|FG002|COMPLETED|Overall Study||72
2879652|NCT00286442|3584793|FG000|NOT COMPLETED|Overall Study||37
2879653|NCT00286442|3584794|FG001|NOT COMPLETED|Overall Study||45
2879654|NCT00286442|3584795|FG002|NOT COMPLETED|Overall Study||32
2879655|NCT00286455|3584806|FG000|STARTED|Overall Study||65
2879656|NCT00286455|3584807|FG001|STARTED|Overall Study||133
2879657|NCT00286455|3584808|FG002|STARTED|Overall Study||131
2879658|NCT00286455|3584806|FG000|COMPLETED|Overall Study||40
2879659|NCT00286455|3584807|FG001|COMPLETED|Overall Study||105
2879660|NCT00286455|3584808|FG002|COMPLETED|Overall Study||107
2879661|NCT00286455|3584806|FG000|NOT COMPLETED|Overall Study||25
2879662|NCT00286455|3584807|FG001|NOT COMPLETED|Overall Study||28
2879663|NCT00286455|3584808|FG002|NOT COMPLETED|Overall Study||24
2879664|NCT00286468|3584819|FG000|STARTED|Overall Study||99
2879665|NCT00286468|3584820|FG001|STARTED|Overall Study||203
2879666|NCT00286468|3584821|FG002|STARTED|Overall Study||198
2879667|NCT00286468|3584819|FG000|COMPLETED|Overall Study||62
2879668|NCT00286468|3584820|FG001|COMPLETED|Overall Study||153
2879669|NCT00286468|3584821|FG002|COMPLETED|Overall Study||148
2879670|NCT00286468|3584819|FG000|NOT COMPLETED|Overall Study||37
2879671|NCT00286468|3584820|FG001|NOT COMPLETED|Overall Study||50
2879672|NCT00286468|3584821|FG002|NOT COMPLETED|Overall Study||50
2879673|NCT00286494|3584832|FG000|STARTED|Overall Study||97
2879674|NCT00286494|3584833|FG001|STARTED|Overall Study||197
2879675|NCT00286494|3584834|FG002|STARTED|Overall Study||199
2879676|NCT00286494|3584832|FG000|COMPLETED|Overall Study||71
2879677|NCT00286494|3584833|FG001|COMPLETED|Overall Study||153
2879678|NCT00286494|3584834|FG002|COMPLETED|Overall Study||160
2879679|NCT00286494|3584832|FG000|NOT COMPLETED|Overall Study||26
2879680|NCT00286494|3584833|FG001|NOT COMPLETED|Overall Study||44
2879681|NCT00286494|3584834|FG002|NOT COMPLETED|Overall Study||39
2879682|NCT00286728|3584844|FG000|STARTED|Overall Study||142
2879683|NCT00286728|3584845|FG001|STARTED|Overall Study||145
2879684|NCT00286728|3584844|FG000|COMPLETED|Overall Study||106
2879685|NCT00286728|3584845|FG001|COMPLETED|Overall Study||116
2879686|NCT00286728|3584844|FG000|NOT COMPLETED|Overall Study||36
2879687|NCT00286728|3584845|FG001|NOT COMPLETED|Overall Study||29
2879688|NCT00286741|3584853|FG000|STARTED|Overall Study||133
2879689|NCT00286741|3584854|FG001|STARTED|Overall Study||106
2879690|NCT00286741|3584853|FG000|COMPLETED|Overall Study||122
2879691|NCT00286741|3584854|FG001|COMPLETED|Overall Study||89
2879692|NCT00286741|3584853|FG000|NOT COMPLETED|Overall Study||11
2879693|NCT00286741|3584854|FG001|NOT COMPLETED|Overall Study||17
2879694|NCT00286754|3584866|FG000|STARTED|Overall Study||176
2879695|NCT00286754|3584867|FG001|STARTED|Overall Study||177
2879696|NCT00286754|3584868|FG002|STARTED|Overall Study||180
2879697|NCT00286754|3584866|FG000|COMPLETED|Overall Study||156
2879698|NCT00286754|3584867|FG001|COMPLETED|Overall Study||159
2879699|NCT00286754|3584868|FG002|COMPLETED|Overall Study||170
2879700|NCT00286754|3584866|FG000|NOT COMPLETED|Overall Study||20
2879701|NCT00286754|3584867|FG001|NOT COMPLETED|Overall Study||18
2879702|NCT00286754|3584868|FG002|NOT COMPLETED|Overall Study||10
2879703|NCT00286949|3584882|FG000|STARTED|Overall Study||12
2879704|NCT00286949|3584882|FG000|COMPLETED|Overall Study||12
2879705|NCT00286949|3584882|FG000|NOT COMPLETED|Overall Study||0
2879706|NCT00287053|3584890|FG000|STARTED|Overall Study||30
2879707|NCT00287053|3584891|FG001|STARTED|Overall Study||27
2879708|NCT00287053|3584890|FG000|COMPLETED|Overall Study||26
2879709|NCT00287053|3584891|FG001|COMPLETED|Overall Study||26
2879710|NCT00287053|3584890|FG000|NOT COMPLETED|Overall Study||4
2879711|NCT00287053|3584891|FG001|NOT COMPLETED|Overall Study||1
2879712|NCT00287079|3584899|FG000|STARTED|Overall Study||32
2879713|NCT00287079|3584900|FG001|STARTED|Overall Study||3
2879714|NCT00287079|3584899|FG000|COMPLETED|Overall Study||10
2879715|NCT00287079|3584900|FG001|COMPLETED|Overall Study||2
2879716|NCT00287079|3584899|FG000|NOT COMPLETED|Overall Study||22
2879717|NCT00287079|3584900|FG001|NOT COMPLETED|Overall Study||1
2879718|NCT00287118|3584906|FG000|STARTED|Overall Study||189
2879719|NCT00287118|3584906|FG000|COMPLETED|Overall Study||137
2879720|NCT00287118|3584906|FG000|NOT COMPLETED|Overall Study||52
2879721|NCT00287222|3584910|FG000|STARTED|Overall Study||21
2879722|NCT00287222|3584910|FG000|COMPLETED|Overall Study||21
2879723|NCT00287222|3584910|FG000|NOT COMPLETED|Overall Study||0
2879724|NCT00287287|3584914|FG000|STARTED|Overall Study||25
2879725|NCT00287287|3584914|FG000|COMPLETED|Overall Study||25
2879726|NCT00287287|3584914|FG000|NOT COMPLETED|Overall Study||0
2879727|NCT00287339|3584920|FG000|STARTED|Overall Study||22
2879728|NCT00287339|3584921|FG001|STARTED|Overall Study||18
2879729|NCT00287339|3584920|FG000|COMPLETED|Overall Study||22
2879730|NCT00287339|3584921|FG001|COMPLETED|Overall Study||18
2879731|NCT00287339|3584920|FG000|NOT COMPLETED|Overall Study||0
2879732|NCT00287339|3584921|FG001|NOT COMPLETED|Overall Study||0
2879733|NCT00287365|3584927|FG000|STARTED|Overall Study||25
2879734|NCT00287365|3584927|FG000|COMPLETED|Overall Study||12
2879735|NCT00287365|3584927|FG000|NOT COMPLETED|Overall Study||13
2879736|NCT00287469|3584934|FG000|STARTED|Overall Study||1000
2879737|NCT00287469|3584935|FG001|STARTED|Overall Study||1000
2879738|NCT00287469|3584934|FG000|COMPLETED|Overall Study||780
2879739|NCT00287469|3584935|FG001|COMPLETED|Overall Study||786
2879740|NCT00287469|3584934|FG000|NOT COMPLETED|Overall Study||220
2879741|NCT00287469|3584935|FG001|NOT COMPLETED|Overall Study||214
2879742|NCT00287586|3584945|FG000|STARTED|Overall Study||156
2879743|NCT00287586|3584946|FG001|STARTED|Overall Study||152
2879744|NCT00287586|3584945|FG000|Intent-to-treat: Received Study Drug|Overall Study||155
2879745|NCT00287586|3584946|FG001|Intent-to-treat: Received Study Drug|Overall Study||151
2879746|NCT00287586|3584945|FG000|COMPLETED|Overall Study||111
2879747|NCT00287586|3584946|FG001|COMPLETED|Overall Study||100
2879748|NCT00287586|3584945|FG000|NOT COMPLETED|Overall Study||45
2879749|NCT00287586|3584946|FG001|NOT COMPLETED|Overall Study||52
2879750|NCT00287690|3584954|FG000|STARTED|Overall Study||33
2879751|NCT00287690|3584955|FG001|STARTED|Overall Study||38
2879752|NCT00287690|3584954|FG000|COMPLETED|Overall Study||13
2879753|NCT00287690|3584955|FG001|COMPLETED|Overall Study||12
2879754|NCT00287690|3584954|FG000|NOT COMPLETED|Overall Study||20
2879755|NCT00287690|3584955|FG001|NOT COMPLETED|Overall Study||26
2879756|NCT00287716|3584964|FG000|STARTED|Overall Study||174
2879757|NCT00287716|3584965|FG001|STARTED|Overall Study||87
2879758|NCT00287716|3584966|FG002|STARTED|Overall Study||174
2879759|NCT00287716|3584964|FG000|COMPLETED|Overall Study||136
2879760|NCT00287716|3584965|FG001|COMPLETED|Overall Study||70
2879761|NCT00287716|3584966|FG002|COMPLETED|Overall Study||143
2879762|NCT00287716|3584964|FG000|NOT COMPLETED|Overall Study||38
2879763|NCT00287716|3584965|FG001|NOT COMPLETED|Overall Study||17
2879764|NCT00287716|3584966|FG002|NOT COMPLETED|Overall Study||31
2879765|NCT00287729|3584976|FG000|STARTED|Overall Study||171
2879766|NCT00287729|3584977|FG001|STARTED|Overall Study||173
2879767|NCT00287729|3584976|FG000|COMPLETED|Overall Study||137
2879768|NCT00287729|3584977|FG001|COMPLETED|Overall Study||142
2879769|NCT00287729|3584976|FG000|NOT COMPLETED|Overall Study||34
2879770|NCT00287729|3584977|FG001|NOT COMPLETED|Overall Study||31
2879771|NCT00287872|3584983|FG000|STARTED|Overall Study||30
2879772|NCT00287872|3584983|FG000|COMPLETED|Overall Study||30
2879773|NCT00287872|3584983|FG000|NOT COMPLETED|Overall Study||0
2879774|NCT00287989|3584991|FG000|STARTED|Overall Study||28
2879775|NCT00287989|3584992|FG001|STARTED|Overall Study||29
2879776|NCT00287989|3584993|FG002|STARTED|Overall Study||29
2879777|NCT00287989|3584991|FG000|COMPLETED|Overall Study||28
2879778|NCT00287989|3584992|FG001|COMPLETED|Overall Study||29
2879779|NCT00287989|3584993|FG002|COMPLETED|Overall Study||29
2879780|NCT00287989|3584991|FG000|NOT COMPLETED|Overall Study||0
2879781|NCT00287989|3584992|FG001|NOT COMPLETED|Overall Study||0
2879782|NCT00287989|3584993|FG002|NOT COMPLETED|Overall Study||0
2879783|NCT00288015|3585001|FG000|STARTED|Registered to Study||32
2879784|NCT00288015|3585001|FG000|COMPLETED|Registered to Study||32
2879785|NCT00288015|3585001|FG000|NOT COMPLETED|Registered to Study||0
2879786|NCT00288015|3585001|FG000|STARTED|Bevacizumab Treatment Cycles 1-2||32
2879787|NCT00288015|3585001|FG000|COMPLETED|Bevacizumab Treatment Cycles 1-2||30
2879788|NCT00288015|3585001|FG000|NOT COMPLETED|Bevacizumab Treatment Cycles 1-2||2
2879789|NCT00288015|3585001|FG000|STARTED|First Response Assessment||30
2879790|NCT00288015|3585001|FG000|COMPLETED|First Response Assessment||26
3170033|NCT01928394|3897410|FG004|Transition- Continued|Treatment Period||0
3170034|NCT01928394|3897411|FG005|Transition- Continued|Treatment Period||3
3170035|NCT01928394|3897412|FG006|Transition- Continued|Treatment Period||6
3170036|NCT01928394|3897413|FG007|Transition- Continued|Treatment Period||0
2879791|NCT00288015|3585001|FG000|NOT COMPLETED|First Response Assessment||4
2879792|NCT00288015|3585001|FG000|STARTED|Continued Bevacizumab Cycle 3+||26
2879793|NCT00288015|3585001|FG000|COMPLETED|Continued Bevacizumab Cycle 3+||19
2879794|NCT00288015|3585001|FG000|NOT COMPLETED|Continued Bevacizumab Cycle 3+||7
2879795|NCT00288015|3585001|FG000|STARTED|Follow up for Survival x 2 Years||29
2879796|NCT00288015|3585001|FG000|COMPLETED|Follow up for Survival x 2 Years||3
2879797|NCT00288015|3585001|FG000|NOT COMPLETED|Follow up for Survival x 2 Years||26
2879798|NCT00288054|3585005|FG000|STARTED|Overall Study||24
2879799|NCT00288054|3585005|FG000|COMPLETED|Overall Study||0
2879800|NCT00288054|3585005|FG000|NOT COMPLETED|Overall Study||24
2879801|NCT00288067|3585011|FG000|STARTED|Overall Study||32
2879802|NCT00288067|3585011|FG000|COMPLETED|Overall Study||32
3314647|NCT03089879|4047917|FG000|NOT COMPLETED|Overall Study||0
3314648|NCT03089879|4047918|FG001|NOT COMPLETED|Overall Study||0
3314649|NCT03089879|4047919|FG002|NOT COMPLETED|Overall Study||0
3314650|NCT03089944|4047928|FG000|STARTED|Overall Study||343
3314651|NCT03089944|4047928|FG000|COMPLETED|Overall Study||331
3314652|NCT03089944|4047928|FG000|NOT COMPLETED|Overall Study||12
3314653|NCT03090100|4047934|FG000|STARTED|Overall Study||534
3314654|NCT03090100|4047935|FG001|STARTED|Overall Study||514
3314655|NCT03090100|4047934|FG000|Treated|Overall Study||534
3314656|NCT03090100|4047935|FG001|Treated|Overall Study||511
3314657|NCT03090100|4047934|FG000|COMPLETED|Overall Study||507
3314658|NCT03090100|4047935|FG001|COMPLETED|Overall Study||466
3314659|NCT03090100|4047934|FG000|NOT COMPLETED|Overall Study||27
3314660|NCT03090100|4047935|FG001|NOT COMPLETED|Overall Study||48
3314661|NCT03090256|4047941|FG000|STARTED|Overall Study||68
3314662|NCT03090256|4047941|FG000|COMPLETED|Overall Study||68
3314663|NCT03090256|4047941|FG000|NOT COMPLETED|Overall Study||0
3314664|NCT03090620|4047948|FG000|STARTED|Overall Study||9
3314665|NCT03090620|4047949|FG001|STARTED|Overall Study||10
3314666|NCT03090620|4047948|FG000|COMPLETED|Overall Study||9
3314667|NCT03090620|4047949|FG001|COMPLETED|Overall Study||10
2879803|NCT00288067|3585011|FG000|NOT COMPLETED|Overall Study||0
2879804|NCT00288366|3585019|FG000|STARTED|Overall Study||23
2879805|NCT00288366|3585020|FG001|STARTED|Overall Study||26
2879806|NCT00288366|3585019|FG000|COMPLETED|Overall Study||23
2879807|NCT00288366|3585020|FG001|COMPLETED|Overall Study||26
3170037|NCT01928394|3897414|FG008|Transition- Continued|Treatment Period||1
3314668|NCT03090620|4047948|FG000|NOT COMPLETED|Overall Study||0
3314669|NCT03090620|4047949|FG001|NOT COMPLETED|Overall Study||0
2879808|NCT00288366|3585019|FG000|NOT COMPLETED|Overall Study||0
2879809|NCT00288366|3585020|FG001|NOT COMPLETED|Overall Study||0
2879810|NCT00288509|3585026|FG000|STARTED|Treatment Cycle 1||108
2879811|NCT00288509|3585026|FG000|COMPLETED|Treatment Cycle 1||102
2879812|NCT00288509|3585026|FG000|NOT COMPLETED|Treatment Cycle 1||6
2879813|NCT00288509|3585026|FG000|STARTED|Treatment Cycle 2|2 subjects completed Cycle 1 but withdrew before Cycle 2 due to insufficient clinical response|100
2879814|NCT00288509|3585026|FG000|COMPLETED|Treatment Cycle 2||97
2879815|NCT00288509|3585026|FG000|NOT COMPLETED|Treatment Cycle 2||3
2879816|NCT00288509|3585026|FG000|STARTED|Treatment Cycle 3|One subject completed Cycle 2 but withdrew before Cycle 3 due to insufficient clinical response|96
2879817|NCT00288509|3585026|FG000|COMPLETED|Treatment Cycle 3||91
2879818|NCT00288509|3585026|FG000|NOT COMPLETED|Treatment Cycle 3||5
2879819|NCT00288509|3585026|FG000|STARTED|Treatment Cycle 4|3 subjects completed Cycle 3 but withdrew before Cycle 4, treatment stopped according to protocol|88
2879820|NCT00288509|3585026|FG000|COMPLETED|Treatment Cycle 4||80
3314670|NCT03090958|4047955|FG000|STARTED|Overall Study||20
3314671|NCT03090958|4047955|FG000|COMPLETED|Overall Study||20
2879821|NCT00288509|3585026|FG000|NOT COMPLETED|Treatment Cycle 4||8
2879822|NCT00288574|3585032|FG000|STARTED|Overall Study||49
2879823|NCT00288574|3585033|FG001|STARTED|Overall Study||44
2879824|NCT00288574|3585032|FG000|COMPLETED|Overall Study||49
2879825|NCT00288574|3585033|FG001|COMPLETED|Overall Study||44
2879826|NCT00288574|3585032|FG000|NOT COMPLETED|Overall Study||0
2879827|NCT00288574|3585033|FG001|NOT COMPLETED|Overall Study||0
2879828|NCT00288587|3585044|FG000|STARTED|Overall Study||19
2879829|NCT00288587|3585045|FG001|STARTED|Overall Study||17
2879830|NCT00288587|3585044|FG000|COMPLETED|Overall Study||14
2879831|NCT00288587|3585045|FG001|COMPLETED|Overall Study||7
2879832|NCT00288587|3585044|FG000|NOT COMPLETED|Overall Study||5
2879833|NCT00288587|3585045|FG001|NOT COMPLETED|Overall Study||10
2879834|NCT00288600|3585053|FG000|STARTED|Overall Study||46
2879835|NCT00288600|3585054|FG001|STARTED|Overall Study||46
2879836|NCT00288600|3585053|FG000|COMPLETED|Overall Study||46
2879837|NCT00288600|3585054|FG001|COMPLETED|Overall Study||46
2879838|NCT00288600|3585053|FG000|NOT COMPLETED|Overall Study||0
2879839|NCT00288600|3585054|FG001|NOT COMPLETED|Overall Study||0
2879840|NCT00288626|3585060|FG000|STARTED|Overall Study||24
2879841|NCT00288626|3585060|FG000|COMPLETED|Overall Study||17
2879842|NCT00288626|3585060|FG000|NOT COMPLETED|Overall Study||7
2919304|NCT00531232|3629658|FG002|COMPLETED|Overall Study||0
2919305|NCT00531232|3629656|FG000|NOT COMPLETED|Overall Study||4
2919306|NCT00531232|3629657|FG001|NOT COMPLETED|Overall Study||9
2919307|NCT00531232|3629658|FG002|NOT COMPLETED|Overall Study||25
2919308|NCT00531284|3629686|FG000|STARTED|Overall Study||3
2919309|NCT00531284|3629687|FG001|STARTED|Overall Study||4
2919310|NCT00531284|3629688|FG002|STARTED|Overall Study||7
2919311|NCT00531284|3629689|FG003|STARTED|Overall Study||65
2919312|NCT00531284|3629690|FG004|STARTED|Overall Study||6
2919313|NCT00531284|3629691|FG005|STARTED|Overall Study||7
2919314|NCT00531284|3629692|FG006|STARTED|Overall Study||6
2919315|NCT00531284|3629693|FG007|STARTED|Overall Study||10
2919316|NCT00531284|3629694|FG008|STARTED|Overall Study||11
2919317|NCT00531284|3629695|FG009|STARTED|Overall Study||4
2919318|NCT00531284|3629696|FG010|STARTED|Overall Study||3
2919319|NCT00531284|3629697|FG011|STARTED|Overall Study||24
2919320|NCT00531284|3629698|FG012|STARTED|Overall Study||2
2919321|NCT00531284|3629699|FG013|STARTED|Overall Study||3
2919322|NCT00531284|3629700|FG014|STARTED|Overall Study||7
2919323|NCT00531284|3629701|FG015|STARTED|Overall Study||14
2919324|NCT00531284|3629702|FG016|STARTED|Overall Study||8
2919325|NCT00531284|3629686|FG000|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of study drug|0
2919326|NCT00531284|3629687|FG001|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of study drug|0
2919327|NCT00531284|3629688|FG002|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of study drug|1
2919328|NCT00531284|3629689|FG003|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of study drug|2
2919329|NCT00531284|3629690|FG004|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
2919330|NCT00531284|3629691|FG005|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
2919331|NCT00531284|3629692|FG006|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
2919332|NCT00531284|3629693|FG007|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
2919333|NCT00531284|3629694|FG008|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
2919334|NCT00531284|3629695|FG009|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
2919335|NCT00531284|3629696|FG010|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
2919336|NCT00531284|3629697|FG011|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
2919337|NCT00531284|3629698|FG012|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
2919338|NCT00531284|3629699|FG013|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
2919339|NCT00531284|3629700|FG014|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|3
2919340|NCT00531284|3629701|FG015|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|2
2919341|NCT00531284|3629702|FG016|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
2919342|NCT00531284|3629686|FG000|NOT COMPLETED|Overall Study||3
2919343|NCT00531284|3629687|FG001|NOT COMPLETED|Overall Study||4
2919344|NCT00531284|3629688|FG002|NOT COMPLETED|Overall Study||6
2919345|NCT00531284|3629689|FG003|NOT COMPLETED|Overall Study||63
2919346|NCT00531284|3629690|FG004|NOT COMPLETED|Overall Study||6
2919347|NCT00531284|3629691|FG005|NOT COMPLETED|Overall Study||7
2919348|NCT00531284|3629692|FG006|NOT COMPLETED|Overall Study||6
2919349|NCT00531284|3629693|FG007|NOT COMPLETED|Overall Study||10
2919350|NCT00531284|3629694|FG008|NOT COMPLETED|Overall Study||11
2919351|NCT00531284|3629695|FG009|NOT COMPLETED|Overall Study||4
2919352|NCT00531284|3629696|FG010|NOT COMPLETED|Overall Study||3
2919353|NCT00531284|3629697|FG011|NOT COMPLETED|Overall Study||24
2919354|NCT00531284|3629698|FG012|NOT COMPLETED|Overall Study||2
2919355|NCT00531284|3629699|FG013|NOT COMPLETED|Overall Study||3
2919356|NCT00531284|3629700|FG014|NOT COMPLETED|Overall Study||4
2919357|NCT00531284|3629701|FG015|NOT COMPLETED|Overall Study||12
2879843|NCT00288639|3585066|FG000|STARTED|Overall Study||98
2879844|NCT00288639|3585066|FG000|COMPLETED|Overall Study||86
2879845|NCT00288639|3585066|FG000|NOT COMPLETED|Overall Study||12
2879846|NCT00288704|3585073|FG000|STARTED|Part A, Double Blind, Weeks 1-6||24
2879847|NCT00288704|3585074|FG001|STARTED|Part A, Double Blind, Weeks 1-6||23
2879848|NCT00288704|3585075|FG002|STARTED|Part A, Double Blind, Weeks 1-6|Subjects enrolled into the open-label phase do not complete this part of the study.|0
2879849|NCT00288704|3585073|FG000|COMPLETED|Part A, Double Blind, Weeks 1-6||24
2879850|NCT00288704|3585074|FG001|COMPLETED|Part A, Double Blind, Weeks 1-6||22
2879851|NCT00288704|3585075|FG002|COMPLETED|Part A, Double Blind, Weeks 1-6||0
2879852|NCT00288704|3585073|FG000|NOT COMPLETED|Part A, Double Blind, Weeks 1-6||0
2879853|NCT00288704|3585074|FG001|NOT COMPLETED|Part A, Double Blind, Weeks 1-6||1
2879854|NCT00288704|3585075|FG002|NOT COMPLETED|Part A, Double Blind, Weeks 1-6||0
2879855|NCT00288704|3585073|FG000|STARTED|Part B, Randomized Withdrawal, Wks 15-24|1 subject discontinued during weeks 6-14 due to non-compliance with study drug dosing procedures.|23
2879856|NCT00288704|3585074|FG001|STARTED|Part B, Randomized Withdrawal, Wks 15-24||22
2879857|NCT00288704|3585075|FG002|STARTED|Part B, Randomized Withdrawal, Wks 15-24||0
2879858|NCT00288704|3585073|FG000|COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||23
2879859|NCT00288704|3585074|FG001|COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||21
2879860|NCT00288704|3585075|FG002|COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||0
2879861|NCT00288704|3585073|FG000|NOT COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||0
2879862|NCT00288704|3585074|FG001|NOT COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||1
2879863|NCT00288704|3585075|FG002|NOT COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||0
2879864|NCT00288704|3585073|FG000|STARTED|Open-Label Extension (OLE) Weeks 24-117|After week 24, all subjects are treated with Open label rilonacept.|0
2879865|NCT00288704|3585074|FG001|STARTED|Open-Label Extension (OLE) Weeks 24-117||0
2879866|NCT00288704|3585075|FG002|STARTED|Open-Label Extension (OLE) Weeks 24-117||101
2879867|NCT00288704|3585073|FG000|COMPLETED|Open-Label Extension (OLE) Weeks 24-117||0
2879868|NCT00288704|3585074|FG001|COMPLETED|Open-Label Extension (OLE) Weeks 24-117||0
2879869|NCT00288704|3585075|FG002|COMPLETED|Open-Label Extension (OLE) Weeks 24-117||81
2879870|NCT00288704|3585073|FG000|NOT COMPLETED|Open-Label Extension (OLE) Weeks 24-117||0
2879871|NCT00288704|3585074|FG001|NOT COMPLETED|Open-Label Extension (OLE) Weeks 24-117||0
2879872|NCT00288704|3585075|FG002|NOT COMPLETED|Open-Label Extension (OLE) Weeks 24-117||20
2879873|NCT00288860|3585084|FG000|STARTED|Overall Study||412
2879874|NCT00288860|3585085|FG001|STARTED|Overall Study||425
2879875|NCT00288860|3585084|FG000|Completed Intake Survey|Overall Study||408
2879876|NCT00288860|3585085|FG001|Completed Intake Survey|Overall Study||417
2879877|NCT00288860|3585084|FG000|Completed 4 Month fu Survey|Overall Study||275
2879878|NCT00288860|3585085|FG001|Completed 4 Month fu Survey|Overall Study||299
2879879|NCT00288860|3585084|FG000|Completed 12 Month fu Survey|Overall Study||257
2879880|NCT00288860|3585085|FG001|Completed 12 Month fu Survey|Overall Study||281
2879881|NCT00288860|3585084|FG000|COMPLETED|Overall Study|310 completed either 4 or 12 month survey. Used all with intake (n = 408) in intent-to-treat.|310
2879882|NCT00288860|3585085|FG001|COMPLETED|Overall Study|328 completed 4 or 12 month survey. Used all with intake (n=417) in intent to treat.|328
2879883|NCT00288860|3585084|FG000|NOT COMPLETED|Overall Study||102
2879884|NCT00288860|3585085|FG001|NOT COMPLETED|Overall Study||97
2879885|NCT00288886|3585096|FG000|STARTED|Overall Study||91
2879886|NCT00288886|3585097|FG001|STARTED|Overall Study||92
2879887|NCT00288886|3585096|FG000|3-month Follow Up|Overall Study||82
2879888|NCT00288886|3585097|FG001|3-month Follow Up|Overall Study||85
2879889|NCT00288886|3585096|FG000|6-month Follow Up|Overall Study||85
2879890|NCT00288886|3585097|FG001|6-month Follow Up|Overall Study||84
2879891|NCT00288886|3585096|FG000|12-month Follow Up|Overall Study||80
2879892|NCT00288886|3585097|FG001|12-month Follow Up|Overall Study||81
2879893|NCT00288886|3585096|FG000|COMPLETED|Overall Study||80
2879894|NCT00288886|3585097|FG001|COMPLETED|Overall Study||81
2879895|NCT00288886|3585096|FG000|NOT COMPLETED|Overall Study||11
2879896|NCT00288886|3585097|FG001|NOT COMPLETED|Overall Study||11
2879897|NCT00288912|3585106|FG000|STARTED|Overall Study||175
2879898|NCT00288912|3585107|FG001|STARTED|Overall Study||174
2879899|NCT00288912|3585108|FG002|STARTED|Overall Study||174
2879900|NCT00288912|3585106|FG000|COMPLETED|Overall Study||158
2879901|NCT00288912|3585107|FG001|COMPLETED|Overall Study||157
2879902|NCT00288912|3585108|FG002|COMPLETED|Overall Study||146
2879903|NCT00288912|3585106|FG000|NOT COMPLETED|Overall Study||17
2879904|NCT00288912|3585107|FG001|NOT COMPLETED|Overall Study||17
2879905|NCT00288912|3585108|FG002|NOT COMPLETED|Overall Study||28
2879906|NCT00289016|3585116|FG000|STARTED|Overall Study||50
2879907|NCT00289016|3585116|FG000|COMPLETED|Overall Study||13
2879908|NCT00289016|3585116|FG000|NOT COMPLETED|Overall Study||37
2879909|NCT00289094|3585122|FG000|STARTED|Overall Study||50
2879910|NCT00289094|3585123|FG001|STARTED|Overall Study||49
2879911|NCT00289094|3585122|FG000|COMPLETED|Overall Study||3
2879912|NCT00289094|3585123|FG001|COMPLETED|Overall Study||2
2879913|NCT00289094|3585122|FG000|NOT COMPLETED|Overall Study||47
2879914|NCT00289094|3585123|FG001|NOT COMPLETED|Overall Study||47
2879915|NCT00289107|3585131|FG000|STARTED|Overall Study||77
2879916|NCT00289107|3585132|FG001|STARTED|Overall Study||72
2879917|NCT00289107|3585131|FG000|COMPLETED|Overall Study||24
2879918|NCT00289107|3585132|FG001|COMPLETED|Overall Study||28
2879919|NCT00289107|3585131|FG000|NOT COMPLETED|Overall Study||53
2879920|NCT00289107|3585132|FG001|NOT COMPLETED|Overall Study||44
2879921|NCT00289120|3585138|FG000|STARTED|Overall Study||13
2879922|NCT00289120|3585138|FG000|COMPLETED|Overall Study||13
2879923|NCT00289120|3585138|FG000|NOT COMPLETED|Overall Study||0
2879924|NCT00289133|3585148|FG000|STARTED|Overall Study||461
2879925|NCT00289133|3585149|FG001|STARTED|Overall Study||477
2879926|NCT00289133|3585148|FG000|COMPLETED|Overall Study||189
2879927|NCT00289133|3585149|FG001|COMPLETED|Overall Study||179
2879928|NCT00289133|3585148|FG000|NOT COMPLETED|Overall Study||272
2879929|NCT00289133|3585149|FG001|NOT COMPLETED|Overall Study||298
2879930|NCT00289185|3585161|FG000|STARTED|Overall Study||170
2879931|NCT00289185|3585162|FG001|STARTED|Overall Study||170
2879932|NCT00289185|3585161|FG000|COMPLETED|Overall Study||142
2879933|NCT00289185|3585162|FG001|COMPLETED|Overall Study||144
2879934|NCT00289185|3585161|FG000|NOT COMPLETED|Overall Study||28
2879935|NCT00289185|3585162|FG001|NOT COMPLETED|Overall Study||26
2879936|NCT00289198|3585171|FG000|STARTED|Overall Study||151
2879937|NCT00289198|3585172|FG001|STARTED|Overall Study||151
2879938|NCT00289198|3585171|FG000|COMPLETED|Overall Study||120
2879939|NCT00289198|3585172|FG001|COMPLETED|Overall Study||121
2879940|NCT00289198|3585171|FG000|NOT COMPLETED|Overall Study||31
2879941|NCT00289198|3585172|FG001|NOT COMPLETED|Overall Study||30
2879942|NCT00289211|3585182|FG000|STARTED|Overall Study||36
2879943|NCT00289211|3585183|FG001|STARTED|Overall Study||35
2879944|NCT00289211|3585184|FG002|STARTED|Overall Study||12
2879945|NCT00289211|3585182|FG000|COMPLETED|Overall Study||36
2879946|NCT00289211|3585183|FG001|COMPLETED|Overall Study||34
2879947|NCT00289211|3585184|FG002|COMPLETED|Overall Study||2
2879948|NCT00289211|3585182|FG000|NOT COMPLETED|Overall Study||0
2879949|NCT00289211|3585183|FG001|NOT COMPLETED|Overall Study||1
2879950|NCT00289211|3585184|FG002|NOT COMPLETED|Overall Study||10
2879951|NCT00289276|3585192|FG000|STARTED|First Part of FAST Study (Pivotal)|11 patients were re-consented under version 7 of the CIP, but are included in Pivotal results only|47
2879952|NCT00289276|3585193|FG001|STARTED|First Part of FAST Study (Pivotal)||0
2879953|NCT00289276|3585192|FG000|COMPLETED|First Part of FAST Study (Pivotal)||47
2879954|NCT00289276|3585193|FG001|COMPLETED|First Part of FAST Study (Pivotal)||0
2879955|NCT00289276|3585192|FG000|NOT COMPLETED|First Part of FAST Study (Pivotal)||0
2879956|NCT00289276|3585193|FG001|NOT COMPLETED|First Part of FAST Study (Pivotal)||0
2879957|NCT00289276|3585192|FG000|STARTED|Second Part of FAST Study (Expansion)||0
2879958|NCT00289276|3585193|FG001|STARTED|Second Part of FAST Study (Expansion)||109
2879959|NCT00289276|3585192|FG000|COMPLETED|Second Part of FAST Study (Expansion)||0
2879960|NCT00289276|3585193|FG001|COMPLETED|Second Part of FAST Study (Expansion)||106
2879961|NCT00289276|3585192|FG000|NOT COMPLETED|Second Part of FAST Study (Expansion)||0
2879962|NCT00289276|3585193|FG001|NOT COMPLETED|Second Part of FAST Study (Expansion)||3
2879963|NCT00289289|3585202|FG000|STARTED|Overall Study||132
2879964|NCT00289289|3585203|FG001|STARTED|Overall Study||124
2879965|NCT00289289|3585204|FG002|STARTED|Overall Study||144
2879966|NCT00289289|3585202|FG000|COMPLETED|Overall Study||113
2879967|NCT00289289|3585203|FG001|COMPLETED|Overall Study||114
2879968|NCT00289289|3585204|FG002|COMPLETED|Overall Study||95
2879969|NCT00289289|3585202|FG000|NOT COMPLETED|Overall Study||19
2879970|NCT00289289|3585203|FG001|NOT COMPLETED|Overall Study||10
2879971|NCT00289289|3585204|FG002|NOT COMPLETED|Overall Study||49
2879972|NCT00289315|3585214|FG000|STARTED|Overall Study||713
2879973|NCT00289315|3585215|FG001|STARTED|Overall Study||760
2879974|NCT00289315|3585216|FG002|STARTED|Overall Study||587
2879975|NCT00289315|3585214|FG000|COMPLETED|Overall Study||612
2879976|NCT00289315|3585215|FG001|COMPLETED|Overall Study||638
2879977|NCT00289315|3585216|FG002|COMPLETED|Overall Study||447
2879978|NCT00289315|3585214|FG000|NOT COMPLETED|Overall Study||101
2879979|NCT00289315|3585215|FG001|NOT COMPLETED|Overall Study||122
2879980|NCT00289315|3585216|FG002|NOT COMPLETED|Overall Study||140
2879981|NCT00289341|3585226|FG000|STARTED|Overall Study||12
2879982|NCT00289341|3585227|FG001|STARTED|Overall Study||12
2879983|NCT00289341|3585226|FG000|COMPLETED|Overall Study||12
2879984|NCT00289341|3585227|FG001|COMPLETED|Overall Study||12
2879985|NCT00289341|3585226|FG000|NOT COMPLETED|Overall Study||0
2879986|NCT00289341|3585227|FG001|NOT COMPLETED|Overall Study||0
2879987|NCT00289458|3585240|FG000|STARTED|Overall Study||25
2879988|NCT00289458|3585241|FG001|STARTED|Overall Study||26
2879989|NCT00289458|3585242|FG002|STARTED|Overall Study||28
2879990|NCT00289458|3585240|FG000|COMPLETED|Overall Study||19
2879991|NCT00289458|3585241|FG001|COMPLETED|Overall Study||20
2879992|NCT00289458|3585242|FG002|COMPLETED|Overall Study||22
2879993|NCT00289458|3585240|FG000|NOT COMPLETED|Overall Study||6
2879994|NCT00289458|3585241|FG001|NOT COMPLETED|Overall Study||6
2879995|NCT00289458|3585242|FG002|NOT COMPLETED|Overall Study||6
2879996|NCT00289471|3585250|FG000|STARTED|Overall Study||630
2879997|NCT00289471|3585250|FG000|COMPLETED|Overall Study||630
2879998|NCT00289471|3585250|FG000|NOT COMPLETED|Overall Study||0
2879999|NCT00289536|3585254|FG000|STARTED|Period 1||9
2880000|NCT00289536|3585255|FG001|STARTED|Period 1||8
2880001|NCT00289536|3585256|FG002|STARTED|Period 1||9
2880002|NCT00289536|3585254|FG000|COMPLETED|Period 1||9
2880003|NCT00289536|3585255|FG001|COMPLETED|Period 1||8
2880004|NCT00289536|3585256|FG002|COMPLETED|Period 1||9
2880005|NCT00289536|3585254|FG000|NOT COMPLETED|Period 1||0
2880006|NCT00289536|3585255|FG001|NOT COMPLETED|Period 1||0
2880007|NCT00289536|3585256|FG002|NOT COMPLETED|Period 1||0
2880008|NCT00289536|3585254|FG000|STARTED|Period 2|5 participants received Medium Dose and 5 participants received High Dose in Period 1|10
2880009|NCT00289536|3585255|FG001|STARTED|Period 2|5 participants received Low Dose and 4 participants received High Dose in Period 1|9
2919358|NCT00531284|3629702|FG016|NOT COMPLETED|Overall Study||8
2880010|NCT00289536|3585256|FG002|STARTED|Period 2|4 participants received Low Dose and 3 participants received Medium Dose in Period 1|7
2880011|NCT00289536|3585254|FG000|COMPLETED|Period 2||10
2880012|NCT00289536|3585255|FG001|COMPLETED|Period 2||9
2880013|NCT00289536|3585256|FG002|COMPLETED|Period 2||7
2880014|NCT00289536|3585254|FG000|NOT COMPLETED|Period 2||0
2880015|NCT00289536|3585255|FG001|NOT COMPLETED|Period 2||0
2880016|NCT00289536|3585256|FG002|NOT COMPLETED|Period 2||0
2880017|NCT00289536|3585254|FG000|STARTED|Period 3|3 participants received Medium Dose and 4 participants received High Dose in Period 2|7
2880018|NCT00289536|3585255|FG001|STARTED|Period 3|5 participants received Low Dose and 4 participants received High Dose in Period 2|9
2880019|NCT00289536|3585256|FG002|STARTED|Period 3|5 participants received Low Dose and 5 participants received Medium Dose in Period 2|10
2880020|NCT00289536|3585254|FG000|COMPLETED|Period 3||7
2880021|NCT00289536|3585255|FG001|COMPLETED|Period 3||9
2880022|NCT00289536|3585256|FG002|COMPLETED|Period 3||9
2880023|NCT00289536|3585254|FG000|NOT COMPLETED|Period 3||0
2880024|NCT00289536|3585255|FG001|NOT COMPLETED|Period 3||0
2880025|NCT00289536|3585256|FG002|NOT COMPLETED|Period 3||1
2880026|NCT00289653|3585262|FG000|STARTED|Overall Study||23
2880027|NCT00289653|3585262|FG000|COMPLETED|Overall Study||12
2880028|NCT00289653|3585262|FG000|NOT COMPLETED|Overall Study||11
2880029|NCT00289718|3585267|FG000|STARTED|Overall Study||51
2880030|NCT00289718|3585267|FG000|COMPLETED|Overall Study||51
2880031|NCT00289718|3585267|FG000|NOT COMPLETED|Overall Study||0
2880032|NCT00289731|3585279|FG000|STARTED|Overall Study||199
2880033|NCT00289731|3585280|FG001|STARTED|Overall Study||200
2880034|NCT00289731|3585281|FG002|STARTED|Overall Study||197
2880035|NCT00289731|3585279|FG000|COMPLETED|Overall Study||197
2880036|NCT00289731|3585280|FG001|COMPLETED|Overall Study||198
2880037|NCT00289731|3585281|FG002|COMPLETED|Overall Study||195
2880038|NCT00289731|3585279|FG000|NOT COMPLETED|Overall Study||2
2880039|NCT00289731|3585280|FG001|NOT COMPLETED|Overall Study||2
2880040|NCT00289731|3585281|FG002|NOT COMPLETED|Overall Study||2
2880041|NCT00289744|3585291|FG000|STARTED|Year 6 Long-term Follow-up|Number of subjects who come back at Year 6 blood sampling time-point|178
2880042|NCT00289744|3585292|FG001|STARTED|Year 6 Long-term Follow-up||0
2880043|NCT00289744|3585293|FG002|STARTED|Year 6 Long-term Follow-up||0
2880044|NCT00289744|3585291|FG000|COMPLETED|Year 6 Long-term Follow-up||178
2880045|NCT00289744|3585292|FG001|COMPLETED|Year 6 Long-term Follow-up||0
2880046|NCT00289744|3585293|FG002|COMPLETED|Year 6 Long-term Follow-up||0
2880047|NCT00289744|3585291|FG000|NOT COMPLETED|Year 6 Long-term Follow-up||0
2880048|NCT00289744|3585292|FG001|NOT COMPLETED|Year 6 Long-term Follow-up||0
2880049|NCT00289744|3585293|FG002|NOT COMPLETED|Year 6 Long-term Follow-up||0
2880050|NCT00289744|3585291|FG000|STARTED|Year 7 Long-term Follow-up|Subjects who came back at Year 7 blood sampling time-point|175
2880051|NCT00289744|3585292|FG001|STARTED|Year 7 Long-term Follow-up||0
2880052|NCT00289744|3585293|FG002|STARTED|Year 7 Long-term Follow-up||0
2880053|NCT00289744|3585291|FG000|COMPLETED|Year 7 Long-term Follow-up||175
2880054|NCT00289744|3585292|FG001|COMPLETED|Year 7 Long-term Follow-up||0
2880055|NCT00289744|3585293|FG002|COMPLETED|Year 7 Long-term Follow-up||0
2880056|NCT00289744|3585291|FG000|NOT COMPLETED|Year 7 Long-term Follow-up||0
2880057|NCT00289744|3585292|FG001|NOT COMPLETED|Year 7 Long-term Follow-up||0
2880058|NCT00289744|3585293|FG002|NOT COMPLETED|Year 7 Long-term Follow-up||0
2880059|NCT00289744|3585291|FG000|STARTED|Year 8 Long-term Follow-up|Subjects who came back at Year 8 blood sampling time-point|174
2880060|NCT00289744|3585292|FG001|STARTED|Year 8 Long-term Follow-up||0
2880061|NCT00289744|3585293|FG002|STARTED|Year 8 Long-term Follow-up||0
2880062|NCT00289744|3585291|FG000|COMPLETED|Year 8 Long-term Follow-up||174
2880063|NCT00289744|3585292|FG001|COMPLETED|Year 8 Long-term Follow-up||0
2880064|NCT00289744|3585293|FG002|COMPLETED|Year 8 Long-term Follow-up||0
2880065|NCT00289744|3585291|FG000|NOT COMPLETED|Year 8 Long-term Follow-up||0
2880066|NCT00289744|3585292|FG001|NOT COMPLETED|Year 8 Long-term Follow-up||0
2880067|NCT00289744|3585293|FG002|NOT COMPLETED|Year 8 Long-term Follow-up||0
2880068|NCT00289744|3585291|FG000|STARTED|Year 9 Long-term Follow-up|Subjects who came back at Year 9 blood sampling time-point|173
2880069|NCT00289744|3585292|FG001|STARTED|Year 9 Long-term Follow-up||0
2880070|NCT00289744|3585293|FG002|STARTED|Year 9 Long-term Follow-up||0
2880071|NCT00289744|3585291|FG000|COMPLETED|Year 9 Long-term Follow-up||173
2880072|NCT00289744|3585292|FG001|COMPLETED|Year 9 Long-term Follow-up||0
2880073|NCT00289744|3585293|FG002|COMPLETED|Year 9 Long-term Follow-up||0
2880074|NCT00289744|3585291|FG000|NOT COMPLETED|Year 9 Long-term Follow-up||0
2880075|NCT00289744|3585292|FG001|NOT COMPLETED|Year 9 Long-term Follow-up||0
2880076|NCT00289744|3585293|FG002|NOT COMPLETED|Year 9 Long-term Follow-up||0
2880077|NCT00289744|3585291|FG000|STARTED|Year 10 Long-term Follow-up|Subjects who came back at Year 10 blood sampling time-point|171
2880078|NCT00289744|3585292|FG001|STARTED|Year 10 Long-term Follow-up||0
2880079|NCT00289744|3585293|FG002|STARTED|Year 10 Long-term Follow-up||0
2880080|NCT00289744|3585291|FG000|COMPLETED|Year 10 Long-term Follow-up||171
2880081|NCT00289744|3585292|FG001|COMPLETED|Year 10 Long-term Follow-up||0
2880082|NCT00289744|3585293|FG002|COMPLETED|Year 10 Long-term Follow-up||0
2880083|NCT00289744|3585291|FG000|NOT COMPLETED|Year 10 Long-term Follow-up||0
2880084|NCT00289744|3585292|FG001|NOT COMPLETED|Year 10 Long-term Follow-up||0
2880085|NCT00289744|3585293|FG002|NOT COMPLETED|Year 10 Long-term Follow-up||0
2880086|NCT00289744|3585291|FG000|STARTED|Additional Dose Phase||0
2880087|NCT00289744|3585292|FG001|STARTED|Additional Dose Phase||19
2880088|NCT00289744|3585293|FG002|STARTED|Additional Dose Phase||6
2880089|NCT00289744|3585291|FG000|COMPLETED|Additional Dose Phase||0
2880090|NCT00289744|3585292|FG001|COMPLETED|Additional Dose Phase||19
2880091|NCT00289744|3585293|FG002|COMPLETED|Additional Dose Phase||6
2880092|NCT00289744|3585291|FG000|NOT COMPLETED|Additional Dose Phase||0
2880093|NCT00289744|3585292|FG001|NOT COMPLETED|Additional Dose Phase||0
2880094|NCT00289744|3585293|FG002|NOT COMPLETED|Additional Dose Phase||0
2880095|NCT00289757|3585301|FG000|STARTED|Overall Study||78
2880096|NCT00289757|3585301|FG000|COMPLETED|Overall Study||78
2880097|NCT00289757|3585301|FG000|NOT COMPLETED|Overall Study||0
2880098|NCT00289770|3585305|FG000|STARTED|Year 11||37
2880099|NCT00289770|3585305|FG000|COMPLETED|Year 11||37
2880100|NCT00289770|3585305|FG000|NOT COMPLETED|Year 11||0
2880101|NCT00289770|3585305|FG000|STARTED|Year 12||40
2880102|NCT00289770|3585305|FG000|COMPLETED|Year 12||40
2880103|NCT00289770|3585305|FG000|NOT COMPLETED|Year 12||0
2880104|NCT00289770|3585305|FG000|STARTED|Year 13||37
2880105|NCT00289770|3585305|FG000|COMPLETED|Year 13||37
2880106|NCT00289770|3585305|FG000|NOT COMPLETED|Year 13||0
2880107|NCT00289770|3585305|FG000|STARTED|Year 14||43
2880108|NCT00289770|3585305|FG000|COMPLETED|Year 14||43
2880109|NCT00289770|3585305|FG000|NOT COMPLETED|Year 14||0
2880110|NCT00289770|3585305|FG000|STARTED|Year 15||50
2880111|NCT00289770|3585305|FG000|COMPLETED|Year 15||49
2880112|NCT00289770|3585305|FG000|NOT COMPLETED|Year 15||1
2880113|NCT00289783|3585311|FG000|STARTED|Primary Phase||3136
2880114|NCT00289783|3585312|FG001|STARTED|Primary Phase||1044
2880115|NCT00289783|3585311|FG000|COMPLETED|Primary Phase||2888
2880116|NCT00289783|3585312|FG001|COMPLETED|Primary Phase||961
2880117|NCT00289783|3585311|FG000|NOT COMPLETED|Primary Phase||248
2880118|NCT00289783|3585312|FG001|NOT COMPLETED|Primary Phase||83
2880119|NCT00289783|3585311|FG000|STARTED|Fourth Dose Phase||2769
2880120|NCT00289783|3585312|FG001|STARTED|Fourth Dose Phase||923
2880121|NCT00289783|3585311|FG000|COMPLETED|Fourth Dose Phase||2682
2880122|NCT00289783|3585312|FG001|COMPLETED|Fourth Dose Phase||899
2880123|NCT00289783|3585311|FG000|NOT COMPLETED|Fourth Dose Phase||87
2880124|NCT00289783|3585312|FG001|NOT COMPLETED|Fourth Dose Phase||24
2880125|NCT00289848|3585328|FG000|STARTED|Overall Study||352
2880126|NCT00289848|3585329|FG001|STARTED|Overall Study||178
2880127|NCT00289848|3585328|FG000|COMPLETED|Overall Study||306
2880128|NCT00289848|3585329|FG001|COMPLETED|Overall Study||133
2880129|NCT00289848|3585328|FG000|NOT COMPLETED|Overall Study||46
2880130|NCT00289848|3585329|FG001|NOT COMPLETED|Overall Study||45
2880131|NCT00289900|3585341|FG000|STARTED|Overall Study||297
2880132|NCT00289900|3585342|FG001|STARTED|Overall Study||436
2880133|NCT00289900|3585343|FG002|STARTED|Overall Study||298
2880134|NCT00289900|3585344|FG003|STARTED|Overall Study||439
2880135|NCT00289900|3585345|FG004|STARTED|Overall Study||437
2880136|NCT00289900|3585346|FG005|STARTED|Overall Study||433
2880137|NCT00289900|3585341|FG000|Treated|Overall Study||297
2880138|NCT00289900|3585342|FG001|Treated|Overall Study||435
2880139|NCT00289900|3585343|FG002|Treated|Overall Study||298
2880140|NCT00289900|3585344|FG003|Treated|Overall Study||439
2880141|NCT00289900|3585345|FG004|Treated|Overall Study||437
2880142|NCT00289900|3585346|FG005|Treated|Overall Study||433
2880143|NCT00289900|3585341|FG000|COMPLETED|Overall Study||229
2880144|NCT00289900|3585342|FG001|COMPLETED|Overall Study||316
2880145|NCT00289900|3585343|FG002|COMPLETED|Overall Study||265
2880146|NCT00289900|3585344|FG003|COMPLETED|Overall Study||380
2880147|NCT00289900|3585345|FG004|COMPLETED|Overall Study||392
2880148|NCT00289900|3585346|FG005|COMPLETED|Overall Study||372
2880149|NCT00289900|3585341|FG000|NOT COMPLETED|Overall Study||68
2880150|NCT00289900|3585342|FG001|NOT COMPLETED|Overall Study||120
2880151|NCT00289900|3585343|FG002|NOT COMPLETED|Overall Study||33
2880152|NCT00289900|3585344|FG003|NOT COMPLETED|Overall Study||59
2880153|NCT00289900|3585345|FG004|NOT COMPLETED|Overall Study||45
2880154|NCT00289900|3585346|FG005|NOT COMPLETED|Overall Study||61
2880155|NCT00289913|3585368|FG000|STARTED|Visit 1 (Stage I and Stage II)||155
2880156|NCT00289913|3585369|FG001|STARTED|Visit 1 (Stage I and Stage II)||151
2880157|NCT00289913|3585370|FG002|STARTED|Visit 1 (Stage I and Stage II)||159
2880158|NCT00289913|3585371|FG003|STARTED|Visit 1 (Stage I and Stage II)||152
2880159|NCT00289913|3585372|FG004|STARTED|Visit 1 (Stage I and Stage II)|Participants were enrolled during Stage II.|654
2880160|NCT00289913|3585368|FG000|COMPLETED|Visit 1 (Stage I and Stage II)||146
2880161|NCT00289913|3585369|FG001|COMPLETED|Visit 1 (Stage I and Stage II)||135
2880162|NCT00289913|3585370|FG002|COMPLETED|Visit 1 (Stage I and Stage II)||150
2880163|NCT00289913|3585371|FG003|COMPLETED|Visit 1 (Stage I and Stage II)||141
2880164|NCT00289913|3585372|FG004|COMPLETED|Visit 1 (Stage I and Stage II)||645
2880165|NCT00289913|3585368|FG000|NOT COMPLETED|Visit 1 (Stage I and Stage II)||9
2880166|NCT00289913|3585369|FG001|NOT COMPLETED|Visit 1 (Stage I and Stage II)||16
2880167|NCT00289913|3585370|FG002|NOT COMPLETED|Visit 1 (Stage I and Stage II)||9
2880168|NCT00289913|3585371|FG003|NOT COMPLETED|Visit 1 (Stage I and Stage II)||11
2880169|NCT00289913|3585372|FG004|NOT COMPLETED|Visit 1 (Stage I and Stage II)||9
2880170|NCT00289913|3585368|FG000|STARTED|Visit 2 (Stage I and Stage II)||146
2880171|NCT00289913|3585369|FG001|STARTED|Visit 2 (Stage I and Stage II)||135
2880172|NCT00289913|3585370|FG002|STARTED|Visit 2 (Stage I and Stage II)||150
2880173|NCT00289913|3585371|FG003|STARTED|Visit 2 (Stage I and Stage II)||141
2880174|NCT00289913|3585372|FG004|STARTED|Visit 2 (Stage I and Stage II)|No vaccine administered at Visit 2 (Stage II), therefore there was no safety F/U period.|645
2880175|NCT00289913|3585368|FG000|COMPLETED|Visit 2 (Stage I and Stage II)||131
2880176|NCT00289913|3585369|FG001|COMPLETED|Visit 2 (Stage I and Stage II)||114
2880177|NCT00289913|3585370|FG002|COMPLETED|Visit 2 (Stage I and Stage II)||140
2880178|NCT00289913|3585371|FG003|COMPLETED|Visit 2 (Stage I and Stage II)||135
2880179|NCT00289913|3585372|FG004|COMPLETED|Visit 2 (Stage I and Stage II)||605
2880180|NCT00289913|3585368|FG000|NOT COMPLETED|Visit 2 (Stage I and Stage II)||15
2880181|NCT00289913|3585369|FG001|NOT COMPLETED|Visit 2 (Stage I and Stage II)||21
2880182|NCT00289913|3585370|FG002|NOT COMPLETED|Visit 2 (Stage I and Stage II)||10
2880183|NCT00289913|3585371|FG003|NOT COMPLETED|Visit 2 (Stage I and Stage II)||6
2880184|NCT00289913|3585372|FG004|NOT COMPLETED|Visit 2 (Stage I and Stage II)||40
2880185|NCT00289913|3585368|FG000|STARTED|Visit 3 (Stage I and Stage II)||131
2880186|NCT00289913|3585369|FG001|STARTED|Visit 3 (Stage I and Stage II)||114
2880187|NCT00289913|3585370|FG002|STARTED|Visit 3 (Stage I and Stage II)||140
2880188|NCT00289913|3585371|FG003|STARTED|Visit 3 (Stage I and Stage II)||135
2880189|NCT00289913|3585372|FG004|STARTED|Visit 3 (Stage I and Stage II)||605
2880190|NCT00289913|3585368|FG000|COMPLETED|Visit 3 (Stage I and Stage II)||122
2880191|NCT00289913|3585369|FG001|COMPLETED|Visit 3 (Stage I and Stage II)||106
2880192|NCT00289913|3585370|FG002|COMPLETED|Visit 3 (Stage I and Stage II)||138
2880193|NCT00289913|3585371|FG003|COMPLETED|Visit 3 (Stage I and Stage II)||131
2880194|NCT00289913|3585372|FG004|COMPLETED|Visit 3 (Stage I and Stage II)||597
2880195|NCT00289913|3585368|FG000|NOT COMPLETED|Visit 3 (Stage I and Stage II)||9
2880196|NCT00289913|3585369|FG001|NOT COMPLETED|Visit 3 (Stage I and Stage II)||8
2880197|NCT00289913|3585370|FG002|NOT COMPLETED|Visit 3 (Stage I and Stage II)||2
2880198|NCT00289913|3585371|FG003|NOT COMPLETED|Visit 3 (Stage I and Stage II)||4
2880199|NCT00289913|3585372|FG004|NOT COMPLETED|Visit 3 (Stage I and Stage II)||8
2880200|NCT00289913|3585368|FG000|STARTED|Visit 4 (Stage I and Stage II)||122
2880201|NCT00289913|3585369|FG001|STARTED|Visit 4 (Stage I and Stage II)||106
2880202|NCT00289913|3585370|FG002|STARTED|Visit 4 (Stage I and Stage II)||138
2880203|NCT00289913|3585371|FG003|STARTED|Visit 4 (Stage I and Stage II)||131
2880204|NCT00289913|3585372|FG004|STARTED|Visit 4 (Stage I and Stage II)||597
2880205|NCT00289913|3585368|FG000|COMPLETED|Visit 4 (Stage I and Stage II)||122
2880206|NCT00289913|3585369|FG001|COMPLETED|Visit 4 (Stage I and Stage II)||106
2880207|NCT00289913|3585370|FG002|COMPLETED|Visit 4 (Stage I and Stage II)||138
2880208|NCT00289913|3585371|FG003|COMPLETED|Visit 4 (Stage I and Stage II)||131
2880209|NCT00289913|3585372|FG004|COMPLETED|Visit 4 (Stage I and Stage II)||597
2880210|NCT00289913|3585368|FG000|NOT COMPLETED|Visit 4 (Stage I and Stage II)||0
2880211|NCT00289913|3585369|FG001|NOT COMPLETED|Visit 4 (Stage I and Stage II)||0
2880212|NCT00289913|3585370|FG002|NOT COMPLETED|Visit 4 (Stage I and Stage II)||0
2880213|NCT00289913|3585371|FG003|NOT COMPLETED|Visit 4 (Stage I and Stage II)||0
2880214|NCT00289913|3585372|FG004|NOT COMPLETED|Visit 4 (Stage I and Stage II)||0
2880215|NCT00289978|3585390|FG000|STARTED|Overall Study||429
2880216|NCT00289978|3585391|FG001|STARTED|Overall Study||425
2880217|NCT00289978|3585392|FG002|STARTED|Overall Study||418
2880218|NCT00289978|3585390|FG000|COMPLETED|Overall Study|296 completed on study drug, 35 completed off study drug.|332
2880219|NCT00289978|3585391|FG001|COMPLETED|Overall Study|345 completed on study drug, 24 completed off study drug.|369
2880220|NCT00289978|3585392|FG002|COMPLETED|Overall Study|303 completed on study drug, 29 completed off study drug.|332
2880221|NCT00289978|3585390|FG000|NOT COMPLETED|Overall Study||97
2880222|NCT00289978|3585391|FG001|NOT COMPLETED|Overall Study||56
2880223|NCT00289978|3585392|FG002|NOT COMPLETED|Overall Study||86
2880224|NCT00289991|3585402|FG000|STARTED|Overall Study||234
2880225|NCT00289991|3585403|FG001|STARTED|Overall Study||255
2880226|NCT00289991|3585402|FG000|COMPLETED|Overall Study||176
2880227|NCT00289991|3585403|FG001|COMPLETED|Overall Study||175
2880228|NCT00289991|3585402|FG000|NOT COMPLETED|Overall Study||58
2880229|NCT00289991|3585403|FG001|NOT COMPLETED|Overall Study||80
2880230|NCT00290147|3585411|FG000|STARTED|Overall Study||10
2880231|NCT00290147|3585412|FG001|STARTED|Overall Study||12
2880232|NCT00290147|3585411|FG000|COMPLETED|Overall Study||10
2880233|NCT00290147|3585412|FG001|COMPLETED|Overall Study||12
2880234|NCT00290147|3585411|FG000|NOT COMPLETED|Overall Study||0
3314672|NCT03090958|4047955|FG000|NOT COMPLETED|Overall Study||0
2880235|NCT00290147|3585412|FG001|NOT COMPLETED|Overall Study||0
2880236|NCT00290186|3585420|FG000|STARTED|Overall Study||25
2880237|NCT00290186|3585421|FG001|STARTED|Overall Study||24
2880238|NCT00290186|3585420|FG000|Completed Baseline Assessments|Overall Study||25
2880239|NCT00290186|3585421|FG001|Completed Baseline Assessments|Overall Study||24
2880240|NCT00290186|3585420|FG000|Completed 8 Weeks of Treatment|Overall Study||24
2880241|NCT00290186|3585421|FG001|Completed 8 Weeks of Treatment|Overall Study||22
2880242|NCT00290186|3585420|FG000|Completed Post-treatment Assessments|Overall Study||24
2880243|NCT00290186|3585421|FG001|Completed Post-treatment Assessments|Overall Study||22
2880244|NCT00290186|3585420|FG000|Completed 3-month Followup Assessments|Overall Study||20
2880245|NCT00290186|3585421|FG001|Completed 3-month Followup Assessments|Overall Study||21
2880246|NCT00290186|3585420|FG000|Completed 6-month Followup Assessments|Overall Study||20
2880247|NCT00290186|3585421|FG001|Completed 6-month Followup Assessments|Overall Study||19
2880248|NCT00290186|3585420|FG000|COMPLETED|Overall Study||20
2880249|NCT00290186|3585421|FG001|COMPLETED|Overall Study||19
2880250|NCT00290186|3585420|FG000|NOT COMPLETED|Overall Study||5
2880251|NCT00290186|3585421|FG001|NOT COMPLETED|Overall Study||5
2880252|NCT00290199|3585431|FG000|STARTED|Overall Study||87
2880253|NCT00290199|3585432|FG001|STARTED|Overall Study||82
2880254|NCT00290199|3585431|FG000|COMPLETED|Overall Study||87
2880255|NCT00290199|3585432|FG001|COMPLETED|Overall Study||82
2880256|NCT00290199|3585431|FG000|NOT COMPLETED|Overall Study||0
2880257|NCT00290199|3585432|FG001|NOT COMPLETED|Overall Study||0
3314673|NCT03091179|4047961|FG000|STARTED|Overall Study||10
2880258|NCT00290238|3585442|FG000|STARTED|Overall Study||57
2880259|NCT00290238|3585443|FG001|STARTED|Overall Study|One subject had an invalid birth date and was excluded from the Age Categorical counts.|65
2880260|NCT00290238|3585442|FG000|COMPLETED|Overall Study||15
2880261|NCT00290238|3585443|FG001|COMPLETED|Overall Study||24
2880262|NCT00290238|3585442|FG000|NOT COMPLETED|Overall Study||42
2880263|NCT00290238|3585443|FG001|NOT COMPLETED|Overall Study||41
2880264|NCT00290251|3585449|FG000|STARTED|Treatment 1 (Months 1 - 3)||14
2880265|NCT00290251|3585450|FG001|STARTED|Treatment 1 (Months 1 - 3)||14
2880266|NCT00290251|3585451|FG002|STARTED|Treatment 1 (Months 1 - 3)||14
2880267|NCT00290251|3585449|FG000|COMPLETED|Treatment 1 (Months 1 - 3)||13
2880268|NCT00290251|3585450|FG001|COMPLETED|Treatment 1 (Months 1 - 3)||13
2880269|NCT00290251|3585451|FG002|COMPLETED|Treatment 1 (Months 1 - 3)||12
2880270|NCT00290251|3585449|FG000|NOT COMPLETED|Treatment 1 (Months 1 - 3)||1
2880271|NCT00290251|3585450|FG001|NOT COMPLETED|Treatment 1 (Months 1 - 3)||1
2880272|NCT00290251|3585451|FG002|NOT COMPLETED|Treatment 1 (Months 1 - 3)||2
2880273|NCT00290251|3585449|FG000|STARTED|Treatment 2 (Months 4 - 6)|2 crossed over from placebo; others in treatment 1 PLC or ulipristal acetate 20 did not continue|8
2880274|NCT00290251|3585450|FG001|STARTED|Treatment 2 (Months 4 - 6)|2 crossed over from placebo; others in treatment 1 PLC or ulipristal acetate 10 grp did not continue|5
2880275|NCT00290251|3585451|FG002|STARTED|Treatment 2 (Months 4 - 6)|Women were randomized from PLC to ulipristal acetate or continued same dose ulipristal acetate|0
2880276|NCT00290251|3585449|FG000|COMPLETED|Treatment 2 (Months 4 - 6)||6
2880277|NCT00290251|3585450|FG001|COMPLETED|Treatment 2 (Months 4 - 6)||5
2880278|NCT00290251|3585451|FG002|COMPLETED|Treatment 2 (Months 4 - 6)||0
2880279|NCT00290251|3585449|FG000|NOT COMPLETED|Treatment 2 (Months 4 - 6)||2
2880280|NCT00290251|3585450|FG001|NOT COMPLETED|Treatment 2 (Months 4 - 6)||0
2880281|NCT00290251|3585451|FG002|NOT COMPLETED|Treatment 2 (Months 4 - 6)||0
2880282|NCT00290251|3585449|FG000|STARTED|Elective Extension (to 12 Months no Rx)|Extension study was elective and observational only; treatment arm given as last study drug group|5
2880283|NCT00290251|3585450|FG001|STARTED|Elective Extension (to 12 Months no Rx)|Extension study was elective and observational only; treatment arm given as last study drug group|3
2880284|NCT00290251|3585451|FG002|STARTED|Elective Extension (to 12 Months no Rx)|Extension study was elective and observational only; treatment arm given as last study drug group|5
2880285|NCT00290251|3585449|FG000|COMPLETED|Elective Extension (to 12 Months no Rx)||5
2880286|NCT00290251|3585450|FG001|COMPLETED|Elective Extension (to 12 Months no Rx)||3
2880287|NCT00290251|3585451|FG002|COMPLETED|Elective Extension (to 12 Months no Rx)||5
2880288|NCT00290251|3585449|FG000|NOT COMPLETED|Elective Extension (to 12 Months no Rx)||0
2880289|NCT00290251|3585450|FG001|NOT COMPLETED|Elective Extension (to 12 Months no Rx)||0
2880290|NCT00290251|3585451|FG002|NOT COMPLETED|Elective Extension (to 12 Months no Rx)||0
2880291|NCT00290290|3585463|FG000|STARTED|Overall Study||440
2880292|NCT00290290|3585464|FG001|STARTED|Overall Study||409
2880293|NCT00290290|3585463|FG000|COMPLETED|Overall Study||422
2880294|NCT00290290|3585464|FG001|COMPLETED|Overall Study||391
2880295|NCT00290290|3585463|FG000|NOT COMPLETED|Overall Study||18
2880296|NCT00290290|3585464|FG001|NOT COMPLETED|Overall Study||18
2880297|NCT00290329|3585473|FG000|STARTED|Overall Study||102
2880298|NCT00290329|3585474|FG001|STARTED|Overall Study||86
2880299|NCT00290329|3585475|FG002|STARTED|Overall Study||61
2880300|NCT00290329|3585473|FG000|COMPLETED|Overall Study||102
2880301|NCT00290329|3585474|FG001|COMPLETED|Overall Study||86
2880302|NCT00290329|3585475|FG002|COMPLETED|Overall Study||61
2880303|NCT00290329|3585473|FG000|NOT COMPLETED|Overall Study||0
2880304|NCT00290329|3585474|FG001|NOT COMPLETED|Overall Study||0
2880305|NCT00290329|3585475|FG002|NOT COMPLETED|Overall Study||0
2880306|NCT00290342|3585487|FG000|STARTED|Overall Study||224
2880307|NCT00290342|3585488|FG001|STARTED|Overall Study||228
2880308|NCT00290342|3585487|FG000|COMPLETED|Overall Study||217
2880309|NCT00290342|3585488|FG001|COMPLETED|Overall Study||223
2880310|NCT00290342|3585487|FG000|NOT COMPLETED|Overall Study||7
2880311|NCT00290342|3585488|FG001|NOT COMPLETED|Overall Study||5
2880312|NCT00290355|3585496|FG000|STARTED|Overall Study||122
2880313|NCT00290355|3585497|FG001|STARTED|Overall Study||60
3170038|NCT01928394|3897415|FG009|Transition- Continued|Treatment Period||1
3170039|NCT01928394|3897416|FG010|Transition- Continued|Treatment Period||0
3170040|NCT01928394|3897417|FG011|Transition- Continued|Treatment Period||0
3170041|NCT01928394|3897418|FG012|Transition- Continued|Treatment Period||17
3170042|NCT01928394|3897419|FG013|Transition- Continued|Treatment Period||0
2880314|NCT00290355|3585496|FG000|COMPLETED|Overall Study||105
2880315|NCT00290355|3585497|FG001|COMPLETED|Overall Study||55
2880316|NCT00290355|3585496|FG000|NOT COMPLETED|Overall Study||17
2880317|NCT00290355|3585497|FG001|NOT COMPLETED|Overall Study||5
2880318|NCT00290433|3585503|FG000|STARTED|Overall Study||53
2880319|NCT00290433|3585503|FG000|COMPLETED|Overall Study||17
2880320|NCT00290433|3585503|FG000|NOT COMPLETED|Overall Study||36
2880321|NCT00290472|3585510|FG000|STARTED|Overall Study||32
2880322|NCT00290472|3585511|FG001|STARTED|Overall Study||39
2880323|NCT00290472|3585512|FG002|STARTED|Overall Study||18
2880324|NCT00290472|3585510|FG000|COMPLETED|Overall Study||32
2880325|NCT00290472|3585511|FG001|COMPLETED|Overall Study||39
2880326|NCT00290472|3585512|FG002|COMPLETED|Overall Study||18
2880327|NCT00290472|3585510|FG000|NOT COMPLETED|Overall Study||0
2880328|NCT00290472|3585511|FG001|NOT COMPLETED|Overall Study||0
2880329|NCT00290472|3585512|FG002|NOT COMPLETED|Overall Study||0
2880330|NCT00290498|3585520|FG000|STARTED|Overall Study||49
2880331|NCT00290498|3585521|FG001|STARTED|Overall Study||10
2880332|NCT00290498|3585520|FG000|COMPLETED|Overall Study||41
2880333|NCT00290498|3585521|FG001|COMPLETED|Overall Study||10
2880334|NCT00290498|3585520|FG000|NOT COMPLETED|Overall Study||8
2880335|NCT00290498|3585521|FG001|NOT COMPLETED|Overall Study||0
2880336|NCT00290537|3585528|FG000|STARTED|Overall Study||4
2880337|NCT00290537|3585529|FG001|STARTED|Overall Study||0
2880338|NCT00290537|3585528|FG000|COMPLETED|Overall Study||4
2880339|NCT00290537|3585529|FG001|COMPLETED|Overall Study||0
2880340|NCT00290537|3585528|FG000|NOT COMPLETED|Overall Study||0
2880341|NCT00290537|3585529|FG001|NOT COMPLETED|Overall Study||0
2880342|NCT00290589|3585536|FG000|STARTED|Overall Study||39
2880343|NCT00290589|3585537|FG001|STARTED|Overall Study||43
2880344|NCT00290589|3585536|FG000|COMPLETED|Overall Study||37
2880345|NCT00290589|3585537|FG001|COMPLETED|Overall Study||41
2880346|NCT00290589|3585536|FG000|NOT COMPLETED|Overall Study||2
2880347|NCT00290589|3585537|FG001|NOT COMPLETED|Overall Study||2
2880348|NCT00290615|3585543|FG000|STARTED|Overall Study||30
2880349|NCT00290615|3585543|FG000|COMPLETED|Overall Study||30
2880350|NCT00290615|3585543|FG000|NOT COMPLETED|Overall Study||0
2880351|NCT00290654|3585547|FG000|STARTED|Overall Study||41
2880352|NCT00290654|3585547|FG000|COMPLETED|Overall Study||41
2880353|NCT00290654|3585547|FG000|NOT COMPLETED|Overall Study||0
2880354|NCT00290693|3585551|FG000|STARTED|Overall Study||45
2880355|NCT00290693|3585551|FG000|COMPLETED|Overall Study||43
2880356|NCT00290693|3585551|FG000|NOT COMPLETED|Overall Study||2
2880357|NCT00290706|3585560|FG000|STARTED|Overall Study||5
2880358|NCT00290706|3585561|FG001|STARTED|Overall Study||6
2880359|NCT00290706|3585562|FG002|STARTED|Overall Study||7
2880360|NCT00290706|3585563|FG003|STARTED|Overall Study||14
2880361|NCT00290706|3585560|FG000|Attempted1st Cycle|Overall Study||5
2880362|NCT00290706|3585561|FG001|Attempted1st Cycle|Overall Study||6
2880363|NCT00290706|3585562|FG002|Attempted1st Cycle|Overall Study||7
2880364|NCT00290706|3585563|FG003|Attempted1st Cycle|Overall Study||14
2880365|NCT00290706|3585560|FG000|Reached 1st Response/Cycle 3|Overall Study||0
2880366|NCT00290706|3585561|FG001|Reached 1st Response/Cycle 3|Overall Study||0
2880367|NCT00290706|3585562|FG002|Reached 1st Response/Cycle 3|Overall Study||1
2880368|NCT00290706|3585563|FG003|Reached 1st Response/Cycle 3|Overall Study||2
2880369|NCT00290706|3585560|FG000|COMPLETED|Overall Study||0
2880370|NCT00290706|3585561|FG001|COMPLETED|Overall Study||0
2880371|NCT00290706|3585562|FG002|COMPLETED|Overall Study||1
2880372|NCT00290706|3585563|FG003|COMPLETED|Overall Study||2
2880373|NCT00290706|3585560|FG000|NOT COMPLETED|Overall Study||5
2880374|NCT00290706|3585561|FG001|NOT COMPLETED|Overall Study||6
2880375|NCT00290706|3585562|FG002|NOT COMPLETED|Overall Study||6
2880376|NCT00290706|3585563|FG003|NOT COMPLETED|Overall Study||12
2880377|NCT00290732|3585576|FG000|STARTED|Overall Study||3
2880378|NCT00290732|3585577|FG001|STARTED|Overall Study||4
2880379|NCT00290732|3585578|FG002|STARTED|Overall Study||4
2880380|NCT00290732|3585579|FG003|STARTED|Overall Study||6
2880381|NCT00290732|3585580|FG004|STARTED|Overall Study||3
2880382|NCT00290732|3585576|FG000|COMPLETED|Overall Study||3
2880383|NCT00290732|3585577|FG001|COMPLETED|Overall Study||3
2880384|NCT00290732|3585578|FG002|COMPLETED|Overall Study||3
2880385|NCT00290732|3585579|FG003|COMPLETED|Overall Study||6
3314674|NCT03091179|4047962|FG001|STARTED|Overall Study||10
3314675|NCT03091179|4047961|FG000|COMPLETED|Overall Study||10
3314676|NCT03091179|4047962|FG001|COMPLETED|Overall Study||10
2880386|NCT00290732|3585580|FG004|COMPLETED|Overall Study||3
2880387|NCT00290732|3585576|FG000|NOT COMPLETED|Overall Study||0
2880388|NCT00290732|3585577|FG001|NOT COMPLETED|Overall Study||1
2880389|NCT00290732|3585578|FG002|NOT COMPLETED|Overall Study||1
2880390|NCT00290732|3585579|FG003|NOT COMPLETED|Overall Study||0
2880391|NCT00290732|3585580|FG004|NOT COMPLETED|Overall Study||0
2880392|NCT00290745|3585593|FG000|STARTED|Overall Study||79
2880393|NCT00290745|3585593|FG000|COMPLETED|Overall Study||67
2880394|NCT00290745|3585593|FG000|NOT COMPLETED|Overall Study||12
2880395|NCT00290771|3585599|FG000|STARTED|Overall Study||131
2880396|NCT00290771|3585600|FG001|STARTED|Overall Study||100
2880397|NCT00290771|3585599|FG000|COMPLETED|Overall Study||4
2880398|NCT00290771|3585600|FG001|COMPLETED|Overall Study||3
2880399|NCT00290771|3585599|FG000|NOT COMPLETED|Overall Study||127
2880400|NCT00290771|3585600|FG001|NOT COMPLETED|Overall Study||97
2880401|NCT00290810|3585607|FG000|STARTED|Overall Study||12
2880402|NCT00290810|3585607|FG000|COMPLETED|Overall Study||12
2880403|NCT00290810|3585607|FG000|NOT COMPLETED|Overall Study||0
2880404|NCT00290888|3585613|FG000|STARTED|Overall Study||41
2880405|NCT00290888|3585614|FG001|STARTED|Overall Study||45
2880406|NCT00290888|3585613|FG000|COMPLETED|Overall Study||38
2880407|NCT00290888|3585614|FG001|COMPLETED|Overall Study||44
2880408|NCT00290888|3585613|FG000|NOT COMPLETED|Overall Study||3
2880409|NCT00290888|3585614|FG001|NOT COMPLETED|Overall Study||1
2880410|NCT00291018|3585624|FG000|STARTED|Overall Study|Enrolled and Treated. 111 PDC subjects were Enrolled but only 103 were Treated.|103
2880411|NCT00291018|3585625|FG001|STARTED|Overall Study|Enrolled and Treated. 117 ACDF subjects were Enrolled but only 106 were Treated.|106
2880412|NCT00291018|3585626|FG002|STARTED|Overall Study|Enrolled and Treated. 140 PDC-CA subjects were Enrolled but only 136 were Treated.|136
3314677|NCT03091179|4047961|FG000|NOT COMPLETED|Overall Study||0
3314678|NCT03091179|4047962|FG001|NOT COMPLETED|Overall Study||0
2880413|NCT00291018|3585624|FG000|Evaluated at 24 Months|Overall Study||99
2880414|NCT00291018|3585625|FG001|Evaluated at 24 Months|Overall Study||92
2880415|NCT00291018|3585626|FG002|Evaluated at 24 Months|Overall Study||105
2880416|NCT00291018|3585624|FG000|COMPLETED|Overall Study|Evaluated at 84 Months|78
2880417|NCT00291018|3585625|FG001|COMPLETED|Overall Study|Evaluated at 84 Months|64
2880418|NCT00291018|3585626|FG002|COMPLETED|Overall Study|Evaluated at 84 Months|93
2880419|NCT00291018|3585624|FG000|NOT COMPLETED|Overall Study||25
2880420|NCT00291018|3585625|FG001|NOT COMPLETED|Overall Study||42
2880421|NCT00291018|3585626|FG002|NOT COMPLETED|Overall Study||43
2880422|NCT00291135|3585637|FG000|STARTED|Overall Study||42
2880423|NCT00291135|3585637|FG000|COMPLETED|Overall Study||42
2880424|NCT00291135|3585637|FG000|NOT COMPLETED|Overall Study||0
2880425|NCT00291161|3585645|FG000|STARTED|Overall Study||316
2880426|NCT00291161|3585646|FG001|STARTED|Overall Study||192
2880427|NCT00291161|3585647|FG002|STARTED|Overall Study||299
2880428|NCT00291161|3585648|FG003|STARTED|Overall Study||187
2880429|NCT00291161|3585645|FG000|COMPLETED|Overall Study||235
2880430|NCT00291161|3585646|FG001|COMPLETED|Overall Study||134
2880431|NCT00291161|3585647|FG002|COMPLETED|Overall Study||206
2880432|NCT00291161|3585648|FG003|COMPLETED|Overall Study||122
2880433|NCT00291161|3585645|FG000|NOT COMPLETED|Overall Study||81
2880434|NCT00291161|3585646|FG001|NOT COMPLETED|Overall Study||58
2880435|NCT00291161|3585647|FG002|NOT COMPLETED|Overall Study||93
2880436|NCT00291161|3585648|FG003|NOT COMPLETED|Overall Study||65
2880437|NCT00291187|3585660|FG000|STARTED|Overall Study||103
2880438|NCT00291187|3585661|FG001|STARTED|Overall Study||100
2880439|NCT00291187|3585662|FG002|STARTED|Overall Study||103
2880440|NCT00291187|3585663|FG003|STARTED|Overall Study||106
2880441|NCT00291187|3585660|FG000|COMPLETED|Overall Study||103
2880442|NCT00291187|3585661|FG001|COMPLETED|Overall Study||100
2880443|NCT00291187|3585662|FG002|COMPLETED|Overall Study||102
2880444|NCT00291187|3585663|FG003|COMPLETED|Overall Study||106
2880445|NCT00291187|3585660|FG000|NOT COMPLETED|Overall Study||0
2880446|NCT00291187|3585661|FG001|NOT COMPLETED|Overall Study||0
2880447|NCT00291187|3585662|FG002|NOT COMPLETED|Overall Study||1
2880448|NCT00291187|3585663|FG003|NOT COMPLETED|Overall Study||0
2880449|NCT00291226|3585679|FG000|STARTED|Overall Study||4
2880450|NCT00291226|3585680|FG001|STARTED|Overall Study||4
2880451|NCT00291226|3585679|FG000|COMPLETED|Overall Study||3
2880452|NCT00291226|3585680|FG001|COMPLETED|Overall Study||3
2880453|NCT00291226|3585679|FG000|NOT COMPLETED|Overall Study||1
2880454|NCT00291226|3585680|FG001|NOT COMPLETED|Overall Study||1
2880455|NCT00291317|3585686|FG000|STARTED|Overall Study||6
2880456|NCT00291317|3585686|FG000|COMPLETED|Overall Study||6
2880457|NCT00291317|3585686|FG000|NOT COMPLETED|Overall Study||0
2880458|NCT00291330|3585693|FG000|STARTED|Overall Study|Started Treatment|1273
2880459|NCT00291330|3585694|FG001|STARTED|Overall Study|Started Treatment|1266
3170043|NCT01928394|3897420|FG014|Transition- Continued|Treatment Period||2
3170044|NCT01928394|3897421|FG015|Transition- Continued|Treatment Period||0
2880460|NCT00291330|3585693|FG000|COMPLETED|Overall Study|Completed planned observation time|1172
2880461|NCT00291330|3585694|FG001|COMPLETED|Overall Study|Completed planned observation time|1169
2880462|NCT00291330|3585693|FG000|NOT COMPLETED|Overall Study||101
2880463|NCT00291330|3585694|FG001|NOT COMPLETED|Overall Study||97
2880464|NCT00291343|3585702|FG000|STARTED|Overall Study||203
2880465|NCT00291343|3585703|FG001|STARTED|Overall Study||93
2880466|NCT00291343|3585702|FG000|COMPLETED|Overall Study||203
2880467|NCT00291343|3585703|FG001|COMPLETED|Overall Study||93
2880468|NCT00291343|3585702|FG000|NOT COMPLETED|Overall Study||0
2880469|NCT00291343|3585703|FG001|NOT COMPLETED|Overall Study||0
2880470|NCT00291447|3585713|FG000|STARTED|Overall Study||2
2880471|NCT00291447|3585714|FG001|STARTED|Overall Study||2
2880472|NCT00291447|3585715|FG002|STARTED|Overall Study||2
2880473|NCT00291447|3585716|FG003|STARTED|Overall Study||2
2880474|NCT00291447|3585713|FG000|COMPLETED|Overall Study||2
2880475|NCT00291447|3585714|FG001|COMPLETED|Overall Study||2
2880476|NCT00291447|3585715|FG002|COMPLETED|Overall Study||2
2880477|NCT00291447|3585716|FG003|COMPLETED|Overall Study||2
2880478|NCT00291447|3585713|FG000|NOT COMPLETED|Overall Study||0
2880479|NCT00291447|3585714|FG001|NOT COMPLETED|Overall Study||0
2880480|NCT00291447|3585715|FG002|NOT COMPLETED|Overall Study||0
2880481|NCT00291447|3585716|FG003|NOT COMPLETED|Overall Study||0
2880482|NCT00291499|3585729|FG000|STARTED|Overall Study||81
2880483|NCT00291499|3585730|FG001|STARTED|Overall Study||82
2880484|NCT00291499|3585729|FG000|Intention to Treat (ITT)|Overall Study||80
2880485|NCT00291499|3585730|FG001|Intention to Treat (ITT)|Overall Study||82
2880486|NCT00291499|3585729|FG000|Per Protocol (PP)|Overall Study||72
2880487|NCT00291499|3585730|FG001|Per Protocol (PP)|Overall Study||67
2880488|NCT00291499|3585729|FG000|Safety Population|Overall Study||81
2880489|NCT00291499|3585730|FG001|Safety Population|Overall Study||82
2880490|NCT00291499|3585729|FG000|COMPLETED|Overall Study||72
2880491|NCT00291499|3585730|FG001|COMPLETED|Overall Study||67
2880492|NCT00291499|3585729|FG000|NOT COMPLETED|Overall Study||9
2880493|NCT00291499|3585730|FG001|NOT COMPLETED|Overall Study||15
2880494|NCT00291551|3585736|FG000|STARTED|Overall Study||39
2880495|NCT00291551|3585736|FG000|COMPLETED|Overall Study||26
2880496|NCT00291551|3585736|FG000|NOT COMPLETED|Overall Study||13
2880497|NCT00291577|3585741|FG000|STARTED|Overall Study||22
2880498|NCT00291577|3585741|FG000|COMPLETED|Overall Study|Subject End of Study=Completed; not per protocol reason. PI reason=withdrawn during active treatment|1
2880499|NCT00291577|3585741|FG000|NOT COMPLETED|Overall Study||21
2880500|NCT00291642|3585750|FG000|STARTED|Overall Study||78
2880501|NCT00291642|3585751|FG001|STARTED|Overall Study||116
2880502|NCT00291642|3585752|FG002|STARTED|Overall Study||119
2880503|NCT00291642|3585753|FG003|STARTED|Overall Study||119
2880504|NCT00291642|3585754|FG004|STARTED|Overall Study||119
2880505|NCT00291642|3585750|FG000|COMPLETED|Overall Study||76
2880506|NCT00291642|3585751|FG001|COMPLETED|Overall Study||116
2880507|NCT00291642|3585752|FG002|COMPLETED|Overall Study||117
2880508|NCT00291642|3585753|FG003|COMPLETED|Overall Study||119
2880509|NCT00291642|3585754|FG004|COMPLETED|Overall Study||118
2880510|NCT00291642|3585750|FG000|NOT COMPLETED|Overall Study||2
2880511|NCT00291642|3585751|FG001|NOT COMPLETED|Overall Study||0
2880512|NCT00291642|3585752|FG002|NOT COMPLETED|Overall Study||2
2880513|NCT00291642|3585753|FG003|NOT COMPLETED|Overall Study||0
2880514|NCT00291642|3585754|FG004|NOT COMPLETED|Overall Study||1
2880515|NCT00291655|3585766|FG000|STARTED|Overall Study||130
2880516|NCT00291655|3585766|FG000|COMPLETED|Overall Study||115
2880517|NCT00291655|3585766|FG000|NOT COMPLETED|Overall Study||15
2880518|NCT00291668|3585773|FG000|STARTED|Overall Study||32
2880519|NCT00291668|3585774|FG001|STARTED|Overall Study||30
2880520|NCT00291668|3585775|FG002|STARTED|Overall Study||32
2880521|NCT00291668|3585773|FG000|COMPLETED|Overall Study||28
2880522|NCT00291668|3585774|FG001|COMPLETED|Overall Study||29
2880523|NCT00291668|3585775|FG002|COMPLETED|Overall Study||31
2880524|NCT00291668|3585773|FG000|NOT COMPLETED|Overall Study||4
2880525|NCT00291668|3585774|FG001|NOT COMPLETED|Overall Study||1
2880526|NCT00291668|3585775|FG002|NOT COMPLETED|Overall Study||1
2880527|NCT00291694|3585785|FG000|STARTED|Overall Study||24
2880528|NCT00291694|3585786|FG001|STARTED|Overall Study||48
2880529|NCT00291694|3585785|FG000|COMPLETED|Overall Study||21
2880530|NCT00291694|3585786|FG001|COMPLETED|Overall Study||43
2880531|NCT00291694|3585785|FG000|NOT COMPLETED|Overall Study||3
2880532|NCT00291694|3585786|FG001|NOT COMPLETED|Overall Study||5
2880533|NCT00291876|3585794|FG000|STARTED|Month 138||107
2880534|NCT00291876|3585794|FG000|COMPLETED|Month 138||107
2880535|NCT00291876|3585794|FG000|NOT COMPLETED|Month 138||0
2880536|NCT00291876|3585794|FG000|STARTED|Month 150||117
2880537|NCT00291876|3585794|FG000|COMPLETED|Month 150||117
2880538|NCT00291876|3585794|FG000|NOT COMPLETED|Month 150||0
2880539|NCT00291876|3585794|FG000|STARTED|Month 162||127
2880540|NCT00291876|3585794|FG000|COMPLETED|Month 162||127
2880541|NCT00291876|3585794|FG000|NOT COMPLETED|Month 162||0
2880542|NCT00291876|3585794|FG000|STARTED|Month 174||127
2880543|NCT00291876|3585794|FG000|COMPLETED|Month 174||127
2880544|NCT00291876|3585794|FG000|NOT COMPLETED|Month 174||0
2880545|NCT00291876|3585794|FG000|STARTED|Month 186||129
2880546|NCT00291876|3585794|FG000|COMPLETED|Month 186||129
2880547|NCT00291876|3585794|FG000|NOT COMPLETED|Month 186||0
2880548|NCT00291876|3585794|FG000|STARTED|Month 198||135
2880549|NCT00291876|3585794|FG000|COMPLETED|Month 198||135
2880550|NCT00291876|3585794|FG000|NOT COMPLETED|Month 198||0
2880551|NCT00291876|3585794|FG000|STARTED|Month 210||124
2880552|NCT00291876|3585794|FG000|COMPLETED|Month 210||124
2880553|NCT00291876|3585794|FG000|NOT COMPLETED|Month 210||0
2880554|NCT00291876|3585794|FG000|STARTED|Month 222||114
2880555|NCT00291876|3585794|FG000|COMPLETED|Month 222||114
2880556|NCT00291876|3585794|FG000|NOT COMPLETED|Month 222||0
2880557|NCT00291876|3585794|FG000|STARTED|Month 234||110
2880558|NCT00291876|3585794|FG000|COMPLETED|Month 234||110
2880559|NCT00291876|3585794|FG000|NOT COMPLETED|Month 234||0
2880560|NCT00291876|3585794|FG000|STARTED|Month 246||116
2880561|NCT00291876|3585794|FG000|COMPLETED|Month 246||116
2880562|NCT00291876|3585794|FG000|NOT COMPLETED|Month 246||0
2880563|NCT00292045|3585798|FG000|STARTED|Core Study (Through Week 13)||15
2880564|NCT00292045|3585798|FG000|COMPLETED|Core Study (Through Week 13)||13
2880565|NCT00292045|3585798|FG000|NOT COMPLETED|Core Study (Through Week 13)||2
2880566|NCT00292045|3585798|FG000|STARTED|Extended Treatment Beyond Week 13||10
2880567|NCT00292045|3585798|FG000|COMPLETED|Extended Treatment Beyond Week 13||10
2880568|NCT00292045|3585798|FG000|NOT COMPLETED|Extended Treatment Beyond Week 13||0
2880569|NCT00292162|3585804|FG000|STARTED|Overall Study||19
2880570|NCT00292162|3585805|FG001|STARTED|Overall Study||22
2880571|NCT00292162|3585804|FG000|COMPLETED|Overall Study||18
2880572|NCT00292162|3585805|FG001|COMPLETED|Overall Study||20
2880573|NCT00292162|3585804|FG000|NOT COMPLETED|Overall Study||1
2880574|NCT00292162|3585805|FG001|NOT COMPLETED|Overall Study||2
2880575|NCT00292188|3585813|FG000|STARTED|Single-Blind||368
2880576|NCT00292188|3585814|FG001|STARTED|Single-Blind||0
2880577|NCT00292188|3585815|FG002|STARTED|Single-Blind||0
2880578|NCT00292188|3585813|FG000|Received Treatment|Single-Blind||367
2880579|NCT00292188|3585814|FG001|Received Treatment|Single-Blind||0
2880580|NCT00292188|3585815|FG002|Received Treatment|Single-Blind||0
2880581|NCT00292188|3585813|FG000|COMPLETED|Single-Blind||254
2880582|NCT00292188|3585814|FG001|COMPLETED|Single-Blind||0
2880583|NCT00292188|3585815|FG002|COMPLETED|Single-Blind||0
2880584|NCT00292188|3585813|FG000|NOT COMPLETED|Single-Blind||114
2880585|NCT00292188|3585814|FG001|NOT COMPLETED|Single-Blind||0
2880586|NCT00292188|3585815|FG002|NOT COMPLETED|Single-Blind||0
2880587|NCT00292188|3585813|FG000|STARTED|Double-Blind||0
2880588|NCT00292188|3585814|FG001|STARTED|Double-Blind||127
2880589|NCT00292188|3585815|FG002|STARTED|Double-Blind||127
2880590|NCT00292188|3585813|FG000|COMPLETED|Double-Blind||0
2880591|NCT00292188|3585814|FG001|COMPLETED|Double-Blind||96
2880592|NCT00292188|3585815|FG002|COMPLETED|Double-Blind||98
2880593|NCT00292188|3585813|FG000|NOT COMPLETED|Double-Blind||0
2880594|NCT00292188|3585814|FG001|NOT COMPLETED|Double-Blind||31
2880595|NCT00292188|3585815|FG002|NOT COMPLETED|Double-Blind||29
2880596|NCT00292227|3585824|FG000|STARTED|Patch Period||66
2880597|NCT00292227|3585825|FG001|STARTED|Patch Period||31
2880598|NCT00292227|3585826|FG002|STARTED|Patch Period||33
2880599|NCT00292227|3585824|FG000|COMPLETED|Patch Period||65
2880600|NCT00292227|3585825|FG001|COMPLETED|Patch Period||31
2880601|NCT00292227|3585826|FG002|COMPLETED|Patch Period||30
2880602|NCT00292227|3585824|FG000|NOT COMPLETED|Patch Period||1
2880603|NCT00292227|3585825|FG001|NOT COMPLETED|Patch Period||0
2880604|NCT00292227|3585826|FG002|NOT COMPLETED|Patch Period||3
2880605|NCT00292227|3585824|FG000|STARTED|Cross-over Period 1 (Day 32)||65
2880606|NCT00292227|3585825|FG001|STARTED|Cross-over Period 1 (Day 32)||31
2880607|NCT00292227|3585826|FG002|STARTED|Cross-over Period 1 (Day 32)||30
2880608|NCT00292227|3585824|FG000|COMPLETED|Cross-over Period 1 (Day 32)||65
2880609|NCT00292227|3585825|FG001|COMPLETED|Cross-over Period 1 (Day 32)||31
2880610|NCT00292227|3585826|FG002|COMPLETED|Cross-over Period 1 (Day 32)||30
2880611|NCT00292227|3585824|FG000|NOT COMPLETED|Cross-over Period 1 (Day 32)||0
2880612|NCT00292227|3585825|FG001|NOT COMPLETED|Cross-over Period 1 (Day 32)||0
2880613|NCT00292227|3585826|FG002|NOT COMPLETED|Cross-over Period 1 (Day 32)||0
2880614|NCT00292227|3585824|FG000|STARTED|Cross-over Period 2 (Day 39)||65
2880615|NCT00292227|3585825|FG001|STARTED|Cross-over Period 2 (Day 39)||31
2880616|NCT00292227|3585826|FG002|STARTED|Cross-over Period 2 (Day 39)||30
2880617|NCT00292227|3585824|FG000|COMPLETED|Cross-over Period 2 (Day 39)||65
2880618|NCT00292227|3585825|FG001|COMPLETED|Cross-over Period 2 (Day 39)||31
2880619|NCT00292227|3585826|FG002|COMPLETED|Cross-over Period 2 (Day 39)||30
2880620|NCT00292227|3585824|FG000|NOT COMPLETED|Cross-over Period 2 (Day 39)||0
2880621|NCT00292227|3585825|FG001|NOT COMPLETED|Cross-over Period 2 (Day 39)||0
2880622|NCT00292227|3585826|FG002|NOT COMPLETED|Cross-over Period 2 (Day 39)||0
2880623|NCT00292318|3585836|FG000|STARTED|Overall Study||4
2880624|NCT00292318|3585837|FG001|STARTED|Overall Study||3
2880625|NCT00292318|3585836|FG000|COMPLETED|Overall Study||2
2880626|NCT00292318|3585837|FG001|COMPLETED|Overall Study||2
2880627|NCT00292318|3585836|FG000|NOT COMPLETED|Overall Study||2
2880628|NCT00292318|3585837|FG001|NOT COMPLETED|Overall Study||1
2880629|NCT00292370|3585846|FG000|STARTED|Phase I - Open-Label Paroxetine (OLP)||124
2880630|NCT00292370|3585847|FG001|STARTED|Phase I - Open-Label Paroxetine (OLP)||0
2880631|NCT00292370|3585848|FG002|STARTED|Phase I - Open-Label Paroxetine (OLP)||0
2880632|NCT00292370|3585846|FG000|COMPLETED|Phase I - Open-Label Paroxetine (OLP)||78
2880633|NCT00292370|3585847|FG001|COMPLETED|Phase I - Open-Label Paroxetine (OLP)||0
2880634|NCT00292370|3585848|FG002|COMPLETED|Phase I - Open-Label Paroxetine (OLP)||0
2880635|NCT00292370|3585846|FG000|NOT COMPLETED|Phase I - Open-Label Paroxetine (OLP)||46
2880636|NCT00292370|3585847|FG001|NOT COMPLETED|Phase I - Open-Label Paroxetine (OLP)||0
2880637|NCT00292370|3585848|FG002|NOT COMPLETED|Phase I - Open-Label Paroxetine (OLP)||0
2880638|NCT00292370|3585846|FG000|STARTED|Phase II: OLP + DB Quetiapine or Placebo|"78 Completed Ph I~28 Excluded Ph II:~20 responded~7 declined~1 medical~50 to Arm 2 & 3"|0
2880639|NCT00292370|3585847|FG001|STARTED|Phase II: OLP + DB Quetiapine or Placebo|25 out of 50 in Arm I PhI, eligible for Ph II|25
2880640|NCT00292370|3585848|FG002|STARTED|Phase II: OLP + DB Quetiapine or Placebo|25 out of 50 in Arm I PhI, eligible for Ph II|25
2880641|NCT00292370|3585846|FG000|COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||0
2880642|NCT00292370|3585847|FG001|COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||21
2880643|NCT00292370|3585848|FG002|COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||18
2880644|NCT00292370|3585846|FG000|NOT COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||0
2880645|NCT00292370|3585847|FG001|NOT COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||4
2880646|NCT00292370|3585848|FG002|NOT COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||7
2880647|NCT00292461|3585857|FG000|STARTED|Overall Study||34
2880648|NCT00292461|3585858|FG001|STARTED|Overall Study||30
2880649|NCT00292461|3585857|FG000|COMPLETED|Overall Study||24
2880650|NCT00292461|3585858|FG001|COMPLETED|Overall Study||24
2880651|NCT00292461|3585857|FG000|NOT COMPLETED|Overall Study||10
2880652|NCT00292461|3585858|FG001|NOT COMPLETED|Overall Study||6
2880653|NCT00292591|3585867|FG000|STARTED|Overall Study||166
2880654|NCT00292591|3585868|FG001|STARTED|Overall Study||167
2880655|NCT00292591|3585869|FG002|STARTED|Overall Study||168
2880656|NCT00292591|3585867|FG000|COMPLETED|Overall Study||102
2880657|NCT00292591|3585868|FG001|COMPLETED|Overall Study||111
2880658|NCT00292591|3585869|FG002|COMPLETED|Overall Study||110
2880659|NCT00292591|3585867|FG000|NOT COMPLETED|Overall Study||64
2880660|NCT00292591|3585868|FG001|NOT COMPLETED|Overall Study||56
2880661|NCT00292591|3585869|FG002|NOT COMPLETED|Overall Study||58
2880662|NCT00292942|3585881|FG000|STARTED|Overall Study||6
2880663|NCT00292942|3585882|FG001|STARTED|Overall Study||6
2880664|NCT00292942|3585883|FG002|STARTED|Overall Study||7
2880665|NCT00292942|3585884|FG003|STARTED|Overall Study||7
2880666|NCT00292942|3585881|FG000|COMPLETED|Overall Study||6
2880667|NCT00292942|3585882|FG001|COMPLETED|Overall Study||6
2880668|NCT00292942|3585883|FG002|COMPLETED|Overall Study||6
2880669|NCT00292942|3585884|FG003|COMPLETED|Overall Study||6
2880670|NCT00292942|3585881|FG000|NOT COMPLETED|Overall Study||0
2880671|NCT00292942|3585882|FG001|NOT COMPLETED|Overall Study||0
2880672|NCT00292942|3585883|FG002|NOT COMPLETED|Overall Study||1
2880673|NCT00292942|3585884|FG003|NOT COMPLETED|Overall Study||1
2880674|NCT00292981|3585897|FG000|STARTED|Overall Study||57
2880675|NCT00292981|3585897|FG000|COMPLETED|Overall Study||18
2880676|NCT00292981|3585897|FG000|NOT COMPLETED|Overall Study||39
2880677|NCT00293020|3585901|FG000|STARTED|Overall Study||244
2880678|NCT00293020|3585901|FG000|COMPLETED|Overall Study||82
2880679|NCT00293020|3585901|FG000|NOT COMPLETED|Overall Study||162
2880680|NCT00293033|3585905|FG000|STARTED|Open-label Titration Period|152 subjects enrolled; 151 subjects received at least one dose of study drug|151
2880681|NCT00293033|3585905|FG000|COMPLETED|Open-label Titration Period||82
2880682|NCT00293033|3585905|FG000|NOT COMPLETED|Open-label Titration Period||69
2880683|NCT00293033|3585905|FG000|STARTED|Double-blind Treatment Period|82 randomized; 1 didn't take double-blind drug; 1 didn't report a pain assessment within 30 minutes|82
2880684|NCT00293033|3585905|FG000|COMPLETED|Double-blind Treatment Period||70
2880685|NCT00293033|3585905|FG000|NOT COMPLETED|Double-blind Treatment Period||12
2880686|NCT00293059|3585915|FG000|STARTED|Overall Study||120
2880687|NCT00293059|3585916|FG001|STARTED|Overall Study||70
2880688|NCT00293059|3585915|FG000|Subjects Received Treatment|Overall Study||119
2880689|NCT00293059|3585916|FG001|Subjects Received Treatment|Overall Study||66
2880690|NCT00293059|3585915|FG000|Cycle 1/Treatment Day 28|Overall Study||115
2880691|NCT00293059|3585916|FG001|Cycle 1/Treatment Day 28|Overall Study||64
2880692|NCT00293059|3585915|FG000|Cycle 3/Treatment Day 84|Overall Study||100
2880693|NCT00293059|3585916|FG001|Cycle 3/Treatment Day 84|Overall Study||55
2880694|NCT00293059|3585915|FG000|Cycle 7/Treatment Day 196|Overall Study|Includes participants that prematurely discontinued and may not be counted in earlier visits.|113
2880695|NCT00293059|3585916|FG001|Cycle 7/Treatment Day 196|Overall Study|Includes participants that prematurely discontinued and may not be counted in earlier visits.|62
2880696|NCT00293059|3585915|FG000|COMPLETED|Overall Study||85
2880697|NCT00293059|3585916|FG001|COMPLETED|Overall Study||51
2880698|NCT00293059|3585915|FG000|NOT COMPLETED|Overall Study||35
2880699|NCT00293059|3585916|FG001|NOT COMPLETED|Overall Study||19
2880700|NCT00293202|3585924|FG000|STARTED|Overall Study||5
2880701|NCT00293202|3585925|FG001|STARTED|Overall Study||5
2880702|NCT00293202|3585924|FG000|COMPLETED|Overall Study||2
2880703|NCT00293202|3585925|FG001|COMPLETED|Overall Study||3
2880704|NCT00293202|3585924|FG000|NOT COMPLETED|Overall Study||3
2880705|NCT00293202|3585925|FG001|NOT COMPLETED|Overall Study||2
2880706|NCT00293215|3585937|FG000|STARTED|Overall Study||6
2880707|NCT00293215|3585938|FG001|STARTED|Overall Study||3
2880708|NCT00293215|3585937|FG000|COMPLETED|Overall Study||1
2880709|NCT00293215|3585938|FG001|COMPLETED|Overall Study||0
2880710|NCT00293215|3585937|FG000|NOT COMPLETED|Overall Study||5
2880711|NCT00293215|3585938|FG001|NOT COMPLETED|Overall Study||3
2880712|NCT00293241|3585946|FG000|STARTED|Overall Study||299
2880713|NCT00293241|3585947|FG001|STARTED|Overall Study||306
2880714|NCT00293241|3585946|FG000|COMPLETED|Overall Study||263
2880715|NCT00293241|3585947|FG001|COMPLETED|Overall Study||265
2880716|NCT00293241|3585946|FG000|NOT COMPLETED|Overall Study||36
2880717|NCT00293241|3585947|FG001|NOT COMPLETED|Overall Study||41
2880718|NCT00293254|3585958|FG000|STARTED|Primary Study - Double-Blind Week 0-48||232
2880719|NCT00293254|3585959|FG001|STARTED|Primary Study - Double-Blind Week 0-48||119
2880720|NCT00293254|3585958|FG000|Treated|Primary Study - Double-Blind Week 0-48||230
2880721|NCT00293254|3585959|FG001|Treated|Primary Study - Double-Blind Week 0-48||119
2880722|NCT00293254|3585958|FG000|Continuing in Double-Blind|Primary Study - Double-Blind Week 0-48|Excludes participants who entered the Open-Label Post-Virologic Failure (OLPVF) Phase|177
2880723|NCT00293254|3585959|FG001|Continuing in Double-Blind|Primary Study - Double-Blind Week 0-48|Excludes participants who entered the OLPVF phase|55
2880724|NCT00293254|3585958|FG000|COMPLETED|Primary Study - Double-Blind Week 0-48||177
2880725|NCT00293254|3585959|FG001|COMPLETED|Primary Study - Double-Blind Week 0-48||55
2880726|NCT00293254|3585958|FG000|NOT COMPLETED|Primary Study - Double-Blind Week 0-48||55
2880727|NCT00293254|3585959|FG001|NOT COMPLETED|Primary Study - Double-Blind Week 0-48||64
2880728|NCT00293254|3585958|FG000|STARTED|Extension - Double-Blind Week 49-156||177
2880729|NCT00293254|3585959|FG001|STARTED|Extension - Double-Blind Week 49-156|1 of 55 participants who completed Week 48 did not enter the extension study.|54
2880730|NCT00293254|3585958|FG000|COMPLETED|Extension - Double-Blind Week 49-156||120
2880731|NCT00293254|3585959|FG001|COMPLETED|Extension - Double-Blind Week 49-156||25
2880732|NCT00293254|3585958|FG000|NOT COMPLETED|Extension - Double-Blind Week 49-156||57
2880733|NCT00293254|3585959|FG001|NOT COMPLETED|Extension - Double-Blind Week 49-156||29
2880734|NCT00293254|3585958|FG000|STARTED|Extension - Open-Label Week 157-240||120
2880735|NCT00293254|3585959|FG001|STARTED|Extension - Open-Label Week 157-240|6 of 25 participants who completed the double-blind phase did not enter this open-label phase.|19
2880736|NCT00293254|3585958|FG000|COMPLETED|Extension - Open-Label Week 157-240||110
2880737|NCT00293254|3585959|FG001|COMPLETED|Extension - Open-Label Week 157-240||18
2880738|NCT00293254|3585958|FG000|NOT COMPLETED|Extension - Open-Label Week 157-240||10
2880739|NCT00293254|3585959|FG001|NOT COMPLETED|Extension - Open-Label Week 157-240||1
2880740|NCT00293254|3585958|FG000|STARTED|Open-Label Post Virologic Failure Phase|Number of participants who failed treatment and consented to enter the OLPVF phase|50
2880741|NCT00293254|3585959|FG001|STARTED|Open-Label Post Virologic Failure Phase|Number of participants who failed treatment and consented to enter the OLPVF phase|64
2880742|NCT00293254|3585958|FG000|COMPLETED|Open-Label Post Virologic Failure Phase||19
2880743|NCT00293254|3585959|FG001|COMPLETED|Open-Label Post Virologic Failure Phase||37
2880744|NCT00293254|3585958|FG000|NOT COMPLETED|Open-Label Post Virologic Failure Phase||31
2880745|NCT00293254|3585959|FG001|NOT COMPLETED|Open-Label Post Virologic Failure Phase||27
2880746|NCT00293267|3585969|FG000|STARTED|Primary Study - Double-Blind Week 0-48||234
2880747|NCT00293267|3585970|FG001|STARTED|Primary Study - Double-Blind Week 0-48||118
2880748|NCT00293267|3585969|FG000|Treated|Primary Study - Double-Blind Week 0-48||232
2880749|NCT00293267|3585970|FG001|Treated|Primary Study - Double-Blind Week 0-48||118
2919359|NCT00531427|3629760|FG000|STARTED|Overall Study||282
2919360|NCT00531427|3629761|FG001|STARTED|Overall Study||285
2880750|NCT00293267|3585969|FG000|Continuing in Double-Blind|Primary Study - Double-Blind Week 0-48|Excludes participants who entered the open-label post virological failure (OLPVF) phase|193
2880751|NCT00293267|3585970|FG001|Continuing in Double-Blind|Primary Study - Double-Blind Week 0-48||50
2880752|NCT00293267|3585969|FG000|COMPLETED|Primary Study - Double-Blind Week 0-48||193
2880753|NCT00293267|3585970|FG001|COMPLETED|Primary Study - Double-Blind Week 0-48||50
2880754|NCT00293267|3585969|FG000|NOT COMPLETED|Primary Study - Double-Blind Week 0-48||41
2880755|NCT00293267|3585970|FG001|NOT COMPLETED|Primary Study - Double-Blind Week 0-48||68
2880756|NCT00293267|3585969|FG000|STARTED|Extension - Double-Blind Week 49-156|2 participants who completed Week 48 did not enter the extension study|191
2880757|NCT00293267|3585970|FG001|STARTED|Extension - Double-Blind Week 49-156||50
2880758|NCT00293267|3585969|FG000|COMPLETED|Extension - Double-Blind Week 49-156||139
2880759|NCT00293267|3585970|FG001|COMPLETED|Extension - Double-Blind Week 49-156||35
2880760|NCT00293267|3585969|FG000|NOT COMPLETED|Extension - Double-Blind Week 49-156||52
2880761|NCT00293267|3585970|FG001|NOT COMPLETED|Extension - Double-Blind Week 49-156||15
2880762|NCT00293267|3585969|FG000|STARTED|Extension - Open-Label Week 157-240|8 of 139 participants who completed the double-blind phase did not enter this open-label phase|131
2880763|NCT00293267|3585970|FG001|STARTED|Extension - Open-Label Week 157-240|7 of 35 participants who completed the double-blind phase did not enter this open-label phase|28
2880764|NCT00293267|3585969|FG000|COMPLETED|Extension - Open-Label Week 157-240||111
2880765|NCT00293267|3585970|FG001|COMPLETED|Extension - Open-Label Week 157-240||26
2880766|NCT00293267|3585969|FG000|NOT COMPLETED|Extension - Open-Label Week 157-240||20
2880767|NCT00293267|3585970|FG001|NOT COMPLETED|Extension - Open-Label Week 157-240||2
2880768|NCT00293267|3585969|FG000|STARTED|Open-Label Post Virologic Failure Phase|Number of participants who failed treatment and consented to enter the OLPVF phase|48
2880769|NCT00293267|3585970|FG001|STARTED|Open-Label Post Virologic Failure Phase|Number of participants who failed treatment and consented to enter the OLPVF phase|66
2880770|NCT00293267|3585969|FG000|COMPLETED|Open-Label Post Virologic Failure Phase||15
2880771|NCT00293267|3585970|FG001|COMPLETED|Open-Label Post Virologic Failure Phase||29
2880772|NCT00293267|3585969|FG000|NOT COMPLETED|Open-Label Post Virologic Failure Phase||33
2880773|NCT00293267|3585970|FG001|NOT COMPLETED|Open-Label Post Virologic Failure Phase||37
2880774|NCT00293293|3585980|FG000|STARTED|Overall Study||20
2880775|NCT00293293|3585981|FG001|STARTED|Overall Study||23
2880776|NCT00293293|3585980|FG000|COMPLETED|Overall Study||18
2880777|NCT00293293|3585981|FG001|COMPLETED|Overall Study||21
2880778|NCT00293293|3585980|FG000|NOT COMPLETED|Overall Study||2
2880779|NCT00293293|3585981|FG001|NOT COMPLETED|Overall Study||2
2880780|NCT00293384|3585988|FG000|STARTED|Overall Study||40
2880781|NCT00293384|3585988|FG000|COMPLETED|Overall Study||35
2880782|NCT00293384|3585988|FG000|NOT COMPLETED|Overall Study||5
2880783|NCT00293397|3585992|FG000|STARTED|Overall Study||20
2880784|NCT00293397|3585992|FG000|Received First DEB-TACE|Overall Study|1 patient death after baseline inclusion screening and before first treatment|19
2880785|NCT00293397|3585992|FG000|COMPLETED|Overall Study|1 patient death within 30 days post-TACE - not attributed to TACE procedure|18
2880786|NCT00293397|3585992|FG000|NOT COMPLETED|Overall Study||2
2880787|NCT00293423|3585999|FG000|STARTED|Surgical Resection||28
2880788|NCT00293423|3586000|FG001|STARTED|Surgical Resection||68
2880789|NCT00293423|3585999|FG000|COMPLETED|Surgical Resection||12
2880790|NCT00293423|3586000|FG001|COMPLETED|Surgical Resection||41
2880791|NCT00293423|3585999|FG000|NOT COMPLETED|Surgical Resection||16
2880792|NCT00293423|3586000|FG001|NOT COMPLETED|Surgical Resection||27
2880793|NCT00293423|3585999|FG000|STARTED|Vaccination Treatment Period||12
2880794|NCT00293423|3586000|FG001|STARTED|Vaccination Treatment Period||41
2880795|NCT00293423|3585999|FG000|COMPLETED|Vaccination Treatment Period||12
2880796|NCT00293423|3586000|FG001|COMPLETED|Vaccination Treatment Period||38
2880797|NCT00293423|3585999|FG000|NOT COMPLETED|Vaccination Treatment Period||0
2880798|NCT00293423|3586000|FG001|NOT COMPLETED|Vaccination Treatment Period||3
2880799|NCT00293462|3586009|FG000|STARTED|Overall Study||31
2880800|NCT00293462|3586010|FG001|STARTED|Overall Study||29
2880801|NCT00293462|3586011|FG002|STARTED|Overall Study||31
2880802|NCT00293462|3586009|FG000|COMPLETED|Overall Study||24
2880803|NCT00293462|3586010|FG001|COMPLETED|Overall Study||21
2880804|NCT00293462|3586011|FG002|COMPLETED|Overall Study||19
2880805|NCT00293462|3586009|FG000|NOT COMPLETED|Overall Study||7
2880806|NCT00293462|3586010|FG001|NOT COMPLETED|Overall Study||8
2880807|NCT00293462|3586011|FG002|NOT COMPLETED|Overall Study||12
2880808|NCT00293540|3586021|FG000|STARTED|Overall Study||122
2880809|NCT00293540|3586022|FG001|STARTED|Overall Study||127
2880810|NCT00293540|3586021|FG000|COMPLETED|Overall Study||115
2880811|NCT00293540|3586022|FG001|COMPLETED|Overall Study||119
2880812|NCT00293540|3586021|FG000|NOT COMPLETED|Overall Study||7
2880813|NCT00293540|3586022|FG001|NOT COMPLETED|Overall Study||8
2880814|NCT00293579|3586028|FG000|STARTED|Overall Study||5
2880815|NCT00293579|3586028|FG000|COMPLETED|Overall Study||4
2880816|NCT00293579|3586028|FG000|NOT COMPLETED|Overall Study||1
2880817|NCT00293709|3586033|FG000|STARTED|Overall Study||149
2880818|NCT00293709|3586033|FG000|COMPLETED|Overall Study||102
2880819|NCT00293709|3586033|FG000|NOT COMPLETED|Overall Study||47
2880820|NCT00293722|3586037|FG000|STARTED|Overall Study||1291
2880821|NCT00293722|3586037|FG000|COMPLETED|Overall Study||864
2880822|NCT00293722|3586037|FG000|NOT COMPLETED|Overall Study||427
2880823|NCT00293813|3586044|FG000|STARTED|Overall Study||82
2880824|NCT00293813|3586045|FG001|STARTED|Overall Study||83
2880825|NCT00293813|3586046|FG002|STARTED|Overall Study||82
2880826|NCT00293813|3586044|FG000|COMPLETED|Overall Study||69
2880827|NCT00293813|3586045|FG001|COMPLETED|Overall Study||74
2880828|NCT00293813|3586046|FG002|COMPLETED|Overall Study||74
2880829|NCT00293813|3586044|FG000|NOT COMPLETED|Overall Study||13
2880830|NCT00293813|3586045|FG001|NOT COMPLETED|Overall Study||9
2880831|NCT00293813|3586046|FG002|NOT COMPLETED|Overall Study||8
2919361|NCT00531427|3629760|FG000|COMPLETED|Overall Study||209
2919362|NCT00531427|3629761|FG001|COMPLETED|Overall Study||191
2919363|NCT00531427|3629760|FG000|NOT COMPLETED|Overall Study||73
2919364|NCT00531427|3629761|FG001|NOT COMPLETED|Overall Study||94
2919365|NCT00531453|3629770|FG000|STARTED|Overall Study|02 October 2007|49
2919366|NCT00531453|3629771|FG001|STARTED|Overall Study|02 October 2007|49
2919367|NCT00531453|3629770|FG000|COMPLETED|Overall Study|10 April 2009|49
2919368|NCT00531453|3629771|FG001|COMPLETED|Overall Study|10 April 2009|49
2919369|NCT00531453|3629770|FG000|NOT COMPLETED|Overall Study||0
2919370|NCT00531453|3629771|FG001|NOT COMPLETED|Overall Study||0
3314679|NCT03091348|4047970|FG000|STARTED|Overall Study||2
3314680|NCT03091348|4047971|FG001|STARTED|Overall Study||2
3314681|NCT03091348|4047970|FG000|COMPLETED|Overall Study||0
3314682|NCT03091348|4047971|FG001|COMPLETED|Overall Study||1
2919371|NCT00531479|3629779|FG000|STARTED|Overall Study||230
2919372|NCT00531479|3629780|FG001|STARTED|Overall Study||229
2919373|NCT00531479|3629779|FG000|Treated|Overall Study||228
2919374|NCT00531479|3629780|FG001|Treated|Overall Study||226
2919375|NCT00531479|3629779|FG000|COMPLETED|Overall Study||154
2919376|NCT00531479|3629780|FG001|COMPLETED|Overall Study||146
2919377|NCT00531479|3629779|FG000|NOT COMPLETED|Overall Study||76
2919378|NCT00531479|3629780|FG001|NOT COMPLETED|Overall Study||83
2919379|NCT00531518|3629788|FG000|STARTED|Overall Study||87
2919380|NCT00531518|3629789|FG001|STARTED|Overall Study||205
2919381|NCT00531518|3629788|FG000|COMPLETED|Overall Study||55
2919382|NCT00531518|3629789|FG001|COMPLETED|Overall Study||134
2919383|NCT00531518|3629788|FG000|NOT COMPLETED|Overall Study||32
2919384|NCT00531518|3629789|FG001|NOT COMPLETED|Overall Study||71
2919385|NCT00531661|3629797|FG000|STARTED|6 Months||270
2919386|NCT00531661|3629798|FG001|STARTED|6 Months||280
2919387|NCT00531661|3629797|FG000|COMPLETED|6 Months||244
2919388|NCT00531661|3629798|FG001|COMPLETED|6 Months||254
2919389|NCT00531661|3629797|FG000|NOT COMPLETED|6 Months||26
2919390|NCT00531661|3629798|FG001|NOT COMPLETED|6 Months||26
2919391|NCT00531661|3629797|FG000|STARTED|Study Duration: 15 Months Avg. Follow-up||244
2919392|NCT00531661|3629798|FG001|STARTED|Study Duration: 15 Months Avg. Follow-up||254
2919393|NCT00531661|3629797|FG000|COMPLETED|Study Duration: 15 Months Avg. Follow-up||186
2919394|NCT00531661|3629798|FG001|COMPLETED|Study Duration: 15 Months Avg. Follow-up||197
2919395|NCT00531661|3629797|FG000|NOT COMPLETED|Study Duration: 15 Months Avg. Follow-up||58
2919396|NCT00531661|3629798|FG001|NOT COMPLETED|Study Duration: 15 Months Avg. Follow-up||57
2919397|NCT00531752|3629811|FG000|STARTED|First Double-blind Intervention Period||17
2919398|NCT00531752|3629812|FG001|STARTED|First Double-blind Intervention Period||17
2919399|NCT00531752|3629813|FG002|STARTED|First Double-blind Intervention Period||16
2919400|NCT00531752|3629814|FG003|STARTED|First Double-blind Intervention Period||16
2919401|NCT00531752|3629811|FG000|Treated|First Double-blind Intervention Period||16
2919402|NCT00531752|3629812|FG001|Treated|First Double-blind Intervention Period||17
2919403|NCT00531752|3629813|FG002|Treated|First Double-blind Intervention Period||16
2919404|NCT00531752|3629814|FG003|Treated|First Double-blind Intervention Period||16
2919405|NCT00531752|3629811|FG000|COMPLETED|First Double-blind Intervention Period||11
2919406|NCT00531752|3629812|FG001|COMPLETED|First Double-blind Intervention Period||13
2919407|NCT00531752|3629813|FG002|COMPLETED|First Double-blind Intervention Period||9
2919408|NCT00531752|3629814|FG003|COMPLETED|First Double-blind Intervention Period||13
2919409|NCT00531752|3629811|FG000|NOT COMPLETED|First Double-blind Intervention Period||6
2919410|NCT00531752|3629812|FG001|NOT COMPLETED|First Double-blind Intervention Period||4
2919411|NCT00531752|3629813|FG002|NOT COMPLETED|First Double-blind Intervention Period||7
2919412|NCT00531752|3629814|FG003|NOT COMPLETED|First Double-blind Intervention Period||3
2919413|NCT00531752|3629811|FG000|STARTED|Wash-out Period (at Least 7 Days)||11
2919414|NCT00531752|3629812|FG001|STARTED|Wash-out Period (at Least 7 Days)||13
2919415|NCT00531752|3629813|FG002|STARTED|Wash-out Period (at Least 7 Days)||9
2919416|NCT00531752|3629814|FG003|STARTED|Wash-out Period (at Least 7 Days)||13
2919417|NCT00531752|3629811|FG000|COMPLETED|Wash-out Period (at Least 7 Days)||11
2919418|NCT00531752|3629812|FG001|COMPLETED|Wash-out Period (at Least 7 Days)||13
2919419|NCT00531752|3629813|FG002|COMPLETED|Wash-out Period (at Least 7 Days)||9
2919420|NCT00531752|3629814|FG003|COMPLETED|Wash-out Period (at Least 7 Days)||13
2919421|NCT00531752|3629811|FG000|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
2919422|NCT00531752|3629812|FG001|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
2919423|NCT00531752|3629813|FG002|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
2919424|NCT00531752|3629814|FG003|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
2919425|NCT00531752|3629811|FG000|STARTED|Second Double-blind Intervention Period||11
2919426|NCT00531752|3629812|FG001|STARTED|Second Double-blind Intervention Period||13
2919427|NCT00531752|3629813|FG002|STARTED|Second Double-blind Intervention Period||9
2919428|NCT00531752|3629814|FG003|STARTED|Second Double-blind Intervention Period||13
2919429|NCT00531752|3629811|FG000|COMPLETED|Second Double-blind Intervention Period||9
3314683|NCT03091348|4047970|FG000|NOT COMPLETED|Overall Study||2
3314684|NCT03091348|4047971|FG001|NOT COMPLETED|Overall Study||1
3314685|NCT03091361|4047978|FG000|STARTED|Overall Study||30
3314686|NCT03091361|4047978|FG000|COMPLETED|Overall Study||30
3314687|NCT03091361|4047978|FG000|NOT COMPLETED|Overall Study||0
2880832|NCT00294047|3586056|FG000|STARTED|Month 48||2881
2880833|NCT00294047|3586057|FG001|STARTED|Month 48||2871
2880834|NCT00294047|3586056|FG000|Participated up to Month 48|Month 48||2305
2880835|NCT00294047|3586057|FG001|Participated up to Month 48|Month 48||2281
2880836|NCT00294047|3586056|FG000|COMPLETED|Month 48||2456
2880837|NCT00294047|3586057|FG001|COMPLETED|Month 48||2438
2880838|NCT00294047|3586056|FG000|NOT COMPLETED|Month 48||425
2880839|NCT00294047|3586057|FG001|NOT COMPLETED|Month 48||433
2880840|NCT00294047|3586056|FG000|STARTED|Month 84||2877
2880841|NCT00294047|3586057|FG001|STARTED|Month 84||2870
2880842|NCT00294047|3586056|FG000|COMPLETED|Month 84|The number of subjects who remained up to Month 48 in the Cervarix Group = 2146|1904
2880843|NCT00294047|3586057|FG001|COMPLETED|Month 84|The number of subjects who remained up to Month 48 in the Aluminium Hydroxide Group = 2116|1881
2880844|NCT00294047|3586056|FG000|NOT COMPLETED|Month 84||973
2880845|NCT00294047|3586057|FG001|NOT COMPLETED|Month 84||989
2880846|NCT00294060|3586064|FG000|STARTED|Overall Study||2013
2880847|NCT00294060|3586064|FG000|COMPLETED|Overall Study||840
2880848|NCT00294060|3586064|FG000|NOT COMPLETED|Overall Study||1173
2880849|NCT00294398|3586070|FG000|STARTED|Overall Study||78
2880850|NCT00294398|3586071|FG001|STARTED|Overall Study||74
2880851|NCT00294398|3586070|FG000|COMPLETED|Overall Study||57
2880852|NCT00294398|3586071|FG001|COMPLETED|Overall Study||48
2880853|NCT00294398|3586070|FG000|NOT COMPLETED|Overall Study||21
2880854|NCT00294398|3586071|FG001|NOT COMPLETED|Overall Study||26
2880855|NCT00294515|3586079|FG000|STARTED|Overall Study|Randomized|166
2880856|NCT00294515|3586080|FG001|STARTED|Overall Study|Randomized|160
2880857|NCT00294515|3586079|FG000|COMPLETED|Overall Study||132
2880858|NCT00294515|3586080|FG001|COMPLETED|Overall Study||132
2880859|NCT00294515|3586079|FG000|NOT COMPLETED|Overall Study||34
2880860|NCT00294515|3586080|FG001|NOT COMPLETED|Overall Study||28
2880861|NCT00294554|3586088|FG000|STARTED|Overall Study||10
2880862|NCT00294554|3586089|FG001|STARTED|Overall Study||10
2880863|NCT00294554|3586088|FG000|COMPLETED|Overall Study||10
2880864|NCT00294554|3586089|FG001|COMPLETED|Overall Study|"1 S withdrew @ 20 wks for lack perceived benefit~1 S withdrawn @ 13 wks b/o extreme agitation"|8
2880865|NCT00294554|3586088|FG000|NOT COMPLETED|Overall Study||0
2880866|NCT00294554|3586089|FG001|NOT COMPLETED|Overall Study||2
2880867|NCT00294632|3586097|FG000|STARTED|Phase I Dose Escalation Period||14
2880868|NCT00294632|3586098|FG001|STARTED|Phase I Dose Escalation Period||0
2880869|NCT00294632|3586097|FG000|Cohort 1: 10 mg|Phase I Dose Escalation Period||3
2880870|NCT00294632|3586098|FG001|Cohort 1: 10 mg|Phase I Dose Escalation Period||0
2880871|NCT00294632|3586097|FG000|Cohort 2: 15 mg|Phase I Dose Escalation Period||3
2880872|NCT00294632|3586098|FG001|Cohort 2: 15 mg|Phase I Dose Escalation Period||0
2880873|NCT00294632|3586097|FG000|Cohort 3: 20 mg|Phase I Dose Escalation Period||6
2880874|NCT00294632|3586098|FG001|Cohort 3: 20 mg|Phase I Dose Escalation Period||0
2880875|NCT00294632|3586097|FG000|Cohort 4: 25 mg|Phase I Dose Escalation Period||2
2880876|NCT00294632|3586098|FG001|Cohort 4: 25 mg|Phase I Dose Escalation Period||0
2880877|NCT00294632|3586097|FG000|COMPLETED|Phase I Dose Escalation Period||14
2880878|NCT00294632|3586098|FG001|COMPLETED|Phase I Dose Escalation Period||0
2880879|NCT00294632|3586097|FG000|NOT COMPLETED|Phase I Dose Escalation Period||0
2880880|NCT00294632|3586098|FG001|NOT COMPLETED|Phase I Dose Escalation Period||0
2880881|NCT00294632|3586097|FG000|STARTED|Phase II: 20 mg Lenalidomide||6
2880882|NCT00294632|3586098|FG001|STARTED|Phase II: 20 mg Lenalidomide||38
2880883|NCT00294632|3586097|FG000|COMPLETED|Phase II: 20 mg Lenalidomide||6
2880884|NCT00294632|3586098|FG001|COMPLETED|Phase II: 20 mg Lenalidomide||38
2880885|NCT00294632|3586097|FG000|NOT COMPLETED|Phase II: 20 mg Lenalidomide||0
2880886|NCT00294632|3586098|FG001|NOT COMPLETED|Phase II: 20 mg Lenalidomide||0
2880887|NCT00294645|3586107|FG000|STARTED|Overall Study||295
2880888|NCT00294645|3586108|FG001|STARTED|Overall Study||602
2880889|NCT00294645|3586107|FG000|COMPLETED|Overall Study||247
2880890|NCT00294645|3586108|FG001|COMPLETED|Overall Study||510
2880891|NCT00294645|3586107|FG000|NOT COMPLETED|Overall Study||48
2880892|NCT00294645|3586108|FG001|NOT COMPLETED|Overall Study||92
2880893|NCT00294658|3586116|FG000|STARTED|Overall Study||66
2880894|NCT00294658|3586117|FG001|STARTED|Overall Study||60
2880895|NCT00294658|3586116|FG000|COMPLETED|Overall Study||60
2880896|NCT00294658|3586117|FG001|COMPLETED|Overall Study||51
2880897|NCT00294658|3586116|FG000|NOT COMPLETED|Overall Study||6
2880898|NCT00294658|3586117|FG001|NOT COMPLETED|Overall Study||9
3170045|NCT01928394|3897422|FG016|Transition- Continued|Treatment Period||0
3170046|NCT01928394|3897423|FG017|Transition- Continued|Treatment Period||0
3170047|NCT01928394|3897424|FG018|Transition- Continued|Treatment Period||1
3170048|NCT01928394|3897425|FG019|Transition- Continued|Treatment Period||19
2880899|NCT00294671|3586125|FG000|STARTED|Overall Study||64
2880900|NCT00294671|3586126|FG001|STARTED|Overall Study||66
2880901|NCT00294671|3586125|FG000|COMPLETED|Overall Study||37
2880902|NCT00294671|3586126|FG001|COMPLETED|Overall Study||26
2880903|NCT00294671|3586125|FG000|NOT COMPLETED|Overall Study||27
2880904|NCT00294671|3586126|FG001|NOT COMPLETED|Overall Study||40
2880905|NCT00294684|3586134|FG000|STARTED|Overall Study||70
2880906|NCT00294684|3586135|FG001|STARTED|Overall Study||70
2880907|NCT00294684|3586134|FG000|COMPLETED|Overall Study||65
2880908|NCT00294684|3586135|FG001|COMPLETED|Overall Study||62
2880909|NCT00294684|3586134|FG000|NOT COMPLETED|Overall Study||5
2880910|NCT00294684|3586135|FG001|NOT COMPLETED|Overall Study||8
2880911|NCT00294723|3586144|FG000|STARTED|Double-Blind Period 52 Weeks|Randomised|247
3038340|NCT01153724|3757759|FG000|NOT COMPLETED|Treatment Period 2||2
2880912|NCT00294723|3586145|FG001|STARTED|Double-Blind Period 52 Weeks|Randomised|251
2880913|NCT00294723|3586146|FG002|STARTED|Double-Blind Period 52 Weeks|Randomised|248
2880914|NCT00294723|3586144|FG000|Exposed to Study Drug|Double-Blind Period 52 Weeks|Subject withdrew before exposure to drug, and thus not included in the safety and ITT analysis sets|246
2880915|NCT00294723|3586145|FG001|Exposed to Study Drug|Double-Blind Period 52 Weeks||251
2880916|NCT00294723|3586146|FG002|Exposed to Study Drug|Double-Blind Period 52 Weeks||248
2880917|NCT00294723|3586144|FG000|COMPLETED|Double-Blind Period 52 Weeks||173
2880918|NCT00294723|3586145|FG001|COMPLETED|Double-Blind Period 52 Weeks||162
2880919|NCT00294723|3586146|FG002|COMPLETED|Double-Blind Period 52 Weeks||152
2880920|NCT00294723|3586144|FG000|NOT COMPLETED|Double-Blind Period 52 Weeks||74
2880921|NCT00294723|3586145|FG001|NOT COMPLETED|Double-Blind Period 52 Weeks||89
2880922|NCT00294723|3586146|FG002|NOT COMPLETED|Double-Blind Period 52 Weeks||96
2880923|NCT00294723|3586144|FG000|STARTED|Open-Label Extension 52 Weeks|19 subjects did not continue into the extension period|154
2880924|NCT00294723|3586145|FG001|STARTED|Open-Label Extension 52 Weeks|13 subjects did not continue into the extension period|149
2880925|NCT00294723|3586146|FG002|STARTED|Open-Label Extension 52 Weeks|15 subjects did not continue into the extension period|137
2880926|NCT00294723|3586144|FG000|COMPLETED|Open-Label Extension 52 Weeks||114
2880927|NCT00294723|3586145|FG001|COMPLETED|Open-Label Extension 52 Weeks||110
2880928|NCT00294723|3586146|FG002|COMPLETED|Open-Label Extension 52 Weeks||97
2880929|NCT00294723|3586144|FG000|NOT COMPLETED|Open-Label Extension 52 Weeks||40
2880930|NCT00294723|3586145|FG001|NOT COMPLETED|Open-Label Extension 52 Weeks||39
2880931|NCT00294723|3586146|FG002|NOT COMPLETED|Open-Label Extension 52 Weeks||40
2880932|NCT00294723|3586144|FG000|STARTED|Additional Open-Label Extension 91 Weeks|52 subjects did not continue into the extension period|62
2880933|NCT00294723|3586145|FG001|STARTED|Additional Open-Label Extension 91 Weeks|57 subjects did not continue into the extension period|53
2880934|NCT00294723|3586146|FG002|STARTED|Additional Open-Label Extension 91 Weeks|69 subjects did not continue into the extension period|28
2880935|NCT00294723|3586144|FG000|COMPLETED|Additional Open-Label Extension 91 Weeks||34
2880936|NCT00294723|3586145|FG001|COMPLETED|Additional Open-Label Extension 91 Weeks||32
2880937|NCT00294723|3586146|FG002|COMPLETED|Additional Open-Label Extension 91 Weeks||8
2880938|NCT00294723|3586144|FG000|NOT COMPLETED|Additional Open-Label Extension 91 Weeks||28
2880939|NCT00294723|3586145|FG001|NOT COMPLETED|Additional Open-Label Extension 91 Weeks||21
2880940|NCT00294723|3586146|FG002|NOT COMPLETED|Additional Open-Label Extension 91 Weeks||20
2880941|NCT00294762|3586159|FG000|STARTED|Overall Study||72
2880942|NCT00294762|3586160|FG001|STARTED|Overall Study||71
2880943|NCT00294762|3586159|FG000|COMPLETED|Overall Study||69
2880944|NCT00294762|3586160|FG001|COMPLETED|Overall Study||68
2880945|NCT00294762|3586159|FG000|NOT COMPLETED|Overall Study||3
2880946|NCT00294762|3586160|FG001|NOT COMPLETED|Overall Study||3
2880947|NCT00295009|3586172|FG000|STARTED|Overall Study||93
2880948|NCT00295009|3586173|FG001|STARTED|Overall Study||183
2880949|NCT00295009|3586174|FG002|STARTED|Overall Study||51
2880950|NCT00295009|3586175|FG003|STARTED|Overall Study||82
2880951|NCT00295009|3586176|FG004|STARTED|Overall Study||174
2880952|NCT00295009|3586177|FG005|STARTED|Overall Study||269
2880953|NCT00295009|3586172|FG000|Treated|Overall Study||80
2880954|NCT00295009|3586173|FG001|Treated|Overall Study||162
2880955|NCT00295009|3586174|FG002|Treated|Overall Study||50
2880956|NCT00295009|3586175|FG003|Treated|Overall Study||72
2880957|NCT00295009|3586176|FG004|Treated|Overall Study||165
2880958|NCT00295009|3586177|FG005|Treated|Overall Study||259
2880959|NCT00295009|3586172|FG000|Completed 24 Month Analysis|Overall Study||71
2880960|NCT00295009|3586173|FG001|Completed 24 Month Analysis|Overall Study||148
2880961|NCT00295009|3586174|FG002|Completed 24 Month Analysis|Overall Study||45
2880962|NCT00295009|3586175|FG003|Completed 24 Month Analysis|Overall Study||60
2880963|NCT00295009|3586176|FG004|Completed 24 Month Analysis|Overall Study||133
2880964|NCT00295009|3586177|FG005|Completed 24 Month Analysis|Overall Study||198
2880965|NCT00295009|3586172|FG000|COMPLETED|Overall Study|Completed 60 month visit|52
2880966|NCT00295009|3586173|FG001|COMPLETED|Overall Study|Completed 60 month visit|134
2880967|NCT00295009|3586174|FG002|COMPLETED|Overall Study|Completed 60 month visit|39
2880968|NCT00295009|3586175|FG003|COMPLETED|Overall Study|Completed 60 month visit|57
2880969|NCT00295009|3586176|FG004|COMPLETED|Overall Study|Completed 60 month visit|116
2880970|NCT00295009|3586177|FG005|COMPLETED|Overall Study|Continued Access patients were only followed out to 24 months|0
2880971|NCT00295009|3586172|FG000|NOT COMPLETED|Overall Study||41
2880972|NCT00295009|3586173|FG001|NOT COMPLETED|Overall Study||49
2880973|NCT00295009|3586174|FG002|NOT COMPLETED|Overall Study||12
2880974|NCT00295009|3586175|FG003|NOT COMPLETED|Overall Study||25
2880975|NCT00295009|3586176|FG004|NOT COMPLETED|Overall Study||58
2880976|NCT00295009|3586177|FG005|NOT COMPLETED|Overall Study||269
2880977|NCT00295022|3586194|FG000|STARTED|Overall Study||105
2880978|NCT00295022|3586195|FG001|STARTED|Overall Study||157
2880979|NCT00295022|3586196|FG002|STARTED|Overall Study||156
2880980|NCT00295022|3586194|FG000|COMPLETED|Overall Study||104
2880981|NCT00295022|3586195|FG001|COMPLETED|Overall Study||156
2880982|NCT00295022|3586196|FG002|COMPLETED|Overall Study||151
2880983|NCT00295022|3586194|FG000|NOT COMPLETED|Overall Study||1
2880984|NCT00295022|3586195|FG001|NOT COMPLETED|Overall Study||1
2880985|NCT00295022|3586196|FG002|NOT COMPLETED|Overall Study||5
2880986|NCT00295061|3586208|FG000|STARTED|Overall Study||12
2880987|NCT00295061|3586209|FG001|STARTED|Overall Study||12
2880988|NCT00295061|3586208|FG000|COMPLETED|Overall Study||12
2880989|NCT00295061|3586209|FG001|COMPLETED|Overall Study||12
2880990|NCT00295061|3586208|FG000|NOT COMPLETED|Overall Study||0
2880991|NCT00295061|3586209|FG001|NOT COMPLETED|Overall Study||0
2880992|NCT00295503|3586215|FG000|STARTED|Overall Study||53
2880993|NCT00295503|3586215|FG000|COMPLETED|Overall Study||53
2880994|NCT00295503|3586215|FG000|NOT COMPLETED|Overall Study||0
2880995|NCT00295620|3586222|FG000|STARTED|Overall Study||1732
2880996|NCT00295620|3586223|FG001|STARTED|Overall Study||1738
2880997|NCT00295620|3586222|FG000|Safety Analysis Set|Overall Study||1705
2880998|NCT00295620|3586223|FG001|Safety Analysis Set|Overall Study||1710
2880999|NCT00295620|3586222|FG000|COMPLETED|Overall Study||860
2881000|NCT00295620|3586223|FG001|COMPLETED|Overall Study||842
2881001|NCT00295620|3586222|FG000|NOT COMPLETED|Overall Study||872
2881002|NCT00295620|3586223|FG001|NOT COMPLETED|Overall Study||896
2881003|NCT00295633|3586232|FG000|STARTED|Overall Study||195
2881004|NCT00295633|3586233|FG001|STARTED|Overall Study||186
2881005|NCT00295633|3586234|FG002|STARTED|Overall Study||184
2881006|NCT00295633|3586232|FG000|Completed Study Without Being Rescued|Overall Study||88
2881007|NCT00295633|3586233|FG001|Completed Study Without Being Rescued|Overall Study||82
2881008|NCT00295633|3586234|FG002|Completed Study Without Being Rescued|Overall Study||51
2881009|NCT00295633|3586232|FG000|COMPLETED|Overall Study||133
2881010|NCT00295633|3586233|FG001|COMPLETED|Overall Study||119
2881011|NCT00295633|3586234|FG002|COMPLETED|Overall Study||108
2881012|NCT00295633|3586232|FG000|NOT COMPLETED|Overall Study||62
2881013|NCT00295633|3586233|FG001|NOT COMPLETED|Overall Study||67
2881014|NCT00295633|3586234|FG002|NOT COMPLETED|Overall Study||76
2881015|NCT00295750|3586245|FG000|STARTED|Overall Study|randomized|206
2881016|NCT00295750|3586246|FG001|STARTED|Overall Study|randomized|210
2881017|NCT00295750|3586247|FG002|STARTED|Overall Study|randomized|204
2881018|NCT00295750|3586245|FG000|Intent-to-treat (ITT) Population|Overall Study|randomized and exposed patients|202
2881019|NCT00295750|3586246|FG001|Intent-to-treat (ITT) Population|Overall Study|randomized and exposed patients|207
2881020|NCT00295750|3586247|FG002|Intent-to-treat (ITT) Population|Overall Study|randomized and exposed patients|201
2881021|NCT00295750|3586245|FG000|COMPLETED|Overall Study||163
2881022|NCT00295750|3586246|FG001|COMPLETED|Overall Study||169
2881023|NCT00295750|3586247|FG002|COMPLETED|Overall Study||172
2881024|NCT00295750|3586245|FG000|NOT COMPLETED|Overall Study||43
2881025|NCT00295750|3586246|FG001|NOT COMPLETED|Overall Study||41
2881026|NCT00295750|3586247|FG002|NOT COMPLETED|Overall Study||32
2881027|NCT00295854|3586258|FG000|STARTED|Overall Study||95
2881028|NCT00295854|3586259|FG001|STARTED|Overall Study||108
2881029|NCT00295854|3586260|FG002|STARTED|Overall Study||102
2881030|NCT00295854|3586258|FG000|Safety Population (N=304)|Overall Study||95
2881031|NCT00295854|3586259|FG001|Safety Population (N=304)|Overall Study||108
2881032|NCT00295854|3586260|FG002|Safety Population (N=304)|Overall Study||101
2881033|NCT00295854|3586258|FG000|ITT Population (N=296)|Overall Study||92
2881034|NCT00295854|3586259|FG001|ITT Population (N=296)|Overall Study||105
2881035|NCT00295854|3586260|FG002|ITT Population (N=296)|Overall Study||99
2881036|NCT00295854|3586258|FG000|COMPLETED|Overall Study||77
2881037|NCT00295854|3586259|FG001|COMPLETED|Overall Study||87
2881038|NCT00295854|3586260|FG002|COMPLETED|Overall Study||87
2881039|NCT00295854|3586258|FG000|NOT COMPLETED|Overall Study||18
2881040|NCT00295854|3586259|FG001|NOT COMPLETED|Overall Study||21
2881041|NCT00295854|3586260|FG002|NOT COMPLETED|Overall Study||15
2881042|NCT00295867|3586268|FG000|STARTED|Overall Study||45
2881043|NCT00295867|3586268|FG000|COMPLETED|Overall Study||34
2881044|NCT00295867|3586268|FG000|NOT COMPLETED|Overall Study||11
2881045|NCT00295880|3586272|FG000|STARTED|Overall Study||12
2881046|NCT00295880|3586272|FG000|COMPLETED|Overall Study||10
2881047|NCT00295880|3586272|FG000|NOT COMPLETED|Overall Study||2
2881048|NCT00295932|3586287|FG000|STARTED|Overall Study||4
2881049|NCT00295932|3586288|FG001|STARTED|Overall Study||6
2881050|NCT00295932|3586289|FG002|STARTED|Overall Study||3
2881051|NCT00295932|3586290|FG003|STARTED|Overall Study||4
2881052|NCT00295932|3586291|FG004|STARTED|Overall Study||2
2881053|NCT00295932|3586292|FG005|STARTED|Overall Study||18
2881054|NCT00295932|3586293|FG006|STARTED|Overall Study||3
2881055|NCT00295932|3586294|FG007|STARTED|Overall Study||4
2881056|NCT00295932|3586295|FG008|STARTED|Overall Study||10
2881057|NCT00295932|3586296|FG009|STARTED|Overall Study||12
2881058|NCT00295932|3586297|FG010|STARTED|Overall Study||13
2881059|NCT00295932|3586287|FG000|COMPLETED|Overall Study||4
2881060|NCT00295932|3586288|FG001|COMPLETED|Overall Study||6
2881061|NCT00295932|3586289|FG002|COMPLETED|Overall Study||3
2881062|NCT00295932|3586290|FG003|COMPLETED|Overall Study||4
2881063|NCT00295932|3586291|FG004|COMPLETED|Overall Study||2
2881064|NCT00295932|3586292|FG005|COMPLETED|Overall Study||18
2881065|NCT00295932|3586293|FG006|COMPLETED|Overall Study||3
2881066|NCT00295932|3586294|FG007|COMPLETED|Overall Study||4
2881067|NCT00295932|3586295|FG008|COMPLETED|Overall Study||10
2881068|NCT00295932|3586296|FG009|COMPLETED|Overall Study||12
2881069|NCT00295932|3586297|FG010|COMPLETED|Overall Study||12
2881070|NCT00295932|3586287|FG000|NOT COMPLETED|Overall Study||0
2881071|NCT00295932|3586288|FG001|NOT COMPLETED|Overall Study||0
2881072|NCT00295932|3586289|FG002|NOT COMPLETED|Overall Study||0
2881073|NCT00295932|3586290|FG003|NOT COMPLETED|Overall Study||0
2881074|NCT00295932|3586291|FG004|NOT COMPLETED|Overall Study||0
2881075|NCT00295932|3586292|FG005|NOT COMPLETED|Overall Study||0
2881076|NCT00295932|3586293|FG006|NOT COMPLETED|Overall Study||0
2881077|NCT00295932|3586294|FG007|NOT COMPLETED|Overall Study||0
2881078|NCT00295932|3586295|FG008|NOT COMPLETED|Overall Study||0
2881079|NCT00295932|3586296|FG009|NOT COMPLETED|Overall Study||0
2881080|NCT00295932|3586297|FG010|NOT COMPLETED|Overall Study||1
2881081|NCT00296036|3586325|FG000|STARTED|Overall Study||19
2881082|NCT00296036|3586326|FG001|STARTED|Overall Study||18
2881083|NCT00296036|3586327|FG002|STARTED|Overall Study||18
2881084|NCT00296036|3586328|FG003|STARTED|Overall Study||17
2881085|NCT00296036|3586329|FG004|STARTED|Overall Study||33
2881086|NCT00296036|3586330|FG005|STARTED|Overall Study||32
2881087|NCT00296036|3586325|FG000|COMPLETED|Overall Study||18
2881088|NCT00296036|3586326|FG001|COMPLETED|Overall Study||18
2881089|NCT00296036|3586327|FG002|COMPLETED|Overall Study||16
2881090|NCT00296036|3586328|FG003|COMPLETED|Overall Study||16
2881091|NCT00296036|3586329|FG004|COMPLETED|Overall Study||31
2881092|NCT00296036|3586330|FG005|COMPLETED|Overall Study||28
2881093|NCT00296036|3586325|FG000|NOT COMPLETED|Overall Study||1
2881094|NCT00296036|3586326|FG001|NOT COMPLETED|Overall Study||0
2881095|NCT00296036|3586327|FG002|NOT COMPLETED|Overall Study||2
2881096|NCT00296036|3586328|FG003|NOT COMPLETED|Overall Study||1
2881097|NCT00296036|3586329|FG004|NOT COMPLETED|Overall Study||2
2881098|NCT00296036|3586330|FG005|NOT COMPLETED|Overall Study||4
2881099|NCT00296140|3586349|FG000|STARTED|Overall Study||33
2881100|NCT00296140|3586350|FG001|STARTED|Overall Study||33
2881101|NCT00296140|3586349|FG000|COMPLETED|Overall Study||30
2881102|NCT00296140|3586350|FG001|COMPLETED|Overall Study||33
2881103|NCT00296140|3586349|FG000|NOT COMPLETED|Overall Study||3
2881104|NCT00296140|3586350|FG001|NOT COMPLETED|Overall Study||0
2881105|NCT00296192|3586361|FG000|STARTED|Overall Study||17
2881106|NCT00296192|3586362|FG001|STARTED|Overall Study||16
2881107|NCT00296192|3586363|FG002|STARTED|Overall Study||16
2881108|NCT00296192|3586364|FG003|STARTED|Overall Study||17
2881109|NCT00296192|3586365|FG004|STARTED|Overall Study||16
2881110|NCT00296192|3586361|FG000|COMPLETED|Overall Study||17
2881111|NCT00296192|3586362|FG001|COMPLETED|Overall Study||16
2881112|NCT00296192|3586363|FG002|COMPLETED|Overall Study||16
2881113|NCT00296192|3586364|FG003|COMPLETED|Overall Study||17
2881114|NCT00296192|3586365|FG004|COMPLETED|Overall Study||16
2881115|NCT00296192|3586361|FG000|NOT COMPLETED|Overall Study||0
2881116|NCT00296192|3586362|FG001|NOT COMPLETED|Overall Study||0
2881117|NCT00296192|3586363|FG002|NOT COMPLETED|Overall Study||0
2881118|NCT00296192|3586364|FG003|NOT COMPLETED|Overall Study||0
2881119|NCT00296192|3586365|FG004|NOT COMPLETED|Overall Study||0
2881120|NCT00296231|3586377|FG000|STARTED|Overall Study||14
2881121|NCT00296231|3586377|FG000|COMPLETED|Overall Study||14
2881122|NCT00296231|3586377|FG000|NOT COMPLETED|Overall Study||0
2881123|NCT00296244|3586383|FG000|STARTED|Overall Study||20
2881124|NCT00296244|3586384|FG001|STARTED|Overall Study||20
2881125|NCT00296244|3586383|FG000|COMPLETED|Overall Study||20
2881126|NCT00296244|3586384|FG001|COMPLETED|Overall Study||19
2881127|NCT00296244|3586383|FG000|NOT COMPLETED|Overall Study||0
2881128|NCT00296244|3586384|FG001|NOT COMPLETED|Overall Study||1
2881129|NCT00296296|3586397|FG000|STARTED|Overall Study||11
2881130|NCT00296296|3586398|FG001|STARTED|Overall Study||18
2881131|NCT00296296|3586397|FG000|COMPLETED|Overall Study||9
2881132|NCT00296296|3586398|FG001|COMPLETED|Overall Study||5
2881133|NCT00296296|3586397|FG000|NOT COMPLETED|Overall Study||2
2881134|NCT00296296|3586398|FG001|NOT COMPLETED|Overall Study||13
2881135|NCT00296322|3586406|FG000|STARTED|Overall Study||258
2881136|NCT00296322|3586407|FG001|STARTED|Overall Study||263
2881137|NCT00296322|3586406|FG000|COMPLETED|Overall Study||237
2881138|NCT00296322|3586407|FG001|COMPLETED|Overall Study||184
2881139|NCT00296322|3586406|FG000|NOT COMPLETED|Overall Study||21
2881140|NCT00296322|3586407|FG001|NOT COMPLETED|Overall Study||79
2881141|NCT00296335|3586415|FG000|STARTED|Overall Study||424
3170049|NCT01928394|3897426|FG020|Transition- Continued|Treatment Period||0
3170050|NCT01928394|3897427|FG021|Transition- Continued|Treatment Period||0
3170051|NCT01928394|3897428|FG022|Transition- Continued|Treatment Period||0
2881142|NCT00296335|3586416|FG001|STARTED|Overall Study||431
3170052|NCT01928394|3897406|FG000|COMPLETED|Treatment Period||0
3170053|NCT01928394|3897407|FG001|COMPLETED|Treatment Period||0
2881143|NCT00296335|3586415|FG000|COMPLETED|Overall Study||394
2881144|NCT00296335|3586416|FG001|COMPLETED|Overall Study||309
2881145|NCT00296335|3586415|FG000|NOT COMPLETED|Overall Study||30
2881146|NCT00296335|3586416|FG001|NOT COMPLETED|Overall Study||122
2881147|NCT00296374|3586427|FG000|STARTED|Overall Study||118
2881148|NCT00296374|3586428|FG001|STARTED|Overall Study||124
2881149|NCT00296374|3586429|FG002|STARTED|Overall Study||111
2881150|NCT00296374|3586427|FG000|COMPLETED|Overall Study||93
2881151|NCT00296374|3586428|FG001|COMPLETED|Overall Study||101
2881152|NCT00296374|3586429|FG002|COMPLETED|Overall Study||82
2881153|NCT00296374|3586427|FG000|NOT COMPLETED|Overall Study||25
2881154|NCT00296374|3586428|FG001|NOT COMPLETED|Overall Study||23
2881155|NCT00296374|3586429|FG002|NOT COMPLETED|Overall Study||29
2881156|NCT00296400|3586446|FG000|STARTED|Overall Study||70
2881157|NCT00296400|3586447|FG001|STARTED|Overall Study||87
2881158|NCT00296400|3586448|FG002|STARTED|Overall Study||80
2881159|NCT00296400|3586446|FG000|COMPLETED|Overall Study||53
2881160|NCT00296400|3586447|FG001|COMPLETED|Overall Study||69
2881161|NCT00296400|3586448|FG002|COMPLETED|Overall Study||67
2881162|NCT00296400|3586446|FG000|NOT COMPLETED|Overall Study||17
2881163|NCT00296400|3586447|FG001|NOT COMPLETED|Overall Study||18
2881164|NCT00296400|3586448|FG002|NOT COMPLETED|Overall Study||13
2919430|NCT00531752|3629812|FG001|COMPLETED|Second Double-blind Intervention Period||11
2881165|NCT00296491|3586463|FG000|STARTED|Overall Study|Please note: Outcome Measures generally conducts analysis of 2 of the 4 Arms at a time.|182
2881166|NCT00296491|3586464|FG001|STARTED|Overall Study||182
2881167|NCT00296491|3586465|FG002|STARTED|Overall Study||180
2881168|NCT00296491|3586466|FG003|STARTED|Overall Study||181
2881169|NCT00296491|3586463|FG000|COMPLETED|Overall Study||140
2881170|NCT00296491|3586464|FG001|COMPLETED|Overall Study||129
2881171|NCT00296491|3586465|FG002|COMPLETED|Overall Study||137
2881172|NCT00296491|3586466|FG003|COMPLETED|Overall Study||138
2881173|NCT00296491|3586463|FG000|NOT COMPLETED|Overall Study||42
2881174|NCT00296491|3586464|FG001|NOT COMPLETED|Overall Study||53
2881175|NCT00296491|3586465|FG002|NOT COMPLETED|Overall Study||43
2881176|NCT00296491|3586466|FG003|NOT COMPLETED|Overall Study||43
2881177|NCT00296504|3586491|FG000|STARTED|Interim Analysis||119
2881178|NCT00296504|3586492|FG001|STARTED|Interim Analysis||18
2881179|NCT00296504|3586493|FG002|STARTED|Interim Analysis||221
2881180|NCT00296504|3586494|FG003|STARTED|Interim Analysis||54
2881181|NCT00296504|3586495|FG004|STARTED|Interim Analysis||73
2881182|NCT00296504|3586496|FG005|STARTED|Interim Analysis||78
2881183|NCT00296504|3586497|FG006|STARTED|Interim Analysis||104
2881184|NCT00296504|3586498|FG007|STARTED|Interim Analysis||86
2881185|NCT00296504|3586499|FG008|STARTED|Interim Analysis||0
2881186|NCT00296504|3586491|FG000|Ongoing|Interim Analysis||32
2881187|NCT00296504|3586492|FG001|Ongoing|Interim Analysis||12
2881188|NCT00296504|3586493|FG002|Ongoing|Interim Analysis||16
2881189|NCT00296504|3586494|FG003|Ongoing|Interim Analysis||22
2881190|NCT00296504|3586495|FG004|Ongoing|Interim Analysis||0
2881191|NCT00296504|3586496|FG005|Ongoing|Interim Analysis||0
2881192|NCT00296504|3586497|FG006|Ongoing|Interim Analysis||30
2881193|NCT00296504|3586498|FG007|Ongoing|Interim Analysis||1
2881194|NCT00296504|3586499|FG008|Ongoing|Interim Analysis||0
2881195|NCT00296504|3586491|FG000|COMPLETED|Interim Analysis||43
2881196|NCT00296504|3586492|FG001|COMPLETED|Interim Analysis||0
2881197|NCT00296504|3586493|FG002|COMPLETED|Interim Analysis||116
2881198|NCT00296504|3586494|FG003|COMPLETED|Interim Analysis||11
2881199|NCT00296504|3586495|FG004|COMPLETED|Interim Analysis||36
2881200|NCT00296504|3586496|FG005|COMPLETED|Interim Analysis||41
2881201|NCT00296504|3586497|FG006|COMPLETED|Interim Analysis||30
2881202|NCT00296504|3586498|FG007|COMPLETED|Interim Analysis||37
2881203|NCT00296504|3586499|FG008|COMPLETED|Interim Analysis||0
2881204|NCT00296504|3586491|FG000|NOT COMPLETED|Interim Analysis||76
2881205|NCT00296504|3586492|FG001|NOT COMPLETED|Interim Analysis||18
2881206|NCT00296504|3586493|FG002|NOT COMPLETED|Interim Analysis||105
2881207|NCT00296504|3586494|FG003|NOT COMPLETED|Interim Analysis||43
2881208|NCT00296504|3586495|FG004|NOT COMPLETED|Interim Analysis||37
2881209|NCT00296504|3586496|FG005|NOT COMPLETED|Interim Analysis||37
2881210|NCT00296504|3586497|FG006|NOT COMPLETED|Interim Analysis||74
2881211|NCT00296504|3586498|FG007|NOT COMPLETED|Interim Analysis||49
2881212|NCT00296504|3586499|FG008|NOT COMPLETED|Interim Analysis||0
2881213|NCT00296504|3586491|FG000|STARTED|Final Analysis||0
2881214|NCT00296504|3586492|FG001|STARTED|Final Analysis||0
2881215|NCT00296504|3586493|FG002|STARTED|Final Analysis||0
2881216|NCT00296504|3586494|FG003|STARTED|Final Analysis||0
2881217|NCT00296504|3586495|FG004|STARTED|Final Analysis||0
2881218|NCT00296504|3586496|FG005|STARTED|Final Analysis||0
2881219|NCT00296504|3586497|FG006|STARTED|Final Analysis||0
2881220|NCT00296504|3586498|FG007|STARTED|Final Analysis||0
2881221|NCT00296504|3586499|FG008|STARTED|Final Analysis|Continued in study; commercial supplies of FPV were unavailable locally at end of Interim Analysis.|111
2881222|NCT00296504|3586491|FG000|COMPLETED|Final Analysis||0
2881223|NCT00296504|3586492|FG001|COMPLETED|Final Analysis||0
2881224|NCT00296504|3586493|FG002|COMPLETED|Final Analysis||0
2881225|NCT00296504|3586494|FG003|COMPLETED|Final Analysis||0
2881226|NCT00296504|3586495|FG004|COMPLETED|Final Analysis||0
2881227|NCT00296504|3586496|FG005|COMPLETED|Final Analysis||0
2881228|NCT00296504|3586497|FG006|COMPLETED|Final Analysis||0
2881229|NCT00296504|3586498|FG007|COMPLETED|Final Analysis||0
2881230|NCT00296504|3586499|FG008|COMPLETED|Final Analysis||90
2881231|NCT00296504|3586491|FG000|NOT COMPLETED|Final Analysis||0
2881232|NCT00296504|3586492|FG001|NOT COMPLETED|Final Analysis||0
2881233|NCT00296504|3586493|FG002|NOT COMPLETED|Final Analysis||0
2881234|NCT00296504|3586494|FG003|NOT COMPLETED|Final Analysis||0
2881235|NCT00296504|3586495|FG004|NOT COMPLETED|Final Analysis||0
2881236|NCT00296504|3586496|FG005|NOT COMPLETED|Final Analysis||0
2881237|NCT00296504|3586497|FG006|NOT COMPLETED|Final Analysis||0
2881238|NCT00296504|3586498|FG007|NOT COMPLETED|Final Analysis||0
2881239|NCT00296504|3586499|FG008|NOT COMPLETED|Final Analysis||21
2881240|NCT00296517|3586526|FG000|STARTED|Dose Level 1 - Week 1||159
2881241|NCT00296517|3586527|FG001|STARTED|Dose Level 1 - Week 1||166
2881242|NCT00296517|3586526|FG000|COMPLETED|Dose Level 1 - Week 1||159
2881243|NCT00296517|3586527|FG001|COMPLETED|Dose Level 1 - Week 1||166
2881244|NCT00296517|3586526|FG000|NOT COMPLETED|Dose Level 1 - Week 1||0
2881245|NCT00296517|3586527|FG001|NOT COMPLETED|Dose Level 1 - Week 1||0
2881246|NCT00296517|3586526|FG000|STARTED|Dose Level 2 - Week 2||159
2881247|NCT00296517|3586527|FG001|STARTED|Dose Level 2 - Week 2||166
2881248|NCT00296517|3586526|FG000|COMPLETED|Dose Level 2 - Week 2||157
2881249|NCT00296517|3586527|FG001|COMPLETED|Dose Level 2 - Week 2||161
2881250|NCT00296517|3586526|FG000|NOT COMPLETED|Dose Level 2 - Week 2||2
2881251|NCT00296517|3586527|FG001|NOT COMPLETED|Dose Level 2 - Week 2||5
2881252|NCT00296517|3586526|FG000|STARTED|Dose Level 3 - Weeks 3-12||157
2881253|NCT00296517|3586527|FG001|STARTED|Dose Level 3 - Weeks 3-12||161
2881254|NCT00296517|3586526|FG000|COMPLETED|Dose Level 3 - Weeks 3-12||112
2881255|NCT00296517|3586527|FG001|COMPLETED|Dose Level 3 - Weeks 3-12||99
2881256|NCT00296517|3586526|FG000|NOT COMPLETED|Dose Level 3 - Weeks 3-12||45
2881257|NCT00296517|3586527|FG001|NOT COMPLETED|Dose Level 3 - Weeks 3-12||62
2881258|NCT00296647|3586538|FG000|STARTED|Overall Study||282
2881259|NCT00296647|3586539|FG001|STARTED|Overall Study||261
2881260|NCT00296647|3586540|FG002|STARTED|Overall Study||256
2881261|NCT00296647|3586541|FG003|STARTED|Overall Study||279
2881262|NCT00296647|3586542|FG004|STARTED|Overall Study||268
2881263|NCT00296647|3586538|FG000|COMPLETED|Overall Study||250
2881264|NCT00296647|3586539|FG001|COMPLETED|Overall Study||233
2881265|NCT00296647|3586540|FG002|COMPLETED|Overall Study||222
2881266|NCT00296647|3586541|FG003|COMPLETED|Overall Study||262
2881267|NCT00296647|3586542|FG004|COMPLETED|Overall Study||248
2881268|NCT00296647|3586538|FG000|NOT COMPLETED|Overall Study||32
2881269|NCT00296647|3586539|FG001|NOT COMPLETED|Overall Study||28
2881270|NCT00296647|3586540|FG002|NOT COMPLETED|Overall Study||34
2881271|NCT00296647|3586541|FG003|NOT COMPLETED|Overall Study||17
2881272|NCT00296647|3586542|FG004|NOT COMPLETED|Overall Study||20
2881273|NCT00296725|3586554|FG000|STARTED|Phase 1: Fluoxetine (1-12 Weeks)||17
2881274|NCT00296725|3586554|FG000|COMPLETED|Phase 1: Fluoxetine (1-12 Weeks)||12
2881275|NCT00296725|3586554|FG000|NOT COMPLETED|Phase 1: Fluoxetine (1-12 Weeks)||5
2881276|NCT00296725|3586554|FG000|STARTED|Phase 2: Imipramine (1-6 Weeks)||8
2881277|NCT00296725|3586554|FG000|COMPLETED|Phase 2: Imipramine (1-6 Weeks)||7
2881278|NCT00296725|3586554|FG000|NOT COMPLETED|Phase 2: Imipramine (1-6 Weeks)||1
2881279|NCT00296816|3586562|FG000|STARTED|Overall Study||132
2881280|NCT00296816|3586562|FG000|COMPLETED|Overall Study|Completed study treatment for a minimum of three years|58
2881281|NCT00296816|3586562|FG000|NOT COMPLETED|Overall Study||74
2881282|NCT00297037|3586568|FG000|STARTED|Overall Study||10
2881283|NCT00297037|3586569|FG001|STARTED|Overall Study||11
2881284|NCT00297037|3586568|FG000|COMPLETED|Overall Study||8
2881285|NCT00297037|3586569|FG001|COMPLETED|Overall Study||11
2881286|NCT00297037|3586568|FG000|NOT COMPLETED|Overall Study||2
2881287|NCT00297037|3586569|FG001|NOT COMPLETED|Overall Study||0
2881288|NCT00297102|3586579|FG000|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|765
2881289|NCT00297102|3586580|FG001|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|758
2881290|NCT00297102|3586579|FG000|COMPLETED|Overall Study||502
2881291|NCT00297102|3586580|FG001|COMPLETED|Overall Study||525
2881292|NCT00297102|3586579|FG000|NOT COMPLETED|Overall Study||263
2881293|NCT00297102|3586580|FG001|NOT COMPLETED|Overall Study||233
2881294|NCT00297115|3586588|FG000|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|772
2881295|NCT00297115|3586589|FG001|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|796
2881296|NCT00297115|3586588|FG000|COMPLETED|Overall Study||527
2881297|NCT00297115|3586589|FG001|COMPLETED|Overall Study||550
2881298|NCT00297115|3586588|FG000|NOT COMPLETED|Overall Study||245
2881299|NCT00297115|3586589|FG001|NOT COMPLETED|Overall Study||246
2881300|NCT00297167|3586595|FG000|STARTED|First Double-blind Intervention Period||17
2881301|NCT00297167|3586596|FG001|STARTED|First Double-blind Intervention Period||16
3170054|NCT01928394|3897408|FG002|COMPLETED|Treatment Period||0
3170055|NCT01928394|3897409|FG003|COMPLETED|Treatment Period||3
3170056|NCT01928394|3897410|FG004|COMPLETED|Treatment Period||0
3170057|NCT01928394|3897411|FG005|COMPLETED|Treatment Period||6
3170058|NCT01928394|3897412|FG006|COMPLETED|Treatment Period||3
3170059|NCT01928394|3897413|FG007|COMPLETED|Treatment Period||0
2881302|NCT00297167|3586597|FG002|STARTED|First Double-blind Intervention Period||0
2881303|NCT00297167|3586595|FG000|COMPLETED|First Double-blind Intervention Period||17
2881304|NCT00297167|3586596|FG001|COMPLETED|First Double-blind Intervention Period||16
2881305|NCT00297167|3586597|FG002|COMPLETED|First Double-blind Intervention Period||0
2881306|NCT00297167|3586595|FG000|NOT COMPLETED|First Double-blind Intervention Period||0
2881307|NCT00297167|3586596|FG001|NOT COMPLETED|First Double-blind Intervention Period||0
2881308|NCT00297167|3586597|FG002|NOT COMPLETED|First Double-blind Intervention Period||0
2881309|NCT00297167|3586595|FG000|STARTED|Open-label Dose Normalization Period 1||0
2881310|NCT00297167|3586596|FG001|STARTED|Open-label Dose Normalization Period 1||0
2881311|NCT00297167|3586597|FG002|STARTED|Open-label Dose Normalization Period 1||33
2881312|NCT00297167|3586595|FG000|COMPLETED|Open-label Dose Normalization Period 1||0
2881313|NCT00297167|3586596|FG001|COMPLETED|Open-label Dose Normalization Period 1||0
2881314|NCT00297167|3586597|FG002|COMPLETED|Open-label Dose Normalization Period 1||32
2881315|NCT00297167|3586595|FG000|NOT COMPLETED|Open-label Dose Normalization Period 1||0
2881316|NCT00297167|3586596|FG001|NOT COMPLETED|Open-label Dose Normalization Period 1||0
2881317|NCT00297167|3586597|FG002|NOT COMPLETED|Open-label Dose Normalization Period 1||1
2881318|NCT00297167|3586595|FG000|STARTED|Second Double-blind Intervention Period||17
2881319|NCT00297167|3586596|FG001|STARTED|Second Double-blind Intervention Period||15
2881320|NCT00297167|3586597|FG002|STARTED|Second Double-blind Intervention Period||0
2881321|NCT00297167|3586595|FG000|COMPLETED|Second Double-blind Intervention Period||16
2881322|NCT00297167|3586596|FG001|COMPLETED|Second Double-blind Intervention Period||15
2881323|NCT00297167|3586597|FG002|COMPLETED|Second Double-blind Intervention Period||0
3038341|NCT01153763|3757765|FG000|STARTED|Overall Study||92
3170060|NCT01928394|3897414|FG008|COMPLETED|Treatment Period||0
3170061|NCT01928394|3897415|FG009|COMPLETED|Treatment Period||0
2881324|NCT00297167|3586595|FG000|NOT COMPLETED|Second Double-blind Intervention Period||1
2881325|NCT00297167|3586596|FG001|NOT COMPLETED|Second Double-blind Intervention Period||0
2881326|NCT00297167|3586597|FG002|NOT COMPLETED|Second Double-blind Intervention Period||0
2881327|NCT00297167|3586595|FG000|STARTED|Open-label Dose Normalization Period 2||0
2881328|NCT00297167|3586596|FG001|STARTED|Open-label Dose Normalization Period 2||0
2881329|NCT00297167|3586597|FG002|STARTED|Open-label Dose Normalization Period 2||31
2881330|NCT00297167|3586595|FG000|COMPLETED|Open-label Dose Normalization Period 2||0
2881331|NCT00297167|3586596|FG001|COMPLETED|Open-label Dose Normalization Period 2||0
2881332|NCT00297167|3586597|FG002|COMPLETED|Open-label Dose Normalization Period 2||31
2881333|NCT00297167|3586595|FG000|NOT COMPLETED|Open-label Dose Normalization Period 2||0
2881334|NCT00297167|3586596|FG001|NOT COMPLETED|Open-label Dose Normalization Period 2||0
2881335|NCT00297167|3586597|FG002|NOT COMPLETED|Open-label Dose Normalization Period 2||0
2881336|NCT00297232|3586604|FG000|STARTED|Overall Study||1094
2881337|NCT00297232|3586604|FG000|COMPLETED|Overall Study||489
2881338|NCT00297232|3586604|FG000|NOT COMPLETED|Overall Study||605
2881339|NCT00297258|3586608|FG000|STARTED|Overall Study||142
2881340|NCT00297258|3586608|FG000|COMPLETED|Overall Study||0
2881341|NCT00297258|3586608|FG000|NOT COMPLETED|Overall Study||142
2881342|NCT00297427|3586617|FG000|STARTED|Phase 1: Initial Intervention|Intention-to-treat analysis; all randomized subjects were included in analysis|64
2881343|NCT00297427|3586618|FG001|STARTED|Phase 1: Initial Intervention|Intention-to-treat analysis; all randomized subjects were included in analysis|63
2881344|NCT00297427|3586617|FG000|COMPLETED|Phase 1: Initial Intervention||56
2881345|NCT00297427|3586618|FG001|COMPLETED|Phase 1: Initial Intervention||54
2881346|NCT00297427|3586617|FG000|NOT COMPLETED|Phase 1: Initial Intervention||8
2881347|NCT00297427|3586618|FG001|NOT COMPLETED|Phase 1: Initial Intervention||9
2881348|NCT00297427|3586617|FG000|STARTED|Phase 2: Optional Crossover for Sham||54
2881349|NCT00297427|3586618|FG001|STARTED|Phase 2: Optional Crossover for Sham|There was no cross-over to sham acupuncture as this was a wait list control design|0
2881350|NCT00297427|3586617|FG000|Crossed Over to True Acupuncture|Phase 2: Optional Crossover for Sham|54 subjects completed the sham acupuncture & were offered the opportunity to cross-over; 12 declined|42
2881351|NCT00297427|3586618|FG001|Crossed Over to True Acupuncture|Phase 2: Optional Crossover for Sham|There was no cross-over to sham acupuncture as this was a wait list control design|0
2881352|NCT00297427|3586617|FG000|COMPLETED|Phase 2: Optional Crossover for Sham||38
2881353|NCT00297427|3586618|FG001|COMPLETED|Phase 2: Optional Crossover for Sham|There was no cross-over to sham acupuncture as this was a wait list control design|0
2881354|NCT00297427|3586617|FG000|NOT COMPLETED|Phase 2: Optional Crossover for Sham||16
2881355|NCT00297427|3586618|FG001|NOT COMPLETED|Phase 2: Optional Crossover for Sham||0
2881356|NCT00297427|3586617|FG000|STARTED|Phase 3: Follow-up Post-True Acupuncture||94
2881357|NCT00297427|3586618|FG001|STARTED|Phase 3: Follow-up Post-True Acupuncture|Only subjects who received true acupuncture initially or after cross-over entered follow-up|0
2881358|NCT00297427|3586617|FG000|COMPLETED|Phase 3: Follow-up Post-True Acupuncture|Subjects who completed=/>1 follow-up visits and were evaluated for booster acupuncture|60
2881359|NCT00297427|3586618|FG001|COMPLETED|Phase 3: Follow-up Post-True Acupuncture|Only subjects who received true acupuncture initially or after cross-over entered follow-up|0
2881360|NCT00297427|3586617|FG000|NOT COMPLETED|Phase 3: Follow-up Post-True Acupuncture||34
2881361|NCT00297427|3586618|FG001|NOT COMPLETED|Phase 3: Follow-up Post-True Acupuncture||0
2881362|NCT00297479|3586635|FG000|STARTED|Overall Study||103
2881363|NCT00297479|3586636|FG001|STARTED|Overall Study||155
2881364|NCT00297479|3586637|FG002|STARTED|Overall Study||154
2881365|NCT00297479|3586635|FG000|4-Week Follow Up|Overall Study||78
2881366|NCT00297479|3586636|FG001|4-Week Follow Up|Overall Study||132
2881367|NCT00297479|3586637|FG002|4-Week Follow Up|Overall Study||128
2881368|NCT00297479|3586635|FG000|26- Week Follow Up|Overall Study||66
2881369|NCT00297479|3586636|FG001|26- Week Follow Up|Overall Study||101
2881370|NCT00297479|3586637|FG002|26- Week Follow Up|Overall Study||103
2881371|NCT00297479|3586635|FG000|COMPLETED|Overall Study||66
2881372|NCT00297479|3586636|FG001|COMPLETED|Overall Study||101
2881373|NCT00297479|3586637|FG002|COMPLETED|Overall Study||103
2881374|NCT00297479|3586635|FG000|NOT COMPLETED|Overall Study||37
2881375|NCT00297479|3586636|FG001|NOT COMPLETED|Overall Study||54
2881376|NCT00297479|3586637|FG002|NOT COMPLETED|Overall Study||51
2881377|NCT00297492|3586648|FG000|STARTED|Set Quit Date||297
2881378|NCT00297492|3586649|FG001|STARTED|Set Quit Date||299
2881379|NCT00297492|3586650|FG002|STARTED|Set Quit Date||150
2881380|NCT00297492|3586648|FG000|COMPLETED|Set Quit Date||290
2881381|NCT00297492|3586649|FG001|COMPLETED|Set Quit Date||286
2881382|NCT00297492|3586650|FG002|COMPLETED|Set Quit Date||145
2881383|NCT00297492|3586648|FG000|NOT COMPLETED|Set Quit Date||7
2881384|NCT00297492|3586649|FG001|NOT COMPLETED|Set Quit Date||13
2881385|NCT00297492|3586650|FG002|NOT COMPLETED|Set Quit Date||5
2881386|NCT00297492|3586648|FG000|STARTED|6 Month Follow-up||290
3170062|NCT01928394|3897416|FG010|COMPLETED|Treatment Period||0
3170063|NCT01928394|3897417|FG011|COMPLETED|Treatment Period||5
3170064|NCT01928394|3897418|FG012|COMPLETED|Treatment Period||6
3170065|NCT01928394|3897419|FG013|COMPLETED|Treatment Period||8
3170066|NCT01928394|3897420|FG014|COMPLETED|Treatment Period||8
3170067|NCT01928394|3897421|FG015|COMPLETED|Treatment Period||1
3170068|NCT01928394|3897422|FG016|COMPLETED|Treatment Period||5
3170069|NCT01928394|3897423|FG017|COMPLETED|Treatment Period||7
3170070|NCT01928394|3897424|FG018|COMPLETED|Treatment Period||22
3170071|NCT01928394|3897425|FG019|COMPLETED|Treatment Period||8
3170072|NCT01928394|3897426|FG020|COMPLETED|Treatment Period||1
2881387|NCT00297492|3586649|FG001|STARTED|6 Month Follow-up||286
2881388|NCT00297492|3586650|FG002|STARTED|6 Month Follow-up||145
2881389|NCT00297492|3586648|FG000|COMPLETED|6 Month Follow-up||227
2881390|NCT00297492|3586649|FG001|COMPLETED|6 Month Follow-up||237
2881391|NCT00297492|3586650|FG002|COMPLETED|6 Month Follow-up||118
2881392|NCT00297492|3586648|FG000|NOT COMPLETED|6 Month Follow-up||63
2881393|NCT00297492|3586649|FG001|NOT COMPLETED|6 Month Follow-up||49
2881394|NCT00297492|3586650|FG002|NOT COMPLETED|6 Month Follow-up||27
2881395|NCT00297596|3586658|FG000|STARTED|Overall Study||25
2881396|NCT00297596|3586658|FG000|COMPLETED|Overall Study||25
2881397|NCT00297596|3586658|FG000|NOT COMPLETED|Overall Study||0
2881398|NCT00297648|3586662|FG000|STARTED|Overall Study||89
2881399|NCT00297648|3586662|FG000|COMPLETED|Overall Study||53
2881400|NCT00297648|3586662|FG000|NOT COMPLETED|Overall Study||36
2881401|NCT00297778|3586668|FG000|STARTED|Overall Study||152
2881402|NCT00297778|3586669|FG001|STARTED|Overall Study||144
2881403|NCT00297778|3586668|FG000|COMPLETED|Overall Study||133
2881404|NCT00297778|3586669|FG001|COMPLETED|Overall Study||124
2881405|NCT00297778|3586668|FG000|NOT COMPLETED|Overall Study||19
2881406|NCT00297778|3586669|FG001|NOT COMPLETED|Overall Study||20
2881407|NCT00297830|3586678|FG000|STARTED|Baseline||41
2881408|NCT00297830|3586679|FG001|STARTED|Baseline||43
2881409|NCT00297830|3586680|FG002|STARTED|Baseline||27
2881410|NCT00297830|3586678|FG000|COMPLETED|Baseline||41
2881411|NCT00297830|3586679|FG001|COMPLETED|Baseline||43
2881412|NCT00297830|3586680|FG002|COMPLETED|Baseline||27
2881413|NCT00297830|3586678|FG000|NOT COMPLETED|Baseline||0
2881414|NCT00297830|3586679|FG001|NOT COMPLETED|Baseline||0
2881415|NCT00297830|3586680|FG002|NOT COMPLETED|Baseline||0
2881416|NCT00297830|3586678|FG000|STARTED|6 Month Visit||41
2881417|NCT00297830|3586679|FG001|STARTED|6 Month Visit||43
2881418|NCT00297830|3586680|FG002|STARTED|6 Month Visit||27
2881419|NCT00297830|3586678|FG000|COMPLETED|6 Month Visit||38
2881420|NCT00297830|3586679|FG001|COMPLETED|6 Month Visit||41
2881421|NCT00297830|3586680|FG002|COMPLETED|6 Month Visit||24
2881422|NCT00297830|3586678|FG000|NOT COMPLETED|6 Month Visit||3
2881423|NCT00297830|3586679|FG001|NOT COMPLETED|6 Month Visit||2
2881424|NCT00297830|3586680|FG002|NOT COMPLETED|6 Month Visit||3
2881425|NCT00297830|3586678|FG000|STARTED|12 Month Visit||38
2881426|NCT00297830|3586679|FG001|STARTED|12 Month Visit||41
2881427|NCT00297830|3586680|FG002|STARTED|12 Month Visit||24
2881428|NCT00297830|3586678|FG000|COMPLETED|12 Month Visit||37
2881429|NCT00297830|3586679|FG001|COMPLETED|12 Month Visit||35
2881430|NCT00297830|3586680|FG002|COMPLETED|12 Month Visit||24
2881431|NCT00297830|3586678|FG000|NOT COMPLETED|12 Month Visit||1
2881432|NCT00297830|3586679|FG001|NOT COMPLETED|12 Month Visit||6
2881433|NCT00297830|3586680|FG002|NOT COMPLETED|12 Month Visit||0
2881434|NCT00297882|3586690|FG000|STARTED|Day 14||204
2881435|NCT00297882|3586691|FG001|STARTED|Day 14||612
2881436|NCT00297882|3586690|FG000|COMPLETED|Day 14||192
2881437|NCT00297882|3586691|FG001|COMPLETED|Day 14||563
2881438|NCT00297882|3586690|FG000|NOT COMPLETED|Day 14||12
2881439|NCT00297882|3586691|FG001|NOT COMPLETED|Day 14||49
2881440|NCT00297882|3586690|FG000|STARTED|Day 28||192
2881441|NCT00297882|3586691|FG001|STARTED|Day 28||563
2881442|NCT00297882|3586690|FG000|COMPLETED|Day 28||176
2881443|NCT00297882|3586691|FG001|COMPLETED|Day 28||540
2881444|NCT00297882|3586690|FG000|NOT COMPLETED|Day 28||16
2881445|NCT00297882|3586691|FG001|NOT COMPLETED|Day 28||23
2881446|NCT00298038|3586701|FG000|STARTED|Overall Study||140
2881447|NCT00298038|3586702|FG001|STARTED|Overall Study||159
2881448|NCT00298038|3586701|FG000|Received At Least 1 Dose Of Study Drug|Overall Study||140
2881449|NCT00298038|3586702|FG001|Received At Least 1 Dose Of Study Drug|Overall Study||159
2881450|NCT00298038|3586701|FG000|COMPLETED|Overall Study||88
2881451|NCT00298038|3586702|FG001|COMPLETED|Overall Study||66
2881452|NCT00298038|3586701|FG000|NOT COMPLETED|Overall Study||52
2881453|NCT00298038|3586702|FG001|NOT COMPLETED|Overall Study||93
2881454|NCT00298090|3586708|FG000|STARTED|Overall Study||47
2881455|NCT00298090|3586708|FG000|COMPLETED|Overall Study|Eighteen subjects were not included in final analysis due to incomplete data sets|29
2881456|NCT00298090|3586708|FG000|NOT COMPLETED|Overall Study||18
2881457|NCT00298155|3586715|FG000|STARTED|Overall Study||12
2881458|NCT00298155|3586716|FG001|STARTED|Overall Study||10
2881459|NCT00298155|3586717|FG002|STARTED|Overall Study||13
2881460|NCT00298155|3586715|FG000|COMPLETED|Overall Study||12
2881461|NCT00298155|3586716|FG001|COMPLETED|Overall Study||10
2881462|NCT00298155|3586717|FG002|COMPLETED|Overall Study||13
2881463|NCT00298155|3586715|FG000|NOT COMPLETED|Overall Study||0
2881464|NCT00298155|3586716|FG001|NOT COMPLETED|Overall Study||0
2881465|NCT00298155|3586717|FG002|NOT COMPLETED|Overall Study||0
2881466|NCT00298233|3586727|FG000|STARTED|Overall Study||39
2881467|NCT00298233|3586728|FG001|STARTED|Overall Study||41
2881468|NCT00298233|3586729|FG002|STARTED|Overall Study||122
2881469|NCT00298233|3586730|FG003|STARTED|Overall Study||124
2881470|NCT00298233|3586727|FG000|COMPLETED|Overall Study||39
2881471|NCT00298233|3586728|FG001|COMPLETED|Overall Study||41
2881472|NCT00298233|3586729|FG002|COMPLETED|Overall Study||122
2881473|NCT00298233|3586730|FG003|COMPLETED|Overall Study||124
2881474|NCT00298233|3586727|FG000|NOT COMPLETED|Overall Study||0
2881475|NCT00298233|3586728|FG001|NOT COMPLETED|Overall Study||0
2881476|NCT00298233|3586729|FG002|NOT COMPLETED|Overall Study||0
2881477|NCT00298233|3586730|FG003|NOT COMPLETED|Overall Study||0
2881478|NCT00298272|3586738|FG000|STARTED|Double-blind Phase|enrolled and randomized (2:1 scheme)|36
2881479|NCT00298272|3586739|FG001|STARTED|Double-blind Phase||18
2881480|NCT00298272|3586738|FG000|Safety Population|Double-blind Phase|received treatment|33
2881481|NCT00298272|3586739|FG001|Safety Population|Double-blind Phase||18
2881482|NCT00298272|3586738|FG000|Completed to Week 24|Double-blind Phase|received full course of rituximab therapy|31
2881483|NCT00298272|3586739|FG001|Completed to Week 24|Double-blind Phase|received full course of placebo therapy|18
2881484|NCT00298272|3586738|FG000|Completed to Week 56|Double-blind Phase||8
2881485|NCT00298272|3586739|FG001|Completed to Week 56|Double-blind Phase||3
2881486|NCT00298272|3586738|FG000|COMPLETED|Double-blind Phase||28
2881487|NCT00298272|3586739|FG001|COMPLETED|Double-blind Phase||18
2881488|NCT00298272|3586738|FG000|NOT COMPLETED|Double-blind Phase||8
2881489|NCT00298272|3586739|FG001|NOT COMPLETED|Double-blind Phase||0
2881490|NCT00298272|3586738|FG000|STARTED|Open Label Retreatment Phase||22
2881491|NCT00298272|3586739|FG001|STARTED|Open Label Retreatment Phase||16
2881492|NCT00298272|3586738|FG000|Completed to Week 24|Open Label Retreatment Phase|received full course of open-label rituximab therapy|22
2881493|NCT00298272|3586739|FG001|Completed to Week 24|Open Label Retreatment Phase|received full course of open-label rituximab therapy|15
2881494|NCT00298272|3586738|FG000|Completed to Week 56|Open Label Retreatment Phase||13
2881495|NCT00298272|3586739|FG001|Completed to Week 56|Open Label Retreatment Phase||12
2881496|NCT00298272|3586738|FG000|COMPLETED|Open Label Retreatment Phase||13
2881497|NCT00298272|3586739|FG001|COMPLETED|Open Label Retreatment Phase||12
2881498|NCT00298272|3586738|FG000|NOT COMPLETED|Open Label Retreatment Phase||9
2881499|NCT00298272|3586739|FG001|NOT COMPLETED|Open Label Retreatment Phase||4
2881500|NCT00298272|3586738|FG000|STARTED|Safety Follow-up Phase||22
2881501|NCT00298272|3586739|FG001|STARTED|Safety Follow-up Phase||17
2881502|NCT00298272|3586738|FG000|COMPLETED|Safety Follow-up Phase||18
2881503|NCT00298272|3586739|FG001|COMPLETED|Safety Follow-up Phase||13
2881504|NCT00298272|3586738|FG000|NOT COMPLETED|Safety Follow-up Phase||4
2881505|NCT00298272|3586739|FG001|NOT COMPLETED|Safety Follow-up Phase||4
2881506|NCT00298363|3586751|FG000|STARTED|Overall Study||45
2881507|NCT00298363|3586752|FG001|STARTED|Overall Study||45
2881508|NCT00298363|3586753|FG002|STARTED|Overall Study||22
2881509|NCT00298363|3586751|FG000|COMPLETED|Overall Study|22 completed while taking DB TDF; 6 completed following switch from DB TDF to OL FTC/TDF.|28
2881510|NCT00298363|3586752|FG001|COMPLETED|Overall Study|34 completed while taking DB FTC/TDF; 3 completed following switch from DB TDF to OL FTC/TDF.|37
2881511|NCT00298363|3586753|FG002|COMPLETED|Overall Study|13 completed while taking DB ETV; 3 completed following switch from DB ETV to OL FTC/TDF.|16
2881512|NCT00298363|3586751|FG000|NOT COMPLETED|Overall Study||17
2881513|NCT00298363|3586752|FG001|NOT COMPLETED|Overall Study||8
2881514|NCT00298363|3586753|FG002|NOT COMPLETED|Overall Study||6
2881515|NCT00298389|3586770|FG000|STARTED|Overall Study||20
2881516|NCT00298389|3586771|FG001|STARTED|Overall Study||17
2881517|NCT00298389|3586772|FG002|STARTED|Overall Study||19
2881518|NCT00298389|3586770|FG000|COMPLETED|Overall Study||20
2881519|NCT00298389|3586771|FG001|COMPLETED|Overall Study||17
2881520|NCT00298389|3586772|FG002|COMPLETED|Overall Study||19
2881521|NCT00298389|3586770|FG000|NOT COMPLETED|Overall Study||0
2881522|NCT00298389|3586771|FG001|NOT COMPLETED|Overall Study||0
2881523|NCT00298389|3586772|FG002|NOT COMPLETED|Overall Study||0
2881524|NCT00298558|3586784|FG000|STARTED|Baseline||711
2881525|NCT00298558|3586785|FG001|STARTED|Baseline||705
2881526|NCT00298558|3586786|FG002|STARTED|Baseline||712
2881527|NCT00298558|3586787|FG003|STARTED|Baseline||704
2881528|NCT00298558|3586784|FG000|COMPLETED|Baseline||711
2881529|NCT00298558|3586785|FG001|COMPLETED|Baseline||705
2881530|NCT00298558|3586786|FG002|COMPLETED|Baseline||712
2881531|NCT00298558|3586787|FG003|COMPLETED|Baseline||704
2881532|NCT00298558|3586784|FG000|NOT COMPLETED|Baseline||0
2881533|NCT00298558|3586785|FG001|NOT COMPLETED|Baseline||0
2881534|NCT00298558|3586786|FG002|NOT COMPLETED|Baseline||0
2881535|NCT00298558|3586787|FG003|NOT COMPLETED|Baseline||0
2881536|NCT00298558|3586784|FG000|STARTED|Intervention||711
2881537|NCT00298558|3586785|FG001|STARTED|Intervention||705
2881538|NCT00298558|3586786|FG002|STARTED|Intervention||712
2881539|NCT00298558|3586787|FG003|STARTED|Intervention||704
2881540|NCT00298558|3586784|FG000|COMPLETED|Intervention||620
2881541|NCT00298558|3586785|FG001|COMPLETED|Intervention||627
2881542|NCT00298558|3586786|FG002|COMPLETED|Intervention||637
2881543|NCT00298558|3586787|FG003|COMPLETED|Intervention||285
3170073|NCT01928394|3897427|FG021|COMPLETED|Treatment Period||1
3170074|NCT01928394|3897428|FG022|COMPLETED|Treatment Period||3
3170075|NCT01928394|3897406|FG000|NOT COMPLETED|Treatment Period||18
2881544|NCT00298558|3586784|FG000|NOT COMPLETED|Intervention||91
2881545|NCT00298558|3586785|FG001|NOT COMPLETED|Intervention||78
2881546|NCT00298558|3586786|FG002|NOT COMPLETED|Intervention||75
3170076|NCT01928394|3897407|FG001|NOT COMPLETED|Treatment Period||3
3170077|NCT01928394|3897408|FG002|NOT COMPLETED|Treatment Period||18
3170078|NCT01928394|3897409|FG003|NOT COMPLETED|Treatment Period||56
3170079|NCT01928394|3897410|FG004|NOT COMPLETED|Treatment Period||3
3170080|NCT01928394|3897411|FG005|NOT COMPLETED|Treatment Period||43
3170081|NCT01928394|3897412|FG006|NOT COMPLETED|Treatment Period||49
3170082|NCT01928394|3897413|FG007|NOT COMPLETED|Treatment Period||18
3170083|NCT01928394|3897414|FG008|NOT COMPLETED|Treatment Period||3
3170084|NCT01928394|3897415|FG009|NOT COMPLETED|Treatment Period||18
3170085|NCT01928394|3897416|FG010|NOT COMPLETED|Treatment Period||30
3170086|NCT01928394|3897417|FG011|NOT COMPLETED|Treatment Period||93
3170087|NCT01928394|3897418|FG012|NOT COMPLETED|Treatment Period||55
3170088|NCT01928394|3897419|FG013|NOT COMPLETED|Treatment Period||139
2881547|NCT00298558|3586787|FG003|NOT COMPLETED|Intervention||419
2881548|NCT00298558|3586784|FG000|STARTED|Immediate Post Test||711
2881549|NCT00298558|3586785|FG001|STARTED|Immediate Post Test||705
2881550|NCT00298558|3586786|FG002|STARTED|Immediate Post Test||712
2881551|NCT00298558|3586787|FG003|STARTED|Immediate Post Test||704
2881552|NCT00298558|3586784|FG000|COMPLETED|Immediate Post Test||640
2881553|NCT00298558|3586785|FG001|COMPLETED|Immediate Post Test||629
2881554|NCT00298558|3586786|FG002|COMPLETED|Immediate Post Test||653
2881555|NCT00298558|3586787|FG003|COMPLETED|Immediate Post Test||639
2881556|NCT00298558|3586784|FG000|NOT COMPLETED|Immediate Post Test||71
2881557|NCT00298558|3586785|FG001|NOT COMPLETED|Immediate Post Test||76
2881558|NCT00298558|3586786|FG002|NOT COMPLETED|Immediate Post Test||59
2881559|NCT00298558|3586787|FG003|NOT COMPLETED|Immediate Post Test||65
2881560|NCT00298558|3586784|FG000|STARTED|Booster||372
2881561|NCT00298558|3586785|FG001|STARTED|Booster||371
2881562|NCT00298558|3586786|FG002|STARTED|Booster||370
2881563|NCT00298558|3586787|FG003|STARTED|Booster||0
2881564|NCT00298558|3586784|FG000|COMPLETED|Booster||283
2881565|NCT00298558|3586785|FG001|COMPLETED|Booster||301
2881566|NCT00298558|3586786|FG002|COMPLETED|Booster||295
2881567|NCT00298558|3586787|FG003|COMPLETED|Booster||0
2881568|NCT00298558|3586784|FG000|NOT COMPLETED|Booster||89
2881569|NCT00298558|3586785|FG001|NOT COMPLETED|Booster||70
2881570|NCT00298558|3586786|FG002|NOT COMPLETED|Booster||75
2881571|NCT00298558|3586787|FG003|NOT COMPLETED|Booster||0
2881572|NCT00298558|3586784|FG000|STARTED|1st Annual (A1)||640
2881573|NCT00298558|3586785|FG001|STARTED|1st Annual (A1)||629
2881574|NCT00298558|3586786|FG002|STARTED|1st Annual (A1)||653
2881575|NCT00298558|3586787|FG003|STARTED|1st Annual (A1)||639
2881576|NCT00298558|3586784|FG000|COMPLETED|1st Annual (A1)||585
2881577|NCT00298558|3586785|FG001|COMPLETED|1st Annual (A1)||566
2881578|NCT00298558|3586786|FG002|COMPLETED|1st Annual (A1)||601
2881579|NCT00298558|3586787|FG003|COMPLETED|1st Annual (A1)||584
2881580|NCT00298558|3586784|FG000|NOT COMPLETED|1st Annual (A1)||55
2881581|NCT00298558|3586785|FG001|NOT COMPLETED|1st Annual (A1)||63
2881582|NCT00298558|3586786|FG002|NOT COMPLETED|1st Annual (A1)||52
2881583|NCT00298558|3586787|FG003|NOT COMPLETED|1st Annual (A1)||55
2881584|NCT00298558|3586784|FG000|STARTED|2nd Annual (A2)||585
2881585|NCT00298558|3586785|FG001|STARTED|2nd Annual (A2)||566
2881586|NCT00298558|3586786|FG002|STARTED|2nd Annual (A2)||601
2881587|NCT00298558|3586787|FG003|STARTED|2nd Annual (A2)||584
2881588|NCT00298558|3586784|FG000|COMPLETED|2nd Annual (A2)||563
2881589|NCT00298558|3586785|FG001|COMPLETED|2nd Annual (A2)||555
2881590|NCT00298558|3586786|FG002|COMPLETED|2nd Annual (A2)||574
2881591|NCT00298558|3586787|FG003|COMPLETED|2nd Annual (A2)||552
2881592|NCT00298558|3586784|FG000|NOT COMPLETED|2nd Annual (A2)||22
2881593|NCT00298558|3586785|FG001|NOT COMPLETED|2nd Annual (A2)||11
2881594|NCT00298558|3586786|FG002|NOT COMPLETED|2nd Annual (A2)||27
2881595|NCT00298558|3586787|FG003|NOT COMPLETED|2nd Annual (A2)||32
2881596|NCT00298558|3586784|FG000|STARTED|3rd Annual Booster||372
2881597|NCT00298558|3586785|FG001|STARTED|3rd Annual Booster||371
2881598|NCT00298558|3586786|FG002|STARTED|3rd Annual Booster||370
2881599|NCT00298558|3586787|FG003|STARTED|3rd Annual Booster||0
2881600|NCT00298558|3586784|FG000|COMPLETED|3rd Annual Booster||250
2881601|NCT00298558|3586785|FG001|COMPLETED|3rd Annual Booster||243
2881602|NCT00298558|3586786|FG002|COMPLETED|3rd Annual Booster||230
2881603|NCT00298558|3586787|FG003|COMPLETED|3rd Annual Booster||0
2881604|NCT00298558|3586784|FG000|NOT COMPLETED|3rd Annual Booster||122
2881605|NCT00298558|3586785|FG001|NOT COMPLETED|3rd Annual Booster||128
2881606|NCT00298558|3586786|FG002|NOT COMPLETED|3rd Annual Booster||140
2881607|NCT00298558|3586787|FG003|NOT COMPLETED|3rd Annual Booster||0
2881608|NCT00298558|3586784|FG000|STARTED|3rd Annual (A3) and 5th Annual (A5)||563
2881609|NCT00298558|3586785|FG001|STARTED|3rd Annual (A3) and 5th Annual (A5)||555
2881610|NCT00298558|3586786|FG002|STARTED|3rd Annual (A3) and 5th Annual (A5)||574
2881611|NCT00298558|3586787|FG003|STARTED|3rd Annual (A3) and 5th Annual (A5)||552
2881612|NCT00298558|3586784|FG000|COMPLETED|3rd Annual (A3) and 5th Annual (A5)||472
2881613|NCT00298558|3586785|FG001|COMPLETED|3rd Annual (A3) and 5th Annual (A5)||469
2881614|NCT00298558|3586786|FG002|COMPLETED|3rd Annual (A3) and 5th Annual (A5)||490
2881615|NCT00298558|3586787|FG003|COMPLETED|3rd Annual (A3) and 5th Annual (A5)||448
2881616|NCT00298558|3586784|FG000|NOT COMPLETED|3rd Annual (A3) and 5th Annual (A5)||91
2881617|NCT00298558|3586785|FG001|NOT COMPLETED|3rd Annual (A3) and 5th Annual (A5)||86
2881618|NCT00298558|3586786|FG002|NOT COMPLETED|3rd Annual (A3) and 5th Annual (A5)||84
2881619|NCT00298558|3586787|FG003|NOT COMPLETED|3rd Annual (A3) and 5th Annual (A5)||104
2881620|NCT00298558|3586784|FG000|STARTED|10th Annual (A10)||472
2881621|NCT00298558|3586785|FG001|STARTED|10th Annual (A10)||469
2881622|NCT00298558|3586786|FG002|STARTED|10th Annual (A10)||490
2881623|NCT00298558|3586787|FG003|STARTED|10th Annual (A10)||448
2881624|NCT00298558|3586784|FG000|COMPLETED|10th Annual (A10)||300
2881625|NCT00298558|3586785|FG001|COMPLETED|10th Annual (A10)||316
2881626|NCT00298558|3586786|FG002|COMPLETED|10th Annual (A10)||319
2881627|NCT00298558|3586787|FG003|COMPLETED|10th Annual (A10)||285
2881628|NCT00298558|3586784|FG000|NOT COMPLETED|10th Annual (A10)||172
2881629|NCT00298558|3586785|FG001|NOT COMPLETED|10th Annual (A10)||153
2881630|NCT00298558|3586786|FG002|NOT COMPLETED|10th Annual (A10)||171
2881631|NCT00298558|3586787|FG003|NOT COMPLETED|10th Annual (A10)||163
2881632|NCT00298610|3586797|FG000|STARTED|Overall Study||30
2881633|NCT00298610|3586797|FG000|COMPLETED|Overall Study||30
2881634|NCT00298610|3586797|FG000|NOT COMPLETED|Overall Study||0
2881635|NCT00298766|3586801|FG000|STARTED|Overall Study||70
2881636|NCT00298766|3586801|FG000|COMPLETED|Overall Study||24
2881637|NCT00298766|3586801|FG000|NOT COMPLETED|Overall Study||46
2881638|NCT00298831|3586805|FG000|STARTED|Overall Study||224
2881639|NCT00298831|3586805|FG000|Treated|Overall Study||197
2881640|NCT00298831|3586805|FG000|COMPLETED|Overall Study||192
2881641|NCT00298831|3586805|FG000|NOT COMPLETED|Overall Study||32
2881642|NCT00298896|3586809|FG000|STARTED|Overall Study||55
2881643|NCT00298896|3586809|FG000|COMPLETED|Overall Study||5
2881644|NCT00298896|3586809|FG000|NOT COMPLETED|Overall Study||50
2881645|NCT00299000|3586815|FG000|STARTED|Overall Study||2
2881646|NCT00299000|3586816|FG001|STARTED|Overall Study||2
2881647|NCT00299000|3586815|FG000|COMPLETED|Overall Study||2
2881648|NCT00299000|3586816|FG001|COMPLETED|Overall Study||2
2881649|NCT00299000|3586815|FG000|NOT COMPLETED|Overall Study||0
2881650|NCT00299000|3586816|FG001|NOT COMPLETED|Overall Study||0
2881651|NCT00299104|3586825|FG000|STARTED|Treatment Period||251
2881652|NCT00299104|3586826|FG001|STARTED|Treatment Period||252
2881653|NCT00299104|3586827|FG002|STARTED|Treatment Period||252
2881654|NCT00299104|3586825|FG000|Safety/ITT: Received Study Drug|Treatment Period||249
2881655|NCT00299104|3586826|FG001|Safety/ITT: Received Study Drug|Treatment Period||249
2881656|NCT00299104|3586827|FG002|Safety/ITT: Received Study Drug|Treatment Period||250
2881657|NCT00299104|3586825|FG000|Completed Week 24|Treatment Period||227
2881658|NCT00299104|3586826|FG001|Completed Week 24|Treatment Period||240
2881659|NCT00299104|3586827|FG002|Completed Week 24|Treatment Period||241
2881660|NCT00299104|3586825|FG000|Completed Week 52|Treatment Period||213
2881661|NCT00299104|3586826|FG001|Completed Week 52|Treatment Period||227
2881662|NCT00299104|3586827|FG002|Completed Week 52|Treatment Period||232
2881663|NCT00299104|3586825|FG000|Completed Week 104|Treatment Period||178
2881664|NCT00299104|3586826|FG001|Completed Week 104|Treatment Period||213
2881665|NCT00299104|3586827|FG002|Completed Week 104|Treatment Period||216
2881666|NCT00299104|3586825|FG000|COMPLETED|Treatment Period|Completed Week 152|62
2881667|NCT00299104|3586826|FG001|COMPLETED|Treatment Period||77
2881668|NCT00299104|3586827|FG002|COMPLETED|Treatment Period||80
2881669|NCT00299104|3586825|FG000|NOT COMPLETED|Treatment Period||189
2881670|NCT00299104|3586826|FG001|NOT COMPLETED|Treatment Period||175
2881671|NCT00299104|3586827|FG002|NOT COMPLETED|Treatment Period||172
2881672|NCT00299104|3586825|FG000|STARTED|Safety Follow-Up (SFU) Period|All participants who received treatment were to enter SFU even if withdrawn during treatment period.|184
2881673|NCT00299104|3586826|FG001|STARTED|Safety Follow-Up (SFU) Period|All participants who received treatment were to enter SFU even if withdrawn during treatment period.|212
2881674|NCT00299104|3586827|FG002|STARTED|Safety Follow-Up (SFU) Period|All participants who received treatment were to enter SFU even if withdrawn during treatment period.|213
2881675|NCT00299104|3586825|FG000|COMPLETED|Safety Follow-Up (SFU) Period||129
2881676|NCT00299104|3586826|FG001|COMPLETED|Safety Follow-Up (SFU) Period||171
2881677|NCT00299104|3586827|FG002|COMPLETED|Safety Follow-Up (SFU) Period||176
2881678|NCT00299104|3586825|FG000|NOT COMPLETED|Safety Follow-Up (SFU) Period||55
3170089|NCT01928394|3897420|FG014|NOT COMPLETED|Treatment Period||88
3170090|NCT01928394|3897421|FG015|NOT COMPLETED|Treatment Period||2
3170091|NCT01928394|3897422|FG016|NOT COMPLETED|Treatment Period||50
3170092|NCT01928394|3897423|FG017|NOT COMPLETED|Treatment Period||71
3170093|NCT01928394|3897424|FG018|NOT COMPLETED|Treatment Period||70
3170094|NCT01928394|3897425|FG019|NOT COMPLETED|Treatment Period||96
2881679|NCT00299104|3586826|FG001|NOT COMPLETED|Safety Follow-Up (SFU) Period||41
2881680|NCT00299104|3586827|FG002|NOT COMPLETED|Safety Follow-Up (SFU) Period||37
2881681|NCT00299104|3586825|FG000|STARTED|Extended Safety Follow-Up (ESFU) Period|Only participants with CD19+ B-cell counts below baseline level or less than 80 cells/microliter.|34
2881682|NCT00299104|3586826|FG001|STARTED|Extended Safety Follow-Up (ESFU) Period|Only participants with CD19+ B-cell counts below baseline level or less than 80 cells/microliter.|40
2881683|NCT00299104|3586827|FG002|STARTED|Extended Safety Follow-Up (ESFU) Period|Only participants with CD19+ B-cell counts below baseline level or less than 80 cells/microliter.|51
2881684|NCT00299104|3586825|FG000|COMPLETED|Extended Safety Follow-Up (ESFU) Period||29
2881685|NCT00299104|3586826|FG001|COMPLETED|Extended Safety Follow-Up (ESFU) Period||31
2881686|NCT00299104|3586827|FG002|COMPLETED|Extended Safety Follow-Up (ESFU) Period||39
2881687|NCT00299104|3586825|FG000|NOT COMPLETED|Extended Safety Follow-Up (ESFU) Period||5
3170095|NCT01928394|3897426|FG020|NOT COMPLETED|Treatment Period||40
3170096|NCT01928394|3897427|FG021|NOT COMPLETED|Treatment Period||42
2881688|NCT00299104|3586826|FG001|NOT COMPLETED|Extended Safety Follow-Up (ESFU) Period||9
2881689|NCT00299104|3586827|FG002|NOT COMPLETED|Extended Safety Follow-Up (ESFU) Period||12
2881690|NCT00299130|3586838|FG000|STARTED|Treatment Period (up to 5 Years)||172
2881691|NCT00299130|3586839|FG001|STARTED|Treatment Period (up to 5 Years)||168
2881692|NCT00299130|3586840|FG002|STARTED|Treatment Period (up to 5 Years)||171
2881693|NCT00299130|3586838|FG000|Treated|Treatment Period (up to 5 Years)|155 participants in placebo arm switched to active therapy (rituximab 2 x 0.5g) between Weeks 16-48.|172
2881694|NCT00299130|3586839|FG001|Treated|Treatment Period (up to 5 Years)||167
2881695|NCT00299130|3586840|FG002|Treated|Treatment Period (up to 5 Years)||170
2881696|NCT00299130|3586838|FG000|Completed 24 Weeks|Treatment Period (up to 5 Years)||159
2881697|NCT00299130|3586839|FG001|Completed 24 Weeks|Treatment Period (up to 5 Years)||162
2881698|NCT00299130|3586840|FG002|Completed 24 Weeks|Treatment Period (up to 5 Years)||166
2881699|NCT00299130|3586838|FG000|Completed 48 Weeks|Treatment Period (up to 5 Years)||155
2881700|NCT00299130|3586839|FG001|Completed 48 Weeks|Treatment Period (up to 5 Years)||157
2881701|NCT00299130|3586840|FG002|Completed 48 Weeks|Treatment Period (up to 5 Years)||158
2881702|NCT00299130|3586838|FG000|Completed 144 Weeks|Treatment Period (up to 5 Years)||133
3170097|NCT01928394|3897428|FG022|NOT COMPLETED|Treatment Period||39
3170098|NCT01928394|3897406|FG000|STARTED|Follow-up Period||15
3170099|NCT01928394|3897407|FG001|STARTED|Follow-up Period||3
3170100|NCT01928394|3897408|FG002|STARTED|Follow-up Period||18
2881703|NCT00299130|3586839|FG001|Completed 144 Weeks|Treatment Period (up to 5 Years)||138
2881704|NCT00299130|3586840|FG002|Completed 144 Weeks|Treatment Period (up to 5 Years)||132
2881705|NCT00299130|3586838|FG000|COMPLETED|Treatment Period (up to 5 Years)||119
2881706|NCT00299130|3586839|FG001|COMPLETED|Treatment Period (up to 5 Years)||125
2881707|NCT00299130|3586840|FG002|COMPLETED|Treatment Period (up to 5 Years)||121
2881708|NCT00299130|3586838|FG000|NOT COMPLETED|Treatment Period (up to 5 Years)||53
2881709|NCT00299130|3586839|FG001|NOT COMPLETED|Treatment Period (up to 5 Years)||43
2881710|NCT00299130|3586840|FG002|NOT COMPLETED|Treatment Period (up to 5 Years)||50
2881711|NCT00299130|3586838|FG000|STARTED|Safety Follow-up (SFU) (48 Weeks)||167
3170101|NCT01928394|3897409|FG003|STARTED|Follow-up Period||50
3170102|NCT01928394|3897410|FG004|STARTED|Follow-up Period||3
3170103|NCT01928394|3897411|FG005|STARTED|Follow-up Period||49
2881712|NCT00299130|3586839|FG001|STARTED|Safety Follow-up (SFU) (48 Weeks)||165
2881713|NCT00299130|3586840|FG002|STARTED|Safety Follow-up (SFU) (48 Weeks)||168
2881714|NCT00299130|3586838|FG000|COMPLETED|Safety Follow-up (SFU) (48 Weeks)||122
2881715|NCT00299130|3586839|FG001|COMPLETED|Safety Follow-up (SFU) (48 Weeks)||120
2881716|NCT00299130|3586840|FG002|COMPLETED|Safety Follow-up (SFU) (48 Weeks)||123
2881717|NCT00299130|3586838|FG000|NOT COMPLETED|Safety Follow-up (SFU) (48 Weeks)||45
2881718|NCT00299130|3586839|FG001|NOT COMPLETED|Safety Follow-up (SFU) (48 Weeks)||45
2881719|NCT00299130|3586840|FG002|NOT COMPLETED|Safety Follow-up (SFU) (48 Weeks)||45
2881720|NCT00299130|3586838|FG000|STARTED|Extended SFU (ESFU) (up to 5.1 Years)||0
2881721|NCT00299130|3586839|FG001|STARTED|Extended SFU (ESFU) (up to 5.1 Years)||82
2881722|NCT00299130|3586840|FG002|STARTED|Extended SFU (ESFU) (up to 5.1 Years)||44
2881723|NCT00299130|3586838|FG000|COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||0
2881724|NCT00299130|3586839|FG001|COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||74
3170104|NCT01928394|3897412|FG006|STARTED|Follow-up Period||52
3170105|NCT01928394|3897413|FG007|STARTED|Follow-up Period||16
3170106|NCT01928394|3897414|FG008|STARTED|Follow-up Period||3
3170107|NCT01928394|3897415|FG009|STARTED|Follow-up Period||18
2881725|NCT00299130|3586840|FG002|COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||38
2881726|NCT00299130|3586838|FG000|NOT COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||0
2881727|NCT00299130|3586839|FG001|NOT COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||8
2881728|NCT00299130|3586840|FG002|NOT COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||6
2881729|NCT00299156|3586858|FG000|STARTED|Period 1 (Non-Randomized)||32
2881730|NCT00299156|3586859|FG001|STARTED|Period 1 (Non-Randomized)||0
2881731|NCT00299156|3586860|FG002|STARTED|Period 1 (Non-Randomized)||0
2881732|NCT00299156|3586858|FG000|COMPLETED|Period 1 (Non-Randomized)||32
2881733|NCT00299156|3586859|FG001|COMPLETED|Period 1 (Non-Randomized)||0
2881734|NCT00299156|3586860|FG002|COMPLETED|Period 1 (Non-Randomized)||0
2881735|NCT00299156|3586858|FG000|NOT COMPLETED|Period 1 (Non-Randomized)||0
2881736|NCT00299156|3586859|FG001|NOT COMPLETED|Period 1 (Non-Randomized)||0
2881737|NCT00299156|3586860|FG002|NOT COMPLETED|Period 1 (Non-Randomized)||0
2881738|NCT00299156|3586858|FG000|STARTED|Period 2 (Randomized)||0
2881739|NCT00299156|3586859|FG001|STARTED|Period 2 (Randomized)||17
2881740|NCT00299156|3586860|FG002|STARTED|Period 2 (Randomized)||16
2881741|NCT00299156|3586858|FG000|COMPLETED|Period 2 (Randomized)||0
2881742|NCT00299156|3586859|FG001|COMPLETED|Period 2 (Randomized)||16
2881743|NCT00299156|3586860|FG002|COMPLETED|Period 2 (Randomized)||16
2881744|NCT00299156|3586858|FG000|NOT COMPLETED|Period 2 (Randomized)||0
2881745|NCT00299156|3586859|FG001|NOT COMPLETED|Period 2 (Randomized)||1
2881746|NCT00299156|3586860|FG002|NOT COMPLETED|Period 2 (Randomized)||0
2881747|NCT00299182|3586875|FG000|STARTED|Overall Study||6
2881748|NCT00299182|3586876|FG001|STARTED|Overall Study||4
2881749|NCT00299182|3586877|FG002|STARTED|Overall Study||6
2881750|NCT00299182|3586878|FG003|STARTED|Overall Study||14
2881751|NCT00299182|3586879|FG004|STARTED|Overall Study||8
2881752|NCT00299182|3586880|FG005|STARTED|Overall Study||7
2881753|NCT00299182|3586881|FG006|STARTED|Overall Study||5
2881754|NCT00299182|3586875|FG000|COMPLETED|Overall Study||6
2881755|NCT00299182|3586876|FG001|COMPLETED|Overall Study||4
2881756|NCT00299182|3586877|FG002|COMPLETED|Overall Study||4
2881757|NCT00299182|3586878|FG003|COMPLETED|Overall Study||14
2881758|NCT00299182|3586879|FG004|COMPLETED|Overall Study||5
2881759|NCT00299182|3586880|FG005|COMPLETED|Overall Study||4
2881760|NCT00299182|3586881|FG006|COMPLETED|Overall Study||4
2881761|NCT00299182|3586875|FG000|NOT COMPLETED|Overall Study||0
2881762|NCT00299182|3586876|FG001|NOT COMPLETED|Overall Study||0
2881763|NCT00299182|3586877|FG002|NOT COMPLETED|Overall Study||2
2881764|NCT00299182|3586878|FG003|NOT COMPLETED|Overall Study||0
2881765|NCT00299182|3586879|FG004|NOT COMPLETED|Overall Study||3
2881766|NCT00299182|3586880|FG005|NOT COMPLETED|Overall Study||3
2881767|NCT00299182|3586881|FG006|NOT COMPLETED|Overall Study||1
2881768|NCT00299221|3586901|FG000|STARTED|Overall Study||79
2881769|NCT00299221|3586902|FG001|STARTED|Overall Study||71
2881770|NCT00299221|3586901|FG000|COMPLETED|Overall Study||79
2881771|NCT00299221|3586902|FG001|COMPLETED|Overall Study||71
3170108|NCT01928394|3897416|FG010|STARTED|Follow-up Period||30
3170109|NCT01928394|3897417|FG011|STARTED|Follow-up Period||81
3170110|NCT01928394|3897418|FG012|STARTED|Follow-up Period||61
3170111|NCT01928394|3897419|FG013|STARTED|Follow-up Period||145
3170112|NCT01928394|3897420|FG014|STARTED|Follow-up Period||96
3170113|NCT01928394|3897421|FG015|STARTED|Follow-up Period||3
2881772|NCT00299221|3586901|FG000|NOT COMPLETED|Overall Study||0
2881773|NCT00299221|3586902|FG001|NOT COMPLETED|Overall Study||0
2881774|NCT00299416|3586908|FG000|STARTED|Overall Study||30
2881775|NCT00299416|3586908|FG000|COMPLETED|Overall Study||30
2881776|NCT00299416|3586908|FG000|NOT COMPLETED|Overall Study||0
2881777|NCT00299494|3586918|FG000|STARTED|Overall Study||5
2881778|NCT00299494|3586919|FG001|STARTED|Overall Study||3
2881779|NCT00299494|3586920|FG002|STARTED|Overall Study||7
2881780|NCT00299494|3586921|FG003|STARTED|Overall Study||34
2881781|NCT00299494|3586922|FG004|STARTED|Overall Study|1 participant received rituximab only, and did not receive inotuzumab ozogamicin|40
2881782|NCT00299494|3586923|FG005|STARTED|Overall Study||30
2881783|NCT00299494|3586918|FG000|COMPLETED|Overall Study||2
2881784|NCT00299494|3586919|FG001|COMPLETED|Overall Study||2
2881785|NCT00299494|3586920|FG002|COMPLETED|Overall Study||3
2881786|NCT00299494|3586921|FG003|COMPLETED|Overall Study||24
2881787|NCT00299494|3586922|FG004|COMPLETED|Overall Study||13
2881788|NCT00299494|3586923|FG005|COMPLETED|Overall Study||4
2881789|NCT00299494|3586918|FG000|NOT COMPLETED|Overall Study||3
2881790|NCT00299494|3586919|FG001|NOT COMPLETED|Overall Study||1
2881791|NCT00299494|3586920|FG002|NOT COMPLETED|Overall Study||4
2881792|NCT00299494|3586921|FG003|NOT COMPLETED|Overall Study||10
2881793|NCT00299494|3586922|FG004|NOT COMPLETED|Overall Study||27
2881794|NCT00299494|3586923|FG005|NOT COMPLETED|Overall Study||26
2881795|NCT00299546|3586951|FG000|STARTED|Overall Study||155
2881796|NCT00299546|3586952|FG001|STARTED|Overall Study||153
2881797|NCT00299546|3586953|FG002|STARTED|Overall Study||153
2881798|NCT00299546|3586951|FG000|COMPLETED|Overall Study||55
2881799|NCT00299546|3586952|FG001|COMPLETED|Overall Study||61
2881800|NCT00299546|3586953|FG002|COMPLETED|Overall Study||67
2881801|NCT00299546|3586951|FG000|NOT COMPLETED|Overall Study||100
2881802|NCT00299546|3586952|FG001|NOT COMPLETED|Overall Study||92
2881803|NCT00299546|3586953|FG002|NOT COMPLETED|Overall Study||86
2881804|NCT00299689|3586962|FG000|STARTED|Overall Study||69
2881805|NCT00299689|3586962|FG000|COMPLETED|Overall Study||69
2881806|NCT00299689|3586962|FG000|NOT COMPLETED|Overall Study||0
2881807|NCT00299702|3586968|FG000|STARTED|Overall Study||179
2881808|NCT00299702|3586969|FG001|STARTED|Overall Study||176
2881809|NCT00299702|3586968|FG000|COMPLETED|Overall Study||126
2881810|NCT00299702|3586969|FG001|COMPLETED|Overall Study||126
2881811|NCT00299702|3586968|FG000|NOT COMPLETED|Overall Study||53
2881812|NCT00299702|3586969|FG001|NOT COMPLETED|Overall Study||50
2881813|NCT00299741|3586975|FG000|STARTED|Overall Study||36
2881814|NCT00299741|3586975|FG000|COMPLETED|Overall Study||36
2881815|NCT00299741|3586975|FG000|NOT COMPLETED|Overall Study||0
2881816|NCT00299975|3586982|FG000|STARTED|Overall Study||32
2881817|NCT00299975|3586983|FG001|STARTED|Overall Study||32
2881818|NCT00299975|3586984|FG002|STARTED|Overall Study||33
2881819|NCT00299975|3586982|FG000|Received Allocated Intervention|Overall Study||32
2881820|NCT00299975|3586983|FG001|Received Allocated Intervention|Overall Study||32
2881821|NCT00299975|3586984|FG002|Received Allocated Intervention|Overall Study||32
2881822|NCT00299975|3586982|FG000|COMPLETED|Overall Study||29
2881823|NCT00299975|3586983|FG001|COMPLETED|Overall Study||31
2881824|NCT00299975|3586984|FG002|COMPLETED|Overall Study||25
2881825|NCT00299975|3586982|FG000|NOT COMPLETED|Overall Study||3
2881826|NCT00299975|3586983|FG001|NOT COMPLETED|Overall Study||1
2881827|NCT00299975|3586984|FG002|NOT COMPLETED|Overall Study||8
2881828|NCT00299988|3586994|FG000|STARTED|Overall Study||16
2881829|NCT00299988|3586995|FG001|STARTED|Overall Study||8
2881830|NCT00299988|3586994|FG000|COMPLETED|Overall Study||16
2881831|NCT00299988|3586995|FG001|COMPLETED|Overall Study||8
2881832|NCT00299988|3586994|FG000|NOT COMPLETED|Overall Study||0
2881833|NCT00299988|3586995|FG001|NOT COMPLETED|Overall Study||0
2881834|NCT00300053|3587005|FG000|STARTED|Overall Study|started = randomized and treated/injected|55
2881835|NCT00300053|3587006|FG001|STARTED|Overall Study|started = randomized and treated/injected|56
2881836|NCT00300053|3587007|FG002|STARTED|Overall Study|started = randomized and treated/injected|56
2881837|NCT00300053|3587005|FG000|3-Month Evaluation|Overall Study||55
2881838|NCT00300053|3587006|FG001|3-Month Evaluation|Overall Study||56
2881839|NCT00300053|3587007|FG002|3-Month Evaluation|Overall Study||54
2881840|NCT00300053|3587005|FG000|6-Month Evaluation|Overall Study||54
2881841|NCT00300053|3587006|FG001|6-Month Evaluation|Overall Study||55
2881842|NCT00300053|3587007|FG002|6-Month Evaluation|Overall Study||53
2881843|NCT00300053|3587005|FG000|COMPLETED|Overall Study||53
2881844|NCT00300053|3587006|FG001|COMPLETED|Overall Study||53
2881845|NCT00300053|3587007|FG002|COMPLETED|Overall Study||50
2881846|NCT00300053|3587005|FG000|NOT COMPLETED|Overall Study||2
2881847|NCT00300053|3587006|FG001|NOT COMPLETED|Overall Study||3
2881848|NCT00300053|3587007|FG002|NOT COMPLETED|Overall Study||6
2881849|NCT00300235|3587021|FG000|STARTED|Overall Study||208
2881850|NCT00300235|3587022|FG001|STARTED|Overall Study||240
2881851|NCT00300235|3587023|FG002|STARTED|Overall Study||398
2881852|NCT00300235|3587024|FG003|STARTED|Overall Study||362
2881853|NCT00300235|3587025|FG004|STARTED|Overall Study||251
2881854|NCT00300235|3587021|FG000|COMPLETED|Overall Study||208
2881855|NCT00300235|3587022|FG001|COMPLETED|Overall Study||240
2881856|NCT00300235|3587023|FG002|COMPLETED|Overall Study||398
2881857|NCT00300235|3587024|FG003|COMPLETED|Overall Study||362
2881858|NCT00300235|3587025|FG004|COMPLETED|Overall Study||251
2881859|NCT00300235|3587021|FG000|NOT COMPLETED|Overall Study||0
2881860|NCT00300235|3587022|FG001|NOT COMPLETED|Overall Study||0
2881861|NCT00300235|3587023|FG002|NOT COMPLETED|Overall Study||0
2881862|NCT00300235|3587024|FG003|NOT COMPLETED|Overall Study||0
2881863|NCT00300235|3587025|FG004|NOT COMPLETED|Overall Study||0
2881864|NCT00300274|3587040|FG000|STARTED|Overall Study||282
2881865|NCT00300274|3587041|FG001|STARTED|Overall Study||168
2881866|NCT00300274|3587042|FG002|STARTED|Overall Study||271
2881867|NCT00300274|3587040|FG000|Completed 12 Month|Overall Study||250
2881868|NCT00300274|3587041|FG001|Completed 12 Month|Overall Study||149
2881869|NCT00300274|3587042|FG002|Completed 12 Month|Overall Study||248
2881870|NCT00300274|3587040|FG000|COMPLETED|Overall Study||236
2881871|NCT00300274|3587041|FG001|COMPLETED|Overall Study||141
2881872|NCT00300274|3587042|FG002|COMPLETED|Overall Study||226
2881873|NCT00300274|3587040|FG000|NOT COMPLETED|Overall Study||46
2881874|NCT00300274|3587041|FG001|NOT COMPLETED|Overall Study||27
2881875|NCT00300274|3587042|FG002|NOT COMPLETED|Overall Study||45
2881876|NCT00300365|3587052|FG000|STARTED|Overall Study||38
2881877|NCT00300365|3587053|FG001|STARTED|Overall Study||40
2881878|NCT00300365|3587052|FG000|COMPLETED|Overall Study||34
2881879|NCT00300365|3587053|FG001|COMPLETED|Overall Study||38
2881880|NCT00300365|3587052|FG000|NOT COMPLETED|Overall Study||4
2881881|NCT00300365|3587053|FG001|NOT COMPLETED|Overall Study||2
2881882|NCT00300391|3587061|FG000|STARTED|Overall Study||16
2881883|NCT00300391|3587062|FG001|STARTED|Overall Study||14
2881884|NCT00300391|3587061|FG000|COMPLETED|Overall Study||16
2881885|NCT00300391|3587062|FG001|COMPLETED|Overall Study||14
2881886|NCT00300391|3587061|FG000|NOT COMPLETED|Overall Study||0
2881887|NCT00300391|3587062|FG001|NOT COMPLETED|Overall Study||0
2881888|NCT00300430|3587072|FG000|STARTED|Overall Study|"Started = received combo therapy in double-blind and/or open-label study."|1186
2881889|NCT00300430|3587073|FG001|STARTED|Overall Study|"Started = received combo therapy in double-blind and/or open-label study."|514
2881890|NCT00300430|3587074|FG002|STARTED|Overall Study|"Started = received combo therapy in double-blind and/or open-label study."|501
2881891|NCT00300430|3587072|FG000|COMPLETED|Overall Study|"Completed = completed both the double-blind and open-label studies."|819
2881892|NCT00300430|3587073|FG001|COMPLETED|Overall Study|"Completed = completed both the double-blind and open-label studies."|345
2881893|NCT00300430|3587074|FG002|COMPLETED|Overall Study|"Completed = completed both the double-blind and open-label studies."|350
2881894|NCT00300430|3587072|FG000|NOT COMPLETED|Overall Study||367
2881895|NCT00300430|3587073|FG001|NOT COMPLETED|Overall Study||169
2881896|NCT00300430|3587074|FG002|NOT COMPLETED|Overall Study||151
2881897|NCT00300456|3587088|FG000|STARTED|Overall Study|"For all arms, started means treated."|119
2881898|NCT00300456|3587089|FG001|STARTED|Overall Study||118
2881899|NCT00300456|3587090|FG002|STARTED|Overall Study||119
2881900|NCT00300456|3587091|FG003|STARTED|Overall Study||119
2881901|NCT00300456|3587092|FG004|STARTED|Overall Study||116
2881902|NCT00300456|3587093|FG005|STARTED|Overall Study||59
2881903|NCT00300456|3587088|FG000|COMPLETED|Overall Study||103
2881904|NCT00300456|3587089|FG001|COMPLETED|Overall Study||102
2881905|NCT00300456|3587090|FG002|COMPLETED|Overall Study||98
2881906|NCT00300456|3587091|FG003|COMPLETED|Overall Study||105
2881907|NCT00300456|3587092|FG004|COMPLETED|Overall Study||99
2881908|NCT00300456|3587093|FG005|COMPLETED|Overall Study||48
2881909|NCT00300456|3587088|FG000|NOT COMPLETED|Overall Study||16
2881910|NCT00300456|3587089|FG001|NOT COMPLETED|Overall Study||16
2881911|NCT00300456|3587090|FG002|NOT COMPLETED|Overall Study||21
2881912|NCT00300456|3587091|FG003|NOT COMPLETED|Overall Study||14
2881913|NCT00300456|3587092|FG004|NOT COMPLETED|Overall Study||17
2881914|NCT00300456|3587093|FG005|NOT COMPLETED|Overall Study||11
2881915|NCT00300469|3587113|FG000|STARTED|Overall Study|"For all arms, started means treated."|110
2881916|NCT00300469|3587114|FG001|STARTED|Overall Study||110
2881917|NCT00300469|3587115|FG002|STARTED|Overall Study||112
2881918|NCT00300469|3587116|FG003|STARTED|Overall Study||113
2881919|NCT00300469|3587117|FG004|STARTED|Overall Study||109
2881920|NCT00300469|3587118|FG005|STARTED|Overall Study||55
2881921|NCT00300469|3587113|FG000|COMPLETED|Overall Study||89
2881922|NCT00300469|3587114|FG001|COMPLETED|Overall Study||89
2881923|NCT00300469|3587115|FG002|COMPLETED|Overall Study||95
2881924|NCT00300469|3587116|FG003|COMPLETED|Overall Study||104
2881925|NCT00300469|3587117|FG004|COMPLETED|Overall Study||95
2881926|NCT00300469|3587118|FG005|COMPLETED|Overall Study||46
2881927|NCT00300469|3587113|FG000|NOT COMPLETED|Overall Study||21
2881928|NCT00300469|3587114|FG001|NOT COMPLETED|Overall Study||21
2881929|NCT00300469|3587115|FG002|NOT COMPLETED|Overall Study||17
2881930|NCT00300469|3587116|FG003|NOT COMPLETED|Overall Study||9
2881931|NCT00300469|3587117|FG004|NOT COMPLETED|Overall Study||14
2881932|NCT00300469|3587118|FG005|NOT COMPLETED|Overall Study||9
2881933|NCT00300482|3587138|FG000|STARTED|Overall Study|"For all arms, started means treated."|261
2881934|NCT00300482|3587139|FG001|STARTED|Overall Study||261
2881935|NCT00300482|3587140|FG002|STARTED|Overall Study||259
2881936|NCT00300482|3587141|FG003|STARTED|Overall Study||261
2881937|NCT00300482|3587142|FG004|STARTED|Overall Study||266
2881938|NCT00300482|3587143|FG005|STARTED|Overall Study||131
2881939|NCT00300482|3587138|FG000|COMPLETED|Overall Study||220
2881940|NCT00300482|3587139|FG001|COMPLETED|Overall Study||220
2881941|NCT00300482|3587140|FG002|COMPLETED|Overall Study||208
2881942|NCT00300482|3587141|FG003|COMPLETED|Overall Study||237
2881943|NCT00300482|3587142|FG004|COMPLETED|Overall Study||243
2881944|NCT00300482|3587143|FG005|COMPLETED|Overall Study||115
2881945|NCT00300482|3587138|FG000|NOT COMPLETED|Overall Study||41
2881946|NCT00300482|3587139|FG001|NOT COMPLETED|Overall Study||41
2881947|NCT00300482|3587140|FG002|NOT COMPLETED|Overall Study||51
2881948|NCT00300482|3587141|FG003|NOT COMPLETED|Overall Study||24
2881949|NCT00300482|3587142|FG004|NOT COMPLETED|Overall Study||23
2881950|NCT00300482|3587143|FG005|NOT COMPLETED|Overall Study||16
2881951|NCT00300495|3587159|FG000|STARTED|Overall Study||10
2881952|NCT00300495|3587160|FG001|STARTED|Overall Study||9
2881953|NCT00300495|3587159|FG000|COMPLETED|Overall Study||6
2881954|NCT00300495|3587160|FG001|COMPLETED|Overall Study||8
2881955|NCT00300495|3587159|FG000|NOT COMPLETED|Overall Study||4
2881956|NCT00300495|3587160|FG001|NOT COMPLETED|Overall Study||1
2881957|NCT00300677|3587166|FG000|STARTED|Overall Study||12
2881958|NCT00300677|3587166|FG000|COMPLETED|Overall Study||12
2881959|NCT00300677|3587166|FG000|NOT COMPLETED|Overall Study||0
2881960|NCT00300742|3587170|FG000|STARTED|Overall Study||5
2881961|NCT00300742|3587170|FG000|COMPLETED|Overall Study||3
2881962|NCT00300742|3587170|FG000|NOT COMPLETED|Overall Study||2
2881963|NCT00300755|3587178|FG000|STARTED|Overall Study||18
2881964|NCT00300755|3587179|FG001|STARTED|Overall Study||21
2881965|NCT00300755|3587180|FG002|STARTED|Overall Study||21
2881966|NCT00300755|3587178|FG000|COMPLETED|Overall Study||17
2881967|NCT00300755|3587179|FG001|COMPLETED|Overall Study||17
2881968|NCT00300755|3587180|FG002|COMPLETED|Overall Study||19
2881969|NCT00300755|3587178|FG000|NOT COMPLETED|Overall Study||1
2881970|NCT00300755|3587179|FG001|NOT COMPLETED|Overall Study||4
2881971|NCT00300755|3587180|FG002|NOT COMPLETED|Overall Study||2
2881972|NCT00300781|3587190|FG000|STARTED|Overall Study||66
2881973|NCT00300781|3587191|FG001|STARTED|Overall Study||70
2881974|NCT00300781|3587190|FG000|COMPLETED|Overall Study||3
2881975|NCT00300781|3587191|FG001|COMPLETED|Overall Study||8
2881976|NCT00300781|3587190|FG000|NOT COMPLETED|Overall Study||63
2881977|NCT00300781|3587191|FG001|NOT COMPLETED|Overall Study||62
2881978|NCT00300885|3587199|FG000|STARTED|Treatment||464
2881979|NCT00300885|3587200|FG001|STARTED|Treatment|ongoing in double -blind treatment at data cut-off|462
2881980|NCT00300885|3587199|FG000|Received Treatment|Treatment||463
2881981|NCT00300885|3587200|FG001|Received Treatment|Treatment||459
2881982|NCT00300885|3587199|FG000|COMPLETED|Treatment||91
2881983|NCT00300885|3587200|FG001|COMPLETED|Treatment||88
2881984|NCT00300885|3587199|FG000|NOT COMPLETED|Treatment||373
2881985|NCT00300885|3587200|FG001|NOT COMPLETED|Treatment||374
2881986|NCT00300885|3587199|FG000|STARTED|Follow-up|Subjects entered Follow-up period after termination of Treatment period due to any reason.|354
2881987|NCT00300885|3587200|FG001|STARTED|Follow-up|Subjects entered Follow-up period after termination of Treatment period due to any reason.|369
2881988|NCT00300885|3587199|FG000|COMPLETED|Follow-up|Subjects still in Follow up period at data cut-off date.|176
2881989|NCT00300885|3587200|FG001|COMPLETED|Follow-up|Subjects still in Follow up period at data cut-off date.|174
2881990|NCT00300885|3587199|FG000|NOT COMPLETED|Follow-up||178
2881991|NCT00300885|3587200|FG001|NOT COMPLETED|Follow-up||195
2881992|NCT00301028|3587206|FG000|STARTED|Overall Study||47
2881993|NCT00301028|3587206|FG000|COMPLETED|Overall Study||47
2881994|NCT00301028|3587206|FG000|NOT COMPLETED|Overall Study||0
2881995|NCT00301067|3587210|FG000|STARTED|Completed DLT Period/1st Cycle||4
2881996|NCT00301067|3587211|FG001|STARTED|Completed DLT Period/1st Cycle||3
2881997|NCT00301067|3587212|FG002|STARTED|Completed DLT Period/1st Cycle||3
2881998|NCT00301067|3587213|FG003|STARTED|Completed DLT Period/1st Cycle|Patients did not participate in the DLT portion of the trial, they completed 1st cycle of treatment.|10
2881999|NCT00301067|3587210|FG000|COMPLETED|Completed DLT Period/1st Cycle||3
2882000|NCT00301067|3587211|FG001|COMPLETED|Completed DLT Period/1st Cycle||3
2882001|NCT00301067|3587212|FG002|COMPLETED|Completed DLT Period/1st Cycle||3
2882002|NCT00301067|3587213|FG003|COMPLETED|Completed DLT Period/1st Cycle||9
2882003|NCT00301067|3587210|FG000|NOT COMPLETED|Completed DLT Period/1st Cycle||1
2882004|NCT00301067|3587211|FG001|NOT COMPLETED|Completed DLT Period/1st Cycle||0
2882005|NCT00301067|3587212|FG002|NOT COMPLETED|Completed DLT Period/1st Cycle||0
2882006|NCT00301067|3587213|FG003|NOT COMPLETED|Completed DLT Period/1st Cycle||1
2882007|NCT00301067|3587210|FG000|STARTED|Reached 1st Response/2 Cycles||3
2882008|NCT00301067|3587211|FG001|STARTED|Reached 1st Response/2 Cycles||3
2882009|NCT00301067|3587212|FG002|STARTED|Reached 1st Response/2 Cycles||3
2882010|NCT00301067|3587213|FG003|STARTED|Reached 1st Response/2 Cycles||9
2882011|NCT00301067|3587210|FG000|COMPLETED|Reached 1st Response/2 Cycles||1
2882012|NCT00301067|3587211|FG001|COMPLETED|Reached 1st Response/2 Cycles||2
2882013|NCT00301067|3587212|FG002|COMPLETED|Reached 1st Response/2 Cycles||2
2882014|NCT00301067|3587213|FG003|COMPLETED|Reached 1st Response/2 Cycles||7
2882015|NCT00301067|3587210|FG000|NOT COMPLETED|Reached 1st Response/2 Cycles||2
2882016|NCT00301067|3587211|FG001|NOT COMPLETED|Reached 1st Response/2 Cycles||1
2882017|NCT00301067|3587212|FG002|NOT COMPLETED|Reached 1st Response/2 Cycles||1
2882018|NCT00301067|3587213|FG003|NOT COMPLETED|Reached 1st Response/2 Cycles||2
2882019|NCT00301067|3587210|FG000|STARTED|Completed 4 Cycles of Treatment||1
2882020|NCT00301067|3587211|FG001|STARTED|Completed 4 Cycles of Treatment||2
2882021|NCT00301067|3587212|FG002|STARTED|Completed 4 Cycles of Treatment||2
2882022|NCT00301067|3587213|FG003|STARTED|Completed 4 Cycles of Treatment||7
2882023|NCT00301067|3587210|FG000|COMPLETED|Completed 4 Cycles of Treatment||0
2882024|NCT00301067|3587211|FG001|COMPLETED|Completed 4 Cycles of Treatment||1
2882025|NCT00301067|3587212|FG002|COMPLETED|Completed 4 Cycles of Treatment||0
2882026|NCT00301067|3587213|FG003|COMPLETED|Completed 4 Cycles of Treatment||2
2882027|NCT00301067|3587210|FG000|NOT COMPLETED|Completed 4 Cycles of Treatment||1
2882028|NCT00301067|3587211|FG001|NOT COMPLETED|Completed 4 Cycles of Treatment||1
2882029|NCT00301067|3587212|FG002|NOT COMPLETED|Completed 4 Cycles of Treatment||2
2882030|NCT00301067|3587213|FG003|NOT COMPLETED|Completed 4 Cycles of Treatment||5
2882031|NCT00301067|3587210|FG000|STARTED|Completed 12 Cycles of Treatment||0
2882032|NCT00301067|3587211|FG001|STARTED|Completed 12 Cycles of Treatment||1
2882033|NCT00301067|3587212|FG002|STARTED|Completed 12 Cycles of Treatment||0
2882034|NCT00301067|3587213|FG003|STARTED|Completed 12 Cycles of Treatment||2
2882035|NCT00301067|3587210|FG000|COMPLETED|Completed 12 Cycles of Treatment||0
2882036|NCT00301067|3587211|FG001|COMPLETED|Completed 12 Cycles of Treatment||0
2882037|NCT00301067|3587212|FG002|COMPLETED|Completed 12 Cycles of Treatment||0
2882038|NCT00301067|3587213|FG003|COMPLETED|Completed 12 Cycles of Treatment||0
2882039|NCT00301067|3587210|FG000|NOT COMPLETED|Completed 12 Cycles of Treatment||0
2882040|NCT00301067|3587211|FG001|NOT COMPLETED|Completed 12 Cycles of Treatment||1
2882041|NCT00301067|3587212|FG002|NOT COMPLETED|Completed 12 Cycles of Treatment||0
2882042|NCT00301067|3587213|FG003|NOT COMPLETED|Completed 12 Cycles of Treatment||2
2882043|NCT00301067|3587210|FG000|STARTED|Follow up Until Death||4
2882044|NCT00301067|3587211|FG001|STARTED|Follow up Until Death||3
2882045|NCT00301067|3587212|FG002|STARTED|Follow up Until Death||3
2882046|NCT00301067|3587213|FG003|STARTED|Follow up Until Death||3
2882047|NCT00301067|3587210|FG000|COMPLETED|Follow up Until Death||3
2882048|NCT00301067|3587211|FG001|COMPLETED|Follow up Until Death||3
2882049|NCT00301067|3587212|FG002|COMPLETED|Follow up Until Death||3
2882050|NCT00301067|3587213|FG003|COMPLETED|Follow up Until Death||2
2882051|NCT00301067|3587210|FG000|NOT COMPLETED|Follow up Until Death||1
2882052|NCT00301067|3587211|FG001|NOT COMPLETED|Follow up Until Death||0
2882053|NCT00301067|3587212|FG002|NOT COMPLETED|Follow up Until Death||0
2882054|NCT00301067|3587213|FG003|NOT COMPLETED|Follow up Until Death||1
2882055|NCT00301366|3587224|FG000|STARTED|Overall Study||38
2882056|NCT00301366|3587224|FG000|COMPLETED|Overall Study||37
2882057|NCT00301366|3587224|FG000|NOT COMPLETED|Overall Study||1
2882058|NCT00301418|3587228|FG000|STARTED|Overall Study||11
2882059|NCT00301418|3587228|FG000|COMPLETED|Overall Study||11
2882060|NCT00301418|3587228|FG000|NOT COMPLETED|Overall Study||0
2882061|NCT00301756|3587232|FG000|STARTED|Overall Study||32
2882062|NCT00301756|3587232|FG000|COMPLETED|Overall Study||32
2882063|NCT00301756|3587232|FG000|NOT COMPLETED|Overall Study||0
2882064|NCT00301808|3587238|FG000|STARTED|Overall Study||29
2882065|NCT00301808|3587238|FG000|COMPLETED|Overall Study||17
2882066|NCT00301808|3587238|FG000|NOT COMPLETED|Overall Study||12
2919431|NCT00531752|3629813|FG002|COMPLETED|Second Double-blind Intervention Period||9
2919432|NCT00531752|3629814|FG003|COMPLETED|Second Double-blind Intervention Period||11
2919433|NCT00531752|3629811|FG000|NOT COMPLETED|Second Double-blind Intervention Period||2
2919434|NCT00531752|3629812|FG001|NOT COMPLETED|Second Double-blind Intervention Period||2
2919435|NCT00531752|3629813|FG002|NOT COMPLETED|Second Double-blind Intervention Period||0
2919436|NCT00531752|3629814|FG003|NOT COMPLETED|Second Double-blind Intervention Period||2
2919437|NCT00531817|3629824|FG000|STARTED|Randomized||412
2919438|NCT00531817|3629825|FG001|STARTED|Randomized||207
2919439|NCT00531817|3629824|FG000|Received Study Drug in Core Study|Randomized|3 patients did not receive any study medication. Intent-to-treat population = 409.|409
2919440|NCT00531817|3629825|FG001|Received Study Drug in Core Study|Randomized|2 patients did not receive any study medication. Intent-to-treat population = 205.|205
2919441|NCT00531817|3629824|FG000|COMPLETED|Randomized||353
2919442|NCT00531817|3629825|FG001|COMPLETED|Randomized||173
2919443|NCT00531817|3629824|FG000|NOT COMPLETED|Randomized||59
2919444|NCT00531817|3629825|FG001|NOT COMPLETED|Randomized||34
2919445|NCT00531817|3629824|FG000|STARTED|Entered Extended Treatment Period|Eligible patients completing core study could participate in extension at investigator's discretion.|343
2919446|NCT00531817|3629825|FG001|STARTED|Entered Extended Treatment Period|Eligible patients completing core study could participate in extension at investigator's discretion.|170
2919447|NCT00531817|3629824|FG000|COMPLETED|Entered Extended Treatment Period||206
2919448|NCT00531817|3629825|FG001|COMPLETED|Entered Extended Treatment Period||113
2919449|NCT00531817|3629824|FG000|NOT COMPLETED|Entered Extended Treatment Period||137
2919450|NCT00531817|3629825|FG001|NOT COMPLETED|Entered Extended Treatment Period||57
2919451|NCT00531843|3629834|FG000|STARTED|Overall Study||81
2919452|NCT00531843|3629835|FG001|STARTED|Overall Study||6
2919453|NCT00531843|3629834|FG000|COMPLETED|Overall Study||81
2919454|NCT00531843|3629835|FG001|COMPLETED|Overall Study||6
2919455|NCT00531843|3629834|FG000|NOT COMPLETED|Overall Study||0
2919456|NCT00531843|3629835|FG001|NOT COMPLETED|Overall Study||0
2920786|NCT00538785|3631361|FG000|STARTED|Overall Study|A subject was randomized without appropriate consent in France and is not included in the results.|623
2920787|NCT00538785|3631362|FG001|STARTED|Overall Study||612
2920788|NCT00538785|3631361|FG000|COMPLETED|Overall Study||604
2920789|NCT00538785|3631362|FG001|COMPLETED|Overall Study||595
2920790|NCT00538785|3631361|FG000|NOT COMPLETED|Overall Study||19
2920791|NCT00538785|3631362|FG001|NOT COMPLETED|Overall Study||17
2920792|NCT00538824|3631368|FG000|STARTED|Overall Study||5
2920793|NCT00538824|3631368|FG000|Progression of Disease|Overall Study||2
2920794|NCT00538824|3631368|FG000|COMPLETED|Overall Study||5
2920795|NCT00538824|3631368|FG000|NOT COMPLETED|Overall Study||0
2920796|NCT00538850|3631372|FG000|STARTED|Titration Period||130
2920797|NCT00538850|3631373|FG001|STARTED|Titration Period|There were no participants in this reporting group in the titration period.|0
2920798|NCT00538850|3631374|FG002|STARTED|Titration Period|There were no participants in this reporting group in the titration period.|0
2920799|NCT00538850|3631372|FG000|COMPLETED|Titration Period||98
2920800|NCT00538850|3631373|FG001|COMPLETED|Titration Period||0
2920801|NCT00538850|3631374|FG002|COMPLETED|Titration Period||0
2882067|NCT00301821|3587242|FG000|STARTED|Overall Study||107
2882068|NCT00301821|3587242|FG000|COMPLETED|Overall Study||81
2882069|NCT00301821|3587242|FG000|NOT COMPLETED|Overall Study||26
2882070|NCT00301834|3587246|FG000|STARTED|Overall Study||35
2882071|NCT00301834|3587246|FG000|COMPLETED|Overall Study||34
2882072|NCT00301834|3587246|FG000|NOT COMPLETED|Overall Study||1
2882073|NCT00301873|3587253|FG000|STARTED|Overall Study||59
2882074|NCT00301873|3587253|FG000|COMPLETED|Overall Study||59
2882075|NCT00301873|3587253|FG000|NOT COMPLETED|Overall Study||0
2882076|NCT00301964|3587257|FG000|STARTED|Overall Study||56
2882077|NCT00301964|3587257|FG000|COMPLETED|Overall Study|Total number of eligible and evaluable participants|52
2882078|NCT00301964|3587257|FG000|NOT COMPLETED|Overall Study||4
2882079|NCT00302003|3587267|FG000|STARTED|Overall Study||287
2882080|NCT00302003|3587267|FG000|COMPLETED|Overall Study||207
2882081|NCT00302003|3587267|FG000|NOT COMPLETED|Overall Study||80
2882082|NCT00302042|3587273|FG000|STARTED|Overall Study||46
2882083|NCT00302042|3587274|FG001|STARTED|Overall Study||46
2882084|NCT00302042|3587273|FG000|COMPLETED|Overall Study||39
2882085|NCT00302042|3587274|FG001|COMPLETED|Overall Study||38
2882086|NCT00302042|3587273|FG000|NOT COMPLETED|Overall Study||7
2882087|NCT00302042|3587274|FG001|NOT COMPLETED|Overall Study||8
2882088|NCT00302055|3587282|FG000|STARTED|Overall Study||23
2882089|NCT00302055|3587283|FG001|STARTED|Overall Study||49
2882090|NCT00302055|3587282|FG000|COMPLETED|Overall Study||14
2882091|NCT00302055|3587283|FG001|COMPLETED|Overall Study||36
2882092|NCT00302055|3587282|FG000|NOT COMPLETED|Overall Study||9
2882093|NCT00302055|3587283|FG001|NOT COMPLETED|Overall Study||13
2882094|NCT00302068|3587292|FG000|STARTED|Overall Study||37
2882095|NCT00302068|3587293|FG001|STARTED|Overall Study||40
2882096|NCT00302068|3587294|FG002|STARTED|Overall Study||24
2882097|NCT00302068|3587292|FG000|COMPLETED|Overall Study||36
2882098|NCT00302068|3587293|FG001|COMPLETED|Overall Study||36
2882099|NCT00302068|3587294|FG002|COMPLETED|Overall Study||23
2882100|NCT00302068|3587292|FG000|NOT COMPLETED|Overall Study||1
2882101|NCT00302068|3587293|FG001|NOT COMPLETED|Overall Study||4
2882102|NCT00302068|3587294|FG002|NOT COMPLETED|Overall Study||1
2882103|NCT00302081|3587306|FG000|STARTED|Overall Study||237
2882104|NCT00302081|3587307|FG001|STARTED|Overall Study||229
2882105|NCT00302081|3587308|FG002|STARTED|Overall Study||230
2882106|NCT00302081|3587306|FG000|COMPLETED|Overall Study||181
2882107|NCT00302081|3587307|FG001|COMPLETED|Overall Study||186
2882108|NCT00302081|3587308|FG002|COMPLETED|Overall Study||178
2882109|NCT00302081|3587306|FG000|NOT COMPLETED|Overall Study||56
2882110|NCT00302081|3587307|FG001|NOT COMPLETED|Overall Study||43
2882111|NCT00302081|3587308|FG002|NOT COMPLETED|Overall Study||52
2882112|NCT00302107|3587318|FG000|STARTED|Overall Study||39
2882113|NCT00302107|3587319|FG001|STARTED|Overall Study||39
2882114|NCT00302107|3587318|FG000|COMPLETED|Overall Study||31
2882115|NCT00302107|3587319|FG001|COMPLETED|Overall Study||30
2882116|NCT00302107|3587318|FG000|NOT COMPLETED|Overall Study||8
2882117|NCT00302107|3587319|FG001|NOT COMPLETED|Overall Study||9
2882118|NCT00302133|3587327|FG000|STARTED|Overall Study||9
2882119|NCT00302133|3587328|FG001|STARTED|Overall Study||9
2882120|NCT00302133|3587327|FG000|COMPLETED|Overall Study||5
2882121|NCT00302133|3587328|FG001|COMPLETED|Overall Study||5
2882122|NCT00302133|3587327|FG000|NOT COMPLETED|Overall Study||4
2882123|NCT00302133|3587328|FG001|NOT COMPLETED|Overall Study||4
2882124|NCT00302159|3587334|FG000|STARTED|Overall Study||43
2882125|NCT00302159|3587334|FG000|COMPLETED|Overall Study||41
2882126|NCT00302159|3587334|FG000|NOT COMPLETED|Overall Study||2
2882127|NCT00302211|3587342|FG000|STARTED|Double Blind Period (New Patients)|These subjects had the option to continue with the same dose of iloprost during the OL period|26
2882128|NCT00302211|3587343|FG001|STARTED|Double Blind Period (New Patients)|These subjects had the option to continue with the same dose of iloprost during the OL period|27
2882129|NCT00302211|3587344|FG002|STARTED|Double Blind Period (New Patients)|These subjects could receive either iloprost 4x/day or 6x/day in the OL period|14
2882130|NCT00302211|3587345|FG003|STARTED|Double Blind Period (New Patients)||0
2882131|NCT00302211|3587346|FG004|STARTED|Double Blind Period (New Patients)||0
2882132|NCT00302211|3587342|FG000|COMPLETED|Double Blind Period (New Patients)||23
2882133|NCT00302211|3587343|FG001|COMPLETED|Double Blind Period (New Patients)||25
2882134|NCT00302211|3587344|FG002|COMPLETED|Double Blind Period (New Patients)||10
3170114|NCT01928394|3897422|FG016|STARTED|Follow-up Period||55
3170115|NCT01928394|3897423|FG017|STARTED|Follow-up Period||58
2882135|NCT00302211|3587345|FG003|COMPLETED|Double Blind Period (New Patients)||0
2882136|NCT00302211|3587346|FG004|COMPLETED|Double Blind Period (New Patients)||0
2882137|NCT00302211|3587342|FG000|NOT COMPLETED|Double Blind Period (New Patients)||3
2882138|NCT00302211|3587343|FG001|NOT COMPLETED|Double Blind Period (New Patients)||2
2882139|NCT00302211|3587344|FG002|NOT COMPLETED|Double Blind Period (New Patients)||4
2882140|NCT00302211|3587345|FG003|NOT COMPLETED|Double Blind Period (New Patients)||0
2882141|NCT00302211|3587346|FG004|NOT COMPLETED|Double Blind Period (New Patients)||0
2882142|NCT00302211|3587342|FG000|STARTED|Open Label-Patients From Double-Blind||0
2882143|NCT00302211|3587343|FG001|STARTED|Open Label-Patients From Double-Blind||0
2882144|NCT00302211|3587344|FG002|STARTED|Open Label-Patients From Double-Blind||0
2882145|NCT00302211|3587345|FG003|STARTED|Open Label-Patients From Double-Blind|21 patients (pts) in 6x/day DB phase & 5 patients in placebo 6x/day DB phase enrolled in OL 6x/day|26
2882146|NCT00302211|3587346|FG004|STARTED|Open Label-Patients From Double-Blind|26 pts in 4x/day + placebo 2x/day DB phase & 6 pts in placebo 6x/day DB phase enrolled in OL 4x/day|32
3170116|NCT01928394|3897424|FG018|STARTED|Follow-up Period||92
2882147|NCT00302211|3587342|FG000|COMPLETED|Open Label-Patients From Double-Blind||0
2882148|NCT00302211|3587343|FG001|COMPLETED|Open Label-Patients From Double-Blind||0
2882149|NCT00302211|3587344|FG002|COMPLETED|Open Label-Patients From Double-Blind||0
2882150|NCT00302211|3587345|FG003|COMPLETED|Open Label-Patients From Double-Blind||18
2882151|NCT00302211|3587346|FG004|COMPLETED|Open Label-Patients From Double-Blind||24
2882152|NCT00302211|3587342|FG000|NOT COMPLETED|Open Label-Patients From Double-Blind||0
2882153|NCT00302211|3587343|FG001|NOT COMPLETED|Open Label-Patients From Double-Blind||0
2882154|NCT00302211|3587344|FG002|NOT COMPLETED|Open Label-Patients From Double-Blind||0
2882155|NCT00302211|3587345|FG003|NOT COMPLETED|Open Label-Patients From Double-Blind||8
2882156|NCT00302211|3587346|FG004|NOT COMPLETED|Open Label-Patients From Double-Blind||8
2882157|NCT00302328|3587361|FG000|STARTED|Overall Study||25
2882158|NCT00302328|3587362|FG001|STARTED|Overall Study||35
2882159|NCT00302328|3587363|FG002|STARTED|Overall Study||18
2882160|NCT00302328|3587361|FG000|COMPLETED|Overall Study||25
2882161|NCT00302328|3587362|FG001|COMPLETED|Overall Study|developed cancer during the study|34
2882162|NCT00302328|3587363|FG002|COMPLETED|Overall Study||18
2882163|NCT00302328|3587361|FG000|NOT COMPLETED|Overall Study||0
2882164|NCT00302328|3587362|FG001|NOT COMPLETED|Overall Study||1
2882165|NCT00302328|3587363|FG002|NOT COMPLETED|Overall Study||0
2882166|NCT00302458|3587374|FG000|STARTED|Overall Study||29
2882167|NCT00302458|3587374|FG000|COMPLETED|Overall Study||26
2882168|NCT00302458|3587374|FG000|NOT COMPLETED|Overall Study||3
2882169|NCT00302718|3587386|FG000|STARTED|Overall Study||20
2882170|NCT00302718|3587387|FG001|STARTED|Overall Study||21
2882171|NCT00302718|3587388|FG002|STARTED|Overall Study||21
2882172|NCT00302718|3587389|FG003|STARTED|Overall Study||21
2882173|NCT00302718|3587386|FG000|COMPLETED|Overall Study||19
2882174|NCT00302718|3587387|FG001|COMPLETED|Overall Study||20
2882175|NCT00302718|3587388|FG002|COMPLETED|Overall Study||19
2882176|NCT00302718|3587389|FG003|COMPLETED|Overall Study||19
2882177|NCT00302718|3587386|FG000|NOT COMPLETED|Overall Study||1
2882178|NCT00302718|3587387|FG001|NOT COMPLETED|Overall Study||1
2882179|NCT00302718|3587388|FG002|NOT COMPLETED|Overall Study||2
2882180|NCT00302718|3587389|FG003|NOT COMPLETED|Overall Study||2
2882181|NCT00302731|3587408|FG000|STARTED|Overall Study||6
2882182|NCT00302731|3587409|FG001|STARTED|Overall Study||6
2882183|NCT00302731|3587410|FG002|STARTED|Overall Study||5
2882184|NCT00302731|3587411|FG003|STARTED|Overall Study||4
2882185|NCT00302731|3587408|FG000|COMPLETED|Overall Study||2
2882186|NCT00302731|3587409|FG001|COMPLETED|Overall Study||1
2882187|NCT00302731|3587410|FG002|COMPLETED|Overall Study||2
2882188|NCT00302731|3587411|FG003|COMPLETED|Overall Study||4
2882189|NCT00302731|3587408|FG000|NOT COMPLETED|Overall Study||4
2882190|NCT00302731|3587409|FG001|NOT COMPLETED|Overall Study||5
2882191|NCT00302731|3587410|FG002|NOT COMPLETED|Overall Study||3
2882192|NCT00302731|3587411|FG003|NOT COMPLETED|Overall Study||0
2882193|NCT00302848|3587424|FG000|STARTED|Overall Study||16534
2882194|NCT00302848|3587425|FG001|STARTED|Overall Study||15428
2882195|NCT00302848|3587426|FG002|STARTED|Overall Study||26341
2882196|NCT00302848|3587424|FG000|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 1.5 and 5.0 years.|16133
2882197|NCT00302848|3587425|FG001|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 1.5 and 5.0 years.|15009
2882198|NCT00302848|3587426|FG002|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 1.5 and 5.0 years.|25762
2882199|NCT00302848|3587424|FG000|NOT COMPLETED|Overall Study||401
2882200|NCT00302848|3587425|FG001|NOT COMPLETED|Overall Study||419
2882201|NCT00302848|3587426|FG002|NOT COMPLETED|Overall Study||579
2882202|NCT00302952|3587435|FG000|STARTED|Overall Study||34
2882203|NCT00302952|3587436|FG001|STARTED|Overall Study||30
2882204|NCT00302952|3587435|FG000|Started Intent-to-Treat (ITT)|Overall Study||34
2882205|NCT00302952|3587436|FG001|Started Intent-to-Treat (ITT)|Overall Study||30
2882206|NCT00302952|3587435|FG000|Completed Intent-to-Treat (ITT)|Overall Study||34
2882207|NCT00302952|3587436|FG001|Completed Intent-to-Treat (ITT)|Overall Study|One participant did not have a baseline C-reactive Protein and was excluded from the ITT population.|29
2882208|NCT00302952|3587435|FG000|COMPLETED|Overall Study||31
2882209|NCT00302952|3587436|FG001|COMPLETED|Overall Study||25
2882210|NCT00302952|3587435|FG000|NOT COMPLETED|Overall Study||3
2882211|NCT00302952|3587436|FG001|NOT COMPLETED|Overall Study||5
2882212|NCT00303069|3587446|FG000|STARTED|Overall Study||31
2882213|NCT00303069|3587447|FG001|STARTED|Overall Study||28
2882214|NCT00303069|3587448|FG002|STARTED|Overall Study||34
2882215|NCT00303069|3587449|FG003|STARTED|Overall Study||31
2882216|NCT00303069|3587446|FG000|COMPLETED|Overall Study||29
2882217|NCT00303069|3587447|FG001|COMPLETED|Overall Study||28
2882218|NCT00303069|3587448|FG002|COMPLETED|Overall Study||33
2882219|NCT00303069|3587449|FG003|COMPLETED|Overall Study||29
2882220|NCT00303069|3587446|FG000|NOT COMPLETED|Overall Study||2
2882221|NCT00303069|3587447|FG001|NOT COMPLETED|Overall Study||0
2882222|NCT00303069|3587448|FG002|NOT COMPLETED|Overall Study||1
2882223|NCT00303069|3587449|FG003|NOT COMPLETED|Overall Study||2
2882224|NCT00303108|3587462|FG000|STARTED|Overall Study||43
2882225|NCT00303108|3587463|FG001|STARTED|Overall Study||46
2882226|NCT00303108|3587464|FG002|STARTED|Overall Study||47
2882227|NCT00303108|3587462|FG000|COMPLETED|Overall Study||31
2882228|NCT00303108|3587463|FG001|COMPLETED|Overall Study||37
2882229|NCT00303108|3587464|FG002|COMPLETED|Overall Study||31
2882230|NCT00303108|3587462|FG000|NOT COMPLETED|Overall Study||12
2882231|NCT00303108|3587463|FG001|NOT COMPLETED|Overall Study||9
2882232|NCT00303108|3587464|FG002|NOT COMPLETED|Overall Study||16
2882233|NCT00303186|3587471|FG000|STARTED|Overall Study||107
2882234|NCT00303186|3587471|FG000|COMPLETED|Overall Study||55
2882235|NCT00303186|3587471|FG000|NOT COMPLETED|Overall Study||52
2882236|NCT00303316|3587477|FG000|STARTED|Overall Study||232
2882237|NCT00303316|3587478|FG001|STARTED|Overall Study||226
2882238|NCT00303316|3587477|FG000|COMPLETED|Overall Study||230
2882239|NCT00303316|3587478|FG001|COMPLETED|Overall Study||223
2882240|NCT00303316|3587477|FG000|NOT COMPLETED|Overall Study||2
2882241|NCT00303316|3587478|FG001|NOT COMPLETED|Overall Study||3
2882242|NCT00303329|3587486|FG000|STARTED|Overall Study||85
2882243|NCT00303329|3587487|FG001|STARTED|Overall Study||99
2882244|NCT00303329|3587486|FG000|COMPLETED|Overall Study||50
2882245|NCT00303329|3587487|FG001|COMPLETED|Overall Study||37
2882246|NCT00303329|3587486|FG000|NOT COMPLETED|Overall Study||35
2882247|NCT00303329|3587487|FG001|NOT COMPLETED|Overall Study||62
2882248|NCT00303446|3587495|FG000|STARTED|Overall Study||25
2882249|NCT00303446|3587496|FG001|STARTED|Overall Study||25
2882250|NCT00303446|3587495|FG000|COMPLETED|Overall Study||23
2882251|NCT00303446|3587496|FG001|COMPLETED|Overall Study||21
2882252|NCT00303446|3587495|FG000|NOT COMPLETED|Overall Study||2
2882253|NCT00303446|3587496|FG001|NOT COMPLETED|Overall Study||4
2882254|NCT00303459|3587504|FG000|STARTED|Overall Study||159
2882255|NCT00303459|3587505|FG001|STARTED|Overall Study|One subject randomized to placebo did not receive study treatment|175
2882256|NCT00303459|3587504|FG000|COMPLETED|Overall Study||76
2882257|NCT00303459|3587505|FG001|COMPLETED|Overall Study||86
2882258|NCT00303459|3587504|FG000|NOT COMPLETED|Overall Study||83
2882259|NCT00303459|3587505|FG001|NOT COMPLETED|Overall Study||89
2882260|NCT00303472|3587519|FG000|STARTED|Treatment Period||6
2882261|NCT00303472|3587520|FG001|STARTED|Treatment Period||11
2882262|NCT00303472|3587521|FG002|STARTED|Treatment Period||11
2882263|NCT00303472|3587522|FG003|STARTED|Treatment Period||16
2882264|NCT00303472|3587523|FG004|STARTED|Treatment Period||11
2882265|NCT00303472|3587524|FG005|STARTED|Treatment Period||12
2882266|NCT00303472|3587525|FG006|STARTED|Treatment Period||5
2882267|NCT00303472|3587519|FG000|COMPLETED|Treatment Period||6
2882268|NCT00303472|3587520|FG001|COMPLETED|Treatment Period||11
2882269|NCT00303472|3587521|FG002|COMPLETED|Treatment Period||11
2882270|NCT00303472|3587522|FG003|COMPLETED|Treatment Period||14
2882271|NCT00303472|3587523|FG004|COMPLETED|Treatment Period||8
2882272|NCT00303472|3587524|FG005|COMPLETED|Treatment Period||11
2882273|NCT00303472|3587525|FG006|COMPLETED|Treatment Period||3
2882274|NCT00303472|3587519|FG000|NOT COMPLETED|Treatment Period||0
2882275|NCT00303472|3587520|FG001|NOT COMPLETED|Treatment Period||0
2882276|NCT00303472|3587521|FG002|NOT COMPLETED|Treatment Period||0
2882277|NCT00303472|3587522|FG003|NOT COMPLETED|Treatment Period||2
2882278|NCT00303472|3587523|FG004|NOT COMPLETED|Treatment Period||3
2882279|NCT00303472|3587524|FG005|NOT COMPLETED|Treatment Period||1
2882280|NCT00303472|3587525|FG006|NOT COMPLETED|Treatment Period||2
2882281|NCT00303472|3587519|FG000|STARTED|Treatment Extension (Optional)||6
2882282|NCT00303472|3587520|FG001|STARTED|Treatment Extension (Optional)||11
2882283|NCT00303472|3587521|FG002|STARTED|Treatment Extension (Optional)||11
2882284|NCT00303472|3587522|FG003|STARTED|Treatment Extension (Optional)||13
2882285|NCT00303472|3587523|FG004|STARTED|Treatment Extension (Optional)||5
2882286|NCT00303472|3587524|FG005|STARTED|Treatment Extension (Optional)||5
2882287|NCT00303472|3587525|FG006|STARTED|Treatment Extension (Optional)||1
2882288|NCT00303472|3587519|FG000|COMPLETED|Treatment Extension (Optional)||1
2882289|NCT00303472|3587520|FG001|COMPLETED|Treatment Extension (Optional)||5
2882290|NCT00303472|3587521|FG002|COMPLETED|Treatment Extension (Optional)||2
2882291|NCT00303472|3587522|FG003|COMPLETED|Treatment Extension (Optional)||5
2882292|NCT00303472|3587523|FG004|COMPLETED|Treatment Extension (Optional)||1
2882293|NCT00303472|3587524|FG005|COMPLETED|Treatment Extension (Optional)||4
2882294|NCT00303472|3587525|FG006|COMPLETED|Treatment Extension (Optional)||1
2882295|NCT00303472|3587519|FG000|NOT COMPLETED|Treatment Extension (Optional)||5
2882296|NCT00303472|3587520|FG001|NOT COMPLETED|Treatment Extension (Optional)||6
2882297|NCT00303472|3587521|FG002|NOT COMPLETED|Treatment Extension (Optional)||9
2882298|NCT00303472|3587522|FG003|NOT COMPLETED|Treatment Extension (Optional)||8
2882299|NCT00303472|3587523|FG004|NOT COMPLETED|Treatment Extension (Optional)||4
2882300|NCT00303472|3587524|FG005|NOT COMPLETED|Treatment Extension (Optional)||1
2882301|NCT00303472|3587525|FG006|NOT COMPLETED|Treatment Extension (Optional)||0
2882302|NCT00303485|3587543|FG000|STARTED|Overall Study||49
2882303|NCT00303485|3587544|FG001|STARTED|Overall Study||17
2882304|NCT00303485|3587543|FG000|COMPLETED|Overall Study||48
2882305|NCT00303485|3587544|FG001|COMPLETED|Overall Study||15
2882306|NCT00303485|3587543|FG000|NOT COMPLETED|Overall Study||1
2882307|NCT00303485|3587544|FG001|NOT COMPLETED|Overall Study||2
2882308|NCT00303511|3587550|FG000|STARTED|Overall Study||10
2882309|NCT00303511|3587550|FG000|COMPLETED|Overall Study||10
2882310|NCT00303511|3587550|FG000|NOT COMPLETED|Overall Study||0
2882311|NCT00303602|3587556|FG000|STARTED|Overall Study||84
2882312|NCT00303602|3587557|FG001|STARTED|Overall Study||65
2882313|NCT00303602|3587556|FG000|COMPLETED|Overall Study||65
2882314|NCT00303602|3587557|FG001|COMPLETED|Overall Study||50
2882315|NCT00303602|3587556|FG000|NOT COMPLETED|Overall Study||19
2882316|NCT00303602|3587557|FG001|NOT COMPLETED|Overall Study||15
2882317|NCT00303628|3587565|FG000|STARTED|Overall Study||176
2882318|NCT00303628|3587566|FG001|STARTED|Overall Study||179
2882319|NCT00303628|3587565|FG000|Eligible|Overall Study||171
2882320|NCT00303628|3587566|FG001|Eligible|Overall Study||177
2882321|NCT00303628|3587565|FG000|Treated|Overall Study||173
2882322|NCT00303628|3587566|FG001|Treated|Overall Study||174
2882323|NCT00303628|3587565|FG000|COMPLETED|Overall Study||126
2882324|NCT00303628|3587566|FG001|COMPLETED|Overall Study||106
2882325|NCT00303628|3587565|FG000|NOT COMPLETED|Overall Study||50
2882326|NCT00303628|3587566|FG001|NOT COMPLETED|Overall Study||73
2882327|NCT00303667|3587574|FG000|STARTED|Overall Study||8
2882328|NCT00303667|3587575|FG001|STARTED|Overall Study||39
2882329|NCT00303667|3587574|FG000|COMPLETED|Overall Study||8
2882330|NCT00303667|3587575|FG001|COMPLETED|Overall Study|Completed = remained alive and on study through Day 0 (day of transplant)|35
2882331|NCT00303667|3587574|FG000|NOT COMPLETED|Overall Study||0
2882332|NCT00303667|3587575|FG001|NOT COMPLETED|Overall Study||4
2882333|NCT00303719|3587583|FG000|STARTED|Overall Study||13
2882334|NCT00303719|3587584|FG001|STARTED|Overall Study||329
2882335|NCT00303719|3587583|FG000|COMPLETED|Overall Study||13
2882336|NCT00303719|3587584|FG001|COMPLETED|Overall Study||292
2882337|NCT00303719|3587583|FG000|NOT COMPLETED|Overall Study||0
2882338|NCT00303719|3587584|FG001|NOT COMPLETED|Overall Study||37
2882339|NCT00303823|3587593|FG000|STARTED|Overall Study||50
2882340|NCT00303823|3587594|FG001|STARTED|Overall Study||48
2882341|NCT00303823|3587593|FG000|COMPLETED|Overall Study||35
2882342|NCT00303823|3587594|FG001|COMPLETED|Overall Study||38
2882343|NCT00303823|3587593|FG000|NOT COMPLETED|Overall Study||15
2882344|NCT00303823|3587594|FG001|NOT COMPLETED|Overall Study||10
2882345|NCT00303862|3587600|FG000|STARTED|Overall Study||10
2882346|NCT00303862|3587600|FG000|COMPLETED|Overall Study||10
2882347|NCT00303862|3587600|FG000|NOT COMPLETED|Overall Study||0
2882348|NCT00303901|3587604|FG000|STARTED|Overall Study||40
2882349|NCT00303901|3587604|FG000|COMPLETED|Overall Study||40
2882350|NCT00303901|3587604|FG000|NOT COMPLETED|Overall Study||0
2882351|NCT00303953|3587608|FG000|STARTED|Overall Study||22
2882352|NCT00303953|3587608|FG000|Eligible|Overall Study||21
2882353|NCT00303953|3587608|FG000|Eligible and Treated|Overall Study||20
2882354|NCT00303953|3587608|FG000|COMPLETED|Overall Study||3
2882355|NCT00303953|3587608|FG000|NOT COMPLETED|Overall Study||19
2882356|NCT00303966|3587612|FG000|STARTED|Overall Study||5
2882357|NCT00303966|3587612|FG000|COMPLETED|Overall Study||5
2882358|NCT00303966|3587612|FG000|NOT COMPLETED|Overall Study||0
2882359|NCT00303979|3587619|FG000|STARTED|Overall Study|at baseline|15177
2882360|NCT00303979|3587620|FG001|STARTED|Overall Study|at 6 months|9992
2882361|NCT00303979|3587621|FG002|STARTED|Overall Study|at 18 months|9641
2882362|NCT00303979|3587619|FG000|COMPLETED|Overall Study|at 24 Months|7605
2882363|NCT00303979|3587620|FG001|COMPLETED|Overall Study|at 6 months|9992
2882364|NCT00303979|3587621|FG002|COMPLETED|Overall Study|at 18 months|9641
2882365|NCT00303979|3587619|FG000|NOT COMPLETED|Overall Study||7572
2882366|NCT00303979|3587620|FG001|NOT COMPLETED|Overall Study||0
2882367|NCT00303979|3587621|FG002|NOT COMPLETED|Overall Study||0
2882368|NCT00304031|3587641|FG000|STARTED|Concomitant RT+TMZ (Pre-randomization)|All participants registered to concomitant treatment; randomized after completing this treatment.|1125
2882369|NCT00304031|3587642|FG001|STARTED|Concomitant RT+TMZ (Pre-randomization)|Participants were not randomized to adjuvant TMZ until after completion of concomitant treatment.|0
2882370|NCT00304031|3587643|FG002|STARTED|Concomitant RT+TMZ (Pre-randomization)|Participants were not randomized to adjuvant TMZ until after completion of concomitant treatment.|0
2882371|NCT00304031|3587641|FG000|Eligible Pre-randomization Population|Concomitant RT+TMZ (Pre-randomization)||1125
2882372|NCT00304031|3587642|FG001|Eligible Pre-randomization Population|Concomitant RT+TMZ (Pre-randomization)||0
2882373|NCT00304031|3587643|FG002|Eligible Pre-randomization Population|Concomitant RT+TMZ (Pre-randomization)||0
2882374|NCT00304031|3587641|FG000|Eligible Pre-randomization Follow-up|Concomitant RT+TMZ (Pre-randomization)||1120
2882375|NCT00304031|3587642|FG001|Eligible Pre-randomization Follow-up|Concomitant RT+TMZ (Pre-randomization)||0
3170117|NCT01928394|3897425|FG019|STARTED|Follow-up Period||104
3170118|NCT01928394|3897426|FG020|STARTED|Follow-up Period||41
3170119|NCT01928394|3897427|FG021|STARTED|Follow-up Period||43
3170120|NCT01928394|3897428|FG022|STARTED|Follow-up Period||42
3170121|NCT01928394|3897406|FG000|COMPLETED|Follow-up Period||12
3170122|NCT01928394|3897407|FG001|COMPLETED|Follow-up Period||3
3170123|NCT01928394|3897408|FG002|COMPLETED|Follow-up Period||15
3170124|NCT01928394|3897409|FG003|COMPLETED|Follow-up Period||40
3170125|NCT01928394|3897410|FG004|COMPLETED|Follow-up Period||3
3170126|NCT01928394|3897411|FG005|COMPLETED|Follow-up Period||41
3170127|NCT01928394|3897412|FG006|COMPLETED|Follow-up Period||40
2882376|NCT00304031|3587643|FG002|Eligible Pre-randomization Follow-up|Concomitant RT+TMZ (Pre-randomization)||0
2882377|NCT00304031|3587641|FG000|COMPLETED|Concomitant RT+TMZ (Pre-randomization)|These participants completed concomitant treatment and met requirements for randomization.|833
2882378|NCT00304031|3587642|FG001|COMPLETED|Concomitant RT+TMZ (Pre-randomization)||0
2882379|NCT00304031|3587643|FG002|COMPLETED|Concomitant RT+TMZ (Pre-randomization)||0
2882380|NCT00304031|3587641|FG000|NOT COMPLETED|Concomitant RT+TMZ (Pre-randomization)||292
2882381|NCT00304031|3587642|FG001|NOT COMPLETED|Concomitant RT+TMZ (Pre-randomization)||0
2882382|NCT00304031|3587643|FG002|NOT COMPLETED|Concomitant RT+TMZ (Pre-randomization)||0
2882383|NCT00304031|3587641|FG000|STARTED|Randomization to Adjuvant TMZ Arm||0
2882384|NCT00304031|3587642|FG001|STARTED|Randomization to Adjuvant TMZ Arm||411
2882385|NCT00304031|3587643|FG002|STARTED|Randomization to Adjuvant TMZ Arm||422
2882386|NCT00304031|3587641|FG000|Eligible Population|Randomization to Adjuvant TMZ Arm||0
2882387|NCT00304031|3587642|FG001|Eligible Population|Randomization to Adjuvant TMZ Arm||411
2882388|NCT00304031|3587643|FG002|Eligible Population|Randomization to Adjuvant TMZ Arm||420
2882389|NCT00304031|3587641|FG000|Unmethylated MGMT Population|Randomization to Adjuvant TMZ Arm||0
2882390|NCT00304031|3587642|FG001|Unmethylated MGMT Population|Randomization to Adjuvant TMZ Arm||254
2882391|NCT00304031|3587643|FG002|Unmethylated MGMT Population|Randomization to Adjuvant TMZ Arm||262
2882392|NCT00304031|3587641|FG000|Methylated MGMT Population|Randomization to Adjuvant TMZ Arm||0
2882393|NCT00304031|3587642|FG001|Methylated MGMT Population|Randomization to Adjuvant TMZ Arm||122
2882394|NCT00304031|3587643|FG002|Methylated MGMT Population|Randomization to Adjuvant TMZ Arm||122
2882395|NCT00304031|3587641|FG000|Quality of Life Population|Randomization to Adjuvant TMZ Arm||0
2882396|NCT00304031|3587642|FG001|Quality of Life Population|Randomization to Adjuvant TMZ Arm||96
2882397|NCT00304031|3587643|FG002|Quality of Life Population|Randomization to Adjuvant TMZ Arm||95
2882398|NCT00304031|3587641|FG000|COMPLETED|Randomization to Adjuvant TMZ Arm||0
2882399|NCT00304031|3587642|FG001|COMPLETED|Randomization to Adjuvant TMZ Arm|Randomized participants contributing data to results are considered to have completed the study.|411
2882400|NCT00304031|3587643|FG002|COMPLETED|Randomization to Adjuvant TMZ Arm|Randomized participants contributing data to results are considered to have completed the study.|420
2882401|NCT00304031|3587641|FG000|NOT COMPLETED|Randomization to Adjuvant TMZ Arm||0
2882402|NCT00304031|3587642|FG001|NOT COMPLETED|Randomization to Adjuvant TMZ Arm||0
2882403|NCT00304031|3587643|FG002|NOT COMPLETED|Randomization to Adjuvant TMZ Arm||2
2882404|NCT00304070|3587661|FG000|STARTED|Overall Study||24
2882405|NCT00304070|3587662|FG001|STARTED|Overall Study||15
2882406|NCT00304070|3587663|FG002|STARTED|Overall Study||39
2882407|NCT00304070|3587661|FG000|COMPLETED|Overall Study||21
2882408|NCT00304070|3587662|FG001|COMPLETED|Overall Study||8
2882409|NCT00304070|3587663|FG002|COMPLETED|Overall Study||27
2882410|NCT00304070|3587661|FG000|NOT COMPLETED|Overall Study||3
2882411|NCT00304070|3587662|FG001|NOT COMPLETED|Overall Study||7
2882412|NCT00304070|3587663|FG002|NOT COMPLETED|Overall Study||12
2882413|NCT00304083|3587677|FG000|STARTED|Overall Study||34
2882414|NCT00304083|3587678|FG001|STARTED|Overall Study||14
2882415|NCT00304083|3587677|FG000|Completed 4 Cycles|Overall Study||22
2882416|NCT00304083|3587678|FG001|Completed 4 Cycles|Overall Study||7
2882417|NCT00304083|3587677|FG000|Patients Treated With Surgery|Overall Study||7
2882418|NCT00304083|3587678|FG001|Patients Treated With Surgery|Overall Study||3
2882419|NCT00304083|3587677|FG000|Patients Treated With Surgery and RT|Overall Study||5
2882420|NCT00304083|3587678|FG001|Patients Treated With Surgery and RT|Overall Study||1
2882421|NCT00304083|3587677|FG000|Patients Treated With RT Only|Overall Study||4
2882422|NCT00304083|3587678|FG001|Patients Treated With RT Only|Overall Study||2
2882423|NCT00304083|3587677|FG000|Patients Had Neither RT or Surgery|Overall Study||6
2882424|NCT00304083|3587678|FG001|Patients Had Neither RT or Surgery|Overall Study||1
2882425|NCT00304083|3587677|FG000|COMPLETED|Overall Study||12
2882426|NCT00304083|3587678|FG001|COMPLETED|Overall Study||6
2882427|NCT00304083|3587677|FG000|NOT COMPLETED|Overall Study||22
2882428|NCT00304083|3587678|FG001|NOT COMPLETED|Overall Study||8
2882429|NCT00304096|3587686|FG000|STARTED|Overall Study||6
2882430|NCT00304096|3587687|FG001|STARTED|Overall Study||5
2882431|NCT00304096|3587686|FG000|COMPLETED|Overall Study||6
2882432|NCT00304096|3587687|FG001|COMPLETED|Overall Study|6 patients enrolled, 1 not treated|5
2882433|NCT00304096|3587686|FG000|NOT COMPLETED|Overall Study||0
2882434|NCT00304096|3587687|FG001|NOT COMPLETED|Overall Study||0
2882435|NCT00304161|3587695|FG000|STARTED|Overall Study||28
2882436|NCT00304161|3587696|FG001|STARTED|Overall Study||27
2882437|NCT00304161|3587695|FG000|COMPLETED|Overall Study||22
2882438|NCT00304161|3587696|FG001|COMPLETED|Overall Study||21
2882439|NCT00304161|3587695|FG000|NOT COMPLETED|Overall Study||6
2882440|NCT00304161|3587696|FG001|NOT COMPLETED|Overall Study||6
2882441|NCT00304187|3587704|FG000|STARTED|Overall Study||15
2882442|NCT00304187|3587705|FG001|STARTED|Overall Study||14
2882443|NCT00304187|3587704|FG000|COMPLETED|Overall Study||13
2882444|NCT00304187|3587705|FG001|COMPLETED|Overall Study||13
2882445|NCT00304187|3587704|FG000|NOT COMPLETED|Overall Study||2
2882446|NCT00304187|3587705|FG001|NOT COMPLETED|Overall Study||1
2882447|NCT00304265|3587715|FG000|STARTED|Overall Study||117
2882448|NCT00304265|3587716|FG001|STARTED|Overall Study||98
2882449|NCT00304265|3587715|FG000|COMPLETED|Overall Study||117
2882450|NCT00304265|3587716|FG001|COMPLETED|Overall Study||98
2882451|NCT00304265|3587715|FG000|NOT COMPLETED|Overall Study||0
2882452|NCT00304265|3587716|FG001|NOT COMPLETED|Overall Study||0
2882453|NCT00304278|3587722|FG000|STARTED|Overall Study||21
2882454|NCT00304278|3587722|FG000|COMPLETED|Overall Study||19
2882455|NCT00304278|3587722|FG000|NOT COMPLETED|Overall Study||2
2882456|NCT00304356|3587726|FG000|STARTED|Nitazoxanide||27
2882457|NCT00304356|3587726|FG000|COMPLETED|Nitazoxanide||22
2882458|NCT00304356|3587726|FG000|NOT COMPLETED|Nitazoxanide||5
2882459|NCT00304356|3587726|FG000|STARTED|Nitazoxanide||27
2882460|NCT00304356|3587726|FG000|COMPLETED|Nitazoxanide||22
2882461|NCT00304356|3587726|FG000|NOT COMPLETED|Nitazoxanide||5
2882462|NCT00304512|3587733|FG000|STARTED|Treatment Period||2
2882463|NCT00304512|3587734|FG001|STARTED|Treatment Period||4
2882464|NCT00304512|3587735|FG002|STARTED|Treatment Period||3
2882465|NCT00304512|3587733|FG000|Safety Population|Treatment Period||2
2882466|NCT00304512|3587734|FG001|Safety Population|Treatment Period||4
2882467|NCT00304512|3587735|FG002|Safety Population|Treatment Period||3
2882468|NCT00304512|3587733|FG000|Pharmacokinetic (PK) Population|Treatment Period||2
2882469|NCT00304512|3587734|FG001|Pharmacokinetic (PK) Population|Treatment Period||4
2882470|NCT00304512|3587735|FG002|Pharmacokinetic (PK) Population|Treatment Period||3
2882471|NCT00304512|3587733|FG000|Pharmacodynamic (PD) Population|Treatment Period||2
2882472|NCT00304512|3587734|FG001|Pharmacodynamic (PD) Population|Treatment Period||4
2882473|NCT00304512|3587735|FG002|Pharmacodynamic (PD) Population|Treatment Period||3
2882474|NCT00304512|3587733|FG000|COMPLETED|Treatment Period||2
2882475|NCT00304512|3587734|FG001|COMPLETED|Treatment Period||4
2882476|NCT00304512|3587735|FG002|COMPLETED|Treatment Period||3
2882477|NCT00304512|3587733|FG000|NOT COMPLETED|Treatment Period||0
2882478|NCT00304512|3587734|FG001|NOT COMPLETED|Treatment Period||0
2882479|NCT00304512|3587735|FG002|NOT COMPLETED|Treatment Period||0
2882480|NCT00304512|3587733|FG000|STARTED|Extension Period||2
2882481|NCT00304512|3587734|FG001|STARTED|Extension Period||4
2882482|NCT00304512|3587735|FG002|STARTED|Extension Period||3
2882483|NCT00304512|3587733|FG000|COMPLETED|Extension Period||2
2882484|NCT00304512|3587734|FG001|COMPLETED|Extension Period||4
2882485|NCT00304512|3587735|FG002|COMPLETED|Extension Period||3
2882486|NCT00304512|3587733|FG000|NOT COMPLETED|Extension Period||0
2882487|NCT00304512|3587734|FG001|NOT COMPLETED|Extension Period||0
2882488|NCT00304512|3587735|FG002|NOT COMPLETED|Extension Period||0
2882489|NCT00304707|3587745|FG000|STARTED|Overall Study||73
2882490|NCT00304707|3587746|FG001|STARTED|Overall Study||70
2882491|NCT00304707|3587745|FG000|COMPLETED|Overall Study||66
2882492|NCT00304707|3587746|FG001|COMPLETED|Overall Study||64
2882493|NCT00304707|3587745|FG000|NOT COMPLETED|Overall Study||7
2882494|NCT00304707|3587746|FG001|NOT COMPLETED|Overall Study||6
2882495|NCT00304746|3587754|FG000|STARTED|Overall Study||50
2882496|NCT00304746|3587755|FG001|STARTED|Overall Study||50
2882497|NCT00304746|3587754|FG000|COMPLETED|Overall Study||50
2882498|NCT00304746|3587755|FG001|COMPLETED|Overall Study||50
2882499|NCT00304746|3587754|FG000|NOT COMPLETED|Overall Study||0
2882500|NCT00304746|3587755|FG001|NOT COMPLETED|Overall Study||0
2882501|NCT00304915|3587763|FG000|STARTED|Overall Study||123
2882502|NCT00304915|3587764|FG001|STARTED|Overall Study||126
2882503|NCT00304915|3587763|FG000|COMPLETED|Overall Study||105
2882504|NCT00304915|3587764|FG001|COMPLETED|Overall Study||110
2882505|NCT00304915|3587763|FG000|NOT COMPLETED|Overall Study||18
2882506|NCT00304915|3587764|FG001|NOT COMPLETED|Overall Study||16
2882507|NCT00304954|3587774|FG000|STARTED|Overall Study||4
2882508|NCT00304954|3587775|FG001|STARTED|Overall Study||3
2882509|NCT00304954|3587776|FG002|STARTED|Overall Study||3
2882510|NCT00304954|3587777|FG003|STARTED|Overall Study||3
2882511|NCT00304954|3587774|FG000|COMPLETED|Overall Study||3
2882512|NCT00304954|3587775|FG001|COMPLETED|Overall Study||3
2882513|NCT00304954|3587776|FG002|COMPLETED|Overall Study||2
2882514|NCT00304954|3587777|FG003|COMPLETED|Overall Study||3
2882515|NCT00304954|3587774|FG000|NOT COMPLETED|Overall Study||1
2882516|NCT00304954|3587775|FG001|NOT COMPLETED|Overall Study||0
2882517|NCT00304954|3587776|FG002|NOT COMPLETED|Overall Study||1
2882518|NCT00304954|3587777|FG003|NOT COMPLETED|Overall Study||0
2882519|NCT00305006|3587797|FG000|STARTED|Overall Study||22
2882520|NCT00305006|3587798|FG001|STARTED|Overall Study||22
2882521|NCT00305006|3587797|FG000|COMPLETED|Overall Study||21
2882522|NCT00305006|3587798|FG001|COMPLETED|Overall Study||21
2882523|NCT00305006|3587797|FG000|NOT COMPLETED|Overall Study||1
2882524|NCT00305006|3587798|FG001|NOT COMPLETED|Overall Study||1
2882525|NCT00305058|3587806|FG000|STARTED|Overall Study||97
2882526|NCT00305058|3587807|FG001|STARTED|Overall Study||97
2882527|NCT00305058|3587806|FG000|Inclusion/Exclusion Verification|Overall Study||96
2882528|NCT00305058|3587807|FG001|Inclusion/Exclusion Verification|Overall Study||97
2882529|NCT00305058|3587806|FG000|All Outcome Data Collected|Overall Study||93
2882530|NCT00305058|3587807|FG001|All Outcome Data Collected|Overall Study||95
2882531|NCT00305058|3587806|FG000|Data Collection Forms Filed for Analysis|Overall Study||90
2882532|NCT00305058|3587807|FG001|Data Collection Forms Filed for Analysis|Overall Study||93
2882533|NCT00305058|3587806|FG000|COMPLETED|Overall Study||90
2882534|NCT00305058|3587807|FG001|COMPLETED|Overall Study||93
2882535|NCT00305058|3587806|FG000|NOT COMPLETED|Overall Study||7
2882536|NCT00305058|3587807|FG001|NOT COMPLETED|Overall Study||4
2882537|NCT00305084|3587818|FG000|STARTED|Overall Study||3
2882538|NCT00305084|3587819|FG001|STARTED|Overall Study||3
2882539|NCT00305084|3587820|FG002|STARTED|Overall Study||3
2882540|NCT00305084|3587821|FG003|STARTED|Overall Study||3
2882541|NCT00305084|3587822|FG004|STARTED|Overall Study||3
2882542|NCT00305084|3587818|FG000|COMPLETED|Overall Study||3
2882543|NCT00305084|3587819|FG001|COMPLETED|Overall Study||3
2882544|NCT00305084|3587820|FG002|COMPLETED|Overall Study||3
2882545|NCT00305084|3587821|FG003|COMPLETED|Overall Study||3
2882546|NCT00305084|3587822|FG004|COMPLETED|Overall Study||3
2882547|NCT00305084|3587818|FG000|NOT COMPLETED|Overall Study||0
2882548|NCT00305084|3587819|FG001|NOT COMPLETED|Overall Study||0
2882549|NCT00305084|3587820|FG002|NOT COMPLETED|Overall Study||0
2882550|NCT00305084|3587821|FG003|NOT COMPLETED|Overall Study||0
2882551|NCT00305084|3587822|FG004|NOT COMPLETED|Overall Study||0
2882552|NCT00305110|3587862|FG000|STARTED|Overall Study||298
2882553|NCT00305110|3587862|FG000|All Necessary Data Collected|Overall Study||269
2882554|NCT00305110|3587862|FG000|COMPLETED|Overall Study||269
2882555|NCT00305110|3587862|FG000|NOT COMPLETED|Overall Study||29
2882556|NCT00305162|3587868|FG000|STARTED|48 Hour Follow-up Period||4435
2882557|NCT00305162|3587869|FG001|STARTED|48 Hour Follow-up Period||4447
2919457|NCT00531882|3629844|FG000|STARTED|Overall Study||10
2882558|NCT00305162|3587868|FG000|Intent-to-treat (ITT): SA/UA/NSTEMI|48 Hour Follow-up Period|Patients who completed through 48 hours|3933
2882559|NCT00305162|3587869|FG001|Intent-to-treat (ITT): SA/UA/NSTEMI|48 Hour Follow-up Period|Patients who completed through 48 hours|3924
2882560|NCT00305162|3587868|FG000|Intent-to-treat (ITT): STEMI|48 Hour Follow-up Period|Patients who completed through 48 hours|482
2882561|NCT00305162|3587869|FG001|Intent-to-treat (ITT): STEMI|48 Hour Follow-up Period|Patients who completed through 48 hours|507
3170128|NCT01928394|3897413|FG007|COMPLETED|Follow-up Period||10
3170129|NCT01928394|3897414|FG008|COMPLETED|Follow-up Period||2
3170130|NCT01928394|3897415|FG009|COMPLETED|Follow-up Period||16
3170131|NCT01928394|3897416|FG010|COMPLETED|Follow-up Period||19
3170132|NCT01928394|3897417|FG011|COMPLETED|Follow-up Period||59
3170133|NCT01928394|3897418|FG012|COMPLETED|Follow-up Period||47
2882562|NCT00305162|3587868|FG000|Modified ITT (mITT): SA/UA/NSTEMI|48 Hour Follow-up Period|Completed through 48 hours; Excludes those who did not receive study drug or undergo index PCI.|3889
2882563|NCT00305162|3587869|FG001|Modified ITT (mITT): SA/UA/NSTEMI|48 Hour Follow-up Period|Completed through 48 hours; Excludes those who did not receive study drug or undergo index PCI.|3865
2882564|NCT00305162|3587868|FG000|Modified ITT (mITT): STEMI|48 Hour Follow-up Period|Completed through 48 hours; Excludes those who did not receive study drug or undergo index PCI.|446
2882565|NCT00305162|3587869|FG001|Modified ITT (mITT): STEMI|48 Hour Follow-up Period|Completed through 48 hours; Excludes those who did not receive study drug or undergo index PCI.|447
2882566|NCT00305162|3587868|FG000|Safety Population|48 Hour Follow-up Period|Patients who received at least 1 dose of study drug, according to the actual treatment received.|4374
2882567|NCT00305162|3587869|FG001|Safety Population|48 Hour Follow-up Period|Patients who received at least 1 dose of study drug, according to the actual treatment received.|4365
2882568|NCT00305162|3587868|FG000|COMPLETED|48 Hour Follow-up Period|intent-to-treat (ITT) completers at 48 hour follow-up|4415
2882569|NCT00305162|3587869|FG001|COMPLETED|48 Hour Follow-up Period|intent-to-treat (ITT) completers at 48 hour follow-up|4431
2882570|NCT00305162|3587868|FG000|NOT COMPLETED|48 Hour Follow-up Period||20
2882571|NCT00305162|3587869|FG001|NOT COMPLETED|48 Hour Follow-up Period||16
2882572|NCT00305162|3587868|FG000|STARTED|30-day Follow-up Period||4435
2882573|NCT00305162|3587869|FG001|STARTED|30-day Follow-up Period||4447
2882574|NCT00305162|3587868|FG000|Intent-to-treat (ITT): SA/UA/NSTEMI|30-day Follow-up Period|Completed through 30-days|3902
2882575|NCT00305162|3587869|FG001|Intent-to-treat (ITT): SA/UA/NSTEMI|30-day Follow-up Period|Completed through 30-days|3883
2882576|NCT00305162|3587868|FG000|Intent-to-treat (ITT): STEMI|30-day Follow-up Period|Completed through 30-days|471
2882577|NCT00305162|3587869|FG001|Intent-to-treat (ITT): STEMI|30-day Follow-up Period|Completed through 30-days|501
2882578|NCT00305162|3587868|FG000|Modified ITT (mITT): SA/UA/NSTEMI|30-day Follow-up Period|Completed through 30-days; Excludes those who did not receive study drug or undergo index PCI.|3860
2882579|NCT00305162|3587869|FG001|Modified ITT (mITT): SA/UA/NSTEMI|30-day Follow-up Period|Completed through 30-days; Excludes those who did not receive study drug or undergo index PCI.|3827
2882580|NCT00305162|3587868|FG000|Modified ITT (mITT): STEMI|30-day Follow-up Period|Completed through 30-days; Excludes those who did not receive study drug or undergo index PCI.|438
2882581|NCT00305162|3587869|FG001|Modified ITT (mITT): STEMI|30-day Follow-up Period|Completed through 30-days; Excludes those who did not receive study drug or undergo index PCI.|444
2882582|NCT00305162|3587868|FG000|COMPLETED|30-day Follow-up Period|intent-to-treat (ITT) completers at 30-day follow-up|4373
2882583|NCT00305162|3587869|FG001|COMPLETED|30-day Follow-up Period|intent-to-treat (ITT) completers at 30-day follow-up|4384
2882584|NCT00305162|3587868|FG000|NOT COMPLETED|30-day Follow-up Period||62
2882585|NCT00305162|3587869|FG001|NOT COMPLETED|30-day Follow-up Period||63
2882586|NCT00305162|3587868|FG000|STARTED|1 Year Follow-up Period||4435
2882587|NCT00305162|3587869|FG001|STARTED|1 Year Follow-up Period||4447
2882588|NCT00305162|3587868|FG000|Intent-to-treat (ITT): SA/UA/NSTEMI|1 Year Follow-up Period|Completed through 1 year|3900
2882589|NCT00305162|3587869|FG001|Intent-to-treat (ITT): SA/UA/NSTEMI|1 Year Follow-up Period|Completed through 1 year|3878
2882590|NCT00305162|3587868|FG000|Intent-to-treat (ITT): STEMI|1 Year Follow-up Period|Completed through 1 year|480
2882591|NCT00305162|3587869|FG001|Intent-to-treat (ITT): STEMI|1 Year Follow-up Period|Completed through 1 year|504
2882592|NCT00305162|3587868|FG000|Modified ITT (mITT): SA/UA/NSTEMI|1 Year Follow-up Period|Completed through 1 year; Excludes those who did not receive study drug or undergo index PCI.|3851
2882593|NCT00305162|3587869|FG001|Modified ITT (mITT): SA/UA/NSTEMI|1 Year Follow-up Period|Completed through 1 year; Excludes those who did not receive study drug or undergo index PCI.|3818
2882594|NCT00305162|3587868|FG000|Modified ITT (mITT): STEMI|1 Year Follow-up Period|Completed through 1 year; Excludes those who did not receive study drug or undergo index PCI.|446
2882595|NCT00305162|3587869|FG001|Modified ITT (mITT): STEMI|1 Year Follow-up Period|Completed through 1 year; Excludes those who did not receive study drug or undergo index PCI.|444
2882596|NCT00305162|3587868|FG000|COMPLETED|1 Year Follow-up Period|intent-to-treat (ITT) completers at 1-year follow-up|4380
2882597|NCT00305162|3587869|FG001|COMPLETED|1 Year Follow-up Period|intent-to-treat (ITT) completers at 1-year follow-up|4382
2882598|NCT00305162|3587868|FG000|NOT COMPLETED|1 Year Follow-up Period||55
2882599|NCT00305162|3587869|FG001|NOT COMPLETED|1 Year Follow-up Period||65
2882600|NCT00305227|3587878|FG000|STARTED|Overall Study||50
2882601|NCT00305227|3587879|FG001|STARTED|Overall Study||50
2882602|NCT00305227|3587878|FG000|COMPLETED|Overall Study|with at least 8 weeks of observation|43
2882603|NCT00305227|3587879|FG001|COMPLETED|Overall Study|with at least 8 weeks of observation|44
2882604|NCT00305227|3587878|FG000|NOT COMPLETED|Overall Study||7
2882605|NCT00305227|3587879|FG001|NOT COMPLETED|Overall Study||6
2882606|NCT00305253|3587887|FG000|STARTED|Overall Study||432
3170134|NCT01928394|3897419|FG013|COMPLETED|Follow-up Period||107
3170135|NCT01928394|3897420|FG014|COMPLETED|Follow-up Period||66
2882607|NCT00305253|3587888|FG001|STARTED|Overall Study||559
2882608|NCT00305253|3587887|FG000|COMPLETED|Overall Study||432
2882609|NCT00305253|3587888|FG001|COMPLETED|Overall Study||558
2882610|NCT00305253|3587887|FG000|NOT COMPLETED|Overall Study||0
2882611|NCT00305253|3587888|FG001|NOT COMPLETED|Overall Study||1
2882612|NCT00305448|3587897|FG000|STARTED|Overall Study||45
2882613|NCT00305448|3587898|FG001|STARTED|Overall Study||51
2882614|NCT00305448|3587899|FG002|STARTED|Overall Study||47
2882615|NCT00305448|3587897|FG000|COMPLETED|Overall Study||14
2882616|NCT00305448|3587898|FG001|COMPLETED|Overall Study||17
2882617|NCT00305448|3587899|FG002|COMPLETED|Overall Study||14
2882618|NCT00305448|3587897|FG000|NOT COMPLETED|Overall Study||31
2882619|NCT00305448|3587898|FG001|NOT COMPLETED|Overall Study||34
2882620|NCT00305448|3587899|FG002|NOT COMPLETED|Overall Study||33
2882621|NCT00305565|3587911|FG000|STARTED|Overall Study (Safety Population)||111
2882622|NCT00305565|3587912|FG001|STARTED|Overall Study (Safety Population)||107
2882623|NCT00305565|3587913|FG002|STARTED|Overall Study (Safety Population)||113
2882624|NCT00305565|3587911|FG000|COMPLETED|Overall Study (Safety Population)||97
2882625|NCT00305565|3587912|FG001|COMPLETED|Overall Study (Safety Population)||95
2882626|NCT00305565|3587913|FG002|COMPLETED|Overall Study (Safety Population)||106
2882627|NCT00305565|3587911|FG000|NOT COMPLETED|Overall Study (Safety Population)||14
2882628|NCT00305565|3587912|FG001|NOT COMPLETED|Overall Study (Safety Population)||12
2882629|NCT00305565|3587913|FG002|NOT COMPLETED|Overall Study (Safety Population)||7
2882630|NCT00305565|3587911|FG000|STARTED|Overall Study (ITT Population)||102
3170136|NCT01928394|3897421|FG015|COMPLETED|Follow-up Period||3
3170137|NCT01928394|3897422|FG016|COMPLETED|Follow-up Period||41
3170138|NCT01928394|3897423|FG017|COMPLETED|Follow-up Period||50
3170139|NCT01928394|3897424|FG018|COMPLETED|Follow-up Period||76
3170140|NCT01928394|3897425|FG019|COMPLETED|Follow-up Period||83
3170141|NCT01928394|3897426|FG020|COMPLETED|Follow-up Period||32
2882631|NCT00305565|3587912|FG001|STARTED|Overall Study (ITT Population)||101
2882632|NCT00305565|3587913|FG002|STARTED|Overall Study (ITT Population)||107
2882633|NCT00305565|3587911|FG000|COMPLETED|Overall Study (ITT Population)||89
2882634|NCT00305565|3587912|FG001|COMPLETED|Overall Study (ITT Population)||90
2882635|NCT00305565|3587913|FG002|COMPLETED|Overall Study (ITT Population)||102
2882636|NCT00305565|3587911|FG000|NOT COMPLETED|Overall Study (ITT Population)||13
2882637|NCT00305565|3587912|FG001|NOT COMPLETED|Overall Study (ITT Population)||11
2882638|NCT00305565|3587913|FG002|NOT COMPLETED|Overall Study (ITT Population)||5
2882639|NCT00305578|3587924|FG000|STARTED|Overall Study||15
2882640|NCT00305578|3587925|FG001|STARTED|Overall Study||14
2882641|NCT00305578|3587924|FG000|COMPLETED|Overall Study||12
2882642|NCT00305578|3587925|FG001|COMPLETED|Overall Study||12
2882643|NCT00305578|3587924|FG000|NOT COMPLETED|Overall Study||3
2882644|NCT00305578|3587925|FG001|NOT COMPLETED|Overall Study||2
2882645|NCT00305604|3587933|FG000|STARTED|Overall Study||102
2882646|NCT00305604|3587934|FG001|STARTED|Overall Study||104
2882647|NCT00305604|3587933|FG000|COMPLETED|Overall Study||70
2882648|NCT00305604|3587934|FG001|COMPLETED|Overall Study||57
2882649|NCT00305604|3587933|FG000|NOT COMPLETED|Overall Study||32
2882650|NCT00305604|3587934|FG001|NOT COMPLETED|Overall Study||47
2882651|NCT00305682|3587946|FG000|STARTED|Overall Study||98
2882652|NCT00305682|3587947|FG001|STARTED|Overall Study||71
2882653|NCT00305682|3587948|FG002|STARTED|Overall Study||7
2882654|NCT00305682|3587949|FG003|STARTED|Overall Study||34
2882655|NCT00305682|3587950|FG004|STARTED|Overall Study||39
2882656|NCT00305682|3587951|FG005|STARTED|Overall Study||35
2882657|NCT00305682|3587946|FG000|COMPLETED|Overall Study||98
2882658|NCT00305682|3587947|FG001|COMPLETED|Overall Study||71
2882659|NCT00305682|3587948|FG002|COMPLETED|Overall Study||7
2882660|NCT00305682|3587949|FG003|COMPLETED|Overall Study||34
2882661|NCT00305682|3587950|FG004|COMPLETED|Overall Study||39
2882662|NCT00305682|3587951|FG005|COMPLETED|Overall Study||35
2882663|NCT00305682|3587946|FG000|NOT COMPLETED|Overall Study||0
2882664|NCT00305682|3587947|FG001|NOT COMPLETED|Overall Study||0
2882665|NCT00305682|3587948|FG002|NOT COMPLETED|Overall Study||0
2882666|NCT00305682|3587949|FG003|NOT COMPLETED|Overall Study||0
2882667|NCT00305682|3587950|FG004|NOT COMPLETED|Overall Study||0
2882668|NCT00305682|3587951|FG005|NOT COMPLETED|Overall Study||0
2882669|NCT00305695|3587967|FG000|STARTED|Overall Study||81
2882670|NCT00305695|3587968|FG001|STARTED|Overall Study||79
2882671|NCT00305695|3587967|FG000|COMPLETED|Overall Study||40
2882672|NCT00305695|3587968|FG001|COMPLETED|Overall Study||52
2882673|NCT00305695|3587967|FG000|NOT COMPLETED|Overall Study||41
2882674|NCT00305695|3587968|FG001|NOT COMPLETED|Overall Study||27
3170142|NCT01928394|3897427|FG021|COMPLETED|Follow-up Period||34
3170143|NCT01928394|3897428|FG022|COMPLETED|Follow-up Period||36
3170144|NCT01928394|3897406|FG000|NOT COMPLETED|Follow-up Period||3
2882675|NCT00305760|3587974|FG000|STARTED|Overall Study||60
2882676|NCT00305760|3587974|FG000|COMPLETED|Overall Study||13
2882677|NCT00305760|3587974|FG000|NOT COMPLETED|Overall Study||47
2882678|NCT00305773|3587980|FG000|STARTED|Overall Study||15
2882679|NCT00305773|3587981|FG001|STARTED|Overall Study||22
2882680|NCT00305773|3587980|FG000|COMPLETED|Overall Study||1
2882681|NCT00305773|3587981|FG001|COMPLETED|Overall Study||4
2882682|NCT00305773|3587980|FG000|NOT COMPLETED|Overall Study||14
2882683|NCT00305773|3587981|FG001|NOT COMPLETED|Overall Study||18
2882684|NCT00305864|3587991|FG000|STARTED|Overall Study||7
2882685|NCT00305864|3587992|FG001|STARTED|Overall Study||10
2882686|NCT00305864|3587993|FG002|STARTED|Overall Study||7
2882687|NCT00305864|3587994|FG003|STARTED|Overall Study||94
2882688|NCT00305864|3587991|FG000|COMPLETED|Overall Study||7
2882689|NCT00305864|3587992|FG001|COMPLETED|Overall Study||9
2882690|NCT00305864|3587993|FG002|COMPLETED|Overall Study||6
2882691|NCT00305864|3587994|FG003|COMPLETED|Overall Study||81
2882692|NCT00305864|3587991|FG000|NOT COMPLETED|Overall Study||0
2882693|NCT00305864|3587992|FG001|NOT COMPLETED|Overall Study||1
2882694|NCT00305864|3587993|FG002|NOT COMPLETED|Overall Study||1
2882695|NCT00305864|3587994|FG003|NOT COMPLETED|Overall Study||13
2882696|NCT00305877|3588006|FG000|STARTED|Overall Study||69
2882697|NCT00305877|3588007|FG001|STARTED|Overall Study||68
2882698|NCT00305877|3588006|FG000|Treated|Overall Study||67
2882699|NCT00305877|3588007|FG001|Treated|Overall Study||63
2882700|NCT00305877|3588006|FG000|Eligible|Overall Study||66
2882701|NCT00305877|3588007|FG001|Eligible|Overall Study||66
2882702|NCT00305877|3588006|FG000|Included in Efficacy Analysis|Overall Study||65
2882703|NCT00305877|3588007|FG001|Included in Efficacy Analysis|Overall Study||62
2882704|NCT00305877|3588006|FG000|COMPLETED|Overall Study||45
2882705|NCT00305877|3588007|FG001|COMPLETED|Overall Study||34
2882706|NCT00305877|3588006|FG000|NOT COMPLETED|Overall Study||24
2882707|NCT00305877|3588007|FG001|NOT COMPLETED|Overall Study||34
2882708|NCT00305942|3588013|FG000|STARTED|Overall Study||61
2882709|NCT00305942|3588013|FG000|COMPLETED|Overall Study||23
2882710|NCT00305942|3588013|FG000|NOT COMPLETED|Overall Study||38
2882711|NCT00306163|3588019|FG000|STARTED|Overall Study||19
2882712|NCT00306163|3588020|FG001|STARTED|Overall Study||18
2882713|NCT00306163|3588019|FG000|COMPLETED|Overall Study||19
2882714|NCT00306163|3588020|FG001|COMPLETED|Overall Study||18
2882715|NCT00306163|3588019|FG000|NOT COMPLETED|Overall Study||0
2882716|NCT00306163|3588020|FG001|NOT COMPLETED|Overall Study||0
2882717|NCT00306189|3588030|FG000|STARTED|Overall Study||57
2882718|NCT00306189|3588031|FG001|STARTED|Overall Study||56
2882719|NCT00306189|3588032|FG002|STARTED|Overall Study||56
2882720|NCT00306189|3588033|FG003|STARTED|Overall Study||57
2882721|NCT00306189|3588030|FG000|COMPLETED|Overall Study||48
2882722|NCT00306189|3588031|FG001|COMPLETED|Overall Study||50
2882723|NCT00306189|3588032|FG002|COMPLETED|Overall Study||45
2882724|NCT00306189|3588033|FG003|COMPLETED|Overall Study||52
2882725|NCT00306189|3588030|FG000|NOT COMPLETED|Overall Study||9
2882726|NCT00306189|3588031|FG001|NOT COMPLETED|Overall Study||6
2882727|NCT00306189|3588032|FG002|NOT COMPLETED|Overall Study||11
2882728|NCT00306189|3588033|FG003|NOT COMPLETED|Overall Study||5
2882729|NCT00306202|3588046|FG000|STARTED|Overall Study|Started = Treated. 18 were enrolled; 1 no longer met study criteria and was never treated|17
2882730|NCT00306202|3588047|FG001|STARTED|Overall Study|Started=Treated. 20 were enrolled;3 never treated(2 no longer met study criteria;1 withdrew consent)|17
2882731|NCT00306202|3588048|FG002|STARTED|Overall Study|Started = Treated. 25 were enrolled; 1 no longer met study criteria and was never treated|24
2882732|NCT00306202|3588046|FG000|COMPLETED|Overall Study|Completed = Off-treatment|17
2882733|NCT00306202|3588047|FG001|COMPLETED|Overall Study|Completed = Off-treatment|17
2882734|NCT00306202|3588048|FG002|COMPLETED|Overall Study|Completed = Off-treatment|24
3170145|NCT01928394|3897407|FG001|NOT COMPLETED|Follow-up Period||0
3170146|NCT01928394|3897408|FG002|NOT COMPLETED|Follow-up Period||3
3170147|NCT01928394|3897409|FG003|NOT COMPLETED|Follow-up Period||10
3170148|NCT01928394|3897410|FG004|NOT COMPLETED|Follow-up Period||0
2882735|NCT00306202|3588046|FG000|NOT COMPLETED|Overall Study||0
2882736|NCT00306202|3588047|FG001|NOT COMPLETED|Overall Study||0
2882737|NCT00306202|3588048|FG002|NOT COMPLETED|Overall Study||0
2882738|NCT00306293|3588094|FG000|STARTED|Period 1 (Day 1 to Day 60)||35
2882739|NCT00306293|3588095|FG001|STARTED|Period 1 (Day 1 to Day 60)||35
2882740|NCT00306293|3588094|FG000|COMPLETED|Period 1 (Day 1 to Day 60)||27
2882741|NCT00306293|3588095|FG001|COMPLETED|Period 1 (Day 1 to Day 60)||27
2882742|NCT00306293|3588094|FG000|NOT COMPLETED|Period 1 (Day 1 to Day 60)||8
2882743|NCT00306293|3588095|FG001|NOT COMPLETED|Period 1 (Day 1 to Day 60)||8
2882744|NCT00306293|3588094|FG000|STARTED|Washout (Day 61 to Day 66)||27
2882745|NCT00306293|3588095|FG001|STARTED|Washout (Day 61 to Day 66)||27
2882746|NCT00306293|3588094|FG000|COMPLETED|Washout (Day 61 to Day 66)||27
2882747|NCT00306293|3588095|FG001|COMPLETED|Washout (Day 61 to Day 66)||27
2882748|NCT00306293|3588094|FG000|NOT COMPLETED|Washout (Day 61 to Day 66)||0
2882749|NCT00306293|3588095|FG001|NOT COMPLETED|Washout (Day 61 to Day 66)||0
2882750|NCT00306293|3588094|FG000|STARTED|Period 2 (Day 67 to Day 126 )||27
2882751|NCT00306293|3588095|FG001|STARTED|Period 2 (Day 67 to Day 126 )||27
2882752|NCT00306293|3588094|FG000|COMPLETED|Period 2 (Day 67 to Day 126 )||24
2882753|NCT00306293|3588095|FG001|COMPLETED|Period 2 (Day 67 to Day 126 )||26
2882754|NCT00306293|3588094|FG000|NOT COMPLETED|Period 2 (Day 67 to Day 126 )||3
2882755|NCT00306293|3588095|FG001|NOT COMPLETED|Period 2 (Day 67 to Day 126 )||1
2882756|NCT00306384|3588106|FG000|STARTED|Overall Study||1396
2882757|NCT00306384|3588107|FG001|STARTED|Overall Study||1399
2882758|NCT00306384|3588108|FG002|STARTED|Overall Study||528
2882759|NCT00306384|3588106|FG000|Safety Set|Overall Study|Patients who received at least one dose of study drug|1395
2882760|NCT00306384|3588107|FG001|Safety Set|Overall Study|Patients who received at least one dose of study drug|1398
2882761|NCT00306384|3588108|FG002|Safety Set|Overall Study|Patients who received at least one dose of study drug|527
2882762|NCT00306384|3588106|FG000|COMPLETED|Overall Study||854
2882763|NCT00306384|3588107|FG001|COMPLETED|Overall Study||891
2882764|NCT00306384|3588108|FG002|COMPLETED|Overall Study||251
2882765|NCT00306384|3588106|FG000|NOT COMPLETED|Overall Study||542
2882766|NCT00306384|3588107|FG001|NOT COMPLETED|Overall Study||508
2882767|NCT00306384|3588108|FG002|NOT COMPLETED|Overall Study||277
2882768|NCT00306488|3588116|FG000|STARTED|Overall Study||11
2882769|NCT00306488|3588116|FG000|COMPLETED|Overall Study||10
2882770|NCT00306488|3588116|FG000|NOT COMPLETED|Overall Study||1
2882771|NCT00306527|3588125|FG000|STARTED|Overall Study||533
2882772|NCT00306527|3588126|FG001|STARTED|Overall Study||534
2882773|NCT00306527|3588127|FG002|STARTED|Overall Study||572
2882774|NCT00306527|3588128|FG003|STARTED|Overall Study||596
2882775|NCT00306527|3588125|FG000|COMPLETED|Overall Study||527
2882776|NCT00306527|3588126|FG001|COMPLETED|Overall Study||527
2882777|NCT00306527|3588127|FG002|COMPLETED|Overall Study|3 of 4 deaths in the elderly subjects resulted in premature discontinuation. Refer to OM2 .|567
2882778|NCT00306527|3588128|FG003|COMPLETED|Overall Study||590
2882779|NCT00306527|3588125|FG000|NOT COMPLETED|Overall Study||6
2882780|NCT00306527|3588126|FG001|NOT COMPLETED|Overall Study||7
2882781|NCT00306527|3588127|FG002|NOT COMPLETED|Overall Study||5
2882782|NCT00306527|3588128|FG003|NOT COMPLETED|Overall Study||6
2882783|NCT00306592|3588142|FG000|STARTED|Overall Study||404
2882784|NCT00306592|3588143|FG001|STARTED|Overall Study||690
2882785|NCT00306592|3588142|FG000|Completed at 24 Weeks|Overall Study||207
2882786|NCT00306592|3588143|FG001|Completed at 24 Weeks|Overall Study||0
2882787|NCT00306592|3588142|FG000|Completed Between 24 and 48 Weeks|Overall Study||85
2882788|NCT00306592|3588143|FG001|Completed Between 24 and 48 Weeks|Overall Study||0
2882789|NCT00306592|3588142|FG000|Completed at 48 Weeks|Overall Study||81
2882790|NCT00306592|3588143|FG001|Completed at 48 Weeks|Overall Study||632
2882791|NCT00306592|3588142|FG000|Entered 101-MS-321 Extension Study|Overall Study||22
2882792|NCT00306592|3588143|FG001|Entered 101-MS-321 Extension Study|Overall Study|pertains to participants transitioning from 101-MS-322 (NCT00306592) study only|0
2882793|NCT00306592|3588142|FG000|COMPLETED|Overall Study||373
2882794|NCT00306592|3588143|FG001|COMPLETED|Overall Study||632
2882795|NCT00306592|3588142|FG000|NOT COMPLETED|Overall Study||31
2882796|NCT00306592|3588143|FG001|NOT COMPLETED|Overall Study||58
2882797|NCT00306670|3588149|FG000|STARTED|Overall Study|no patients recruited; Genentech, the study sponsor, pulled funding and discontinued the protocol|0
2882798|NCT00306670|3588150|FG001|STARTED|Overall Study|2 patients recruited; Genentech, the study sponsor, discontinued trial before treatment started|2
2882799|NCT00306670|3588149|FG000|COMPLETED|Overall Study|no patients recruited; Genentech, the study sponsor, pulled funding and discontinued the protocol|0
2882800|NCT00306670|3588150|FG001|COMPLETED|Overall Study|2 patients recruited; Genentech, the study sponsor, discontinued study before treatment initiated|0
2882801|NCT00306670|3588149|FG000|NOT COMPLETED|Overall Study||0
2882802|NCT00306670|3588150|FG001|NOT COMPLETED|Overall Study||2
2882803|NCT00306787|3588158|FG000|STARTED|Overall Study||579
2882804|NCT00306787|3588159|FG001|STARTED|Overall Study||600
2882805|NCT00306787|3588158|FG000|Received Study Drug (Safety Population)|Overall Study||371
2882806|NCT00306787|3588159|FG001|Received Study Drug (Safety Population)|Overall Study||385
2882807|NCT00306787|3588158|FG000|Intent to Treat (ITT) Population|Overall Study||370
2882808|NCT00306787|3588159|FG001|Intent to Treat (ITT) Population|Overall Study||381
2882809|NCT00306787|3588158|FG000|COMPLETED|Overall Study||345
3170149|NCT01928394|3897411|FG005|NOT COMPLETED|Follow-up Period||8
3170150|NCT01928394|3897412|FG006|NOT COMPLETED|Follow-up Period||12
2882810|NCT00306787|3588159|FG001|COMPLETED|Overall Study||359
2882811|NCT00306787|3588158|FG000|NOT COMPLETED|Overall Study||234
2882812|NCT00306787|3588159|FG001|NOT COMPLETED|Overall Study||241
2882813|NCT00306852|3588167|FG000|STARTED|Overall Study||105
2882814|NCT00306852|3588168|FG001|STARTED|Overall Study||107
2882815|NCT00306852|3588167|FG000|COMPLETED|Overall Study||76
2882816|NCT00306852|3588168|FG001|COMPLETED|Overall Study||69
2882817|NCT00306852|3588167|FG000|NOT COMPLETED|Overall Study||29
2882818|NCT00306852|3588168|FG001|NOT COMPLETED|Overall Study||38
2882819|NCT00306891|3588178|FG000|STARTED|Part A||23
2882820|NCT00306891|3588179|FG001|STARTED|Part A||22
2882821|NCT00306891|3588180|FG002|STARTED|Part A||0
2882822|NCT00306891|3588181|FG003|STARTED|Part A||0
2882823|NCT00306891|3588178|FG000|COMPLETED|Part A||18
2882824|NCT00306891|3588179|FG001|COMPLETED|Part A||16
2882825|NCT00306891|3588180|FG002|COMPLETED|Part A||0
2882826|NCT00306891|3588181|FG003|COMPLETED|Part A||0
2882827|NCT00306891|3588178|FG000|NOT COMPLETED|Part A||5
2882828|NCT00306891|3588179|FG001|NOT COMPLETED|Part A||6
2882829|NCT00306891|3588180|FG002|NOT COMPLETED|Part A||0
2882830|NCT00306891|3588181|FG003|NOT COMPLETED|Part A||0
2882831|NCT00306891|3588178|FG000|STARTED|Part B||0
2882832|NCT00306891|3588179|FG001|STARTED|Part B||0
2882833|NCT00306891|3588180|FG002|STARTED|Part B|In Part B: Cediranib 45 mg Fixed Dose 4 new patients were randomized|16
2882834|NCT00306891|3588181|FG003|STARTED|Part B|in Part B: Cediranib Dose Escalation 11 new patients were randomized.|31
2882835|NCT00306891|3588178|FG000|COMPLETED|Part B||0
2882836|NCT00306891|3588179|FG001|COMPLETED|Part B||0
2882837|NCT00306891|3588180|FG002|COMPLETED|Part B||5
2882838|NCT00306891|3588181|FG003|COMPLETED|Part B||14
2882839|NCT00306891|3588178|FG000|NOT COMPLETED|Part B||0
2882840|NCT00306891|3588179|FG001|NOT COMPLETED|Part B||0
2882841|NCT00306891|3588180|FG002|NOT COMPLETED|Part B||11
2882842|NCT00306891|3588181|FG003|NOT COMPLETED|Part B||17
2882843|NCT00306917|3588194|FG000|STARTED|Overall Study|400 subjects were to be followed for 5 years; due to slow enrollment study closed early with 245.|121
2882844|NCT00306917|3588195|FG001|STARTED|Overall Study|400 subjects were to be followed for 5 years; due to slow enrollment study closed early with 245.|124
2882845|NCT00306917|3588194|FG000|Postoperative to 6 Month Follow up|Overall Study||93
3170151|NCT01928394|3897413|FG007|NOT COMPLETED|Follow-up Period||6
3170152|NCT01928394|3897414|FG008|NOT COMPLETED|Follow-up Period||1
2882846|NCT00306917|3588195|FG001|Postoperative to 6 Month Follow up|Overall Study||100
2882847|NCT00306917|3588194|FG000|12 Month Follow|Overall Study||86
2882848|NCT00306917|3588195|FG001|12 Month Follow|Overall Study||94
2882849|NCT00306917|3588194|FG000|24 Month Follow up|Overall Study||60
2882850|NCT00306917|3588195|FG001|24 Month Follow up|Overall Study||71
2882851|NCT00306917|3588194|FG000|36 Month Follow up|Overall Study||56
2882852|NCT00306917|3588195|FG001|36 Month Follow up|Overall Study||42
2882853|NCT00306917|3588194|FG000|48 Month Follow up|Overall Study||29
2882854|NCT00306917|3588195|FG001|48 Month Follow up|Overall Study||22
2882855|NCT00306917|3588194|FG000|60 Month Follow up|Overall Study||13
2882856|NCT00306917|3588195|FG001|60 Month Follow up|Overall Study||15
2882857|NCT00306917|3588194|FG000|COMPLETED|Overall Study||13
2882858|NCT00306917|3588195|FG001|COMPLETED|Overall Study||15
2882859|NCT00306917|3588194|FG000|NOT COMPLETED|Overall Study||108
2882860|NCT00306917|3588195|FG001|NOT COMPLETED|Overall Study||109
2882861|NCT00306995|3588208|FG000|STARTED|Study Part I||55
2882862|NCT00306995|3588209|FG001|STARTED|Study Part I||55
2882863|NCT00306995|3588210|FG002|STARTED|Study Part I||55
2882864|NCT00306995|3588211|FG003|STARTED|Study Part I||55
2882865|NCT00306995|3588212|FG004|STARTED|Study Part I||55
2882866|NCT00306995|3588213|FG005|STARTED|Study Part I||55
2882867|NCT00306995|3588214|FG006|STARTED|Study Part I||55
2882868|NCT00306995|3588208|FG000|COMPLETED|Study Part I||55
2882869|NCT00306995|3588209|FG001|COMPLETED|Study Part I||55
2882870|NCT00306995|3588210|FG002|COMPLETED|Study Part I||55
2882871|NCT00306995|3588211|FG003|COMPLETED|Study Part I||55
2882872|NCT00306995|3588212|FG004|COMPLETED|Study Part I||55
2882873|NCT00306995|3588213|FG005|COMPLETED|Study Part I||55
2882874|NCT00306995|3588214|FG006|COMPLETED|Study Part I||54
2882875|NCT00306995|3588208|FG000|NOT COMPLETED|Study Part I||0
2882876|NCT00306995|3588209|FG001|NOT COMPLETED|Study Part I||0
2882877|NCT00306995|3588210|FG002|NOT COMPLETED|Study Part I||0
2882878|NCT00306995|3588211|FG003|NOT COMPLETED|Study Part I||0
2882879|NCT00306995|3588212|FG004|NOT COMPLETED|Study Part I||0
2882880|NCT00306995|3588213|FG005|NOT COMPLETED|Study Part I||0
2882881|NCT00306995|3588214|FG006|NOT COMPLETED|Study Part I||1
2882882|NCT00306995|3588208|FG000|STARTED|Study Part II for Subset 1||27
2882883|NCT00306995|3588209|FG001|STARTED|Study Part II for Subset 1||26
2882884|NCT00306995|3588210|FG002|STARTED|Study Part II for Subset 1||27
2882885|NCT00306995|3588211|FG003|STARTED|Study Part II for Subset 1||27
2882886|NCT00306995|3588212|FG004|STARTED|Study Part II for Subset 1||27
2882887|NCT00306995|3588213|FG005|STARTED|Study Part II for Subset 1||26
2882888|NCT00306995|3588214|FG006|STARTED|Study Part II for Subset 1||23
2882889|NCT00306995|3588208|FG000|COMPLETED|Study Part II for Subset 1||27
2882890|NCT00306995|3588209|FG001|COMPLETED|Study Part II for Subset 1||26
2882891|NCT00306995|3588210|FG002|COMPLETED|Study Part II for Subset 1||27
2882892|NCT00306995|3588211|FG003|COMPLETED|Study Part II for Subset 1||27
2882893|NCT00306995|3588212|FG004|COMPLETED|Study Part II for Subset 1||27
2882894|NCT00306995|3588213|FG005|COMPLETED|Study Part II for Subset 1||26
2882895|NCT00306995|3588214|FG006|COMPLETED|Study Part II for Subset 1||23
2882896|NCT00306995|3588208|FG000|NOT COMPLETED|Study Part II for Subset 1||0
2882897|NCT00306995|3588209|FG001|NOT COMPLETED|Study Part II for Subset 1||0
2882898|NCT00306995|3588210|FG002|NOT COMPLETED|Study Part II for Subset 1||0
2882899|NCT00306995|3588211|FG003|NOT COMPLETED|Study Part II for Subset 1||0
2882900|NCT00306995|3588212|FG004|NOT COMPLETED|Study Part II for Subset 1||0
2882901|NCT00306995|3588213|FG005|NOT COMPLETED|Study Part II for Subset 1||0
2882902|NCT00306995|3588214|FG006|NOT COMPLETED|Study Part II for Subset 1||0
2882903|NCT00306995|3588208|FG000|STARTED|Study Part II for Subset 2||23
2882904|NCT00306995|3588209|FG001|STARTED|Study Part II for Subset 2||24
2882905|NCT00306995|3588210|FG002|STARTED|Study Part II for Subset 2||23
2882906|NCT00306995|3588211|FG003|STARTED|Study Part II for Subset 2||22
2882907|NCT00306995|3588212|FG004|STARTED|Study Part II for Subset 2||23
2882908|NCT00306995|3588213|FG005|STARTED|Study Part II for Subset 2||26
2882909|NCT00306995|3588214|FG006|STARTED|Study Part II for Subset 2||24
2882910|NCT00306995|3588208|FG000|COMPLETED|Study Part II for Subset 2||23
2882911|NCT00306995|3588209|FG001|COMPLETED|Study Part II for Subset 2||23
2882912|NCT00306995|3588210|FG002|COMPLETED|Study Part II for Subset 2||23
2882913|NCT00306995|3588211|FG003|COMPLETED|Study Part II for Subset 2||22
2882914|NCT00306995|3588212|FG004|COMPLETED|Study Part II for Subset 2||23
2882915|NCT00306995|3588213|FG005|COMPLETED|Study Part II for Subset 2||26
2882916|NCT00306995|3588214|FG006|COMPLETED|Study Part II for Subset 2||24
2882917|NCT00306995|3588208|FG000|NOT COMPLETED|Study Part II for Subset 2||0
2882918|NCT00306995|3588209|FG001|NOT COMPLETED|Study Part II for Subset 2||1
2882919|NCT00306995|3588210|FG002|NOT COMPLETED|Study Part II for Subset 2||0
2882920|NCT00306995|3588211|FG003|NOT COMPLETED|Study Part II for Subset 2||0
2882921|NCT00306995|3588212|FG004|NOT COMPLETED|Study Part II for Subset 2||0
2882922|NCT00306995|3588213|FG005|NOT COMPLETED|Study Part II for Subset 2||0
2882923|NCT00306995|3588214|FG006|NOT COMPLETED|Study Part II for Subset 2||0
2882924|NCT00307034|3588261|FG000|STARTED|Overall Study||175
2882925|NCT00307034|3588262|FG001|STARTED|Overall Study||176
2882926|NCT00307034|3588261|FG000|COMPLETED|Overall Study||173
2882927|NCT00307034|3588262|FG001|COMPLETED|Overall Study||169
2882928|NCT00307034|3588261|FG000|NOT COMPLETED|Overall Study||2
3170153|NCT01928394|3897415|FG009|NOT COMPLETED|Follow-up Period||2
3170154|NCT01928394|3897416|FG010|NOT COMPLETED|Follow-up Period||11
3170155|NCT01928394|3897417|FG011|NOT COMPLETED|Follow-up Period||22
2882929|NCT00307034|3588262|FG001|NOT COMPLETED|Overall Study||7
2882930|NCT00307047|3588270|FG000|STARTED|Overall Study||2458
2882931|NCT00307047|3588271|FG001|STARTED|Overall Study||1229
2882932|NCT00307047|3588270|FG000|COMPLETED|Overall Study||2389
2882933|NCT00307047|3588271|FG001|COMPLETED|Overall Study||1180
2882934|NCT00307047|3588270|FG000|NOT COMPLETED|Overall Study||69
2882935|NCT00307047|3588271|FG001|NOT COMPLETED|Overall Study||49
2882936|NCT00307086|3588277|FG000|STARTED|Overall Study||30
2882937|NCT00307086|3588277|FG000|COMPLETED|Overall Study||25
2882938|NCT00307086|3588277|FG000|NOT COMPLETED|Overall Study||5
2882939|NCT00307125|3588283|FG000|STARTED|Screening Phase||757
2882940|NCT00307125|3588284|FG001|STARTED|Screening Phase||0
2882941|NCT00307125|3588285|FG002|STARTED|Screening Phase||0
2882942|NCT00307125|3588283|FG000|COMPLETED|Screening Phase||303
2882943|NCT00307125|3588284|FG001|COMPLETED|Screening Phase||0
2882944|NCT00307125|3588285|FG002|COMPLETED|Screening Phase||0
2882945|NCT00307125|3588283|FG000|NOT COMPLETED|Screening Phase||454
2882946|NCT00307125|3588284|FG001|NOT COMPLETED|Screening Phase||0
2882947|NCT00307125|3588285|FG002|NOT COMPLETED|Screening Phase||0
2882948|NCT00307125|3588283|FG000|STARTED|Pilot Phase||0
2882949|NCT00307125|3588284|FG001|STARTED|Pilot Phase||15
2882950|NCT00307125|3588285|FG002|STARTED|Pilot Phase||7
2882951|NCT00307125|3588283|FG000|COMPLETED|Pilot Phase||0
2882952|NCT00307125|3588284|FG001|COMPLETED|Pilot Phase|2 participants had reduced follow-up|13
2882953|NCT00307125|3588285|FG002|COMPLETED|Pilot Phase|1 participant had reduced follow-up|6
2882954|NCT00307125|3588283|FG000|NOT COMPLETED|Pilot Phase||0
2882955|NCT00307125|3588284|FG001|NOT COMPLETED|Pilot Phase||2
2882956|NCT00307125|3588285|FG002|NOT COMPLETED|Pilot Phase||1
2882957|NCT00307151|3588299|FG000|STARTED|Overall Study||82
2882958|NCT00307151|3588300|FG001|STARTED|Overall Study||82
2882959|NCT00307151|3588301|FG002|STARTED|Overall Study||147
2882960|NCT00307151|3588302|FG003|STARTED|Overall Study|One participant never started treatment, were not followed and not included in analysis.|140
2882961|NCT00307151|3588299|FG000|COMPLETED|Overall Study|Results are through date DSMB closed Cohort I to accrual (April 20, 2009)|71
2882962|NCT00307151|3588300|FG001|COMPLETED|Overall Study|Results are through date DSMB closed Cohort I to accrual (April 20, 2009)|75
2882963|NCT00307151|3588301|FG002|COMPLETED|Overall Study|Results are through date DSMB recommended Cohort II results be unblinded (October 27, 2010)|127
2882964|NCT00307151|3588302|FG003|COMPLETED|Overall Study|Results are through date DSMB recommended Cohort II results be unblinded (October 27, 2010)|129
2882965|NCT00307151|3588299|FG000|NOT COMPLETED|Overall Study||11
2882966|NCT00307151|3588300|FG001|NOT COMPLETED|Overall Study||7
2882967|NCT00307151|3588301|FG002|NOT COMPLETED|Overall Study||20
2882968|NCT00307151|3588302|FG003|NOT COMPLETED|Overall Study||11
2882969|NCT00307164|3588314|FG000|STARTED|Overall Study||83
2882970|NCT00307164|3588315|FG001|STARTED|Overall Study||82
2882971|NCT00307164|3588314|FG000|COMPLETED|Overall Study||68
2882972|NCT00307164|3588315|FG001|COMPLETED|Overall Study||68
2882973|NCT00307164|3588314|FG000|NOT COMPLETED|Overall Study||15
2882974|NCT00307164|3588315|FG001|NOT COMPLETED|Overall Study||14
2882975|NCT00307294|3588321|FG000|STARTED|Overall Study||40
2882976|NCT00307294|3588321|FG000|COMPLETED|Overall Study||39
2882977|NCT00307294|3588321|FG000|NOT COMPLETED|Overall Study||1
2882978|NCT00307333|3588328|FG000|STARTED|Overall Study||1511
2882979|NCT00307333|3588329|FG001|STARTED|Overall Study||1492
2882980|NCT00307333|3588328|FG000|COMPLETED|Overall Study||1500
2882981|NCT00307333|3588329|FG001|COMPLETED|Overall Study||1489
2882982|NCT00307333|3588328|FG000|NOT COMPLETED|Overall Study||11
2882983|NCT00307333|3588329|FG001|NOT COMPLETED|Overall Study||3
2882984|NCT00307437|3588338|FG000|STARTED|Controlled Period||410
2882985|NCT00307437|3588339|FG001|STARTED|Controlled Period||409
2882986|NCT00307437|3588340|FG002|STARTED|Controlled Period||411
2882987|NCT00307437|3588341|FG003|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
2882988|NCT00307437|3588342|FG004|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
2882989|NCT00307437|3588343|FG005|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
2882990|NCT00307437|3588344|FG006|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
2882991|NCT00307437|3588338|FG000|COMPLETED|Controlled Period||394
2882992|NCT00307437|3588339|FG001|COMPLETED|Controlled Period||403
2882993|NCT00307437|3588340|FG002|COMPLETED|Controlled Period||402
2882994|NCT00307437|3588341|FG003|COMPLETED|Controlled Period||0
2882995|NCT00307437|3588342|FG004|COMPLETED|Controlled Period||0
2882996|NCT00307437|3588343|FG005|COMPLETED|Controlled Period||0
2882997|NCT00307437|3588344|FG006|COMPLETED|Controlled Period||0
2882998|NCT00307437|3588338|FG000|NOT COMPLETED|Controlled Period||16
2882999|NCT00307437|3588339|FG001|NOT COMPLETED|Controlled Period||6
2883000|NCT00307437|3588340|FG002|NOT COMPLETED|Controlled Period||9
2883001|NCT00307437|3588341|FG003|NOT COMPLETED|Controlled Period||0
2883002|NCT00307437|3588342|FG004|NOT COMPLETED|Controlled Period||0
2883003|NCT00307437|3588343|FG005|NOT COMPLETED|Controlled Period||0
2883004|NCT00307437|3588344|FG006|NOT COMPLETED|Controlled Period||0
2883005|NCT00307437|3588338|FG000|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
2883006|NCT00307437|3588339|FG001|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
2883007|NCT00307437|3588340|FG002|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
2883008|NCT00307437|3588341|FG003|STARTED|After Controlled Period||197
2883009|NCT00307437|3588342|FG004|STARTED|After Controlled Period|2 participants from placebo group in CP did not crossover to this group after CP.|195
2883010|NCT00307437|3588343|FG005|STARTED|After Controlled Period||403
2883011|NCT00307437|3588344|FG006|STARTED|After Controlled Period||402
2883012|NCT00307437|3588338|FG000|COMPLETED|After Controlled Period||0
2883013|NCT00307437|3588339|FG001|COMPLETED|After Controlled Period||0
2883014|NCT00307437|3588340|FG002|COMPLETED|After Controlled Period||0
2883015|NCT00307437|3588341|FG003|COMPLETED|After Controlled Period||139
2883016|NCT00307437|3588342|FG004|COMPLETED|After Controlled Period||140
2883017|NCT00307437|3588343|FG005|COMPLETED|After Controlled Period||281
2883018|NCT00307437|3588344|FG006|COMPLETED|After Controlled Period||289
2883019|NCT00307437|3588338|FG000|NOT COMPLETED|After Controlled Period||0
2883020|NCT00307437|3588339|FG001|NOT COMPLETED|After Controlled Period||0
2883021|NCT00307437|3588340|FG002|NOT COMPLETED|After Controlled Period||0
2883022|NCT00307437|3588341|FG003|NOT COMPLETED|After Controlled Period||58
2883023|NCT00307437|3588342|FG004|NOT COMPLETED|After Controlled Period||55
2883024|NCT00307437|3588343|FG005|NOT COMPLETED|After Controlled Period||122
2883025|NCT00307437|3588344|FG006|NOT COMPLETED|After Controlled Period||113
2883026|NCT00307489|3588368|FG000|STARTED|Baseline Through Week 48||53
2883027|NCT00307489|3588369|FG001|STARTED|Baseline Through Week 48||52
2883028|NCT00307489|3588368|FG000|COMPLETED|Baseline Through Week 48|16 of the 52 subjects switched to open-label FTC/TDF prior to Week 48.|52
2883029|NCT00307489|3588369|FG001|COMPLETED|Baseline Through Week 48|9 of the 50 subjects switched to open-label FTC/TDF prior to Week 48.|50
2883030|NCT00307489|3588368|FG000|NOT COMPLETED|Baseline Through Week 48||1
2883031|NCT00307489|3588369|FG001|NOT COMPLETED|Baseline Through Week 48||2
2883032|NCT00307489|3588368|FG000|STARTED|Week 48 Through Week 168||52
2883033|NCT00307489|3588369|FG001|STARTED|Week 48 Through Week 168||50
2883034|NCT00307489|3588368|FG000|COMPLETED|Week 48 Through Week 168|11 of the 46 subjects switched to open-label FTC/TDF prior to Week 168.|46
2883035|NCT00307489|3588369|FG001|COMPLETED|Week 48 Through Week 168|5 of the 44 subjects switched to open-label FTC/TDF prior to Week 168.|44
2883036|NCT00307489|3588368|FG000|NOT COMPLETED|Week 48 Through Week 168||6
2883037|NCT00307489|3588369|FG001|NOT COMPLETED|Week 48 Through Week 168||6
2883038|NCT00307684|3588375|FG000|STARTED|Open Label Phase||0
2883039|NCT00307684|3588376|FG001|STARTED|Open Label Phase||0
2883040|NCT00307684|3588377|FG002|STARTED|Open Label Phase|1 screening failure|155
2883041|NCT00307684|3588375|FG000|COMPLETED|Open Label Phase||0
2883042|NCT00307684|3588376|FG001|COMPLETED|Open Label Phase||0
2883043|NCT00307684|3588377|FG002|COMPLETED|Open Label Phase||99
2883044|NCT00307684|3588375|FG000|NOT COMPLETED|Open Label Phase||0
2883045|NCT00307684|3588376|FG001|NOT COMPLETED|Open Label Phase||0
2883046|NCT00307684|3588377|FG002|NOT COMPLETED|Open Label Phase||56
2883047|NCT00307684|3588375|FG000|STARTED|Double Blind Phase||23
2883048|NCT00307684|3588376|FG001|STARTED|Double Blind Phase||22
2883049|NCT00307684|3588377|FG002|STARTED|Double Blind Phase||0
2883050|NCT00307684|3588375|FG000|COMPLETED|Double Blind Phase||21
2883051|NCT00307684|3588376|FG001|COMPLETED|Double Blind Phase||17
2883052|NCT00307684|3588377|FG002|COMPLETED|Double Blind Phase||0
2883053|NCT00307684|3588375|FG000|NOT COMPLETED|Double Blind Phase||2
2883054|NCT00307684|3588376|FG001|NOT COMPLETED|Double Blind Phase||5
2883055|NCT00307684|3588377|FG002|NOT COMPLETED|Double Blind Phase||0
2883056|NCT00307736|3588385|FG000|STARTED|Overall Study||3
2883057|NCT00307736|3588386|FG001|STARTED|Overall Study||3
2883058|NCT00307736|3588387|FG002|STARTED|Overall Study||3
2883059|NCT00307736|3588388|FG003|STARTED|Overall Study||23
2883060|NCT00307736|3588385|FG000|COMPLETED|Overall Study||3
2883061|NCT00307736|3588386|FG001|COMPLETED|Overall Study||3
2883062|NCT00307736|3588387|FG002|COMPLETED|Overall Study||0
2883063|NCT00307736|3588388|FG003|COMPLETED|Overall Study||20
2883064|NCT00307736|3588385|FG000|NOT COMPLETED|Overall Study||0
2883065|NCT00307736|3588386|FG001|NOT COMPLETED|Overall Study||0
2883066|NCT00307736|3588387|FG002|NOT COMPLETED|Overall Study||3
2883067|NCT00307736|3588388|FG003|NOT COMPLETED|Overall Study||3
2883068|NCT00307801|3588401|FG000|STARTED|Overall Study||149
2883069|NCT00307801|3588402|FG001|STARTED|Overall Study||82
2883070|NCT00307801|3588401|FG000|Subjects Received Treatment|Overall Study||145
2883071|NCT00307801|3588402|FG001|Subjects Received Treatment|Overall Study||81
2883072|NCT00307801|3588401|FG000|Cycle 1, Visit 5, Baseline|Overall Study||145
2883073|NCT00307801|3588402|FG001|Cycle 1, Visit 5, Baseline|Overall Study||81
2883074|NCT00307801|3588401|FG000|Cycle 3, Visit 7, Treatment Day 84|Overall Study||130
2883075|NCT00307801|3588402|FG001|Cycle 3, Visit 7, Treatment Day 84|Overall Study||71
2883076|NCT00307801|3588401|FG000|Cycle 7, Treatment Day 196|Overall Study|Includes subjects that prematurely discontinued the study and may not be counted in earlier visits.|141
2883077|NCT00307801|3588402|FG001|Cycle 7, Treatment Day 196|Overall Study|Includes subjects that prematurely discontinued the study and may not be counted in earlier visits.|77
2883078|NCT00307801|3588401|FG000|COMPLETED|Overall Study||117
2883079|NCT00307801|3588402|FG001|COMPLETED|Overall Study||65
2883080|NCT00307801|3588401|FG000|NOT COMPLETED|Overall Study||32
2883081|NCT00307801|3588402|FG001|NOT COMPLETED|Overall Study||17
2883082|NCT00307931|3588409|FG000|STARTED|Overall Study|Number of subjects who entered the study and have been treated|16
2883083|NCT00307931|3588409|FG000|COMPLETED|Overall Study|Number of subjects who completed the Week 12 visit|15
2883084|NCT00307931|3588409|FG000|NOT COMPLETED|Overall Study||1
2883085|NCT00308061|3588415|FG000|STARTED|Overall Study||20
2883086|NCT00308061|3588416|FG001|STARTED|Overall Study||20
2883087|NCT00308061|3588415|FG000|COMPLETED|Overall Study||20
2883088|NCT00308061|3588416|FG001|COMPLETED|Overall Study||20
2883089|NCT00308061|3588415|FG000|NOT COMPLETED|Overall Study||0
2883090|NCT00308061|3588416|FG001|NOT COMPLETED|Overall Study||0
2919458|NCT00531882|3629845|FG001|STARTED|Overall Study||10
2919459|NCT00531882|3629846|FG002|STARTED|Overall Study||5
2919460|NCT00531882|3629844|FG000|COMPLETED|Overall Study||10
2919461|NCT00531882|3629845|FG001|COMPLETED|Overall Study||10
2919462|NCT00531882|3629846|FG002|COMPLETED|Overall Study||5
2919463|NCT00531882|3629844|FG000|NOT COMPLETED|Overall Study||0
2919464|NCT00531882|3629845|FG001|NOT COMPLETED|Overall Study||0
2919465|NCT00531882|3629846|FG002|NOT COMPLETED|Overall Study||0
2919466|NCT00531934|3629856|FG000|STARTED|Overall Study||73
2919467|NCT00531934|3629857|FG001|STARTED|Overall Study||74
2919468|NCT00531934|3629856|FG000|COMPLETED|Overall Study||7
2919469|NCT00531934|3629857|FG001|COMPLETED|Overall Study||11
2919470|NCT00531934|3629856|FG000|NOT COMPLETED|Overall Study||66
2919471|NCT00531934|3629857|FG001|NOT COMPLETED|Overall Study||63
2919472|NCT00531947|3629865|FG000|STARTED|Overall Study|all randomized subjects who received at least one dose of placebo study medication|156
2919473|NCT00531947|3629866|FG001|STARTED|Overall Study|all randomized subjects who received at least one dose of EMSAM study medication|152
2919474|NCT00531947|3629865|FG000|COMPLETED|Overall Study||114
2919475|NCT00531947|3629866|FG001|COMPLETED|Overall Study||101
2919476|NCT00531947|3629865|FG000|NOT COMPLETED|Overall Study||42
2919477|NCT00531947|3629866|FG001|NOT COMPLETED|Overall Study||51
2919478|NCT00531960|3629874|FG000|STARTED|Overall Study||61
2919479|NCT00531960|3629875|FG001|STARTED|Overall Study||63
2919480|NCT00531960|3629874|FG000|COMPLETED|Overall Study||0
2919481|NCT00531960|3629875|FG001|COMPLETED|Overall Study||0
2919482|NCT00531960|3629874|FG000|NOT COMPLETED|Overall Study||61
2919483|NCT00531960|3629875|FG001|NOT COMPLETED|Overall Study||63
2919484|NCT00532129|3629881|FG000|STARTED|Treatment Period||100
2919485|NCT00532129|3629881|FG000|COMPLETED|Treatment Period||51
2919486|NCT00532129|3629881|FG000|NOT COMPLETED|Treatment Period||49
2919487|NCT00532129|3629881|FG000|STARTED|Follow-up Period||98
2919488|NCT00532129|3629881|FG000|COMPLETED|Follow-up Period||33
2919489|NCT00532129|3629881|FG000|NOT COMPLETED|Follow-up Period||65
2919490|NCT00532155|3629887|FG000|STARTED|Overall Study||457
2919491|NCT00532155|3629888|FG001|STARTED|Overall Study||456
2919492|NCT00532155|3629887|FG000|SAFETY POPULATION|Overall Study||455
2919493|NCT00532155|3629888|FG001|SAFETY POPULATION|Overall Study||450
2919494|NCT00532155|3629887|FG000|COMPLETED|Overall Study|Participants continued treatment until they met treatment discontinuation criteria|0
2919495|NCT00532155|3629888|FG001|COMPLETED|Overall Study|Participants continued treatment until they met treatment discontinuation criteria|0
2919496|NCT00532155|3629887|FG000|NOT COMPLETED|Overall Study||457
2919497|NCT00532155|3629888|FG001|NOT COMPLETED|Overall Study||456
2919498|NCT00532259|3629894|FG000|STARTED|Overall Study||72
2919499|NCT00532259|3629894|FG000|COMPLETED|Overall Study||40
2919500|NCT00532259|3629894|FG000|NOT COMPLETED|Overall Study||32
2919501|NCT00532298|3629905|FG000|STARTED|Overall Study||269
2919502|NCT00532298|3629906|FG001|STARTED|Overall Study||266
2919503|NCT00532298|3629907|FG002|STARTED|Overall Study||264
2919504|NCT00532298|3629908|FG003|STARTED|Overall Study||264
2919505|NCT00532298|3629909|FG004|STARTED|Overall Study||268
2919506|NCT00532298|3629910|FG005|STARTED|Overall Study||263
2919507|NCT00532298|3629905|FG000|COMPLETED|Overall Study||267
2919508|NCT00532298|3629906|FG001|COMPLETED|Overall Study||265
2919509|NCT00532298|3629907|FG002|COMPLETED|Overall Study||263
2919510|NCT00532298|3629908|FG003|COMPLETED|Overall Study||264
2919511|NCT00532298|3629909|FG004|COMPLETED|Overall Study||267
2919512|NCT00532298|3629910|FG005|COMPLETED|Overall Study||261
2919513|NCT00532298|3629905|FG000|NOT COMPLETED|Overall Study||2
2919514|NCT00532298|3629906|FG001|NOT COMPLETED|Overall Study||1
2919515|NCT00532298|3629907|FG002|NOT COMPLETED|Overall Study||1
2919516|NCT00532298|3629908|FG003|NOT COMPLETED|Overall Study||0
2919517|NCT00532298|3629909|FG004|NOT COMPLETED|Overall Study||1
2919518|NCT00532298|3629910|FG005|NOT COMPLETED|Overall Study||2
2919519|NCT00532441|3629924|FG000|STARTED|Overall Study||14
2919520|NCT00532441|3629925|FG001|STARTED|Overall Study||11
2919521|NCT00532441|3629924|FG000|COMPLETED|Overall Study||13
2919522|NCT00532441|3629925|FG001|COMPLETED|Overall Study||11
2919523|NCT00532441|3629924|FG000|NOT COMPLETED|Overall Study||1
2919524|NCT00532441|3629925|FG001|NOT COMPLETED|Overall Study||0
2919525|NCT00532480|3629934|FG000|STARTED|Overall Study||10
2919526|NCT00532480|3629934|FG000|COMPLETED|Overall Study||7
2919527|NCT00532480|3629934|FG000|NOT COMPLETED|Overall Study||3
2919528|NCT00532493|3629940|FG000|STARTED|Overall Study||152
2919529|NCT00532493|3629941|FG001|STARTED|Overall Study||152
2919530|NCT00532493|3629940|FG000|COMPLETED|Overall Study||122
2919531|NCT00532493|3629941|FG001|COMPLETED|Overall Study||123
2919532|NCT00532493|3629940|FG000|NOT COMPLETED|Overall Study||30
2919533|NCT00532493|3629941|FG001|NOT COMPLETED|Overall Study||29
2919534|NCT00532779|3629952|FG000|STARTED|Overall Study||578
2919535|NCT00532779|3629953|FG001|STARTED|Overall Study||583
2919536|NCT00532779|3629954|FG002|STARTED|Overall Study||581
2919537|NCT00532779|3629952|FG000|COMPLETED|Overall Study||284
2919538|NCT00532779|3629953|FG001|COMPLETED|Overall Study||296
2919539|NCT00532779|3629954|FG002|COMPLETED|Overall Study||290
2919540|NCT00532779|3629952|FG000|NOT COMPLETED|Overall Study||294
2919541|NCT00532779|3629953|FG001|NOT COMPLETED|Overall Study||287
2919542|NCT00532779|3629954|FG002|NOT COMPLETED|Overall Study||291
2919543|NCT00532844|3629964|FG000|STARTED|Treatment Period - Day 1 to Day 14|Only the 48 subjects enrolled in the final protocol are included in the participant flow.|24
2883091|NCT00308074|3588423|FG000|STARTED|Overall Study||14
2883092|NCT00308074|3588423|FG000|COMPLETED|Overall Study||13
2883093|NCT00308074|3588423|FG000|NOT COMPLETED|Overall Study||1
2883094|NCT00308087|3588429|FG000|STARTED|Overall Study||37
2883095|NCT00308087|3588430|FG001|STARTED|Overall Study||38
2883096|NCT00308087|3588429|FG000|COMPLETED|Overall Study|Completers finished treatment and the 24 month follow-up.|1
2883097|NCT00308087|3588430|FG001|COMPLETED|Overall Study|Completers finished treatment and the 24 month follow-up.|1
2883098|NCT00308087|3588429|FG000|NOT COMPLETED|Overall Study||36
2883099|NCT00308087|3588430|FG001|NOT COMPLETED|Overall Study||37
2883100|NCT00308139|3588438|FG000|STARTED|Overall Study||152
2883101|NCT00308139|3588439|FG001|STARTED|Overall Study||151
2883102|NCT00308139|3588438|FG000|Intent to Treat (ITT)|Overall Study|Subjects who received at least one injection of lead-in exenatide 5 mcg.|148
2883103|NCT00308139|3588439|FG001|Intent to Treat (ITT)|Overall Study|Subjects who received at least one injection of lead-in exenatide 5 mcg.|147
2883104|NCT00308139|3588438|FG000|ITT in the 30-Week Assessment|Overall Study|ITT Subjects who received at least one injection of randomized dose.|148
2883105|NCT00308139|3588439|FG001|ITT in the 30-Week Assessment|Overall Study|ITT Subjects who received at least one injection of randomized dose.|145
2883106|NCT00308139|3588438|FG000|Pharmacokinetics Population|Overall Study||129
2883107|NCT00308139|3588439|FG001|Pharmacokinetics Population|Overall Study||0
2883108|NCT00308139|3588438|FG000|Evaluable Meal Tolerance Cohort|Overall Study||27
2883109|NCT00308139|3588439|FG001|Evaluable Meal Tolerance Cohort|Overall Study||24
2883110|NCT00308139|3588438|FG000|30-Week Completed|Overall Study|Subjects who completed 30 weeks of assessment|128
2883111|NCT00308139|3588439|FG001|30-Week Completed|Overall Study|Subjects who completed 30 weeks of assessment|130
2883112|NCT00308139|3588438|FG000|COMPLETED|Overall Study|Subjects who completed 364 weeks of assessment|58
2883113|NCT00308139|3588439|FG001|COMPLETED|Overall Study|Subjects who completed 364 weeks of assessment|64
2883114|NCT00308139|3588438|FG000|NOT COMPLETED|Overall Study||94
2883115|NCT00308139|3588439|FG001|NOT COMPLETED|Overall Study||87
2883116|NCT00308230|3588468|FG000|STARTED|Overall Study||6
2883117|NCT00308230|3588469|FG001|STARTED|Overall Study||8
2883118|NCT00308230|3588470|FG002|STARTED|Overall Study||20
2883119|NCT00308230|3588468|FG000|COMPLETED|Overall Study||6
2883120|NCT00308230|3588469|FG001|COMPLETED|Overall Study||8
2883121|NCT00308230|3588470|FG002|COMPLETED|Overall Study||20
2883122|NCT00308230|3588468|FG000|NOT COMPLETED|Overall Study||0
2883123|NCT00308230|3588469|FG001|NOT COMPLETED|Overall Study||0
2883124|NCT00308230|3588470|FG002|NOT COMPLETED|Overall Study||0
2883125|NCT00308282|3588482|FG000|STARTED|Overall Study||34
2883126|NCT00308282|3588483|FG001|STARTED|Overall Study||34
2883127|NCT00308282|3588484|FG002|STARTED|Overall Study||34
2883128|NCT00308282|3588485|FG003|STARTED|Overall Study||34
2883129|NCT00308282|3588482|FG000|Received at Least One Dose of Study Drug|Overall Study||34
2883130|NCT00308282|3588483|FG001|Received at Least One Dose of Study Drug|Overall Study||34
2883131|NCT00308282|3588484|FG002|Received at Least One Dose of Study Drug|Overall Study||34
2883132|NCT00308282|3588485|FG003|Received at Least One Dose of Study Drug|Overall Study||34
2883133|NCT00308282|3588482|FG000|COMPLETED|Overall Study||31
2883134|NCT00308282|3588483|FG001|COMPLETED|Overall Study||30
2883135|NCT00308282|3588484|FG002|COMPLETED|Overall Study||33
2883136|NCT00308282|3588485|FG003|COMPLETED|Overall Study||32
2883137|NCT00308282|3588482|FG000|NOT COMPLETED|Overall Study||3
2883138|NCT00308282|3588483|FG001|NOT COMPLETED|Overall Study||4
2883139|NCT00308282|3588484|FG002|NOT COMPLETED|Overall Study||1
2883140|NCT00308282|3588485|FG003|NOT COMPLETED|Overall Study||2
2883141|NCT00308308|3588500|FG000|STARTED|Overall Study||301
2883142|NCT00308308|3588501|FG001|STARTED|Overall Study||288
2883143|NCT00308308|3588500|FG000|COMPLETED|Overall Study||198
2883144|NCT00308308|3588501|FG001|COMPLETED|Overall Study||220
2883145|NCT00308308|3588500|FG000|NOT COMPLETED|Overall Study||103
2883146|NCT00308308|3588501|FG001|NOT COMPLETED|Overall Study||68
2883147|NCT00308555|3588509|FG000|STARTED|Overall Study||13
2883148|NCT00308555|3588510|FG001|STARTED|Overall Study||11
2883149|NCT00308555|3588509|FG000|COMPLETED|Overall Study||10
2883150|NCT00308555|3588510|FG001|COMPLETED|Overall Study||11
2883151|NCT00308555|3588509|FG000|NOT COMPLETED|Overall Study||3
2883152|NCT00308555|3588510|FG001|NOT COMPLETED|Overall Study||0
2883153|NCT00308581|3588516|FG000|STARTED|Induction Phase|Not applicable in this period|0
2883154|NCT00308581|3588517|FG001|STARTED|Induction Phase|Not applicable in this period|0
2883155|NCT00308581|3588518|FG002|STARTED|Induction Phase||539
2883156|NCT00308581|3588516|FG000|COMPLETED|Induction Phase|Not applicable in this period|0
2883157|NCT00308581|3588517|FG001|COMPLETED|Induction Phase|Not applicable in this period|0
2883158|NCT00308581|3588518|FG002|COMPLETED|Induction Phase||373
2883159|NCT00308581|3588516|FG000|NOT COMPLETED|Induction Phase||0
2883160|NCT00308581|3588517|FG001|NOT COMPLETED|Induction Phase||0
2883161|NCT00308581|3588518|FG002|NOT COMPLETED|Induction Phase||166
2883162|NCT00308581|3588516|FG000|STARTED|Randomized Maintenance Phase||187
2883163|NCT00308581|3588517|FG001|STARTED|Randomized Maintenance Phase||186
2883164|NCT00308581|3588518|FG002|STARTED|Randomized Maintenance Phase||0
2883165|NCT00308581|3588516|FG000|COMPLETED|Randomized Maintenance Phase||82
2883166|NCT00308581|3588517|FG001|COMPLETED|Randomized Maintenance Phase||83
2883167|NCT00308581|3588518|FG002|COMPLETED|Randomized Maintenance Phase||0
2883168|NCT00308581|3588516|FG000|NOT COMPLETED|Randomized Maintenance Phase||105
2883169|NCT00308581|3588517|FG001|NOT COMPLETED|Randomized Maintenance Phase||103
2883170|NCT00308581|3588518|FG002|NOT COMPLETED|Randomized Maintenance Phase||0
2883171|NCT00308620|3588529|FG000|STARTED|Overall Study||3
2883172|NCT00308620|3588530|FG001|STARTED|Overall Study||4
2883173|NCT00308620|3588531|FG002|STARTED|Overall Study||6
2883174|NCT00308620|3588529|FG000|COMPLETED|Overall Study||2
2883175|NCT00308620|3588530|FG001|COMPLETED|Overall Study||3
2883176|NCT00308620|3588531|FG002|COMPLETED|Overall Study||5
2883177|NCT00308620|3588529|FG000|NOT COMPLETED|Overall Study||1
2883178|NCT00308620|3588530|FG001|NOT COMPLETED|Overall Study||1
2883179|NCT00308620|3588531|FG002|NOT COMPLETED|Overall Study||1
2883180|NCT00308711|3588542|FG000|STARTED|Overall Study||428
2883181|NCT00308711|3588543|FG001|STARTED|Overall Study||444
2883182|NCT00308711|3588544|FG002|STARTED|Overall Study||436
2883183|NCT00308711|3588542|FG000|COMPLETED|Overall Study||426
2883184|NCT00308711|3588543|FG001|COMPLETED|Overall Study||440
2883185|NCT00308711|3588544|FG002|COMPLETED|Overall Study||431
2883186|NCT00308711|3588542|FG000|NOT COMPLETED|Overall Study||2
2883187|NCT00308711|3588543|FG001|NOT COMPLETED|Overall Study||4
2883188|NCT00308711|3588544|FG002|NOT COMPLETED|Overall Study||5
2883189|NCT00308737|3588555|FG000|STARTED|Overall Study||938
2883190|NCT00308737|3588556|FG001|STARTED|Overall Study||951
2883191|NCT00308737|3588557|FG002|STARTED|Overall Study||164
2883192|NCT00308737|3588555|FG000|COMPLETED|Overall Study||475
2883193|NCT00308737|3588556|FG001|COMPLETED|Overall Study||662
2883194|NCT00308737|3588557|FG002|COMPLETED|Overall Study||127
2883195|NCT00308737|3588555|FG000|NOT COMPLETED|Overall Study||463
2883196|NCT00308737|3588556|FG001|NOT COMPLETED|Overall Study||289
2883197|NCT00308737|3588557|FG002|NOT COMPLETED|Overall Study||37
2883198|NCT00308750|3588568|FG000|STARTED|Overall Study||72
2883199|NCT00308750|3588569|FG001|STARTED|Overall Study||74
2883200|NCT00308750|3588570|FG002|STARTED|Overall Study||72
2883201|NCT00308750|3588568|FG000|Received at Least 1 Dose of Study Drug|Overall Study||67
2883202|NCT00308750|3588569|FG001|Received at Least 1 Dose of Study Drug|Overall Study||72
2883203|NCT00308750|3588570|FG002|Received at Least 1 Dose of Study Drug|Overall Study||70
2883204|NCT00308750|3588568|FG000|COMPLETED|Overall Study||0
2883205|NCT00308750|3588569|FG001|COMPLETED|Overall Study||34
2883206|NCT00308750|3588570|FG002|COMPLETED|Overall Study||23
2883207|NCT00308750|3588568|FG000|NOT COMPLETED|Overall Study||72
2883208|NCT00308750|3588569|FG001|NOT COMPLETED|Overall Study||40
2883209|NCT00308750|3588570|FG002|NOT COMPLETED|Overall Study||49
2883210|NCT00308997|3588581|FG000|STARTED|Overall Study||56
2883211|NCT00308997|3588582|FG001|STARTED|Overall Study||29
2883212|NCT00308997|3588581|FG000|COMPLETED|Overall Study||55
2883213|NCT00308997|3588582|FG001|COMPLETED|Overall Study||28
2883214|NCT00308997|3588581|FG000|NOT COMPLETED|Overall Study||1
2883215|NCT00308997|3588582|FG001|NOT COMPLETED|Overall Study||1
2883216|NCT00309140|3588588|FG000|STARTED|Overall Study||23
2883217|NCT00309140|3588588|FG000|Received at Least 1 Dose of Study Drug|Overall Study||23
2883218|NCT00309140|3588588|FG000|COMPLETED|Overall Study||23
2883219|NCT00309140|3588588|FG000|NOT COMPLETED|Overall Study||0
2883220|NCT00309166|3588594|FG000|STARTED|Overall Study||181
2883221|NCT00309166|3588595|FG001|STARTED|Overall Study||89
2883222|NCT00309166|3588594|FG000|COMPLETED|Overall Study||176
2883223|NCT00309166|3588595|FG001|COMPLETED|Overall Study||86
2883224|NCT00309166|3588594|FG000|NOT COMPLETED|Overall Study||5
2883225|NCT00309166|3588595|FG001|NOT COMPLETED|Overall Study||3
2883226|NCT00309244|3588603|FG000|STARTED|Overall Study||334
2883227|NCT00309244|3588604|FG001|STARTED|Overall Study||343
2883228|NCT00309244|3588603|FG000|COMPLETED|Overall Study||216
2883229|NCT00309244|3588604|FG001|COMPLETED|Overall Study||246
2883230|NCT00309244|3588603|FG000|NOT COMPLETED|Overall Study||118
2883231|NCT00309244|3588604|FG001|NOT COMPLETED|Overall Study||97
2883232|NCT00309387|3588612|FG000|STARTED|Overall Study||510
2883233|NCT00309387|3588613|FG001|STARTED|Overall Study||510
2883234|NCT00309387|3588612|FG000|COMPLETED|Overall Study||368
2883235|NCT00309387|3588613|FG001|COMPLETED|Overall Study||351
2883236|NCT00309387|3588612|FG000|NOT COMPLETED|Overall Study||142
2883237|NCT00309387|3588613|FG001|NOT COMPLETED|Overall Study||159
2883238|NCT00309452|3588622|FG000|STARTED|Overall Study||60
2883239|NCT00309452|3588623|FG001|STARTED|Overall Study||60
2883240|NCT00309452|3588622|FG000|COMPLETED|Overall Study||57
2883241|NCT00309452|3588623|FG001|COMPLETED|Overall Study||60
2883242|NCT00309452|3588622|FG000|NOT COMPLETED|Overall Study||3
2883243|NCT00309452|3588623|FG001|NOT COMPLETED|Overall Study||0
2883244|NCT00309465|3588635|FG000|STARTED|Overall Study||58
2883245|NCT00309465|3588636|FG001|STARTED|Overall Study||58
2883246|NCT00309465|3588637|FG002|STARTED|Overall Study||58
3314688|NCT03091400|4047984|FG000|STARTED|Phase 1 - 6 Weeks||5
3314689|NCT03091400|4047985|FG001|STARTED|Phase 1 - 6 Weeks||6
3314690|NCT03091400|4047984|FG000|COMPLETED|Phase 1 - 6 Weeks||5
3314691|NCT03091400|4047985|FG001|COMPLETED|Phase 1 - 6 Weeks||6
3314692|NCT03091400|4047984|FG000|NOT COMPLETED|Phase 1 - 6 Weeks||0
3314693|NCT03091400|4047985|FG001|NOT COMPLETED|Phase 1 - 6 Weeks||0
3314694|NCT03091400|4047984|FG000|STARTED|Washout - 2 Weeks||5
3314695|NCT03091400|4047985|FG001|STARTED|Washout - 2 Weeks||6
3314696|NCT03091400|4047984|FG000|COMPLETED|Washout - 2 Weeks||4
3314697|NCT03091400|4047985|FG001|COMPLETED|Washout - 2 Weeks||6
2883247|NCT00309465|3588638|FG003|STARTED|Overall Study||76
2883248|NCT00309465|3588639|FG004|STARTED|Overall Study||76
2883249|NCT00309465|3588640|FG005|STARTED|Overall Study||76
2883250|NCT00309465|3588635|FG000|COMPLETED|Overall Study||58
2883251|NCT00309465|3588636|FG001|COMPLETED|Overall Study||58
2883252|NCT00309465|3588637|FG002|COMPLETED|Overall Study||58
2883253|NCT00309465|3588638|FG003|COMPLETED|Overall Study|One subject was excluded due to eligibility error.|75
2883254|NCT00309465|3588639|FG004|COMPLETED|Overall Study||76
2883255|NCT00309465|3588640|FG005|COMPLETED|Overall Study||76
2883256|NCT00309465|3588635|FG000|NOT COMPLETED|Overall Study||0
2883257|NCT00309465|3588636|FG001|NOT COMPLETED|Overall Study||0
2883258|NCT00309465|3588637|FG002|NOT COMPLETED|Overall Study||0
2883259|NCT00309465|3588638|FG003|NOT COMPLETED|Overall Study||1
2883260|NCT00309465|3588639|FG004|NOT COMPLETED|Overall Study||0
2883261|NCT00309465|3588640|FG005|NOT COMPLETED|Overall Study||0
2883262|NCT00309608|3588659|FG000|STARTED|Overall Study||71
2883263|NCT00309608|3588660|FG001|STARTED|Overall Study||65
2883264|NCT00309608|3588661|FG002|STARTED|Overall Study||66
2883265|NCT00309608|3588662|FG003|STARTED|Overall Study||66
2883266|NCT00309608|3588663|FG004|STARTED|Overall Study||65
2883267|NCT00309608|3588659|FG000|COMPLETED|Overall Study||57
2883268|NCT00309608|3588660|FG001|COMPLETED|Overall Study||52
2883269|NCT00309608|3588661|FG002|COMPLETED|Overall Study||56
2883270|NCT00309608|3588662|FG003|COMPLETED|Overall Study||60
2883271|NCT00309608|3588663|FG004|COMPLETED|Overall Study||61
2883272|NCT00309608|3588659|FG000|NOT COMPLETED|Overall Study||14
2883273|NCT00309608|3588660|FG001|NOT COMPLETED|Overall Study||13
2883274|NCT00309608|3588661|FG002|NOT COMPLETED|Overall Study||10
2883275|NCT00309608|3588662|FG003|NOT COMPLETED|Overall Study||6
2883276|NCT00309608|3588663|FG004|NOT COMPLETED|Overall Study||4
2883277|NCT00309738|3588677|FG000|STARTED|Overall Study||236
2883278|NCT00309738|3588678|FG001|STARTED|Overall Study||119
2883279|NCT00309738|3588677|FG000|Safety Population|Overall Study|Subjects who received at least one dose of study medication|233
2883280|NCT00309738|3588678|FG001|Safety Population|Overall Study|Subjects who received at least one dose of study medication|119
2883281|NCT00309738|3588677|FG000|COMPLETED|Overall Study||223
2883282|NCT00309738|3588678|FG001|COMPLETED|Overall Study||107
2883283|NCT00309738|3588677|FG000|NOT COMPLETED|Overall Study||13
2883284|NCT00309738|3588678|FG001|NOT COMPLETED|Overall Study||12
2883285|NCT00309751|3588686|FG000|STARTED|Overall Study||279
2883286|NCT00309751|3588687|FG001|STARTED|Overall Study||139
2883287|NCT00309751|3588686|FG000|Safety Population|Overall Study|Subjects who received at least 1 dose of study drug|275
2883288|NCT00309751|3588687|FG001|Safety Population|Overall Study|Subjects who received at least 1 dose of study drug|137
2883289|NCT00309751|3588686|FG000|COMPLETED|Overall Study||248
2883290|NCT00309751|3588687|FG001|COMPLETED|Overall Study||124
2883291|NCT00309751|3588686|FG000|NOT COMPLETED|Overall Study||31
2883292|NCT00309751|3588687|FG001|NOT COMPLETED|Overall Study||15
2883293|NCT00309777|3588697|FG000|STARTED|Overall Study||315
2883294|NCT00309777|3588698|FG001|STARTED|Overall Study||108
2883295|NCT00309777|3588699|FG002|STARTED|Overall Study||323
2883296|NCT00309777|3588700|FG003|STARTED|Overall Study||111
2883297|NCT00309777|3588697|FG000|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|311
2883298|NCT00309777|3588698|FG001|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|107
2883299|NCT00309777|3588699|FG002|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|320
2883300|NCT00309777|3588700|FG003|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|110
2883301|NCT00309777|3588697|FG000|COMPLETED|Overall Study||292
2883302|NCT00309777|3588698|FG001|COMPLETED|Overall Study||99
2883303|NCT00309777|3588699|FG002|COMPLETED|Overall Study||304
2883304|NCT00309777|3588700|FG003|COMPLETED|Overall Study||107
2883305|NCT00309777|3588697|FG000|NOT COMPLETED|Overall Study||23
2883306|NCT00309777|3588698|FG001|NOT COMPLETED|Overall Study||9
2883307|NCT00309777|3588699|FG002|NOT COMPLETED|Overall Study||19
2883308|NCT00309777|3588700|FG003|NOT COMPLETED|Overall Study||4
2883309|NCT00309842|3588710|FG000|STARTED|Overall Study||213
2883310|NCT00309842|3588710|FG000|COMPLETED|Overall Study||212
2883311|NCT00309842|3588710|FG000|NOT COMPLETED|Overall Study||1
2883312|NCT00309907|3588714|FG000|STARTED|Overall Study||39
2883313|NCT00309907|3588714|FG000|COMPLETED|Overall Study||19
2883314|NCT00309907|3588714|FG000|NOT COMPLETED|Overall Study||20
2883315|NCT00309946|3588719|FG000|STARTED|Overall Study||51
2883316|NCT00309946|3588719|FG000|COMPLETED|Overall Study||50
2883317|NCT00309946|3588719|FG000|NOT COMPLETED|Overall Study||1
2883318|NCT00309959|3588723|FG000|STARTED|Overall Study||37
2883319|NCT00309959|3588723|FG000|COMPLETED|Overall Study||35
2883320|NCT00309959|3588723|FG000|NOT COMPLETED|Overall Study||2
2883321|NCT00309985|3588734|FG000|STARTED|Overall Study||397
2883322|NCT00309985|3588735|FG001|STARTED|Overall Study||393
2883323|NCT00309985|3588734|FG000|Toxicity Analysis|Overall Study||390
2883324|NCT00309985|3588735|FG001|Toxicity Analysis|Overall Study||392
2883325|NCT00309985|3588734|FG000|Both Baseline and 3-month FACT-P Evals|Overall Study||334
2883326|NCT00309985|3588735|FG001|Both Baseline and 3-month FACT-P Evals|Overall Study||299
2883327|NCT00309985|3588734|FG000|COMPLETED|Overall Study||335
2883328|NCT00309985|3588735|FG001|COMPLETED|Overall Study|"Arm B tx info was not collected so only 1 patient w/o follow-up data was considered not completed."|392
2883329|NCT00309985|3588734|FG000|NOT COMPLETED|Overall Study||62
2883330|NCT00309985|3588735|FG001|NOT COMPLETED|Overall Study||1
2883331|NCT00310037|3588743|FG000|STARTED|Overall Study||52
2883332|NCT00310037|3588744|FG001|STARTED|Overall Study||50
2883333|NCT00310037|3588743|FG000|COMPLETED|Overall Study||34
2883334|NCT00310037|3588744|FG001|COMPLETED|Overall Study||33
2883335|NCT00310037|3588743|FG000|NOT COMPLETED|Overall Study||18
2883336|NCT00310037|3588744|FG001|NOT COMPLETED|Overall Study||17
2883337|NCT00310050|3588750|FG000|STARTED|Overall Study||4
2883338|NCT00310050|3588750|FG000|COMPLETED|Overall Study||3
2883339|NCT00310050|3588750|FG000|NOT COMPLETED|Overall Study||1
2883340|NCT00310076|3588754|FG000|STARTED|Overall Study||29
2883341|NCT00310076|3588754|FG000|COMPLETED|Overall Study||26
2883342|NCT00310076|3588754|FG000|NOT COMPLETED|Overall Study||3
2883343|NCT00310310|3588760|FG000|STARTED|Overall Study||120
2883344|NCT00310310|3588761|FG001|STARTED|Overall Study||120
2883345|NCT00310310|3588760|FG000|COMPLETED|Overall Study||90
2883346|NCT00310310|3588761|FG001|COMPLETED|Overall Study||100
2883347|NCT00310310|3588760|FG000|NOT COMPLETED|Overall Study||30
2883348|NCT00310310|3588761|FG001|NOT COMPLETED|Overall Study||20
2883349|NCT00310362|3588770|FG000|STARTED|Overall Study||1199
2883350|NCT00310362|3588771|FG001|STARTED|Overall Study||1205
2883351|NCT00310362|3588772|FG002|STARTED|Overall Study||1206
2883352|NCT00310362|3588770|FG000|COMPLETED|Overall Study||1199
2883353|NCT00310362|3588771|FG001|COMPLETED|Overall Study||1205
2883354|NCT00310362|3588772|FG002|COMPLETED|Overall Study||1206
2883355|NCT00310362|3588770|FG000|NOT COMPLETED|Overall Study||0
2883356|NCT00310362|3588771|FG001|NOT COMPLETED|Overall Study||0
2883357|NCT00310362|3588772|FG002|NOT COMPLETED|Overall Study||0
2883358|NCT00310375|3588788|FG000|STARTED|Primary Reporting Phase||102
2883359|NCT00310375|3588789|FG001|STARTED|Primary Reporting Phase||79
2883360|NCT00310375|3588790|FG002|STARTED|Primary Reporting Phase||0
2883361|NCT00310375|3588788|FG000|COMPLETED|Primary Reporting Phase||11
2883362|NCT00310375|3588789|FG001|COMPLETED|Primary Reporting Phase||11
2883363|NCT00310375|3588790|FG002|COMPLETED|Primary Reporting Phase||0
2883364|NCT00310375|3588788|FG000|NOT COMPLETED|Primary Reporting Phase||91
2883365|NCT00310375|3588789|FG001|NOT COMPLETED|Primary Reporting Phase||68
2883366|NCT00310375|3588790|FG002|NOT COMPLETED|Primary Reporting Phase||0
2883367|NCT00310375|3588788|FG000|STARTED|Safety Follow-up Continuation Phase||0
2883368|NCT00310375|3588789|FG001|STARTED|Safety Follow-up Continuation Phase||0
2883369|NCT00310375|3588790|FG002|STARTED|Safety Follow-up Continuation Phase||19
2883370|NCT00310375|3588788|FG000|COMPLETED|Safety Follow-up Continuation Phase||0
2883371|NCT00310375|3588789|FG001|COMPLETED|Safety Follow-up Continuation Phase||0
2883372|NCT00310375|3588790|FG002|COMPLETED|Safety Follow-up Continuation Phase|Met the protocol defined stopping criteria|18
2883373|NCT00310375|3588788|FG000|NOT COMPLETED|Safety Follow-up Continuation Phase||0
2883374|NCT00310375|3588789|FG001|NOT COMPLETED|Safety Follow-up Continuation Phase||0
2883375|NCT00310375|3588790|FG002|NOT COMPLETED|Safety Follow-up Continuation Phase||1
2883376|NCT00310401|3588801|FG000|STARTED|Overall Study||260
2883377|NCT00310401|3588802|FG001|STARTED|Overall Study||246
2883378|NCT00310401|3588801|FG000|COMPLETED|Overall Study||260
2883379|NCT00310401|3588802|FG001|COMPLETED|Overall Study||246
2883380|NCT00310401|3588801|FG000|NOT COMPLETED|Overall Study||0
2883381|NCT00310401|3588802|FG001|NOT COMPLETED|Overall Study||0
2883382|NCT00310427|3588812|FG000|STARTED|Overall Study||27
2883383|NCT00310427|3588813|FG001|STARTED|Overall Study||26
2883384|NCT00310427|3588812|FG000|COMPLETED|Overall Study||25
2883385|NCT00310427|3588813|FG001|COMPLETED|Overall Study||25
2883386|NCT00310427|3588812|FG000|NOT COMPLETED|Overall Study||2
2883387|NCT00310427|3588813|FG001|NOT COMPLETED|Overall Study||1
2883388|NCT00310440|3588821|FG000|STARTED|Overall Study||165
2883389|NCT00310440|3588822|FG001|STARTED|Overall Study||154
2883390|NCT00310440|3588821|FG000|COMPLETED|Overall Study||139
3314698|NCT03091400|4047984|FG000|NOT COMPLETED|Washout - 2 Weeks||1
3314699|NCT03091400|4047985|FG001|NOT COMPLETED|Washout - 2 Weeks||0
3314700|NCT03091400|4047984|FG000|STARTED|Phase 2 - 6 Weeks||4
3314701|NCT03091400|4047985|FG001|STARTED|Phase 2 - 6 Weeks||6
2883391|NCT00310440|3588822|FG001|COMPLETED|Overall Study||141
2883392|NCT00310440|3588821|FG000|NOT COMPLETED|Overall Study||26
2883393|NCT00310440|3588822|FG001|NOT COMPLETED|Overall Study||13
2883394|NCT00310466|3588830|FG000|STARTED|Overall Study||113
2883395|NCT00310466|3588831|FG001|STARTED|Overall Study||113
2883396|NCT00310466|3588830|FG000|COMPLETED|Overall Study||95
2883397|NCT00310466|3588831|FG001|COMPLETED|Overall Study||101
2883398|NCT00310466|3588830|FG000|NOT COMPLETED|Overall Study||18
2883399|NCT00310466|3588831|FG001|NOT COMPLETED|Overall Study||12
2883400|NCT00310791|3588839|FG000|STARTED|Overall Study||40
2883401|NCT00310791|3588840|FG001|STARTED|Overall Study||40
2883402|NCT00310791|3588839|FG000|COMPLETED|Overall Study||30
2883403|NCT00310791|3588840|FG001|COMPLETED|Overall Study||30
2883404|NCT00310791|3588839|FG000|NOT COMPLETED|Overall Study||10
2883405|NCT00310791|3588840|FG001|NOT COMPLETED|Overall Study||10
2883406|NCT00310804|3588848|FG000|STARTED|Overall Study||1029
2883407|NCT00310804|3588849|FG001|STARTED|Overall Study||171
2883408|NCT00310804|3588848|FG000|COMPLETED|Overall Study||1024
2883409|NCT00310804|3588849|FG001|COMPLETED|Overall Study||171
2883410|NCT00310804|3588848|FG000|NOT COMPLETED|Overall Study||5
2883411|NCT00310804|3588849|FG001|NOT COMPLETED|Overall Study||0
2883412|NCT00310817|3588873|FG000|STARTED|Overall Study||207
2883413|NCT00310817|3588874|FG001|STARTED|Overall Study||206
2883414|NCT00310817|3588875|FG002|STARTED|Overall Study||128
2883415|NCT00310817|3588876|FG003|STARTED|Overall Study||82
2883416|NCT00310817|3588873|FG000|COMPLETED|Overall Study||196
2883417|NCT00310817|3588874|FG001|COMPLETED|Overall Study||198
2883418|NCT00310817|3588875|FG002|COMPLETED|Overall Study||120
2883419|NCT00310817|3588876|FG003|COMPLETED|Overall Study||74
2883420|NCT00310817|3588873|FG000|NOT COMPLETED|Overall Study||11
2883421|NCT00310817|3588874|FG001|NOT COMPLETED|Overall Study||8
2883422|NCT00310817|3588875|FG002|NOT COMPLETED|Overall Study||8
3170156|NCT01928394|3897418|FG012|NOT COMPLETED|Follow-up Period||14
3170157|NCT01928394|3897419|FG013|NOT COMPLETED|Follow-up Period||38
3170158|NCT01928394|3897420|FG014|NOT COMPLETED|Follow-up Period||30
2883423|NCT00310817|3588876|FG003|NOT COMPLETED|Overall Study||8
2883424|NCT00310856|3588922|FG000|STARTED|Overall Study||64
2883425|NCT00310856|3588923|FG001|STARTED|Overall Study||61
2883426|NCT00310856|3588924|FG002|STARTED|Overall Study||50
2883427|NCT00310856|3588922|FG000|COMPLETED|Overall Study||59
2883428|NCT00310856|3588923|FG001|COMPLETED|Overall Study||56
2883429|NCT00310856|3588924|FG002|COMPLETED|Overall Study||42
2883430|NCT00310856|3588922|FG000|NOT COMPLETED|Overall Study||5
2883431|NCT00310856|3588923|FG001|NOT COMPLETED|Overall Study||5
2883432|NCT00310856|3588924|FG002|NOT COMPLETED|Overall Study||8
2883433|NCT00311155|3588933|FG000|STARTED|Overall Study||694
2883434|NCT00311155|3588933|FG000|COMPLETED|Overall Study|Some participants had multiple reasons for discontinuation|601
2883435|NCT00311155|3588933|FG000|NOT COMPLETED|Overall Study||93
2883436|NCT00311168|3588939|FG000|STARTED|First Intervention||66
2883437|NCT00311168|3588940|FG001|STARTED|First Intervention||68
2883438|NCT00311168|3588939|FG000|COMPLETED|First Intervention||59
2883439|NCT00311168|3588940|FG001|COMPLETED|First Intervention||62
2883440|NCT00311168|3588939|FG000|NOT COMPLETED|First Intervention||7
2883441|NCT00311168|3588940|FG001|NOT COMPLETED|First Intervention||6
2883442|NCT00311168|3588939|FG000|STARTED|Second Intervention||59
2883443|NCT00311168|3588940|FG001|STARTED|Second Intervention||62
2883444|NCT00311168|3588939|FG000|COMPLETED|Second Intervention||49
2883445|NCT00311168|3588940|FG001|COMPLETED|Second Intervention||58
2883446|NCT00311168|3588939|FG000|NOT COMPLETED|Second Intervention||10
2883447|NCT00311168|3588940|FG001|NOT COMPLETED|Second Intervention||4
2883448|NCT00311181|3588948|FG000|STARTED|Overall Study||217
2883449|NCT00311181|3588948|FG000|COMPLETED|Overall Study||121
2883450|NCT00311181|3588948|FG000|NOT COMPLETED|Overall Study||96
2883451|NCT00311246|3588952|FG000|STARTED|Overall Study||11
2883452|NCT00311246|3588952|FG000|COMPLETED|Overall Study||11
2883453|NCT00311246|3588952|FG000|NOT COMPLETED|Overall Study||0
2883454|NCT00311311|3588961|FG000|STARTED|Overall Study||37
2883455|NCT00311311|3588962|FG001|STARTED|Overall Study||35
2883456|NCT00311311|3588961|FG000|COMPLETED|Overall Study||29
2883457|NCT00311311|3588962|FG001|COMPLETED|Overall Study||26
2883458|NCT00311311|3588961|FG000|NOT COMPLETED|Overall Study||8
2883459|NCT00311311|3588962|FG001|NOT COMPLETED|Overall Study||9
2883460|NCT00311363|3588971|FG000|STARTED|24-Week Single-Blind Treatment Period||327
2883461|NCT00311363|3588972|FG001|STARTED|24-Week Single-Blind Treatment Period||0
2883462|NCT00311363|3588973|FG002|STARTED|24-Week Single-Blind Treatment Period||0
2883463|NCT00311363|3588971|FG000|COMPLETED|24-Week Single-Blind Treatment Period||221
2883464|NCT00311363|3588972|FG001|COMPLETED|24-Week Single-Blind Treatment Period||0
2883465|NCT00311363|3588973|FG002|COMPLETED|24-Week Single-Blind Treatment Period||0
2883466|NCT00311363|3588971|FG000|NOT COMPLETED|24-Week Single-Blind Treatment Period||106
2883467|NCT00311363|3588972|FG001|NOT COMPLETED|24-Week Single-Blind Treatment Period||0
2883468|NCT00311363|3588973|FG002|NOT COMPLETED|24-Week Single-Blind Treatment Period||0
2883469|NCT00311363|3588971|FG000|STARTED|12-Week Double-Blind Treatment Period||0
2883470|NCT00311363|3588972|FG001|STARTED|12-Week Double-Blind Treatment Period||98
2883471|NCT00311363|3588973|FG002|STARTED|12-Week Double-Blind Treatment Period||96
2883472|NCT00311363|3588971|FG000|COMPLETED|12-Week Double-Blind Treatment Period||0
2883473|NCT00311363|3588972|FG001|COMPLETED|12-Week Double-Blind Treatment Period||84
2883474|NCT00311363|3588973|FG002|COMPLETED|12-Week Double-Blind Treatment Period||84
2883475|NCT00311363|3588971|FG000|NOT COMPLETED|12-Week Double-Blind Treatment Period||0
2883476|NCT00311363|3588972|FG001|NOT COMPLETED|12-Week Double-Blind Treatment Period||14
2883477|NCT00311363|3588973|FG002|NOT COMPLETED|12-Week Double-Blind Treatment Period||12
2883478|NCT00311376|3588986|FG000|STARTED|Treatment Cycle 1||132
2883479|NCT00311376|3588987|FG001|STARTED|Treatment Cycle 1||135
2883480|NCT00311376|3588988|FG002|STARTED|Treatment Cycle 1||149
2883481|NCT00311376|3588986|FG000|COMPLETED|Treatment Cycle 1||105
2883482|NCT00311376|3588987|FG001|COMPLETED|Treatment Cycle 1||118
2883483|NCT00311376|3588988|FG002|COMPLETED|Treatment Cycle 1||132
2883484|NCT00311376|3588986|FG000|NOT COMPLETED|Treatment Cycle 1||27
2883485|NCT00311376|3588987|FG001|NOT COMPLETED|Treatment Cycle 1||17
2883486|NCT00311376|3588988|FG002|NOT COMPLETED|Treatment Cycle 1||17
2883487|NCT00311376|3588986|FG000|STARTED|Treatment Cycle 2|69 from the 300U group + 46 from the Placebo group entered Cycle 2|115
2883488|NCT00311376|3588987|FG001|STARTED|Treatment Cycle 2|74 from the 200U group + 51 from the Placebo group entered Cycle 2|125
2883489|NCT00311376|3588988|FG002|STARTED|Treatment Cycle 2|Cycle 1 Placebo pts were randomized to receive 300U or 200U in Cycle 2|0
2883490|NCT00311376|3588986|FG000|COMPLETED|Treatment Cycle 2||106
2883491|NCT00311376|3588987|FG001|COMPLETED|Treatment Cycle 2||112
2883492|NCT00311376|3588988|FG002|COMPLETED|Treatment Cycle 2||0
2883493|NCT00311376|3588986|FG000|NOT COMPLETED|Treatment Cycle 2||9
2883494|NCT00311376|3588987|FG001|NOT COMPLETED|Treatment Cycle 2||13
2883495|NCT00311376|3588988|FG002|NOT COMPLETED|Treatment Cycle 2||0
2883496|NCT00311402|3588998|FG000|STARTED|Overall Study||655
2883497|NCT00311402|3588999|FG001|STARTED|Overall Study||639
2883498|NCT00311402|3588998|FG000|COMPLETED|Overall Study||445
2883499|NCT00311402|3588999|FG001|COMPLETED|Overall Study||462
2883500|NCT00311402|3588998|FG000|NOT COMPLETED|Overall Study||210
2883501|NCT00311402|3588999|FG001|NOT COMPLETED|Overall Study||177
2883502|NCT00311584|3589007|FG000|STARTED|Overall Study||29
3170159|NCT01928394|3897421|FG015|NOT COMPLETED|Follow-up Period||0
2883503|NCT00311584|3589008|FG001|STARTED|Overall Study||30
2883504|NCT00311584|3589007|FG000|COMPLETED|Overall Study||9
2883505|NCT00311584|3589008|FG001|COMPLETED|Overall Study||7
2883506|NCT00311584|3589007|FG000|NOT COMPLETED|Overall Study||20
2883507|NCT00311584|3589008|FG001|NOT COMPLETED|Overall Study||23
2883508|NCT00311623|3589017|FG000|STARTED|Overall Study||10
2883509|NCT00311623|3589018|FG001|STARTED|Overall Study||20
2883510|NCT00311623|3589019|FG002|STARTED|Overall Study||2
2883511|NCT00311623|3589017|FG000|COMPLETED|Overall Study||10
2883512|NCT00311623|3589018|FG001|COMPLETED|Overall Study||20
2883513|NCT00311623|3589019|FG002|COMPLETED|Overall Study||0
2883514|NCT00311623|3589017|FG000|NOT COMPLETED|Overall Study||0
2883515|NCT00311623|3589018|FG001|NOT COMPLETED|Overall Study||0
2883516|NCT00311623|3589019|FG002|NOT COMPLETED|Overall Study||2
2883517|NCT00311766|3589030|FG000|STARTED|Overall Study||8
2883518|NCT00311766|3589031|FG001|STARTED|Overall Study||22
2883519|NCT00311766|3589030|FG000|COMPLETED|Overall Study||8
2883520|NCT00311766|3589031|FG001|COMPLETED|Overall Study||17
2883521|NCT00311766|3589030|FG000|NOT COMPLETED|Overall Study||0
2883522|NCT00311766|3589031|FG001|NOT COMPLETED|Overall Study||5
2883523|NCT00312195|3589039|FG000|STARTED|Overall Study||138
2883524|NCT00312195|3589040|FG001|STARTED|Overall Study||129
2883525|NCT00312195|3589039|FG000|COMPLETED|Overall Study||132
2883526|NCT00312195|3589040|FG001|COMPLETED|Overall Study||123
2883527|NCT00312195|3589039|FG000|NOT COMPLETED|Overall Study||6
2883528|NCT00312195|3589040|FG001|NOT COMPLETED|Overall Study||6
2883529|NCT00312208|3589050|FG000|STARTED|Overall Study|1649 patients randomized, 1634 patients treated|1649
2883530|NCT00312208|3589051|FG001|STARTED|Overall Study|1649 patients randomized 1635 patients treated|1649
2883531|NCT00312208|3589050|FG000|COMPLETED|Overall Study||1477
2883532|NCT00312208|3589051|FG001|COMPLETED|Overall Study||1526
2883533|NCT00312208|3589050|FG000|NOT COMPLETED|Overall Study||172
2883534|NCT00312208|3589051|FG001|NOT COMPLETED|Overall Study||123
2883535|NCT00312221|3589060|FG000|STARTED|Open-label Run-in Period||652
2883536|NCT00312221|3589061|FG001|STARTED|Open-label Run-in Period||0
2883537|NCT00312221|3589062|FG002|STARTED|Open-label Run-in Period||0
2883538|NCT00312221|3589063|FG003|STARTED|Open-label Run-in Period||0
2883539|NCT00312221|3589060|FG000|COMPLETED|Open-label Run-in Period||418
2883540|NCT00312221|3589061|FG001|COMPLETED|Open-label Run-in Period||0
2883541|NCT00312221|3589062|FG002|COMPLETED|Open-label Run-in Period||0
2883542|NCT00312221|3589063|FG003|COMPLETED|Open-label Run-in Period||0
2883543|NCT00312221|3589060|FG000|NOT COMPLETED|Open-label Run-in Period||234
2883544|NCT00312221|3589061|FG001|NOT COMPLETED|Open-label Run-in Period||0
2883545|NCT00312221|3589062|FG002|NOT COMPLETED|Open-label Run-in Period||0
2883546|NCT00312221|3589063|FG003|NOT COMPLETED|Open-label Run-in Period||0
2883547|NCT00312221|3589060|FG000|STARTED|Double-blind Phase||0
2883548|NCT00312221|3589061|FG001|STARTED|Double-blind Phase||136
2883549|NCT00312221|3589062|FG002|STARTED|Double-blind Phase||149
2883550|NCT00312221|3589063|FG003|STARTED|Double-blind Phase||133
2883551|NCT00312221|3589060|FG000|COMPLETED|Double-blind Phase||0
2883552|NCT00312221|3589061|FG001|COMPLETED|Double-blind Phase||77
2883553|NCT00312221|3589062|FG002|COMPLETED|Double-blind Phase||77
2883554|NCT00312221|3589063|FG003|COMPLETED|Double-blind Phase||63
2883555|NCT00312221|3589060|FG000|NOT COMPLETED|Double-blind Phase||0
2883556|NCT00312221|3589061|FG001|NOT COMPLETED|Double-blind Phase||59
2883557|NCT00312221|3589062|FG002|NOT COMPLETED|Double-blind Phase||72
2883558|NCT00312221|3589063|FG003|NOT COMPLETED|Double-blind Phase||70
2883559|NCT00312338|3589074|FG000|STARTED|Overall Study||105
2883560|NCT00312338|3589075|FG001|STARTED|Overall Study||57
2883561|NCT00312338|3589074|FG000|COMPLETED|Overall Study||83
2883562|NCT00312338|3589075|FG001|COMPLETED|Overall Study||54
2883563|NCT00312338|3589074|FG000|NOT COMPLETED|Overall Study||22
2883564|NCT00312338|3589075|FG001|NOT COMPLETED|Overall Study||3
2883565|NCT00312377|3589083|FG000|STARTED|Overall Study|randomised patients|694
2883566|NCT00312377|3589084|FG001|STARTED|Overall Study|randomised patients|697
2883567|NCT00312377|3589083|FG000|COMPLETED|Overall Study|ongoing study treatment at data cut-off|50
2883568|NCT00312377|3589084|FG001|COMPLETED|Overall Study|ongoing study treatment at data cut-off|29
2883569|NCT00312377|3589083|FG000|NOT COMPLETED|Overall Study||644
2883570|NCT00312377|3589084|FG001|NOT COMPLETED|Overall Study||668
2883571|NCT00312494|3589093|FG000|STARTED|Overall Study||232
2883572|NCT00312494|3589094|FG001|STARTED|Overall Study||226
2883573|NCT00312494|3589095|FG002|STARTED|Overall Study||222
2883574|NCT00312494|3589093|FG000|Received Study Treatment|Overall Study|1 subject randomized to higher dose; received lower dose at baseline, higher dose weeks 1 and 2.|223
2883575|NCT00312494|3589094|FG001|Received Study Treatment|Overall Study||216
2883576|NCT00312494|3589095|FG002|Received Study Treatment|Overall Study||217
2883577|NCT00312494|3589093|FG000|COMPLETED|Overall Study|1 subject randomized to higher dose; received lower dose baseline and/or week 1; higher dose week 2.|161
2883578|NCT00312494|3589094|FG001|COMPLETED|Overall Study||168
2883579|NCT00312494|3589095|FG002|COMPLETED|Overall Study||179
2883580|NCT00312494|3589093|FG000|NOT COMPLETED|Overall Study||71
2883581|NCT00312494|3589094|FG001|NOT COMPLETED|Overall Study||58
2883582|NCT00312494|3589095|FG002|NOT COMPLETED|Overall Study||43
2883583|NCT00312572|3589105|FG000|STARTED|Overall Study||101
2883584|NCT00312572|3589106|FG001|STARTED|Overall Study||103
2883585|NCT00312572|3589105|FG000|COMPLETED|Overall Study||85
2883586|NCT00312572|3589106|FG001|COMPLETED|Overall Study||82
2883587|NCT00312572|3589105|FG000|NOT COMPLETED|Overall Study||16
2883588|NCT00312572|3589106|FG001|NOT COMPLETED|Overall Study||21
2883589|NCT00312663|3589117|FG000|STARTED|Immunization Phase||5
2883590|NCT00312663|3589118|FG001|STARTED|Immunization Phase||13
2883591|NCT00312663|3589119|FG002|STARTED|Immunization Phase||0
2883592|NCT00312663|3589117|FG000|COMPLETED|Immunization Phase||5
2883593|NCT00312663|3589118|FG001|COMPLETED|Immunization Phase||12
2883594|NCT00312663|3589119|FG002|COMPLETED|Immunization Phase||0
2883595|NCT00312663|3589117|FG000|NOT COMPLETED|Immunization Phase||0
2883596|NCT00312663|3589118|FG001|NOT COMPLETED|Immunization Phase||1
2883597|NCT00312663|3589119|FG002|NOT COMPLETED|Immunization Phase||0
2883598|NCT00312663|3589117|FG000|STARTED|Challenge Phase|low dose subjects didn't participate in the challenge phase|0
2883599|NCT00312663|3589118|FG001|STARTED|Challenge Phase|10 subjects from the high dose group participated in the challenge phase|10
2883600|NCT00312663|3589119|FG002|STARTED|Challenge Phase|6 non-immunized subjects participated in the challenge phase|6
2883601|NCT00312663|3589117|FG000|COMPLETED|Challenge Phase||0
2883602|NCT00312663|3589118|FG001|COMPLETED|Challenge Phase||10
2883603|NCT00312663|3589119|FG002|COMPLETED|Challenge Phase||6
2883604|NCT00312663|3589117|FG000|NOT COMPLETED|Challenge Phase||0
2883605|NCT00312663|3589118|FG001|NOT COMPLETED|Challenge Phase||0
2883606|NCT00312663|3589119|FG002|NOT COMPLETED|Challenge Phase||0
2883607|NCT00312702|3589131|FG000|STARTED|Immunization Phase||5
2883608|NCT00312702|3589132|FG001|STARTED|Immunization Phase||13
2883609|NCT00312702|3589133|FG002|STARTED|Immunization Phase||0
2883610|NCT00312702|3589131|FG000|COMPLETED|Immunization Phase||5
2883611|NCT00312702|3589132|FG001|COMPLETED|Immunization Phase||12
2883612|NCT00312702|3589133|FG002|COMPLETED|Immunization Phase||0
2883613|NCT00312702|3589131|FG000|NOT COMPLETED|Immunization Phase||0
2883614|NCT00312702|3589132|FG001|NOT COMPLETED|Immunization Phase||1
2883615|NCT00312702|3589133|FG002|NOT COMPLETED|Immunization Phase||0
2883616|NCT00312702|3589131|FG000|STARTED|Challenge Phase|low dose subjects didn't participate in the challenge phase|0
2883617|NCT00312702|3589132|FG001|STARTED|Challenge Phase|12 subjects from the high dose group participated in the challenge phase|12
2883618|NCT00312702|3589133|FG002|STARTED|Challenge Phase|1 non-immunized subjects participated in the challenge phase.|1
2883619|NCT00312702|3589131|FG000|COMPLETED|Challenge Phase||0
2883620|NCT00312702|3589132|FG001|COMPLETED|Challenge Phase||12
2883621|NCT00312702|3589133|FG002|COMPLETED|Challenge Phase||1
2883622|NCT00312702|3589131|FG000|NOT COMPLETED|Challenge Phase||0
2883623|NCT00312702|3589132|FG001|NOT COMPLETED|Challenge Phase||0
2883624|NCT00312702|3589133|FG002|NOT COMPLETED|Challenge Phase||0
2883625|NCT00312728|3589141|FG000|STARTED|Overall Study||115
2883626|NCT00312728|3589141|FG000|COMPLETED|Overall Study||5
2883627|NCT00312728|3589141|FG000|NOT COMPLETED|Overall Study||110
2883628|NCT00312845|3589147|FG000|STARTED|Overall Study||336
2883629|NCT00312845|3589148|FG001|STARTED|Overall Study||340
2883630|NCT00312845|3589147|FG000|COMPLETED|Overall Study||237
2883631|NCT00312845|3589148|FG001|COMPLETED|Overall Study||245
2883632|NCT00312845|3589147|FG000|NOT COMPLETED|Overall Study||99
2883633|NCT00312845|3589148|FG001|NOT COMPLETED|Overall Study||95
2883634|NCT00312858|3589156|FG000|STARTED|Overall Study||330
2883635|NCT00312858|3589157|FG001|STARTED|Overall Study||323
2883636|NCT00312858|3589156|FG000|Visit 1|Overall Study||330
2883637|NCT00312858|3589157|FG001|Visit 1|Overall Study||323
2883638|NCT00312858|3589156|FG000|Visit 2|Overall Study||305
2883639|NCT00312858|3589157|FG001|Visit 2|Overall Study||294
2883640|NCT00312858|3589156|FG000|Visit 3|Overall Study||273
2883641|NCT00312858|3589157|FG001|Visit 3|Overall Study||261
2883642|NCT00312858|3589156|FG000|Visit 4|Overall Study||262
2883643|NCT00312858|3589157|FG001|Visit 4|Overall Study||240
2883644|NCT00312858|3589156|FG000|COMPLETED|Overall Study||262
2883645|NCT00312858|3589157|FG001|COMPLETED|Overall Study||230
2883646|NCT00312858|3589156|FG000|NOT COMPLETED|Overall Study||68
2883647|NCT00312858|3589157|FG001|NOT COMPLETED|Overall Study||93
2883648|NCT00312884|3589165|FG000|STARTED|Overall Study||91
2883649|NCT00312884|3589166|FG001|STARTED|Overall Study||91
2883650|NCT00312884|3589165|FG000|COMPLETED|Overall Study||74
2883651|NCT00312884|3589166|FG001|COMPLETED|Overall Study||79
2883652|NCT00312884|3589165|FG000|NOT COMPLETED|Overall Study||17
2883653|NCT00312884|3589166|FG001|NOT COMPLETED|Overall Study||12
2883654|NCT00312897|3589174|FG000|STARTED|Overall Study||27
2883655|NCT00312897|3589175|FG001|STARTED|Overall Study||24
2883656|NCT00312897|3589174|FG000|COMPLETED|Overall Study||21
2883657|NCT00312897|3589175|FG001|COMPLETED|Overall Study||18
2883658|NCT00312897|3589174|FG000|NOT COMPLETED|Overall Study||6
2883659|NCT00312897|3589175|FG001|NOT COMPLETED|Overall Study||6
2883660|NCT00312923|3589183|FG000|STARTED|Overall Study||28
2883661|NCT00312923|3589184|FG001|STARTED|Overall Study||26
2883662|NCT00312923|3589183|FG000|COMPLETED|Overall Study||19
2883663|NCT00312923|3589184|FG001|COMPLETED|Overall Study||20
2883664|NCT00312923|3589183|FG000|NOT COMPLETED|Overall Study||9
2883665|NCT00312923|3589184|FG001|NOT COMPLETED|Overall Study||6
2883666|NCT00313014|3589193|FG000|STARTED|Overall Study||221
2883667|NCT00313014|3589194|FG001|STARTED|Overall Study||219
2883668|NCT00313014|3589195|FG002|STARTED|Overall Study||220
2883669|NCT00313014|3589193|FG000|COMPLETED|Overall Study||128
2883670|NCT00313014|3589194|FG001|COMPLETED|Overall Study||146
2883671|NCT00313014|3589195|FG002|COMPLETED|Overall Study||159
2883672|NCT00313014|3589193|FG000|NOT COMPLETED|Overall Study||93
2883673|NCT00313014|3589194|FG001|NOT COMPLETED|Overall Study||73
2883674|NCT00313014|3589195|FG002|NOT COMPLETED|Overall Study||61
2883675|NCT00313144|3589204|FG000|STARTED|Overall Study||127
2883676|NCT00313144|3589204|FG000|COMPLETED|Overall Study||17
2883677|NCT00313144|3589204|FG000|NOT COMPLETED|Overall Study||110
2883678|NCT00313170|3589220|FG000|STARTED|Overall Study||47
2883679|NCT00313170|3589221|FG001|STARTED|Overall Study||51
2883680|NCT00313170|3589222|FG002|STARTED|Overall Study||46
2883681|NCT00313170|3589220|FG000|COMPLETED|Overall Study||11
2883682|NCT00313170|3589221|FG001|COMPLETED|Overall Study||17
2883683|NCT00313170|3589222|FG002|COMPLETED|Overall Study||14
2883684|NCT00313170|3589220|FG000|NOT COMPLETED|Overall Study||36
2883685|NCT00313170|3589221|FG001|NOT COMPLETED|Overall Study||34
2883686|NCT00313170|3589222|FG002|NOT COMPLETED|Overall Study||32
2883687|NCT00313209|3589233|FG000|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|466
2883688|NCT00313209|3589234|FG001|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|467
2883689|NCT00313209|3589233|FG000|COMPLETED|Overall Study||359
2883690|NCT00313209|3589234|FG001|COMPLETED|Overall Study||385
2883691|NCT00313209|3589233|FG000|NOT COMPLETED|Overall Study||107
2883692|NCT00313209|3589234|FG001|NOT COMPLETED|Overall Study||82
2883693|NCT00313300|3589245|FG000|STARTED|Randomized in Phase A (26 Weeks)||184
2883694|NCT00313300|3589246|FG001|STARTED|Randomized in Phase A (26 Weeks)||179
2883695|NCT00313300|3589247|FG002|STARTED|Randomized in Phase A (26 Weeks)||184
2883696|NCT00313300|3589248|FG003|STARTED|Randomized in Phase A (26 Weeks)||0
2883697|NCT00313300|3589249|FG004|STARTED|Randomized in Phase A (26 Weeks)||0
2883698|NCT00313300|3589245|FG000|COMPLETED|Randomized in Phase A (26 Weeks)||130
2883699|NCT00313300|3589246|FG001|COMPLETED|Randomized in Phase A (26 Weeks)||140
2883700|NCT00313300|3589247|FG002|COMPLETED|Randomized in Phase A (26 Weeks)||149
2883701|NCT00313300|3589248|FG003|COMPLETED|Randomized in Phase A (26 Weeks)||0
2883702|NCT00313300|3589249|FG004|COMPLETED|Randomized in Phase A (26 Weeks)||0
2883703|NCT00313300|3589245|FG000|NOT COMPLETED|Randomized in Phase A (26 Weeks)||54
2883704|NCT00313300|3589246|FG001|NOT COMPLETED|Randomized in Phase A (26 Weeks)||39
2883705|NCT00313300|3589247|FG002|NOT COMPLETED|Randomized in Phase A (26 Weeks)||35
2883706|NCT00313300|3589248|FG003|NOT COMPLETED|Randomized in Phase A (26 Weeks)||0
2883707|NCT00313300|3589249|FG004|NOT COMPLETED|Randomized in Phase A (26 Weeks)||0
2883708|NCT00313300|3589245|FG000|STARTED|Randomized in Phase B (26 Weeks)||427
2883709|NCT00313300|3589246|FG001|STARTED|Randomized in Phase B (26 Weeks)||138
2883710|NCT00313300|3589247|FG002|STARTED|Randomized in Phase B (26 Weeks)||134
2883711|NCT00313300|3589248|FG003|STARTED|Randomized in Phase B (26 Weeks)||248
2883712|NCT00313300|3589249|FG004|STARTED|Randomized in Phase B (26 Weeks)||221
2883713|NCT00313300|3589245|FG000|Start of Phase B to High Dose Terminated|Randomized in Phase B (26 Weeks)||368
2883714|NCT00313300|3589246|FG001|Start of Phase B to High Dose Terminated|Randomized in Phase B (26 Weeks)||120
2883715|NCT00313300|3589247|FG002|Start of Phase B to High Dose Terminated|Randomized in Phase B (26 Weeks)||110
2883716|NCT00313300|3589248|FG003|Start of Phase B to High Dose Terminated|Randomized in Phase B (26 Weeks)||248
2883717|NCT00313300|3589249|FG004|Start of Phase B to High Dose Terminated|Randomized in Phase B (26 Weeks)||221
2883718|NCT00313300|3589245|FG000|COMPLETED|Randomized in Phase B (26 Weeks)||333
2883719|NCT00313300|3589246|FG001|COMPLETED|Randomized in Phase B (26 Weeks)||105
2883720|NCT00313300|3589247|FG002|COMPLETED|Randomized in Phase B (26 Weeks)||94
2883721|NCT00313300|3589248|FG003|COMPLETED|Randomized in Phase B (26 Weeks)||15
2883722|NCT00313300|3589249|FG004|COMPLETED|Randomized in Phase B (26 Weeks)||13
2883723|NCT00313300|3589245|FG000|NOT COMPLETED|Randomized in Phase B (26 Weeks)||94
2883724|NCT00313300|3589246|FG001|NOT COMPLETED|Randomized in Phase B (26 Weeks)||33
2883725|NCT00313300|3589247|FG002|NOT COMPLETED|Randomized in Phase B (26 Weeks)||40
2883726|NCT00313300|3589248|FG003|NOT COMPLETED|Randomized in Phase B (26 Weeks)||233
2883727|NCT00313300|3589249|FG004|NOT COMPLETED|Randomized in Phase B (26 Weeks)||208
2883728|NCT00313300|3589245|FG000|STARTED|Follow-Up(30days)-Randomized Phase A||163
2883729|NCT00313300|3589246|FG001|STARTED|Follow-Up(30days)-Randomized Phase A||162
2883730|NCT00313300|3589247|FG002|STARTED|Follow-Up(30days)-Randomized Phase A||174
2883731|NCT00313300|3589248|FG003|STARTED|Follow-Up(30days)-Randomized Phase A||0
2883732|NCT00313300|3589249|FG004|STARTED|Follow-Up(30days)-Randomized Phase A||0
2883733|NCT00313300|3589245|FG000|COMPLETED|Follow-Up(30days)-Randomized Phase A||158
2883734|NCT00313300|3589246|FG001|COMPLETED|Follow-Up(30days)-Randomized Phase A||156
2883735|NCT00313300|3589247|FG002|COMPLETED|Follow-Up(30days)-Randomized Phase A||172
2883736|NCT00313300|3589248|FG003|COMPLETED|Follow-Up(30days)-Randomized Phase A||0
2883737|NCT00313300|3589249|FG004|COMPLETED|Follow-Up(30days)-Randomized Phase A||0
2883738|NCT00313300|3589245|FG000|NOT COMPLETED|Follow-Up(30days)-Randomized Phase A||5
2883739|NCT00313300|3589246|FG001|NOT COMPLETED|Follow-Up(30days)-Randomized Phase A||6
2883740|NCT00313300|3589247|FG002|NOT COMPLETED|Follow-Up(30days)-Randomized Phase A||2
2883741|NCT00313300|3589248|FG003|NOT COMPLETED|Follow-Up(30days)-Randomized Phase A||0
2883742|NCT00313300|3589249|FG004|NOT COMPLETED|Follow-Up(30days)-Randomized Phase A||0
2883743|NCT00313300|3589245|FG000|STARTED|Follow-Up(30days)-Randomized Phase B||383
2883744|NCT00313300|3589246|FG001|STARTED|Follow-Up(30days)-Randomized Phase B||123
2883745|NCT00313300|3589247|FG002|STARTED|Follow-Up(30days)-Randomized Phase B||119
2883746|NCT00313300|3589248|FG003|STARTED|Follow-Up(30days)-Randomized Phase B||222
2883747|NCT00313300|3589249|FG004|STARTED|Follow-Up(30days)-Randomized Phase B||201
2883748|NCT00313300|3589245|FG000|COMPLETED|Follow-Up(30days)-Randomized Phase B||380
2883749|NCT00313300|3589246|FG001|COMPLETED|Follow-Up(30days)-Randomized Phase B||123
2883750|NCT00313300|3589247|FG002|COMPLETED|Follow-Up(30days)-Randomized Phase B||117
2883751|NCT00313300|3589248|FG003|COMPLETED|Follow-Up(30days)-Randomized Phase B||217
2883752|NCT00313300|3589249|FG004|COMPLETED|Follow-Up(30days)-Randomized Phase B||199
2883753|NCT00313300|3589245|FG000|NOT COMPLETED|Follow-Up(30days)-Randomized Phase B||3
2883754|NCT00313300|3589246|FG001|NOT COMPLETED|Follow-Up(30days)-Randomized Phase B||0
2883755|NCT00313300|3589247|FG002|NOT COMPLETED|Follow-Up(30days)-Randomized Phase B||2
2883756|NCT00313300|3589248|FG003|NOT COMPLETED|Follow-Up(30days)-Randomized Phase B||5
2883757|NCT00313300|3589249|FG004|NOT COMPLETED|Follow-Up(30days)-Randomized Phase B||2
2883758|NCT00313313|3589270|FG000|STARTED|Overall Study||248
2883759|NCT00313313|3589271|FG001|STARTED|Overall Study||253
2883760|NCT00313313|3589272|FG002|STARTED|Overall Study||267
2883761|NCT00313313|3589270|FG000|COMPLETED|Overall Study|61 subjects completed the study without being rescued|185
2883762|NCT00313313|3589271|FG001|COMPLETED|Overall Study|55 subjects completed the study without being rescued|187
2883763|NCT00313313|3589272|FG002|COMPLETED|Overall Study|26 subjects completed the study without being rescued|185
2883764|NCT00313313|3589270|FG000|NOT COMPLETED|Overall Study||63
2883765|NCT00313313|3589271|FG001|NOT COMPLETED|Overall Study||66
2883766|NCT00313313|3589272|FG002|NOT COMPLETED|Overall Study||82
2883767|NCT00313443|3589280|FG000|STARTED|Overall Study||30
2883768|NCT00313443|3589280|FG000|COMPLETED|Overall Study||30
2883769|NCT00313443|3589280|FG000|NOT COMPLETED|Overall Study||0
2883770|NCT00313560|3589284|FG000|STARTED|Overall Study||48
2883771|NCT00313560|3589284|FG000|COMPLETED|Overall Study||48
2883772|NCT00313560|3589284|FG000|NOT COMPLETED|Overall Study||0
2883773|NCT00313586|3589296|FG000|STARTED|Overall Study||75
2883774|NCT00313586|3589297|FG001|STARTED|Overall Study||75
2883775|NCT00313586|3589298|FG002|STARTED|Overall Study||24
2883776|NCT00313586|3589299|FG003|STARTED|Overall Study||23
2883777|NCT00313586|3589296|FG000|Treated|Overall Study||74
2883778|NCT00313586|3589297|FG001|Treated|Overall Study||75
2883779|NCT00313586|3589298|FG002|Treated|Overall Study||24
2883780|NCT00313586|3589299|FG003|Treated|Overall Study||23
2883781|NCT00313586|3589296|FG000|COMPLETED|Overall Study||5
2883782|NCT00313586|3589297|FG001|COMPLETED|Overall Study||5
2883783|NCT00313586|3589298|FG002|COMPLETED|Overall Study||0
2883784|NCT00313586|3589299|FG003|COMPLETED|Overall Study||0
2883785|NCT00313586|3589296|FG000|NOT COMPLETED|Overall Study||70
2883786|NCT00313586|3589297|FG001|NOT COMPLETED|Overall Study||70
2883787|NCT00313586|3589298|FG002|NOT COMPLETED|Overall Study||24
2883788|NCT00313586|3589299|FG003|NOT COMPLETED|Overall Study||23
2883789|NCT00313612|3589309|FG000|STARTED|Overall Study||19
2883790|NCT00313612|3589310|FG001|STARTED|Overall Study||20
2883791|NCT00313612|3589309|FG000|COMPLETED|Overall Study||19
2883792|NCT00313612|3589310|FG001|COMPLETED|Overall Study||19
2883793|NCT00313612|3589309|FG000|NOT COMPLETED|Overall Study||0
2883794|NCT00313612|3589310|FG001|NOT COMPLETED|Overall Study||1
2883795|NCT00313703|3589320|FG000|STARTED|Overall Study||186
2883796|NCT00313703|3589321|FG001|STARTED|Overall Study||34
2883797|NCT00313703|3589322|FG002|STARTED|Overall Study||77
2883798|NCT00313703|3589323|FG003|STARTED|Overall Study||12
2883799|NCT00313703|3589320|FG000|COMPLETED|Overall Study|Some subjects lost to follow-up|175
2883800|NCT00313703|3589321|FG001|COMPLETED|Overall Study|Some subjects lost-to follow-up|32
2883801|NCT00313703|3589322|FG002|COMPLETED|Overall Study|Some subjects lost-to-follow-up|72
2883802|NCT00313703|3589323|FG003|COMPLETED|Overall Study|Outcomes not reported due to heterogeneity of this group|0
2883803|NCT00313703|3589320|FG000|NOT COMPLETED|Overall Study||11
2883804|NCT00313703|3589321|FG001|NOT COMPLETED|Overall Study||2
2883805|NCT00313703|3589322|FG002|NOT COMPLETED|Overall Study||5
2883806|NCT00313703|3589323|FG003|NOT COMPLETED|Overall Study||12
2883807|NCT00313716|3589339|FG000|STARTED|Overall Study||18
2883808|NCT00313716|3589340|FG001|STARTED|Overall Study||31
2883809|NCT00313716|3589341|FG002|STARTED|Overall Study||50
2883810|NCT00313716|3589342|FG003|STARTED|Overall Study||20
2883811|NCT00313716|3589343|FG004|STARTED|Overall Study||33
2883812|NCT00313716|3589344|FG005|STARTED|Overall Study||48
2883813|NCT00313716|3589339|FG000|COMPLETED|Overall Study||13
2883814|NCT00313716|3589340|FG001|COMPLETED|Overall Study||23
2883815|NCT00313716|3589341|FG002|COMPLETED|Overall Study||38
2883816|NCT00313716|3589342|FG003|COMPLETED|Overall Study||16
2883817|NCT00313716|3589343|FG004|COMPLETED|Overall Study||27
2883818|NCT00313716|3589344|FG005|COMPLETED|Overall Study||35
2883819|NCT00313716|3589339|FG000|NOT COMPLETED|Overall Study||5
2883820|NCT00313716|3589340|FG001|NOT COMPLETED|Overall Study||8
2883821|NCT00313716|3589341|FG002|NOT COMPLETED|Overall Study||12
2883822|NCT00313716|3589342|FG003|NOT COMPLETED|Overall Study||4
2883823|NCT00313716|3589343|FG004|NOT COMPLETED|Overall Study||6
2883824|NCT00313716|3589344|FG005|NOT COMPLETED|Overall Study||13
2883825|NCT00313729|3589362|FG000|STARTED|Overall Study||120
2883826|NCT00313729|3589362|FG000|COMPLETED|Overall Study||120
2883827|NCT00313729|3589362|FG000|NOT COMPLETED|Overall Study||0
2883828|NCT00313781|3589368|FG000|STARTED|Before Crossover||102
2883829|NCT00313781|3589369|FG001|STARTED|Before Crossover||102
2883830|NCT00313781|3589370|FG002|STARTED|Before Crossover||0
2883831|NCT00313781|3589368|FG000|Treated|Before Crossover||97
2883832|NCT00313781|3589369|FG001|Treated|Before Crossover||102
2883833|NCT00313781|3589370|FG002|Treated|Before Crossover||0
2883834|NCT00313781|3589368|FG000|COMPLETED|Before Crossover||27
2883835|NCT00313781|3589369|FG001|COMPLETED|Before Crossover||23
2883836|NCT00313781|3589370|FG002|COMPLETED|Before Crossover||0
2883837|NCT00313781|3589368|FG000|NOT COMPLETED|Before Crossover||75
2883838|NCT00313781|3589369|FG001|NOT COMPLETED|Before Crossover||79
2883839|NCT00313781|3589370|FG002|NOT COMPLETED|Before Crossover||0
2883840|NCT00313781|3589368|FG000|STARTED|After Crossover||0
2883841|NCT00313781|3589369|FG001|STARTED|After Crossover||0
2883842|NCT00313781|3589370|FG002|STARTED|After Crossover||37
2883843|NCT00313781|3589368|FG000|COMPLETED|After Crossover||0
2883844|NCT00313781|3589369|FG001|COMPLETED|After Crossover||0
2883845|NCT00313781|3589370|FG002|COMPLETED|After Crossover||10
2883846|NCT00313781|3589368|FG000|NOT COMPLETED|After Crossover||0
2883847|NCT00313781|3589369|FG001|NOT COMPLETED|After Crossover||0
2883848|NCT00313781|3589370|FG002|NOT COMPLETED|After Crossover||27
2883849|NCT00313820|3589381|FG000|STARTED|Assigned to Treatment||111
2883850|NCT00313820|3589382|FG001|STARTED|Assigned to Treatment||109
2883851|NCT00313820|3589381|FG000|COMPLETED|Assigned to Treatment||110
2883852|NCT00313820|3589382|FG001|COMPLETED|Assigned to Treatment||109
2883853|NCT00313820|3589381|FG000|NOT COMPLETED|Assigned to Treatment||1
2883854|NCT00313820|3589382|FG001|NOT COMPLETED|Assigned to Treatment||0
2883855|NCT00313820|3589381|FG000|STARTED|Pregabalin or Placebo Treatment Period||110
2883856|NCT00313820|3589382|FG001|STARTED|Pregabalin or Placebo Treatment Period||109
2883857|NCT00313820|3589381|FG000|COMPLETED|Pregabalin or Placebo Treatment Period||93
2883858|NCT00313820|3589382|FG001|COMPLETED|Pregabalin or Placebo Treatment Period||90
2883859|NCT00313820|3589381|FG000|NOT COMPLETED|Pregabalin or Placebo Treatment Period||17
2883860|NCT00313820|3589382|FG001|NOT COMPLETED|Pregabalin or Placebo Treatment Period||19
2883861|NCT00313846|3589390|FG000|STARTED|Overall Study||162
2883862|NCT00313846|3589391|FG001|STARTED|Overall Study|327 subjects were randomized: 1 subject was lost to follow-up (N = 326).|164
2883863|NCT00313846|3589390|FG000|COMPLETED|Overall Study||157
2883864|NCT00313846|3589391|FG001|COMPLETED|Overall Study||153
2883865|NCT00313846|3589390|FG000|NOT COMPLETED|Overall Study||5
2883866|NCT00313846|3589391|FG001|NOT COMPLETED|Overall Study||11
2883867|NCT00313911|3589400|FG000|STARTED|Overall Study|N for outcomes adjusted to include participant in Group 2 that got vaccine assigned to this group.|1422
2883868|NCT00313911|3589401|FG001|STARTED|Overall Study|A participant in this group mistakenly got Group 1 vaccine. N in outcomes adjusted accordingly.|711
3170160|NCT01928394|3897422|FG016|NOT COMPLETED|Follow-up Period||14
3170161|NCT01928394|3897423|FG017|NOT COMPLETED|Follow-up Period||8
3314702|NCT03091400|4047984|FG000|COMPLETED|Phase 2 - 6 Weeks||4
2883869|NCT00313911|3589400|FG000|COMPLETED|Overall Study||1328
2883870|NCT00313911|3589401|FG001|COMPLETED|Overall Study||670
2883871|NCT00313911|3589400|FG000|NOT COMPLETED|Overall Study||94
2883872|NCT00313911|3589401|FG001|NOT COMPLETED|Overall Study||41
2883873|NCT00314106|3589409|FG000|STARTED|Overall Study||18
2883874|NCT00314106|3589410|FG001|STARTED|Overall Study||8
2883875|NCT00314106|3589409|FG000|COMPLETED|Overall Study||18
2883876|NCT00314106|3589410|FG001|COMPLETED|Overall Study||8
2883877|NCT00314106|3589409|FG000|NOT COMPLETED|Overall Study||0
2883878|NCT00314106|3589410|FG001|NOT COMPLETED|Overall Study||0
2883879|NCT00314132|3589418|FG000|STARTED|Overall Study||403
2883880|NCT00314132|3589419|FG001|STARTED|Overall Study||1601
2883881|NCT00314132|3589418|FG000|COMPLETED|Overall Study||395
2883882|NCT00314132|3589419|FG001|COMPLETED|Overall Study||1583
2883883|NCT00314132|3589418|FG000|NOT COMPLETED|Overall Study||8
2883884|NCT00314132|3589419|FG001|NOT COMPLETED|Overall Study||18
2883885|NCT00314145|3589429|FG000|STARTED|Overall Study||410
2883886|NCT00314145|3589430|FG001|STARTED|Overall Study||410
2883887|NCT00314145|3589429|FG000|COMPLETED|Overall Study||389
2883888|NCT00314145|3589430|FG001|COMPLETED|Overall Study||381
2883889|NCT00314145|3589429|FG000|NOT COMPLETED|Overall Study||21
2883890|NCT00314145|3589430|FG001|NOT COMPLETED|Overall Study||29
2883891|NCT00314236|3589439|FG000|STARTED|Overall Study||41
2883892|NCT00314236|3589440|FG001|STARTED|Overall Study||39
2883893|NCT00314236|3589439|FG000|COMPLETED|Overall Study||41
2883894|NCT00314236|3589440|FG001|COMPLETED|Overall Study||37
2883895|NCT00314236|3589439|FG000|NOT COMPLETED|Overall Study||0
2883896|NCT00314236|3589440|FG001|NOT COMPLETED|Overall Study||2
2883897|NCT00314249|3589448|FG000|STARTED|Overall Study||509
2883898|NCT00314249|3589449|FG001|STARTED|Overall Study||516
2883899|NCT00314249|3589448|FG000|COMPLETED|Overall Study||357
2883900|NCT00314249|3589449|FG001|COMPLETED|Overall Study||353
2883901|NCT00314249|3589448|FG000|NOT COMPLETED|Overall Study||152
2883902|NCT00314249|3589449|FG001|NOT COMPLETED|Overall Study||163
2883903|NCT00314262|3589455|FG000|STARTED|Overall Study||12
2883904|NCT00314262|3589455|FG000|COMPLETED|Overall Study||7
2883905|NCT00314262|3589455|FG000|NOT COMPLETED|Overall Study||5
2883906|NCT00314340|3589459|FG000|STARTED|Overall Study||12
2883907|NCT00314340|3589459|FG000|ER Morphine|Overall Study||11
2883908|NCT00314340|3589459|FG000|Hydrocodone Plus APAP|Overall Study||12
2883909|NCT00314340|3589459|FG000|Placebo|Overall Study||12
2883910|NCT00314340|3589459|FG000|COMPLETED|Overall Study||11
3314703|NCT03091400|4047985|FG001|COMPLETED|Phase 2 - 6 Weeks||6
3314704|NCT03091400|4047984|FG000|NOT COMPLETED|Phase 2 - 6 Weeks||0
3314705|NCT03091400|4047985|FG001|NOT COMPLETED|Phase 2 - 6 Weeks||0
3314706|NCT03091439|4047993|FG000|STARTED|Overall Study||1
3314707|NCT03091439|4047994|FG001|STARTED|Overall Study||0
3314708|NCT03091439|4047993|FG000|COMPLETED|Overall Study||0
3314709|NCT03091439|4047994|FG001|COMPLETED|Overall Study||0
3314710|NCT03091439|4047993|FG000|NOT COMPLETED|Overall Study||1
3314711|NCT03091439|4047994|FG001|NOT COMPLETED|Overall Study||0
2883911|NCT00314340|3589459|FG000|NOT COMPLETED|Overall Study||1
2883912|NCT00314366|3589467|FG000|STARTED|Overall Study||11
3314712|NCT03091478|4048000|FG000|STARTED|Overall Study||13
3314713|NCT03091478|4048000|FG000|COMPLETED|Overall Study||13
3314714|NCT03091478|4048000|FG000|NOT COMPLETED|Overall Study||0
2883913|NCT00314366|3589468|FG001|STARTED|Overall Study||10
2883914|NCT00314366|3589467|FG000|COMPLETED|Overall Study||10
2883915|NCT00314366|3589468|FG001|COMPLETED|Overall Study||10
2883916|NCT00314366|3589467|FG000|NOT COMPLETED|Overall Study||1
2883917|NCT00314366|3589468|FG001|NOT COMPLETED|Overall Study||0
2883918|NCT00314574|3589479|FG000|STARTED|Overall Study||423
2883919|NCT00314574|3589480|FG001|STARTED|Overall Study||427
2883920|NCT00314574|3589479|FG000|Received at Least One Dose of Study Drug|Overall Study||421
2883921|NCT00314574|3589480|FG001|Received at Least One Dose of Study Drug|Overall Study||427
2883922|NCT00314574|3589479|FG000|Safety Population|Overall Study|1 patient in the placebo arm received Xolair and was added to the Xolair arm for Safety analyses.|420
2883923|NCT00314574|3589480|FG001|Safety Population|Overall Study||428
2883924|NCT00314574|3589479|FG000|COMPLETED|Overall Study||329
2883925|NCT00314574|3589480|FG001|COMPLETED|Overall Study||344
2883926|NCT00314574|3589479|FG000|NOT COMPLETED|Overall Study||94
2883927|NCT00314574|3589480|FG001|NOT COMPLETED|Overall Study||83
2883928|NCT00314795|3589486|FG000|STARTED|Overall Study||22
2883929|NCT00314795|3589486|FG000|COMPLETED|Overall Study||2
2883930|NCT00314795|3589486|FG000|NOT COMPLETED|Overall Study||20
2883931|NCT00314808|3589490|FG000|STARTED|Overall Study||33
2883932|NCT00314808|3589490|FG000|COMPLETED|Overall Study|Completed 2 cycles of Dronabinol or terminated early due to treatment-related adverse events (AE)|25
2883933|NCT00314808|3589490|FG000|NOT COMPLETED|Overall Study||8
2883934|NCT00314951|3589496|FG000|STARTED|Enrollment||323
2883935|NCT00314951|3589497|FG001|STARTED|Enrollment||306
2883936|NCT00314951|3589496|FG000|COMPLETED|Enrollment|6 subjects took incorrect treatment assignment, 6 subjects didn't take drug|323
2883937|NCT00314951|3589497|FG001|COMPLETED|Enrollment|6 subjects took incorrect treatment assignment, 6 subjects didn't take drug|300
2883938|NCT00314951|3589496|FG000|NOT COMPLETED|Enrollment||0
2883939|NCT00314951|3589497|FG001|NOT COMPLETED|Enrollment||6
2883940|NCT00314951|3589496|FG000|STARTED|Treatment||323
2883941|NCT00314951|3589497|FG001|STARTED|Treatment||300
2883942|NCT00314951|3589496|FG000|COMPLETED|Treatment||307
2883943|NCT00314951|3589497|FG001|COMPLETED|Treatment||289
2883944|NCT00314951|3589496|FG000|NOT COMPLETED|Treatment||16
2883945|NCT00314951|3589497|FG001|NOT COMPLETED|Treatment||11
2883946|NCT00314951|3589496|FG000|STARTED|Follow-up||307
2883947|NCT00314951|3589497|FG001|STARTED|Follow-up||289
2883948|NCT00314951|3589496|FG000|COMPLETED|Follow-up||263
2883949|NCT00314951|3589497|FG001|COMPLETED|Follow-up||255
2883950|NCT00314951|3589496|FG000|NOT COMPLETED|Follow-up||44
2883951|NCT00314951|3589497|FG001|NOT COMPLETED|Follow-up||34
2883952|NCT00315055|3589505|FG000|STARTED|Overall Study||155
2883953|NCT00315055|3589506|FG001|STARTED|Overall Study||155
2883954|NCT00315055|3589505|FG000|COMPLETED|Overall Study||152
2883955|NCT00315055|3589506|FG001|COMPLETED|Overall Study||150
2883956|NCT00315055|3589505|FG000|NOT COMPLETED|Overall Study||3
2883957|NCT00315055|3589506|FG001|NOT COMPLETED|Overall Study||5
2883958|NCT00315120|3589519|FG000|STARTED|Overall Study||115
2883959|NCT00315120|3589520|FG001|STARTED|Overall Study||118
2883960|NCT00315120|3589521|FG002|STARTED|Overall Study||115
2883961|NCT00315120|3589522|FG003|STARTED|Overall Study||107
2883962|NCT00315120|3589519|FG000|COMPLETED|Overall Study||115
2883963|NCT00315120|3589520|FG001|COMPLETED|Overall Study||118
2883964|NCT00315120|3589521|FG002|COMPLETED|Overall Study||115
2883965|NCT00315120|3589522|FG003|COMPLETED|Overall Study||107
2883966|NCT00315120|3589519|FG000|NOT COMPLETED|Overall Study||0
2883967|NCT00315120|3589520|FG001|NOT COMPLETED|Overall Study||0
2883968|NCT00315120|3589521|FG002|NOT COMPLETED|Overall Study||0
2883969|NCT00315120|3589522|FG003|NOT COMPLETED|Overall Study||0
2883970|NCT00315146|3589538|FG000|STARTED|Overall Study||22
2883971|NCT00315146|3589539|FG001|STARTED|Overall Study||22
2883972|NCT00315146|3589540|FG002|STARTED|Overall Study||22
2883973|NCT00315146|3589541|FG003|STARTED|Overall Study||22
2883974|NCT00315146|3589538|FG000|COMPLETED|Overall Study||20
2883975|NCT00315146|3589539|FG001|COMPLETED|Overall Study||19
2883976|NCT00315146|3589540|FG002|COMPLETED|Overall Study||20
2883977|NCT00315146|3589541|FG003|COMPLETED|Overall Study||22
2883978|NCT00315146|3589538|FG000|NOT COMPLETED|Overall Study||2
2883979|NCT00315146|3589539|FG001|NOT COMPLETED|Overall Study||3
2883980|NCT00315146|3589540|FG002|NOT COMPLETED|Overall Study||2
2883981|NCT00315146|3589541|FG003|NOT COMPLETED|Overall Study||0
2919544|NCT00532844|3629965|FG001|STARTED|Treatment Period - Day 1 to Day 14|Only the 48 subjects enrolled in the final protocol are included in the participant flow.|24
2919545|NCT00532844|3629964|FG000|COMPLETED|Treatment Period - Day 1 to Day 14||24
2919546|NCT00532844|3629965|FG001|COMPLETED|Treatment Period - Day 1 to Day 14||23
2919547|NCT00532844|3629964|FG000|NOT COMPLETED|Treatment Period - Day 1 to Day 14||0
2919548|NCT00532844|3629965|FG001|NOT COMPLETED|Treatment Period - Day 1 to Day 14||1
2919549|NCT00532844|3629964|FG000|STARTED|Washout (1 Day)||24
2919550|NCT00532844|3629965|FG001|STARTED|Washout (1 Day)||23
2919551|NCT00532844|3629964|FG000|COMPLETED|Washout (1 Day)||24
2919552|NCT00532844|3629965|FG001|COMPLETED|Washout (1 Day)||23
2919553|NCT00532844|3629964|FG000|NOT COMPLETED|Washout (1 Day)||0
2919554|NCT00532844|3629965|FG001|NOT COMPLETED|Washout (1 Day)||0
2919555|NCT00532844|3629964|FG000|STARTED|Treatment Period - Day 15 to Day 28||24
2919556|NCT00532844|3629965|FG001|STARTED|Treatment Period - Day 15 to Day 28||23
2919557|NCT00532844|3629964|FG000|COMPLETED|Treatment Period - Day 15 to Day 28||20
2919558|NCT00532844|3629965|FG001|COMPLETED|Treatment Period - Day 15 to Day 28||23
2919559|NCT00532844|3629964|FG000|NOT COMPLETED|Treatment Period - Day 15 to Day 28||4
2919560|NCT00532844|3629965|FG001|NOT COMPLETED|Treatment Period - Day 15 to Day 28||0
2883982|NCT00315302|3589559|FG000|STARTED|Overall Study||90
2883983|NCT00315302|3589560|FG001|STARTED|Overall Study||90
2883984|NCT00315302|3589561|FG002|STARTED|Overall Study||26
2883985|NCT00315302|3589562|FG003|STARTED|Overall Study||34
2883986|NCT00315302|3589559|FG000|5 Week Visit|Overall Study||85
2883987|NCT00315302|3589560|FG001|5 Week Visit|Overall Study||86
2883988|NCT00315302|3589561|FG002|5 Week Visit|Overall Study||26
2883989|NCT00315302|3589562|FG003|5 Week Visit|Overall Study||30
2883990|NCT00315302|3589559|FG000|10 Week Visit|Overall Study|Can be higher as includes subjects who may have missed the 5 week visit|86
2883991|NCT00315302|3589560|FG001|10 Week Visit|Overall Study||85
2883992|NCT00315302|3589561|FG002|10 Week Visit|Overall Study||24
2883993|NCT00315302|3589562|FG003|10 Week Visit|Overall Study||29
2883994|NCT00315302|3589559|FG000|18 Week Primary Outcome Visit|Overall Study||84
2883995|NCT00315302|3589560|FG001|18 Week Primary Outcome Visit|Overall Study|Can be higher as includes subjects who may have missed the 10 week or other visit|88
2883996|NCT00315302|3589561|FG002|18 Week Primary Outcome Visit|Overall Study||24
2883997|NCT00315302|3589562|FG003|18 Week Primary Outcome Visit|Overall Study|Can be higher as includes subjects who may have missed the 10 week or other visit|31
2883998|NCT00315302|3589559|FG000|Partial Responder Phase (Post 18 Weeks)|Overall Study|Those who improved in the amblyopic eye at 18wk outcome continued on treatment w/ visits every 8wks.|16
2883999|NCT00315302|3589560|FG001|Partial Responder Phase (Post 18 Weeks)|Overall Study|Those who improved in the amblyopic eye at 18wk outcome continued on treatment w/ visits every 8wks.|13
2884000|NCT00315302|3589561|FG002|Partial Responder Phase (Post 18 Weeks)|Overall Study|Those who improved in the amblyopic eye at 18wk outcome continued on treatment w/ visits every 8wks.|9
2884001|NCT00315302|3589562|FG003|Partial Responder Phase (Post 18 Weeks)|Overall Study|Those who improved in the amblyopic eye at 18wk outcome continued on treatment w/ visits every 8wks.|11
2884002|NCT00315302|3589559|FG000|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|84
2884003|NCT00315302|3589560|FG001|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|88
2884004|NCT00315302|3589561|FG002|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|24
2884005|NCT00315302|3589562|FG003|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|31
2884006|NCT00315302|3589559|FG000|NOT COMPLETED|Overall Study||6
2884007|NCT00315302|3589560|FG001|NOT COMPLETED|Overall Study||2
2884008|NCT00315302|3589561|FG002|NOT COMPLETED|Overall Study||2
2884009|NCT00315302|3589562|FG003|NOT COMPLETED|Overall Study||3
2884010|NCT00315328|3589576|FG000|STARTED|Overall Study|Includes subjects with moderate amblyopia only (20/40 to 20/100 at baseline)|98
2884011|NCT00315328|3589577|FG001|STARTED|Overall Study|Includes subjects with moderate amblyopia only (20/40 to 20/100 at baseline)|95
2884012|NCT00315328|3589578|FG002|STARTED|Overall Study|Includes subjects with severe amblyopia only (20/125 to 20/400 at baseline)|18
2884013|NCT00315328|3589579|FG003|STARTED|Overall Study|Includes subjects with severe amblyopia only (20/125 to 20/400 at baseline)|22
2884014|NCT00315328|3589576|FG000|5 Week Visit|Overall Study||91
2884015|NCT00315328|3589577|FG001|5 Week Visit|Overall Study||89
2884016|NCT00315328|3589578|FG002|5 Week Visit|Overall Study||17
2884017|NCT00315328|3589579|FG003|5 Week Visit|Overall Study||19
2884018|NCT00315328|3589576|FG000|COMPLETED|Overall Study|Completed defined as completing 17 week primary outcome exam|84
2884019|NCT00315328|3589577|FG001|COMPLETED|Overall Study|Completed defined as completing 17 week primary outcome exam|88
2884020|NCT00315328|3589578|FG002|COMPLETED|Overall Study|Completed defined as completing 17 week primary outcome exam|13
2884021|NCT00315328|3589579|FG003|COMPLETED|Overall Study|Completed defined as completing 17 week primary outcome exam|20
2884022|NCT00315328|3589576|FG000|NOT COMPLETED|Overall Study||14
2884023|NCT00315328|3589577|FG001|NOT COMPLETED|Overall Study||7
2884024|NCT00315328|3589578|FG002|NOT COMPLETED|Overall Study||5
2884025|NCT00315328|3589579|FG003|NOT COMPLETED|Overall Study||2
2884026|NCT00315341|3589591|FG000|STARTED|Overall Study||740
2884027|NCT00315341|3589592|FG001|STARTED|Overall Study||529
2884028|NCT00315341|3589591|FG000|COMPLETED|Overall Study||340
2884029|NCT00315341|3589592|FG001|COMPLETED|Overall Study||391
2884030|NCT00315341|3589591|FG000|NOT COMPLETED|Overall Study||400
2884031|NCT00315341|3589592|FG001|NOT COMPLETED|Overall Study||138
2884032|NCT00315445|3589601|FG000|STARTED|Overall Study||45
2884033|NCT00315445|3589602|FG001|STARTED|Overall Study||43
2884034|NCT00315445|3589603|FG002|STARTED|Overall Study||46
2884035|NCT00315445|3589601|FG000|COMPLETED|Overall Study||18
2884036|NCT00315445|3589602|FG001|COMPLETED|Overall Study||27
2884037|NCT00315445|3589603|FG002|COMPLETED|Overall Study||22
2884038|NCT00315445|3589601|FG000|NOT COMPLETED|Overall Study||27
2884039|NCT00315445|3589602|FG001|NOT COMPLETED|Overall Study||16
2884040|NCT00315445|3589603|FG002|NOT COMPLETED|Overall Study||24
2884041|NCT00315458|3589613|FG000|STARTED|Overall Study||51
2884042|NCT00315458|3589614|FG001|STARTED|Overall Study||56
2884043|NCT00315458|3589615|FG002|STARTED|Overall Study||159
2884044|NCT00315458|3589616|FG003|STARTED|Overall Study||39
2884045|NCT00315458|3589613|FG000|COMPLETED|Overall Study||48
2884046|NCT00315458|3589614|FG001|COMPLETED|Overall Study||44
2884047|NCT00315458|3589615|FG002|COMPLETED|Overall Study||107
2884048|NCT00315458|3589616|FG003|COMPLETED|Overall Study||10
2884049|NCT00315458|3589613|FG000|NOT COMPLETED|Overall Study||3
2884050|NCT00315458|3589614|FG001|NOT COMPLETED|Overall Study||12
2884051|NCT00315458|3589615|FG002|NOT COMPLETED|Overall Study||52
2884052|NCT00315458|3589616|FG003|NOT COMPLETED|Overall Study||29
2884053|NCT00315588|3589626|FG000|STARTED|Overall Study||7
2884054|NCT00315588|3589626|FG000|COMPLETED|Overall Study||7
2884055|NCT00315588|3589626|FG000|NOT COMPLETED|Overall Study||0
2884056|NCT00315614|3589632|FG000|STARTED|Overall Study||3
2884057|NCT00315614|3589632|FG000|COMPLETED|Overall Study||3
2884058|NCT00315614|3589632|FG000|NOT COMPLETED|Overall Study||0
2884059|NCT00315627|3589637|FG000|STARTED|Overall Study||3
2884060|NCT00315627|3589637|FG000|COMPLETED|Overall Study||3
2884061|NCT00315627|3589637|FG000|NOT COMPLETED|Overall Study||0
2884062|NCT00315705|3589645|FG000|STARTED|Phase 1||25
2884063|NCT00315705|3589645|FG000|COMPLETED|Phase 1|No Phase 1 participants completed the treatment period (i.e. all 8 cycles and follow-up)|0
2884064|NCT00315705|3589645|FG000|NOT COMPLETED|Phase 1||25
2884065|NCT00315705|3589645|FG000|STARTED|Phase 2|Phase 1 and phase 2 are separate populations|25
2884066|NCT00315705|3589645|FG000|COMPLETED|Phase 2|No Phase 2 participants completed the treatment period (i.e. all 8 cycles and follow-up)|0
2884067|NCT00315705|3589645|FG000|NOT COMPLETED|Phase 2||25
2884068|NCT00315731|3589662|FG000|STARTED|Overall Study||15
2884069|NCT00315731|3589662|FG000|COMPLETED|Overall Study||9
2884070|NCT00315731|3589662|FG000|NOT COMPLETED|Overall Study||6
2884071|NCT00315822|3589670|FG000|STARTED|Overall Study||198
2884072|NCT00315822|3589671|FG001|STARTED|Overall Study||202
2884073|NCT00315822|3589670|FG000|COMPLETED|Overall Study||198
2884074|NCT00315822|3589671|FG001|COMPLETED|Overall Study||202
2884075|NCT00315822|3589670|FG000|NOT COMPLETED|Overall Study||0
2884076|NCT00315822|3589671|FG001|NOT COMPLETED|Overall Study||0
2884077|NCT00315939|3589679|FG000|STARTED|Admission 1 (3 Months)||59
2884078|NCT00315939|3589680|FG001|STARTED|Admission 1 (3 Months)||61
2884079|NCT00315939|3589679|FG000|COMPLETED|Admission 1 (3 Months)||56
2884080|NCT00315939|3589680|FG001|COMPLETED|Admission 1 (3 Months)||55
2884081|NCT00315939|3589679|FG000|NOT COMPLETED|Admission 1 (3 Months)||3
2884082|NCT00315939|3589680|FG001|NOT COMPLETED|Admission 1 (3 Months)||6
2884083|NCT00315939|3589679|FG000|STARTED|Admission 2 (3 Months)||56
2884084|NCT00315939|3589680|FG001|STARTED|Admission 2 (3 Months)||55
2884085|NCT00315939|3589679|FG000|COMPLETED|Admission 2 (3 Months)||52
2884086|NCT00315939|3589680|FG001|COMPLETED|Admission 2 (3 Months)||51
2884087|NCT00315939|3589679|FG000|NOT COMPLETED|Admission 2 (3 Months)||4
2884088|NCT00315939|3589680|FG001|NOT COMPLETED|Admission 2 (3 Months)||4
2884089|NCT00315939|3589679|FG000|STARTED|Admission 3 (3 Months)||52
2884090|NCT00315939|3589680|FG001|STARTED|Admission 3 (3 Months)||51
2884091|NCT00315939|3589679|FG000|COMPLETED|Admission 3 (3 Months)||48
2884092|NCT00315939|3589680|FG001|COMPLETED|Admission 3 (3 Months)||49
2884093|NCT00315939|3589679|FG000|NOT COMPLETED|Admission 3 (3 Months)||4
2884094|NCT00315939|3589680|FG001|NOT COMPLETED|Admission 3 (3 Months)||2
2884095|NCT00316004|3589688|FG000|STARTED|Overall Study||373
2884096|NCT00316004|3589689|FG001|STARTED|Overall Study||355
2884097|NCT00316004|3589690|FG002|STARTED|Overall Study||603
2884098|NCT00316004|3589688|FG000|COMPLETED|Overall Study||359
2884099|NCT00316004|3589689|FG001|COMPLETED|Overall Study||341
2884100|NCT00316004|3589690|FG002|COMPLETED|Overall Study||582
2884101|NCT00316004|3589688|FG000|NOT COMPLETED|Overall Study||14
2884102|NCT00316004|3589689|FG001|NOT COMPLETED|Overall Study||14
2884103|NCT00316004|3589690|FG002|NOT COMPLETED|Overall Study||21
2884104|NCT00316017|3589701|FG000|STARTED|Overall Study|"11 of 11 not completed due to Bag Opened Not Given (BONG)"|231
2884105|NCT00316017|3589702|FG001|STARTED|Overall Study|12 of 13 not completed due to BONG; 1 not completed was a prisoner who was excluded|269
2884106|NCT00316017|3589703|FG002|STARTED|Overall Study|19 of 19 not complete due to BONG|395
2884107|NCT00316017|3589701|FG000|COMPLETED|Overall Study||220
2884108|NCT00316017|3589702|FG001|COMPLETED|Overall Study||256
2884109|NCT00316017|3589703|FG002|COMPLETED|Overall Study||376
2884110|NCT00316017|3589701|FG000|NOT COMPLETED|Overall Study||11
2884111|NCT00316017|3589702|FG001|NOT COMPLETED|Overall Study||13
2884112|NCT00316017|3589703|FG002|NOT COMPLETED|Overall Study||19
2884113|NCT00316082|3589716|FG000|STARTED|Overall Study||74
2884114|NCT00316082|3589717|FG001|STARTED|Overall Study||74
2884115|NCT00316082|3589718|FG002|STARTED|Overall Study||71
2884116|NCT00316082|3589719|FG003|STARTED|Overall Study||72
2884117|NCT00316082|3589720|FG004|STARTED|Overall Study||74
2884118|NCT00316082|3589716|FG000|Completed Study Without Being Rescued|Overall Study||25
2884119|NCT00316082|3589717|FG001|Completed Study Without Being Rescued|Overall Study||35
2884120|NCT00316082|3589718|FG002|Completed Study Without Being Rescued|Overall Study||29
2884121|NCT00316082|3589719|FG003|Completed Study Without Being Rescued|Overall Study||27
2884122|NCT00316082|3589720|FG004|Completed Study Without Being Rescued|Overall Study||31
2884123|NCT00316082|3589716|FG000|COMPLETED|Overall Study||41
2884124|NCT00316082|3589717|FG001|COMPLETED|Overall Study||52
2884125|NCT00316082|3589718|FG002|COMPLETED|Overall Study||44
2884126|NCT00316082|3589719|FG003|COMPLETED|Overall Study||46
2884127|NCT00316082|3589720|FG004|COMPLETED|Overall Study||48
2884128|NCT00316082|3589716|FG000|NOT COMPLETED|Overall Study||33
2884129|NCT00316082|3589717|FG001|NOT COMPLETED|Overall Study||22
2884130|NCT00316082|3589718|FG002|NOT COMPLETED|Overall Study||27
2884131|NCT00316082|3589719|FG003|NOT COMPLETED|Overall Study||26
2884132|NCT00316082|3589720|FG004|NOT COMPLETED|Overall Study||26
2884133|NCT00316121|3589738|FG000|STARTED|Overall Study||92
2884134|NCT00316121|3589739|FG001|STARTED|Overall Study||46
2884135|NCT00316121|3589738|FG000|COMPLETED|Overall Study||70
2884136|NCT00316121|3589739|FG001|COMPLETED|Overall Study||37
2884137|NCT00316121|3589738|FG000|NOT COMPLETED|Overall Study||22
2884138|NCT00316121|3589739|FG001|NOT COMPLETED|Overall Study||9
2884139|NCT00316173|3589747|FG000|STARTED|Run-in Phase||22
2884140|NCT00316173|3589748|FG001|STARTED|Run-in Phase||0
2884141|NCT00316173|3589747|FG000|COMPLETED|Run-in Phase||15
2884142|NCT00316173|3589748|FG001|COMPLETED|Run-in Phase||0
2884143|NCT00316173|3589747|FG000|NOT COMPLETED|Run-in Phase||7
2884144|NCT00316173|3589748|FG001|NOT COMPLETED|Run-in Phase||0
2884145|NCT00316173|3589747|FG000|STARTED|Treatment Phase||0
2884146|NCT00316173|3589748|FG001|STARTED|Treatment Phase||55
2884147|NCT00316173|3589747|FG000|COMPLETED|Treatment Phase||0
2884148|NCT00316173|3589748|FG001|COMPLETED|Treatment Phase||13
2884149|NCT00316173|3589747|FG000|NOT COMPLETED|Treatment Phase||0
2884150|NCT00316173|3589748|FG001|NOT COMPLETED|Treatment Phase||42
3170162|NCT01928394|3897424|FG018|NOT COMPLETED|Follow-up Period||16
3170163|NCT01928394|3897425|FG019|NOT COMPLETED|Follow-up Period||21
3170164|NCT01928394|3897426|FG020|NOT COMPLETED|Follow-up Period||9
3170165|NCT01928394|3897427|FG021|NOT COMPLETED|Follow-up Period||9
3170166|NCT01928394|3897428|FG022|NOT COMPLETED|Follow-up Period||6
3170167|NCT01928433|3897479|FG000|STARTED|Overall Study||76
3170168|NCT01928433|3897480|FG001|STARTED|Overall Study||75
3170169|NCT01928433|3897481|FG002|STARTED|Overall Study||74
2884151|NCT00316186|3589753|FG000|STARTED|Overall Study||33
2884152|NCT00316186|3589753|FG000|COMPLETED|Overall Study||21
2884153|NCT00316186|3589753|FG000|NOT COMPLETED|Overall Study||12
2884154|NCT00316199|3589757|FG000|STARTED|Overall Study||60
2884155|NCT00316199|3589757|FG000|COMPLETED|Overall Study||48
2884156|NCT00316199|3589757|FG000|NOT COMPLETED|Overall Study||12
2884157|NCT00316225|3589761|FG000|STARTED|Overall Study||31
2884158|NCT00316225|3589761|FG000|COMPLETED|Overall Study||6
2884159|NCT00316225|3589761|FG000|NOT COMPLETED|Overall Study||25
2884160|NCT00316264|3589768|FG000|STARTED|Overall Study||83
2884161|NCT00316264|3589769|FG001|STARTED|Overall Study||84
2884162|NCT00316264|3589770|FG002|STARTED|Overall Study||93
2884163|NCT00316264|3589768|FG000|COMPLETED|Overall Study||77
2884164|NCT00316264|3589769|FG001|COMPLETED|Overall Study||77
2884165|NCT00316264|3589770|FG002|COMPLETED|Overall Study||87
2884166|NCT00316264|3589768|FG000|NOT COMPLETED|Overall Study||6
2884167|NCT00316264|3589769|FG001|NOT COMPLETED|Overall Study||7
2884168|NCT00316264|3589770|FG002|NOT COMPLETED|Overall Study||6
2884169|NCT00316277|3589780|FG000|STARTED|Phase 1 (12 Weeks)||329
2884170|NCT00316277|3589781|FG001|STARTED|Phase 1 (12 Weeks)||324
2884171|NCT00316277|3589780|FG000|COMPLETED|Phase 1 (12 Weeks)||19
2884172|NCT00316277|3589781|FG001|COMPLETED|Phase 1 (12 Weeks)||24
2884173|NCT00316277|3589780|FG000|NOT COMPLETED|Phase 1 (12 Weeks)||310
2884174|NCT00316277|3589781|FG001|NOT COMPLETED|Phase 1 (12 Weeks)||300
2884175|NCT00316277|3589780|FG000|STARTED|Phase 2 (24 Weeks)||180
2884176|NCT00316277|3589781|FG001|STARTED|Phase 2 (24 Weeks)||180
2884177|NCT00316277|3589780|FG000|COMPLETED|Phase 2 (24 Weeks)||161
2884178|NCT00316277|3589781|FG001|COMPLETED|Phase 2 (24 Weeks)||161
2884179|NCT00316277|3589780|FG000|NOT COMPLETED|Phase 2 (24 Weeks)||19
2884180|NCT00316277|3589781|FG001|NOT COMPLETED|Phase 2 (24 Weeks)||19
2884181|NCT00316303|3589797|FG000|STARTED|Overall Study||118
2884182|NCT00316303|3589798|FG001|STARTED|Overall Study||118
2884183|NCT00316303|3589797|FG000|COMPLETED|Overall Study||107
2884184|NCT00316303|3589798|FG001|COMPLETED|Overall Study||102
2884185|NCT00316303|3589797|FG000|NOT COMPLETED|Overall Study||11
2884186|NCT00316303|3589798|FG001|NOT COMPLETED|Overall Study||16
2884187|NCT00316355|3589809|FG000|STARTED|Overall Study||15
2884188|NCT00316355|3589810|FG001|STARTED|Overall Study||19
2884189|NCT00316355|3589809|FG000|Started Treatment|Overall Study||12
2884190|NCT00316355|3589810|FG001|Started Treatment|Overall Study||18
2884191|NCT00316355|3589809|FG000|COMPLETED|Overall Study||10
2884192|NCT00316355|3589810|FG001|COMPLETED|Overall Study||12
2884193|NCT00316355|3589809|FG000|NOT COMPLETED|Overall Study||5
2884194|NCT00316355|3589810|FG001|NOT COMPLETED|Overall Study||7
2884195|NCT00316524|3589820|FG000|STARTED|Overall Study||183
2884196|NCT00316524|3589821|FG001|STARTED|Overall Study||181
2884197|NCT00316524|3589822|FG002|STARTED|Overall Study||181
2884198|NCT00316524|3589823|FG003|STARTED|Overall Study||200
2884199|NCT00316524|3589820|FG000|COMPLETED|Overall Study||175
2884200|NCT00316524|3589821|FG001|COMPLETED|Overall Study||173
2884201|NCT00316524|3589822|FG002|COMPLETED|Overall Study||175
2884202|NCT00316524|3589823|FG003|COMPLETED|Overall Study||200
2884203|NCT00316524|3589820|FG000|NOT COMPLETED|Overall Study||8
2884204|NCT00316524|3589821|FG001|NOT COMPLETED|Overall Study||8
2884205|NCT00316524|3589822|FG002|NOT COMPLETED|Overall Study||6
2884206|NCT00316524|3589823|FG003|NOT COMPLETED|Overall Study||0
2884207|NCT00316589|3589841|FG000|STARTED|Overall Study||88
2884208|NCT00316589|3589842|FG001|STARTED|Overall Study||352
2884209|NCT00316589|3589843|FG002|STARTED|Overall Study||9
2884210|NCT00316589|3589844|FG003|STARTED|Overall Study||132
2884211|NCT00316589|3589841|FG000|COMPLETED|Overall Study||87
2884212|NCT00316589|3589842|FG001|COMPLETED|Overall Study||328
2884213|NCT00316589|3589843|FG002|COMPLETED|Overall Study||8
2884214|NCT00316589|3589844|FG003|COMPLETED|Overall Study||127
2884215|NCT00316589|3589841|FG000|NOT COMPLETED|Overall Study||1
2884216|NCT00316589|3589842|FG001|NOT COMPLETED|Overall Study||24
2884217|NCT00316589|3589843|FG002|NOT COMPLETED|Overall Study||1
2884218|NCT00316589|3589844|FG003|NOT COMPLETED|Overall Study||5
2884219|NCT00316602|3589858|FG000|STARTED|Overall Study||282
2884220|NCT00316602|3589859|FG001|STARTED|Overall Study||350
2884221|NCT00316602|3589858|FG000|COMPLETED|Overall Study||272
2884222|NCT00316602|3589859|FG001|COMPLETED|Overall Study||325
2884223|NCT00316602|3589858|FG000|NOT COMPLETED|Overall Study||10
3170170|NCT01928433|3897479|FG000|COMPLETED|Overall Study||56
3170171|NCT01928433|3897480|FG001|COMPLETED|Overall Study||54
2884224|NCT00316602|3589859|FG001|NOT COMPLETED|Overall Study||25
2884225|NCT00316693|3589867|FG000|STARTED|Overall Study||519
2884226|NCT00316693|3589868|FG001|STARTED|Overall Study||521
2884227|NCT00316693|3589867|FG000|COMPLETED|Overall Study||442
2884228|NCT00316693|3589868|FG001|COMPLETED|Overall Study||436
2884229|NCT00316693|3589867|FG000|NOT COMPLETED|Overall Study||77
2884230|NCT00316693|3589868|FG001|NOT COMPLETED|Overall Study||85
2884231|NCT00316706|3589876|FG000|STARTED|Overall Study||626
2884232|NCT00316706|3589877|FG001|STARTED|Overall Study||619
2884233|NCT00316706|3589876|FG000|COMPLETED|Overall Study|Subjects in Cervarix group that completed the study at Month 48|588
2884234|NCT00316706|3589877|FG001|COMPLETED|Overall Study|Subjects in Havrix group that completed the study at Month 24|571
2884235|NCT00316706|3589876|FG000|NOT COMPLETED|Overall Study||38
2884236|NCT00316706|3589877|FG001|NOT COMPLETED|Overall Study||48
2884237|NCT00316719|3589885|FG000|STARTED|Overall Study||52
2884238|NCT00316719|3589886|FG001|STARTED|Overall Study||53
2884239|NCT00316719|3589885|FG000|COMPLETED|Overall Study||50
2884240|NCT00316719|3589886|FG001|COMPLETED|Overall Study||47
2884241|NCT00316719|3589885|FG000|NOT COMPLETED|Overall Study||2
2884242|NCT00316719|3589886|FG001|NOT COMPLETED|Overall Study||6
2884243|NCT00316862|3589892|FG000|STARTED|Overall Study||82
2884244|NCT00316862|3589892|FG000|COMPLETED|Overall Study||82
2884245|NCT00316862|3589892|FG000|NOT COMPLETED|Overall Study||0
2884246|NCT00316888|3589898|FG000|STARTED|Overall Study||28
2884247|NCT00316888|3589899|FG001|STARTED|Overall Study||35
2884248|NCT00316888|3589898|FG000|Eligible|Overall Study||28
2884249|NCT00316888|3589899|FG001|Eligible|Overall Study||35
2884250|NCT00316888|3589898|FG000|Treated|Overall Study|Received induction and/or chemo+radiation therapy|28
2884251|NCT00316888|3589899|FG001|Treated|Overall Study||34
2884252|NCT00316888|3589898|FG000|Started Induction Chemotherapy|Overall Study||28
2884253|NCT00316888|3589899|FG001|Started Induction Chemotherapy|Overall Study|Induction chemotherapy was removed for patients on this arm|0
2884254|NCT00316888|3589898|FG000|Started Chemo+Radiation+Cetuximab|Overall Study|One patient did not start chemo+radiation therapy after completing induction therapy|27
2884255|NCT00316888|3589899|FG001|Started Chemo+Radiation+Cetuximab|Overall Study||34
2884256|NCT00316888|3589898|FG000|COMPLETED|Overall Study||22
2884257|NCT00316888|3589899|FG001|COMPLETED|Overall Study||27
2884258|NCT00316888|3589898|FG000|NOT COMPLETED|Overall Study||6
2884259|NCT00316888|3589899|FG001|NOT COMPLETED|Overall Study||8
2884260|NCT00316914|3589907|FG000|STARTED|Overall Study||50
2884261|NCT00316914|3589908|FG001|STARTED|Overall Study||52
2884262|NCT00316914|3589907|FG000|COMPLETED|Overall Study||17
2884263|NCT00316914|3589908|FG001|COMPLETED|Overall Study||16
2884264|NCT00316914|3589907|FG000|NOT COMPLETED|Overall Study||33
2884265|NCT00316914|3589908|FG001|NOT COMPLETED|Overall Study||36
2884266|NCT00317044|3589917|FG000|STARTED|Overall Study||320
2884267|NCT00317044|3589918|FG001|STARTED|Overall Study||313
2884268|NCT00317044|3589919|FG002|STARTED|Overall Study||328
2884269|NCT00317044|3589917|FG000|COMPLETED|Overall Study||272
2884270|NCT00317044|3589918|FG001|COMPLETED|Overall Study||273
2884271|NCT00317044|3589919|FG002|COMPLETED|Overall Study||283
2884272|NCT00317044|3589917|FG000|NOT COMPLETED|Overall Study||48
2884273|NCT00317044|3589918|FG001|NOT COMPLETED|Overall Study||40
2884274|NCT00317044|3589919|FG002|NOT COMPLETED|Overall Study||45
2884275|NCT00317109|3589929|FG000|STARTED|Overall Study||84
3314715|NCT03091673|4048007|FG000|STARTED|First Dose||31
3314716|NCT03091673|4048008|FG001|STARTED|First Dose|All 31 subjects received the 0.5 mg dose during period 1.|0
3314717|NCT03091673|4048007|FG000|COMPLETED|First Dose||31
3314718|NCT03091673|4048008|FG001|COMPLETED|First Dose||0
3314719|NCT03091673|4048007|FG000|NOT COMPLETED|First Dose||0
3314720|NCT03091673|4048008|FG001|NOT COMPLETED|First Dose||0
3314721|NCT03091673|4048007|FG000|STARTED|Second Dose|No subjects received the 0.5 mg dose during period 2.|0
3314722|NCT03091673|4048008|FG001|STARTED|Second Dose|Only the 11 study subjects ages 12-<18 years were assigned the 1 mg dose during period 2.|11
2884276|NCT00317109|3589930|FG001|STARTED|Overall Study||84
2884277|NCT00317109|3589929|FG000|COMPLETED|Overall Study||81
2884278|NCT00317109|3589930|FG001|COMPLETED|Overall Study||84
2884279|NCT00317109|3589929|FG000|NOT COMPLETED|Overall Study||3
2884280|NCT00317109|3589930|FG001|NOT COMPLETED|Overall Study||0
2884281|NCT00317226|3589936|FG000|STARTED|Overall Study||127
2884282|NCT00317226|3589936|FG000|COMPLETED|Overall Study||104
2884283|NCT00317226|3589936|FG000|NOT COMPLETED|Overall Study||23
2884284|NCT00317239|3589942|FG000|STARTED|Overall Study||147
2884285|NCT00317239|3589943|FG001|STARTED|Overall Study||103
2884286|NCT00317239|3589942|FG000|COMPLETED|Overall Study||134
2884287|NCT00317239|3589943|FG001|COMPLETED|Overall Study||84
2884288|NCT00317239|3589942|FG000|NOT COMPLETED|Overall Study||13
2884289|NCT00317239|3589943|FG001|NOT COMPLETED|Overall Study||19
2884290|NCT00317356|3589953|FG000|STARTED|Overall Study||11
2884291|NCT00317356|3589954|FG001|STARTED|Overall Study||11
2884292|NCT00317356|3589955|FG002|STARTED|Overall Study||10
2884293|NCT00317356|3589956|FG003|STARTED|Overall Study||11
2884294|NCT00317356|3589953|FG000|COMPLETED|Overall Study||10
2884295|NCT00317356|3589954|FG001|COMPLETED|Overall Study||9
2884296|NCT00317356|3589955|FG002|COMPLETED|Overall Study||9
2884297|NCT00317356|3589956|FG003|COMPLETED|Overall Study||8
2884298|NCT00317356|3589953|FG000|NOT COMPLETED|Overall Study||1
2884299|NCT00317356|3589954|FG001|NOT COMPLETED|Overall Study||2
2884300|NCT00317356|3589955|FG002|NOT COMPLETED|Overall Study||1
2884301|NCT00317356|3589956|FG003|NOT COMPLETED|Overall Study||3
3314723|NCT03091673|4048007|FG000|COMPLETED|Second Dose||0
2884302|NCT00317369|3589969|FG000|STARTED|Overall Study||10
2884303|NCT00317369|3589970|FG001|STARTED|Overall Study||9
2884304|NCT00317369|3589971|FG002|STARTED|Overall Study||10
2884305|NCT00317369|3589969|FG000|COMPLETED|Overall Study||8
2884306|NCT00317369|3589970|FG001|COMPLETED|Overall Study||7
2884307|NCT00317369|3589971|FG002|COMPLETED|Overall Study||8
2884308|NCT00317369|3589969|FG000|NOT COMPLETED|Overall Study||2
2884309|NCT00317369|3589970|FG001|NOT COMPLETED|Overall Study||2
2884310|NCT00317369|3589971|FG002|NOT COMPLETED|Overall Study||2
2884311|NCT00317473|3589985|FG000|STARTED|Overall Study||30
2884312|NCT00317473|3589986|FG001|STARTED|Overall Study||15
2884313|NCT00317473|3589987|FG002|STARTED|Overall Study||30
2884314|NCT00317473|3589988|FG003|STARTED|Overall Study||15
2884315|NCT00317473|3589989|FG004|STARTED|Overall Study||30
2884316|NCT00317473|3589990|FG005|STARTED|Overall Study||15
2884317|NCT00317473|3589985|FG000|COMPLETED|Overall Study||26
2884318|NCT00317473|3589986|FG001|COMPLETED|Overall Study||12
2884319|NCT00317473|3589987|FG002|COMPLETED|Overall Study||27
2884320|NCT00317473|3589988|FG003|COMPLETED|Overall Study||13
2884321|NCT00317473|3589989|FG004|COMPLETED|Overall Study||22
2884322|NCT00317473|3589990|FG005|COMPLETED|Overall Study||12
2884323|NCT00317473|3589985|FG000|NOT COMPLETED|Overall Study||4
2884324|NCT00317473|3589986|FG001|NOT COMPLETED|Overall Study||3
2884325|NCT00317473|3589987|FG002|NOT COMPLETED|Overall Study||3
2884326|NCT00317473|3589988|FG003|NOT COMPLETED|Overall Study||2
2884327|NCT00317473|3589989|FG004|NOT COMPLETED|Overall Study||8
2884328|NCT00317473|3589990|FG005|NOT COMPLETED|Overall Study||3
2884329|NCT00317603|3590014|FG000|STARTED|Overall Study||15
2884330|NCT00317603|3590014|FG000|Treated|Overall Study||12
2884331|NCT00317603|3590014|FG000|COMPLETED|Overall Study||12
2884332|NCT00317603|3590014|FG000|NOT COMPLETED|Overall Study||3
2884333|NCT00317642|3590020|FG000|STARTED|Overall Study||163
2884334|NCT00317642|3590021|FG001|STARTED|Overall Study||163
2884335|NCT00317642|3590020|FG000|Full Analysis Set|Overall Study|AML Centrally Confirmed|162
2884336|NCT00317642|3590021|FG001|Full Analysis Set|Overall Study|AML Centrally Confirmed|158
2884337|NCT00317642|3590020|FG000|Received >= 1 Study Drug (Safety Set)|Overall Study||161
2884338|NCT00317642|3590021|FG001|Received >= 1 Study Drug (Safety Set)|Overall Study||155
2884339|NCT00317642|3590020|FG000|COMPLETED|Overall Study|achieved remission and completed consolidation|41
2884340|NCT00317642|3590021|FG001|COMPLETED|Overall Study|achieved remission and completed consolidation|28
2884341|NCT00317642|3590020|FG000|NOT COMPLETED|Overall Study||122
2884342|NCT00317642|3590021|FG001|NOT COMPLETED|Overall Study||135
2884343|NCT00317720|3590034|FG000|STARTED|Overall Study||40
2884344|NCT00317720|3590035|FG001|STARTED|Overall Study||7
2884345|NCT00317720|3590034|FG000|COMPLETED|Overall Study||40
2884346|NCT00317720|3590035|FG001|COMPLETED|Overall Study||7
2884347|NCT00317720|3590034|FG000|NOT COMPLETED|Overall Study||0
2884348|NCT00317720|3590035|FG001|NOT COMPLETED|Overall Study||0
2884349|NCT00317941|3590041|FG000|STARTED|Overall Study||73
2884350|NCT00317941|3590042|FG001|STARTED|Overall Study||79
2884351|NCT00317941|3590043|FG002|STARTED|Overall Study||68
2884352|NCT00317941|3590041|FG000|Participants Received Treatment|Overall Study||73
2884353|NCT00317941|3590042|FG001|Participants Received Treatment|Overall Study||79
2884354|NCT00317941|3590043|FG002|Participants Received Treatment|Overall Study||68
2884355|NCT00317941|3590041|FG000|Fulfilled Requirement Safety Population|Overall Study||73
2884356|NCT00317941|3590042|FG001|Fulfilled Requirement Safety Population|Overall Study||77
2884357|NCT00317941|3590043|FG002|Fulfilled Requirement Safety Population|Overall Study||65
2884358|NCT00317941|3590041|FG000|Fulfilled Requirements PP Population|Overall Study||66
2884359|NCT00317941|3590042|FG001|Fulfilled Requirements PP Population|Overall Study||76
3170172|NCT01928433|3897481|FG002|COMPLETED|Overall Study||46
3170173|NCT01928433|3897479|FG000|NOT COMPLETED|Overall Study||20
3170174|NCT01928433|3897480|FG001|NOT COMPLETED|Overall Study||21
3170175|NCT01928433|3897481|FG002|NOT COMPLETED|Overall Study||28
3170176|NCT01928446|3897494|FG000|STARTED|Overall Study||255
2884360|NCT00317941|3590043|FG002|Fulfilled Requirements PP Population|Overall Study||63
2884361|NCT00317941|3590041|FG000|COMPLETED|Overall Study||66
2884362|NCT00317941|3590042|FG001|COMPLETED|Overall Study||74
2884363|NCT00317941|3590043|FG002|COMPLETED|Overall Study||60
2884364|NCT00317941|3590041|FG000|NOT COMPLETED|Overall Study||7
2884365|NCT00317941|3590042|FG001|NOT COMPLETED|Overall Study||5
2884366|NCT00317941|3590043|FG002|NOT COMPLETED|Overall Study||8
2884367|NCT00318136|3590052|FG000|STARTED|Overall Study||47
2884368|NCT00318136|3590052|FG000|COMPLETED|Overall Study||2
2884369|NCT00318136|3590052|FG000|NOT COMPLETED|Overall Study||45
2884370|NCT00318149|3590062|FG000|STARTED|Overall Study||75
2884371|NCT00318149|3590063|FG001|STARTED|Overall Study||50
2884372|NCT00318149|3590064|FG002|STARTED|Overall Study||75
2884373|NCT00318149|3590065|FG003|STARTED|Overall Study||75
2884374|NCT00318149|3590066|FG004|STARTED|Overall Study||75
2884375|NCT00318149|3590067|FG005|STARTED|Overall Study||75
2884376|NCT00318149|3590062|FG000|COMPLETED|Overall Study||75
2884377|NCT00318149|3590063|FG001|COMPLETED|Overall Study||50
2884378|NCT00318149|3590064|FG002|COMPLETED|Overall Study||75
2884379|NCT00318149|3590065|FG003|COMPLETED|Overall Study||75
2884380|NCT00318149|3590066|FG004|COMPLETED|Overall Study||75
2884381|NCT00318149|3590067|FG005|COMPLETED|Overall Study||73
2884382|NCT00318149|3590062|FG000|NOT COMPLETED|Overall Study||0
2884383|NCT00318149|3590063|FG001|NOT COMPLETED|Overall Study||0
3170177|NCT01928446|3897495|FG001|STARTED|Overall Study||264
2884384|NCT00318149|3590064|FG002|NOT COMPLETED|Overall Study||0
2884385|NCT00318149|3590065|FG003|NOT COMPLETED|Overall Study||0
2884386|NCT00318149|3590066|FG004|NOT COMPLETED|Overall Study||0
2884387|NCT00318149|3590067|FG005|NOT COMPLETED|Overall Study||2
2884388|NCT00318292|3590085|FG000|STARTED|Overall Study||45
2884389|NCT00318292|3590086|FG001|STARTED|Overall Study||45
2884390|NCT00318292|3590085|FG000|COMPLETED|Overall Study||45
2884391|NCT00318292|3590086|FG001|COMPLETED|Overall Study||45
2884392|NCT00318292|3590085|FG000|NOT COMPLETED|Overall Study||0
2884393|NCT00318292|3590086|FG001|NOT COMPLETED|Overall Study||0
2884394|NCT00318357|3590094|FG000|STARTED|Overall Study||173
2884395|NCT00318357|3590095|FG001|STARTED|Overall Study||136
2884396|NCT00318357|3590094|FG000|COMPLETED|Overall Study||134
2884397|NCT00318357|3590095|FG001|COMPLETED|Overall Study||104
2884398|NCT00318357|3590094|FG000|NOT COMPLETED|Overall Study||39
2884399|NCT00318357|3590095|FG001|NOT COMPLETED|Overall Study||32
2884400|NCT00318370|3590101|FG000|STARTED|Period 1||28
2884401|NCT00318370|3590102|FG001|STARTED|Period 1||0
2884402|NCT00318370|3590103|FG002|STARTED|Period 1||0
2884403|NCT00318370|3590101|FG000|COMPLETED|Period 1|21 participants proceeded from Far Only to Chemo Plus Far.|21
2884404|NCT00318370|3590102|FG001|COMPLETED|Period 1||0
2884405|NCT00318370|3590103|FG002|COMPLETED|Period 1||0
2884406|NCT00318370|3590101|FG000|NOT COMPLETED|Period 1||7
2884407|NCT00318370|3590102|FG001|NOT COMPLETED|Period 1||0
2884408|NCT00318370|3590103|FG002|NOT COMPLETED|Period 1||0
2884409|NCT00318370|3590101|FG000|STARTED|Period 2||0
2884410|NCT00318370|3590102|FG001|STARTED|Period 2|26 participants enrolled directly into Chemo Plus Far plus 21 participants from Far Only.|47
2884411|NCT00318370|3590103|FG002|STARTED|Period 2||0
2884412|NCT00318370|3590101|FG000|COMPLETED|Period 2||0
2884413|NCT00318370|3590102|FG001|COMPLETED|Period 2||36
2884414|NCT00318370|3590103|FG002|COMPLETED|Period 2||0
2884415|NCT00318370|3590101|FG000|NOT COMPLETED|Period 2||0
2884416|NCT00318370|3590102|FG001|NOT COMPLETED|Period 2||11
2884417|NCT00318370|3590103|FG002|NOT COMPLETED|Period 2||0
2884418|NCT00318370|3590101|FG000|STARTED|Period 3||0
2884419|NCT00318370|3590102|FG001|STARTED|Period 3||0
2884420|NCT00318370|3590103|FG002|STARTED|Period 3||36
2884421|NCT00318370|3590101|FG000|COMPLETED|Period 3||0
2884422|NCT00318370|3590102|FG001|COMPLETED|Period 3||0
2884423|NCT00318370|3590103|FG002|COMPLETED|Period 3||3
2884424|NCT00318370|3590101|FG000|NOT COMPLETED|Period 3||0
2884425|NCT00318370|3590102|FG001|NOT COMPLETED|Period 3||0
2884426|NCT00318370|3590103|FG002|NOT COMPLETED|Period 3||33
2884427|NCT00318409|3590111|FG000|STARTED|Overall Study||20
2884428|NCT00318409|3590112|FG001|STARTED|Overall Study||10
2884429|NCT00318409|3590111|FG000|COMPLETED|Overall Study||18
2884430|NCT00318409|3590112|FG001|COMPLETED|Overall Study||9
2884431|NCT00318409|3590111|FG000|NOT COMPLETED|Overall Study||2
2884432|NCT00318409|3590112|FG001|NOT COMPLETED|Overall Study||1
2884433|NCT00318461|3590124|FG000|STARTED|Double-Blind, 6 Months|Randomised|242
2884434|NCT00318461|3590125|FG001|STARTED|Double-Blind, 6 Months|Randomised|241
2884435|NCT00318461|3590126|FG002|STARTED|Double-Blind, 6 Months|Randomised|242
2884436|NCT00318461|3590127|FG003|STARTED|Double-Blind, 6 Months|Randomised|122
2884437|NCT00318461|3590128|FG004|STARTED|Double-Blind, 6 Months|Randomised|244
2884438|NCT00318461|3590124|FG000|Exposed to Study Drug|Double-Blind, 6 Months||242
2884439|NCT00318461|3590125|FG001|Exposed to Study Drug|Double-Blind, 6 Months|Subject withdrew before exposure to drug, and thus not included in the safety and ITT analysis sets|240
2884440|NCT00318461|3590126|FG002|Exposed to Study Drug|Double-Blind, 6 Months||242
2884441|NCT00318461|3590127|FG003|Exposed to Study Drug|Double-Blind, 6 Months|Subject withdrew before exposure to drug, and thus not included in the safety and ITT analysis sets|121
2884442|NCT00318461|3590128|FG004|Exposed to Study Drug|Double-Blind, 6 Months|Subjects withdrew before exposure to drug, and thus not included in the safety and ITT analysis sets|242
2884443|NCT00318461|3590124|FG000|COMPLETED|Double-Blind, 6 Months||208
2884444|NCT00318461|3590125|FG001|COMPLETED|Double-Blind, 6 Months||197
2884445|NCT00318461|3590126|FG002|COMPLETED|Double-Blind, 6 Months||191
2884446|NCT00318461|3590127|FG003|COMPLETED|Double-Blind, 6 Months||74
2884447|NCT00318461|3590128|FG004|COMPLETED|Double-Blind, 6 Months||210
2884448|NCT00318461|3590124|FG000|NOT COMPLETED|Double-Blind, 6 Months||34
2884449|NCT00318461|3590125|FG001|NOT COMPLETED|Double-Blind, 6 Months||44
2884450|NCT00318461|3590126|FG002|NOT COMPLETED|Double-Blind, 6 Months||51
2884451|NCT00318461|3590127|FG003|NOT COMPLETED|Double-Blind, 6 Months||48
2884452|NCT00318461|3590128|FG004|NOT COMPLETED|Double-Blind, 6 Months||34
2884453|NCT00318461|3590124|FG000|STARTED|Open-Label Extension, 18 Months||208
2884454|NCT00318461|3590125|FG001|STARTED|Open-Label Extension, 18 Months||197
2884455|NCT00318461|3590126|FG002|STARTED|Open-Label Extension, 18 Months||191
2884456|NCT00318461|3590127|FG003|STARTED|Open-Label Extension, 18 Months||74
2884457|NCT00318461|3590128|FG004|STARTED|Open-Label Extension, 18 Months||210
2884458|NCT00318461|3590124|FG000|COMPLETED|Open-Label Extension, 18 Months||130
2884459|NCT00318461|3590125|FG001|COMPLETED|Open-Label Extension, 18 Months||137
2884460|NCT00318461|3590126|FG002|COMPLETED|Open-Label Extension, 18 Months||118
2884461|NCT00318461|3590127|FG003|COMPLETED|Open-Label Extension, 18 Months||31
2884462|NCT00318461|3590128|FG004|COMPLETED|Open-Label Extension, 18 Months||113
2884463|NCT00318461|3590124|FG000|NOT COMPLETED|Open-Label Extension, 18 Months||78
2884464|NCT00318461|3590125|FG001|NOT COMPLETED|Open-Label Extension, 18 Months||60
2884465|NCT00318461|3590126|FG002|NOT COMPLETED|Open-Label Extension, 18 Months||73
2884466|NCT00318461|3590127|FG003|NOT COMPLETED|Open-Label Extension, 18 Months||43
2884467|NCT00318461|3590128|FG004|NOT COMPLETED|Open-Label Extension, 18 Months||97
2884468|NCT00318474|3590142|FG000|STARTED|Overall Study||25
2884469|NCT00318474|3590143|FG001|STARTED|Overall Study||27
2884470|NCT00318474|3590142|FG000|COMPLETED|Overall Study||7
2884471|NCT00318474|3590143|FG001|COMPLETED|Overall Study||10
2884472|NCT00318474|3590142|FG000|NOT COMPLETED|Overall Study||18
2884473|NCT00318474|3590143|FG001|NOT COMPLETED|Overall Study||17
2884474|NCT00318565|3590149|FG000|STARTED|Overall Study||291
2884475|NCT00318565|3590149|FG000|COMPLETED|Overall Study||267
2884476|NCT00318565|3590149|FG000|NOT COMPLETED|Overall Study||24
2884477|NCT00318591|3590155|FG000|STARTED|Overall Study||105
2884478|NCT00318591|3590156|FG001|STARTED|Overall Study||114
2884479|NCT00318591|3590155|FG000|COMPLETED|Overall Study||45
2884480|NCT00318591|3590156|FG001|COMPLETED|Overall Study||69
2884481|NCT00318591|3590155|FG000|NOT COMPLETED|Overall Study||60
2884482|NCT00318591|3590156|FG001|NOT COMPLETED|Overall Study||45
2884483|NCT00318643|3590169|FG000|STARTED|Overall Study||3
2884484|NCT00318643|3590170|FG001|STARTED|Overall Study||3
2884485|NCT00318643|3590171|FG002|STARTED|Overall Study||6
2884486|NCT00318643|3590172|FG003|STARTED|Overall Study||3
2884487|NCT00318643|3590173|FG004|STARTED|Overall Study||12
2884488|NCT00318643|3590169|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
2884489|NCT00318643|3590170|FG001|Received at Least 1 Dose of Study Drug|Overall Study||3
2884490|NCT00318643|3590171|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
2884491|NCT00318643|3590172|FG003|Received at Least 1 Dose of Study Drug|Overall Study||3
2884492|NCT00318643|3590173|FG004|Received at Least 1 Dose of Study Drug|Overall Study||12
2884493|NCT00318643|3590169|FG000|COMPLETED|Overall Study||3
2884494|NCT00318643|3590170|FG001|COMPLETED|Overall Study||3
2884495|NCT00318643|3590171|FG002|COMPLETED|Overall Study||6
2884496|NCT00318643|3590172|FG003|COMPLETED|Overall Study||3
2884497|NCT00318643|3590173|FG004|COMPLETED|Overall Study||9
2884498|NCT00318643|3590169|FG000|NOT COMPLETED|Overall Study||0
2884499|NCT00318643|3590170|FG001|NOT COMPLETED|Overall Study||0
2884500|NCT00318643|3590171|FG002|NOT COMPLETED|Overall Study||0
2884501|NCT00318643|3590172|FG003|NOT COMPLETED|Overall Study||0
2884502|NCT00318643|3590173|FG004|NOT COMPLETED|Overall Study||3
2884503|NCT00318708|3590188|FG000|STARTED|Overall Study||47
2884504|NCT00318708|3590189|FG001|STARTED|Overall Study||45
3170178|NCT01928446|3897494|FG000|COMPLETED|Overall Study|39 subjects stopped study drug but continued with followup|144
3170179|NCT01928446|3897495|FG001|COMPLETED|Overall Study|23 subjects stopped study drug but continued with followup|125
3170180|NCT01928446|3897494|FG000|NOT COMPLETED|Overall Study||111
2884505|NCT00318708|3590188|FG000|8-week Milestone|Overall Study||42
2884506|NCT00318708|3590189|FG001|8-week Milestone|Overall Study||42
2884507|NCT00318708|3590188|FG000|COMPLETED|Overall Study||39
2884508|NCT00318708|3590189|FG001|COMPLETED|Overall Study||40
2884509|NCT00318708|3590188|FG000|NOT COMPLETED|Overall Study||8
2884510|NCT00318708|3590189|FG001|NOT COMPLETED|Overall Study||5
2884511|NCT00318812|3590201|FG000|STARTED|Overall Study||18
2884512|NCT00318812|3590202|FG001|STARTED|Overall Study||22
2884513|NCT00318812|3590201|FG000|COMPLETED|Overall Study||18
2884514|NCT00318812|3590202|FG001|COMPLETED|Overall Study||22
2884515|NCT00318812|3590201|FG000|NOT COMPLETED|Overall Study||0
2884516|NCT00318812|3590202|FG001|NOT COMPLETED|Overall Study||0
2884517|NCT00318929|3590208|FG000|STARTED|Overall Study||14
2884518|NCT00318929|3590208|FG000|COMPLETED|Overall Study||14
2884519|NCT00318929|3590208|FG000|NOT COMPLETED|Overall Study||0
2884520|NCT00319020|3590214|FG000|STARTED|Overall Study||15
2884521|NCT00319020|3590215|FG001|STARTED|Overall Study||21
2884522|NCT00319020|3590214|FG000|Enrollment in FUTURE 2 (F-2)|Overall Study||13
2884523|NCT00319020|3590215|FG001|Enrollment in FUTURE 2 (F-2)|Overall Study||20
2884524|NCT00319020|3590214|FG000|COMPLETED|Overall Study||8
2884525|NCT00319020|3590215|FG001|COMPLETED|Overall Study||8
2884526|NCT00319020|3590214|FG000|NOT COMPLETED|Overall Study||7
2884527|NCT00319020|3590215|FG001|NOT COMPLETED|Overall Study||13
2884528|NCT00319046|3590223|FG000|STARTED|Overall Study|One patient was excluded from analysis as the baseline liver volume not available|42
2884529|NCT00319046|3590223|FG000|COMPLETED|Overall Study||34
2884530|NCT00319046|3590223|FG000|NOT COMPLETED|Overall Study||8
2884531|NCT00319098|3590231|FG000|STARTED|Overall Study||3802
2884532|NCT00319098|3590232|FG001|STARTED|Overall Study||1269
2884533|NCT00319098|3590231|FG000|COMPLETED|Overall Study||3667
2884534|NCT00319098|3590232|FG001|COMPLETED|Overall Study||1237
2884535|NCT00319098|3590231|FG000|NOT COMPLETED|Overall Study||135
2884536|NCT00319098|3590232|FG001|NOT COMPLETED|Overall Study||32
2884537|NCT00319111|3590242|FG000|STARTED|Overall Study|148 patients enrolled in BENEFIT OL & 3 prematurely discontinued from BENEFIT (NCT00313222)|151
2884538|NCT00319111|3590242|FG000|COMPLETED|Overall Study||104
2884539|NCT00319111|3590242|FG000|NOT COMPLETED|Overall Study||47
2884540|NCT00319254|3590246|FG000|STARTED|Overall Study||75
2884541|NCT00319254|3590246|FG000|Treated|Overall Study||73
2884542|NCT00319254|3590246|FG000|COMPLETED|Overall Study||21
2884543|NCT00319254|3590246|FG000|NOT COMPLETED|Overall Study||54
2884544|NCT00319436|3590252|FG000|STARTED|Overall Study||23
2884545|NCT00319436|3590253|FG001|STARTED|Overall Study||24
2884546|NCT00319436|3590252|FG000|COMPLETED|Overall Study||17
2884547|NCT00319436|3590253|FG001|COMPLETED|Overall Study||17
2884548|NCT00319436|3590252|FG000|NOT COMPLETED|Overall Study||6
2884549|NCT00319436|3590253|FG001|NOT COMPLETED|Overall Study||7
2884550|NCT00319501|3590261|FG000|STARTED|Double-blind Period|Randomized participants|124
2884551|NCT00319501|3590262|FG001|STARTED|Double-blind Period|Randomized participants|110
2884552|NCT00319501|3590261|FG000|Received Treatment|Double-blind Period||82
2884553|NCT00319501|3590262|FG001|Received Treatment|Double-blind Period||81
2884554|NCT00319501|3590261|FG000|COMPLETED|Double-blind Period||81
2884555|NCT00319501|3590262|FG001|COMPLETED|Double-blind Period||78
2884556|NCT00319501|3590261|FG000|NOT COMPLETED|Double-blind Period||43
2884557|NCT00319501|3590262|FG001|NOT COMPLETED|Double-blind Period||32
2884558|NCT00319501|3590261|FG000|STARTED|Open-label Period|Participants who continued to meet eligibility requirements|161
2884559|NCT00319501|3590262|FG001|STARTED|Open-label Period||0
2884560|NCT00319501|3590261|FG000|Received Treatment|Open-label Period||128
2884561|NCT00319501|3590262|FG001|Received Treatment|Open-label Period||0
2884562|NCT00319501|3590261|FG000|COMPLETED|Open-label Period|Competed=continuing treatment|45
2884563|NCT00319501|3590262|FG001|COMPLETED|Open-label Period||0
2884564|NCT00319501|3590261|FG000|NOT COMPLETED|Open-label Period||116
2884565|NCT00319501|3590262|FG001|NOT COMPLETED|Open-label Period||0
2884566|NCT00319501|3590261|FG000|STARTED|Open-label Extension Period|Eligible participants who chose to continue treatment|51
2884567|NCT00319501|3590262|FG001|STARTED|Open-label Extension Period||0
2884568|NCT00319501|3590261|FG000|Received Treatment|Open-label Extension Period||33
2884569|NCT00319501|3590262|FG001|Received Treatment|Open-label Extension Period||0
2884570|NCT00319501|3590261|FG000|COMPLETED|Open-label Extension Period||0
2884571|NCT00319501|3590262|FG001|COMPLETED|Open-label Extension Period||0
2884572|NCT00319501|3590261|FG000|NOT COMPLETED|Open-label Extension Period||51
2884573|NCT00319501|3590262|FG001|NOT COMPLETED|Open-label Extension Period||0
2884574|NCT00319553|3590275|FG000|STARTED|Overall Study||323
2884575|NCT00319553|3590276|FG001|STARTED|Overall Study||321
2884576|NCT00319553|3590275|FG000|COMPLETED|Overall Study||319
2884577|NCT00319553|3590276|FG001|COMPLETED|Overall Study||317
2884578|NCT00319553|3590275|FG000|NOT COMPLETED|Overall Study||4
2884579|NCT00319553|3590276|FG001|NOT COMPLETED|Overall Study||4
2884580|NCT00319592|3590284|FG000|STARTED|Overall Study||30
2884581|NCT00319592|3590285|FG001|STARTED|Overall Study||30
2884582|NCT00319592|3590284|FG000|COMPLETED|Overall Study||29
2884583|NCT00319592|3590285|FG001|COMPLETED|Overall Study||29
2884584|NCT00319592|3590284|FG000|NOT COMPLETED|Overall Study||1
2884585|NCT00319592|3590285|FG001|NOT COMPLETED|Overall Study||1
2884586|NCT00319644|3590293|FG000|STARTED|Overall Study||21
2884587|NCT00319644|3590294|FG001|STARTED|Overall Study||16
2884588|NCT00319644|3590293|FG000|COMPLETED|Overall Study||21
2884589|NCT00319644|3590294|FG001|COMPLETED|Overall Study||16
2884590|NCT00319644|3590293|FG000|NOT COMPLETED|Overall Study||0
2884591|NCT00319644|3590294|FG001|NOT COMPLETED|Overall Study||0
2884592|NCT00319696|3590300|FG000|STARTED|Overall Study||116
2884593|NCT00319696|3590300|FG000|COMPLETED|Overall Study||56
2884594|NCT00319696|3590300|FG000|NOT COMPLETED|Overall Study||60
2884595|NCT00319735|3590310|FG000|STARTED|Overall Study||41
2884596|NCT00319735|3590310|FG000|COMPLETED|Overall Study||39
2884597|NCT00319735|3590310|FG000|NOT COMPLETED|Overall Study||2
2884598|NCT00319748|3590315|FG000|STARTED|Overall Study||13
2884599|NCT00319748|3590315|FG000|COMPLETED|Overall Study||13
2884600|NCT00319748|3590315|FG000|NOT COMPLETED|Overall Study||0
2884601|NCT00319956|3590327|FG000|STARTED|Overall Study||111
2884602|NCT00319956|3590328|FG001|STARTED|Overall Study||109
2884603|NCT00319956|3590327|FG000|COMPLETED|Overall Study||91
2884604|NCT00319956|3590328|FG001|COMPLETED|Overall Study||85
2884605|NCT00319956|3590327|FG000|NOT COMPLETED|Overall Study||20
2884606|NCT00319956|3590328|FG001|NOT COMPLETED|Overall Study||24
2884607|NCT00319982|3590336|FG000|STARTED|Overall Study||19
2884608|NCT00319982|3590337|FG001|STARTED|Overall Study||20
2884609|NCT00319982|3590336|FG000|COMPLETED|Overall Study||18
2884610|NCT00319982|3590337|FG001|COMPLETED|Overall Study||20
2884611|NCT00319982|3590336|FG000|NOT COMPLETED|Overall Study||1
2884612|NCT00319982|3590337|FG001|NOT COMPLETED|Overall Study||0
2884613|NCT00320112|3590345|FG000|STARTED|Overall Study||125
2884614|NCT00320112|3590346|FG001|STARTED|Overall Study||119
2884615|NCT00320112|3590345|FG000|COMPLETED|Overall Study||117
2884616|NCT00320112|3590346|FG001|COMPLETED|Overall Study||114
2884617|NCT00320112|3590345|FG000|NOT COMPLETED|Overall Study||8
2884618|NCT00320112|3590346|FG001|NOT COMPLETED|Overall Study||5
2884619|NCT00320190|3590360|FG000|STARTED|First 12 Months||19
2884620|NCT00320190|3590361|FG001|STARTED|First 12 Months||13
2884621|NCT00320190|3590360|FG000|COMPLETED|First 12 Months||11
2884622|NCT00320190|3590361|FG001|COMPLETED|First 12 Months||3
2884623|NCT00320190|3590360|FG000|NOT COMPLETED|First 12 Months||8
2884624|NCT00320190|3590361|FG001|NOT COMPLETED|First 12 Months||10
2884625|NCT00320190|3590360|FG000|STARTED|Long-term (12-month) Extension||11
2884626|NCT00320190|3590361|FG001|STARTED|Long-term (12-month) Extension||3
2884627|NCT00320190|3590360|FG000|COMPLETED|Long-term (12-month) Extension||2
2884628|NCT00320190|3590361|FG001|COMPLETED|Long-term (12-month) Extension||1
2884629|NCT00320190|3590360|FG000|NOT COMPLETED|Long-term (12-month) Extension||9
2884630|NCT00320190|3590361|FG001|NOT COMPLETED|Long-term (12-month) Extension||2
2884631|NCT00320216|3590372|FG000|STARTED|Overall Study||64
2884632|NCT00320216|3590373|FG001|STARTED|Overall Study|1 patient randomized but not treated was included as discontinued due to Other reason.|64
2884633|NCT00320216|3590374|FG002|STARTED|Overall Study|1 patient randomized but not treated was included as discontinued due to Other reason.|64
2884634|NCT00320216|3590375|FG003|STARTED|Overall Study||64
2884635|NCT00320216|3590376|FG004|STARTED|Overall Study||64
2884636|NCT00320216|3590372|FG000|COMPLETED|Overall Study||48
2884637|NCT00320216|3590373|FG001|COMPLETED|Overall Study||54
2884638|NCT00320216|3590374|FG002|COMPLETED|Overall Study||58
2884639|NCT00320216|3590375|FG003|COMPLETED|Overall Study||61
2884640|NCT00320216|3590376|FG004|COMPLETED|Overall Study||58
2884641|NCT00320216|3590372|FG000|NOT COMPLETED|Overall Study||16
2884642|NCT00320216|3590373|FG001|NOT COMPLETED|Overall Study||10
2884643|NCT00320216|3590374|FG002|NOT COMPLETED|Overall Study||6
2884644|NCT00320216|3590375|FG003|NOT COMPLETED|Overall Study||3
2884645|NCT00320216|3590376|FG004|NOT COMPLETED|Overall Study||6
2884646|NCT00320242|3590393|FG000|STARTED|Overall Study||16
2884647|NCT00320242|3590394|FG001|STARTED|Overall Study||16
2884648|NCT00320242|3590393|FG000|COMPLETED|Overall Study||14
2884649|NCT00320242|3590394|FG001|COMPLETED|Overall Study||12
2884650|NCT00320242|3590393|FG000|NOT COMPLETED|Overall Study||2
2884651|NCT00320242|3590394|FG001|NOT COMPLETED|Overall Study||4
2884652|NCT00320255|3590407|FG000|STARTED|Overall Study||30
2884653|NCT00320255|3590408|FG001|STARTED|Overall Study||32
2884654|NCT00320255|3590409|FG002|STARTED|Overall Study||30
2884655|NCT00320255|3590410|FG003|STARTED|Overall Study||33
2884656|NCT00320255|3590411|FG004|STARTED|Overall Study||2
2884657|NCT00320255|3590412|FG005|STARTED|Overall Study||3
2884658|NCT00320255|3590407|FG000|Received Treatment|Overall Study||29
2884659|NCT00320255|3590408|FG001|Received Treatment|Overall Study||32
2884660|NCT00320255|3590409|FG002|Received Treatment|Overall Study||29
2884661|NCT00320255|3590410|FG003|Received Treatment|Overall Study||32
2884662|NCT00320255|3590411|FG004|Received Treatment|Overall Study||2
2884663|NCT00320255|3590412|FG005|Received Treatment|Overall Study||3
2884664|NCT00320255|3590407|FG000|COMPLETED|Overall Study||19
2884665|NCT00320255|3590408|FG001|COMPLETED|Overall Study||25
2884666|NCT00320255|3590409|FG002|COMPLETED|Overall Study||24
2884667|NCT00320255|3590410|FG003|COMPLETED|Overall Study||25
2884668|NCT00320255|3590411|FG004|COMPLETED|Overall Study||2
2884669|NCT00320255|3590412|FG005|COMPLETED|Overall Study||3
2884670|NCT00320255|3590407|FG000|NOT COMPLETED|Overall Study||11
2884671|NCT00320255|3590408|FG001|NOT COMPLETED|Overall Study||7
2884672|NCT00320255|3590409|FG002|NOT COMPLETED|Overall Study||6
2884673|NCT00320255|3590410|FG003|NOT COMPLETED|Overall Study||8
2884674|NCT00320255|3590411|FG004|NOT COMPLETED|Overall Study||0
2884675|NCT00320255|3590412|FG005|NOT COMPLETED|Overall Study||0
2884676|NCT00320281|3590429|FG000|STARTED|Overall Study||10
2884677|NCT00320281|3590430|FG001|STARTED|Overall Study||9
2884678|NCT00320281|3590429|FG000|COMPLETED|Overall Study||10
2884679|NCT00320281|3590430|FG001|COMPLETED|Overall Study||9
2884680|NCT00320281|3590429|FG000|NOT COMPLETED|Overall Study||0
2884681|NCT00320281|3590430|FG001|NOT COMPLETED|Overall Study||0
2884682|NCT00320372|3590441|FG000|STARTED|Overall Study||494
2884683|NCT00320372|3590442|FG001|STARTED|Overall Study||301
2884684|NCT00320372|3590441|FG000|VNS Therapy D-23 Original|Overall Study||335
2884685|NCT00320372|3590442|FG001|VNS Therapy D-23 Original|Overall Study||0
2884686|NCT00320372|3590441|FG000|VNS Therapy D-21 (NCT00305565) Rollovers|Overall Study||159
2884687|NCT00320372|3590442|FG001|VNS Therapy D-21 (NCT00305565) Rollovers|Overall Study||0
2884688|NCT00320372|3590441|FG000|COMPLETED|Overall Study||299
2884689|NCT00320372|3590442|FG001|COMPLETED|Overall Study||138
2884690|NCT00320372|3590441|FG000|NOT COMPLETED|Overall Study||195
2884691|NCT00320372|3590442|FG001|NOT COMPLETED|Overall Study||163
2884692|NCT00320385|3590458|FG000|STARTED|Overall Study||148
2884693|NCT00320385|3590459|FG001|STARTED|Overall Study||148
2884694|NCT00320385|3590458|FG000|COMPLETED|Overall Study||130
2884695|NCT00320385|3590459|FG001|COMPLETED|Overall Study||126
2884696|NCT00320385|3590458|FG000|NOT COMPLETED|Overall Study||18
2884697|NCT00320385|3590459|FG001|NOT COMPLETED|Overall Study||22
2884698|NCT00320398|3590467|FG000|STARTED|Overall Study||58
2884699|NCT00320398|3590468|FG001|STARTED|Overall Study||56
2884700|NCT00320398|3590467|FG000|COMPLETED|Overall Study||56
2884701|NCT00320398|3590468|FG001|COMPLETED|Overall Study||52
2884702|NCT00320398|3590467|FG000|NOT COMPLETED|Overall Study||2
2884703|NCT00320398|3590468|FG001|NOT COMPLETED|Overall Study||4
2884704|NCT00320411|3590475|FG000|STARTED|Overall Study||62
2884705|NCT00320411|3590475|FG000|COMPLETED|Overall Study||58
2884706|NCT00320411|3590475|FG000|NOT COMPLETED|Overall Study||4
2884707|NCT00320424|3590479|FG000|STARTED|Overall Study||48
2884708|NCT00320424|3590479|FG000|COMPLETED|Overall Study||42
2884709|NCT00320424|3590479|FG000|NOT COMPLETED|Overall Study||6
2884710|NCT00320489|3590485|FG000|STARTED|Overall Study||264
2884711|NCT00320489|3590486|FG001|STARTED|Overall Study||260
2884712|NCT00320489|3590485|FG000|COMPLETED|Overall Study||119
2884713|NCT00320489|3590486|FG001|COMPLETED|Overall Study||124
2884714|NCT00320489|3590485|FG000|NOT COMPLETED|Overall Study||145
2884715|NCT00320489|3590486|FG001|NOT COMPLETED|Overall Study||136
2884716|NCT00320515|3590492|FG000|STARTED|Overall Study||69
2884717|NCT00320515|3590492|FG000|COMPLETED|Overall Study||20
2884718|NCT00320515|3590492|FG000|NOT COMPLETED|Overall Study||49
2884719|NCT00320528|3590499|FG000|STARTED|Study Period II||98
2884720|NCT00320528|3590500|FG001|STARTED|Study Period II||41
2884721|NCT00320528|3590501|FG002|STARTED|Study Period II||130
2884722|NCT00320528|3590499|FG000|Received at Least One Dose of Study Drug|Study Period II||97
2884723|NCT00320528|3590500|FG001|Received at Least One Dose of Study Drug|Study Period II||38
2884724|NCT00320528|3590501|FG002|Received at Least One Dose of Study Drug|Study Period II||128
2884725|NCT00320528|3590499|FG000|COMPLETED|Study Period II||87
2884726|NCT00320528|3590500|FG001|COMPLETED|Study Period II||31
2884727|NCT00320528|3590501|FG002|COMPLETED|Study Period II||108
2884728|NCT00320528|3590499|FG000|NOT COMPLETED|Study Period II||11
2884729|NCT00320528|3590500|FG001|NOT COMPLETED|Study Period II||10
2884730|NCT00320528|3590501|FG002|NOT COMPLETED|Study Period II||22
2884731|NCT00320528|3590499|FG000|STARTED|Study Period III||87
2884732|NCT00320528|3590500|FG001|STARTED|Study Period III||31
2884733|NCT00320528|3590501|FG002|STARTED|Study Period III||108
2884734|NCT00320528|3590499|FG000|COMPLETED|Study Period III||0
2884735|NCT00320528|3590500|FG001|COMPLETED|Study Period III||0
2884736|NCT00320528|3590501|FG002|COMPLETED|Study Period III||2
2884737|NCT00320528|3590499|FG000|NOT COMPLETED|Study Period III||87
2884738|NCT00320528|3590500|FG001|NOT COMPLETED|Study Period III||31
2884739|NCT00320528|3590501|FG002|NOT COMPLETED|Study Period III||106
2884740|NCT00320541|3590511|FG000|STARTED|Overall Study||94
2884741|NCT00320541|3590512|FG001|STARTED|Overall Study||93
2884742|NCT00320541|3590511|FG000|COMPLETED|Overall Study||44
2884743|NCT00320541|3590512|FG001|COMPLETED|Overall Study||36
2884744|NCT00320541|3590511|FG000|NOT COMPLETED|Overall Study||50
2884745|NCT00320541|3590512|FG001|NOT COMPLETED|Overall Study||57
2884746|NCT00320593|3590520|FG000|STARTED|Overall Study||59
2884747|NCT00320593|3590521|FG001|STARTED|Overall Study||59
2884748|NCT00320593|3590520|FG000|COMPLETED|Overall Study|Completed defined as completing the 3 year primary outcome exam|52
2884749|NCT00320593|3590521|FG001|COMPLETED|Overall Study|Completed defined as completing the 3 year primary outcome exam|58
2884750|NCT00320593|3590520|FG000|NOT COMPLETED|Overall Study||7
2884751|NCT00320593|3590521|FG001|NOT COMPLETED|Overall Study||1
2884752|NCT00320606|3590527|FG000|STARTED|Overall Study||20
2884753|NCT00320606|3590527|FG000|COMPLETED|Overall Study||17
2884754|NCT00320606|3590527|FG000|NOT COMPLETED|Overall Study||3
2884755|NCT00320671|3590534|FG000|STARTED|Overall Study||102
2884756|NCT00320671|3590535|FG001|STARTED|Overall Study||96
2884757|NCT00320671|3590534|FG000|COMPLETED|Overall Study||69
2884758|NCT00320671|3590535|FG001|COMPLETED|Overall Study||58
2884759|NCT00320671|3590534|FG000|NOT COMPLETED|Overall Study||33
2884760|NCT00320671|3590535|FG001|NOT COMPLETED|Overall Study||38
2884761|NCT00320710|3590544|FG000|STARTED|Overall Study||200
2884762|NCT00320710|3590545|FG001|STARTED|Overall Study||203
2884763|NCT00320710|3590546|FG002|STARTED|Overall Study||13
2884764|NCT00320710|3590544|FG000|Treated (Safety Set)|Overall Study||198
2884765|NCT00320710|3590545|FG001|Treated (Safety Set)|Overall Study||202
2884766|NCT00320710|3590546|FG002|Treated (Safety Set)|Overall Study||13
2884767|NCT00320710|3590544|FG000|COMPLETED|Overall Study||106
2884768|NCT00320710|3590545|FG001|COMPLETED|Overall Study||127
2884769|NCT00320710|3590546|FG002|COMPLETED|Overall Study||8
2884770|NCT00320710|3590544|FG000|NOT COMPLETED|Overall Study||94
2884771|NCT00320710|3590545|FG001|NOT COMPLETED|Overall Study||76
2884772|NCT00320710|3590546|FG002|NOT COMPLETED|Overall Study||5
2884773|NCT00320749|3590553|FG000|STARTED|Overall Study||3
2884774|NCT00320749|3590554|FG001|STARTED|Overall Study||8
2884775|NCT00320749|3590555|FG002|STARTED|Overall Study||10
2884776|NCT00320749|3590553|FG000|COMPLETED|Overall Study||3
2884777|NCT00320749|3590554|FG001|COMPLETED|Overall Study||6
2884778|NCT00320749|3590555|FG002|COMPLETED|Overall Study||1
2884779|NCT00320749|3590553|FG000|NOT COMPLETED|Overall Study||0
2884780|NCT00320749|3590554|FG001|NOT COMPLETED|Overall Study||2
2884781|NCT00320749|3590555|FG002|NOT COMPLETED|Overall Study||9
2884782|NCT00320788|3590565|FG000|STARTED|Overall Study||32
2884783|NCT00320788|3590566|FG001|STARTED|Overall Study||32
2884784|NCT00320788|3590567|FG002|STARTED|Overall Study||32
2884785|NCT00320788|3590568|FG003|STARTED|Overall Study|Participants Randomized|32
2884786|NCT00320788|3590569|FG004|STARTED|Overall Study||31
2884787|NCT00320788|3590565|FG000|Participants Received Treatment (SAF)|Overall Study||32
2884788|NCT00320788|3590566|FG001|Participants Received Treatment (SAF)|Overall Study||32
2884789|NCT00320788|3590567|FG002|Participants Received Treatment (SAF)|Overall Study|One participant in this group did not receive treatment and was not included in the SAF and FAS|31
2884790|NCT00320788|3590568|FG003|Participants Received Treatment (SAF)|Overall Study|One participant in this group did not receive treatment and was not included in the SAF and FAS|31
2884791|NCT00320788|3590569|FG004|Participants Received Treatment (SAF)|Overall Study||31
2884792|NCT00320788|3590565|FG000|COMPLETED|Overall Study||26
2884793|NCT00320788|3590566|FG001|COMPLETED|Overall Study||26
2884794|NCT00320788|3590567|FG002|COMPLETED|Overall Study||29
2884795|NCT00320788|3590568|FG003|COMPLETED|Overall Study||27
2884796|NCT00320788|3590569|FG004|COMPLETED|Overall Study||26
2884797|NCT00320788|3590565|FG000|NOT COMPLETED|Overall Study||6
2884798|NCT00320788|3590566|FG001|NOT COMPLETED|Overall Study||6
2884799|NCT00320788|3590567|FG002|NOT COMPLETED|Overall Study||3
2884800|NCT00320788|3590568|FG003|NOT COMPLETED|Overall Study||5
2884801|NCT00320788|3590569|FG004|NOT COMPLETED|Overall Study||5
2884802|NCT00320801|3590589|FG000|STARTED|Open-label Run-in Period||188
2884803|NCT00320801|3590590|FG001|STARTED|Open-label Run-in Period||0
2884804|NCT00320801|3590591|FG002|STARTED|Open-label Run-in Period||0
2884805|NCT00320801|3590592|FG003|STARTED|Open-label Run-in Period||0
2884806|NCT00320801|3590589|FG000|COMPLETED|Open-label Run-in Period||96
2884807|NCT00320801|3590590|FG001|COMPLETED|Open-label Run-in Period||0
2884808|NCT00320801|3590591|FG002|COMPLETED|Open-label Run-in Period||0
2884809|NCT00320801|3590592|FG003|COMPLETED|Open-label Run-in Period||0
2884810|NCT00320801|3590589|FG000|NOT COMPLETED|Open-label Run-in Period||92
2884811|NCT00320801|3590590|FG001|NOT COMPLETED|Open-label Run-in Period||0
2884812|NCT00320801|3590591|FG002|NOT COMPLETED|Open-label Run-in Period||0
2884813|NCT00320801|3590592|FG003|NOT COMPLETED|Open-label Run-in Period||0
2884814|NCT00320801|3590589|FG000|STARTED|Double-blind Phase||0
2884815|NCT00320801|3590590|FG001|STARTED|Double-blind Phase||47
2884816|NCT00320801|3590591|FG002|STARTED|Double-blind Phase||49
2884817|NCT00320801|3590592|FG003|STARTED|Double-blind Phase||0
2884818|NCT00320801|3590589|FG000|COMPLETED|Double-blind Phase||0
2884819|NCT00320801|3590590|FG001|COMPLETED|Double-blind Phase||36
2884820|NCT00320801|3590591|FG002|COMPLETED|Double-blind Phase||35
2884821|NCT00320801|3590592|FG003|COMPLETED|Double-blind Phase||0
2884822|NCT00320801|3590589|FG000|NOT COMPLETED|Double-blind Phase||0
2884823|NCT00320801|3590590|FG001|NOT COMPLETED|Double-blind Phase||11
2884824|NCT00320801|3590591|FG002|NOT COMPLETED|Double-blind Phase||14
2884825|NCT00320801|3590592|FG003|NOT COMPLETED|Double-blind Phase||0
2884826|NCT00320801|3590589|FG000|STARTED|Extension Phase||0
2884827|NCT00320801|3590590|FG001|STARTED|Extension Phase||0
2884828|NCT00320801|3590591|FG002|STARTED|Extension Phase||0
2884829|NCT00320801|3590592|FG003|STARTED|Extension Phase||55
2884830|NCT00320801|3590589|FG000|COMPLETED|Extension Phase||0
2884831|NCT00320801|3590590|FG001|COMPLETED|Extension Phase||0
2884832|NCT00320801|3590591|FG002|COMPLETED|Extension Phase||0
2884833|NCT00320801|3590592|FG003|COMPLETED|Extension Phase||7
2884834|NCT00320801|3590589|FG000|NOT COMPLETED|Extension Phase||0
2884835|NCT00320801|3590590|FG001|NOT COMPLETED|Extension Phase||0
2884836|NCT00320801|3590591|FG002|NOT COMPLETED|Extension Phase||0
2884837|NCT00320801|3590592|FG003|NOT COMPLETED|Extension Phase||48
2884838|NCT00321048|3590604|FG000|STARTED|Overall Study||28
2884839|NCT00321048|3590605|FG001|STARTED|Overall Study||29
3133748|NCT01697579|3858712|FG000|STARTED|Base Study-Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6 arms.|74
3133749|NCT01697579|3858713|FG001|STARTED|Base Study-Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6 arms.|43
3133750|NCT01697579|3858714|FG002|STARTED|Base Study-Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6 arms.|44
3133751|NCT01697579|3858715|FG003|STARTED|Base Study-Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6 arms.|41
3133752|NCT01697579|3858716|FG004|STARTED|Base Study-Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6 arms.|38
3133753|NCT01697579|3858717|FG005|STARTED|Base Study-Cycle 1|Enrollment in Cycles 2-6 was optional.|0
3170181|NCT01928446|3897495|FG001|NOT COMPLETED|Overall Study||139
3170182|NCT01928472|3897507|FG000|STARTED|Overall Study||98
3170183|NCT01928472|3897508|FG001|STARTED|Overall Study||104
3170184|NCT01928472|3897509|FG002|STARTED|Overall Study||98
3170185|NCT01928472|3897510|FG003|STARTED|Overall Study||102
3170186|NCT01928472|3897507|FG000|COMPLETED|Overall Study||90
3170187|NCT01928472|3897508|FG001|COMPLETED|Overall Study||96
3170188|NCT01928472|3897509|FG002|COMPLETED|Overall Study||91
3170189|NCT01928472|3897510|FG003|COMPLETED|Overall Study||100
3170190|NCT01928472|3897507|FG000|NOT COMPLETED|Overall Study||8
3170191|NCT01928472|3897508|FG001|NOT COMPLETED|Overall Study||8
3170192|NCT01928472|3897509|FG002|NOT COMPLETED|Overall Study||7
3170193|NCT01928472|3897510|FG003|NOT COMPLETED|Overall Study||2
3170194|NCT01928485|3897523|FG000|STARTED|Overall Study||4
3170195|NCT01928485|3897524|FG001|STARTED|Overall Study||2
3170196|NCT01928485|3897523|FG000|COMPLETED|Overall Study||4
3170197|NCT01928485|3897524|FG001|COMPLETED|Overall Study||1
3170198|NCT01928485|3897523|FG000|NOT COMPLETED|Overall Study||0
3170199|NCT01928485|3897524|FG001|NOT COMPLETED|Overall Study||1
3170200|NCT01928524|3897537|FG000|STARTED|Overall Study||3
3170201|NCT01928524|3897538|FG001|STARTED|Overall Study||3
3170202|NCT01928524|3897539|FG002|STARTED|Overall Study||6
3170203|NCT01928524|3897540|FG003|STARTED|Overall Study||6
3170204|NCT01928524|3897541|FG004|STARTED|Overall Study||3
3170205|NCT01928524|3897542|FG005|STARTED|Overall Study||8
3170206|NCT01928524|3897543|FG006|STARTED|Overall Study||5
3170207|NCT01928524|3897537|FG000|COMPLETED|Overall Study||3
3170208|NCT01928524|3897538|FG001|COMPLETED|Overall Study||3
3170209|NCT01928524|3897539|FG002|COMPLETED|Overall Study||6
3170210|NCT01928524|3897540|FG003|COMPLETED|Overall Study||6
3170211|NCT01928524|3897541|FG004|COMPLETED|Overall Study||3
3170212|NCT01928524|3897542|FG005|COMPLETED|Overall Study||8
2884840|NCT00321048|3590604|FG000|COMPLETED|Overall Study||22
2884841|NCT00321048|3590605|FG001|COMPLETED|Overall Study||21
2884842|NCT00321048|3590604|FG000|NOT COMPLETED|Overall Study||6
2884843|NCT00321048|3590605|FG001|NOT COMPLETED|Overall Study||8
2884844|NCT00321269|3590613|FG000|STARTED|Overall Study||74
2884845|NCT00321269|3590614|FG001|STARTED|Overall Study||74
2884846|NCT00321269|3590613|FG000|COMPLETED|Overall Study||66
2884847|NCT00321269|3590614|FG001|COMPLETED|Overall Study||68
2884848|NCT00321269|3590613|FG000|NOT COMPLETED|Overall Study||8
2884849|NCT00321269|3590614|FG001|NOT COMPLETED|Overall Study||6
2884850|NCT00321321|3590622|FG000|STARTED|Overall Study||12
2884851|NCT00321321|3590622|FG000|COMPLETED|Overall Study||12
2884852|NCT00321321|3590622|FG000|NOT COMPLETED|Overall Study||0
2884853|NCT00321373|3590629|FG000|STARTED|Overall Study||407
2884854|NCT00321373|3590630|FG001|STARTED|Overall Study||406
2884855|NCT00321373|3590631|FG002|STARTED|Overall Study||407
2884856|NCT00321373|3590629|FG000|COMPLETED|Overall Study||405
2884857|NCT00321373|3590630|FG001|COMPLETED|Overall Study||406
2884858|NCT00321373|3590631|FG002|COMPLETED|Overall Study||404
2884859|NCT00321373|3590629|FG000|NOT COMPLETED|Overall Study||2
2884860|NCT00321373|3590630|FG001|NOT COMPLETED|Overall Study||0
2884861|NCT00321373|3590631|FG002|NOT COMPLETED|Overall Study||3
2884862|NCT00321464|3590641|FG000|STARTED|Overall Study||1020
2884863|NCT00321464|3590642|FG001|STARTED|Overall Study||1026
2884864|NCT00321464|3590641|FG000|Received Investigational Product|Overall Study||1014
2884865|NCT00321464|3590642|FG001|Received Investigational Product|Overall Study||1019
2884866|NCT00321464|3590641|FG000|COMPLETED|Overall Study||461
2884867|NCT00321464|3590642|FG001|COMPLETED|Overall Study||468
2884868|NCT00321464|3590641|FG000|NOT COMPLETED|Overall Study||559
2884869|NCT00321464|3590642|FG001|NOT COMPLETED|Overall Study||558
2919561|NCT00532883|3629988|FG000|STARTED|Overall Study||11
2919562|NCT00532883|3629989|FG001|STARTED|Overall Study||12
2919563|NCT00532883|3629990|FG002|STARTED|Overall Study||10
2919564|NCT00532883|3629991|FG003|STARTED|Overall Study||11
2919565|NCT00532883|3629988|FG000|COMPLETED|Overall Study|Study terminated early.|5
2919566|NCT00532883|3629989|FG001|COMPLETED|Overall Study|Study terminated early.|5
2919567|NCT00532883|3629990|FG002|COMPLETED|Overall Study|Study terminated early.|6
2919568|NCT00532883|3629991|FG003|COMPLETED|Overall Study|Study terminated early.|6
2919569|NCT00532883|3629988|FG000|NOT COMPLETED|Overall Study||6
2919570|NCT00532883|3629989|FG001|NOT COMPLETED|Overall Study||7
2919571|NCT00532883|3629990|FG002|NOT COMPLETED|Overall Study||4
2919572|NCT00532883|3629991|FG003|NOT COMPLETED|Overall Study||5
2919573|NCT00532935|3630003|FG000|STARTED|Overall Study|Excludes 1 patient who was randomized twice at different sites.|261
2919574|NCT00532935|3630004|FG001|STARTED|Overall Study|Excludes 1 patient who was randomized twice at different sites.|256
2919575|NCT00532935|3630003|FG000|COMPLETED|Overall Study||210
2919576|NCT00532935|3630004|FG001|COMPLETED|Overall Study||204
2919577|NCT00532935|3630003|FG000|NOT COMPLETED|Overall Study||51
2919578|NCT00532935|3630004|FG001|NOT COMPLETED|Overall Study||52
3170213|NCT01928524|3897543|FG006|COMPLETED|Overall Study||5
3170214|NCT01928524|3897537|FG000|NOT COMPLETED|Overall Study||0
3170215|NCT01928524|3897538|FG001|NOT COMPLETED|Overall Study||0
2919579|NCT00532948|3630013|FG000|STARTED|Overall Study||4
2919580|NCT00532948|3630014|FG001|STARTED|Overall Study||14
2919581|NCT00532948|3630015|FG002|STARTED|Overall Study||6
2919582|NCT00532948|3630013|FG000|COMPLETED|Overall Study||0
2919583|NCT00532948|3630014|FG001|COMPLETED|Overall Study||9
2919584|NCT00532948|3630015|FG002|COMPLETED|Overall Study||2
2919585|NCT00532948|3630013|FG000|NOT COMPLETED|Overall Study||4
2919586|NCT00532948|3630014|FG001|NOT COMPLETED|Overall Study||5
2919587|NCT00532948|3630015|FG002|NOT COMPLETED|Overall Study||4
2919588|NCT00533117|3630031|FG000|STARTED|Overall Study||18
2919589|NCT00533117|3630032|FG001|STARTED|Overall Study||19
2919590|NCT00533117|3630033|FG002|STARTED|Overall Study||20
2919591|NCT00533117|3630034|FG003|STARTED|Overall Study||18
2919592|NCT00533117|3630031|FG000|COMPLETED|Overall Study||14
2919593|NCT00533117|3630032|FG001|COMPLETED|Overall Study||14
2919594|NCT00533117|3630033|FG002|COMPLETED|Overall Study||14
2919595|NCT00533117|3630034|FG003|COMPLETED|Overall Study||13
2919596|NCT00533117|3630031|FG000|NOT COMPLETED|Overall Study||4
2919597|NCT00533117|3630032|FG001|NOT COMPLETED|Overall Study||5
2919598|NCT00533117|3630033|FG002|NOT COMPLETED|Overall Study||6
2919599|NCT00533117|3630034|FG003|NOT COMPLETED|Overall Study||5
2919600|NCT00533273|3630046|FG000|STARTED|Double-blind||45
2919601|NCT00533273|3630047|FG001|STARTED|Double-blind||21
2919602|NCT00533273|3630046|FG000|COMPLETED|Double-blind||45
2919603|NCT00533273|3630047|FG001|COMPLETED|Double-blind||19
2919604|NCT00533273|3630046|FG000|NOT COMPLETED|Double-blind||0
2919605|NCT00533273|3630047|FG001|NOT COMPLETED|Double-blind||2
2919606|NCT00533273|3630046|FG000|STARTED|Open-label|open-label was extension of double-blind; 64 of 66 patients continued into open-label|64
2919607|NCT00533273|3630047|FG001|STARTED|Open-label|no placebo - this phase was open label|0
2919608|NCT00533273|3630046|FG000|COMPLETED|Open-label||58
2919609|NCT00533273|3630047|FG001|COMPLETED|Open-label||0
2919610|NCT00533273|3630046|FG000|NOT COMPLETED|Open-label||6
2919611|NCT00533273|3630047|FG001|NOT COMPLETED|Open-label||0
2919612|NCT00533429|3630055|FG000|STARTED|Overall Study||20
2919613|NCT00533429|3630056|FG001|STARTED|Overall Study||20
2919614|NCT00533429|3630055|FG000|Received at Least 1 Dose of Study Drug|Overall Study||20
2919615|NCT00533429|3630056|FG001|Received at Least 1 Dose of Study Drug|Overall Study||20
2919616|NCT00533429|3630055|FG000|Entered Maintenance|Overall Study||8
2919617|NCT00533429|3630056|FG001|Entered Maintenance|Overall Study||10
2919618|NCT00533429|3630055|FG000|COMPLETED|Overall Study||1
2919619|NCT00533429|3630056|FG001|COMPLETED|Overall Study||4
2919620|NCT00533429|3630055|FG000|NOT COMPLETED|Overall Study||19
2919621|NCT00533429|3630056|FG001|NOT COMPLETED|Overall Study||16
2919622|NCT00533442|3630066|FG000|STARTED|Allocation and Intent to Treat Analysis||86
2919623|NCT00533442|3630067|FG001|STARTED|Allocation and Intent to Treat Analysis||84
2919624|NCT00533442|3630066|FG000|COMPLETED|Allocation and Intent to Treat Analysis||86
2919625|NCT00533442|3630067|FG001|COMPLETED|Allocation and Intent to Treat Analysis||84
2919626|NCT00533442|3630066|FG000|NOT COMPLETED|Allocation and Intent to Treat Analysis||0
2919627|NCT00533442|3630067|FG001|NOT COMPLETED|Allocation and Intent to Treat Analysis||0
2919628|NCT00533442|3630066|FG000|STARTED|Follow-up|Ongoing Follow-up at 13-123 months (N=77); Lost to Follow-up (N=9, at 5-100 months).|86
2919629|NCT00533442|3630067|FG001|STARTED|Follow-up|Ongoing Follow-up at 17-124 months (N=74); Lost to Follow-up (N=10, at 5-67 months).|84
2919630|NCT00533442|3630066|FG000|COMPLETED|Follow-up||77
2919631|NCT00533442|3630067|FG001|COMPLETED|Follow-up||74
2919632|NCT00533442|3630066|FG000|NOT COMPLETED|Follow-up||9
2919633|NCT00533442|3630067|FG001|NOT COMPLETED|Follow-up||10
3170216|NCT01928524|3897539|FG002|NOT COMPLETED|Overall Study||0
3170217|NCT01928524|3897540|FG003|NOT COMPLETED|Overall Study||0
2884870|NCT00321555|3590648|FG000|STARTED|Overall Study||15
2884871|NCT00321555|3590648|FG000|COMPLETED|Overall Study||9
2884872|NCT00321555|3590648|FG000|NOT COMPLETED|Overall Study||6
2884873|NCT00321594|3590654|FG000|STARTED|Phase I, Level 1-4||3
2884874|NCT00321594|3590655|FG001|STARTED|Phase I, Level 1-4||3
2884875|NCT00321594|3590656|FG002|STARTED|Phase I, Level 1-4||6
2884876|NCT00321594|3590657|FG003|STARTED|Phase I, Level 1-4||6
2884877|NCT00321594|3590658|FG004|STARTED|Phase I, Level 1-4||0
2884878|NCT00321594|3590654|FG000|COMPLETED|Phase I, Level 1-4||3
2884879|NCT00321594|3590655|FG001|COMPLETED|Phase I, Level 1-4||3
2884880|NCT00321594|3590656|FG002|COMPLETED|Phase I, Level 1-4||6
2884881|NCT00321594|3590657|FG003|COMPLETED|Phase I, Level 1-4||6
2884882|NCT00321594|3590658|FG004|COMPLETED|Phase I, Level 1-4||0
2884883|NCT00321594|3590654|FG000|NOT COMPLETED|Phase I, Level 1-4||0
2884884|NCT00321594|3590655|FG001|NOT COMPLETED|Phase I, Level 1-4||0
2884885|NCT00321594|3590656|FG002|NOT COMPLETED|Phase I, Level 1-4||0
2884886|NCT00321594|3590657|FG003|NOT COMPLETED|Phase I, Level 1-4||0
2884887|NCT00321594|3590658|FG004|NOT COMPLETED|Phase I, Level 1-4||0
2884888|NCT00321594|3590654|FG000|STARTED|Phase II, MTD Dose|Only last six patients in Phase I, Level 4 include in Phase II MTD Dose|0
2884889|NCT00321594|3590655|FG001|STARTED|Phase II, MTD Dose|Only last six patients in Phase I, Level 4 include in Phase II MTD Dose|0
2884890|NCT00321594|3590656|FG002|STARTED|Phase II, MTD Dose|Only last six patients in Phase I, Level 4 include in Phase II MTD Dose|0
2884891|NCT00321594|3590657|FG003|STARTED|Phase II, MTD Dose|Only last six patients in Phase I, Level 4 include in Phase II MTD Dose|6
2884892|NCT00321594|3590658|FG004|STARTED|Phase II, MTD Dose|last six patients in Phase I, Level 4 include in Phase II MTD Dose total number = 6 + 36 = 42|36
2884893|NCT00321594|3590654|FG000|COMPLETED|Phase II, MTD Dose||0
2884894|NCT00321594|3590655|FG001|COMPLETED|Phase II, MTD Dose||0
2884895|NCT00321594|3590656|FG002|COMPLETED|Phase II, MTD Dose||0
2884896|NCT00321594|3590657|FG003|COMPLETED|Phase II, MTD Dose||6
2884897|NCT00321594|3590658|FG004|COMPLETED|Phase II, MTD Dose||36
2884898|NCT00321594|3590654|FG000|NOT COMPLETED|Phase II, MTD Dose||0
2884899|NCT00321594|3590655|FG001|NOT COMPLETED|Phase II, MTD Dose||0
2884900|NCT00321594|3590656|FG002|NOT COMPLETED|Phase II, MTD Dose||0
2884901|NCT00321594|3590657|FG003|NOT COMPLETED|Phase II, MTD Dose||0
2884902|NCT00321594|3590658|FG004|NOT COMPLETED|Phase II, MTD Dose||0
2884903|NCT00321620|3590672|FG000|STARTED|Overall Study||951
2884904|NCT00321620|3590673|FG001|STARTED|Overall Study||950
2884905|NCT00321620|3590672|FG000|Received Investigational Product|Overall Study||946
2884906|NCT00321620|3590673|FG001|Received Investigational Product|Overall Study||942
2884907|NCT00321620|3590672|FG000|COMPLETED|Overall Study||208
2884908|NCT00321620|3590673|FG001|COMPLETED|Overall Study||228
2884909|NCT00321620|3590672|FG000|NOT COMPLETED|Overall Study||743
2884910|NCT00321620|3590673|FG001|NOT COMPLETED|Overall Study||722
2884911|NCT00321646|3590679|FG000|STARTED|Neoadjuvant Chemotherapy||42
2884912|NCT00321646|3590679|FG000|COMPLETED|Neoadjuvant Chemotherapy|1 pt withdrew before start of therapy, 38 completed 6 cycles neoadjuvant therapy.|38
2884913|NCT00321646|3590679|FG000|NOT COMPLETED|Neoadjuvant Chemotherapy||4
2884914|NCT00321646|3590679|FG000|STARTED|Prostatectomy||37
2884915|NCT00321646|3590679|FG000|COMPLETED|Prostatectomy||37
2884916|NCT00321646|3590679|FG000|NOT COMPLETED|Prostatectomy||0
2884917|NCT00321672|3590687|FG000|STARTED|Overall Study||165
2884918|NCT00321672|3590688|FG001|STARTED|Overall Study|One randomized to 30 minutes received 60 minutes. Under 30 for efficacy and under 60 for safety.|89
2884919|NCT00321672|3590689|FG002|STARTED|Overall Study||167
2884920|NCT00321672|3590690|FG003|STARTED|Overall Study|One randomized to 30 minutes received 60 minutes. Under 30 for efficacy and under 60 for safety.|73
2884921|NCT00321672|3590687|FG000|COMPLETED|Overall Study||153
2884922|NCT00321672|3590688|FG001|COMPLETED|Overall Study||81
2884923|NCT00321672|3590689|FG002|COMPLETED|Overall Study||156
2884924|NCT00321672|3590690|FG003|COMPLETED|Overall Study||71
2884925|NCT00321672|3590687|FG000|NOT COMPLETED|Overall Study||12
2884926|NCT00321672|3590688|FG001|NOT COMPLETED|Overall Study||8
2884927|NCT00321672|3590689|FG002|NOT COMPLETED|Overall Study||11
2884928|NCT00321672|3590690|FG003|NOT COMPLETED|Overall Study||2
2884929|NCT00321685|3590704|FG000|STARTED|Overall Study||57
2884930|NCT00321685|3590704|FG000|Eligible|Overall Study||55
2884931|NCT00321685|3590704|FG000|Started Protocol Therapy|Overall Study||55
2884932|NCT00321685|3590704|FG000|Eligible and Treated|Overall Study||53
2884933|NCT00321685|3590704|FG000|COMPLETED|Overall Study||18
2884934|NCT00321685|3590704|FG000|NOT COMPLETED|Overall Study||39
2884935|NCT00321698|3590713|FG000|STARTED|Phase I, Rad Only & Dose 1-3||3
2884936|NCT00321698|3590714|FG001|STARTED|Phase I, Rad Only & Dose 1-3||3
2884937|NCT00321698|3590715|FG002|STARTED|Phase I, Rad Only & Dose 1-3||3
2884938|NCT00321698|3590716|FG003|STARTED|Phase I, Rad Only & Dose 1-3||3
2884939|NCT00321698|3590717|FG004|STARTED|Phase I, Rad Only & Dose 1-3||0
2884940|NCT00321698|3590713|FG000|COMPLETED|Phase I, Rad Only & Dose 1-3||3
2884941|NCT00321698|3590714|FG001|COMPLETED|Phase I, Rad Only & Dose 1-3||3
2884942|NCT00321698|3590715|FG002|COMPLETED|Phase I, Rad Only & Dose 1-3||3
2884943|NCT00321698|3590716|FG003|COMPLETED|Phase I, Rad Only & Dose 1-3||3
2884944|NCT00321698|3590717|FG004|COMPLETED|Phase I, Rad Only & Dose 1-3||0
2884945|NCT00321698|3590713|FG000|NOT COMPLETED|Phase I, Rad Only & Dose 1-3||0
2884946|NCT00321698|3590714|FG001|NOT COMPLETED|Phase I, Rad Only & Dose 1-3||0
2884947|NCT00321698|3590715|FG002|NOT COMPLETED|Phase I, Rad Only & Dose 1-3||0
2884948|NCT00321698|3590716|FG003|NOT COMPLETED|Phase I, Rad Only & Dose 1-3||0
2884949|NCT00321698|3590717|FG004|NOT COMPLETED|Phase I, Rad Only & Dose 1-3||0
2884950|NCT00321698|3590713|FG000|STARTED|Phase II, MTD Dose||0
2884951|NCT00321698|3590714|FG001|STARTED|Phase II, MTD Dose||0
2884952|NCT00321698|3590715|FG002|STARTED|Phase II, MTD Dose||0
2884953|NCT00321698|3590716|FG003|STARTED|Phase II, MTD Dose||0
2884954|NCT00321698|3590717|FG004|STARTED|Phase II, MTD Dose|+1 screen failure|13
2884955|NCT00321698|3590713|FG000|COMPLETED|Phase II, MTD Dose||0
2884956|NCT00321698|3590714|FG001|COMPLETED|Phase II, MTD Dose||0
2884957|NCT00321698|3590715|FG002|COMPLETED|Phase II, MTD Dose||0
2884958|NCT00321698|3590716|FG003|COMPLETED|Phase II, MTD Dose||0
2884959|NCT00321698|3590717|FG004|COMPLETED|Phase II, MTD Dose||13
2884960|NCT00321698|3590713|FG000|NOT COMPLETED|Phase II, MTD Dose||0
2884961|NCT00321698|3590714|FG001|NOT COMPLETED|Phase II, MTD Dose||0
2884962|NCT00321698|3590715|FG002|NOT COMPLETED|Phase II, MTD Dose||0
2884963|NCT00321698|3590716|FG003|NOT COMPLETED|Phase II, MTD Dose||0
2884964|NCT00321698|3590717|FG004|NOT COMPLETED|Phase II, MTD Dose||0
2884965|NCT00321711|3590734|FG000|STARTED|Part A||13
2884966|NCT00321711|3590735|FG001|STARTED|Part A||13
2884967|NCT00321711|3590736|FG002|STARTED|Part A||14
2884968|NCT00321711|3590737|FG003|STARTED|Part A||0
2884969|NCT00321711|3590738|FG004|STARTED|Part A||0
2884970|NCT00321711|3590734|FG000|COMPLETED|Part A|Participants in Part A were not eligible for enrollment in Part B|8
2884971|NCT00321711|3590735|FG001|COMPLETED|Part A|Participants in Part A were not eligible for enrollment in Part B|3
2884972|NCT00321711|3590736|FG002|COMPLETED|Part A|Participants in Part A were not eligible for enrollment in Part B|3
2884973|NCT00321711|3590737|FG003|COMPLETED|Part A||0
2884974|NCT00321711|3590738|FG004|COMPLETED|Part A||0
2884975|NCT00321711|3590734|FG000|NOT COMPLETED|Part A||5
2884976|NCT00321711|3590735|FG001|NOT COMPLETED|Part A||10
2884977|NCT00321711|3590736|FG002|NOT COMPLETED|Part A||11
2884978|NCT00321711|3590737|FG003|NOT COMPLETED|Part A||0
2884979|NCT00321711|3590738|FG004|NOT COMPLETED|Part A||0
2884980|NCT00321711|3590734|FG000|STARTED|Part B|Participants in Part A were not eligible for enrollment in Part B|0
2884981|NCT00321711|3590735|FG001|STARTED|Part B|Participants in Part A were not eligible for enrollment in Part B|0
2884982|NCT00321711|3590736|FG002|STARTED|Part B|Participants in Part A were not eligible for enrollment in Part B|0
2884983|NCT00321711|3590737|FG003|STARTED|Part B||14
2884984|NCT00321711|3590738|FG004|STARTED|Part B||15
2884985|NCT00321711|3590734|FG000|COMPLETED|Part B||0
2884986|NCT00321711|3590735|FG001|COMPLETED|Part B||0
2884987|NCT00321711|3590736|FG002|COMPLETED|Part B||0
2884988|NCT00321711|3590737|FG003|COMPLETED|Part B||8
2884989|NCT00321711|3590738|FG004|COMPLETED|Part B||10
2884990|NCT00321711|3590734|FG000|NOT COMPLETED|Part B||0
2884991|NCT00321711|3590735|FG001|NOT COMPLETED|Part B||0
2884992|NCT00321711|3590736|FG002|NOT COMPLETED|Part B||0
2884993|NCT00321711|3590737|FG003|NOT COMPLETED|Part B||6
2884994|NCT00321711|3590738|FG004|NOT COMPLETED|Part B||5
2884995|NCT00321737|3590753|FG000|STARTED|Overall Study||147
2884996|NCT00321737|3590754|FG001|STARTED|Overall Study||140
2884997|NCT00321737|3590755|FG002|STARTED|Overall Study||158
2884998|NCT00321737|3590753|FG000|COMPLETED|Overall Study||25
2884999|NCT00321737|3590754|FG001|COMPLETED|Overall Study||92
2885000|NCT00321737|3590755|FG002|COMPLETED|Overall Study||104
2885001|NCT00321737|3590753|FG000|NOT COMPLETED|Overall Study||122
3170218|NCT01928524|3897541|FG004|NOT COMPLETED|Overall Study||0
3170219|NCT01928524|3897542|FG005|NOT COMPLETED|Overall Study||0
3170220|NCT01928524|3897543|FG006|NOT COMPLETED|Overall Study||0
2885002|NCT00321737|3590754|FG001|NOT COMPLETED|Overall Study||48
2885003|NCT00321737|3590755|FG002|NOT COMPLETED|Overall Study||54
2885004|NCT00321763|3590767|FG000|STARTED|Overall Study||850
2885005|NCT00321763|3590768|FG001|STARTED|Overall Study||850
2885006|NCT00321763|3590769|FG002|STARTED|Overall Study||854
2885007|NCT00321763|3590770|FG003|STARTED|Overall Study||570
2885008|NCT00321763|3590767|FG000|COMPLETED|Overall Study||844
2885009|NCT00321763|3590768|FG001|COMPLETED|Overall Study||848
2885010|NCT00321763|3590769|FG002|COMPLETED|Overall Study||848
2885011|NCT00321763|3590770|FG003|COMPLETED|Overall Study||565
2885012|NCT00321763|3590767|FG000|NOT COMPLETED|Overall Study||6
2885013|NCT00321763|3590768|FG001|NOT COMPLETED|Overall Study||2
2885014|NCT00321763|3590769|FG002|NOT COMPLETED|Overall Study||6
2885015|NCT00321763|3590770|FG003|NOT COMPLETED|Overall Study||5
2885016|NCT00321789|3590784|FG000|STARTED|Overall Study||127
2885017|NCT00321789|3590785|FG001|STARTED|Overall Study||128
2885018|NCT00321789|3590784|FG000|COMPLETED|Overall Study||112
2885019|NCT00321789|3590785|FG001|COMPLETED|Overall Study||112
2885020|NCT00321789|3590784|FG000|NOT COMPLETED|Overall Study||15
2885021|NCT00321789|3590785|FG001|NOT COMPLETED|Overall Study||16
2885022|NCT00321828|3590791|FG000|STARTED|Overall Study||90
2885023|NCT00321828|3590791|FG000|COMPLETED|Overall Study||86
3170221|NCT01928680|3897559|FG000|STARTED|Overall Study||33
3170222|NCT01928680|3897559|FG000|COMPLETED|Overall Study||33
3170223|NCT01928680|3897559|FG000|NOT COMPLETED|Overall Study||0
3170224|NCT01928693|3897566|FG000|STARTED|Overall Study||0
3170225|NCT01928693|3897567|FG001|STARTED|Overall Study||1
2885024|NCT00321828|3590791|FG000|NOT COMPLETED|Overall Study||4
2885025|NCT00321854|3590797|FG000|STARTED|Overall Study||261
2885026|NCT00321854|3590798|FG001|STARTED|Overall Study||274
2885027|NCT00321854|3590797|FG000|COMPLETED|Overall Study||198
2885028|NCT00321854|3590798|FG001|COMPLETED|Overall Study||192
2885029|NCT00321854|3590797|FG000|NOT COMPLETED|Overall Study||63
2885030|NCT00321854|3590798|FG001|NOT COMPLETED|Overall Study||82
2885031|NCT00321893|3590808|FG000|STARTED|Overall Study||101
2885032|NCT00321893|3590809|FG001|STARTED|Overall Study||101
2885033|NCT00321893|3590808|FG000|COMPLETED|Overall Study||77
2885034|NCT00321893|3590809|FG001|COMPLETED|Overall Study||87
2885035|NCT00321893|3590808|FG000|NOT COMPLETED|Overall Study||24
2885036|NCT00321893|3590809|FG001|NOT COMPLETED|Overall Study||14
2885037|NCT00321906|3590817|FG000|STARTED|Overall Study||94
2885038|NCT00321906|3590818|FG001|STARTED|Overall Study||87
2885039|NCT00321906|3590817|FG000|COMPLETED|Overall Study||48
2885040|NCT00321906|3590818|FG001|COMPLETED|Overall Study||31
2885041|NCT00321906|3590817|FG000|NOT COMPLETED|Overall Study||46
2885042|NCT00321906|3590818|FG001|NOT COMPLETED|Overall Study||56
2885043|NCT00321919|3590826|FG000|STARTED|Overall Study||301
2885044|NCT00321919|3590827|FG001|STARTED|Overall Study||302
2885045|NCT00321919|3590826|FG000|COMPLETED|Overall Study||226
2885046|NCT00321919|3590827|FG001|COMPLETED|Overall Study||250
2885047|NCT00321919|3590826|FG000|NOT COMPLETED|Overall Study||75
2885048|NCT00321919|3590827|FG001|NOT COMPLETED|Overall Study||52
2885049|NCT00321932|3590836|FG000|STARTED|Overall Study||29
2885050|NCT00321932|3590837|FG001|STARTED|Overall Study||32
2885051|NCT00321932|3590836|FG000|COMPLETED|Overall Study||19
2885052|NCT00321932|3590837|FG001|COMPLETED|Overall Study||11
2885053|NCT00321932|3590836|FG000|NOT COMPLETED|Overall Study||10
2885054|NCT00321932|3590837|FG001|NOT COMPLETED|Overall Study||21
2885055|NCT00321971|3590846|FG000|STARTED|Overall Study|Subject recruitment began in February 2007 and ended in December 2011|36
2885056|NCT00321971|3590847|FG001|STARTED|Overall Study||37
2885057|NCT00321971|3590846|FG000|COMPLETED|Overall Study||28
2885058|NCT00321971|3590847|FG001|COMPLETED|Overall Study||26
2885059|NCT00321971|3590846|FG000|NOT COMPLETED|Overall Study||8
2885060|NCT00321971|3590847|FG001|NOT COMPLETED|Overall Study||11
2885061|NCT00321984|3590856|FG000|STARTED|Overall Study||317
2885062|NCT00321984|3590857|FG001|STARTED|Overall Study||315
2885063|NCT00321984|3590858|FG002|STARTED|Overall Study||315
2885064|NCT00321984|3590856|FG000|COMPLETED|Overall Study||290
2885065|NCT00321984|3590857|FG001|COMPLETED|Overall Study||294
2885066|NCT00321984|3590858|FG002|COMPLETED|Overall Study||289
2885067|NCT00321984|3590856|FG000|NOT COMPLETED|Overall Study||27
2885068|NCT00321984|3590857|FG001|NOT COMPLETED|Overall Study||21
2885069|NCT00321984|3590858|FG002|NOT COMPLETED|Overall Study||26
2885070|NCT00322023|3590869|FG000|STARTED|Overall Study||12
2885071|NCT00322023|3590870|FG001|STARTED|Overall Study||21
2885072|NCT00322023|3590871|FG002|STARTED|Overall Study||22
2885073|NCT00322023|3590869|FG000|COMPLETED|Overall Study||12
2885074|NCT00322023|3590870|FG001|COMPLETED|Overall Study||19
2885075|NCT00322023|3590871|FG002|COMPLETED|Overall Study||16
2885076|NCT00322023|3590869|FG000|NOT COMPLETED|Overall Study||0
2885077|NCT00322023|3590870|FG001|NOT COMPLETED|Overall Study||2
2885078|NCT00322023|3590871|FG002|NOT COMPLETED|Overall Study||6
2885079|NCT00322049|3590883|FG000|STARTED|Overall Study||4
2885080|NCT00322049|3590884|FG001|STARTED|Overall Study||10
2885081|NCT00322049|3590885|FG002|STARTED|Overall Study||20
2885082|NCT00322049|3590886|FG003|STARTED|Overall Study||17
2885083|NCT00322049|3590883|FG000|COMPLETED|Overall Study||4
2885084|NCT00322049|3590884|FG001|COMPLETED|Overall Study||9
2885085|NCT00322049|3590885|FG002|COMPLETED|Overall Study||20
2885086|NCT00322049|3590886|FG003|COMPLETED|Overall Study||16
2885087|NCT00322049|3590883|FG000|NOT COMPLETED|Overall Study||0
2885088|NCT00322049|3590884|FG001|NOT COMPLETED|Overall Study||1
2885089|NCT00322049|3590885|FG002|NOT COMPLETED|Overall Study||0
2885090|NCT00322049|3590886|FG003|NOT COMPLETED|Overall Study||1
2885091|NCT00322101|3590907|FG000|STARTED|Overall Study||14
2885092|NCT00322101|3590908|FG001|STARTED|Overall Study||11
2885093|NCT00322101|3590907|FG000|COMPLETED|Overall Study||14
2885094|NCT00322101|3590908|FG001|COMPLETED|Overall Study||11
2885095|NCT00322101|3590907|FG000|NOT COMPLETED|Overall Study||0
2885096|NCT00322101|3590908|FG001|NOT COMPLETED|Overall Study||0
2885097|NCT00322153|3590916|FG000|STARTED|Overall Study|Randomized to placebo|335
2885098|NCT00322153|3590917|FG001|STARTED|Overall Study|Randomized to Memantine ER|342
2885099|NCT00322153|3590916|FG000|SAFETY POPULATION|Overall Study|Safety population defined as all patients who took at least one dose of double-blind study drug.|335
2885100|NCT00322153|3590917|FG001|SAFETY POPULATION|Overall Study|Safety population: one patient was randomized but did not receive double-blind study drug.|341
2885101|NCT00322153|3590916|FG000|COMPLETED|Overall Study||272
2885102|NCT00322153|3590917|FG001|COMPLETED|Overall Study||273
2885103|NCT00322153|3590916|FG000|NOT COMPLETED|Overall Study||63
2885104|NCT00322153|3590917|FG001|NOT COMPLETED|Overall Study||69
2885105|NCT00322231|3590925|FG000|STARTED|Period 1||51
2885106|NCT00322231|3590926|FG001|STARTED|Period 1||50
2885107|NCT00322231|3590925|FG000|COMPLETED|Period 1||51
2885108|NCT00322231|3590926|FG001|COMPLETED|Period 1||50
2885109|NCT00322231|3590925|FG000|NOT COMPLETED|Period 1||0
2885110|NCT00322231|3590926|FG001|NOT COMPLETED|Period 1||0
2885111|NCT00322231|3590925|FG000|STARTED|Period 2||51
2885112|NCT00322231|3590926|FG001|STARTED|Period 2|One participant was lost between Period 1 and Period 2|49
2885113|NCT00322231|3590925|FG000|COMPLETED|Period 2||51
2885114|NCT00322231|3590926|FG001|COMPLETED|Period 2||49
2885115|NCT00322231|3590925|FG000|NOT COMPLETED|Period 2||0
2885116|NCT00322231|3590926|FG001|NOT COMPLETED|Period 2||0
2885117|NCT00322309|3590938|FG000|STARTED|Overall Study||11
2885118|NCT00322309|3590939|FG001|STARTED|Overall Study||13
2885119|NCT00322309|3590938|FG000|COMPLETED|Overall Study||9
2885120|NCT00322309|3590939|FG001|COMPLETED|Overall Study||9
2885121|NCT00322309|3590938|FG000|NOT COMPLETED|Overall Study||2
2885122|NCT00322309|3590939|FG001|NOT COMPLETED|Overall Study||4
2885123|NCT00322335|3590951|FG000|STARTED|Subjects 18 Months After Booster Dose||58
2885124|NCT00322335|3590952|FG001|STARTED|Subjects 18 Months After Booster Dose||123
2885125|NCT00322335|3590953|FG002|STARTED|Subjects 18 Months After Booster Dose|Subjects who received Meningitec booster outside scope study NCT00323050 eliminated from this period|3
2885126|NCT00322335|3590951|FG000|COMPLETED|Subjects 18 Months After Booster Dose||58
2885127|NCT00322335|3590952|FG001|COMPLETED|Subjects 18 Months After Booster Dose||123
2885128|NCT00322335|3590953|FG002|COMPLETED|Subjects 18 Months After Booster Dose||3
2885129|NCT00322335|3590951|FG000|NOT COMPLETED|Subjects 18 Months After Booster Dose||0
2885130|NCT00322335|3590952|FG001|NOT COMPLETED|Subjects 18 Months After Booster Dose||0
2885131|NCT00322335|3590953|FG002|NOT COMPLETED|Subjects 18 Months After Booster Dose||0
2885132|NCT00322335|3590951|FG000|STARTED|Subjects 30 Months After Booster Dose||54
2885133|NCT00322335|3590952|FG001|STARTED|Subjects 30 Months After Booster Dose||119
2885134|NCT00322335|3590953|FG002|STARTED|Subjects 30 Months After Booster Dose|Subjects eliminated from previous timepoint were included again from this timepoint onwards|57
2885135|NCT00322335|3590951|FG000|COMPLETED|Subjects 30 Months After Booster Dose||54
3170226|NCT01928693|3897568|FG002|STARTED|Overall Study||1
3170227|NCT01928693|3897566|FG000|COMPLETED|Overall Study||0
2885136|NCT00322335|3590952|FG001|COMPLETED|Subjects 30 Months After Booster Dose||119
2885137|NCT00322335|3590953|FG002|COMPLETED|Subjects 30 Months After Booster Dose||57
2885138|NCT00322335|3590951|FG000|NOT COMPLETED|Subjects 30 Months After Booster Dose||0
2885139|NCT00322335|3590952|FG001|NOT COMPLETED|Subjects 30 Months After Booster Dose||0
2885140|NCT00322335|3590953|FG002|NOT COMPLETED|Subjects 30 Months After Booster Dose||0
2885141|NCT00322335|3590951|FG000|STARTED|Subjects 42 Months After Booster Dose||51
2885142|NCT00322335|3590952|FG001|STARTED|Subjects 42 Months After Booster Dose||113
2885143|NCT00322335|3590953|FG002|STARTED|Subjects 42 Months After Booster Dose||56
2885144|NCT00322335|3590951|FG000|COMPLETED|Subjects 42 Months After Booster Dose||51
2885145|NCT00322335|3590952|FG001|COMPLETED|Subjects 42 Months After Booster Dose||113
2885146|NCT00322335|3590953|FG002|COMPLETED|Subjects 42 Months After Booster Dose||56
2885147|NCT00322335|3590951|FG000|NOT COMPLETED|Subjects 42 Months After Booster Dose||0
2885148|NCT00322335|3590952|FG001|NOT COMPLETED|Subjects 42 Months After Booster Dose||0
2885149|NCT00322335|3590953|FG002|NOT COMPLETED|Subjects 42 Months After Booster Dose||0
2885150|NCT00322335|3590951|FG000|STARTED|Subjects 54 Months After Booster Dose||50
2885151|NCT00322335|3590952|FG001|STARTED|Subjects 54 Months After Booster Dose||108
2885152|NCT00322335|3590953|FG002|STARTED|Subjects 54 Months After Booster Dose||56
2885153|NCT00322335|3590951|FG000|COMPLETED|Subjects 54 Months After Booster Dose||50
2885154|NCT00322335|3590952|FG001|COMPLETED|Subjects 54 Months After Booster Dose||108
2885155|NCT00322335|3590953|FG002|COMPLETED|Subjects 54 Months After Booster Dose||56
2885156|NCT00322335|3590951|FG000|NOT COMPLETED|Subjects 54 Months After Booster Dose||0
2885157|NCT00322335|3590952|FG001|NOT COMPLETED|Subjects 54 Months After Booster Dose||0
2885158|NCT00322335|3590953|FG002|NOT COMPLETED|Subjects 54 Months After Booster Dose||0
2885159|NCT00322335|3590951|FG000|STARTED|Subjects 66 Months After Booster Dose||48
2885160|NCT00322335|3590952|FG001|STARTED|Subjects 66 Months After Booster Dose||104
2885161|NCT00322335|3590953|FG002|STARTED|Subjects 66 Months After Booster Dose||53
2885162|NCT00322335|3590951|FG000|COMPLETED|Subjects 66 Months After Booster Dose||48
2885163|NCT00322335|3590952|FG001|COMPLETED|Subjects 66 Months After Booster Dose||104
2885164|NCT00322335|3590953|FG002|COMPLETED|Subjects 66 Months After Booster Dose||53
2885165|NCT00322335|3590951|FG000|NOT COMPLETED|Subjects 66 Months After Booster Dose||0
2885166|NCT00322335|3590952|FG001|NOT COMPLETED|Subjects 66 Months After Booster Dose||0
2885167|NCT00322335|3590953|FG002|NOT COMPLETED|Subjects 66 Months After Booster Dose||0
2885168|NCT00322348|3590963|FG000|STARTED|Overall Study||49
2885169|NCT00322348|3590964|FG001|STARTED|Overall Study||49
2885170|NCT00322348|3590963|FG000|Received Study Treatment|Overall Study||50
2885171|NCT00322348|3590964|FG001|Received Study Treatment|Overall Study||48
2885172|NCT00322348|3590963|FG000|COMPLETED|Overall Study|Number of participants completed up to Week 96|12
2885173|NCT00322348|3590964|FG001|COMPLETED|Overall Study|Number of participants completed up to Week 96|16
2885174|NCT00322348|3590963|FG000|NOT COMPLETED|Overall Study||37
2885175|NCT00322348|3590964|FG001|NOT COMPLETED|Overall Study||33
2885176|NCT00322374|3590973|FG000|STARTED|Enrollment||0
2885177|NCT00322374|3590974|FG001|STARTED|Enrollment||0
2885178|NCT00322374|3590975|FG002|STARTED|Enrollment||0
2885179|NCT00322374|3590976|FG003|STARTED|Enrollment||42
2885180|NCT00322374|3590973|FG000|COMPLETED|Enrollment||0
2885181|NCT00322374|3590974|FG001|COMPLETED|Enrollment||0
2885182|NCT00322374|3590975|FG002|COMPLETED|Enrollment||0
2885183|NCT00322374|3590976|FG003|COMPLETED|Enrollment||42
2885184|NCT00322374|3590973|FG000|NOT COMPLETED|Enrollment||0
2885185|NCT00322374|3590974|FG001|NOT COMPLETED|Enrollment||0
2885186|NCT00322374|3590975|FG002|NOT COMPLETED|Enrollment||0
2885187|NCT00322374|3590976|FG003|NOT COMPLETED|Enrollment||0
2885188|NCT00322374|3590973|FG000|STARTED|Starting Dose||6
2885189|NCT00322374|3590974|FG001|STARTED|Starting Dose||0
2885190|NCT00322374|3590975|FG002|STARTED|Starting Dose||0
2885191|NCT00322374|3590976|FG003|STARTED|Starting Dose||0
2885192|NCT00322374|3590973|FG000|COMPLETED|Starting Dose||0
2885193|NCT00322374|3590974|FG001|COMPLETED|Starting Dose||0
2885194|NCT00322374|3590975|FG002|COMPLETED|Starting Dose||0
2885195|NCT00322374|3590976|FG003|COMPLETED|Starting Dose||0
2885196|NCT00322374|3590973|FG000|NOT COMPLETED|Starting Dose||6
3170228|NCT01928693|3897567|FG001|COMPLETED|Overall Study||1
2885197|NCT00322374|3590974|FG001|NOT COMPLETED|Starting Dose||0
2885198|NCT00322374|3590975|FG002|NOT COMPLETED|Starting Dose||0
2885199|NCT00322374|3590976|FG003|NOT COMPLETED|Starting Dose||0
2885200|NCT00322374|3590973|FG000|STARTED|First Escalation||0
2885201|NCT00322374|3590974|FG001|STARTED|First Escalation||30
2885202|NCT00322374|3590975|FG002|STARTED|First Escalation||0
2885203|NCT00322374|3590976|FG003|STARTED|First Escalation||0
2885204|NCT00322374|3590973|FG000|COMPLETED|First Escalation||0
2885205|NCT00322374|3590974|FG001|COMPLETED|First Escalation||0
2885206|NCT00322374|3590975|FG002|COMPLETED|First Escalation||0
2885207|NCT00322374|3590976|FG003|COMPLETED|First Escalation||0
2885208|NCT00322374|3590973|FG000|NOT COMPLETED|First Escalation||0
2885209|NCT00322374|3590974|FG001|NOT COMPLETED|First Escalation||30
2885210|NCT00322374|3590975|FG002|NOT COMPLETED|First Escalation||0
2885211|NCT00322374|3590976|FG003|NOT COMPLETED|First Escalation||0
2885212|NCT00322374|3590973|FG000|STARTED|Second Escalation||0
2885213|NCT00322374|3590974|FG001|STARTED|Second Escalation||0
3314724|NCT03091673|4048008|FG001|COMPLETED|Second Dose||11
3314725|NCT03091673|4048007|FG000|NOT COMPLETED|Second Dose||0
2885214|NCT00322374|3590975|FG002|STARTED|Second Escalation||6
2885215|NCT00322374|3590976|FG003|STARTED|Second Escalation||0
2885216|NCT00322374|3590973|FG000|COMPLETED|Second Escalation||0
2885217|NCT00322374|3590974|FG001|COMPLETED|Second Escalation||0
2885218|NCT00322374|3590975|FG002|COMPLETED|Second Escalation||0
2885219|NCT00322374|3590976|FG003|COMPLETED|Second Escalation||0
2885220|NCT00322374|3590973|FG000|NOT COMPLETED|Second Escalation||0
2885221|NCT00322374|3590974|FG001|NOT COMPLETED|Second Escalation||0
2885222|NCT00322374|3590975|FG002|NOT COMPLETED|Second Escalation||6
2885223|NCT00322374|3590976|FG003|NOT COMPLETED|Second Escalation||0
2885224|NCT00322387|3590991|FG000|STARTED|Treatment Period|Plerixafor PM=7, Plerixafor AM=6, Low CD34+ Count/Plerixafor PM=0, and Plerixafor After Chemo=1|14
2885225|NCT00322387|3590992|FG001|STARTED|Treatment Period|Plerixafor PM=12, Plerixafor AM=9, Low CD34+ Count/Plerixafor PM=1, and Plerixafor After Chemo=4|26
2885226|NCT00322387|3590991|FG000|COMPLETED|Treatment Period|Completed refers to completed all treatment visits.|14
2885227|NCT00322387|3590992|FG001|COMPLETED|Treatment Period|Completed refers to completed all treatment visits.|25
2885228|NCT00322387|3590991|FG000|NOT COMPLETED|Treatment Period||0
2885229|NCT00322387|3590992|FG001|NOT COMPLETED|Treatment Period||1
2885230|NCT00322387|3590991|FG000|STARTED|Follow-up Period|Participants who had transplants|14
2885231|NCT00322387|3590992|FG001|STARTED|Follow-up Period|Participants who had transplants. One participant did not complete therapy but had a transplant.|26
2885232|NCT00322387|3590991|FG000|COMPLETED|Follow-up Period|Follow-up visit 12 months post-transplant|12
2885233|NCT00322387|3590992|FG001|COMPLETED|Follow-up Period|Follow-up visit 12 months post-transplant|23
2885234|NCT00322387|3590991|FG000|NOT COMPLETED|Follow-up Period||2
2885235|NCT00322387|3590992|FG001|NOT COMPLETED|Follow-up Period||3
2885236|NCT00322439|3591009|FG000|STARTED|Overall Study||2511
2885237|NCT00322439|3591009|FG000|Received at Least 1 Dose of Etanercept|Overall Study||2510
2885238|NCT00322439|3591009|FG000|COMPLETED|Overall Study||1455
2885239|NCT00322439|3591009|FG000|NOT COMPLETED|Overall Study||1056
2885240|NCT00322452|3591015|FG000|STARTED|Overall Study|Number of patients randomized|609
2885241|NCT00322452|3591016|FG001|STARTED|Overall Study|Number of patients randomized|608
2885242|NCT00322452|3591015|FG000|COMPLETED|Overall Study|Patients still in study at PFS Data Cut Off (14 April 2008), 97 remained at OS DCO (14 June 2010)|362
2885243|NCT00322452|3591016|FG001|COMPLETED|Overall Study|Patients still in study at PFS Data Cut Off (14 April 2008), 84 remained at OS DCO (14 June 2010)|332
2885244|NCT00322452|3591015|FG000|NOT COMPLETED|Overall Study||247
2885245|NCT00322452|3591016|FG001|NOT COMPLETED|Overall Study||276
2885246|NCT00322465|3591026|FG000|STARTED|Overall Study|Randomized|76
2885247|NCT00322465|3591027|FG001|STARTED|Overall Study|Randomized|73
2885248|NCT00322465|3591028|FG002|STARTED|Overall Study|Randomized|77
2885249|NCT00322465|3591029|FG003|STARTED|Overall Study|Randomized|79
2885250|NCT00322465|3591026|FG000|COMPLETED|Overall Study|Second follow-up visit or clinical failure at first follow-up visit|56
2885251|NCT00322465|3591027|FG001|COMPLETED|Overall Study|Second follow-up visit or clinical failure at first follow-up visit|49
2885252|NCT00322465|3591028|FG002|COMPLETED|Overall Study|Second follow-up visit or clinical failure at first follow-up visit|51
2885253|NCT00322465|3591029|FG003|COMPLETED|Overall Study|Second follow-up visit or clinical failure at first follow-up visit|53
2885254|NCT00322465|3591026|FG000|NOT COMPLETED|Overall Study||20
2885255|NCT00322465|3591027|FG001|NOT COMPLETED|Overall Study||24
2885256|NCT00322465|3591028|FG002|NOT COMPLETED|Overall Study||26
2885257|NCT00322465|3591029|FG003|NOT COMPLETED|Overall Study||26
2885258|NCT00322491|3591044|FG000|STARTED|Overall Study||23
2885259|NCT00322491|3591045|FG001|STARTED|Overall Study||26
2885260|NCT00322491|3591044|FG000|COMPLETED|Overall Study||21
2885261|NCT00322491|3591045|FG001|COMPLETED|Overall Study||24
2885262|NCT00322491|3591044|FG000|NOT COMPLETED|Overall Study||2
2885263|NCT00322491|3591045|FG001|NOT COMPLETED|Overall Study||2
2885264|NCT00322556|3591052|FG000|STARTED|Overall Study||55
2885265|NCT00322556|3591052|FG000|COMPLETED|Overall Study||43
2885266|NCT00322556|3591052|FG000|NOT COMPLETED|Overall Study||12
2885267|NCT00322621|3591059|FG000|STARTED|Period II - Acute Therapy Phase||216
2885268|NCT00322621|3591060|FG001|STARTED|Period II - Acute Therapy Phase||0
2885269|NCT00322621|3591061|FG002|STARTED|Period II - Acute Therapy Phase||0
2885270|NCT00322621|3591059|FG000|COMPLETED|Period II - Acute Therapy Phase||184
2885271|NCT00322621|3591060|FG001|COMPLETED|Period II - Acute Therapy Phase||0
2885272|NCT00322621|3591061|FG002|COMPLETED|Period II - Acute Therapy Phase||0
3170229|NCT01928693|3897568|FG002|COMPLETED|Overall Study||1
3170230|NCT01928693|3897566|FG000|NOT COMPLETED|Overall Study||0
3170231|NCT01928693|3897567|FG001|NOT COMPLETED|Overall Study||0
3170232|NCT01928693|3897568|FG002|NOT COMPLETED|Overall Study||0
3170233|NCT01928719|3897578|FG000|STARTED|Overall Study||122
3170234|NCT01928719|3897579|FG001|STARTED|Overall Study||123
3170235|NCT01928719|3897578|FG000|COMPLETED|Overall Study||70
3170236|NCT01928719|3897579|FG001|COMPLETED|Overall Study||104
3170237|NCT01928719|3897578|FG000|NOT COMPLETED|Overall Study||52
3170238|NCT01928719|3897579|FG001|NOT COMPLETED|Overall Study||19
3170239|NCT01928758|3897589|FG000|STARTED|Overall Study||94
3170240|NCT01928758|3897590|FG001|STARTED|Overall Study||94
3170241|NCT01928758|3897589|FG000|COMPLETED|Overall Study||69
3170242|NCT01928758|3897590|FG001|COMPLETED|Overall Study||74
3170243|NCT01928758|3897589|FG000|NOT COMPLETED|Overall Study||25
3170244|NCT01928758|3897590|FG001|NOT COMPLETED|Overall Study||20
3170245|NCT01928771|3897600|FG000|STARTED|Overall Study||400
3170246|NCT01928771|3897601|FG001|STARTED|Overall Study||398
3170247|NCT01928771|3897602|FG002|STARTED|Overall Study||407
3170248|NCT01928771|3897600|FG000|Received Treatment|Overall Study||399
3170249|NCT01928771|3897601|FG001|Received Treatment|Overall Study||398
3170250|NCT01928771|3897602|FG002|Received Treatment|Overall Study||407
3170251|NCT01928771|3897600|FG000|COMPLETED|Overall Study||354
3170252|NCT01928771|3897601|FG001|COMPLETED|Overall Study||358
3170253|NCT01928771|3897602|FG002|COMPLETED|Overall Study||367
3170254|NCT01928771|3897600|FG000|NOT COMPLETED|Overall Study||46
3170255|NCT01928771|3897601|FG001|NOT COMPLETED|Overall Study||40
3170256|NCT01928771|3897602|FG002|NOT COMPLETED|Overall Study||40
3170257|NCT01928797|3897612|FG000|STARTED|Overall Study||30
3170258|NCT01928797|3897613|FG001|STARTED|Overall Study||30
3170259|NCT01928797|3897612|FG000|COMPLETED|Overall Study||30
2885273|NCT00322621|3591059|FG000|NOT COMPLETED|Period II - Acute Therapy Phase||32
2885274|NCT00322621|3591060|FG001|NOT COMPLETED|Period II - Acute Therapy Phase||0
2885275|NCT00322621|3591061|FG002|NOT COMPLETED|Period II - Acute Therapy Phase||0
2885276|NCT00322621|3591059|FG000|STARTED|Period III - Maintenance / Rescue Phase||0
2885277|NCT00322621|3591060|FG001|STARTED|Period III - Maintenance / Rescue Phase||115
2885278|NCT00322621|3591061|FG002|STARTED|Period III - Maintenance / Rescue Phase||69
2885279|NCT00322621|3591059|FG000|COMPLETED|Period III - Maintenance / Rescue Phase||0
2885280|NCT00322621|3591060|FG001|COMPLETED|Period III - Maintenance / Rescue Phase||86
2885281|NCT00322621|3591061|FG002|COMPLETED|Period III - Maintenance / Rescue Phase||33
2885282|NCT00322621|3591059|FG000|NOT COMPLETED|Period III - Maintenance / Rescue Phase||0
2885283|NCT00322621|3591060|FG001|NOT COMPLETED|Period III - Maintenance / Rescue Phase||29
2885284|NCT00322621|3591061|FG002|NOT COMPLETED|Period III - Maintenance / Rescue Phase||36
2885285|NCT00322712|3591074|FG000|STARTED|Overall Study||12
2885286|NCT00322712|3591074|FG000|COMPLETED|Overall Study||11
2885287|NCT00322712|3591074|FG000|NOT COMPLETED|Overall Study||1
2885288|NCT00322777|3591080|FG000|STARTED|Overall Study||39
2885289|NCT00322777|3591081|FG001|STARTED|Overall Study||45
2885290|NCT00322777|3591080|FG000|"Data Collection at BASELINE|"|Overall Study||39
2885291|NCT00322777|3591081|FG001|"Data Collection at BASELINE|"|Overall Study||45
2885292|NCT00322777|3591080|FG000|Data Collection at Week 8|Overall Study||39
2885293|NCT00322777|3591081|FG001|Data Collection at Week 8|Overall Study||45
2885294|NCT00322777|3591080|FG000|Data Collection at Week 16|Overall Study||39
2885295|NCT00322777|3591081|FG001|Data Collection at Week 16|Overall Study||45
2885296|NCT00322777|3591080|FG000|Data Collection at Week 24|Overall Study||39
2885297|NCT00322777|3591081|FG001|Data Collection at Week 24|Overall Study||45
2885298|NCT00322777|3591080|FG000|COMPLETED|Overall Study||39
2885299|NCT00322777|3591081|FG001|COMPLETED|Overall Study||45
2885300|NCT00322777|3591080|FG000|NOT COMPLETED|Overall Study||0
2885301|NCT00322777|3591081|FG001|NOT COMPLETED|Overall Study||0
2885302|NCT00322842|3591089|FG000|STARTED|Overall Study||4
2885303|NCT00322842|3591090|FG001|STARTED|Overall Study||31
2885304|NCT00322842|3591089|FG000|COMPLETED|Overall Study|One participant discontinued (d/c) treatment early, received a transplant, and completed the study.|2
2885305|NCT00322842|3591090|FG001|COMPLETED|Overall Study|One participant d/c treatment early, received a transplant, and was lost to follow-up after 6 months|29
2885306|NCT00322842|3591089|FG000|NOT COMPLETED|Overall Study||2
2885307|NCT00322842|3591090|FG001|NOT COMPLETED|Overall Study||2
2885308|NCT00322868|3591097|FG000|STARTED|Overall Study||21
2885309|NCT00322868|3591097|FG000|COMPLETED|Overall Study||20
2885310|NCT00322868|3591097|FG000|NOT COMPLETED|Overall Study||1
2885311|NCT00322881|3591102|FG000|STARTED|Overall Study||12
2885312|NCT00322881|3591102|FG000|COMPLETED|Overall Study||7
2885313|NCT00322881|3591102|FG000|NOT COMPLETED|Overall Study||5
2885314|NCT00323063|3591108|FG000|STARTED|Overall Study||26
2885315|NCT00323063|3591109|FG001|STARTED|Overall Study||23
2885316|NCT00323063|3591108|FG000|COMPLETED|Overall Study||24
2885317|NCT00323063|3591109|FG001|COMPLETED|Overall Study||23
2885318|NCT00323063|3591108|FG000|NOT COMPLETED|Overall Study||2
2885319|NCT00323063|3591109|FG001|NOT COMPLETED|Overall Study||0
2885320|NCT00323115|3591115|FG000|STARTED|Vaccine Administration||11
2885321|NCT00323115|3591115|FG000|COMPLETED|Vaccine Administration||10
2885322|NCT00323115|3591115|FG000|NOT COMPLETED|Vaccine Administration||1
3170260|NCT01928797|3897613|FG001|COMPLETED|Overall Study||30
3170261|NCT01928797|3897612|FG000|NOT COMPLETED|Overall Study||0
3170262|NCT01928797|3897613|FG001|NOT COMPLETED|Overall Study||0
3170263|NCT01928849|3897623|FG000|STARTED|Overall Study||66
3170264|NCT01928849|3897624|FG001|STARTED|Overall Study||62
2885323|NCT00323115|3591115|FG000|STARTED|Adjuvant Therapy & Survival Follow-Up||10
2885324|NCT00323115|3591115|FG000|COMPLETED|Adjuvant Therapy & Survival Follow-Up||2
2885325|NCT00323115|3591115|FG000|NOT COMPLETED|Adjuvant Therapy & Survival Follow-Up||8
2885326|NCT00323193|3591126|FG000|STARTED|Overall Study||53
2885327|NCT00323193|3591127|FG001|STARTED|Overall Study||56
2885328|NCT00323193|3591126|FG000|COMPLETED|Overall Study||30
2885329|NCT00323193|3591127|FG001|COMPLETED|Overall Study||41
2885330|NCT00323193|3591126|FG000|NOT COMPLETED|Overall Study||23
2885331|NCT00323193|3591127|FG001|NOT COMPLETED|Overall Study||15
2885332|NCT00323258|3591135|FG000|STARTED|Primary Outcome (Phone Call at 6 Months)||71
2885333|NCT00323258|3591136|FG001|STARTED|Primary Outcome (Phone Call at 6 Months)||72
2885334|NCT00323258|3591135|FG000|COMPLETED|Primary Outcome (Phone Call at 6 Months)||55
2885335|NCT00323258|3591136|FG001|COMPLETED|Primary Outcome (Phone Call at 6 Months)||53
2885336|NCT00323258|3591135|FG000|NOT COMPLETED|Primary Outcome (Phone Call at 6 Months)||16
2885337|NCT00323258|3591136|FG001|NOT COMPLETED|Primary Outcome (Phone Call at 6 Months)||19
2885338|NCT00323258|3591135|FG000|STARTED|Secondary Outcome (6 Mon Refill Records)||71
2885339|NCT00323258|3591136|FG001|STARTED|Secondary Outcome (6 Mon Refill Records)||72
2885340|NCT00323258|3591135|FG000|COMPLETED|Secondary Outcome (6 Mon Refill Records)||57
2885341|NCT00323258|3591136|FG001|COMPLETED|Secondary Outcome (6 Mon Refill Records)||58
2885342|NCT00323258|3591135|FG000|NOT COMPLETED|Secondary Outcome (6 Mon Refill Records)||14
2885343|NCT00323258|3591136|FG001|NOT COMPLETED|Secondary Outcome (6 Mon Refill Records)||14
2885344|NCT00323271|3591144|FG000|STARTED|Overall Study||13
2885345|NCT00323271|3591145|FG001|STARTED|Overall Study||12
2885346|NCT00323271|3591144|FG000|COMPLETED|Overall Study||11
2885347|NCT00323271|3591145|FG001|COMPLETED|Overall Study||9
2885348|NCT00323271|3591144|FG000|NOT COMPLETED|Overall Study||2
2885349|NCT00323271|3591145|FG001|NOT COMPLETED|Overall Study||3
2885350|NCT00323284|3591153|FG000|STARTED|12 Months Follow-up||116
2885351|NCT00323284|3591154|FG001|STARTED|12 Months Follow-up||123
2885352|NCT00323284|3591153|FG000|COMPLETED|12 Months Follow-up||111
2885353|NCT00323284|3591154|FG001|COMPLETED|12 Months Follow-up||114
2885354|NCT00323284|3591153|FG000|NOT COMPLETED|12 Months Follow-up||5
2885355|NCT00323284|3591154|FG001|NOT COMPLETED|12 Months Follow-up||9
2885356|NCT00323284|3591153|FG000|STARTED|24 Months Follow-up||116
2885357|NCT00323284|3591154|FG001|STARTED|24 Months Follow-up||123
2885358|NCT00323284|3591153|FG000|COMPLETED|24 Months Follow-up||98
2885359|NCT00323284|3591154|FG001|COMPLETED|24 Months Follow-up||101
2885360|NCT00323284|3591153|FG000|NOT COMPLETED|24 Months Follow-up||18
2885361|NCT00323284|3591154|FG001|NOT COMPLETED|24 Months Follow-up||22
2885362|NCT00323297|3591162|FG000|STARTED|Part A (Double Blind Randomized)||53
2885363|NCT00323297|3591163|FG001|STARTED|Part A (Double Blind Randomized)||50
2885364|NCT00323297|3591162|FG000|COMPLETED|Part A (Double Blind Randomized)||48
2885365|NCT00323297|3591163|FG001|COMPLETED|Part A (Double Blind Randomized)||43
2885366|NCT00323297|3591162|FG000|NOT COMPLETED|Part A (Double Blind Randomized)||5
2885367|NCT00323297|3591163|FG001|NOT COMPLETED|Part A (Double Blind Randomized)||7
2885368|NCT00323297|3591162|FG000|STARTED|Part B (Open-label)||48
2885369|NCT00323297|3591163|FG001|STARTED|Part B (Open-label)||43
2885370|NCT00323297|3591162|FG000|COMPLETED|Part B (Open-label)||39
2885371|NCT00323297|3591163|FG001|COMPLETED|Part B (Open-label)||31
2885372|NCT00323297|3591162|FG000|NOT COMPLETED|Part B (Open-label)||9
3133754|NCT01697579|3858718|FG006|STARTED|Base Study-Cycle 1|Enrollment in Cycles 2-6 was optional.|0
3133755|NCT01697579|3858712|FG000|COMPLETED|Base Study-Cycle 1||72
3133756|NCT01697579|3858713|FG001|COMPLETED|Base Study-Cycle 1||42
3133757|NCT01697579|3858714|FG002|COMPLETED|Base Study-Cycle 1||43
3133758|NCT01697579|3858715|FG003|COMPLETED|Base Study-Cycle 1||40
3133759|NCT01697579|3858716|FG004|COMPLETED|Base Study-Cycle 1||35
2885373|NCT00323297|3591163|FG001|NOT COMPLETED|Part B (Open-label)||12
2885374|NCT00323310|3591169|FG000|STARTED|Overall Study||92
2885375|NCT00323310|3591169|FG000|COMPLETED|Overall Study||89
2885376|NCT00323310|3591169|FG000|NOT COMPLETED|Overall Study||3
2885377|NCT00323362|3591173|FG000|STARTED|Overall Study||17
2885378|NCT00323362|3591173|FG000|COMPLETED|Overall Study||17
2885379|NCT00323362|3591173|FG000|NOT COMPLETED|Overall Study||0
2885380|NCT00323414|3591179|FG000|STARTED|Overall Study||18
2885381|NCT00323414|3591180|FG001|STARTED|Overall Study||19
2885382|NCT00323414|3591179|FG000|COMPLETED|Overall Study||18
2885383|NCT00323414|3591180|FG001|COMPLETED|Overall Study||18
2885384|NCT00323414|3591179|FG000|NOT COMPLETED|Overall Study||0
2885385|NCT00323414|3591180|FG001|NOT COMPLETED|Overall Study||1
2885386|NCT00323427|3591188|FG000|STARTED|Overall Study||69
2885387|NCT00323427|3591189|FG001|STARTED|Overall Study||66
2885388|NCT00323427|3591188|FG000|COMPLETED|Overall Study||38
2885389|NCT00323427|3591189|FG001|COMPLETED|Overall Study||43
2885390|NCT00323427|3591188|FG000|NOT COMPLETED|Overall Study||31
2885391|NCT00323427|3591189|FG001|NOT COMPLETED|Overall Study||23
2885392|NCT00323453|3591197|FG000|STARTED|Overall Study||61
2885393|NCT00323453|3591198|FG001|STARTED|Overall Study||48
2885394|NCT00323453|3591197|FG000|COMPLETED|Overall Study||61
2885395|NCT00323453|3591198|FG001|COMPLETED|Overall Study||48
2885396|NCT00323453|3591197|FG000|NOT COMPLETED|Overall Study||0
2885397|NCT00323453|3591198|FG001|NOT COMPLETED|Overall Study||0
2885398|NCT00323479|3591204|FG000|STARTED|Overall Study||114
2885399|NCT00323479|3591204|FG000|Safety Population|Overall Study|Patients who taken at least one dose of treatment|110
2885400|NCT00323479|3591204|FG000|COMPLETED|Overall Study|with at least 1 evaluation for primary efficacy endpoint|106
2885401|NCT00323479|3591204|FG000|NOT COMPLETED|Overall Study||8
2885402|NCT00323492|3591210|FG000|STARTED|Study Phase 1||47
2885403|NCT00323492|3591211|FG001|STARTED|Study Phase 1||45
2885404|NCT00323492|3591212|FG002|STARTED|Study Phase 1|Not applicable to Phase 1.|0
2885405|NCT00323492|3591210|FG000|Intent-to-Treat (ITT) Analysis Set|Study Phase 1|One subject was excluded from ITT analysis set due to protocol violation.|46
2885406|NCT00323492|3591211|FG001|Intent-to-Treat (ITT) Analysis Set|Study Phase 1||45
2885407|NCT00323492|3591212|FG002|Intent-to-Treat (ITT) Analysis Set|Study Phase 1||0
2885408|NCT00323492|3591210|FG000|COMPLETED|Study Phase 1||45
2885409|NCT00323492|3591211|FG001|COMPLETED|Study Phase 1||45
2885410|NCT00323492|3591212|FG002|COMPLETED|Study Phase 1||0
2885411|NCT00323492|3591210|FG000|NOT COMPLETED|Study Phase 1||2
2885412|NCT00323492|3591211|FG001|NOT COMPLETED|Study Phase 1||0
2885413|NCT00323492|3591212|FG002|NOT COMPLETED|Study Phase 1||0
2885414|NCT00323492|3591210|FG000|STARTED|Study Phase 2|1/45 subjects completed Phase 1 but did not start Phase 2. Week 48 ITT N=46|44
2885415|NCT00323492|3591211|FG001|STARTED|Study Phase 2|2/45 subjects completed Phase 1 but did not start Phase 2. Week 48 ITT N=20 (no switch to Truvada)|18
2885416|NCT00323492|3591212|FG002|STARTED|Study Phase 2|N=25 switched to Truvada in Phase 2.|25
2885417|NCT00323492|3591210|FG000|COMPLETED|Study Phase 2||40
2885418|NCT00323492|3591211|FG001|COMPLETED|Study Phase 2||17
2885419|NCT00323492|3591212|FG002|COMPLETED|Study Phase 2||24
2885420|NCT00323492|3591210|FG000|NOT COMPLETED|Study Phase 2||4
2885421|NCT00323492|3591211|FG001|NOT COMPLETED|Study Phase 2||1
2885422|NCT00323492|3591212|FG002|NOT COMPLETED|Study Phase 2||1
2885423|NCT00323557|3591221|FG000|STARTED|Overall Study|GM-CSF pre and post vaccine.|25
2885424|NCT00323557|3591222|FG001|STARTED|Overall Study||7
2885425|NCT00323557|3591221|FG000|COMPLETED|Overall Study||24
2885426|NCT00323557|3591222|FG001|COMPLETED|Overall Study||7
2885427|NCT00323557|3591221|FG000|NOT COMPLETED|Overall Study||1
2885428|NCT00323557|3591222|FG001|NOT COMPLETED|Overall Study||0
2885429|NCT00323609|3591231|FG000|STARTED|Overall Study||191
2885430|NCT00323609|3591232|FG001|STARTED|Overall Study||190
2885431|NCT00323609|3591233|FG002|STARTED|Overall Study||8
2885432|NCT00323609|3591234|FG003|STARTED|Overall Study||15
2885433|NCT00323609|3591231|FG000|COMPLETED|Overall Study|Revision retains subjects with follow-up data in a visit window when terminated in same visit window|100
2885434|NCT00323609|3591232|FG001|COMPLETED|Overall Study|Revision retains subjects with follow-up data in a visit window when terminated in same visit window|91
2885435|NCT00323609|3591233|FG002|COMPLETED|Overall Study||0
2885436|NCT00323609|3591234|FG003|COMPLETED|Overall Study||0
2885437|NCT00323609|3591231|FG000|NOT COMPLETED|Overall Study||91
2885438|NCT00323609|3591232|FG001|NOT COMPLETED|Overall Study||99
2885439|NCT00323609|3591233|FG002|NOT COMPLETED|Overall Study||8
2885440|NCT00323609|3591234|FG003|NOT COMPLETED|Overall Study||15
2885441|NCT00323622|3591248|FG000|STARTED|Overall Study||176
2885442|NCT00323622|3591249|FG001|STARTED|Overall Study||515
2885443|NCT00323622|3591250|FG002|STARTED|Overall Study||42
2885444|NCT00323622|3591251|FG003|STARTED|Overall Study||134
2885445|NCT00323622|3591252|FG004|STARTED|Overall Study||159
2885446|NCT00323622|3591253|FG005|STARTED|Overall Study||528
2885447|NCT00323622|3591254|FG006|STARTED|Overall Study||43
2885448|NCT00323622|3591255|FG007|STARTED|Overall Study||140
2885449|NCT00323622|3591248|FG000|COMPLETED|Overall Study||145
2885450|NCT00323622|3591249|FG001|COMPLETED|Overall Study||423
2885451|NCT00323622|3591250|FG002|COMPLETED|Overall Study||38
2885452|NCT00323622|3591251|FG003|COMPLETED|Overall Study||122
2885453|NCT00323622|3591252|FG004|COMPLETED|Overall Study||120
2885454|NCT00323622|3591253|FG005|COMPLETED|Overall Study||454
2885455|NCT00323622|3591254|FG006|COMPLETED|Overall Study||38
2885456|NCT00323622|3591255|FG007|COMPLETED|Overall Study||125
2885457|NCT00323622|3591248|FG000|NOT COMPLETED|Overall Study||31
2885458|NCT00323622|3591249|FG001|NOT COMPLETED|Overall Study||92
2885459|NCT00323622|3591250|FG002|NOT COMPLETED|Overall Study||4
2885460|NCT00323622|3591251|FG003|NOT COMPLETED|Overall Study||12
2885461|NCT00323622|3591252|FG004|NOT COMPLETED|Overall Study||39
2885462|NCT00323622|3591253|FG005|NOT COMPLETED|Overall Study||74
2885463|NCT00323622|3591254|FG006|NOT COMPLETED|Overall Study||5
2885464|NCT00323622|3591255|FG007|NOT COMPLETED|Overall Study||15
2885465|NCT00323739|3591281|FG000|STARTED|Overall Study||80
2885466|NCT00323739|3591281|FG000|COMPLETED|Overall Study||80
2885467|NCT00323739|3591281|FG000|NOT COMPLETED|Overall Study||0
2885468|NCT00323869|3591285|FG000|STARTED|Overall Study|Enrollment|48
2885469|NCT00323869|3591285|FG000|Treatment Initiation|Overall Study|One participant died before receiving therapy, not included in analysis|47
2885470|NCT00323869|3591285|FG000|COMPLETED|Overall Study||47
2885471|NCT00323869|3591285|FG000|NOT COMPLETED|Overall Study||1
2885472|NCT00323882|3591294|FG000|STARTED|Overall Study||8
2885473|NCT00323882|3591295|FG001|STARTED|Overall Study||6
2885474|NCT00323882|3591296|FG002|STARTED|Overall Study||16
2885475|NCT00323882|3591297|FG003|STARTED|Overall Study||7
2885476|NCT00323882|3591298|FG004|STARTED|Overall Study||34
2885477|NCT00323882|3591294|FG000|COMPLETED|Overall Study||0
2885478|NCT00323882|3591295|FG001|COMPLETED|Overall Study||0
2885479|NCT00323882|3591296|FG002|COMPLETED|Overall Study||3
2885480|NCT00323882|3591297|FG003|COMPLETED|Overall Study||0
2885481|NCT00323882|3591298|FG004|COMPLETED|Overall Study||2
2885482|NCT00323882|3591294|FG000|NOT COMPLETED|Overall Study||8
2885483|NCT00323882|3591295|FG001|NOT COMPLETED|Overall Study||6
2885484|NCT00323882|3591296|FG002|NOT COMPLETED|Overall Study||13
2885485|NCT00323882|3591297|FG003|NOT COMPLETED|Overall Study||7
2885486|NCT00323882|3591298|FG004|NOT COMPLETED|Overall Study||32
2885487|NCT00323960|3591322|FG000|STARTED|Overall Study||47
2885488|NCT00323960|3591323|FG001|STARTED|Overall Study||46
2885489|NCT00323960|3591324|FG002|STARTED|Overall Study||46
2885490|NCT00323960|3591322|FG000|COMPLETED|Overall Study||47
2885491|NCT00323960|3591323|FG001|COMPLETED|Overall Study||46
2885492|NCT00323960|3591324|FG002|COMPLETED|Overall Study||46
2885493|NCT00323960|3591322|FG000|NOT COMPLETED|Overall Study||0
2885494|NCT00323960|3591323|FG001|NOT COMPLETED|Overall Study||0
2885495|NCT00323960|3591324|FG002|NOT COMPLETED|Overall Study||0
2885496|NCT00324038|3591337|FG000|STARTED|Overall Study||110
2885497|NCT00324038|3591338|FG001|STARTED|Overall Study||109
2885498|NCT00324038|3591337|FG000|COMPLETED|Overall Study||61
2885499|NCT00324038|3591338|FG001|COMPLETED|Overall Study||58
2885500|NCT00324038|3591337|FG000|NOT COMPLETED|Overall Study||49
2885501|NCT00324038|3591338|FG001|NOT COMPLETED|Overall Study||51
2885502|NCT00324116|3591344|FG000|STARTED|Overall Study|subjects received treatment|81
2885503|NCT00324116|3591344|FG000|COMPLETED|Overall Study||49
2885504|NCT00324116|3591344|FG000|NOT COMPLETED|Overall Study||32
2885505|NCT00324155|3591350|FG000|STARTED|Enrolled and Randomized||250
2885506|NCT00324155|3591351|FG001|STARTED|Enrolled and Randomized||252
2885507|NCT00324155|3591350|FG000|COMPLETED|Enrolled and Randomized|3 randomized but who did not receive treatment (no longer met study criteria).|247
2885508|NCT00324155|3591351|FG001|COMPLETED|Enrolled and Randomized|1 randomized but who did not receive treatment (lost to follow-up).|251
2885509|NCT00324155|3591350|FG000|NOT COMPLETED|Enrolled and Randomized||3
2885510|NCT00324155|3591351|FG001|NOT COMPLETED|Enrolled and Randomized||1
2885511|NCT00324155|3591350|FG000|STARTED|Received Treatment in Induction Phase||247
2885512|NCT00324155|3591351|FG001|STARTED|Received Treatment in Induction Phase||251
2885513|NCT00324155|3591350|FG000|COMPLETED|Received Treatment in Induction Phase|45 participants on treatment at end of Induction Phase. Study undergoing closure.|45
2885514|NCT00324155|3591351|FG001|COMPLETED|Received Treatment in Induction Phase|54 participants on treatment at end of Induction Phase. Study undergoing closure.|54
2885515|NCT00324155|3591350|FG000|NOT COMPLETED|Received Treatment in Induction Phase||202
2885516|NCT00324155|3591351|FG001|NOT COMPLETED|Received Treatment in Induction Phase||197
2885517|NCT00324155|3591350|FG000|STARTED|Received Treatment in Maintenance Phase|2 completed Induction Phase but did not enter Maintenance Phase|43
2885518|NCT00324155|3591351|FG001|STARTED|Received Treatment in Maintenance Phase|1 completed Induction Phase but did not enter Maintenance Phase|53
2885519|NCT00324155|3591350|FG000|COMPLETED|Received Treatment in Maintenance Phase|Study is in closure at this time. 11 in Maintenance Phase not yet summarized.|11
2885520|NCT00324155|3591351|FG001|COMPLETED|Received Treatment in Maintenance Phase|Study is in closure. 6 participants in Maintenance Phase not yet summarized.|6
2885521|NCT00324155|3591350|FG000|NOT COMPLETED|Received Treatment in Maintenance Phase||32
2885522|NCT00324155|3591351|FG001|NOT COMPLETED|Received Treatment in Maintenance Phase||47
2885523|NCT00324155|3591350|FG000|STARTED|Follow-up Phase|All participants received study drug. Follow-up was performed for those leaving earlier phases.|247
2885524|NCT00324155|3591351|FG001|STARTED|Follow-up Phase|All participants received study drug. Follow-up was performed for those leaving earlier phases.|251
2885525|NCT00324155|3591350|FG000|COMPLETED|Follow-up Phase||236
2885526|NCT00324155|3591351|FG001|COMPLETED|Follow-up Phase||245
2885527|NCT00324155|3591350|FG000|NOT COMPLETED|Follow-up Phase||11
2885528|NCT00324155|3591351|FG001|NOT COMPLETED|Follow-up Phase||6
2885529|NCT00324168|3591372|FG000|STARTED|Overall Study||250
2885530|NCT00324168|3591373|FG001|STARTED|Overall Study||250
2885531|NCT00324168|3591372|FG000|COMPLETED|Overall Study||222
2885532|NCT00324168|3591373|FG001|COMPLETED|Overall Study||220
2885533|NCT00324168|3591372|FG000|NOT COMPLETED|Overall Study||28
2885534|NCT00324168|3591373|FG001|NOT COMPLETED|Overall Study||30
2885535|NCT00324233|3591381|FG000|STARTED|First Period||18
2885536|NCT00324233|3591382|FG001|STARTED|First Period||18
2885537|NCT00324233|3591381|FG000|COMPLETED|First Period||17
2885538|NCT00324233|3591382|FG001|COMPLETED|First Period||18
2885539|NCT00324233|3591381|FG000|NOT COMPLETED|First Period||1
2885540|NCT00324233|3591382|FG001|NOT COMPLETED|First Period||0
2885541|NCT00324233|3591381|FG000|STARTED|Second Period||17
2885542|NCT00324233|3591382|FG001|STARTED|Second Period||18
2885543|NCT00324233|3591381|FG000|COMPLETED|Second Period||12
2885544|NCT00324233|3591382|FG001|COMPLETED|Second Period||11
2885545|NCT00324233|3591381|FG000|NOT COMPLETED|Second Period||5
2885546|NCT00324233|3591382|FG001|NOT COMPLETED|Second Period||7
2885547|NCT00324259|3591390|FG000|STARTED|Overall Study||34
2885548|NCT00324259|3591391|FG001|STARTED|Overall Study||32
2885549|NCT00324259|3591390|FG000|COMPLETED|Overall Study||34
2885550|NCT00324259|3591391|FG001|COMPLETED|Overall Study||32
2885551|NCT00324259|3591390|FG000|NOT COMPLETED|Overall Study||0
2885552|NCT00324259|3591391|FG001|NOT COMPLETED|Overall Study||0
2885553|NCT00324272|3591402|FG000|STARTED|Overall Study||18
2885554|NCT00324272|3591403|FG001|STARTED|Overall Study||20
2885555|NCT00324272|3591404|FG002|STARTED|Overall Study||18
2885556|NCT00324272|3591405|FG003|STARTED|Overall Study||18
2885557|NCT00324272|3591402|FG000|COMPLETED|Overall Study||18
2885558|NCT00324272|3591403|FG001|COMPLETED|Overall Study||20
2885559|NCT00324272|3591404|FG002|COMPLETED|Overall Study||18
2885560|NCT00324272|3591405|FG003|COMPLETED|Overall Study||18
2885561|NCT00324272|3591402|FG000|NOT COMPLETED|Overall Study||0
2885562|NCT00324272|3591403|FG001|NOT COMPLETED|Overall Study||0
2885563|NCT00324272|3591404|FG002|NOT COMPLETED|Overall Study||0
2885564|NCT00324272|3591405|FG003|NOT COMPLETED|Overall Study||0
2885565|NCT00324350|3591417|FG000|STARTED|Overall Study||3655
2885566|NCT00324350|3591418|FG001|STARTED|Overall Study||3632
2885567|NCT00324350|3591417|FG000|Non-Vertebral Fracture Follow-Up|Overall Study||3655
2885568|NCT00324350|3591418|FG001|Non-Vertebral Fracture Follow-Up|Overall Study||3632
2885569|NCT00324350|3591417|FG000|Falls Follow-Up|Overall Study||3364
2885570|NCT00324350|3591418|FG001|Falls Follow-Up|Overall Study||3418
2885571|NCT00324350|3591417|FG000|COMPLETED|Overall Study||3655
2885572|NCT00324350|3591418|FG001|COMPLETED|Overall Study||3632
2885573|NCT00324350|3591417|FG000|NOT COMPLETED|Overall Study||0
2885574|NCT00324350|3591418|FG001|NOT COMPLETED|Overall Study||0
2885575|NCT00324415|3591425|FG000|STARTED|Overall Study||45
2885576|NCT00324415|3591425|FG000|COMPLETED|Overall Study||45
2885577|NCT00324415|3591425|FG000|NOT COMPLETED|Overall Study||0
2885578|NCT00324649|3591432|FG000|STARTED|Overall Study||39
2885579|NCT00324649|3591433|FG001|STARTED|Overall Study||41
2885580|NCT00324649|3591432|FG000|COMPLETED|Overall Study||37
2885581|NCT00324649|3591433|FG001|COMPLETED|Overall Study||36
2885582|NCT00324649|3591432|FG000|NOT COMPLETED|Overall Study||2
2885583|NCT00324649|3591433|FG001|NOT COMPLETED|Overall Study||5
2885584|NCT00324675|3591441|FG000|STARTED|Overall Study||14
2885585|NCT00324675|3591442|FG001|STARTED|Overall Study||14
2885586|NCT00324675|3591441|FG000|COMPLETED|Overall Study||13
2885587|NCT00324675|3591442|FG001|COMPLETED|Overall Study||14
2885588|NCT00324675|3591441|FG000|NOT COMPLETED|Overall Study||1
2885589|NCT00324675|3591442|FG001|NOT COMPLETED|Overall Study||0
2885590|NCT00324701|3591450|FG000|STARTED|Overall Study||120
2885591|NCT00324701|3591451|FG001|STARTED|Overall Study||121
2885592|NCT00324701|3591450|FG000|Week 8 Assessment|Overall Study||108
2885593|NCT00324701|3591451|FG001|Week 8 Assessment|Overall Study||107
2885594|NCT00324701|3591450|FG000|COMPLETED|Overall Study||100
2885595|NCT00324701|3591451|FG001|COMPLETED|Overall Study||104
2885596|NCT00324701|3591450|FG000|NOT COMPLETED|Overall Study||20
2885597|NCT00324701|3591451|FG001|NOT COMPLETED|Overall Study||17
2885598|NCT00324740|3591457|FG000|STARTED|Overall Study||7
2885599|NCT00324740|3591458|FG001|STARTED|Overall Study||3
2885600|NCT00324740|3591459|FG002|STARTED|Overall Study||4
2885601|NCT00324740|3591457|FG000|COMPLETED|Overall Study||6
2885602|NCT00324740|3591458|FG001|COMPLETED|Overall Study||3
2885603|NCT00324740|3591459|FG002|COMPLETED|Overall Study||3
2885604|NCT00324740|3591457|FG000|NOT COMPLETED|Overall Study||1
2885605|NCT00324740|3591458|FG001|NOT COMPLETED|Overall Study||0
2885606|NCT00324740|3591459|FG002|NOT COMPLETED|Overall Study||1
2885607|NCT00324753|3591468|FG000|STARTED|Overall Study||190
2885608|NCT00324753|3591469|FG001|STARTED|Overall Study||264
2885609|NCT00324753|3591468|FG000|COMPLETED|Overall Study||190
2885610|NCT00324753|3591469|FG001|COMPLETED|Overall Study||264
2885611|NCT00324753|3591468|FG000|NOT COMPLETED|Overall Study||0
2885612|NCT00324753|3591469|FG001|NOT COMPLETED|Overall Study||0
2885613|NCT00324857|3591481|FG000|STARTED|Overall Study||167
2885614|NCT00324857|3591482|FG001|STARTED|Overall Study||168
2885615|NCT00324857|3591483|FG002|STARTED|Overall Study||165
2885616|NCT00324857|3591484|FG003|STARTED|Overall Study||163
2885617|NCT00324857|3591481|FG000|COMPLETED|Overall Study||161
2885618|NCT00324857|3591482|FG001|COMPLETED|Overall Study||162
2885619|NCT00324857|3591483|FG002|COMPLETED|Overall Study||158
2885620|NCT00324857|3591484|FG003|COMPLETED|Overall Study||158
2885621|NCT00324857|3591481|FG000|NOT COMPLETED|Overall Study||6
2885622|NCT00324857|3591482|FG001|NOT COMPLETED|Overall Study||6
2885623|NCT00324857|3591483|FG002|NOT COMPLETED|Overall Study||7
2885624|NCT00324857|3591484|FG003|NOT COMPLETED|Overall Study||5
2885625|NCT00324870|3591498|FG000|STARTED|Overall Study||37
2885626|NCT00324870|3591498|FG000|COMPLETED|Overall Study||37
2885627|NCT00324870|3591498|FG000|NOT COMPLETED|Overall Study||0
2885628|NCT00324896|3591504|FG000|STARTED|Overall Study||15
2885629|NCT00324896|3591505|FG001|STARTED|Overall Study||15
2885630|NCT00324896|3591504|FG000|COMPLETED|Overall Study||12
2885631|NCT00324896|3591505|FG001|COMPLETED|Overall Study||7
2885632|NCT00324896|3591504|FG000|NOT COMPLETED|Overall Study||3
2885633|NCT00324896|3591505|FG001|NOT COMPLETED|Overall Study||8
2885634|NCT00324961|3591511|FG000|STARTED|Overall Study||533
2885635|NCT00324961|3591511|FG000|COMPLETED|Overall Study||490
2885636|NCT00324961|3591511|FG000|NOT COMPLETED|Overall Study||43
2885637|NCT00324987|3591519|FG000|STARTED|Overall Study||6
2885638|NCT00324987|3591520|FG001|STARTED|Overall Study||6
2885639|NCT00324987|3591519|FG000|COMPLETED|Overall Study|Patients were to be treated until progression|0
2885640|NCT00324987|3591520|FG001|COMPLETED|Overall Study|Patients were to be treated until progression|0
2885641|NCT00324987|3591519|FG000|NOT COMPLETED|Overall Study||6
2885642|NCT00324987|3591520|FG001|NOT COMPLETED|Overall Study||6
2885643|NCT00325039|3591528|FG000|STARTED|Overall Study||298
2885644|NCT00325039|3591529|FG001|STARTED|Overall Study||299
2885645|NCT00325039|3591528|FG000|COMPLETED|Overall Study||280
2885646|NCT00325039|3591529|FG001|COMPLETED|Overall Study||285
2885647|NCT00325039|3591528|FG000|NOT COMPLETED|Overall Study||18
2885648|NCT00325039|3591529|FG001|NOT COMPLETED|Overall Study||14
2885649|NCT00325078|3591538|FG000|STARTED|Overall Study||8
2885650|NCT00325078|3591539|FG001|STARTED|Overall Study||7
2885651|NCT00325078|3591540|FG002|STARTED|Overall Study||25
2885652|NCT00325078|3591538|FG000|COMPLETED|Overall Study||3
2885653|NCT00325078|3591539|FG001|COMPLETED|Overall Study||2
2885654|NCT00325078|3591540|FG002|COMPLETED|Overall Study||23
2885655|NCT00325078|3591538|FG000|NOT COMPLETED|Overall Study||5
2885656|NCT00325078|3591539|FG001|NOT COMPLETED|Overall Study||5
2885657|NCT00325078|3591540|FG002|NOT COMPLETED|Overall Study||2
2885658|NCT00325130|3591551|FG000|STARTED|Overall Study||518
2885659|NCT00325130|3591552|FG001|STARTED|Overall Study||524
2885660|NCT00325130|3591551|FG000|COMPLETED|Overall Study||499
2885661|NCT00325130|3591552|FG001|COMPLETED|Overall Study||494
2885662|NCT00325130|3591551|FG000|NOT COMPLETED|Overall Study||19
2885663|NCT00325130|3591552|FG001|NOT COMPLETED|Overall Study||30
2885664|NCT00325143|3591558|FG000|STARTED|Overall Study||702
2885665|NCT00325143|3591558|FG000|COMPLETED|Overall Study||676
2885666|NCT00325143|3591558|FG000|NOT COMPLETED|Overall Study||26
2885667|NCT00325156|3591562|FG000|STARTED|Overall Study||2590
2885668|NCT00325156|3591562|FG000|COMPLETED|Overall Study||2478
2885669|NCT00325156|3591562|FG000|NOT COMPLETED|Overall Study||112
2885670|NCT00325195|3591569|FG000|STARTED|Randomized||90
2885671|NCT00325195|3591570|FG001|STARTED|Randomized||89
2885672|NCT00325195|3591571|FG002|STARTED|Randomized||46
2885673|NCT00325195|3591569|FG000|COMPLETED|Randomized||85
2885674|NCT00325195|3591570|FG001|COMPLETED|Randomized||84
2885675|NCT00325195|3591571|FG002|COMPLETED|Randomized||43
2885676|NCT00325195|3591569|FG000|NOT COMPLETED|Randomized||5
2885677|NCT00325195|3591570|FG001|NOT COMPLETED|Randomized||5
2885678|NCT00325195|3591571|FG002|NOT COMPLETED|Randomized||3
2885679|NCT00325195|3591569|FG000|STARTED|Received Intervention: ITT Population||85
2885680|NCT00325195|3591570|FG001|STARTED|Received Intervention: ITT Population||84
2885681|NCT00325195|3591571|FG002|STARTED|Received Intervention: ITT Population||43
2885682|NCT00325195|3591569|FG000|COMPLETED|Received Intervention: ITT Population||59
2885683|NCT00325195|3591570|FG001|COMPLETED|Received Intervention: ITT Population||59
2885684|NCT00325195|3591571|FG002|COMPLETED|Received Intervention: ITT Population||39
2885685|NCT00325195|3591569|FG000|NOT COMPLETED|Received Intervention: ITT Population||26
2885686|NCT00325195|3591570|FG001|NOT COMPLETED|Received Intervention: ITT Population||25
2885687|NCT00325195|3591571|FG002|NOT COMPLETED|Received Intervention: ITT Population||4
2885688|NCT00325234|3591581|FG000|STARTED|Overall Study||69
2885689|NCT00325234|3591582|FG001|STARTED|Overall Study||66
2885690|NCT00325234|3591581|FG000|Received At Least 1 Dose of Study Drug|Overall Study||65
2885691|NCT00325234|3591582|FG001|Received At Least 1 Dose of Study Drug|Overall Study||66
2885692|NCT00325234|3591581|FG000|COMPLETED|Overall Study||0
2885693|NCT00325234|3591582|FG001|COMPLETED|Overall Study||0
2885694|NCT00325234|3591581|FG000|NOT COMPLETED|Overall Study||69
2885695|NCT00325234|3591582|FG001|NOT COMPLETED|Overall Study||66
2885696|NCT00325403|3591592|FG000|STARTED|Overall Study||116
2885697|NCT00325403|3591593|FG001|STARTED|Overall Study||233
2885698|NCT00325403|3591592|FG000|COMPLETED|Overall Study|98 subjects receiving placebo completed the study on study drug|98
2885699|NCT00325403|3591593|FG001|COMPLETED|Overall Study|182 subjects receiving oral treprostinil completed the study on study drug|182
2885700|NCT00325403|3591592|FG000|NOT COMPLETED|Overall Study||18
2885701|NCT00325403|3591593|FG001|NOT COMPLETED|Overall Study||51
2885702|NCT00325416|3591603|FG000|STARTED|Phase I: Dose Escalation||70
2885703|NCT00325416|3591604|FG001|STARTED|Phase I: Dose Escalation||60
2885704|NCT00325416|3591603|FG000|COMPLETED|Phase I: Dose Escalation||48
2885705|NCT00325416|3591604|FG001|COMPLETED|Phase I: Dose Escalation||44
2885706|NCT00325416|3591603|FG000|NOT COMPLETED|Phase I: Dose Escalation||22
2885707|NCT00325416|3591604|FG001|NOT COMPLETED|Phase I: Dose Escalation||16
2885708|NCT00325416|3591603|FG000|STARTED|Phase II: Treatment at MTD||78
2885709|NCT00325416|3591604|FG001|STARTED|Phase II: Treatment at MTD||42
2885710|NCT00325416|3591603|FG000|Proceeded From Phase I to Phase II|Phase II: Treatment at MTD||38
2885711|NCT00325416|3591604|FG001|Proceeded From Phase I to Phase II|Phase II: Treatment at MTD||34
2885712|NCT00325416|3591603|FG000|Enrolled During Phase II|Phase II: Treatment at MTD||40
2885713|NCT00325416|3591604|FG001|Enrolled During Phase II|Phase II: Treatment at MTD||8
2885714|NCT00325416|3591603|FG000|COMPLETED|Phase II: Treatment at MTD||78
2885715|NCT00325416|3591604|FG001|COMPLETED|Phase II: Treatment at MTD||40
2885716|NCT00325416|3591603|FG000|NOT COMPLETED|Phase II: Treatment at MTD||0
2885717|NCT00325416|3591604|FG001|NOT COMPLETED|Phase II: Treatment at MTD||2
2885718|NCT00325442|3591612|FG000|STARTED|Overall Study||176
2885719|NCT00325442|3591613|FG001|STARTED|Overall Study||174
2885720|NCT00325442|3591612|FG000|COMPLETED|Overall Study||167
2885721|NCT00325442|3591613|FG001|COMPLETED|Overall Study||153
2885722|NCT00325442|3591612|FG000|NOT COMPLETED|Overall Study||9
2885723|NCT00325442|3591613|FG001|NOT COMPLETED|Overall Study||21
2885724|NCT00325468|3591627|FG000|STARTED|Overall Study||23
2885725|NCT00325468|3591628|FG001|STARTED|Overall Study||17
2885726|NCT00325468|3591629|FG002|STARTED|Overall Study||14
2885727|NCT00325468|3591630|FG003|STARTED|Overall Study||124
2885728|NCT00325468|3591631|FG004|STARTED|Overall Study||22
2885729|NCT00325468|3591627|FG000|COMPLETED|Overall Study||12
2885730|NCT00325468|3591628|FG001|COMPLETED|Overall Study||12
2885731|NCT00325468|3591629|FG002|COMPLETED|Overall Study||10
2885732|NCT00325468|3591630|FG003|COMPLETED|Overall Study||90
2885733|NCT00325468|3591631|FG004|COMPLETED|Overall Study||14
2885734|NCT00325468|3591627|FG000|NOT COMPLETED|Overall Study||11
2885735|NCT00325468|3591628|FG001|NOT COMPLETED|Overall Study||5
2885736|NCT00325468|3591629|FG002|NOT COMPLETED|Overall Study||4
2885737|NCT00325468|3591630|FG003|NOT COMPLETED|Overall Study||34
2885738|NCT00325468|3591631|FG004|NOT COMPLETED|Overall Study||8
2885739|NCT00325598|3591646|FG000|STARTED|Overall Study||50
2885740|NCT00325598|3591647|FG001|STARTED|Overall Study||50
2885741|NCT00325598|3591646|FG000|COMPLETED|Overall Study||50
2885742|NCT00325598|3591647|FG001|COMPLETED|Overall Study||50
2885743|NCT00325598|3591646|FG000|NOT COMPLETED|Overall Study||0
2885744|NCT00325598|3591647|FG001|NOT COMPLETED|Overall Study||0
2885745|NCT00325754|3591657|FG000|STARTED|Overall Study||11
2885746|NCT00325754|3591658|FG001|STARTED|Overall Study||11
2885747|NCT00325754|3591657|FG000|COMPLETED|Overall Study||7
2885748|NCT00325754|3591658|FG001|COMPLETED|Overall Study||10
2885749|NCT00325754|3591657|FG000|NOT COMPLETED|Overall Study||4
2885750|NCT00325754|3591658|FG001|NOT COMPLETED|Overall Study||1
2885751|NCT00325780|3591664|FG000|STARTED|Overall Study||1355
2885752|NCT00325780|3591664|FG000|Safety Population|Overall Study|Patients who received at least one dose of study treatment in this extension study.|1353
2885753|NCT00325780|3591664|FG000|COMPLETED|Overall Study||1200
2885754|NCT00325780|3591664|FG000|NOT COMPLETED|Overall Study||155
2885755|NCT00325819|3591670|FG000|STARTED|Overall Study||185
2885756|NCT00325819|3591671|FG001|STARTED|Overall Study||189
2885757|NCT00325819|3591670|FG000|COMPLETED|Overall Study||176
2885758|NCT00325819|3591671|FG001|COMPLETED|Overall Study||176
2885759|NCT00325819|3591670|FG000|NOT COMPLETED|Overall Study||9
2885760|NCT00325819|3591671|FG001|NOT COMPLETED|Overall Study||13
2885761|NCT00325897|3591681|FG000|STARTED|Overall Study||570
2885762|NCT00325897|3591682|FG001|STARTED|Overall Study||572
2885763|NCT00325897|3591681|FG000|COMPLETED|Overall Study||558
2885764|NCT00325897|3591682|FG001|COMPLETED|Overall Study||559
2885765|NCT00325897|3591681|FG000|NOT COMPLETED|Overall Study||12
2885766|NCT00325897|3591682|FG001|NOT COMPLETED|Overall Study||13
2885767|NCT00326001|3591693|FG000|STARTED|Overall Study||236
2885768|NCT00326001|3591694|FG001|STARTED|Overall Study||227
2885769|NCT00326001|3591693|FG000|COMPLETED|Overall Study||229
2885770|NCT00326001|3591694|FG001|COMPLETED|Overall Study||219
2885771|NCT00326001|3591693|FG000|NOT COMPLETED|Overall Study||7
2885772|NCT00326001|3591694|FG001|NOT COMPLETED|Overall Study||8
2885773|NCT00326118|3591702|FG000|STARTED|Active Phase||324
2885774|NCT00326118|3591703|FG001|STARTED|Active Phase||109
2885775|NCT00326118|3591702|FG000|COMPLETED|Active Phase||320
2885776|NCT00326118|3591703|FG001|COMPLETED|Active Phase||108
2885777|NCT00326118|3591702|FG000|NOT COMPLETED|Active Phase||4
2885778|NCT00326118|3591703|FG001|NOT COMPLETED|Active Phase||1
2885779|NCT00326118|3591702|FG000|STARTED|Year 1 Follow-up||295
2885780|NCT00326118|3591703|FG001|STARTED|Year 1 Follow-up||100
2885781|NCT00326118|3591702|FG000|COMPLETED|Year 1 Follow-up||295
2885782|NCT00326118|3591703|FG001|COMPLETED|Year 1 Follow-up||100
2885783|NCT00326118|3591702|FG000|NOT COMPLETED|Year 1 Follow-up||0
2885784|NCT00326118|3591703|FG001|NOT COMPLETED|Year 1 Follow-up||0
2885785|NCT00326118|3591702|FG000|STARTED|Year 2 Follow-up||270
2885786|NCT00326118|3591703|FG001|STARTED|Year 2 Follow-up||92
2885787|NCT00326118|3591702|FG000|COMPLETED|Year 2 Follow-up||270
2885788|NCT00326118|3591703|FG001|COMPLETED|Year 2 Follow-up||92
2885789|NCT00326118|3591702|FG000|NOT COMPLETED|Year 2 Follow-up||0
2885790|NCT00326118|3591703|FG001|NOT COMPLETED|Year 2 Follow-up||0
2885791|NCT00326118|3591702|FG000|STARTED|Year 3 Follow-up||256
2885792|NCT00326118|3591703|FG001|STARTED|Year 3 Follow-up||89
2885793|NCT00326118|3591702|FG000|COMPLETED|Year 3 Follow-up||256
2885794|NCT00326118|3591703|FG001|COMPLETED|Year 3 Follow-up||89
2885795|NCT00326118|3591702|FG000|NOT COMPLETED|Year 3 Follow-up||0
2885796|NCT00326118|3591703|FG001|NOT COMPLETED|Year 3 Follow-up||0
2885797|NCT00326118|3591702|FG000|STARTED|Year 4 Follow-up||228
2885798|NCT00326118|3591703|FG001|STARTED|Year 4 Follow-up||80
2885799|NCT00326118|3591702|FG000|COMPLETED|Year 4 Follow-up||228
2885800|NCT00326118|3591703|FG001|COMPLETED|Year 4 Follow-up||80
2885801|NCT00326118|3591702|FG000|NOT COMPLETED|Year 4 Follow-up||0
2885802|NCT00326118|3591703|FG001|NOT COMPLETED|Year 4 Follow-up||0
2885803|NCT00326118|3591702|FG000|STARTED|Year 5 Follow up||217
2885804|NCT00326118|3591703|FG001|STARTED|Year 5 Follow up||78
2885805|NCT00326118|3591702|FG000|COMPLETED|Year 5 Follow up||217
2885806|NCT00326118|3591703|FG001|COMPLETED|Year 5 Follow up||78
2885807|NCT00326118|3591702|FG000|NOT COMPLETED|Year 5 Follow up||0
2885808|NCT00326118|3591703|FG001|NOT COMPLETED|Year 5 Follow up||0
2885809|NCT00326170|3591710|FG000|STARTED|Overall Study||34
2885810|NCT00326170|3591710|FG000|COMPLETED|Overall Study||34
2885811|NCT00326170|3591710|FG000|NOT COMPLETED|Overall Study||0
2885812|NCT00326196|3591716|FG000|STARTED|Overall Study||101
2885813|NCT00326196|3591717|FG001|STARTED|Overall Study||97
2885814|NCT00326196|3591716|FG000|COMPLETED|Overall Study||101
2885815|NCT00326196|3591717|FG001|COMPLETED|Overall Study||97
2885816|NCT00326196|3591716|FG000|NOT COMPLETED|Overall Study||0
2885817|NCT00326196|3591717|FG001|NOT COMPLETED|Overall Study||0
2919634|NCT00533507|3630075|FG000|STARTED|Overall Study||230
2919635|NCT00533507|3630075|FG000|COMPLETED|Overall Study||229
2919636|NCT00533507|3630075|FG000|NOT COMPLETED|Overall Study||1
2919637|NCT00533546|3630079|FG000|STARTED|Overall Study||12
2919638|NCT00533546|3630079|FG000|COMPLETED|Overall Study||12
2919639|NCT00533546|3630079|FG000|NOT COMPLETED|Overall Study||0
2919640|NCT00533702|3630086|FG000|STARTED|Overall Study||54
2919641|NCT00533702|3630087|FG001|STARTED|Overall Study||52
2919642|NCT00533702|3630086|FG000|Received Any Quantity of Study Drug|Overall Study||52
2919643|NCT00533702|3630087|FG001|Received Any Quantity of Study Drug|Overall Study||50
2919644|NCT00533702|3630086|FG000|COMPLETED|Overall Study||49
2919645|NCT00533702|3630087|FG001|COMPLETED|Overall Study||50
2919646|NCT00533702|3630086|FG000|NOT COMPLETED|Overall Study||5
2919647|NCT00533702|3630087|FG001|NOT COMPLETED|Overall Study||2
2919648|NCT00533845|3630095|FG000|STARTED|Overall Study||15
2919649|NCT00533845|3630096|FG001|STARTED|Overall Study||15
2919650|NCT00533845|3630095|FG000|COMPLETED|Overall Study||14
2885818|NCT00326209|3591723|FG000|STARTED|Overall Study||393
2885819|NCT00326209|3591723|FG000|Safety Population|Overall Study||388
2885820|NCT00326209|3591723|FG000|COMPLETED|Overall Study||111
2885821|NCT00326209|3591723|FG000|NOT COMPLETED|Overall Study||282
2885822|NCT00326417|3591729|FG000|STARTED|Overall Study||14
2885823|NCT00326417|3591730|FG001|STARTED|Overall Study||41
2885824|NCT00326417|3591731|FG002|STARTED|Overall Study||39
2885825|NCT00326417|3591732|FG003|STARTED|Overall Study||3
2885826|NCT00326417|3591729|FG000|Phase I|Overall Study||6
2885827|NCT00326417|3591730|FG001|Phase I|Overall Study||6
2885828|NCT00326417|3591731|FG002|Phase I|Overall Study||6
2885829|NCT00326417|3591732|FG003|Phase I|Overall Study||3
2885830|NCT00326417|3591729|FG000|Phase II|Overall Study||8
2885831|NCT00326417|3591730|FG001|Phase II|Overall Study||35
2885832|NCT00326417|3591731|FG002|Phase II|Overall Study||33
2885833|NCT00326417|3591732|FG003|Phase II|Overall Study||0
2885834|NCT00326417|3591729|FG000|COMPLETED|Overall Study|Dose level was closed for excessive toxicity after 8 patients in Phase II accrued.|0
2885835|NCT00326417|3591730|FG001|COMPLETED|Overall Study||41
2885836|NCT00326417|3591731|FG002|COMPLETED|Overall Study||38
2885837|NCT00326417|3591732|FG003|COMPLETED|Overall Study|Arm was closed to accrual after 3 patients experienced graft failure.|0
2885838|NCT00326417|3591729|FG000|NOT COMPLETED|Overall Study||14
2885839|NCT00326417|3591730|FG001|NOT COMPLETED|Overall Study||0
2885840|NCT00326417|3591731|FG002|NOT COMPLETED|Overall Study||1
2885841|NCT00326417|3591732|FG003|NOT COMPLETED|Overall Study||3
2885842|NCT00326495|3591740|FG000|STARTED|Overall Study||51
2885843|NCT00326495|3591740|FG000|COMPLETED|Overall Study||46
2885844|NCT00326495|3591740|FG000|NOT COMPLETED|Overall Study||5
2885845|NCT00326599|3591748|FG000|STARTED|Overall Study||6
2885846|NCT00326599|3591749|FG001|STARTED|Overall Study||3
2885847|NCT00326599|3591750|FG002|STARTED|Overall Study||58
2885848|NCT00326599|3591751|FG003|STARTED|Overall Study||29
2885849|NCT00326599|3591748|FG000|COMPLETED|Overall Study||0
2885850|NCT00326599|3591749|FG001|COMPLETED|Overall Study||2
2885851|NCT00326599|3591750|FG002|COMPLETED|Overall Study||5
2885852|NCT00326599|3591751|FG003|COMPLETED|Overall Study||10
2885853|NCT00326599|3591748|FG000|NOT COMPLETED|Overall Study||6
2885854|NCT00326599|3591749|FG001|NOT COMPLETED|Overall Study||1
2885855|NCT00326599|3591750|FG002|NOT COMPLETED|Overall Study||53
2885856|NCT00326599|3591751|FG003|NOT COMPLETED|Overall Study||19
2885857|NCT00326612|3591762|FG000|STARTED|Overall Study||179
2885858|NCT00326612|3591763|FG001|STARTED|Overall Study||179
2885859|NCT00326612|3591762|FG000|COMPLETED|Overall Study||50
2885860|NCT00326612|3591763|FG001|COMPLETED|Overall Study||42
2885861|NCT00326612|3591762|FG000|NOT COMPLETED|Overall Study||129
2885862|NCT00326612|3591763|FG001|NOT COMPLETED|Overall Study||137
2885863|NCT00326625|3591775|FG000|STARTED|Overall Study||184
2885864|NCT00326625|3591776|FG001|STARTED|Overall Study||182
2885865|NCT00326625|3591775|FG000|COMPLETED|Overall Study||130
2885866|NCT00326625|3591776|FG001|COMPLETED|Overall Study||144
2885867|NCT00326625|3591775|FG000|NOT COMPLETED|Overall Study||54
2885868|NCT00326625|3591776|FG001|NOT COMPLETED|Overall Study||38
2885869|NCT00326716|3591784|FG000|STARTED|Pre-Natal Mothers||20
2885870|NCT00326716|3591785|FG001|STARTED|Pre-Natal Mothers||21
2885871|NCT00326716|3591786|FG002|STARTED|Pre-Natal Mothers||0
2885872|NCT00326716|3591787|FG003|STARTED|Pre-Natal Mothers||0
2885873|NCT00326716|3591784|FG000|COMPLETED|Pre-Natal Mothers|Completion was defined as completing the study.|19
2885874|NCT00326716|3591785|FG001|COMPLETED|Pre-Natal Mothers|Completion was defined as completing the study.|19
2885875|NCT00326716|3591786|FG002|COMPLETED|Pre-Natal Mothers|Completion was defined as completing all follow up visits through 6 months.|0
2885876|NCT00326716|3591787|FG003|COMPLETED|Pre-Natal Mothers|Completion was defined as completing all follow up visits through 6 months.|0
2885877|NCT00326716|3591784|FG000|NOT COMPLETED|Pre-Natal Mothers||1
2885878|NCT00326716|3591785|FG001|NOT COMPLETED|Pre-Natal Mothers||2
2885879|NCT00326716|3591786|FG002|NOT COMPLETED|Pre-Natal Mothers||0
2885880|NCT00326716|3591787|FG003|NOT COMPLETED|Pre-Natal Mothers||0
2885881|NCT00326716|3591784|FG000|STARTED|Infants||0
2885882|NCT00326716|3591785|FG001|STARTED|Infants||0
2885883|NCT00326716|3591786|FG002|STARTED|Infants|All infants were followed.|20
2885884|NCT00326716|3591787|FG003|STARTED|Infants|All infants were followed. One mother withdrew consent pre-delivery and her infant was not followed.|20
2885885|NCT00326716|3591784|FG000|COMPLETED|Infants||0
2885886|NCT00326716|3591785|FG001|COMPLETED|Infants||0
2885887|NCT00326716|3591786|FG002|COMPLETED|Infants||20
2885888|NCT00326716|3591787|FG003|COMPLETED|Infants||20
2885889|NCT00326716|3591784|FG000|NOT COMPLETED|Infants||0
2885890|NCT00326716|3591785|FG001|NOT COMPLETED|Infants||0
2885891|NCT00326716|3591786|FG002|NOT COMPLETED|Infants||0
2885892|NCT00326716|3591787|FG003|NOT COMPLETED|Infants||0
2885893|NCT00326781|3591819|FG000|STARTED|Overall Study||344
2885894|NCT00326781|3591820|FG001|STARTED|Overall Study||330
2885895|NCT00326781|3591819|FG000|COMPLETED|Overall Study||302
2885896|NCT00326781|3591820|FG001|COMPLETED|Overall Study||298
2885897|NCT00326781|3591819|FG000|NOT COMPLETED|Overall Study||42
2885898|NCT00326781|3591820|FG001|NOT COMPLETED|Overall Study||32
2885899|NCT00326872|3591826|FG000|STARTED|Overall Study||26
2885900|NCT00326872|3591826|FG000|COMPLETED|Overall Study||26
2885901|NCT00326872|3591826|FG000|NOT COMPLETED|Overall Study||0
2885902|NCT00326885|3591830|FG000|STARTED|Overall Study||32
2885903|NCT00326885|3591830|FG000|COMPLETED|Overall Study||25
2885904|NCT00326885|3591830|FG000|NOT COMPLETED|Overall Study||7
2885905|NCT00326911|3591837|FG000|STARTED|Overall Study|This number reflects all randomized patients.|30
2885906|NCT00326911|3591838|FG001|STARTED|Overall Study|This number reflects all randomized patients.|31
2885907|NCT00326911|3591837|FG000|COMPLETED|Overall Study|This number reflects all treated patients.|29
2885908|NCT00326911|3591838|FG001|COMPLETED|Overall Study|This number reflects all treated patients.|29
2885909|NCT00326911|3591837|FG000|NOT COMPLETED|Overall Study||1
2885910|NCT00326911|3591838|FG001|NOT COMPLETED|Overall Study||2
2885911|NCT00326924|3591846|FG000|STARTED|Overall Study||188
2885912|NCT00326924|3591847|FG001|STARTED|Overall Study||189
2885913|NCT00326924|3591846|FG000|COMPLETED|Overall Study||187
2885914|NCT00326924|3591847|FG001|COMPLETED|Overall Study||188
2885915|NCT00326924|3591846|FG000|NOT COMPLETED|Overall Study||1
2885916|NCT00326924|3591847|FG001|NOT COMPLETED|Overall Study||1
2885917|NCT00326950|3591853|FG000|STARTED|Overall Study||15
2885918|NCT00326950|3591853|FG000|COMPLETED|Overall Study||14
2885919|NCT00326950|3591853|FG000|NOT COMPLETED|Overall Study||1
2885920|NCT00326963|3591857|FG000|STARTED|Overall Study||140
2885921|NCT00326963|3591857|FG000|COMPLETED|Overall Study||107
2885922|NCT00326963|3591857|FG000|NOT COMPLETED|Overall Study||33
2885923|NCT00327015|3591866|FG000|STARTED|Overall Study||320
2885924|NCT00327015|3591867|FG001|STARTED|Overall Study||323
2885925|NCT00327015|3591868|FG002|STARTED|Overall Study||335
2885926|NCT00327015|3591869|FG003|STARTED|Overall Study||328
2885927|NCT00327015|3591866|FG000|Completed Study Without Being Rescued|Overall Study||179
2885928|NCT00327015|3591867|FG001|Completed Study Without Being Rescued|Overall Study||177
2885929|NCT00327015|3591868|FG002|Completed Study Without Being Rescued|Overall Study||113
2885930|NCT00327015|3591869|FG003|Completed Study Without Being Rescued|Overall Study||144
2885931|NCT00327015|3591866|FG000|COMPLETED|Overall Study||229
2885932|NCT00327015|3591867|FG001|COMPLETED|Overall Study||231
2885933|NCT00327015|3591868|FG002|COMPLETED|Overall Study||209
2885934|NCT00327015|3591869|FG003|COMPLETED|Overall Study||219
2885935|NCT00327015|3591866|FG000|NOT COMPLETED|Overall Study||91
2885936|NCT00327015|3591867|FG001|NOT COMPLETED|Overall Study||92
2885937|NCT00327015|3591868|FG002|NOT COMPLETED|Overall Study||126
2885938|NCT00327015|3591869|FG003|NOT COMPLETED|Overall Study||109
2885939|NCT00327171|3591881|FG000|STARTED|Overall Study||109
2885940|NCT00327171|3591882|FG001|STARTED|Overall Study||109
2885941|NCT00327171|3591881|FG000|COMPLETED|Overall Study|Participants received treatment until they met treatment discontinuation criteria|1
2885942|NCT00327171|3591882|FG001|COMPLETED|Overall Study|Participants received treatment until they met treatment discontinuation criteria|0
2885943|NCT00327171|3591881|FG000|NOT COMPLETED|Overall Study||108
2885944|NCT00327171|3591882|FG001|NOT COMPLETED|Overall Study||109
2885945|NCT00327340|3591890|FG000|STARTED|Overall Study||23
2885946|NCT00327340|3591891|FG001|STARTED|Overall Study||46
2885947|NCT00327340|3591890|FG000|COMPLETED|Overall Study||8
2885948|NCT00327340|3591891|FG001|COMPLETED|Overall Study||16
2885949|NCT00327340|3591890|FG000|NOT COMPLETED|Overall Study||15
2885950|NCT00327340|3591891|FG001|NOT COMPLETED|Overall Study||30
2885951|NCT00327392|3591899|FG000|STARTED|Overall Study||123
2885952|NCT00327392|3591899|FG000|COMPLETED|Overall Study||123
2885953|NCT00327392|3591899|FG000|NOT COMPLETED|Overall Study||0
2885954|NCT00327444|3591905|FG000|STARTED|Double Blind Treatment (DB) Period||26
2885955|NCT00327444|3591906|FG001|STARTED|Double Blind Treatment (DB) Period||29
2885956|NCT00327444|3591905|FG000|SAFETY|Double Blind Treatment (DB) Period|Excludes one participant from the Placebo arm who received aflibercept in error in the DB period.|25
2885957|NCT00327444|3591906|FG001|SAFETY|Double Blind Treatment (DB) Period|Includes 1 from Placebo who received aflibercept in DB period|30
2885958|NCT00327444|3591905|FG000|COMPLETED|Double Blind Treatment (DB) Period||0
2885959|NCT00327444|3591906|FG001|COMPLETED|Double Blind Treatment (DB) Period||0
2885960|NCT00327444|3591905|FG000|NOT COMPLETED|Double Blind Treatment (DB) Period||26
2885961|NCT00327444|3591906|FG001|NOT COMPLETED|Double Blind Treatment (DB) Period||29
2885962|NCT00327444|3591905|FG000|STARTED|Open Label Treatment (OL) Period||11
2885963|NCT00327444|3591906|FG001|STARTED|Open Label Treatment (OL) Period||10
2885964|NCT00327444|3591905|FG000|ONGOING TREATMENT|Open Label Treatment (OL) Period||1
2885965|NCT00327444|3591906|FG001|ONGOING TREATMENT|Open Label Treatment (OL) Period||0
2885966|NCT00327444|3591905|FG000|COMPLETED|Open Label Treatment (OL) Period|All participants were treated till they met treatment discontinuation criteria|0
2885967|NCT00327444|3591906|FG001|COMPLETED|Open Label Treatment (OL) Period|All participants were treated till they met treatment discontinuation criteria|0
2885968|NCT00327444|3591905|FG000|NOT COMPLETED|Open Label Treatment (OL) Period||11
2885969|NCT00327444|3591906|FG001|NOT COMPLETED|Open Label Treatment (OL) Period||10
2885970|NCT00327470|3591916|FG000|STARTED|Overall Study||107
2885971|NCT00327470|3591917|FG001|STARTED|Overall Study||181
2885972|NCT00327470|3591916|FG000|Treated|Overall Study||107
2885973|NCT00327470|3591917|FG001|Treated|Overall Study||179
2885974|NCT00327470|3591916|FG000|COMPLETED|Overall Study||78
2885975|NCT00327470|3591917|FG001|COMPLETED|Overall Study||118
2885976|NCT00327470|3591916|FG000|NOT COMPLETED|Overall Study||29
2885977|NCT00327470|3591917|FG001|NOT COMPLETED|Overall Study||63
2885978|NCT00327717|3591925|FG000|STARTED|Overall Study||120
2885979|NCT00327717|3591926|FG001|STARTED|Overall Study||120
2885980|NCT00327717|3591925|FG000|COMPLETED|Overall Study||111
2885981|NCT00327717|3591926|FG001|COMPLETED|Overall Study||106
2885982|NCT00327717|3591925|FG000|NOT COMPLETED|Overall Study||9
2885983|NCT00327717|3591926|FG001|NOT COMPLETED|Overall Study||14
2885984|NCT00328016|3591934|FG000|STARTED|Overall Study||23
2885985|NCT00328016|3591935|FG001|STARTED|Overall Study||21
2885986|NCT00328016|3591934|FG000|COMPLETED|Overall Study||23
2885987|NCT00328016|3591935|FG001|COMPLETED|Overall Study||21
2885988|NCT00328016|3591934|FG000|NOT COMPLETED|Overall Study||0
2885989|NCT00328016|3591935|FG001|NOT COMPLETED|Overall Study||0
2885990|NCT00328042|3591944|FG000|STARTED|Overall Study||69
2885991|NCT00328042|3591945|FG001|STARTED|Overall Study||65
2885992|NCT00328042|3591944|FG000|COMPLETED|Overall Study||69
2885993|NCT00328042|3591945|FG001|COMPLETED|Overall Study||63
2885994|NCT00328042|3591944|FG000|NOT COMPLETED|Overall Study||0
2885995|NCT00328042|3591945|FG001|NOT COMPLETED|Overall Study||2
2885996|NCT00328094|3591955|FG000|STARTED|Overall Study||117
2885997|NCT00328094|3591956|FG001|STARTED|Overall Study||125
2885998|NCT00328094|3591955|FG000|COMPLETED|Overall Study|2 did not receive intervention. 1 patient refusal|114
2885999|NCT00328094|3591956|FG001|COMPLETED|Overall Study|3 did not receive interevention. 1 post induction arrest. 1 case cancelled.|122
2886000|NCT00328094|3591955|FG000|NOT COMPLETED|Overall Study||3
2886001|NCT00328094|3591956|FG001|NOT COMPLETED|Overall Study||3
2886002|NCT00328172|3591967|FG000|STARTED|Overall Study||67
2886003|NCT00328172|3591968|FG001|STARTED|Overall Study||58
2886004|NCT00328172|3591969|FG002|STARTED|Overall Study||57
2886005|NCT00328172|3591970|FG003|STARTED|Overall Study||55
2886006|NCT00328172|3591971|FG004|STARTED|Overall Study||65
2886007|NCT00328172|3591967|FG000|COMPLETED|Overall Study||45
2886008|NCT00328172|3591968|FG001|COMPLETED|Overall Study||44
2886009|NCT00328172|3591969|FG002|COMPLETED|Overall Study||47
2886010|NCT00328172|3591970|FG003|COMPLETED|Overall Study||42
2886011|NCT00328172|3591971|FG004|COMPLETED|Overall Study||60
2886012|NCT00328172|3591967|FG000|NOT COMPLETED|Overall Study||22
2886013|NCT00328172|3591968|FG001|NOT COMPLETED|Overall Study||14
2886014|NCT00328172|3591969|FG002|NOT COMPLETED|Overall Study||10
2886015|NCT00328172|3591970|FG003|NOT COMPLETED|Overall Study||13
2886016|NCT00328172|3591971|FG004|NOT COMPLETED|Overall Study||5
2886017|NCT00328198|3591983|FG000|STARTED|Treatment|16 participants escalated the dose. 70 participants started at the 30 mg target dose.|86
2886018|NCT00328198|3591983|FG000|COMPLETED|Treatment|Depending upon protocol version, completed treatment was either 12 or 18 weeks in duration.|48
2886019|NCT00328198|3591983|FG000|NOT COMPLETED|Treatment||38
2886020|NCT00328198|3591983|FG000|STARTED|Follow-up|Eight participants did not enter Follow-up|78
2886021|NCT00328198|3591983|FG000|COMPLETED|Follow-up||43
2886022|NCT00328198|3591983|FG000|NOT COMPLETED|Follow-up||35
2886023|NCT00328263|3591989|FG000|STARTED|Overall Study||216
2886024|NCT00328263|3591990|FG001|STARTED|Overall Study||221
2886025|NCT00328263|3591989|FG000|COMPLETED|Overall Study|3 deaths occured during the study. None of the deaths were causally related to the study product.|213
2886026|NCT00328263|3591990|FG001|COMPLETED|Overall Study|4 deaths occured during the study. None of the deaths were causally related to the study product.|217
2886027|NCT00328263|3591989|FG000|NOT COMPLETED|Overall Study||3
2886028|NCT00328263|3591990|FG001|NOT COMPLETED|Overall Study||4
2886029|NCT00328510|3591998|FG000|STARTED|Overall Study||42
2886030|NCT00328510|3591999|FG001|STARTED|Overall Study||41
2886031|NCT00328510|3591998|FG000|COMPLETED|Overall Study||32
2886032|NCT00328510|3591999|FG001|COMPLETED|Overall Study||37
2886033|NCT00328510|3591998|FG000|NOT COMPLETED|Overall Study||10
2886034|NCT00328510|3591999|FG001|NOT COMPLETED|Overall Study||4
2886035|NCT00328562|3592005|FG000|STARTED|Overall Study||13
2886036|NCT00328562|3592005|FG000|COMPLETED|Overall Study||12
2886037|NCT00328562|3592005|FG000|NOT COMPLETED|Overall Study||1
2886038|NCT00328614|3592015|FG000|STARTED|Overall Study||4
2886039|NCT00328614|3592016|FG001|STARTED|Overall Study||4
2886040|NCT00328614|3592017|FG002|STARTED|Overall Study||6
2886041|NCT00328614|3592018|FG003|STARTED|Overall Study||6
2886042|NCT00328614|3592019|FG004|STARTED|Overall Study||6
2886043|NCT00328614|3592020|FG005|STARTED|Overall Study||6
2886044|NCT00328614|3592015|FG000|COMPLETED|Overall Study||4
2886045|NCT00328614|3592016|FG001|COMPLETED|Overall Study||4
2886046|NCT00328614|3592017|FG002|COMPLETED|Overall Study||6
2886047|NCT00328614|3592018|FG003|COMPLETED|Overall Study||5
2886048|NCT00328614|3592019|FG004|COMPLETED|Overall Study||5
2886049|NCT00328614|3592020|FG005|COMPLETED|Overall Study||5
2886050|NCT00328614|3592015|FG000|NOT COMPLETED|Overall Study||0
2886051|NCT00328614|3592016|FG001|NOT COMPLETED|Overall Study||0
2886052|NCT00328614|3592017|FG002|NOT COMPLETED|Overall Study||0
2886053|NCT00328614|3592018|FG003|NOT COMPLETED|Overall Study||1
2886054|NCT00328614|3592019|FG004|NOT COMPLETED|Overall Study||1
2886055|NCT00328614|3592020|FG005|NOT COMPLETED|Overall Study||1
2886056|NCT00328627|3592041|FG000|STARTED|Overall Study||129
2886057|NCT00328627|3592042|FG001|STARTED|Overall Study||128
2886058|NCT00328627|3592043|FG002|STARTED|Overall Study||129
2886059|NCT00328627|3592044|FG003|STARTED|Overall Study||130
2886060|NCT00328627|3592045|FG004|STARTED|Overall Study||130
2886061|NCT00328627|3592046|FG005|STARTED|Overall Study||130
2886062|NCT00328627|3592047|FG006|STARTED|Overall Study||129
2886063|NCT00328627|3592048|FG007|STARTED|Overall Study||130
2886064|NCT00328627|3592049|FG008|STARTED|Overall Study||130
2886065|NCT00328627|3592050|FG009|STARTED|Overall Study||129
2886066|NCT00328627|3592051|FG010|STARTED|Overall Study||130
2886067|NCT00328627|3592052|FG011|STARTED|Overall Study||130
2886068|NCT00328627|3592041|FG000|Safety Set|Overall Study|All patients who took at least 1 dose of double-blind study drug.|129
2886069|NCT00328627|3592042|FG001|Safety Set|Overall Study||128
2886070|NCT00328627|3592043|FG002|Safety Set|Overall Study||129
2886071|NCT00328627|3592044|FG003|Safety Set|Overall Study||129
2886072|NCT00328627|3592045|FG004|Safety Set|Overall Study||130
2886073|NCT00328627|3592046|FG005|Safety Set|Overall Study||130
2886074|NCT00328627|3592047|FG006|Safety Set|Overall Study||129
2886075|NCT00328627|3592048|FG007|Safety Set|Overall Study||130
2886076|NCT00328627|3592049|FG008|Safety Set|Overall Study||130
2886077|NCT00328627|3592050|FG009|Safety Set|Overall Study||129
2886078|NCT00328627|3592051|FG010|Safety Set|Overall Study||130
2886079|NCT00328627|3592052|FG011|Safety Set|Overall Study||130
2886080|NCT00328627|3592041|FG000|COMPLETED|Overall Study||70
2886081|NCT00328627|3592042|FG001|COMPLETED|Overall Study||97
2886082|NCT00328627|3592043|FG002|COMPLETED|Overall Study||101
2886083|NCT00328627|3592044|FG003|COMPLETED|Overall Study||93
2886084|NCT00328627|3592045|FG004|COMPLETED|Overall Study||115
2886085|NCT00328627|3592046|FG005|COMPLETED|Overall Study||110
2886086|NCT00328627|3592047|FG006|COMPLETED|Overall Study||94
2886087|NCT00328627|3592048|FG007|COMPLETED|Overall Study||116
2886088|NCT00328627|3592049|FG008|COMPLETED|Overall Study||113
2886089|NCT00328627|3592050|FG009|COMPLETED|Overall Study||97
2886090|NCT00328627|3592051|FG010|COMPLETED|Overall Study||112
2886091|NCT00328627|3592052|FG011|COMPLETED|Overall Study||114
2886092|NCT00328627|3592041|FG000|NOT COMPLETED|Overall Study||59
2886093|NCT00328627|3592042|FG001|NOT COMPLETED|Overall Study||31
2886094|NCT00328627|3592043|FG002|NOT COMPLETED|Overall Study||28
2886095|NCT00328627|3592044|FG003|NOT COMPLETED|Overall Study||37
2886096|NCT00328627|3592045|FG004|NOT COMPLETED|Overall Study||15
2886097|NCT00328627|3592046|FG005|NOT COMPLETED|Overall Study||20
2886098|NCT00328627|3592047|FG006|NOT COMPLETED|Overall Study||35
2886099|NCT00328627|3592048|FG007|NOT COMPLETED|Overall Study||14
2886100|NCT00328627|3592049|FG008|NOT COMPLETED|Overall Study||17
2886101|NCT00328627|3592050|FG009|NOT COMPLETED|Overall Study||32
2886102|NCT00328627|3592051|FG010|NOT COMPLETED|Overall Study||18
2886103|NCT00328627|3592052|FG011|NOT COMPLETED|Overall Study||16
2886104|NCT00328770|3592086|FG000|STARTED|Overall Study||70
2886105|NCT00328770|3592086|FG000|COMPLETED|Overall Study||70
2886106|NCT00328770|3592086|FG000|NOT COMPLETED|Overall Study||0
2886107|NCT00328783|3592091|FG000|STARTED|Overall Study||112
2886108|NCT00328783|3592091|FG000|COMPLETED|Overall Study||86
2886109|NCT00328783|3592091|FG000|NOT COMPLETED|Overall Study||26
2886110|NCT00328861|3592099|FG000|STARTED|Overall Study||7
2886111|NCT00328861|3592100|FG001|STARTED|Overall Study||1
2886112|NCT00328861|3592099|FG000|COMPLETED|Overall Study||7
2886113|NCT00328861|3592100|FG001|COMPLETED|Overall Study||1
2886114|NCT00328861|3592099|FG000|NOT COMPLETED|Overall Study||0
2886115|NCT00328861|3592100|FG001|NOT COMPLETED|Overall Study||0
2886116|NCT00328926|3592109|FG000|STARTED|Overall Study||5
2886117|NCT00328926|3592110|FG001|STARTED|Overall Study||3
2886118|NCT00328926|3592111|FG002|STARTED|Overall Study||3
2886119|NCT00328926|3592109|FG000|COMPLETED|Overall Study||3
2886120|NCT00328926|3592110|FG001|COMPLETED|Overall Study||0
2886121|NCT00328926|3592111|FG002|COMPLETED|Overall Study||1
2886122|NCT00328926|3592109|FG000|NOT COMPLETED|Overall Study||2
2886123|NCT00328926|3592110|FG001|NOT COMPLETED|Overall Study||3
2886124|NCT00328926|3592111|FG002|NOT COMPLETED|Overall Study||2
2886125|NCT00329030|3592121|FG000|STARTED|Overall Study||111
2886126|NCT00329030|3592122|FG001|STARTED|Overall Study||113
2886127|NCT00329030|3592121|FG000|COMPLETED|Overall Study||103
2886128|NCT00329030|3592122|FG001|COMPLETED|Overall Study||107
2886129|NCT00329030|3592121|FG000|NOT COMPLETED|Overall Study||8
2886130|NCT00329030|3592122|FG001|NOT COMPLETED|Overall Study||6
2886131|NCT00329160|3592128|FG000|STARTED|Overall Study||214
2886132|NCT00329160|3592128|FG000|Observation Period|Overall Study||214
2886133|NCT00329160|3592128|FG000|Treatment Period|Overall Study||214
2886134|NCT00329160|3592128|FG000|COMPLETED|Overall Study||126
2886135|NCT00329160|3592128|FG000|NOT COMPLETED|Overall Study||88
3170265|NCT01928849|3897623|FG000|COMPLETED|Overall Study||52
3170266|NCT01928849|3897624|FG001|COMPLETED|Overall Study||55
3170267|NCT01928849|3897623|FG000|NOT COMPLETED|Overall Study||14
2886136|NCT00329238|3592134|FG000|STARTED|Overall Study|2866 were randomized. A total of ten did not receive treatment resulting in 2856 starting study.|1430
2886137|NCT00329238|3592135|FG001|STARTED|Overall Study|2866 were randomized. A total of ten did not receive treatment resulting in 2856 starting study.|1426
2886138|NCT00329238|3592134|FG000|COMPLETED|Overall Study||1154
2886139|NCT00329238|3592135|FG001|COMPLETED|Overall Study||1145
2886140|NCT00329238|3592134|FG000|NOT COMPLETED|Overall Study||276
2886141|NCT00329238|3592135|FG001|NOT COMPLETED|Overall Study||281
2886142|NCT00329303|3592145|FG000|STARTED|Overall Study||34
2886143|NCT00329303|3592146|FG001|STARTED|Overall Study||37
2886144|NCT00329303|3592145|FG000|COMPLETED|Overall Study||32
2886145|NCT00329303|3592146|FG001|COMPLETED|Overall Study||35
2886146|NCT00329303|3592145|FG000|NOT COMPLETED|Overall Study||2
2886147|NCT00329303|3592146|FG001|NOT COMPLETED|Overall Study||2
2886148|NCT00329407|3592153|FG000|STARTED|Overall Study||10
2886149|NCT00329407|3592153|FG000|COMPLETED|Overall Study||9
2886150|NCT00329407|3592153|FG000|NOT COMPLETED|Overall Study||1
2886151|NCT00329420|3592160|FG000|STARTED|Re-induction Phase||18
2886152|NCT00329420|3592161|FG001|STARTED|Re-induction Phase||13
2886153|NCT00329420|3592162|FG002|STARTED|Re-induction Phase||15
2886154|NCT00329420|3592160|FG000|COMPLETED|Re-induction Phase|Completed = Reached Week 14 (end of re-induction phase) and responded to re-induction at that time.|12
2886155|NCT00329420|3592161|FG001|COMPLETED|Re-induction Phase|Completed = Reached Week 14 (end of re-induction phase) and responded to re-induction at that time.|7
2886156|NCT00329420|3592162|FG002|COMPLETED|Re-induction Phase|Completed = Reached Week 14 (end of re-induction phase) and responded to re-induction at that time.|7
2886157|NCT00329420|3592160|FG000|NOT COMPLETED|Re-induction Phase||6
2886158|NCT00329420|3592161|FG001|NOT COMPLETED|Re-induction Phase||6
2886159|NCT00329420|3592162|FG002|NOT COMPLETED|Re-induction Phase||8
2886160|NCT00329420|3592160|FG000|STARTED|4-weekly Dosing Phase (Responders Only)||12
2886161|NCT00329420|3592161|FG001|STARTED|4-weekly Dosing Phase (Responders Only)||7
2886162|NCT00329420|3592162|FG002|STARTED|4-weekly Dosing Phase (Responders Only)||7
2886163|NCT00329420|3592160|FG000|COMPLETED|4-weekly Dosing Phase (Responders Only)||8
2886164|NCT00329420|3592161|FG001|COMPLETED|4-weekly Dosing Phase (Responders Only)||5
2886165|NCT00329420|3592162|FG002|COMPLETED|4-weekly Dosing Phase (Responders Only)||6
2886166|NCT00329420|3592160|FG000|NOT COMPLETED|4-weekly Dosing Phase (Responders Only)||4
2886167|NCT00329420|3592161|FG001|NOT COMPLETED|4-weekly Dosing Phase (Responders Only)||2
2886168|NCT00329420|3592162|FG002|NOT COMPLETED|4-weekly Dosing Phase (Responders Only)||1
2886169|NCT00329433|3592174|FG000|STARTED|Overall Study||61
2886170|NCT00329433|3592175|FG001|STARTED|Overall Study||59
2886171|NCT00329433|3592174|FG000|COMPLETED|Overall Study||61
2886172|NCT00329433|3592175|FG001|COMPLETED|Overall Study||59
2886173|NCT00329433|3592174|FG000|NOT COMPLETED|Overall Study||0
2886174|NCT00329433|3592175|FG001|NOT COMPLETED|Overall Study||0
2886175|NCT00329524|3592181|FG000|STARTED|Overall Study||5
2886176|NCT00329524|3592181|FG000|COMPLETED|Overall Study||5
2886177|NCT00329524|3592181|FG000|NOT COMPLETED|Overall Study||0
2886178|NCT00329550|3592188|FG000|STARTED|Overall Study||9
2886179|NCT00329550|3592189|FG001|STARTED|Overall Study||15
2886180|NCT00329550|3592190|FG002|STARTED|Overall Study|1 subject in Safety Set is not in Full Analysis Set due to Good Clinical Practice non-compliance.|16
2886181|NCT00329550|3592188|FG000|COMPLETED|Overall Study||5
2886182|NCT00329550|3592189|FG001|COMPLETED|Overall Study||11
2886183|NCT00329550|3592190|FG002|COMPLETED|Overall Study||12
2886184|NCT00329550|3592188|FG000|NOT COMPLETED|Overall Study||4
2886185|NCT00329550|3592189|FG001|NOT COMPLETED|Overall Study||4
2886186|NCT00329550|3592190|FG002|NOT COMPLETED|Overall Study||4
2886187|NCT00329602|3592202|FG000|STARTED|26-Week Double-Blind Treatment Phase|"Numbers of participants in the Participant Flow section are based on the Safety Population."|207
2886188|NCT00329602|3592203|FG001|STARTED|26-Week Double-Blind Treatment Phase||197
2886189|NCT00329602|3592204|FG002|STARTED|26-Week Double-Blind Treatment Phase||0
2886190|NCT00329602|3592202|FG000|COMPLETED|26-Week Double-Blind Treatment Phase||88
2886191|NCT00329602|3592203|FG001|COMPLETED|26-Week Double-Blind Treatment Phase||98
2886192|NCT00329602|3592204|FG002|COMPLETED|26-Week Double-Blind Treatment Phase||0
2886193|NCT00329602|3592202|FG000|NOT COMPLETED|26-Week Double-Blind Treatment Phase||119
2886194|NCT00329602|3592203|FG001|NOT COMPLETED|26-Week Double-Blind Treatment Phase||99
2886195|NCT00329602|3592204|FG002|NOT COMPLETED|26-Week Double-Blind Treatment Phase||0
2886196|NCT00329602|3592202|FG000|STARTED|40-Week Open-Label Treatment Phase||0
2886197|NCT00329602|3592203|FG001|STARTED|40-Week Open-Label Treatment Phase||0
2886198|NCT00329602|3592204|FG002|STARTED|40-Week Open-Label Treatment Phase|148 and 121 par. randomized to DB placebo and ropinirole IR, respectively, entered the OL phase.|269
2886199|NCT00329602|3592202|FG000|COMPLETED|40-Week Open-Label Treatment Phase||0
2886200|NCT00329602|3592203|FG001|COMPLETED|40-Week Open-Label Treatment Phase||0
2886201|NCT00329602|3592204|FG002|COMPLETED|40-Week Open-Label Treatment Phase||233
2886202|NCT00329602|3592202|FG000|NOT COMPLETED|40-Week Open-Label Treatment Phase||0
2886203|NCT00329602|3592203|FG001|NOT COMPLETED|40-Week Open-Label Treatment Phase||0
2886204|NCT00329602|3592204|FG002|NOT COMPLETED|40-Week Open-Label Treatment Phase||36
2886205|NCT00329641|3592220|FG000|STARTED|Overall Study||25
2886206|NCT00329641|3592220|FG000|Eligible|Overall Study||25
2886207|NCT00329641|3592220|FG000|Eligible and Received Treatment|Overall Study||24
2886208|NCT00329641|3592220|FG000|COMPLETED|Overall Study||19
2886209|NCT00329641|3592220|FG000|NOT COMPLETED|Overall Study||6
2886210|NCT00329719|3592229|FG000|STARTED|Overall Study||12
2886211|NCT00329719|3592230|FG001|STARTED|Overall Study||49
2886212|NCT00329719|3592231|FG002|STARTED|Overall Study||9
2886213|NCT00329719|3592232|FG003|STARTED|Overall Study||45
2886214|NCT00329719|3592229|FG000|COMPLETED|Overall Study||12
2886215|NCT00329719|3592230|FG001|COMPLETED|Overall Study||49
2886216|NCT00329719|3592231|FG002|COMPLETED|Overall Study||9
2886217|NCT00329719|3592232|FG003|COMPLETED|Overall Study||44
2886218|NCT00329719|3592229|FG000|NOT COMPLETED|Overall Study||0
2886219|NCT00329719|3592230|FG001|NOT COMPLETED|Overall Study||0
2886220|NCT00329719|3592231|FG002|NOT COMPLETED|Overall Study||0
2886221|NCT00329719|3592232|FG003|NOT COMPLETED|Overall Study||1
2886222|NCT00329745|3592244|FG000|STARTED|Overall Study||4359
2886223|NCT00329745|3592245|FG001|STARTED|Overall Study||4328
2886224|NCT00329745|3592244|FG000|COMPLETED|Overall Study||4272
2886225|NCT00329745|3592245|FG001|COMPLETED|Overall Study||4226
2886226|NCT00329745|3592244|FG000|NOT COMPLETED|Overall Study||87
2886227|NCT00329745|3592245|FG001|NOT COMPLETED|Overall Study||102
2886228|NCT00329771|3592251|FG000|STARTED|Overall Study||28
2886229|NCT00329771|3592251|FG000|COMPLETED|Overall Study|3 subjects withdrew or were lost to follow-up|25
2886230|NCT00329771|3592251|FG000|NOT COMPLETED|Overall Study||3
2886231|NCT00329784|3592259|FG000|STARTED|Overall Study||270
2886232|NCT00329784|3592260|FG001|STARTED|Overall Study||272
2886233|NCT00329784|3592261|FG002|STARTED|Overall Study||51
2886234|NCT00329784|3592262|FG003|STARTED|Overall Study||47
2886235|NCT00329784|3592259|FG000|COMPLETED|Overall Study||265
2886236|NCT00329784|3592260|FG001|COMPLETED|Overall Study||267
2886237|NCT00329784|3592261|FG002|COMPLETED|Overall Study||51
2886238|NCT00329784|3592262|FG003|COMPLETED|Overall Study||47
2886239|NCT00329784|3592259|FG000|NOT COMPLETED|Overall Study||5
2886240|NCT00329784|3592260|FG001|NOT COMPLETED|Overall Study||5
2886241|NCT00329784|3592261|FG002|NOT COMPLETED|Overall Study||0
2886242|NCT00329784|3592262|FG003|NOT COMPLETED|Overall Study||0
2886243|NCT00329797|3592276|FG000|STARTED|Overall Study||57
2886244|NCT00329797|3592277|FG001|STARTED|Overall Study||52
2886245|NCT00329797|3592276|FG000|COMPLETED|Overall Study||50
2886246|NCT00329797|3592277|FG001|COMPLETED|Overall Study||46
2886247|NCT00329797|3592276|FG000|NOT COMPLETED|Overall Study||7
2886248|NCT00329797|3592277|FG001|NOT COMPLETED|Overall Study||6
2886249|NCT00329836|3592283|FG000|STARTED|Overall Study||41
2886250|NCT00329836|3592283|FG000|COMPLETED|Overall Study||41
2886251|NCT00329836|3592283|FG000|NOT COMPLETED|Overall Study||0
2886252|NCT00329849|3592289|FG000|STARTED|Overall Study||950
2886253|NCT00329849|3592290|FG001|STARTED|Overall Study||550
2886254|NCT00329849|3592289|FG000|COMPLETED|Overall Study||944
2886255|NCT00329849|3592290|FG001|COMPLETED|Overall Study||546
2886256|NCT00329849|3592289|FG000|NOT COMPLETED|Overall Study||6
2886257|NCT00329849|3592290|FG001|NOT COMPLETED|Overall Study||4
2886258|NCT00329901|3592303|FG000|STARTED|Overall Study||361
2886259|NCT00329901|3592304|FG001|STARTED|Overall Study||354
2886260|NCT00329901|3592305|FG002|STARTED|Overall Study||357
2886261|NCT00329901|3592303|FG000|COMPLETED|Overall Study||352
2886262|NCT00329901|3592304|FG001|COMPLETED|Overall Study||349
2886263|NCT00329901|3592305|FG002|COMPLETED|Overall Study||353
2886264|NCT00329901|3592303|FG000|NOT COMPLETED|Overall Study||9
2886265|NCT00329901|3592304|FG001|NOT COMPLETED|Overall Study||5
2886266|NCT00329901|3592305|FG002|NOT COMPLETED|Overall Study||4
2886267|NCT00330161|3592317|FG000|STARTED|Overall Study||29
2886268|NCT00330161|3592317|FG000|COMPLETED|Overall Study||29
2886269|NCT00330161|3592317|FG000|NOT COMPLETED|Overall Study||0
2886270|NCT00330174|3592323|FG000|STARTED|Overall Study||45
2886271|NCT00330174|3592324|FG001|STARTED|Overall Study||45
2886272|NCT00330174|3592323|FG000|COMPLETED|Overall Study||23
2886273|NCT00330174|3592324|FG001|COMPLETED|Overall Study||26
2886274|NCT00330174|3592323|FG000|NOT COMPLETED|Overall Study||22
2886275|NCT00330174|3592324|FG001|NOT COMPLETED|Overall Study||19
2886276|NCT00330187|3592334|FG000|STARTED|Overall Study||37
2886277|NCT00330187|3592335|FG001|STARTED|Overall Study||36
2886278|NCT00330187|3592336|FG002|STARTED|Overall Study||29
2886279|NCT00330187|3592337|FG003|STARTED|Overall Study||32
2886280|NCT00330187|3592334|FG000|COMPLETED|Overall Study||17
2886281|NCT00330187|3592335|FG001|COMPLETED|Overall Study||18
2886282|NCT00330187|3592336|FG002|COMPLETED|Overall Study||11
2886283|NCT00330187|3592337|FG003|COMPLETED|Overall Study||18
2886284|NCT00330187|3592334|FG000|NOT COMPLETED|Overall Study||20
2886285|NCT00330187|3592335|FG001|NOT COMPLETED|Overall Study||18
2886286|NCT00330187|3592336|FG002|NOT COMPLETED|Overall Study||18
2886287|NCT00330187|3592337|FG003|NOT COMPLETED|Overall Study||14
2886288|NCT00330343|3592347|FG000|STARTED|Overall Study||64
2886289|NCT00330343|3592347|FG000|COMPLETED|Overall Study||59
2886290|NCT00330343|3592347|FG000|NOT COMPLETED|Overall Study||5
2886291|NCT00330382|3592353|FG000|STARTED|Overall Study||67
2886292|NCT00330382|3592354|FG001|STARTED|Overall Study||65
2886293|NCT00330382|3592353|FG000|COMPLETED|Overall Study||43
2886294|NCT00330382|3592354|FG001|COMPLETED|Overall Study||48
2886295|NCT00330382|3592353|FG000|NOT COMPLETED|Overall Study||24
2886296|NCT00330382|3592354|FG001|NOT COMPLETED|Overall Study||17
2886297|NCT00330421|3592361|FG000|STARTED|Overall Study||15
2886298|NCT00330421|3592362|FG001|STARTED|Overall Study||0
2886299|NCT00330421|3592361|FG000|COMPLETED|Overall Study||15
2886300|NCT00330421|3592362|FG001|COMPLETED|Overall Study||0
2886301|NCT00330421|3592361|FG000|NOT COMPLETED|Overall Study||0
2886302|NCT00330421|3592362|FG001|NOT COMPLETED|Overall Study||0
2886303|NCT00330460|3592368|FG000|STARTED|Overall Study||595
2886304|NCT00330460|3592369|FG001|STARTED|Overall Study||594
2886305|NCT00330460|3592368|FG000|COMPLETED|Overall Study||553
2886306|NCT00330460|3592369|FG001|COMPLETED|Overall Study||561
2886307|NCT00330460|3592368|FG000|NOT COMPLETED|Overall Study||42
2886308|NCT00330460|3592369|FG001|NOT COMPLETED|Overall Study||33
2886309|NCT00330551|3592377|FG000|STARTED|Overall Study||40
2886310|NCT00330551|3592378|FG001|STARTED|Overall Study||43
2886311|NCT00330551|3592377|FG000|COMPLETED|Overall Study||30
2886312|NCT00330551|3592378|FG001|COMPLETED|Overall Study||27
2886313|NCT00330551|3592377|FG000|NOT COMPLETED|Overall Study||10
2886314|NCT00330551|3592378|FG001|NOT COMPLETED|Overall Study||16
2886315|NCT00330564|3592386|FG000|STARTED|Overall Study||15
2886316|NCT00330564|3592386|FG000|COMPLETED|Overall Study||15
2886317|NCT00330564|3592386|FG000|NOT COMPLETED|Overall Study||0
2886318|NCT00330616|3592390|FG000|STARTED|Overall Study||35
2886319|NCT00330616|3592390|FG000|COMPLETED|Overall Study||14
2886320|NCT00330616|3592390|FG000|NOT COMPLETED|Overall Study||21
2886321|NCT00330668|3592394|FG000|STARTED|BID Dosing Period||114
2886322|NCT00330668|3592394|FG000|COMPLETED|BID Dosing Period||78
2886323|NCT00330668|3592394|FG000|NOT COMPLETED|BID Dosing Period||36
2886324|NCT00330668|3592394|FG000|STARTED|QD Dosing Period||78
2886325|NCT00330668|3592394|FG000|COMPLETED|QD Dosing Period||0
2886326|NCT00330668|3592394|FG000|NOT COMPLETED|QD Dosing Period||78
2886327|NCT00330681|3592400|FG000|STARTED|Overall Study||102
2886328|NCT00330681|3592401|FG001|STARTED|Overall Study||104
2886329|NCT00330681|3592400|FG000|COMPLETED|Overall Study||93
2886330|NCT00330681|3592401|FG001|COMPLETED|Overall Study||90
2886331|NCT00330681|3592400|FG000|NOT COMPLETED|Overall Study||9
2886332|NCT00330681|3592401|FG001|NOT COMPLETED|Overall Study||14
2886333|NCT00330733|3592409|FG000|STARTED|Overall Study||37
2886334|NCT00330733|3592410|FG001|STARTED|Overall Study||34
2886335|NCT00330733|3592409|FG000|Received Study Medication|Overall Study||36
2886336|NCT00330733|3592410|FG001|Received Study Medication|Overall Study||34
2886337|NCT00330733|3592409|FG000|COMPLETED|Overall Study||30
2886338|NCT00330733|3592410|FG001|COMPLETED|Overall Study||29
2886339|NCT00330733|3592409|FG000|NOT COMPLETED|Overall Study||7
2886340|NCT00330733|3592410|FG001|NOT COMPLETED|Overall Study||5
2886341|NCT00330759|3592418|FG000|STARTED|Overall Study||890
2886342|NCT00330759|3592419|FG001|STARTED|Overall Study||886
2886343|NCT00330759|3592418|FG000|Received Investigational Product|Overall Study||878
2886344|NCT00330759|3592419|FG001|Received Investigational Product|Overall Study||878
2886345|NCT00330759|3592418|FG000|COMPLETED|Overall Study||178
2886346|NCT00330759|3592419|FG001|COMPLETED|Overall Study||180
2886347|NCT00330759|3592418|FG000|NOT COMPLETED|Overall Study||712
2886348|NCT00330759|3592419|FG001|NOT COMPLETED|Overall Study||706
2886349|NCT00330863|3592427|FG000|STARTED|Overall Study||153
2886350|NCT00330863|3592428|FG001|STARTED|Overall Study||152
2886351|NCT00330863|3592427|FG000|COMPLETED|Overall Study||72
2886352|NCT00330863|3592428|FG001|COMPLETED|Overall Study||72
2886353|NCT00330863|3592427|FG000|NOT COMPLETED|Overall Study||81
2886354|NCT00330863|3592428|FG001|NOT COMPLETED|Overall Study||80
2886355|NCT00330876|3592434|FG000|STARTED|Overall Study||449
2886356|NCT00330876|3592435|FG001|STARTED|Overall Study||90
2886357|NCT00330876|3592434|FG000|COMPLETED|Overall Study||378
2886358|NCT00330876|3592435|FG001|COMPLETED|Overall Study||77
2886359|NCT00330876|3592434|FG000|NOT COMPLETED|Overall Study||71
2886360|NCT00330876|3592435|FG001|NOT COMPLETED|Overall Study||13
2886361|NCT00330915|3592441|FG000|STARTED|Overall Study||37
2886362|NCT00330915|3592441|FG000|COMPLETED|Overall Study||37
2886363|NCT00330915|3592441|FG000|NOT COMPLETED|Overall Study||0
2886364|NCT00330928|3592445|FG000|STARTED|Overall Study|Subjects that signed consent and were subject to research procedures.|106
2886365|NCT00330928|3592445|FG000|7 Day Phone Contact|Overall Study||99
2886366|NCT00330928|3592445|FG000|1 Year Phone Contact|Overall Study||89
2886367|NCT00330928|3592445|FG000|COMPLETED|Overall Study||89
2886368|NCT00330928|3592445|FG000|NOT COMPLETED|Overall Study||17
2886369|NCT00330967|3592451|FG000|STARTED|Overall Study||0
2886370|NCT00330967|3592452|FG001|STARTED|Overall Study||25
2886371|NCT00330967|3592451|FG000|COMPLETED|Overall Study||0
2886372|NCT00330967|3592452|FG001|COMPLETED|Overall Study||11
2886373|NCT00330967|3592451|FG000|NOT COMPLETED|Overall Study||0
2886374|NCT00330967|3592452|FG001|NOT COMPLETED|Overall Study||14
2886375|NCT00331006|3592458|FG000|STARTED|Screening Phase||23
2886376|NCT00331006|3592458|FG000|COMPLETED|Screening Phase|subjects eligible for the treatment phase if inhibitor titer following Factor VIII was at least 5 BU|16
2886377|NCT00331006|3592458|FG000|NOT COMPLETED|Screening Phase||7
2886378|NCT00331006|3592458|FG000|STARTED|Treatment Phase||16
2886379|NCT00331006|3592458|FG000|COMPLETED|Treatment Phase||15
2886380|NCT00331006|3592458|FG000|NOT COMPLETED|Treatment Phase||1
2886381|NCT00331006|3592458|FG000|STARTED|Follow-Up Phase I||15
2886382|NCT00331006|3592458|FG000|COMPLETED|Follow-Up Phase I||14
2886383|NCT00331006|3592458|FG000|NOT COMPLETED|Follow-Up Phase I||1
2886384|NCT00331006|3592458|FG000|STARTED|Follow-Up Phase II||14
2886385|NCT00331006|3592458|FG000|COMPLETED|Follow-Up Phase II||11
2886386|NCT00331006|3592458|FG000|NOT COMPLETED|Follow-Up Phase II||3
2886387|NCT00331136|3592466|FG000|STARTED|Overall Study||15
2886388|NCT00331136|3592467|FG001|STARTED|Overall Study||15
2886389|NCT00331136|3592468|FG002|STARTED|Overall Study||15
2886390|NCT00331136|3592469|FG003|STARTED|Overall Study||15
2886391|NCT00331136|3592466|FG000|COMPLETED|Overall Study||10
2886392|NCT00331136|3592467|FG001|COMPLETED|Overall Study||8
2886393|NCT00331136|3592468|FG002|COMPLETED|Overall Study||15
2886394|NCT00331136|3592469|FG003|COMPLETED|Overall Study||14
2886395|NCT00331136|3592466|FG000|NOT COMPLETED|Overall Study||5
2886396|NCT00331136|3592467|FG001|NOT COMPLETED|Overall Study||7
2886397|NCT00331136|3592468|FG002|NOT COMPLETED|Overall Study||0
2886398|NCT00331136|3592469|FG003|NOT COMPLETED|Overall Study||1
2886399|NCT00331162|3592481|FG000|STARTED|Overall Study||113
2886400|NCT00331162|3592482|FG001|STARTED|Overall Study||109
2886401|NCT00331162|3592481|FG000|COMPLETED|Overall Study||113
2886402|NCT00331162|3592482|FG001|COMPLETED|Overall Study||109
2886403|NCT00331162|3592481|FG000|NOT COMPLETED|Overall Study||0
2886404|NCT00331162|3592482|FG001|NOT COMPLETED|Overall Study||0
2886405|NCT00331344|3592488|FG000|STARTED|Phase I||3
2886406|NCT00331344|3592489|FG001|STARTED|Phase I||3
2886407|NCT00331344|3592490|FG002|STARTED|Phase I||3
2886408|NCT00331344|3592491|FG003|STARTED|Phase I||6
2886409|NCT00331344|3592492|FG004|STARTED|Phase I||6
2886410|NCT00331344|3592493|FG005|STARTED|Phase I||5
2886411|NCT00331344|3592494|FG006|STARTED|Phase I||4
2886412|NCT00331344|3592495|FG007|STARTED|Phase I|1 participant who was enrolled died prior to initiating protocol therapy.|6
2886413|NCT00331344|3592496|FG008|STARTED|Phase I||0
2886414|NCT00331344|3592488|FG000|COMPLETED|Phase I||3
2886415|NCT00331344|3592489|FG001|COMPLETED|Phase I||3
2886416|NCT00331344|3592490|FG002|COMPLETED|Phase I||3
2886417|NCT00331344|3592491|FG003|COMPLETED|Phase I|1 participant reached dose limiting toxicity|5
2886418|NCT00331344|3592492|FG004|COMPLETED|Phase I|2 participants reached dose limiting toxicity|4
2886419|NCT00331344|3592493|FG005|COMPLETED|Phase I|2 participants reached dose limiting toxicity|3
2886420|NCT00331344|3592494|FG006|COMPLETED|Phase I||4
2886421|NCT00331344|3592495|FG007|COMPLETED|Phase I|1 participant reached dose limiting toxicity|5
2886422|NCT00331344|3592496|FG008|COMPLETED|Phase I||0
2886423|NCT00331344|3592488|FG000|NOT COMPLETED|Phase I||0
2886424|NCT00331344|3592489|FG001|NOT COMPLETED|Phase I||0
2886425|NCT00331344|3592490|FG002|NOT COMPLETED|Phase I||0
2886426|NCT00331344|3592491|FG003|NOT COMPLETED|Phase I||1
2886427|NCT00331344|3592492|FG004|NOT COMPLETED|Phase I||2
2886428|NCT00331344|3592493|FG005|NOT COMPLETED|Phase I||2
2886429|NCT00331344|3592494|FG006|NOT COMPLETED|Phase I||0
2886430|NCT00331344|3592495|FG007|NOT COMPLETED|Phase I||1
2886431|NCT00331344|3592496|FG008|NOT COMPLETED|Phase I||0
2886432|NCT00331344|3592488|FG000|STARTED|Phase II||0
2886433|NCT00331344|3592489|FG001|STARTED|Phase II||0
2886434|NCT00331344|3592490|FG002|STARTED|Phase II||0
3170268|NCT01928849|3897624|FG001|NOT COMPLETED|Overall Study||7
3170269|NCT01928862|3897635|FG000|STARTED|Overall Study||16
3170270|NCT01928862|3897636|FG001|STARTED|Overall Study||16
3170271|NCT01928862|3897637|FG002|STARTED|Overall Study||16
3170272|NCT01928862|3897638|FG003|STARTED|Overall Study||16
3170273|NCT01928862|3897639|FG004|STARTED|Overall Study||14
2886435|NCT00331344|3592491|FG003|STARTED|Phase II||0
2886436|NCT00331344|3592492|FG004|STARTED|Phase II||0
2886437|NCT00331344|3592493|FG005|STARTED|Phase II||0
2886438|NCT00331344|3592494|FG006|STARTED|Phase II||0
2886439|NCT00331344|3592495|FG007|STARTED|Phase II|6 patients in Phase I Group VIa continued to the Phase II period.|6
2886440|NCT00331344|3592496|FG008|STARTED|Phase II|Protocol enrollment (63) minus 11 ineligible prior to receiving treatment.|52
2886441|NCT00331344|3592488|FG000|COMPLETED|Phase II||0
2886442|NCT00331344|3592489|FG001|COMPLETED|Phase II||0
2886443|NCT00331344|3592490|FG002|COMPLETED|Phase II||0
2886444|NCT00331344|3592491|FG003|COMPLETED|Phase II||0
2886445|NCT00331344|3592492|FG004|COMPLETED|Phase II||0
2886446|NCT00331344|3592493|FG005|COMPLETED|Phase II||0
2886447|NCT00331344|3592494|FG006|COMPLETED|Phase II||0
2886448|NCT00331344|3592495|FG007|COMPLETED|Phase II||6
2886449|NCT00331344|3592496|FG008|COMPLETED|Phase II||48
2886450|NCT00331344|3592488|FG000|NOT COMPLETED|Phase II||0
2886451|NCT00331344|3592489|FG001|NOT COMPLETED|Phase II||0
2886452|NCT00331344|3592490|FG002|NOT COMPLETED|Phase II||0
2886453|NCT00331344|3592491|FG003|NOT COMPLETED|Phase II||0
2886454|NCT00331344|3592492|FG004|NOT COMPLETED|Phase II||0
2886455|NCT00331344|3592493|FG005|NOT COMPLETED|Phase II||0
3170274|NCT01928862|3897635|FG000|COMPLETED|Overall Study||15
3170275|NCT01928862|3897636|FG001|COMPLETED|Overall Study||16
3170276|NCT01928862|3897637|FG002|COMPLETED|Overall Study||16
3170277|NCT01928862|3897638|FG003|COMPLETED|Overall Study||16
3170278|NCT01928862|3897639|FG004|COMPLETED|Overall Study||13
3170279|NCT01928862|3897635|FG000|NOT COMPLETED|Overall Study||1
3170280|NCT01928862|3897636|FG001|NOT COMPLETED|Overall Study||0
3170281|NCT01928862|3897637|FG002|NOT COMPLETED|Overall Study||0
2886456|NCT00331344|3592494|FG006|NOT COMPLETED|Phase II||0
2886457|NCT00331344|3592495|FG007|NOT COMPLETED|Phase II||0
2886458|NCT00331344|3592496|FG008|NOT COMPLETED|Phase II||4
2886459|NCT00331409|3592509|FG000|STARTED|Overall Study|19 patients were enrolled in the first stage due to 4 patients who withdrew early.|19
2886460|NCT00331409|3592509|FG000|COMPLETED|Overall Study|15 patients accrued to the first stage;if>9 were progression-free at 3 months,enrollment continued.|15
2886461|NCT00331409|3592509|FG000|NOT COMPLETED|Overall Study||4
2886462|NCT00331422|3592513|FG000|STARTED|Overall Study|Patients who met study criteria and received at least one dose of study drug.|7
2886463|NCT00331422|3592513|FG000|COMPLETED|Overall Study|Completed all 6 courses of chemotherapy and had surgery to remove all tumor lesions.|2
2886464|NCT00331422|3592513|FG000|NOT COMPLETED|Overall Study||5
2886465|NCT00331552|3592520|FG000|STARTED|Period 1: Doxil 30 mg/m^2 (Phase I)||3
2886466|NCT00331552|3592521|FG001|STARTED|Period 1: Doxil 30 mg/m^2 (Phase I)||0
2886467|NCT00331552|3592520|FG000|COMPLETED|Period 1: Doxil 30 mg/m^2 (Phase I)||3
2886468|NCT00331552|3592521|FG001|COMPLETED|Period 1: Doxil 30 mg/m^2 (Phase I)||0
2886469|NCT00331552|3592520|FG000|NOT COMPLETED|Period 1: Doxil 30 mg/m^2 (Phase I)||0
2886470|NCT00331552|3592521|FG001|NOT COMPLETED|Period 1: Doxil 30 mg/m^2 (Phase I)||0
2886471|NCT00331552|3592520|FG000|STARTED|Period 2: Doxil 35 mg/m^2 (Phase I)||0
2886472|NCT00331552|3592521|FG001|STARTED|Period 2: Doxil 35 mg/m^2 (Phase I)||3
2886473|NCT00331552|3592520|FG000|COMPLETED|Period 2: Doxil 35 mg/m^2 (Phase I)||0
2886474|NCT00331552|3592521|FG001|COMPLETED|Period 2: Doxil 35 mg/m^2 (Phase I)||3
2886475|NCT00331552|3592520|FG000|NOT COMPLETED|Period 2: Doxil 35 mg/m^2 (Phase I)||0
2886476|NCT00331552|3592521|FG001|NOT COMPLETED|Period 2: Doxil 35 mg/m^2 (Phase I)||0
2886477|NCT00331552|3592520|FG000|STARTED|Period 3: Phase II||24
2886478|NCT00331552|3592521|FG001|STARTED|Period 3: Phase II||0
2886479|NCT00331552|3592520|FG000|COMPLETED|Period 3: Phase II||22
2886480|NCT00331552|3592521|FG001|COMPLETED|Period 3: Phase II||0
2886481|NCT00331552|3592520|FG000|NOT COMPLETED|Period 3: Phase II||2
2886482|NCT00331552|3592521|FG001|NOT COMPLETED|Period 3: Phase II||0
2886483|NCT00331630|3592532|FG000|STARTED|Treatment on Study||30
2886484|NCT00331630|3592532|FG000|Completed 1st Cycle|Treatment on Study||30
2886485|NCT00331630|3592532|FG000|Completed 4 Cycles|Treatment on Study||30
2886486|NCT00331630|3592532|FG000|COMPLETED|Treatment on Study||30
2886487|NCT00331630|3592532|FG000|NOT COMPLETED|Treatment on Study||0
2886488|NCT00331630|3592532|FG000|STARTED|Evaluated for and Completed SOC Surgery||30
2886489|NCT00331630|3592532|FG000|COMPLETED|Evaluated for and Completed SOC Surgery||28
2886490|NCT00331630|3592532|FG000|NOT COMPLETED|Evaluated for and Completed SOC Surgery||2
2919651|NCT00533845|3630096|FG001|COMPLETED|Overall Study||15
3170282|NCT01928862|3897638|FG003|NOT COMPLETED|Overall Study||0
2886491|NCT00331630|3592532|FG000|STARTED|Follow up for 5 Years|One patient did not enter follow up as was lost to follow up|29
2886492|NCT00331630|3592532|FG000|COMPLETED|Follow up for 5 Years||0
2886493|NCT00331630|3592532|FG000|NOT COMPLETED|Follow up for 5 Years||29
2886494|NCT00331682|3592536|FG000|STARTED|Overall Study||10
2886495|NCT00331682|3592536|FG000|COMPLETED|Overall Study||9
2886496|NCT00331682|3592536|FG000|NOT COMPLETED|Overall Study||1
2886497|NCT00331760|3592542|FG000|STARTED|Overall Study||58
2886498|NCT00331760|3592543|FG001|STARTED|Overall Study||48
2886499|NCT00331760|3592542|FG000|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|43
2886500|NCT00331760|3592543|FG001|COMPLETED|Overall Study||40
2886501|NCT00331760|3592542|FG000|NOT COMPLETED|Overall Study||15
2886502|NCT00331760|3592543|FG001|NOT COMPLETED|Overall Study||8
2886503|NCT00331773|3592552|FG000|STARTED|Overall Study||558
2886504|NCT00331773|3592553|FG001|STARTED|Overall Study||557
2886505|NCT00331773|3592552|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|542
2886506|NCT00331773|3592553|FG001|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|550
2886507|NCT00331773|3592552|FG000|NOT COMPLETED|Overall Study||16
2886508|NCT00331773|3592553|FG001|NOT COMPLETED|Overall Study||7
2886509|NCT00331799|3592560|FG000|STARTED|Overall Study||18
2886510|NCT00331799|3592560|FG000|COMPLETED|Overall Study||15
2886511|NCT00331799|3592560|FG000|NOT COMPLETED|Overall Study||3
2886512|NCT00331864|3592566|FG000|STARTED|Overall Study||513
2886513|NCT00331864|3592567|FG001|STARTED|Overall Study||18
2886514|NCT00331864|3592566|FG000|COMPLETED|Overall Study||455
2886515|NCT00331864|3592567|FG001|COMPLETED|Overall Study||14
2886516|NCT00331864|3592566|FG000|NOT COMPLETED|Overall Study||58
2886517|NCT00331864|3592567|FG001|NOT COMPLETED|Overall Study||4
2886518|NCT00332163|3592575|FG000|STARTED|Overall Study||48
2886519|NCT00332163|3592576|FG001|STARTED|Overall Study||47
2886520|NCT00332163|3592575|FG000|Received Treatment|Overall Study||48
2886521|NCT00332163|3592576|FG001|Received Treatment|Overall Study||47
2886522|NCT00332163|3592575|FG000|COMPLETED|Overall Study||48
2886523|NCT00332163|3592576|FG001|COMPLETED|Overall Study||47
2886524|NCT00332163|3592575|FG000|NOT COMPLETED|Overall Study||0
2886525|NCT00332163|3592576|FG001|NOT COMPLETED|Overall Study||0
2886526|NCT00332189|3592582|FG000|STARTED|Overall Study||111
2886527|NCT00332189|3592582|FG000|COMPLETED|Overall Study|Subjects in this extension study continued until there was market approval in their region.|90
2886528|NCT00332189|3592582|FG000|NOT COMPLETED|Overall Study||21
2886529|NCT00332202|3592589|FG000|STARTED|Overall Study||504
2886530|NCT00332202|3592590|FG001|STARTED|Overall Study||254
2886531|NCT00332202|3592589|FG000|Received At Least One Dose of Study Drug|Overall Study||493
2886532|NCT00332202|3592590|FG001|Received At Least One Dose of Study Drug|Overall Study||249
2886533|NCT00332202|3592589|FG000|COMPLETED|Overall Study||263
2886534|NCT00332202|3592590|FG001|COMPLETED|Overall Study||129
2886535|NCT00332202|3592589|FG000|NOT COMPLETED|Overall Study||241
2886536|NCT00332202|3592590|FG001|NOT COMPLETED|Overall Study||125
2886537|NCT00332241|3592607|FG000|STARTED|Overall Study||51
2886538|NCT00332241|3592608|FG001|STARTED|Overall Study||47
2886539|NCT00332241|3592607|FG000|COMPLETED|Overall Study||36
2886540|NCT00332241|3592608|FG001|COMPLETED|Overall Study||39
2886541|NCT00332241|3592607|FG000|NOT COMPLETED|Overall Study||15
2886542|NCT00332241|3592608|FG001|NOT COMPLETED|Overall Study||8
2886543|NCT00332332|3592614|FG000|STARTED|Overall Study||246
2886544|NCT00332332|3592614|FG000|Received Study Medication|Overall Study||230
2886545|NCT00332332|3592614|FG000|COMPLETED|Overall Study||178
2886546|NCT00332332|3592614|FG000|NOT COMPLETED|Overall Study||68
2886547|NCT00332462|3592618|FG000|STARTED|Overall Study|Safety and Intention to treat population.|34
2886548|NCT00332462|3592618|FG000|Patients Treated With Sandimmun® i.v.|Overall Study||34
2886549|NCT00332462|3592618|FG000|Patients Treated With Sandimmun® Optoral|Overall Study||29
2886550|NCT00332462|3592618|FG000|COMPLETED|Overall Study||18
2886551|NCT00332462|3592618|FG000|NOT COMPLETED|Overall Study||16
2886552|NCT00332488|3592628|FG000|STARTED|Initial Treatment Phase (Weeks 0 - 12)||183
2886553|NCT00332488|3592629|FG001|STARTED|Initial Treatment Phase (Weeks 0 - 12)||170
2886554|NCT00332488|3592630|FG002|STARTED|Initial Treatment Phase (Weeks 0 - 12)||175
2886555|NCT00332488|3592628|FG000|COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||133
2886556|NCT00332488|3592629|FG001|COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||152
2886557|NCT00332488|3592630|FG002|COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||119
2886558|NCT00332488|3592628|FG000|NOT COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||50
2886559|NCT00332488|3592629|FG001|NOT COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||18
2886560|NCT00332488|3592630|FG002|NOT COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||56
2919652|NCT00533845|3630095|FG000|NOT COMPLETED|Overall Study||1
3170283|NCT01928862|3897639|FG004|NOT COMPLETED|Overall Study||1
3170284|NCT01928927|3897654|FG000|STARTED|Overall Study||29
3170285|NCT01928927|3897655|FG001|STARTED|Overall Study||15
3170286|NCT01928927|3897654|FG000|COMPLETED|Overall Study||27
3170287|NCT01928927|3897655|FG001|COMPLETED|Overall Study||14
3170288|NCT01928927|3897654|FG000|NOT COMPLETED|Overall Study||2
3170289|NCT01928927|3897655|FG001|NOT COMPLETED|Overall Study||1
3170290|NCT01928940|3897667|FG000|STARTED|Overall Study||6
3170291|NCT01928940|3897668|FG001|STARTED|Overall Study||6
3170292|NCT01928940|3897667|FG000|COMPLETED|Overall Study||6
3170293|NCT01928940|3897668|FG001|COMPLETED|Overall Study||5
3170294|NCT01928940|3897667|FG000|NOT COMPLETED|Overall Study||0
2886561|NCT00332488|3592628|FG000|STARTED|Transfer Treatment Phase (Weeks 12 - 24)|Subjects on TI who achieved an HbA1c < 7.5% or had an HbA1c decrease from baseline >= 1.0%|29
2886562|NCT00332488|3592629|FG001|STARTED|Transfer Treatment Phase (Weeks 12 - 24)|Subjects on treatment who achieved an HbA1c < 7.5% or had an HbA1c decrease from baseline >= 1.0%|72
2886563|NCT00332488|3592630|FG002|STARTED|Transfer Treatment Phase (Weeks 12 - 24)|Subjects in this arm who met HbA1c criteria + subjects from other arms who did not|254
2886564|NCT00332488|3592628|FG000|COMPLETED|Transfer Treatment Phase (Weeks 12 - 24)||27
2886565|NCT00332488|3592629|FG001|COMPLETED|Transfer Treatment Phase (Weeks 12 - 24)||70
2886566|NCT00332488|3592630|FG002|COMPLETED|Transfer Treatment Phase (Weeks 12 - 24)||233
2886567|NCT00332488|3592628|FG000|NOT COMPLETED|Transfer Treatment Phase (Weeks 12 - 24)||2
2886568|NCT00332488|3592629|FG001|NOT COMPLETED|Transfer Treatment Phase (Weeks 12 - 24)||2
2886569|NCT00332488|3592630|FG002|NOT COMPLETED|Transfer Treatment Phase (Weeks 12 - 24)||21
2886570|NCT00332579|3592642|FG000|STARTED|Overall Study||12
2886571|NCT00332579|3592643|FG001|STARTED|Overall Study||13
2886572|NCT00332579|3592642|FG000|COMPLETED|Overall Study||11
2886573|NCT00332579|3592643|FG001|COMPLETED|Overall Study||12
2886574|NCT00332579|3592642|FG000|NOT COMPLETED|Overall Study||1
2886575|NCT00332579|3592643|FG001|NOT COMPLETED|Overall Study||1
2886576|NCT00332605|3592652|FG000|STARTED|Overall Study||14
2886577|NCT00332605|3592653|FG001|STARTED|Overall Study||14
2886578|NCT00332605|3592654|FG002|STARTED|Overall Study||17
2886579|NCT00332605|3592652|FG000|COMPLETED|Overall Study||12
2886580|NCT00332605|3592653|FG001|COMPLETED|Overall Study||12
2886581|NCT00332605|3592654|FG002|COMPLETED|Overall Study||9
2886582|NCT00332605|3592652|FG000|NOT COMPLETED|Overall Study||2
2886583|NCT00332605|3592653|FG001|NOT COMPLETED|Overall Study||2
2886584|NCT00332605|3592654|FG002|NOT COMPLETED|Overall Study||8
2886585|NCT00332644|3592668|FG000|STARTED|Overall Study||262
2886586|NCT00332644|3592669|FG001|STARTED|Overall Study||260
2886587|NCT00332644|3592670|FG002|STARTED|Overall Study||267
2886588|NCT00332644|3592671|FG003|STARTED|Overall Study||264
2886589|NCT00332644|3592672|FG004|STARTED|Overall Study||262
2886590|NCT00332644|3592673|FG005|STARTED|Overall Study||189
2886591|NCT00332644|3592668|FG000|COMPLETED|Overall Study||250
2886592|NCT00332644|3592669|FG001|COMPLETED|Overall Study||238
2886593|NCT00332644|3592670|FG002|COMPLETED|Overall Study||258
2886594|NCT00332644|3592671|FG003|COMPLETED|Overall Study||244
2886595|NCT00332644|3592672|FG004|COMPLETED|Overall Study||250
2886596|NCT00332644|3592673|FG005|COMPLETED|Overall Study||174
2886597|NCT00332644|3592668|FG000|NOT COMPLETED|Overall Study||12
2886598|NCT00332644|3592669|FG001|NOT COMPLETED|Overall Study||22
2886599|NCT00332644|3592670|FG002|NOT COMPLETED|Overall Study||9
2886600|NCT00332644|3592671|FG003|NOT COMPLETED|Overall Study||20
2886601|NCT00332644|3592672|FG004|NOT COMPLETED|Overall Study||12
2886602|NCT00332644|3592673|FG005|NOT COMPLETED|Overall Study||15
2886603|NCT00332696|3592689|FG000|STARTED|Overall Study||32
2886604|NCT00332696|3592690|FG001|STARTED|Overall Study||32
2886605|NCT00332696|3592689|FG000|Completed Day 14 Visit|Overall Study|Primary Endpoint|21
2886606|NCT00332696|3592690|FG001|Completed Day 14 Visit|Overall Study||15
2886607|NCT00332696|3592689|FG000|COMPLETED|Overall Study|Completed Month 3 Visit|2
2886608|NCT00332696|3592690|FG001|COMPLETED|Overall Study||2
2886609|NCT00332696|3592689|FG000|NOT COMPLETED|Overall Study||30
2886610|NCT00332696|3592690|FG001|NOT COMPLETED|Overall Study||30
2886611|NCT00332709|3592698|FG000|STARTED|Overall Study||40
2886612|NCT00332709|3592699|FG001|STARTED|Overall Study||41
2886613|NCT00332709|3592698|FG000|COMPLETED|Overall Study||24
2886614|NCT00332709|3592699|FG001|COMPLETED|Overall Study||21
2886615|NCT00332709|3592698|FG000|NOT COMPLETED|Overall Study||16
2886616|NCT00332709|3592699|FG001|NOT COMPLETED|Overall Study||20
2886617|NCT00332722|3592707|FG000|STARTED|Overall Study||60
3170295|NCT01928940|3897668|FG001|NOT COMPLETED|Overall Study||1
3170296|NCT01929018|3897677|FG000|STARTED|Overall Study||19
3170297|NCT01929018|3897678|FG001|STARTED|Overall Study||19
3170298|NCT01929018|3897677|FG000|COMPLETED|Overall Study||18
3170299|NCT01929018|3897678|FG001|COMPLETED|Overall Study||18
3170300|NCT01929018|3897677|FG000|NOT COMPLETED|Overall Study||1
2886618|NCT00332722|3592708|FG001|STARTED|Overall Study||60
2886619|NCT00332722|3592707|FG000|COMPLETED|Overall Study||60
2886620|NCT00332722|3592708|FG001|COMPLETED|Overall Study||60
2886621|NCT00332722|3592707|FG000|NOT COMPLETED|Overall Study||0
2886622|NCT00332722|3592708|FG001|NOT COMPLETED|Overall Study||0
2886623|NCT00332839|3592716|FG000|STARTED|Core (Months 0 - 12)||47
2886624|NCT00332839|3592717|FG001|STARTED|Core (Months 0 - 12)||46
2886625|NCT00332839|3592716|FG000|Safety Set|Core (Months 0 - 12)||47
2886626|NCT00332839|3592717|FG001|Safety Set|Core (Months 0 - 12)||46
2886627|NCT00332839|3592716|FG000|COMPLETED|Core (Months 0 - 12)||37
2886628|NCT00332839|3592717|FG001|COMPLETED|Core (Months 0 - 12)||28
2886629|NCT00332839|3592716|FG000|NOT COMPLETED|Core (Months 0 - 12)||10
2886630|NCT00332839|3592717|FG001|NOT COMPLETED|Core (Months 0 - 12)||18
2886631|NCT00332839|3592716|FG000|STARTED|Follow-up (Months 12 - 60)|Follow-up included core participants (completed or discontinued) who wished to be followed.|33
2886632|NCT00332839|3592717|FG001|STARTED|Follow-up (Months 12 - 60)|Follow-up included core participants (completed or discontinued) who wished to be followed.|34
2886633|NCT00332839|3592716|FG000|COMPLETED|Follow-up (Months 12 - 60)||29
2886634|NCT00332839|3592717|FG001|COMPLETED|Follow-up (Months 12 - 60)||31
2886635|NCT00332839|3592716|FG000|NOT COMPLETED|Follow-up (Months 12 - 60)||4
2886636|NCT00332839|3592717|FG001|NOT COMPLETED|Follow-up (Months 12 - 60)||3
3170301|NCT01929018|3897678|FG001|NOT COMPLETED|Overall Study||1
2886637|NCT00333138|3592726|FG000|STARTED|Core Study (6 Months)||93
2886638|NCT00333138|3592727|FG001|STARTED|Core Study (6 Months)||94
2886639|NCT00333138|3592728|FG002|STARTED|Core Study (6 Months)||94
2886640|NCT00333138|3592726|FG000|COMPLETED|Core Study (6 Months)||86
2886641|NCT00333138|3592727|FG001|COMPLETED|Core Study (6 Months)||88
2886642|NCT00333138|3592728|FG002|COMPLETED|Core Study (6 Months)||82
2886643|NCT00333138|3592726|FG000|NOT COMPLETED|Core Study (6 Months)||7
2886644|NCT00333138|3592727|FG001|NOT COMPLETED|Core Study (6 Months)||6
2886645|NCT00333138|3592728|FG002|NOT COMPLETED|Core Study (6 Months)||12
2886646|NCT00333138|3592726|FG000|STARTED|Extension Study (Month6 to End of Study)||83
2886647|NCT00333138|3592727|FG001|STARTED|Extension Study (Month6 to End of Study)||87
2886648|NCT00333138|3592728|FG002|STARTED|Extension Study (Month6 to End of Study)||80
2886649|NCT00333138|3592726|FG000|COMPLETED|Extension Study (Month6 to End of Study)||40
2886650|NCT00333138|3592727|FG001|COMPLETED|Extension Study (Month6 to End of Study)||45
2886651|NCT00333138|3592728|FG002|COMPLETED|Extension Study (Month6 to End of Study)||37
2886652|NCT00333138|3592726|FG000|NOT COMPLETED|Extension Study (Month6 to End of Study)||43
2886653|NCT00333138|3592727|FG001|NOT COMPLETED|Extension Study (Month6 to End of Study)||42
2886654|NCT00333138|3592728|FG002|NOT COMPLETED|Extension Study (Month6 to End of Study)||43
2886655|NCT00333177|3592742|FG000|STARTED|Overall Study||12
2886656|NCT00333177|3592743|FG001|STARTED|Overall Study||17
2886657|NCT00333177|3592744|FG002|STARTED|Overall Study||17
2886658|NCT00333177|3592745|FG003|STARTED|Overall Study||14
2886659|NCT00333177|3592742|FG000|Received Intervention|Overall Study||12
2886660|NCT00333177|3592743|FG001|Received Intervention|Overall Study||16
2886661|NCT00333177|3592744|FG002|Received Intervention|Overall Study||16
2886662|NCT00333177|3592745|FG003|Received Intervention|Overall Study||12
2886663|NCT00333177|3592742|FG000|COMPLETED|Overall Study||12
2886664|NCT00333177|3592743|FG001|COMPLETED|Overall Study||16
2886665|NCT00333177|3592744|FG002|COMPLETED|Overall Study||16
2886666|NCT00333177|3592745|FG003|COMPLETED|Overall Study||12
2886667|NCT00333177|3592742|FG000|NOT COMPLETED|Overall Study||0
2886668|NCT00333177|3592743|FG001|NOT COMPLETED|Overall Study||1
2886669|NCT00333177|3592744|FG002|NOT COMPLETED|Overall Study||1
2886670|NCT00333177|3592745|FG003|NOT COMPLETED|Overall Study||2
2886671|NCT00333359|3592759|FG000|STARTED|Overall Study||199
2886672|NCT00333359|3592760|FG001|STARTED|Overall Study||382
2886673|NCT00333359|3592759|FG000|COMPLETED|Overall Study||126
2886674|NCT00333359|3592760|FG001|COMPLETED|Overall Study||260
2886675|NCT00333359|3592759|FG000|NOT COMPLETED|Overall Study||73
2886676|NCT00333359|3592760|FG001|NOT COMPLETED|Overall Study||122
2886677|NCT00333437|3592768|FG000|STARTED|Overall Study||7
2886678|NCT00333437|3592768|FG000|COMPLETED|Overall Study||7
2886679|NCT00333437|3592768|FG000|NOT COMPLETED|Overall Study||0
2886680|NCT00333606|3592775|FG000|STARTED|Overall Study||30
2886681|NCT00333606|3592776|FG001|STARTED|Overall Study||30
2886682|NCT00333606|3592775|FG000|COMPLETED|Overall Study||30
2886683|NCT00333606|3592776|FG001|COMPLETED|Overall Study||30
2886684|NCT00333606|3592775|FG000|NOT COMPLETED|Overall Study||0
2886685|NCT00333606|3592776|FG001|NOT COMPLETED|Overall Study||0
2886686|NCT00333619|3592786|FG000|STARTED|Overall Study||110
2886687|NCT00333619|3592787|FG001|STARTED|Overall Study||109
2886688|NCT00333619|3592786|FG000|Post-treatment|Overall Study||109
2886689|NCT00333619|3592787|FG001|Post-treatment|Overall Study||109
2886690|NCT00333619|3592786|FG000|3-month Follow-up|Overall Study||101
2886691|NCT00333619|3592787|FG001|3-month Follow-up|Overall Study||105
2886692|NCT00333619|3592786|FG000|COMPLETED|Overall Study||89
2886693|NCT00333619|3592787|FG001|COMPLETED|Overall Study||99
2886694|NCT00333619|3592786|FG000|NOT COMPLETED|Overall Study||21
2886695|NCT00333619|3592787|FG001|NOT COMPLETED|Overall Study||10
2886696|NCT00333710|3592798|FG000|STARTED|Overall Study||19
2886697|NCT00333710|3592799|FG001|STARTED|Overall Study||18
2886698|NCT00333710|3592800|FG002|STARTED|Overall Study||16
2886699|NCT00333710|3592798|FG000|COMPLETED|Overall Study||8
2886700|NCT00333710|3592799|FG001|COMPLETED|Overall Study||14
2886701|NCT00333710|3592800|FG002|COMPLETED|Overall Study||15
2886702|NCT00333710|3592798|FG000|NOT COMPLETED|Overall Study||11
2886703|NCT00333710|3592799|FG001|NOT COMPLETED|Overall Study||4
2886704|NCT00333710|3592800|FG002|NOT COMPLETED|Overall Study||1
2886705|NCT00333775|3592811|FG000|STARTED|Overall Study||241
2886706|NCT00333775|3592812|FG001|STARTED|Overall Study||248
2886707|NCT00333775|3592813|FG002|STARTED|Overall Study||247
2886708|NCT00333775|3592811|FG000|Received Treatment|Overall Study||238
2886709|NCT00333775|3592812|FG001|Received Treatment|Overall Study||247
2886710|NCT00333775|3592813|FG002|Received Treatment|Overall Study||245
2886711|NCT00333775|3592811|FG000|COMPLETED|Overall Study||0
2886712|NCT00333775|3592812|FG001|COMPLETED|Overall Study||0
2886713|NCT00333775|3592813|FG002|COMPLETED|Overall Study||0
2886714|NCT00333775|3592811|FG000|NOT COMPLETED|Overall Study||241
2886715|NCT00333775|3592812|FG001|NOT COMPLETED|Overall Study||248
2886716|NCT00333775|3592813|FG002|NOT COMPLETED|Overall Study||247
2886717|NCT00333788|3592821|FG000|STARTED|Overall Study|Participant flow based on All Subjects population; Baseline characteristics based on ITT population.|233
2886718|NCT00333788|3592821|FG000|COMPLETED|Overall Study||71
2886719|NCT00333788|3592821|FG000|NOT COMPLETED|Overall Study||162
2886720|NCT00333801|3592827|FG000|STARTED|Overall Study||43
2886721|NCT00333801|3592828|FG001|STARTED|Overall Study||42
2886722|NCT00333801|3592827|FG000|COMPLETED|Overall Study||35
2886723|NCT00333801|3592828|FG001|COMPLETED|Overall Study||36
2886724|NCT00333801|3592827|FG000|NOT COMPLETED|Overall Study||8
2886725|NCT00333801|3592828|FG001|NOT COMPLETED|Overall Study||6
2886726|NCT00333814|3592837|FG000|STARTED|Overall Study||76
2886727|NCT00333814|3592838|FG001|STARTED|Overall Study||77
2886728|NCT00333814|3592839|FG002|STARTED|Overall Study||76
2886729|NCT00333814|3592837|FG000|COMPLETED|Overall Study||73
2886730|NCT00333814|3592838|FG001|COMPLETED|Overall Study||73
2886731|NCT00333814|3592839|FG002|COMPLETED|Overall Study||71
2886732|NCT00333814|3592837|FG000|NOT COMPLETED|Overall Study||3
2886733|NCT00333814|3592838|FG001|NOT COMPLETED|Overall Study||4
2886734|NCT00333814|3592839|FG002|NOT COMPLETED|Overall Study||5
2886735|NCT00333840|3592849|FG000|STARTED|First-line Treatment Period||553
2886736|NCT00333840|3592850|FG001|STARTED|First-line Treatment Period||553
2886737|NCT00333840|3592851|FG002|STARTED|First-line Treatment Period||0
2886738|NCT00333840|3592852|FG003|STARTED|First-line Treatment Period||0
2886739|NCT00333840|3592849|FG000|Safety Population; Received Study Drug|First-line Treatment Period||551
2886740|NCT00333840|3592850|FG001|Safety Population; Received Study Drug|First-line Treatment Period||533
2886741|NCT00333840|3592851|FG002|Safety Population; Received Study Drug|First-line Treatment Period||0
2886742|NCT00333840|3592852|FG003|Safety Population; Received Study Drug|First-line Treatment Period||0
2886743|NCT00333840|3592849|FG000|COMPLETED|First-line Treatment Period||267
2886744|NCT00333840|3592850|FG001|COMPLETED|First-line Treatment Period||7
2886745|NCT00333840|3592851|FG002|COMPLETED|First-line Treatment Period||0
2886746|NCT00333840|3592852|FG003|COMPLETED|First-line Treatment Period||0
2886747|NCT00333840|3592849|FG000|NOT COMPLETED|First-line Treatment Period||286
2886748|NCT00333840|3592850|FG001|NOT COMPLETED|First-line Treatment Period||546
2886749|NCT00333840|3592851|FG002|NOT COMPLETED|First-line Treatment Period||0
2886750|NCT00333840|3592852|FG003|NOT COMPLETED|First-line Treatment Period||0
2886751|NCT00333840|3592849|FG000|STARTED|Second-line Treatment Period||0
2886752|NCT00333840|3592850|FG001|STARTED|Second-line Treatment Period||0
2886753|NCT00333840|3592851|FG002|STARTED|Second-line Treatment Period||14
2886754|NCT00333840|3592852|FG003|STARTED|Second-line Treatment Period||363
2886755|NCT00333840|3592849|FG000|COMPLETED|Second-line Treatment Period||0
2886756|NCT00333840|3592850|FG001|COMPLETED|Second-line Treatment Period||0
2886757|NCT00333840|3592851|FG002|COMPLETED|Second-line Treatment Period||0
2886758|NCT00333840|3592852|FG003|COMPLETED|Second-line Treatment Period||175
2886759|NCT00333840|3592849|FG000|NOT COMPLETED|Second-line Treatment Period||0
2886760|NCT00333840|3592850|FG001|NOT COMPLETED|Second-line Treatment Period||0
2886761|NCT00333840|3592851|FG002|NOT COMPLETED|Second-line Treatment Period||14
2886762|NCT00333840|3592852|FG003|NOT COMPLETED|Second-line Treatment Period||188
2886763|NCT00333866|3592870|FG000|STARTED|Overall Study||189
2886764|NCT00333866|3592871|FG001|STARTED|Overall Study||187
2886765|NCT00333866|3592872|FG002|STARTED|Overall Study||184
2886766|NCT00333866|3592873|FG003|STARTED|Overall Study||187
2886767|NCT00333866|3592870|FG000|TREATED|Overall Study||184
2886768|NCT00333866|3592871|FG001|TREATED|Overall Study||184
2886769|NCT00333866|3592872|FG002|TREATED|Overall Study||182
2886770|NCT00333866|3592873|FG003|TREATED|Overall Study||186
2886771|NCT00333866|3592870|FG000|COMPLETED|Overall Study||141
2886772|NCT00333866|3592871|FG001|COMPLETED|Overall Study||123
2886773|NCT00333866|3592872|FG002|COMPLETED|Overall Study||133
2886774|NCT00333866|3592873|FG003|COMPLETED|Overall Study||121
2886775|NCT00333866|3592870|FG000|NOT COMPLETED|Overall Study||48
2886776|NCT00333866|3592871|FG001|NOT COMPLETED|Overall Study||64
2886777|NCT00333866|3592872|FG002|NOT COMPLETED|Overall Study||51
2886778|NCT00333866|3592873|FG003|NOT COMPLETED|Overall Study||66
2886779|NCT00333879|3592883|FG000|STARTED|Overall Study||4
2886780|NCT00333879|3592883|FG000|COMPLETED|Overall Study||4
2886781|NCT00333879|3592883|FG000|NOT COMPLETED|Overall Study||0
2886782|NCT00333970|3592889|FG000|STARTED|Overall Study||50
2886783|NCT00333970|3592890|FG001|STARTED|Overall Study||25
2886784|NCT00333970|3592889|FG000|COMPLETED|Overall Study||37
2886785|NCT00333970|3592890|FG001|COMPLETED|Overall Study||18
2886786|NCT00333970|3592889|FG000|NOT COMPLETED|Overall Study||13
2886787|NCT00333970|3592890|FG001|NOT COMPLETED|Overall Study||7
2886788|NCT00333983|3592899|FG000|STARTED|Overall Study||20
2886789|NCT00333983|3592900|FG001|STARTED|Overall Study||21
2886790|NCT00333983|3592901|FG002|STARTED|Overall Study||21
2886791|NCT00333983|3592899|FG000|COMPLETED|Overall Study||17
2886792|NCT00333983|3592900|FG001|COMPLETED|Overall Study||16
2886793|NCT00333983|3592901|FG002|COMPLETED|Overall Study||19
2886794|NCT00333983|3592899|FG000|NOT COMPLETED|Overall Study||3
2886795|NCT00333983|3592900|FG001|NOT COMPLETED|Overall Study||5
2886796|NCT00333983|3592901|FG002|NOT COMPLETED|Overall Study||2
2886797|NCT00334061|3592909|FG000|STARTED|Overall Study|June 2006|125
2886798|NCT00334061|3592909|FG000|COMPLETED|Overall Study|November 2007|125
2886799|NCT00334061|3592909|FG000|NOT COMPLETED|Overall Study||0
2886800|NCT00334074|3592913|FG000|STARTED|Overall Study||30
2886801|NCT00334074|3592913|FG000|COMPLETED|Overall Study||30
2886802|NCT00334074|3592913|FG000|NOT COMPLETED|Overall Study||0
2886803|NCT00334113|3592920|FG000|STARTED|Overall Study||32
2886804|NCT00334113|3592921|FG001|STARTED|Overall Study||34
2886805|NCT00334113|3592920|FG000|COMPLETED|Overall Study||30
2886806|NCT00334113|3592921|FG001|COMPLETED|Overall Study||31
2886807|NCT00334113|3592920|FG000|NOT COMPLETED|Overall Study||2
2886808|NCT00334113|3592921|FG001|NOT COMPLETED|Overall Study||3
2886809|NCT00334204|3592927|FG000|STARTED|Overall Study||58
2886810|NCT00334204|3592927|FG000|COMPLETED|Overall Study||56
2886811|NCT00334204|3592927|FG000|NOT COMPLETED|Overall Study||2
2886812|NCT00334282|3592934|FG000|STARTED|Overall Study||290
2886813|NCT00334282|3592935|FG001|STARTED|Overall Study||145
2886814|NCT00334282|3592934|FG000|COMPLETED|Overall Study||68
2886815|NCT00334282|3592935|FG001|COMPLETED|Overall Study||37
2886816|NCT00334282|3592934|FG000|NOT COMPLETED|Overall Study||222
2886817|NCT00334282|3592935|FG001|NOT COMPLETED|Overall Study||108
2886818|NCT00334295|3592945|FG000|STARTED|Overall Study||35
2886819|NCT00334295|3592945|FG000|COMPLETED|Overall Study||30
2886820|NCT00334295|3592945|FG000|NOT COMPLETED|Overall Study||5
2886821|NCT00334542|3592949|FG000|STARTED|Overall Study||50
2886822|NCT00334542|3592949|FG000|COMPLETED|Overall Study||45
2886823|NCT00334542|3592949|FG000|NOT COMPLETED|Overall Study||5
2886824|NCT00334633|3592957|FG000|STARTED|Overall Study||197
2886825|NCT00334633|3592958|FG001|STARTED|Overall Study||200
2886826|NCT00334633|3592959|FG002|STARTED|Overall Study||196
2886827|NCT00334633|3592957|FG000|COMPLETED|Overall Study||117
2886828|NCT00334633|3592958|FG001|COMPLETED|Overall Study||118
2886829|NCT00334633|3592959|FG002|COMPLETED|Overall Study||114
2886830|NCT00334633|3592957|FG000|NOT COMPLETED|Overall Study||80
2886831|NCT00334633|3592958|FG001|NOT COMPLETED|Overall Study||82
2886832|NCT00334633|3592959|FG002|NOT COMPLETED|Overall Study||82
2886833|NCT00334737|3592973|FG000|STARTED|Hospital Phase||34
2886834|NCT00334737|3592974|FG001|STARTED|Hospital Phase||34
2886835|NCT00334737|3592975|FG002|STARTED|Hospital Phase||34
2886836|NCT00334737|3592973|FG000|COMPLETED|Hospital Phase||32
2886837|NCT00334737|3592974|FG001|COMPLETED|Hospital Phase||32
2886838|NCT00334737|3592975|FG002|COMPLETED|Hospital Phase||30
2886839|NCT00334737|3592973|FG000|NOT COMPLETED|Hospital Phase||2
2886840|NCT00334737|3592974|FG001|NOT COMPLETED|Hospital Phase||2
2886841|NCT00334737|3592975|FG002|NOT COMPLETED|Hospital Phase||4
2886842|NCT00334737|3592973|FG000|STARTED|Follow up Phase||32
2886843|NCT00334737|3592974|FG001|STARTED|Follow up Phase||32
2886844|NCT00334737|3592975|FG002|STARTED|Follow up Phase||30
2886845|NCT00334737|3592973|FG000|COMPLETED|Follow up Phase||27
2886846|NCT00334737|3592974|FG001|COMPLETED|Follow up Phase||29
2886847|NCT00334737|3592975|FG002|COMPLETED|Follow up Phase||24
2886848|NCT00334737|3592973|FG000|NOT COMPLETED|Follow up Phase||5
2886849|NCT00334737|3592974|FG001|NOT COMPLETED|Follow up Phase||3
2886850|NCT00334737|3592975|FG002|NOT COMPLETED|Follow up Phase||6
2886851|NCT00334802|3592985|FG000|STARTED|Overall Study||6
2886852|NCT00334802|3592986|FG001|STARTED|Overall Study||56
2886853|NCT00334802|3592985|FG000|COMPLETED|Overall Study||0
2886854|NCT00334802|3592986|FG001|COMPLETED|Overall Study||16
2886855|NCT00334802|3592985|FG000|NOT COMPLETED|Overall Study||6
2886856|NCT00334802|3592986|FG001|NOT COMPLETED|Overall Study||40
2886857|NCT00334815|3592997|FG000|STARTED|Overall Study||16
2886858|NCT00334815|3592998|FG001|STARTED|Overall Study||13
2886859|NCT00334815|3592997|FG000|COMPLETED|Overall Study||9
2886860|NCT00334815|3592998|FG001|COMPLETED|Overall Study||3
2886861|NCT00334815|3592997|FG000|NOT COMPLETED|Overall Study||7
2886862|NCT00334815|3592998|FG001|NOT COMPLETED|Overall Study||10
2886863|NCT00334893|3593008|FG000|STARTED|Overall Study||37
2886864|NCT00334893|3593009|FG001|STARTED|Overall Study||37
2886865|NCT00334893|3593008|FG000|COMPLETED|Overall Study||36
2886866|NCT00334893|3593009|FG001|COMPLETED|Overall Study||37
2886867|NCT00334893|3593008|FG000|NOT COMPLETED|Overall Study||1
2886868|NCT00334893|3593009|FG001|NOT COMPLETED|Overall Study||0
2886869|NCT00334958|3593019|FG000|STARTED|Overall Study||176
2886870|NCT00334958|3593020|FG001|STARTED|Overall Study|1 participant withdrawn prior to study drug dosing due to not obtaining labs|180
2886871|NCT00334958|3593019|FG000|COMPLETED|Overall Study||139
2886872|NCT00334958|3593020|FG001|COMPLETED|Overall Study||156
2886873|NCT00334958|3593019|FG000|NOT COMPLETED|Overall Study||37
2886874|NCT00334958|3593020|FG001|NOT COMPLETED|Overall Study||24
2886875|NCT00335140|3593026|FG000|STARTED|Overall Study||26
2886876|NCT00335140|3593026|FG000|Eligible|Overall Study||25
2886877|NCT00335140|3593026|FG000|Treated|Overall Study||25
2886878|NCT00335140|3593026|FG000|COMPLETED|Overall Study||25
2886879|NCT00335140|3593026|FG000|NOT COMPLETED|Overall Study||1
2886880|NCT00335153|3593030|FG000|STARTED|Nasojejunal (NJ) Test Period||354
2886881|NCT00335153|3593030|FG000|COMPLETED|Nasojejunal (NJ) Test Period||324
2886882|NCT00335153|3593030|FG000|NOT COMPLETED|Nasojejunal (NJ) Test Period||30
2886883|NCT00335153|3593030|FG000|STARTED|Post-PEG-J Long-Term Treatment Period||324
2886884|NCT00335153|3593030|FG000|COMPLETED|Post-PEG-J Long-Term Treatment Period||272
2886885|NCT00335153|3593030|FG000|NOT COMPLETED|Post-PEG-J Long-Term Treatment Period||52
2886886|NCT00335257|3593037|FG000|STARTED|Overall Study||15542
2886887|NCT00335257|3593038|FG001|STARTED|Overall Study||9377
2886888|NCT00335257|3593039|FG002|STARTED|Overall Study||60190
2886889|NCT00335257|3593037|FG000|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 0.5 and 6.0 years.|15542
2886890|NCT00335257|3593038|FG001|COMPLETED|Overall Study||9377
2886891|NCT00335257|3593039|FG002|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 0.5 and 6.0 years.|60190
2886892|NCT00335257|3593037|FG000|NOT COMPLETED|Overall Study||0
2886893|NCT00335257|3593038|FG001|NOT COMPLETED|Overall Study||0
2886894|NCT00335257|3593039|FG002|NOT COMPLETED|Overall Study||0
2886895|NCT00335283|3593055|FG000|STARTED|Overall Study||36
2886896|NCT00335283|3593056|FG001|STARTED|Overall Study||39
2886897|NCT00335283|3593055|FG000|COMPLETED|Overall Study||30
2886898|NCT00335283|3593056|FG001|COMPLETED|Overall Study||34
2886899|NCT00335283|3593055|FG000|NOT COMPLETED|Overall Study||6
2886900|NCT00335283|3593056|FG001|NOT COMPLETED|Overall Study||5
2886901|NCT00335322|3593065|FG000|STARTED|Overall Study||115
2886902|NCT00335322|3593066|FG001|STARTED|Overall Study||107
2886903|NCT00335322|3593067|FG002|STARTED|Overall Study||105
2886904|NCT00335322|3593065|FG000|COMPLETED|Overall Study||114
2886905|NCT00335322|3593066|FG001|COMPLETED|Overall Study||105
2886906|NCT00335322|3593067|FG002|COMPLETED|Overall Study||103
2886907|NCT00335322|3593065|FG000|NOT COMPLETED|Overall Study||1
2886908|NCT00335322|3593066|FG001|NOT COMPLETED|Overall Study||2
2886909|NCT00335322|3593067|FG002|NOT COMPLETED|Overall Study||2
2886910|NCT00335452|3593082|FG000|STARTED|Overall Study|Randomized|6312
2886911|NCT00335452|3593083|FG001|STARTED|Overall Study|Randomized|6254
2886912|NCT00335452|3593084|FG002|STARTED|Overall Study|Randomized|6267
2886913|NCT00335452|3593085|FG003|STARTED|Overall Study|Randomized|6253
2886914|NCT00335452|3593082|FG000|TREATED WITH CLOPIDOGREL|Overall Study||6271
2886915|NCT00335452|3593083|FG001|TREATED WITH CLOPIDOGREL|Overall Study||6218
2886916|NCT00335452|3593084|FG002|TREATED WITH CLOPIDOGREL|Overall Study||6228
2886917|NCT00335452|3593085|FG003|TREATED WITH CLOPIDOGREL|Overall Study||6217
2886918|NCT00335452|3593082|FG000|TREATED WITH ASA|Overall Study||6302
2886919|NCT00335452|3593083|FG001|TREATED WITH ASA|Overall Study||6251
2886920|NCT00335452|3593084|FG002|TREATED WITH ASA|Overall Study||6261
2886921|NCT00335452|3593085|FG003|TREATED WITH ASA|Overall Study||6247
2886922|NCT00335452|3593082|FG000|COMPLETED|Overall Study|Completed 30 days follow-up period|6154
2886923|NCT00335452|3593083|FG001|COMPLETED|Overall Study|Completed 30 days follow-up period|6107
2886924|NCT00335452|3593084|FG002|COMPLETED|Overall Study|Completed 30 days follow-up period|6108
2886925|NCT00335452|3593085|FG003|COMPLETED|Overall Study|Completed 30 days follow-up period|6122
2886926|NCT00335452|3593082|FG000|NOT COMPLETED|Overall Study||158
2886927|NCT00335452|3593083|FG001|NOT COMPLETED|Overall Study||147
2886928|NCT00335452|3593084|FG002|NOT COMPLETED|Overall Study||159
2886929|NCT00335452|3593085|FG003|NOT COMPLETED|Overall Study||131
2886930|NCT00335478|3593100|FG000|STARTED|Overall Study||54
2886931|NCT00335478|3593100|FG000|COMPLETED|Overall Study||30
2886932|NCT00335478|3593100|FG000|NOT COMPLETED|Overall Study||24
2886933|NCT00335504|3593108|FG000|STARTED|Overall Study||22
2886934|NCT00335504|3593109|FG001|STARTED|Overall Study||21
2886935|NCT00335504|3593110|FG002|STARTED|Overall Study||20
2886936|NCT00335504|3593111|FG003|STARTED|Overall Study||22
2886937|NCT00335504|3593108|FG000|COMPLETED|Overall Study||22
2886938|NCT00335504|3593109|FG001|COMPLETED|Overall Study||21
2886939|NCT00335504|3593110|FG002|COMPLETED|Overall Study||20
2886940|NCT00335504|3593111|FG003|COMPLETED|Overall Study||22
2886941|NCT00335504|3593108|FG000|NOT COMPLETED|Overall Study||0
2886942|NCT00335504|3593109|FG001|NOT COMPLETED|Overall Study||0
2886943|NCT00335504|3593110|FG002|NOT COMPLETED|Overall Study||0
2886944|NCT00335504|3593111|FG003|NOT COMPLETED|Overall Study||0
2886945|NCT00335517|3593121|FG000|STARTED|Overall Study||100
2886946|NCT00335517|3593121|FG000|COMPLETED|Overall Study|Due to pharmacy error two patients were enolled and recieved EREM, but were not included in analysis|98
2886947|NCT00335517|3593121|FG000|NOT COMPLETED|Overall Study||2
2886948|NCT00335556|3593131|FG000|STARTED|Overall Study||68
2886949|NCT00335556|3593132|FG001|STARTED|Overall Study||98
2886950|NCT00335556|3593133|FG002|STARTED|Overall Study||7
2886951|NCT00335556|3593134|FG003|STARTED|Overall Study||10
2886952|NCT00335556|3593135|FG004|STARTED|Overall Study||78
2886953|NCT00335556|3593136|FG005|STARTED|Overall Study||30
3170302|NCT01929031|3897688|FG000|STARTED|Overall Study||213
3170303|NCT01929031|3897689|FG001|STARTED|Overall Study||209
3170304|NCT01929031|3897690|FG002|STARTED|Overall Study||35
3170305|NCT01929031|3897691|FG003|STARTED|Overall Study||35
3170306|NCT01929031|3897692|FG004|STARTED|Overall Study||34
3170307|NCT01929031|3897693|FG005|STARTED|Overall Study||36
2886954|NCT00335556|3593131|FG000|COMPLETED|Overall Study||66
2886955|NCT00335556|3593132|FG001|COMPLETED|Overall Study||64
2886956|NCT00335556|3593133|FG002|COMPLETED|Overall Study||2
2886957|NCT00335556|3593134|FG003|COMPLETED|Overall Study||5
2886958|NCT00335556|3593135|FG004|COMPLETED|Overall Study||77
2886959|NCT00335556|3593136|FG005|COMPLETED|Overall Study||29
2886960|NCT00335556|3593131|FG000|NOT COMPLETED|Overall Study||2
2886961|NCT00335556|3593132|FG001|NOT COMPLETED|Overall Study||34
2886962|NCT00335556|3593133|FG002|NOT COMPLETED|Overall Study||5
2886963|NCT00335556|3593134|FG003|NOT COMPLETED|Overall Study||5
2886964|NCT00335556|3593135|FG004|NOT COMPLETED|Overall Study||1
2886965|NCT00335556|3593136|FG005|NOT COMPLETED|Overall Study||1
2886966|NCT00335725|3593157|FG000|STARTED|Overall Study||75
2886967|NCT00335725|3593158|FG001|STARTED|Overall Study||76
2886968|NCT00335725|3593157|FG000|COMPLETED|Overall Study||71
2886969|NCT00335725|3593158|FG001|COMPLETED|Overall Study||71
2886970|NCT00335725|3593157|FG000|NOT COMPLETED|Overall Study||4
2886971|NCT00335725|3593158|FG001|NOT COMPLETED|Overall Study||5
2886972|NCT00335738|3593167|FG000|STARTED|Overall Study||108
2886973|NCT00335738|3593168|FG001|STARTED|Overall Study||223
3170308|NCT01929031|3897688|FG000|COMPLETED|Overall Study||209
2886974|NCT00335738|3593167|FG000|COMPLETED|Overall Study||97
2886975|NCT00335738|3593168|FG001|COMPLETED|Overall Study||219
2886976|NCT00335738|3593167|FG000|NOT COMPLETED|Overall Study||11
2886977|NCT00335738|3593168|FG001|NOT COMPLETED|Overall Study||4
2886978|NCT00335764|3593180|FG000|STARTED|Overall Study||17
2886979|NCT00335764|3593181|FG001|STARTED|Overall Study||13
2886980|NCT00335764|3593182|FG002|STARTED|Overall Study||24
2886981|NCT00335764|3593183|FG003|STARTED|Overall Study||19
2886982|NCT00335764|3593184|FG004|STARTED|Overall Study||19
3170309|NCT01929031|3897689|FG001|COMPLETED|Overall Study||207
2886983|NCT00335764|3593180|FG000|COMPLETED|Overall Study||16
2886984|NCT00335764|3593181|FG001|COMPLETED|Overall Study||13
2886985|NCT00335764|3593182|FG002|COMPLETED|Overall Study||24
2886986|NCT00335764|3593183|FG003|COMPLETED|Overall Study||19
2886987|NCT00335764|3593184|FG004|COMPLETED|Overall Study||18
2886988|NCT00335764|3593180|FG000|NOT COMPLETED|Overall Study||1
2886989|NCT00335764|3593181|FG001|NOT COMPLETED|Overall Study||0
2886990|NCT00335764|3593182|FG002|NOT COMPLETED|Overall Study||0
2886991|NCT00335764|3593183|FG003|NOT COMPLETED|Overall Study||0
2886992|NCT00335764|3593184|FG004|NOT COMPLETED|Overall Study||1
2886993|NCT00335829|3593220|FG000|STARTED|Overall Study||26
2886994|NCT00335829|3593220|FG000|Received Bevacizumab|Overall Study||26
2886995|NCT00335829|3593220|FG000|Received First TACE|Overall Study|1 patient left after receiving bevacizumab but prior to first TACE|25
2886996|NCT00335829|3593220|FG000|COMPLETED|Overall Study||23
2886997|NCT00335829|3593220|FG000|NOT COMPLETED|Overall Study||3
2886998|NCT00335959|3593224|FG000|STARTED|Overall Study||7
2886999|NCT00335959|3593224|FG000|Eligible|Overall Study||6
2887000|NCT00335959|3593224|FG000|Eligible and Began Protocol Therapy|Overall Study||6
2887001|NCT00335959|3593224|FG000|COMPLETED|Overall Study||4
2887002|NCT00335959|3593224|FG000|NOT COMPLETED|Overall Study||3
2887003|NCT00335972|3593231|FG000|STARTED|Overall Study||71
2887004|NCT00335972|3593232|FG001|STARTED|Overall Study||71
2887005|NCT00335972|3593231|FG000|COMPLETED|Overall Study||71
2887006|NCT00335972|3593232|FG001|COMPLETED|Overall Study||68
2887007|NCT00335972|3593231|FG000|NOT COMPLETED|Overall Study||0
2887008|NCT00335972|3593232|FG001|NOT COMPLETED|Overall Study||3
2887009|NCT00336024|3593240|FG000|STARTED|Overall Study||46
2887010|NCT00336024|3593241|FG001|STARTED|Overall Study||45
2887011|NCT00336024|3593240|FG000|COMPLETED|Overall Study||26
2887012|NCT00336024|3593241|FG001|COMPLETED|Overall Study||26
2887013|NCT00336024|3593240|FG000|NOT COMPLETED|Overall Study||20
2887014|NCT00336024|3593241|FG001|NOT COMPLETED|Overall Study||19
2887015|NCT00336232|3593247|FG000|STARTED|Baseline (200mcg Daily)||59
2887016|NCT00336232|3593247|FG000|COMPLETED|Baseline (200mcg Daily)||42
2887017|NCT00336232|3593247|FG000|NOT COMPLETED|Baseline (200mcg Daily)||17
2887018|NCT00336232|3593247|FG000|STARTED|Low Vitamin K (10mcg Daily)||42
2887019|NCT00336232|3593247|FG000|COMPLETED|Low Vitamin K (10mcg Daily)||42
2887020|NCT00336232|3593247|FG000|NOT COMPLETED|Low Vitamin K (10mcg Daily)||0
2887021|NCT00336232|3593247|FG000|STARTED|High Vitamin K (500mcg Daily)||42
2887022|NCT00336232|3593247|FG000|COMPLETED|High Vitamin K (500mcg Daily)||42
2887023|NCT00336232|3593247|FG000|NOT COMPLETED|High Vitamin K (500mcg Daily)||0
2887024|NCT00336284|3593253|FG000|STARTED|Overall Study||977
2887025|NCT00336284|3593254|FG001|STARTED|Overall Study||473
2887026|NCT00336284|3593253|FG000|COMPLETED|Overall Study||741
2887027|NCT00336284|3593254|FG001|COMPLETED|Overall Study||322
2887028|NCT00336284|3593253|FG000|NOT COMPLETED|Overall Study||236
2887029|NCT00336284|3593254|FG001|NOT COMPLETED|Overall Study||151
2887030|NCT00336323|3593265|FG000|STARTED|Overall Study||19
2887031|NCT00336323|3593266|FG001|STARTED|Overall Study||22
2887032|NCT00336323|3593267|FG002|STARTED|Overall Study||24
2887033|NCT00336323|3593268|FG003|STARTED|Overall Study||22
2887034|NCT00336323|3593269|FG004|STARTED|Overall Study||22
2887035|NCT00336323|3593265|FG000|3 Week Visit|Overall Study||18
2887036|NCT00336323|3593266|FG001|3 Week Visit|Overall Study||21
2887037|NCT00336323|3593267|FG002|3 Week Visit|Overall Study||24
2887038|NCT00336323|3593268|FG003|3 Week Visit|Overall Study||22
2887039|NCT00336323|3593269|FG004|3 Week Visit|Overall Study|Laser given late at six weeks for one patient|20
2887040|NCT00336323|3593265|FG000|6 Week Visit|Overall Study||18
2887041|NCT00336323|3593266|FG001|6 Week Visit|Overall Study||22
2887042|NCT00336323|3593267|FG002|6 Week Visit|Overall Study||24
2887043|NCT00336323|3593268|FG003|6 Week Visit|Overall Study||22
2887044|NCT00336323|3593269|FG004|6 Week Visit|Overall Study|1 patient was dropped - injection was given late at 9 wks for one patient|20
2887045|NCT00336323|3593265|FG000|9 Week Visit|Overall Study||18
2887046|NCT00336323|3593266|FG001|9 Week Visit|Overall Study||21
2887047|NCT00336323|3593267|FG002|9 Week Visit|Overall Study||23
2887048|NCT00336323|3593268|FG003|9 Week Visit|Overall Study||21
2887049|NCT00336323|3593269|FG004|9 Week Visit|Overall Study||19
2887050|NCT00336323|3593265|FG000|12 Week Visit|Overall Study||19
2887051|NCT00336323|3593266|FG001|12 Week Visit|Overall Study||21
2887052|NCT00336323|3593267|FG002|12 Week Visit|Overall Study||24
2887053|NCT00336323|3593268|FG003|12 Week Visit|Overall Study||22
2887054|NCT00336323|3593269|FG004|12 Week Visit|Overall Study|1 patient was dropped from study|20
2887055|NCT00336323|3593265|FG000|18 Week Visit|Overall Study||19
2887056|NCT00336323|3593266|FG001|18 Week Visit|Overall Study||22
2887057|NCT00336323|3593267|FG002|18 Week Visit|Overall Study||23
2887058|NCT00336323|3593268|FG003|18 Week Visit|Overall Study||21
2887059|NCT00336323|3593269|FG004|18 Week Visit|Overall Study|1 patient was dropped from the study|18
2887060|NCT00336323|3593265|FG000|24 Week Visit|Overall Study||18
2887061|NCT00336323|3593266|FG001|24 Week Visit|Overall Study|1 patient was dropped from the study|20
2887062|NCT00336323|3593267|FG002|24 Week Visit|Overall Study|1 patient was dropped from the study|22
2887063|NCT00336323|3593268|FG003|24 Week Visit|Overall Study||22
2887064|NCT00336323|3593269|FG004|24 Week Visit|Overall Study||19
2887065|NCT00336323|3593265|FG000|COMPLETED|Overall Study||19
2887066|NCT00336323|3593266|FG001|COMPLETED|Overall Study||21
2887067|NCT00336323|3593267|FG002|COMPLETED|Overall Study||23
2887068|NCT00336323|3593268|FG003|COMPLETED|Overall Study||22
2887069|NCT00336323|3593269|FG004|COMPLETED|Overall Study||19
2887070|NCT00336323|3593265|FG000|NOT COMPLETED|Overall Study||0
2887071|NCT00336323|3593266|FG001|NOT COMPLETED|Overall Study||1
2887072|NCT00336323|3593267|FG002|NOT COMPLETED|Overall Study||1
2887073|NCT00336323|3593268|FG003|NOT COMPLETED|Overall Study||0
2887074|NCT00336323|3593269|FG004|NOT COMPLETED|Overall Study||3
2887075|NCT00336479|3593289|FG000|STARTED|Overall Study||75
2887076|NCT00336479|3593290|FG001|STARTED|Overall Study||79
2887077|NCT00336479|3593291|FG002|STARTED|Overall Study||79
2887078|NCT00336479|3593292|FG003|STARTED|Overall Study||17
2887079|NCT00336479|3593289|FG000|COMPLETED|Overall Study||38
2887080|NCT00336479|3593290|FG001|COMPLETED|Overall Study||54
2887081|NCT00336479|3593291|FG002|COMPLETED|Overall Study||53
2887082|NCT00336479|3593292|FG003|COMPLETED|Overall Study||13
2887083|NCT00336479|3593289|FG000|NOT COMPLETED|Overall Study||37
2887084|NCT00336479|3593290|FG001|NOT COMPLETED|Overall Study||25
2887085|NCT00336479|3593291|FG002|NOT COMPLETED|Overall Study||26
2887086|NCT00336479|3593292|FG003|NOT COMPLETED|Overall Study||4
2887087|NCT00336492|3593306|FG000|STARTED|Overall Study||15
2887088|NCT00336492|3593307|FG001|STARTED|Overall Study||22
2887089|NCT00336492|3593308|FG002|STARTED|Overall Study||23
2887090|NCT00336492|3593306|FG000|COMPLETED|Overall Study||0
2887091|NCT00336492|3593307|FG001|COMPLETED|Overall Study||18
2887092|NCT00336492|3593308|FG002|COMPLETED|Overall Study||12
2887093|NCT00336492|3593306|FG000|NOT COMPLETED|Overall Study||15
2887094|NCT00336492|3593307|FG001|NOT COMPLETED|Overall Study||4
2887095|NCT00336492|3593308|FG002|NOT COMPLETED|Overall Study||11
2887096|NCT00336505|3593318|FG000|STARTED|Overall Study|All subjects who were randomized and dosed.|291
2887097|NCT00336505|3593319|FG001|STARTED|Overall Study|All subjects who were randomized and dosed.|291
2887098|NCT00336505|3593318|FG000|COMPLETED|Overall Study|Number of subjects completing the test of cure (TOC) visit.|254
2887099|NCT00336505|3593319|FG001|COMPLETED|Overall Study|Number of subjects completing the test of cure (TOC) visit.|264
2887100|NCT00336505|3593318|FG000|NOT COMPLETED|Overall Study||37
2887101|NCT00336505|3593319|FG001|NOT COMPLETED|Overall Study||27
2887102|NCT00336544|3593327|FG000|STARTED|Overall Study|All subjects who were randomized and dosed.|261
2887103|NCT00336544|3593328|FG001|STARTED|Overall Study|All subjects who were randomized and dosed.|260
2887104|NCT00336544|3593327|FG000|COMPLETED|Overall Study|Number of subjects completing the test of cure (TOC) visit.|242
2887105|NCT00336544|3593328|FG001|COMPLETED|Overall Study|Number of subjects completing the test of cure (TOC) visit.|238
2887106|NCT00336544|3593327|FG000|NOT COMPLETED|Overall Study||19
2887107|NCT00336544|3593328|FG001|NOT COMPLETED|Overall Study||22
2887108|NCT00336583|3593334|FG000|STARTED|Overall Study||27
2887109|NCT00336583|3593334|FG000|COMPLETED|Overall Study||25
2887110|NCT00336583|3593334|FG000|NOT COMPLETED|Overall Study||2
2887111|NCT00336700|3593338|FG000|STARTED|Overall Study||25
2887112|NCT00336700|3593338|FG000|COMPLETED|Overall Study||25
2887113|NCT00336700|3593338|FG000|NOT COMPLETED|Overall Study||0
2887114|NCT00336817|3593344|FG000|STARTED|Overall Study||15
2887115|NCT00336817|3593345|FG001|STARTED|Overall Study||15
2887116|NCT00336817|3593344|FG000|COMPLETED|Overall Study||14
2887117|NCT00336817|3593345|FG001|COMPLETED|Overall Study||13
2887118|NCT00336817|3593344|FG000|NOT COMPLETED|Overall Study||1
2887119|NCT00336817|3593345|FG001|NOT COMPLETED|Overall Study||2
2887120|NCT00336856|3593353|FG000|STARTED|Overall Study|Number of patients consented and registered for the study|35
2887121|NCT00336856|3593353|FG000|COMPLETED|Overall Study||31
2887122|NCT00336856|3593353|FG000|NOT COMPLETED|Overall Study||4
2887123|NCT00336895|3593357|FG000|STARTED|Overall Study||30
2887124|NCT00336895|3593357|FG000|COMPLETED|Overall Study||26
2887125|NCT00336895|3593357|FG000|NOT COMPLETED|Overall Study||4
2887126|NCT00337077|3593364|FG000|STARTED|Overall Study||43
2887127|NCT00337077|3593365|FG001|STARTED|Overall Study||53
2887128|NCT00337077|3593366|FG002|STARTED|Overall Study||25
2887129|NCT00337077|3593364|FG000|Treated|Overall Study||42
2887130|NCT00337077|3593365|FG001|Treated|Overall Study||52
2887131|NCT00337077|3593366|FG002|Treated|Overall Study||25
2887132|NCT00337077|3593364|FG000|Toxicity Assessed|Overall Study||42
2887133|NCT00337077|3593365|FG001|Toxicity Assessed|Overall Study||51
2887134|NCT00337077|3593366|FG002|Toxicity Assessed|Overall Study||25
2887135|NCT00337077|3593364|FG000|Eligible and Treated|Overall Study||41
2887136|NCT00337077|3593365|FG001|Eligible and Treated|Overall Study||51
2887137|NCT00337077|3593366|FG002|Eligible and Treated|Overall Study||24
2887138|NCT00337077|3593364|FG000|Patients With Measurable Disease|Overall Study||26
2887139|NCT00337077|3593365|FG001|Patients With Measurable Disease|Overall Study||38
2887140|NCT00337077|3593366|FG002|Patients With Measurable Disease|Overall Study||13
2887141|NCT00337077|3593364|FG000|COMPLETED|Overall Study|No completion of treatment because treatment was given until PD or unacceptable toxicity.|0
2887142|NCT00337077|3593365|FG001|COMPLETED|Overall Study|No completion of treatment because treatment was given until PD or unacceptable toxicity.|0
2887143|NCT00337077|3593366|FG002|COMPLETED|Overall Study|No completion of treatment because treatment was given until PD or unacceptable toxicity.|0
2887144|NCT00337077|3593364|FG000|NOT COMPLETED|Overall Study||43
2887145|NCT00337077|3593365|FG001|NOT COMPLETED|Overall Study||53
2887146|NCT00337077|3593366|FG002|NOT COMPLETED|Overall Study||25
2887147|NCT00337103|3593374|FG000|STARTED|Overall Study||554
2887148|NCT00337103|3593375|FG001|STARTED|Overall Study||548
2887149|NCT00337103|3593374|FG000|Treated (Safety Population)|Overall Study||544
2887150|NCT00337103|3593375|FG001|Treated (Safety Population)|Overall Study||546
2887151|NCT00337103|3593374|FG000|COMPLETED|Overall Study||0
2887152|NCT00337103|3593375|FG001|COMPLETED|Overall Study||0
2887153|NCT00337103|3593374|FG000|NOT COMPLETED|Overall Study||554
2887154|NCT00337103|3593375|FG001|NOT COMPLETED|Overall Study||548
2887155|NCT00337129|3593382|FG000|STARTED|Overall Study||40
2887156|NCT00337129|3593382|FG000|COMPLETED|Overall Study|Treatment is not for a fixed period and continues until discontinuation criterion is met.|0
2887157|NCT00337129|3593382|FG000|NOT COMPLETED|Overall Study||40
2887158|NCT00337168|3593386|FG000|STARTED|Overall Study||37
2887159|NCT00337168|3593386|FG000|Eligible|Overall Study||37
2887160|NCT00337168|3593386|FG000|Eligible and Treated|Overall Study||36
2887161|NCT00337168|3593386|FG000|COMPLETED|Overall Study||29
2887162|NCT00337168|3593386|FG000|NOT COMPLETED|Overall Study||8
2887163|NCT00337181|3593393|FG000|STARTED|Overall Study||49
2887164|NCT00337181|3593394|FG001|STARTED|Overall Study||65
2887165|NCT00337181|3593393|FG000|COMPLETED|Overall Study||49
2887166|NCT00337181|3593394|FG001|COMPLETED|Overall Study||65
2887167|NCT00337181|3593393|FG000|NOT COMPLETED|Overall Study||0
2887168|NCT00337181|3593394|FG001|NOT COMPLETED|Overall Study||0
2887169|NCT00337194|3593402|FG000|STARTED|Overall Study||23
2887170|NCT00337194|3593403|FG001|STARTED|Overall Study||7
2887171|NCT00337194|3593402|FG000|COMPLETED|Overall Study||11
2887172|NCT00337194|3593403|FG001|COMPLETED|Overall Study||3
2887173|NCT00337194|3593402|FG000|NOT COMPLETED|Overall Study||12
2887174|NCT00337194|3593403|FG001|NOT COMPLETED|Overall Study||4
2887175|NCT00337207|3593411|FG000|STARTED|Overall Study||55
2887176|NCT00337207|3593411|FG000|COMPLETED|Overall Study||52
2887177|NCT00337207|3593411|FG000|NOT COMPLETED|Overall Study||3
2887178|NCT00337272|3593418|FG000|STARTED|Screening Period (Pre-randomization)|22 subjects were consented. All subjects received placebo during the 2 week screening period.|22
2887179|NCT00337272|3593419|FG001|STARTED|Screening Period (Pre-randomization)||0
2887180|NCT00337272|3593418|FG000|COMPLETED|Screening Period (Pre-randomization)|16 subjects completed the screening period and were eligible for randomization.|16
2887181|NCT00337272|3593419|FG001|COMPLETED|Screening Period (Pre-randomization)||0
2887182|NCT00337272|3593418|FG000|NOT COMPLETED|Screening Period (Pre-randomization)||6
2887183|NCT00337272|3593419|FG001|NOT COMPLETED|Screening Period (Pre-randomization)||0
2887184|NCT00337272|3593418|FG000|STARTED|Treatment Period|16 subjects were randomized to either placebo or ramelteon before starting treatment period.|7
2887185|NCT00337272|3593419|FG001|STARTED|Treatment Period|16 subjects were randomized to either placebo or ramelteon before starting treatment period.|9
2887186|NCT00337272|3593418|FG000|Randomization|Treatment Period||7
2887187|NCT00337272|3593419|FG001|Randomization|Treatment Period||9
2887188|NCT00337272|3593418|FG000|COMPLETED|Treatment Period||6
2887189|NCT00337272|3593419|FG001|COMPLETED|Treatment Period||7
2887190|NCT00337272|3593418|FG000|NOT COMPLETED|Treatment Period||1
2887191|NCT00337272|3593419|FG001|NOT COMPLETED|Treatment Period||2
2887192|NCT00337272|3593418|FG000|STARTED|Withdrawal Period|Subjects in both groups received placebo for one week.|6
2887193|NCT00337272|3593419|FG001|STARTED|Withdrawal Period|Subjects in both groups received placebo for one week.|7
2887194|NCT00337272|3593418|FG000|COMPLETED|Withdrawal Period||6
2887195|NCT00337272|3593419|FG001|COMPLETED|Withdrawal Period||6
2887196|NCT00337272|3593418|FG000|NOT COMPLETED|Withdrawal Period||0
2887197|NCT00337272|3593419|FG001|NOT COMPLETED|Withdrawal Period||1
2887198|NCT00337285|3593425|FG000|STARTED|Overall Study||349
2887199|NCT00337285|3593425|FG000|COMPLETED|Overall Study||191
2887200|NCT00337285|3593425|FG000|NOT COMPLETED|Overall Study||158
2887201|NCT00337350|3593431|FG000|STARTED|Overall Study||9
2887202|NCT00337350|3593432|FG001|STARTED|Overall Study||11
2887203|NCT00337350|3593431|FG000|COMPLETED|Overall Study||8
2887204|NCT00337350|3593432|FG001|COMPLETED|Overall Study||10
2887205|NCT00337350|3593431|FG000|NOT COMPLETED|Overall Study||1
2887206|NCT00337350|3593432|FG001|NOT COMPLETED|Overall Study||1
2887207|NCT00337428|3593440|FG000|STARTED|Overall Study||419
2887208|NCT00337428|3593441|FG001|STARTED|Overall Study||424
2887209|NCT00337428|3593440|FG000|COMPLETED|Overall Study||415
2887210|NCT00337428|3593441|FG001|COMPLETED|Overall Study||421
2887211|NCT00337428|3593440|FG000|NOT COMPLETED|Overall Study||4
2887212|NCT00337428|3593441|FG001|NOT COMPLETED|Overall Study||3
2887213|NCT00337467|3593447|FG000|STARTED|Overall Study||61
2887214|NCT00337467|3593447|FG000|Discontinued Prior to Week 96|Overall Study|5 of these participants discontinued prior to Week 48|10
2887215|NCT00337467|3593447|FG000|COMPLETED|Overall Study||51
2887216|NCT00337467|3593447|FG000|NOT COMPLETED|Overall Study||10
2887217|NCT00337571|3593458|FG000|STARTED|Overall Study||52
2887218|NCT00337571|3593459|FG001|STARTED|Overall Study||53
2887219|NCT00337571|3593460|FG002|STARTED|Overall Study||59
2887220|NCT00337571|3593461|FG003|STARTED|Overall Study||54
2887221|NCT00337571|3593458|FG000|COMPLETED|Overall Study||38
2887222|NCT00337571|3593459|FG001|COMPLETED|Overall Study||44
2887223|NCT00337571|3593460|FG002|COMPLETED|Overall Study||49
2887224|NCT00337571|3593461|FG003|COMPLETED|Overall Study||47
2887225|NCT00337571|3593458|FG000|NOT COMPLETED|Overall Study||14
2887226|NCT00337571|3593459|FG001|NOT COMPLETED|Overall Study||9
2887227|NCT00337571|3593460|FG002|NOT COMPLETED|Overall Study||10
2887228|NCT00337571|3593461|FG003|NOT COMPLETED|Overall Study||7
2887229|NCT00337610|3593473|FG000|STARTED|Overall Study||96
2887230|NCT00337610|3593474|FG001|STARTED|Overall Study||94
2887231|NCT00337610|3593473|FG000|Completed Week 18|Overall Study||89
2887232|NCT00337610|3593474|FG001|Completed Week 18|Overall Study||82
2887233|NCT00337610|3593473|FG000|COMPLETED|Overall Study||79
2887234|NCT00337610|3593474|FG001|COMPLETED|Overall Study||80
2887235|NCT00337610|3593473|FG000|NOT COMPLETED|Overall Study||17
2887236|NCT00337610|3593474|FG001|NOT COMPLETED|Overall Study||14
2887237|NCT00337662|3593483|FG000|STARTED|Study Period II||0
2887238|NCT00337662|3593484|FG001|STARTED|Study Period II||0
2887239|NCT00337662|3593485|FG002|STARTED|Study Period II||0
2887240|NCT00337662|3593486|FG003|STARTED|Study Period II||628
2887241|NCT00337662|3593483|FG000|COMPLETED|Study Period II||0
2887242|NCT00337662|3593484|FG001|COMPLETED|Study Period II||0
2887243|NCT00337662|3593485|FG002|COMPLETED|Study Period II||0
2887244|NCT00337662|3593486|FG003|COMPLETED|Study Period II||522
2887245|NCT00337662|3593483|FG000|NOT COMPLETED|Study Period II||0
2887246|NCT00337662|3593484|FG001|NOT COMPLETED|Study Period II||0
2887247|NCT00337662|3593485|FG002|NOT COMPLETED|Study Period II||0
2887248|NCT00337662|3593486|FG003|NOT COMPLETED|Study Period II||106
2887249|NCT00337662|3593483|FG000|STARTED|Study Period III||186
2887250|NCT00337662|3593484|FG001|STARTED|Study Period III||192
2887251|NCT00337662|3593485|FG002|STARTED|Study Period III||144
2887252|NCT00337662|3593486|FG003|STARTED|Study Period III||0
2887253|NCT00337662|3593483|FG000|COMPLETED|Study Period III||126
2887254|NCT00337662|3593484|FG001|COMPLETED|Study Period III||134
2887255|NCT00337662|3593485|FG002|COMPLETED|Study Period III||100
2887256|NCT00337662|3593486|FG003|COMPLETED|Study Period III||0
2887257|NCT00337662|3593483|FG000|NOT COMPLETED|Study Period III||60
2887258|NCT00337662|3593484|FG001|NOT COMPLETED|Study Period III||58
2887259|NCT00337662|3593485|FG002|NOT COMPLETED|Study Period III||44
2887260|NCT00337662|3593486|FG003|NOT COMPLETED|Study Period III||0
2887261|NCT00337727|3593499|FG000|STARTED|Overall Study||430
2887262|NCT00337727|3593500|FG001|STARTED|Overall Study||418
2887263|NCT00337727|3593499|FG000|COMPLETED|Overall Study||412
2887264|NCT00337727|3593500|FG001|COMPLETED|Overall Study||406
2887265|NCT00337727|3593499|FG000|NOT COMPLETED|Overall Study||18
2887266|NCT00337727|3593500|FG001|NOT COMPLETED|Overall Study||12
2887267|NCT00337779|3593508|FG000|STARTED|Overall Study||586
2887268|NCT00337779|3593509|FG001|STARTED|Overall Study||569
2887269|NCT00337779|3593508|FG000|COMPLETED|Overall Study||534
3133760|NCT01697579|3858717|FG005|COMPLETED|Base Study-Cycle 1||0
3133761|NCT01697579|3858718|FG006|COMPLETED|Base Study-Cycle 1||0
3133762|NCT01697579|3858712|FG000|NOT COMPLETED|Base Study-Cycle 1||2
3133763|NCT01697579|3858713|FG001|NOT COMPLETED|Base Study-Cycle 1||1
3133764|NCT01697579|3858714|FG002|NOT COMPLETED|Base Study-Cycle 1||1
3133765|NCT01697579|3858715|FG003|NOT COMPLETED|Base Study-Cycle 1||1
3133766|NCT01697579|3858716|FG004|NOT COMPLETED|Base Study-Cycle 1||3
3133767|NCT01697579|3858717|FG005|NOT COMPLETED|Base Study-Cycle 1||0
2887270|NCT00337779|3593509|FG001|COMPLETED|Overall Study||490
2887271|NCT00337779|3593508|FG000|NOT COMPLETED|Overall Study||52
2887272|NCT00337779|3593509|FG001|NOT COMPLETED|Overall Study||79
2887273|NCT00337818|3593518|FG000|STARTED|Overall Study||458
2887274|NCT00337818|3593519|FG001|STARTED|Overall Study||154
2887275|NCT00337818|3593520|FG002|STARTED|Overall Study||158
2887276|NCT00337818|3593518|FG000|COMPLETED|Overall Study||169
2887277|NCT00337818|3593519|FG001|COMPLETED|Overall Study||63
2887278|NCT00337818|3593520|FG002|COMPLETED|Overall Study||51
2887279|NCT00337818|3593518|FG000|NOT COMPLETED|Overall Study||289
2887280|NCT00337818|3593519|FG001|NOT COMPLETED|Overall Study||91
2887281|NCT00337818|3593520|FG002|NOT COMPLETED|Overall Study||107
2887282|NCT00337935|3593530|FG000|STARTED|Overall Study||39
2887283|NCT00337935|3593531|FG001|STARTED|Overall Study||118
2887284|NCT00337935|3593530|FG000|COMPLETED|Overall Study||29
2887285|NCT00337935|3593531|FG001|COMPLETED|Overall Study||91
2887286|NCT00337935|3593530|FG000|NOT COMPLETED|Overall Study||10
2887287|NCT00337935|3593531|FG001|NOT COMPLETED|Overall Study||27
2887288|NCT00337987|3593538|FG000|STARTED|Overall Study||49
2887289|NCT00337987|3593538|FG000|COMPLETED|Overall Study||49
2887290|NCT00337987|3593538|FG000|NOT COMPLETED|Overall Study||0
2887291|NCT00338039|3593542|FG000|STARTED|Overall Study||69
2887292|NCT00338039|3593542|FG000|COMPLETED|Overall Study||69
2887293|NCT00338039|3593542|FG000|NOT COMPLETED|Overall Study||0
2887294|NCT00338286|3593548|FG000|STARTED|Overall Study||1048
2887295|NCT00338286|3593549|FG001|STARTED|Overall Study||1050
2887296|NCT00338286|3593548|FG000|COMPLETED|Overall Study||815
2887297|NCT00338286|3593549|FG001|COMPLETED|Overall Study||837
2887298|NCT00338286|3593548|FG000|NOT COMPLETED|Overall Study||233
2887299|NCT00338286|3593549|FG001|NOT COMPLETED|Overall Study||213
2887300|NCT00338598|3593557|FG000|STARTED|Overall Study||10
2887301|NCT00338598|3593558|FG001|STARTED|Overall Study||10
2887302|NCT00338598|3593557|FG000|COMPLETED|Overall Study||10
2887303|NCT00338598|3593558|FG001|COMPLETED|Overall Study||8
2887304|NCT00338598|3593557|FG000|NOT COMPLETED|Overall Study||0
2887305|NCT00338598|3593558|FG001|NOT COMPLETED|Overall Study||2
2887306|NCT00338728|3593564|FG000|STARTED|Overall Study||59
2887307|NCT00338728|3593564|FG000|COMPLETED|Overall Study||45
2887308|NCT00338728|3593564|FG000|NOT COMPLETED|Overall Study||14
2887309|NCT00338741|3593570|FG000|STARTED|Overall Study|2 subjects signed a consent form but no data were received for either subject|34
2887310|NCT00338741|3593571|FG001|STARTED|Overall Study||2
2887311|NCT00338741|3593570|FG000|COMPLETED|Overall Study||32
2887312|NCT00338741|3593571|FG001|COMPLETED|Overall Study||2
2887313|NCT00338741|3593570|FG000|NOT COMPLETED|Overall Study||2
2887314|NCT00338741|3593571|FG001|NOT COMPLETED|Overall Study||0
2887315|NCT00338806|3593579|FG000|STARTED|Acute Phase||2
2887316|NCT00338806|3593580|FG001|STARTED|Acute Phase||5
2887317|NCT00338806|3593579|FG000|COMPLETED|Acute Phase||2
2887318|NCT00338806|3593580|FG001|COMPLETED|Acute Phase||4
2887319|NCT00338806|3593579|FG000|NOT COMPLETED|Acute Phase||0
2887320|NCT00338806|3593580|FG001|NOT COMPLETED|Acute Phase||1
2887321|NCT00338806|3593579|FG000|STARTED|Follow-up||2
2887322|NCT00338806|3593580|FG001|STARTED|Follow-up||4
2887323|NCT00338806|3593579|FG000|COMPLETED|Follow-up||1
2887324|NCT00338806|3593580|FG001|COMPLETED|Follow-up||1
2887325|NCT00338806|3593579|FG000|NOT COMPLETED|Follow-up||1
2887326|NCT00338806|3593580|FG001|NOT COMPLETED|Follow-up||3
2887327|NCT00338884|3593588|FG000|STARTED|Overall Study||120
2887328|NCT00338884|3593588|FG000|Received Treatment|Overall Study||119
2887329|NCT00338884|3593588|FG000|COMPLETED|Overall Study||42
2887330|NCT00338884|3593588|FG000|NOT COMPLETED|Overall Study||78
2887331|NCT00338949|3593594|FG000|STARTED|Subject Screening||36
2887332|NCT00338949|3593595|FG001|STARTED|Subject Screening||41
2887333|NCT00338949|3593594|FG000|COMPLETED|Subject Screening||25
2887334|NCT00338949|3593595|FG001|COMPLETED|Subject Screening||30
2887335|NCT00338949|3593594|FG000|NOT COMPLETED|Subject Screening||11
2887336|NCT00338949|3593595|FG001|NOT COMPLETED|Subject Screening||11
2887337|NCT00338949|3593594|FG000|STARTED|Randomization||25
2887338|NCT00338949|3593595|FG001|STARTED|Randomization||30
2887339|NCT00338949|3593594|FG000|COMPLETED|Randomization|1 subject withdrew after relapse and hospitalization|24
2887340|NCT00338949|3593595|FG001|COMPLETED|Randomization|"Reasons for drop out:~2- insomnia 2- symptom exacerbation~1- akathisia"|25
2887341|NCT00338949|3593594|FG000|NOT COMPLETED|Randomization||1
2887342|NCT00338949|3593595|FG001|NOT COMPLETED|Randomization||5
2887343|NCT00338962|3593605|FG000|STARTED|Overall Study||22
2887344|NCT00338962|3593606|FG001|STARTED|Overall Study||20
2887345|NCT00338962|3593607|FG002|STARTED|Overall Study||22
2887346|NCT00338962|3593608|FG003|STARTED|Overall Study||24
2887347|NCT00338962|3593605|FG000|COMPLETED|Overall Study||14
2887348|NCT00338962|3593606|FG001|COMPLETED|Overall Study||16
2887349|NCT00338962|3593607|FG002|COMPLETED|Overall Study||16
2887350|NCT00338962|3593608|FG003|COMPLETED|Overall Study||21
2887351|NCT00338962|3593605|FG000|NOT COMPLETED|Overall Study||8
2887352|NCT00338962|3593606|FG001|NOT COMPLETED|Overall Study||4
2887353|NCT00338962|3593607|FG002|NOT COMPLETED|Overall Study||6
2887354|NCT00338962|3593608|FG003|NOT COMPLETED|Overall Study||3
2887355|NCT00338988|3593618|FG000|STARTED|Overall Study||44
2887356|NCT00338988|3593618|FG000|COMPLETED|Overall Study||43
2887357|NCT00338988|3593618|FG000|NOT COMPLETED|Overall Study||1
2887358|NCT00339040|3593625|FG000|STARTED|Stage I||96
2887359|NCT00339040|3593626|FG001|STARTED|Stage I||30
2887360|NCT00339040|3593625|FG000|Vaccination 1 at Week 0|Stage I||96
2887361|NCT00339040|3593626|FG001|Vaccination 1 at Week 0|Stage I||30
2887362|NCT00339040|3593625|FG000|Vaccination 2 at Week 8|Stage I||95
2887363|NCT00339040|3593626|FG001|Vaccination 2 at Week 8|Stage I||30
2887364|NCT00339040|3593625|FG000|Vaccination 3 at Week 24|Stage I||94
2887365|NCT00339040|3593626|FG001|Vaccination 3 at Week 24|Stage I||30
2887366|NCT00339040|3593625|FG000|COMPLETED|Stage I||94
2887367|NCT00339040|3593626|FG001|COMPLETED|Stage I||29
2887368|NCT00339040|3593625|FG000|NOT COMPLETED|Stage I||2
2887369|NCT00339040|3593626|FG001|NOT COMPLETED|Stage I||1
2887370|NCT00339040|3593625|FG000|STARTED|Stage II||94
2887371|NCT00339040|3593626|FG001|STARTED|Stage II||29
2887372|NCT00339040|3593625|FG000|Vaccination 4 at Week 96|Stage II||84
2887373|NCT00339040|3593626|FG001|Vaccination 4 at Week 96|Stage II||29
2887374|NCT00339040|3593625|FG000|Vaccination 5 at Week 104|Stage II||0
2887375|NCT00339040|3593626|FG001|Vaccination 5 at Week 104|Stage II||28
2887376|NCT00339040|3593625|FG000|Vaccination 6 at Week 120|Stage II||0
2887377|NCT00339040|3593626|FG001|Vaccination 6 at Week 120|Stage II||27
2887378|NCT00339040|3593625|FG000|COMPLETED|Stage II||84
2887379|NCT00339040|3593626|FG001|COMPLETED|Stage II||27
2887380|NCT00339040|3593625|FG000|NOT COMPLETED|Stage II||10
2887381|NCT00339040|3593626|FG001|NOT COMPLETED|Stage II||2
2887382|NCT00339079|3593636|FG000|STARTED|Overall Study||53
2887383|NCT00339079|3593637|FG001|STARTED|Overall Study||44
2887384|NCT00339079|3593638|FG002|STARTED|Overall Study||45
2887385|NCT00339079|3593639|FG003|STARTED|Overall Study||53
2887386|NCT00339079|3593636|FG000|COMPLETED|Overall Study||20
2887387|NCT00339079|3593637|FG001|COMPLETED|Overall Study||21
2887388|NCT00339079|3593638|FG002|COMPLETED|Overall Study||27
2887389|NCT00339079|3593639|FG003|COMPLETED|Overall Study||29
2887390|NCT00339079|3593636|FG000|NOT COMPLETED|Overall Study||33
2887391|NCT00339079|3593637|FG001|NOT COMPLETED|Overall Study||23
2887392|NCT00339079|3593638|FG002|NOT COMPLETED|Overall Study||18
2887393|NCT00339079|3593639|FG003|NOT COMPLETED|Overall Study||24
2887394|NCT00339144|3593656|FG000|STARTED|Overall Study|Number of participants enrolled and treated|9
2887395|NCT00339144|3593657|FG001|STARTED|Overall Study|Number of participants enrolled and treated|3
2887396|NCT00339144|3593658|FG002|STARTED|Overall Study|Number of participants enrolled and treated|4
2887397|NCT00339144|3593656|FG000|COMPLETED|Overall Study||0
2887398|NCT00339144|3593657|FG001|COMPLETED|Overall Study||0
2887399|NCT00339144|3593658|FG002|COMPLETED|Overall Study||0
2887400|NCT00339144|3593656|FG000|NOT COMPLETED|Overall Study||9
2887401|NCT00339144|3593657|FG001|NOT COMPLETED|Overall Study||3
2887402|NCT00339144|3593658|FG002|NOT COMPLETED|Overall Study||4
2887403|NCT00339183|3593669|FG000|STARTED|Overall Study||591
2887404|NCT00339183|3593670|FG001|STARTED|Overall Study||595
2887405|NCT00339183|3593669|FG000|Received Study Drug|Overall Study|Includes one participant who received FOLFIRI Alone|588
2887406|NCT00339183|3593670|FG001|Received Study Drug|Overall Study||593
2887407|NCT00339183|3593669|FG000|COMPLETED|Overall Study|Indicates participants who had completed the safety visit 30 days after last dose or had died|470
2919653|NCT00533845|3630096|FG001|NOT COMPLETED|Overall Study||0
2887408|NCT00339183|3593670|FG001|COMPLETED|Overall Study|Indicates participants who had completed the safety visit 30 days after last dose or had died|490
2887409|NCT00339183|3593669|FG000|NOT COMPLETED|Overall Study||121
2887410|NCT00339183|3593670|FG001|NOT COMPLETED|Overall Study||105
2887411|NCT00339833|3593682|FG000|STARTED|Overall Study||28
2887412|NCT00339833|3593683|FG001|STARTED|Overall Study||26
2887413|NCT00339833|3593682|FG000|COMPLETED|Overall Study||22
2887414|NCT00339833|3593683|FG001|COMPLETED|Overall Study||18
2887415|NCT00339833|3593682|FG000|NOT COMPLETED|Overall Study||6
2887416|NCT00339833|3593683|FG001|NOT COMPLETED|Overall Study||8
2887417|NCT00340379|3593691|FG000|STARTED|Overall Study||35
2887418|NCT00340379|3593692|FG001|STARTED|Overall Study||37
2887419|NCT00340379|3593691|FG000|COMPLETED|Overall Study||27
2887420|NCT00340379|3593692|FG001|COMPLETED|Overall Study||28
2887421|NCT00340379|3593691|FG000|NOT COMPLETED|Overall Study||8
2887422|NCT00340379|3593692|FG001|NOT COMPLETED|Overall Study||9
2887423|NCT00340678|3593702|FG000|STARTED|Overall Study||46
2887424|NCT00340678|3593703|FG001|STARTED|Overall Study||46
2887425|NCT00340678|3593704|FG002|STARTED|Overall Study||39
2887426|NCT00340678|3593705|FG003|STARTED|Overall Study||39
2887427|NCT00340678|3593702|FG000|COMPLETED|Overall Study||45
2887428|NCT00340678|3593703|FG001|COMPLETED|Overall Study||46
2887429|NCT00340678|3593704|FG002|COMPLETED|Overall Study||39
2887430|NCT00340678|3593705|FG003|COMPLETED|Overall Study||39
2887431|NCT00340678|3593702|FG000|NOT COMPLETED|Overall Study||1
2887432|NCT00340678|3593703|FG001|NOT COMPLETED|Overall Study||0
2887433|NCT00340678|3593704|FG002|NOT COMPLETED|Overall Study||0
2887434|NCT00340678|3593705|FG003|NOT COMPLETED|Overall Study||0
2887435|NCT00340704|3593722|FG000|STARTED|PK Study||10
2887436|NCT00340704|3593723|FG001|STARTED|PK Study||10
2887437|NCT00340704|3593724|FG002|STARTED|PK Study||11
2887438|NCT00340704|3593725|FG003|STARTED|PK Study||0
2887439|NCT00340704|3593726|FG004|STARTED|PK Study||0
2887440|NCT00340704|3593727|FG005|STARTED|PK Study||0
2887441|NCT00340704|3593728|FG006|STARTED|PK Study||0
2887442|NCT00340704|3593729|FG007|STARTED|PK Study||0
2887443|NCT00340704|3593730|FG008|STARTED|PK Study||0
2887444|NCT00340704|3593722|FG000|COMPLETED|PK Study||10
2887445|NCT00340704|3593723|FG001|COMPLETED|PK Study||9
2887446|NCT00340704|3593724|FG002|COMPLETED|PK Study||10
2887447|NCT00340704|3593725|FG003|COMPLETED|PK Study||0
2887448|NCT00340704|3593726|FG004|COMPLETED|PK Study||0
2887449|NCT00340704|3593727|FG005|COMPLETED|PK Study||0
2887450|NCT00340704|3593728|FG006|COMPLETED|PK Study||0
2887451|NCT00340704|3593729|FG007|COMPLETED|PK Study||0
2887452|NCT00340704|3593730|FG008|COMPLETED|PK Study||0
2887453|NCT00340704|3593722|FG000|NOT COMPLETED|PK Study||0
2887454|NCT00340704|3593723|FG001|NOT COMPLETED|PK Study||1
2887455|NCT00340704|3593724|FG002|NOT COMPLETED|PK Study||1
2887456|NCT00340704|3593725|FG003|NOT COMPLETED|PK Study||0
2887457|NCT00340704|3593726|FG004|NOT COMPLETED|PK Study||0
2887458|NCT00340704|3593727|FG005|NOT COMPLETED|PK Study||0
2887459|NCT00340704|3593728|FG006|NOT COMPLETED|PK Study||0
2887460|NCT00340704|3593729|FG007|NOT COMPLETED|PK Study||0
2887461|NCT00340704|3593730|FG008|NOT COMPLETED|PK Study||0
2887462|NCT00340704|3593722|FG000|STARTED|Group D- Denovo & 527.51 Rollover Study||0
2887463|NCT00340704|3593723|FG001|STARTED|Group D- Denovo & 527.51 Rollover Study||0
2887464|NCT00340704|3593724|FG002|STARTED|Group D- Denovo & 527.51 Rollover Study||0
2887465|NCT00340704|3593725|FG003|STARTED|Group D- Denovo & 527.51 Rollover Study||29
2887466|NCT00340704|3593726|FG004|STARTED|Group D- Denovo & 527.51 Rollover Study||21
2887467|NCT00340704|3593727|FG005|STARTED|Group D- Denovo & 527.51 Rollover Study||37
2887468|NCT00340704|3593728|FG006|STARTED|Group D- Denovo & 527.51 Rollover Study||54
2887469|NCT00340704|3593729|FG007|STARTED|Group D- Denovo & 527.51 Rollover Study||13
2887470|NCT00340704|3593730|FG008|STARTED|Group D- Denovo & 527.51 Rollover Study||29
2887471|NCT00340704|3593722|FG000|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
2887472|NCT00340704|3593723|FG001|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
2887473|NCT00340704|3593724|FG002|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
2887474|NCT00340704|3593725|FG003|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||7
2887475|NCT00340704|3593726|FG004|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||5
2887476|NCT00340704|3593727|FG005|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||18
2887477|NCT00340704|3593728|FG006|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
2887478|NCT00340704|3593729|FG007|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
2887479|NCT00340704|3593730|FG008|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
2887480|NCT00340704|3593722|FG000|COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
2887481|NCT00340704|3593723|FG001|COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
2887482|NCT00340704|3593724|FG002|COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
2887483|NCT00340704|3593725|FG003|COMPLETED|Group D- Denovo & 527.51 Rollover Study||27
2887484|NCT00340704|3593726|FG004|COMPLETED|Group D- Denovo & 527.51 Rollover Study||16
2887485|NCT00340704|3593727|FG005|COMPLETED|Group D- Denovo & 527.51 Rollover Study||30
2887486|NCT00340704|3593728|FG006|COMPLETED|Group D- Denovo & 527.51 Rollover Study||1
2887487|NCT00340704|3593729|FG007|COMPLETED|Group D- Denovo & 527.51 Rollover Study||1
2887488|NCT00340704|3593730|FG008|COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
2887489|NCT00340704|3593722|FG000|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
2887490|NCT00340704|3593723|FG001|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
2887491|NCT00340704|3593724|FG002|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
2887492|NCT00340704|3593725|FG003|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||2
2887493|NCT00340704|3593726|FG004|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||5
2887494|NCT00340704|3593727|FG005|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||7
2887495|NCT00340704|3593728|FG006|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||53
2887496|NCT00340704|3593729|FG007|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||12
2887497|NCT00340704|3593730|FG008|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||29
2887498|NCT00340834|3593761|FG000|STARTED|Core Phase of Study||426
2887499|NCT00340834|3593762|FG001|STARTED|Core Phase of Study||431
2887500|NCT00340834|3593763|FG002|STARTED|Core Phase of Study||435
2887501|NCT00340834|3593764|FG003|STARTED|Core Phase of Study|This group was formed at the beginning of the extension phase of the study.|0
2887502|NCT00340834|3593765|FG004|STARTED|Core Phase of Study|This group was formed at the beginning of the extension phase of the study.|0
2887503|NCT00340834|3593761|FG000|COMPLETED|Core Phase of Study|On study drug: 358, Off study drug: 11|369
2887504|NCT00340834|3593762|FG001|COMPLETED|Core Phase of Study|On study drug: 385, Off study drug: 13|398
2887505|NCT00340834|3593763|FG002|COMPLETED|Core Phase of Study|On study drug: 380, Off study drug: 6|386
2887506|NCT00340834|3593764|FG003|COMPLETED|Core Phase of Study||0
2887507|NCT00340834|3593765|FG004|COMPLETED|Core Phase of Study||0
2887508|NCT00340834|3593761|FG000|NOT COMPLETED|Core Phase of Study||57
2887509|NCT00340834|3593762|FG001|NOT COMPLETED|Core Phase of Study||33
2887510|NCT00340834|3593763|FG002|NOT COMPLETED|Core Phase of Study||49
2887511|NCT00340834|3593764|FG003|NOT COMPLETED|Core Phase of Study||0
2887512|NCT00340834|3593765|FG004|NOT COMPLETED|Core Phase of Study||0
2887513|NCT00340834|3593761|FG000|STARTED|Extension Phase of Study|Entry into the extension phase of the study was optional.|330
2887514|NCT00340834|3593762|FG001|STARTED|Extension Phase of Study|Entry into the extension phase of the study was optional.|357
2887515|NCT00340834|3593763|FG002|STARTED|Extension Phase of Study|This group did not exist in the extension phase of the study.|0
2887516|NCT00340834|3593764|FG003|STARTED|Extension Phase of Study|Entry into the extension phase of the study was optional.|176
2887517|NCT00340834|3593765|FG004|STARTED|Extension Phase of Study|Entry into the extension phase of the study was optional.|167
2887518|NCT00340834|3593761|FG000|Received Study Drug|Extension Phase of Study||330
2887519|NCT00340834|3593762|FG001|Received Study Drug|Extension Phase of Study||356
2887520|NCT00340834|3593763|FG002|Received Study Drug|Extension Phase of Study||0
2887521|NCT00340834|3593764|FG003|Received Study Drug|Extension Phase of Study||174
2887522|NCT00340834|3593765|FG004|Received Study Drug|Extension Phase of Study||167
2887523|NCT00340834|3593761|FG000|COMPLETED|Extension Phase of Study||245
2887524|NCT00340834|3593762|FG001|COMPLETED|Extension Phase of Study||281
2887525|NCT00340834|3593763|FG002|COMPLETED|Extension Phase of Study||0
2887526|NCT00340834|3593764|FG003|COMPLETED|Extension Phase of Study||123
2887527|NCT00340834|3593765|FG004|COMPLETED|Extension Phase of Study||123
2887528|NCT00340834|3593761|FG000|NOT COMPLETED|Extension Phase of Study||85
2887529|NCT00340834|3593762|FG001|NOT COMPLETED|Extension Phase of Study||76
2887530|NCT00340834|3593763|FG002|NOT COMPLETED|Extension Phase of Study||0
2887531|NCT00340834|3593764|FG003|NOT COMPLETED|Extension Phase of Study||53
2887532|NCT00340834|3593765|FG004|NOT COMPLETED|Extension Phase of Study||44
2887533|NCT00342355|3593779|FG000|STARTED|Overall Study||444
2887534|NCT00342355|3593780|FG001|STARTED|Overall Study||440
2887535|NCT00342355|3593781|FG002|STARTED|Overall Study||444
2887536|NCT00342355|3593782|FG003|STARTED|Overall Study||443
2887537|NCT00342355|3593779|FG000|COMPLETED|Overall Study||444
2887538|NCT00342355|3593780|FG001|COMPLETED|Overall Study||440
2887539|NCT00342355|3593781|FG002|COMPLETED|Overall Study||444
2887540|NCT00342355|3593782|FG003|COMPLETED|Overall Study||443
2887541|NCT00342355|3593779|FG000|NOT COMPLETED|Overall Study||0
2887542|NCT00342355|3593780|FG001|NOT COMPLETED|Overall Study||0
2887543|NCT00342355|3593781|FG002|NOT COMPLETED|Overall Study||0
2887544|NCT00342355|3593782|FG003|NOT COMPLETED|Overall Study||0
2887545|NCT00342563|3593796|FG000|STARTED|Overall Study||41
2887546|NCT00342563|3593797|FG001|STARTED|Overall Study||27
2887547|NCT00342563|3593798|FG002|STARTED|Overall Study||40
2887548|NCT00342563|3593799|FG003|STARTED|Overall Study||28
2887549|NCT00342563|3593796|FG000|COMPLETED|Overall Study||35
2887550|NCT00342563|3593797|FG001|COMPLETED|Overall Study||19
2887551|NCT00342563|3593798|FG002|COMPLETED|Overall Study||26
2887552|NCT00342563|3593799|FG003|COMPLETED|Overall Study||22
2887553|NCT00342563|3593796|FG000|NOT COMPLETED|Overall Study||6
2887554|NCT00342563|3593797|FG001|NOT COMPLETED|Overall Study||8
2887555|NCT00342563|3593798|FG002|NOT COMPLETED|Overall Study||14
2887556|NCT00342563|3593799|FG003|NOT COMPLETED|Overall Study||6
2887557|NCT00342628|3593814|FG000|STARTED|Overall Study||100
2887558|NCT00342628|3593815|FG001|STARTED|Overall Study||101
2887559|NCT00342628|3593816|FG002|STARTED|Overall Study||100
2887560|NCT00342628|3593814|FG000|COMPLETED|Overall Study|84 completed 4 injections, 4 were lost-to-followup after the 4th injection|80
2887561|NCT00342628|3593815|FG001|COMPLETED|Overall Study|83 completed 4 injections, 3 were lost-to-followup after 4th injection|80
2887562|NCT00342628|3593816|FG002|COMPLETED|Overall Study|97 completed 3 injections of DTP alone, 16 were lost-to-followup for blood drawing at 12 months.|81
2887563|NCT00342628|3593814|FG000|NOT COMPLETED|Overall Study||20
2887564|NCT00342628|3593815|FG001|NOT COMPLETED|Overall Study||21
2887565|NCT00342628|3593816|FG002|NOT COMPLETED|Overall Study||19
2919654|NCT00533897|3630105|FG000|STARTED|Lead-in (LI) Period 1||167
2919655|NCT00533897|3630106|FG001|STARTED|Lead-in (LI) Period 1||0
2887566|NCT00343044|3593824|FG000|STARTED|Overall Study||40
2887567|NCT00343044|3593824|FG000|COMPLETED|Overall Study||40
2887568|NCT00343044|3593824|FG000|NOT COMPLETED|Overall Study||0
2887569|NCT00343083|3593828|FG000|STARTED|Overall Study||43
2887570|NCT00343083|3593828|FG000|COMPLETED|Overall Study||22
2887571|NCT00343083|3593828|FG000|NOT COMPLETED|Overall Study||21
2887572|NCT00343252|3593835|FG000|STARTED|All Randomized Participants||361
2887573|NCT00343252|3593836|FG001|STARTED|All Randomized Participants||351
2887574|NCT00343252|3593835|FG000|COMPLETED|All Randomized Participants||259
2887575|NCT00343252|3593836|FG001|COMPLETED|All Randomized Participants||269
2887576|NCT00343252|3593835|FG000|NOT COMPLETED|All Randomized Participants||102
2887577|NCT00343252|3593836|FG001|NOT COMPLETED|All Randomized Participants||82
2887578|NCT00343252|3593835|FG000|STARTED|6 Months (All Treated Participants)|361 participants were randomized but 1 did not receive study drug and was not analyzed.|360
2887579|NCT00343252|3593836|FG001|STARTED|6 Months (All Treated Participants)|351 participants were randomized but 1 did not receive study drug and was not analyzed.|350
2887580|NCT00343252|3593835|FG000|COMPLETED|6 Months (All Treated Participants)||304
2887581|NCT00343252|3593836|FG001|COMPLETED|6 Months (All Treated Participants)||306
2887582|NCT00343252|3593835|FG000|NOT COMPLETED|6 Months (All Treated Participants)||56
2887583|NCT00343252|3593836|FG001|NOT COMPLETED|6 Months (All Treated Participants)||44
2887584|NCT00343252|3593835|FG000|STARTED|12 Months (All Treated Participants)|361 participants were randomized but 1 did not receive study drug and was not analyzed.|360
2887585|NCT00343252|3593836|FG001|STARTED|12 Months (All Treated Participants)|351 participants were randomized but 1 did not receive study drug and was not analyzed.|350
2887586|NCT00343252|3593835|FG000|COMPLETED|12 Months (All Treated Participants)|Completed 12 Months.|274
2887587|NCT00343252|3593836|FG001|COMPLETED|12 Months (All Treated Participants)|Completed 12 Months.|281
2887588|NCT00343252|3593835|FG000|NOT COMPLETED|12 Months (All Treated Participants)||86
2887589|NCT00343252|3593836|FG001|NOT COMPLETED|12 Months (All Treated Participants)||69
2887590|NCT00343252|3593835|FG000|STARTED|18 Months (All Treated Participants)||360
2887591|NCT00343252|3593836|FG001|STARTED|18 Months (All Treated Participants)||350
2887592|NCT00343252|3593835|FG000|COMPLETED|18 Months (All Treated Participants)||259
2887593|NCT00343252|3593836|FG001|COMPLETED|18 Months (All Treated Participants)||269
2887594|NCT00343252|3593835|FG000|NOT COMPLETED|18 Months (All Treated Participants)||101
2887595|NCT00343252|3593836|FG001|NOT COMPLETED|18 Months (All Treated Participants)||81
2887596|NCT00343291|3593844|FG000|STARTED|Overall Study||60
2887597|NCT00343291|3593845|FG001|STARTED|Overall Study||61
2887598|NCT00343291|3593844|FG000|RECEIVED AT LEAST ONE DOSE OF STUDY DRUG|Overall Study||58
2887599|NCT00343291|3593845|FG001|RECEIVED AT LEAST ONE DOSE OF STUDY DRUG|Overall Study||58
2887600|NCT00343291|3593844|FG000|COMPLETED|Overall Study|Participants completed 6 cycles of treatment. Did not start subsequent weekly cetuximab monotherapy.|3
2887601|NCT00343291|3593845|FG001|COMPLETED|Overall Study|Participants completed 6 cycles of treatment. Did not start subsequent weekly cetuximab monotherapy.|5
2887602|NCT00343291|3593844|FG000|NOT COMPLETED|Overall Study||57
2887603|NCT00343291|3593845|FG001|NOT COMPLETED|Overall Study||56
2887604|NCT00343382|3593854|FG000|STARTED|Overall Study||64
2887605|NCT00343382|3593855|FG001|STARTED|Overall Study||65
2887606|NCT00343382|3593856|FG002|STARTED|Overall Study||66
2887607|NCT00343382|3593854|FG000|COMPLETED|Overall Study||60
2887608|NCT00343382|3593855|FG001|COMPLETED|Overall Study||51
2887609|NCT00343382|3593856|FG002|COMPLETED|Overall Study||49
2887610|NCT00343382|3593854|FG000|NOT COMPLETED|Overall Study||4
2887611|NCT00343382|3593855|FG001|NOT COMPLETED|Overall Study||14
2887612|NCT00343382|3593856|FG002|NOT COMPLETED|Overall Study||17
2887613|NCT00343460|3593870|FG000|STARTED|Cycle 1||475
2887614|NCT00343460|3593871|FG001|STARTED|Cycle 1||481
2887615|NCT00343460|3593872|FG002|STARTED|Cycle 1||472
2887616|NCT00343460|3593870|FG000|COMPLETED|Cycle 1||453
2887617|NCT00343460|3593871|FG001|COMPLETED|Cycle 1||459
2887618|NCT00343460|3593872|FG002|COMPLETED|Cycle 1||454
2887619|NCT00343460|3593870|FG000|NOT COMPLETED|Cycle 1||22
2887620|NCT00343460|3593871|FG001|NOT COMPLETED|Cycle 1||22
2887621|NCT00343460|3593872|FG002|NOT COMPLETED|Cycle 1||18
2887622|NCT00343460|3593870|FG000|STARTED|Cycle 2 - 4||584
2887623|NCT00343460|3593871|FG001|STARTED|Cycle 2 - 4||565
2887624|NCT00343460|3593872|FG002|STARTED|Cycle 2 - 4||0
2887625|NCT00343460|3593870|FG000|COMPLETED|Cycle 2 - 4||528
2887626|NCT00343460|3593871|FG001|COMPLETED|Cycle 2 - 4||515
2887627|NCT00343460|3593872|FG002|COMPLETED|Cycle 2 - 4||0
2887628|NCT00343460|3593870|FG000|NOT COMPLETED|Cycle 2 - 4||56
2887629|NCT00343460|3593871|FG001|NOT COMPLETED|Cycle 2 - 4||50
2887630|NCT00343460|3593872|FG002|NOT COMPLETED|Cycle 2 - 4||0
2887631|NCT00343512|3593890|FG000|STARTED|Overall Study||34
2887632|NCT00343512|3593890|FG000|COMPLETED|Overall Study||32
2887633|NCT00343512|3593890|FG000|NOT COMPLETED|Overall Study||2
2887634|NCT00343564|3593906|FG000|STARTED|Overall Study||6
2887635|NCT00343564|3593907|FG001|STARTED|Overall Study||7
2887636|NCT00343564|3593908|FG002|STARTED|Overall Study||3
2887637|NCT00343564|3593909|FG003|STARTED|Overall Study||7
2887638|NCT00343564|3593910|FG004|STARTED|Overall Study||10
2887639|NCT00343564|3593911|FG005|STARTED|Overall Study||9
2887640|NCT00343564|3593912|FG006|STARTED|Overall Study||4
2887641|NCT00343564|3593913|FG007|STARTED|Overall Study||3
2887642|NCT00343564|3593914|FG008|STARTED|Overall Study||3
2887643|NCT00343564|3593915|FG009|STARTED|Overall Study||8
2887644|NCT00343564|3593916|FG010|STARTED|Overall Study||8
2887645|NCT00343564|3593906|FG000|COMPLETED|Overall Study||6
2887646|NCT00343564|3593907|FG001|COMPLETED|Overall Study||7
2887647|NCT00343564|3593908|FG002|COMPLETED|Overall Study||3
2887648|NCT00343564|3593909|FG003|COMPLETED|Overall Study||7
2887649|NCT00343564|3593910|FG004|COMPLETED|Overall Study||10
2887650|NCT00343564|3593911|FG005|COMPLETED|Overall Study||9
2887651|NCT00343564|3593912|FG006|COMPLETED|Overall Study||4
2887652|NCT00343564|3593913|FG007|COMPLETED|Overall Study||3
2887653|NCT00343564|3593914|FG008|COMPLETED|Overall Study||3
2887654|NCT00343564|3593915|FG009|COMPLETED|Overall Study||8
2887655|NCT00343564|3593916|FG010|COMPLETED|Overall Study||8
2887656|NCT00343564|3593906|FG000|NOT COMPLETED|Overall Study||0
2887657|NCT00343564|3593907|FG001|NOT COMPLETED|Overall Study||0
2887658|NCT00343564|3593908|FG002|NOT COMPLETED|Overall Study||0
2887659|NCT00343564|3593909|FG003|NOT COMPLETED|Overall Study||0
2887660|NCT00343564|3593910|FG004|NOT COMPLETED|Overall Study||0
2887661|NCT00343564|3593911|FG005|NOT COMPLETED|Overall Study||0
2887662|NCT00343564|3593912|FG006|NOT COMPLETED|Overall Study||0
2887663|NCT00343564|3593913|FG007|NOT COMPLETED|Overall Study||0
2887664|NCT00343564|3593914|FG008|NOT COMPLETED|Overall Study||0
2887665|NCT00343564|3593915|FG009|NOT COMPLETED|Overall Study||0
2887666|NCT00343564|3593916|FG010|NOT COMPLETED|Overall Study||0
2887667|NCT00343642|3594014|FG000|STARTED|Overall Study||19
2887668|NCT00343642|3594015|FG001|STARTED|Overall Study||19
2887669|NCT00343642|3594016|FG002|STARTED|Overall Study||16
2887670|NCT00343642|3594014|FG000|Upto 3 Months Complete or Flare|Overall Study||2
2887671|NCT00343642|3594015|FG001|Upto 3 Months Complete or Flare|Overall Study||0
2887672|NCT00343642|3594016|FG002|Upto 3 Months Complete or Flare|Overall Study||1
2887673|NCT00343642|3594014|FG000|3-6 Months Complete or Flare|Overall Study||4
2887674|NCT00343642|3594015|FG001|3-6 Months Complete or Flare|Overall Study||2
2887675|NCT00343642|3594016|FG002|3-6 Months Complete or Flare|Overall Study||2
2887676|NCT00343642|3594014|FG000|COMPLETED|Overall Study||10
2887677|NCT00343642|3594015|FG001|COMPLETED|Overall Study||11
2887678|NCT00343642|3594016|FG002|COMPLETED|Overall Study||9
2887679|NCT00343642|3594014|FG000|NOT COMPLETED|Overall Study||9
2887680|NCT00343642|3594015|FG001|NOT COMPLETED|Overall Study||8
2887681|NCT00343642|3594016|FG002|NOT COMPLETED|Overall Study||7
2887682|NCT00343785|3594027|FG000|STARTED|Overall Study||21
2887683|NCT00343785|3594027|FG000|COMPLETED|Overall Study||21
2887684|NCT00343785|3594027|FG000|NOT COMPLETED|Overall Study||0
2887685|NCT00343863|3594034|FG000|STARTED|Overall Study||7
2887686|NCT00343863|3594035|FG001|STARTED|Overall Study||34
2887687|NCT00343863|3594034|FG000|COMPLETED|Overall Study||7
2887688|NCT00343863|3594035|FG001|COMPLETED|Overall Study||34
2887689|NCT00343863|3594034|FG000|NOT COMPLETED|Overall Study||0
2887690|NCT00343863|3594035|FG001|NOT COMPLETED|Overall Study||0
2887691|NCT00343889|3594045|FG000|STARTED|Overall Study||190
2887692|NCT00343889|3594046|FG001|STARTED|Overall Study||189
2887693|NCT00343889|3594045|FG000|COMPLETED|Overall Study||187
2887694|NCT00343889|3594046|FG001|COMPLETED|Overall Study||188
2887695|NCT00343889|3594045|FG000|NOT COMPLETED|Overall Study||3
2887696|NCT00343889|3594046|FG001|NOT COMPLETED|Overall Study||1
2887697|NCT00343915|3594054|FG000|STARTED|Primary Study||258
2887698|NCT00343915|3594055|FG001|STARTED|Primary Study||126
2887699|NCT00343915|3594054|FG000|COMPLETED|Primary Study||254
2887700|NCT00343915|3594055|FG001|COMPLETED|Primary Study||123
2887701|NCT00343915|3594054|FG000|NOT COMPLETED|Primary Study||4
2887702|NCT00343915|3594055|FG001|NOT COMPLETED|Primary Study||3
2887703|NCT00343915|3594054|FG000|STARTED|Month 30 Follow-up|Subjects, previously vaccinated, that returned for the Month 30 follow-up.|179
2887704|NCT00343915|3594055|FG001|STARTED|Month 30 Follow-up||88
2887705|NCT00343915|3594054|FG000|COMPLETED|Month 30 Follow-up||179
2887706|NCT00343915|3594055|FG001|COMPLETED|Month 30 Follow-up||88
2887707|NCT00343915|3594054|FG000|NOT COMPLETED|Month 30 Follow-up||0
2887708|NCT00343915|3594055|FG001|NOT COMPLETED|Month 30 Follow-up||0
2887709|NCT00343915|3594054|FG000|STARTED|Month 42 Follow-up|Subjects, previously vaccinated, that returned for the Month 42 follow-up.|174
2887710|NCT00343915|3594055|FG001|STARTED|Month 42 Follow-up||84
2887711|NCT00343915|3594054|FG000|COMPLETED|Month 42 Follow-up||174
2887712|NCT00343915|3594055|FG001|COMPLETED|Month 42 Follow-up||84
2887713|NCT00343915|3594054|FG000|NOT COMPLETED|Month 42 Follow-up||0
2887714|NCT00343915|3594055|FG001|NOT COMPLETED|Month 42 Follow-up||0
2887715|NCT00343915|3594054|FG000|STARTED|Month 54 Follow-up|Subjects, previously vaccinated, that returned for the Month 54 follow-up.|166
2887716|NCT00343915|3594055|FG001|STARTED|Month 54 Follow-up||79
2887717|NCT00343915|3594054|FG000|COMPLETED|Month 54 Follow-up||166
2887718|NCT00343915|3594055|FG001|COMPLETED|Month 54 Follow-up||79
2887719|NCT00343915|3594054|FG000|NOT COMPLETED|Month 54 Follow-up||0
2887720|NCT00343915|3594055|FG001|NOT COMPLETED|Month 54 Follow-up||0
2887721|NCT00343915|3594054|FG000|STARTED|Month 66 Follow-up|Subjects, previously vaccinated, that returned for the Month 66 follow-up.|158
2887722|NCT00343915|3594055|FG001|STARTED|Month 66 Follow-up||76
2887723|NCT00343915|3594054|FG000|COMPLETED|Month 66 Follow-up||158
2887724|NCT00343915|3594055|FG001|COMPLETED|Month 66 Follow-up||76
2887725|NCT00343915|3594054|FG000|NOT COMPLETED|Month 66 Follow-up||0
2887726|NCT00343915|3594055|FG001|NOT COMPLETED|Month 66 Follow-up||0
2887727|NCT00344032|3594066|FG000|STARTED|Overall Study||176
2887728|NCT00344032|3594067|FG001|STARTED|Overall Study||178
2887729|NCT00344032|3594066|FG000|COMPLETED|Overall Study||162
2887730|NCT00344032|3594067|FG001|COMPLETED|Overall Study||168
2887731|NCT00344032|3594066|FG000|NOT COMPLETED|Overall Study||14
2887732|NCT00344032|3594067|FG001|NOT COMPLETED|Overall Study||10
2887733|NCT00344175|3594075|FG000|STARTED|Overall Study||121
2887734|NCT00344175|3594076|FG001|STARTED|Overall Study||57
2887735|NCT00344175|3594075|FG000|COMPLETED|Overall Study||109
2887736|NCT00344175|3594076|FG001|COMPLETED|Overall Study||47
2887737|NCT00344175|3594075|FG000|NOT COMPLETED|Overall Study||12
2887738|NCT00344175|3594076|FG001|NOT COMPLETED|Overall Study||10
2887739|NCT00344305|3594084|FG000|STARTED|Overall Study||100
2887740|NCT00344305|3594085|FG001|STARTED|Overall Study||100
2887741|NCT00344305|3594084|FG000|COMPLETED|Overall Study||98
2887742|NCT00344305|3594085|FG001|COMPLETED|Overall Study||99
2887743|NCT00344305|3594084|FG000|NOT COMPLETED|Overall Study||2
2887744|NCT00344305|3594085|FG001|NOT COMPLETED|Overall Study||1
2887745|NCT00344318|3594096|FG000|STARTED|Overall Study||300
2887746|NCT00344318|3594097|FG001|STARTED|Overall Study||303
2887747|NCT00344318|3594098|FG002|STARTED|Overall Study||100
2887748|NCT00344318|3594099|FG003|STARTED|Overall Study||103
2887749|NCT00344318|3594096|FG000|COMPLETED|Overall Study||296
2887750|NCT00344318|3594097|FG001|COMPLETED|Overall Study||298
2887751|NCT00344318|3594098|FG002|COMPLETED|Overall Study||99
2887752|NCT00344318|3594099|FG003|COMPLETED|Overall Study||100
2887753|NCT00344318|3594096|FG000|NOT COMPLETED|Overall Study||4
2887754|NCT00344318|3594097|FG001|NOT COMPLETED|Overall Study||5
2887755|NCT00344318|3594098|FG002|NOT COMPLETED|Overall Study||1
2887756|NCT00344318|3594099|FG003|NOT COMPLETED|Overall Study||3
2887757|NCT00344370|3594113|FG000|STARTED|Overall Study||143
2887758|NCT00344370|3594114|FG001|STARTED|Overall Study||71
2887759|NCT00344370|3594113|FG000|COMPLETED|Overall Study||128
2887760|NCT00344370|3594114|FG001|COMPLETED|Overall Study||68
2887761|NCT00344370|3594113|FG000|NOT COMPLETED|Overall Study||15
2887762|NCT00344370|3594114|FG001|NOT COMPLETED|Overall Study||3
2887763|NCT00344448|3594122|FG000|STARTED|Screening|No randomization during the screening phase|6
2887764|NCT00344448|3594123|FG001|STARTED|Screening||4
2887765|NCT00344448|3594122|FG000|COMPLETED|Screening||6
2887766|NCT00344448|3594123|FG001|COMPLETED|Screening||3
2887767|NCT00344448|3594122|FG000|NOT COMPLETED|Screening||0
2887768|NCT00344448|3594123|FG001|NOT COMPLETED|Screening||1
2887769|NCT00344448|3594122|FG000|STARTED|Double Blind, Placebo Controlled||6
2887770|NCT00344448|3594123|FG001|STARTED|Double Blind, Placebo Controlled||3
2887771|NCT00344448|3594122|FG000|COMPLETED|Double Blind, Placebo Controlled||4
2887772|NCT00344448|3594123|FG001|COMPLETED|Double Blind, Placebo Controlled||3
2887773|NCT00344448|3594122|FG000|NOT COMPLETED|Double Blind, Placebo Controlled||2
2887774|NCT00344448|3594123|FG001|NOT COMPLETED|Double Blind, Placebo Controlled||0
2887775|NCT00344448|3594122|FG000|STARTED|Open Label||4
2887776|NCT00344448|3594123|FG001|STARTED|Open Label||3
2887777|NCT00344448|3594122|FG000|COMPLETED|Open Label||2
2887778|NCT00344448|3594123|FG001|COMPLETED|Open Label||2
2887779|NCT00344448|3594122|FG000|NOT COMPLETED|Open Label||2
2887780|NCT00344448|3594123|FG001|NOT COMPLETED|Open Label||1
2887781|NCT00344461|3594129|FG000|STARTED|Overall Study||54
2887782|NCT00344461|3594129|FG000|COMPLETED|Overall Study||33
2887783|NCT00344461|3594129|FG000|NOT COMPLETED|Overall Study||21
2887784|NCT00344500|3594136|FG000|STARTED|Overall Study||48
2887785|NCT00344500|3594137|FG001|STARTED|Overall Study||60
2887786|NCT00344500|3594138|FG002|STARTED|Overall Study||14
2887787|NCT00344500|3594136|FG000|COMPLETED|Overall Study||25
2887788|NCT00344500|3594137|FG001|COMPLETED|Overall Study||25
2887789|NCT00344500|3594138|FG002|COMPLETED|Overall Study||12
2887790|NCT00344500|3594136|FG000|NOT COMPLETED|Overall Study||23
2887791|NCT00344500|3594137|FG001|NOT COMPLETED|Overall Study||35
2887792|NCT00344500|3594138|FG002|NOT COMPLETED|Overall Study||2
2887793|NCT00344682|3594147|FG000|STARTED|Overall Study||16
2887794|NCT00344682|3594148|FG001|STARTED|Overall Study||15
2887795|NCT00344682|3594147|FG000|COMPLETED|Overall Study||12
2887796|NCT00344682|3594148|FG001|COMPLETED|Overall Study||14
2887797|NCT00344682|3594147|FG000|NOT COMPLETED|Overall Study||4
2887798|NCT00344682|3594148|FG001|NOT COMPLETED|Overall Study||1
2887799|NCT00344773|3594154|FG000|STARTED|Overall Study||46
2887800|NCT00344773|3594154|FG000|COMPLETED|Overall Study||25
2887801|NCT00344773|3594154|FG000|NOT COMPLETED|Overall Study||21
2887802|NCT00344968|3594161|FG000|STARTED|Overall Study||185
2887803|NCT00344968|3594162|FG001|STARTED|Overall Study||376
2887804|NCT00344968|3594163|FG002|STARTED|Overall Study||395
2887805|NCT00344968|3594161|FG000|COMPLETED|Overall Study||126
2887806|NCT00344968|3594162|FG001|COMPLETED|Overall Study||274
2887807|NCT00344968|3594163|FG002|COMPLETED|Overall Study||279
2887808|NCT00344968|3594161|FG000|NOT COMPLETED|Overall Study||59
2887809|NCT00344968|3594162|FG001|NOT COMPLETED|Overall Study||102
2887810|NCT00344968|3594163|FG002|NOT COMPLETED|Overall Study||116
2887811|NCT00345033|3594174|FG000|STARTED|Overall Study||20
2887812|NCT00345033|3594175|FG001|STARTED|Overall Study||18
2887813|NCT00345033|3594174|FG000|COMPLETED|Overall Study||16
2887814|NCT00345033|3594175|FG001|COMPLETED|Overall Study||14
2887815|NCT00345033|3594174|FG000|NOT COMPLETED|Overall Study||4
2887816|NCT00345033|3594175|FG001|NOT COMPLETED|Overall Study||4
2887817|NCT00345046|3594184|FG000|STARTED|Overall Study||18
2887818|NCT00345046|3594185|FG001|STARTED|Overall Study||22
2887819|NCT00345046|3594186|FG002|STARTED|Overall Study||16
2887820|NCT00345046|3594184|FG000|COMPLETED|Overall Study||17
2887821|NCT00345046|3594185|FG001|COMPLETED|Overall Study||21
2887822|NCT00345046|3594186|FG002|COMPLETED|Overall Study||14
2887823|NCT00345046|3594184|FG000|NOT COMPLETED|Overall Study||1
2887824|NCT00345046|3594185|FG001|NOT COMPLETED|Overall Study||1
2887825|NCT00345046|3594186|FG002|NOT COMPLETED|Overall Study||2
2887826|NCT00345176|3594198|FG000|STARTED|Overall Study||1012
2887827|NCT00345176|3594199|FG001|STARTED|Overall Study||1044
2887828|NCT00345176|3594200|FG002|STARTED|Overall Study||1068
2887829|NCT00345176|3594201|FG003|STARTED|Overall Study||1079
2887830|NCT00345176|3594198|FG000|COMPLETED|Overall Study||1007
2887831|NCT00345176|3594199|FG001|COMPLETED|Overall Study||1038
2887832|NCT00345176|3594200|FG002|COMPLETED|Overall Study||1062
2887833|NCT00345176|3594201|FG003|COMPLETED|Overall Study||1069
2887834|NCT00345176|3594198|FG000|NOT COMPLETED|Overall Study||5
2887835|NCT00345176|3594199|FG001|NOT COMPLETED|Overall Study||6
2887836|NCT00345176|3594200|FG002|NOT COMPLETED|Overall Study||6
2887837|NCT00345176|3594201|FG003|NOT COMPLETED|Overall Study||10
2887838|NCT00345254|3594215|FG000|STARTED|Overall Study||30
2887839|NCT00345254|3594216|FG001|STARTED|Overall Study||30
2887840|NCT00345254|3594215|FG000|COMPLETED|Overall Study||30
2887841|NCT00345254|3594216|FG001|COMPLETED|Overall Study||30
2887842|NCT00345254|3594215|FG000|NOT COMPLETED|Overall Study||0
2887843|NCT00345254|3594216|FG001|NOT COMPLETED|Overall Study||0
2887844|NCT00345293|3594222|FG000|STARTED|Overall Study||10
2887845|NCT00345293|3594223|FG001|STARTED|Overall Study||3
2887846|NCT00345293|3594222|FG000|COMPLETED|Overall Study||8
2887847|NCT00345293|3594223|FG001|COMPLETED|Overall Study||3
2887848|NCT00345293|3594222|FG000|NOT COMPLETED|Overall Study||2
2887849|NCT00345293|3594223|FG001|NOT COMPLETED|Overall Study||0
2887850|NCT00345332|3594231|FG000|STARTED|Overall Study||11
2887851|NCT00345332|3594232|FG001|STARTED|Overall Study||20
2887852|NCT00345332|3594231|FG000|COMPLETED|Overall Study||11
2887853|NCT00345332|3594232|FG001|COMPLETED|Overall Study||20
2887854|NCT00345332|3594231|FG000|NOT COMPLETED|Overall Study||0
2887855|NCT00345332|3594232|FG001|NOT COMPLETED|Overall Study||0
2887856|NCT00345371|3594240|FG000|STARTED|Overall Study||69
2887857|NCT00345371|3594241|FG001|STARTED|Overall Study||71
2887858|NCT00345371|3594240|FG000|COMPLETED|Overall Study||39
2887859|NCT00345371|3594241|FG001|COMPLETED|Overall Study||38
2887860|NCT00345371|3594240|FG000|NOT COMPLETED|Overall Study||30
2887861|NCT00345371|3594241|FG001|NOT COMPLETED|Overall Study||33
2887862|NCT00345384|3594249|FG000|STARTED|Overall Study||19
2887863|NCT00345384|3594250|FG001|STARTED|Overall Study||19
2887864|NCT00345384|3594249|FG000|COMPLETED|Overall Study||19
2887865|NCT00345384|3594250|FG001|COMPLETED|Overall Study||19
2887866|NCT00345384|3594249|FG000|NOT COMPLETED|Overall Study||0
2887867|NCT00345384|3594250|FG001|NOT COMPLETED|Overall Study||0
2887868|NCT00345397|3594258|FG000|STARTED|Overall Study||7
2887869|NCT00345397|3594258|FG000|COMPLETED|Overall Study||6
2887870|NCT00345397|3594258|FG000|NOT COMPLETED|Overall Study||1
2887871|NCT00345540|3594263|FG000|STARTED|Overall Study|1 subject enrolled but not treated (off-trial for patient discretion)|16
2887872|NCT00345540|3594263|FG000|COMPLETED|Overall Study||15
2887873|NCT00345540|3594263|FG000|NOT COMPLETED|Overall Study||1
2887874|NCT00345579|3594269|FG000|STARTED|Overall Study||3278
2887875|NCT00345579|3594270|FG001|STARTED|Overall Study||1113
2887876|NCT00345579|3594269|FG000|COMPLETED|Overall Study||3114
2887877|NCT00345579|3594270|FG001|COMPLETED|Overall Study||1048
2887878|NCT00345579|3594269|FG000|NOT COMPLETED|Overall Study||164
2887879|NCT00345579|3594270|FG001|NOT COMPLETED|Overall Study||65
2887880|NCT00345592|3594279|FG000|STARTED|Overall Study||199
2887881|NCT00345592|3594280|FG001|STARTED|Overall Study||197
2887882|NCT00345592|3594279|FG000|COMPLETED|Overall Study||174
2887883|NCT00345592|3594280|FG001|COMPLETED|Overall Study||173
2887884|NCT00345592|3594279|FG000|NOT COMPLETED|Overall Study||25
2887885|NCT00345592|3594280|FG001|NOT COMPLETED|Overall Study||24
2887886|NCT00345605|3594286|FG000|STARTED|Initial Washout||6
2887887|NCT00345605|3594287|FG001|STARTED|Initial Washout||6
2887888|NCT00345605|3594286|FG000|COMPLETED|Initial Washout||6
2887889|NCT00345605|3594287|FG001|COMPLETED|Initial Washout||6
2887890|NCT00345605|3594286|FG000|NOT COMPLETED|Initial Washout||0
2887891|NCT00345605|3594287|FG001|NOT COMPLETED|Initial Washout||0
2887892|NCT00345605|3594286|FG000|STARTED|Arm 1||6
2887893|NCT00345605|3594287|FG001|STARTED|Arm 1||6
2887894|NCT00345605|3594286|FG000|COMPLETED|Arm 1||6
2887895|NCT00345605|3594287|FG001|COMPLETED|Arm 1||5
2887896|NCT00345605|3594286|FG000|NOT COMPLETED|Arm 1||0
2887897|NCT00345605|3594287|FG001|NOT COMPLETED|Arm 1||1
2887898|NCT00345605|3594286|FG000|STARTED|Interval||6
2887899|NCT00345605|3594287|FG001|STARTED|Interval||6
2887900|NCT00345605|3594286|FG000|COMPLETED|Interval||6
2887901|NCT00345605|3594287|FG001|COMPLETED|Interval||6
2887902|NCT00345605|3594286|FG000|NOT COMPLETED|Interval||0
2887903|NCT00345605|3594287|FG001|NOT COMPLETED|Interval||0
2887904|NCT00345605|3594286|FG000|STARTED|Crossover Wash-out||6
2887905|NCT00345605|3594287|FG001|STARTED|Crossover Wash-out||6
2887906|NCT00345605|3594286|FG000|COMPLETED|Crossover Wash-out||6
2887907|NCT00345605|3594287|FG001|COMPLETED|Crossover Wash-out||6
2887908|NCT00345605|3594286|FG000|NOT COMPLETED|Crossover Wash-out||0
2887909|NCT00345605|3594287|FG001|NOT COMPLETED|Crossover Wash-out||0
2887910|NCT00345605|3594286|FG000|STARTED|Arm 2, Opposite Treatment||6
2887911|NCT00345605|3594287|FG001|STARTED|Arm 2, Opposite Treatment||6
2887912|NCT00345605|3594286|FG000|COMPLETED|Arm 2, Opposite Treatment||5
2887913|NCT00345605|3594287|FG001|COMPLETED|Arm 2, Opposite Treatment||6
2887914|NCT00345605|3594286|FG000|NOT COMPLETED|Arm 2, Opposite Treatment||1
2887915|NCT00345605|3594287|FG001|NOT COMPLETED|Arm 2, Opposite Treatment||0
2887916|NCT00345631|3594298|FG000|STARTED|Overall Study||87
2887917|NCT00345631|3594299|FG001|STARTED|Overall Study||267
2887918|NCT00345631|3594300|FG002|STARTED|Overall Study||134
2887919|NCT00345631|3594298|FG000|COMPLETED|Overall Study||83
2887920|NCT00345631|3594299|FG001|COMPLETED|Overall Study||259
2887921|NCT00345631|3594300|FG002|COMPLETED|Overall Study||128
2887922|NCT00345631|3594298|FG000|NOT COMPLETED|Overall Study||4
2887923|NCT00345631|3594299|FG001|NOT COMPLETED|Overall Study||8
2887924|NCT00345631|3594300|FG002|NOT COMPLETED|Overall Study||6
2887925|NCT00345683|3594312|FG000|STARTED|Overall Study||3010
2887926|NCT00345683|3594313|FG001|STARTED|Overall Study||1010
2887927|NCT00345683|3594312|FG000|COMPLETED|Overall Study||2985
2887928|NCT00345683|3594313|FG001|COMPLETED|Overall Study||1001
2887929|NCT00345683|3594312|FG000|NOT COMPLETED|Overall Study||25
2887930|NCT00345683|3594313|FG001|NOT COMPLETED|Overall Study||9
2887931|NCT00345839|3594321|FG000|STARTED|Overall Study|Randomized to cinacalcet|1948
2887932|NCT00345839|3594322|FG001|STARTED|Overall Study|Randomized to placebo|1935
2887933|NCT00345839|3594321|FG000|COMPLETED|Overall Study|Participants who completed study includes those with ended study due to death.|1799
2887934|NCT00345839|3594322|FG001|COMPLETED|Overall Study|Participants who completed study includes those with ended study due to death.|1776
2887935|NCT00345839|3594321|FG000|NOT COMPLETED|Overall Study||149
2887936|NCT00345839|3594322|FG001|NOT COMPLETED|Overall Study||159
2887937|NCT00345865|3594333|FG000|STARTED|Overall Study||171
2887938|NCT00345865|3594334|FG001|STARTED|Overall Study||149
2887939|NCT00345865|3594335|FG002|STARTED|Overall Study||2
2887940|NCT00345865|3594336|FG003|STARTED|Overall Study||5
2887941|NCT00345865|3594337|FG004|STARTED|Overall Study||146
2887942|NCT00345865|3594333|FG000|COMPLETED|Overall Study||171
2887943|NCT00345865|3594334|FG001|COMPLETED|Overall Study||149
2887944|NCT00345865|3594335|FG002|COMPLETED|Overall Study||2
2887945|NCT00345865|3594336|FG003|COMPLETED|Overall Study||5
2887946|NCT00345865|3594337|FG004|COMPLETED|Overall Study||146
2887947|NCT00345865|3594333|FG000|NOT COMPLETED|Overall Study||0
2887948|NCT00345865|3594334|FG001|NOT COMPLETED|Overall Study||0
2887949|NCT00345865|3594335|FG002|NOT COMPLETED|Overall Study||0
2887950|NCT00345865|3594336|FG003|NOT COMPLETED|Overall Study||0
2887951|NCT00345865|3594337|FG004|NOT COMPLETED|Overall Study||0
2887952|NCT00345878|3594351|FG000|STARTED|Overall Study||135
2887953|NCT00345878|3594352|FG001|STARTED|Overall Study||136
2887954|NCT00345878|3594351|FG000|COMPLETED|Overall Study||131
2887955|NCT00345878|3594352|FG001|COMPLETED|Overall Study||135
2887956|NCT00345878|3594351|FG000|NOT COMPLETED|Overall Study||4
2887957|NCT00345878|3594352|FG001|NOT COMPLETED|Overall Study||1
2887958|NCT00345969|3594360|FG000|STARTED|Overall Study||12
2887959|NCT00345969|3594361|FG001|STARTED|Overall Study||13
2887960|NCT00345969|3594360|FG000|COMPLETED|Overall Study||11
2887961|NCT00345969|3594361|FG001|COMPLETED|Overall Study||11
2887962|NCT00345969|3594360|FG000|NOT COMPLETED|Overall Study||1
2887963|NCT00345969|3594361|FG001|NOT COMPLETED|Overall Study||2
2887964|NCT00346034|3594367|FG000|STARTED|Overall Study||357
2887965|NCT00346034|3594367|FG000|COMPLETED|Overall Study||300
2887966|NCT00346034|3594367|FG000|NOT COMPLETED|Overall Study||57
2887967|NCT00346073|3594373|FG000|STARTED|Overall Study||1522
2887968|NCT00346073|3594374|FG001|STARTED|Overall Study||762
2887969|NCT00346073|3594373|FG000|COMPLETED|Overall Study||1481
2887970|NCT00346073|3594374|FG001|COMPLETED|Overall Study||738
2887971|NCT00346073|3594373|FG000|NOT COMPLETED|Overall Study||41
2887972|NCT00346073|3594374|FG001|NOT COMPLETED|Overall Study||24
2887973|NCT00346151|3594380|FG000|STARTED|Overall Study||5
2887974|NCT00346151|3594380|FG000|COMPLETED|Overall Study||2
2887975|NCT00346151|3594380|FG000|NOT COMPLETED|Overall Study||3
2887976|NCT00346164|3594388|FG000|STARTED|Overall Study||222
2887977|NCT00346164|3594389|FG001|STARTED|Overall Study||21
2887978|NCT00346164|3594390|FG002|STARTED|Overall Study||122
2887979|NCT00346164|3594391|FG003|STARTED|Overall Study||223
2887980|NCT00346164|3594388|FG000|COMPLETED|Overall Study||205
2887981|NCT00346164|3594389|FG001|COMPLETED|Overall Study||14
2887982|NCT00346164|3594390|FG002|COMPLETED|Overall Study||96
2887983|NCT00346164|3594391|FG003|COMPLETED|Overall Study||117
2887984|NCT00346164|3594388|FG000|NOT COMPLETED|Overall Study||17
2887985|NCT00346164|3594389|FG001|NOT COMPLETED|Overall Study||7
2887986|NCT00346164|3594390|FG002|NOT COMPLETED|Overall Study||26
2887987|NCT00346164|3594391|FG003|NOT COMPLETED|Overall Study||106
2887988|NCT00346216|3594420|FG000|STARTED|Overall Study||8072
2887989|NCT00346216|3594421|FG001|STARTED|Overall Study||8040
2887990|NCT00346216|3594422|FG002|STARTED|Overall Study||7969
2887991|NCT00346216|3594420|FG000|COMPLETED|Overall Study||5664
2887992|NCT00346216|3594421|FG001|COMPLETED|Overall Study||5580
2887993|NCT00346216|3594422|FG002|COMPLETED|Overall Study||5621
2887994|NCT00346216|3594420|FG000|NOT COMPLETED|Overall Study||2408
2887995|NCT00346216|3594421|FG001|NOT COMPLETED|Overall Study||2460
2887996|NCT00346216|3594422|FG002|NOT COMPLETED|Overall Study||2348
2887997|NCT00346268|3594432|FG000|STARTED|Overall Study||52
2887998|NCT00346268|3594433|FG001|STARTED|Overall Study||53
2887999|NCT00346268|3594432|FG000|COMPLETED|Overall Study||50
2888000|NCT00346268|3594433|FG001|COMPLETED|Overall Study||50
2888001|NCT00346268|3594432|FG000|NOT COMPLETED|Overall Study||2
2888002|NCT00346268|3594433|FG001|NOT COMPLETED|Overall Study||3
2888003|NCT00346333|3594441|FG000|STARTED|Overall Study||121
2888004|NCT00346333|3594442|FG001|STARTED|Overall Study||119
2888005|NCT00346333|3594441|FG000|COMPLETED|Overall Study||116
2888006|NCT00346333|3594442|FG001|COMPLETED|Overall Study||111
2888007|NCT00346333|3594441|FG000|NOT COMPLETED|Overall Study||5
2888008|NCT00346333|3594442|FG001|NOT COMPLETED|Overall Study||8
2888009|NCT00346398|3594452|FG000|STARTED|Overall Study||25
2888010|NCT00346398|3594453|FG001|STARTED|Overall Study||26
2888011|NCT00346398|3594452|FG000|COMPLETED|Overall Study||22
2888012|NCT00346398|3594453|FG001|COMPLETED|Overall Study||24
2888013|NCT00346398|3594452|FG000|NOT COMPLETED|Overall Study||3
2888014|NCT00346398|3594453|FG001|NOT COMPLETED|Overall Study||2
2888015|NCT00346476|3594459|FG000|STARTED|Overall Study||1250
2888016|NCT00346476|3594459|FG000|COMPLETED|Overall Study||1250
2888017|NCT00346476|3594459|FG000|NOT COMPLETED|Overall Study||0
2888018|NCT00346632|3594465|FG000|STARTED|Overall Study||3
2888019|NCT00346632|3594466|FG001|STARTED|Overall Study||3
2888020|NCT00346632|3594467|FG002|STARTED|Overall Study||6
2888021|NCT00346632|3594468|FG003|STARTED|Overall Study||3
2888022|NCT00346632|3594469|FG004|STARTED|Overall Study||4
2888023|NCT00346632|3594470|FG005|STARTED|Overall Study||2
2888024|NCT00346632|3594471|FG006|STARTED|Overall Study||5
2888025|NCT00346632|3594472|FG007|STARTED|Overall Study||4
2888026|NCT00346632|3594473|FG008|STARTED|Overall Study||4
2888027|NCT00346632|3594474|FG009|STARTED|Overall Study||3
2888028|NCT00346632|3594465|FG000|COMPLETED|Overall Study||0
2888029|NCT00346632|3594466|FG001|COMPLETED|Overall Study||0
2888030|NCT00346632|3594467|FG002|COMPLETED|Overall Study||0
2888031|NCT00346632|3594468|FG003|COMPLETED|Overall Study||0
2888032|NCT00346632|3594469|FG004|COMPLETED|Overall Study||0
2888033|NCT00346632|3594470|FG005|COMPLETED|Overall Study||0
2888034|NCT00346632|3594471|FG006|COMPLETED|Overall Study||0
2888035|NCT00346632|3594472|FG007|COMPLETED|Overall Study||0
2888036|NCT00346632|3594473|FG008|COMPLETED|Overall Study||0
2888037|NCT00346632|3594474|FG009|COMPLETED|Overall Study||0
2888038|NCT00346632|3594465|FG000|NOT COMPLETED|Overall Study||3
2888039|NCT00346632|3594466|FG001|NOT COMPLETED|Overall Study||3
2888040|NCT00346632|3594467|FG002|NOT COMPLETED|Overall Study||6
2888041|NCT00346632|3594468|FG003|NOT COMPLETED|Overall Study||3
2888042|NCT00346632|3594469|FG004|NOT COMPLETED|Overall Study||4
2888043|NCT00346632|3594470|FG005|NOT COMPLETED|Overall Study||2
2888044|NCT00346632|3594471|FG006|NOT COMPLETED|Overall Study||5
2888045|NCT00346632|3594472|FG007|NOT COMPLETED|Overall Study||4
2888046|NCT00346632|3594473|FG008|NOT COMPLETED|Overall Study||4
2888047|NCT00346632|3594474|FG009|NOT COMPLETED|Overall Study||3
2888048|NCT00346697|3594538|FG000|STARTED|Overall Study||24
2888049|NCT00346697|3594539|FG001|STARTED|Overall Study||24
2888050|NCT00346697|3594538|FG000|COMPLETED|Overall Study||24
2888051|NCT00346697|3594539|FG001|COMPLETED|Overall Study||23
2888052|NCT00346697|3594538|FG000|NOT COMPLETED|Overall Study||0
2888053|NCT00346697|3594539|FG001|NOT COMPLETED|Overall Study||1
2888054|NCT00346775|3594547|FG000|STARTED|Period 1: Intervention Period 1||49
2888055|NCT00346775|3594548|FG001|STARTED|Period 1: Intervention Period 1||48
2888056|NCT00346775|3594547|FG000|COMPLETED|Period 1: Intervention Period 1||44
2888057|NCT00346775|3594548|FG001|COMPLETED|Period 1: Intervention Period 1||45
2888058|NCT00346775|3594547|FG000|NOT COMPLETED|Period 1: Intervention Period 1||5
2888059|NCT00346775|3594548|FG001|NOT COMPLETED|Period 1: Intervention Period 1||3
2888060|NCT00346775|3594547|FG000|STARTED|Period 2: Washout Period (7 Days)||44
2888061|NCT00346775|3594548|FG001|STARTED|Period 2: Washout Period (7 Days)||45
2888062|NCT00346775|3594547|FG000|COMPLETED|Period 2: Washout Period (7 Days)||44
2888063|NCT00346775|3594548|FG001|COMPLETED|Period 2: Washout Period (7 Days)||45
2888064|NCT00346775|3594547|FG000|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
2888065|NCT00346775|3594548|FG001|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
2888066|NCT00346775|3594547|FG000|STARTED|Period 3: Intervention Period 2||44
2888067|NCT00346775|3594548|FG001|STARTED|Period 3: Intervention Period 2||45
2888068|NCT00346775|3594547|FG000|COMPLETED|Period 3: Intervention Period 2||44
2888069|NCT00346775|3594548|FG001|COMPLETED|Period 3: Intervention Period 2||45
2888070|NCT00346775|3594547|FG000|NOT COMPLETED|Period 3: Intervention Period 2||0
2888071|NCT00346775|3594548|FG001|NOT COMPLETED|Period 3: Intervention Period 2||0
2888072|NCT00346905|3594558|FG000|STARTED|Overall Study||16
2888073|NCT00346905|3594558|FG000|COMPLETED|Overall Study||12
2888074|NCT00346905|3594558|FG000|NOT COMPLETED|Overall Study||4
2888075|NCT00347009|3594562|FG000|STARTED|Overall Study||155
2888076|NCT00347009|3594562|FG000|COMPLETED|Overall Study||128
2888077|NCT00347009|3594562|FG000|NOT COMPLETED|Overall Study||27
2888078|NCT00347022|3594568|FG000|STARTED|Overall Study||74
2888079|NCT00347022|3594569|FG001|STARTED|Overall Study||71
2888080|NCT00347022|3594568|FG000|COMPLETED|Overall Study||62
2888081|NCT00347022|3594569|FG001|COMPLETED|Overall Study||66
2888082|NCT00347022|3594568|FG000|NOT COMPLETED|Overall Study||12
2888083|NCT00347022|3594569|FG001|NOT COMPLETED|Overall Study||5
2888084|NCT00347269|3594577|FG000|STARTED|Overall Study||503
2888085|NCT00347269|3594578|FG001|STARTED|Overall Study||501
2888086|NCT00347269|3594577|FG000|COMPLETED|Overall Study||409
2888087|NCT00347269|3594578|FG001|COMPLETED|Overall Study||395
2888088|NCT00347269|3594577|FG000|NOT COMPLETED|Overall Study||94
2888089|NCT00347269|3594578|FG001|NOT COMPLETED|Overall Study||106
2888090|NCT00347308|3594584|FG000|STARTED|Overall Study||40
2888091|NCT00347308|3594584|FG000|COMPLETED|Overall Study||40
2888092|NCT00347308|3594584|FG000|NOT COMPLETED|Overall Study||0
2888093|NCT00347360|3594603|FG000|STARTED|Overall Study||44
2888094|NCT00347360|3594604|FG001|STARTED|Overall Study||43
2888095|NCT00347360|3594605|FG002|STARTED|Overall Study||43
2888096|NCT00347360|3594606|FG003|STARTED|Overall Study||43
2888097|NCT00347360|3594607|FG004|STARTED|Overall Study||44
2888098|NCT00347360|3594608|FG005|STARTED|Overall Study||44
2888099|NCT00347360|3594609|FG006|STARTED|Overall Study||44
2888100|NCT00347360|3594610|FG007|STARTED|Overall Study||43
2888101|NCT00347360|3594611|FG008|STARTED|Overall Study||44
2888102|NCT00347360|3594612|FG009|STARTED|Overall Study||44
2888103|NCT00347360|3594613|FG010|STARTED|Overall Study||44
2888104|NCT00347360|3594614|FG011|STARTED|Overall Study||43
2888105|NCT00347360|3594615|FG012|STARTED|Overall Study||44
2888106|NCT00347360|3594616|FG013|STARTED|Overall Study||44
2888107|NCT00347360|3594617|FG014|STARTED|Overall Study||43
2888108|NCT00347360|3594603|FG000|COMPLETED|Overall Study||39
2888109|NCT00347360|3594604|FG001|COMPLETED|Overall Study||35
2888110|NCT00347360|3594605|FG002|COMPLETED|Overall Study||37
2888111|NCT00347360|3594606|FG003|COMPLETED|Overall Study||30
2888112|NCT00347360|3594607|FG004|COMPLETED|Overall Study||39
2888113|NCT00347360|3594608|FG005|COMPLETED|Overall Study||36
2888114|NCT00347360|3594609|FG006|COMPLETED|Overall Study||37
2888115|NCT00347360|3594610|FG007|COMPLETED|Overall Study||40
2888116|NCT00347360|3594611|FG008|COMPLETED|Overall Study||38
2888117|NCT00347360|3594612|FG009|COMPLETED|Overall Study||35
2888118|NCT00347360|3594613|FG010|COMPLETED|Overall Study||39
2888119|NCT00347360|3594614|FG011|COMPLETED|Overall Study||37
2888120|NCT00347360|3594615|FG012|COMPLETED|Overall Study||34
2888121|NCT00347360|3594616|FG013|COMPLETED|Overall Study||36
2888122|NCT00347360|3594617|FG014|COMPLETED|Overall Study||39
2888123|NCT00347360|3594603|FG000|NOT COMPLETED|Overall Study||5
2888124|NCT00347360|3594604|FG001|NOT COMPLETED|Overall Study||8
2888125|NCT00347360|3594605|FG002|NOT COMPLETED|Overall Study||6
2888126|NCT00347360|3594606|FG003|NOT COMPLETED|Overall Study||13
2888127|NCT00347360|3594607|FG004|NOT COMPLETED|Overall Study||5
2888128|NCT00347360|3594608|FG005|NOT COMPLETED|Overall Study||8
2888129|NCT00347360|3594609|FG006|NOT COMPLETED|Overall Study||7
2888130|NCT00347360|3594610|FG007|NOT COMPLETED|Overall Study||3
2888131|NCT00347360|3594611|FG008|NOT COMPLETED|Overall Study||6
2888132|NCT00347360|3594612|FG009|NOT COMPLETED|Overall Study||9
2888133|NCT00347360|3594613|FG010|NOT COMPLETED|Overall Study||5
2888134|NCT00347360|3594614|FG011|NOT COMPLETED|Overall Study||6
2888135|NCT00347360|3594615|FG012|NOT COMPLETED|Overall Study||10
2888136|NCT00347360|3594616|FG013|NOT COMPLETED|Overall Study||8
2888137|NCT00347360|3594617|FG014|NOT COMPLETED|Overall Study||4
2888138|NCT00347438|3594649|FG000|STARTED|Overall Study||18
2888139|NCT00347438|3594649|FG000|COMPLETED|Overall Study||16
2888140|NCT00347438|3594649|FG000|NOT COMPLETED|Overall Study||2
2888141|NCT00347776|3594656|FG000|STARTED|1.5 Month Follow-up||484
2888142|NCT00347776|3594657|FG001|STARTED|1.5 Month Follow-up||483
2888143|NCT00347776|3594658|FG002|STARTED|1.5 Month Follow-up||485
2888144|NCT00347776|3594656|FG000|COMPLETED|1.5 Month Follow-up||470
2888145|NCT00347776|3594657|FG001|COMPLETED|1.5 Month Follow-up|473 had no recurrence.2 were lost to follow-up but were still eligible for follow-up at next visits|475
2888146|NCT00347776|3594658|FG002|COMPLETED|1.5 Month Follow-up|472 had no recurrence.1 was lost to follow-up but was still eligible for follow-up at next visits|473
2888147|NCT00347776|3594656|FG000|NOT COMPLETED|1.5 Month Follow-up||14
2888148|NCT00347776|3594657|FG001|NOT COMPLETED|1.5 Month Follow-up||8
2888149|NCT00347776|3594658|FG002|NOT COMPLETED|1.5 Month Follow-up||12
2888150|NCT00347776|3594656|FG000|STARTED|6 Month Follow-up||470
2888151|NCT00347776|3594657|FG001|STARTED|6 Month Follow-up||475
2888152|NCT00347776|3594658|FG002|STARTED|6 Month Follow-up||473
2888153|NCT00347776|3594656|FG000|COMPLETED|6 Month Follow-up|440 had no recurrence.8 were lost to follow-up but were still eligible for follow-up at next visits|448
2888154|NCT00347776|3594657|FG001|COMPLETED|6 Month Follow-up|459 had no recurrence.3 were lost to follow-up but were still eligible for follow-up at next visits|462
2888155|NCT00347776|3594658|FG002|COMPLETED|6 Month Follow-up|452 had no recurrence.3 were lost to follow-up but were still eligible for follow-up at next visits|455
2888156|NCT00347776|3594656|FG000|NOT COMPLETED|6 Month Follow-up||22
2888157|NCT00347776|3594657|FG001|NOT COMPLETED|6 Month Follow-up||13
2888158|NCT00347776|3594658|FG002|NOT COMPLETED|6 Month Follow-up||18
2888159|NCT00347776|3594656|FG000|STARTED|12 Month Follow-up||448
2888160|NCT00347776|3594657|FG001|STARTED|12 Month Follow-up||462
2888161|NCT00347776|3594658|FG002|STARTED|12 Month Follow-up||455
2888162|NCT00347776|3594656|FG000|COMPLETED|12 Month Follow-up||425
2888163|NCT00347776|3594657|FG001|COMPLETED|12 Month Follow-up||446
2888164|NCT00347776|3594658|FG002|COMPLETED|12 Month Follow-up||436
2888165|NCT00347776|3594656|FG000|NOT COMPLETED|12 Month Follow-up||23
2888166|NCT00347776|3594657|FG001|NOT COMPLETED|12 Month Follow-up||16
2888167|NCT00347776|3594658|FG002|NOT COMPLETED|12 Month Follow-up||19
2888168|NCT00347919|3594669|FG000|STARTED|Overall Study|Safety Population|73
2888169|NCT00347919|3594670|FG001|STARTED|Overall Study|Safety Population|76
2888170|NCT00347919|3594671|FG002|STARTED|Overall Study|Safety Population|40
2888171|NCT00347919|3594669|FG000|COMPLETED|Overall Study||2
2888172|NCT00347919|3594670|FG001|COMPLETED|Overall Study||0
2888173|NCT00347919|3594671|FG002|COMPLETED|Overall Study||2
2888174|NCT00347919|3594669|FG000|NOT COMPLETED|Overall Study||71
2888175|NCT00347919|3594670|FG001|NOT COMPLETED|Overall Study||76
2888176|NCT00347919|3594671|FG002|NOT COMPLETED|Overall Study||38
2888177|NCT00347932|3594683|FG000|STARTED|Overall Study|As Randomized population - received at least one dose of study medication|475
2888178|NCT00347932|3594684|FG001|STARTED|Overall Study|As Randomized Population - received at least one dose of study medication|482
2888179|NCT00347932|3594683|FG000|COMPLETED|Overall Study||444
2888180|NCT00347932|3594684|FG001|COMPLETED|Overall Study||430
2888181|NCT00347932|3594683|FG000|NOT COMPLETED|Overall Study||31
2888182|NCT00347932|3594684|FG001|NOT COMPLETED|Overall Study||52
2888183|NCT00347958|3594690|FG000|STARTED|Overall Study||544
2888184|NCT00347958|3594690|FG000|COMPLETED|Overall Study||540
2888185|NCT00347958|3594690|FG000|NOT COMPLETED|Overall Study||4
2888186|NCT00348140|3594697|FG000|STARTED|Overall Study||487
2888187|NCT00348140|3594698|FG001|STARTED|Overall Study||490
2888188|NCT00348140|3594699|FG002|STARTED|Overall Study||491
2888189|NCT00348140|3594697|FG000|COMPLETED|Overall Study||361
2888190|NCT00348140|3594698|FG001|COMPLETED|Overall Study||351
2888191|NCT00348140|3594699|FG002|COMPLETED|Overall Study||328
2888192|NCT00348140|3594697|FG000|NOT COMPLETED|Overall Study||126
2888193|NCT00348140|3594698|FG001|NOT COMPLETED|Overall Study||139
2888194|NCT00348140|3594699|FG002|NOT COMPLETED|Overall Study||163
2888195|NCT00348205|3594708|FG000|STARTED|Overall Study||80
2888196|NCT00348205|3594708|FG000|COMPLETED|Overall Study||78
2888197|NCT00348205|3594708|FG000|NOT COMPLETED|Overall Study||2
2888198|NCT00348283|3594714|FG000|STARTED|Induction||0
2888199|NCT00348283|3594715|FG001|STARTED|Induction|Subjects received an open- label dose of 80 mg adalimumab at Week 2 (induction dose).|135
2888200|NCT00348283|3594714|FG000|COMPLETED|Induction||0
2888201|NCT00348283|3594715|FG001|COMPLETED|Induction|Subjects provided more than one reason for discontinuing during induction.|129
2888202|NCT00348283|3594714|FG000|NOT COMPLETED|Induction||0
2888203|NCT00348283|3594715|FG001|NOT COMPLETED|Induction||6
2888204|NCT00348283|3594714|FG000|STARTED|Double Blind|At Week 4, subjects were randomized to either adalimumab 40 mg eow or placebo eow.|65
2888205|NCT00348283|3594715|FG001|STARTED|Double Blind|At Week 4, subjects were randomized to either adalimumab 40 mg eow or placebo eow.|64
2888206|NCT00348283|3594714|FG000|COMPLETED|Double Blind||60
2888207|NCT00348283|3594715|FG001|COMPLETED|Double Blind||54
2888208|NCT00348283|3594714|FG000|NOT COMPLETED|Double Blind||5
2888209|NCT00348283|3594715|FG001|NOT COMPLETED|Double Blind||10
2888210|NCT00348283|3594714|FG000|STARTED|Open Label|No comparator was used in the Open Label portion of the study.|0
2888211|NCT00348283|3594715|FG001|STARTED|Open Label|14 subjects completed the Double Blind portion of the study but did not enter the Open Label period.|100
2888212|NCT00348283|3594714|FG000|COMPLETED|Open Label||0
2888213|NCT00348283|3594715|FG001|COMPLETED|Open Label||66
2888214|NCT00348283|3594714|FG000|NOT COMPLETED|Open Label||0
2888215|NCT00348283|3594715|FG001|NOT COMPLETED|Open Label||34
2888216|NCT00348309|3594724|FG000|STARTED|Overall Study||496
2888217|NCT00348309|3594725|FG001|STARTED|Overall Study||494
2888218|NCT00348309|3594726|FG002|STARTED|Overall Study||489
2888219|NCT00348309|3594724|FG000|COMPLETED|Overall Study||362
2888220|NCT00348309|3594725|FG001|COMPLETED|Overall Study||396
2888221|NCT00348309|3594726|FG002|COMPLETED|Overall Study||346
2888222|NCT00348309|3594724|FG000|NOT COMPLETED|Overall Study||134
2888223|NCT00348309|3594725|FG001|NOT COMPLETED|Overall Study||98
2888224|NCT00348309|3594726|FG002|NOT COMPLETED|Overall Study||143
2888225|NCT00348348|3594737|FG000|STARTED|Overall Study|Received at least one drop of study medication (Safety Population)|579
2888226|NCT00348348|3594738|FG001|STARTED|Overall Study|Received at least one drop of study medication(Safety Population)|582
2888227|NCT00348348|3594737|FG000|COMPLETED|Overall Study||554
2888228|NCT00348348|3594738|FG001|COMPLETED|Overall Study||555
2888229|NCT00348348|3594737|FG000|NOT COMPLETED|Overall Study||25
2888230|NCT00348348|3594738|FG001|NOT COMPLETED|Overall Study||27
2888231|NCT00348374|3594746|FG000|STARTED|Overall Study||88
2888232|NCT00348374|3594747|FG001|STARTED|Overall Study||103
2888233|NCT00348374|3594746|FG000|Received Study Treatment|Overall Study||88
2888234|NCT00348374|3594747|FG001|Received Study Treatment|Overall Study||96
2888235|NCT00348374|3594746|FG000|COMPLETED|Overall Study||69
2888236|NCT00348374|3594747|FG001|COMPLETED|Overall Study||71
2888237|NCT00348374|3594746|FG000|NOT COMPLETED|Overall Study||19
2888238|NCT00348374|3594747|FG001|NOT COMPLETED|Overall Study||32
2888239|NCT00348595|3594756|FG000|STARTED|Overall Study||26
2888240|NCT00348595|3594757|FG001|STARTED|Overall Study||34
2888241|NCT00348595|3594756|FG000|COMPLETED|Overall Study||21
2888242|NCT00348595|3594757|FG001|COMPLETED|Overall Study||26
2888243|NCT00348595|3594756|FG000|NOT COMPLETED|Overall Study||5
2888244|NCT00348595|3594757|FG001|NOT COMPLETED|Overall Study||8
2888245|NCT00348673|3594771|FG000|STARTED|Stage 1||6
2888246|NCT00348673|3594772|FG001|STARTED|Stage 1||6
2888247|NCT00348673|3594773|FG002|STARTED|Stage 1||7
2888248|NCT00348673|3594774|FG003|STARTED|Stage 1||6
2888249|NCT00348673|3594775|FG004|STARTED|Stage 1||4
2888250|NCT00348673|3594776|FG005|STARTED|Stage 1||0
2888251|NCT00348673|3594777|FG006|STARTED|Stage 1||0
2888252|NCT00348673|3594778|FG007|STARTED|Stage 1||0
2888253|NCT00348673|3594779|FG008|STARTED|Stage 1||0
2888254|NCT00348673|3594771|FG000|Treated|Stage 1||6
2888255|NCT00348673|3594772|FG001|Treated|Stage 1||6
2888256|NCT00348673|3594773|FG002|Treated|Stage 1||6
2888257|NCT00348673|3594774|FG003|Treated|Stage 1||6
2888258|NCT00348673|3594775|FG004|Treated|Stage 1||4
2888259|NCT00348673|3594776|FG005|Treated|Stage 1||0
2888260|NCT00348673|3594777|FG006|Treated|Stage 1||0
2888261|NCT00348673|3594778|FG007|Treated|Stage 1||0
2888262|NCT00348673|3594779|FG008|Treated|Stage 1||0
3170310|NCT01929031|3897690|FG002|COMPLETED|Overall Study||34
3170311|NCT01929031|3897691|FG003|COMPLETED|Overall Study||35
3170312|NCT01929031|3897692|FG004|COMPLETED|Overall Study||33
2888263|NCT00348673|3594771|FG000|COMPLETED|Stage 1||6
2888264|NCT00348673|3594772|FG001|COMPLETED|Stage 1||6
2888265|NCT00348673|3594773|FG002|COMPLETED|Stage 1||6
2888266|NCT00348673|3594774|FG003|COMPLETED|Stage 1||6
2888267|NCT00348673|3594775|FG004|COMPLETED|Stage 1||4
2888268|NCT00348673|3594776|FG005|COMPLETED|Stage 1||0
2888269|NCT00348673|3594777|FG006|COMPLETED|Stage 1||0
2888270|NCT00348673|3594778|FG007|COMPLETED|Stage 1||0
2888271|NCT00348673|3594779|FG008|COMPLETED|Stage 1||0
2888272|NCT00348673|3594771|FG000|NOT COMPLETED|Stage 1||0
2888273|NCT00348673|3594772|FG001|NOT COMPLETED|Stage 1||0
2888274|NCT00348673|3594773|FG002|NOT COMPLETED|Stage 1||1
2888275|NCT00348673|3594774|FG003|NOT COMPLETED|Stage 1||0
2888276|NCT00348673|3594775|FG004|NOT COMPLETED|Stage 1||0
2888277|NCT00348673|3594776|FG005|NOT COMPLETED|Stage 1||0
2888278|NCT00348673|3594777|FG006|NOT COMPLETED|Stage 1||0
2888279|NCT00348673|3594778|FG007|NOT COMPLETED|Stage 1||0
2888280|NCT00348673|3594779|FG008|NOT COMPLETED|Stage 1||0
2888281|NCT00348673|3594771|FG000|STARTED|Stage 2||0
2888282|NCT00348673|3594772|FG001|STARTED|Stage 2||0
2888283|NCT00348673|3594773|FG002|STARTED|Stage 2||0
2888284|NCT00348673|3594774|FG003|STARTED|Stage 2||0
2888285|NCT00348673|3594775|FG004|STARTED|Stage 2||0
2888286|NCT00348673|3594776|FG005|STARTED|Stage 2||6
2888287|NCT00348673|3594777|FG006|STARTED|Stage 2||6
2888288|NCT00348673|3594778|FG007|STARTED|Stage 2||6
2888289|NCT00348673|3594779|FG008|STARTED|Stage 2||2
2888290|NCT00348673|3594771|FG000|COMPLETED|Stage 2||0
2888291|NCT00348673|3594772|FG001|COMPLETED|Stage 2||0
2888292|NCT00348673|3594773|FG002|COMPLETED|Stage 2||0
2888293|NCT00348673|3594774|FG003|COMPLETED|Stage 2||0
2888294|NCT00348673|3594775|FG004|COMPLETED|Stage 2||0
2888295|NCT00348673|3594776|FG005|COMPLETED|Stage 2||6
2888296|NCT00348673|3594777|FG006|COMPLETED|Stage 2||6
2888297|NCT00348673|3594778|FG007|COMPLETED|Stage 2||6
2888298|NCT00348673|3594779|FG008|COMPLETED|Stage 2||2
2888299|NCT00348673|3594771|FG000|NOT COMPLETED|Stage 2||0
2888300|NCT00348673|3594772|FG001|NOT COMPLETED|Stage 2||0
2888301|NCT00348673|3594773|FG002|NOT COMPLETED|Stage 2||0
2888302|NCT00348673|3594774|FG003|NOT COMPLETED|Stage 2||0
2888303|NCT00348673|3594775|FG004|NOT COMPLETED|Stage 2||0
2888304|NCT00348673|3594776|FG005|NOT COMPLETED|Stage 2||0
2888305|NCT00348673|3594777|FG006|NOT COMPLETED|Stage 2||0
2888306|NCT00348673|3594778|FG007|NOT COMPLETED|Stage 2||0
2888307|NCT00348673|3594779|FG008|NOT COMPLETED|Stage 2||0
2888308|NCT00348686|3594797|FG000|STARTED|Overall Study||315
2888309|NCT00348686|3594797|FG000|COMPLETED|Overall Study||249
2888310|NCT00348686|3594797|FG000|NOT COMPLETED|Overall Study||66
2888311|NCT00348790|3594801|FG000|STARTED|Began Treatment||25
2888312|NCT00348790|3594801|FG000|COMPLETED|Began Treatment||25
2888313|NCT00348790|3594801|FG000|NOT COMPLETED|Began Treatment||0
2888314|NCT00348790|3594801|FG000|STARTED|Completed Treatment||25
2888315|NCT00348790|3594801|FG000|COMPLETED|Completed Treatment||0
2888316|NCT00348790|3594801|FG000|NOT COMPLETED|Completed Treatment||25
2888317|NCT00348816|3594806|FG000|STARTED|Overall Study||20
2888318|NCT00348816|3594806|FG000|COMPLETED|Overall Study||19
2888319|NCT00348816|3594806|FG000|NOT COMPLETED|Overall Study||1
2888320|NCT00348881|3594814|FG000|STARTED|Overall Study||1424
2888321|NCT00348881|3594815|FG001|STARTED|Overall Study||709
2888322|NCT00348881|3594814|FG000|COMPLETED|Overall Study||1407
2888323|NCT00348881|3594815|FG001|COMPLETED|Overall Study||697
2888324|NCT00348881|3594814|FG000|NOT COMPLETED|Overall Study||17
2888325|NCT00348881|3594815|FG001|NOT COMPLETED|Overall Study||12
2888326|NCT00348933|3594825|FG000|STARTED|Overall Study||90
2888327|NCT00348933|3594825|FG000|COMPLETED|Overall Study||65
2888328|NCT00348933|3594825|FG000|NOT COMPLETED|Overall Study||25
2888329|NCT00348946|3594832|FG000|STARTED|Overall Study||46
2888330|NCT00348946|3594833|FG001|STARTED|Overall Study||47
2888331|NCT00348946|3594832|FG000|COMPLETED|Overall Study||35
2888332|NCT00348946|3594833|FG001|COMPLETED|Overall Study||35
2888333|NCT00348946|3594832|FG000|NOT COMPLETED|Overall Study||11
2888334|NCT00348946|3594833|FG001|NOT COMPLETED|Overall Study||12
2888335|NCT00349336|3594843|FG000|STARTED|Overall Study||32
2888336|NCT00349336|3594844|FG001|STARTED|Overall Study||32
2888337|NCT00349336|3594843|FG000|COMPLETED|Overall Study||19
2888338|NCT00349336|3594844|FG001|COMPLETED|Overall Study||18
2888339|NCT00349336|3594843|FG000|NOT COMPLETED|Overall Study||13
2888340|NCT00349336|3594844|FG001|NOT COMPLETED|Overall Study||14
2888341|NCT00349349|3594853|FG000|STARTED|Overall Study||95
2888342|NCT00349349|3594854|FG001|STARTED|Overall Study||112
2888343|NCT00349349|3594855|FG002|STARTED|Overall Study||16
2888344|NCT00349349|3594853|FG000|COMPLETED|Overall Study||42
2888345|NCT00349349|3594854|FG001|COMPLETED|Overall Study||50
2888346|NCT00349349|3594855|FG002|COMPLETED|Overall Study||10
2888347|NCT00349349|3594853|FG000|NOT COMPLETED|Overall Study||53
2888348|NCT00349349|3594854|FG001|NOT COMPLETED|Overall Study||62
2888349|NCT00349349|3594855|FG002|NOT COMPLETED|Overall Study||6
2888350|NCT00349388|3594867|FG000|STARTED|Overall Study|no patients enrolled|0
2888351|NCT00349388|3594868|FG001|STARTED|Overall Study||1
2888352|NCT00349388|3594867|FG000|COMPLETED|Overall Study|no patients enrolled , therefore no patients completed|0
2888353|NCT00349388|3594868|FG001|COMPLETED|Overall Study||1
2888354|NCT00349388|3594867|FG000|NOT COMPLETED|Overall Study||0
2888355|NCT00349388|3594868|FG001|NOT COMPLETED|Overall Study||0
2888356|NCT00349466|3594876|FG000|STARTED|Overall Study||42
2888357|NCT00349466|3594877|FG001|STARTED|Overall Study||38
2888358|NCT00349466|3594876|FG000|COMPLETED|Overall Study||33
2888359|NCT00349466|3594877|FG001|COMPLETED|Overall Study||35
2888360|NCT00349466|3594876|FG000|NOT COMPLETED|Overall Study||9
2888361|NCT00349466|3594877|FG001|NOT COMPLETED|Overall Study||3
2888362|NCT00349622|3594885|FG000|STARTED|Overall Study||340
2888363|NCT00349622|3594886|FG001|STARTED|Overall Study||173
2888364|NCT00349622|3594885|FG000|COMPLETED|Overall Study||162
2888365|NCT00349622|3594886|FG001|COMPLETED|Overall Study||77
2888366|NCT00349622|3594885|FG000|NOT COMPLETED|Overall Study||178
2888367|NCT00349622|3594886|FG001|NOT COMPLETED|Overall Study||96
2888368|NCT00349713|3594895|FG000|STARTED|Overall Study||20
2888369|NCT00349713|3594896|FG001|STARTED|Overall Study||20
2888370|NCT00349713|3594897|FG002|STARTED|Overall Study||20
2888371|NCT00349713|3594895|FG000|COMPLETED|Overall Study||20
2888372|NCT00349713|3594896|FG001|COMPLETED|Overall Study||20
2888373|NCT00349713|3594897|FG002|COMPLETED|Overall Study||20
2888374|NCT00349713|3594895|FG000|NOT COMPLETED|Overall Study||0
2888375|NCT00349713|3594896|FG001|NOT COMPLETED|Overall Study||0
2888376|NCT00349713|3594897|FG002|NOT COMPLETED|Overall Study||0
2888377|NCT00349752|3594907|FG000|STARTED|Overall Study||87
2888378|NCT00349752|3594908|FG001|STARTED|Overall Study||87
2888379|NCT00349752|3594907|FG000|COMPLETED|Overall Study||28
2888380|NCT00349752|3594908|FG001|COMPLETED|Overall Study||23
2888381|NCT00349752|3594907|FG000|NOT COMPLETED|Overall Study||59
2888382|NCT00349752|3594908|FG001|NOT COMPLETED|Overall Study||64
2888383|NCT00349778|3594914|FG000|STARTED|Overall Study||102
2888384|NCT00349778|3594914|FG000|COMPLETED|Overall Study||102
2888385|NCT00349778|3594914|FG000|NOT COMPLETED|Overall Study||0
2888386|NCT00349908|3594920|FG000|STARTED|Overall Study||10
2888387|NCT00349908|3594921|FG001|STARTED|Overall Study||10
2888388|NCT00349908|3594920|FG000|COMPLETED|Overall Study||10
2888389|NCT00349908|3594921|FG001|COMPLETED|Overall Study|9 returned for 30 day follow-up, 7 returned for 6 month and 6/7 had 6 month angiogram|6
2888390|NCT00349908|3594920|FG000|NOT COMPLETED|Overall Study||0
2888391|NCT00349908|3594921|FG001|NOT COMPLETED|Overall Study||4
2888392|NCT00349921|3594932|FG000|STARTED|First Spinal Injection||10
2888393|NCT00349921|3594933|FG001|STARTED|First Spinal Injection||10
2888394|NCT00349921|3594934|FG002|STARTED|First Spinal Injection||1
2888395|NCT00349921|3594935|FG003|STARTED|First Spinal Injection||1
2888396|NCT00349921|3594932|FG000|COMPLETED|First Spinal Injection||9
2888397|NCT00349921|3594933|FG001|COMPLETED|First Spinal Injection||10
2888398|NCT00349921|3594934|FG002|COMPLETED|First Spinal Injection||0
2888399|NCT00349921|3594935|FG003|COMPLETED|First Spinal Injection||1
2888400|NCT00349921|3594932|FG000|NOT COMPLETED|First Spinal Injection||1
2888401|NCT00349921|3594933|FG001|NOT COMPLETED|First Spinal Injection||0
2888402|NCT00349921|3594934|FG002|NOT COMPLETED|First Spinal Injection||1
2888403|NCT00349921|3594935|FG003|NOT COMPLETED|First Spinal Injection||0
2888404|NCT00349921|3594932|FG000|STARTED|Second Spinal Injection|One patient experienced an adverse event after period one and did not participate in period two|9
2888405|NCT00349921|3594933|FG001|STARTED|Second Spinal Injection||10
2888406|NCT00349921|3594934|FG002|STARTED|Second Spinal Injection||0
2888407|NCT00349921|3594935|FG003|STARTED|Second Spinal Injection||1
2888408|NCT00349921|3594932|FG000|COMPLETED|Second Spinal Injection||9
2888409|NCT00349921|3594933|FG001|COMPLETED|Second Spinal Injection||10
2888410|NCT00349921|3594934|FG002|COMPLETED|Second Spinal Injection||0
2888411|NCT00349921|3594935|FG003|COMPLETED|Second Spinal Injection||1
2888412|NCT00349921|3594932|FG000|NOT COMPLETED|Second Spinal Injection||0
2888413|NCT00349921|3594933|FG001|NOT COMPLETED|Second Spinal Injection||0
2888414|NCT00349921|3594934|FG002|NOT COMPLETED|Second Spinal Injection||0
2888415|NCT00349921|3594935|FG003|NOT COMPLETED|Second Spinal Injection||0
2888416|NCT00349973|3594946|FG000|STARTED|Overall Study||12
2888417|NCT00349973|3594947|FG001|STARTED|Overall Study||8
2888418|NCT00349973|3594946|FG000|COMPLETED|Overall Study||8
2888419|NCT00349973|3594947|FG001|COMPLETED|Overall Study||5
2888420|NCT00349973|3594946|FG000|NOT COMPLETED|Overall Study||4
2888421|NCT00349973|3594947|FG001|NOT COMPLETED|Overall Study||3
2888422|NCT00350025|3594955|FG000|STARTED|Overall Study||11
2888423|NCT00350025|3594956|FG001|STARTED|Overall Study||30
2888424|NCT00350025|3594955|FG000|COMPLETED|Overall Study||11
2888425|NCT00350025|3594956|FG001|COMPLETED|Overall Study||28
2888426|NCT00350025|3594955|FG000|NOT COMPLETED|Overall Study||0
2888427|NCT00350025|3594956|FG001|NOT COMPLETED|Overall Study||2
2888428|NCT00350142|3594962|FG000|STARTED|Overall Study||20
2888429|NCT00350142|3594962|FG000|COMPLETED|Overall Study||20
2888430|NCT00350142|3594962|FG000|NOT COMPLETED|Overall Study||0
2888431|NCT00350207|3594970|FG000|STARTED|Overall Study||128
2888432|NCT00350207|3594971|FG001|STARTED|Overall Study||134
2888433|NCT00350207|3594972|FG002|STARTED|Overall Study||126
2888434|NCT00350207|3594970|FG000|COMPLETED|Overall Study||120
2888435|NCT00350207|3594971|FG001|COMPLETED|Overall Study||128
2888436|NCT00350207|3594972|FG002|COMPLETED|Overall Study||119
2888437|NCT00350207|3594970|FG000|NOT COMPLETED|Overall Study||8
2888438|NCT00350207|3594971|FG001|NOT COMPLETED|Overall Study||6
2888439|NCT00350207|3594972|FG002|NOT COMPLETED|Overall Study||7
2888440|NCT00350220|3594982|FG000|STARTED|Overall Study||30
2888441|NCT00350220|3594983|FG001|STARTED|Overall Study||30
2888442|NCT00350220|3594982|FG000|COMPLETED|Overall Study||30
2888443|NCT00350220|3594983|FG001|COMPLETED|Overall Study||30
2888444|NCT00350220|3594982|FG000|NOT COMPLETED|Overall Study||0
2888445|NCT00350220|3594983|FG001|NOT COMPLETED|Overall Study||0
2888446|NCT00350272|3594991|FG000|STARTED|Blinded 12 Week Treatment||39
2888447|NCT00350272|3594992|FG001|STARTED|Blinded 12 Week Treatment||37
2888448|NCT00350272|3594991|FG000|COMPLETED|Blinded 12 Week Treatment||30
2888449|NCT00350272|3594992|FG001|COMPLETED|Blinded 12 Week Treatment||35
2888450|NCT00350272|3594991|FG000|NOT COMPLETED|Blinded 12 Week Treatment||9
2888451|NCT00350272|3594992|FG001|NOT COMPLETED|Blinded 12 Week Treatment||2
2888452|NCT00350272|3594991|FG000|STARTED|Open-Label 84 Week Treatment||30
2888453|NCT00350272|3594992|FG001|STARTED|Open-Label 84 Week Treatment||35
2888454|NCT00350272|3594991|FG000|COMPLETED|Open-Label 84 Week Treatment||21
2888455|NCT00350272|3594992|FG001|COMPLETED|Open-Label 84 Week Treatment||27
2888456|NCT00350272|3594991|FG000|NOT COMPLETED|Open-Label 84 Week Treatment||9
2888457|NCT00350272|3594992|FG001|NOT COMPLETED|Open-Label 84 Week Treatment||8
3170313|NCT01929031|3897693|FG005|COMPLETED|Overall Study||35
3170314|NCT01929031|3897688|FG000|NOT COMPLETED|Overall Study||4
3170315|NCT01929031|3897689|FG001|NOT COMPLETED|Overall Study||2
3170316|NCT01929031|3897690|FG002|NOT COMPLETED|Overall Study||1
3170317|NCT01929031|3897691|FG003|NOT COMPLETED|Overall Study||0
2888458|NCT00350298|3595002|FG000|STARTED|Overall Study||101
2888459|NCT00350298|3595003|FG001|STARTED|Overall Study||99
2888460|NCT00350298|3595002|FG000|COMPLETED|Overall Study||92
2888461|NCT00350298|3595003|FG001|COMPLETED|Overall Study||86
2888462|NCT00350298|3595002|FG000|NOT COMPLETED|Overall Study||9
2888463|NCT00350298|3595003|FG001|NOT COMPLETED|Overall Study||13
2888464|NCT00350337|3595013|FG000|STARTED|Overall Study||22
2888465|NCT00350337|3595014|FG001|STARTED|Overall Study||22
2888466|NCT00350337|3595015|FG002|STARTED|Overall Study||21
2888467|NCT00350337|3595016|FG003|STARTED|Overall Study||21
2888468|NCT00350337|3595013|FG000|COMPLETED|Overall Study||17
2888469|NCT00350337|3595014|FG001|COMPLETED|Overall Study||19
2888470|NCT00350337|3595015|FG002|COMPLETED|Overall Study||18
2888471|NCT00350337|3595016|FG003|COMPLETED|Overall Study||21
2888472|NCT00350337|3595013|FG000|NOT COMPLETED|Overall Study||5
2888473|NCT00350337|3595014|FG001|NOT COMPLETED|Overall Study||3
2888474|NCT00350337|3595015|FG002|NOT COMPLETED|Overall Study||3
2888475|NCT00350337|3595016|FG003|NOT COMPLETED|Overall Study||0
2888476|NCT00350363|3595027|FG000|STARTED|Overall Study||60
2888477|NCT00350363|3595027|FG000|COMPLETED|Overall Study||60
2888478|NCT00350363|3595027|FG000|NOT COMPLETED|Overall Study||0
2888479|NCT00350402|3595033|FG000|STARTED|Overall Study||21
2888480|NCT00350402|3595034|FG001|STARTED|Overall Study||21
2888481|NCT00350402|3595033|FG000|COMPLETED|Overall Study||20
2888482|NCT00350402|3595034|FG001|COMPLETED|Overall Study||20
2888483|NCT00350402|3595033|FG000|NOT COMPLETED|Overall Study||1
2888484|NCT00350402|3595034|FG001|NOT COMPLETED|Overall Study||1
2919656|NCT00533897|3630107|FG002|STARTED|Lead-in (LI) Period 1||0
2919657|NCT00533897|3630108|FG003|STARTED|Lead-in (LI) Period 1||0
2919658|NCT00533897|3630109|FG004|STARTED|Lead-in (LI) Period 1||0
2919659|NCT00533897|3630110|FG005|STARTED|Lead-in (LI) Period 1||0
2919660|NCT00533897|3630111|FG006|STARTED|Lead-in (LI) Period 1||0
2919661|NCT00533897|3630112|FG007|STARTED|Lead-in (LI) Period 1||0
2919662|NCT00533897|3630105|FG000|COMPLETED|Lead-in (LI) Period 1|37 participants entered the LTE directly and did not enter the DBW Period nor receive DBW treatment.|157
2919663|NCT00533897|3630106|FG001|COMPLETED|Lead-in (LI) Period 1||0
2919664|NCT00533897|3630107|FG002|COMPLETED|Lead-in (LI) Period 1||0
2919665|NCT00533897|3630108|FG003|COMPLETED|Lead-in (LI) Period 1||0
2919666|NCT00533897|3630109|FG004|COMPLETED|Lead-in (LI) Period 1||0
2919667|NCT00533897|3630110|FG005|COMPLETED|Lead-in (LI) Period 1||0
2919668|NCT00533897|3630111|FG006|COMPLETED|Lead-in (LI) Period 1||0
2919669|NCT00533897|3630112|FG007|COMPLETED|Lead-in (LI) Period 1||0
2919670|NCT00533897|3630105|FG000|NOT COMPLETED|Lead-in (LI) Period 1||10
2919671|NCT00533897|3630106|FG001|NOT COMPLETED|Lead-in (LI) Period 1||0
2919672|NCT00533897|3630107|FG002|NOT COMPLETED|Lead-in (LI) Period 1||0
2919673|NCT00533897|3630108|FG003|NOT COMPLETED|Lead-in (LI) Period 1||0
2919674|NCT00533897|3630109|FG004|NOT COMPLETED|Lead-in (LI) Period 1||0
2919675|NCT00533897|3630110|FG005|NOT COMPLETED|Lead-in (LI) Period 1||0
2919676|NCT00533897|3630111|FG006|NOT COMPLETED|Lead-in (LI) Period 1||0
2919677|NCT00533897|3630112|FG007|NOT COMPLETED|Lead-in (LI) Period 1||0
2919678|NCT00533897|3630105|FG000|STARTED|Double-blind Withdrawal (DBW) Period 2||0
2919679|NCT00533897|3630106|FG001|STARTED|Double-blind Withdrawal (DBW) Period 2||40
2919680|NCT00533897|3630107|FG002|STARTED|Double-blind Withdrawal (DBW) Period 2||80
2919681|NCT00533897|3630108|FG003|STARTED|Double-blind Withdrawal (DBW) Period 2||0
2919682|NCT00533897|3630109|FG004|STARTED|Double-blind Withdrawal (DBW) Period 2||0
2919683|NCT00533897|3630110|FG005|STARTED|Double-blind Withdrawal (DBW) Period 2||0
2919684|NCT00533897|3630111|FG006|STARTED|Double-blind Withdrawal (DBW) Period 2||0
2919685|NCT00533897|3630112|FG007|STARTED|Double-blind Withdrawal (DBW) Period 2||0
2919686|NCT00533897|3630105|FG000|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
2919687|NCT00533897|3630106|FG001|COMPLETED|Double-blind Withdrawal (DBW) Period 2|One participant discontinued the DBW Period due to Lack of Efficacy to enter the RI Period early|39
2919688|NCT00533897|3630107|FG002|COMPLETED|Double-blind Withdrawal (DBW) Period 2|Two participants discontinued the DBW Period due to Lack of Efficacy to enter the RI Period early|77
2919689|NCT00533897|3630108|FG003|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
2919690|NCT00533897|3630109|FG004|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
2919691|NCT00533897|3630110|FG005|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
2919692|NCT00533897|3630111|FG006|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
2919693|NCT00533897|3630112|FG007|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
2919694|NCT00533897|3630105|FG000|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
2919695|NCT00533897|3630106|FG001|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||1
2919696|NCT00533897|3630107|FG002|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||3
2919697|NCT00533897|3630108|FG003|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
2919698|NCT00533897|3630109|FG004|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
2919699|NCT00533897|3630110|FG005|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
2919700|NCT00533897|3630111|FG006|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
2888485|NCT00350519|3595048|FG000|STARTED|Overall Study||18
2888486|NCT00350519|3595049|FG001|STARTED|Overall Study||19
2888487|NCT00350519|3595048|FG000|COMPLETED|Overall Study||14
2888488|NCT00350519|3595049|FG001|COMPLETED|Overall Study||13
2888489|NCT00350519|3595048|FG000|NOT COMPLETED|Overall Study||4
2888490|NCT00350519|3595049|FG001|NOT COMPLETED|Overall Study||6
2888491|NCT00350532|3595057|FG000|STARTED|Overall Study||24
2888492|NCT00350532|3595058|FG001|STARTED|Overall Study||19
2888493|NCT00350532|3595057|FG000|COMPLETED|Overall Study||24
2888494|NCT00350532|3595058|FG001|COMPLETED|Overall Study||19
2888495|NCT00350532|3595057|FG000|NOT COMPLETED|Overall Study||0
2888496|NCT00350532|3595058|FG001|NOT COMPLETED|Overall Study||0
2888497|NCT00350545|3595064|FG000|STARTED|Overall Study||37
2888498|NCT00350545|3595064|FG000|COMPLETED|Overall Study||35
2888499|NCT00350545|3595064|FG000|NOT COMPLETED|Overall Study||2
2888500|NCT00350636|3595070|FG000|STARTED|Overall Study||389
2888501|NCT00350636|3595071|FG001|STARTED|Overall Study||400
2888502|NCT00350636|3595070|FG000|COMPLETED|Overall Study||346
2888503|NCT00350636|3595071|FG001|COMPLETED|Overall Study||355
2888504|NCT00350636|3595070|FG000|NOT COMPLETED|Overall Study||43
2888505|NCT00350636|3595071|FG001|NOT COMPLETED|Overall Study||45
2888506|NCT00350727|3595080|FG000|STARTED|Phase I: Dose Escalation||34
2888507|NCT00350727|3595081|FG001|STARTED|Phase I: Dose Escalation||0
2888508|NCT00350727|3595082|FG002|STARTED|Phase I: Dose Escalation||0
2888509|NCT00350727|3595080|FG000|COMPLETED|Phase I: Dose Escalation||0
2888510|NCT00350727|3595081|FG001|COMPLETED|Phase I: Dose Escalation||0
2888511|NCT00350727|3595082|FG002|COMPLETED|Phase I: Dose Escalation||0
2888512|NCT00350727|3595080|FG000|NOT COMPLETED|Phase I: Dose Escalation||34
2888513|NCT00350727|3595081|FG001|NOT COMPLETED|Phase I: Dose Escalation||0
2888514|NCT00350727|3595082|FG002|NOT COMPLETED|Phase I: Dose Escalation||0
2888515|NCT00350727|3595080|FG000|STARTED|Phase II||0
2888516|NCT00350727|3595081|FG001|STARTED|Phase II||19
2888517|NCT00350727|3595082|FG002|STARTED|Phase II||22
2888518|NCT00350727|3595080|FG000|COMPLETED|Phase II||0
2888519|NCT00350727|3595081|FG001|COMPLETED|Phase II||0
2888520|NCT00350727|3595082|FG002|COMPLETED|Phase II||0
2888521|NCT00350727|3595080|FG000|NOT COMPLETED|Phase II||0
2888522|NCT00350727|3595081|FG001|NOT COMPLETED|Phase II||19
2888523|NCT00350727|3595082|FG002|NOT COMPLETED|Phase II||22
2888524|NCT00350779|3595103|FG000|STARTED|Overall Study||170
2888525|NCT00350779|3595104|FG001|STARTED|Overall Study||92
2888526|NCT00350779|3595103|FG000|COMPLETED|Overall Study||148
2888527|NCT00350779|3595104|FG001|COMPLETED|Overall Study||71
2888528|NCT00350779|3595103|FG000|NOT COMPLETED|Overall Study||22
2888529|NCT00350779|3595104|FG001|NOT COMPLETED|Overall Study||21
2888530|NCT00350792|3595112|FG000|STARTED|Overall Study||62
2888531|NCT00350792|3595112|FG000|COMPLETED|Overall Study||29
2888532|NCT00350792|3595112|FG000|NOT COMPLETED|Overall Study||33
2888533|NCT00350870|3595120|FG000|STARTED|Overall Study||27
2888534|NCT00350870|3595121|FG001|STARTED|Overall Study||28
2888535|NCT00350870|3595122|FG002|STARTED|Overall Study||22
2888536|NCT00350870|3595123|FG003|STARTED|Overall Study||22
2888537|NCT00350870|3595120|FG000|Had at Least 1 Day of Med|Overall Study||19
2888538|NCT00350870|3595121|FG001|Had at Least 1 Day of Med|Overall Study||24
2888539|NCT00350870|3595122|FG002|Had at Least 1 Day of Med|Overall Study||18
2888540|NCT00350870|3595123|FG003|Had at Least 1 Day of Med|Overall Study||19
2888541|NCT00350870|3595120|FG000|COMPLETED|Overall Study||5
2888542|NCT00350870|3595121|FG001|COMPLETED|Overall Study||11
2888543|NCT00350870|3595122|FG002|COMPLETED|Overall Study||6
2888544|NCT00350870|3595123|FG003|COMPLETED|Overall Study||7
2888545|NCT00350870|3595120|FG000|NOT COMPLETED|Overall Study||22
2888546|NCT00350870|3595121|FG001|NOT COMPLETED|Overall Study||17
2888547|NCT00350870|3595122|FG002|NOT COMPLETED|Overall Study||16
2888548|NCT00350870|3595123|FG003|NOT COMPLETED|Overall Study||15
2888549|NCT00351000|3595133|FG000|STARTED|Overall Study||24
2888550|NCT00351000|3595133|FG000|COMPLETED|Overall Study||21
2888551|NCT00351000|3595133|FG000|NOT COMPLETED|Overall Study||3
2888552|NCT00351039|3595140|FG000|STARTED|Overall Study||8
2888553|NCT00351039|3595140|FG000|COMPLETED|Overall Study|The study was halted before Phase II was initiated.|8
2888554|NCT00351039|3595140|FG000|NOT COMPLETED|Overall Study||0
2888555|NCT00351273|3595148|FG000|STARTED|Overall Study||15
2888556|NCT00351273|3595149|FG001|STARTED|Overall Study||12
2888557|NCT00351273|3595150|FG002|STARTED|Overall Study||15
2888558|NCT00351273|3595148|FG000|COMPLETED|Overall Study||14
2888559|NCT00351273|3595149|FG001|COMPLETED|Overall Study||10
2888560|NCT00351273|3595150|FG002|COMPLETED|Overall Study||10
2888561|NCT00351273|3595148|FG000|NOT COMPLETED|Overall Study||1
2888562|NCT00351273|3595149|FG001|NOT COMPLETED|Overall Study||2
2888563|NCT00351273|3595150|FG002|NOT COMPLETED|Overall Study||5
2888564|NCT00351299|3595165|FG000|STARTED|Overall Study||25
2888565|NCT00351299|3595166|FG001|STARTED|Overall Study||28
2888566|NCT00351299|3595165|FG000|COMPLETED|Overall Study||25
2888567|NCT00351299|3595166|FG001|COMPLETED|Overall Study||28
2888568|NCT00351299|3595165|FG000|NOT COMPLETED|Overall Study||0
2888569|NCT00351299|3595166|FG001|NOT COMPLETED|Overall Study||0
2888570|NCT00351351|3595178|FG000|STARTED|Overall Study||34
2888571|NCT00351351|3595179|FG001|STARTED|Overall Study||36
2888572|NCT00351351|3595178|FG000|COMPLETED|Overall Study||25
2888573|NCT00351351|3595179|FG001|COMPLETED|Overall Study||32
2888574|NCT00351351|3595178|FG000|NOT COMPLETED|Overall Study||9
2888575|NCT00351351|3595179|FG001|NOT COMPLETED|Overall Study||4
2888576|NCT00351377|3595185|FG000|STARTED|Overall Study||111
2888577|NCT00351377|3595185|FG000|COMPLETED|Overall Study||104
2888578|NCT00351377|3595185|FG000|NOT COMPLETED|Overall Study||7
2888579|NCT00351416|3595191|FG000|STARTED|Overall Study||6
2888580|NCT00351416|3595192|FG001|STARTED|Overall Study||9
2888581|NCT00351416|3595191|FG000|COMPLETED|Overall Study||6
2888582|NCT00351416|3595192|FG001|COMPLETED|Overall Study||9
2888583|NCT00351416|3595191|FG000|NOT COMPLETED|Overall Study||0
2888584|NCT00351416|3595192|FG001|NOT COMPLETED|Overall Study||0
2888585|NCT00351468|3595198|FG000|STARTED|Overall Study||302
2888586|NCT00351468|3595198|FG000|Subjects From TRA100773A|Overall Study||51
2888587|NCT00351468|3595198|FG000|Subjects From TRA100773B|Overall Study||61
2888588|NCT00351468|3595198|FG000|Subjects From TRA102537 Raise|Overall Study||146
2888589|NCT00351468|3595198|FG000|Subjects From TRA108057 Repeat|Overall Study||43
2888590|NCT00351468|3595198|FG000|Unknown - Not From Previous Trial|Overall Study|Mistakenly enrolled (not in any of the 3 trials) On 50 mg/d eltrombopag for 18 days and withdrawn|1
2888591|NCT00351468|3595198|FG000|COMPLETED|Overall Study||135
2888592|NCT00351468|3595198|FG000|NOT COMPLETED|Overall Study||167
2888593|NCT00351533|3595205|FG000|STARTED|Overall Study||41
2888594|NCT00351533|3595206|FG001|STARTED|Overall Study||49
2888595|NCT00351533|3595205|FG000|COMPLETED|Overall Study|Pts did not undergo BALs if not intubated|39
2888596|NCT00351533|3595206|FG001|COMPLETED|Overall Study|Pts did not undergo BALs if not intubated|44
2888597|NCT00351533|3595205|FG000|NOT COMPLETED|Overall Study||2
2888598|NCT00351533|3595206|FG001|NOT COMPLETED|Overall Study||5
2888599|NCT00351611|3595214|FG000|STARTED|Overall Study||89
2888600|NCT00351611|3595215|FG001|STARTED|Overall Study||98
2888601|NCT00351611|3595214|FG000|Treated|Overall Study||89
2888602|NCT00351611|3595215|FG001|Treated|Overall Study||98
2888603|NCT00351611|3595214|FG000|COMPLETED|Overall Study||75
2888604|NCT00351611|3595215|FG001|COMPLETED|Overall Study||88
2888605|NCT00351611|3595214|FG000|NOT COMPLETED|Overall Study||14
2888606|NCT00351611|3595215|FG001|NOT COMPLETED|Overall Study||10
2888607|NCT00351741|3595223|FG000|STARTED|Overall Study||31
2888608|NCT00351741|3595224|FG001|STARTED|Overall Study||31
2888609|NCT00351741|3595223|FG000|COMPLETED|Overall Study||31
2888610|NCT00351741|3595224|FG001|COMPLETED|Overall Study||31
2888611|NCT00351741|3595223|FG000|NOT COMPLETED|Overall Study||0
2888612|NCT00351741|3595224|FG001|NOT COMPLETED|Overall Study||0
2888613|NCT00351819|3595232|FG000|STARTED|Overall Study||43
2888614|NCT00351819|3595233|FG001|STARTED|Overall Study||41
2888615|NCT00351819|3595232|FG000|COMPLETED|Overall Study||36
2888616|NCT00351819|3595233|FG001|COMPLETED|Overall Study||29
2888617|NCT00351819|3595232|FG000|NOT COMPLETED|Overall Study||7
2888618|NCT00351819|3595233|FG001|NOT COMPLETED|Overall Study||12
2888619|NCT00351936|3595239|FG000|STARTED|Overall Study||15
2888620|NCT00351936|3595239|FG000|COMPLETED|Overall Study||15
2888621|NCT00351936|3595239|FG000|NOT COMPLETED|Overall Study||0
2888622|NCT00352001|3595244|FG000|STARTED|Overall Study||37
2888623|NCT00352001|3595244|FG000|Azacitidine 75mg/Lenalidomide 5mg-14 Day|Overall Study||3
2888624|NCT00352001|3595244|FG000|Azacitidine 75mg/Lenalidomide 5mg-21 Day|Overall Study||3
2888625|NCT00352001|3595244|FG000|Azacitidine 75mg/Lenalidomide 10mg-14day|Overall Study||3
2888626|NCT00352001|3595244|FG000|COMPLETED|Overall Study||37
2888627|NCT00352001|3595244|FG000|NOT COMPLETED|Overall Study||0
2888628|NCT00352027|3595248|FG000|STARTED|Overall Study||80
2888629|NCT00352027|3595248|FG000|COMPLETED|Overall Study||77
2888630|NCT00352027|3595248|FG000|NOT COMPLETED|Overall Study||3
2888631|NCT00352053|3595276|FG000|STARTED|Double-Blind Phase (Through Week 48)||45
2888632|NCT00352053|3595277|FG001|STARTED|Double-Blind Phase (Through Week 48)||42
2888633|NCT00352053|3595276|FG000|COMPLETED|Double-Blind Phase (Through Week 48)||27
2888634|NCT00352053|3595277|FG001|COMPLETED|Double-Blind Phase (Through Week 48)|The 10 participants discontinued for virologic failure enrolled early in the open-label extension.|29
2888635|NCT00352053|3595276|FG000|NOT COMPLETED|Double-Blind Phase (Through Week 48)||18
2888636|NCT00352053|3595277|FG001|NOT COMPLETED|Double-Blind Phase (Through Week 48)||13
2888637|NCT00352053|3595276|FG000|STARTED|First Extension Phase (Weeks 48-144)|3 participants completed the double-blind phase but did not enroll in the 1st extension phase.|24
2888638|NCT00352053|3595277|FG001|STARTED|First Extension Phase (Weeks 48-144)|3 participants completed the double-blind phase but did not enroll in the 1st extension phase.|36
2888639|NCT00352053|3595276|FG000|COMPLETED|First Extension Phase (Weeks 48-144)||12
2888640|NCT00352053|3595277|FG001|COMPLETED|First Extension Phase (Weeks 48-144)||19
2888641|NCT00352053|3595276|FG000|NOT COMPLETED|First Extension Phase (Weeks 48-144)||12
2888642|NCT00352053|3595277|FG001|NOT COMPLETED|First Extension Phase (Weeks 48-144)||17
2888643|NCT00352053|3595276|FG000|STARTED|Second Extension Phase (Weeks 144-240)|3 participants completed the 1st extension phase but did not enroll in the 2nd extension phase.|9
2888644|NCT00352053|3595277|FG001|STARTED|Second Extension Phase (Weeks 144-240)|5 participants completed the 1st extension phase but did not enroll in the 2nd extension phase.|14
2888645|NCT00352053|3595276|FG000|COMPLETED|Second Extension Phase (Weeks 144-240)||4
2888646|NCT00352053|3595277|FG001|COMPLETED|Second Extension Phase (Weeks 144-240)||9
2888647|NCT00352053|3595276|FG000|NOT COMPLETED|Second Extension Phase (Weeks 144-240)||5
2888648|NCT00352053|3595277|FG001|NOT COMPLETED|Second Extension Phase (Weeks 144-240)||5
2888649|NCT00352053|3595276|FG000|STARTED|Third Extension Phase (Weeks 240-294)|3 participants completed the 2nd extension phase but did not enroll in the 3rd extension phase.|1
2888650|NCT00352053|3595277|FG001|STARTED|Third Extension Phase (Weeks 240-294)|5 participants completed the 2nd extension phase but did not enroll in the 3rd extension phase.|4
2888651|NCT00352053|3595276|FG000|COMPLETED|Third Extension Phase (Weeks 240-294)||0
2888652|NCT00352053|3595277|FG001|COMPLETED|Third Extension Phase (Weeks 240-294)||2
2888653|NCT00352053|3595276|FG000|NOT COMPLETED|Third Extension Phase (Weeks 240-294)||1
2888654|NCT00352053|3595277|FG001|NOT COMPLETED|Third Extension Phase (Weeks 240-294)||2
2888655|NCT00352105|3595291|FG000|STARTED|Overall Study||60
2888656|NCT00352105|3595291|FG000|COMPLETED|Overall Study||20
2888657|NCT00352105|3595291|FG000|NOT COMPLETED|Overall Study||40
2888658|NCT00352365|3595295|FG000|STARTED|Induction Therapy||41
2888659|NCT00352365|3595295|FG000|Eligible|Induction Therapy||38
2888660|NCT00352365|3595295|FG000|Eligible and Began Protocol Therapy|Induction Therapy||37
2888661|NCT00352365|3595295|FG000|COMPLETED|Induction Therapy||14
2888662|NCT00352365|3595295|FG000|NOT COMPLETED|Induction Therapy||27
2888663|NCT00352365|3595295|FG000|STARTED|Maintenance Therapy||12
2888664|NCT00352365|3595295|FG000|Eligible and Began Protocol Therapy|Maintenance Therapy||8
2888665|NCT00352365|3595295|FG000|COMPLETED|Maintenance Therapy||0
2888666|NCT00352365|3595295|FG000|NOT COMPLETED|Maintenance Therapy||12
2888667|NCT00352417|3595305|FG000|STARTED|Overall Study||24
2888668|NCT00352417|3595306|FG001|STARTED|Overall Study||26
2888669|NCT00352417|3595305|FG000|COMPLETED|Overall Study||19
2888670|NCT00352417|3595306|FG001|COMPLETED|Overall Study||21
2888671|NCT00352417|3595305|FG000|NOT COMPLETED|Overall Study||5
2888672|NCT00352417|3595306|FG001|NOT COMPLETED|Overall Study||5
2888673|NCT00352612|3595314|FG000|STARTED|Overall Study||100
2888674|NCT00352612|3595315|FG001|STARTED|Overall Study||100
2888675|NCT00352612|3595314|FG000|COMPLETED|Overall Study||100
2888676|NCT00352612|3595315|FG001|COMPLETED|Overall Study||100
2888677|NCT00352612|3595314|FG000|NOT COMPLETED|Overall Study||0
2888678|NCT00352612|3595315|FG001|NOT COMPLETED|Overall Study||0
2888679|NCT00352664|3595323|FG000|STARTED|Overall Study||27
2888680|NCT00352664|3595324|FG001|STARTED|Overall Study||0
2888681|NCT00352664|3595323|FG000|COMPLETED|Overall Study||20
2888682|NCT00352664|3595324|FG001|COMPLETED|Overall Study||0
2888683|NCT00352664|3595323|FG000|NOT COMPLETED|Overall Study||7
2888684|NCT00352664|3595324|FG001|NOT COMPLETED|Overall Study||0
2888685|NCT00352690|3595332|FG000|STARTED|Overall Study||10
2888686|NCT00352690|3595333|FG001|STARTED|Overall Study||0
2888687|NCT00352690|3595332|FG000|COMPLETED|Overall Study||8
2888688|NCT00352690|3595333|FG001|COMPLETED|Overall Study||0
2888689|NCT00352690|3595332|FG000|NOT COMPLETED|Overall Study||2
2888690|NCT00352690|3595333|FG001|NOT COMPLETED|Overall Study||0
2888691|NCT00352755|3595339|FG000|STARTED|Overall Study||18
2888692|NCT00352755|3595339|FG000|COMPLETED|Overall Study||16
2888693|NCT00352755|3595339|FG000|NOT COMPLETED|Overall Study||2
2888694|NCT00352781|3595343|FG000|STARTED|Overall Study||1767
2888695|NCT00352781|3595343|FG000|COMPLETED|Overall Study||884
2888696|NCT00352781|3595343|FG000|NOT COMPLETED|Overall Study||883
2888697|NCT00352794|3595347|FG000|STARTED|Overall Study||40
2888698|NCT00352794|3595347|FG000|COMPLETED|Overall Study||40
2888699|NCT00352794|3595347|FG000|NOT COMPLETED|Overall Study||0
2888700|NCT00352846|3595353|FG000|STARTED|Overall Study||37
2888701|NCT00352846|3595354|FG001|STARTED|Overall Study||37
2888702|NCT00352846|3595353|FG000|COMPLETED|Overall Study||29
2888703|NCT00352846|3595354|FG001|COMPLETED|Overall Study||24
2888704|NCT00352846|3595353|FG000|NOT COMPLETED|Overall Study||8
2888705|NCT00352846|3595354|FG001|NOT COMPLETED|Overall Study||13
2888706|NCT00352885|3595362|FG000|STARTED|Overall Study||9
2888707|NCT00352885|3595363|FG001|STARTED|Overall Study||11
2888708|NCT00352885|3595362|FG000|Completed Cycle 1 of IL-2 Treatment|Overall Study||9
2888709|NCT00352885|3595363|FG001|Completed Cycle 1 of IL-2 Treatment|Overall Study||11
2888710|NCT00352885|3595362|FG000|Completed Cycle 2 of IL-2 Treatment|Overall Study||8
2888711|NCT00352885|3595363|FG001|Completed Cycle 2 of IL-2 Treatment|Overall Study||9
2888712|NCT00352885|3595362|FG000|Completed Cycle 3 of IL-2 Treatment|Overall Study||4
2888713|NCT00352885|3595363|FG001|Completed Cycle 3 of IL-2 Treatment|Overall Study||7
2888714|NCT00352885|3595362|FG000|COMPLETED|Overall Study||3
2888715|NCT00352885|3595363|FG001|COMPLETED|Overall Study||4
2888716|NCT00352885|3595362|FG000|NOT COMPLETED|Overall Study||6
2888717|NCT00352885|3595363|FG001|NOT COMPLETED|Overall Study||7
2888718|NCT00352911|3595371|FG000|STARTED|150mg Twice Daily (14 Days)||16
2888719|NCT00352911|3595372|FG001|STARTED|150mg Twice Daily (14 Days)||3
2888720|NCT00352911|3595371|FG000|COMPLETED|150mg Twice Daily (14 Days)||16
2888721|NCT00352911|3595372|FG001|COMPLETED|150mg Twice Daily (14 Days)||3
2888722|NCT00352911|3595371|FG000|NOT COMPLETED|150mg Twice Daily (14 Days)||0
2888723|NCT00352911|3595372|FG001|NOT COMPLETED|150mg Twice Daily (14 Days)||0
2888724|NCT00352911|3595371|FG000|STARTED|300mg Twice Daily (14 Days)||16
2888725|NCT00352911|3595372|FG001|STARTED|300mg Twice Daily (14 Days)||3
2888726|NCT00352911|3595371|FG000|COMPLETED|300mg Twice Daily (14 Days)||15
2888727|NCT00352911|3595372|FG001|COMPLETED|300mg Twice Daily (14 Days)||3
2888728|NCT00352911|3595371|FG000|NOT COMPLETED|300mg Twice Daily (14 Days)||1
2888729|NCT00352911|3595372|FG001|NOT COMPLETED|300mg Twice Daily (14 Days)||0
2888730|NCT00352976|3595378|FG000|STARTED|Overall Study||83
2888731|NCT00352976|3595378|FG000|COMPLETED|Overall Study||83
2888732|NCT00352976|3595378|FG000|NOT COMPLETED|Overall Study||0
2888733|NCT00353119|3595385|FG000|STARTED|First Intervention Day 0 to Week 12||5
2888734|NCT00353119|3595386|FG001|STARTED|First Intervention Day 0 to Week 12||10
2888735|NCT00353119|3595385|FG000|COMPLETED|First Intervention Day 0 to Week 12||5
2888736|NCT00353119|3595386|FG001|COMPLETED|First Intervention Day 0 to Week 12||10
2888737|NCT00353119|3595385|FG000|NOT COMPLETED|First Intervention Day 0 to Week 12||0
3170318|NCT01929031|3897692|FG004|NOT COMPLETED|Overall Study||1
2888738|NCT00353119|3595386|FG001|NOT COMPLETED|First Intervention Day 0 to Week 12||0
2888739|NCT00353119|3595385|FG000|STARTED|Second Intervention Week 12 to Week 28||5
2888740|NCT00353119|3595386|FG001|STARTED|Second Intervention Week 12 to Week 28||10
2888741|NCT00353119|3595385|FG000|COMPLETED|Second Intervention Week 12 to Week 28||5
2888742|NCT00353119|3595386|FG001|COMPLETED|Second Intervention Week 12 to Week 28||10
2888743|NCT00353119|3595385|FG000|NOT COMPLETED|Second Intervention Week 12 to Week 28||0
2888744|NCT00353119|3595386|FG001|NOT COMPLETED|Second Intervention Week 12 to Week 28||0
2888745|NCT00353262|3595395|FG000|STARTED|Overall Study||36
2888746|NCT00353262|3595395|FG000|COMPLETED|Overall Study||7
2888747|NCT00353262|3595395|FG000|NOT COMPLETED|Overall Study||29
2888748|NCT00353301|3595399|FG000|STARTED|Overall Study||25
2888749|NCT00353301|3595399|FG000|COMPLETED|Overall Study||25
2888750|NCT00353301|3595399|FG000|NOT COMPLETED|Overall Study||0
2888751|NCT00353366|3595403|FG000|STARTED|Overall Study||1439
2888752|NCT00353366|3595403|FG000|COMPLETED|Overall Study||1296
2888753|NCT00353366|3595403|FG000|NOT COMPLETED|Overall Study||143
2888754|NCT00353418|3595409|FG000|STARTED|Overall Study||138
2888755|NCT00353418|3595410|FG001|STARTED|Overall Study||277
2888756|NCT00353418|3595409|FG000|COMPLETED|Overall Study||55
2888757|NCT00353418|3595410|FG001|COMPLETED|Overall Study||119
2888758|NCT00353418|3595409|FG000|NOT COMPLETED|Overall Study||83
2888759|NCT00353418|3595410|FG001|NOT COMPLETED|Overall Study||158
2888760|NCT00353431|3595418|FG000|STARTED|Overall Study||63
2888761|NCT00353431|3595419|FG001|STARTED|Overall Study||67
2888762|NCT00353431|3595418|FG000|COMPLETED|Overall Study||63
2888763|NCT00353431|3595419|FG001|COMPLETED|Overall Study||67
2888764|NCT00353431|3595418|FG000|NOT COMPLETED|Overall Study||0
2888765|NCT00353431|3595419|FG001|NOT COMPLETED|Overall Study||0
2888766|NCT00353496|3595427|FG000|STARTED|Overall Study||101
2888767|NCT00353496|3595428|FG001|STARTED|Overall Study||103
2888768|NCT00353496|3595427|FG000|COMPLETED|Overall Study|Patients who completed specified assessments or met primary efficacy endpoint criteria for an event.|85
2888769|NCT00353496|3595428|FG001|COMPLETED|Overall Study||86
2888770|NCT00353496|3595427|FG000|NOT COMPLETED|Overall Study||16
2888771|NCT00353496|3595428|FG001|NOT COMPLETED|Overall Study||17
2888772|NCT00353522|3595437|FG000|STARTED|Overall Study||89
2888773|NCT00353522|3595438|FG001|STARTED|Overall Study||46
2888774|NCT00353522|3595437|FG000|COMPLETED|Overall Study||74
2888775|NCT00353522|3595438|FG001|COMPLETED|Overall Study||37
2888776|NCT00353522|3595437|FG000|NOT COMPLETED|Overall Study||15
2888777|NCT00353522|3595438|FG001|NOT COMPLETED|Overall Study||9
2888778|NCT00353652|3595446|FG000|STARTED|First Intervention - 3 Months||15
2888779|NCT00353652|3595447|FG001|STARTED|First Intervention - 3 Months||15
2888780|NCT00353652|3595448|FG002|STARTED|First Intervention - 3 Months||6
2888781|NCT00353652|3595449|FG003|STARTED|First Intervention - 3 Months||7
2888782|NCT00353652|3595450|FG004|STARTED|First Intervention - 3 Months||3
2888783|NCT00353652|3595451|FG005|STARTED|First Intervention - 3 Months||0
2888784|NCT00353652|3595452|FG006|STARTED|First Intervention - 3 Months||1
2888785|NCT00353652|3595453|FG007|STARTED|First Intervention - 3 Months||0
2888786|NCT00353652|3595446|FG000|COMPLETED|First Intervention - 3 Months||12
2888787|NCT00353652|3595447|FG001|COMPLETED|First Intervention - 3 Months||11
2888788|NCT00353652|3595448|FG002|COMPLETED|First Intervention - 3 Months||6
2888789|NCT00353652|3595449|FG003|COMPLETED|First Intervention - 3 Months||7
2888790|NCT00353652|3595450|FG004|COMPLETED|First Intervention - 3 Months||3
2888791|NCT00353652|3595451|FG005|COMPLETED|First Intervention - 3 Months||0
2888792|NCT00353652|3595452|FG006|COMPLETED|First Intervention - 3 Months||1
2888793|NCT00353652|3595453|FG007|COMPLETED|First Intervention - 3 Months||0
2888794|NCT00353652|3595446|FG000|NOT COMPLETED|First Intervention - 3 Months||3
2888795|NCT00353652|3595447|FG001|NOT COMPLETED|First Intervention - 3 Months||4
2888796|NCT00353652|3595448|FG002|NOT COMPLETED|First Intervention - 3 Months||0
2888797|NCT00353652|3595449|FG003|NOT COMPLETED|First Intervention - 3 Months||0
2888798|NCT00353652|3595450|FG004|NOT COMPLETED|First Intervention - 3 Months||0
2888799|NCT00353652|3595451|FG005|NOT COMPLETED|First Intervention - 3 Months||0
2888800|NCT00353652|3595452|FG006|NOT COMPLETED|First Intervention - 3 Months||0
2888801|NCT00353652|3595453|FG007|NOT COMPLETED|First Intervention - 3 Months||0
2888802|NCT00353652|3595446|FG000|STARTED|Second Intervention - 3 Months||12
2888803|NCT00353652|3595447|FG001|STARTED|Second Intervention - 3 Months||11
2888804|NCT00353652|3595448|FG002|STARTED|Second Intervention - 3 Months||6
2888805|NCT00353652|3595449|FG003|STARTED|Second Intervention - 3 Months||7
2888806|NCT00353652|3595450|FG004|STARTED|Second Intervention - 3 Months||3
2888807|NCT00353652|3595451|FG005|STARTED|Second Intervention - 3 Months||0
2888808|NCT00353652|3595452|FG006|STARTED|Second Intervention - 3 Months||1
2888809|NCT00353652|3595453|FG007|STARTED|Second Intervention - 3 Months||0
2888810|NCT00353652|3595446|FG000|COMPLETED|Second Intervention - 3 Months||12
2888811|NCT00353652|3595447|FG001|COMPLETED|Second Intervention - 3 Months||11
2888812|NCT00353652|3595448|FG002|COMPLETED|Second Intervention - 3 Months||6
2888813|NCT00353652|3595449|FG003|COMPLETED|Second Intervention - 3 Months||7
2888814|NCT00353652|3595450|FG004|COMPLETED|Second Intervention - 3 Months||3
2888815|NCT00353652|3595451|FG005|COMPLETED|Second Intervention - 3 Months||0
2888816|NCT00353652|3595452|FG006|COMPLETED|Second Intervention - 3 Months||1
2888817|NCT00353652|3595453|FG007|COMPLETED|Second Intervention - 3 Months||0
2888818|NCT00353652|3595446|FG000|NOT COMPLETED|Second Intervention - 3 Months||0
2888819|NCT00353652|3595447|FG001|NOT COMPLETED|Second Intervention - 3 Months||0
2888820|NCT00353652|3595448|FG002|NOT COMPLETED|Second Intervention - 3 Months||0
2888821|NCT00353652|3595449|FG003|NOT COMPLETED|Second Intervention - 3 Months||0
2888822|NCT00353652|3595450|FG004|NOT COMPLETED|Second Intervention - 3 Months||0
2888823|NCT00353652|3595451|FG005|NOT COMPLETED|Second Intervention - 3 Months||0
2888824|NCT00353652|3595452|FG006|NOT COMPLETED|Second Intervention - 3 Months||0
2888825|NCT00353652|3595453|FG007|NOT COMPLETED|Second Intervention - 3 Months||0
2888826|NCT00353652|3595446|FG000|STARTED|Third Intervention - 3 Months||0
2888827|NCT00353652|3595447|FG001|STARTED|Third Intervention - 3 Months||0
2888828|NCT00353652|3595448|FG002|STARTED|Third Intervention - 3 Months||6
2888829|NCT00353652|3595449|FG003|STARTED|Third Intervention - 3 Months||7
2888830|NCT00353652|3595450|FG004|STARTED|Third Intervention - 3 Months||3
2888831|NCT00353652|3595451|FG005|STARTED|Third Intervention - 3 Months||0
2888832|NCT00353652|3595452|FG006|STARTED|Third Intervention - 3 Months||1
2888833|NCT00353652|3595453|FG007|STARTED|Third Intervention - 3 Months||0
2888834|NCT00353652|3595446|FG000|COMPLETED|Third Intervention - 3 Months||0
2888835|NCT00353652|3595447|FG001|COMPLETED|Third Intervention - 3 Months||0
2888836|NCT00353652|3595448|FG002|COMPLETED|Third Intervention - 3 Months||6
2888837|NCT00353652|3595449|FG003|COMPLETED|Third Intervention - 3 Months||6
2888838|NCT00353652|3595450|FG004|COMPLETED|Third Intervention - 3 Months||3
2888839|NCT00353652|3595451|FG005|COMPLETED|Third Intervention - 3 Months||0
2888840|NCT00353652|3595452|FG006|COMPLETED|Third Intervention - 3 Months||1
2888841|NCT00353652|3595453|FG007|COMPLETED|Third Intervention - 3 Months||0
2888842|NCT00353652|3595446|FG000|NOT COMPLETED|Third Intervention - 3 Months||0
2888843|NCT00353652|3595447|FG001|NOT COMPLETED|Third Intervention - 3 Months||0
2888844|NCT00353652|3595448|FG002|NOT COMPLETED|Third Intervention - 3 Months||0
2888845|NCT00353652|3595449|FG003|NOT COMPLETED|Third Intervention - 3 Months||1
2888846|NCT00353652|3595450|FG004|NOT COMPLETED|Third Intervention - 3 Months||0
2888847|NCT00353652|3595451|FG005|NOT COMPLETED|Third Intervention - 3 Months||0
2888848|NCT00353652|3595452|FG006|NOT COMPLETED|Third Intervention - 3 Months||0
2888849|NCT00353652|3595453|FG007|NOT COMPLETED|Third Intervention - 3 Months||0
2888850|NCT00353704|3595470|FG000|STARTED|Overall Study||25
2888851|NCT00353704|3595471|FG001|STARTED|Overall Study||25
2888852|NCT00353704|3595470|FG000|COMPLETED|Overall Study||22
2888853|NCT00353704|3595471|FG001|COMPLETED|Overall Study||24
3170319|NCT01929031|3897693|FG005|NOT COMPLETED|Overall Study||1
3170320|NCT01929044|3897705|FG000|STARTED|Overall Study||153
3170321|NCT01929044|3897706|FG001|STARTED|Overall Study||146
3170322|NCT01929044|3897705|FG000|COMPLETED|Overall Study||142
3170323|NCT01929044|3897706|FG001|COMPLETED|Overall Study||129
2888854|NCT00353704|3595470|FG000|NOT COMPLETED|Overall Study||3
2888855|NCT00353704|3595471|FG001|NOT COMPLETED|Overall Study||1
2888856|NCT00353795|3595477|FG000|STARTED|Overall Study||179
2888857|NCT00353795|3595477|FG000|COMPLETED|Overall Study||179
2888858|NCT00353795|3595477|FG000|NOT COMPLETED|Overall Study||0
2888859|NCT00353834|3595483|FG000|STARTED|Overall Study||26
2888860|NCT00353834|3595484|FG001|STARTED|Overall Study||27
2888861|NCT00353834|3595483|FG000|COMPLETED|Overall Study||26
2888862|NCT00353834|3595484|FG001|COMPLETED|Overall Study||27
2888863|NCT00353834|3595483|FG000|NOT COMPLETED|Overall Study||0
2888864|NCT00353834|3595484|FG001|NOT COMPLETED|Overall Study||0
2888865|NCT00353873|3595492|FG000|STARTED|Overall Study||153
2888866|NCT00353873|3595493|FG001|STARTED|Overall Study||150
2888867|NCT00353873|3595492|FG000|COMPLETED|Overall Study||147
2888868|NCT00353873|3595493|FG001|COMPLETED|Overall Study||147
2888869|NCT00353873|3595492|FG000|NOT COMPLETED|Overall Study||6
2888870|NCT00353873|3595493|FG001|NOT COMPLETED|Overall Study||3
2888871|NCT00353977|3595499|FG000|STARTED|Overall Study||38
2888872|NCT00353977|3595499|FG000|COMPLETED|Overall Study||38
2888873|NCT00353977|3595499|FG000|NOT COMPLETED|Overall Study||0
2888874|NCT00354029|3595505|FG000|STARTED|Overall Study||43
2888875|NCT00354029|3595506|FG001|STARTED|Overall Study||40
2888876|NCT00354029|3595505|FG000|COMPLETED|Overall Study||39
2888877|NCT00354029|3595506|FG001|COMPLETED|Overall Study||38
2888878|NCT00354029|3595505|FG000|NOT COMPLETED|Overall Study||4
2888879|NCT00354029|3595506|FG001|NOT COMPLETED|Overall Study||2
2888880|NCT00354107|3595512|FG000|STARTED|Overall Study||5
2888881|NCT00354107|3595512|FG000|COMPLETED|Overall Study||0
2888882|NCT00354107|3595512|FG000|NOT COMPLETED|Overall Study||5
2888883|NCT00354159|3595518|FG000|STARTED|Randomized Study Period||202
2888884|NCT00354159|3595519|FG001|STARTED|Randomized Study Period||198
2888885|NCT00354159|3595518|FG000|COMPLETED|Randomized Study Period||180
2888886|NCT00354159|3595519|FG001|COMPLETED|Randomized Study Period||176
2888887|NCT00354159|3595518|FG000|NOT COMPLETED|Randomized Study Period||22
2888888|NCT00354159|3595519|FG001|NOT COMPLETED|Randomized Study Period||22
2888889|NCT00354159|3595518|FG000|STARTED|Long-term Follow-up|Number entering post 12-month non-randomized long-term follow-up period|180
2888890|NCT00354159|3595519|FG001|STARTED|Long-term Follow-up|Number entering post 12-month non-randomized long-term follow-up period|176
2888891|NCT00354159|3595518|FG000|COMPLETED|Long-term Follow-up|All subjects were exited at the time of study closure|0
2888892|NCT00354159|3595519|FG001|COMPLETED|Long-term Follow-up|All subjects were exited at the time of study closure|0
2888893|NCT00354159|3595518|FG000|NOT COMPLETED|Long-term Follow-up||180
2888894|NCT00354159|3595519|FG001|NOT COMPLETED|Long-term Follow-up||176
2888895|NCT00354172|3595532|FG000|STARTED|Overall Study||16
2888896|NCT00354172|3595532|FG000|COMPLETED|Overall Study|1 patient did not reach umbilical cord blood transplant|15
2888897|NCT00354172|3595532|FG000|NOT COMPLETED|Overall Study||1
2888898|NCT00354224|3595536|FG000|STARTED|Overall Study||10
2888899|NCT00354224|3595536|FG000|COMPLETED|Overall Study||10
2888900|NCT00354224|3595536|FG000|NOT COMPLETED|Overall Study||0
2888901|NCT00354341|3595542|FG000|STARTED|Overall Study||88
2888902|NCT00354341|3595543|FG001|STARTED|Overall Study||82
2888903|NCT00354341|3595542|FG000|COMPLETED|Overall Study||85
2888904|NCT00354341|3595543|FG001|COMPLETED|Overall Study||75
2888905|NCT00354341|3595542|FG000|NOT COMPLETED|Overall Study||3
2888906|NCT00354341|3595543|FG001|NOT COMPLETED|Overall Study||7
2888907|NCT00354432|3595553|FG000|STARTED|Overall Study||30
2888908|NCT00354432|3595554|FG001|STARTED|Overall Study||30
2888909|NCT00354432|3595555|FG002|STARTED|Overall Study||30
2888910|NCT00354432|3595556|FG003|STARTED|Overall Study||30
2888911|NCT00354432|3595553|FG000|COMPLETED|Overall Study||24
2888912|NCT00354432|3595554|FG001|COMPLETED|Overall Study||22
2888913|NCT00354432|3595555|FG002|COMPLETED|Overall Study||20
2888914|NCT00354432|3595556|FG003|COMPLETED|Overall Study||20
2888915|NCT00354432|3595553|FG000|NOT COMPLETED|Overall Study||6
2888916|NCT00354432|3595554|FG001|NOT COMPLETED|Overall Study||8
2888917|NCT00354432|3595555|FG002|NOT COMPLETED|Overall Study||10
2888918|NCT00354432|3595556|FG003|NOT COMPLETED|Overall Study||10
2888919|NCT00354484|3595568|FG000|STARTED|Overall Study||142
2888920|NCT00354484|3595569|FG001|STARTED|Overall Study||147
2888921|NCT00354484|3595568|FG000|COMPLETED|Overall Study||138
2888922|NCT00354484|3595569|FG001|COMPLETED|Overall Study||144
2888923|NCT00354484|3595568|FG000|NOT COMPLETED|Overall Study||4
2888924|NCT00354484|3595569|FG001|NOT COMPLETED|Overall Study||3
2888925|NCT00354601|3595575|FG000|STARTED|Overall Study||2
2888926|NCT00354601|3595575|FG000|COMPLETED|Overall Study||0
2888927|NCT00354601|3595575|FG000|NOT COMPLETED|Overall Study||2
2888928|NCT00354614|3595579|FG000|STARTED|Overall Study||81
2888929|NCT00354614|3595579|FG000|COMPLETED|Overall Study||53
2888930|NCT00354614|3595579|FG000|NOT COMPLETED|Overall Study||28
2888931|NCT00354640|3595583|FG000|STARTED|Overall Study||11
2888932|NCT00354640|3595583|FG000|COMPLETED|Overall Study||11
2888933|NCT00354640|3595583|FG000|NOT COMPLETED|Overall Study||0
2888934|NCT00354679|3595587|FG000|STARTED|Overall Study||34
2888935|NCT00354679|3595587|FG000|COMPLETED|Overall Study||33
2888936|NCT00354679|3595587|FG000|NOT COMPLETED|Overall Study||1
2888937|NCT00354744|3595591|FG000|STARTED|Overall Study||109
2888938|NCT00354744|3595591|FG000|COMPLETED|Overall Study||67
2888939|NCT00354744|3595591|FG000|NOT COMPLETED|Overall Study||42
2888940|NCT00354770|3595599|FG000|STARTED|Overall Study||25
2888941|NCT00354770|3595600|FG001|STARTED|Overall Study||25
2888942|NCT00354770|3595599|FG000|COMPLETED|Overall Study||22
2888943|NCT00354770|3595600|FG001|COMPLETED|Overall Study||22
2888944|NCT00354770|3595599|FG000|NOT COMPLETED|Overall Study||3
2888945|NCT00354770|3595600|FG001|NOT COMPLETED|Overall Study||3
2888946|NCT00354887|3595606|FG000|STARTED|Overall Study||30
2888947|NCT00354887|3595606|FG000|COMPLETED|Overall Study||29
2888948|NCT00354887|3595606|FG000|NOT COMPLETED|Overall Study||1
2888949|NCT00354913|3595610|FG000|STARTED|Overall Study||21
2888950|NCT00354913|3595610|FG000|COMPLETED|Overall Study||21
2888951|NCT00354913|3595610|FG000|NOT COMPLETED|Overall Study||0
2888952|NCT00354978|3595614|FG000|STARTED|Overall Study||43
2888953|NCT00354978|3595614|FG000|COMPLETED|Overall Study||43
2888954|NCT00354978|3595614|FG000|NOT COMPLETED|Overall Study||0
2888955|NCT00355030|3595620|FG000|STARTED|Study Period 1 Treatment||46
2888956|NCT00355030|3595621|FG001|STARTED|Study Period 1 Treatment||45
2888957|NCT00355030|3595620|FG000|Received At Least One Dose of Study Drug|Study Period 1 Treatment|1 non-eligible participant received somatropin from previous control group|45
2888958|NCT00355030|3595621|FG001|Received At Least One Dose of Study Drug|Study Period 1 Treatment|2 non-eligible participants received somatropin from previous control group|43
2888959|NCT00355030|3595620|FG000|COMPLETED|Study Period 1 Treatment|Participants from the Netherlands exited the study after Study Period 1.|1
2888960|NCT00355030|3595621|FG001|COMPLETED|Study Period 1 Treatment|Participants from the Netherlands exited the study after Study Period 1.|1
2888961|NCT00355030|3595620|FG000|NOT COMPLETED|Study Period 1 Treatment||45
2888962|NCT00355030|3595621|FG001|NOT COMPLETED|Study Period 1 Treatment||44
2888963|NCT00355030|3595620|FG000|STARTED|Study Period 2 Long Term Follow-Up|Participants from France were given the option to re-consent for Study Period 2.|20
2888964|NCT00355030|3595621|FG001|STARTED|Study Period 2 Long Term Follow-Up|Participants from France were given the option to re-consent for Study Period 2.|19
2888965|NCT00355030|3595620|FG000|COMPLETED|Study Period 2 Long Term Follow-Up||19
2888966|NCT00355030|3595621|FG001|COMPLETED|Study Period 2 Long Term Follow-Up||17
2888967|NCT00355030|3595620|FG000|NOT COMPLETED|Study Period 2 Long Term Follow-Up||1
2888968|NCT00355030|3595621|FG001|NOT COMPLETED|Study Period 2 Long Term Follow-Up||2
2888969|NCT00355056|3595629|FG000|STARTED|Randomization Period||107
2888970|NCT00355056|3595630|FG001|STARTED|Randomization Period||123
2888971|NCT00355056|3595629|FG000|COMPLETED|Randomization Period||103
2888972|NCT00355056|3595630|FG001|COMPLETED|Randomization Period||117
2888973|NCT00355056|3595629|FG000|NOT COMPLETED|Randomization Period||4
2888974|NCT00355056|3595630|FG001|NOT COMPLETED|Randomization Period||6
2888975|NCT00355056|3595629|FG000|STARTED|Optional Patent Foramen Ovale Closure|A sham procedure was not part of this period.|0
2888976|NCT00355056|3595630|FG001|STARTED|Optional Patent Foramen Ovale Closure|Participants who completed Sham Procedure randomization Arm were eligible. 87/103 consented.|87
2888977|NCT00355056|3595629|FG000|COMPLETED|Optional Patent Foramen Ovale Closure||0
2888978|NCT00355056|3595630|FG001|COMPLETED|Optional Patent Foramen Ovale Closure||84
2888979|NCT00355056|3595629|FG000|NOT COMPLETED|Optional Patent Foramen Ovale Closure||0
2888980|NCT00355056|3595630|FG001|NOT COMPLETED|Optional Patent Foramen Ovale Closure||3
2888981|NCT00355082|3595646|FG000|STARTED|Double-Blind (DB) Treatment Phase|112 participants have baseline data; 1 participant did not receive study drug.|113
2888982|NCT00355082|3595647|FG001|STARTED|Double-Blind (DB) Treatment Phase|111 participants have baseline data; 2 participants did not receive study drug.|113
2888983|NCT00355082|3595648|FG002|STARTED|Double-Blind (DB) Treatment Phase||0
2888984|NCT00355082|3595646|FG000|COMPLETED|Double-Blind (DB) Treatment Phase||94
2888985|NCT00355082|3595647|FG001|COMPLETED|Double-Blind (DB) Treatment Phase||79
2888986|NCT00355082|3595648|FG002|COMPLETED|Double-Blind (DB) Treatment Phase||0
2888987|NCT00355082|3595646|FG000|NOT COMPLETED|Double-Blind (DB) Treatment Phase||19
2888988|NCT00355082|3595647|FG001|NOT COMPLETED|Double-Blind (DB) Treatment Phase||34
2888989|NCT00355082|3595648|FG002|NOT COMPLETED|Double-Blind (DB) Treatment Phase||0
2888990|NCT00355082|3595646|FG000|STARTED|Continuation Phase|83 and 101 participants from the 250 and 300 mg groups (DB Phase), respectively, entered the CP.|184
2888991|NCT00355082|3595647|FG001|STARTED|Continuation Phase||0
2888992|NCT00355082|3595648|FG002|STARTED|Continuation Phase|"See Pre-assign. Details for reasons why number starting CP does not equal number completing TP."|11
2888993|NCT00355082|3595646|FG000|COMPLETED|Continuation Phase||160
2888994|NCT00355082|3595647|FG001|COMPLETED|Continuation Phase||0
2888995|NCT00355082|3595648|FG002|COMPLETED|Continuation Phase||8
2888996|NCT00355082|3595646|FG000|NOT COMPLETED|Continuation Phase||24
2888997|NCT00355082|3595647|FG001|NOT COMPLETED|Continuation Phase||0
2888998|NCT00355082|3595648|FG002|NOT COMPLETED|Continuation Phase||3
2888999|NCT00355121|3595662|FG000|STARTED|Overall Study||353
2889000|NCT00355121|3595663|FG001|STARTED|Overall Study||353
2889001|NCT00355121|3595664|FG002|STARTED|Overall Study||175
2889002|NCT00355121|3595662|FG000|COMPLETED|Overall Study||332
2889003|NCT00355121|3595663|FG001|COMPLETED|Overall Study||324
2889004|NCT00355121|3595664|FG002|COMPLETED|Overall Study||170
2889005|NCT00355121|3595662|FG000|NOT COMPLETED|Overall Study||21
2889006|NCT00355121|3595663|FG001|NOT COMPLETED|Overall Study||29
2889007|NCT00355121|3595664|FG002|NOT COMPLETED|Overall Study||5
2889008|NCT00355134|3595680|FG000|STARTED|Core Phase||370
2889009|NCT00355134|3595681|FG001|STARTED|Core Phase||358
2889010|NCT00355134|3595682|FG002|STARTED|Core Phase||355
2889011|NCT00355134|3595683|FG003|STARTED|Core Phase||0
2889012|NCT00355134|3595684|FG004|STARTED|Core Phase||0
2889013|NCT00355134|3595680|FG000|COMPLETED|Core Phase||251
2889014|NCT00355134|3595681|FG001|COMPLETED|Core Phase||272
2889015|NCT00355134|3595682|FG002|COMPLETED|Core Phase||255
2889016|NCT00355134|3595683|FG003|COMPLETED|Core Phase||0
2889017|NCT00355134|3595684|FG004|COMPLETED|Core Phase||0
2889018|NCT00355134|3595680|FG000|NOT COMPLETED|Core Phase||119
2889019|NCT00355134|3595681|FG001|NOT COMPLETED|Core Phase||86
2889020|NCT00355134|3595682|FG002|NOT COMPLETED|Core Phase||100
2889021|NCT00355134|3595683|FG003|NOT COMPLETED|Core Phase||0
2889022|NCT00355134|3595684|FG004|NOT COMPLETED|Core Phase||0
2889023|NCT00355134|3595680|FG000|STARTED|Extension Phase||203
2889024|NCT00355134|3595681|FG001|STARTED|Extension Phase||217
2889025|NCT00355134|3595682|FG002|STARTED|Extension Phase||0
2889026|NCT00355134|3595683|FG003|STARTED|Extension Phase||105
2889027|NCT00355134|3595684|FG004|STARTED|Extension Phase||107
2889028|NCT00355134|3595680|FG000|COMPLETED|Extension Phase||172
2889029|NCT00355134|3595681|FG001|COMPLETED|Extension Phase||180
2889030|NCT00355134|3595682|FG002|COMPLETED|Extension Phase||0
2889031|NCT00355134|3595683|FG003|COMPLETED|Extension Phase||89
2889032|NCT00355134|3595684|FG004|COMPLETED|Extension Phase||88
2889033|NCT00355134|3595680|FG000|NOT COMPLETED|Extension Phase||31
2889034|NCT00355134|3595681|FG001|NOT COMPLETED|Extension Phase||37
2889035|NCT00355134|3595682|FG002|NOT COMPLETED|Extension Phase||0
2889036|NCT00355134|3595683|FG003|NOT COMPLETED|Extension Phase||16
2889037|NCT00355134|3595684|FG004|NOT COMPLETED|Extension Phase||19
3170324|NCT01929044|3897705|FG000|NOT COMPLETED|Overall Study||11
3170325|NCT01929044|3897706|FG001|NOT COMPLETED|Overall Study||17
3170326|NCT01929057|3897714|FG000|STARTED|Overall Study||31
2889038|NCT00355147|3595696|FG000|STARTED|Overall Study||87
2889039|NCT00355147|3595697|FG001|STARTED|Overall Study||87
2889040|NCT00355147|3595696|FG000|COMPLETED|Overall Study||69
2889041|NCT00355147|3595697|FG001|COMPLETED|Overall Study||67
2889042|NCT00355147|3595696|FG000|NOT COMPLETED|Overall Study||18
2889043|NCT00355147|3595697|FG001|NOT COMPLETED|Overall Study||20
2889044|NCT00355199|3595709|FG000|STARTED|Overall Study||120
2889045|NCT00355199|3595710|FG001|STARTED|Overall Study||126
2889046|NCT00355199|3595709|FG000|COMPLETED|Overall Study||113
2889047|NCT00355199|3595710|FG001|COMPLETED|Overall Study||122
2889048|NCT00355199|3595709|FG000|NOT COMPLETED|Overall Study||7
2889049|NCT00355199|3595710|FG001|NOT COMPLETED|Overall Study||4
2889050|NCT00355264|3595716|FG000|STARTED|Part 1 (2 Weeks)||12
2889051|NCT00355264|3595716|FG000|COMPLETED|Part 1 (2 Weeks)||12
2889052|NCT00355264|3595716|FG000|NOT COMPLETED|Part 1 (2 Weeks)||0
2889053|NCT00355264|3595716|FG000|STARTED|Part 2 (8 Weeks)||12
2889054|NCT00355264|3595716|FG000|COMPLETED|Part 2 (8 Weeks)||12
2889055|NCT00355264|3595716|FG000|NOT COMPLETED|Part 2 (8 Weeks)||0
2889056|NCT00355264|3595716|FG000|STARTED|Part 3 (7 Weeks of Extension)||2
2889057|NCT00355264|3595716|FG000|COMPLETED|Part 3 (7 Weeks of Extension)||2
2889058|NCT00355264|3595716|FG000|NOT COMPLETED|Part 3 (7 Weeks of Extension)||0
2889059|NCT00355264|3595716|FG000|STARTED|Extension (Variable Duration)||12
2889060|NCT00355264|3595716|FG000|COMPLETED|Extension (Variable Duration)||10
2889061|NCT00355264|3595716|FG000|NOT COMPLETED|Extension (Variable Duration)||2
3170327|NCT01929057|3897715|FG001|STARTED|Overall Study||3
2889062|NCT00355342|3595727|FG000|STARTED|Overall Study||94
2889063|NCT00355342|3595728|FG001|STARTED|Overall Study||92
2889064|NCT00355342|3595727|FG000|COMPLETED|Overall Study||55
2889065|NCT00355342|3595728|FG001|COMPLETED|Overall Study||56
2889066|NCT00355342|3595727|FG000|NOT COMPLETED|Overall Study||39
2889067|NCT00355342|3595728|FG001|NOT COMPLETED|Overall Study||36
2889068|NCT00355368|3595736|FG000|STARTED|Overall Study||210
2889069|NCT00355368|3595737|FG001|STARTED|Overall Study||210
2889070|NCT00355368|3595736|FG000|COMPLETED|Overall Study||200
2889071|NCT00355368|3595737|FG001|COMPLETED|Overall Study||201
2889072|NCT00355368|3595736|FG000|NOT COMPLETED|Overall Study||10
2889073|NCT00355368|3595737|FG001|NOT COMPLETED|Overall Study||9
2889074|NCT00355394|3595745|FG000|STARTED|Overall Study||15
2889075|NCT00355394|3595746|FG001|STARTED|Overall Study||16
2889076|NCT00355394|3595745|FG000|COMPLETED|Overall Study||15
2889077|NCT00355394|3595746|FG001|COMPLETED|Overall Study||16
2889078|NCT00355394|3595745|FG000|NOT COMPLETED|Overall Study||0
2889079|NCT00355394|3595746|FG001|NOT COMPLETED|Overall Study||0
2889080|NCT00355472|3595754|FG000|STARTED|Overall Study||16
2889081|NCT00355472|3595754|FG000|COMPLETED|Overall Study||15
2889082|NCT00355472|3595754|FG000|NOT COMPLETED|Overall Study||1
2889083|NCT00355615|3595770|FG000|STARTED|Randomized Double Blind Period||42
2889084|NCT00355615|3595771|FG001|STARTED|Randomized Double Blind Period||44
2889085|NCT00355615|3595772|FG002|STARTED|Randomized Double Blind Period||45
2889086|NCT00355615|3595773|FG003|STARTED|Randomized Double Blind Period||46
2889087|NCT00355615|3595774|FG004|STARTED|Randomized Double Blind Period|open label phase followed the randomized phase|0
2889088|NCT00355615|3595770|FG000|COMPLETED|Randomized Double Blind Period|1 dropped out due to adverse event|41
2889089|NCT00355615|3595771|FG001|COMPLETED|Randomized Double Blind Period||44
2889090|NCT00355615|3595772|FG002|COMPLETED|Randomized Double Blind Period|45 were randomized but 1 never received drug|44
2889091|NCT00355615|3595773|FG003|COMPLETED|Randomized Double Blind Period|1 dropped out due to an adverse event|45
2889092|NCT00355615|3595774|FG004|COMPLETED|Randomized Double Blind Period||0
2889093|NCT00355615|3595770|FG000|NOT COMPLETED|Randomized Double Blind Period||1
2889094|NCT00355615|3595771|FG001|NOT COMPLETED|Randomized Double Blind Period||0
2889095|NCT00355615|3595772|FG002|NOT COMPLETED|Randomized Double Blind Period||1
2889096|NCT00355615|3595773|FG003|NOT COMPLETED|Randomized Double Blind Period||1
2889097|NCT00355615|3595774|FG004|NOT COMPLETED|Randomized Double Blind Period||0
2889098|NCT00355615|3595770|FG000|STARTED|40-week Rosuvastatin Open Label Period||0
2889099|NCT00355615|3595771|FG001|STARTED|40-week Rosuvastatin Open Label Period||0
2889100|NCT00355615|3595772|FG002|STARTED|40-week Rosuvastatin Open Label Period||0
2889101|NCT00355615|3595773|FG003|STARTED|40-week Rosuvastatin Open Label Period||0
2889102|NCT00355615|3595774|FG004|STARTED|40-week Rosuvastatin Open Label Period||173
2889103|NCT00355615|3595770|FG000|COMPLETED|40-week Rosuvastatin Open Label Period||0
2889104|NCT00355615|3595771|FG001|COMPLETED|40-week Rosuvastatin Open Label Period||0
2889105|NCT00355615|3595772|FG002|COMPLETED|40-week Rosuvastatin Open Label Period||0
2889106|NCT00355615|3595773|FG003|COMPLETED|40-week Rosuvastatin Open Label Period||0
2889107|NCT00355615|3595774|FG004|COMPLETED|40-week Rosuvastatin Open Label Period||164
2889108|NCT00355615|3595770|FG000|NOT COMPLETED|40-week Rosuvastatin Open Label Period||0
2889109|NCT00355615|3595771|FG001|NOT COMPLETED|40-week Rosuvastatin Open Label Period||0
2889110|NCT00355615|3595772|FG002|NOT COMPLETED|40-week Rosuvastatin Open Label Period||0
2889111|NCT00355615|3595773|FG003|NOT COMPLETED|40-week Rosuvastatin Open Label Period||0
2889112|NCT00355615|3595774|FG004|NOT COMPLETED|40-week Rosuvastatin Open Label Period||9
2889113|NCT00355706|3595787|FG000|STARTED|Overall Study||50
2889114|NCT00355706|3595788|FG001|STARTED|Overall Study||50
2889115|NCT00355706|3595787|FG000|COMPLETED|Overall Study||50
2889116|NCT00355706|3595788|FG001|COMPLETED|Overall Study||50
2889117|NCT00355706|3595787|FG000|NOT COMPLETED|Overall Study||0
2889118|NCT00355706|3595788|FG001|NOT COMPLETED|Overall Study||0
2889119|NCT00355784|3595799|FG000|STARTED|Overall Study||9
2889120|NCT00355784|3595800|FG001|STARTED|Overall Study||8
2889121|NCT00355784|3595801|FG002|STARTED|Overall Study||7
2889122|NCT00355784|3595799|FG000|COMPLETED|Overall Study||9
2889123|NCT00355784|3595800|FG001|COMPLETED|Overall Study||8
2889124|NCT00355784|3595801|FG002|COMPLETED|Overall Study||5
2889125|NCT00355784|3595799|FG000|NOT COMPLETED|Overall Study||0
2889126|NCT00355784|3595800|FG001|NOT COMPLETED|Overall Study||0
2889127|NCT00355784|3595801|FG002|NOT COMPLETED|Overall Study||2
2889128|NCT00355797|3595813|FG000|STARTED|Overall Study||741
2889129|NCT00355797|3595814|FG001|STARTED|Overall Study||369
2889130|NCT00355797|3595815|FG002|STARTED|Overall Study||381
2889131|NCT00355797|3595813|FG000|COMPLETED|Overall Study||501
2889132|NCT00355797|3595814|FG001|COMPLETED|Overall Study||221
2889133|NCT00355797|3595815|FG002|COMPLETED|Overall Study||239
2889134|NCT00355797|3595813|FG000|NOT COMPLETED|Overall Study||240
2889135|NCT00355797|3595814|FG001|NOT COMPLETED|Overall Study||148
2889136|NCT00355797|3595815|FG002|NOT COMPLETED|Overall Study||142
2889137|NCT00355914|3595825|FG000|STARTED|Overall Study||60
2889138|NCT00355914|3595826|FG001|STARTED|Overall Study||60
2889139|NCT00355914|3595825|FG000|COMPLETED|Overall Study||60
2889140|NCT00355914|3595826|FG001|COMPLETED|Overall Study||60
2889141|NCT00355914|3595825|FG000|NOT COMPLETED|Overall Study||0
2889142|NCT00355914|3595826|FG001|NOT COMPLETED|Overall Study||0
2889143|NCT00356031|3595834|FG000|STARTED|Overall Study||20
2889144|NCT00356031|3595834|FG000|COMPLETED|Overall Study||20
2889145|NCT00356031|3595834|FG000|NOT COMPLETED|Overall Study||0
2889146|NCT00356057|3595843|FG000|STARTED|Overall Study||58
2889147|NCT00356057|3595844|FG001|STARTED|Overall Study||61
2889148|NCT00356057|3595845|FG002|STARTED|Overall Study||34
2889149|NCT00356057|3595843|FG000|IMPLANTED|Overall Study||49
2889150|NCT00356057|3595844|FG001|IMPLANTED|Overall Study||52
2889151|NCT00356057|3595845|FG002|IMPLANTED|Overall Study||25
2889152|NCT00356057|3595843|FG000|COMPLETED|Overall Study||45
2889153|NCT00356057|3595844|FG001|COMPLETED|Overall Study||47
2889154|NCT00356057|3595845|FG002|COMPLETED|Overall Study||22
2889155|NCT00356057|3595843|FG000|NOT COMPLETED|Overall Study||13
2889156|NCT00356057|3595844|FG001|NOT COMPLETED|Overall Study||14
2889157|NCT00356057|3595845|FG002|NOT COMPLETED|Overall Study||12
2889158|NCT00356122|3595857|FG000|STARTED|TREATMENT||53
2889159|NCT00356122|3595857|FG000|COMPLETED|TREATMENT||8
2889160|NCT00356122|3595857|FG000|NOT COMPLETED|TREATMENT||45
2889161|NCT00356122|3595857|FG000|STARTED|FOLLOW-UP||53
2889162|NCT00356122|3595857|FG000|COMPLETED|FOLLOW-UP||12
2889163|NCT00356122|3595857|FG000|NOT COMPLETED|FOLLOW-UP||41
2889164|NCT00356135|3595864|FG000|STARTED|Overall Study||47
2889165|NCT00356135|3595865|FG001|STARTED|Overall Study||48
2889166|NCT00356135|3595866|FG002|STARTED|Overall Study||44
2889167|NCT00356135|3595864|FG000|COMPLETED|Overall Study||43
2889168|NCT00356135|3595865|FG001|COMPLETED|Overall Study||46
2889169|NCT00356135|3595866|FG002|COMPLETED|Overall Study||39
2889170|NCT00356135|3595864|FG000|NOT COMPLETED|Overall Study||4
2889171|NCT00356135|3595865|FG001|NOT COMPLETED|Overall Study||2
2889172|NCT00356135|3595866|FG002|NOT COMPLETED|Overall Study||5
2889173|NCT00356148|3595878|FG000|STARTED|Overall Study||189
2889174|NCT00356148|3595879|FG001|STARTED|Overall Study||183
2889175|NCT00356148|3595878|FG000|COMPLETED|Overall Study||187
2889176|NCT00356148|3595879|FG001|COMPLETED|Overall Study||182
2889177|NCT00356148|3595878|FG000|NOT COMPLETED|Overall Study||2
2889178|NCT00356148|3595879|FG001|NOT COMPLETED|Overall Study||1
2889179|NCT00356200|3595888|FG000|STARTED|Cohort 1: 10 ug/ml||5
2889180|NCT00356200|3595889|FG001|STARTED|Cohort 1: 10 ug/ml||0
2889181|NCT00356200|3595888|FG000|COMPLETED|Cohort 1: 10 ug/ml||4
2889182|NCT00356200|3595889|FG001|COMPLETED|Cohort 1: 10 ug/ml||0
2889183|NCT00356200|3595888|FG000|NOT COMPLETED|Cohort 1: 10 ug/ml||1
2889184|NCT00356200|3595889|FG001|NOT COMPLETED|Cohort 1: 10 ug/ml||0
2889185|NCT00356200|3595888|FG000|STARTED|Cohort 2: 100 ug/ml (New Patients)||0
2889186|NCT00356200|3595889|FG001|STARTED|Cohort 2: 100 ug/ml (New Patients)||5
2889187|NCT00356200|3595888|FG000|COMPLETED|Cohort 2: 100 ug/ml (New Patients)||0
2889188|NCT00356200|3595889|FG001|COMPLETED|Cohort 2: 100 ug/ml (New Patients)||3
2889189|NCT00356200|3595888|FG000|NOT COMPLETED|Cohort 2: 100 ug/ml (New Patients)||0
2889190|NCT00356200|3595889|FG001|NOT COMPLETED|Cohort 2: 100 ug/ml (New Patients)||2
2889191|NCT00356265|3595904|FG000|STARTED|Overall Study||7
2889192|NCT00356265|3595905|FG001|STARTED|Overall Study||2
2889193|NCT00356265|3595906|FG002|STARTED|Overall Study||6
2889194|NCT00356265|3595904|FG000|COMPLETED|Overall Study||7
2889195|NCT00356265|3595905|FG001|COMPLETED|Overall Study||2
2889196|NCT00356265|3595906|FG002|COMPLETED|Overall Study||5
2889197|NCT00356265|3595904|FG000|NOT COMPLETED|Overall Study||0
2889198|NCT00356265|3595905|FG001|NOT COMPLETED|Overall Study||0
2889199|NCT00356265|3595906|FG002|NOT COMPLETED|Overall Study||1
2889200|NCT00356278|3595918|FG000|STARTED|Overall Study||53
2889201|NCT00356278|3595919|FG001|STARTED|Overall Study||50
2889202|NCT00356278|3595920|FG002|STARTED|Overall Study||53
2889203|NCT00356278|3595918|FG000|COMPLETED|Overall Study||28
2889204|NCT00356278|3595919|FG001|COMPLETED|Overall Study||35
2889205|NCT00356278|3595920|FG002|COMPLETED|Overall Study||34
2889206|NCT00356278|3595918|FG000|NOT COMPLETED|Overall Study||25
2889207|NCT00356278|3595919|FG001|NOT COMPLETED|Overall Study||15
2889208|NCT00356278|3595920|FG002|NOT COMPLETED|Overall Study||19
2889209|NCT00356304|3595930|FG000|STARTED|Overall Study||26
2889210|NCT00356304|3595931|FG001|STARTED|Overall Study||24
2889211|NCT00356304|3595930|FG000|COMPLETED|Overall Study||24
2889212|NCT00356304|3595931|FG001|COMPLETED|Overall Study||20
2889213|NCT00356304|3595930|FG000|NOT COMPLETED|Overall Study||2
2889214|NCT00356304|3595931|FG001|NOT COMPLETED|Overall Study||4
2889215|NCT00356369|3595939|FG000|STARTED|Active Phase||374
2889216|NCT00356369|3595940|FG001|STARTED|Active Phase||126
2889217|NCT00356369|3595939|FG000|COMPLETED|Active Phase||372
2889218|NCT00356369|3595940|FG001|COMPLETED|Active Phase||125
2889219|NCT00356369|3595939|FG000|NOT COMPLETED|Active Phase||2
2889220|NCT00356369|3595940|FG001|NOT COMPLETED|Active Phase||1
2889221|NCT00356369|3595939|FG000|STARTED|Year 1||364
2889222|NCT00356369|3595940|FG001|STARTED|Year 1||121
2889223|NCT00356369|3595939|FG000|COMPLETED|Year 1||364
2889224|NCT00356369|3595940|FG001|COMPLETED|Year 1||121
2889225|NCT00356369|3595939|FG000|NOT COMPLETED|Year 1||0
2889226|NCT00356369|3595940|FG001|NOT COMPLETED|Year 1||0
2889227|NCT00356369|3595939|FG000|STARTED|Year 2||354
2889228|NCT00356369|3595940|FG001|STARTED|Year 2||117
2889229|NCT00356369|3595939|FG000|COMPLETED|Year 2||354
2889230|NCT00356369|3595940|FG001|COMPLETED|Year 2||117
2889231|NCT00356369|3595939|FG000|NOT COMPLETED|Year 2||0
2889232|NCT00356369|3595940|FG001|NOT COMPLETED|Year 2||0
2889233|NCT00356369|3595939|FG000|STARTED|Year 3||344
2889234|NCT00356369|3595940|FG001|STARTED|Year 3||116
2889235|NCT00356369|3595939|FG000|COMPLETED|Year 3||344
2889236|NCT00356369|3595940|FG001|COMPLETED|Year 3||116
2889237|NCT00356369|3595939|FG000|NOT COMPLETED|Year 3||0
2889238|NCT00356369|3595940|FG001|NOT COMPLETED|Year 3||0
2889239|NCT00356369|3595939|FG000|STARTED|Year 4||317
2889240|NCT00356369|3595940|FG001|STARTED|Year 4||109
2889241|NCT00356369|3595939|FG000|COMPLETED|Year 4||317
2889242|NCT00356369|3595940|FG001|COMPLETED|Year 4||109
2889243|NCT00356369|3595939|FG000|NOT COMPLETED|Year 4||0
2889244|NCT00356369|3595940|FG001|NOT COMPLETED|Year 4||0
2889245|NCT00356369|3595939|FG000|STARTED|Year 5||299
2889246|NCT00356369|3595940|FG001|STARTED|Year 5||105
2889247|NCT00356369|3595939|FG000|COMPLETED|Year 5||299
2889248|NCT00356369|3595940|FG001|COMPLETED|Year 5||105
2889249|NCT00356369|3595939|FG000|NOT COMPLETED|Year 5||0
2889250|NCT00356369|3595940|FG001|NOT COMPLETED|Year 5||0
2889251|NCT00356408|3595950|FG000|STARTED|Overall Study|106 subjects enrolled, however only 103 were included in the Intent to Treat (ITT) population.|103
2889252|NCT00356408|3595950|FG000|COMPLETED|Overall Study||43
2889253|NCT00356408|3595950|FG000|NOT COMPLETED|Overall Study||60
2889254|NCT00356434|3595963|FG000|STARTED|Overall Study||4
2889255|NCT00356434|3595964|FG001|STARTED|Overall Study||7
2889256|NCT00356434|3595963|FG000|COMPLETED|Overall Study||4
2889257|NCT00356434|3595964|FG001|COMPLETED|Overall Study||7
2889258|NCT00356434|3595963|FG000|NOT COMPLETED|Overall Study||0
2889259|NCT00356434|3595964|FG001|NOT COMPLETED|Overall Study||0
2889260|NCT00356525|3595975|FG000|STARTED|Overall Study||14
2889261|NCT00356525|3595976|FG001|STARTED|Overall Study||11
2889262|NCT00356525|3595977|FG002|STARTED|Overall Study||7
2889263|NCT00356525|3595978|FG003|STARTED|Overall Study||9
2889264|NCT00356525|3595975|FG000|COMPLETED|Overall Study||0
2889265|NCT00356525|3595976|FG001|COMPLETED|Overall Study||0
2889266|NCT00356525|3595977|FG002|COMPLETED|Overall Study||0
2889267|NCT00356525|3595978|FG003|COMPLETED|Overall Study||0
2889268|NCT00356525|3595975|FG000|NOT COMPLETED|Overall Study||14
2889269|NCT00356525|3595976|FG001|NOT COMPLETED|Overall Study||11
2889270|NCT00356525|3595977|FG002|NOT COMPLETED|Overall Study||7
2889271|NCT00356525|3595978|FG003|NOT COMPLETED|Overall Study||9
2889272|NCT00356590|3595988|FG000|STARTED|Overall Study||468
2889273|NCT00356590|3595988|FG000|COMPLETED|Overall Study||194
2889274|NCT00356590|3595988|FG000|NOT COMPLETED|Overall Study||274
2889275|NCT00356603|3595994|FG000|STARTED|Overall Study||39
2889276|NCT00356603|3595995|FG001|STARTED|Overall Study||36
2889277|NCT00356603|3595994|FG000|COMPLETED|Overall Study||33
2889278|NCT00356603|3595995|FG001|COMPLETED|Overall Study||33
2889279|NCT00356603|3595994|FG000|NOT COMPLETED|Overall Study||6
2889280|NCT00356603|3595995|FG001|NOT COMPLETED|Overall Study||3
2919701|NCT00533897|3630112|FG007|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
2919702|NCT00533897|3630105|FG000|STARTED|Re-introduction (RI) Period 3||0
2919703|NCT00533897|3630106|FG001|STARTED|Re-introduction (RI) Period 3||0
2919704|NCT00533897|3630107|FG002|STARTED|Re-introduction (RI) Period 3||0
2919705|NCT00533897|3630108|FG003|STARTED|Re-introduction (RI) Period 3|1 participant discontinued the DBW Period due to Lack of Efficacy to enter RI Period early|40
2919706|NCT00533897|3630109|FG004|STARTED|Re-introduction (RI) Period 3|1 participant discontinued the DBW Period due to Lack of Efficacy to enter RI Period early|35
2919707|NCT00533897|3630110|FG005|STARTED|Re-introduction (RI) Period 3|1 participant discontinued the DBW Period due to Lack of Efficacy to enter RI Period early|44
2919708|NCT00533897|3630111|FG006|STARTED|Re-introduction (RI) Period 3||0
2919709|NCT00533897|3630112|FG007|STARTED|Re-introduction (RI) Period 3||0
2919710|NCT00533897|3630105|FG000|COMPLETED|Re-introduction (RI) Period 3||0
2919711|NCT00533897|3630106|FG001|COMPLETED|Re-introduction (RI) Period 3||0
2919712|NCT00533897|3630107|FG002|COMPLETED|Re-introduction (RI) Period 3||0
2919713|NCT00533897|3630108|FG003|COMPLETED|Re-introduction (RI) Period 3||40
2919714|NCT00533897|3630109|FG004|COMPLETED|Re-introduction (RI) Period 3||35
2919715|NCT00533897|3630110|FG005|COMPLETED|Re-introduction (RI) Period 3||42
2919716|NCT00533897|3630111|FG006|COMPLETED|Re-introduction (RI) Period 3||0
2919717|NCT00533897|3630112|FG007|COMPLETED|Re-introduction (RI) Period 3||0
2919718|NCT00533897|3630105|FG000|NOT COMPLETED|Re-introduction (RI) Period 3||0
2919719|NCT00533897|3630106|FG001|NOT COMPLETED|Re-introduction (RI) Period 3||0
2919720|NCT00533897|3630107|FG002|NOT COMPLETED|Re-introduction (RI) Period 3||0
2919721|NCT00533897|3630108|FG003|NOT COMPLETED|Re-introduction (RI) Period 3||0
2919722|NCT00533897|3630109|FG004|NOT COMPLETED|Re-introduction (RI) Period 3||0
2919723|NCT00533897|3630110|FG005|NOT COMPLETED|Re-introduction (RI) Period 3||2
2919724|NCT00533897|3630111|FG006|NOT COMPLETED|Re-introduction (RI) Period 3||0
2919725|NCT00533897|3630112|FG007|NOT COMPLETED|Re-introduction (RI) Period 3||0
2919726|NCT00533897|3630105|FG000|STARTED|Long Term Extension (LTE)||0
2919727|NCT00533897|3630106|FG001|STARTED|Long Term Extension (LTE)||0
2919728|NCT00533897|3630107|FG002|STARTED|Long Term Extension (LTE)||0
2919729|NCT00533897|3630108|FG003|STARTED|Long Term Extension (LTE)||0
2919730|NCT00533897|3630109|FG004|STARTED|Long Term Extension (LTE)||0
2919731|NCT00533897|3630110|FG005|STARTED|Long Term Extension (LTE)||0
2919732|NCT00533897|3630111|FG006|STARTED|Long Term Extension (LTE)|37 non-responders in Lead-In entered the LTE directly and didn't participate in DBW or RI Periods.|37
2919733|NCT00533897|3630112|FG007|STARTED|Long Term Extension (LTE)|117 completed RI but 4 did not enter LTE: 1 lack of efficacy and 3 had their site closed.|113
2919734|NCT00533897|3630105|FG000|COMPLETED|Long Term Extension (LTE)||0
2919735|NCT00533897|3630106|FG001|COMPLETED|Long Term Extension (LTE)||0
2919736|NCT00533897|3630107|FG002|COMPLETED|Long Term Extension (LTE)||0
2919737|NCT00533897|3630108|FG003|COMPLETED|Long Term Extension (LTE)||0
2919738|NCT00533897|3630109|FG004|COMPLETED|Long Term Extension (LTE)||0
2919739|NCT00533897|3630110|FG005|COMPLETED|Long Term Extension (LTE)||0
2920802|NCT00538850|3631372|FG000|NOT COMPLETED|Titration Period||32
2889281|NCT00356759|3596005|FG000|STARTED|Overall Study||126
2889282|NCT00356759|3596006|FG001|STARTED|Overall Study||124
2889283|NCT00356759|3596005|FG000|COMPLETED|Overall Study||112
2889284|NCT00356759|3596006|FG001|COMPLETED|Overall Study||114
2889285|NCT00356759|3596005|FG000|NOT COMPLETED|Overall Study||14
2889286|NCT00356759|3596006|FG001|NOT COMPLETED|Overall Study||10
2889287|NCT00356811|3596012|FG000|STARTED|Overall Study||57
2889288|NCT00356811|3596012|FG000|COMPLETED|Overall Study||8
2889289|NCT00356811|3596012|FG000|NOT COMPLETED|Overall Study||49
2889290|NCT00356863|3596019|FG000|STARTED|Overall Study||504
2889291|NCT00356863|3596020|FG001|STARTED|Overall Study||520
2889292|NCT00356863|3596019|FG000|COMPLETED|Overall Study||412
2889293|NCT00356863|3596020|FG001|COMPLETED|Overall Study||445
2889294|NCT00356863|3596019|FG000|NOT COMPLETED|Overall Study||92
2889295|NCT00356863|3596020|FG001|NOT COMPLETED|Overall Study||75
2889296|NCT00356889|3596030|FG000|STARTED|Overall Study||56
2889297|NCT00356889|3596030|FG000|COMPLETED|Overall Study||53
2889298|NCT00356889|3596030|FG000|NOT COMPLETED|Overall Study||3
2889299|NCT00356915|3596038|FG000|STARTED|Overall Study||593
2889300|NCT00356915|3596039|FG001|STARTED|Overall Study||590
2889301|NCT00356915|3596040|FG002|STARTED|Overall Study||198
2889302|NCT00356915|3596038|FG000|COMPLETED|Overall Study||517
2889303|NCT00356915|3596039|FG001|COMPLETED|Overall Study||496
2889304|NCT00356915|3596040|FG002|COMPLETED|Overall Study||156
2889305|NCT00356915|3596038|FG000|NOT COMPLETED|Overall Study||76
2889306|NCT00356915|3596039|FG001|NOT COMPLETED|Overall Study||94
2889307|NCT00356915|3596040|FG002|NOT COMPLETED|Overall Study||42
2889308|NCT00356993|3596054|FG000|STARTED|Overall Study||6009
3314726|NCT03091673|4048008|FG001|NOT COMPLETED|Second Dose||0
2889309|NCT00356993|3596054|FG000|COMPLETED|Overall Study||2088
2889310|NCT00356993|3596054|FG000|NOT COMPLETED|Overall Study||3921
2889311|NCT00357006|3596061|FG000|STARTED|Overall Study||62
2889312|NCT00357006|3596062|FG001|STARTED|Overall Study||56
2889313|NCT00357006|3596063|FG002|STARTED|Overall Study||62
2889314|NCT00357006|3596061|FG000|COMPLETED|Overall Study||60
2889315|NCT00357006|3596062|FG001|COMPLETED|Overall Study||51
2889316|NCT00357006|3596063|FG002|COMPLETED|Overall Study||59
2889317|NCT00357006|3596061|FG000|NOT COMPLETED|Overall Study||2
2889318|NCT00357006|3596062|FG001|NOT COMPLETED|Overall Study||5
2889319|NCT00357006|3596063|FG002|NOT COMPLETED|Overall Study||3
2889320|NCT00357032|3596071|FG000|STARTED|Overall Study||12
2889321|NCT00357032|3596071|FG000|COMPLETED|Overall Study||12
2889322|NCT00357032|3596071|FG000|NOT COMPLETED|Overall Study||0
2889323|NCT00357097|3596077|FG000|STARTED|Overall Study|199 were randomized. Only 198 took investigational product.|199
2889324|NCT00357097|3596078|FG001|STARTED|Overall Study||67
2889325|NCT00357097|3596077|FG000|COMPLETED|Overall Study||145
2889326|NCT00357097|3596078|FG001|COMPLETED|Overall Study||38
2889327|NCT00357097|3596077|FG000|NOT COMPLETED|Overall Study||54
2889328|NCT00357097|3596078|FG001|NOT COMPLETED|Overall Study||29
2889329|NCT00357110|3596086|FG000|STARTED|Overall Study||6
2889330|NCT00357110|3596087|FG001|STARTED|Overall Study||7
2889331|NCT00357110|3596086|FG000|COMPLETED|Overall Study||1
2889332|NCT00357110|3596087|FG001|COMPLETED|Overall Study||2
2889333|NCT00357110|3596086|FG000|NOT COMPLETED|Overall Study||5
2889334|NCT00357110|3596087|FG001|NOT COMPLETED|Overall Study||5
2889335|NCT00357162|3596093|FG000|STARTED|Overall Study||21
2889336|NCT00357162|3596093|FG000|COMPLETED|Overall Study||21
2889337|NCT00357162|3596093|FG000|NOT COMPLETED|Overall Study||0
2889338|NCT00357214|3596101|FG000|STARTED|Overall Study||43
2889339|NCT00357214|3596102|FG001|STARTED|Overall Study||43
2889340|NCT00357214|3596103|FG002|STARTED|Overall Study||42
2889341|NCT00357214|3596104|FG003|STARTED|Overall Study||43
2889342|NCT00357214|3596101|FG000|COMPLETED|Overall Study||39
2889343|NCT00357214|3596102|FG001|COMPLETED|Overall Study||39
2889344|NCT00357214|3596103|FG002|COMPLETED|Overall Study||42
2889345|NCT00357214|3596104|FG003|COMPLETED|Overall Study||42
2889346|NCT00357214|3596101|FG000|NOT COMPLETED|Overall Study||4
2889347|NCT00357214|3596102|FG001|NOT COMPLETED|Overall Study||4
2889348|NCT00357214|3596103|FG002|NOT COMPLETED|Overall Study||0
2889349|NCT00357214|3596104|FG003|NOT COMPLETED|Overall Study||1
2889350|NCT00357331|3596116|FG000|STARTED|Overall Study||42
2889351|NCT00357331|3596117|FG001|STARTED|Overall Study||41
2889352|NCT00357331|3596116|FG000|COMPLETED|Overall Study||42
2889353|NCT00357331|3596117|FG001|COMPLETED|Overall Study||41
2889354|NCT00357331|3596116|FG000|NOT COMPLETED|Overall Study||0
2889355|NCT00357331|3596117|FG001|NOT COMPLETED|Overall Study||0
2889356|NCT00357370|3596126|FG000|STARTED|Cohort 1||4
2889357|NCT00357370|3596127|FG001|STARTED|Cohort 1||0
2889358|NCT00357370|3596128|FG002|STARTED|Cohort 1||0
2889359|NCT00357370|3596126|FG000|COMPLETED|Cohort 1||4
2889360|NCT00357370|3596127|FG001|COMPLETED|Cohort 1||0
2889361|NCT00357370|3596128|FG002|COMPLETED|Cohort 1||0
2889362|NCT00357370|3596126|FG000|NOT COMPLETED|Cohort 1||0
2889363|NCT00357370|3596127|FG001|NOT COMPLETED|Cohort 1||0
2889364|NCT00357370|3596128|FG002|NOT COMPLETED|Cohort 1||0
2889365|NCT00357370|3596126|FG000|STARTED|Cohort 2||24
2889366|NCT00357370|3596127|FG001|STARTED|Cohort 2||23
2889367|NCT00357370|3596128|FG002|STARTED|Cohort 2||24
2889368|NCT00357370|3596126|FG000|COMPLETED|Cohort 2||22
2889369|NCT00357370|3596127|FG001|COMPLETED|Cohort 2||16
2889370|NCT00357370|3596128|FG002|COMPLETED|Cohort 2||22
2889371|NCT00357370|3596126|FG000|NOT COMPLETED|Cohort 2||2
2889372|NCT00357370|3596127|FG001|NOT COMPLETED|Cohort 2||7
2889373|NCT00357370|3596128|FG002|NOT COMPLETED|Cohort 2||2
2889374|NCT00357396|3596138|FG000|STARTED|Overall Study||6
2889375|NCT00357396|3596139|FG001|STARTED|Overall Study||4
2889376|NCT00357396|3596138|FG000|COMPLETED|Overall Study||5
2889377|NCT00357396|3596139|FG001|COMPLETED|Overall Study||4
2889378|NCT00357396|3596138|FG000|NOT COMPLETED|Overall Study||1
2889379|NCT00357396|3596139|FG001|NOT COMPLETED|Overall Study||0
2889380|NCT00357500|3596144|FG000|STARTED|Overall Study||101
2889381|NCT00357500|3596144|FG000|Began Protocol Therapy|Overall Study|4 pts did not start treatment due either to removal of consent or inability to get insurance.|97
2889382|NCT00357500|3596144|FG000|COMPLETED|Overall Study||24
2889383|NCT00357500|3596144|FG000|NOT COMPLETED|Overall Study||77
2889384|NCT00357552|3596148|FG000|STARTED|Screening|The number of participants who started this period, is the number of participants who screened.|207
2889385|NCT00357552|3596148|FG000|COMPLETED|Screening|The number of participants who completed this period, is the number of participants who enrolled.|123
2889386|NCT00357552|3596148|FG000|NOT COMPLETED|Screening||84
2889387|NCT00357552|3596148|FG000|STARTED|Weeks 0 to 24||123
2889388|NCT00357552|3596148|FG000|COMPLETED|Weeks 0 to 24|One subject died prior to week 24.|122
2889389|NCT00357552|3596148|FG000|NOT COMPLETED|Weeks 0 to 24||1
2889390|NCT00357552|3596148|FG000|STARTED|Weeks 24 to 104||122
2889391|NCT00357552|3596148|FG000|COMPLETED|Weeks 24 to 104||117
2889392|NCT00357552|3596148|FG000|NOT COMPLETED|Weeks 24 to 104||5
2889393|NCT00357656|3596158|FG000|STARTED|Overall Study||31
2889394|NCT00357656|3596159|FG001|STARTED|Overall Study||32
2889395|NCT00357656|3596158|FG000|COMPLETED|Overall Study||31
2889396|NCT00357656|3596159|FG001|COMPLETED|Overall Study||29
2889397|NCT00357656|3596158|FG000|NOT COMPLETED|Overall Study||0
2889398|NCT00357656|3596159|FG001|NOT COMPLETED|Overall Study||3
2889399|NCT00357734|3596177|FG000|STARTED|Overall Study||14
2889400|NCT00357734|3596177|FG000|Patients Received 250 mg of ZD1839|Overall Study||13
2889401|NCT00357734|3596177|FG000|Patient Received 500 mg of ZD1839|Overall Study||1
2889402|NCT00357734|3596177|FG000|COMPLETED|Overall Study||10
2889403|NCT00357734|3596177|FG000|NOT COMPLETED|Overall Study||4
2889404|NCT00357760|3596183|FG000|STARTED|Overall Study||59
2889405|NCT00357760|3596184|FG001|STARTED|Overall Study||35
2889406|NCT00357760|3596183|FG000|Patients Who Started Treatment|Overall Study||57
2889407|NCT00357760|3596184|FG001|Patients Who Started Treatment|Overall Study||34
2889408|NCT00357760|3596183|FG000|Eligible and Treated Patients|Overall Study||57
2889409|NCT00357760|3596184|FG001|Eligible and Treated Patients|Overall Study||32
2889410|NCT00357760|3596183|FG000|Patients Who Undergo Dose Escalation|Overall Study|Only patients who progressed on the low dose (Arm B) had the opportunity to undergo dose escalation.|0
2889411|NCT00357760|3596184|FG001|Patients Who Undergo Dose Escalation|Overall Study||16
2889412|NCT00357760|3596183|FG000|COMPLETED|Overall Study|Patients continued receiving protocol treatment until progressive disease or unacceptable toxicity.|0
2889413|NCT00357760|3596184|FG001|COMPLETED|Overall Study|Patients continued receiving protocol treatment until progressive disease or unacceptable toxicity.|0
2889414|NCT00357760|3596183|FG000|NOT COMPLETED|Overall Study||59
2889415|NCT00357760|3596184|FG001|NOT COMPLETED|Overall Study||35
2889416|NCT00357877|3596192|FG000|STARTED|Overall Study||493
2889417|NCT00357877|3596193|FG001|STARTED|Overall Study||490
2889418|NCT00357877|3596192|FG000|COMPLETED|Overall Study||467
2889419|NCT00357877|3596193|FG001|COMPLETED|Overall Study||460
2889420|NCT00357877|3596192|FG000|NOT COMPLETED|Overall Study||26
2889421|NCT00357877|3596193|FG001|NOT COMPLETED|Overall Study||30
2889422|NCT00357903|3596203|FG000|STARTED|Overall Study||581
2889423|NCT00357903|3596204|FG001|STARTED|Overall Study||58
2889424|NCT00357903|3596203|FG000|COMPLETED|Overall Study||218
2889425|NCT00357903|3596204|FG001|COMPLETED|Overall Study||15
2889426|NCT00357903|3596203|FG000|NOT COMPLETED|Overall Study||363
2889427|NCT00357903|3596204|FG001|NOT COMPLETED|Overall Study||43
2889428|NCT00357955|3596213|FG000|STARTED|Overall Study||64
2889429|NCT00357955|3596214|FG001|STARTED|Overall Study||54
2889430|NCT00357955|3596213|FG000|COMPLETED|Overall Study||58
2889431|NCT00357955|3596214|FG001|COMPLETED|Overall Study||51
2889432|NCT00357955|3596213|FG000|NOT COMPLETED|Overall Study||6
2889433|NCT00357955|3596214|FG001|NOT COMPLETED|Overall Study||3
2889434|NCT00357968|3596222|FG000|STARTED|First Maintenance Dose Phase||102
2889435|NCT00357968|3596223|FG001|STARTED|First Maintenance Dose Phase||99
2889436|NCT00357968|3596222|FG000|Received Loading Dose|First Maintenance Dose Phase||102
2889437|NCT00357968|3596223|FG001|Received Loading Dose|First Maintenance Dose Phase||99
2889438|NCT00357968|3596222|FG000|Percutaneous Coronary Intervention (PCI)|First Maintenance Dose Phase||55
2889439|NCT00357968|3596223|FG001|Percutaneous Coronary Intervention (PCI)|First Maintenance Dose Phase||57
2889440|NCT00357968|3596222|FG000|Started Maintenance Dose|First Maintenance Dose Phase||55
2889441|NCT00357968|3596223|FG001|Started Maintenance Dose|First Maintenance Dose Phase||55
2889442|NCT00357968|3596222|FG000|COMPLETED|First Maintenance Dose Phase||54
2889443|NCT00357968|3596223|FG001|COMPLETED|First Maintenance Dose Phase||55
2889444|NCT00357968|3596222|FG000|NOT COMPLETED|First Maintenance Dose Phase||48
2889445|NCT00357968|3596223|FG001|NOT COMPLETED|First Maintenance Dose Phase||44
2889446|NCT00357968|3596222|FG000|STARTED|Crossover Maintenance Dose Phase|1 subject discontinued study drug-did not take clopidogrel during the 2nd phase but completed study|54
2889447|NCT00357968|3596223|FG001|STARTED|Crossover Maintenance Dose Phase||55
2889448|NCT00357968|3596222|FG000|COMPLETED|Crossover Maintenance Dose Phase||54
2889449|NCT00357968|3596223|FG001|COMPLETED|Crossover Maintenance Dose Phase||55
2889450|NCT00357968|3596222|FG000|NOT COMPLETED|Crossover Maintenance Dose Phase||0
2889451|NCT00357968|3596223|FG001|NOT COMPLETED|Crossover Maintenance Dose Phase||0
2889452|NCT00357994|3596246|FG000|STARTED|Overall Study||37
2889453|NCT00357994|3596247|FG001|STARTED|Overall Study||34
2889454|NCT00357994|3596246|FG000|COMPLETED|Overall Study||35
2889455|NCT00357994|3596247|FG001|COMPLETED|Overall Study||31
2889456|NCT00357994|3596246|FG000|NOT COMPLETED|Overall Study||2
2889457|NCT00357994|3596247|FG001|NOT COMPLETED|Overall Study||3
2889458|NCT00358007|3596253|FG000|STARTED|Overall Study||30
2889459|NCT00358007|3596253|FG000|COMPLETED|Overall Study||28
2889460|NCT00358007|3596253|FG000|NOT COMPLETED|Overall Study||2
2889461|NCT00358150|3596257|FG000|STARTED|Overall Study||26
2889462|NCT00358150|3596257|FG000|COMPLETED|Overall Study||19
2889463|NCT00358150|3596257|FG000|NOT COMPLETED|Overall Study||7
2889464|NCT00358215|3596266|FG000|STARTED|Overall Study||1142
2889465|NCT00358215|3596267|FG001|STARTED|Overall Study||1136
2889466|NCT00358215|3596266|FG000|Received Investigational Product|Overall Study||1140
2889467|NCT00358215|3596267|FG001|Received Investigational Product|Overall Study||1133
2889468|NCT00358215|3596266|FG000|COMPLETED|Overall Study|Participants who completed investigational product|463
2889469|NCT00358215|3596267|FG001|COMPLETED|Overall Study|Participants who completed investigational product|484
2889470|NCT00358215|3596266|FG000|NOT COMPLETED|Overall Study||679
2889471|NCT00358215|3596267|FG001|NOT COMPLETED|Overall Study||652
2889472|NCT00358332|3596277|FG000|STARTED|Overall Study||15
2889473|NCT00358332|3596278|FG001|STARTED|Overall Study||30
2889474|NCT00358332|3596279|FG002|STARTED|Overall Study||30
2889475|NCT00358332|3596280|FG003|STARTED|Overall Study||25
3314727|NCT03091738|4048019|FG000|STARTED|Overall Study||10
3314728|NCT03091738|4048019|FG000|COMPLETED|Overall Study||8
3314729|NCT03091738|4048019|FG000|NOT COMPLETED|Overall Study||2
3314730|NCT03091751|4048023|FG000|STARTED|Overall Study||22
3314731|NCT03091751|4048023|FG000|COMPLETED|Overall Study||22
3314732|NCT03091751|4048023|FG000|NOT COMPLETED|Overall Study||0
3314733|NCT03091777|4048030|FG000|STARTED|Overall Study||289
3314734|NCT03091777|4048031|FG001|STARTED|Overall Study||288
3314735|NCT03091777|4048032|FG002|STARTED|Overall Study||294
2889476|NCT00358332|3596277|FG000|COMPLETED|Overall Study||15
2889477|NCT00358332|3596278|FG001|COMPLETED|Overall Study||27
2889478|NCT00358332|3596279|FG002|COMPLETED|Overall Study||29
2889479|NCT00358332|3596280|FG003|COMPLETED|Overall Study||25
2889480|NCT00358332|3596277|FG000|NOT COMPLETED|Overall Study||0
2889481|NCT00358332|3596278|FG001|NOT COMPLETED|Overall Study||3
2889482|NCT00358332|3596279|FG002|NOT COMPLETED|Overall Study||1
2889483|NCT00358332|3596280|FG003|NOT COMPLETED|Overall Study||0
2889484|NCT00358436|3596292|FG000|STARTED|Overall Study||600
2889485|NCT00358436|3596293|FG001|STARTED|Overall Study||204
2889486|NCT00358436|3596292|FG000|COMPLETED|Overall Study||446
2889487|NCT00358436|3596293|FG001|COMPLETED|Overall Study||118
2889488|NCT00358436|3596292|FG000|NOT COMPLETED|Overall Study||154
2889489|NCT00358436|3596293|FG001|NOT COMPLETED|Overall Study||86
2889490|NCT00358449|3596304|FG000|STARTED|Overall Study||19
2889491|NCT00358449|3596305|FG001|STARTED|Overall Study||20
2889492|NCT00358449|3596306|FG002|STARTED|Overall Study||20
2889493|NCT00358449|3596304|FG000|COMPLETED|Overall Study||15
2889494|NCT00358449|3596305|FG001|COMPLETED|Overall Study||19
2889495|NCT00358449|3596306|FG002|COMPLETED|Overall Study||18
2889496|NCT00358449|3596304|FG000|NOT COMPLETED|Overall Study||4
2889497|NCT00358449|3596305|FG001|NOT COMPLETED|Overall Study||1
2889498|NCT00358449|3596306|FG002|NOT COMPLETED|Overall Study||2
2889499|NCT00358462|3596318|FG000|STARTED|Overall Study||304
2889500|NCT00358462|3596319|FG001|STARTED|Overall Study||302
2889501|NCT00358462|3596318|FG000|COMPLETED|Overall Study||245
2889502|NCT00358462|3596319|FG001|COMPLETED|Overall Study||238
2889503|NCT00358462|3596318|FG000|NOT COMPLETED|Overall Study||59
2889504|NCT00358462|3596319|FG001|NOT COMPLETED|Overall Study||64
2889505|NCT00358501|3596337|FG000|STARTED|Overall Study||102
2889506|NCT00358501|3596338|FG001|STARTED|Overall Study||32
2889507|NCT00358501|3596337|FG000|COMPLETED|Overall Study||102
2889508|NCT00358501|3596338|FG001|COMPLETED|Overall Study||32
2889509|NCT00358501|3596337|FG000|NOT COMPLETED|Overall Study||0
2889510|NCT00358501|3596338|FG001|NOT COMPLETED|Overall Study||0
2889511|NCT00358579|3596347|FG000|STARTED|Overall Study||353
2889512|NCT00358579|3596348|FG001|STARTED|Overall Study||374
2889513|NCT00358579|3596347|FG000|COMPLETED|Overall Study||353
2889514|NCT00358579|3596348|FG001|COMPLETED|Overall Study||374
2889515|NCT00358579|3596347|FG000|NOT COMPLETED|Overall Study||0
2889516|NCT00358579|3596348|FG001|NOT COMPLETED|Overall Study||0
2889517|NCT00358644|3596354|FG000|STARTED|Overall Study||55
2889518|NCT00358644|3596354|FG000|COMPLETED|Overall Study||5
2889519|NCT00358644|3596354|FG000|NOT COMPLETED|Overall Study||50
2889520|NCT00358657|3596358|FG000|STARTED|Overall Study||14
3170328|NCT01929057|3897714|FG000|COMPLETED|Overall Study||31
3170329|NCT01929057|3897715|FG001|COMPLETED|Overall Study||3
3170330|NCT01929057|3897714|FG000|NOT COMPLETED|Overall Study||0
2889521|NCT00358657|3596358|FG000|COMPLETED|Overall Study||14
2889522|NCT00358657|3596358|FG000|NOT COMPLETED|Overall Study||0
2889523|NCT00358670|3596364|FG000|STARTED|Overall Study||222
2889524|NCT00358670|3596365|FG001|STARTED|Overall Study||219
2889525|NCT00358670|3596364|FG000|COMPLETED|Overall Study||0
2889526|NCT00358670|3596365|FG001|COMPLETED|Overall Study||0
2889527|NCT00358670|3596364|FG000|NOT COMPLETED|Overall Study||222
3314736|NCT03091777|4048030|FG000|COMPLETED|Overall Study||257
2889528|NCT00358670|3596365|FG001|NOT COMPLETED|Overall Study||219
2889529|NCT00358735|3596373|FG000|STARTED|Overall Study||204
3170331|NCT01929057|3897715|FG001|NOT COMPLETED|Overall Study||0
2889530|NCT00358735|3596374|FG001|STARTED|Overall Study||207
2889531|NCT00358735|3596373|FG000|Completed Safety|Overall Study||198
2889532|NCT00358735|3596374|FG001|Completed Safety|Overall Study||194
2889533|NCT00358735|3596373|FG000|Not Completed Safety|Overall Study||6
2889534|NCT00358735|3596374|FG001|Not Completed Safety|Overall Study||13
2889535|NCT00358735|3596373|FG000|COMPLETED|Overall Study|Efficacy|196
2889536|NCT00358735|3596374|FG001|COMPLETED|Overall Study|Efficacy|190
2889537|NCT00358735|3596373|FG000|NOT COMPLETED|Overall Study||8
2889538|NCT00358735|3596374|FG001|NOT COMPLETED|Overall Study||17
2889539|NCT00358826|3596384|FG000|STARTED|Core Study||49
2889540|NCT00358826|3596385|FG001|STARTED|Core Study||46
2889541|NCT00358826|3596386|FG002|STARTED|Core Study||44
2889542|NCT00358826|3596387|FG003|STARTED|Core Study||52
2889543|NCT00358826|3596388|FG004|STARTED|Core Study||0
2889544|NCT00358826|3596389|FG005|STARTED|Core Study||0
2889545|NCT00358826|3596390|FG006|STARTED|Core Study||0
2889546|NCT00358826|3596391|FG007|STARTED|Core Study||0
2889547|NCT00358826|3596384|FG000|COMPLETED|Core Study||46
2889548|NCT00358826|3596385|FG001|COMPLETED|Core Study||41
2889549|NCT00358826|3596386|FG002|COMPLETED|Core Study||42
2889550|NCT00358826|3596387|FG003|COMPLETED|Core Study||50
2889551|NCT00358826|3596388|FG004|COMPLETED|Core Study||0
2889552|NCT00358826|3596389|FG005|COMPLETED|Core Study||0
2889553|NCT00358826|3596390|FG006|COMPLETED|Core Study||0
2889554|NCT00358826|3596391|FG007|COMPLETED|Core Study||0
2889555|NCT00358826|3596384|FG000|NOT COMPLETED|Core Study||3
2889556|NCT00358826|3596385|FG001|NOT COMPLETED|Core Study||5
2889557|NCT00358826|3596386|FG002|NOT COMPLETED|Core Study||2
2889558|NCT00358826|3596387|FG003|NOT COMPLETED|Core Study||2
2889559|NCT00358826|3596388|FG004|NOT COMPLETED|Core Study||0
2889560|NCT00358826|3596389|FG005|NOT COMPLETED|Core Study||0
2889561|NCT00358826|3596390|FG006|NOT COMPLETED|Core Study||0
2889562|NCT00358826|3596391|FG007|NOT COMPLETED|Core Study||0
2889563|NCT00358826|3596384|FG000|STARTED|MDCT Substudy||0
2889564|NCT00358826|3596385|FG001|STARTED|MDCT Substudy||0
2889565|NCT00358826|3596386|FG002|STARTED|MDCT Substudy||0
2889566|NCT00358826|3596387|FG003|STARTED|MDCT Substudy||0
2889567|NCT00358826|3596388|FG004|STARTED|MDCT Substudy||25
2889568|NCT00358826|3596389|FG005|STARTED|MDCT Substudy||22
2889569|NCT00358826|3596390|FG006|STARTED|MDCT Substudy||19
2889570|NCT00358826|3596391|FG007|STARTED|MDCT Substudy||27
2889571|NCT00358826|3596384|FG000|COMPLETED|MDCT Substudy||0
2889572|NCT00358826|3596385|FG001|COMPLETED|MDCT Substudy||0
2889573|NCT00358826|3596386|FG002|COMPLETED|MDCT Substudy||0
2889574|NCT00358826|3596387|FG003|COMPLETED|MDCT Substudy||0
2889575|NCT00358826|3596388|FG004|COMPLETED|MDCT Substudy||24
2889576|NCT00358826|3596389|FG005|COMPLETED|MDCT Substudy||20
2889577|NCT00358826|3596390|FG006|COMPLETED|MDCT Substudy||19
2889578|NCT00358826|3596391|FG007|COMPLETED|MDCT Substudy||27
2889579|NCT00358826|3596384|FG000|NOT COMPLETED|MDCT Substudy||0
2889580|NCT00358826|3596385|FG001|NOT COMPLETED|MDCT Substudy||0
2889581|NCT00358826|3596386|FG002|NOT COMPLETED|MDCT Substudy||0
2889582|NCT00358826|3596387|FG003|NOT COMPLETED|MDCT Substudy||0
2889583|NCT00358826|3596388|FG004|NOT COMPLETED|MDCT Substudy||1
2889584|NCT00358826|3596389|FG005|NOT COMPLETED|MDCT Substudy||2
2889585|NCT00358826|3596390|FG006|NOT COMPLETED|MDCT Substudy||0
2889586|NCT00358826|3596391|FG007|NOT COMPLETED|MDCT Substudy||0
2889587|NCT00358917|3596407|FG000|STARTED|Overall Study||300
2889588|NCT00358917|3596408|FG001|STARTED|Overall Study||299
2889589|NCT00358917|3596407|FG000|COMPLETED|Overall Study||234
2889590|NCT00358917|3596408|FG001|COMPLETED|Overall Study||230
2889591|NCT00358917|3596407|FG000|NOT COMPLETED|Overall Study||66
2889592|NCT00358917|3596408|FG001|NOT COMPLETED|Overall Study||69
2889593|NCT00358956|3596416|FG000|STARTED|Overall Study||19
2889594|NCT00358956|3596416|FG000|COMPLETED|Overall Study|ongoing study treatment at data cut-off|11
2889595|NCT00358956|3596416|FG000|NOT COMPLETED|Overall Study||8
2889596|NCT00359021|3596422|FG000|STARTED|Overall Study||256
2889597|NCT00359021|3596423|FG001|STARTED|Overall Study||247
2889598|NCT00359021|3596422|FG000|COMPLETED|Overall Study||175
2889599|NCT00359021|3596423|FG001|COMPLETED|Overall Study||195
2889600|NCT00359021|3596422|FG000|NOT COMPLETED|Overall Study||81
2889601|NCT00359021|3596423|FG001|NOT COMPLETED|Overall Study||52
2889602|NCT00359073|3596433|FG000|STARTED|Overall Study||12
2889603|NCT00359073|3596434|FG001|STARTED|Overall Study||13
2889604|NCT00359073|3596433|FG000|COMPLETED|Overall Study||8
2889605|NCT00359073|3596434|FG001|COMPLETED|Overall Study||11
2889606|NCT00359073|3596433|FG000|NOT COMPLETED|Overall Study||4
2889607|NCT00359073|3596434|FG001|NOT COMPLETED|Overall Study||2
2889608|NCT00359203|3596444|FG000|STARTED|Overall Study||39
2889609|NCT00359203|3596445|FG001|STARTED|Overall Study||38
2889610|NCT00359203|3596444|FG000|COMPLETED|Overall Study||39
2889611|NCT00359203|3596445|FG001|COMPLETED|Overall Study||38
2889612|NCT00359203|3596444|FG000|NOT COMPLETED|Overall Study||0
2889613|NCT00359203|3596445|FG001|NOT COMPLETED|Overall Study||0
2889614|NCT00359281|3596460|FG000|STARTED|Overall Study||16
2889615|NCT00359281|3596461|FG001|STARTED|Overall Study||15
2889616|NCT00359281|3596462|FG002|STARTED|Overall Study||10
2889617|NCT00359281|3596463|FG003|STARTED|Overall Study||10
2889618|NCT00359281|3596464|FG004|STARTED|Overall Study||10
2889619|NCT00359281|3596465|FG005|STARTED|Overall Study||15
2889620|NCT00359281|3596466|FG006|STARTED|Overall Study||18
2889621|NCT00359281|3596467|FG007|STARTED|Overall Study||15
2889622|NCT00359281|3596468|FG008|STARTED|Overall Study||20
2889623|NCT00359281|3596460|FG000|COMPLETED|Overall Study||15
2889624|NCT00359281|3596461|FG001|COMPLETED|Overall Study||15
2889625|NCT00359281|3596462|FG002|COMPLETED|Overall Study||10
2889626|NCT00359281|3596463|FG003|COMPLETED|Overall Study||10
2889627|NCT00359281|3596464|FG004|COMPLETED|Overall Study||10
2889628|NCT00359281|3596465|FG005|COMPLETED|Overall Study||15
2889629|NCT00359281|3596466|FG006|COMPLETED|Overall Study||16
2889630|NCT00359281|3596467|FG007|COMPLETED|Overall Study||15
2889631|NCT00359281|3596468|FG008|COMPLETED|Overall Study||20
2889632|NCT00359281|3596460|FG000|NOT COMPLETED|Overall Study||1
2889633|NCT00359281|3596461|FG001|NOT COMPLETED|Overall Study||0
2889634|NCT00359281|3596462|FG002|NOT COMPLETED|Overall Study||0
2889635|NCT00359281|3596463|FG003|NOT COMPLETED|Overall Study||0
2889636|NCT00359281|3596464|FG004|NOT COMPLETED|Overall Study||0
2889637|NCT00359281|3596465|FG005|NOT COMPLETED|Overall Study||0
2889638|NCT00359281|3596466|FG006|NOT COMPLETED|Overall Study||2
2889639|NCT00359281|3596467|FG007|NOT COMPLETED|Overall Study||0
2889640|NCT00359281|3596468|FG008|NOT COMPLETED|Overall Study||0
2889641|NCT00359294|3596500|FG000|STARTED|Overall Study||1
2889642|NCT00359294|3596501|FG001|STARTED|Overall Study||1
2889643|NCT00359294|3596502|FG002|STARTED|Overall Study||3
2889644|NCT00359294|3596503|FG003|STARTED|Overall Study||4
2889645|NCT00359294|3596504|FG004|STARTED|Overall Study||3
2889646|NCT00359294|3596500|FG000|COMPLETED|Overall Study||0
2889647|NCT00359294|3596501|FG001|COMPLETED|Overall Study||0
2889648|NCT00359294|3596502|FG002|COMPLETED|Overall Study||0
2889649|NCT00359294|3596503|FG003|COMPLETED|Overall Study||0
2889650|NCT00359294|3596504|FG004|COMPLETED|Overall Study||0
2889651|NCT00359294|3596500|FG000|NOT COMPLETED|Overall Study||1
2889652|NCT00359294|3596501|FG001|NOT COMPLETED|Overall Study||1
2889653|NCT00359294|3596502|FG002|NOT COMPLETED|Overall Study||3
2889654|NCT00359294|3596503|FG003|NOT COMPLETED|Overall Study||4
2889655|NCT00359294|3596504|FG004|NOT COMPLETED|Overall Study||3
2889656|NCT00359424|3596514|FG000|STARTED|Overall Study||434
2889657|NCT00359424|3596515|FG001|STARTED|Overall Study||222
2889658|NCT00359424|3596514|FG000|90 Day Follow up|Overall Study||343
2889659|NCT00359424|3596515|FG001|90 Day Follow up|Overall Study||172
2889660|NCT00359424|3596514|FG000|180 Day Follow up|Overall Study||325
2889661|NCT00359424|3596515|FG001|180 Day Follow up|Overall Study||167
2889662|NCT00359424|3596514|FG000|270 Day Follow up|Overall Study||313
2889663|NCT00359424|3596515|FG001|270 Day Follow up|Overall Study||159
2889664|NCT00359424|3596514|FG000|COMPLETED|Overall Study||304
2889665|NCT00359424|3596515|FG001|COMPLETED|Overall Study||155
2889666|NCT00359424|3596514|FG000|NOT COMPLETED|Overall Study||130
2889667|NCT00359424|3596515|FG001|NOT COMPLETED|Overall Study||67
2889668|NCT00359619|3596528|FG000|STARTED|Overall Study||88
2889669|NCT00359619|3596529|FG001|STARTED|Overall Study||50
2889670|NCT00359619|3596530|FG002|STARTED|Overall Study||49
2889671|NCT00359619|3596531|FG003|STARTED|Overall Study||48
2889672|NCT00359619|3596532|FG004|STARTED|Overall Study||48
2889673|NCT00359619|3596533|FG005|STARTED|Overall Study||50
2889674|NCT00359619|3596534|FG006|STARTED|Overall Study||50
2889675|NCT00359619|3596528|FG000|COMPLETED|Overall Study||80
2889676|NCT00359619|3596529|FG001|COMPLETED|Overall Study||45
2889677|NCT00359619|3596530|FG002|COMPLETED|Overall Study||42
2889678|NCT00359619|3596531|FG003|COMPLETED|Overall Study||45
2889679|NCT00359619|3596532|FG004|COMPLETED|Overall Study||45
2889680|NCT00359619|3596533|FG005|COMPLETED|Overall Study||45
2889681|NCT00359619|3596534|FG006|COMPLETED|Overall Study||46
2889682|NCT00359619|3596528|FG000|NOT COMPLETED|Overall Study||8
2889683|NCT00359619|3596529|FG001|NOT COMPLETED|Overall Study||5
2889684|NCT00359619|3596530|FG002|NOT COMPLETED|Overall Study||7
2889685|NCT00359619|3596531|FG003|NOT COMPLETED|Overall Study||3
2889686|NCT00359619|3596532|FG004|NOT COMPLETED|Overall Study||3
2889687|NCT00359619|3596533|FG005|NOT COMPLETED|Overall Study||5
2889688|NCT00359619|3596534|FG006|NOT COMPLETED|Overall Study||4
2889689|NCT00359632|3596552|FG000|STARTED|Overall Study||24
2889690|NCT00359632|3596553|FG001|STARTED|Overall Study||9
2889691|NCT00359632|3596552|FG000|COMPLETED|Overall Study||20
2889692|NCT00359632|3596553|FG001|COMPLETED|Overall Study||9
2889693|NCT00359632|3596552|FG000|NOT COMPLETED|Overall Study||4
2889694|NCT00359632|3596553|FG001|NOT COMPLETED|Overall Study||0
2889695|NCT00359736|3596561|FG000|STARTED|Overall Study||14
2889696|NCT00359736|3596562|FG001|STARTED|Overall Study||15
2889697|NCT00359736|3596561|FG000|COMPLETED|Overall Study||14
2889698|NCT00359736|3596562|FG001|COMPLETED|Overall Study||15
2889699|NCT00359736|3596561|FG000|NOT COMPLETED|Overall Study||0
2889700|NCT00359736|3596562|FG001|NOT COMPLETED|Overall Study||0
2889701|NCT00359762|3596572|FG000|STARTED|Period II||514
2889702|NCT00359762|3596573|FG001|STARTED|Period II||0
2889703|NCT00359762|3596574|FG002|STARTED|Period II||0
2889704|NCT00359762|3596575|FG003|STARTED|Period II||0
2889705|NCT00359762|3596576|FG004|STARTED|Period II||515
2889706|NCT00359762|3596572|FG000|Intent to Treat (ITT) Safety Population|Period II||508
2889707|NCT00359762|3596573|FG001|Intent to Treat (ITT) Safety Population|Period II||0
2889708|NCT00359762|3596574|FG002|Intent to Treat (ITT) Safety Population|Period II||0
2889709|NCT00359762|3596575|FG003|Intent to Treat (ITT) Safety Population|Period II||0
2889710|NCT00359762|3596576|FG004|Intent to Treat (ITT) Safety Population|Period II||511
2889711|NCT00359762|3596572|FG000|ITT Efficacy Population|Period II||487
2889712|NCT00359762|3596573|FG001|ITT Efficacy Population|Period II||0
2889713|NCT00359762|3596574|FG002|ITT Efficacy Population|Period II||0
2889714|NCT00359762|3596575|FG003|ITT Efficacy Population|Period II||0
2889715|NCT00359762|3596576|FG004|ITT Efficacy Population|Period II||490
2889716|NCT00359762|3596572|FG000|Met Primary Endpoint|Period II||262
2889717|NCT00359762|3596573|FG001|Met Primary Endpoint|Period II||0
2889718|NCT00359762|3596574|FG002|Met Primary Endpoint|Period II||0
2889719|NCT00359762|3596575|FG003|Met Primary Endpoint|Period II||0
2889720|NCT00359762|3596576|FG004|Met Primary Endpoint|Period II||203
2889721|NCT00359762|3596572|FG000|Without Treatment Failure|Period II||124
2889722|NCT00359762|3596573|FG001|Without Treatment Failure|Period II||0
2889723|NCT00359762|3596574|FG002|Without Treatment Failure|Period II||0
2889724|NCT00359762|3596575|FG003|Without Treatment Failure|Period II||0
2889725|NCT00359762|3596576|FG004|Without Treatment Failure|Period II||138
2889726|NCT00359762|3596572|FG000|COMPLETED|Period II||386
2889727|NCT00359762|3596573|FG001|COMPLETED|Period II||0
2889728|NCT00359762|3596574|FG002|COMPLETED|Period II||0
2889729|NCT00359762|3596575|FG003|COMPLETED|Period II||0
2889730|NCT00359762|3596576|FG004|COMPLETED|Period II||341
2889731|NCT00359762|3596572|FG000|NOT COMPLETED|Period II||128
2889732|NCT00359762|3596573|FG001|NOT COMPLETED|Period II||0
2889733|NCT00359762|3596574|FG002|NOT COMPLETED|Period II||0
2889734|NCT00359762|3596575|FG003|NOT COMPLETED|Period II||0
2889735|NCT00359762|3596576|FG004|NOT COMPLETED|Period II||174
2889736|NCT00359762|3596572|FG000|STARTED|Period III||0
2889737|NCT00359762|3596573|FG001|STARTED|Period III||77
2889738|NCT00359762|3596574|FG002|STARTED|Period III||77
2889739|NCT00359762|3596575|FG003|STARTED|Period III||166
2889740|NCT00359762|3596576|FG004|STARTED|Period III||0
2889741|NCT00359762|3596572|FG000|Extension ITT Safety Population|Period III||0
2889742|NCT00359762|3596573|FG001|Extension ITT Safety Population|Period III||74
2889743|NCT00359762|3596574|FG002|Extension ITT Safety Population|Period III||76
2889744|NCT00359762|3596575|FG003|Extension ITT Safety Population|Period III||166
2889745|NCT00359762|3596576|FG004|Extension ITT Safety Population|Period III||0
2889746|NCT00359762|3596572|FG000|Extension ITT Efficacy Population|Period III||0
2889747|NCT00359762|3596573|FG001|Extension ITT Efficacy Population|Period III||73
2889748|NCT00359762|3596574|FG002|Extension ITT Efficacy Population|Period III||75
2889749|NCT00359762|3596575|FG003|Extension ITT Efficacy Population|Period III||164
2889750|NCT00359762|3596576|FG004|Extension ITT Efficacy Population|Period III||0
2889751|NCT00359762|3596572|FG000|COMPLETED|Period III||0
3170332|NCT01929083|3897723|FG000|STARTED|Intervention 1|Number of patients randomized to receive progesterone first|10
3170333|NCT01929083|3897724|FG001|STARTED|Intervention 1||9
3170334|NCT01929083|3897723|FG000|Returned for 1st Ibutilide Administratio|Intervention 1||7
3170335|NCT01929083|3897724|FG001|Returned for 1st Ibutilide Administratio|Intervention 1||9
3170336|NCT01929083|3897723|FG000|COMPLETED|Intervention 1||7
3170337|NCT01929083|3897724|FG001|COMPLETED|Intervention 1||9
3170338|NCT01929083|3897723|FG000|NOT COMPLETED|Intervention 1||3
3170339|NCT01929083|3897724|FG001|NOT COMPLETED|Intervention 1||0
3170340|NCT01929083|3897723|FG000|STARTED|Intervention 2||7
3170341|NCT01929083|3897724|FG001|STARTED|Intervention 2||9
2889752|NCT00359762|3596573|FG001|COMPLETED|Period III||48
2889753|NCT00359762|3596574|FG002|COMPLETED|Period III||47
2889754|NCT00359762|3596575|FG003|COMPLETED|Period III||101
2889755|NCT00359762|3596576|FG004|COMPLETED|Period III||0
2889756|NCT00359762|3596572|FG000|NOT COMPLETED|Period III||0
2889757|NCT00359762|3596573|FG001|NOT COMPLETED|Period III||29
2889758|NCT00359762|3596574|FG002|NOT COMPLETED|Period III||30
2889759|NCT00359762|3596575|FG003|NOT COMPLETED|Period III||65
2889760|NCT00359762|3596576|FG004|NOT COMPLETED|Period III||0
2889761|NCT00359762|3596572|FG000|STARTED|Period I||0
2889762|NCT00359762|3596573|FG001|STARTED|Period I||0
2889763|NCT00359762|3596574|FG002|STARTED|Period I||0
2889764|NCT00359762|3596575|FG003|STARTED|Period I||0
2889765|NCT00359762|3596576|FG004|STARTED|Period I||0
2889766|NCT00359762|3596572|FG000|COMPLETED|Period I||0
2889767|NCT00359762|3596573|FG001|COMPLETED|Period I||0
2889768|NCT00359762|3596574|FG002|COMPLETED|Period I||0
2889769|NCT00359762|3596575|FG003|COMPLETED|Period I||0
2889770|NCT00359762|3596576|FG004|COMPLETED|Period I||0
2889771|NCT00359762|3596572|FG000|NOT COMPLETED|Period I||0
2889772|NCT00359762|3596573|FG001|NOT COMPLETED|Period I||0
2889773|NCT00359762|3596574|FG002|NOT COMPLETED|Period I||0
2889774|NCT00359762|3596575|FG003|NOT COMPLETED|Period I||0
2889775|NCT00359762|3596576|FG004|NOT COMPLETED|Period I||0
2889776|NCT00359788|3596592|FG000|STARTED|Overall Study||173
2889777|NCT00359788|3596593|FG001|STARTED|Overall Study||176
2889778|NCT00359788|3596592|FG000|COMPLETED|Overall Study||150
2889779|NCT00359788|3596593|FG001|COMPLETED|Overall Study||159
2889780|NCT00359788|3596592|FG000|NOT COMPLETED|Overall Study||23
2889781|NCT00359788|3596593|FG001|NOT COMPLETED|Overall Study||17
2889782|NCT00359801|3596601|FG000|STARTED|Overall Study||987
2889783|NCT00359801|3596602|FG001|STARTED|Overall Study||989
2889784|NCT00359801|3596601|FG000|COMPLETED|Overall Study|7 additional subjects had missing data and final status (completed/discontinued) is unknown.|682
2889785|NCT00359801|3596602|FG001|COMPLETED|Overall Study|4 additional subjects had missing data and final status (completed/discontinued) is unknown.|769
2889786|NCT00359801|3596601|FG000|NOT COMPLETED|Overall Study||305
2889787|NCT00359801|3596602|FG001|NOT COMPLETED|Overall Study||220
2889788|NCT00359944|3596611|FG000|STARTED|Overall Study||50
2889789|NCT00359944|3596612|FG001|STARTED|Overall Study||47
2889790|NCT00359944|3596613|FG002|STARTED|Overall Study||57
2889791|NCT00359944|3596611|FG000|COMPLETED|Overall Study||34
2889792|NCT00359944|3596612|FG001|COMPLETED|Overall Study||28
2889793|NCT00359944|3596613|FG002|COMPLETED|Overall Study||38
2889794|NCT00359944|3596611|FG000|NOT COMPLETED|Overall Study||16
2889795|NCT00359944|3596612|FG001|NOT COMPLETED|Overall Study||19
2889796|NCT00359944|3596613|FG002|NOT COMPLETED|Overall Study||19
2889797|NCT00359983|3596624|FG000|STARTED|Year 1 Persistence Follow-up||138
2889798|NCT00359983|3596625|FG001|STARTED|Year 1 Persistence Follow-up||70
2889799|NCT00359983|3596626|FG002|STARTED|Year 1 Persistence Follow-up||62
2889800|NCT00359983|3596624|FG000|COMPLETED|Year 1 Persistence Follow-up||138
2889801|NCT00359983|3596625|FG001|COMPLETED|Year 1 Persistence Follow-up||70
2889802|NCT00359983|3596626|FG002|COMPLETED|Year 1 Persistence Follow-up||62
2889803|NCT00359983|3596624|FG000|NOT COMPLETED|Year 1 Persistence Follow-up||0
2889804|NCT00359983|3596625|FG001|NOT COMPLETED|Year 1 Persistence Follow-up||0
2889805|NCT00359983|3596626|FG002|NOT COMPLETED|Year 1 Persistence Follow-up||0
2889806|NCT00359983|3596624|FG000|STARTED|Year 3 Persistence Follow-up||103
2889807|NCT00359983|3596625|FG001|STARTED|Year 3 Persistence Follow-up||47
2889808|NCT00359983|3596626|FG002|STARTED|Year 3 Persistence Follow-up||51
2889809|NCT00359983|3596624|FG000|COMPLETED|Year 3 Persistence Follow-up||103
2889810|NCT00359983|3596625|FG001|COMPLETED|Year 3 Persistence Follow-up||47
2889811|NCT00359983|3596626|FG002|COMPLETED|Year 3 Persistence Follow-up||51
2889812|NCT00359983|3596624|FG000|NOT COMPLETED|Year 3 Persistence Follow-up||0
2889813|NCT00359983|3596625|FG001|NOT COMPLETED|Year 3 Persistence Follow-up||0
2889814|NCT00359983|3596626|FG002|NOT COMPLETED|Year 3 Persistence Follow-up||0
2889815|NCT00359983|3596624|FG000|STARTED|Year 5 Persistence Follow-up||95
2889816|NCT00359983|3596625|FG001|STARTED|Year 5 Persistence Follow-up||44
2889817|NCT00359983|3596626|FG002|STARTED|Year 5 Persistence Follow-up||42
2889818|NCT00359983|3596624|FG000|COMPLETED|Year 5 Persistence Follow-up||95
2889819|NCT00359983|3596625|FG001|COMPLETED|Year 5 Persistence Follow-up||44
2889820|NCT00359983|3596626|FG002|COMPLETED|Year 5 Persistence Follow-up||42
2889821|NCT00359983|3596624|FG000|NOT COMPLETED|Year 5 Persistence Follow-up||0
2889822|NCT00359983|3596625|FG001|NOT COMPLETED|Year 5 Persistence Follow-up||0
2889823|NCT00359983|3596626|FG002|NOT COMPLETED|Year 5 Persistence Follow-up||0
2889824|NCT00360009|3596637|FG000|STARTED|Overall Study||10
2889825|NCT00360009|3596638|FG001|STARTED|Overall Study||26
2889826|NCT00360009|3596639|FG002|STARTED|Overall Study||26
2889827|NCT00360009|3596637|FG000|COMPLETED|Overall Study||10
2889828|NCT00360009|3596638|FG001|COMPLETED|Overall Study||22
2889829|NCT00360009|3596639|FG002|COMPLETED|Overall Study||23
2889830|NCT00360009|3596637|FG000|NOT COMPLETED|Overall Study||0
2889831|NCT00360009|3596638|FG001|NOT COMPLETED|Overall Study||4
2889832|NCT00360009|3596639|FG002|NOT COMPLETED|Overall Study||3
2889833|NCT00360126|3596647|FG000|STARTED|Overall Study||11
2889834|NCT00360126|3596647|FG000|COMPLETED|Overall Study||11
2889835|NCT00360126|3596647|FG000|NOT COMPLETED|Overall Study||0
2889836|NCT00360230|3596658|FG000|STARTED|Overall Study||90
2889837|NCT00360230|3596659|FG001|STARTED|Overall Study||90
2889838|NCT00360230|3596660|FG002|STARTED|Overall Study||45
2889839|NCT00360230|3596661|FG003|STARTED|Overall Study||90
2889840|NCT00360230|3596662|FG004|STARTED|Overall Study||90
2889841|NCT00360230|3596663|FG005|STARTED|Overall Study||90
2889842|NCT00360230|3596664|FG006|STARTED|Overall Study||45
2889843|NCT00360230|3596658|FG000|COMPLETED|Overall Study||84
2889844|NCT00360230|3596659|FG001|COMPLETED|Overall Study||87
2889845|NCT00360230|3596660|FG002|COMPLETED|Overall Study||42
2889846|NCT00360230|3596661|FG003|COMPLETED|Overall Study||88
2889847|NCT00360230|3596662|FG004|COMPLETED|Overall Study||85
2889848|NCT00360230|3596663|FG005|COMPLETED|Overall Study||86
2889849|NCT00360230|3596664|FG006|COMPLETED|Overall Study||43
2889850|NCT00360230|3596658|FG000|NOT COMPLETED|Overall Study||6
3170342|NCT01929083|3897723|FG000|Returned for 2nd Ibutilide Administratio|Intervention 2||7
3170343|NCT01929083|3897724|FG001|Returned for 2nd Ibutilide Administratio|Intervention 2||8
2889851|NCT00360230|3596659|FG001|NOT COMPLETED|Overall Study||3
2889852|NCT00360230|3596660|FG002|NOT COMPLETED|Overall Study||3
2889853|NCT00360230|3596661|FG003|NOT COMPLETED|Overall Study||2
2889854|NCT00360230|3596662|FG004|NOT COMPLETED|Overall Study||5
2889855|NCT00360230|3596663|FG005|NOT COMPLETED|Overall Study||4
2889856|NCT00360230|3596664|FG006|NOT COMPLETED|Overall Study||2
2889857|NCT00360243|3596686|FG000|STARTED|Overall Study||337
2889858|NCT00360243|3596687|FG001|STARTED|Overall Study||363
2889859|NCT00360243|3596688|FG002|STARTED|Overall Study||336
2889860|NCT00360243|3596689|FG003|STARTED|Overall Study||349
2889861|NCT00360243|3596686|FG000|COMPLETED|Overall Study||235
2889862|NCT00360243|3596687|FG001|COMPLETED|Overall Study||243
2889863|NCT00360243|3596688|FG002|COMPLETED|Overall Study||180
2889864|NCT00360243|3596689|FG003|COMPLETED|Overall Study||224
2889865|NCT00360243|3596686|FG000|NOT COMPLETED|Overall Study||102
2889866|NCT00360243|3596687|FG001|NOT COMPLETED|Overall Study||120
2889867|NCT00360243|3596688|FG002|NOT COMPLETED|Overall Study||156
2889868|NCT00360243|3596689|FG003|NOT COMPLETED|Overall Study||125
2889869|NCT00360269|3596701|FG000|STARTED|Overall Study||19
2889870|NCT00360269|3596702|FG001|STARTED|Overall Study||19
2889871|NCT00360269|3596701|FG000|COMPLETED|Overall Study||9
2889872|NCT00360269|3596702|FG001|COMPLETED|Overall Study||7
2889873|NCT00360269|3596701|FG000|NOT COMPLETED|Overall Study||10
2889874|NCT00360269|3596702|FG001|NOT COMPLETED|Overall Study||12
2889875|NCT00360282|3596708|FG000|STARTED|First Intervention||6
2889876|NCT00360282|3596709|FG001|STARTED|First Intervention||8
2889877|NCT00360282|3596710|FG002|STARTED|First Intervention||7
2889878|NCT00360282|3596711|FG003|STARTED|First Intervention||6
2889879|NCT00360282|3596708|FG000|COMPLETED|First Intervention||6
2889880|NCT00360282|3596709|FG001|COMPLETED|First Intervention||8
2889881|NCT00360282|3596710|FG002|COMPLETED|First Intervention||7
2889882|NCT00360282|3596711|FG003|COMPLETED|First Intervention||6
2889883|NCT00360282|3596708|FG000|NOT COMPLETED|First Intervention||0
2889884|NCT00360282|3596709|FG001|NOT COMPLETED|First Intervention||0
2889885|NCT00360282|3596710|FG002|NOT COMPLETED|First Intervention||0
2889886|NCT00360282|3596711|FG003|NOT COMPLETED|First Intervention||0
2889887|NCT00360282|3596708|FG000|STARTED|Washout 1-3 Weeks||6
2889888|NCT00360282|3596709|FG001|STARTED|Washout 1-3 Weeks||8
2889889|NCT00360282|3596710|FG002|STARTED|Washout 1-3 Weeks||7
2889890|NCT00360282|3596711|FG003|STARTED|Washout 1-3 Weeks||6
2889891|NCT00360282|3596708|FG000|COMPLETED|Washout 1-3 Weeks||6
2889892|NCT00360282|3596709|FG001|COMPLETED|Washout 1-3 Weeks||8
2889893|NCT00360282|3596710|FG002|COMPLETED|Washout 1-3 Weeks||6
2889894|NCT00360282|3596711|FG003|COMPLETED|Washout 1-3 Weeks||6
2889895|NCT00360282|3596708|FG000|NOT COMPLETED|Washout 1-3 Weeks||0
2889896|NCT00360282|3596709|FG001|NOT COMPLETED|Washout 1-3 Weeks||0
2889897|NCT00360282|3596710|FG002|NOT COMPLETED|Washout 1-3 Weeks||1
2889898|NCT00360282|3596711|FG003|NOT COMPLETED|Washout 1-3 Weeks||0
2889899|NCT00360282|3596708|FG000|STARTED|Second Intervention||6
2889900|NCT00360282|3596709|FG001|STARTED|Second Intervention||8
2889901|NCT00360282|3596710|FG002|STARTED|Second Intervention||6
2889902|NCT00360282|3596711|FG003|STARTED|Second Intervention||6
2889903|NCT00360282|3596708|FG000|COMPLETED|Second Intervention||6
2889904|NCT00360282|3596709|FG001|COMPLETED|Second Intervention||7
2889905|NCT00360282|3596710|FG002|COMPLETED|Second Intervention||6
2889906|NCT00360282|3596711|FG003|COMPLETED|Second Intervention||6
2889907|NCT00360282|3596708|FG000|NOT COMPLETED|Second Intervention||0
2889908|NCT00360282|3596709|FG001|NOT COMPLETED|Second Intervention||1
2889909|NCT00360282|3596710|FG002|NOT COMPLETED|Second Intervention||0
2889910|NCT00360282|3596711|FG003|NOT COMPLETED|Second Intervention||0
2889911|NCT00360308|3596722|FG000|STARTED|Overall Study||247
2889912|NCT00360308|3596723|FG001|STARTED|Overall Study||234
2889913|NCT00360308|3596724|FG002|STARTED|Overall Study||242
2889914|NCT00360308|3596722|FG000|COMPLETED|Overall Study||171
2889915|NCT00360308|3596723|FG001|COMPLETED|Overall Study||155
2889916|NCT00360308|3596724|FG002|COMPLETED|Overall Study||154
2889917|NCT00360308|3596722|FG000|NOT COMPLETED|Overall Study||76
2889918|NCT00360308|3596723|FG001|NOT COMPLETED|Overall Study||79
2889919|NCT00360308|3596724|FG002|NOT COMPLETED|Overall Study||88
2889920|NCT00360334|3596738|FG000|STARTED|Overall Study||118
2889921|NCT00360334|3596739|FG001|STARTED|Overall Study||117
2889922|NCT00360334|3596738|FG000|Full Analysis Set (FAS)|Overall Study|FAS = received ≥ 1 dose of study drug|118
2889923|NCT00360334|3596739|FG001|Full Analysis Set (FAS)|Overall Study|FAS = received ≥ 1 dose of study drug|116
2889924|NCT00360334|3596738|FG000|COMPLETED|Overall Study||99
2889925|NCT00360334|3596739|FG001|COMPLETED|Overall Study||104
2889926|NCT00360334|3596738|FG000|NOT COMPLETED|Overall Study||19
2889927|NCT00360334|3596739|FG001|NOT COMPLETED|Overall Study||13
2889928|NCT00360360|3596745|FG000|STARTED|Overall Study||60
2889929|NCT00360360|3596745|FG000|COMPLETED|Overall Study||54
2889930|NCT00360360|3596745|FG000|NOT COMPLETED|Overall Study||6
2889931|NCT00360399|3596752|FG000|STARTED|Overall Study||114
2889932|NCT00360399|3596753|FG001|STARTED|Overall Study||115
2889933|NCT00360399|3596754|FG002|STARTED|Overall Study||115
2889934|NCT00360399|3596752|FG000|Had Post-randomization Assessment|Overall Study||105
2889935|NCT00360399|3596753|FG001|Had Post-randomization Assessment|Overall Study||106
2889936|NCT00360399|3596754|FG002|Had Post-randomization Assessment|Overall Study||105
2889937|NCT00360399|3596752|FG000|COMPLETED|Overall Study||86
2889938|NCT00360399|3596753|FG001|COMPLETED|Overall Study||79
3170344|NCT01929083|3897723|FG000|COMPLETED|Intervention 2||7
3170345|NCT01929083|3897724|FG001|COMPLETED|Intervention 2||8
3170346|NCT01929083|3897723|FG000|NOT COMPLETED|Intervention 2||0
3170347|NCT01929083|3897724|FG001|NOT COMPLETED|Intervention 2||1
3170348|NCT01929109|3897735|FG000|STARTED|Period 1 (All Groups)||14
2889939|NCT00360399|3596754|FG002|COMPLETED|Overall Study||69
2889940|NCT00360399|3596752|FG000|NOT COMPLETED|Overall Study||28
2889941|NCT00360399|3596753|FG001|NOT COMPLETED|Overall Study||36
2889942|NCT00360399|3596754|FG002|NOT COMPLETED|Overall Study||46
2889943|NCT00360412|3596764|FG000|STARTED|Overall Study||333
2889944|NCT00360412|3596765|FG001|STARTED|Overall Study||664
2889945|NCT00360412|3596764|FG000|COMPLETED|Overall Study||0
2889946|NCT00360412|3596765|FG001|COMPLETED|Overall Study||2
2889947|NCT00360412|3596764|FG000|NOT COMPLETED|Overall Study||333
2889948|NCT00360412|3596765|FG001|NOT COMPLETED|Overall Study||662
2889949|NCT00360490|3596773|FG000|STARTED|Overall Study||82
2889950|NCT00360490|3596774|FG001|STARTED|Overall Study||83
2889951|NCT00360490|3596773|FG000|COMPLETED|Overall Study||73
2889952|NCT00360490|3596774|FG001|COMPLETED|Overall Study||72
2889953|NCT00360490|3596773|FG000|NOT COMPLETED|Overall Study||9
2889954|NCT00360490|3596774|FG001|NOT COMPLETED|Overall Study||11
2889955|NCT00360529|3596783|FG000|STARTED|Overall Study||295
2889956|NCT00360529|3596784|FG001|STARTED|Overall Study||295
2889957|NCT00360529|3596785|FG002|STARTED|Overall Study||290
2889958|NCT00360529|3596783|FG000|COMPLETED|Overall Study||234
2889959|NCT00360529|3596784|FG001|COMPLETED|Overall Study||230
2889960|NCT00360529|3596785|FG002|COMPLETED|Overall Study||199
2889961|NCT00360529|3596783|FG000|NOT COMPLETED|Overall Study||61
2889962|NCT00360529|3596784|FG001|NOT COMPLETED|Overall Study||65
2889963|NCT00360529|3596785|FG002|NOT COMPLETED|Overall Study||91
2889964|NCT00360555|3596797|FG000|STARTED|Overall Study||396
2889965|NCT00360555|3596798|FG001|STARTED|Overall Study||393
2889966|NCT00360555|3596799|FG002|STARTED|Overall Study||396
2889967|NCT00360555|3596800|FG003|STARTED|Overall Study||399
2889968|NCT00360555|3596797|FG000|COMPLETED|Overall Study||274
2889969|NCT00360555|3596798|FG001|COMPLETED|Overall Study||259
2889970|NCT00360555|3596799|FG002|COMPLETED|Overall Study||251
2889971|NCT00360555|3596800|FG003|COMPLETED|Overall Study||287
2889972|NCT00360555|3596797|FG000|NOT COMPLETED|Overall Study||122
2889973|NCT00360555|3596798|FG001|NOT COMPLETED|Overall Study||134
2889974|NCT00360555|3596799|FG002|NOT COMPLETED|Overall Study||145
2889975|NCT00360555|3596800|FG003|NOT COMPLETED|Overall Study||112
2889976|NCT00360568|3596812|FG000|STARTED|Overall Study||33
2889977|NCT00360568|3596813|FG001|STARTED|Overall Study||29
2889978|NCT00360568|3596812|FG000|COMPLETED|Overall Study||31
2889979|NCT00360568|3596813|FG001|COMPLETED|Overall Study||24
2889980|NCT00360568|3596812|FG000|NOT COMPLETED|Overall Study||2
2889981|NCT00360568|3596813|FG001|NOT COMPLETED|Overall Study||5
2889982|NCT00360672|3596821|FG000|STARTED|Overall Study||27
2889983|NCT00360672|3596821|FG000|COMPLETED|Overall Study||27
2889984|NCT00360672|3596821|FG000|NOT COMPLETED|Overall Study||0
2889985|NCT00360685|3596827|FG000|STARTED|Overall Study||47
2889986|NCT00360685|3596828|FG001|STARTED|Overall Study||42
2889987|NCT00360685|3596827|FG000|COMPLETED|Overall Study||47
2889988|NCT00360685|3596828|FG001|COMPLETED|Overall Study||42
2889989|NCT00360685|3596827|FG000|NOT COMPLETED|Overall Study||0
2889990|NCT00360685|3596828|FG001|NOT COMPLETED|Overall Study||0
2889991|NCT00360698|3596837|FG000|STARTED|Run-In||0
2889992|NCT00360698|3596838|FG001|STARTED|Run-In||135
2889993|NCT00360698|3596837|FG000|COMPLETED|Run-In||0
2889994|NCT00360698|3596838|FG001|COMPLETED|Run-In|19 patients completed the run-in but were not eligible for randomization in the treatment period|125
2889995|NCT00360698|3596837|FG000|NOT COMPLETED|Run-In||0
2889996|NCT00360698|3596838|FG001|NOT COMPLETED|Run-In||10
2889997|NCT00360698|3596837|FG000|STARTED|Treatment Period||49
2889998|NCT00360698|3596838|FG001|STARTED|Treatment Period||57
2889999|NCT00360698|3596837|FG000|COMPLETED|Treatment Period||48
2890000|NCT00360698|3596838|FG001|COMPLETED|Treatment Period||56
2890001|NCT00360698|3596837|FG000|NOT COMPLETED|Treatment Period||1
2890002|NCT00360698|3596838|FG001|NOT COMPLETED|Treatment Period||1
2890003|NCT00360724|3596846|FG000|STARTED|Overall Study||33
2890004|NCT00360724|3596847|FG001|STARTED|Overall Study||32
2890005|NCT00360724|3596846|FG000|COMPLETED|Overall Study||29
2890006|NCT00360724|3596847|FG001|COMPLETED|Overall Study||28
2890007|NCT00360724|3596846|FG000|NOT COMPLETED|Overall Study||4
2890008|NCT00360724|3596847|FG001|NOT COMPLETED|Overall Study||4
2890009|NCT00360828|3596856|FG000|STARTED|Overall Study||10
2890010|NCT00360828|3596856|FG000|COMPLETED|Overall Study||9
2890011|NCT00360828|3596856|FG000|NOT COMPLETED|Overall Study||1
2890012|NCT00360971|3596862|FG000|STARTED|Overall Study||10
2890013|NCT00360971|3596863|FG001|STARTED|Overall Study||11
2890014|NCT00360971|3596862|FG000|COMPLETED|Overall Study|Subjects with data for planned primary analysis are considered to have completed the study.|10
2890015|NCT00360971|3596863|FG001|COMPLETED|Overall Study|Subjects with data for planned primary analysis are considered to have completed the study.|11
2890016|NCT00360971|3596862|FG000|NOT COMPLETED|Overall Study||0
2890017|NCT00360971|3596863|FG001|NOT COMPLETED|Overall Study||0
2890018|NCT00361140|3596872|FG000|STARTED|Overall Study||40
2890019|NCT00361140|3596873|FG001|STARTED|Overall Study||29
2890020|NCT00361140|3596874|FG002|STARTED|Overall Study||3
2890021|NCT00361140|3596872|FG000|COMPLETED|Overall Study||40
2890022|NCT00361140|3596873|FG001|COMPLETED|Overall Study||29
2890023|NCT00361140|3596874|FG002|COMPLETED|Overall Study||3
2890024|NCT00361140|3596872|FG000|NOT COMPLETED|Overall Study||0
2890025|NCT00361140|3596873|FG001|NOT COMPLETED|Overall Study||0
2890026|NCT00361140|3596874|FG002|NOT COMPLETED|Overall Study||0
2890027|NCT00361218|3596882|FG000|STARTED|Overall Study|met eligibility criteria and enrolled in the study|53
2890028|NCT00361218|3596882|FG000|Completed Baseline Assessment|Overall Study||47
2890029|NCT00361218|3596882|FG000|COMPLETED|Overall Study||30
2890030|NCT00361218|3596882|FG000|NOT COMPLETED|Overall Study||23
2890031|NCT00361231|3596886|FG000|STARTED|Overall Study||35
2890032|NCT00361231|3596886|FG000|COMPLETED|Overall Study||1
2890033|NCT00361231|3596886|FG000|NOT COMPLETED|Overall Study||34
2890034|NCT00361257|3596892|FG000|STARTED|Step 1: Minocycline vs. Placebo||52
2890035|NCT00361257|3596893|FG001|STARTED|Step 1: Minocycline vs. Placebo||55
2890036|NCT00361257|3596892|FG000|COMPLETED|Step 1: Minocycline vs. Placebo||40
2890037|NCT00361257|3596893|FG001|COMPLETED|Step 1: Minocycline vs. Placebo||43
2890038|NCT00361257|3596892|FG000|NOT COMPLETED|Step 1: Minocycline vs. Placebo||12
2890039|NCT00361257|3596893|FG001|NOT COMPLETED|Step 1: Minocycline vs. Placebo||12
2890040|NCT00361257|3596892|FG000|STARTED|Step 2: Minocycline(Open Label) for All|40 participants completed Step 1; however,12 decided not to enroll Step 2,so 40-12=28 started Step 2|28
2890041|NCT00361257|3596893|FG001|STARTED|Step 2: Minocycline(Open Label) for All|43 participants completed Step 1; however, 9 decided not to enroll Step 2,so 43-9=34 started Step 2.|34
2890042|NCT00361257|3596892|FG000|COMPLETED|Step 2: Minocycline(Open Label) for All||13
2890043|NCT00361257|3596893|FG001|COMPLETED|Step 2: Minocycline(Open Label) for All||19
2890044|NCT00361257|3596892|FG000|NOT COMPLETED|Step 2: Minocycline(Open Label) for All||15
2890045|NCT00361257|3596893|FG001|NOT COMPLETED|Step 2: Minocycline(Open Label) for All||15
2890046|NCT00361270|3596905|FG000|STARTED|Overall Study||49
2890047|NCT00361270|3596906|FG001|STARTED|Overall Study||39
2890048|NCT00361270|3596907|FG002|STARTED|Overall Study||35
2890049|NCT00361270|3596908|FG003|STARTED|Overall Study||38
2890050|NCT00361270|3596905|FG000|COMPLETED|Overall Study||25
2890051|NCT00361270|3596906|FG001|COMPLETED|Overall Study||25
2890052|NCT00361270|3596907|FG002|COMPLETED|Overall Study||25
2890053|NCT00361270|3596908|FG003|COMPLETED|Overall Study||25
2890054|NCT00361270|3596905|FG000|NOT COMPLETED|Overall Study||24
2890055|NCT00361270|3596906|FG001|NOT COMPLETED|Overall Study||14
2890056|NCT00361270|3596907|FG002|NOT COMPLETED|Overall Study||10
2890057|NCT00361270|3596908|FG003|NOT COMPLETED|Overall Study||13
2890058|NCT00361283|3596925|FG000|STARTED|Overall Study||108
2890059|NCT00361283|3596925|FG000|COMPLETED|Overall Study||81
2890060|NCT00361283|3596925|FG000|NOT COMPLETED|Overall Study||27
2890061|NCT00361296|3596929|FG000|STARTED|Overall Study||5
2890062|NCT00361296|3596929|FG000|COMPLETED|Overall Study||2
2890063|NCT00361296|3596929|FG000|NOT COMPLETED|Overall Study||3
2890064|NCT00361335|3596938|FG000|STARTED|IV Period: Baseline to E0||129
2890065|NCT00361335|3596939|FG001|STARTED|IV Period: Baseline to E0||128
2890066|NCT00361335|3596940|FG002|STARTED|IV Period: Baseline to E0||128
2890067|NCT00361335|3596941|FG003|STARTED|IV Period: Baseline to E0||129
2890068|NCT00361335|3596942|FG004|STARTED|IV Period: Baseline to E0||129
2890069|NCT00361335|3596943|FG005|STARTED|IV Period: Baseline to E0|"0 in column indicates this reporting group is not relevant to the IV Period."|0
2890070|NCT00361335|3596944|FG006|STARTED|IV Period: Baseline to E0|"0 in column indicates this reporting group is not relevant to the IV Period."|0
2890071|NCT00361335|3596938|FG000|COMPLETED|IV Period: Baseline to E0||109
2890072|NCT00361335|3596939|FG001|COMPLETED|IV Period: Baseline to E0||99
2890073|NCT00361335|3596940|FG002|COMPLETED|IV Period: Baseline to E0||107
2890074|NCT00361335|3596941|FG003|COMPLETED|IV Period: Baseline to E0||102
2890075|NCT00361335|3596942|FG004|COMPLETED|IV Period: Baseline to E0||105
2890076|NCT00361335|3596943|FG005|COMPLETED|IV Period: Baseline to E0||0
2890077|NCT00361335|3596944|FG006|COMPLETED|IV Period: Baseline to E0||0
2890078|NCT00361335|3596938|FG000|NOT COMPLETED|IV Period: Baseline to E0||20
2890079|NCT00361335|3596939|FG001|NOT COMPLETED|IV Period: Baseline to E0||29
2890080|NCT00361335|3596940|FG002|NOT COMPLETED|IV Period: Baseline to E0||21
2890081|NCT00361335|3596941|FG003|NOT COMPLETED|IV Period: Baseline to E0||27
2890082|NCT00361335|3596942|FG004|NOT COMPLETED|IV Period: Baseline to E0||24
2890083|NCT00361335|3596943|FG005|NOT COMPLETED|IV Period: Baseline to E0||0
2890084|NCT00361335|3596944|FG006|NOT COMPLETED|IV Period: Baseline to E0||0
2890085|NCT00361335|3596938|FG000|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|82
2890086|NCT00361335|3596939|FG001|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|59
2890087|NCT00361335|3596940|FG002|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|104
2890088|NCT00361335|3596941|FG003|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|63
2890089|NCT00361335|3596942|FG004|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|3
2890090|NCT00361335|3596943|FG005|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|24
2890091|NCT00361335|3596944|FG006|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|173
2890092|NCT00361335|3596938|FG000|COMPLETED|SC Period: Week E0 to Week E24||80
2890093|NCT00361335|3596939|FG001|COMPLETED|SC Period: Week E0 to Week E24||56
2890094|NCT00361335|3596940|FG002|COMPLETED|SC Period: Week E0 to Week E24||99
2890095|NCT00361335|3596941|FG003|COMPLETED|SC Period: Week E0 to Week E24||59
2890096|NCT00361335|3596942|FG004|COMPLETED|SC Period: Week E0 to Week E24||3
2890097|NCT00361335|3596943|FG005|COMPLETED|SC Period: Week E0 to Week E24||23
2890098|NCT00361335|3596944|FG006|COMPLETED|SC Period: Week E0 to Week E24||164
2890099|NCT00361335|3596938|FG000|NOT COMPLETED|SC Period: Week E0 to Week E24||2
2890100|NCT00361335|3596939|FG001|NOT COMPLETED|SC Period: Week E0 to Week E24||3
2890101|NCT00361335|3596940|FG002|NOT COMPLETED|SC Period: Week E0 to Week E24||5
2890102|NCT00361335|3596941|FG003|NOT COMPLETED|SC Period: Week E0 to Week E24||4
2890103|NCT00361335|3596942|FG004|NOT COMPLETED|SC Period: Week E0 to Week E24||0
2890104|NCT00361335|3596943|FG005|NOT COMPLETED|SC Period: Week E0 to Week E24||1
2890105|NCT00361335|3596944|FG006|NOT COMPLETED|SC Period: Week E0 to Week E24||9
2890106|NCT00361374|3596963|FG000|STARTED|Overall Study||66
2890107|NCT00361374|3596964|FG001|STARTED|Overall Study||65
2890108|NCT00361374|3596965|FG002|STARTED|Overall Study||65
2890109|NCT00361374|3596963|FG000|COMPLETED|Overall Study||51
2890110|NCT00361374|3596964|FG001|COMPLETED|Overall Study||50
2890111|NCT00361374|3596965|FG002|COMPLETED|Overall Study||53
2890112|NCT00361374|3596963|FG000|NOT COMPLETED|Overall Study||15
2890113|NCT00361374|3596964|FG001|NOT COMPLETED|Overall Study||15
2890114|NCT00361374|3596965|FG002|NOT COMPLETED|Overall Study||12
2890115|NCT00361439|3596975|FG000|STARTED|Overall Study||8
2890116|NCT00361439|3596976|FG001|STARTED|Overall Study||9
2890117|NCT00361439|3596975|FG000|COMPLETED|Overall Study||8
2890118|NCT00361439|3596976|FG001|COMPLETED|Overall Study||9
2890119|NCT00361439|3596975|FG000|NOT COMPLETED|Overall Study||0
2890120|NCT00361439|3596976|FG001|NOT COMPLETED|Overall Study||0
2890121|NCT00361504|3596984|FG000|STARTED|Overall Study|Number of participants who received at least 1 dose of study medication|894
2890122|NCT00361504|3596985|FG001|STARTED|Overall Study|Number of participants who received at least 1 dose of study medication|223
2890123|NCT00361504|3596984|FG000|COMPLETED|Overall Study||413
2890124|NCT00361504|3596985|FG001|COMPLETED|Overall Study||78
2890125|NCT00361504|3596984|FG000|NOT COMPLETED|Overall Study||481
2890126|NCT00361504|3596985|FG001|NOT COMPLETED|Overall Study||145
2890127|NCT00361569|3596995|FG000|STARTED|Overall Study||150
2890128|NCT00361569|3596996|FG001|STARTED|Overall Study||161
2890129|NCT00361569|3596997|FG002|STARTED|Overall Study||155
2890130|NCT00361569|3596998|FG003|STARTED|Overall Study||156
2890131|NCT00361569|3596995|FG000|COMPLETED|Overall Study||138
2890132|NCT00361569|3596996|FG001|COMPLETED|Overall Study||150
2890133|NCT00361569|3596997|FG002|COMPLETED|Overall Study||137
2890134|NCT00361569|3596998|FG003|COMPLETED|Overall Study||135
2890135|NCT00361569|3596995|FG000|NOT COMPLETED|Overall Study||12
2890136|NCT00361569|3596996|FG001|NOT COMPLETED|Overall Study||11
2890137|NCT00361569|3596997|FG002|NOT COMPLETED|Overall Study||18
2890138|NCT00361569|3596998|FG003|NOT COMPLETED|Overall Study||21
2890139|NCT00361595|3597008|FG000|STARTED|Overall Study||35
2890140|NCT00361595|3597008|FG000|COMPLETED|Overall Study||35
2890141|NCT00361595|3597008|FG000|NOT COMPLETED|Overall Study||0
2890142|NCT00361634|3597012|FG000|STARTED|Overall Study||14
2890143|NCT00361634|3597012|FG000|Treated|Overall Study|The safety analysis set consisted of all patients who received at least one dose of etanercept.|13
2890144|NCT00361634|3597012|FG000|COMPLETED|Overall Study||12
2890145|NCT00361634|3597012|FG000|NOT COMPLETED|Overall Study||2
2890146|NCT00361712|3597018|FG000|STARTED|Overall Study||20
2890147|NCT00361712|3597019|FG001|STARTED|Overall Study||21
2890148|NCT00361712|3597018|FG000|COMPLETED|Overall Study||20
2890149|NCT00361712|3597019|FG001|COMPLETED|Overall Study||21
2890150|NCT00361712|3597018|FG000|NOT COMPLETED|Overall Study||0
2890151|NCT00361712|3597019|FG001|NOT COMPLETED|Overall Study||0
2890152|NCT00361842|3597027|FG000|STARTED|Overall Study||28
2890153|NCT00361842|3597028|FG001|STARTED|Overall Study||35
2890154|NCT00361842|3597027|FG000|COMPLETED|Overall Study||1
2890155|NCT00361842|3597028|FG001|COMPLETED|Overall Study||1
2890156|NCT00361842|3597027|FG000|NOT COMPLETED|Overall Study||27
2890157|NCT00361842|3597028|FG001|NOT COMPLETED|Overall Study||34
2890158|NCT00361972|3597038|FG000|STARTED|Overall Study||8
2890159|NCT00361972|3597039|FG001|STARTED|Overall Study||9
2890160|NCT00361972|3597038|FG000|COMPLETED|Overall Study||8
2890161|NCT00361972|3597039|FG001|COMPLETED|Overall Study||9
2890162|NCT00361972|3597038|FG000|NOT COMPLETED|Overall Study||0
2890163|NCT00361972|3597039|FG001|NOT COMPLETED|Overall Study||0
2890164|NCT00362115|3597053|FG000|STARTED|Overall Study||65
2890165|NCT00362115|3597054|FG001|STARTED|Overall Study|1 participant failed to receive double-blind medication.|65
2890166|NCT00362115|3597055|FG002|STARTED|Overall Study||64
2890167|NCT00362115|3597056|FG003|STARTED|Overall Study|1 participant failed to receive double-blind medication.|63
2890168|NCT00362115|3597057|FG004|STARTED|Overall Study||64
2890169|NCT00362115|3597058|FG005|STARTED|Overall Study|1 participant failed to receive double-blind medication.|64
2890170|NCT00362115|3597059|FG006|STARTED|Overall Study|1 participant failed to receive double-blind medication.|64
2890171|NCT00362115|3597053|FG000|COMPLETED|Overall Study||63
2890172|NCT00362115|3597054|FG001|COMPLETED|Overall Study||59
2890173|NCT00362115|3597055|FG002|COMPLETED|Overall Study||57
2890174|NCT00362115|3597056|FG003|COMPLETED|Overall Study||59
2890175|NCT00362115|3597057|FG004|COMPLETED|Overall Study||57
2890176|NCT00362115|3597058|FG005|COMPLETED|Overall Study||57
2890177|NCT00362115|3597059|FG006|COMPLETED|Overall Study||52
2890178|NCT00362115|3597053|FG000|NOT COMPLETED|Overall Study||2
2890179|NCT00362115|3597054|FG001|NOT COMPLETED|Overall Study||6
2890180|NCT00362115|3597055|FG002|NOT COMPLETED|Overall Study||7
2890181|NCT00362115|3597056|FG003|NOT COMPLETED|Overall Study||4
2890182|NCT00362115|3597057|FG004|NOT COMPLETED|Overall Study||7
2890183|NCT00362115|3597058|FG005|NOT COMPLETED|Overall Study||7
2890184|NCT00362115|3597059|FG006|NOT COMPLETED|Overall Study||12
2890185|NCT00362128|3597075|FG000|STARTED|Overall Study|Enrollment was initiated in 2007.|2072
2890186|NCT00362128|3597075|FG000|COMPLETED|Overall Study|Enrollment was completed in October 2009.|2072
2890187|NCT00362128|3597075|FG000|NOT COMPLETED|Overall Study||0
2890188|NCT00362180|3597088|FG000|STARTED|Treated Period||4
2890189|NCT00362180|3597089|FG001|STARTED|Treated Period||2
2890190|NCT00362180|3597090|FG002|STARTED|Treated Period||1
2890191|NCT00362180|3597091|FG003|STARTED|Treated Period||0
2890192|NCT00362180|3597092|FG004|STARTED|Treated Period||11
2890193|NCT00362180|3597093|FG005|STARTED|Treated Period||10
2890194|NCT00362180|3597094|FG006|STARTED|Treated Period||6
2890195|NCT00362180|3597095|FG007|STARTED|Treated Period||3
2890196|NCT00362180|3597096|FG008|STARTED|Treated Period||1
2890197|NCT00362180|3597088|FG000|COMPLETED|Treated Period||3
2890198|NCT00362180|3597089|FG001|COMPLETED|Treated Period||2
2890199|NCT00362180|3597090|FG002|COMPLETED|Treated Period||1
2890200|NCT00362180|3597091|FG003|COMPLETED|Treated Period||0
2890201|NCT00362180|3597092|FG004|COMPLETED|Treated Period||11
2890202|NCT00362180|3597093|FG005|COMPLETED|Treated Period||9
2890203|NCT00362180|3597094|FG006|COMPLETED|Treated Period||6
2890204|NCT00362180|3597095|FG007|COMPLETED|Treated Period||2
2890205|NCT00362180|3597096|FG008|COMPLETED|Treated Period||1
2890206|NCT00362180|3597088|FG000|NOT COMPLETED|Treated Period||1
2890207|NCT00362180|3597089|FG001|NOT COMPLETED|Treated Period||0
2890208|NCT00362180|3597090|FG002|NOT COMPLETED|Treated Period||0
2890209|NCT00362180|3597091|FG003|NOT COMPLETED|Treated Period||0
2890210|NCT00362180|3597092|FG004|NOT COMPLETED|Treated Period||0
2890211|NCT00362180|3597093|FG005|NOT COMPLETED|Treated Period||1
2890212|NCT00362180|3597094|FG006|NOT COMPLETED|Treated Period||0
2890213|NCT00362180|3597095|FG007|NOT COMPLETED|Treated Period||1
2890214|NCT00362180|3597096|FG008|NOT COMPLETED|Treated Period||0
2890215|NCT00362180|3597088|FG000|STARTED|20 Week Safety Follow-up||3
2890216|NCT00362180|3597089|FG001|STARTED|20 Week Safety Follow-up||2
2890217|NCT00362180|3597090|FG002|STARTED|20 Week Safety Follow-up||1
2890218|NCT00362180|3597091|FG003|STARTED|20 Week Safety Follow-up||0
2890219|NCT00362180|3597092|FG004|STARTED|20 Week Safety Follow-up||11
2890220|NCT00362180|3597093|FG005|STARTED|20 Week Safety Follow-up||9
2890221|NCT00362180|3597094|FG006|STARTED|20 Week Safety Follow-up|This observational cohort did not include a safety follow-up period.|0
2890222|NCT00362180|3597095|FG007|STARTED|20 Week Safety Follow-up||3
2890223|NCT00362180|3597096|FG008|STARTED|20 Week Safety Follow-up||1
2890224|NCT00362180|3597088|FG000|COMPLETED|20 Week Safety Follow-up||3
2890225|NCT00362180|3597089|FG001|COMPLETED|20 Week Safety Follow-up||2
2890226|NCT00362180|3597090|FG002|COMPLETED|20 Week Safety Follow-up||1
2890227|NCT00362180|3597091|FG003|COMPLETED|20 Week Safety Follow-up||0
2890228|NCT00362180|3597092|FG004|COMPLETED|20 Week Safety Follow-up||11
2890229|NCT00362180|3597093|FG005|COMPLETED|20 Week Safety Follow-up||9
2890230|NCT00362180|3597094|FG006|COMPLETED|20 Week Safety Follow-up||0
2890231|NCT00362180|3597095|FG007|COMPLETED|20 Week Safety Follow-up||3
2890232|NCT00362180|3597096|FG008|COMPLETED|20 Week Safety Follow-up||1
2890233|NCT00362180|3597088|FG000|NOT COMPLETED|20 Week Safety Follow-up||0
2890234|NCT00362180|3597089|FG001|NOT COMPLETED|20 Week Safety Follow-up||0
2890235|NCT00362180|3597090|FG002|NOT COMPLETED|20 Week Safety Follow-up||0
2890236|NCT00362180|3597091|FG003|NOT COMPLETED|20 Week Safety Follow-up||0
2890237|NCT00362180|3597092|FG004|NOT COMPLETED|20 Week Safety Follow-up||0
2890238|NCT00362180|3597093|FG005|NOT COMPLETED|20 Week Safety Follow-up||0
2890239|NCT00362180|3597094|FG006|NOT COMPLETED|20 Week Safety Follow-up||0
2890240|NCT00362180|3597095|FG007|NOT COMPLETED|20 Week Safety Follow-up||0
2890241|NCT00362180|3597096|FG008|NOT COMPLETED|20 Week Safety Follow-up||0
2890242|NCT00362232|3597116|FG000|STARTED|Treatment (12 +/- 2 Days)||1584
2890243|NCT00362232|3597117|FG001|STARTED|Treatment (12 +/- 2 Days)||1564
2890244|NCT00362232|3597116|FG000|Received Treatment|Treatment (12 +/- 2 Days)|Safety population|1526
2890245|NCT00362232|3597117|FG001|Received Treatment|Treatment (12 +/- 2 Days)|Safety population|1508
2890246|NCT00362232|3597116|FG000|COMPLETED|Treatment (12 +/- 2 Days)||1425
2890247|NCT00362232|3597117|FG001|COMPLETED|Treatment (12 +/- 2 Days)||1413
2890248|NCT00362232|3597116|FG000|NOT COMPLETED|Treatment (12 +/- 2 Days)||159
2890249|NCT00362232|3597117|FG001|NOT COMPLETED|Treatment (12 +/- 2 Days)||151
2890250|NCT00362232|3597116|FG000|STARTED|Follow-up (30 (+ 5) Days)||1471
2890251|NCT00362232|3597117|FG001|STARTED|Follow-up (30 (+ 5) Days)||1455
2890252|NCT00362232|3597116|FG000|COMPLETED|Follow-up (30 (+ 5) Days)||1433
2890253|NCT00362232|3597117|FG001|COMPLETED|Follow-up (30 (+ 5) Days)||1416
2890254|NCT00362232|3597116|FG000|NOT COMPLETED|Follow-up (30 (+ 5) Days)||38
2890255|NCT00362232|3597117|FG001|NOT COMPLETED|Follow-up (30 (+ 5) Days)||39
2890256|NCT00362297|3597125|FG000|STARTED|Treatment 1 (Initial Drug Assignment)||16
2890257|NCT00362297|3597126|FG001|STARTED|Treatment 1 (Initial Drug Assignment)||15
2890258|NCT00362297|3597125|FG000|COMPLETED|Treatment 1 (Initial Drug Assignment)||16
2890259|NCT00362297|3597126|FG001|COMPLETED|Treatment 1 (Initial Drug Assignment)||11
2890260|NCT00362297|3597125|FG000|NOT COMPLETED|Treatment 1 (Initial Drug Assignment)||0
2890261|NCT00362297|3597126|FG001|NOT COMPLETED|Treatment 1 (Initial Drug Assignment)||4
2890262|NCT00362297|3597125|FG000|STARTED|Treatment 2||16
2890263|NCT00362297|3597126|FG001|STARTED|Treatment 2||11
2890264|NCT00362297|3597125|FG000|COMPLETED|Treatment 2||16
2890265|NCT00362297|3597126|FG001|COMPLETED|Treatment 2||11
2890266|NCT00362297|3597125|FG000|NOT COMPLETED|Treatment 2||0
2890267|NCT00362297|3597126|FG001|NOT COMPLETED|Treatment 2||0
2890268|NCT00362336|3597135|FG000|STARTED|Overall Study||243
2890269|NCT00362336|3597136|FG001|STARTED|Overall Study||242
2890270|NCT00362336|3597137|FG002|STARTED|Overall Study||137
2890271|NCT00362336|3597135|FG000|COMPLETED|Overall Study||233
2890272|NCT00362336|3597136|FG001|COMPLETED|Overall Study||235
2890273|NCT00362336|3597137|FG002|COMPLETED|Overall Study||134
2890274|NCT00362336|3597135|FG000|NOT COMPLETED|Overall Study||10
2890275|NCT00362336|3597136|FG001|NOT COMPLETED|Overall Study||7
2890276|NCT00362336|3597137|FG002|NOT COMPLETED|Overall Study||3
2890277|NCT00362375|3597154|FG000|STARTED|Overall Study|Number eligible and randomized|161
2890278|NCT00362375|3597155|FG001|STARTED|Overall Study|Number eligible and randomized|152
2890279|NCT00362375|3597154|FG000|COMPLETED|Overall Study|Number completed 6-month follow-up assessment|121
2890280|NCT00362375|3597155|FG001|COMPLETED|Overall Study|Number completed 6-month follow-up assessment|117
2890281|NCT00362375|3597154|FG000|NOT COMPLETED|Overall Study||40
2890282|NCT00362375|3597155|FG001|NOT COMPLETED|Overall Study||35
2919740|NCT00533897|3630111|FG006|COMPLETED|Long Term Extension (LTE)|Participant continued until SC ABA was available in respective country or Sponsor ended study.|24
2919741|NCT00533897|3630112|FG007|COMPLETED|Long Term Extension (LTE)|Participant continued until SC ABA was available in respective country or Sponsor ended study.|88
2919742|NCT00533897|3630105|FG000|NOT COMPLETED|Long Term Extension (LTE)||0
2919743|NCT00533897|3630106|FG001|NOT COMPLETED|Long Term Extension (LTE)||0
2919744|NCT00533897|3630107|FG002|NOT COMPLETED|Long Term Extension (LTE)||0
2919745|NCT00533897|3630108|FG003|NOT COMPLETED|Long Term Extension (LTE)||0
2919746|NCT00533897|3630109|FG004|NOT COMPLETED|Long Term Extension (LTE)||0
2919747|NCT00533897|3630110|FG005|NOT COMPLETED|Long Term Extension (LTE)||0
2919748|NCT00533897|3630111|FG006|NOT COMPLETED|Long Term Extension (LTE)||13
2890283|NCT00362414|3597161|FG000|STARTED|Overall Study||15
2890284|NCT00362414|3597161|FG000|COMPLETED|Overall Study||12
2890285|NCT00362414|3597161|FG000|NOT COMPLETED|Overall Study||3
2890286|NCT00362440|3597170|FG000|STARTED|Overall Study||5
2890287|NCT00362440|3597171|FG001|STARTED|Overall Study||4
2890288|NCT00362440|3597170|FG000|COMPLETED|Overall Study||3
2890289|NCT00362440|3597171|FG001|COMPLETED|Overall Study||3
2890290|NCT00362440|3597170|FG000|NOT COMPLETED|Overall Study||2
2890291|NCT00362440|3597171|FG001|NOT COMPLETED|Overall Study||1
2890292|NCT00362453|3597179|FG000|STARTED|Overall Study||20
2890293|NCT00362453|3597180|FG001|STARTED|Overall Study||20
2890294|NCT00362453|3597179|FG000|COMPLETED|Overall Study|No patient withdrew from the study (20/20 participants completed follow-ups at 12, 24 and 48 weeks).|20
2890295|NCT00362453|3597180|FG001|COMPLETED|Overall Study|No patient withdrew from the study (20/20 participants completed follow-ups at 12, 24 and 48 weeks).|20
2890296|NCT00362453|3597179|FG000|NOT COMPLETED|Overall Study||0
2890297|NCT00362453|3597180|FG001|NOT COMPLETED|Overall Study||0
2890298|NCT00362466|3597188|FG000|STARTED|Overall Study||2
2890299|NCT00362466|3597189|FG001|STARTED|Overall Study||1
2890300|NCT00362466|3597188|FG000|COMPLETED|Overall Study||2
2890301|NCT00362466|3597189|FG001|COMPLETED|Overall Study||1
2890302|NCT00362466|3597188|FG000|NOT COMPLETED|Overall Study||0
2890303|NCT00362466|3597189|FG001|NOT COMPLETED|Overall Study||0
2890304|NCT00362609|3597197|FG000|STARTED|Overall Study||19
2890305|NCT00362609|3597198|FG001|STARTED|Overall Study||40
2890306|NCT00362609|3597197|FG000|COMPLETED|Overall Study||19
2890307|NCT00362609|3597198|FG001|COMPLETED|Overall Study||38
2890308|NCT00362609|3597197|FG000|NOT COMPLETED|Overall Study||0
2890309|NCT00362609|3597198|FG001|NOT COMPLETED|Overall Study||2
3170349|NCT01929109|3897736|FG001|STARTED|Period 1 (All Groups)||8
3170350|NCT01929109|3897737|FG002|STARTED|Period 1 (All Groups)||9
3170351|NCT01929109|3897738|FG003|STARTED|Period 1 (All Groups)||8
2890310|NCT00362648|3597208|FG000|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|2733
2890311|NCT00362648|3597209|FG001|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|2735
2890312|NCT00362648|3597210|FG002|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|1018
2890313|NCT00362648|3597211|FG003|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|1018
2890314|NCT00362648|3597208|FG000|Vaccinated at Visit 1|Overall Study||2733
2890315|NCT00362648|3597209|FG001|Vaccinated at Visit 1|Overall Study||2735
2890316|NCT00362648|3597210|FG002|Vaccinated at Visit 1|Overall Study||1018
2890317|NCT00362648|3597211|FG003|Vaccinated at Visit 1|Overall Study||1018
2890318|NCT00362648|3597208|FG000|Vaccinated at Visit 2|Overall Study||2657
2890319|NCT00362648|3597209|FG001|Vaccinated at Visit 2|Overall Study||2666
2890320|NCT00362648|3597210|FG002|Vaccinated at Visit 2|Overall Study||1013
2890321|NCT00362648|3597211|FG003|Vaccinated at Visit 2|Overall Study||1009
2890322|NCT00362648|3597208|FG000|Vaccinated at Visit 3|Overall Study||2613
2890323|NCT00362648|3597209|FG001|Vaccinated at Visit 3|Overall Study||2612
2890324|NCT00362648|3597210|FG002|Vaccinated at Visit 3|Overall Study||1009
2890325|NCT00362648|3597211|FG003|Vaccinated at Visit 3|Overall Study||1007
2890326|NCT00362648|3597208|FG000|COMPLETED|Overall Study|Subjects vaccinated and followed up to 14 days after each dose|2607
2890327|NCT00362648|3597209|FG001|COMPLETED|Overall Study|Subjects vaccinated and followed up to 14 days after each dose|2601
2890328|NCT00362648|3597210|FG002|COMPLETED|Overall Study|Subjects vaccinated and followed up to 14 days after each dose|1009
2890329|NCT00362648|3597211|FG003|COMPLETED|Overall Study|Subjects vaccinated and followed up to 14 days after each dose|1007
2890330|NCT00362648|3597208|FG000|NOT COMPLETED|Overall Study||126
2890331|NCT00362648|3597209|FG001|NOT COMPLETED|Overall Study||134
2890332|NCT00362648|3597210|FG002|NOT COMPLETED|Overall Study||9
2890333|NCT00362648|3597211|FG003|NOT COMPLETED|Overall Study||11
2890334|NCT00362817|3597225|FG000|STARTED|Overall Study||17
2890335|NCT00362817|3597225|FG000|COMPLETED|Overall Study||17
2890336|NCT00362817|3597225|FG000|NOT COMPLETED|Overall Study||0
2890337|NCT00362882|3597232|FG000|STARTED|Overall Study||40
2890338|NCT00362882|3597233|FG001|STARTED|Overall Study||41
2890339|NCT00362882|3597232|FG000|COMPLETED|Overall Study||40
2890340|NCT00362882|3597233|FG001|COMPLETED|Overall Study||41
2890341|NCT00362882|3597232|FG000|NOT COMPLETED|Overall Study||0
2890342|NCT00362882|3597233|FG001|NOT COMPLETED|Overall Study||0
2890343|NCT00363051|3597241|FG000|STARTED|Overall Study||115
2890344|NCT00363051|3597242|FG001|STARTED|Overall Study||45
2890345|NCT00363051|3597241|FG000|COMPLETED|Overall Study|Patients with documented disease progression per RECIST criteria|77
2890346|NCT00363051|3597242|FG001|COMPLETED|Overall Study||23
2890347|NCT00363051|3597241|FG000|NOT COMPLETED|Overall Study||38
2890348|NCT00363051|3597242|FG001|NOT COMPLETED|Overall Study||22
2890349|NCT00363077|3597252|FG000|STARTED|Overall Study||75
2890350|NCT00363077|3597253|FG001|STARTED|Overall Study||75
2890351|NCT00363077|3597252|FG000|COMPLETED|Overall Study||75
2890352|NCT00363077|3597253|FG001|COMPLETED|Overall Study||75
2890353|NCT00363077|3597252|FG000|NOT COMPLETED|Overall Study||0
2890354|NCT00363077|3597253|FG001|NOT COMPLETED|Overall Study||0
2890355|NCT00363129|3597261|FG000|STARTED|Overall Study||96
2890356|NCT00363129|3597262|FG001|STARTED|Overall Study||93
2890357|NCT00363129|3597261|FG000|COMPLETED|Overall Study||67
2890358|NCT00363129|3597262|FG001|COMPLETED|Overall Study||60
2890359|NCT00363129|3597261|FG000|NOT COMPLETED|Overall Study||29
2890360|NCT00363129|3597262|FG001|NOT COMPLETED|Overall Study||33
2890361|NCT00363142|3597270|FG000|STARTED|Overall Study||140
2890362|NCT00363142|3597271|FG001|STARTED|Overall Study||69
2890363|NCT00363142|3597270|FG000|COMPLETED|Overall Study||133
2890364|NCT00363142|3597271|FG001|COMPLETED|Overall Study||66
2890365|NCT00363142|3597270|FG000|NOT COMPLETED|Overall Study||7
2890366|NCT00363142|3597271|FG001|NOT COMPLETED|Overall Study||3
2890367|NCT00363168|3597282|FG000|STARTED|Overall Study||5
2890368|NCT00363168|3597283|FG001|STARTED|Overall Study||2
2890369|NCT00363168|3597282|FG000|COMPLETED|Overall Study||5
2890370|NCT00363168|3597283|FG001|COMPLETED|Overall Study||2
2890371|NCT00363168|3597282|FG000|NOT COMPLETED|Overall Study||0
2890372|NCT00363168|3597283|FG001|NOT COMPLETED|Overall Study||0
2890373|NCT00363246|3597289|FG000|STARTED|Overall Study||766
2890374|NCT00363246|3597289|FG000|COMPLETED|Overall Study||669
2890375|NCT00363246|3597289|FG000|NOT COMPLETED|Overall Study||97
2890376|NCT00363298|3597296|FG000|STARTED|First Study Week||12
2890377|NCT00363298|3597297|FG001|STARTED|First Study Week||12
2890378|NCT00363298|3597296|FG000|COMPLETED|First Study Week|At end of week 1, 6/12 subjects met Y-BOCS response criterion and began 4-week continuation phase|6
2890379|NCT00363298|3597297|FG001|COMPLETED|First Study Week|At end of week 1, 7/12 subjects met Y-BOCS response criterion and began 4-week continuation phase|7
2890380|NCT00363298|3597296|FG000|NOT COMPLETED|First Study Week||6
2890381|NCT00363298|3597297|FG001|NOT COMPLETED|First Study Week||5
2890382|NCT00363298|3597296|FG000|STARTED|4-week Study Continuation Phase||6
2890383|NCT00363298|3597297|FG001|STARTED|4-week Study Continuation Phase||7
2890384|NCT00363298|3597296|FG000|COMPLETED|4-week Study Continuation Phase||5
2890385|NCT00363298|3597297|FG001|COMPLETED|4-week Study Continuation Phase||7
2890386|NCT00363298|3597296|FG000|NOT COMPLETED|4-week Study Continuation Phase||1
2890387|NCT00363298|3597297|FG001|NOT COMPLETED|4-week Study Continuation Phase||0
2890388|NCT00363311|3597306|FG000|STARTED|Overall Study||155
2890389|NCT00363311|3597307|FG001|STARTED|Overall Study||147
2890390|NCT00363311|3597306|FG000|COMPLETED|Overall Study||79
2890391|NCT00363311|3597307|FG001|COMPLETED|Overall Study||102
2890392|NCT00363311|3597306|FG000|NOT COMPLETED|Overall Study||76
2890393|NCT00363311|3597307|FG001|NOT COMPLETED|Overall Study||45
2890394|NCT00363415|3597315|FG000|STARTED|Overall Study||453
2890395|NCT00363415|3597316|FG001|STARTED|Overall Study||455
2890396|NCT00363415|3597315|FG000|Received at Least One Dose of Study Drug|Overall Study||433
2890397|NCT00363415|3597316|FG001|Received at Least One Dose of Study Drug|Overall Study||447
2890398|NCT00363415|3597315|FG000|COMPLETED|Overall Study||92
2890399|NCT00363415|3597316|FG001|COMPLETED|Overall Study||206
2890400|NCT00363415|3597315|FG000|NOT COMPLETED|Overall Study||361
2890401|NCT00363415|3597316|FG001|NOT COMPLETED|Overall Study||249
2890402|NCT00363467|3597322|FG000|STARTED|Overall Study||3
2890403|NCT00363467|3597322|FG000|COMPLETED|Overall Study||2
2890404|NCT00363467|3597322|FG000|NOT COMPLETED|Overall Study||1
2890405|NCT00363480|3597326|FG000|STARTED|Overall Study||221
2890406|NCT00363480|3597326|FG000|COMPLETED|Overall Study||204
2890407|NCT00363480|3597326|FG000|NOT COMPLETED|Overall Study||17
2890408|NCT00363545|3597332|FG000|STARTED|Overall Study||636
2890409|NCT00363545|3597333|FG001|STARTED|Overall Study||638
2890410|NCT00363545|3597332|FG000|COMPLETED|Overall Study||592
2890411|NCT00363545|3597333|FG001|COMPLETED|Overall Study||581
2890412|NCT00363545|3597332|FG000|NOT COMPLETED|Overall Study||44
2890413|NCT00363545|3597333|FG001|NOT COMPLETED|Overall Study||57
2890414|NCT00363649|3597341|FG000|STARTED|Overall Study||18
2890415|NCT00363649|3597342|FG001|STARTED|Overall Study||16
2890416|NCT00363649|3597341|FG000|Crossed Over to Arm B|Overall Study||9
2890417|NCT00363649|3597342|FG001|Crossed Over to Arm B|Overall Study||0
2890418|NCT00363649|3597341|FG000|Crossed Over to Arm A|Overall Study||0
2890419|NCT00363649|3597342|FG001|Crossed Over to Arm A|Overall Study||12
2890420|NCT00363649|3597341|FG000|Did Not Cross Over|Overall Study||2
2890421|NCT00363649|3597342|FG001|Did Not Cross Over|Overall Study||3
2890422|NCT00363649|3597341|FG000|COMPLETED|Overall Study||11
2890423|NCT00363649|3597342|FG001|COMPLETED|Overall Study||15
2890424|NCT00363649|3597341|FG000|NOT COMPLETED|Overall Study||7
2890425|NCT00363649|3597342|FG001|NOT COMPLETED|Overall Study||1
2890426|NCT00363675|3597348|FG000|STARTED|Overall Study||3
2890427|NCT00363675|3597348|FG000|Completed Testing|Overall Study||3
2890428|NCT00363675|3597348|FG000|COMPLETED|Overall Study||3
2890429|NCT00363675|3597348|FG000|NOT COMPLETED|Overall Study||0
2890430|NCT00363766|3597355|FG000|STARTED|Overall Study||32
2890431|NCT00363766|3597356|FG001|STARTED|Overall Study||20
2890432|NCT00363766|3597355|FG000|COMPLETED|Overall Study||0
2890433|NCT00363766|3597356|FG001|COMPLETED|Overall Study||0
2890434|NCT00363766|3597355|FG000|NOT COMPLETED|Overall Study||32
2890435|NCT00363766|3597356|FG001|NOT COMPLETED|Overall Study||20
2890436|NCT00363779|3597363|FG000|STARTED|Overall Study||5
2890437|NCT00363779|3597363|FG000|COMPLETED|Overall Study||5
2890438|NCT00363779|3597363|FG000|NOT COMPLETED|Overall Study||0
2890439|NCT00363805|3597370|FG000|STARTED|Overall Study||42
2890440|NCT00363805|3597371|FG001|STARTED|Overall Study||63
2890441|NCT00363805|3597372|FG002|STARTED|Overall Study||73
2890442|NCT00363805|3597370|FG000|COMPLETED|Overall Study||38
2890443|NCT00363805|3597371|FG001|COMPLETED|Overall Study||57
2890444|NCT00363805|3597372|FG002|COMPLETED|Overall Study||70
2890445|NCT00363805|3597370|FG000|NOT COMPLETED|Overall Study||4
2890446|NCT00363805|3597371|FG001|NOT COMPLETED|Overall Study||6
2890447|NCT00363805|3597372|FG002|NOT COMPLETED|Overall Study||3
2890448|NCT00363883|3597380|FG000|STARTED|Overall Study||14
2890449|NCT00363883|3597380|FG000|COMPLETED|Overall Study||14
2890450|NCT00363883|3597380|FG000|NOT COMPLETED|Overall Study||0
2890451|NCT00363896|3597386|FG000|STARTED|Overall Study||627
2890452|NCT00363896|3597387|FG001|STARTED|Overall Study||216
2890453|NCT00363896|3597386|FG000|COMPLETED|Overall Study||538
2890454|NCT00363896|3597387|FG001|COMPLETED|Overall Study||169
2890455|NCT00363896|3597386|FG000|NOT COMPLETED|Overall Study||89
2890456|NCT00363896|3597387|FG001|NOT COMPLETED|Overall Study||47
2890457|NCT00364013|3597398|FG000|STARTED|Overall Study||593
2890458|NCT00364013|3597399|FG001|STARTED|Overall Study||590
2890459|NCT00364013|3597398|FG000|Received Study Drug|Overall Study|One participant randomized to this group did not receive any panitumumab|586
2890460|NCT00364013|3597399|FG001|Received Study Drug|Overall Study||583
2890461|NCT00364013|3597398|FG000|COMPLETED|Overall Study|Indicates participants who had completed the safety visit 30 days after last dose or had died|492
2890462|NCT00364013|3597399|FG001|COMPLETED|Overall Study|Indicates participants who had completed the safety visit 30 days after last dose or had died|495
2890463|NCT00364013|3597398|FG000|NOT COMPLETED|Overall Study||101
2890464|NCT00364013|3597399|FG001|NOT COMPLETED|Overall Study||95
2890465|NCT00364130|3597411|FG000|STARTED|Intervention Period||69
2890466|NCT00364130|3597412|FG001|STARTED|Intervention Period||69
2890467|NCT00364130|3597411|FG000|COMPLETED|Intervention Period||60
2890468|NCT00364130|3597412|FG001|COMPLETED|Intervention Period||61
2890469|NCT00364130|3597411|FG000|NOT COMPLETED|Intervention Period||9
2890470|NCT00364130|3597412|FG001|NOT COMPLETED|Intervention Period||8
2890471|NCT00364130|3597411|FG000|STARTED|Post Intervention Follow-up Period||60
2890472|NCT00364130|3597412|FG001|STARTED|Post Intervention Follow-up Period||61
2890473|NCT00364130|3597411|FG000|COMPLETED|Post Intervention Follow-up Period||55
2890474|NCT00364130|3597412|FG001|COMPLETED|Post Intervention Follow-up Period||50
2890475|NCT00364130|3597411|FG000|NOT COMPLETED|Post Intervention Follow-up Period||5
2890476|NCT00364130|3597412|FG001|NOT COMPLETED|Post Intervention Follow-up Period||11
2890477|NCT00364156|3597422|FG000|STARTED|Overall Study||282
2890478|NCT00364156|3597423|FG001|STARTED|Overall Study||286
2890479|NCT00364156|3597422|FG000|COMPLETED|Overall Study||203
2890480|NCT00364156|3597423|FG001|COMPLETED|Overall Study||205
2890481|NCT00364156|3597422|FG000|NOT COMPLETED|Overall Study||79
2890482|NCT00364156|3597423|FG001|NOT COMPLETED|Overall Study||81
2890483|NCT00364182|3597432|FG000|STARTED|First Intervention||3
2890484|NCT00364182|3597433|FG001|STARTED|First Intervention||22
2890485|NCT00364182|3597434|FG002|STARTED|First Intervention||25
2890486|NCT00364182|3597432|FG000|COMPLETED|First Intervention||0
2890487|NCT00364182|3597433|FG001|COMPLETED|First Intervention||22
2890488|NCT00364182|3597434|FG002|COMPLETED|First Intervention||25
2890489|NCT00364182|3597432|FG000|NOT COMPLETED|First Intervention||3
2890490|NCT00364182|3597433|FG001|NOT COMPLETED|First Intervention||0
3133768|NCT01697579|3858718|FG006|NOT COMPLETED|Base Study-Cycle 1||0
3133769|NCT01697579|3858712|FG000|STARTED|Optional Extension-Cycles 2-6|47 participants from this arm in Cycle 1 entered optional Cycles 2-6 at 5 mg/kg|0
2890491|NCT00364182|3597434|FG002|NOT COMPLETED|First Intervention||0
2890492|NCT00364182|3597432|FG000|STARTED|Second Intervention||0
2890493|NCT00364182|3597433|FG001|STARTED|Second Intervention||22
2890494|NCT00364182|3597434|FG002|STARTED|Second Intervention||25
2890495|NCT00364182|3597432|FG000|Randomized|Second Intervention||0
2890496|NCT00364182|3597433|FG001|Randomized|Second Intervention||22
2890497|NCT00364182|3597434|FG002|Randomized|Second Intervention||25
2890498|NCT00364182|3597432|FG000|COMPLETED|Second Intervention||0
2890499|NCT00364182|3597433|FG001|COMPLETED|Second Intervention||20
2890500|NCT00364182|3597434|FG002|COMPLETED|Second Intervention||23
2890501|NCT00364182|3597432|FG000|NOT COMPLETED|Second Intervention||0
2890502|NCT00364182|3597433|FG001|NOT COMPLETED|Second Intervention||2
2890503|NCT00364182|3597434|FG002|NOT COMPLETED|Second Intervention||2
2890504|NCT00364182|3597432|FG000|STARTED|Third Intervention||0
2890505|NCT00364182|3597433|FG001|STARTED|Third Intervention||20
2890506|NCT00364182|3597434|FG002|STARTED|Third Intervention||23
2890507|NCT00364182|3597432|FG000|COMPLETED|Third Intervention||0
2890508|NCT00364182|3597433|FG001|COMPLETED|Third Intervention||19
2890509|NCT00364182|3597434|FG002|COMPLETED|Third Intervention||22
2890510|NCT00364182|3597432|FG000|NOT COMPLETED|Third Intervention||0
2890511|NCT00364182|3597433|FG001|NOT COMPLETED|Third Intervention||1
2890512|NCT00364182|3597434|FG002|NOT COMPLETED|Third Intervention||1
2890513|NCT00364182|3597432|FG000|STARTED|Fourth Intervention||0
2890514|NCT00364182|3597433|FG001|STARTED|Fourth Intervention||19
2890515|NCT00364182|3597434|FG002|STARTED|Fourth Intervention||22
2890516|NCT00364182|3597432|FG000|COMPLETED|Fourth Intervention||0
2890517|NCT00364182|3597433|FG001|COMPLETED|Fourth Intervention||19
2890518|NCT00364182|3597434|FG002|COMPLETED|Fourth Intervention||22
2890519|NCT00364182|3597432|FG000|NOT COMPLETED|Fourth Intervention||0
2890520|NCT00364182|3597433|FG001|NOT COMPLETED|Fourth Intervention||0
2890521|NCT00364182|3597434|FG002|NOT COMPLETED|Fourth Intervention||0
2890522|NCT00364286|3597444|FG000|STARTED|Overall Study||17
2890523|NCT00364286|3597444|FG000|COMPLETED|Overall Study||14
2890524|NCT00364286|3597444|FG000|NOT COMPLETED|Overall Study||3
2890525|NCT00364351|3597450|FG000|STARTED|Overall Study|randomised patients|623
2890526|NCT00364351|3597451|FG001|STARTED|Overall Study|randomised patients|617
2890527|NCT00364351|3597450|FG000|COMPLETED|Overall Study|Ongoing study treatment at data cut-off date 26 Sep 2008.|31
2890528|NCT00364351|3597451|FG001|COMPLETED|Overall Study|Ongoing study treatment at data cut-off date 26 Sep 2008.|34
2890529|NCT00364351|3597450|FG000|NOT COMPLETED|Overall Study||592
2890530|NCT00364351|3597451|FG001|NOT COMPLETED|Overall Study||583
2890531|NCT00364377|3597459|FG000|STARTED|Overall Study||11
2890532|NCT00364377|3597460|FG001|STARTED|Overall Study||11
2890533|NCT00364377|3597459|FG000|COMPLETED|Overall Study||11
2890534|NCT00364377|3597460|FG001|COMPLETED|Overall Study||11
2890535|NCT00364377|3597459|FG000|NOT COMPLETED|Overall Study||0
2890536|NCT00364377|3597460|FG001|NOT COMPLETED|Overall Study||0
2890537|NCT00364533|3597471|FG000|STARTED|Overall Study||77
2890538|NCT00364533|3597472|FG001|STARTED|Overall Study||71
2890539|NCT00364533|3597473|FG002|STARTED|Overall Study||75
2890540|NCT00364533|3597474|FG003|STARTED|Overall Study||67
2890541|NCT00364533|3597475|FG004|STARTED|Overall Study||75
2890542|NCT00364533|3597471|FG000|COMPLETED|Overall Study||35
2890543|NCT00364533|3597472|FG001|COMPLETED|Overall Study||31
2890544|NCT00364533|3597473|FG002|COMPLETED|Overall Study||30
2890545|NCT00364533|3597474|FG003|COMPLETED|Overall Study||36
2890546|NCT00364533|3597475|FG004|COMPLETED|Overall Study||24
2890547|NCT00364533|3597471|FG000|NOT COMPLETED|Overall Study||42
2890548|NCT00364533|3597472|FG001|NOT COMPLETED|Overall Study||40
2890549|NCT00364533|3597473|FG002|NOT COMPLETED|Overall Study||45
2890550|NCT00364533|3597474|FG003|NOT COMPLETED|Overall Study||31
2890551|NCT00364533|3597475|FG004|NOT COMPLETED|Overall Study||51
2890552|NCT00364611|3597489|FG000|STARTED|Overall Study||52
2890553|NCT00364611|3597490|FG001|STARTED|Overall Study||21
2890554|NCT00364611|3597489|FG000|TREATED (SAFTEY POPULATION)|Overall Study|Received at least one dose of study medication|52
2890555|NCT00364611|3597490|FG001|TREATED (SAFTEY POPULATION)|Overall Study|Received at least one dose of study medication|20
2890556|NCT00364611|3597489|FG000|COMPLETED|Overall Study|Ongoing treatment (June 2011-initial analysis). Continued treatment till March 2012 (study closed).|1
2890557|NCT00364611|3597490|FG001|COMPLETED|Overall Study||0
2890558|NCT00364611|3597489|FG000|NOT COMPLETED|Overall Study||51
2890559|NCT00364611|3597490|FG001|NOT COMPLETED|Overall Study||21
2890560|NCT00364793|3597500|FG000|STARTED|Overall Study||15
2890561|NCT00364793|3597501|FG001|STARTED|Overall Study||10
2890562|NCT00364793|3597502|FG002|STARTED|Overall Study||4
2890563|NCT00364793|3597503|FG003|STARTED|Overall Study||8
2890564|NCT00364793|3597500|FG000|COMPLETED|Overall Study||7
2890565|NCT00364793|3597501|FG001|COMPLETED|Overall Study||5
2890566|NCT00364793|3597502|FG002|COMPLETED|Overall Study||0
2890567|NCT00364793|3597503|FG003|COMPLETED|Overall Study||5
2890568|NCT00364793|3597500|FG000|NOT COMPLETED|Overall Study||8
2890569|NCT00364793|3597501|FG001|NOT COMPLETED|Overall Study||5
2890570|NCT00364793|3597502|FG002|NOT COMPLETED|Overall Study||4
2890571|NCT00364793|3597503|FG003|NOT COMPLETED|Overall Study||3
2890572|NCT00364819|3597516|FG000|STARTED|Overall Study||6
2890573|NCT00364819|3597516|FG000|COMPLETED|Overall Study||6
2890574|NCT00364819|3597516|FG000|NOT COMPLETED|Overall Study||0
2890575|NCT00364832|3597529|FG000|STARTED|Core Period||16
2890576|NCT00364832|3597530|FG001|STARTED|Core Period||15
2890577|NCT00364832|3597531|FG002|STARTED|Core Period||15
2890578|NCT00364832|3597532|FG003|STARTED|Core Period||16
2890579|NCT00364832|3597533|FG004|STARTED|Core Period||16
2890580|NCT00364832|3597534|FG005|STARTED|Core Period||12
2890581|NCT00364832|3597535|FG006|STARTED|Core Period||16
2890582|NCT00364832|3597536|FG007|STARTED|Core Period||15
2890583|NCT00364832|3597537|FG008|STARTED|Core Period||16
2890584|NCT00364832|3597538|FG009|STARTED|Core Period||0
2890585|NCT00364832|3597539|FG010|STARTED|Core Period||0
2890586|NCT00364832|3597540|FG011|STARTED|Core Period||0
2890587|NCT00364832|3597529|FG000|COMPLETED|Core Period||14
2890588|NCT00364832|3597530|FG001|COMPLETED|Core Period||13
2890589|NCT00364832|3597531|FG002|COMPLETED|Core Period||14
2890590|NCT00364832|3597532|FG003|COMPLETED|Core Period||15
2890591|NCT00364832|3597533|FG004|COMPLETED|Core Period||16
2890592|NCT00364832|3597534|FG005|COMPLETED|Core Period||12
2890593|NCT00364832|3597535|FG006|COMPLETED|Core Period||12
2890594|NCT00364832|3597536|FG007|COMPLETED|Core Period||14
2890595|NCT00364832|3597537|FG008|COMPLETED|Core Period||16
2890596|NCT00364832|3597538|FG009|COMPLETED|Core Period||0
2890597|NCT00364832|3597539|FG010|COMPLETED|Core Period||0
2890598|NCT00364832|3597540|FG011|COMPLETED|Core Period||0
2890599|NCT00364832|3597529|FG000|NOT COMPLETED|Core Period||2
2890600|NCT00364832|3597530|FG001|NOT COMPLETED|Core Period||2
2890601|NCT00364832|3597531|FG002|NOT COMPLETED|Core Period||1
2890602|NCT00364832|3597532|FG003|NOT COMPLETED|Core Period||1
2890603|NCT00364832|3597533|FG004|NOT COMPLETED|Core Period||0
2890604|NCT00364832|3597534|FG005|NOT COMPLETED|Core Period||0
2890605|NCT00364832|3597535|FG006|NOT COMPLETED|Core Period||4
2890606|NCT00364832|3597536|FG007|NOT COMPLETED|Core Period||1
2890607|NCT00364832|3597537|FG008|NOT COMPLETED|Core Period||0
2890608|NCT00364832|3597538|FG009|NOT COMPLETED|Core Period||0
2890609|NCT00364832|3597539|FG010|NOT COMPLETED|Core Period||0
2890610|NCT00364832|3597540|FG011|NOT COMPLETED|Core Period||0
2890611|NCT00364832|3597529|FG000|STARTED|Extension Year 1||0
2890612|NCT00364832|3597530|FG001|STARTED|Extension Year 1||0
2890613|NCT00364832|3597531|FG002|STARTED|Extension Year 1||0
2890614|NCT00364832|3597532|FG003|STARTED|Extension Year 1||0
2890615|NCT00364832|3597533|FG004|STARTED|Extension Year 1||0
2890616|NCT00364832|3597534|FG005|STARTED|Extension Year 1||0
2890617|NCT00364832|3597535|FG006|STARTED|Extension Year 1||0
2890618|NCT00364832|3597536|FG007|STARTED|Extension Year 1||0
2890619|NCT00364832|3597537|FG008|STARTED|Extension Year 1||0
2890620|NCT00364832|3597538|FG009|STARTED|Extension Year 1|Participants (Cohorts A, D, and G) who completed core, entered extension period (entry optional).|18
2890621|NCT00364832|3597539|FG010|STARTED|Extension Year 1|Participants (Cohorts B, E, and H) who completed core, entered extension period (entry optional).|17
2890622|NCT00364832|3597540|FG011|STARTED|Extension Year 1|Participants (Cohorts C, F, and I) who completed core, entered extension period (entry optional).|27
2890623|NCT00364832|3597529|FG000|COMPLETED|Extension Year 1||0
2890624|NCT00364832|3597530|FG001|COMPLETED|Extension Year 1||0
2890625|NCT00364832|3597531|FG002|COMPLETED|Extension Year 1||0
2890626|NCT00364832|3597532|FG003|COMPLETED|Extension Year 1||0
2890627|NCT00364832|3597533|FG004|COMPLETED|Extension Year 1||0
2890628|NCT00364832|3597534|FG005|COMPLETED|Extension Year 1||0
2890629|NCT00364832|3597535|FG006|COMPLETED|Extension Year 1||0
2890630|NCT00364832|3597536|FG007|COMPLETED|Extension Year 1||0
2890631|NCT00364832|3597537|FG008|COMPLETED|Extension Year 1||0
2890632|NCT00364832|3597538|FG009|COMPLETED|Extension Year 1||14
2890633|NCT00364832|3597539|FG010|COMPLETED|Extension Year 1||15
2890634|NCT00364832|3597540|FG011|COMPLETED|Extension Year 1||17
2890635|NCT00364832|3597529|FG000|NOT COMPLETED|Extension Year 1||0
2890636|NCT00364832|3597530|FG001|NOT COMPLETED|Extension Year 1||0
2890637|NCT00364832|3597531|FG002|NOT COMPLETED|Extension Year 1||0
2890638|NCT00364832|3597532|FG003|NOT COMPLETED|Extension Year 1||0
2890639|NCT00364832|3597533|FG004|NOT COMPLETED|Extension Year 1||0
2890640|NCT00364832|3597534|FG005|NOT COMPLETED|Extension Year 1||0
2890641|NCT00364832|3597535|FG006|NOT COMPLETED|Extension Year 1||0
2890642|NCT00364832|3597536|FG007|NOT COMPLETED|Extension Year 1||0
2890643|NCT00364832|3597537|FG008|NOT COMPLETED|Extension Year 1||0
2890644|NCT00364832|3597538|FG009|NOT COMPLETED|Extension Year 1||4
2890645|NCT00364832|3597539|FG010|NOT COMPLETED|Extension Year 1||2
2890646|NCT00364832|3597540|FG011|NOT COMPLETED|Extension Year 1||10
2890647|NCT00364832|3597529|FG000|STARTED|Extension Year 2||0
2890648|NCT00364832|3597530|FG001|STARTED|Extension Year 2||0
2890649|NCT00364832|3597531|FG002|STARTED|Extension Year 2||0
2890650|NCT00364832|3597532|FG003|STARTED|Extension Year 2||0
2890651|NCT00364832|3597533|FG004|STARTED|Extension Year 2||0
2890652|NCT00364832|3597534|FG005|STARTED|Extension Year 2||0
2890653|NCT00364832|3597535|FG006|STARTED|Extension Year 2||0
2890654|NCT00364832|3597536|FG007|STARTED|Extension Year 2||0
2890655|NCT00364832|3597537|FG008|STARTED|Extension Year 2||0
2890656|NCT00364832|3597538|FG009|STARTED|Extension Year 2||14
2890657|NCT00364832|3597539|FG010|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1, entered Extension Year 2 (entry optional).|14
2890658|NCT00364832|3597540|FG011|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1, entered Extension Year 2 (entry optional).|14
2890659|NCT00364832|3597529|FG000|COMPLETED|Extension Year 2||0
2890660|NCT00364832|3597530|FG001|COMPLETED|Extension Year 2||0
2890661|NCT00364832|3597531|FG002|COMPLETED|Extension Year 2||0
2890662|NCT00364832|3597532|FG003|COMPLETED|Extension Year 2||0
2890663|NCT00364832|3597533|FG004|COMPLETED|Extension Year 2||0
2890664|NCT00364832|3597534|FG005|COMPLETED|Extension Year 2||0
2890665|NCT00364832|3597535|FG006|COMPLETED|Extension Year 2||0
2890666|NCT00364832|3597536|FG007|COMPLETED|Extension Year 2||0
2890667|NCT00364832|3597537|FG008|COMPLETED|Extension Year 2||0
2890668|NCT00364832|3597538|FG009|COMPLETED|Extension Year 2||9
2890669|NCT00364832|3597539|FG010|COMPLETED|Extension Year 2||9
2890670|NCT00364832|3597540|FG011|COMPLETED|Extension Year 2||11
2890671|NCT00364832|3597529|FG000|NOT COMPLETED|Extension Year 2||0
2890672|NCT00364832|3597530|FG001|NOT COMPLETED|Extension Year 2||0
2890673|NCT00364832|3597531|FG002|NOT COMPLETED|Extension Year 2||0
3170352|NCT01929109|3897739|FG004|STARTED|Period 1 (All Groups)||8
3170353|NCT01929109|3897735|FG000|COMPLETED|Period 1 (All Groups)||14
3170354|NCT01929109|3897736|FG001|COMPLETED|Period 1 (All Groups)||8
3170355|NCT01929109|3897737|FG002|COMPLETED|Period 1 (All Groups)||8
3170356|NCT01929109|3897738|FG003|COMPLETED|Period 1 (All Groups)||8
3170357|NCT01929109|3897739|FG004|COMPLETED|Period 1 (All Groups)||8
3170358|NCT01929109|3897735|FG000|NOT COMPLETED|Period 1 (All Groups)||0
2890674|NCT00364832|3597532|FG003|NOT COMPLETED|Extension Year 2||0
2890675|NCT00364832|3597533|FG004|NOT COMPLETED|Extension Year 2||0
2890676|NCT00364832|3597534|FG005|NOT COMPLETED|Extension Year 2||0
2890677|NCT00364832|3597535|FG006|NOT COMPLETED|Extension Year 2||0
2890678|NCT00364832|3597536|FG007|NOT COMPLETED|Extension Year 2||0
2890679|NCT00364832|3597537|FG008|NOT COMPLETED|Extension Year 2||0
2890680|NCT00364832|3597538|FG009|NOT COMPLETED|Extension Year 2||5
2890681|NCT00364832|3597539|FG010|NOT COMPLETED|Extension Year 2||5
2890682|NCT00364832|3597540|FG011|NOT COMPLETED|Extension Year 2||3
2890683|NCT00364845|3597559|FG000|STARTED|Overall Study||28
2890684|NCT00364845|3597560|FG001|STARTED|Overall Study||23
2890685|NCT00364845|3597559|FG000|COMPLETED|Overall Study|Completed 36-week titration/treatment phase|17
2890686|NCT00364845|3597560|FG001|COMPLETED|Overall Study|Completed 36-week titration/treatment phase|12
2890687|NCT00364845|3597559|FG000|NOT COMPLETED|Overall Study||11
2890688|NCT00364845|3597560|FG001|NOT COMPLETED|Overall Study||11
2890689|NCT00364858|3597568|FG000|STARTED|Overall Study||33
2890690|NCT00364858|3597569|FG001|STARTED|Overall Study||62
2890691|NCT00364858|3597568|FG000|COMPLETED|Overall Study||26
2890692|NCT00364858|3597569|FG001|COMPLETED|Overall Study||40
2890693|NCT00364858|3597568|FG000|NOT COMPLETED|Overall Study||7
2890694|NCT00364858|3597569|FG001|NOT COMPLETED|Overall Study||22
2890695|NCT00364923|3597576|FG000|STARTED|Treatment With Pralatrexate|Received at least one dose of pralatrexate.|111
2890696|NCT00364923|3597576|FG000|COMPLETED|Treatment With Pralatrexate|Treatment duration not limited. After treatment ends, patients attend survival follow-up visits.|107
2890697|NCT00364923|3597576|FG000|NOT COMPLETED|Treatment With Pralatrexate||4
2890698|NCT00364923|3597576|FG000|STARTED|Survival Follow-up, After Pralatrexate|Patients (pts) who stop treatment with pralatrexate are followed for survival|107
2890699|NCT00364923|3597576|FG000|COMPLETED|Survival Follow-up, After Pralatrexate|Pts who completed follow-up either died, were followed for 24 months, or withdrew|83
2890700|NCT00364923|3597576|FG000|NOT COMPLETED|Survival Follow-up, After Pralatrexate||24
2890701|NCT00364949|3597582|FG000|STARTED|Overall Study||31
2890702|NCT00364949|3597583|FG001|STARTED|Overall Study||39
2890703|NCT00364949|3597582|FG000|COMPLETED|Overall Study||31
2890704|NCT00364949|3597583|FG001|COMPLETED|Overall Study||39
2890705|NCT00364949|3597582|FG000|NOT COMPLETED|Overall Study||0
2890706|NCT00364949|3597583|FG001|NOT COMPLETED|Overall Study||0
2890707|NCT00365053|3597589|FG000|STARTED|Overall Study||13
2890708|NCT00365053|3597589|FG000|COMPLETED|Overall Study||13
2890709|NCT00365053|3597589|FG000|NOT COMPLETED|Overall Study||0
2890710|NCT00365105|3597595|FG000|STARTED|Overall Study||129
2890711|NCT00365105|3597596|FG001|STARTED|Overall Study||132
2890712|NCT00365105|3597595|FG000|Eligible|Overall Study||124
2890713|NCT00365105|3597596|FG001|Eligible|Overall Study||124
2890714|NCT00365105|3597595|FG000|Eligible With Adverse Event Data|Overall Study||123
2890715|NCT00365105|3597596|FG001|Eligible With Adverse Event Data|Overall Study||124
2890716|NCT00365105|3597595|FG000|COMPLETED|Overall Study||124
2890717|NCT00365105|3597596|FG001|COMPLETED|Overall Study||124
2890718|NCT00365105|3597595|FG000|NOT COMPLETED|Overall Study||5
2890719|NCT00365105|3597596|FG001|NOT COMPLETED|Overall Study||8
2890720|NCT00365144|3597602|FG000|STARTED|Overall Study||36
2890721|NCT00365144|3597602|FG000|COMPLETED|Overall Study||36
2890722|NCT00365144|3597602|FG000|NOT COMPLETED|Overall Study||0
2890723|NCT00365209|3597607|FG000|STARTED|Stage 1: Receiving 2g Curcumin||23
2890724|NCT00365209|3597607|FG000|COMPLETED|Stage 1: Receiving 2g Curcumin||21
2890725|NCT00365209|3597607|FG000|NOT COMPLETED|Stage 1: Receiving 2g Curcumin||2
2890726|NCT00365209|3597607|FG000|STARTED|Stage 2: Receiving 4g Curcumin||21
2890727|NCT00365209|3597607|FG000|COMPLETED|Stage 2: Receiving 4g Curcumin||19
2890728|NCT00365209|3597607|FG000|NOT COMPLETED|Stage 2: Receiving 4g Curcumin||2
2890729|NCT00365261|3597614|FG000|STARTED|Overall Study||23
2890730|NCT00365261|3597615|FG001|STARTED|Overall Study||22
2890731|NCT00365261|3597614|FG000|COMPLETED|Overall Study||20
2890732|NCT00365261|3597615|FG001|COMPLETED|Overall Study||19
2890733|NCT00365261|3597614|FG000|NOT COMPLETED|Overall Study||3
2890734|NCT00365261|3597615|FG001|NOT COMPLETED|Overall Study||3
2890735|NCT00365274|3597623|FG000|STARTED|Overall Study||6
2890736|NCT00365274|3597623|FG000|COMPLETED|Overall Study||6
2890737|NCT00365274|3597623|FG000|NOT COMPLETED|Overall Study||0
2890738|NCT00365300|3597629|FG000|STARTED|Open-label Phase||129
2890739|NCT00365300|3597630|FG001|STARTED|Open-label Phase||0
2890740|NCT00365300|3597629|FG000|COMPLETED|Open-label Phase||107
2890741|NCT00365300|3597630|FG001|COMPLETED|Open-label Phase||0
2890742|NCT00365300|3597629|FG000|NOT COMPLETED|Open-label Phase||22
2890743|NCT00365300|3597630|FG001|NOT COMPLETED|Open-label Phase||0
2890744|NCT00365300|3597629|FG000|STARTED|Double-blind Phase||54
2890745|NCT00365300|3597630|FG001|STARTED|Double-blind Phase||54
2890746|NCT00365300|3597629|FG000|COMPLETED|Double-blind Phase||43
2890747|NCT00365300|3597630|FG001|COMPLETED|Double-blind Phase||45
2890748|NCT00365300|3597629|FG000|NOT COMPLETED|Double-blind Phase||11
2890749|NCT00365300|3597630|FG001|NOT COMPLETED|Double-blind Phase||9
2890750|NCT00365352|3597642|FG000|STARTED|Overall Study||97
2890751|NCT00365352|3597643|FG001|STARTED|Overall Study||115
2890752|NCT00365352|3597644|FG002|STARTED|Overall Study||113
2890753|NCT00365352|3597642|FG000|Safety Population|Overall Study||96
2890754|NCT00365352|3597643|FG001|Safety Population|Overall Study||115
2890755|NCT00365352|3597644|FG002|Safety Population|Overall Study||111
2890756|NCT00365352|3597642|FG000|Modified Intent-to-Treat Population|Overall Study||96
2890757|NCT00365352|3597643|FG001|Modified Intent-to-Treat Population|Overall Study||114
2890758|NCT00365352|3597644|FG002|Modified Intent-to-Treat Population|Overall Study||111
2890759|NCT00365352|3597642|FG000|COMPLETED|Overall Study||77
2890760|NCT00365352|3597643|FG001|COMPLETED|Overall Study||104
2890761|NCT00365352|3597644|FG002|COMPLETED|Overall Study||98
2890762|NCT00365352|3597642|FG000|NOT COMPLETED|Overall Study||20
2890763|NCT00365352|3597643|FG001|NOT COMPLETED|Overall Study||11
2890764|NCT00365352|3597644|FG002|NOT COMPLETED|Overall Study||15
2890765|NCT00365365|3597658|FG000|STARTED|Overall Study||78
2890766|NCT00365365|3597659|FG001|STARTED|Overall Study||77
2890767|NCT00365365|3597660|FG002|STARTED|Overall Study||59
2890768|NCT00365365|3597658|FG000|TREATED (SAFETY POPULATION)|Overall Study||78
2890769|NCT00365365|3597659|FG001|TREATED (SAFETY POPULATION)|Overall Study||75
2890770|NCT00365365|3597660|FG002|TREATED (SAFETY POPULATION)|Overall Study||59
2890771|NCT00365365|3597658|FG000|COMPLETED TREATMENT|Overall Study||38
2890772|NCT00365365|3597659|FG001|COMPLETED TREATMENT|Overall Study||36
2890773|NCT00365365|3597660|FG002|COMPLETED TREATMENT|Overall Study||45
2890774|NCT00365365|3597658|FG000|COMPLETED|Overall Study||44
2890775|NCT00365365|3597659|FG001|COMPLETED|Overall Study||41
2890776|NCT00365365|3597660|FG002|COMPLETED|Overall Study||44
2890777|NCT00365365|3597658|FG000|NOT COMPLETED|Overall Study||34
2890778|NCT00365365|3597659|FG001|NOT COMPLETED|Overall Study||36
2890779|NCT00365365|3597660|FG002|NOT COMPLETED|Overall Study||15
2890780|NCT00365378|3597670|FG000|STARTED|Vaccination (Day 1 to Month 7)||1204
2890781|NCT00365378|3597671|FG001|STARTED|Vaccination (Day 1 to Month 7)||1205
2890782|NCT00365378|3597672|FG002|STARTED|Vaccination (Day 1 to Month 7)||0
2890783|NCT00365378|3597670|FG000|Entered Vaccination Period|Vaccination (Day 1 to Month 7)||1193
2890784|NCT00365378|3597671|FG001|Entered Vaccination Period|Vaccination (Day 1 to Month 7)||1198
2890785|NCT00365378|3597672|FG002|Entered Vaccination Period|Vaccination (Day 1 to Month 7)||0
2890786|NCT00365378|3597670|FG000|COMPLETED|Vaccination (Day 1 to Month 7)||993
2890787|NCT00365378|3597671|FG001|COMPLETED|Vaccination (Day 1 to Month 7)||1038
2890788|NCT00365378|3597672|FG002|COMPLETED|Vaccination (Day 1 to Month 7)||0
2890789|NCT00365378|3597670|FG000|NOT COMPLETED|Vaccination (Day 1 to Month 7)||211
2890790|NCT00365378|3597671|FG001|NOT COMPLETED|Vaccination (Day 1 to Month 7)||167
2890791|NCT00365378|3597672|FG002|NOT COMPLETED|Vaccination (Day 1 to Month 7)||0
2890792|NCT00365378|3597670|FG000|STARTED|Follow-up (Month 7 Though Month 48)||993
2890793|NCT00365378|3597671|FG001|STARTED|Follow-up (Month 7 Though Month 48)||1038
2890794|NCT00365378|3597672|FG002|STARTED|Follow-up (Month 7 Though Month 48)||0
2890795|NCT00365378|3597670|FG000|COMPLETED|Follow-up (Month 7 Though Month 48)||835
2890796|NCT00365378|3597671|FG001|COMPLETED|Follow-up (Month 7 Though Month 48)||836
2890797|NCT00365378|3597672|FG002|COMPLETED|Follow-up (Month 7 Though Month 48)||0
2890798|NCT00365378|3597670|FG000|NOT COMPLETED|Follow-up (Month 7 Though Month 48)||158
2890799|NCT00365378|3597671|FG001|NOT COMPLETED|Follow-up (Month 7 Though Month 48)||202
2890800|NCT00365378|3597672|FG002|NOT COMPLETED|Follow-up (Month 7 Though Month 48)||0
2890801|NCT00365378|3597670|FG000|STARTED|Extension||0
2890802|NCT00365378|3597671|FG001|STARTED|Extension||0
2890803|NCT00365378|3597672|FG002|STARTED|Extension||400
2890804|NCT00365378|3597670|FG000|COMPLETED|Extension||0
2890805|NCT00365378|3597671|FG001|COMPLETED|Extension||0
2890806|NCT00365378|3597672|FG002|COMPLETED|Extension||203
2890807|NCT00365378|3597670|FG000|NOT COMPLETED|Extension||0
2890808|NCT00365378|3597671|FG001|NOT COMPLETED|Extension||0
2890809|NCT00365378|3597672|FG002|NOT COMPLETED|Extension||197
2890810|NCT00365391|3597679|FG000|STARTED|Overall Study||27
2890811|NCT00365391|3597679|FG000|COMPLETED|Overall Study||27
2890812|NCT00365391|3597679|FG000|NOT COMPLETED|Overall Study||0
2890813|NCT00365417|3597683|FG000|STARTED|Overall Study||45
2890814|NCT00365417|3597683|FG000|COMPLETED|Overall Study||45
2890815|NCT00365417|3597683|FG000|NOT COMPLETED|Overall Study||0
2890816|NCT00365456|3597688|FG000|STARTED|Trial Period I (12 Months)||407
2890817|NCT00365456|3597689|FG001|STARTED|Trial Period I (12 Months)||0
2890818|NCT00365456|3597688|FG000|COMPLETED|Trial Period I (12 Months)||282
2890819|NCT00365456|3597689|FG001|COMPLETED|Trial Period I (12 Months)||0
2890820|NCT00365456|3597688|FG000|NOT COMPLETED|Trial Period I (12 Months)||125
2890821|NCT00365456|3597689|FG001|NOT COMPLETED|Trial Period I (12 Months)||0
2890822|NCT00365456|3597688|FG000|STARTED|Trial Period II (12 Months)||0
2890823|NCT00365456|3597689|FG001|STARTED|Trial Period II (12 Months)||282
2890824|NCT00365456|3597688|FG000|COMPLETED|Trial Period II (12 Months)||0
2890825|NCT00365456|3597689|FG001|COMPLETED|Trial Period II (12 Months)||268
2890826|NCT00365456|3597688|FG000|NOT COMPLETED|Trial Period II (12 Months)||0
2890827|NCT00365456|3597689|FG001|NOT COMPLETED|Trial Period II (12 Months)||14
2890828|NCT00365456|3597688|FG000|STARTED|Trial Period III (12 Months)||136
2890829|NCT00365456|3597689|FG001|STARTED|Trial Period III (12 Months)||132
2890830|NCT00365456|3597688|FG000|COMPLETED|Trial Period III (12 Months)||118
2890831|NCT00365456|3597689|FG001|COMPLETED|Trial Period III (12 Months)||127
2890832|NCT00365456|3597688|FG000|NOT COMPLETED|Trial Period III (12 Months)||18
2890833|NCT00365456|3597689|FG001|NOT COMPLETED|Trial Period III (12 Months)||5
2890834|NCT00365508|3597697|FG000|STARTED|Overall Study||321
2890835|NCT00365508|3597698|FG001|STARTED|Overall Study||321
2890836|NCT00365508|3597697|FG000|COMPLETED|Overall Study||182
2890837|NCT00365508|3597698|FG001|COMPLETED|Overall Study||167
2890838|NCT00365508|3597697|FG000|NOT COMPLETED|Overall Study||139
2890839|NCT00365508|3597698|FG001|NOT COMPLETED|Overall Study||154
2890840|NCT00365547|3597704|FG000|STARTED|Overall Study||46
2890841|NCT00365547|3597704|FG000|COMPLETED|Overall Study||43
2890842|NCT00365547|3597704|FG000|NOT COMPLETED|Overall Study||3
2890843|NCT00365599|3597711|FG000|STARTED|Overall Study||43
2890844|NCT00365599|3597711|FG000|COMPLETED|Overall Study||43
2890845|NCT00365599|3597711|FG000|NOT COMPLETED|Overall Study||0
2890846|NCT00365716|3597720|FG000|STARTED|Base Study (Day 1 to Month 7)||290
2890847|NCT00365716|3597721|FG001|STARTED|Base Study (Day 1 to Month 7)||284
2890848|NCT00365716|3597722|FG002|STARTED|Base Study (Day 1 to Month 7)||292
2890849|NCT00365716|3597723|FG003|STARTED|Base Study (Day 1 to Month 7)||146
2890850|NCT00365716|3597724|FG004|STARTED|Base Study (Day 1 to Month 7)||146
2890851|NCT00365716|3597725|FG005|STARTED|Base Study (Day 1 to Month 7)||0
2890852|NCT00365716|3597726|FG006|STARTED|Base Study (Day 1 to Month 7)||0
2890853|NCT00365716|3597720|FG000|COMPLETED|Base Study (Day 1 to Month 7)||269
2890854|NCT00365716|3597721|FG001|COMPLETED|Base Study (Day 1 to Month 7)||260
2890855|NCT00365716|3597722|FG002|COMPLETED|Base Study (Day 1 to Month 7)||271
2890856|NCT00365716|3597723|FG003|COMPLETED|Base Study (Day 1 to Month 7)||136
2890857|NCT00365716|3597724|FG004|COMPLETED|Base Study (Day 1 to Month 7)||139
2890858|NCT00365716|3597725|FG005|COMPLETED|Base Study (Day 1 to Month 7)||0
2890859|NCT00365716|3597726|FG006|COMPLETED|Base Study (Day 1 to Month 7)||0
2890860|NCT00365716|3597720|FG000|NOT COMPLETED|Base Study (Day 1 to Month 7)||21
2890861|NCT00365716|3597721|FG001|NOT COMPLETED|Base Study (Day 1 to Month 7)||24
2890862|NCT00365716|3597722|FG002|NOT COMPLETED|Base Study (Day 1 to Month 7)||21
2890863|NCT00365716|3597723|FG003|NOT COMPLETED|Base Study (Day 1 to Month 7)||10
2890864|NCT00365716|3597724|FG004|NOT COMPLETED|Base Study (Day 1 to Month 7)||7
2890865|NCT00365716|3597725|FG005|NOT COMPLETED|Base Study (Day 1 to Month 7)||0
2890866|NCT00365716|3597726|FG006|NOT COMPLETED|Base Study (Day 1 to Month 7)||0
2890867|NCT00365716|3597720|FG000|STARTED|Long Term Follow-up (Month 7 toMonth 36)||269
2890868|NCT00365716|3597721|FG001|STARTED|Long Term Follow-up (Month 7 toMonth 36)||260
2890869|NCT00365716|3597722|FG002|STARTED|Long Term Follow-up (Month 7 toMonth 36)||271
2890870|NCT00365716|3597723|FG003|STARTED|Long Term Follow-up (Month 7 toMonth 36)||136
2890871|NCT00365716|3597724|FG004|STARTED|Long Term Follow-up (Month 7 toMonth 36)||139
2890872|NCT00365716|3597725|FG005|STARTED|Long Term Follow-up (Month 7 toMonth 36)||0
2890873|NCT00365716|3597726|FG006|STARTED|Long Term Follow-up (Month 7 toMonth 36)||0
2890874|NCT00365716|3597720|FG000|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||137
2890875|NCT00365716|3597721|FG001|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||245
2890876|NCT00365716|3597722|FG002|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||251
2890877|NCT00365716|3597723|FG003|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||57
2890878|NCT00365716|3597724|FG004|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||57
2890879|NCT00365716|3597725|FG005|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||0
2890880|NCT00365716|3597726|FG006|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||0
2890881|NCT00365716|3597720|FG000|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||132
2890882|NCT00365716|3597721|FG001|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||15
2890883|NCT00365716|3597722|FG002|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||20
2890884|NCT00365716|3597723|FG003|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||79
2890885|NCT00365716|3597724|FG004|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||82
2890886|NCT00365716|3597725|FG005|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||0
2890887|NCT00365716|3597726|FG006|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||0
2890888|NCT00365716|3597720|FG000|STARTED|Extension 1||0
2890889|NCT00365716|3597721|FG001|STARTED|Extension 1||0
2890890|NCT00365716|3597722|FG002|STARTED|Extension 1||0
2890891|NCT00365716|3597723|FG003|STARTED|Extension 1||0
2890892|NCT00365716|3597724|FG004|STARTED|Extension 1||0
2890893|NCT00365716|3597725|FG005|STARTED|Extension 1||241
2890894|NCT00365716|3597726|FG006|STARTED|Extension 1||0
2890895|NCT00365716|3597720|FG000|COMPLETED|Extension 1||0
2890896|NCT00365716|3597721|FG001|COMPLETED|Extension 1||0
2890897|NCT00365716|3597722|FG002|COMPLETED|Extension 1||0
2890898|NCT00365716|3597723|FG003|COMPLETED|Extension 1||0
2890899|NCT00365716|3597724|FG004|COMPLETED|Extension 1||0
2890900|NCT00365716|3597725|FG005|COMPLETED|Extension 1||219
2890901|NCT00365716|3597726|FG006|COMPLETED|Extension 1||0
2890902|NCT00365716|3597720|FG000|NOT COMPLETED|Extension 1||0
2890903|NCT00365716|3597721|FG001|NOT COMPLETED|Extension 1||0
2890904|NCT00365716|3597722|FG002|NOT COMPLETED|Extension 1||0
2890905|NCT00365716|3597723|FG003|NOT COMPLETED|Extension 1||0
2890906|NCT00365716|3597724|FG004|NOT COMPLETED|Extension 1||0
2890907|NCT00365716|3597725|FG005|NOT COMPLETED|Extension 1||22
2890908|NCT00365716|3597726|FG006|NOT COMPLETED|Extension 1||0
2890909|NCT00365716|3597720|FG000|STARTED|Extension 2||0
2890910|NCT00365716|3597721|FG001|STARTED|Extension 2||0
2890911|NCT00365716|3597722|FG002|STARTED|Extension 2||0
2890912|NCT00365716|3597723|FG003|STARTED|Extension 2||0
2890913|NCT00365716|3597724|FG004|STARTED|Extension 2||0
2890914|NCT00365716|3597725|FG005|STARTED|Extension 2||0
2890915|NCT00365716|3597726|FG006|STARTED|Extension 2|17 Participants continued into Extension 2 from Extension 1|17
2890916|NCT00365716|3597720|FG000|COMPLETED|Extension 2||0
2890917|NCT00365716|3597721|FG001|COMPLETED|Extension 2||0
2890918|NCT00365716|3597722|FG002|COMPLETED|Extension 2||0
2890919|NCT00365716|3597723|FG003|COMPLETED|Extension 2||0
2890920|NCT00365716|3597724|FG004|COMPLETED|Extension 2||0
2890921|NCT00365716|3597725|FG005|COMPLETED|Extension 2||0
2890922|NCT00365716|3597726|FG006|COMPLETED|Extension 2||7
2890923|NCT00365716|3597720|FG000|NOT COMPLETED|Extension 2||0
2890924|NCT00365716|3597721|FG001|NOT COMPLETED|Extension 2||0
2890925|NCT00365716|3597722|FG002|NOT COMPLETED|Extension 2||0
2890926|NCT00365716|3597723|FG003|NOT COMPLETED|Extension 2||0
2890927|NCT00365716|3597724|FG004|NOT COMPLETED|Extension 2||0
2890928|NCT00365716|3597725|FG005|NOT COMPLETED|Extension 2||0
2890929|NCT00365716|3597726|FG006|NOT COMPLETED|Extension 2||10
2890930|NCT00365768|3597742|FG000|STARTED|Overall Study||24
2890931|NCT00365768|3597743|FG001|STARTED|Overall Study||25
2890932|NCT00365768|3597742|FG000|COMPLETED|Overall Study||24
2890933|NCT00365768|3597743|FG001|COMPLETED|Overall Study||25
2890934|NCT00365768|3597742|FG000|NOT COMPLETED|Overall Study||0
2890935|NCT00365768|3597743|FG001|NOT COMPLETED|Overall Study||0
2890936|NCT00365794|3597749|FG000|STARTED|Overall Study|22 subjects were enrolled since only 20 completed all post treatment measures.|22
2890937|NCT00365794|3597749|FG000|COMPLETED|Overall Study||20
2890938|NCT00365794|3597749|FG000|NOT COMPLETED|Overall Study||2
2890939|NCT00365846|3597754|FG000|STARTED|Overall Study||29
2890940|NCT00365846|3597754|FG000|COMPLETED|Overall Study||28
2890941|NCT00365846|3597754|FG000|NOT COMPLETED|Overall Study||1
2890942|NCT00365859|3597763|FG000|STARTED|Overall Study||86
2890943|NCT00365859|3597764|FG001|STARTED|Overall Study||70
2890944|NCT00365859|3597765|FG002|STARTED|Overall Study||174
2890945|NCT00365859|3597766|FG003|STARTED|Overall Study||330
2890946|NCT00365859|3597763|FG000|Safety Population|Overall Study||86
2890947|NCT00365859|3597764|FG001|Safety Population|Overall Study||70
2890948|NCT00365859|3597765|FG002|Safety Population|Overall Study||174
2890949|NCT00365859|3597766|FG003|Safety Population|Overall Study||330
2890950|NCT00365859|3597763|FG000|Efficacy Population|Overall Study|1 patient was lost to follow-up and 1 not included due to moderate sedation (total=2)|84
2919749|NCT00533897|3630112|FG007|NOT COMPLETED|Long Term Extension (LTE)||25
2890951|NCT00365859|3597764|FG001|Efficacy Population|Overall Study|1 not included due to increased alanine aminotransferase (ALT) prior to treatment with aripiprazole|69
2890952|NCT00365859|3597765|FG002|Efficacy Population|Overall Study|3 lost to follow-up, 1 not included due to mild increased appetite, 1 to family emergency (total=5)|169
2890953|NCT00365859|3597766|FG003|Efficacy Population|Overall Study||322
2890954|NCT00365859|3597763|FG000|COMPLETED|Overall Study||55
2890955|NCT00365859|3597764|FG001|COMPLETED|Overall Study||37
2890956|NCT00365859|3597765|FG002|COMPLETED|Overall Study||107
2890957|NCT00365859|3597766|FG003|COMPLETED|Overall Study||199
2890958|NCT00365859|3597763|FG000|NOT COMPLETED|Overall Study||31
2890959|NCT00365859|3597764|FG001|NOT COMPLETED|Overall Study||33
2890960|NCT00365859|3597765|FG002|NOT COMPLETED|Overall Study||67
2890961|NCT00365859|3597766|FG003|NOT COMPLETED|Overall Study||131
2890962|NCT00365872|3597778|FG000|STARTED|Overall Study||5
2890963|NCT00365872|3597779|FG001|STARTED|Overall Study||6
2890964|NCT00365872|3597780|FG002|STARTED|Overall Study||6
2890965|NCT00365872|3597778|FG000|COMPLETED|Overall Study||5
2890966|NCT00365872|3597779|FG001|COMPLETED|Overall Study||6
2890967|NCT00365872|3597780|FG002|COMPLETED|Overall Study||6
2890968|NCT00365872|3597778|FG000|NOT COMPLETED|Overall Study||0
2890969|NCT00365872|3597779|FG001|NOT COMPLETED|Overall Study||0
2890970|NCT00365872|3597780|FG002|NOT COMPLETED|Overall Study||0
2890971|NCT00365976|3597789|FG000|STARTED|Overall Study||33
2890972|NCT00365976|3597790|FG001|STARTED|Overall Study||25
2890973|NCT00365976|3597789|FG000|COMPLETED|Overall Study||32
2890974|NCT00365976|3597790|FG001|COMPLETED|Overall Study||20
2890975|NCT00365976|3597789|FG000|NOT COMPLETED|Overall Study||1
2890976|NCT00365976|3597790|FG001|NOT COMPLETED|Overall Study||5
2890977|NCT00365989|3597796|FG000|STARTED|Overall Study||50
2890978|NCT00365989|3597796|FG000|COMPLETED|Overall Study||48
2890979|NCT00365989|3597796|FG000|NOT COMPLETED|Overall Study||2
2890980|NCT00366028|3597803|FG000|STARTED|Overall Study||889
2890981|NCT00366028|3597804|FG001|STARTED|Overall Study||735
2890982|NCT00366028|3597803|FG000|COMPLETED|Overall Study||889
2890983|NCT00366028|3597804|FG001|COMPLETED|Overall Study||735
2890984|NCT00366028|3597803|FG000|NOT COMPLETED|Overall Study||0
2890985|NCT00366028|3597804|FG001|NOT COMPLETED|Overall Study||0
2890986|NCT00366106|3597812|FG000|STARTED|Overall Study||32
2890987|NCT00366106|3597812|FG000|COMPLETED|Overall Study||32
2890988|NCT00366106|3597812|FG000|NOT COMPLETED|Overall Study||0
2890989|NCT00366249|3597818|FG000|STARTED|Overall Study||553
2890990|NCT00366249|3597819|FG001|STARTED|Overall Study||508
2890991|NCT00366249|3597818|FG000|COMPLETED|Overall Study||422
2890992|NCT00366249|3597819|FG001|COMPLETED|Overall Study||430
2890993|NCT00366249|3597818|FG000|NOT COMPLETED|Overall Study||131
2890994|NCT00366249|3597819|FG001|NOT COMPLETED|Overall Study||78
2890995|NCT00366275|3597825|FG000|STARTED|Overall Study||64
2890996|NCT00366275|3597825|FG000|COMPLETED|Overall Study||58
2890997|NCT00366275|3597825|FG000|NOT COMPLETED|Overall Study||6
2890998|NCT00366301|3597833|FG000|STARTED|Overall Study||124
2890999|NCT00366301|3597834|FG001|STARTED|Overall Study||126
2891000|NCT00366301|3597835|FG002|STARTED|Overall Study||126
2891001|NCT00366301|3597836|FG003|STARTED|Overall Study||124
2891002|NCT00366301|3597833|FG000|Either 6W or 14W CRP Obtained|Overall Study||120
2891003|NCT00366301|3597834|FG001|Either 6W or 14W CRP Obtained|Overall Study||124
2891004|NCT00366301|3597835|FG002|Either 6W or 14W CRP Obtained|Overall Study||124
2891005|NCT00366301|3597836|FG003|Either 6W or 14W CRP Obtained|Overall Study||119
2891006|NCT00366301|3597833|FG000|COMPLETED|Overall Study||116
2891007|NCT00366301|3597834|FG001|COMPLETED|Overall Study||120
2891008|NCT00366301|3597835|FG002|COMPLETED|Overall Study||122
2891009|NCT00366301|3597836|FG003|COMPLETED|Overall Study||116
2891010|NCT00366301|3597833|FG000|NOT COMPLETED|Overall Study||8
2891011|NCT00366301|3597834|FG001|NOT COMPLETED|Overall Study||6
2891012|NCT00366301|3597835|FG002|NOT COMPLETED|Overall Study||4
2891013|NCT00366301|3597836|FG003|NOT COMPLETED|Overall Study||8
2891014|NCT00366340|3597848|FG000|STARTED|Infant Series||301
2891015|NCT00366340|3597849|FG001|STARTED|Infant Series||303
2891016|NCT00366340|3597848|FG000|Vaccinated Dose 1|Infant Series||300
2891017|NCT00366340|3597849|FG001|Vaccinated Dose 1|Infant Series||303
2891018|NCT00366340|3597848|FG000|Vaccinated Dose 2|Infant Series||296
2891019|NCT00366340|3597849|FG001|Vaccinated Dose 2|Infant Series||297
2891020|NCT00366340|3597848|FG000|Vaccinated Dose 3|Infant Series||294
2891021|NCT00366340|3597849|FG001|Vaccinated Dose 3|Infant Series||293
2891022|NCT00366340|3597848|FG000|COMPLETED|Infant Series||293
2891023|NCT00366340|3597849|FG001|COMPLETED|Infant Series||293
2891024|NCT00366340|3597848|FG000|NOT COMPLETED|Infant Series||8
2891025|NCT00366340|3597849|FG001|NOT COMPLETED|Infant Series||10
2891026|NCT00366340|3597848|FG000|STARTED|After the Infant Series||293
2891027|NCT00366340|3597849|FG001|STARTED|After the Infant Series||293
2891028|NCT00366340|3597848|FG000|COMPLETED|After the Infant Series||290
2891029|NCT00366340|3597849|FG001|COMPLETED|After the Infant Series||287
2891030|NCT00366340|3597848|FG000|NOT COMPLETED|After the Infant Series||3
2891031|NCT00366340|3597849|FG001|NOT COMPLETED|After the Infant Series||6
2891032|NCT00366340|3597848|FG000|STARTED|Toddler Dose||290
2891033|NCT00366340|3597849|FG001|STARTED|Toddler Dose||287
2891034|NCT00366340|3597848|FG000|COMPLETED|Toddler Dose||289
2891035|NCT00366340|3597849|FG001|COMPLETED|Toddler Dose||286
2891036|NCT00366340|3597848|FG000|NOT COMPLETED|Toddler Dose||1
2891037|NCT00366340|3597849|FG001|NOT COMPLETED|Toddler Dose||1
2891038|NCT00366444|3597881|FG000|STARTED|Overall Study||102
2891039|NCT00366444|3597882|FG001|STARTED|Overall Study||99
2891040|NCT00366444|3597881|FG000|COMPLETED|Overall Study||101
2891041|NCT00366444|3597882|FG001|COMPLETED|Overall Study||97
2891042|NCT00366444|3597881|FG000|NOT COMPLETED|Overall Study||1
2891043|NCT00366444|3597882|FG001|NOT COMPLETED|Overall Study||2
2891044|NCT00366457|3597888|FG000|STARTED|Overall Study||32
2891045|NCT00366457|3597888|FG000|COMPLETED|Overall Study||30
2891046|NCT00366457|3597888|FG000|NOT COMPLETED|Overall Study||2
2891047|NCT00366535|3597894|FG000|STARTED|First Phase: 12 Weeks||27
2891048|NCT00366535|3597895|FG001|STARTED|First Phase: 12 Weeks||29
2891049|NCT00366535|3597894|FG000|COMPLETED|First Phase: 12 Weeks||24
2891050|NCT00366535|3597895|FG001|COMPLETED|First Phase: 12 Weeks||21
2891051|NCT00366535|3597894|FG000|NOT COMPLETED|First Phase: 12 Weeks||3
2891052|NCT00366535|3597895|FG001|NOT COMPLETED|First Phase: 12 Weeks||8
2891053|NCT00366535|3597894|FG000|STARTED|Washout Period (at Least a Week)||24
2891054|NCT00366535|3597895|FG001|STARTED|Washout Period (at Least a Week)||21
2891055|NCT00366535|3597894|FG000|COMPLETED|Washout Period (at Least a Week)||24
2891056|NCT00366535|3597895|FG001|COMPLETED|Washout Period (at Least a Week)||21
2891057|NCT00366535|3597894|FG000|NOT COMPLETED|Washout Period (at Least a Week)||0
2891058|NCT00366535|3597895|FG001|NOT COMPLETED|Washout Period (at Least a Week)||0
2891059|NCT00366535|3597894|FG000|STARTED|Second Phase: 12 Weeks||24
2891060|NCT00366535|3597895|FG001|STARTED|Second Phase: 12 Weeks||21
2891061|NCT00366535|3597894|FG000|COMPLETED|Second Phase: 12 Weeks||21
2891062|NCT00366535|3597895|FG001|COMPLETED|Second Phase: 12 Weeks||18
2891063|NCT00366535|3597894|FG000|NOT COMPLETED|Second Phase: 12 Weeks||3
2891064|NCT00366535|3597895|FG001|NOT COMPLETED|Second Phase: 12 Weeks||3
2891065|NCT00366548|3597911|FG000|STARTED|Infant Series||250
2891066|NCT00366548|3597912|FG001|STARTED|Infant Series||250
2891067|NCT00366548|3597911|FG000|Vaccinated Dose 1|Infant Series||250
2891068|NCT00366548|3597912|FG001|Vaccinated Dose 1|Infant Series||250
2891069|NCT00366548|3597911|FG000|Vaccinated Dose 2|Infant Series||246
2891070|NCT00366548|3597912|FG001|Vaccinated Dose 2|Infant Series||249
2891071|NCT00366548|3597911|FG000|Vaccinated Dose 3|Infant Series||246
2891072|NCT00366548|3597912|FG001|Vaccinated Dose 3|Infant Series||247
2891073|NCT00366548|3597911|FG000|COMPLETED|Infant Series||246
2891074|NCT00366548|3597912|FG001|COMPLETED|Infant Series||245
2891075|NCT00366548|3597911|FG000|NOT COMPLETED|Infant Series||4
2891076|NCT00366548|3597912|FG001|NOT COMPLETED|Infant Series||5
2891077|NCT00366548|3597911|FG000|STARTED|After Infant Series||246
2891078|NCT00366548|3597912|FG001|STARTED|After Infant Series||245
2891079|NCT00366548|3597911|FG000|COMPLETED|After Infant Series||240
2891080|NCT00366548|3597912|FG001|COMPLETED|After Infant Series||244
2891081|NCT00366548|3597911|FG000|NOT COMPLETED|After Infant Series||6
2891082|NCT00366548|3597912|FG001|NOT COMPLETED|After Infant Series||1
2891083|NCT00366548|3597911|FG000|STARTED|Toddler Dose||240
2891084|NCT00366548|3597912|FG001|STARTED|Toddler Dose||244
2891085|NCT00366548|3597911|FG000|COMPLETED|Toddler Dose||240
2891086|NCT00366548|3597912|FG001|COMPLETED|Toddler Dose||244
2891087|NCT00366548|3597911|FG000|NOT COMPLETED|Toddler Dose||0
2891088|NCT00366548|3597912|FG001|NOT COMPLETED|Toddler Dose||0
2891089|NCT00366626|3597938|FG000|STARTED|Overall Study||38
2891090|NCT00366626|3597939|FG001|STARTED|Overall Study||45
2891091|NCT00366626|3597938|FG000|COMPLETED|Overall Study||38
2891092|NCT00366626|3597939|FG001|COMPLETED|Overall Study||45
2891093|NCT00366626|3597938|FG000|NOT COMPLETED|Overall Study||0
2891094|NCT00366626|3597939|FG001|NOT COMPLETED|Overall Study||0
2891095|NCT00366678|3597949|FG000|STARTED|Infant Series||304
2891096|NCT00366678|3597950|FG001|STARTED|Infant Series||309
2891097|NCT00366678|3597951|FG002|STARTED|Infant Series||0
2891098|NCT00366678|3597949|FG000|Vaccinated Dose 1|Infant Series||302
2891099|NCT00366678|3597950|FG001|Vaccinated Dose 1|Infant Series||309
2891100|NCT00366678|3597951|FG002|Vaccinated Dose 1|Infant Series||0
2891101|NCT00366678|3597949|FG000|Vaccinated Dose 2|Infant Series||295
2891102|NCT00366678|3597950|FG001|Vaccinated Dose 2|Infant Series||304
2891103|NCT00366678|3597951|FG002|Vaccinated Dose 2|Infant Series||0
2891104|NCT00366678|3597949|FG000|Vaccinated Dose 3|Infant Series||291
2891105|NCT00366678|3597950|FG001|Vaccinated Dose 3|Infant Series||302
2891106|NCT00366678|3597951|FG002|Vaccinated Dose 3|Infant Series||0
2891107|NCT00366678|3597949|FG000|COMPLETED|Infant Series||290
2891108|NCT00366678|3597950|FG001|COMPLETED|Infant Series||299
2891109|NCT00366678|3597951|FG002|COMPLETED|Infant Series||0
2891110|NCT00366678|3597949|FG000|NOT COMPLETED|Infant Series||14
2891111|NCT00366678|3597950|FG001|NOT COMPLETED|Infant Series||10
2891112|NCT00366678|3597951|FG002|NOT COMPLETED|Infant Series||0
2891113|NCT00366678|3597949|FG000|STARTED|After Infant||290
2891114|NCT00366678|3597950|FG001|STARTED|After Infant||299
2891115|NCT00366678|3597951|FG002|STARTED|After Infant||0
2891116|NCT00366678|3597949|FG000|COMPLETED|After Infant||273
2891117|NCT00366678|3597950|FG001|COMPLETED|After Infant||289
2891118|NCT00366678|3597951|FG002|COMPLETED|After Infant||0
2891119|NCT00366678|3597949|FG000|NOT COMPLETED|After Infant||17
2891120|NCT00366678|3597950|FG001|NOT COMPLETED|After Infant||10
2891121|NCT00366678|3597951|FG002|NOT COMPLETED|After Infant||0
2891122|NCT00366678|3597949|FG000|STARTED|Toddler Dose||273
2891123|NCT00366678|3597950|FG001|STARTED|Toddler Dose||152
2891124|NCT00366678|3597951|FG002|STARTED|Toddler Dose||137
2891125|NCT00366678|3597949|FG000|COMPLETED|Toddler Dose||268
2891126|NCT00366678|3597950|FG001|COMPLETED|Toddler Dose||151
2891127|NCT00366678|3597951|FG002|COMPLETED|Toddler Dose||137
2891128|NCT00366678|3597949|FG000|NOT COMPLETED|Toddler Dose||5
2891129|NCT00366678|3597950|FG001|NOT COMPLETED|Toddler Dose||1
2891130|NCT00366678|3597951|FG002|NOT COMPLETED|Toddler Dose||0
2891131|NCT00366899|3597998|FG000|STARTED|Infant Series|1 participant was counted twice, 1 participant randomized to 13vPnC, incorrectly received 7vPnC|303
2891132|NCT00366899|3597999|FG001|STARTED|Infant Series|1 participant randomized to 7vPnC but never vaccinated|303
2891133|NCT00366899|3597998|FG000|Vaccinated Dose 1|Infant Series|2 participants randomized to 13vPnC, incorrectly received 7vPnC|302
2891134|NCT00366899|3597999|FG001|Vaccinated Dose 1|Infant Series||302
2891135|NCT00366899|3597998|FG000|Vaccinated Dose 2|Infant Series|1 participant randomized to 13vPnC, incorrectly received 7vPnC|296
2891136|NCT00366899|3597999|FG001|Vaccinated Dose 2|Infant Series||293
2891137|NCT00366899|3597998|FG000|COMPLETED|Infant Series||294
2891138|NCT00366899|3597999|FG001|COMPLETED|Infant Series||291
2891139|NCT00366899|3597998|FG000|NOT COMPLETED|Infant Series||9
2891140|NCT00366899|3597999|FG001|NOT COMPLETED|Infant Series||12
2891141|NCT00366899|3597998|FG000|STARTED|After Infant Series||294
2891142|NCT00366899|3597999|FG001|STARTED|After Infant Series||291
3170359|NCT01929109|3897736|FG001|NOT COMPLETED|Period 1 (All Groups)||0
3170360|NCT01929109|3897737|FG002|NOT COMPLETED|Period 1 (All Groups)||1
3170361|NCT01929109|3897738|FG003|NOT COMPLETED|Period 1 (All Groups)||0
3170362|NCT01929109|3897739|FG004|NOT COMPLETED|Period 1 (All Groups)||0
3170363|NCT01929109|3897735|FG000|STARTED|Period 2 (End Stage Renal Disease Only)||0
3170364|NCT01929109|3897736|FG001|STARTED|Period 2 (End Stage Renal Disease Only)||0
3170365|NCT01929109|3897737|FG002|STARTED|Period 2 (End Stage Renal Disease Only)||0
3170366|NCT01929109|3897738|FG003|STARTED|Period 2 (End Stage Renal Disease Only)||0
3170367|NCT01929109|3897739|FG004|STARTED|Period 2 (End Stage Renal Disease Only)||8
3170368|NCT01929109|3897735|FG000|COMPLETED|Period 2 (End Stage Renal Disease Only)||0
3170369|NCT01929109|3897736|FG001|COMPLETED|Period 2 (End Stage Renal Disease Only)||0
3170370|NCT01929109|3897737|FG002|COMPLETED|Period 2 (End Stage Renal Disease Only)||0
3170371|NCT01929109|3897738|FG003|COMPLETED|Period 2 (End Stage Renal Disease Only)||0
3170372|NCT01929109|3897739|FG004|COMPLETED|Period 2 (End Stage Renal Disease Only)||8
3170373|NCT01929109|3897735|FG000|NOT COMPLETED|Period 2 (End Stage Renal Disease Only)||0
3170374|NCT01929109|3897736|FG001|NOT COMPLETED|Period 2 (End Stage Renal Disease Only)||0
3170375|NCT01929109|3897737|FG002|NOT COMPLETED|Period 2 (End Stage Renal Disease Only)||0
3170376|NCT01929109|3897738|FG003|NOT COMPLETED|Period 2 (End Stage Renal Disease Only)||0
3170377|NCT01929109|3897739|FG004|NOT COMPLETED|Period 2 (End Stage Renal Disease Only)||0
3170378|NCT01929135|3897756|FG000|STARTED|Overall Study||19
3170379|NCT01929135|3897757|FG001|STARTED|Overall Study||19
3170380|NCT01929135|3897756|FG000|COMPLETED|Overall Study||18
3170381|NCT01929135|3897757|FG001|COMPLETED|Overall Study||18
3170382|NCT01929135|3897756|FG000|NOT COMPLETED|Overall Study||1
3170383|NCT01929135|3897757|FG001|NOT COMPLETED|Overall Study||1
3170384|NCT01929226|3897767|FG000|STARTED|Overall Study||210
3170385|NCT01929226|3897768|FG001|STARTED|Overall Study||70
3170386|NCT01929226|3897767|FG000|COMPLETED|Overall Study||205
3170387|NCT01929226|3897768|FG001|COMPLETED|Overall Study||69
3170388|NCT01929226|3897767|FG000|NOT COMPLETED|Overall Study||5
3170389|NCT01929226|3897768|FG001|NOT COMPLETED|Overall Study||1
3170390|NCT01929291|3897775|FG000|STARTED|Overall Study||672
3170391|NCT01929291|3897775|FG000|COMPLETED|Overall Study||672
3170392|NCT01929291|3897775|FG000|NOT COMPLETED|Overall Study||0
3170393|NCT01929317|3897781|FG000|STARTED|Dose Increase Effect Verification Phase||61
3170394|NCT01929317|3897782|FG001|STARTED|Dose Increase Effect Verification Phase||20
3170395|NCT01929317|3897781|FG000|COMPLETED|Dose Increase Effect Verification Phase||52
3170396|NCT01929317|3897782|FG001|COMPLETED|Dose Increase Effect Verification Phase||19
3170397|NCT01929317|3897781|FG000|NOT COMPLETED|Dose Increase Effect Verification Phase||9
3170398|NCT01929317|3897782|FG001|NOT COMPLETED|Dose Increase Effect Verification Phase||1
3170399|NCT01929317|3897781|FG000|STARTED|Long-term Phase||44
3170400|NCT01929317|3897782|FG001|STARTED|Long-term Phase||18
3170401|NCT01929317|3897781|FG000|COMPLETED|Long-term Phase||25
3170402|NCT01929317|3897782|FG001|COMPLETED|Long-term Phase||14
3170403|NCT01929317|3897781|FG000|NOT COMPLETED|Long-term Phase||19
3170404|NCT01929317|3897782|FG001|NOT COMPLETED|Long-term Phase||4
3170405|NCT01929343|3897797|FG000|STARTED|Overall Study||12
3170406|NCT01929343|3897798|FG001|STARTED|Overall Study||9
3170407|NCT01929343|3897799|FG002|STARTED|Overall Study||12
3170408|NCT01929343|3897797|FG000|COMPLETED|Overall Study||11
3170409|NCT01929343|3897798|FG001|COMPLETED|Overall Study||7
3170410|NCT01929343|3897799|FG002|COMPLETED|Overall Study||12
3170411|NCT01929343|3897797|FG000|NOT COMPLETED|Overall Study||1
3170412|NCT01929343|3897798|FG001|NOT COMPLETED|Overall Study||2
3170413|NCT01929343|3897799|FG002|NOT COMPLETED|Overall Study||0
3170414|NCT01929395|3897810|FG000|STARTED|Overall Study||19
3170415|NCT01929395|3897811|FG001|STARTED|Overall Study||70
3170416|NCT01929395|3897812|FG002|STARTED|Overall Study||70
3170417|NCT01929395|3897810|FG000|COMPLETED|Overall Study||18
3170418|NCT01929395|3897811|FG001|COMPLETED|Overall Study||69
3170419|NCT01929395|3897812|FG002|COMPLETED|Overall Study||69
3170420|NCT01929395|3897810|FG000|NOT COMPLETED|Overall Study||1
3170421|NCT01929395|3897811|FG001|NOT COMPLETED|Overall Study||1
3170422|NCT01929395|3897812|FG002|NOT COMPLETED|Overall Study||1
3170423|NCT01929408|3897820|FG000|STARTED|Overall Study||703
3170424|NCT01929408|3897820|FG000|COMPLETED|Overall Study||695
3170425|NCT01929408|3897820|FG000|NOT COMPLETED|Overall Study||8
3171794|NCT01937195|3898992|FG000|NOT COMPLETED|Overall Study||0
3171795|NCT01937260|3898998|FG000|STARTED|Overall Study||21
3171796|NCT01937260|3898999|FG001|STARTED|Overall Study||10
3170426|NCT01929460|3897826|FG000|STARTED|Overall Study||13
3170427|NCT01929460|3897827|FG001|STARTED|Overall Study||13
3170428|NCT01929460|3897826|FG000|COMPLETED|Overall Study||13
3170429|NCT01929460|3897827|FG001|COMPLETED|Overall Study||13
3170430|NCT01929460|3897826|FG000|NOT COMPLETED|Overall Study||0
3170431|NCT01929460|3897827|FG001|NOT COMPLETED|Overall Study||0
3170432|NCT01929473|3897833|FG000|STARTED|Overall Study|0 day|3830
3170433|NCT01929473|3897833|FG000|365 Day|Overall Study||3589
3170434|NCT01929473|3897833|FG000|COMPLETED|Overall Study||3243
3170435|NCT01929473|3897833|FG000|NOT COMPLETED|Overall Study||587
3170436|NCT01929642|3897837|FG000|STARTED|Overall Study||3
3170437|NCT01929642|3897837|FG000|COMPLETED|Overall Study||1
3170438|NCT01929642|3897837|FG000|NOT COMPLETED|Overall Study||2
3170439|NCT01929681|3897845|FG000|STARTED|Overall Study||28
3170440|NCT01929681|3897846|FG001|STARTED|Overall Study||25
3170441|NCT01929681|3897845|FG000|COMPLETED|Overall Study||26
3170442|NCT01929681|3897846|FG001|COMPLETED|Overall Study||24
3170443|NCT01929681|3897845|FG000|NOT COMPLETED|Overall Study||2
3170444|NCT01929681|3897846|FG001|NOT COMPLETED|Overall Study||1
3170445|NCT01929707|3897852|FG000|STARTED|Intervention Period 1||6
3170446|NCT01929707|3897853|FG001|STARTED|Intervention Period 1||8
3170447|NCT01929707|3897854|FG002|STARTED|Intervention Period 1||12
3170448|NCT01929707|3897855|FG003|STARTED|Intervention Period 1||10
3170449|NCT01929707|3897856|FG004|STARTED|Intervention Period 1||0
3170450|NCT01929707|3897857|FG005|STARTED|Intervention Period 1||0
3170451|NCT01929707|3897858|FG006|STARTED|Intervention Period 1||0
3170452|NCT01929707|3897859|FG007|STARTED|Intervention Period 1||0
3170453|NCT01929707|3897852|FG000|Received at Least 1 Dose of Study Drug|Intervention Period 1||6
3170454|NCT01929707|3897853|FG001|Received at Least 1 Dose of Study Drug|Intervention Period 1||8
3170455|NCT01929707|3897854|FG002|Received at Least 1 Dose of Study Drug|Intervention Period 1||12
3170456|NCT01929707|3897855|FG003|Received at Least 1 Dose of Study Drug|Intervention Period 1||10
3170457|NCT01929707|3897856|FG004|Received at Least 1 Dose of Study Drug|Intervention Period 1||0
3170458|NCT01929707|3897857|FG005|Received at Least 1 Dose of Study Drug|Intervention Period 1||0
3170459|NCT01929707|3897858|FG006|Received at Least 1 Dose of Study Drug|Intervention Period 1||0
3170460|NCT01929707|3897859|FG007|Received at Least 1 Dose of Study Drug|Intervention Period 1||0
3170461|NCT01929707|3897852|FG000|COMPLETED|Intervention Period 1||6
3170462|NCT01929707|3897853|FG001|COMPLETED|Intervention Period 1||8
3170463|NCT01929707|3897854|FG002|COMPLETED|Intervention Period 1||12
3170464|NCT01929707|3897855|FG003|COMPLETED|Intervention Period 1|Two discontinued participants were replaced in Period 2|7
3170465|NCT01929707|3897856|FG004|COMPLETED|Intervention Period 1||0
3170466|NCT01929707|3897857|FG005|COMPLETED|Intervention Period 1||0
3170467|NCT01929707|3897858|FG006|COMPLETED|Intervention Period 1||0
3170468|NCT01929707|3897859|FG007|COMPLETED|Intervention Period 1||0
2891143|NCT00366899|3597998|FG000|COMPLETED|After Infant Series||287
2891144|NCT00366899|3597999|FG001|COMPLETED|After Infant Series||282
2891145|NCT00366899|3597998|FG000|NOT COMPLETED|After Infant Series||7
2891146|NCT00366899|3597999|FG001|NOT COMPLETED|After Infant Series||9
2891147|NCT00366899|3597998|FG000|STARTED|Toddler Dose||287
2891148|NCT00366899|3597999|FG001|STARTED|Toddler Dose||282
2891149|NCT00366899|3597998|FG000|COMPLETED|Toddler Dose||285
2891150|NCT00366899|3597999|FG001|COMPLETED|Toddler Dose||281
2891151|NCT00366899|3597998|FG000|NOT COMPLETED|Toddler Dose||2
2891152|NCT00366899|3597999|FG001|NOT COMPLETED|Toddler Dose||1
2891153|NCT00367003|3598031|FG000|STARTED|Overall Study||37
2891154|NCT00367003|3598031|FG000|COMPLETED|Overall Study||28
2891155|NCT00367003|3598031|FG000|NOT COMPLETED|Overall Study||9
3170469|NCT01929707|3897852|FG000|NOT COMPLETED|Intervention Period 1||0
3170470|NCT01929707|3897853|FG001|NOT COMPLETED|Intervention Period 1||0
3170471|NCT01929707|3897854|FG002|NOT COMPLETED|Intervention Period 1||0
3170472|NCT01929707|3897855|FG003|NOT COMPLETED|Intervention Period 1||3
3170473|NCT01929707|3897856|FG004|NOT COMPLETED|Intervention Period 1||0
3170474|NCT01929707|3897857|FG005|NOT COMPLETED|Intervention Period 1||0
3170475|NCT01929707|3897858|FG006|NOT COMPLETED|Intervention Period 1||0
3170476|NCT01929707|3897859|FG007|NOT COMPLETED|Intervention Period 1||0
3170477|NCT01929707|3897852|FG000|STARTED|Washout Period ≥7 Days||6
2891156|NCT00367016|3598037|FG000|STARTED|Overall Study||3
2891157|NCT00367016|3598038|FG001|STARTED|Overall Study||3
2891158|NCT00367016|3598037|FG000|First Intervention|Overall Study||3
2891159|NCT00367016|3598038|FG001|First Intervention|Overall Study||3
2891160|NCT00367016|3598037|FG000|Second Intervention|Overall Study||3
2891161|NCT00367016|3598038|FG001|Second Intervention|Overall Study||3
2891162|NCT00367016|3598037|FG000|COMPLETED|Overall Study||3
2891163|NCT00367016|3598038|FG001|COMPLETED|Overall Study||3
2891164|NCT00367016|3598037|FG000|NOT COMPLETED|Overall Study||0
2891165|NCT00367016|3598038|FG001|NOT COMPLETED|Overall Study||0
2891166|NCT00367055|3598048|FG000|STARTED|Overall Study||43
2891167|NCT00367055|3598049|FG001|STARTED|Overall Study||41
2891168|NCT00367055|3598048|FG000|COMPLETED|Overall Study||32
2891169|NCT00367055|3598049|FG001|COMPLETED|Overall Study||30
2891170|NCT00367055|3598048|FG000|NOT COMPLETED|Overall Study||11
3170478|NCT01929707|3897853|FG001|STARTED|Washout Period ≥7 Days||8
2891171|NCT00367055|3598049|FG001|NOT COMPLETED|Overall Study||11
2891172|NCT00367133|3598058|FG000|STARTED|2 Years|Number of Eyes|330
2891173|NCT00367133|3598059|FG001|STARTED|2 Years|Number of Eyes|256
3170479|NCT01929707|3897854|FG002|STARTED|Washout Period ≥7 Days||12
3170480|NCT01929707|3897855|FG003|STARTED|Washout Period ≥7 Days||7
2891174|NCT00367133|3598060|FG002|STARTED|2 Years|Number of Eyes|254
2891175|NCT00367133|3598058|FG000|COMPLETED|2 Years||272
2891176|NCT00367133|3598059|FG001|COMPLETED|2 Years||220
2891177|NCT00367133|3598060|FG002|COMPLETED|2 Years||205
2891178|NCT00367133|3598058|FG000|NOT COMPLETED|2 Years||58
2891179|NCT00367133|3598059|FG001|NOT COMPLETED|2 Years||36
2891180|NCT00367133|3598060|FG002|NOT COMPLETED|2 Years||49
2891181|NCT00367133|3598058|FG000|STARTED|3 Years|Since trial ended early, includes only those with potential for 3 year follow-up -excludes deaths|143
2891182|NCT00367133|3598059|FG001|STARTED|3 Years|Since trial ended early, includes only those with potential for 3 year follow-up -excludes deaths|116
2891183|NCT00367133|3598060|FG002|STARTED|3 Years|Since trial ended early, includes only those with potential for 3 year follow-up -excludes deaths|116
2891184|NCT00367133|3598058|FG000|COMPLETED|3 Years||115
2891185|NCT00367133|3598059|FG001|COMPLETED|3 Years||93
2891186|NCT00367133|3598060|FG002|COMPLETED|3 Years||98
2891187|NCT00367133|3598058|FG000|NOT COMPLETED|3 Years||28
2891188|NCT00367133|3598059|FG001|NOT COMPLETED|3 Years||23
2891189|NCT00367133|3598060|FG002|NOT COMPLETED|3 Years||18
2891190|NCT00367237|3598070|FG000|STARTED|Overall Study|Number of subjects randomized|57
2891191|NCT00367237|3598071|FG001|STARTED|Overall Study|Number of subjects randomized|58
2891192|NCT00367237|3598070|FG000|COMPLETED|Overall Study||47
2891193|NCT00367237|3598071|FG001|COMPLETED|Overall Study||47
2891194|NCT00367237|3598070|FG000|NOT COMPLETED|Overall Study||10
2891195|NCT00367237|3598071|FG001|NOT COMPLETED|Overall Study||11
2891196|NCT00367341|3598079|FG000|STARTED|Overall Study||42
2891197|NCT00367341|3598080|FG001|STARTED|Overall Study||40
2891198|NCT00367341|3598079|FG000|COMPLETED|Overall Study||40
2891199|NCT00367341|3598080|FG001|COMPLETED|Overall Study||40
2891200|NCT00367341|3598079|FG000|NOT COMPLETED|Overall Study||2
2891201|NCT00367341|3598080|FG001|NOT COMPLETED|Overall Study||0
2891202|NCT00367380|3598089|FG000|STARTED|Overall Study||6
2891203|NCT00367380|3598090|FG001|STARTED|Overall Study||6
2891204|NCT00367380|3598091|FG002|STARTED|Overall Study||6
2891205|NCT00367380|3598089|FG000|COMPLETED|Overall Study||6
2891206|NCT00367380|3598090|FG001|COMPLETED|Overall Study||6
2891207|NCT00367380|3598091|FG002|COMPLETED|Overall Study||6
2891208|NCT00367380|3598089|FG000|NOT COMPLETED|Overall Study||0
2891209|NCT00367380|3598090|FG001|NOT COMPLETED|Overall Study||0
2891210|NCT00367380|3598091|FG002|NOT COMPLETED|Overall Study||0
2891211|NCT00367432|3598099|FG000|STARTED|First Period (16 Weeks)|Eligible subjects from preceding study N01221 [NCT00280696] entered the First Period of N01222|313
2891212|NCT00367432|3598100|FG001|STARTED|First Period (16 Weeks)||0
2891213|NCT00367432|3598099|FG000|COMPLETED|First Period (16 Weeks)||275
2891214|NCT00367432|3598100|FG001|COMPLETED|First Period (16 Weeks)||0
2891215|NCT00367432|3598099|FG000|NOT COMPLETED|First Period (16 Weeks)||38
2891216|NCT00367432|3598100|FG001|NOT COMPLETED|First Period (16 Weeks)||0
2891217|NCT00367432|3598099|FG000|STARTED|Second Period (up to 54 Months)|275 subjects from N01221 [NCT00280696] completed First Period and entered Second Period of N01222|275
2891218|NCT00367432|3598100|FG001|STARTED|Second Period (up to 54 Months)|85 subjects from N01020 [NCT00160615] entered Second Period of N01222|85
2891219|NCT00367432|3598099|FG000|COMPLETED|Second Period (up to 54 Months)||188
2891220|NCT00367432|3598100|FG001|COMPLETED|Second Period (up to 54 Months)||69
2891221|NCT00367432|3598099|FG000|NOT COMPLETED|Second Period (up to 54 Months)||87
2891222|NCT00367432|3598100|FG001|NOT COMPLETED|Second Period (up to 54 Months)||16
2891223|NCT00367458|3598106|FG000|STARTED|First Intervention - 8 Weeks||12
2891224|NCT00367458|3598107|FG001|STARTED|First Intervention - 8 Weeks||12
2891225|NCT00367458|3598106|FG000|COMPLETED|First Intervention - 8 Weeks||10
2891226|NCT00367458|3598107|FG001|COMPLETED|First Intervention - 8 Weeks||12
2891227|NCT00367458|3598106|FG000|NOT COMPLETED|First Intervention - 8 Weeks||2
2891228|NCT00367458|3598107|FG001|NOT COMPLETED|First Intervention - 8 Weeks||0
2891229|NCT00367458|3598106|FG000|STARTED|Washout Period - 4-6 Weeks||10
2891230|NCT00367458|3598107|FG001|STARTED|Washout Period - 4-6 Weeks||12
2891231|NCT00367458|3598106|FG000|COMPLETED|Washout Period - 4-6 Weeks||10
2891232|NCT00367458|3598107|FG001|COMPLETED|Washout Period - 4-6 Weeks||12
2891233|NCT00367458|3598106|FG000|NOT COMPLETED|Washout Period - 4-6 Weeks||0
2891234|NCT00367458|3598107|FG001|NOT COMPLETED|Washout Period - 4-6 Weeks||0
2891235|NCT00367458|3598106|FG000|STARTED|Second Intervention - 8 Weeks||10
2891236|NCT00367458|3598107|FG001|STARTED|Second Intervention - 8 Weeks||12
2891237|NCT00367458|3598106|FG000|COMPLETED|Second Intervention - 8 Weeks||10
2891238|NCT00367458|3598107|FG001|COMPLETED|Second Intervention - 8 Weeks||12
2891239|NCT00367458|3598106|FG000|NOT COMPLETED|Second Intervention - 8 Weeks||0
2891240|NCT00367458|3598107|FG001|NOT COMPLETED|Second Intervention - 8 Weeks||0
2891241|NCT00367484|3598113|FG000|STARTED|Overall Study||460
2891242|NCT00367484|3598113|FG000|COMPLETED|Overall Study|Safety population = 460 Intent To Treat (ITT) population = 458|443
2891243|NCT00367484|3598113|FG000|NOT COMPLETED|Overall Study||17
2891244|NCT00367601|3598117|FG000|STARTED|Overall Study||25
2891245|NCT00367601|3598117|FG000|COMPLETED|Overall Study||25
2891246|NCT00367601|3598117|FG000|NOT COMPLETED|Overall Study||0
2891247|NCT00367640|3598126|FG000|STARTED|Overall Study||157
2891248|NCT00367640|3598127|FG001|STARTED|Overall Study||155
2891249|NCT00367640|3598128|FG002|STARTED|Overall Study||160
2891250|NCT00367640|3598129|FG003|STARTED|Overall Study||156
3314737|NCT03091777|4048031|FG001|COMPLETED|Overall Study||255
3314738|NCT03091777|4048032|FG002|COMPLETED|Overall Study||257
3314739|NCT03091777|4048030|FG000|NOT COMPLETED|Overall Study||32
3314740|NCT03091777|4048031|FG001|NOT COMPLETED|Overall Study||33
3314741|NCT03091777|4048032|FG002|NOT COMPLETED|Overall Study||37
2891251|NCT00367640|3598126|FG000|COMPLETED|Overall Study||139
2891252|NCT00367640|3598127|FG001|COMPLETED|Overall Study||133
2891253|NCT00367640|3598128|FG002|COMPLETED|Overall Study||141
2891254|NCT00367640|3598129|FG003|COMPLETED|Overall Study||146
2891255|NCT00367640|3598126|FG000|NOT COMPLETED|Overall Study||18
2891256|NCT00367640|3598127|FG001|NOT COMPLETED|Overall Study||22
2891257|NCT00367640|3598128|FG002|NOT COMPLETED|Overall Study||19
2891258|NCT00367640|3598129|FG003|NOT COMPLETED|Overall Study||10
2891259|NCT00367679|3598139|FG000|STARTED|Overall Study||35
2891260|NCT00367679|3598139|FG000|COMPLETED|Overall Study||35
2891261|NCT00367679|3598139|FG000|NOT COMPLETED|Overall Study||0
2891262|NCT00367744|3598147|FG000|STARTED|Overall Study||34
2891263|NCT00367744|3598148|FG001|STARTED|Overall Study||37
2891264|NCT00367744|3598147|FG000|COMPLETED|Overall Study||30
2891265|NCT00367744|3598148|FG001|COMPLETED|Overall Study||32
2891266|NCT00367744|3598147|FG000|NOT COMPLETED|Overall Study||4
3170481|NCT01929707|3897856|FG004|STARTED|Washout Period ≥7 Days||0
3170482|NCT01929707|3897857|FG005|STARTED|Washout Period ≥7 Days||0
3170483|NCT01929707|3897858|FG006|STARTED|Washout Period ≥7 Days||0
2891267|NCT00367744|3598148|FG001|NOT COMPLETED|Overall Study||5
2891268|NCT00367770|3598155|FG000|STARTED|Overall Study||37
2891269|NCT00367770|3598155|FG000|COMPLETED|Overall Study||35
2891270|NCT00367770|3598155|FG000|NOT COMPLETED|Overall Study||2
2891271|NCT00367835|3598161|FG000|STARTED|Overall Study||138
2891272|NCT00367835|3598162|FG001|STARTED|Overall Study||79
2891273|NCT00367835|3598161|FG000|COMPLETED|Overall Study||109
2891274|NCT00367835|3598162|FG001|COMPLETED|Overall Study||48
2891275|NCT00367835|3598161|FG000|NOT COMPLETED|Overall Study||29
2891276|NCT00367835|3598162|FG001|NOT COMPLETED|Overall Study||31
2891277|NCT00367991|3598170|FG000|STARTED|Overall Study||29
2891278|NCT00367991|3598171|FG001|STARTED|Overall Study||15
2891279|NCT00367991|3598170|FG000|COMPLETED|Overall Study||27
2891280|NCT00367991|3598171|FG001|COMPLETED|Overall Study||13
2891281|NCT00367991|3598170|FG000|NOT COMPLETED|Overall Study||2
2891282|NCT00367991|3598171|FG001|NOT COMPLETED|Overall Study||2
2891283|NCT00368069|3598179|FG000|STARTED|Overall Study||79
2891284|NCT00368069|3598180|FG001|STARTED|Overall Study||79
3170484|NCT01929707|3897859|FG007|STARTED|Washout Period ≥7 Days||0
2891285|NCT00368069|3598179|FG000|COMPLETED|Overall Study||71
2891286|NCT00368069|3598180|FG001|COMPLETED|Overall Study||72
2891287|NCT00368069|3598179|FG000|NOT COMPLETED|Overall Study||8
2891288|NCT00368069|3598180|FG001|NOT COMPLETED|Overall Study||7
2891289|NCT00368108|3598189|FG000|STARTED|Overall Study|One subject had stopped medication prior to notifying staff. Remaining results will have 250.|251
2891290|NCT00368108|3598190|FG001|STARTED|Overall Study||251
2891291|NCT00368108|3598191|FG002|STARTED|Overall Study||250
2891292|NCT00368108|3598189|FG000|COMPLETED|Overall Study||187
2891293|NCT00368108|3598190|FG001|COMPLETED|Overall Study||198
2891294|NCT00368108|3598191|FG002|COMPLETED|Overall Study||182
2891295|NCT00368108|3598189|FG000|NOT COMPLETED|Overall Study||64
2891296|NCT00368108|3598190|FG001|NOT COMPLETED|Overall Study||53
2891297|NCT00368108|3598191|FG002|NOT COMPLETED|Overall Study||68
2891298|NCT00368251|3598202|FG000|STARTED|Overall Study||18
2891299|NCT00368251|3598203|FG001|STARTED|Overall Study||20
2891300|NCT00368251|3598204|FG002|STARTED|Overall Study||18
2891301|NCT00368251|3598202|FG000|COMPLETED|Overall Study||17
2891302|NCT00368251|3598203|FG001|COMPLETED|Overall Study||20
2891303|NCT00368251|3598204|FG002|COMPLETED|Overall Study||17
2891304|NCT00368251|3598202|FG000|NOT COMPLETED|Overall Study||1
2891305|NCT00368251|3598203|FG001|NOT COMPLETED|Overall Study||0
2891306|NCT00368251|3598204|FG002|NOT COMPLETED|Overall Study||1
2919750|NCT00533910|3630145|FG000|STARTED|Overall Study||21
2919751|NCT00533910|3630146|FG001|STARTED|Overall Study||21
2919752|NCT00533910|3630145|FG000|COMPLETED|Overall Study||21
2919753|NCT00533910|3630146|FG001|COMPLETED|Overall Study||21
2919754|NCT00533910|3630145|FG000|NOT COMPLETED|Overall Study||0
2919755|NCT00533910|3630146|FG001|NOT COMPLETED|Overall Study||0
2919756|NCT00533949|3630156|FG000|STARTED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|166
2919757|NCT00533949|3630157|FG001|STARTED|Overall Study||121
2919758|NCT00533949|3630158|FG002|STARTED|Overall Study||147
2919759|NCT00533949|3630159|FG003|STARTED|Overall Study||110
2919760|NCT00533949|3630156|FG000|COMPLETED|Overall Study||151
2919761|NCT00533949|3630157|FG001|COMPLETED|Overall Study||107
2919762|NCT00533949|3630158|FG002|COMPLETED|Overall Study||137
2919763|NCT00533949|3630159|FG003|COMPLETED|Overall Study||100
2919764|NCT00533949|3630156|FG000|NOT COMPLETED|Overall Study||15
2919765|NCT00533949|3630157|FG001|NOT COMPLETED|Overall Study||14
2919766|NCT00533949|3630158|FG002|NOT COMPLETED|Overall Study||10
2919767|NCT00533949|3630159|FG003|NOT COMPLETED|Overall Study||10
3170485|NCT01929707|3897852|FG000|COMPLETED|Washout Period ≥7 Days||6
2919768|NCT00534001|3630179|FG000|STARTED|Overall Study||48
2919769|NCT00534001|3630180|FG001|STARTED|Overall Study||47
2919770|NCT00534001|3630179|FG000|COMPLETED|Overall Study||43
2919771|NCT00534001|3630180|FG001|COMPLETED|Overall Study||43
2919772|NCT00534001|3630179|FG000|NOT COMPLETED|Overall Study||5
2919773|NCT00534001|3630180|FG001|NOT COMPLETED|Overall Study||4
2919774|NCT00534092|3630188|FG000|STARTED|Overall Study||55
2919775|NCT00534092|3630189|FG001|STARTED|Overall Study||14
2919776|NCT00534092|3630188|FG000|COMPLETED|Overall Study||53
2919777|NCT00534092|3630189|FG001|COMPLETED|Overall Study||14
2919778|NCT00534092|3630188|FG000|NOT COMPLETED|Overall Study||2
3170486|NCT01929707|3897853|FG001|COMPLETED|Washout Period ≥7 Days||8
2891307|NCT00368277|3598214|FG000|STARTED|Overall Study||457
2891308|NCT00368277|3598215|FG001|STARTED|Overall Study||444
2891309|NCT00368277|3598214|FG000|COMPLETED|Overall Study||344
2891310|NCT00368277|3598215|FG001|COMPLETED|Overall Study||336
2891311|NCT00368277|3598214|FG000|NOT COMPLETED|Overall Study||113
2891312|NCT00368277|3598215|FG001|NOT COMPLETED|Overall Study||108
2891313|NCT00368290|3598223|FG000|STARTED|Overall Study||47
2891314|NCT00368290|3598224|FG001|STARTED|Overall Study||47
2891315|NCT00368290|3598223|FG000|COMPLETED|Overall Study||34
2891316|NCT00368290|3598224|FG001|COMPLETED|Overall Study||37
2891317|NCT00368290|3598223|FG000|NOT COMPLETED|Overall Study||13
2891318|NCT00368290|3598224|FG001|NOT COMPLETED|Overall Study||10
2891319|NCT00368316|3598232|FG000|STARTED|Overall Study||1434
2891320|NCT00368316|3598233|FG001|STARTED|Overall Study||1365
2891321|NCT00368316|3598232|FG000|COMPLETED|Overall Study||1392
2891322|NCT00368316|3598233|FG001|COMPLETED|Overall Study||1319
2891323|NCT00368316|3598232|FG000|NOT COMPLETED|Overall Study||42
2891324|NCT00368316|3598233|FG001|NOT COMPLETED|Overall Study||46
2891325|NCT00368355|3598241|FG000|STARTED|Overall Study||18
2891326|NCT00368355|3598242|FG001|STARTED|Overall Study||28
2891327|NCT00368355|3598241|FG000|COMPLETED|Overall Study||7
2891328|NCT00368355|3598242|FG001|COMPLETED|Overall Study||11
2891329|NCT00368355|3598241|FG000|NOT COMPLETED|Overall Study||11
2891330|NCT00368355|3598242|FG001|NOT COMPLETED|Overall Study||17
2891331|NCT00368459|3598250|FG000|STARTED|Overall Study||21
2891332|NCT00368459|3598251|FG001|STARTED|Overall Study||21
2891333|NCT00368459|3598250|FG000|COMPLETED|Overall Study||19
2891334|NCT00368459|3598251|FG001|COMPLETED|Overall Study||20
2891335|NCT00368459|3598250|FG000|NOT COMPLETED|Overall Study||2
2891336|NCT00368459|3598251|FG001|NOT COMPLETED|Overall Study||1
2891337|NCT00368472|3598257|FG000|STARTED|Overall Study||138
2891338|NCT00368472|3598257|FG000|COMPLETED|Overall Study||33
2891339|NCT00368472|3598257|FG000|NOT COMPLETED|Overall Study||105
2891340|NCT00368537|3598263|FG000|STARTED|Randomization||281
2891341|NCT00368537|3598264|FG001|STARTED|Randomization||269
2891342|NCT00368537|3598263|FG000|COMPLETED|Randomization||268
2891343|NCT00368537|3598264|FG001|COMPLETED|Randomization||263
2891344|NCT00368537|3598263|FG000|NOT COMPLETED|Randomization||13
2891345|NCT00368537|3598264|FG001|NOT COMPLETED|Randomization||6
2891346|NCT00368537|3598263|FG000|STARTED|Baseline Participants||268
2891347|NCT00368537|3598264|FG001|STARTED|Baseline Participants||263
2891348|NCT00368537|3598263|FG000|COMPLETED|Baseline Participants||244
2891349|NCT00368537|3598264|FG001|COMPLETED|Baseline Participants||239
2891350|NCT00368537|3598263|FG000|NOT COMPLETED|Baseline Participants||24
2891351|NCT00368537|3598264|FG001|NOT COMPLETED|Baseline Participants||24
2891352|NCT00368550|3598272|FG000|STARTED|Overall Study||63
2891353|NCT00368550|3598273|FG001|STARTED|Overall Study||71
2891354|NCT00368550|3598272|FG000|COMPLETED|Overall Study||35
2891355|NCT00368550|3598273|FG001|COMPLETED|Overall Study||48
2891356|NCT00368550|3598272|FG000|NOT COMPLETED|Overall Study||28
2891357|NCT00368550|3598273|FG001|NOT COMPLETED|Overall Study||23
2891358|NCT00368641|3598281|FG000|STARTED|Overall Study||6
2891359|NCT00368641|3598282|FG001|STARTED|Overall Study||6
2891360|NCT00368641|3598281|FG000|COMPLETED|Overall Study|study was terminated prior to completion of treatment period|0
2891361|NCT00368641|3598282|FG001|COMPLETED|Overall Study|study was terminated prior to completion of treatment period|0
2891362|NCT00368641|3598281|FG000|NOT COMPLETED|Overall Study||6
2891363|NCT00368641|3598282|FG001|NOT COMPLETED|Overall Study||6
2891364|NCT00368745|3598290|FG000|STARTED|Randomized to Double-blind Treatment||57
2891365|NCT00368745|3598291|FG001|STARTED|Randomized to Double-blind Treatment||51
2891366|NCT00368745|3598290|FG000|COMPLETED|Randomized to Double-blind Treatment|One subject did not return following randomization; study drug not dispensed.|56
2891367|NCT00368745|3598291|FG001|COMPLETED|Randomized to Double-blind Treatment|One subject did not want to participate in study.|50
2891368|NCT00368745|3598290|FG000|NOT COMPLETED|Randomized to Double-blind Treatment||1
2891369|NCT00368745|3598291|FG001|NOT COMPLETED|Randomized to Double-blind Treatment||1
2891370|NCT00368745|3598290|FG000|STARTED|Double-blind Treatment Period||56
2891371|NCT00368745|3598291|FG001|STARTED|Double-blind Treatment Period||50
2891372|NCT00368745|3598290|FG000|COMPLETED|Double-blind Treatment Period||30
2891373|NCT00368745|3598291|FG001|COMPLETED|Double-blind Treatment Period||19
2891374|NCT00368745|3598290|FG000|NOT COMPLETED|Double-blind Treatment Period||26
2891375|NCT00368745|3598291|FG001|NOT COMPLETED|Double-blind Treatment Period||31
2891376|NCT00368836|3598299|FG000|STARTED|Phase II||350
2891377|NCT00368836|3598299|FG000|COMPLETED|Phase II||329
2891378|NCT00368836|3598299|FG000|NOT COMPLETED|Phase II||21
2891379|NCT00368836|3598299|FG000|STARTED|Phase I Pre-op/Post-op|The phases consisted of unique subjects. Those enrolled in Phase I did not carry over to Phase II.|125
2891380|NCT00368836|3598299|FG000|COMPLETED|Phase I Pre-op/Post-op||104
2891381|NCT00368836|3598299|FG000|NOT COMPLETED|Phase I Pre-op/Post-op||21
2891382|NCT00368849|3598306|FG000|STARTED|Overall Study||10
2891383|NCT00368849|3598307|FG001|STARTED|Overall Study||10
2891384|NCT00368849|3598306|FG000|COMPLETED|Overall Study||10
2891385|NCT00368849|3598307|FG001|COMPLETED|Overall Study||8
2891386|NCT00368849|3598306|FG000|NOT COMPLETED|Overall Study||0
2891387|NCT00368849|3598307|FG001|NOT COMPLETED|Overall Study||2
2891388|NCT00368875|3598314|FG000|STARTED|Overall Study||6
2891389|NCT00368875|3598315|FG001|STARTED|Overall Study||48
2891390|NCT00368875|3598314|FG000|COMPLETED|Overall Study||0
2891391|NCT00368875|3598315|FG001|COMPLETED|Overall Study||0
2891392|NCT00368875|3598314|FG000|NOT COMPLETED|Overall Study||6
2891393|NCT00368875|3598315|FG001|NOT COMPLETED|Overall Study||48
2891394|NCT00368927|3598323|FG000|STARTED|Overall Study||31
2891395|NCT00368927|3598324|FG001|STARTED|Overall Study||30
2891396|NCT00368927|3598323|FG000|COMPLETED|Overall Study||26
2891397|NCT00368927|3598324|FG001|COMPLETED|Overall Study||27
2891398|NCT00368927|3598323|FG000|NOT COMPLETED|Overall Study||5
2891399|NCT00368927|3598324|FG001|NOT COMPLETED|Overall Study||3
2891400|NCT00368940|3598332|FG000|STARTED|Intention-to-Treat||37
3170487|NCT01929707|3897854|FG002|COMPLETED|Washout Period ≥7 Days||12
3170488|NCT01929707|3897855|FG003|COMPLETED|Washout Period ≥7 Days||7
3170489|NCT01929707|3897856|FG004|COMPLETED|Washout Period ≥7 Days||0
3170490|NCT01929707|3897857|FG005|COMPLETED|Washout Period ≥7 Days||0
3170491|NCT01929707|3897858|FG006|COMPLETED|Washout Period ≥7 Days||0
3170492|NCT01929707|3897859|FG007|COMPLETED|Washout Period ≥7 Days||0
3170493|NCT01929707|3897852|FG000|NOT COMPLETED|Washout Period ≥7 Days||0
3170494|NCT01929707|3897853|FG001|NOT COMPLETED|Washout Period ≥7 Days||0
3170495|NCT01929707|3897854|FG002|NOT COMPLETED|Washout Period ≥7 Days||0
3170496|NCT01929707|3897855|FG003|NOT COMPLETED|Washout Period ≥7 Days||0
3170497|NCT01929707|3897856|FG004|NOT COMPLETED|Washout Period ≥7 Days||0
3170498|NCT01929707|3897857|FG005|NOT COMPLETED|Washout Period ≥7 Days||0
3170499|NCT01929707|3897858|FG006|NOT COMPLETED|Washout Period ≥7 Days||0
3170500|NCT01929707|3897859|FG007|NOT COMPLETED|Washout Period ≥7 Days||0
3170501|NCT01929707|3897852|FG000|STARTED|Intervention Period 2|Incomplete-crossover design|0
2891401|NCT00368940|3598333|FG001|STARTED|Intention-to-Treat||37
2891402|NCT00368940|3598332|FG000|COMPLETED|Intention-to-Treat||37
2891403|NCT00368940|3598333|FG001|COMPLETED|Intention-to-Treat||37
2891404|NCT00368940|3598332|FG000|NOT COMPLETED|Intention-to-Treat||0
2891405|NCT00368940|3598333|FG001|NOT COMPLETED|Intention-to-Treat||0
2891406|NCT00368940|3598332|FG000|STARTED|Completed 12-wk Treatment||37
2891407|NCT00368940|3598333|FG001|STARTED|Completed 12-wk Treatment||37
2891408|NCT00368940|3598332|FG000|COMPLETED|Completed 12-wk Treatment||31
2891409|NCT00368940|3598333|FG001|COMPLETED|Completed 12-wk Treatment||32
2891410|NCT00368940|3598332|FG000|NOT COMPLETED|Completed 12-wk Treatment||6
2891411|NCT00368940|3598333|FG001|NOT COMPLETED|Completed 12-wk Treatment||5
2891412|NCT00368966|3598342|FG000|STARTED|Infant Series||315
2891413|NCT00368966|3598343|FG001|STARTED|Infant Series||304
2891414|NCT00368966|3598342|FG000|Vaccinated Dose 1|Infant Series||314
2891415|NCT00368966|3598343|FG001|Vaccinated Dose 1|Infant Series|1 randomized to 7vPnC but given 13vPnC vaccine; 1 was withdrawn before receiving 7vPnC vaccine|302
2891416|NCT00368966|3598342|FG000|Vaccinated Dose 2|Infant Series|1 randomized but incorrectly given 7vPnC|307
2891417|NCT00368966|3598343|FG001|Vaccinated Dose 2|Infant Series||298
2891418|NCT00368966|3598342|FG000|Vaccinated Dose 3|Infant Series||301
2891419|NCT00368966|3598343|FG001|Vaccinated Dose 3|Infant Series|1 randomized but incorrectly given 13vPnC|296
2891420|NCT00368966|3598342|FG000|COMPLETED|Infant Series||299
2891421|NCT00368966|3598343|FG001|COMPLETED|Infant Series||294
2891422|NCT00368966|3598342|FG000|NOT COMPLETED|Infant Series||16
2891423|NCT00368966|3598343|FG001|NOT COMPLETED|Infant Series||10
2891424|NCT00368966|3598342|FG000|STARTED|After Infant||299
2891425|NCT00368966|3598343|FG001|STARTED|After Infant||294
2891426|NCT00368966|3598342|FG000|COMPLETED|After Infant||293
2891427|NCT00368966|3598343|FG001|COMPLETED|After Infant||289
2891428|NCT00368966|3598342|FG000|NOT COMPLETED|After Infant||6
2891429|NCT00368966|3598343|FG001|NOT COMPLETED|After Infant||5
2891430|NCT00368966|3598342|FG000|STARTED|Toddler Dose||293
2891431|NCT00368966|3598343|FG001|STARTED|Toddler Dose||289
2891432|NCT00368966|3598342|FG000|COMPLETED|Toddler Dose||292
2891433|NCT00368966|3598343|FG001|COMPLETED|Toddler Dose||286
2891434|NCT00368966|3598342|FG000|NOT COMPLETED|Toddler Dose||1
2891435|NCT00368966|3598343|FG001|NOT COMPLETED|Toddler Dose||3
2891436|NCT00368979|3598376|FG000|STARTED|Overall Study||185
2891437|NCT00368979|3598377|FG001|STARTED|Overall Study||193
2891438|NCT00368979|3598376|FG000|COMPLETED|Overall Study||160
2891439|NCT00368979|3598377|FG001|COMPLETED|Overall Study||163
2891440|NCT00368979|3598376|FG000|NOT COMPLETED|Overall Study||25
2891441|NCT00368979|3598377|FG001|NOT COMPLETED|Overall Study||30
2891442|NCT00368992|3598383|FG000|STARTED|Overall Study||110
2891443|NCT00368992|3598383|FG000|COMPLETED|Overall Study||0
2891444|NCT00368992|3598383|FG000|NOT COMPLETED|Overall Study||110
2891445|NCT00369122|3598388|FG000|STARTED|Overall Study||60
2891446|NCT00369122|3598388|FG000|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|49
2891447|NCT00369122|3598388|FG000|NOT COMPLETED|Overall Study||11
2891448|NCT00369161|3598394|FG000|STARTED|Overall Study|"Started indicates randomized and safety population."|109
2891449|NCT00369161|3598395|FG001|STARTED|Overall Study||119
2891450|NCT00369161|3598394|FG000|Intention to Treat (ITT)|Overall Study||107
2891451|NCT00369161|3598395|FG001|Intention to Treat (ITT)|Overall Study||117
2891452|NCT00369161|3598394|FG000|COMPLETED|Overall Study||82
2891453|NCT00369161|3598395|FG001|COMPLETED|Overall Study||95
2891454|NCT00369161|3598394|FG000|NOT COMPLETED|Overall Study||27
2891455|NCT00369161|3598395|FG001|NOT COMPLETED|Overall Study||24
2891456|NCT00369226|3598403|FG000|STARTED|Phase I (45 Days)||13
2891457|NCT00369226|3598404|FG001|STARTED|Phase I (45 Days)||0
2891458|NCT00369226|3598403|FG000|COMPLETED|Phase I (45 Days)|Once MTD established, additional 10 patients were accrued at MTD to better estimate toxicity.|13
3170502|NCT01929707|3897853|FG001|STARTED|Intervention Period 2|Incomplete-crossover design|0
3170503|NCT01929707|3897854|FG002|STARTED|Intervention Period 2|Incomplete-crossover design|0
2891459|NCT00369226|3598404|FG001|COMPLETED|Phase I (45 Days)||0
2891460|NCT00369226|3598403|FG000|NOT COMPLETED|Phase I (45 Days)||0
2891461|NCT00369226|3598404|FG001|NOT COMPLETED|Phase I (45 Days)||0
2891462|NCT00369226|3598403|FG000|STARTED|Phase II (45 Days)||0
2891463|NCT00369226|3598404|FG001|STARTED|Phase II (45 Days)||32
2891464|NCT00369226|3598403|FG000|COMPLETED|Phase II (45 Days)||0
2891465|NCT00369226|3598404|FG001|COMPLETED|Phase II (45 Days)|This includes 10 patients treated at candidate MTD in Phase I.|32
2891466|NCT00369226|3598403|FG000|NOT COMPLETED|Phase II (45 Days)||0
2891467|NCT00369226|3598404|FG001|NOT COMPLETED|Phase II (45 Days)||0
2891468|NCT00369278|3598415|FG000|STARTED|Overall Study||63
2891469|NCT00369278|3598416|FG001|STARTED|Overall Study||65
2891470|NCT00369278|3598415|FG000|COMPLETED|Overall Study||39
2891471|NCT00369278|3598416|FG001|COMPLETED|Overall Study||44
2891472|NCT00369278|3598415|FG000|NOT COMPLETED|Overall Study||24
2891473|NCT00369278|3598416|FG001|NOT COMPLETED|Overall Study||21
2891474|NCT00369343|3598424|FG000|STARTED|Double-blind Phase||256
2891475|NCT00369343|3598425|FG001|STARTED|Double-blind Phase||125
2891476|NCT00369343|3598424|FG000|COMPLETED|Double-blind Phase||212
2891477|NCT00369343|3598425|FG001|COMPLETED|Double-blind Phase||109
2891478|NCT00369343|3598424|FG000|NOT COMPLETED|Double-blind Phase||44
2891479|NCT00369343|3598425|FG001|NOT COMPLETED|Double-blind Phase||16
2891480|NCT00369343|3598424|FG000|STARTED|Open-label Phase||212
2891481|NCT00369343|3598425|FG001|STARTED|Open-label Phase||109
2891482|NCT00369343|3598424|FG000|COMPLETED|Open-label Phase||155
2891483|NCT00369343|3598425|FG001|COMPLETED|Open-label Phase||79
2891484|NCT00369343|3598424|FG000|NOT COMPLETED|Open-label Phase||57
2891485|NCT00369343|3598425|FG001|NOT COMPLETED|Open-label Phase||30
2891486|NCT00369382|3598440|FG000|STARTED|Overall Study||59
2891487|NCT00369382|3598441|FG001|STARTED|Overall Study||57
2891488|NCT00369382|3598440|FG000|Received Treatment|Overall Study||57
2891489|NCT00369382|3598441|FG001|Received Treatment|Overall Study||57
2891490|NCT00369382|3598440|FG000|Completed Assigned Treatment Regimen|Overall Study||48
2891491|NCT00369382|3598441|FG001|Completed Assigned Treatment Regimen|Overall Study||33
2891492|NCT00369382|3598440|FG000|COMPLETED|Overall Study||49
2891493|NCT00369382|3598441|FG001|COMPLETED|Overall Study||54
2891494|NCT00369382|3598440|FG000|NOT COMPLETED|Overall Study||10
2891495|NCT00369382|3598441|FG001|NOT COMPLETED|Overall Study||3
2891496|NCT00369486|3598453|FG000|STARTED|4-Week Visit|Number of eyes|38
2891497|NCT00369486|3598454|FG001|STARTED|4-Week Visit|Number of eyes|21
2891498|NCT00369486|3598455|FG002|STARTED|4-Week Visit|Number of eyes|23
2891499|NCT00369486|3598456|FG003|STARTED|4-Week Visit|Number of eyes|22
2891500|NCT00369486|3598457|FG004|STARTED|4-Week Visit|Number of eyes|25
2891501|NCT00369486|3598453|FG000|COMPLETED|4-Week Visit|Number of eyes|36
2891502|NCT00369486|3598454|FG001|COMPLETED|4-Week Visit|Number of eyes;|19
2891503|NCT00369486|3598455|FG002|COMPLETED|4-Week Visit|Number of eyes|22
2891504|NCT00369486|3598456|FG003|COMPLETED|4-Week Visit|Number of eyes|20
2891505|NCT00369486|3598457|FG004|COMPLETED|4-Week Visit|Number of eyes|24
2891506|NCT00369486|3598453|FG000|NOT COMPLETED|4-Week Visit||2
2891507|NCT00369486|3598454|FG001|NOT COMPLETED|4-Week Visit||2
2891508|NCT00369486|3598455|FG002|NOT COMPLETED|4-Week Visit||1
2891509|NCT00369486|3598456|FG003|NOT COMPLETED|4-Week Visit||2
2891510|NCT00369486|3598457|FG004|NOT COMPLETED|4-Week Visit||1
2891511|NCT00369486|3598453|FG000|STARTED|8-Week Visit|Number of eyes|38
2891512|NCT00369486|3598454|FG001|STARTED|8-Week Visit|Number of eyes|21
2891513|NCT00369486|3598455|FG002|STARTED|8-Week Visit|Number of eyes|22
2891514|NCT00369486|3598456|FG003|STARTED|8-Week Visit|Number of eyes|22
2891515|NCT00369486|3598457|FG004|STARTED|8-Week Visit|Number of eyes|25
2891516|NCT00369486|3598453|FG000|COMPLETED|8-Week Visit|Number of eyes|38
2891517|NCT00369486|3598454|FG001|COMPLETED|8-Week Visit|Number of eyes|20
2891518|NCT00369486|3598455|FG002|COMPLETED|8-Week Visit|Number of eyes|22
2891519|NCT00369486|3598456|FG003|COMPLETED|8-Week Visit|Number of eyes|21
2891520|NCT00369486|3598457|FG004|COMPLETED|8-Week Visit|Number of eyes|24
2891521|NCT00369486|3598453|FG000|NOT COMPLETED|8-Week Visit||0
2891522|NCT00369486|3598454|FG001|NOT COMPLETED|8-Week Visit||1
2891523|NCT00369486|3598455|FG002|NOT COMPLETED|8-Week Visit||0
2891524|NCT00369486|3598456|FG003|NOT COMPLETED|8-Week Visit||1
2891525|NCT00369486|3598457|FG004|NOT COMPLETED|8-Week Visit||1
2891526|NCT00369486|3598453|FG000|STARTED|17-Week Visit|Number of eyes|38
2891527|NCT00369486|3598454|FG001|STARTED|17-Week Visit|Number of eyes|21
2891528|NCT00369486|3598455|FG002|STARTED|17-Week Visit|Number of eyes|23
2891529|NCT00369486|3598456|FG003|STARTED|17-Week Visit|Number of eyes|22
3170504|NCT01929707|3897855|FG003|STARTED|Intervention Period 2|Incomplete-crossover design|5
3170505|NCT01929707|3897856|FG004|STARTED|Intervention Period 2|Incomplete-crossover design|6
3170506|NCT01929707|3897857|FG005|STARTED|Intervention Period 2|Incomplete-crossover design|8
3170507|NCT01929707|3897858|FG006|STARTED|Intervention Period 2|Incomplete-crossover design|12
3170508|NCT01929707|3897859|FG007|STARTED|Intervention Period 2|Incomplete-crossover design|4
3170509|NCT01929707|3897852|FG000|COMPLETED|Intervention Period 2||0
3170510|NCT01929707|3897853|FG001|COMPLETED|Intervention Period 2||0
3170511|NCT01929707|3897854|FG002|COMPLETED|Intervention Period 2||0
3170512|NCT01929707|3897855|FG003|COMPLETED|Intervention Period 2||5
3170513|NCT01929707|3897856|FG004|COMPLETED|Intervention Period 2||6
3170514|NCT01929707|3897857|FG005|COMPLETED|Intervention Period 2||6
2891530|NCT00369486|3598457|FG004|STARTED|17-Week Visit|Number of eyes|25
2891531|NCT00369486|3598453|FG000|COMPLETED|17-Week Visit|Number of eyes|38
3170515|NCT01929707|3897858|FG006|COMPLETED|Intervention Period 2||12
3170516|NCT01929707|3897859|FG007|COMPLETED|Intervention Period 2||4
2891532|NCT00369486|3598454|FG001|COMPLETED|17-Week Visit|Number of eyes|21
2891533|NCT00369486|3598455|FG002|COMPLETED|17-Week Visit|Number of eyes|22
2891534|NCT00369486|3598456|FG003|COMPLETED|17-Week Visit|Number of eyes|21
2891535|NCT00369486|3598457|FG004|COMPLETED|17-Week Visit|Number of eyes|24
2891536|NCT00369486|3598453|FG000|NOT COMPLETED|17-Week Visit||0
2891537|NCT00369486|3598454|FG001|NOT COMPLETED|17-Week Visit||0
2891538|NCT00369486|3598455|FG002|NOT COMPLETED|17-Week Visit||1
2891539|NCT00369486|3598456|FG003|NOT COMPLETED|17-Week Visit||1
2891540|NCT00369486|3598457|FG004|NOT COMPLETED|17-Week Visit||1
2891541|NCT00369486|3598453|FG000|STARTED|34-Week Visit|Number of eyes|38
2891542|NCT00369486|3598454|FG001|STARTED|34-Week Visit|Number of eyes|21
2891543|NCT00369486|3598455|FG002|STARTED|34-Week Visit|Number of eyes|23
2891544|NCT00369486|3598456|FG003|STARTED|34-Week Visit|Number of eyes|22
2891545|NCT00369486|3598457|FG004|STARTED|34-Week Visit|Number of eyes that|25
2891546|NCT00369486|3598453|FG000|COMPLETED|34-Week Visit|Number of eyes|38
2891547|NCT00369486|3598454|FG001|COMPLETED|34-Week Visit|Number of eyes|20
2891548|NCT00369486|3598455|FG002|COMPLETED|34-Week Visit|Number of eyes|22
2891549|NCT00369486|3598456|FG003|COMPLETED|34-Week Visit|Number of eyes|19
2891550|NCT00369486|3598457|FG004|COMPLETED|34-Week Visit|Number of eyes|22
2891551|NCT00369486|3598453|FG000|NOT COMPLETED|34-Week Visit||0
2891552|NCT00369486|3598454|FG001|NOT COMPLETED|34-Week Visit||1
2891553|NCT00369486|3598455|FG002|NOT COMPLETED|34-Week Visit||1
2891554|NCT00369486|3598456|FG003|NOT COMPLETED|34-Week Visit||3
2891555|NCT00369486|3598457|FG004|NOT COMPLETED|34-Week Visit||3
2891556|NCT00369512|3598469|FG000|STARTED|Overall Study||15
2891557|NCT00369512|3598469|FG000|COMPLETED|Overall Study||15
2891558|NCT00369512|3598469|FG000|NOT COMPLETED|Overall Study||0
2891559|NCT00369564|3598475|FG000|STARTED|Overall Study||127
2891560|NCT00369564|3598476|FG001|STARTED|Overall Study||123
2891561|NCT00369564|3598475|FG000|COMPLETED|Overall Study||84
2891562|NCT00369564|3598476|FG001|COMPLETED|Overall Study||100
2891563|NCT00369564|3598475|FG000|NOT COMPLETED|Overall Study||43
2891564|NCT00369564|3598476|FG001|NOT COMPLETED|Overall Study||23
2891565|NCT00369577|3598489|FG000|STARTED|Overall Study||43
2891566|NCT00369577|3598490|FG001|STARTED|Overall Study||45
2891567|NCT00369577|3598491|FG002|STARTED|Overall Study||41
2891568|NCT00369577|3598489|FG000|COMPLETED|Overall Study||43
2891569|NCT00369577|3598490|FG001|COMPLETED|Overall Study||45
2891570|NCT00369577|3598491|FG002|COMPLETED|Overall Study||40
2891571|NCT00369577|3598489|FG000|NOT COMPLETED|Overall Study||0
2891572|NCT00369577|3598490|FG001|NOT COMPLETED|Overall Study||0
2891573|NCT00369577|3598491|FG002|NOT COMPLETED|Overall Study||1
2891574|NCT00369590|3598501|FG000|STARTED|Overall Study||16
2891575|NCT00369590|3598502|FG001|STARTED|Overall Study||42
2891576|NCT00369590|3598501|FG000|COMPLETED|Overall Study||16
2891577|NCT00369590|3598502|FG001|COMPLETED|Overall Study||42
2891578|NCT00369590|3598501|FG000|NOT COMPLETED|Overall Study||0
2891579|NCT00369590|3598502|FG001|NOT COMPLETED|Overall Study||0
2891580|NCT00369629|3598507|FG000|STARTED|Treated 2 Cycles/Reached First Response||6
2891581|NCT00369629|3598508|FG001|STARTED|Treated 2 Cycles/Reached First Response||3
2891582|NCT00369629|3598509|FG002|STARTED|Treated 2 Cycles/Reached First Response||5
2891583|NCT00369629|3598510|FG003|STARTED|Treated 2 Cycles/Reached First Response|No patients were enrolled at this dose level as the study closed early due to lack of funding.|0
2891584|NCT00369629|3598507|FG000|COMPLETED|Treated 2 Cycles/Reached First Response||4
2891585|NCT00369629|3598508|FG001|COMPLETED|Treated 2 Cycles/Reached First Response||2
2891586|NCT00369629|3598509|FG002|COMPLETED|Treated 2 Cycles/Reached First Response||3
2891587|NCT00369629|3598510|FG003|COMPLETED|Treated 2 Cycles/Reached First Response||0
2891588|NCT00369629|3598507|FG000|NOT COMPLETED|Treated 2 Cycles/Reached First Response||2
2891589|NCT00369629|3598508|FG001|NOT COMPLETED|Treated 2 Cycles/Reached First Response||1
2891590|NCT00369629|3598509|FG002|NOT COMPLETED|Treated 2 Cycles/Reached First Response||2
2891591|NCT00369629|3598510|FG003|NOT COMPLETED|Treated 2 Cycles/Reached First Response||0
2891592|NCT00369629|3598507|FG000|STARTED|Moved on to 4 More Cycles||4
2891593|NCT00369629|3598508|FG001|STARTED|Moved on to 4 More Cycles||2
2891594|NCT00369629|3598509|FG002|STARTED|Moved on to 4 More Cycles||3
2891595|NCT00369629|3598510|FG003|STARTED|Moved on to 4 More Cycles||0
2891596|NCT00369629|3598507|FG000|COMPLETED|Moved on to 4 More Cycles||4
2891597|NCT00369629|3598508|FG001|COMPLETED|Moved on to 4 More Cycles||2
2891598|NCT00369629|3598509|FG002|COMPLETED|Moved on to 4 More Cycles||2
2891599|NCT00369629|3598510|FG003|COMPLETED|Moved on to 4 More Cycles||0
2891600|NCT00369629|3598507|FG000|NOT COMPLETED|Moved on to 4 More Cycles||0
2891601|NCT00369629|3598508|FG001|NOT COMPLETED|Moved on to 4 More Cycles||0
2891602|NCT00369629|3598509|FG002|NOT COMPLETED|Moved on to 4 More Cycles||1
2891603|NCT00369629|3598510|FG003|NOT COMPLETED|Moved on to 4 More Cycles||0
2891604|NCT00369629|3598507|FG000|STARTED|Completed 4 More Cycles||4
2891605|NCT00369629|3598508|FG001|STARTED|Completed 4 More Cycles||2
2891606|NCT00369629|3598509|FG002|STARTED|Completed 4 More Cycles||2
2891607|NCT00369629|3598510|FG003|STARTED|Completed 4 More Cycles||0
2891608|NCT00369629|3598507|FG000|COMPLETED|Completed 4 More Cycles||0
2891609|NCT00369629|3598508|FG001|COMPLETED|Completed 4 More Cycles||0
2891610|NCT00369629|3598509|FG002|COMPLETED|Completed 4 More Cycles||0
2891611|NCT00369629|3598510|FG003|COMPLETED|Completed 4 More Cycles||0
2891612|NCT00369629|3598507|FG000|NOT COMPLETED|Completed 4 More Cycles||4
2891613|NCT00369629|3598508|FG001|NOT COMPLETED|Completed 4 More Cycles||2
2891614|NCT00369629|3598509|FG002|NOT COMPLETED|Completed 4 More Cycles||2
2891615|NCT00369629|3598510|FG003|NOT COMPLETED|Completed 4 More Cycles||0
2891616|NCT00369629|3598507|FG000|STARTED|Follow up for 1 Year|All patients treated on study go into the follow up period|6
2891617|NCT00369629|3598508|FG001|STARTED|Follow up for 1 Year||3
2891618|NCT00369629|3598509|FG002|STARTED|Follow up for 1 Year||5
2891619|NCT00369629|3598510|FG003|STARTED|Follow up for 1 Year||0
2891620|NCT00369629|3598507|FG000|COMPLETED|Follow up for 1 Year||4
2891621|NCT00369629|3598508|FG001|COMPLETED|Follow up for 1 Year||1
2891622|NCT00369629|3598509|FG002|COMPLETED|Follow up for 1 Year||2
2891623|NCT00369629|3598510|FG003|COMPLETED|Follow up for 1 Year||0
2891624|NCT00369629|3598507|FG000|NOT COMPLETED|Follow up for 1 Year||2
2891625|NCT00369629|3598508|FG001|NOT COMPLETED|Follow up for 1 Year||2
2891626|NCT00369629|3598509|FG002|NOT COMPLETED|Follow up for 1 Year||3
2891627|NCT00369629|3598510|FG003|NOT COMPLETED|Follow up for 1 Year||0
2891628|NCT00369655|3598520|FG000|STARTED|Overall Study||21
2891629|NCT00369655|3598520|FG000|COMPLETED|Overall Study||19
2891630|NCT00369655|3598520|FG000|NOT COMPLETED|Overall Study||2
2891631|NCT00369668|3598527|FG000|STARTED|Overall Study|Original number of participants to be recruited for each group.|10
2891632|NCT00369668|3598528|FG001|STARTED|Overall Study||10
2891633|NCT00369668|3598529|FG002|STARTED|Overall Study||10
2891634|NCT00369668|3598527|FG000|COMPLETED|Overall Study||6
2891635|NCT00369668|3598528|FG001|COMPLETED|Overall Study||5
2891636|NCT00369668|3598529|FG002|COMPLETED|Overall Study||3
2891637|NCT00369668|3598527|FG000|NOT COMPLETED|Overall Study||4
2891638|NCT00369668|3598528|FG001|NOT COMPLETED|Overall Study||5
2891639|NCT00369668|3598529|FG002|NOT COMPLETED|Overall Study||7
2891640|NCT00369681|3598540|FG000|STARTED|Overall Study||50
2891641|NCT00369681|3598540|FG000|COMPLETED|Overall Study||49
2891642|NCT00369681|3598540|FG000|NOT COMPLETED|Overall Study||1
2891643|NCT00369707|3598544|FG000|STARTED|Induction Part A (1 Cycle -35 Days)||42
2891644|NCT00369707|3598544|FG000|COMPLETED|Induction Part A (1 Cycle -35 Days)||42
2891645|NCT00369707|3598544|FG000|NOT COMPLETED|Induction Part A (1 Cycle -35 Days)||0
2891646|NCT00369707|3598544|FG000|STARTED|Induction Part B (2 Cycles)||42
2891647|NCT00369707|3598544|FG000|COMPLETED|Induction Part B (2 Cycles)||35
2891648|NCT00369707|3598544|FG000|NOT COMPLETED|Induction Part B (2 Cycles)||7
2891649|NCT00369707|3598544|FG000|STARTED|Maintenance Period (up to 4 Cycles)||35
2891650|NCT00369707|3598544|FG000|COMPLETED|Maintenance Period (up to 4 Cycles)||27
2891651|NCT00369707|3598544|FG000|NOT COMPLETED|Maintenance Period (up to 4 Cycles)||8
2891652|NCT00369707|3598544|FG000|STARTED|Follow up for 2 Years After Treatment||41
2891653|NCT00369707|3598544|FG000|COMPLETED|Follow up for 2 Years After Treatment||38
2891654|NCT00369707|3598544|FG000|NOT COMPLETED|Follow up for 2 Years After Treatment||3
2891655|NCT00369746|3598550|FG000|STARTED|Overall Study||138
2891656|NCT00369746|3598551|FG001|STARTED|Overall Study||536
2891657|NCT00369746|3598550|FG000|COMPLETED|Overall Study||138
2891658|NCT00369746|3598551|FG001|COMPLETED|Overall Study||536
2891659|NCT00369746|3598550|FG000|NOT COMPLETED|Overall Study||0
2891660|NCT00369746|3598551|FG001|NOT COMPLETED|Overall Study||0
2891661|NCT00369785|3598559|FG000|STARTED|Overall Study||99
2891662|NCT00369785|3598560|FG001|STARTED|Overall Study||99
2891663|NCT00369785|3598559|FG000|COMPLETED|Overall Study||72
2891664|NCT00369785|3598560|FG001|COMPLETED|Overall Study||74
2891665|NCT00369785|3598559|FG000|NOT COMPLETED|Overall Study||27
2891666|NCT00369785|3598560|FG001|NOT COMPLETED|Overall Study||25
2891667|NCT00369824|3598572|FG000|STARTED|Overall Study||212
2891668|NCT00369824|3598573|FG001|STARTED|Overall Study||214
2891669|NCT00369824|3598574|FG002|STARTED|Overall Study||214
2891670|NCT00369824|3598575|FG003|STARTED|Overall Study||214
2891671|NCT00369824|3598576|FG004|STARTED|Overall Study||214
2891672|NCT00369824|3598577|FG005|STARTED|Overall Study||215
2891673|NCT00369824|3598572|FG000|COMPLETED|Overall Study||197
2891674|NCT00369824|3598573|FG001|COMPLETED|Overall Study||195
2891675|NCT00369824|3598574|FG002|COMPLETED|Overall Study||202
2891676|NCT00369824|3598575|FG003|COMPLETED|Overall Study||199
2891677|NCT00369824|3598576|FG004|COMPLETED|Overall Study||196
2891678|NCT00369824|3598577|FG005|COMPLETED|Overall Study||204
2891679|NCT00369824|3598572|FG000|NOT COMPLETED|Overall Study||15
2891680|NCT00369824|3598573|FG001|NOT COMPLETED|Overall Study||19
2891681|NCT00369824|3598574|FG002|NOT COMPLETED|Overall Study||12
2891682|NCT00369824|3598575|FG003|NOT COMPLETED|Overall Study||15
2891683|NCT00369824|3598576|FG004|NOT COMPLETED|Overall Study||18
2891684|NCT00369824|3598577|FG005|NOT COMPLETED|Overall Study||11
2891685|NCT00369915|3598593|FG000|STARTED|Overall Study||10
2891686|NCT00369915|3598594|FG001|STARTED|Overall Study||7
2891687|NCT00369915|3598593|FG000|COMPLETED|Overall Study||4
2891688|NCT00369915|3598594|FG001|COMPLETED|Overall Study||4
2891689|NCT00369915|3598593|FG000|NOT COMPLETED|Overall Study||6
2891690|NCT00369915|3598594|FG001|NOT COMPLETED|Overall Study||3
2891691|NCT00369928|3598603|FG000|STARTED|Overall Study||85
2891692|NCT00369928|3598604|FG001|STARTED|Overall Study||85
2891693|NCT00369928|3598605|FG002|STARTED|Overall Study||86
2891694|NCT00369928|3598603|FG000|COMPLETED|Overall Study||77
2891695|NCT00369928|3598604|FG001|COMPLETED|Overall Study||69
2891696|NCT00369928|3598605|FG002|COMPLETED|Overall Study||66
2891697|NCT00369928|3598603|FG000|NOT COMPLETED|Overall Study||8
2891698|NCT00369928|3598604|FG001|NOT COMPLETED|Overall Study||16
2891699|NCT00369928|3598605|FG002|NOT COMPLETED|Overall Study||20
2891700|NCT00369941|3598615|FG000|STARTED|Overall Study||282
2891701|NCT00369941|3598616|FG001|STARTED|Overall Study||284
2891702|NCT00369941|3598615|FG000|Treated|Overall Study||281
2891703|NCT00369941|3598616|FG001|Treated|Overall Study||282
2891704|NCT00369941|3598615|FG000|COMPLETED|Overall Study||210
2891705|NCT00369941|3598616|FG001|COMPLETED|Overall Study||184
2891706|NCT00369941|3598615|FG000|NOT COMPLETED|Overall Study||72
2891707|NCT00369941|3598616|FG001|NOT COMPLETED|Overall Study||100
2891708|NCT00369967|3598625|FG000|STARTED|Overall Study||31
2891709|NCT00369967|3598626|FG001|STARTED|Overall Study||17
2891710|NCT00369967|3598625|FG000|COMPLETED|Overall Study||8
2891711|NCT00369967|3598626|FG001|COMPLETED|Overall Study||5
2891712|NCT00369967|3598625|FG000|NOT COMPLETED|Overall Study||23
2891713|NCT00369967|3598626|FG001|NOT COMPLETED|Overall Study||12
2891714|NCT00370032|3598638|FG000|STARTED|Treatment Period 1|Safety Population - all subjects who took at least one dose of study medication.|24
2891715|NCT00370032|3598639|FG001|STARTED|Treatment Period 1|Safety Population - all subjects who took at least one dose of study medication.|25
2891716|NCT00370032|3598638|FG000|COMPLETED|Treatment Period 1||24
2891717|NCT00370032|3598639|FG001|COMPLETED|Treatment Period 1||24
2891718|NCT00370032|3598638|FG000|NOT COMPLETED|Treatment Period 1||0
2891719|NCT00370032|3598639|FG001|NOT COMPLETED|Treatment Period 1||1
2891720|NCT00370032|3598638|FG000|STARTED|Washout Period||24
2891721|NCT00370032|3598639|FG001|STARTED|Washout Period||24
2891722|NCT00370032|3598638|FG000|COMPLETED|Washout Period||23
2891723|NCT00370032|3598639|FG001|COMPLETED|Washout Period||22
2891724|NCT00370032|3598638|FG000|NOT COMPLETED|Washout Period||1
2891725|NCT00370032|3598639|FG001|NOT COMPLETED|Washout Period||2
2891726|NCT00370032|3598638|FG000|STARTED|Treatment Period 2||23
2891727|NCT00370032|3598639|FG001|STARTED|Treatment Period 2||22
2891728|NCT00370032|3598638|FG000|COMPLETED|Treatment Period 2||23
2891729|NCT00370032|3598639|FG001|COMPLETED|Treatment Period 2||22
2891730|NCT00370032|3598638|FG000|NOT COMPLETED|Treatment Period 2||0
2891731|NCT00370032|3598639|FG001|NOT COMPLETED|Treatment Period 2||0
2891732|NCT00370032|3598638|FG000|STARTED|Follow-up Period||23
2891733|NCT00370032|3598639|FG001|STARTED|Follow-up Period||22
2891734|NCT00370032|3598638|FG000|COMPLETED|Follow-up Period||22
2891735|NCT00370032|3598639|FG001|COMPLETED|Follow-up Period||22
2891736|NCT00370032|3598638|FG000|NOT COMPLETED|Follow-up Period||1
2891737|NCT00370032|3598639|FG001|NOT COMPLETED|Follow-up Period||0
2891738|NCT00370071|3598654|FG000|STARTED|Overall Study||39
2891739|NCT00370071|3598654|FG000|COMPLETED|Overall Study||37
2891740|NCT00370071|3598654|FG000|NOT COMPLETED|Overall Study||2
2891741|NCT00370149|3598660|FG000|STARTED|Overall Study||165
2891742|NCT00370149|3598661|FG001|STARTED|Overall Study||161
2891743|NCT00370149|3598660|FG000|COMPLETED|Overall Study||146
2891744|NCT00370149|3598661|FG001|COMPLETED|Overall Study||142
2891745|NCT00370149|3598660|FG000|NOT COMPLETED|Overall Study||19
2891746|NCT00370149|3598661|FG001|NOT COMPLETED|Overall Study||19
2891747|NCT00370292|3598672|FG000|STARTED|Overall Study||19
2891748|NCT00370292|3598672|FG000|COMPLETED|Overall Study||6
2891749|NCT00370292|3598672|FG000|NOT COMPLETED|Overall Study||13
2891750|NCT00370331|3598685|FG000|STARTED|Overall Study||62
2891751|NCT00370331|3598686|FG001|STARTED|Overall Study||135
2891752|NCT00370331|3598685|FG000|COMPLETED|Overall Study||55
2891753|NCT00370331|3598686|FG001|COMPLETED|Overall Study||112
2891754|NCT00370331|3598685|FG000|NOT COMPLETED|Overall Study||7
2891755|NCT00370331|3598686|FG001|NOT COMPLETED|Overall Study||23
2891756|NCT00370396|3598695|FG000|STARTED|Overall Study||737
2891757|NCT00370396|3598696|FG001|STARTED|Overall Study||92
2891758|NCT00370396|3598697|FG002|STARTED|Overall Study||283
2891759|NCT00370396|3598695|FG000|COMPLETED|Overall Study||726
2891760|NCT00370396|3598696|FG001|COMPLETED|Overall Study||91
2891761|NCT00370396|3598697|FG002|COMPLETED|Overall Study||282
2891762|NCT00370396|3598695|FG000|NOT COMPLETED|Overall Study||11
2891763|NCT00370396|3598696|FG001|NOT COMPLETED|Overall Study||1
2891764|NCT00370396|3598697|FG002|NOT COMPLETED|Overall Study||1
2891765|NCT00370552|3598708|FG000|STARTED|Overall Study|Randomized|46
2891766|NCT00370552|3598709|FG001|STARTED|Overall Study|Randomized|45
2891767|NCT00370552|3598710|FG002|STARTED|Overall Study|Randomized|32
2891768|NCT00370552|3598708|FG000|COMPLETED|Overall Study||0
2891769|NCT00370552|3598709|FG001|COMPLETED|Overall Study||0
2891770|NCT00370552|3598710|FG002|COMPLETED|Overall Study||0
2891771|NCT00370552|3598708|FG000|NOT COMPLETED|Overall Study||46
2891772|NCT00370552|3598709|FG001|NOT COMPLETED|Overall Study||45
2891773|NCT00370552|3598710|FG002|NOT COMPLETED|Overall Study||32
2891774|NCT00370682|3598721|FG000|STARTED|Overall Study||40
2891775|NCT00370682|3598722|FG001|STARTED|Overall Study||40
2891776|NCT00370682|3598723|FG002|STARTED|Overall Study||40
2891777|NCT00370682|3598721|FG000|COMPLETED|Overall Study||40
2891778|NCT00370682|3598722|FG001|COMPLETED|Overall Study||37
2891779|NCT00370682|3598723|FG002|COMPLETED|Overall Study||39
2891780|NCT00370682|3598721|FG000|NOT COMPLETED|Overall Study||0
2891781|NCT00370682|3598722|FG001|NOT COMPLETED|Overall Study||3
2891782|NCT00370682|3598723|FG002|NOT COMPLETED|Overall Study||1
2891783|NCT00370838|3598737|FG000|STARTED|Period 1 (Days 8-50)||7
2891784|NCT00370838|3598738|FG001|STARTED|Period 1 (Days 8-50)||3
2891785|NCT00370838|3598737|FG000|COMPLETED|Period 1 (Days 8-50)||7
2891786|NCT00370838|3598738|FG001|COMPLETED|Period 1 (Days 8-50)||3
2891787|NCT00370838|3598737|FG000|NOT COMPLETED|Period 1 (Days 8-50)||0
2891788|NCT00370838|3598738|FG001|NOT COMPLETED|Period 1 (Days 8-50)||0
2891789|NCT00370838|3598737|FG000|STARTED|Washout (Days 51-64)||7
2891790|NCT00370838|3598738|FG001|STARTED|Washout (Days 51-64)||3
2891791|NCT00370838|3598737|FG000|COMPLETED|Washout (Days 51-64)||7
2891792|NCT00370838|3598738|FG001|COMPLETED|Washout (Days 51-64)||3
2891793|NCT00370838|3598737|FG000|NOT COMPLETED|Washout (Days 51-64)||0
2891794|NCT00370838|3598738|FG001|NOT COMPLETED|Washout (Days 51-64)||0
2891795|NCT00370838|3598737|FG000|STARTED|Period 2 (Days 65-107)||7
2891796|NCT00370838|3598738|FG001|STARTED|Period 2 (Days 65-107)||3
2891797|NCT00370838|3598737|FG000|COMPLETED|Period 2 (Days 65-107)||7
2891798|NCT00370838|3598738|FG001|COMPLETED|Period 2 (Days 65-107)||3
2891799|NCT00370838|3598737|FG000|NOT COMPLETED|Period 2 (Days 65-107)||0
2891800|NCT00370838|3598738|FG001|NOT COMPLETED|Period 2 (Days 65-107)||0
2891801|NCT00370838|3598737|FG000|STARTED|Taper||7
2891802|NCT00370838|3598738|FG001|STARTED|Taper||3
2891803|NCT00370838|3598737|FG000|COMPLETED|Taper||7
2891804|NCT00370838|3598738|FG001|COMPLETED|Taper||3
2891805|NCT00370838|3598737|FG000|NOT COMPLETED|Taper||0
2891806|NCT00370838|3598738|FG001|NOT COMPLETED|Taper||0
2891807|NCT00370994|3598746|FG000|STARTED|Overall Study|Sample size was 200, due to the difficulties of recruiting we changed to 120|60
2891808|NCT00370994|3598747|FG001|STARTED|Overall Study||60
2891809|NCT00370994|3598746|FG000|COMPLETED|Overall Study||60
2891810|NCT00370994|3598747|FG001|COMPLETED|Overall Study||60
2891811|NCT00370994|3598746|FG000|NOT COMPLETED|Overall Study||0
2891812|NCT00370994|3598747|FG001|NOT COMPLETED|Overall Study||0
2891813|NCT00371137|3598756|FG000|STARTED|Overall Study||183
2891814|NCT00371137|3598757|FG001|STARTED|Overall Study||182
2891815|NCT00371137|3598758|FG002|STARTED|Overall Study||183
2891816|NCT00371137|3598756|FG000|Treated|Overall Study||183
2891817|NCT00371137|3598757|FG001|Treated|Overall Study||182
2891818|NCT00371137|3598758|FG002|Treated|Overall Study||182
2891819|NCT00371137|3598756|FG000|COMPLETED|Overall Study||111
2891820|NCT00371137|3598757|FG001|COMPLETED|Overall Study||119
3170517|NCT01929707|3897852|FG000|NOT COMPLETED|Intervention Period 2||0
3170518|NCT01929707|3897853|FG001|NOT COMPLETED|Intervention Period 2||0
3170519|NCT01929707|3897854|FG002|NOT COMPLETED|Intervention Period 2||0
3170520|NCT01929707|3897855|FG003|NOT COMPLETED|Intervention Period 2||0
3170521|NCT01929707|3897856|FG004|NOT COMPLETED|Intervention Period 2||0
3170522|NCT01929707|3897857|FG005|NOT COMPLETED|Intervention Period 2||2
3170523|NCT01929707|3897858|FG006|NOT COMPLETED|Intervention Period 2||0
3170524|NCT01929707|3897859|FG007|NOT COMPLETED|Intervention Period 2||0
2891821|NCT00371137|3598758|FG002|COMPLETED|Overall Study||104
2891822|NCT00371137|3598756|FG000|NOT COMPLETED|Overall Study||72
2891823|NCT00371137|3598757|FG001|NOT COMPLETED|Overall Study||63
2891824|NCT00371137|3598758|FG002|NOT COMPLETED|Overall Study||79
2891825|NCT00371150|3598768|FG000|STARTED|Overall Study||40
2891826|NCT00371150|3598769|FG001|STARTED|Overall Study||6
2891827|NCT00371150|3598768|FG000|Discontinued Prior to Week 48 Visit|Overall Study||1
2891828|NCT00371150|3598769|FG001|Discontinued Prior to Week 48 Visit|Overall Study||1
2891829|NCT00371150|3598768|FG000|Discontinued at or After Week 48 Visit|Overall Study||2
2891830|NCT00371150|3598769|FG001|Discontinued at or After Week 48 Visit|Overall Study||1
2891831|NCT00371150|3598768|FG000|COMPLETED|Overall Study|"Completion of treatment means received treatment through Week 52"|37
2891832|NCT00371150|3598769|FG001|COMPLETED|Overall Study|"Completion of treatment means received treatment through Week 52"|4
2891833|NCT00371150|3598768|FG000|NOT COMPLETED|Overall Study||3
3170525|NCT01929759|3897880|FG000|STARTED|Overall Study||10
3170526|NCT01929759|3897880|FG000|COMPLETED|Overall Study||10
3170527|NCT01929759|3897880|FG000|NOT COMPLETED|Overall Study||0
3170528|NCT01929863|3897884|FG000|STARTED|Period 1:Intervention Period 1 (7 Days)||7
3170529|NCT01929863|3897885|FG001|STARTED|Period 1:Intervention Period 1 (7 Days)||8
3170530|NCT01929863|3897884|FG000|COMPLETED|Period 1:Intervention Period 1 (7 Days)||6
3170531|NCT01929863|3897885|FG001|COMPLETED|Period 1:Intervention Period 1 (7 Days)||7
3170532|NCT01929863|3897884|FG000|NOT COMPLETED|Period 1:Intervention Period 1 (7 Days)||1
3170533|NCT01929863|3897885|FG001|NOT COMPLETED|Period 1:Intervention Period 1 (7 Days)||1
3314742|NCT03091920|4048043|FG000|STARTED|Overall Study||6
3314743|NCT03091920|4048044|FG001|STARTED|Overall Study||10
2891834|NCT00371150|3598769|FG001|NOT COMPLETED|Overall Study||2
2891835|NCT00371176|3598781|FG000|STARTED|Overall Study||13
2891836|NCT00371176|3598782|FG001|STARTED|Overall Study||13
2891837|NCT00371176|3598781|FG000|Completed Treatment|Overall Study||10
2891838|NCT00371176|3598782|FG001|Completed Treatment|Overall Study||9
2891839|NCT00371176|3598781|FG000|COMPLETED|Overall Study||8
2891840|NCT00371176|3598782|FG001|COMPLETED|Overall Study||5
2891841|NCT00371176|3598781|FG000|NOT COMPLETED|Overall Study||5
2891842|NCT00371176|3598782|FG001|NOT COMPLETED|Overall Study||8
2891843|NCT00371254|3598790|FG000|STARTED|Overall Study|Number of participants treated|23
2891844|NCT00371254|3598791|FG001|STARTED|Overall Study|Number of participants treated|21
2891845|NCT00371254|3598790|FG000|COMPLETED|Overall Study|Number of participants remained on study till the study drug could be tolerated|0
2891846|NCT00371254|3598791|FG001|COMPLETED|Overall Study|Number of participants remained on study till the study drug could be tolerated|0
2891847|NCT00371254|3598790|FG000|NOT COMPLETED|Overall Study||23
2891848|NCT00371254|3598791|FG001|NOT COMPLETED|Overall Study||21
2891849|NCT00371267|3598799|FG000|STARTED|Overall Study||48
2891850|NCT00371267|3598800|FG001|STARTED|Overall Study||50
2891851|NCT00371267|3598799|FG000|COMPLETED|Overall Study||39
2891852|NCT00371267|3598800|FG001|COMPLETED|Overall Study||32
2891853|NCT00371267|3598799|FG000|NOT COMPLETED|Overall Study||9
2891854|NCT00371267|3598800|FG001|NOT COMPLETED|Overall Study||18
2891855|NCT00371293|3598809|FG000|STARTED|Overall Study||58
2891856|NCT00371293|3598810|FG001|STARTED|Overall Study||61
2891857|NCT00371293|3598811|FG002|STARTED|Overall Study||62
2891858|NCT00371293|3598809|FG000|COMPLETED|Overall Study||48
2891859|NCT00371293|3598810|FG001|COMPLETED|Overall Study||42
2891860|NCT00371293|3598811|FG002|COMPLETED|Overall Study||46
2891861|NCT00371293|3598809|FG000|NOT COMPLETED|Overall Study||10
2891862|NCT00371293|3598810|FG001|NOT COMPLETED|Overall Study||19
2891863|NCT00371293|3598811|FG002|NOT COMPLETED|Overall Study||16
2891864|NCT00371345|3598822|FG000|STARTED|Overall Study||24
2891865|NCT00371345|3598823|FG001|STARTED|Overall Study||46
2891866|NCT00371345|3598822|FG000|COMPLETED|Overall Study||0
2891867|NCT00371345|3598823|FG001|COMPLETED|Overall Study||0
2891868|NCT00371345|3598822|FG000|NOT COMPLETED|Overall Study||24
2891869|NCT00371345|3598823|FG001|NOT COMPLETED|Overall Study||46
2891870|NCT00371397|3598843|FG000|STARTED|Session 1||5
2891871|NCT00371397|3598844|FG001|STARTED|Session 1||7
2891872|NCT00371397|3598845|FG002|STARTED|Session 1||5
2891873|NCT00371397|3598846|FG003|STARTED|Session 1||2
2891874|NCT00371397|3598847|FG004|STARTED|Session 1||3
2891875|NCT00371397|3598848|FG005|STARTED|Session 1||4
2891876|NCT00371397|3598849|FG006|STARTED|Session 1||4
2891877|NCT00371397|3598850|FG007|STARTED|Session 1||5
2891878|NCT00371397|3598851|FG008|STARTED|Session 1||6
2891879|NCT00371397|3598852|FG009|STARTED|Session 1||5
2891880|NCT00371397|3598853|FG010|STARTED|Session 1||4
2891881|NCT00371397|3598854|FG011|STARTED|Session 1||2
2891882|NCT00371397|3598843|FG000|COMPLETED|Session 1||4
2891883|NCT00371397|3598844|FG001|COMPLETED|Session 1||7
2891884|NCT00371397|3598845|FG002|COMPLETED|Session 1||5
2891885|NCT00371397|3598846|FG003|COMPLETED|Session 1||2
2891886|NCT00371397|3598847|FG004|COMPLETED|Session 1||3
2891887|NCT00371397|3598848|FG005|COMPLETED|Session 1||4
2891888|NCT00371397|3598849|FG006|COMPLETED|Session 1||4
2891889|NCT00371397|3598850|FG007|COMPLETED|Session 1||4
2891890|NCT00371397|3598851|FG008|COMPLETED|Session 1||6
2891891|NCT00371397|3598852|FG009|COMPLETED|Session 1||5
2891892|NCT00371397|3598853|FG010|COMPLETED|Session 1||4
2891893|NCT00371397|3598854|FG011|COMPLETED|Session 1||2
2891894|NCT00371397|3598843|FG000|NOT COMPLETED|Session 1||1
2891895|NCT00371397|3598844|FG001|NOT COMPLETED|Session 1||0
2891896|NCT00371397|3598845|FG002|NOT COMPLETED|Session 1||0
2891897|NCT00371397|3598846|FG003|NOT COMPLETED|Session 1||0
2891898|NCT00371397|3598847|FG004|NOT COMPLETED|Session 1||0
2891899|NCT00371397|3598848|FG005|NOT COMPLETED|Session 1||0
2891900|NCT00371397|3598849|FG006|NOT COMPLETED|Session 1||0
2891901|NCT00371397|3598850|FG007|NOT COMPLETED|Session 1||1
2891902|NCT00371397|3598851|FG008|NOT COMPLETED|Session 1||0
2891903|NCT00371397|3598852|FG009|NOT COMPLETED|Session 1||0
2891904|NCT00371397|3598853|FG010|NOT COMPLETED|Session 1||0
2891905|NCT00371397|3598854|FG011|NOT COMPLETED|Session 1||0
2891906|NCT00371397|3598843|FG000|STARTED|Session 2||4
2891907|NCT00371397|3598844|FG001|STARTED|Session 2||7
2891908|NCT00371397|3598845|FG002|STARTED|Session 2||5
2891909|NCT00371397|3598846|FG003|STARTED|Session 2||2
2891910|NCT00371397|3598847|FG004|STARTED|Session 2||3
2891911|NCT00371397|3598848|FG005|STARTED|Session 2||4
2891912|NCT00371397|3598849|FG006|STARTED|Session 2||4
2891913|NCT00371397|3598850|FG007|STARTED|Session 2||4
2891914|NCT00371397|3598851|FG008|STARTED|Session 2||6
2891915|NCT00371397|3598852|FG009|STARTED|Session 2||5
2891916|NCT00371397|3598853|FG010|STARTED|Session 2||4
2891917|NCT00371397|3598854|FG011|STARTED|Session 2||2
2891918|NCT00371397|3598843|FG000|COMPLETED|Session 2||4
2891919|NCT00371397|3598844|FG001|COMPLETED|Session 2||7
2891920|NCT00371397|3598845|FG002|COMPLETED|Session 2||5
2891921|NCT00371397|3598846|FG003|COMPLETED|Session 2||2
2891922|NCT00371397|3598847|FG004|COMPLETED|Session 2||3
2891923|NCT00371397|3598848|FG005|COMPLETED|Session 2||4
2891924|NCT00371397|3598849|FG006|COMPLETED|Session 2||4
2891925|NCT00371397|3598850|FG007|COMPLETED|Session 2||4
2891926|NCT00371397|3598851|FG008|COMPLETED|Session 2||6
2891927|NCT00371397|3598852|FG009|COMPLETED|Session 2||5
2891928|NCT00371397|3598853|FG010|COMPLETED|Session 2||4
2891929|NCT00371397|3598854|FG011|COMPLETED|Session 2||2
2891930|NCT00371397|3598843|FG000|NOT COMPLETED|Session 2||0
2891931|NCT00371397|3598844|FG001|NOT COMPLETED|Session 2||0
2891932|NCT00371397|3598845|FG002|NOT COMPLETED|Session 2||0
2891933|NCT00371397|3598846|FG003|NOT COMPLETED|Session 2||0
2891934|NCT00371397|3598847|FG004|NOT COMPLETED|Session 2||0
2891935|NCT00371397|3598848|FG005|NOT COMPLETED|Session 2||0
2891936|NCT00371397|3598849|FG006|NOT COMPLETED|Session 2||0
2891937|NCT00371397|3598850|FG007|NOT COMPLETED|Session 2||0
2891938|NCT00371397|3598851|FG008|NOT COMPLETED|Session 2||0
2891939|NCT00371397|3598852|FG009|NOT COMPLETED|Session 2||0
2891940|NCT00371397|3598853|FG010|NOT COMPLETED|Session 2||0
2891941|NCT00371397|3598854|FG011|NOT COMPLETED|Session 2||0
2891942|NCT00371397|3598843|FG000|STARTED|Session 3||4
2891943|NCT00371397|3598844|FG001|STARTED|Session 3||7
2891944|NCT00371397|3598845|FG002|STARTED|Session 3||5
2891945|NCT00371397|3598846|FG003|STARTED|Session 3||2
2891946|NCT00371397|3598847|FG004|STARTED|Session 3||3
2891947|NCT00371397|3598848|FG005|STARTED|Session 3||4
2891948|NCT00371397|3598849|FG006|STARTED|Session 3||4
2891949|NCT00371397|3598850|FG007|STARTED|Session 3||4
2891950|NCT00371397|3598851|FG008|STARTED|Session 3||6
2891951|NCT00371397|3598852|FG009|STARTED|Session 3||5
2891952|NCT00371397|3598853|FG010|STARTED|Session 3||4
2891953|NCT00371397|3598854|FG011|STARTED|Session 3||2
2891954|NCT00371397|3598843|FG000|COMPLETED|Session 3||4
2891955|NCT00371397|3598844|FG001|COMPLETED|Session 3||7
2891956|NCT00371397|3598845|FG002|COMPLETED|Session 3||5
2891957|NCT00371397|3598846|FG003|COMPLETED|Session 3||2
2891958|NCT00371397|3598847|FG004|COMPLETED|Session 3||3
2891959|NCT00371397|3598848|FG005|COMPLETED|Session 3||4
2891960|NCT00371397|3598849|FG006|COMPLETED|Session 3||4
2891961|NCT00371397|3598850|FG007|COMPLETED|Session 3||4
2891962|NCT00371397|3598851|FG008|COMPLETED|Session 3||6
2891963|NCT00371397|3598852|FG009|COMPLETED|Session 3||5
2891964|NCT00371397|3598853|FG010|COMPLETED|Session 3||4
2891965|NCT00371397|3598854|FG011|COMPLETED|Session 3||2
2891966|NCT00371397|3598843|FG000|NOT COMPLETED|Session 3||0
2891967|NCT00371397|3598844|FG001|NOT COMPLETED|Session 3||0
2891968|NCT00371397|3598845|FG002|NOT COMPLETED|Session 3||0
2891969|NCT00371397|3598846|FG003|NOT COMPLETED|Session 3||0
2891970|NCT00371397|3598847|FG004|NOT COMPLETED|Session 3||0
2891971|NCT00371397|3598848|FG005|NOT COMPLETED|Session 3||0
2891972|NCT00371397|3598849|FG006|NOT COMPLETED|Session 3||0
2891973|NCT00371397|3598850|FG007|NOT COMPLETED|Session 3||0
2891974|NCT00371397|3598851|FG008|NOT COMPLETED|Session 3||0
2891975|NCT00371397|3598852|FG009|NOT COMPLETED|Session 3||0
2891976|NCT00371397|3598853|FG010|NOT COMPLETED|Session 3||0
2891977|NCT00371397|3598854|FG011|NOT COMPLETED|Session 3||0
2891978|NCT00371436|3598862|FG000|STARTED|Overall Study||92
2891979|NCT00371436|3598863|FG001|STARTED|Overall Study||89
2891980|NCT00371436|3598862|FG000|COMPLETED|Overall Study||58
2891981|NCT00371436|3598863|FG001|COMPLETED|Overall Study||68
2891982|NCT00371436|3598862|FG000|NOT COMPLETED|Overall Study||34
2891983|NCT00371436|3598863|FG001|NOT COMPLETED|Overall Study||21
2891984|NCT00371449|3598869|FG000|STARTED|Overall Study||120
2891985|NCT00371449|3598869|FG000|COMPLETED|Overall Study||120
2891986|NCT00371449|3598869|FG000|NOT COMPLETED|Overall Study||0
2891987|NCT00371540|3598877|FG000|STARTED|Overall Study||112
2891988|NCT00371540|3598878|FG001|STARTED|Overall Study||96
2891989|NCT00371540|3598877|FG000|COMPLETED|Overall Study||102
2891990|NCT00371540|3598878|FG001|COMPLETED|Overall Study||87
2891991|NCT00371540|3598877|FG000|NOT COMPLETED|Overall Study||10
2891992|NCT00371540|3598878|FG001|NOT COMPLETED|Overall Study||9
2891993|NCT00371566|3598886|FG000|STARTED|Treatment Phase||36
2891994|NCT00371566|3598887|FG001|STARTED|Treatment Phase||71
2891995|NCT00371566|3598886|FG000|COMPLETED|Treatment Phase||36
2891996|NCT00371566|3598887|FG001|COMPLETED|Treatment Phase|1 screen failure included in the ITT population|68
2891997|NCT00371566|3598886|FG000|NOT COMPLETED|Treatment Phase||0
2891998|NCT00371566|3598887|FG001|NOT COMPLETED|Treatment Phase||3
2891999|NCT00371566|3598886|FG000|STARTED|Chemoradiation Phase||36
2892000|NCT00371566|3598887|FG001|STARTED|Chemoradiation Phase||68
2892001|NCT00371566|3598886|FG000|COMPLETED|Chemoradiation Phase||31
2892002|NCT00371566|3598887|FG001|COMPLETED|Chemoradiation Phase||65
2892003|NCT00371566|3598886|FG000|NOT COMPLETED|Chemoradiation Phase||5
2892004|NCT00371566|3598887|FG001|NOT COMPLETED|Chemoradiation Phase||3
2892005|NCT00371566|3598886|FG000|STARTED|Follow Up Phase||31
2892006|NCT00371566|3598887|FG001|STARTED|Follow Up Phase||65
2892007|NCT00371566|3598886|FG000|COMPLETED|Follow Up Phase||28
2892008|NCT00371566|3598887|FG001|COMPLETED|Follow Up Phase||58
2892009|NCT00371566|3598886|FG000|NOT COMPLETED|Follow Up Phase||3
2892010|NCT00371566|3598887|FG001|NOT COMPLETED|Follow Up Phase||7
2892011|NCT00371631|3598893|FG000|STARTED|Overall Study||13
2892012|NCT00371631|3598893|FG000|COMPLETED|Overall Study||13
2892013|NCT00371631|3598893|FG000|NOT COMPLETED|Overall Study||0
2892014|NCT00371644|3598899|FG000|STARTED|Overall Study||72
2892015|NCT00371644|3598900|FG001|STARTED|Overall Study||57
2892016|NCT00371644|3598899|FG000|COMPLETED|Overall Study||44
2892017|NCT00371644|3598900|FG001|COMPLETED|Overall Study||44
2892018|NCT00371644|3598899|FG000|NOT COMPLETED|Overall Study||28
2892019|NCT00371644|3598900|FG001|NOT COMPLETED|Overall Study||13
2892020|NCT00371683|3598908|FG000|STARTED|DB Treatment Period-Randomized Patients||1599
2892021|NCT00371683|3598909|FG001|STARTED|DB Treatment Period-Randomized Patients||1596
2892022|NCT00371683|3598908|FG000|COMPLETED|DB Treatment Period-Randomized Patients||1509
2892023|NCT00371683|3598909|FG001|COMPLETED|DB Treatment Period-Randomized Patients||1489
2892024|NCT00371683|3598908|FG000|NOT COMPLETED|DB Treatment Period-Randomized Patients||90
2892025|NCT00371683|3598909|FG001|NOT COMPLETED|DB Treatment Period-Randomized Patients||107
2892026|NCT00371683|3598908|FG000|STARTED|Follow-Up Period - Randomized Patients||1553
2892027|NCT00371683|3598909|FG001|STARTED|Follow-Up Period - Randomized Patients||1533
2892028|NCT00371683|3598908|FG000|COMPLETED|Follow-Up Period - Randomized Patients||1492
2892029|NCT00371683|3598909|FG001|COMPLETED|Follow-Up Period - Randomized Patients||1461
2892030|NCT00371683|3598908|FG000|NOT COMPLETED|Follow-Up Period - Randomized Patients||61
2892031|NCT00371683|3598909|FG001|NOT COMPLETED|Follow-Up Period - Randomized Patients||72
2892032|NCT00371761|3598927|FG000|STARTED|Overall Study||13
2892033|NCT00371761|3598928|FG001|STARTED|Overall Study||12
2892034|NCT00371761|3598927|FG000|COMPLETED|Overall Study||5
2892035|NCT00371761|3598928|FG001|COMPLETED|Overall Study||2
2892036|NCT00371761|3598927|FG000|NOT COMPLETED|Overall Study||8
2892037|NCT00371761|3598928|FG001|NOT COMPLETED|Overall Study||10
2892038|NCT00371787|3598936|FG000|STARTED|Overall Study||26
2892039|NCT00371787|3598937|FG001|STARTED|Overall Study||12
2892040|NCT00371787|3598936|FG000|COMPLETED|Overall Study||23
2892041|NCT00371787|3598937|FG001|COMPLETED|Overall Study||11
2892042|NCT00371787|3598936|FG000|NOT COMPLETED|Overall Study||3
2892043|NCT00371787|3598937|FG001|NOT COMPLETED|Overall Study||1
2892044|NCT00371826|3598946|FG000|STARTED|Core Phase (12 Months)|"Started indicates patients in Randomized, Intent to treat (ITT) and Safety set."|49
2892045|NCT00371826|3598947|FG001|STARTED|Core Phase (12 Months)||47
2892046|NCT00371826|3598948|FG002|STARTED|Core Phase (12 Months)||30
2892047|NCT00371826|3598946|FG000|Modified Intent to Treat (mITT)- Add|Core Phase (12 Months)||46
2892048|NCT00371826|3598947|FG001|Modified Intent to Treat (mITT)- Add|Core Phase (12 Months)||44
2892049|NCT00371826|3598948|FG002|Modified Intent to Treat (mITT)- Add|Core Phase (12 Months)||20
2892050|NCT00371826|3598946|FG000|Modified Intent to Treat (mITT)|Core Phase (12 Months)||27
2892051|NCT00371826|3598947|FG001|Modified Intent to Treat (mITT)|Core Phase (12 Months)||39
2892052|NCT00371826|3598948|FG002|Modified Intent to Treat (mITT)|Core Phase (12 Months)||6
2892053|NCT00371826|3598946|FG000|COMPLETED|Core Phase (12 Months)|"Completed means patients were still on study medication by month 12."|25
2892054|NCT00371826|3598947|FG001|COMPLETED|Core Phase (12 Months)||39
2892055|NCT00371826|3598948|FG002|COMPLETED|Core Phase (12 Months)||6
2892056|NCT00371826|3598946|FG000|NOT COMPLETED|Core Phase (12 Months)||24
2892057|NCT00371826|3598947|FG001|NOT COMPLETED|Core Phase (12 Months)||8
2892058|NCT00371826|3598948|FG002|NOT COMPLETED|Core Phase (12 Months)||24
2892059|NCT00371826|3598946|FG000|STARTED|Extension Phase (24 Months)|2 patients who completed 12 month core did not wish to continue in extension.|23
2892060|NCT00371826|3598947|FG001|STARTED|Extension Phase (24 Months)||39
2892061|NCT00371826|3598948|FG002|STARTED|Extension Phase (24 Months)|One patient completed core, did not wish to continue to extension.|5
2892062|NCT00371826|3598946|FG000|Intention to Treat - Extenstion (ITT-Ex)|Extension Phase (24 Months)||23
2892063|NCT00371826|3598947|FG001|Intention to Treat - Extenstion (ITT-Ex)|Extension Phase (24 Months)||39
2892064|NCT00371826|3598948|FG002|Intention to Treat - Extenstion (ITT-Ex)|Extension Phase (24 Months)|One patient entered extension, was withdrawn (no efficacy data in extension) due to DMC suggestion|4
2892065|NCT00371826|3598946|FG000|Safety Set|Extension Phase (24 Months)|One patient randomized to this arm, was treated with the control regimen (CNI+MPA+Steroid)|22
2892066|NCT00371826|3598947|FG001|Safety Set|Extension Phase (24 Months)|One patient mis-randomised to 1st arm but treated in this arm, evaluated for safety in this arm.|40
2892067|NCT00371826|3598948|FG002|Safety Set|Extension Phase (24 Months)|Patient withdrawn as per DMC suggestion had no efficacy data, but was included in safety set.|5
2892068|NCT00371826|3598946|FG000|COMPLETED|Extension Phase (24 Months)||18
2892069|NCT00371826|3598947|FG001|COMPLETED|Extension Phase (24 Months)||29
2892070|NCT00371826|3598948|FG002|COMPLETED|Extension Phase (24 Months)||3
2892071|NCT00371826|3598946|FG000|NOT COMPLETED|Extension Phase (24 Months)||5
2892072|NCT00371826|3598947|FG001|NOT COMPLETED|Extension Phase (24 Months)||10
2892073|NCT00371826|3598948|FG002|NOT COMPLETED|Extension Phase (24 Months)||2
2892074|NCT00371839|3598959|FG000|STARTED|Overall Study||49
2892075|NCT00371839|3598960|FG001|STARTED|Overall Study||20
2892076|NCT00371839|3598961|FG002|STARTED|Overall Study||9
2892077|NCT00371839|3598959|FG000|COMPLETED|Overall Study||32
2892078|NCT00371839|3598960|FG001|COMPLETED|Overall Study||13
2892079|NCT00371839|3598961|FG002|COMPLETED|Overall Study||7
2892080|NCT00371839|3598959|FG000|NOT COMPLETED|Overall Study||17
2892081|NCT00371839|3598960|FG001|NOT COMPLETED|Overall Study||7
2892082|NCT00371839|3598961|FG002|NOT COMPLETED|Overall Study||2
2892083|NCT00371865|3598969|FG000|STARTED|Overall Study||57
2892084|NCT00371865|3598970|FG001|STARTED|Overall Study||57
2892085|NCT00371865|3598969|FG000|COMPLETED|Overall Study|7 withdrew before starting the intervention. 8 withdrew after starting the intervention.|42
2892086|NCT00371865|3598970|FG001|COMPLETED|Overall Study|8 withdrew before starting the intervention. 6 withdrew after starting the intervention.|43
2892087|NCT00371865|3598969|FG000|NOT COMPLETED|Overall Study||15
2892088|NCT00371865|3598970|FG001|NOT COMPLETED|Overall Study||14
2892089|NCT00372060|3598978|FG000|STARTED|Period I - Double-blind (Weeks 0-12)|The planned number of enrolled patients was 130. The actual number of enrolled patients was 134.|66
2892090|NCT00372060|3598979|FG001|STARTED|Period I - Double-blind (Weeks 0-12)||68
2892091|NCT00372060|3598978|FG000|COMPLETED|Period I - Double-blind (Weeks 0-12)||63
2892092|NCT00372060|3598979|FG001|COMPLETED|Period I - Double-blind (Weeks 0-12)||67
2892093|NCT00372060|3598978|FG000|NOT COMPLETED|Period I - Double-blind (Weeks 0-12)||3
2892094|NCT00372060|3598979|FG001|NOT COMPLETED|Period I - Double-blind (Weeks 0-12)||1
2892095|NCT00372060|3598978|FG000|STARTED|Period II - Open-label (Weeks 12-52)||63
2892096|NCT00372060|3598979|FG001|STARTED|Period II - Open-label (Weeks 12-52)||67
2892097|NCT00372060|3598978|FG000|COMPLETED|Period II - Open-label (Weeks 12-52)||49
2892098|NCT00372060|3598979|FG001|COMPLETED|Period II - Open-label (Weeks 12-52)||59
2892099|NCT00372060|3598978|FG000|NOT COMPLETED|Period II - Open-label (Weeks 12-52)||14
2892100|NCT00372060|3598979|FG001|NOT COMPLETED|Period II - Open-label (Weeks 12-52)||8
2892101|NCT00372112|3598992|FG000|STARTED|Overall Study||17
2892102|NCT00372112|3598993|FG001|STARTED|Overall Study||16
2892103|NCT00372112|3598994|FG002|STARTED|Overall Study||17
2892104|NCT00372112|3598995|FG003|STARTED|Overall Study||18
2892105|NCT00372112|3598992|FG000|COMPLETED|Overall Study||16
2892106|NCT00372112|3598993|FG001|COMPLETED|Overall Study||15
2892107|NCT00372112|3598994|FG002|COMPLETED|Overall Study||13
2892108|NCT00372112|3598995|FG003|COMPLETED|Overall Study||14
2892109|NCT00372112|3598992|FG000|NOT COMPLETED|Overall Study||1
2892110|NCT00372112|3598993|FG001|NOT COMPLETED|Overall Study||1
2892111|NCT00372112|3598994|FG002|NOT COMPLETED|Overall Study||4
2892112|NCT00372112|3598995|FG003|NOT COMPLETED|Overall Study||4
2892113|NCT00372190|3599010|FG000|STARTED|Overall Study|95 were allocated to mesh group, however 2 never underwent any surgery|93
2892114|NCT00372190|3599011|FG001|STARTED|Overall Study|99 were allocated to conventional arm, however 2 never underwent any surgery|97
2892115|NCT00372190|3599010|FG000|COMPLETED|Overall Study||90
2892116|NCT00372190|3599011|FG001|COMPLETED|Overall Study||96
2892117|NCT00372190|3599010|FG000|NOT COMPLETED|Overall Study||3
2892118|NCT00372190|3599011|FG001|NOT COMPLETED|Overall Study||1
2892119|NCT00372255|3599021|FG000|STARTED|Overall Study||110
2892120|NCT00372255|3599022|FG001|STARTED|Overall Study||114
2892121|NCT00372255|3599021|FG000|COMPLETED|Overall Study||108
2892122|NCT00372255|3599022|FG001|COMPLETED|Overall Study||113
2892123|NCT00372255|3599021|FG000|NOT COMPLETED|Overall Study||2
2892124|NCT00372255|3599022|FG001|NOT COMPLETED|Overall Study||1
2892125|NCT00372385|3599033|FG000|STARTED|Overall Study||82
2892126|NCT00372385|3599034|FG001|STARTED|Overall Study||81
2892127|NCT00372385|3599035|FG002|STARTED|Overall Study||82
2892128|NCT00372385|3599036|FG003|STARTED|Overall Study||78
2892129|NCT00372385|3599033|FG000|COMPLETED|Overall Study||49
2892130|NCT00372385|3599034|FG001|COMPLETED|Overall Study||61
2892131|NCT00372385|3599035|FG002|COMPLETED|Overall Study||72
2892132|NCT00372385|3599036|FG003|COMPLETED|Overall Study||70
2892133|NCT00372385|3599033|FG000|NOT COMPLETED|Overall Study||33
2892134|NCT00372385|3599034|FG001|NOT COMPLETED|Overall Study||20
2892135|NCT00372385|3599035|FG002|NOT COMPLETED|Overall Study||10
2892136|NCT00372385|3599036|FG003|NOT COMPLETED|Overall Study||8
2892137|NCT00372411|3599050|FG000|STARTED|Overall Study||49
2892138|NCT00372411|3599051|FG001|STARTED|Overall Study||50
2892139|NCT00372411|3599052|FG002|STARTED|Overall Study||28
2892140|NCT00372411|3599050|FG000|COMPLETED|Overall Study||44
2892141|NCT00372411|3599051|FG001|COMPLETED|Overall Study||42
2892142|NCT00372411|3599052|FG002|COMPLETED|Overall Study||25
2892143|NCT00372411|3599050|FG000|NOT COMPLETED|Overall Study||5
2892144|NCT00372411|3599051|FG001|NOT COMPLETED|Overall Study||8
2892145|NCT00372411|3599052|FG002|NOT COMPLETED|Overall Study||3
2892146|NCT00372424|3599060|FG000|STARTED|Overall Study||26
2892147|NCT00372424|3599060|FG000|Treated|Overall Study||25
2892148|NCT00372424|3599060|FG000|COMPLETED|Overall Study||0
2892149|NCT00372424|3599060|FG000|NOT COMPLETED|Overall Study||26
2892150|NCT00372489|3599064|FG000|STARTED|Overall Study||81
2892151|NCT00372489|3599064|FG000|COMPLETED|Overall Study||2
2892152|NCT00372489|3599064|FG000|NOT COMPLETED|Overall Study||79
2892153|NCT00372528|3599068|FG000|STARTED|Overall Study||21
2892154|NCT00372528|3599068|FG000|COMPLETED|Overall Study||0
2892155|NCT00372528|3599068|FG000|NOT COMPLETED|Overall Study||21
2892156|NCT00372567|3599075|FG000|STARTED|Phase 1 Sub-study||0
2892157|NCT00372567|3599076|FG001|STARTED|Phase 1 Sub-study||0
2892158|NCT00372567|3599077|FG002|STARTED|Phase 1 Sub-study||12
2892159|NCT00372567|3599075|FG000|COMPLETED|Phase 1 Sub-study||0
2892160|NCT00372567|3599076|FG001|COMPLETED|Phase 1 Sub-study||0
2892161|NCT00372567|3599077|FG002|COMPLETED|Phase 1 Sub-study||12
2892162|NCT00372567|3599075|FG000|NOT COMPLETED|Phase 1 Sub-study||0
2892163|NCT00372567|3599076|FG001|NOT COMPLETED|Phase 1 Sub-study||0
2892164|NCT00372567|3599077|FG002|NOT COMPLETED|Phase 1 Sub-study||0
2892165|NCT00372567|3599075|FG000|STARTED|Phase 3 Study||31
2892166|NCT00372567|3599076|FG001|STARTED|Phase 3 Study||26
2892167|NCT00372567|3599077|FG002|STARTED|Phase 3 Study||12
2892168|NCT00372567|3599075|FG000|Received Treatment|Phase 3 Study||31
2892169|NCT00372567|3599076|FG001|Received Treatment|Phase 3 Study||25
2892170|NCT00372567|3599077|FG002|Received Treatment|Phase 3 Study||12
2892171|NCT00372567|3599075|FG000|COMPLETED|Phase 3 Study||0
2892172|NCT00372567|3599076|FG001|COMPLETED|Phase 3 Study||0
2892173|NCT00372567|3599077|FG002|COMPLETED|Phase 3 Study||0
2892174|NCT00372567|3599075|FG000|NOT COMPLETED|Phase 3 Study||31
2892175|NCT00372567|3599076|FG001|NOT COMPLETED|Phase 3 Study||26
2892176|NCT00372567|3599077|FG002|NOT COMPLETED|Phase 3 Study||12
2892177|NCT00372593|3599088|FG000|STARTED|Overall Study||531
2892178|NCT00372593|3599089|FG001|STARTED|Overall Study||532
2892179|NCT00372593|3599090|FG002|STARTED|Overall Study||7
2892180|NCT00372593|3599088|FG000|COMPLETED|Overall Study||327
2892181|NCT00372593|3599089|FG001|COMPLETED|Overall Study||334
2892182|NCT00372593|3599090|FG002|COMPLETED|Overall Study||3
2892183|NCT00372593|3599088|FG000|NOT COMPLETED|Overall Study||204
2892184|NCT00372593|3599089|FG001|NOT COMPLETED|Overall Study||198
2892185|NCT00372593|3599090|FG002|NOT COMPLETED|Overall Study||4
2892186|NCT00372619|3599106|FG000|STARTED|Overall Study||8
2892187|NCT00372619|3599107|FG001|STARTED|Overall Study||2
2892188|NCT00372619|3599108|FG002|STARTED|Overall Study||3
2892189|NCT00372619|3599109|FG003|STARTED|Overall Study||10
2892190|NCT00372619|3599110|FG004|STARTED|Overall Study||7
2892191|NCT00372619|3599111|FG005|STARTED|Overall Study||42
2892192|NCT00372619|3599112|FG006|STARTED|Overall Study||2
2892193|NCT00372619|3599106|FG000|COMPLETED|Overall Study||8
2892194|NCT00372619|3599107|FG001|COMPLETED|Overall Study||2
2892195|NCT00372619|3599108|FG002|COMPLETED|Overall Study||3
2892196|NCT00372619|3599109|FG003|COMPLETED|Overall Study||10
2892197|NCT00372619|3599110|FG004|COMPLETED|Overall Study||7
2892198|NCT00372619|3599111|FG005|COMPLETED|Overall Study||39
2892199|NCT00372619|3599112|FG006|COMPLETED|Overall Study||2
2892200|NCT00372619|3599106|FG000|NOT COMPLETED|Overall Study||0
2892201|NCT00372619|3599107|FG001|NOT COMPLETED|Overall Study||0
2892202|NCT00372619|3599108|FG002|NOT COMPLETED|Overall Study||0
2892203|NCT00372619|3599109|FG003|NOT COMPLETED|Overall Study||0
2892204|NCT00372619|3599110|FG004|NOT COMPLETED|Overall Study||0
2892205|NCT00372619|3599111|FG005|NOT COMPLETED|Overall Study||3
2892206|NCT00372619|3599112|FG006|NOT COMPLETED|Overall Study||0
2892207|NCT00372697|3599130|FG000|STARTED|Overall Study||16
2892208|NCT00372697|3599131|FG001|STARTED|Overall Study||12
2892209|NCT00372697|3599130|FG000|COMPLETED|Overall Study||15
2892210|NCT00372697|3599131|FG001|COMPLETED|Overall Study||11
2892211|NCT00372697|3599130|FG000|NOT COMPLETED|Overall Study||1
2892212|NCT00372697|3599131|FG001|NOT COMPLETED|Overall Study||1
2892213|NCT00372775|3599137|FG000|STARTED|Overall Study||66
2892214|NCT00372775|3599137|FG000|Received Treatment|Overall Study||64
2892215|NCT00372775|3599137|FG000|COMPLETED|Overall Study||3
2892216|NCT00372775|3599137|FG000|NOT COMPLETED|Overall Study||63
2892217|NCT00372905|3599141|FG000|STARTED|Cohort 1: Dose Level 1.0mg/m2||3
2892218|NCT00372905|3599142|FG001|STARTED|Cohort 1: Dose Level 1.0mg/m2||0
2892219|NCT00372905|3599143|FG002|STARTED|Cohort 1: Dose Level 1.0mg/m2||0
2892220|NCT00372905|3599144|FG003|STARTED|Cohort 1: Dose Level 1.0mg/m2||0
2892221|NCT00372905|3599141|FG000|Registered to Study|Cohort 1: Dose Level 1.0mg/m2||3
2892222|NCT00372905|3599142|FG001|Registered to Study|Cohort 1: Dose Level 1.0mg/m2||0
2892223|NCT00372905|3599143|FG002|Registered to Study|Cohort 1: Dose Level 1.0mg/m2||0
2892224|NCT00372905|3599144|FG003|Registered to Study|Cohort 1: Dose Level 1.0mg/m2||0
2892225|NCT00372905|3599141|FG000|Treated 1 Cycle of Induction Therapy|Cohort 1: Dose Level 1.0mg/m2||3
2892226|NCT00372905|3599142|FG001|Treated 1 Cycle of Induction Therapy|Cohort 1: Dose Level 1.0mg/m2||0
2892227|NCT00372905|3599143|FG002|Treated 1 Cycle of Induction Therapy|Cohort 1: Dose Level 1.0mg/m2||0
2892228|NCT00372905|3599144|FG003|Treated 1 Cycle of Induction Therapy|Cohort 1: Dose Level 1.0mg/m2||0
2892229|NCT00372905|3599141|FG000|Completed 3 Cycles of Consolidation|Cohort 1: Dose Level 1.0mg/m2||1
2892230|NCT00372905|3599142|FG001|Completed 3 Cycles of Consolidation|Cohort 1: Dose Level 1.0mg/m2||0
2892231|NCT00372905|3599143|FG002|Completed 3 Cycles of Consolidation|Cohort 1: Dose Level 1.0mg/m2||0
2892232|NCT00372905|3599144|FG003|Completed 3 Cycles of Consolidation|Cohort 1: Dose Level 1.0mg/m2||0
2892233|NCT00372905|3599141|FG000|COMPLETED|Cohort 1: Dose Level 1.0mg/m2||1
2892234|NCT00372905|3599142|FG001|COMPLETED|Cohort 1: Dose Level 1.0mg/m2||0
2892235|NCT00372905|3599143|FG002|COMPLETED|Cohort 1: Dose Level 1.0mg/m2||0
2892236|NCT00372905|3599144|FG003|COMPLETED|Cohort 1: Dose Level 1.0mg/m2||0
2892237|NCT00372905|3599141|FG000|NOT COMPLETED|Cohort 1: Dose Level 1.0mg/m2||2
2892238|NCT00372905|3599142|FG001|NOT COMPLETED|Cohort 1: Dose Level 1.0mg/m2||0
2892239|NCT00372905|3599143|FG002|NOT COMPLETED|Cohort 1: Dose Level 1.0mg/m2||0
2892240|NCT00372905|3599144|FG003|NOT COMPLETED|Cohort 1: Dose Level 1.0mg/m2||0
2892241|NCT00372905|3599141|FG000|STARTED|Cohort 2: Dose Level 1.3mg/m2||0
2892242|NCT00372905|3599142|FG001|STARTED|Cohort 2: Dose Level 1.3mg/m2||3
2892243|NCT00372905|3599143|FG002|STARTED|Cohort 2: Dose Level 1.3mg/m2||0
2892244|NCT00372905|3599144|FG003|STARTED|Cohort 2: Dose Level 1.3mg/m2||0
2892245|NCT00372905|3599141|FG000|Registered to Study|Cohort 2: Dose Level 1.3mg/m2||0
2892246|NCT00372905|3599142|FG001|Registered to Study|Cohort 2: Dose Level 1.3mg/m2||3
2892247|NCT00372905|3599143|FG002|Registered to Study|Cohort 2: Dose Level 1.3mg/m2||0
2892248|NCT00372905|3599144|FG003|Registered to Study|Cohort 2: Dose Level 1.3mg/m2||0
2892249|NCT00372905|3599141|FG000|Treated 1 Cycle of Induction Therapy|Cohort 2: Dose Level 1.3mg/m2||0
2892250|NCT00372905|3599142|FG001|Treated 1 Cycle of Induction Therapy|Cohort 2: Dose Level 1.3mg/m2||3
2892251|NCT00372905|3599143|FG002|Treated 1 Cycle of Induction Therapy|Cohort 2: Dose Level 1.3mg/m2||0
2892252|NCT00372905|3599144|FG003|Treated 1 Cycle of Induction Therapy|Cohort 2: Dose Level 1.3mg/m2||0
2892253|NCT00372905|3599141|FG000|Completed 3 Cycles of Consolidation|Cohort 2: Dose Level 1.3mg/m2||0
2892254|NCT00372905|3599142|FG001|Completed 3 Cycles of Consolidation|Cohort 2: Dose Level 1.3mg/m2||3
2892255|NCT00372905|3599143|FG002|Completed 3 Cycles of Consolidation|Cohort 2: Dose Level 1.3mg/m2||0
2892256|NCT00372905|3599144|FG003|Completed 3 Cycles of Consolidation|Cohort 2: Dose Level 1.3mg/m2||0
2892257|NCT00372905|3599141|FG000|COMPLETED|Cohort 2: Dose Level 1.3mg/m2||0
2892258|NCT00372905|3599142|FG001|COMPLETED|Cohort 2: Dose Level 1.3mg/m2||3
2892259|NCT00372905|3599143|FG002|COMPLETED|Cohort 2: Dose Level 1.3mg/m2||0
2892260|NCT00372905|3599144|FG003|COMPLETED|Cohort 2: Dose Level 1.3mg/m2||0
2892261|NCT00372905|3599141|FG000|NOT COMPLETED|Cohort 2: Dose Level 1.3mg/m2||0
2892262|NCT00372905|3599142|FG001|NOT COMPLETED|Cohort 2: Dose Level 1.3mg/m2||0
2892263|NCT00372905|3599143|FG002|NOT COMPLETED|Cohort 2: Dose Level 1.3mg/m2||0
2892264|NCT00372905|3599144|FG003|NOT COMPLETED|Cohort 2: Dose Level 1.3mg/m2||0
2892265|NCT00372905|3599141|FG000|STARTED|Cohort 3: Dose Level 1.6mg/m2||0
2892266|NCT00372905|3599142|FG001|STARTED|Cohort 3: Dose Level 1.6mg/m2||0
2892267|NCT00372905|3599143|FG002|STARTED|Cohort 3: Dose Level 1.6mg/m2||4
2892268|NCT00372905|3599144|FG003|STARTED|Cohort 3: Dose Level 1.6mg/m2||0
2892269|NCT00372905|3599141|FG000|Registered|Cohort 3: Dose Level 1.6mg/m2||0
2892270|NCT00372905|3599142|FG001|Registered|Cohort 3: Dose Level 1.6mg/m2||0
2892271|NCT00372905|3599143|FG002|Registered|Cohort 3: Dose Level 1.6mg/m2||4
2892272|NCT00372905|3599144|FG003|Registered|Cohort 3: Dose Level 1.6mg/m2||0
2892273|NCT00372905|3599141|FG000|Treated 1 Cycle of Induction Therapy|Cohort 3: Dose Level 1.6mg/m2||0
2892274|NCT00372905|3599142|FG001|Treated 1 Cycle of Induction Therapy|Cohort 3: Dose Level 1.6mg/m2||0
2892275|NCT00372905|3599143|FG002|Treated 1 Cycle of Induction Therapy|Cohort 3: Dose Level 1.6mg/m2||3
2892276|NCT00372905|3599144|FG003|Treated 1 Cycle of Induction Therapy|Cohort 3: Dose Level 1.6mg/m2||0
2892277|NCT00372905|3599141|FG000|Completed 3 Cycles of Consolidation|Cohort 3: Dose Level 1.6mg/m2||0
2892278|NCT00372905|3599142|FG001|Completed 3 Cycles of Consolidation|Cohort 3: Dose Level 1.6mg/m2||0
2892279|NCT00372905|3599143|FG002|Completed 3 Cycles of Consolidation|Cohort 3: Dose Level 1.6mg/m2||1
2892280|NCT00372905|3599144|FG003|Completed 3 Cycles of Consolidation|Cohort 3: Dose Level 1.6mg/m2||0
2892281|NCT00372905|3599141|FG000|COMPLETED|Cohort 3: Dose Level 1.6mg/m2||0
2892282|NCT00372905|3599142|FG001|COMPLETED|Cohort 3: Dose Level 1.6mg/m2||0
2892283|NCT00372905|3599143|FG002|COMPLETED|Cohort 3: Dose Level 1.6mg/m2||1
2892284|NCT00372905|3599144|FG003|COMPLETED|Cohort 3: Dose Level 1.6mg/m2||0
2892285|NCT00372905|3599141|FG000|NOT COMPLETED|Cohort 3: Dose Level 1.6mg/m2||0
2892286|NCT00372905|3599142|FG001|NOT COMPLETED|Cohort 3: Dose Level 1.6mg/m2||0
2892287|NCT00372905|3599143|FG002|NOT COMPLETED|Cohort 3: Dose Level 1.6mg/m2||3
2892288|NCT00372905|3599144|FG003|NOT COMPLETED|Cohort 3: Dose Level 1.6mg/m2||0
2892289|NCT00372905|3599141|FG000|STARTED|Expansion Phase at Dose 1.3mg/m2||0
2892290|NCT00372905|3599142|FG001|STARTED|Expansion Phase at Dose 1.3mg/m2||0
2892291|NCT00372905|3599143|FG002|STARTED|Expansion Phase at Dose 1.3mg/m2||0
2892292|NCT00372905|3599144|FG003|STARTED|Expansion Phase at Dose 1.3mg/m2||8
2892293|NCT00372905|3599141|FG000|Registration|Expansion Phase at Dose 1.3mg/m2||0
2892294|NCT00372905|3599142|FG001|Registration|Expansion Phase at Dose 1.3mg/m2||0
2892295|NCT00372905|3599143|FG002|Registration|Expansion Phase at Dose 1.3mg/m2||0
2892296|NCT00372905|3599144|FG003|Registration|Expansion Phase at Dose 1.3mg/m2||8
2892297|NCT00372905|3599141|FG000|Treated 1 Cycle Induction Therapy|Expansion Phase at Dose 1.3mg/m2||0
2892298|NCT00372905|3599142|FG001|Treated 1 Cycle Induction Therapy|Expansion Phase at Dose 1.3mg/m2||0
2892299|NCT00372905|3599143|FG002|Treated 1 Cycle Induction Therapy|Expansion Phase at Dose 1.3mg/m2||0
2892300|NCT00372905|3599144|FG003|Treated 1 Cycle Induction Therapy|Expansion Phase at Dose 1.3mg/m2||8
2892301|NCT00372905|3599141|FG000|Completed 3 Cycles of Consolidation|Expansion Phase at Dose 1.3mg/m2||0
2892302|NCT00372905|3599142|FG001|Completed 3 Cycles of Consolidation|Expansion Phase at Dose 1.3mg/m2||0
2892303|NCT00372905|3599143|FG002|Completed 3 Cycles of Consolidation|Expansion Phase at Dose 1.3mg/m2||0
2892304|NCT00372905|3599144|FG003|Completed 3 Cycles of Consolidation|Expansion Phase at Dose 1.3mg/m2||6
2892305|NCT00372905|3599141|FG000|COMPLETED|Expansion Phase at Dose 1.3mg/m2||0
2892306|NCT00372905|3599142|FG001|COMPLETED|Expansion Phase at Dose 1.3mg/m2||0
2892307|NCT00372905|3599143|FG002|COMPLETED|Expansion Phase at Dose 1.3mg/m2||0
2892308|NCT00372905|3599144|FG003|COMPLETED|Expansion Phase at Dose 1.3mg/m2||6
2892309|NCT00372905|3599141|FG000|NOT COMPLETED|Expansion Phase at Dose 1.3mg/m2||0
2892310|NCT00372905|3599142|FG001|NOT COMPLETED|Expansion Phase at Dose 1.3mg/m2||0
2892311|NCT00372905|3599143|FG002|NOT COMPLETED|Expansion Phase at Dose 1.3mg/m2||0
2892312|NCT00372905|3599144|FG003|NOT COMPLETED|Expansion Phase at Dose 1.3mg/m2||2
2892313|NCT00372905|3599141|FG000|STARTED|Follow up Until Relapse or Progression|All patients that are treated on study move into the follow up phase at the completion of therapy.|3
2892314|NCT00372905|3599142|FG001|STARTED|Follow up Until Relapse or Progression||3
2892315|NCT00372905|3599143|FG002|STARTED|Follow up Until Relapse or Progression||3
2892316|NCT00372905|3599144|FG003|STARTED|Follow up Until Relapse or Progression||8
2892317|NCT00372905|3599141|FG000|COMPLETED|Follow up Until Relapse or Progression||3
2892318|NCT00372905|3599142|FG001|COMPLETED|Follow up Until Relapse or Progression||2
2892319|NCT00372905|3599143|FG002|COMPLETED|Follow up Until Relapse or Progression||3
2892320|NCT00372905|3599144|FG003|COMPLETED|Follow up Until Relapse or Progression||5
2892321|NCT00372905|3599141|FG000|NOT COMPLETED|Follow up Until Relapse or Progression||0
2892322|NCT00372905|3599142|FG001|NOT COMPLETED|Follow up Until Relapse or Progression||1
2892323|NCT00372905|3599143|FG002|NOT COMPLETED|Follow up Until Relapse or Progression||0
2892324|NCT00372905|3599144|FG003|NOT COMPLETED|Follow up Until Relapse or Progression||3
2892325|NCT00372957|3599157|FG000|STARTED|Overall Study||10
2892326|NCT00372957|3599158|FG001|STARTED|Overall Study||10
2892327|NCT00372957|3599159|FG002|STARTED|Overall Study||10
2892328|NCT00372957|3599157|FG000|COMPLETED|Overall Study||10
2892329|NCT00372957|3599158|FG001|COMPLETED|Overall Study||10
2892330|NCT00372957|3599159|FG002|COMPLETED|Overall Study||10
2892331|NCT00372957|3599157|FG000|NOT COMPLETED|Overall Study||0
2892332|NCT00372957|3599158|FG001|NOT COMPLETED|Overall Study||0
2892333|NCT00372957|3599159|FG002|NOT COMPLETED|Overall Study||0
2892334|NCT00372970|3599171|FG000|STARTED|Overall Study||16
2892335|NCT00372970|3599172|FG001|STARTED|Overall Study||16
2892336|NCT00372970|3599171|FG000|COMPLETED|Overall Study||16
2892337|NCT00372970|3599172|FG001|COMPLETED|Overall Study||16
2892338|NCT00372970|3599171|FG000|NOT COMPLETED|Overall Study||0
2892339|NCT00372970|3599172|FG001|NOT COMPLETED|Overall Study||0
2892340|NCT00372996|3599180|FG000|STARTED|Overall Study||79
2892341|NCT00372996|3599181|FG001|STARTED|Overall Study||36
2892342|NCT00372996|3599182|FG002|STARTED|Overall Study||61
2892343|NCT00372996|3599183|FG003|STARTED|Overall Study||43
2892344|NCT00372996|3599180|FG000|COMPLETED|Overall Study||42
2892345|NCT00372996|3599181|FG001|COMPLETED|Overall Study||22
2892346|NCT00372996|3599182|FG002|COMPLETED|Overall Study||33
2892347|NCT00372996|3599183|FG003|COMPLETED|Overall Study||23
2892348|NCT00372996|3599180|FG000|NOT COMPLETED|Overall Study||37
2892349|NCT00372996|3599181|FG001|NOT COMPLETED|Overall Study||14
2892350|NCT00372996|3599182|FG002|NOT COMPLETED|Overall Study||28
2892351|NCT00372996|3599183|FG003|NOT COMPLETED|Overall Study||20
2892352|NCT00373113|3599195|FG000|STARTED|Overall Study||238
2892353|NCT00373113|3599196|FG001|STARTED|Overall Study||244
2892354|NCT00373113|3599195|FG000|Received Treatment|Overall Study||238
2892355|NCT00373113|3599196|FG001|Received Treatment|Overall Study||240
2892356|NCT00373113|3599195|FG000|COMPLETED|Overall Study||0
2892357|NCT00373113|3599196|FG001|COMPLETED|Overall Study||0
2892358|NCT00373113|3599195|FG000|NOT COMPLETED|Overall Study||238
2892359|NCT00373113|3599196|FG001|NOT COMPLETED|Overall Study||244
2892360|NCT00373256|3599204|FG000|STARTED|Overall Study||241
2892361|NCT00373256|3599205|FG001|STARTED|Overall Study||247
2892362|NCT00373256|3599204|FG000|Treated|Overall Study||235
2892363|NCT00373256|3599205|FG001|Treated|Overall Study||236
2892364|NCT00373256|3599204|FG000|COMPLETED|Overall Study||0
2892365|NCT00373256|3599205|FG001|COMPLETED|Overall Study||0
2892366|NCT00373256|3599204|FG000|NOT COMPLETED|Overall Study||241
2892367|NCT00373256|3599205|FG001|NOT COMPLETED|Overall Study||247
2892368|NCT00373269|3599213|FG000|STARTED|Overall Study||11
2892369|NCT00373269|3599214|FG001|STARTED|Overall Study||10
2892370|NCT00373269|3599213|FG000|COMPLETED|Overall Study||11
2892371|NCT00373269|3599214|FG001|COMPLETED|Overall Study||10
2892372|NCT00373269|3599213|FG000|NOT COMPLETED|Overall Study||0
2892373|NCT00373269|3599214|FG001|NOT COMPLETED|Overall Study||0
2892374|NCT00373295|3599220|FG000|STARTED|Intervention 1 (8 Days)||2
2892375|NCT00373295|3599221|FG001|STARTED|Intervention 1 (8 Days)||3
2892376|NCT00373295|3599222|FG002|STARTED|Intervention 1 (8 Days)||1
2892377|NCT00373295|3599223|FG003|STARTED|Intervention 1 (8 Days)||2
2892378|NCT00373295|3599224|FG004|STARTED|Intervention 1 (8 Days)||3
2892379|NCT00373295|3599225|FG005|STARTED|Intervention 1 (8 Days)||2
2892380|NCT00373295|3599220|FG000|COMPLETED|Intervention 1 (8 Days)||2
2892381|NCT00373295|3599221|FG001|COMPLETED|Intervention 1 (8 Days)||1
2892382|NCT00373295|3599222|FG002|COMPLETED|Intervention 1 (8 Days)||1
2892383|NCT00373295|3599223|FG003|COMPLETED|Intervention 1 (8 Days)||2
2892384|NCT00373295|3599224|FG004|COMPLETED|Intervention 1 (8 Days)||2
2892385|NCT00373295|3599225|FG005|COMPLETED|Intervention 1 (8 Days)||2
2892386|NCT00373295|3599220|FG000|NOT COMPLETED|Intervention 1 (8 Days)||0
2892387|NCT00373295|3599221|FG001|NOT COMPLETED|Intervention 1 (8 Days)||2
2892388|NCT00373295|3599222|FG002|NOT COMPLETED|Intervention 1 (8 Days)||0
2892389|NCT00373295|3599223|FG003|NOT COMPLETED|Intervention 1 (8 Days)||0
2892390|NCT00373295|3599224|FG004|NOT COMPLETED|Intervention 1 (8 Days)||1
2892391|NCT00373295|3599225|FG005|NOT COMPLETED|Intervention 1 (8 Days)||0
2892392|NCT00373295|3599220|FG000|STARTED|Intervention 2 (8 Days)||2
2892393|NCT00373295|3599221|FG001|STARTED|Intervention 2 (8 Days)||1
2892394|NCT00373295|3599222|FG002|STARTED|Intervention 2 (8 Days)||1
2892395|NCT00373295|3599223|FG003|STARTED|Intervention 2 (8 Days)||2
2892396|NCT00373295|3599224|FG004|STARTED|Intervention 2 (8 Days)||2
2892397|NCT00373295|3599225|FG005|STARTED|Intervention 2 (8 Days)||2
2892398|NCT00373295|3599220|FG000|COMPLETED|Intervention 2 (8 Days)||2
2892399|NCT00373295|3599221|FG001|COMPLETED|Intervention 2 (8 Days)||1
2892400|NCT00373295|3599222|FG002|COMPLETED|Intervention 2 (8 Days)||1
2892401|NCT00373295|3599223|FG003|COMPLETED|Intervention 2 (8 Days)||2
2892402|NCT00373295|3599224|FG004|COMPLETED|Intervention 2 (8 Days)||2
2892403|NCT00373295|3599225|FG005|COMPLETED|Intervention 2 (8 Days)||2
2892404|NCT00373295|3599220|FG000|NOT COMPLETED|Intervention 2 (8 Days)||0
2892405|NCT00373295|3599221|FG001|NOT COMPLETED|Intervention 2 (8 Days)||0
2892406|NCT00373295|3599222|FG002|NOT COMPLETED|Intervention 2 (8 Days)||0
2892407|NCT00373295|3599223|FG003|NOT COMPLETED|Intervention 2 (8 Days)||0
2892408|NCT00373295|3599224|FG004|NOT COMPLETED|Intervention 2 (8 Days)||0
2892409|NCT00373295|3599225|FG005|NOT COMPLETED|Intervention 2 (8 Days)||0
2892410|NCT00373295|3599220|FG000|STARTED|Intervention 3 (8 Days)||2
2892411|NCT00373295|3599221|FG001|STARTED|Intervention 3 (8 Days)||1
2892412|NCT00373295|3599222|FG002|STARTED|Intervention 3 (8 Days)||1
2892413|NCT00373295|3599223|FG003|STARTED|Intervention 3 (8 Days)||2
2892414|NCT00373295|3599224|FG004|STARTED|Intervention 3 (8 Days)||2
2892415|NCT00373295|3599225|FG005|STARTED|Intervention 3 (8 Days)||2
2892416|NCT00373295|3599220|FG000|COMPLETED|Intervention 3 (8 Days)||2
2892417|NCT00373295|3599221|FG001|COMPLETED|Intervention 3 (8 Days)||1
2892418|NCT00373295|3599222|FG002|COMPLETED|Intervention 3 (8 Days)||1
2892419|NCT00373295|3599223|FG003|COMPLETED|Intervention 3 (8 Days)||2
2892420|NCT00373295|3599224|FG004|COMPLETED|Intervention 3 (8 Days)||2
2892421|NCT00373295|3599225|FG005|COMPLETED|Intervention 3 (8 Days)||2
2892422|NCT00373295|3599220|FG000|NOT COMPLETED|Intervention 3 (8 Days)||0
2892423|NCT00373295|3599221|FG001|NOT COMPLETED|Intervention 3 (8 Days)||0
2892424|NCT00373295|3599222|FG002|NOT COMPLETED|Intervention 3 (8 Days)||0
2892425|NCT00373295|3599223|FG003|NOT COMPLETED|Intervention 3 (8 Days)||0
2892426|NCT00373295|3599224|FG004|NOT COMPLETED|Intervention 3 (8 Days)||0
2892427|NCT00373295|3599225|FG005|NOT COMPLETED|Intervention 3 (8 Days)||0
2892428|NCT00373334|3599236|FG000|STARTED|Overall Study||43
2892429|NCT00373334|3599237|FG001|STARTED|Overall Study||50
2892430|NCT00373334|3599238|FG002|STARTED|Overall Study||45
2892431|NCT00373334|3599236|FG000|COMPLETED|Overall Study||33
2892432|NCT00373334|3599237|FG001|COMPLETED|Overall Study||32
2892433|NCT00373334|3599238|FG002|COMPLETED|Overall Study||32
2892434|NCT00373334|3599236|FG000|NOT COMPLETED|Overall Study||10
2892435|NCT00373334|3599237|FG001|NOT COMPLETED|Overall Study||18
2892436|NCT00373334|3599238|FG002|NOT COMPLETED|Overall Study||13
2892437|NCT00373360|3599246|FG000|STARTED|Overall Study||10
2892438|NCT00373360|3599246|FG000|COMPLETED|Overall Study||10
2892439|NCT00373360|3599246|FG000|NOT COMPLETED|Overall Study||0
2892440|NCT00373386|3599250|FG000|STARTED|Overall Study||9
2892441|NCT00373386|3599250|FG000|COMPLETED|Overall Study||9
2892442|NCT00373386|3599250|FG000|NOT COMPLETED|Overall Study||0
2892443|NCT00373399|3599256|FG000|STARTED|Overall Study||5
2892444|NCT00373399|3599257|FG001|STARTED|Overall Study||7
2892445|NCT00373399|3599258|FG002|STARTED|Overall Study||4
2892446|NCT00373399|3599259|FG003|STARTED|Overall Study||6
2892447|NCT00373399|3599260|FG004|STARTED|Overall Study||7
2892448|NCT00373399|3599261|FG005|STARTED|Overall Study||7
2892449|NCT00373399|3599256|FG000|COMPLETED|Overall Study||5
2892450|NCT00373399|3599257|FG001|COMPLETED|Overall Study||7
2892451|NCT00373399|3599258|FG002|COMPLETED|Overall Study||4
2892452|NCT00373399|3599259|FG003|COMPLETED|Overall Study||6
2892453|NCT00373399|3599260|FG004|COMPLETED|Overall Study||7
2892454|NCT00373399|3599261|FG005|COMPLETED|Overall Study||7
2892455|NCT00373399|3599256|FG000|NOT COMPLETED|Overall Study||0
2892456|NCT00373399|3599257|FG001|NOT COMPLETED|Overall Study||0
2892457|NCT00373399|3599258|FG002|NOT COMPLETED|Overall Study||0
2892458|NCT00373399|3599259|FG003|NOT COMPLETED|Overall Study||0
2892459|NCT00373399|3599260|FG004|NOT COMPLETED|Overall Study||0
2892460|NCT00373399|3599261|FG005|NOT COMPLETED|Overall Study||0
2892461|NCT00373425|3599274|FG000|STARTED|Overall Study||623
2892462|NCT00373425|3599275|FG001|STARTED|Overall Study||350
2892463|NCT00373425|3599276|FG002|STARTED|Overall Study||134
2892464|NCT00373425|3599277|FG003|STARTED|Overall Study||11
2892465|NCT00373425|3599278|FG004|STARTED|Overall Study||132
2892466|NCT00373425|3599274|FG000|Received Treatment|Overall Study||612
2892467|NCT00373425|3599275|FG001|Received Treatment|Overall Study||342
2892468|NCT00373425|3599276|FG002|Received Treatment|Overall Study||134
2892469|NCT00373425|3599277|FG003|Received Treatment|Overall Study||7
2892470|NCT00373425|3599278|FG004|Received Treatment|Overall Study||132
2892471|NCT00373425|3599274|FG000|COMPLETED|Overall Study|Completed 2 years of study treatment|253
2892472|NCT00373425|3599275|FG001|COMPLETED|Overall Study|Completed 2 years of study treatment|197
2892473|NCT00373425|3599276|FG002|COMPLETED|Overall Study|Completed 2 years of study treatment|0
2892474|NCT00373425|3599277|FG003|COMPLETED|Overall Study|Completed 2 years of study treatment|0
2892475|NCT00373425|3599278|FG004|COMPLETED|Overall Study|Completed 2 years of study treatment|60
2892476|NCT00373425|3599274|FG000|NOT COMPLETED|Overall Study||370
2892477|NCT00373425|3599275|FG001|NOT COMPLETED|Overall Study||153
2892478|NCT00373425|3599276|FG002|NOT COMPLETED|Overall Study||134
2892479|NCT00373425|3599277|FG003|NOT COMPLETED|Overall Study||11
2892480|NCT00373425|3599278|FG004|NOT COMPLETED|Overall Study||72
2892481|NCT00373490|3599289|FG000|STARTED|Overall Study||10
2892482|NCT00373490|3599290|FG001|STARTED|Overall Study||6
2892483|NCT00373490|3599289|FG000|COMPLETED|Overall Study||1
2892484|NCT00373490|3599290|FG001|COMPLETED|Overall Study||0
2892485|NCT00373490|3599289|FG000|NOT COMPLETED|Overall Study||9
3170534|NCT01929863|3897884|FG000|STARTED|Period 2:Washout Period (13-15 Days)||6
3170535|NCT01929863|3897885|FG001|STARTED|Period 2:Washout Period (13-15 Days)||7
3170536|NCT01929863|3897884|FG000|COMPLETED|Period 2:Washout Period (13-15 Days)||6
3170537|NCT01929863|3897885|FG001|COMPLETED|Period 2:Washout Period (13-15 Days)||7
3170538|NCT01929863|3897884|FG000|NOT COMPLETED|Period 2:Washout Period (13-15 Days)||0
2892486|NCT00373490|3599290|FG001|NOT COMPLETED|Overall Study||6
2892487|NCT00373529|3599296|FG000|STARTED|Overall Study||116
2892488|NCT00373529|3599296|FG000|Full Analysis Set|Overall Study|3 Failed Independent Confirmation of AML; 1 consent violation|112
2892489|NCT00373529|3599296|FG000|COMPLETED|Overall Study|Completed: initiated full 6 cycles of treatment. Not Completed: initiated <6 cycles of treatment|8
2892490|NCT00373529|3599296|FG000|NOT COMPLETED|Overall Study||108
2919779|NCT00534092|3630189|FG001|NOT COMPLETED|Overall Study||0
2919780|NCT00534105|3630199|FG000|STARTED|Overall Study||47
2919781|NCT00534105|3630200|FG001|STARTED|Overall Study||59
2919782|NCT00534105|3630199|FG000|COMPLETED|Overall Study||24
2919783|NCT00534105|3630200|FG001|COMPLETED|Overall Study||20
2919784|NCT00534105|3630199|FG000|NOT COMPLETED|Overall Study||23
2919785|NCT00534105|3630200|FG001|NOT COMPLETED|Overall Study||39
2919786|NCT00534118|3630208|FG000|STARTED|Overall Study||17
2919787|NCT00534118|3630209|FG001|STARTED|Overall Study||22
2919788|NCT00534118|3630208|FG000|COMPLETED|Overall Study||17
2919789|NCT00534118|3630209|FG001|COMPLETED|Overall Study||22
2919790|NCT00534118|3630208|FG000|NOT COMPLETED|Overall Study||0
2919791|NCT00534118|3630209|FG001|NOT COMPLETED|Overall Study||0
2919792|NCT00534209|3630217|FG000|STARTED|Overall Study||1
2919793|NCT00534209|3630217|FG000|COMPLETED|Overall Study||1
2919794|NCT00534209|3630217|FG000|NOT COMPLETED|Overall Study||0
2919795|NCT00534235|3630225|FG000|STARTED|Overall Study||107
2919796|NCT00534235|3630226|FG001|STARTED|Overall Study||215
2919797|NCT00534235|3630225|FG000|COMPLETED|Overall Study||91
2919798|NCT00534235|3630226|FG001|COMPLETED|Overall Study||192
2919799|NCT00534235|3630225|FG000|NOT COMPLETED|Overall Study||16
2919800|NCT00534235|3630226|FG001|NOT COMPLETED|Overall Study||23
2919801|NCT00534248|3630235|FG000|STARTED|Overall Study||11211
2919802|NCT00534248|3630236|FG001|STARTED|Overall Study||11228
2919803|NCT00534248|3630235|FG000|VACCINATED|Overall Study||11186
2919804|NCT00534248|3630236|FG001|VACCINATED|Overall Study||11210
2919805|NCT00534248|3630235|FG000|COMPLETED|Overall Study||10550
2919806|NCT00534248|3630236|FG001|COMPLETED|Overall Study||10555
2919807|NCT00534248|3630235|FG000|NOT COMPLETED|Overall Study||661
2919808|NCT00534248|3630236|FG001|NOT COMPLETED|Overall Study||673
2919809|NCT00534313|3630246|FG000|STARTED|Short-term Period||43
2919810|NCT00534313|3630247|FG001|STARTED|Short-term Period||40
2919811|NCT00534313|3630248|FG002|STARTED|Short-term Period||45
2919812|NCT00534313|3630249|FG003|STARTED|Short-term Period||42
2919813|NCT00534313|3630246|FG000|COMPLETED|Short-term Period|Completed the short-term study|37
2919814|NCT00534313|3630247|FG001|COMPLETED|Short-term Period|Completed the short-term study|34
2919815|NCT00534313|3630248|FG002|COMPLETED|Short-term Period|Completed the short-term study|43
2919816|NCT00534313|3630249|FG003|COMPLETED|Short-term Period|Completed the short-term study|33
2919817|NCT00534313|3630246|FG000|NOT COMPLETED|Short-term Period||6
2919818|NCT00534313|3630247|FG001|NOT COMPLETED|Short-term Period||6
2919819|NCT00534313|3630248|FG002|NOT COMPLETED|Short-term Period||2
2892491|NCT00373685|3599302|FG000|STARTED|Overall Study||4035
2892492|NCT00373685|3599303|FG001|STARTED|Overall Study||4032
2892493|NCT00373685|3599302|FG000|Treated|Overall Study||3984
2892494|NCT00373685|3599303|FG001|Treated|Overall Study||3955
2892495|NCT00373685|3599302|FG000|COMPLETED|Overall Study||2596
2892496|NCT00373685|3599303|FG001|COMPLETED|Overall Study||2611
2892497|NCT00373685|3599302|FG000|NOT COMPLETED|Overall Study||1439
2892498|NCT00373685|3599303|FG001|NOT COMPLETED|Overall Study||1421
2892499|NCT00373698|3599311|FG000|STARTED|Overall Study||96
2892500|NCT00373698|3599312|FG001|STARTED|Overall Study||99
2892501|NCT00373698|3599311|FG000|COMPLETED|Overall Study||85
2892502|NCT00373698|3599312|FG001|COMPLETED|Overall Study||99
2892503|NCT00373698|3599311|FG000|NOT COMPLETED|Overall Study||11
2892504|NCT00373698|3599312|FG001|NOT COMPLETED|Overall Study||0
2892505|NCT00373880|3599320|FG000|STARTED|Overall Study||26
2892506|NCT00373880|3599320|FG000|COMPLETED|Overall Study||8
2892507|NCT00373880|3599320|FG000|NOT COMPLETED|Overall Study||18
2892508|NCT00373958|3599334|FG000|STARTED|Infant Series|One participant was prerandomized but not consented.|334
2892509|NCT00373958|3599335|FG001|STARTED|Infant Series||332
2892510|NCT00373958|3599334|FG000|Vaccinated Dose 1|Infant Series||332
2892511|NCT00373958|3599335|FG001|Vaccinated Dose 1|Infant Series||331
2892512|NCT00373958|3599334|FG000|Vaccinated Dose 2|Infant Series||309
2892513|NCT00373958|3599335|FG001|Vaccinated Dose 2|Infant Series||305
2892514|NCT00373958|3599334|FG000|Vaccinated Dose 3|Infant Series||298
2892515|NCT00373958|3599335|FG001|Vaccinated Dose 3|Infant Series||300
2892516|NCT00373958|3599334|FG000|COMPLETED|Infant Series||294
2892517|NCT00373958|3599335|FG001|COMPLETED|Infant Series||290
2892518|NCT00373958|3599334|FG000|NOT COMPLETED|Infant Series||40
2892519|NCT00373958|3599335|FG001|NOT COMPLETED|Infant Series||42
2892520|NCT00373958|3599334|FG000|STARTED|Toddler Dose||294
2892521|NCT00373958|3599335|FG001|STARTED|Toddler Dose||290
2892522|NCT00373958|3599334|FG000|Withdrawn After Infant Series|Toddler Dose||22
2892523|NCT00373958|3599335|FG001|Withdrawn After Infant Series|Toddler Dose||25
2892524|NCT00373958|3599334|FG000|Vaccinated Toddler Dose|Toddler Dose||272
2892525|NCT00373958|3599335|FG001|Vaccinated Toddler Dose|Toddler Dose||265
2892526|NCT00373958|3599334|FG000|COMPLETED|Toddler Dose||264
2892527|NCT00373958|3599335|FG001|COMPLETED|Toddler Dose||252
2892528|NCT00373958|3599334|FG000|NOT COMPLETED|Toddler Dose||30
2892529|NCT00373958|3599335|FG001|NOT COMPLETED|Toddler Dose||38
2892530|NCT00374088|3599366|FG000|STARTED|Overall Study||10
2892531|NCT00374088|3599367|FG001|STARTED|Overall Study||11
2892532|NCT00374088|3599366|FG000|COMPLETED|Overall Study||9
2892533|NCT00374088|3599367|FG001|COMPLETED|Overall Study||10
2892534|NCT00374088|3599366|FG000|NOT COMPLETED|Overall Study||1
2892535|NCT00374088|3599367|FG001|NOT COMPLETED|Overall Study||1
2892536|NCT00374127|3599373|FG000|STARTED|Overall Study||35
2892537|NCT00374127|3599373|FG000|COMPLETED|Overall Study||24
2892538|NCT00374127|3599373|FG000|NOT COMPLETED|Overall Study||11
2892539|NCT00374140|3599383|FG000|STARTED|Overall Study||40
2892540|NCT00374140|3599383|FG000|COMPLETED|Overall Study||38
2892541|NCT00374140|3599383|FG000|NOT COMPLETED|Overall Study||2
2892542|NCT00374231|3599387|FG000|STARTED|Overall Study||40
2892543|NCT00374231|3599387|FG000|COMPLETED|Overall Study||40
2892544|NCT00374231|3599387|FG000|NOT COMPLETED|Overall Study||0
2892545|NCT00374244|3599394|FG000|STARTED|Overall Study||14
2892546|NCT00374244|3599395|FG001|STARTED|Overall Study||14
2892547|NCT00374244|3599394|FG000|COMPLETED|Overall Study||14
2892548|NCT00374244|3599395|FG001|COMPLETED|Overall Study||14
2892549|NCT00374244|3599394|FG000|NOT COMPLETED|Overall Study||0
2892550|NCT00374244|3599395|FG001|NOT COMPLETED|Overall Study||0
2892551|NCT00374322|3599403|FG000|STARTED|Overall Study||1579
2892552|NCT00374322|3599404|FG001|STARTED|Overall Study||1582
2892553|NCT00374322|3599403|FG000|Received >=1 Dose of Study Treatment|Overall Study||1571
2892554|NCT00374322|3599404|FG001|Received >=1 Dose of Study Treatment|Overall Study||1576
2892555|NCT00374322|3599403|FG000|COMPLETED|Overall Study||322
2892556|NCT00374322|3599404|FG001|COMPLETED|Overall Study||278
2892557|NCT00374322|3599403|FG000|NOT COMPLETED|Overall Study||1257
2892558|NCT00374322|3599404|FG001|NOT COMPLETED|Overall Study||1304
2892559|NCT00374335|3599411|FG000|STARTED|Overall Study||261
2892560|NCT00374335|3599411|FG000|COMPLETED|Overall Study||261
2892561|NCT00374335|3599411|FG000|NOT COMPLETED|Overall Study||0
2892562|NCT00374452|3599417|FG000|STARTED|Overall Study||34
2892563|NCT00374452|3599418|FG001|STARTED|Overall Study||48
2892564|NCT00374452|3599417|FG000|Intervention Started|Overall Study||30
2892565|NCT00374452|3599418|FG001|Intervention Started|Overall Study||46
2892566|NCT00374452|3599417|FG000|COMPLETED|Overall Study||29
2892567|NCT00374452|3599418|FG001|COMPLETED|Overall Study||43
2892568|NCT00374452|3599417|FG000|NOT COMPLETED|Overall Study||5
2892569|NCT00374452|3599418|FG001|NOT COMPLETED|Overall Study||5
2892570|NCT00374556|3599426|FG000|STARTED|Overall Study||14
2892571|NCT00374556|3599427|FG001|STARTED|Overall Study||16
2892572|NCT00374556|3599426|FG000|COMPLETED|Overall Study||13
2892573|NCT00374556|3599427|FG001|COMPLETED|Overall Study||15
2892574|NCT00374556|3599426|FG000|NOT COMPLETED|Overall Study||1
2892575|NCT00374556|3599427|FG001|NOT COMPLETED|Overall Study||1
2892576|NCT00374803|3599435|FG000|STARTED|Overall Study||22
2892577|NCT00374803|3599436|FG001|STARTED|Overall Study||23
2892578|NCT00374803|3599435|FG000|COMPLETED|Overall Study||22
2892579|NCT00374803|3599436|FG001|COMPLETED|Overall Study||23
2892580|NCT00374803|3599435|FG000|NOT COMPLETED|Overall Study||0
2892581|NCT00374803|3599436|FG001|NOT COMPLETED|Overall Study||0
2892582|NCT00374842|3599447|FG000|STARTED|Overall Study||100
2892583|NCT00374842|3599448|FG001|STARTED|Overall Study||100
2892584|NCT00374842|3599449|FG002|STARTED|Overall Study||100
2892585|NCT00374842|3599447|FG000|COMPLETED|Overall Study||100
2892586|NCT00374842|3599448|FG001|COMPLETED|Overall Study||100
2892587|NCT00374842|3599449|FG002|COMPLETED|Overall Study||100
2892588|NCT00374842|3599447|FG000|NOT COMPLETED|Overall Study||0
2892589|NCT00374842|3599448|FG001|NOT COMPLETED|Overall Study||0
2892590|NCT00374842|3599449|FG002|NOT COMPLETED|Overall Study||0
2892591|NCT00374868|3599459|FG000|STARTED|Overall Study||38
2892592|NCT00374868|3599459|FG000|COMPLETED|Overall Study||2
2892593|NCT00374868|3599459|FG000|NOT COMPLETED|Overall Study||36
2892594|NCT00374907|3599465|FG000|STARTED|12-Week Short-term Period||20
2892595|NCT00374907|3599466|FG001|STARTED|12-Week Short-term Period||16
2892596|NCT00374907|3599465|FG000|COMPLETED|12-Week Short-term Period||17
2892597|NCT00374907|3599466|FG001|COMPLETED|12-Week Short-term Period||15
2892598|NCT00374907|3599465|FG000|NOT COMPLETED|12-Week Short-term Period||3
2892599|NCT00374907|3599466|FG001|NOT COMPLETED|12-Week Short-term Period||1
2892600|NCT00374907|3599465|FG000|STARTED|116-Week Short-term + Long-term Period||20
2892601|NCT00374907|3599466|FG001|STARTED|116-Week Short-term + Long-term Period||16
2892602|NCT00374907|3599465|FG000|Completed 12-week Short Term Period|116-Week Short-term + Long-term Period||17
2892603|NCT00374907|3599466|FG001|Completed 12-week Short Term Period|116-Week Short-term + Long-term Period||15
2892604|NCT00374907|3599465|FG000|COMPLETED|116-Week Short-term + Long-term Period||7
2892605|NCT00374907|3599466|FG001|COMPLETED|116-Week Short-term + Long-term Period||2
2892606|NCT00374907|3599465|FG000|NOT COMPLETED|116-Week Short-term + Long-term Period||13
2892607|NCT00374907|3599466|FG001|NOT COMPLETED|116-Week Short-term + Long-term Period||14
2892608|NCT00375167|3599476|FG000|STARTED|Overall Study|Clients were already receiving ACT services and this continued after study completion|16
2892609|NCT00375167|3599477|FG001|STARTED|Overall Study|Participants were already clients of ACT and continued receiving services following this period|17
2892610|NCT00375167|3599476|FG000|COMPLETED|Overall Study||16
2892611|NCT00375167|3599477|FG001|COMPLETED|Overall Study||17
2892612|NCT00375167|3599476|FG000|NOT COMPLETED|Overall Study||0
2892613|NCT00375167|3599477|FG001|NOT COMPLETED|Overall Study||0
2892614|NCT00375219|3599488|FG000|STARTED|Overall Study||62
2892615|NCT00375219|3599489|FG001|STARTED|Overall Study||20
2892616|NCT00375219|3599490|FG002|STARTED|Overall Study||21
2892617|NCT00375219|3599488|FG000|COMPLETED|Overall Study||3
2892618|NCT00375219|3599489|FG001|COMPLETED|Overall Study||0
2892619|NCT00375219|3599490|FG002|COMPLETED|Overall Study||0
2892620|NCT00375219|3599488|FG000|NOT COMPLETED|Overall Study||59
2892621|NCT00375219|3599489|FG001|NOT COMPLETED|Overall Study||20
2892622|NCT00375219|3599490|FG002|NOT COMPLETED|Overall Study||21
2892623|NCT00375427|3599499|FG000|STARTED|Overall Study|Total enrollment was 430 but five patients were screened but not treated.|209
2892624|NCT00375427|3599500|FG001|STARTED|Overall Study||216
2892625|NCT00375427|3599499|FG000|COMPLETED|Overall Study||149
2892626|NCT00375427|3599500|FG001|COMPLETED|Overall Study||142
2892627|NCT00375427|3599499|FG000|NOT COMPLETED|Overall Study||60
2892628|NCT00375427|3599500|FG001|NOT COMPLETED|Overall Study||74
2892629|NCT00375492|3599508|FG000|STARTED|Overall Study||96
2892630|NCT00375492|3599509|FG001|STARTED|Overall Study||98
2892631|NCT00375492|3599508|FG000|COMPLETED|Overall Study||70
2892632|NCT00375492|3599509|FG001|COMPLETED|Overall Study||72
2892633|NCT00375492|3599508|FG000|NOT COMPLETED|Overall Study||26
2892634|NCT00375492|3599509|FG001|NOT COMPLETED|Overall Study||26
2892635|NCT00375505|3599517|FG000|STARTED|Overall Study||36
2892636|NCT00375505|3599518|FG001|STARTED|Overall Study||34
2892637|NCT00375505|3599517|FG000|COMPLETED|Overall Study||35
2892638|NCT00375505|3599518|FG001|COMPLETED|Overall Study||32
2892639|NCT00375505|3599517|FG000|NOT COMPLETED|Overall Study||1
2892640|NCT00375505|3599518|FG001|NOT COMPLETED|Overall Study||2
2892641|NCT00375518|3599526|FG000|STARTED|Overall Study||80
2892642|NCT00375518|3599527|FG001|STARTED|Overall Study||82
2892643|NCT00375518|3599526|FG000|COMPLETED|Overall Study||72
2892644|NCT00375518|3599527|FG001|COMPLETED|Overall Study||65
2892645|NCT00375518|3599526|FG000|NOT COMPLETED|Overall Study||8
2892646|NCT00375518|3599527|FG001|NOT COMPLETED|Overall Study||17
2892647|NCT00375609|3599536|FG000|STARTED|Overall Study||88
2892648|NCT00375609|3599537|FG001|STARTED|Overall Study||84
2892649|NCT00375609|3599538|FG002|STARTED|Overall Study||43
2892650|NCT00375609|3599536|FG000|COMPLETED|Overall Study||84
2892651|NCT00375609|3599537|FG001|COMPLETED|Overall Study||77
2892652|NCT00375609|3599538|FG002|COMPLETED|Overall Study||42
2892653|NCT00375609|3599536|FG000|NOT COMPLETED|Overall Study||4
2892654|NCT00375609|3599537|FG001|NOT COMPLETED|Overall Study||7
2892655|NCT00375609|3599538|FG002|NOT COMPLETED|Overall Study||1
2892656|NCT00375674|3599548|FG000|STARTED|Overall Study||309
2892657|NCT00375674|3599549|FG001|STARTED|Overall Study||306
2892658|NCT00375674|3599548|FG000|Intent-to-Treat Population|Overall Study||309
2892659|NCT00375674|3599549|FG001|Intent-to-Treat Population|Overall Study||306
2892660|NCT00375674|3599548|FG000|As-Treated Population|Overall Study|3 were randomized but not treated: 2 refused treatment & 1 withdrew before receiving study drug|306
2892661|NCT00375674|3599549|FG001|As-Treated Population|Overall Study|2 were randomized but not treated: 1 was screening failure & 1 discontinued due to new liver lesions|304
2892662|NCT00375674|3599548|FG000|COMPLETED|Overall Study||165
2892663|NCT00375674|3599549|FG001|COMPLETED|Overall Study||165
2892664|NCT00375674|3599548|FG000|NOT COMPLETED|Overall Study||144
2892665|NCT00375674|3599549|FG001|NOT COMPLETED|Overall Study||141
2892666|NCT00375713|3599557|FG000|STARTED|Overall Study|Randomized population (N=232).|232
2892667|NCT00375713|3599558|FG001|STARTED|Overall Study|Randomized population (N=234).|234
2892668|NCT00375713|3599557|FG000|COMPLETED|Overall Study|20 Patients were not treated or discontinued after randomization in Levocetirizine group.|212
2892669|NCT00375713|3599558|FG001|COMPLETED|Overall Study|23 Patients were not treated or discontinued after randomization in Cetirizine group.|211
2892670|NCT00375713|3599557|FG000|NOT COMPLETED|Overall Study||20
2892671|NCT00375713|3599558|FG001|NOT COMPLETED|Overall Study||23
2892672|NCT00375752|3599566|FG000|STARTED|Overall Study||79
2892673|NCT00375752|3599567|FG001|STARTED|Overall Study||89
2892674|NCT00375752|3599566|FG000|COMPLETED|Overall Study||67
2892675|NCT00375752|3599567|FG001|COMPLETED|Overall Study||74
2892676|NCT00375752|3599566|FG000|NOT COMPLETED|Overall Study||12
2892677|NCT00375752|3599567|FG001|NOT COMPLETED|Overall Study||15
2892678|NCT00375830|3599576|FG000|STARTED|Overall Study||10
2892679|NCT00375830|3599577|FG001|STARTED|Overall Study||30
2892680|NCT00375830|3599578|FG002|STARTED|Overall Study||74
2892681|NCT00375830|3599576|FG000|COMPLETED|Overall Study||10
2892682|NCT00375830|3599577|FG001|COMPLETED|Overall Study||30
2892683|NCT00375830|3599578|FG002|COMPLETED|Overall Study||74
2892684|NCT00375830|3599576|FG000|NOT COMPLETED|Overall Study||0
2892685|NCT00375830|3599577|FG001|NOT COMPLETED|Overall Study||0
2892686|NCT00375830|3599578|FG002|NOT COMPLETED|Overall Study||0
2892687|NCT00375934|3599600|FG000|STARTED|Overall Study||99
2892688|NCT00375934|3599601|FG001|STARTED|Overall Study||101
2892689|NCT00375934|3599600|FG000|COMPLETED|Overall Study||96
2892690|NCT00375934|3599601|FG001|COMPLETED|Overall Study||95
2892691|NCT00375934|3599600|FG000|NOT COMPLETED|Overall Study||3
2892692|NCT00375934|3599601|FG001|NOT COMPLETED|Overall Study||6
2892693|NCT00375973|3599609|FG000|STARTED|Overall Study||30
2892694|NCT00375973|3599610|FG001|STARTED|Overall Study||30
2892695|NCT00375973|3599609|FG000|COMPLETED|Overall Study||20
2892696|NCT00375973|3599610|FG001|COMPLETED|Overall Study||28
2892697|NCT00375973|3599609|FG000|NOT COMPLETED|Overall Study||10
2892698|NCT00375973|3599610|FG001|NOT COMPLETED|Overall Study||2
2892699|NCT00375999|3599616|FG000|STARTED|Overall Study||34
2892700|NCT00375999|3599616|FG000|COMPLETED|Overall Study||32
2892701|NCT00375999|3599616|FG000|NOT COMPLETED|Overall Study||2
2892702|NCT00376168|3599622|FG000|STARTED|Overall Study||16
2892703|NCT00376168|3599623|FG001|STARTED|Overall Study|One patient randomized but not treated|16
2892704|NCT00376168|3599622|FG000|COMPLETED|Overall Study||14
2892705|NCT00376168|3599623|FG001|COMPLETED|Overall Study||15
2892706|NCT00376168|3599622|FG000|NOT COMPLETED|Overall Study||2
2892707|NCT00376168|3599623|FG001|NOT COMPLETED|Overall Study||1
2892708|NCT00376220|3599631|FG000|STARTED|Overall Study||47
2892709|NCT00376220|3599632|FG001|STARTED|Overall Study||47
2892710|NCT00376220|3599631|FG000|COMPLETED|Overall Study||37
2892711|NCT00376220|3599632|FG001|COMPLETED|Overall Study||35
2892712|NCT00376220|3599631|FG000|NOT COMPLETED|Overall Study||10
2892713|NCT00376220|3599632|FG001|NOT COMPLETED|Overall Study||12
2892714|NCT00376246|3599638|FG000|STARTED|First Intervention (2 Weeks)||14
2892715|NCT00376246|3599639|FG001|STARTED|First Intervention (2 Weeks)||14
2892716|NCT00376246|3599638|FG000|COMPLETED|First Intervention (2 Weeks)||10
2892717|NCT00376246|3599639|FG001|COMPLETED|First Intervention (2 Weeks)||12
2892718|NCT00376246|3599638|FG000|NOT COMPLETED|First Intervention (2 Weeks)||4
2892719|NCT00376246|3599639|FG001|NOT COMPLETED|First Intervention (2 Weeks)||2
2892720|NCT00376246|3599638|FG000|STARTED|Washout (2 Weeks)||10
2892721|NCT00376246|3599639|FG001|STARTED|Washout (2 Weeks)||12
2892722|NCT00376246|3599638|FG000|COMPLETED|Washout (2 Weeks)||10
2892723|NCT00376246|3599639|FG001|COMPLETED|Washout (2 Weeks)||12
2892724|NCT00376246|3599638|FG000|NOT COMPLETED|Washout (2 Weeks)||0
2892725|NCT00376246|3599639|FG001|NOT COMPLETED|Washout (2 Weeks)||0
2892726|NCT00376246|3599638|FG000|STARTED|Second Intervention (2 Weeks)||10
2892727|NCT00376246|3599639|FG001|STARTED|Second Intervention (2 Weeks)||12
2892728|NCT00376246|3599638|FG000|COMPLETED|Second Intervention (2 Weeks)||10
2892729|NCT00376246|3599639|FG001|COMPLETED|Second Intervention (2 Weeks)||12
2892730|NCT00376246|3599638|FG000|NOT COMPLETED|Second Intervention (2 Weeks)||0
2892731|NCT00376246|3599639|FG001|NOT COMPLETED|Second Intervention (2 Weeks)||0
2892732|NCT00376259|3599649|FG000|STARTED|Overall Study||22
2892733|NCT00376259|3599650|FG001|STARTED|Overall Study||21
2892734|NCT00376259|3599649|FG000|Received Study Drug|Overall Study||21
2892735|NCT00376259|3599650|FG001|Received Study Drug|Overall Study||21
2892736|NCT00376259|3599649|FG000|COMPLETED|Overall Study||0
2892737|NCT00376259|3599650|FG001|COMPLETED|Overall Study||0
2892738|NCT00376259|3599649|FG000|NOT COMPLETED|Overall Study||22
2892739|NCT00376259|3599650|FG001|NOT COMPLETED|Overall Study||21
2892740|NCT00376363|3599658|FG000|STARTED|Overall Study||143
2892741|NCT00376363|3599659|FG001|STARTED|Overall Study||133
2892742|NCT00376363|3599658|FG000|COMPLETED|Overall Study||87
2892743|NCT00376363|3599659|FG001|COMPLETED|Overall Study||87
2892744|NCT00376363|3599658|FG000|NOT COMPLETED|Overall Study||56
2892745|NCT00376363|3599659|FG001|NOT COMPLETED|Overall Study||46
2892746|NCT00376506|3599667|FG000|STARTED|Overall Study||4
2892747|NCT00376506|3599668|FG001|STARTED|Overall Study||6
2892748|NCT00376506|3599667|FG000|COMPLETED|Overall Study||4
2892749|NCT00376506|3599668|FG001|COMPLETED|Overall Study||4
2892750|NCT00376506|3599667|FG000|NOT COMPLETED|Overall Study||0
2892751|NCT00376506|3599668|FG001|NOT COMPLETED|Overall Study||2
2892752|NCT00376532|3599679|FG000|STARTED|Overall Study|Subjects with an event were enrolled beginning 09/14/2006.|31
2892753|NCT00376532|3599680|FG001|STARTED|Overall Study|Subjects without an event were enrolled beginning 09/15/2006.|32
2892754|NCT00376532|3599679|FG000|COMPLETED|Overall Study|Last event subject enrolled 2/22/2008|25
2892755|NCT00376532|3599680|FG001|COMPLETED|Overall Study|Last non-event subject enrolled 3/18/2008.|26
2892756|NCT00376532|3599679|FG000|NOT COMPLETED|Overall Study||6
2892757|NCT00376532|3599680|FG001|NOT COMPLETED|Overall Study||6
2892758|NCT00376558|3599688|FG000|STARTED|Overall Study||25
2892759|NCT00376558|3599689|FG001|STARTED|Overall Study||25
2892760|NCT00376558|3599688|FG000|COMPLETED|Overall Study||25
2892761|NCT00376558|3599689|FG001|COMPLETED|Overall Study||25
2892762|NCT00376558|3599688|FG000|NOT COMPLETED|Overall Study||0
2892763|NCT00376558|3599689|FG001|NOT COMPLETED|Overall Study||0
2892764|NCT00376597|3599698|FG000|STARTED|Overall Study||253
2892765|NCT00376597|3599699|FG001|STARTED|Overall Study||315
2892766|NCT00376597|3599698|FG000|COMPLETED|Overall Study||242
2892767|NCT00376597|3599699|FG001|COMPLETED|Overall Study||312
2892768|NCT00376597|3599698|FG000|NOT COMPLETED|Overall Study||11
2892769|NCT00376597|3599699|FG001|NOT COMPLETED|Overall Study||3
2892770|NCT00376675|3599709|FG000|STARTED|Overall Study||69
2892771|NCT00376675|3599710|FG001|STARTED|Overall Study||70
2892772|NCT00376675|3599709|FG000|COMPLETED|Overall Study||49
2892773|NCT00376675|3599710|FG001|COMPLETED|Overall Study||56
2892774|NCT00376675|3599709|FG000|NOT COMPLETED|Overall Study||20
2892775|NCT00376675|3599710|FG001|NOT COMPLETED|Overall Study||14
2892776|NCT00376688|3599716|FG000|STARTED|Overall Study||31
2892777|NCT00376688|3599716|FG000|COMPLETED|Overall Study||27
2892778|NCT00376688|3599716|FG000|NOT COMPLETED|Overall Study||4
2892779|NCT00376805|3599720|FG000|STARTED|Overall Study||6
2892780|NCT00376805|3599720|FG000|COMPLETED|Overall Study||6
2892781|NCT00376805|3599720|FG000|NOT COMPLETED|Overall Study||0
2892782|NCT00376935|3599728|FG000|STARTED|Overall Study||25
2892783|NCT00376935|3599729|FG001|STARTED|Overall Study||25
2892784|NCT00376935|3599730|FG002|STARTED|Overall Study||25
2892785|NCT00376935|3599731|FG003|STARTED|Overall Study||24
2892786|NCT00376935|3599728|FG000|COMPLETED|Overall Study||25
2892787|NCT00376935|3599729|FG001|COMPLETED|Overall Study||25
2892788|NCT00376935|3599730|FG002|COMPLETED|Overall Study||25
2892789|NCT00376935|3599731|FG003|COMPLETED|Overall Study||24
2892790|NCT00376935|3599728|FG000|NOT COMPLETED|Overall Study||0
2892791|NCT00376935|3599729|FG001|NOT COMPLETED|Overall Study||0
2892792|NCT00376935|3599730|FG002|NOT COMPLETED|Overall Study||0
2892793|NCT00376935|3599731|FG003|NOT COMPLETED|Overall Study||0
2892794|NCT00376948|3599741|FG000|STARTED|Overall Study||20
2892795|NCT00376948|3599741|FG000|COMPLETED|Overall Study||20
2892796|NCT00376948|3599741|FG000|NOT COMPLETED|Overall Study||0
2892797|NCT00376961|3599745|FG000|STARTED|Initial Registration||68
2892798|NCT00376961|3599746|FG001|STARTED|Initial Registration||0
2892799|NCT00376961|3599745|FG000|Eligible|Initial Registration||65
2892800|NCT00376961|3599746|FG001|Eligible|Initial Registration||0
2892801|NCT00376961|3599745|FG000|COMPLETED|Initial Registration||61
2892802|NCT00376961|3599746|FG001|COMPLETED|Initial Registration||0
2892803|NCT00376961|3599745|FG000|NOT COMPLETED|Initial Registration||7
2892804|NCT00376961|3599746|FG001|NOT COMPLETED|Initial Registration||0
2892805|NCT00376961|3599745|FG000|STARTED|Maintenance||0
2892806|NCT00376961|3599746|FG001|STARTED|Maintenance||50
2892807|NCT00376961|3599745|FG000|Eligible|Maintenance||0
2892808|NCT00376961|3599746|FG001|Eligible|Maintenance||47
2892809|NCT00376961|3599745|FG000|COMPLETED|Maintenance||0
2892810|NCT00376961|3599746|FG001|COMPLETED|Maintenance||27
2892811|NCT00376961|3599745|FG000|NOT COMPLETED|Maintenance||0
2892812|NCT00376961|3599746|FG001|NOT COMPLETED|Maintenance||23
2892813|NCT00377156|3599756|FG000|STARTED|Overall Study||111
2892814|NCT00377156|3599757|FG001|STARTED|Overall Study||102
2892815|NCT00377156|3599756|FG000|COMPLETED|Overall Study||63
2892816|NCT00377156|3599757|FG001|COMPLETED|Overall Study||48
2892817|NCT00377156|3599756|FG000|NOT COMPLETED|Overall Study||48
2892818|NCT00377156|3599757|FG001|NOT COMPLETED|Overall Study||54
2892819|NCT00377234|3599767|FG000|STARTED|Overall Study||180
2892820|NCT00377234|3599768|FG001|STARTED|Overall Study||176
2892821|NCT00377234|3599767|FG000|Randomized|Overall Study||180
2892822|NCT00377234|3599768|FG001|Randomized|Overall Study||176
2892823|NCT00377234|3599767|FG000|Did Not Receive Study Treatment|Overall Study||3
2892824|NCT00377234|3599768|FG001|Did Not Receive Study Treatment|Overall Study||2
2892825|NCT00377234|3599767|FG000|Received Treatment|Overall Study||177
2892826|NCT00377234|3599768|FG001|Received Treatment|Overall Study||174
2892827|NCT00377234|3599767|FG000|Safety Analysis Set: Period 1|Overall Study||177
2892828|NCT00377234|3599768|FG001|Safety Analysis Set: Period 1|Overall Study||174
2892829|NCT00377234|3599767|FG000|Safety Analysis Set: Period 2|Overall Study||153
2892830|NCT00377234|3599768|FG001|Safety Analysis Set: Period 2|Overall Study||150
2892831|NCT00377234|3599767|FG000|Safety Analysis Set: Ibandronate|Overall Study||177
2892832|NCT00377234|3599768|FG001|Safety Analysis Set: Ibandronate|Overall Study||150
2892833|NCT00377234|3599767|FG000|Safety Analysis Set: Risedronate|Overall Study||153
2892834|NCT00377234|3599768|FG001|Safety Analysis Set: Risedronate|Overall Study||174
2892835|NCT00377234|3599767|FG000|COMPLETED|Overall Study||146
2892836|NCT00377234|3599768|FG001|COMPLETED|Overall Study||145
2892837|NCT00377234|3599767|FG000|NOT COMPLETED|Overall Study||34
2892838|NCT00377234|3599768|FG001|NOT COMPLETED|Overall Study||31
2892839|NCT00377260|3599782|FG000|STARTED|Overall Study||144
2892840|NCT00377260|3599783|FG001|STARTED|Overall Study||147
2919820|NCT00534313|3630249|FG003|NOT COMPLETED|Short-term Period||9
2892841|NCT00377260|3599782|FG000|COMPLETED|Overall Study|A child is considered a completer if he/she had at least one visit after the end of therapy.|142
2892842|NCT00377260|3599783|FG001|COMPLETED|Overall Study|A child is considered a completer if he/she had at least one visit after the end of therapy.|142
2892843|NCT00377260|3599782|FG000|NOT COMPLETED|Overall Study||2
2892844|NCT00377260|3599783|FG001|NOT COMPLETED|Overall Study||5
2892845|NCT00377299|3599791|FG000|STARTED|Overall Study||32
2892846|NCT00377299|3599792|FG001|STARTED|Overall Study||28
2892847|NCT00377299|3599791|FG000|COMPLETED|Overall Study||13
2892848|NCT00377299|3599792|FG001|COMPLETED|Overall Study||4
2892849|NCT00377299|3599791|FG000|NOT COMPLETED|Overall Study||19
2892850|NCT00377299|3599792|FG001|NOT COMPLETED|Overall Study||24
2892851|NCT00377312|3599801|FG000|STARTED|Overall Study||6
2892852|NCT00377312|3599802|FG001|STARTED|Overall Study||5
2892853|NCT00377312|3599801|FG000|COMPLETED|Overall Study||5
2892854|NCT00377312|3599802|FG001|COMPLETED|Overall Study||4
2892855|NCT00377312|3599801|FG000|NOT COMPLETED|Overall Study||1
2892856|NCT00377312|3599802|FG001|NOT COMPLETED|Overall Study||1
2892857|NCT00377364|3599810|FG000|STARTED|Overall Study||16
2892858|NCT00377364|3599811|FG001|STARTED|Overall Study||14
2892859|NCT00377364|3599810|FG000|COMPLETED|Overall Study||14
2892860|NCT00377364|3599811|FG001|COMPLETED|Overall Study||14
2892861|NCT00377364|3599810|FG000|NOT COMPLETED|Overall Study||2
2892862|NCT00377364|3599811|FG001|NOT COMPLETED|Overall Study||0
2892863|NCT00377403|3599821|FG000|STARTED|Overall Study||85
2892864|NCT00377403|3599822|FG001|STARTED|Overall Study||81
2892865|NCT00377403|3599821|FG000|Day -3 Assessment|Overall Study||81
2892866|NCT00377403|3599822|FG001|Day -3 Assessment|Overall Study||74
2892867|NCT00377403|3599821|FG000|Day 7 Assessment|Overall Study||80
2892868|NCT00377403|3599822|FG001|Day 7 Assessment|Overall Study||75
2892869|NCT00377403|3599821|FG000|Day 10 Assessment|Overall Study||81
2892870|NCT00377403|3599822|FG001|Day 10 Assessment|Overall Study||71
2892871|NCT00377403|3599821|FG000|Day 28 Assessment|Overall Study||82
2892872|NCT00377403|3599822|FG001|Day 28 Assessment|Overall Study||77
2892873|NCT00377403|3599821|FG000|COMPLETED|Overall Study|The number varied by day of follow-up from 80 to 82 in the intervention group.|81
2892874|NCT00377403|3599822|FG001|COMPLETED|Overall Study|The number varied by day of follow-up from 71 to 77 in the symptomatic treatment only group.|74
2892875|NCT00377403|3599821|FG000|NOT COMPLETED|Overall Study||4
2892876|NCT00377403|3599822|FG001|NOT COMPLETED|Overall Study||7
2892877|NCT00377429|3599828|FG000|STARTED|Overall Study|Treated|47
2892878|NCT00377429|3599828|FG000|COMPLETED|Overall Study|Completed main study|32
2892879|NCT00377429|3599828|FG000|NOT COMPLETED|Overall Study||15
2892880|NCT00377520|3599832|FG000|STARTED|Overall Study||27
2892881|NCT00377520|3599832|FG000|COMPLETED|Overall Study|Completed means the patient was evaluable for response.|26
2892882|NCT00377520|3599832|FG000|NOT COMPLETED|Overall Study||1
2892883|NCT00377572|3599838|FG000|STARTED|Overall Study||208
2892884|NCT00377572|3599839|FG001|STARTED|Overall Study||211
2892885|NCT00377572|3599838|FG000|COMPLETED|Overall Study||155
2892886|NCT00377572|3599839|FG001|COMPLETED|Overall Study||157
2892887|NCT00377572|3599838|FG000|NOT COMPLETED|Overall Study||53
2892888|NCT00377572|3599839|FG001|NOT COMPLETED|Overall Study||54
2892889|NCT00377611|3599847|FG000|STARTED|Overall Study||1047
2892890|NCT00377611|3599848|FG001|STARTED|Overall Study||2007
3170539|NCT01929863|3897885|FG001|NOT COMPLETED|Period 2:Washout Period (13-15 Days)||0
3170540|NCT01929863|3897884|FG000|STARTED|Period 3:Intervention Period 2 (7 Days)||6
3170541|NCT01929863|3897885|FG001|STARTED|Period 3:Intervention Period 2 (7 Days)||7
2892891|NCT00377611|3599847|FG000|COMPLETED|Overall Study||1025
2892892|NCT00377611|3599848|FG001|COMPLETED|Overall Study||1974
2892893|NCT00377611|3599847|FG000|NOT COMPLETED|Overall Study||22
2892894|NCT00377611|3599848|FG001|NOT COMPLETED|Overall Study||33
2892895|NCT00377637|3599859|FG000|STARTED|Induction Phase|Intent-To-Treat|185
2892896|NCT00377637|3599860|FG001|STARTED|Induction Phase|Intent-To-Treat|185
2892897|NCT00377637|3599861|FG002|STARTED|Induction Phase||0
2892898|NCT00377637|3599862|FG003|STARTED|Induction Phase||0
2892899|NCT00377637|3599859|FG000|Safety Population|Induction Phase||180
2892900|NCT00377637|3599860|FG001|Safety Population|Induction Phase||184
2892901|NCT00377637|3599861|FG002|Safety Population|Induction Phase||0
2892902|NCT00377637|3599862|FG003|Safety Population|Induction Phase||0
3170542|NCT01929863|3897884|FG000|COMPLETED|Period 3:Intervention Period 2 (7 Days)||6
2892903|NCT00377637|3599859|FG000|COMPLETED|Induction Phase||156
2892904|NCT00377637|3599860|FG001|COMPLETED|Induction Phase||150
2892905|NCT00377637|3599861|FG002|COMPLETED|Induction Phase||0
2892906|NCT00377637|3599862|FG003|COMPLETED|Induction Phase||0
2892907|NCT00377637|3599859|FG000|NOT COMPLETED|Induction Phase||29
2892908|NCT00377637|3599860|FG001|NOT COMPLETED|Induction Phase||35
2892909|NCT00377637|3599861|FG002|NOT COMPLETED|Induction Phase||0
2892910|NCT00377637|3599862|FG003|NOT COMPLETED|Induction Phase||0
2892911|NCT00377637|3599859|FG000|STARTED|Maintenance Phase||0
2892912|NCT00377637|3599860|FG001|STARTED|Maintenance Phase||0
3170543|NCT01929863|3897885|FG001|COMPLETED|Period 3:Intervention Period 2 (7 Days)||6
3170544|NCT01929863|3897884|FG000|NOT COMPLETED|Period 3:Intervention Period 2 (7 Days)||0
3170545|NCT01929863|3897885|FG001|NOT COMPLETED|Period 3:Intervention Period 2 (7 Days)||1
3170546|NCT01929863|3897884|FG000|STARTED|Period 4:Follow-up-Metformin (7-10 Days)||6
2892913|NCT00377637|3599861|FG002|STARTED|Maintenance Phase||116
2892914|NCT00377637|3599862|FG003|STARTED|Maintenance Phase||111
2892915|NCT00377637|3599859|FG000|COMPLETED|Maintenance Phase||0
2892916|NCT00377637|3599860|FG001|COMPLETED|Maintenance Phase||0
2892917|NCT00377637|3599861|FG002|COMPLETED|Maintenance Phase||73
2892918|NCT00377637|3599862|FG003|COMPLETED|Maintenance Phase||54
2892919|NCT00377637|3599859|FG000|NOT COMPLETED|Maintenance Phase||0
2892920|NCT00377637|3599860|FG001|NOT COMPLETED|Maintenance Phase||0
2892921|NCT00377637|3599861|FG002|NOT COMPLETED|Maintenance Phase||43
2892922|NCT00377637|3599862|FG003|NOT COMPLETED|Maintenance Phase||57
2892923|NCT00377676|3599878|FG000|STARTED|Overall Study|25 subjects did not receive study drug - thus 3070 were randomized and received drug|2054
2892924|NCT00377676|3599879|FG001|STARTED|Overall Study||1016
2892925|NCT00377676|3599878|FG000|COMPLETED|Overall Study||1093
2892926|NCT00377676|3599879|FG001|COMPLETED|Overall Study||694
2892927|NCT00377676|3599878|FG000|NOT COMPLETED|Overall Study||961
2892928|NCT00377676|3599879|FG001|NOT COMPLETED|Overall Study||322
2892929|NCT00377741|3599887|FG000|STARTED|Overall Study||16
2892930|NCT00377741|3599888|FG001|STARTED|Overall Study||15
2892931|NCT00377741|3599887|FG000|COMPLETED|Overall Study||16
2892932|NCT00377741|3599888|FG001|COMPLETED|Overall Study||15
2892933|NCT00377741|3599887|FG000|NOT COMPLETED|Overall Study||0
2892934|NCT00377741|3599888|FG001|NOT COMPLETED|Overall Study||0
2892935|NCT00377819|3599896|FG000|STARTED|Overall Study||251
2892936|NCT00377819|3599897|FG001|STARTED|Overall Study||253
2892937|NCT00377819|3599896|FG000|Received Study Medication|Overall Study||249
2892938|NCT00377819|3599897|FG001|Received Study Medication|Overall Study||253
2892939|NCT00377819|3599896|FG000|COMPLETED|Overall Study||238
2892940|NCT00377819|3599897|FG001|COMPLETED|Overall Study||243
2892941|NCT00377819|3599896|FG000|NOT COMPLETED|Overall Study||13
2892942|NCT00377819|3599897|FG001|NOT COMPLETED|Overall Study||10
2892943|NCT00377832|3599905|FG000|STARTED|Overall Study||7
2892944|NCT00377832|3599906|FG001|STARTED|Overall Study||6
2892945|NCT00377832|3599905|FG000|COMPLETED|Overall Study||7
2892946|NCT00377832|3599906|FG001|COMPLETED|Overall Study||6
2892947|NCT00377832|3599905|FG000|NOT COMPLETED|Overall Study||0
2892948|NCT00377832|3599906|FG001|NOT COMPLETED|Overall Study||0
2892949|NCT00377858|3599917|FG000|STARTED|Overall Study||242
2892950|NCT00377858|3599918|FG001|STARTED|Overall Study||242
2892951|NCT00377858|3599917|FG000|Had at Least One Post-Baseline Value|Overall Study||239
2892952|NCT00377858|3599918|FG001|Had at Least One Post-Baseline Value|Overall Study||240
2892953|NCT00377858|3599917|FG000|COMPLETED|Overall Study||211
2892954|NCT00377858|3599918|FG001|COMPLETED|Overall Study||215
2892955|NCT00377858|3599917|FG000|NOT COMPLETED|Overall Study||31
2892956|NCT00377858|3599918|FG001|NOT COMPLETED|Overall Study||27
2892957|NCT00377962|3599926|FG000|STARTED|Core Study: 0-12 Months||140
2892958|NCT00377962|3599927|FG001|STARTED|Core Study: 0-12 Months||142
2892959|NCT00377962|3599926|FG000|COMPLETED|Core Study: 0-12 Months||112
2892960|NCT00377962|3599927|FG001|COMPLETED|Core Study: 0-12 Months||133
2892961|NCT00377962|3599926|FG000|NOT COMPLETED|Core Study: 0-12 Months||28
2892962|NCT00377962|3599927|FG001|NOT COMPLETED|Core Study: 0-12 Months||9
2892963|NCT00377962|3599926|FG000|STARTED|Extension Study: 12-24 Months||108
2892964|NCT00377962|3599927|FG001|STARTED|Extension Study: 12-24 Months||127
2892965|NCT00377962|3599926|FG000|COMPLETED|Extension Study: 12-24 Months||98
2892966|NCT00377962|3599927|FG001|COMPLETED|Extension Study: 12-24 Months||123
2892967|NCT00377962|3599926|FG000|NOT COMPLETED|Extension Study: 12-24 Months||10
2892968|NCT00377962|3599927|FG001|NOT COMPLETED|Extension Study: 12-24 Months||4
2892969|NCT00378014|3599941|FG000|STARTED|Core (Randomization to Month 11)||101
2892970|NCT00378014|3599942|FG001|STARTED|Core (Randomization to Month 11)||102
2892971|NCT00378014|3599941|FG000|Intent-to-treat (ITT) Population|Core (Randomization to Month 11)|ITT contained all randomized patients who had at least one post baseline GFR measurement.|96
2892972|NCT00378014|3599942|FG001|Intent-to-treat (ITT) Population|Core (Randomization to Month 11)|ITT contained all randomized patients who had at least one post baseline GFR measurement.|98
2892973|NCT00378014|3599941|FG000|COMPLETED|Core (Randomization to Month 11)||87
2892974|NCT00378014|3599942|FG001|COMPLETED|Core (Randomization to Month 11)||90
2892975|NCT00378014|3599941|FG000|NOT COMPLETED|Core (Randomization to Month 11)||14
2892976|NCT00378014|3599942|FG001|NOT COMPLETED|Core (Randomization to Month 11)||12
2892977|NCT00378014|3599941|FG000|STARTED|Extension (Month 12 to Month 59)||41
2892978|NCT00378014|3599942|FG001|STARTED|Extension (Month 12 to Month 59)||40
2892979|NCT00378014|3599941|FG000|COMPLETED|Extension (Month 12 to Month 59)||27
2892980|NCT00378014|3599942|FG001|COMPLETED|Extension (Month 12 to Month 59)||26
2892981|NCT00378014|3599941|FG000|NOT COMPLETED|Extension (Month 12 to Month 59)||14
2892982|NCT00378014|3599942|FG001|NOT COMPLETED|Extension (Month 12 to Month 59)||14
2892983|NCT00378079|3599953|FG000|STARTED|Overall Study||70
2892984|NCT00378079|3599954|FG001|STARTED|Overall Study||70
2892985|NCT00378079|3599955|FG002|STARTED|Overall Study||71
2892986|NCT00378079|3599953|FG000|COMPLETED|Overall Study||64
2892987|NCT00378079|3599954|FG001|COMPLETED|Overall Study||69
2892988|NCT00378079|3599955|FG002|COMPLETED|Overall Study||71
2892989|NCT00378079|3599953|FG000|NOT COMPLETED|Overall Study||6
2892990|NCT00378079|3599954|FG001|NOT COMPLETED|Overall Study||1
2892991|NCT00378079|3599955|FG002|NOT COMPLETED|Overall Study||0
2892992|NCT00378105|3599965|FG000|STARTED|Overall Study|Out of 33 enrolled, two patients went off study before start of therapy.|31
2892993|NCT00378105|3599966|FG001|STARTED|Overall Study||35
2892994|NCT00378105|3599965|FG000|COMPLETED|Overall Study||11
2892995|NCT00378105|3599966|FG001|COMPLETED|Overall Study||5
2892996|NCT00378105|3599965|FG000|NOT COMPLETED|Overall Study||20
2892997|NCT00378105|3599966|FG001|NOT COMPLETED|Overall Study||30
2892998|NCT00378209|3599973|FG000|STARTED|Overall Study|1 patient who never started treatment was excluded in the analysis.|64
2919821|NCT00534313|3630246|FG000|STARTED|Long-term Period||37
2892999|NCT00378209|3599973|FG000|COMPLETED|Overall Study|This included patients who completed at least 8 cycles of combination therapy with all drugs.|42
2893000|NCT00378209|3599973|FG000|NOT COMPLETED|Overall Study||22
2893001|NCT00378326|3599978|FG000|STARTED|Overall Study||26
2893002|NCT00378326|3599978|FG000|COMPLETED|Overall Study||26
2893003|NCT00378326|3599978|FG000|NOT COMPLETED|Overall Study||0
2893004|NCT00378352|3599986|FG000|STARTED|Dose Escalation 15,000 Units||20
2893005|NCT00378352|3599987|FG001|STARTED|Dose Escalation 15,000 Units||0
2893006|NCT00378352|3599988|FG002|STARTED|Dose Escalation 15,000 Units||0
2893007|NCT00378352|3599989|FG003|STARTED|Dose Escalation 15,000 Units||11
2893008|NCT00378352|3599990|FG004|STARTED|Dose Escalation 15,000 Units||0
2893009|NCT00378352|3599991|FG005|STARTED|Dose Escalation 15,000 Units||0
2893010|NCT00378352|3599986|FG000|Safety Analysis|Dose Escalation 15,000 Units||19
2893011|NCT00378352|3599987|FG001|Safety Analysis|Dose Escalation 15,000 Units||0
2893012|NCT00378352|3599988|FG002|Safety Analysis|Dose Escalation 15,000 Units||0
2893013|NCT00378352|3599989|FG003|Safety Analysis|Dose Escalation 15,000 Units||11
2893014|NCT00378352|3599990|FG004|Safety Analysis|Dose Escalation 15,000 Units||0
2893015|NCT00378352|3599991|FG005|Safety Analysis|Dose Escalation 15,000 Units||0
2893016|NCT00378352|3599986|FG000|COMPLETED|Dose Escalation 15,000 Units||15
2893017|NCT00378352|3599987|FG001|COMPLETED|Dose Escalation 15,000 Units||0
2893018|NCT00378352|3599988|FG002|COMPLETED|Dose Escalation 15,000 Units||0
2893019|NCT00378352|3599989|FG003|COMPLETED|Dose Escalation 15,000 Units||10
2893020|NCT00378352|3599990|FG004|COMPLETED|Dose Escalation 15,000 Units||0
2893021|NCT00378352|3599991|FG005|COMPLETED|Dose Escalation 15,000 Units||0
2893022|NCT00378352|3599986|FG000|NOT COMPLETED|Dose Escalation 15,000 Units||5
2893023|NCT00378352|3599987|FG001|NOT COMPLETED|Dose Escalation 15,000 Units||0
2893024|NCT00378352|3599988|FG002|NOT COMPLETED|Dose Escalation 15,000 Units||0
2893025|NCT00378352|3599989|FG003|NOT COMPLETED|Dose Escalation 15,000 Units||1
2893026|NCT00378352|3599990|FG004|NOT COMPLETED|Dose Escalation 15,000 Units||0
2893027|NCT00378352|3599991|FG005|NOT COMPLETED|Dose Escalation 15,000 Units||0
2893028|NCT00378352|3599986|FG000|STARTED|Dose Escalation 30,000 Units||0
2893029|NCT00378352|3599987|FG001|STARTED|Dose Escalation 30,000 Units||19
2893030|NCT00378352|3599988|FG002|STARTED|Dose Escalation 30,000 Units||0
2893031|NCT00378352|3599989|FG003|STARTED|Dose Escalation 30,000 Units||11
2893032|NCT00378352|3599990|FG004|STARTED|Dose Escalation 30,000 Units||0
2893033|NCT00378352|3599991|FG005|STARTED|Dose Escalation 30,000 Units||0
2893034|NCT00378352|3599986|FG000|Safety Analysis|Dose Escalation 30,000 Units||0
2893035|NCT00378352|3599987|FG001|Safety Analysis|Dose Escalation 30,000 Units|One participant randomized to 60,000 units received 30,000 units|20
2893036|NCT00378352|3599988|FG002|Safety Analysis|Dose Escalation 30,000 Units||0
2893037|NCT00378352|3599989|FG003|Safety Analysis|Dose Escalation 30,000 Units||11
2893038|NCT00378352|3599990|FG004|Safety Analysis|Dose Escalation 30,000 Units||0
2893039|NCT00378352|3599991|FG005|Safety Analysis|Dose Escalation 30,000 Units||0
2893040|NCT00378352|3599986|FG000|COMPLETED|Dose Escalation 30,000 Units||0
2893041|NCT00378352|3599987|FG001|COMPLETED|Dose Escalation 30,000 Units||16
2893042|NCT00378352|3599988|FG002|COMPLETED|Dose Escalation 30,000 Units||0
2893043|NCT00378352|3599989|FG003|COMPLETED|Dose Escalation 30,000 Units||9
2893044|NCT00378352|3599990|FG004|COMPLETED|Dose Escalation 30,000 Units||0
2893045|NCT00378352|3599991|FG005|COMPLETED|Dose Escalation 30,000 Units||0
2893046|NCT00378352|3599986|FG000|NOT COMPLETED|Dose Escalation 30,000 Units||0
2893047|NCT00378352|3599987|FG001|NOT COMPLETED|Dose Escalation 30,000 Units||3
2893048|NCT00378352|3599988|FG002|NOT COMPLETED|Dose Escalation 30,000 Units||0
2893049|NCT00378352|3599989|FG003|NOT COMPLETED|Dose Escalation 30,000 Units||2
2893050|NCT00378352|3599990|FG004|NOT COMPLETED|Dose Escalation 30,000 Units||0
2893051|NCT00378352|3599991|FG005|NOT COMPLETED|Dose Escalation 30,000 Units||0
2893052|NCT00378352|3599986|FG000|STARTED|Dose Escalation 60,000 Units||0
2893053|NCT00378352|3599987|FG001|STARTED|Dose Escalation 60,000 Units||0
2893054|NCT00378352|3599988|FG002|STARTED|Dose Escalation 60,000 Units||20
2893055|NCT00378352|3599989|FG003|STARTED|Dose Escalation 60,000 Units||11
2893056|NCT00378352|3599990|FG004|STARTED|Dose Escalation 60,000 Units||0
2893057|NCT00378352|3599991|FG005|STARTED|Dose Escalation 60,000 Units||0
2893058|NCT00378352|3599986|FG000|Safety Analysis|Dose Escalation 60,000 Units||0
2893059|NCT00378352|3599987|FG001|Safety Analysis|Dose Escalation 60,000 Units||0
2893060|NCT00378352|3599988|FG002|Safety Analysis|Dose Escalation 60,000 Units||19
2893061|NCT00378352|3599989|FG003|Safety Analysis|Dose Escalation 60,000 Units||11
2893062|NCT00378352|3599990|FG004|Safety Analysis|Dose Escalation 60,000 Units||0
2893063|NCT00378352|3599991|FG005|Safety Analysis|Dose Escalation 60,000 Units||0
2893064|NCT00378352|3599986|FG000|COMPLETED|Dose Escalation 60,000 Units||0
2893065|NCT00378352|3599987|FG001|COMPLETED|Dose Escalation 60,000 Units||0
2893066|NCT00378352|3599988|FG002|COMPLETED|Dose Escalation 60,000 Units||17
2893067|NCT00378352|3599989|FG003|COMPLETED|Dose Escalation 60,000 Units||10
2893068|NCT00378352|3599990|FG004|COMPLETED|Dose Escalation 60,000 Units||0
2893069|NCT00378352|3599991|FG005|COMPLETED|Dose Escalation 60,000 Units||0
2893070|NCT00378352|3599986|FG000|NOT COMPLETED|Dose Escalation 60,000 Units||0
2893071|NCT00378352|3599987|FG001|NOT COMPLETED|Dose Escalation 60,000 Units||0
2893072|NCT00378352|3599988|FG002|NOT COMPLETED|Dose Escalation 60,000 Units||3
2893073|NCT00378352|3599989|FG003|NOT COMPLETED|Dose Escalation 60,000 Units||1
2893074|NCT00378352|3599990|FG004|NOT COMPLETED|Dose Escalation 60,000 Units||0
2893075|NCT00378352|3599991|FG005|NOT COMPLETED|Dose Escalation 60,000 Units||0
3170547|NCT01929863|3897885|FG001|STARTED|Period 4:Follow-up-Metformin (7-10 Days)||6
3170548|NCT01929863|3897884|FG000|COMPLETED|Period 4:Follow-up-Metformin (7-10 Days)||0
3170549|NCT01929863|3897885|FG001|COMPLETED|Period 4:Follow-up-Metformin (7-10 Days)||0
3170550|NCT01929863|3897884|FG000|NOT COMPLETED|Period 4:Follow-up-Metformin (7-10 Days)||6
3170551|NCT01929863|3897885|FG001|NOT COMPLETED|Period 4:Follow-up-Metformin (7-10 Days)||6
3170552|NCT01929876|3897896|FG000|STARTED|Period 1||16
3170553|NCT01929876|3897896|FG000|COMPLETED|Period 1||16
2893076|NCT00378352|3599986|FG000|STARTED|Efficacy Phase||0
2893077|NCT00378352|3599987|FG001|STARTED|Efficacy Phase||0
2893078|NCT00378352|3599988|FG002|STARTED|Efficacy Phase||0
2893079|NCT00378352|3599989|FG003|STARTED|Efficacy Phase||0
2893080|NCT00378352|3599990|FG004|STARTED|Efficacy Phase||65
2893081|NCT00378352|3599991|FG005|STARTED|Efficacy Phase||66
2893082|NCT00378352|3599986|FG000|Safety Analysis|Efficacy Phase||0
2893083|NCT00378352|3599987|FG001|Safety Analysis|Efficacy Phase||0
2893084|NCT00378352|3599988|FG002|Safety Analysis|Efficacy Phase||0
2893085|NCT00378352|3599989|FG003|Safety Analysis|Efficacy Phase||0
2893086|NCT00378352|3599990|FG004|Safety Analysis|Efficacy Phase|Two participants randomized to placebo received 60,000 units Epoetin alfa|67
2893087|NCT00378352|3599991|FG005|Safety Analysis|Efficacy Phase||64
2893088|NCT00378352|3599986|FG000|COMPLETED|Efficacy Phase||0
2893089|NCT00378352|3599987|FG001|COMPLETED|Efficacy Phase||0
2893090|NCT00378352|3599988|FG002|COMPLETED|Efficacy Phase||0
2893091|NCT00378352|3599989|FG003|COMPLETED|Efficacy Phase||0
2893092|NCT00378352|3599990|FG004|COMPLETED|Efficacy Phase||54
2893093|NCT00378352|3599991|FG005|COMPLETED|Efficacy Phase||59
2893094|NCT00378352|3599986|FG000|NOT COMPLETED|Efficacy Phase||0
2893095|NCT00378352|3599987|FG001|NOT COMPLETED|Efficacy Phase||0
2893096|NCT00378352|3599988|FG002|NOT COMPLETED|Efficacy Phase||0
2893097|NCT00378352|3599989|FG003|NOT COMPLETED|Efficacy Phase||0
2893098|NCT00378352|3599990|FG004|NOT COMPLETED|Efficacy Phase||11
2893099|NCT00378352|3599991|FG005|NOT COMPLETED|Efficacy Phase||7
2893100|NCT00378482|3599999|FG000|STARTED|Overall Study||37
2893101|NCT00378482|3599999|FG000|COMPLETED|Overall Study||6
2893102|NCT00378482|3599999|FG000|NOT COMPLETED|Overall Study||31
2893103|NCT00378508|3600005|FG000|STARTED|Overall Study||29
2893104|NCT00378508|3600006|FG001|STARTED|Overall Study||34
2893105|NCT00378508|3600005|FG000|Randomized|Overall Study||29
2893106|NCT00378508|3600006|FG001|Randomized|Overall Study||34
2893107|NCT00378508|3600005|FG000|Received Intervention/Placebo|Overall Study||28
2893108|NCT00378508|3600006|FG001|Received Intervention/Placebo|Overall Study||31
2893109|NCT00378508|3600005|FG000|COMPLETED|Overall Study||27
2893110|NCT00378508|3600006|FG001|COMPLETED|Overall Study||31
2893111|NCT00378508|3600005|FG000|NOT COMPLETED|Overall Study||2
2893112|NCT00378508|3600006|FG001|NOT COMPLETED|Overall Study||3
2893113|NCT00378534|3600015|FG000|STARTED|Overall Study||58
2893114|NCT00378534|3600016|FG001|STARTED|Overall Study||58
2893115|NCT00378534|3600015|FG000|COMPLETED|Overall Study||55
2893116|NCT00378534|3600016|FG001|COMPLETED|Overall Study||58
2893117|NCT00378534|3600015|FG000|NOT COMPLETED|Overall Study||3
2893118|NCT00378534|3600016|FG001|NOT COMPLETED|Overall Study||0
2893119|NCT00378560|3600023|FG000|STARTED|Overall Study||509
2893120|NCT00378560|3600024|FG001|STARTED|Overall Study||512
2893121|NCT00378560|3600023|FG000|Vaccinated|Overall Study||509
2893122|NCT00378560|3600024|FG001|Vaccinated|Overall Study||512
2893123|NCT00378560|3600023|FG000|COMPLETED|Overall Study||453
2893124|NCT00378560|3600024|FG001|COMPLETED|Overall Study||454
2893125|NCT00378560|3600023|FG000|NOT COMPLETED|Overall Study||56
2893126|NCT00378560|3600024|FG001|NOT COMPLETED|Overall Study||58
2893127|NCT00378573|3600030|FG000|STARTED|Treatment Period||17
2893128|NCT00378573|3600030|FG000|COMPLETED|Treatment Period|Patients who did not complete treatment moved directly to the follow-up phase of the study.|0
2893129|NCT00378573|3600030|FG000|NOT COMPLETED|Treatment Period||17
2893130|NCT00378573|3600030|FG000|STARTED|Follow-up||17
2893131|NCT00378573|3600030|FG000|COMPLETED|Follow-up||3
2893132|NCT00378573|3600030|FG000|NOT COMPLETED|Follow-up||14
2893133|NCT00378599|3600034|FG000|STARTED|Overall Study||125
2893134|NCT00378599|3600034|FG000|COMPLETED|Overall Study||73
2893135|NCT00378599|3600034|FG000|NOT COMPLETED|Overall Study||52
2893136|NCT00378703|3600042|FG000|STARTED|Overall Study|Number of patients randomized to this treatment arm.|89
2893137|NCT00378703|3600043|FG001|STARTED|Overall Study|Number of patients randomized to this treatment arm.|91
2893138|NCT00378703|3600044|FG002|STARTED|Overall Study|Number of patients randomized to this treatment arm.|90
2893139|NCT00378703|3600045|FG003|STARTED|Overall Study|Number of patients randomized to this treatment arm.|91
2893140|NCT00378703|3600042|FG000|Treated|Overall Study|Number of patients included in the toxicity analysis.|88
2893141|NCT00378703|3600043|FG001|Treated|Overall Study|Number of patients included in the toxicity analysis.|86
2893142|NCT00378703|3600044|FG002|Treated|Overall Study|Number of patients included in the toxicity analysis.|90
2919822|NCT00534313|3630247|FG001|STARTED|Long-term Period||34
3170554|NCT01929876|3897896|FG000|NOT COMPLETED|Period 1||0
3170555|NCT01929876|3897896|FG000|STARTED|Period 2||16
3170556|NCT01929876|3897896|FG000|COMPLETED|Period 2||15
3170557|NCT01929876|3897896|FG000|NOT COMPLETED|Period 2||1
3170558|NCT01929889|3897900|FG000|STARTED|Overall Study|Target enrollment goal was 20 completed subjects.|8
3170559|NCT01929889|3897900|FG000|COMPLETED|Overall Study|3 subjects completed the study.|3
3170560|NCT01929889|3897900|FG000|NOT COMPLETED|Overall Study||5
3170561|NCT01929980|3897904|FG000|STARTED|Overall Study||4
3170562|NCT01929980|3897904|FG000|COMPLETED|Overall Study||3
3170563|NCT01929980|3897904|FG000|NOT COMPLETED|Overall Study||1
3170564|NCT01929993|3897910|FG000|STARTED|Overall Study||82
3170565|NCT01929993|3897911|FG001|STARTED|Overall Study||82
3170566|NCT01929993|3897910|FG000|COMPLETED|Overall Study||52
3170567|NCT01929993|3897911|FG001|COMPLETED|Overall Study||54
3170568|NCT01929993|3897910|FG000|NOT COMPLETED|Overall Study||30
3170569|NCT01929993|3897911|FG001|NOT COMPLETED|Overall Study||28
3170570|NCT01930045|3897917|FG000|STARTED|Part 1 - Period 1||3
3170571|NCT01930045|3897918|FG001|STARTED|Part 1 - Period 1||3
2893143|NCT00378703|3600045|FG003|Treated|Overall Study|Number of patients included in the toxicity analysis.|91
2893144|NCT00378703|3600042|FG000|Eligible and Treated|Overall Study|Number of patients included in the primary analysis.|84
2893145|NCT00378703|3600043|FG001|Eligible and Treated|Overall Study|Number of patients included in the primary analysis.|80
2893146|NCT00378703|3600044|FG002|Eligible and Treated|Overall Study|Number of patients included in the primary analysis.|83
2893147|NCT00378703|3600045|FG003|Eligible and Treated|Overall Study|Number of patients included in the primary analysis.|84
2893148|NCT00378703|3600042|FG000|COMPLETED|Overall Study|There is no limit to the number of treatment cycles allowed on any treatment arm.|0
2893149|NCT00378703|3600043|FG001|COMPLETED|Overall Study|There is no limit to the number of treatment cycles allowed on any treatment arm.|0
2893150|NCT00378703|3600044|FG002|COMPLETED|Overall Study|There is no limit to the number of treatment cycles allowed on any treatment arm.|0
2893151|NCT00378703|3600045|FG003|COMPLETED|Overall Study|There is no limit to the number of treatment cycles allowed on any treatment arm.|0
2893152|NCT00378703|3600042|FG000|NOT COMPLETED|Overall Study||89
2893153|NCT00378703|3600043|FG001|NOT COMPLETED|Overall Study||91
2893154|NCT00378703|3600044|FG002|NOT COMPLETED|Overall Study||90
2893155|NCT00378703|3600045|FG003|NOT COMPLETED|Overall Study||91
2893156|NCT00378898|3600057|FG000|STARTED|Overall Study||22
2893157|NCT00378898|3600058|FG001|STARTED|Overall Study||17
2893158|NCT00378898|3600057|FG000|COMPLETED|Overall Study||11
2893159|NCT00378898|3600058|FG001|COMPLETED|Overall Study||11
2893160|NCT00378898|3600057|FG000|NOT COMPLETED|Overall Study||11
2893161|NCT00378898|3600058|FG001|NOT COMPLETED|Overall Study||6
2893162|NCT00379080|3600069|FG000|STARTED|Overall Study||6
2893163|NCT00379080|3600070|FG001|STARTED|Overall Study||19
2893164|NCT00379080|3600071|FG002|STARTED|Overall Study||31
2893165|NCT00379080|3600069|FG000|COMPLETED|Overall Study||6
2893166|NCT00379080|3600070|FG001|COMPLETED|Overall Study||15
2893167|NCT00379080|3600071|FG002|COMPLETED|Overall Study||31
2893168|NCT00379080|3600069|FG000|NOT COMPLETED|Overall Study||0
2893169|NCT00379080|3600070|FG001|NOT COMPLETED|Overall Study||4
2893170|NCT00379080|3600071|FG002|NOT COMPLETED|Overall Study||0
2893171|NCT00379145|3600094|FG000|STARTED|Overall Study||20
2893172|NCT00379145|3600094|FG000|COMPLETED|Overall Study||20
2893173|NCT00379145|3600094|FG000|NOT COMPLETED|Overall Study||0
2893174|NCT00379197|3600103|FG000|STARTED|Overall Study||13
2893175|NCT00379197|3600103|FG000|COMPLETED|Overall Study||8
2893176|NCT00379197|3600103|FG000|NOT COMPLETED|Overall Study||5
2893177|NCT00379210|3600110|FG000|STARTED|Overall Study||30
2893178|NCT00379210|3600111|FG001|STARTED|Overall Study||30
2893179|NCT00379210|3600110|FG000|COMPLETED|Overall Study||20
2893180|NCT00379210|3600111|FG001|COMPLETED|Overall Study||23
2893181|NCT00379210|3600110|FG000|NOT COMPLETED|Overall Study||10
2893182|NCT00379210|3600111|FG001|NOT COMPLETED|Overall Study||7
2893183|NCT00379236|3600119|FG000|STARTED|Double-blind||293
2893184|NCT00379236|3600120|FG001|STARTED|Double-blind||295
2893185|NCT00379236|3600121|FG002|STARTED|Double-blind||0
2893186|NCT00379236|3600119|FG000|COMPLETED|Double-blind|Data could not be retrieved for two participants|257
2893187|NCT00379236|3600120|FG001|COMPLETED|Double-blind|Data could not be retrieved for two participants|259
2893188|NCT00379236|3600121|FG002|COMPLETED|Double-blind||0
2893189|NCT00379236|3600119|FG000|NOT COMPLETED|Double-blind||36
2893190|NCT00379236|3600120|FG001|NOT COMPLETED|Double-blind||36
2893191|NCT00379236|3600121|FG002|NOT COMPLETED|Double-blind||0
2893192|NCT00379236|3600119|FG000|STARTED|Open-label Extension||0
2893193|NCT00379236|3600120|FG001|STARTED|Open-label Extension||0
2893194|NCT00379236|3600121|FG002|STARTED|Open-label Extension||433
2893195|NCT00379236|3600119|FG000|COMPLETED|Open-label Extension||0
2893196|NCT00379236|3600120|FG001|COMPLETED|Open-label Extension||0
2893197|NCT00379236|3600121|FG002|COMPLETED|Open-label Extension||378
2893198|NCT00379236|3600119|FG000|NOT COMPLETED|Open-label Extension||0
2893199|NCT00379236|3600120|FG001|NOT COMPLETED|Open-label Extension||0
2893200|NCT00379236|3600121|FG002|NOT COMPLETED|Open-label Extension||55
2893201|NCT00379340|3600138|FG000|STARTED|Overall Study||120
2893202|NCT00379340|3600139|FG001|STARTED|Overall Study||135
2893203|NCT00379340|3600140|FG002|STARTED|Overall Study||52
2893204|NCT00379340|3600141|FG003|STARTED|Overall Study||50
2893205|NCT00379340|3600142|FG004|STARTED|Overall Study||23
2893206|NCT00379340|3600138|FG000|COMPLETED|Overall Study||107
2893207|NCT00379340|3600139|FG001|COMPLETED|Overall Study||132
2893208|NCT00379340|3600140|FG002|COMPLETED|Overall Study||50
2893209|NCT00379340|3600141|FG003|COMPLETED|Overall Study||37
2893210|NCT00379340|3600142|FG004|COMPLETED|Overall Study||9
2893211|NCT00379340|3600138|FG000|NOT COMPLETED|Overall Study||13
2893212|NCT00379340|3600139|FG001|NOT COMPLETED|Overall Study||3
2893213|NCT00379340|3600140|FG002|NOT COMPLETED|Overall Study||2
2893214|NCT00379340|3600141|FG003|NOT COMPLETED|Overall Study||13
3170572|NCT01930045|3897919|FG002|STARTED|Part 1 - Period 1||3
3170573|NCT01930045|3897920|FG003|STARTED|Part 1 - Period 1||3
3170574|NCT01930045|3897921|FG004|STARTED|Part 1 - Period 1||3
2893215|NCT00379340|3600142|FG004|NOT COMPLETED|Overall Study||14
2893216|NCT00379353|3600157|FG000|STARTED|Overall Study||16
2893217|NCT00379353|3600158|FG001|STARTED|Overall Study||15
2893218|NCT00379353|3600157|FG000|COMPLETED|Overall Study||5
2893219|NCT00379353|3600158|FG001|COMPLETED|Overall Study||9
2893220|NCT00379353|3600157|FG000|NOT COMPLETED|Overall Study||11
2893221|NCT00379353|3600158|FG001|NOT COMPLETED|Overall Study||6
2893222|NCT00379574|3600174|FG000|STARTED|Overall Study|Phase I (9) + Phase II (40)|49
2893223|NCT00379574|3600174|FG000|COMPLETED|Overall Study|Phase I (9) + Phase II (40)|49
2893224|NCT00379574|3600174|FG000|NOT COMPLETED|Overall Study||0
2893225|NCT00379587|3600178|FG000|STARTED|Overall Study||65
2893226|NCT00379587|3600178|FG000|COMPLETED|Overall Study||63
2893227|NCT00379587|3600178|FG000|NOT COMPLETED|Overall Study||2
2893228|NCT00379639|3600187|FG000|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|7
2893229|NCT00379639|3600188|FG001|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|7
2893230|NCT00379639|3600189|FG002|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|10
2893231|NCT00379639|3600190|FG003|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|6
2893232|NCT00379639|3600191|FG004|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|6
2893233|NCT00379639|3600187|FG000|Efficacy Evaluable Population|Overall Study|Completed ≥2 consecutive treatment cycles, had ≥1 efficacy assessment & no major protocol violations|6
2893234|NCT00379639|3600188|FG001|Efficacy Evaluable Population|Overall Study|Completed ≥2 consecutive treatment cycles, had ≥1 efficacy assessment & no major protocol violations|7
2893235|NCT00379639|3600189|FG002|Efficacy Evaluable Population|Overall Study|Completed ≥2 consecutive treatment cycles, had ≥1 efficacy assessment & no major protocol violations|7
2893236|NCT00379639|3600190|FG003|Efficacy Evaluable Population|Overall Study|Completed ≥2 consecutive treatment cycles, had ≥1 efficacy assessment & no major protocol violations|4
2893237|NCT00379639|3600191|FG004|Efficacy Evaluable Population|Overall Study|Completed ≥2 consecutive treatment cycles, had ≥1 efficacy assessment & no major protocol violations|3
2893238|NCT00379639|3600187|FG000|Completed 6 Cycles of Therapy|Overall Study||4
2893239|NCT00379639|3600188|FG001|Completed 6 Cycles of Therapy|Overall Study||2
2893240|NCT00379639|3600189|FG002|Completed 6 Cycles of Therapy|Overall Study||1
2893241|NCT00379639|3600190|FG003|Completed 6 Cycles of Therapy|Overall Study||0
2893242|NCT00379639|3600191|FG004|Completed 6 Cycles of Therapy|Overall Study||0
2893243|NCT00379639|3600187|FG000|COMPLETED|Overall Study|Represents patients who completed the study through Cycle 6|4
2893244|NCT00379639|3600188|FG001|COMPLETED|Overall Study|Represents patients who completed the study through Cycle 6|2
2893245|NCT00379639|3600189|FG002|COMPLETED|Overall Study|Represents patients who completed the study through Cycle 6|1
2893246|NCT00379639|3600190|FG003|COMPLETED|Overall Study|Represents patients who completed the study through Cycle 6|0
2893247|NCT00379639|3600191|FG004|COMPLETED|Overall Study|Represents patients who completed the study through Cycle 6|0
2893248|NCT00379639|3600187|FG000|NOT COMPLETED|Overall Study||3
2893249|NCT00379639|3600188|FG001|NOT COMPLETED|Overall Study||5
2893250|NCT00379639|3600189|FG002|NOT COMPLETED|Overall Study||9
2893251|NCT00379639|3600190|FG003|NOT COMPLETED|Overall Study||6
2893252|NCT00379639|3600191|FG004|NOT COMPLETED|Overall Study||6
2893253|NCT00379769|3600207|FG000|STARTED|Main Study||1117
2893254|NCT00379769|3600208|FG001|STARTED|Main Study||1105
2893255|NCT00379769|3600209|FG002|STARTED|Main Study||1103
2893256|NCT00379769|3600210|FG003|STARTED|Main Study||1122
2893257|NCT00379769|3600211|FG004|STARTED|Main Study||0
2893258|NCT00379769|3600212|FG005|STARTED|Main Study||0
2893259|NCT00379769|3600207|FG000|COMPLETED|Main Study||939
2893260|NCT00379769|3600208|FG001|COMPLETED|Main Study||906
2893261|NCT00379769|3600209|FG002|COMPLETED|Main Study||896
2893262|NCT00379769|3600210|FG003|COMPLETED|Main Study||892
2893263|NCT00379769|3600211|FG004|COMPLETED|Main Study||0
2893264|NCT00379769|3600212|FG005|COMPLETED|Main Study||0
2893265|NCT00379769|3600207|FG000|NOT COMPLETED|Main Study||178
2893266|NCT00379769|3600208|FG001|NOT COMPLETED|Main Study||199
2893267|NCT00379769|3600209|FG002|NOT COMPLETED|Main Study||207
2893268|NCT00379769|3600210|FG003|NOT COMPLETED|Main Study||230
2893269|NCT00379769|3600211|FG004|NOT COMPLETED|Main Study||0
2893270|NCT00379769|3600212|FG005|NOT COMPLETED|Main Study||0
2893271|NCT00379769|3600207|FG000|STARTED|Observational Follow-up||0
2893272|NCT00379769|3600208|FG001|STARTED|Observational Follow-up||0
2893273|NCT00379769|3600209|FG002|STARTED|Observational Follow-up||0
2893274|NCT00379769|3600210|FG003|STARTED|Observational Follow-up||0
2893275|NCT00379769|3600211|FG004|STARTED|Observational Follow-up|"665 from RSG in Addition to Background MET arm; 615 from RGS in Addition to Background SU arm."|1280
2893276|NCT00379769|3600212|FG005|STARTED|Observational Follow-up|"647 from SU in Addition to Background MET arm; 603 from MET in Addition to Background SU arm."|1250
2893277|NCT00379769|3600207|FG000|COMPLETED|Observational Follow-up||0
2893278|NCT00379769|3600208|FG001|COMPLETED|Observational Follow-up||0
2893279|NCT00379769|3600209|FG002|COMPLETED|Observational Follow-up||0
2893280|NCT00379769|3600210|FG003|COMPLETED|Observational Follow-up||0
2893281|NCT00379769|3600211|FG004|COMPLETED|Observational Follow-up||1131
2893282|NCT00379769|3600212|FG005|COMPLETED|Observational Follow-up||1102
2893283|NCT00379769|3600207|FG000|NOT COMPLETED|Observational Follow-up||0
2893284|NCT00379769|3600208|FG001|NOT COMPLETED|Observational Follow-up||0
2893285|NCT00379769|3600209|FG002|NOT COMPLETED|Observational Follow-up||0
2893286|NCT00379769|3600210|FG003|NOT COMPLETED|Observational Follow-up||0
2893287|NCT00379769|3600211|FG004|NOT COMPLETED|Observational Follow-up||149
2893288|NCT00379769|3600212|FG005|NOT COMPLETED|Observational Follow-up||148
2893289|NCT00379795|3600244|FG000|STARTED|Overall Study||526
2893290|NCT00379795|3600245|FG001|STARTED|Overall Study||74
2893291|NCT00379795|3600246|FG002|STARTED|Overall Study||116
2893292|NCT00379795|3600247|FG003|STARTED|Overall Study||74
2893293|NCT00379795|3600248|FG004|STARTED|Overall Study||63
2893294|NCT00379795|3600244|FG000|Received Ranibizumab in Extension Study|Overall Study||377
2893295|NCT00379795|3600245|FG001|Received Ranibizumab in Extension Study|Overall Study||41
2893296|NCT00379795|3600246|FG002|Received Ranibizumab in Extension Study|Overall Study||113
2893297|NCT00379795|3600247|FG003|Received Ranibizumab in Extension Study|Overall Study||55
2893298|NCT00379795|3600248|FG004|Received Ranibizumab in Extension Study|Overall Study||0
2893299|NCT00379795|3600244|FG000|COMPLETED|Overall Study||50
2893300|NCT00379795|3600245|FG001|COMPLETED|Overall Study||23
2893301|NCT00379795|3600246|FG002|COMPLETED|Overall Study||23
2893302|NCT00379795|3600247|FG003|COMPLETED|Overall Study||6
2893303|NCT00379795|3600248|FG004|COMPLETED|Overall Study||14
2893304|NCT00379795|3600244|FG000|NOT COMPLETED|Overall Study||476
2893305|NCT00379795|3600245|FG001|NOT COMPLETED|Overall Study||51
2893306|NCT00379795|3600246|FG002|NOT COMPLETED|Overall Study||93
2893307|NCT00379795|3600247|FG003|NOT COMPLETED|Overall Study||68
2893308|NCT00379795|3600248|FG004|NOT COMPLETED|Overall Study||49
2893309|NCT00379808|3600263|FG000|STARTED|Intervention Period 1 (4 Weeks)||11
2893310|NCT00379808|3600264|FG001|STARTED|Intervention Period 1 (4 Weeks)||11
2893311|NCT00379808|3600263|FG000|COMPLETED|Intervention Period 1 (4 Weeks)||11
2893312|NCT00379808|3600264|FG001|COMPLETED|Intervention Period 1 (4 Weeks)||11
2893313|NCT00379808|3600263|FG000|NOT COMPLETED|Intervention Period 1 (4 Weeks)||0
2893314|NCT00379808|3600264|FG001|NOT COMPLETED|Intervention Period 1 (4 Weeks)||0
2893315|NCT00379808|3600263|FG000|STARTED|Intervention Period 2 (4 Weeks)||11
2893316|NCT00379808|3600264|FG001|STARTED|Intervention Period 2 (4 Weeks)||11
2893317|NCT00379808|3600263|FG000|COMPLETED|Intervention Period 2 (4 Weeks)||11
2893318|NCT00379808|3600264|FG001|COMPLETED|Intervention Period 2 (4 Weeks)||10
2893319|NCT00379808|3600263|FG000|NOT COMPLETED|Intervention Period 2 (4 Weeks)||0
2893320|NCT00379808|3600264|FG001|NOT COMPLETED|Intervention Period 2 (4 Weeks)||1
2893321|NCT00379821|3600274|FG000|STARTED|Overall Study||160
2893322|NCT00379821|3600275|FG001|STARTED|Overall Study||160
2893323|NCT00379821|3600276|FG002|STARTED|Overall Study||160
2893324|NCT00379821|3600277|FG003|STARTED|Overall Study||160
2893325|NCT00379821|3600274|FG000|COMPLETED|Overall Study||87
2893326|NCT00379821|3600275|FG001|COMPLETED|Overall Study||71
2893327|NCT00379821|3600276|FG002|COMPLETED|Overall Study||93
2893328|NCT00379821|3600277|FG003|COMPLETED|Overall Study||81
2893329|NCT00379821|3600274|FG000|NOT COMPLETED|Overall Study||73
2893330|NCT00379821|3600275|FG001|NOT COMPLETED|Overall Study||89
2893331|NCT00379821|3600276|FG002|NOT COMPLETED|Overall Study||67
3170575|NCT01930045|3897922|FG005|STARTED|Part 1 - Period 1||3
3170576|NCT01930045|3897917|FG000|COMPLETED|Part 1 - Period 1||3
2893332|NCT00379821|3600277|FG003|NOT COMPLETED|Overall Study||79
2893333|NCT00379834|3600294|FG000|STARTED|Overall Study||10
2893334|NCT00379834|3600294|FG000|COMPLETED|Overall Study||8
2893335|NCT00379834|3600294|FG000|NOT COMPLETED|Overall Study||2
2893336|NCT00379899|3600300|FG000|STARTED|Overall Study||180
2893337|NCT00379899|3600301|FG001|STARTED|Overall Study||180
2893338|NCT00379899|3600300|FG000|COMPLETED|Overall Study||140
2893339|NCT00379899|3600301|FG001|COMPLETED|Overall Study||140
2893340|NCT00379899|3600300|FG000|NOT COMPLETED|Overall Study||40
2893341|NCT00379899|3600301|FG001|NOT COMPLETED|Overall Study||40
2893342|NCT00379912|3600309|FG000|STARTED|Overall Study||7
2893343|NCT00379912|3600310|FG001|STARTED|Overall Study||8
2893344|NCT00379912|3600309|FG000|COMPLETED|Overall Study||6
2893345|NCT00379912|3600310|FG001|COMPLETED|Overall Study||8
2893346|NCT00379912|3600309|FG000|NOT COMPLETED|Overall Study||1
2893347|NCT00379912|3600310|FG001|NOT COMPLETED|Overall Study||0
2893348|NCT00380029|3600322|FG000|STARTED|Overall Study||20
2893349|NCT00380029|3600322|FG000|COMPLETED|Overall Study||20
2893350|NCT00380029|3600322|FG000|NOT COMPLETED|Overall Study||0
2893351|NCT00380068|3600330|FG000|STARTED|Overall Study||224
2893352|NCT00380068|3600330|FG000|COMPLETED|Overall Study||155
2893353|NCT00380068|3600330|FG000|NOT COMPLETED|Overall Study||69
2893354|NCT00380081|3600340|FG000|STARTED|Overall Study||14
2893355|NCT00380081|3600341|FG001|STARTED|Overall Study||13
2893356|NCT00380081|3600342|FG002|STARTED|Overall Study||13
2893357|NCT00380081|3600343|FG003|STARTED|Overall Study||15
2893358|NCT00380081|3600344|FG004|STARTED|Overall Study||13
2893359|NCT00380081|3600345|FG005|STARTED|Overall Study||14
2893360|NCT00380081|3600340|FG000|COMPLETED|Overall Study||14
2893361|NCT00380081|3600341|FG001|COMPLETED|Overall Study||13
2893362|NCT00380081|3600342|FG002|COMPLETED|Overall Study||13
2893363|NCT00380081|3600343|FG003|COMPLETED|Overall Study||15
2893364|NCT00380081|3600344|FG004|COMPLETED|Overall Study||12
2893365|NCT00380081|3600345|FG005|COMPLETED|Overall Study||13
2893366|NCT00380081|3600340|FG000|NOT COMPLETED|Overall Study||0
2893367|NCT00380081|3600341|FG001|NOT COMPLETED|Overall Study||0
2893368|NCT00380081|3600342|FG002|NOT COMPLETED|Overall Study||0
2893369|NCT00380081|3600343|FG003|NOT COMPLETED|Overall Study||0
2893370|NCT00380081|3600344|FG004|NOT COMPLETED|Overall Study||1
2893371|NCT00380081|3600345|FG005|NOT COMPLETED|Overall Study||1
2893372|NCT00380250|3600355|FG000|STARTED|Overall Study||396
2893373|NCT00380250|3600356|FG001|STARTED|Overall Study||194
2893374|NCT00380250|3600355|FG000|COMPLETED|Overall Study||297
2893375|NCT00380250|3600356|FG001|COMPLETED|Overall Study||139
2893376|NCT00380250|3600355|FG000|NOT COMPLETED|Overall Study||99
2893377|NCT00380250|3600356|FG001|NOT COMPLETED|Overall Study||55
2893378|NCT00380367|3600362|FG000|STARTED|Overall Study||110
2893379|NCT00380367|3600362|FG000|COMPLETED|Overall Study||108
2893380|NCT00380367|3600362|FG000|NOT COMPLETED|Overall Study||2
2919823|NCT00534313|3630248|FG002|STARTED|Long-term Period||43
2919824|NCT00534313|3630249|FG003|STARTED|Long-term Period||33
2919825|NCT00534313|3630246|FG000|COMPLETED|Long-term Period||0
2919826|NCT00534313|3630247|FG001|COMPLETED|Long-term Period||0
2919827|NCT00534313|3630248|FG002|COMPLETED|Long-term Period||0
2919828|NCT00534313|3630249|FG003|COMPLETED|Long-term Period||0
2919829|NCT00534313|3630246|FG000|NOT COMPLETED|Long-term Period||37
2919830|NCT00534313|3630247|FG001|NOT COMPLETED|Long-term Period||34
2919831|NCT00534313|3630248|FG002|NOT COMPLETED|Long-term Period||43
2919832|NCT00534313|3630249|FG003|NOT COMPLETED|Long-term Period||33
2919833|NCT00534352|3630294|FG000|STARTED|Treatment A: TMC125 + TDF/FTC||23
3170577|NCT01930045|3897918|FG001|COMPLETED|Part 1 - Period 1||3
3170578|NCT01930045|3897919|FG002|COMPLETED|Part 1 - Period 1||3
3170579|NCT01930045|3897920|FG003|COMPLETED|Part 1 - Period 1||3
3170580|NCT01930045|3897921|FG004|COMPLETED|Part 1 - Period 1||3
3170581|NCT01930045|3897922|FG005|COMPLETED|Part 1 - Period 1||3
3170582|NCT01930045|3897917|FG000|NOT COMPLETED|Part 1 - Period 1||0
3170583|NCT01930045|3897918|FG001|NOT COMPLETED|Part 1 - Period 1||0
3170584|NCT01930045|3897919|FG002|NOT COMPLETED|Part 1 - Period 1||0
2919834|NCT00534352|3630294|FG000|COMPLETED|Treatment A: TMC125 + TDF/FTC||21
2919835|NCT00534352|3630294|FG000|NOT COMPLETED|Treatment A: TMC125 + TDF/FTC||2
2919836|NCT00534352|3630294|FG000|STARTED|Treatment B: TMC125 + TDF/FTC + DRV/Rtv||21
2919837|NCT00534352|3630294|FG000|COMPLETED|Treatment B: TMC125 + TDF/FTC + DRV/Rtv||21
2919838|NCT00534352|3630294|FG000|NOT COMPLETED|Treatment B: TMC125 + TDF/FTC + DRV/Rtv||0
2919839|NCT00534352|3630294|FG000|STARTED|Treatment C: DRV/Rtv + TDF/FTC||21
2919840|NCT00534352|3630294|FG000|COMPLETED|Treatment C: DRV/Rtv + TDF/FTC||20
2919841|NCT00534352|3630294|FG000|NOT COMPLETED|Treatment C: DRV/Rtv + TDF/FTC||1
2919842|NCT00534352|3630294|FG000|STARTED|Optional Extension: DRV/Rtv + TDF/FTC||18
2919843|NCT00534352|3630294|FG000|COMPLETED|Optional Extension: DRV/Rtv + TDF/FTC||14
2919844|NCT00534352|3630294|FG000|NOT COMPLETED|Optional Extension: DRV/Rtv + TDF/FTC||4
2919845|NCT00534365|3630309|FG000|STARTED|Overall Study||127
2919846|NCT00534365|3630310|FG001|STARTED|Overall Study||136
2919847|NCT00534365|3630309|FG000|Received Procedure|Overall Study||127
2919848|NCT00534365|3630310|FG001|Received Procedure|Overall Study|7 patients excluded due to receipt of sling other than mini-sling|129
2919849|NCT00534365|3630309|FG000|Any Follow up|Overall Study||126
2919850|NCT00534365|3630310|FG001|Any Follow up|Overall Study||135
2919851|NCT00534365|3630309|FG000|Follow up at 12 Months or More|Overall Study||119
2919852|NCT00534365|3630310|FG001|Follow up at 12 Months or More|Overall Study||128
2919853|NCT00534365|3630309|FG000|Included in Intent to Treat Analysis|Overall Study||127
2919854|NCT00534365|3630310|FG001|Included in Intent to Treat Analysis|Overall Study||136
2919855|NCT00534365|3630309|FG000|COMPLETED|Overall Study||127
2919856|NCT00534365|3630310|FG001|COMPLETED|Overall Study||129
2919857|NCT00534365|3630309|FG000|NOT COMPLETED|Overall Study||0
2919858|NCT00534365|3630310|FG001|NOT COMPLETED|Overall Study||7
2919859|NCT00534404|3630321|FG000|STARTED|Overall Study||827
2919860|NCT00534404|3630322|FG001|STARTED|Overall Study||830
2919861|NCT00534404|3630323|FG002|STARTED|Overall Study||828
2919862|NCT00534404|3630321|FG000|Completed at Least 1 Online Session|Overall Study||781
2919863|NCT00534404|3630322|FG001|Completed at Least 1 Online Session|Overall Study||813
2919864|NCT00534404|3630323|FG002|Completed at Least 1 Online Session|Overall Study||658
2919865|NCT00534404|3630321|FG000|Completed First NRT Order|Overall Study||765
2919866|NCT00534404|3630322|FG001|Completed First NRT Order|Overall Study|Participants could order NRT without completing a web session|821
2919867|NCT00534404|3630323|FG002|Completed First NRT Order|Overall Study|NRT was not available for this arm|0
2919868|NCT00534404|3630321|FG000|Completed Second NRT Order|Overall Study||640
2919869|NCT00534404|3630322|FG001|Completed Second NRT Order|Overall Study||789
2919870|NCT00534404|3630323|FG002|Completed Second NRT Order|Overall Study|NRT not available for this arm.|0
2919871|NCT00534404|3630321|FG000|Completed at Least 1 Counseling Call|Overall Study||813
2919872|NCT00534404|3630322|FG001|Completed at Least 1 Counseling Call|Overall Study|There was no counseling offered in this arm|0
2919873|NCT00534404|3630323|FG002|Completed at Least 1 Counseling Call|Overall Study|There was no counseling offered in this arm|0
2919874|NCT00534404|3630321|FG000|1-month Follow up Completed|Overall Study||742
2919875|NCT00534404|3630322|FG001|1-month Follow up Completed|Overall Study||781
2919876|NCT00534404|3630323|FG002|1-month Follow up Completed|Overall Study||626
2919877|NCT00534404|3630321|FG000|3-month Follow up Completed|Overall Study||682
2919878|NCT00534404|3630322|FG001|3-month Follow up Completed|Overall Study||731
2919879|NCT00534404|3630323|FG002|3-month Follow up Completed|Overall Study||593
2919880|NCT00534404|3630321|FG000|COMPLETED|Overall Study||647
2919881|NCT00534404|3630322|FG001|COMPLETED|Overall Study||687
2919882|NCT00534404|3630323|FG002|COMPLETED|Overall Study||586
2919883|NCT00534404|3630321|FG000|NOT COMPLETED|Overall Study||180
3170585|NCT01930045|3897920|FG003|NOT COMPLETED|Part 1 - Period 1||0
3170586|NCT01930045|3897921|FG004|NOT COMPLETED|Part 1 - Period 1||0
2919884|NCT00534404|3630322|FG001|NOT COMPLETED|Overall Study||143
2919885|NCT00534404|3630323|FG002|NOT COMPLETED|Overall Study||242
2919886|NCT00534417|3630331|FG000|STARTED|Overall Study||41
3170587|NCT01930045|3897922|FG005|NOT COMPLETED|Part 1 - Period 1||0
3170588|NCT01930045|3897917|FG000|STARTED|Part 1 - Period 2||3
3170589|NCT01930045|3897918|FG001|STARTED|Part 1 - Period 2||3
3170590|NCT01930045|3897919|FG002|STARTED|Part 1 - Period 2||3
3170591|NCT01930045|3897920|FG003|STARTED|Part 1 - Period 2||3
3170592|NCT01930045|3897921|FG004|STARTED|Part 1 - Period 2||3
3170593|NCT01930045|3897922|FG005|STARTED|Part 1 - Period 2||3
2893381|NCT00380393|3600368|FG000|STARTED|Month 8 (Cross-sectional Visit)||447
2893382|NCT00380393|3600369|FG001|STARTED|Month 8 (Cross-sectional Visit)||447
2893383|NCT00380393|3600368|FG000|COMPLETED|Month 8 (Cross-sectional Visit)||398
2893384|NCT00380393|3600369|FG001|COMPLETED|Month 8 (Cross-sectional Visit)||407
2893385|NCT00380393|3600368|FG000|NOT COMPLETED|Month 8 (Cross-sectional Visit)||49
2893386|NCT00380393|3600369|FG001|NOT COMPLETED|Month 8 (Cross-sectional Visit)||40
2893387|NCT00380393|3600368|FG000|STARTED|Month 14||447
2893388|NCT00380393|3600369|FG001|STARTED|Month 14||447
2893389|NCT00380393|3600368|FG000|COMPLETED|Month 14||390
2893390|NCT00380393|3600369|FG001|COMPLETED|Month 14||391
2893391|NCT00380393|3600368|FG000|NOT COMPLETED|Month 14||57
2893392|NCT00380393|3600369|FG001|NOT COMPLETED|Month 14||56
2893393|NCT00380588|3600377|FG000|STARTED|Overall Study||42
2893394|NCT00380588|3600378|FG001|STARTED|Overall Study||42
2893395|NCT00380588|3600377|FG000|Received at Least One Dose of Study Drug|Overall Study||41
2893396|NCT00380588|3600378|FG001|Received at Least One Dose of Study Drug|Overall Study||42
2893397|NCT00380588|3600377|FG000|COMPLETED|Overall Study|Treatment period reached 48 week maximum.|3
2893398|NCT00380588|3600378|FG001|COMPLETED|Overall Study|Treatment period reached 48 week maximum.|2
2893399|NCT00380588|3600377|FG000|NOT COMPLETED|Overall Study||39
2893400|NCT00380588|3600378|FG001|NOT COMPLETED|Overall Study||40
2893401|NCT00380692|3600386|FG000|STARTED|Study Period II - Double Blind||48
2893402|NCT00380692|3600387|FG001|STARTED|Study Period II - Double Blind||49
2893403|NCT00380692|3600386|FG000|COMPLETED|Study Period II - Double Blind||43
2893404|NCT00380692|3600387|FG001|COMPLETED|Study Period II - Double Blind||46
2893405|NCT00380692|3600386|FG000|NOT COMPLETED|Study Period II - Double Blind||5
2893406|NCT00380692|3600387|FG001|NOT COMPLETED|Study Period II - Double Blind||3
2893407|NCT00380692|3600386|FG000|STARTED|Study Period III - Open Label|One patient who completed Study Period II did not enter Study Period III.|42
2893408|NCT00380692|3600387|FG001|STARTED|Study Period III - Open Label||46
2893409|NCT00380692|3600386|FG000|COMPLETED|Study Period III - Open Label||36
2893410|NCT00380692|3600387|FG001|COMPLETED|Study Period III - Open Label||34
2893411|NCT00380692|3600386|FG000|NOT COMPLETED|Study Period III - Open Label||6
2893412|NCT00380692|3600387|FG001|NOT COMPLETED|Study Period III - Open Label||12
2893413|NCT00380718|3600393|FG000|STARTED|Overall Study||33
2893414|NCT00380718|3600393|FG000|Received at Least One Dose of Study Drug|Overall Study||33
2893415|NCT00380718|3600393|FG000|Received Escalated Dose in Cycle 2|Overall Study||25
2893416|NCT00380718|3600393|FG000|COMPLETED|Overall Study||15
2893417|NCT00380718|3600393|FG000|NOT COMPLETED|Overall Study||18
2893418|NCT00380744|3600404|FG000|STARTED|Overall Study||20
2893419|NCT00380744|3600405|FG001|STARTED|Overall Study||4
2893420|NCT00380744|3600406|FG002|STARTED|Overall Study||20
2893421|NCT00380744|3600407|FG003|STARTED|Overall Study||4
2893422|NCT00380744|3600408|FG004|STARTED|Overall Study||23
2893423|NCT00380744|3600409|FG005|STARTED|Overall Study||25
2893424|NCT00380744|3600410|FG006|STARTED|Overall Study||25
2893425|NCT00380744|3600404|FG000|Received at Least 1 Dose of Study Drug|Overall Study||20
2893426|NCT00380744|3600405|FG001|Received at Least 1 Dose of Study Drug|Overall Study||4
2893427|NCT00380744|3600406|FG002|Received at Least 1 Dose of Study Drug|Overall Study||20
2893428|NCT00380744|3600407|FG003|Received at Least 1 Dose of Study Drug|Overall Study||4
2893429|NCT00380744|3600408|FG004|Received at Least 1 Dose of Study Drug|Overall Study||23
2893430|NCT00380744|3600409|FG005|Received at Least 1 Dose of Study Drug|Overall Study||25
2893431|NCT00380744|3600410|FG006|Received at Least 1 Dose of Study Drug|Overall Study||25
2893432|NCT00380744|3600404|FG000|COMPLETED|Overall Study||19
2893433|NCT00380744|3600405|FG001|COMPLETED|Overall Study||4
2893434|NCT00380744|3600406|FG002|COMPLETED|Overall Study||20
2893435|NCT00380744|3600407|FG003|COMPLETED|Overall Study||4
2893436|NCT00380744|3600408|FG004|COMPLETED|Overall Study||23
2893437|NCT00380744|3600409|FG005|COMPLETED|Overall Study||25
2893438|NCT00380744|3600410|FG006|COMPLETED|Overall Study||24
2893439|NCT00380744|3600404|FG000|NOT COMPLETED|Overall Study||1
2893440|NCT00380744|3600405|FG001|NOT COMPLETED|Overall Study||0
2893441|NCT00380744|3600406|FG002|NOT COMPLETED|Overall Study||0
2893442|NCT00380744|3600407|FG003|NOT COMPLETED|Overall Study||0
2893443|NCT00380744|3600408|FG004|NOT COMPLETED|Overall Study||0
2893444|NCT00380744|3600409|FG005|NOT COMPLETED|Overall Study||0
2893445|NCT00380744|3600410|FG006|NOT COMPLETED|Overall Study||1
2893446|NCT00380861|3600429|FG000|STARTED|Overall Study||93
2893447|NCT00380861|3600430|FG001|STARTED|Overall Study|Two subjects received the PFC Sigma RP-F device but not the RP and their results are not included.|91
2893448|NCT00380861|3600429|FG000|COMPLETED|Overall Study||75
2893449|NCT00380861|3600430|FG001|COMPLETED|Overall Study||74
2893450|NCT00380861|3600429|FG000|NOT COMPLETED|Overall Study||18
2893451|NCT00380861|3600430|FG001|NOT COMPLETED|Overall Study||17
2893452|NCT00380874|3600438|FG000|STARTED|Overall Study||32
2893453|NCT00380874|3600439|FG001|STARTED|Overall Study||29
2893454|NCT00380874|3600438|FG000|COMPLETED|Overall Study||19
2893455|NCT00380874|3600439|FG001|COMPLETED|Overall Study||19
2893456|NCT00380874|3600438|FG000|NOT COMPLETED|Overall Study||13
3170594|NCT01930045|3897917|FG000|COMPLETED|Part 1 - Period 2||3
2893457|NCT00380874|3600439|FG001|NOT COMPLETED|Overall Study||10
2893458|NCT00380978|3600447|FG000|STARTED|Overall Study||408
2893459|NCT00380978|3600448|FG001|STARTED|Overall Study||410
2893460|NCT00380978|3600447|FG000|COMPLETED|Overall Study||406
2893461|NCT00380978|3600448|FG001|COMPLETED|Overall Study||400
2893462|NCT00380978|3600447|FG000|NOT COMPLETED|Overall Study||2
2893463|NCT00380978|3600448|FG001|NOT COMPLETED|Overall Study||10
2893464|NCT00381004|3600454|FG000|STARTED|Overall Study||60
2893465|NCT00381004|3600454|FG000|COMPLETED|Overall Study||60
2893466|NCT00381004|3600454|FG000|NOT COMPLETED|Overall Study||0
2893467|NCT00381043|3600460|FG000|STARTED|Overall Study||51
2893468|NCT00381043|3600461|FG001|STARTED|Overall Study||49
2893469|NCT00381043|3600460|FG000|COMPLETED|Overall Study||39
2893470|NCT00381043|3600461|FG001|COMPLETED|Overall Study||41
2893471|NCT00381043|3600460|FG000|NOT COMPLETED|Overall Study||12
2893472|NCT00381043|3600461|FG001|NOT COMPLETED|Overall Study||8
3170595|NCT01930045|3897918|FG001|COMPLETED|Part 1 - Period 2||3
3170596|NCT01930045|3897919|FG002|COMPLETED|Part 1 - Period 2||3
3170597|NCT01930045|3897920|FG003|COMPLETED|Part 1 - Period 2||3
3170598|NCT01930045|3897921|FG004|COMPLETED|Part 1 - Period 2||3
3170599|NCT01930045|3897922|FG005|COMPLETED|Part 1 - Period 2||3
2893473|NCT00381095|3600469|FG000|STARTED|Overall Study||72
2893474|NCT00381095|3600470|FG001|STARTED|Overall Study||80
2893475|NCT00381095|3600469|FG000|COMPLETED|Overall Study||59
2893476|NCT00381095|3600470|FG001|COMPLETED|Overall Study||59
2893477|NCT00381095|3600469|FG000|NOT COMPLETED|Overall Study||13
2893478|NCT00381095|3600470|FG001|NOT COMPLETED|Overall Study||21
2893479|NCT00381238|3600476|FG000|STARTED|Overall Study||33
2893480|NCT00381238|3600476|FG000|COMPLETED|Overall Study||21
2893481|NCT00381238|3600476|FG000|NOT COMPLETED|Overall Study||12
2893482|NCT00381303|3600482|FG000|STARTED|Overall Study||287
2893483|NCT00381303|3600483|FG001|STARTED|Overall Study||142
2893484|NCT00381303|3600482|FG000|COMPLETED|Overall Study||193
2893485|NCT00381303|3600483|FG001|COMPLETED|Overall Study||109
2893486|NCT00381303|3600482|FG000|NOT COMPLETED|Overall Study||94
2893487|NCT00381303|3600483|FG001|NOT COMPLETED|Overall Study||33
2893488|NCT00381550|3600501|FG000|STARTED|Overall Study||35
2893489|NCT00381550|3600501|FG000|COMPLETED|Overall Study||35
2893490|NCT00381550|3600501|FG000|NOT COMPLETED|Overall Study||0
2893491|NCT00381563|3600507|FG000|STARTED|Overall Study||41
2893492|NCT00381563|3600508|FG001|STARTED|Overall Study||39
2893493|NCT00381563|3600507|FG000|COMPLETED|Overall Study||34
2893494|NCT00381563|3600508|FG001|COMPLETED|Overall Study||33
2893495|NCT00381563|3600507|FG000|NOT COMPLETED|Overall Study||7
2893496|NCT00381563|3600508|FG001|NOT COMPLETED|Overall Study||6
2893497|NCT00381615|3600517|FG000|STARTED|Overall Study||48
2893498|NCT00381615|3600518|FG001|STARTED|Overall Study||50
2893499|NCT00381615|3600519|FG002|STARTED|Overall Study||25
2893500|NCT00381615|3600520|FG003|STARTED|Overall Study||24
2893501|NCT00381615|3600517|FG000|COMPLETED|Overall Study||44
2893502|NCT00381615|3600518|FG001|COMPLETED|Overall Study||45
2893503|NCT00381615|3600519|FG002|COMPLETED|Overall Study||24
2893504|NCT00381615|3600520|FG003|COMPLETED|Overall Study||22
2893505|NCT00381615|3600517|FG000|NOT COMPLETED|Overall Study||4
2893506|NCT00381615|3600518|FG001|NOT COMPLETED|Overall Study||5
2893507|NCT00381615|3600519|FG002|NOT COMPLETED|Overall Study||1
2893508|NCT00381615|3600520|FG003|NOT COMPLETED|Overall Study||2
2893509|NCT00381628|3600536|FG000|STARTED|Overall Study||18
2893510|NCT00381628|3600537|FG001|STARTED|Overall Study||27
2893511|NCT00381628|3600538|FG002|STARTED|Overall Study||0
2893512|NCT00381628|3600539|FG003|STARTED|Overall Study||14
2893513|NCT00381628|3600536|FG000|COMPLETED|Overall Study||18
2893514|NCT00381628|3600537|FG001|COMPLETED|Overall Study||27
2893515|NCT00381628|3600538|FG002|COMPLETED|Overall Study||0
2893516|NCT00381628|3600539|FG003|COMPLETED|Overall Study||14
2893517|NCT00381628|3600536|FG000|NOT COMPLETED|Overall Study||0
2893518|NCT00381628|3600537|FG001|NOT COMPLETED|Overall Study||0
2893519|NCT00381628|3600538|FG002|NOT COMPLETED|Overall Study||0
2893520|NCT00381628|3600539|FG003|NOT COMPLETED|Overall Study||0
2893521|NCT00381641|3600551|FG000|STARTED|Overall Study||38
2893522|NCT00381641|3600552|FG001|STARTED|Overall Study||25
2893523|NCT00381641|3600551|FG000|COMPLETED|Overall Study||38
2893524|NCT00381641|3600552|FG001|COMPLETED|Overall Study||23
2893525|NCT00381641|3600551|FG000|NOT COMPLETED|Overall Study||0
2893526|NCT00381641|3600552|FG001|NOT COMPLETED|Overall Study||2
2893527|NCT00381680|3600560|FG000|STARTED|Overall Study||206
2893528|NCT00381680|3600561|FG001|STARTED|Overall Study||69
2893529|NCT00381680|3600560|FG000|COMPLETED|Overall Study||81
2893530|NCT00381680|3600561|FG001|COMPLETED|Overall Study||19
2893531|NCT00381680|3600560|FG000|NOT COMPLETED|Overall Study||125
2893532|NCT00381680|3600561|FG001|NOT COMPLETED|Overall Study||50
2893533|NCT00381693|3600571|FG000|STARTED|Overall Study||10
2893534|NCT00381693|3600571|FG000|COMPLETED|Overall Study||2
2893535|NCT00381693|3600571|FG000|NOT COMPLETED|Overall Study||8
2893536|NCT00381706|3600581|FG000|STARTED|Overall Study||82
2893537|NCT00381706|3600582|FG001|STARTED|Overall Study||83
2893538|NCT00381706|3600583|FG002|STARTED|Overall Study||80
2893539|NCT00381706|3600581|FG000|COMPLETED|Overall Study||75
2893540|NCT00381706|3600582|FG001|COMPLETED|Overall Study||81
2893541|NCT00381706|3600583|FG002|COMPLETED|Overall Study||79
2893542|NCT00381706|3600581|FG000|NOT COMPLETED|Overall Study||7
2893543|NCT00381706|3600582|FG001|NOT COMPLETED|Overall Study||2
2893544|NCT00381706|3600583|FG002|NOT COMPLETED|Overall Study||1
2893545|NCT00381797|3600602|FG000|STARTED|Overall Study||18
2893546|NCT00381797|3600603|FG001|STARTED|Overall Study||17
2893547|NCT00381797|3600604|FG002|STARTED|Overall Study||10
2893548|NCT00381797|3600605|FG003|STARTED|Overall Study||15
2893549|NCT00381797|3600606|FG004|STARTED|Overall Study||37
2893550|NCT00381797|3600602|FG000|COMPLETED|Overall Study||17
2893551|NCT00381797|3600603|FG001|COMPLETED|Overall Study||16
2893552|NCT00381797|3600604|FG002|COMPLETED|Overall Study||10
2893553|NCT00381797|3600605|FG003|COMPLETED|Overall Study||14
2893554|NCT00381797|3600606|FG004|COMPLETED|Overall Study||35
2893555|NCT00381797|3600602|FG000|NOT COMPLETED|Overall Study||1
2893556|NCT00381797|3600603|FG001|NOT COMPLETED|Overall Study||1
2893557|NCT00381797|3600604|FG002|NOT COMPLETED|Overall Study||0
2893558|NCT00381797|3600605|FG003|NOT COMPLETED|Overall Study||1
2893559|NCT00381797|3600606|FG004|NOT COMPLETED|Overall Study||2
2893560|NCT00381810|3600639|FG000|STARTED|Treatment and Safety Follow-up||31
2893561|NCT00381810|3600639|FG000|COMPLETED|Treatment and Safety Follow-up||16
2893562|NCT00381810|3600639|FG000|NOT COMPLETED|Treatment and Safety Follow-up||15
2893563|NCT00381810|3600639|FG000|STARTED|B Cell Follow-up|Participants only entered the B cell follow-up period if their peripheral B cells were depleted.|7
2893564|NCT00381810|3600639|FG000|COMPLETED|B Cell Follow-up||0
2893565|NCT00381810|3600639|FG000|NOT COMPLETED|B Cell Follow-up||7
2893566|NCT00381849|3600645|FG000|STARTED|First Intervention||10
2893567|NCT00381849|3600646|FG001|STARTED|First Intervention||10
2893568|NCT00381849|3600645|FG000|COMPLETED|First Intervention||10
2893569|NCT00381849|3600646|FG001|COMPLETED|First Intervention||10
2893570|NCT00381849|3600645|FG000|NOT COMPLETED|First Intervention||0
2893571|NCT00381849|3600646|FG001|NOT COMPLETED|First Intervention||0
2893572|NCT00381849|3600645|FG000|STARTED|Wash Out||10
2893573|NCT00381849|3600646|FG001|STARTED|Wash Out||10
2893574|NCT00381849|3600645|FG000|COMPLETED|Wash Out||10
2893575|NCT00381849|3600646|FG001|COMPLETED|Wash Out||9
2893576|NCT00381849|3600645|FG000|NOT COMPLETED|Wash Out||0
2893577|NCT00381849|3600646|FG001|NOT COMPLETED|Wash Out||1
2893578|NCT00381849|3600645|FG000|STARTED|Second Intervention||10
2893579|NCT00381849|3600646|FG001|STARTED|Second Intervention||9
2893580|NCT00381849|3600645|FG000|COMPLETED|Second Intervention||10
2893581|NCT00381849|3600646|FG001|COMPLETED|Second Intervention||9
2893582|NCT00381849|3600645|FG000|NOT COMPLETED|Second Intervention||0
2893583|NCT00381849|3600646|FG001|NOT COMPLETED|Second Intervention||0
2893584|NCT00381849|3600645|FG000|STARTED|Open-label||10
2893585|NCT00381849|3600646|FG001|STARTED|Open-label||9
2893586|NCT00381849|3600645|FG000|COMPLETED|Open-label||10
2893587|NCT00381849|3600646|FG001|COMPLETED|Open-label||9
2893588|NCT00381849|3600645|FG000|NOT COMPLETED|Open-label||0
2893589|NCT00381849|3600646|FG001|NOT COMPLETED|Open-label||0
2893590|NCT00381862|3600652|FG000|STARTED|Overall Study||54
2893591|NCT00381862|3600652|FG000|COMPLETED|Overall Study||44
2893592|NCT00381862|3600652|FG000|NOT COMPLETED|Overall Study||10
2893593|NCT00381888|3600656|FG000|STARTED|Overall Study||44
2893594|NCT00381888|3600656|FG000|COMPLETED|Overall Study||27
2893595|NCT00381888|3600656|FG000|NOT COMPLETED|Overall Study||17
2893596|NCT00381940|3600660|FG000|STARTED|Overall Study||26
2893597|NCT00381940|3600660|FG000|COMPLETED|Overall Study||21
2893598|NCT00381940|3600660|FG000|NOT COMPLETED|Overall Study||5
2893599|NCT00381966|3600664|FG000|STARTED|Overall Study||5
2893600|NCT00381966|3600664|FG000|COMPLETED|Overall Study||5
2893601|NCT00381966|3600664|FG000|NOT COMPLETED|Overall Study||0
2893602|NCT00382018|3600672|FG000|STARTED|Overall Study||276
2893603|NCT00382018|3600673|FG001|STARTED|Overall Study||165
2893604|NCT00382018|3600674|FG002|STARTED|Overall Study||64
2893605|NCT00382018|3600675|FG003|STARTED|Overall Study||59
2893606|NCT00382018|3600672|FG000|COMPLETED|Overall Study|This group of patients did not receive protocol treatment.|276
2893607|NCT00382018|3600673|FG001|COMPLETED|Overall Study||0
2893608|NCT00382018|3600674|FG002|COMPLETED|Overall Study||0
2893609|NCT00382018|3600675|FG003|COMPLETED|Overall Study||0
2893610|NCT00382018|3600672|FG000|NOT COMPLETED|Overall Study||0
2893611|NCT00382018|3600673|FG001|NOT COMPLETED|Overall Study||165
2893612|NCT00382018|3600674|FG002|NOT COMPLETED|Overall Study||64
2893613|NCT00382018|3600675|FG003|NOT COMPLETED|Overall Study||59
2893614|NCT00382031|3600690|FG000|STARTED|Overall Study|Of the 191 randomized patients 189 received at least one infusion of zalutumumab|191
2893615|NCT00382031|3600691|FG001|STARTED|Overall Study|Of the 95 randomized patients 94 attended Visit2.|95
2893616|NCT00382031|3600690|FG000|COMPLETED|Overall Study||191
2893617|NCT00382031|3600691|FG001|COMPLETED|Overall Study||95
2893618|NCT00382031|3600690|FG000|NOT COMPLETED|Overall Study||0
2893619|NCT00382031|3600691|FG001|NOT COMPLETED|Overall Study||0
2893620|NCT00382070|3600699|FG000|STARTED|Overall Study||1983
2893621|NCT00382070|3600700|FG001|STARTED|Overall Study||1983
2893622|NCT00382070|3600699|FG000|COMPLETED|Overall Study||1950
2893623|NCT00382070|3600700|FG001|COMPLETED|Overall Study||1953
2893624|NCT00382070|3600699|FG000|NOT COMPLETED|Overall Study||33
2893625|NCT00382070|3600700|FG001|NOT COMPLETED|Overall Study||30
2893626|NCT00382109|3600708|FG000|STARTED|Overall Study||76
2893627|NCT00382109|3600709|FG001|STARTED|Overall Study||70
2893628|NCT00382109|3600708|FG000|COMPLETED|Overall Study||64
2893629|NCT00382109|3600709|FG001|COMPLETED|Overall Study||66
2893630|NCT00382109|3600708|FG000|NOT COMPLETED|Overall Study||12
2893631|NCT00382109|3600709|FG001|NOT COMPLETED|Overall Study||4
2893632|NCT00382148|3600720|FG000|STARTED|Overall Study||4
2893633|NCT00382148|3600721|FG001|STARTED|Overall Study||7
2893634|NCT00382148|3600720|FG000|COMPLETED|Overall Study||3
2893635|NCT00382148|3600721|FG001|COMPLETED|Overall Study||7
2893636|NCT00382148|3600720|FG000|NOT COMPLETED|Overall Study||1
2893637|NCT00382148|3600721|FG001|NOT COMPLETED|Overall Study||0
2893638|NCT00382174|3600729|FG000|STARTED|Overall Study||18
2893639|NCT00382174|3600730|FG001|STARTED|Overall Study||54
2893640|NCT00382174|3600731|FG002|STARTED|Overall Study||72
2893641|NCT00382174|3600729|FG000|COMPLETED|Overall Study||14
2893642|NCT00382174|3600730|FG001|COMPLETED|Overall Study||37
2893643|NCT00382174|3600731|FG002|COMPLETED|Overall Study||51
2893644|NCT00382174|3600729|FG000|NOT COMPLETED|Overall Study||4
2893645|NCT00382174|3600730|FG001|NOT COMPLETED|Overall Study||17
2893646|NCT00382174|3600731|FG002|NOT COMPLETED|Overall Study||21
2893647|NCT00382265|3600741|FG000|STARTED|Overall Study||267
2893648|NCT00382265|3600742|FG001|STARTED|Overall Study||245
2893649|NCT00382265|3600741|FG000|COMPLETED|Overall Study||258
2893650|NCT00382265|3600742|FG001|COMPLETED|Overall Study||239
2893651|NCT00382265|3600741|FG000|NOT COMPLETED|Overall Study||9
2893652|NCT00382265|3600742|FG001|NOT COMPLETED|Overall Study||6
2893653|NCT00382291|3600755|FG000|STARTED|Overall Study||18
2893654|NCT00382291|3600756|FG001|STARTED|Overall Study||17
2893655|NCT00382291|3600757|FG002|STARTED|Overall Study||21
2893656|NCT00382291|3600755|FG000|COMPLETED|Overall Study||14
2893657|NCT00382291|3600756|FG001|COMPLETED|Overall Study||10
3170600|NCT01930045|3897917|FG000|NOT COMPLETED|Part 1 - Period 2||0
3170601|NCT01930045|3897918|FG001|NOT COMPLETED|Part 1 - Period 2||0
3170602|NCT01930045|3897919|FG002|NOT COMPLETED|Part 1 - Period 2||0
3170603|NCT01930045|3897920|FG003|NOT COMPLETED|Part 1 - Period 2||0
3170604|NCT01930045|3897921|FG004|NOT COMPLETED|Part 1 - Period 2||0
3170605|NCT01930045|3897922|FG005|NOT COMPLETED|Part 1 - Period 2||0
3170606|NCT01930045|3897917|FG000|STARTED|Part 1 - Period 3||3
3170607|NCT01930045|3897918|FG001|STARTED|Part 1 - Period 3||3
3170608|NCT01930045|3897919|FG002|STARTED|Part 1 - Period 3|One participant missed treatment during Period 3 only.|2
3170609|NCT01930045|3897920|FG003|STARTED|Part 1 - Period 3||3
3170610|NCT01930045|3897921|FG004|STARTED|Part 1 - Period 3||3
3170611|NCT01930045|3897922|FG005|STARTED|Part 1 - Period 3||3
2893658|NCT00382291|3600757|FG002|COMPLETED|Overall Study||13
2893659|NCT00382291|3600755|FG000|NOT COMPLETED|Overall Study||4
2893660|NCT00382291|3600756|FG001|NOT COMPLETED|Overall Study||7
2893661|NCT00382291|3600757|FG002|NOT COMPLETED|Overall Study||8
2893662|NCT00382408|3600769|FG000|STARTED|Overall Study||3031
2893663|NCT00382408|3600770|FG001|STARTED|Overall Study||1009
2893664|NCT00382408|3600769|FG000|COMPLETED|Overall Study||2887
2893665|NCT00382408|3600770|FG001|COMPLETED|Overall Study||955
2893666|NCT00382408|3600769|FG000|NOT COMPLETED|Overall Study||144
2893667|NCT00382408|3600770|FG001|NOT COMPLETED|Overall Study||54
2893668|NCT00382590|3600778|FG000|STARTED|Overall Study||4
2893669|NCT00382590|3600779|FG001|STARTED|Overall Study||6
2893670|NCT00382590|3600778|FG000|COMPLETED|Overall Study||4
2893671|NCT00382590|3600779|FG001|COMPLETED|Overall Study||6
2893672|NCT00382590|3600778|FG000|NOT COMPLETED|Overall Study||0
2893673|NCT00382590|3600779|FG001|NOT COMPLETED|Overall Study||0
2893674|NCT00382720|3600788|FG000|STARTED|Overall Study||79
2893675|NCT00382720|3600789|FG001|STARTED|Overall Study||89
2893676|NCT00382720|3600790|FG002|STARTED|Overall Study||86
2893677|NCT00382720|3600788|FG000|Administered Non-Optimal Dose (Part I)|Overall Study||10
2893678|NCT00382720|3600789|FG001|Administered Non-Optimal Dose (Part I)|Overall Study||11
2893679|NCT00382720|3600790|FG002|Administered Non-Optimal Dose (Part I)|Overall Study||0
2893680|NCT00382720|3600788|FG000|Administered Optimal Dose (Parts I & II)|Overall Study||78
2893681|NCT00382720|3600789|FG001|Administered Optimal Dose (Parts I & II)|Overall Study||88
2893682|NCT00382720|3600790|FG002|Administered Optimal Dose (Parts I & II)|Overall Study||82
2893683|NCT00382720|3600788|FG000|Full Analysis Population (FAP)|Overall Study|ITT who received at least one dose of study medication|78
2893684|NCT00382720|3600789|FG001|Full Analysis Population (FAP)|Overall Study|ITT who received at least one dose of study medication|88
2893685|NCT00382720|3600790|FG002|Full Analysis Population (FAP)|Overall Study|ITT who received at least one dose of study medication|82
2893686|NCT00382720|3600788|FG000|COMPLETED|Overall Study||0
2893687|NCT00382720|3600789|FG001|COMPLETED|Overall Study||0
2893688|NCT00382720|3600790|FG002|COMPLETED|Overall Study||0
2893689|NCT00382720|3600788|FG000|NOT COMPLETED|Overall Study||79
2893690|NCT00382720|3600789|FG001|NOT COMPLETED|Overall Study||89
2893691|NCT00382720|3600790|FG002|NOT COMPLETED|Overall Study||86
2893692|NCT00382733|3600798|FG000|STARTED|Overall Study||3
2893693|NCT00382733|3600799|FG001|STARTED|Overall Study||4
2893694|NCT00382733|3600800|FG002|STARTED|Overall Study||3
2893695|NCT00382733|3600801|FG003|STARTED|Overall Study||14
2893696|NCT00382733|3600802|FG004|STARTED|Overall Study||2
2893697|NCT00382733|3600798|FG000|COMPLETED|Overall Study||3
2893698|NCT00382733|3600799|FG001|COMPLETED|Overall Study|1 subject withdrew consent before completing Cycle 1 - that subject was replaced|3
2893699|NCT00382733|3600800|FG002|COMPLETED|Overall Study||3
2893700|NCT00382733|3600801|FG003|COMPLETED|Overall Study||14
2893701|NCT00382733|3600802|FG004|COMPLETED|Overall Study||2
2893702|NCT00382733|3600798|FG000|NOT COMPLETED|Overall Study||0
2893703|NCT00382733|3600799|FG001|NOT COMPLETED|Overall Study||1
2893704|NCT00382733|3600800|FG002|NOT COMPLETED|Overall Study||0
2893705|NCT00382733|3600801|FG003|NOT COMPLETED|Overall Study||0
2893706|NCT00382733|3600802|FG004|NOT COMPLETED|Overall Study||0
2893707|NCT00382785|3600817|FG000|STARTED|Overall Study||25
3170612|NCT01930045|3897917|FG000|COMPLETED|Part 1 - Period 3||3
3170613|NCT01930045|3897918|FG001|COMPLETED|Part 1 - Period 3||3
2893708|NCT00382785|3600818|FG001|STARTED|Overall Study||26
2893709|NCT00382785|3600817|FG000|COMPLETED|Overall Study||25
2893710|NCT00382785|3600818|FG001|COMPLETED|Overall Study||26
2893711|NCT00382785|3600817|FG000|NOT COMPLETED|Overall Study||0
2893712|NCT00382785|3600818|FG001|NOT COMPLETED|Overall Study||0
2893713|NCT00382824|3600826|FG000|STARTED|Overall Study||32
2893714|NCT00382824|3600827|FG001|STARTED|Overall Study||29
2893715|NCT00382824|3600826|FG000|COMPLETED|Overall Study||20
2893716|NCT00382824|3600827|FG001|COMPLETED|Overall Study||16
2893717|NCT00382824|3600826|FG000|NOT COMPLETED|Overall Study||12
2893718|NCT00382824|3600827|FG001|NOT COMPLETED|Overall Study||13
2893719|NCT00382863|3600835|FG000|STARTED|Overall Study||96
2893720|NCT00382863|3600836|FG001|STARTED|Overall Study||114
2893721|NCT00382863|3600835|FG000|COMPLETED|Overall Study||81
3170614|NCT01930045|3897919|FG002|COMPLETED|Part 1 - Period 3||2
3170615|NCT01930045|3897920|FG003|COMPLETED|Part 1 - Period 3||3
3170616|NCT01930045|3897921|FG004|COMPLETED|Part 1 - Period 3||3
2893722|NCT00382863|3600836|FG001|COMPLETED|Overall Study||78
2893723|NCT00382863|3600835|FG000|NOT COMPLETED|Overall Study||15
2893724|NCT00382863|3600836|FG001|NOT COMPLETED|Overall Study||36
2893725|NCT00382928|3600844|FG000|STARTED|Overall Study||97
2893726|NCT00382928|3600845|FG001|STARTED|Overall Study||95
2893727|NCT00382928|3600844|FG000|COMPLETED|Overall Study||97
2893728|NCT00382928|3600845|FG001|COMPLETED|Overall Study||95
2893729|NCT00382928|3600844|FG000|NOT COMPLETED|Overall Study||0
2893730|NCT00382928|3600845|FG001|NOT COMPLETED|Overall Study||0
2893731|NCT00382967|3600858|FG000|STARTED|Overall Study|135 subjects enrolled at the start of the study, however, 13 subjects withdrew prior to dosing.|122
2893732|NCT00382967|3600859|FG001|STARTED|Overall Study||138
2893733|NCT00382967|3600858|FG000|COMPLETED|Overall Study|Patient lost to followup and the data was not recorded.|121
2893734|NCT00382967|3600859|FG001|COMPLETED|Overall Study|Subject dosed in error, should not have received Datscan product|137
2893735|NCT00382967|3600858|FG000|NOT COMPLETED|Overall Study||1
2893736|NCT00382967|3600859|FG001|NOT COMPLETED|Overall Study||1
2893737|NCT00382993|3600865|FG000|STARTED|Migraine Attack 1 (Period 1)||84
2893738|NCT00382993|3600866|FG001|STARTED|Migraine Attack 1 (Period 1)||85
2893739|NCT00382993|3600865|FG000|COMPLETED|Migraine Attack 1 (Period 1)|Participant considered to have completed period if treated a migraine with investigational product.|70
2893740|NCT00382993|3600866|FG001|COMPLETED|Migraine Attack 1 (Period 1)||67
2893741|NCT00382993|3600865|FG000|NOT COMPLETED|Migraine Attack 1 (Period 1)||14
2893742|NCT00382993|3600866|FG001|NOT COMPLETED|Migraine Attack 1 (Period 1)||18
2893743|NCT00382993|3600865|FG000|STARTED|Migraine Attack 2 (Period 2)||70
2893744|NCT00382993|3600866|FG001|STARTED|Migraine Attack 2 (Period 2)||67
2893745|NCT00382993|3600865|FG000|COMPLETED|Migraine Attack 2 (Period 2)||68
2893746|NCT00382993|3600866|FG001|COMPLETED|Migraine Attack 2 (Period 2)||63
2893747|NCT00382993|3600865|FG000|NOT COMPLETED|Migraine Attack 2 (Period 2)||2
2893748|NCT00382993|3600866|FG001|NOT COMPLETED|Migraine Attack 2 (Period 2)||4
2893749|NCT00383019|3600874|FG000|STARTED|Overall Study||144
2893750|NCT00383019|3600875|FG001|STARTED|Overall Study||145
2893751|NCT00383019|3600874|FG000|COMPLETED|Overall Study||139
2893752|NCT00383019|3600875|FG001|COMPLETED|Overall Study||143
2893753|NCT00383019|3600874|FG000|NOT COMPLETED|Overall Study||5
2893754|NCT00383019|3600875|FG001|NOT COMPLETED|Overall Study||2
2893755|NCT00383071|3600885|FG000|STARTED|Overall Study||25
2893756|NCT00383071|3600886|FG001|STARTED|Overall Study||25
2893757|NCT00383071|3600887|FG002|STARTED|Overall Study||51
2893758|NCT00383071|3600888|FG003|STARTED|Overall Study||25
2893759|NCT00383071|3600885|FG000|COMPLETED|Overall Study||25
2893760|NCT00383071|3600886|FG001|COMPLETED|Overall Study||21
2893761|NCT00383071|3600887|FG002|COMPLETED|Overall Study||44
2893762|NCT00383071|3600888|FG003|COMPLETED|Overall Study||22
2893763|NCT00383071|3600885|FG000|NOT COMPLETED|Overall Study||0
2893764|NCT00383071|3600886|FG001|NOT COMPLETED|Overall Study||4
2893765|NCT00383071|3600887|FG002|NOT COMPLETED|Overall Study||7
2893766|NCT00383071|3600888|FG003|NOT COMPLETED|Overall Study||3
2893767|NCT00383084|3600900|FG000|STARTED|Overall Study||46
2893768|NCT00383084|3600901|FG001|STARTED|Overall Study||38
2893769|NCT00383084|3600900|FG000|COMPLETED|Overall Study||34
2893770|NCT00383084|3600901|FG001|COMPLETED|Overall Study||28
2893771|NCT00383084|3600900|FG000|NOT COMPLETED|Overall Study||12
2893772|NCT00383084|3600901|FG001|NOT COMPLETED|Overall Study||10
2893773|NCT00383110|3600909|FG000|STARTED|Overall Study||150
2893774|NCT00383110|3600910|FG001|STARTED|Overall Study||150
2893775|NCT00383110|3600909|FG000|COMPLETED|Overall Study||150
2893776|NCT00383110|3600910|FG001|COMPLETED|Overall Study||150
2893777|NCT00383110|3600909|FG000|NOT COMPLETED|Overall Study||0
2893778|NCT00383110|3600910|FG001|NOT COMPLETED|Overall Study||0
2893779|NCT00383123|3600919|FG000|STARTED|Overall Study||2115
3170617|NCT01930045|3897922|FG005|COMPLETED|Part 1 - Period 3||3
3170618|NCT01930045|3897917|FG000|NOT COMPLETED|Part 1 - Period 3||0
3170619|NCT01930045|3897918|FG001|NOT COMPLETED|Part 1 - Period 3||0
3170620|NCT01930045|3897919|FG002|NOT COMPLETED|Part 1 - Period 3||0
3170621|NCT01930045|3897920|FG003|NOT COMPLETED|Part 1 - Period 3||0
3170622|NCT01930045|3897921|FG004|NOT COMPLETED|Part 1 - Period 3||0
2893780|NCT00383123|3600920|FG001|STARTED|Overall Study||1210
2893781|NCT00383123|3600919|FG000|COMPLETED|Overall Study||2004
2893782|NCT00383123|3600920|FG001|COMPLETED|Overall Study||1124
2893783|NCT00383123|3600919|FG000|NOT COMPLETED|Overall Study||111
2893784|NCT00383123|3600920|FG001|NOT COMPLETED|Overall Study||86
2893785|NCT00383149|3600926|FG000|STARTED|Overall Study||54
2893786|NCT00383149|3600926|FG000|COMPLETED|Overall Study||0
2893787|NCT00383149|3600926|FG000|NOT COMPLETED|Overall Study||54
2893788|NCT00383162|3600932|FG000|STARTED|Migraine Attack 1 (Period 1)||87
2893789|NCT00383162|3600933|FG001|STARTED|Migraine Attack 1 (Period 1)||86
2893790|NCT00383162|3600932|FG000|COMPLETED|Migraine Attack 1 (Period 1)|Participants completing a period treated a migraine with investigational product.|67
2893791|NCT00383162|3600933|FG001|COMPLETED|Migraine Attack 1 (Period 1)|Participants not completing did not take investigational product.|73
2893792|NCT00383162|3600932|FG000|NOT COMPLETED|Migraine Attack 1 (Period 1)||20
2893793|NCT00383162|3600933|FG001|NOT COMPLETED|Migraine Attack 1 (Period 1)||13
2893794|NCT00383162|3600932|FG000|STARTED|Migraine Attack 2 (Period 2)||67
2893795|NCT00383162|3600933|FG001|STARTED|Migraine Attack 2 (Period 2)||73
2893796|NCT00383162|3600932|FG000|COMPLETED|Migraine Attack 2 (Period 2)||65
2893797|NCT00383162|3600933|FG001|COMPLETED|Migraine Attack 2 (Period 2)||66
2893798|NCT00383162|3600932|FG000|NOT COMPLETED|Migraine Attack 2 (Period 2)||2
3170623|NCT01930045|3897922|FG005|NOT COMPLETED|Part 1 - Period 3||0
3170624|NCT01930045|3897917|FG000|STARTED|Pause (up to 37 Days)||3
3170625|NCT01930045|3897918|FG001|STARTED|Pause (up to 37 Days)||3
3170626|NCT01930045|3897919|FG002|STARTED|Pause (up to 37 Days)|The participant who missed treatment in Period 3, resumed the study|3
3170627|NCT01930045|3897920|FG003|STARTED|Pause (up to 37 Days)||3
2893799|NCT00383162|3600933|FG001|NOT COMPLETED|Migraine Attack 2 (Period 2)||7
2893800|NCT00383188|3600944|FG000|STARTED|Overall Study||69
2893801|NCT00383188|3600945|FG001|STARTED|Overall Study||74
2893802|NCT00383188|3600946|FG002|STARTED|Overall Study||44
2893803|NCT00383188|3600947|FG003|STARTED|Overall Study||40
2893804|NCT00383188|3600948|FG004|STARTED|Overall Study||75
2893805|NCT00383188|3600944|FG000|COMPLETED|Overall Study||52
2893806|NCT00383188|3600945|FG001|COMPLETED|Overall Study||63
2893807|NCT00383188|3600946|FG002|COMPLETED|Overall Study||31
2893808|NCT00383188|3600947|FG003|COMPLETED|Overall Study||28
2893809|NCT00383188|3600948|FG004|COMPLETED|Overall Study||52
2893810|NCT00383188|3600944|FG000|NOT COMPLETED|Overall Study||17
2893811|NCT00383188|3600945|FG001|NOT COMPLETED|Overall Study||11
2893812|NCT00383188|3600946|FG002|NOT COMPLETED|Overall Study||13
2893813|NCT00383188|3600947|FG003|NOT COMPLETED|Overall Study||12
2893814|NCT00383188|3600948|FG004|NOT COMPLETED|Overall Study||23
2893815|NCT00383266|3600962|FG000|STARTED|Overall Study||9
2893816|NCT00383266|3600962|FG000|COMPLETED|Overall Study||9
2893817|NCT00383266|3600962|FG000|NOT COMPLETED|Overall Study||0
2893818|NCT00383292|3600969|FG000|STARTED|Overall Study||68
2893819|NCT00383292|3600970|FG001|STARTED|Overall Study||32
2893820|NCT00383292|3600971|FG002|STARTED|Overall Study||30
2893821|NCT00383292|3600969|FG000|Received at Least One Dose of Study Drug|Overall Study||68
2893822|NCT00383292|3600970|FG001|Received at Least One Dose of Study Drug|Overall Study||32
2893823|NCT00383292|3600971|FG002|Received at Least One Dose of Study Drug|Overall Study||30
2893824|NCT00383292|3600969|FG000|COMPLETED|Overall Study||53
2893825|NCT00383292|3600970|FG001|COMPLETED|Overall Study||26
2893826|NCT00383292|3600971|FG002|COMPLETED|Overall Study||22
2893827|NCT00383292|3600969|FG000|NOT COMPLETED|Overall Study||15
2893828|NCT00383292|3600970|FG001|NOT COMPLETED|Overall Study||6
2893829|NCT00383292|3600971|FG002|NOT COMPLETED|Overall Study||8
2893830|NCT00383331|3600982|FG000|STARTED|Overall Study||10
2893831|NCT00383331|3600983|FG001|STARTED|Overall Study||9
2893832|NCT00383331|3600982|FG000|COMPLETED|Overall Study||10
2893833|NCT00383331|3600983|FG001|COMPLETED|Overall Study||8
2893834|NCT00383331|3600982|FG000|NOT COMPLETED|Overall Study||0
2893835|NCT00383331|3600983|FG001|NOT COMPLETED|Overall Study||1
2893836|NCT00383448|3600989|FG000|STARTED|Overall Study||38
2893837|NCT00383448|3600989|FG000|COMPLETED|Overall Study||38
2893838|NCT00383448|3600989|FG000|NOT COMPLETED|Overall Study||0
2893839|NCT00383500|3600997|FG000|STARTED|Overall Study||27
2893840|NCT00383500|3600998|FG001|STARTED|Overall Study||24
2893841|NCT00383500|3600999|FG002|STARTED|Overall Study||24
2893842|NCT00383500|3600997|FG000|COMPLETED|Overall Study||19
2893843|NCT00383500|3600998|FG001|COMPLETED|Overall Study||21
2893844|NCT00383500|3600999|FG002|COMPLETED|Overall Study||22
2893845|NCT00383500|3600997|FG000|NOT COMPLETED|Overall Study||8
2893846|NCT00383500|3600998|FG001|NOT COMPLETED|Overall Study||3
2893847|NCT00383500|3600999|FG002|NOT COMPLETED|Overall Study||2
2893848|NCT00383565|3601008|FG000|STARTED|Overall Study||9
2893849|NCT00383565|3601008|FG000|COMPLETED|Overall Study||9
2893850|NCT00383565|3601008|FG000|NOT COMPLETED|Overall Study||0
2893851|NCT00383643|3601015|FG000|STARTED|Overall Study||18
2893852|NCT00383643|3601016|FG001|STARTED|Overall Study||16
2893853|NCT00383643|3601017|FG002|STARTED|Overall Study||14
2893854|NCT00383643|3601015|FG000|COMPLETED|Overall Study||17
2893855|NCT00383643|3601016|FG001|COMPLETED|Overall Study||15
2893856|NCT00383643|3601017|FG002|COMPLETED|Overall Study||13
2893857|NCT00383643|3601015|FG000|NOT COMPLETED|Overall Study||1
2893858|NCT00383643|3601016|FG001|NOT COMPLETED|Overall Study||1
2893859|NCT00383643|3601017|FG002|NOT COMPLETED|Overall Study||1
2893860|NCT00383747|3601027|FG000|STARTED|Visit 1||14
2893861|NCT00383747|3601028|FG001|STARTED|Visit 1||14
2893862|NCT00383747|3601029|FG002|STARTED|Visit 1||16
2893863|NCT00383747|3601030|FG003|STARTED|Visit 1||16
2893864|NCT00383747|3601027|FG000|COMPLETED|Visit 1||14
2893865|NCT00383747|3601028|FG001|COMPLETED|Visit 1||14
2893866|NCT00383747|3601029|FG002|COMPLETED|Visit 1||16
2893867|NCT00383747|3601030|FG003|COMPLETED|Visit 1||16
2893868|NCT00383747|3601027|FG000|NOT COMPLETED|Visit 1||0
3314744|NCT03091920|4048045|FG002|STARTED|Overall Study||10
3314745|NCT03091920|4048043|FG000|COMPLETED|Overall Study||6
3314746|NCT03091920|4048044|FG001|COMPLETED|Overall Study||9
3314747|NCT03091920|4048045|FG002|COMPLETED|Overall Study||10
3314748|NCT03091920|4048043|FG000|NOT COMPLETED|Overall Study||0
3314749|NCT03091920|4048044|FG001|NOT COMPLETED|Overall Study||1
3314750|NCT03091920|4048045|FG002|NOT COMPLETED|Overall Study||0
3314751|NCT03092024|4048061|FG000|STARTED|Overall Study||24
3314752|NCT03092024|4048062|FG001|STARTED|Overall Study||16
3314753|NCT03092024|4048061|FG000|COMPLETED|Overall Study||24
3314754|NCT03092024|4048062|FG001|COMPLETED|Overall Study||16
3314755|NCT03092024|4048061|FG000|NOT COMPLETED|Overall Study||0
3314756|NCT03092024|4048062|FG001|NOT COMPLETED|Overall Study||0
3314757|NCT03092089|4048068|FG000|STARTED|Overall Study||15
3314758|NCT03092089|4048068|FG000|COMPLETED|Overall Study||15
3314759|NCT03092089|4048068|FG000|NOT COMPLETED|Overall Study||0
3314760|NCT03092375|4048076|FG000|STARTED|Overall Study||78
3314761|NCT03092375|4048077|FG001|STARTED|Overall Study||49
3314762|NCT03092375|4048078|FG002|STARTED|Overall Study||21
3314763|NCT03092375|4048079|FG003|STARTED|Overall Study||29
3314764|NCT03092375|4048076|FG000|COMPLETED|Overall Study||78
3314765|NCT03092375|4048077|FG001|COMPLETED|Overall Study||48
3314766|NCT03092375|4048078|FG002|COMPLETED|Overall Study||20
3314767|NCT03092375|4048079|FG003|COMPLETED|Overall Study||29
3314768|NCT03092375|4048076|FG000|NOT COMPLETED|Overall Study||0
3314769|NCT03092375|4048077|FG001|NOT COMPLETED|Overall Study||1
3314770|NCT03092375|4048078|FG002|NOT COMPLETED|Overall Study||1
3314771|NCT03092375|4048079|FG003|NOT COMPLETED|Overall Study||0
3314772|NCT03092479|4048098|FG000|STARTED|Overall Study||24
3314773|NCT03092479|4048099|FG001|STARTED|Overall Study||26
3314774|NCT03092479|4048098|FG000|COMPLETED|Overall Study||17
3314775|NCT03092479|4048099|FG001|COMPLETED|Overall Study||24
3314776|NCT03092479|4048098|FG000|NOT COMPLETED|Overall Study||7
3314777|NCT03092479|4048099|FG001|NOT COMPLETED|Overall Study||2
3314778|NCT03092726|4048107|FG000|STARTED|Overall Study||88
3314779|NCT03092726|4048108|FG001|STARTED|Overall Study||95
3314780|NCT03092726|4048107|FG000|Treated|Overall Study||88
3314781|NCT03092726|4048108|FG001|Treated|Overall Study||95
3314782|NCT03092726|4048107|FG000|COMPLETED|Overall Study||79
3314783|NCT03092726|4048108|FG001|COMPLETED|Overall Study||81
3314784|NCT03092726|4048107|FG000|NOT COMPLETED|Overall Study||9
3314785|NCT03092726|4048108|FG001|NOT COMPLETED|Overall Study||14
3314786|NCT03092752|4048114|FG000|STARTED|Overall Study||523585
3314787|NCT03092752|4048114|FG000|COMPLETED|Overall Study||162116
3314788|NCT03092752|4048114|FG000|NOT COMPLETED|Overall Study||361469
3314789|NCT03092791|4048143|FG000|STARTED|Overall Study||20
3314790|NCT03092791|4048144|FG001|STARTED|Overall Study||20
3314791|NCT03092791|4048145|FG002|STARTED|Overall Study||30
3314792|NCT03092791|4048146|FG003|STARTED|Overall Study||30
3314793|NCT03092791|4048147|FG004|STARTED|Overall Study||60
3314794|NCT03092791|4048148|FG005|STARTED|Overall Study||60
3314795|NCT03092791|4048149|FG006|STARTED|Overall Study||60
3314796|NCT03092791|4048150|FG007|STARTED|Overall Study||60
3314797|NCT03092791|4048143|FG000|COMPLETED|Overall Study||20
3314798|NCT03092791|4048144|FG001|COMPLETED|Overall Study||20
3314799|NCT03092791|4048145|FG002|COMPLETED|Overall Study||30
3314800|NCT03092791|4048146|FG003|COMPLETED|Overall Study||30
3314801|NCT03092791|4048147|FG004|COMPLETED|Overall Study||0
3314802|NCT03092791|4048148|FG005|COMPLETED|Overall Study||0
3314803|NCT03092791|4048149|FG006|COMPLETED|Overall Study||0
3314804|NCT03092791|4048150|FG007|COMPLETED|Overall Study||0
3314805|NCT03092791|4048143|FG000|NOT COMPLETED|Overall Study||0
3314806|NCT03092791|4048144|FG001|NOT COMPLETED|Overall Study||0
3314807|NCT03092791|4048145|FG002|NOT COMPLETED|Overall Study||0
3314808|NCT03092791|4048146|FG003|NOT COMPLETED|Overall Study||0
3314809|NCT03092791|4048147|FG004|NOT COMPLETED|Overall Study||60
3314810|NCT03092791|4048148|FG005|NOT COMPLETED|Overall Study||60
3314811|NCT03092791|4048149|FG006|NOT COMPLETED|Overall Study||60
3314812|NCT03092791|4048150|FG007|NOT COMPLETED|Overall Study||60
3314813|NCT03092934|4048172|FG000|STARTED|Overall Study||8
3314814|NCT03092934|4048173|FG001|STARTED|Overall Study||2
3314815|NCT03092934|4048174|FG002|STARTED|Overall Study||2
2893869|NCT00383747|3601028|FG001|NOT COMPLETED|Visit 1||0
2893870|NCT00383747|3601029|FG002|NOT COMPLETED|Visit 1||0
2893871|NCT00383747|3601030|FG003|NOT COMPLETED|Visit 1||0
2893872|NCT00383747|3601027|FG000|STARTED|Visit 2||14
2893873|NCT00383747|3601028|FG001|STARTED|Visit 2||14
2893874|NCT00383747|3601029|FG002|STARTED|Visit 2||16
2893875|NCT00383747|3601030|FG003|STARTED|Visit 2||16
2893876|NCT00383747|3601027|FG000|COMPLETED|Visit 2||14
2893877|NCT00383747|3601028|FG001|COMPLETED|Visit 2||14
2893878|NCT00383747|3601029|FG002|COMPLETED|Visit 2||16
2893879|NCT00383747|3601030|FG003|COMPLETED|Visit 2||16
2893880|NCT00383747|3601027|FG000|NOT COMPLETED|Visit 2||0
2893881|NCT00383747|3601028|FG001|NOT COMPLETED|Visit 2||0
2893882|NCT00383747|3601029|FG002|NOT COMPLETED|Visit 2||0
2893883|NCT00383747|3601030|FG003|NOT COMPLETED|Visit 2||0
2893884|NCT00383760|3601043|FG000|STARTED|Overall Study||15
3314816|NCT03092934|4048175|FG003|STARTED|Overall Study||1
3314817|NCT03092934|4048172|FG000|Received at Least One Dose of Study Drug|Overall Study||8
3314818|NCT03092934|4048173|FG001|Received at Least One Dose of Study Drug|Overall Study||2
2893885|NCT00383760|3601043|FG000|COMPLETED|Overall Study||15
2893886|NCT00383760|3601043|FG000|NOT COMPLETED|Overall Study||0
2893887|NCT00383786|3601050|FG000|STARTED|Overall Study||22
2893888|NCT00383786|3601051|FG001|STARTED|Overall Study||25
2893889|NCT00383786|3601050|FG000|COMPLETED|Overall Study||18
2893890|NCT00383786|3601051|FG001|COMPLETED|Overall Study||13
2893891|NCT00383786|3601050|FG000|NOT COMPLETED|Overall Study||4
2893892|NCT00383786|3601051|FG001|NOT COMPLETED|Overall Study||12
2893893|NCT00383942|3601059|FG000|STARTED|Overall Study||40
2893894|NCT00383942|3601060|FG001|STARTED|Overall Study||40
2893895|NCT00383942|3601059|FG000|COMPLETED|Overall Study||40
2893896|NCT00383942|3601060|FG001|COMPLETED|Overall Study||40
2893897|NCT00383942|3601059|FG000|NOT COMPLETED|Overall Study||0
2893898|NCT00383942|3601060|FG001|NOT COMPLETED|Overall Study||0
2893899|NCT00384033|3601070|FG000|STARTED|Overall Study||164
2893900|NCT00384033|3601071|FG001|STARTED|Overall Study||155
2893901|NCT00384033|3601072|FG002|STARTED|Overall Study||160
2893902|NCT00384033|3601073|FG003|STARTED|Overall Study||159
2893903|NCT00384033|3601070|FG000|Treated|Overall Study||161
2893904|NCT00384033|3601071|FG001|Treated|Overall Study||148
2893905|NCT00384033|3601072|FG002|Treated|Overall Study||150
2893906|NCT00384033|3601073|FG003|Treated|Overall Study||157
2893907|NCT00384033|3601070|FG000|COMPLETED|Overall Study||123
2893908|NCT00384033|3601071|FG001|COMPLETED|Overall Study||120
2893909|NCT00384033|3601072|FG002|COMPLETED|Overall Study||117
2893910|NCT00384033|3601073|FG003|COMPLETED|Overall Study||119
2893911|NCT00384033|3601070|FG000|NOT COMPLETED|Overall Study||41
2893912|NCT00384033|3601071|FG001|NOT COMPLETED|Overall Study||35
2893913|NCT00384033|3601072|FG002|NOT COMPLETED|Overall Study||43
2893914|NCT00384033|3601073|FG003|NOT COMPLETED|Overall Study||40
2893915|NCT00384059|3601085|FG000|STARTED|Infant Series||141
2893916|NCT00384059|3601086|FG001|STARTED|Infant Series||145
2893917|NCT00384059|3601085|FG000|Vaccinated Dose 1|Infant Series||139
2893918|NCT00384059|3601086|FG001|Vaccinated Dose 1|Infant Series||139
2893919|NCT00384059|3601085|FG000|Vaccinated Dose 2|Infant Series||136
2893920|NCT00384059|3601086|FG001|Vaccinated Dose 2|Infant Series||135
3170628|NCT01930045|3897921|FG004|STARTED|Pause (up to 37 Days)||3
3170629|NCT01930045|3897922|FG005|STARTED|Pause (up to 37 Days)||3
3170630|NCT01930045|3897917|FG000|COMPLETED|Pause (up to 37 Days)||3
3170631|NCT01930045|3897918|FG001|COMPLETED|Pause (up to 37 Days)||3
3170632|NCT01930045|3897919|FG002|COMPLETED|Pause (up to 37 Days)||3
3170633|NCT01930045|3897920|FG003|COMPLETED|Pause (up to 37 Days)||3
3170634|NCT01930045|3897921|FG004|COMPLETED|Pause (up to 37 Days)||3
3170635|NCT01930045|3897922|FG005|COMPLETED|Pause (up to 37 Days)||1
3170636|NCT01930045|3897917|FG000|NOT COMPLETED|Pause (up to 37 Days)||0
3170637|NCT01930045|3897918|FG001|NOT COMPLETED|Pause (up to 37 Days)||0
3170638|NCT01930045|3897919|FG002|NOT COMPLETED|Pause (up to 37 Days)||0
3170639|NCT01930045|3897920|FG003|NOT COMPLETED|Pause (up to 37 Days)||0
3170640|NCT01930045|3897921|FG004|NOT COMPLETED|Pause (up to 37 Days)||0
3170641|NCT01930045|3897922|FG005|NOT COMPLETED|Pause (up to 37 Days)||2
3170642|NCT01930045|3897917|FG000|STARTED|Part 2 - Period 4||3
3170643|NCT01930045|3897918|FG001|STARTED|Part 2 - Period 4||3
3170644|NCT01930045|3897919|FG002|STARTED|Part 2 - Period 4||3
3170645|NCT01930045|3897920|FG003|STARTED|Part 2 - Period 4||3
3170646|NCT01930045|3897921|FG004|STARTED|Part 2 - Period 4||3
3170647|NCT01930045|3897922|FG005|STARTED|Part 2 - Period 4||1
3170648|NCT01930045|3897917|FG000|COMPLETED|Part 2 - Period 4||3
3170649|NCT01930045|3897918|FG001|COMPLETED|Part 2 - Period 4||3
3170650|NCT01930045|3897919|FG002|COMPLETED|Part 2 - Period 4||3
3170651|NCT01930045|3897920|FG003|COMPLETED|Part 2 - Period 4||3
3170652|NCT01930045|3897921|FG004|COMPLETED|Part 2 - Period 4||3
3170653|NCT01930045|3897922|FG005|COMPLETED|Part 2 - Period 4||1
3170654|NCT01930045|3897917|FG000|NOT COMPLETED|Part 2 - Period 4||0
3170655|NCT01930045|3897918|FG001|NOT COMPLETED|Part 2 - Period 4||0
3170656|NCT01930045|3897919|FG002|NOT COMPLETED|Part 2 - Period 4||0
3170657|NCT01930045|3897920|FG003|NOT COMPLETED|Part 2 - Period 4||0
3170658|NCT01930045|3897921|FG004|NOT COMPLETED|Part 2 - Period 4||0
3170659|NCT01930045|3897922|FG005|NOT COMPLETED|Part 2 - Period 4||0
3170660|NCT01930045|3897917|FG000|STARTED|Part 2 - Period 5||3
3170661|NCT01930045|3897918|FG001|STARTED|Part 2 - Period 5||3
3170662|NCT01930045|3897919|FG002|STARTED|Part 2 - Period 5||3
3170663|NCT01930045|3897920|FG003|STARTED|Part 2 - Period 5||3
3170664|NCT01930045|3897921|FG004|STARTED|Part 2 - Period 5||3
3170665|NCT01930045|3897922|FG005|STARTED|Part 2 - Period 5||1
3170666|NCT01930045|3897917|FG000|COMPLETED|Part 2 - Period 5||3
3170667|NCT01930045|3897918|FG001|COMPLETED|Part 2 - Period 5||3
3170668|NCT01930045|3897919|FG002|COMPLETED|Part 2 - Period 5||3
3170669|NCT01930045|3897920|FG003|COMPLETED|Part 2 - Period 5||3
3170670|NCT01930045|3897921|FG004|COMPLETED|Part 2 - Period 5||3
3170671|NCT01930045|3897922|FG005|COMPLETED|Part 2 - Period 5||1
3170672|NCT01930045|3897917|FG000|NOT COMPLETED|Part 2 - Period 5||0
3170673|NCT01930045|3897918|FG001|NOT COMPLETED|Part 2 - Period 5||0
3170674|NCT01930045|3897919|FG002|NOT COMPLETED|Part 2 - Period 5||0
3170675|NCT01930045|3897920|FG003|NOT COMPLETED|Part 2 - Period 5||0
3170676|NCT01930045|3897921|FG004|NOT COMPLETED|Part 2 - Period 5||0
3170677|NCT01930045|3897922|FG005|NOT COMPLETED|Part 2 - Period 5||0
3170678|NCT01930058|3897937|FG000|STARTED|Overall Study||3
3170679|NCT01930058|3897938|FG001|STARTED|Overall Study||3
3170680|NCT01930058|3897939|FG002|STARTED|Overall Study||3
3170681|NCT01930058|3897937|FG000|COMPLETED|Overall Study||3
3170682|NCT01930058|3897938|FG001|COMPLETED|Overall Study||3
3170683|NCT01930058|3897939|FG002|COMPLETED|Overall Study||3
2893921|NCT00384059|3601085|FG000|COMPLETED|Infant Series||135
2893922|NCT00384059|3601086|FG001|COMPLETED|Infant Series||132
3170684|NCT01930058|3897937|FG000|NOT COMPLETED|Overall Study||0
3170685|NCT01930058|3897938|FG001|NOT COMPLETED|Overall Study||0
3170686|NCT01930058|3897939|FG002|NOT COMPLETED|Overall Study||0
3170687|NCT01930162|3897946|FG000|STARTED|Overall Study||9
3170688|NCT01930162|3897946|FG000|COMPLETED|Overall Study||4
3170689|NCT01930162|3897946|FG000|NOT COMPLETED|Overall Study||5
3170690|NCT01930175|3897954|FG000|STARTED|Core Study||7
3170691|NCT01930175|3897955|FG001|STARTED|Core Study||2
3170692|NCT01930175|3897956|FG002|STARTED|Core Study||4
3170693|NCT01930175|3897954|FG000|Safety Analysis Set|Core Study||7
3170694|NCT01930175|3897955|FG001|Safety Analysis Set|Core Study||2
3170695|NCT01930175|3897956|FG002|Safety Analysis Set|Core Study||4
3170696|NCT01930175|3897954|FG000|Pharmacokinetics (PK) Analysis Set|Core Study||7
3170697|NCT01930175|3897955|FG001|Pharmacokinetics (PK) Analysis Set|Core Study||2
3170698|NCT01930175|3897956|FG002|Pharmacokinetics (PK) Analysis Set|Core Study|Placebo patients were excluded from the PK analyses|0
3170699|NCT01930175|3897954|FG000|COMPLETED|Core Study||7
3170700|NCT01930175|3897955|FG001|COMPLETED|Core Study||1
3170701|NCT01930175|3897956|FG002|COMPLETED|Core Study||3
2893923|NCT00384059|3601085|FG000|NOT COMPLETED|Infant Series||6
2893924|NCT00384059|3601086|FG001|NOT COMPLETED|Infant Series||13
2893925|NCT00384059|3601085|FG000|STARTED|After Infant Series||135
2893926|NCT00384059|3601086|FG001|STARTED|After Infant Series||132
2893927|NCT00384059|3601085|FG000|COMPLETED|After Infant Series||131
2893928|NCT00384059|3601086|FG001|COMPLETED|After Infant Series||122
2893929|NCT00384059|3601085|FG000|NOT COMPLETED|After Infant Series||4
2893930|NCT00384059|3601086|FG001|NOT COMPLETED|After Infant Series||10
2893931|NCT00384059|3601085|FG000|STARTED|Toddler Dose||131
2893932|NCT00384059|3601086|FG001|STARTED|Toddler Dose||122
2893933|NCT00384059|3601085|FG000|COMPLETED|Toddler Dose||130
2893934|NCT00384059|3601086|FG001|COMPLETED|Toddler Dose||120
2893935|NCT00384059|3601085|FG000|NOT COMPLETED|Toddler Dose||1
2893936|NCT00384059|3601086|FG001|NOT COMPLETED|Toddler Dose||2
2893937|NCT00384085|3601116|FG000|STARTED|Overall Study|Randomized|195
2893938|NCT00384085|3601117|FG001|STARTED|Overall Study|Randomized|196
2893939|NCT00384085|3601118|FG002|STARTED|Overall Study|Randomized|197
2893940|NCT00384085|3601116|FG000|Intent-To-Treat (ITT)|Overall Study||195
2893941|NCT00384085|3601117|FG001|Intent-To-Treat (ITT)|Overall Study||196
2893942|NCT00384085|3601118|FG002|Intent-To-Treat (ITT)|Overall Study||197
2893943|NCT00384085|3601116|FG000|Treated (Safety Population)|Overall Study||194
2893944|NCT00384085|3601117|FG001|Treated (Safety Population)|Overall Study||194
2893945|NCT00384085|3601118|FG002|Treated (Safety Population)|Overall Study||194
2893946|NCT00384085|3601116|FG000|Intent-To-Treat (Excluding nonGCP Sites)|Overall Study||187
2893947|NCT00384085|3601117|FG001|Intent-To-Treat (Excluding nonGCP Sites)|Overall Study||186
2893948|NCT00384085|3601118|FG002|Intent-To-Treat (Excluding nonGCP Sites)|Overall Study||189
2893949|NCT00384085|3601116|FG000|COMPLETED|Overall Study|Based on the entire ITT population|156
2893950|NCT00384085|3601117|FG001|COMPLETED|Overall Study|Based on the entire ITT population|150
2893951|NCT00384085|3601118|FG002|COMPLETED|Overall Study|Based on the entire ITT population|141
2893952|NCT00384085|3601116|FG000|NOT COMPLETED|Overall Study||39
2893953|NCT00384085|3601117|FG001|NOT COMPLETED|Overall Study||46
2893954|NCT00384085|3601118|FG002|NOT COMPLETED|Overall Study||56
2893955|NCT00384176|3601131|FG000|STARTED|Overall Study||709
2893956|NCT00384176|3601132|FG001|STARTED|Overall Study||713
2893957|NCT00384176|3601133|FG002|STARTED|Overall Study||192
2893958|NCT00384176|3601131|FG000|COMPLETED|Overall Study||397
2893959|NCT00384176|3601132|FG001|COMPLETED|Overall Study||394
2893960|NCT00384176|3601133|FG002|COMPLETED|Overall Study||60
2893961|NCT00384176|3601131|FG000|NOT COMPLETED|Overall Study||312
2893962|NCT00384176|3601132|FG001|NOT COMPLETED|Overall Study||319
2893963|NCT00384176|3601133|FG002|NOT COMPLETED|Overall Study||132
2893964|NCT00384189|3601145|FG000|STARTED|Overall Study||305
2893965|NCT00384189|3601146|FG001|STARTED|Overall Study||312
2893966|NCT00384189|3601147|FG002|STARTED|Overall Study||313
2893967|NCT00384189|3601148|FG003|STARTED|Overall Study||150
2893968|NCT00384189|3601145|FG000|Randomized, Not Treated|Overall Study||1
2893969|NCT00384189|3601146|FG001|Randomized, Not Treated|Overall Study||0
2893970|NCT00384189|3601147|FG002|Randomized, Not Treated|Overall Study||2
2893971|NCT00384189|3601148|FG003|Randomized, Not Treated|Overall Study||4
2893972|NCT00384189|3601145|FG000|Actual Treatment Received|Overall Study|1 participant randomized to 160 μg who actually received 40 μg is included.|305
2893973|NCT00384189|3601146|FG001|Actual Treatment Received|Overall Study||312
2893974|NCT00384189|3601147|FG002|Actual Treatment Received|Overall Study|1 participants in the 160 μg arm actually received 40 μg and is moved to that arm.|310
2893975|NCT00384189|3601148|FG003|Actual Treatment Received|Overall Study||146
2893976|NCT00384189|3601145|FG000|COMPLETED|Overall Study||255
2893977|NCT00384189|3601146|FG001|COMPLETED|Overall Study||255
2893978|NCT00384189|3601147|FG002|COMPLETED|Overall Study||255
2893979|NCT00384189|3601148|FG003|COMPLETED|Overall Study||110
2893980|NCT00384189|3601145|FG000|NOT COMPLETED|Overall Study||50
3170702|NCT01930175|3897954|FG000|NOT COMPLETED|Core Study||0
3170703|NCT01930175|3897955|FG001|NOT COMPLETED|Core Study||1
3170704|NCT01930175|3897956|FG002|NOT COMPLETED|Core Study||1
3170705|NCT01930175|3897954|FG000|STARTED|Open Label VAY736 10 mg/kg at Week 24|Only patients originally randomized to Placebo were allowed to enter this Period.|0
3171797|NCT01937260|3898998|FG000|COMPLETED|Overall Study||20
3171798|NCT01937260|3898999|FG001|COMPLETED|Overall Study||10
2893981|NCT00384189|3601146|FG001|NOT COMPLETED|Overall Study||57
2893982|NCT00384189|3601147|FG002|NOT COMPLETED|Overall Study||58
2893983|NCT00384189|3601148|FG003|NOT COMPLETED|Overall Study||40
2893984|NCT00384241|3601160|FG000|STARTED|Overall Study||500
2893985|NCT00384241|3601161|FG001|STARTED|Overall Study||599
2893986|NCT00384241|3601160|FG000|COMPLETED|Overall Study||500
2893987|NCT00384241|3601161|FG001|COMPLETED|Overall Study||599
2893988|NCT00384241|3601160|FG000|NOT COMPLETED|Overall Study||0
2893989|NCT00384241|3601161|FG001|NOT COMPLETED|Overall Study||0
2893990|NCT00384332|3601168|FG000|STARTED|Overall Study||13
2893991|NCT00384332|3601169|FG001|STARTED|Overall Study||10
2893992|NCT00384332|3601168|FG000|COMPLETED|Overall Study||9
2893993|NCT00384332|3601169|FG001|COMPLETED|Overall Study||10
2893994|NCT00384332|3601168|FG000|NOT COMPLETED|Overall Study||4
2893995|NCT00384332|3601169|FG001|NOT COMPLETED|Overall Study||0
2893996|NCT00384397|3601180|FG000|STARTED|Overall Study||407
2893997|NCT00384397|3601181|FG001|STARTED|Overall Study||293
2893998|NCT00384397|3601182|FG002|STARTED|Overall Study||418
2893999|NCT00384397|3601180|FG000|COMPLETED|Overall Study||375
2894000|NCT00384397|3601181|FG001|COMPLETED|Overall Study||247
2894001|NCT00384397|3601182|FG002|COMPLETED|Overall Study||385
2894002|NCT00384397|3601180|FG000|NOT COMPLETED|Overall Study||32
2894003|NCT00384397|3601181|FG001|NOT COMPLETED|Overall Study||46
2894004|NCT00384397|3601182|FG002|NOT COMPLETED|Overall Study||33
2894005|NCT00384449|3601190|FG000|STARTED|Overall Study||1
2894006|NCT00384449|3601190|FG000|COMPLETED|Overall Study||1
2894007|NCT00384449|3601190|FG000|NOT COMPLETED|Overall Study||0
2894008|NCT00384670|3601194|FG000|STARTED|Overall Study||7
2894009|NCT00384670|3601194|FG000|COMPLETED|Overall Study||7
2894010|NCT00384670|3601194|FG000|NOT COMPLETED|Overall Study||0
2894011|NCT00384748|3601200|FG000|STARTED|Overall Study||25
2894012|NCT00384748|3601201|FG001|STARTED|Overall Study||23
2894013|NCT00384748|3601200|FG000|COMPLETED|Overall Study||25
2894014|NCT00384748|3601201|FG001|COMPLETED|Overall Study||23
2894015|NCT00384748|3601200|FG000|NOT COMPLETED|Overall Study||0
2894016|NCT00384748|3601201|FG001|NOT COMPLETED|Overall Study||0
2894017|NCT00384774|3601214|FG000|STARTED|Overall Study||42
2894018|NCT00384774|3601215|FG001|STARTED|Overall Study||4
2894019|NCT00384774|3601216|FG002|STARTED|Overall Study||12
2894020|NCT00384774|3601217|FG003|STARTED|Overall Study||24
2894021|NCT00384774|3601218|FG004|STARTED|Overall Study||28
2894022|NCT00384774|3601219|FG005|STARTED|Overall Study||16
2894023|NCT00384774|3601220|FG006|STARTED|Overall Study||4
3170706|NCT01930175|3897955|FG001|STARTED|Open Label VAY736 10 mg/kg at Week 24|Only patients originally randomized to Placebo were allowed to enter this Period.|0
3170707|NCT01930175|3897956|FG002|STARTED|Open Label VAY736 10 mg/kg at Week 24|Only patients originally randomized to Placebo were allowed to enter this Period.|3
3170708|NCT01930175|3897954|FG000|COMPLETED|Open Label VAY736 10 mg/kg at Week 24||0
3170709|NCT01930175|3897955|FG001|COMPLETED|Open Label VAY736 10 mg/kg at Week 24||0
3170710|NCT01930175|3897956|FG002|COMPLETED|Open Label VAY736 10 mg/kg at Week 24||3
3170711|NCT01930175|3897954|FG000|NOT COMPLETED|Open Label VAY736 10 mg/kg at Week 24||0
3170712|NCT01930175|3897955|FG001|NOT COMPLETED|Open Label VAY736 10 mg/kg at Week 24||0
3170713|NCT01930175|3897956|FG002|NOT COMPLETED|Open Label VAY736 10 mg/kg at Week 24||0
3170714|NCT01930188|3897968|FG000|STARTED|Overall Study||409
3170715|NCT01930188|3897969|FG001|STARTED|Overall Study||409
2894024|NCT00384774|3601214|FG000|Received at Least 1 Dose of Study Drug|Overall Study||42
2894025|NCT00384774|3601215|FG001|Received at Least 1 Dose of Study Drug|Overall Study||4
2894026|NCT00384774|3601216|FG002|Received at Least 1 Dose of Study Drug|Overall Study||12
2894027|NCT00384774|3601217|FG003|Received at Least 1 Dose of Study Drug|Overall Study||24
2894028|NCT00384774|3601218|FG004|Received at Least 1 Dose of Study Drug|Overall Study||28
2894029|NCT00384774|3601219|FG005|Received at Least 1 Dose of Study Drug|Overall Study||16
2894030|NCT00384774|3601220|FG006|Received at Least 1 Dose of Study Drug|Overall Study||4
2894031|NCT00384774|3601214|FG000|COMPLETED|Overall Study||42
2894032|NCT00384774|3601215|FG001|COMPLETED|Overall Study||4
2894033|NCT00384774|3601216|FG002|COMPLETED|Overall Study||12
2894034|NCT00384774|3601217|FG003|COMPLETED|Overall Study||24
2894035|NCT00384774|3601218|FG004|COMPLETED|Overall Study||28
2894036|NCT00384774|3601219|FG005|COMPLETED|Overall Study||16
2894037|NCT00384774|3601220|FG006|COMPLETED|Overall Study||4
2894038|NCT00384774|3601214|FG000|NOT COMPLETED|Overall Study||0
2894039|NCT00384774|3601215|FG001|NOT COMPLETED|Overall Study||0
2894040|NCT00384774|3601216|FG002|NOT COMPLETED|Overall Study||0
2894041|NCT00384774|3601217|FG003|NOT COMPLETED|Overall Study||0
2894042|NCT00384774|3601218|FG004|NOT COMPLETED|Overall Study||0
2894043|NCT00384774|3601219|FG005|NOT COMPLETED|Overall Study||0
2894044|NCT00384774|3601220|FG006|NOT COMPLETED|Overall Study||0
2894045|NCT00384813|3601238|FG000|STARTED|Overall Study||23
2894046|NCT00384813|3601239|FG001|STARTED|Overall Study||20
2894047|NCT00384813|3601238|FG000|COMPLETED|Overall Study||21
2894048|NCT00384813|3601239|FG001|COMPLETED|Overall Study||20
2894049|NCT00384813|3601238|FG000|NOT COMPLETED|Overall Study||2
2894050|NCT00384813|3601239|FG001|NOT COMPLETED|Overall Study||0
3170716|NCT01930188|3897970|FG002|STARTED|Overall Study||407
2894051|NCT00384839|3601245|FG000|STARTED|Overall Study||36
2894052|NCT00384839|3601245|FG000|COMPLETED|Overall Study||28
2894053|NCT00384839|3601245|FG000|NOT COMPLETED|Overall Study||8
2894054|NCT00384865|3601253|FG000|STARTED|Overall Study||16
2894055|NCT00384865|3601254|FG001|STARTED|Overall Study||16
2894056|NCT00384865|3601255|FG002|STARTED|Overall Study||16
2894057|NCT00384865|3601256|FG003|STARTED|Overall Study||16
2894058|NCT00384865|3601253|FG000|Completed Six Month Assessment|Overall Study||11
2894059|NCT00384865|3601254|FG001|Completed Six Month Assessment|Overall Study||12
2894060|NCT00384865|3601255|FG002|Completed Six Month Assessment|Overall Study||15
2894061|NCT00384865|3601256|FG003|Completed Six Month Assessment|Overall Study||11
2894062|NCT00384865|3601253|FG000|COMPLETED|Overall Study||16
2894063|NCT00384865|3601254|FG001|COMPLETED|Overall Study||16
2894064|NCT00384865|3601255|FG002|COMPLETED|Overall Study||16
2894065|NCT00384865|3601256|FG003|COMPLETED|Overall Study||16
2894066|NCT00384865|3601253|FG000|NOT COMPLETED|Overall Study||0
2894067|NCT00384865|3601254|FG001|NOT COMPLETED|Overall Study||0
2894068|NCT00384865|3601255|FG002|NOT COMPLETED|Overall Study||0
2894069|NCT00384865|3601256|FG003|NOT COMPLETED|Overall Study||0
2894070|NCT00384930|3601271|FG000|STARTED|Overall Study||212
2894071|NCT00384930|3601272|FG001|STARTED|Overall Study||209
2894072|NCT00384930|3601273|FG002|STARTED|Overall Study||212
2894073|NCT00384930|3601274|FG003|STARTED|Overall Study||216
2894074|NCT00384930|3601275|FG004|STARTED|Overall Study||209
2894075|NCT00384930|3601271|FG000|Received Double-Blind Study Drug|Overall Study||211
2894076|NCT00384930|3601272|FG001|Received Double-Blind Study Drug|Overall Study||208
2894077|NCT00384930|3601273|FG002|Received Double-Blind Study Drug|Overall Study||212
2894078|NCT00384930|3601274|FG003|Received Double-Blind Study Drug|Overall Study||216
2894079|NCT00384930|3601275|FG004|Received Double-Blind Study Drug|Overall Study||209
2894080|NCT00384930|3601271|FG000|COMPLETED|Overall Study||185
2894081|NCT00384930|3601272|FG001|COMPLETED|Overall Study||182
2894082|NCT00384930|3601273|FG002|COMPLETED|Overall Study||182
2894083|NCT00384930|3601274|FG003|COMPLETED|Overall Study||175
2894084|NCT00384930|3601275|FG004|COMPLETED|Overall Study||162
2894085|NCT00384930|3601271|FG000|NOT COMPLETED|Overall Study||27
2894086|NCT00384930|3601272|FG001|NOT COMPLETED|Overall Study||27
2894087|NCT00384930|3601273|FG002|NOT COMPLETED|Overall Study||30
2894088|NCT00384930|3601274|FG003|NOT COMPLETED|Overall Study||41
2894089|NCT00384930|3601275|FG004|NOT COMPLETED|Overall Study||47
2894090|NCT00384956|3601290|FG000|STARTED|Overall Study||25
2894091|NCT00384956|3601290|FG000|COMPLETED|Overall Study||22
2894092|NCT00384956|3601290|FG000|NOT COMPLETED|Overall Study||3
2894093|NCT00385008|3601296|FG000|STARTED|Overall Study||10
2894094|NCT00385008|3601297|FG001|STARTED|Overall Study||10
2894095|NCT00385008|3601296|FG000|In Absence of Migraine|Overall Study||10
2894096|NCT00385008|3601297|FG001|In Absence of Migraine|Overall Study||10
2894097|NCT00385008|3601296|FG000|In Presence of Migraine|Overall Study||5
2894098|NCT00385008|3601297|FG001|In Presence of Migraine|Overall Study||5
2894099|NCT00385008|3601296|FG000|COMPLETED|Overall Study||10
2894100|NCT00385008|3601297|FG001|COMPLETED|Overall Study||10
2894101|NCT00385008|3601296|FG000|NOT COMPLETED|Overall Study||0
2894102|NCT00385008|3601297|FG001|NOT COMPLETED|Overall Study||0
2894103|NCT00385138|3601306|FG000|STARTED|Overall Study||2695
2894104|NCT00385138|3601307|FG001|STARTED|Overall Study||2669
2894105|NCT00385138|3601306|FG000|Intent-to-treat (ITT)|Overall Study|All patients randomized excluding two (2) who withdrew consent for using study data.|2693
2894106|NCT00385138|3601307|FG001|Intent-to-treat (ITT)|Overall Study||2669
2894107|NCT00385138|3601306|FG000|Modified Intent-to-treat (mITT)|Overall Study|Excludes 37 patients who either did not receive study drug or have PCI.|2656
2894108|NCT00385138|3601307|FG001|Modified Intent-to-treat (mITT)|Overall Study|Excludes 24 patients who either did not received study drug or have PCI.|2645
2894109|NCT00385138|3601306|FG000|Safety Population|Overall Study|Includes all randomized patients who received at least one dose of study drug.|2662
2894110|NCT00385138|3601307|FG001|Safety Population|Overall Study|Includes all randomized patients who received at least one dose of study drug.|2650
2894111|NCT00385138|3601306|FG000|COMPLETED|Overall Study|"Completed means patient completed scheduled visits or developed a primary endpoint event."|2665
2894112|NCT00385138|3601307|FG001|COMPLETED|Overall Study|"Completed means patient completed scheduled visits or developed a primary endpoint event."|2641
2894113|NCT00385138|3601306|FG000|NOT COMPLETED|Overall Study||30
2894114|NCT00385138|3601307|FG001|NOT COMPLETED|Overall Study||28
2894115|NCT00385203|3601315|FG000|STARTED|Overall Study||26
2894116|NCT00385203|3601316|FG001|STARTED|Overall Study||10
2894117|NCT00385203|3601315|FG000|COMPLETED|Overall Study||0
2894118|NCT00385203|3601316|FG001|COMPLETED|Overall Study||3
2894119|NCT00385203|3601315|FG000|NOT COMPLETED|Overall Study||26
2894120|NCT00385203|3601316|FG001|NOT COMPLETED|Overall Study||7
2894121|NCT00385216|3601323|FG000|STARTED|First Intervention||11
2894122|NCT00385216|3601324|FG001|STARTED|First Intervention||9
2894123|NCT00385216|3601323|FG000|COMPLETED|First Intervention||11
2894124|NCT00385216|3601324|FG001|COMPLETED|First Intervention||9
2894125|NCT00385216|3601323|FG000|NOT COMPLETED|First Intervention||0
2894126|NCT00385216|3601324|FG001|NOT COMPLETED|First Intervention||0
2894127|NCT00385216|3601323|FG000|STARTED|Second Intervention||11
2894128|NCT00385216|3601324|FG001|STARTED|Second Intervention||9
2894129|NCT00385216|3601323|FG000|COMPLETED|Second Intervention||11
2894130|NCT00385216|3601324|FG001|COMPLETED|Second Intervention||9
2894131|NCT00385216|3601323|FG000|NOT COMPLETED|Second Intervention||0
2894132|NCT00385216|3601324|FG001|NOT COMPLETED|Second Intervention||0
2894133|NCT00385255|3601332|FG000|STARTED|Overall Study||860
2894134|NCT00385255|3601333|FG001|STARTED|Overall Study||858
2894135|NCT00385255|3601332|FG000|≥ 65 Years of Age (YOA) Cohort|Overall Study||112
2894136|NCT00385255|3601333|FG001|≥ 65 Years of Age (YOA) Cohort|Overall Study||109
2894137|NCT00385255|3601332|FG000|19-64 Years of Age (YOA) Cohort|Overall Study||748
2894138|NCT00385255|3601333|FG001|19-64 Years of Age (YOA) Cohort|Overall Study||749
2894139|NCT00385255|3601332|FG000|COMPLETED|Overall Study||839
2894140|NCT00385255|3601333|FG001|COMPLETED|Overall Study||785
2894141|NCT00385255|3601332|FG000|NOT COMPLETED|Overall Study||21
2894142|NCT00385255|3601333|FG001|NOT COMPLETED|Overall Study||73
2894143|NCT00385268|3601345|FG000|STARTED|Overall Study||34
2894144|NCT00385268|3601346|FG001|STARTED|Overall Study||26
2894145|NCT00385268|3601345|FG000|COMPLETED|Overall Study||18
2894146|NCT00385268|3601346|FG001|COMPLETED|Overall Study||18
2894147|NCT00385268|3601345|FG000|NOT COMPLETED|Overall Study||16
2894148|NCT00385268|3601346|FG001|NOT COMPLETED|Overall Study||8
2894149|NCT00385541|3601354|FG000|STARTED|Overall Study||25
2894150|NCT00385541|3601355|FG001|STARTED|Overall Study||25
2894151|NCT00385541|3601354|FG000|COMPLETED|Overall Study||25
2894152|NCT00385541|3601355|FG001|COMPLETED|Overall Study||24
2894153|NCT00385541|3601354|FG000|NOT COMPLETED|Overall Study||0
2894154|NCT00385541|3601355|FG001|NOT COMPLETED|Overall Study||1
2894155|NCT00385580|3601363|FG000|STARTED|Overall Study|Number of participants treated.|48
2894156|NCT00385580|3601364|FG001|STARTED|Overall Study|Number of participants treated.|47
2894157|NCT00385580|3601363|FG000|COMPLETED|Overall Study|Completed=off study. Major reasons for being off study are disease progression, and study toxicity.|48
2894158|NCT00385580|3601364|FG001|COMPLETED|Overall Study|Completed=off study. Major reasons for being off study are disease progression, and study toxicity.|47
2894159|NCT00385580|3601363|FG000|NOT COMPLETED|Overall Study||0
2894160|NCT00385580|3601364|FG001|NOT COMPLETED|Overall Study||0
2894161|NCT00385593|3601382|FG000|STARTED|Overall Study||328
2894162|NCT00385593|3601383|FG001|STARTED|Overall Study||326
2894163|NCT00385593|3601382|FG000|COMPLETED|Overall Study||270
2894164|NCT00385593|3601383|FG001|COMPLETED|Overall Study||289
2894165|NCT00385593|3601382|FG000|NOT COMPLETED|Overall Study||58
2894166|NCT00385593|3601383|FG001|NOT COMPLETED|Overall Study||37
2894167|NCT00385671|3601392|FG000|STARTED|Overall Study||134
2894168|NCT00385671|3601393|FG001|STARTED|Overall Study||138
2894169|NCT00385671|3601394|FG002|STARTED|Overall Study||135
2894170|NCT00385671|3601392|FG000|COMPLETED|Overall Study||96
2894171|NCT00385671|3601393|FG001|COMPLETED|Overall Study||87
2894172|NCT00385671|3601394|FG002|COMPLETED|Overall Study||99
2894173|NCT00385671|3601392|FG000|NOT COMPLETED|Overall Study||38
2894174|NCT00385671|3601393|FG001|NOT COMPLETED|Overall Study||51
2894175|NCT00385671|3601394|FG002|NOT COMPLETED|Overall Study||36
2894176|NCT00385684|3601404|FG000|STARTED|FIRST INTERVENTION OF PHASE A||6
2894177|NCT00385684|3601405|FG001|STARTED|FIRST INTERVENTION OF PHASE A||5
2894178|NCT00385684|3601404|FG000|COMPLETED|FIRST INTERVENTION OF PHASE A||5
2894179|NCT00385684|3601405|FG001|COMPLETED|FIRST INTERVENTION OF PHASE A||5
2894180|NCT00385684|3601404|FG000|NOT COMPLETED|FIRST INTERVENTION OF PHASE A||1
2894181|NCT00385684|3601405|FG001|NOT COMPLETED|FIRST INTERVENTION OF PHASE A||0
2894182|NCT00385684|3601404|FG000|STARTED|SECOND INTERVENTION OF PHASE A||5
2894183|NCT00385684|3601405|FG001|STARTED|SECOND INTERVENTION OF PHASE A||5
2894184|NCT00385684|3601404|FG000|COMPLETED|SECOND INTERVENTION OF PHASE A||5
2894185|NCT00385684|3601405|FG001|COMPLETED|SECOND INTERVENTION OF PHASE A||3
2894186|NCT00385684|3601404|FG000|NOT COMPLETED|SECOND INTERVENTION OF PHASE A||0
2894187|NCT00385684|3601405|FG001|NOT COMPLETED|SECOND INTERVENTION OF PHASE A||2
2894188|NCT00385684|3601404|FG000|STARTED|PHASE B||5
2894189|NCT00385684|3601405|FG001|STARTED|PHASE B||3
2894190|NCT00385684|3601404|FG000|COMPLETED|PHASE B||5
2894191|NCT00385684|3601405|FG001|COMPLETED|PHASE B||3
2894192|NCT00385684|3601404|FG000|NOT COMPLETED|PHASE B||0
2894193|NCT00385684|3601405|FG001|NOT COMPLETED|PHASE B||0
2894194|NCT00385723|3601414|FG000|STARTED|Overall Study||46
2894195|NCT00385723|3601415|FG001|STARTED|Overall Study||46
2894196|NCT00385723|3601416|FG002|STARTED|Overall Study||46
2894197|NCT00385723|3601414|FG000|COMPLETED|Overall Study||44
2894198|NCT00385723|3601415|FG001|COMPLETED|Overall Study||45
2894199|NCT00385723|3601416|FG002|COMPLETED|Overall Study||44
2894200|NCT00385723|3601414|FG000|NOT COMPLETED|Overall Study||2
2894201|NCT00385723|3601415|FG001|NOT COMPLETED|Overall Study||1
2894202|NCT00385723|3601416|FG002|NOT COMPLETED|Overall Study||2
2894203|NCT00385736|3601427|FG000|STARTED|Efficacy Analysis Set - Induction|Enrolled under Amendment 3 or 4 of the protocol.|130
2894204|NCT00385736|3601428|FG001|STARTED|Efficacy Analysis Set - Induction|Enrolled under Amendment 3 or 4 of the protocol.|130
2894205|NCT00385736|3601429|FG002|STARTED|Efficacy Analysis Set - Induction|Enrolled under Amendment 3 or 4 of the protocol.|130
2894206|NCT00385736|3601427|FG000|COMPLETED|Efficacy Analysis Set - Induction|Completed Week 8 of the study.|121
2894207|NCT00385736|3601428|FG001|COMPLETED|Efficacy Analysis Set - Induction|Completed Week 8 of the study.|118
2894208|NCT00385736|3601429|FG002|COMPLETED|Efficacy Analysis Set - Induction|Completed Week 8 of the study.|121
2894209|NCT00385736|3601427|FG000|NOT COMPLETED|Efficacy Analysis Set - Induction||9
2894210|NCT00385736|3601428|FG001|NOT COMPLETED|Efficacy Analysis Set - Induction||12
2894211|NCT00385736|3601429|FG002|NOT COMPLETED|Efficacy Analysis Set - Induction||9
2894212|NCT00385736|3601427|FG000|STARTED|Efficacy Analysis Set - Maintenance|Includes all subjects with confirmed UC enrolled since the start of the study|222
2894213|NCT00385736|3601428|FG001|STARTED|Efficacy Analysis Set - Maintenance|Includes all subjects with confirmed UC enrolled since the start of the study|130
2894214|NCT00385736|3601429|FG002|STARTED|Efficacy Analysis Set - Maintenance|Includes all subjects with confirmed UC enrolled since the start of the study|223
2894215|NCT00385736|3601427|FG000|COMPLETED|Efficacy Analysis Set - Maintenance||153
2894216|NCT00385736|3601428|FG001|COMPLETED|Efficacy Analysis Set - Maintenance||86
2894217|NCT00385736|3601429|FG002|COMPLETED|Efficacy Analysis Set - Maintenance||143
2894218|NCT00385736|3601427|FG000|NOT COMPLETED|Efficacy Analysis Set - Maintenance||69
2894219|NCT00385736|3601428|FG001|NOT COMPLETED|Efficacy Analysis Set - Maintenance||44
2894220|NCT00385736|3601429|FG002|NOT COMPLETED|Efficacy Analysis Set - Maintenance||80
2894221|NCT00385736|3601427|FG000|STARTED|Safety Analysis Set|Includes all subjects enrolled since the start of the study.|223
2894222|NCT00385736|3601428|FG001|STARTED|Safety Analysis Set|Includes all subjects enrolled since the start of the study.|130
2894223|NCT00385736|3601429|FG002|STARTED|Safety Analysis Set|Includes all subjects enrolled since the start of the study.|223
3170717|NCT01930188|3897968|FG000|Premature Discontinuation of Treatment|Overall Study|Subjects prematurely discontinued treatment were allowed to continue participation in the trial.|53
3170718|NCT01930188|3897969|FG001|Premature Discontinuation of Treatment|Overall Study|Subjects prematurely discontinued treatment were allowed to continue participation in the trial.|61
2894224|NCT00385736|3601427|FG000|COMPLETED|Safety Analysis Set||153
2894225|NCT00385736|3601428|FG001|COMPLETED|Safety Analysis Set||86
2894226|NCT00385736|3601429|FG002|COMPLETED|Safety Analysis Set||143
2894227|NCT00385736|3601427|FG000|NOT COMPLETED|Safety Analysis Set||70
2894228|NCT00385736|3601428|FG001|NOT COMPLETED|Safety Analysis Set||44
2894229|NCT00385736|3601429|FG002|NOT COMPLETED|Safety Analysis Set||80
2894230|NCT00385762|3601440|FG000|STARTED|Overall Study||35
2894231|NCT00385762|3601440|FG000|COMPLETED|Overall Study||33
2894232|NCT00385762|3601440|FG000|NOT COMPLETED|Overall Study||2
2894233|NCT00385788|3601446|FG000|STARTED|Overall Study||12
2894234|NCT00385788|3601447|FG001|STARTED|Overall Study||40
2894235|NCT00385788|3601446|FG000|COMPLETED|Overall Study||12
2894236|NCT00385788|3601447|FG001|COMPLETED|Overall Study||40
2894237|NCT00385788|3601446|FG000|NOT COMPLETED|Overall Study||0
2894238|NCT00385788|3601447|FG001|NOT COMPLETED|Overall Study||0
2894239|NCT00385801|3601455|FG000|STARTED|Overall Study||15
2894240|NCT00385801|3601456|FG001|STARTED|Overall Study||16
2894241|NCT00385801|3601455|FG000|COMPLETED|Overall Study||6
2894242|NCT00385801|3601456|FG001|COMPLETED|Overall Study||8
2894243|NCT00385801|3601455|FG000|NOT COMPLETED|Overall Study||9
2894244|NCT00385801|3601456|FG001|NOT COMPLETED|Overall Study||8
2894245|NCT00385827|3601466|FG000|STARTED|Part 1||9
2894246|NCT00385827|3601467|FG001|STARTED|Part 1||0
2894247|NCT00385827|3601468|FG002|STARTED|Part 1||0
2894248|NCT00385827|3601466|FG000|Treated|Part 1||9
2894249|NCT00385827|3601467|FG001|Treated|Part 1||0
2894250|NCT00385827|3601468|FG002|Treated|Part 1||0
2894251|NCT00385827|3601466|FG000|COMPLETED|Part 1||0
2894252|NCT00385827|3601467|FG001|COMPLETED|Part 1||0
2894253|NCT00385827|3601468|FG002|COMPLETED|Part 1||0
2894254|NCT00385827|3601466|FG000|NOT COMPLETED|Part 1||9
2894255|NCT00385827|3601467|FG001|NOT COMPLETED|Part 1||0
2894256|NCT00385827|3601468|FG002|NOT COMPLETED|Part 1||0
2894257|NCT00385827|3601466|FG000|STARTED|Part 2||0
2894258|NCT00385827|3601467|FG001|STARTED|Part 2||49
2894259|NCT00385827|3601468|FG002|STARTED|Part 2||48
2894260|NCT00385827|3601466|FG000|Treated|Part 2||0
2894261|NCT00385827|3601467|FG001|Treated|Part 2||47
2894262|NCT00385827|3601468|FG002|Treated|Part 2||46
2894263|NCT00385827|3601466|FG000|COMPLETED|Part 2||0
2894264|NCT00385827|3601467|FG001|COMPLETED|Part 2||16
2894265|NCT00385827|3601468|FG002|COMPLETED|Part 2||0
2894266|NCT00385827|3601466|FG000|NOT COMPLETED|Part 2||0
2894267|NCT00385827|3601467|FG001|NOT COMPLETED|Part 2||33
2894268|NCT00385827|3601468|FG002|NOT COMPLETED|Part 2||48
2894269|NCT00385840|3601480|FG000|STARTED|Overall Study||133
2894270|NCT00385840|3601481|FG001|STARTED|Overall Study||545
2894271|NCT00385840|3601480|FG000|COMPLETED|Overall Study||129
2894272|NCT00385840|3601481|FG001|COMPLETED|Overall Study||531
2894273|NCT00385840|3601480|FG000|NOT COMPLETED|Overall Study||4
2894274|NCT00385840|3601481|FG001|NOT COMPLETED|Overall Study||14
2919887|NCT00534417|3630331|FG000|COMPLETED|Overall Study||41
2919888|NCT00534417|3630331|FG000|NOT COMPLETED|Overall Study||0
2919889|NCT00534495|3630337|FG000|STARTED|Double Blind Placebo Phase Week 0-4||36
2919890|NCT00534495|3630338|FG001|STARTED|Double Blind Placebo Phase Week 0-4||35
2919891|NCT00534495|3630339|FG002|STARTED|Double Blind Placebo Phase Week 0-4||0
2919892|NCT00534495|3630337|FG000|COMPLETED|Double Blind Placebo Phase Week 0-4||36
2919893|NCT00534495|3630338|FG001|COMPLETED|Double Blind Placebo Phase Week 0-4||34
2919894|NCT00534495|3630339|FG002|COMPLETED|Double Blind Placebo Phase Week 0-4||0
2919895|NCT00534495|3630337|FG000|NOT COMPLETED|Double Blind Placebo Phase Week 0-4||0
2919896|NCT00534495|3630338|FG001|NOT COMPLETED|Double Blind Placebo Phase Week 0-4||1
2919897|NCT00534495|3630339|FG002|NOT COMPLETED|Double Blind Placebo Phase Week 0-4||0
2919898|NCT00534495|3630337|FG000|STARTED|All Active Treatment Phase Week 4-24||36
2919899|NCT00534495|3630338|FG001|STARTED|All Active Treatment Phase Week 4-24||34
2919900|NCT00534495|3630339|FG002|STARTED|All Active Treatment Phase Week 4-24||0
2919901|NCT00534495|3630337|FG000|COMPLETED|All Active Treatment Phase Week 4-24||32
2919902|NCT00534495|3630338|FG001|COMPLETED|All Active Treatment Phase Week 4-24||25
2919903|NCT00534495|3630339|FG002|COMPLETED|All Active Treatment Phase Week 4-24||0
2919904|NCT00534495|3630337|FG000|NOT COMPLETED|All Active Treatment Phase Week 4-24||4
2919905|NCT00534495|3630338|FG001|NOT COMPLETED|All Active Treatment Phase Week 4-24||9
2919906|NCT00534495|3630339|FG002|NOT COMPLETED|All Active Treatment Phase Week 4-24||0
2919907|NCT00534495|3630337|FG000|STARTED|Long Term Ext. Phase Week 24-month 21||0
2919908|NCT00534495|3630338|FG001|STARTED|Long Term Ext. Phase Week 24-month 21||0
2919909|NCT00534495|3630339|FG002|STARTED|Long Term Ext. Phase Week 24-month 21||40
2919910|NCT00534495|3630337|FG000|COMPLETED|Long Term Ext. Phase Week 24-month 21||0
2919911|NCT00534495|3630338|FG001|COMPLETED|Long Term Ext. Phase Week 24-month 21||0
2919912|NCT00534495|3630339|FG002|COMPLETED|Long Term Ext. Phase Week 24-month 21||29
2894275|NCT00385918|3601489|FG000|STARTED|Feasibility & Baseline Measurement Phase||0
2894276|NCT00385918|3601490|FG001|STARTED|Feasibility & Baseline Measurement Phase||0
2894277|NCT00385918|3601491|FG002|STARTED|Feasibility & Baseline Measurement Phase|Total # of subjects screened.The screening occurred before randomization.|35
2894278|NCT00385918|3601489|FG000|Number Eligible|Feasibility & Baseline Measurement Phase||0
2894279|NCT00385918|3601490|FG001|Number Eligible|Feasibility & Baseline Measurement Phase||0
2894280|NCT00385918|3601491|FG002|Number Eligible|Feasibility & Baseline Measurement Phase|8 subjects failed screening.|27
2894281|NCT00385918|3601489|FG000|Completed Baseline Tests|Feasibility & Baseline Measurement Phase||0
2894282|NCT00385918|3601490|FG001|Completed Baseline Tests|Feasibility & Baseline Measurement Phase||0
2894283|NCT00385918|3601491|FG002|Completed Baseline Tests|Feasibility & Baseline Measurement Phase|6 subjects did not complete all baseline tests.|21
2894284|NCT00385918|3601489|FG000|COMPLETED|Feasibility & Baseline Measurement Phase||0
2894285|NCT00385918|3601490|FG001|COMPLETED|Feasibility & Baseline Measurement Phase||0
2894286|NCT00385918|3601491|FG002|COMPLETED|Feasibility & Baseline Measurement Phase||21
2894287|NCT00385918|3601489|FG000|NOT COMPLETED|Feasibility & Baseline Measurement Phase||0
2894288|NCT00385918|3601490|FG001|NOT COMPLETED|Feasibility & Baseline Measurement Phase||0
2894289|NCT00385918|3601491|FG002|NOT COMPLETED|Feasibility & Baseline Measurement Phase||14
2894290|NCT00385918|3601489|FG000|STARTED|Intervention Phase After Randomization|Participant successfully completed screening; this is the number in the Lokomat training arm.|15
2894291|NCT00385918|3601490|FG001|STARTED|Intervention Phase After Randomization|Participants successfully completed screening; this is the number in the home stretching arm.|6
2894292|NCT00385918|3601491|FG002|STARTED|Intervention Phase After Randomization||0
2894293|NCT00385918|3601489|FG000|COMPLETED|Intervention Phase After Randomization|Participants completed the 3-month training intervention|12
2894294|NCT00385918|3601490|FG001|COMPLETED|Intervention Phase After Randomization|Participants completed the 3-month home-base intervention|6
2894295|NCT00385918|3601491|FG002|COMPLETED|Intervention Phase After Randomization||0
2894296|NCT00385918|3601489|FG000|NOT COMPLETED|Intervention Phase After Randomization||3
2894297|NCT00385918|3601490|FG001|NOT COMPLETED|Intervention Phase After Randomization||0
2894298|NCT00385918|3601491|FG002|NOT COMPLETED|Intervention Phase After Randomization||0
2894299|NCT00385944|3601500|FG000|STARTED|Loading Dose||0
2894300|NCT00385944|3601501|FG001|STARTED|Loading Dose||0
2894301|NCT00385944|3601502|FG002|STARTED|Loading Dose||56
2894302|NCT00385944|3601500|FG000|COMPLETED|Loading Dose||0
2894303|NCT00385944|3601501|FG001|COMPLETED|Loading Dose||0
2894304|NCT00385944|3601502|FG002|COMPLETED|Loading Dose||56
3170719|NCT01930188|3897970|FG002|Premature Discontinuation of Treatment|Overall Study|Subjects prematurely discontinued treatment were allowed to continue participation in the trial.|32
3170720|NCT01930188|3897968|FG000|COMPLETED|Overall Study||387
3170721|NCT01930188|3897969|FG001|COMPLETED|Overall Study||388
3170722|NCT01930188|3897970|FG002|COMPLETED|Overall Study||388
3170723|NCT01930188|3897968|FG000|NOT COMPLETED|Overall Study||22
3170724|NCT01930188|3897969|FG001|NOT COMPLETED|Overall Study||21
3170725|NCT01930188|3897970|FG002|NOT COMPLETED|Overall Study||19
3170726|NCT01930214|3897982|FG000|STARTED|Overall Study||100
3170727|NCT01930214|3897983|FG001|STARTED|Overall Study||117
3170728|NCT01930214|3897984|FG002|STARTED|Overall Study||133
3170729|NCT01930214|3897982|FG000|COMPLETED|Overall Study||80
3170730|NCT01930214|3897983|FG001|COMPLETED|Overall Study||96
3170731|NCT01930214|3897984|FG002|COMPLETED|Overall Study||108
3170732|NCT01930214|3897982|FG000|NOT COMPLETED|Overall Study||20
3170733|NCT01930214|3897983|FG001|NOT COMPLETED|Overall Study||21
3170734|NCT01930214|3897984|FG002|NOT COMPLETED|Overall Study||25
3170735|NCT01930435|3897992|FG000|STARTED|Overall Study||20
3170736|NCT01930435|3897992|FG000|COMPLETED|Overall Study||20
3170737|NCT01930435|3897992|FG000|NOT COMPLETED|Overall Study||0
2894305|NCT00385944|3601500|FG000|NOT COMPLETED|Loading Dose||0
2894306|NCT00385944|3601501|FG001|NOT COMPLETED|Loading Dose||0
2894307|NCT00385944|3601502|FG002|NOT COMPLETED|Loading Dose||0
2894308|NCT00385944|3601500|FG000|STARTED|1st Maintenance Dose Period||29
2894309|NCT00385944|3601501|FG001|STARTED|1st Maintenance Dose Period|Two patients withdrew from the study after randomization but prior to receiving the 1st MD.|25
2894310|NCT00385944|3601502|FG002|STARTED|1st Maintenance Dose Period||0
2894311|NCT00385944|3601500|FG000|COMPLETED|1st Maintenance Dose Period||25
2894312|NCT00385944|3601501|FG001|COMPLETED|1st Maintenance Dose Period||24
2894313|NCT00385944|3601502|FG002|COMPLETED|1st Maintenance Dose Period||0
2894314|NCT00385944|3601500|FG000|NOT COMPLETED|1st Maintenance Dose Period||4
2894315|NCT00385944|3601501|FG001|NOT COMPLETED|1st Maintenance Dose Period||1
2894316|NCT00385944|3601502|FG002|NOT COMPLETED|1st Maintenance Dose Period||0
2894317|NCT00385944|3601500|FG000|STARTED|2nd Maintenance Dose Period|1 patient discontinued prior to the 2nd MD Period (Sponsor decision due to early study termination)|24
2894318|NCT00385944|3601501|FG001|STARTED|2nd Maintenance Dose Period|2 patients discontinued prior to the 2nd MD Period (Sponsor decision due to early study termination)|22
2894319|NCT00385944|3601502|FG002|STARTED|2nd Maintenance Dose Period||0
2894320|NCT00385944|3601500|FG000|COMPLETED|2nd Maintenance Dose Period||22
2894321|NCT00385944|3601501|FG001|COMPLETED|2nd Maintenance Dose Period||19
2894322|NCT00385944|3601502|FG002|COMPLETED|2nd Maintenance Dose Period||0
2894323|NCT00385944|3601500|FG000|NOT COMPLETED|2nd Maintenance Dose Period||2
2894324|NCT00385944|3601501|FG001|NOT COMPLETED|2nd Maintenance Dose Period||3
2894325|NCT00385944|3601502|FG002|NOT COMPLETED|2nd Maintenance Dose Period||0
2894326|NCT00385996|3601517|FG000|STARTED|Overall Study||22
2894327|NCT00385996|3601517|FG000|COMPLETED|Overall Study||22
2894328|NCT00385996|3601517|FG000|NOT COMPLETED|Overall Study||0
2894329|NCT00386009|3601524|FG000|STARTED|Overall Study||101
2894330|NCT00386009|3601525|FG001|STARTED|Overall Study||99
2894331|NCT00386009|3601524|FG000|COMPLETED|Overall Study||92
2894332|NCT00386009|3601525|FG001|COMPLETED|Overall Study||89
2894333|NCT00386009|3601524|FG000|NOT COMPLETED|Overall Study||9
2894334|NCT00386009|3601525|FG001|NOT COMPLETED|Overall Study||10
2894335|NCT00386022|3601533|FG000|STARTED|Baseline||10
2894336|NCT00386022|3601534|FG001|STARTED|Baseline||9
2894337|NCT00386022|3601533|FG000|All Doses of GnRH|Baseline||10
2894338|NCT00386022|3601534|FG001|All Doses of GnRH|Baseline||9
2894339|NCT00386022|3601533|FG000|COMPLETED|Baseline||10
2894340|NCT00386022|3601534|FG001|COMPLETED|Baseline||9
2894341|NCT00386022|3601533|FG000|NOT COMPLETED|Baseline||0
2894342|NCT00386022|3601534|FG001|NOT COMPLETED|Baseline||0
2894343|NCT00386022|3601533|FG000|STARTED|Plus Estrogen||10
2894344|NCT00386022|3601534|FG001|STARTED|Plus Estrogen||9
2894345|NCT00386022|3601533|FG000|Estrogen Patch|Plus Estrogen||8
2894346|NCT00386022|3601534|FG001|Estrogen Patch|Plus Estrogen||9
2894347|NCT00386022|3601533|FG000|All Doses GnRH|Plus Estrogen||8
2894348|NCT00386022|3601534|FG001|All Doses GnRH|Plus Estrogen||8
2894349|NCT00386022|3601533|FG000|COMPLETED|Plus Estrogen||8
2894350|NCT00386022|3601534|FG001|COMPLETED|Plus Estrogen||8
2894351|NCT00386022|3601533|FG000|NOT COMPLETED|Plus Estrogen||2
2894352|NCT00386022|3601534|FG001|NOT COMPLETED|Plus Estrogen||1
2894353|NCT00386100|3601544|FG000|STARTED|Overall Study||340
2894354|NCT00386100|3601545|FG001|STARTED|Overall Study||348
2894355|NCT00386100|3601544|FG000|COMPLETED|Overall Study||186
2894356|NCT00386100|3601545|FG001|COMPLETED|Overall Study||217
2894357|NCT00386100|3601544|FG000|NOT COMPLETED|Overall Study||154
2894358|NCT00386100|3601545|FG001|NOT COMPLETED|Overall Study||131
2894359|NCT00386152|3601554|FG000|STARTED|Overall Study|number of subjects treated|75
2894360|NCT00386152|3601555|FG001|STARTED|Overall Study|number of subjects treated|77
2894361|NCT00386152|3601556|FG002|STARTED|Overall Study|number of subjects treated|75
2894362|NCT00386152|3601554|FG000|COMPLETED|Overall Study||31
2894363|NCT00386152|3601555|FG001|COMPLETED|Overall Study||37
2894364|NCT00386152|3601556|FG002|COMPLETED|Overall Study||42
2894365|NCT00386152|3601554|FG000|NOT COMPLETED|Overall Study||44
2894366|NCT00386152|3601555|FG001|NOT COMPLETED|Overall Study||40
2894367|NCT00386152|3601556|FG002|NOT COMPLETED|Overall Study||33
2894368|NCT00386243|3601566|FG000|STARTED|Overall Study||121
2894369|NCT00386243|3601567|FG001|STARTED|Overall Study||121
2894370|NCT00386243|3601566|FG000|COMPLETED|Overall Study||114
2894371|NCT00386243|3601567|FG001|COMPLETED|Overall Study||108
2894372|NCT00386243|3601566|FG000|NOT COMPLETED|Overall Study||7
2894373|NCT00386243|3601567|FG001|NOT COMPLETED|Overall Study||13
2894374|NCT00386256|3601577|FG000|STARTED|Overall Study||16
2894375|NCT00386256|3601578|FG001|STARTED|Overall Study||15
2894376|NCT00386256|3601579|FG002|STARTED|Overall Study||4
2894377|NCT00386256|3601580|FG003|STARTED|Overall Study||3
2894378|NCT00386256|3601577|FG000|COMPLETED|Overall Study||16
2894379|NCT00386256|3601578|FG001|COMPLETED|Overall Study||15
2894380|NCT00386256|3601579|FG002|COMPLETED|Overall Study||4
2894381|NCT00386256|3601580|FG003|COMPLETED|Overall Study||3
2894382|NCT00386256|3601577|FG000|NOT COMPLETED|Overall Study||0
2894383|NCT00386256|3601578|FG001|NOT COMPLETED|Overall Study||0
2894384|NCT00386256|3601579|FG002|NOT COMPLETED|Overall Study||0
2894385|NCT00386256|3601580|FG003|NOT COMPLETED|Overall Study||0
2894386|NCT00386308|3601592|FG000|STARTED|Overall Study||123
2894387|NCT00386308|3601593|FG001|STARTED|Overall Study||73
2894388|NCT00386308|3601592|FG000|Intent to Treat Population|Overall Study||117
2894389|NCT00386308|3601593|FG001|Intent to Treat Population|Overall Study||72
2894390|NCT00386308|3601592|FG000|Modified Intent to Treat Population|Overall Study||115
2894391|NCT00386308|3601593|FG001|Modified Intent to Treat Population|Overall Study||72
2894392|NCT00386308|3601592|FG000|COMPLETED|Overall Study||94
2894393|NCT00386308|3601593|FG001|COMPLETED|Overall Study||54
2894394|NCT00386308|3601592|FG000|NOT COMPLETED|Overall Study||29
2894395|NCT00386308|3601593|FG001|NOT COMPLETED|Overall Study||19
2894396|NCT00386334|3601601|FG000|STARTED|Double Blind Period||194
2894397|NCT00386334|3601602|FG001|STARTED|Double Blind Period||194
2894398|NCT00386334|3601601|FG000|COMPLETED|Double Blind Period||148
2894399|NCT00386334|3601602|FG001|COMPLETED|Double Blind Period||147
2894400|NCT00386334|3601601|FG000|NOT COMPLETED|Double Blind Period||46
2894401|NCT00386334|3601602|FG001|NOT COMPLETED|Double Blind Period||47
2894402|NCT00386334|3601601|FG000|STARTED|Follow up:2 Week Placebo, 2 Week no Drug|Two subjects withdrew consent prior to starting the follow up period.|146
2894403|NCT00386334|3601602|FG001|STARTED|Follow up:2 Week Placebo, 2 Week no Drug|Two subjects withdrew consent prior to starting the follow up period.|145
2894404|NCT00386334|3601601|FG000|COMPLETED|Follow up:2 Week Placebo, 2 Week no Drug||143
2894405|NCT00386334|3601602|FG001|COMPLETED|Follow up:2 Week Placebo, 2 Week no Drug||144
2894406|NCT00386334|3601601|FG000|NOT COMPLETED|Follow up:2 Week Placebo, 2 Week no Drug||3
2894407|NCT00386334|3601602|FG001|NOT COMPLETED|Follow up:2 Week Placebo, 2 Week no Drug||1
2894408|NCT00386360|3601610|FG000|STARTED|Overall Study||49
2894409|NCT00386360|3601611|FG001|STARTED|Overall Study||112
2894410|NCT00386360|3601610|FG000|Intent to Treat Population (ITT)|Overall Study|Includes all patients randomized and took at least one dose of study drug.|49
2894411|NCT00386360|3601611|FG001|Intent to Treat Population (ITT)|Overall Study||110
2894412|NCT00386360|3601610|FG000|Primary Efficacy|Overall Study|Per-protocol patients with evaluable BVTV (trabecular bone volume/tissue volume) at baseline & M12.|36
2894413|NCT00386360|3601611|FG001|Primary Efficacy|Overall Study||77
2894414|NCT00386360|3601610|FG000|COMPLETED|Overall Study||40
2894415|NCT00386360|3601611|FG001|COMPLETED|Overall Study||95
2894416|NCT00386360|3601610|FG000|NOT COMPLETED|Overall Study||9
2894417|NCT00386360|3601611|FG001|NOT COMPLETED|Overall Study||17
3170738|NCT01930487|3897997|FG000|STARTED|First Intervention (30 Days)||21
3170739|NCT01930487|3897998|FG001|STARTED|First Intervention (30 Days)||25
3314819|NCT03092934|4048174|FG002|Received at Least One Dose of Study Drug|Overall Study||2
3314820|NCT03092934|4048175|FG003|Received at Least One Dose of Study Drug|Overall Study||1
3314821|NCT03092934|4048172|FG000|COMPLETED|Overall Study||8
3314822|NCT03092934|4048173|FG001|COMPLETED|Overall Study||2
2894418|NCT00386425|3601620|FG000|STARTED|Overall Study|51 severe protein C deficiency; 176 moderate protein C deficiency|227
2894419|NCT00386425|3601621|FG001|STARTED|Overall Study|33 severe protein C deficiency; 173 moderate protein C deficiency|206
2894420|NCT00386425|3601622|FG002|STARTED|Overall Study||53
2894421|NCT00386425|3601620|FG000|Received Study Drug|Overall Study||227
2894422|NCT00386425|3601621|FG001|Received Study Drug|Overall Study||206
2894423|NCT00386425|3601622|FG002|Received Study Drug|Overall Study||53
2894424|NCT00386425|3601620|FG000|COMPLETED|Overall Study|51 severe protein C deficiency; 173 moderate protein C deficiency|224
2894425|NCT00386425|3601621|FG001|COMPLETED|Overall Study|33 severe protein C deficiency; 172 moderate protein C deficiency|205
2894426|NCT00386425|3601622|FG002|COMPLETED|Overall Study||53
2894427|NCT00386425|3601620|FG000|NOT COMPLETED|Overall Study||3
2894428|NCT00386425|3601621|FG001|NOT COMPLETED|Overall Study||1
2894429|NCT00386425|3601622|FG002|NOT COMPLETED|Overall Study||0
2894430|NCT00386477|3601636|FG000|STARTED|Overall Study||155
2894431|NCT00386477|3601637|FG001|STARTED|Overall Study||145
2894432|NCT00386477|3601636|FG000|COMPLETED|Overall Study||155
2894433|NCT00386477|3601637|FG001|COMPLETED|Overall Study||145
2894434|NCT00386477|3601636|FG000|NOT COMPLETED|Overall Study||0
2894435|NCT00386477|3601637|FG001|NOT COMPLETED|Overall Study||0
2894436|NCT00386607|3601643|FG000|STARTED|Core||601
2894437|NCT00386607|3601644|FG001|STARTED|Core||0
2894438|NCT00386607|3601643|FG000|COMPLETED|Core||486
2894439|NCT00386607|3601644|FG001|COMPLETED|Core||0
2894440|NCT00386607|3601643|FG000|NOT COMPLETED|Core||115
2894441|NCT00386607|3601644|FG001|NOT COMPLETED|Core||0
2894442|NCT00386607|3601643|FG000|STARTED|Extension||0
2894443|NCT00386607|3601644|FG001|STARTED|Extension||162
2894444|NCT00386607|3601643|FG000|COMPLETED|Extension||0
2894445|NCT00386607|3601644|FG001|COMPLETED|Extension||145
2894446|NCT00386607|3601643|FG000|NOT COMPLETED|Extension||0
2894447|NCT00386607|3601644|FG001|NOT COMPLETED|Extension||17
2894448|NCT00386776|3601656|FG000|STARTED|Overall Study||40
2894449|NCT00386776|3601656|FG000|COMPLETED|Overall Study||32
2894450|NCT00386776|3601656|FG000|NOT COMPLETED|Overall Study||8
2894451|NCT00386880|3601662|FG000|STARTED|Overall Study||30
2894452|NCT00386880|3601663|FG001|STARTED|Overall Study||8
2894453|NCT00386880|3601662|FG000|COMPLETED|Overall Study||30
2894454|NCT00386880|3601663|FG001|COMPLETED|Overall Study||8
2894455|NCT00386880|3601662|FG000|NOT COMPLETED|Overall Study||0
2894456|NCT00386880|3601663|FG001|NOT COMPLETED|Overall Study||0
2894457|NCT00387010|3601668|FG000|STARTED|Dose Titration Period||218
2894458|NCT00387010|3601668|FG000|COMPLETED|Dose Titration Period||180
2894459|NCT00387010|3601668|FG000|NOT COMPLETED|Dose Titration Period||38
2894460|NCT00387010|3601668|FG000|STARTED|Treatment Period||180
2894461|NCT00387010|3601668|FG000|Full Analysis Set|Treatment Period|FAS: treated patients with at least 1 paired baseline and post baseline efficacy assessment|175
2894462|NCT00387010|3601668|FG000|COMPLETED|Treatment Period||169
2894463|NCT00387010|3601668|FG000|NOT COMPLETED|Treatment Period||11
2894464|NCT00387023|3601672|FG000|STARTED|Overall Study||12
2894465|NCT00387023|3601672|FG000|COMPLETED|Overall Study||12
2894466|NCT00387023|3601672|FG000|NOT COMPLETED|Overall Study||0
2894467|NCT00387036|3601676|FG000|STARTED|2-Week First Intervention||6
2894468|NCT00387036|3601677|FG001|STARTED|2-Week First Intervention||6
2894469|NCT00387036|3601676|FG000|COMPLETED|2-Week First Intervention||6
2894470|NCT00387036|3601677|FG001|COMPLETED|2-Week First Intervention||6
2894471|NCT00387036|3601676|FG000|NOT COMPLETED|2-Week First Intervention||0
2894472|NCT00387036|3601677|FG001|NOT COMPLETED|2-Week First Intervention||0
2894473|NCT00387036|3601676|FG000|STARTED|2-Week Placebo Washout||6
2894474|NCT00387036|3601677|FG001|STARTED|2-Week Placebo Washout||6
2894475|NCT00387036|3601676|FG000|COMPLETED|2-Week Placebo Washout||6
2894476|NCT00387036|3601677|FG001|COMPLETED|2-Week Placebo Washout||6
2894477|NCT00387036|3601676|FG000|NOT COMPLETED|2-Week Placebo Washout||0
3314823|NCT03092934|4048174|FG002|COMPLETED|Overall Study||2
3314824|NCT03092934|4048175|FG003|COMPLETED|Overall Study||1
3314825|NCT03092934|4048172|FG000|NOT COMPLETED|Overall Study||0
3314826|NCT03092934|4048173|FG001|NOT COMPLETED|Overall Study||0
3314827|NCT03092934|4048174|FG002|NOT COMPLETED|Overall Study||0
3314828|NCT03092934|4048175|FG003|NOT COMPLETED|Overall Study||0
3314829|NCT03092960|4048187|FG000|STARTED|Overall Study||212
3314830|NCT03092960|4048188|FG001|STARTED|Overall Study||212
3314831|NCT03092960|4048187|FG000|COMPLETED|Overall Study||180
3314832|NCT03092960|4048188|FG001|COMPLETED|Overall Study||186
3314833|NCT03092960|4048187|FG000|NOT COMPLETED|Overall Study||32
2894478|NCT00387036|3601677|FG001|NOT COMPLETED|2-Week Placebo Washout||0
2894479|NCT00387036|3601676|FG000|STARTED|2-Week Crossover Second Intervention||6
2894480|NCT00387036|3601677|FG001|STARTED|2-Week Crossover Second Intervention||6
2894481|NCT00387036|3601676|FG000|COMPLETED|2-Week Crossover Second Intervention||6
2894482|NCT00387036|3601677|FG001|COMPLETED|2-Week Crossover Second Intervention||6
2894483|NCT00387036|3601676|FG000|NOT COMPLETED|2-Week Crossover Second Intervention||0
2894484|NCT00387036|3601677|FG001|NOT COMPLETED|2-Week Crossover Second Intervention||0
2894485|NCT00387088|3601685|FG000|STARTED|Overall Study||1989
2894486|NCT00387088|3601686|FG001|STARTED|Overall Study||2002
2894487|NCT00387088|3601685|FG000|COMPLETED|Overall Study||1671
3314834|NCT03092960|4048188|FG001|NOT COMPLETED|Overall Study||26
3314835|NCT03093025|4048197|FG000|STARTED|Overall Study||16
3314836|NCT03093025|4048198|FG001|STARTED|Overall Study|One participant did not take any dose of investigational product after randomization.|17
3314837|NCT03093025|4048199|FG002|STARTED|Overall Study||18
3314838|NCT03093025|4048197|FG000|COMPLETED|Overall Study||12
2894488|NCT00387088|3601686|FG001|COMPLETED|Overall Study||1629
2894489|NCT00387088|3601685|FG000|NOT COMPLETED|Overall Study||318
2894490|NCT00387088|3601686|FG001|NOT COMPLETED|Overall Study||373
2894491|NCT00387127|3601694|FG000|STARTED|Overall Study||33
2894492|NCT00387127|3601695|FG001|STARTED|Overall Study||34
2894493|NCT00387127|3601694|FG000|COMPLETED|Overall Study||0
2894494|NCT00387127|3601695|FG001|COMPLETED|Overall Study||0
2894495|NCT00387127|3601694|FG000|NOT COMPLETED|Overall Study||33
2894496|NCT00387127|3601695|FG001|NOT COMPLETED|Overall Study||34
2894497|NCT00387153|3601703|FG000|STARTED|Overall Study||8
2894498|NCT00387153|3601703|FG000|COMPLETED|Overall Study||0
2894499|NCT00387153|3601703|FG000|NOT COMPLETED|Overall Study||8
2894500|NCT00387335|3601709|FG000|STARTED|Overall Study||15
2894501|NCT00387335|3601710|FG001|STARTED|Overall Study||7
2894502|NCT00387335|3601709|FG000|COMPLETED|Overall Study||15
2894503|NCT00387335|3601710|FG001|COMPLETED|Overall Study||7
2894504|NCT00387335|3601709|FG000|NOT COMPLETED|Overall Study||0
2894505|NCT00387335|3601710|FG001|NOT COMPLETED|Overall Study||0
2894506|NCT00387348|3601719|FG000|STARTED|Overall Study||8
2894507|NCT00387348|3601720|FG001|STARTED|Overall Study||5
2894508|NCT00387348|3601721|FG002|STARTED|Overall Study||11
2894509|NCT00387348|3601719|FG000|COMPLETED|Overall Study||5
2894510|NCT00387348|3601720|FG001|COMPLETED|Overall Study||2
2894511|NCT00387348|3601721|FG002|COMPLETED|Overall Study||7
2894512|NCT00387348|3601719|FG000|NOT COMPLETED|Overall Study||3
2894513|NCT00387348|3601720|FG001|NOT COMPLETED|Overall Study||3
2894514|NCT00387348|3601721|FG002|NOT COMPLETED|Overall Study||4
2894515|NCT00387426|3601734|FG000|STARTED|Overall Study||14
2894516|NCT00387426|3601734|FG000|COMPLETED|Overall Study||0
2894517|NCT00387426|3601734|FG000|NOT COMPLETED|Overall Study||14
2894518|NCT00387465|3601741|FG000|STARTED|Overall Study||3
2894519|NCT00387465|3601742|FG001|STARTED|Overall Study||7
2894520|NCT00387465|3601743|FG002|STARTED|Overall Study||35
2894521|NCT00387465|3601741|FG000|COMPLETED|Overall Study||3
2894522|NCT00387465|3601742|FG001|COMPLETED|Overall Study||6
2894523|NCT00387465|3601743|FG002|COMPLETED|Overall Study||35
2894524|NCT00387465|3601741|FG000|NOT COMPLETED|Overall Study||0
2894525|NCT00387465|3601742|FG001|NOT COMPLETED|Overall Study||1
2894526|NCT00387465|3601743|FG002|NOT COMPLETED|Overall Study||0
2894527|NCT00387621|3601754|FG000|STARTED|First Intervention||29
2894528|NCT00387621|3601755|FG001|STARTED|First Intervention||29
2894529|NCT00387621|3601754|FG000|COMPLETED|First Intervention||29
2894530|NCT00387621|3601755|FG001|COMPLETED|First Intervention||29
2894531|NCT00387621|3601754|FG000|NOT COMPLETED|First Intervention||0
2894532|NCT00387621|3601755|FG001|NOT COMPLETED|First Intervention||0
2894533|NCT00387621|3601754|FG000|STARTED|Washout Period of 2 Weeks||29
2894534|NCT00387621|3601755|FG001|STARTED|Washout Period of 2 Weeks||29
2894535|NCT00387621|3601754|FG000|COMPLETED|Washout Period of 2 Weeks||29
2894536|NCT00387621|3601755|FG001|COMPLETED|Washout Period of 2 Weeks||29
2894537|NCT00387621|3601754|FG000|NOT COMPLETED|Washout Period of 2 Weeks||0
2894538|NCT00387621|3601755|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0
2894539|NCT00387621|3601754|FG000|STARTED|Second Intervention||29
2894540|NCT00387621|3601755|FG001|STARTED|Second Intervention||29
2894541|NCT00387621|3601754|FG000|COMPLETED|Second Intervention||29
2894542|NCT00387621|3601755|FG001|COMPLETED|Second Intervention||29
2894543|NCT00387621|3601754|FG000|NOT COMPLETED|Second Intervention||0
2894544|NCT00387621|3601755|FG001|NOT COMPLETED|Second Intervention||0
2894545|NCT00387647|3601767|FG000|STARTED|Overall Study||24
2894546|NCT00387647|3601767|FG000|COMPLETED|Overall Study||6
2894547|NCT00387647|3601767|FG000|NOT COMPLETED|Overall Study||18
2894548|NCT00387660|3601773|FG000|STARTED|Overall Study||40
2894549|NCT00387660|3601774|FG001|STARTED|Overall Study||40
2894550|NCT00387660|3601773|FG000|COMPLETED|Overall Study||40
2894551|NCT00387660|3601774|FG001|COMPLETED|Overall Study||40
2894552|NCT00387660|3601773|FG000|NOT COMPLETED|Overall Study||0
2894553|NCT00387660|3601774|FG001|NOT COMPLETED|Overall Study||0
2894554|NCT00387712|3601782|FG000|STARTED|Overall Study||47
2894555|NCT00387712|3601783|FG001|STARTED|Overall Study||52
2894556|NCT00387712|3601782|FG000|COMPLETED|Overall Study||18
2894557|NCT00387712|3601783|FG001|COMPLETED|Overall Study||16
3314839|NCT03093025|4048198|FG001|COMPLETED|Overall Study||15
3314840|NCT03093025|4048199|FG002|COMPLETED|Overall Study||16
2894558|NCT00387712|3601782|FG000|NOT COMPLETED|Overall Study||29
2894559|NCT00387712|3601783|FG001|NOT COMPLETED|Overall Study||36
2894560|NCT00387725|3601793|FG000|STARTED|Overall Study||21
2894561|NCT00387725|3601794|FG001|STARTED|Overall Study||16
2894562|NCT00387725|3601795|FG002|STARTED|Overall Study||45
2894563|NCT00387725|3601796|FG003|STARTED|Overall Study||45
2894564|NCT00387725|3601793|FG000|COMPLETED|Overall Study||20
2894565|NCT00387725|3601794|FG001|COMPLETED|Overall Study||15
2894566|NCT00387725|3601795|FG002|COMPLETED|Overall Study||43
2894567|NCT00387725|3601796|FG003|COMPLETED|Overall Study||43
2894568|NCT00387725|3601793|FG000|NOT COMPLETED|Overall Study||1
2894569|NCT00387725|3601794|FG001|NOT COMPLETED|Overall Study||1
2894570|NCT00387725|3601795|FG002|NOT COMPLETED|Overall Study||2
2894571|NCT00387725|3601796|FG003|NOT COMPLETED|Overall Study||2
2894572|NCT00387751|3601806|FG000|STARTED|Overall Study||14
2894573|NCT00387751|3601806|FG000|COMPLETED|Overall Study||14
2894574|NCT00387751|3601806|FG000|NOT COMPLETED|Overall Study||0
2894575|NCT00387764|3601812|FG000|STARTED|Overall Study||80
2894576|NCT00387764|3601812|FG000|COMPLETED|Overall Study|Participants completed treatment (until disease progression), but may not have completed the study.|49
2894577|NCT00387764|3601812|FG000|NOT COMPLETED|Overall Study||31
2894578|NCT00387790|3601816|FG000|STARTED|Overall Study||64
2894579|NCT00387790|3601816|FG000|COMPLETED|Overall Study||50
2894580|NCT00387790|3601816|FG000|NOT COMPLETED|Overall Study||14
2894581|NCT00387829|3601822|FG000|STARTED|Safety Population||178
2894582|NCT00387829|3601823|FG001|STARTED|Safety Population||169
2894583|NCT00387829|3601822|FG000|COMPLETED|Safety Population||139
2894584|NCT00387829|3601823|FG001|COMPLETED|Safety Population||136
2894585|NCT00387829|3601822|FG000|NOT COMPLETED|Safety Population||39
2894586|NCT00387829|3601823|FG001|NOT COMPLETED|Safety Population||33
2894587|NCT00387829|3601822|FG000|STARTED|Intent-to-treat Population||177
2894588|NCT00387829|3601823|FG001|STARTED|Intent-to-treat Population||166
2894589|NCT00387829|3601822|FG000|COMPLETED|Intent-to-treat Population||139
2894590|NCT00387829|3601823|FG001|COMPLETED|Intent-to-treat Population||136
2894591|NCT00387829|3601822|FG000|NOT COMPLETED|Intent-to-treat Population||38
2894592|NCT00387829|3601823|FG001|NOT COMPLETED|Intent-to-treat Population||30
2894593|NCT00387881|3601831|FG000|STARTED|Overall Study||334
2894594|NCT00387881|3601832|FG001|STARTED|Overall Study||345
2894595|NCT00387881|3601831|FG000|COMPLETED|Overall Study||245
2894596|NCT00387881|3601832|FG001|COMPLETED|Overall Study||243
2894597|NCT00387881|3601831|FG000|NOT COMPLETED|Overall Study||89
2894598|NCT00387881|3601832|FG001|NOT COMPLETED|Overall Study||102
2894599|NCT00387894|3601838|FG000|STARTED|Overall Study||6
2894600|NCT00387894|3601838|FG000|COMPLETED|Overall Study||5
2894601|NCT00387894|3601838|FG000|NOT COMPLETED|Overall Study||1
2894602|NCT00387959|3601842|FG000|STARTED|Overall Study||17
2894603|NCT00387959|3601842|FG000|COMPLETED|Overall Study||16
2894604|NCT00387959|3601842|FG000|NOT COMPLETED|Overall Study||1
2894605|NCT00388037|3601846|FG000|STARTED|Overall Study||31
2894606|NCT00388037|3601846|FG000|COMPLETED|Overall Study||30
2894607|NCT00388037|3601846|FG000|NOT COMPLETED|Overall Study||1
2894608|NCT00388154|3601850|FG000|STARTED|Overall Study||21
2894609|NCT00388154|3601850|FG000|COMPLETED|Overall Study||20
2894610|NCT00388154|3601850|FG000|NOT COMPLETED|Overall Study||1
2894611|NCT00388297|3601858|FG000|STARTED|Overall Study||339
2894612|NCT00388297|3601859|FG001|STARTED|Overall Study||338
2894613|NCT00388297|3601860|FG002|STARTED|Overall Study||265
2894614|NCT00388297|3601861|FG003|STARTED|Overall Study||261
2894615|NCT00388297|3601858|FG000|COMPLETED|Overall Study||323
2894616|NCT00388297|3601859|FG001|COMPLETED|Overall Study||326
2894617|NCT00388297|3601860|FG002|COMPLETED|Overall Study||254
2894618|NCT00388297|3601861|FG003|COMPLETED|Overall Study||253
2894619|NCT00388297|3601858|FG000|NOT COMPLETED|Overall Study||16
2894620|NCT00388297|3601859|FG001|NOT COMPLETED|Overall Study||12
2894621|NCT00388297|3601860|FG002|NOT COMPLETED|Overall Study||11
2894622|NCT00388297|3601861|FG003|NOT COMPLETED|Overall Study||8
2894623|NCT00388349|3601871|FG000|STARTED|Phase I Dose Escalation||3
2894624|NCT00388349|3601872|FG001|STARTED|Phase I Dose Escalation||4
2894625|NCT00388349|3601871|FG000|COMPLETED|Phase I Dose Escalation||3
2894626|NCT00388349|3601872|FG001|COMPLETED|Phase I Dose Escalation||1
3170740|NCT01930487|3897997|FG000|COMPLETED|First Intervention (30 Days)||19
3170741|NCT01930487|3897998|FG001|COMPLETED|First Intervention (30 Days)||23
3170742|NCT01930487|3897997|FG000|NOT COMPLETED|First Intervention (30 Days)||2
3170743|NCT01930487|3897998|FG001|NOT COMPLETED|First Intervention (30 Days)||2
3170744|NCT01930487|3897997|FG000|STARTED|Washout Period (3 Weeks)||19
3170745|NCT01930487|3897998|FG001|STARTED|Washout Period (3 Weeks)||23
3170746|NCT01930487|3897997|FG000|COMPLETED|Washout Period (3 Weeks)||19
3170747|NCT01930487|3897998|FG001|COMPLETED|Washout Period (3 Weeks)||23
3170748|NCT01930487|3897997|FG000|NOT COMPLETED|Washout Period (3 Weeks)||0
2894627|NCT00388349|3601871|FG000|NOT COMPLETED|Phase I Dose Escalation||0
2894628|NCT00388349|3601872|FG001|NOT COMPLETED|Phase I Dose Escalation||3
2894629|NCT00388349|3601871|FG000|STARTED|Phase 2 Dose Expansion|Includes the three phase 1 participants who received 1250 mg/m2 gemcitabine (MTD)|139
2894630|NCT00388349|3601872|FG001|STARTED|Phase 2 Dose Expansion|No participants were treated in Phase 2 at 1500 mg/m2 gemcitabine (MTD exceeded)|0
2894631|NCT00388349|3601871|FG000|COMPLETED|Phase 2 Dose Expansion||139
2894632|NCT00388349|3601872|FG001|COMPLETED|Phase 2 Dose Expansion||0
2894633|NCT00388349|3601871|FG000|NOT COMPLETED|Phase 2 Dose Expansion||0
2894634|NCT00388349|3601872|FG001|NOT COMPLETED|Phase 2 Dose Expansion||0
2894635|NCT00388362|3601880|FG000|STARTED|Enrolled||36
2894636|NCT00388362|3601880|FG000|COMPLETED|Enrolled||23
2894637|NCT00388362|3601880|FG000|NOT COMPLETED|Enrolled||13
2894638|NCT00388362|3601880|FG000|STARTED|Remained on Study Median of 514 Days||23
3170749|NCT01930487|3897998|FG001|NOT COMPLETED|Washout Period (3 Weeks)||0
2894639|NCT00388362|3601880|FG000|COMPLETED|Remained on Study Median of 514 Days||21
2894640|NCT00388362|3601880|FG000|NOT COMPLETED|Remained on Study Median of 514 Days||2
2894641|NCT00388414|3601886|FG000|STARTED|First Intervention (8 Weeks)||7
2894642|NCT00388414|3601887|FG001|STARTED|First Intervention (8 Weeks)||7
2894643|NCT00388414|3601886|FG000|COMPLETED|First Intervention (8 Weeks)||7
2894644|NCT00388414|3601887|FG001|COMPLETED|First Intervention (8 Weeks)||7
2894645|NCT00388414|3601886|FG000|NOT COMPLETED|First Intervention (8 Weeks)||0
2894646|NCT00388414|3601887|FG001|NOT COMPLETED|First Intervention (8 Weeks)||0
2894647|NCT00388414|3601886|FG000|STARTED|Washout (1 Week)||7
2894648|NCT00388414|3601887|FG001|STARTED|Washout (1 Week)||7
2894649|NCT00388414|3601886|FG000|COMPLETED|Washout (1 Week)||7
2894650|NCT00388414|3601887|FG001|COMPLETED|Washout (1 Week)||7
2894651|NCT00388414|3601886|FG000|NOT COMPLETED|Washout (1 Week)||0
2894652|NCT00388414|3601887|FG001|NOT COMPLETED|Washout (1 Week)||0
2894653|NCT00388414|3601886|FG000|STARTED|Second Intervention (8 Weeks)||7
2894654|NCT00388414|3601887|FG001|STARTED|Second Intervention (8 Weeks)||7
2894655|NCT00388414|3601886|FG000|COMPLETED|Second Intervention (8 Weeks)||7
2894656|NCT00388414|3601887|FG001|COMPLETED|Second Intervention (8 Weeks)||7
2894657|NCT00388414|3601886|FG000|NOT COMPLETED|Second Intervention (8 Weeks)||0
2894658|NCT00388414|3601887|FG001|NOT COMPLETED|Second Intervention (8 Weeks)||0
2894659|NCT00388453|3601898|FG000|STARTED|Overall Study||20
2894660|NCT00388453|3601899|FG001|STARTED|Overall Study||17
2894661|NCT00388453|3601900|FG002|STARTED|Overall Study||10
2894662|NCT00388453|3601898|FG000|COMPLETED|Overall Study||20
2894663|NCT00388453|3601899|FG001|COMPLETED|Overall Study||17
2894664|NCT00388453|3601900|FG002|COMPLETED|Overall Study||10
2894665|NCT00388453|3601898|FG000|NOT COMPLETED|Overall Study||0
2894666|NCT00388453|3601899|FG001|NOT COMPLETED|Overall Study||0
2894667|NCT00388453|3601900|FG002|NOT COMPLETED|Overall Study||0
2894668|NCT00388505|3601910|FG000|STARTED|Overall Study|Randomized patients who received any amount of study medication|308
2894669|NCT00388505|3601911|FG001|STARTED|Overall Study|Randomized patients who received any amount of study medication|209
2894670|NCT00388505|3601910|FG000|COMPLETED|Overall Study||225
2894671|NCT00388505|3601911|FG001|COMPLETED|Overall Study||171
2894672|NCT00388505|3601910|FG000|NOT COMPLETED|Overall Study||83
2894673|NCT00388505|3601911|FG001|NOT COMPLETED|Overall Study||38
2894674|NCT00388583|3601919|FG000|STARTED|Overall Study||407
2894675|NCT00388583|3601920|FG001|STARTED|Overall Study||410
2894676|NCT00388583|3601919|FG000|COMPLETED|Overall Study||401
2894677|NCT00388583|3601920|FG001|COMPLETED|Overall Study||406
2894678|NCT00388583|3601919|FG000|NOT COMPLETED|Overall Study||6
2894679|NCT00388583|3601920|FG001|NOT COMPLETED|Overall Study||4
2894680|NCT00388674|3601928|FG000|STARTED|Initial Treatment||6216
2894681|NCT00388674|3601929|FG001|STARTED|Initial Treatment||6162
2894682|NCT00388674|3601928|FG000|COMPLETED|Initial Treatment|Completed=Reason of 'successful treatment', 'other: successful treatment' or 'other: end of study'|4388
2894683|NCT00388674|3601929|FG001|COMPLETED|Initial Treatment|"Completed=discontinued initial treatment reason of successful treatment or end of study"|3576
2894684|NCT00388674|3601928|FG000|NOT COMPLETED|Initial Treatment||1828
2894685|NCT00388674|3601929|FG001|NOT COMPLETED|Initial Treatment||2586
2894686|NCT00388674|3601928|FG000|STARTED|End of Study||6216
2894687|NCT00388674|3601929|FG001|STARTED|End of Study||6162
2894688|NCT00388674|3601928|FG000|COMPLETED|End of Study|Completed=Reason of 'other: end of study'|4482
2894689|NCT00388674|3601929|FG001|COMPLETED|End of Study|Completed=Reason of 'other: end of study'|3993
2894690|NCT00388674|3601928|FG000|NOT COMPLETED|End of Study||1734
2894691|NCT00388674|3601929|FG001|NOT COMPLETED|End of Study||2169
2894692|NCT00388726|3601937|FG000|STARTED|Overall Study||508
2894693|NCT00388726|3601938|FG001|STARTED|Overall Study||254
2894694|NCT00388726|3601937|FG000|COMPLETED|Overall Study||24
2894695|NCT00388726|3601938|FG001|COMPLETED|Overall Study||10
2894696|NCT00388726|3601937|FG000|NOT COMPLETED|Overall Study||484
2894697|NCT00388726|3601938|FG001|NOT COMPLETED|Overall Study||244
2894698|NCT00388804|3601946|FG000|STARTED|Overall Study||17
2894699|NCT00388804|3601947|FG001|STARTED|Overall Study||21
2894700|NCT00388804|3601946|FG000|COMPLETED|Overall Study||17
2894701|NCT00388804|3601947|FG001|COMPLETED|Overall Study||21
2894702|NCT00388804|3601946|FG000|NOT COMPLETED|Overall Study||0
2894703|NCT00388804|3601947|FG001|NOT COMPLETED|Overall Study||0
2894704|NCT00388947|3601953|FG000|STARTED|Overall Study||1590
2894705|NCT00388947|3601953|FG000|COMPLETED|Overall Study|47 patients excluded because no AMS prolapse device was noted.|1543
2894706|NCT00388947|3601953|FG000|NOT COMPLETED|Overall Study||47
2894707|NCT00388973|3601959|FG000|STARTED|Overall Study|Randomized|166
2894708|NCT00388973|3601960|FG001|STARTED|Overall Study|Randomized|172
2894709|NCT00388973|3601959|FG000|Completed Study|Overall Study||110
2894710|NCT00388973|3601960|FG001|Completed Study|Overall Study||114
2894711|NCT00388973|3601959|FG000|COMPLETED|Overall Study|Completed 9-week treatment and 2 week follow-up|110
2894712|NCT00388973|3601960|FG001|COMPLETED|Overall Study|Completed 9-week treatment and 2 week follow-up|114
2894713|NCT00388973|3601959|FG000|NOT COMPLETED|Overall Study||56
2894714|NCT00388973|3601960|FG001|NOT COMPLETED|Overall Study||58
2894715|NCT00389064|3601968|FG000|STARTED|Overall Study||223
2894716|NCT00389064|3601969|FG001|STARTED|Overall Study||227
2894717|NCT00389064|3601968|FG000|COMPLETED|Overall Study||178
2894718|NCT00389064|3601969|FG001|COMPLETED|Overall Study||168
2894719|NCT00389064|3601968|FG000|NOT COMPLETED|Overall Study||45
2894720|NCT00389064|3601969|FG001|NOT COMPLETED|Overall Study||59
2894721|NCT00389168|3601977|FG000|STARTED|Overall Study||56
2894722|NCT00389168|3601978|FG001|STARTED|Overall Study||58
2894723|NCT00389168|3601977|FG000|COMPLETED|Overall Study||47
2894724|NCT00389168|3601978|FG001|COMPLETED|Overall Study||53
2894725|NCT00389168|3601977|FG000|NOT COMPLETED|Overall Study||9
2894726|NCT00389168|3601978|FG001|NOT COMPLETED|Overall Study||5
2894727|NCT00389207|3601987|FG000|STARTED|Overall Study|3 patients were randomized to NVP QD but not treated and so not part of the Full Analysis Set (FAS)|188
2894728|NCT00389207|3601988|FG001|STARTED|Overall Study|4 patients were randomized to NVP BID but not treated and so are not part of the FAS|188
2894729|NCT00389207|3601989|FG002|STARTED|Overall Study||193
2894730|NCT00389207|3601987|FG000|COMPLETED|Overall Study||125
2894731|NCT00389207|3601988|FG001|COMPLETED|Overall Study||116
2894732|NCT00389207|3601989|FG002|COMPLETED|Overall Study||152
2894733|NCT00389207|3601987|FG000|NOT COMPLETED|Overall Study||63
3170750|NCT01930487|3897997|FG000|STARTED|Second Intervention (30 Days)||19
3170751|NCT01930487|3897998|FG001|STARTED|Second Intervention (30 Days)||23
3170752|NCT01930487|3897997|FG000|COMPLETED|Second Intervention (30 Days)||19
3170753|NCT01930487|3897998|FG001|COMPLETED|Second Intervention (30 Days)||23
3170754|NCT01930487|3897997|FG000|NOT COMPLETED|Second Intervention (30 Days)||0
3170755|NCT01930487|3897998|FG001|NOT COMPLETED|Second Intervention (30 Days)||0
2894734|NCT00389207|3601988|FG001|NOT COMPLETED|Overall Study||72
2894735|NCT00389207|3601989|FG002|NOT COMPLETED|Overall Study||41
2894736|NCT00389324|3602002|FG000|STARTED|Run-In Phase||21
2894737|NCT00389324|3602002|FG000|COMPLETED|Run-In Phase||18
2894738|NCT00389324|3602002|FG000|NOT COMPLETED|Run-In Phase||3
2894739|NCT00389324|3602002|FG000|STARTED|Intravenous Phase|18 subjects entered from the Run-in Phase and 14 new participants entered directly|32
2894740|NCT00389324|3602002|FG000|COMPLETED|Intravenous Phase||32
2894741|NCT00389324|3602002|FG000|NOT COMPLETED|Intravenous Phase||0
2894742|NCT00389324|3602002|FG000|STARTED|Subcutaneous Phase||32
2894743|NCT00389324|3602002|FG000|COMPLETED|Subcutaneous Phase||25
2894744|NCT00389324|3602002|FG000|NOT COMPLETED|Subcutaneous Phase||7
2894745|NCT00389441|3602009|FG000|STARTED|Overall Study||52
2894746|NCT00389441|3602009|FG000|COMPLETED|Overall Study||0
2894747|NCT00389441|3602009|FG000|NOT COMPLETED|Overall Study||52
2894748|NCT00389467|3602017|FG000|STARTED|Overall Study||34
2894749|NCT00389467|3602018|FG001|STARTED|Overall Study||34
2894750|NCT00389467|3602019|FG002|STARTED|Overall Study||30
2894751|NCT00389467|3602020|FG003|STARTED|Overall Study||20
2894752|NCT00389467|3602017|FG000|COMPLETED|Overall Study||34
2894753|NCT00389467|3602018|FG001|COMPLETED|Overall Study||34
2894754|NCT00389467|3602019|FG002|COMPLETED|Overall Study||30
2894755|NCT00389467|3602020|FG003|COMPLETED|Overall Study||20
2894756|NCT00389467|3602017|FG000|NOT COMPLETED|Overall Study||0
2894757|NCT00389467|3602018|FG001|NOT COMPLETED|Overall Study||0
2894758|NCT00389467|3602019|FG002|NOT COMPLETED|Overall Study||0
2894759|NCT00389467|3602020|FG003|NOT COMPLETED|Overall Study||0
2894760|NCT00389493|3602034|FG000|STARTED|Overall Study||40
2894761|NCT00389493|3602035|FG001|STARTED|Overall Study||40
2894762|NCT00389493|3602036|FG002|STARTED|Overall Study||20
2894763|NCT00389493|3602034|FG000|COMPLETED|Overall Study||37
2894764|NCT00389493|3602035|FG001|COMPLETED|Overall Study||32
2894765|NCT00389493|3602036|FG002|COMPLETED|Overall Study||17
2894766|NCT00389493|3602034|FG000|NOT COMPLETED|Overall Study||3
2894767|NCT00389493|3602035|FG001|NOT COMPLETED|Overall Study||8
2894768|NCT00389493|3602036|FG002|NOT COMPLETED|Overall Study||3
2894769|NCT00389519|3602051|FG000|STARTED|Placebo Run-In||422
2894770|NCT00389519|3602052|FG001|STARTED|Placebo Run-In||0
2894771|NCT00389519|3602053|FG002|STARTED|Placebo Run-In||0
2894772|NCT00389519|3602054|FG003|STARTED|Placebo Run-In||0
2894773|NCT00389519|3602051|FG000|COMPLETED|Placebo Run-In||244
2894774|NCT00389519|3602052|FG001|COMPLETED|Placebo Run-In||0
2894775|NCT00389519|3602053|FG002|COMPLETED|Placebo Run-In||0
2894776|NCT00389519|3602054|FG003|COMPLETED|Placebo Run-In||0
2894777|NCT00389519|3602051|FG000|NOT COMPLETED|Placebo Run-In||178
2894778|NCT00389519|3602052|FG001|NOT COMPLETED|Placebo Run-In||0
2894779|NCT00389519|3602053|FG002|NOT COMPLETED|Placebo Run-In||0
2894780|NCT00389519|3602054|FG003|NOT COMPLETED|Placebo Run-In||0
2894781|NCT00389519|3602051|FG000|STARTED|Randomized||83
2894782|NCT00389519|3602052|FG001|STARTED|Randomized||41
2894783|NCT00389519|3602053|FG002|STARTED|Randomized||40
2894784|NCT00389519|3602054|FG003|STARTED|Randomized||80
2894785|NCT00389519|3602051|FG000|COMPLETED|Randomized||81
2894786|NCT00389519|3602052|FG001|COMPLETED|Randomized||41
2894787|NCT00389519|3602053|FG002|COMPLETED|Randomized||40
2894788|NCT00389519|3602054|FG003|COMPLETED|Randomized||80
2894789|NCT00389519|3602051|FG000|NOT COMPLETED|Randomized||2
2894790|NCT00389519|3602052|FG001|NOT COMPLETED|Randomized||0
2894791|NCT00389519|3602053|FG002|NOT COMPLETED|Randomized||0
2894792|NCT00389519|3602054|FG003|NOT COMPLETED|Randomized||0
3170756|NCT01930643|3898006|FG000|STARTED|Overall Study||7
2894793|NCT00389519|3602051|FG000|STARTED|Treated||81
2894794|NCT00389519|3602052|FG001|STARTED|Treated||41
2894795|NCT00389519|3602053|FG002|STARTED|Treated||40
2894796|NCT00389519|3602054|FG003|STARTED|Treated||80
2894797|NCT00389519|3602051|FG000|COMPLETED|Treated||79
2894798|NCT00389519|3602052|FG001|COMPLETED|Treated||40
2894799|NCT00389519|3602053|FG002|COMPLETED|Treated||40
3170757|NCT01930643|3898007|FG001|STARTED|Overall Study||6
3170758|NCT01930643|3898006|FG000|COMPLETED|Overall Study||7
2894800|NCT00389519|3602054|FG003|COMPLETED|Treated||76
2894801|NCT00389519|3602051|FG000|NOT COMPLETED|Treated||2
2894802|NCT00389519|3602052|FG001|NOT COMPLETED|Treated||1
2894803|NCT00389519|3602053|FG002|NOT COMPLETED|Treated||0
2894804|NCT00389519|3602054|FG003|NOT COMPLETED|Treated||4
2894805|NCT00389532|3602066|FG000|STARTED|Overall Study||60
2894806|NCT00389532|3602067|FG001|STARTED|Overall Study||56
2894807|NCT00389532|3602066|FG000|COMPLETED|Overall Study|3 of the participants did not have valid post-vaccination serological results|60
2894808|NCT00389532|3602067|FG001|COMPLETED|Overall Study||56
2894809|NCT00389532|3602066|FG000|NOT COMPLETED|Overall Study||0
2894810|NCT00389532|3602067|FG001|NOT COMPLETED|Overall Study||0
2894811|NCT00389597|3602077|FG000|STARTED|Overall Study||164
2894812|NCT00389597|3602078|FG001|STARTED|Overall Study||81
2894813|NCT00389597|3602079|FG002|STARTED|Overall Study||225
2894814|NCT00389597|3602080|FG003|STARTED|Overall Study||105
2894815|NCT00389597|3602077|FG000|24 mo|Overall Study||156
2894816|NCT00389597|3602078|FG001|24 mo|Overall Study||75
2894817|NCT00389597|3602079|FG002|24 mo|Overall Study||221
2894818|NCT00389597|3602080|FG003|24 mo|Overall Study||99
2894819|NCT00389597|3602077|FG000|COMPLETED|Overall Study||156
2894820|NCT00389597|3602078|FG001|COMPLETED|Overall Study||75
2894821|NCT00389597|3602079|FG002|COMPLETED|Overall Study||221
2894822|NCT00389597|3602080|FG003|COMPLETED|Overall Study||99
2894823|NCT00389597|3602077|FG000|NOT COMPLETED|Overall Study||8
2894824|NCT00389597|3602078|FG001|NOT COMPLETED|Overall Study||6
2894825|NCT00389597|3602079|FG002|NOT COMPLETED|Overall Study||4
2894826|NCT00389597|3602080|FG003|NOT COMPLETED|Overall Study||6
2894827|NCT00389805|3602092|FG000|STARTED|Phase I||15
2894828|NCT00389805|3602093|FG001|STARTED|Phase I||12
2894829|NCT00389805|3602092|FG000|COMPLETED|Phase I||15
2894830|NCT00389805|3602093|FG001|COMPLETED|Phase I||12
2894831|NCT00389805|3602092|FG000|NOT COMPLETED|Phase I||0
2894832|NCT00389805|3602093|FG001|NOT COMPLETED|Phase I||0
2894833|NCT00389805|3602092|FG000|STARTED|Phase II|The Phase II study was not conducted.|0
2894834|NCT00389805|3602093|FG001|STARTED|Phase II|The Phase II study was not conducted.|0
2894835|NCT00389805|3602092|FG000|COMPLETED|Phase II||0
2894836|NCT00389805|3602093|FG001|COMPLETED|Phase II||0
2894837|NCT00389805|3602092|FG000|NOT COMPLETED|Phase II||0
2894838|NCT00389805|3602093|FG001|NOT COMPLETED|Phase II||0
2894839|NCT00389818|3602099|FG000|STARTED|Overall Study||43
2894840|NCT00389818|3602099|FG000|COMPLETED|Overall Study||40
2894841|NCT00389818|3602099|FG000|NOT COMPLETED|Overall Study||3
2894842|NCT00389831|3602105|FG000|STARTED|Overall Study||10
2894843|NCT00389831|3602106|FG001|STARTED|Overall Study||34
2894844|NCT00389831|3602105|FG000|COMPLETED|Overall Study||10
2894845|NCT00389831|3602106|FG001|COMPLETED|Overall Study||27
2894846|NCT00389831|3602105|FG000|NOT COMPLETED|Overall Study||0
2894847|NCT00389831|3602106|FG001|NOT COMPLETED|Overall Study||7
2894848|NCT00389857|3602126|FG000|STARTED|Overall Study||14
2894849|NCT00389857|3602127|FG001|STARTED|Overall Study||17
2894850|NCT00389857|3602126|FG000|COMPLETED|Overall Study||14
2894851|NCT00389857|3602127|FG001|COMPLETED|Overall Study||17
2894852|NCT00389857|3602126|FG000|NOT COMPLETED|Overall Study||0
2894853|NCT00389857|3602127|FG001|NOT COMPLETED|Overall Study||0
2894854|NCT00389974|3602133|FG000|STARTED|Overall Study||19
2894855|NCT00389974|3602133|FG000|COMPLETED|Overall Study||19
2894856|NCT00389974|3602133|FG000|NOT COMPLETED|Overall Study||0
2894857|NCT00390013|3602140|FG000|STARTED|Phase 1||0
2894858|NCT00390013|3602141|FG001|STARTED|Phase 1||0
2894859|NCT00390013|3602142|FG002|STARTED|Phase 1||2
2894860|NCT00390013|3602143|FG003|STARTED|Phase 1||2
2894861|NCT00390013|3602140|FG000|COMPLETED|Phase 1||0
2894862|NCT00390013|3602141|FG001|COMPLETED|Phase 1||0
2894863|NCT00390013|3602142|FG002|COMPLETED|Phase 1||2
2894864|NCT00390013|3602143|FG003|COMPLETED|Phase 1||1
2894865|NCT00390013|3602140|FG000|NOT COMPLETED|Phase 1||0
2894866|NCT00390013|3602141|FG001|NOT COMPLETED|Phase 1||0
2894867|NCT00390013|3602142|FG002|NOT COMPLETED|Phase 1||0
2894868|NCT00390013|3602143|FG003|NOT COMPLETED|Phase 1||1
2894869|NCT00390013|3602140|FG000|STARTED|Phase 2 First Treatment||3
2894870|NCT00390013|3602141|FG001|STARTED|Phase 2 First Treatment||2
2894871|NCT00390013|3602142|FG002|STARTED|Phase 2 First Treatment||0
2894872|NCT00390013|3602143|FG003|STARTED|Phase 2 First Treatment||0
2894873|NCT00390013|3602140|FG000|COMPLETED|Phase 2 First Treatment||2
2894874|NCT00390013|3602141|FG001|COMPLETED|Phase 2 First Treatment||1
2894875|NCT00390013|3602142|FG002|COMPLETED|Phase 2 First Treatment||0
2894876|NCT00390013|3602143|FG003|COMPLETED|Phase 2 First Treatment||0
2894877|NCT00390013|3602140|FG000|NOT COMPLETED|Phase 2 First Treatment||1
2894878|NCT00390013|3602141|FG001|NOT COMPLETED|Phase 2 First Treatment||1
2894879|NCT00390013|3602142|FG002|NOT COMPLETED|Phase 2 First Treatment||0
2894880|NCT00390013|3602143|FG003|NOT COMPLETED|Phase 2 First Treatment||0
2894881|NCT00390013|3602140|FG000|STARTED|Phase 2 Second Treatment||2
2894882|NCT00390013|3602141|FG001|STARTED|Phase 2 Second Treatment||1
2894883|NCT00390013|3602142|FG002|STARTED|Phase 2 Second Treatment||0
2894884|NCT00390013|3602143|FG003|STARTED|Phase 2 Second Treatment||0
2894885|NCT00390013|3602140|FG000|COMPLETED|Phase 2 Second Treatment||2
2894886|NCT00390013|3602141|FG001|COMPLETED|Phase 2 Second Treatment||1
2894887|NCT00390013|3602142|FG002|COMPLETED|Phase 2 Second Treatment||0
2894888|NCT00390013|3602143|FG003|COMPLETED|Phase 2 Second Treatment||0
2894889|NCT00390013|3602140|FG000|NOT COMPLETED|Phase 2 Second Treatment||0
2894890|NCT00390013|3602141|FG001|NOT COMPLETED|Phase 2 Second Treatment||0
2894891|NCT00390013|3602142|FG002|NOT COMPLETED|Phase 2 Second Treatment||0
2894892|NCT00390013|3602143|FG003|NOT COMPLETED|Phase 2 Second Treatment||0
2894893|NCT00390182|3602149|FG000|STARTED|Overall Study||38
2894894|NCT00390182|3602149|FG000|COMPLETED|Overall Study||33
2894895|NCT00390182|3602149|FG000|NOT COMPLETED|Overall Study||5
2894896|NCT00390221|3602156|FG000|STARTED|Overall Study||204
2894897|NCT00390221|3602157|FG001|STARTED|Overall Study||208
2894898|NCT00390221|3602158|FG002|STARTED|Overall Study||209
2894899|NCT00390221|3602156|FG000|COMPLETED|Overall Study||186
2894900|NCT00390221|3602157|FG001|COMPLETED|Overall Study||188
2894901|NCT00390221|3602158|FG002|COMPLETED|Overall Study||194
2894902|NCT00390221|3602156|FG000|NOT COMPLETED|Overall Study||18
2894903|NCT00390221|3602157|FG001|NOT COMPLETED|Overall Study||20
2894904|NCT00390221|3602158|FG002|NOT COMPLETED|Overall Study||15
2894905|NCT00390234|3602167|FG000|STARTED|Overall Study||63
2894906|NCT00390234|3602167|FG000|COMPLETED|Overall Study||63
2894907|NCT00390234|3602167|FG000|NOT COMPLETED|Overall Study||0
2894908|NCT00390299|3602177|FG000|STARTED|Overall Study||4
2894909|NCT00390299|3602178|FG001|STARTED|Overall Study||3
2894910|NCT00390299|3602179|FG002|STARTED|Overall Study||3
2894911|NCT00390299|3602180|FG003|STARTED|Overall Study||3
2894912|NCT00390299|3602181|FG004|STARTED|Overall Study||10
2894913|NCT00390299|3602177|FG000|COMPLETED|Overall Study||3
2894914|NCT00390299|3602178|FG001|COMPLETED|Overall Study||3
2894915|NCT00390299|3602179|FG002|COMPLETED|Overall Study||3
2894916|NCT00390299|3602180|FG003|COMPLETED|Overall Study||3
2894917|NCT00390299|3602181|FG004|COMPLETED|Overall Study||10
2894918|NCT00390299|3602177|FG000|NOT COMPLETED|Overall Study||1
2894919|NCT00390299|3602178|FG001|NOT COMPLETED|Overall Study||0
2894920|NCT00390299|3602179|FG002|NOT COMPLETED|Overall Study||0
2894921|NCT00390299|3602180|FG003|NOT COMPLETED|Overall Study||0
2894922|NCT00390299|3602181|FG004|NOT COMPLETED|Overall Study||0
2894923|NCT00390325|3602197|FG000|STARTED|Overall Study||5
2894924|NCT00390325|3602198|FG001|STARTED|Overall Study||16
2894925|NCT00390325|3602197|FG000|COMPLETED|Overall Study||5
2894926|NCT00390325|3602198|FG001|COMPLETED|Overall Study||16
2894927|NCT00390325|3602197|FG000|NOT COMPLETED|Overall Study||0
2894928|NCT00390325|3602198|FG001|NOT COMPLETED|Overall Study||0
2894929|NCT00390364|3602208|FG000|STARTED|Overall Study||1
2894930|NCT00390364|3602208|FG000|COMPLETED|Overall Study||1
2894931|NCT00390364|3602208|FG000|NOT COMPLETED|Overall Study||0
2894932|NCT00390416|3602212|FG000|STARTED|Overall Study||48
2894933|NCT00390416|3602212|FG000|COMPLETED|Overall Study||44
2894934|NCT00390416|3602212|FG000|NOT COMPLETED|Overall Study||4
2894935|NCT00390429|3602219|FG000|STARTED|Overall Study||5
2894936|NCT00390429|3602220|FG001|STARTED|Overall Study||12
2894937|NCT00390429|3602221|FG002|STARTED|Overall Study||25
2894938|NCT00390429|3602222|FG003|STARTED|Overall Study||39
2894939|NCT00390429|3602219|FG000|COMPLETED|Overall Study||5
2894940|NCT00390429|3602220|FG001|COMPLETED|Overall Study||12
2894941|NCT00390429|3602221|FG002|COMPLETED|Overall Study||25
2894942|NCT00390429|3602222|FG003|COMPLETED|Overall Study||39
2894943|NCT00390429|3602219|FG000|NOT COMPLETED|Overall Study||0
2894944|NCT00390429|3602220|FG001|NOT COMPLETED|Overall Study||0
2894945|NCT00390429|3602221|FG002|NOT COMPLETED|Overall Study||0
2894946|NCT00390429|3602222|FG003|NOT COMPLETED|Overall Study||0
2894947|NCT00390455|3602235|FG000|STARTED|Overall Study||148
2894948|NCT00390455|3602236|FG001|STARTED|Overall Study||147
2894949|NCT00390455|3602235|FG000|COMPLETED|Overall Study||116
2894950|NCT00390455|3602236|FG001|COMPLETED|Overall Study||124
2894951|NCT00390455|3602235|FG000|NOT COMPLETED|Overall Study||32
2894952|NCT00390455|3602236|FG001|NOT COMPLETED|Overall Study||23
2894953|NCT00390468|3602242|FG000|STARTED|Overall Study||18
2894954|NCT00390468|3602242|FG000|COMPLETED|Overall Study||15
2894955|NCT00390468|3602242|FG000|NOT COMPLETED|Overall Study||3
2894956|NCT00390546|3602248|FG000|STARTED|Overall Study||33
2894957|NCT00390546|3602249|FG001|STARTED|Overall Study||39
2894958|NCT00390546|3602248|FG000|COMPLETED|Overall Study||27
2894959|NCT00390546|3602249|FG001|COMPLETED|Overall Study||34
2894960|NCT00390546|3602248|FG000|NOT COMPLETED|Overall Study||6
2894961|NCT00390546|3602249|FG001|NOT COMPLETED|Overall Study||5
2894962|NCT00390559|3602256|FG000|STARTED|Overall Study||124
2894963|NCT00390559|3602256|FG000|Received PlaceboP/Active C|Overall Study||93
2894964|NCT00390559|3602256|FG000|ActiveP/ActiveC|Overall Study||87
2894965|NCT00390559|3602256|FG000|PlaceboP/PlaceboC|Overall Study||93
2894966|NCT00390559|3602256|FG000|ActiveP/PlaceboC|Overall Study||90
2894967|NCT00390559|3602256|FG000|COMPLETED|Overall Study||80
2894968|NCT00390559|3602256|FG000|NOT COMPLETED|Overall Study||44
2894969|NCT00390572|3602268|FG000|STARTED|Overall Study||68
2894970|NCT00390572|3602269|FG001|STARTED|Overall Study||69
2894971|NCT00390572|3602268|FG000|COMPLETED|Overall Study||60
2894972|NCT00390572|3602269|FG001|COMPLETED|Overall Study||64
2894973|NCT00390572|3602268|FG000|NOT COMPLETED|Overall Study||8
2894974|NCT00390572|3602269|FG001|NOT COMPLETED|Overall Study||5
2894975|NCT00390611|3602277|FG000|STARTED|6 Cycles of Study Treatment||43
2894976|NCT00390611|3602278|FG001|STARTED|6 Cycles of Study Treatment||42
2894977|NCT00390611|3602277|FG000|COMPLETED|6 Cycles of Study Treatment||34
2894978|NCT00390611|3602278|FG001|COMPLETED|6 Cycles of Study Treatment||37
3314841|NCT03093025|4048197|FG000|NOT COMPLETED|Overall Study||4
3314842|NCT03093025|4048198|FG001|NOT COMPLETED|Overall Study||2
3314843|NCT03093025|4048199|FG002|NOT COMPLETED|Overall Study||2
3317227|NCT03124563|4050754|FG001|NOT COMPLETED|Overall Study||2
3317228|NCT03124602|4050760|FG000|STARTED|Overall Study||35
3317229|NCT03124602|4050760|FG000|COMPLETED|Overall Study||25
3317230|NCT03124602|4050760|FG000|NOT COMPLETED|Overall Study||10
2894979|NCT00390611|3602277|FG000|NOT COMPLETED|6 Cycles of Study Treatment||9
2894980|NCT00390611|3602278|FG001|NOT COMPLETED|6 Cycles of Study Treatment||5
2894981|NCT00390611|3602277|FG000|STARTED|Maintenance Sorafenib to Month 12|11 patients came off-study between the end of cycle 6 and the start of maintenance|23
3317231|NCT03124693|4050764|FG000|STARTED|Overall Study||90
2894982|NCT00390611|3602278|FG001|STARTED|Maintenance Sorafenib to Month 12|Patients in the Paclitaxel/carboplatin arm did not recieve maintenance sorafenib|0
2894983|NCT00390611|3602277|FG000|COMPLETED|Maintenance Sorafenib to Month 12||13
2894984|NCT00390611|3602278|FG001|COMPLETED|Maintenance Sorafenib to Month 12||0
2894985|NCT00390611|3602277|FG000|NOT COMPLETED|Maintenance Sorafenib to Month 12||10
2894986|NCT00390611|3602278|FG001|NOT COMPLETED|Maintenance Sorafenib to Month 12||0
2894987|NCT00390689|3602289|FG000|STARTED|Overall Study||48
2894988|NCT00390689|3602290|FG001|STARTED|Overall Study||53
2894989|NCT00390689|3602291|FG002|STARTED|Overall Study||53
2894990|NCT00390689|3602289|FG000|COMPLETED|Overall Study||43
2894991|NCT00390689|3602290|FG001|COMPLETED|Overall Study||48
2894992|NCT00390689|3602291|FG002|COMPLETED|Overall Study||50
2894993|NCT00390689|3602289|FG000|NOT COMPLETED|Overall Study||5
2894994|NCT00390689|3602290|FG001|NOT COMPLETED|Overall Study||5
2894995|NCT00390689|3602291|FG002|NOT COMPLETED|Overall Study||3
2894996|NCT00390780|3602310|FG000|STARTED|Overall Study||291
2894997|NCT00390780|3602311|FG001|STARTED|Overall Study||287
2894998|NCT00390780|3602310|FG000|Treatment|Overall Study|One patient randomized to miconazole lost study drug, never started treatment, and was discontinued.|290
2894999|NCT00390780|3602311|FG001|Treatment|Overall Study||287
2895000|NCT00390780|3602310|FG000|COMPLETED|Overall Study||268
2895001|NCT00390780|3602311|FG001|COMPLETED|Overall Study||260
2895002|NCT00390780|3602310|FG000|NOT COMPLETED|Overall Study||23
2895003|NCT00390780|3602311|FG001|NOT COMPLETED|Overall Study||27
2895004|NCT00390806|3602319|FG000|STARTED|Overall Study||236
2895005|NCT00390806|3602320|FG001|STARTED|Overall Study||236
2895006|NCT00390806|3602319|FG000|Ongoing|Overall Study||4
2895007|NCT00390806|3602320|FG001|Ongoing|Overall Study||2
3314844|NCT03093181|4048210|FG000|STARTED|Overall Study||44
3314845|NCT03093181|4048211|FG001|STARTED|Overall Study||44
2895008|NCT00390806|3602319|FG000|COMPLETED|Overall Study||206
2895009|NCT00390806|3602320|FG001|COMPLETED|Overall Study||204
2895010|NCT00390806|3602319|FG000|NOT COMPLETED|Overall Study||30
2895011|NCT00390806|3602320|FG001|NOT COMPLETED|Overall Study||32
2895012|NCT00390858|3602328|FG000|STARTED|Overall Study|20 participants started the Core Study|20
2895013|NCT00390858|3602329|FG001|STARTED|Overall Study|20 Participants started the Core Study|20
2895014|NCT00390858|3602328|FG000|Completed Core & Entered Extension Study|Overall Study||19
2895015|NCT00390858|3602329|FG001|Completed Core & Entered Extension Study|Overall Study||20
2895016|NCT00390858|3602328|FG000|COMPLETED|Overall Study|11 participants Completed the Extension Study|11
2895017|NCT00390858|3602329|FG001|COMPLETED|Overall Study|13 Participants completed the Extension Study|13
2895018|NCT00390858|3602328|FG000|NOT COMPLETED|Overall Study||9
2895019|NCT00390858|3602329|FG001|NOT COMPLETED|Overall Study||7
2895020|NCT00390884|3602337|FG000|STARTED|Overall Study||116
2895021|NCT00390884|3602338|FG001|STARTED|Overall Study||57
2895022|NCT00390884|3602337|FG000|COMPLETED|Overall Study||114
2895023|NCT00390884|3602338|FG001|COMPLETED|Overall Study||55
2895024|NCT00390884|3602337|FG000|NOT COMPLETED|Overall Study||2
2895025|NCT00390884|3602338|FG001|NOT COMPLETED|Overall Study||2
2895026|NCT00390910|3602347|FG000|STARTED|Overall Study||50
2895027|NCT00390910|3602348|FG001|STARTED|Overall Study||87
2895028|NCT00390910|3602349|FG002|STARTED|Overall Study||149
2895029|NCT00390910|3602347|FG000|COMPLETED|Overall Study||48
2895030|NCT00390910|3602348|FG001|COMPLETED|Overall Study||83
2895031|NCT00390910|3602349|FG002|COMPLETED|Overall Study||139
2895032|NCT00390910|3602347|FG000|NOT COMPLETED|Overall Study||2
2895033|NCT00390910|3602348|FG001|NOT COMPLETED|Overall Study||4
2895034|NCT00390910|3602349|FG002|NOT COMPLETED|Overall Study||10
2895035|NCT00390949|3602361|FG000|STARTED|Overall Study||4662
2895036|NCT00390949|3602362|FG001|STARTED|Overall Study||4792
2895037|NCT00390949|3602361|FG000|COMPLETED|Overall Study||2564
2895038|NCT00390949|3602362|FG001|COMPLETED|Overall Study||2664
2895039|NCT00390949|3602361|FG000|NOT COMPLETED|Overall Study||2098
2895040|NCT00390949|3602362|FG001|NOT COMPLETED|Overall Study||2128
2895041|NCT00391027|3602370|FG000|STARTED|Overall Study|Full Analysis Set = 134; 1 subject excluded; missing a baseline or postbaseline HbA1c measurement.|135
2895042|NCT00391027|3602371|FG001|STARTED|Overall Study|Full Analysis Set = 121; 1 subject excluded; missing a baseline or postbaseline HbA1c measurement.|122
2895043|NCT00391027|3602370|FG000|COMPLETED|Overall Study||110
2895044|NCT00391027|3602371|FG001|COMPLETED|Overall Study||110
2895045|NCT00391027|3602370|FG000|NOT COMPLETED|Overall Study||25
2895046|NCT00391027|3602371|FG001|NOT COMPLETED|Overall Study||12
2895047|NCT00391053|3602381|FG000|STARTED|Overall Study||857
2895048|NCT00391053|3602382|FG001|STARTED|Overall Study||848
2895049|NCT00391053|3602383|FG002|STARTED|Overall Study||870
2895050|NCT00391053|3602384|FG003|STARTED|Overall Study||1262
2895051|NCT00391053|3602381|FG000|COMPLETED|Overall Study||848
2895052|NCT00391053|3602382|FG001|COMPLETED|Overall Study||847
2895053|NCT00391053|3602383|FG002|COMPLETED|Overall Study||868
2895054|NCT00391053|3602384|FG003|COMPLETED|Overall Study||1252
2895055|NCT00391053|3602381|FG000|NOT COMPLETED|Overall Study||9
2895056|NCT00391053|3602382|FG001|NOT COMPLETED|Overall Study||1
2895057|NCT00391053|3602383|FG002|NOT COMPLETED|Overall Study||2
2895058|NCT00391053|3602384|FG003|NOT COMPLETED|Overall Study||10
2895059|NCT00391079|3602396|FG000|STARTED|Overall Study||167
2895060|NCT00391079|3602397|FG001|STARTED|Overall Study||172
2895061|NCT00391079|3602396|FG000|COMPLETED|Overall Study||141
2895062|NCT00391079|3602397|FG001|COMPLETED|Overall Study||156
2895063|NCT00391079|3602396|FG000|NOT COMPLETED|Overall Study||26
2895064|NCT00391079|3602397|FG001|NOT COMPLETED|Overall Study||16
2895065|NCT00391092|3602405|FG000|STARTED|Overall Study||208
2895066|NCT00391092|3602406|FG001|STARTED|Overall Study||216
2895067|NCT00391092|3602405|FG000|Received Treatment|Overall Study||206
2895068|NCT00391092|3602406|FG001|Received Treatment|Overall Study||215
2895069|NCT00391092|3602405|FG000|COMPLETED|Overall Study|This was using a data cutoff of 30 June 2011.|0
2895070|NCT00391092|3602406|FG001|COMPLETED|Overall Study|This was using a data cutoff of 30 June 2011.|0
2895071|NCT00391092|3602405|FG000|NOT COMPLETED|Overall Study||208
2895072|NCT00391092|3602406|FG001|NOT COMPLETED|Overall Study||216
2895073|NCT00391118|3602415|FG000|STARTED|Overall Study||11
2895074|NCT00391118|3602416|FG001|STARTED|Overall Study||69
2895075|NCT00391118|3602417|FG002|STARTED|Overall Study||73
2895076|NCT00391118|3602415|FG000|Received ≥1 Dose of Assigned Study Drug|Overall Study||11
2895077|NCT00391118|3602416|FG001|Received ≥1 Dose of Assigned Study Drug|Overall Study||67
2895078|NCT00391118|3602417|FG002|Received ≥1 Dose of Assigned Study Drug|Overall Study||72
2895079|NCT00391118|3602415|FG000|COMPLETED|Overall Study||0
2895080|NCT00391118|3602416|FG001|COMPLETED|Overall Study||14
2895081|NCT00391118|3602417|FG002|COMPLETED|Overall Study||15
2895082|NCT00391118|3602415|FG000|NOT COMPLETED|Overall Study||11
2895083|NCT00391118|3602416|FG001|NOT COMPLETED|Overall Study||55
2895084|NCT00391118|3602417|FG002|NOT COMPLETED|Overall Study||58
2895085|NCT00391222|3602431|FG000|STARTED|Period II (Open-label Risperidone LAI)||0
2895086|NCT00391222|3602432|FG001|STARTED|Period II (Open-label Risperidone LAI)||0
2895087|NCT00391222|3602433|FG002|STARTED|Period II (Open-label Risperidone LAI)||0
2895088|NCT00391222|3602434|FG003|STARTED|Period II (Open-label Risperidone LAI)|The 25 patients at the site of Dr. Parikh were excluded from the analysis due to GCP non-compliance|560
2895089|NCT00391222|3602431|FG000|COMPLETED|Period II (Open-label Risperidone LAI)||0
2895090|NCT00391222|3602432|FG001|COMPLETED|Period II (Open-label Risperidone LAI)||0
2895091|NCT00391222|3602433|FG002|COMPLETED|Period II (Open-label Risperidone LAI)||0
2895092|NCT00391222|3602434|FG003|COMPLETED|Period II (Open-label Risperidone LAI)||398
2895093|NCT00391222|3602431|FG000|NOT COMPLETED|Period II (Open-label Risperidone LAI)||0
2895094|NCT00391222|3602432|FG001|NOT COMPLETED|Period II (Open-label Risperidone LAI)||0
2895095|NCT00391222|3602433|FG002|NOT COMPLETED|Period II (Open-label Risperidone LAI)||0
2895096|NCT00391222|3602434|FG003|NOT COMPLETED|Period II (Open-label Risperidone LAI)||162
2895097|NCT00391222|3602431|FG000|STARTED|Period III (Double-Blind Treatment)|Patients were randomized to one of 3 arms in Period III, after completing open-label Period II|132
2895098|NCT00391222|3602432|FG001|STARTED|Period III (Double-Blind Treatment)|Patients were randomized to one of 3 arms in Period III, after completing open-label Period II|135
2895099|NCT00391222|3602433|FG002|STARTED|Period III (Double-Blind Treatment)|Patients were randomized to one of 3 arms in Period III, after completing open-label Period II|131
2895100|NCT00391222|3602434|FG003|STARTED|Period III (Double-Blind Treatment)||0
2895101|NCT00391222|3602431|FG000|COMPLETED|Period III (Double-Blind Treatment)||104
2895102|NCT00391222|3602432|FG001|COMPLETED|Period III (Double-Blind Treatment)||113
2895103|NCT00391222|3602433|FG002|COMPLETED|Period III (Double-Blind Treatment)||108
2895104|NCT00391222|3602434|FG003|COMPLETED|Period III (Double-Blind Treatment)||0
2895105|NCT00391222|3602431|FG000|NOT COMPLETED|Period III (Double-Blind Treatment)||28
2895106|NCT00391222|3602432|FG001|NOT COMPLETED|Period III (Double-Blind Treatment)||22
2895107|NCT00391222|3602433|FG002|NOT COMPLETED|Period III (Double-Blind Treatment)||23
2895108|NCT00391222|3602434|FG003|NOT COMPLETED|Period III (Double-Blind Treatment)||0
2895109|NCT00391274|3602446|FG000|STARTED|Overall Study||107
2895110|NCT00391274|3602447|FG001|STARTED|Overall Study||104
2895111|NCT00391274|3602446|FG000|Received at Least One Dose of Study Drug|Overall Study||106
2895112|NCT00391274|3602447|FG001|Received at Least One Dose of Study Drug|Overall Study||102
2895113|NCT00391274|3602446|FG000|COMPLETED|Overall Study||46
2895114|NCT00391274|3602447|FG001|COMPLETED|Overall Study||47
2895115|NCT00391274|3602446|FG000|NOT COMPLETED|Overall Study||61
2895116|NCT00391274|3602447|FG001|NOT COMPLETED|Overall Study||57
2895117|NCT00391365|3602455|FG000|STARTED|Overall Study||103
2895118|NCT00391365|3602456|FG001|STARTED|Overall Study||170
2895119|NCT00391365|3602455|FG000|COMPLETED|Overall Study||78
2895120|NCT00391365|3602456|FG001|COMPLETED|Overall Study||151
2895121|NCT00391365|3602455|FG000|NOT COMPLETED|Overall Study||25
2895122|NCT00391365|3602456|FG001|NOT COMPLETED|Overall Study||19
2895123|NCT00391391|3602467|FG000|STARTED|Overall Study|1 participant was not vaccinated.|98
2895124|NCT00391391|3602468|FG001|STARTED|Overall Study||97
2895125|NCT00391391|3602469|FG002|STARTED|Overall Study|1 participant was not vaccinated.|161
2895126|NCT00391391|3602470|FG003|STARTED|Overall Study|1 participant was not vaccinated.|164
2895127|NCT00391391|3602467|FG000|COMPLETED|Overall Study||89
2895128|NCT00391391|3602468|FG001|COMPLETED|Overall Study||87
2895129|NCT00391391|3602469|FG002|COMPLETED|Overall Study||138
2895130|NCT00391391|3602470|FG003|COMPLETED|Overall Study||145
2895131|NCT00391391|3602467|FG000|NOT COMPLETED|Overall Study||9
2895132|NCT00391391|3602468|FG001|NOT COMPLETED|Overall Study||10
2895133|NCT00391391|3602469|FG002|NOT COMPLETED|Overall Study||23
2895134|NCT00391391|3602470|FG003|NOT COMPLETED|Overall Study||19
2895135|NCT00391443|3602482|FG000|STARTED|Overall Study|1 patient in the bosentan arm did not receive treatment & was excluded from the Safety Population.|209
2895136|NCT00391443|3602483|FG001|STARTED|Overall Study||407
2895137|NCT00391443|3602482|FG000|COMPLETED|Overall Study||209
2895138|NCT00391443|3602483|FG001|COMPLETED|Overall Study||407
2895139|NCT00391443|3602482|FG000|NOT COMPLETED|Overall Study||0
2895140|NCT00391443|3602483|FG001|NOT COMPLETED|Overall Study||0
2920803|NCT00538850|3631373|FG001|NOT COMPLETED|Titration Period||0
2895141|NCT00391469|3602493|FG000|STARTED|Overall Study||688
2895142|NCT00391469|3602494|FG001|STARTED|Overall Study||671
2895143|NCT00391469|3602493|FG000|COMPLETED|Overall Study|5 patients were found to be incarcerated at time of randomization, thus data was not included|688
2895144|NCT00391469|3602494|FG001|COMPLETED|Overall Study||671
2895145|NCT00391469|3602493|FG000|NOT COMPLETED|Overall Study||0
2895146|NCT00391469|3602494|FG001|NOT COMPLETED|Overall Study||0
2895147|NCT00391586|3602502|FG000|STARTED|Overall Study||45
2895148|NCT00391586|3602502|FG000|Received First-line Erlotinib|Overall Study|These patients received at least one dose of on-study first-line erlotinib|43
2895149|NCT00391586|3602502|FG000|Received Platinum-based Chemotherapy|Overall Study|Total number of patients who received platinum-based chemotherapy after erlotinib treatment|10
2895150|NCT00391586|3602502|FG000|COMPLETED|Overall Study|These patients received at least 2 cycles of erlotinib|21
2895151|NCT00391586|3602502|FG000|NOT COMPLETED|Overall Study||24
2895152|NCT00391599|3602508|FG000|STARTED|Overall Study||65
2895153|NCT00391599|3602509|FG001|STARTED|Overall Study||65
2895154|NCT00391599|3602508|FG000|COMPLETED|Overall Study||65
2895155|NCT00391599|3602509|FG001|COMPLETED|Overall Study||65
2895156|NCT00391599|3602508|FG000|NOT COMPLETED|Overall Study||0
2895157|NCT00391599|3602509|FG001|NOT COMPLETED|Overall Study||0
2895158|NCT00391625|3602517|FG000|STARTED|Baseline||10
2895159|NCT00391625|3602517|FG000|COMPLETED|Baseline||10
2895160|NCT00391625|3602517|FG000|NOT COMPLETED|Baseline||0
2895161|NCT00391625|3602517|FG000|STARTED|Month 14||10
2895162|NCT00391625|3602517|FG000|COMPLETED|Month 14||9
2895163|NCT00391625|3602517|FG000|NOT COMPLETED|Month 14||1
2895164|NCT00391625|3602517|FG000|STARTED|Month 50||9
2895165|NCT00391625|3602517|FG000|COMPLETED|Month 50||8
2895166|NCT00391625|3602517|FG000|NOT COMPLETED|Month 50||1
2895167|NCT00391625|3602517|FG000|STARTED|Month 84||8
2895168|NCT00391625|3602517|FG000|COMPLETED|Month 84||8
2895169|NCT00391625|3602517|FG000|NOT COMPLETED|Month 84||0
2895170|NCT00391716|3602547|FG000|STARTED|Overall Study||54
2895171|NCT00391716|3602548|FG001|STARTED|Overall Study||47
2895172|NCT00391716|3602549|FG002|STARTED|Overall Study||49
2895173|NCT00391716|3602547|FG000|COMPLETED|Overall Study||27
2895174|NCT00391716|3602548|FG001|COMPLETED|Overall Study||28
2895175|NCT00391716|3602549|FG002|COMPLETED|Overall Study||30
2895176|NCT00391716|3602547|FG000|NOT COMPLETED|Overall Study||27
2895177|NCT00391716|3602548|FG001|NOT COMPLETED|Overall Study||19
2895178|NCT00391716|3602549|FG002|NOT COMPLETED|Overall Study||19
2895179|NCT00391768|3602564|FG000|STARTED|Overall Study||12
2895180|NCT00391768|3602565|FG001|STARTED|Overall Study||3
2895181|NCT00391768|3602566|FG002|STARTED|Overall Study||7
2895182|NCT00391768|3602567|FG003|STARTED|Overall Study||8
3314846|NCT03093181|4048212|FG002|STARTED|Overall Study||44
3314847|NCT03093181|4048210|FG000|COMPLETED|Overall Study||41
3314848|NCT03093181|4048211|FG001|COMPLETED|Overall Study||42
2895183|NCT00391768|3602568|FG004|STARTED|Overall Study||24
2895184|NCT00391768|3602569|FG005|STARTED|Overall Study||10
2895185|NCT00391768|3602570|FG006|STARTED|Overall Study||23
2895186|NCT00391768|3602564|FG000|COMPLETED|Overall Study||12
2895187|NCT00391768|3602565|FG001|COMPLETED|Overall Study||3
2895188|NCT00391768|3602566|FG002|COMPLETED|Overall Study||6
2895189|NCT00391768|3602567|FG003|COMPLETED|Overall Study||7
2895190|NCT00391768|3602568|FG004|COMPLETED|Overall Study||22
2895191|NCT00391768|3602569|FG005|COMPLETED|Overall Study||7
2895192|NCT00391768|3602570|FG006|COMPLETED|Overall Study||19
2895193|NCT00391768|3602564|FG000|NOT COMPLETED|Overall Study||0
2895194|NCT00391768|3602565|FG001|NOT COMPLETED|Overall Study||0
2895195|NCT00391768|3602566|FG002|NOT COMPLETED|Overall Study||1
2895196|NCT00391768|3602567|FG003|NOT COMPLETED|Overall Study||1
2895197|NCT00391768|3602568|FG004|NOT COMPLETED|Overall Study||2
2895198|NCT00391768|3602569|FG005|NOT COMPLETED|Overall Study||3
2895199|NCT00391768|3602570|FG006|NOT COMPLETED|Overall Study||4
2895200|NCT00391807|3602604|FG000|STARTED|Overall Study||1683
2895201|NCT00391807|3602604|FG000|COMPLETED|Overall Study||968
2895202|NCT00391807|3602604|FG000|NOT COMPLETED|Overall Study||715
2895203|NCT00391846|3602610|FG000|STARTED|Overall Study|Of the 127 randomised patients 8 were discontinued|127
2895204|NCT00391846|3602611|FG001|STARTED|Overall Study|Of th 125 randomised patients 7 were discontinued|125
2895205|NCT00391846|3602610|FG000|COMPLETED|Overall Study|119 completed patients includes 4 CV related deaths|119
2895206|NCT00391846|3602611|FG001|COMPLETED|Overall Study|118 completed patients includes 5 CV related deaths|118
2895207|NCT00391846|3602610|FG000|NOT COMPLETED|Overall Study||8
2895208|NCT00391846|3602611|FG001|NOT COMPLETED|Overall Study||7
2895209|NCT00391872|3602619|FG000|STARTED|Overall Study||9333
2895210|NCT00391872|3602620|FG001|STARTED|Overall Study||9291
2895211|NCT00391872|3602619|FG000|COMPLETED|Overall Study||9026
2895212|NCT00391872|3602620|FG001|COMPLETED|Overall Study||9036
2895213|NCT00391872|3602619|FG000|NOT COMPLETED|Overall Study||307
2895214|NCT00391872|3602620|FG001|NOT COMPLETED|Overall Study||255
2895215|NCT00391898|3602628|FG000|STARTED|Overall Study|Safety population for Levodopa/carbidopa/entacapone is 45, for Levodopa/carbidopa, per randomized.|46
2895216|NCT00391898|3602629|FG001|STARTED|Overall Study||49
2895217|NCT00391898|3602628|FG000|COMPLETED|Overall Study||35
2895218|NCT00391898|3602629|FG001|COMPLETED|Overall Study||39
2895219|NCT00391898|3602628|FG000|NOT COMPLETED|Overall Study||11
2895220|NCT00391898|3602629|FG001|NOT COMPLETED|Overall Study||10
2895221|NCT00391976|3602638|FG000|STARTED|Overall Study|Started indicates all patients who were enrolled at Visit 1|45
2895222|NCT00391976|3602639|FG001|STARTED|Overall Study||43
3314849|NCT03093181|4048212|FG002|COMPLETED|Overall Study||41
2895223|NCT00391976|3602640|FG002|STARTED|Overall Study||35
2895224|NCT00391976|3602638|FG000|Randomized|Overall Study|Randomization occurred after 28 days of treatment & negative antibody test aeruginosa antibody test|45
2895225|NCT00391976|3602639|FG001|Randomized|Overall Study||43
2895226|NCT00391976|3602640|FG002|Randomized|Overall Study||0
2895227|NCT00391976|3602638|FG000|Safety Population|Overall Study|Patients who were enrolled and received at least one dose of study medication.|44
2895228|NCT00391976|3602639|FG001|Safety Population|Overall Study||43
2895229|NCT00391976|3602640|FG002|Safety Population|Overall Study||35
2895230|NCT00391976|3602638|FG000|COMPLETED|Overall Study||18
2895231|NCT00391976|3602639|FG001|COMPLETED|Overall Study||18
2895232|NCT00391976|3602640|FG002|COMPLETED|Overall Study||0
2895233|NCT00391976|3602638|FG000|NOT COMPLETED|Overall Study||27
2895234|NCT00391976|3602639|FG001|NOT COMPLETED|Overall Study||25
2895235|NCT00391976|3602640|FG002|NOT COMPLETED|Overall Study||35
2895236|NCT00391989|3602650|FG000|STARTED|Overall Study||55
2895237|NCT00391989|3602650|FG000|COMPLETED|Overall Study||53
2895238|NCT00391989|3602650|FG000|NOT COMPLETED|Overall Study||2
2895239|NCT00392015|3602660|FG000|STARTED|Overall Study||6
2895240|NCT00392015|3602661|FG001|STARTED|Overall Study||6
3170759|NCT01930643|3898007|FG001|COMPLETED|Overall Study||6
3170760|NCT01930643|3898006|FG000|NOT COMPLETED|Overall Study||0
3170761|NCT01930643|3898007|FG001|NOT COMPLETED|Overall Study||0
2895241|NCT00392015|3602662|FG002|STARTED|Overall Study||20
2895242|NCT00392015|3602663|FG003|STARTED|Overall Study||6
2895243|NCT00392015|3602664|FG004|STARTED|Overall Study||15
2895244|NCT00392015|3602665|FG005|STARTED|Overall Study||6
2895245|NCT00392015|3602660|FG000|COMPLETED|Overall Study||4
2895246|NCT00392015|3602661|FG001|COMPLETED|Overall Study||6
2895247|NCT00392015|3602662|FG002|COMPLETED|Overall Study||16
2895248|NCT00392015|3602663|FG003|COMPLETED|Overall Study||5
2895249|NCT00392015|3602664|FG004|COMPLETED|Overall Study||12
2895250|NCT00392015|3602665|FG005|COMPLETED|Overall Study||6
2895251|NCT00392015|3602660|FG000|NOT COMPLETED|Overall Study||2
2895252|NCT00392015|3602661|FG001|NOT COMPLETED|Overall Study||0
2895253|NCT00392015|3602662|FG002|NOT COMPLETED|Overall Study||4
2895254|NCT00392015|3602663|FG003|NOT COMPLETED|Overall Study||1
2895255|NCT00392015|3602664|FG004|NOT COMPLETED|Overall Study||3
2895256|NCT00392015|3602665|FG005|NOT COMPLETED|Overall Study||0
2895257|NCT00392041|3602686|FG000|STARTED|First 4 Weeks||19
2895258|NCT00392041|3602687|FG001|STARTED|First 4 Weeks||17
2895259|NCT00392041|3602686|FG000|COMPLETED|First 4 Weeks||11
2895260|NCT00392041|3602687|FG001|COMPLETED|First 4 Weeks||14
2895261|NCT00392041|3602686|FG000|NOT COMPLETED|First 4 Weeks||8
2895262|NCT00392041|3602687|FG001|NOT COMPLETED|First 4 Weeks||3
2895263|NCT00392041|3602686|FG000|STARTED|Weeks 5 - 12||11
2895264|NCT00392041|3602687|FG001|STARTED|Weeks 5 - 12||14
2895265|NCT00392041|3602686|FG000|COMPLETED|Weeks 5 - 12||7
2895266|NCT00392041|3602687|FG001|COMPLETED|Weeks 5 - 12||9
2895267|NCT00392041|3602686|FG000|NOT COMPLETED|Weeks 5 - 12||4
2895268|NCT00392041|3602687|FG001|NOT COMPLETED|Weeks 5 - 12||5
2895269|NCT00392054|3602695|FG000|STARTED|Overall Study|All participants randomized are included in final analysis|66
2895270|NCT00392054|3602696|FG001|STARTED|Overall Study|All participants randomized are included in final analysis|61
2895271|NCT00392054|3602695|FG000|Received Allocated Intervention|Overall Study||65
2895272|NCT00392054|3602696|FG001|Received Allocated Intervention|Overall Study||60
2895273|NCT00392054|3602695|FG000|COMPLETED|Overall Study||66
2895274|NCT00392054|3602696|FG001|COMPLETED|Overall Study||61
2895275|NCT00392054|3602695|FG000|NOT COMPLETED|Overall Study||0
2895276|NCT00392054|3602696|FG001|NOT COMPLETED|Overall Study||0
2895277|NCT00392171|3602706|FG000|STARTED|Overall Study||120
2895278|NCT00392171|3602706|FG000|COMPLETED|Overall Study||15
2895279|NCT00392171|3602706|FG000|NOT COMPLETED|Overall Study||105
2895280|NCT00392197|3602712|FG000|STARTED|Overall Study||48
2895281|NCT00392197|3602713|FG001|STARTED|Overall Study||63
2895282|NCT00392197|3602712|FG000|COMPLETED|Overall Study||27
2895283|NCT00392197|3602713|FG001|COMPLETED|Overall Study||33
2895284|NCT00392197|3602712|FG000|NOT COMPLETED|Overall Study||21
2895285|NCT00392197|3602713|FG001|NOT COMPLETED|Overall Study||30
2895286|NCT00392210|3602721|FG000|STARTED|First Voiding Trial||36
2895287|NCT00392210|3602722|FG001|STARTED|First Voiding Trial||33
2895288|NCT00392210|3602721|FG000|COMPLETED|First Voiding Trial||34
2895289|NCT00392210|3602722|FG001|COMPLETED|First Voiding Trial||31
2895290|NCT00392210|3602721|FG000|NOT COMPLETED|First Voiding Trial||2
2895291|NCT00392210|3602722|FG001|NOT COMPLETED|First Voiding Trial||2
2895292|NCT00392210|3602721|FG000|STARTED|Second Voiding Trial||34
2895293|NCT00392210|3602722|FG001|STARTED|Second Voiding Trial||31
2895294|NCT00392210|3602721|FG000|COMPLETED|Second Voiding Trial||34
2895295|NCT00392210|3602722|FG001|COMPLETED|Second Voiding Trial||31
2895296|NCT00392210|3602721|FG000|NOT COMPLETED|Second Voiding Trial||0
2895297|NCT00392210|3602722|FG001|NOT COMPLETED|Second Voiding Trial||0
2895298|NCT00392223|3602730|FG000|STARTED|Overall Study||58
2895299|NCT00392223|3602731|FG001|STARTED|Overall Study||60
2895300|NCT00392223|3602730|FG000|COMPLETED|Overall Study||49
2895301|NCT00392223|3602731|FG001|COMPLETED|Overall Study||47
2895302|NCT00392223|3602730|FG000|NOT COMPLETED|Overall Study||9
2895303|NCT00392223|3602731|FG001|NOT COMPLETED|Overall Study||13
2895304|NCT00392236|3602739|FG000|STARTED|Overall Study|1 subject post randomization was found to not meet inclusion criteria|20
2895305|NCT00392236|3602740|FG001|STARTED|Overall Study|1 subject post randomization was found to not meet inclusion criteria|18
2895306|NCT00392236|3602739|FG000|COMPLETED|Overall Study|Defined as having adherence data for month 6 of the study.|8
2895307|NCT00392236|3602740|FG001|COMPLETED|Overall Study|Defined as having adherence data for month 6 of the study.|12
2895308|NCT00392236|3602739|FG000|NOT COMPLETED|Overall Study||12
2895309|NCT00392236|3602740|FG001|NOT COMPLETED|Overall Study||6
2895310|NCT00392288|3602749|FG000|STARTED|Overall Study|Number of randomized subjects is different to number of ITT population in Outcome Measures.|175
2895311|NCT00392288|3602750|FG001|STARTED|Overall Study|Number of randomized subjects is different to number of ITT population in Outcome Measures.|177
2895312|NCT00392288|3602751|FG002|STARTED|Overall Study|Number of randomized subjects is different to number of ITT population in Outcome Measures.|176
2895313|NCT00392288|3602749|FG000|Treatment Period|Overall Study||172
2895314|NCT00392288|3602750|FG001|Treatment Period|Overall Study||174
2895315|NCT00392288|3602751|FG002|Treatment Period|Overall Study||175
2895316|NCT00392288|3602749|FG000|COMPLETED|Overall Study|ITT set = 163 patients|143
2895317|NCT00392288|3602750|FG001|COMPLETED|Overall Study|ITT set = 166 patients|155
2895318|NCT00392288|3602751|FG002|COMPLETED|Overall Study|ITT set = 172 patients|159
2895319|NCT00392288|3602749|FG000|NOT COMPLETED|Overall Study||32
2895320|NCT00392288|3602750|FG001|NOT COMPLETED|Overall Study||22
2895321|NCT00392288|3602751|FG002|NOT COMPLETED|Overall Study||17
2895322|NCT00392379|3602761|FG000|STARTED|Overall Study|Medication period|136
2895323|NCT00392379|3602762|FG001|STARTED|Overall Study|Medication period|134
2895324|NCT00392379|3602761|FG000|COMPLETED|Overall Study|Medication period|114
2895325|NCT00392379|3602762|FG001|COMPLETED|Overall Study|Medication period|96
2895326|NCT00392379|3602761|FG000|NOT COMPLETED|Overall Study||22
2895327|NCT00392379|3602762|FG001|NOT COMPLETED|Overall Study||38
2895328|NCT00392392|3602768|FG000|STARTED|Overall Study||29
2895329|NCT00392392|3602768|FG000|COMPLETED|Overall Study||9
2895330|NCT00392392|3602768|FG000|NOT COMPLETED|Overall Study||20
2895331|NCT00392444|3602772|FG000|STARTED|Overall Study||39
2895332|NCT00392444|3602772|FG000|COMPLETED|Overall Study||39
2895333|NCT00392444|3602772|FG000|NOT COMPLETED|Overall Study||0
2895334|NCT00392496|3602776|FG000|STARTED|Overall Study||19
2895335|NCT00392496|3602776|FG000|COMPLETED|Overall Study||19
2895336|NCT00392496|3602776|FG000|NOT COMPLETED|Overall Study||0
2895337|NCT00392665|3602782|FG000|STARTED|Overall Study||18
2895338|NCT00392665|3602783|FG001|STARTED|Overall Study||18
2895339|NCT00392665|3602782|FG000|COMPLETED|Overall Study||1
2895340|NCT00392665|3602783|FG001|COMPLETED|Overall Study||3
2895341|NCT00392665|3602782|FG000|NOT COMPLETED|Overall Study||17
2895342|NCT00392665|3602783|FG001|NOT COMPLETED|Overall Study||15
2895343|NCT00392678|3602793|FG000|STARTED|Overall Study||27
2895344|NCT00392678|3602794|FG001|STARTED|Overall Study||27
2895345|NCT00392678|3602795|FG002|STARTED|Overall Study||27
2895346|NCT00392678|3602796|FG003|STARTED|Overall Study||27
2895347|NCT00392678|3602793|FG000|COMPLETED|Overall Study||27
2895348|NCT00392678|3602794|FG001|COMPLETED|Overall Study||26
2895349|NCT00392678|3602795|FG002|COMPLETED|Overall Study||25
2895350|NCT00392678|3602796|FG003|COMPLETED|Overall Study||26
2895351|NCT00392678|3602793|FG000|NOT COMPLETED|Overall Study||0
2895352|NCT00392678|3602794|FG001|NOT COMPLETED|Overall Study||1
2895353|NCT00392678|3602795|FG002|NOT COMPLETED|Overall Study||2
2895354|NCT00392678|3602796|FG003|NOT COMPLETED|Overall Study||1
2895355|NCT00392704|3602815|FG000|STARTED|Neoadjuvant Chemotherapy||60
2895356|NCT00392704|3602815|FG000|COMPLETED|Neoadjuvant Chemotherapy||54
2895357|NCT00392704|3602815|FG000|NOT COMPLETED|Neoadjuvant Chemotherapy||6
2895358|NCT00392704|3602815|FG000|STARTED|Combined Modality Therapy||54
2895359|NCT00392704|3602815|FG000|COMPLETED|Combined Modality Therapy||49
2895360|NCT00392704|3602815|FG000|NOT COMPLETED|Combined Modality Therapy||5
2895361|NCT00392769|3602819|FG000|STARTED|Overall Study||33
2895362|NCT00392769|3602819|FG000|COMPLETED|Overall Study||23
2895363|NCT00392769|3602819|FG000|NOT COMPLETED|Overall Study||10
2895364|NCT00392782|3602823|FG000|STARTED|Overall Study||24
2895365|NCT00392782|3602823|FG000|COMPLETED|Overall Study||24
2895366|NCT00392782|3602823|FG000|NOT COMPLETED|Overall Study||0
2895367|NCT00392808|3602831|FG000|STARTED|Overall Study||87
2895368|NCT00392808|3602832|FG001|STARTED|Overall Study||89
2895369|NCT00392808|3602833|FG002|STARTED|Overall Study||109
2895370|NCT00392808|3602834|FG003|STARTED|Overall Study||104
2895371|NCT00392808|3602831|FG000|COMPLETED|Overall Study||81
2895372|NCT00392808|3602832|FG001|COMPLETED|Overall Study||86
2895373|NCT00392808|3602833|FG002|COMPLETED|Overall Study||107
2895374|NCT00392808|3602834|FG003|COMPLETED|Overall Study||100
2895375|NCT00392808|3602831|FG000|NOT COMPLETED|Overall Study||6
2895376|NCT00392808|3602832|FG001|NOT COMPLETED|Overall Study||3
2895377|NCT00392808|3602833|FG002|NOT COMPLETED|Overall Study||2
2895378|NCT00392808|3602834|FG003|NOT COMPLETED|Overall Study||4
2895379|NCT00392821|3602844|FG000|STARTED|Overall Study||78
2895380|NCT00392821|3602844|FG000|COMPLETED|Overall Study||59
2895381|NCT00392821|3602844|FG000|NOT COMPLETED|Overall Study||19
2895382|NCT00392834|3602850|FG000|STARTED|Overall Study||2
2895383|NCT00392834|3602851|FG001|STARTED|Overall Study||32
2895384|NCT00392834|3602850|FG000|COMPLETED|Overall Study||2
2895385|NCT00392834|3602851|FG001|COMPLETED|Overall Study||32
2895386|NCT00392834|3602850|FG000|NOT COMPLETED|Overall Study||0
2895387|NCT00392834|3602851|FG001|NOT COMPLETED|Overall Study||0
2895388|NCT00392925|3602861|FG000|STARTED|4 Week Lead-In Period - Non-Randomized||177
2895389|NCT00392925|3602862|FG001|STARTED|4 Week Lead-In Period - Non-Randomized||0
2895390|NCT00392925|3602863|FG002|STARTED|4 Week Lead-In Period - Non-Randomized||0
2895391|NCT00392925|3602864|FG003|STARTED|4 Week Lead-In Period - Non-Randomized||0
2895392|NCT00392925|3602861|FG000|COMPLETED|4 Week Lead-In Period - Non-Randomized||139
2895393|NCT00392925|3602862|FG001|COMPLETED|4 Week Lead-In Period - Non-Randomized||0
2895394|NCT00392925|3602863|FG002|COMPLETED|4 Week Lead-In Period - Non-Randomized||0
2895395|NCT00392925|3602864|FG003|COMPLETED|4 Week Lead-In Period - Non-Randomized||0
2895396|NCT00392925|3602861|FG000|NOT COMPLETED|4 Week Lead-In Period - Non-Randomized||38
2895397|NCT00392925|3602862|FG001|NOT COMPLETED|4 Week Lead-In Period - Non-Randomized||0
2895398|NCT00392925|3602863|FG002|NOT COMPLETED|4 Week Lead-In Period - Non-Randomized||0
2895399|NCT00392925|3602864|FG003|NOT COMPLETED|4 Week Lead-In Period - Non-Randomized||0
2895400|NCT00392925|3602861|FG000|STARTED|Randomization to Treatment Group Period||0
2895401|NCT00392925|3602862|FG001|STARTED|Randomization to Treatment Group Period||27
2895402|NCT00392925|3602863|FG002|STARTED|Randomization to Treatment Group Period||56
2895403|NCT00392925|3602864|FG003|STARTED|Randomization to Treatment Group Period||56
2895404|NCT00392925|3602861|FG000|COMPLETED|Randomization to Treatment Group Period||0
2895405|NCT00392925|3602862|FG001|COMPLETED|Randomization to Treatment Group Period|AT Week 20|19
2895406|NCT00392925|3602863|FG002|COMPLETED|Randomization to Treatment Group Period|At Week 20|37
2895407|NCT00392925|3602864|FG003|COMPLETED|Randomization to Treatment Group Period|At Week 20|38
2895408|NCT00392925|3602861|FG000|NOT COMPLETED|Randomization to Treatment Group Period||0
2895409|NCT00392925|3602862|FG001|NOT COMPLETED|Randomization to Treatment Group Period||8
2895410|NCT00392925|3602863|FG002|NOT COMPLETED|Randomization to Treatment Group Period||19
2895411|NCT00392925|3602864|FG003|NOT COMPLETED|Randomization to Treatment Group Period||18
2895412|NCT00392951|3602880|FG000|STARTED|Overall Study||30
2895413|NCT00392951|3602880|FG000|COMPLETED|Overall Study||30
2895414|NCT00392951|3602880|FG000|NOT COMPLETED|Overall Study||0
2895415|NCT00392990|3602886|FG000|STARTED|Treatment on Study||20
2895416|NCT00392990|3602887|FG001|STARTED|Treatment on Study||5
2895417|NCT00392990|3602886|FG000|COMPLETED|Treatment on Study||17
2895418|NCT00392990|3602887|FG001|COMPLETED|Treatment on Study||4
2895419|NCT00392990|3602886|FG000|NOT COMPLETED|Treatment on Study||3
2895420|NCT00392990|3602887|FG001|NOT COMPLETED|Treatment on Study||1
2895421|NCT00392990|3602886|FG000|STARTED|Follow up for 2 Years||20
2895422|NCT00392990|3602887|FG001|STARTED|Follow up for 2 Years||5
2895423|NCT00392990|3602886|FG000|COMPLETED|Follow up for 2 Years||16
2895424|NCT00392990|3602887|FG001|COMPLETED|Follow up for 2 Years||5
3170762|NCT01930747|3898016|FG000|STARTED|Overall Study||16
3170763|NCT01930747|3898017|FG001|STARTED|Overall Study||14
2895425|NCT00392990|3602886|FG000|NOT COMPLETED|Follow up for 2 Years||4
2895426|NCT00392990|3602887|FG001|NOT COMPLETED|Follow up for 2 Years||0
2895427|NCT00393029|3602895|FG000|STARTED|Overall Study||2
2895428|NCT00393029|3602896|FG001|STARTED|Overall Study||10
2895429|NCT00393029|3602895|FG000|COMPLETED|Overall Study||2
2895430|NCT00393029|3602896|FG001|COMPLETED|Overall Study||9
2895431|NCT00393029|3602895|FG000|NOT COMPLETED|Overall Study||0
2895432|NCT00393029|3602896|FG001|NOT COMPLETED|Overall Study||1
2895433|NCT00393042|3602903|FG000|STARTED|First Intervention||31
2895434|NCT00393042|3602904|FG001|STARTED|First Intervention||33
2895435|NCT00393042|3602903|FG000|Completed the Placebo Dosage|First Intervention||27
2895436|NCT00393042|3602904|FG001|Completed the Placebo Dosage|First Intervention||29
2895437|NCT00393042|3602903|FG000|Completed 10mg Dosage|First Intervention||29
2895438|NCT00393042|3602904|FG001|Completed 10mg Dosage|First Intervention||29
2895439|NCT00393042|3602903|FG000|Completed 20 mg Dosage|First Intervention||26
2895440|NCT00393042|3602904|FG001|Completed 20 mg Dosage|First Intervention||28
2895441|NCT00393042|3602903|FG000|Completed 25/30mg Dosage|First Intervention||27
2895442|NCT00393042|3602904|FG001|Completed 25/30mg Dosage|First Intervention||27
2895443|NCT00393042|3602903|FG000|COMPLETED|First Intervention||26
2895444|NCT00393042|3602904|FG001|COMPLETED|First Intervention||27
2895445|NCT00393042|3602903|FG000|NOT COMPLETED|First Intervention||5
2895446|NCT00393042|3602904|FG001|NOT COMPLETED|First Intervention||6
2895447|NCT00393042|3602903|FG000|STARTED|Second Intervetion||26
2895448|NCT00393042|3602904|FG001|STARTED|Second Intervetion||27
2895449|NCT00393042|3602903|FG000|Completed Placebo Dosage|Second Intervetion||25
2895450|NCT00393042|3602904|FG001|Completed Placebo Dosage|Second Intervetion||21
2895451|NCT00393042|3602903|FG000|Completed 10 mg Dosage|Second Intervetion||26
2895452|NCT00393042|3602904|FG001|Completed 10 mg Dosage|Second Intervetion||24
2895453|NCT00393042|3602903|FG000|Completed the 20mg Dosage|Second Intervetion||24
2895454|NCT00393042|3602904|FG001|Completed the 20mg Dosage|Second Intervetion||21
2895455|NCT00393042|3602903|FG000|Completed 25/30 mg Dosage|Second Intervetion||24
2895456|NCT00393042|3602904|FG001|Completed 25/30 mg Dosage|Second Intervetion||20
2895457|NCT00393042|3602903|FG000|COMPLETED|Second Intervetion||24
2895458|NCT00393042|3602904|FG001|COMPLETED|Second Intervetion||19
2895459|NCT00393042|3602903|FG000|NOT COMPLETED|Second Intervetion||2
2895460|NCT00393042|3602904|FG001|NOT COMPLETED|Second Intervetion||8
2895461|NCT00393068|3602958|FG000|STARTED|Overall Study||62
2895462|NCT00393068|3602958|FG000|COMPLETED|Overall Study||44
2895463|NCT00393068|3602958|FG000|NOT COMPLETED|Overall Study||18
2895464|NCT00393094|3602962|FG000|STARTED|Period1Bevacizumab & Irinotecan Patients||31
2895465|NCT00393094|3602962|FG000|COMPLETED|Period1Bevacizumab & Irinotecan Patients||30
2895466|NCT00393094|3602962|FG000|NOT COMPLETED|Period1Bevacizumab & Irinotecan Patients||1
2895467|NCT00393094|3602962|FG000|STARTED|Disease Progression After Trtmt: Onstudy||30
2895468|NCT00393094|3602962|FG000|COMPLETED|Disease Progression After Trtmt: Onstudy||29
2895469|NCT00393094|3602962|FG000|NOT COMPLETED|Disease Progression After Trtmt: Onstudy||1
2895470|NCT00393367|3602970|FG000|STARTED|Overall Study||91
2895471|NCT00393367|3602971|FG001|STARTED|Overall Study||88
2895472|NCT00393367|3602970|FG000|COMPLETED|Overall Study||89
2895473|NCT00393367|3602971|FG001|COMPLETED|Overall Study||81
2895474|NCT00393367|3602970|FG000|NOT COMPLETED|Overall Study||2
3314850|NCT03093181|4048210|FG000|NOT COMPLETED|Overall Study||3
3314851|NCT03093181|4048211|FG001|NOT COMPLETED|Overall Study||2
3314852|NCT03093181|4048212|FG002|NOT COMPLETED|Overall Study||3
3314853|NCT03093207|4048222|FG000|STARTED|Overall Study||17
2895475|NCT00393367|3602971|FG001|NOT COMPLETED|Overall Study||7
2895476|NCT00393380|3602979|FG000|STARTED|Overall Study||13
2895477|NCT00393380|3602979|FG000|COMPLETED|Overall Study||13
2895478|NCT00393380|3602979|FG000|NOT COMPLETED|Overall Study||0
2895479|NCT00393458|3602987|FG000|STARTED|Overall Study||437
2895480|NCT00393458|3602988|FG001|STARTED|Overall Study||428
2895481|NCT00393458|3602989|FG002|STARTED|Overall Study||435
2895482|NCT00393458|3602990|FG003|STARTED|Overall Study||432
2895483|NCT00393458|3602987|FG000|Exposed to Study Medication or Placebo|Overall Study||437
2895484|NCT00393458|3602988|FG001|Exposed to Study Medication or Placebo|Overall Study||425
2895485|NCT00393458|3602989|FG002|Exposed to Study Medication or Placebo|Overall Study||434
2895486|NCT00393458|3602990|FG003|Exposed to Study Medication or Placebo|Overall Study||432
2895487|NCT00393458|3602987|FG000|COMPLETED|Overall Study||338
2895488|NCT00393458|3602988|FG001|COMPLETED|Overall Study||326
2895489|NCT00393458|3602989|FG002|COMPLETED|Overall Study||323
2895490|NCT00393458|3602990|FG003|COMPLETED|Overall Study||295
2895491|NCT00393458|3602987|FG000|NOT COMPLETED|Overall Study||99
2895492|NCT00393458|3602988|FG001|NOT COMPLETED|Overall Study||102
2895493|NCT00393458|3602989|FG002|NOT COMPLETED|Overall Study||112
2895494|NCT00393458|3602990|FG003|NOT COMPLETED|Overall Study||137
2895495|NCT00393484|3603002|FG000|STARTED|Double-blind Period (Day 1 to Week 96)|Number treated|56
2895496|NCT00393484|3603003|FG001|STARTED|Double-blind Period (Day 1 to Week 96)|Number treated|64
2895497|NCT00393484|3603002|FG000|Participants Excluded From Analysis|Double-blind Period (Day 1 to Week 96)||1
3170764|NCT01930747|3898018|FG002|STARTED|Overall Study||12
3170765|NCT01930747|3898016|FG000|COMPLETED|Overall Study||16
3170766|NCT01930747|3898017|FG001|COMPLETED|Overall Study||14
3170767|NCT01930747|3898018|FG002|COMPLETED|Overall Study||12
3170768|NCT01930747|3898016|FG000|NOT COMPLETED|Overall Study||0
3314854|NCT03093207|4048223|FG001|STARTED|Overall Study||17
2895498|NCT00393484|3603003|FG001|Participants Excluded From Analysis|Double-blind Period (Day 1 to Week 96)||1
2895499|NCT00393484|3603002|FG000|COMPLETED|Double-blind Period (Day 1 to Week 96)||54
2895500|NCT00393484|3603003|FG001|COMPLETED|Double-blind Period (Day 1 to Week 96)||52
2895501|NCT00393484|3603002|FG000|NOT COMPLETED|Double-blind Period (Day 1 to Week 96)||2
2895502|NCT00393484|3603003|FG001|NOT COMPLETED|Double-blind Period (Day 1 to Week 96)||12
2895503|NCT00393484|3603002|FG000|STARTED|Open-label Period (Weeks 96 to 240)||48
2895504|NCT00393484|3603003|FG001|STARTED|Open-label Period (Weeks 96 to 240)||44
2895505|NCT00393484|3603002|FG000|Withdrew Consent|Open-label Period (Weeks 96 to 240)|Did not participate in open-label period|6
2895506|NCT00393484|3603003|FG001|Withdrew Consent|Open-label Period (Weeks 96 to 240)|Did not participate in open-label period|6
2895507|NCT00393484|3603002|FG000|Lack of Efficacy|Open-label Period (Weeks 96 to 240)|Did not participate in open-label period|0
2895508|NCT00393484|3603003|FG001|Lack of Efficacy|Open-label Period (Weeks 96 to 240)|Did not participate in open-label period|2
2895509|NCT00393484|3603002|FG000|COMPLETED|Open-label Period (Weeks 96 to 240)||40
2895510|NCT00393484|3603003|FG001|COMPLETED|Open-label Period (Weeks 96 to 240)||21
2895511|NCT00393484|3603002|FG000|NOT COMPLETED|Open-label Period (Weeks 96 to 240)||8
2895512|NCT00393484|3603003|FG001|NOT COMPLETED|Open-label Period (Weeks 96 to 240)||23
2895513|NCT00393510|3603013|FG000|STARTED|Overall Study||40
2895514|NCT00393510|3603014|FG001|STARTED|Overall Study||40
2895515|NCT00393510|3603013|FG000|COMPLETED|Overall Study||37
2895516|NCT00393510|3603014|FG001|COMPLETED|Overall Study||31
2895517|NCT00393510|3603013|FG000|NOT COMPLETED|Overall Study||3
2895518|NCT00393510|3603014|FG001|NOT COMPLETED|Overall Study||9
2895519|NCT00393523|3603025|FG000|STARTED|Overall Study||376
2895520|NCT00393523|3603026|FG001|STARTED|Overall Study||375
2895521|NCT00393523|3603027|FG002|STARTED|Overall Study||353
2895522|NCT00393523|3603028|FG003|STARTED|Overall Study||354
2895523|NCT00393523|3603029|FG004|STARTED|Overall Study||20
2895524|NCT00393523|3603025|FG000|Vaccination Visit 1|Overall Study||374
2895525|NCT00393523|3603026|FG001|Vaccination Visit 1|Overall Study||375
2895526|NCT00393523|3603027|FG002|Vaccination Visit 1|Overall Study||349
2895527|NCT00393523|3603028|FG003|Vaccination Visit 1|Overall Study||352
2895528|NCT00393523|3603029|FG004|Vaccination Visit 1|Overall Study||20
2895529|NCT00393523|3603025|FG000|COMPLETED|Overall Study||364
2895530|NCT00393523|3603026|FG001|COMPLETED|Overall Study||366
2895531|NCT00393523|3603027|FG002|COMPLETED|Overall Study||349
2895532|NCT00393523|3603028|FG003|COMPLETED|Overall Study||348
2895533|NCT00393523|3603029|FG004|COMPLETED|Overall Study||19
2895534|NCT00393523|3603025|FG000|NOT COMPLETED|Overall Study||12
2895535|NCT00393523|3603026|FG001|NOT COMPLETED|Overall Study||9
2895536|NCT00393523|3603027|FG002|NOT COMPLETED|Overall Study||4
2895537|NCT00393523|3603028|FG003|NOT COMPLETED|Overall Study||6
2895538|NCT00393523|3603029|FG004|NOT COMPLETED|Overall Study||1
2895539|NCT00393705|3603042|FG000|STARTED|Overall Study||151
2895540|NCT00393705|3603043|FG001|STARTED|Overall Study||151
2895541|NCT00393705|3603042|FG000|Received at Least One Dose of Study Drug|Overall Study||139
2895542|NCT00393705|3603043|FG001|Received at Least One Dose of Study Drug|Overall Study||139
2895543|NCT00393705|3603042|FG000|COMPLETED|Overall Study||128
2895544|NCT00393705|3603043|FG001|COMPLETED|Overall Study||128
2895545|NCT00393705|3603042|FG000|NOT COMPLETED|Overall Study||23
2895546|NCT00393705|3603043|FG001|NOT COMPLETED|Overall Study||23
2895547|NCT00393718|3603051|FG000|STARTED|Overall Study||268
2895548|NCT00393718|3603052|FG001|STARTED|Overall Study||132
2895549|NCT00393718|3603051|FG000|COMPLETED|Overall Study||225
2895550|NCT00393718|3603052|FG001|COMPLETED|Overall Study||110
2895551|NCT00393718|3603051|FG000|NOT COMPLETED|Overall Study||43
2895552|NCT00393718|3603052|FG001|NOT COMPLETED|Overall Study||22
2895553|NCT00393796|3603060|FG000|STARTED|Double Blind Period||26
2895554|NCT00393796|3603061|FG001|STARTED|Double Blind Period||28
2895555|NCT00393796|3603060|FG000|COMPLETED|Double Blind Period||26
2895556|NCT00393796|3603061|FG001|COMPLETED|Double Blind Period||28
2895557|NCT00393796|3603060|FG000|NOT COMPLETED|Double Blind Period||0
2895558|NCT00393796|3603061|FG001|NOT COMPLETED|Double Blind Period||0
2895559|NCT00393796|3603060|FG000|STARTED|Open Label Period - Placebo to SUTENT||0
2895560|NCT00393796|3603061|FG001|STARTED|Open Label Period - Placebo to SUTENT||16
2895561|NCT00393796|3603060|FG000|COMPLETED|Open Label Period - Placebo to SUTENT||0
2895562|NCT00393796|3603061|FG001|COMPLETED|Open Label Period - Placebo to SUTENT||16
2895563|NCT00393796|3603060|FG000|NOT COMPLETED|Open Label Period - Placebo to SUTENT||0
2895564|NCT00393796|3603061|FG001|NOT COMPLETED|Open Label Period - Placebo to SUTENT||0
2895565|NCT00393848|3603071|FG000|STARTED|Overall Study||16
2895566|NCT00393848|3603072|FG001|STARTED|Overall Study||9
2895567|NCT00393848|3603073|FG002|STARTED|Overall Study||6
2895568|NCT00393848|3603074|FG003|STARTED|Overall Study||9
2895569|NCT00393848|3603071|FG000|COMPLETED|Overall Study||16
2895570|NCT00393848|3603072|FG001|COMPLETED|Overall Study||9
2895571|NCT00393848|3603073|FG002|COMPLETED|Overall Study||4
2895572|NCT00393848|3603074|FG003|COMPLETED|Overall Study||8
2895573|NCT00393848|3603071|FG000|NOT COMPLETED|Overall Study||0
2895574|NCT00393848|3603072|FG001|NOT COMPLETED|Overall Study||0
2895575|NCT00393848|3603073|FG002|NOT COMPLETED|Overall Study||2
2895576|NCT00393848|3603074|FG003|NOT COMPLETED|Overall Study||1
2895577|NCT00393861|3603085|FG000|STARTED|Overall Study||29
2895578|NCT00393861|3603085|FG000|COMPLETED|Overall Study||3
2895579|NCT00393861|3603085|FG000|NOT COMPLETED|Overall Study||26
2895580|NCT00393874|3603092|FG000|STARTED|Overall Study||18
2895581|NCT00393874|3603093|FG001|STARTED|Overall Study||17
2895582|NCT00393874|3603094|FG002|STARTED|Overall Study||15
2895583|NCT00393874|3603092|FG000|COMPLETED|Overall Study||15
2895584|NCT00393874|3603093|FG001|COMPLETED|Overall Study||13
2895585|NCT00393874|3603094|FG002|COMPLETED|Overall Study||13
2895586|NCT00393874|3603092|FG000|NOT COMPLETED|Overall Study||3
2895587|NCT00393874|3603093|FG001|NOT COMPLETED|Overall Study||4
2895588|NCT00393874|3603094|FG002|NOT COMPLETED|Overall Study||2
2895589|NCT00393887|3603107|FG000|STARTED|Overall Study||50
2895590|NCT00393887|3603108|FG001|STARTED|Overall Study||50
2895591|NCT00393887|3603107|FG000|1 Year|Overall Study||45
2895592|NCT00393887|3603108|FG001|1 Year|Overall Study||50
2895593|NCT00393887|3603107|FG000|COMPLETED|Overall Study||34
2895594|NCT00393887|3603108|FG001|COMPLETED|Overall Study||41
2895595|NCT00393887|3603107|FG000|NOT COMPLETED|Overall Study||16
2895596|NCT00393887|3603108|FG001|NOT COMPLETED|Overall Study||9
2895597|NCT00393913|3603114|FG000|STARTED|Initial Assessment||144
2895598|NCT00393913|3603114|FG000|COMPLETED|Initial Assessment||107
2895599|NCT00393913|3603114|FG000|NOT COMPLETED|Initial Assessment||37
2895600|NCT00393913|3603114|FG000|STARTED|CPAP|Excludes normal volunteers without OSA|100
2895601|NCT00393913|3603114|FG000|COMPLETED|CPAP||93
2895602|NCT00393913|3603114|FG000|NOT COMPLETED|CPAP||7
2895603|NCT00393913|3603114|FG000|STARTED|CPAP Withdrawal|Includes only subjects with good CPAP adherence|42
2895604|NCT00393913|3603114|FG000|CPAP Compliance|CPAP Withdrawal|Only subjects with sufficient CPAP complaince (>4 hrs/night) were included.|42
2895605|NCT00393913|3603114|FG000|COMPLETED|CPAP Withdrawal||42
2895606|NCT00393913|3603114|FG000|NOT COMPLETED|CPAP Withdrawal||0
2895607|NCT00393939|3603121|FG000|STARTED|Overall Study||296
2895608|NCT00393939|3603122|FG001|STARTED|Overall Study||297
2895609|NCT00393939|3603121|FG000|Treated|Overall Study||295
2895610|NCT00393939|3603122|FG001|Treated|Overall Study||293
2895611|NCT00393939|3603121|FG000|COMPLETED|Overall Study||0
2895612|NCT00393939|3603122|FG001|COMPLETED|Overall Study||0
2895613|NCT00393939|3603121|FG000|NOT COMPLETED|Overall Study||296
2895614|NCT00393939|3603122|FG001|NOT COMPLETED|Overall Study||297
2895615|NCT00393978|3603130|FG000|STARTED|Overall Study||37
2895616|NCT00393978|3603131|FG001|STARTED|Overall Study||38
2895617|NCT00393978|3603130|FG000|COMPLETED|Overall Study||21
2895618|NCT00393978|3603131|FG001|COMPLETED|Overall Study||18
2895619|NCT00393978|3603130|FG000|NOT COMPLETED|Overall Study||16
2895620|NCT00393978|3603131|FG001|NOT COMPLETED|Overall Study||20
2895621|NCT00394082|3603137|FG000|STARTED|Overall Study||50
2895622|NCT00394082|3603137|FG000|At Least One Response Assessment|Overall Study||43
2895623|NCT00394082|3603137|FG000|COMPLETED|Overall Study|Treatment completed upon disease progression|24
2895624|NCT00394082|3603137|FG000|NOT COMPLETED|Overall Study||26
2895625|NCT00394095|3603143|FG000|STARTED|Overall Study||17
2895626|NCT00394095|3603144|FG001|STARTED|Overall Study||14
2895627|NCT00394095|3603143|FG000|Screened|Overall Study||17
2895628|NCT00394095|3603144|FG001|Screened|Overall Study||14
2895629|NCT00394095|3603143|FG000|COMPLETED|Overall Study||16
2895630|NCT00394095|3603144|FG001|COMPLETED|Overall Study||14
3170769|NCT01930747|3898017|FG001|NOT COMPLETED|Overall Study||0
3170770|NCT01930747|3898018|FG002|NOT COMPLETED|Overall Study||0
3170771|NCT01930799|3898026|FG000|STARTED|Overall Study||120
2895631|NCT00394095|3603143|FG000|NOT COMPLETED|Overall Study||1
2895632|NCT00394095|3603144|FG001|NOT COMPLETED|Overall Study||0
2895633|NCT00394212|3603153|FG000|STARTED|Overall Study|2 subjects assigned to suturing underwent sham procedure, results based on Intent-To-Treat (ITT)|50
2895634|NCT00394212|3603154|FG001|STARTED|Overall Study||27
2895635|NCT00394212|3603153|FG000|6 Week Follow-up|Overall Study||45
2895636|NCT00394212|3603154|FG001|6 Week Follow-up|Overall Study||26
2895637|NCT00394212|3603153|FG000|3 Month Follow-up|Overall Study||45
2895638|NCT00394212|3603154|FG001|3 Month Follow-up|Overall Study||26
2895639|NCT00394212|3603153|FG000|6 Month Follow-up|Overall Study||43
2895640|NCT00394212|3603154|FG001|6 Month Follow-up|Overall Study||26
2895641|NCT00394212|3603153|FG000|COMPLETED|Overall Study||43
2895642|NCT00394212|3603154|FG001|COMPLETED|Overall Study||26
2895643|NCT00394212|3603153|FG000|NOT COMPLETED|Overall Study||7
2895644|NCT00394212|3603154|FG001|NOT COMPLETED|Overall Study||1
2895645|NCT00394251|3603162|FG000|STARTED|Overall Study||98
3170772|NCT01930799|3898026|FG000|COMPLETED|Overall Study||112
3170773|NCT01930799|3898026|FG000|NOT COMPLETED|Overall Study||8
3170774|NCT01930890|3898034|FG000|STARTED|Overall Study||14
3170775|NCT01930890|3898035|FG001|STARTED|Overall Study||33
3170776|NCT01930890|3898036|FG002|STARTED|Overall Study||13
3170777|NCT01930890|3898037|FG003|STARTED|Overall Study||27
2895646|NCT00394251|3603163|FG001|STARTED|Overall Study||99
2895647|NCT00394251|3603162|FG000|At Least One Dose of Taxane|Overall Study||93
2895648|NCT00394251|3603163|FG001|At Least One Dose of Taxane|Overall Study||93
2895649|NCT00394251|3603162|FG000|COMPLETED|Overall Study||61
2895650|NCT00394251|3603163|FG001|COMPLETED|Overall Study||61
2895651|NCT00394251|3603162|FG000|NOT COMPLETED|Overall Study||37
2895652|NCT00394251|3603163|FG001|NOT COMPLETED|Overall Study||38
2895653|NCT00394277|3603177|FG000|STARTED|Overall Study||195
2895654|NCT00394277|3603178|FG001|STARTED|Overall Study||196
2895655|NCT00394277|3603179|FG002|STARTED|Overall Study||393
2895656|NCT00394277|3603180|FG003|STARTED|Overall Study||391
2895657|NCT00394277|3603177|FG000|COMPLETED|Overall Study||137
2895658|NCT00394277|3603178|FG001|COMPLETED|Overall Study||136
2895659|NCT00394277|3603179|FG002|COMPLETED|Overall Study||273
2895660|NCT00394277|3603180|FG003|COMPLETED|Overall Study||266
2895661|NCT00394277|3603177|FG000|NOT COMPLETED|Overall Study||58
2895662|NCT00394277|3603178|FG001|NOT COMPLETED|Overall Study||60
2895663|NCT00394277|3603179|FG002|NOT COMPLETED|Overall Study||120
2895664|NCT00394277|3603180|FG003|NOT COMPLETED|Overall Study||125
2895665|NCT00394329|3603194|FG000|STARTED|Overall Study||71
2895666|NCT00394329|3603195|FG001|STARTED|Overall Study||72
2895667|NCT00394329|3603196|FG002|STARTED|Overall Study||71
2895668|NCT00394329|3603197|FG003|STARTED|Overall Study||74
2895669|NCT00394329|3603194|FG000|COMPLETED|Overall Study||63
2895670|NCT00394329|3603195|FG001|COMPLETED|Overall Study||63
2895671|NCT00394329|3603196|FG002|COMPLETED|Overall Study||58
2895672|NCT00394329|3603197|FG003|COMPLETED|Overall Study||50
2895673|NCT00394329|3603194|FG000|NOT COMPLETED|Overall Study||8
2895674|NCT00394329|3603195|FG001|NOT COMPLETED|Overall Study||9
2895675|NCT00394329|3603196|FG002|NOT COMPLETED|Overall Study||13
2895676|NCT00394329|3603197|FG003|NOT COMPLETED|Overall Study||24
2895677|NCT00394433|3603213|FG000|STARTED|Overall Study||38
2895678|NCT00394433|3603213|FG000|Evaluable and Treated|Overall Study||35
2895679|NCT00394433|3603213|FG000|COMPLETED|Overall Study||35
2895680|NCT00394433|3603213|FG000|NOT COMPLETED|Overall Study||3
2895681|NCT00394472|3603219|FG000|STARTED|Overall Study||122
2895682|NCT00394472|3603220|FG001|STARTED|Overall Study||122
2895683|NCT00394472|3603219|FG000|COMPLETED|Overall Study||113
2895684|NCT00394472|3603220|FG001|COMPLETED|Overall Study||111
2895685|NCT00394472|3603219|FG000|NOT COMPLETED|Overall Study||9
2895686|NCT00394472|3603220|FG001|NOT COMPLETED|Overall Study||11
2895687|NCT00394524|3603228|FG000|STARTED|Overall Study||80
2895688|NCT00394524|3603229|FG001|STARTED|Overall Study||80
2895689|NCT00394524|3603228|FG000|COMPLETED|Overall Study||77
2895690|NCT00394524|3603229|FG001|COMPLETED|Overall Study||76
2895691|NCT00394524|3603228|FG000|NOT COMPLETED|Overall Study||3
2895692|NCT00394524|3603229|FG001|NOT COMPLETED|Overall Study||4
3314855|NCT03093207|4048222|FG000|COMPLETED|Overall Study||17
3314856|NCT03093207|4048223|FG001|COMPLETED|Overall Study||17
3314857|NCT03093207|4048222|FG000|NOT COMPLETED|Overall Study||0
3314858|NCT03093207|4048223|FG001|NOT COMPLETED|Overall Study||0
3314859|NCT03093272|4048229|FG000|STARTED|Overall Study||9
3314860|NCT03093272|4048229|FG000|COMPLETED|Overall Study||9
3314861|NCT03093272|4048229|FG000|NOT COMPLETED|Overall Study||0
2895693|NCT00394589|3603240|FG000|STARTED|Overall Study||14
2895694|NCT00394589|3603241|FG001|STARTED|Overall Study||11
2895695|NCT00394589|3603242|FG002|STARTED|Overall Study||18
2895696|NCT00394589|3603240|FG000|COMPLETED|Overall Study||6
2895697|NCT00394589|3603241|FG001|COMPLETED|Overall Study||8
2895698|NCT00394589|3603242|FG002|COMPLETED|Overall Study||11
2895699|NCT00394589|3603240|FG000|NOT COMPLETED|Overall Study||8
2895700|NCT00394589|3603241|FG001|NOT COMPLETED|Overall Study||3
2895701|NCT00394589|3603242|FG002|NOT COMPLETED|Overall Study||7
2895702|NCT00394654|3603252|FG000|STARTED|Overall Study||15
2895703|NCT00394654|3603253|FG001|STARTED|Overall Study||15
2895704|NCT00394654|3603252|FG000|COMPLETED|Overall Study||13
3314862|NCT03093324|4048235|FG000|STARTED|Overall Study||254
3314863|NCT03093324|4048236|FG001|STARTED|Overall Study||252
2895705|NCT00394654|3603253|FG001|COMPLETED|Overall Study||15
2895706|NCT00394654|3603252|FG000|NOT COMPLETED|Overall Study||2
2895707|NCT00394654|3603253|FG001|NOT COMPLETED|Overall Study||0
2895708|NCT00394706|3603267|FG000|STARTED|Overall Study||1819
2895709|NCT00394706|3603268|FG001|STARTED|Overall Study||1862
2895710|NCT00394706|3603269|FG002|STARTED|Overall Study||1624
2895711|NCT00394706|3603270|FG003|STARTED|Overall Study||1633
2895712|NCT00394706|3603271|FG004|STARTED|Overall Study||1636
2895713|NCT00394706|3603272|FG005|STARTED|Overall Study||1384
2895714|NCT00394706|3603273|FG006|STARTED|Overall Study||929
2895715|NCT00394706|3603274|FG007|STARTED|Overall Study||851
2895716|NCT00394706|3603267|FG000|COMPLETED|Overall Study||1815
2895717|NCT00394706|3603268|FG001|COMPLETED|Overall Study||1860
2895718|NCT00394706|3603269|FG002|COMPLETED|Overall Study||1615
2895719|NCT00394706|3603270|FG003|COMPLETED|Overall Study||1632
2895720|NCT00394706|3603271|FG004|COMPLETED|Overall Study||1634
2895721|NCT00394706|3603272|FG005|COMPLETED|Overall Study||1377
2895722|NCT00394706|3603273|FG006|COMPLETED|Overall Study||926
2895723|NCT00394706|3603274|FG007|COMPLETED|Overall Study||851
2895724|NCT00394706|3603267|FG000|NOT COMPLETED|Overall Study||4
2895725|NCT00394706|3603268|FG001|NOT COMPLETED|Overall Study||2
2895726|NCT00394706|3603269|FG002|NOT COMPLETED|Overall Study||9
2895727|NCT00394706|3603270|FG003|NOT COMPLETED|Overall Study||1
2895728|NCT00394706|3603271|FG004|NOT COMPLETED|Overall Study||2
2895729|NCT00394706|3603272|FG005|NOT COMPLETED|Overall Study||7
2895730|NCT00394706|3603273|FG006|NOT COMPLETED|Overall Study||3
2895731|NCT00394706|3603274|FG007|NOT COMPLETED|Overall Study||0
2895732|NCT00394771|3603292|FG000|STARTED|Overall Study|Safety population of treated participants|140
2895733|NCT00394771|3603293|FG001|STARTED|Overall Study|Safety population of treated participants|136
2895734|NCT00394771|3603294|FG002|STARTED|Overall Study|Safety population of treated participants|143
2895735|NCT00394771|3603295|FG003|STARTED|Overall Study|Safety population of treated participants|148
2895736|NCT00394771|3603292|FG000|Intent to Treat (ITT) Population|Overall Study|At least one completed 91 day cycle of treatment|110
2895737|NCT00394771|3603293|FG001|Intent to Treat (ITT) Population|Overall Study|At least one completed 91 day cycle of treatment|110
2895738|NCT00394771|3603294|FG002|Intent to Treat (ITT) Population|Overall Study|At least one completed 91 day cycle of treatment|108
2895739|NCT00394771|3603295|FG003|Intent to Treat (ITT) Population|Overall Study|At least one completed 91 day cycle of treatment|120
2895740|NCT00394771|3603292|FG000|COMPLETED|Overall Study||99
2895741|NCT00394771|3603293|FG001|COMPLETED|Overall Study||102
2895742|NCT00394771|3603294|FG002|COMPLETED|Overall Study||96
2895743|NCT00394771|3603295|FG003|COMPLETED|Overall Study||109
2895744|NCT00394771|3603292|FG000|NOT COMPLETED|Overall Study||41
2895745|NCT00394771|3603293|FG001|NOT COMPLETED|Overall Study||34
2895746|NCT00394771|3603294|FG002|NOT COMPLETED|Overall Study||47
2895747|NCT00394771|3603295|FG003|NOT COMPLETED|Overall Study||39
2895748|NCT00394836|3603307|FG000|STARTED|Teatment or Follow-up Phase||30
2895749|NCT00394836|3603308|FG001|STARTED|Teatment or Follow-up Phase||86
2895750|NCT00394836|3603307|FG000|Early Follow-up Entry|Teatment or Follow-up Phase|Did not complete treatment.|4
2895751|NCT00394836|3603308|FG001|Early Follow-up Entry|Teatment or Follow-up Phase|Did not complete treatment.|8
2895752|NCT00394836|3603307|FG000|COMPLETED|Teatment or Follow-up Phase||2
2895753|NCT00394836|3603308|FG001|COMPLETED|Teatment or Follow-up Phase||8
2895754|NCT00394836|3603307|FG000|NOT COMPLETED|Teatment or Follow-up Phase||28
2895755|NCT00394836|3603308|FG001|NOT COMPLETED|Teatment or Follow-up Phase||78
2895756|NCT00394836|3603307|FG000|STARTED|Extended Follow-up Phase (2-5 Years)|Not all participants went into extended follow up per protocol.|20
2895757|NCT00394836|3603308|FG001|STARTED|Extended Follow-up Phase (2-5 Years)|Not all participants went into extended follow up per protocol.|58
2895758|NCT00394836|3603307|FG000|COMPLETED|Extended Follow-up Phase (2-5 Years)||0
2895759|NCT00394836|3603308|FG001|COMPLETED|Extended Follow-up Phase (2-5 Years)||5
2895760|NCT00394836|3603307|FG000|NOT COMPLETED|Extended Follow-up Phase (2-5 Years)||20
2895761|NCT00394836|3603308|FG001|NOT COMPLETED|Extended Follow-up Phase (2-5 Years)||53
2895762|NCT00394888|3603319|FG000|STARTED|Overall Study||108
2895763|NCT00394888|3603320|FG001|STARTED|Overall Study||48
2895764|NCT00394888|3603321|FG002|STARTED|Overall Study||201
2895765|NCT00394888|3603319|FG000|COMPLETED|Overall Study||108
2895766|NCT00394888|3603320|FG001|COMPLETED|Overall Study||48
2895767|NCT00394888|3603321|FG002|COMPLETED|Overall Study||201
2895768|NCT00394888|3603319|FG000|NOT COMPLETED|Overall Study||0
2895769|NCT00394888|3603320|FG001|NOT COMPLETED|Overall Study||0
2895770|NCT00394888|3603321|FG002|NOT COMPLETED|Overall Study||0
2895771|NCT00394901|3603331|FG000|STARTED|Baseline Phase|Subjects randomized|98
2895772|NCT00394901|3603332|FG001|STARTED|Baseline Phase|Subjects randomized|87
2895773|NCT00394901|3603333|FG002|STARTED|Baseline Phase|Subjects randomized|90
2895774|NCT00394901|3603334|FG003|STARTED|Baseline Phase|Subjects randomized|97
2895775|NCT00394901|3603331|FG000|COMPLETED|Baseline Phase||98
2895776|NCT00394901|3603332|FG001|COMPLETED|Baseline Phase||87
2895777|NCT00394901|3603333|FG002|COMPLETED|Baseline Phase||89
2895778|NCT00394901|3603334|FG003|COMPLETED|Baseline Phase||97
2895779|NCT00394901|3603331|FG000|NOT COMPLETED|Baseline Phase||0
2895780|NCT00394901|3603332|FG001|NOT COMPLETED|Baseline Phase||0
2895781|NCT00394901|3603333|FG002|NOT COMPLETED|Baseline Phase||1
2895782|NCT00394901|3603334|FG003|NOT COMPLETED|Baseline Phase||0
2895783|NCT00394901|3603331|FG000|STARTED|Double-blind Phase|Subjects treated with the study drug.|98
2895784|NCT00394901|3603332|FG001|STARTED|Double-blind Phase|Subjects treated with the study drug.|87
2920804|NCT00538850|3631374|FG002|NOT COMPLETED|Titration Period||0
3170778|NCT01930890|3898034|FG000|COMPLETED|Overall Study||0
3170779|NCT01930890|3898035|FG001|COMPLETED|Overall Study||0
3170780|NCT01930890|3898036|FG002|COMPLETED|Overall Study||0
2895785|NCT00394901|3603333|FG002|STARTED|Double-blind Phase|Subjects treated with the study drug.|89
2895786|NCT00394901|3603334|FG003|STARTED|Double-blind Phase|Subjects treated with the study drug.|97
2895787|NCT00394901|3603331|FG000|COMPLETED|Double-blind Phase||83
2895788|NCT00394901|3603332|FG001|COMPLETED|Double-blind Phase||73
2895789|NCT00394901|3603333|FG002|COMPLETED|Double-blind Phase||71
2895790|NCT00394901|3603334|FG003|COMPLETED|Double-blind Phase||70
3170781|NCT01930890|3898037|FG003|COMPLETED|Overall Study||0
3170782|NCT01930890|3898034|FG000|NOT COMPLETED|Overall Study||14
3170783|NCT01930890|3898035|FG001|NOT COMPLETED|Overall Study||33
3170784|NCT01930890|3898036|FG002|NOT COMPLETED|Overall Study||13
3170785|NCT01930890|3898037|FG003|NOT COMPLETED|Overall Study||27
3170786|NCT01931059|3898049|FG000|STARTED|Day 1||6
2895791|NCT00394901|3603331|FG000|NOT COMPLETED|Double-blind Phase||15
2895792|NCT00394901|3603332|FG001|NOT COMPLETED|Double-blind Phase||14
2895793|NCT00394901|3603333|FG002|NOT COMPLETED|Double-blind Phase||18
2895794|NCT00394901|3603334|FG003|NOT COMPLETED|Double-blind Phase||27
2895795|NCT00394914|3603349|FG000|STARTED|Screening Period||311
3170787|NCT01931059|3898050|FG001|STARTED|Day 1||5
3170788|NCT01931059|3898049|FG000|COMPLETED|Day 1||6
2895796|NCT00394914|3603350|FG001|STARTED|Screening Period||0
2895797|NCT00394914|3603351|FG002|STARTED|Screening Period||0
2895798|NCT00394914|3603349|FG000|COMPLETED|Screening Period||311
2895799|NCT00394914|3603350|FG001|COMPLETED|Screening Period||0
2895800|NCT00394914|3603351|FG002|COMPLETED|Screening Period||0
2895801|NCT00394914|3603349|FG000|NOT COMPLETED|Screening Period||0
2895802|NCT00394914|3603350|FG001|NOT COMPLETED|Screening Period||0
2895803|NCT00394914|3603351|FG002|NOT COMPLETED|Screening Period||0
2895804|NCT00394914|3603349|FG000|STARTED|Pre-exposure Period||311
2895805|NCT00394914|3603350|FG001|STARTED|Pre-exposure Period||0
2895806|NCT00394914|3603351|FG002|STARTED|Pre-exposure Period||0
2895807|NCT00394914|3603349|FG000|COMPLETED|Pre-exposure Period||311
2895808|NCT00394914|3603350|FG001|COMPLETED|Pre-exposure Period||0
2895809|NCT00394914|3603351|FG002|COMPLETED|Pre-exposure Period||0
2895810|NCT00394914|3603349|FG000|NOT COMPLETED|Pre-exposure Period||0
2895811|NCT00394914|3603350|FG001|NOT COMPLETED|Pre-exposure Period||0
2895812|NCT00394914|3603351|FG002|NOT COMPLETED|Pre-exposure Period||0
2895813|NCT00394914|3603349|FG000|STARTED|Treatment Period||0
2895814|NCT00394914|3603350|FG001|STARTED|Treatment Period||154
2895815|NCT00394914|3603351|FG002|STARTED|Treatment Period||157
2895816|NCT00394914|3603349|FG000|COMPLETED|Treatment Period||0
2895817|NCT00394914|3603350|FG001|COMPLETED|Treatment Period||144
2895818|NCT00394914|3603351|FG002|COMPLETED|Treatment Period||151
2895819|NCT00394914|3603349|FG000|NOT COMPLETED|Treatment Period||0
2895820|NCT00394914|3603350|FG001|NOT COMPLETED|Treatment Period||10
2895821|NCT00394914|3603351|FG002|NOT COMPLETED|Treatment Period||6
2895822|NCT00394953|3603359|FG000|STARTED|First Treatment Period||245
2895823|NCT00394953|3603360|FG001|STARTED|First Treatment Period||244
2895824|NCT00394953|3603359|FG000|COMPLETED|First Treatment Period||216
2895825|NCT00394953|3603360|FG001|COMPLETED|First Treatment Period||222
2895826|NCT00394953|3603359|FG000|NOT COMPLETED|First Treatment Period||29
2895827|NCT00394953|3603360|FG001|NOT COMPLETED|First Treatment Period||22
2895828|NCT00394953|3603359|FG000|STARTED|Second Treatment Period||216
2895829|NCT00394953|3603360|FG001|STARTED|Second Treatment Period||222
2895830|NCT00394953|3603359|FG000|COMPLETED|Second Treatment Period||187
2895831|NCT00394953|3603360|FG001|COMPLETED|Second Treatment Period||148
2895832|NCT00394953|3603359|FG000|NOT COMPLETED|Second Treatment Period||29
2895833|NCT00394953|3603360|FG001|NOT COMPLETED|Second Treatment Period||74
2895834|NCT00395018|3603366|FG000|STARTED|On-Treatment|Started = treated (participants who received at least 1 dose of study therapy)|65
2895835|NCT00395018|3603366|FG000|DISCONTINUED PRIOR TO WEEK 72 VISIT|On-Treatment||10
2895836|NCT00395018|3603366|FG000|DISCONTINUED AT OR AFTER WEEK 72 VISIT|On-Treatment||0
2895837|NCT00395018|3603366|FG000|COMPLETED|On-Treatment|"Completed means received treatment through Week 72"|55
2895838|NCT00395018|3603366|FG000|NOT COMPLETED|On-Treatment||10
2895839|NCT00395018|3603366|FG000|STARTED|Off-Treatment Follow-up|Treated participants who discontinued =<72 weeks and did not start other anti-HBV therapy|5
2895840|NCT00395018|3603366|FG000|COMPLETED|Off-Treatment Follow-up|"Completed means completed the study"|1
2895841|NCT00395018|3603366|FG000|NOT COMPLETED|Off-Treatment Follow-up||4
2895842|NCT00395044|3603372|FG000|STARTED|Overall Study||25
2895843|NCT00395044|3603373|FG001|STARTED|Overall Study||25
2895844|NCT00395044|3603372|FG000|COMPLETED|Overall Study||7
2895845|NCT00395044|3603373|FG001|COMPLETED|Overall Study||11
2895846|NCT00395044|3603372|FG000|NOT COMPLETED|Overall Study||18
2895847|NCT00395044|3603373|FG001|NOT COMPLETED|Overall Study||14
2895848|NCT00395057|3603383|FG000|STARTED|Overall Study||34
2895849|NCT00395057|3603384|FG001|STARTED|Overall Study||35
2895850|NCT00395057|3603385|FG002|STARTED|Overall Study||35
2895851|NCT00395057|3603386|FG003|STARTED|Overall Study||34
2895852|NCT00395057|3603383|FG000|COMPLETED|Overall Study||2
2895853|NCT00395057|3603384|FG001|COMPLETED|Overall Study||1
2895854|NCT00395057|3603385|FG002|COMPLETED|Overall Study||2
2895855|NCT00395057|3603386|FG003|COMPLETED|Overall Study||1
2895856|NCT00395057|3603383|FG000|NOT COMPLETED|Overall Study||32
2895857|NCT00395057|3603384|FG001|NOT COMPLETED|Overall Study||34
2895858|NCT00395057|3603385|FG002|NOT COMPLETED|Overall Study||33
2895859|NCT00395057|3603386|FG003|NOT COMPLETED|Overall Study||33
2895860|NCT00395083|3603398|FG000|STARTED|Overall Study||217
2895861|NCT00395083|3603399|FG001|STARTED|Overall Study||209
2895862|NCT00395083|3603398|FG000|COMPLETED|Overall Study||207
2895863|NCT00395083|3603399|FG001|COMPLETED|Overall Study||201
2895864|NCT00395083|3603398|FG000|NOT COMPLETED|Overall Study||10
2895865|NCT00395083|3603399|FG001|NOT COMPLETED|Overall Study||8
2895866|NCT00395135|3603407|FG000|STARTED|Year 1||1595
2895867|NCT00395135|3603408|FG001|STARTED|Year 1||1587
2895868|NCT00395135|3603409|FG002|STARTED|Year 1||0
2895869|NCT00395135|3603410|FG003|STARTED|Year 1||0
2895870|NCT00395135|3603411|FG004|STARTED|Year 1||0
2895871|NCT00395135|3603407|FG000|COMPLETED|Year 1||883
2895872|NCT00395135|3603408|FG001|COMPLETED|Year 1||716
2895873|NCT00395135|3603409|FG002|COMPLETED|Year 1||0
2895874|NCT00395135|3603410|FG003|COMPLETED|Year 1||0
2895875|NCT00395135|3603411|FG004|COMPLETED|Year 1||0
2895876|NCT00395135|3603407|FG000|NOT COMPLETED|Year 1||712
2895877|NCT00395135|3603408|FG001|NOT COMPLETED|Year 1||871
2895878|NCT00395135|3603409|FG002|NOT COMPLETED|Year 1||0
2895879|NCT00395135|3603410|FG003|NOT COMPLETED|Year 1||0
2895880|NCT00395135|3603411|FG004|NOT COMPLETED|Year 1||0
2895881|NCT00395135|3603407|FG000|STARTED|Year 2||0
2895882|NCT00395135|3603408|FG001|STARTED|Year 2||0
2895883|NCT00395135|3603409|FG002|STARTED|Year 2||573
2895884|NCT00395135|3603410|FG003|STARTED|Year 2||283
2895885|NCT00395135|3603411|FG004|STARTED|Year 2||697
2895886|NCT00395135|3603407|FG000|COMPLETED|Year 2||0
2895887|NCT00395135|3603408|FG001|COMPLETED|Year 2||0
2895888|NCT00395135|3603409|FG002|COMPLETED|Year 2||426
2895889|NCT00395135|3603410|FG003|COMPLETED|Year 2||195
2895890|NCT00395135|3603411|FG004|COMPLETED|Year 2||507
2895891|NCT00395135|3603407|FG000|NOT COMPLETED|Year 2||0
2895892|NCT00395135|3603408|FG001|NOT COMPLETED|Year 2||0
2895893|NCT00395135|3603409|FG002|NOT COMPLETED|Year 2||147
2895894|NCT00395135|3603410|FG003|NOT COMPLETED|Year 2||88
2895895|NCT00395135|3603411|FG004|NOT COMPLETED|Year 2||190
2895896|NCT00395161|3603427|FG000|STARTED|Overall Study||149
2895897|NCT00395161|3603428|FG001|STARTED|Overall Study||144
2895898|NCT00395161|3603427|FG000|COMPLETED|Overall Study||149
2895899|NCT00395161|3603428|FG001|COMPLETED|Overall Study||144
2895900|NCT00395161|3603427|FG000|NOT COMPLETED|Overall Study||0
2895901|NCT00395161|3603428|FG001|NOT COMPLETED|Overall Study||0
2895902|NCT00395226|3603438|FG000|STARTED|Overall Study||26
2895903|NCT00395226|3603439|FG001|STARTED|Overall Study||27
2895904|NCT00395226|3603438|FG000|COMPLETED|Overall Study||22
2895905|NCT00395226|3603439|FG001|COMPLETED|Overall Study||22
2895906|NCT00395226|3603438|FG000|NOT COMPLETED|Overall Study||4
2895907|NCT00395226|3603439|FG001|NOT COMPLETED|Overall Study||5
2895908|NCT00395291|3603445|FG000|STARTED|First Intervention||17
2895909|NCT00395291|3603446|FG001|STARTED|First Intervention||9
2895910|NCT00395291|3603445|FG000|COMPLETED|First Intervention||15
2895911|NCT00395291|3603446|FG001|COMPLETED|First Intervention||9
2895912|NCT00395291|3603445|FG000|NOT COMPLETED|First Intervention||2
2895913|NCT00395291|3603446|FG001|NOT COMPLETED|First Intervention||0
2895914|NCT00395291|3603445|FG000|STARTED|Washout Period for 30 Days||15
2895915|NCT00395291|3603446|FG001|STARTED|Washout Period for 30 Days||9
2895916|NCT00395291|3603445|FG000|COMPLETED|Washout Period for 30 Days||13
2895917|NCT00395291|3603446|FG001|COMPLETED|Washout Period for 30 Days||9
2895918|NCT00395291|3603445|FG000|NOT COMPLETED|Washout Period for 30 Days||2
2895919|NCT00395291|3603446|FG001|NOT COMPLETED|Washout Period for 30 Days||0
2895920|NCT00395291|3603445|FG000|STARTED|Second Intervention||13
2895921|NCT00395291|3603446|FG001|STARTED|Second Intervention||9
2895922|NCT00395291|3603445|FG000|COMPLETED|Second Intervention||13
2895923|NCT00395291|3603446|FG001|COMPLETED|Second Intervention||9
2895924|NCT00395291|3603445|FG000|NOT COMPLETED|Second Intervention||0
2895925|NCT00395291|3603446|FG001|NOT COMPLETED|Second Intervention||0
2895926|NCT00395304|3603452|FG000|STARTED|Treatment Period 1||31
2895927|NCT00395304|3603453|FG001|STARTED|Treatment Period 1||30
2895928|NCT00395304|3603454|FG002|STARTED|Treatment Period 1||30
2895929|NCT00395304|3603455|FG003|STARTED|Treatment Period 1||31
2895930|NCT00395304|3603456|FG004|STARTED|Treatment Period 1||28
2895931|NCT00395304|3603457|FG005|STARTED|Treatment Period 1||32
2895932|NCT00395304|3603452|FG000|COMPLETED|Treatment Period 1||30
2895933|NCT00395304|3603453|FG001|COMPLETED|Treatment Period 1||26
2895934|NCT00395304|3603454|FG002|COMPLETED|Treatment Period 1||30
2895935|NCT00395304|3603455|FG003|COMPLETED|Treatment Period 1||28
2895936|NCT00395304|3603456|FG004|COMPLETED|Treatment Period 1||27
2895937|NCT00395304|3603457|FG005|COMPLETED|Treatment Period 1||30
2895938|NCT00395304|3603452|FG000|NOT COMPLETED|Treatment Period 1||1
2895939|NCT00395304|3603453|FG001|NOT COMPLETED|Treatment Period 1||4
2895940|NCT00395304|3603454|FG002|NOT COMPLETED|Treatment Period 1||0
2895941|NCT00395304|3603455|FG003|NOT COMPLETED|Treatment Period 1||3
2895942|NCT00395304|3603456|FG004|NOT COMPLETED|Treatment Period 1||1
2895943|NCT00395304|3603457|FG005|NOT COMPLETED|Treatment Period 1||2
2895944|NCT00395304|3603452|FG000|STARTED|Treatment Period 2||30
2895945|NCT00395304|3603453|FG001|STARTED|Treatment Period 2||26
2895946|NCT00395304|3603454|FG002|STARTED|Treatment Period 2||30
2895947|NCT00395304|3603455|FG003|STARTED|Treatment Period 2||28
2895948|NCT00395304|3603456|FG004|STARTED|Treatment Period 2||27
2895949|NCT00395304|3603457|FG005|STARTED|Treatment Period 2||30
2895950|NCT00395304|3603452|FG000|COMPLETED|Treatment Period 2||30
2895951|NCT00395304|3603453|FG001|COMPLETED|Treatment Period 2||22
2895952|NCT00395304|3603454|FG002|COMPLETED|Treatment Period 2||29
2895953|NCT00395304|3603455|FG003|COMPLETED|Treatment Period 2||27
2895954|NCT00395304|3603456|FG004|COMPLETED|Treatment Period 2||27
2895955|NCT00395304|3603457|FG005|COMPLETED|Treatment Period 2||28
2895956|NCT00395304|3603452|FG000|NOT COMPLETED|Treatment Period 2||0
2895957|NCT00395304|3603453|FG001|NOT COMPLETED|Treatment Period 2||4
2895958|NCT00395304|3603454|FG002|NOT COMPLETED|Treatment Period 2||1
2895959|NCT00395304|3603455|FG003|NOT COMPLETED|Treatment Period 2||1
2895960|NCT00395304|3603456|FG004|NOT COMPLETED|Treatment Period 2||0
2895961|NCT00395304|3603457|FG005|NOT COMPLETED|Treatment Period 2||2
2895962|NCT00395304|3603452|FG000|STARTED|Treatment Period 3||30
2895963|NCT00395304|3603453|FG001|STARTED|Treatment Period 3||22
2895964|NCT00395304|3603454|FG002|STARTED|Treatment Period 3||29
2895965|NCT00395304|3603455|FG003|STARTED|Treatment Period 3||27
2895966|NCT00395304|3603456|FG004|STARTED|Treatment Period 3||27
2895967|NCT00395304|3603457|FG005|STARTED|Treatment Period 3||28
2895968|NCT00395304|3603452|FG000|COMPLETED|Treatment Period 3||29
2895969|NCT00395304|3603453|FG001|COMPLETED|Treatment Period 3||20
2895970|NCT00395304|3603454|FG002|COMPLETED|Treatment Period 3||29
2895971|NCT00395304|3603455|FG003|COMPLETED|Treatment Period 3||25
2895972|NCT00395304|3603456|FG004|COMPLETED|Treatment Period 3||27
2895973|NCT00395304|3603457|FG005|COMPLETED|Treatment Period 3||27
2895974|NCT00395304|3603452|FG000|NOT COMPLETED|Treatment Period 3||1
2895975|NCT00395304|3603453|FG001|NOT COMPLETED|Treatment Period 3||2
2895976|NCT00395304|3603454|FG002|NOT COMPLETED|Treatment Period 3||0
2895977|NCT00395304|3603455|FG003|NOT COMPLETED|Treatment Period 3||2
2895978|NCT00395304|3603456|FG004|NOT COMPLETED|Treatment Period 3||0
2895979|NCT00395304|3603457|FG005|NOT COMPLETED|Treatment Period 3||1
2895980|NCT00395343|3603466|FG000|STARTED|Overall Study||322
2895981|NCT00395343|3603467|FG001|STARTED|Overall Study||319
2895982|NCT00395343|3603466|FG000|COMPLETED|Overall Study||281
2895983|NCT00395343|3603467|FG001|COMPLETED|Overall Study||283
2895984|NCT00395343|3603466|FG000|NOT COMPLETED|Overall Study||41
2895985|NCT00395343|3603467|FG001|NOT COMPLETED|Overall Study||36
2895986|NCT00395447|3603475|FG000|STARTED|Overall Study||1031
2895987|NCT00395447|3603476|FG001|STARTED|Overall Study||713
2895988|NCT00395447|3603475|FG000|COMPLETED|Overall Study||910
2895989|NCT00395447|3603476|FG001|COMPLETED|Overall Study||602
2895990|NCT00395447|3603475|FG000|NOT COMPLETED|Overall Study||121
2895991|NCT00395447|3603476|FG001|NOT COMPLETED|Overall Study||111
2895992|NCT00395460|3603484|FG000|STARTED|Overall Study||72
2895993|NCT00395460|3603485|FG001|STARTED|Overall Study||75
2895994|NCT00395460|3603484|FG000|Received Treatment|Overall Study|1 participant withdrew consent prior to study drug injection and did not receive any study drug.|71
2895995|NCT00395460|3603485|FG001|Received Treatment|Overall Study||75
2895996|NCT00395460|3603484|FG000|COMPLETED|Overall Study||71
2895997|NCT00395460|3603485|FG001|COMPLETED|Overall Study||75
2895998|NCT00395460|3603484|FG000|NOT COMPLETED|Overall Study||1
2895999|NCT00395460|3603485|FG001|NOT COMPLETED|Overall Study||0
2896000|NCT00395486|3603493|FG000|STARTED|Overall Study|Randomized subjects|132
2896001|NCT00395486|3603494|FG001|STARTED|Overall Study|Randomized subjects|126
2896002|NCT00395486|3603493|FG000|COMPLETED|Overall Study|Completed subjects|126
2896003|NCT00395486|3603494|FG001|COMPLETED|Overall Study|Completed subjects|121
2896004|NCT00395486|3603493|FG000|NOT COMPLETED|Overall Study||6
2896005|NCT00395486|3603494|FG001|NOT COMPLETED|Overall Study||5
2896006|NCT00395512|3603504|FG000|STARTED|Overall Study||164
2896007|NCT00395512|3603505|FG001|STARTED|Overall Study||163
2896008|NCT00395512|3603506|FG002|STARTED|Overall Study||164
2896009|NCT00395512|3603507|FG003|STARTED|Overall Study||164
2896010|NCT00395512|3603504|FG000|Safety Set|Overall Study||164
2896011|NCT00395512|3603505|FG001|Safety Set|Overall Study||163
2896012|NCT00395512|3603506|FG002|Safety Set|Overall Study||164
2896013|NCT00395512|3603507|FG003|Safety Set|Overall Study|1 participant was lost to follow-up post visit 1. It is unknown if they took any study medication.|163
2896014|NCT00395512|3603504|FG000|COMPLETED|Overall Study||126
2896015|NCT00395512|3603505|FG001|COMPLETED|Overall Study||126
2896016|NCT00395512|3603506|FG002|COMPLETED|Overall Study||136
2896017|NCT00395512|3603507|FG003|COMPLETED|Overall Study||126
2896018|NCT00395512|3603504|FG000|NOT COMPLETED|Overall Study||38
2896019|NCT00395512|3603505|FG001|NOT COMPLETED|Overall Study||37
2896020|NCT00395512|3603506|FG002|NOT COMPLETED|Overall Study||28
2896021|NCT00395512|3603507|FG003|NOT COMPLETED|Overall Study||38
2896022|NCT00395538|3603520|FG000|STARTED|Overall Study||8
2896023|NCT00395538|3603521|FG001|STARTED|Overall Study||15
2896024|NCT00395538|3603522|FG002|STARTED|Overall Study||23
2896025|NCT00395538|3603520|FG000|Signed Consent to the New Protocol|Overall Study||7
2896026|NCT00395538|3603521|FG001|Signed Consent to the New Protocol|Overall Study||5
2896027|NCT00395538|3603522|FG002|Signed Consent to the New Protocol|Overall Study||23
2896028|NCT00395538|3603520|FG000|Received HPTH on New Protocol|Overall Study||7
2896029|NCT00395538|3603521|FG001|Received HPTH on New Protocol|Overall Study||5
2896030|NCT00395538|3603522|FG002|Received HPTH on New Protocol|Overall Study||19
2896031|NCT00395538|3603520|FG000|Randomized to Bone Biopsy Year 1|Overall Study||0
2896032|NCT00395538|3603521|FG001|Randomized to Bone Biopsy Year 1|Overall Study||1
2896033|NCT00395538|3603522|FG002|Randomized to Bone Biopsy Year 1|Overall Study||5
2896034|NCT00395538|3603520|FG000|Randomized to Bone Biopsy Year 2|Overall Study||0
2896035|NCT00395538|3603521|FG001|Randomized to Bone Biopsy Year 2|Overall Study||2
2896036|NCT00395538|3603522|FG002|Randomized to Bone Biopsy Year 2|Overall Study||6
2896037|NCT00395538|3603520|FG000|Randomized to Bone Biospy Year 4|Overall Study||0
2896038|NCT00395538|3603521|FG001|Randomized to Bone Biospy Year 4|Overall Study||2
2896039|NCT00395538|3603522|FG002|Randomized to Bone Biospy Year 4|Overall Study||8
2896040|NCT00395538|3603520|FG000|Completed Bone Biopsy Year 1|Overall Study||0
2896041|NCT00395538|3603521|FG001|Completed Bone Biopsy Year 1|Overall Study||1
2896042|NCT00395538|3603522|FG002|Completed Bone Biopsy Year 1|Overall Study||4
2896043|NCT00395538|3603520|FG000|Completed Bone Biopsy Year 2|Overall Study||0
2896044|NCT00395538|3603521|FG001|Completed Bone Biopsy Year 2|Overall Study||2
2896045|NCT00395538|3603522|FG002|Completed Bone Biopsy Year 2|Overall Study||3
2896046|NCT00395538|3603520|FG000|Completed Bone Biopsy Year 4|Overall Study||0
2896047|NCT00395538|3603521|FG001|Completed Bone Biopsy Year 4|Overall Study||1
2896048|NCT00395538|3603522|FG002|Completed Bone Biopsy Year 4|Overall Study||1
2896049|NCT00395538|3603520|FG000|COMPLETED|Overall Study||5
2896050|NCT00395538|3603521|FG001|COMPLETED|Overall Study||2
2896051|NCT00395538|3603522|FG002|COMPLETED|Overall Study||0
2896052|NCT00395538|3603520|FG000|NOT COMPLETED|Overall Study||3
2896053|NCT00395538|3603521|FG001|NOT COMPLETED|Overall Study||13
2896054|NCT00395538|3603522|FG002|NOT COMPLETED|Overall Study||23
2896055|NCT00395629|3603533|FG000|STARTED|Core Study||11
2896056|NCT00395629|3603534|FG001|STARTED|Core Study||15
2896057|NCT00395629|3603535|FG002|STARTED|Core Study||23
2896058|NCT00395629|3603533|FG000|COMPLETED|Core Study||10
2896059|NCT00395629|3603534|FG001|COMPLETED|Core Study||11
2896060|NCT00395629|3603535|FG002|COMPLETED|Core Study||16
2896061|NCT00395629|3603533|FG000|NOT COMPLETED|Core Study||1
2896062|NCT00395629|3603534|FG001|NOT COMPLETED|Core Study||4
2896063|NCT00395629|3603535|FG002|NOT COMPLETED|Core Study||7
2896064|NCT00395629|3603533|FG000|STARTED|Extension Study||9
2896065|NCT00395629|3603534|FG001|STARTED|Extension Study||6
2896066|NCT00395629|3603535|FG002|STARTED|Extension Study||11
2896067|NCT00395629|3603533|FG000|COMPLETED|Extension Study||9
2896068|NCT00395629|3603534|FG001|COMPLETED|Extension Study||6
2896069|NCT00395629|3603535|FG002|COMPLETED|Extension Study||8
2896070|NCT00395629|3603533|FG000|NOT COMPLETED|Extension Study||0
2896071|NCT00395629|3603534|FG001|NOT COMPLETED|Extension Study||0
2896072|NCT00395629|3603535|FG002|NOT COMPLETED|Extension Study||3
2896073|NCT00395642|3603546|FG000|STARTED|Overall Study||66
2896074|NCT00395642|3603546|FG000|COMPLETED|Overall Study||53
2896075|NCT00395642|3603546|FG000|NOT COMPLETED|Overall Study||13
2896076|NCT00395694|3603552|FG000|STARTED|Escalation Phase + Maintenance Phase||51
2896077|NCT00395694|3603553|FG001|STARTED|Escalation Phase + Maintenance Phase||51
2896078|NCT00395694|3603552|FG000|COMPLETED|Escalation Phase + Maintenance Phase||50
2896079|NCT00395694|3603553|FG001|COMPLETED|Escalation Phase + Maintenance Phase||49
2896080|NCT00395694|3603552|FG000|NOT COMPLETED|Escalation Phase + Maintenance Phase||1
2896081|NCT00395694|3603553|FG001|NOT COMPLETED|Escalation Phase + Maintenance Phase||2
2896082|NCT00395694|3603552|FG000|STARTED|Continuation Phase|One participant completing the Escalation/Maintenance Phase did not start the Continuation Phase.|49
2896083|NCT00395694|3603553|FG001|STARTED|Continuation Phase|One participant completing the Escalation/Maintenance Phase did not start the Continuation Phase.|48
2896084|NCT00395694|3603552|FG000|COMPLETED|Continuation Phase||34
2896085|NCT00395694|3603553|FG001|COMPLETED|Continuation Phase||35
2896086|NCT00395694|3603552|FG000|NOT COMPLETED|Continuation Phase||15
2896087|NCT00395694|3603553|FG001|NOT COMPLETED|Continuation Phase||13
2896088|NCT00395733|3603564|FG000|STARTED|Period 1||41
2896089|NCT00395733|3603565|FG001|STARTED|Period 1||42
2896090|NCT00395733|3603564|FG000|COMPLETED|Period 1||41
2896091|NCT00395733|3603565|FG001|COMPLETED|Period 1||42
2896092|NCT00395733|3603564|FG000|NOT COMPLETED|Period 1||0
2896093|NCT00395733|3603565|FG001|NOT COMPLETED|Period 1||0
2896094|NCT00395733|3603564|FG000|STARTED|Period 2||41
2896095|NCT00395733|3603565|FG001|STARTED|Period 2||42
2896096|NCT00395733|3603564|FG000|COMPLETED|Period 2||39
2896097|NCT00395733|3603565|FG001|COMPLETED|Period 2||37
2896098|NCT00395733|3603564|FG000|NOT COMPLETED|Period 2||2
2896099|NCT00395733|3603565|FG001|NOT COMPLETED|Period 2||5
2896100|NCT00395746|3603574|FG000|STARTED|Overall Study|Exposed to study drug|88
2896101|NCT00395746|3603575|FG001|STARTED|Overall Study|Exposed to study drug|88
2896102|NCT00395746|3603576|FG002|STARTED|Overall Study|Exposed to study drug|88
2896103|NCT00395746|3603574|FG000|COMPLETED|Overall Study|Completed 52 weeks treatment|78
2896104|NCT00395746|3603575|FG001|COMPLETED|Overall Study|Completed 52 weeks treatment|84
2896105|NCT00395746|3603576|FG002|COMPLETED|Overall Study|Completed 52 weeks treatment|66
2896106|NCT00395746|3603574|FG000|NOT COMPLETED|Overall Study||10
2896107|NCT00395746|3603575|FG001|NOT COMPLETED|Overall Study||4
2896108|NCT00395746|3603576|FG002|NOT COMPLETED|Overall Study||22
2896109|NCT00395850|3603588|FG000|STARTED|Pre-randomization Baseline/Induction|Pre-randomization and disulfiram (disulf) administration|118
2896110|NCT00395850|3603589|FG001|STARTED|Pre-randomization Baseline/Induction||0
2896111|NCT00395850|3603590|FG002|STARTED|Pre-randomization Baseline/Induction||0
2896112|NCT00395850|3603591|FG003|STARTED|Pre-randomization Baseline/Induction||0
2896113|NCT00395850|3603588|FG000|COMPLETED|Pre-randomization Baseline/Induction||107
2896114|NCT00395850|3603589|FG001|COMPLETED|Pre-randomization Baseline/Induction||0
2896115|NCT00395850|3603590|FG002|COMPLETED|Pre-randomization Baseline/Induction||0
2896116|NCT00395850|3603591|FG003|COMPLETED|Pre-randomization Baseline/Induction||0
2896117|NCT00395850|3603588|FG000|NOT COMPLETED|Pre-randomization Baseline/Induction||11
2896118|NCT00395850|3603589|FG001|NOT COMPLETED|Pre-randomization Baseline/Induction||0
3038342|NCT01153763|3757765|FG000|COMPLETED|Overall Study||71
2896119|NCT00395850|3603590|FG002|NOT COMPLETED|Pre-randomization Baseline/Induction||0
2896120|NCT00395850|3603591|FG003|NOT COMPLETED|Pre-randomization Baseline/Induction||0
2896121|NCT00395850|3603588|FG000|STARTED|Randomization to Disulfiram/ Pre-admin||27
2896122|NCT00395850|3603589|FG001|STARTED|Randomization to Disulfiram/ Pre-admin||25
2896123|NCT00395850|3603590|FG002|STARTED|Randomization to Disulfiram/ Pre-admin||30
2896124|NCT00395850|3603591|FG003|STARTED|Randomization to Disulfiram/ Pre-admin||25
2896125|NCT00395850|3603588|FG000|COMPLETED|Randomization to Disulfiram/ Pre-admin||22
2896126|NCT00395850|3603589|FG001|COMPLETED|Randomization to Disulfiram/ Pre-admin||23
2896127|NCT00395850|3603590|FG002|COMPLETED|Randomization to Disulfiram/ Pre-admin||24
2896128|NCT00395850|3603591|FG003|COMPLETED|Randomization to Disulfiram/ Pre-admin||21
2896129|NCT00395850|3603588|FG000|NOT COMPLETED|Randomization to Disulfiram/ Pre-admin||5
2896130|NCT00395850|3603589|FG001|NOT COMPLETED|Randomization to Disulfiram/ Pre-admin||2
2896131|NCT00395850|3603590|FG002|NOT COMPLETED|Randomization to Disulfiram/ Pre-admin||6
2896132|NCT00395850|3603591|FG003|NOT COMPLETED|Randomization to Disulfiram/ Pre-admin||4
2896133|NCT00395850|3603588|FG000|STARTED|Disulfiram/Placebo Treatment|Received >= 1 disulfiram dose. Two baseline/randomized subjects dropped out before receiving disulf|20
2896134|NCT00395850|3603589|FG001|STARTED|Disulfiram/Placebo Treatment|Received at least one dose of disulfiram|23
2896135|NCT00395850|3603590|FG002|STARTED|Disulfiram/Placebo Treatment|Received at least one dose of disulfiram|24
2896136|NCT00395850|3603591|FG003|STARTED|Disulfiram/Placebo Treatment|Received at least one dose of disulfiram|21
2896137|NCT00395850|3603588|FG000|COMPLETED|Disulfiram/Placebo Treatment||11
2896138|NCT00395850|3603589|FG001|COMPLETED|Disulfiram/Placebo Treatment||9
2896139|NCT00395850|3603590|FG002|COMPLETED|Disulfiram/Placebo Treatment||5
2896140|NCT00395850|3603591|FG003|COMPLETED|Disulfiram/Placebo Treatment||8
2896141|NCT00395850|3603588|FG000|NOT COMPLETED|Disulfiram/Placebo Treatment||9
2896142|NCT00395850|3603589|FG001|NOT COMPLETED|Disulfiram/Placebo Treatment||14
2896143|NCT00395850|3603590|FG002|NOT COMPLETED|Disulfiram/Placebo Treatment||19
2896144|NCT00395850|3603591|FG003|NOT COMPLETED|Disulfiram/Placebo Treatment||13
2896145|NCT00395863|3603603|FG000|STARTED|Overall Study||23
2896146|NCT00395863|3603604|FG001|STARTED|Overall Study||23
2896147|NCT00395863|3603603|FG000|COMPLETED|Overall Study||21
2896148|NCT00395863|3603604|FG001|COMPLETED|Overall Study||20
2896149|NCT00395863|3603603|FG000|NOT COMPLETED|Overall Study||2
2896150|NCT00395863|3603604|FG001|NOT COMPLETED|Overall Study||3
2896151|NCT00395876|3603615|FG000|STARTED|Overall Study||50
2896152|NCT00395876|3603616|FG001|STARTED|Overall Study||50
2896153|NCT00395876|3603615|FG000|COMPLETED|Overall Study||47
2896154|NCT00395876|3603616|FG001|COMPLETED|Overall Study||50
2896155|NCT00395876|3603615|FG000|NOT COMPLETED|Overall Study||3
2896156|NCT00395876|3603616|FG001|NOT COMPLETED|Overall Study||0
2896157|NCT00395967|3603622|FG000|STARTED|Treatment Period||5
2896158|NCT00395967|3603622|FG000|COMPLETED|Treatment Period|Failed mobilization due to <2 fold yield after one day of plerixafor treatment|4
2896159|NCT00395967|3603622|FG000|NOT COMPLETED|Treatment Period||1
2896160|NCT00395967|3603622|FG000|STARTED|Follow-up Period|Participants who had transplants.|5
2896161|NCT00395967|3603622|FG000|COMPLETED|Follow-up Period||3
2896162|NCT00395967|3603622|FG000|NOT COMPLETED|Follow-up Period||2
2896163|NCT00395993|3603628|FG000|STARTED|Overall Study||246
2896164|NCT00395993|3603629|FG001|STARTED|Overall Study||231
2896165|NCT00395993|3603628|FG000|COMPLETED|Overall Study||211
2896166|NCT00395993|3603629|FG001|COMPLETED|Overall Study||212
2896167|NCT00395993|3603628|FG000|NOT COMPLETED|Overall Study||35
2896168|NCT00395993|3603629|FG001|NOT COMPLETED|Overall Study||19
2896169|NCT00396006|3603635|FG000|STARTED|Overall Study||13
2896170|NCT00396006|3603635|FG000|COMPLETED|Overall Study||13
2896171|NCT00396006|3603635|FG000|NOT COMPLETED|Overall Study||0
2919913|NCT00534495|3630337|FG000|NOT COMPLETED|Long Term Ext. Phase Week 24-month 21||0
2919914|NCT00534495|3630338|FG001|NOT COMPLETED|Long Term Ext. Phase Week 24-month 21||0
2919915|NCT00534495|3630339|FG002|NOT COMPLETED|Long Term Ext. Phase Week 24-month 21||11
2919916|NCT00534599|3630352|FG000|STARTED|Overall Study|Randomized|209
2919917|NCT00534599|3630353|FG001|STARTED|Overall Study|Randomized|200
2919918|NCT00534599|3630352|FG000|COMPLETED|Overall Study||152
2919919|NCT00534599|3630353|FG001|COMPLETED|Overall Study||168
2919920|NCT00534599|3630352|FG000|NOT COMPLETED|Overall Study||57
2919921|NCT00534599|3630353|FG001|NOT COMPLETED|Overall Study||32
2919922|NCT00534638|3630361|FG000|STARTED|Overall Study||14837
2919923|NCT00534638|3630362|FG001|STARTED|Overall Study||17338
2919924|NCT00534638|3630361|FG000|COMPLETED|Overall Study||8346
2919925|NCT00534638|3630362|FG001|COMPLETED|Overall Study||5547
2919926|NCT00534638|3630361|FG000|NOT COMPLETED|Overall Study||6491
2919927|NCT00534638|3630362|FG001|NOT COMPLETED|Overall Study||11791
2919928|NCT00534703|3630375|FG000|STARTED|Overall Study||4
2919929|NCT00534703|3630376|FG001|STARTED|Overall Study||1
2919930|NCT00534703|3630375|FG000|COMPLETED|Overall Study||4
2919931|NCT00534703|3630376|FG001|COMPLETED|Overall Study||1
2919932|NCT00534703|3630375|FG000|NOT COMPLETED|Overall Study||0
2919933|NCT00534703|3630376|FG001|NOT COMPLETED|Overall Study||0
2919934|NCT00534794|3630386|FG000|STARTED|Overall Study||40
2919935|NCT00534794|3630387|FG001|STARTED|Overall Study||39
2919936|NCT00534794|3630386|FG000|COMPLETED|Overall Study||40
2919937|NCT00534794|3630387|FG001|COMPLETED|Overall Study||39
2919938|NCT00534794|3630386|FG000|NOT COMPLETED|Overall Study||0
2919939|NCT00534794|3630387|FG001|NOT COMPLETED|Overall Study||0
2919940|NCT00534833|3630395|FG000|STARTED|Overall Study||182
2919941|NCT00534833|3630396|FG001|STARTED|Overall Study||180
2896172|NCT00396019|3603643|FG000|STARTED|Overall Study||27
2896173|NCT00396019|3603644|FG001|STARTED|Overall Study||29
2896174|NCT00396019|3603645|FG002|STARTED|Overall Study||30
2896175|NCT00396019|3603643|FG000|COMPLETED|Overall Study||27
2896176|NCT00396019|3603644|FG001|COMPLETED|Overall Study||26
2896177|NCT00396019|3603645|FG002|COMPLETED|Overall Study||29
2896178|NCT00396019|3603643|FG000|NOT COMPLETED|Overall Study||0
2896179|NCT00396019|3603644|FG001|NOT COMPLETED|Overall Study||3
2896180|NCT00396019|3603645|FG002|NOT COMPLETED|Overall Study||1
2896181|NCT00396032|3603656|FG000|STARTED|Overall Study||74
2896182|NCT00396032|3603657|FG001|STARTED|Overall Study||76
2896183|NCT00396032|3603656|FG000|COMPLETED|Overall Study||70
2896184|NCT00396032|3603657|FG001|COMPLETED|Overall Study||71
2896185|NCT00396032|3603656|FG000|NOT COMPLETED|Overall Study||4
2896186|NCT00396032|3603657|FG001|NOT COMPLETED|Overall Study||5
2896187|NCT00396084|3603669|FG000|STARTED|Overall Study||10
2896188|NCT00396084|3603670|FG001|STARTED|Overall Study||10
2896189|NCT00396084|3603671|FG002|STARTED|Overall Study||10
2896190|NCT00396084|3603672|FG003|STARTED|Overall Study||10
2896191|NCT00396084|3603673|FG004|STARTED|Overall Study||10
2896192|NCT00396084|3603674|FG005|STARTED|Overall Study||20
2896193|NCT00396084|3603669|FG000|COMPLETED|Overall Study||10
2896194|NCT00396084|3603670|FG001|COMPLETED|Overall Study||10
2896195|NCT00396084|3603671|FG002|COMPLETED|Overall Study||10
2896196|NCT00396084|3603672|FG003|COMPLETED|Overall Study||9
2896197|NCT00396084|3603673|FG004|COMPLETED|Overall Study||9
2896198|NCT00396084|3603674|FG005|COMPLETED|Overall Study||18
2896199|NCT00396084|3603669|FG000|NOT COMPLETED|Overall Study||0
2896200|NCT00396084|3603670|FG001|NOT COMPLETED|Overall Study||0
2896201|NCT00396084|3603671|FG002|NOT COMPLETED|Overall Study||0
2896202|NCT00396084|3603672|FG003|NOT COMPLETED|Overall Study||1
2896203|NCT00396084|3603673|FG004|NOT COMPLETED|Overall Study||1
2896204|NCT00396084|3603674|FG005|NOT COMPLETED|Overall Study||2
2896205|NCT00396097|3603694|FG000|STARTED|Overall Study|4 participants randomized to Individualized Dose, received Standard Dose throughout the study.|114
2896206|NCT00396097|3603695|FG001|STARTED|Overall Study||202
2896207|NCT00396097|3603694|FG000|COMPLETED|Overall Study||88
2896208|NCT00396097|3603695|FG001|COMPLETED|Overall Study||156
2896209|NCT00396097|3603694|FG000|NOT COMPLETED|Overall Study||26
2896210|NCT00396097|3603695|FG001|NOT COMPLETED|Overall Study||46
2896211|NCT00396136|3603705|FG000|STARTED|Overall Study||221
2896212|NCT00396136|3603705|FG000|COMPLETED|Overall Study||96
2896213|NCT00396136|3603705|FG000|NOT COMPLETED|Overall Study||125
3170789|NCT01931059|3898050|FG001|COMPLETED|Day 1||4
3170790|NCT01931059|3898049|FG000|NOT COMPLETED|Day 1||0
3170791|NCT01931059|3898050|FG001|NOT COMPLETED|Day 1||1
3170792|NCT01931059|3898049|FG000|STARTED|Day2||6
3170793|NCT01931059|3898050|FG001|STARTED|Day2||4
3170794|NCT01931059|3898049|FG000|COMPLETED|Day2||6
2896214|NCT00396162|3603711|FG000|STARTED|Overall Study||39
2896215|NCT00396162|3603712|FG001|STARTED|Overall Study||38
2896216|NCT00396162|3603711|FG000|COMPLETED|Overall Study||37
2896217|NCT00396162|3603712|FG001|COMPLETED|Overall Study||35
2896218|NCT00396162|3603711|FG000|NOT COMPLETED|Overall Study||2
2896219|NCT00396162|3603712|FG001|NOT COMPLETED|Overall Study||3
2896220|NCT00396201|3603722|FG000|STARTED|Treatment Period||22
2896221|NCT00396201|3603722|FG000|COMPLETED|Treatment Period|Completed refers to completed all treatment visits.|22
2896222|NCT00396201|3603722|FG000|NOT COMPLETED|Treatment Period||0
2896223|NCT00396201|3603722|FG000|STARTED|Follow-up Period|Participants who had transplants. One had insufficient collection of cells so no transplant.|21
2896224|NCT00396201|3603722|FG000|COMPLETED|Follow-up Period|Follow-up visit 12 months post-transplant|21
2896225|NCT00396201|3603722|FG000|NOT COMPLETED|Follow-up Period||0
2896226|NCT00396253|3603727|FG000|STARTED|Overall Study||223
2896227|NCT00396253|3603727|FG000|COMPLETED|Overall Study||210
2896228|NCT00396253|3603727|FG000|NOT COMPLETED|Overall Study||13
2896229|NCT00396266|3603733|FG000|STARTED|Overall Study||8
2896230|NCT00396266|3603734|FG001|STARTED|Overall Study||14
2896231|NCT00396266|3603733|FG000|COMPLETED|Overall Study||8
2896232|NCT00396266|3603734|FG001|COMPLETED|Overall Study||14
2896233|NCT00396266|3603733|FG000|NOT COMPLETED|Overall Study||0
2896234|NCT00396266|3603734|FG001|NOT COMPLETED|Overall Study||0
2896235|NCT00396279|3603744|FG000|STARTED|Overall Study||37
2896236|NCT00396279|3603744|FG000|COMPLETED|Overall Study|Defined as participants with a complete resection|7
2896237|NCT00396279|3603744|FG000|NOT COMPLETED|Overall Study||30
2896238|NCT00396292|3603750|FG000|STARTED|Overall Study||174
2896239|NCT00396292|3603751|FG001|STARTED|Overall Study||178
2896240|NCT00396292|3603750|FG000|COMPLETED|Overall Study||165
2896241|NCT00396292|3603751|FG001|COMPLETED|Overall Study||162
2896242|NCT00396292|3603750|FG000|NOT COMPLETED|Overall Study||9
2896243|NCT00396292|3603751|FG001|NOT COMPLETED|Overall Study||16
2896244|NCT00396318|3603757|FG000|STARTED|At Least One Dose of Tenecteplase (MITT)||246
2896245|NCT00396318|3603757|FG000|COMPLETED|At Least One Dose of Tenecteplase (MITT)||241
2896246|NCT00396318|3603757|FG000|NOT COMPLETED|At Least One Dose of Tenecteplase (MITT)||5
2896247|NCT00396318|3603757|FG000|STARTED|48- to 96-Hour Follow-Up Period||246
2896248|NCT00396318|3603757|FG000|COMPLETED|48- to 96-Hour Follow-Up Period||241
2896249|NCT00396318|3603757|FG000|NOT COMPLETED|48- to 96-Hour Follow-Up Period||5
2896250|NCT00396318|3603757|FG000|STARTED|7-Day Post-Treatment Contact||241
2896251|NCT00396318|3603757|FG000|COMPLETED|7-Day Post-Treatment Contact||240
2896252|NCT00396318|3603757|FG000|NOT COMPLETED|7-Day Post-Treatment Contact||1
2896253|NCT00396331|3603765|FG000|STARTED|Overall Study||100
2896254|NCT00396331|3603765|FG000|Number of Participants Treated|Overall Study||100
2896255|NCT00396331|3603765|FG000|Number of Participants Transplanted|Overall Study|7 participants had two transplants|87
2896256|NCT00396331|3603765|FG000|COMPLETED|Overall Study||68
2896257|NCT00396331|3603765|FG000|NOT COMPLETED|Overall Study||32
2896258|NCT00396383|3603777|FG000|STARTED|Overall Study||9
2896259|NCT00396383|3603777|FG000|COMPLETED|Overall Study||6
2896260|NCT00396383|3603777|FG000|NOT COMPLETED|Overall Study||3
2896261|NCT00396409|3603783|FG000|STARTED|Period 1 - 2007||65
2896262|NCT00396409|3603784|FG001|STARTED|Period 1 - 2007||63
2896263|NCT00396409|3603783|FG000|COMPLETED|Period 1 - 2007||62
2896264|NCT00396409|3603784|FG001|COMPLETED|Period 1 - 2007||57
2896265|NCT00396409|3603783|FG000|NOT COMPLETED|Period 1 - 2007||3
2896266|NCT00396409|3603784|FG001|NOT COMPLETED|Period 1 - 2007||6
2896267|NCT00396409|3603783|FG000|STARTED|Between Period 1 and Period 2||62
2896268|NCT00396409|3603784|FG001|STARTED|Between Period 1 and Period 2||57
2896269|NCT00396409|3603783|FG000|COMPLETED|Between Period 1 and Period 2||59
2896270|NCT00396409|3603784|FG001|COMPLETED|Between Period 1 and Period 2||55
2896271|NCT00396409|3603783|FG000|NOT COMPLETED|Between Period 1 and Period 2||3
2896272|NCT00396409|3603784|FG001|NOT COMPLETED|Between Period 1 and Period 2||2
2896273|NCT00396409|3603783|FG000|STARTED|Period 2 - 2008||59
2896274|NCT00396409|3603784|FG001|STARTED|Period 2 - 2008||55
2896275|NCT00396409|3603783|FG000|COMPLETED|Period 2 - 2008||52
2896276|NCT00396409|3603784|FG001|COMPLETED|Period 2 - 2008||53
2896277|NCT00396409|3603783|FG000|NOT COMPLETED|Period 2 - 2008||7
2896278|NCT00396409|3603784|FG001|NOT COMPLETED|Period 2 - 2008||2
2896279|NCT00396565|3603795|FG000|STARTED|Overall Study||136
2896280|NCT00396565|3603796|FG001|STARTED|Overall Study||138
2896281|NCT00396565|3603797|FG002|STARTED|Overall Study||47
2896282|NCT00396565|3603795|FG000|COMPLETED|Overall Study||88
2896283|NCT00396565|3603796|FG001|COMPLETED|Overall Study||47
2896284|NCT00396565|3603797|FG002|COMPLETED|Overall Study||30
2896285|NCT00396565|3603795|FG000|NOT COMPLETED|Overall Study||48
2896286|NCT00396565|3603796|FG001|NOT COMPLETED|Overall Study||91
2896287|NCT00396565|3603797|FG002|NOT COMPLETED|Overall Study||17
2896288|NCT00396591|3603805|FG000|STARTED|Overall Study||16
2896289|NCT00396591|3603805|FG000|COMPLETED|Overall Study||0
2896290|NCT00396591|3603805|FG000|NOT COMPLETED|Overall Study||16
2896291|NCT00396630|3603811|FG000|STARTED|Overall Study||100
2896292|NCT00396630|3603812|FG001|STARTED|Overall Study||100
2896293|NCT00396630|3603811|FG000|COMPLETED|Overall Study|Completed Visit 4 (Week 17).|95
2896294|NCT00396630|3603812|FG001|COMPLETED|Overall Study|Completed Visit 4 (Week 17).|95
2896295|NCT00396630|3603811|FG000|NOT COMPLETED|Overall Study||5
2896296|NCT00396630|3603812|FG001|NOT COMPLETED|Overall Study||5
2896297|NCT00396656|3603819|FG000|STARTED|First Treatment Period||15
2896298|NCT00396656|3603820|FG001|STARTED|First Treatment Period||15
2896299|NCT00396656|3603819|FG000|COMPLETED|First Treatment Period||15
2896300|NCT00396656|3603820|FG001|COMPLETED|First Treatment Period||13
2896301|NCT00396656|3603819|FG000|NOT COMPLETED|First Treatment Period||0
2896302|NCT00396656|3603820|FG001|NOT COMPLETED|First Treatment Period||2
2896303|NCT00396656|3603819|FG000|STARTED|Second Treatment Period||15
2896304|NCT00396656|3603820|FG001|STARTED|Second Treatment Period||13
2896305|NCT00396656|3603819|FG000|COMPLETED|Second Treatment Period||15
2896306|NCT00396656|3603820|FG001|COMPLETED|Second Treatment Period||12
2896307|NCT00396656|3603819|FG000|NOT COMPLETED|Second Treatment Period||0
2896308|NCT00396656|3603820|FG001|NOT COMPLETED|Second Treatment Period||1
2896309|NCT00396812|3603826|FG000|STARTED|Overall Study||4
2896310|NCT00396812|3603826|FG000|COMPLETED|Overall Study|4 subjects completed treatment, but 1 subject terminated early due to disease progression|3
2896311|NCT00396812|3603826|FG000|NOT COMPLETED|Overall Study||1
2896312|NCT00396877|3603832|FG000|STARTED|Overall Study|Randomized|439
2896313|NCT00396877|3603833|FG001|STARTED|Overall Study|Randomized|467
2896314|NCT00396877|3603832|FG000|Treated|Overall Study||436
2896315|NCT00396877|3603833|FG001|Treated|Overall Study||464
2896316|NCT00396877|3603832|FG000|Completed Treatment|Overall Study||356
2896317|NCT00396877|3603833|FG001|Completed Treatment|Overall Study||352
2896318|NCT00396877|3603832|FG000|COMPLETED|Overall Study|Completed follow-up|433
2896319|NCT00396877|3603833|FG001|COMPLETED|Overall Study|Completed follow-up|459
2896320|NCT00396877|3603832|FG000|NOT COMPLETED|Overall Study||6
2896321|NCT00396877|3603833|FG001|NOT COMPLETED|Overall Study||8
3314864|NCT03093324|4048235|FG000|Safety Population|Overall Study||253
3314865|NCT03093324|4048236|FG001|Safety Population|Overall Study||251
3314866|NCT03093324|4048235|FG000|COMPLETED|Overall Study||245
3314867|NCT03093324|4048236|FG001|COMPLETED|Overall Study||233
3314868|NCT03093324|4048235|FG000|NOT COMPLETED|Overall Study||9
3314869|NCT03093324|4048236|FG001|NOT COMPLETED|Overall Study||19
3314870|NCT03093350|4048242|FG000|STARTED|Overall Study||12
3314871|NCT03093350|4048242|FG000|Started Treatment|Overall Study||10
3314872|NCT03093350|4048242|FG000|COMPLETED|Overall Study||10
3314873|NCT03093350|4048242|FG000|NOT COMPLETED|Overall Study||2
3314874|NCT03093415|4048249|FG000|STARTED|Assessed for Eligibility --> Enrollment||165
3314875|NCT03093415|4048250|FG001|STARTED|Assessed for Eligibility --> Enrollment||135
3314876|NCT03093415|4048251|FG002|STARTED|Assessed for Eligibility --> Enrollment||50
3314877|NCT03093415|4048249|FG000|COMPLETED|Assessed for Eligibility --> Enrollment||25
3314878|NCT03093415|4048250|FG001|COMPLETED|Assessed for Eligibility --> Enrollment||25
2896322|NCT00396981|3603841|FG000|STARTED|Overall Study||311
2896323|NCT00396981|3603842|FG001|STARTED|Overall Study||315
2896324|NCT00396981|3603841|FG000|COMPLETED|Overall Study||296
2896325|NCT00396981|3603842|FG001|COMPLETED|Overall Study||306
2896326|NCT00396981|3603841|FG000|NOT COMPLETED|Overall Study||15
2896327|NCT00396981|3603842|FG001|NOT COMPLETED|Overall Study||9
2896328|NCT00397020|3603850|FG000|STARTED|Overall Study||14
2896329|NCT00397020|3603851|FG001|STARTED|Overall Study||16
2896330|NCT00397020|3603850|FG000|COMPLETED|Overall Study||13
2896331|NCT00397020|3603851|FG001|COMPLETED|Overall Study||15
2896332|NCT00397020|3603850|FG000|NOT COMPLETED|Overall Study||1
2896333|NCT00397020|3603851|FG001|NOT COMPLETED|Overall Study||1
2896334|NCT00397033|3603860|FG000|STARTED|Overall Study||107
2896335|NCT00397033|3603861|FG001|STARTED|Overall Study||109
2896336|NCT00397033|3603862|FG002|STARTED|Overall Study||100
2896337|NCT00397033|3603860|FG000|Safety Population: >= 1 Dose of Drug|Overall Study||107
2896338|NCT00397033|3603861|FG001|Safety Population: >= 1 Dose of Drug|Overall Study||108
2896339|NCT00397033|3603862|FG002|Safety Population: >= 1 Dose of Drug|Overall Study||98
2896340|NCT00397033|3603860|FG000|ITT Population|Overall Study||107
2896341|NCT00397033|3603861|FG001|ITT Population|Overall Study||105
2896342|NCT00397033|3603862|FG002|ITT Population|Overall Study||98
2896343|NCT00397033|3603860|FG000|COMPLETED|Overall Study||63
2896344|NCT00397033|3603861|FG001|COMPLETED|Overall Study||72
2896345|NCT00397033|3603862|FG002|COMPLETED|Overall Study||77
2896346|NCT00397033|3603860|FG000|NOT COMPLETED|Overall Study||44
2896347|NCT00397033|3603861|FG001|NOT COMPLETED|Overall Study||37
2896348|NCT00397033|3603862|FG002|NOT COMPLETED|Overall Study||23
2896349|NCT00397046|3603874|FG000|STARTED|Overall Study||3
2896350|NCT00397046|3603875|FG001|STARTED|Overall Study||3
2896351|NCT00397046|3603876|FG002|STARTED|Overall Study||10
2896352|NCT00397046|3603877|FG003|STARTED|Overall Study||5
2896353|NCT00397046|3603874|FG000|COMPLETED|Overall Study||0
2896354|NCT00397046|3603875|FG001|COMPLETED|Overall Study||0
2896355|NCT00397046|3603876|FG002|COMPLETED|Overall Study||0
2896356|NCT00397046|3603877|FG003|COMPLETED|Overall Study||0
2896357|NCT00397046|3603874|FG000|NOT COMPLETED|Overall Study||3
2896358|NCT00397046|3603875|FG001|NOT COMPLETED|Overall Study||3
3314879|NCT03093415|4048251|FG002|COMPLETED|Assessed for Eligibility --> Enrollment||50
3314880|NCT03093415|4048249|FG000|NOT COMPLETED|Assessed for Eligibility --> Enrollment||140
3314881|NCT03093415|4048250|FG001|NOT COMPLETED|Assessed for Eligibility --> Enrollment||110
3314882|NCT03093415|4048251|FG002|NOT COMPLETED|Assessed for Eligibility --> Enrollment||0
3314883|NCT03093415|4048249|FG000|STARTED|Enrollment to SVR12 Results|Pre-specified 25 participants to were enrolled.|25
3314884|NCT03093415|4048250|FG001|STARTED|Enrollment to SVR12 Results|Pre-specified 25 participants to were enrolled.|25
3314885|NCT03093415|4048251|FG002|STARTED|Enrollment to SVR12 Results|Prespecified 50 participants enrolled.|50
3314886|NCT03093415|4048249|FG000|COMPLETED|Enrollment to SVR12 Results||24
3314887|NCT03093415|4048250|FG001|COMPLETED|Enrollment to SVR12 Results||17
3314888|NCT03093415|4048251|FG002|COMPLETED|Enrollment to SVR12 Results||47
3314889|NCT03093415|4048249|FG000|NOT COMPLETED|Enrollment to SVR12 Results||1
3314890|NCT03093415|4048250|FG001|NOT COMPLETED|Enrollment to SVR12 Results||8
3314891|NCT03093415|4048251|FG002|NOT COMPLETED|Enrollment to SVR12 Results||3
3314892|NCT03093454|4048261|FG000|STARTED|Overall Study||28
3314893|NCT03093454|4048262|FG001|STARTED|Overall Study||30
3314894|NCT03093454|4048261|FG000|COMPLETED|Overall Study||22
3314895|NCT03093454|4048262|FG001|COMPLETED|Overall Study||27
3314896|NCT03093454|4048261|FG000|NOT COMPLETED|Overall Study||6
3314897|NCT03093454|4048262|FG001|NOT COMPLETED|Overall Study||3
3314898|NCT03093480|4048268|FG000|STARTED|Overall Study||16
3314899|NCT03093480|4048268|FG000|Tapering Period|Overall Study||10
3314900|NCT03093480|4048268|FG000|Follow-up Period|Overall Study||10
3314901|NCT03093480|4048268|FG000|COMPLETED|Overall Study||16
3314902|NCT03093480|4048268|FG000|NOT COMPLETED|Overall Study||0
3314903|NCT03093662|4048274|FG000|STARTED|First Intervention (3 Minutes)||18
3314904|NCT03093662|4048275|FG001|STARTED|First Intervention (3 Minutes)||19
3314905|NCT03093662|4048274|FG000|COMPLETED|First Intervention (3 Minutes)||18
3314906|NCT03093662|4048275|FG001|COMPLETED|First Intervention (3 Minutes)||19
3314907|NCT03093662|4048274|FG000|NOT COMPLETED|First Intervention (3 Minutes)||0
3314908|NCT03093662|4048275|FG001|NOT COMPLETED|First Intervention (3 Minutes)||0
3314909|NCT03093662|4048274|FG000|STARTED|Washout Period (5 Minutes)||18
3314910|NCT03093662|4048275|FG001|STARTED|Washout Period (5 Minutes)||19
3314911|NCT03093662|4048274|FG000|COMPLETED|Washout Period (5 Minutes)||18
3314912|NCT03093662|4048275|FG001|COMPLETED|Washout Period (5 Minutes)||19
3314913|NCT03093662|4048274|FG000|NOT COMPLETED|Washout Period (5 Minutes)||0
3314914|NCT03093662|4048275|FG001|NOT COMPLETED|Washout Period (5 Minutes)||0
3314915|NCT03093662|4048274|FG000|STARTED|Second Intervention (3 Minutes)||18
3314916|NCT03093662|4048275|FG001|STARTED|Second Intervention (3 Minutes)||19
3314917|NCT03093662|4048274|FG000|COMPLETED|Second Intervention (3 Minutes)||18
3314918|NCT03093662|4048275|FG001|COMPLETED|Second Intervention (3 Minutes)||19
3314919|NCT03093662|4048274|FG000|NOT COMPLETED|Second Intervention (3 Minutes)||0
3314920|NCT03093662|4048275|FG001|NOT COMPLETED|Second Intervention (3 Minutes)||0
3314921|NCT03093870|4048284|FG000|STARTED|Overall Study||24
3314922|NCT03093870|4048285|FG001|STARTED|Overall Study||64
3314923|NCT03093870|4048286|FG002|STARTED|Overall Study||63
2896359|NCT00397046|3603876|FG002|NOT COMPLETED|Overall Study||10
3314924|NCT03093870|4048284|FG000|COMPLETED|Overall Study||0
3314925|NCT03093870|4048285|FG001|COMPLETED|Overall Study||23
2896360|NCT00397046|3603877|FG003|NOT COMPLETED|Overall Study||5
2896361|NCT00397150|3603890|FG000|STARTED|Overall Study||1323
2896362|NCT00397150|3603891|FG001|STARTED|Overall Study||1256
2896363|NCT00397150|3603890|FG000|COMPLETED|Overall Study||1188
2896364|NCT00397150|3603891|FG001|COMPLETED|Overall Study||1111
2896365|NCT00397150|3603890|FG000|NOT COMPLETED|Overall Study||135
2896366|NCT00397150|3603891|FG001|NOT COMPLETED|Overall Study||145
2896367|NCT00397189|3603899|FG000|STARTED|3 Weeks Period||394
2896368|NCT00397189|3603900|FG001|STARTED|3 Weeks Period||395
2896369|NCT00397189|3603899|FG000|COMPLETED|3 Weeks Period|out of 373, 360 were included in the ITT population detailed in the Baseline Characteristics.|373
2896370|NCT00397189|3603900|FG001|COMPLETED|3 Weeks Period|out of 373, 362 were included in the ITT population detailed in the Baseline Characteristics|373
2896371|NCT00397189|3603899|FG000|NOT COMPLETED|3 Weeks Period||21
2896372|NCT00397189|3603900|FG001|NOT COMPLETED|3 Weeks Period||22
2896373|NCT00397189|3603899|FG000|STARTED|Extension Period|Not all completers continued to extension as only patients who wished to proceed were randomized.|534
2896374|NCT00397189|3603900|FG001|STARTED|Extension Period|Please note randomization ratio in extension is 3:1|177
3170795|NCT01931059|3898050|FG001|COMPLETED|Day2||4
3170796|NCT01931059|3898049|FG000|NOT COMPLETED|Day2||0
3170797|NCT01931059|3898050|FG001|NOT COMPLETED|Day2||0
2896375|NCT00397189|3603899|FG000|COMPLETED|Extension Period||421
2896376|NCT00397189|3603900|FG001|COMPLETED|Extension Period||134
2896377|NCT00397189|3603899|FG000|NOT COMPLETED|Extension Period||113
2896378|NCT00397189|3603900|FG001|NOT COMPLETED|Extension Period||43
2896379|NCT00397215|3603912|FG000|STARTED|Month 0 (Day 0)||165
2896380|NCT00397215|3603913|FG001|STARTED|Month 0 (Day 0)||61
2896381|NCT00397215|3603914|FG002|STARTED|Month 0 (Day 0)||159
2896382|NCT00397215|3603915|FG003|STARTED|Month 0 (Day 0)||52
2896383|NCT00397215|3603912|FG000|COMPLETED|Month 0 (Day 0)||158
2896384|NCT00397215|3603913|FG001|COMPLETED|Month 0 (Day 0)||56
2896385|NCT00397215|3603914|FG002|COMPLETED|Month 0 (Day 0)||153
2896386|NCT00397215|3603915|FG003|COMPLETED|Month 0 (Day 0)||48
2896387|NCT00397215|3603912|FG000|NOT COMPLETED|Month 0 (Day 0)||7
2896388|NCT00397215|3603913|FG001|NOT COMPLETED|Month 0 (Day 0)||5
2896389|NCT00397215|3603914|FG002|NOT COMPLETED|Month 0 (Day 0)||6
2896390|NCT00397215|3603915|FG003|NOT COMPLETED|Month 0 (Day 0)||4
2896391|NCT00397215|3603912|FG000|STARTED|Month 6 (Day 180)||164
2896392|NCT00397215|3603913|FG001|STARTED|Month 6 (Day 180)||58
2896393|NCT00397215|3603914|FG002|STARTED|Month 6 (Day 180)||158
2896394|NCT00397215|3603915|FG003|STARTED|Month 6 (Day 180)||51
2896395|NCT00397215|3603912|FG000|COMPLETED|Month 6 (Day 180)||162
2896396|NCT00397215|3603913|FG001|COMPLETED|Month 6 (Day 180)||55
2896397|NCT00397215|3603914|FG002|COMPLETED|Month 6 (Day 180)||153
2896398|NCT00397215|3603915|FG003|COMPLETED|Month 6 (Day 180)||51
2896399|NCT00397215|3603912|FG000|NOT COMPLETED|Month 6 (Day 180)||2
2896400|NCT00397215|3603913|FG001|NOT COMPLETED|Month 6 (Day 180)||3
2896401|NCT00397215|3603914|FG002|NOT COMPLETED|Month 6 (Day 180)||5
2896402|NCT00397215|3603915|FG003|NOT COMPLETED|Month 6 (Day 180)||0
2896403|NCT00397215|3603912|FG000|STARTED|Month 12 (Day 360)||130
2896404|NCT00397215|3603913|FG001|STARTED|Month 12 (Day 360)||48
2896405|NCT00397215|3603914|FG002|STARTED|Month 12 (Day 360)||125
2896406|NCT00397215|3603915|FG003|STARTED|Month 12 (Day 360)||42
2896407|NCT00397215|3603912|FG000|COMPLETED|Month 12 (Day 360)||130
2896408|NCT00397215|3603913|FG001|COMPLETED|Month 12 (Day 360)||48
2896409|NCT00397215|3603914|FG002|COMPLETED|Month 12 (Day 360)||125
2896410|NCT00397215|3603915|FG003|COMPLETED|Month 12 (Day 360)||42
2896411|NCT00397215|3603912|FG000|NOT COMPLETED|Month 12 (Day 360)||0
2896412|NCT00397215|3603913|FG001|NOT COMPLETED|Month 12 (Day 360)||0
2896413|NCT00397215|3603914|FG002|NOT COMPLETED|Month 12 (Day 360)||0
2896414|NCT00397215|3603915|FG003|NOT COMPLETED|Month 12 (Day 360)||0
2896415|NCT00397215|3603912|FG000|STARTED|Month 24 (Day 720)||122
2896416|NCT00397215|3603913|FG001|STARTED|Month 24 (Day 720)||45
2896417|NCT00397215|3603914|FG002|STARTED|Month 24 (Day 720)||117
2896418|NCT00397215|3603915|FG003|STARTED|Month 24 (Day 720)||36
2896419|NCT00397215|3603912|FG000|COMPLETED|Month 24 (Day 720)||122
2896420|NCT00397215|3603913|FG001|COMPLETED|Month 24 (Day 720)||45
2896421|NCT00397215|3603914|FG002|COMPLETED|Month 24 (Day 720)||117
2896422|NCT00397215|3603915|FG003|COMPLETED|Month 24 (Day 720)||36
2896423|NCT00397215|3603912|FG000|NOT COMPLETED|Month 24 (Day 720)||0
2896424|NCT00397215|3603913|FG001|NOT COMPLETED|Month 24 (Day 720)||0
2896425|NCT00397215|3603914|FG002|NOT COMPLETED|Month 24 (Day 720)||0
2896426|NCT00397215|3603915|FG003|NOT COMPLETED|Month 24 (Day 720)||0
2896427|NCT00397462|3603931|FG000|STARTED|Overall Study||16
2896428|NCT00397462|3603932|FG001|STARTED|Overall Study||13
2896429|NCT00397462|3603933|FG002|STARTED|Overall Study||15
2896430|NCT00397462|3603931|FG000|COMPLETED|Overall Study||16
2896431|NCT00397462|3603932|FG001|COMPLETED|Overall Study||13
2896432|NCT00397462|3603933|FG002|COMPLETED|Overall Study||15
2896433|NCT00397462|3603931|FG000|NOT COMPLETED|Overall Study||0
2896434|NCT00397462|3603932|FG001|NOT COMPLETED|Overall Study||0
2896435|NCT00397462|3603933|FG002|NOT COMPLETED|Overall Study||0
2896436|NCT00397488|3603941|FG000|STARTED|Overall Study||78
2896437|NCT00397488|3603941|FG000|COMPLETED|Overall Study||71
2896438|NCT00397488|3603941|FG000|NOT COMPLETED|Overall Study||7
2896439|NCT00397514|3603945|FG000|STARTED|Overall Study||34
2896440|NCT00397514|3603945|FG000|COMPLETED|Overall Study||25
2896441|NCT00397514|3603945|FG000|NOT COMPLETED|Overall Study||9
2896442|NCT00397540|3603957|FG000|STARTED|Overall Study||60
2896443|NCT00397540|3603958|FG001|STARTED|Overall Study||85
2896444|NCT00397540|3603957|FG000|COMPLETED|Overall Study||59
3314926|NCT03093870|4048286|FG002|COMPLETED|Overall Study||22
2896445|NCT00397540|3603958|FG001|COMPLETED|Overall Study||85
3170798|NCT01931059|3898049|FG000|STARTED|Day3||6
2896446|NCT00397540|3603957|FG000|NOT COMPLETED|Overall Study||1
2896447|NCT00397540|3603958|FG001|NOT COMPLETED|Overall Study||0
2896448|NCT00397579|3603965|FG000|STARTED|Overall Study||11
2896449|NCT00397579|3603965|FG000|COMPLETED|Overall Study||11
2896450|NCT00397579|3603965|FG000|NOT COMPLETED|Overall Study||0
2896451|NCT00397631|3603971|FG000|STARTED|Overall Study|Randomization ratio was 1:1|261
2896452|NCT00397631|3603972|FG001|STARTED|Overall Study||259
2896453|NCT00397631|3603971|FG000|COMPLETED|Overall Study||231
2896454|NCT00397631|3603972|FG001|COMPLETED|Overall Study||215
2896455|NCT00397631|3603971|FG000|NOT COMPLETED|Overall Study||30
2896456|NCT00397631|3603972|FG001|NOT COMPLETED|Overall Study||44
2896457|NCT00397813|3603984|FG000|STARTED|Overall Study||36
2896458|NCT00397813|3603985|FG001|STARTED|Overall Study||0
2896459|NCT00397813|3603986|FG002|STARTED|Overall Study||0
2896460|NCT00397813|3603987|FG003|STARTED|Overall Study||12
2896461|NCT00397813|3603988|FG004|STARTED|Overall Study||5
2896462|NCT00397813|3603989|FG005|STARTED|Overall Study||24
2896463|NCT00397813|3603984|FG000|COMPLETED|Overall Study||36
2896464|NCT00397813|3603985|FG001|COMPLETED|Overall Study||0
2896465|NCT00397813|3603986|FG002|COMPLETED|Overall Study||0
2896466|NCT00397813|3603987|FG003|COMPLETED|Overall Study||12
2896467|NCT00397813|3603988|FG004|COMPLETED|Overall Study||5
2896468|NCT00397813|3603989|FG005|COMPLETED|Overall Study||24
2896469|NCT00397813|3603984|FG000|NOT COMPLETED|Overall Study||0
2896470|NCT00397813|3603985|FG001|NOT COMPLETED|Overall Study||0
2896471|NCT00397813|3603986|FG002|NOT COMPLETED|Overall Study||0
3170799|NCT01931059|3898050|FG001|STARTED|Day3||4
3170800|NCT01931059|3898049|FG000|COMPLETED|Day3||5
3170801|NCT01931059|3898050|FG001|COMPLETED|Day3||4
3170802|NCT01931059|3898049|FG000|NOT COMPLETED|Day3||1
3170803|NCT01931059|3898050|FG001|NOT COMPLETED|Day3||0
2896472|NCT00397813|3603987|FG003|NOT COMPLETED|Overall Study||0
2896473|NCT00397813|3603988|FG004|NOT COMPLETED|Overall Study||0
2896474|NCT00397813|3603989|FG005|NOT COMPLETED|Overall Study||0
2896475|NCT00397839|3604005|FG000|STARTED|Overall Study||48
2896476|NCT00397839|3604006|FG001|STARTED|Overall Study||87
2896477|NCT00397839|3604005|FG000|COMPLETED|Overall Study||41
2896478|NCT00397839|3604006|FG001|COMPLETED|Overall Study||69
2896479|NCT00397839|3604005|FG000|NOT COMPLETED|Overall Study||7
2896480|NCT00397839|3604006|FG001|NOT COMPLETED|Overall Study||18
2896481|NCT00397878|3604012|FG000|STARTED|Overall Study||10
2896482|NCT00397878|3604012|FG000|COMPLETED|Overall Study||10
2896483|NCT00397878|3604012|FG000|NOT COMPLETED|Overall Study||0
2896484|NCT00397891|3604021|FG000|STARTED|Overall Study||6
2896485|NCT00397891|3604022|FG001|STARTED|Overall Study||6
2896486|NCT00397891|3604023|FG002|STARTED|Overall Study||6
2896487|NCT00397891|3604024|FG003|STARTED|Overall Study||6
2896488|NCT00397891|3604025|FG004|STARTED|Overall Study||8
2896489|NCT00397891|3604021|FG000|COMPLETED|Overall Study||5
2896490|NCT00397891|3604022|FG001|COMPLETED|Overall Study||6
2896491|NCT00397891|3604023|FG002|COMPLETED|Overall Study||6
2896492|NCT00397891|3604024|FG003|COMPLETED|Overall Study||6
2896493|NCT00397891|3604025|FG004|COMPLETED|Overall Study||7
2896494|NCT00397891|3604021|FG000|NOT COMPLETED|Overall Study||1
2896495|NCT00397891|3604022|FG001|NOT COMPLETED|Overall Study||0
2896496|NCT00397891|3604023|FG002|NOT COMPLETED|Overall Study||0
2896497|NCT00397891|3604024|FG003|NOT COMPLETED|Overall Study||0
2896498|NCT00397891|3604025|FG004|NOT COMPLETED|Overall Study||1
2896499|NCT00397904|3604037|FG000|STARTED|Overall Study||16
2896500|NCT00397904|3604037|FG000|COMPLETED|Overall Study||16
2896501|NCT00397904|3604037|FG000|NOT COMPLETED|Overall Study||0
2896502|NCT00397930|3604043|FG000|STARTED|Overall Study||206
2896503|NCT00397930|3604044|FG001|STARTED|Overall Study||204
2896504|NCT00397930|3604043|FG000|COMPLETED|Overall Study||168
2896505|NCT00397930|3604044|FG001|COMPLETED|Overall Study||153
2896506|NCT00397930|3604043|FG000|NOT COMPLETED|Overall Study||38
2896507|NCT00397930|3604044|FG001|NOT COMPLETED|Overall Study||51
2896508|NCT00397943|3604055|FG000|STARTED|Overall Study||40
2896509|NCT00397943|3604056|FG001|STARTED|Overall Study||40
2896510|NCT00397943|3604057|FG002|STARTED|Overall Study||10
2896511|NCT00397943|3604058|FG003|STARTED|Overall Study||10
2896512|NCT00397943|3604059|FG004|STARTED|Overall Study||10
2896513|NCT00397943|3604055|FG000|COMPLETED|Overall Study||28
2896514|NCT00397943|3604056|FG001|COMPLETED|Overall Study||31
2896515|NCT00397943|3604057|FG002|COMPLETED|Overall Study||10
2896516|NCT00397943|3604058|FG003|COMPLETED|Overall Study||10
2896517|NCT00397943|3604059|FG004|COMPLETED|Overall Study||10
2896518|NCT00397943|3604055|FG000|NOT COMPLETED|Overall Study||12
2896519|NCT00397943|3604056|FG001|NOT COMPLETED|Overall Study||9
2896520|NCT00397943|3604057|FG002|NOT COMPLETED|Overall Study||0
2896521|NCT00397943|3604058|FG003|NOT COMPLETED|Overall Study||0
2896522|NCT00397943|3604059|FG004|NOT COMPLETED|Overall Study||0
2896523|NCT00397982|3604071|FG000|STARTED|Overall Study||17
2896524|NCT00397982|3604071|FG000|COMPLETED|Overall Study||13
2896525|NCT00397982|3604071|FG000|NOT COMPLETED|Overall Study||4
2896526|NCT00398047|3604076|FG000|STARTED|Overall Study||3
2896527|NCT00398047|3604076|FG000|COMPLETED|Overall Study|all three patients progressed before completing|0
2896528|NCT00398047|3604076|FG000|NOT COMPLETED|Overall Study||3
2896529|NCT00398073|3604083|FG000|STARTED|Overall Study||18
2896530|NCT00398073|3604084|FG001|STARTED|Overall Study||17
2896531|NCT00398073|3604083|FG000|COMPLETED|Overall Study||17
2896532|NCT00398073|3604084|FG001|COMPLETED|Overall Study||17
2896533|NCT00398073|3604083|FG000|NOT COMPLETED|Overall Study||1
2896534|NCT00398073|3604084|FG001|NOT COMPLETED|Overall Study||0
2896535|NCT00398086|3604093|FG000|STARTED|Overall Study||20
2896536|NCT00398086|3604094|FG001|STARTED|Overall Study||44
2896537|NCT00398086|3604095|FG002|STARTED|Overall Study||3
2896538|NCT00398086|3604093|FG000|Phase 1, Dose Escalation Population|Overall Study||20
2896539|NCT00398086|3604094|FG001|Phase 1, Dose Escalation Population|Overall Study||7
2896540|NCT00398086|3604095|FG002|Phase 1, Dose Escalation Population|Overall Study||3
2896541|NCT00398086|3604093|FG000|COMPLETED|Overall Study|Completed defined as discontinuation due to progressive disease.|11
2896542|NCT00398086|3604094|FG001|COMPLETED|Overall Study|Completed defined as discontinuation due to progressive disease.|21
2896543|NCT00398086|3604095|FG002|COMPLETED|Overall Study|Completed defined as discontinuation due to progressive disease.|1
2896544|NCT00398086|3604093|FG000|NOT COMPLETED|Overall Study||9
2896545|NCT00398086|3604094|FG001|NOT COMPLETED|Overall Study||23
2896546|NCT00398086|3604095|FG002|NOT COMPLETED|Overall Study||2
2896547|NCT00398112|3604103|FG000|STARTED|Overall Study||18
2896548|NCT00398112|3604103|FG000|COMPLETED|Overall Study||0
2896549|NCT00398112|3604103|FG000|NOT COMPLETED|Overall Study||18
2896550|NCT00398138|3604107|FG000|STARTED|Overall Study||12
2896551|NCT00398138|3604107|FG000|COMPLETED|Overall Study||10
2896552|NCT00398138|3604107|FG000|NOT COMPLETED|Overall Study||2
2896553|NCT00398216|3604116|FG000|STARTED|Overall Study||192
2896554|NCT00398216|3604117|FG001|STARTED|Overall Study||170
2896555|NCT00398216|3604118|FG002|STARTED|Overall Study||185
2896556|NCT00398216|3604119|FG003|STARTED|Overall Study||177
2896557|NCT00398216|3604120|FG004|STARTED|Overall Study||172
2896558|NCT00398216|3604116|FG000|COMPLETED|Overall Study||181
2896559|NCT00398216|3604117|FG001|COMPLETED|Overall Study||151
2896560|NCT00398216|3604118|FG002|COMPLETED|Overall Study||164
2896561|NCT00398216|3604119|FG003|COMPLETED|Overall Study||155
2896562|NCT00398216|3604120|FG004|COMPLETED|Overall Study||157
2896563|NCT00398216|3604116|FG000|NOT COMPLETED|Overall Study||11
2896564|NCT00398216|3604117|FG001|NOT COMPLETED|Overall Study||19
2896565|NCT00398216|3604118|FG002|NOT COMPLETED|Overall Study||21
2896566|NCT00398216|3604119|FG003|NOT COMPLETED|Overall Study||22
2896567|NCT00398216|3604120|FG004|NOT COMPLETED|Overall Study||15
2896568|NCT00398320|3604132|FG000|STARTED|Overall Study||40
2896569|NCT00398320|3604132|FG000|COMPLETED|Overall Study||34
2896570|NCT00398320|3604132|FG000|NOT COMPLETED|Overall Study||6
2896571|NCT00398398|3604136|FG000|STARTED|Overall Study||44
2896572|NCT00398398|3604136|FG000|COMPLETED|Overall Study||44
2896573|NCT00398398|3604136|FG000|NOT COMPLETED|Overall Study||0
2896574|NCT00398411|3604142|FG000|STARTED|Overall Study||34
2896575|NCT00398411|3604143|FG001|STARTED|Overall Study||32
2896576|NCT00398411|3604142|FG000|COMPLETED|Overall Study||34
2896577|NCT00398411|3604143|FG001|COMPLETED|Overall Study||31
3170804|NCT01931150|3898064|FG000|STARTED|Overall Study||5
3170805|NCT01931150|3898065|FG001|STARTED|Overall Study||6
3170806|NCT01931150|3898064|FG000|COMPLETED|Overall Study||4
3170807|NCT01931150|3898065|FG001|COMPLETED|Overall Study||4
3170808|NCT01931150|3898064|FG000|NOT COMPLETED|Overall Study||1
3170809|NCT01931150|3898065|FG001|NOT COMPLETED|Overall Study||2
3170810|NCT01931163|3898071|FG000|STARTED|Overall Study||22
3170811|NCT01931163|3898071|FG000|COMPLETED|Overall Study||22
3170812|NCT01931163|3898071|FG000|NOT COMPLETED|Overall Study||0
3170813|NCT01931202|3898078|FG000|STARTED|Overall Study||8
3170814|NCT01931202|3898079|FG001|STARTED|Overall Study||51
3170815|NCT01931202|3898080|FG002|STARTED|Overall Study||49
3170816|NCT01931202|3898078|FG000|COMPLETED|Overall Study||8
3170817|NCT01931202|3898079|FG001|COMPLETED|Overall Study||46
3170818|NCT01931202|3898080|FG002|COMPLETED|Overall Study||45
3170819|NCT01931202|3898078|FG000|NOT COMPLETED|Overall Study||0
3170820|NCT01931202|3898079|FG001|NOT COMPLETED|Overall Study||5
2896578|NCT00398411|3604142|FG000|NOT COMPLETED|Overall Study||0
2896579|NCT00398411|3604143|FG001|NOT COMPLETED|Overall Study||1
2896580|NCT00398476|3604149|FG000|STARTED|Treatment Period 1||63
2896581|NCT00398476|3604150|FG001|STARTED|Treatment Period 1||64
2896582|NCT00398476|3604149|FG000|COMPLETED|Treatment Period 1||63
2896583|NCT00398476|3604150|FG001|COMPLETED|Treatment Period 1||64
2896584|NCT00398476|3604149|FG000|NOT COMPLETED|Treatment Period 1||0
2896585|NCT00398476|3604150|FG001|NOT COMPLETED|Treatment Period 1||0
2896586|NCT00398476|3604149|FG000|STARTED|Washout Period (20 Minutes)||63
2896587|NCT00398476|3604150|FG001|STARTED|Washout Period (20 Minutes)||64
2896588|NCT00398476|3604149|FG000|COMPLETED|Washout Period (20 Minutes)||63
2896589|NCT00398476|3604150|FG001|COMPLETED|Washout Period (20 Minutes)||64
2896590|NCT00398476|3604149|FG000|NOT COMPLETED|Washout Period (20 Minutes)||0
2896591|NCT00398476|3604150|FG001|NOT COMPLETED|Washout Period (20 Minutes)||0
2896592|NCT00398476|3604149|FG000|STARTED|Treatment Period 2||63
2896593|NCT00398476|3604150|FG001|STARTED|Treatment Period 2||64
2896594|NCT00398476|3604149|FG000|COMPLETED|Treatment Period 2||63
2896595|NCT00398476|3604150|FG001|COMPLETED|Treatment Period 2||64
2896596|NCT00398476|3604149|FG000|NOT COMPLETED|Treatment Period 2||0
2896597|NCT00398476|3604150|FG001|NOT COMPLETED|Treatment Period 2||0
2896598|NCT00398567|3604161|FG000|STARTED|Overall Study||4
2896599|NCT00398567|3604162|FG001|STARTED|Overall Study||4
2896600|NCT00398567|3604163|FG002|STARTED|Overall Study||37
2896601|NCT00398567|3604161|FG000|COMPLETED|Overall Study||0
2896602|NCT00398567|3604162|FG001|COMPLETED|Overall Study||0
2896603|NCT00398567|3604163|FG002|COMPLETED|Overall Study||3
2896604|NCT00398567|3604161|FG000|NOT COMPLETED|Overall Study||4
3170821|NCT01931202|3898080|FG002|NOT COMPLETED|Overall Study||4
2896605|NCT00398567|3604162|FG001|NOT COMPLETED|Overall Study||4
2896606|NCT00398567|3604163|FG002|NOT COMPLETED|Overall Study||34
2896607|NCT00398632|3604169|FG000|STARTED|Overall Study||6
2896608|NCT00398632|3604169|FG000|COMPLETED|Overall Study|2/6 subjects withdrew at end of week 6; 1 for lack of efficacy, 1 because of time constraints.|4
2896609|NCT00398632|3604169|FG000|NOT COMPLETED|Overall Study||2
2896610|NCT00398866|3604177|FG000|STARTED|Overall Study||66
2896611|NCT00398866|3604178|FG001|STARTED|Overall Study||68
2896612|NCT00398866|3604179|FG002|STARTED|Overall Study||66
2896613|NCT00398866|3604177|FG000|COMPLETED|Overall Study||52
2896614|NCT00398866|3604178|FG001|COMPLETED|Overall Study||60
2896615|NCT00398866|3604179|FG002|COMPLETED|Overall Study||58
2896616|NCT00398866|3604177|FG000|NOT COMPLETED|Overall Study||14
2896617|NCT00398866|3604178|FG001|NOT COMPLETED|Overall Study||8
2896618|NCT00398866|3604179|FG002|NOT COMPLETED|Overall Study||8
2896619|NCT00398918|3604188|FG000|STARTED|Overall Study||10
2896620|NCT00398918|3604188|FG000|COMPLETED|Overall Study||10
2896621|NCT00398918|3604188|FG000|NOT COMPLETED|Overall Study||0
2896622|NCT00398983|3604194|FG000|STARTED|Overall Study||20
2896623|NCT00398983|3604195|FG001|STARTED|Overall Study||25
2896624|NCT00398983|3604194|FG000|COMPLETED|Overall Study||20
2896625|NCT00398983|3604195|FG001|COMPLETED|Overall Study||25
2896626|NCT00398983|3604194|FG000|NOT COMPLETED|Overall Study||0
2896627|NCT00398983|3604195|FG001|NOT COMPLETED|Overall Study||0
2896628|NCT00399035|3604204|FG000|STARTED|Overall Study||502
2896629|NCT00399035|3604205|FG001|STARTED|Overall Study||216
2896630|NCT00399035|3604206|FG002|STARTED|Overall Study||358
2896631|NCT00399035|3604204|FG000|COMPLETED|Overall Study||189
2896632|NCT00399035|3604205|FG001|COMPLETED|Overall Study||58
2896633|NCT00399035|3604206|FG002|COMPLETED|Overall Study||106
2896634|NCT00399035|3604204|FG000|NOT COMPLETED|Overall Study||313
2896635|NCT00399035|3604205|FG001|NOT COMPLETED|Overall Study||158
2896636|NCT00399035|3604206|FG002|NOT COMPLETED|Overall Study||252
2896637|NCT00399308|3604216|FG000|STARTED|Overall Study||13
2896638|NCT00399308|3604217|FG001|STARTED|Overall Study||15
2896639|NCT00399308|3604218|FG002|STARTED|Overall Study||12
2896640|NCT00399308|3604216|FG000|COMPLETED|Overall Study||13
2896641|NCT00399308|3604217|FG001|COMPLETED|Overall Study||15
2896642|NCT00399308|3604218|FG002|COMPLETED|Overall Study|One patient withdrew: did not want to comply with study requirements|11
2896643|NCT00399308|3604216|FG000|NOT COMPLETED|Overall Study||0
2896644|NCT00399308|3604217|FG001|NOT COMPLETED|Overall Study||0
2896645|NCT00399308|3604218|FG002|NOT COMPLETED|Overall Study||1
2896646|NCT00399360|3604230|FG000|STARTED|Overall Study||11
2896647|NCT00399360|3604231|FG001|STARTED|Overall Study||11
2896648|NCT00399360|3604232|FG002|STARTED|Overall Study||13
2896649|NCT00399360|3604233|FG003|STARTED|Overall Study||15
2896650|NCT00399360|3604230|FG000|COMPLETED|Overall Study||9
2896651|NCT00399360|3604231|FG001|COMPLETED|Overall Study||8
2896652|NCT00399360|3604232|FG002|COMPLETED|Overall Study||10
2896653|NCT00399360|3604233|FG003|COMPLETED|Overall Study||9
2896654|NCT00399360|3604230|FG000|NOT COMPLETED|Overall Study||2
2896655|NCT00399360|3604231|FG001|NOT COMPLETED|Overall Study||3
2896656|NCT00399360|3604232|FG002|NOT COMPLETED|Overall Study||3
2896657|NCT00399360|3604233|FG003|NOT COMPLETED|Overall Study||6
2896658|NCT00399490|3604248|FG000|STARTED|Overall Study||281
2896659|NCT00399490|3604248|FG000|COMPLETED|Overall Study||183
2896660|NCT00399490|3604248|FG000|NOT COMPLETED|Overall Study||98
2896661|NCT00399516|3604254|FG000|STARTED|Overall Study||21
2896662|NCT00399516|3604254|FG000|COMPLETED|Overall Study||19
2896663|NCT00399516|3604254|FG000|NOT COMPLETED|Overall Study||2
2896664|NCT00399529|3604258|FG000|STARTED|Overall Study||22
2896665|NCT00399529|3604258|FG000|COMPLETED|Overall Study||20
2896666|NCT00399529|3604258|FG000|NOT COMPLETED|Overall Study||2
2896667|NCT00399542|3604265|FG000|STARTED|Overall Study||387
2896668|NCT00399542|3604266|FG001|STARTED|Overall Study||194
2896669|NCT00399542|3604265|FG000|COMPLETED|Overall Study||303
2896670|NCT00399542|3604266|FG001|COMPLETED|Overall Study||151
2896671|NCT00399542|3604265|FG000|NOT COMPLETED|Overall Study||84
2896672|NCT00399542|3604266|FG001|NOT COMPLETED|Overall Study||43
2896673|NCT00399568|3604274|FG000|STARTED|Overall Study||166
2896674|NCT00399568|3604275|FG001|STARTED|Overall Study||165
2896675|NCT00399568|3604274|FG000|COMPLETED|Overall Study||154
2896676|NCT00399568|3604275|FG001|COMPLETED|Overall Study||156
2896677|NCT00399568|3604274|FG000|NOT COMPLETED|Overall Study||12
2896678|NCT00399568|3604275|FG001|NOT COMPLETED|Overall Study||9
2896679|NCT00399763|3604285|FG000|STARTED|Overall Study||35
2896680|NCT00399763|3604286|FG001|STARTED|Overall Study||35
2896681|NCT00399763|3604285|FG000|COMPLETED|Overall Study||33
2896682|NCT00399763|3604286|FG001|COMPLETED|Overall Study||32
2896683|NCT00399763|3604285|FG000|NOT COMPLETED|Overall Study||2
2896684|NCT00399763|3604286|FG001|NOT COMPLETED|Overall Study||3
2896685|NCT00399802|3604294|FG000|STARTED|Overall Study||14
2896686|NCT00399802|3604295|FG001|STARTED|Overall Study||29
2896687|NCT00399802|3604294|FG000|COMPLETED|Overall Study||14
2896688|NCT00399802|3604295|FG001|COMPLETED|Overall Study||26
2896689|NCT00399802|3604294|FG000|NOT COMPLETED|Overall Study||0
2896690|NCT00399802|3604295|FG001|NOT COMPLETED|Overall Study||3
2896691|NCT00399880|3604303|FG000|STARTED|Overall Study||65
2896692|NCT00399880|3604304|FG001|STARTED|Overall Study||65
2896693|NCT00399880|3604303|FG000|COMPLETED|Overall Study||65
2896694|NCT00399880|3604304|FG001|COMPLETED|Overall Study||65
2896695|NCT00399880|3604303|FG000|NOT COMPLETED|Overall Study||0
2896696|NCT00399880|3604304|FG001|NOT COMPLETED|Overall Study||0
2896697|NCT00399893|3604312|FG000|STARTED|Overall Study||2
2896698|NCT00399893|3604313|FG001|STARTED|Overall Study||3
2896699|NCT00399893|3604312|FG000|COMPLETED|Overall Study|Participant withdrew after 3 months but was included in results|1
2896700|NCT00399893|3604313|FG001|COMPLETED|Overall Study||3
2896701|NCT00399893|3604312|FG000|NOT COMPLETED|Overall Study||1
2896702|NCT00399893|3604313|FG001|NOT COMPLETED|Overall Study||0
2896703|NCT00400153|3604322|FG000|STARTED|Overall Study||486
2896704|NCT00400153|3604323|FG001|STARTED|Overall Study||491
2896705|NCT00400153|3604324|FG002|STARTED|Overall Study||483
2896706|NCT00400153|3604322|FG000|COMPLETED|Overall Study||438
2896707|NCT00400153|3604323|FG001|COMPLETED|Overall Study||436
2896708|NCT00400153|3604324|FG002|COMPLETED|Overall Study||422
2896709|NCT00400153|3604322|FG000|NOT COMPLETED|Overall Study||48
2896710|NCT00400153|3604323|FG001|NOT COMPLETED|Overall Study||55
2896711|NCT00400153|3604324|FG002|NOT COMPLETED|Overall Study||61
2896712|NCT00400179|3604339|FG000|STARTED|Overall Study|Signed informed consent form and randomized|527
2896713|NCT00400179|3604340|FG001|STARTED|Overall Study||526
2896714|NCT00400179|3604339|FG000|COMPLETED|Overall Study|Received Treatment|521
2896715|NCT00400179|3604340|FG001|COMPLETED|Overall Study||508
2896716|NCT00400179|3604339|FG000|NOT COMPLETED|Overall Study||6
2896717|NCT00400179|3604340|FG001|NOT COMPLETED|Overall Study||18
2896718|NCT00400205|3604346|FG000|STARTED|Overall Study||14
2896719|NCT00400205|3604346|FG000|COMPLETED|Overall Study||9
2896720|NCT00400205|3604346|FG000|NOT COMPLETED|Overall Study||5
2896721|NCT00400400|3604353|FG000|STARTED|Overall Study||200
2896722|NCT00400400|3604354|FG001|STARTED|Overall Study||200
2896723|NCT00400400|3604353|FG000|Intent-to-Treat Population|Overall Study|Participants who received study drug.|199
2896724|NCT00400400|3604354|FG001|Intent-to-Treat Population|Overall Study||197
2896725|NCT00400400|3604353|FG000|COMPLETED|Overall Study||186
2896726|NCT00400400|3604354|FG001|COMPLETED|Overall Study||185
2896727|NCT00400400|3604353|FG000|NOT COMPLETED|Overall Study||14
2896728|NCT00400400|3604354|FG001|NOT COMPLETED|Overall Study||15
2896729|NCT00400439|3604362|FG000|STARTED|Overall Study||52
2896730|NCT00400439|3604363|FG001|STARTED|Overall Study||25
2896731|NCT00400439|3604362|FG000|COMPLETED|Overall Study||47
2896732|NCT00400439|3604363|FG001|COMPLETED|Overall Study||23
2896733|NCT00400439|3604362|FG000|NOT COMPLETED|Overall Study||5
2896734|NCT00400439|3604363|FG001|NOT COMPLETED|Overall Study||2
2896735|NCT00400517|3604369|FG000|STARTED|Overall Study|1 pt w/d consent. 1 pt found to have unresectable dx at time of sx and is exc. in tissue analysis.|28
2896736|NCT00400517|3604369|FG000|COMPLETED|Overall Study||26
2896737|NCT00400517|3604369|FG000|NOT COMPLETED|Overall Study||2
2896738|NCT00400569|3604373|FG000|STARTED|Overall Study||48
2896739|NCT00400569|3604373|FG000|COMPLETED|Overall Study||47
2896740|NCT00400569|3604373|FG000|NOT COMPLETED|Overall Study||1
2896741|NCT00400634|3604382|FG000|STARTED|Overall Study||38
2896742|NCT00400634|3604383|FG001|STARTED|Overall Study||20
2896743|NCT00400634|3604382|FG000|COMPLETED|Overall Study||34
2896744|NCT00400634|3604383|FG001|COMPLETED|Overall Study||19
2896745|NCT00400634|3604382|FG000|NOT COMPLETED|Overall Study||4
2896746|NCT00400634|3604383|FG001|NOT COMPLETED|Overall Study||1
2896747|NCT00400686|3604389|FG000|STARTED|Overall Study||31
2896748|NCT00400686|3604389|FG000|COMPLETED|Overall Study||31
3314927|NCT03093870|4048284|FG000|NOT COMPLETED|Overall Study||24
3314928|NCT03093870|4048285|FG001|NOT COMPLETED|Overall Study||41
3314929|NCT03093870|4048286|FG002|NOT COMPLETED|Overall Study||41
3314930|NCT03094195|4048297|FG000|STARTED|Double-Blind Treatment Period (DB)||43
3314931|NCT03094195|4048298|FG001|STARTED|Double-Blind Treatment Period (DB)||43
3314932|NCT03094195|4048299|FG002|STARTED|Double-Blind Treatment Period (DB)||43
3314933|NCT03094195|4048300|FG003|STARTED|Double-Blind Treatment Period (DB)||0
3314934|NCT03094195|4048301|FG004|STARTED|Double-Blind Treatment Period (DB)||0
3314935|NCT03094195|4048302|FG005|STARTED|Double-Blind Treatment Period (DB)||0
3314936|NCT03094195|4048303|FG006|STARTED|Double-Blind Treatment Period (DB)||0
3314937|NCT03094195|4048304|FG007|STARTED|Double-Blind Treatment Period (DB)||0
3314938|NCT03094195|4048297|FG000|COMPLETED|Double-Blind Treatment Period (DB)||28
3314939|NCT03094195|4048298|FG001|COMPLETED|Double-Blind Treatment Period (DB)||30
3314940|NCT03094195|4048299|FG002|COMPLETED|Double-Blind Treatment Period (DB)||29
3314941|NCT03094195|4048300|FG003|COMPLETED|Double-Blind Treatment Period (DB)||0
3314942|NCT03094195|4048301|FG004|COMPLETED|Double-Blind Treatment Period (DB)||0
3314943|NCT03094195|4048302|FG005|COMPLETED|Double-Blind Treatment Period (DB)||0
3314944|NCT03094195|4048303|FG006|COMPLETED|Double-Blind Treatment Period (DB)||0
3314945|NCT03094195|4048304|FG007|COMPLETED|Double-Blind Treatment Period (DB)||0
3314946|NCT03094195|4048297|FG000|NOT COMPLETED|Double-Blind Treatment Period (DB)||15
3314947|NCT03094195|4048298|FG001|NOT COMPLETED|Double-Blind Treatment Period (DB)||13
3314948|NCT03094195|4048299|FG002|NOT COMPLETED|Double-Blind Treatment Period (DB)||14
3314949|NCT03094195|4048300|FG003|NOT COMPLETED|Double-Blind Treatment Period (DB)||0
3314950|NCT03094195|4048301|FG004|NOT COMPLETED|Double-Blind Treatment Period (DB)||0
3314951|NCT03094195|4048302|FG005|NOT COMPLETED|Double-Blind Treatment Period (DB)||0
3314952|NCT03094195|4048303|FG006|NOT COMPLETED|Double-Blind Treatment Period (DB)||0
2896749|NCT00400686|3604389|FG000|NOT COMPLETED|Overall Study||0
2896750|NCT00400712|3604395|FG000|STARTED|Overall Study||52
2896751|NCT00400712|3604396|FG001|STARTED|Overall Study||51
2896752|NCT00400712|3604395|FG000|COMPLETED|Overall Study||35
2896753|NCT00400712|3604396|FG001|COMPLETED|Overall Study||35
2896754|NCT00400712|3604395|FG000|NOT COMPLETED|Overall Study||17
2896755|NCT00400712|3604396|FG001|NOT COMPLETED|Overall Study||16
2896756|NCT00400764|3604409|FG000|STARTED|Phase Ib||6
2896757|NCT00400764|3604410|FG001|STARTED|Phase Ib||6
2896758|NCT00400764|3604411|FG002|STARTED|Phase Ib||0
2896759|NCT00400764|3604412|FG003|STARTED|Phase Ib||0
2896760|NCT00400764|3604413|FG004|STARTED|Phase Ib||0
2896761|NCT00400764|3604409|FG000|Treated|Phase Ib||6
2896762|NCT00400764|3604410|FG001|Treated|Phase Ib||6
2896763|NCT00400764|3604411|FG002|Treated|Phase Ib||0
2896764|NCT00400764|3604412|FG003|Treated|Phase Ib||0
2896765|NCT00400764|3604413|FG004|Treated|Phase Ib||0
2896766|NCT00400764|3604409|FG000|COMPLETED|Phase Ib|One patient reported as discontinued due to an AE should have been reported as death.|0
2896767|NCT00400764|3604410|FG001|COMPLETED|Phase Ib||2
2896768|NCT00400764|3604411|FG002|COMPLETED|Phase Ib||0
2896769|NCT00400764|3604412|FG003|COMPLETED|Phase Ib||0
2896770|NCT00400764|3604413|FG004|COMPLETED|Phase Ib||0
2896771|NCT00400764|3604409|FG000|NOT COMPLETED|Phase Ib||6
2896772|NCT00400764|3604410|FG001|NOT COMPLETED|Phase Ib||4
2896773|NCT00400764|3604411|FG002|NOT COMPLETED|Phase Ib||0
2896774|NCT00400764|3604412|FG003|NOT COMPLETED|Phase Ib||0
2896775|NCT00400764|3604413|FG004|NOT COMPLETED|Phase Ib||0
2896776|NCT00400764|3604409|FG000|STARTED|Phase II||0
2896777|NCT00400764|3604410|FG001|STARTED|Phase II||0
2896778|NCT00400764|3604411|FG002|STARTED|Phase II||23
2896779|NCT00400764|3604412|FG003|STARTED|Phase II||26
2896780|NCT00400764|3604413|FG004|STARTED|Phase II||11
2896781|NCT00400764|3604409|FG000|Treated|Phase II||0
2896782|NCT00400764|3604410|FG001|Treated|Phase II||0
2896783|NCT00400764|3604411|FG002|Treated|Phase II|One patient in the Rituximab arm withdrew prior to treatment|22
2896784|NCT00400764|3604412|FG003|Treated|Phase II||26
2896785|NCT00400764|3604413|FG004|Treated|Phase II||11
2896786|NCT00400764|3604409|FG000|COMPLETED|Phase II||0
2896787|NCT00400764|3604410|FG001|COMPLETED|Phase II||0
2896788|NCT00400764|3604411|FG002|COMPLETED|Phase II||0
2896789|NCT00400764|3604412|FG003|COMPLETED|Phase II||0
2896790|NCT00400764|3604413|FG004|COMPLETED|Phase II||0
2896791|NCT00400764|3604409|FG000|NOT COMPLETED|Phase II||0
2896792|NCT00400764|3604410|FG001|NOT COMPLETED|Phase II||0
2896793|NCT00400764|3604411|FG002|NOT COMPLETED|Phase II||23
2896794|NCT00400764|3604412|FG003|NOT COMPLETED|Phase II||26
2896795|NCT00400764|3604413|FG004|NOT COMPLETED|Phase II||11
2896796|NCT00400803|3604430|FG000|STARTED|Overall Study||35
2896797|NCT00400803|3604430|FG000|COMPLETED|Overall Study||35
2896798|NCT00400803|3604430|FG000|NOT COMPLETED|Overall Study||0
2896799|NCT00400829|3604438|FG000|STARTED|Overall Study||66
2896800|NCT00400829|3604438|FG000|COMPLETED|Overall Study||66
2896801|NCT00400829|3604438|FG000|NOT COMPLETED|Overall Study||0
2896802|NCT00400881|3604444|FG000|STARTED|Overall Study||62
2896803|NCT00400881|3604445|FG001|STARTED|Overall Study||60
2896804|NCT00400881|3604444|FG000|COMPLETED|Overall Study||62
2896805|NCT00400881|3604445|FG001|COMPLETED|Overall Study||60
2896806|NCT00400881|3604444|FG000|NOT COMPLETED|Overall Study||0
2896807|NCT00400881|3604445|FG001|NOT COMPLETED|Overall Study||0
2896808|NCT00400946|3604457|FG000|STARTED|Overall Study||231
2896809|NCT00400946|3604458|FG001|STARTED|Overall Study||232
2896810|NCT00400946|3604459|FG002|STARTED|Overall Study||42
2896811|NCT00400946|3604460|FG003|STARTED|Overall Study||51
2896812|NCT00400946|3604461|FG004|STARTED|Overall Study||244
2896813|NCT00400946|3604457|FG000|Evaluable for CNS Directed-Treatment|Overall Study||231
2896814|NCT00400946|3604458|FG001|Evaluable for CNS Directed-Treatment|Overall Study||232
2896815|NCT00400946|3604459|FG002|Evaluable for CNS Directed-Treatment|Overall Study||42
2896816|NCT00400946|3604460|FG003|Evaluable for CNS Directed-Treatment|Overall Study||21
2896817|NCT00400946|3604461|FG004|Evaluable for CNS Directed-Treatment|Overall Study||227
2896818|NCT00400946|3604457|FG000|Evaluable for Day 18 Marrow Morphology|Overall Study||158
2896819|NCT00400946|3604458|FG001|Evaluable for Day 18 Marrow Morphology|Overall Study||161
2896820|NCT00400946|3604459|FG002|Evaluable for Day 18 Marrow Morphology|Overall Study||19
2896821|NCT00400946|3604460|FG003|Evaluable for Day 18 Marrow Morphology|Overall Study||13
2896822|NCT00400946|3604461|FG004|Evaluable for Day 18 Marrow Morphology|Overall Study||152
2896823|NCT00400946|3604457|FG000|Evaluable for Day 32 MRD|Overall Study||166
2896824|NCT00400946|3604458|FG001|Evaluable for Day 32 MRD|Overall Study||167
2896825|NCT00400946|3604459|FG002|Evaluable for Day 32 MRD|Overall Study||33
2896826|NCT00400946|3604460|FG003|Evaluable for Day 32 MRD|Overall Study||12
2896827|NCT00400946|3604461|FG004|Evaluable for Day 32 MRD|Overall Study||168
2896828|NCT00400946|3604457|FG000|Eligible and Treated|Overall Study||231
2896829|NCT00400946|3604458|FG001|Eligible and Treated|Overall Study||232
2896830|NCT00400946|3604459|FG002|Eligible and Treated|Overall Study||42
2896831|NCT00400946|3604460|FG003|Eligible and Treated|Overall Study||46
2896832|NCT00400946|3604461|FG004|Eligible and Treated|Overall Study||243
2896833|NCT00400946|3604457|FG000|COMPLETED|Overall Study||217
2896834|NCT00400946|3604458|FG001|COMPLETED|Overall Study||221
2896835|NCT00400946|3604459|FG002|COMPLETED|Overall Study||40
2896836|NCT00400946|3604460|FG003|COMPLETED|Overall Study||4
2896837|NCT00400946|3604461|FG004|COMPLETED|Overall Study||206
2896838|NCT00400946|3604457|FG000|NOT COMPLETED|Overall Study||14
2896839|NCT00400946|3604458|FG001|NOT COMPLETED|Overall Study||11
2896840|NCT00400946|3604459|FG002|NOT COMPLETED|Overall Study||2
2896841|NCT00400946|3604460|FG003|NOT COMPLETED|Overall Study||47
2896842|NCT00400946|3604461|FG004|NOT COMPLETED|Overall Study||38
2896843|NCT00400985|3604479|FG000|STARTED|Overall Study||501
2896844|NCT00400985|3604479|FG000|COMPLETED|Overall Study||449
2896845|NCT00400985|3604479|FG000|NOT COMPLETED|Overall Study||52
2896846|NCT00401102|3604483|FG000|STARTED|Overall Study||12
2896847|NCT00401102|3604483|FG000|COMPLETED|Overall Study||5
2896848|NCT00401102|3604483|FG000|NOT COMPLETED|Overall Study||7
2896849|NCT00401193|3604490|FG000|STARTED|Overall Study||118
2896850|NCT00401193|3604491|FG001|STARTED|Overall Study||117
2896851|NCT00401193|3604492|FG002|STARTED|Overall Study||69
2896852|NCT00401193|3604490|FG000|Intent to Treat Population|Overall Study||115
2896853|NCT00401193|3604491|FG001|Intent to Treat Population|Overall Study||115
2896854|NCT00401193|3604492|FG002|Intent to Treat Population|Overall Study||67
2896855|NCT00401193|3604490|FG000|Modified Intent to Treat Population|Overall Study||112
2896856|NCT00401193|3604491|FG001|Modified Intent to Treat Population|Overall Study||115
2896857|NCT00401193|3604492|FG002|Modified Intent to Treat Population|Overall Study||67
2896858|NCT00401193|3604490|FG000|COMPLETED|Overall Study||103
2896859|NCT00401193|3604491|FG001|COMPLETED|Overall Study||106
2896860|NCT00401193|3604492|FG002|COMPLETED|Overall Study||63
2896861|NCT00401193|3604490|FG000|NOT COMPLETED|Overall Study||15
2896862|NCT00401193|3604491|FG001|NOT COMPLETED|Overall Study||11
2896863|NCT00401193|3604492|FG002|NOT COMPLETED|Overall Study||6
2896864|NCT00401245|3604505|FG000|STARTED|Double Blind Titration Phase||126
2896865|NCT00401245|3604506|FG001|STARTED|Double Blind Titration Phase||121
2896866|NCT00401245|3604507|FG002|STARTED|Double Blind Titration Phase||124
2896867|NCT00401245|3604508|FG003|STARTED|Double Blind Titration Phase||122
2896868|NCT00401245|3604509|FG004|STARTED|Double Blind Titration Phase||0
2896869|NCT00401245|3604510|FG005|STARTED|Double Blind Titration Phase||0
2896870|NCT00401245|3604511|FG006|STARTED|Double Blind Titration Phase||0
2896871|NCT00401245|3604512|FG007|STARTED|Double Blind Titration Phase||0
2896872|NCT00401245|3604505|FG000|COMPLETED|Double Blind Titration Phase||122
2896873|NCT00401245|3604506|FG001|COMPLETED|Double Blind Titration Phase||118
2896874|NCT00401245|3604507|FG002|COMPLETED|Double Blind Titration Phase||118
2896875|NCT00401245|3604508|FG003|COMPLETED|Double Blind Titration Phase||107
2896876|NCT00401245|3604509|FG004|COMPLETED|Double Blind Titration Phase||0
2896877|NCT00401245|3604510|FG005|COMPLETED|Double Blind Titration Phase||0
2896878|NCT00401245|3604511|FG006|COMPLETED|Double Blind Titration Phase||0
2896879|NCT00401245|3604512|FG007|COMPLETED|Double Blind Titration Phase||0
2896880|NCT00401245|3604505|FG000|NOT COMPLETED|Double Blind Titration Phase||4
2896881|NCT00401245|3604506|FG001|NOT COMPLETED|Double Blind Titration Phase||3
2896882|NCT00401245|3604507|FG002|NOT COMPLETED|Double Blind Titration Phase||6
2896883|NCT00401245|3604508|FG003|NOT COMPLETED|Double Blind Titration Phase||15
2896884|NCT00401245|3604509|FG004|NOT COMPLETED|Double Blind Titration Phase||0
2896885|NCT00401245|3604510|FG005|NOT COMPLETED|Double Blind Titration Phase||0
2896886|NCT00401245|3604511|FG006|NOT COMPLETED|Double Blind Titration Phase||0
2896887|NCT00401245|3604512|FG007|NOT COMPLETED|Double Blind Titration Phase||0
2896888|NCT00401245|3604505|FG000|STARTED|Between Titration and Open Label Phase||122
2896889|NCT00401245|3604506|FG001|STARTED|Between Titration and Open Label Phase||118
2896890|NCT00401245|3604507|FG002|STARTED|Between Titration and Open Label Phase||118
2896891|NCT00401245|3604508|FG003|STARTED|Between Titration and Open Label Phase||107
2896892|NCT00401245|3604509|FG004|STARTED|Between Titration and Open Label Phase||0
2896893|NCT00401245|3604510|FG005|STARTED|Between Titration and Open Label Phase||0
2896894|NCT00401245|3604511|FG006|STARTED|Between Titration and Open Label Phase||0
2896895|NCT00401245|3604512|FG007|STARTED|Between Titration and Open Label Phase||0
2896896|NCT00401245|3604505|FG000|COMPLETED|Between Titration and Open Label Phase||122
2896897|NCT00401245|3604506|FG001|COMPLETED|Between Titration and Open Label Phase||116
2896898|NCT00401245|3604507|FG002|COMPLETED|Between Titration and Open Label Phase||118
2896899|NCT00401245|3604508|FG003|COMPLETED|Between Titration and Open Label Phase||105
2919942|NCT00534833|3630395|FG000|COMPLETED|Overall Study||182
3314953|NCT03094195|4048304|FG007|NOT COMPLETED|Double-Blind Treatment Period (DB)||0
3314954|NCT03094195|4048297|FG000|STARTED|Treatment Withdrawal Period (TW)||0
3314955|NCT03094195|4048298|FG001|STARTED|Treatment Withdrawal Period (TW)||0
3314956|NCT03094195|4048299|FG002|STARTED|Treatment Withdrawal Period (TW)||0
3314957|NCT03094195|4048300|FG003|STARTED|Treatment Withdrawal Period (TW)||13
3314958|NCT03094195|4048301|FG004|STARTED|Treatment Withdrawal Period (TW)||13
3314959|NCT03094195|4048302|FG005|STARTED|Treatment Withdrawal Period (TW)||15
3314960|NCT03094195|4048303|FG006|STARTED|Treatment Withdrawal Period (TW)||13
3314961|NCT03094195|4048304|FG007|STARTED|Treatment Withdrawal Period (TW)||26
3314962|NCT03094195|4048297|FG000|COMPLETED|Treatment Withdrawal Period (TW)||0
3314963|NCT03094195|4048298|FG001|COMPLETED|Treatment Withdrawal Period (TW)||0
3314964|NCT03094195|4048299|FG002|COMPLETED|Treatment Withdrawal Period (TW)||0
3314965|NCT03094195|4048300|FG003|COMPLETED|Treatment Withdrawal Period (TW)||13
3314966|NCT03094195|4048301|FG004|COMPLETED|Treatment Withdrawal Period (TW)||13
3314967|NCT03094195|4048302|FG005|COMPLETED|Treatment Withdrawal Period (TW)||15
3314968|NCT03094195|4048303|FG006|COMPLETED|Treatment Withdrawal Period (TW)||13
3314969|NCT03094195|4048304|FG007|COMPLETED|Treatment Withdrawal Period (TW)||26
3314970|NCT03094195|4048297|FG000|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
3314971|NCT03094195|4048298|FG001|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
3314972|NCT03094195|4048299|FG002|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
3314973|NCT03094195|4048300|FG003|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
3314974|NCT03094195|4048301|FG004|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
3314975|NCT03094195|4048302|FG005|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
2896900|NCT00401245|3604509|FG004|COMPLETED|Between Titration and Open Label Phase||0
2896901|NCT00401245|3604510|FG005|COMPLETED|Between Titration and Open Label Phase||0
2896902|NCT00401245|3604511|FG006|COMPLETED|Between Titration and Open Label Phase||0
2896903|NCT00401245|3604512|FG007|COMPLETED|Between Titration and Open Label Phase||0
2896904|NCT00401245|3604505|FG000|NOT COMPLETED|Between Titration and Open Label Phase||0
2896905|NCT00401245|3604506|FG001|NOT COMPLETED|Between Titration and Open Label Phase||2
2896906|NCT00401245|3604507|FG002|NOT COMPLETED|Between Titration and Open Label Phase||0
2896907|NCT00401245|3604508|FG003|NOT COMPLETED|Between Titration and Open Label Phase||2
2896908|NCT00401245|3604509|FG004|NOT COMPLETED|Between Titration and Open Label Phase||0
2896909|NCT00401245|3604510|FG005|NOT COMPLETED|Between Titration and Open Label Phase||0
2896910|NCT00401245|3604511|FG006|NOT COMPLETED|Between Titration and Open Label Phase||0
2896911|NCT00401245|3604512|FG007|NOT COMPLETED|Between Titration and Open Label Phase||0
2896912|NCT00401245|3604505|FG000|STARTED|Open Label Phase||122
2896913|NCT00401245|3604506|FG001|STARTED|Open Label Phase||116
2896914|NCT00401245|3604507|FG002|STARTED|Open Label Phase||118
2896915|NCT00401245|3604508|FG003|STARTED|Open Label Phase||105
2896916|NCT00401245|3604509|FG004|STARTED|Open Label Phase||0
2896917|NCT00401245|3604510|FG005|STARTED|Open Label Phase||0
2896918|NCT00401245|3604511|FG006|STARTED|Open Label Phase||0
2896919|NCT00401245|3604512|FG007|STARTED|Open Label Phase||0
2896920|NCT00401245|3604505|FG000|COMPLETED|Open Label Phase||101
2896921|NCT00401245|3604506|FG001|COMPLETED|Open Label Phase||81
2896922|NCT00401245|3604507|FG002|COMPLETED|Open Label Phase||95
2896923|NCT00401245|3604508|FG003|COMPLETED|Open Label Phase||84
2896924|NCT00401245|3604509|FG004|COMPLETED|Open Label Phase||0
2896925|NCT00401245|3604510|FG005|COMPLETED|Open Label Phase||0
2896926|NCT00401245|3604511|FG006|COMPLETED|Open Label Phase||0
2896927|NCT00401245|3604512|FG007|COMPLETED|Open Label Phase||0
2896928|NCT00401245|3604505|FG000|NOT COMPLETED|Open Label Phase||21
2896929|NCT00401245|3604506|FG001|NOT COMPLETED|Open Label Phase||35
2896930|NCT00401245|3604507|FG002|NOT COMPLETED|Open Label Phase||23
2896931|NCT00401245|3604508|FG003|NOT COMPLETED|Open Label Phase||21
2896932|NCT00401245|3604509|FG004|NOT COMPLETED|Open Label Phase||0
2896933|NCT00401245|3604510|FG005|NOT COMPLETED|Open Label Phase||0
2896934|NCT00401245|3604511|FG006|NOT COMPLETED|Open Label Phase||0
2896935|NCT00401245|3604512|FG007|NOT COMPLETED|Open Label Phase||0
2896936|NCT00401245|3604505|FG000|STARTED|Double Blind Tapering Phase||0
2896937|NCT00401245|3604506|FG001|STARTED|Double Blind Tapering Phase||0
2896938|NCT00401245|3604507|FG002|STARTED|Double Blind Tapering Phase||0
2896939|NCT00401245|3604508|FG003|STARTED|Double Blind Tapering Phase||0
2896940|NCT00401245|3604509|FG004|STARTED|Double Blind Tapering Phase||101
2896941|NCT00401245|3604510|FG005|STARTED|Double Blind Tapering Phase||94
2896942|NCT00401245|3604511|FG006|STARTED|Double Blind Tapering Phase||87
2896943|NCT00401245|3604512|FG007|STARTED|Double Blind Tapering Phase||102
2896944|NCT00401245|3604505|FG000|COMPLETED|Double Blind Tapering Phase||0
2896945|NCT00401245|3604506|FG001|COMPLETED|Double Blind Tapering Phase||0
2896946|NCT00401245|3604507|FG002|COMPLETED|Double Blind Tapering Phase||0
2896947|NCT00401245|3604508|FG003|COMPLETED|Double Blind Tapering Phase||0
2896948|NCT00401245|3604509|FG004|COMPLETED|Double Blind Tapering Phase||97
2896949|NCT00401245|3604510|FG005|COMPLETED|Double Blind Tapering Phase||90
2896950|NCT00401245|3604511|FG006|COMPLETED|Double Blind Tapering Phase||80
2896951|NCT00401245|3604512|FG007|COMPLETED|Double Blind Tapering Phase||95
2896952|NCT00401245|3604505|FG000|NOT COMPLETED|Double Blind Tapering Phase||0
2896953|NCT00401245|3604506|FG001|NOT COMPLETED|Double Blind Tapering Phase||0
2896954|NCT00401245|3604507|FG002|NOT COMPLETED|Double Blind Tapering Phase||0
2896955|NCT00401245|3604508|FG003|NOT COMPLETED|Double Blind Tapering Phase||0
2896956|NCT00401245|3604509|FG004|NOT COMPLETED|Double Blind Tapering Phase||4
2896957|NCT00401245|3604510|FG005|NOT COMPLETED|Double Blind Tapering Phase||4
2896958|NCT00401245|3604511|FG006|NOT COMPLETED|Double Blind Tapering Phase||7
2896959|NCT00401245|3604512|FG007|NOT COMPLETED|Double Blind Tapering Phase||7
2896960|NCT00401258|3604532|FG000|STARTED|Overall Study||15
2896961|NCT00401258|3604532|FG000|COMPLETED|Overall Study||8
2896962|NCT00401258|3604532|FG000|NOT COMPLETED|Overall Study||7
2896963|NCT00401375|3604539|FG000|STARTED|Overall Study||174
2896964|NCT00401375|3604540|FG001|STARTED|Overall Study||176
2896965|NCT00401375|3604541|FG002|STARTED|Overall Study||174
2896966|NCT00401375|3604539|FG000|Received at Least 1 Dose of Study Drug|Overall Study||171
2896967|NCT00401375|3604540|FG001|Received at Least 1 Dose of Study Drug|Overall Study||173
2896968|NCT00401375|3604541|FG002|Received at Least 1 Dose of Study Drug|Overall Study||171
2896969|NCT00401375|3604539|FG000|COMPLETED|Overall Study||152
2896970|NCT00401375|3604540|FG001|COMPLETED|Overall Study||151
2896971|NCT00401375|3604541|FG002|COMPLETED|Overall Study||149
2896972|NCT00401375|3604539|FG000|NOT COMPLETED|Overall Study||22
2896973|NCT00401375|3604540|FG001|NOT COMPLETED|Overall Study||25
2896974|NCT00401375|3604541|FG002|NOT COMPLETED|Overall Study||25
2896975|NCT00401401|3604553|FG000|STARTED|Overall Study||6
2896976|NCT00401401|3604554|FG001|STARTED|Overall Study||6
2896977|NCT00401401|3604555|FG002|STARTED|Overall Study||6
2896978|NCT00401401|3604556|FG003|STARTED|Overall Study||12
2896979|NCT00401401|3604553|FG000|COMPLETED|Overall Study||6
2896980|NCT00401401|3604554|FG001|COMPLETED|Overall Study||6
2896981|NCT00401401|3604555|FG002|COMPLETED|Overall Study||5
2896982|NCT00401401|3604556|FG003|COMPLETED|Overall Study||9
2896983|NCT00401401|3604553|FG000|NOT COMPLETED|Overall Study||0
3314976|NCT03094195|4048303|FG006|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
3314977|NCT03094195|4048304|FG007|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
3314978|NCT03094325|4048322|FG000|STARTED|Overall Study||10
3314979|NCT03094325|4048322|FG000|TEE Before Cardiopulmonary Bypass|Overall Study||10
3314980|NCT03094325|4048322|FG000|OPIE Before Cardiopulmonary Bypass|Overall Study||10
3314981|NCT03094325|4048322|FG000|TEE After Cardiopulmonary Bypass|Overall Study||10
3314982|NCT03094325|4048322|FG000|OPIE After Cardiopulmonary Bypass|Overall Study||10
3314983|NCT03094325|4048322|FG000|COMPLETED|Overall Study||10
3314984|NCT03094325|4048322|FG000|NOT COMPLETED|Overall Study||0
3314985|NCT03094611|4048328|FG000|STARTED|Overall Study||4
3314986|NCT03094611|4048328|FG000|COMPLETED|Overall Study||2
3314987|NCT03094611|4048328|FG000|NOT COMPLETED|Overall Study||2
3314988|NCT03094637|4048334|FG000|STARTED|Overall Study||17
2896984|NCT00401401|3604554|FG001|NOT COMPLETED|Overall Study||0
2896985|NCT00401401|3604555|FG002|NOT COMPLETED|Overall Study||1
2896986|NCT00401401|3604556|FG003|NOT COMPLETED|Overall Study||3
2896987|NCT00401414|3604573|FG000|STARTED|Overall Study||118
2896988|NCT00401414|3604574|FG001|STARTED|Overall Study||147
2896989|NCT00401414|3604575|FG002|STARTED|Overall Study||79
2896990|NCT00401414|3604573|FG000|COMPLETED|Overall Study||118
2896991|NCT00401414|3604574|FG001|COMPLETED|Overall Study||147
2896992|NCT00401414|3604575|FG002|COMPLETED|Overall Study||79
2896993|NCT00401414|3604573|FG000|NOT COMPLETED|Overall Study||0
2896994|NCT00401414|3604574|FG001|NOT COMPLETED|Overall Study||0
2896995|NCT00401414|3604575|FG002|NOT COMPLETED|Overall Study||0
2896996|NCT00401518|3604588|FG000|STARTED|Overall Study||46
2896997|NCT00401518|3604589|FG001|STARTED|Overall Study||227
2896998|NCT00401518|3604590|FG002|STARTED|Overall Study||117
2896999|NCT00401518|3604588|FG000|COMPLETED|Overall Study||40
2897000|NCT00401518|3604589|FG001|COMPLETED|Overall Study||190
2897001|NCT00401518|3604590|FG002|COMPLETED|Overall Study||94
2897002|NCT00401518|3604588|FG000|NOT COMPLETED|Overall Study||6
2897003|NCT00401518|3604589|FG001|NOT COMPLETED|Overall Study||37
2897004|NCT00401518|3604590|FG002|NOT COMPLETED|Overall Study||23
2897005|NCT00401531|3604600|FG000|STARTED|Overall Study||206
2897006|NCT00401531|3604601|FG001|STARTED|Overall Study||206
2897007|NCT00401531|3604600|FG000|COMPLETED|Overall Study||197
2897008|NCT00401531|3604601|FG001|COMPLETED|Overall Study||196
2897009|NCT00401531|3604600|FG000|NOT COMPLETED|Overall Study||9
2897010|NCT00401531|3604601|FG001|NOT COMPLETED|Overall Study||10
2897011|NCT00401544|3604611|FG000|STARTED|Overall Study|Randomized and treated|56
2897012|NCT00401544|3604612|FG001|STARTED|Overall Study|Randomized and treated|62
2897013|NCT00401544|3604613|FG002|STARTED|Overall Study|Randomized and treated|60
2897014|NCT00401544|3604614|FG003|STARTED|Overall Study|Randomized and treated|60
2897015|NCT00401544|3604611|FG000|COMPLETED|Overall Study||38
2897016|NCT00401544|3604612|FG001|COMPLETED|Overall Study||44
2897017|NCT00401544|3604613|FG002|COMPLETED|Overall Study||48
2897018|NCT00401544|3604614|FG003|COMPLETED|Overall Study||44
2897019|NCT00401544|3604611|FG000|NOT COMPLETED|Overall Study||18
2897020|NCT00401544|3604612|FG001|NOT COMPLETED|Overall Study||18
2897021|NCT00401544|3604613|FG002|NOT COMPLETED|Overall Study||12
2897022|NCT00401544|3604614|FG003|NOT COMPLETED|Overall Study||16
2897023|NCT00401622|3604631|FG000|STARTED|Overall Study||160
3314989|NCT03094637|4048335|FG001|STARTED|Overall Study||20
3314990|NCT03094637|4048334|FG000|COMPLETED|Overall Study||17
3314991|NCT03094637|4048335|FG001|COMPLETED|Overall Study||20
3314992|NCT03094637|4048334|FG000|NOT COMPLETED|Overall Study||0
3314993|NCT03094637|4048335|FG001|NOT COMPLETED|Overall Study||0
3314994|NCT03094806|4048344|FG000|STARTED|Overall Study||44
3314995|NCT03094806|4048345|FG001|STARTED|Overall Study||47
3314996|NCT03094806|4048344|FG000|COMPLETED|Overall Study||44
3314997|NCT03094806|4048345|FG001|COMPLETED|Overall Study||47
3314998|NCT03094806|4048344|FG000|NOT COMPLETED|Overall Study||0
3314999|NCT03094806|4048345|FG001|NOT COMPLETED|Overall Study||0
3315000|NCT03095027|4048351|FG000|STARTED|Period 1, First Week of Wear||27
3315001|NCT03095027|4048352|FG001|STARTED|Period 1, First Week of Wear||24
3315002|NCT03095027|4048351|FG000|COMPLETED|Period 1, First Week of Wear||27
3315003|NCT03095027|4048352|FG001|COMPLETED|Period 1, First Week of Wear||24
3315004|NCT03095027|4048351|FG000|NOT COMPLETED|Period 1, First Week of Wear||0
3315005|NCT03095027|4048352|FG001|NOT COMPLETED|Period 1, First Week of Wear||0
3315006|NCT03095027|4048351|FG000|STARTED|Period 2, Second Week of Wear||27
3315007|NCT03095027|4048352|FG001|STARTED|Period 2, Second Week of Wear||24
3315008|NCT03095027|4048351|FG000|COMPLETED|Period 2, Second Week of Wear||26
3315009|NCT03095027|4048352|FG001|COMPLETED|Period 2, Second Week of Wear||24
3315010|NCT03095027|4048351|FG000|NOT COMPLETED|Period 2, Second Week of Wear||1
3315011|NCT03095027|4048352|FG001|NOT COMPLETED|Period 2, Second Week of Wear||0
3315012|NCT03095053|4048360|FG000|STARTED|Overall Study|All blastocysts scored morphologically PGT-A of the single best blastocyst from the cohort|109
3315013|NCT03095053|4048361|FG001|STARTED|Overall Study|All blastocysts scored morphologically|111
3315014|NCT03095053|4048360|FG000|COMPLETED|Overall Study|29 excluded as blastocyst was predicted to be aneuploid|80
2897024|NCT00401622|3604632|FG001|STARTED|Overall Study||160
2897025|NCT00401622|3604631|FG000|COMPLETED|Overall Study||126
2897026|NCT00401622|3604632|FG001|COMPLETED|Overall Study||117
2897027|NCT00401622|3604631|FG000|NOT COMPLETED|Overall Study||34
2897028|NCT00401622|3604632|FG001|NOT COMPLETED|Overall Study||43
2897029|NCT00401726|3604640|FG000|STARTED|Overall Study||269
2897030|NCT00401726|3604641|FG001|STARTED|Overall Study||268
3315015|NCT03095053|4048361|FG001|COMPLETED|Overall Study||111
2897031|NCT00401726|3604640|FG000|COMPLETED|Overall Study||172
2897032|NCT00401726|3604641|FG001|COMPLETED|Overall Study||156
2897033|NCT00401726|3604640|FG000|NOT COMPLETED|Overall Study||97
2897034|NCT00401726|3604641|FG001|NOT COMPLETED|Overall Study||112
2897035|NCT00401752|3604649|FG000|STARTED|Overall Study||107
2897036|NCT00401752|3604650|FG001|STARTED|Overall Study||112
2897037|NCT00401752|3604649|FG000|Number of Patients Received Treatment|Overall Study||107
2897038|NCT00401752|3604650|FG001|Number of Patients Received Treatment|Overall Study||111
2897039|NCT00401752|3604649|FG000|Patients Included in ITT Population|Overall Study||106
2897040|NCT00401752|3604650|FG001|Patients Included in ITT Population|Overall Study||111
2897041|NCT00401752|3604649|FG000|Patients Included in Safety Population|Overall Study||107
2897042|NCT00401752|3604650|FG001|Patients Included in Safety Population|Overall Study||110
2897043|NCT00401752|3604649|FG000|Patients Included in Per-Protocol Popula|Overall Study||100
2897044|NCT00401752|3604650|FG001|Patients Included in Per-Protocol Popula|Overall Study||99
2897045|NCT00401752|3604649|FG000|COMPLETED|Overall Study||97
2897046|NCT00401752|3604650|FG001|COMPLETED|Overall Study||94
2897047|NCT00401752|3604649|FG000|NOT COMPLETED|Overall Study||10
2897048|NCT00401752|3604650|FG001|NOT COMPLETED|Overall Study||18
2897049|NCT00401778|3604659|FG000|STARTED|Overall Study||10
2897050|NCT00401778|3604660|FG001|STARTED|Overall Study||12
2897051|NCT00401778|3604661|FG002|STARTED|Overall Study||11
2897052|NCT00401778|3604659|FG000|COMPLETED|Overall Study||9
2897053|NCT00401778|3604660|FG001|COMPLETED|Overall Study||11
2897054|NCT00401778|3604661|FG002|COMPLETED|Overall Study||10
2897055|NCT00401778|3604659|FG000|NOT COMPLETED|Overall Study||1
2897056|NCT00401778|3604660|FG001|NOT COMPLETED|Overall Study||1
2897057|NCT00401778|3604661|FG002|NOT COMPLETED|Overall Study||1
2897058|NCT00401817|3604669|FG000|STARTED|Overall Study||11
2897059|NCT00401817|3604669|FG000|COMPLETED|Overall Study||11
2897060|NCT00401817|3604669|FG000|NOT COMPLETED|Overall Study||0
2919943|NCT00534833|3630396|FG001|COMPLETED|Overall Study||180
2919944|NCT00534833|3630395|FG000|NOT COMPLETED|Overall Study||0
2919945|NCT00534833|3630396|FG001|NOT COMPLETED|Overall Study||0
2919946|NCT00534937|3630406|FG000|STARTED|Overall Study||42
2919947|NCT00534937|3630407|FG001|STARTED|Overall Study||47
2919948|NCT00534937|3630406|FG000|COMPLETED|Overall Study||34
2919949|NCT00534937|3630407|FG001|COMPLETED|Overall Study||35
2919950|NCT00534937|3630406|FG000|NOT COMPLETED|Overall Study||8
2919951|NCT00534937|3630407|FG001|NOT COMPLETED|Overall Study||12
2919952|NCT00535002|3630423|FG000|STARTED|Overall Study||19
2919953|NCT00535002|3630424|FG001|STARTED|Overall Study||12
2919954|NCT00535002|3630425|FG002|STARTED|Overall Study||13
2919955|NCT00535002|3630426|FG003|STARTED|Overall Study||14
2919956|NCT00535002|3630427|FG004|STARTED|Overall Study||9
2919957|NCT00535002|3630428|FG005|STARTED|Overall Study||17
2919958|NCT00535002|3630429|FG006|STARTED|Overall Study||12
2919959|NCT00535002|3630430|FG007|STARTED|Overall Study||16
2919960|NCT00535002|3630423|FG000|COMPLETED|Overall Study||19
2919961|NCT00535002|3630424|FG001|COMPLETED|Overall Study||12
2919962|NCT00535002|3630425|FG002|COMPLETED|Overall Study||13
2919963|NCT00535002|3630426|FG003|COMPLETED|Overall Study||14
2919964|NCT00535002|3630427|FG004|COMPLETED|Overall Study||9
2919965|NCT00535002|3630428|FG005|COMPLETED|Overall Study||17
2919966|NCT00535002|3630429|FG006|COMPLETED|Overall Study||12
2919967|NCT00535002|3630430|FG007|COMPLETED|Overall Study||16
2919968|NCT00535002|3630423|FG000|NOT COMPLETED|Overall Study||0
2919969|NCT00535002|3630424|FG001|NOT COMPLETED|Overall Study||0
2919970|NCT00535002|3630425|FG002|NOT COMPLETED|Overall Study||0
2919971|NCT00535002|3630426|FG003|NOT COMPLETED|Overall Study||0
2919972|NCT00535002|3630427|FG004|NOT COMPLETED|Overall Study||0
2919973|NCT00535002|3630428|FG005|NOT COMPLETED|Overall Study||0
2919974|NCT00535002|3630429|FG006|NOT COMPLETED|Overall Study||0
2919975|NCT00535002|3630430|FG007|NOT COMPLETED|Overall Study||0
2919976|NCT00535132|3630446|FG000|STARTED|Randomized Population|Number of Subjects Randomized|100
2919977|NCT00535132|3630447|FG001|STARTED|Randomized Population|Number of Subjects Randomized|101
2919978|NCT00535132|3630446|FG000|COMPLETED|Randomized Population||100
2919979|NCT00535132|3630447|FG001|COMPLETED|Randomized Population||101
2919980|NCT00535132|3630446|FG000|NOT COMPLETED|Randomized Population||0
2919981|NCT00535132|3630447|FG001|NOT COMPLETED|Randomized Population||0
2919982|NCT00535132|3630446|FG000|STARTED|Safety Analysis Set||100
2919983|NCT00535132|3630447|FG001|STARTED|Safety Analysis Set||101
2919984|NCT00535132|3630446|FG000|COMPLETED|Safety Analysis Set|Two patients were randomized but not treated.|98
2919985|NCT00535132|3630447|FG001|COMPLETED|Safety Analysis Set|Two patients were randomized but not treated.|99
2919986|NCT00535132|3630446|FG000|NOT COMPLETED|Safety Analysis Set||2
2919987|NCT00535132|3630447|FG001|NOT COMPLETED|Safety Analysis Set||2
2919988|NCT00535132|3630446|FG000|STARTED|Intent-to-Treat (ITT) Analysis Set||98
2919989|NCT00535132|3630447|FG001|STARTED|Intent-to-Treat (ITT) Analysis Set||99
2919990|NCT00535132|3630446|FG000|COMPLETED|Intent-to-Treat (ITT) Analysis Set|Patients who received at least one dose of study drug and have some follow-up efficacy data.|95
2919991|NCT00535132|3630447|FG001|COMPLETED|Intent-to-Treat (ITT) Analysis Set|Patients who received at least one dose of study drug and have some follow-up efficacy data.|96
2919992|NCT00535132|3630446|FG000|NOT COMPLETED|Intent-to-Treat (ITT) Analysis Set||3
2919993|NCT00535132|3630447|FG001|NOT COMPLETED|Intent-to-Treat (ITT) Analysis Set||3
2919994|NCT00535145|3630455|FG000|STARTED|Phase I||114
2919995|NCT00535145|3630455|FG000|COMPLETED|Phase I||85
2919996|NCT00535145|3630455|FG000|NOT COMPLETED|Phase I||29
3038343|NCT01153763|3757765|FG000|NOT COMPLETED|Overall Study||21
2897061|NCT00401830|3604676|FG000|STARTED|Overall Study||81
2897062|NCT00401830|3604677|FG001|STARTED|Overall Study||78
2897063|NCT00401830|3604676|FG000|COMPLETED|Overall Study||50
2897064|NCT00401830|3604677|FG001|COMPLETED|Overall Study||46
2897065|NCT00401830|3604676|FG000|NOT COMPLETED|Overall Study||31
2897066|NCT00401830|3604677|FG001|NOT COMPLETED|Overall Study||32
2897067|NCT00401843|3604686|FG000|STARTED|Overall Study||21
2897068|NCT00401843|3604687|FG001|STARTED|Overall Study||144
2897069|NCT00401843|3604688|FG002|STARTED|Overall Study||142
2897070|NCT00401843|3604686|FG000|Treated|Overall Study||21
2897071|NCT00401843|3604687|FG001|Treated|Overall Study||142
2897072|NCT00401843|3604688|FG002|Treated|Overall Study||139
2897073|NCT00401843|3604686|FG000|COMPLETED|Overall Study||0
2897074|NCT00401843|3604687|FG001|COMPLETED|Overall Study||0
2897075|NCT00401843|3604688|FG002|COMPLETED|Overall Study||0
2897076|NCT00401843|3604686|FG000|NOT COMPLETED|Overall Study||21
2897077|NCT00401843|3604687|FG001|NOT COMPLETED|Overall Study||144
2897078|NCT00401843|3604688|FG002|NOT COMPLETED|Overall Study||142
2897079|NCT00401882|3604700|FG000|STARTED|Overall Study||2
2897080|NCT00401882|3604701|FG001|STARTED|Overall Study||5
2897081|NCT00401882|3604700|FG000|COMPLETED|Overall Study||2
2897082|NCT00401882|3604701|FG001|COMPLETED|Overall Study||5
2897083|NCT00401882|3604700|FG000|NOT COMPLETED|Overall Study||0
2897084|NCT00401882|3604701|FG001|NOT COMPLETED|Overall Study||0
2897085|NCT00401960|3604715|FG000|STARTED|Overall Study||5
2897086|NCT00401960|3604716|FG001|STARTED|Overall Study||1
2897087|NCT00401960|3604715|FG000|COMPLETED|Overall Study||0
2897088|NCT00401960|3604716|FG001|COMPLETED|Overall Study||1
2897089|NCT00401960|3604715|FG000|NOT COMPLETED|Overall Study||5
2897090|NCT00401960|3604716|FG001|NOT COMPLETED|Overall Study||0
3315016|NCT03095053|4048360|FG000|NOT COMPLETED|Overall Study||29
3315017|NCT03095053|4048361|FG001|NOT COMPLETED|Overall Study||0
3315018|NCT03095118|4048367|FG000|STARTED|Overall Study||12
3315019|NCT03095118|4048367|FG000|COMPLETED|Overall Study||10
3315020|NCT03095118|4048367|FG000|NOT COMPLETED|Overall Study||2
3315021|NCT03095508|4048373|FG000|STARTED|Overall Study||114
2897091|NCT00401973|3604727|FG000|STARTED|Overall Study||50
2897092|NCT00401973|3604728|FG001|STARTED|Overall Study||76
2897093|NCT00401973|3604729|FG002|STARTED|Overall Study||73
2897094|NCT00401973|3604727|FG000|COMPLETED|Overall Study||39
2897095|NCT00401973|3604728|FG001|COMPLETED|Overall Study||50
2897096|NCT00401973|3604729|FG002|COMPLETED|Overall Study||50
2897097|NCT00401973|3604727|FG000|NOT COMPLETED|Overall Study||11
2897098|NCT00401973|3604728|FG001|NOT COMPLETED|Overall Study||26
2897099|NCT00401973|3604729|FG002|NOT COMPLETED|Overall Study||23
2897100|NCT00401986|3604739|FG000|STARTED|Overall Study||14
2897101|NCT00401986|3604739|FG000|COMPLETED|Overall Study||12
2897102|NCT00401986|3604739|FG000|NOT COMPLETED|Overall Study||2
2897103|NCT00402025|3604751|FG000|STARTED|Overall Study||3
2897104|NCT00402025|3604752|FG001|STARTED|Overall Study||4
2897105|NCT00402025|3604753|FG002|STARTED|Overall Study||10
2897106|NCT00402025|3604751|FG000|COMPLETED|Overall Study||1
2897107|NCT00402025|3604752|FG001|COMPLETED|Overall Study||1
2897108|NCT00402025|3604753|FG002|COMPLETED|Overall Study||0
2897109|NCT00402025|3604751|FG000|NOT COMPLETED|Overall Study||2
2897110|NCT00402025|3604752|FG001|NOT COMPLETED|Overall Study||3
2897111|NCT00402025|3604753|FG002|NOT COMPLETED|Overall Study||10
2897112|NCT00402051|3604763|FG000|STARTED|Overall Study||66
2897113|NCT00402051|3604764|FG001|STARTED|Overall Study||67
2897114|NCT00402051|3604763|FG000|Received Treatment|Overall Study||65
3315022|NCT03095508|4048374|FG001|STARTED|Overall Study||115
3315023|NCT03095508|4048373|FG000|Per Protocol Population|Overall Study||112
3315024|NCT03095508|4048374|FG001|Per Protocol Population|Overall Study||111
3315025|NCT03095508|4048373|FG000|Safety Population|Overall Study||114
3315026|NCT03095508|4048374|FG001|Safety Population|Overall Study||115
3315027|NCT03095508|4048373|FG000|ITT Population|Overall Study||114
3315028|NCT03095508|4048374|FG001|ITT Population|Overall Study||115
3315029|NCT03095508|4048373|FG000|COMPLETED|Overall Study||114
3315030|NCT03095508|4048374|FG001|COMPLETED|Overall Study||114
3315031|NCT03095508|4048373|FG000|NOT COMPLETED|Overall Study||0
3315032|NCT03095508|4048374|FG001|NOT COMPLETED|Overall Study||1
3315033|NCT03095521|4048382|FG000|STARTED|Overall Study||115
3315034|NCT03095521|4048383|FG001|STARTED|Overall Study||113
3315035|NCT03095521|4048382|FG000|Intent to Treat Population ITT|Overall Study||115
3315036|NCT03095521|4048383|FG001|Intent to Treat Population ITT|Overall Study||113
3315037|NCT03095521|4048382|FG000|Per Protocol Population PP|Overall Study||113
3315038|NCT03095521|4048383|FG001|Per Protocol Population PP|Overall Study||107
3315039|NCT03095521|4048382|FG000|Safety Population|Overall Study||115
3315040|NCT03095521|4048383|FG001|Safety Population|Overall Study||113
3315041|NCT03095521|4048382|FG000|COMPLETED|Overall Study||115
3315042|NCT03095521|4048383|FG001|COMPLETED|Overall Study||111
3315043|NCT03095521|4048382|FG000|NOT COMPLETED|Overall Study||0
2897115|NCT00402051|3604764|FG001|Received Treatment|Overall Study||65
2897116|NCT00402051|3604763|FG000|COMPLETED|Overall Study|Completed 6 treatment cycles and 30 days of follow-up after last dose of study drug|28
2897117|NCT00402051|3604764|FG001|COMPLETED|Overall Study|Completed 6 treatment cycles and 30 days of follow-up after last dose of study drug|32
2897118|NCT00402051|3604763|FG000|NOT COMPLETED|Overall Study||38
2897119|NCT00402051|3604764|FG001|NOT COMPLETED|Overall Study||35
2897120|NCT00402103|3604772|FG000|STARTED|Overall Study||470
2897121|NCT00402103|3604773|FG001|STARTED|Overall Study||86
2897122|NCT00402103|3604772|FG000|COMPLETED|Overall Study||379
2897123|NCT00402103|3604773|FG001|COMPLETED|Overall Study||73
2897124|NCT00402103|3604772|FG000|NOT COMPLETED|Overall Study||91
2897125|NCT00402103|3604773|FG001|NOT COMPLETED|Overall Study||13
2897126|NCT00402116|3604786|FG000|STARTED|Overall Study||6
2897127|NCT00402116|3604787|FG001|STARTED|Overall Study||6
3170822|NCT01931397|3898091|FG000|STARTED|Overall Study||30
3170823|NCT01931397|3898091|FG000|COMPLETED|Overall Study||19
3170824|NCT01931397|3898091|FG000|NOT COMPLETED|Overall Study||11
3170825|NCT01931462|3898099|FG000|STARTED|Overall Study||2
3315044|NCT03095521|4048383|FG001|NOT COMPLETED|Overall Study||2
3315045|NCT03095599|4048391|FG000|STARTED|Overall Study||741
2897128|NCT00402116|3604788|FG002|STARTED|Overall Study||60
2897129|NCT00402116|3604786|FG000|COMPLETED|Overall Study||3
2897130|NCT00402116|3604787|FG001|COMPLETED|Overall Study||0
2897131|NCT00402116|3604788|FG002|COMPLETED|Overall Study||5
2897132|NCT00402116|3604786|FG000|NOT COMPLETED|Overall Study||3
2897133|NCT00402116|3604787|FG001|NOT COMPLETED|Overall Study||6
2897134|NCT00402116|3604788|FG002|NOT COMPLETED|Overall Study||55
2897135|NCT00402168|3604818|FG000|STARTED|Randomized||84
2897136|NCT00402168|3604819|FG001|STARTED|Randomized||89
2897137|NCT00402168|3604818|FG000|COMPLETED|Randomized||83
2897138|NCT00402168|3604819|FG001|COMPLETED|Randomized||88
2897139|NCT00402168|3604818|FG000|NOT COMPLETED|Randomized||1
2897140|NCT00402168|3604819|FG001|NOT COMPLETED|Randomized||1
2897141|NCT00402168|3604818|FG000|STARTED|Treatment (up to 12 Months)||83
2897142|NCT00402168|3604819|FG001|STARTED|Treatment (up to 12 Months)||88
2897143|NCT00402168|3604818|FG000|COMPLETED|Treatment (up to 12 Months)||81
2897144|NCT00402168|3604819|FG001|COMPLETED|Treatment (up to 12 Months)||86
2897145|NCT00402168|3604818|FG000|NOT COMPLETED|Treatment (up to 12 Months)||2
2897146|NCT00402168|3604819|FG001|NOT COMPLETED|Treatment (up to 12 Months)||2
2897147|NCT00402168|3604818|FG000|STARTED|Long Term (LT)||81
2897148|NCT00402168|3604819|FG001|STARTED|Long Term (LT)|5 completed 12 months, did not enter long term: 1 AE, 1 lack of efficacy, 3 other(non-specified).|81
2897149|NCT00402168|3604818|FG000|COMPLETED|Long Term (LT)||70
2897150|NCT00402168|3604819|FG001|COMPLETED|Long Term (LT)||64
2897151|NCT00402168|3604818|FG000|NOT COMPLETED|Long Term (LT)||11
2897152|NCT00402168|3604819|FG001|NOT COMPLETED|Long Term (LT)||17
2897153|NCT00402168|3604818|FG000|STARTED|Switched From CNI to Belatacept in LT|Participants switched from CNI to Belatacept during LT period.|38
2897154|NCT00402168|3604819|FG001|STARTED|Switched From CNI to Belatacept in LT|Out of 81 starting LT period in CNI group, 38 switched from CNI to Belatacept during the LT period.|0
2897155|NCT00402168|3604818|FG000|COMPLETED|Switched From CNI to Belatacept in LT||32
2897156|NCT00402168|3604819|FG001|COMPLETED|Switched From CNI to Belatacept in LT||0
2897157|NCT00402168|3604818|FG000|NOT COMPLETED|Switched From CNI to Belatacept in LT||6
2897158|NCT00402168|3604819|FG001|NOT COMPLETED|Switched From CNI to Belatacept in LT||0
2897159|NCT00402194|3604835|FG000|STARTED|Overall Study||9
2897160|NCT00402194|3604836|FG001|STARTED|Overall Study||8
2897161|NCT00402194|3604835|FG000|COMPLETED|Overall Study||9
2897162|NCT00402194|3604836|FG001|COMPLETED|Overall Study||8
2897163|NCT00402194|3604835|FG000|NOT COMPLETED|Overall Study||0
2897164|NCT00402194|3604836|FG001|NOT COMPLETED|Overall Study||0
2897165|NCT00402233|3604846|FG000|STARTED|Overall Study||77
2897166|NCT00402233|3604847|FG001|STARTED|Overall Study||80
2897167|NCT00402233|3604848|FG002|STARTED|Overall Study||81
2897168|NCT00402233|3604849|FG003|STARTED|Overall Study||73
2897169|NCT00402233|3604846|FG000|COMPLETED|Overall Study||72
2897170|NCT00402233|3604847|FG001|COMPLETED|Overall Study||70
2897171|NCT00402233|3604848|FG002|COMPLETED|Overall Study||70
2897172|NCT00402233|3604849|FG003|COMPLETED|Overall Study||62
2897173|NCT00402233|3604846|FG000|NOT COMPLETED|Overall Study||5
2897174|NCT00402233|3604847|FG001|NOT COMPLETED|Overall Study||10
2897175|NCT00402233|3604848|FG002|NOT COMPLETED|Overall Study||11
2897176|NCT00402233|3604849|FG003|NOT COMPLETED|Overall Study||11
2897177|NCT00402246|3604861|FG000|STARTED|Overall Study||1014
2897178|NCT00402246|3604862|FG001|STARTED|Overall Study||983
3315046|NCT03095599|4048392|FG001|STARTED|Overall Study||148
3315047|NCT03095599|4048391|FG000|Withdrawal Before Vaccination|Overall Study||1
3315048|NCT03095599|4048392|FG001|Withdrawal Before Vaccination|Overall Study||0
3315049|NCT03095599|4048391|FG000|Vaccinated|Overall Study||740
3315050|NCT03095599|4048392|FG001|Vaccinated|Overall Study||148
3315051|NCT03095599|4048391|FG000|COMPLETED|Overall Study||738
3315052|NCT03095599|4048392|FG001|COMPLETED|Overall Study||148
3315053|NCT03095599|4048391|FG000|NOT COMPLETED|Overall Study||3
3315054|NCT03095599|4048392|FG001|NOT COMPLETED|Overall Study||0
3315055|NCT03095638|4048402|FG000|STARTED|P1: Period 1 (4 Days)||7
3315056|NCT03095638|4048403|FG001|STARTED|P1: Period 1 (4 Days)||7
3315057|NCT03095638|4048404|FG002|STARTED|P1: Period 1 (4 Days)||0
3315058|NCT03095638|4048405|FG003|STARTED|P1: Period 1 (4 Days)||0
3315059|NCT03095638|4048406|FG004|STARTED|P1: Period 1 (4 Days)||0
3315060|NCT03095638|4048407|FG005|STARTED|P1: Period 1 (4 Days)||0
3315061|NCT03095638|4048408|FG006|STARTED|P1: Period 1 (4 Days)||0
3315062|NCT03095638|4048409|FG007|STARTED|P1: Period 1 (4 Days)||0
3315063|NCT03095638|4048402|FG000|COMPLETED|P1: Period 1 (4 Days)||7
3315064|NCT03095638|4048403|FG001|COMPLETED|P1: Period 1 (4 Days)||7
3315065|NCT03095638|4048404|FG002|COMPLETED|P1: Period 1 (4 Days)||0
3315066|NCT03095638|4048405|FG003|COMPLETED|P1: Period 1 (4 Days)||0
3315067|NCT03095638|4048406|FG004|COMPLETED|P1: Period 1 (4 Days)||0
3315068|NCT03095638|4048407|FG005|COMPLETED|P1: Period 1 (4 Days)||0
3315069|NCT03095638|4048408|FG006|COMPLETED|P1: Period 1 (4 Days)||0
2897179|NCT00402246|3604861|FG000|COMPLETED|Overall Study||794
2897180|NCT00402246|3604862|FG001|COMPLETED|Overall Study||749
2897181|NCT00402246|3604861|FG000|NOT COMPLETED|Overall Study||220
2897182|NCT00402246|3604862|FG001|NOT COMPLETED|Overall Study||234
2897183|NCT00402285|3604873|FG000|STARTED|Overall Study||29
2897184|NCT00402285|3604874|FG001|STARTED|Overall Study||27
2897185|NCT00402285|3604875|FG002|STARTED|Overall Study||28
2897186|NCT00402285|3604873|FG000|COMPLETED|Overall Study||22
2897187|NCT00402285|3604874|FG001|COMPLETED|Overall Study||21
2897188|NCT00402285|3604875|FG002|COMPLETED|Overall Study||26
2897189|NCT00402285|3604873|FG000|NOT COMPLETED|Overall Study||7
2897190|NCT00402285|3604874|FG001|NOT COMPLETED|Overall Study||6
2897191|NCT00402285|3604875|FG002|NOT COMPLETED|Overall Study||2
2897192|NCT00402298|3604883|FG000|STARTED|Overall Study||3
2897193|NCT00402298|3604884|FG001|STARTED|Overall Study||2
2897194|NCT00402298|3604883|FG000|COMPLETED|Overall Study||2
2897195|NCT00402298|3604884|FG001|COMPLETED|Overall Study||2
2897196|NCT00402298|3604883|FG000|NOT COMPLETED|Overall Study||1
2897197|NCT00402298|3604884|FG001|NOT COMPLETED|Overall Study||0
2897198|NCT00402324|3604892|FG000|STARTED|Overall Study||101
2897199|NCT00402324|3604893|FG001|STARTED|Overall Study||101
2897200|NCT00402324|3604892|FG000|COMPLETED|Overall Study||58
2897201|NCT00402324|3604893|FG001|COMPLETED|Overall Study||60
2897202|NCT00402324|3604892|FG000|NOT COMPLETED|Overall Study||43
2897203|NCT00402324|3604893|FG001|NOT COMPLETED|Overall Study||41
2897204|NCT00402337|3604904|FG000|STARTED|Overall Study||59
2897205|NCT00402337|3604905|FG001|STARTED|Overall Study||57
2897206|NCT00402337|3604906|FG002|STARTED|Overall Study||62
2897207|NCT00402337|3604907|FG003|STARTED|Overall Study||63
2897208|NCT00402337|3604908|FG004|STARTED|Overall Study||69
2897209|NCT00402337|3604904|FG000|COMPLETED|Overall Study||54
2897210|NCT00402337|3604905|FG001|COMPLETED|Overall Study||51
2897211|NCT00402337|3604906|FG002|COMPLETED|Overall Study||58
2897212|NCT00402337|3604907|FG003|COMPLETED|Overall Study||51
2897213|NCT00402337|3604908|FG004|COMPLETED|Overall Study||61
2897214|NCT00402337|3604904|FG000|NOT COMPLETED|Overall Study||5
2897215|NCT00402337|3604905|FG001|NOT COMPLETED|Overall Study||6
2897216|NCT00402337|3604906|FG002|NOT COMPLETED|Overall Study||4
2897217|NCT00402337|3604907|FG003|NOT COMPLETED|Overall Study||12
2897218|NCT00402337|3604908|FG004|NOT COMPLETED|Overall Study||8
2897219|NCT00402363|3604924|FG000|STARTED|Overall Study||266
2897220|NCT00402363|3604925|FG001|STARTED|Overall Study||276
2897221|NCT00402363|3604926|FG002|STARTED|Overall Study||66
2897222|NCT00402363|3604927|FG003|STARTED|Overall Study||55
2897223|NCT00402363|3604924|FG000|COMPLETED|Overall Study||233
2897224|NCT00402363|3604925|FG001|COMPLETED|Overall Study||246
2897225|NCT00402363|3604926|FG002|COMPLETED|Overall Study||60
2897226|NCT00402363|3604927|FG003|COMPLETED|Overall Study||45
2897227|NCT00402363|3604924|FG000|NOT COMPLETED|Overall Study||33
2897228|NCT00402363|3604925|FG001|NOT COMPLETED|Overall Study||30
2897229|NCT00402363|3604926|FG002|NOT COMPLETED|Overall Study||6
2897230|NCT00402363|3604927|FG003|NOT COMPLETED|Overall Study||10
2897231|NCT00402597|3604948|FG000|STARTED|Overall Study||1153
2897232|NCT00402597|3604949|FG001|STARTED|Overall Study||307
2897233|NCT00402597|3604950|FG002|STARTED|Overall Study||1046
3315070|NCT03095638|4048409|FG007|COMPLETED|P1: Period 1 (4 Days)||0
3315071|NCT03095638|4048402|FG000|NOT COMPLETED|P1: Period 1 (4 Days)||0
3315072|NCT03095638|4048403|FG001|NOT COMPLETED|P1: Period 1 (4 Days)||0
3315073|NCT03095638|4048404|FG002|NOT COMPLETED|P1: Period 1 (4 Days)||0
3315074|NCT03095638|4048405|FG003|NOT COMPLETED|P1: Period 1 (4 Days)||0
3315075|NCT03095638|4048406|FG004|NOT COMPLETED|P1: Period 1 (4 Days)||0
3315076|NCT03095638|4048407|FG005|NOT COMPLETED|P1: Period 1 (4 Days)||0
3315077|NCT03095638|4048408|FG006|NOT COMPLETED|P1: Period 1 (4 Days)||0
3315078|NCT03095638|4048409|FG007|NOT COMPLETED|P1: Period 1 (4 Days)||0
3315079|NCT03095638|4048402|FG000|STARTED|P1: Period 1, Washout (7 [-4 Hours])||7
3315080|NCT03095638|4048403|FG001|STARTED|P1: Period 1, Washout (7 [-4 Hours])||7
3315081|NCT03095638|4048404|FG002|STARTED|P1: Period 1, Washout (7 [-4 Hours])||0
3315082|NCT03095638|4048405|FG003|STARTED|P1: Period 1, Washout (7 [-4 Hours])||0
3315083|NCT03095638|4048406|FG004|STARTED|P1: Period 1, Washout (7 [-4 Hours])||0
3315084|NCT03095638|4048407|FG005|STARTED|P1: Period 1, Washout (7 [-4 Hours])||0
3315085|NCT03095638|4048408|FG006|STARTED|P1: Period 1, Washout (7 [-4 Hours])||0
3315086|NCT03095638|4048409|FG007|STARTED|P1: Period 1, Washout (7 [-4 Hours])||0
3315087|NCT03095638|4048402|FG000|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||7
3315088|NCT03095638|4048403|FG001|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||7
2897234|NCT00402597|3604951|FG003|STARTED|Overall Study||353
2897235|NCT00402597|3604952|FG004|STARTED|Overall Study||603
2897236|NCT00402597|3604948|FG000|COMPLETED|Overall Study||962
2897237|NCT00402597|3604949|FG001|COMPLETED|Overall Study||261
2897238|NCT00402597|3604950|FG002|COMPLETED|Overall Study||834
2897239|NCT00402597|3604951|FG003|COMPLETED|Overall Study||279
2897240|NCT00402597|3604952|FG004|COMPLETED|Overall Study||479
2897241|NCT00402597|3604948|FG000|NOT COMPLETED|Overall Study||191
2897242|NCT00402597|3604949|FG001|NOT COMPLETED|Overall Study||46
2897243|NCT00402597|3604950|FG002|NOT COMPLETED|Overall Study||212
2897244|NCT00402597|3604951|FG003|NOT COMPLETED|Overall Study||74
2897245|NCT00402597|3604952|FG004|NOT COMPLETED|Overall Study||124
2897246|NCT00402649|3604964|FG000|STARTED|Overall Study||35
2897247|NCT00402649|3604964|FG000|COMPLETED|Overall Study||33
2897248|NCT00402649|3604964|FG000|NOT COMPLETED|Overall Study||2
2897249|NCT00402688|3604971|FG000|STARTED|Overall Study||81
3170826|NCT01931462|3898099|FG000|COMPLETED|Overall Study||1
3170827|NCT01931462|3898099|FG000|NOT COMPLETED|Overall Study||1
3170828|NCT01931475|3898105|FG000|STARTED|Period 1: Double-Blind Treatment Phase||205
3170829|NCT01931475|3898106|FG001|STARTED|Period 1: Double-Blind Treatment Phase||202
3170830|NCT01931475|3898105|FG000|Received at Least 1 Dose of Study Drug|Period 1: Double-Blind Treatment Phase||199
3170831|NCT01931475|3898106|FG001|Received at Least 1 Dose of Study Drug|Period 1: Double-Blind Treatment Phase||198
3170832|NCT01931475|3898105|FG000|COMPLETED|Period 1: Double-Blind Treatment Phase||166
3170833|NCT01931475|3898106|FG001|COMPLETED|Period 1: Double-Blind Treatment Phase||176
3170834|NCT01931475|3898105|FG000|NOT COMPLETED|Period 1: Double-Blind Treatment Phase||39
3170835|NCT01931475|3898106|FG001|NOT COMPLETED|Period 1: Double-Blind Treatment Phase||26
3170836|NCT01931475|3898105|FG000|STARTED|Period 2: Extension Treatment Phase||166
3170837|NCT01931475|3898106|FG001|STARTED|Period 2: Extension Treatment Phase||176
3170838|NCT01931475|3898105|FG000|Received at Least 1 Dose of Study Drug|Period 2: Extension Treatment Phase||166
3170839|NCT01931475|3898106|FG001|Received at Least 1 Dose of Study Drug|Period 2: Extension Treatment Phase||175
3170840|NCT01931475|3898105|FG000|COMPLETED|Period 2: Extension Treatment Phase||162
3315089|NCT03095638|4048404|FG002|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
3315090|NCT03095638|4048405|FG003|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
2897250|NCT00402688|3604972|FG001|STARTED|Overall Study||81
2897251|NCT00402688|3604973|FG002|STARTED|Overall Study||80
2897252|NCT00402688|3604971|FG000|COMPLETED|Overall Study||60
2897253|NCT00402688|3604972|FG001|COMPLETED|Overall Study||65
2897254|NCT00402688|3604973|FG002|COMPLETED|Overall Study||65
2897255|NCT00402688|3604971|FG000|NOT COMPLETED|Overall Study||21
2897256|NCT00402688|3604972|FG001|NOT COMPLETED|Overall Study||16
2897257|NCT00402688|3604973|FG002|NOT COMPLETED|Overall Study||15
2897258|NCT00402714|3604983|FG000|STARTED|Overall Study||3
2897259|NCT00402714|3604984|FG001|STARTED|Overall Study||11
2897260|NCT00402714|3604983|FG000|COMPLETED|Overall Study||3
2897261|NCT00402714|3604984|FG001|COMPLETED|Overall Study||11
2897262|NCT00402714|3604983|FG000|NOT COMPLETED|Overall Study||0
2897263|NCT00402714|3604984|FG001|NOT COMPLETED|Overall Study||0
2897264|NCT00402727|3604994|FG000|STARTED|Overall Study||432
2897265|NCT00402727|3604995|FG001|STARTED|Overall Study||381
2897266|NCT00402727|3604994|FG000|Achieving End Of Treatment (EOT)|Overall Study||408
2897267|NCT00402727|3604995|FG001|Achieving End Of Treatment (EOT)|Overall Study||355
2897268|NCT00402727|3604994|FG000|Achieving Test Of Cure (TOC)|Overall Study||390
2897269|NCT00402727|3604995|FG001|Achieving Test Of Cure (TOC)|Overall Study||347
2897270|NCT00402727|3604994|FG000|COMPLETED|Overall Study||390
2897271|NCT00402727|3604995|FG001|COMPLETED|Overall Study||347
2897272|NCT00402727|3604994|FG000|NOT COMPLETED|Overall Study||42
2897273|NCT00402727|3604995|FG001|NOT COMPLETED|Overall Study||34
2897274|NCT00402740|3605001|FG000|STARTED|Overall Study||322
2897275|NCT00402740|3605001|FG000|COMPLETED|Overall Study||242
2897276|NCT00402740|3605001|FG000|NOT COMPLETED|Overall Study||80
2897277|NCT00402779|3605011|FG000|STARTED|Overall Study||152
2897278|NCT00402779|3605012|FG001|STARTED|Overall Study||151
2897279|NCT00402779|3605011|FG000|COMPLETED|Overall Study||75
2897280|NCT00402779|3605012|FG001|COMPLETED|Overall Study||75
2897281|NCT00402779|3605011|FG000|NOT COMPLETED|Overall Study||77
2897282|NCT00402779|3605012|FG001|NOT COMPLETED|Overall Study||76
2897283|NCT00402831|3605020|FG000|STARTED|Overall Study||202
2897284|NCT00402831|3605021|FG001|STARTED|Overall Study||203
3315091|NCT03095638|4048406|FG004|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
3315092|NCT03095638|4048407|FG005|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
3315093|NCT03095638|4048408|FG006|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
3315094|NCT03095638|4048409|FG007|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
3315095|NCT03095638|4048402|FG000|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
3315096|NCT03095638|4048403|FG001|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
3315097|NCT03095638|4048404|FG002|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
3315098|NCT03095638|4048405|FG003|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
3315099|NCT03095638|4048406|FG004|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
3315100|NCT03095638|4048407|FG005|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
3315101|NCT03095638|4048408|FG006|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
3315102|NCT03095638|4048409|FG007|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
3315103|NCT03095638|4048402|FG000|STARTED|P1: Period 2 (4 Days)||7
3315104|NCT03095638|4048403|FG001|STARTED|P1: Period 2 (4 Days)||7
3315105|NCT03095638|4048404|FG002|STARTED|P1: Period 2 (4 Days)||0
3315106|NCT03095638|4048405|FG003|STARTED|P1: Period 2 (4 Days)||0
3315107|NCT03095638|4048406|FG004|STARTED|P1: Period 2 (4 Days)||0
3315108|NCT03095638|4048407|FG005|STARTED|P1: Period 2 (4 Days)||0
2897285|NCT00402831|3605020|FG000|ProQuad® Dose 1 (Day 1)|Overall Study||202
2897286|NCT00402831|3605021|FG001|ProQuad® Dose 1 (Day 1)|Overall Study||203
2897287|NCT00402831|3605020|FG000|ProQuad® Dose 1 (Day 30)|Overall Study||202
2897288|NCT00402831|3605021|FG001|ProQuad® Dose 1 (Day 30)|Overall Study||203
2897289|NCT00402831|3605020|FG000|COMPLETED|Overall Study||201
2897290|NCT00402831|3605021|FG001|COMPLETED|Overall Study||200
2897291|NCT00402831|3605020|FG000|NOT COMPLETED|Overall Study||1
2897292|NCT00402831|3605021|FG001|NOT COMPLETED|Overall Study||3
2897293|NCT00402896|3605029|FG000|STARTED|Overall Study||20
2897294|NCT00402896|3605029|FG000|COMPLETED|Overall Study||20
2897295|NCT00402896|3605029|FG000|NOT COMPLETED|Overall Study||0
2897296|NCT00402987|3605037|FG000|STARTED|Overall Study||90
2897297|NCT00402987|3605038|FG001|STARTED|Overall Study||45
2897298|NCT00402987|3605039|FG002|STARTED|Overall Study||45
2897299|NCT00402987|3605040|FG003|STARTED|Overall Study||89
2897300|NCT00402987|3605037|FG000|COMPLETED|Overall Study||90
2897301|NCT00402987|3605038|FG001|COMPLETED|Overall Study||45
2897302|NCT00402987|3605039|FG002|COMPLETED|Overall Study||44
2897303|NCT00402987|3605040|FG003|COMPLETED|Overall Study||89
2897304|NCT00402987|3605037|FG000|NOT COMPLETED|Overall Study||0
2897305|NCT00402987|3605038|FG001|NOT COMPLETED|Overall Study||0
2897306|NCT00402987|3605039|FG002|NOT COMPLETED|Overall Study||1
2897307|NCT00402987|3605040|FG003|NOT COMPLETED|Overall Study||0
2897308|NCT00403117|3605064|FG000|STARTED|Overall Study||49
2897309|NCT00403117|3605064|FG000|COMPLETED|Overall Study||29
2897310|NCT00403117|3605064|FG000|NOT COMPLETED|Overall Study||20
2897311|NCT00403130|3605095|FG000|STARTED|2 Years From Start of Treatment||31
2897312|NCT00403130|3605095|FG000|COMPLETED|2 Years From Start of Treatment||26
2897313|NCT00403130|3605095|FG000|NOT COMPLETED|2 Years From Start of Treatment||5
2897314|NCT00403130|3605095|FG000|STARTED|Survival Follow-up up to 6 Years||26
2897315|NCT00403130|3605095|FG000|COMPLETED|Survival Follow-up up to 6 Years||16
2897316|NCT00403130|3605095|FG000|NOT COMPLETED|Survival Follow-up up to 6 Years||10
2897317|NCT00403234|3605103|FG000|STARTED|Overall Study||2
2897318|NCT00403234|3605104|FG001|STARTED|Overall Study||3
2897319|NCT00403234|3605105|FG002|STARTED|Overall Study||3
2897320|NCT00403234|3605106|FG003|STARTED|Overall Study||2
2897321|NCT00403234|3605103|FG000|COMPLETED|Overall Study||1
2897322|NCT00403234|3605104|FG001|COMPLETED|Overall Study||2
2897323|NCT00403234|3605105|FG002|COMPLETED|Overall Study||2
2897324|NCT00403234|3605106|FG003|COMPLETED|Overall Study||2
2897325|NCT00403234|3605103|FG000|NOT COMPLETED|Overall Study||1
2897326|NCT00403234|3605104|FG001|NOT COMPLETED|Overall Study||1
2897327|NCT00403234|3605105|FG002|NOT COMPLETED|Overall Study||1
2897328|NCT00403234|3605106|FG003|NOT COMPLETED|Overall Study||0
2897329|NCT00403260|3605118|FG000|STARTED|Overall Study|Patients randomized and treated.|848
2897330|NCT00403260|3605119|FG001|STARTED|Overall Study|Patients randomized and treated.|423
2897331|NCT00403260|3605118|FG000|COMPLETED|Overall Study||723
2897332|NCT00403260|3605119|FG001|COMPLETED|Overall Study||357
2897333|NCT00403260|3605118|FG000|NOT COMPLETED|Overall Study||125
2897334|NCT00403260|3605119|FG001|NOT COMPLETED|Overall Study||66
2897335|NCT00403273|3605127|FG000|STARTED|Overall Study||25
2897336|NCT00403273|3605128|FG001|STARTED|Overall Study||29
2897337|NCT00403273|3605127|FG000|COMPLETED|Overall Study||22
2897338|NCT00403273|3605128|FG001|COMPLETED|Overall Study||25
2897339|NCT00403273|3605127|FG000|NOT COMPLETED|Overall Study||3
2897340|NCT00403273|3605128|FG001|NOT COMPLETED|Overall Study||4
2897341|NCT00403390|3605138|FG000|STARTED|Overall Study||16
2897342|NCT00403390|3605139|FG001|STARTED|Overall Study||18
2897343|NCT00403390|3605138|FG000|COMPLETED|Overall Study||13
2897344|NCT00403390|3605139|FG001|COMPLETED|Overall Study||18
2897345|NCT00403390|3605138|FG000|NOT COMPLETED|Overall Study||3
2897346|NCT00403390|3605139|FG001|NOT COMPLETED|Overall Study||0
2897347|NCT00403403|3605147|FG000|STARTED|Overall Study||50
2897348|NCT00403403|3605148|FG001|STARTED|Overall Study||52
2897349|NCT00403403|3605147|FG000|Safety-Evaluable Patients|Overall Study||47
3315109|NCT03095638|4048408|FG006|STARTED|P1: Period 2 (4 Days)||0
3315110|NCT03095638|4048409|FG007|STARTED|P1: Period 2 (4 Days)||0
3315111|NCT03095638|4048402|FG000|COMPLETED|P1: Period 2 (4 Days)||7
3315112|NCT03095638|4048403|FG001|COMPLETED|P1: Period 2 (4 Days)||7
3315113|NCT03095638|4048404|FG002|COMPLETED|P1: Period 2 (4 Days)||0
3315114|NCT03095638|4048405|FG003|COMPLETED|P1: Period 2 (4 Days)||0
3315115|NCT03095638|4048406|FG004|COMPLETED|P1: Period 2 (4 Days)||0
3315116|NCT03095638|4048407|FG005|COMPLETED|P1: Period 2 (4 Days)||0
3315117|NCT03095638|4048408|FG006|COMPLETED|P1: Period 2 (4 Days)||0
3315118|NCT03095638|4048409|FG007|COMPLETED|P1: Period 2 (4 Days)||0
3315119|NCT03095638|4048402|FG000|NOT COMPLETED|P1: Period 2 (4 Days)||0
3315120|NCT03095638|4048403|FG001|NOT COMPLETED|P1: Period 2 (4 Days)||0
3315121|NCT03095638|4048404|FG002|NOT COMPLETED|P1: Period 2 (4 Days)||0
3315122|NCT03095638|4048405|FG003|NOT COMPLETED|P1: Period 2 (4 Days)||0
3315123|NCT03095638|4048406|FG004|NOT COMPLETED|P1: Period 2 (4 Days)||0
3315124|NCT03095638|4048407|FG005|NOT COMPLETED|P1: Period 2 (4 Days)||0
3315125|NCT03095638|4048408|FG006|NOT COMPLETED|P1: Period 2 (4 Days)||0
3315126|NCT03095638|4048409|FG007|NOT COMPLETED|P1: Period 2 (4 Days)||0
3315127|NCT03095638|4048402|FG000|STARTED|P1: Period 2, Washout (7[-4 Hours])||7
3315128|NCT03095638|4048403|FG001|STARTED|P1: Period 2, Washout (7[-4 Hours])||7
3315129|NCT03095638|4048404|FG002|STARTED|P1: Period 2, Washout (7[-4 Hours])||0
3315130|NCT03095638|4048405|FG003|STARTED|P1: Period 2, Washout (7[-4 Hours])||0
3315131|NCT03095638|4048406|FG004|STARTED|P1: Period 2, Washout (7[-4 Hours])||0
3315132|NCT03095638|4048407|FG005|STARTED|P1: Period 2, Washout (7[-4 Hours])||0
3315133|NCT03095638|4048408|FG006|STARTED|P1: Period 2, Washout (7[-4 Hours])||0
2897350|NCT00403403|3605148|FG001|Safety-Evaluable Patients|Overall Study||51
2897351|NCT00403403|3605147|FG000|COMPLETED|Overall Study||50
2897352|NCT00403403|3605148|FG001|COMPLETED|Overall Study||52
2897353|NCT00403403|3605147|FG000|NOT COMPLETED|Overall Study||0
2897354|NCT00403403|3605148|FG001|NOT COMPLETED|Overall Study||0
2897355|NCT00403455|3605154|FG000|STARTED|Overall Study||38
2897356|NCT00403455|3605154|FG000|COMPLETED|Overall Study||37
2897357|NCT00403455|3605154|FG000|NOT COMPLETED|Overall Study||1
2897358|NCT00403481|3605158|FG000|STARTED|Olmesartan Medoxomil (Olm) 20 mg||192
2897359|NCT00403481|3605158|FG000|COMPLETED|Olmesartan Medoxomil (Olm) 20 mg||186
2897360|NCT00403481|3605158|FG000|NOT COMPLETED|Olmesartan Medoxomil (Olm) 20 mg||6
2897361|NCT00403481|3605158|FG000|STARTED|Olm 40 mg|186 -4 met their blood pressure goal (remained on olmesartan 20 mg) = 182|182
2897362|NCT00403481|3605158|FG000|COMPLETED|Olm 40 mg||177
2897363|NCT00403481|3605158|FG000|NOT COMPLETED|Olm 40 mg||5
2897364|NCT00403481|3605158|FG000|STARTED|Olm 40 mg + Hydrochlorothiazide 12.5 mg|177 -4 met their blood pressure goal (remained on olmesartan 40 mg)= 173|173
2897365|NCT00403481|3605158|FG000|COMPLETED|Olm 40 mg + Hydrochlorothiazide 12.5 mg||168
2897366|NCT00403481|3605158|FG000|NOT COMPLETED|Olm 40 mg + Hydrochlorothiazide 12.5 mg||5
2897367|NCT00403481|3605158|FG000|STARTED|Olm 40 mg + Hydrochlorothiazide 25 mg|168 -24 met their blood pressure goal (remained on olmesartan 40 mg/hydrochlorothiazide 12.5mg)= 144|144
2897368|NCT00403481|3605158|FG000|COMPLETED|Olm 40 mg + Hydrochlorothiazide 25 mg||142
2897369|NCT00403481|3605158|FG000|NOT COMPLETED|Olm 40 mg + Hydrochlorothiazide 25 mg||2
2897370|NCT00403494|3605167|FG000|STARTED|Overall Study||96
2897371|NCT00403494|3605168|FG001|STARTED|Overall Study||94
2897372|NCT00403494|3605167|FG000|Intent to Treat|Overall Study||87
2897373|NCT00403494|3605168|FG001|Intent to Treat|Overall Study||83
2897374|NCT00403494|3605167|FG000|Per-protocol|Overall Study||69
2897375|NCT00403494|3605168|FG001|Per-protocol|Overall Study||69
2897376|NCT00403494|3605167|FG000|Safety Population|Overall Study||97
2897377|NCT00403494|3605168|FG001|Safety Population|Overall Study||91
2897378|NCT00403494|3605167|FG000|COMPLETED|Overall Study||81
2897379|NCT00403494|3605168|FG001|COMPLETED|Overall Study||80
2897380|NCT00403494|3605167|FG000|NOT COMPLETED|Overall Study||15
2897381|NCT00403494|3605168|FG001|NOT COMPLETED|Overall Study||14
2897382|NCT00403546|3605178|FG000|STARTED|Signed Informed Consent/Open-Label||131
2897383|NCT00403546|3605179|FG001|STARTED|Signed Informed Consent/Open-Label||0
2897384|NCT00403546|3605180|FG002|STARTED|Signed Informed Consent/Open-Label||0
2897385|NCT00403546|3605178|FG000|COMPLETED|Signed Informed Consent/Open-Label||103
2897386|NCT00403546|3605179|FG001|COMPLETED|Signed Informed Consent/Open-Label||0
2897387|NCT00403546|3605180|FG002|COMPLETED|Signed Informed Consent/Open-Label||0
2897388|NCT00403546|3605178|FG000|NOT COMPLETED|Signed Informed Consent/Open-Label||28
2897389|NCT00403546|3605179|FG001|NOT COMPLETED|Signed Informed Consent/Open-Label||0
2897390|NCT00403546|3605180|FG002|NOT COMPLETED|Signed Informed Consent/Open-Label||0
2897391|NCT00403546|3605178|FG000|STARTED|Screening Phase||103
2897392|NCT00403546|3605179|FG001|STARTED|Screening Phase||0
2897393|NCT00403546|3605180|FG002|STARTED|Screening Phase||0
2897394|NCT00403546|3605178|FG000|COMPLETED|Screening Phase|All participants who completed Screening were randomized to the High-Dose and Placebo arms.|75
2897395|NCT00403546|3605179|FG001|COMPLETED|Screening Phase||0
2897396|NCT00403546|3605180|FG002|COMPLETED|Screening Phase||0
2897397|NCT00403546|3605178|FG000|NOT COMPLETED|Screening Phase||28
2897398|NCT00403546|3605179|FG001|NOT COMPLETED|Screening Phase||0
2897399|NCT00403546|3605180|FG002|NOT COMPLETED|Screening Phase||0
2897400|NCT00403546|3605178|FG000|STARTED|Randomized Trial|All participants who completed Screening were randomized to the High-Dose and Placebo arms.|0
2897401|NCT00403546|3605179|FG001|STARTED|Randomized Trial||38
2897402|NCT00403546|3605180|FG002|STARTED|Randomized Trial||37
2897403|NCT00403546|3605178|FG000|COMPLETED|Randomized Trial||0
3315134|NCT03095638|4048409|FG007|STARTED|P1: Period 2, Washout (7[-4 Hours])||0
3315135|NCT03095638|4048402|FG000|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||7
3315136|NCT03095638|4048403|FG001|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||7
3315137|NCT03095638|4048404|FG002|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
3315138|NCT03095638|4048405|FG003|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
3315139|NCT03095638|4048406|FG004|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
3315140|NCT03095638|4048407|FG005|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
3315141|NCT03095638|4048408|FG006|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
3315142|NCT03095638|4048409|FG007|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
3315143|NCT03095638|4048402|FG000|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
3315144|NCT03095638|4048403|FG001|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
3315145|NCT03095638|4048404|FG002|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
3315146|NCT03095638|4048405|FG003|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
3315147|NCT03095638|4048406|FG004|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
3315148|NCT03095638|4048407|FG005|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
3315149|NCT03095638|4048408|FG006|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
3315150|NCT03095638|4048409|FG007|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
3315151|NCT03095638|4048402|FG000|STARTED|P2: Period 1 (4 Days)||0
3315152|NCT03095638|4048403|FG001|STARTED|P2: Period 1 (4 Days)||0
3315153|NCT03095638|4048404|FG002|STARTED|P2: Period 1 (4 Days)||4
3315154|NCT03095638|4048405|FG003|STARTED|P2: Period 1 (4 Days)||4
3315155|NCT03095638|4048406|FG004|STARTED|P2: Period 1 (4 Days)||4
3315156|NCT03095638|4048407|FG005|STARTED|P2: Period 1 (4 Days)||4
3315157|NCT03095638|4048408|FG006|STARTED|P2: Period 1 (4 Days)||4
3315158|NCT03095638|4048409|FG007|STARTED|P2: Period 1 (4 Days)||4
3315159|NCT03095638|4048402|FG000|COMPLETED|P2: Period 1 (4 Days)||0
2897404|NCT00403546|3605179|FG001|COMPLETED|Randomized Trial||21
2897405|NCT00403546|3605180|FG002|COMPLETED|Randomized Trial||21
2897406|NCT00403546|3605178|FG000|NOT COMPLETED|Randomized Trial||0
2897407|NCT00403546|3605179|FG001|NOT COMPLETED|Randomized Trial||17
2897408|NCT00403546|3605180|FG002|NOT COMPLETED|Randomized Trial||16
2897409|NCT00403585|3605189|FG000|STARTED|Initial Treatment Phase||104
2897410|NCT00403585|3605189|FG000|COMPLETED|Initial Treatment Phase||102
2897411|NCT00403585|3605189|FG000|NOT COMPLETED|Initial Treatment Phase||2
2897412|NCT00403585|3605189|FG000|STARTED|Open-Label Phase; Extension Study|80 of 102 participants completing Study 103814 enrolled in extension (22 didn't continue medication)|80
2897413|NCT00403585|3605189|FG000|COMPLETED|Open-Label Phase; Extension Study||74
2897414|NCT00403585|3605189|FG000|NOT COMPLETED|Open-Label Phase; Extension Study||6
2897415|NCT00403754|3605193|FG000|STARTED|Core Treatment Period 1||11
2897416|NCT00403754|3605194|FG001|STARTED|Core Treatment Period 1||10
2897417|NCT00403754|3605195|FG002|STARTED|Core Treatment Period 1||9
2897418|NCT00403754|3605196|FG003|STARTED|Core Treatment Period 1||11
2897419|NCT00403754|3605193|FG000|COMPLETED|Core Treatment Period 1||11
2897420|NCT00403754|3605194|FG001|COMPLETED|Core Treatment Period 1||9
2897421|NCT00403754|3605195|FG002|COMPLETED|Core Treatment Period 1||9
2897422|NCT00403754|3605196|FG003|COMPLETED|Core Treatment Period 1||11
2897423|NCT00403754|3605193|FG000|NOT COMPLETED|Core Treatment Period 1||0
2897424|NCT00403754|3605194|FG001|NOT COMPLETED|Core Treatment Period 1||1
2897425|NCT00403754|3605195|FG002|NOT COMPLETED|Core Treatment Period 1||0
2897426|NCT00403754|3605196|FG003|NOT COMPLETED|Core Treatment Period 1||0
2897427|NCT00403754|3605193|FG000|STARTED|Core Treatment Period 2||11
2897428|NCT00403754|3605194|FG001|STARTED|Core Treatment Period 2||9
2897429|NCT00403754|3605195|FG002|STARTED|Core Treatment Period 2||9
2897430|NCT00403754|3605196|FG003|STARTED|Core Treatment Period 2||11
2897431|NCT00403754|3605193|FG000|COMPLETED|Core Treatment Period 2||11
2897432|NCT00403754|3605194|FG001|COMPLETED|Core Treatment Period 2||9
2897433|NCT00403754|3605195|FG002|COMPLETED|Core Treatment Period 2||8
2897434|NCT00403754|3605196|FG003|COMPLETED|Core Treatment Period 2||11
2897435|NCT00403754|3605193|FG000|NOT COMPLETED|Core Treatment Period 2||0
2897436|NCT00403754|3605194|FG001|NOT COMPLETED|Core Treatment Period 2||0
2897437|NCT00403754|3605195|FG002|NOT COMPLETED|Core Treatment Period 2||1
2897438|NCT00403754|3605196|FG003|NOT COMPLETED|Core Treatment Period 2||0
2897439|NCT00403754|3605193|FG000|STARTED|Core Treatment Period 3||11
2897440|NCT00403754|3605194|FG001|STARTED|Core Treatment Period 3||9
2897441|NCT00403754|3605195|FG002|STARTED|Core Treatment Period 3||8
2897442|NCT00403754|3605196|FG003|STARTED|Core Treatment Period 3||11
2897443|NCT00403754|3605193|FG000|COMPLETED|Core Treatment Period 3||11
2897444|NCT00403754|3605194|FG001|COMPLETED|Core Treatment Period 3||9
2897445|NCT00403754|3605195|FG002|COMPLETED|Core Treatment Period 3||8
2897446|NCT00403754|3605196|FG003|COMPLETED|Core Treatment Period 3||11
2897447|NCT00403754|3605193|FG000|NOT COMPLETED|Core Treatment Period 3||0
2897448|NCT00403754|3605194|FG001|NOT COMPLETED|Core Treatment Period 3||0
2897449|NCT00403754|3605195|FG002|NOT COMPLETED|Core Treatment Period 3||0
2897450|NCT00403754|3605196|FG003|NOT COMPLETED|Core Treatment Period 3||0
2897451|NCT00403754|3605193|FG000|STARTED|Core Treatment Period 4||11
2897452|NCT00403754|3605194|FG001|STARTED|Core Treatment Period 4||9
2897453|NCT00403754|3605195|FG002|STARTED|Core Treatment Period 4||8
2897454|NCT00403754|3605196|FG003|STARTED|Core Treatment Period 4||11
2897455|NCT00403754|3605193|FG000|COMPLETED|Core Treatment Period 4||11
2897456|NCT00403754|3605194|FG001|COMPLETED|Core Treatment Period 4||9
2897457|NCT00403754|3605195|FG002|COMPLETED|Core Treatment Period 4||8
2897458|NCT00403754|3605196|FG003|COMPLETED|Core Treatment Period 4||11
2897459|NCT00403754|3605193|FG000|NOT COMPLETED|Core Treatment Period 4||0
2897460|NCT00403754|3605194|FG001|NOT COMPLETED|Core Treatment Period 4||0
2897461|NCT00403754|3605195|FG002|NOT COMPLETED|Core Treatment Period 4||0
2897462|NCT00403754|3605196|FG003|NOT COMPLETED|Core Treatment Period 4||0
2897463|NCT00403754|3605193|FG000|STARTED|Open Label: Salmeterol||11
2897464|NCT00403754|3605194|FG001|STARTED|Open Label: Salmeterol||9
2897465|NCT00403754|3605195|FG002|STARTED|Open Label: Salmeterol||8
2897466|NCT00403754|3605196|FG003|STARTED|Open Label: Salmeterol||11
2897467|NCT00403754|3605193|FG000|COMPLETED|Open Label: Salmeterol||11
2897468|NCT00403754|3605194|FG001|COMPLETED|Open Label: Salmeterol||9
2897469|NCT00403754|3605195|FG002|COMPLETED|Open Label: Salmeterol||8
2897470|NCT00403754|3605196|FG003|COMPLETED|Open Label: Salmeterol||11
2897471|NCT00403754|3605193|FG000|NOT COMPLETED|Open Label: Salmeterol||0
2897472|NCT00403754|3605194|FG001|NOT COMPLETED|Open Label: Salmeterol||0
2897473|NCT00403754|3605195|FG002|NOT COMPLETED|Open Label: Salmeterol||0
2897474|NCT00403754|3605196|FG003|NOT COMPLETED|Open Label: Salmeterol||0
2897475|NCT00403767|3605210|FG000|STARTED|Overall Study||7111
2897476|NCT00403767|3605211|FG001|STARTED|Overall Study||7125
2897477|NCT00403767|3605210|FG000|COMPLETED|Overall Study||4591
2897478|NCT00403767|3605211|FG001|COMPLETED|Overall Study||4657
2897479|NCT00403767|3605210|FG000|NOT COMPLETED|Overall Study||2520
3315160|NCT03095638|4048403|FG001|COMPLETED|P2: Period 1 (4 Days)||0
3315161|NCT03095638|4048404|FG002|COMPLETED|P2: Period 1 (4 Days)||4
3315162|NCT03095638|4048405|FG003|COMPLETED|P2: Period 1 (4 Days)||4
3315163|NCT03095638|4048406|FG004|COMPLETED|P2: Period 1 (4 Days)||4
3315164|NCT03095638|4048407|FG005|COMPLETED|P2: Period 1 (4 Days)||4
3315165|NCT03095638|4048408|FG006|COMPLETED|P2: Period 1 (4 Days)||4
3315166|NCT03095638|4048409|FG007|COMPLETED|P2: Period 1 (4 Days)||4
3315167|NCT03095638|4048402|FG000|NOT COMPLETED|P2: Period 1 (4 Days)||0
3315168|NCT03095638|4048403|FG001|NOT COMPLETED|P2: Period 1 (4 Days)||0
3315169|NCT03095638|4048404|FG002|NOT COMPLETED|P2: Period 1 (4 Days)||0
3315170|NCT03095638|4048405|FG003|NOT COMPLETED|P2: Period 1 (4 Days)||0
3315171|NCT03095638|4048406|FG004|NOT COMPLETED|P2: Period 1 (4 Days)||0
3315172|NCT03095638|4048407|FG005|NOT COMPLETED|P2: Period 1 (4 Days)||0
3315173|NCT03095638|4048408|FG006|NOT COMPLETED|P2: Period 1 (4 Days)||0
2897480|NCT00403767|3605211|FG001|NOT COMPLETED|Overall Study||2468
2897481|NCT00403845|3605217|FG000|STARTED|Treatment Period 1||12
2897482|NCT00403845|3605218|FG001|STARTED|Treatment Period 1||13
2897483|NCT00403845|3605219|FG002|STARTED|Treatment Period 1||11
2897484|NCT00403845|3605220|FG003|STARTED|Treatment Period 1||14
2897485|NCT00403845|3605217|FG000|COMPLETED|Treatment Period 1||11
2897486|NCT00403845|3605218|FG001|COMPLETED|Treatment Period 1||13
2897487|NCT00403845|3605219|FG002|COMPLETED|Treatment Period 1||11
2897488|NCT00403845|3605220|FG003|COMPLETED|Treatment Period 1||13
2897489|NCT00403845|3605217|FG000|NOT COMPLETED|Treatment Period 1||1
2897490|NCT00403845|3605218|FG001|NOT COMPLETED|Treatment Period 1||0
2897491|NCT00403845|3605219|FG002|NOT COMPLETED|Treatment Period 1||0
2897492|NCT00403845|3605220|FG003|NOT COMPLETED|Treatment Period 1||1
2897493|NCT00403845|3605217|FG000|STARTED|Treatment Period 2||11
2897494|NCT00403845|3605218|FG001|STARTED|Treatment Period 2||13
2897495|NCT00403845|3605219|FG002|STARTED|Treatment Period 2||11
2897496|NCT00403845|3605220|FG003|STARTED|Treatment Period 2||13
2897497|NCT00403845|3605217|FG000|COMPLETED|Treatment Period 2||10
2897498|NCT00403845|3605218|FG001|COMPLETED|Treatment Period 2||13
2897499|NCT00403845|3605219|FG002|COMPLETED|Treatment Period 2||11
2897500|NCT00403845|3605220|FG003|COMPLETED|Treatment Period 2||13
2897501|NCT00403845|3605217|FG000|NOT COMPLETED|Treatment Period 2||1
2897502|NCT00403845|3605218|FG001|NOT COMPLETED|Treatment Period 2||0
2897503|NCT00403845|3605219|FG002|NOT COMPLETED|Treatment Period 2||0
2897504|NCT00403845|3605220|FG003|NOT COMPLETED|Treatment Period 2||0
2897505|NCT00403845|3605217|FG000|STARTED|Treatment Period 3||10
2897506|NCT00403845|3605218|FG001|STARTED|Treatment Period 3||13
2897507|NCT00403845|3605219|FG002|STARTED|Treatment Period 3||11
2897508|NCT00403845|3605220|FG003|STARTED|Treatment Period 3||13
2897509|NCT00403845|3605217|FG000|COMPLETED|Treatment Period 3||10
2897510|NCT00403845|3605218|FG001|COMPLETED|Treatment Period 3||13
2897511|NCT00403845|3605219|FG002|COMPLETED|Treatment Period 3||11
2897512|NCT00403845|3605220|FG003|COMPLETED|Treatment Period 3||11
2897513|NCT00403845|3605217|FG000|NOT COMPLETED|Treatment Period 3||0
2897514|NCT00403845|3605218|FG001|NOT COMPLETED|Treatment Period 3||0
2897515|NCT00403845|3605219|FG002|NOT COMPLETED|Treatment Period 3||0
2897516|NCT00403845|3605220|FG003|NOT COMPLETED|Treatment Period 3||2
2897517|NCT00403845|3605217|FG000|STARTED|Treatment Period 4||10
2897518|NCT00403845|3605218|FG001|STARTED|Treatment Period 4||13
2897519|NCT00403845|3605219|FG002|STARTED|Treatment Period 4||11
2897520|NCT00403845|3605220|FG003|STARTED|Treatment Period 4||11
2897521|NCT00403845|3605217|FG000|COMPLETED|Treatment Period 4||10
2897522|NCT00403845|3605218|FG001|COMPLETED|Treatment Period 4||13
2897523|NCT00403845|3605219|FG002|COMPLETED|Treatment Period 4||11
2897524|NCT00403845|3605220|FG003|COMPLETED|Treatment Period 4||11
2897525|NCT00403845|3605217|FG000|NOT COMPLETED|Treatment Period 4||0
2897526|NCT00403845|3605218|FG001|NOT COMPLETED|Treatment Period 4||0
2897527|NCT00403845|3605219|FG002|NOT COMPLETED|Treatment Period 4||0
2897528|NCT00403845|3605220|FG003|NOT COMPLETED|Treatment Period 4||0
2897529|NCT00404066|3605230|FG000|STARTED|Overall Study|1 subject started but withdrew after adriamycin+cytoxan, but before study drugs lapatinib+docetaxel.|21
2897530|NCT00404066|3605230|FG000|COMPLETED|Overall Study||18
2897531|NCT00404066|3605230|FG000|NOT COMPLETED|Overall Study||3
2897532|NCT00404079|3605236|FG000|STARTED|Overall Study||125
2897533|NCT00404079|3605237|FG001|STARTED|Overall Study||125
2897534|NCT00404079|3605236|FG000|COMPLETED|Overall Study||103
2897535|NCT00404079|3605237|FG001|COMPLETED|Overall Study||105
2897536|NCT00404079|3605236|FG000|NOT COMPLETED|Overall Study||22
3170841|NCT01931475|3898106|FG001|COMPLETED|Period 2: Extension Treatment Phase||157
3170842|NCT01931475|3898105|FG000|NOT COMPLETED|Period 2: Extension Treatment Phase||4
3170843|NCT01931475|3898106|FG001|NOT COMPLETED|Period 2: Extension Treatment Phase||19
3170844|NCT01931527|3898119|FG000|STARTED|Overall Study||16
3170845|NCT01931527|3898120|FG001|STARTED|Overall Study||15
3170846|NCT01931527|3898119|FG000|COMPLETED|Overall Study||16
2897537|NCT00404079|3605237|FG001|NOT COMPLETED|Overall Study||20
2897538|NCT00404092|3605247|FG000|STARTED|Overall Study||9
2897539|NCT00404092|3605248|FG001|STARTED|Overall Study||8
2897540|NCT00404092|3605249|FG002|STARTED|Overall Study||9
2897541|NCT00404092|3605250|FG003|STARTED|Overall Study||20
2897542|NCT00404092|3605247|FG000|COMPLETED|Overall Study||8
2897543|NCT00404092|3605248|FG001|COMPLETED|Overall Study||8
2897544|NCT00404092|3605249|FG002|COMPLETED|Overall Study||8
2897545|NCT00404092|3605250|FG003|COMPLETED|Overall Study||20
2897546|NCT00404092|3605247|FG000|NOT COMPLETED|Overall Study||1
2897547|NCT00404092|3605248|FG001|NOT COMPLETED|Overall Study||0
2897548|NCT00404092|3605249|FG002|NOT COMPLETED|Overall Study||1
2897549|NCT00404092|3605250|FG003|NOT COMPLETED|Overall Study||0
2897550|NCT00404235|3605262|FG000|STARTED|Overall Study||35
2897551|NCT00404235|3605263|FG001|STARTED|Overall Study||41
2897552|NCT00404235|3605262|FG000|COMPLETED|Overall Study||34
2897553|NCT00404235|3605263|FG001|COMPLETED|Overall Study||39
2897554|NCT00404235|3605262|FG000|NOT COMPLETED|Overall Study||1
2897555|NCT00404235|3605263|FG001|NOT COMPLETED|Overall Study||2
2897556|NCT00404248|3605272|FG000|STARTED|Overall Study||3
2897557|NCT00404248|3605273|FG001|STARTED|Overall Study||4
2897558|NCT00404248|3605274|FG002|STARTED|Overall Study||5
2897559|NCT00404248|3605275|FG003|STARTED|Overall Study||2
2897560|NCT00404248|3605276|FG004|STARTED|Overall Study||3
2897561|NCT00404248|3605277|FG005|STARTED|Overall Study||3
2897562|NCT00404248|3605278|FG006|STARTED|Overall Study||6
2897563|NCT00404248|3605279|FG007|STARTED|Overall Study||6
2897564|NCT00404248|3605280|FG008|STARTED|Overall Study||3
2897565|NCT00404248|3605272|FG000|COMPLETED|Overall Study||3
2897566|NCT00404248|3605273|FG001|COMPLETED|Overall Study||3
2897567|NCT00404248|3605274|FG002|COMPLETED|Overall Study||5
2897568|NCT00404248|3605275|FG003|COMPLETED|Overall Study||2
2897569|NCT00404248|3605276|FG004|COMPLETED|Overall Study||3
2897570|NCT00404248|3605277|FG005|COMPLETED|Overall Study||3
2897571|NCT00404248|3605278|FG006|COMPLETED|Overall Study||6
2897572|NCT00404248|3605279|FG007|COMPLETED|Overall Study||6
2897573|NCT00404248|3605280|FG008|COMPLETED|Overall Study||3
2897574|NCT00404248|3605272|FG000|NOT COMPLETED|Overall Study||0
2897575|NCT00404248|3605273|FG001|NOT COMPLETED|Overall Study||1
2897576|NCT00404248|3605274|FG002|NOT COMPLETED|Overall Study||0
2897577|NCT00404248|3605275|FG003|NOT COMPLETED|Overall Study||0
2897578|NCT00404248|3605276|FG004|NOT COMPLETED|Overall Study||0
2897579|NCT00404248|3605277|FG005|NOT COMPLETED|Overall Study||0
2897580|NCT00404248|3605278|FG006|NOT COMPLETED|Overall Study||0
2897581|NCT00404248|3605279|FG007|NOT COMPLETED|Overall Study||0
2897582|NCT00404248|3605280|FG008|NOT COMPLETED|Overall Study||0
2897583|NCT00404352|3605309|FG000|STARTED|Double Blind (up to 24 Month)||171
2897584|NCT00404352|3605310|FG001|STARTED|Double Blind (up to 24 Month)||175
2897585|NCT00404352|3605311|FG002|STARTED|Double Blind (up to 24 Month)||171
2897586|NCT00404352|3605312|FG003|STARTED|Double Blind (up to 24 Month)||0
2897587|NCT00404352|3605313|FG004|STARTED|Double Blind (up to 24 Month)||0
2897588|NCT00404352|3605314|FG005|STARTED|Double Blind (up to 24 Month)||0
2897589|NCT00404352|3605315|FG006|STARTED|Double Blind (up to 24 Month)||0
2897590|NCT00404352|3605316|FG007|STARTED|Double Blind (up to 24 Month)||0
2897591|NCT00404352|3605317|FG008|STARTED|Double Blind (up to 24 Month)||0
2897592|NCT00404352|3605309|FG000|Treated|Double Blind (up to 24 Month)||171
2897593|NCT00404352|3605310|FG001|Treated|Double Blind (up to 24 Month)||173
2897594|NCT00404352|3605311|FG002|Treated|Double Blind (up to 24 Month)||171
2897595|NCT00404352|3605312|FG003|Treated|Double Blind (up to 24 Month)||0
2897596|NCT00404352|3605313|FG004|Treated|Double Blind (up to 24 Month)||0
2897597|NCT00404352|3605314|FG005|Treated|Double Blind (up to 24 Month)||0
2897598|NCT00404352|3605315|FG006|Treated|Double Blind (up to 24 Month)||0
2897599|NCT00404352|3605316|FG007|Treated|Double Blind (up to 24 Month)||0
2897600|NCT00404352|3605317|FG008|Treated|Double Blind (up to 24 Month)||0
2897601|NCT00404352|3605309|FG000|COMPLETED|Double Blind (up to 24 Month)||119
2897602|NCT00404352|3605310|FG001|COMPLETED|Double Blind (up to 24 Month)||128
2897603|NCT00404352|3605311|FG002|COMPLETED|Double Blind (up to 24 Month)||92
2897604|NCT00404352|3605312|FG003|COMPLETED|Double Blind (up to 24 Month)||0
2897605|NCT00404352|3605313|FG004|COMPLETED|Double Blind (up to 24 Month)||0
2897606|NCT00404352|3605314|FG005|COMPLETED|Double Blind (up to 24 Month)||0
2897607|NCT00404352|3605315|FG006|COMPLETED|Double Blind (up to 24 Month)||0
2897608|NCT00404352|3605316|FG007|COMPLETED|Double Blind (up to 24 Month)||0
2897609|NCT00404352|3605317|FG008|COMPLETED|Double Blind (up to 24 Month)||0
2897610|NCT00404352|3605309|FG000|NOT COMPLETED|Double Blind (up to 24 Month)||52
2897611|NCT00404352|3605310|FG001|NOT COMPLETED|Double Blind (up to 24 Month)||47
2897612|NCT00404352|3605311|FG002|NOT COMPLETED|Double Blind (up to 24 Month)||79
2897613|NCT00404352|3605312|FG003|NOT COMPLETED|Double Blind (up to 24 Month)||0
2897614|NCT00404352|3605313|FG004|NOT COMPLETED|Double Blind (up to 24 Month)||0
2897615|NCT00404352|3605314|FG005|NOT COMPLETED|Double Blind (up to 24 Month)||0
2897616|NCT00404352|3605315|FG006|NOT COMPLETED|Double Blind (up to 24 Month)||0
2897617|NCT00404352|3605316|FG007|NOT COMPLETED|Double Blind (up to 24 Month)||0
2897618|NCT00404352|3605317|FG008|NOT COMPLETED|Double Blind (up to 24 Month)||0
2897619|NCT00404352|3605309|FG000|STARTED|Open Label (up to 24 Month)||0
2897620|NCT00404352|3605310|FG001|STARTED|Open Label (up to 24 Month)||0
2897621|NCT00404352|3605311|FG002|STARTED|Open Label (up to 24 Month)||0
2897622|NCT00404352|3605312|FG003|STARTED|Open Label (up to 24 Month)|From DB period, 31 participants converted to CDMS and switched to OL period in this study|31
2897623|NCT00404352|3605313|FG004|STARTED|Open Label (up to 24 Month)|From DB period, 30 participants converted to CDMS and switched to OL period in this study|30
2897624|NCT00404352|3605314|FG005|STARTED|Open Label (up to 24 Month)|From DB period, 59 participants converted to CDMS and switched to OL period in this study|59
2897625|NCT00404352|3605315|FG006|STARTED|Open Label (up to 24 Month)||0
2897626|NCT00404352|3605316|FG007|STARTED|Open Label (up to 24 Month)||0
2897627|NCT00404352|3605317|FG008|STARTED|Open Label (up to 24 Month)||0
2897628|NCT00404352|3605309|FG000|COMPLETED|Open Label (up to 24 Month)||0
2897629|NCT00404352|3605310|FG001|COMPLETED|Open Label (up to 24 Month)||0
2897630|NCT00404352|3605311|FG002|COMPLETED|Open Label (up to 24 Month)||0
2897631|NCT00404352|3605312|FG003|COMPLETED|Open Label (up to 24 Month)||28
2897632|NCT00404352|3605313|FG004|COMPLETED|Open Label (up to 24 Month)||28
2897633|NCT00404352|3605314|FG005|COMPLETED|Open Label (up to 24 Month)||52
2897634|NCT00404352|3605315|FG006|COMPLETED|Open Label (up to 24 Month)||0
2897635|NCT00404352|3605316|FG007|COMPLETED|Open Label (up to 24 Month)||0
2897636|NCT00404352|3605317|FG008|COMPLETED|Open Label (up to 24 Month)||0
2897637|NCT00404352|3605309|FG000|NOT COMPLETED|Open Label (up to 24 Month)||0
2897638|NCT00404352|3605310|FG001|NOT COMPLETED|Open Label (up to 24 Month)||0
2897639|NCT00404352|3605311|FG002|NOT COMPLETED|Open Label (up to 24 Month)||0
2897640|NCT00404352|3605312|FG003|NOT COMPLETED|Open Label (up to 24 Month)||3
2897641|NCT00404352|3605313|FG004|NOT COMPLETED|Open Label (up to 24 Month)||2
2897642|NCT00404352|3605314|FG005|NOT COMPLETED|Open Label (up to 24 Month)||7
2897643|NCT00404352|3605315|FG006|NOT COMPLETED|Open Label (up to 24 Month)||0
2897644|NCT00404352|3605316|FG007|NOT COMPLETED|Open Label (up to 24 Month)||0
2897645|NCT00404352|3605317|FG008|NOT COMPLETED|Open Label (up to 24 Month)||0
2897646|NCT00404352|3605309|FG000|STARTED|Open Label Extension (up to 36 Months)||0
2897647|NCT00404352|3605310|FG001|STARTED|Open Label Extension (up to 36 Months)||0
2897648|NCT00404352|3605311|FG002|STARTED|Open Label Extension (up to 36 Months)||0
2897649|NCT00404352|3605312|FG003|STARTED|Open Label Extension (up to 36 Months)||0
2897650|NCT00404352|3605313|FG004|STARTED|Open Label Extension (up to 36 Months)||0
2897651|NCT00404352|3605314|FG005|STARTED|Open Label Extension (up to 36 Months)||0
2897652|NCT00404352|3605315|FG006|STARTED|Open Label Extension (up to 36 Months)|4 participants who did not convert to CDMS in 24 months and gave consent to enroll in OLE period|4
2897653|NCT00404352|3605316|FG007|STARTED|Open Label Extension (up to 36 Months)|5 participants who did not convert to CDMS in 24 months and gave consent to enroll in OLE period|5
2897654|NCT00404352|3605317|FG008|STARTED|Open Label Extension (up to 36 Months)|11 participants who did not convert to CDMS in 24 months and gave consent to enroll in OLE period|11
2897655|NCT00404352|3605309|FG000|COMPLETED|Open Label Extension (up to 36 Months)||0
2897656|NCT00404352|3605310|FG001|COMPLETED|Open Label Extension (up to 36 Months)||0
2897657|NCT00404352|3605311|FG002|COMPLETED|Open Label Extension (up to 36 Months)||0
2897658|NCT00404352|3605312|FG003|COMPLETED|Open Label Extension (up to 36 Months)||0
2897659|NCT00404352|3605313|FG004|COMPLETED|Open Label Extension (up to 36 Months)||0
2897660|NCT00404352|3605314|FG005|COMPLETED|Open Label Extension (up to 36 Months)||0
2897661|NCT00404352|3605315|FG006|COMPLETED|Open Label Extension (up to 36 Months)||3
2897662|NCT00404352|3605316|FG007|COMPLETED|Open Label Extension (up to 36 Months)||4
2897663|NCT00404352|3605317|FG008|COMPLETED|Open Label Extension (up to 36 Months)||9
2897664|NCT00404352|3605309|FG000|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
2897665|NCT00404352|3605310|FG001|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
2897666|NCT00404352|3605311|FG002|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
2897667|NCT00404352|3605312|FG003|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
2897668|NCT00404352|3605313|FG004|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
3315174|NCT03095638|4048409|FG007|NOT COMPLETED|P2: Period 1 (4 Days)||0
3315175|NCT03095638|4048402|FG000|STARTED|P2: Period 1, Washout (7[-4 Hours])||0
3315176|NCT03095638|4048403|FG001|STARTED|P2: Period 1, Washout (7[-4 Hours])||0
3315177|NCT03095638|4048404|FG002|STARTED|P2: Period 1, Washout (7[-4 Hours])||4
3315178|NCT03095638|4048405|FG003|STARTED|P2: Period 1, Washout (7[-4 Hours])||4
3315179|NCT03095638|4048406|FG004|STARTED|P2: Period 1, Washout (7[-4 Hours])||4
3315180|NCT03095638|4048407|FG005|STARTED|P2: Period 1, Washout (7[-4 Hours])||4
3315181|NCT03095638|4048408|FG006|STARTED|P2: Period 1, Washout (7[-4 Hours])||4
3315182|NCT03095638|4048409|FG007|STARTED|P2: Period 1, Washout (7[-4 Hours])||4
3315183|NCT03095638|4048402|FG000|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
3315184|NCT03095638|4048403|FG001|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
3315185|NCT03095638|4048404|FG002|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||4
3315186|NCT03095638|4048405|FG003|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||4
3315187|NCT03095638|4048406|FG004|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||4
3315188|NCT03095638|4048407|FG005|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||4
3315189|NCT03095638|4048408|FG006|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||4
3315190|NCT03095638|4048409|FG007|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||4
3315191|NCT03095638|4048402|FG000|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
3315192|NCT03095638|4048403|FG001|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
3315193|NCT03095638|4048404|FG002|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
3315194|NCT03095638|4048405|FG003|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
3315195|NCT03095638|4048406|FG004|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
3315196|NCT03095638|4048407|FG005|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
3315197|NCT03095638|4048408|FG006|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
3315198|NCT03095638|4048409|FG007|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
3315199|NCT03095638|4048402|FG000|STARTED|P2: Period 2 (4 Days)||0
3315200|NCT03095638|4048403|FG001|STARTED|P2: Period 2 (4 Days)||0
3315201|NCT03095638|4048404|FG002|STARTED|P2: Period 2 (4 Days)||4
3315202|NCT03095638|4048405|FG003|STARTED|P2: Period 2 (4 Days)||4
3315203|NCT03095638|4048406|FG004|STARTED|P2: Period 2 (4 Days)||4
3315204|NCT03095638|4048407|FG005|STARTED|P2: Period 2 (4 Days)||4
3315205|NCT03095638|4048408|FG006|STARTED|P2: Period 2 (4 Days)||4
3315206|NCT03095638|4048409|FG007|STARTED|P2: Period 2 (4 Days)||4
3315207|NCT03095638|4048402|FG000|COMPLETED|P2: Period 2 (4 Days)||0
3315208|NCT03095638|4048403|FG001|COMPLETED|P2: Period 2 (4 Days)||0
3315209|NCT03095638|4048404|FG002|COMPLETED|P2: Period 2 (4 Days)||4
3315210|NCT03095638|4048405|FG003|COMPLETED|P2: Period 2 (4 Days)||4
3315211|NCT03095638|4048406|FG004|COMPLETED|P2: Period 2 (4 Days)||4
3315212|NCT03095638|4048407|FG005|COMPLETED|P2: Period 2 (4 Days)||4
3315213|NCT03095638|4048408|FG006|COMPLETED|P2: Period 2 (4 Days)||4
3315214|NCT03095638|4048409|FG007|COMPLETED|P2: Period 2 (4 Days)||4
3315215|NCT03095638|4048402|FG000|NOT COMPLETED|P2: Period 2 (4 Days)||0
3315216|NCT03095638|4048403|FG001|NOT COMPLETED|P2: Period 2 (4 Days)||0
3315217|NCT03095638|4048404|FG002|NOT COMPLETED|P2: Period 2 (4 Days)||0
3315218|NCT03095638|4048405|FG003|NOT COMPLETED|P2: Period 2 (4 Days)||0
3315219|NCT03095638|4048406|FG004|NOT COMPLETED|P2: Period 2 (4 Days)||0
3315220|NCT03095638|4048407|FG005|NOT COMPLETED|P2: Period 2 (4 Days)||0
3315221|NCT03095638|4048408|FG006|NOT COMPLETED|P2: Period 2 (4 Days)||0
3315222|NCT03095638|4048409|FG007|NOT COMPLETED|P2: Period 2 (4 Days)||0
3317232|NCT03124693|4050764|FG000|COMPLETED|Overall Study||90
2897669|NCT00404352|3605314|FG005|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
2897670|NCT00404352|3605315|FG006|NOT COMPLETED|Open Label Extension (up to 36 Months)||1
2897671|NCT00404352|3605316|FG007|NOT COMPLETED|Open Label Extension (up to 36 Months)||1
2897672|NCT00404352|3605317|FG008|NOT COMPLETED|Open Label Extension (up to 36 Months)||2
3170847|NCT01931527|3898120|FG001|COMPLETED|Overall Study||15
3170848|NCT01931527|3898119|FG000|NOT COMPLETED|Overall Study||0
3170849|NCT01931527|3898120|FG001|NOT COMPLETED|Overall Study||0
3170850|NCT01931566|3898133|FG000|STARTED|Overall Study||433
3170851|NCT01931566|3898134|FG001|STARTED|Overall Study||1516
3170852|NCT01931566|3898135|FG002|STARTED|Overall Study||1545
2897673|NCT00404495|3605336|FG000|STARTED|Overall Study||66
2897674|NCT00404495|3605337|FG001|STARTED|Overall Study||17
2897675|NCT00404495|3605336|FG000|COMPLETED|Overall Study||22
2897676|NCT00404495|3605337|FG001|COMPLETED|Overall Study||6
2897677|NCT00404495|3605336|FG000|NOT COMPLETED|Overall Study||44
2897678|NCT00404495|3605337|FG001|NOT COMPLETED|Overall Study||11
2897679|NCT00404547|3605345|FG000|STARTED|Overall Study||762
2897680|NCT00404547|3605346|FG001|STARTED|Overall Study||359
2897681|NCT00404547|3605345|FG000|COMPLETED|Overall Study||672
2897682|NCT00404547|3605346|FG001|COMPLETED|Overall Study||334
2897683|NCT00404547|3605345|FG000|NOT COMPLETED|Overall Study||90
2897684|NCT00404547|3605346|FG001|NOT COMPLETED|Overall Study||25
2897685|NCT00404651|3605356|FG000|STARTED|Overall Study||340
2897686|NCT00404651|3605357|FG001|STARTED|Overall Study||343
2897687|NCT00404651|3605358|FG002|STARTED|Overall Study||339
2897688|NCT00404651|3605359|FG003|STARTED|Overall Study||167
2897689|NCT00404651|3605356|FG000|COMPLETED|Overall Study||301
2897690|NCT00404651|3605357|FG001|COMPLETED|Overall Study||315
2897691|NCT00404651|3605358|FG002|COMPLETED|Overall Study||294
2897692|NCT00404651|3605359|FG003|COMPLETED|Overall Study||146
2897693|NCT00404651|3605356|FG000|NOT COMPLETED|Overall Study||39
2897694|NCT00404651|3605357|FG001|NOT COMPLETED|Overall Study||28
2897695|NCT00404651|3605358|FG002|NOT COMPLETED|Overall Study||45
2897696|NCT00404651|3605359|FG003|NOT COMPLETED|Overall Study||21
2897697|NCT00404755|3605369|FG000|STARTED|Phase I (Bupropion)|3 went directly into Phase II (intolerant of bupropion), 1 withdrew consent and 4 did not return|17
2897698|NCT00404755|3605369|FG000|COMPLETED|Phase I (Bupropion)||13
2897699|NCT00404755|3605369|FG000|NOT COMPLETED|Phase I (Bupropion)||4
3170853|NCT01931566|3898133|FG000|Treated|Overall Study||427
3315223|NCT03095638|4048402|FG000|STARTED|P2: Period 2, Washout (7[-4 Hours])||0
3315224|NCT03095638|4048403|FG001|STARTED|P2: Period 2, Washout (7[-4 Hours])||0
3315225|NCT03095638|4048404|FG002|STARTED|P2: Period 2, Washout (7[-4 Hours])||4
3315226|NCT03095638|4048405|FG003|STARTED|P2: Period 2, Washout (7[-4 Hours])||4
3315227|NCT03095638|4048406|FG004|STARTED|P2: Period 2, Washout (7[-4 Hours])||4
3315228|NCT03095638|4048407|FG005|STARTED|P2: Period 2, Washout (7[-4 Hours])||4
3315229|NCT03095638|4048408|FG006|STARTED|P2: Period 2, Washout (7[-4 Hours])||4
3315230|NCT03095638|4048409|FG007|STARTED|P2: Period 2, Washout (7[-4 Hours])||4
3315231|NCT03095638|4048402|FG000|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
3315232|NCT03095638|4048403|FG001|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
3315233|NCT03095638|4048404|FG002|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||4
3315234|NCT03095638|4048405|FG003|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||4
3315235|NCT03095638|4048406|FG004|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||4
3315236|NCT03095638|4048407|FG005|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||4
3315237|NCT03095638|4048408|FG006|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||4
3315238|NCT03095638|4048409|FG007|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||4
3315239|NCT03095638|4048402|FG000|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
3315240|NCT03095638|4048403|FG001|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
3315241|NCT03095638|4048404|FG002|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
3315242|NCT03095638|4048405|FG003|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
3315243|NCT03095638|4048406|FG004|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
3315244|NCT03095638|4048407|FG005|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
3315245|NCT03095638|4048408|FG006|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
3315246|NCT03095638|4048409|FG007|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
3315247|NCT03095638|4048402|FG000|STARTED|P2: Period 3 (4 Days)||0
3315248|NCT03095638|4048403|FG001|STARTED|P2: Period 3 (4 Days)||0
3315249|NCT03095638|4048404|FG002|STARTED|P2: Period 3 (4 Days)||4
3315250|NCT03095638|4048405|FG003|STARTED|P2: Period 3 (4 Days)||4
3315251|NCT03095638|4048406|FG004|STARTED|P2: Period 3 (4 Days)||4
3315252|NCT03095638|4048407|FG005|STARTED|P2: Period 3 (4 Days)||4
3315253|NCT03095638|4048408|FG006|STARTED|P2: Period 3 (4 Days)||4
3315254|NCT03095638|4048409|FG007|STARTED|P2: Period 3 (4 Days)||4
3315255|NCT03095638|4048402|FG000|COMPLETED|P2: Period 3 (4 Days)||0
3315256|NCT03095638|4048403|FG001|COMPLETED|P2: Period 3 (4 Days)||0
3315257|NCT03095638|4048404|FG002|COMPLETED|P2: Period 3 (4 Days)||4
3315258|NCT03095638|4048405|FG003|COMPLETED|P2: Period 3 (4 Days)||4
3315259|NCT03095638|4048406|FG004|COMPLETED|P2: Period 3 (4 Days)||4
3315260|NCT03095638|4048407|FG005|COMPLETED|P2: Period 3 (4 Days)||4
3315261|NCT03095638|4048408|FG006|COMPLETED|P2: Period 3 (4 Days)||4
3315262|NCT03095638|4048409|FG007|COMPLETED|P2: Period 3 (4 Days)||4
3315263|NCT03095638|4048402|FG000|NOT COMPLETED|P2: Period 3 (4 Days)||0
3315264|NCT03095638|4048403|FG001|NOT COMPLETED|P2: Period 3 (4 Days)||0
3315265|NCT03095638|4048404|FG002|NOT COMPLETED|P2: Period 3 (4 Days)||0
3315266|NCT03095638|4048405|FG003|NOT COMPLETED|P2: Period 3 (4 Days)||0
3315267|NCT03095638|4048406|FG004|NOT COMPLETED|P2: Period 3 (4 Days)||0
2897700|NCT00404755|3605369|FG000|STARTED|Phase II (Escitalopram)||11
2897701|NCT00404755|3605369|FG000|COMPLETED|Phase II (Escitalopram)||9
2897702|NCT00404755|3605369|FG000|NOT COMPLETED|Phase II (Escitalopram)||2
2897703|NCT00404755|3605369|FG000|STARTED|Phase III (Imipramine)||3
2897704|NCT00404755|3605369|FG000|COMPLETED|Phase III (Imipramine)||3
2897705|NCT00404755|3605369|FG000|NOT COMPLETED|Phase III (Imipramine)||0
2897706|NCT00404768|3605381|FG000|STARTED|Part A and B||20
2897707|NCT00404768|3605382|FG001|STARTED|Part A and B||9
3170854|NCT01931566|3898134|FG001|Treated|Overall Study||1507
3170855|NCT01931566|3898135|FG002|Treated|Overall Study||1531
3170856|NCT01931566|3898133|FG000|COMPLETED|Overall Study||4
3170857|NCT01931566|3898134|FG001|COMPLETED|Overall Study||40
3170858|NCT01931566|3898135|FG002|COMPLETED|Overall Study||39
3315268|NCT03095638|4048407|FG005|NOT COMPLETED|P2: Period 3 (4 Days)||0
2897708|NCT00404768|3605383|FG002|STARTED|Part A and B||0
2897709|NCT00404768|3605384|FG003|STARTED|Part A and B||0
2897710|NCT00404768|3605381|FG000|COMPLETED|Part A and B||19
2897711|NCT00404768|3605382|FG001|COMPLETED|Part A and B||8
2897712|NCT00404768|3605383|FG002|COMPLETED|Part A and B||0
2897713|NCT00404768|3605384|FG003|COMPLETED|Part A and B||0
2897714|NCT00404768|3605381|FG000|NOT COMPLETED|Part A and B||1
2897715|NCT00404768|3605382|FG001|NOT COMPLETED|Part A and B||1
2897716|NCT00404768|3605383|FG002|NOT COMPLETED|Part A and B||0
2897717|NCT00404768|3605384|FG003|NOT COMPLETED|Part A and B||0
2897718|NCT00404768|3605381|FG000|STARTED|Part C||0
2897719|NCT00404768|3605382|FG001|STARTED|Part C||0
2897720|NCT00404768|3605383|FG002|STARTED|Part C||30
2897721|NCT00404768|3605384|FG003|STARTED|Part C||34
2897722|NCT00404768|3605381|FG000|COMPLETED|Part C||0
2897723|NCT00404768|3605382|FG001|COMPLETED|Part C||0
2897724|NCT00404768|3605383|FG002|COMPLETED|Part C||22
2897725|NCT00404768|3605384|FG003|COMPLETED|Part C||20
2897726|NCT00404768|3605381|FG000|NOT COMPLETED|Part C||0
3315269|NCT03095638|4048408|FG006|NOT COMPLETED|P2: Period 3 (4 Days)||0
3315270|NCT03095638|4048409|FG007|NOT COMPLETED|P2: Period 3 (4 Days)||0
3315271|NCT03095638|4048402|FG000|STARTED|P2: Period 3, Washout (7[-4 Hours])||0
3315272|NCT03095638|4048403|FG001|STARTED|P2: Period 3, Washout (7[-4 Hours])||0
3315273|NCT03095638|4048404|FG002|STARTED|P2: Period 3, Washout (7[-4 Hours])||4
3315274|NCT03095638|4048405|FG003|STARTED|P2: Period 3, Washout (7[-4 Hours])||4
3315275|NCT03095638|4048406|FG004|STARTED|P2: Period 3, Washout (7[-4 Hours])||4
3315276|NCT03095638|4048407|FG005|STARTED|P2: Period 3, Washout (7[-4 Hours])||4
3315277|NCT03095638|4048408|FG006|STARTED|P2: Period 3, Washout (7[-4 Hours])||4
3315278|NCT03095638|4048409|FG007|STARTED|P2: Period 3, Washout (7[-4 Hours])||4
3315279|NCT03095638|4048402|FG000|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
3315280|NCT03095638|4048403|FG001|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
3315281|NCT03095638|4048404|FG002|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||4
3315282|NCT03095638|4048405|FG003|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||4
3315283|NCT03095638|4048406|FG004|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||4
3315284|NCT03095638|4048407|FG005|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||4
3315285|NCT03095638|4048408|FG006|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||4
3315286|NCT03095638|4048409|FG007|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||4
3315287|NCT03095638|4048402|FG000|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
3315288|NCT03095638|4048403|FG001|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
3315289|NCT03095638|4048404|FG002|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
3315290|NCT03095638|4048405|FG003|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
3315291|NCT03095638|4048406|FG004|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
3315292|NCT03095638|4048407|FG005|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
3315293|NCT03095638|4048408|FG006|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
3315294|NCT03095638|4048409|FG007|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
3315295|NCT03095651|4048437|FG000|STARTED|Overall Study||6
3315296|NCT03095651|4048438|FG001|STARTED|Overall Study||6
3315297|NCT03095651|4048439|FG002|STARTED|Overall Study||0
3315298|NCT03095651|4048440|FG003|STARTED|Overall Study||4
3315299|NCT03095651|4048441|FG004|STARTED|Overall Study||0
3315300|NCT03095651|4048442|FG005|STARTED|Overall Study||7
3315301|NCT03095651|4048443|FG006|STARTED|Overall Study||6
3315302|NCT03095651|4048444|FG007|STARTED|Overall Study||4
3315303|NCT03095651|4048437|FG000|COMPLETED|Overall Study||5
3315304|NCT03095651|4048438|FG001|COMPLETED|Overall Study||5
3315305|NCT03095651|4048439|FG002|COMPLETED|Overall Study||0
3315306|NCT03095651|4048440|FG003|COMPLETED|Overall Study||3
3315307|NCT03095651|4048441|FG004|COMPLETED|Overall Study||0
3315308|NCT03095651|4048442|FG005|COMPLETED|Overall Study||6
3315309|NCT03095651|4048443|FG006|COMPLETED|Overall Study||6
3315310|NCT03095651|4048444|FG007|COMPLETED|Overall Study||4
3315311|NCT03095651|4048437|FG000|NOT COMPLETED|Overall Study||1
3315312|NCT03095651|4048438|FG001|NOT COMPLETED|Overall Study||1
3315313|NCT03095651|4048439|FG002|NOT COMPLETED|Overall Study||0
3315314|NCT03095651|4048440|FG003|NOT COMPLETED|Overall Study||1
3315315|NCT03095651|4048441|FG004|NOT COMPLETED|Overall Study||0
3315316|NCT03095651|4048442|FG005|NOT COMPLETED|Overall Study||1
3315317|NCT03095651|4048443|FG006|NOT COMPLETED|Overall Study||0
3315318|NCT03095651|4048444|FG007|NOT COMPLETED|Overall Study||0
3315319|NCT03095885|4048462|FG000|STARTED|Overall Study||22
3315320|NCT03095885|4048462|FG000|COMPLETED|Overall Study||22
3315321|NCT03095885|4048462|FG000|NOT COMPLETED|Overall Study||0
3315322|NCT03095976|4048466|FG000|STARTED|Overall Study||4
2897727|NCT00404768|3605382|FG001|NOT COMPLETED|Part C||0
2897728|NCT00404768|3605383|FG002|NOT COMPLETED|Part C||8
2897729|NCT00404768|3605384|FG003|NOT COMPLETED|Part C||14
2897730|NCT00404820|3605401|FG000|STARTED|Overall Study||408
2897731|NCT00404820|3605402|FG001|STARTED|Overall Study||196
2897732|NCT00404820|3605401|FG000|Started Treatment|Overall Study||408
2897733|NCT00404820|3605402|FG001|Started Treatment|Overall Study|The reason why 2 patients did not start treatment is unavailable.|194
2897734|NCT00404820|3605401|FG000|COMPLETED|Overall Study||389
2897735|NCT00404820|3605402|FG001|COMPLETED|Overall Study||172
2897736|NCT00404820|3605401|FG000|NOT COMPLETED|Overall Study||19
2897737|NCT00404820|3605402|FG001|NOT COMPLETED|Overall Study||24
3170859|NCT01931566|3898133|FG000|NOT COMPLETED|Overall Study||429
3170860|NCT01931566|3898134|FG001|NOT COMPLETED|Overall Study||1476
3170861|NCT01931566|3898135|FG002|NOT COMPLETED|Overall Study||1506
3170862|NCT01931670|3898147|FG000|STARTED|Treatment Period||360
3170863|NCT01931670|3898148|FG001|STARTED|Treatment Period||226
3315323|NCT03095976|4048466|FG000|COMPLETED|Overall Study||4
2897738|NCT00404924|3605410|FG000|STARTED|Overall Study|randomised patients|617
2897739|NCT00404924|3605411|FG001|STARTED|Overall Study|randomised patients|307
2897740|NCT00404924|3605410|FG000|COMPLETED|Overall Study|ongoing study treatment at data cut-off|14
2897741|NCT00404924|3605411|FG001|COMPLETED|Overall Study|ongoing study treatment at data cut-off|1
2897742|NCT00404924|3605410|FG000|NOT COMPLETED|Overall Study||603
2897743|NCT00404924|3605411|FG001|NOT COMPLETED|Overall Study||306
2897744|NCT00405067|3605420|FG000|STARTED|Overall Study||28
2897745|NCT00405067|3605421|FG001|STARTED|Overall Study||28
2897746|NCT00405067|3605422|FG002|STARTED|Overall Study||29
2897747|NCT00405067|3605420|FG000|COMPLETED|Overall Study||24
2897748|NCT00405067|3605421|FG001|COMPLETED|Overall Study||19
2897749|NCT00405067|3605422|FG002|COMPLETED|Overall Study||24
2897750|NCT00405067|3605420|FG000|NOT COMPLETED|Overall Study||4
2897751|NCT00405067|3605421|FG001|NOT COMPLETED|Overall Study||9
2897752|NCT00405067|3605422|FG002|NOT COMPLETED|Overall Study||5
2897753|NCT00405275|3605432|FG000|STARTED|Overall Study||178
2897754|NCT00405275|3605433|FG001|STARTED|Overall Study||175
2897755|NCT00405275|3605432|FG000|24 Weeks (Total)|Overall Study||163
2897756|NCT00405275|3605433|FG001|24 Weeks (Total)|Overall Study||165
2897757|NCT00405275|3605432|FG000|24 Week (no Switch)|Overall Study||119
2897758|NCT00405275|3605433|FG001|24 Week (no Switch)|Overall Study||121
2897759|NCT00405275|3605432|FG000|24 Week (Switch)|Overall Study||44
2897760|NCT00405275|3605433|FG001|24 Week (Switch)|Overall Study||44
2897761|NCT00405275|3605432|FG000|COMPLETED|Overall Study||155
2897762|NCT00405275|3605433|FG001|COMPLETED|Overall Study||156
2897763|NCT00405275|3605432|FG000|NOT COMPLETED|Overall Study||23
2897764|NCT00405275|3605433|FG001|NOT COMPLETED|Overall Study||19
2897765|NCT00405288|3605441|FG000|STARTED|Overall Study||204
3315324|NCT03095976|4048466|FG000|NOT COMPLETED|Overall Study||0
3315325|NCT03096314|4048472|FG000|STARTED|Screened Vitamin D Deficient||690
3315326|NCT03096314|4048473|FG001|STARTED|Screened Vitamin D Deficient|2 randomized but not included in analysis; 1 treated but inadequate consent and 1 withdrew.|668
3315327|NCT03096314|4048472|FG000|COMPLETED|Screened Vitamin D Deficient||681
3315328|NCT03096314|4048473|FG001|COMPLETED|Screened Vitamin D Deficient||656
3315329|NCT03096314|4048472|FG000|NOT COMPLETED|Screened Vitamin D Deficient||9
3315330|NCT03096314|4048473|FG001|NOT COMPLETED|Screened Vitamin D Deficient||12
3315331|NCT03096314|4048472|FG000|STARTED|Confirmed Vitamin D Deficient|Confirmed deficient (a prior primary analysis subgroup) is a subgroup of the screened deficient.|538
3315332|NCT03096314|4048473|FG001|STARTED|Confirmed Vitamin D Deficient|Confirmed deficient (a prior primary analysis subgroup) is a subgroup of the screened deficient.|540
3315333|NCT03096314|4048472|FG000|COMPLETED|Confirmed Vitamin D Deficient||531
3315334|NCT03096314|4048473|FG001|COMPLETED|Confirmed Vitamin D Deficient||528
3315335|NCT03096314|4048472|FG000|NOT COMPLETED|Confirmed Vitamin D Deficient||7
3315336|NCT03096314|4048473|FG001|NOT COMPLETED|Confirmed Vitamin D Deficient||12
3315337|NCT03096353|4048481|FG000|STARTED|Period 1||15
3315338|NCT03096353|4048482|FG001|STARTED|Period 1||13
3315339|NCT03096353|4048481|FG000|COMPLETED|Period 1||12
3315340|NCT03096353|4048482|FG001|COMPLETED|Period 1||12
3315341|NCT03096353|4048481|FG000|NOT COMPLETED|Period 1||3
3315342|NCT03096353|4048482|FG001|NOT COMPLETED|Period 1||1
3315343|NCT03096353|4048481|FG000|STARTED|Period 2||12
3315344|NCT03096353|4048482|FG001|STARTED|Period 2||12
3315345|NCT03096353|4048481|FG000|COMPLETED|Period 2||12
3315346|NCT03096353|4048482|FG001|COMPLETED|Period 2||12
3315347|NCT03096353|4048481|FG000|NOT COMPLETED|Period 2||0
3315348|NCT03096353|4048482|FG001|NOT COMPLETED|Period 2||0
3315349|NCT03096444|4048488|FG000|STARTED|Overall Study||13
3315350|NCT03096444|4048488|FG000|COMPLETED|Overall Study||13
3315351|NCT03096444|4048488|FG000|NOT COMPLETED|Overall Study||0
3315352|NCT03096483|4048500|FG000|STARTED|Overall Study||12
3315353|NCT03096483|4048500|FG000|COMPLETED|Overall Study||11
3315354|NCT03096483|4048500|FG000|NOT COMPLETED|Overall Study||1
3315355|NCT03096730|4048509|FG000|STARTED|Overall Study||30
3315356|NCT03096730|4048510|FG001|STARTED|Overall Study||30
3315357|NCT03096730|4048511|FG002|STARTED|Overall Study||30
3315358|NCT03096730|4048512|FG003|STARTED|Overall Study||30
3315359|NCT03096730|4048513|FG004|STARTED|Overall Study||30
3315360|NCT03096730|4048509|FG000|COMPLETED|Overall Study||27
3315361|NCT03096730|4048510|FG001|COMPLETED|Overall Study||27
3315362|NCT03096730|4048511|FG002|COMPLETED|Overall Study||27
3315363|NCT03096730|4048512|FG003|COMPLETED|Overall Study||27
3315364|NCT03096730|4048513|FG004|COMPLETED|Overall Study||27
3315365|NCT03096730|4048509|FG000|NOT COMPLETED|Overall Study||3
2897766|NCT00405288|3605442|FG001|STARTED|Overall Study||204
2897767|NCT00405288|3605441|FG000|COMPLETED|Overall Study||204
2897768|NCT00405288|3605442|FG001|COMPLETED|Overall Study||204
2897769|NCT00405288|3605441|FG000|NOT COMPLETED|Overall Study||0
2897770|NCT00405288|3605442|FG001|NOT COMPLETED|Overall Study||0
2897771|NCT00405353|3605448|FG000|STARTED|Overall Study||10
2897772|NCT00405353|3605448|FG000|COMPLETED|Overall Study||10
2897773|NCT00405353|3605448|FG000|NOT COMPLETED|Overall Study||0
2897774|NCT00405392|3605454|FG000|STARTED|Overall Study||183
2897775|NCT00405392|3605455|FG001|STARTED|Overall Study||182
2897776|NCT00405392|3605454|FG000|COMPLETED|Overall Study||153
2897777|NCT00405392|3605455|FG001|COMPLETED|Overall Study||155
2897778|NCT00405392|3605454|FG000|NOT COMPLETED|Overall Study||30
2897779|NCT00405392|3605455|FG001|NOT COMPLETED|Overall Study||27
2897780|NCT00405509|3605463|FG000|STARTED|Overall Study||11
2897781|NCT00405509|3605464|FG001|STARTED|Overall Study||22
2897782|NCT00405509|3605463|FG000|COMPLETED|Overall Study||11
2897783|NCT00405509|3605464|FG001|COMPLETED|Overall Study||22
2897784|NCT00405509|3605463|FG000|NOT COMPLETED|Overall Study||0
2897785|NCT00405509|3605464|FG001|NOT COMPLETED|Overall Study||0
2897786|NCT00405522|3605472|FG000|STARTED|Overall Study||17
2897787|NCT00405522|3605473|FG001|STARTED|Overall Study||17
2897788|NCT00405522|3605472|FG000|COMPLETED|Overall Study||17
3315366|NCT03096730|4048510|FG001|NOT COMPLETED|Overall Study||3
3315367|NCT03096730|4048511|FG002|NOT COMPLETED|Overall Study||3
3315368|NCT03096730|4048512|FG003|NOT COMPLETED|Overall Study||3
3315369|NCT03096730|4048513|FG004|NOT COMPLETED|Overall Study||3
3315370|NCT03096847|4048528|FG000|STARTED|Overall Study||319
3315371|NCT03096847|4048529|FG001|STARTED|Overall Study||26
3315372|NCT03096847|4048530|FG002|STARTED|Overall Study||157
3315373|NCT03096847|4048528|FG000|Full Analysis Set|Overall Study||307
3315374|NCT03096847|4048529|FG001|Full Analysis Set|Overall Study||26
3315375|NCT03096847|4048530|FG002|Full Analysis Set|Overall Study||154
3315376|NCT03096847|4048528|FG000|COMPLETED|Overall Study|Only the primary reason for disc. is included in this table.|100
3315377|NCT03096847|4048529|FG001|COMPLETED|Overall Study|Only the primary reason for disc. is included in this table.|6
3315378|NCT03096847|4048530|FG002|COMPLETED|Overall Study|Only the primary reason for disc. is included in this table.|19
3315379|NCT03096847|4048528|FG000|NOT COMPLETED|Overall Study||219
3315380|NCT03096847|4048529|FG001|NOT COMPLETED|Overall Study||20
3315381|NCT03096847|4048530|FG002|NOT COMPLETED|Overall Study||138
3315382|NCT03096873|4048548|FG000|STARTED|Overall Study||20
3315383|NCT03096873|4048549|FG001|STARTED|Overall Study||20
3315384|NCT03096873|4048548|FG000|COMPLETED|Overall Study||20
3315385|NCT03096873|4048549|FG001|COMPLETED|Overall Study||20
3315386|NCT03096873|4048548|FG000|NOT COMPLETED|Overall Study||0
3315387|NCT03096873|4048549|FG001|NOT COMPLETED|Overall Study||0
3315388|NCT03097029|4048557|FG000|STARTED|Overall Study||15
3315389|NCT03097029|4048557|FG000|COMPLETED|Overall Study||14
3315390|NCT03097029|4048557|FG000|NOT COMPLETED|Overall Study||1
3315391|NCT03097133|4048563|FG000|STARTED|Overall Study||115
3315392|NCT03097133|4048564|FG001|STARTED|Overall Study||115
3315393|NCT03097133|4048563|FG000|Treated|Overall Study||113
3315394|NCT03097133|4048564|FG001|Treated|Overall Study||114
3315395|NCT03097133|4048563|FG000|COMPLETED|Overall Study||85
3315396|NCT03097133|4048564|FG001|COMPLETED|Overall Study||81
3315397|NCT03097133|4048563|FG000|NOT COMPLETED|Overall Study||30
3315398|NCT03097133|4048564|FG001|NOT COMPLETED|Overall Study||34
3315399|NCT03097289|4048570|FG000|STARTED|Overall Study||32
3315400|NCT03097289|4048570|FG000|COMPLETED|Overall Study||26
3315401|NCT03097289|4048570|FG000|NOT COMPLETED|Overall Study||6
3315402|NCT03097315|4048575|FG000|STARTED|Overall Study||38
3315403|NCT03097315|4048575|FG000|Intention-to-Treat Population|Overall Study||38
3315404|NCT03097315|4048575|FG000|Safety Population|Overall Study||38
3315405|NCT03097315|4048575|FG000|COMPLETED|Overall Study||37
3315406|NCT03097315|4048575|FG000|NOT COMPLETED|Overall Study||1
3315407|NCT03097341|4048584|FG000|STARTED|Overall Study||4
3315408|NCT03097341|4048585|FG001|STARTED|Overall Study||4
3315409|NCT03097341|4048586|FG002|STARTED|Overall Study||4
3315410|NCT03097341|4048587|FG003|STARTED|Overall Study||4
3315411|NCT03097341|4048588|FG004|STARTED|Overall Study||5
3315412|NCT03097341|4048584|FG000|COMPLETED|Overall Study||4
3315413|NCT03097341|4048585|FG001|COMPLETED|Overall Study||4
3315414|NCT03097341|4048586|FG002|COMPLETED|Overall Study||4
3315415|NCT03097341|4048587|FG003|COMPLETED|Overall Study||4
3315416|NCT03097341|4048588|FG004|COMPLETED|Overall Study||5
3315417|NCT03097341|4048584|FG000|NOT COMPLETED|Overall Study||0
3315418|NCT03097341|4048585|FG001|NOT COMPLETED|Overall Study||0
3315419|NCT03097341|4048586|FG002|NOT COMPLETED|Overall Study||0
3315420|NCT03097341|4048587|FG003|NOT COMPLETED|Overall Study||0
3315421|NCT03097341|4048588|FG004|NOT COMPLETED|Overall Study||0
3315422|NCT03097484|4048602|FG000|STARTED|Overall Study||19
3315423|NCT03097484|4048603|FG001|STARTED|Overall Study||19
3315424|NCT03097484|4048602|FG000|COMPLETED|Overall Study||19
3315425|NCT03097484|4048603|FG001|COMPLETED|Overall Study||19
3315426|NCT03097484|4048602|FG000|NOT COMPLETED|Overall Study||0
3315427|NCT03097484|4048603|FG001|NOT COMPLETED|Overall Study||0
3315428|NCT03097588|4048609|FG000|STARTED|Overall Study||43
3315429|NCT03097588|4048609|FG000|COMPLETED|Overall Study||42
3315430|NCT03097588|4048609|FG000|NOT COMPLETED|Overall Study||1
2897789|NCT00405522|3605473|FG001|COMPLETED|Overall Study||17
3315431|NCT03097614|4048613|FG000|STARTED|Overall Study||57
3315432|NCT03097614|4048613|FG000|COMPLETED|Overall Study||54
2897790|NCT00405522|3605472|FG000|NOT COMPLETED|Overall Study||0
2897791|NCT00405522|3605473|FG001|NOT COMPLETED|Overall Study||0
2897792|NCT00405548|3605481|FG000|STARTED|Overall Study||28
2897793|NCT00405548|3605482|FG001|STARTED|Overall Study||13
2897794|NCT00405548|3605481|FG000|COMPLETED|Overall Study||24
2897795|NCT00405548|3605482|FG001|COMPLETED|Overall Study||12
2897796|NCT00405548|3605481|FG000|NOT COMPLETED|Overall Study||4
2897797|NCT00405548|3605482|FG001|NOT COMPLETED|Overall Study||1
2897798|NCT00405587|3605492|FG000|STARTED|Overall Study||26
2897799|NCT00405587|3605493|FG001|STARTED|Overall Study||30
2897800|NCT00405587|3605494|FG002|STARTED|Overall Study||32
2897801|NCT00405587|3605495|FG003|STARTED|Overall Study||21
2897802|NCT00405587|3605492|FG000|COMPLETED|Overall Study||0
2897803|NCT00405587|3605493|FG001|COMPLETED|Overall Study||2
2897804|NCT00405587|3605494|FG002|COMPLETED|Overall Study||10
2897805|NCT00405587|3605495|FG003|COMPLETED|Overall Study||1
2897806|NCT00405587|3605492|FG000|NOT COMPLETED|Overall Study||26
2897807|NCT00405587|3605493|FG001|NOT COMPLETED|Overall Study||28
2897808|NCT00405587|3605494|FG002|NOT COMPLETED|Overall Study||22
2897809|NCT00405587|3605495|FG003|NOT COMPLETED|Overall Study||20
2897810|NCT00405639|3605533|FG000|STARTED|Overall Study||25
2897811|NCT00405639|3605534|FG001|STARTED|Overall Study||12
2897812|NCT00405639|3605533|FG000|COMPLETED|Overall Study||22
2897813|NCT00405639|3605534|FG001|COMPLETED|Overall Study||12
2897814|NCT00405639|3605533|FG000|NOT COMPLETED|Overall Study||3
2897815|NCT00405639|3605534|FG001|NOT COMPLETED|Overall Study||0
2897816|NCT00405652|3605540|FG000|STARTED|Overall Study||34
2897817|NCT00405652|3605540|FG000|COMPLETED|Overall Study||30
2897818|NCT00405652|3605540|FG000|NOT COMPLETED|Overall Study||4
2897819|NCT00405704|3605546|FG000|STARTED|Overall Study||302
2897820|NCT00405704|3605547|FG001|STARTED|Overall Study||305
2897821|NCT00405704|3605546|FG000|Completed Outcome Renal Scan|Overall Study||227
2897822|NCT00405704|3605547|FG001|Completed Outcome Renal Scan|Overall Study||235
2897823|NCT00405704|3605546|FG000|Completed Assessments for New Scarring|Overall Study||220
2897824|NCT00405704|3605547|FG001|Completed Assessments for New Scarring|Overall Study||227
2897825|NCT00405704|3605546|FG000|Outcome Stool Assessed|Overall Study||203
2897826|NCT00405704|3605547|FG001|Outcome Stool Assessed|Overall Study||210
2897827|NCT00405704|3605546|FG000|Recurrent UTI With E. Coli|Overall Study||30
2897828|NCT00405704|3605547|FG001|Recurrent UTI With E. Coli|Overall Study||57
2897829|NCT00405704|3605546|FG000|Recurrent UTI With TMP-SMZ Panel|Overall Study||38
3315433|NCT03097614|4048613|FG000|NOT COMPLETED|Overall Study||3
3315434|NCT03097653|4048619|FG000|STARTED|Overall Study||472
3315435|NCT03097653|4048620|FG001|STARTED|Overall Study||529
3315436|NCT03097653|4048619|FG000|COMPLETED|Overall Study||472
3315437|NCT03097653|4048620|FG001|COMPLETED|Overall Study||529
3315438|NCT03097653|4048619|FG000|NOT COMPLETED|Overall Study||0
3315439|NCT03097653|4048620|FG001|NOT COMPLETED|Overall Study||0
3315440|NCT03097783|4048628|FG000|STARTED|Overall Study||132
3315441|NCT03097783|4048629|FG001|STARTED|Overall Study||37
3315442|NCT03097783|4048628|FG000|COMPLETED|Overall Study||123
3315443|NCT03097783|4048629|FG001|COMPLETED|Overall Study||31
3315444|NCT03097783|4048628|FG000|NOT COMPLETED|Overall Study||9
3315445|NCT03097783|4048629|FG001|NOT COMPLETED|Overall Study||6
3315446|NCT03097861|4048638|FG000|STARTED|Overall Study||145
3315447|NCT03097861|4048639|FG001|STARTED|Overall Study||276
3315448|NCT03097861|4048640|FG002|STARTED|Overall Study||131
3315449|NCT03097861|4048638|FG000|Safety Population|Overall Study||143
3315450|NCT03097861|4048639|FG001|Safety Population|Overall Study||275
3315451|NCT03097861|4048640|FG002|Safety Population|Overall Study||130
3315452|NCT03097861|4048638|FG000|Modified Intent to Treat|Overall Study||143
3315453|NCT03097861|4048639|FG001|Modified Intent to Treat|Overall Study||275
3315454|NCT03097861|4048640|FG002|Modified Intent to Treat|Overall Study||130
3315455|NCT03097861|4048638|FG000|Completers|Overall Study||129
3315456|NCT03097861|4048639|FG001|Completers|Overall Study||255
3315457|NCT03097861|4048640|FG002|Completers|Overall Study||121
3315458|NCT03097861|4048638|FG000|Per-protocol Population (PP)|Overall Study||126
3315459|NCT03097861|4048639|FG001|Per-protocol Population (PP)|Overall Study||234
3315460|NCT03097861|4048640|FG002|Per-protocol Population (PP)|Overall Study||113
3315461|NCT03097861|4048638|FG000|COMPLETED|Overall Study||138
3315462|NCT03097861|4048639|FG001|COMPLETED|Overall Study||254
3315463|NCT03097861|4048640|FG002|COMPLETED|Overall Study||122
3315464|NCT03097861|4048638|FG000|NOT COMPLETED|Overall Study||7
3315465|NCT03097861|4048639|FG001|NOT COMPLETED|Overall Study||22
3315466|NCT03097861|4048640|FG002|NOT COMPLETED|Overall Study||9
3315467|NCT03098030|4048654|FG000|STARTED|Overall Study||12
3315468|NCT03098030|4048655|FG001|STARTED|Overall Study||187
3315469|NCT03098030|4048656|FG002|STARTED|Overall Study||190
3315470|NCT03098030|4048657|FG003|STARTED|Overall Study||94
3315471|NCT03098030|4048654|FG000|COMPLETED|Overall Study|Represents number of subjects that had not discontinued the study at time of data lock.|2
3315472|NCT03098030|4048655|FG001|COMPLETED|Overall Study|Represents number of subjects that had not discontinued the study at time of data lock.|24
3315473|NCT03098030|4048656|FG002|COMPLETED|Overall Study|Represents number of subjects that had not discontinued the study at time of data lock.|24
3315474|NCT03098030|4048657|FG003|COMPLETED|Overall Study|Represents number of subjects that had not discontinued the study at time of data lock.|9
3315475|NCT03098030|4048654|FG000|NOT COMPLETED|Overall Study||10
3315476|NCT03098030|4048655|FG001|NOT COMPLETED|Overall Study||163
3315477|NCT03098030|4048656|FG002|NOT COMPLETED|Overall Study||166
3315478|NCT03098030|4048657|FG003|NOT COMPLETED|Overall Study||85
2897830|NCT00405704|3605547|FG001|Recurrent UTI With TMP-SMZ Panel|Overall Study||69
2897831|NCT00405704|3605546|FG000|COMPLETED|Overall Study||261
2897832|NCT00405704|3605547|FG001|COMPLETED|Overall Study||259
2897833|NCT00405704|3605546|FG000|NOT COMPLETED|Overall Study||41
2897834|NCT00405704|3605547|FG001|NOT COMPLETED|Overall Study||46
2897835|NCT00405756|3605557|FG000|STARTED|Double-blind Treatment|Intent to treat population of all randomized participants|152
2897836|NCT00405756|3605558|FG001|STARTED|Double-blind Treatment||153
2897837|NCT00405756|3605559|FG002|STARTED|Double-blind Treatment||154
2897838|NCT00405756|3605557|FG000|Safety Population|Double-blind Treatment|Participants who took at least one dose of study drug.|150
2897839|NCT00405756|3605558|FG001|Safety Population|Double-blind Treatment||152
2897840|NCT00405756|3605559|FG002|Safety Population|Double-blind Treatment||153
2897841|NCT00405756|3605557|FG000|COMPLETED|Double-blind Treatment|Double-blind Treatment Period had no defined completion.|0
2897842|NCT00405756|3605558|FG001|COMPLETED|Double-blind Treatment||0
2897843|NCT00405756|3605559|FG002|COMPLETED|Double-blind Treatment||0
2897844|NCT00405756|3605557|FG000|NOT COMPLETED|Double-blind Treatment||152
2897845|NCT00405756|3605558|FG001|NOT COMPLETED|Double-blind Treatment||153
2897846|NCT00405756|3605559|FG002|NOT COMPLETED|Double-blind Treatment||154
2897847|NCT00405756|3605557|FG000|STARTED|Open-label Extension||19
2897848|NCT00405756|3605558|FG001|STARTED|Open-label Extension||47
2897849|NCT00405756|3605559|FG002|STARTED|Open-label Extension||72
2897850|NCT00405756|3605557|FG000|COMPLETED|Open-label Extension|Participants continue until disease progression or other reason for discontinuing.|0
2897851|NCT00405756|3605558|FG001|COMPLETED|Open-label Extension||0
2897852|NCT00405756|3605559|FG002|COMPLETED|Open-label Extension||0
2897853|NCT00405756|3605557|FG000|NOT COMPLETED|Open-label Extension||19
2897854|NCT00405756|3605558|FG001|NOT COMPLETED|Open-label Extension||47
2897855|NCT00405756|3605559|FG002|NOT COMPLETED|Open-label Extension||72
2897856|NCT00405756|3605557|FG000|STARTED|Follow-up|66 participants from Double-blind and 9 from the Open Label Extension|75
2897857|NCT00405756|3605558|FG001|STARTED|Follow-up|65 participants from the Double-blind and 25 from the Open Label Extension|90
2897858|NCT00405756|3605559|FG002|STARTED|Follow-up|52 participants from the Double-blind and 36 from the Open Label Extension|88
2897859|NCT00405756|3605557|FG000|COMPLETED|Follow-up||0
2897860|NCT00405756|3605558|FG001|COMPLETED|Follow-up||0
2897861|NCT00405756|3605559|FG002|COMPLETED|Follow-up||0
2897862|NCT00405756|3605557|FG000|NOT COMPLETED|Follow-up||75
3315479|NCT03098173|4048668|FG000|STARTED|Overall Study||81
3315480|NCT03098173|4048669|FG001|STARTED|Overall Study||81
3315481|NCT03098173|4048668|FG000|COMPLETED|Overall Study||80
3315482|NCT03098173|4048669|FG001|COMPLETED|Overall Study||79
3315483|NCT03098173|4048668|FG000|NOT COMPLETED|Overall Study||1
3315484|NCT03098173|4048669|FG001|NOT COMPLETED|Overall Study||2
3315485|NCT03098420|4048680|FG000|STARTED|Overall Study||7
3315486|NCT03098420|4048681|FG001|STARTED|Overall Study||9
3315487|NCT03098420|4048682|FG002|STARTED|Overall Study||13
3315488|NCT03098420|4048680|FG000|COMPLETED|Overall Study||7
3315489|NCT03098420|4048681|FG001|COMPLETED|Overall Study||9
3315490|NCT03098420|4048682|FG002|COMPLETED|Overall Study||13
3315491|NCT03098420|4048680|FG000|NOT COMPLETED|Overall Study||0
3315492|NCT03098420|4048681|FG001|NOT COMPLETED|Overall Study||0
3315493|NCT03098420|4048682|FG002|NOT COMPLETED|Overall Study||0
3315494|NCT03098433|4048690|FG000|STARTED|Overall Study||22
3315495|NCT03098433|4048690|FG000|COMPLETED|Overall Study||12
3315496|NCT03098433|4048690|FG000|NOT COMPLETED|Overall Study||10
3315497|NCT03098550|4048698|FG000|STARTED|Overall Study||41
3315498|NCT03098550|4048699|FG001|STARTED|Overall Study||21
3315499|NCT03098550|4048700|FG002|STARTED|Overall Study||43
3315500|NCT03098550|4048698|FG000|COMPLETED|Overall Study||0
3315501|NCT03098550|4048699|FG001|COMPLETED|Overall Study||1
3315502|NCT03098550|4048700|FG002|COMPLETED|Overall Study||0
3315503|NCT03098550|4048698|FG000|NOT COMPLETED|Overall Study||41
3315504|NCT03098550|4048699|FG001|NOT COMPLETED|Overall Study||20
3315505|NCT03098550|4048700|FG002|NOT COMPLETED|Overall Study||43
3315506|NCT03098615|4048712|FG000|STARTED|Overall Study||19
3315507|NCT03098615|4048712|FG000|COMPLETED|Overall Study||17
3315508|NCT03098615|4048712|FG000|NOT COMPLETED|Overall Study||2
3315509|NCT03098641|4048717|FG000|STARTED|Overall Study||272
3315510|NCT03098641|4048717|FG000|COMPLETED|Overall Study||220
3315511|NCT03098641|4048717|FG000|NOT COMPLETED|Overall Study||52
3315512|NCT03098745|4048721|FG000|STARTED|Day 1||7
3315513|NCT03098745|4048722|FG001|STARTED|Day 1||3
3315514|NCT03098745|4048723|FG002|STARTED|Day 1||8
3315515|NCT03098745|4048724|FG003|STARTED|Day 1||8
3315516|NCT03098745|4048725|FG004|STARTED|Day 1||10
3315517|NCT03098745|4048726|FG005|STARTED|Day 1||4
3315518|NCT03098745|4048721|FG000|COMPLETED|Day 1||7
3315519|NCT03098745|4048722|FG001|COMPLETED|Day 1||3
3315520|NCT03098745|4048723|FG002|COMPLETED|Day 1||8
3315521|NCT03098745|4048724|FG003|COMPLETED|Day 1||8
3315522|NCT03098745|4048725|FG004|COMPLETED|Day 1||10
3315523|NCT03098745|4048726|FG005|COMPLETED|Day 1||4
3315524|NCT03098745|4048721|FG000|NOT COMPLETED|Day 1||0
3315525|NCT03098745|4048722|FG001|NOT COMPLETED|Day 1||0
3315526|NCT03098745|4048723|FG002|NOT COMPLETED|Day 1||0
3315527|NCT03098745|4048724|FG003|NOT COMPLETED|Day 1||0
3315528|NCT03098745|4048725|FG004|NOT COMPLETED|Day 1||0
3315529|NCT03098745|4048726|FG005|NOT COMPLETED|Day 1||0
3315530|NCT03098745|4048721|FG000|STARTED|Day 2||7
3315531|NCT03098745|4048722|FG001|STARTED|Day 2||3
3315532|NCT03098745|4048723|FG002|STARTED|Day 2||8
3315533|NCT03098745|4048724|FG003|STARTED|Day 2||8
2897863|NCT00405756|3605558|FG001|NOT COMPLETED|Follow-up||90
2897864|NCT00405756|3605559|FG002|NOT COMPLETED|Follow-up||88
2897865|NCT00405821|3605569|FG000|STARTED|Overall Study||220
2897866|NCT00405821|3605570|FG001|STARTED|Overall Study||220
2897867|NCT00405821|3605569|FG000|COMPLETED|Overall Study||198
2897868|NCT00405821|3605570|FG001|COMPLETED|Overall Study||198
2897869|NCT00405821|3605569|FG000|NOT COMPLETED|Overall Study||22
2897870|NCT00405821|3605570|FG001|NOT COMPLETED|Overall Study||22
2897871|NCT00405912|3605579|FG000|STARTED|Overall Study||39
2897872|NCT00405912|3605580|FG001|STARTED|Overall Study||40
2897873|NCT00405912|3605581|FG002|STARTED|Overall Study||39
2897874|NCT00405912|3605579|FG000|COMPLETED|Overall Study||23
2897875|NCT00405912|3605580|FG001|COMPLETED|Overall Study||21
2897876|NCT00405912|3605581|FG002|COMPLETED|Overall Study||23
2897877|NCT00405912|3605579|FG000|NOT COMPLETED|Overall Study||16
2897878|NCT00405912|3605580|FG001|NOT COMPLETED|Overall Study||19
2897879|NCT00405912|3605581|FG002|NOT COMPLETED|Overall Study||16
2897880|NCT00405938|3605591|FG000|STARTED|Overall Study||38
2897881|NCT00405938|3605592|FG001|STARTED|Overall Study||41
2897882|NCT00405938|3605591|FG000|COMPLETED|Overall Study||38
2897883|NCT00405938|3605592|FG001|COMPLETED|Overall Study||41
2897884|NCT00405938|3605591|FG000|NOT COMPLETED|Overall Study||0
3315534|NCT03098745|4048725|FG004|STARTED|Day 2||10
3315535|NCT03098745|4048726|FG005|STARTED|Day 2||4
3315536|NCT03098745|4048721|FG000|COMPLETED|Day 2||7
3315537|NCT03098745|4048722|FG001|COMPLETED|Day 2||3
3315538|NCT03098745|4048723|FG002|COMPLETED|Day 2||8
3315539|NCT03098745|4048724|FG003|COMPLETED|Day 2||8
3315540|NCT03098745|4048725|FG004|COMPLETED|Day 2||10
3315541|NCT03098745|4048726|FG005|COMPLETED|Day 2||4
3315542|NCT03098745|4048721|FG000|NOT COMPLETED|Day 2||0
3315543|NCT03098745|4048722|FG001|NOT COMPLETED|Day 2||0
3315544|NCT03098745|4048723|FG002|NOT COMPLETED|Day 2||0
3315545|NCT03098745|4048724|FG003|NOT COMPLETED|Day 2||0
3315546|NCT03098745|4048725|FG004|NOT COMPLETED|Day 2||0
3315547|NCT03098745|4048726|FG005|NOT COMPLETED|Day 2||0
3315548|NCT03098745|4048721|FG000|STARTED|Day 3||7
3315549|NCT03098745|4048722|FG001|STARTED|Day 3||3
3315550|NCT03098745|4048723|FG002|STARTED|Day 3||8
3315551|NCT03098745|4048724|FG003|STARTED|Day 3||8
3315552|NCT03098745|4048725|FG004|STARTED|Day 3||10
3315553|NCT03098745|4048726|FG005|STARTED|Day 3||4
3315554|NCT03098745|4048721|FG000|COMPLETED|Day 3||7
3315555|NCT03098745|4048722|FG001|COMPLETED|Day 3||3
3315556|NCT03098745|4048723|FG002|COMPLETED|Day 3||8
3315557|NCT03098745|4048724|FG003|COMPLETED|Day 3||8
3315558|NCT03098745|4048725|FG004|COMPLETED|Day 3||10
3315559|NCT03098745|4048726|FG005|COMPLETED|Day 3||4
3315560|NCT03098745|4048721|FG000|NOT COMPLETED|Day 3||0
3315561|NCT03098745|4048722|FG001|NOT COMPLETED|Day 3||0
3315562|NCT03098745|4048723|FG002|NOT COMPLETED|Day 3||0
3315563|NCT03098745|4048724|FG003|NOT COMPLETED|Day 3||0
3315564|NCT03098745|4048725|FG004|NOT COMPLETED|Day 3||0
3315565|NCT03098745|4048726|FG005|NOT COMPLETED|Day 3||0
3315566|NCT03098966|4048735|FG000|STARTED|Overall Study||368
3315567|NCT03098966|4048735|FG000|COMPLETED|Overall Study||368
3315568|NCT03098966|4048735|FG000|NOT COMPLETED|Overall Study||0
3315569|NCT03098979|4048745|FG000|STARTED|Overall Study||76
3315570|NCT03098979|4048746|FG001|STARTED|Overall Study||27
3315571|NCT03098979|4048747|FG002|STARTED|Overall Study||50
3315572|NCT03098979|4048748|FG003|STARTED|Overall Study||51
3315573|NCT03098979|4048749|FG004|STARTED|Overall Study||50
3315574|NCT03098979|4048750|FG005|STARTED|Overall Study||51
3315575|NCT03098979|4048745|FG000|COMPLETED|Overall Study||70
3315576|NCT03098979|4048746|FG001|COMPLETED|Overall Study||25
3315577|NCT03098979|4048747|FG002|COMPLETED|Overall Study||46
3315578|NCT03098979|4048748|FG003|COMPLETED|Overall Study||46
3315579|NCT03098979|4048749|FG004|COMPLETED|Overall Study||41
3315580|NCT03098979|4048750|FG005|COMPLETED|Overall Study||47
3315581|NCT03098979|4048745|FG000|NOT COMPLETED|Overall Study||6
3315582|NCT03098979|4048746|FG001|NOT COMPLETED|Overall Study||2
3315583|NCT03098979|4048747|FG002|NOT COMPLETED|Overall Study||4
3315584|NCT03098979|4048748|FG003|NOT COMPLETED|Overall Study||5
3315585|NCT03098979|4048749|FG004|NOT COMPLETED|Overall Study||9
3315586|NCT03098979|4048750|FG005|NOT COMPLETED|Overall Study||4
3315587|NCT03099096|4048764|FG000|STARTED|Overall Study||159
3315588|NCT03099096|4048764|FG000|COMPLETED|Overall Study||157
3315589|NCT03099096|4048764|FG000|NOT COMPLETED|Overall Study||2
3315590|NCT03099161|4048771|FG000|STARTED|Overall Study||3
3315591|NCT03099161|4048772|FG001|STARTED|Overall Study||4
3315592|NCT03099161|4048773|FG002|STARTED|Overall Study||3
3315593|NCT03099161|4048771|FG000|COMPLETED|Overall Study||0
3315594|NCT03099161|4048772|FG001|COMPLETED|Overall Study||0
3315595|NCT03099161|4048773|FG002|COMPLETED|Overall Study||0
3315596|NCT03099161|4048771|FG000|NOT COMPLETED|Overall Study||3
3315597|NCT03099161|4048772|FG001|NOT COMPLETED|Overall Study||4
3315598|NCT03099161|4048773|FG002|NOT COMPLETED|Overall Study||3
3315599|NCT03099187|4048783|FG000|STARTED|Double-blind Treatment||127
3315600|NCT03099187|4048784|FG001|STARTED|Double-blind Treatment||126
3315601|NCT03099187|4048785|FG002|STARTED|Double-blind Treatment||0
3315602|NCT03099187|4048786|FG003|STARTED|Double-blind Treatment||0
3315603|NCT03099187|4048783|FG000|COMPLETED|Double-blind Treatment||94
3315604|NCT03099187|4048784|FG001|COMPLETED|Double-blind Treatment||110
3315605|NCT03099187|4048785|FG002|COMPLETED|Double-blind Treatment||0
2897885|NCT00405938|3605592|FG001|NOT COMPLETED|Overall Study||0
3315606|NCT03099187|4048786|FG003|COMPLETED|Double-blind Treatment||0
2897886|NCT00406029|3605603|FG000|STARTED|Overall Study||49
2897887|NCT00406029|3605604|FG001|STARTED|Overall Study||49
2897888|NCT00406029|3605605|FG002|STARTED|Overall Study||49
2897889|NCT00406029|3605606|FG003|STARTED|Overall Study||57
2897890|NCT00406029|3605607|FG004|STARTED|Overall Study||49
2897891|NCT00406029|3605603|FG000|Treated|Overall Study||49
2897892|NCT00406029|3605604|FG001|Treated|Overall Study||49
2897893|NCT00406029|3605605|FG002|Treated|Overall Study||47
2897894|NCT00406029|3605606|FG003|Treated|Overall Study||54
2897895|NCT00406029|3605607|FG004|Treated|Overall Study||47
2897896|NCT00406029|3605603|FG000|COMPLETED|Overall Study||33
2897897|NCT00406029|3605604|FG001|COMPLETED|Overall Study||41
2897898|NCT00406029|3605605|FG002|COMPLETED|Overall Study||39
2897899|NCT00406029|3605606|FG003|COMPLETED|Overall Study||40
2897900|NCT00406029|3605607|FG004|COMPLETED|Overall Study||41
2897901|NCT00406029|3605603|FG000|NOT COMPLETED|Overall Study||16
2897902|NCT00406029|3605604|FG001|NOT COMPLETED|Overall Study||8
2897903|NCT00406029|3605605|FG002|NOT COMPLETED|Overall Study||10
2897904|NCT00406029|3605606|FG003|NOT COMPLETED|Overall Study||17
2897905|NCT00406029|3605607|FG004|NOT COMPLETED|Overall Study||8
2897906|NCT00406107|3605621|FG000|STARTED|Overall Study||15
2897907|NCT00406107|3605622|FG001|STARTED|Overall Study||5
2897908|NCT00406107|3605621|FG000|COMPLETED|Overall Study||14
2897909|NCT00406107|3605622|FG001|COMPLETED|Overall Study||4
2897910|NCT00406107|3605621|FG000|NOT COMPLETED|Overall Study||1
2897911|NCT00406107|3605622|FG001|NOT COMPLETED|Overall Study||1
3170864|NCT01931670|3898149|FG002|STARTED|Treatment Period||229
3170865|NCT01931670|3898147|FG000|COMPLETED|Treatment Period||270
3170866|NCT01931670|3898148|FG001|COMPLETED|Treatment Period||178
3170867|NCT01931670|3898149|FG002|COMPLETED|Treatment Period||184
3315607|NCT03099187|4048783|FG000|NOT COMPLETED|Double-blind Treatment||33
3315608|NCT03099187|4048784|FG001|NOT COMPLETED|Double-blind Treatment||16
3315609|NCT03099187|4048785|FG002|NOT COMPLETED|Double-blind Treatment||0
3315610|NCT03099187|4048786|FG003|NOT COMPLETED|Double-blind Treatment||0
3315611|NCT03099187|4048783|FG000|STARTED|12-month Safety Follow-up||0
3315612|NCT03099187|4048784|FG001|STARTED|12-month Safety Follow-up||0
3315613|NCT03099187|4048785|FG002|STARTED|12-month Safety Follow-up||94
3315614|NCT03099187|4048786|FG003|STARTED|12-month Safety Follow-up||110
3315615|NCT03099187|4048783|FG000|COMPLETED|12-month Safety Follow-up||0
3315616|NCT03099187|4048784|FG001|COMPLETED|12-month Safety Follow-up||0
3315617|NCT03099187|4048785|FG002|COMPLETED|12-month Safety Follow-up||75
3315618|NCT03099187|4048786|FG003|COMPLETED|12-month Safety Follow-up||84
3315619|NCT03099187|4048783|FG000|NOT COMPLETED|12-month Safety Follow-up||0
3315620|NCT03099187|4048784|FG001|NOT COMPLETED|12-month Safety Follow-up||0
3315621|NCT03099187|4048785|FG002|NOT COMPLETED|12-month Safety Follow-up||19
3315622|NCT03099187|4048786|FG003|NOT COMPLETED|12-month Safety Follow-up||26
3315623|NCT03099369|4048798|FG000|STARTED|Overall Study||11
3315624|NCT03099369|4048799|FG001|STARTED|Overall Study||9
3315625|NCT03099369|4048798|FG000|COMPLETED|Overall Study||5
3315626|NCT03099369|4048799|FG001|COMPLETED|Overall Study||5
3315627|NCT03099369|4048798|FG000|NOT COMPLETED|Overall Study||6
3315628|NCT03099369|4048799|FG001|NOT COMPLETED|Overall Study||4
3315629|NCT03099538|4048806|FG000|STARTED|Overall Study||4
3315630|NCT03099538|4048806|FG000|COMPLETED|Overall Study||1
3315631|NCT03099538|4048806|FG000|NOT COMPLETED|Overall Study||3
3315632|NCT03099655|4048810|FG000|STARTED|Overall Study||440
3315633|NCT03099655|4048810|FG000|COMPLETED|Overall Study|6-Month visit with original 4798 lead implanted|379
3315634|NCT03099655|4048810|FG000|NOT COMPLETED|Overall Study||61
3315635|NCT03099694|4048819|FG000|STARTED|Overall Study||170
3315636|NCT03099694|4048820|FG001|STARTED|Overall Study||170
3315637|NCT03099694|4048819|FG000|COMPLETED|Overall Study||150
3315638|NCT03099694|4048820|FG001|COMPLETED|Overall Study||152
3315639|NCT03099694|4048819|FG000|NOT COMPLETED|Overall Study||20
3315640|NCT03099694|4048820|FG001|NOT COMPLETED|Overall Study||18
3315641|NCT03100058|4048836|FG000|STARTED|Epoch 3 (24 Weeks of Treatment)||38
3315642|NCT03100058|4048837|FG001|STARTED|Epoch 3 (24 Weeks of Treatment)||38
3315643|NCT03100058|4048838|FG002|STARTED|Epoch 3 (24 Weeks of Treatment)||38
3315644|NCT03100058|4048839|FG003|STARTED|Epoch 3 (24 Weeks of Treatment)||77
3315645|NCT03100058|4048840|FG004|STARTED|Epoch 3 (24 Weeks of Treatment)||38
3315646|NCT03100058|4048841|FG005|STARTED|Epoch 3 (24 Weeks of Treatment)||39
3315647|NCT03100058|4048842|FG006|STARTED|Epoch 3 (24 Weeks of Treatment)||38
3315648|NCT03100058|4048843|FG007|STARTED|Epoch 3 (24 Weeks of Treatment)||76
3315649|NCT03100058|4048844|FG008|STARTED|Epoch 3 (24 Weeks of Treatment)||78
3315650|NCT03100058|4048845|FG009|STARTED|Epoch 3 (24 Weeks of Treatment)||0
3315651|NCT03100058|4048846|FG010|STARTED|Epoch 3 (24 Weeks of Treatment)||0
3315652|NCT03100058|4048847|FG011|STARTED|Epoch 3 (24 Weeks of Treatment)||0
3315653|NCT03100058|4048848|FG012|STARTED|Epoch 3 (24 Weeks of Treatment)||0
3315654|NCT03100058|4048836|FG000|COMPLETED|Epoch 3 (24 Weeks of Treatment)||35
3315655|NCT03100058|4048837|FG001|COMPLETED|Epoch 3 (24 Weeks of Treatment)||31
3315656|NCT03100058|4048838|FG002|COMPLETED|Epoch 3 (24 Weeks of Treatment)||29
3315657|NCT03100058|4048839|FG003|COMPLETED|Epoch 3 (24 Weeks of Treatment)||63
3315658|NCT03100058|4048840|FG004|COMPLETED|Epoch 3 (24 Weeks of Treatment)||36
3315659|NCT03100058|4048841|FG005|COMPLETED|Epoch 3 (24 Weeks of Treatment)||37
3315660|NCT03100058|4048842|FG006|COMPLETED|Epoch 3 (24 Weeks of Treatment)||30
3315661|NCT03100058|4048843|FG007|COMPLETED|Epoch 3 (24 Weeks of Treatment)||60
2897912|NCT00406133|3605633|FG000|STARTED|Phase 1 (First 26 Week Period)||165
2897913|NCT00406133|3605634|FG001|STARTED|Phase 1 (First 26 Week Period)||157
3170868|NCT01931670|3898147|FG000|NOT COMPLETED|Treatment Period||90
3315662|NCT03100058|4048844|FG008|COMPLETED|Epoch 3 (24 Weeks of Treatment)||73
2897914|NCT00406133|3605635|FG002|STARTED|Phase 1 (First 26 Week Period)||67
2897915|NCT00406133|3605636|FG003|STARTED|Phase 1 (First 26 Week Period)||62
2897916|NCT00406133|3605633|FG000|COMPLETED|Phase 1 (First 26 Week Period)||162
2897917|NCT00406133|3605634|FG001|COMPLETED|Phase 1 (First 26 Week Period)||155
2897918|NCT00406133|3605635|FG002|COMPLETED|Phase 1 (First 26 Week Period)||67
2897919|NCT00406133|3605636|FG003|COMPLETED|Phase 1 (First 26 Week Period)||60
2897920|NCT00406133|3605633|FG000|NOT COMPLETED|Phase 1 (First 26 Week Period)||3
2897921|NCT00406133|3605634|FG001|NOT COMPLETED|Phase 1 (First 26 Week Period)||2
2897922|NCT00406133|3605635|FG002|NOT COMPLETED|Phase 1 (First 26 Week Period)||0
2897923|NCT00406133|3605636|FG003|NOT COMPLETED|Phase 1 (First 26 Week Period)||2
2897924|NCT00406133|3605633|FG000|STARTED|Phase 2 (Second 26 Week Period)|3 subjects completed phase 1 but elected not to go into phase 2.|159
2897925|NCT00406133|3605634|FG001|STARTED|Phase 2 (Second 26 Week Period)||155
2897926|NCT00406133|3605635|FG002|STARTED|Phase 2 (Second 26 Week Period)||67
2897927|NCT00406133|3605636|FG003|STARTED|Phase 2 (Second 26 Week Period)||60
2897928|NCT00406133|3605633|FG000|COMPLETED|Phase 2 (Second 26 Week Period)||157
2897929|NCT00406133|3605634|FG001|COMPLETED|Phase 2 (Second 26 Week Period)||152
2897930|NCT00406133|3605635|FG002|COMPLETED|Phase 2 (Second 26 Week Period)||67
2897931|NCT00406133|3605636|FG003|COMPLETED|Phase 2 (Second 26 Week Period)||60
2897932|NCT00406133|3605633|FG000|NOT COMPLETED|Phase 2 (Second 26 Week Period)||2
2897933|NCT00406133|3605634|FG001|NOT COMPLETED|Phase 2 (Second 26 Week Period)||3
2897934|NCT00406133|3605635|FG002|NOT COMPLETED|Phase 2 (Second 26 Week Period)||0
2897935|NCT00406133|3605636|FG003|NOT COMPLETED|Phase 2 (Second 26 Week Period)||0
2897936|NCT00406276|3605651|FG000|STARTED|Overall Study||28
2897937|NCT00406276|3605651|FG000|COMPLETED|Overall Study||24
2897938|NCT00406276|3605651|FG000|NOT COMPLETED|Overall Study||4
2897939|NCT00406315|3605656|FG000|STARTED|Overall Study|Started = Treated|241
2897940|NCT00406315|3605656|FG000|COMPLETED|Overall Study||100
2897941|NCT00406315|3605656|FG000|NOT COMPLETED|Overall Study||141
2897942|NCT00406354|3605663|FG000|STARTED|All Randomized Patients||60
2897943|NCT00406354|3605664|FG001|STARTED|All Randomized Patients||61
2897944|NCT00406354|3605665|FG002|STARTED|All Randomized Patients||60
2897945|NCT00406354|3605663|FG000|COMPLETED|All Randomized Patients||60
2897946|NCT00406354|3605664|FG001|COMPLETED|All Randomized Patients||61
2897947|NCT00406354|3605665|FG002|COMPLETED|All Randomized Patients|One patient was randomized but never received study treatment.|59
2897948|NCT00406354|3605663|FG000|NOT COMPLETED|All Randomized Patients||0
2897949|NCT00406354|3605664|FG001|NOT COMPLETED|All Randomized Patients||0
2897950|NCT00406354|3605665|FG002|NOT COMPLETED|All Randomized Patients||1
2897951|NCT00406354|3605663|FG000|STARTED|All Randomized and Treated Patients||60
2897952|NCT00406354|3605664|FG001|STARTED|All Randomized and Treated Patients||61
2897953|NCT00406354|3605665|FG002|STARTED|All Randomized and Treated Patients||59
2897954|NCT00406354|3605663|FG000|COMPLETED|All Randomized and Treated Patients||44
2897955|NCT00406354|3605664|FG001|COMPLETED|All Randomized and Treated Patients||48
2897956|NCT00406354|3605665|FG002|COMPLETED|All Randomized and Treated Patients||37
2897957|NCT00406354|3605663|FG000|NOT COMPLETED|All Randomized and Treated Patients||16
2897958|NCT00406354|3605664|FG001|NOT COMPLETED|All Randomized and Treated Patients||13
2897959|NCT00406354|3605665|FG002|NOT COMPLETED|All Randomized and Treated Patients||22
2897960|NCT00406367|3605675|FG000|STARTED|Main Period - 6 to 20 Weeks||75
2897961|NCT00406367|3605676|FG001|STARTED|Main Period - 6 to 20 Weeks||34
2897962|NCT00406367|3605675|FG000|COMPLETED|Main Period - 6 to 20 Weeks||70
2897963|NCT00406367|3605676|FG001|COMPLETED|Main Period - 6 to 20 Weeks||32
3170869|NCT01931670|3898148|FG001|NOT COMPLETED|Treatment Period||48
3315663|NCT03100058|4048845|FG009|COMPLETED|Epoch 3 (24 Weeks of Treatment)||0
3315664|NCT03100058|4048846|FG010|COMPLETED|Epoch 3 (24 Weeks of Treatment)||0
3315665|NCT03100058|4048847|FG011|COMPLETED|Epoch 3 (24 Weeks of Treatment)||0
3315666|NCT03100058|4048848|FG012|COMPLETED|Epoch 3 (24 Weeks of Treatment)||0
3315667|NCT03100058|4048836|FG000|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||3
3315668|NCT03100058|4048837|FG001|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||7
3315669|NCT03100058|4048838|FG002|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||9
3315670|NCT03100058|4048839|FG003|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||14
3315671|NCT03100058|4048840|FG004|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||2
3315672|NCT03100058|4048841|FG005|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||2
3315673|NCT03100058|4048842|FG006|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||8
3315674|NCT03100058|4048843|FG007|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||16
3315675|NCT03100058|4048844|FG008|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||5
3315676|NCT03100058|4048845|FG009|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||0
3315677|NCT03100058|4048846|FG010|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||0
3315678|NCT03100058|4048847|FG011|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||0
3315679|NCT03100058|4048848|FG012|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||0
3315680|NCT03100058|4048836|FG000|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0
3315681|NCT03100058|4048837|FG001|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0
3315682|NCT03100058|4048838|FG002|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0
3315683|NCT03100058|4048839|FG003|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0
3315684|NCT03100058|4048840|FG004|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0
3315685|NCT03100058|4048841|FG005|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0
3315686|NCT03100058|4048842|FG006|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0
3317233|NCT03124693|4050764|FG000|NOT COMPLETED|Overall Study||0
2897964|NCT00406367|3605675|FG000|NOT COMPLETED|Main Period - 6 to 20 Weeks||5
2897965|NCT00406367|3605676|FG001|NOT COMPLETED|Main Period - 6 to 20 Weeks||2
2897966|NCT00406367|3605675|FG000|STARTED|Open-Label Ext. Period - up to 68 Weeks||102
2897967|NCT00406367|3605676|FG001|STARTED|Open-Label Ext. Period - up to 68 Weeks|In the Open-Label Extension Period no placebo treatment arm was given.|0
2897968|NCT00406367|3605675|FG000|COMPLETED|Open-Label Ext. Period - up to 68 Weeks||82
2897969|NCT00406367|3605676|FG001|COMPLETED|Open-Label Ext. Period - up to 68 Weeks||0
2897970|NCT00406367|3605675|FG000|NOT COMPLETED|Open-Label Ext. Period - up to 68 Weeks||20
3038344|NCT01153815|3757771|FG000|STARTED|Overall Study||83
3315687|NCT03100058|4048843|FG007|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0
3315688|NCT03100058|4048844|FG008|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0
3315689|NCT03100058|4048845|FG009|STARTED|Epoch 4 (Last 24 Weeks of the Study)||158
3315690|NCT03100058|4048846|FG010|STARTED|Epoch 4 (Last 24 Weeks of the Study)||163
3315691|NCT03100058|4048847|FG011|STARTED|Epoch 4 (Last 24 Weeks of the Study)||39
3315692|NCT03100058|4048848|FG012|STARTED|Epoch 4 (Last 24 Weeks of the Study)||34
3315693|NCT03100058|4048836|FG000|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
3315694|NCT03100058|4048837|FG001|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
3315695|NCT03100058|4048838|FG002|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
3315696|NCT03100058|4048839|FG003|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
3315697|NCT03100058|4048840|FG004|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
3315698|NCT03100058|4048841|FG005|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
3315699|NCT03100058|4048842|FG006|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
3315700|NCT03100058|4048843|FG007|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
3315701|NCT03100058|4048844|FG008|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
3315702|NCT03100058|4048845|FG009|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||153
3315703|NCT03100058|4048846|FG010|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||148
3315704|NCT03100058|4048847|FG011|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||36
3315705|NCT03100058|4048848|FG012|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||30
3315706|NCT03100058|4048836|FG000|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
3315707|NCT03100058|4048837|FG001|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
3315708|NCT03100058|4048838|FG002|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
3315709|NCT03100058|4048839|FG003|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
3315710|NCT03100058|4048840|FG004|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
3315711|NCT03100058|4048841|FG005|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
3315712|NCT03100058|4048842|FG006|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
3315713|NCT03100058|4048843|FG007|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
3315714|NCT03100058|4048844|FG008|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
3315715|NCT03100058|4048845|FG009|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||5
3315716|NCT03100058|4048846|FG010|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||15
3315717|NCT03100058|4048847|FG011|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||3
3315718|NCT03100058|4048848|FG012|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||4
3315719|NCT03100123|4048879|FG000|STARTED|Overall Study||0
3315720|NCT03100123|4048880|FG001|STARTED|Overall Study||1
3315721|NCT03100123|4048879|FG000|COMPLETED|Overall Study||0
3315722|NCT03100123|4048880|FG001|COMPLETED|Overall Study||1
3315723|NCT03100123|4048879|FG000|NOT COMPLETED|Overall Study||0
3315724|NCT03100123|4048880|FG001|NOT COMPLETED|Overall Study||0
3315725|NCT03100344|4048895|FG000|STARTED|Overall Study||57
3315726|NCT03100344|4048896|FG001|STARTED|Overall Study||55
3315727|NCT03100344|4048897|FG002|STARTED|Overall Study||57
3315728|NCT03100344|4048898|FG003|STARTED|Overall Study||57
3315729|NCT03100344|4048895|FG000|COMPLETED|Overall Study||43
3315730|NCT03100344|4048896|FG001|COMPLETED|Overall Study||44
3315731|NCT03100344|4048897|FG002|COMPLETED|Overall Study||50
3315732|NCT03100344|4048898|FG003|COMPLETED|Overall Study||45
3315733|NCT03100344|4048895|FG000|NOT COMPLETED|Overall Study||14
3315734|NCT03100344|4048896|FG001|NOT COMPLETED|Overall Study||11
3315735|NCT03100344|4048897|FG002|NOT COMPLETED|Overall Study||7
3315736|NCT03100344|4048898|FG003|NOT COMPLETED|Overall Study||12
3315737|NCT03100500|4048909|FG000|STARTED|Overall Study||51
3315738|NCT03100500|4048909|FG000|COMPLETED|Overall Study||51
3315739|NCT03100500|4048909|FG000|NOT COMPLETED|Overall Study||0
3315740|NCT03100825|4048913|FG000|STARTED|Overall Study||94
3315741|NCT03100825|4048913|FG000|COMPLETED|Overall Study||86
3315742|NCT03100825|4048913|FG000|NOT COMPLETED|Overall Study||8
3315743|NCT03100838|4048917|FG000|STARTED|Overall Study||16
3315744|NCT03100838|4048918|FG001|STARTED|Overall Study||16
3315745|NCT03100838|4048919|FG002|STARTED|Overall Study||16
3315746|NCT03100838|4048920|FG003|STARTED|Overall Study||16
3315747|NCT03100838|4048917|FG000|COMPLETED|Overall Study||14
3315748|NCT03100838|4048918|FG001|COMPLETED|Overall Study||14
3315749|NCT03100838|4048919|FG002|COMPLETED|Overall Study||14
3315750|NCT03100838|4048920|FG003|COMPLETED|Overall Study||15
3315751|NCT03100838|4048917|FG000|NOT COMPLETED|Overall Study||2
3315752|NCT03100838|4048918|FG001|NOT COMPLETED|Overall Study||2
3315753|NCT03100838|4048919|FG002|NOT COMPLETED|Overall Study||2
3315754|NCT03100838|4048920|FG003|NOT COMPLETED|Overall Study||1
3315755|NCT03100864|4048930|FG000|STARTED|Overall Study||8
3315756|NCT03100864|4048930|FG000|COMPLETED|Overall Study||8
3315757|NCT03100864|4048930|FG000|NOT COMPLETED|Overall Study||0
3315758|NCT03100942|4048938|FG000|STARTED|Randomized Treatment Period||38
3315759|NCT03100942|4048939|FG001|STARTED|Randomized Treatment Period||38
2897971|NCT00406367|3605676|FG001|NOT COMPLETED|Open-Label Ext. Period - up to 68 Weeks||0
2897972|NCT00406393|3605684|FG000|STARTED|Overall Study||151
3315760|NCT03100942|4048940|FG002|STARTED|Randomized Treatment Period||39
3315761|NCT03100942|4048941|FG003|STARTED|Randomized Treatment Period||37
3315762|NCT03100942|4048942|FG004|STARTED|Randomized Treatment Period||0
3315763|NCT03100942|4048943|FG005|STARTED|Randomized Treatment Period||0
3315764|NCT03100942|4048944|FG006|STARTED|Randomized Treatment Period||0
3315765|NCT03100942|4048938|FG000|COMPLETED|Randomized Treatment Period||26
3315766|NCT03100942|4048939|FG001|COMPLETED|Randomized Treatment Period||29
3315767|NCT03100942|4048940|FG002|COMPLETED|Randomized Treatment Period||33
3315768|NCT03100942|4048941|FG003|COMPLETED|Randomized Treatment Period||32
3315769|NCT03100942|4048942|FG004|COMPLETED|Randomized Treatment Period||0
3315770|NCT03100942|4048943|FG005|COMPLETED|Randomized Treatment Period||0
3315771|NCT03100942|4048944|FG006|COMPLETED|Randomized Treatment Period||0
3315772|NCT03100942|4048938|FG000|NOT COMPLETED|Randomized Treatment Period||12
3315773|NCT03100942|4048939|FG001|NOT COMPLETED|Randomized Treatment Period||9
3315774|NCT03100942|4048940|FG002|NOT COMPLETED|Randomized Treatment Period||6
3315775|NCT03100942|4048941|FG003|NOT COMPLETED|Randomized Treatment Period||5
3315776|NCT03100942|4048942|FG004|NOT COMPLETED|Randomized Treatment Period||0
3315777|NCT03100942|4048943|FG005|NOT COMPLETED|Randomized Treatment Period||0
3315778|NCT03100942|4048944|FG006|NOT COMPLETED|Randomized Treatment Period||0
3315779|NCT03100942|4048938|FG000|STARTED|Placebo Arm Re-Randomized||0
3315780|NCT03100942|4048939|FG001|STARTED|Placebo Arm Re-Randomized||0
3315781|NCT03100942|4048940|FG002|STARTED|Placebo Arm Re-Randomized||0
3315782|NCT03100942|4048941|FG003|STARTED|Placebo Arm Re-Randomized||0
3315783|NCT03100942|4048942|FG004|STARTED|Placebo Arm Re-Randomized||10
3315784|NCT03100942|4048943|FG005|STARTED|Placebo Arm Re-Randomized||12
3315785|NCT03100942|4048944|FG006|STARTED|Placebo Arm Re-Randomized||10
3315786|NCT03100942|4048938|FG000|COMPLETED|Placebo Arm Re-Randomized||0
3315787|NCT03100942|4048939|FG001|COMPLETED|Placebo Arm Re-Randomized||0
3315788|NCT03100942|4048940|FG002|COMPLETED|Placebo Arm Re-Randomized||0
3315789|NCT03100942|4048941|FG003|COMPLETED|Placebo Arm Re-Randomized||0
3315790|NCT03100942|4048942|FG004|COMPLETED|Placebo Arm Re-Randomized||10
3315791|NCT03100942|4048943|FG005|COMPLETED|Placebo Arm Re-Randomized||12
3315792|NCT03100942|4048944|FG006|COMPLETED|Placebo Arm Re-Randomized||9
3315793|NCT03100942|4048938|FG000|NOT COMPLETED|Placebo Arm Re-Randomized||0
3315794|NCT03100942|4048939|FG001|NOT COMPLETED|Placebo Arm Re-Randomized||0
3315795|NCT03100942|4048940|FG002|NOT COMPLETED|Placebo Arm Re-Randomized||0
3315796|NCT03100942|4048941|FG003|NOT COMPLETED|Placebo Arm Re-Randomized||0
3315797|NCT03100942|4048942|FG004|NOT COMPLETED|Placebo Arm Re-Randomized||0
3315798|NCT03100942|4048943|FG005|NOT COMPLETED|Placebo Arm Re-Randomized||0
3315799|NCT03100942|4048944|FG006|NOT COMPLETED|Placebo Arm Re-Randomized||1
3315800|NCT03100968|4048959|FG000|STARTED|Overall Study||75
3315801|NCT03100968|4048960|FG001|STARTED|Overall Study||75
3315802|NCT03100968|4048959|FG000|COMPLETED|Overall Study||75
3315803|NCT03100968|4048960|FG001|COMPLETED|Overall Study||75
3315804|NCT03100968|4048959|FG000|NOT COMPLETED|Overall Study||0
3315805|NCT03100968|4048960|FG001|NOT COMPLETED|Overall Study||0
3315806|NCT03101020|4048968|FG000|STARTED|Overall Study||10
3315807|NCT03101020|4048969|FG001|STARTED|Overall Study||10
3315808|NCT03101020|4048968|FG000|COMPLETED|Overall Study||9
3315809|NCT03101020|4048969|FG001|COMPLETED|Overall Study||7
3315810|NCT03101020|4048968|FG000|NOT COMPLETED|Overall Study||1
3315811|NCT03101020|4048969|FG001|NOT COMPLETED|Overall Study||3
3315812|NCT03101033|4048977|FG000|STARTED|Overall Study||32
3315813|NCT03101033|4048978|FG001|STARTED|Overall Study||60
3315814|NCT03101033|4048977|FG000|COMPLETED|Overall Study||27
3315815|NCT03101033|4048978|FG001|COMPLETED|Overall Study||51
3315816|NCT03101033|4048977|FG000|NOT COMPLETED|Overall Study||5
3315817|NCT03101033|4048978|FG001|NOT COMPLETED|Overall Study||9
3315818|NCT03101111|4048986|FG000|STARTED|Overall Study|First subject signed ICF (MV-CHIK group)|26
3315819|NCT03101111|4048987|FG001|STARTED|Overall Study|First subject signed ICF (MMR group)|8
3315820|NCT03101111|4048986|FG000|COMPLETED|Overall Study|End of Study Visit|23
3315821|NCT03101111|4048987|FG001|COMPLETED|Overall Study|End of Study Visit|7
3315822|NCT03101111|4048986|FG000|NOT COMPLETED|Overall Study||3
3315823|NCT03101111|4048987|FG001|NOT COMPLETED|Overall Study||1
3315824|NCT03101150|4048999|FG000|STARTED|Overall Study||86
3315825|NCT03101150|4049000|FG001|STARTED|Overall Study||93
3315826|NCT03101150|4048999|FG000|COMPLETED|Overall Study||81
3315827|NCT03101150|4049000|FG001|COMPLETED|Overall Study||83
3315828|NCT03101150|4048999|FG000|NOT COMPLETED|Overall Study||5
3315829|NCT03101150|4049000|FG001|NOT COMPLETED|Overall Study||10
3315830|NCT03101241|4049008|FG000|STARTED|Overall Study||48
3315831|NCT03101241|4049009|FG001|STARTED|Overall Study||47
3315832|NCT03101241|4049008|FG000|COMPLETED|Overall Study||37
3315833|NCT03101241|4049009|FG001|COMPLETED|Overall Study||42
3315834|NCT03101241|4049008|FG000|NOT COMPLETED|Overall Study||11
3315835|NCT03101241|4049009|FG001|NOT COMPLETED|Overall Study||5
3315836|NCT03101267|4049018|FG000|STARTED|Primary Study Period||50
3315837|NCT03101267|4049019|FG001|STARTED|Primary Study Period||50
3315838|NCT03101267|4049020|FG002|STARTED|Primary Study Period||50
3315839|NCT03101267|4049018|FG000|COMPLETED|Primary Study Period||47
3315840|NCT03101267|4049019|FG001|COMPLETED|Primary Study Period||48
3315841|NCT03101267|4049020|FG002|COMPLETED|Primary Study Period||47
3315842|NCT03101267|4049018|FG000|NOT COMPLETED|Primary Study Period||3
3315843|NCT03101267|4049019|FG001|NOT COMPLETED|Primary Study Period||2
2897973|NCT00406393|3605685|FG001|STARTED|Overall Study||153
2897974|NCT00406393|3605684|FG000|COMPLETED|Overall Study||149
2897975|NCT00406393|3605685|FG001|COMPLETED|Overall Study||152
2897976|NCT00406393|3605684|FG000|NOT COMPLETED|Overall Study||2
2897977|NCT00406393|3605685|FG001|NOT COMPLETED|Overall Study||1
2897978|NCT00406419|3605694|FG000|STARTED|Overall Study||324
2897979|NCT00406419|3605695|FG001|STARTED|Overall Study||344
2897980|NCT00406419|3605696|FG002|STARTED|Overall Study||347
2897981|NCT00406419|3605694|FG000|COMPLETED|Overall Study||0
2897982|NCT00406419|3605695|FG001|COMPLETED|Overall Study||0
2897983|NCT00406419|3605696|FG002|COMPLETED|Overall Study||0
2897984|NCT00406419|3605694|FG000|NOT COMPLETED|Overall Study||324
2897985|NCT00406419|3605695|FG001|NOT COMPLETED|Overall Study||344
2897986|NCT00406419|3605696|FG002|NOT COMPLETED|Overall Study||347
2897987|NCT00406640|3605706|FG000|STARTED|Acute Phase||296
2897988|NCT00406640|3605707|FG001|STARTED|Acute Phase||299
2897989|NCT00406640|3605706|FG000|COMPLETED|Acute Phase||245
2897990|NCT00406640|3605707|FG001|COMPLETED|Acute Phase||256
2897991|NCT00406640|3605706|FG000|NOT COMPLETED|Acute Phase||51
2897992|NCT00406640|3605707|FG001|NOT COMPLETED|Acute Phase||43
2897993|NCT00406640|3605706|FG000|STARTED|DB Continuation Phase for Responders||172
2897994|NCT00406640|3605707|FG001|STARTED|DB Continuation Phase for Responders||188
2897995|NCT00406640|3605706|FG000|COMPLETED|DB Continuation Phase for Responders||139
2897996|NCT00406640|3605707|FG001|COMPLETED|DB Continuation Phase for Responders||151
2897997|NCT00406640|3605706|FG000|NOT COMPLETED|DB Continuation Phase for Responders||33
2897998|NCT00406640|3605707|FG001|NOT COMPLETED|DB Continuation Phase for Responders||37
2897999|NCT00406640|3605706|FG000|STARTED|OL Extension Phase for Non-Responders||69
2898000|NCT00406640|3605707|FG001|STARTED|OL Extension Phase for Non-Responders||60
2898001|NCT00406640|3605706|FG000|COMPLETED|OL Extension Phase for Non-Responders||47
2898002|NCT00406640|3605707|FG001|COMPLETED|OL Extension Phase for Non-Responders||36
2898003|NCT00406640|3605706|FG000|NOT COMPLETED|OL Extension Phase for Non-Responders||22
2898004|NCT00406640|3605707|FG001|NOT COMPLETED|OL Extension Phase for Non-Responders||24
2898005|NCT00406653|3605723|FG000|STARTED|Induction Period||65
2898006|NCT00406653|3605724|FG001|STARTED|Induction Period||128
2898007|NCT00406653|3605725|FG002|STARTED|Induction Period||130
2898008|NCT00406653|3605726|FG003|STARTED|Induction Period||128
2898009|NCT00406653|3605727|FG004|STARTED|Induction Period||0
2898010|NCT00406653|3605728|FG005|STARTED|Induction Period||0
2898011|NCT00406653|3605729|FG006|STARTED|Induction Period||0
2898012|NCT00406653|3605723|FG000|COMPLETED|Induction Period||50
2898013|NCT00406653|3605724|FG001|COMPLETED|Induction Period||94
2898014|NCT00406653|3605725|FG002|COMPLETED|Induction Period||112
2898015|NCT00406653|3605726|FG003|COMPLETED|Induction Period||102
2898016|NCT00406653|3605727|FG004|COMPLETED|Induction Period||0
2898017|NCT00406653|3605728|FG005|COMPLETED|Induction Period||0
2898018|NCT00406653|3605729|FG006|COMPLETED|Induction Period||0
2898019|NCT00406653|3605723|FG000|NOT COMPLETED|Induction Period||15
2898020|NCT00406653|3605724|FG001|NOT COMPLETED|Induction Period||34
2898021|NCT00406653|3605725|FG002|NOT COMPLETED|Induction Period||18
2898022|NCT00406653|3605726|FG003|NOT COMPLETED|Induction Period||26
3315844|NCT03101267|4049020|FG002|NOT COMPLETED|Primary Study Period||3
3315845|NCT03101267|4049018|FG000|STARTED|Pollinosis Symptoms Survey Period||47
3315846|NCT03101267|4049019|FG001|STARTED|Pollinosis Symptoms Survey Period||48
3315847|NCT03101267|4049020|FG002|STARTED|Pollinosis Symptoms Survey Period||47
3315848|NCT03101267|4049018|FG000|COMPLETED|Pollinosis Symptoms Survey Period||47
3315849|NCT03101267|4049019|FG001|COMPLETED|Pollinosis Symptoms Survey Period||48
3315850|NCT03101267|4049020|FG002|COMPLETED|Pollinosis Symptoms Survey Period||47
3315851|NCT03101267|4049018|FG000|NOT COMPLETED|Pollinosis Symptoms Survey Period||0
3315852|NCT03101267|4049019|FG001|NOT COMPLETED|Pollinosis Symptoms Survey Period||0
3315853|NCT03101267|4049020|FG002|NOT COMPLETED|Pollinosis Symptoms Survey Period||0
3315854|NCT03101293|4049030|FG000|STARTED|Intervention Period 1||7
3315855|NCT03101293|4049031|FG001|STARTED|Intervention Period 1||8
3315856|NCT03101293|4049030|FG000|COMPLETED|Intervention Period 1||7
3170870|NCT01931670|3898149|FG002|NOT COMPLETED|Treatment Period||45
3170871|NCT01931670|3898147|FG000|STARTED|Post-Treatment Follow-Up (PTFU) Period||61
3170872|NCT01931670|3898148|FG001|STARTED|Post-Treatment Follow-Up (PTFU) Period||40
3170873|NCT01931670|3898149|FG002|STARTED|Post-Treatment Follow-Up (PTFU) Period||54
3170874|NCT01931670|3898147|FG000|Completed PTFU Month 6|Post-Treatment Follow-Up (PTFU) Period||42
3315857|NCT03101293|4049031|FG001|COMPLETED|Intervention Period 1||8
2898023|NCT00406653|3605727|FG004|NOT COMPLETED|Induction Period||0
2898024|NCT00406653|3605728|FG005|NOT COMPLETED|Induction Period||0
2898025|NCT00406653|3605729|FG006|NOT COMPLETED|Induction Period||0
2898026|NCT00406653|3605723|FG000|STARTED|Maintenance Period||0
2898027|NCT00406653|3605724|FG001|STARTED|Maintenance Period||0
2898028|NCT00406653|3605725|FG002|STARTED|Maintenance Period||0
2898029|NCT00406653|3605726|FG003|STARTED|Maintenance Period||0
2898030|NCT00406653|3605727|FG004|STARTED|Maintenance Period|At end of IP, 44 participants met response criteria and were randomly assigned to abatacept in MP.|44
2898031|NCT00406653|3605728|FG005|STARTED|Maintenance Period|At end of IP, 46 participants met response criteria and were randomly assigned to placebo in MP.|46
2898032|NCT00406653|3605729|FG006|STARTED|Maintenance Period||0
2898033|NCT00406653|3605723|FG000|COMPLETED|Maintenance Period||0
2898034|NCT00406653|3605724|FG001|COMPLETED|Maintenance Period||0
2898035|NCT00406653|3605725|FG002|COMPLETED|Maintenance Period||0
2898036|NCT00406653|3605726|FG003|COMPLETED|Maintenance Period||0
2898037|NCT00406653|3605727|FG004|COMPLETED|Maintenance Period||14
3315858|NCT03101293|4049030|FG000|NOT COMPLETED|Intervention Period 1||0
3315859|NCT03101293|4049031|FG001|NOT COMPLETED|Intervention Period 1||0
3315860|NCT03101293|4049030|FG000|STARTED|Washout Period (at Least 7 Days)||7
3315861|NCT03101293|4049031|FG001|STARTED|Washout Period (at Least 7 Days)||8
3315862|NCT03101293|4049030|FG000|COMPLETED|Washout Period (at Least 7 Days)||6
3315863|NCT03101293|4049031|FG001|COMPLETED|Washout Period (at Least 7 Days)||8
3315864|NCT03101293|4049030|FG000|NOT COMPLETED|Washout Period (at Least 7 Days)||1
3315865|NCT03101293|4049031|FG001|NOT COMPLETED|Washout Period (at Least 7 Days)||0
3315866|NCT03101293|4049030|FG000|STARTED|Intervention Period 2||6
3315867|NCT03101293|4049031|FG001|STARTED|Intervention Period 2||8
3315868|NCT03101293|4049030|FG000|COMPLETED|Intervention Period 2||6
3315869|NCT03101293|4049031|FG001|COMPLETED|Intervention Period 2||8
3315870|NCT03101293|4049030|FG000|NOT COMPLETED|Intervention Period 2||0
3315871|NCT03101293|4049031|FG001|NOT COMPLETED|Intervention Period 2||0
3315872|NCT03101358|4049041|FG000|STARTED|Overall Study||4
3315873|NCT03101358|4049042|FG001|STARTED|Overall Study||3
3315874|NCT03101358|4049043|FG002|STARTED|Overall Study||5
3315875|NCT03101358|4049044|FG003|STARTED|Overall Study||11
3315876|NCT03101358|4049041|FG000|Completed All Dosing|Overall Study||3
3315877|NCT03101358|4049042|FG001|Completed All Dosing|Overall Study||3
3315878|NCT03101358|4049043|FG002|Completed All Dosing|Overall Study||3
3315879|NCT03101358|4049044|FG003|Completed All Dosing|Overall Study||10
3315880|NCT03101358|4049041|FG000|COMPLETED|Overall Study||1
3315881|NCT03101358|4049042|FG001|COMPLETED|Overall Study||3
3315882|NCT03101358|4049043|FG002|COMPLETED|Overall Study||3
3315883|NCT03101358|4049044|FG003|COMPLETED|Overall Study||5
3315884|NCT03101358|4049041|FG000|NOT COMPLETED|Overall Study||3
3315885|NCT03101358|4049042|FG001|NOT COMPLETED|Overall Study||0
3315886|NCT03101358|4049043|FG002|NOT COMPLETED|Overall Study||2
3315887|NCT03101358|4049044|FG003|NOT COMPLETED|Overall Study||6
3315888|NCT03101371|4049057|FG000|STARTED|Overall Study||48
3315889|NCT03101371|4049058|FG001|STARTED|Overall Study||51
3315890|NCT03101371|4049057|FG000|COMPLETED|Overall Study||45
3315891|NCT03101371|4049058|FG001|COMPLETED|Overall Study||45
3315892|NCT03101371|4049057|FG000|NOT COMPLETED|Overall Study||3
3315893|NCT03101371|4049058|FG001|NOT COMPLETED|Overall Study||6
3315894|NCT03101462|4049066|FG000|STARTED|Overall Study||19
3315895|NCT03101462|4049067|FG001|STARTED|Overall Study||19
3315896|NCT03101462|4049066|FG000|COMPLETED|Overall Study||18
3315897|NCT03101462|4049067|FG001|COMPLETED|Overall Study||18
3315898|NCT03101462|4049066|FG000|NOT COMPLETED|Overall Study||1
3315899|NCT03101462|4049067|FG001|NOT COMPLETED|Overall Study||1
3315900|NCT03101514|4049073|FG000|STARTED|Overall Study||53
3315901|NCT03101514|4049073|FG000|COMPLETED|Overall Study||46
3315902|NCT03101514|4049073|FG000|NOT COMPLETED|Overall Study||7
3315903|NCT03101592|4049080|FG000|STARTED|Overall Study||3123
3315904|NCT03101592|4049081|FG001|STARTED|Overall Study||2896
3315905|NCT03101592|4049082|FG002|STARTED|Overall Study||3099
3315906|NCT03101592|4049080|FG000|COMPLETED|Overall Study||3012
3315907|NCT03101592|4049081|FG001|COMPLETED|Overall Study||2726
3315908|NCT03101592|4049082|FG002|COMPLETED|Overall Study||2981
3315909|NCT03101592|4049080|FG000|NOT COMPLETED|Overall Study||111
3315910|NCT03101592|4049081|FG001|NOT COMPLETED|Overall Study||170
3315911|NCT03101592|4049082|FG002|NOT COMPLETED|Overall Study||118
3315912|NCT03102190|4049096|FG000|STARTED|Overall Study||6
3315913|NCT03102190|4049096|FG000|COMPLETED|Overall Study||6
3315914|NCT03102190|4049096|FG000|NOT COMPLETED|Overall Study||0
3315915|NCT03102411|4049100|FG000|STARTED|Overall Study||1881
3315916|NCT03102411|4049100|FG000|COMPLETED|Overall Study||1718
3315917|NCT03102411|4049100|FG000|NOT COMPLETED|Overall Study||163
3315918|NCT03102437|4049107|FG000|STARTED|Overall Study||70
3315919|NCT03102437|4049108|FG001|STARTED|Overall Study||36
3315920|NCT03102437|4049107|FG000|COMPLETED|Overall Study||65
3315921|NCT03102437|4049108|FG001|COMPLETED|Overall Study||36
3315922|NCT03102437|4049107|FG000|NOT COMPLETED|Overall Study||5
3315923|NCT03102437|4049108|FG001|NOT COMPLETED|Overall Study||0
3315924|NCT03102645|4049116|FG000|STARTED|Overall Study||8
3315925|NCT03102645|4049117|FG001|STARTED|Overall Study||8
3315926|NCT03102645|4049116|FG000|COMPLETED|Overall Study||8
3315927|NCT03102645|4049117|FG001|COMPLETED|Overall Study||8
3315928|NCT03102645|4049116|FG000|NOT COMPLETED|Overall Study||0
3315929|NCT03102645|4049117|FG001|NOT COMPLETED|Overall Study||0
3315930|NCT03102710|4049127|FG000|STARTED|Overall Study||28
3315931|NCT03102710|4049128|FG001|STARTED|Overall Study||30
3315932|NCT03102710|4049129|FG002|STARTED|Overall Study||27
3315933|NCT03102710|4049127|FG000|COMPLETED|Overall Study||27
3315934|NCT03102710|4049128|FG001|COMPLETED|Overall Study||27
3315935|NCT03102710|4049129|FG002|COMPLETED|Overall Study||27
3315936|NCT03102710|4049127|FG000|NOT COMPLETED|Overall Study||1
3315937|NCT03102710|4049128|FG001|NOT COMPLETED|Overall Study||3
3315938|NCT03102710|4049129|FG002|NOT COMPLETED|Overall Study||0
3315939|NCT03102736|4049139|FG000|STARTED|Overall Study||7
3315940|NCT03102736|4049140|FG001|STARTED|Overall Study||9
3315941|NCT03102736|4049139|FG000|COMPLETED|Overall Study||7
3315942|NCT03102736|4049140|FG001|COMPLETED|Overall Study||9
3315943|NCT03102736|4049139|FG000|NOT COMPLETED|Overall Study||0
2898038|NCT00406653|3605728|FG005|COMPLETED|Maintenance Period||10
3315944|NCT03102736|4049140|FG001|NOT COMPLETED|Overall Study||0
3315945|NCT03102762|4049148|FG000|STARTED|Overall Study||35
3315946|NCT03102762|4049149|FG001|STARTED|Overall Study||35
2898039|NCT00406653|3605729|FG006|COMPLETED|Maintenance Period||0
2898040|NCT00406653|3605723|FG000|NOT COMPLETED|Maintenance Period||0
2898041|NCT00406653|3605724|FG001|NOT COMPLETED|Maintenance Period||0
2898042|NCT00406653|3605725|FG002|NOT COMPLETED|Maintenance Period||0
2898043|NCT00406653|3605726|FG003|NOT COMPLETED|Maintenance Period||0
3170875|NCT01931670|3898148|FG001|Completed PTFU Month 6|Post-Treatment Follow-Up (PTFU) Period||24
3315947|NCT03102762|4049148|FG000|COMPLETED|Overall Study||34
3315948|NCT03102762|4049149|FG001|COMPLETED|Overall Study||35
3315949|NCT03102762|4049148|FG000|NOT COMPLETED|Overall Study||1
3315950|NCT03102762|4049149|FG001|NOT COMPLETED|Overall Study||0
3315951|NCT03102879|4049158|FG000|STARTED|Overall Study||18
3315952|NCT03102879|4049159|FG001|STARTED|Overall Study||18
3315953|NCT03102879|4049158|FG000|COMPLETED|Overall Study||18
3315954|NCT03102879|4049159|FG001|COMPLETED|Overall Study||18
3315955|NCT03102879|4049158|FG000|NOT COMPLETED|Overall Study||0
3315956|NCT03102879|4049159|FG001|NOT COMPLETED|Overall Study||0
3315957|NCT03102918|4049171|FG000|STARTED|Overall Study||5
3315958|NCT03102918|4049172|FG001|STARTED|Overall Study||5
3315959|NCT03102918|4049171|FG000|COMPLETED|Overall Study||4
3315960|NCT03102918|4049172|FG001|COMPLETED|Overall Study||5
3315961|NCT03102918|4049171|FG000|NOT COMPLETED|Overall Study||1
3315962|NCT03102918|4049172|FG001|NOT COMPLETED|Overall Study||0
3315963|NCT03103061|4049178|FG000|STARTED|Overall Study||24
3315964|NCT03103061|4049178|FG000|COMPLETED|Overall Study||24
3315965|NCT03103061|4049178|FG000|NOT COMPLETED|Overall Study||0
3315966|NCT03103100|4049185|FG000|STARTED|Overall Study||25
3315967|NCT03103100|4049186|FG001|STARTED|Overall Study||25
3315968|NCT03103100|4049187|FG002|STARTED|Overall Study||25
3315969|NCT03103100|4049185|FG000|COMPLETED|Overall Study||23
3315970|NCT03103100|4049186|FG001|COMPLETED|Overall Study||25
3315971|NCT03103100|4049187|FG002|COMPLETED|Overall Study||23
3315972|NCT03103100|4049185|FG000|NOT COMPLETED|Overall Study||2
3315973|NCT03103100|4049186|FG001|NOT COMPLETED|Overall Study||0
3315974|NCT03103100|4049187|FG002|NOT COMPLETED|Overall Study||2
3315975|NCT03103282|4049195|FG000|STARTED|Overall Study||65
3315976|NCT03103282|4049195|FG000|COMPLETED|Overall Study||65
3315977|NCT03103282|4049195|FG000|NOT COMPLETED|Overall Study||0
3315978|NCT03103438|4049206|FG000|STARTED|Overall Study||1
3315979|NCT03103438|4049207|FG001|STARTED|Overall Study||3
3315980|NCT03103438|4049208|FG002|STARTED|Overall Study||3
3315981|NCT03103438|4049209|FG003|STARTED|Overall Study||3
3315982|NCT03103438|4049210|FG004|STARTED|Overall Study||3
3315983|NCT03103438|4049211|FG005|STARTED|Overall Study||3
3315984|NCT03103438|4049212|FG006|STARTED|Overall Study||3
3315985|NCT03103438|4049206|FG000|COMPLETED|Overall Study||1
3315986|NCT03103438|4049207|FG001|COMPLETED|Overall Study||3
3315987|NCT03103438|4049208|FG002|COMPLETED|Overall Study||3
3315988|NCT03103438|4049209|FG003|COMPLETED|Overall Study||3
3315989|NCT03103438|4049210|FG004|COMPLETED|Overall Study||3
3315990|NCT03103438|4049211|FG005|COMPLETED|Overall Study||3
3315991|NCT03103438|4049212|FG006|COMPLETED|Overall Study||3
3315992|NCT03103438|4049206|FG000|NOT COMPLETED|Overall Study||0
3315993|NCT03103438|4049207|FG001|NOT COMPLETED|Overall Study||0
3315994|NCT03103438|4049208|FG002|NOT COMPLETED|Overall Study||0
3315995|NCT03103438|4049209|FG003|NOT COMPLETED|Overall Study||0
3315996|NCT03103438|4049210|FG004|NOT COMPLETED|Overall Study||0
3315997|NCT03103438|4049211|FG005|NOT COMPLETED|Overall Study||0
3315998|NCT03103438|4049212|FG006|NOT COMPLETED|Overall Study||0
3315999|NCT03103503|4049228|FG000|STARTED|Overall Study||901
3316000|NCT03103503|4049228|FG000|COMPLETED|Overall Study||0
3316001|NCT03103503|4049228|FG000|NOT COMPLETED|Overall Study||901
3316002|NCT03103542|4049232|FG000|STARTED|Overall Study|18 - screened 16 - enrolled|16
3316003|NCT03103542|4049232|FG000|COMPLETED|Overall Study||9
3316004|NCT03103542|4049232|FG000|NOT COMPLETED|Overall Study||7
3316005|NCT03103763|4049240|FG000|STARTED|Overall Study||44
3316006|NCT03103763|4049241|FG001|STARTED|Overall Study||44
3316007|NCT03103763|4049242|FG002|STARTED|Overall Study||44
3170876|NCT01931670|3898149|FG002|Completed PTFU Month 6|Post-Treatment Follow-Up (PTFU) Period||18
3170877|NCT01931670|3898147|FG000|Completed PTFU Month 12|Post-Treatment Follow-Up (PTFU) Period||0
3170878|NCT01931670|3898148|FG001|Completed PTFU Month 12|Post-Treatment Follow-Up (PTFU) Period||4
3170879|NCT01931670|3898149|FG002|Completed PTFU Month 12|Post-Treatment Follow-Up (PTFU) Period||15
3170880|NCT01931670|3898147|FG000|COMPLETED|Post-Treatment Follow-Up (PTFU) Period||42
3170881|NCT01931670|3898148|FG001|COMPLETED|Post-Treatment Follow-Up (PTFU) Period||28
3316008|NCT03103763|4049240|FG000|COMPLETED|Overall Study||29
3316009|NCT03103763|4049241|FG001|COMPLETED|Overall Study||36
3316010|NCT03103763|4049242|FG002|COMPLETED|Overall Study||37
3316011|NCT03103763|4049240|FG000|NOT COMPLETED|Overall Study||15
3316012|NCT03103763|4049241|FG001|NOT COMPLETED|Overall Study||8
3316013|NCT03103763|4049242|FG002|NOT COMPLETED|Overall Study||7
3316014|NCT03103906|4049252|FG000|STARTED|Overall Study||40
3316015|NCT03103906|4049253|FG001|STARTED|Overall Study||42
3316016|NCT03103906|4049252|FG000|COMPLETED|Overall Study||36
3170882|NCT01931670|3898149|FG002|COMPLETED|Post-Treatment Follow-Up (PTFU) Period||33
3170883|NCT01931670|3898147|FG000|NOT COMPLETED|Post-Treatment Follow-Up (PTFU) Period||19
3170884|NCT01931670|3898148|FG001|NOT COMPLETED|Post-Treatment Follow-Up (PTFU) Period||12
3170885|NCT01931670|3898149|FG002|NOT COMPLETED|Post-Treatment Follow-Up (PTFU) Period||21
3316017|NCT03103906|4049253|FG001|COMPLETED|Overall Study||39
3316018|NCT03103906|4049252|FG000|NOT COMPLETED|Overall Study||4
3316019|NCT03103906|4049253|FG001|NOT COMPLETED|Overall Study||3
2898044|NCT00406653|3605727|FG004|NOT COMPLETED|Maintenance Period||30
2898045|NCT00406653|3605728|FG005|NOT COMPLETED|Maintenance Period||36
2898046|NCT00406653|3605729|FG006|NOT COMPLETED|Maintenance Period||0
2898047|NCT00406653|3605723|FG000|STARTED|Open-Label Period||0
2898048|NCT00406653|3605724|FG001|STARTED|Open-Label Period||0
2898049|NCT00406653|3605725|FG002|STARTED|Open-Label Period||0
2898050|NCT00406653|3605726|FG003|STARTED|Open-Label Period||0
2898051|NCT00406653|3605727|FG004|STARTED|Open-Label Period||0
2898052|NCT00406653|3605728|FG005|STARTED|Open-Label Period||0
2898053|NCT00406653|3605729|FG006|STARTED|Open-Label Period|All completing IP but failing response criteria and those completing or relapsing on MP entered OL.|324
2898054|NCT00406653|3605723|FG000|COMPLETED|Open-Label Period||0
2898055|NCT00406653|3605724|FG001|COMPLETED|Open-Label Period||0
2898056|NCT00406653|3605725|FG002|COMPLETED|Open-Label Period||0
2898057|NCT00406653|3605726|FG003|COMPLETED|Open-Label Period||0
2898058|NCT00406653|3605727|FG004|COMPLETED|Open-Label Period||0
2898059|NCT00406653|3605728|FG005|COMPLETED|Open-Label Period||0
2898060|NCT00406653|3605729|FG006|COMPLETED|Open-Label Period||0
2898061|NCT00406653|3605723|FG000|NOT COMPLETED|Open-Label Period||0
3170886|NCT01931709|3898157|FG000|STARTED|Overall Study||35
3170887|NCT01931709|3898157|FG000|COMPLETED|Overall Study||35
3170888|NCT01931709|3898157|FG000|NOT COMPLETED|Overall Study||0
3170889|NCT01931735|3898167|FG000|STARTED|Randomized Phase||4
3170890|NCT01931735|3898168|FG001|STARTED|Randomized Phase||3
3170891|NCT01931735|3898169|FG002|STARTED|Randomized Phase||9
3170892|NCT01931735|3898170|FG003|STARTED|Randomized Phase||0
3170893|NCT01931735|3898167|FG000|COMPLETED|Randomized Phase||2
3170894|NCT01931735|3898168|FG001|COMPLETED|Randomized Phase||1
3170895|NCT01931735|3898169|FG002|COMPLETED|Randomized Phase||4
3170896|NCT01931735|3898170|FG003|COMPLETED|Randomized Phase||0
3170897|NCT01931735|3898167|FG000|NOT COMPLETED|Randomized Phase||2
3170898|NCT01931735|3898168|FG001|NOT COMPLETED|Randomized Phase||2
3170899|NCT01931735|3898169|FG002|NOT COMPLETED|Randomized Phase||5
3170900|NCT01931735|3898170|FG003|NOT COMPLETED|Randomized Phase||0
3170901|NCT01931735|3898167|FG000|STARTED|Observational Non-Randomized Phase|Participants continued from the randomized phase|2
3170902|NCT01931735|3898168|FG001|STARTED|Observational Non-Randomized Phase|Participants continued from the randomized phase|1
3170903|NCT01931735|3898169|FG002|STARTED|Observational Non-Randomized Phase||0
3170904|NCT01931735|3898170|FG003|STARTED|Observational Non-Randomized Phase|Participants recruited post-amendment|11
3170905|NCT01931735|3898167|FG000|COMPLETED|Observational Non-Randomized Phase||2
3170906|NCT01931735|3898168|FG001|COMPLETED|Observational Non-Randomized Phase||1
3170907|NCT01931735|3898169|FG002|COMPLETED|Observational Non-Randomized Phase||0
3170908|NCT01931735|3898170|FG003|COMPLETED|Observational Non-Randomized Phase||9
3170909|NCT01931735|3898167|FG000|NOT COMPLETED|Observational Non-Randomized Phase||0
3170910|NCT01931735|3898168|FG001|NOT COMPLETED|Observational Non-Randomized Phase||0
3170911|NCT01931735|3898169|FG002|NOT COMPLETED|Observational Non-Randomized Phase||0
3170912|NCT01931735|3898170|FG003|NOT COMPLETED|Observational Non-Randomized Phase||2
3170913|NCT01931839|3898187|FG000|STARTED|Overall Study||335
3170914|NCT01931839|3898188|FG001|STARTED|Overall Study||178
3170915|NCT01931839|3898189|FG002|STARTED|Overall Study||340
3170916|NCT01931839|3898190|FG003|STARTED|Overall Study||176
3170917|NCT01931839|3898191|FG004|STARTED|Overall Study||19
3170918|NCT01931839|3898192|FG005|STARTED|Overall Study||55
3170919|NCT01931839|3898193|FG006|STARTED|Overall Study||60
3170920|NCT01931839|3898187|FG000|Full Analysis Set (As Randomized)|Overall Study||334
3170921|NCT01931839|3898188|FG001|Full Analysis Set (As Randomized)|Overall Study||179
3170922|NCT01931839|3898189|FG002|Full Analysis Set (As Randomized)|Overall Study||340
3170923|NCT01931839|3898190|FG003|Full Analysis Set (As Randomized)|Overall Study||176
3170924|NCT01931839|3898191|FG004|Full Analysis Set (As Randomized)|Overall Study||19
3170925|NCT01931839|3898192|FG005|Full Analysis Set (As Randomized)|Overall Study||55
3170926|NCT01931839|3898193|FG006|Full Analysis Set (As Randomized)|Overall Study||60
3170927|NCT01931839|3898187|FG000|Safety Analysis Set (As Dosed)|Overall Study||335
3170928|NCT01931839|3898188|FG001|Safety Analysis Set (As Dosed)|Overall Study||178
3170929|NCT01931839|3898189|FG002|Safety Analysis Set (As Dosed)|Overall Study||340
3170930|NCT01931839|3898190|FG003|Safety Analysis Set (As Dosed)|Overall Study||176
3170931|NCT01931839|3898191|FG004|Safety Analysis Set (As Dosed)|Overall Study||19
3316020|NCT03103919|4049261|FG000|STARTED|Overall Study||20
3316021|NCT03103919|4049262|FG001|STARTED|Overall Study||19
3316022|NCT03103919|4049261|FG000|COMPLETED|Overall Study||18
3316023|NCT03103919|4049262|FG001|COMPLETED|Overall Study||17
3316024|NCT03103919|4049261|FG000|NOT COMPLETED|Overall Study||2
3316025|NCT03103919|4049262|FG001|NOT COMPLETED|Overall Study||2
3316026|NCT03104192|4049274|FG000|STARTED|Overall Study||9
3316027|NCT03104192|4049275|FG001|STARTED|Overall Study||27
3316028|NCT03104192|4049276|FG002|STARTED|Overall Study||16
3316029|NCT03104192|4049277|FG003|STARTED|Overall Study||17
3316030|NCT03104192|4049274|FG000|COMPLETED|Overall Study||9
3316031|NCT03104192|4049275|FG001|COMPLETED|Overall Study||23
3316032|NCT03104192|4049276|FG002|COMPLETED|Overall Study||14
3316033|NCT03104192|4049277|FG003|COMPLETED|Overall Study||14
3316034|NCT03104192|4049274|FG000|NOT COMPLETED|Overall Study||0
3316035|NCT03104192|4049275|FG001|NOT COMPLETED|Overall Study||4
3316036|NCT03104192|4049276|FG002|NOT COMPLETED|Overall Study||2
3316037|NCT03104192|4049277|FG003|NOT COMPLETED|Overall Study||3
3317234|NCT03124758|4050768|FG000|STARTED|Overall Study||354
3317235|NCT03124758|4050768|FG000|COMPLETED|Overall Study||354
2898062|NCT00406653|3605724|FG001|NOT COMPLETED|Open-Label Period||0
2898063|NCT00406653|3605725|FG002|NOT COMPLETED|Open-Label Period||0
2898064|NCT00406653|3605726|FG003|NOT COMPLETED|Open-Label Period||0
2898065|NCT00406653|3605727|FG004|NOT COMPLETED|Open-Label Period||0
3316038|NCT03104322|4049293|FG000|STARTED|Overall Study||7
3316039|NCT03104322|4049293|FG000|COMPLETED|Overall Study||6
3316040|NCT03104322|4049293|FG000|NOT COMPLETED|Overall Study||1
3316041|NCT03104647|4049297|FG000|STARTED|Overall Study||20
3316042|NCT03104647|4049297|FG000|COMPLETED|Overall Study||20
3316043|NCT03104647|4049297|FG000|NOT COMPLETED|Overall Study||0
3316044|NCT03104725|4049303|FG000|STARTED|Overall Study||2
3316045|NCT03104725|4049304|FG001|STARTED|Overall Study||4
3316046|NCT03104725|4049303|FG000|COMPLETED|Overall Study||2
3316047|NCT03104725|4049304|FG001|COMPLETED|Overall Study||4
3316048|NCT03104725|4049303|FG000|NOT COMPLETED|Overall Study||0
3316049|NCT03104725|4049304|FG001|NOT COMPLETED|Overall Study||0
3316050|NCT03104738|4049312|FG000|STARTED|Overall Study||20
3316051|NCT03104738|4049313|FG001|STARTED|Overall Study||20
3316052|NCT03104738|4049312|FG000|COMPLETED|Overall Study||20
3316053|NCT03104738|4049313|FG001|COMPLETED|Overall Study||20
3316054|NCT03104738|4049312|FG000|NOT COMPLETED|Overall Study||0
3316055|NCT03104738|4049313|FG001|NOT COMPLETED|Overall Study||0
3316056|NCT03104816|4049322|FG000|STARTED|Overall Study||11
3316057|NCT03104816|4049323|FG001|STARTED|Overall Study||11
3316058|NCT03104816|4049324|FG002|STARTED|Overall Study||6
3316059|NCT03104816|4049322|FG000|COMPLETED|Overall Study||9
3316060|NCT03104816|4049323|FG001|COMPLETED|Overall Study||9
3316061|NCT03104816|4049324|FG002|COMPLETED|Overall Study||4
3316062|NCT03104816|4049322|FG000|NOT COMPLETED|Overall Study||2
3316063|NCT03104816|4049323|FG001|NOT COMPLETED|Overall Study||2
3316064|NCT03104816|4049324|FG002|NOT COMPLETED|Overall Study||2
3316065|NCT03104985|4049334|FG000|STARTED|Overall Study||34
3316066|NCT03104985|4049335|FG001|STARTED|Overall Study||34
3316067|NCT03104985|4049334|FG000|COMPLETED|Overall Study||34
3316068|NCT03104985|4049335|FG001|COMPLETED|Overall Study||34
3316069|NCT03104985|4049334|FG000|NOT COMPLETED|Overall Study||0
3316070|NCT03104985|4049335|FG001|NOT COMPLETED|Overall Study||0
3316071|NCT03105297|4049341|FG000|STARTED|Baseline Phase (Day 1)||91
3316072|NCT03105297|4049341|FG000|COMPLETED|Baseline Phase (Day 1)||70
3316073|NCT03105297|4049341|FG000|NOT COMPLETED|Baseline Phase (Day 1)||21
3316074|NCT03105297|4049341|FG000|STARTED|Active Phase (Day 2-29)||70
3316075|NCT03105297|4049341|FG000|COMPLETED|Active Phase (Day 2-29)||70
3316076|NCT03105297|4049341|FG000|NOT COMPLETED|Active Phase (Day 2-29)||0
3316077|NCT03105297|4049341|FG000|STARTED|Nasal Resistance Phase (Day 30, 31)|14 participants withdrew from the study after the completion of active phase|56
3316078|NCT03105297|4049341|FG000|Treated|Nasal Resistance Phase (Day 30, 31)||55
3316079|NCT03105297|4049341|FG000|COMPLETED|Nasal Resistance Phase (Day 30, 31)||48
3316080|NCT03105297|4049341|FG000|NOT COMPLETED|Nasal Resistance Phase (Day 30, 31)||8
3316081|NCT03105362|4049352|FG000|STARTED|Overall Study||4
3316082|NCT03105362|4049352|FG000|Completed 1 Week of Study|Overall Study||4
3316083|NCT03105362|4049352|FG000|Completed 2 Weeks of Study|Overall Study||3
3316084|NCT03105362|4049352|FG000|Completed 2 Week Questionaire|Overall Study||2
3316085|NCT03105362|4049352|FG000|COMPLETED|Overall Study||2
3316086|NCT03105362|4049352|FG000|NOT COMPLETED|Overall Study||2
3316087|NCT03105479|4049359|FG000|STARTED|Overall Study||1
3316088|NCT03105479|4049360|FG001|STARTED|Overall Study||0
3316089|NCT03105479|4049361|FG002|STARTED|Overall Study||0
3316090|NCT03105479|4049362|FG003|STARTED|Overall Study||0
3316091|NCT03105479|4049363|FG004|STARTED|Overall Study||0
3316092|NCT03105479|4049364|FG005|STARTED|Overall Study||0
3316093|NCT03105479|4049365|FG006|STARTED|Overall Study||0
3316094|NCT03105479|4049359|FG000|COMPLETED|Overall Study||1
3316095|NCT03105479|4049360|FG001|COMPLETED|Overall Study||0
3316096|NCT03105479|4049361|FG002|COMPLETED|Overall Study||0
3316097|NCT03105479|4049362|FG003|COMPLETED|Overall Study||0
3316098|NCT03105479|4049363|FG004|COMPLETED|Overall Study||0
3316099|NCT03105479|4049364|FG005|COMPLETED|Overall Study||0
3316100|NCT03105479|4049365|FG006|COMPLETED|Overall Study||0
3316101|NCT03105479|4049359|FG000|NOT COMPLETED|Overall Study||0
3316102|NCT03105479|4049360|FG001|NOT COMPLETED|Overall Study||0
3316103|NCT03105479|4049361|FG002|NOT COMPLETED|Overall Study||0
3316104|NCT03105479|4049362|FG003|NOT COMPLETED|Overall Study||0
3316105|NCT03105479|4049363|FG004|NOT COMPLETED|Overall Study||0
3316106|NCT03105479|4049364|FG005|NOT COMPLETED|Overall Study||0
3316107|NCT03105479|4049365|FG006|NOT COMPLETED|Overall Study||0
3316108|NCT03105518|4049372|FG000|STARTED|Overall Study||100
3316109|NCT03105518|4049372|FG000|COMPLETED|Overall Study||100
3316110|NCT03105518|4049372|FG000|NOT COMPLETED|Overall Study||0
3316111|NCT03106077|4049376|FG000|STARTED|Overall Study||96
3316112|NCT03106077|4049377|FG001|STARTED|Overall Study||0
3316113|NCT03106077|4049376|FG000|COMPLETED|Overall Study||2
3316114|NCT03106077|4049377|FG001|COMPLETED|Overall Study||0
3316115|NCT03106077|4049376|FG000|NOT COMPLETED|Overall Study||94
3316116|NCT03106077|4049377|FG001|NOT COMPLETED|Overall Study||0
3316117|NCT03106337|4049382|FG000|STARTED|Overall Study||35
3316118|NCT03106337|4049382|FG000|COMPLETED|Overall Study||35
3316119|NCT03106337|4049382|FG000|NOT COMPLETED|Overall Study||0
3316120|NCT03106636|4049389|FG000|STARTED|Overall Study||226
3316121|NCT03106636|4049390|FG001|STARTED|Overall Study||190
3316122|NCT03106636|4049389|FG000|COMPLETED|Overall Study||182
3316123|NCT03106636|4049390|FG001|COMPLETED|Overall Study||164
3316124|NCT03106636|4049389|FG000|NOT COMPLETED|Overall Study||44
2898066|NCT00406653|3605728|FG005|NOT COMPLETED|Open-Label Period||0
2898067|NCT00406653|3605729|FG006|NOT COMPLETED|Open-Label Period||324
2898068|NCT00406692|3605749|FG000|STARTED|Overall Study||16
2898069|NCT00406692|3605749|FG000|COMPLETED|Overall Study||9
2898070|NCT00406692|3605749|FG000|NOT COMPLETED|Overall Study||7
2898071|NCT00406718|3605756|FG000|STARTED|Overall Study||47
2898072|NCT00406718|3605757|FG001|STARTED|Overall Study||48
2898073|NCT00406718|3605758|FG002|STARTED|Overall Study||47
2898074|NCT00406718|3605756|FG000|COMPLETED|Overall Study||43
2898075|NCT00406718|3605757|FG001|COMPLETED|Overall Study||34
2898076|NCT00406718|3605758|FG002|COMPLETED|Overall Study||39
2898077|NCT00406718|3605756|FG000|NOT COMPLETED|Overall Study||4
2898078|NCT00406718|3605757|FG001|NOT COMPLETED|Overall Study||14
2898079|NCT00406718|3605758|FG002|NOT COMPLETED|Overall Study||8
2898080|NCT00406848|3605770|FG000|STARTED|Overall Study|Represents full safety analysis population. Efficacy analysis population (c,d,e) N=204.|249
2898081|NCT00406848|3605771|FG001|STARTED|Overall Study|Represents full safety analysis population. Efficacy analysis population (c,d,e) N=95.|121
2898082|NCT00406848|3605770|FG000|COMPLETED|Overall Study||156
2898083|NCT00406848|3605771|FG001|COMPLETED|Overall Study||67
2898084|NCT00406848|3605770|FG000|NOT COMPLETED|Overall Study||93
2898085|NCT00406848|3605771|FG001|NOT COMPLETED|Overall Study||54
2898086|NCT00407030|3605783|FG000|STARTED|Main Period - 8 to 20 Weeks||81
2898087|NCT00407030|3605784|FG001|STARTED|Main Period - 8 to 20 Weeks||78
2898088|NCT00407030|3605785|FG002|STARTED|Main Period - 8 to 20 Weeks||74
2898089|NCT00407030|3605783|FG000|COMPLETED|Main Period - 8 to 20 Weeks||76
2898090|NCT00407030|3605784|FG001|COMPLETED|Main Period - 8 to 20 Weeks||75
2898091|NCT00407030|3605785|FG002|COMPLETED|Main Period - 8 to 20 Weeks||68
2898092|NCT00407030|3605783|FG000|NOT COMPLETED|Main Period - 8 to 20 Weeks||5
2898093|NCT00407030|3605784|FG001|NOT COMPLETED|Main Period - 8 to 20 Weeks||3
2898094|NCT00407030|3605785|FG002|NOT COMPLETED|Main Period - 8 to 20 Weeks||6
2898095|NCT00407030|3605783|FG000|STARTED|Extension Period - up to 68 Weeks|2 subjects did not enter the Ext. Period, 3 subjects never expressed any need for a new injection|111
2898096|NCT00407030|3605784|FG001|STARTED|Extension Period - up to 68 Weeks|2 subjects did not enter the Ext. Period, 3 subjects never expressed any need for a new injection|103
2898097|NCT00407030|3605785|FG002|STARTED|Extension Period - up to 68 Weeks|After the Main Period all patients were randomly assigned to the 2 active treatment arms.|0
2898098|NCT00407030|3605783|FG000|COMPLETED|Extension Period - up to 68 Weeks||84
2898099|NCT00407030|3605784|FG001|COMPLETED|Extension Period - up to 68 Weeks||74
2898100|NCT00407030|3605785|FG002|COMPLETED|Extension Period - up to 68 Weeks||0
2898101|NCT00407030|3605783|FG000|NOT COMPLETED|Extension Period - up to 68 Weeks||27
2898102|NCT00407030|3605784|FG001|NOT COMPLETED|Extension Period - up to 68 Weeks||29
2898103|NCT00407030|3605785|FG002|NOT COMPLETED|Extension Period - up to 68 Weeks||0
2898104|NCT00407355|3605797|FG000|STARTED|Overall Study||20
2898105|NCT00407355|3605798|FG001|STARTED|Overall Study||20
2898106|NCT00407355|3605797|FG000|COMPLETED|Overall Study||10
2898107|NCT00407355|3605798|FG001|COMPLETED|Overall Study||9
2898108|NCT00407355|3605797|FG000|NOT COMPLETED|Overall Study||10
2898109|NCT00407355|3605798|FG001|NOT COMPLETED|Overall Study||11
2898110|NCT00407381|3605807|FG000|STARTED|Overall Study||42
2898111|NCT00407381|3605808|FG001|STARTED|Overall Study||42
2898112|NCT00407381|3605809|FG002|STARTED|Overall Study||42
2898113|NCT00407381|3605807|FG000|COMPLETED|Overall Study||39
2898114|NCT00407381|3605808|FG001|COMPLETED|Overall Study||38
2898115|NCT00407381|3605809|FG002|COMPLETED|Overall Study||40
2898116|NCT00407381|3605807|FG000|NOT COMPLETED|Overall Study||3
2898117|NCT00407381|3605808|FG001|NOT COMPLETED|Overall Study||4
2898118|NCT00407381|3605809|FG002|NOT COMPLETED|Overall Study||2
2898119|NCT00407420|3605819|FG000|STARTED|Overall Study||54
2898120|NCT00407420|3605820|FG001|STARTED|Overall Study||52
2898121|NCT00407420|3605819|FG000|COMPLETED|Overall Study||45
2898122|NCT00407420|3605820|FG001|COMPLETED|Overall Study||46
2898123|NCT00407420|3605819|FG000|NOT COMPLETED|Overall Study||9
2898124|NCT00407420|3605820|FG001|NOT COMPLETED|Overall Study||6
2898125|NCT00407485|3605828|FG000|STARTED|Overall Study||22
2898126|NCT00407485|3605828|FG000|COMPLETED|Overall Study||22
2898127|NCT00407485|3605828|FG000|NOT COMPLETED|Overall Study||0
2898128|NCT00407511|3605833|FG000|STARTED|Overall Study||121
2898129|NCT00407511|3605833|FG000|COMPLETED|Overall Study||99
2898130|NCT00407511|3605833|FG000|NOT COMPLETED|Overall Study||22
2898131|NCT00407537|3605839|FG000|STARTED|Overall Study||779
2898132|NCT00407537|3605840|FG001|STARTED|Overall Study|4 participants assigned to Caduet treatment received usual care only during the study|682
2898133|NCT00407537|3605839|FG000|Eligible for Efficacy Analysis|Overall Study||760
2898134|NCT00407537|3605840|FG001|Eligible for Efficacy Analysis|Overall Study||657
2898135|NCT00407537|3605839|FG000|COMPLETED|Overall Study||686
2898136|NCT00407537|3605840|FG001|COMPLETED|Overall Study||638
3316125|NCT03106636|4049390|FG001|NOT COMPLETED|Overall Study||26
3316126|NCT03106753|4049398|FG000|STARTED|Overall Study||17
3316127|NCT03106753|4049399|FG001|STARTED|Overall Study||17
3316128|NCT03106753|4049398|FG000|COMPLETED|Overall Study||17
3316129|NCT03106753|4049399|FG001|COMPLETED|Overall Study||16
3316130|NCT03106753|4049398|FG000|NOT COMPLETED|Overall Study||0
3316131|NCT03106753|4049399|FG001|NOT COMPLETED|Overall Study||1
3316132|NCT03106844|4049407|FG000|STARTED|Overall Study||50
3316133|NCT03106844|4049407|FG000|COMPLETED|Overall Study||49
3316134|NCT03106844|4049407|FG000|NOT COMPLETED|Overall Study||1
3316135|NCT03106870|4049413|FG000|STARTED|Overall Study||31
3316136|NCT03106870|4049414|FG001|STARTED|Overall Study||31
2898137|NCT00407537|3605839|FG000|NOT COMPLETED|Overall Study||93
2898138|NCT00407537|3605840|FG001|NOT COMPLETED|Overall Study||44
2898139|NCT00407550|3605848|FG000|STARTED|Overall Study||10
2898140|NCT00407550|3605849|FG001|STARTED|Overall Study||9
2898141|NCT00407550|3605848|FG000|COMPLETED|Overall Study||7
2898142|NCT00407550|3605849|FG001|COMPLETED|Overall Study||5
2898143|NCT00407550|3605848|FG000|NOT COMPLETED|Overall Study||3
2898144|NCT00407550|3605849|FG001|NOT COMPLETED|Overall Study||4
2898145|NCT00407563|3605855|FG000|STARTED|Overall Study||48
2898146|NCT00407563|3605855|FG000|COMPLETED|Overall Study|One patient remains on study treatment.|47
2898147|NCT00407563|3605855|FG000|NOT COMPLETED|Overall Study||1
2898148|NCT00407654|3605859|FG000|STARTED|Overall Study||75
2898149|NCT00407654|3605859|FG000|COMPLETED|Overall Study||75
2898150|NCT00407654|3605859|FG000|NOT COMPLETED|Overall Study||0
2898151|NCT00407745|3605866|FG000|STARTED|Overall Study||112
2898152|NCT00407745|3605867|FG001|STARTED|Overall Study||108
2898153|NCT00407745|3605866|FG000|Treated|Overall Study||112
2898154|NCT00407745|3605867|FG001|Treated|Overall Study||107
2898155|NCT00407745|3605866|FG000|COMPLETED|Overall Study||93
2898156|NCT00407745|3605867|FG001|COMPLETED|Overall Study||91
2898157|NCT00407745|3605866|FG000|NOT COMPLETED|Overall Study||19
2898158|NCT00407745|3605867|FG001|NOT COMPLETED|Overall Study||17
2898159|NCT00407758|3605873|FG000|STARTED|Overall Study||28
2898160|NCT00407758|3605873|FG000|COMPLETED|Overall Study||27
2898161|NCT00407758|3605873|FG000|NOT COMPLETED|Overall Study||1
2898162|NCT00407797|3605877|FG000|STARTED|Overall Study||136
2898163|NCT00407797|3605877|FG000|Full Analysis Set|Overall Study|At least 1 dose of study medication and had a baseline and at least 1 post-baseline measurement.|135
2898164|NCT00407797|3605877|FG000|COMPLETED|Overall Study||118
2898165|NCT00407797|3605877|FG000|NOT COMPLETED|Overall Study||18
2919997|NCT00535145|3630455|FG000|STARTED|Phase II|Of the 85 participants who completed Phase 1, 84 met the criteria to enroll into Phase 2|84
2919998|NCT00535145|3630455|FG000|COMPLETED|Phase II||69
2919999|NCT00535145|3630455|FG000|NOT COMPLETED|Phase II||15
2920000|NCT00535223|3630465|FG000|STARTED|Overall Study|Patients were randomized in cohorts of ten.|41
2920001|NCT00535223|3630466|FG001|STARTED|Overall Study|Patients were randomized in cohorts of ten.|40
2920002|NCT00535223|3630465|FG000|COMPLETED|Overall Study||37
2920003|NCT00535223|3630466|FG001|COMPLETED|Overall Study||39
2920004|NCT00535223|3630465|FG000|NOT COMPLETED|Overall Study||4
2920005|NCT00535223|3630466|FG001|NOT COMPLETED|Overall Study||1
2920006|NCT00535236|3630482|FG000|STARTED|Overall Study||40
2920007|NCT00535236|3630483|FG001|STARTED|Overall Study||10
2920008|NCT00535236|3630484|FG002|STARTED|Overall Study||41
2920009|NCT00535236|3630485|FG003|STARTED|Overall Study||10
2920010|NCT00535236|3630486|FG004|STARTED|Overall Study||59
2920011|NCT00535236|3630487|FG005|STARTED|Overall Study||20
2920012|NCT00535236|3630488|FG006|STARTED|Overall Study||62
2920013|NCT00535236|3630489|FG007|STARTED|Overall Study||19
2920014|NCT00535236|3630490|FG008|STARTED|Overall Study||60
2920015|NCT00535236|3630491|FG009|STARTED|Overall Study||20
2920016|NCT00535236|3630482|FG000|Vaccination 1|Overall Study||40
2920017|NCT00535236|3630483|FG001|Vaccination 1|Overall Study||10
2920018|NCT00535236|3630484|FG002|Vaccination 1|Overall Study||40
2920019|NCT00535236|3630485|FG003|Vaccination 1|Overall Study||10
2920020|NCT00535236|3630486|FG004|Vaccination 1|Overall Study||58
2920021|NCT00535236|3630487|FG005|Vaccination 1|Overall Study||19
2920022|NCT00535236|3630488|FG006|Vaccination 1|Overall Study||61
2920023|NCT00535236|3630489|FG007|Vaccination 1|Overall Study||19
2920024|NCT00535236|3630490|FG008|Vaccination 1|Overall Study||60
2920025|NCT00535236|3630491|FG009|Vaccination 1|Overall Study||20
2920026|NCT00535236|3630482|FG000|Vaccination 2|Overall Study||35
2920027|NCT00535236|3630483|FG001|Vaccination 2|Overall Study||10
2920028|NCT00535236|3630484|FG002|Vaccination 2|Overall Study||37
2920029|NCT00535236|3630485|FG003|Vaccination 2|Overall Study||8
2920030|NCT00535236|3630486|FG004|Vaccination 2|Overall Study||52
2920031|NCT00535236|3630487|FG005|Vaccination 2|Overall Study||19
2920032|NCT00535236|3630488|FG006|Vaccination 2|Overall Study||58
2920033|NCT00535236|3630489|FG007|Vaccination 2|Overall Study||19
2920034|NCT00535236|3630490|FG008|Vaccination 2|Overall Study||57
2920035|NCT00535236|3630491|FG009|Vaccination 2|Overall Study||19
2920036|NCT00535236|3630482|FG000|Vaccination 3|Overall Study||34
2920037|NCT00535236|3630483|FG001|Vaccination 3|Overall Study||10
2920038|NCT00535236|3630484|FG002|Vaccination 3|Overall Study||35
2920039|NCT00535236|3630485|FG003|Vaccination 3|Overall Study||8
2920040|NCT00535236|3630486|FG004|Vaccination 3|Overall Study||48
2920041|NCT00535236|3630487|FG005|Vaccination 3|Overall Study||19
2920042|NCT00535236|3630488|FG006|Vaccination 3|Overall Study||51
2920043|NCT00535236|3630489|FG007|Vaccination 3|Overall Study||18
2920044|NCT00535236|3630490|FG008|Vaccination 3|Overall Study||53
2920045|NCT00535236|3630491|FG009|Vaccination 3|Overall Study||18
2920046|NCT00535236|3630482|FG000|Vaccination 4|Overall Study||34
2920047|NCT00535236|3630483|FG001|Vaccination 4|Overall Study||10
2920048|NCT00535236|3630484|FG002|Vaccination 4|Overall Study||32
2920049|NCT00535236|3630485|FG003|Vaccination 4|Overall Study||6
2920050|NCT00535236|3630486|FG004|Vaccination 4|Overall Study||47
2920051|NCT00535236|3630487|FG005|Vaccination 4|Overall Study||19
2920052|NCT00535236|3630488|FG006|Vaccination 4|Overall Study||51
2920053|NCT00535236|3630489|FG007|Vaccination 4|Overall Study||18
2920054|NCT00535236|3630490|FG008|Vaccination 4|Overall Study||50
2920055|NCT00535236|3630491|FG009|Vaccination 4|Overall Study||17
2898166|NCT00407888|3605881|FG000|STARTED|Overall Study||60
2898167|NCT00407888|3605881|FG000|COMPLETED|Overall Study||60
2898168|NCT00407888|3605881|FG000|NOT COMPLETED|Overall Study||0
2898169|NCT00407966|3605885|FG000|STARTED|Overall Study||45
2898170|NCT00407966|3605885|FG000|CR|Overall Study||30
2898171|NCT00407966|3605885|FG000|COMPLETED|Overall Study||45
2898172|NCT00407966|3605885|FG000|NOT COMPLETED|Overall Study||0
2898173|NCT00408005|3605891|FG000|STARTED|Induction||1596
2898174|NCT00408005|3605892|FG001|STARTED|Induction||299
2898175|NCT00408005|3605893|FG002|STARTED|Induction||0
2898176|NCT00408005|3605894|FG003|STARTED|Induction||0
2898177|NCT00408005|3605895|FG004|STARTED|Induction||0
2898178|NCT00408005|3605896|FG005|STARTED|Induction||0
2898179|NCT00408005|3605897|FG006|STARTED|Induction||0
2898180|NCT00408005|3605898|FG007|STARTED|Induction||0
2898181|NCT00408005|3605891|FG000|COMPLETED|Induction||1189
2898182|NCT00408005|3605892|FG001|COMPLETED|Induction||205
2898183|NCT00408005|3605893|FG002|COMPLETED|Induction||0
2898184|NCT00408005|3605894|FG003|COMPLETED|Induction||0
2898185|NCT00408005|3605895|FG004|COMPLETED|Induction||0
2898186|NCT00408005|3605896|FG005|COMPLETED|Induction||0
2898187|NCT00408005|3605897|FG006|COMPLETED|Induction||0
2898188|NCT00408005|3605898|FG007|COMPLETED|Induction||0
2898189|NCT00408005|3605891|FG000|NOT COMPLETED|Induction||407
2898190|NCT00408005|3605892|FG001|NOT COMPLETED|Induction||94
2898191|NCT00408005|3605893|FG002|NOT COMPLETED|Induction||0
2898192|NCT00408005|3605894|FG003|NOT COMPLETED|Induction||0
2898193|NCT00408005|3605895|FG004|NOT COMPLETED|Induction||0
2898194|NCT00408005|3605896|FG005|NOT COMPLETED|Induction||0
2898195|NCT00408005|3605897|FG006|NOT COMPLETED|Induction||0
2898196|NCT00408005|3605898|FG007|NOT COMPLETED|Induction||0
2898197|NCT00408005|3605891|FG000|STARTED|Post Induction Therapy by Tx Assignment||0
2898198|NCT00408005|3605892|FG001|STARTED|Post Induction Therapy by Tx Assignment||0
2898199|NCT00408005|3605893|FG002|STARTED|Post Induction Therapy by Tx Assignment||372
2898200|NCT00408005|3605894|FG003|STARTED|Post Induction Therapy by Tx Assignment||147
2898201|NCT00408005|3605895|FG004|STARTED|Post Induction Therapy by Tx Assignment||451
2898202|NCT00408005|3605896|FG005|STARTED|Post Induction Therapy by Tx Assignment||219
2898203|NCT00408005|3605897|FG006|STARTED|Post Induction Therapy by Tx Assignment||143
2898204|NCT00408005|3605898|FG007|STARTED|Post Induction Therapy by Tx Assignment||62
2898205|NCT00408005|3605891|FG000|Low Risk|Post Induction Therapy by Tx Assignment||0
2898206|NCT00408005|3605892|FG001|Low Risk|Post Induction Therapy by Tx Assignment||0
2898207|NCT00408005|3605893|FG002|Low Risk|Post Induction Therapy by Tx Assignment||217
2898208|NCT00408005|3605894|FG003|Low Risk|Post Induction Therapy by Tx Assignment||0
2898209|NCT00408005|3605895|FG004|Low Risk|Post Induction Therapy by Tx Assignment||55
2898210|NCT00408005|3605896|FG005|Low Risk|Post Induction Therapy by Tx Assignment||0
2898211|NCT00408005|3605897|FG006|Low Risk|Post Induction Therapy by Tx Assignment||0
2898212|NCT00408005|3605898|FG007|Low Risk|Post Induction Therapy by Tx Assignment||0
2898213|NCT00408005|3605891|FG000|Intermediate Risk|Post Induction Therapy by Tx Assignment||0
2898214|NCT00408005|3605892|FG001|Intermediate Risk|Post Induction Therapy by Tx Assignment||0
2898215|NCT00408005|3605893|FG002|Intermediate Risk|Post Induction Therapy by Tx Assignment||99
2898216|NCT00408005|3605894|FG003|Intermediate Risk|Post Induction Therapy by Tx Assignment||95
2898217|NCT00408005|3605895|FG004|Intermediate Risk|Post Induction Therapy by Tx Assignment||257
2898218|NCT00408005|3605896|FG005|Intermediate Risk|Post Induction Therapy by Tx Assignment||93
2898219|NCT00408005|3605897|FG006|Intermediate Risk|Post Induction Therapy by Tx Assignment||0
2898220|NCT00408005|3605898|FG007|Intermediate Risk|Post Induction Therapy by Tx Assignment||0
2898221|NCT00408005|3605891|FG000|High Risk|Post Induction Therapy by Tx Assignment||0
2898222|NCT00408005|3605892|FG001|High Risk|Post Induction Therapy by Tx Assignment||0
2898223|NCT00408005|3605893|FG002|High Risk|Post Induction Therapy by Tx Assignment||56
2898224|NCT00408005|3605894|FG003|High Risk|Post Induction Therapy by Tx Assignment||52
2898225|NCT00408005|3605895|FG004|High Risk|Post Induction Therapy by Tx Assignment||55
2898226|NCT00408005|3605896|FG005|High Risk|Post Induction Therapy by Tx Assignment||52
2898227|NCT00408005|3605897|FG006|High Risk|Post Induction Therapy by Tx Assignment||0
2898228|NCT00408005|3605898|FG007|High Risk|Post Induction Therapy by Tx Assignment||0
2898229|NCT00408005|3605891|FG000|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||0
2898230|NCT00408005|3605892|FG001|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||0
2898231|NCT00408005|3605893|FG002|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||0
2898232|NCT00408005|3605894|FG003|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||0
2898233|NCT00408005|3605895|FG004|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||84
2898234|NCT00408005|3605896|FG005|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||31
2898235|NCT00408005|3605897|FG006|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||0
2898236|NCT00408005|3605898|FG007|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||0
2898237|NCT00408005|3605891|FG000|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||0
2898238|NCT00408005|3605892|FG001|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||0
2898239|NCT00408005|3605893|FG002|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||0
2898240|NCT00408005|3605894|FG003|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||0
2898241|NCT00408005|3605895|FG004|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||0
2898242|NCT00408005|3605896|FG005|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||43
2898243|NCT00408005|3605897|FG006|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||0
2898244|NCT00408005|3605898|FG007|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||0
2898245|NCT00408005|3605891|FG000|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||0
2898246|NCT00408005|3605892|FG001|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||0
2898247|NCT00408005|3605893|FG002|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||0
2898248|NCT00408005|3605894|FG003|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||0
2898249|NCT00408005|3605895|FG004|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||0
2898250|NCT00408005|3605896|FG005|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||0
2898251|NCT00408005|3605897|FG006|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||82
2898252|NCT00408005|3605898|FG007|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||0
2898253|NCT00408005|3605891|FG000|T-LLy High Risk|Post Induction Therapy by Tx Assignment||0
2898254|NCT00408005|3605892|FG001|T-LLy High Risk|Post Induction Therapy by Tx Assignment||0
2898255|NCT00408005|3605893|FG002|T-LLy High Risk|Post Induction Therapy by Tx Assignment||0
2898256|NCT00408005|3605894|FG003|T-LLy High Risk|Post Induction Therapy by Tx Assignment||0
2898257|NCT00408005|3605895|FG004|T-LLy High Risk|Post Induction Therapy by Tx Assignment||0
2898258|NCT00408005|3605896|FG005|T-LLy High Risk|Post Induction Therapy by Tx Assignment||0
2898259|NCT00408005|3605897|FG006|T-LLy High Risk|Post Induction Therapy by Tx Assignment||61
2898260|NCT00408005|3605898|FG007|T-LLy High Risk|Post Induction Therapy by Tx Assignment||60
2898261|NCT00408005|3605891|FG000|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||0
2898262|NCT00408005|3605892|FG001|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||0
2898263|NCT00408005|3605893|FG002|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||0
2898264|NCT00408005|3605894|FG003|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||0
2898265|NCT00408005|3605895|FG004|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||0
2898266|NCT00408005|3605896|FG005|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||0
2898267|NCT00408005|3605897|FG006|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||0
2898268|NCT00408005|3605898|FG007|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||2
2898269|NCT00408005|3605891|FG000|COMPLETED|Post Induction Therapy by Tx Assignment||0
2898270|NCT00408005|3605892|FG001|COMPLETED|Post Induction Therapy by Tx Assignment||0
2898271|NCT00408005|3605893|FG002|COMPLETED|Post Induction Therapy by Tx Assignment||287
2898272|NCT00408005|3605894|FG003|COMPLETED|Post Induction Therapy by Tx Assignment||103
2898273|NCT00408005|3605895|FG004|COMPLETED|Post Induction Therapy by Tx Assignment||319
2898274|NCT00408005|3605896|FG005|COMPLETED|Post Induction Therapy by Tx Assignment||118
2898275|NCT00408005|3605897|FG006|COMPLETED|Post Induction Therapy by Tx Assignment||115
2898276|NCT00408005|3605898|FG007|COMPLETED|Post Induction Therapy by Tx Assignment||48
2898277|NCT00408005|3605891|FG000|NOT COMPLETED|Post Induction Therapy by Tx Assignment||0
2898278|NCT00408005|3605892|FG001|NOT COMPLETED|Post Induction Therapy by Tx Assignment||0
2898279|NCT00408005|3605893|FG002|NOT COMPLETED|Post Induction Therapy by Tx Assignment||85
2898280|NCT00408005|3605894|FG003|NOT COMPLETED|Post Induction Therapy by Tx Assignment||44
2898281|NCT00408005|3605895|FG004|NOT COMPLETED|Post Induction Therapy by Tx Assignment||132
2898282|NCT00408005|3605896|FG005|NOT COMPLETED|Post Induction Therapy by Tx Assignment||101
2898283|NCT00408005|3605897|FG006|NOT COMPLETED|Post Induction Therapy by Tx Assignment||28
3170932|NCT01931839|3898192|FG005|Safety Analysis Set (As Dosed)|Overall Study||55
3170933|NCT01931839|3898193|FG006|Safety Analysis Set (As Dosed)|Overall Study||60
3170934|NCT01931839|3898187|FG000|COMPLETED|Overall Study||294
3170935|NCT01931839|3898188|FG001|COMPLETED|Overall Study||152
3170936|NCT01931839|3898189|FG002|COMPLETED|Overall Study||301
3170937|NCT01931839|3898190|FG003|COMPLETED|Overall Study||162
3170938|NCT01931839|3898191|FG004|COMPLETED|Overall Study||18
3170939|NCT01931839|3898192|FG005|COMPLETED|Overall Study||50
3170940|NCT01931839|3898193|FG006|COMPLETED|Overall Study||56
2898284|NCT00408005|3605898|FG007|NOT COMPLETED|Post Induction Therapy by Tx Assignment||14
2898285|NCT00408070|3605918|FG000|STARTED|Overall Study||5
2898286|NCT00408070|3605918|FG000|COMPLETED|Overall Study||5
2898287|NCT00408070|3605918|FG000|NOT COMPLETED|Overall Study||0
2898288|NCT00408200|3605924|FG000|STARTED|Overall Study||57
2898289|NCT00408200|3605925|FG001|STARTED|Overall Study||53
2898290|NCT00408200|3605924|FG000|COMPLETED|Overall Study||57
2898291|NCT00408200|3605925|FG001|COMPLETED|Overall Study||53
2898292|NCT00408200|3605924|FG000|NOT COMPLETED|Overall Study||0
2898293|NCT00408200|3605925|FG001|NOT COMPLETED|Overall Study||0
2898294|NCT00408317|3605931|FG000|STARTED|First Intervention Period||14
2898295|NCT00408317|3605932|FG001|STARTED|First Intervention Period||17
2898296|NCT00408317|3605931|FG000|COMPLETED|First Intervention Period||14
2898297|NCT00408317|3605932|FG001|COMPLETED|First Intervention Period||16
2898298|NCT00408317|3605931|FG000|NOT COMPLETED|First Intervention Period||0
2898299|NCT00408317|3605932|FG001|NOT COMPLETED|First Intervention Period||1
2898300|NCT00408317|3605931|FG000|STARTED|Second Intervention Period||14
2898301|NCT00408317|3605932|FG001|STARTED|Second Intervention Period||16
2898302|NCT00408317|3605931|FG000|COMPLETED|Second Intervention Period||12
2898303|NCT00408317|3605932|FG001|COMPLETED|Second Intervention Period||14
2898304|NCT00408317|3605931|FG000|NOT COMPLETED|Second Intervention Period||2
2898305|NCT00408317|3605932|FG001|NOT COMPLETED|Second Intervention Period||2
2898306|NCT00408408|3605944|FG000|STARTED|Overall Study||201
2898307|NCT00408408|3605945|FG001|STARTED|Overall Study||199
3170941|NCT01931839|3898187|FG000|NOT COMPLETED|Overall Study||41
3170942|NCT01931839|3898188|FG001|NOT COMPLETED|Overall Study||26
3170943|NCT01931839|3898189|FG002|NOT COMPLETED|Overall Study||39
2898308|NCT00408408|3605946|FG002|STARTED|Overall Study||204
2898309|NCT00408408|3605947|FG003|STARTED|Overall Study||201
2898310|NCT00408408|3605948|FG004|STARTED|Overall Study||197
2898311|NCT00408408|3605949|FG005|STARTED|Overall Study||204
2898312|NCT00408408|3605944|FG000|COMPLETED|Overall Study||199
2898313|NCT00408408|3605945|FG001|COMPLETED|Overall Study||196
2898314|NCT00408408|3605946|FG002|COMPLETED|Overall Study||204
2898315|NCT00408408|3605947|FG003|COMPLETED|Overall Study||194
2898316|NCT00408408|3605948|FG004|COMPLETED|Overall Study||192
2898317|NCT00408408|3605949|FG005|COMPLETED|Overall Study||201
2898318|NCT00408408|3605944|FG000|NOT COMPLETED|Overall Study||2
2898319|NCT00408408|3605945|FG001|NOT COMPLETED|Overall Study||3
2898320|NCT00408408|3605946|FG002|NOT COMPLETED|Overall Study||0
2898321|NCT00408408|3605947|FG003|NOT COMPLETED|Overall Study||7
2898322|NCT00408408|3605948|FG004|NOT COMPLETED|Overall Study||5
2898323|NCT00408408|3605949|FG005|NOT COMPLETED|Overall Study||3
2898324|NCT00408421|3605965|FG000|STARTED|Treatment Initial Randomization||120
2898325|NCT00408421|3605966|FG001|STARTED|Treatment Initial Randomization||111
2898326|NCT00408421|3605967|FG002|STARTED|Treatment Initial Randomization||0
2898327|NCT00408421|3605965|FG000|COMPLETED|Treatment Initial Randomization|Pre-Re-Randomization (Visit 4)|103
2898328|NCT00408421|3605966|FG001|COMPLETED|Treatment Initial Randomization|Pre-Re-Randomization (Visit 4)|89
2898329|NCT00408421|3605967|FG002|COMPLETED|Treatment Initial Randomization|Patients weren't randomized to Duloxetine 120 mg until Visit 4.|0
2898330|NCT00408421|3605965|FG000|NOT COMPLETED|Treatment Initial Randomization||17
2898331|NCT00408421|3605966|FG001|NOT COMPLETED|Treatment Initial Randomization||22
2898332|NCT00408421|3605967|FG002|NOT COMPLETED|Treatment Initial Randomization||0
2898333|NCT00408421|3605965|FG000|STARTED|Treatment Re-Randomization||103
2898334|NCT00408421|3605966|FG001|STARTED|Treatment Re-Randomization||46
2898335|NCT00408421|3605967|FG002|STARTED|Treatment Re-Randomization||43
2898336|NCT00408421|3605965|FG000|COMPLETED|Treatment Re-Randomization||96
2898337|NCT00408421|3605966|FG001|COMPLETED|Treatment Re-Randomization||39
2898338|NCT00408421|3605967|FG002|COMPLETED|Treatment Re-Randomization||38
2898339|NCT00408421|3605965|FG000|NOT COMPLETED|Treatment Re-Randomization||7
2898340|NCT00408421|3605966|FG001|NOT COMPLETED|Treatment Re-Randomization||7
2898341|NCT00408421|3605967|FG002|NOT COMPLETED|Treatment Re-Randomization||5
2898342|NCT00408434|3605982|FG000|STARTED|Overall Study||6
2898343|NCT00408434|3605983|FG001|STARTED|Overall Study||3
2898344|NCT00408434|3605984|FG002|STARTED|Overall Study||6
2898345|NCT00408434|3605985|FG003|STARTED|Overall Study||3
2898346|NCT00408434|3605986|FG004|STARTED|Overall Study||6
2898347|NCT00408434|3605987|FG005|STARTED|Overall Study||3
2898348|NCT00408434|3605988|FG006|STARTED|Overall Study||4
2898349|NCT00408434|3605982|FG000|COMPLETED|Overall Study||0
2898350|NCT00408434|3605983|FG001|COMPLETED|Overall Study||0
2898351|NCT00408434|3605984|FG002|COMPLETED|Overall Study||0
2898352|NCT00408434|3605985|FG003|COMPLETED|Overall Study||0
2898353|NCT00408434|3605986|FG004|COMPLETED|Overall Study||0
2898354|NCT00408434|3605987|FG005|COMPLETED|Overall Study||0
2898355|NCT00408434|3605988|FG006|COMPLETED|Overall Study||0
2898356|NCT00408434|3605982|FG000|NOT COMPLETED|Overall Study||6
2898357|NCT00408434|3605983|FG001|NOT COMPLETED|Overall Study||3
2898358|NCT00408434|3605984|FG002|NOT COMPLETED|Overall Study||6
2898359|NCT00408434|3605985|FG003|NOT COMPLETED|Overall Study||3
2898360|NCT00408434|3605986|FG004|NOT COMPLETED|Overall Study||6
2898361|NCT00408434|3605987|FG005|NOT COMPLETED|Overall Study||3
2898362|NCT00408434|3605988|FG006|NOT COMPLETED|Overall Study||4
2898363|NCT00408460|3606005|FG000|STARTED|Overall Study||34
2898364|NCT00408460|3606005|FG000|COMPLETED|Overall Study||34
2898365|NCT00408460|3606005|FG000|NOT COMPLETED|Overall Study||0
2898366|NCT00408499|3606009|FG000|STARTED|Phase 1: Dose Levels 1-4||4
2898367|NCT00408499|3606010|FG001|STARTED|Phase 1: Dose Levels 1-4||7
2898368|NCT00408499|3606011|FG002|STARTED|Phase 1: Dose Levels 1-4||3
2898369|NCT00408499|3606012|FG003|STARTED|Phase 1: Dose Levels 1-4||6
2898370|NCT00408499|3606013|FG004|STARTED|Phase 1: Dose Levels 1-4||0
2898371|NCT00408499|3606009|FG000|COMPLETED|Phase 1: Dose Levels 1-4||2
2898372|NCT00408499|3606010|FG001|COMPLETED|Phase 1: Dose Levels 1-4||5
2898373|NCT00408499|3606011|FG002|COMPLETED|Phase 1: Dose Levels 1-4||2
2898374|NCT00408499|3606012|FG003|COMPLETED|Phase 1: Dose Levels 1-4||6
2898375|NCT00408499|3606013|FG004|COMPLETED|Phase 1: Dose Levels 1-4||0
2898376|NCT00408499|3606009|FG000|NOT COMPLETED|Phase 1: Dose Levels 1-4||2
2898377|NCT00408499|3606010|FG001|NOT COMPLETED|Phase 1: Dose Levels 1-4||2
2898378|NCT00408499|3606011|FG002|NOT COMPLETED|Phase 1: Dose Levels 1-4||1
2898379|NCT00408499|3606012|FG003|NOT COMPLETED|Phase 1: Dose Levels 1-4||0
2898380|NCT00408499|3606013|FG004|NOT COMPLETED|Phase 1: Dose Levels 1-4||0
2898381|NCT00408499|3606009|FG000|STARTED|Phase II- MTD Expansion||0
2898382|NCT00408499|3606010|FG001|STARTED|Phase II- MTD Expansion||0
2898383|NCT00408499|3606011|FG002|STARTED|Phase II- MTD Expansion||0
2898384|NCT00408499|3606012|FG003|STARTED|Phase II- MTD Expansion||0
2898385|NCT00408499|3606013|FG004|STARTED|Phase II- MTD Expansion||44
2898386|NCT00408499|3606009|FG000|COMPLETED|Phase II- MTD Expansion||0
2898387|NCT00408499|3606010|FG001|COMPLETED|Phase II- MTD Expansion||0
2898388|NCT00408499|3606011|FG002|COMPLETED|Phase II- MTD Expansion||0
2898389|NCT00408499|3606012|FG003|COMPLETED|Phase II- MTD Expansion||0
2898390|NCT00408499|3606013|FG004|COMPLETED|Phase II- MTD Expansion||24
2898391|NCT00408499|3606009|FG000|NOT COMPLETED|Phase II- MTD Expansion||0
2898392|NCT00408499|3606010|FG001|NOT COMPLETED|Phase II- MTD Expansion||0
2898393|NCT00408499|3606011|FG002|NOT COMPLETED|Phase II- MTD Expansion||0
2898394|NCT00408499|3606012|FG003|NOT COMPLETED|Phase II- MTD Expansion||0
2898395|NCT00408499|3606013|FG004|NOT COMPLETED|Phase II- MTD Expansion||20
2898396|NCT00408564|3606022|FG000|STARTED|Overall Study||39
2898397|NCT00408564|3606022|FG000|COMPLETED|Overall Study||39
2898398|NCT00408564|3606022|FG000|NOT COMPLETED|Overall Study||0
2898399|NCT00408590|3606029|FG000|STARTED|Overall Study||3
2898400|NCT00408590|3606030|FG001|STARTED|Overall Study||3
2898401|NCT00408590|3606031|FG002|STARTED|Overall Study||3
2898402|NCT00408590|3606032|FG003|STARTED|Overall Study||3
2898403|NCT00408590|3606033|FG004|STARTED|Overall Study||3
2898404|NCT00408590|3606034|FG005|STARTED|Overall Study||3
2898405|NCT00408590|3606035|FG006|STARTED|Overall Study||3
2898406|NCT00408590|3606036|FG007|STARTED|Overall Study||3
2898407|NCT00408590|3606037|FG008|STARTED|Overall Study||13
2898408|NCT00408590|3606029|FG000|COMPLETED|Overall Study||3
2898409|NCT00408590|3606030|FG001|COMPLETED|Overall Study||3
2898410|NCT00408590|3606031|FG002|COMPLETED|Overall Study||3
2898411|NCT00408590|3606032|FG003|COMPLETED|Overall Study||3
2898412|NCT00408590|3606033|FG004|COMPLETED|Overall Study||3
2898413|NCT00408590|3606034|FG005|COMPLETED|Overall Study||3
2898414|NCT00408590|3606035|FG006|COMPLETED|Overall Study||3
3170944|NCT01931839|3898190|FG003|NOT COMPLETED|Overall Study||14
3170945|NCT01931839|3898191|FG004|NOT COMPLETED|Overall Study||1
2898415|NCT00408590|3606036|FG007|COMPLETED|Overall Study||3
2898416|NCT00408590|3606037|FG008|COMPLETED|Overall Study||13
2898417|NCT00408590|3606029|FG000|NOT COMPLETED|Overall Study||0
2898418|NCT00408590|3606030|FG001|NOT COMPLETED|Overall Study||0
2898419|NCT00408590|3606031|FG002|NOT COMPLETED|Overall Study||0
2898420|NCT00408590|3606032|FG003|NOT COMPLETED|Overall Study||0
2898421|NCT00408590|3606033|FG004|NOT COMPLETED|Overall Study||0
2898422|NCT00408590|3606034|FG005|NOT COMPLETED|Overall Study||0
2898423|NCT00408590|3606035|FG006|NOT COMPLETED|Overall Study||0
2898424|NCT00408590|3606036|FG007|NOT COMPLETED|Overall Study||0
2898425|NCT00408590|3606037|FG008|NOT COMPLETED|Overall Study||0
2898426|NCT00408603|3606055|FG000|STARTED|Overall Study||69
2898427|NCT00408603|3606056|FG001|STARTED|Overall Study||39
2898428|NCT00408603|3606057|FG002|STARTED|Overall Study||75
2898429|NCT00408603|3606055|FG000|COMPLETED|Overall Study||65
2898430|NCT00408603|3606056|FG001|COMPLETED|Overall Study||37
2898431|NCT00408603|3606057|FG002|COMPLETED|Overall Study||35
2898432|NCT00408603|3606055|FG000|NOT COMPLETED|Overall Study||4
2898433|NCT00408603|3606056|FG001|NOT COMPLETED|Overall Study||2
2898434|NCT00408603|3606057|FG002|NOT COMPLETED|Overall Study||40
2898435|NCT00408629|3606069|FG000|STARTED|Overall Study|10 ADA recipients from 3 noncompliant clinical sites in Safety, but not in Efficacy analyses (248).|258
2898436|NCT00408629|3606070|FG001|STARTED|Overall Study|14 PLB recipients from 3 noncompliant clinical sites in Safety, but not in Efficacy analyses (246).|260
2898437|NCT00408629|3606069|FG000|COMPLETED|Overall Study|1 ADA recipient did not receive study drug and discontinued due to other reasons.|161
2898438|NCT00408629|3606070|FG001|COMPLETED|Overall Study||135
2898439|NCT00408629|3606069|FG000|NOT COMPLETED|Overall Study||97
2898440|NCT00408629|3606070|FG001|NOT COMPLETED|Overall Study||125
2898441|NCT00408681|3606077|FG000|STARTED|Overall Study||20
2898442|NCT00408681|3606077|FG000|COMPLETED|Overall Study|Completion was defined as administration of the study product for at least 28 days.|11
2898443|NCT00408681|3606077|FG000|NOT COMPLETED|Overall Study||9
2898444|NCT00408694|3606082|FG000|STARTED|Overall Study||46
2898445|NCT00408694|3606082|FG000|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|44
2898446|NCT00408694|3606082|FG000|NOT COMPLETED|Overall Study||2
2898447|NCT00408876|3606090|FG000|STARTED|Overall Study||59
2898448|NCT00408876|3606091|FG001|STARTED|Overall Study||116
2898449|NCT00408876|3606092|FG002|STARTED|Overall Study||112
2898450|NCT00408876|3606093|FG003|STARTED|Overall Study||117
2898451|NCT00408876|3606090|FG000|COMPLETED|Overall Study||43
2898452|NCT00408876|3606091|FG001|COMPLETED|Overall Study||80
2898453|NCT00408876|3606092|FG002|COMPLETED|Overall Study||62
2898454|NCT00408876|3606093|FG003|COMPLETED|Overall Study||82
2898455|NCT00408876|3606090|FG000|NOT COMPLETED|Overall Study||16
2898456|NCT00408876|3606091|FG001|NOT COMPLETED|Overall Study||36
2898457|NCT00408876|3606092|FG002|NOT COMPLETED|Overall Study||50
2898458|NCT00408876|3606093|FG003|NOT COMPLETED|Overall Study||35
2898459|NCT00408902|3606103|FG000|STARTED|Overall Study||10
2898460|NCT00408902|3606103|FG000|COMPLETED|Overall Study||0
2898461|NCT00408902|3606103|FG000|NOT COMPLETED|Overall Study||10
2898462|NCT00408928|3606108|FG000|STARTED|Overall Study||11
2898463|NCT00408928|3606108|FG000|COMPLETED|Overall Study||8
2898464|NCT00408928|3606108|FG000|NOT COMPLETED|Overall Study||3
2898465|NCT00408993|3606114|FG000|STARTED|Overall Study||106
2898466|NCT00408993|3606115|FG001|STARTED|Overall Study||109
2898467|NCT00408993|3606114|FG000|COMPLETED|Overall Study||87
2898468|NCT00408993|3606115|FG001|COMPLETED|Overall Study||92
2898469|NCT00408993|3606114|FG000|NOT COMPLETED|Overall Study||19
2898470|NCT00408993|3606115|FG001|NOT COMPLETED|Overall Study||17
2898471|NCT00409006|3606127|FG000|STARTED|Overall Study||39
2898472|NCT00409006|3606128|FG001|STARTED|Overall Study||31
2898473|NCT00409006|3606127|FG000|COMPLETED|Overall Study||19
2898474|NCT00409006|3606128|FG001|COMPLETED|Overall Study||19
2898475|NCT00409006|3606127|FG000|NOT COMPLETED|Overall Study||20
2898476|NCT00409006|3606128|FG001|NOT COMPLETED|Overall Study||12
2898477|NCT00409175|3606136|FG000|STARTED|Overall Study||65
2898478|NCT00409175|3606137|FG001|STARTED|Overall Study||63
3170946|NCT01931839|3898192|FG005|NOT COMPLETED|Overall Study||5
2898479|NCT00409175|3606136|FG000|COMPLETED|Overall Study||47
2898480|NCT00409175|3606137|FG001|COMPLETED|Overall Study||44
2898481|NCT00409175|3606136|FG000|NOT COMPLETED|Overall Study||18
2898482|NCT00409175|3606137|FG001|NOT COMPLETED|Overall Study||19
2898483|NCT00409188|3606145|FG000|STARTED|Overall Study||1006
2898484|NCT00409188|3606146|FG001|STARTED|Overall Study||507
2898485|NCT00409188|3606145|FG000|COMPLETED|Overall Study||623
2898486|NCT00409188|3606146|FG001|COMPLETED|Overall Study||332
2898487|NCT00409188|3606145|FG000|NOT COMPLETED|Overall Study||383
2898488|NCT00409188|3606146|FG001|NOT COMPLETED|Overall Study||175
2898489|NCT00409240|3606154|FG000|STARTED|Overall Study||53
2898490|NCT00409240|3606155|FG001|STARTED|Overall Study||50
2898491|NCT00409240|3606154|FG000|COMPLETED|Overall Study||50
2898492|NCT00409240|3606155|FG001|COMPLETED|Overall Study||49
2898493|NCT00409240|3606154|FG000|NOT COMPLETED|Overall Study||3
3170947|NCT01931839|3898193|FG006|NOT COMPLETED|Overall Study||4
3170948|NCT01931865|3898213|FG000|STARTED|Overall Study||12
2898494|NCT00409240|3606155|FG001|NOT COMPLETED|Overall Study||1
2898495|NCT00409292|3606161|FG000|STARTED|Overall Study||33
2898496|NCT00409292|3606161|FG000|COMPLETED|Overall Study||33
2898497|NCT00409292|3606161|FG000|NOT COMPLETED|Overall Study||0
2898498|NCT00409409|3606169|FG000|STARTED|Overall Study||139
2898499|NCT00409409|3606170|FG001|STARTED|Overall Study||139
2898500|NCT00409409|3606169|FG000|COMPLETED|Overall Study||131
2898501|NCT00409409|3606170|FG001|COMPLETED|Overall Study||135
2898502|NCT00409409|3606169|FG000|NOT COMPLETED|Overall Study||8
2898503|NCT00409409|3606170|FG001|NOT COMPLETED|Overall Study||4
2898504|NCT00409539|3606181|FG000|STARTED|Overall Study||111
2898505|NCT00409539|3606182|FG001|STARTED|Overall Study||111
2898506|NCT00409539|3606183|FG002|STARTED|Overall Study||109
2898507|NCT00409539|3606184|FG003|STARTED|Overall Study||109
2898508|NCT00409539|3606185|FG004|STARTED|Overall Study||110
2898509|NCT00409539|3606181|FG000|COMPLETED|Overall Study||100
2898510|NCT00409539|3606182|FG001|COMPLETED|Overall Study||100
2898511|NCT00409539|3606183|FG002|COMPLETED|Overall Study||95
2898512|NCT00409539|3606184|FG003|COMPLETED|Overall Study||97
2898513|NCT00409539|3606185|FG004|COMPLETED|Overall Study||85
2898514|NCT00409539|3606181|FG000|NOT COMPLETED|Overall Study||11
2898515|NCT00409539|3606182|FG001|NOT COMPLETED|Overall Study||11
2898516|NCT00409539|3606183|FG002|NOT COMPLETED|Overall Study||14
2898517|NCT00409539|3606184|FG003|NOT COMPLETED|Overall Study||12
2898518|NCT00409539|3606185|FG004|NOT COMPLETED|Overall Study||25
2898519|NCT00409565|3606197|FG000|STARTED|Overall Study||46
2898520|NCT00409565|3606197|FG000|Overall Response Rate|Overall Study||7
2898521|NCT00409565|3606197|FG000|COMPLETED|Overall Study||45
2898522|NCT00409565|3606197|FG000|NOT COMPLETED|Overall Study||1
2898523|NCT00409578|3606205|FG000|STARTED|Overall Study||280
2898524|NCT00409578|3606206|FG001|STARTED|Overall Study||271
2898525|NCT00409578|3606207|FG002|STARTED|Overall Study||269
2898526|NCT00409578|3606208|FG003|STARTED|Overall Study||281
2898527|NCT00409578|3606205|FG000|COMPLETED|Overall Study||228
2898528|NCT00409578|3606206|FG001|COMPLETED|Overall Study||201
2898529|NCT00409578|3606207|FG002|COMPLETED|Overall Study||215
2898530|NCT00409578|3606208|FG003|COMPLETED|Overall Study||214
2898531|NCT00409578|3606205|FG000|NOT COMPLETED|Overall Study||52
2898532|NCT00409578|3606206|FG001|NOT COMPLETED|Overall Study||70
2898533|NCT00409578|3606207|FG002|NOT COMPLETED|Overall Study||54
2898534|NCT00409578|3606208|FG003|NOT COMPLETED|Overall Study||67
2898535|NCT00409617|3606218|FG000|STARTED|Overall Study||945
2898536|NCT00409617|3606218|FG000|COMPLETED|Overall Study||785
2898537|NCT00409617|3606218|FG000|NOT COMPLETED|Overall Study||160
2898538|NCT00409682|3606225|FG000|STARTED|Open-label Induction Period||192
2898539|NCT00409682|3606226|FG001|STARTED|Open-label Induction Period||0
2898540|NCT00409682|3606227|FG002|STARTED|Open-label Induction Period||0
2898541|NCT00409682|3606225|FG000|COMPLETED|Open-label Induction Period||188
2898542|NCT00409682|3606226|FG001|COMPLETED|Open-label Induction Period||0
2898543|NCT00409682|3606227|FG002|COMPLETED|Open-label Induction Period||0
2898544|NCT00409682|3606225|FG000|NOT COMPLETED|Open-label Induction Period||4
2898545|NCT00409682|3606226|FG001|NOT COMPLETED|Open-label Induction Period||0
2898546|NCT00409682|3606227|FG002|NOT COMPLETED|Open-label Induction Period||0
2898547|NCT00409682|3606225|FG000|STARTED|EOW Double-blind Maintenance Period||0
2898548|NCT00409682|3606226|FG001|STARTED|EOW Double-blind Maintenance Period||95
2898549|NCT00409682|3606227|FG002|STARTED|EOW Double-blind Maintenance Period||93
2898550|NCT00409682|3606225|FG000|COMPLETED|EOW Double-blind Maintenance Period||0
2898551|NCT00409682|3606226|FG001|COMPLETED|EOW Double-blind Maintenance Period||58
2898552|NCT00409682|3606227|FG002|COMPLETED|EOW Double-blind Maintenance Period||66
2898553|NCT00409682|3606225|FG000|NOT COMPLETED|EOW Double-blind Maintenance Period||0
2898554|NCT00409682|3606226|FG001|NOT COMPLETED|EOW Double-blind Maintenance Period||37
2898555|NCT00409682|3606227|FG002|NOT COMPLETED|EOW Double-blind Maintenance Period||27
2898556|NCT00409708|3606236|FG000|STARTED|Treatment|A total of 142 participants were screened for the study but only 109 were randomized to treatment|53
2898557|NCT00409708|3606237|FG001|STARTED|Treatment||56
2898558|NCT00409708|3606236|FG000|COMPLETED|Treatment||38
2898559|NCT00409708|3606237|FG001|COMPLETED|Treatment||39
2898560|NCT00409708|3606236|FG000|NOT COMPLETED|Treatment||15
2898561|NCT00409708|3606237|FG001|NOT COMPLETED|Treatment||17
2898562|NCT00409708|3606236|FG000|STARTED|Washout||38
2898563|NCT00409708|3606237|FG001|STARTED|Washout||39
2898564|NCT00409708|3606236|FG000|COMPLETED|Washout||17
2898565|NCT00409708|3606237|FG001|COMPLETED|Washout||29
3170949|NCT01931865|3898213|FG000|COMPLETED|Overall Study||8
2898566|NCT00409708|3606236|FG000|NOT COMPLETED|Washout||21
2898567|NCT00409708|3606237|FG001|NOT COMPLETED|Washout||10
2898568|NCT00409747|3606243|FG000|STARTED|Overall Study||11
2898569|NCT00409747|3606243|FG000|COMPLETED|Overall Study||10
2898570|NCT00409747|3606243|FG000|NOT COMPLETED|Overall Study||1
2898571|NCT00409786|3606247|FG000|STARTED|Overall Study||50
2898572|NCT00409786|3606247|FG000|COMPLETED|Overall Study||47
2898573|NCT00409786|3606247|FG000|NOT COMPLETED|Overall Study||3
2898574|NCT00409825|3606251|FG000|STARTED|Overall Study||61
3170950|NCT01931865|3898213|FG000|NOT COMPLETED|Overall Study||4
3170951|NCT01931878|3898218|FG000|STARTED|First Intervention||10
3170952|NCT01931878|3898219|FG001|STARTED|First Intervention||14
2898575|NCT00409825|3606251|FG000|COMPLETED|Overall Study||61
2898576|NCT00409825|3606251|FG000|NOT COMPLETED|Overall Study||0
2898577|NCT00409838|3606257|FG000|STARTED|Short-term Period|Randomized|56
2898578|NCT00409838|3606258|FG001|STARTED|Short-term Period|Randomized|57
2898579|NCT00409838|3606257|FG000|Treated (Baseline) Population|Short-term Period||55
2898580|NCT00409838|3606258|FG001|Treated (Baseline) Population|Short-term Period||57
2898581|NCT00409838|3606257|FG000|COMPLETED|Short-term Period||53
2898582|NCT00409838|3606258|FG001|COMPLETED|Short-term Period|Participants who received placebo in this period received abatacept in next period.|52
2898583|NCT00409838|3606257|FG000|NOT COMPLETED|Short-term Period||3
2898584|NCT00409838|3606258|FG001|NOT COMPLETED|Short-term Period||5
2898585|NCT00409838|3606257|FG000|STARTED|Long-term Extension Period||105
2898586|NCT00409838|3606258|FG001|STARTED|Long-term Extension Period||0
2898587|NCT00409838|3606257|FG000|COMPLETED|Long-term Extension Period||87
2898588|NCT00409838|3606258|FG001|COMPLETED|Long-term Extension Period||0
2898589|NCT00409838|3606257|FG000|NOT COMPLETED|Long-term Extension Period||18
2898590|NCT00409838|3606258|FG001|NOT COMPLETED|Long-term Extension Period||0
2898591|NCT00410046|3606281|FG000|STARTED|Overall Study||84
2898592|NCT00410046|3606281|FG000|COMPLETED|Overall Study||79
2898593|NCT00410046|3606281|FG000|NOT COMPLETED|Overall Study||5
2898594|NCT00410059|3606286|FG000|STARTED|Overall Study||59
2898595|NCT00410059|3606286|FG000|COMPLETED|Overall Study||59
2898596|NCT00410059|3606286|FG000|NOT COMPLETED|Overall Study||0
2898597|NCT00410072|3606292|FG000|STARTED|Day 1 to Week 48|Number of participants randomized and treated; 4 more were randomized but not treated.|182
2898598|NCT00410072|3606293|FG001|STARTED|Day 1 to Week 48|Number of participants randomized and treated; 1 more was randomized but not treated.|197
2898599|NCT00410072|3606292|FG000|COMPLETED|Day 1 to Week 48||176
2898600|NCT00410072|3606293|FG001|COMPLETED|Day 1 to Week 48||185
2898601|NCT00410072|3606292|FG000|NOT COMPLETED|Day 1 to Week 48||6
2898602|NCT00410072|3606293|FG001|NOT COMPLETED|Day 1 to Week 48||12
2898603|NCT00410072|3606292|FG000|STARTED|After Week 48 to Week 96||176
2898604|NCT00410072|3606293|FG001|STARTED|After Week 48 to Week 96||185
2898605|NCT00410072|3606292|FG000|COMPLETED|After Week 48 to Week 96||170
2898606|NCT00410072|3606293|FG001|COMPLETED|After Week 48 to Week 96||174
2898607|NCT00410072|3606292|FG000|NOT COMPLETED|After Week 48 to Week 96||6
2898608|NCT00410072|3606293|FG001|NOT COMPLETED|After Week 48 to Week 96||11
2898609|NCT00410124|3606301|FG000|STARTED|Core Phase Double Blind (15 Months)|Started indicates randomized (FAS) and treated|277
2898610|NCT00410124|3606302|FG001|STARTED|Core Phase Double Blind (15 Months)||139
2898611|NCT00410124|3606301|FG000|Ongoing|Core Phase Double Blind (15 Months)||13
2898612|NCT00410124|3606302|FG001|Ongoing|Core Phase Double Blind (15 Months)||4
2898613|NCT00410124|3606301|FG000|Completed Double Blind Treatment|Core Phase Double Blind (15 Months)||62
2898614|NCT00410124|3606302|FG001|Completed Double Blind Treatment|Core Phase Double Blind (15 Months)||2
2898615|NCT00410124|3606301|FG000|COMPLETED|Core Phase Double Blind (15 Months)|Patients ongoing/completed double blind phase had option entering extension phase continuing RAD001.|75
2898616|NCT00410124|3606302|FG001|COMPLETED|Core Phase Double Blind (15 Months)|All patients ongoing/completed/not completed in core had option to enter extension taking RAD001.|6
2898617|NCT00410124|3606301|FG000|NOT COMPLETED|Core Phase Double Blind (15 Months)||202
2898618|NCT00410124|3606302|FG001|NOT COMPLETED|Core Phase Double Blind (15 Months)||133
2898619|NCT00410124|3606301|FG000|STARTED|Extension Phase - Open Label (45 Months)||67
2898620|NCT00410124|3606302|FG001|STARTED|Extension Phase - Open Label (45 Months)|Patients on placebo in core received RAD001 in extension phase.|111
2898621|NCT00410124|3606301|FG000|COMPLETED|Extension Phase - Open Label (45 Months)||0
2898622|NCT00410124|3606302|FG001|COMPLETED|Extension Phase - Open Label (45 Months)||0
2898623|NCT00410124|3606301|FG000|NOT COMPLETED|Extension Phase - Open Label (45 Months)||67
2898624|NCT00410124|3606302|FG001|NOT COMPLETED|Extension Phase - Open Label (45 Months)||111
2898625|NCT00410150|3606314|FG000|STARTED|Overall Study||22
2898626|NCT00410150|3606315|FG001|STARTED|Overall Study||20
2898627|NCT00410150|3606314|FG000|COMPLETED|Overall Study|2 study withdrawals (analyzed by intention-to-treat)|20
2898628|NCT00410150|3606315|FG001|COMPLETED|Overall Study|3 study withdrawals (analyzed by intention-to-treat0|17
2898629|NCT00410150|3606314|FG000|NOT COMPLETED|Overall Study||2
2898630|NCT00410150|3606315|FG001|NOT COMPLETED|Overall Study||3
2898631|NCT00410163|3606323|FG000|STARTED|Treatment and Follow-up Phase (2 Years)||31
2898632|NCT00410163|3606324|FG001|STARTED|Treatment and Follow-up Phase (2 Years)||30
2898633|NCT00410163|3606323|FG000|COMPLETED|Treatment and Follow-up Phase (2 Years)||19
2898634|NCT00410163|3606324|FG001|COMPLETED|Treatment and Follow-up Phase (2 Years)||19
2898635|NCT00410163|3606323|FG000|NOT COMPLETED|Treatment and Follow-up Phase (2 Years)||12
2898636|NCT00410163|3606324|FG001|NOT COMPLETED|Treatment and Follow-up Phase (2 Years)||11
2920056|NCT00535236|3630482|FG000|COMPLETED|Overall Study||33
2898637|NCT00410163|3606323|FG000|STARTED|Extended Follow-up (FU) Phase (2-5 Years|Participants who withdrew from the Treatment Phase were eligible to enter the Extended FU Phase.|20
2898638|NCT00410163|3606324|FG001|STARTED|Extended Follow-up (FU) Phase (2-5 Years|Participants who withdrew from the Treatment Phase were eligible to enter the Extended FU Phase.|21
2898639|NCT00410163|3606323|FG000|COMPLETED|Extended Follow-up (FU) Phase (2-5 Years||10
2898640|NCT00410163|3606324|FG001|COMPLETED|Extended Follow-up (FU) Phase (2-5 Years||11
2898641|NCT00410163|3606323|FG000|NOT COMPLETED|Extended Follow-up (FU) Phase (2-5 Years||10
2898642|NCT00410163|3606324|FG001|NOT COMPLETED|Extended Follow-up (FU) Phase (2-5 Years||10
2898643|NCT00410189|3606334|FG000|STARTED|Overall Study||54
2898644|NCT00410189|3606334|FG000|COMPLETED|Overall Study||54
2898645|NCT00410189|3606334|FG000|NOT COMPLETED|Overall Study||0
2898646|NCT00410202|3606341|FG000|STARTED|On-Treatment||138
2898647|NCT00410202|3606342|FG001|STARTED|On-Treatment||140
2898648|NCT00410202|3606343|FG002|STARTED|On-Treatment||137
2898649|NCT00410202|3606341|FG000|Discontinued Prior to Week 48 Visit|On-Treatment||4
2898650|NCT00410202|3606342|FG001|Discontinued Prior to Week 48 Visit|On-Treatment||2
2898651|NCT00410202|3606343|FG002|Discontinued Prior to Week 48 Visit|On-Treatment||2
2898652|NCT00410202|3606341|FG000|Discontinued at or After Week 48 Visit|On-Treatment||2
2898653|NCT00410202|3606342|FG001|Discontinued at or After Week 48 Visit|On-Treatment||6
2898654|NCT00410202|3606343|FG002|Discontinued at or After Week 48 Visit|On-Treatment||3
2898655|NCT00410202|3606341|FG000|COMPLETED|On-Treatment|Completed the 100 week dosing|63
2898656|NCT00410202|3606342|FG001|COMPLETED|On-Treatment|Completed the 100 week dosing|61
2898657|NCT00410202|3606343|FG002|COMPLETED|On-Treatment|Completed the 100 week dosing|66
2898658|NCT00410202|3606341|FG000|NOT COMPLETED|On-Treatment||75
2898659|NCT00410202|3606342|FG001|NOT COMPLETED|On-Treatment||79
2898660|NCT00410202|3606343|FG002|NOT COMPLETED|On-Treatment||71
2898661|NCT00410202|3606341|FG000|STARTED|Off-treatment Follow up||15
2898662|NCT00410202|3606342|FG001|STARTED|Off-treatment Follow up||8
2898663|NCT00410202|3606343|FG002|STARTED|Off-treatment Follow up||14
2898664|NCT00410202|3606341|FG000|COMPLETED|Off-treatment Follow up||1
2898665|NCT00410202|3606342|FG001|COMPLETED|Off-treatment Follow up||0
2898666|NCT00410202|3606343|FG002|COMPLETED|Off-treatment Follow up||2
2898667|NCT00410202|3606341|FG000|NOT COMPLETED|Off-treatment Follow up||14
2898668|NCT00410202|3606342|FG001|NOT COMPLETED|Off-treatment Follow up||8
2898669|NCT00410202|3606343|FG002|NOT COMPLETED|Off-treatment Follow up||12
2898670|NCT00410280|3606354|FG000|STARTED|Overall Study||14
2898671|NCT00410280|3606355|FG001|STARTED|Overall Study||13
2898672|NCT00410280|3606354|FG000|COMPLETED|Overall Study||14
3170953|NCT01931878|3898218|FG000|COMPLETED|First Intervention||9
3170954|NCT01931878|3898219|FG001|COMPLETED|First Intervention||14
3170955|NCT01931878|3898218|FG000|NOT COMPLETED|First Intervention||1
3170956|NCT01931878|3898219|FG001|NOT COMPLETED|First Intervention||0
3170957|NCT01931878|3898218|FG000|STARTED|Second Intervention (After 3 Months)||9
3170958|NCT01931878|3898219|FG001|STARTED|Second Intervention (After 3 Months)||14
3170959|NCT01931878|3898218|FG000|COMPLETED|Second Intervention (After 3 Months)||9
3170960|NCT01931878|3898219|FG001|COMPLETED|Second Intervention (After 3 Months)||12
3170961|NCT01931878|3898218|FG000|NOT COMPLETED|Second Intervention (After 3 Months)||0
3170962|NCT01931878|3898219|FG001|NOT COMPLETED|Second Intervention (After 3 Months)||2
3170963|NCT01931956|3898233|FG000|STARTED|Overall Study||59
3170964|NCT01931956|3898234|FG001|STARTED|Overall Study||7
3170965|NCT01931956|3898235|FG002|STARTED|Overall Study||628
3170966|NCT01931956|3898236|FG003|STARTED|Overall Study||271
3170967|NCT01931956|3898233|FG000|COMPLETED|Overall Study||8
3170968|NCT01931956|3898234|FG001|COMPLETED|Overall Study||0
3170969|NCT01931956|3898235|FG002|COMPLETED|Overall Study||141
3170970|NCT01931956|3898236|FG003|COMPLETED|Overall Study||138
3170971|NCT01931956|3898233|FG000|NOT COMPLETED|Overall Study||51
3170972|NCT01931956|3898234|FG001|NOT COMPLETED|Overall Study||7
3170973|NCT01931956|3898235|FG002|NOT COMPLETED|Overall Study||487
3170974|NCT01931956|3898236|FG003|NOT COMPLETED|Overall Study||133
3170975|NCT01931995|3898261|FG000|STARTED|First Intervention (1 Day)||23
3170976|NCT01931995|3898262|FG001|STARTED|First Intervention (1 Day)||22
3170977|NCT01931995|3898261|FG000|COMPLETED|First Intervention (1 Day)||19
3170978|NCT01931995|3898262|FG001|COMPLETED|First Intervention (1 Day)||18
3170979|NCT01931995|3898261|FG000|NOT COMPLETED|First Intervention (1 Day)||4
3170980|NCT01931995|3898262|FG001|NOT COMPLETED|First Intervention (1 Day)||4
3170981|NCT01931995|3898261|FG000|STARTED|Washout (at Least 6 Days)||19
3170982|NCT01931995|3898262|FG001|STARTED|Washout (at Least 6 Days)||18
3170983|NCT01931995|3898261|FG000|COMPLETED|Washout (at Least 6 Days)||19
3170984|NCT01931995|3898262|FG001|COMPLETED|Washout (at Least 6 Days)||18
3170985|NCT01931995|3898261|FG000|NOT COMPLETED|Washout (at Least 6 Days)||0
3170986|NCT01931995|3898262|FG001|NOT COMPLETED|Washout (at Least 6 Days)||0
3170987|NCT01931995|3898261|FG000|STARTED|Second Intervention (1 Day)||18
3170988|NCT01931995|3898262|FG001|STARTED|Second Intervention (1 Day)||19
3170989|NCT01931995|3898261|FG000|COMPLETED|Second Intervention (1 Day)||18
3170990|NCT01931995|3898262|FG001|COMPLETED|Second Intervention (1 Day)||19
3170991|NCT01931995|3898261|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
3170992|NCT01931995|3898262|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
3170993|NCT01932060|3898270|FG000|STARTED|Overall Study||27
3170994|NCT01932060|3898271|FG001|STARTED|Overall Study||24
3170995|NCT01932060|3898270|FG000|COMPLETED|Overall Study||27
3170996|NCT01932060|3898271|FG001|COMPLETED|Overall Study||24
3170997|NCT01932060|3898270|FG000|NOT COMPLETED|Overall Study||0
3170998|NCT01932060|3898271|FG001|NOT COMPLETED|Overall Study||0
3170999|NCT01932112|3898277|FG000|STARTED|Overall Study||378
3171000|NCT01932112|3898277|FG000|COMPLETED|Overall Study||378
3171001|NCT01932112|3898277|FG000|NOT COMPLETED|Overall Study||0
3171002|NCT01932164|3898281|FG000|STARTED|Overall Study|It was performed the selection of 5 patients to participate of these study (08/2013)|5
3171003|NCT01932164|3898281|FG000|Cleft Lip and Palate|Overall Study|It was performed de extraction of deciduous teeth of 5 cleft lip/palate patients (09/2013)|5
3171004|NCT01932164|3898281|FG000|Cleft Lip and Palate|Overall Study|Dental pulp was obtained from teeth of 5 different patients (09/2013)|5
3171005|NCT01932164|3898281|FG000|Cleft Lip and Palate|Overall Study|Mesenchymal stem cell obtained from dental pulp of 5patients was obtained, caractherized and frozen|5
3171006|NCT01932164|3898281|FG000|Cleft Lip and Palate|Overall Study|Alveolar bone graft surgeries were did using their dental pulp stem cells with biomaterial|5
3171007|NCT01932164|3898281|FG000|Cleft Lip and Palate|Overall Study|The surgeries were performed between december 2013 and june 2014.|5
3171008|NCT01932164|3898281|FG000|COMPLETED|Overall Study|In all 5 patients we observed bone formation closing the alveolar cleft after 6 months|5
3171009|NCT01932164|3898281|FG000|NOT COMPLETED|Overall Study||0
3171010|NCT01932242|3898287|FG000|STARTED|Overall Study||35
3171011|NCT01932242|3898288|FG001|STARTED|Overall Study||35
3171012|NCT01932242|3898287|FG000|COMPLETED|Overall Study||30
3171013|NCT01932242|3898288|FG001|COMPLETED|Overall Study||30
3171014|NCT01932242|3898287|FG000|NOT COMPLETED|Overall Study||5
3171015|NCT01932242|3898288|FG001|NOT COMPLETED|Overall Study||5
3171016|NCT01932294|3898294|FG000|STARTED|Overall Study||171
3171017|NCT01932294|3898294|FG000|COMPLETED|Overall Study||72
3171018|NCT01932294|3898294|FG000|NOT COMPLETED|Overall Study||99
3171019|NCT01932437|3898301|FG000|STARTED|Cohort 1 - ETI-204 4 mg/kg or Placebo||1
3171020|NCT01932437|3898302|FG001|STARTED|Cohort 1 - ETI-204 4 mg/kg or Placebo||3
3171021|NCT01932437|3898303|FG002|STARTED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
3171022|NCT01932437|3898304|FG003|STARTED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
3171023|NCT01932437|3898305|FG004|STARTED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
3171024|NCT01932437|3898306|FG005|STARTED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
3171025|NCT01932437|3898301|FG000|COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||1
3171026|NCT01932437|3898302|FG001|COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||3
3171027|NCT01932437|3898303|FG002|COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
3171028|NCT01932437|3898304|FG003|COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
3171029|NCT01932437|3898305|FG004|COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
3171030|NCT01932437|3898306|FG005|COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
3171031|NCT01932437|3898301|FG000|NOT COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
3171032|NCT01932437|3898302|FG001|NOT COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
3171033|NCT01932437|3898303|FG002|NOT COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
3171034|NCT01932437|3898304|FG003|NOT COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
3171035|NCT01932437|3898305|FG004|NOT COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
3171036|NCT01932437|3898306|FG005|NOT COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
3171037|NCT01932437|3898301|FG000|STARTED|Cohort 2 - ETI-204 8 mg/kg or Placebo||2
3171038|NCT01932437|3898302|FG001|STARTED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
3171039|NCT01932437|3898303|FG002|STARTED|Cohort 2 - ETI-204 8 mg/kg or Placebo||6
3171040|NCT01932437|3898304|FG003|STARTED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
3171041|NCT01932437|3898305|FG004|STARTED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
3171042|NCT01932437|3898306|FG005|STARTED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
3171043|NCT01932437|3898301|FG000|COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||2
3171044|NCT01932437|3898302|FG001|COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
3171045|NCT01932437|3898303|FG002|COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||6
3171046|NCT01932437|3898304|FG003|COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
3171047|NCT01932437|3898305|FG004|COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
3171048|NCT01932437|3898306|FG005|COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
3171049|NCT01932437|3898301|FG000|NOT COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
3171050|NCT01932437|3898302|FG001|NOT COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
3171051|NCT01932437|3898303|FG002|NOT COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
3171052|NCT01932437|3898304|FG003|NOT COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
3171053|NCT01932437|3898305|FG004|NOT COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
3171054|NCT01932437|3898306|FG005|NOT COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
3171055|NCT01932437|3898301|FG000|STARTED|Cohort 3 - ETI-204 16 mg/kg or Placebo||2
3171056|NCT01932437|3898302|FG001|STARTED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
3171057|NCT01932437|3898303|FG002|STARTED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
3171058|NCT01932437|3898304|FG003|STARTED|Cohort 3 - ETI-204 16 mg/kg or Placebo||6
3171059|NCT01932437|3898305|FG004|STARTED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
3171060|NCT01932437|3898306|FG005|STARTED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
3171061|NCT01932437|3898301|FG000|COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||2
3171062|NCT01932437|3898302|FG001|COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
3384507|NCT02180217|4119614|FG002|Discont. at/Prior to W26 But After W12|Overall Study||12
3384508|NCT02180217|4119612|FG000|Discontinued Prior to W48 But After W26|Overall Study||0
2898673|NCT00410280|3606355|FG001|COMPLETED|Overall Study||13
2898674|NCT00410280|3606354|FG000|NOT COMPLETED|Overall Study||0
2898675|NCT00410280|3606355|FG001|NOT COMPLETED|Overall Study||0
2898676|NCT00410384|3606364|FG000|STARTED|Overall Study||275
2898677|NCT00410384|3606365|FG001|STARTED|Overall Study||271
2898678|NCT00410384|3606366|FG002|STARTED|Overall Study||273
3384509|NCT02180217|4119613|FG001|Discontinued Prior to W48 But After W26|Overall Study||2
2898679|NCT00410384|3606364|FG000|COMPLETED|Overall Study||186
2898680|NCT00410384|3606365|FG001|COMPLETED|Overall Study||199
2898681|NCT00410384|3606366|FG002|COMPLETED|Overall Study||191
2898682|NCT00410384|3606364|FG000|NOT COMPLETED|Overall Study||89
2898683|NCT00410384|3606365|FG001|NOT COMPLETED|Overall Study||72
2898684|NCT00410384|3606366|FG002|NOT COMPLETED|Overall Study||82
2898685|NCT00410410|3606380|FG000|STARTED|Induction Period (IP)||141
2898686|NCT00410410|3606381|FG001|STARTED|Induction Period (IP)||139
2898687|NCT00410410|3606382|FG002|STARTED|Induction Period (IP)||70
2898688|NCT00410410|3606383|FG003|STARTED|Induction Period (IP)||140
2898689|NCT00410410|3606384|FG004|STARTED|Induction Period (IP)||51
2898690|NCT00410410|3606385|FG005|STARTED|Induction Period (IP)||50
2898691|NCT00410410|3606386|FG006|STARTED|Induction Period (IP)||0
2898692|NCT00410410|3606387|FG007|STARTED|Induction Period (IP)||0
2898693|NCT00410410|3606388|FG008|STARTED|Induction Period (IP)||0
2898694|NCT00410410|3606380|FG000|COMPLETED|Induction Period (IP)||106
2898695|NCT00410410|3606381|FG001|COMPLETED|Induction Period (IP)||104
2898696|NCT00410410|3606382|FG002|COMPLETED|Induction Period (IP)||53
2898697|NCT00410410|3606383|FG003|COMPLETED|Induction Period (IP)||120
2898698|NCT00410410|3606384|FG004|COMPLETED|Induction Period (IP)||19
2898699|NCT00410410|3606385|FG005|COMPLETED|Induction Period (IP)||21
2898700|NCT00410410|3606386|FG006|COMPLETED|Induction Period (IP)||0
2898701|NCT00410410|3606387|FG007|COMPLETED|Induction Period (IP)||0
2898702|NCT00410410|3606388|FG008|COMPLETED|Induction Period (IP)||0
2898703|NCT00410410|3606380|FG000|NOT COMPLETED|Induction Period (IP)||35
2898704|NCT00410410|3606381|FG001|NOT COMPLETED|Induction Period (IP)||35
2898705|NCT00410410|3606382|FG002|NOT COMPLETED|Induction Period (IP)||17
2898706|NCT00410410|3606383|FG003|NOT COMPLETED|Induction Period (IP)||20
2898707|NCT00410410|3606384|FG004|NOT COMPLETED|Induction Period (IP)||32
2898708|NCT00410410|3606385|FG005|NOT COMPLETED|Induction Period (IP)||29
2898709|NCT00410410|3606386|FG006|NOT COMPLETED|Induction Period (IP)||0
2898710|NCT00410410|3606387|FG007|NOT COMPLETED|Induction Period (IP)||0
2898711|NCT00410410|3606388|FG008|NOT COMPLETED|Induction Period (IP)||0
2898712|NCT00410410|3606380|FG000|STARTED|Maintenance Period (MP)||0
2898713|NCT00410410|3606381|FG001|STARTED|Maintenance Period (MP)||0
2898714|NCT00410410|3606382|FG002|STARTED|Maintenance Period (MP)||0
2898715|NCT00410410|3606383|FG003|STARTED|Maintenance Period (MP)||0
2898716|NCT00410410|3606384|FG004|STARTED|Maintenance Period (MP)||0
2898717|NCT00410410|3606385|FG005|STARTED|Maintenance Period (MP)||0
2898718|NCT00410410|3606386|FG006|STARTED|Maintenance Period (MP)|At end of IP, 65 participants met response criteria and were randomly assigned to abatacept in MP.|65
2898719|NCT00410410|3606387|FG007|STARTED|Maintenance Period (MP)|At end of IP, 66 participants met response criteria and were randomly assigned to placebo in MP.|66
2898720|NCT00410410|3606388|FG008|STARTED|Maintenance Period (MP)||0
2898721|NCT00410410|3606380|FG000|COMPLETED|Maintenance Period (MP)||0
2898722|NCT00410410|3606381|FG001|COMPLETED|Maintenance Period (MP)||0
2898723|NCT00410410|3606382|FG002|COMPLETED|Maintenance Period (MP)||0
2898724|NCT00410410|3606383|FG003|COMPLETED|Maintenance Period (MP)||0
2898725|NCT00410410|3606384|FG004|COMPLETED|Maintenance Period (MP)||0
2898726|NCT00410410|3606385|FG005|COMPLETED|Maintenance Period (MP)||0
2898727|NCT00410410|3606386|FG006|COMPLETED|Maintenance Period (MP)||15
2898728|NCT00410410|3606387|FG007|COMPLETED|Maintenance Period (MP)||11
2898729|NCT00410410|3606388|FG008|COMPLETED|Maintenance Period (MP)||0
2898730|NCT00410410|3606380|FG000|NOT COMPLETED|Maintenance Period (MP)||0
2898731|NCT00410410|3606381|FG001|NOT COMPLETED|Maintenance Period (MP)||0
2898732|NCT00410410|3606382|FG002|NOT COMPLETED|Maintenance Period (MP)||0
2898733|NCT00410410|3606383|FG003|NOT COMPLETED|Maintenance Period (MP)||0
2898734|NCT00410410|3606384|FG004|NOT COMPLETED|Maintenance Period (MP)||0
2898735|NCT00410410|3606385|FG005|NOT COMPLETED|Maintenance Period (MP)||0
2898736|NCT00410410|3606386|FG006|NOT COMPLETED|Maintenance Period (MP)||50
2898737|NCT00410410|3606387|FG007|NOT COMPLETED|Maintenance Period (MP)||55
2898738|NCT00410410|3606388|FG008|NOT COMPLETED|Maintenance Period (MP)||0
2898739|NCT00410410|3606380|FG000|STARTED|Open-Label Period (OL)||0
2898740|NCT00410410|3606381|FG001|STARTED|Open-Label Period (OL)||0
2898741|NCT00410410|3606382|FG002|STARTED|Open-Label Period (OL)||0
2898742|NCT00410410|3606383|FG003|STARTED|Open-Label Period (OL)||0
2898743|NCT00410410|3606384|FG004|STARTED|Open-Label Period (OL)||0
2898744|NCT00410410|3606385|FG005|STARTED|Open-Label Period (OL)||0
2898745|NCT00410410|3606386|FG006|STARTED|Open-Label Period (OL)||0
2898746|NCT00410410|3606387|FG007|STARTED|Open-Label Period (OL)||0
2898747|NCT00410410|3606388|FG008|STARTED|Open-Label Period (OL)|349 entered OL (those who completed IP but failed response criteria, or completed/relapsed on MP).|349
2898748|NCT00410410|3606380|FG000|COMPLETED|Open-Label Period (OL)||0
2898749|NCT00410410|3606381|FG001|COMPLETED|Open-Label Period (OL)||0
2898750|NCT00410410|3606382|FG002|COMPLETED|Open-Label Period (OL)||0
2898751|NCT00410410|3606383|FG003|COMPLETED|Open-Label Period (OL)||0
2898752|NCT00410410|3606384|FG004|COMPLETED|Open-Label Period (OL)||0
2898753|NCT00410410|3606385|FG005|COMPLETED|Open-Label Period (OL)||0
2898754|NCT00410410|3606386|FG006|COMPLETED|Open-Label Period (OL)||0
2898755|NCT00410410|3606387|FG007|COMPLETED|Open-Label Period (OL)||0
2898756|NCT00410410|3606388|FG008|COMPLETED|Open-Label Period (OL)||0
2898757|NCT00410410|3606380|FG000|NOT COMPLETED|Open-Label Period (OL)||0
2898758|NCT00410410|3606381|FG001|NOT COMPLETED|Open-Label Period (OL)||0
2898759|NCT00410410|3606382|FG002|NOT COMPLETED|Open-Label Period (OL)||0
2898760|NCT00410410|3606383|FG003|NOT COMPLETED|Open-Label Period (OL)||0
2898761|NCT00410410|3606384|FG004|NOT COMPLETED|Open-Label Period (OL)||0
2898762|NCT00410410|3606385|FG005|NOT COMPLETED|Open-Label Period (OL)||0
2898763|NCT00410410|3606386|FG006|NOT COMPLETED|Open-Label Period (OL)||0
2898764|NCT00410410|3606387|FG007|NOT COMPLETED|Open-Label Period (OL)||0
2898765|NCT00410410|3606388|FG008|NOT COMPLETED|Open-Label Period (OL)||349
2898766|NCT00410423|3606423|FG000|STARTED|Phase 1 - Dose Level 1||3
2898767|NCT00410423|3606424|FG001|STARTED|Phase 1 - Dose Level 1||0
2898768|NCT00410423|3606425|FG002|STARTED|Phase 1 - Dose Level 1||0
2898769|NCT00410423|3606426|FG003|STARTED|Phase 1 - Dose Level 1||0
2898770|NCT00410423|3606423|FG000|COMPLETED|Phase 1 - Dose Level 1||3
2898771|NCT00410423|3606424|FG001|COMPLETED|Phase 1 - Dose Level 1||0
2898772|NCT00410423|3606425|FG002|COMPLETED|Phase 1 - Dose Level 1||0
2898773|NCT00410423|3606426|FG003|COMPLETED|Phase 1 - Dose Level 1||0
2898774|NCT00410423|3606423|FG000|NOT COMPLETED|Phase 1 - Dose Level 1||0
2898775|NCT00410423|3606424|FG001|NOT COMPLETED|Phase 1 - Dose Level 1||0
2898776|NCT00410423|3606425|FG002|NOT COMPLETED|Phase 1 - Dose Level 1||0
2898777|NCT00410423|3606426|FG003|NOT COMPLETED|Phase 1 - Dose Level 1||0
2898778|NCT00410423|3606423|FG000|STARTED|Phase 1 - Dose Level 2||0
2898779|NCT00410423|3606424|FG001|STARTED|Phase 1 - Dose Level 2||5
2898780|NCT00410423|3606425|FG002|STARTED|Phase 1 - Dose Level 2||0
2898781|NCT00410423|3606426|FG003|STARTED|Phase 1 - Dose Level 2||0
2898782|NCT00410423|3606423|FG000|COMPLETED|Phase 1 - Dose Level 2||0
2898783|NCT00410423|3606424|FG001|COMPLETED|Phase 1 - Dose Level 2||5
2898784|NCT00410423|3606425|FG002|COMPLETED|Phase 1 - Dose Level 2||0
2898785|NCT00410423|3606426|FG003|COMPLETED|Phase 1 - Dose Level 2||0
2898786|NCT00410423|3606423|FG000|NOT COMPLETED|Phase 1 - Dose Level 2||0
2898787|NCT00410423|3606424|FG001|NOT COMPLETED|Phase 1 - Dose Level 2||0
2898788|NCT00410423|3606425|FG002|NOT COMPLETED|Phase 1 - Dose Level 2||0
2898789|NCT00410423|3606426|FG003|NOT COMPLETED|Phase 1 - Dose Level 2||0
2898790|NCT00410423|3606423|FG000|STARTED|Phase 1 - Dose Level 3||0
2898791|NCT00410423|3606424|FG001|STARTED|Phase 1 - Dose Level 3||0
2898792|NCT00410423|3606425|FG002|STARTED|Phase 1 - Dose Level 3||3
2898793|NCT00410423|3606426|FG003|STARTED|Phase 1 - Dose Level 3||0
2898794|NCT00410423|3606423|FG000|COMPLETED|Phase 1 - Dose Level 3||0
2898795|NCT00410423|3606424|FG001|COMPLETED|Phase 1 - Dose Level 3||0
2898796|NCT00410423|3606425|FG002|COMPLETED|Phase 1 - Dose Level 3||3
2898797|NCT00410423|3606426|FG003|COMPLETED|Phase 1 - Dose Level 3||0
2898798|NCT00410423|3606423|FG000|NOT COMPLETED|Phase 1 - Dose Level 3||0
2898799|NCT00410423|3606424|FG001|NOT COMPLETED|Phase 1 - Dose Level 3||0
2898800|NCT00410423|3606425|FG002|NOT COMPLETED|Phase 1 - Dose Level 3||0
2898801|NCT00410423|3606426|FG003|NOT COMPLETED|Phase 1 - Dose Level 3||0
2898802|NCT00410423|3606423|FG000|STARTED|Phase 2||0
2898803|NCT00410423|3606424|FG001|STARTED|Phase 2||0
2898804|NCT00410423|3606425|FG002|STARTED|Phase 2||0
2898805|NCT00410423|3606426|FG003|STARTED|Phase 2||44
2898806|NCT00410423|3606423|FG000|COMPLETED|Phase 2||0
2898807|NCT00410423|3606424|FG001|COMPLETED|Phase 2||0
2898808|NCT00410423|3606425|FG002|COMPLETED|Phase 2||0
2898809|NCT00410423|3606426|FG003|COMPLETED|Phase 2||44
2898810|NCT00410423|3606423|FG000|NOT COMPLETED|Phase 2||0
2898811|NCT00410423|3606424|FG001|NOT COMPLETED|Phase 2||0
2898812|NCT00410423|3606425|FG002|NOT COMPLETED|Phase 2||0
2898813|NCT00410423|3606426|FG003|NOT COMPLETED|Phase 2||0
2898814|NCT00410488|3606435|FG000|STARTED|Overall Study||16
2898815|NCT00410488|3606436|FG001|STARTED|Overall Study||34
2898816|NCT00410488|3606435|FG000|COMPLETED|Overall Study||16
2898817|NCT00410488|3606436|FG001|COMPLETED|Overall Study||34
2898818|NCT00410488|3606435|FG000|NOT COMPLETED|Overall Study||0
2898819|NCT00410488|3606436|FG001|NOT COMPLETED|Overall Study||0
2898820|NCT00410514|3606444|FG000|STARTED|Overall Study||65
2898821|NCT00410514|3606445|FG001|STARTED|Overall Study||70
2898822|NCT00410514|3606446|FG002|STARTED|Overall Study||65
2898823|NCT00410514|3606444|FG000|Safety Analysis Set (SAF)|Overall Study|All patients who received at least 1 dose of double-blind study drug.|65
2898824|NCT00410514|3606445|FG001|Safety Analysis Set (SAF)|Overall Study|All patients who received at least 1 dose of double-blind study drug.|70
2898825|NCT00410514|3606446|FG002|Safety Analysis Set (SAF)|Overall Study|All patients who received at least 1 dose of double-blind study drug.|65
2898826|NCT00410514|3606444|FG000|Full Analysis Set (FAS)|Overall Study|SAF patients with both Qmax & PdetQmax measurements at baseline and 1 or both measured postbaseline.|63
2898827|NCT00410514|3606445|FG001|Full Analysis Set (FAS)|Overall Study|SAF patients with both Qmax & PdetQmax measurements at baseline and 1 or both measured postbaseline.|64
2898828|NCT00410514|3606446|FG002|Full Analysis Set (FAS)|Overall Study|SAF patients with both Qmax & PdetQmax measurements at baseline and 1 or both measured postbaseline.|58
2898829|NCT00410514|3606444|FG000|COMPLETED|Overall Study||63
2898830|NCT00410514|3606445|FG001|COMPLETED|Overall Study||67
2898831|NCT00410514|3606446|FG002|COMPLETED|Overall Study||58
2898832|NCT00410514|3606444|FG000|NOT COMPLETED|Overall Study||2
2898833|NCT00410514|3606445|FG001|NOT COMPLETED|Overall Study||3
2898834|NCT00410514|3606446|FG002|NOT COMPLETED|Overall Study||7
2898835|NCT00410605|3606454|FG000|STARTED|Overall Study||39
2898836|NCT00410605|3606454|FG000|COMPLETED|Overall Study||14
2898837|NCT00410605|3606454|FG000|NOT COMPLETED|Overall Study||25
2898838|NCT00410761|3606460|FG000|STARTED|Overall Study|randomised patients|231
2898839|NCT00410761|3606461|FG001|STARTED|Overall Study|randomised patients|100
2898840|NCT00410761|3606460|FG000|COMPLETED|Overall Study|ongoing study treatment at data cut-off|111
2898841|NCT00410761|3606461|FG001|COMPLETED|Overall Study|ongoing study treatment at data cut-off|28
2898842|NCT00410761|3606460|FG000|NOT COMPLETED|Overall Study||120
2898843|NCT00410761|3606461|FG001|NOT COMPLETED|Overall Study||72
2898844|NCT00410813|3606469|FG000|STARTED|Overall Study||43
2898845|NCT00410813|3606470|FG001|STARTED|Overall Study||42
2898846|NCT00410813|3606469|FG000|Eligible|Overall Study||41
2898847|NCT00410813|3606470|FG001|Eligible|Overall Study||38
2898848|NCT00410813|3606469|FG000|COMPLETED|Overall Study|Patients treated until progression.|0
2898849|NCT00410813|3606470|FG001|COMPLETED|Overall Study||0
2898850|NCT00410813|3606469|FG000|NOT COMPLETED|Overall Study||43
2898851|NCT00410813|3606470|FG001|NOT COMPLETED|Overall Study||42
2898852|NCT00410826|3606501|FG000|STARTED|Overall Study||105
2898853|NCT00410826|3606502|FG001|STARTED|Overall Study||99
2898854|NCT00410826|3606501|FG000|COMPLETED|Overall Study||96
2898855|NCT00410826|3606502|FG001|COMPLETED|Overall Study||95
2898856|NCT00410826|3606501|FG000|NOT COMPLETED|Overall Study||9
2898857|NCT00410826|3606502|FG001|NOT COMPLETED|Overall Study||4
2898858|NCT00410891|3606508|FG000|STARTED|Overall Study||129
2898859|NCT00410891|3606508|FG000|COMPLETED|Overall Study||129
2898860|NCT00410891|3606508|FG000|NOT COMPLETED|Overall Study||0
2898861|NCT00410904|3606514|FG000|STARTED|Overall Study||40
2898862|NCT00410904|3606515|FG001|STARTED|Overall Study||20
2898863|NCT00410904|3606514|FG000|COMPLETED|Overall Study||40
2898864|NCT00410904|3606515|FG001|COMPLETED|Overall Study||20
2898865|NCT00410904|3606514|FG000|NOT COMPLETED|Overall Study||0
2898866|NCT00410904|3606515|FG001|NOT COMPLETED|Overall Study||0
2898867|NCT00411086|3606522|FG000|STARTED|Overall Study||52
2898868|NCT00411086|3606522|FG000|COMPLETED|Overall Study||52
2898869|NCT00411086|3606522|FG000|NOT COMPLETED|Overall Study||0
2898870|NCT00411151|3606526|FG000|STARTED|Overall Study||52
2898871|NCT00411151|3606526|FG000|COMPLETED|Overall Study||5
2898872|NCT00411151|3606526|FG000|NOT COMPLETED|Overall Study||47
2898873|NCT00411216|3606532|FG000|STARTED|Overall Study||13
2898874|NCT00411216|3606533|FG001|STARTED|Overall Study||10
2898875|NCT00411216|3606532|FG000|COMPLETED|Overall Study||13
2898876|NCT00411216|3606533|FG001|COMPLETED|Overall Study||8
2898877|NCT00411216|3606532|FG000|NOT COMPLETED|Overall Study||0
2898878|NCT00411216|3606533|FG001|NOT COMPLETED|Overall Study||2
2898879|NCT00411398|3606539|FG000|STARTED|Overall Study||15
2898880|NCT00411398|3606539|FG000|COMPLETED|Overall Study||10
2898881|NCT00411398|3606539|FG000|NOT COMPLETED|Overall Study||5
2898882|NCT00411411|3606545|FG000|STARTED|Overall Study||24
2898883|NCT00411411|3606546|FG001|STARTED|Overall Study||25
2898884|NCT00411411|3606545|FG000|COMPLETED|Overall Study||24
2898885|NCT00411411|3606546|FG001|COMPLETED|Overall Study||25
2898886|NCT00411411|3606545|FG000|NOT COMPLETED|Overall Study||0
2898887|NCT00411411|3606546|FG001|NOT COMPLETED|Overall Study||0
2898888|NCT00411450|3606553|FG000|STARTED|Overall Study||116
2898889|NCT00411450|3606553|FG000|Received Treatment|Overall Study||115
2898890|NCT00411450|3606553|FG000|COMPLETED|Overall Study|Ended second-line treatment|113
2898891|NCT00411450|3606553|FG000|NOT COMPLETED|Overall Study||3
2898892|NCT00411463|3606561|FG000|STARTED|Overall Study||14
2898893|NCT00411463|3606562|FG001|STARTED|Overall Study||11
2898894|NCT00411463|3606561|FG000|COMPLETED|Overall Study||11
2898895|NCT00411463|3606562|FG001|COMPLETED|Overall Study||8
2898896|NCT00411463|3606561|FG000|NOT COMPLETED|Overall Study||3
2898897|NCT00411463|3606562|FG001|NOT COMPLETED|Overall Study||3
2898898|NCT00411554|3606573|FG000|STARTED|Overall Study|Study enrolled slightly more than the target of N=155|163
2898899|NCT00411554|3606574|FG001|STARTED|Overall Study|Study enrolled slightly more than the target of N=155|156
2898900|NCT00411554|3606573|FG000|COMPLETED|Overall Study||155
2898901|NCT00411554|3606574|FG001|COMPLETED|Overall Study||147
2898902|NCT00411554|3606573|FG000|NOT COMPLETED|Overall Study||8
2898903|NCT00411554|3606574|FG001|NOT COMPLETED|Overall Study||9
2898904|NCT00411619|3606580|FG000|STARTED|Overall Study||28
2898905|NCT00411619|3606580|FG000|COMPLETED|Overall Study||22
2898906|NCT00411619|3606580|FG000|NOT COMPLETED|Overall Study||6
2898907|NCT00411632|3606585|FG000|STARTED|Overall Study||37
2898908|NCT00411632|3606585|FG000|COMPLETED|Overall Study||36
2898909|NCT00411632|3606585|FG000|NOT COMPLETED|Overall Study||1
2898910|NCT00411645|3606591|FG000|STARTED|Overall Study||227
2898911|NCT00411645|3606592|FG001|STARTED|Overall Study||454
2898912|NCT00411645|3606591|FG000|COMPLETED|Overall Study||146
2898913|NCT00411645|3606592|FG001|COMPLETED|Overall Study||290
2898914|NCT00411645|3606591|FG000|NOT COMPLETED|Overall Study||81
2898915|NCT00411645|3606592|FG001|NOT COMPLETED|Overall Study||164
2898916|NCT00411671|3606599|FG000|STARTED|Overall Study||105
2898917|NCT00411671|3606599|FG000|COMPLETED|Overall Study||85
2898918|NCT00411671|3606599|FG000|NOT COMPLETED|Overall Study||20
2898919|NCT00411684|3606603|FG000|STARTED|Overall Study||1533
2898920|NCT00411684|3606603|FG000|COMPLETED|Overall Study||1241
3171063|NCT01932437|3898303|FG002|COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
3171064|NCT01932437|3898304|FG003|COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||6
3171065|NCT01932437|3898305|FG004|COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
3171066|NCT01932437|3898306|FG005|COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
3171067|NCT01932437|3898301|FG000|NOT COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
3171068|NCT01932437|3898302|FG001|NOT COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
3171069|NCT01932437|3898303|FG002|NOT COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
3171070|NCT01932437|3898304|FG003|NOT COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
2898921|NCT00411684|3606603|FG000|NOT COMPLETED|Overall Study||292
2898922|NCT00411749|3606609|FG000|STARTED|Overall Study||82
2898923|NCT00411749|3606610|FG001|STARTED|Overall Study||25
2898924|NCT00411749|3606609|FG000|Vaccinated|Overall Study||82
2898925|NCT00411749|3606610|FG001|Vaccinated|Overall Study||25
2898926|NCT00411749|3606609|FG000|COMPLETED|Overall Study|Completed at 24 month after vaccination series (Month 30). Subjects were followed until Month 30|82
2898927|NCT00411749|3606610|FG001|COMPLETED|Overall Study|Completed at 1 month after vaccination series (Month 7). Subjects were followed until Month 7|25
2898928|NCT00411749|3606609|FG000|NOT COMPLETED|Overall Study||0
2898929|NCT00411749|3606610|FG001|NOT COMPLETED|Overall Study||0
2898930|NCT00411762|3606620|FG000|STARTED|Overall Study||25
2898931|NCT00411762|3606620|FG000|COMPLETED|Overall Study||20
2898932|NCT00411762|3606620|FG000|NOT COMPLETED|Overall Study||5
2898933|NCT00411788|3606624|FG000|STARTED|Overall Study||11
2898934|NCT00411788|3606624|FG000|COMPLETED|Overall Study||9
2898935|NCT00411788|3606624|FG000|NOT COMPLETED|Overall Study||2
2898936|NCT00412061|3606630|FG000|STARTED|Double Blind Phase||216
2898937|NCT00412061|3606631|FG001|STARTED|Double Blind Phase||213
2898938|NCT00412061|3606630|FG000|Safety Set|Double Blind Phase|1 patient did not provide at laest one valid post baseline safety assessment.|215
3171071|NCT01932437|3898305|FG004|NOT COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
3171072|NCT01932437|3898306|FG005|NOT COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
3171073|NCT01932437|3898301|FG000|STARTED|Cohort 4 - ETI-204 20 mg/kg or Placebo||2
3171074|NCT01932437|3898302|FG001|STARTED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
2898939|NCT00412061|3606631|FG001|Safety Set|Double Blind Phase|1 pt randomized never took drug Another randomized did not have valid post BL safety assessment|211
2898940|NCT00412061|3606630|FG000|COMPLETED|Double Blind Phase||0
2898941|NCT00412061|3606631|FG001|COMPLETED|Double Blind Phase||0
2898942|NCT00412061|3606630|FG000|NOT COMPLETED|Double Blind Phase||216
2898943|NCT00412061|3606631|FG001|NOT COMPLETED|Double Blind Phase||213
2898944|NCT00412061|3606630|FG000|STARTED|Open Label Phase||0
2898945|NCT00412061|3606631|FG001|STARTED|Open Label Phase||170
2898946|NCT00412061|3606630|FG000|COMPLETED|Open Label Phase||0
2898947|NCT00412061|3606631|FG001|COMPLETED|Open Label Phase||0
2898948|NCT00412061|3606630|FG000|NOT COMPLETED|Open Label Phase||0
2898949|NCT00412061|3606631|FG001|NOT COMPLETED|Open Label Phase||170
2898950|NCT00412074|3606643|FG000|STARTED|Overall Study||199
2898951|NCT00412074|3606644|FG001|STARTED|Overall Study||66
2898952|NCT00412074|3606645|FG002|STARTED|Overall Study||195
2898953|NCT00412074|3606643|FG000|COMPLETED|Overall Study||122
2898954|NCT00412074|3606644|FG001|COMPLETED|Overall Study||44
2898955|NCT00412074|3606645|FG002|COMPLETED|Overall Study||128
2898956|NCT00412074|3606643|FG000|NOT COMPLETED|Overall Study||77
2898957|NCT00412074|3606644|FG001|NOT COMPLETED|Overall Study||22
2898958|NCT00412074|3606645|FG002|NOT COMPLETED|Overall Study||67
2898959|NCT00412087|3606658|FG000|STARTED|Overall Study||134
2898960|NCT00412087|3606659|FG001|STARTED|Overall Study||131
2898961|NCT00412087|3606658|FG000|COMPLETED|Overall Study||72
2898962|NCT00412087|3606659|FG001|COMPLETED|Overall Study||66
2898963|NCT00412087|3606658|FG000|NOT COMPLETED|Overall Study||62
2898964|NCT00412087|3606659|FG001|NOT COMPLETED|Overall Study||65
2898965|NCT00412113|3606667|FG000|STARTED|Overall Study|15-January-2007|123
2898966|NCT00412113|3606668|FG001|STARTED|Overall Study|15-January-2007|122
2898967|NCT00412113|3606667|FG000|Received Treatment|Overall Study|One subject assigned to Norvasc and TLC did not receive treatment and was excluded from all analyses|122
2898968|NCT00412113|3606668|FG001|Received Treatment|Overall Study||122
2898969|NCT00412113|3606667|FG000|COMPLETED|Overall Study|15-April-2008|111
2898970|NCT00412113|3606668|FG001|COMPLETED|Overall Study|15-April-2008|107
2898971|NCT00412113|3606667|FG000|NOT COMPLETED|Overall Study||12
2898972|NCT00412113|3606668|FG001|NOT COMPLETED|Overall Study||15
2898973|NCT00412217|3606676|FG000|STARTED|Overall Study||46
2898974|NCT00412217|3606677|FG001|STARTED|Overall Study||48
2898975|NCT00412217|3606676|FG000|COMPLETED|Overall Study||0
2898976|NCT00412217|3606677|FG001|COMPLETED|Overall Study||0
2898977|NCT00412217|3606676|FG000|NOT COMPLETED|Overall Study||46
2898978|NCT00412217|3606677|FG001|NOT COMPLETED|Overall Study||48
2898979|NCT00412243|3606683|FG000|STARTED|Overall Study||50
2898980|NCT00412243|3606683|FG000|COMPLETED|Overall Study||50
2898981|NCT00412243|3606683|FG000|NOT COMPLETED|Overall Study||0
2898982|NCT00412360|3606689|FG000|STARTED|Overall Study||113
2898983|NCT00412360|3606690|FG001|STARTED|Overall Study||111
2898984|NCT00412360|3606689|FG000|COMPLETED|Overall Study||112
2898985|NCT00412360|3606690|FG001|COMPLETED|Overall Study||108
2898986|NCT00412360|3606689|FG000|NOT COMPLETED|Overall Study||1
2898987|NCT00412360|3606690|FG001|NOT COMPLETED|Overall Study||3
2898988|NCT00412373|3606698|FG000|STARTED|Overall Study|Number of Subjects in Intent-to-Treat Analysis Set.|93
2898989|NCT00412373|3606699|FG001|STARTED|Overall Study|Number of Subjects Intent-to-Treat Analysis Set.|211
2898990|NCT00412373|3606698|FG000|COMPLETED|Overall Study|Number of Subjects Who Completed Double-Blind Treatment.|52
2898991|NCT00412373|3606699|FG001|COMPLETED|Overall Study|Number of Subjects Who Completed Double-Blind Treatment..|134
2898992|NCT00412373|3606698|FG000|NOT COMPLETED|Overall Study||41
2898993|NCT00412373|3606699|FG001|NOT COMPLETED|Overall Study||77
2898994|NCT00412425|3606707|FG000|STARTED|Overall Study||15
2898995|NCT00412425|3606708|FG001|STARTED|Overall Study||15
2898996|NCT00412425|3606707|FG000|COMPLETED|Overall Study||15
2898997|NCT00412425|3606708|FG001|COMPLETED|Overall Study||15
2898998|NCT00412425|3606707|FG000|NOT COMPLETED|Overall Study||0
2898999|NCT00412425|3606708|FG001|NOT COMPLETED|Overall Study||0
2899000|NCT00412451|3606718|FG000|STARTED|Overall Study||8
2899001|NCT00412451|3606719|FG001|STARTED|Overall Study||15
2899002|NCT00412451|3606720|FG002|STARTED|Overall Study||15
2899003|NCT00412451|3606721|FG003|STARTED|Overall Study||13
2899004|NCT00412451|3606718|FG000|COMPLETED|Overall Study||8
2899005|NCT00412451|3606719|FG001|COMPLETED|Overall Study||15
2899006|NCT00412451|3606720|FG002|COMPLETED|Overall Study||14
2899007|NCT00412451|3606721|FG003|COMPLETED|Overall Study||11
2899008|NCT00412451|3606718|FG000|NOT COMPLETED|Overall Study||0
2899009|NCT00412451|3606719|FG001|NOT COMPLETED|Overall Study||0
2899010|NCT00412451|3606720|FG002|NOT COMPLETED|Overall Study||1
2899011|NCT00412451|3606721|FG003|NOT COMPLETED|Overall Study||2
2899012|NCT00412464|3606731|FG000|STARTED|Overall Study|Age Groups: 1-5 Years (10); 6-12 Years (7); 13-18 years (7)|24
2899013|NCT00412464|3606731|FG000|COMPLETED|Overall Study|Age Groups: 1-5 Years (10); 6-12 Years (7); 13-18 years (7)|24
2899014|NCT00412464|3606731|FG000|NOT COMPLETED|Overall Study||0
2899015|NCT00412516|3606738|FG000|STARTED|Overall Study||93
2899016|NCT00412516|3606739|FG001|STARTED|Overall Study||212
2899017|NCT00412516|3606740|FG002|STARTED|Overall Study||214
2899018|NCT00412516|3606738|FG000|COMPLETED|Overall Study||93
2899019|NCT00412516|3606739|FG001|COMPLETED|Overall Study||212
2899020|NCT00412516|3606740|FG002|COMPLETED|Overall Study||214
2899021|NCT00412516|3606738|FG000|NOT COMPLETED|Overall Study||0
2899022|NCT00412516|3606739|FG001|NOT COMPLETED|Overall Study||0
2899023|NCT00412516|3606740|FG002|NOT COMPLETED|Overall Study||0
2899024|NCT00412529|3606750|FG000|STARTED|Overall Study||23
2899025|NCT00412529|3606751|FG001|STARTED|Overall Study||21
2899026|NCT00412529|3606750|FG000|COMPLETED|Overall Study||23
2899027|NCT00412529|3606751|FG001|COMPLETED|Overall Study||21
2899028|NCT00412529|3606750|FG000|NOT COMPLETED|Overall Study||0
2899029|NCT00412529|3606751|FG001|NOT COMPLETED|Overall Study||0
2899030|NCT00412542|3606759|FG000|STARTED|Overall Study||33
2899031|NCT00412542|3606760|FG001|STARTED|Overall Study||45
2899032|NCT00412542|3606759|FG000|COMPLETED|Overall Study||33
2899033|NCT00412542|3606760|FG001|COMPLETED|Overall Study||42
2899034|NCT00412542|3606759|FG000|NOT COMPLETED|Overall Study||0
2899035|NCT00412542|3606760|FG001|NOT COMPLETED|Overall Study||3
2899036|NCT00412607|3606764|FG000|STARTED|Overall Study||249
2899037|NCT00412607|3606764|FG000|Started Study Catheter|Overall Study||233
2899038|NCT00412607|3606764|FG000|COMPLETED|Overall Study||145
2899039|NCT00412607|3606764|FG000|NOT COMPLETED|Overall Study||104
2899040|NCT00412737|3606773|FG000|STARTED|Overall Study||237
2899041|NCT00412737|3606774|FG001|STARTED|Overall Study||238
2899042|NCT00412737|3606773|FG000|COMPLETED|Overall Study||221
2899043|NCT00412737|3606774|FG001|COMPLETED|Overall Study||232
2899044|NCT00412737|3606773|FG000|NOT COMPLETED|Overall Study||16
2899045|NCT00412737|3606774|FG001|NOT COMPLETED|Overall Study||6
2899046|NCT00412750|3606783|FG000|STARTED|Overall Study||50
2899047|NCT00412750|3606784|FG001|STARTED|Overall Study||55
2899048|NCT00412750|3606785|FG002|STARTED|Overall Study||54
2899049|NCT00412750|3606783|FG000|COMPLETED|Overall Study||19
2899050|NCT00412750|3606784|FG001|COMPLETED|Overall Study||34
2899051|NCT00412750|3606785|FG002|COMPLETED|Overall Study||31
2899052|NCT00412750|3606783|FG000|NOT COMPLETED|Overall Study||31
2899053|NCT00412750|3606784|FG001|NOT COMPLETED|Overall Study||21
2899054|NCT00412750|3606785|FG002|NOT COMPLETED|Overall Study||23
2899055|NCT00412841|3606797|FG000|STARTED|Overall Study||22
2899056|NCT00412841|3606798|FG001|STARTED|Overall Study||21
2899057|NCT00412841|3606797|FG000|COMPLETED|Overall Study||12
2899058|NCT00412841|3606798|FG001|COMPLETED|Overall Study||16
2899059|NCT00412841|3606797|FG000|NOT COMPLETED|Overall Study||10
2899060|NCT00412841|3606798|FG001|NOT COMPLETED|Overall Study||5
2899061|NCT00412854|3606807|FG000|STARTED|Overall Study||330
2899062|NCT00412854|3606808|FG001|STARTED|Overall Study||330
2899063|NCT00412854|3606807|FG000|COMPLETED|Overall Study||316
2899064|NCT00412854|3606808|FG001|COMPLETED|Overall Study||314
2899065|NCT00412854|3606807|FG000|NOT COMPLETED|Overall Study||14
2899066|NCT00412854|3606808|FG001|NOT COMPLETED|Overall Study||16
2899067|NCT00412867|3606814|FG000|STARTED|Overall Study||58
2899068|NCT00412867|3606814|FG000|COMPLETED|Overall Study||58
2899069|NCT00412867|3606814|FG000|NOT COMPLETED|Overall Study||0
2899070|NCT00412893|3606821|FG000|STARTED|Overall Study||263
2899071|NCT00412893|3606822|FG001|STARTED|Overall Study||264
2899072|NCT00412893|3606821|FG000|Received Treatment|Overall Study|One participant randomized to this group received voriconazole treatment for the first 7 days|258
2899073|NCT00412893|3606822|FG001|Received Treatment|Overall Study||258
2899074|NCT00412893|3606821|FG000|COMPLETED|Overall Study|Defined as completed treatment|118
2899075|NCT00412893|3606822|FG001|COMPLETED|Overall Study|Defined as completed treatment|120
2899076|NCT00412893|3606821|FG000|NOT COMPLETED|Overall Study||145
2899077|NCT00412893|3606822|FG001|NOT COMPLETED|Overall Study||144
2899078|NCT00412958|3606832|FG000|STARTED|Overall Study||29
2899079|NCT00412958|3606833|FG001|STARTED|Overall Study||33
2899080|NCT00412958|3606834|FG002|STARTED|Overall Study||32
2899081|NCT00412958|3606835|FG003|STARTED|Overall Study||31
2899082|NCT00412958|3606832|FG000|COMPLETED|Overall Study||26
2899083|NCT00412958|3606833|FG001|COMPLETED|Overall Study||29
2899084|NCT00412958|3606834|FG002|COMPLETED|Overall Study||32
2899085|NCT00412958|3606835|FG003|COMPLETED|Overall Study||30
2899086|NCT00412958|3606832|FG000|NOT COMPLETED|Overall Study||3
2899087|NCT00412958|3606833|FG001|NOT COMPLETED|Overall Study||4
2899088|NCT00412958|3606834|FG002|NOT COMPLETED|Overall Study||0
2899089|NCT00412958|3606835|FG003|NOT COMPLETED|Overall Study||1
2899090|NCT00412971|3606847|FG000|STARTED|Overall Study||115
2899091|NCT00412971|3606848|FG001|STARTED|Overall Study||118
2899092|NCT00412971|3606847|FG000|COMPLETED|Overall Study||85
2899093|NCT00412971|3606848|FG001|COMPLETED|Overall Study||108
2899094|NCT00412971|3606847|FG000|NOT COMPLETED|Overall Study||30
2899095|NCT00412971|3606848|FG001|NOT COMPLETED|Overall Study||10
2899096|NCT00412984|3606856|FG000|STARTED|Overall Study|Randomized participants|9120
2899097|NCT00412984|3606857|FG001|STARTED|Overall Study|Randomized participants|9081
2899098|NCT00412984|3606856|FG000|COMPLETED|Overall Study||6810
2899099|NCT00412984|3606857|FG001|COMPLETED|Overall Study||6588
2899100|NCT00412984|3606856|FG000|NOT COMPLETED|Overall Study||2310
2899101|NCT00412984|3606857|FG001|NOT COMPLETED|Overall Study||2493
2899102|NCT00413010|3606865|FG000|STARTED|Overall Study||180
2899103|NCT00413010|3606866|FG001|STARTED|Overall Study||176
2899104|NCT00413010|3606865|FG000|COMPLETED|Overall Study||108
2899105|NCT00413010|3606866|FG001|COMPLETED|Overall Study||113
2899106|NCT00413010|3606865|FG000|NOT COMPLETED|Overall Study||72
2899107|NCT00413010|3606866|FG001|NOT COMPLETED|Overall Study||63
2899108|NCT00413036|3606872|FG000|STARTED|Overall Study||217
2899109|NCT00413036|3606872|FG000|COMPLETED|Overall Study|Participants remain on study drug until progressive disease or unacceptable adverse events develop.|0
2899110|NCT00413036|3606872|FG000|NOT COMPLETED|Overall Study||217
2899111|NCT00413049|3606878|FG000|STARTED|Overall Study||349
2899112|NCT00413049|3606879|FG001|STARTED|Overall Study||349
2899113|NCT00413049|3606878|FG000|COMPLETED|Overall Study||325
2899114|NCT00413049|3606879|FG001|COMPLETED|Overall Study||331
2899115|NCT00413049|3606878|FG000|NOT COMPLETED|Overall Study||24
2899116|NCT00413049|3606879|FG001|NOT COMPLETED|Overall Study||18
2920057|NCT00535236|3630483|FG001|COMPLETED|Overall Study||8
2920058|NCT00535236|3630484|FG002|COMPLETED|Overall Study||29
2920059|NCT00535236|3630485|FG003|COMPLETED|Overall Study||6
2920060|NCT00535236|3630486|FG004|COMPLETED|Overall Study||47
2920061|NCT00535236|3630487|FG005|COMPLETED|Overall Study||19
2920062|NCT00535236|3630488|FG006|COMPLETED|Overall Study||51
2920063|NCT00535236|3630489|FG007|COMPLETED|Overall Study||18
2920064|NCT00535236|3630490|FG008|COMPLETED|Overall Study||47
2920065|NCT00535236|3630491|FG009|COMPLETED|Overall Study||16
2920066|NCT00535236|3630482|FG000|NOT COMPLETED|Overall Study||7
2920067|NCT00535236|3630483|FG001|NOT COMPLETED|Overall Study||2
2920068|NCT00535236|3630484|FG002|NOT COMPLETED|Overall Study||12
2920069|NCT00535236|3630485|FG003|NOT COMPLETED|Overall Study||4
2920070|NCT00535236|3630486|FG004|NOT COMPLETED|Overall Study||12
2920071|NCT00535236|3630487|FG005|NOT COMPLETED|Overall Study||1
2920072|NCT00535236|3630488|FG006|NOT COMPLETED|Overall Study||11
2920073|NCT00535236|3630489|FG007|NOT COMPLETED|Overall Study||1
2920074|NCT00535236|3630490|FG008|NOT COMPLETED|Overall Study||13
2920075|NCT00535236|3630491|FG009|NOT COMPLETED|Overall Study||4
2920076|NCT00535288|3630521|FG000|STARTED|Overall Study|2 participants randomized to receive placebo did not receive placebo|314
2920077|NCT00535288|3630522|FG001|STARTED|Overall Study||162
2920078|NCT00535288|3630523|FG002|STARTED|Overall Study||160
2920079|NCT00535288|3630524|FG003|STARTED|Overall Study||151
2920080|NCT00535288|3630525|FG004|STARTED|Overall Study|One participant randomized to receive placebo received esmirtazapine 18 mg.|158
2920081|NCT00535288|3630521|FG000|COMPLETED|Overall Study||260
2920082|NCT00535288|3630522|FG001|COMPLETED|Overall Study||130
2920083|NCT00535288|3630523|FG002|COMPLETED|Overall Study||127
2920084|NCT00535288|3630524|FG003|COMPLETED|Overall Study||122
2920085|NCT00535288|3630525|FG004|COMPLETED|Overall Study||116
2920086|NCT00535288|3630521|FG000|NOT COMPLETED|Overall Study||54
2920087|NCT00535288|3630522|FG001|NOT COMPLETED|Overall Study||32
2920088|NCT00535288|3630523|FG002|NOT COMPLETED|Overall Study||33
2920089|NCT00535288|3630524|FG003|NOT COMPLETED|Overall Study||29
2920090|NCT00535288|3630525|FG004|NOT COMPLETED|Overall Study||42
2920091|NCT00535301|3630544|FG000|STARTED|Overall Study||38
2920092|NCT00535301|3630545|FG001|STARTED|Overall Study||38
2920093|NCT00535301|3630544|FG000|COMPLETED|Overall Study||33
2920094|NCT00535301|3630545|FG001|COMPLETED|Overall Study||33
2920095|NCT00535301|3630544|FG000|NOT COMPLETED|Overall Study||5
2920096|NCT00535301|3630545|FG001|NOT COMPLETED|Overall Study||5
2920097|NCT00535392|3630553|FG000|STARTED|Overall Study||33
2920098|NCT00535392|3630553|FG000|COMPLETED|Overall Study||33
2920099|NCT00535392|3630553|FG000|NOT COMPLETED|Overall Study||0
2920100|NCT00535496|3630559|FG000|STARTED|Overall Study||15
2920101|NCT00535496|3630560|FG001|STARTED|Overall Study||15
2920102|NCT00535496|3630561|FG002|STARTED|Overall Study||30
2920103|NCT00535496|3630562|FG003|STARTED|Overall Study||31
2920104|NCT00535496|3630559|FG000|All-Subjects-Treated (AST) Group|Overall Study||15
2920105|NCT00535496|3630560|FG001|All-Subjects-Treated (AST) Group|Overall Study||14
2920106|NCT00535496|3630561|FG002|All-Subjects-Treated (AST) Group|Overall Study||30
2920107|NCT00535496|3630562|FG003|All-Subjects-Treated (AST) Group|Overall Study||31
2920108|NCT00535496|3630559|FG000|COMPLETED|Overall Study||15
2920109|NCT00535496|3630560|FG001|COMPLETED|Overall Study||13
2920110|NCT00535496|3630561|FG002|COMPLETED|Overall Study||30
2920111|NCT00535496|3630562|FG003|COMPLETED|Overall Study||31
2920112|NCT00535496|3630559|FG000|NOT COMPLETED|Overall Study||0
2920113|NCT00535496|3630560|FG001|NOT COMPLETED|Overall Study||2
2920114|NCT00535496|3630561|FG002|NOT COMPLETED|Overall Study||0
2920115|NCT00535496|3630562|FG003|NOT COMPLETED|Overall Study||0
2920116|NCT00535587|3630573|FG000|STARTED|Overall Study||53
2920117|NCT00535587|3630574|FG001|STARTED|Overall Study||53
2920118|NCT00535587|3630575|FG002|STARTED|Overall Study||47
2920119|NCT00535587|3630576|FG003|STARTED|Overall Study||54
2920120|NCT00535587|3630573|FG000|COMPLETED|Overall Study||43
2920121|NCT00535587|3630574|FG001|COMPLETED|Overall Study||42
2899117|NCT00413153|3606887|FG000|STARTED|Overall Study||7
2899118|NCT00413153|3606888|FG001|STARTED|Overall Study||8
2899119|NCT00413153|3606887|FG000|COMPLETED|Overall Study||5
2899120|NCT00413153|3606888|FG001|COMPLETED|Overall Study||7
2899121|NCT00413153|3606887|FG000|NOT COMPLETED|Overall Study||2
2899122|NCT00413153|3606888|FG001|NOT COMPLETED|Overall Study||1
2899123|NCT00413166|3606897|FG000|STARTED|Overall Study||57
2899124|NCT00413166|3606898|FG001|STARTED|Overall Study||5
2899125|NCT00413166|3606899|FG002|STARTED|Overall Study||16
3171075|NCT01932437|3898303|FG002|STARTED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
3171076|NCT01932437|3898304|FG003|STARTED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
3171077|NCT01932437|3898305|FG004|STARTED|Cohort 4 - ETI-204 20 mg/kg or Placebo||6
2899126|NCT00413166|3606897|FG000|COMPLETED|Overall Study||57
2899127|NCT00413166|3606898|FG001|COMPLETED|Overall Study||5
2899128|NCT00413166|3606899|FG002|COMPLETED|Overall Study||16
2899129|NCT00413166|3606897|FG000|NOT COMPLETED|Overall Study||0
2899130|NCT00413166|3606898|FG001|NOT COMPLETED|Overall Study||0
2899131|NCT00413166|3606899|FG002|NOT COMPLETED|Overall Study||0
2899132|NCT00413192|3606911|FG000|STARTED|Overall Study||37
2899133|NCT00413192|3606912|FG001|STARTED|Overall Study||40
2899134|NCT00413192|3606913|FG002|STARTED|Overall Study||19
2899135|NCT00413192|3606914|FG003|STARTED|Overall Study||32
2899136|NCT00413192|3606911|FG000|COMPLETED|Overall Study||0
2899137|NCT00413192|3606912|FG001|COMPLETED|Overall Study||0
2899138|NCT00413192|3606913|FG002|COMPLETED|Overall Study||0
2899139|NCT00413192|3606914|FG003|COMPLETED|Overall Study||0
2899140|NCT00413192|3606911|FG000|NOT COMPLETED|Overall Study||37
2899141|NCT00413192|3606912|FG001|NOT COMPLETED|Overall Study||40
2899142|NCT00413192|3606913|FG002|NOT COMPLETED|Overall Study||19
2899143|NCT00413192|3606914|FG003|NOT COMPLETED|Overall Study||32
2899144|NCT00413218|3606926|FG000|STARTED|Overall Study||223
2899145|NCT00413218|3606927|FG001|STARTED|Overall Study||227
2899146|NCT00413218|3606926|FG000|Intent to Treat Population (ITT)|Overall Study||221
2899147|NCT00413218|3606927|FG001|Intent to Treat Population (ITT)|Overall Study||219
2899148|NCT00413218|3606926|FG000|COMPLETED|Overall Study||120
2899149|NCT00413218|3606927|FG001|COMPLETED|Overall Study||131
2899150|NCT00413218|3606926|FG000|NOT COMPLETED|Overall Study||103
2899151|NCT00413218|3606927|FG001|NOT COMPLETED|Overall Study||96
2899152|NCT00413231|3606934|FG000|STARTED|0 to 30-day Post Treatment||160
2899153|NCT00413231|3606934|FG000|COMPLETED|0 to 30-day Post Treatment||152
2899154|NCT00413231|3606934|FG000|NOT COMPLETED|0 to 30-day Post Treatment||8
2899155|NCT00413231|3606934|FG000|STARTED|30-day to 365-day Post Treatment||152
2899156|NCT00413231|3606934|FG000|COMPLETED|30-day to 365-day Post Treatment||139
2899157|NCT00413231|3606934|FG000|NOT COMPLETED|30-day to 365-day Post Treatment||13
2899158|NCT00413231|3606934|FG000|STARTED|365-day to 60-month Post Treatment||139
2899159|NCT00413231|3606934|FG000|COMPLETED|365-day to 60-month Post Treatment||93
2899160|NCT00413231|3606934|FG000|NOT COMPLETED|365-day to 60-month Post Treatment||46
2899161|NCT00413244|3606941|FG000|STARTED|Overall Study||31
2899162|NCT00413244|3606942|FG001|STARTED|Overall Study||20
2899163|NCT00413244|3606941|FG000|COMPLETED|Overall Study||21
2899164|NCT00413244|3606942|FG001|COMPLETED|Overall Study||19
2899165|NCT00413244|3606941|FG000|NOT COMPLETED|Overall Study||10
2899166|NCT00413244|3606942|FG001|NOT COMPLETED|Overall Study||1
2899167|NCT00413283|3606952|FG000|STARTED|Overall Study||12
2899168|NCT00413283|3606953|FG001|STARTED|Overall Study||16
2899169|NCT00413283|3606954|FG002|STARTED|Overall Study||18
2899170|NCT00413283|3606955|FG003|STARTED|Overall Study||17
2899171|NCT00413283|3606952|FG000|Received Study Drug|Overall Study||12
3171078|NCT01932437|3898306|FG005|STARTED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
3171079|NCT01932437|3898301|FG000|COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||2
3171080|NCT01932437|3898302|FG001|COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
3171081|NCT01932437|3898303|FG002|COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
3171082|NCT01932437|3898304|FG003|COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
3171083|NCT01932437|3898305|FG004|COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||6
3171084|NCT01932437|3898306|FG005|COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
3171085|NCT01932437|3898301|FG000|NOT COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
2899172|NCT00413283|3606953|FG001|Received Study Drug|Overall Study||16
2899173|NCT00413283|3606954|FG002|Received Study Drug|Overall Study||18
2899174|NCT00413283|3606955|FG003|Received Study Drug|Overall Study||16
2899175|NCT00413283|3606952|FG000|COMPLETED|Overall Study||11
2899176|NCT00413283|3606953|FG001|COMPLETED|Overall Study||13
2899177|NCT00413283|3606954|FG002|COMPLETED|Overall Study||16
2899178|NCT00413283|3606955|FG003|COMPLETED|Overall Study||13
2899179|NCT00413283|3606952|FG000|NOT COMPLETED|Overall Study||1
2899180|NCT00413283|3606953|FG001|NOT COMPLETED|Overall Study||3
2899181|NCT00413283|3606954|FG002|NOT COMPLETED|Overall Study||2
2899182|NCT00413283|3606955|FG003|NOT COMPLETED|Overall Study||4
2899183|NCT00413335|3606967|FG000|STARTED|Overall Study||12
2899184|NCT00413335|3606968|FG001|STARTED|Overall Study||9
2899185|NCT00413335|3606967|FG000|COMPLETED|Overall Study||12
2899186|NCT00413335|3606968|FG001|COMPLETED|Overall Study||9
2899187|NCT00413335|3606967|FG000|NOT COMPLETED|Overall Study||0
2899188|NCT00413335|3606968|FG001|NOT COMPLETED|Overall Study||0
2899189|NCT00413374|3606976|FG000|STARTED|Overall Study||40
2899190|NCT00413374|3606977|FG001|STARTED|Overall Study||80
2899191|NCT00413374|3606976|FG000|COMPLETED|Overall Study||34
2899192|NCT00413374|3606977|FG001|COMPLETED|Overall Study||80
2899193|NCT00413374|3606976|FG000|NOT COMPLETED|Overall Study||6
2899194|NCT00413374|3606977|FG001|NOT COMPLETED|Overall Study||0
2899195|NCT00413400|3606988|FG000|STARTED|Overall Study||24
2899196|NCT00413400|3606989|FG001|STARTED|Overall Study||16
2899197|NCT00413400|3606988|FG000|3 Month Visit|Overall Study||22
2899198|NCT00413400|3606989|FG001|3 Month Visit|Overall Study||12
2899199|NCT00413400|3606988|FG000|COMPLETED|Overall Study||22
2899200|NCT00413400|3606989|FG001|COMPLETED|Overall Study||12
2899201|NCT00413400|3606988|FG000|NOT COMPLETED|Overall Study||2
2899202|NCT00413400|3606989|FG001|NOT COMPLETED|Overall Study||4
2899203|NCT00413413|3606998|FG000|STARTED|Single-Blind|In single-blind period participants were only enrolled to Valsartan 80 mg arm.|0
2899204|NCT00413413|3606999|FG001|STARTED|Single-Blind||1134
2899205|NCT00413413|3607000|FG002|STARTED|Single-Blind|In single-blind period participants were only enrolled to Valsartan 80 mg arm.|0
2899206|NCT00413413|3606998|FG000|COMPLETED|Single-Blind||0
2899207|NCT00413413|3606999|FG001|COMPLETED|Single-Blind||918
2899208|NCT00413413|3607000|FG002|COMPLETED|Single-Blind||0
2899209|NCT00413413|3606998|FG000|NOT COMPLETED|Single-Blind||0
2899210|NCT00413413|3606999|FG001|NOT COMPLETED|Single-Blind||216
2899211|NCT00413413|3607000|FG002|NOT COMPLETED|Single-Blind||0
2899212|NCT00413413|3606998|FG000|STARTED|Double-Blind||308
2899213|NCT00413413|3606999|FG001|STARTED|Double-Blind||307
2899214|NCT00413413|3607000|FG002|STARTED|Double-Blind||303
2899215|NCT00413413|3606998|FG000|COMPLETED|Double-Blind||293
2899216|NCT00413413|3606999|FG001|COMPLETED|Double-Blind||293
2899217|NCT00413413|3607000|FG002|COMPLETED|Double-Blind||285
2899218|NCT00413413|3606998|FG000|NOT COMPLETED|Double-Blind||15
2899219|NCT00413413|3606999|FG001|NOT COMPLETED|Double-Blind||14
2899220|NCT00413413|3607000|FG002|NOT COMPLETED|Double-Blind||18
2899221|NCT00413478|3607008|FG000|STARTED|Overall Study||9
2899222|NCT00413478|3607008|FG000|COMPLETED|Overall Study||9
2899223|NCT00413478|3607008|FG000|NOT COMPLETED|Overall Study||0
2899224|NCT00413582|3607014|FG000|STARTED|Overall Study|all enrolled completed|55
2899225|NCT00413582|3607015|FG001|STARTED|Overall Study|all enrolled completed|55
2899226|NCT00413582|3607014|FG000|Completion of Study|Overall Study|all enrolled completed|55
2899227|NCT00413582|3607015|FG001|Completion of Study|Overall Study|all enrolled completed|55
2899228|NCT00413582|3607014|FG000|COMPLETED|Overall Study|all enrolled completed|55
2899229|NCT00413582|3607015|FG001|COMPLETED|Overall Study|all enrolled completed|55
2899230|NCT00413582|3607014|FG000|NOT COMPLETED|Overall Study||0
2899231|NCT00413582|3607015|FG001|NOT COMPLETED|Overall Study||0
3171086|NCT01932437|3898302|FG001|NOT COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
3171087|NCT01932437|3898303|FG002|NOT COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
3171088|NCT01932437|3898304|FG003|NOT COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
3171089|NCT01932437|3898305|FG004|NOT COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
3171090|NCT01932437|3898306|FG005|NOT COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
3171091|NCT01932437|3898301|FG000|STARTED|Cohort 5 - ETI-204 24 mg/kg or Placebo||2
2899232|NCT00413634|3607023|FG000|STARTED|Overall Study||12
2899233|NCT00413634|3607024|FG001|STARTED|Overall Study||12
2899234|NCT00413634|3607023|FG000|COMPLETED|Overall Study||12
2899235|NCT00413634|3607024|FG001|COMPLETED|Overall Study||12
2899236|NCT00413634|3607023|FG000|NOT COMPLETED|Overall Study||0
2899237|NCT00413634|3607024|FG001|NOT COMPLETED|Overall Study||0
2899238|NCT00413660|3607039|FG000|STARTED|Up To Week 12||71
2899239|NCT00413660|3607040|FG001|STARTED|Up To Week 12||68
2899240|NCT00413660|3607041|FG002|STARTED|Up To Week 12||71
2899241|NCT00413660|3607042|FG003|STARTED|Up To Week 12||75
2899242|NCT00413660|3607043|FG004|STARTED|Up To Week 12||75
2899243|NCT00413660|3607044|FG005|STARTED|Up To Week 12||80
2899244|NCT00413660|3607045|FG006|STARTED|Up To Week 12||69
2899245|NCT00413660|3607046|FG007|STARTED|Up To Week 12||0
2899246|NCT00413660|3607047|FG008|STARTED|Up To Week 12||0
2899247|NCT00413660|3607048|FG009|STARTED|Up To Week 12||0
2899248|NCT00413660|3607049|FG010|STARTED|Up To Week 12||0
2899249|NCT00413660|3607039|FG000|Treated|Up To Week 12||70
2899250|NCT00413660|3607040|FG001|Treated|Up To Week 12||68
2899251|NCT00413660|3607041|FG002|Treated|Up To Week 12||71
2899252|NCT00413660|3607042|FG003|Treated|Up To Week 12||74
2899253|NCT00413660|3607043|FG004|Treated|Up To Week 12||75
2899254|NCT00413660|3607044|FG005|Treated|Up To Week 12||80
3171092|NCT01932437|3898302|FG001|STARTED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
3171093|NCT01932437|3898303|FG002|STARTED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
3171094|NCT01932437|3898304|FG003|STARTED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
3171095|NCT01932437|3898305|FG004|STARTED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
3171096|NCT01932437|3898306|FG005|STARTED|Cohort 5 - ETI-204 24 mg/kg or Placebo||6
2899255|NCT00413660|3607045|FG006|Treated|Up To Week 12||69
2899256|NCT00413660|3607046|FG007|Treated|Up To Week 12||0
2899257|NCT00413660|3607047|FG008|Treated|Up To Week 12||0
2899258|NCT00413660|3607048|FG009|Treated|Up To Week 12||0
2899259|NCT00413660|3607049|FG010|Treated|Up To Week 12||0
2899260|NCT00413660|3607039|FG000|COMPLETED|Up To Week 12||64
2899261|NCT00413660|3607040|FG001|COMPLETED|Up To Week 12||61
2899262|NCT00413660|3607041|FG002|COMPLETED|Up To Week 12||64
2899263|NCT00413660|3607042|FG003|COMPLETED|Up To Week 12||67
2899264|NCT00413660|3607043|FG004|COMPLETED|Up To Week 12||66
2899265|NCT00413660|3607044|FG005|COMPLETED|Up To Week 12||70
2899266|NCT00413660|3607045|FG006|COMPLETED|Up To Week 12||58
2899267|NCT00413660|3607046|FG007|COMPLETED|Up To Week 12||0
2899268|NCT00413660|3607047|FG008|COMPLETED|Up To Week 12||0
2899269|NCT00413660|3607048|FG009|COMPLETED|Up To Week 12||0
2899270|NCT00413660|3607049|FG010|COMPLETED|Up To Week 12||0
2899271|NCT00413660|3607039|FG000|NOT COMPLETED|Up To Week 12||7
2899272|NCT00413660|3607040|FG001|NOT COMPLETED|Up To Week 12||7
2899273|NCT00413660|3607041|FG002|NOT COMPLETED|Up To Week 12||7
2899274|NCT00413660|3607042|FG003|NOT COMPLETED|Up To Week 12||8
2899275|NCT00413660|3607043|FG004|NOT COMPLETED|Up To Week 12||9
2899276|NCT00413660|3607044|FG005|NOT COMPLETED|Up To Week 12||10
2899277|NCT00413660|3607045|FG006|NOT COMPLETED|Up To Week 12||11
2899278|NCT00413660|3607046|FG007|NOT COMPLETED|Up To Week 12||0
2899279|NCT00413660|3607047|FG008|NOT COMPLETED|Up To Week 12||0
2899280|NCT00413660|3607048|FG009|NOT COMPLETED|Up To Week 12||0
2899281|NCT00413660|3607049|FG010|NOT COMPLETED|Up To Week 12||0
2899282|NCT00413660|3607039|FG000|STARTED|Post Week 12||43
2899283|NCT00413660|3607040|FG001|STARTED|Post Week 12||48
2899284|NCT00413660|3607041|FG002|STARTED|Post Week 12||64
2899285|NCT00413660|3607042|FG003|STARTED|Post Week 12||67
2899286|NCT00413660|3607043|FG004|STARTED|Post Week 12||66
2899287|NCT00413660|3607044|FG005|STARTED|Post Week 12||57
2899288|NCT00413660|3607045|FG006|STARTED|Post Week 12||40
2899289|NCT00413660|3607046|FG007|STARTED|Post Week 12||21
2899290|NCT00413660|3607047|FG008|STARTED|Post Week 12||13
2899291|NCT00413660|3607048|FG009|STARTED|Post Week 12||13
2899292|NCT00413660|3607049|FG010|STARTED|Post Week 12||18
2899293|NCT00413660|3607039|FG000|COMPLETED|Post Week 12||40
2899294|NCT00413660|3607040|FG001|COMPLETED|Post Week 12||44
2899295|NCT00413660|3607041|FG002|COMPLETED|Post Week 12||56
2899296|NCT00413660|3607042|FG003|COMPLETED|Post Week 12||66
2899297|NCT00413660|3607043|FG004|COMPLETED|Post Week 12||60
2899298|NCT00413660|3607044|FG005|COMPLETED|Post Week 12||54
2899299|NCT00413660|3607045|FG006|COMPLETED|Post Week 12||37
2899300|NCT00413660|3607046|FG007|COMPLETED|Post Week 12||21
2899301|NCT00413660|3607047|FG008|COMPLETED|Post Week 12||13
2899302|NCT00413660|3607048|FG009|COMPLETED|Post Week 12||12
2899303|NCT00413660|3607049|FG010|COMPLETED|Post Week 12||17
2899304|NCT00413660|3607039|FG000|NOT COMPLETED|Post Week 12||3
2899305|NCT00413660|3607040|FG001|NOT COMPLETED|Post Week 12||4
2899306|NCT00413660|3607041|FG002|NOT COMPLETED|Post Week 12||8
2899307|NCT00413660|3607042|FG003|NOT COMPLETED|Post Week 12||1
2899308|NCT00413660|3607043|FG004|NOT COMPLETED|Post Week 12||6
2899309|NCT00413660|3607044|FG005|NOT COMPLETED|Post Week 12||3
2899310|NCT00413660|3607045|FG006|NOT COMPLETED|Post Week 12||3
2899311|NCT00413660|3607046|FG007|NOT COMPLETED|Post Week 12||0
2899312|NCT00413660|3607047|FG008|NOT COMPLETED|Post Week 12||0
2899313|NCT00413660|3607048|FG009|NOT COMPLETED|Post Week 12||1
2899314|NCT00413660|3607049|FG010|NOT COMPLETED|Post Week 12||1
2899315|NCT00413777|3607081|FG000|STARTED|Fixed-dose Period||22
2899316|NCT00413777|3607082|FG001|STARTED|Fixed-dose Period||24
2899317|NCT00413777|3607081|FG000|COMPLETED|Fixed-dose Period||18
2899318|NCT00413777|3607082|FG001|COMPLETED|Fixed-dose Period||21
2899319|NCT00413777|3607081|FG000|NOT COMPLETED|Fixed-dose Period||4
2899320|NCT00413777|3607082|FG001|NOT COMPLETED|Fixed-dose Period||3
2899321|NCT00413777|3607081|FG000|STARTED|Extension Period||17
2899322|NCT00413777|3607082|FG001|STARTED|Extension Period||18
2899323|NCT00413777|3607081|FG000|COMPLETED|Extension Period||17
2899324|NCT00413777|3607082|FG001|COMPLETED|Extension Period||18
2899325|NCT00413777|3607081|FG000|NOT COMPLETED|Extension Period||0
2899326|NCT00413777|3607082|FG001|NOT COMPLETED|Extension Period||0
2899327|NCT00413894|3607088|FG000|STARTED|Overall Study||424
2899328|NCT00413894|3607088|FG000|COMPLETED|Overall Study||344
2899329|NCT00413894|3607088|FG000|NOT COMPLETED|Overall Study||80
2899330|NCT00413920|3607097|FG000|STARTED|Overall Study||112
2899331|NCT00413920|3607098|FG001|STARTED|Overall Study||110
2899332|NCT00413920|3607097|FG000|COMPLETED|Overall Study||84
2899333|NCT00413920|3607098|FG001|COMPLETED|Overall Study||82
2899334|NCT00413920|3607097|FG000|NOT COMPLETED|Overall Study||28
2899335|NCT00413920|3607098|FG001|NOT COMPLETED|Overall Study||28
2899336|NCT00413959|3607104|FG000|STARTED|Overall Study||12
2899337|NCT00413959|3607104|FG000|COMPLETED|Overall Study||11
2899338|NCT00413959|3607104|FG000|NOT COMPLETED|Overall Study||1
2899339|NCT00414011|3607108|FG000|STARTED|Overall Study||40
2899340|NCT00414011|3607108|FG000|COMPLETED|Overall Study||35
2899341|NCT00414011|3607108|FG000|NOT COMPLETED|Overall Study||5
2899342|NCT00414050|3607117|FG000|STARTED|Overall Study||431
2899343|NCT00414050|3607118|FG001|STARTED|Overall Study||427
2899344|NCT00414050|3607119|FG002|STARTED|Overall Study||429
2899345|NCT00414050|3607120|FG003|STARTED|Overall Study||431
2899346|NCT00414050|3607117|FG000|Received Vaccination 1|Overall Study||431
2899347|NCT00414050|3607118|FG001|Received Vaccination 1|Overall Study||426
2899348|NCT00414050|3607119|FG002|Received Vaccination 1|Overall Study||429
2899349|NCT00414050|3607120|FG003|Received Vaccination 1|Overall Study||431
2899350|NCT00414050|3607117|FG000|Received Vaccination 2|Overall Study||425
2899351|NCT00414050|3607118|FG001|Received Vaccination 2|Overall Study||421
2899352|NCT00414050|3607119|FG002|Received Vaccination 2|Overall Study||425
2899353|NCT00414050|3607120|FG003|Received Vaccination 2|Overall Study||425
2899354|NCT00414050|3607117|FG000|Received Vaccination 3|Overall Study||424
2899355|NCT00414050|3607118|FG001|Received Vaccination 3|Overall Study||419
2899356|NCT00414050|3607119|FG002|Received Vaccination 3|Overall Study||425
2899357|NCT00414050|3607120|FG003|Received Vaccination 3|Overall Study||424
2899358|NCT00414050|3607117|FG000|COMPLETED|Overall Study||422
2899359|NCT00414050|3607118|FG001|COMPLETED|Overall Study||419
2899360|NCT00414050|3607119|FG002|COMPLETED|Overall Study||423
2899361|NCT00414050|3607120|FG003|COMPLETED|Overall Study||423
2899362|NCT00414050|3607117|FG000|NOT COMPLETED|Overall Study||9
2899363|NCT00414050|3607118|FG001|NOT COMPLETED|Overall Study||8
2899364|NCT00414050|3607119|FG002|NOT COMPLETED|Overall Study||6
2899365|NCT00414050|3607120|FG003|NOT COMPLETED|Overall Study||8
2899366|NCT00414076|3607132|FG000|STARTED|Overall Study||4
2899367|NCT00414076|3607133|FG001|STARTED|Overall Study||5
2899368|NCT00414076|3607132|FG000|COMPLETED|Overall Study||1
2899369|NCT00414076|3607133|FG001|COMPLETED|Overall Study||0
2899370|NCT00414076|3607132|FG000|NOT COMPLETED|Overall Study||3
2899371|NCT00414076|3607133|FG001|NOT COMPLETED|Overall Study||5
2899372|NCT00414167|3607141|FG000|STARTED|Overall Study||31
2899373|NCT00414167|3607142|FG001|STARTED|Overall Study||30
2899374|NCT00414167|3607141|FG000|COMPLETED|Overall Study||27
2899375|NCT00414167|3607142|FG001|COMPLETED|Overall Study||27
2899376|NCT00414167|3607141|FG000|NOT COMPLETED|Overall Study||4
2899377|NCT00414167|3607142|FG001|NOT COMPLETED|Overall Study||3
2899378|NCT00414206|3607153|FG000|STARTED|Overall Study||115
2899379|NCT00414206|3607154|FG001|STARTED|Overall Study||114
2899380|NCT00414206|3607155|FG002|STARTED|Overall Study||114
2899381|NCT00414206|3607153|FG000|COMPLETED|Overall Study||57
2899382|NCT00414206|3607154|FG001|COMPLETED|Overall Study||58
2899383|NCT00414206|3607155|FG002|COMPLETED|Overall Study||59
2899384|NCT00414206|3607153|FG000|NOT COMPLETED|Overall Study||58
2899385|NCT00414206|3607154|FG001|NOT COMPLETED|Overall Study||56
2899386|NCT00414206|3607155|FG002|NOT COMPLETED|Overall Study||55
2899387|NCT00414271|3607163|FG000|STARTED|Overall Study||18
2899388|NCT00414271|3607163|FG000|COMPLETED|Overall Study||18
2899389|NCT00414271|3607163|FG000|NOT COMPLETED|Overall Study||0
2899390|NCT00414310|3607169|FG000|STARTED|Overall Study||71
2899391|NCT00414310|3607170|FG001|STARTED|Overall Study||79
2899392|NCT00414310|3607169|FG000|COMPLETED|Overall Study||70
2899393|NCT00414310|3607170|FG001|COMPLETED|Overall Study||79
2899394|NCT00414310|3607169|FG000|NOT COMPLETED|Overall Study||1
2899395|NCT00414310|3607170|FG001|NOT COMPLETED|Overall Study||0
2899396|NCT00414388|3607178|FG000|STARTED|Overall Study||22
2899397|NCT00414388|3607178|FG000|COMPLETED|Overall Study||21
2899398|NCT00414388|3607178|FG000|NOT COMPLETED|Overall Study||1
2899399|NCT00414440|3607185|FG000|STARTED|Core Period|Core period|214
2899400|NCT00414440|3607186|FG001|STARTED|Core Period|Core period|217
2899401|NCT00414440|3607185|FG000|COMPLETED|Core Period|Core period|144
2899402|NCT00414440|3607186|FG001|COMPLETED|Core Period|Core period|185
2899403|NCT00414440|3607185|FG000|NOT COMPLETED|Core Period||70
2899404|NCT00414440|3607186|FG001|NOT COMPLETED|Core Period||32
2899405|NCT00414440|3607185|FG000|STARTED|Extension Period|Extension|214
2899406|NCT00414440|3607186|FG001|STARTED|Extension Period|Extension|217
2899407|NCT00414440|3607185|FG000|COMPLETED|Extension Period|Extension|64
2899408|NCT00414440|3607186|FG001|COMPLETED|Extension Period|Extension|77
2899409|NCT00414440|3607185|FG000|NOT COMPLETED|Extension Period||150
2899410|NCT00414440|3607186|FG001|NOT COMPLETED|Extension Period||140
2899411|NCT00414466|3607196|FG000|STARTED|Overall Study||44
2899412|NCT00414466|3607197|FG001|STARTED|Overall Study||42
2899413|NCT00414466|3607198|FG002|STARTED|Overall Study||41
2899414|NCT00414466|3607199|FG003|STARTED|Overall Study||43
2899415|NCT00414466|3607196|FG000|COMPLETED|Overall Study||42
2899416|NCT00414466|3607197|FG001|COMPLETED|Overall Study||42
2899417|NCT00414466|3607198|FG002|COMPLETED|Overall Study||40
2899418|NCT00414466|3607199|FG003|COMPLETED|Overall Study||42
2899419|NCT00414466|3607196|FG000|NOT COMPLETED|Overall Study||2
2899420|NCT00414466|3607197|FG001|NOT COMPLETED|Overall Study||0
2899421|NCT00414466|3607198|FG002|NOT COMPLETED|Overall Study||1
2899422|NCT00414466|3607199|FG003|NOT COMPLETED|Overall Study||1
2899423|NCT00414518|3607214|FG000|STARTED|Overall Study||7
2899424|NCT00414518|3607215|FG001|STARTED|Overall Study||9
2899425|NCT00414518|3607214|FG000|COMPLETED|Overall Study||7
2899426|NCT00414518|3607215|FG001|COMPLETED|Overall Study||9
2899427|NCT00414518|3607214|FG000|NOT COMPLETED|Overall Study||0
2899428|NCT00414518|3607215|FG001|NOT COMPLETED|Overall Study||0
2899429|NCT00414544|3607225|FG000|STARTED|Overall Study||145
2899430|NCT00414544|3607225|FG000|COMPLETED|Overall Study||131
2899431|NCT00414544|3607225|FG000|NOT COMPLETED|Overall Study||14
2899432|NCT00414596|3607231|FG000|STARTED|Overall Study|December 2006|20
2899433|NCT00414596|3607231|FG000|COMPLETED|Overall Study|April 2007|18
2899434|NCT00414596|3607231|FG000|NOT COMPLETED|Overall Study||2
2899435|NCT00414609|3607237|FG000|STARTED|Core Study||397
2899436|NCT00414609|3607238|FG001|STARTED|Core Study||423
2899437|NCT00414609|3607239|FG002|STARTED|Core Study||0
2899438|NCT00414609|3607237|FG000|Received Study Drug|Core Study||397
2899439|NCT00414609|3607238|FG001|Received Study Drug|Core Study||422
2899440|NCT00414609|3607239|FG002|Received Study Drug|Core Study||0
2899441|NCT00414609|3607237|FG000|Echocardiogram Evaluable Set|Core Study||330
2899442|NCT00414609|3607238|FG001|Echocardiogram Evaluable Set|Core Study||343
2899443|NCT00414609|3607239|FG002|Echocardiogram Evaluable Set|Core Study||0
2899444|NCT00414609|3607237|FG000|COMPLETED|Core Study||363
2899445|NCT00414609|3607238|FG001|COMPLETED|Core Study||378
2899446|NCT00414609|3607239|FG002|COMPLETED|Core Study||0
2899447|NCT00414609|3607237|FG000|NOT COMPLETED|Core Study||34
2899448|NCT00414609|3607238|FG001|NOT COMPLETED|Core Study||45
2899449|NCT00414609|3607239|FG002|NOT COMPLETED|Core Study||0
2899450|NCT00414609|3607237|FG000|STARTED|Extension Study||0
2899451|NCT00414609|3607238|FG001|STARTED|Extension Study||0
2899452|NCT00414609|3607239|FG002|STARTED|Extension Study|Patients of both core arms who completed core study and signed informed consent form for extension.|422
2899453|NCT00414609|3607237|FG000|Echocardiogram (ECHO) Analysis Set|Extension Study||0
2899454|NCT00414609|3607238|FG001|Echocardiogram (ECHO) Analysis Set|Extension Study||0
2899455|NCT00414609|3607239|FG002|Echocardiogram (ECHO) Analysis Set|Extension Study||400
2899456|NCT00414609|3607237|FG000|COMPLETED|Extension Study||0
2899457|NCT00414609|3607238|FG001|COMPLETED|Extension Study||0
2899458|NCT00414609|3607239|FG002|COMPLETED|Extension Study||365
2899459|NCT00414609|3607237|FG000|NOT COMPLETED|Extension Study||0
2899460|NCT00414609|3607238|FG001|NOT COMPLETED|Extension Study||0
2899461|NCT00414609|3607239|FG002|NOT COMPLETED|Extension Study||57
2899462|NCT00414635|3607250|FG000|STARTED|Overall Study||30
2899463|NCT00414635|3607251|FG001|STARTED|Overall Study||30
2899464|NCT00414635|3607250|FG000|COMPLETED|Overall Study||25
2899465|NCT00414635|3607251|FG001|COMPLETED|Overall Study||28
2899466|NCT00414635|3607250|FG000|NOT COMPLETED|Overall Study||5
2899467|NCT00414635|3607251|FG001|NOT COMPLETED|Overall Study||2
2899468|NCT00414661|3607261|FG000|STARTED|Overall Study||48
2899469|NCT00414661|3607262|FG001|STARTED|Overall Study||89
2899470|NCT00414661|3607263|FG002|STARTED|Overall Study||22
2899471|NCT00414661|3607264|FG003|STARTED|Overall Study||3
2899472|NCT00414661|3607261|FG000|COMPLETED|Overall Study||34
2899473|NCT00414661|3607262|FG001|COMPLETED|Overall Study||75
2899474|NCT00414661|3607263|FG002|COMPLETED|Overall Study||20
2899475|NCT00414661|3607264|FG003|COMPLETED|Overall Study||0
2899476|NCT00414661|3607261|FG000|NOT COMPLETED|Overall Study||14
2899477|NCT00414661|3607262|FG001|NOT COMPLETED|Overall Study||14
2899478|NCT00414661|3607263|FG002|NOT COMPLETED|Overall Study||2
2899479|NCT00414661|3607264|FG003|NOT COMPLETED|Overall Study||3
2899480|NCT00414700|3607276|FG000|STARTED|Overall Study||57
2899481|NCT00414700|3607277|FG001|STARTED|Overall Study||61
2899482|NCT00414700|3607276|FG000|COMPLETED|Overall Study||51
2899483|NCT00414700|3607277|FG001|COMPLETED|Overall Study||58
2899484|NCT00414700|3607276|FG000|NOT COMPLETED|Overall Study||6
2899485|NCT00414700|3607277|FG001|NOT COMPLETED|Overall Study||3
2899486|NCT00414726|3607285|FG000|STARTED|Overall Study||43
2899487|NCT00414726|3607286|FG001|STARTED|Overall Study||42
2899488|NCT00414726|3607285|FG000|COMPLETED|Overall Study||43
2899489|NCT00414726|3607286|FG001|COMPLETED|Overall Study||41
2899490|NCT00414726|3607285|FG000|NOT COMPLETED|Overall Study||0
2899491|NCT00414726|3607286|FG001|NOT COMPLETED|Overall Study||1
2899492|NCT00414765|3607294|FG000|STARTED|Overall Study||7
2899493|NCT00414765|3607295|FG001|STARTED|Overall Study||19
2899494|NCT00414765|3607294|FG000|Completed Study|Overall Study||7
2899495|NCT00414765|3607295|FG001|Completed Study|Overall Study||18
2899496|NCT00414765|3607294|FG000|Completed Cycle 1|Overall Study||7
2899497|NCT00414765|3607295|FG001|Completed Cycle 1|Overall Study||19
2899498|NCT00414765|3607294|FG000|Completed Cycle 2|Overall Study||4
2899499|NCT00414765|3607295|FG001|Completed Cycle 2|Overall Study||16
2899500|NCT00414765|3607294|FG000|COMPLETED|Overall Study||1
2899501|NCT00414765|3607295|FG001|COMPLETED|Overall Study||8
2899502|NCT00414765|3607294|FG000|NOT COMPLETED|Overall Study||6
2899503|NCT00414765|3607295|FG001|NOT COMPLETED|Overall Study||11
2899504|NCT00414817|3607303|FG000|STARTED|Overall Study||7033
2899505|NCT00414817|3607304|FG001|STARTED|Overall Study||7031
2899506|NCT00414817|3607303|FG000|Never Started on ICS|Overall Study|Not initial users of ICS and not starting during study, hence don't qualify for analysis sample.|1465
2899507|NCT00414817|3607304|FG001|Never Started on ICS|Overall Study|Not initial users of ICS and not starting during study, hence don't qualify for analysis sample.|1392
2899508|NCT00414817|3607303|FG000|Died or Left Health Plan|Overall Study|These individuals died or terminated Health Plan membership prior to ever qualifying for a call.|451
2899509|NCT00414817|3607304|FG001|Died or Left Health Plan|Overall Study|These individuals died or terminated Health Plan membership prior to ever qualifying for a call.|417
2899510|NCT00414817|3607303|FG000|Adherent ICS User|Overall Study|Fully adherent ICS users who never qualified for an intervention call.|922
2899511|NCT00414817|3607304|FG001|Adherent ICS User|Overall Study|Fully adherent ICS users who never qualified for an intervention call.|900
2899512|NCT00414817|3607303|FG000|Daily Oral Steroid User|Overall Study|qualified for analysis sample, but excluded due to subsequent determination of oral steroid use.|117
2899513|NCT00414817|3607304|FG001|Daily Oral Steroid User|Overall Study|qualified for analysis sample, but excluded due to subsequent determination of oral steroid use.|123
2899514|NCT00414817|3607303|FG000|<3 Months Follow-up|Overall Study|qualified for analysis sample, but excluded since follow-up too short to assess adherence reliably.|175
2899515|NCT00414817|3607304|FG001|<3 Months Follow-up|Overall Study|qualified for analysis sample, but excluded since follow-up too short to assess adherence reliably.|184
2899516|NCT00414817|3607303|FG000|COMPLETED|Overall Study|Qualified for primary analysis (3171 prior ICS users) or secondary analysis (732 new users) samples.|3903
2899517|NCT00414817|3607304|FG001|COMPLETED|Overall Study|Qualified for primary analysis (3260 prior ICS users) or secondary analysis (755 new users) samples.|4015
2899518|NCT00414817|3607303|FG000|NOT COMPLETED|Overall Study||3130
2899519|NCT00414817|3607304|FG001|NOT COMPLETED|Overall Study||3016
2899520|NCT00414908|3607312|FG000|STARTED|Overall Study||25
2899521|NCT00414908|3607313|FG001|STARTED|Overall Study||29
2899522|NCT00414908|3607312|FG000|COMPLETED|Overall Study||24
2899523|NCT00414908|3607313|FG001|COMPLETED|Overall Study||28
2899524|NCT00414908|3607312|FG000|NOT COMPLETED|Overall Study||1
2899525|NCT00414908|3607313|FG001|NOT COMPLETED|Overall Study||1
2899526|NCT00414960|3607323|FG000|STARTED|Overall Study||25
2899527|NCT00414960|3607324|FG001|STARTED|Overall Study||15
2899528|NCT00414960|3607323|FG000|Received at Least One Dose of Study Drug|Overall Study||24
2899529|NCT00414960|3607324|FG001|Received at Least One Dose of Study Drug|Overall Study||15
2899530|NCT00414960|3607323|FG000|COMPLETED|Overall Study||18
2899531|NCT00414960|3607324|FG001|COMPLETED|Overall Study||14
2899532|NCT00414960|3607323|FG000|NOT COMPLETED|Overall Study||7
2899533|NCT00414960|3607324|FG001|NOT COMPLETED|Overall Study||1
2899534|NCT00414973|3607334|FG000|STARTED|Overall Study||218
2899535|NCT00414973|3607335|FG001|STARTED|Overall Study||109
2899536|NCT00414973|3607336|FG002|STARTED|Overall Study||24
2899537|NCT00414973|3607337|FG003|STARTED|Overall Study||11
2899538|NCT00414973|3607334|FG000|COMPLETED|Overall Study||190
2899539|NCT00414973|3607335|FG001|COMPLETED|Overall Study||99
2899540|NCT00414973|3607336|FG002|COMPLETED|Overall Study||21
2899541|NCT00414973|3607337|FG003|COMPLETED|Overall Study||11
2899542|NCT00414973|3607334|FG000|NOT COMPLETED|Overall Study||28
2899543|NCT00414973|3607335|FG001|NOT COMPLETED|Overall Study||10
2899544|NCT00414973|3607336|FG002|NOT COMPLETED|Overall Study||3
2899545|NCT00414973|3607337|FG003|NOT COMPLETED|Overall Study||0
2899546|NCT00415051|3607347|FG000|STARTED|Overall Study||20
2899547|NCT00415051|3607347|FG000|COMPLETED|Overall Study||19
2899548|NCT00415051|3607347|FG000|NOT COMPLETED|Overall Study||1
2899549|NCT00415168|3607351|FG000|STARTED|Overall Study||53
2899550|NCT00415168|3607351|FG000|Completed Treatment|Overall Study||15
2899551|NCT00415168|3607351|FG000|COMPLETED|Overall Study||1
2899552|NCT00415168|3607351|FG000|NOT COMPLETED|Overall Study||52
2899553|NCT00415194|3607357|FG000|STARTED|Overall Study||398
2899554|NCT00415194|3607358|FG001|STARTED|Overall Study||397
2899555|NCT00415194|3607357|FG000|Received at Least 1 Dose of Study Drug|Overall Study||392
2899556|NCT00415194|3607358|FG001|Received at Least 1 Dose of Study Drug|Overall Study||385
2899557|NCT00415194|3607357|FG000|COMPLETED|Overall Study||70
2899558|NCT00415194|3607358|FG001|COMPLETED|Overall Study||55
2899559|NCT00415194|3607357|FG000|NOT COMPLETED|Overall Study||328
2899560|NCT00415194|3607358|FG001|NOT COMPLETED|Overall Study||342
2899561|NCT00415363|3607366|FG000|STARTED|Overall Study||55
2899562|NCT00415363|3607367|FG001|STARTED|Overall Study||54
2899563|NCT00415363|3607366|FG000|Safety Population|Overall Study||54
2899564|NCT00415363|3607367|FG001|Safety Population|Overall Study||53
2899565|NCT00415363|3607366|FG000|COMPLETED|Overall Study||0
2899566|NCT00415363|3607367|FG001|COMPLETED|Overall Study||0
2899567|NCT00415363|3607366|FG000|NOT COMPLETED|Overall Study||55
2899568|NCT00415363|3607367|FG001|NOT COMPLETED|Overall Study||54
2899569|NCT00415493|3607376|FG000|STARTED|Overall Study||12
2899570|NCT00415493|3607377|FG001|STARTED|Overall Study||12
2899571|NCT00415493|3607376|FG000|COMPLETED|Overall Study||12
2899572|NCT00415493|3607377|FG001|COMPLETED|Overall Study||12
2899573|NCT00415493|3607376|FG000|NOT COMPLETED|Overall Study||0
2899574|NCT00415493|3607377|FG001|NOT COMPLETED|Overall Study||0
2899575|NCT00415506|3607385|FG000|STARTED|Overall Study||12
2899576|NCT00415506|3607386|FG001|STARTED|Overall Study||10
2899577|NCT00415506|3607385|FG000|COMPLETED|Overall Study||9
2899578|NCT00415506|3607386|FG001|COMPLETED|Overall Study||9
2899579|NCT00415506|3607385|FG000|NOT COMPLETED|Overall Study||3
2899580|NCT00415506|3607386|FG001|NOT COMPLETED|Overall Study||1
2899581|NCT00415519|3607394|FG000|STARTED|Overall Study||13
2899582|NCT00415519|3607395|FG001|STARTED|Overall Study||12
2899583|NCT00415519|3607394|FG000|COMPLETED|Overall Study||9
2899584|NCT00415519|3607395|FG001|COMPLETED|Overall Study||12
2899585|NCT00415519|3607394|FG000|NOT COMPLETED|Overall Study||4
2899586|NCT00415519|3607395|FG001|NOT COMPLETED|Overall Study||0
2899587|NCT00415532|3607403|FG000|STARTED|Treatment Period||77
2899588|NCT00415532|3607404|FG001|STARTED|Treatment Period||157
2899589|NCT00415532|3607403|FG000|Received Treatment|Treatment Period||75
2899590|NCT00415532|3607404|FG001|Received Treatment|Treatment Period||154
2899591|NCT00415532|3607403|FG000|Switched to Romiplostim Group|Treatment Period||2
2899592|NCT00415532|3607404|FG001|Switched to Romiplostim Group|Treatment Period||0
2899593|NCT00415532|3607403|FG000|COMPLETED|Treatment Period||60
2899594|NCT00415532|3607404|FG001|COMPLETED|Treatment Period||142
2899595|NCT00415532|3607403|FG000|NOT COMPLETED|Treatment Period||17
2899596|NCT00415532|3607404|FG001|NOT COMPLETED|Treatment Period||15
2899597|NCT00415532|3607403|FG000|STARTED|Safety Follow Up Period|Participants who completed the treatment period were not required to participate in this follow-up|43
2899598|NCT00415532|3607404|FG001|STARTED|Safety Follow Up Period|Participants who completed the treatment period were not required to participate in this follow-up|30
2899599|NCT00415532|3607403|FG000|COMPLETED|Safety Follow Up Period||34
2899600|NCT00415532|3607404|FG001|COMPLETED|Safety Follow Up Period||18
2899601|NCT00415532|3607403|FG000|NOT COMPLETED|Safety Follow Up Period||9
2899602|NCT00415532|3607404|FG001|NOT COMPLETED|Safety Follow Up Period||12
2899603|NCT00415597|3607410|FG000|STARTED|Enrollment||467
2899604|NCT00415597|3607410|FG000|COMPLETED|Enrollment||465
2899605|NCT00415597|3607410|FG000|NOT COMPLETED|Enrollment||2
2899606|NCT00415597|3607410|FG000|STARTED|Treatment||465
2899607|NCT00415597|3607410|FG000|COMPLETED|Treatment||160
2899608|NCT00415597|3607410|FG000|NOT COMPLETED|Treatment||305
2899609|NCT00415610|3607417|FG000|STARTED|Overall Study||18
2899610|NCT00415610|3607418|FG001|STARTED|Overall Study||20
2899611|NCT00415610|3607419|FG002|STARTED|Overall Study||22
2899612|NCT00415610|3607417|FG000|COMPLETED|Overall Study||15
2899613|NCT00415610|3607418|FG001|COMPLETED|Overall Study||18
2899614|NCT00415610|3607419|FG002|COMPLETED|Overall Study||17
2899615|NCT00415610|3607417|FG000|NOT COMPLETED|Overall Study||3
2899616|NCT00415610|3607418|FG001|NOT COMPLETED|Overall Study||2
2899617|NCT00415610|3607419|FG002|NOT COMPLETED|Overall Study||5
2899618|NCT00415636|3607433|FG000|STARTED|Overall Study||3
2899619|NCT00415636|3607434|FG001|STARTED|Overall Study||3
2899620|NCT00415636|3607435|FG002|STARTED|Overall Study||3
2899621|NCT00415636|3607436|FG003|STARTED|Overall Study||13
2899622|NCT00415636|3607437|FG004|STARTED|Overall Study||6
2899623|NCT00415636|3607438|FG005|STARTED|Overall Study||3
2899624|NCT00415636|3607433|FG000|COMPLETED|Overall Study|Completed = Participant received 2 cycles of treatment|2
2899625|NCT00415636|3607434|FG001|COMPLETED|Overall Study|Completed = Participant received 2 cycles of treatment|3
2899626|NCT00415636|3607435|FG002|COMPLETED|Overall Study|Completed = Participant received 2 cycles of treatment|2
2899627|NCT00415636|3607436|FG003|COMPLETED|Overall Study|Completed = Participant received 2 cycles of treatment|7
2899628|NCT00415636|3607437|FG004|COMPLETED|Overall Study|Completed = Participant received 2 cycles of treatment|4
2899629|NCT00415636|3607438|FG005|COMPLETED|Overall Study|Completed = Participant received 2 cycles of treatment|1
2899630|NCT00415636|3607433|FG000|NOT COMPLETED|Overall Study||1
2899631|NCT00415636|3607434|FG001|NOT COMPLETED|Overall Study||0
2899632|NCT00415636|3607435|FG002|NOT COMPLETED|Overall Study||1
2899633|NCT00415636|3607436|FG003|NOT COMPLETED|Overall Study||6
2899634|NCT00415636|3607437|FG004|NOT COMPLETED|Overall Study||2
2899635|NCT00415636|3607438|FG005|NOT COMPLETED|Overall Study||2
2899636|NCT00415857|3607462|FG000|STARTED|Overall Study||2
2899637|NCT00415857|3607463|FG001|STARTED|Overall Study||3
2899638|NCT00415857|3607462|FG000|COMPLETED|Overall Study||2
2899639|NCT00415857|3607463|FG001|COMPLETED|Overall Study||3
2899640|NCT00415857|3607462|FG000|NOT COMPLETED|Overall Study||0
2899641|NCT00415857|3607463|FG001|NOT COMPLETED|Overall Study||0
2899642|NCT00415870|3607471|FG000|STARTED|Overall Study||32
2899643|NCT00415870|3607472|FG001|STARTED|Overall Study||33
2899644|NCT00415870|3607471|FG000|COMPLETED|Overall Study||26
2899645|NCT00415870|3607472|FG001|COMPLETED|Overall Study||26
2899646|NCT00415870|3607471|FG000|NOT COMPLETED|Overall Study||6
2899647|NCT00415870|3607472|FG001|NOT COMPLETED|Overall Study||7
2899648|NCT00415909|3607478|FG000|STARTED|Overall Study||3
2899649|NCT00415909|3607478|FG000|COMPLETED|Overall Study||0
2899650|NCT00415909|3607478|FG000|NOT COMPLETED|Overall Study||3
2899651|NCT00416078|3607484|FG000|STARTED|Overall Study||29
2899652|NCT00416078|3607485|FG001|STARTED|Overall Study||24
2899653|NCT00416078|3607484|FG000|COMPLETED|Overall Study||18
2899654|NCT00416078|3607485|FG001|COMPLETED|Overall Study||16
2899655|NCT00416078|3607484|FG000|NOT COMPLETED|Overall Study||11
2899656|NCT00416078|3607485|FG001|NOT COMPLETED|Overall Study||8
2899657|NCT00416182|3607493|FG000|STARTED|Overall Study||8
2899658|NCT00416182|3607494|FG001|STARTED|Overall Study||8
2899659|NCT00416182|3607493|FG000|COMPLETED|Overall Study||5
2899660|NCT00416182|3607494|FG001|COMPLETED|Overall Study||6
2899661|NCT00416182|3607493|FG000|NOT COMPLETED|Overall Study||3
2899662|NCT00416182|3607494|FG001|NOT COMPLETED|Overall Study||2
2899663|NCT00416195|3607508|FG000|STARTED|Overall Study||10
2899664|NCT00416195|3607509|FG001|STARTED|Overall Study||38
2899665|NCT00416195|3607508|FG000|COMPLETED|Overall Study||8
2899666|NCT00416195|3607509|FG001|COMPLETED|Overall Study||34
2899667|NCT00416195|3607508|FG000|NOT COMPLETED|Overall Study||2
2899668|NCT00416195|3607509|FG001|NOT COMPLETED|Overall Study||4
2899669|NCT00416312|3607515|FG000|STARTED|Overall Study||9
2899670|NCT00416312|3607515|FG000|Conventional Dosimetry|Overall Study||9
2899671|NCT00416312|3607515|FG000|Patient-specific Dosimetry|Overall Study||9
2899672|NCT00416312|3607515|FG000|COMPLETED|Overall Study||7
2899673|NCT00416312|3607515|FG000|NOT COMPLETED|Overall Study||2
2899674|NCT00416455|3607521|FG000|STARTED|Overall Study|This is a diagnostic imaging study.|169
2899675|NCT00416455|3607522|FG001|STARTED|Overall Study|This is a diagnostic imaging study.|215
2899676|NCT00416455|3607521|FG000|COMPLETED|Overall Study|Number of patients with adequate imaging and pathology|153
2899677|NCT00416455|3607522|FG001|COMPLETED|Overall Study|Number of patients with adequate imaging and pathology|207
2899678|NCT00416455|3607521|FG000|NOT COMPLETED|Overall Study||16
2899679|NCT00416455|3607522|FG001|NOT COMPLETED|Overall Study||8
2899680|NCT00416494|3607541|FG000|STARTED|Overall Study||19
2899681|NCT00416494|3607542|FG001|STARTED|Overall Study||31
2899682|NCT00416494|3607541|FG000|COMPLETED|Overall Study||19
2899683|NCT00416494|3607542|FG001|COMPLETED|Overall Study||31
2899684|NCT00416494|3607541|FG000|NOT COMPLETED|Overall Study||0
2899685|NCT00416494|3607542|FG001|NOT COMPLETED|Overall Study||0
2899686|NCT00416520|3607550|FG000|STARTED|Open-label Period||165
2899687|NCT00416520|3607551|FG001|STARTED|Open-label Period||171
2899688|NCT00416520|3607552|FG002|STARTED|Open-label Period||0
2899689|NCT00416520|3607553|FG003|STARTED|Open-label Period||0
2899690|NCT00416520|3607550|FG000|COMPLETED|Open-label Period||105
2899691|NCT00416520|3607551|FG001|COMPLETED|Open-label Period||139
2899692|NCT00416520|3607552|FG002|COMPLETED|Open-label Period||0
2899693|NCT00416520|3607553|FG003|COMPLETED|Open-label Period||0
2899694|NCT00416520|3607550|FG000|NOT COMPLETED|Open-label Period||60
2899695|NCT00416520|3607551|FG001|NOT COMPLETED|Open-label Period||32
2899696|NCT00416520|3607552|FG002|NOT COMPLETED|Open-label Period||0
2899697|NCT00416520|3607553|FG003|NOT COMPLETED|Open-label Period||0
2899698|NCT00416520|3607550|FG000|STARTED|Placebo-controlled Withdrawal Period||0
2899699|NCT00416520|3607551|FG001|STARTED|Placebo-controlled Withdrawal Period||0
2899700|NCT00416520|3607552|FG002|STARTED|Placebo-controlled Withdrawal Period||50
2899701|NCT00416520|3607553|FG003|STARTED|Placebo-controlled Withdrawal Period||54
2899702|NCT00416520|3607550|FG000|COMPLETED|Placebo-controlled Withdrawal Period||0
2899703|NCT00416520|3607551|FG001|COMPLETED|Placebo-controlled Withdrawal Period||0
2899704|NCT00416520|3607552|FG002|COMPLETED|Placebo-controlled Withdrawal Period||49
2899705|NCT00416520|3607553|FG003|COMPLETED|Placebo-controlled Withdrawal Period||49
2899706|NCT00416520|3607550|FG000|NOT COMPLETED|Placebo-controlled Withdrawal Period||0
2899707|NCT00416520|3607551|FG001|NOT COMPLETED|Placebo-controlled Withdrawal Period||0
2899708|NCT00416520|3607552|FG002|NOT COMPLETED|Placebo-controlled Withdrawal Period||1
2899709|NCT00416520|3607553|FG003|NOT COMPLETED|Placebo-controlled Withdrawal Period||5
2899710|NCT00416572|3607566|FG000|STARTED|Overall Study||83
2899711|NCT00416572|3607567|FG001|STARTED|Overall Study||85
2899712|NCT00416572|3607568|FG002|STARTED|Overall Study||84
2899713|NCT00416572|3607566|FG000|COMPLETED|Overall Study||70
2899714|NCT00416572|3607567|FG001|COMPLETED|Overall Study||78
2899715|NCT00416572|3607568|FG002|COMPLETED|Overall Study||76
2899716|NCT00416572|3607566|FG000|NOT COMPLETED|Overall Study||13
2899717|NCT00416572|3607567|FG001|NOT COMPLETED|Overall Study||7
2899718|NCT00416572|3607568|FG002|NOT COMPLETED|Overall Study||8
2899719|NCT00416598|3607576|FG000|STARTED|Induction & Intensification||546
2899720|NCT00416598|3607576|FG000|COMPLETED|Induction & Intensification||134
2899721|NCT00416598|3607576|FG000|NOT COMPLETED|Induction & Intensification||412
2899722|NCT00416598|3607576|FG000|STARTED|Decitabine Maintenance||134
2899723|NCT00416598|3607576|FG000|COMPLETED|Decitabine Maintenance||62
2899724|NCT00416598|3607576|FG000|NOT COMPLETED|Decitabine Maintenance||72
2899725|NCT00416624|3607584|FG000|STARTED|Overall Study||61
2899726|NCT00416624|3607585|FG001|STARTED|Overall Study||60
2899727|NCT00416624|3607586|FG002|STARTED|Overall Study||58
2899728|NCT00416624|3607587|FG003|STARTED|Overall Study||57
2899729|NCT00416624|3607584|FG000|COMPLETED|Overall Study||39
2899730|NCT00416624|3607585|FG001|COMPLETED|Overall Study||33
2899731|NCT00416624|3607586|FG002|COMPLETED|Overall Study||40
2899732|NCT00416624|3607587|FG003|COMPLETED|Overall Study||40
2899733|NCT00416624|3607584|FG000|NOT COMPLETED|Overall Study||22
2899734|NCT00416624|3607585|FG001|NOT COMPLETED|Overall Study||27
2899735|NCT00416624|3607586|FG002|NOT COMPLETED|Overall Study||18
2899736|NCT00416624|3607587|FG003|NOT COMPLETED|Overall Study||17
2899737|NCT00416715|3607597|FG000|STARTED|Overall Study||100
2899738|NCT00416715|3607597|FG000|COMPLETED|Overall Study||85
2899739|NCT00416715|3607597|FG000|NOT COMPLETED|Overall Study||15
2899740|NCT00416793|3607604|FG000|STARTED|Overall Study||9
2899741|NCT00416793|3607604|FG000|COMPLETED|Overall Study||9
2899742|NCT00416793|3607604|FG000|NOT COMPLETED|Overall Study||0
2899743|NCT00416884|3607608|FG000|STARTED|Overall Study||1
2899744|NCT00416884|3607608|FG000|COMPLETED|Overall Study||0
2899745|NCT00416884|3607608|FG000|NOT COMPLETED|Overall Study||1
2899746|NCT00416949|3607612|FG000|STARTED|Overall Study||9
2899747|NCT00416949|3607612|FG000|COMPLETED|Overall Study||4
2899748|NCT00416949|3607612|FG000|NOT COMPLETED|Overall Study||5
2899749|NCT00417027|3607619|FG000|STARTED|Overall Study||66
2899750|NCT00417027|3607620|FG001|STARTED|Overall Study||65
2899751|NCT00417027|3607621|FG002|STARTED|Overall Study||59
2899752|NCT00417027|3607619|FG000|COMPLETED|Overall Study||66
2899753|NCT00417027|3607620|FG001|COMPLETED|Overall Study||60
2899754|NCT00417027|3607621|FG002|COMPLETED|Overall Study||54
2899755|NCT00417027|3607619|FG000|NOT COMPLETED|Overall Study||0
2899756|NCT00417027|3607620|FG001|NOT COMPLETED|Overall Study||5
2899757|NCT00417027|3607621|FG002|NOT COMPLETED|Overall Study||5
2899758|NCT00417079|3607631|FG000|STARTED|Overall Study|Randomized patients|377
2899759|NCT00417079|3607632|FG001|STARTED|Overall Study|Randomized patients|378
2899760|NCT00417079|3607631|FG000|COMPLETED|Overall Study|Randomized patients|46
2899761|NCT00417079|3607632|FG001|COMPLETED|Overall Study|Randomized patients|105
2899762|NCT00417079|3607631|FG000|NOT COMPLETED|Overall Study||331
2899763|NCT00417079|3607632|FG001|NOT COMPLETED|Overall Study||273
2899764|NCT00417170|3607640|FG000|STARTED|Overall Study|"Started indicates Safety population."|23
2899765|NCT00417170|3607641|FG001|STARTED|Overall Study||25
2899766|NCT00417170|3607640|FG000|Pharmacodynamics Population|Overall Study||21
2899767|NCT00417170|3607641|FG001|Pharmacodynamics Population|Overall Study||23
2899768|NCT00417170|3607640|FG000|COMPLETED|Overall Study||21
3171097|NCT01932437|3898301|FG000|COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||2
3171098|NCT01932437|3898302|FG001|COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
2899769|NCT00417170|3607641|FG001|COMPLETED|Overall Study||22
2899770|NCT00417170|3607640|FG000|NOT COMPLETED|Overall Study||2
2899771|NCT00417170|3607641|FG001|NOT COMPLETED|Overall Study||3
2899772|NCT00417274|3607647|FG000|STARTED|Overall Study||31
2899773|NCT00417274|3607647|FG000|COMPLETED|Overall Study||31
2899774|NCT00417274|3607647|FG000|NOT COMPLETED|Overall Study||0
2899775|NCT00417417|3607653|FG000|STARTED|Overall Study||4
2899776|NCT00417417|3607654|FG001|STARTED|Overall Study||6
2899777|NCT00417417|3607653|FG000|COMPLETED|Overall Study||4
2899778|NCT00417417|3607654|FG001|COMPLETED|Overall Study||6
2899779|NCT00417417|3607653|FG000|NOT COMPLETED|Overall Study||0
2899780|NCT00417417|3607654|FG001|NOT COMPLETED|Overall Study||0
2899781|NCT00417482|3607665|FG000|STARTED|Phase B 1st 16 Weeks|Risperidone 16 weeks.|32
2899782|NCT00417482|3607666|FG001|STARTED|Phase B 1st 16 Weeks|Risperidone 16 weeks.|38
2899783|NCT00417482|3607667|FG002|STARTED|Phase B 1st 16 Weeks|Placebo 16 weeks.|40
2899784|NCT00417482|3607665|FG000|COMPLETED|Phase B 1st 16 Weeks||13
2899785|NCT00417482|3607666|FG001|COMPLETED|Phase B 1st 16 Weeks||27
2899786|NCT00417482|3607667|FG002|COMPLETED|Phase B 1st 16 Weeks||13
2899787|NCT00417482|3607665|FG000|NOT COMPLETED|Phase B 1st 16 Weeks||19
2899788|NCT00417482|3607666|FG001|NOT COMPLETED|Phase B 1st 16 Weeks||11
2899789|NCT00417482|3607667|FG002|NOT COMPLETED|Phase B 1st 16 Weeks||27
2899790|NCT00417482|3607665|FG000|STARTED|Phase B 2nd 16 Weeks|Risperidone for 16 weeks.|13
2899791|NCT00417482|3607666|FG001|STARTED|Phase B 2nd 16 Weeks|Placebo for 16 weeks.|27
2899792|NCT00417482|3607667|FG002|STARTED|Phase B 2nd 16 Weeks|Placebo for 16 weeks.|13
2899793|NCT00417482|3607665|FG000|COMPLETED|Phase B 2nd 16 Weeks||10
2899794|NCT00417482|3607666|FG001|COMPLETED|Phase B 2nd 16 Weeks||14
2899795|NCT00417482|3607667|FG002|COMPLETED|Phase B 2nd 16 Weeks||10
2899796|NCT00417482|3607665|FG000|NOT COMPLETED|Phase B 2nd 16 Weeks||3
2899797|NCT00417482|3607666|FG001|NOT COMPLETED|Phase B 2nd 16 Weeks||13
2899798|NCT00417482|3607667|FG002|NOT COMPLETED|Phase B 2nd 16 Weeks||3
2899799|NCT00417612|3607683|FG000|STARTED|Overall Study||22
2899800|NCT00417612|3607684|FG001|STARTED|Overall Study||11
2899801|NCT00417612|3607683|FG000|COMPLETED|Overall Study||19
2899802|NCT00417612|3607684|FG001|COMPLETED|Overall Study||8
2899803|NCT00417612|3607683|FG000|NOT COMPLETED|Overall Study||3
2899804|NCT00417612|3607684|FG001|NOT COMPLETED|Overall Study||3
2899805|NCT00417859|3607694|FG000|STARTED|Overall Study||26
2899806|NCT00417859|3607695|FG001|STARTED|Overall Study||30
2899807|NCT00417859|3607694|FG000|COMPLETED|Overall Study||26
2899808|NCT00417859|3607695|FG001|COMPLETED|Overall Study||29
2899809|NCT00417859|3607694|FG000|NOT COMPLETED|Overall Study||0
2899810|NCT00417859|3607695|FG001|NOT COMPLETED|Overall Study||1
2899811|NCT00417885|3607703|FG000|STARTED|Overall Study||6
2899812|NCT00417885|3607703|FG000|COMPLETED|Overall Study||0
2899813|NCT00417885|3607703|FG000|NOT COMPLETED|Overall Study||6
2899814|NCT00417963|3607707|FG000|STARTED|Overall Study|79 participants were enrolled in the roll-in cohort and 407 in the pivotal cohort.|486
2899815|NCT00417963|3607707|FG000|COMPLETED|Overall Study|79 subjects completed in the roll-in cohort and 371 in the pivotal cohort.|445
2899816|NCT00417963|3607707|FG000|NOT COMPLETED|Overall Study||41
2899817|NCT00417976|3607716|FG000|STARTED|Overall Study||42
2899818|NCT00417976|3607716|FG000|COMPLETED|Overall Study||39
2899819|NCT00417976|3607716|FG000|NOT COMPLETED|Overall Study||3
2899820|NCT00417989|3607723|FG000|STARTED|Overall Study|Intent to Treat include safety population & subjects with baseline & 1 post baseline A1C measurement|244
2899821|NCT00417989|3607724|FG001|STARTED|Overall Study||241
2899822|NCT00417989|3607723|FG000|COMPLETED|Overall Study||224
2899823|NCT00417989|3607724|FG001|COMPLETED|Overall Study||219
2899824|NCT00417989|3607723|FG000|NOT COMPLETED|Overall Study||20
2899825|NCT00417989|3607724|FG001|NOT COMPLETED|Overall Study||22
2899826|NCT00418015|3607736|FG000|STARTED|Overall Study||144
2899827|NCT00418015|3607737|FG001|STARTED|Overall Study||46
2899828|NCT00418015|3607738|FG002|STARTED|Overall Study||78
2899829|NCT00418015|3607739|FG003|STARTED|Overall Study||25
2899830|NCT00418015|3607736|FG000|COMPLETED|Overall Study||144
2899831|NCT00418015|3607737|FG001|COMPLETED|Overall Study||46
2899832|NCT00418015|3607738|FG002|COMPLETED|Overall Study||78
2899833|NCT00418015|3607739|FG003|COMPLETED|Overall Study||25
2899834|NCT00418015|3607736|FG000|NOT COMPLETED|Overall Study||0
2899835|NCT00418015|3607737|FG001|NOT COMPLETED|Overall Study||0
2899836|NCT00418015|3607738|FG002|NOT COMPLETED|Overall Study||0
2899837|NCT00418015|3607739|FG003|NOT COMPLETED|Overall Study||0
2899838|NCT00418028|3607751|FG000|STARTED|Overall Study||97
2899839|NCT00418028|3607752|FG001|STARTED|Overall Study||98
2899840|NCT00418028|3607751|FG000|COMPLETED|Overall Study||95
2899841|NCT00418028|3607752|FG001|COMPLETED|Overall Study||97
2899842|NCT00418028|3607751|FG000|NOT COMPLETED|Overall Study||2
2899843|NCT00418028|3607752|FG001|NOT COMPLETED|Overall Study||1
2899844|NCT00418093|3607758|FG000|STARTED|Overall Study||19
2899845|NCT00418093|3607758|FG000|Completed Study|Overall Study||19
2899846|NCT00418093|3607758|FG000|COMPLETED|Overall Study||19
2899847|NCT00418093|3607758|FG000|NOT COMPLETED|Overall Study||0
2899848|NCT00418184|3607764|FG000|STARTED|Double-blind Phase||137
2899849|NCT00418184|3607765|FG001|STARTED|Double-blind Phase||63
2899850|NCT00418184|3607764|FG000|COMPLETED|Double-blind Phase||110
2899851|NCT00418184|3607765|FG001|COMPLETED|Double-blind Phase||52
2899852|NCT00418184|3607764|FG000|NOT COMPLETED|Double-blind Phase||27
2899853|NCT00418184|3607765|FG001|NOT COMPLETED|Double-blind Phase||11
2899854|NCT00418184|3607764|FG000|STARTED|Open-label Phase|3 were not included due to low compliance in the double blind phase, 5 didn't want to participate.|102
2899855|NCT00418184|3607765|FG001|STARTED|Open-label Phase|1 was not included due to low compliance in the double blind phase, 3 didn't want to participate.|48
2899856|NCT00418184|3607764|FG000|COMPLETED|Open-label Phase|5 dropped out|97
2899857|NCT00418184|3607765|FG001|COMPLETED|Open-label Phase|5 dropped out|43
2899858|NCT00418184|3607764|FG000|NOT COMPLETED|Open-label Phase||5
2899859|NCT00418184|3607765|FG001|NOT COMPLETED|Open-label Phase||5
2899860|NCT00418262|3607771|FG000|STARTED|Visits 1 (Baseline) Thru 5||27
2899861|NCT00418262|3607771|FG000|COMPLETED|Visits 1 (Baseline) Thru 5||25
2899862|NCT00418262|3607771|FG000|NOT COMPLETED|Visits 1 (Baseline) Thru 5||2
2899863|NCT00418262|3607771|FG000|STARTED|Visits 5 Thru 8||25
2899864|NCT00418262|3607771|FG000|COMPLETED|Visits 5 Thru 8||16
2899865|NCT00418262|3607771|FG000|NOT COMPLETED|Visits 5 Thru 8||9
2899866|NCT00418262|3607771|FG000|STARTED|Visits 8 Thru 10||16
2899867|NCT00418262|3607771|FG000|COMPLETED|Visits 8 Thru 10||11
2899868|NCT00418262|3607771|FG000|NOT COMPLETED|Visits 8 Thru 10||5
2899869|NCT00418314|3607781|FG000|STARTED|Overall Study||817
2899870|NCT00418314|3607782|FG001|STARTED|Overall Study||830
2899871|NCT00418314|3607781|FG000|COMPLETED|Overall Study||816
2899872|NCT00418314|3607782|FG001|COMPLETED|Overall Study||828
2899873|NCT00418314|3607781|FG000|NOT COMPLETED|Overall Study||1
2899874|NCT00418314|3607782|FG001|NOT COMPLETED|Overall Study||2
2899875|NCT00418379|3607791|FG000|STARTED|Year 1||207
2899876|NCT00418379|3607792|FG001|STARTED|Year 1||207
2899877|NCT00418379|3607793|FG002|STARTED|Year 1||219
2899878|NCT00418379|3607791|FG000|COMPLETED|Year 1||189
2899879|NCT00418379|3607792|FG001|COMPLETED|Year 1||179
2899880|NCT00418379|3607793|FG002|COMPLETED|Year 1||204
2899881|NCT00418379|3607791|FG000|NOT COMPLETED|Year 1||18
2899882|NCT00418379|3607792|FG001|NOT COMPLETED|Year 1||28
2899883|NCT00418379|3607793|FG002|NOT COMPLETED|Year 1||15
2899884|NCT00418379|3607791|FG000|STARTED|Year 2|22 patients withdrew between Year 1 and Year 2 treatment periods.|167
2899885|NCT00418379|3607792|FG001|STARTED|Year 2|20 patients withdrew between Year 1 and Year 2 treatment periods.|159
2899886|NCT00418379|3607793|FG002|STARTED|Year 2|22 patients withdrew between Year 1 and Year 2 treatment periods.|182
2899887|NCT00418379|3607791|FG000|COMPLETED|Year 2||159
2899888|NCT00418379|3607792|FG001|COMPLETED|Year 2||155
2899889|NCT00418379|3607793|FG002|COMPLETED|Year 2||172
2899890|NCT00418379|3607791|FG000|NOT COMPLETED|Year 2||8
2899891|NCT00418379|3607792|FG001|NOT COMPLETED|Year 2||4
2899892|NCT00418379|3607793|FG002|NOT COMPLETED|Year 2||10
2899893|NCT00418379|3607791|FG000|STARTED|Year 3|8 patients withdrew between Year 2 and Year 3 treatment periods.|151
2899894|NCT00418379|3607792|FG001|STARTED|Year 3|7 patients withdrew between Year 2 and Year 3 treatment periods.|148
2899895|NCT00418379|3607793|FG002|STARTED|Year 3|6 patients withdrew between Year 2 and Year 3 treatment periods.|166
2899896|NCT00418379|3607791|FG000|COMPLETED|Year 3||148
2899897|NCT00418379|3607792|FG001|COMPLETED|Year 3||146
2899898|NCT00418379|3607793|FG002|COMPLETED|Year 3||163
2899899|NCT00418379|3607791|FG000|NOT COMPLETED|Year 3||3
2899900|NCT00418379|3607792|FG001|NOT COMPLETED|Year 3||2
2899901|NCT00418379|3607793|FG002|NOT COMPLETED|Year 3||3
2899902|NCT00418379|3607791|FG000|STARTED|Year 4|3 patients withdrew between Year 3 and Year 4 study periods.|145
2899903|NCT00418379|3607792|FG001|STARTED|Year 4|5 patients withdrew between Year 3 and Year 4 study periods.|141
2899904|NCT00418379|3607793|FG002|STARTED|Year 4|7 patients withdrew between Year 3 and Year 4 study periods.|156
2899905|NCT00418379|3607791|FG000|COMPLETED|Year 4||142
2899906|NCT00418379|3607792|FG001|COMPLETED|Year 4||136
2899907|NCT00418379|3607793|FG002|COMPLETED|Year 4||154
2899908|NCT00418379|3607791|FG000|NOT COMPLETED|Year 4||3
2899909|NCT00418379|3607792|FG001|NOT COMPLETED|Year 4||5
2899910|NCT00418379|3607793|FG002|NOT COMPLETED|Year 4||2
2899911|NCT00418379|3607791|FG000|STARTED|Year 5|14 patients withdrew between Year 4 and Year 5 study periods.|128
2899912|NCT00418379|3607792|FG001|STARTED|Year 5|16 patients withdrew between Year 4 and Year 5 study periods.|120
2899913|NCT00418379|3607793|FG002|STARTED|Year 5|20 patients withdrew between Year 4 and Year 5 study periods.|134
2899914|NCT00418379|3607791|FG000|COMPLETED|Year 5||126
2899915|NCT00418379|3607792|FG001|COMPLETED|Year 5||115
2899916|NCT00418379|3607793|FG002|COMPLETED|Year 5||131
2899917|NCT00418379|3607791|FG000|NOT COMPLETED|Year 5||2
2899918|NCT00418379|3607792|FG001|NOT COMPLETED|Year 5||5
2899919|NCT00418379|3607793|FG002|NOT COMPLETED|Year 5||3
2899920|NCT00418457|3607803|FG000|STARTED|Overall Study||1065
2899921|NCT00418457|3607804|FG001|STARTED|Overall Study||1043
2899922|NCT00418457|3607803|FG000|COMPLETED|Overall Study||1065
2899923|NCT00418457|3607804|FG001|COMPLETED|Overall Study||1043
2899924|NCT00418457|3607803|FG000|NOT COMPLETED|Overall Study||0
2899925|NCT00418457|3607804|FG001|NOT COMPLETED|Overall Study||0
2899926|NCT00418522|3607812|FG000|STARTED|Overall Study||219
2899927|NCT00418522|3607813|FG001|STARTED|Overall Study||194
2899928|NCT00418522|3607812|FG000|Received Treatment|Overall Study||212
2899929|NCT00418522|3607813|FG001|Received Treatment|Overall Study||190
2899930|NCT00418522|3607812|FG000|COMPLETED|Overall Study||136
2899931|NCT00418522|3607813|FG001|COMPLETED|Overall Study||152
2899932|NCT00418522|3607812|FG000|NOT COMPLETED|Overall Study||83
2899933|NCT00418522|3607813|FG001|NOT COMPLETED|Overall Study||42
2899934|NCT00418561|3607822|FG000|STARTED|Overall Study||4
2899935|NCT00418561|3607823|FG001|STARTED|Overall Study||5
2899936|NCT00418561|3607824|FG002|STARTED|Overall Study||4
2899937|NCT00418561|3607822|FG000|COMPLETED|Overall Study||4
2899938|NCT00418561|3607823|FG001|COMPLETED|Overall Study||4
2899939|NCT00418561|3607824|FG002|COMPLETED|Overall Study||4
2899940|NCT00418561|3607822|FG000|NOT COMPLETED|Overall Study||0
2899941|NCT00418561|3607823|FG001|NOT COMPLETED|Overall Study||1
2899942|NCT00418561|3607824|FG002|NOT COMPLETED|Overall Study||0
2899943|NCT00418574|3607834|FG000|STARTED|Overall Study||593
2899944|NCT00418574|3607835|FG001|STARTED|Overall Study||295
2899945|NCT00418574|3607834|FG000|TREATED|Overall Study||592
2899946|NCT00418574|3607835|FG001|TREATED|Overall Study||294
2899947|NCT00418574|3607834|FG000|COMPLETED|Overall Study||545
2899948|NCT00418574|3607835|FG001|COMPLETED|Overall Study||272
2899949|NCT00418574|3607834|FG000|NOT COMPLETED|Overall Study||48
2899950|NCT00418574|3607835|FG001|NOT COMPLETED|Overall Study||23
2899951|NCT00418665|3607844|FG000|STARTED|Treatment Period||12
2899952|NCT00418665|3607845|FG001|STARTED|Treatment Period||14
2899953|NCT00418665|3607846|FG002|STARTED|Treatment Period||13
2899954|NCT00418665|3607844|FG000|Received Study Medication|Treatment Period||11
2899955|NCT00418665|3607845|FG001|Received Study Medication|Treatment Period||13
2899956|NCT00418665|3607846|FG002|Received Study Medication|Treatment Period||13
2899957|NCT00418665|3607844|FG000|COMPLETED|Treatment Period||7
2899958|NCT00418665|3607845|FG001|COMPLETED|Treatment Period||8
2899959|NCT00418665|3607846|FG002|COMPLETED|Treatment Period||9
2899960|NCT00418665|3607844|FG000|NOT COMPLETED|Treatment Period||5
2899961|NCT00418665|3607845|FG001|NOT COMPLETED|Treatment Period||6
3171099|NCT01932437|3898303|FG002|COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
3171100|NCT01932437|3898304|FG003|COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
3171101|NCT01932437|3898305|FG004|COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
2899962|NCT00418665|3607846|FG002|NOT COMPLETED|Treatment Period||4
2899963|NCT00418665|3607844|FG000|STARTED|Treatment Extension||7
2899964|NCT00418665|3607845|FG001|STARTED|Treatment Extension||8
2899965|NCT00418665|3607846|FG002|STARTED|Treatment Extension||9
2899966|NCT00418665|3607844|FG000|COMPLETED|Treatment Extension||1
2899967|NCT00418665|3607845|FG001|COMPLETED|Treatment Extension||4
2899968|NCT00418665|3607846|FG002|COMPLETED|Treatment Extension||7
2899969|NCT00418665|3607844|FG000|NOT COMPLETED|Treatment Extension||6
2899970|NCT00418665|3607845|FG001|NOT COMPLETED|Treatment Extension||4
2899971|NCT00418665|3607846|FG002|NOT COMPLETED|Treatment Extension||2
2899972|NCT00418691|3607857|FG000|STARTED|Overall Study||11
2899973|NCT00418691|3607858|FG001|STARTED|Overall Study||12
2899974|NCT00418691|3607859|FG002|STARTED|Overall Study||10
2899975|NCT00418691|3607857|FG000|COMPLETED|Overall Study||9
2899976|NCT00418691|3607858|FG001|COMPLETED|Overall Study||10
2899977|NCT00418691|3607859|FG002|COMPLETED|Overall Study||5
2899978|NCT00418691|3607857|FG000|NOT COMPLETED|Overall Study||2
2899979|NCT00418691|3607858|FG001|NOT COMPLETED|Overall Study||2
2899980|NCT00418691|3607859|FG002|NOT COMPLETED|Overall Study||5
2899981|NCT00418717|3607867|FG000|STARTED|Treatment Period A - Weeks 1-4||42
2899982|NCT00418717|3607867|FG000|COMPLETED|Treatment Period A - Weeks 1-4||41
2899983|NCT00418717|3607867|FG000|NOT COMPLETED|Treatment Period A - Weeks 1-4||1
2899984|NCT00418717|3607867|FG000|STARTED|Treatment Period B - Weeks 5-12||41
2899985|NCT00418717|3607867|FG000|COMPLETED|Treatment Period B - Weeks 5-12||39
2899986|NCT00418717|3607867|FG000|NOT COMPLETED|Treatment Period B - Weeks 5-12||2
2899987|NCT00418886|3607873|FG000|STARTED|Overall Study|randomised patients|256
2899988|NCT00418886|3607874|FG001|STARTED|Overall Study|randomised patients|278
2899989|NCT00418886|3607873|FG000|COMPLETED|Overall Study|ongoing study treatment at data cut-off|30
2899990|NCT00418886|3607874|FG001|COMPLETED|Overall Study|ongoing study treatment at data cut-off|23
2899991|NCT00418886|3607873|FG000|NOT COMPLETED|Overall Study||226
2899992|NCT00418886|3607874|FG001|NOT COMPLETED|Overall Study||255
2899993|NCT00418938|3607882|FG000|STARTED|Overall Study||133
2899994|NCT00418938|3607883|FG001|STARTED|Overall Study||131
2899995|NCT00418938|3607882|FG000|COMPLETED|Overall Study||109
2899996|NCT00418938|3607883|FG001|COMPLETED|Overall Study||108
2899997|NCT00418938|3607882|FG000|NOT COMPLETED|Overall Study||24
2899998|NCT00418938|3607883|FG001|NOT COMPLETED|Overall Study||23
2899999|NCT00418951|3607892|FG000|STARTED|Overall Study||39
2900000|NCT00418951|3607893|FG001|STARTED|Overall Study||33
2900001|NCT00418951|3607894|FG002|STARTED|Overall Study||40
2900002|NCT00418951|3607892|FG000|COMPLETED|Overall Study||39
2900003|NCT00418951|3607893|FG001|COMPLETED|Overall Study||33
2900004|NCT00418951|3607894|FG002|COMPLETED|Overall Study||40
2900005|NCT00418951|3607892|FG000|NOT COMPLETED|Overall Study||0
2900006|NCT00418951|3607893|FG001|NOT COMPLETED|Overall Study||0
2900007|NCT00418951|3607894|FG002|NOT COMPLETED|Overall Study||0
2900008|NCT00418964|3607905|FG000|STARTED|Overall Study||22
2900009|NCT00418964|3607906|FG001|STARTED|Overall Study||20
2900010|NCT00418964|3607907|FG002|STARTED|Overall Study||20
2900011|NCT00418964|3607905|FG000|COMPLETED|Overall Study||21
2900012|NCT00418964|3607906|FG001|COMPLETED|Overall Study||17
2900013|NCT00418964|3607907|FG002|COMPLETED|Overall Study||14
2900014|NCT00418964|3607905|FG000|NOT COMPLETED|Overall Study||1
2900015|NCT00418964|3607906|FG001|NOT COMPLETED|Overall Study||3
2900016|NCT00418964|3607907|FG002|NOT COMPLETED|Overall Study||6
2920122|NCT00535587|3630575|FG002|COMPLETED|Overall Study||39
2920123|NCT00535587|3630576|FG003|COMPLETED|Overall Study||41
2920124|NCT00535587|3630573|FG000|NOT COMPLETED|Overall Study||10
2920125|NCT00535587|3630574|FG001|NOT COMPLETED|Overall Study||11
2920126|NCT00535587|3630575|FG002|NOT COMPLETED|Overall Study||8
2920127|NCT00535587|3630576|FG003|NOT COMPLETED|Overall Study||13
2920128|NCT00535613|3630586|FG000|STARTED|Overall Study||49
2920129|NCT00535613|3630587|FG001|STARTED|Overall Study||50
2920130|NCT00535613|3630586|FG000|COMPLETED|Overall Study||49
2920131|NCT00535613|3630587|FG001|COMPLETED|Overall Study||50
2920132|NCT00535613|3630586|FG000|NOT COMPLETED|Overall Study||0
2920133|NCT00535613|3630587|FG001|NOT COMPLETED|Overall Study||0
2920134|NCT00535626|3630593|FG000|STARTED|Overall Study||190
2920135|NCT00535626|3630593|FG000|COMPLETED|Overall Study||85
2920136|NCT00535626|3630593|FG000|NOT COMPLETED|Overall Study||105
2920137|NCT00535652|3630598|FG000|STARTED|Overall Study||23
2920138|NCT00535652|3630598|FG000|COMPLETED|Overall Study||20
2920139|NCT00535652|3630598|FG000|NOT COMPLETED|Overall Study||3
2920140|NCT00535730|3630604|FG000|STARTED|Overall Study||236
2920141|NCT00535730|3630605|FG001|STARTED|Overall Study|Two subjects were allocated but not vaccinated making the number of subjects vaccinated 235|237
2920142|NCT00535730|3630604|FG000|COMPLETED|Overall Study||234
2920143|NCT00535730|3630605|FG001|COMPLETED|Overall Study||230
2920144|NCT00535730|3630604|FG000|NOT COMPLETED|Overall Study||2
2920145|NCT00535730|3630605|FG001|NOT COMPLETED|Overall Study||7
2920146|NCT00535743|3630636|FG000|STARTED|Overall Study||5
2920147|NCT00535743|3630637|FG001|STARTED|Overall Study||11
2920148|NCT00535743|3630638|FG002|STARTED|Overall Study||11
2920149|NCT00535743|3630639|FG003|STARTED|Overall Study||11
2920150|NCT00535743|3630640|FG004|STARTED|Overall Study||11
2920151|NCT00535743|3630641|FG005|STARTED|Overall Study||10
2920152|NCT00535743|3630642|FG006|STARTED|Overall Study||3
2900017|NCT00418977|3607917|FG000|STARTED|Overall Study||43
2900018|NCT00418977|3607918|FG001|STARTED|Overall Study||16
2900019|NCT00418977|3607917|FG000|COMPLETED|Overall Study||40
2900020|NCT00418977|3607918|FG001|COMPLETED|Overall Study||13
2900021|NCT00418977|3607917|FG000|NOT COMPLETED|Overall Study||3
2900022|NCT00418977|3607918|FG001|NOT COMPLETED|Overall Study||3
2900023|NCT00419003|3607926|FG000|STARTED|Phase I, Ketamine Infusion||13
2900024|NCT00419003|3607927|FG001|STARTED|Phase I, Ketamine Infusion||13
2900025|NCT00419003|3607926|FG000|COMPLETED|Phase I, Ketamine Infusion||7
2900026|NCT00419003|3607927|FG001|COMPLETED|Phase I, Ketamine Infusion||7
2900027|NCT00419003|3607926|FG000|NOT COMPLETED|Phase I, Ketamine Infusion||6
2900028|NCT00419003|3607927|FG001|NOT COMPLETED|Phase I, Ketamine Infusion||6
2900029|NCT00419003|3607926|FG000|STARTED|Phase 2, Riluzole/Placebo Follow-Up|14 completers of phase I didn't split up evenly (same way as phase I) in the riluzole/placebo phase.|6
2900030|NCT00419003|3607927|FG001|STARTED|Phase 2, Riluzole/Placebo Follow-Up|14 completers of phase I didn't split up evenly (same way as phase I) in the riluzole/placebo phase.|8
2900031|NCT00419003|3607926|FG000|COMPLETED|Phase 2, Riluzole/Placebo Follow-Up||5
2900032|NCT00419003|3607927|FG001|COMPLETED|Phase 2, Riluzole/Placebo Follow-Up||8
2900033|NCT00419003|3607926|FG000|NOT COMPLETED|Phase 2, Riluzole/Placebo Follow-Up||1
3316137|NCT03106870|4049413|FG000|COMPLETED|Overall Study||31
3316138|NCT03106870|4049414|FG001|COMPLETED|Overall Study||31
3316139|NCT03106870|4049413|FG000|NOT COMPLETED|Overall Study||0
3316140|NCT03106870|4049414|FG001|NOT COMPLETED|Overall Study||0
3316141|NCT03107026|4049423|FG000|STARTED|Overall Study||163
2900034|NCT00419003|3607927|FG001|NOT COMPLETED|Phase 2, Riluzole/Placebo Follow-Up||0
3171102|NCT01932437|3898306|FG005|COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||5
3171103|NCT01932437|3898301|FG000|NOT COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
3171104|NCT01932437|3898302|FG001|NOT COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
3171105|NCT01932437|3898303|FG002|NOT COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
3171106|NCT01932437|3898304|FG003|NOT COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
3171107|NCT01932437|3898305|FG004|NOT COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
2900035|NCT00419094|3607938|FG000|STARTED|Overall Study|Number started refers to number randomized; 303 subjects were screened/enrolled and 228 randomized.|57
2900036|NCT00419094|3607939|FG001|STARTED|Overall Study||171
2900037|NCT00419094|3607938|FG000|COMPLETED|Overall Study||50
2900038|NCT00419094|3607939|FG001|COMPLETED|Overall Study||141
2900039|NCT00419094|3607938|FG000|NOT COMPLETED|Overall Study||7
2900040|NCT00419094|3607939|FG001|NOT COMPLETED|Overall Study||30
2900041|NCT00419120|3607945|FG000|STARTED|Primary Study Period||10
2900042|NCT00419120|3607945|FG000|COMPLETED|Primary Study Period||10
2900043|NCT00419120|3607945|FG000|NOT COMPLETED|Primary Study Period||0
2900044|NCT00419120|3607945|FG000|STARTED|Long Term Follow up Period|10 patients are being followed in long term follow up.|10
2900045|NCT00419120|3607945|FG000|COMPLETED|Long Term Follow up Period||0
2900046|NCT00419120|3607945|FG000|NOT COMPLETED|Long Term Follow up Period||10
2900047|NCT00419159|3607951|FG000|STARTED|Overall Study|Full Analysis Set|99
2900048|NCT00419159|3607952|FG001|STARTED|Overall Study||100
2900049|NCT00419159|3607951|FG000|COMPLETED|Overall Study||0
2900050|NCT00419159|3607952|FG001|COMPLETED|Overall Study||0
2900051|NCT00419159|3607951|FG000|NOT COMPLETED|Overall Study||99
2900052|NCT00419159|3607952|FG001|NOT COMPLETED|Overall Study||100
2900053|NCT00419263|3607969|FG000|STARTED|Overall Study||115
2900054|NCT00419263|3607970|FG001|STARTED|Overall Study||114
2900055|NCT00419263|3607971|FG002|STARTED|Overall Study||115
2900056|NCT00419263|3607969|FG000|COMPLETED|Overall Study||112
2900057|NCT00419263|3607970|FG001|COMPLETED|Overall Study||112
2900058|NCT00419263|3607971|FG002|COMPLETED|Overall Study||112
2900059|NCT00419263|3607969|FG000|NOT COMPLETED|Overall Study||3
2900060|NCT00419263|3607970|FG001|NOT COMPLETED|Overall Study||2
2900061|NCT00419263|3607971|FG002|NOT COMPLETED|Overall Study||3
2900062|NCT00419315|3607982|FG000|STARTED|Overall Study||85
2900063|NCT00419315|3607983|FG001|STARTED|Overall Study||78
2900064|NCT00419315|3607982|FG000|COMPLETED|Overall Study||85
2900065|NCT00419315|3607983|FG001|COMPLETED|Overall Study||78
2900066|NCT00419315|3607982|FG000|NOT COMPLETED|Overall Study||0
2900067|NCT00419315|3607983|FG001|NOT COMPLETED|Overall Study||0
2900068|NCT00419341|3607989|FG000|STARTED|Wash in/Wash Out Period||49
2900069|NCT00419341|3607989|FG000|COMPLETED|Wash in/Wash Out Period||38
2900070|NCT00419341|3607989|FG000|NOT COMPLETED|Wash in/Wash Out Period||11
2900071|NCT00419341|3607989|FG000|STARTED|Efficacy Period||38
2900072|NCT00419341|3607989|FG000|COMPLETED|Efficacy Period||28
2900073|NCT00419341|3607989|FG000|NOT COMPLETED|Efficacy Period||10
2900074|NCT00419380|3607997|FG000|STARTED|Overall Study||19
2900075|NCT00419380|3607998|FG001|STARTED|Overall Study||22
3316142|NCT03107026|4049424|FG001|STARTED|Overall Study||161
2900076|NCT00419380|3607997|FG000|COMPLETED|Overall Study||18
2900077|NCT00419380|3607998|FG001|COMPLETED|Overall Study||12
2900078|NCT00419380|3607997|FG000|NOT COMPLETED|Overall Study||1
2900079|NCT00419380|3607998|FG001|NOT COMPLETED|Overall Study||10
2900080|NCT00419393|3608004|FG000|STARTED|Overall Study|One subject did not receive medication|190
2900081|NCT00419393|3608004|FG000|COMPLETED|Overall Study||166
2900082|NCT00419393|3608004|FG000|NOT COMPLETED|Overall Study||24
2900083|NCT00419445|3608011|FG000|STARTED|Overall Study||8
2900084|NCT00419445|3608012|FG001|STARTED|Overall Study||16
2900085|NCT00419445|3608013|FG002|STARTED|Overall Study||8
2900086|NCT00419445|3608011|FG000|COMPLETED|Overall Study||7
2900087|NCT00419445|3608012|FG001|COMPLETED|Overall Study||14
2900088|NCT00419445|3608013|FG002|COMPLETED|Overall Study||7
2900089|NCT00419445|3608011|FG000|NOT COMPLETED|Overall Study||1
2900090|NCT00419445|3608012|FG001|NOT COMPLETED|Overall Study||2
2900091|NCT00419445|3608013|FG002|NOT COMPLETED|Overall Study||1
2900092|NCT00419562|3608023|FG000|STARTED|Overall Study||283
2900093|NCT00419562|3608024|FG001|STARTED|Overall Study||277
2900094|NCT00419562|3608023|FG000|COMPLETED|Overall Study||250
2900095|NCT00419562|3608024|FG001|COMPLETED|Overall Study||246
2900096|NCT00419562|3608023|FG000|NOT COMPLETED|Overall Study||33
2900097|NCT00419562|3608024|FG001|NOT COMPLETED|Overall Study||31
2900098|NCT00419666|3608030|FG000|STARTED|Overall Study||25
2900099|NCT00419666|3608030|FG000|COMPLETED|Overall Study||25
2900100|NCT00419666|3608030|FG000|NOT COMPLETED|Overall Study||0
2900101|NCT00419744|3608037|FG000|STARTED|Overall Study||407
2900102|NCT00419744|3608038|FG001|STARTED|Overall Study||408
2900103|NCT00419744|3608039|FG002|STARTED|Overall Study||404
2900104|NCT00419744|3608037|FG000|COMPLETED|Overall Study||290
2900105|NCT00419744|3608038|FG001|COMPLETED|Overall Study||290
2900106|NCT00419744|3608039|FG002|COMPLETED|Overall Study||271
2900107|NCT00419744|3608037|FG000|NOT COMPLETED|Overall Study||117
2900108|NCT00419744|3608038|FG001|NOT COMPLETED|Overall Study||118
2900109|NCT00419744|3608039|FG002|NOT COMPLETED|Overall Study||133
2900110|NCT00419757|3608049|FG000|STARTED|Overall Study|Randomized patients|127
2900111|NCT00419757|3608050|FG001|STARTED|Overall Study|Randomized patients|123
2900112|NCT00419757|3608049|FG000|COMPLETED|Overall Study|Randomized patients|109
2900113|NCT00419757|3608050|FG001|COMPLETED|Overall Study|Randomized patients|102
2900114|NCT00419757|3608049|FG000|NOT COMPLETED|Overall Study||18
2900115|NCT00419757|3608050|FG001|NOT COMPLETED|Overall Study||21
2900116|NCT00419770|3608060|FG000|STARTED|Overall Study||11
2900117|NCT00419770|3608061|FG001|STARTED|Overall Study||9
2900118|NCT00419770|3608060|FG000|COMPLETED|Overall Study||6
2900119|NCT00419770|3608061|FG001|COMPLETED|Overall Study||8
2900120|NCT00419770|3608060|FG000|NOT COMPLETED|Overall Study||5
2900121|NCT00419770|3608061|FG001|NOT COMPLETED|Overall Study||1
2900122|NCT00419926|3608069|FG000|STARTED|Overall Study|Intention to treat population, 150 is safety population.|155
2900123|NCT00419926|3608070|FG001|STARTED|Overall Study|Intention to treat population, 154 is safety population.|158
2900124|NCT00419926|3608069|FG000|COMPLETED|Overall Study||141
2900125|NCT00419926|3608070|FG001|COMPLETED|Overall Study||148
2900126|NCT00419926|3608069|FG000|NOT COMPLETED|Overall Study||14
2900127|NCT00419926|3608070|FG001|NOT COMPLETED|Overall Study||10
2900128|NCT00419952|3608078|FG000|STARTED|Overall Study||377
2900129|NCT00419952|3608079|FG001|STARTED|Overall Study||365
2900130|NCT00419952|3608078|FG000|COMPLETED|Overall Study||228
2900131|NCT00419952|3608079|FG001|COMPLETED|Overall Study||240
2900132|NCT00419952|3608078|FG000|NOT COMPLETED|Overall Study||149
2900133|NCT00419952|3608079|FG001|NOT COMPLETED|Overall Study||125
2900134|NCT00420004|3608088|FG000|STARTED|Overall Study||269
2900135|NCT00420004|3608089|FG001|STARTED|Overall Study||138
2900136|NCT00420004|3608090|FG002|STARTED|Overall Study||62
2900137|NCT00420004|3608088|FG000|Received at Least 1 Dose of Study Drug|Overall Study|Participants who received >=1 dose of study drug and had baseline and post-baseline data available|249
2900138|NCT00420004|3608089|FG001|Received at Least 1 Dose of Study Drug|Overall Study|Participants who received >=1 dose of study drug and had baseline and post-baseline data available|122
2900139|NCT00420004|3608090|FG002|Received at Least 1 Dose of Study Drug|Overall Study|Participants who received >=1 dose of study drug and had baseline and post-baseline data available|54
2900140|NCT00420004|3608088|FG000|COMPLETED|Overall Study||140
2900141|NCT00420004|3608089|FG001|COMPLETED|Overall Study||67
2900142|NCT00420004|3608090|FG002|COMPLETED|Overall Study||30
2900143|NCT00420004|3608088|FG000|NOT COMPLETED|Overall Study||129
2900144|NCT00420004|3608089|FG001|NOT COMPLETED|Overall Study||71
2900145|NCT00420004|3608090|FG002|NOT COMPLETED|Overall Study||32
2900146|NCT00420017|3608104|FG000|STARTED|Overall Study||40
2900147|NCT00420017|3608105|FG001|STARTED|Overall Study||40
2900148|NCT00420017|3608104|FG000|COMPLETED|Overall Study|40 completed analysis|38
2900149|NCT00420017|3608105|FG001|COMPLETED|Overall Study||40
2900150|NCT00420017|3608104|FG000|NOT COMPLETED|Overall Study||2
2900151|NCT00420017|3608105|FG001|NOT COMPLETED|Overall Study||0
2900152|NCT00420056|3608111|FG000|STARTED|Overall Study||17
2900153|NCT00420056|3608111|FG000|COMPLETED|Overall Study||0
2900154|NCT00420056|3608111|FG000|NOT COMPLETED|Overall Study||17
2900155|NCT00420095|3608117|FG000|STARTED|Overall Study||57
2900156|NCT00420095|3608118|FG001|STARTED|Overall Study||60
2900157|NCT00420095|3608117|FG000|COMPLETED|Overall Study||54
2900158|NCT00420095|3608118|FG001|COMPLETED|Overall Study||59
2900159|NCT00420095|3608117|FG000|NOT COMPLETED|Overall Study||3
2900160|NCT00420095|3608118|FG001|NOT COMPLETED|Overall Study||1
2900161|NCT00420147|3608126|FG000|STARTED|Overall Study||19
2900162|NCT00420147|3608127|FG001|STARTED|Overall Study||19
2900163|NCT00420147|3608126|FG000|COMPLETED|Overall Study||19
2900164|NCT00420147|3608127|FG001|COMPLETED|Overall Study||19
2900165|NCT00420147|3608126|FG000|NOT COMPLETED|Overall Study||0
2900166|NCT00420147|3608127|FG001|NOT COMPLETED|Overall Study||0
2900167|NCT00420199|3608135|FG000|STARTED|Overall Study||27
2900168|NCT00420199|3608136|FG001|STARTED|Overall Study||23
2900169|NCT00420199|3608135|FG000|COMPLETED|Overall Study||26
2900170|NCT00420199|3608136|FG001|COMPLETED|Overall Study||23
2900171|NCT00420199|3608135|FG000|NOT COMPLETED|Overall Study||1
2900172|NCT00420199|3608136|FG001|NOT COMPLETED|Overall Study||0
2900173|NCT00420212|3608150|FG000|STARTED|Overall Study|408 participants were dosed; 410 participants were randomized|408
2920153|NCT00535743|3630643|FG007|STARTED|Overall Study||5
2900174|NCT00420212|3608151|FG001|STARTED|Overall Study|410 participants were dosed; 411 participants were randomized|410
2900175|NCT00420212|3608152|FG002|STARTED|Overall Study|416 participants were dosed; 416 participants were randomized|416
2900176|NCT00420212|3608150|FG000|COMPLETED|Overall Study||317
2900177|NCT00420212|3608151|FG001|COMPLETED|Overall Study||315
2900178|NCT00420212|3608152|FG002|COMPLETED|Overall Study||320
2900179|NCT00420212|3608150|FG000|NOT COMPLETED|Overall Study||91
2900180|NCT00420212|3608151|FG001|NOT COMPLETED|Overall Study||95
2900181|NCT00420212|3608152|FG002|NOT COMPLETED|Overall Study||96
2900182|NCT00420238|3608165|FG000|STARTED|12 Week Double-Blind Treatment Period 1||39
2900183|NCT00420238|3608166|FG001|STARTED|12 Week Double-Blind Treatment Period 1||43
2900184|NCT00420238|3608165|FG000|COMPLETED|12 Week Double-Blind Treatment Period 1||38
2900185|NCT00420238|3608166|FG001|COMPLETED|12 Week Double-Blind Treatment Period 1||39
2900186|NCT00420238|3608165|FG000|NOT COMPLETED|12 Week Double-Blind Treatment Period 1||1
2900187|NCT00420238|3608166|FG001|NOT COMPLETED|12 Week Double-Blind Treatment Period 1||4
2900188|NCT00420238|3608165|FG000|STARTED|12 Week Open-Label Treatment Period 2||38
2900189|NCT00420238|3608166|FG001|STARTED|12 Week Open-Label Treatment Period 2||39
2900190|NCT00420238|3608165|FG000|COMPLETED|12 Week Open-Label Treatment Period 2||36
2900191|NCT00420238|3608166|FG001|COMPLETED|12 Week Open-Label Treatment Period 2||38
2900192|NCT00420238|3608165|FG000|NOT COMPLETED|12 Week Open-Label Treatment Period 2||2
2900193|NCT00420238|3608166|FG001|NOT COMPLETED|12 Week Open-Label Treatment Period 2||1
2900194|NCT00420290|3608180|FG000|STARTED|Overall Study||11
2900195|NCT00420290|3608181|FG001|STARTED|Overall Study||11
2900196|NCT00420290|3608180|FG000|COMPLETED|Overall Study||7
2900197|NCT00420290|3608181|FG001|COMPLETED|Overall Study||7
2900198|NCT00420290|3608180|FG000|NOT COMPLETED|Overall Study||4
2900199|NCT00420290|3608181|FG001|NOT COMPLETED|Overall Study||4
2900200|NCT00420303|3608189|FG000|STARTED|Overall Study||12
2900201|NCT00420303|3608190|FG001|STARTED|Overall Study||12
2900202|NCT00420303|3608189|FG000|COMPLETED|Overall Study||11
2900203|NCT00420303|3608190|FG001|COMPLETED|Overall Study||8
2900204|NCT00420303|3608189|FG000|NOT COMPLETED|Overall Study||1
2900205|NCT00420303|3608190|FG001|NOT COMPLETED|Overall Study||4
2900206|NCT00420316|3608198|FG000|STARTED|Overall Study||1082
2900207|NCT00420316|3608199|FG001|STARTED|Overall Study||531
2900208|NCT00420316|3608198|FG000|COMPLETED|Overall Study||1070
2900209|NCT00420316|3608199|FG001|COMPLETED|Overall Study||522
2900210|NCT00420316|3608198|FG000|NOT COMPLETED|Overall Study||12
2900211|NCT00420316|3608199|FG001|NOT COMPLETED|Overall Study||9
2900212|NCT00420342|3608208|FG000|STARTED|Overall Study||30
2900213|NCT00420342|3608209|FG001|STARTED|Overall Study||33
2900214|NCT00420342|3608210|FG002|STARTED|Overall Study||29
2900215|NCT00420342|3608208|FG000|Received Treatment|Overall Study|1 subject did not confirm if she ever took the study medication.|29
2900216|NCT00420342|3608209|FG001|Received Treatment|Overall Study|1 subject did not confirm if she ever took the study medication.|32
2900217|NCT00420342|3608210|FG002|Received Treatment|Overall Study||29
2900218|NCT00420342|3608208|FG000|COMPLETED|Overall Study||29
2900219|NCT00420342|3608209|FG001|COMPLETED|Overall Study||31
2900220|NCT00420342|3608210|FG002|COMPLETED|Overall Study||28
2900221|NCT00420342|3608208|FG000|NOT COMPLETED|Overall Study||1
2900222|NCT00420342|3608209|FG001|NOT COMPLETED|Overall Study||2
2900223|NCT00420342|3608210|FG002|NOT COMPLETED|Overall Study||1
2900224|NCT00420381|3608218|FG000|STARTED|Overall Study||28
2900225|NCT00420381|3608218|FG000|Received at Least One Dose of Study Drug|Overall Study||27
2900226|NCT00420381|3608218|FG000|COMPLETED|Overall Study||27
2900227|NCT00420381|3608218|FG000|NOT COMPLETED|Overall Study||1
2900228|NCT00420407|3608224|FG000|STARTED|Overall Study||41
2900229|NCT00420407|3608225|FG001|STARTED|Overall Study||40
2900230|NCT00420407|3608224|FG000|COMPLETED|Overall Study||37
2900231|NCT00420407|3608225|FG001|COMPLETED|Overall Study||34
2900232|NCT00420407|3608224|FG000|NOT COMPLETED|Overall Study||4
2900233|NCT00420407|3608225|FG001|NOT COMPLETED|Overall Study||6
2900234|NCT00420420|3608234|FG000|STARTED|Overall Study|Number of patients randomized.|73
2900235|NCT00420420|3608235|FG001|STARTED|Overall Study|Number of patients randomized.|71
2900236|NCT00420420|3608234|FG000|COMPLETED|Overall Study|One patient from the MK-0249 arm discontinued the trial due to an AE prior to receiving study drug.|65
2900237|NCT00420420|3608235|FG001|COMPLETED|Overall Study||67
2900238|NCT00420420|3608234|FG000|NOT COMPLETED|Overall Study||8
2900239|NCT00420420|3608235|FG001|NOT COMPLETED|Overall Study||4
2900240|NCT00420459|3608241|FG000|STARTED|Overall Study||12
2900241|NCT00420459|3608241|FG000|COMPLETED|Overall Study||12
2900242|NCT00420459|3608241|FG000|NOT COMPLETED|Overall Study||0
2900243|NCT00420511|3608249|FG000|STARTED|Overall Study||10
2900244|NCT00420511|3608250|FG001|STARTED|Overall Study||11
2900245|NCT00420511|3608249|FG000|COMPLETED|Overall Study||8
2900246|NCT00420511|3608250|FG001|COMPLETED|Overall Study||10
2900247|NCT00420511|3608249|FG000|NOT COMPLETED|Overall Study||2
2900248|NCT00420511|3608250|FG001|NOT COMPLETED|Overall Study||1
2900249|NCT00420628|3608260|FG000|STARTED|Overall Study||72
2900250|NCT00420628|3608261|FG001|STARTED|Overall Study||36
2900251|NCT00420628|3608260|FG000|COMPLETED|Overall Study||63
2900252|NCT00420628|3608261|FG001|COMPLETED|Overall Study||32
2900253|NCT00420628|3608260|FG000|NOT COMPLETED|Overall Study||9
2900254|NCT00420628|3608261|FG001|NOT COMPLETED|Overall Study||4
2900255|NCT00420641|3608270|FG000|STARTED|Overall Study||160
2900256|NCT00420641|3608271|FG001|STARTED|Overall Study||172
2900257|NCT00420641|3608272|FG002|STARTED|Overall Study||172
2900258|NCT00420641|3608270|FG000|COMPLETED|Overall Study||115
2900259|NCT00420641|3608271|FG001|COMPLETED|Overall Study||100
2900260|NCT00420641|3608272|FG002|COMPLETED|Overall Study||128
2900261|NCT00420641|3608270|FG000|NOT COMPLETED|Overall Study||45
2900262|NCT00420641|3608271|FG001|NOT COMPLETED|Overall Study||72
2900263|NCT00420641|3608272|FG002|NOT COMPLETED|Overall Study||44
2900264|NCT00420745|3608282|FG000|STARTED|Overall Study||670
2900265|NCT00420745|3608283|FG001|STARTED|Overall Study||339
2900266|NCT00420745|3608282|FG000|COMPLETED|Overall Study||655
2900267|NCT00420745|3608283|FG001|COMPLETED|Overall Study||333
2900268|NCT00420745|3608282|FG000|NOT COMPLETED|Overall Study||15
2900269|NCT00420745|3608283|FG001|NOT COMPLETED|Overall Study||6
2900270|NCT00420771|3608291|FG000|STARTED|Overall Study||8
2900271|NCT00420771|3608292|FG001|STARTED|Overall Study||11
2900272|NCT00420771|3608291|FG000|COMPLETED|Overall Study||5
2900273|NCT00420771|3608292|FG001|COMPLETED|Overall Study||7
2900274|NCT00420771|3608291|FG000|NOT COMPLETED|Overall Study||3
2900275|NCT00420771|3608292|FG001|NOT COMPLETED|Overall Study||4
2900276|NCT00420784|3608302|FG000|STARTED|Overall Study||115
2900277|NCT00420784|3608303|FG001|STARTED|Overall Study||113
2900278|NCT00420784|3608304|FG002|STARTED|Overall Study||111
2900279|NCT00420784|3608305|FG003|STARTED|Overall Study||114
2900280|NCT00420784|3608302|FG000|COMPLETED|Overall Study||86
2900281|NCT00420784|3608303|FG001|COMPLETED|Overall Study||55
2900282|NCT00420784|3608304|FG002|COMPLETED|Overall Study||58
2900283|NCT00420784|3608305|FG003|COMPLETED|Overall Study||36
2900284|NCT00420784|3608302|FG000|NOT COMPLETED|Overall Study||29
3316143|NCT03107026|4049425|FG002|STARTED|Overall Study||162
3316144|NCT03107026|4049423|FG000|COMPLETED|Overall Study||131
3316145|NCT03107026|4049424|FG001|COMPLETED|Overall Study||123
3316146|NCT03107026|4049425|FG002|COMPLETED|Overall Study||106
3316147|NCT03107026|4049423|FG000|NOT COMPLETED|Overall Study||32
2900285|NCT00420784|3608303|FG001|NOT COMPLETED|Overall Study||58
2900286|NCT00420784|3608304|FG002|NOT COMPLETED|Overall Study||53
2900287|NCT00420784|3608305|FG003|NOT COMPLETED|Overall Study||78
2900288|NCT00420849|3608316|FG000|STARTED|Overall Study||587
2900289|NCT00420849|3608316|FG000|COMPLETED|Overall Study|Participants completed the study upon commercial availability of lenalidomide|256
2900290|NCT00420849|3608316|FG000|NOT COMPLETED|Overall Study||331
2900291|NCT00420927|3608330|FG000|STARTED|Period 1||515
2900292|NCT00420927|3608331|FG001|STARTED|Period 1||517
2900293|NCT00420927|3608332|FG002|STARTED|Period 1|This treatment group is not relevant to Period 1.|0
2900294|NCT00420927|3608333|FG003|STARTED|Period 1|This treatment group is not relevant to Period 1.|0
2900295|NCT00420927|3608334|FG004|STARTED|Period 1|This treatment group is not relevant to Period 1.|0
2900296|NCT00420927|3608335|FG005|STARTED|Period 1|This treatment group is not relevant to Period 1.|0
2900297|NCT00420927|3608336|FG006|STARTED|Period 1|This treatment group is not relevant to Period 1.|0
2900298|NCT00420927|3608330|FG000|COMPLETED|Period 1||466
2900299|NCT00420927|3608331|FG001|COMPLETED|Period 1||460
2900300|NCT00420927|3608332|FG002|COMPLETED|Period 1||0
2900301|NCT00420927|3608333|FG003|COMPLETED|Period 1||0
2900302|NCT00420927|3608334|FG004|COMPLETED|Period 1||0
2900303|NCT00420927|3608335|FG005|COMPLETED|Period 1||0
2900304|NCT00420927|3608336|FG006|COMPLETED|Period 1||0
2900305|NCT00420927|3608330|FG000|NOT COMPLETED|Period 1||49
3171108|NCT01932437|3898306|FG005|NOT COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||1
3171109|NCT01932606|3898329|FG000|STARTED|Overall Study||14
2900306|NCT00420927|3608331|FG001|NOT COMPLETED|Period 1||57
2900307|NCT00420927|3608332|FG002|NOT COMPLETED|Period 1||0
2900308|NCT00420927|3608333|FG003|NOT COMPLETED|Period 1||0
2900309|NCT00420927|3608334|FG004|NOT COMPLETED|Period 1||0
2900310|NCT00420927|3608335|FG005|NOT COMPLETED|Period 1||0
2900311|NCT00420927|3608336|FG006|NOT COMPLETED|Period 1||0
2900312|NCT00420927|3608330|FG000|STARTED|Period 2|This treatment group is not relevant to Period 2.|0
2900313|NCT00420927|3608331|FG001|STARTED|Period 2|This treatment group is not relevant to Period 2.|0
2900314|NCT00420927|3608332|FG002|STARTED|Period 2||102
2900315|NCT00420927|3608333|FG003|STARTED|Period 2||105
2900316|NCT00420927|3608334|FG004|STARTED|Period 2||259
2900317|NCT00420927|3608335|FG005|STARTED|Period 2||112
2900318|NCT00420927|3608336|FG006|STARTED|Period 2||348
2900319|NCT00420927|3608330|FG000|COMPLETED|Period 2||0
2900320|NCT00420927|3608331|FG001|COMPLETED|Period 2||0
2900321|NCT00420927|3608332|FG002|COMPLETED|Period 2||89
2900322|NCT00420927|3608333|FG003|COMPLETED|Period 2||95
2900323|NCT00420927|3608334|FG004|COMPLETED|Period 2||216
2900324|NCT00420927|3608335|FG005|COMPLETED|Period 2||97
2900325|NCT00420927|3608336|FG006|COMPLETED|Period 2||295
2900326|NCT00420927|3608330|FG000|NOT COMPLETED|Period 2||0
2900327|NCT00420927|3608331|FG001|NOT COMPLETED|Period 2||0
2900328|NCT00420927|3608332|FG002|NOT COMPLETED|Period 2||13
2900329|NCT00420927|3608333|FG003|NOT COMPLETED|Period 2||10
2900330|NCT00420927|3608334|FG004|NOT COMPLETED|Period 2||43
2900331|NCT00420927|3608335|FG005|NOT COMPLETED|Period 2||15
2900332|NCT00420927|3608336|FG006|NOT COMPLETED|Period 2||53
2900333|NCT00420992|3608352|FG000|STARTED|Titration Phase|All patients received ALO-01 during open-label titration phase|547
2900334|NCT00420992|3608353|FG001|STARTED|Titration Phase||0
2900335|NCT00420992|3608352|FG000|COMPLETED|Titration Phase||344
2900336|NCT00420992|3608353|FG001|COMPLETED|Titration Phase||0
2900337|NCT00420992|3608352|FG000|NOT COMPLETED|Titration Phase||203
2900338|NCT00420992|3608353|FG001|NOT COMPLETED|Titration Phase||0
3171110|NCT01932606|3898330|FG001|STARTED|Overall Study||14
3316148|NCT03107026|4049424|FG001|NOT COMPLETED|Overall Study||38
3316149|NCT03107026|4049425|FG002|NOT COMPLETED|Overall Study||56
2900339|NCT00420992|3608352|FG000|STARTED|Maintenance Phase||171
2900340|NCT00420992|3608353|FG001|STARTED|Maintenance Phase||173
2900341|NCT00420992|3608352|FG000|COMPLETED|Maintenance Phase||110
2900342|NCT00420992|3608353|FG001|COMPLETED|Maintenance Phase||98
2900343|NCT00420992|3608352|FG000|NOT COMPLETED|Maintenance Phase||61
2900344|NCT00420992|3608353|FG001|NOT COMPLETED|Maintenance Phase||75
2900345|NCT00421148|3608380|FG000|STARTED|Overall Study||2
2900346|NCT00421148|3608381|FG001|STARTED|Overall Study||2
2900347|NCT00421148|3608382|FG002|STARTED|Overall Study||2
2900348|NCT00421148|3608383|FG003|STARTED|Overall Study||1
2900349|NCT00421148|3608384|FG004|STARTED|Overall Study||1
2900350|NCT00421148|3608385|FG005|STARTED|Overall Study||5
2900351|NCT00421148|3608386|FG006|STARTED|Overall Study||6
2900352|NCT00421148|3608387|FG007|STARTED|Overall Study||5
2900353|NCT00421148|3608388|FG008|STARTED|Overall Study||5
2900354|NCT00421148|3608389|FG009|STARTED|Overall Study||5
2900355|NCT00421148|3608390|FG010|STARTED|Overall Study||6
2900356|NCT00421148|3608391|FG011|STARTED|Overall Study||6
2900357|NCT00421148|3608392|FG012|STARTED|Overall Study||6
2900358|NCT00421148|3608393|FG013|STARTED|Overall Study||6
2900359|NCT00421148|3608394|FG014|STARTED|Overall Study||6
2900360|NCT00421148|3608395|FG015|STARTED|Overall Study||6
2900361|NCT00421148|3608396|FG016|STARTED|Overall Study||6
2900362|NCT00421148|3608397|FG017|STARTED|Overall Study||6
2900363|NCT00421148|3608398|FG018|STARTED|Overall Study||6
2900364|NCT00421148|3608399|FG019|STARTED|Overall Study||6
3171111|NCT01932606|3898329|FG000|COMPLETED|Overall Study||14
3171112|NCT01932606|3898330|FG001|COMPLETED|Overall Study||14
3171113|NCT01932606|3898329|FG000|NOT COMPLETED|Overall Study||0
2900365|NCT00421148|3608380|FG000|Treated|Overall Study||2
2900366|NCT00421148|3608381|FG001|Treated|Overall Study||2
2900367|NCT00421148|3608382|FG002|Treated|Overall Study||2
2900368|NCT00421148|3608383|FG003|Treated|Overall Study||1
2900369|NCT00421148|3608384|FG004|Treated|Overall Study||1
2900370|NCT00421148|3608385|FG005|Treated|Overall Study|1 additional participant discontinued prior to receiving study treatment|4
2900371|NCT00421148|3608386|FG006|Treated|Overall Study||6
2900372|NCT00421148|3608387|FG007|Treated|Overall Study||5
2900373|NCT00421148|3608388|FG008|Treated|Overall Study||5
2900374|NCT00421148|3608389|FG009|Treated|Overall Study|Includes 1 participant who was inadvertently randomized to group but was an adolescent|5
2900375|NCT00421148|3608390|FG010|Treated|Overall Study||6
2900376|NCT00421148|3608391|FG011|Treated|Overall Study|Includes 1 participant who was inadvertently randomized to group but received 5 mg/kg sugammadex|6
2900377|NCT00421148|3608392|FG012|Treated|Overall Study||6
2900378|NCT00421148|3608393|FG013|Treated|Overall Study||6
2900379|NCT00421148|3608394|FG014|Treated|Overall Study||6
2900380|NCT00421148|3608395|FG015|Treated|Overall Study||6
2900381|NCT00421148|3608396|FG016|Treated|Overall Study||6
2900382|NCT00421148|3608397|FG017|Treated|Overall Study|1 additional participant discontinued prior to receiving study treatment|5
2900383|NCT00421148|3608398|FG018|Treated|Overall Study|1 additional participant discontinued prior to receiving study treatment|5
2900384|NCT00421148|3608399|FG019|Treated|Overall Study||6
2900385|NCT00421148|3608380|FG000|COMPLETED|Overall Study||2
2900386|NCT00421148|3608381|FG001|COMPLETED|Overall Study||2
2900387|NCT00421148|3608382|FG002|COMPLETED|Overall Study||2
2900388|NCT00421148|3608383|FG003|COMPLETED|Overall Study||1
2900389|NCT00421148|3608384|FG004|COMPLETED|Overall Study||1
2900390|NCT00421148|3608385|FG005|COMPLETED|Overall Study||4
2900391|NCT00421148|3608386|FG006|COMPLETED|Overall Study||6
2900392|NCT00421148|3608387|FG007|COMPLETED|Overall Study||5
2900393|NCT00421148|3608388|FG008|COMPLETED|Overall Study||5
2900394|NCT00421148|3608389|FG009|COMPLETED|Overall Study||5
2900395|NCT00421148|3608390|FG010|COMPLETED|Overall Study||6
2900396|NCT00421148|3608391|FG011|COMPLETED|Overall Study||6
2900397|NCT00421148|3608392|FG012|COMPLETED|Overall Study||6
2900398|NCT00421148|3608393|FG013|COMPLETED|Overall Study||6
2900399|NCT00421148|3608394|FG014|COMPLETED|Overall Study||6
2900400|NCT00421148|3608395|FG015|COMPLETED|Overall Study||6
2900401|NCT00421148|3608396|FG016|COMPLETED|Overall Study||6
3171114|NCT01932606|3898330|FG001|NOT COMPLETED|Overall Study||0
3171115|NCT01932697|3898338|FG000|STARTED|Overall Study||38
3171116|NCT01932697|3898339|FG001|STARTED|Overall Study||43
3171117|NCT01932697|3898338|FG000|COMPLETED|Overall Study||36
3171118|NCT01932697|3898339|FG001|COMPLETED|Overall Study||43
3171119|NCT01932697|3898338|FG000|NOT COMPLETED|Overall Study||2
2900402|NCT00421148|3608397|FG017|COMPLETED|Overall Study||4
2900403|NCT00421148|3608398|FG018|COMPLETED|Overall Study||5
2900404|NCT00421148|3608399|FG019|COMPLETED|Overall Study||6
2900405|NCT00421148|3608380|FG000|NOT COMPLETED|Overall Study||0
2900406|NCT00421148|3608381|FG001|NOT COMPLETED|Overall Study||0
2900407|NCT00421148|3608382|FG002|NOT COMPLETED|Overall Study||0
2900408|NCT00421148|3608383|FG003|NOT COMPLETED|Overall Study||0
2900409|NCT00421148|3608384|FG004|NOT COMPLETED|Overall Study||0
2900410|NCT00421148|3608385|FG005|NOT COMPLETED|Overall Study||1
2900411|NCT00421148|3608386|FG006|NOT COMPLETED|Overall Study||0
2900412|NCT00421148|3608387|FG007|NOT COMPLETED|Overall Study||0
2900413|NCT00421148|3608388|FG008|NOT COMPLETED|Overall Study||0
2900414|NCT00421148|3608389|FG009|NOT COMPLETED|Overall Study||0
2900415|NCT00421148|3608390|FG010|NOT COMPLETED|Overall Study||0
2900416|NCT00421148|3608391|FG011|NOT COMPLETED|Overall Study||0
2900417|NCT00421148|3608392|FG012|NOT COMPLETED|Overall Study||0
2900418|NCT00421148|3608393|FG013|NOT COMPLETED|Overall Study||0
2900419|NCT00421148|3608394|FG014|NOT COMPLETED|Overall Study||0
2900420|NCT00421148|3608395|FG015|NOT COMPLETED|Overall Study||0
2900421|NCT00421148|3608396|FG016|NOT COMPLETED|Overall Study||0
2900422|NCT00421148|3608397|FG017|NOT COMPLETED|Overall Study||2
2900423|NCT00421148|3608398|FG018|NOT COMPLETED|Overall Study||1
2900424|NCT00421148|3608399|FG019|NOT COMPLETED|Overall Study||0
2900425|NCT00421174|3608443|FG000|STARTED|Overall Study||18
2900426|NCT00421174|3608444|FG001|STARTED|Overall Study||19
2900427|NCT00421174|3608443|FG000|COMPLETED|Overall Study||16
2900428|NCT00421174|3608444|FG001|COMPLETED|Overall Study||18
2900429|NCT00421174|3608443|FG000|NOT COMPLETED|Overall Study||2
2900430|NCT00421174|3608444|FG001|NOT COMPLETED|Overall Study||1
2900431|NCT00421304|3608453|FG000|STARTED|Overall Study||40
2900432|NCT00421304|3608454|FG001|STARTED|Overall Study||39
2900433|NCT00421304|3608455|FG002|STARTED|Overall Study||39
2900434|NCT00421304|3608453|FG000|COMPLETED|Overall Study||32
2900435|NCT00421304|3608454|FG001|COMPLETED|Overall Study||35
2900436|NCT00421304|3608455|FG002|COMPLETED|Overall Study||31
2900437|NCT00421304|3608453|FG000|NOT COMPLETED|Overall Study||8
2900438|NCT00421304|3608454|FG001|NOT COMPLETED|Overall Study||4
2900439|NCT00421304|3608455|FG002|NOT COMPLETED|Overall Study||8
2900440|NCT00421343|3608465|FG000|STARTED|Overall Study||29
2900441|NCT00421343|3608465|FG000|COMPLETED|Overall Study||23
2900442|NCT00421343|3608465|FG000|NOT COMPLETED|Overall Study||6
2900443|NCT00421408|3608471|FG000|STARTED|Overall Study||102
2900444|NCT00421408|3608472|FG001|STARTED|Overall Study||106
2900445|NCT00421408|3608471|FG000|COMPLETED|Overall Study||60
2900446|NCT00421408|3608472|FG001|COMPLETED|Overall Study||61
2900447|NCT00421408|3608471|FG000|NOT COMPLETED|Overall Study||42
2900448|NCT00421408|3608472|FG001|NOT COMPLETED|Overall Study||45
2900449|NCT00421603|3608480|FG000|STARTED|Overall Study||39
2900450|NCT00421603|3608481|FG001|STARTED|Overall Study||42
2900451|NCT00421603|3608480|FG000|COMPLETED|Overall Study|Completed all 14 week sof trial|28
2900452|NCT00421603|3608481|FG001|COMPLETED|Overall Study|Completed all 14 week sof trial|30
2900453|NCT00421603|3608480|FG000|NOT COMPLETED|Overall Study||11
2900454|NCT00421603|3608481|FG001|NOT COMPLETED|Overall Study||12
2900455|NCT00421707|3608489|FG000|STARTED|Period 1: Treatment Period 1||67
2900456|NCT00421707|3608490|FG001|STARTED|Period 1: Treatment Period 1||65
2900457|NCT00421707|3608489|FG000|COMPLETED|Period 1: Treatment Period 1||56
2900458|NCT00421707|3608490|FG001|COMPLETED|Period 1: Treatment Period 1||56
2900459|NCT00421707|3608489|FG000|NOT COMPLETED|Period 1: Treatment Period 1||11
2900460|NCT00421707|3608490|FG001|NOT COMPLETED|Period 1: Treatment Period 1||9
2900461|NCT00421707|3608489|FG000|STARTED|Period 2: Washout||56
2900462|NCT00421707|3608490|FG001|STARTED|Period 2: Washout||56
2900463|NCT00421707|3608489|FG000|COMPLETED|Period 2: Washout||55
2900464|NCT00421707|3608490|FG001|COMPLETED|Period 2: Washout||52
2900465|NCT00421707|3608489|FG000|NOT COMPLETED|Period 2: Washout||1
2900466|NCT00421707|3608490|FG001|NOT COMPLETED|Period 2: Washout||4
2900467|NCT00421707|3608489|FG000|STARTED|Period 3:Treatment Period 2||55
2900468|NCT00421707|3608490|FG001|STARTED|Period 3:Treatment Period 2||52
2900469|NCT00421707|3608489|FG000|COMPLETED|Period 3:Treatment Period 2||53
2900470|NCT00421707|3608490|FG001|COMPLETED|Period 3:Treatment Period 2||49
2900471|NCT00421707|3608489|FG000|NOT COMPLETED|Period 3:Treatment Period 2||2
2900472|NCT00421707|3608490|FG001|NOT COMPLETED|Period 3:Treatment Period 2||3
2900473|NCT00421733|3608502|FG000|STARTED|Overall Study||93
2900474|NCT00421733|3608503|FG001|STARTED|Overall Study||95
2900475|NCT00421733|3608504|FG002|STARTED|Overall Study||93
2900476|NCT00421733|3608502|FG000|COMPLETED|Overall Study||78
2900477|NCT00421733|3608503|FG001|COMPLETED|Overall Study||69
2900478|NCT00421733|3608504|FG002|COMPLETED|Overall Study||73
2900479|NCT00421733|3608502|FG000|NOT COMPLETED|Overall Study||15
2900480|NCT00421733|3608503|FG001|NOT COMPLETED|Overall Study||26
2900481|NCT00421733|3608504|FG002|NOT COMPLETED|Overall Study||20
2900482|NCT00421889|3608525|FG000|STARTED|Overall Study||5
2900483|NCT00421889|3608526|FG001|STARTED|Overall Study||5
2900484|NCT00421889|3608527|FG002|STARTED|Overall Study||3
2900485|NCT00421889|3608528|FG003|STARTED|Overall Study||4
2900486|NCT00421889|3608529|FG004|STARTED|Overall Study||6
2900487|NCT00421889|3608530|FG005|STARTED|Overall Study||35
2900488|NCT00421889|3608531|FG006|STARTED|Overall Study||4
2900489|NCT00421889|3608532|FG007|STARTED|Overall Study||3
2900490|NCT00421889|3608533|FG008|STARTED|Overall Study||15
2900491|NCT00421889|3608525|FG000|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 5.20|0
2900492|NCT00421889|3608526|FG001|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 8.20|0
2900493|NCT00421889|3608527|FG002|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 3.33|0
2900494|NCT00421889|3608528|FG003|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 9.25|0
2900495|NCT00421889|3608529|FG004|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 5.00|0
2900496|NCT00421889|3608530|FG005|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 7.69|0
2900497|NCT00421889|3608531|FG006|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 5.50|0
2900498|NCT00421889|3608532|FG007|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 3.33|1
2900499|NCT00421889|3608533|FG008|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 4.27|4
2900500|NCT00421889|3608525|FG000|NOT COMPLETED|Overall Study||5
2900501|NCT00421889|3608526|FG001|NOT COMPLETED|Overall Study||5
2900502|NCT00421889|3608527|FG002|NOT COMPLETED|Overall Study||3
2900503|NCT00421889|3608528|FG003|NOT COMPLETED|Overall Study||4
2900504|NCT00421889|3608529|FG004|NOT COMPLETED|Overall Study||6
2900505|NCT00421889|3608530|FG005|NOT COMPLETED|Overall Study||35
2900506|NCT00421889|3608531|FG006|NOT COMPLETED|Overall Study||4
2900507|NCT00421889|3608532|FG007|NOT COMPLETED|Overall Study||2
2900508|NCT00421889|3608533|FG008|NOT COMPLETED|Overall Study||11
2900509|NCT00421928|3608560|FG000|STARTED|Overall Study|2 randomly assigned to this treatment group did not receive drug|344
2900510|NCT00421928|3608561|FG001|STARTED|Overall Study|2 randomly assigned to this treatment group did not receive drug. One subject was enrolled twice.|342
2900511|NCT00421928|3608562|FG002|STARTED|Overall Study|2 randomly assigned to this treatment group did not receive drug|337
2900512|NCT00421928|3608560|FG000|COMPLETED|Overall Study||181
2900513|NCT00421928|3608561|FG001|COMPLETED|Overall Study||118
2900514|NCT00421928|3608562|FG002|COMPLETED|Overall Study||203
2900515|NCT00421928|3608560|FG000|NOT COMPLETED|Overall Study||163
2900516|NCT00421928|3608561|FG001|NOT COMPLETED|Overall Study||224
2900517|NCT00421928|3608562|FG002|NOT COMPLETED|Overall Study||134
2900518|NCT00421993|3608574|FG000|STARTED|Overall Study||419
2900519|NCT00421993|3608575|FG001|STARTED|Overall Study||418
2900520|NCT00421993|3608576|FG002|STARTED|Overall Study||415
2900521|NCT00421993|3608577|FG003|STARTED|Overall Study||418
2900522|NCT00421993|3608574|FG000|COMPLETED|Overall Study||366
2900523|NCT00421993|3608575|FG001|COMPLETED|Overall Study||369
2900524|NCT00421993|3608576|FG002|COMPLETED|Overall Study||363
2900525|NCT00421993|3608577|FG003|COMPLETED|Overall Study||361
2900526|NCT00421993|3608574|FG000|NOT COMPLETED|Overall Study||53
2900527|NCT00421993|3608575|FG001|NOT COMPLETED|Overall Study||49
2900528|NCT00421993|3608576|FG002|NOT COMPLETED|Overall Study||52
2900529|NCT00421993|3608577|FG003|NOT COMPLETED|Overall Study||57
2900530|NCT00422032|3608589|FG000|STARTED|Overall Study||37
2900531|NCT00422032|3608590|FG001|STARTED|Overall Study||21
2900532|NCT00422032|3608589|FG000|COMPLETED|Overall Study||37
2900533|NCT00422032|3608590|FG001|COMPLETED|Overall Study||21
2900534|NCT00422032|3608589|FG000|NOT COMPLETED|Overall Study||0
2900535|NCT00422032|3608590|FG001|NOT COMPLETED|Overall Study||0
2900536|NCT00422058|3608602|FG000|STARTED|Double-Blind, Week 0-20||98
2900537|NCT00422058|3608603|FG001|STARTED|Double-Blind, Week 0-20||95
2900538|NCT00422058|3608604|FG002|STARTED|Double-Blind, Week 0-20||90
2900539|NCT00422058|3608605|FG003|STARTED|Double-Blind, Week 0-20||93
2900540|NCT00422058|3608606|FG004|STARTED|Double-Blind, Week 0-20||93
2900541|NCT00422058|3608607|FG005|STARTED|Double-Blind, Week 0-20||95
2900542|NCT00422058|3608602|FG000|COMPLETED|Double-Blind, Week 0-20||79
2900543|NCT00422058|3608603|FG001|COMPLETED|Double-Blind, Week 0-20||85
2900544|NCT00422058|3608604|FG002|COMPLETED|Double-Blind, Week 0-20||74
2900545|NCT00422058|3608605|FG003|COMPLETED|Double-Blind, Week 0-20||73
2900546|NCT00422058|3608606|FG004|COMPLETED|Double-Blind, Week 0-20||82
2900547|NCT00422058|3608607|FG005|COMPLETED|Double-Blind, Week 0-20||79
2900548|NCT00422058|3608602|FG000|NOT COMPLETED|Double-Blind, Week 0-20||19
2900549|NCT00422058|3608603|FG001|NOT COMPLETED|Double-Blind, Week 0-20||10
2900550|NCT00422058|3608604|FG002|NOT COMPLETED|Double-Blind, Week 0-20||16
2900551|NCT00422058|3608605|FG003|NOT COMPLETED|Double-Blind, Week 0-20||20
2900552|NCT00422058|3608606|FG004|NOT COMPLETED|Double-Blind, Week 0-20||11
2900553|NCT00422058|3608607|FG005|NOT COMPLETED|Double-Blind, Week 0-20||16
2900554|NCT00422058|3608602|FG000|STARTED|Open-Label Extension, Week 20-104||79
2900555|NCT00422058|3608603|FG001|STARTED|Open-Label Extension, Week 20-104||85
2900556|NCT00422058|3608604|FG002|STARTED|Open-Label Extension, Week 20-104||74
2900557|NCT00422058|3608605|FG003|STARTED|Open-Label Extension, Week 20-104||73
2900558|NCT00422058|3608606|FG004|STARTED|Open-Label Extension, Week 20-104||82
2900559|NCT00422058|3608607|FG005|STARTED|Open-Label Extension, Week 20-104||79
2900560|NCT00422058|3608602|FG000|Enrolled in Extension|Open-Label Extension, Week 20-104||67
2900561|NCT00422058|3608603|FG001|Enrolled in Extension|Open-Label Extension, Week 20-104||68
2900562|NCT00422058|3608604|FG002|Enrolled in Extension|Open-Label Extension, Week 20-104||59
2900563|NCT00422058|3608605|FG003|Enrolled in Extension|Open-Label Extension, Week 20-104||65
2900564|NCT00422058|3608606|FG004|Enrolled in Extension|Open-Label Extension, Week 20-104||72
2900565|NCT00422058|3608607|FG005|Enrolled in Extension|Open-Label Extension, Week 20-104||67
2900566|NCT00422058|3608602|FG000|COMPLETED|Open-Label Extension, Week 20-104||47
2900567|NCT00422058|3608603|FG001|COMPLETED|Open-Label Extension, Week 20-104||46
2900568|NCT00422058|3608604|FG002|COMPLETED|Open-Label Extension, Week 20-104||38
2900569|NCT00422058|3608605|FG003|COMPLETED|Open-Label Extension, Week 20-104||45
2900570|NCT00422058|3608606|FG004|COMPLETED|Open-Label Extension, Week 20-104||47
2900571|NCT00422058|3608607|FG005|COMPLETED|Open-Label Extension, Week 20-104||45
2900572|NCT00422058|3608602|FG000|NOT COMPLETED|Open-Label Extension, Week 20-104||32
2900573|NCT00422058|3608603|FG001|NOT COMPLETED|Open-Label Extension, Week 20-104||39
2900574|NCT00422058|3608604|FG002|NOT COMPLETED|Open-Label Extension, Week 20-104||36
2900575|NCT00422058|3608605|FG003|NOT COMPLETED|Open-Label Extension, Week 20-104||28
2900576|NCT00422058|3608606|FG004|NOT COMPLETED|Open-Label Extension, Week 20-104||35
2900577|NCT00422058|3608607|FG005|NOT COMPLETED|Open-Label Extension, Week 20-104||34
2900578|NCT00422084|3608623|FG000|STARTED|Overall Study||849
2900579|NCT00422084|3608624|FG001|STARTED|Overall Study||423
2900580|NCT00422084|3608623|FG000|COMPLETED|Overall Study||751
2900581|NCT00422084|3608624|FG001|COMPLETED|Overall Study||347
2900582|NCT00422084|3608623|FG000|NOT COMPLETED|Overall Study||98
2900583|NCT00422084|3608624|FG001|NOT COMPLETED|Overall Study||76
2900584|NCT00422097|3608636|FG000|STARTED|Dose Level 1||3
2900585|NCT00422097|3608637|FG001|STARTED|Dose Level 1||0
2900586|NCT00422097|3608638|FG002|STARTED|Dose Level 1||0
2900587|NCT00422097|3608639|FG003|STARTED|Dose Level 1||0
2900588|NCT00422097|3608640|FG004|STARTED|Dose Level 1||0
2900589|NCT00422097|3608641|FG005|STARTED|Dose Level 1||0
2900590|NCT00422097|3608642|FG006|STARTED|Dose Level 1||0
2900591|NCT00422097|3608643|FG007|STARTED|Dose Level 1||0
2900592|NCT00422097|3608636|FG000|COMPLETED|Dose Level 1||3
2900593|NCT00422097|3608637|FG001|COMPLETED|Dose Level 1||0
2900594|NCT00422097|3608638|FG002|COMPLETED|Dose Level 1||0
2900595|NCT00422097|3608639|FG003|COMPLETED|Dose Level 1||0
2900596|NCT00422097|3608640|FG004|COMPLETED|Dose Level 1||0
2900597|NCT00422097|3608641|FG005|COMPLETED|Dose Level 1||0
2900598|NCT00422097|3608642|FG006|COMPLETED|Dose Level 1||0
2900599|NCT00422097|3608643|FG007|COMPLETED|Dose Level 1||0
2900600|NCT00422097|3608636|FG000|NOT COMPLETED|Dose Level 1||0
2900601|NCT00422097|3608637|FG001|NOT COMPLETED|Dose Level 1||0
2900602|NCT00422097|3608638|FG002|NOT COMPLETED|Dose Level 1||0
2900603|NCT00422097|3608639|FG003|NOT COMPLETED|Dose Level 1||0
2900604|NCT00422097|3608640|FG004|NOT COMPLETED|Dose Level 1||0
2900605|NCT00422097|3608641|FG005|NOT COMPLETED|Dose Level 1||0
2900606|NCT00422097|3608642|FG006|NOT COMPLETED|Dose Level 1||0
2900607|NCT00422097|3608643|FG007|NOT COMPLETED|Dose Level 1||0
2900608|NCT00422097|3608636|FG000|STARTED|Dose Level 2||0
2900609|NCT00422097|3608637|FG001|STARTED|Dose Level 2||6
2900610|NCT00422097|3608638|FG002|STARTED|Dose Level 2||0
2900611|NCT00422097|3608639|FG003|STARTED|Dose Level 2||0
2900612|NCT00422097|3608640|FG004|STARTED|Dose Level 2||0
2900613|NCT00422097|3608641|FG005|STARTED|Dose Level 2||0
2900614|NCT00422097|3608642|FG006|STARTED|Dose Level 2||0
2900615|NCT00422097|3608643|FG007|STARTED|Dose Level 2||0
2900616|NCT00422097|3608636|FG000|COMPLETED|Dose Level 2||0
2900617|NCT00422097|3608637|FG001|COMPLETED|Dose Level 2||5
2900618|NCT00422097|3608638|FG002|COMPLETED|Dose Level 2||0
2900619|NCT00422097|3608639|FG003|COMPLETED|Dose Level 2||0
2900620|NCT00422097|3608640|FG004|COMPLETED|Dose Level 2||0
2900621|NCT00422097|3608641|FG005|COMPLETED|Dose Level 2||0
2900622|NCT00422097|3608642|FG006|COMPLETED|Dose Level 2||0
2900623|NCT00422097|3608643|FG007|COMPLETED|Dose Level 2||0
2900624|NCT00422097|3608636|FG000|NOT COMPLETED|Dose Level 2||0
2900625|NCT00422097|3608637|FG001|NOT COMPLETED|Dose Level 2||1
2900626|NCT00422097|3608638|FG002|NOT COMPLETED|Dose Level 2||0
2900627|NCT00422097|3608639|FG003|NOT COMPLETED|Dose Level 2||0
2900628|NCT00422097|3608640|FG004|NOT COMPLETED|Dose Level 2||0
2900629|NCT00422097|3608641|FG005|NOT COMPLETED|Dose Level 2||0
2900630|NCT00422097|3608642|FG006|NOT COMPLETED|Dose Level 2||0
2900631|NCT00422097|3608643|FG007|NOT COMPLETED|Dose Level 2||0
2900632|NCT00422097|3608636|FG000|STARTED|Dose Level 3||0
2900633|NCT00422097|3608637|FG001|STARTED|Dose Level 3||0
2900634|NCT00422097|3608638|FG002|STARTED|Dose Level 3||3
2900635|NCT00422097|3608639|FG003|STARTED|Dose Level 3||0
2900636|NCT00422097|3608640|FG004|STARTED|Dose Level 3||0
2900637|NCT00422097|3608641|FG005|STARTED|Dose Level 3||0
2900638|NCT00422097|3608642|FG006|STARTED|Dose Level 3||0
2900639|NCT00422097|3608643|FG007|STARTED|Dose Level 3||0
2900640|NCT00422097|3608636|FG000|COMPLETED|Dose Level 3||0
2900641|NCT00422097|3608637|FG001|COMPLETED|Dose Level 3||0
2900642|NCT00422097|3608638|FG002|COMPLETED|Dose Level 3||3
2900643|NCT00422097|3608639|FG003|COMPLETED|Dose Level 3||0
2900644|NCT00422097|3608640|FG004|COMPLETED|Dose Level 3||0
2900645|NCT00422097|3608641|FG005|COMPLETED|Dose Level 3||0
2900646|NCT00422097|3608642|FG006|COMPLETED|Dose Level 3||0
2900647|NCT00422097|3608643|FG007|COMPLETED|Dose Level 3||0
2900648|NCT00422097|3608636|FG000|NOT COMPLETED|Dose Level 3||0
2900649|NCT00422097|3608637|FG001|NOT COMPLETED|Dose Level 3||0
2900650|NCT00422097|3608638|FG002|NOT COMPLETED|Dose Level 3||0
2900651|NCT00422097|3608639|FG003|NOT COMPLETED|Dose Level 3||0
2900652|NCT00422097|3608640|FG004|NOT COMPLETED|Dose Level 3||0
2900653|NCT00422097|3608641|FG005|NOT COMPLETED|Dose Level 3||0
2900654|NCT00422097|3608642|FG006|NOT COMPLETED|Dose Level 3||0
2900655|NCT00422097|3608643|FG007|NOT COMPLETED|Dose Level 3||0
2900656|NCT00422097|3608636|FG000|STARTED|Dose Level 4||0
2900657|NCT00422097|3608637|FG001|STARTED|Dose Level 4||0
2900658|NCT00422097|3608638|FG002|STARTED|Dose Level 4||0
2900659|NCT00422097|3608639|FG003|STARTED|Dose Level 4||3
2900660|NCT00422097|3608640|FG004|STARTED|Dose Level 4||0
2900661|NCT00422097|3608641|FG005|STARTED|Dose Level 4||0
2900662|NCT00422097|3608642|FG006|STARTED|Dose Level 4||0
2900663|NCT00422097|3608643|FG007|STARTED|Dose Level 4||0
2900664|NCT00422097|3608636|FG000|COMPLETED|Dose Level 4||0
2900665|NCT00422097|3608637|FG001|COMPLETED|Dose Level 4||0
2900666|NCT00422097|3608638|FG002|COMPLETED|Dose Level 4||0
2900667|NCT00422097|3608639|FG003|COMPLETED|Dose Level 4||3
2900668|NCT00422097|3608640|FG004|COMPLETED|Dose Level 4||0
2900669|NCT00422097|3608641|FG005|COMPLETED|Dose Level 4||0
2900670|NCT00422097|3608642|FG006|COMPLETED|Dose Level 4||0
2900671|NCT00422097|3608643|FG007|COMPLETED|Dose Level 4||0
2900672|NCT00422097|3608636|FG000|NOT COMPLETED|Dose Level 4||0
2900673|NCT00422097|3608637|FG001|NOT COMPLETED|Dose Level 4||0
2900674|NCT00422097|3608638|FG002|NOT COMPLETED|Dose Level 4||0
2900675|NCT00422097|3608639|FG003|NOT COMPLETED|Dose Level 4||0
2900676|NCT00422097|3608640|FG004|NOT COMPLETED|Dose Level 4||0
2900677|NCT00422097|3608641|FG005|NOT COMPLETED|Dose Level 4||0
2900678|NCT00422097|3608642|FG006|NOT COMPLETED|Dose Level 4||0
2900679|NCT00422097|3608643|FG007|NOT COMPLETED|Dose Level 4||0
2900680|NCT00422097|3608636|FG000|STARTED|Dose Level 5||0
2900681|NCT00422097|3608637|FG001|STARTED|Dose Level 5||0
2900682|NCT00422097|3608638|FG002|STARTED|Dose Level 5||0
2900683|NCT00422097|3608639|FG003|STARTED|Dose Level 5||0
2900684|NCT00422097|3608640|FG004|STARTED|Dose Level 5||23
2900685|NCT00422097|3608641|FG005|STARTED|Dose Level 5||0
2900686|NCT00422097|3608642|FG006|STARTED|Dose Level 5||0
2900687|NCT00422097|3608643|FG007|STARTED|Dose Level 5||0
2900688|NCT00422097|3608636|FG000|COMPLETED|Dose Level 5||0
2900689|NCT00422097|3608637|FG001|COMPLETED|Dose Level 5||0
2900690|NCT00422097|3608638|FG002|COMPLETED|Dose Level 5||0
2900691|NCT00422097|3608639|FG003|COMPLETED|Dose Level 5||0
2900692|NCT00422097|3608640|FG004|COMPLETED|Dose Level 5||23
2900693|NCT00422097|3608641|FG005|COMPLETED|Dose Level 5||0
2900694|NCT00422097|3608642|FG006|COMPLETED|Dose Level 5||0
2900695|NCT00422097|3608643|FG007|COMPLETED|Dose Level 5||0
2900696|NCT00422097|3608636|FG000|NOT COMPLETED|Dose Level 5||0
2900697|NCT00422097|3608637|FG001|NOT COMPLETED|Dose Level 5||0
2900698|NCT00422097|3608638|FG002|NOT COMPLETED|Dose Level 5||0
2900699|NCT00422097|3608639|FG003|NOT COMPLETED|Dose Level 5||0
2900700|NCT00422097|3608640|FG004|NOT COMPLETED|Dose Level 5||0
2900701|NCT00422097|3608641|FG005|NOT COMPLETED|Dose Level 5||0
2900702|NCT00422097|3608642|FG006|NOT COMPLETED|Dose Level 5||0
2900703|NCT00422097|3608643|FG007|NOT COMPLETED|Dose Level 5||0
2900704|NCT00422097|3608636|FG000|STARTED|Dose Level 6||0
2900705|NCT00422097|3608637|FG001|STARTED|Dose Level 6||0
2900706|NCT00422097|3608638|FG002|STARTED|Dose Level 6||0
2900707|NCT00422097|3608639|FG003|STARTED|Dose Level 6||0
2900708|NCT00422097|3608640|FG004|STARTED|Dose Level 6||0
2900709|NCT00422097|3608641|FG005|STARTED|Dose Level 6||6
2900710|NCT00422097|3608642|FG006|STARTED|Dose Level 6||0
2900711|NCT00422097|3608643|FG007|STARTED|Dose Level 6||0
2900712|NCT00422097|3608636|FG000|COMPLETED|Dose Level 6||0
2900713|NCT00422097|3608637|FG001|COMPLETED|Dose Level 6||0
2900714|NCT00422097|3608638|FG002|COMPLETED|Dose Level 6||0
2900715|NCT00422097|3608639|FG003|COMPLETED|Dose Level 6||0
2900716|NCT00422097|3608640|FG004|COMPLETED|Dose Level 6||0
2900717|NCT00422097|3608641|FG005|COMPLETED|Dose Level 6||6
2900718|NCT00422097|3608642|FG006|COMPLETED|Dose Level 6||0
2900719|NCT00422097|3608643|FG007|COMPLETED|Dose Level 6||0
2900720|NCT00422097|3608636|FG000|NOT COMPLETED|Dose Level 6||0
2900721|NCT00422097|3608637|FG001|NOT COMPLETED|Dose Level 6||0
2900722|NCT00422097|3608638|FG002|NOT COMPLETED|Dose Level 6||0
2900723|NCT00422097|3608639|FG003|NOT COMPLETED|Dose Level 6||0
2900724|NCT00422097|3608640|FG004|NOT COMPLETED|Dose Level 6||0
2900725|NCT00422097|3608641|FG005|NOT COMPLETED|Dose Level 6||0
2900726|NCT00422097|3608642|FG006|NOT COMPLETED|Dose Level 6||0
2900727|NCT00422097|3608643|FG007|NOT COMPLETED|Dose Level 6||0
2900728|NCT00422097|3608636|FG000|STARTED|Ixabepilone With Famotidine or Food||0
2900729|NCT00422097|3608637|FG001|STARTED|Ixabepilone With Famotidine or Food||0
2900730|NCT00422097|3608638|FG002|STARTED|Ixabepilone With Famotidine or Food||0
2900731|NCT00422097|3608639|FG003|STARTED|Ixabepilone With Famotidine or Food||0
2900732|NCT00422097|3608640|FG004|STARTED|Ixabepilone With Famotidine or Food||0
2900733|NCT00422097|3608641|FG005|STARTED|Ixabepilone With Famotidine or Food||0
2900734|NCT00422097|3608642|FG006|STARTED|Ixabepilone With Famotidine or Food||8
2900735|NCT00422097|3608643|FG007|STARTED|Ixabepilone With Famotidine or Food||7
2900736|NCT00422097|3608636|FG000|COMPLETED|Ixabepilone With Famotidine or Food||0
2900737|NCT00422097|3608637|FG001|COMPLETED|Ixabepilone With Famotidine or Food||0
2900738|NCT00422097|3608638|FG002|COMPLETED|Ixabepilone With Famotidine or Food||0
2900739|NCT00422097|3608639|FG003|COMPLETED|Ixabepilone With Famotidine or Food||0
2900740|NCT00422097|3608640|FG004|COMPLETED|Ixabepilone With Famotidine or Food||0
2900741|NCT00422097|3608641|FG005|COMPLETED|Ixabepilone With Famotidine or Food||0
2900742|NCT00422097|3608642|FG006|COMPLETED|Ixabepilone With Famotidine or Food||8
2900743|NCT00422097|3608643|FG007|COMPLETED|Ixabepilone With Famotidine or Food||7
2900744|NCT00422097|3608636|FG000|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
2900745|NCT00422097|3608637|FG001|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
2900746|NCT00422097|3608638|FG002|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
2900747|NCT00422097|3608639|FG003|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
2900748|NCT00422097|3608640|FG004|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
2900749|NCT00422097|3608641|FG005|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
2900750|NCT00422097|3608642|FG006|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
2900751|NCT00422097|3608643|FG007|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
2900752|NCT00422162|3608669|FG000|STARTED|Overall Study||167
2900753|NCT00422162|3608670|FG001|STARTED|Overall Study||172
2900754|NCT00422162|3608669|FG000|Received Treatment|Overall Study||167
2900755|NCT00422162|3608670|FG001|Received Treatment|Overall Study||171
2900756|NCT00422162|3608669|FG000|COMPLETED|Overall Study||143
2900757|NCT00422162|3608670|FG001|COMPLETED|Overall Study||142
2900758|NCT00422162|3608669|FG000|NOT COMPLETED|Overall Study||24
2900759|NCT00422162|3608670|FG001|NOT COMPLETED|Overall Study||30
2900760|NCT00422201|3608686|FG000|STARTED|Overall Study||18
2900761|NCT00422201|3608686|FG000|COMPLETED|Overall Study||7
2900762|NCT00422201|3608686|FG000|NOT COMPLETED|Overall Study||11
2900763|NCT00422227|3608693|FG000|STARTED|Overall Study||197
2900764|NCT00422227|3608694|FG001|STARTED|Overall Study||103
2900765|NCT00422227|3608693|FG000|COMPLETED|Overall Study||193
2900766|NCT00422227|3608694|FG001|COMPLETED|Overall Study||88
2900767|NCT00422227|3608693|FG000|NOT COMPLETED|Overall Study||4
2900768|NCT00422227|3608694|FG001|NOT COMPLETED|Overall Study||15
2900769|NCT00422279|3608702|FG000|STARTED|Overall Study||2
2900770|NCT00422279|3608703|FG001|STARTED|Overall Study||2
2900771|NCT00422279|3608702|FG000|24 Month After Loading Period|Overall Study||2
2900772|NCT00422279|3608703|FG001|24 Month After Loading Period|Overall Study||2
2900773|NCT00422279|3608702|FG000|COMPLETED|Overall Study||2
2900774|NCT00422279|3608703|FG001|COMPLETED|Overall Study||2
2900775|NCT00422279|3608702|FG000|NOT COMPLETED|Overall Study||0
2900776|NCT00422279|3608703|FG001|NOT COMPLETED|Overall Study||0
2900777|NCT00422292|3608715|FG000|STARTED|Overall Study||257
2900778|NCT00422292|3608716|FG001|STARTED|Overall Study||664
2900779|NCT00422292|3608717|FG002|STARTED|Overall Study||246
2900780|NCT00422292|3608718|FG003|STARTED|Overall Study||476
2900781|NCT00422292|3608715|FG000|COMPLETED|Overall Study||239
2900782|NCT00422292|3608716|FG001|COMPLETED|Overall Study||598
2900783|NCT00422292|3608717|FG002|COMPLETED|Overall Study||224
2900784|NCT00422292|3608718|FG003|COMPLETED|Overall Study||452
2900785|NCT00422292|3608715|FG000|NOT COMPLETED|Overall Study||18
2900786|NCT00422292|3608716|FG001|NOT COMPLETED|Overall Study||66
2900787|NCT00422292|3608717|FG002|NOT COMPLETED|Overall Study||22
2900788|NCT00422292|3608718|FG003|NOT COMPLETED|Overall Study||24
2900789|NCT00422383|3608733|FG000|STARTED|Overall Study||134
2900790|NCT00422383|3608734|FG001|STARTED|Overall Study||120
2900791|NCT00422383|3608735|FG002|STARTED|Overall Study||93
2900792|NCT00422383|3608736|FG003|STARTED|Overall Study||6
2900793|NCT00422383|3608737|FG004|STARTED|Overall Study||25
2900794|NCT00422383|3608733|FG000|COMPLETED|Overall Study||119
2900795|NCT00422383|3608734|FG001|COMPLETED|Overall Study||106
2900796|NCT00422383|3608735|FG002|COMPLETED|Overall Study||89
2900797|NCT00422383|3608736|FG003|COMPLETED|Overall Study||4
2900798|NCT00422383|3608737|FG004|COMPLETED|Overall Study||22
2900799|NCT00422383|3608733|FG000|NOT COMPLETED|Overall Study||15
2900800|NCT00422383|3608734|FG001|NOT COMPLETED|Overall Study||14
2900801|NCT00422383|3608735|FG002|NOT COMPLETED|Overall Study||4
2900802|NCT00422383|3608736|FG003|NOT COMPLETED|Overall Study||2
2900803|NCT00422383|3608737|FG004|NOT COMPLETED|Overall Study||3
2900804|NCT00422422|3608755|FG000|STARTED|Overall Study||100
2900805|NCT00422422|3608755|FG000|COMPLETED|Overall Study||90
2900806|NCT00422422|3608755|FG000|NOT COMPLETED|Overall Study||10
2900807|NCT00422448|3608761|FG000|STARTED|Overall Study|22 prospectively enrolled during study period and 21 retrospectively enrolled|43
2900808|NCT00422448|3608761|FG000|COMPLETED|Overall Study||43
2900809|NCT00422448|3608761|FG000|NOT COMPLETED|Overall Study||0
2900810|NCT00422461|3608769|FG000|STARTED|Overall Study||35
2900811|NCT00422461|3608770|FG001|STARTED|Overall Study||35
2900812|NCT00422461|3608771|FG002|STARTED|Overall Study||32
2900813|NCT00422461|3608772|FG003|STARTED|Overall Study||33
2900814|NCT00422461|3608769|FG000|Treated|Overall Study||34
2900815|NCT00422461|3608770|FG001|Treated|Overall Study||34
2900816|NCT00422461|3608771|FG002|Treated|Overall Study||32
2900817|NCT00422461|3608772|FG003|Treated|Overall Study||33
2900818|NCT00422461|3608769|FG000|Full Analysis Set|Overall Study||34
2900819|NCT00422461|3608770|FG001|Full Analysis Set|Overall Study||34
2900820|NCT00422461|3608771|FG002|Full Analysis Set|Overall Study||31
2900821|NCT00422461|3608772|FG003|Full Analysis Set|Overall Study||33
2900822|NCT00422461|3608769|FG000|COMPLETED|Overall Study||32
2900823|NCT00422461|3608770|FG001|COMPLETED|Overall Study||32
2900824|NCT00422461|3608771|FG002|COMPLETED|Overall Study||31
2900825|NCT00422461|3608772|FG003|COMPLETED|Overall Study||30
2900826|NCT00422461|3608769|FG000|NOT COMPLETED|Overall Study||3
2900827|NCT00422461|3608770|FG001|NOT COMPLETED|Overall Study||3
2900828|NCT00422461|3608771|FG002|NOT COMPLETED|Overall Study||1
2900829|NCT00422461|3608772|FG003|NOT COMPLETED|Overall Study||3
2900830|NCT00422513|3608784|FG000|STARTED|Overall Study||130
2900831|NCT00422513|3608785|FG001|STARTED|Overall Study||130
2900832|NCT00422513|3608784|FG000|COMPLETED|Overall Study||23
2900833|NCT00422513|3608785|FG001|COMPLETED|Overall Study||24
2900834|NCT00422513|3608784|FG000|NOT COMPLETED|Overall Study||107
2900835|NCT00422513|3608785|FG001|NOT COMPLETED|Overall Study||106
2900836|NCT00422591|3608791|FG000|STARTED|Overall Study||175
2900837|NCT00422591|3608791|FG000|COMPLETED|Overall Study||169
2900838|NCT00422591|3608791|FG000|NOT COMPLETED|Overall Study||6
2900839|NCT00422656|3608795|FG000|STARTED|Overall Study||37
2900840|NCT00422656|3608795|FG000|COMPLETED|Overall Study||37
2900841|NCT00422656|3608795|FG000|NOT COMPLETED|Overall Study||0
2900842|NCT00422695|3608801|FG000|STARTED|Overall Study||105
2900843|NCT00422695|3608802|FG001|STARTED|Overall Study||38
2900844|NCT00422695|3608801|FG000|COMPLETED|Overall Study||105
2900845|NCT00422695|3608802|FG001|COMPLETED|Overall Study||38
2900846|NCT00422695|3608801|FG000|NOT COMPLETED|Overall Study||0
2900847|NCT00422695|3608802|FG001|NOT COMPLETED|Overall Study||0
2900848|NCT00422734|3608810|FG000|STARTED|Overall Study||78
2900849|NCT00422734|3608811|FG001|STARTED|Overall Study||264
2900850|NCT00422734|3608810|FG000|COMPLETED|Overall Study||64
2900851|NCT00422734|3608811|FG001|COMPLETED|Overall Study||243
2900852|NCT00422734|3608810|FG000|NOT COMPLETED|Overall Study||14
2900853|NCT00422734|3608811|FG001|NOT COMPLETED|Overall Study||21
2900854|NCT00422799|3608817|FG000|STARTED|Overall Study||63
2900855|NCT00422799|3608817|FG000|COMPLETED|Overall Study||50
2900856|NCT00422799|3608817|FG000|NOT COMPLETED|Overall Study||13
2900857|NCT00422812|3608825|FG000|STARTED|Overall Study||98
2900858|NCT00422812|3608826|FG001|STARTED|Overall Study||104
2900859|NCT00422812|3608827|FG002|STARTED|Overall Study||93
2900860|NCT00422812|3608828|FG003|STARTED|Overall Study||105
2900861|NCT00422812|3608825|FG000|COMPLETED|Overall Study||98
2900862|NCT00422812|3608826|FG001|COMPLETED|Overall Study||103
2900863|NCT00422812|3608827|FG002|COMPLETED|Overall Study||91
2900864|NCT00422812|3608828|FG003|COMPLETED|Overall Study||103
2900865|NCT00422812|3608825|FG000|NOT COMPLETED|Overall Study||0
2900866|NCT00422812|3608826|FG001|NOT COMPLETED|Overall Study||1
2900867|NCT00422812|3608827|FG002|NOT COMPLETED|Overall Study||2
2900868|NCT00422812|3608828|FG003|NOT COMPLETED|Overall Study||2
2900869|NCT00422903|3608840|FG000|STARTED|Overall Study||49
2900870|NCT00422903|3608841|FG001|STARTED|Overall Study||43
2900871|NCT00422903|3608840|FG000|COMPLETED|Overall Study||45
2900872|NCT00422903|3608841|FG001|COMPLETED|Overall Study||38
2900873|NCT00422903|3608840|FG000|NOT COMPLETED|Overall Study||4
2900874|NCT00422903|3608841|FG001|NOT COMPLETED|Overall Study||5
2900875|NCT00423046|3608849|FG000|STARTED|Overall Study||553
2900876|NCT00423046|3608850|FG001|STARTED|Overall Study||553
2900877|NCT00423046|3608849|FG000|COMPLETED|Overall Study|Completed until Month 60|213
2900878|NCT00423046|3608850|FG001|COMPLETED|Overall Study|Completed until Month 60|208
2900879|NCT00423046|3608849|FG000|NOT COMPLETED|Overall Study||340
2900880|NCT00423046|3608850|FG001|NOT COMPLETED|Overall Study||345
2900881|NCT00423085|3608861|FG000|STARTED|24-Week Double-Blind Treatment Phase||288
2900882|NCT00423085|3608862|FG001|STARTED|24-Week Double-Blind Treatment Phase||284
2900883|NCT00423085|3608863|FG002|STARTED|24-Week Double-Blind Treatment Phase||287
2900884|NCT00423085|3608864|FG003|STARTED|24-Week Double-Blind Treatment Phase||0
2900885|NCT00423085|3608861|FG000|COMPLETED|24-Week Double-Blind Treatment Phase||242
2900886|NCT00423085|3608862|FG001|COMPLETED|24-Week Double-Blind Treatment Phase||220
2900887|NCT00423085|3608863|FG002|COMPLETED|24-Week Double-Blind Treatment Phase||228
2900888|NCT00423085|3608864|FG003|COMPLETED|24-Week Double-Blind Treatment Phase||0
2900889|NCT00423085|3608861|FG000|NOT COMPLETED|24-Week Double-Blind Treatment Phase||46
2900890|NCT00423085|3608862|FG001|NOT COMPLETED|24-Week Double-Blind Treatment Phase||64
2900891|NCT00423085|3608863|FG002|NOT COMPLETED|24-Week Double-Blind Treatment Phase||59
2900892|NCT00423085|3608864|FG003|NOT COMPLETED|24-Week Double-Blind Treatment Phase||0
2900893|NCT00423085|3608861|FG000|STARTED|52-Week Open-Label Extension Phase||0
2900894|NCT00423085|3608862|FG001|STARTED|52-Week Open-Label Extension Phase||0
2900895|NCT00423085|3608863|FG002|STARTED|52-Week Open-Label Extension Phase||0
2900896|NCT00423085|3608864|FG003|STARTED|52-Week Open-Label Extension Phase|Patients who completed the 24-wk treatment phase were eligible to enroll in the open-label extension|637
2900897|NCT00423085|3608861|FG000|COMPLETED|52-Week Open-Label Extension Phase||0
2900898|NCT00423085|3608862|FG001|COMPLETED|52-Week Open-Label Extension Phase||0
2900899|NCT00423085|3608863|FG002|COMPLETED|52-Week Open-Label Extension Phase||0
2900900|NCT00423085|3608864|FG003|COMPLETED|52-Week Open-Label Extension Phase||474
2900901|NCT00423085|3608861|FG000|NOT COMPLETED|52-Week Open-Label Extension Phase||0
2900902|NCT00423085|3608862|FG001|NOT COMPLETED|52-Week Open-Label Extension Phase||0
2900903|NCT00423085|3608863|FG002|NOT COMPLETED|52-Week Open-Label Extension Phase||0
2900904|NCT00423085|3608864|FG003|NOT COMPLETED|52-Week Open-Label Extension Phase||163
2900905|NCT00423098|3608876|FG000|STARTED|Overall Study|Total number of patients screened was 90, but the total number of randomized patients was 81.|42
2900906|NCT00423098|3608877|FG001|STARTED|Overall Study||39
2900907|NCT00423098|3608876|FG000|COMPLETED|Overall Study|Completed 24 weeks of study medication.|39
2900908|NCT00423098|3608877|FG001|COMPLETED|Overall Study||35
2900909|NCT00423098|3608876|FG000|NOT COMPLETED|Overall Study||3
2900910|NCT00423098|3608877|FG001|NOT COMPLETED|Overall Study||4
2900911|NCT00423137|3608887|FG000|STARTED|Overall Study||11
2900912|NCT00423137|3608888|FG001|STARTED|Overall Study||12
2900913|NCT00423137|3608889|FG002|STARTED|Overall Study||13
2900914|NCT00423137|3608890|FG003|STARTED|Overall Study||12
2900915|NCT00423137|3608887|FG000|COMPLETED|Overall Study||10
2900916|NCT00423137|3608888|FG001|COMPLETED|Overall Study||12
2900917|NCT00423137|3608889|FG002|COMPLETED|Overall Study||7
2900918|NCT00423137|3608890|FG003|COMPLETED|Overall Study||10
2900919|NCT00423137|3608887|FG000|NOT COMPLETED|Overall Study||1
2900920|NCT00423137|3608888|FG001|NOT COMPLETED|Overall Study||0
2900921|NCT00423137|3608889|FG002|NOT COMPLETED|Overall Study||6
2900922|NCT00423137|3608890|FG003|NOT COMPLETED|Overall Study||2
2900923|NCT00423150|3608903|FG000|STARTED|Overall Study||86
2900924|NCT00423150|3608903|FG000|COMPLETED|Overall Study||0
2900925|NCT00423150|3608903|FG000|NOT COMPLETED|Overall Study||86
2900926|NCT00423189|3608910|FG000|STARTED|Overall Study||2
2900927|NCT00423189|3608911|FG001|STARTED|Overall Study||3
2900928|NCT00423189|3608912|FG002|STARTED|Overall Study||2
2900929|NCT00423189|3608910|FG000|COMPLETED|Overall Study||2
2900930|NCT00423189|3608911|FG001|COMPLETED|Overall Study||2
2900931|NCT00423189|3608912|FG002|COMPLETED|Overall Study||2
2900932|NCT00423189|3608910|FG000|NOT COMPLETED|Overall Study||0
2900933|NCT00423189|3608911|FG001|NOT COMPLETED|Overall Study||1
2900934|NCT00423189|3608912|FG002|NOT COMPLETED|Overall Study||0
2900935|NCT00423267|3608927|FG000|STARTED|Period A||9
2900936|NCT00423267|3608928|FG001|STARTED|Period A||7
2900937|NCT00423267|3608927|FG000|COMPLETED|Period A||7
2900938|NCT00423267|3608928|FG001|COMPLETED|Period A||6
2900939|NCT00423267|3608927|FG000|NOT COMPLETED|Period A||2
2900940|NCT00423267|3608928|FG001|NOT COMPLETED|Period A||1
2900941|NCT00423267|3608927|FG000|STARTED|Period B||12
2900942|NCT00423267|3608928|FG001|STARTED|Period B||0
2900943|NCT00423267|3608927|FG000|COMPLETED|Period B||12
2900944|NCT00423267|3608928|FG001|COMPLETED|Period B||0
2900945|NCT00423267|3608927|FG000|NOT COMPLETED|Period B||0
2900946|NCT00423267|3608928|FG001|NOT COMPLETED|Period B||0
2900947|NCT00423293|3608936|FG000|STARTED|Overall Study||63
2900948|NCT00423293|3608936|FG000|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|52
2900949|NCT00423293|3608936|FG000|NOT COMPLETED|Overall Study||11
2900950|NCT00423319|3608942|FG000|STARTED|Overall Study|Randomized|2708
2900951|NCT00423319|3608943|FG001|STARTED|Overall Study|Randomized|2699
2900952|NCT00423319|3608942|FG000|Participants Who Received Treatment|Overall Study||2673
2900953|NCT00423319|3608943|FG001|Participants Who Received Treatment|Overall Study||2659
2900954|NCT00423319|3608942|FG000|COMPLETED|Overall Study||2484
2900955|NCT00423319|3608943|FG001|COMPLETED|Overall Study||2447
2900956|NCT00423319|3608942|FG000|NOT COMPLETED|Overall Study||224
2900957|NCT00423319|3608943|FG001|NOT COMPLETED|Overall Study||252
2900958|NCT00423332|3608952|FG000|STARTED|Overall Study|Randomised|53
2900959|NCT00423332|3608953|FG001|STARTED|Overall Study|Number randomised|18
2900960|NCT00423332|3608952|FG000|Continuing After Unblinding|Overall Study|Number starting/ continuing AZD2171 after unblinding|44
2900961|NCT00423332|3608953|FG001|Continuing After Unblinding|Overall Study|Number starting/ continuing AZD2171 after unblinding|14
2900962|NCT00423332|3608952|FG000|Ongoing at Data Cut Off (8th March 2009)|Overall Study|Number ongoing at data cut off (8th March 2009)|22
2900963|NCT00423332|3608953|FG001|Ongoing at Data Cut Off (8th March 2009)|Overall Study|Number ongoing at data cut off (8th March 2009)|4
2900964|NCT00423332|3608952|FG000|COMPLETED|Overall Study|Number completing 12 weeks blinded randomised treatment|44
2900965|NCT00423332|3608953|FG001|COMPLETED|Overall Study|Number completing 12 weeks blinded randomised treatment|11
2900966|NCT00423332|3608952|FG000|NOT COMPLETED|Overall Study||9
2900967|NCT00423332|3608953|FG001|NOT COMPLETED|Overall Study||7
2900968|NCT00423358|3608962|FG000|STARTED|Overall Study||11
2900969|NCT00423358|3608963|FG001|STARTED|Overall Study||11
2900970|NCT00423358|3608962|FG000|COMPLETED|Overall Study||11
2900971|NCT00423358|3608963|FG001|COMPLETED|Overall Study||11
2900972|NCT00423358|3608962|FG000|NOT COMPLETED|Overall Study||0
2900973|NCT00423358|3608963|FG001|NOT COMPLETED|Overall Study||0
2900974|NCT00423436|3608971|FG000|STARTED|Overall Study||35
2900975|NCT00423436|3608972|FG001|STARTED|Overall Study||33
2900976|NCT00423436|3608971|FG000|COMPLETED|Overall Study||35
2900977|NCT00423436|3608972|FG001|COMPLETED|Overall Study||33
2900978|NCT00423436|3608971|FG000|NOT COMPLETED|Overall Study||0
2900979|NCT00423436|3608972|FG001|NOT COMPLETED|Overall Study||0
2900980|NCT00423449|3608978|FG000|STARTED|Overall Study||4
2900981|NCT00423449|3608979|FG001|STARTED|Overall Study||6
2900982|NCT00423449|3608980|FG002|STARTED|Overall Study||17
2900983|NCT00423449|3608981|FG003|STARTED|Overall Study||27
2900984|NCT00423449|3608982|FG004|STARTED|Overall Study||7
2900985|NCT00423449|3608978|FG000|COMPLETED|Overall Study||1
2900986|NCT00423449|3608979|FG001|COMPLETED|Overall Study||2
2900987|NCT00423449|3608980|FG002|COMPLETED|Overall Study||2
2900988|NCT00423449|3608981|FG003|COMPLETED|Overall Study||5
2900989|NCT00423449|3608982|FG004|COMPLETED|Overall Study||0
2900990|NCT00423449|3608978|FG000|NOT COMPLETED|Overall Study||3
2900991|NCT00423449|3608979|FG001|NOT COMPLETED|Overall Study||4
2900992|NCT00423449|3608980|FG002|NOT COMPLETED|Overall Study||15
2900993|NCT00423449|3608981|FG003|NOT COMPLETED|Overall Study||22
2900994|NCT00423449|3608982|FG004|NOT COMPLETED|Overall Study||7
2900995|NCT00423592|3608995|FG000|STARTED|Overall Study|Enrolled|36
2900996|NCT00423592|3608995|FG000|Completed Preliminary Analysis Cut-off|Overall Study|Preliminary analysis cut-off at Week 12 for primary/secondary endpoint analysis|34
2900997|NCT00423592|3608995|FG000|COMPLETED|Overall Study|Completed study|29
2900998|NCT00423592|3608995|FG000|NOT COMPLETED|Overall Study||7
2900999|NCT00423605|3608999|FG000|STARTED|Overall Study||560
2901000|NCT00423605|3608999|FG000|COMPLETED|Overall Study||319
2901001|NCT00423605|3608999|FG000|NOT COMPLETED|Overall Study||241
2901002|NCT00423657|3609005|FG000|STARTED|Overall Study||342
2901003|NCT00423657|3609006|FG001|STARTED|Overall Study||338
2901004|NCT00423657|3609005|FG000|COMPLETED|Overall Study||316
2901005|NCT00423657|3609006|FG001|COMPLETED|Overall Study||313
2901006|NCT00423657|3609005|FG000|NOT COMPLETED|Overall Study||26
2901007|NCT00423657|3609006|FG001|NOT COMPLETED|Overall Study||25
2901008|NCT00423670|3609019|FG000|STARTED|Treatment Period||104
2901009|NCT00423670|3609020|FG001|STARTED|Treatment Period||107
2901010|NCT00423670|3609021|FG002|STARTED|Treatment Period||103
2901011|NCT00423670|3609022|FG003|STARTED|Treatment Period||103
2901012|NCT00423670|3609023|FG004|STARTED|Treatment Period||103
2901013|NCT00423670|3609024|FG005|STARTED|Treatment Period||16
2901014|NCT00423670|3609025|FG006|STARTED|Treatment Period||59
2901015|NCT00423670|3609026|FG007|STARTED|Treatment Period|Arm 8 were Arm 1 participants that were positive for HCV-RNA at TW 24 and had the option to switch.|36
2901016|NCT00423670|3609019|FG000|COMPLETED|Treatment Period||52
2901017|NCT00423670|3609020|FG001|COMPLETED|Treatment Period||77
2901018|NCT00423670|3609021|FG002|COMPLETED|Treatment Period||76
2901019|NCT00423670|3609022|FG003|COMPLETED|Treatment Period||63
2901020|NCT00423670|3609023|FG004|COMPLETED|Treatment Period||76
2901021|NCT00423670|3609024|FG005|COMPLETED|Treatment Period||8
2901022|NCT00423670|3609025|FG006|COMPLETED|Treatment Period||28
2901023|NCT00423670|3609026|FG007|COMPLETED|Treatment Period||15
2901024|NCT00423670|3609019|FG000|NOT COMPLETED|Treatment Period||52
2901025|NCT00423670|3609020|FG001|NOT COMPLETED|Treatment Period||30
2901026|NCT00423670|3609021|FG002|NOT COMPLETED|Treatment Period||27
2901027|NCT00423670|3609022|FG003|NOT COMPLETED|Treatment Period||40
2901028|NCT00423670|3609023|FG004|NOT COMPLETED|Treatment Period||27
2901029|NCT00423670|3609024|FG005|NOT COMPLETED|Treatment Period||8
2901030|NCT00423670|3609025|FG006|NOT COMPLETED|Treatment Period||31
2901031|NCT00423670|3609026|FG007|NOT COMPLETED|Treatment Period||21
2901032|NCT00423670|3609019|FG000|STARTED|Follow-up Period||97
2901033|NCT00423670|3609020|FG001|STARTED|Follow-up Period||100
2901034|NCT00423670|3609021|FG002|STARTED|Follow-up Period||96
2901035|NCT00423670|3609022|FG003|STARTED|Follow-up Period||96
2901036|NCT00423670|3609023|FG004|STARTED|Follow-up Period||91
2901037|NCT00423670|3609024|FG005|STARTED|Follow-up Period||14
2901038|NCT00423670|3609025|FG006|STARTED|Follow-up Period||50
2901039|NCT00423670|3609026|FG007|STARTED|Follow-up Period||35
2901040|NCT00423670|3609019|FG000|COMPLETED|Follow-up Period||94
2901041|NCT00423670|3609020|FG001|COMPLETED|Follow-up Period||84
2901042|NCT00423670|3609021|FG002|COMPLETED|Follow-up Period||85
2901043|NCT00423670|3609022|FG003|COMPLETED|Follow-up Period||91
2901044|NCT00423670|3609023|FG004|COMPLETED|Follow-up Period||89
2901045|NCT00423670|3609024|FG005|COMPLETED|Follow-up Period||14
2901046|NCT00423670|3609025|FG006|COMPLETED|Follow-up Period||41
2901047|NCT00423670|3609026|FG007|COMPLETED|Follow-up Period||32
2901048|NCT00423670|3609019|FG000|NOT COMPLETED|Follow-up Period||3
2901049|NCT00423670|3609020|FG001|NOT COMPLETED|Follow-up Period||16
2901050|NCT00423670|3609021|FG002|NOT COMPLETED|Follow-up Period||11
2901051|NCT00423670|3609022|FG003|NOT COMPLETED|Follow-up Period||5
2901052|NCT00423670|3609023|FG004|NOT COMPLETED|Follow-up Period||2
2901053|NCT00423670|3609024|FG005|NOT COMPLETED|Follow-up Period||0
2901054|NCT00423670|3609025|FG006|NOT COMPLETED|Follow-up Period||9
2901055|NCT00423670|3609026|FG007|NOT COMPLETED|Follow-up Period||3
2901056|NCT00423683|3609049|FG000|STARTED|Overall Study||31
2901057|NCT00423683|3609050|FG001|STARTED|Overall Study||33
2901058|NCT00423683|3609049|FG000|COMPLETED|Overall Study||30
2901059|NCT00423683|3609050|FG001|COMPLETED|Overall Study||33
2901060|NCT00423683|3609049|FG000|NOT COMPLETED|Overall Study||1
2901061|NCT00423683|3609050|FG001|NOT COMPLETED|Overall Study||0
2901062|NCT00423722|3609060|FG000|STARTED|Overall Study||63
2901063|NCT00423722|3609061|FG001|STARTED|Overall Study||66
2901064|NCT00423722|3609060|FG000|COMPLETED|Overall Study||49
2901065|NCT00423722|3609061|FG001|COMPLETED|Overall Study||53
2901066|NCT00423722|3609060|FG000|NOT COMPLETED|Overall Study||14
2901067|NCT00423722|3609061|FG001|NOT COMPLETED|Overall Study||13
2901068|NCT00423735|3609076|FG000|STARTED|Overall Study||29
2901069|NCT00423735|3609077|FG001|STARTED|Overall Study||35
2901070|NCT00423735|3609078|FG002|STARTED|Overall Study||0
2901071|NCT00423735|3609076|FG000|COMPLETED|Overall Study||21
2901072|NCT00423735|3609077|FG001|COMPLETED|Overall Study||29
2901073|NCT00423735|3609078|FG002|COMPLETED|Overall Study||0
2901074|NCT00423735|3609076|FG000|NOT COMPLETED|Overall Study||8
2901075|NCT00423735|3609077|FG001|NOT COMPLETED|Overall Study||6
2901076|NCT00423735|3609078|FG002|NOT COMPLETED|Overall Study||0
2901077|NCT00423800|3609090|FG000|STARTED|Overall Study||3
2901078|NCT00423800|3609091|FG001|STARTED|Overall Study||2
2901079|NCT00423800|3609090|FG000|COMPLETED|Overall Study||3
2901080|NCT00423800|3609091|FG001|COMPLETED|Overall Study||1
2901081|NCT00423800|3609090|FG000|NOT COMPLETED|Overall Study||0
2901082|NCT00423800|3609091|FG001|NOT COMPLETED|Overall Study||1
2901083|NCT00423813|3609101|FG000|STARTED|Overall Study||188
2901084|NCT00423813|3609102|FG001|STARTED|Overall Study||195
2901085|NCT00423813|3609103|FG002|STARTED|Overall Study||190
2901086|NCT00423813|3609101|FG000|Treated|Overall Study||188
2901087|NCT00423813|3609102|FG001|Treated|Overall Study||194
2901088|NCT00423813|3609103|FG002|Treated|Overall Study||189
2901089|NCT00423813|3609101|FG000|COMPLETED|Overall Study||131
2901090|NCT00423813|3609102|FG001|COMPLETED|Overall Study||129
2901091|NCT00423813|3609103|FG002|COMPLETED|Overall Study||116
2901092|NCT00423813|3609101|FG000|NOT COMPLETED|Overall Study||57
2901093|NCT00423813|3609102|FG001|NOT COMPLETED|Overall Study||66
2901094|NCT00423813|3609103|FG002|NOT COMPLETED|Overall Study||74
2901095|NCT00423852|3609111|FG000|STARTED|Overall Study||26
2901096|NCT00423852|3609111|FG000|COMPLETED|Overall Study||23
2901097|NCT00423852|3609111|FG000|NOT COMPLETED|Overall Study||3
2901098|NCT00423878|3609117|FG000|STARTED|Overall Study||109
2901099|NCT00423878|3609118|FG001|STARTED|Overall Study||106
3171120|NCT01932697|3898339|FG001|NOT COMPLETED|Overall Study||0
3171121|NCT01932762|3898351|FG000|STARTED|Overall Study||30
2901100|NCT00423878|3609117|FG000|COMPLETED|Overall Study||89
2901101|NCT00423878|3609118|FG001|COMPLETED|Overall Study||98
2901102|NCT00423878|3609117|FG000|NOT COMPLETED|Overall Study||20
2901103|NCT00423878|3609118|FG001|NOT COMPLETED|Overall Study||8
2901104|NCT00423891|3609127|FG000|STARTED|Enrolled||35
2901105|NCT00423891|3609128|FG001|STARTED|Enrolled||21
2901106|NCT00423891|3609129|FG002|STARTED|Enrolled||8
2901107|NCT00423891|3609127|FG000|COMPLETED|Enrolled||24
2901108|NCT00423891|3609128|FG001|COMPLETED|Enrolled||19
2901109|NCT00423891|3609129|FG002|COMPLETED|Enrolled||5
2901110|NCT00423891|3609127|FG000|NOT COMPLETED|Enrolled||11
2901111|NCT00423891|3609128|FG001|NOT COMPLETED|Enrolled||2
2901112|NCT00423891|3609129|FG002|NOT COMPLETED|Enrolled||3
2901113|NCT00423891|3609127|FG000|STARTED|Treatment||24
2901114|NCT00423891|3609128|FG001|STARTED|Treatment||19
2901115|NCT00423891|3609129|FG002|STARTED|Treatment||5
2901116|NCT00423891|3609127|FG000|COMPLETED|Treatment||22
2901117|NCT00423891|3609128|FG001|COMPLETED|Treatment||19
2901118|NCT00423891|3609129|FG002|COMPLETED|Treatment||5
2901119|NCT00423891|3609127|FG000|NOT COMPLETED|Treatment||2
2901120|NCT00423891|3609128|FG001|NOT COMPLETED|Treatment||0
2901121|NCT00423891|3609129|FG002|NOT COMPLETED|Treatment||0
2901122|NCT00423891|3609127|FG000|STARTED|Post-Dosing Follow Up||22
2901123|NCT00423891|3609128|FG001|STARTED|Post-Dosing Follow Up||18
2901124|NCT00423891|3609129|FG002|STARTED|Post-Dosing Follow Up||5
2901125|NCT00423891|3609127|FG000|COMPLETED|Post-Dosing Follow Up||20
2901126|NCT00423891|3609128|FG001|COMPLETED|Post-Dosing Follow Up||15
2901127|NCT00423891|3609129|FG002|COMPLETED|Post-Dosing Follow Up||3
2901128|NCT00423891|3609127|FG000|NOT COMPLETED|Post-Dosing Follow Up||2
2901129|NCT00423891|3609128|FG001|NOT COMPLETED|Post-Dosing Follow Up||3
2901130|NCT00423891|3609129|FG002|NOT COMPLETED|Post-Dosing Follow Up||2
2920154|NCT00535743|3630644|FG008|STARTED|Overall Study||5
2920155|NCT00535743|3630645|FG009|STARTED|Overall Study||5
2920156|NCT00535743|3630646|FG010|STARTED|Overall Study||5
2920157|NCT00535743|3630647|FG011|STARTED|Overall Study||5
2920158|NCT00535743|3630648|FG012|STARTED|Overall Study||5
2920159|NCT00535743|3630649|FG013|STARTED|Overall Study||10
2920160|NCT00535743|3630650|FG014|STARTED|Overall Study||9
2920161|NCT00535743|3630651|FG015|STARTED|Overall Study|N=11 randomized to Arm P. An additional N=2 (randomized to Arm O) are counted as Started in Arm P|13
2920162|NCT00535743|3630652|FG016|STARTED|Overall Study||10
2920163|NCT00535743|3630653|FG017|STARTED|Overall Study||11
2920164|NCT00535743|3630654|FG018|STARTED|Overall Study||3
2920165|NCT00535743|3630655|FG019|STARTED|Overall Study||5
2920166|NCT00535743|3630656|FG020|STARTED|Overall Study||5
2920167|NCT00535743|3630657|FG021|STARTED|Overall Study||5
2920168|NCT00535743|3630658|FG022|STARTED|Overall Study|N=5 randomized to Arm W. An additional N=1 (randomized to Arm Q) is counted as Started in Arm W|6
2920169|NCT00535743|3630659|FG023|STARTED|Overall Study||5
2920170|NCT00535743|3630636|FG000|Treated|Overall Study||5
2920171|NCT00535743|3630637|FG001|Treated|Overall Study||11
2920172|NCT00535743|3630638|FG002|Treated|Overall Study||11
2920173|NCT00535743|3630639|FG003|Treated|Overall Study||11
2920174|NCT00535743|3630640|FG004|Treated|Overall Study||11
2920175|NCT00535743|3630641|FG005|Treated|Overall Study||10
2920176|NCT00535743|3630642|FG006|Treated|Overall Study||3
2920177|NCT00535743|3630643|FG007|Treated|Overall Study||5
2920178|NCT00535743|3630644|FG008|Treated|Overall Study||4
2920179|NCT00535743|3630645|FG009|Treated|Overall Study||5
2920180|NCT00535743|3630646|FG010|Treated|Overall Study||5
2920181|NCT00535743|3630647|FG011|Treated|Overall Study||5
2920182|NCT00535743|3630648|FG012|Treated|Overall Study||5
2920183|NCT00535743|3630649|FG013|Treated|Overall Study||10
2920184|NCT00535743|3630650|FG014|Treated|Overall Study||9
2920185|NCT00535743|3630651|FG015|Treated|Overall Study|N=2 (randomized to Arm O) rec'd 8 mg/kg Sugammadex, 3 min after 1.2 mg/kg Esmeron®|13
2920186|NCT00535743|3630652|FG016|Treated|Overall Study||10
2920187|NCT00535743|3630653|FG017|Treated|Overall Study||11
2920188|NCT00535743|3630654|FG018|Treated|Overall Study||3
2920189|NCT00535743|3630655|FG019|Treated|Overall Study||5
2920190|NCT00535743|3630656|FG020|Treated|Overall Study||5
2920191|NCT00535743|3630657|FG021|Treated|Overall Study||5
2920192|NCT00535743|3630658|FG022|Treated|Overall Study|N=1 (randomized to Arm Q) rec'd 12 mg/kg Sugammadex, 29 min after 1.2 mg/kg Esmeron®|6
2920193|NCT00535743|3630659|FG023|Treated|Overall Study||5
2920194|NCT00535743|3630636|FG000|COMPLETED|Overall Study||5
2920195|NCT00535743|3630637|FG001|COMPLETED|Overall Study||11
2920196|NCT00535743|3630638|FG002|COMPLETED|Overall Study||11
2920197|NCT00535743|3630639|FG003|COMPLETED|Overall Study||11
2920198|NCT00535743|3630640|FG004|COMPLETED|Overall Study||11
2920199|NCT00535743|3630641|FG005|COMPLETED|Overall Study||10
2920200|NCT00535743|3630642|FG006|COMPLETED|Overall Study||3
2920201|NCT00535743|3630643|FG007|COMPLETED|Overall Study||5
2920202|NCT00535743|3630644|FG008|COMPLETED|Overall Study||4
2920203|NCT00535743|3630645|FG009|COMPLETED|Overall Study||4
2920204|NCT00535743|3630646|FG010|COMPLETED|Overall Study||5
2920205|NCT00535743|3630647|FG011|COMPLETED|Overall Study||5
2920206|NCT00535743|3630648|FG012|COMPLETED|Overall Study||5
2920207|NCT00535743|3630649|FG013|COMPLETED|Overall Study||10
2920208|NCT00535743|3630650|FG014|COMPLETED|Overall Study||9
2920209|NCT00535743|3630651|FG015|COMPLETED|Overall Study||13
2920210|NCT00535743|3630652|FG016|COMPLETED|Overall Study||10
2920211|NCT00535743|3630653|FG017|COMPLETED|Overall Study||11
2920212|NCT00535743|3630654|FG018|COMPLETED|Overall Study||3
2920213|NCT00535743|3630655|FG019|COMPLETED|Overall Study||5
2920214|NCT00535743|3630656|FG020|COMPLETED|Overall Study||5
2920215|NCT00535743|3630657|FG021|COMPLETED|Overall Study||4
2920216|NCT00535743|3630658|FG022|COMPLETED|Overall Study||6
2920217|NCT00535743|3630659|FG023|COMPLETED|Overall Study||5
2920218|NCT00535743|3630636|FG000|NOT COMPLETED|Overall Study||0
2920219|NCT00535743|3630637|FG001|NOT COMPLETED|Overall Study||0
2920220|NCT00535743|3630638|FG002|NOT COMPLETED|Overall Study||0
2920221|NCT00535743|3630639|FG003|NOT COMPLETED|Overall Study||0
2920222|NCT00535743|3630640|FG004|NOT COMPLETED|Overall Study||0
2920223|NCT00535743|3630641|FG005|NOT COMPLETED|Overall Study||0
2920224|NCT00535743|3630642|FG006|NOT COMPLETED|Overall Study||0
2920225|NCT00535743|3630643|FG007|NOT COMPLETED|Overall Study||0
2920226|NCT00535743|3630644|FG008|NOT COMPLETED|Overall Study||1
2920227|NCT00535743|3630645|FG009|NOT COMPLETED|Overall Study||1
2920228|NCT00535743|3630646|FG010|NOT COMPLETED|Overall Study||0
2920229|NCT00535743|3630647|FG011|NOT COMPLETED|Overall Study||0
2920230|NCT00535743|3630648|FG012|NOT COMPLETED|Overall Study||0
2920231|NCT00535743|3630649|FG013|NOT COMPLETED|Overall Study||0
2920232|NCT00535743|3630650|FG014|NOT COMPLETED|Overall Study||0
2920233|NCT00535743|3630651|FG015|NOT COMPLETED|Overall Study||0
2901131|NCT00423917|3609139|FG000|STARTED|Overall Study||36
2901132|NCT00423917|3609139|FG000|COMPLETED|Overall Study||33
2901133|NCT00423917|3609139|FG000|NOT COMPLETED|Overall Study||3
2901134|NCT00423930|3609143|FG000|STARTED|Overall Study||44
2901135|NCT00423930|3609143|FG000|COMPLETED|Overall Study||42
2901136|NCT00423930|3609143|FG000|NOT COMPLETED|Overall Study||2
2901137|NCT00423943|3609149|FG000|STARTED|Overall Study||19
2901138|NCT00423943|3609150|FG001|STARTED|Overall Study||14
2901139|NCT00423943|3609149|FG000|COMPLETED|Overall Study||16
2901140|NCT00423943|3609150|FG001|COMPLETED|Overall Study||13
2901141|NCT00423943|3609149|FG000|NOT COMPLETED|Overall Study||3
2901142|NCT00423943|3609150|FG001|NOT COMPLETED|Overall Study||1
2901143|NCT00424021|3609160|FG000|STARTED|NCT00046319 Study Period||16
2901144|NCT00424021|3609161|FG001|STARTED|NCT00046319 Study Period||19
2901145|NCT00424021|3609162|FG002|STARTED|NCT00046319 Study Period||16
2901146|NCT00424021|3609163|FG003|STARTED|NCT00046319 Study Period||13
2901147|NCT00424021|3609160|FG000|COMPLETED|NCT00046319 Study Period||15
2901148|NCT00424021|3609161|FG001|COMPLETED|NCT00046319 Study Period||16
2901149|NCT00424021|3609162|FG002|COMPLETED|NCT00046319 Study Period||15
2901150|NCT00424021|3609163|FG003|COMPLETED|NCT00046319 Study Period||12
2901151|NCT00424021|3609160|FG000|NOT COMPLETED|NCT00046319 Study Period||1
2901152|NCT00424021|3609161|FG001|NOT COMPLETED|NCT00046319 Study Period||3
2901153|NCT00424021|3609162|FG002|NOT COMPLETED|NCT00046319 Study Period||1
2901154|NCT00424021|3609163|FG003|NOT COMPLETED|NCT00046319 Study Period||1
2901155|NCT00424021|3609160|FG000|STARTED|AMB-220-E Study Period||2
2901156|NCT00424021|3609161|FG001|STARTED|AMB-220-E Study Period||7
2901157|NCT00424021|3609162|FG002|STARTED|AMB-220-E Study Period||19
2901158|NCT00424021|3609163|FG003|STARTED|AMB-220-E Study Period||26
2901159|NCT00424021|3609160|FG000|COMPLETED|AMB-220-E Study Period||1
2901160|NCT00424021|3609161|FG001|COMPLETED|AMB-220-E Study Period||5
2901161|NCT00424021|3609162|FG002|COMPLETED|AMB-220-E Study Period||14
2901162|NCT00424021|3609163|FG003|COMPLETED|AMB-220-E Study Period||16
2901163|NCT00424021|3609160|FG000|NOT COMPLETED|AMB-220-E Study Period||1
2901164|NCT00424021|3609161|FG001|NOT COMPLETED|AMB-220-E Study Period||2
2901165|NCT00424021|3609162|FG002|NOT COMPLETED|AMB-220-E Study Period||5
2901166|NCT00424021|3609163|FG003|NOT COMPLETED|AMB-220-E Study Period||10
2901167|NCT00424047|3609182|FG000|STARTED|Blinded Treatment (Up to 03 Aug 2005)||176
2901168|NCT00424047|3609183|FG001|STARTED|Blinded Treatment (Up to 03 Aug 2005)||175
2901169|NCT00424047|3609182|FG000|Safety Population|Blinded Treatment (Up to 03 Aug 2005)|Includes those who took at least one dose of study medication regimen|176
2901170|NCT00424047|3609183|FG001|Safety Population|Blinded Treatment (Up to 03 Aug 2005)|Includes those who took at least one dose of study medication regimen|175
2901171|NCT00424047|3609182|FG000|Evaluable Population|Blinded Treatment (Up to 03 Aug 2005)|1 participant excluded because they had no baseline M-protein assessment|175
2901172|NCT00424047|3609183|FG001|Evaluable Population|Blinded Treatment (Up to 03 Aug 2005)|4 participants excluded because they had no baseline M-protein assessment|171
2901173|NCT00424047|3609182|FG000|COMPLETED|Blinded Treatment (Up to 03 Aug 2005)|54 participants ongoing and continuing on lenalidomide/dexamethasone treatment|54
2901174|NCT00424047|3609183|FG001|COMPLETED|Blinded Treatment (Up to 03 Aug 2005)|Ongoing and includes 15 participants who crossed over to lenalidomide/dexamethasone after unblinding|19
2901175|NCT00424047|3609182|FG000|NOT COMPLETED|Blinded Treatment (Up to 03 Aug 2005)||122
2901176|NCT00424047|3609183|FG001|NOT COMPLETED|Blinded Treatment (Up to 03 Aug 2005)||156
2901177|NCT00424047|3609182|FG000|STARTED|On Study at Time of Unblinding|Refers to original treatment group assignment in the study.|176
2901178|NCT00424047|3609183|FG001|STARTED|On Study at Time of Unblinding||175
2901179|NCT00424047|3609182|FG000|COMPLETED|On Study at Time of Unblinding|Participants completed = those continuing on long term Lenalidomide and dexamethasone|21
2901180|NCT00424047|3609183|FG001|COMPLETED|On Study at Time of Unblinding|Participants completed = those continuing on long term dexamethasone|8
2901181|NCT00424047|3609182|FG000|NOT COMPLETED|On Study at Time of Unblinding||155
2901182|NCT00424047|3609183|FG001|NOT COMPLETED|On Study at Time of Unblinding||167
2901183|NCT00424047|3609182|FG000|STARTED|Long Term Extension (Up to 25 Jun 2013)||21
2901184|NCT00424047|3609183|FG001|STARTED|Long Term Extension (Up to 25 Jun 2013)|2 participants opted to receive dex alone, 3 crossed over to Len/Dex and 3 added Len at a later date|8
2901185|NCT00424047|3609182|FG000|COMPLETED|Long Term Extension (Up to 25 Jun 2013)||0
2901186|NCT00424047|3609183|FG001|COMPLETED|Long Term Extension (Up to 25 Jun 2013)||0
2901187|NCT00424047|3609182|FG000|NOT COMPLETED|Long Term Extension (Up to 25 Jun 2013)||21
2901188|NCT00424047|3609183|FG001|NOT COMPLETED|Long Term Extension (Up to 25 Jun 2013)||8
2901189|NCT00424177|3609194|FG000|STARTED|Cycle 1: Eltrombopag 50 mg Starting Dose||66
2901190|NCT00424177|3609194|FG000|COMPLETED|Cycle 1: Eltrombopag 50 mg Starting Dose||55
2901191|NCT00424177|3609194|FG000|NOT COMPLETED|Cycle 1: Eltrombopag 50 mg Starting Dose||11
2901192|NCT00424177|3609194|FG000|STARTED|Cycle 2: Eltrombopag 50 or 75 mg||55
2901193|NCT00424177|3609194|FG000|COMPLETED|Cycle 2: Eltrombopag 50 or 75 mg||51
2901194|NCT00424177|3609194|FG000|NOT COMPLETED|Cycle 2: Eltrombopag 50 or 75 mg||4
2901195|NCT00424177|3609194|FG000|STARTED|Cycle 3: Eltrombopag 50 or 75 mg||51
2901196|NCT00424177|3609194|FG000|COMPLETED|Cycle 3: Eltrombopag 50 or 75 mg||48
2901197|NCT00424177|3609194|FG000|NOT COMPLETED|Cycle 3: Eltrombopag 50 or 75 mg||3
2901198|NCT00424190|3609208|FG000|STARTED|Overall Study||351
2901199|NCT00424190|3609209|FG001|STARTED|Overall Study||347
2901200|NCT00424190|3609208|FG000|COMPLETED|Overall Study||329
2901201|NCT00424190|3609209|FG001|COMPLETED|Overall Study||317
2901202|NCT00424190|3609208|FG000|NOT COMPLETED|Overall Study||22
2901203|NCT00424190|3609209|FG001|NOT COMPLETED|Overall Study||30
2901204|NCT00424255|3609217|FG000|STARTED|Overall Study||342
2901205|NCT00424255|3609218|FG001|STARTED|Overall Study||346
2901206|NCT00424255|3609217|FG000|COMPLETED|Overall Study||0
2901207|NCT00424255|3609218|FG001|COMPLETED|Overall Study||0
2901208|NCT00424255|3609217|FG000|NOT COMPLETED|Overall Study||342
2901209|NCT00424255|3609218|FG001|NOT COMPLETED|Overall Study||346
2901210|NCT00424268|3609226|FG000|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|371
2901211|NCT00424268|3609227|FG001|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|372
2901212|NCT00424268|3609226|FG000|COMPLETED|Overall Study||309
2901213|NCT00424268|3609227|FG001|COMPLETED|Overall Study||333
2901214|NCT00424268|3609226|FG000|NOT COMPLETED|Overall Study||62
2901215|NCT00424268|3609227|FG001|NOT COMPLETED|Overall Study||39
2901216|NCT00424294|3609235|FG000|STARTED|Overall Study||36
2901217|NCT00424294|3609236|FG001|STARTED|Overall Study||34
2901218|NCT00424294|3609235|FG000|Treated|Overall Study||35
2901219|NCT00424294|3609236|FG001|Treated|Overall Study||34
2901220|NCT00424294|3609235|FG000|COMPLETED|Overall Study||28
2901221|NCT00424294|3609236|FG001|COMPLETED|Overall Study||19
2901222|NCT00424294|3609235|FG000|NOT COMPLETED|Overall Study||8
2901223|NCT00424294|3609236|FG001|NOT COMPLETED|Overall Study||15
2901224|NCT00424346|3609246|FG000|STARTED|Core Study||71
2901225|NCT00424346|3609247|FG001|STARTED|Core Study||64
2901226|NCT00424346|3609248|FG002|STARTED|Core Study||69
2901227|NCT00424346|3609249|FG003|STARTED|Core Study||70
2901228|NCT00424346|3609246|FG000|COMPLETED|Core Study||62
2901229|NCT00424346|3609247|FG001|COMPLETED|Core Study||56
2901230|NCT00424346|3609248|FG002|COMPLETED|Core Study||65
2901231|NCT00424346|3609249|FG003|COMPLETED|Core Study||63
2901232|NCT00424346|3609246|FG000|NOT COMPLETED|Core Study||9
2901233|NCT00424346|3609247|FG001|NOT COMPLETED|Core Study||8
2901234|NCT00424346|3609248|FG002|NOT COMPLETED|Core Study||4
2901235|NCT00424346|3609249|FG003|NOT COMPLETED|Core Study||7
2901236|NCT00424346|3609246|FG000|STARTED|Extension Phase|Participants are represented in the Canakinumab 300 mg q2wk treatment group.|0
2901237|NCT00424346|3609247|FG001|STARTED|Extension Phase|Includes participants who completed the Core phase in the Canakinumab 600 mg IV + 300 mg q2wk group.|110
2901238|NCT00424346|3609248|FG002|STARTED|Extension Phase||59
2901239|NCT00424346|3609249|FG003|STARTED|Extension Phase||58
2901240|NCT00424346|3609246|FG000|COMPLETED|Extension Phase||0
2901241|NCT00424346|3609247|FG001|COMPLETED|Extension Phase||8
2901242|NCT00424346|3609248|FG002|COMPLETED|Extension Phase||4
2901243|NCT00424346|3609249|FG003|COMPLETED|Extension Phase||3
2901244|NCT00424346|3609246|FG000|NOT COMPLETED|Extension Phase||0
2901245|NCT00424346|3609247|FG001|NOT COMPLETED|Extension Phase||102
2901246|NCT00424346|3609248|FG002|NOT COMPLETED|Extension Phase||55
2901247|NCT00424346|3609249|FG003|NOT COMPLETED|Extension Phase||55
2901248|NCT00424372|3609262|FG000|STARTED|Overall Study||126
2901249|NCT00424372|3609262|FG000|COMPLETED|Overall Study||95
2901250|NCT00424372|3609262|FG000|NOT COMPLETED|Overall Study||31
2901251|NCT00424385|3609266|FG000|STARTED|Cohort 0||12
2901252|NCT00424385|3609266|FG000|COMPLETED|Cohort 0||6
2901253|NCT00424385|3609266|FG000|NOT COMPLETED|Cohort 0||6
2901254|NCT00424385|3609266|FG000|STARTED|Cohort 1||5
2901255|NCT00424385|3609266|FG000|COMPLETED|Cohort 1||4
2901256|NCT00424385|3609266|FG000|NOT COMPLETED|Cohort 1||1
2901257|NCT00424398|3609275|FG000|STARTED|Overall Study||35
2901258|NCT00424398|3609276|FG001|STARTED|Overall Study||36
2901259|NCT00424398|3609277|FG002|STARTED|Overall Study||36
2901260|NCT00424398|3609275|FG000|COMPLETED|Overall Study||32
2901261|NCT00424398|3609276|FG001|COMPLETED|Overall Study||35
2901262|NCT00424398|3609277|FG002|COMPLETED|Overall Study||36
2901263|NCT00424398|3609275|FG000|NOT COMPLETED|Overall Study||3
2901264|NCT00424398|3609276|FG001|NOT COMPLETED|Overall Study||1
2901265|NCT00424398|3609277|FG002|NOT COMPLETED|Overall Study||0
2901266|NCT00424463|3609288|FG000|STARTED|Overall Study||45
2901267|NCT00424463|3609289|FG001|STARTED|Overall Study||48
2901268|NCT00424463|3609290|FG002|STARTED|Overall Study||88
2901269|NCT00424463|3609288|FG000|COMPLETED|Overall Study||38
2901270|NCT00424463|3609289|FG001|COMPLETED|Overall Study||34
2901271|NCT00424463|3609290|FG002|COMPLETED|Overall Study||72
2901272|NCT00424463|3609288|FG000|NOT COMPLETED|Overall Study||7
2901273|NCT00424463|3609289|FG001|NOT COMPLETED|Overall Study||14
2901274|NCT00424463|3609290|FG002|NOT COMPLETED|Overall Study||16
2901275|NCT00424476|3609301|FG000|STARTED|Overall Study||287
2901276|NCT00424476|3609302|FG001|STARTED|Overall Study||288
2901277|NCT00424476|3609303|FG002|STARTED|Overall Study||290
2901278|NCT00424476|3609301|FG000|COMPLETED|Overall Study||226
2901279|NCT00424476|3609302|FG001|COMPLETED|Overall Study||240
2901280|NCT00424476|3609303|FG002|COMPLETED|Overall Study||241
2901281|NCT00424476|3609301|FG000|NOT COMPLETED|Overall Study||61
2901282|NCT00424476|3609302|FG001|NOT COMPLETED|Overall Study||48
2901283|NCT00424476|3609303|FG002|NOT COMPLETED|Overall Study||49
2901284|NCT00424489|3609311|FG000|STARTED|Overall Study||9
2901285|NCT00424489|3609311|FG000|COMPLETED|Overall Study||6
2901286|NCT00424489|3609311|FG000|NOT COMPLETED|Overall Study||3
2901287|NCT00424502|3609315|FG000|STARTED|Overall Study||20
2901288|NCT00424502|3609315|FG000|COMPLETED|Overall Study||20
2901289|NCT00424502|3609315|FG000|NOT COMPLETED|Overall Study||0
2901290|NCT00424515|3609321|FG000|STARTED|Overall Study||11
2901291|NCT00424515|3609322|FG001|STARTED|Overall Study||13
2901292|NCT00424515|3609321|FG000|COMPLETED|Overall Study||0
2901293|NCT00424515|3609322|FG001|COMPLETED|Overall Study||0
2901294|NCT00424515|3609321|FG000|NOT COMPLETED|Overall Study||11
2901295|NCT00424515|3609322|FG001|NOT COMPLETED|Overall Study||13
2901296|NCT00424528|3609331|FG000|STARTED|Overall Study||76
2901297|NCT00424528|3609332|FG001|STARTED|Overall Study||80
2901298|NCT00424528|3609333|FG002|STARTED|Overall Study||78
2901299|NCT00424528|3609331|FG000|COMPLETED|Overall Study||71
2901300|NCT00424528|3609332|FG001|COMPLETED|Overall Study||76
2901301|NCT00424528|3609333|FG002|COMPLETED|Overall Study||74
2901302|NCT00424528|3609331|FG000|NOT COMPLETED|Overall Study||5
2901303|NCT00424528|3609332|FG001|NOT COMPLETED|Overall Study||4
2901304|NCT00424528|3609333|FG002|NOT COMPLETED|Overall Study||4
2901305|NCT00424554|3609343|FG000|STARTED|Overall Study||34
2901306|NCT00424554|3609344|FG001|STARTED|Overall Study||6
2901307|NCT00424554|3609343|FG000|COMPLETED|Overall Study||34
2901308|NCT00424554|3609344|FG001|COMPLETED|Overall Study||6
2901309|NCT00424554|3609343|FG000|NOT COMPLETED|Overall Study||0
2901310|NCT00424554|3609344|FG001|NOT COMPLETED|Overall Study||0
2901311|NCT00424593|3609352|FG000|STARTED|Acute Double-Blind Period||115
2901312|NCT00424593|3609353|FG001|STARTED|Acute Double-Blind Period||121
2901313|NCT00424593|3609352|FG000|COMPLETED|Acute Double-Blind Period||84
2901314|NCT00424593|3609353|FG001|COMPLETED|Acute Double-Blind Period||98
2901315|NCT00424593|3609352|FG000|NOT COMPLETED|Acute Double-Blind Period||31
2901316|NCT00424593|3609353|FG001|NOT COMPLETED|Acute Double-Blind Period||23
2901317|NCT00424593|3609352|FG000|STARTED|Dose-Blind Extension Period|83 duloxetine patients from the acute phase entered the dose-blind period.|181
2901318|NCT00424593|3609353|FG001|STARTED|Dose-Blind Extension Period|98 placebo patients from acute phase entered dose-blind period and received duloxetine.|0
2901319|NCT00424593|3609352|FG000|COMPLETED|Dose-Blind Extension Period||117
2901320|NCT00424593|3609353|FG001|COMPLETED|Dose-Blind Extension Period||0
2901321|NCT00424593|3609352|FG000|NOT COMPLETED|Dose-Blind Extension Period||64
2901322|NCT00424593|3609353|FG001|NOT COMPLETED|Dose-Blind Extension Period||0
2901323|NCT00424619|3609362|FG000|STARTED|Baseline||22
2901324|NCT00424619|3609363|FG001|STARTED|Baseline||22
2901325|NCT00424619|3609364|FG002|STARTED|Baseline|n=21 but one participant was lost as a screen failure|21
2901326|NCT00424619|3609362|FG000|COMPLETED|Baseline||22
2901327|NCT00424619|3609363|FG001|COMPLETED|Baseline||22
2901328|NCT00424619|3609364|FG002|COMPLETED|Baseline||20
2901329|NCT00424619|3609362|FG000|NOT COMPLETED|Baseline||0
2901330|NCT00424619|3609363|FG001|NOT COMPLETED|Baseline||0
2901331|NCT00424619|3609364|FG002|NOT COMPLETED|Baseline||1
2901332|NCT00424619|3609362|FG000|STARTED|4 Week||18
2901333|NCT00424619|3609363|FG001|STARTED|4 Week||17
2901334|NCT00424619|3609364|FG002|STARTED|4 Week||17
2901335|NCT00424619|3609362|FG000|COMPLETED|4 Week||18
2901336|NCT00424619|3609363|FG001|COMPLETED|4 Week||17
2901337|NCT00424619|3609364|FG002|COMPLETED|4 Week||17
2901338|NCT00424619|3609362|FG000|NOT COMPLETED|4 Week||0
2901339|NCT00424619|3609363|FG001|NOT COMPLETED|4 Week||0
2901340|NCT00424619|3609364|FG002|NOT COMPLETED|4 Week||0
2901341|NCT00424619|3609362|FG000|STARTED|3 Month||12
2901342|NCT00424619|3609363|FG001|STARTED|3 Month||18
2901343|NCT00424619|3609364|FG002|STARTED|3 Month||17
2901344|NCT00424619|3609362|FG000|COMPLETED|3 Month||12
2901345|NCT00424619|3609363|FG001|COMPLETED|3 Month||18
2901346|NCT00424619|3609364|FG002|COMPLETED|3 Month||17
2901347|NCT00424619|3609362|FG000|NOT COMPLETED|3 Month||0
2901348|NCT00424619|3609363|FG001|NOT COMPLETED|3 Month||0
2901349|NCT00424619|3609364|FG002|NOT COMPLETED|3 Month||0
2901350|NCT00424632|3609374|FG000|STARTED|Overall Study||1
2901351|NCT00424632|3609375|FG001|STARTED|Overall Study||1
2901352|NCT00424632|3609376|FG002|STARTED|Overall Study||1
2901353|NCT00424632|3609377|FG003|STARTED|Overall Study||4
2901354|NCT00424632|3609378|FG004|STARTED|Overall Study||3
2901355|NCT00424632|3609379|FG005|STARTED|Overall Study||15
2901356|NCT00424632|3609380|FG006|STARTED|Overall Study||7
2901357|NCT00424632|3609381|FG007|STARTED|Overall Study||3
2901358|NCT00424632|3609382|FG008|STARTED|Overall Study||16
2901359|NCT00424632|3609383|FG009|STARTED|Overall Study||6
2901360|NCT00424632|3609374|FG000|COMPLETED|Overall Study||0
2901361|NCT00424632|3609375|FG001|COMPLETED|Overall Study||0
2901362|NCT00424632|3609376|FG002|COMPLETED|Overall Study||0
2901363|NCT00424632|3609377|FG003|COMPLETED|Overall Study||0
2901364|NCT00424632|3609378|FG004|COMPLETED|Overall Study||0
2901365|NCT00424632|3609379|FG005|COMPLETED|Overall Study||0
2901366|NCT00424632|3609380|FG006|COMPLETED|Overall Study||0
2901367|NCT00424632|3609381|FG007|COMPLETED|Overall Study||0
2901368|NCT00424632|3609382|FG008|COMPLETED|Overall Study||0
2901369|NCT00424632|3609383|FG009|COMPLETED|Overall Study||0
2901370|NCT00424632|3609374|FG000|NOT COMPLETED|Overall Study||1
2901371|NCT00424632|3609375|FG001|NOT COMPLETED|Overall Study||1
2901372|NCT00424632|3609376|FG002|NOT COMPLETED|Overall Study||1
2901373|NCT00424632|3609377|FG003|NOT COMPLETED|Overall Study||4
2901374|NCT00424632|3609378|FG004|NOT COMPLETED|Overall Study||3
2901375|NCT00424632|3609379|FG005|NOT COMPLETED|Overall Study||15
2901376|NCT00424632|3609380|FG006|NOT COMPLETED|Overall Study||7
2901377|NCT00424632|3609381|FG007|NOT COMPLETED|Overall Study||3
2901378|NCT00424632|3609382|FG008|NOT COMPLETED|Overall Study||16
2901379|NCT00424632|3609383|FG009|NOT COMPLETED|Overall Study||6
2901380|NCT00424749|3609414|FG000|STARTED|Overall Study||4
2901381|NCT00424749|3609414|FG000|COMPLETED|Overall Study||3
2901382|NCT00424749|3609414|FG000|NOT COMPLETED|Overall Study||1
2901383|NCT00424762|3609420|FG000|STARTED|Overall Study||74
2901384|NCT00424762|3609421|FG001|STARTED|Overall Study||76
2901385|NCT00424762|3609420|FG000|COMPLETED|Overall Study||54
2901386|NCT00424762|3609421|FG001|COMPLETED|Overall Study||54
2901387|NCT00424762|3609420|FG000|NOT COMPLETED|Overall Study||20
2901388|NCT00424762|3609421|FG001|NOT COMPLETED|Overall Study||22
2901389|NCT00424775|3609427|FG000|STARTED|Overall Study||3
2901390|NCT00424775|3609428|FG001|STARTED|Overall Study||0
2901391|NCT00424775|3609427|FG000|COMPLETED|Overall Study||0
2901392|NCT00424775|3609428|FG001|COMPLETED|Overall Study||0
2901393|NCT00424775|3609427|FG000|NOT COMPLETED|Overall Study||3
2901394|NCT00424775|3609428|FG001|NOT COMPLETED|Overall Study||0
2901395|NCT00424827|3609432|FG000|STARTED|Overall Study||11
2901396|NCT00424827|3609432|FG000|COMPLETED|Overall Study||10
2901397|NCT00424827|3609432|FG000|NOT COMPLETED|Overall Study||1
2901398|NCT00424840|3609437|FG000|STARTED|Overall Study||3
2901399|NCT00424840|3609438|FG001|STARTED|Overall Study||4
2901400|NCT00424840|3609439|FG002|STARTED|Overall Study||5
2901401|NCT00424840|3609437|FG000|COMPLETED|Overall Study||3
2901402|NCT00424840|3609438|FG001|COMPLETED|Overall Study||4
2901403|NCT00424840|3609439|FG002|COMPLETED|Overall Study||5
2901404|NCT00424840|3609437|FG000|NOT COMPLETED|Overall Study||0
2901405|NCT00424840|3609438|FG001|NOT COMPLETED|Overall Study||0
2901406|NCT00424840|3609439|FG002|NOT COMPLETED|Overall Study||0
2901407|NCT00425061|3609452|FG000|STARTED|Overall Study||16
2901408|NCT00425061|3609453|FG001|STARTED|Overall Study||17
2901409|NCT00425061|3609454|FG002|STARTED|Overall Study||16
2901410|NCT00425061|3609455|FG003|STARTED|Overall Study||16
2901411|NCT00425061|3609456|FG004|STARTED|Overall Study||45
2901412|NCT00425061|3609457|FG005|STARTED|Overall Study||4
2901413|NCT00425061|3609458|FG006|STARTED|Overall Study||45
2901414|NCT00425061|3609452|FG000|COMPLETED|Overall Study||14
2901415|NCT00425061|3609453|FG001|COMPLETED|Overall Study||15
2901416|NCT00425061|3609454|FG002|COMPLETED|Overall Study||16
2901417|NCT00425061|3609455|FG003|COMPLETED|Overall Study||14
2901418|NCT00425061|3609456|FG004|COMPLETED|Overall Study||19
2901419|NCT00425061|3609457|FG005|COMPLETED|Overall Study||0
2901420|NCT00425061|3609458|FG006|COMPLETED|Overall Study||26
2901421|NCT00425061|3609452|FG000|NOT COMPLETED|Overall Study||2
2901422|NCT00425061|3609453|FG001|NOT COMPLETED|Overall Study||2
2901423|NCT00425061|3609454|FG002|NOT COMPLETED|Overall Study||0
2901424|NCT00425061|3609455|FG003|NOT COMPLETED|Overall Study||2
2901425|NCT00425061|3609456|FG004|NOT COMPLETED|Overall Study||26
2901426|NCT00425061|3609457|FG005|NOT COMPLETED|Overall Study||4
2901427|NCT00425061|3609458|FG006|NOT COMPLETED|Overall Study||19
2901428|NCT00425113|3609478|FG000|STARTED|Overall Study||17
2901429|NCT00425113|3609479|FG001|STARTED|Overall Study||18
2901430|NCT00425113|3609478|FG000|Exposed to Study Drug|Overall Study||16
2901431|NCT00425113|3609479|FG001|Exposed to Study Drug|Overall Study||17
2901432|NCT00425113|3609478|FG000|COMPLETED|Overall Study|Included in modified intent-to-treat analysis|15
2901433|NCT00425113|3609479|FG001|COMPLETED|Overall Study|Included in modified intent-to-treat analysis|16
2901434|NCT00425113|3609478|FG000|NOT COMPLETED|Overall Study||2
2901435|NCT00425113|3609479|FG001|NOT COMPLETED|Overall Study||2
2920234|NCT00535743|3630652|FG016|NOT COMPLETED|Overall Study||0
2920235|NCT00535743|3630653|FG017|NOT COMPLETED|Overall Study||0
2920236|NCT00535743|3630654|FG018|NOT COMPLETED|Overall Study||0
2920237|NCT00535743|3630655|FG019|NOT COMPLETED|Overall Study||0
2920238|NCT00535743|3630656|FG020|NOT COMPLETED|Overall Study||0
2920239|NCT00535743|3630657|FG021|NOT COMPLETED|Overall Study||1
2920240|NCT00535743|3630658|FG022|NOT COMPLETED|Overall Study||0
2920241|NCT00535743|3630659|FG023|NOT COMPLETED|Overall Study||0
2920242|NCT00535769|3630711|FG000|STARTED|Overall Study||35
2920243|NCT00535769|3630712|FG001|STARTED|Overall Study||35
2920244|NCT00535769|3630711|FG000|COMPLETED|Overall Study||35
2920245|NCT00535769|3630712|FG001|COMPLETED|Overall Study||35
2920246|NCT00535769|3630711|FG000|NOT COMPLETED|Overall Study||0
2920247|NCT00535769|3630712|FG001|NOT COMPLETED|Overall Study||0
2920248|NCT00535782|3630721|FG000|STARTED|Part 1: 24-Week Double-blind Period||69
2920249|NCT00535782|3630722|FG001|STARTED|Part 1: 24-Week Double-blind Period||63
2920250|NCT00535782|3630723|FG002|STARTED|Part 1: 24-Week Double-blind Period||0
2920251|NCT00535782|3630721|FG000|Treated With TCZ + MTX|Part 1: 24-Week Double-blind Period||69
2920252|NCT00535782|3630722|FG001|Treated With TCZ + MTX|Part 1: 24-Week Double-blind Period|1 misrandomized patient received the TCZ in error, and 1 patient received TCZ as rescue therapy.|2
2920253|NCT00535782|3630723|FG002|Treated With TCZ + MTX|Part 1: 24-Week Double-blind Period||0
2920254|NCT00535782|3630721|FG000|Treated With Placebo + MTX|Part 1: 24-Week Double-blind Period||0
2920255|NCT00535782|3630722|FG001|Treated With Placebo + MTX|Part 1: 24-Week Double-blind Period||62
2920256|NCT00535782|3630723|FG002|Treated With Placebo + MTX|Part 1: 24-Week Double-blind Period||0
2920257|NCT00535782|3630721|FG000|COMPLETED|Part 1: 24-Week Double-blind Period||65
2920258|NCT00535782|3630722|FG001|COMPLETED|Part 1: 24-Week Double-blind Period||59
2920259|NCT00535782|3630723|FG002|COMPLETED|Part 1: 24-Week Double-blind Period||0
2920260|NCT00535782|3630721|FG000|NOT COMPLETED|Part 1: 24-Week Double-blind Period||4
2920261|NCT00535782|3630722|FG001|NOT COMPLETED|Part 1: 24-Week Double-blind Period||4
2920262|NCT00535782|3630723|FG002|NOT COMPLETED|Part 1: 24-Week Double-blind Period||0
2920263|NCT00535782|3630721|FG000|STARTED|Part 2: 80-Week Open-label Period||0
2920264|NCT00535782|3630722|FG001|STARTED|Part 2: 80-Week Open-label Period||0
2920265|NCT00535782|3630723|FG002|STARTED|Part 2: 80-Week Open-label Period||124
2920266|NCT00535782|3630721|FG000|COMPLETED|Part 2: 80-Week Open-label Period||0
2920267|NCT00535782|3630722|FG001|COMPLETED|Part 2: 80-Week Open-label Period||0
2901436|NCT00425269|3609488|FG000|STARTED|Overall Study||101
2901437|NCT00425269|3609489|FG001|STARTED|Overall Study||97
2901438|NCT00425269|3609488|FG000|COMPLETED|Overall Study||82
2901439|NCT00425269|3609489|FG001|COMPLETED|Overall Study||77
2901440|NCT00425269|3609488|FG000|NOT COMPLETED|Overall Study||19
2901441|NCT00425269|3609489|FG001|NOT COMPLETED|Overall Study||20
2901442|NCT00425308|3609497|FG000|STARTED|Overall Study||15
2901443|NCT00425308|3609498|FG001|STARTED|Overall Study||15
2901444|NCT00425308|3609497|FG000|COMPLETED|Overall Study||11
2901445|NCT00425308|3609498|FG001|COMPLETED|Overall Study||14
2901446|NCT00425308|3609497|FG000|NOT COMPLETED|Overall Study||4
3171122|NCT01932762|3898352|FG001|STARTED|Overall Study||30
3171123|NCT01932762|3898353|FG002|STARTED|Overall Study||19
3171124|NCT01932762|3898354|FG003|STARTED|Overall Study||19
3171125|NCT01932762|3898351|FG000|COMPLETED|Overall Study||24
3171126|NCT01932762|3898352|FG001|COMPLETED|Overall Study||28
3171127|NCT01932762|3898353|FG002|COMPLETED|Overall Study||19
3171128|NCT01932762|3898354|FG003|COMPLETED|Overall Study||18
3171129|NCT01932762|3898351|FG000|NOT COMPLETED|Overall Study||6
3171130|NCT01932762|3898352|FG001|NOT COMPLETED|Overall Study||2
3171131|NCT01932762|3898353|FG002|NOT COMPLETED|Overall Study||0
3171132|NCT01932762|3898354|FG003|NOT COMPLETED|Overall Study||1
3171133|NCT01932788|3898366|FG000|STARTED|Overall Study||173
3171134|NCT01932788|3898367|FG001|STARTED|Overall Study||169
3171135|NCT01932788|3898366|FG000|COMPLETED|Overall Study||135
3171136|NCT01932788|3898367|FG001|COMPLETED|Overall Study||118
3171137|NCT01932788|3898366|FG000|NOT COMPLETED|Overall Study||38
3171138|NCT01932788|3898367|FG001|NOT COMPLETED|Overall Study||51
3171139|NCT01932970|3898373|FG000|STARTED|Overall Study|Includes all participants who enrolled into the washout period.|158
3171140|NCT01932970|3898373|FG000|Received Treatment|Overall Study|Includes participants who completed the washout period and received etelcalcetide|148
3171141|NCT01932970|3898373|FG000|COMPLETED|Overall Study||140
3171142|NCT01932970|3898373|FG000|NOT COMPLETED|Overall Study||18
3171143|NCT01932996|3898379|FG000|STARTED|Overall Study||172
3171144|NCT01932996|3898380|FG001|STARTED|Overall Study||180
3171145|NCT01932996|3898379|FG000|COMPLETED|Overall Study||170
3171146|NCT01932996|3898380|FG001|COMPLETED|Overall Study||180
3171147|NCT01932996|3898379|FG000|NOT COMPLETED|Overall Study||2
3171148|NCT01932996|3898380|FG001|NOT COMPLETED|Overall Study||0
2901447|NCT00425308|3609498|FG001|NOT COMPLETED|Overall Study||1
2901448|NCT00425373|3609513|FG000|STARTED|Overall Study||159
3171149|NCT01933048|3898388|FG000|STARTED|Overall Study||548
3171150|NCT01933048|3898389|FG001|STARTED|Overall Study||529
3171151|NCT01933048|3898388|FG000|COMPLETED|Overall Study||523
3171152|NCT01933048|3898389|FG001|COMPLETED|Overall Study||501
3171153|NCT01933048|3898388|FG000|NOT COMPLETED|Overall Study||25
3171154|NCT01933048|3898389|FG001|NOT COMPLETED|Overall Study||28
3171155|NCT01933113|3898398|FG000|STARTED|Overall Study||3
3171156|NCT01933113|3898398|FG000|COMPLETED|Overall Study||2
3171157|NCT01933113|3898398|FG000|NOT COMPLETED|Overall Study||1
3171158|NCT01933217|3898404|FG000|STARTED|Randomization (4 Weeks)||12
3171159|NCT01933217|3898405|FG001|STARTED|Randomization (4 Weeks)||14
3171160|NCT01933217|3898404|FG000|COMPLETED|Randomization (4 Weeks)||10
3171161|NCT01933217|3898405|FG001|COMPLETED|Randomization (4 Weeks)||10
3171162|NCT01933217|3898404|FG000|NOT COMPLETED|Randomization (4 Weeks)||2
3171163|NCT01933217|3898405|FG001|NOT COMPLETED|Randomization (4 Weeks)||4
3171164|NCT01933217|3898404|FG000|STARTED|Crossover (4 Weeks)||10
3171165|NCT01933217|3898405|FG001|STARTED|Crossover (4 Weeks)||10
3171166|NCT01933217|3898404|FG000|COMPLETED|Crossover (4 Weeks)||10
3171167|NCT01933217|3898405|FG001|COMPLETED|Crossover (4 Weeks)||10
3171168|NCT01933217|3898404|FG000|NOT COMPLETED|Crossover (4 Weeks)||0
3171169|NCT01933217|3898405|FG001|NOT COMPLETED|Crossover (4 Weeks)||0
3171170|NCT01933230|3898413|FG000|STARTED|Overall Study||2
3171171|NCT01933230|3898413|FG000|COMPLETED|Overall Study||2
3171172|NCT01933230|3898413|FG000|NOT COMPLETED|Overall Study||0
3171173|NCT01933243|3898419|FG000|STARTED|Overall Study||12
3171174|NCT01933243|3898420|FG001|STARTED|Overall Study||12
3171175|NCT01933243|3898419|FG000|COMPLETED|Overall Study||10
3171176|NCT01933243|3898420|FG001|COMPLETED|Overall Study||8
3171177|NCT01933243|3898419|FG000|NOT COMPLETED|Overall Study||2
3171178|NCT01933243|3898420|FG001|NOT COMPLETED|Overall Study||4
3171179|NCT01933334|3898428|FG000|STARTED|Overall Study||32
3171180|NCT01933334|3898429|FG001|STARTED|Overall Study||31
3171181|NCT01933334|3898428|FG000|COMPLETED|Overall Study||27
3171182|NCT01933334|3898429|FG001|COMPLETED|Overall Study||29
3171183|NCT01933334|3898428|FG000|NOT COMPLETED|Overall Study||5
3171184|NCT01933334|3898429|FG001|NOT COMPLETED|Overall Study||2
3171185|NCT01933399|3898438|FG000|STARTED|Overall Study||29
3171186|NCT01933399|3898439|FG001|STARTED|Overall Study||32
3171187|NCT01933399|3898440|FG002|STARTED|Overall Study||37
3171188|NCT01933399|3898438|FG000|COMPLETED|Overall Study||29
3171189|NCT01933399|3898439|FG001|COMPLETED|Overall Study||32
3171190|NCT01933399|3898440|FG002|COMPLETED|Overall Study||37
3171191|NCT01933399|3898438|FG000|NOT COMPLETED|Overall Study||0
3171192|NCT01933399|3898439|FG001|NOT COMPLETED|Overall Study||0
3171193|NCT01933399|3898440|FG002|NOT COMPLETED|Overall Study||0
3171194|NCT01933425|3898448|FG000|STARTED|Overall Study||7
3171195|NCT01933425|3898449|FG001|STARTED|Overall Study||7
3171196|NCT01933425|3898448|FG000|COMPLETED|Overall Study||7
3171197|NCT01933425|3898449|FG001|COMPLETED|Overall Study||7
3171198|NCT01933425|3898448|FG000|NOT COMPLETED|Overall Study||0
3171199|NCT01933425|3898449|FG001|NOT COMPLETED|Overall Study||0
3171200|NCT01933464|3898459|FG000|STARTED|Overall Study||5
3171201|NCT01933464|3898460|FG001|STARTED|Overall Study||5
3171202|NCT01933464|3898459|FG000|COMPLETED|Overall Study||5
3171203|NCT01933464|3898460|FG001|COMPLETED|Overall Study||5
3171204|NCT01933464|3898459|FG000|NOT COMPLETED|Overall Study||0
3171205|NCT01933464|3898460|FG001|NOT COMPLETED|Overall Study||0
3171206|NCT01933594|3898472|FG000|STARTED|Overall Study||12
3171207|NCT01933594|3898473|FG001|STARTED|Overall Study||12
3171208|NCT01933594|3898474|FG002|STARTED|Overall Study||12
3171209|NCT01933594|3898475|FG003|STARTED|Overall Study||7
2901449|NCT00425373|3609514|FG001|STARTED|Overall Study||167
2901450|NCT00425373|3609515|FG002|STARTED|Overall Study||160
2901451|NCT00425373|3609516|FG003|STARTED|Overall Study||162
2901452|NCT00425373|3609517|FG004|STARTED|Overall Study||169
2901453|NCT00425373|3609518|FG005|STARTED|Overall Study||163
2901454|NCT00425373|3609519|FG006|STARTED|Overall Study||161
2901455|NCT00425373|3609520|FG007|STARTED|Overall Study||161
2901456|NCT00425373|3609521|FG008|STARTED|Overall Study||166
2901457|NCT00425373|3609513|FG000|COMPLETED|Overall Study||154
2901458|NCT00425373|3609514|FG001|COMPLETED|Overall Study||164
2901459|NCT00425373|3609515|FG002|COMPLETED|Overall Study||157
2901460|NCT00425373|3609516|FG003|COMPLETED|Overall Study||160
2901461|NCT00425373|3609517|FG004|COMPLETED|Overall Study||159
2901462|NCT00425373|3609518|FG005|COMPLETED|Overall Study||154
2901463|NCT00425373|3609519|FG006|COMPLETED|Overall Study||154
2901464|NCT00425373|3609520|FG007|COMPLETED|Overall Study||151
2901465|NCT00425373|3609521|FG008|COMPLETED|Overall Study||148
2901466|NCT00425373|3609513|FG000|NOT COMPLETED|Overall Study||5
2901467|NCT00425373|3609514|FG001|NOT COMPLETED|Overall Study||3
2901468|NCT00425373|3609515|FG002|NOT COMPLETED|Overall Study||3
2901469|NCT00425373|3609516|FG003|NOT COMPLETED|Overall Study||2
2901470|NCT00425373|3609517|FG004|NOT COMPLETED|Overall Study||10
2901471|NCT00425373|3609518|FG005|NOT COMPLETED|Overall Study||9
2901472|NCT00425373|3609519|FG006|NOT COMPLETED|Overall Study||7
2901473|NCT00425373|3609520|FG007|NOT COMPLETED|Overall Study||10
2901474|NCT00425373|3609521|FG008|NOT COMPLETED|Overall Study||18
2901475|NCT00425386|3609541|FG000|STARTED|Overall Study||46
2901476|NCT00425386|3609541|FG000|COMPLETED|Overall Study||43
2901477|NCT00425386|3609541|FG000|NOT COMPLETED|Overall Study||3
2901478|NCT00425477|3609545|FG000|STARTED|Overall Study||26
2901479|NCT00425477|3609545|FG000|COMPLETED|Overall Study||13
2901480|NCT00425477|3609545|FG000|NOT COMPLETED|Overall Study||13
2901481|NCT00425503|3609549|FG000|STARTED|Overall Study||40
2901482|NCT00425503|3609549|FG000|COMPLETED|Overall Study||37
2901483|NCT00425503|3609549|FG000|NOT COMPLETED|Overall Study||3
2901484|NCT00425555|3609555|FG000|STARTED|Overall Study||79
2901485|NCT00425555|3609556|FG001|STARTED|Overall Study||60
2901486|NCT00425555|3609555|FG000|COMPLETED|Overall Study||0
2901487|NCT00425555|3609556|FG001|COMPLETED|Overall Study||0
2901488|NCT00425555|3609555|FG000|NOT COMPLETED|Overall Study||79
2901489|NCT00425555|3609556|FG001|NOT COMPLETED|Overall Study||60
2901490|NCT00425607|3609565|FG000|STARTED|Overall Study||29
2901491|NCT00425607|3609565|FG000|Received Treatment|Overall Study||28
2901492|NCT00425607|3609565|FG000|COMPLETED|Overall Study||27
2901493|NCT00425607|3609565|FG000|NOT COMPLETED|Overall Study||2
2901494|NCT00425672|3609569|FG000|STARTED|Overall Study||15
2901495|NCT00425672|3609569|FG000|COMPLETED|Overall Study||14
2901496|NCT00425672|3609569|FG000|NOT COMPLETED|Overall Study||1
2901497|NCT00425698|3609575|FG000|STARTED|Overall Study||44
2901498|NCT00425698|3609576|FG001|STARTED|Overall Study||44
2901499|NCT00425698|3609575|FG000|COMPLETED|Overall Study||41
2901500|NCT00425698|3609576|FG001|COMPLETED|Overall Study||42
2901501|NCT00425698|3609575|FG000|NOT COMPLETED|Overall Study||3
2901502|NCT00425698|3609576|FG001|NOT COMPLETED|Overall Study||2
2901503|NCT00425750|3609582|FG000|STARTED|Overall Study||25
2901504|NCT00425750|3609582|FG000|COMPLETED|Overall Study||0
2901505|NCT00425750|3609582|FG000|NOT COMPLETED|Overall Study||25
2901506|NCT00425802|3609586|FG000|STARTED|Overall Study||61
3171210|NCT01933594|3898476|FG004|STARTED|Overall Study||13
3171211|NCT01933594|3898477|FG005|STARTED|Overall Study||3
3171212|NCT01933594|3898472|FG000|COMPLETED|Overall Study||11
3171213|NCT01933594|3898473|FG001|COMPLETED|Overall Study||12
3171214|NCT01933594|3898474|FG002|COMPLETED|Overall Study||12
3171215|NCT01933594|3898475|FG003|COMPLETED|Overall Study||7
3171216|NCT01933594|3898476|FG004|COMPLETED|Overall Study||11
3171217|NCT01933594|3898477|FG005|COMPLETED|Overall Study||3
3171218|NCT01933594|3898472|FG000|NOT COMPLETED|Overall Study||1
3171219|NCT01933594|3898473|FG001|NOT COMPLETED|Overall Study||0
3171220|NCT01933594|3898474|FG002|NOT COMPLETED|Overall Study||0
3171221|NCT01933594|3898475|FG003|NOT COMPLETED|Overall Study||0
3171222|NCT01933594|3898476|FG004|NOT COMPLETED|Overall Study||2
3171223|NCT01933594|3898477|FG005|NOT COMPLETED|Overall Study||0
3171224|NCT01933672|3898495|FG000|STARTED|Metformin Run-in Period||43
2901507|NCT00425802|3609586|FG000|COMPLETED|Overall Study||61
2901508|NCT00425802|3609586|FG000|NOT COMPLETED|Overall Study||0
2901509|NCT00425854|3609592|FG000|STARTED|Overall Study|Treated|29
2901510|NCT00425854|3609593|FG001|STARTED|Overall Study|Treated|21
2901511|NCT00425854|3609592|FG000|COMPLETED|Overall Study|On treatment at analysis cut-off date (30 Sep 2009)|0
2901512|NCT00425854|3609593|FG001|COMPLETED|Overall Study|On treatment at analysis cut-off date (30 Sep 2009)|0
2901513|NCT00425854|3609592|FG000|NOT COMPLETED|Overall Study||29
3171225|NCT01933672|3898496|FG001|STARTED|Metformin Run-in Period||0
3171226|NCT01933672|3898497|FG002|STARTED|Metformin Run-in Period||0
3316150|NCT03107052|4049436|FG000|STARTED|Overall Study||145
3316151|NCT03107052|4049437|FG001|STARTED|Overall Study||60
3316152|NCT03107052|4049438|FG002|STARTED|Overall Study||70
3316153|NCT03107052|4049436|FG000|Safety Analysis Set|Overall Study|1 participant assigned to 225 mg monthly arm but received 675 mg quarterly after >12 weeks remission|144
3316154|NCT03107052|4049437|FG001|Safety Analysis Set|Overall Study||60
3316155|NCT03107052|4049438|FG002|Safety Analysis Set|Overall Study|1 participant assigned to 225 mg monthly arm but received 675 mg quarterly after >12 weeks remission|71
3316156|NCT03107052|4049436|FG000|COMPLETED|Overall Study||26
3316157|NCT03107052|4049437|FG001|COMPLETED|Overall Study||14
3316158|NCT03107052|4049438|FG002|COMPLETED|Overall Study||29
3171227|NCT01933672|3898498|FG003|STARTED|Metformin Run-in Period||0
3171228|NCT01933672|3898499|FG004|STARTED|Metformin Run-in Period||0
3171229|NCT01933672|3898500|FG005|STARTED|Metformin Run-in Period||0
3171230|NCT01933672|3898501|FG006|STARTED|Metformin Run-in Period||0
3171231|NCT01933672|3898495|FG000|Received Treatment|Metformin Run-in Period||43
3171232|NCT01933672|3898496|FG001|Received Treatment|Metformin Run-in Period||0
3171233|NCT01933672|3898497|FG002|Received Treatment|Metformin Run-in Period||0
2901514|NCT00425854|3609593|FG001|NOT COMPLETED|Overall Study||21
2901515|NCT00425945|3609602|FG000|STARTED|Overall Study||64
2901516|NCT00425945|3609603|FG001|STARTED|Overall Study||66
2901517|NCT00425945|3609602|FG000|COMPLETED|Overall Study||60
2901518|NCT00425945|3609603|FG001|COMPLETED|Overall Study||61
2901519|NCT00425945|3609602|FG000|NOT COMPLETED|Overall Study||4
2901520|NCT00425945|3609603|FG001|NOT COMPLETED|Overall Study||5
2901521|NCT00426127|3609611|FG000|STARTED|Overall Study||2
2901522|NCT00426127|3609611|FG000|COMPLETED|Overall Study||0
2901523|NCT00426127|3609611|FG000|NOT COMPLETED|Overall Study||2
2901524|NCT00426153|3609617|FG000|STARTED|Overall Study|Participants were randomized in a 2:1 ratio, Octreotide LAR depot: Placebo|28
2901525|NCT00426153|3609618|FG001|STARTED|Overall Study||14
2901526|NCT00426153|3609617|FG000|COMPLETED|Overall Study||28
2901527|NCT00426153|3609618|FG001|COMPLETED|Overall Study||14
2901528|NCT00426153|3609617|FG000|NOT COMPLETED|Overall Study||0
2901529|NCT00426153|3609618|FG001|NOT COMPLETED|Overall Study||0
2901530|NCT00426231|3609626|FG000|STARTED|Overall Study||36
2901531|NCT00426231|3609627|FG001|STARTED|Overall Study||37
2901532|NCT00426231|3609626|FG000|COMPLETED|Overall Study|For the 6 month endpoint|27
2901533|NCT00426231|3609627|FG001|COMPLETED|Overall Study|For the 6-month endpoint|25
2901534|NCT00426231|3609626|FG000|NOT COMPLETED|Overall Study||9
2901535|NCT00426231|3609627|FG001|NOT COMPLETED|Overall Study||12
2901536|NCT00426270|3609633|FG000|STARTED|Overall Study||116
2901537|NCT00426270|3609633|FG000|COMPLETED|Overall Study||110
2901538|NCT00426270|3609633|FG000|NOT COMPLETED|Overall Study||6
2901539|NCT00426283|3609639|FG000|STARTED|Overall Study||28
2901540|NCT00426283|3609640|FG001|STARTED|Overall Study||14
2901541|NCT00426283|3609639|FG000|COMPLETED|Overall Study||23
2901542|NCT00426283|3609640|FG001|COMPLETED|Overall Study||13
2901543|NCT00426283|3609639|FG000|NOT COMPLETED|Overall Study||5
2901544|NCT00426283|3609640|FG001|NOT COMPLETED|Overall Study||1
2901545|NCT00426361|3609653|FG000|STARTED|Overall Study||248
2901546|NCT00426361|3609654|FG001|STARTED|Overall Study||255
2901547|NCT00426361|3609655|FG002|STARTED|Overall Study||248
2901548|NCT00426361|3609653|FG000|COMPLETED|Overall Study||244
2901549|NCT00426361|3609654|FG001|COMPLETED|Overall Study||250
2901550|NCT00426361|3609655|FG002|COMPLETED|Overall Study||243
2901551|NCT00426361|3609653|FG000|NOT COMPLETED|Overall Study||4
2901552|NCT00426361|3609654|FG001|NOT COMPLETED|Overall Study||5
2901553|NCT00426361|3609655|FG002|NOT COMPLETED|Overall Study||5
2901554|NCT00426517|3609667|FG000|STARTED|Overall Study||7
2901555|NCT00426517|3609668|FG001|STARTED|Overall Study||36
2901556|NCT00426517|3609669|FG002|STARTED|Overall Study||3
2901557|NCT00426517|3609670|FG003|STARTED|Overall Study||2
2901558|NCT00426517|3609667|FG000|COMPLETED|Overall Study||7
2901559|NCT00426517|3609668|FG001|COMPLETED|Overall Study||36
2901560|NCT00426517|3609669|FG002|COMPLETED|Overall Study||3
2901561|NCT00426517|3609670|FG003|COMPLETED|Overall Study||2
2901562|NCT00426517|3609667|FG000|NOT COMPLETED|Overall Study||0
2901563|NCT00426517|3609668|FG001|NOT COMPLETED|Overall Study||0
2901564|NCT00426517|3609669|FG002|NOT COMPLETED|Overall Study||0
2901565|NCT00426517|3609670|FG003|NOT COMPLETED|Overall Study||0
2901566|NCT00426556|3609684|FG000|STARTED|Phase I - Core Phase||6
2901567|NCT00426556|3609685|FG001|STARTED|Phase I - Core Phase||17
2901568|NCT00426556|3609686|FG002|STARTED|Phase I - Core Phase||10
2901569|NCT00426556|3609687|FG003|STARTED|Phase I - Core Phase||0
2901570|NCT00426556|3609684|FG000|COMPLETED|Phase I - Core Phase||5
2901571|NCT00426556|3609685|FG001|COMPLETED|Phase I - Core Phase||7
2901572|NCT00426556|3609686|FG002|COMPLETED|Phase I - Core Phase||7
2901573|NCT00426556|3609687|FG003|COMPLETED|Phase I - Core Phase||0
3171234|NCT01933672|3898498|FG003|Received Treatment|Metformin Run-in Period||0
2901574|NCT00426556|3609684|FG000|NOT COMPLETED|Phase I - Core Phase||1
2901575|NCT00426556|3609685|FG001|NOT COMPLETED|Phase I - Core Phase||10
2901576|NCT00426556|3609686|FG002|NOT COMPLETED|Phase I - Core Phase||3
2901577|NCT00426556|3609687|FG003|NOT COMPLETED|Phase I - Core Phase||0
2901578|NCT00426556|3609684|FG000|STARTED|Phase I - Extension Phase||5
2901579|NCT00426556|3609685|FG001|STARTED|Phase I - Extension Phase||7
2901580|NCT00426556|3609686|FG002|STARTED|Phase I - Extension Phase||7
2901581|NCT00426556|3609687|FG003|STARTED|Phase I - Extension Phase||0
2901582|NCT00426556|3609684|FG000|COMPLETED|Phase I - Extension Phase||0
2901583|NCT00426556|3609685|FG001|COMPLETED|Phase I - Extension Phase||1
2901584|NCT00426556|3609686|FG002|COMPLETED|Phase I - Extension Phase||0
2901585|NCT00426556|3609687|FG003|COMPLETED|Phase I - Extension Phase||0
2901586|NCT00426556|3609684|FG000|NOT COMPLETED|Phase I - Extension Phase||5
2901587|NCT00426556|3609685|FG001|NOT COMPLETED|Phase I - Extension Phase||6
2901588|NCT00426556|3609686|FG002|NOT COMPLETED|Phase I - Extension Phase||7
2901589|NCT00426556|3609687|FG003|NOT COMPLETED|Phase I - Extension Phase||0
2901590|NCT00426556|3609684|FG000|STARTED|Phase II - Core Phase||0
2901591|NCT00426556|3609685|FG001|STARTED|Phase II - Core Phase||0
2901592|NCT00426556|3609686|FG002|STARTED|Phase II - Core Phase||0
2901593|NCT00426556|3609687|FG003|STARTED|Phase II - Core Phase||55
2901594|NCT00426556|3609684|FG000|COMPLETED|Phase II - Core Phase||0
2901595|NCT00426556|3609685|FG001|COMPLETED|Phase II - Core Phase||0
2901596|NCT00426556|3609686|FG002|COMPLETED|Phase II - Core Phase||0
2901597|NCT00426556|3609687|FG003|COMPLETED|Phase II - Core Phase||28
2901598|NCT00426556|3609684|FG000|NOT COMPLETED|Phase II - Core Phase||0
2901599|NCT00426556|3609685|FG001|NOT COMPLETED|Phase II - Core Phase||0
2901600|NCT00426556|3609686|FG002|NOT COMPLETED|Phase II - Core Phase||0
2901601|NCT00426556|3609687|FG003|NOT COMPLETED|Phase II - Core Phase||27
2901602|NCT00426556|3609684|FG000|STARTED|Phase II - Extension Phase||0
2901603|NCT00426556|3609685|FG001|STARTED|Phase II - Extension Phase||0
2901604|NCT00426556|3609686|FG002|STARTED|Phase II - Extension Phase||0
2901605|NCT00426556|3609687|FG003|STARTED|Phase II - Extension Phase|4 patients did not enter the Extension phase.|24
2901606|NCT00426556|3609684|FG000|COMPLETED|Phase II - Extension Phase||0
2901607|NCT00426556|3609685|FG001|COMPLETED|Phase II - Extension Phase||0
2901608|NCT00426556|3609686|FG002|COMPLETED|Phase II - Extension Phase||0
2901609|NCT00426556|3609687|FG003|COMPLETED|Phase II - Extension Phase|Completed means 'Ongoing'|1
2901610|NCT00426556|3609684|FG000|NOT COMPLETED|Phase II - Extension Phase||0
2901611|NCT00426556|3609685|FG001|NOT COMPLETED|Phase II - Extension Phase||0
2901612|NCT00426556|3609686|FG002|NOT COMPLETED|Phase II - Extension Phase||0
2901613|NCT00426556|3609687|FG003|NOT COMPLETED|Phase II - Extension Phase||23
2901614|NCT00426660|3609697|FG000|STARTED|Overall Study||1047
2901615|NCT00426660|3609697|FG000|Treated|Overall Study||1032
3171235|NCT01933672|3898499|FG004|Received Treatment|Metformin Run-in Period||0
3171236|NCT01933672|3898500|FG005|Received Treatment|Metformin Run-in Period||0
3171237|NCT01933672|3898501|FG006|Received Treatment|Metformin Run-in Period||0
3171238|NCT01933672|3898495|FG000|COMPLETED|Metformin Run-in Period||33
3171239|NCT01933672|3898496|FG001|COMPLETED|Metformin Run-in Period||0
3171240|NCT01933672|3898497|FG002|COMPLETED|Metformin Run-in Period||0
3171241|NCT01933672|3898498|FG003|COMPLETED|Metformin Run-in Period||0
3171242|NCT01933672|3898499|FG004|COMPLETED|Metformin Run-in Period||0
3171243|NCT01933672|3898500|FG005|COMPLETED|Metformin Run-in Period||0
3171244|NCT01933672|3898501|FG006|COMPLETED|Metformin Run-in Period||0
3171245|NCT01933672|3898495|FG000|NOT COMPLETED|Metformin Run-in Period||10
3171246|NCT01933672|3898496|FG001|NOT COMPLETED|Metformin Run-in Period||0
3171247|NCT01933672|3898497|FG002|NOT COMPLETED|Metformin Run-in Period||0
3171248|NCT01933672|3898498|FG003|NOT COMPLETED|Metformin Run-in Period||0
3171249|NCT01933672|3898499|FG004|NOT COMPLETED|Metformin Run-in Period||0
3171250|NCT01933672|3898500|FG005|NOT COMPLETED|Metformin Run-in Period||0
3171251|NCT01933672|3898501|FG006|NOT COMPLETED|Metformin Run-in Period||0
3171252|NCT01933672|3898495|FG000|STARTED|First Intervention Period (12-16 Days)||0
3171253|NCT01933672|3898496|FG001|STARTED|First Intervention Period (12-16 Days)||7
3171254|NCT01933672|3898497|FG002|STARTED|First Intervention Period (12-16 Days)||3
3171255|NCT01933672|3898498|FG003|STARTED|First Intervention Period (12-16 Days)||5
3171256|NCT01933672|3898499|FG004|STARTED|First Intervention Period (12-16 Days)||7
3171257|NCT01933672|3898500|FG005|STARTED|First Intervention Period (12-16 Days)||5
3171258|NCT01933672|3898501|FG006|STARTED|First Intervention Period (12-16 Days)||6
3171259|NCT01933672|3898495|FG000|COMPLETED|First Intervention Period (12-16 Days)||0
3171260|NCT01933672|3898496|FG001|COMPLETED|First Intervention Period (12-16 Days)||7
3171261|NCT01933672|3898497|FG002|COMPLETED|First Intervention Period (12-16 Days)||2
3171262|NCT01933672|3898498|FG003|COMPLETED|First Intervention Period (12-16 Days)||5
3171263|NCT01933672|3898499|FG004|COMPLETED|First Intervention Period (12-16 Days)||6
2901616|NCT00426660|3609697|FG000|Safety Analysis Set|Overall Study||1032
2901617|NCT00426660|3609697|FG000|COMPLETED|Overall Study||916
2901618|NCT00426660|3609697|FG000|NOT COMPLETED|Overall Study||131
2901619|NCT00426751|3609703|FG000|STARTED|Overall Study||226
2901620|NCT00426751|3609704|FG001|STARTED|Overall Study||203
2901621|NCT00426751|3609703|FG000|COMPLETED|Overall Study||204
2901622|NCT00426751|3609704|FG001|COMPLETED|Overall Study||183
2901623|NCT00426751|3609703|FG000|NOT COMPLETED|Overall Study||22
2901624|NCT00426751|3609704|FG001|NOT COMPLETED|Overall Study||20
2901625|NCT00426764|3609710|FG000|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|131
2901626|NCT00426764|3609710|FG000|Discontinued Prior to or During Cycle 6|Overall Study||98
2901627|NCT00426764|3609710|FG000|Discontinued at End of or After Cycle 6|Overall Study||33
2901628|NCT00426764|3609710|FG000|COMPLETED|Overall Study||0
2901629|NCT00426764|3609710|FG000|NOT COMPLETED|Overall Study||131
2901630|NCT00426842|3609720|FG000|STARTED|Overall Study||11
2901631|NCT00426842|3609720|FG000|COMPLETED|Overall Study||10
2901632|NCT00426842|3609720|FG000|NOT COMPLETED|Overall Study||1
2901633|NCT00426855|3609726|FG000|STARTED|Overall Study||12
2901634|NCT00426855|3609726|FG000|COMPLETED|Overall Study||12
2901635|NCT00426855|3609726|FG000|NOT COMPLETED|Overall Study||0
2901636|NCT00427011|3609730|FG000|STARTED|Overall Study||25
2901637|NCT00427011|3609730|FG000|COMPLETED|Overall Study||0
2901638|NCT00427011|3609730|FG000|NOT COMPLETED|Overall Study||25
2901639|NCT00427037|3609737|FG000|STARTED|Overall Study||17
2901640|NCT00427037|3609738|FG001|STARTED|Overall Study||17
2901641|NCT00427037|3609737|FG000|COMPLETED|Overall Study||10
2901642|NCT00427037|3609738|FG001|COMPLETED|Overall Study||10
2901643|NCT00427037|3609737|FG000|NOT COMPLETED|Overall Study||7
2901644|NCT00427037|3609738|FG001|NOT COMPLETED|Overall Study||7
2901645|NCT00427193|3609748|FG000|STARTED|Overall Study||143
2901646|NCT00427193|3609749|FG001|STARTED|Overall Study||75
2901647|NCT00427193|3609748|FG000|COMPLETED|Overall Study||117
2901648|NCT00427193|3609749|FG001|COMPLETED|Overall Study||71
2901649|NCT00427193|3609748|FG000|NOT COMPLETED|Overall Study||26
2901650|NCT00427193|3609749|FG001|NOT COMPLETED|Overall Study||4
2901651|NCT00427297|3609759|FG000|STARTED|Overall Study||17
2901652|NCT00427297|3609760|FG001|STARTED|Overall Study||17
2901653|NCT00427297|3609759|FG000|COMPLETED|Overall Study||17
2901654|NCT00427297|3609760|FG001|COMPLETED|Overall Study||17
2901655|NCT00427297|3609759|FG000|NOT COMPLETED|Overall Study||0
2901656|NCT00427297|3609760|FG001|NOT COMPLETED|Overall Study||0
2901657|NCT00427336|3609766|FG000|STARTED|Overall Study||9
2901658|NCT00427336|3609766|FG000|COMPLETED|Overall Study||9
2901659|NCT00427336|3609766|FG000|NOT COMPLETED|Overall Study||0
2901660|NCT00427349|3609770|FG000|STARTED|Overall Study||46
2901661|NCT00427349|3609770|FG000|Eligible|Overall Study||45
2901662|NCT00427349|3609770|FG000|Treated|Overall Study||45
2901663|NCT00427349|3609770|FG000|Eligible and Treated|Overall Study||44
2901664|NCT00427349|3609770|FG000|COMPLETED|Overall Study|Treatment continued until disease progression or intolerable toxicity|0
2901665|NCT00427349|3609770|FG000|NOT COMPLETED|Overall Study||46
2901666|NCT00427557|3609774|FG000|STARTED|Overall Study||30
2901667|NCT00427557|3609774|FG000|COMPLETED|Overall Study||30
2901668|NCT00427557|3609774|FG000|NOT COMPLETED|Overall Study||0
2901669|NCT00427635|3609780|FG000|STARTED|Treatment Phase|Randomised|26
2901670|NCT00427635|3609781|FG001|STARTED|Treatment Phase|Randomised|26
2901671|NCT00427635|3609780|FG000|COMPLETED|Treatment Phase|ITT population. One voluntary discontinuation by parent/guardian|25
2901672|NCT00427635|3609781|FG001|COMPLETED|Treatment Phase|ITT population|26
2901673|NCT00427635|3609780|FG000|NOT COMPLETED|Treatment Phase||1
2901674|NCT00427635|3609781|FG001|NOT COMPLETED|Treatment Phase||0
2901675|NCT00427635|3609780|FG000|STARTED|Study Completion to Safety Follow-up||25
2901676|NCT00427635|3609781|FG001|STARTED|Study Completion to Safety Follow-up||26
2901677|NCT00427635|3609780|FG000|COMPLETED|Study Completion to Safety Follow-up||25
2901678|NCT00427635|3609781|FG001|COMPLETED|Study Completion to Safety Follow-up|One participant lost to follow-up|25
2901679|NCT00427635|3609780|FG000|NOT COMPLETED|Study Completion to Safety Follow-up||0
2901680|NCT00427635|3609781|FG001|NOT COMPLETED|Study Completion to Safety Follow-up||1
2901681|NCT00427648|3609789|FG000|STARTED|Overall Study||12
2901682|NCT00427648|3609790|FG001|STARTED|Overall Study||10
2901683|NCT00427648|3609789|FG000|COMPLETED|Overall Study||11
2901684|NCT00427648|3609790|FG001|COMPLETED|Overall Study||7
2901685|NCT00427648|3609789|FG000|NOT COMPLETED|Overall Study||1
2901686|NCT00427648|3609790|FG001|NOT COMPLETED|Overall Study||3
2901687|NCT00427661|3609798|FG000|STARTED|Overall Study||8
2901688|NCT00427661|3609798|FG000|COMPLETED|Overall Study||8
2901689|NCT00427661|3609798|FG000|NOT COMPLETED|Overall Study||0
2901690|NCT00427700|3609805|FG000|STARTED|Overall Study||40
2901691|NCT00427700|3609806|FG001|STARTED|Overall Study||42
2901692|NCT00427700|3609805|FG000|COMPLETED|Overall Study||37
2901693|NCT00427700|3609806|FG001|COMPLETED|Overall Study||31
2901694|NCT00427700|3609805|FG000|NOT COMPLETED|Overall Study||3
2901695|NCT00427700|3609806|FG001|NOT COMPLETED|Overall Study||11
2901696|NCT00427765|3609813|FG000|STARTED|Overall Study||164
2901697|NCT00427765|3609813|FG000|COMPLETED|Overall Study||164
3316159|NCT03107052|4049436|FG000|NOT COMPLETED|Overall Study||119
3316160|NCT03107052|4049437|FG001|NOT COMPLETED|Overall Study||46
3316161|NCT03107052|4049438|FG002|NOT COMPLETED|Overall Study||41
3316162|NCT03107091|4049446|FG000|STARTED|Overall Study||6
2901698|NCT00427765|3609813|FG000|NOT COMPLETED|Overall Study||0
2901699|NCT00427778|3609817|FG000|STARTED|First Intervention (4 Weeks)||14
2901700|NCT00427778|3609818|FG001|STARTED|First Intervention (4 Weeks)||15
2901701|NCT00427778|3609817|FG000|COMPLETED|First Intervention (4 Weeks)||10
2901702|NCT00427778|3609818|FG001|COMPLETED|First Intervention (4 Weeks)||14
2901703|NCT00427778|3609817|FG000|NOT COMPLETED|First Intervention (4 Weeks)||4
2901704|NCT00427778|3609818|FG001|NOT COMPLETED|First Intervention (4 Weeks)||1
2901705|NCT00427778|3609817|FG000|STARTED|Wash Out (2 Weeks)||10
2901706|NCT00427778|3609818|FG001|STARTED|Wash Out (2 Weeks)||14
2901707|NCT00427778|3609817|FG000|COMPLETED|Wash Out (2 Weeks)||10
2901708|NCT00427778|3609818|FG001|COMPLETED|Wash Out (2 Weeks)||14
2901709|NCT00427778|3609817|FG000|NOT COMPLETED|Wash Out (2 Weeks)||0
2901710|NCT00427778|3609818|FG001|NOT COMPLETED|Wash Out (2 Weeks)||0
2901711|NCT00427778|3609817|FG000|STARTED|Second Intervention (4 Weeks)||10
2901712|NCT00427778|3609818|FG001|STARTED|Second Intervention (4 Weeks)||14
2901713|NCT00427778|3609817|FG000|COMPLETED|Second Intervention (4 Weeks)||10
2901714|NCT00427778|3609818|FG001|COMPLETED|Second Intervention (4 Weeks)||14
2901715|NCT00427778|3609817|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||0
3316163|NCT03107091|4049446|FG000|COMPLETED|Overall Study||5
2901716|NCT00427778|3609818|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||0
2901717|NCT00427791|3609839|FG000|STARTED|Overall Study||10
2901718|NCT00427791|3609840|FG001|STARTED|Overall Study||13
2901719|NCT00427791|3609839|FG000|COMPLETED|Overall Study||10
2901720|NCT00427791|3609840|FG001|COMPLETED|Overall Study||13
2901721|NCT00427791|3609839|FG000|NOT COMPLETED|Overall Study||0
2901722|NCT00427791|3609840|FG001|NOT COMPLETED|Overall Study||0
2901723|NCT00427804|3609848|FG000|STARTED|Overall Study||4
2901724|NCT00427804|3609849|FG001|STARTED|Overall Study||5
2901725|NCT00427804|3609848|FG000|COMPLETED|Overall Study||4
2901726|NCT00427804|3609849|FG001|COMPLETED|Overall Study||5
2901727|NCT00427804|3609848|FG000|NOT COMPLETED|Overall Study||0
2901728|NCT00427804|3609849|FG001|NOT COMPLETED|Overall Study||0
2901729|NCT00427895|3609859|FG000|STARTED|Between 6-Month Follow-up - Year 1||411
2901730|NCT00427895|3609860|FG001|STARTED|Between 6-Month Follow-up - Year 1||411
2901731|NCT00427895|3609861|FG002|STARTED|Between 6-Month Follow-up - Year 1||392
2901732|NCT00427895|3609862|FG003|STARTED|Between 6-Month Follow-up - Year 1||854
2901733|NCT00427895|3609863|FG004|STARTED|Between 6-Month Follow-up - Year 1||0
2901734|NCT00427895|3609864|FG005|STARTED|Between 6-Month Follow-up - Year 1||0
2901735|NCT00427895|3609865|FG006|STARTED|Between 6-Month Follow-up - Year 1||0
2901736|NCT00427895|3609866|FG007|STARTED|Between 6-Month Follow-up - Year 1||0
2901737|NCT00427895|3609859|FG000|COMPLETED|Between 6-Month Follow-up - Year 1||411
2901738|NCT00427895|3609860|FG001|COMPLETED|Between 6-Month Follow-up - Year 1||411
2901739|NCT00427895|3609861|FG002|COMPLETED|Between 6-Month Follow-up - Year 1||392
2901740|NCT00427895|3609862|FG003|COMPLETED|Between 6-Month Follow-up - Year 1||502
2901741|NCT00427895|3609863|FG004|COMPLETED|Between 6-Month Follow-up - Year 1||0
2901742|NCT00427895|3609864|FG005|COMPLETED|Between 6-Month Follow-up - Year 1||0
2901743|NCT00427895|3609865|FG006|COMPLETED|Between 6-Month Follow-up - Year 1||0
2901744|NCT00427895|3609866|FG007|COMPLETED|Between 6-Month Follow-up - Year 1||0
2901745|NCT00427895|3609859|FG000|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
2901746|NCT00427895|3609860|FG001|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
2901747|NCT00427895|3609861|FG002|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
2901748|NCT00427895|3609862|FG003|NOT COMPLETED|Between 6-Month Follow-up - Year 1||352
2901749|NCT00427895|3609863|FG004|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
2901750|NCT00427895|3609864|FG005|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
2901751|NCT00427895|3609865|FG006|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
2901752|NCT00427895|3609866|FG007|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
2901753|NCT00427895|3609859|FG000|STARTED|Vax 2/Year 3 to 4||0
2901754|NCT00427895|3609860|FG001|STARTED|Vax 2/Year 3 to 4||0
2901755|NCT00427895|3609861|FG002|STARTED|Vax 2/Year 3 to 4||0
2901756|NCT00427895|3609862|FG003|STARTED|Vax 2/Year 3 to 4||0
2901757|NCT00427895|3609863|FG004|STARTED|Vax 2/Year 3 to 4||108
2901758|NCT00427895|3609864|FG005|STARTED|Vax 2/Year 3 to 4||108
2901759|NCT00427895|3609865|FG006|STARTED|Vax 2/Year 3 to 4||189
2901760|NCT00427895|3609866|FG007|STARTED|Vax 2/Year 3 to 4||214
2901761|NCT00427895|3609859|FG000|COMPLETED|Vax 2/Year 3 to 4||0
2901762|NCT00427895|3609860|FG001|COMPLETED|Vax 2/Year 3 to 4||0
3171264|NCT01933672|3898500|FG005|COMPLETED|First Intervention Period (12-16 Days)||4
3171265|NCT01933672|3898501|FG006|COMPLETED|First Intervention Period (12-16 Days)||6
3171266|NCT01933672|3898495|FG000|NOT COMPLETED|First Intervention Period (12-16 Days)||0
2901763|NCT00427895|3609861|FG002|COMPLETED|Vax 2/Year 3 to 4||0
2901764|NCT00427895|3609862|FG003|COMPLETED|Vax 2/Year 3 to 4||0
2901765|NCT00427895|3609863|FG004|COMPLETED|Vax 2/Year 3 to 4||107
2901766|NCT00427895|3609864|FG005|COMPLETED|Vax 2/Year 3 to 4||108
2901767|NCT00427895|3609865|FG006|COMPLETED|Vax 2/Year 3 to 4||189
2901768|NCT00427895|3609866|FG007|COMPLETED|Vax 2/Year 3 to 4||212
2901769|NCT00427895|3609859|FG000|NOT COMPLETED|Vax 2/Year 3 to 4||0
3171267|NCT01933672|3898496|FG001|NOT COMPLETED|First Intervention Period (12-16 Days)||0
3171268|NCT01933672|3898497|FG002|NOT COMPLETED|First Intervention Period (12-16 Days)||1
2901770|NCT00427895|3609860|FG001|NOT COMPLETED|Vax 2/Year 3 to 4||0
2901771|NCT00427895|3609861|FG002|NOT COMPLETED|Vax 2/Year 3 to 4||0
2901772|NCT00427895|3609862|FG003|NOT COMPLETED|Vax 2/Year 3 to 4||0
2901773|NCT00427895|3609863|FG004|NOT COMPLETED|Vax 2/Year 3 to 4||1
2901774|NCT00427895|3609864|FG005|NOT COMPLETED|Vax 2/Year 3 to 4||0
2901775|NCT00427895|3609865|FG006|NOT COMPLETED|Vax 2/Year 3 to 4||0
2901776|NCT00427895|3609866|FG007|NOT COMPLETED|Vax 2/Year 3 to 4||2
2901777|NCT00427895|3609859|FG000|STARTED|Vax 1 Baseline/6-Month Follow-up||418
2901778|NCT00427895|3609860|FG001|STARTED|Vax 1 Baseline/6-Month Follow-up||417
2901779|NCT00427895|3609861|FG002|STARTED|Vax 1 Baseline/6-Month Follow-up||406
2901780|NCT00427895|3609862|FG003|STARTED|Vax 1 Baseline/6-Month Follow-up||900
2901781|NCT00427895|3609863|FG004|STARTED|Vax 1 Baseline/6-Month Follow-up||0
2901782|NCT00427895|3609864|FG005|STARTED|Vax 1 Baseline/6-Month Follow-up||0
2901783|NCT00427895|3609865|FG006|STARTED|Vax 1 Baseline/6-Month Follow-up||0
2901784|NCT00427895|3609866|FG007|STARTED|Vax 1 Baseline/6-Month Follow-up||0
2901785|NCT00427895|3609859|FG000|Vaccinated|Vax 1 Baseline/6-Month Follow-up||417
2901786|NCT00427895|3609860|FG001|Vaccinated|Vax 1 Baseline/6-Month Follow-up||414
2901787|NCT00427895|3609861|FG002|Vaccinated|Vax 1 Baseline/6-Month Follow-up||404
2901788|NCT00427895|3609862|FG003|Vaccinated|Vax 1 Baseline/6-Month Follow-up||899
2901789|NCT00427895|3609863|FG004|Vaccinated|Vax 1 Baseline/6-Month Follow-up||0
2901790|NCT00427895|3609864|FG005|Vaccinated|Vax 1 Baseline/6-Month Follow-up||0
2901791|NCT00427895|3609865|FG006|Vaccinated|Vax 1 Baseline/6-Month Follow-up||0
2901792|NCT00427895|3609866|FG007|Vaccinated|Vax 1 Baseline/6-Month Follow-up||0
2901793|NCT00427895|3609859|FG000|COMPLETED|Vax 1 Baseline/6-Month Follow-up||411
2901794|NCT00427895|3609860|FG001|COMPLETED|Vax 1 Baseline/6-Month Follow-up||411
2901795|NCT00427895|3609861|FG002|COMPLETED|Vax 1 Baseline/6-Month Follow-up||392
2901796|NCT00427895|3609862|FG003|COMPLETED|Vax 1 Baseline/6-Month Follow-up||854
2901797|NCT00427895|3609863|FG004|COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
2901798|NCT00427895|3609864|FG005|COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
2901799|NCT00427895|3609865|FG006|COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
2901800|NCT00427895|3609866|FG007|COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
2901801|NCT00427895|3609859|FG000|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||7
2901802|NCT00427895|3609860|FG001|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||6
2901803|NCT00427895|3609861|FG002|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||14
2901804|NCT00427895|3609862|FG003|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||46
2901805|NCT00427895|3609863|FG004|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
2901806|NCT00427895|3609864|FG005|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
2901807|NCT00427895|3609865|FG006|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
2901808|NCT00427895|3609866|FG007|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
2901809|NCT00427895|3609859|FG000|STARTED|Vax 1/Year 1 Follow-up||411
2901810|NCT00427895|3609860|FG001|STARTED|Vax 1/Year 1 Follow-up||411
2901811|NCT00427895|3609861|FG002|STARTED|Vax 1/Year 1 Follow-up||392
2901812|NCT00427895|3609862|FG003|STARTED|Vax 1/Year 1 Follow-up||502
2901813|NCT00427895|3609863|FG004|STARTED|Vax 1/Year 1 Follow-up||0
2901814|NCT00427895|3609864|FG005|STARTED|Vax 1/Year 1 Follow-up||0
2901815|NCT00427895|3609865|FG006|STARTED|Vax 1/Year 1 Follow-up||0
2901816|NCT00427895|3609866|FG007|STARTED|Vax 1/Year 1 Follow-up||0
2901817|NCT00427895|3609859|FG000|COMPLETED|Vax 1/Year 1 Follow-up||404
2901818|NCT00427895|3609860|FG001|COMPLETED|Vax 1/Year 1 Follow-up||396
2901819|NCT00427895|3609861|FG002|COMPLETED|Vax 1/Year 1 Follow-up||373
2901820|NCT00427895|3609862|FG003|COMPLETED|Vax 1/Year 1 Follow-up||469
2901821|NCT00427895|3609863|FG004|COMPLETED|Vax 1/Year 1 Follow-up||0
2901822|NCT00427895|3609864|FG005|COMPLETED|Vax 1/Year 1 Follow-up||0
2901823|NCT00427895|3609865|FG006|COMPLETED|Vax 1/Year 1 Follow-up||0
2901824|NCT00427895|3609866|FG007|COMPLETED|Vax 1/Year 1 Follow-up||0
2901825|NCT00427895|3609859|FG000|NOT COMPLETED|Vax 1/Year 1 Follow-up||7
2901826|NCT00427895|3609860|FG001|NOT COMPLETED|Vax 1/Year 1 Follow-up||15
2901827|NCT00427895|3609861|FG002|NOT COMPLETED|Vax 1/Year 1 Follow-up||19
2901828|NCT00427895|3609862|FG003|NOT COMPLETED|Vax 1/Year 1 Follow-up||33
2901829|NCT00427895|3609863|FG004|NOT COMPLETED|Vax 1/Year 1 Follow-up||0
2901830|NCT00427895|3609864|FG005|NOT COMPLETED|Vax 1/Year 1 Follow-up||0
2901831|NCT00427895|3609865|FG006|NOT COMPLETED|Vax 1/Year 1 Follow-up||0
2901832|NCT00427895|3609866|FG007|NOT COMPLETED|Vax 1/Year 1 Follow-up||0
2901833|NCT00427895|3609859|FG000|STARTED|Between Year 1 - Vax 2/Year 3 to 4||404
2901834|NCT00427895|3609860|FG001|STARTED|Between Year 1 - Vax 2/Year 3 to 4||396
2901835|NCT00427895|3609861|FG002|STARTED|Between Year 1 - Vax 2/Year 3 to 4||373
2901836|NCT00427895|3609862|FG003|STARTED|Between Year 1 - Vax 2/Year 3 to 4||469
2901837|NCT00427895|3609863|FG004|STARTED|Between Year 1 - Vax 2/Year 3 to 4||0
2901838|NCT00427895|3609864|FG005|STARTED|Between Year 1 - Vax 2/Year 3 to 4||0
2901839|NCT00427895|3609865|FG006|STARTED|Between Year 1 - Vax 2/Year 3 to 4||0
2901840|NCT00427895|3609866|FG007|STARTED|Between Year 1 - Vax 2/Year 3 to 4||0
2901841|NCT00427895|3609859|FG000|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||216
2901842|NCT00427895|3609860|FG001|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||189
2901843|NCT00427895|3609861|FG002|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||214
2901844|NCT00427895|3609862|FG003|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
2901845|NCT00427895|3609863|FG004|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
2901846|NCT00427895|3609864|FG005|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
2901847|NCT00427895|3609865|FG006|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
2901848|NCT00427895|3609866|FG007|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
2901849|NCT00427895|3609859|FG000|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||188
2901850|NCT00427895|3609860|FG001|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||207
2901851|NCT00427895|3609861|FG002|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||159
2901852|NCT00427895|3609862|FG003|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||469
2901853|NCT00427895|3609863|FG004|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
2901854|NCT00427895|3609864|FG005|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
2901855|NCT00427895|3609865|FG006|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
2901856|NCT00427895|3609866|FG007|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
2901857|NCT00427908|3609909|FG000|STARTED|Primary Phase||229
2901858|NCT00427908|3609910|FG001|STARTED|Primary Phase||231
2901859|NCT00427908|3609911|FG002|STARTED|Primary Phase||75
2901860|NCT00427908|3609912|FG003|STARTED|Primary Phase||78
2901861|NCT00427908|3609909|FG000|COMPLETED|Primary Phase||224
2901862|NCT00427908|3609910|FG001|COMPLETED|Primary Phase||228
2901863|NCT00427908|3609911|FG002|COMPLETED|Primary Phase||72
2901864|NCT00427908|3609912|FG003|COMPLETED|Primary Phase||78
2901865|NCT00427908|3609909|FG000|NOT COMPLETED|Primary Phase||5
2901866|NCT00427908|3609910|FG001|NOT COMPLETED|Primary Phase||3
2901867|NCT00427908|3609911|FG002|NOT COMPLETED|Primary Phase||3
2901868|NCT00427908|3609912|FG003|NOT COMPLETED|Primary Phase||0
2901869|NCT00427908|3609909|FG000|STARTED|Persistence Phase Year 1||222
2901870|NCT00427908|3609910|FG001|STARTED|Persistence Phase Year 1||221
2901871|NCT00427908|3609911|FG002|STARTED|Persistence Phase Year 1||71
2901872|NCT00427908|3609912|FG003|STARTED|Persistence Phase Year 1||78
2901873|NCT00427908|3609909|FG000|COMPLETED|Persistence Phase Year 1||222
2901874|NCT00427908|3609910|FG001|COMPLETED|Persistence Phase Year 1||221
2901875|NCT00427908|3609911|FG002|COMPLETED|Persistence Phase Year 1||71
2901876|NCT00427908|3609912|FG003|COMPLETED|Persistence Phase Year 1||78
2901877|NCT00427908|3609909|FG000|NOT COMPLETED|Persistence Phase Year 1||0
2901878|NCT00427908|3609910|FG001|NOT COMPLETED|Persistence Phase Year 1||0
2901879|NCT00427908|3609911|FG002|NOT COMPLETED|Persistence Phase Year 1||0
2901880|NCT00427908|3609912|FG003|NOT COMPLETED|Persistence Phase Year 1||0
2901881|NCT00427908|3609909|FG000|STARTED|Persistence Phase Year 2||208
2901882|NCT00427908|3609910|FG001|STARTED|Persistence Phase Year 2||215
2901883|NCT00427908|3609911|FG002|STARTED|Persistence Phase Year 2||53
2901884|NCT00427908|3609912|FG003|STARTED|Persistence Phase Year 2||61
2901885|NCT00427908|3609909|FG000|COMPLETED|Persistence Phase Year 2||208
2901886|NCT00427908|3609910|FG001|COMPLETED|Persistence Phase Year 2||215
2901887|NCT00427908|3609911|FG002|COMPLETED|Persistence Phase Year 2||53
2901888|NCT00427908|3609912|FG003|COMPLETED|Persistence Phase Year 2||61
2901889|NCT00427908|3609909|FG000|NOT COMPLETED|Persistence Phase Year 2||0
2901890|NCT00427908|3609910|FG001|NOT COMPLETED|Persistence Phase Year 2||0
2901891|NCT00427908|3609911|FG002|NOT COMPLETED|Persistence Phase Year 2||0
2901892|NCT00427908|3609912|FG003|NOT COMPLETED|Persistence Phase Year 2||0
2901893|NCT00427908|3609909|FG000|STARTED|Persistence Phase Year 3||185
2901894|NCT00427908|3609910|FG001|STARTED|Persistence Phase Year 3||201
2901895|NCT00427908|3609911|FG002|STARTED|Persistence Phase Year 3||38
2901896|NCT00427908|3609912|FG003|STARTED|Persistence Phase Year 3||38
2901897|NCT00427908|3609909|FG000|COMPLETED|Persistence Phase Year 3||185
2901898|NCT00427908|3609910|FG001|COMPLETED|Persistence Phase Year 3||201
2901899|NCT00427908|3609911|FG002|COMPLETED|Persistence Phase Year 3||38
2901900|NCT00427908|3609912|FG003|COMPLETED|Persistence Phase Year 3||38
2901901|NCT00427908|3609909|FG000|NOT COMPLETED|Persistence Phase Year 3||0
2901902|NCT00427908|3609910|FG001|NOT COMPLETED|Persistence Phase Year 3||0
2901903|NCT00427908|3609911|FG002|NOT COMPLETED|Persistence Phase Year 3||0
2901904|NCT00427908|3609912|FG003|NOT COMPLETED|Persistence Phase Year 3||0
2901905|NCT00427908|3609909|FG000|STARTED|Persistence Phase Year 4||165
2901906|NCT00427908|3609910|FG001|STARTED|Persistence Phase Year 4||192
2901907|NCT00427908|3609911|FG002|STARTED|Persistence Phase Year 4||34
2901908|NCT00427908|3609912|FG003|STARTED|Persistence Phase Year 4||32
2901909|NCT00427908|3609909|FG000|COMPLETED|Persistence Phase Year 4||165
2901910|NCT00427908|3609910|FG001|COMPLETED|Persistence Phase Year 4||192
2901911|NCT00427908|3609911|FG002|COMPLETED|Persistence Phase Year 4||34
2901912|NCT00427908|3609912|FG003|COMPLETED|Persistence Phase Year 4||32
2901913|NCT00427908|3609909|FG000|NOT COMPLETED|Persistence Phase Year 4||0
2901914|NCT00427908|3609910|FG001|NOT COMPLETED|Persistence Phase Year 4||0
2901915|NCT00427908|3609911|FG002|NOT COMPLETED|Persistence Phase Year 4||0
2901916|NCT00427908|3609912|FG003|NOT COMPLETED|Persistence Phase Year 4||0
2901917|NCT00427908|3609909|FG000|STARTED|Persistence Phase Year 5||52
2901918|NCT00427908|3609910|FG001|STARTED|Persistence Phase Year 5||99
2901919|NCT00427908|3609911|FG002|STARTED|Persistence Phase Year 5||12
2901920|NCT00427908|3609912|FG003|STARTED|Persistence Phase Year 5||13
2901921|NCT00427908|3609909|FG000|COMPLETED|Persistence Phase Year 5||52
2901922|NCT00427908|3609910|FG001|COMPLETED|Persistence Phase Year 5||99
2901923|NCT00427908|3609911|FG002|COMPLETED|Persistence Phase Year 5||12
2901924|NCT00427908|3609912|FG003|COMPLETED|Persistence Phase Year 5||13
2901925|NCT00427908|3609909|FG000|NOT COMPLETED|Persistence Phase Year 5||0
2901926|NCT00427908|3609910|FG001|NOT COMPLETED|Persistence Phase Year 5||0
2901927|NCT00427908|3609911|FG002|NOT COMPLETED|Persistence Phase Year 5||0
2901928|NCT00427908|3609912|FG003|NOT COMPLETED|Persistence Phase Year 5||0
2901929|NCT00427921|3609947|FG000|STARTED|Overall Study||304
2901930|NCT00427921|3609947|FG000|COMPLETED|Overall Study||254
2901931|NCT00427921|3609947|FG000|NOT COMPLETED|Overall Study||50
2901932|NCT00427934|3609955|FG000|STARTED|Overall Study||8
2901933|NCT00427934|3609956|FG001|STARTED|Overall Study||8
2901934|NCT00427934|3609957|FG002|STARTED|Overall Study||78
2901935|NCT00427934|3609958|FG003|STARTED|Overall Study||34
2901936|NCT00427934|3609955|FG000|Treated|Overall Study||8
3171269|NCT01933672|3898498|FG003|NOT COMPLETED|First Intervention Period (12-16 Days)||0
3171270|NCT01933672|3898499|FG004|NOT COMPLETED|First Intervention Period (12-16 Days)||1
3171271|NCT01933672|3898500|FG005|NOT COMPLETED|First Intervention Period (12-16 Days)||1
3171272|NCT01933672|3898501|FG006|NOT COMPLETED|First Intervention Period (12-16 Days)||0
3171273|NCT01933672|3898495|FG000|STARTED|First Washout Period (7-14 Days)||0
3171274|NCT01933672|3898496|FG001|STARTED|First Washout Period (7-14 Days)||7
2901937|NCT00427934|3609956|FG001|Treated|Overall Study||8
2901938|NCT00427934|3609957|FG002|Treated|Overall Study||77
2901939|NCT00427934|3609958|FG003|Treated|Overall Study||33
2901940|NCT00427934|3609955|FG000|COMPLETED|Overall Study||7
2901941|NCT00427934|3609956|FG001|COMPLETED|Overall Study||8
2901942|NCT00427934|3609957|FG002|COMPLETED|Overall Study||55
2901943|NCT00427934|3609958|FG003|COMPLETED|Overall Study||19
2901944|NCT00427934|3609955|FG000|NOT COMPLETED|Overall Study||1
2901945|NCT00427934|3609956|FG001|NOT COMPLETED|Overall Study||0
3171275|NCT01933672|3898497|FG002|STARTED|First Washout Period (7-14 Days)||2
3171276|NCT01933672|3898498|FG003|STARTED|First Washout Period (7-14 Days)||5
2901946|NCT00427934|3609957|FG002|NOT COMPLETED|Overall Study||23
2901947|NCT00427934|3609958|FG003|NOT COMPLETED|Overall Study||15
2901948|NCT00427960|3609972|FG000|STARTED|Overall Study||30
2901949|NCT00427960|3609973|FG001|STARTED|Overall Study||25
2901950|NCT00427960|3609972|FG000|COMPLETED|Overall Study||28
2901951|NCT00427960|3609973|FG001|COMPLETED|Overall Study||21
2901952|NCT00427960|3609972|FG000|NOT COMPLETED|Overall Study||2
2901953|NCT00427960|3609973|FG001|NOT COMPLETED|Overall Study||4
2901954|NCT00427973|3609979|FG000|STARTED|Overall Study||17
2901955|NCT00427973|3609979|FG000|COMPLETED|Overall Study||17
2901956|NCT00427973|3609979|FG000|NOT COMPLETED|Overall Study||0
2901957|NCT00427999|3609983|FG000|STARTED|Overall Study||65
2901958|NCT00427999|3609983|FG000|Intent to Treat (ITT)|Overall Study||61
2901959|NCT00427999|3609983|FG000|Extension Follow-up|Overall Study||19
2901960|NCT00427999|3609983|FG000|COMPLETED|Overall Study||33
2901961|NCT00427999|3609983|FG000|NOT COMPLETED|Overall Study||32
2901962|NCT00428077|3609988|FG000|STARTED|Overall Study||4
2901963|NCT00428077|3609988|FG000|COMPLETED|Overall Study||4
2901964|NCT00428077|3609988|FG000|NOT COMPLETED|Overall Study||0
2901965|NCT00428090|3609996|FG000|STARTED|Overall Study||165
2901966|NCT00428090|3609997|FG001|STARTED|Overall Study||166
2901967|NCT00428090|3609998|FG002|STARTED|Overall Study||165
2901968|NCT00428090|3609999|FG003|STARTED|Overall Study||83
2901969|NCT00428090|3609996|FG000|COMPLETED|Overall Study||131
2901970|NCT00428090|3609997|FG001|COMPLETED|Overall Study||135
2901971|NCT00428090|3609998|FG002|COMPLETED|Overall Study||127
2901972|NCT00428090|3609999|FG003|COMPLETED|Overall Study||55
2901973|NCT00428090|3609996|FG000|NOT COMPLETED|Overall Study||34
2901974|NCT00428090|3609997|FG001|NOT COMPLETED|Overall Study||31
2901975|NCT00428090|3609998|FG002|NOT COMPLETED|Overall Study||38
2901976|NCT00428090|3609999|FG003|NOT COMPLETED|Overall Study||28
2901977|NCT00428116|3610019|FG000|STARTED|Overall Study||21
2901978|NCT00428116|3610020|FG001|STARTED|Overall Study||21
2901979|NCT00428116|3610019|FG000|COMPLETED|Overall Study||18
2901980|NCT00428116|3610020|FG001|COMPLETED|Overall Study||21
2901981|NCT00428116|3610019|FG000|NOT COMPLETED|Overall Study||3
2901982|NCT00428116|3610020|FG001|NOT COMPLETED|Overall Study||0
2901983|NCT00428220|3610027|FG000|STARTED|Overall Study||223
2901984|NCT00428220|3610027|FG000|COMPLETED|Overall Study||0
2901985|NCT00428220|3610027|FG000|NOT COMPLETED|Overall Study||223
2901986|NCT00428246|3610045|FG000|STARTED|Overall Study||8
2901987|NCT00428246|3610046|FG001|STARTED|Overall Study||8
2901988|NCT00428246|3610047|FG002|STARTED|Overall Study||8
2901989|NCT00428246|3610045|FG000|COMPLETED|Overall Study||7
2901990|NCT00428246|3610046|FG001|COMPLETED|Overall Study||8
2901991|NCT00428246|3610047|FG002|COMPLETED|Overall Study||7
2901992|NCT00428246|3610045|FG000|NOT COMPLETED|Overall Study||1
2901993|NCT00428246|3610046|FG001|NOT COMPLETED|Overall Study||0
2901994|NCT00428246|3610047|FG002|NOT COMPLETED|Overall Study||1
2901995|NCT00428298|3610057|FG000|STARTED|Overall Study||30
2901996|NCT00428298|3610058|FG001|STARTED|Overall Study||30
2901997|NCT00428298|3610057|FG000|Second RBANS at Study Exit|Overall Study||3
2901998|NCT00428298|3610058|FG001|Second RBANS at Study Exit|Overall Study||3
2901999|NCT00428298|3610057|FG000|COMPLETED|Overall Study||16
2902000|NCT00428298|3610058|FG001|COMPLETED|Overall Study||19
2902001|NCT00428298|3610057|FG000|NOT COMPLETED|Overall Study||14
2902002|NCT00428298|3610058|FG001|NOT COMPLETED|Overall Study||11
2902003|NCT00428389|3610068|FG000|STARTED|Core Phase||131
2902004|NCT00428389|3610069|FG001|STARTED|Core Phase||131
2902005|NCT00428389|3610068|FG000|Intent-to-treat Population|Core Phase||131
2902006|NCT00428389|3610069|FG001|Intent-to-treat Population|Core Phase|1 patient was discontinued from the study the same day as randomization & excluded from all analyses|130
2902007|NCT00428389|3610068|FG000|COMPLETED|Core Phase||120
2902008|NCT00428389|3610069|FG001|COMPLETED|Core Phase||120
2902009|NCT00428389|3610068|FG000|NOT COMPLETED|Core Phase||11
2902010|NCT00428389|3610069|FG001|NOT COMPLETED|Core Phase||11
2902011|NCT00428389|3610068|FG000|STARTED|Extension Phase|Participants were required to sign a separate informed consent prior to entering the extension phase|117
2902012|NCT00428389|3610069|FG001|STARTED|Extension Phase||117
2902013|NCT00428389|3610068|FG000|COMPLETED|Extension Phase||85
2902014|NCT00428389|3610069|FG001|COMPLETED|Extension Phase||91
2902015|NCT00428389|3610068|FG000|NOT COMPLETED|Extension Phase||32
2902016|NCT00428389|3610069|FG001|NOT COMPLETED|Extension Phase||26
2902017|NCT00428441|3610075|FG000|STARTED|Overall Study||75
2902018|NCT00428441|3610075|FG000|COMPLETED|Overall Study||74
2902019|NCT00428441|3610075|FG000|NOT COMPLETED|Overall Study||1
2902020|NCT00428584|3610081|FG000|STARTED|Comparative Phase||65
2902021|NCT00428584|3610082|FG001|STARTED|Comparative Phase||64
2902022|NCT00428584|3610081|FG000|COMPLETED|Comparative Phase|Comparator Phase - new formulation of rebif and Betaseron|56
2902023|NCT00428584|3610082|FG001|COMPLETED|Comparative Phase||63
2902024|NCT00428584|3610081|FG000|NOT COMPLETED|Comparative Phase||9
2902025|NCT00428584|3610082|FG001|NOT COMPLETED|Comparative Phase||1
2902026|NCT00428584|3610081|FG000|STARTED|Extension Phase|Extension Phase - new formulation of rebif to new formulation of rebif|56
2902027|NCT00428584|3610082|FG001|STARTED|Extension Phase||63
2902028|NCT00428584|3610081|FG000|COMPLETED|Extension Phase||35
2902029|NCT00428584|3610082|FG001|COMPLETED|Extension Phase||34
2902030|NCT00428584|3610081|FG000|NOT COMPLETED|Extension Phase||21
2902031|NCT00428584|3610082|FG001|NOT COMPLETED|Extension Phase||29
2902032|NCT00428597|3610094|FG000|STARTED|Overall Study||86
2902033|NCT00428597|3610095|FG001|STARTED|Overall Study||85
2902034|NCT00428597|3610094|FG000|Received Treatment|Overall Study||83
2902035|NCT00428597|3610095|FG001|Received Treatment|Overall Study||82
2902036|NCT00428597|3610094|FG000|COMPLETED|Overall Study||0
2902037|NCT00428597|3610095|FG001|COMPLETED|Overall Study||0
2902038|NCT00428597|3610094|FG000|NOT COMPLETED|Overall Study||86
2902039|NCT00428597|3610095|FG001|NOT COMPLETED|Overall Study||85
2902040|NCT00428610|3610104|FG000|STARTED|Overall Study||53
2902041|NCT00428610|3610105|FG001|STARTED|Overall Study||18
2902042|NCT00428610|3610106|FG002|STARTED|Overall Study||32
2902043|NCT00428610|3610104|FG000|Received at Least One Dose of Study Drug|Overall Study||53
2902044|NCT00428610|3610105|FG001|Received at Least One Dose of Study Drug|Overall Study||18
2902045|NCT00428610|3610106|FG002|Received at Least One Dose of Study Drug|Overall Study||32
2902046|NCT00428610|3610104|FG000|COMPLETED|Overall Study||0
2902047|NCT00428610|3610105|FG001|COMPLETED|Overall Study||0
2902048|NCT00428610|3610106|FG002|COMPLETED|Overall Study||0
2902049|NCT00428610|3610104|FG000|NOT COMPLETED|Overall Study||53
2902050|NCT00428610|3610105|FG001|NOT COMPLETED|Overall Study||18
2902051|NCT00428610|3610106|FG002|NOT COMPLETED|Overall Study||32
2902052|NCT00428714|3610116|FG000|STARTED|Overall Study||31
2902053|NCT00428714|3610117|FG001|STARTED|Overall Study||42
2902054|NCT00428714|3610116|FG000|Received at Least 1 Dose of Study Drug|Overall Study||31
2902055|NCT00428714|3610117|FG001|Received at Least 1 Dose of Study Drug|Overall Study||42
2902056|NCT00428714|3610116|FG000|COMPLETED|Overall Study||0
2902057|NCT00428714|3610117|FG001|COMPLETED|Overall Study||0
2902058|NCT00428714|3610116|FG000|NOT COMPLETED|Overall Study||31
2902059|NCT00428714|3610117|FG001|NOT COMPLETED|Overall Study||42
2902060|NCT00428792|3610126|FG000|STARTED|Overall Study||80
2902061|NCT00428792|3610127|FG001|STARTED|Overall Study||70
2902062|NCT00428792|3610126|FG000|COMPLETED|Overall Study|Information is not available during which cross-over period patients discontinued.|79
2902063|NCT00428792|3610127|FG001|COMPLETED|Overall Study|Information is not available during which cross-over period patients discontinued.|66
2902064|NCT00428792|3610126|FG000|NOT COMPLETED|Overall Study||1
2902065|NCT00428792|3610127|FG001|NOT COMPLETED|Overall Study||4
2902066|NCT00428844|3610136|FG000|STARTED|Completed Study Drug Treatment||25
2902067|NCT00428844|3610137|FG001|STARTED|Completed Study Drug Treatment||24
2902068|NCT00428844|3610138|FG002|STARTED|Completed Study Drug Treatment||26
2902069|NCT00428844|3610136|FG000|Received First Dose|Completed Study Drug Treatment||25
2902070|NCT00428844|3610137|FG001|Received First Dose|Completed Study Drug Treatment||24
2902071|NCT00428844|3610138|FG002|Received First Dose|Completed Study Drug Treatment||25
2902072|NCT00428844|3610136|FG000|COMPLETED|Completed Study Drug Treatment||23
2902073|NCT00428844|3610137|FG001|COMPLETED|Completed Study Drug Treatment||18
2902074|NCT00428844|3610138|FG002|COMPLETED|Completed Study Drug Treatment||19
2902075|NCT00428844|3610136|FG000|NOT COMPLETED|Completed Study Drug Treatment||2
3171277|NCT01933672|3898499|FG004|STARTED|First Washout Period (7-14 Days)||6
3171278|NCT01933672|3898500|FG005|STARTED|First Washout Period (7-14 Days)||4
3171279|NCT01933672|3898501|FG006|STARTED|First Washout Period (7-14 Days)||6
3171280|NCT01933672|3898495|FG000|COMPLETED|First Washout Period (7-14 Days)||0
3171281|NCT01933672|3898496|FG001|COMPLETED|First Washout Period (7-14 Days)||7
3171282|NCT01933672|3898497|FG002|COMPLETED|First Washout Period (7-14 Days)||2
2902076|NCT00428844|3610137|FG001|NOT COMPLETED|Completed Study Drug Treatment||6
2902077|NCT00428844|3610138|FG002|NOT COMPLETED|Completed Study Drug Treatment||7
2902078|NCT00428844|3610136|FG000|STARTED|Completed Test of Cure (TOC) Visit||23
2902079|NCT00428844|3610137|FG001|STARTED|Completed Test of Cure (TOC) Visit||18
2902080|NCT00428844|3610138|FG002|STARTED|Completed Test of Cure (TOC) Visit||19
2902081|NCT00428844|3610136|FG000|COMPLETED|Completed Test of Cure (TOC) Visit||20
2902082|NCT00428844|3610137|FG001|COMPLETED|Completed Test of Cure (TOC) Visit||16
2902083|NCT00428844|3610138|FG002|COMPLETED|Completed Test of Cure (TOC) Visit||17
2902084|NCT00428844|3610136|FG000|NOT COMPLETED|Completed Test of Cure (TOC) Visit||3
2902085|NCT00428844|3610137|FG001|NOT COMPLETED|Completed Test of Cure (TOC) Visit||2
2902086|NCT00428844|3610138|FG002|NOT COMPLETED|Completed Test of Cure (TOC) Visit||2
2902087|NCT00428922|3610146|FG000|STARTED|Overall Study||26
2902088|NCT00428922|3610146|FG000|COMPLETED|Overall Study||26
2902089|NCT00428922|3610146|FG000|NOT COMPLETED|Overall Study||0
2902090|NCT00428948|3610152|FG000|STARTED|Overall Study||961
2902091|NCT00428948|3610153|FG001|STARTED|Overall Study||484
2902092|NCT00428948|3610152|FG000|Received Treatment|Overall Study||961
2902093|NCT00428948|3610153|FG001|Received Treatment|Overall Study||483
2902094|NCT00428948|3610152|FG000|COMPLETED|Overall Study||740
2902095|NCT00428948|3610153|FG001|COMPLETED|Overall Study||417
2902096|NCT00428948|3610152|FG000|NOT COMPLETED|Overall Study||221
2902097|NCT00428948|3610153|FG001|NOT COMPLETED|Overall Study||67
2902098|NCT00428974|3610163|FG000|STARTED|Overall Study|one patient was randomized but never received study treatment|25
2902099|NCT00428974|3610164|FG001|STARTED|Overall Study||17
2902100|NCT00428974|3610165|FG002|STARTED|Overall Study||15
2902101|NCT00428974|3610166|FG003|STARTED|Overall Study||19
2902102|NCT00428974|3610163|FG000|COMPLETED|Overall Study||17
2902103|NCT00428974|3610164|FG001|COMPLETED|Overall Study||17
2902104|NCT00428974|3610165|FG002|COMPLETED|Overall Study||14
2902105|NCT00428974|3610166|FG003|COMPLETED|Overall Study||16
2902106|NCT00428974|3610163|FG000|NOT COMPLETED|Overall Study||8
2902107|NCT00428974|3610164|FG001|NOT COMPLETED|Overall Study||0
2902108|NCT00428974|3610165|FG002|NOT COMPLETED|Overall Study||1
2902109|NCT00428974|3610166|FG003|NOT COMPLETED|Overall Study||3
2902110|NCT00429104|3610177|FG000|STARTED|Overall Study||18
2902111|NCT00429104|3610177|FG000|COMPLETED|Overall Study||17
2902112|NCT00429104|3610177|FG000|NOT COMPLETED|Overall Study||1
2902113|NCT00429143|3610181|FG000|STARTED|Overall Study||27
2902114|NCT00429143|3610181|FG000|COMPLETED|Overall Study||27
2902115|NCT00429143|3610181|FG000|NOT COMPLETED|Overall Study||0
2902116|NCT00429169|3610187|FG000|STARTED|Overall Study||38
2902117|NCT00429169|3610188|FG001|STARTED|Overall Study||40
2902118|NCT00429169|3610187|FG000|COMPLETED|Overall Study|2 subjects excluded due to re-diagnosis/ineligibility.|36
2902119|NCT00429169|3610188|FG001|COMPLETED|Overall Study|2 subjects excluded: re-diagnosis/ineligibility (1), and did not return after randomization (1).|38
2902120|NCT00429169|3610187|FG000|NOT COMPLETED|Overall Study||2
2902121|NCT00429169|3610188|FG001|NOT COMPLETED|Overall Study||2
2920268|NCT00535782|3630723|FG002|COMPLETED|Part 2: 80-Week Open-label Period||98
2920269|NCT00535782|3630721|FG000|NOT COMPLETED|Part 2: 80-Week Open-label Period||0
2920270|NCT00535782|3630722|FG001|NOT COMPLETED|Part 2: 80-Week Open-label Period||0
2920271|NCT00535782|3630723|FG002|NOT COMPLETED|Part 2: 80-Week Open-label Period||26
2920272|NCT00535821|3630732|FG000|STARTED|Overall Study||2
2920273|NCT00535821|3630733|FG001|STARTED|Overall Study||3
2920274|NCT00535821|3630732|FG000|COMPLETED|Overall Study||2
2920275|NCT00535821|3630733|FG001|COMPLETED|Overall Study||3
2920276|NCT00535821|3630732|FG000|NOT COMPLETED|Overall Study||0
2920277|NCT00535821|3630733|FG001|NOT COMPLETED|Overall Study||0
2920278|NCT00535847|3630742|FG000|STARTED|Overall Study||81
2920279|NCT00535847|3630743|FG001|STARTED|Overall Study||34
2920280|NCT00535847|3630744|FG002|STARTED|Overall Study||2
2920281|NCT00535847|3630742|FG000|COMPLETED|Overall Study||59
2920282|NCT00535847|3630743|FG001|COMPLETED|Overall Study||20
2920283|NCT00535847|3630744|FG002|COMPLETED|Overall Study||0
2920284|NCT00535847|3630742|FG000|NOT COMPLETED|Overall Study||22
2920285|NCT00535847|3630743|FG001|NOT COMPLETED|Overall Study||14
2920286|NCT00535847|3630744|FG002|NOT COMPLETED|Overall Study||2
2920287|NCT00535873|3630756|FG000|STARTED|Overall Study||60
2920288|NCT00535873|3630756|FG000|COMPLETED|Overall Study||60
2920289|NCT00535873|3630756|FG000|NOT COMPLETED|Overall Study||0
2920290|NCT00535925|3630762|FG000|STARTED|Overall Study||188
2920291|NCT00535925|3630763|FG001|STARTED|Overall Study||207
2920292|NCT00535925|3630762|FG000|COMPLETED|Overall Study||169
2920293|NCT00535925|3630763|FG001|COMPLETED|Overall Study||199
2920294|NCT00535925|3630762|FG000|NOT COMPLETED|Overall Study||19
2920295|NCT00535925|3630763|FG001|NOT COMPLETED|Overall Study||8
2920296|NCT00535938|3630773|FG000|STARTED|Overall Study||506
2920297|NCT00535938|3630774|FG001|STARTED|Overall Study||866
2920298|NCT00535938|3630773|FG000|COMPLETED|Overall Study||115
2920299|NCT00535938|3630774|FG001|COMPLETED|Overall Study||404
2920300|NCT00535938|3630773|FG000|NOT COMPLETED|Overall Study||391
2920301|NCT00535938|3630774|FG001|NOT COMPLETED|Overall Study||462
2920302|NCT00536107|3630782|FG000|STARTED|Overall Study||8
2920303|NCT00536107|3630783|FG001|STARTED|Overall Study||6
2920304|NCT00536107|3630782|FG000|COMPLETED|Overall Study||0
2920305|NCT00536107|3630783|FG001|COMPLETED|Overall Study||0
2920306|NCT00536107|3630782|FG000|NOT COMPLETED|Overall Study||8
2920307|NCT00536107|3630783|FG001|NOT COMPLETED|Overall Study||6
2920308|NCT00536120|3630791|FG000|STARTED|Overall Study||30
2920309|NCT00536120|3630792|FG001|STARTED|Overall Study||30
2920310|NCT00536120|3630791|FG000|COMPLETED|Overall Study||24
2920311|NCT00536120|3630792|FG001|COMPLETED|Overall Study||27
2920312|NCT00536120|3630791|FG000|NOT COMPLETED|Overall Study||6
2920313|NCT00536120|3630792|FG001|NOT COMPLETED|Overall Study||3
2920314|NCT00536172|3630800|FG000|STARTED|Overall Study||74
2920315|NCT00536172|3630801|FG001|STARTED|Overall Study||74
2920316|NCT00536172|3630800|FG000|COMPLETED|Overall Study||60
2920317|NCT00536172|3630801|FG001|COMPLETED|Overall Study||65
2920318|NCT00536172|3630800|FG000|NOT COMPLETED|Overall Study||14
2920319|NCT00536172|3630801|FG001|NOT COMPLETED|Overall Study||9
2920320|NCT00536198|3630809|FG000|STARTED|Overall Study||125
2920321|NCT00536198|3630810|FG001|STARTED|Overall Study||127
2920322|NCT00536198|3630809|FG000|Cycle 1|Overall Study||110
2920323|NCT00536198|3630810|FG001|Cycle 1|Overall Study||123
2920324|NCT00536198|3630809|FG000|Cycle 2|Overall Study||104
2920325|NCT00536198|3630810|FG001|Cycle 2|Overall Study||112
2920326|NCT00536198|3630809|FG000|Cycle 3|Overall Study||100
2920327|NCT00536198|3630810|FG001|Cycle 3|Overall Study||101
2920328|NCT00536198|3630809|FG000|Cycle 4|Overall Study||95
2920329|NCT00536198|3630810|FG001|Cycle 4|Overall Study||98
2920330|NCT00536198|3630809|FG000|Cycle 5|Overall Study||88
2920331|NCT00536198|3630810|FG001|Cycle 5|Overall Study||85
2920332|NCT00536198|3630809|FG000|Cycle 6|Overall Study||88
2920333|NCT00536198|3630810|FG001|Cycle 6|Overall Study||88
2920334|NCT00536198|3630809|FG000|COMPLETED|Overall Study||88
2920335|NCT00536198|3630810|FG001|COMPLETED|Overall Study||88
2920336|NCT00536198|3630809|FG000|NOT COMPLETED|Overall Study||37
2920337|NCT00536198|3630810|FG001|NOT COMPLETED|Overall Study||39
2920338|NCT00536263|3630821|FG000|STARTED|Overall Study||225
2920339|NCT00536263|3630822|FG001|STARTED|Overall Study||221
2920340|NCT00536263|3630823|FG002|STARTED|Overall Study|One (1) participant withdrawn from study for non-compliance.|225
2920341|NCT00536263|3630821|FG000|COMPLETED|Overall Study||214
2920342|NCT00536263|3630822|FG001|COMPLETED|Overall Study||207
2920343|NCT00536263|3630823|FG002|COMPLETED|Overall Study||204
2920344|NCT00536263|3630821|FG000|NOT COMPLETED|Overall Study||11
2920345|NCT00536263|3630822|FG001|NOT COMPLETED|Overall Study||14
2920346|NCT00536263|3630823|FG002|NOT COMPLETED|Overall Study||21
2920347|NCT00536341|3630833|FG000|STARTED|Overall Study||10
2920348|NCT00536341|3630834|FG001|STARTED|Overall Study||54
2920349|NCT00536341|3630833|FG000|COMPLETED|Overall Study||5
2920350|NCT00536341|3630834|FG001|COMPLETED|Overall Study||43
2920351|NCT00536341|3630833|FG000|NOT COMPLETED|Overall Study||5
2920352|NCT00536341|3630834|FG001|NOT COMPLETED|Overall Study||11
2902122|NCT00429182|3610196|FG000|STARTED|Overall Study||32
2902123|NCT00429182|3610196|FG000|COMPLETED|Overall Study||25
2902124|NCT00429182|3610196|FG000|NOT COMPLETED|Overall Study||7
2902125|NCT00429273|3610203|FG000|STARTED|Overall Study||68
2902126|NCT00429273|3610204|FG001|STARTED|Overall Study||69
2902127|NCT00429273|3610205|FG002|STARTED|Overall Study||70
2902128|NCT00429273|3610203|FG000|COMPLETED|Overall Study||60
2902129|NCT00429273|3610204|FG001|COMPLETED|Overall Study||61
2902130|NCT00429273|3610205|FG002|COMPLETED|Overall Study||61
2902131|NCT00429273|3610203|FG000|NOT COMPLETED|Overall Study||8
2902132|NCT00429273|3610204|FG001|NOT COMPLETED|Overall Study||8
2902133|NCT00429273|3610205|FG002|NOT COMPLETED|Overall Study||9
2902134|NCT00429299|3610216|FG000|STARTED|Overall Study||36
2902135|NCT00429299|3610217|FG001|STARTED|Overall Study||39
2902136|NCT00429299|3610218|FG002|STARTED|Overall Study||46
2902137|NCT00429299|3610216|FG000|COMPLETED|Overall Study||32
2902138|NCT00429299|3610217|FG001|COMPLETED|Overall Study||32
2902139|NCT00429299|3610218|FG002|COMPLETED|Overall Study||42
2902140|NCT00429299|3610216|FG000|NOT COMPLETED|Overall Study||4
2902141|NCT00429299|3610217|FG001|NOT COMPLETED|Overall Study||7
2902142|NCT00429299|3610218|FG002|NOT COMPLETED|Overall Study||4
2902143|NCT00429364|3610228|FG000|STARTED|Overall Study||303
2902144|NCT00429364|3610229|FG001|STARTED|Overall Study||305
2902145|NCT00429364|3610228|FG000|COMPLETED|Overall Study||271
2902146|NCT00429364|3610229|FG001|COMPLETED|Overall Study||272
2902147|NCT00429364|3610228|FG000|NOT COMPLETED|Overall Study||32
2902148|NCT00429364|3610229|FG001|NOT COMPLETED|Overall Study||33
2902149|NCT00429403|3610237|FG000|STARTED|Overall Study||1
2902150|NCT00429403|3610238|FG001|STARTED|Overall Study||0
2902151|NCT00429403|3610237|FG000|COMPLETED|Overall Study||1
2902152|NCT00429403|3610238|FG001|COMPLETED|Overall Study||0
2902153|NCT00429403|3610237|FG000|NOT COMPLETED|Overall Study||0
2902154|NCT00429403|3610238|FG001|NOT COMPLETED|Overall Study||0
2902155|NCT00429416|3610244|FG000|STARTED|Overall Study||14
2902156|NCT00429416|3610244|FG000|COMPLETED|Overall Study||13
2902157|NCT00429416|3610244|FG000|NOT COMPLETED|Overall Study||1
2902158|NCT00429494|3610248|FG000|STARTED|Overall Study||59
2902159|NCT00429494|3610248|FG000|COMPLETED|Overall Study||44
2902160|NCT00429494|3610248|FG000|NOT COMPLETED|Overall Study||15
2902161|NCT00429507|3610252|FG000|STARTED|Overall Study||12
2902162|NCT00429507|3610252|FG000|COMPLETED|Overall Study||12
2902163|NCT00429507|3610252|FG000|NOT COMPLETED|Overall Study||0
2902164|NCT00429572|3610256|FG000|STARTED|Overall Study||19
2902165|NCT00429572|3610256|FG000|COMPLETED|Overall Study||18
2902166|NCT00429572|3610256|FG000|NOT COMPLETED|Overall Study||1
2902167|NCT00429585|3610262|FG000|STARTED|Overall Study||52
2902168|NCT00429585|3610263|FG001|STARTED|Overall Study||47
2902169|NCT00429585|3610262|FG000|COMPLETED|Overall Study||22
3171283|NCT01933672|3898498|FG003|COMPLETED|First Washout Period (7-14 Days)||5
3171284|NCT01933672|3898499|FG004|COMPLETED|First Washout Period (7-14 Days)||6
3171285|NCT01933672|3898500|FG005|COMPLETED|First Washout Period (7-14 Days)||4
2902170|NCT00429585|3610263|FG001|COMPLETED|Overall Study||27
2902171|NCT00429585|3610262|FG000|NOT COMPLETED|Overall Study||30
2902172|NCT00429585|3610263|FG001|NOT COMPLETED|Overall Study||20
2902173|NCT00429663|3610271|FG000|STARTED|Overall Study||76
2902174|NCT00429663|3610272|FG001|STARTED|Overall Study||80
2902175|NCT00429663|3610271|FG000|COMPLETED|Overall Study||40
2902176|NCT00429663|3610272|FG001|COMPLETED|Overall Study||41
2902177|NCT00429663|3610271|FG000|NOT COMPLETED|Overall Study||36
2902178|NCT00429663|3610272|FG001|NOT COMPLETED|Overall Study||39
2902179|NCT00429702|3610280|FG000|STARTED|Overall Study||3
2902180|NCT00429702|3610281|FG001|STARTED|Overall Study||4
2902181|NCT00429702|3610280|FG000|COMPLETED|Overall Study||3
2902182|NCT00429702|3610281|FG001|COMPLETED|Overall Study||4
2902183|NCT00429702|3610280|FG000|NOT COMPLETED|Overall Study||0
2902184|NCT00429702|3610281|FG001|NOT COMPLETED|Overall Study||0
2902185|NCT00429793|3610287|FG000|STARTED|Overall Study||60
2902186|NCT00429793|3610287|FG000|COMPLETED|Overall Study||54
2902187|NCT00429793|3610287|FG000|NOT COMPLETED|Overall Study||6
2902188|NCT00429949|3610296|FG000|STARTED|Overall Study||21
2902189|NCT00429949|3610296|FG000|COMPLETED|Overall Study||21
2902190|NCT00429949|3610296|FG000|NOT COMPLETED|Overall Study||0
2902191|NCT00430183|3610304|FG000|STARTED|Overall Study||391
2902192|NCT00430183|3610305|FG001|STARTED|Overall Study||397
2902193|NCT00430183|3610304|FG000|COMPLETED|Overall Study||391
2902194|NCT00430183|3610305|FG001|COMPLETED|Overall Study||397
2902195|NCT00430183|3610304|FG000|NOT COMPLETED|Overall Study||0
2902196|NCT00430183|3610305|FG001|NOT COMPLETED|Overall Study||0
2902197|NCT00430248|3610314|FG000|STARTED|Overall Study||757
2902198|NCT00430248|3610315|FG001|STARTED|Overall Study||756
3171286|NCT01933672|3898501|FG006|COMPLETED|First Washout Period (7-14 Days)||6
2902199|NCT00430248|3610316|FG002|STARTED|Overall Study||756
2902200|NCT00430248|3610314|FG000|COMPLETED|Overall Study||632
2902201|NCT00430248|3610315|FG001|COMPLETED|Overall Study||598
2902202|NCT00430248|3610316|FG002|COMPLETED|Overall Study||621
2902203|NCT00430248|3610314|FG000|NOT COMPLETED|Overall Study||125
2902204|NCT00430248|3610315|FG001|NOT COMPLETED|Overall Study||158
2902205|NCT00430248|3610316|FG002|NOT COMPLETED|Overall Study||135
2902206|NCT00430300|3610328|FG000|STARTED|Overall Study||17
2902207|NCT00430300|3610329|FG001|STARTED|Overall Study||18
2902208|NCT00430300|3610330|FG002|STARTED|Overall Study||35
2902209|NCT00430300|3610331|FG003|STARTED|Overall Study||17
2902210|NCT00430300|3610328|FG000|COMPLETED|Overall Study||15
2902211|NCT00430300|3610329|FG001|COMPLETED|Overall Study||16
2902212|NCT00430300|3610330|FG002|COMPLETED|Overall Study||29
2902213|NCT00430300|3610331|FG003|COMPLETED|Overall Study||15
2902214|NCT00430300|3610328|FG000|NOT COMPLETED|Overall Study||2
2902215|NCT00430300|3610329|FG001|NOT COMPLETED|Overall Study||2
2902216|NCT00430300|3610330|FG002|NOT COMPLETED|Overall Study||6
2902217|NCT00430300|3610331|FG003|NOT COMPLETED|Overall Study||2
2902218|NCT00430352|3610341|FG000|STARTED|Overall Study||545
2902219|NCT00430352|3610341|FG000|COMPLETED|Overall Study||407
2902220|NCT00430352|3610341|FG000|NOT COMPLETED|Overall Study||138
2902221|NCT00430482|3610347|FG000|STARTED|Completed Treatment||41
2902222|NCT00430482|3610348|FG001|STARTED|Completed Treatment||37
2902223|NCT00430482|3610347|FG000|Completed ASI at Midpoint|Completed Treatment||35
2902224|NCT00430482|3610348|FG001|Completed ASI at Midpoint|Completed Treatment||29
2902225|NCT00430482|3610347|FG000|COMPLETED|Completed Treatment||34
3171287|NCT01933672|3898495|FG000|NOT COMPLETED|First Washout Period (7-14 Days)||0
3171288|NCT01933672|3898496|FG001|NOT COMPLETED|First Washout Period (7-14 Days)||0
3171289|NCT01933672|3898497|FG002|NOT COMPLETED|First Washout Period (7-14 Days)||0
3171290|NCT01933672|3898498|FG003|NOT COMPLETED|First Washout Period (7-14 Days)||0
3171291|NCT01933672|3898499|FG004|NOT COMPLETED|First Washout Period (7-14 Days)||0
3171292|NCT01933672|3898500|FG005|NOT COMPLETED|First Washout Period (7-14 Days)||0
3171293|NCT01933672|3898501|FG006|NOT COMPLETED|First Washout Period (7-14 Days)||0
3171294|NCT01933672|3898495|FG000|STARTED|Second Intervention Period (12-16 Days)||0
2902226|NCT00430482|3610348|FG001|COMPLETED|Completed Treatment||26
2902227|NCT00430482|3610347|FG000|NOT COMPLETED|Completed Treatment||7
2902228|NCT00430482|3610348|FG001|NOT COMPLETED|Completed Treatment||11
2902229|NCT00430482|3610347|FG000|STARTED|Completed 2 Follow-Up Visits||34
2902230|NCT00430482|3610348|FG001|STARTED|Completed 2 Follow-Up Visits||26
2902231|NCT00430482|3610347|FG000|Completed ASI at Follow-Up #1|Completed 2 Follow-Up Visits||27
3171295|NCT01933672|3898496|FG001|STARTED|Second Intervention Period (12-16 Days)||7
3171296|NCT01933672|3898497|FG002|STARTED|Second Intervention Period (12-16 Days)||2
3171297|NCT01933672|3898498|FG003|STARTED|Second Intervention Period (12-16 Days)||5
3171298|NCT01933672|3898499|FG004|STARTED|Second Intervention Period (12-16 Days)||6
3171299|NCT01933672|3898500|FG005|STARTED|Second Intervention Period (12-16 Days)||4
3171300|NCT01933672|3898501|FG006|STARTED|Second Intervention Period (12-16 Days)||6
2902232|NCT00430482|3610348|FG001|Completed ASI at Follow-Up #1|Completed 2 Follow-Up Visits||20
2902233|NCT00430482|3610347|FG000|Completed ASI at Follow-Up #2|Completed 2 Follow-Up Visits||29
2902234|NCT00430482|3610348|FG001|Completed ASI at Follow-Up #2|Completed 2 Follow-Up Visits||20
2902235|NCT00430482|3610347|FG000|COMPLETED|Completed 2 Follow-Up Visits||29
2902236|NCT00430482|3610348|FG001|COMPLETED|Completed 2 Follow-Up Visits||20
2902237|NCT00430482|3610347|FG000|NOT COMPLETED|Completed 2 Follow-Up Visits||5
2902238|NCT00430482|3610348|FG001|NOT COMPLETED|Completed 2 Follow-Up Visits||6
2902239|NCT00430495|3610358|FG000|STARTED|Overall Study||64
2902240|NCT00430495|3610359|FG001|STARTED|Overall Study||66
2902241|NCT00430495|3610360|FG002|STARTED|Overall Study||62
2902242|NCT00430495|3610361|FG003|STARTED|Overall Study||64
2902243|NCT00430495|3610358|FG000|Treated|Overall Study||62
2902244|NCT00430495|3610359|FG001|Treated|Overall Study||66
2902245|NCT00430495|3610360|FG002|Treated|Overall Study||62
2902246|NCT00430495|3610361|FG003|Treated|Overall Study||64
2902247|NCT00430495|3610358|FG000|COMPLETED|Overall Study||50
2902248|NCT00430495|3610359|FG001|COMPLETED|Overall Study||59
2902249|NCT00430495|3610360|FG002|COMPLETED|Overall Study||49
2902250|NCT00430495|3610361|FG003|COMPLETED|Overall Study||60
2902251|NCT00430495|3610358|FG000|NOT COMPLETED|Overall Study||14
2902252|NCT00430495|3610359|FG001|NOT COMPLETED|Overall Study||7
2902253|NCT00430495|3610360|FG002|NOT COMPLETED|Overall Study||13
2902254|NCT00430495|3610361|FG003|NOT COMPLETED|Overall Study||4
2902255|NCT00430521|3610379|FG000|STARTED|Overall Study||63
2902256|NCT00430521|3610380|FG001|STARTED|Overall Study||66
2902257|NCT00430521|3610381|FG002|STARTED|Overall Study||64
2902258|NCT00430521|3610382|FG003|STARTED|Overall Study||63
2902259|NCT00430521|3610383|FG004|STARTED|Overall Study||64
2902260|NCT00430521|3610384|FG005|STARTED|Overall Study||64
2902261|NCT00430521|3610385|FG006|STARTED|Overall Study||65
2902262|NCT00430521|3610386|FG007|STARTED|Overall Study||63
2902263|NCT00430521|3610379|FG000|COMPLETED|Overall Study||52
2902264|NCT00430521|3610380|FG001|COMPLETED|Overall Study||57
2902265|NCT00430521|3610381|FG002|COMPLETED|Overall Study||61
2902266|NCT00430521|3610382|FG003|COMPLETED|Overall Study||55
2902267|NCT00430521|3610383|FG004|COMPLETED|Overall Study||59
2902268|NCT00430521|3610384|FG005|COMPLETED|Overall Study||59
2902269|NCT00430521|3610385|FG006|COMPLETED|Overall Study||55
2902270|NCT00430521|3610386|FG007|COMPLETED|Overall Study||51
2902271|NCT00430521|3610379|FG000|NOT COMPLETED|Overall Study||11
3171301|NCT01933672|3898495|FG000|COMPLETED|Second Intervention Period (12-16 Days)||0
3171302|NCT01933672|3898496|FG001|COMPLETED|Second Intervention Period (12-16 Days)||6
3171303|NCT01933672|3898497|FG002|COMPLETED|Second Intervention Period (12-16 Days)||1
3171304|NCT01933672|3898498|FG003|COMPLETED|Second Intervention Period (12-16 Days)||5
3171305|NCT01933672|3898499|FG004|COMPLETED|Second Intervention Period (12-16 Days)||6
2902272|NCT00430521|3610380|FG001|NOT COMPLETED|Overall Study||9
2902273|NCT00430521|3610381|FG002|NOT COMPLETED|Overall Study||3
2902274|NCT00430521|3610382|FG003|NOT COMPLETED|Overall Study||8
2902275|NCT00430521|3610383|FG004|NOT COMPLETED|Overall Study||5
2902276|NCT00430521|3610384|FG005|NOT COMPLETED|Overall Study||5
2902277|NCT00430521|3610385|FG006|NOT COMPLETED|Overall Study||10
2902278|NCT00430521|3610386|FG007|NOT COMPLETED|Overall Study||12
2902279|NCT00430573|3610417|FG000|STARTED|Overall Study||10
2902280|NCT00430573|3610417|FG000|COMPLETED|Overall Study|Only 5 took study drug on at least one occasion and 8 completed the baseline ASI.|5
2902281|NCT00430573|3610417|FG000|NOT COMPLETED|Overall Study||5
2902282|NCT00430625|3610424|FG000|STARTED|Overall Study||13
2902283|NCT00430625|3610425|FG001|STARTED|Overall Study||12
2902284|NCT00430625|3610424|FG000|COMPLETED|Overall Study||13
2902285|NCT00430625|3610425|FG001|COMPLETED|Overall Study||12
2902286|NCT00430625|3610424|FG000|NOT COMPLETED|Overall Study||0
2902287|NCT00430625|3610425|FG001|NOT COMPLETED|Overall Study||0
2902288|NCT00430638|3610434|FG000|STARTED|Overall Study||138
2902289|NCT00430638|3610435|FG001|STARTED|Overall Study|2 participants were erroneously assigned to olmesartan 40 mg instead of 20 mg|140
2902290|NCT00430638|3610434|FG000|COMPLETED|Overall Study||60
2902291|NCT00430638|3610435|FG001|COMPLETED|Overall Study||92
2902292|NCT00430638|3610434|FG000|NOT COMPLETED|Overall Study||78
2902293|NCT00430638|3610435|FG001|NOT COMPLETED|Overall Study||48
2902294|NCT00430677|3610448|FG000|STARTED|Short-term Period|1 participant died before receiving the first dose of study medication|99
2902295|NCT00430677|3610449|FG001|STARTED|Short-term Period|1 participant took infliximab on day 1 and was discontinued before receiving study medication.|99
2902296|NCT00430677|3610450|FG002|STARTED|Short-term Period||100
2902297|NCT00430677|3610448|FG000|COMPLETED|Short-term Period|Completed the short-term period|76
2902298|NCT00430677|3610449|FG001|COMPLETED|Short-term Period|Completed the short-term period|74
2902299|NCT00430677|3610450|FG002|COMPLETED|Short-term Period|Completed the short-term period|78
2902300|NCT00430677|3610448|FG000|NOT COMPLETED|Short-term Period||23
2902301|NCT00430677|3610449|FG001|NOT COMPLETED|Short-term Period||25
2902302|NCT00430677|3610450|FG002|NOT COMPLETED|Short-term Period||22
2902303|NCT00430677|3610448|FG000|STARTED|Long-term Extension Period||70
2902304|NCT00430677|3610449|FG001|STARTED|Long-term Extension Period||67
2902305|NCT00430677|3610450|FG002|STARTED|Long-term Extension Period||74
2902306|NCT00430677|3610448|FG000|COMPLETED|Long-term Extension Period|Completed the long-term extension period|10
2902307|NCT00430677|3610449|FG001|COMPLETED|Long-term Extension Period|Completed the long-term extension period|9
2902308|NCT00430677|3610450|FG002|COMPLETED|Long-term Extension Period|Completed the long-term extension period|11
2902309|NCT00430677|3610448|FG000|NOT COMPLETED|Long-term Extension Period||60
2902310|NCT00430677|3610449|FG001|NOT COMPLETED|Long-term Extension Period||58
2902311|NCT00430677|3610450|FG002|NOT COMPLETED|Long-term Extension Period||63
2902312|NCT00430716|3610479|FG000|STARTED|Double Blind Phase||42
2902313|NCT00430716|3610480|FG001|STARTED|Double Blind Phase||43
2902314|NCT00430716|3610481|FG002|STARTED|Double Blind Phase||45
2902315|NCT00430716|3610479|FG000|Treated|Double Blind Phase||41
2902316|NCT00430716|3610480|FG001|Treated|Double Blind Phase||43
2902317|NCT00430716|3610481|FG002|Treated|Double Blind Phase||45
2902318|NCT00430716|3610479|FG000|COMPLETED|Double Blind Phase||36
2902319|NCT00430716|3610480|FG001|COMPLETED|Double Blind Phase||38
2902320|NCT00430716|3610481|FG002|COMPLETED|Double Blind Phase||39
2902321|NCT00430716|3610479|FG000|NOT COMPLETED|Double Blind Phase||6
2902322|NCT00430716|3610480|FG001|NOT COMPLETED|Double Blind Phase||5
2902323|NCT00430716|3610481|FG002|NOT COMPLETED|Double Blind Phase||6
2902324|NCT00430716|3610479|FG000|STARTED|Open Label Phase||36
2902325|NCT00430716|3610480|FG001|STARTED|Open Label Phase||38
2902326|NCT00430716|3610481|FG002|STARTED|Open Label Phase||39
2902327|NCT00430716|3610479|FG000|COMPLETED|Open Label Phase||27
2902328|NCT00430716|3610480|FG001|COMPLETED|Open Label Phase||31
2902329|NCT00430716|3610481|FG002|COMPLETED|Open Label Phase||32
2902330|NCT00430716|3610479|FG000|NOT COMPLETED|Open Label Phase||9
2902331|NCT00430716|3610480|FG001|NOT COMPLETED|Open Label Phase||7
2902332|NCT00430716|3610481|FG002|NOT COMPLETED|Open Label Phase||7
2902333|NCT00430755|3610489|FG000|STARTED|Overall Study||98
2902334|NCT00430755|3610489|FG000|COMPLETED|Overall Study||45
2902335|NCT00430755|3610489|FG000|NOT COMPLETED|Overall Study||53
2902336|NCT00430768|3610496|FG000|STARTED|Overall Study||3
2902337|NCT00430768|3610497|FG001|STARTED|Overall Study||3
2902338|NCT00430768|3610498|FG002|STARTED|Overall Study||3
2902339|NCT00430768|3610496|FG000|COMPLETED|Overall Study||3
2902340|NCT00430768|3610497|FG001|COMPLETED|Overall Study||3
2902341|NCT00430768|3610498|FG002|COMPLETED|Overall Study||3
2902342|NCT00430768|3610496|FG000|NOT COMPLETED|Overall Study||0
2902343|NCT00430768|3610497|FG001|NOT COMPLETED|Overall Study||0
2902344|NCT00430768|3610498|FG002|NOT COMPLETED|Overall Study||0
2902345|NCT00430781|3610515|FG000|STARTED|Interim Analysis; 11 February 2008||59
2902346|NCT00430781|3610516|FG001|STARTED|Interim Analysis; 11 February 2008||58
2902347|NCT00430781|3610517|FG002|STARTED|Interim Analysis; 11 February 2008||60
2902348|NCT00430781|3610515|FG000|Ongoing|Interim Analysis; 11 February 2008||23
2902349|NCT00430781|3610516|FG001|Ongoing|Interim Analysis; 11 February 2008||20
2902350|NCT00430781|3610517|FG002|Ongoing|Interim Analysis; 11 February 2008||25
2902351|NCT00430781|3610515|FG000|COMPLETED|Interim Analysis; 11 February 2008||0
2902352|NCT00430781|3610516|FG001|COMPLETED|Interim Analysis; 11 February 2008||0
2902353|NCT00430781|3610517|FG002|COMPLETED|Interim Analysis; 11 February 2008||0
2902354|NCT00430781|3610515|FG000|NOT COMPLETED|Interim Analysis; 11 February 2008||59
2902355|NCT00430781|3610516|FG001|NOT COMPLETED|Interim Analysis; 11 February 2008||58
2902356|NCT00430781|3610517|FG002|NOT COMPLETED|Interim Analysis; 11 February 2008||60
2902357|NCT00430781|3610515|FG000|STARTED|Final Analysis; 31 July 2008||0
2902358|NCT00430781|3610516|FG001|STARTED|Final Analysis; 31 July 2008||78
2902359|NCT00430781|3610517|FG002|STARTED|Final Analysis; 31 July 2008||74
2902360|NCT00430781|3610515|FG000|Ongoing|Final Analysis; 31 July 2008||0
2902361|NCT00430781|3610516|FG001|Ongoing|Final Analysis; 31 July 2008||29
2902362|NCT00430781|3610517|FG002|Ongoing|Final Analysis; 31 July 2008||32
2902363|NCT00430781|3610515|FG000|COMPLETED|Final Analysis; 31 July 2008||0
2902364|NCT00430781|3610516|FG001|COMPLETED|Final Analysis; 31 July 2008||39
2902365|NCT00430781|3610517|FG002|COMPLETED|Final Analysis; 31 July 2008||26
2902366|NCT00430781|3610515|FG000|NOT COMPLETED|Final Analysis; 31 July 2008||0
2902367|NCT00430781|3610516|FG001|NOT COMPLETED|Final Analysis; 31 July 2008||39
2902368|NCT00430781|3610517|FG002|NOT COMPLETED|Final Analysis; 31 July 2008||48
2902369|NCT00430781|3610515|FG000|STARTED|End-of-Study Analysis; 28 July 2011|Enrollment continued in this arm after data cut for Interim Analysis and before arm closed.|77
2902370|NCT00430781|3610516|FG001|STARTED|End-of-Study Analysis; 28 July 2011|1 participant randomized to lapatinib (final analysis table) actually received combination therapy.|77
2902371|NCT00430781|3610517|FG002|STARTED|End-of-Study Analysis; 28 July 2011||74
2902372|NCT00430781|3610515|FG000|COMPLETED|End-of-Study Analysis; 28 July 2011||53
2902373|NCT00430781|3610516|FG001|COMPLETED|End-of-Study Analysis; 28 July 2011||59
2902374|NCT00430781|3610517|FG002|COMPLETED|End-of-Study Analysis; 28 July 2011||54
2902375|NCT00430781|3610515|FG000|NOT COMPLETED|End-of-Study Analysis; 28 July 2011||24
2902376|NCT00430781|3610516|FG001|NOT COMPLETED|End-of-Study Analysis; 28 July 2011||18
2902377|NCT00430781|3610517|FG002|NOT COMPLETED|End-of-Study Analysis; 28 July 2011||20
2902378|NCT00430937|3610530|FG000|STARTED|Overall Study|Additional 5 participants were randomized; however, they were not exposed to study drug by mistake.|97
2902379|NCT00430937|3610531|FG001|STARTED|Overall Study||92
2902380|NCT00430937|3610530|FG000|COMPLETED|Overall Study||70
2902381|NCT00430937|3610531|FG001|COMPLETED|Overall Study||64
2902382|NCT00430937|3610530|FG000|NOT COMPLETED|Overall Study||27
2902383|NCT00430937|3610531|FG001|NOT COMPLETED|Overall Study||28
2902384|NCT00430989|3610539|FG000|STARTED|Overall Study||3543
2902385|NCT00430989|3610540|FG001|STARTED|Overall Study||3569
2902386|NCT00430989|3610539|FG000|COMPLETED|Overall Study||3483
2902387|NCT00430989|3610540|FG001|COMPLETED|Overall Study||3509
2902388|NCT00430989|3610539|FG000|NOT COMPLETED|Overall Study||60
2902389|NCT00430989|3610540|FG001|NOT COMPLETED|Overall Study||60
2902390|NCT00431041|3610550|FG000|STARTED|Overall Study|Data represents Intention To Treat(ITT) Population: All randomized subjects|68
2902391|NCT00431041|3610551|FG001|STARTED|Overall Study|Data represents ITT Population: All randomized subjects|64
2902392|NCT00431041|3610550|FG000|COMPLETED|Overall Study||52
2902393|NCT00431041|3610551|FG001|COMPLETED|Overall Study||40
2902394|NCT00431041|3610550|FG000|NOT COMPLETED|Overall Study||16
2902395|NCT00431041|3610551|FG001|NOT COMPLETED|Overall Study||24
2902396|NCT00431067|3610557|FG000|STARTED|Overall Study|52 patients screened, 41 treated|41
2902397|NCT00431067|3610557|FG000|COMPLETED|Overall Study|On treatment at analysis cut-off date (22-Sep-2009)|0
2902398|NCT00431067|3610557|FG000|NOT COMPLETED|Overall Study||41
2902399|NCT00431132|3610561|FG000|STARTED|Overall Study||336
2902400|NCT00431132|3610561|FG000|COMPLETED|Overall Study||292
2902401|NCT00431132|3610561|FG000|NOT COMPLETED|Overall Study||44
2902402|NCT00431184|3610567|FG000|STARTED|1st Intervention (Day 1)||10
2902403|NCT00431184|3610568|FG001|STARTED|1st Intervention (Day 1)||9
2902404|NCT00431184|3610567|FG000|COMPLETED|1st Intervention (Day 1)||10
2902405|NCT00431184|3610568|FG001|COMPLETED|1st Intervention (Day 1)||9
2902406|NCT00431184|3610567|FG000|NOT COMPLETED|1st Intervention (Day 1)||0
2902407|NCT00431184|3610568|FG001|NOT COMPLETED|1st Intervention (Day 1)||0
2902408|NCT00431184|3610567|FG000|STARTED|Second Intervention (Day 2)||10
2902409|NCT00431184|3610568|FG001|STARTED|Second Intervention (Day 2)||9
2902410|NCT00431184|3610567|FG000|COMPLETED|Second Intervention (Day 2)||10
2902411|NCT00431184|3610568|FG001|COMPLETED|Second Intervention (Day 2)||9
2902412|NCT00431184|3610567|FG000|NOT COMPLETED|Second Intervention (Day 2)||0
2902413|NCT00431184|3610568|FG001|NOT COMPLETED|Second Intervention (Day 2)||0
2902414|NCT00431444|3610578|FG000|STARTED|Overall Study||56
2902415|NCT00431444|3610579|FG001|STARTED|Overall Study|"Initially 110 randomized, 1 participant of Raloxifene group never took study drug."|53
2902416|NCT00431444|3610578|FG000|COMPLETED|Overall Study||51
2902417|NCT00431444|3610579|FG001|COMPLETED|Overall Study||46
2902418|NCT00431444|3610578|FG000|NOT COMPLETED|Overall Study||5
2902419|NCT00431444|3610579|FG001|NOT COMPLETED|Overall Study||7
2902420|NCT00431496|3610585|FG000|STARTED|Overall Study||71
2902421|NCT00431496|3610585|FG000|COMPLETED|Overall Study||60
2902422|NCT00431496|3610585|FG000|NOT COMPLETED|Overall Study||11
2902423|NCT00431626|3610591|FG000|STARTED|Overall Study||4
2902424|NCT00431626|3610592|FG001|STARTED|Overall Study||0
2902425|NCT00431626|3610591|FG000|COMPLETED|Overall Study||4
2902426|NCT00431626|3610592|FG001|COMPLETED|Overall Study||0
2902427|NCT00431626|3610591|FG000|NOT COMPLETED|Overall Study||0
2902428|NCT00431626|3610592|FG001|NOT COMPLETED|Overall Study||0
2902429|NCT00431834|3610598|FG000|STARTED|Overall Study||75
2902430|NCT00431834|3610598|FG000|COMPLETED|Overall Study||62
2902431|NCT00431834|3610598|FG000|NOT COMPLETED|Overall Study||13
2902432|NCT00431847|3610609|FG000|STARTED|Overall Study||132
2902433|NCT00431847|3610610|FG001|STARTED|Overall Study||45
2902434|NCT00431847|3610611|FG002|STARTED|Overall Study||24
2902435|NCT00431847|3610612|FG003|STARTED|Overall Study||184
2902436|NCT00431847|3610613|FG004|STARTED|Overall Study||1
2902437|NCT00431847|3610609|FG000|COMPLETED|Overall Study|All participants with at least two study visits were included in analysis.|126
2902438|NCT00431847|3610610|FG001|COMPLETED|Overall Study|All participants with at least two study visits were included in analysis.|42
2902439|NCT00431847|3610611|FG002|COMPLETED|Overall Study|All participants with at least two study visits were included in analysis.|20
2902440|NCT00431847|3610612|FG003|COMPLETED|Overall Study|All participants with at least two study visits were included in analysis.|170
2902441|NCT00431847|3610613|FG004|COMPLETED|Overall Study||0
2902442|NCT00431847|3610609|FG000|NOT COMPLETED|Overall Study||6
2902443|NCT00431847|3610610|FG001|NOT COMPLETED|Overall Study||3
2902444|NCT00431847|3610611|FG002|NOT COMPLETED|Overall Study||4
2902445|NCT00431847|3610612|FG003|NOT COMPLETED|Overall Study||14
2902446|NCT00431847|3610613|FG004|NOT COMPLETED|Overall Study||1
2902447|NCT00431951|3610627|FG000|STARTED|Overall Study||8
2902448|NCT00431951|3610628|FG001|STARTED|Overall Study||8
2902449|NCT00431951|3610629|FG002|STARTED|Overall Study||8
2902450|NCT00431951|3610630|FG003|STARTED|Overall Study||6
2902451|NCT00431951|3610627|FG000|COMPLETED|Overall Study||7
2902452|NCT00431951|3610628|FG001|COMPLETED|Overall Study||6
2902453|NCT00431951|3610629|FG002|COMPLETED|Overall Study||6
2902454|NCT00431951|3610630|FG003|COMPLETED|Overall Study||4
2902455|NCT00431951|3610627|FG000|NOT COMPLETED|Overall Study||1
2902456|NCT00431951|3610628|FG001|NOT COMPLETED|Overall Study||2
2902457|NCT00431951|3610629|FG002|NOT COMPLETED|Overall Study||2
2902458|NCT00431951|3610630|FG003|NOT COMPLETED|Overall Study||2
2902459|NCT00431964|3610646|FG000|STARTED|Overall Study||131
2902460|NCT00431964|3610647|FG001|STARTED|Overall Study||132
2902461|NCT00431964|3610646|FG000|Randomized/Received Drug|Overall Study||131
2902462|NCT00431964|3610647|FG001|Randomized/Received Drug|Overall Study||129
2902463|NCT00431964|3610646|FG000|Did Not Receive Drug|Overall Study||0
2902464|NCT00431964|3610647|FG001|Did Not Receive Drug|Overall Study||3
2902465|NCT00431964|3610646|FG000|Withdrew From Study|Overall Study||6
2902466|NCT00431964|3610647|FG001|Withdrew From Study|Overall Study||5
2902467|NCT00431964|3610646|FG000|COMPLETED|Overall Study||125
2902468|NCT00431964|3610647|FG001|COMPLETED|Overall Study||124
2902469|NCT00431964|3610646|FG000|NOT COMPLETED|Overall Study||6
2902470|NCT00431964|3610647|FG001|NOT COMPLETED|Overall Study||8
2902471|NCT00432042|3610656|FG000|STARTED|Overall Study|Number randomized.|479
2902472|NCT00432042|3610657|FG001|STARTED|Overall Study|Number randomized.|235
2902473|NCT00432042|3610658|FG002|STARTED|Overall Study|Number randomized.|241
2902474|NCT00432042|3610656|FG000|Vaccinated|Overall Study||477
2902475|NCT00432042|3610657|FG001|Vaccinated|Overall Study||235
2902476|NCT00432042|3610658|FG002|Vaccinated|Overall Study||240
2902477|NCT00432042|3610656|FG000|COMPLETED|Overall Study||472
2902478|NCT00432042|3610657|FG001|COMPLETED|Overall Study||234
2902479|NCT00432042|3610658|FG002|COMPLETED|Overall Study||239
2902480|NCT00432042|3610656|FG000|NOT COMPLETED|Overall Study||7
2902481|NCT00432042|3610657|FG001|NOT COMPLETED|Overall Study||1
2902482|NCT00432042|3610658|FG002|NOT COMPLETED|Overall Study||2
2902483|NCT00432159|3610671|FG000|STARTED|Overall Study||185
2902484|NCT00432159|3610672|FG001|STARTED|Overall Study||167
2902485|NCT00432159|3610673|FG002|STARTED|Overall Study||39
2902486|NCT00432159|3610674|FG003|STARTED|Overall Study||20
2902487|NCT00432159|3610675|FG004|STARTED|Overall Study||89
2902488|NCT00432159|3610671|FG000|COMPLETED|Overall Study|Actual (Complete efficacy)|163
2902489|NCT00432159|3610672|FG001|COMPLETED|Overall Study|Actual (Complete efficacy)|137
2902490|NCT00432159|3610673|FG002|COMPLETED|Overall Study|Actual (Complete efficacy)|35
2902491|NCT00432159|3610674|FG003|COMPLETED|Overall Study|Actual (Complete efficacy)|15
2902492|NCT00432159|3610675|FG004|COMPLETED|Overall Study|Actual (Complete efficacy)|79
2902493|NCT00432159|3610671|FG000|NOT COMPLETED|Overall Study||22
2902494|NCT00432159|3610672|FG001|NOT COMPLETED|Overall Study||30
2902495|NCT00432159|3610673|FG002|NOT COMPLETED|Overall Study||4
2902496|NCT00432159|3610674|FG003|NOT COMPLETED|Overall Study||5
2902497|NCT00432159|3610675|FG004|NOT COMPLETED|Overall Study||10
2902498|NCT00432172|3610691|FG000|STARTED|Overall Study||47
2902499|NCT00432172|3610692|FG001|STARTED|Overall Study||48
2902500|NCT00432172|3610693|FG002|STARTED|Overall Study||46
2902501|NCT00432172|3610694|FG003|STARTED|Overall Study||48
2902502|NCT00432172|3610691|FG000|COMPLETED|Overall Study||41
2902503|NCT00432172|3610692|FG001|COMPLETED|Overall Study||41
2902504|NCT00432172|3610693|FG002|COMPLETED|Overall Study||35
2902505|NCT00432172|3610694|FG003|COMPLETED|Overall Study||41
2902506|NCT00432172|3610691|FG000|NOT COMPLETED|Overall Study||6
2902507|NCT00432172|3610692|FG001|NOT COMPLETED|Overall Study||7
2902508|NCT00432172|3610693|FG002|NOT COMPLETED|Overall Study||11
2902509|NCT00432172|3610694|FG003|NOT COMPLETED|Overall Study||7
2902510|NCT00432237|3610710|FG000|STARTED|Overall Study|1 patient in the MK0974 50 mg group was treated but withdrew consent.|244
2902511|NCT00432237|3610711|FG001|STARTED|Overall Study||485
2902512|NCT00432237|3610712|FG002|STARTED|Overall Study|1 patient in the MK0974 300 mg group was treated but withdrew consent.|484
2902513|NCT00432237|3610713|FG003|STARTED|Overall Study||490
2902514|NCT00432237|3610710|FG000|Completed--With Data|Overall Study||176
2902515|NCT00432237|3610711|FG001|Completed--With Data|Overall Study||381
2902516|NCT00432237|3610712|FG002|Completed--With Data|Overall Study||370
2902517|NCT00432237|3610713|FG003|Completed--With Data|Overall Study||365
2902518|NCT00432237|3610710|FG000|Completed--No Data|Overall Study|For patients in this category, diaries were collected but lost prior to data entry.|1
2902519|NCT00432237|3610711|FG001|Completed--No Data|Overall Study|For patients in this category, diaries were collected but lost prior to data entry.|3
2920353|NCT00536471|3630845|FG000|STARTED|Overall Study||257
2902520|NCT00432237|3610712|FG002|Completed--No Data|Overall Study|For patients in this category, diaries were collected but lost prior to data entry.|5
2902521|NCT00432237|3610713|FG003|Completed--No Data|Overall Study|For patients in this category, diaries were collected but lost prior to data entry.|1
2902522|NCT00432237|3610710|FG000|COMPLETED|Overall Study||177
2902523|NCT00432237|3610711|FG001|COMPLETED|Overall Study||384
2902524|NCT00432237|3610712|FG002|COMPLETED|Overall Study||375
2902525|NCT00432237|3610713|FG003|COMPLETED|Overall Study||366
2902526|NCT00432237|3610710|FG000|NOT COMPLETED|Overall Study||67
2902527|NCT00432237|3610711|FG001|NOT COMPLETED|Overall Study||101
2902528|NCT00432237|3610712|FG002|NOT COMPLETED|Overall Study||109
2902529|NCT00432237|3610713|FG003|NOT COMPLETED|Overall Study||124
2902530|NCT00432276|3610725|FG000|STARTED|Overall Study||404
2902531|NCT00432276|3610726|FG001|STARTED|Overall Study||399
2902532|NCT00432276|3610725|FG000|Per Protocol Set|Overall Study|Patients who received at least 1 dose of study medication and who had no major protocol violations.|303
2902533|NCT00432276|3610726|FG001|Per Protocol Set|Overall Study||306
2902534|NCT00432276|3610725|FG000|COMPLETED|Overall Study||283
2902535|NCT00432276|3610726|FG001|COMPLETED|Overall Study||243
2902536|NCT00432276|3610725|FG000|NOT COMPLETED|Overall Study||121
2902537|NCT00432276|3610726|FG001|NOT COMPLETED|Overall Study||156
2902538|NCT00432341|3610734|FG000|STARTED|Overall Study||24
2902539|NCT00432341|3610735|FG001|STARTED|Overall Study||30
2902540|NCT00432341|3610734|FG000|COMPLETED|Overall Study||24
2902541|NCT00432341|3610735|FG001|COMPLETED|Overall Study||30
2902542|NCT00432341|3610734|FG000|NOT COMPLETED|Overall Study||0
2902543|NCT00432341|3610735|FG001|NOT COMPLETED|Overall Study||0
2902544|NCT00432380|3610744|FG000|STARTED|Overall Study||150
2902545|NCT00432380|3610745|FG001|STARTED|Overall Study||150
2902546|NCT00432380|3610746|FG002|STARTED|Overall Study||75
2902547|NCT00432380|3610744|FG000|COMPLETED|Overall Study||146
2902548|NCT00432380|3610745|FG001|COMPLETED|Overall Study||146
2902549|NCT00432380|3610746|FG002|COMPLETED|Overall Study||74
2902550|NCT00432380|3610744|FG000|NOT COMPLETED|Overall Study||4
2902551|NCT00432380|3610745|FG001|NOT COMPLETED|Overall Study||4
2902552|NCT00432380|3610746|FG002|NOT COMPLETED|Overall Study||1
2902553|NCT00432458|3610757|FG000|STARTED|Overall Study||35
2902554|NCT00432458|3610758|FG001|STARTED|Overall Study||33
2902555|NCT00432458|3610757|FG000|COMPLETED|Overall Study||30
2902556|NCT00432458|3610758|FG001|COMPLETED|Overall Study||32
2902557|NCT00432458|3610757|FG000|NOT COMPLETED|Overall Study||5
2902558|NCT00432458|3610758|FG001|NOT COMPLETED|Overall Study||1
2902559|NCT00432562|3610766|FG000|STARTED|Overall Study||16
2902560|NCT00432562|3610767|FG001|STARTED|Overall Study||15
2902561|NCT00432562|3610766|FG000|COMPLETED|Overall Study||13
2902562|NCT00432562|3610767|FG001|COMPLETED|Overall Study||15
2902563|NCT00432562|3610766|FG000|NOT COMPLETED|Overall Study||3
2902564|NCT00432562|3610767|FG001|NOT COMPLETED|Overall Study||0
2902565|NCT00432601|3610775|FG000|STARTED|Time 1 to Time 2||510
2902566|NCT00432601|3610776|FG001|STARTED|Time 1 to Time 2||512
2902567|NCT00432601|3610775|FG000|COMPLETED|Time 1 to Time 2|There is large drop-off as only one-third of subjects enrolled were eligible to continue the study|141
2902568|NCT00432601|3610776|FG001|COMPLETED|Time 1 to Time 2|There is large drop-off as only one-third of subjects enrolled were eligible to continue the study|144
2902569|NCT00432601|3610775|FG000|NOT COMPLETED|Time 1 to Time 2||369
2902570|NCT00432601|3610776|FG001|NOT COMPLETED|Time 1 to Time 2||368
2902571|NCT00432601|3610775|FG000|STARTED|Time 2 to Time 3||141
2902572|NCT00432601|3610776|FG001|STARTED|Time 2 to Time 3||144
2902573|NCT00432601|3610775|FG000|COMPLETED|Time 2 to Time 3||122
2902574|NCT00432601|3610776|FG001|COMPLETED|Time 2 to Time 3||122
2902575|NCT00432601|3610775|FG000|NOT COMPLETED|Time 2 to Time 3||19
2902576|NCT00432601|3610776|FG001|NOT COMPLETED|Time 2 to Time 3||22
2902577|NCT00432666|3610784|FG000|STARTED|Main Period||73
2902578|NCT00432666|3610785|FG001|STARTED|Main Period||75
2902579|NCT00432666|3610784|FG000|COMPLETED|Main Period||71
2902580|NCT00432666|3610785|FG001|COMPLETED|Main Period||74
2902581|NCT00432666|3610784|FG000|NOT COMPLETED|Main Period||2
2902582|NCT00432666|3610785|FG001|NOT COMPLETED|Main Period||1
2902583|NCT00432666|3610784|FG000|STARTED|Open-Label Extension Period||145
2902584|NCT00432666|3610785|FG001|STARTED|Open-Label Extension Period|In the Open-Label Extension Period no placebo treatment arm was given.|0
2902585|NCT00432666|3610784|FG000|COMPLETED|Open-Label Extension Period||120
2902586|NCT00432666|3610785|FG001|COMPLETED|Open-Label Extension Period||0
2902587|NCT00432666|3610784|FG000|NOT COMPLETED|Open-Label Extension Period||25
2902588|NCT00432666|3610785|FG001|NOT COMPLETED|Open-Label Extension Period||0
2902589|NCT00432679|3610793|FG000|STARTED|Overall Study||74
2902590|NCT00432679|3610794|FG001|STARTED|Overall Study||75
2902591|NCT00432679|3610793|FG000|COMPLETED|Overall Study||69
2902592|NCT00432679|3610794|FG001|COMPLETED|Overall Study||72
2902593|NCT00432679|3610793|FG000|NOT COMPLETED|Overall Study||5
2902594|NCT00432679|3610794|FG001|NOT COMPLETED|Overall Study||3
2902595|NCT00432744|3610802|FG000|STARTED|Months 0-6||12
2902596|NCT00432744|3610803|FG001|STARTED|Months 0-6||12
2902597|NCT00432744|3610802|FG000|COMPLETED|Months 0-6||7
2902598|NCT00432744|3610803|FG001|COMPLETED|Months 0-6|"One patient in period 1 other reason for loss became too disabled to complete the 6 month test."|8
2902599|NCT00432744|3610802|FG000|NOT COMPLETED|Months 0-6||5
2902600|NCT00432744|3610803|FG001|NOT COMPLETED|Months 0-6||4
2902601|NCT00432744|3610802|FG000|STARTED|Months 7 - 12||7
2902602|NCT00432744|3610803|FG001|STARTED|Months 7 - 12||8
2902603|NCT00432744|3610802|FG000|COMPLETED|Months 7 - 12||6
2902604|NCT00432744|3610803|FG001|COMPLETED|Months 7 - 12||7
2902605|NCT00432744|3610802|FG000|NOT COMPLETED|Months 7 - 12||1
2902606|NCT00432744|3610803|FG001|NOT COMPLETED|Months 7 - 12||1
2902607|NCT00432809|3610812|FG000|STARTED|1 Year Follow-up||50
2902608|NCT00432809|3610813|FG001|STARTED|1 Year Follow-up||50
2902609|NCT00432809|3610814|FG002|STARTED|1 Year Follow-up||50
2902610|NCT00432809|3610812|FG000|COMPLETED|1 Year Follow-up||41
2902611|NCT00432809|3610813|FG001|COMPLETED|1 Year Follow-up||50
2902612|NCT00432809|3610814|FG002|COMPLETED|1 Year Follow-up||49
2902613|NCT00432809|3610812|FG000|NOT COMPLETED|1 Year Follow-up||9
2902614|NCT00432809|3610813|FG001|NOT COMPLETED|1 Year Follow-up||0
2902615|NCT00432809|3610814|FG002|NOT COMPLETED|1 Year Follow-up||1
2902616|NCT00432809|3610812|FG000|STARTED|2 Year Sub-study||20
2902617|NCT00432809|3610813|FG001|STARTED|2 Year Sub-study||20
2902618|NCT00432809|3610814|FG002|STARTED|2 Year Sub-study||20
2902619|NCT00432809|3610812|FG000|COMPLETED|2 Year Sub-study||17
2902620|NCT00432809|3610813|FG001|COMPLETED|2 Year Sub-study||18
2902621|NCT00432809|3610814|FG002|COMPLETED|2 Year Sub-study||19
2902622|NCT00432809|3610812|FG000|NOT COMPLETED|2 Year Sub-study||3
2902623|NCT00432809|3610813|FG001|NOT COMPLETED|2 Year Sub-study||2
2902624|NCT00432809|3610814|FG002|NOT COMPLETED|2 Year Sub-study||1
2902625|NCT00432835|3610824|FG000|STARTED|Overall Study||28
2902626|NCT00432835|3610825|FG001|STARTED|Overall Study||30
2902627|NCT00432835|3610824|FG000|Completed 1st Intervention|Overall Study||22
2902628|NCT00432835|3610825|FG001|Completed 1st Intervention|Overall Study||23
2902629|NCT00432835|3610824|FG000|Completed 2nd Intervention|Overall Study||22
2902630|NCT00432835|3610825|FG001|Completed 2nd Intervention|Overall Study||23
2902631|NCT00432835|3610824|FG000|COMPLETED|Overall Study|These 22 patients completed the entire 8 day protocol.|22
2902632|NCT00432835|3610825|FG001|COMPLETED|Overall Study|These 23 patients completed the entire 8 day protocol.|23
2902633|NCT00432835|3610824|FG000|NOT COMPLETED|Overall Study||6
2902634|NCT00432835|3610825|FG001|NOT COMPLETED|Overall Study||7
2902635|NCT00432965|3610833|FG000|STARTED|Overall Study||169
2902636|NCT00432965|3610834|FG001|STARTED|Overall Study||166
2902637|NCT00432965|3610833|FG000|COMPLETED|Overall Study||75
2902638|NCT00432965|3610834|FG001|COMPLETED|Overall Study||80
2902639|NCT00432965|3610833|FG000|NOT COMPLETED|Overall Study||94
2902640|NCT00432965|3610834|FG001|NOT COMPLETED|Overall Study||86
2902641|NCT00432991|3610842|FG000|STARTED|Overall Study||22
2902642|NCT00432991|3610843|FG001|STARTED|Overall Study||31
2902643|NCT00432991|3610842|FG000|COMPLETED|Overall Study||15
2902644|NCT00432991|3610843|FG001|COMPLETED|Overall Study||19
2902645|NCT00432991|3610842|FG000|NOT COMPLETED|Overall Study||7
2902646|NCT00432991|3610843|FG001|NOT COMPLETED|Overall Study||12
2902647|NCT00433004|3610851|FG000|STARTED|Overall Study||27
2902648|NCT00433004|3610852|FG001|STARTED|Overall Study||23
2902649|NCT00433004|3610851|FG000|COMPLETED|Overall Study||22
2902650|NCT00433004|3610852|FG001|COMPLETED|Overall Study||16
2902651|NCT00433004|3610851|FG000|NOT COMPLETED|Overall Study||5
2902652|NCT00433004|3610852|FG001|NOT COMPLETED|Overall Study||7
2902653|NCT00433017|3610860|FG000|STARTED|Overall Study||122
2902654|NCT00433017|3610861|FG001|STARTED|Overall Study||133
2902655|NCT00433017|3610860|FG000|Completed 12 Month Phase|Overall Study||114
2902656|NCT00433017|3610861|FG001|Completed 12 Month Phase|Overall Study||126
2902657|NCT00433017|3610860|FG000|COMPLETED|Overall Study||26
2902658|NCT00433017|3610861|FG001|COMPLETED|Overall Study||32
2902659|NCT00433017|3610860|FG000|NOT COMPLETED|Overall Study||96
2902660|NCT00433017|3610861|FG001|NOT COMPLETED|Overall Study||101
2902661|NCT00433147|3610871|FG000|STARTED|Overall Study||7
2902662|NCT00433147|3610872|FG001|STARTED|Overall Study||7
2902663|NCT00433147|3610873|FG002|STARTED|Overall Study||9
2902664|NCT00433147|3610874|FG003|STARTED|Overall Study||7
2902665|NCT00433147|3610871|FG000|Safety Population|Overall Study||7
2902666|NCT00433147|3610872|FG001|Safety Population|Overall Study||7
2902667|NCT00433147|3610873|FG002|Safety Population|Overall Study||9
2902668|NCT00433147|3610874|FG003|Safety Population|Overall Study||7
2902669|NCT00433147|3610871|FG000|PD Population|Overall Study||7
2902670|NCT00433147|3610872|FG001|PD Population|Overall Study||6
2902671|NCT00433147|3610873|FG002|PD Population|Overall Study||9
2902672|NCT00433147|3610874|FG003|PD Population|Overall Study||7
2902673|NCT00433147|3610871|FG000|Received at Least One Dose of Study Drug|Overall Study||7
2902674|NCT00433147|3610872|FG001|Received at Least One Dose of Study Drug|Overall Study||7
2902675|NCT00433147|3610873|FG002|Received at Least One Dose of Study Drug|Overall Study||9
2902676|NCT00433147|3610874|FG003|Received at Least One Dose of Study Drug|Overall Study||7
2902677|NCT00433147|3610871|FG000|COMPLETED|Overall Study||7
2902678|NCT00433147|3610872|FG001|COMPLETED|Overall Study||6
2902679|NCT00433147|3610873|FG002|COMPLETED|Overall Study||9
2902680|NCT00433147|3610874|FG003|COMPLETED|Overall Study||7
2902681|NCT00433147|3610871|FG000|NOT COMPLETED|Overall Study||0
2902682|NCT00433147|3610872|FG001|NOT COMPLETED|Overall Study||1
2902683|NCT00433147|3610873|FG002|NOT COMPLETED|Overall Study||0
2902684|NCT00433147|3610874|FG003|NOT COMPLETED|Overall Study||0
2902685|NCT00433160|3610886|FG000|STARTED|52-Week Double-Blind (DB) Period||137
2902686|NCT00433160|3610887|FG001|STARTED|52-Week Double-Blind (DB) Period||70
2902687|NCT00433160|3610886|FG000|Received Treatment|52-Week Double-Blind (DB) Period||136
2902688|NCT00433160|3610887|FG001|Received Treatment|52-Week Double-Blind (DB) Period||68
2902689|NCT00433160|3610886|FG000|COMPLETED|52-Week Double-Blind (DB) Period||120
2902690|NCT00433160|3610887|FG001|COMPLETED|52-Week Double-Blind (DB) Period||60
2902691|NCT00433160|3610886|FG000|NOT COMPLETED|52-Week Double-Blind (DB) Period||17
2902692|NCT00433160|3610887|FG001|NOT COMPLETED|52-Week Double-Blind (DB) Period||10
2902693|NCT00433160|3610886|FG000|STARTED|76 Weeks, 24-Week Open Label (OL) Period|One participant did not continue to first OL period due to adverse event after completing DB period.|119
2902694|NCT00433160|3610887|FG001|STARTED|76 Weeks, 24-Week Open Label (OL) Period|One participant did not continue to first OL period due to adverse event after completing DB period.|59
2902695|NCT00433160|3610886|FG000|Received Treatment|76 Weeks, 24-Week Open Label (OL) Period||119
2902696|NCT00433160|3610887|FG001|Received Treatment|76 Weeks, 24-Week Open Label (OL) Period||59
2902697|NCT00433160|3610886|FG000|COMPLETED|76 Weeks, 24-Week Open Label (OL) Period||113
2902698|NCT00433160|3610887|FG001|COMPLETED|76 Weeks, 24-Week Open Label (OL) Period||55
2902699|NCT00433160|3610886|FG000|NOT COMPLETED|76 Weeks, 24-Week Open Label (OL) Period||6
2902700|NCT00433160|3610887|FG001|NOT COMPLETED|76 Weeks, 24-Week Open Label (OL) Period||4
2902701|NCT00433160|3610886|FG000|STARTED|104 Weeks, 28-Week OL Period|Eleven participants withdrew at end of first OL period and did not continue on to second OL period.|102
2902702|NCT00433160|3610887|FG001|STARTED|104 Weeks, 28-Week OL Period|Five participants withdrew at end of first OL period and did not continue on to second OL period.|50
2902703|NCT00433160|3610886|FG000|Received Treatment|104 Weeks, 28-Week OL Period||102
2902704|NCT00433160|3610887|FG001|Received Treatment|104 Weeks, 28-Week OL Period||50
2902705|NCT00433160|3610886|FG000|COMPLETED|104 Weeks, 28-Week OL Period||92
2902706|NCT00433160|3610887|FG001|COMPLETED|104 Weeks, 28-Week OL Period||47
2902707|NCT00433160|3610886|FG000|NOT COMPLETED|104 Weeks, 28-Week OL Period||10
2902708|NCT00433160|3610887|FG001|NOT COMPLETED|104 Weeks, 28-Week OL Period||3
2902709|NCT00433199|3610899|FG000|STARTED|Double-Blind Period||40
2902710|NCT00433199|3610900|FG001|STARTED|Double-Blind Period||234
2902711|NCT00433199|3610899|FG000|COMPLETED|Double-Blind Period||28
2902712|NCT00433199|3610900|FG001|COMPLETED|Double-Blind Period||168
2902713|NCT00433199|3610899|FG000|NOT COMPLETED|Double-Blind Period||12
2902714|NCT00433199|3610900|FG001|NOT COMPLETED|Double-Blind Period||66
2902715|NCT00433199|3610899|FG000|STARTED|Open-Label Period||0
2902716|NCT00433199|3610900|FG001|STARTED|Open-Label Period||219
2902717|NCT00433199|3610899|FG000|COMPLETED|Open-Label Period||0
2902718|NCT00433199|3610900|FG001|COMPLETED|Open-Label Period||185
2902719|NCT00433199|3610899|FG000|NOT COMPLETED|Open-Label Period||0
2902720|NCT00433199|3610900|FG001|NOT COMPLETED|Open-Label Period||34
2902721|NCT00433290|3610913|FG000|STARTED|Overall Study||128
2902722|NCT00433290|3610914|FG001|STARTED|Overall Study||128
2902723|NCT00433290|3610913|FG000|COMPLETED|Overall Study||93
2902724|NCT00433290|3610914|FG001|COMPLETED|Overall Study||111
2902725|NCT00433290|3610913|FG000|NOT COMPLETED|Overall Study||35
2902726|NCT00433290|3610914|FG001|NOT COMPLETED|Overall Study||17
2902727|NCT00433329|3610920|FG000|STARTED|Overall Study||100
2902728|NCT00433329|3610920|FG000|COMPLETED|Overall Study||79
2902729|NCT00433329|3610920|FG000|NOT COMPLETED|Overall Study||21
2902730|NCT00433381|3610926|FG000|STARTED|Overall Study||63
2902731|NCT00433381|3610927|FG001|STARTED|Overall Study||60
2902732|NCT00433381|3610926|FG000|COMPLETED|Overall Study|Subjects contributing data to [the primary] analysis are considered to have completed the study.|60
2902733|NCT00433381|3610927|FG001|COMPLETED|Overall Study||57
2902734|NCT00433381|3610926|FG000|NOT COMPLETED|Overall Study||3
2902735|NCT00433381|3610927|FG001|NOT COMPLETED|Overall Study||3
2902736|NCT00433446|3610941|FG000|STARTED|Overall Study||62
2902737|NCT00433446|3610941|FG000|Eligible|Overall Study||53
2902738|NCT00433446|3610941|FG000|Eligible and Began Protocol Therapy|Overall Study||53
2902739|NCT00433446|3610941|FG000|COMPLETED|Overall Study||1
2902740|NCT00433446|3610941|FG000|NOT COMPLETED|Overall Study||61
2902741|NCT00433537|3610945|FG000|STARTED|Step 1 - VcR-CVAD Induction||45
2902742|NCT00433537|3610946|FG001|STARTED|Step 1 - VcR-CVAD Induction||22
2902743|NCT00433537|3610947|FG002|STARTED|Step 1 - VcR-CVAD Induction||10
2902744|NCT00433537|3610945|FG000|Eligible and Treated|Step 1 - VcR-CVAD Induction||44
2902745|NCT00433537|3610946|FG001|Eligible and Treated|Step 1 - VcR-CVAD Induction||22
2902746|NCT00433537|3610947|FG002|Eligible and Treated|Step 1 - VcR-CVAD Induction||9
2902747|NCT00433537|3610945|FG000|COMPLETED|Step 1 - VcR-CVAD Induction||44
2902748|NCT00433537|3610946|FG001|COMPLETED|Step 1 - VcR-CVAD Induction||22
2902749|NCT00433537|3610947|FG002|COMPLETED|Step 1 - VcR-CVAD Induction||1
2902750|NCT00433537|3610945|FG000|NOT COMPLETED|Step 1 - VcR-CVAD Induction||1
2902751|NCT00433537|3610946|FG001|NOT COMPLETED|Step 1 - VcR-CVAD Induction||0
2902752|NCT00433537|3610947|FG002|NOT COMPLETED|Step 1 - VcR-CVAD Induction||9
2902753|NCT00433537|3610945|FG000|STARTED|Step 2 - Maintenance Rituximab or ASCT|This included all treated patients regardless of eligibility.|45
2902754|NCT00433537|3610946|FG001|STARTED|Step 2 - Maintenance Rituximab or ASCT||22
2902755|NCT00433537|3610947|FG002|STARTED|Step 2 - Maintenance Rituximab or ASCT|One patient completed VcR-CVAD and then withdrew from the study.|0
2902756|NCT00433537|3610945|FG000|Eligible and Treated|Step 2 - Maintenance Rituximab or ASCT||44
2902757|NCT00433537|3610946|FG001|Eligible and Treated|Step 2 - Maintenance Rituximab or ASCT||22
2902758|NCT00433537|3610947|FG002|Eligible and Treated|Step 2 - Maintenance Rituximab or ASCT||0
2902759|NCT00433537|3610945|FG000|COMPLETED|Step 2 - Maintenance Rituximab or ASCT||29
2902760|NCT00433537|3610946|FG001|COMPLETED|Step 2 - Maintenance Rituximab or ASCT||22
2902761|NCT00433537|3610947|FG002|COMPLETED|Step 2 - Maintenance Rituximab or ASCT||0
2902762|NCT00433537|3610945|FG000|NOT COMPLETED|Step 2 - Maintenance Rituximab or ASCT||16
2902763|NCT00433537|3610946|FG001|NOT COMPLETED|Step 2 - Maintenance Rituximab or ASCT||0
2902764|NCT00433537|3610947|FG002|NOT COMPLETED|Step 2 - Maintenance Rituximab or ASCT||0
2902765|NCT00433550|3610957|FG000|STARTED|Overall Study||17
2902766|NCT00433550|3610958|FG001|STARTED|Overall Study||10
2902767|NCT00433550|3610959|FG002|STARTED|Overall Study||6
2902768|NCT00433550|3610957|FG000|COMPLETED|Overall Study||17
2902769|NCT00433550|3610958|FG001|COMPLETED|Overall Study||10
2902770|NCT00433550|3610959|FG002|COMPLETED|Overall Study||6
2902771|NCT00433550|3610957|FG000|NOT COMPLETED|Overall Study||0
2902772|NCT00433550|3610958|FG001|NOT COMPLETED|Overall Study||0
2902773|NCT00433550|3610959|FG002|NOT COMPLETED|Overall Study||0
2902774|NCT00433654|3610969|FG000|STARTED|Overall Study||258
2902775|NCT00433654|3610970|FG001|STARTED|Overall Study||206
2902776|NCT00433654|3610969|FG000|COMPLETED|Overall Study|Subjects completing the 4-month follow-up.|243
2902777|NCT00433654|3610970|FG001|COMPLETED|Overall Study|Subjects completing the 4-month follow-up.|201
2902778|NCT00433654|3610969|FG000|NOT COMPLETED|Overall Study||15
2902779|NCT00433654|3610970|FG001|NOT COMPLETED|Overall Study||5
2902780|NCT00433745|3610982|FG000|STARTED|Overall Study||4
2902781|NCT00433745|3610982|FG000|COMPLETED|Overall Study||4
2902782|NCT00433745|3610982|FG000|NOT COMPLETED|Overall Study||0
2902783|NCT00433771|3610987|FG000|STARTED|Overall Study|74 enrolled patients(signed an Informed Consent Form)were screened.58 were eligible(intent to treat)|74
2902784|NCT00433771|3610987|FG000|COMPLETED|Overall Study|55 out of 58 patients were evaluable(had a stent placed and had at least 1 week of follow up)|55
2902785|NCT00433771|3610987|FG000|NOT COMPLETED|Overall Study||19
2902786|NCT00433836|3610993|FG000|STARTED|Overall Study||151
2902787|NCT00433836|3610994|FG001|STARTED|Overall Study||149
2902788|NCT00433836|3610993|FG000|COMPLETED|Overall Study||138
2902789|NCT00433836|3610994|FG001|COMPLETED|Overall Study||143
2902790|NCT00433836|3610993|FG000|NOT COMPLETED|Overall Study||13
2902791|NCT00433836|3610994|FG001|NOT COMPLETED|Overall Study||6
2902792|NCT00433914|3611002|FG000|STARTED|Overall Study||30
2902793|NCT00433914|3611003|FG001|STARTED|Overall Study||30
2902794|NCT00433914|3611002|FG000|COMPLETED|Overall Study||30
2902795|NCT00433914|3611003|FG001|COMPLETED|Overall Study||27
2902796|NCT00433914|3611002|FG000|NOT COMPLETED|Overall Study||0
2902797|NCT00433914|3611003|FG001|NOT COMPLETED|Overall Study||3
2902798|NCT00433966|3611011|FG000|STARTED|Pharmacology Intervention/Randomization||1800
2902799|NCT00433966|3611012|FG001|STARTED|Pharmacology Intervention/Randomization||1802
2902800|NCT00433966|3611013|FG002|STARTED|Pharmacology Intervention/Randomization||0
2902801|NCT00433966|3611014|FG003|STARTED|Pharmacology Intervention/Randomization||0
2902802|NCT00433966|3611011|FG000|30-Day Follow-up|Pharmacology Intervention/Randomization||1787
2902803|NCT00433966|3611012|FG001|30-Day Follow-up|Pharmacology Intervention/Randomization||1791
2902804|NCT00433966|3611013|FG002|30-Day Follow-up|Pharmacology Intervention/Randomization||0
2902805|NCT00433966|3611014|FG003|30-Day Follow-up|Pharmacology Intervention/Randomization||0
2902806|NCT00433966|3611011|FG000|1-Year Follow-up|Pharmacology Intervention/Randomization||1696
2902807|NCT00433966|3611012|FG001|1-Year Follow-up|Pharmacology Intervention/Randomization||1702
2902808|NCT00433966|3611013|FG002|1-Year Follow-up|Pharmacology Intervention/Randomization||0
2902809|NCT00433966|3611014|FG003|1-Year Follow-up|Pharmacology Intervention/Randomization||0
2902810|NCT00433966|3611011|FG000|3-Year Follow-up|Pharmacology Intervention/Randomization||1634
2902811|NCT00433966|3611012|FG001|3-Year Follow-up|Pharmacology Intervention/Randomization||1628
2902812|NCT00433966|3611013|FG002|3-Year Follow-up|Pharmacology Intervention/Randomization||0
2902813|NCT00433966|3611014|FG003|3-Year Follow-up|Pharmacology Intervention/Randomization||0
2902814|NCT00433966|3611011|FG000|COMPLETED|Pharmacology Intervention/Randomization||1634
2902815|NCT00433966|3611012|FG001|COMPLETED|Pharmacology Intervention/Randomization||1628
2902816|NCT00433966|3611013|FG002|COMPLETED|Pharmacology Intervention/Randomization||0
2902817|NCT00433966|3611014|FG003|COMPLETED|Pharmacology Intervention/Randomization||0
2902818|NCT00433966|3611011|FG000|NOT COMPLETED|Pharmacology Intervention/Randomization||166
2902819|NCT00433966|3611012|FG001|NOT COMPLETED|Pharmacology Intervention/Randomization||174
2902820|NCT00433966|3611013|FG002|NOT COMPLETED|Pharmacology Intervention/Randomization||0
2902821|NCT00433966|3611014|FG003|NOT COMPLETED|Pharmacology Intervention/Randomization||0
2902822|NCT00433966|3611011|FG000|STARTED|Stent Intervention/Randomization||0
2902823|NCT00433966|3611012|FG001|STARTED|Stent Intervention/Randomization||0
2902824|NCT00433966|3611013|FG002|STARTED|Stent Intervention/Randomization||2257
2902825|NCT00433966|3611014|FG003|STARTED|Stent Intervention/Randomization||749
2902826|NCT00433966|3611011|FG000|1-Year Follow-up|Stent Intervention/Randomization||0
2902827|NCT00433966|3611012|FG001|1-Year Follow-up|Stent Intervention/Randomization||0
2902828|NCT00433966|3611013|FG002|1-Year Follow-up|Stent Intervention/Randomization||2186
2902829|NCT00433966|3611014|FG003|1-Year Follow-up|Stent Intervention/Randomization||715
2902830|NCT00433966|3611011|FG000|3-Year Follow-up|Stent Intervention/Randomization||0
2902831|NCT00433966|3611012|FG001|3-Year Follow-up|Stent Intervention/Randomization||0
2902832|NCT00433966|3611013|FG002|3-Year Follow-up|Stent Intervention/Randomization||2103
2902833|NCT00433966|3611014|FG003|3-Year Follow-up|Stent Intervention/Randomization||687
2902834|NCT00433966|3611011|FG000|COMPLETED|Stent Intervention/Randomization||0
2902835|NCT00433966|3611012|FG001|COMPLETED|Stent Intervention/Randomization||0
2902836|NCT00433966|3611013|FG002|COMPLETED|Stent Intervention/Randomization||2103
2902837|NCT00433966|3611014|FG003|COMPLETED|Stent Intervention/Randomization||687
2902838|NCT00433966|3611011|FG000|NOT COMPLETED|Stent Intervention/Randomization||0
2902839|NCT00433966|3611012|FG001|NOT COMPLETED|Stent Intervention/Randomization||0
2902840|NCT00433966|3611013|FG002|NOT COMPLETED|Stent Intervention/Randomization||154
3316164|NCT03107091|4049446|FG000|NOT COMPLETED|Overall Study||1
3316165|NCT03107377|4049453|FG000|STARTED|Overall Study||426
3316166|NCT03107377|4049454|FG001|STARTED|Overall Study||434
2902841|NCT00433966|3611014|FG003|NOT COMPLETED|Stent Intervention/Randomization||62
2902842|NCT00433992|3611026|FG000|STARTED|Overall Study||28
2902843|NCT00433992|3611027|FG001|STARTED|Overall Study||28
2902844|NCT00433992|3611026|FG000|COMPLETED|Overall Study||19
2902845|NCT00433992|3611027|FG001|COMPLETED|Overall Study||20
2902846|NCT00433992|3611026|FG000|NOT COMPLETED|Overall Study||9
2902847|NCT00433992|3611027|FG001|NOT COMPLETED|Overall Study||8
2902848|NCT00434018|3611039|FG000|STARTED|Overall Study||69
2902849|NCT00434018|3611040|FG001|STARTED|Overall Study||69
2902850|NCT00434018|3611039|FG000|COMPLETED|Overall Study||52
2902851|NCT00434018|3611040|FG001|COMPLETED|Overall Study||57
2902852|NCT00434018|3611039|FG000|NOT COMPLETED|Overall Study||17
2902853|NCT00434018|3611040|FG001|NOT COMPLETED|Overall Study||12
2902854|NCT00434057|3611047|FG000|STARTED|Overall Study||1383
2902855|NCT00434057|3611047|FG000|COMPLETED|Overall Study|One patient withdrew from the study after signing the Informed Consent Form|1382
2902856|NCT00434057|3611047|FG000|NOT COMPLETED|Overall Study||1
2902857|NCT00434109|3611051|FG000|STARTED|Overall Study||39
2902858|NCT00434109|3611051|FG000|COMPLETED|Overall Study|Patients completing the maximum eight cycles of sunitinib.|21
2902859|NCT00434109|3611051|FG000|NOT COMPLETED|Overall Study||18
2902860|NCT00434122|3611057|FG000|STARTED|Overall Study|Randomised|42
2902861|NCT00434122|3611058|FG001|STARTED|Overall Study|Randomised|43
2902862|NCT00434122|3611057|FG000|Intention-to-treat (ITT) Population|Overall Study|All randomised and exposed subjects not withdrawn before Stimulation Day 1.|39
2902863|NCT00434122|3611058|FG001|Intention-to-treat (ITT) Population|Overall Study|All randomised and exposed subjects not withdrawn before Stimulation Day 1.|39
2902864|NCT00434122|3611057|FG000|COMPLETED|Overall Study||36
3316167|NCT03107377|4049453|FG000|COMPLETED|Overall Study||335
3316168|NCT03107377|4049454|FG001|COMPLETED|Overall Study||335
3316169|NCT03107377|4049453|FG000|NOT COMPLETED|Overall Study||91
3316170|NCT03107377|4049454|FG001|NOT COMPLETED|Overall Study||99
2902865|NCT00434122|3611058|FG001|COMPLETED|Overall Study||36
2902866|NCT00434122|3611057|FG000|NOT COMPLETED|Overall Study||6
2902867|NCT00434122|3611058|FG001|NOT COMPLETED|Overall Study||7
2902868|NCT00434148|3611068|FG000|STARTED|Overall Study|"Started indicates Full Analysis Set. Patients randomized and treated."|82
2902869|NCT00434148|3611069|FG001|STARTED|Overall Study||80
2902870|NCT00434148|3611068|FG000|Completed Month 12|Overall Study||39
2902871|NCT00434148|3611069|FG001|Completed Month 12|Overall Study||39
2902872|NCT00434148|3611068|FG000|Completed m. 12; Did Not Enter Extension|Overall Study||13
2902873|NCT00434148|3611069|FG001|Completed m. 12; Did Not Enter Extension|Overall Study||7
2902874|NCT00434148|3611068|FG000|Completed Month 12; Entered Extension|Overall Study||26
2902875|NCT00434148|3611069|FG001|Completed Month 12; Entered Extension|Overall Study||32
2902876|NCT00434148|3611068|FG000|COMPLETED|Overall Study||13
2902877|NCT00434148|3611069|FG001|COMPLETED|Overall Study||7
2902878|NCT00434148|3611068|FG000|NOT COMPLETED|Overall Study||69
2902879|NCT00434148|3611069|FG001|NOT COMPLETED|Overall Study||73
2902880|NCT00434161|3611078|FG000|STARTED|Overall Study||109
2902881|NCT00434161|3611079|FG001|STARTED|Overall Study||57
2902882|NCT00434161|3611080|FG002|STARTED|Overall Study||115
2902883|NCT00434161|3611078|FG000|COMPLETED|Overall Study||99
2902884|NCT00434161|3611079|FG001|COMPLETED|Overall Study||54
2902885|NCT00434161|3611080|FG002|COMPLETED|Overall Study||104
2902886|NCT00434161|3611078|FG000|NOT COMPLETED|Overall Study||10
2902887|NCT00434161|3611079|FG001|NOT COMPLETED|Overall Study||3
2902888|NCT00434161|3611080|FG002|NOT COMPLETED|Overall Study||11
2902889|NCT00434213|3611095|FG000|STARTED|Overall Study||309
2902890|NCT00434213|3611095|FG000|COMPLETED|Overall Study||260
2902891|NCT00434213|3611095|FG000|NOT COMPLETED|Overall Study||49
2902892|NCT00434252|3611101|FG000|STARTED|Overall Study||71
2902893|NCT00434252|3611102|FG001|STARTED|Overall Study||143
2902894|NCT00434252|3611101|FG000|Treated|Overall Study|One patient died and one patient withdrew prior to receiving study treatment|69
2902895|NCT00434252|3611102|FG001|Treated|Overall Study||143
2902896|NCT00434252|3611101|FG000|COMPLETED|Overall Study|Continuing study drug treatment at the time of the data cutoff.|7
2902897|NCT00434252|3611102|FG001|COMPLETED|Overall Study|Continuing study drug treatment at the time of the data cutoff.|12
2902898|NCT00434252|3611101|FG000|NOT COMPLETED|Overall Study||64
2902899|NCT00434252|3611102|FG001|NOT COMPLETED|Overall Study||131
2902900|NCT00434278|3611110|FG000|STARTED|Overall Study||14
2902901|NCT00434278|3611111|FG001|STARTED|Overall Study||13
2902902|NCT00434278|3611110|FG000|COMPLETED|Overall Study||12
2902903|NCT00434278|3611111|FG001|COMPLETED|Overall Study||13
2902904|NCT00434278|3611110|FG000|NOT COMPLETED|Overall Study||2
2902905|NCT00434278|3611111|FG001|NOT COMPLETED|Overall Study||0
2902906|NCT00434304|3611117|FG000|STARTED|Overall Study||62
2902907|NCT00434304|3611117|FG000|COMPLETED|Overall Study||42
2902908|NCT00434304|3611117|FG000|NOT COMPLETED|Overall Study||20
2902909|NCT00434330|3611128|FG000|STARTED|Overall Study||15
2902910|NCT00434330|3611129|FG001|STARTED|Overall Study||15
2902911|NCT00434330|3611130|FG002|STARTED|Overall Study||16
2902912|NCT00434330|3611131|FG003|STARTED|Overall Study||15
2902913|NCT00434330|3611132|FG004|STARTED|Overall Study||15
2902914|NCT00434330|3611133|FG005|STARTED|Overall Study||15
2902915|NCT00434330|3611128|FG000|COMPLETED|Overall Study||14
2902916|NCT00434330|3611129|FG001|COMPLETED|Overall Study||15
2902917|NCT00434330|3611130|FG002|COMPLETED|Overall Study||13
2902918|NCT00434330|3611131|FG003|COMPLETED|Overall Study||13
2902919|NCT00434330|3611132|FG004|COMPLETED|Overall Study||14
3316171|NCT03107611|4049463|FG000|STARTED|Overall Study||217
3316172|NCT03107611|4049464|FG001|STARTED|Overall Study||216
2902920|NCT00434330|3611133|FG005|COMPLETED|Overall Study||14
2902921|NCT00434330|3611128|FG000|NOT COMPLETED|Overall Study||1
2902922|NCT00434330|3611129|FG001|NOT COMPLETED|Overall Study||0
2902923|NCT00434330|3611130|FG002|NOT COMPLETED|Overall Study||3
2902924|NCT00434330|3611131|FG003|NOT COMPLETED|Overall Study||2
2902925|NCT00434330|3611132|FG004|NOT COMPLETED|Overall Study||1
2902926|NCT00434330|3611133|FG005|NOT COMPLETED|Overall Study||1
2902927|NCT00434356|3611149|FG000|STARTED|Overall Study||23
2902928|NCT00434356|3611150|FG001|STARTED|Overall Study||23
2902929|NCT00434356|3611149|FG000|COMPLETED|Overall Study||0
2902930|NCT00434356|3611150|FG001|COMPLETED|Overall Study||0
2902931|NCT00434356|3611149|FG000|NOT COMPLETED|Overall Study||23
2902932|NCT00434356|3611150|FG001|NOT COMPLETED|Overall Study||23
2902933|NCT00434421|3611156|FG000|STARTED|Overall Study||28
2902934|NCT00434421|3611156|FG000|COMPLETED|Overall Study||26
2902935|NCT00434421|3611156|FG000|NOT COMPLETED|Overall Study||2
2902936|NCT00434434|3611163|FG000|STARTED|Overall Study||23
2902937|NCT00434434|3611164|FG001|STARTED|Overall Study||24
2902938|NCT00434434|3611165|FG002|STARTED|Overall Study||14
2902939|NCT00434434|3611163|FG000|COMPLETED|Overall Study||21
2902940|NCT00434434|3611164|FG001|COMPLETED|Overall Study||24
2902941|NCT00434434|3611165|FG002|COMPLETED|Overall Study||13
2902942|NCT00434434|3611163|FG000|NOT COMPLETED|Overall Study||2
2902943|NCT00434434|3611164|FG001|NOT COMPLETED|Overall Study||0
2902944|NCT00434434|3611165|FG002|NOT COMPLETED|Overall Study||1
2902945|NCT00434512|3611179|FG000|STARTED|Overall Study||10
2902946|NCT00434512|3611180|FG001|STARTED|Overall Study||10
2902947|NCT00434512|3611181|FG002|STARTED|Overall Study||10
2902948|NCT00434512|3611182|FG003|STARTED|Overall Study||50
2902949|NCT00434512|3611183|FG004|STARTED|Overall Study||50
2902950|NCT00434512|3611184|FG005|STARTED|Overall Study||50
2902951|NCT00434512|3611179|FG000|COMPLETED|Overall Study||10
2902952|NCT00434512|3611180|FG001|COMPLETED|Overall Study||9
2902953|NCT00434512|3611181|FG002|COMPLETED|Overall Study||10
2902954|NCT00434512|3611182|FG003|COMPLETED|Overall Study||49
2902955|NCT00434512|3611183|FG004|COMPLETED|Overall Study||49
2902956|NCT00434512|3611184|FG005|COMPLETED|Overall Study||49
2902957|NCT00434512|3611179|FG000|NOT COMPLETED|Overall Study||0
2902958|NCT00434512|3611180|FG001|NOT COMPLETED|Overall Study||1
2902959|NCT00434512|3611181|FG002|NOT COMPLETED|Overall Study||0
2902960|NCT00434512|3611182|FG003|NOT COMPLETED|Overall Study||1
2902961|NCT00434512|3611183|FG004|NOT COMPLETED|Overall Study||1
2902962|NCT00434512|3611184|FG005|NOT COMPLETED|Overall Study||1
2902963|NCT00434577|3611207|FG000|STARTED|Months 0-3||164
2902964|NCT00434577|3611208|FG001|STARTED|Months 0-3||166
2902965|NCT00434577|3611209|FG002|STARTED|Months 0-3||165
2902966|NCT00434577|3611210|FG003|STARTED|Months 0-3||165
2902967|NCT00434577|3611211|FG004|STARTED|Months 0-3||54
2902968|NCT00434577|3611207|FG000|COMPLETED|Months 0-3||161
2902969|NCT00434577|3611208|FG001|COMPLETED|Months 0-3||164
2902970|NCT00434577|3611209|FG002|COMPLETED|Months 0-3||161
2902971|NCT00434577|3611210|FG003|COMPLETED|Months 0-3||164
2902972|NCT00434577|3611211|FG004|COMPLETED|Months 0-3||51
2902973|NCT00434577|3611207|FG000|NOT COMPLETED|Months 0-3||3
2902974|NCT00434577|3611208|FG001|NOT COMPLETED|Months 0-3||2
2902975|NCT00434577|3611209|FG002|NOT COMPLETED|Months 0-3||4
2902976|NCT00434577|3611210|FG003|NOT COMPLETED|Months 0-3||1
2902977|NCT00434577|3611211|FG004|NOT COMPLETED|Months 0-3||3
2902978|NCT00434577|3611207|FG000|STARTED|Month 12||156
2902979|NCT00434577|3611208|FG001|STARTED|Month 12||159
2902980|NCT00434577|3611209|FG002|STARTED|Month 12||159
2902981|NCT00434577|3611210|FG003|STARTED|Month 12||161
2902982|NCT00434577|3611211|FG004|STARTED|Month 12||50
2902983|NCT00434577|3611207|FG000|COMPLETED|Month 12||156
2902984|NCT00434577|3611208|FG001|COMPLETED|Month 12||159
2902985|NCT00434577|3611209|FG002|COMPLETED|Month 12||159
2902986|NCT00434577|3611210|FG003|COMPLETED|Month 12||161
2902987|NCT00434577|3611211|FG004|COMPLETED|Month 12||50
2902988|NCT00434577|3611207|FG000|NOT COMPLETED|Month 12||0
2902989|NCT00434577|3611208|FG001|NOT COMPLETED|Month 12||0
2902990|NCT00434577|3611209|FG002|NOT COMPLETED|Month 12||0
2902991|NCT00434577|3611210|FG003|NOT COMPLETED|Month 12||0
2902992|NCT00434577|3611211|FG004|NOT COMPLETED|Month 12||0
2902993|NCT00434577|3611207|FG000|STARTED|Month 24||150
2902994|NCT00434577|3611208|FG001|STARTED|Month 24||155
2902995|NCT00434577|3611209|FG002|STARTED|Month 24||154
2902996|NCT00434577|3611210|FG003|STARTED|Month 24||157
2902997|NCT00434577|3611211|FG004|STARTED|Month 24||49
2902998|NCT00434577|3611207|FG000|COMPLETED|Month 24||150
2902999|NCT00434577|3611208|FG001|COMPLETED|Month 24||155
2903000|NCT00434577|3611209|FG002|COMPLETED|Month 24||154
2903001|NCT00434577|3611210|FG003|COMPLETED|Month 24||157
2903002|NCT00434577|3611211|FG004|COMPLETED|Month 24||49
2903003|NCT00434577|3611207|FG000|NOT COMPLETED|Month 24||0
2903004|NCT00434577|3611208|FG001|NOT COMPLETED|Month 24||0
2903005|NCT00434577|3611209|FG002|NOT COMPLETED|Month 24||0
2903006|NCT00434577|3611210|FG003|NOT COMPLETED|Month 24||0
2903007|NCT00434577|3611211|FG004|NOT COMPLETED|Month 24||0
2903008|NCT00434577|3611207|FG000|STARTED|Month 36||147
2903009|NCT00434577|3611208|FG001|STARTED|Month 36||147
2903010|NCT00434577|3611209|FG002|STARTED|Month 36||150
2903011|NCT00434577|3611210|FG003|STARTED|Month 36||155
2903012|NCT00434577|3611211|FG004|STARTED|Month 36||47
2903013|NCT00434577|3611207|FG000|COMPLETED|Month 36||147
2903014|NCT00434577|3611208|FG001|COMPLETED|Month 36||147
2903015|NCT00434577|3611209|FG002|COMPLETED|Month 36||150
2903016|NCT00434577|3611210|FG003|COMPLETED|Month 36||155
2903017|NCT00434577|3611211|FG004|COMPLETED|Month 36||47
2903018|NCT00434577|3611207|FG000|NOT COMPLETED|Month 36||0
2903019|NCT00434577|3611208|FG001|NOT COMPLETED|Month 36||0
2903020|NCT00434577|3611209|FG002|NOT COMPLETED|Month 36||0
2903021|NCT00434577|3611210|FG003|NOT COMPLETED|Month 36||0
2903022|NCT00434577|3611211|FG004|NOT COMPLETED|Month 36||0
2903023|NCT00434642|3611225|FG000|STARTED|Blinded Treatment Phase||242
2903024|NCT00434642|3611226|FG001|STARTED|Blinded Treatment Phase||242
2903025|NCT00434642|3611225|FG000|COMPLETED|Blinded Treatment Phase||0
2903026|NCT00434642|3611226|FG001|COMPLETED|Blinded Treatment Phase||13
2903027|NCT00434642|3611225|FG000|NOT COMPLETED|Blinded Treatment Phase||242
2903028|NCT00434642|3611226|FG001|NOT COMPLETED|Blinded Treatment Phase||229
2903029|NCT00434642|3611225|FG000|STARTED|Open-label Treatment Phase||0
2903030|NCT00434642|3611226|FG001|STARTED|Open-label Treatment Phase|One participant did not continue into the open-label treatment phase.|12
2903031|NCT00434642|3611225|FG000|COMPLETED|Open-label Treatment Phase||0
2903032|NCT00434642|3611226|FG001|COMPLETED|Open-label Treatment Phase||1
2903033|NCT00434642|3611225|FG000|NOT COMPLETED|Open-label Treatment Phase||0
2903034|NCT00434642|3611226|FG001|NOT COMPLETED|Open-label Treatment Phase||11
2903035|NCT00434759|3611234|FG000|STARTED|Overall Study||46
2903036|NCT00434759|3611235|FG001|STARTED|Overall Study||43
2903037|NCT00434759|3611234|FG000|COMPLETED|Overall Study||22
2903038|NCT00434759|3611235|FG001|COMPLETED|Overall Study||38
2903039|NCT00434759|3611234|FG000|NOT COMPLETED|Overall Study||24
2903040|NCT00434759|3611235|FG001|NOT COMPLETED|Overall Study||5
2903041|NCT00434876|3611245|FG000|STARTED|Overall Study||11
2903042|NCT00434876|3611246|FG001|STARTED|Overall Study||11
2903043|NCT00434876|3611245|FG000|COMPLETED|Overall Study||10
2903044|NCT00434876|3611246|FG001|COMPLETED|Overall Study||10
2903045|NCT00434876|3611245|FG000|NOT COMPLETED|Overall Study||1
2903046|NCT00434876|3611246|FG001|NOT COMPLETED|Overall Study||1
2903047|NCT00434954|3611254|FG000|STARTED|Overall Study||248
2903048|NCT00434954|3611255|FG001|STARTED|Overall Study||246
2903049|NCT00434954|3611254|FG000|Started - Previous Treatment MET Only|Overall Study||182
2903050|NCT00434954|3611255|FG001|Started - Previous Treatment MET Only|Overall Study||181
2903051|NCT00434954|3611254|FG000|Started - Previous Treatment MET + SU|Overall Study||66
2903052|NCT00434954|3611255|FG001|Started - Previous Treatment MET + SU|Overall Study||65
2903053|NCT00434954|3611254|FG000|Full Analysis Set (FAS) Overall|Overall Study|FAS=received >=1 dose of study drug. Adverse event data reported for Overall FAS.|247
2903054|NCT00434954|3611255|FG001|Full Analysis Set (FAS) Overall|Overall Study|FAS=received >=1 dose of study drug. Adverse event data reported for Overall FAS.|233
2903055|NCT00434954|3611254|FG000|FAS - Previous Treatment MET Only|Overall Study|"Baseline and efficacy data reported for FAS-Previous Treatment MET Only group."|181
2903056|NCT00434954|3611255|FG001|FAS - Previous Treatment MET Only|Overall Study|"Baseline and efficacy data reported for FAS-Previous Treatment MET Only group."|173
2903057|NCT00434954|3611254|FG000|FAS - Previous Treatment MET + SU|Overall Study||66
2903058|NCT00434954|3611255|FG001|FAS - Previous Treatment MET + SU|Overall Study||60
2903059|NCT00434954|3611254|FG000|Completed - Previous Treatment MET Only|Overall Study||135
2903060|NCT00434954|3611255|FG001|Completed - Previous Treatment MET Only|Overall Study||137
2903061|NCT00434954|3611254|FG000|Completed - Previous Treatment MET + SU|Overall Study||31
2903062|NCT00434954|3611255|FG001|Completed - Previous Treatment MET + SU|Overall Study||38
2903063|NCT00434954|3611254|FG000|COMPLETED|Overall Study||166
2903064|NCT00434954|3611255|FG001|COMPLETED|Overall Study||175
2903065|NCT00434954|3611254|FG000|NOT COMPLETED|Overall Study||82
2903066|NCT00434954|3611255|FG001|NOT COMPLETED|Overall Study||71
2903067|NCT00434967|3611265|FG000|STARTED|Overall Study||97
2903068|NCT00434967|3611266|FG001|STARTED|Overall Study||465
2903069|NCT00434967|3611267|FG002|STARTED|Overall Study||470
2903070|NCT00434967|3611268|FG003|STARTED|Overall Study||492
2903071|NCT00434967|3611265|FG000|COMPLETED|Overall Study||90
2903072|NCT00434967|3611266|FG001|COMPLETED|Overall Study||457
2903073|NCT00434967|3611267|FG002|COMPLETED|Overall Study||461
2903074|NCT00434967|3611268|FG003|COMPLETED|Overall Study||478
2903075|NCT00434967|3611265|FG000|NOT COMPLETED|Overall Study||7
2903076|NCT00434967|3611266|FG001|NOT COMPLETED|Overall Study||8
2903077|NCT00434967|3611267|FG002|NOT COMPLETED|Overall Study||9
2903078|NCT00434967|3611268|FG003|NOT COMPLETED|Overall Study||14
2903079|NCT00434993|3611280|FG000|STARTED|Overall Study||152
2903080|NCT00434993|3611281|FG001|STARTED|Overall Study||130
2903081|NCT00434993|3611280|FG000|COMPLETED|Overall Study||152
2903082|NCT00434993|3611281|FG001|COMPLETED|Overall Study||130
2903083|NCT00434993|3611280|FG000|NOT COMPLETED|Overall Study||0
2903084|NCT00434993|3611281|FG001|NOT COMPLETED|Overall Study||0
2903085|NCT00435019|3611289|FG000|STARTED|Overall Study|Randomised|177
2903086|NCT00435019|3611290|FG001|STARTED|Overall Study|Randomised|171
2903087|NCT00435019|3611289|FG000|Exposed to Study Drug|Overall Study||177
2903088|NCT00435019|3611290|FG001|Exposed to Study Drug|Overall Study|One subject withdrew before receiving study drug, and thus not included in the full analysis set.|170
2903089|NCT00435019|3611289|FG000|COMPLETED|Overall Study||164
2903090|NCT00435019|3611290|FG001|COMPLETED|Overall Study||161
2903091|NCT00435019|3611289|FG000|NOT COMPLETED|Overall Study||13
2903092|NCT00435019|3611290|FG001|NOT COMPLETED|Overall Study||10
2920354|NCT00536471|3630846|FG001|STARTED|Overall Study||127
3171799|NCT01937260|3898998|FG000|NOT COMPLETED|Overall Study||1
2920355|NCT00536471|3630847|FG002|STARTED|Overall Study||261
2920356|NCT00536471|3630848|FG003|STARTED|Overall Study||131
2920357|NCT00536471|3630845|FG000|COMPLETED|Overall Study||101
2903093|NCT00435045|3611298|FG000|STARTED|Weeks 1-8 / 10 mg Dose Level||123
2903094|NCT00435045|3611299|FG001|STARTED|Weeks 1-8 / 10 mg Dose Level||122
2903095|NCT00435045|3611298|FG000|COMPLETED|Weeks 1-8 / 10 mg Dose Level||118
2903096|NCT00435045|3611299|FG001|COMPLETED|Weeks 1-8 / 10 mg Dose Level||118
2903097|NCT00435045|3611298|FG000|NOT COMPLETED|Weeks 1-8 / 10 mg Dose Level||5
2903098|NCT00435045|3611299|FG001|NOT COMPLETED|Weeks 1-8 / 10 mg Dose Level||4
2903099|NCT00435045|3611298|FG000|STARTED|Weeks 9-12 / 20mg Dose Level||118
2903100|NCT00435045|3611299|FG001|STARTED|Weeks 9-12 / 20mg Dose Level||118
2903101|NCT00435045|3611298|FG000|COMPLETED|Weeks 9-12 / 20mg Dose Level||113
2903102|NCT00435045|3611299|FG001|COMPLETED|Weeks 9-12 / 20mg Dose Level||113
2903103|NCT00435045|3611298|FG000|NOT COMPLETED|Weeks 9-12 / 20mg Dose Level||5
2903104|NCT00435045|3611299|FG001|NOT COMPLETED|Weeks 9-12 / 20mg Dose Level||5
2903105|NCT00435045|3611298|FG000|STARTED|Weeks 13-16 / 40mg Dose Level||113
2903106|NCT00435045|3611299|FG001|STARTED|Weeks 13-16 / 40mg Dose Level||113
2903107|NCT00435045|3611298|FG000|COMPLETED|Weeks 13-16 / 40mg Dose Level||108
2903108|NCT00435045|3611299|FG001|COMPLETED|Weeks 13-16 / 40mg Dose Level||111
2903109|NCT00435045|3611298|FG000|NOT COMPLETED|Weeks 13-16 / 40mg Dose Level||5
2903110|NCT00435045|3611299|FG001|NOT COMPLETED|Weeks 13-16 / 40mg Dose Level||2
2903111|NCT00435162|3611308|FG000|STARTED|Period 1 (6 Weeks)||15
2903112|NCT00435162|3611309|FG001|STARTED|Period 1 (6 Weeks)||15
2903113|NCT00435162|3611310|FG002|STARTED|Period 1 (6 Weeks)||6
2903114|NCT00435162|3611311|FG003|STARTED|Period 1 (6 Weeks)||8
2903115|NCT00435162|3611312|FG004|STARTED|Period 1 (6 Weeks)||15
2903116|NCT00435162|3611313|FG005|STARTED|Period 1 (6 Weeks)||15
2903117|NCT00435162|3611308|FG000|COMPLETED|Period 1 (6 Weeks)||15
2903118|NCT00435162|3611309|FG001|COMPLETED|Period 1 (6 Weeks)||15
2903119|NCT00435162|3611310|FG002|COMPLETED|Period 1 (6 Weeks)||6
2903120|NCT00435162|3611311|FG003|COMPLETED|Period 1 (6 Weeks)||8
2903121|NCT00435162|3611312|FG004|COMPLETED|Period 1 (6 Weeks)||15
2903122|NCT00435162|3611313|FG005|COMPLETED|Period 1 (6 Weeks)||15
2903123|NCT00435162|3611308|FG000|NOT COMPLETED|Period 1 (6 Weeks)||0
2903124|NCT00435162|3611309|FG001|NOT COMPLETED|Period 1 (6 Weeks)||0
2903125|NCT00435162|3611310|FG002|NOT COMPLETED|Period 1 (6 Weeks)||0
2903126|NCT00435162|3611311|FG003|NOT COMPLETED|Period 1 (6 Weeks)||0
2903127|NCT00435162|3611312|FG004|NOT COMPLETED|Period 1 (6 Weeks)||0
2903128|NCT00435162|3611313|FG005|NOT COMPLETED|Period 1 (6 Weeks)||0
2903129|NCT00435162|3611308|FG000|STARTED|Period 2 (2 Weeks)||15
2903130|NCT00435162|3611309|FG001|STARTED|Period 2 (2 Weeks)||15
2903131|NCT00435162|3611310|FG002|STARTED|Period 2 (2 Weeks)||6
2903132|NCT00435162|3611311|FG003|STARTED|Period 2 (2 Weeks)||8
2903133|NCT00435162|3611312|FG004|STARTED|Period 2 (2 Weeks)||15
2903134|NCT00435162|3611313|FG005|STARTED|Period 2 (2 Weeks)||15
2903135|NCT00435162|3611308|FG000|COMPLETED|Period 2 (2 Weeks)||15
2903136|NCT00435162|3611309|FG001|COMPLETED|Period 2 (2 Weeks)||14
2903137|NCT00435162|3611310|FG002|COMPLETED|Period 2 (2 Weeks)||6
2903138|NCT00435162|3611311|FG003|COMPLETED|Period 2 (2 Weeks)||8
2903139|NCT00435162|3611312|FG004|COMPLETED|Period 2 (2 Weeks)||15
2903140|NCT00435162|3611313|FG005|COMPLETED|Period 2 (2 Weeks)||15
2903141|NCT00435162|3611308|FG000|NOT COMPLETED|Period 2 (2 Weeks)||0
2903142|NCT00435162|3611309|FG001|NOT COMPLETED|Period 2 (2 Weeks)||1
2903143|NCT00435162|3611310|FG002|NOT COMPLETED|Period 2 (2 Weeks)||0
2903144|NCT00435162|3611311|FG003|NOT COMPLETED|Period 2 (2 Weeks)||0
2903145|NCT00435162|3611312|FG004|NOT COMPLETED|Period 2 (2 Weeks)||0
2903146|NCT00435162|3611313|FG005|NOT COMPLETED|Period 2 (2 Weeks)||0
2903147|NCT00435188|3611328|FG000|STARTED|Overall Study||199
2903148|NCT00435188|3611329|FG001|STARTED|Overall Study||199
3171306|NCT01933672|3898500|FG005|COMPLETED|Second Intervention Period (12-16 Days)||4
3171307|NCT01933672|3898501|FG006|COMPLETED|Second Intervention Period (12-16 Days)||6
3171308|NCT01933672|3898495|FG000|NOT COMPLETED|Second Intervention Period (12-16 Days)||0
3171309|NCT01933672|3898496|FG001|NOT COMPLETED|Second Intervention Period (12-16 Days)||1
3171310|NCT01933672|3898497|FG002|NOT COMPLETED|Second Intervention Period (12-16 Days)||1
3171311|NCT01933672|3898498|FG003|NOT COMPLETED|Second Intervention Period (12-16 Days)||0
3171800|NCT01937260|3898999|FG001|NOT COMPLETED|Overall Study||0
2903149|NCT00435188|3611328|FG000|COMPLETED|Overall Study||177
2903150|NCT00435188|3611329|FG001|COMPLETED|Overall Study||176
2903151|NCT00435188|3611328|FG000|NOT COMPLETED|Overall Study||22
2903152|NCT00435188|3611329|FG001|NOT COMPLETED|Overall Study||23
2903153|NCT00435370|3611339|FG000|STARTED|Overall Study||90
2903154|NCT00435370|3611340|FG001|STARTED|Overall Study|The recruitment restarted in August, 2010.|89
2903155|NCT00435370|3611339|FG000|COMPLETED|Overall Study||68
2903156|NCT00435370|3611340|FG001|COMPLETED|Overall Study|The entire recruitment has been completed in December, 2011.|69
2903157|NCT00435370|3611339|FG000|NOT COMPLETED|Overall Study||22
2903158|NCT00435370|3611340|FG001|NOT COMPLETED|Overall Study||20
2903159|NCT00435409|3611348|FG000|STARTED|Overall Study||221
2903160|NCT00435409|3611349|FG001|STARTED|Overall Study||143
2903161|NCT00435409|3611350|FG002|STARTED|Overall Study||78
2903162|NCT00435409|3611348|FG000|Treated|Overall Study||217
2903163|NCT00435409|3611349|FG001|Treated|Overall Study||139
2903164|NCT00435409|3611350|FG002|Treated|Overall Study||78
2903165|NCT00435409|3611348|FG000|COMPLETED|Overall Study||0
2903166|NCT00435409|3611349|FG001|COMPLETED|Overall Study||0
2903167|NCT00435409|3611350|FG002|COMPLETED|Overall Study||0
2903168|NCT00435409|3611348|FG000|NOT COMPLETED|Overall Study||221
2903169|NCT00435409|3611349|FG001|NOT COMPLETED|Overall Study||143
2903170|NCT00435409|3611350|FG002|NOT COMPLETED|Overall Study||78
2903171|NCT00435461|3611359|FG000|STARTED|Overall Study||313
2903172|NCT00435461|3611360|FG001|STARTED|Overall Study||312
2903173|NCT00435461|3611361|FG002|STARTED|Overall Study||311
2903174|NCT00435461|3611359|FG000|COMPLETED|Overall Study||290
2903175|NCT00435461|3611360|FG001|COMPLETED|Overall Study||298
2903176|NCT00435461|3611361|FG002|COMPLETED|Overall Study||287
2903177|NCT00435461|3611359|FG000|NOT COMPLETED|Overall Study||23
2903178|NCT00435461|3611360|FG001|NOT COMPLETED|Overall Study||14
2903179|NCT00435461|3611361|FG002|NOT COMPLETED|Overall Study||24
3171312|NCT01933672|3898499|FG004|NOT COMPLETED|Second Intervention Period (12-16 Days)||0
3171313|NCT01933672|3898500|FG005|NOT COMPLETED|Second Intervention Period (12-16 Days)||0
3171314|NCT01933672|3898501|FG006|NOT COMPLETED|Second Intervention Period (12-16 Days)||0
2903180|NCT00435487|3611371|FG000|STARTED|Overall Study|87 subjects were randomized however one additional subject originally randomized to UFH was treated.|88
2903181|NCT00435487|3611372|FG001|STARTED|Overall Study||86
2903182|NCT00435487|3611371|FG000|TREATED|Overall Study|One additional subject originally randomized to Unfractioned Heparin was treated with Dalteparin.|88
2903183|NCT00435487|3611372|FG001|TREATED|Overall Study|One subject was mistakenly treated with Dalteparin, two subjects withdrew consent before treatment.|83
2903184|NCT00435487|3611371|FG000|COMPLETED|Overall Study||76
2903185|NCT00435487|3611372|FG001|COMPLETED|Overall Study||71
2903186|NCT00435487|3611371|FG000|NOT COMPLETED|Overall Study||12
2903187|NCT00435487|3611372|FG001|NOT COMPLETED|Overall Study||15
2903188|NCT00435539|3611383|FG000|STARTED|Overall Study||12
3171315|NCT01933672|3898495|FG000|STARTED|Second Washout Period (7-14 Days)||0
3171316|NCT01933672|3898496|FG001|STARTED|Second Washout Period (7-14 Days)||6
3171317|NCT01933672|3898497|FG002|STARTED|Second Washout Period (7-14 Days)||1
3171318|NCT01933672|3898498|FG003|STARTED|Second Washout Period (7-14 Days)||5
3171319|NCT01933672|3898499|FG004|STARTED|Second Washout Period (7-14 Days)||6
3171320|NCT01933672|3898500|FG005|STARTED|Second Washout Period (7-14 Days)||4
2903189|NCT00435539|3611384|FG001|STARTED|Overall Study||13
2903190|NCT00435539|3611385|FG002|STARTED|Overall Study||11
2903191|NCT00435539|3611386|FG003|STARTED|Overall Study||12
2903192|NCT00435539|3611387|FG004|STARTED|Overall Study||12
2903193|NCT00435539|3611383|FG000|COMPLETED|Overall Study||12
2903194|NCT00435539|3611384|FG001|COMPLETED|Overall Study||13
2903195|NCT00435539|3611385|FG002|COMPLETED|Overall Study||11
2903196|NCT00435539|3611386|FG003|COMPLETED|Overall Study||12
2903197|NCT00435539|3611387|FG004|COMPLETED|Overall Study||12
2903198|NCT00435539|3611383|FG000|NOT COMPLETED|Overall Study||0
2903199|NCT00435539|3611384|FG001|NOT COMPLETED|Overall Study||0
2903200|NCT00435539|3611385|FG002|NOT COMPLETED|Overall Study||0
2903201|NCT00435539|3611386|FG003|NOT COMPLETED|Overall Study||0
2903202|NCT00435539|3611387|FG004|NOT COMPLETED|Overall Study||0
2903203|NCT00435591|3611402|FG000|STARTED|Overall Study||30
2903204|NCT00435591|3611403|FG001|STARTED|Overall Study||31
2903205|NCT00435591|3611404|FG002|STARTED|Overall Study||30
2903206|NCT00435591|3611405|FG003|STARTED|Overall Study||30
2903207|NCT00435591|3611402|FG000|Safety Analysis Set|Overall Study||28
2903208|NCT00435591|3611403|FG001|Safety Analysis Set|Overall Study||30
2903209|NCT00435591|3611404|FG002|Safety Analysis Set|Overall Study||30
2903210|NCT00435591|3611405|FG003|Safety Analysis Set|Overall Study||29
2903211|NCT00435591|3611402|FG000|Full Analysis Set|Overall Study||28
2903212|NCT00435591|3611403|FG001|Full Analysis Set|Overall Study||29
2903213|NCT00435591|3611404|FG002|Full Analysis Set|Overall Study||30
2903214|NCT00435591|3611405|FG003|Full Analysis Set|Overall Study||29
2903215|NCT00435591|3611402|FG000|End of Treatment|Overall Study||25
2903216|NCT00435591|3611403|FG001|End of Treatment|Overall Study||27
2903217|NCT00435591|3611404|FG002|End of Treatment|Overall Study||27
2903218|NCT00435591|3611405|FG003|End of Treatment|Overall Study||23
2903219|NCT00435591|3611402|FG000|COMPLETED|Overall Study||23
2903220|NCT00435591|3611403|FG001|COMPLETED|Overall Study||27
2903221|NCT00435591|3611404|FG002|COMPLETED|Overall Study||25
2903222|NCT00435591|3611405|FG003|COMPLETED|Overall Study||19
2903223|NCT00435591|3611402|FG000|NOT COMPLETED|Overall Study||7
2903224|NCT00435591|3611403|FG001|NOT COMPLETED|Overall Study||4
2903225|NCT00435591|3611404|FG002|NOT COMPLETED|Overall Study||5
2903226|NCT00435591|3611405|FG003|NOT COMPLETED|Overall Study||11
2903227|NCT00435812|3611420|FG000|STARTED|Overall Study||1820
2903228|NCT00435812|3611421|FG001|STARTED|Overall Study||608
2903229|NCT00435812|3611420|FG000|COMPLETED|Overall Study||1757
2903230|NCT00435812|3611421|FG001|COMPLETED|Overall Study||590
2903231|NCT00435812|3611420|FG000|NOT COMPLETED|Overall Study||63
2903232|NCT00435812|3611421|FG001|NOT COMPLETED|Overall Study||18
2903233|NCT00435825|3611431|FG000|STARTED|Overall Study||141
2903234|NCT00435825|3611432|FG001|STARTED|Overall Study||136
2903235|NCT00435825|3611433|FG002|STARTED|Overall Study||138
2903236|NCT00435825|3611434|FG003|STARTED|Overall Study||136
2903237|NCT00435825|3611431|FG000|Received Study Drug|Overall Study||140
2903238|NCT00435825|3611432|FG001|Received Study Drug|Overall Study||136
2903239|NCT00435825|3611433|FG002|Received Study Drug|Overall Study||136
2903240|NCT00435825|3611434|FG003|Received Study Drug|Overall Study||136
2903241|NCT00435825|3611431|FG000|Entered Follow-up|Overall Study||140
2903242|NCT00435825|3611432|FG001|Entered Follow-up|Overall Study||132
2903243|NCT00435825|3611433|FG002|Entered Follow-up|Overall Study||135
2903244|NCT00435825|3611434|FG003|Entered Follow-up|Overall Study||133
2903245|NCT00435825|3611431|FG000|Completed 24 Weeks Treatment|Overall Study||128
2903246|NCT00435825|3611432|FG001|Completed 24 Weeks Treatment|Overall Study||126
2920358|NCT00536471|3630846|FG001|COMPLETED|Overall Study||43
2903247|NCT00435825|3611433|FG002|Completed 24 Weeks Treatment|Overall Study||134
2903248|NCT00435825|3611434|FG003|Completed 24 Weeks Treatment|Overall Study||131
2903249|NCT00435825|3611431|FG000|Completed 48 Weeks Treatment|Overall Study||0
2903250|NCT00435825|3611432|FG001|Completed 48 Weeks Treatment|Overall Study||0
2903251|NCT00435825|3611433|FG002|Completed 48 Weeks Treatment|Overall Study||124
2903252|NCT00435825|3611434|FG003|Completed 48 Weeks Treatment|Overall Study||117
2903253|NCT00435825|3611431|FG000|COMPLETED|Overall Study|Completed is the number of participants who received study treatment and completed follow-up.|123
2903254|NCT00435825|3611432|FG001|COMPLETED|Overall Study||124
2903255|NCT00435825|3611433|FG002|COMPLETED|Overall Study||127
2903256|NCT00435825|3611434|FG003|COMPLETED|Overall Study||120
2903257|NCT00435825|3611431|FG000|NOT COMPLETED|Overall Study||18
2903258|NCT00435825|3611432|FG001|NOT COMPLETED|Overall Study||12
2903259|NCT00435825|3611433|FG002|NOT COMPLETED|Overall Study||11
2903260|NCT00435825|3611434|FG003|NOT COMPLETED|Overall Study||16
2903261|NCT00435929|3611446|FG000|STARTED|Overall Study||7
2903262|NCT00435929|3611447|FG001|STARTED|Overall Study||9
2903263|NCT00435929|3611446|FG000|COMPLETED|Overall Study||7
2903264|NCT00435929|3611447|FG001|COMPLETED|Overall Study||9
2903265|NCT00435929|3611446|FG000|NOT COMPLETED|Overall Study||0
2903266|NCT00435929|3611447|FG001|NOT COMPLETED|Overall Study||0
2903267|NCT00435942|3611455|FG000|STARTED|Overall Study||120
3133770|NCT01697579|3858713|FG001|STARTED|Optional Extension-Cycles 2-6|33 participants from this arm in Cycle 1 entered optional Cycles 2-6 at 3 mg/kg|0
3133771|NCT01697579|3858714|FG002|STARTED|Optional Extension-Cycles 2-6|25 participants from this arm in Cycle 1 entered optional Cycles 2-6 at 3 mg/kg|0
3136750|NCT01714804|3862004|FG001|COMPLETED|Overall Study||30
2903268|NCT00435942|3611456|FG001|STARTED|Overall Study||60
2903269|NCT00435942|3611455|FG000|COMPLETED|Overall Study||97
2903270|NCT00435942|3611456|FG001|COMPLETED|Overall Study||33
2903271|NCT00435942|3611455|FG000|NOT COMPLETED|Overall Study||23
2903272|NCT00435942|3611456|FG001|NOT COMPLETED|Overall Study||27
2903273|NCT00435994|3611465|FG000|STARTED|Overall Study||22
2903274|NCT00435994|3611466|FG001|STARTED|Overall Study||25
2903275|NCT00435994|3611467|FG002|STARTED|Overall Study||12
2903276|NCT00435994|3611465|FG000|COMPLETED|Overall Study|7 of the subjects were consented and did not complete the study procedures.|15
2903277|NCT00435994|3611466|FG001|COMPLETED|Overall Study||25
2903278|NCT00435994|3611467|FG002|COMPLETED|Overall Study||12
2903279|NCT00435994|3611465|FG000|NOT COMPLETED|Overall Study||7
2903280|NCT00435994|3611466|FG001|NOT COMPLETED|Overall Study||0
2903281|NCT00435994|3611467|FG002|NOT COMPLETED|Overall Study||0
2903282|NCT00436007|3611479|FG000|STARTED|Overall Study||170
2903283|NCT00436007|3611480|FG001|STARTED|Overall Study||170
2903284|NCT00436007|3611481|FG002|STARTED|Overall Study||171
2903285|NCT00436007|3611479|FG000|COMPLETED|Overall Study||151
2903286|NCT00436007|3611480|FG001|COMPLETED|Overall Study||156
2903287|NCT00436007|3611481|FG002|COMPLETED|Overall Study||148
2903288|NCT00436007|3611479|FG000|NOT COMPLETED|Overall Study||19
2903289|NCT00436007|3611480|FG001|NOT COMPLETED|Overall Study||14
2903290|NCT00436007|3611481|FG002|NOT COMPLETED|Overall Study||23
2903291|NCT00436046|3611497|FG000|STARTED|Overall Study||32
2903292|NCT00436046|3611498|FG001|STARTED|Overall Study||32
2903293|NCT00436046|3611499|FG002|STARTED|Overall Study||31
2903294|NCT00436046|3611497|FG000|COMPLETED|Overall Study||32
2903295|NCT00436046|3611498|FG001|COMPLETED|Overall Study||32
2903296|NCT00436046|3611499|FG002|COMPLETED|Overall Study||31
2903297|NCT00436046|3611497|FG000|NOT COMPLETED|Overall Study||0
2903298|NCT00436046|3611498|FG001|NOT COMPLETED|Overall Study||0
2903299|NCT00436046|3611499|FG002|NOT COMPLETED|Overall Study||0
2903300|NCT00436163|3611507|FG000|STARTED|Overall Study||39
2903301|NCT00436163|3611507|FG000|COMPLETED|Overall Study||36
2903302|NCT00436163|3611507|FG000|NOT COMPLETED|Overall Study||3
2903303|NCT00436215|3611512|FG000|STARTED|Overall Study||55
2903304|NCT00436215|3611512|FG000|COMPLETED|Overall Study||51
2903305|NCT00436215|3611512|FG000|NOT COMPLETED|Overall Study||4
2903306|NCT00436280|3611516|FG000|STARTED|Period 1: Induction||68
2903307|NCT00436280|3611516|FG000|Received at Least 1 Dose of Study Drug|Period 1: Induction||68
2903308|NCT00436280|3611516|FG000|COMPLETED|Period 1: Induction||40
2903309|NCT00436280|3611516|FG000|NOT COMPLETED|Period 1: Induction||28
2903310|NCT00436280|3611516|FG000|STARTED|Period 2: Consolidation||40
2903311|NCT00436280|3611516|FG000|COMPLETED|Period 2: Consolidation||23
2903312|NCT00436280|3611516|FG000|NOT COMPLETED|Period 2: Consolidation||17
2903313|NCT00436280|3611516|FG000|STARTED|Period 3: Maintenance||23
2903314|NCT00436280|3611516|FG000|COMPLETED|Period 3: Maintenance||5
2903315|NCT00436280|3611516|FG000|NOT COMPLETED|Period 3: Maintenance||18
2903316|NCT00436332|3611520|FG000|STARTED|Overall Study||84
2903317|NCT00436332|3611520|FG000|Eligible|Overall Study||82
2903318|NCT00436332|3611520|FG000|Eligible and Began Protocol Therapy|Overall Study||79
2903319|NCT00436332|3611520|FG000|COMPLETED|Overall Study||1
2903320|NCT00436332|3611520|FG000|NOT COMPLETED|Overall Study||83
2903321|NCT00436345|3611526|FG000|STARTED|Overall Study||21
2903322|NCT00436345|3611527|FG001|STARTED|Overall Study||18
2903323|NCT00436345|3611526|FG000|COMPLETED|Overall Study||18
2903324|NCT00436345|3611527|FG001|COMPLETED|Overall Study||18
2903325|NCT00436345|3611526|FG000|NOT COMPLETED|Overall Study||3
2903326|NCT00436345|3611527|FG001|NOT COMPLETED|Overall Study||0
2903327|NCT00436436|3611534|FG000|STARTED|Overall Study||12
2903328|NCT00436436|3611534|FG000|COMPLETED|Overall Study||0
2903329|NCT00436436|3611534|FG000|NOT COMPLETED|Overall Study||12
3171321|NCT01933672|3898501|FG006|STARTED|Second Washout Period (7-14 Days)||6
3171322|NCT01933672|3898495|FG000|COMPLETED|Second Washout Period (7-14 Days)||0
3171323|NCT01933672|3898496|FG001|COMPLETED|Second Washout Period (7-14 Days)||6
3171324|NCT01933672|3898497|FG002|COMPLETED|Second Washout Period (7-14 Days)||1
3171325|NCT01933672|3898498|FG003|COMPLETED|Second Washout Period (7-14 Days)||5
3171326|NCT01933672|3898499|FG004|COMPLETED|Second Washout Period (7-14 Days)||6
3171327|NCT01933672|3898500|FG005|COMPLETED|Second Washout Period (7-14 Days)||4
3171328|NCT01933672|3898501|FG006|COMPLETED|Second Washout Period (7-14 Days)||6
2903330|NCT00436475|3611542|FG000|STARTED|Overall Study||23
2903331|NCT00436475|3611543|FG001|STARTED|Overall Study||23
2903332|NCT00436475|3611544|FG002|STARTED|Overall Study||22
2903333|NCT00436475|3611545|FG003|STARTED|Overall Study||24
2903334|NCT00436475|3611542|FG000|COMPLETED|Overall Study||23
2903335|NCT00436475|3611543|FG001|COMPLETED|Overall Study||22
2903336|NCT00436475|3611544|FG002|COMPLETED|Overall Study||21
2903337|NCT00436475|3611545|FG003|COMPLETED|Overall Study||22
2903338|NCT00436475|3611542|FG000|NOT COMPLETED|Overall Study||0
2903339|NCT00436475|3611543|FG001|NOT COMPLETED|Overall Study||1
2903340|NCT00436475|3611544|FG002|NOT COMPLETED|Overall Study||1
2903341|NCT00436475|3611545|FG003|NOT COMPLETED|Overall Study||2
2903342|NCT00436501|3611557|FG000|STARTED|Complete Study Participation|Phase 1 opened on January 17, 2007 and closed to new patient entry on March 7, 2008.|9
2903343|NCT00436501|3611558|FG001|STARTED|Complete Study Participation|After toxicity observations, Phase 2 opened June 4, 2008 and closed September 27, 2010.|49
2903344|NCT00436501|3611557|FG000|COMPLETED|Complete Study Participation||9
2903345|NCT00436501|3611558|FG001|COMPLETED|Complete Study Participation||49
2903346|NCT00436501|3611557|FG000|NOT COMPLETED|Complete Study Participation||0
2903347|NCT00436501|3611558|FG001|NOT COMPLETED|Complete Study Participation||0
2903348|NCT00436501|3611557|FG000|STARTED|Phase 1: VEGF Trap Escalating Dose|Phase 1 opened on January 17, 2007 and closed to new patient entry on March 7, 2008.|9
2903349|NCT00436501|3611558|FG001|STARTED|Phase 1: VEGF Trap Escalating Dose|Participants registered in next period.|0
2903350|NCT00436501|3611557|FG000|COMPLETED|Phase 1: VEGF Trap Escalating Dose||9
2903351|NCT00436501|3611558|FG001|COMPLETED|Phase 1: VEGF Trap Escalating Dose||0
2903352|NCT00436501|3611557|FG000|NOT COMPLETED|Phase 1: VEGF Trap Escalating Dose||0
2903353|NCT00436501|3611558|FG001|NOT COMPLETED|Phase 1: VEGF Trap Escalating Dose||0
2903354|NCT00436501|3611557|FG000|STARTED|Phase 2: MTD VEGF Trap + Docetaxel||0
2903355|NCT00436501|3611558|FG001|STARTED|Phase 2: MTD VEGF Trap + Docetaxel|After toxicity observations Phase 2 opened June 4, 2008 and closed to entry September 27, 2010.|49
2903356|NCT00436501|3611557|FG000|COMPLETED|Phase 2: MTD VEGF Trap + Docetaxel||0
2903357|NCT00436501|3611558|FG001|COMPLETED|Phase 2: MTD VEGF Trap + Docetaxel||46
2903358|NCT00436501|3611557|FG000|NOT COMPLETED|Phase 2: MTD VEGF Trap + Docetaxel||0
2903359|NCT00436501|3611558|FG001|NOT COMPLETED|Phase 2: MTD VEGF Trap + Docetaxel||3
2903360|NCT00436553|3611568|FG000|STARTED|Overall Study|"The table shows 12 month data. Started indicates Randomized set of population."|104
2903361|NCT00436553|3611569|FG001|STARTED|Overall Study||105
2903362|NCT00436553|3611570|FG002|STARTED|Overall Study||112
2903363|NCT00436553|3611568|FG000|COMPLETED|Overall Study|Completed the 12 month study phase.|91
2903364|NCT00436553|3611569|FG001|COMPLETED|Overall Study||93
2903365|NCT00436553|3611570|FG002|COMPLETED|Overall Study||102
2903366|NCT00436553|3611568|FG000|NOT COMPLETED|Overall Study||13
2903367|NCT00436553|3611569|FG001|NOT COMPLETED|Overall Study||12
2903368|NCT00436553|3611570|FG002|NOT COMPLETED|Overall Study||10
2903369|NCT00436566|3611578|FG000|STARTED|Overall Study||112
2903370|NCT00436566|3611578|FG000|COMPLETED|Overall Study||109
2903371|NCT00436566|3611578|FG000|NOT COMPLETED|Overall Study||3
2903372|NCT00436605|3611582|FG000|STARTED|Overall Study||39
2903373|NCT00436605|3611582|FG000|COMPLETED|Overall Study||36
2903374|NCT00436605|3611582|FG000|NOT COMPLETED|Overall Study||3
2903375|NCT00436618|3611589|FG000|STARTED|Overall Study||114
2903376|NCT00436618|3611590|FG001|STARTED|Overall Study||55
2903377|NCT00436618|3611591|FG002|STARTED|Overall Study||107
2903378|NCT00436618|3611589|FG000|COMPLETED|Overall Study||84
2903379|NCT00436618|3611590|FG001|COMPLETED|Overall Study||28
2903380|NCT00436618|3611591|FG002|COMPLETED|Overall Study||46
2903381|NCT00436618|3611589|FG000|NOT COMPLETED|Overall Study||30
2903382|NCT00436618|3611590|FG001|NOT COMPLETED|Overall Study||27
2903383|NCT00436618|3611591|FG002|NOT COMPLETED|Overall Study||61
2903384|NCT00436644|3611599|FG000|STARTED|Overall Study||18
2903385|NCT00436644|3611599|FG000|COMPLETED|Overall Study||15
2903386|NCT00436644|3611599|FG000|NOT COMPLETED|Overall Study||3
2903387|NCT00436748|3611605|FG000|STARTED|Overall Study||59
2903388|NCT00436748|3611606|FG001|STARTED|Overall Study||57
2903389|NCT00436748|3611605|FG000|Received Treatment|Overall Study||58
2903390|NCT00436748|3611606|FG001|Received Treatment|Overall Study||56
2903391|NCT00436748|3611605|FG000|COMPLETED|Overall Study||48
2903392|NCT00436748|3611606|FG001|COMPLETED|Overall Study||45
3171329|NCT01933672|3898495|FG000|NOT COMPLETED|Second Washout Period (7-14 Days)||0
3171330|NCT01933672|3898496|FG001|NOT COMPLETED|Second Washout Period (7-14 Days)||0
3171331|NCT01933672|3898497|FG002|NOT COMPLETED|Second Washout Period (7-14 Days)||0
3171332|NCT01933672|3898498|FG003|NOT COMPLETED|Second Washout Period (7-14 Days)||0
3171333|NCT01933672|3898499|FG004|NOT COMPLETED|Second Washout Period (7-14 Days)||0
2903393|NCT00436748|3611605|FG000|NOT COMPLETED|Overall Study||11
2903394|NCT00436748|3611606|FG001|NOT COMPLETED|Overall Study||12
2903395|NCT00436852|3611614|FG000|STARTED|Overall Study||45
2903396|NCT00436852|3611615|FG001|STARTED|Overall Study||47
2903397|NCT00436852|3611614|FG000|COMPLETED|Overall Study||10
2903398|NCT00436852|3611615|FG001|COMPLETED|Overall Study||2
2903399|NCT00436852|3611614|FG000|NOT COMPLETED|Overall Study||35
2903400|NCT00436852|3611615|FG001|NOT COMPLETED|Overall Study||45
2903401|NCT00436904|3611624|FG000|STARTED|Overall Study||30
2903402|NCT00436904|3611624|FG000|COMPLETED|Overall Study||30
2903403|NCT00436904|3611624|FG000|NOT COMPLETED|Overall Study||0
2903404|NCT00436917|3611628|FG000|STARTED|Overall Study|7 participants (1 cancellation, 1 major violation, 5 ineligibles) were excluded from all analysis.|53
2903405|NCT00436917|3611628|FG000|COMPLETED|Overall Study||32
2903406|NCT00436917|3611628|FG000|NOT COMPLETED|Overall Study||21
2903407|NCT00436956|3611632|FG000|STARTED|Overall Study||36
2903408|NCT00436956|3611633|FG001|STARTED|Overall Study||23
2903409|NCT00436956|3611632|FG000|COMPLETED|Overall Study|One pt was not evaluable due to a cord compression on day 2 of therapy; was removed from the trial.|35
2903410|NCT00436956|3611633|FG001|COMPLETED|Overall Study||23
2903411|NCT00436956|3611632|FG000|NOT COMPLETED|Overall Study||1
2903412|NCT00436956|3611633|FG001|NOT COMPLETED|Overall Study||0
2903413|NCT00436969|3611642|FG000|STARTED|Overall Study||88
2903414|NCT00436969|3611643|FG001|STARTED|Overall Study||186
2903415|NCT00436969|3611642|FG000|Randomized But Not Treated|Overall Study||1
2903416|NCT00436969|3611643|FG001|Randomized But Not Treated|Overall Study||3
2903417|NCT00436969|3611642|FG000|COMPLETED|Overall Study||66
2903418|NCT00436969|3611643|FG001|COMPLETED|Overall Study||134
2903419|NCT00436969|3611642|FG000|NOT COMPLETED|Overall Study||22
2903420|NCT00436969|3611643|FG001|NOT COMPLETED|Overall Study||52
2903421|NCT00436982|3611651|FG000|STARTED|Overall Study||30
2903422|NCT00436982|3611652|FG001|STARTED|Overall Study||30
2903423|NCT00436982|3611651|FG000|COMPLETED|Overall Study||26
2903424|NCT00436982|3611652|FG001|COMPLETED|Overall Study||26
2903425|NCT00436982|3611651|FG000|NOT COMPLETED|Overall Study||4
2903426|NCT00436982|3611652|FG001|NOT COMPLETED|Overall Study||4
2903427|NCT00437034|3611662|FG000|STARTED|Overall Study||6
2903428|NCT00437034|3611662|FG000|COMPLETED|Overall Study||0
2903429|NCT00437034|3611662|FG000|NOT COMPLETED|Overall Study||6
2903430|NCT00437073|3611668|FG000|STARTED|Overall Study||13
2903431|NCT00437073|3611669|FG001|STARTED|Overall Study||9
2903432|NCT00437073|3611668|FG000|COMPLETED|Overall Study||12
2903433|NCT00437073|3611669|FG001|COMPLETED|Overall Study||8
2903434|NCT00437073|3611668|FG000|NOT COMPLETED|Overall Study||1
2903435|NCT00437073|3611669|FG001|NOT COMPLETED|Overall Study||1
2903436|NCT00437125|3611675|FG000|STARTED|Overall Study||151
2903437|NCT00437125|3611675|FG000|COMPLETED|Overall Study||119
2903438|NCT00437125|3611675|FG000|NOT COMPLETED|Overall Study||32
2903439|NCT00437203|3611689|FG000|STARTED|Overall Study||6
2903440|NCT00437203|3611690|FG001|STARTED|Overall Study||8
2903441|NCT00437203|3611691|FG002|STARTED|Overall Study||3
2903442|NCT00437203|3611692|FG003|STARTED|Overall Study||3
2903443|NCT00437203|3611693|FG004|STARTED|Overall Study||3
2903444|NCT00437203|3611694|FG005|STARTED|Overall Study||3
2903445|NCT00437203|3611695|FG006|STARTED|Overall Study||7
2903446|NCT00437203|3611696|FG007|STARTED|Overall Study||3
2903447|NCT00437203|3611697|FG008|STARTED|Overall Study||3
2903448|NCT00437203|3611698|FG009|STARTED|Overall Study||4
2903449|NCT00437203|3611689|FG000|COMPLETED|Overall Study||0
2903450|NCT00437203|3611690|FG001|COMPLETED|Overall Study||0
2903451|NCT00437203|3611691|FG002|COMPLETED|Overall Study||0
2903452|NCT00437203|3611692|FG003|COMPLETED|Overall Study||0
2903453|NCT00437203|3611693|FG004|COMPLETED|Overall Study||0
2903454|NCT00437203|3611694|FG005|COMPLETED|Overall Study||0
2903455|NCT00437203|3611695|FG006|COMPLETED|Overall Study||0
2903456|NCT00437203|3611696|FG007|COMPLETED|Overall Study||0
2903457|NCT00437203|3611697|FG008|COMPLETED|Overall Study||0
2903458|NCT00437203|3611698|FG009|COMPLETED|Overall Study||0
2903459|NCT00437203|3611689|FG000|NOT COMPLETED|Overall Study||6
2903460|NCT00437203|3611690|FG001|NOT COMPLETED|Overall Study||8
2903461|NCT00437203|3611691|FG002|NOT COMPLETED|Overall Study||3
2903462|NCT00437203|3611692|FG003|NOT COMPLETED|Overall Study||3
2903463|NCT00437203|3611693|FG004|NOT COMPLETED|Overall Study||3
2903464|NCT00437203|3611694|FG005|NOT COMPLETED|Overall Study||3
2903465|NCT00437203|3611695|FG006|NOT COMPLETED|Overall Study||7
2903466|NCT00437203|3611696|FG007|NOT COMPLETED|Overall Study||3
2903467|NCT00437203|3611697|FG008|NOT COMPLETED|Overall Study||3
2903468|NCT00437203|3611698|FG009|NOT COMPLETED|Overall Study||4
2903469|NCT00437268|3611731|FG000|STARTED|Overall Study||13
2903470|NCT00437268|3611732|FG001|STARTED|Overall Study||13
2903471|NCT00437268|3611731|FG000|Received at Least 1 Dose of Study Drug|Overall Study||13
2903472|NCT00437268|3611732|FG001|Received at Least 1 Dose of Study Drug|Overall Study||13
2903473|NCT00437268|3611731|FG000|Protocol Qualified (PQ) Participant|Overall Study|PQ population: randomized participants without an immune reaction to cetuximab after the first dose|13
2903474|NCT00437268|3611732|FG001|Protocol Qualified (PQ) Participant|Overall Study|PQ population: randomized participants without an immune reaction to cetuximab after the first dose|12
2903475|NCT00437268|3611731|FG000|COMPLETED|Overall Study||0
2903476|NCT00437268|3611732|FG001|COMPLETED|Overall Study||0
2903477|NCT00437268|3611731|FG000|NOT COMPLETED|Overall Study||13
2903478|NCT00437268|3611732|FG001|NOT COMPLETED|Overall Study||13
2903479|NCT00437281|3611760|FG000|STARTED|Overall Study||3
2903480|NCT00437281|3611761|FG001|STARTED|Overall Study||3
2903481|NCT00437281|3611762|FG002|STARTED|Overall Study||3
2903482|NCT00437281|3611763|FG003|STARTED|Overall Study||3
2903483|NCT00437281|3611764|FG004|STARTED|Overall Study||4
2903484|NCT00437281|3611765|FG005|STARTED|Overall Study||4
2903485|NCT00437281|3611766|FG006|STARTED|Overall Study||3
2903486|NCT00437281|3611767|FG007|STARTED|Overall Study||3
2903487|NCT00437281|3611768|FG008|STARTED|Overall Study||3
2903488|NCT00437281|3611769|FG009|STARTED|Overall Study||5
2903489|NCT00437281|3611770|FG010|STARTED|Overall Study||3
2903490|NCT00437281|3611771|FG011|STARTED|Overall Study||3
2903491|NCT00437281|3611772|FG012|STARTED|Overall Study||2
2903492|NCT00437281|3611773|FG013|STARTED|Overall Study||3
2903493|NCT00437281|3611774|FG014|STARTED|Overall Study||5
2903494|NCT00437281|3611775|FG015|STARTED|Overall Study||3
2903495|NCT00437281|3611776|FG016|STARTED|Overall Study||3
2903496|NCT00437281|3611777|FG017|STARTED|Overall Study||4
2903497|NCT00437281|3611778|FG018|STARTED|Overall Study||2
2903498|NCT00437281|3611779|FG019|STARTED|Overall Study||3
2903499|NCT00437281|3611760|FG000|COMPLETED|Overall Study||3
2903500|NCT00437281|3611761|FG001|COMPLETED|Overall Study||3
2903501|NCT00437281|3611762|FG002|COMPLETED|Overall Study||3
2903502|NCT00437281|3611763|FG003|COMPLETED|Overall Study||2
2903503|NCT00437281|3611764|FG004|COMPLETED|Overall Study||4
2903504|NCT00437281|3611765|FG005|COMPLETED|Overall Study||3
2903505|NCT00437281|3611766|FG006|COMPLETED|Overall Study||3
2903506|NCT00437281|3611767|FG007|COMPLETED|Overall Study||3
2903507|NCT00437281|3611768|FG008|COMPLETED|Overall Study||3
2903508|NCT00437281|3611769|FG009|COMPLETED|Overall Study||4
2903509|NCT00437281|3611770|FG010|COMPLETED|Overall Study||3
2903510|NCT00437281|3611771|FG011|COMPLETED|Overall Study||3
2903511|NCT00437281|3611772|FG012|COMPLETED|Overall Study||2
2903512|NCT00437281|3611773|FG013|COMPLETED|Overall Study||2
2903513|NCT00437281|3611774|FG014|COMPLETED|Overall Study||4
2903514|NCT00437281|3611775|FG015|COMPLETED|Overall Study||3
2903515|NCT00437281|3611776|FG016|COMPLETED|Overall Study||3
2903516|NCT00437281|3611777|FG017|COMPLETED|Overall Study||4
2903517|NCT00437281|3611778|FG018|COMPLETED|Overall Study||1
2903518|NCT00437281|3611779|FG019|COMPLETED|Overall Study||2
2903519|NCT00437281|3611760|FG000|NOT COMPLETED|Overall Study||0
2903520|NCT00437281|3611761|FG001|NOT COMPLETED|Overall Study||0
2903521|NCT00437281|3611762|FG002|NOT COMPLETED|Overall Study||0
2903522|NCT00437281|3611763|FG003|NOT COMPLETED|Overall Study||1
2903523|NCT00437281|3611764|FG004|NOT COMPLETED|Overall Study||0
2903524|NCT00437281|3611765|FG005|NOT COMPLETED|Overall Study||1
2903525|NCT00437281|3611766|FG006|NOT COMPLETED|Overall Study||0
2903526|NCT00437281|3611767|FG007|NOT COMPLETED|Overall Study||0
2903527|NCT00437281|3611768|FG008|NOT COMPLETED|Overall Study||0
2903528|NCT00437281|3611769|FG009|NOT COMPLETED|Overall Study||1
2903529|NCT00437281|3611770|FG010|NOT COMPLETED|Overall Study||0
2903530|NCT00437281|3611771|FG011|NOT COMPLETED|Overall Study||0
2903531|NCT00437281|3611772|FG012|NOT COMPLETED|Overall Study||0
2903532|NCT00437281|3611773|FG013|NOT COMPLETED|Overall Study||1
2903533|NCT00437281|3611774|FG014|NOT COMPLETED|Overall Study||1
2903534|NCT00437281|3611775|FG015|NOT COMPLETED|Overall Study||0
2903535|NCT00437281|3611776|FG016|NOT COMPLETED|Overall Study||0
2903536|NCT00437281|3611777|FG017|NOT COMPLETED|Overall Study||0
2903537|NCT00437281|3611778|FG018|NOT COMPLETED|Overall Study||1
2903538|NCT00437281|3611779|FG019|NOT COMPLETED|Overall Study||1
2903539|NCT00437294|3611853|FG000|STARTED|Overall Study||43
2903540|NCT00437294|3611854|FG001|STARTED|Overall Study||43
2903541|NCT00437294|3611853|FG000|Received at Least 1 Dose of Study Drug|Overall Study||42
2903542|NCT00437294|3611854|FG001|Received at Least 1 Dose of Study Drug|Overall Study||43
2903543|NCT00437294|3611853|FG000|COMPLETED|Overall Study||0
2903544|NCT00437294|3611854|FG001|COMPLETED|Overall Study||0
2903545|NCT00437294|3611853|FG000|NOT COMPLETED|Overall Study||43
2903546|NCT00437294|3611854|FG001|NOT COMPLETED|Overall Study||43
2903547|NCT00437489|3611868|FG000|STARTED|Overall Study||25
2903548|NCT00437489|3611869|FG001|STARTED|Overall Study||24
2903549|NCT00437489|3611868|FG000|COMPLETED|Overall Study|2 subjects completed prior to study termination.|2
2903550|NCT00437489|3611869|FG001|COMPLETED|Overall Study|2 subjects completed prior to study termination.|2
2903551|NCT00437489|3611868|FG000|NOT COMPLETED|Overall Study||23
2903552|NCT00437489|3611869|FG001|NOT COMPLETED|Overall Study||22
2903553|NCT00437645|3611877|FG000|STARTED|Overall Study||592
2903554|NCT00437645|3611878|FG001|STARTED|Overall Study||591
2903555|NCT00437645|3611877|FG000|COMPLETED|Overall Study||557
2903556|NCT00437645|3611878|FG001|COMPLETED|Overall Study||476
2903557|NCT00437645|3611877|FG000|NOT COMPLETED|Overall Study||35
2903558|NCT00437645|3611878|FG001|NOT COMPLETED|Overall Study||115
2903559|NCT00437658|3611887|FG000|STARTED|Treatment Period (24 Weeks)||84
2903560|NCT00437658|3611888|FG001|STARTED|Treatment Period (24 Weeks)||84
2903561|NCT00437658|3611889|FG002|STARTED|Treatment Period (24 Weeks)||84
2903562|NCT00437658|3611887|FG000|Received Study Drug|Treatment Period (24 Weeks)||84
2903563|NCT00437658|3611888|FG001|Received Study Drug|Treatment Period (24 Weeks)||84
2903564|NCT00437658|3611889|FG002|Received Study Drug|Treatment Period (24 Weeks)||84
2903565|NCT00437658|3611887|FG000|COMPLETED|Treatment Period (24 Weeks)||56
2903566|NCT00437658|3611888|FG001|COMPLETED|Treatment Period (24 Weeks)||62
2903567|NCT00437658|3611889|FG002|COMPLETED|Treatment Period (24 Weeks)||51
2903568|NCT00437658|3611887|FG000|NOT COMPLETED|Treatment Period (24 Weeks)||28
2903569|NCT00437658|3611888|FG001|NOT COMPLETED|Treatment Period (24 Weeks)||22
2903570|NCT00437658|3611889|FG002|NOT COMPLETED|Treatment Period (24 Weeks)||33
2903571|NCT00437658|3611887|FG000|STARTED|Post-treatment Period (24 Weeks)||56
2903572|NCT00437658|3611888|FG001|STARTED|Post-treatment Period (24 Weeks)||62
2903573|NCT00437658|3611889|FG002|STARTED|Post-treatment Period (24 Weeks)||51
2903574|NCT00437658|3611887|FG000|COMPLETED|Post-treatment Period (24 Weeks)||32
2903575|NCT00437658|3611888|FG001|COMPLETED|Post-treatment Period (24 Weeks)||54
2903576|NCT00437658|3611889|FG002|COMPLETED|Post-treatment Period (24 Weeks)||37
2903577|NCT00437658|3611887|FG000|NOT COMPLETED|Post-treatment Period (24 Weeks)||24
2903578|NCT00437658|3611888|FG001|NOT COMPLETED|Post-treatment Period (24 Weeks)||8
2903579|NCT00437658|3611889|FG002|NOT COMPLETED|Post-treatment Period (24 Weeks)||14
2903580|NCT00437983|3611899|FG000|STARTED|Overall Study||79
2903581|NCT00437983|3611900|FG001|STARTED|Overall Study||78
2903582|NCT00437983|3611899|FG000|COMPLETED|Overall Study||66
2903583|NCT00437983|3611900|FG001|COMPLETED|Overall Study||65
2903584|NCT00437983|3611899|FG000|NOT COMPLETED|Overall Study||13
2903585|NCT00437983|3611900|FG001|NOT COMPLETED|Overall Study||13
2903586|NCT00438100|3611908|FG000|STARTED|Overall Study||73
2903587|NCT00438100|3611909|FG001|STARTED|Overall Study||69
2903588|NCT00438100|3611908|FG000|COMPLETED|Overall Study||71
2903589|NCT00438100|3611909|FG001|COMPLETED|Overall Study||65
2903590|NCT00438100|3611908|FG000|NOT COMPLETED|Overall Study||2
2903591|NCT00438100|3611909|FG001|NOT COMPLETED|Overall Study||4
2903592|NCT00438191|3611917|FG000|STARTED|Overall Study||43
2903593|NCT00438191|3611918|FG001|STARTED|Overall Study||40
2903594|NCT00438191|3611917|FG000|COMPLETED|Overall Study||32
2903595|NCT00438191|3611918|FG001|COMPLETED|Overall Study||26
2903596|NCT00438191|3611917|FG000|NOT COMPLETED|Overall Study||11
2903597|NCT00438191|3611918|FG001|NOT COMPLETED|Overall Study||14
2903598|NCT00438204|3611924|FG000|STARTED|Overall Study||39
2903599|NCT00438204|3611924|FG000|COMPLETED|Overall Study||39
2903600|NCT00438204|3611924|FG000|NOT COMPLETED|Overall Study||0
2903601|NCT00438256|3611929|FG000|STARTED|Overall Study||3
2903602|NCT00438256|3611930|FG001|STARTED|Overall Study||3
2903603|NCT00438256|3611931|FG002|STARTED|Overall Study||3
2903604|NCT00438256|3611932|FG003|STARTED|Overall Study||41
2903605|NCT00438256|3611929|FG000|Surgical Resection|Overall Study||1
2903606|NCT00438256|3611930|FG001|Surgical Resection|Overall Study||2
2903607|NCT00438256|3611931|FG002|Surgical Resection|Overall Study||2
2903608|NCT00438256|3611932|FG003|Surgical Resection|Overall Study||34
2903609|NCT00438256|3611929|FG000|COMPLETED|Overall Study||1
2903610|NCT00438256|3611930|FG001|COMPLETED|Overall Study||2
2903611|NCT00438256|3611931|FG002|COMPLETED|Overall Study||2
2903612|NCT00438256|3611932|FG003|COMPLETED|Overall Study||32
2903613|NCT00438256|3611929|FG000|NOT COMPLETED|Overall Study||2
2903614|NCT00438256|3611930|FG001|NOT COMPLETED|Overall Study||1
2903615|NCT00438256|3611931|FG002|NOT COMPLETED|Overall Study||1
2903616|NCT00438256|3611932|FG003|NOT COMPLETED|Overall Study||9
2903617|NCT00438360|3611947|FG000|STARTED|Overall Study|"Started indicates randomized patients."|162
2903618|NCT00438360|3611948|FG001|STARTED|Overall Study||81
2903619|NCT00438360|3611947|FG000|Intention to Treat (ITT) Population|Overall Study|These numbers are different from those started (randomized) as 2 pts from each arm never took drug.|160
2903620|NCT00438360|3611948|FG001|Intention to Treat (ITT) Population|Overall Study||79
2903621|NCT00438360|3611947|FG000|COMPLETED|Overall Study||90
2903622|NCT00438360|3611948|FG001|COMPLETED|Overall Study||38
2903623|NCT00438360|3611947|FG000|NOT COMPLETED|Overall Study||72
2903624|NCT00438360|3611948|FG001|NOT COMPLETED|Overall Study||43
2903625|NCT00438399|3611957|FG000|STARTED|Overall Study||38
2903626|NCT00438399|3611958|FG001|STARTED|Overall Study||40
2903627|NCT00438399|3611959|FG002|STARTED|Overall Study||35
2903628|NCT00438399|3611960|FG003|STARTED|Overall Study||36
2903629|NCT00438399|3611961|FG004|STARTED|Overall Study||33
2903630|NCT00438399|3611962|FG005|STARTED|Overall Study||37
2903631|NCT00438399|3611957|FG000|TREATED & ANALYZED|Overall Study||30
2903632|NCT00438399|3611958|FG001|TREATED & ANALYZED|Overall Study||32
2903633|NCT00438399|3611959|FG002|TREATED & ANALYZED|Overall Study||28
2903634|NCT00438399|3611960|FG003|TREATED & ANALYZED|Overall Study||32
2903635|NCT00438399|3611961|FG004|TREATED & ANALYZED|Overall Study||30
2903636|NCT00438399|3611962|FG005|TREATED & ANALYZED|Overall Study||31
2903637|NCT00438399|3611957|FG000|COMPLETED|Overall Study||30
2903638|NCT00438399|3611958|FG001|COMPLETED|Overall Study||32
2903639|NCT00438399|3611959|FG002|COMPLETED|Overall Study||28
2903640|NCT00438399|3611960|FG003|COMPLETED|Overall Study||32
2903641|NCT00438399|3611961|FG004|COMPLETED|Overall Study||30
2903642|NCT00438399|3611962|FG005|COMPLETED|Overall Study||31
2903643|NCT00438399|3611957|FG000|NOT COMPLETED|Overall Study||8
2903644|NCT00438399|3611958|FG001|NOT COMPLETED|Overall Study||8
2903645|NCT00438399|3611959|FG002|NOT COMPLETED|Overall Study||7
2903646|NCT00438399|3611960|FG003|NOT COMPLETED|Overall Study||4
2903647|NCT00438399|3611961|FG004|NOT COMPLETED|Overall Study||3
2903648|NCT00438399|3611962|FG005|NOT COMPLETED|Overall Study||6
2903649|NCT00438451|3611974|FG000|STARTED|Overall Study||122
2903650|NCT00438451|3611975|FG001|STARTED|Overall Study||121
2903651|NCT00438451|3611976|FG002|STARTED|Overall Study||118
2903652|NCT00438451|3611974|FG000|Safety Population|Overall Study||122
2903653|NCT00438451|3611975|FG001|Safety Population|Overall Study||121
2903654|NCT00438451|3611976|FG002|Safety Population|Overall Study||117
2903655|NCT00438451|3611974|FG000|ITT Population|Overall Study||122
2903656|NCT00438451|3611975|FG001|ITT Population|Overall Study||120
2903657|NCT00438451|3611976|FG002|ITT Population|Overall Study||117
2903658|NCT00438451|3611974|FG000|Maintenance Phase (Week 7-58)|Overall Study||93
2903659|NCT00438451|3611975|FG001|Maintenance Phase (Week 7-58)|Overall Study||89
2903660|NCT00438451|3611976|FG002|Maintenance Phase (Week 7-58)|Overall Study||93
2903661|NCT00438451|3611974|FG000|COMPLETED|Overall Study||75
2903662|NCT00438451|3611975|FG001|COMPLETED|Overall Study||55
2903663|NCT00438451|3611976|FG002|COMPLETED|Overall Study||65
2903664|NCT00438451|3611974|FG000|NOT COMPLETED|Overall Study||47
2903665|NCT00438451|3611975|FG001|NOT COMPLETED|Overall Study||66
2903666|NCT00438451|3611976|FG002|NOT COMPLETED|Overall Study||53
2903667|NCT00438464|3611986|FG000|STARTED|Overall Study||103
2903668|NCT00438464|3611987|FG001|STARTED|Overall Study||101
2903669|NCT00438464|3611986|FG000|Received Assigned Intervention|Overall Study||89
2903670|NCT00438464|3611987|FG001|Received Assigned Intervention|Overall Study||94
2903671|NCT00438464|3611986|FG000|COMPLETED|Overall Study||89
2903672|NCT00438464|3611987|FG001|COMPLETED|Overall Study||94
2903673|NCT00438464|3611986|FG000|NOT COMPLETED|Overall Study||14
2903674|NCT00438464|3611987|FG001|NOT COMPLETED|Overall Study||7
2903675|NCT00438490|3612007|FG000|STARTED|Overall Study||12
2903676|NCT00438490|3612008|FG001|STARTED|Overall Study||9
2903677|NCT00438490|3612007|FG000|COMPLETED|Overall Study||12
2903678|NCT00438490|3612008|FG001|COMPLETED|Overall Study||9
2903679|NCT00438490|3612007|FG000|NOT COMPLETED|Overall Study||0
2903680|NCT00438490|3612008|FG001|NOT COMPLETED|Overall Study||0
2903681|NCT00438633|3612020|FG000|STARTED|Overall Study||32
2903682|NCT00438633|3612021|FG001|STARTED|Overall Study||31
2903683|NCT00438633|3612020|FG000|3-month Follow-up|Overall Study||26
2903684|NCT00438633|3612021|FG001|3-month Follow-up|Overall Study||24
2903685|NCT00438633|3612020|FG000|COMPLETED|Overall Study||16
2903686|NCT00438633|3612021|FG001|COMPLETED|Overall Study||14
2903687|NCT00438633|3612020|FG000|NOT COMPLETED|Overall Study||16
2903688|NCT00438633|3612021|FG001|NOT COMPLETED|Overall Study||17
2903689|NCT00438659|3612029|FG000|STARTED|Overall Study||90
2903690|NCT00438659|3612030|FG001|STARTED|Overall Study||86
2903691|NCT00438659|3612029|FG000|COMPLETED|Overall Study||84
2903692|NCT00438659|3612030|FG001|COMPLETED|Overall Study||82
2903693|NCT00438659|3612029|FG000|NOT COMPLETED|Overall Study||6
2903694|NCT00438659|3612030|FG001|NOT COMPLETED|Overall Study||4
2903695|NCT00438672|3612039|FG000|STARTED|Overall Study||31
2903696|NCT00438672|3612040|FG001|STARTED|Overall Study||33
2903697|NCT00438672|3612039|FG000|COMPLETED|Overall Study||24
2903698|NCT00438672|3612040|FG001|COMPLETED|Overall Study||24
2903699|NCT00438672|3612039|FG000|NOT COMPLETED|Overall Study||7
2903700|NCT00438672|3612040|FG001|NOT COMPLETED|Overall Study||9
2903701|NCT00438750|3612048|FG000|STARTED|Overall Study||48
2903702|NCT00438750|3612049|FG001|STARTED|Overall Study||46
2903703|NCT00438750|3612048|FG000|COMPLETED|Overall Study||39
2903704|NCT00438750|3612049|FG001|COMPLETED|Overall Study||37
2903705|NCT00438750|3612048|FG000|NOT COMPLETED|Overall Study||9
2903706|NCT00438750|3612049|FG001|NOT COMPLETED|Overall Study||9
2903707|NCT00438802|3612058|FG000|STARTED|Overall Study||6
2903708|NCT00438802|3612059|FG001|STARTED|Overall Study||8
2903709|NCT00438802|3612060|FG002|STARTED|Overall Study||9
2903710|NCT00438802|3612058|FG000|COMPLETED|Overall Study||6
2903711|NCT00438802|3612059|FG001|COMPLETED|Overall Study||8
2903712|NCT00438802|3612060|FG002|COMPLETED|Overall Study||9
2903713|NCT00438802|3612058|FG000|NOT COMPLETED|Overall Study||0
2903714|NCT00438802|3612059|FG001|NOT COMPLETED|Overall Study||0
2903715|NCT00438802|3612060|FG002|NOT COMPLETED|Overall Study||0
2903716|NCT00438815|3612070|FG000|STARTED|Overall Study||113
2903717|NCT00438815|3612070|FG000|COMPLETED|Overall Study||43
2903718|NCT00438815|3612070|FG000|NOT COMPLETED|Overall Study||70
2903719|NCT00438854|3612074|FG000|STARTED|Overall Study||15
2903720|NCT00438854|3612074|FG000|COMPLETED|Overall Study||15
2903721|NCT00438854|3612074|FG000|NOT COMPLETED|Overall Study||0
2903722|NCT00438880|3612080|FG000|STARTED|Overall Study||30
2903723|NCT00438880|3612081|FG001|STARTED|Overall Study||8
2903724|NCT00438880|3612080|FG000|COMPLETED|Overall Study||30
2903725|NCT00438880|3612081|FG001|COMPLETED|Overall Study||8
2903726|NCT00438880|3612080|FG000|NOT COMPLETED|Overall Study||0
2903727|NCT00438880|3612081|FG001|NOT COMPLETED|Overall Study||0
2903728|NCT00438932|3612091|FG000|STARTED|Overall Study||4
2903729|NCT00438932|3612092|FG001|STARTED|Overall Study||4
2903730|NCT00438932|3612093|FG002|STARTED|Overall Study||4
2903731|NCT00438932|3612094|FG003|STARTED|Overall Study||4
2903732|NCT00438932|3612091|FG000|COMPLETED|Overall Study||4
2903733|NCT00438932|3612092|FG001|COMPLETED|Overall Study||4
2903734|NCT00438932|3612093|FG002|COMPLETED|Overall Study||4
2903735|NCT00438932|3612094|FG003|COMPLETED|Overall Study||4
2903736|NCT00438932|3612091|FG000|NOT COMPLETED|Overall Study||0
2903737|NCT00438932|3612092|FG001|NOT COMPLETED|Overall Study||0
2903738|NCT00438932|3612093|FG002|NOT COMPLETED|Overall Study||0
2903739|NCT00438932|3612094|FG003|NOT COMPLETED|Overall Study||0
2903740|NCT00438971|3612104|FG000|STARTED|Overall Study||17
2903741|NCT00438971|3612104|FG000|COMPLETED|Overall Study||15
2903742|NCT00438971|3612104|FG000|NOT COMPLETED|Overall Study||2
2903743|NCT00439140|3612112|FG000|STARTED|Treatment Cycle 1||15
2903744|NCT00439140|3612113|FG001|STARTED|Treatment Cycle 1||14
2903745|NCT00439140|3612114|FG002|STARTED|Treatment Cycle 1||12
2903746|NCT00439140|3612112|FG000|COMPLETED|Treatment Cycle 1||14
2903747|NCT00439140|3612113|FG001|COMPLETED|Treatment Cycle 1||10
2903748|NCT00439140|3612114|FG002|COMPLETED|Treatment Cycle 1|5 patients did not enter Cycle 2. 6 patients received botulinum toxin Type A in Cycle 2.|11
2903749|NCT00439140|3612112|FG000|NOT COMPLETED|Treatment Cycle 1||1
2903750|NCT00439140|3612113|FG001|NOT COMPLETED|Treatment Cycle 1||4
2903751|NCT00439140|3612114|FG002|NOT COMPLETED|Treatment Cycle 1||1
2920359|NCT00536471|3630847|FG002|COMPLETED|Overall Study||122
2903752|NCT00439140|3612112|FG000|STARTED|Treatment Cycle 2|8 patients from the 200U arm plus 5 patients from the placebo arm in Cycle 1 entered Cycle 2.|13
2903753|NCT00439140|3612113|FG001|STARTED|Treatment Cycle 2|6 patients from the 300U arm plus 1 patient from the placebo arm in Cycle 1 entered Cycle 2.|7
2903754|NCT00439140|3612114|FG002|STARTED|Treatment Cycle 2|No patients received placebo in Cycle 2.|0
2903755|NCT00439140|3612112|FG000|COMPLETED|Treatment Cycle 2||11
2903756|NCT00439140|3612113|FG001|COMPLETED|Treatment Cycle 2||6
2903757|NCT00439140|3612114|FG002|COMPLETED|Treatment Cycle 2||0
3171334|NCT01933672|3898500|FG005|NOT COMPLETED|Second Washout Period (7-14 Days)||0
3171335|NCT01933672|3898501|FG006|NOT COMPLETED|Second Washout Period (7-14 Days)||0
3171336|NCT01933672|3898495|FG000|STARTED|Third Intervention Period (12-16 Days)||0
2903758|NCT00439140|3612112|FG000|NOT COMPLETED|Treatment Cycle 2||2
2903759|NCT00439140|3612113|FG001|NOT COMPLETED|Treatment Cycle 2||1
2903760|NCT00439140|3612114|FG002|NOT COMPLETED|Treatment Cycle 2||0
2903761|NCT00439179|3612126|FG000|STARTED|Overall Study|1 with biliary|3
2903762|NCT00439179|3612127|FG001|STARTED|Overall Study|2 with biliary|13
2903763|NCT00439179|3612128|FG002|STARTED|Overall Study|2 with biliary|6
2903764|NCT00439179|3612129|FG003|STARTED|Overall Study|2 with biliry|5
2903765|NCT00439179|3612126|FG000|COMPLETED|Overall Study||3
2903766|NCT00439179|3612127|FG001|COMPLETED|Overall Study||11
2903767|NCT00439179|3612128|FG002|COMPLETED|Overall Study||6
2903768|NCT00439179|3612129|FG003|COMPLETED|Overall Study||5
2903769|NCT00439179|3612126|FG000|NOT COMPLETED|Overall Study||0
2903770|NCT00439179|3612127|FG001|NOT COMPLETED|Overall Study||2
2903771|NCT00439179|3612128|FG002|NOT COMPLETED|Overall Study||0
2903772|NCT00439179|3612129|FG003|NOT COMPLETED|Overall Study||0
2903773|NCT00439218|3612142|FG000|STARTED|Cohort 1 (500 mg/kg/Day)||4
2903774|NCT00439218|3612142|FG000|COMPLETED|Cohort 1 (500 mg/kg/Day)|3 subjects completed the study in Cohort 1. Cohort 2 was then opened for new enrollments.|3
2903775|NCT00439218|3612142|FG000|NOT COMPLETED|Cohort 1 (500 mg/kg/Day)||1
2903776|NCT00439218|3612142|FG000|STARTED|Cohort 2 (500 mg/kg/Day)|One new subject was enrolled into the study after Cohort 1 completed the study.|1
2903777|NCT00439218|3612142|FG000|COMPLETED|Cohort 2 (500 mg/kg/Day)||1
2903778|NCT00439218|3612142|FG000|NOT COMPLETED|Cohort 2 (500 mg/kg/Day)||0
2903779|NCT00439231|3612146|FG000|STARTED|Overall Study||33
2903780|NCT00439231|3612146|FG000|COMPLETED|Overall Study|5 subjects had a partial response, 0 complete response, 28 completed off study,|5
2903781|NCT00439231|3612146|FG000|NOT COMPLETED|Overall Study||28
2903782|NCT00439244|3612153|FG000|STARTED|Overall Study|"Started indicates randomized as well as intent to treat (ITT) population enrolled to study."|137
2903783|NCT00439244|3612154|FG001|STARTED|Overall Study||137
2903784|NCT00439244|3612155|FG002|STARTED|Overall Study||138
2903785|NCT00439244|3612153|FG000|Safety Population|Overall Study|Total safety population is 411. One patient was randomized, but never received any study medication.|137
2903786|NCT00439244|3612154|FG001|Safety Population|Overall Study||137
2903787|NCT00439244|3612155|FG002|Safety Population|Overall Study||137
2903788|NCT00439244|3612153|FG000|COMPLETED|Overall Study||126
2903789|NCT00439244|3612154|FG001|COMPLETED|Overall Study||131
2903790|NCT00439244|3612155|FG002|COMPLETED|Overall Study||131
2903791|NCT00439244|3612153|FG000|NOT COMPLETED|Overall Study||11
2903792|NCT00439244|3612154|FG001|NOT COMPLETED|Overall Study||6
2903793|NCT00439244|3612155|FG002|NOT COMPLETED|Overall Study||7
3171337|NCT01933672|3898496|FG001|STARTED|Third Intervention Period (12-16 Days)||6
3171338|NCT01933672|3898497|FG002|STARTED|Third Intervention Period (12-16 Days)||1
3171339|NCT01933672|3898498|FG003|STARTED|Third Intervention Period (12-16 Days)||5
3171340|NCT01933672|3898499|FG004|STARTED|Third Intervention Period (12-16 Days)||6
3171341|NCT01933672|3898500|FG005|STARTED|Third Intervention Period (12-16 Days)||4
2903794|NCT00439270|3612168|FG000|STARTED|Phase 1 (18.1 Months)|Participants who received treatment|3
2903795|NCT00439270|3612169|FG001|STARTED|Phase 1 (18.1 Months)|Participants who received treatment|3
2903796|NCT00439270|3612170|FG002|STARTED|Phase 1 (18.1 Months)|Participants who received treatment|3
2903797|NCT00439270|3612171|FG003|STARTED|Phase 1 (18.1 Months)|Participants who received treatment|4
2903798|NCT00439270|3612172|FG004|STARTED|Phase 1 (18.1 Months)|Participants who received treatment|3
2903799|NCT00439270|3612168|FG000|COMPLETED|Phase 1 (18.1 Months)|Remained on study|0
2903800|NCT00439270|3612169|FG001|COMPLETED|Phase 1 (18.1 Months)|Remained on study|0
2903801|NCT00439270|3612170|FG002|COMPLETED|Phase 1 (18.1 Months)|Remained on study|0
2903802|NCT00439270|3612171|FG003|COMPLETED|Phase 1 (18.1 Months)|Remained on study|4
2903803|NCT00439270|3612172|FG004|COMPLETED|Phase 1 (18.1 Months)|Remained on study|0
2903804|NCT00439270|3612168|FG000|NOT COMPLETED|Phase 1 (18.1 Months)||3
2903805|NCT00439270|3612169|FG001|NOT COMPLETED|Phase 1 (18.1 Months)||3
2903806|NCT00439270|3612170|FG002|NOT COMPLETED|Phase 1 (18.1 Months)||3
2903807|NCT00439270|3612171|FG003|NOT COMPLETED|Phase 1 (18.1 Months)||0
2903808|NCT00439270|3612172|FG004|NOT COMPLETED|Phase 1 (18.1 Months)||3
2903809|NCT00439270|3612168|FG000|STARTED|Phase 2 (51.6 Months)||0
2903810|NCT00439270|3612169|FG001|STARTED|Phase 2 (51.6 Months)||0
2903811|NCT00439270|3612170|FG002|STARTED|Phase 2 (51.6 Months)||0
2903812|NCT00439270|3612171|FG003|STARTED|Phase 2 (51.6 Months)|Includes 4 patients who completed Phase 1|34
2903813|NCT00439270|3612172|FG004|STARTED|Phase 2 (51.6 Months)||0
2903814|NCT00439270|3612168|FG000|COMPLETED|Phase 2 (51.6 Months)||0
2903815|NCT00439270|3612169|FG001|COMPLETED|Phase 2 (51.6 Months)||0
2903816|NCT00439270|3612170|FG002|COMPLETED|Phase 2 (51.6 Months)||0
2903817|NCT00439270|3612171|FG003|COMPLETED|Phase 2 (51.6 Months)||0
2903818|NCT00439270|3612172|FG004|COMPLETED|Phase 2 (51.6 Months)||0
2903819|NCT00439270|3612168|FG000|NOT COMPLETED|Phase 2 (51.6 Months)||0
2903820|NCT00439270|3612169|FG001|NOT COMPLETED|Phase 2 (51.6 Months)||0
2903821|NCT00439270|3612170|FG002|NOT COMPLETED|Phase 2 (51.6 Months)||0
2903822|NCT00439270|3612171|FG003|NOT COMPLETED|Phase 2 (51.6 Months)||34
2903823|NCT00439270|3612172|FG004|NOT COMPLETED|Phase 2 (51.6 Months)||0
2903824|NCT00439296|3612193|FG000|STARTED|Overall Study||5
2903825|NCT00439296|3612194|FG001|STARTED|Overall Study||4
2903826|NCT00439296|3612193|FG000|Treatment Course 1|Overall Study||5
2903827|NCT00439296|3612194|FG001|Treatment Course 1|Overall Study||3
2903828|NCT00439296|3612193|FG000|Treatment Course 2|Overall Study||1
2903829|NCT00439296|3612194|FG001|Treatment Course 2|Overall Study||1
2903830|NCT00439296|3612193|FG000|COMPLETED|Overall Study||5
2903831|NCT00439296|3612194|FG001|COMPLETED|Overall Study||4
2903832|NCT00439296|3612193|FG000|NOT COMPLETED|Overall Study||0
2903833|NCT00439296|3612194|FG001|NOT COMPLETED|Overall Study||0
2903834|NCT00439309|3612202|FG000|STARTED|Treatment||54
2903835|NCT00439309|3612203|FG001|STARTED|Treatment||15
2903836|NCT00439309|3612202|FG000|COMPLETED|Treatment||54
2903837|NCT00439309|3612203|FG001|COMPLETED|Treatment||15
2903838|NCT00439309|3612202|FG000|NOT COMPLETED|Treatment||0
2903839|NCT00439309|3612203|FG001|NOT COMPLETED|Treatment||0
2903840|NCT00439309|3612202|FG000|STARTED|Follow-Up||54
2903841|NCT00439309|3612203|FG001|STARTED|Follow-Up||15
2903842|NCT00439309|3612202|FG000|COMPLETED|Follow-Up||51
2903843|NCT00439309|3612203|FG001|COMPLETED|Follow-Up||13
2903844|NCT00439309|3612202|FG000|NOT COMPLETED|Follow-Up||3
2903845|NCT00439309|3612203|FG001|NOT COMPLETED|Follow-Up||2
2903846|NCT00439335|3612211|FG000|STARTED|Overall Study||113
2903847|NCT00439335|3612212|FG001|STARTED|Overall Study||114
2903848|NCT00439335|3612211|FG000|COMPLETED|Overall Study||111
2903849|NCT00439335|3612212|FG001|COMPLETED|Overall Study||114
2903850|NCT00439335|3612211|FG000|NOT COMPLETED|Overall Study||2
2903851|NCT00439335|3612212|FG001|NOT COMPLETED|Overall Study||0
2903852|NCT00439374|3612220|FG000|STARTED|Overall Study||327
2903853|NCT00439374|3612221|FG001|STARTED|Overall Study||330
2903854|NCT00439374|3612220|FG000|COMPLETED|Overall Study||327
2903855|NCT00439374|3612221|FG001|COMPLETED|Overall Study||330
2903856|NCT00439374|3612220|FG000|NOT COMPLETED|Overall Study||0
2903857|NCT00439374|3612221|FG001|NOT COMPLETED|Overall Study||0
2903858|NCT00439413|3612229|FG000|STARTED|Overall Study||121
2903859|NCT00439413|3612230|FG001|STARTED|Overall Study||125
2903860|NCT00439413|3612229|FG000|COMPLETED|Overall Study||90
2903861|NCT00439413|3612230|FG001|COMPLETED|Overall Study||88
2903862|NCT00439413|3612229|FG000|NOT COMPLETED|Overall Study||31
2903863|NCT00439413|3612230|FG001|NOT COMPLETED|Overall Study||37
2903864|NCT00439465|3612238|FG000|STARTED|Overall Study||23
2903865|NCT00439465|3612238|FG000|COMPLETED|Overall Study||19
2903866|NCT00439465|3612238|FG000|NOT COMPLETED|Overall Study||4
2903867|NCT00439517|3612247|FG000|STARTED|Overall Study||152
2903868|NCT00439517|3612248|FG001|STARTED|Overall Study||150
2903869|NCT00439517|3612247|FG000|COMPLETED|Overall Study||150
2903870|NCT00439517|3612248|FG001|COMPLETED|Overall Study||150
2903871|NCT00439517|3612247|FG000|NOT COMPLETED|Overall Study||2
2903872|NCT00439517|3612248|FG001|NOT COMPLETED|Overall Study||0
2903873|NCT00439556|3612257|FG000|STARTED|Overall Study||36
2903874|NCT00439556|3612258|FG001|STARTED|Overall Study||4
2903875|NCT00439556|3612259|FG002|STARTED|Overall Study||0
2903876|NCT00439556|3612257|FG000|COMPLETED|Overall Study||36
2903877|NCT00439556|3612258|FG001|COMPLETED|Overall Study||3
2903878|NCT00439556|3612259|FG002|COMPLETED|Overall Study||0
2903879|NCT00439556|3612257|FG000|NOT COMPLETED|Overall Study||0
2903880|NCT00439556|3612258|FG001|NOT COMPLETED|Overall Study||1
2903881|NCT00439556|3612259|FG002|NOT COMPLETED|Overall Study||0
2903882|NCT00439608|3612268|FG000|STARTED|Overall Study||60
2903883|NCT00439608|3612268|FG000|COMPLETED|Overall Study||60
2903884|NCT00439608|3612268|FG000|NOT COMPLETED|Overall Study||0
2903885|NCT00439647|3612274|FG000|STARTED|Overall Study|"Started indicates intent to treat (ITT) and safety set."|588
2903886|NCT00439647|3612275|FG001|STARTED|Overall Study||611
2903887|NCT00439647|3612274|FG000|Modified Intent to Treat (mITT)|Overall Study||553
2903888|NCT00439647|3612275|FG001|Modified Intent to Treat (mITT)|Overall Study||574
2903889|NCT00439647|3612274|FG000|COMPLETED|Overall Study||530
2903890|NCT00439647|3612275|FG001|COMPLETED|Overall Study||540
2903891|NCT00439647|3612274|FG000|NOT COMPLETED|Overall Study||58
2903892|NCT00439647|3612275|FG001|NOT COMPLETED|Overall Study||71
2903893|NCT00439673|3612281|FG000|STARTED|Overall Study||62
2903894|NCT00439673|3612281|FG000|COMPLETED|Overall Study||26
2903895|NCT00439673|3612281|FG000|NOT COMPLETED|Overall Study||36
2903896|NCT00439725|3612287|FG000|STARTED|Treatment Period||602
2903897|NCT00439725|3612288|FG001|STARTED|Treatment Period||595
2903898|NCT00439725|3612287|FG000|Participants Received Treatment|Treatment Period|Safety population|598
2903899|NCT00439725|3612288|FG001|Participants Received Treatment|Treatment Period|Safety population|590
2903900|NCT00439725|3612287|FG000|COMPLETED|Treatment Period||366
2903901|NCT00439725|3612288|FG001|COMPLETED|Treatment Period||349
2903902|NCT00439725|3612287|FG000|NOT COMPLETED|Treatment Period||236
2903903|NCT00439725|3612288|FG001|NOT COMPLETED|Treatment Period||246
2903904|NCT00439725|3612287|FG000|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|577
2903905|NCT00439725|3612288|FG001|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|560
2903906|NCT00439725|3612287|FG000|COMPLETED|Observational Period||569
2903907|NCT00439725|3612288|FG001|COMPLETED|Observational Period||553
2903908|NCT00439725|3612287|FG000|NOT COMPLETED|Observational Period||8
3171342|NCT01933672|3898501|FG006|STARTED|Third Intervention Period (12-16 Days)||6
3171343|NCT01933672|3898495|FG000|COMPLETED|Third Intervention Period (12-16 Days)||0
3171344|NCT01933672|3898496|FG001|COMPLETED|Third Intervention Period (12-16 Days)||5
2903909|NCT00439725|3612288|FG001|NOT COMPLETED|Observational Period||7
2903910|NCT00439777|3612296|FG000|STARTED|Treatment Period||2420
2903911|NCT00439777|3612297|FG001|STARTED|Treatment Period||2413
2903912|NCT00439777|3612296|FG000|Participants Received Treatment|Treatment Period||2412
2903913|NCT00439777|3612297|FG001|Participants Received Treatment|Treatment Period||2405
2903914|NCT00439777|3612296|FG000|COMPLETED|Treatment Period||2001
2903915|NCT00439777|3612297|FG001|COMPLETED|Treatment Period||1954
2903916|NCT00439777|3612296|FG000|NOT COMPLETED|Treatment Period||419
2903917|NCT00439777|3612297|FG001|NOT COMPLETED|Treatment Period||459
2903918|NCT00439777|3612296|FG000|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|2206
2903919|NCT00439777|3612297|FG001|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|2197
2903920|NCT00439777|3612296|FG000|COMPLETED|Observational Period||2165
2903921|NCT00439777|3612297|FG001|COMPLETED|Observational Period||2156
2903922|NCT00439777|3612296|FG000|NOT COMPLETED|Observational Period||41
2903923|NCT00439777|3612297|FG001|NOT COMPLETED|Observational Period||41
2903924|NCT00439946|3612303|FG000|STARTED|Overall Study||8
2903925|NCT00439946|3612303|FG000|COMPLETED|Overall Study||8
2903926|NCT00439946|3612303|FG000|NOT COMPLETED|Overall Study||0
2903927|NCT00440011|3612309|FG000|STARTED|Overall Study||131
2903928|NCT00440011|3612310|FG001|STARTED|Overall Study||135
2903929|NCT00440011|3612309|FG000|COMPLETED|Overall Study||127
2903930|NCT00440011|3612310|FG001|COMPLETED|Overall Study||132
2903931|NCT00440011|3612309|FG000|NOT COMPLETED|Overall Study||4
2903932|NCT00440011|3612310|FG001|NOT COMPLETED|Overall Study||3
2903933|NCT00440037|3612316|FG000|STARTED|Overall Study||44
2903934|NCT00440037|3612316|FG000|COMPLETED|Overall Study||35
2903935|NCT00440037|3612316|FG000|NOT COMPLETED|Overall Study||9
2903936|NCT00440050|3612322|FG000|STARTED|Overall Study||164
2903937|NCT00440050|3612323|FG001|STARTED|Overall Study||238
2903938|NCT00440050|3612322|FG000|COMPLETED|Overall Study||124
2903939|NCT00440050|3612323|FG001|COMPLETED|Overall Study||171
2903940|NCT00440050|3612322|FG000|NOT COMPLETED|Overall Study||40
2903941|NCT00440050|3612323|FG001|NOT COMPLETED|Overall Study||67
2903942|NCT00440115|3612332|FG000|STARTED|Overall Study||251
2903943|NCT00440115|3612333|FG001|STARTED|Overall Study||249
2903944|NCT00440115|3612334|FG002|STARTED|Overall Study||250
2903945|NCT00440115|3612332|FG000|COMPLETED|Overall Study||244
2903946|NCT00440115|3612333|FG001|COMPLETED|Overall Study||238
2903947|NCT00440115|3612334|FG002|COMPLETED|Overall Study||244
2903948|NCT00440115|3612332|FG000|NOT COMPLETED|Overall Study||7
2903949|NCT00440115|3612333|FG001|NOT COMPLETED|Overall Study||11
2903950|NCT00440115|3612334|FG002|NOT COMPLETED|Overall Study||6
2903951|NCT00440180|3612344|FG000|STARTED|Overall Study||10
2903952|NCT00440180|3612345|FG001|STARTED|Overall Study||10
2903953|NCT00440180|3612344|FG000|COMPLETED|Overall Study||10
2903954|NCT00440180|3612345|FG001|COMPLETED|Overall Study||10
2903955|NCT00440180|3612344|FG000|NOT COMPLETED|Overall Study||0
2903956|NCT00440180|3612345|FG001|NOT COMPLETED|Overall Study||0
2903957|NCT00440193|3612353|FG000|STARTED|Treatment Period||1731
2903958|NCT00440193|3612354|FG001|STARTED|Treatment Period||1718
2903959|NCT00440193|3612353|FG000|Participants Received Treatment|Treatment Period||1718
2903960|NCT00440193|3612354|FG001|Participants Received Treatment|Treatment Period||1711
2903961|NCT00440193|3612353|FG000|COMPLETED|Treatment Period||1426
2903962|NCT00440193|3612354|FG001|COMPLETED|Treatment Period||1367
2903963|NCT00440193|3612353|FG000|NOT COMPLETED|Treatment Period||305
2903964|NCT00440193|3612354|FG001|NOT COMPLETED|Treatment Period||351
2903965|NCT00440193|3612353|FG000|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|1425
2903966|NCT00440193|3612354|FG001|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|1407
2903967|NCT00440193|3612353|FG000|COMPLETED|Observational Period||1380
2903968|NCT00440193|3612354|FG001|COMPLETED|Observational Period||1369
2903969|NCT00440193|3612353|FG000|NOT COMPLETED|Observational Period||45
2903970|NCT00440193|3612354|FG001|NOT COMPLETED|Observational Period||38
2903971|NCT00440232|3612362|FG000|STARTED|Overall Study||36
2903972|NCT00440232|3612363|FG001|STARTED|Overall Study||38
2903973|NCT00440232|3612362|FG000|COMPLETED|Overall Study||33
2903974|NCT00440232|3612363|FG001|COMPLETED|Overall Study||34
2903975|NCT00440232|3612362|FG000|NOT COMPLETED|Overall Study||3
2903976|NCT00440232|3612363|FG001|NOT COMPLETED|Overall Study||4
2903977|NCT00440297|3612371|FG000|STARTED|Overall Study||139
2903978|NCT00440297|3612372|FG001|STARTED|Overall Study||138
2903979|NCT00440297|3612371|FG000|Vaccination Visit 1|Overall Study||138
2903980|NCT00440297|3612372|FG001|Vaccination Visit 1|Overall Study||138
2903981|NCT00440297|3612371|FG000|Vaccination Visit 2|Overall Study||136
2903982|NCT00440297|3612372|FG001|Vaccination Visit 2|Overall Study||134
2903983|NCT00440297|3612371|FG000|Vaccination Visit 3|Overall Study||124
2903984|NCT00440297|3612372|FG001|Vaccination Visit 3|Overall Study||125
2903985|NCT00440297|3612371|FG000|Vaccination Visit 4|Overall Study||116
2903986|NCT00440297|3612372|FG001|Vaccination Visit 4|Overall Study||122
2903987|NCT00440297|3612371|FG000|COMPLETED|Overall Study||116
2903988|NCT00440297|3612372|FG001|COMPLETED|Overall Study||120
2903989|NCT00440297|3612371|FG000|NOT COMPLETED|Overall Study||23
2903990|NCT00440297|3612372|FG001|NOT COMPLETED|Overall Study||18
2903991|NCT00440310|3612380|FG000|STARTED|Overall Study||244
2903992|NCT00440310|3612381|FG001|STARTED|Overall Study||239
2903993|NCT00440310|3612380|FG000|Treated|Overall Study||222
2903994|NCT00440310|3612381|FG001|Treated|Overall Study||232
2903995|NCT00440310|3612380|FG000|COMPLETED|Overall Study||216
2903996|NCT00440310|3612381|FG001|COMPLETED|Overall Study||209
2903997|NCT00440310|3612380|FG000|NOT COMPLETED|Overall Study||28
2903998|NCT00440310|3612381|FG001|NOT COMPLETED|Overall Study||30
2903999|NCT00440401|3612389|FG000|STARTED|Overall Study||59
2904000|NCT00440401|3612390|FG001|STARTED|Overall Study||60
2904001|NCT00440401|3612389|FG000|COMPLETED|Overall Study||55
2904002|NCT00440401|3612390|FG001|COMPLETED|Overall Study||54
2904003|NCT00440401|3612389|FG000|NOT COMPLETED|Overall Study||4
2904004|NCT00440401|3612390|FG001|NOT COMPLETED|Overall Study||6
2904005|NCT00440466|3612399|FG000|STARTED|Overall Study||108
2904006|NCT00440466|3612400|FG001|STARTED|Overall Study||107
2904007|NCT00440466|3612401|FG002|STARTED|Overall Study||215
2904008|NCT00440466|3612399|FG000|COMPLETED|Overall Study||95
2904009|NCT00440466|3612400|FG001|COMPLETED|Overall Study||92
2904010|NCT00440466|3612401|FG002|COMPLETED|Overall Study||174
2904011|NCT00440466|3612399|FG000|NOT COMPLETED|Overall Study||13
2904012|NCT00440466|3612400|FG001|NOT COMPLETED|Overall Study||15
2904013|NCT00440466|3612401|FG002|NOT COMPLETED|Overall Study||41
2904014|NCT00440505|3612409|FG000|STARTED|First Intervention||5
2904015|NCT00440505|3612410|FG001|STARTED|First Intervention||2
2904016|NCT00440505|3612411|FG002|STARTED|First Intervention||1
2904017|NCT00440505|3612412|FG003|STARTED|First Intervention||2
2904018|NCT00440505|3612413|FG004|STARTED|First Intervention||5
2904019|NCT00440505|3612414|FG005|STARTED|First Intervention||5
2904020|NCT00440505|3612409|FG000|COMPLETED|First Intervention||5
2904021|NCT00440505|3612410|FG001|COMPLETED|First Intervention||2
2904022|NCT00440505|3612411|FG002|COMPLETED|First Intervention||1
2904023|NCT00440505|3612412|FG003|COMPLETED|First Intervention||2
2904024|NCT00440505|3612413|FG004|COMPLETED|First Intervention||5
2904025|NCT00440505|3612414|FG005|COMPLETED|First Intervention||5
2904026|NCT00440505|3612409|FG000|NOT COMPLETED|First Intervention||0
2904027|NCT00440505|3612410|FG001|NOT COMPLETED|First Intervention||0
2904028|NCT00440505|3612411|FG002|NOT COMPLETED|First Intervention||0
2904029|NCT00440505|3612412|FG003|NOT COMPLETED|First Intervention||0
2904030|NCT00440505|3612413|FG004|NOT COMPLETED|First Intervention||0
2904031|NCT00440505|3612414|FG005|NOT COMPLETED|First Intervention||0
2904032|NCT00440505|3612409|FG000|STARTED|Second Intervention||5
2904033|NCT00440505|3612410|FG001|STARTED|Second Intervention||2
2904034|NCT00440505|3612411|FG002|STARTED|Second Intervention||1
2904035|NCT00440505|3612412|FG003|STARTED|Second Intervention||2
2904036|NCT00440505|3612413|FG004|STARTED|Second Intervention||5
2904037|NCT00440505|3612414|FG005|STARTED|Second Intervention||5
2904038|NCT00440505|3612409|FG000|COMPLETED|Second Intervention||5
2904039|NCT00440505|3612410|FG001|COMPLETED|Second Intervention||2
2904040|NCT00440505|3612411|FG002|COMPLETED|Second Intervention||1
2904041|NCT00440505|3612412|FG003|COMPLETED|Second Intervention||2
2904042|NCT00440505|3612413|FG004|COMPLETED|Second Intervention||5
2904043|NCT00440505|3612414|FG005|COMPLETED|Second Intervention||5
2904044|NCT00440505|3612409|FG000|NOT COMPLETED|Second Intervention||0
2904045|NCT00440505|3612410|FG001|NOT COMPLETED|Second Intervention||0
2904046|NCT00440505|3612411|FG002|NOT COMPLETED|Second Intervention||0
2904047|NCT00440505|3612412|FG003|NOT COMPLETED|Second Intervention||0
3171345|NCT01933672|3898497|FG002|COMPLETED|Third Intervention Period (12-16 Days)||1
3171346|NCT01933672|3898498|FG003|COMPLETED|Third Intervention Period (12-16 Days)||4
3171347|NCT01933672|3898499|FG004|COMPLETED|Third Intervention Period (12-16 Days)||6
2904048|NCT00440505|3612413|FG004|NOT COMPLETED|Second Intervention||0
2904049|NCT00440505|3612414|FG005|NOT COMPLETED|Second Intervention||0
2904050|NCT00440505|3612409|FG000|STARTED|Third Intervention||5
2904051|NCT00440505|3612410|FG001|STARTED|Third Intervention||2
2904052|NCT00440505|3612411|FG002|STARTED|Third Intervention||1
2904053|NCT00440505|3612412|FG003|STARTED|Third Intervention||2
2904054|NCT00440505|3612413|FG004|STARTED|Third Intervention||5
2904055|NCT00440505|3612414|FG005|STARTED|Third Intervention||5
2904056|NCT00440505|3612409|FG000|COMPLETED|Third Intervention||5
2904057|NCT00440505|3612410|FG001|COMPLETED|Third Intervention||2
2904058|NCT00440505|3612411|FG002|COMPLETED|Third Intervention||1
2904059|NCT00440505|3612412|FG003|COMPLETED|Third Intervention||1
2904060|NCT00440505|3612413|FG004|COMPLETED|Third Intervention||5
2904061|NCT00440505|3612414|FG005|COMPLETED|Third Intervention||5
2904062|NCT00440505|3612409|FG000|NOT COMPLETED|Third Intervention||0
2904063|NCT00440505|3612410|FG001|NOT COMPLETED|Third Intervention||0
2904064|NCT00440505|3612411|FG002|NOT COMPLETED|Third Intervention||0
2904065|NCT00440505|3612412|FG003|NOT COMPLETED|Third Intervention||1
2904066|NCT00440505|3612413|FG004|NOT COMPLETED|Third Intervention||0
2904067|NCT00440505|3612414|FG005|NOT COMPLETED|Third Intervention||0
2904068|NCT00440518|3612425|FG000|STARTED|Randomized /Titration Period||72
2904069|NCT00440518|3612426|FG001|STARTED|Randomized /Titration Period||72
2904070|NCT00440518|3612427|FG002|STARTED|Randomized /Titration Period||74
2904071|NCT00440518|3612425|FG000|COMPLETED|Randomized /Titration Period||59
2904072|NCT00440518|3612426|FG001|COMPLETED|Randomized /Titration Period||63
2904073|NCT00440518|3612427|FG002|COMPLETED|Randomized /Titration Period||70
2904074|NCT00440518|3612425|FG000|NOT COMPLETED|Randomized /Titration Period||13
2904075|NCT00440518|3612426|FG001|NOT COMPLETED|Randomized /Titration Period||9
2904076|NCT00440518|3612427|FG002|NOT COMPLETED|Randomized /Titration Period||4
3171348|NCT01933672|3898500|FG005|COMPLETED|Third Intervention Period (12-16 Days)||4
3171349|NCT01933672|3898501|FG006|COMPLETED|Third Intervention Period (12-16 Days)||6
3171350|NCT01933672|3898495|FG000|NOT COMPLETED|Third Intervention Period (12-16 Days)||0
3171351|NCT01933672|3898496|FG001|NOT COMPLETED|Third Intervention Period (12-16 Days)||1
3171352|NCT01933672|3898497|FG002|NOT COMPLETED|Third Intervention Period (12-16 Days)||0
3171353|NCT01933672|3898498|FG003|NOT COMPLETED|Third Intervention Period (12-16 Days)||1
3171354|NCT01933672|3898499|FG004|NOT COMPLETED|Third Intervention Period (12-16 Days)||0
3171355|NCT01933672|3898500|FG005|NOT COMPLETED|Third Intervention Period (12-16 Days)||0
2904077|NCT00440518|3612425|FG000|STARTED|Maintenance and Safety Follow-up Periods||59
2904078|NCT00440518|3612426|FG001|STARTED|Maintenance and Safety Follow-up Periods||63
2904079|NCT00440518|3612427|FG002|STARTED|Maintenance and Safety Follow-up Periods||70
2904080|NCT00440518|3612425|FG000|COMPLETED|Maintenance and Safety Follow-up Periods||52
2904081|NCT00440518|3612426|FG001|COMPLETED|Maintenance and Safety Follow-up Periods||51
2904082|NCT00440518|3612427|FG002|COMPLETED|Maintenance and Safety Follow-up Periods||55
2904083|NCT00440518|3612425|FG000|NOT COMPLETED|Maintenance and Safety Follow-up Periods||7
2904084|NCT00440518|3612426|FG001|NOT COMPLETED|Maintenance and Safety Follow-up Periods||12
2904085|NCT00440518|3612427|FG002|NOT COMPLETED|Maintenance and Safety Follow-up Periods||15
2904086|NCT00440557|3612438|FG000|STARTED|Overall Study|Safety population defined as all subjects who received at least 1 injection of study drug.|123
2904087|NCT00440557|3612439|FG001|STARTED|Overall Study|Safety population defined as all subjects who received at least 1 injection of study drug.|125
2904088|NCT00440557|3612440|FG002|STARTED|Overall Study|Safety population defined as all subjects who received at least 1 injection of study drug.|125
2904089|NCT00440557|3612438|FG000|COMPLETED|Overall Study||98
2904090|NCT00440557|3612439|FG001|COMPLETED|Overall Study||96
2904091|NCT00440557|3612440|FG002|COMPLETED|Overall Study||90
2904092|NCT00440557|3612438|FG000|NOT COMPLETED|Overall Study||25
2904093|NCT00440557|3612439|FG001|NOT COMPLETED|Overall Study||29
2904094|NCT00440557|3612440|FG002|NOT COMPLETED|Overall Study||35
2920360|NCT00536471|3630848|FG003|COMPLETED|Overall Study||57
2920361|NCT00536471|3630845|FG000|NOT COMPLETED|Overall Study||156
2920362|NCT00536471|3630846|FG001|NOT COMPLETED|Overall Study||84
2920363|NCT00536471|3630847|FG002|NOT COMPLETED|Overall Study||139
2920364|NCT00536471|3630848|FG003|NOT COMPLETED|Overall Study||74
2920365|NCT00536484|3630867|FG000|STARTED|Overall Study|448 participants randomised; 3 not treated|445
2920366|NCT00536484|3630868|FG001|STARTED|Overall Study|448 participants randomised; 10 not treated|438
2920367|NCT00536484|3630867|FG000|COMPLETED|Overall Study|88 completed on matched 4mg dose and 297 on matched 8mg dose|385
2920368|NCT00536484|3630868|FG001|COMPLETED|Overall Study|134 completed on 4mg dose and 248 on 8mg dose|382
2920369|NCT00536484|3630867|FG000|NOT COMPLETED|Overall Study||60
2920370|NCT00536484|3630868|FG001|NOT COMPLETED|Overall Study||56
2920371|NCT00536510|3630876|FG000|STARTED|Overall Study||322
2920372|NCT00536510|3630877|FG001|STARTED|Overall Study||324
2920373|NCT00536510|3630876|FG000|COMPLETED|Overall Study||240
2920374|NCT00536510|3630877|FG001|COMPLETED|Overall Study||295
2920375|NCT00536510|3630876|FG000|NOT COMPLETED|Overall Study||82
2920376|NCT00536510|3630877|FG001|NOT COMPLETED|Overall Study||29
2920377|NCT00536575|3630883|FG000|STARTED|Overall Study||13
2920378|NCT00536575|3630883|FG000|COMPLETED|Overall Study||11
2920379|NCT00536575|3630883|FG000|NOT COMPLETED|Overall Study||2
2920380|NCT00536601|3630892|FG000|STARTED|Overall Study||6
2920381|NCT00536601|3630893|FG001|STARTED|Overall Study||21
2920382|NCT00536601|3630894|FG002|STARTED|Overall Study||71
2920383|NCT00536601|3630895|FG003|STARTED|Overall Study||65
2920384|NCT00536601|3630896|FG004|STARTED|Overall Study||11
2920385|NCT00536601|3630892|FG000|COMPLETED|Overall Study||6
2920386|NCT00536601|3630893|FG001|COMPLETED|Overall Study||21
2920387|NCT00536601|3630894|FG002|COMPLETED|Overall Study||71
2920388|NCT00536601|3630895|FG003|COMPLETED|Overall Study||65
2920389|NCT00536601|3630896|FG004|COMPLETED|Overall Study||11
2920390|NCT00536601|3630892|FG000|NOT COMPLETED|Overall Study||0
2920391|NCT00536601|3630893|FG001|NOT COMPLETED|Overall Study||0
2920392|NCT00536601|3630894|FG002|NOT COMPLETED|Overall Study||0
2920393|NCT00536601|3630895|FG003|NOT COMPLETED|Overall Study||0
2920394|NCT00536601|3630896|FG004|NOT COMPLETED|Overall Study||0
2920395|NCT00536731|3630911|FG000|STARTED|Overall Study||253
2920396|NCT00536731|3630912|FG001|STARTED|Overall Study||246
2920397|NCT00536731|3630913|FG002|STARTED|Overall Study||243
2920398|NCT00536731|3630911|FG000|COMPLETED|Overall Study||249
2920399|NCT00536731|3630912|FG001|COMPLETED|Overall Study||241
2920400|NCT00536731|3630913|FG002|COMPLETED|Overall Study||238
2920401|NCT00536731|3630911|FG000|NOT COMPLETED|Overall Study||4
2920402|NCT00536731|3630912|FG001|NOT COMPLETED|Overall Study||5
2920403|NCT00536731|3630913|FG002|NOT COMPLETED|Overall Study||5
2920404|NCT00536744|3630923|FG000|STARTED|Overall Study||107
2920405|NCT00536744|3630924|FG001|STARTED|Overall Study||99
2920406|NCT00536744|3630923|FG000|COMPLETED|Overall Study||78
2920407|NCT00536744|3630924|FG001|COMPLETED|Overall Study||71
2920408|NCT00536744|3630923|FG000|NOT COMPLETED|Overall Study||29
2920409|NCT00536744|3630924|FG001|NOT COMPLETED|Overall Study||28
2920410|NCT00536809|3630930|FG000|STARTED|Phase I (Dose-finding Phase)||10
2920411|NCT00536809|3630930|FG000|COMPLETED|Phase I (Dose-finding Phase)||10
2920412|NCT00536809|3630930|FG000|NOT COMPLETED|Phase I (Dose-finding Phase)||0
2920413|NCT00536809|3630930|FG000|STARTED|Phase II||2
2920414|NCT00536809|3630930|FG000|COMPLETED|Phase II||0
2920415|NCT00536809|3630930|FG000|NOT COMPLETED|Phase II||2
2904095|NCT00440596|3612450|FG000|STARTED|Overall Study||28
2904096|NCT00440596|3612451|FG001|STARTED|Overall Study||28
2904097|NCT00440596|3612450|FG000|COMPLETED|Overall Study||21
2904098|NCT00440596|3612451|FG001|COMPLETED|Overall Study||17
2904099|NCT00440596|3612450|FG000|NOT COMPLETED|Overall Study||7
2904100|NCT00440596|3612451|FG001|NOT COMPLETED|Overall Study||11
2904101|NCT00440700|3612462|FG000|STARTED|Overall Study||122
2904102|NCT00440700|3612463|FG001|STARTED|Overall Study||118
2904103|NCT00440700|3612464|FG002|STARTED|Overall Study||124
2904104|NCT00440700|3612462|FG000|COMPLETED|Overall Study||114
3171356|NCT01933672|3898501|FG006|NOT COMPLETED|Third Intervention Period (12-16 Days)||0
3171357|NCT01933776|3898516|FG000|STARTED|Overall Study||20
2904105|NCT00440700|3612463|FG001|COMPLETED|Overall Study||110
2904106|NCT00440700|3612464|FG002|COMPLETED|Overall Study||120
2904107|NCT00440700|3612462|FG000|NOT COMPLETED|Overall Study||8
2904108|NCT00440700|3612463|FG001|NOT COMPLETED|Overall Study||8
2904109|NCT00440700|3612464|FG002|NOT COMPLETED|Overall Study||4
2904110|NCT00440726|3612475|FG000|STARTED|Phase 1||4
2904111|NCT00440726|3612476|FG001|STARTED|Phase 1||6
2904112|NCT00440726|3612477|FG002|STARTED|Phase 1||0
2904113|NCT00440726|3612475|FG000|COMPLETED|Phase 1||3
2904114|NCT00440726|3612476|FG001|COMPLETED|Phase 1||5
2904115|NCT00440726|3612477|FG002|COMPLETED|Phase 1||0
2904116|NCT00440726|3612475|FG000|NOT COMPLETED|Phase 1||1
2904117|NCT00440726|3612476|FG001|NOT COMPLETED|Phase 1||1
2904118|NCT00440726|3612477|FG002|NOT COMPLETED|Phase 1||0
2904119|NCT00440726|3612475|FG000|STARTED|Phase 2||0
2904120|NCT00440726|3612476|FG001|STARTED|Phase 2||0
2904121|NCT00440726|3612477|FG002|STARTED|Phase 2||22
2904122|NCT00440726|3612475|FG000|COMPLETED|Phase 2||0
2904123|NCT00440726|3612476|FG001|COMPLETED|Phase 2||0
2904124|NCT00440726|3612477|FG002|COMPLETED|Phase 2||20
2904125|NCT00440726|3612475|FG000|NOT COMPLETED|Phase 2||0
2904126|NCT00440726|3612476|FG001|NOT COMPLETED|Phase 2||0
2904127|NCT00440726|3612477|FG002|NOT COMPLETED|Phase 2||2
2904128|NCT00440830|3612492|FG000|STARTED|Overall Study||20
2904129|NCT00440830|3612493|FG001|STARTED|Overall Study||8
2904130|NCT00440830|3612494|FG002|STARTED|Overall Study||30
2904131|NCT00440830|3612495|FG003|STARTED|Overall Study||10
2904132|NCT00440830|3612492|FG000|COMPLETED|Overall Study||20
2904133|NCT00440830|3612493|FG001|COMPLETED|Overall Study||8
2904134|NCT00440830|3612494|FG002|COMPLETED|Overall Study||30
2904135|NCT00440830|3612495|FG003|COMPLETED|Overall Study||10
2904136|NCT00440830|3612492|FG000|NOT COMPLETED|Overall Study||0
2904137|NCT00440830|3612493|FG001|NOT COMPLETED|Overall Study||0
2904138|NCT00440830|3612494|FG002|NOT COMPLETED|Overall Study||0
2904139|NCT00440830|3612495|FG003|NOT COMPLETED|Overall Study||0
2904140|NCT00440947|3612509|FG000|STARTED|36-Week Induction Phase||515
2904141|NCT00440947|3612510|FG001|STARTED|36-Week Induction Phase||0
2904142|NCT00440947|3612511|FG002|STARTED|36-Week Induction Phase||0
2904143|NCT00440947|3612512|FG003|STARTED|36-Week Induction Phase||0
2904144|NCT00440947|3612513|FG004|STARTED|36-Week Induction Phase||0
2904145|NCT00440947|3612509|FG000|COMPLETED|36-Week Induction Phase|23 PAR without confirmed HIV-RNA<50c/mL prior to Wk 36 couldn't be randomized but weren't withdrawn.|442
2904146|NCT00440947|3612510|FG001|COMPLETED|36-Week Induction Phase||0
2904147|NCT00440947|3612511|FG002|COMPLETED|36-Week Induction Phase||0
2904148|NCT00440947|3612512|FG003|COMPLETED|36-Week Induction Phase||0
2904149|NCT00440947|3612513|FG004|COMPLETED|36-Week Induction Phase||0
2904150|NCT00440947|3612509|FG000|NOT COMPLETED|36-Week Induction Phase||73
2904151|NCT00440947|3612510|FG001|NOT COMPLETED|36-Week Induction Phase||0
2904152|NCT00440947|3612511|FG002|NOT COMPLETED|36-Week Induction Phase||0
2904153|NCT00440947|3612512|FG003|NOT COMPLETED|36-Week Induction Phase||0
2904154|NCT00440947|3612513|FG004|NOT COMPLETED|36-Week Induction Phase||0
2904155|NCT00440947|3612509|FG000|STARTED|48-Week Randomization Phase||0
2904156|NCT00440947|3612510|FG001|STARTED|48-Week Randomization Phase||210
2904157|NCT00440947|3612511|FG002|STARTED|48-Week Randomization Phase||209
2904158|NCT00440947|3612512|FG003|STARTED|48-Week Randomization Phase||0
2904159|NCT00440947|3612513|FG004|STARTED|48-Week Randomization Phase||0
2904160|NCT00440947|3612509|FG000|COMPLETED|48-Week Randomization Phase||0
2904161|NCT00440947|3612510|FG001|COMPLETED|48-Week Randomization Phase||194
2904162|NCT00440947|3612511|FG002|COMPLETED|48-Week Randomization Phase||185
2904163|NCT00440947|3612512|FG003|COMPLETED|48-Week Randomization Phase||0
2904164|NCT00440947|3612513|FG004|COMPLETED|48-Week Randomization Phase||0
2904165|NCT00440947|3612509|FG000|NOT COMPLETED|48-Week Randomization Phase||0
2904166|NCT00440947|3612510|FG001|NOT COMPLETED|48-Week Randomization Phase||16
2904167|NCT00440947|3612511|FG002|NOT COMPLETED|48-Week Randomization Phase||24
2904168|NCT00440947|3612512|FG003|NOT COMPLETED|48-Week Randomization Phase||0
2904169|NCT00440947|3612513|FG004|NOT COMPLETED|48-Week Randomization Phase||0
2904170|NCT00440947|3612509|FG000|STARTED|Optional 60-Week Extension Phase||0
2904171|NCT00440947|3612510|FG001|STARTED|Optional 60-Week Extension Phase||0
2904172|NCT00440947|3612511|FG002|STARTED|Optional 60-Week Extension Phase||0
2904173|NCT00440947|3612512|FG003|STARTED|Optional 60-Week Extension Phase||189
2904174|NCT00440947|3612513|FG004|STARTED|Optional 60-Week Extension Phase||180
2904175|NCT00440947|3612509|FG000|COMPLETED|Optional 60-Week Extension Phase||0
2904176|NCT00440947|3612510|FG001|COMPLETED|Optional 60-Week Extension Phase||0
2904177|NCT00440947|3612511|FG002|COMPLETED|Optional 60-Week Extension Phase||0
2904178|NCT00440947|3612512|FG003|COMPLETED|Optional 60-Week Extension Phase||160
2904179|NCT00440947|3612513|FG004|COMPLETED|Optional 60-Week Extension Phase||154
2904180|NCT00440947|3612509|FG000|NOT COMPLETED|Optional 60-Week Extension Phase||0
2904181|NCT00440947|3612510|FG001|NOT COMPLETED|Optional 60-Week Extension Phase||0
2904182|NCT00440947|3612511|FG002|NOT COMPLETED|Optional 60-Week Extension Phase||0
2904183|NCT00440947|3612512|FG003|NOT COMPLETED|Optional 60-Week Extension Phase||29
2904184|NCT00440947|3612513|FG004|NOT COMPLETED|Optional 60-Week Extension Phase||26
2904185|NCT00440999|3612527|FG000|STARTED|Overall Study||228
2904186|NCT00440999|3612528|FG001|STARTED|Overall Study||228
2904187|NCT00440999|3612527|FG000|COMPLETED|Overall Study||193
2904188|NCT00440999|3612528|FG001|COMPLETED|Overall Study||187
2904189|NCT00440999|3612527|FG000|NOT COMPLETED|Overall Study||35
2904190|NCT00440999|3612528|FG001|NOT COMPLETED|Overall Study||41
2904191|NCT00441012|3612538|FG000|STARTED|Overall Study||270
2904192|NCT00441012|3612539|FG001|STARTED|Overall Study||276
2904193|NCT00441012|3612538|FG000|Vaccination Visit 1|Overall Study|1 participant was randomized but not vaccinated in the Modified Process Vaccine group|269
2904194|NCT00441012|3612539|FG001|Vaccination Visit 1|Overall Study|3 participants were vaccinated but were never randomized in the COMVAX™ group|276
2904195|NCT00441012|3612538|FG000|Vaccination Visit 2|Overall Study||267
2904196|NCT00441012|3612539|FG001|Vaccination Visit 2|Overall Study||272
2904197|NCT00441012|3612538|FG000|Vaccination Visit 3|Overall Study||265
2904198|NCT00441012|3612539|FG001|Vaccination Visit 3|Overall Study||269
2904199|NCT00441012|3612538|FG000|COMPLETED|Overall Study||252
2904200|NCT00441012|3612539|FG001|COMPLETED|Overall Study||263
2904201|NCT00441012|3612538|FG000|NOT COMPLETED|Overall Study||18
2904202|NCT00441012|3612539|FG001|NOT COMPLETED|Overall Study||13
2904203|NCT00441064|3612547|FG000|STARTED|Overall Study||69
2904204|NCT00441064|3612548|FG001|STARTED|Overall Study||63
2904205|NCT00441064|3612547|FG000|Safety Population (SP)|Overall Study||69
2904206|NCT00441064|3612548|FG001|Safety Population (SP)|Overall Study||63
2904207|NCT00441064|3612547|FG000|Intent-to-treat (ITT) Population|Overall Study||61
2904208|NCT00441064|3612548|FG001|Intent-to-treat (ITT) Population|Overall Study||57
2904209|NCT00441064|3612547|FG000|COMPLETED|Overall Study||59
2904210|NCT00441064|3612548|FG001|COMPLETED|Overall Study||56
2904211|NCT00441064|3612547|FG000|NOT COMPLETED|Overall Study||10
2904212|NCT00441064|3612548|FG001|NOT COMPLETED|Overall Study||7
2904213|NCT00441090|3612559|FG000|STARTED|Overall Study||15
2904214|NCT00441090|3612560|FG001|STARTED|Overall Study||15
2904215|NCT00441090|3612561|FG002|STARTED|Overall Study||14
2904216|NCT00441090|3612562|FG003|STARTED|Overall Study||15
2904217|NCT00441090|3612563|FG004|STARTED|Overall Study||5
2904218|NCT00441090|3612559|FG000|COMPLETED|Overall Study||13
3171358|NCT01933776|3898517|FG001|STARTED|Overall Study||20
3171359|NCT01933776|3898516|FG000|COMPLETED|Overall Study||20
3316173|NCT03107611|4049465|FG002|STARTED|Overall Study||221
2904219|NCT00441090|3612560|FG001|COMPLETED|Overall Study||14
2904220|NCT00441090|3612561|FG002|COMPLETED|Overall Study||12
2904221|NCT00441090|3612562|FG003|COMPLETED|Overall Study||13
2904222|NCT00441090|3612563|FG004|COMPLETED|Overall Study||5
2904223|NCT00441090|3612559|FG000|NOT COMPLETED|Overall Study||2
2904224|NCT00441090|3612560|FG001|NOT COMPLETED|Overall Study||1
2904225|NCT00441090|3612561|FG002|NOT COMPLETED|Overall Study||2
2904226|NCT00441090|3612562|FG003|NOT COMPLETED|Overall Study||2
2904227|NCT00441090|3612563|FG004|NOT COMPLETED|Overall Study||0
2904228|NCT00441103|3612577|FG000|STARTED|Overall Study|Intent to treat (ITT) population: all participants who received at least one dose of study drug.|120
2904229|NCT00441103|3612578|FG001|STARTED|Overall Study|Intent to treat (ITT) population: all participants who received at least one dose of study drug.|60
2904230|NCT00441103|3612577|FG000|COMPLETED|Overall Study||109
2904231|NCT00441103|3612578|FG001|COMPLETED|Overall Study||56
2904232|NCT00441103|3612577|FG000|NOT COMPLETED|Overall Study||11
2904233|NCT00441103|3612578|FG001|NOT COMPLETED|Overall Study||4
3316174|NCT03107611|4049463|FG000|Dosed|Overall Study||215
3316175|NCT03107611|4049464|FG001|Dosed|Overall Study||214
2904234|NCT00441116|3612587|FG000|STARTED|Overall Study||76
2904235|NCT00441116|3612588|FG001|STARTED|Overall Study||77
2904236|NCT00441116|3612587|FG000|COMPLETED|Overall Study||73
2904237|NCT00441116|3612588|FG001|COMPLETED|Overall Study||75
2904238|NCT00441116|3612587|FG000|NOT COMPLETED|Overall Study||3
2904239|NCT00441116|3612588|FG001|NOT COMPLETED|Overall Study||2
2904240|NCT00441129|3612596|FG000|STARTED|Overall Study||60
2904241|NCT00441129|3612597|FG001|STARTED|Overall Study||55
2904242|NCT00441129|3612596|FG000|COMPLETED|Overall Study||54
2904243|NCT00441129|3612597|FG001|COMPLETED|Overall Study||41
2904244|NCT00441129|3612596|FG000|NOT COMPLETED|Overall Study||6
2904245|NCT00441129|3612597|FG001|NOT COMPLETED|Overall Study||14
2904246|NCT00441142|3612607|FG000|STARTED|Overall Study||6
2904247|NCT00441142|3612608|FG001|STARTED|Overall Study||7
2904248|NCT00441142|3612609|FG002|STARTED|Overall Study||29
2904249|NCT00441142|3612610|FG003|STARTED|Overall Study||69
2904250|NCT00441142|3612607|FG000|COMPLETED|Overall Study||0
2904251|NCT00441142|3612608|FG001|COMPLETED|Overall Study||0
2904252|NCT00441142|3612609|FG002|COMPLETED|Overall Study||7
2904253|NCT00441142|3612610|FG003|COMPLETED|Overall Study||1
2904254|NCT00441142|3612607|FG000|NOT COMPLETED|Overall Study||6
2904255|NCT00441142|3612608|FG001|NOT COMPLETED|Overall Study||7
2904256|NCT00441142|3612609|FG002|NOT COMPLETED|Overall Study||22
2904257|NCT00441142|3612610|FG003|NOT COMPLETED|Overall Study||68
3171360|NCT01933776|3898517|FG001|COMPLETED|Overall Study||20
3316176|NCT03107611|4049465|FG002|Dosed|Overall Study||220
3316177|NCT03107611|4049463|FG000|COMPLETED|Overall Study||210
2904258|NCT00441168|3612624|FG000|STARTED|Treatment Period||17
2904259|NCT00441168|3612625|FG001|STARTED|Treatment Period||13
2904260|NCT00441168|3612624|FG000|TREATED|Treatment Period||16
2904261|NCT00441168|3612625|FG001|TREATED|Treatment Period||13
2904262|NCT00441168|3612624|FG000|COMPLETED|Treatment Period||6
2904263|NCT00441168|3612625|FG001|COMPLETED|Treatment Period||7
2904264|NCT00441168|3612624|FG000|NOT COMPLETED|Treatment Period||11
2904265|NCT00441168|3612625|FG001|NOT COMPLETED|Treatment Period||6
2904266|NCT00441168|3612624|FG000|STARTED|Follow-up Period|Subjects who did not complete the treatment period could be entered into the follow-up period|17
3171361|NCT01933776|3898516|FG000|NOT COMPLETED|Overall Study||0
3171362|NCT01933776|3898517|FG001|NOT COMPLETED|Overall Study||0
3171363|NCT01933789|3898532|FG000|STARTED|Overall Study||65
2904267|NCT00441168|3612625|FG001|STARTED|Follow-up Period|Subjects who did not complete the treatment period could be entered into the follow-up period|13
2904268|NCT00441168|3612624|FG000|COMPLETED|Follow-up Period||5
2904269|NCT00441168|3612625|FG001|COMPLETED|Follow-up Period||4
2904270|NCT00441168|3612624|FG000|NOT COMPLETED|Follow-up Period||12
2904271|NCT00441168|3612625|FG001|NOT COMPLETED|Follow-up Period||9
2904272|NCT00441259|3612633|FG000|STARTED|Overall Study||48
2904273|NCT00441259|3612634|FG001|STARTED|Overall Study||48
2904274|NCT00441259|3612633|FG000|COMPLETED|Overall Study||48
2904275|NCT00441259|3612634|FG001|COMPLETED|Overall Study||48
2904276|NCT00441259|3612633|FG000|NOT COMPLETED|Overall Study||0
2904277|NCT00441259|3612634|FG001|NOT COMPLETED|Overall Study||0
2904278|NCT00441285|3612645|FG000|STARTED|Overall Study||16
2904279|NCT00441285|3612646|FG001|STARTED|Overall Study||16
2904280|NCT00441285|3612647|FG002|STARTED|Overall Study||41
2904281|NCT00441285|3612648|FG003|STARTED|Overall Study||40
2904282|NCT00441285|3612649|FG004|STARTED|Overall Study||43
2904283|NCT00441285|3612645|FG000|COMPLETED|Overall Study||16
2904284|NCT00441285|3612646|FG001|COMPLETED|Overall Study||16
2904285|NCT00441285|3612647|FG002|COMPLETED|Overall Study||41
2904286|NCT00441285|3612648|FG003|COMPLETED|Overall Study||40
2904287|NCT00441285|3612649|FG004|COMPLETED|Overall Study||43
2904288|NCT00441285|3612645|FG000|NOT COMPLETED|Overall Study||0
2904289|NCT00441285|3612646|FG001|NOT COMPLETED|Overall Study||0
2904290|NCT00441285|3612647|FG002|NOT COMPLETED|Overall Study||0
2904291|NCT00441285|3612648|FG003|NOT COMPLETED|Overall Study||0
2904292|NCT00441285|3612649|FG004|NOT COMPLETED|Overall Study||0
2904293|NCT00441337|3612665|FG000|STARTED|Overall Study||6
2904294|NCT00441337|3612666|FG001|STARTED|Overall Study||6
2904295|NCT00441337|3612667|FG002|STARTED|Overall Study||6
2904296|NCT00441337|3612668|FG003|STARTED|Overall Study||21
2904297|NCT00441337|3612665|FG000|COMPLETED|Overall Study||0
2904298|NCT00441337|3612666|FG001|COMPLETED|Overall Study||0
2904299|NCT00441337|3612667|FG002|COMPLETED|Overall Study||0
2904300|NCT00441337|3612668|FG003|COMPLETED|Overall Study||0
2904301|NCT00441337|3612665|FG000|NOT COMPLETED|Overall Study||6
2904302|NCT00441337|3612666|FG001|NOT COMPLETED|Overall Study||6
2904303|NCT00441337|3612667|FG002|NOT COMPLETED|Overall Study||6
2904304|NCT00441337|3612668|FG003|NOT COMPLETED|Overall Study||21
2904305|NCT00441350|3612688|FG000|STARTED|Phase A: Randomization to Week 8||285
2904306|NCT00441350|3612689|FG001|STARTED|Phase A: Randomization to Week 8||561
2904307|NCT00441350|3612690|FG002|STARTED|Phase A: Randomization to Week 8||0
2904308|NCT00441350|3612691|FG003|STARTED|Phase A: Randomization to Week 8||0
2904309|NCT00441350|3612692|FG004|STARTED|Phase A: Randomization to Week 8||0
2904310|NCT00441350|3612693|FG005|STARTED|Phase A: Randomization to Week 8||0
2904311|NCT00441350|3612688|FG000|COMPLETED|Phase A: Randomization to Week 8||268
2904312|NCT00441350|3612689|FG001|COMPLETED|Phase A: Randomization to Week 8||524
2904313|NCT00441350|3612690|FG002|COMPLETED|Phase A: Randomization to Week 8||0
2904314|NCT00441350|3612691|FG003|COMPLETED|Phase A: Randomization to Week 8||0
2904315|NCT00441350|3612692|FG004|COMPLETED|Phase A: Randomization to Week 8||0
2904316|NCT00441350|3612693|FG005|COMPLETED|Phase A: Randomization to Week 8||0
2904317|NCT00441350|3612688|FG000|NOT COMPLETED|Phase A: Randomization to Week 8||17
2904318|NCT00441350|3612689|FG001|NOT COMPLETED|Phase A: Randomization to Week 8||37
2904319|NCT00441350|3612690|FG002|NOT COMPLETED|Phase A: Randomization to Week 8||0
2904320|NCT00441350|3612691|FG003|NOT COMPLETED|Phase A: Randomization to Week 8||0
2904321|NCT00441350|3612692|FG004|NOT COMPLETED|Phase A: Randomization to Week 8||0
2904322|NCT00441350|3612693|FG005|NOT COMPLETED|Phase A: Randomization to Week 8||0
2904323|NCT00441350|3612688|FG000|STARTED|Phase B: Week 8 to Week 16||0
2904324|NCT00441350|3612689|FG001|STARTED|Phase B: Week 8 to Week 16||0
2904325|NCT00441350|3612690|FG002|STARTED|Phase B: Week 8 to Week 16||129
2904326|NCT00441350|3612691|FG003|STARTED|Phase B: Week 8 to Week 16||139
2904327|NCT00441350|3612692|FG004|STARTED|Phase B: Week 8 to Week 16||336
2904328|NCT00441350|3612693|FG005|STARTED|Phase B: Week 8 to Week 16||188
2904329|NCT00441350|3612688|FG000|COMPLETED|Phase B: Week 8 to Week 16||0
2904330|NCT00441350|3612689|FG001|COMPLETED|Phase B: Week 8 to Week 16||0
2904331|NCT00441350|3612690|FG002|COMPLETED|Phase B: Week 8 to Week 16||128
2904332|NCT00441350|3612691|FG003|COMPLETED|Phase B: Week 8 to Week 16||137
2904333|NCT00441350|3612692|FG004|COMPLETED|Phase B: Week 8 to Week 16||333
2904334|NCT00441350|3612693|FG005|COMPLETED|Phase B: Week 8 to Week 16||186
2904335|NCT00441350|3612688|FG000|NOT COMPLETED|Phase B: Week 8 to Week 16||0
2904336|NCT00441350|3612689|FG001|NOT COMPLETED|Phase B: Week 8 to Week 16||0
2904337|NCT00441350|3612690|FG002|NOT COMPLETED|Phase B: Week 8 to Week 16||1
2904338|NCT00441350|3612691|FG003|NOT COMPLETED|Phase B: Week 8 to Week 16||2
2904339|NCT00441350|3612692|FG004|NOT COMPLETED|Phase B: Week 8 to Week 16||3
2904340|NCT00441350|3612693|FG005|NOT COMPLETED|Phase B: Week 8 to Week 16||2
2904341|NCT00441363|3612709|FG000|STARTED|Overall Study||32
2904342|NCT00441363|3612710|FG001|STARTED|Overall Study||34
2904343|NCT00441363|3612709|FG000|COMPLETED|Overall Study|no subject withdrew early since the trial was terminated|15
2904344|NCT00441363|3612710|FG001|COMPLETED|Overall Study||19
2904345|NCT00441363|3612709|FG000|NOT COMPLETED|Overall Study||17
2904346|NCT00441363|3612710|FG001|NOT COMPLETED|Overall Study||15
2904347|NCT00441441|3612718|FG000|STARTED|Overall Study||173
2904348|NCT00441441|3612719|FG001|STARTED|Overall Study||177
2904349|NCT00441441|3612718|FG000|COMPLETED|Overall Study||162
2904350|NCT00441441|3612719|FG001|COMPLETED|Overall Study||163
2904351|NCT00441441|3612718|FG000|NOT COMPLETED|Overall Study||11
2904352|NCT00441441|3612719|FG001|NOT COMPLETED|Overall Study||14
2904353|NCT00441467|3612739|FG000|STARTED|Overall Study||22
2904354|NCT00441467|3612739|FG000|2 Cycles|Overall Study||17
2904355|NCT00441467|3612739|FG000|4 Cycles|Overall Study||7
2904356|NCT00441467|3612739|FG000|COMPLETED|Overall Study||4
2904357|NCT00441467|3612739|FG000|NOT COMPLETED|Overall Study||18
2904358|NCT00441480|3612745|FG000|STARTED|Overall Study||46
2904359|NCT00441480|3612746|FG001|STARTED|Overall Study||45
2904360|NCT00441480|3612745|FG000|COMPLETED|Overall Study||43
2904361|NCT00441480|3612746|FG001|COMPLETED|Overall Study||41
2904362|NCT00441480|3612745|FG000|NOT COMPLETED|Overall Study||3
2904363|NCT00441480|3612746|FG001|NOT COMPLETED|Overall Study||4
2904364|NCT00441545|3612752|FG000|STARTED|First Intervention||95
2904365|NCT00441545|3612753|FG001|STARTED|First Intervention||87
2904366|NCT00441545|3612752|FG000|COMPLETED|First Intervention||77
2904367|NCT00441545|3612753|FG001|COMPLETED|First Intervention||75
2904368|NCT00441545|3612752|FG000|NOT COMPLETED|First Intervention||18
2904369|NCT00441545|3612753|FG001|NOT COMPLETED|First Intervention||12
2904370|NCT00441545|3612752|FG000|STARTED|Washout||77
2904371|NCT00441545|3612753|FG001|STARTED|Washout||75
2904372|NCT00441545|3612752|FG000|COMPLETED|Washout||77
2904373|NCT00441545|3612753|FG001|COMPLETED|Washout||75
2904374|NCT00441545|3612752|FG000|NOT COMPLETED|Washout||0
2904375|NCT00441545|3612753|FG001|NOT COMPLETED|Washout||0
2904376|NCT00441545|3612752|FG000|STARTED|Second Intervention||77
2904377|NCT00441545|3612753|FG001|STARTED|Second Intervention||75
2904378|NCT00441545|3612752|FG000|COMPLETED|Second Intervention||65
2904379|NCT00441545|3612753|FG001|COMPLETED|Second Intervention||68
2904380|NCT00441545|3612752|FG000|NOT COMPLETED|Second Intervention||12
2904381|NCT00441545|3612753|FG001|NOT COMPLETED|Second Intervention||7
2904382|NCT00441558|3612759|FG000|STARTED|Overall Study||1723
2904383|NCT00441558|3612759|FG000|COMPLETED|Overall Study||667
2904384|NCT00441558|3612759|FG000|NOT COMPLETED|Overall Study||1056
2904385|NCT00441584|3612763|FG000|STARTED|Overall Study||117
2904386|NCT00441584|3612763|FG000|COMPLETED|Overall Study||12
2904387|NCT00441584|3612763|FG000|NOT COMPLETED|Overall Study||105
2904388|NCT00441701|3612777|FG000|STARTED|Overall Study||22
2904389|NCT00441701|3612778|FG001|STARTED|Overall Study||11
2904390|NCT00441701|3612779|FG002|STARTED|Overall Study||22
2904391|NCT00441701|3612780|FG003|STARTED|Overall Study||11
2904392|NCT00441701|3612781|FG004|STARTED|Overall Study||22
2904393|NCT00441701|3612782|FG005|STARTED|Overall Study||11
2904394|NCT00441701|3612783|FG006|STARTED|Overall Study||0
2904395|NCT00441701|3612784|FG007|STARTED|Overall Study||0
2904396|NCT00441701|3612785|FG008|STARTED|Overall Study||0
2904397|NCT00441701|3612786|FG009|STARTED|Overall Study||0
2904398|NCT00441701|3612777|FG000|COMPLETED|Overall Study||17
2904399|NCT00441701|3612778|FG001|COMPLETED|Overall Study||7
2904400|NCT00441701|3612779|FG002|COMPLETED|Overall Study||18
2904401|NCT00441701|3612780|FG003|COMPLETED|Overall Study||8
2904402|NCT00441701|3612781|FG004|COMPLETED|Overall Study||20
2904403|NCT00441701|3612782|FG005|COMPLETED|Overall Study||8
2904404|NCT00441701|3612783|FG006|COMPLETED|Overall Study||0
2904405|NCT00441701|3612784|FG007|COMPLETED|Overall Study||0
2904406|NCT00441701|3612785|FG008|COMPLETED|Overall Study||0
2904407|NCT00441701|3612786|FG009|COMPLETED|Overall Study||0
2904408|NCT00441701|3612777|FG000|NOT COMPLETED|Overall Study||5
2904409|NCT00441701|3612778|FG001|NOT COMPLETED|Overall Study||4
2904410|NCT00441701|3612779|FG002|NOT COMPLETED|Overall Study||4
3171364|NCT01933789|3898533|FG001|STARTED|Overall Study||67
3171365|NCT01933789|3898534|FG002|STARTED|Overall Study||2
2904411|NCT00441701|3612780|FG003|NOT COMPLETED|Overall Study||3
2904412|NCT00441701|3612781|FG004|NOT COMPLETED|Overall Study||2
2904413|NCT00441701|3612782|FG005|NOT COMPLETED|Overall Study||3
2904414|NCT00441701|3612783|FG006|NOT COMPLETED|Overall Study||0
2904415|NCT00441701|3612784|FG007|NOT COMPLETED|Overall Study||0
2904416|NCT00441701|3612785|FG008|NOT COMPLETED|Overall Study||0
2904417|NCT00441701|3612786|FG009|NOT COMPLETED|Overall Study||0
2904418|NCT00441727|3612807|FG000|STARTED|Overall Study|ITT/randomised|817
2904419|NCT00441727|3612808|FG001|STARTED|Overall Study|ITT/randomised|804
2904420|NCT00441727|3612809|FG002|STARTED|Overall Study|ITT/randomised|805
2904421|NCT00441727|3612807|FG000|COMPLETED|Overall Study|ITT/randomised|711
2904422|NCT00441727|3612808|FG001|COMPLETED|Overall Study|ITT/randomised|686
2904423|NCT00441727|3612809|FG002|COMPLETED|Overall Study|ITT/randomised|637
2904424|NCT00441727|3612807|FG000|NOT COMPLETED|Overall Study||106
2904425|NCT00441727|3612808|FG001|NOT COMPLETED|Overall Study||118
2904426|NCT00441727|3612809|FG002|NOT COMPLETED|Overall Study||168
2904427|NCT00441766|3612826|FG000|STARTED|Overall Study||53
2904428|NCT00441766|3612827|FG001|STARTED|Overall Study||53
2904429|NCT00441766|3612828|FG002|STARTED|Overall Study||53
2904430|NCT00441766|3612829|FG003|STARTED|Overall Study||54
2904431|NCT00441766|3612826|FG000|COMPLETED|Overall Study||39
2904432|NCT00441766|3612827|FG001|COMPLETED|Overall Study||46
2904433|NCT00441766|3612828|FG002|COMPLETED|Overall Study||44
2904434|NCT00441766|3612829|FG003|COMPLETED|Overall Study||48
2904435|NCT00441766|3612826|FG000|NOT COMPLETED|Overall Study||14
2904436|NCT00441766|3612827|FG001|NOT COMPLETED|Overall Study||7
2904437|NCT00441766|3612828|FG002|NOT COMPLETED|Overall Study||9
2904438|NCT00441766|3612829|FG003|NOT COMPLETED|Overall Study||6
2904439|NCT00441792|3612841|FG000|STARTED|Overall Study||59
2904440|NCT00441792|3612842|FG001|STARTED|Overall Study||63
2904441|NCT00441792|3612841|FG000|COMPLETED|Overall Study||59
2904442|NCT00441792|3612842|FG001|COMPLETED|Overall Study|2 patients lost to follow up in Etomidate arm due to transfer to outside hospital.|61
2904443|NCT00441792|3612841|FG000|NOT COMPLETED|Overall Study||0
2904444|NCT00441792|3612842|FG001|NOT COMPLETED|Overall Study||2
2904445|NCT00441883|3612853|FG000|STARTED|Overall Study||43
2904446|NCT00441883|3612854|FG001|STARTED|Overall Study||32
2904447|NCT00441883|3612855|FG002|STARTED|Overall Study||28
2904448|NCT00441883|3612856|FG003|STARTED|Overall Study||28
2904449|NCT00441883|3612857|FG004|STARTED|Overall Study||45
2904450|NCT00441883|3612853|FG000|ITT Population|Overall Study||43
2904451|NCT00441883|3612854|FG001|ITT Population|Overall Study||30
2904452|NCT00441883|3612855|FG002|ITT Population|Overall Study||30
2904453|NCT00441883|3612856|FG003|ITT Population|Overall Study||30
2904454|NCT00441883|3612857|FG004|ITT Population|Overall Study||43
2904455|NCT00441883|3612853|FG000|Per Protocol Population|Overall Study||38
2904456|NCT00441883|3612854|FG001|Per Protocol Population|Overall Study||29
2904457|NCT00441883|3612855|FG002|Per Protocol Population|Overall Study||25
2904458|NCT00441883|3612856|FG003|Per Protocol Population|Overall Study||24
2904459|NCT00441883|3612857|FG004|Per Protocol Population|Overall Study||38
2904460|NCT00441883|3612853|FG000|Safety Population|Overall Study||43
2904461|NCT00441883|3612854|FG001|Safety Population|Overall Study||32
2904462|NCT00441883|3612855|FG002|Safety Population|Overall Study||28
2904463|NCT00441883|3612856|FG003|Safety Population|Overall Study||28
2904464|NCT00441883|3612857|FG004|Safety Population|Overall Study||45
2904465|NCT00441883|3612853|FG000|COMPLETED|Overall Study||42
2904466|NCT00441883|3612854|FG001|COMPLETED|Overall Study||32
2904467|NCT00441883|3612855|FG002|COMPLETED|Overall Study||28
2904468|NCT00441883|3612856|FG003|COMPLETED|Overall Study||28
2904469|NCT00441883|3612857|FG004|COMPLETED|Overall Study||43
2904470|NCT00441883|3612853|FG000|NOT COMPLETED|Overall Study||1
2904471|NCT00441883|3612854|FG001|NOT COMPLETED|Overall Study||0
2904472|NCT00441883|3612855|FG002|NOT COMPLETED|Overall Study||0
2904473|NCT00441883|3612856|FG003|NOT COMPLETED|Overall Study||0
2904474|NCT00441883|3612857|FG004|NOT COMPLETED|Overall Study||2
2904475|NCT00441974|3612869|FG000|STARTED|Overall Study||1470
2904476|NCT00441974|3612869|FG000|COMPLETED|Overall Study||1342
2904477|NCT00441974|3612869|FG000|NOT COMPLETED|Overall Study||128
2904478|NCT00442013|3612878|FG000|STARTED|Overall Study||157
2904479|NCT00442013|3612879|FG001|STARTED|Overall Study||149
2904480|NCT00442013|3612878|FG000|COMPLETED|Overall Study||131
2904481|NCT00442013|3612879|FG001|COMPLETED|Overall Study||132
2904482|NCT00442013|3612878|FG000|NOT COMPLETED|Overall Study||26
2904483|NCT00442013|3612879|FG001|NOT COMPLETED|Overall Study||17
2904484|NCT00442169|3612892|FG000|STARTED|Part 1||17
2904485|NCT00442169|3612893|FG001|STARTED|Part 1||24
2904486|NCT00442169|3612894|FG002|STARTED|Part 1||40
2904487|NCT00442169|3612895|FG003|STARTED|Part 1||31
2904488|NCT00442169|3612896|FG004|STARTED|Part 1|Participants in Part 2 are not the same as those in Part 1|0
2904489|NCT00442169|3612897|FG005|STARTED|Part 1|Participants in Part 2 are not the same as those in Part 1|0
2904490|NCT00442169|3612892|FG000|COMPLETED|Part 1||17
2904491|NCT00442169|3612893|FG001|COMPLETED|Part 1||24
2904492|NCT00442169|3612894|FG002|COMPLETED|Part 1||40
2904493|NCT00442169|3612895|FG003|COMPLETED|Part 1||31
2904494|NCT00442169|3612896|FG004|COMPLETED|Part 1||0
2904495|NCT00442169|3612897|FG005|COMPLETED|Part 1||0
2904496|NCT00442169|3612892|FG000|NOT COMPLETED|Part 1||0
2904497|NCT00442169|3612893|FG001|NOT COMPLETED|Part 1||0
2904498|NCT00442169|3612894|FG002|NOT COMPLETED|Part 1||0
2904499|NCT00442169|3612895|FG003|NOT COMPLETED|Part 1||0
2904500|NCT00442169|3612896|FG004|NOT COMPLETED|Part 1||0
2904501|NCT00442169|3612897|FG005|NOT COMPLETED|Part 1||0
2904502|NCT00442169|3612892|FG000|STARTED|Part 2|Participants in Part 1 are not the same as those in Part 2|0
2904503|NCT00442169|3612893|FG001|STARTED|Part 2|Participants in Part 1 are not the same as those in Part 2|0
2904504|NCT00442169|3612894|FG002|STARTED|Part 2|Participants in Part 1 are not the same as those in Part 2|0
2904505|NCT00442169|3612895|FG003|STARTED|Part 2|Participants in Part 1 are not the same as those in Part 2|0
2904506|NCT00442169|3612896|FG004|STARTED|Part 2||25
2904507|NCT00442169|3612897|FG005|STARTED|Part 2||57
2904508|NCT00442169|3612892|FG000|COMPLETED|Part 2||0
2904509|NCT00442169|3612893|FG001|COMPLETED|Part 2||0
2904510|NCT00442169|3612894|FG002|COMPLETED|Part 2||0
2904511|NCT00442169|3612895|FG003|COMPLETED|Part 2||0
2904512|NCT00442169|3612896|FG004|COMPLETED|Part 2||25
2904513|NCT00442169|3612897|FG005|COMPLETED|Part 2||57
2904514|NCT00442169|3612892|FG000|NOT COMPLETED|Part 2||0
2904515|NCT00442169|3612893|FG001|NOT COMPLETED|Part 2||0
2904516|NCT00442169|3612894|FG002|NOT COMPLETED|Part 2||0
2904517|NCT00442169|3612895|FG003|NOT COMPLETED|Part 2||0
2904518|NCT00442169|3612896|FG004|NOT COMPLETED|Part 2||0
2904519|NCT00442169|3612897|FG005|NOT COMPLETED|Part 2||0
2904520|NCT00442286|3612914|FG000|STARTED|Overall Study||181
2904521|NCT00442286|3612915|FG001|STARTED|Overall Study||84
2904522|NCT00442286|3612914|FG000|6 Months|Overall Study||177
2904523|NCT00442286|3612915|FG001|6 Months|Overall Study||83
2904524|NCT00442286|3612914|FG000|12 Months|Overall Study||174
2904525|NCT00442286|3612915|FG001|12 Months|Overall Study||82
2904526|NCT00442286|3612914|FG000|COMPLETED|Overall Study||174
2904527|NCT00442286|3612915|FG001|COMPLETED|Overall Study||82
2904528|NCT00442286|3612914|FG000|NOT COMPLETED|Overall Study||7
2904529|NCT00442286|3612915|FG001|NOT COMPLETED|Overall Study||2
2904530|NCT00442364|3612923|FG000|STARTED|Overall Study||60
2904531|NCT00442364|3612923|FG000|COMPLETED|Overall Study||60
2904532|NCT00442364|3612923|FG000|NOT COMPLETED|Overall Study||0
2904533|NCT00442416|3612929|FG000|STARTED|Overall Study||39
2904534|NCT00442416|3612930|FG001|STARTED|Overall Study||41
2904535|NCT00442416|3612929|FG000|COMPLETED|Overall Study||2
2904536|NCT00442416|3612930|FG001|COMPLETED|Overall Study||2
2904537|NCT00442416|3612929|FG000|NOT COMPLETED|Overall Study||37
2904538|NCT00442416|3612930|FG001|NOT COMPLETED|Overall Study||39
2904539|NCT00442468|3612936|FG000|STARTED|Overall Study||1283
2904540|NCT00442468|3612936|FG000|COMPLETED|Overall Study||1100
2904541|NCT00442468|3612936|FG000|NOT COMPLETED|Overall Study||183
2904542|NCT00442507|3612940|FG000|STARTED|Overall Study||6
2904543|NCT00442507|3612940|FG000|COMPLETED|Overall Study||6
2904544|NCT00442507|3612940|FG000|NOT COMPLETED|Overall Study||0
2904545|NCT00442572|3612946|FG000|STARTED|Overall Study||17
2904546|NCT00442572|3612947|FG001|STARTED|Overall Study||4
2904547|NCT00442572|3612946|FG000|COMPLETED|Overall Study||9
2904548|NCT00442572|3612947|FG001|COMPLETED|Overall Study||1
2904549|NCT00442572|3612946|FG000|NOT COMPLETED|Overall Study||8
2904550|NCT00442572|3612947|FG001|NOT COMPLETED|Overall Study||3
2904551|NCT00442598|3612957|FG000|STARTED|Overall Study||7
2904552|NCT00442598|3612958|FG001|STARTED|Overall Study||10
2904553|NCT00442598|3612959|FG002|STARTED|Overall Study||0
2904554|NCT00442598|3612957|FG000|Two Cycles|Overall Study||5
2904555|NCT00442598|3612958|FG001|Two Cycles|Overall Study||6
2904556|NCT00442598|3612959|FG002|Two Cycles|Overall Study||0
2904557|NCT00442598|3612957|FG000|COMPLETED|Overall Study||1
2904558|NCT00442598|3612958|FG001|COMPLETED|Overall Study||2
2904559|NCT00442598|3612959|FG002|COMPLETED|Overall Study||0
2904560|NCT00442598|3612957|FG000|NOT COMPLETED|Overall Study||6
2904561|NCT00442598|3612958|FG001|NOT COMPLETED|Overall Study||8
2904562|NCT00442598|3612959|FG002|NOT COMPLETED|Overall Study||0
2904563|NCT00442611|3612968|FG000|STARTED|Overall Study||7
2904564|NCT00442611|3612969|FG001|STARTED|Overall Study||3
2904565|NCT00442611|3612968|FG000|COMPLETED|Overall Study||6
2904566|NCT00442611|3612969|FG001|COMPLETED|Overall Study||3
2904567|NCT00442611|3612968|FG000|NOT COMPLETED|Overall Study||1
2904568|NCT00442611|3612969|FG001|NOT COMPLETED|Overall Study||0
2904569|NCT00442689|3612978|FG000|STARTED|Overall Study||21
2904570|NCT00442689|3612979|FG001|STARTED|Overall Study||24
2904571|NCT00442689|3612980|FG002|STARTED|Overall Study||22
2904572|NCT00442689|3612978|FG000|COMPLETED|Overall Study||11
2904573|NCT00442689|3612979|FG001|COMPLETED|Overall Study||13
2904574|NCT00442689|3612980|FG002|COMPLETED|Overall Study||13
2904575|NCT00442689|3612978|FG000|NOT COMPLETED|Overall Study||10
2904576|NCT00442689|3612979|FG001|NOT COMPLETED|Overall Study||11
2904577|NCT00442689|3612980|FG002|NOT COMPLETED|Overall Study||9
2904578|NCT00442702|3612990|FG000|STARTED|Titration Period||114
2904579|NCT00442702|3612991|FG001|STARTED|Titration Period||114
2904580|NCT00442702|3612990|FG000|Safety Population|Titration Period|One patient was randomized to darbepoetin alfa but treated by mistake with Mircera|115
2904581|NCT00442702|3612991|FG001|Safety Population|Titration Period||113
2904582|NCT00442702|3612990|FG000|COMPLETED|Titration Period||102
2904583|NCT00442702|3612991|FG001|COMPLETED|Titration Period||111
2904584|NCT00442702|3612990|FG000|NOT COMPLETED|Titration Period||12
2904585|NCT00442702|3612991|FG001|NOT COMPLETED|Titration Period||3
2904586|NCT00442702|3612990|FG000|STARTED|Evaluation Period||102
3171366|NCT01933789|3898535|FG003|STARTED|Overall Study||2
3171367|NCT01933789|3898536|FG004|STARTED|Overall Study||249
3171368|NCT01933789|3898537|FG005|STARTED|Overall Study||288
2904587|NCT00442702|3612991|FG001|STARTED|Evaluation Period||111
2904588|NCT00442702|3612990|FG000|COMPLETED|Evaluation Period||97
2904589|NCT00442702|3612991|FG001|COMPLETED|Evaluation Period||107
2904590|NCT00442702|3612990|FG000|NOT COMPLETED|Evaluation Period||5
2904591|NCT00442702|3612991|FG001|NOT COMPLETED|Evaluation Period||4
2904592|NCT00442767|3612997|FG000|STARTED|Overall Study||8
2904593|NCT00442767|3612997|FG000|COMPLETED|Overall Study||8
2904594|NCT00442767|3612997|FG000|NOT COMPLETED|Overall Study||0
2904595|NCT00442936|3613007|FG000|STARTED|Overall Study||333
2904596|NCT00442936|3613008|FG001|STARTED|Overall Study||354
2904597|NCT00442936|3613009|FG002|STARTED|Overall Study||345
2904598|NCT00442936|3613010|FG003|STARTED|Overall Study||348
2904599|NCT00442936|3613007|FG000|COMPLETED|Overall Study||332
2904600|NCT00442936|3613008|FG001|COMPLETED|Overall Study||354
2904601|NCT00442936|3613009|FG002|COMPLETED|Overall Study||344
2904602|NCT00442936|3613010|FG003|COMPLETED|Overall Study||347
2904603|NCT00442936|3613007|FG000|NOT COMPLETED|Overall Study||1
2904604|NCT00442936|3613008|FG001|NOT COMPLETED|Overall Study||0
2904605|NCT00442936|3613009|FG002|NOT COMPLETED|Overall Study||1
2904606|NCT00442936|3613010|FG003|NOT COMPLETED|Overall Study||1
2904607|NCT00442962|3613020|FG000|STARTED|Overall Study||54
2904608|NCT00442962|3613020|FG000|Primary Outcome Evaluation|Overall Study|Primary outcome evaluation at week 24.|52
2904609|NCT00442962|3613020|FG000|COMPLETED|Overall Study|Completed 48 weeks of follow-up.|46
3171369|NCT01933789|3898538|FG006|STARTED|Overall Study||58
2904610|NCT00442962|3613020|FG000|NOT COMPLETED|Overall Study||8
2904611|NCT00443053|3613026|FG000|STARTED|Overall Study||1502
2904612|NCT00443053|3613027|FG001|STARTED|Overall Study||1500
2904613|NCT00443053|3613026|FG000|COMPLETED|Overall Study||1481
2904614|NCT00443053|3613027|FG001|COMPLETED|Overall Study||1467
2904615|NCT00443053|3613026|FG000|NOT COMPLETED|Overall Study||21
2904616|NCT00443053|3613027|FG001|NOT COMPLETED|Overall Study||33
2904617|NCT00443079|3613035|FG000|STARTED|Overall Study||3
2904618|NCT00443079|3613036|FG001|STARTED|Overall Study||3
2904619|NCT00443079|3613035|FG000|COMPLETED|Overall Study||3
2904620|NCT00443079|3613036|FG001|COMPLETED|Overall Study||2
2904621|NCT00443079|3613035|FG000|NOT COMPLETED|Overall Study||0
2904622|NCT00443079|3613036|FG001|NOT COMPLETED|Overall Study||1
2904623|NCT00443118|3613047|FG000|STARTED|Overall Study||515
2904624|NCT00443118|3613048|FG001|STARTED|Overall Study||291
2904625|NCT00443118|3613049|FG002|STARTED|Overall Study||226
2904626|NCT00443118|3613047|FG000|COMPLETED|Overall Study||511
2904627|NCT00443118|3613048|FG001|COMPLETED|Overall Study||290
2904628|NCT00443118|3613049|FG002|COMPLETED|Overall Study||226
2904629|NCT00443118|3613047|FG000|NOT COMPLETED|Overall Study||4
2904630|NCT00443118|3613048|FG001|NOT COMPLETED|Overall Study||1
2904631|NCT00443118|3613049|FG002|NOT COMPLETED|Overall Study||0
2904632|NCT00443209|3613077|FG000|STARTED|Months 1 to 12 Treatment Period||712
2904633|NCT00443209|3613078|FG001|STARTED|Months 1 to 12 Treatment Period||356
2904634|NCT00443209|3613077|FG000|Treated|Months 1 to 12 Treatment Period||641
2904635|NCT00443209|3613078|FG001|Treated|Months 1 to 12 Treatment Period||313
2904636|NCT00443209|3613077|FG000|COMPLETED|Months 1 to 12 Treatment Period|Trial terminated used for participants not completing 12 months of treatment due to trial completion|367
2904637|NCT00443209|3613078|FG001|COMPLETED|Months 1 to 12 Treatment Period|Trial terminated used for participants not completing 12 months of treatment due to trial completion|202
2904638|NCT00443209|3613077|FG000|NOT COMPLETED|Months 1 to 12 Treatment Period||345
2904639|NCT00443209|3613078|FG001|NOT COMPLETED|Months 1 to 12 Treatment Period||154
2904640|NCT00443209|3613077|FG000|STARTED|Months 13 to 18 Treatment Period|The Months 13 to 18 Treatment Period.was optional. 181 participants chose not to continue.|186
2904641|NCT00443209|3613078|FG001|STARTED|Months 13 to 18 Treatment Period|The Months 13 to 18 Treatment Period was optional. 116 participants chose not to continue.|86
2904642|NCT00443209|3613077|FG000|COMPLETED|Months 13 to 18 Treatment Period|Trial terminated used for participants not completing 18 months of treatment due to trial completion|87
2904643|NCT00443209|3613078|FG001|COMPLETED|Months 13 to 18 Treatment Period|Trial terminated used for participants not completing 18 months of treatment due to trial completion|39
2904644|NCT00443209|3613077|FG000|NOT COMPLETED|Months 13 to 18 Treatment Period||99
2904645|NCT00443209|3613078|FG001|NOT COMPLETED|Months 13 to 18 Treatment Period||47
2904646|NCT00443261|3613084|FG000|STARTED|Overall Study||1
2904647|NCT00443261|3613084|FG000|Accrual in 10 Months|Overall Study|Patient died due to progressive disease after cycle 1 of treatment|1
2904648|NCT00443261|3613084|FG000|COMPLETED|Overall Study|Study terminated due to poor accrual and only patient enrolled died|0
2904649|NCT00443261|3613084|FG000|NOT COMPLETED|Overall Study||1
2904650|NCT00443352|3613088|FG000|STARTED|Overall Study||27
2904651|NCT00443352|3613088|FG000|COMPLETED|Overall Study||22
2904652|NCT00443352|3613088|FG000|NOT COMPLETED|Overall Study||5
2904653|NCT00443430|3613094|FG000|STARTED|Overall Study||43
2904654|NCT00443430|3613095|FG001|STARTED|Overall Study||42
2904655|NCT00443430|3613094|FG000|COMPLETED|Overall Study||39
2904656|NCT00443430|3613095|FG001|COMPLETED|Overall Study||38
2904657|NCT00443430|3613094|FG000|NOT COMPLETED|Overall Study||4
2904658|NCT00443430|3613095|FG001|NOT COMPLETED|Overall Study||4
2904659|NCT00443456|3613101|FG000|STARTED|Overall Study||134
2904660|NCT00443456|3613101|FG000|COMPLETED|Overall Study||116
2904661|NCT00443456|3613101|FG000|NOT COMPLETED|Overall Study||18
2904662|NCT00443534|3613109|FG000|STARTED|Overall Study||123
2904663|NCT00443534|3613109|FG000|Treated|Overall Study||122
2904664|NCT00443534|3613109|FG000|COMPLETED|Overall Study||0
2904665|NCT00443534|3613109|FG000|NOT COMPLETED|Overall Study||123
2904666|NCT00443547|3613117|FG000|STARTED|Overall Study|Enrolled and Treated Per Protocol|89
2904667|NCT00443547|3613118|FG001|STARTED|Overall Study|Enrolled and Treated Per Protocol|88
2904668|NCT00443547|3613119|FG002|STARTED|Overall Study|Enrolled and Treated Per Protocol|48
2904669|NCT00443547|3613120|FG003|STARTED|Overall Study|Enrolled and Treated Per Protocol|6
2904670|NCT00443547|3613117|FG000|Evaluated at 12 Months|Overall Study||58
2904671|NCT00443547|3613118|FG001|Evaluated at 12 Months|Overall Study||55
2904672|NCT00443547|3613119|FG002|Evaluated at 12 Months|Overall Study||37
2904673|NCT00443547|3613120|FG003|Evaluated at 12 Months|Overall Study||5
2904674|NCT00443547|3613117|FG000|COMPLETED|Overall Study||44
2904675|NCT00443547|3613118|FG001|COMPLETED|Overall Study||46
2904676|NCT00443547|3613119|FG002|COMPLETED|Overall Study||27
2904677|NCT00443547|3613120|FG003|COMPLETED|Overall Study||4
2904678|NCT00443547|3613117|FG000|NOT COMPLETED|Overall Study||45
2904679|NCT00443547|3613118|FG001|NOT COMPLETED|Overall Study||42
2904680|NCT00443547|3613119|FG002|NOT COMPLETED|Overall Study||21
2904681|NCT00443547|3613120|FG003|NOT COMPLETED|Overall Study||2
2904682|NCT00443560|3613132|FG000|STARTED|Overall Study||1081
2904683|NCT00443560|3613133|FG001|STARTED|Overall Study||1081
2904684|NCT00443560|3613132|FG000|COMPLETED|Overall Study||1021
2904685|NCT00443560|3613133|FG001|COMPLETED|Overall Study||1051
2904686|NCT00443560|3613132|FG000|NOT COMPLETED|Overall Study||60
2904687|NCT00443560|3613133|FG001|NOT COMPLETED|Overall Study||30
2904688|NCT00443599|3613141|FG000|STARTED|Overall Study|Randomly Assigned to Tight Glycemic Control|496
2904689|NCT00443599|3613142|FG001|STARTED|Overall Study|Randomly Assigned to Standard Care|493
2904690|NCT00443599|3613141|FG000|COMPLETED|Overall Study|Included in per-protocol analysis|490
2904691|NCT00443599|3613142|FG001|COMPLETED|Overall Study|Included in per-protocol analysis|490
2904692|NCT00443599|3613141|FG000|NOT COMPLETED|Overall Study||6
2904693|NCT00443599|3613142|FG001|NOT COMPLETED|Overall Study||3
2904694|NCT00443651|3613150|FG000|STARTED|Overall Study||401
2904695|NCT00443651|3613151|FG001|STARTED|Overall Study||176
2904696|NCT00443651|3613150|FG000|Week 24|Overall Study||376
2904697|NCT00443651|3613151|FG001|Week 24|Overall Study||160
2904698|NCT00443651|3613150|FG000|Week 48|Overall Study||338
2904699|NCT00443651|3613151|FG001|Week 48|Overall Study||134
2904700|NCT00443651|3613150|FG000|COMPLETED|Overall Study|Completed the study or the safety follow-up period.|306
2904701|NCT00443651|3613151|FG001|COMPLETED|Overall Study|Completed the study or the safety follow-up period.|118
2904702|NCT00443651|3613150|FG000|NOT COMPLETED|Overall Study||95
2904703|NCT00443651|3613151|FG001|NOT COMPLETED|Overall Study||58
2904704|NCT00443703|3613159|FG000|STARTED|Overall Study||177
2904705|NCT00443703|3613160|FG001|STARTED|Overall Study||175
2904706|NCT00443703|3613159|FG000|Treated|Overall Study||174
2904707|NCT00443703|3613160|FG001|Treated|Overall Study||174
2904708|NCT00443703|3613159|FG000|COMPLETED|Overall Study||149
2904709|NCT00443703|3613160|FG001|COMPLETED|Overall Study||157
2904710|NCT00443703|3613159|FG000|NOT COMPLETED|Overall Study||28
2904711|NCT00443703|3613160|FG001|NOT COMPLETED|Overall Study||18
2904712|NCT00443729|3613168|FG000|STARTED|Overall Study||176
2904713|NCT00443729|3613169|FG001|STARTED|Overall Study||179
2904714|NCT00443729|3613168|FG000|Treated|Overall Study||176
2904715|NCT00443729|3613169|FG001|Treated|Overall Study||178
2904716|NCT00443729|3613168|FG000|COMPLETED|Overall Study||166
2904717|NCT00443729|3613169|FG001|COMPLETED|Overall Study||172
2904718|NCT00443729|3613168|FG000|NOT COMPLETED|Overall Study||10
2904719|NCT00443729|3613169|FG001|NOT COMPLETED|Overall Study||7
2904720|NCT00443755|3613177|FG000|STARTED|Overall Study||14
2904721|NCT00443755|3613178|FG001|STARTED|Overall Study||14
2904722|NCT00443755|3613177|FG000|COMPLETED|Overall Study||12
2904723|NCT00443755|3613178|FG001|COMPLETED|Overall Study||13
2904724|NCT00443755|3613177|FG000|NOT COMPLETED|Overall Study||2
2904725|NCT00443755|3613178|FG001|NOT COMPLETED|Overall Study||1
2904726|NCT00443781|3613184|FG000|STARTED|Overall Study||62
2904727|NCT00443781|3613184|FG000|COMPLETED|Overall Study||37
2904728|NCT00443781|3613184|FG000|NOT COMPLETED|Overall Study||25
2904729|NCT00443820|3613192|FG000|STARTED|Overall Study||133
2904730|NCT00443820|3613193|FG001|STARTED|Overall Study||130
2904731|NCT00443820|3613194|FG002|STARTED|Overall Study||135
2904732|NCT00443820|3613195|FG003|STARTED|Overall Study||128
2904733|NCT00443820|3613192|FG000|Safety Population|Overall Study|Participants who received study drug and had at least one post-baseline safety assessment.|131
2904734|NCT00443820|3613193|FG001|Safety Population|Overall Study||129
2904735|NCT00443820|3613194|FG002|Safety Population|Overall Study||134
2904736|NCT00443820|3613195|FG003|Safety Population|Overall Study||126
2904737|NCT00443820|3613192|FG000|COMPLETED|Overall Study||112
2904738|NCT00443820|3613193|FG001|COMPLETED|Overall Study|A participant from this gr. discont'ed due to renal failure, was counted as an AE and also as a SAE.|111
2904739|NCT00443820|3613194|FG002|COMPLETED|Overall Study||117
2904740|NCT00443820|3613195|FG003|COMPLETED|Overall Study||111
2904741|NCT00443820|3613192|FG000|NOT COMPLETED|Overall Study||21
2904742|NCT00443820|3613193|FG001|NOT COMPLETED|Overall Study||19
2904743|NCT00443820|3613194|FG002|NOT COMPLETED|Overall Study||18
2904744|NCT00443820|3613195|FG003|NOT COMPLETED|Overall Study||17
2904745|NCT00443846|3613207|FG000|STARTED|Overall Study||124
2904746|NCT00443846|3613208|FG001|STARTED|Overall Study||123
2904747|NCT00443846|3613207|FG000|Vaccinated|Overall Study||116
2904748|NCT00443846|3613208|FG001|Vaccinated|Overall Study||123
2904749|NCT00443846|3613207|FG000|COMPLETED|Overall Study||113
2904750|NCT00443846|3613208|FG001|COMPLETED|Overall Study||117
2904751|NCT00443846|3613207|FG000|NOT COMPLETED|Overall Study||11
2904752|NCT00443846|3613208|FG001|NOT COMPLETED|Overall Study||6
2904753|NCT00443872|3613214|FG000|STARTED|Overall Study||77
2904754|NCT00443872|3613214|FG000|COMPLETED|Overall Study||60
2904755|NCT00443872|3613214|FG000|NOT COMPLETED|Overall Study||17
2904756|NCT00443898|3613231|FG000|STARTED|Overall Study||126
2904757|NCT00443898|3613232|FG001|STARTED|Overall Study||128
2904758|NCT00443898|3613233|FG002|STARTED|Overall Study||136
2904759|NCT00443898|3613234|FG003|STARTED|Overall Study||128
2904760|NCT00443898|3613231|FG000|COMPLETED|Overall Study||102
2904761|NCT00443898|3613232|FG001|COMPLETED|Overall Study||103
2904762|NCT00443898|3613233|FG002|COMPLETED|Overall Study||107
2904763|NCT00443898|3613234|FG003|COMPLETED|Overall Study||110
2904764|NCT00443898|3613231|FG000|NOT COMPLETED|Overall Study||24
2904765|NCT00443898|3613232|FG001|NOT COMPLETED|Overall Study||25
2904766|NCT00443898|3613233|FG002|NOT COMPLETED|Overall Study||29
2904767|NCT00443898|3613234|FG003|NOT COMPLETED|Overall Study||18
2904768|NCT00444028|3613250|FG000|STARTED|Overall Study||14
2904769|NCT00444028|3613251|FG001|STARTED|Overall Study||7
2904770|NCT00444028|3613252|FG002|STARTED|Overall Study||8
2904771|NCT00444028|3613253|FG003|STARTED|Overall Study||6
2904772|NCT00444028|3613254|FG004|STARTED|Overall Study||7
2904773|NCT00444028|3613255|FG005|STARTED|Overall Study||8
2904774|NCT00444028|3613250|FG000|COMPLETED|Overall Study||14
2904775|NCT00444028|3613251|FG001|COMPLETED|Overall Study||7
2904776|NCT00444028|3613252|FG002|COMPLETED|Overall Study||8
2904777|NCT00444028|3613253|FG003|COMPLETED|Overall Study||6
2904778|NCT00444028|3613254|FG004|COMPLETED|Overall Study||7
2904779|NCT00444028|3613255|FG005|COMPLETED|Overall Study||8
2904780|NCT00444028|3613250|FG000|NOT COMPLETED|Overall Study||0
2904781|NCT00444028|3613251|FG001|NOT COMPLETED|Overall Study||0
2904782|NCT00444028|3613252|FG002|NOT COMPLETED|Overall Study||0
2904783|NCT00444028|3613253|FG003|NOT COMPLETED|Overall Study||0
2904784|NCT00444028|3613254|FG004|NOT COMPLETED|Overall Study||0
2904785|NCT00444028|3613255|FG005|NOT COMPLETED|Overall Study||0
2904786|NCT00444067|3613270|FG000|STARTED|Overall Study||74
2904787|NCT00444067|3613271|FG001|STARTED|Overall Study||24
2904788|NCT00444067|3613270|FG000|COMPLETED|Overall Study||74
2904789|NCT00444067|3613271|FG001|COMPLETED|Overall Study||23
2904790|NCT00444067|3613270|FG000|NOT COMPLETED|Overall Study||0
2904791|NCT00444067|3613271|FG001|NOT COMPLETED|Overall Study||1
2904792|NCT00444080|3613279|FG000|STARTED|Overall Study||61
2904793|NCT00444080|3613280|FG001|STARTED|Overall Study||59
2904794|NCT00444080|3613279|FG000|COMPLETED|Overall Study||61
2904795|NCT00444080|3613280|FG001|COMPLETED|Overall Study||59
2904796|NCT00444080|3613279|FG000|NOT COMPLETED|Overall Study||0
2904797|NCT00444080|3613280|FG001|NOT COMPLETED|Overall Study||0
2904798|NCT00444106|3613292|FG000|STARTED|Overall Study||159
2904799|NCT00444106|3613293|FG001|STARTED|Overall Study||53
2904800|NCT00444106|3613294|FG002|STARTED|Overall Study||53
2904801|NCT00444106|3613292|FG000|Completed Treatment Period|Overall Study||159
2904802|NCT00444106|3613293|FG001|Completed Treatment Period|Overall Study||53
2904803|NCT00444106|3613294|FG002|Completed Treatment Period|Overall Study||53
2904804|NCT00444106|3613292|FG000|COMPLETED|Overall Study||157
2904805|NCT00444106|3613293|FG001|COMPLETED|Overall Study||52
2904806|NCT00444106|3613294|FG002|COMPLETED|Overall Study||52
2904807|NCT00444106|3613292|FG000|NOT COMPLETED|Overall Study||2
2904808|NCT00444106|3613293|FG001|NOT COMPLETED|Overall Study||1
2904809|NCT00444106|3613294|FG002|NOT COMPLETED|Overall Study||1
2904810|NCT00444145|3613305|FG000|STARTED|Overall Study||38
2904811|NCT00444145|3613305|FG000|COMPLETED|Overall Study||19
2904812|NCT00444145|3613305|FG000|NOT COMPLETED|Overall Study||19
2904813|NCT00444275|3613312|FG000|STARTED|Initial Treatment Phase||2156
2904814|NCT00444275|3613313|FG001|STARTED|Initial Treatment Phase||873
2904815|NCT00444275|3613314|FG002|STARTED|Initial Treatment Phase||0
2904816|NCT00444275|3613315|FG003|STARTED|Initial Treatment Phase||0
2904817|NCT00444275|3613316|FG004|STARTED|Initial Treatment Phase||0
2904818|NCT00444275|3613312|FG000|COMPLETED|Initial Treatment Phase||1908
2904819|NCT00444275|3613313|FG001|COMPLETED|Initial Treatment Phase||777
2904820|NCT00444275|3613314|FG002|COMPLETED|Initial Treatment Phase||0
2904821|NCT00444275|3613315|FG003|COMPLETED|Initial Treatment Phase||0
2904822|NCT00444275|3613316|FG004|COMPLETED|Initial Treatment Phase||0
2904823|NCT00444275|3613312|FG000|NOT COMPLETED|Initial Treatment Phase||248
2904824|NCT00444275|3613313|FG001|NOT COMPLETED|Initial Treatment Phase||96
2904825|NCT00444275|3613314|FG002|NOT COMPLETED|Initial Treatment Phase||0
2904826|NCT00444275|3613315|FG003|NOT COMPLETED|Initial Treatment Phase||0
2904827|NCT00444275|3613316|FG004|NOT COMPLETED|Initial Treatment Phase||0
2904828|NCT00444275|3613312|FG000|STARTED|Maintenance Treatment Phase||0
2904829|NCT00444275|3613313|FG001|STARTED|Maintenance Treatment Phase||0
2904830|NCT00444275|3613314|FG002|STARTED|Maintenance Treatment Phase||908
2904831|NCT00444275|3613315|FG003|STARTED|Maintenance Treatment Phase||897
2904832|NCT00444275|3613316|FG004|STARTED|Maintenance Treatment Phase||880
2904833|NCT00444275|3613312|FG000|COMPLETED|Maintenance Treatment Phase||0
2904834|NCT00444275|3613313|FG001|COMPLETED|Maintenance Treatment Phase||0
2904835|NCT00444275|3613314|FG002|COMPLETED|Maintenance Treatment Phase||747
2904836|NCT00444275|3613315|FG003|COMPLETED|Maintenance Treatment Phase||764
2904837|NCT00444275|3613316|FG004|COMPLETED|Maintenance Treatment Phase||701
2904838|NCT00444275|3613312|FG000|NOT COMPLETED|Maintenance Treatment Phase||0
2904839|NCT00444275|3613313|FG001|NOT COMPLETED|Maintenance Treatment Phase||0
2904840|NCT00444275|3613314|FG002|NOT COMPLETED|Maintenance Treatment Phase||161
2904841|NCT00444275|3613315|FG003|NOT COMPLETED|Maintenance Treatment Phase||133
2904842|NCT00444275|3613316|FG004|NOT COMPLETED|Maintenance Treatment Phase||179
2904843|NCT00444457|3613335|FG000|STARTED|Infant Series||489
2904844|NCT00444457|3613336|FG001|STARTED|Infant Series||488
2904845|NCT00444457|3613337|FG002|STARTED|Infant Series||489
2904846|NCT00444457|3613338|FG003|STARTED|Infant Series||246
2904847|NCT00444457|3613335|FG000|Vaccinated Dose 1|Infant Series||486
3171370|NCT01933789|3898539|FG007|STARTED|Overall Study||61
3171371|NCT01933789|3898540|FG008|STARTED|Overall Study||25
3171372|NCT01933789|3898532|FG000|Had Target Visit|Overall Study|Had target visit(s) completed before clinician or patient withdrawal|61
3171801|NCT01937299|3899007|FG000|STARTED|Overall Study||117
2904848|NCT00444457|3613336|FG001|Vaccinated Dose 1|Infant Series||484
2904849|NCT00444457|3613337|FG002|Vaccinated Dose 1|Infant Series||485
2904850|NCT00444457|3613338|FG003|Vaccinated Dose 1|Infant Series||244
2904851|NCT00444457|3613335|FG000|Vaccinated Dose 2|Infant Series||455
2904852|NCT00444457|3613336|FG001|Vaccinated Dose 2|Infant Series||447
2904853|NCT00444457|3613337|FG002|Vaccinated Dose 2|Infant Series||455
2904854|NCT00444457|3613338|FG003|Vaccinated Dose 2|Infant Series||228
2904855|NCT00444457|3613335|FG000|Vaccinated Dose 3|Infant Series||442
2904856|NCT00444457|3613336|FG001|Vaccinated Dose 3|Infant Series||435
2904857|NCT00444457|3613337|FG002|Vaccinated Dose 3|Infant Series||438
2904858|NCT00444457|3613338|FG003|Vaccinated Dose 3|Infant Series||225
2904859|NCT00444457|3613335|FG000|COMPLETED|Infant Series||435
2904860|NCT00444457|3613336|FG001|COMPLETED|Infant Series||427
2904861|NCT00444457|3613337|FG002|COMPLETED|Infant Series||428
2904862|NCT00444457|3613338|FG003|COMPLETED|Infant Series||218
2904863|NCT00444457|3613335|FG000|NOT COMPLETED|Infant Series||54
2904864|NCT00444457|3613336|FG001|NOT COMPLETED|Infant Series||61
2904865|NCT00444457|3613337|FG002|NOT COMPLETED|Infant Series||61
2904866|NCT00444457|3613338|FG003|NOT COMPLETED|Infant Series||28
2904867|NCT00444457|3613335|FG000|STARTED|After Infant Series||435
2904868|NCT00444457|3613336|FG001|STARTED|After Infant Series||427
2904869|NCT00444457|3613337|FG002|STARTED|After Infant Series||427
2904870|NCT00444457|3613338|FG003|STARTED|After Infant Series||218
2904871|NCT00444457|3613335|FG000|COMPLETED|After Infant Series|Not completed=Withdrawn after infant series|415
2904872|NCT00444457|3613336|FG001|COMPLETED|After Infant Series|Not completed=Withdrawn after infant series|397
2904873|NCT00444457|3613337|FG002|COMPLETED|After Infant Series|Not completed=Withdrawn after infant series|408
2904874|NCT00444457|3613338|FG003|COMPLETED|After Infant Series|Not completed=Withdrawn after infant series|208
2904875|NCT00444457|3613335|FG000|NOT COMPLETED|After Infant Series||20
2904876|NCT00444457|3613336|FG001|NOT COMPLETED|After Infant Series||30
2904877|NCT00444457|3613337|FG002|NOT COMPLETED|After Infant Series||19
2904878|NCT00444457|3613338|FG003|NOT COMPLETED|After Infant Series||10
2904879|NCT00444457|3613335|FG000|STARTED|Toddler Dose|Vaccinated toddler dose|415
2904880|NCT00444457|3613336|FG001|STARTED|Toddler Dose|Vaccinated toddler dose|397
2904881|NCT00444457|3613337|FG002|STARTED|Toddler Dose|Vaccinated toddler dose|408
2904882|NCT00444457|3613338|FG003|STARTED|Toddler Dose|Vaccinated toddler dose|208
2904883|NCT00444457|3613335|FG000|COMPLETED|Toddler Dose||408
2904884|NCT00444457|3613336|FG001|COMPLETED|Toddler Dose||391
2904885|NCT00444457|3613337|FG002|COMPLETED|Toddler Dose||404
2904886|NCT00444457|3613338|FG003|COMPLETED|Toddler Dose||200
2904887|NCT00444457|3613335|FG000|NOT COMPLETED|Toddler Dose||7
2904888|NCT00444457|3613336|FG001|NOT COMPLETED|Toddler Dose||6
2904889|NCT00444457|3613337|FG002|NOT COMPLETED|Toddler Dose||4
2904890|NCT00444457|3613338|FG003|NOT COMPLETED|Toddler Dose||8
2904891|NCT00444535|3613359|FG000|STARTED|Overall Study||52
2904892|NCT00444535|3613359|FG000|COMPLETED|Overall Study||39
2904893|NCT00444535|3613359|FG000|NOT COMPLETED|Overall Study||13
2904894|NCT00444587|3613365|FG000|STARTED|Overall Study||93
2904895|NCT00444587|3613366|FG001|STARTED|Overall Study||16
2904896|NCT00444587|3613365|FG000|COMPLETED|Overall Study||10
2904897|NCT00444587|3613366|FG001|COMPLETED|Overall Study||1
2904898|NCT00444587|3613365|FG000|NOT COMPLETED|Overall Study||83
2904899|NCT00444587|3613366|FG001|NOT COMPLETED|Overall Study||15
2904900|NCT00444600|3613378|FG000|STARTED|Overall Study|Number of eyes|293
2904901|NCT00444600|3613379|FG001|STARTED|Overall Study|Number of eyes|187
2904902|NCT00444600|3613380|FG002|STARTED|Overall Study|Number of eyes|188
2904903|NCT00444600|3613381|FG003|STARTED|Overall Study|Number of eyes|186
2904904|NCT00444600|3613378|FG000|COMPLETED|Overall Study|Number of eyes|274
2904905|NCT00444600|3613379|FG001|COMPLETED|Overall Study|Number of eyes|171
2904906|NCT00444600|3613380|FG002|COMPLETED|Overall Study|Number of eyes|178
2904907|NCT00444600|3613381|FG003|COMPLETED|Overall Study|Number of eyes|176
2904908|NCT00444600|3613378|FG000|NOT COMPLETED|Overall Study||19
2904909|NCT00444600|3613379|FG001|NOT COMPLETED|Overall Study||16
2904910|NCT00444600|3613380|FG002|NOT COMPLETED|Overall Study||10
2904911|NCT00444600|3613381|FG003|NOT COMPLETED|Overall Study||10
2904912|NCT00444626|3613397|FG000|STARTED|Initial Treatment Period||140
2904913|NCT00444626|3613397|FG000|COMPLETED|Initial Treatment Period||128
2904914|NCT00444626|3613397|FG000|NOT COMPLETED|Initial Treatment Period||12
2904915|NCT00444626|3613397|FG000|STARTED|Repeat Treatment Period|23 subjects withdrew after completing the Initial Treatment and did not enter the Repeat Treatment|105
2904916|NCT00444626|3613397|FG000|COMPLETED|Repeat Treatment Period||105
2904917|NCT00444626|3613397|FG000|NOT COMPLETED|Repeat Treatment Period||0
2904918|NCT00444678|3613410|FG000|STARTED|Overall Study||36
2904919|NCT00444678|3613410|FG000|COMPLETED|Overall Study||5
2904920|NCT00444678|3613410|FG000|NOT COMPLETED|Overall Study||31
2904921|NCT00444795|3613414|FG000|STARTED|Overall Study||620
2904922|NCT00444795|3613414|FG000|COMPLETED|Overall Study|Refer to the Safety Analysis Set.|617
2904923|NCT00444795|3613414|FG000|NOT COMPLETED|Overall Study||3
2904924|NCT00444821|3613420|FG000|STARTED|Overall Study||362
2904925|NCT00444821|3613421|FG001|STARTED|Overall Study||366
2904926|NCT00444821|3613420|FG000|Received AAA Repair|Overall Study|Crossed over to AAA repair|122
2904927|NCT00444821|3613421|FG001|Received AAA Repair|Overall Study|Underwent AAA repair per protocol|326
2904928|NCT00444821|3613420|FG000|COMPLETED|Overall Study||0
2904929|NCT00444821|3613421|FG001|COMPLETED|Overall Study||0
2904930|NCT00444821|3613420|FG000|NOT COMPLETED|Overall Study||362
2904931|NCT00444821|3613421|FG001|NOT COMPLETED|Overall Study||366
2904932|NCT00444912|3613429|FG000|STARTED|Overall Study||15
2904933|NCT00444912|3613430|FG001|STARTED|Overall Study||15
2904934|NCT00444912|3613429|FG000|Received Plerixafor|Overall Study||15
2904935|NCT00444912|3613430|FG001|Received Plerixafor|Overall Study||15
2904936|NCT00444912|3613429|FG000|Received Transplant|Overall Study||14
2904937|NCT00444912|3613430|FG001|Received Transplant|Overall Study||14
2904938|NCT00444912|3613429|FG000|COMPLETED|Overall Study||12
2904939|NCT00444912|3613430|FG001|COMPLETED|Overall Study||13
2904940|NCT00444912|3613429|FG000|NOT COMPLETED|Overall Study||3
2904941|NCT00444912|3613430|FG001|NOT COMPLETED|Overall Study||2
2904942|NCT00444925|3613439|FG000|STARTED|Single-blind Placebo Run-In Period||2446
2904943|NCT00444925|3613440|FG001|STARTED|Single-blind Placebo Run-In Period||0
2904944|NCT00444925|3613441|FG002|STARTED|Single-blind Placebo Run-In Period||0
2920416|NCT00536874|3630934|FG000|STARTED|Overall Study||39
2904945|NCT00444925|3613439|FG000|COMPLETED|Single-blind Placebo Run-In Period|progressed to randomization in double-blind treatment period|1712
2904946|NCT00444925|3613440|FG001|COMPLETED|Single-blind Placebo Run-In Period||0
2904947|NCT00444925|3613441|FG002|COMPLETED|Single-blind Placebo Run-In Period||0
2904948|NCT00444925|3613439|FG000|NOT COMPLETED|Single-blind Placebo Run-In Period||734
2904949|NCT00444925|3613440|FG001|NOT COMPLETED|Single-blind Placebo Run-In Period||0
2904950|NCT00444925|3613441|FG002|NOT COMPLETED|Single-blind Placebo Run-In Period||0
2904951|NCT00444925|3613439|FG000|STARTED|Randomized to Double-blind Treatment||337
2904952|NCT00444925|3613440|FG001|STARTED|Randomized to Double-blind Treatment||690
2904953|NCT00444925|3613441|FG002|STARTED|Randomized to Double-blind Treatment||685
2904954|NCT00444925|3613439|FG000|COMPLETED|Randomized to Double-blind Treatment||334
2904955|NCT00444925|3613440|FG001|COMPLETED|Randomized to Double-blind Treatment||684
2904956|NCT00444925|3613441|FG002|COMPLETED|Randomized to Double-blind Treatment||679
2904957|NCT00444925|3613439|FG000|NOT COMPLETED|Randomized to Double-blind Treatment||3
2904958|NCT00444925|3613440|FG001|NOT COMPLETED|Randomized to Double-blind Treatment||6
2904959|NCT00444925|3613441|FG002|NOT COMPLETED|Randomized to Double-blind Treatment||6
2904960|NCT00444925|3613439|FG000|STARTED|Double-blind Treatment Period||334
2904961|NCT00444925|3613440|FG001|STARTED|Double-blind Treatment Period||684
2904962|NCT00444925|3613441|FG002|STARTED|Double-blind Treatment Period||679
2904963|NCT00444925|3613439|FG000|COMPLETED|Double-blind Treatment Period||304
2904964|NCT00444925|3613440|FG001|COMPLETED|Double-blind Treatment Period||628
2904965|NCT00444925|3613441|FG002|COMPLETED|Double-blind Treatment Period||598
2904966|NCT00444925|3613439|FG000|NOT COMPLETED|Double-blind Treatment Period||30
2904967|NCT00444925|3613440|FG001|NOT COMPLETED|Double-blind Treatment Period||56
2904968|NCT00444925|3613441|FG002|NOT COMPLETED|Double-blind Treatment Period||81
2904969|NCT00444951|3613452|FG000|STARTED|Overall Study||145
2904970|NCT00444951|3613453|FG001|STARTED|Overall Study||142
2904971|NCT00444951|3613454|FG002|STARTED|Overall Study||163
2904972|NCT00444951|3613452|FG000|COMPLETED|Overall Study||140
2904973|NCT00444951|3613453|FG001|COMPLETED|Overall Study||136
2904974|NCT00444951|3613454|FG002|COMPLETED|Overall Study||160
2904975|NCT00444951|3613452|FG000|NOT COMPLETED|Overall Study||5
2904976|NCT00444951|3613453|FG001|NOT COMPLETED|Overall Study||6
2904977|NCT00444951|3613454|FG002|NOT COMPLETED|Overall Study||3
2904978|NCT00444964|3613462|FG000|STARTED|Overall Study||11
2904979|NCT00444964|3613462|FG000|COMPLETED|Overall Study||11
2904980|NCT00444964|3613462|FG000|NOT COMPLETED|Overall Study||0
2904981|NCT00445003|3613469|FG000|STARTED|Overall Study||123
2904982|NCT00445003|3613470|FG001|STARTED|Overall Study||113
2904983|NCT00445003|3613471|FG002|STARTED|Overall Study||109
2904984|NCT00445003|3613469|FG000|COMPLETED|Overall Study||118
2904985|NCT00445003|3613470|FG001|COMPLETED|Overall Study||103
2904986|NCT00445003|3613471|FG002|COMPLETED|Overall Study||105
2904987|NCT00445003|3613469|FG000|NOT COMPLETED|Overall Study||5
2904988|NCT00445003|3613470|FG001|NOT COMPLETED|Overall Study||10
2904989|NCT00445003|3613471|FG002|NOT COMPLETED|Overall Study||4
2904990|NCT00445068|3613479|FG000|STARTED|Overall Study||38
2904991|NCT00445068|3613479|FG000|COMPLETED|Overall Study||2
2904992|NCT00445068|3613479|FG000|NOT COMPLETED|Overall Study||36
2904993|NCT00445146|3613483|FG000|STARTED|Overall Study||192
2904994|NCT00445146|3613483|FG000|COMPLETED|Overall Study||73
2904995|NCT00445146|3613483|FG000|NOT COMPLETED|Overall Study||119
2904996|NCT00445211|3613489|FG000|STARTED|Overall Study||23
2904997|NCT00445211|3613490|FG001|STARTED|Overall Study||23
2904998|NCT00445211|3613489|FG000|COMPLETED|Overall Study||23
2904999|NCT00445211|3613490|FG001|COMPLETED|Overall Study||23
2905000|NCT00445211|3613489|FG000|NOT COMPLETED|Overall Study||0
2905001|NCT00445211|3613490|FG001|NOT COMPLETED|Overall Study||0
2905002|NCT00445224|3613498|FG000|STARTED|Specific Exercises||17
2905003|NCT00445224|3613499|FG001|STARTED|Specific Exercises||16
2905004|NCT00445224|3613498|FG000|Baseline|Specific Exercises||17
2905005|NCT00445224|3613499|FG001|Baseline|Specific Exercises||16
2905006|NCT00445224|3613498|FG000|4 Weeks|Specific Exercises|Participants withdrew due to time conflicts|14
2905007|NCT00445224|3613499|FG001|4 Weeks|Specific Exercises|Participants withdrew due to time conflicts|13
2905008|NCT00445224|3613498|FG000|COMPLETED|Specific Exercises|No adverse event occurred|13
2905009|NCT00445224|3613499|FG001|COMPLETED|Specific Exercises|No adverse event occurred|13
2905010|NCT00445224|3613498|FG000|NOT COMPLETED|Specific Exercises||4
2905011|NCT00445224|3613499|FG001|NOT COMPLETED|Specific Exercises||3
2905012|NCT00445224|3613498|FG000|STARTED|Combined Exercises||13
2905013|NCT00445224|3613499|FG001|STARTED|Combined Exercises||13
2905014|NCT00445224|3613498|FG000|COMPLETED|Combined Exercises||13
2905015|NCT00445224|3613499|FG001|COMPLETED|Combined Exercises||13
2905016|NCT00445224|3613498|FG000|NOT COMPLETED|Combined Exercises||0
2905017|NCT00445224|3613499|FG001|NOT COMPLETED|Combined Exercises||0
2905018|NCT00445263|3613507|FG000|STARTED|Overall Study||83
2905019|NCT00445263|3613508|FG001|STARTED|Overall Study||87
2905020|NCT00445263|3613507|FG000|COMPLETED|Overall Study||83
2905021|NCT00445263|3613508|FG001|COMPLETED|Overall Study||86
2905022|NCT00445263|3613507|FG000|NOT COMPLETED|Overall Study||0
2905023|NCT00445263|3613508|FG001|NOT COMPLETED|Overall Study||1
2905024|NCT00445302|3613518|FG000|STARTED|Overall Study||6
2905025|NCT00445302|3613519|FG001|STARTED|Overall Study||5
2905026|NCT00445302|3613520|FG002|STARTED|Overall Study||6
2905027|NCT00445302|3613521|FG003|STARTED|Overall Study||6
2905028|NCT00445302|3613518|FG000|COMPLETED|Overall Study||6
2905029|NCT00445302|3613519|FG001|COMPLETED|Overall Study||5
2905030|NCT00445302|3613520|FG002|COMPLETED|Overall Study||6
2905031|NCT00445302|3613521|FG003|COMPLETED|Overall Study||6
2905032|NCT00445302|3613518|FG000|NOT COMPLETED|Overall Study||0
2905033|NCT00445302|3613519|FG001|NOT COMPLETED|Overall Study||0
2905034|NCT00445302|3613520|FG002|NOT COMPLETED|Overall Study||0
2905035|NCT00445302|3613521|FG003|NOT COMPLETED|Overall Study||0
2905036|NCT00445315|3613536|FG000|STARTED|Overall Study||6
2905037|NCT00445315|3613537|FG001|STARTED|Overall Study||6
2905038|NCT00445315|3613538|FG002|STARTED|Overall Study||6
2905039|NCT00445315|3613539|FG003|STARTED|Overall Study||6
2905040|NCT00445315|3613540|FG004|STARTED|Overall Study||8
2905041|NCT00445315|3613536|FG000|COMPLETED|Overall Study||6
2905042|NCT00445315|3613537|FG001|COMPLETED|Overall Study||6
2905043|NCT00445315|3613538|FG002|COMPLETED|Overall Study||6
2905044|NCT00445315|3613539|FG003|COMPLETED|Overall Study||6
2905045|NCT00445315|3613540|FG004|COMPLETED|Overall Study||8
2905046|NCT00445315|3613536|FG000|NOT COMPLETED|Overall Study||0
2905047|NCT00445315|3613537|FG001|NOT COMPLETED|Overall Study||0
2905048|NCT00445315|3613538|FG002|NOT COMPLETED|Overall Study||0
2905049|NCT00445315|3613539|FG003|NOT COMPLETED|Overall Study||0
2905050|NCT00445315|3613540|FG004|NOT COMPLETED|Overall Study||0
2905051|NCT00445328|3613555|FG000|STARTED|Overall Study||42
2905052|NCT00445328|3613556|FG001|STARTED|Overall Study||42
2905053|NCT00445328|3613555|FG000|Received Treatment|Overall Study|1 subject discontinued after enrollment but prior to study treatment.|41
2905054|NCT00445328|3613556|FG001|Received Treatment|Overall Study||42
2905055|NCT00445328|3613555|FG000|COMPLETED|Overall Study||39
2905056|NCT00445328|3613556|FG001|COMPLETED|Overall Study||36
2905057|NCT00445328|3613555|FG000|NOT COMPLETED|Overall Study||3
2905058|NCT00445328|3613556|FG001|NOT COMPLETED|Overall Study||6
2905059|NCT00445341|3613562|FG000|STARTED|Overall Study||28
2905060|NCT00445341|3613562|FG000|COMPLETED|Overall Study||26
2905061|NCT00445341|3613562|FG000|NOT COMPLETED|Overall Study||2
2905062|NCT00445432|3613569|FG000|STARTED|Through Week 52 of NCT00445432 (M06-837)||25
2905063|NCT00445432|3613570|FG001|STARTED|Through Week 52 of NCT00445432 (M06-837)||25
2905064|NCT00445432|3613571|FG002|STARTED|Through Week 52 of NCT00445432 (M06-837)||32
2905065|NCT00445432|3613572|FG003|STARTED|Through Week 52 of NCT00445432 (M06-837)|This treatment group is not applicable for this period.|0
2905066|NCT00445432|3613569|FG000|COMPLETED|Through Week 52 of NCT00445432 (M06-837)||10
2905067|NCT00445432|3613570|FG001|COMPLETED|Through Week 52 of NCT00445432 (M06-837)||2
2905068|NCT00445432|3613571|FG002|COMPLETED|Through Week 52 of NCT00445432 (M06-837)||21
2905069|NCT00445432|3613572|FG003|COMPLETED|Through Week 52 of NCT00445432 (M06-837)||0
2905070|NCT00445432|3613569|FG000|NOT COMPLETED|Through Week 52 of NCT00445432 (M06-837)||15
2905071|NCT00445432|3613570|FG001|NOT COMPLETED|Through Week 52 of NCT00445432 (M06-837)||23
2905072|NCT00445432|3613571|FG002|NOT COMPLETED|Through Week 52 of NCT00445432 (M06-837)||11
2905073|NCT00445432|3613572|FG003|NOT COMPLETED|Through Week 52 of NCT00445432 (M06-837)||0
2905074|NCT00445432|3613569|FG000|STARTED|148 Weeks of Adalimumab Treatment|This group is not applicable for this period.|0
2905075|NCT00445432|3613570|FG001|STARTED|148 Weeks of Adalimumab Treatment|This group is not applicable for this period.|0
2905076|NCT00445432|3613571|FG002|STARTED|148 Weeks of Adalimumab Treatment|This group is not applicable for this period.|0
2905077|NCT00445432|3613572|FG003|STARTED|148 Weeks of Adalimumab Treatment|3 participants discontinued while receiving double-blind placebo and never received any adalimumab|79
2905078|NCT00445432|3613569|FG000|COMPLETED|148 Weeks of Adalimumab Treatment||0
2905079|NCT00445432|3613570|FG001|COMPLETED|148 Weeks of Adalimumab Treatment||0
2905080|NCT00445432|3613571|FG002|COMPLETED|148 Weeks of Adalimumab Treatment||0
2905081|NCT00445432|3613572|FG003|COMPLETED|148 Weeks of Adalimumab Treatment||35
2905082|NCT00445432|3613569|FG000|NOT COMPLETED|148 Weeks of Adalimumab Treatment||0
2905083|NCT00445432|3613570|FG001|NOT COMPLETED|148 Weeks of Adalimumab Treatment||0
2905084|NCT00445432|3613571|FG002|NOT COMPLETED|148 Weeks of Adalimumab Treatment||0
2905085|NCT00445432|3613572|FG003|NOT COMPLETED|148 Weeks of Adalimumab Treatment||44
2905086|NCT00445458|3613587|FG000|STARTED|Overall Study||3
2905087|NCT00445458|3613588|FG001|STARTED|Overall Study||5
2905088|NCT00445458|3613589|FG002|STARTED|Overall Study||71
2905089|NCT00445458|3613590|FG003|STARTED|Overall Study||31
2905090|NCT00445458|3613587|FG000|COMPLETED|Overall Study||0
2905091|NCT00445458|3613588|FG001|COMPLETED|Overall Study||0
2905092|NCT00445458|3613589|FG002|COMPLETED|Overall Study||3
2905093|NCT00445458|3613590|FG003|COMPLETED|Overall Study||3
2905094|NCT00445458|3613587|FG000|NOT COMPLETED|Overall Study||3
2905095|NCT00445458|3613588|FG001|NOT COMPLETED|Overall Study||5
2905096|NCT00445458|3613589|FG002|NOT COMPLETED|Overall Study||68
2905097|NCT00445458|3613590|FG003|NOT COMPLETED|Overall Study||28
2905098|NCT00445484|3613605|FG000|STARTED|Overall Study||11
2905099|NCT00445484|3613606|FG001|STARTED|Overall Study||11
2905100|NCT00445484|3613605|FG000|COMPLETED|Overall Study||7
2905101|NCT00445484|3613606|FG001|COMPLETED|Overall Study||10
2905102|NCT00445484|3613605|FG000|NOT COMPLETED|Overall Study||4
2905103|NCT00445484|3613606|FG001|NOT COMPLETED|Overall Study||1
2905104|NCT00445549|3613612|FG000|STARTED|Overall Study||12
2905105|NCT00445549|3613612|FG000|COMPLETED|Overall Study||0
2905106|NCT00445549|3613612|FG000|NOT COMPLETED|Overall Study||12
2905107|NCT00445588|3613616|FG000|STARTED|Overall Study||56
2905108|NCT00445588|3613616|FG000|COMPLETED|Overall Study||56
2905109|NCT00445588|3613616|FG000|NOT COMPLETED|Overall Study||0
2920417|NCT00536874|3630934|FG000|COMPLETED|Overall Study||35
2920418|NCT00536874|3630934|FG000|NOT COMPLETED|Overall Study||4
2905110|NCT00445601|3613623|FG000|STARTED|Overall Study||201
2905111|NCT00445601|3613624|FG001|STARTED|Overall Study||205
2905112|NCT00445601|3613623|FG000|Received TURBT|Overall Study||190
2905113|NCT00445601|3613624|FG001|Received TURBT|Overall Study||193
2905114|NCT00445601|3613623|FG000|COMPLETED|Overall Study||168
2905115|NCT00445601|3613624|FG001|COMPLETED|Overall Study||177
2905116|NCT00445601|3613623|FG000|NOT COMPLETED|Overall Study||33
2905117|NCT00445601|3613624|FG001|NOT COMPLETED|Overall Study||28
2905118|NCT00445679|3613638|FG000|STARTED|Overall Study||203
2905119|NCT00445679|3613639|FG001|STARTED|Overall Study||203
2905120|NCT00445679|3613640|FG002|STARTED|Overall Study||205
2905121|NCT00445679|3613641|FG003|STARTED|Overall Study||196
2905122|NCT00445679|3613638|FG000|COMPLETED|Overall Study||155
2905123|NCT00445679|3613639|FG001|COMPLETED|Overall Study||157
2905124|NCT00445679|3613640|FG002|COMPLETED|Overall Study||139
2905125|NCT00445679|3613641|FG003|COMPLETED|Overall Study||149
2905126|NCT00445679|3613638|FG000|NOT COMPLETED|Overall Study||48
2905127|NCT00445679|3613639|FG001|NOT COMPLETED|Overall Study||46
2905128|NCT00445679|3613640|FG002|NOT COMPLETED|Overall Study||66
2905129|NCT00445679|3613641|FG003|NOT COMPLETED|Overall Study||47
2905130|NCT00445692|3613651|FG000|STARTED|Overall Study||31
2905131|NCT00445692|3613651|FG000|COMPLETED|Overall Study||15
2905132|NCT00445692|3613651|FG000|NOT COMPLETED|Overall Study||16
2905133|NCT00445705|3613661|FG000|STARTED|Overall Study||53
2905134|NCT00445705|3613662|FG001|STARTED|Overall Study||53
2905135|NCT00445705|3613663|FG002|STARTED|Overall Study||52
2905136|NCT00445705|3613664|FG003|STARTED|Overall Study||53
2905137|NCT00445705|3613661|FG000|COMPLETED|Overall Study||44
2905138|NCT00445705|3613662|FG001|COMPLETED|Overall Study||42
2905139|NCT00445705|3613663|FG002|COMPLETED|Overall Study||41
2905140|NCT00445705|3613664|FG003|COMPLETED|Overall Study||39
2905141|NCT00445705|3613661|FG000|NOT COMPLETED|Overall Study||9
2905142|NCT00445705|3613662|FG001|NOT COMPLETED|Overall Study||11
2905143|NCT00445705|3613663|FG002|NOT COMPLETED|Overall Study||11
2905144|NCT00445705|3613664|FG003|NOT COMPLETED|Overall Study||14
2905145|NCT00445744|3613674|FG000|STARTED|Overall Study||52
2905146|NCT00445744|3613674|FG000|COMPLETED|Overall Study||51
2905147|NCT00445744|3613674|FG000|NOT COMPLETED|Overall Study||1
2905148|NCT00445770|3613681|FG000|STARTED|Overall Study||176
2905149|NCT00445770|3613682|FG001|STARTED|Overall Study||192
2905150|NCT00445770|3613683|FG002|STARTED|Overall Study||182
2905151|NCT00445770|3613681|FG000|COMPLETED|Overall Study||123
2905152|NCT00445770|3613682|FG001|COMPLETED|Overall Study||157
2905153|NCT00445770|3613683|FG002|COMPLETED|Overall Study||151
2905154|NCT00445770|3613681|FG000|NOT COMPLETED|Overall Study||53
2905155|NCT00445770|3613682|FG001|NOT COMPLETED|Overall Study||35
2905156|NCT00445770|3613683|FG002|NOT COMPLETED|Overall Study||31
2905157|NCT00445848|3613693|FG000|STARTED|Overall Study||85
2905158|NCT00445848|3613693|FG000|COMPLETED|Overall Study||0
2905159|NCT00445848|3613693|FG000|NOT COMPLETED|Overall Study||85
2905160|NCT00445887|3613699|FG000|STARTED|Overall Study||33
2905161|NCT00445887|3613700|FG001|STARTED|Overall Study||31
2905162|NCT00445887|3613699|FG000|COMPLETED|Overall Study||33
2905163|NCT00445887|3613700|FG001|COMPLETED|Overall Study||31
2905164|NCT00445887|3613699|FG000|NOT COMPLETED|Overall Study||0
2905165|NCT00445887|3613700|FG001|NOT COMPLETED|Overall Study||0
2905166|NCT00445939|3613719|FG000|STARTED|Period A - Week 0 - Week 4||33
2905167|NCT00445939|3613720|FG001|STARTED|Period A - Week 0 - Week 4||34
2905168|NCT00445939|3613721|FG002|STARTED|Period A - Week 0 - Week 4||23
2905169|NCT00445939|3613722|FG003|STARTED|Period A - Week 0 - Week 4||0
2905170|NCT00445939|3613719|FG000|COMPLETED|Period A - Week 0 - Week 4|23 rated as responders and 9 rated as non-responders in evaluation on Week 4.|32
2905171|NCT00445939|3613720|FG001|COMPLETED|Period A - Week 0 - Week 4|20 rated as responders and 12 rated as non-responders in evaluation on Week 4.|32
2905172|NCT00445939|3613721|FG002|COMPLETED|Period A - Week 0 - Week 4|7 rated as responders and 16 rated as non-responders in evaluation on Week 4.|23
2905173|NCT00445939|3613722|FG003|COMPLETED|Period A - Week 0 - Week 4||0
2905174|NCT00445939|3613719|FG000|NOT COMPLETED|Period A - Week 0 - Week 4||1
2905175|NCT00445939|3613720|FG001|NOT COMPLETED|Period A - Week 0 - Week 4||2
2905176|NCT00445939|3613721|FG002|NOT COMPLETED|Period A - Week 0 - Week 4||0
2905177|NCT00445939|3613722|FG003|NOT COMPLETED|Period A - Week 0 - Week 4||0
2905178|NCT00445939|3613719|FG000|STARTED|Period B - Week 4 - Week 8|Non-responders continued after 4 weeks, previous 16 placebo subjects allocated to 160/80 mg group.|16
2905179|NCT00445939|3613720|FG001|STARTED|Period B - Week 4 - Week 8|Non-responders continued after 4 weeks, previous 80/40 mg subjects allocated to 40/40 mg group.|0
2905180|NCT00445939|3613721|FG002|STARTED|Period B - Week 4 - Week 8|Non-responders continued after 4 weeks, previous placebo subjects allocated to 160/80 mg group.|0
2905181|NCT00445939|3613722|FG003|STARTED|Period B - Week 4 - Week 8|Non-responders continued after 4 weeks, previous 160/80 and 80/40 subjects allocated to 40/40 group.|21
2905182|NCT00445939|3613719|FG000|COMPLETED|Period B - Week 4 - Week 8||14
2905183|NCT00445939|3613720|FG001|COMPLETED|Period B - Week 4 - Week 8||0
2905184|NCT00445939|3613721|FG002|COMPLETED|Period B - Week 4 - Week 8||0
2905185|NCT00445939|3613722|FG003|COMPLETED|Period B - Week 4 - Week 8||20
2905186|NCT00445939|3613719|FG000|NOT COMPLETED|Period B - Week 4 - Week 8||2
2905187|NCT00445939|3613720|FG001|NOT COMPLETED|Period B - Week 4 - Week 8||0
2905188|NCT00445939|3613721|FG002|NOT COMPLETED|Period B - Week 4 - Week 8||0
2905189|NCT00445939|3613722|FG003|NOT COMPLETED|Period B - Week 4 - Week 8||1
2905190|NCT00445978|3613742|FG000|STARTED|Week 0 - Week 4 (2.5 mg/kg/Day)||32
2905191|NCT00445978|3613742|FG000|COMPLETED|Week 0 - Week 4 (2.5 mg/kg/Day)||29
2905192|NCT00445978|3613742|FG000|NOT COMPLETED|Week 0 - Week 4 (2.5 mg/kg/Day)||3
2905193|NCT00445978|3613742|FG000|STARTED|Week 4 - Week 8 (5 mg/kg/Day)||29
2905194|NCT00445978|3613742|FG000|Received Escalated Dose|Week 4 - Week 8 (5 mg/kg/Day)||29
2905195|NCT00445978|3613742|FG000|COMPLETED|Week 4 - Week 8 (5 mg/kg/Day)||25
2905196|NCT00445978|3613742|FG000|NOT COMPLETED|Week 4 - Week 8 (5 mg/kg/Day)||4
2905197|NCT00445978|3613742|FG000|STARTED|Week 8 - Week 12 (10 mg/kg/Day)||25
2905198|NCT00445978|3613742|FG000|Received Escalated Dose|Week 8 - Week 12 (10 mg/kg/Day)||25
2905199|NCT00445978|3613742|FG000|COMPLETED|Week 8 - Week 12 (10 mg/kg/Day)||24
2905200|NCT00445978|3613742|FG000|NOT COMPLETED|Week 8 - Week 12 (10 mg/kg/Day)||1
2905201|NCT00445978|3613742|FG000|STARTED|Week 12 - Week 16 (20 mg/kg/Day)||24
2905202|NCT00445978|3613742|FG000|Received Escalated Dose|Week 12 - Week 16 (20 mg/kg/Day)||21
2905203|NCT00445978|3613742|FG000|COMPLETED|Week 12 - Week 16 (20 mg/kg/Day)||23
2905204|NCT00445978|3613742|FG000|NOT COMPLETED|Week 12 - Week 16 (20 mg/kg/Day)||1
2905205|NCT00446030|3613755|FG000|STARTED|TREATMENT (up to 52 Weeks)||93
2905206|NCT00446030|3613756|FG001|STARTED|TREATMENT (up to 52 Weeks)||34
2905207|NCT00446030|3613755|FG000|RECEIVED TREATMENT|TREATMENT (up to 52 Weeks)||92
2905208|NCT00446030|3613756|FG001|RECEIVED TREATMENT|TREATMENT (up to 52 Weeks)||34
2905209|NCT00446030|3613755|FG000|COMPLETED|TREATMENT (up to 52 Weeks)|Participants who completed treatment|49
2905210|NCT00446030|3613756|FG001|COMPLETED|TREATMENT (up to 52 Weeks)|Participants who completed treatment|25
2905211|NCT00446030|3613755|FG000|NOT COMPLETED|TREATMENT (up to 52 Weeks)||44
2905212|NCT00446030|3613756|FG001|NOT COMPLETED|TREATMENT (up to 52 Weeks)||9
2905213|NCT00446030|3613755|FG000|STARTED|FOLLOW-UP (up to 2-years)|All participants, including those who discontinued treatment, continued to the follow-up period.|93
2905214|NCT00446030|3613756|FG001|STARTED|FOLLOW-UP (up to 2-years)||34
2905215|NCT00446030|3613755|FG000|COMPLETED|FOLLOW-UP (up to 2-years)||63
2905216|NCT00446030|3613756|FG001|COMPLETED|FOLLOW-UP (up to 2-years)||25
2905217|NCT00446030|3613755|FG000|NOT COMPLETED|FOLLOW-UP (up to 2-years)||30
2905218|NCT00446030|3613756|FG001|NOT COMPLETED|FOLLOW-UP (up to 2-years)||9
2905219|NCT00446095|3613767|FG000|STARTED|Phase II (8 Weeks)||23
2905220|NCT00446095|3613768|FG001|STARTED|Phase II (8 Weeks)||21
2905221|NCT00446095|3613769|FG002|STARTED|Phase II (8 Weeks)||24
2905222|NCT00446095|3613770|FG003|STARTED|Phase II (8 Weeks)||0
2905223|NCT00446095|3613771|FG004|STARTED|Phase II (8 Weeks)||0
2905224|NCT00446095|3613767|FG000|COMPLETED|Phase II (8 Weeks)||11
2905225|NCT00446095|3613768|FG001|COMPLETED|Phase II (8 Weeks)||18
2905226|NCT00446095|3613769|FG002|COMPLETED|Phase II (8 Weeks)||21
2905227|NCT00446095|3613770|FG003|COMPLETED|Phase II (8 Weeks)||0
2905228|NCT00446095|3613771|FG004|COMPLETED|Phase II (8 Weeks)||0
2905229|NCT00446095|3613767|FG000|NOT COMPLETED|Phase II (8 Weeks)||12
2905230|NCT00446095|3613768|FG001|NOT COMPLETED|Phase II (8 Weeks)||3
2905231|NCT00446095|3613769|FG002|NOT COMPLETED|Phase II (8 Weeks)||3
2905232|NCT00446095|3613770|FG003|NOT COMPLETED|Phase II (8 Weeks)||0
2905233|NCT00446095|3613771|FG004|NOT COMPLETED|Phase II (8 Weeks)||0
2905234|NCT00446095|3613767|FG000|STARTED|Phase I (28 Days)||0
2905235|NCT00446095|3613768|FG001|STARTED|Phase I (28 Days)||0
2905236|NCT00446095|3613769|FG002|STARTED|Phase I (28 Days)||0
2905237|NCT00446095|3613770|FG003|STARTED|Phase I (28 Days)||6
2905238|NCT00446095|3613771|FG004|STARTED|Phase I (28 Days)||7
2905239|NCT00446095|3613767|FG000|COMPLETED|Phase I (28 Days)||0
2905240|NCT00446095|3613768|FG001|COMPLETED|Phase I (28 Days)||0
2905241|NCT00446095|3613769|FG002|COMPLETED|Phase I (28 Days)||0
2905242|NCT00446095|3613770|FG003|COMPLETED|Phase I (28 Days)||5
2905243|NCT00446095|3613771|FG004|COMPLETED|Phase I (28 Days)||4
2905244|NCT00446095|3613767|FG000|NOT COMPLETED|Phase I (28 Days)||0
2905245|NCT00446095|3613768|FG001|NOT COMPLETED|Phase I (28 Days)||0
2905246|NCT00446095|3613769|FG002|NOT COMPLETED|Phase I (28 Days)||0
2905247|NCT00446095|3613770|FG003|NOT COMPLETED|Phase I (28 Days)||1
2905248|NCT00446095|3613771|FG004|NOT COMPLETED|Phase I (28 Days)||3
2905249|NCT00446134|3613786|FG000|STARTED|Overall Study|Includes 2 patients who did not receive study drug and was not included in any other analysis|69
2905250|NCT00446134|3613787|FG001|STARTED|Overall Study||70
2905251|NCT00446134|3613788|FG002|STARTED|Overall Study|Includes 1 patient who did not receive study drug and was not included in any other analysis|69
2905252|NCT00446134|3613789|FG003|STARTED|Overall Study||70
2905253|NCT00446134|3613786|FG000|COMPLETED|Overall Study||35
2905254|NCT00446134|3613787|FG001|COMPLETED|Overall Study||25
2905255|NCT00446134|3613788|FG002|COMPLETED|Overall Study||26
2905256|NCT00446134|3613789|FG003|COMPLETED|Overall Study||25
2905257|NCT00446134|3613786|FG000|NOT COMPLETED|Overall Study||34
2905258|NCT00446134|3613787|FG001|NOT COMPLETED|Overall Study||45
2905259|NCT00446134|3613788|FG002|NOT COMPLETED|Overall Study||43
2905260|NCT00446134|3613789|FG003|NOT COMPLETED|Overall Study||45
2905261|NCT00446147|3613801|FG000|STARTED|Overall Study||195
2905262|NCT00446147|3613802|FG001|STARTED|Overall Study||194
2905263|NCT00446147|3613801|FG000|COMPLETED|Overall Study||180
2905264|NCT00446147|3613802|FG001|COMPLETED|Overall Study||180
2905265|NCT00446147|3613801|FG000|NOT COMPLETED|Overall Study||15
2905266|NCT00446147|3613802|FG001|NOT COMPLETED|Overall Study||14
2905267|NCT00446199|3613812|FG000|STARTED|Overall Study||183
2905268|NCT00446199|3613813|FG001|STARTED|Overall Study||184
2905269|NCT00446199|3613814|FG002|STARTED|Overall Study||185
2905270|NCT00446199|3613815|FG003|STARTED|Overall Study||183
2905271|NCT00446199|3613812|FG000|Participants Received Treatment|Overall Study|SAF=all randomized participants who took at least 1 dose of study medication.|181
2905272|NCT00446199|3613813|FG001|Participants Received Treatment|Overall Study|SAF=all randomized participants who took at least 1 dose of study medication.|183
2905273|NCT00446199|3613814|FG002|Participants Received Treatment|Overall Study|SAF=all randomized participants who took at least 1 dose of study medication.|182
2905274|NCT00446199|3613815|FG003|Participants Received Treatment|Overall Study|SAF=all randomized participants who took at least 1 dose of study medication.|180
2905275|NCT00446199|3613812|FG000|Baseline and Postdose VMS Data Available|Overall Study|FAS=all randomized participants with Baseline VMS data and at least 1 day VMS data postdose.|178
2905276|NCT00446199|3613813|FG001|Baseline and Postdose VMS Data Available|Overall Study|FAS=all randomized participants with Baseline VMS data and at least 1 day VMS data postdose.|177
2905277|NCT00446199|3613814|FG002|Baseline and Postdose VMS Data Available|Overall Study|FAS=all randomized participants with Baseline VMS data and at least 1 day VMS data postdose.|179
2905278|NCT00446199|3613815|FG003|Baseline and Postdose VMS Data Available|Overall Study|FAS=all randomized participants with Baseline VMS data and at least 1 day VMS data postdose.|176
2905279|NCT00446199|3613812|FG000|COMPLETED|Overall Study||160
2905280|NCT00446199|3613813|FG001|COMPLETED|Overall Study||164
2905281|NCT00446199|3613814|FG002|COMPLETED|Overall Study||158
2905282|NCT00446199|3613815|FG003|COMPLETED|Overall Study||153
2905283|NCT00446199|3613812|FG000|NOT COMPLETED|Overall Study||23
2905284|NCT00446199|3613813|FG001|NOT COMPLETED|Overall Study||20
2905285|NCT00446199|3613814|FG002|NOT COMPLETED|Overall Study||27
2905286|NCT00446199|3613815|FG003|NOT COMPLETED|Overall Study||30
2905287|NCT00446251|3613825|FG000|STARTED|Overall Study|14 subjects were enrolled in this Rituximab-mycophenolic mofetil group.|14
2905288|NCT00446251|3613825|FG000|COMPLETED|Overall Study||9
2905289|NCT00446251|3613825|FG000|NOT COMPLETED|Overall Study||5
2905290|NCT00446264|3613829|FG000|STARTED|Overall Study||14
2905291|NCT00446264|3613829|FG000|COMPLETED|Overall Study||14
2905292|NCT00446264|3613829|FG000|NOT COMPLETED|Overall Study||0
2905293|NCT00446290|3613833|FG000|STARTED|Overall Study||22
2905294|NCT00446290|3613833|FG000|COMPLETED|Overall Study||22
2905295|NCT00446290|3613833|FG000|NOT COMPLETED|Overall Study||0
2905296|NCT00446446|3613837|FG000|STARTED|Overall Study||52
2905297|NCT00446446|3613837|FG000|COMPLETED|Overall Study|Participants who completed the 60-day safety visit|28
2905298|NCT00446446|3613837|FG000|NOT COMPLETED|Overall Study||24
2905299|NCT00446459|3613841|FG000|STARTED|8 Months|34 subjects received any amount of MMF.|34
2905300|NCT00446459|3613841|FG000|COMPLETED|8 Months|22 subjects were on study at month 8.|22
2905301|NCT00446459|3613841|FG000|NOT COMPLETED|8 Months||12
2905302|NCT00446459|3613841|FG000|STARTED|12 Months|22 subjects remained on-study at month 8|22
2905303|NCT00446459|3613841|FG000|COMPLETED|12 Months|4 subjects remained at month 12|4
2905304|NCT00446459|3613841|FG000|NOT COMPLETED|12 Months||18
2905305|NCT00446511|3613849|FG000|STARTED|Overall Study||21
2905306|NCT00446511|3613850|FG001|STARTED|Overall Study||17
2905307|NCT00446511|3613851|FG002|STARTED|Overall Study||103
2905308|NCT00446511|3613852|FG003|STARTED|Overall Study||109
2905309|NCT00446511|3613849|FG000|COMPLETED|Overall Study||11
2905310|NCT00446511|3613850|FG001|COMPLETED|Overall Study||15
2905311|NCT00446511|3613851|FG002|COMPLETED|Overall Study||96
2905312|NCT00446511|3613852|FG003|COMPLETED|Overall Study||103
2905313|NCT00446511|3613849|FG000|NOT COMPLETED|Overall Study||10
2905314|NCT00446511|3613850|FG001|NOT COMPLETED|Overall Study||2
2905315|NCT00446511|3613851|FG002|NOT COMPLETED|Overall Study||7
2905316|NCT00446511|3613852|FG003|NOT COMPLETED|Overall Study||6
2905317|NCT00446550|3613866|FG000|STARTED|Overall Study||11
2905318|NCT00446550|3613867|FG001|STARTED|Overall Study||8
2905319|NCT00446550|3613866|FG000|Safety Population|Overall Study||11
2905320|NCT00446550|3613867|FG001|Safety Population|Overall Study||8
2905321|NCT00446550|3613866|FG000|PD Population|Overall Study||11
2905322|NCT00446550|3613867|FG001|PD Population|Overall Study||8
2905323|NCT00446550|3613866|FG000|COMPLETED|Overall Study||10
2905324|NCT00446550|3613867|FG001|COMPLETED|Overall Study||8
2905325|NCT00446550|3613866|FG000|NOT COMPLETED|Overall Study||1
2905326|NCT00446550|3613867|FG001|NOT COMPLETED|Overall Study||0
2905327|NCT00446563|3613876|FG000|STARTED|Overall Study||43
2905328|NCT00446563|3613877|FG001|STARTED|Overall Study||47
2905329|NCT00446563|3613876|FG000|COMPLETED|Overall Study||36
2905330|NCT00446563|3613877|FG001|COMPLETED|Overall Study||38
2905331|NCT00446563|3613876|FG000|NOT COMPLETED|Overall Study||7
2905332|NCT00446563|3613877|FG001|NOT COMPLETED|Overall Study||9
2905333|NCT00446641|3613885|FG000|STARTED|Overall Study||125
2905334|NCT00446641|3613886|FG001|STARTED|Overall Study||119
2905335|NCT00446641|3613885|FG000|COMPLETED|Overall Study||108
2905336|NCT00446641|3613886|FG001|COMPLETED|Overall Study||109
2905337|NCT00446641|3613885|FG000|NOT COMPLETED|Overall Study||17
2905338|NCT00446641|3613886|FG001|NOT COMPLETED|Overall Study||10
2905339|NCT00446654|3613894|FG000|STARTED|Overall Study||21
2905340|NCT00446654|3613895|FG001|STARTED|Overall Study||22
2905341|NCT00446654|3613894|FG000|COMPLETED|Overall Study||19
2905342|NCT00446654|3613895|FG001|COMPLETED|Overall Study||22
2905343|NCT00446654|3613894|FG000|NOT COMPLETED|Overall Study||2
2905344|NCT00446654|3613895|FG001|NOT COMPLETED|Overall Study||0
2905345|NCT00446797|3613903|FG000|STARTED|Overall Study||141
2905346|NCT00446797|3613904|FG001|STARTED|Overall Study||137
2905347|NCT00446797|3613903|FG000|COMPLETED|Overall Study||133
2905348|NCT00446797|3613904|FG001|COMPLETED|Overall Study||125
2905349|NCT00446797|3613903|FG000|NOT COMPLETED|Overall Study||8
2905350|NCT00446797|3613904|FG001|NOT COMPLETED|Overall Study||12
2905351|NCT00446849|3613910|FG000|STARTED|Acute Phase||138
2905352|NCT00446849|3613910|FG000|COMPLETED|Acute Phase||56
2905353|NCT00446849|3613910|FG000|NOT COMPLETED|Acute Phase||82
2905354|NCT00446849|3613910|FG000|STARTED|Maintenance Phase||208
2905355|NCT00446849|3613910|FG000|COMPLETED|Maintenance Phase||138
2905356|NCT00446849|3613910|FG000|NOT COMPLETED|Maintenance Phase||70
2905357|NCT00446966|3613917|FG000|STARTED|Overall Study||130
2905358|NCT00446966|3613918|FG001|STARTED|Overall Study||130
2905359|NCT00446966|3613917|FG000|COMPLETED|Overall Study||120
2905360|NCT00446966|3613918|FG001|COMPLETED|Overall Study||123
2905361|NCT00446966|3613917|FG000|NOT COMPLETED|Overall Study||10
2905362|NCT00446966|3613918|FG001|NOT COMPLETED|Overall Study||7
2905363|NCT00446992|3613924|FG000|STARTED|Overall Study|Beginning of Intervention|30
2905364|NCT00446992|3613924|FG000|COMPLETED|Overall Study|Intervention Completion|14
2905365|NCT00446992|3613924|FG000|NOT COMPLETED|Overall Study||16
2905366|NCT00447005|3613928|FG000|STARTED|Overall Study||12
2905367|NCT00447005|3613928|FG000|COMPLETED|Overall Study||0
2905368|NCT00447005|3613928|FG000|NOT COMPLETED|Overall Study||12
2905369|NCT00447057|3613936|FG000|STARTED|Overall Study||83
2905370|NCT00447057|3613937|FG001|STARTED|Overall Study||76
2905371|NCT00447057|3613938|FG002|STARTED|Overall Study||19
2905372|NCT00447057|3613939|FG003|STARTED|Overall Study||26
2905373|NCT00447057|3613936|FG000|COMPLETED|Overall Study||0
2905374|NCT00447057|3613937|FG001|COMPLETED|Overall Study||3
2905375|NCT00447057|3613938|FG002|COMPLETED|Overall Study||0
2905376|NCT00447057|3613939|FG003|COMPLETED|Overall Study||0
2905377|NCT00447057|3613936|FG000|NOT COMPLETED|Overall Study||83
2905378|NCT00447057|3613937|FG001|NOT COMPLETED|Overall Study||73
2905379|NCT00447057|3613938|FG002|NOT COMPLETED|Overall Study||19
2905380|NCT00447057|3613939|FG003|NOT COMPLETED|Overall Study||26
2905381|NCT00447083|3613949|FG000|STARTED|Phase I||10
2905382|NCT00447083|3613950|FG001|STARTED|Phase I||9
2905383|NCT00447083|3613951|FG002|STARTED|Phase I||0
2905384|NCT00447083|3613952|FG003|STARTED|Phase I||0
2905385|NCT00447083|3613949|FG000|COMPLETED|Phase I|2 participants did not acclimate to phase II|10
2905386|NCT00447083|3613950|FG001|COMPLETED|Phase I|1 participant did not acclimate to phase II|9
2905387|NCT00447083|3613951|FG002|COMPLETED|Phase I||0
2905388|NCT00447083|3613952|FG003|COMPLETED|Phase I||0
2905389|NCT00447083|3613949|FG000|NOT COMPLETED|Phase I||0
2905390|NCT00447083|3613950|FG001|NOT COMPLETED|Phase I||0
2905391|NCT00447083|3613951|FG002|NOT COMPLETED|Phase I||0
2905392|NCT00447083|3613952|FG003|NOT COMPLETED|Phase I||0
2905393|NCT00447083|3613949|FG000|STARTED|Phase II|Participants in this group will then be randomized to a phase 2 group in phase2|0
2905394|NCT00447083|3613950|FG001|STARTED|Phase II|Participants in this group will then be randomized to a phase 2 group in phase2|0
2905395|NCT00447083|3613951|FG002|STARTED|Phase II|Only 8 participants qualified from the end of phase 1|8
2905396|NCT00447083|3613952|FG003|STARTED|Phase II|Only 8 participants qualified from the end of phase 1|8
2905397|NCT00447083|3613949|FG000|COMPLETED|Phase II||0
2905398|NCT00447083|3613950|FG001|COMPLETED|Phase II||0
2905399|NCT00447083|3613951|FG002|COMPLETED|Phase II||7
2905400|NCT00447083|3613952|FG003|COMPLETED|Phase II||7
2905401|NCT00447083|3613949|FG000|NOT COMPLETED|Phase II||0
2905402|NCT00447083|3613950|FG001|NOT COMPLETED|Phase II||0
2905403|NCT00447083|3613951|FG002|NOT COMPLETED|Phase II||1
2905404|NCT00447083|3613952|FG003|NOT COMPLETED|Phase II||1
2905405|NCT00447122|3613960|FG000|STARTED|Overall Study||31
2905406|NCT00447122|3613960|FG000|COMPLETED|Overall Study|29 evaluable thus 29 represented in efficacy and safety portion|29
2905407|NCT00447122|3613960|FG000|NOT COMPLETED|Overall Study||2
2905408|NCT00447226|3613964|FG000|STARTED|12-Week Open-label Phase||0
2905409|NCT00447226|3613965|FG001|STARTED|12-Week Open-label Phase||32
2905410|NCT00447226|3613964|FG000|COMPLETED|12-Week Open-label Phase||0
2905411|NCT00447226|3613965|FG001|COMPLETED|12-Week Open-label Phase||7
2905412|NCT00447226|3613964|FG000|NOT COMPLETED|12-Week Open-label Phase||0
2905413|NCT00447226|3613965|FG001|NOT COMPLETED|12-Week Open-label Phase||25
2905414|NCT00447226|3613964|FG000|STARTED|Double-blind Phase||4
2905415|NCT00447226|3613965|FG001|STARTED|Double-blind Phase||3
2905416|NCT00447226|3613964|FG000|COMPLETED|Double-blind Phase||0
2905417|NCT00447226|3613965|FG001|COMPLETED|Double-blind Phase||0
2905418|NCT00447226|3613964|FG000|NOT COMPLETED|Double-blind Phase||4
2905419|NCT00447226|3613965|FG001|NOT COMPLETED|Double-blind Phase||3
2905420|NCT00447265|3613980|FG000|STARTED|Overall Study||1
2905421|NCT00447265|3613981|FG001|STARTED|Overall Study||0
2905422|NCT00447265|3613980|FG000|COMPLETED|Overall Study|The participant completed treatment and discontinued follow-up at week 39 after randomization|0
2905423|NCT00447265|3613981|FG001|COMPLETED|Overall Study||0
2905424|NCT00447265|3613980|FG000|NOT COMPLETED|Overall Study||1
2905425|NCT00447265|3613981|FG001|NOT COMPLETED|Overall Study||0
2905426|NCT00447278|3613987|FG000|STARTED|Period II (6 Month Open-Label)||199
2905427|NCT00447278|3613988|FG001|STARTED|Period II (6 Month Open-Label)||200
2905428|NCT00447278|3613987|FG000|Received at Least One Dose of Study Drug|Period II (6 Month Open-Label)||199
2905429|NCT00447278|3613988|FG001|Received at Least One Dose of Study Drug|Period II (6 Month Open-Label)|1 patient withdrew due to parent/guardian decision prior to receiving study drug.|199
2905430|NCT00447278|3613987|FG000|COMPLETED|Period II (6 Month Open-Label)||157
2905431|NCT00447278|3613988|FG001|COMPLETED|Period II (6 Month Open-Label)||171
2905432|NCT00447278|3613987|FG000|NOT COMPLETED|Period II (6 Month Open-Label)||42
2905433|NCT00447278|3613988|FG001|NOT COMPLETED|Period II (6 Month Open-Label)||29
2905434|NCT00447278|3613987|FG000|STARTED|Period III (Optional 6 Month Extension)|18 choose not to enter this optional period.|139
2905435|NCT00447278|3613988|FG001|STARTED|Period III (Optional 6 Month Extension)|16 choose not to enter this optional period.|155
2905436|NCT00447278|3613987|FG000|COMPLETED|Period III (Optional 6 Month Extension)||109
2905437|NCT00447278|3613988|FG001|COMPLETED|Period III (Optional 6 Month Extension)||140
2905438|NCT00447278|3613987|FG000|NOT COMPLETED|Period III (Optional 6 Month Extension)||30
2905439|NCT00447278|3613988|FG001|NOT COMPLETED|Period III (Optional 6 Month Extension)||15
2905440|NCT00447330|3613995|FG000|STARTED|Overall Study|2 subjects signed the ICF, but were withdrawn from study prior to receiving any study drug|60
2905441|NCT00447330|3613995|FG000|COMPLETED|Overall Study||58
2905442|NCT00447330|3613995|FG000|NOT COMPLETED|Overall Study||2
2905443|NCT00447382|3614002|FG000|STARTED|Overall Study||164
2905444|NCT00447382|3614003|FG001|STARTED|Overall Study||166
2905445|NCT00447382|3614002|FG000|COMPLETED|Overall Study||158
2905446|NCT00447382|3614003|FG001|COMPLETED|Overall Study||160
2905447|NCT00447382|3614002|FG000|NOT COMPLETED|Overall Study||6
2905448|NCT00447382|3614003|FG001|NOT COMPLETED|Overall Study||6
2905449|NCT00447499|3614009|FG000|STARTED|Overall Study||59
2905450|NCT00447499|3614009|FG000|COMPLETED|Overall Study||52
2905451|NCT00447499|3614009|FG000|NOT COMPLETED|Overall Study||7
2905452|NCT00447590|3614015|FG000|STARTED|Overall Study|153 participants were treated with the LAP-BAND System.|153
2905453|NCT00447590|3614015|FG000|COMPLETED|Overall Study|Completing the study was defined as the number of participants in the study at month 60 (5 years).|93
2905454|NCT00447590|3614015|FG000|NOT COMPLETED|Overall Study||60
2905455|NCT00447694|3614019|FG000|STARTED|Overall Study||28
2905456|NCT00447694|3614019|FG000|COMPLETED|Overall Study||22
2905457|NCT00447694|3614019|FG000|NOT COMPLETED|Overall Study||6
2905458|NCT00447772|3614023|FG000|STARTED|Overall Study||516
2905459|NCT00447772|3614023|FG000|COMPLETED|Overall Study||489
2905460|NCT00447772|3614023|FG000|NOT COMPLETED|Overall Study||27
2905461|NCT00447876|3614032|FG000|STARTED|Overall Study||20
2905462|NCT00447876|3614033|FG001|STARTED|Overall Study||20
2905463|NCT00447876|3614032|FG000|COMPLETED|Overall Study||17
2905464|NCT00447876|3614033|FG001|COMPLETED|Overall Study||16
2905465|NCT00447876|3614032|FG000|NOT COMPLETED|Overall Study||3
2905466|NCT00447876|3614033|FG001|NOT COMPLETED|Overall Study||4
2905467|NCT00447902|3614041|FG000|STARTED|Overall Study||5
2905468|NCT00447902|3614042|FG001|STARTED|Overall Study||6
2905469|NCT00447902|3614041|FG000|COMPLETED|Overall Study||1
2905470|NCT00447902|3614042|FG001|COMPLETED|Overall Study||0
2905471|NCT00447902|3614041|FG000|NOT COMPLETED|Overall Study||4
2905472|NCT00447902|3614042|FG001|NOT COMPLETED|Overall Study||6
2905473|NCT00448019|3614048|FG000|STARTED|Overall Study||64
2905474|NCT00448019|3614048|FG000|COMPLETED|Overall Study||57
2905475|NCT00448019|3614048|FG000|NOT COMPLETED|Overall Study||7
2905476|NCT00448123|3614054|FG000|STARTED|Overall Study||62
2905477|NCT00448123|3614055|FG001|STARTED|Overall Study||65
2905478|NCT00448123|3614054|FG000|COMPLETED|Overall Study||47
2905479|NCT00448123|3614055|FG001|COMPLETED|Overall Study||53
2905480|NCT00448123|3614054|FG000|NOT COMPLETED|Overall Study||15
2905481|NCT00448123|3614055|FG001|NOT COMPLETED|Overall Study||12
2905482|NCT00448136|3614066|FG000|STARTED|Overall Study||34
2905483|NCT00448136|3614067|FG001|STARTED|Overall Study||49
2905484|NCT00448136|3614066|FG000|COMPLETED|Overall Study||30
2905485|NCT00448136|3614067|FG001|COMPLETED|Overall Study||41
2905486|NCT00448136|3614066|FG000|NOT COMPLETED|Overall Study||4
2905487|NCT00448136|3614067|FG001|NOT COMPLETED|Overall Study||8
2905488|NCT00448175|3614075|FG000|STARTED|12 Weeks PTNS vs. Drug||50
2905489|NCT00448175|3614076|FG001|STARTED|12 Weeks PTNS vs. Drug||50
2905490|NCT00448175|3614075|FG000|COMPLETED|12 Weeks PTNS vs. Drug||41
2905491|NCT00448175|3614076|FG001|COMPLETED|12 Weeks PTNS vs. Drug||43
2905492|NCT00448175|3614075|FG000|NOT COMPLETED|12 Weeks PTNS vs. Drug||9
2905493|NCT00448175|3614076|FG001|NOT COMPLETED|12 Weeks PTNS vs. Drug||7
2905494|NCT00448175|3614075|FG000|STARTED|Continued PTNS Through 12 Months||35
2905495|NCT00448175|3614076|FG001|STARTED|Continued PTNS Through 12 Months||0
2905496|NCT00448175|3614075|FG000|COMPLETED|Continued PTNS Through 12 Months||25
2905497|NCT00448175|3614076|FG001|COMPLETED|Continued PTNS Through 12 Months||0
2905498|NCT00448175|3614075|FG000|NOT COMPLETED|Continued PTNS Through 12 Months||10
2905499|NCT00448175|3614076|FG001|NOT COMPLETED|Continued PTNS Through 12 Months||0
2905500|NCT00448201|3614082|FG000|STARTED|Overall Study||71
2905501|NCT00448201|3614082|FG000|COMPLETED|Overall Study||71
2905502|NCT00448201|3614082|FG000|NOT COMPLETED|Overall Study||0
2905503|NCT00448227|3614088|FG000|STARTED|Overall Study||18
2905504|NCT00448227|3614088|FG000|COMPLETED|Overall Study||18
2905505|NCT00448227|3614088|FG000|NOT COMPLETED|Overall Study||0
2905506|NCT00448279|3614097|FG000|STARTED|Overall Study||29
2905507|NCT00448279|3614098|FG001|STARTED|Overall Study||29
2905508|NCT00448279|3614097|FG000|COMPLETED|Overall Study||0
2905509|NCT00448279|3614098|FG001|COMPLETED|Overall Study||0
2905510|NCT00448279|3614097|FG000|NOT COMPLETED|Overall Study||29
2905511|NCT00448279|3614098|FG001|NOT COMPLETED|Overall Study||29
2905512|NCT00448344|3614106|FG000|STARTED|Overall Study||235
2905513|NCT00448344|3614107|FG001|STARTED|Overall Study||236
2905514|NCT00448344|3614106|FG000|COMPLETED|Overall Study||205
2905515|NCT00448344|3614107|FG001|COMPLETED|Overall Study||200
2905516|NCT00448344|3614106|FG000|NOT COMPLETED|Overall Study||30
2905517|NCT00448344|3614107|FG001|NOT COMPLETED|Overall Study||36
2905518|NCT00448357|3614113|FG000|STARTED|Overall Study||54
2905519|NCT00448357|3614113|FG000|COMPLETED|Overall Study||54
2905520|NCT00448357|3614113|FG000|NOT COMPLETED|Overall Study||0
2905521|NCT00448435|3614129|FG000|STARTED|Treatment Period I - 4 Weeks||26
2905522|NCT00448435|3614130|FG001|STARTED|Treatment Period I - 4 Weeks||25
2905523|NCT00448435|3614129|FG000|COMPLETED|Treatment Period I - 4 Weeks||26
2905524|NCT00448435|3614130|FG001|COMPLETED|Treatment Period I - 4 Weeks||25
2905525|NCT00448435|3614129|FG000|NOT COMPLETED|Treatment Period I - 4 Weeks||0
2905526|NCT00448435|3614130|FG001|NOT COMPLETED|Treatment Period I - 4 Weeks||0
2905527|NCT00448435|3614129|FG000|STARTED|Washout Period - 2 Weeks||26
2905528|NCT00448435|3614130|FG001|STARTED|Washout Period - 2 Weeks||25
2905529|NCT00448435|3614129|FG000|COMPLETED|Washout Period - 2 Weeks||25
2905530|NCT00448435|3614130|FG001|COMPLETED|Washout Period - 2 Weeks||25
2905531|NCT00448435|3614129|FG000|NOT COMPLETED|Washout Period - 2 Weeks||1
2905532|NCT00448435|3614130|FG001|NOT COMPLETED|Washout Period - 2 Weeks||0
2905533|NCT00448435|3614129|FG000|STARTED|Treatment Period II - 4 Weeks||25
2905534|NCT00448435|3614130|FG001|STARTED|Treatment Period II - 4 Weeks||25
2905535|NCT00448435|3614129|FG000|COMPLETED|Treatment Period II - 4 Weeks||25
2905536|NCT00448435|3614130|FG001|COMPLETED|Treatment Period II - 4 Weeks||25
2905537|NCT00448435|3614129|FG000|NOT COMPLETED|Treatment Period II - 4 Weeks||0
2905538|NCT00448435|3614130|FG001|NOT COMPLETED|Treatment Period II - 4 Weeks||0
2905539|NCT00448435|3614129|FG000|STARTED|Extension Period - 20 Weeks||50
2905540|NCT00448435|3614130|FG001|STARTED|Extension Period - 20 Weeks||0
2905541|NCT00448435|3614129|FG000|COMPLETED|Extension Period - 20 Weeks||50
2905542|NCT00448435|3614130|FG001|COMPLETED|Extension Period - 20 Weeks||0
2905543|NCT00448435|3614129|FG000|NOT COMPLETED|Extension Period - 20 Weeks||0
2905544|NCT00448435|3614130|FG001|NOT COMPLETED|Extension Period - 20 Weeks||0
2905545|NCT00448448|3614141|FG000|STARTED|Overall Study||246
2905546|NCT00448448|3614142|FG001|STARTED|Overall Study||137
2905547|NCT00448448|3614141|FG000|COMPLETED|Overall Study||146
2905548|NCT00448448|3614142|FG001|COMPLETED|Overall Study||96
2905549|NCT00448448|3614141|FG000|NOT COMPLETED|Overall Study||100
2905550|NCT00448448|3614142|FG001|NOT COMPLETED|Overall Study||41
2905551|NCT00448539|3614150|FG000|STARTED|Overall Study||134
2905552|NCT00448539|3614151|FG001|STARTED|Overall Study||152
2905553|NCT00448539|3614150|FG000|COMPLETED|Overall Study||0
2905554|NCT00448539|3614151|FG001|COMPLETED|Overall Study||0
2905555|NCT00448539|3614150|FG000|NOT COMPLETED|Overall Study||134
2905556|NCT00448539|3614151|FG001|NOT COMPLETED|Overall Study||152
2905557|NCT00448591|3614157|FG000|STARTED|Overall Study||2296
2905558|NCT00448591|3614157|FG000|COMPLETED|Overall Study||0
2905559|NCT00448591|3614157|FG000|NOT COMPLETED|Overall Study||2296
2905560|NCT00448630|3614163|FG000|STARTED|Overall Study||328
2905561|NCT00448630|3614163|FG000|COMPLETED|Overall Study|Number of patients who remained on same medication to end of study.|301
2905562|NCT00448630|3614163|FG000|NOT COMPLETED|Overall Study||27
2905563|NCT00448669|3614182|FG000|STARTED|Overall Study||611
2905564|NCT00448669|3614183|FG001|STARTED|Overall Study||608
2905565|NCT00448669|3614182|FG000|COMPLETED|Overall Study||393
2905566|NCT00448669|3614183|FG001|COMPLETED|Overall Study||410
2905567|NCT00448669|3614182|FG000|NOT COMPLETED|Overall Study||218
2905568|NCT00448669|3614183|FG001|NOT COMPLETED|Overall Study||198
2905569|NCT00448708|3614193|FG000|STARTED|Overall Study||112
2905570|NCT00448708|3614194|FG001|STARTED|Overall Study||110
2905571|NCT00448708|3614193|FG000|COMPLETED|Overall Study||77
2905572|NCT00448708|3614194|FG001|COMPLETED|Overall Study||79
2905573|NCT00448708|3614193|FG000|NOT COMPLETED|Overall Study||35
2905574|NCT00448708|3614194|FG001|NOT COMPLETED|Overall Study||31
2905575|NCT00448747|3614202|FG000|STARTED|Overall Study||53
2905576|NCT00448747|3614203|FG001|STARTED|Overall Study||48
2905577|NCT00448747|3614202|FG000|Received First Drug Administration|Overall Study||53
2905578|NCT00448747|3614203|FG001|Received First Drug Administration|Overall Study||48
2905579|NCT00448747|3614202|FG000|Received Second Drug Administration|Overall Study||42
2905580|NCT00448747|3614203|FG001|Received Second Drug Administration|Overall Study||10
2905581|NCT00448747|3614202|FG000|Received AEZS-130|Overall Study||52
3171373|NCT01933789|3898533|FG001|Had Target Visit|Overall Study|Had target visit(s) completed before clinician or patient withdrawal|65
3171374|NCT01933789|3898534|FG002|Had Target Visit|Overall Study||2
3171375|NCT01933789|3898535|FG003|Had Target Visit|Overall Study||2
3171376|NCT01933789|3898536|FG004|Had Target Visit|Overall Study||228
3171377|NCT01933789|3898537|FG005|Had Target Visit|Overall Study||266
3171378|NCT01933789|3898538|FG006|Had Target Visit|Overall Study||0
3171379|NCT01933789|3898539|FG007|Had Target Visit|Overall Study||0
3171380|NCT01933789|3898540|FG008|Had Target Visit|Overall Study||0
3171381|NCT01933789|3898532|FG000|Completed After-visit Survey|Overall Study|Number reflects individual clinicians who returned surveys for up to 6 enrolled patients|57
2905582|NCT00448747|3614203|FG001|Received AEZS-130|Overall Study||48
2905583|NCT00448747|3614202|FG000|Received L-ARG-GHRH|Overall Study||43
2905584|NCT00448747|3614203|FG001|Received L-ARG-GHRH|Overall Study||10
2905585|NCT00448747|3614202|FG000|Received L-ARG-GHRH and AEZS-130|Overall Study||42
2905586|NCT00448747|3614203|FG001|Received L-ARG-GHRH and AEZS-130|Overall Study||10
2905587|NCT00448747|3614202|FG000|Per Protocol Population (PPS)|Overall Study||50
2905588|NCT00448747|3614203|FG001|Per Protocol Population (PPS)|Overall Study||48
2905589|NCT00448747|3614202|FG000|COMPLETED|Overall Study||52
2905590|NCT00448747|3614203|FG001|COMPLETED|Overall Study||48
2905591|NCT00448747|3614202|FG000|NOT COMPLETED|Overall Study||1
2905592|NCT00448747|3614203|FG001|NOT COMPLETED|Overall Study||0
2905593|NCT00448760|3614219|FG000|STARTED|Overall Study||29
2905594|NCT00448760|3614219|FG000|COMPLETED|Overall Study||26
2905595|NCT00448760|3614219|FG000|NOT COMPLETED|Overall Study||3
2905596|NCT00448812|3614225|FG000|STARTED|Year 1||45
2905597|NCT00448812|3614226|FG001|STARTED|Year 1||24
2905598|NCT00448812|3614225|FG000|COMPLETED|Year 1||45
2905599|NCT00448812|3614226|FG001|COMPLETED|Year 1||24
2905600|NCT00448812|3614225|FG000|NOT COMPLETED|Year 1||0
2905601|NCT00448812|3614226|FG001|NOT COMPLETED|Year 1||0
2905602|NCT00448812|3614225|FG000|STARTED|Year 2||45
2905603|NCT00448812|3614226|FG001|STARTED|Year 2||24
2905604|NCT00448812|3614225|FG000|COMPLETED|Year 2||41
2905605|NCT00448812|3614226|FG001|COMPLETED|Year 2||23
2905606|NCT00448812|3614225|FG000|NOT COMPLETED|Year 2||4
2905607|NCT00448812|3614226|FG001|NOT COMPLETED|Year 2||1
2905608|NCT00448812|3614225|FG000|STARTED|Year 3||45
2905609|NCT00448812|3614226|FG001|STARTED|Year 3||24
2905610|NCT00448812|3614225|FG000|COMPLETED|Year 3||41
2905611|NCT00448812|3614226|FG001|COMPLETED|Year 3||21
2905612|NCT00448812|3614225|FG000|NOT COMPLETED|Year 3||4
2905613|NCT00448812|3614226|FG001|NOT COMPLETED|Year 3||3
2905614|NCT00448812|3614225|FG000|STARTED|Year 4||43
2905615|NCT00448812|3614226|FG001|STARTED|Year 4|Control group subjects exited from study after completing Year 3 evaluation.|0
2905616|NCT00448812|3614225|FG000|COMPLETED|Year 4||43
2905617|NCT00448812|3614226|FG001|COMPLETED|Year 4|Control group subjects exited from study after completing Year 3 evaluation.|0
2905618|NCT00448812|3614225|FG000|NOT COMPLETED|Year 4||0
2905619|NCT00448812|3614226|FG001|NOT COMPLETED|Year 4||0
2905620|NCT00448812|3614225|FG000|STARTED|Year 5||43
2905621|NCT00448812|3614226|FG001|STARTED|Year 5|Control group subjects exited from study after completing Year 3 evaluation.|0
2905622|NCT00448812|3614225|FG000|COMPLETED|Year 5||42
2905623|NCT00448812|3614226|FG001|COMPLETED|Year 5|Control group subjects exited from study after completing Year 3 evaluation.|0
2905624|NCT00448812|3614225|FG000|NOT COMPLETED|Year 5||1
2905625|NCT00448812|3614226|FG001|NOT COMPLETED|Year 5||0
2905626|NCT00448864|3614247|FG000|STARTED|Overall Study||27
2905627|NCT00448864|3614248|FG001|STARTED|Overall Study||29
2905628|NCT00448864|3614249|FG002|STARTED|Overall Study||19
2905629|NCT00448864|3614247|FG000|Received at Least 1 Dose of Study Drug|Overall Study||26
2905630|NCT00448864|3614248|FG001|Received at Least 1 Dose of Study Drug|Overall Study||25
2905631|NCT00448864|3614249|FG002|Received at Least 1 Dose of Study Drug|Overall Study||18
2905632|NCT00448864|3614247|FG000|Started Post-operative Period|Overall Study||26
2905633|NCT00448864|3614248|FG001|Started Post-operative Period|Overall Study||25
2905634|NCT00448864|3614249|FG002|Started Post-operative Period|Overall Study||18
2905635|NCT00448864|3614247|FG000|Completed Post-operative Period|Overall Study||26
2905636|NCT00448864|3614248|FG001|Completed Post-operative Period|Overall Study||25
2905637|NCT00448864|3614249|FG002|Completed Post-operative Period|Overall Study||18
2905638|NCT00448864|3614247|FG000|COMPLETED|Overall Study||22
2905639|NCT00448864|3614248|FG001|COMPLETED|Overall Study||24
2905640|NCT00448864|3614249|FG002|COMPLETED|Overall Study||18
2905641|NCT00448864|3614247|FG000|NOT COMPLETED|Overall Study||5
2905642|NCT00448864|3614248|FG001|NOT COMPLETED|Overall Study||5
2905643|NCT00448864|3614249|FG002|NOT COMPLETED|Overall Study||1
2905644|NCT00448916|3614263|FG000|STARTED|Overall Study||16
2905645|NCT00448916|3614264|FG001|STARTED|Overall Study||15
2905646|NCT00448916|3614265|FG002|STARTED|Overall Study||12
2905647|NCT00448916|3614266|FG003|STARTED|Overall Study||11
2905648|NCT00448916|3614263|FG000|COMPLETED|Overall Study||9
2905649|NCT00448916|3614264|FG001|COMPLETED|Overall Study||9
2905650|NCT00448916|3614265|FG002|COMPLETED|Overall Study||6
2905651|NCT00448916|3614266|FG003|COMPLETED|Overall Study||5
2905652|NCT00448916|3614263|FG000|NOT COMPLETED|Overall Study||7
2905653|NCT00448916|3614264|FG001|NOT COMPLETED|Overall Study||6
2905654|NCT00448916|3614265|FG002|NOT COMPLETED|Overall Study||6
2905655|NCT00448916|3614266|FG003|NOT COMPLETED|Overall Study||6
2905656|NCT00449007|3614280|FG000|STARTED|Overall Study||2
2905657|NCT00449007|3614281|FG001|STARTED|Overall Study||3
2905658|NCT00449007|3614280|FG000|COMPLETED|Overall Study||2
2905659|NCT00449007|3614281|FG001|COMPLETED|Overall Study||3
2905660|NCT00449007|3614280|FG000|NOT COMPLETED|Overall Study||0
2905661|NCT00449007|3614281|FG001|NOT COMPLETED|Overall Study||0
2905662|NCT00449033|3614291|FG000|STARTED|Treatment Period||452
2905663|NCT00449033|3614292|FG001|STARTED|Treatment Period|Reasons for not treated: Adverse event (N=1); Consent withdrawn (N=1); Reason missing (N=1)|452
2905664|NCT00449033|3614291|FG000|Received Treatment|Treatment Period||452
2905665|NCT00449033|3614292|FG001|Received Treatment|Treatment Period||449
2905666|NCT00449033|3614291|FG000|COMPLETED|Treatment Period||0
2905667|NCT00449033|3614292|FG001|COMPLETED|Treatment Period||0
2905668|NCT00449033|3614291|FG000|NOT COMPLETED|Treatment Period||452
2905669|NCT00449033|3614292|FG001|NOT COMPLETED|Treatment Period||452
2905670|NCT00449033|3614291|FG000|STARTED|Follow-up Period|425 entered, comprising 452 randomized less 21 deaths & 6 ongoing on treatment|425
2905671|NCT00449033|3614292|FG001|STARTED|Follow-up Period|434 entered, comprising 452 randomized less 12 deaths, 2 lost to follow-up & 4 ongoing on treatment|434
2905672|NCT00449033|3614291|FG000|COMPLETED|Follow-up Period||0
2905673|NCT00449033|3614292|FG001|COMPLETED|Follow-up Period||0
2905674|NCT00449033|3614291|FG000|NOT COMPLETED|Follow-up Period||425
2905675|NCT00449033|3614292|FG001|NOT COMPLETED|Follow-up Period||434
2905676|NCT00449046|3614298|FG000|STARTED|Overall Study||40
2905677|NCT00449046|3614298|FG000|COMPLETED|Overall Study||40
2905678|NCT00449046|3614298|FG000|NOT COMPLETED|Overall Study||0
2905679|NCT00449072|3614304|FG000|STARTED|Overall Study||148
2905680|NCT00449072|3614305|FG001|STARTED|Overall Study||151
2905681|NCT00449072|3614304|FG000|COMPLETED|Overall Study||107
2905682|NCT00449072|3614305|FG001|COMPLETED|Overall Study||109
2905683|NCT00449072|3614304|FG000|NOT COMPLETED|Overall Study||41
2905684|NCT00449072|3614305|FG001|NOT COMPLETED|Overall Study||42
2905685|NCT00449150|3614314|FG000|STARTED|Overall Study||219
2905686|NCT00449150|3614315|FG001|STARTED|Overall Study||230
2905687|NCT00449150|3614316|FG002|STARTED|Overall Study||218
2905688|NCT00449150|3614314|FG000|COMPLETED|Overall Study|Subjects could have more than one reason for not completing.|173
2905689|NCT00449150|3614315|FG001|COMPLETED|Overall Study|Subjects could have more than one reason for not completing.|177
2905690|NCT00449150|3614316|FG002|COMPLETED|Overall Study|Subjects could have more than one reason for not completing.|171
2905691|NCT00449150|3614314|FG000|NOT COMPLETED|Overall Study||46
2905692|NCT00449150|3614315|FG001|NOT COMPLETED|Overall Study||53
2905693|NCT00449150|3614316|FG002|NOT COMPLETED|Overall Study||47
2905694|NCT00449163|3614327|FG000|STARTED|Overall Study||25
2905695|NCT00449163|3614327|FG000|COMPLETED|Overall Study||22
2905696|NCT00449163|3614327|FG000|NOT COMPLETED|Overall Study||3
2905697|NCT00449176|3614334|FG000|STARTED|Overall Study|3 randomly assigned to this treatment group did not take drug (of 321 subjects initially randomized)|318
2905698|NCT00449176|3614335|FG001|STARTED|Overall Study|6 randomly assigned to this treatment group did not take drug (of 334 subjects initially randomized)|328
2905699|NCT00449176|3614336|FG002|STARTED|Overall Study|5 randomly assigned to this group did not receive drug, 2 enrolled twice(of 326 subjects randomized)|319
2905700|NCT00449176|3614334|FG000|COMPLETED|Overall Study||166
2905701|NCT00449176|3614335|FG001|COMPLETED|Overall Study||133
2905702|NCT00449176|3614336|FG002|COMPLETED|Overall Study||152
2905703|NCT00449176|3614334|FG000|NOT COMPLETED|Overall Study||152
2905704|NCT00449176|3614335|FG001|NOT COMPLETED|Overall Study||195
2905705|NCT00449176|3614336|FG002|NOT COMPLETED|Overall Study||167
2905706|NCT00449540|3614346|FG000|STARTED|Pretreatment Phase||267
2905707|NCT00449540|3614347|FG001|STARTED|Pretreatment Phase||0
2905708|NCT00449540|3614348|FG002|STARTED|Pretreatment Phase||0
2905709|NCT00449540|3614346|FG000|COMPLETED|Pretreatment Phase||201
2905710|NCT00449540|3614347|FG001|COMPLETED|Pretreatment Phase||0
2905711|NCT00449540|3614348|FG002|COMPLETED|Pretreatment Phase||0
2905712|NCT00449540|3614346|FG000|NOT COMPLETED|Pretreatment Phase||66
2905713|NCT00449540|3614347|FG001|NOT COMPLETED|Pretreatment Phase||0
2905714|NCT00449540|3614348|FG002|NOT COMPLETED|Pretreatment Phase||0
2905715|NCT00449540|3614346|FG000|STARTED|Treatment Phase||0
2905716|NCT00449540|3614347|FG001|STARTED|Treatment Phase||102
2905717|NCT00449540|3614348|FG002|STARTED|Treatment Phase||99
2905718|NCT00449540|3614346|FG000|COMPLETED|Treatment Phase||0
2905719|NCT00449540|3614347|FG001|COMPLETED|Treatment Phase||82
2905720|NCT00449540|3614348|FG002|COMPLETED|Treatment Phase||82
2905721|NCT00449540|3614346|FG000|NOT COMPLETED|Treatment Phase||0
2905722|NCT00449540|3614347|FG001|NOT COMPLETED|Treatment Phase||20
2905723|NCT00449540|3614348|FG002|NOT COMPLETED|Treatment Phase||17
2905724|NCT00449644|3614360|FG000|STARTED|Overall Study||23
2905725|NCT00449644|3614361|FG001|STARTED|Overall Study||24
2905726|NCT00449644|3614362|FG002|STARTED|Overall Study||79
2905727|NCT00449644|3614363|FG003|STARTED|Overall Study||81
2905728|NCT00449644|3614360|FG000|Rollover|Overall Study||0
2905729|NCT00449644|3614361|FG001|Rollover|Overall Study||0
2905730|NCT00449644|3614362|FG002|Rollover|Overall Study||0
2905731|NCT00449644|3614363|FG003|Rollover|Overall Study||1
2905732|NCT00449644|3614360|FG000|COMPLETED|Overall Study||13
2905733|NCT00449644|3614361|FG001|COMPLETED|Overall Study||11
2905734|NCT00449644|3614362|FG002|COMPLETED|Overall Study||50
2905735|NCT00449644|3614363|FG003|COMPLETED|Overall Study|After Week 24, 1 patient rolled over to treatment with TMC207 and was not completed or discontinued.|49
2905736|NCT00449644|3614360|FG000|NOT COMPLETED|Overall Study||10
2905737|NCT00449644|3614361|FG001|NOT COMPLETED|Overall Study||13
2905738|NCT00449644|3614362|FG002|NOT COMPLETED|Overall Study||29
2905739|NCT00449644|3614363|FG003|NOT COMPLETED|Overall Study||32
2905740|NCT00449670|3614378|FG000|STARTED|Primary Phase (Study no.109630)||961
2905741|NCT00449670|3614379|FG001|STARTED|Primary Phase (Study no.109630)||245
2905742|NCT00449670|3614378|FG000|COMPLETED|Primary Phase (Study no.109630)||947
2905743|NCT00449670|3614379|FG001|COMPLETED|Primary Phase (Study no.109630)||243
2905744|NCT00449670|3614378|FG000|NOT COMPLETED|Primary Phase (Study no.109630)||14
2905745|NCT00449670|3614379|FG001|NOT COMPLETED|Primary Phase (Study no.109630)||2
2905746|NCT00449670|3614378|FG000|STARTED|Booster Phase (Study no.109873)||265
2905747|NCT00449670|3614379|FG001|STARTED|Booster Phase (Study no.109873)||236
2905748|NCT00449670|3614378|FG000|COMPLETED|Booster Phase (Study no.109873)||265
2905749|NCT00449670|3614379|FG001|COMPLETED|Booster Phase (Study no.109873)||233
2905750|NCT00449670|3614378|FG000|NOT COMPLETED|Booster Phase (Study no.109873)||0
2905751|NCT00449670|3614379|FG001|NOT COMPLETED|Booster Phase (Study no.109873)||3
2905752|NCT00449696|3614394|FG000|STARTED|Overall Study||251
2905753|NCT00449696|3614395|FG001|STARTED|Overall Study||128
2905754|NCT00449696|3614394|FG000|Received Injection|Overall Study||249
2905755|NCT00449696|3614395|FG001|Received Injection|Overall Study||128
2905756|NCT00449696|3614394|FG000|Analyzed Participants|Overall Study|2 subjects removed from ITT analyses because of no post treatment data (pre-defined criteria).|247
2905757|NCT00449696|3614395|FG001|Analyzed Participants|Overall Study||128
2905758|NCT00449696|3614394|FG000|COMPLETED|Overall Study||231
2905759|NCT00449696|3614395|FG001|COMPLETED|Overall Study||119
2905760|NCT00449696|3614394|FG000|NOT COMPLETED|Overall Study||20
2905761|NCT00449696|3614395|FG001|NOT COMPLETED|Overall Study||9
2905762|NCT00449748|3614401|FG000|STARTED|Overall Study||10
2905763|NCT00449748|3614401|FG000|COMPLETED|Overall Study||10
2905764|NCT00449748|3614401|FG000|NOT COMPLETED|Overall Study||0
2905765|NCT00449761|3614405|FG000|STARTED|Overall Study||27
2905766|NCT00449761|3614405|FG000|COMPLETED|Overall Study||9
2905767|NCT00449761|3614405|FG000|NOT COMPLETED|Overall Study||18
2905768|NCT00449787|3614412|FG000|STARTED|Overall Study||203
2905769|NCT00449787|3614413|FG001|STARTED|Overall Study||198
2905770|NCT00449787|3614412|FG000|COMPLETED|Overall Study||98
2905771|NCT00449787|3614413|FG001|COMPLETED|Overall Study||98
2905772|NCT00449787|3614412|FG000|NOT COMPLETED|Overall Study||105
2905773|NCT00449787|3614413|FG001|NOT COMPLETED|Overall Study||100
2905774|NCT00449865|3614423|FG000|STARTED|Overall Study||867
2905775|NCT00449865|3614424|FG001|STARTED|Overall Study||874
2905776|NCT00449865|3614423|FG000|Completed Year 1|Overall Study|867 Expected at Year 1|802
2905777|NCT00449865|3614424|FG001|Completed Year 1|Overall Study|874 Expected at Year 1|822
2905778|NCT00449865|3614423|FG000|Completed Year 2|Overall Study|867 Expected at Year 2|768
2905779|NCT00449865|3614424|FG001|Completed Year 2|Overall Study|874 Expected at Year 2|766
2905780|NCT00449865|3614423|FG000|Completed Year 3|Overall Study|867 Expected at Year 3|719
2905781|NCT00449865|3614424|FG001|Completed Year 3|Overall Study|874 Expected at Year 3|715
2905782|NCT00449865|3614423|FG000|Completed Year 4|Overall Study|679 Expected at Year 4|521
2905783|NCT00449865|3614424|FG001|Completed Year 4|Overall Study|686 Expected at Year 4|523
2905784|NCT00449865|3614423|FG000|COMPLETED|Overall Study|478 Expected at Year 5|345
2905785|NCT00449865|3614424|FG001|COMPLETED|Overall Study|477 Expected at Year 5|340
2905786|NCT00449865|3614423|FG000|NOT COMPLETED|Overall Study||522
2905787|NCT00449865|3614424|FG001|NOT COMPLETED|Overall Study||534
2905788|NCT00449930|3614432|FG000|STARTED|Overall Study||528
2905789|NCT00449930|3614433|FG001|STARTED|Overall Study||522
2905790|NCT00449930|3614432|FG000|COMPLETED|Overall Study||467
2905791|NCT00449930|3614433|FG001|COMPLETED|Overall Study||447
2905792|NCT00449930|3614432|FG000|NOT COMPLETED|Overall Study||61
2905793|NCT00449930|3614433|FG001|NOT COMPLETED|Overall Study||75
2905794|NCT00449956|3614442|FG000|STARTED|Overall Study||189
2905795|NCT00449956|3614443|FG001|STARTED|Overall Study||92
2905796|NCT00449956|3614444|FG002|STARTED|Overall Study||193
2905797|NCT00449956|3614442|FG000|COMPLETED|Overall Study||179
2905798|NCT00449956|3614443|FG001|COMPLETED|Overall Study||88
2905799|NCT00449956|3614444|FG002|COMPLETED|Overall Study||184
2905800|NCT00449956|3614442|FG000|NOT COMPLETED|Overall Study||10
2905801|NCT00449956|3614443|FG001|NOT COMPLETED|Overall Study||4
2905802|NCT00449956|3614444|FG002|NOT COMPLETED|Overall Study||9
2905803|NCT00450073|3614455|FG000|STARTED|Overall Study||10
2905804|NCT00450073|3614456|FG001|STARTED|Overall Study||10
2905805|NCT00450073|3614457|FG002|STARTED|Overall Study||10
2905806|NCT00450073|3614455|FG000|COMPLETED|Overall Study||9
2905807|NCT00450073|3614456|FG001|COMPLETED|Overall Study||10
2905808|NCT00450073|3614457|FG002|COMPLETED|Overall Study||9
2905809|NCT00450073|3614455|FG000|NOT COMPLETED|Overall Study||1
2905810|NCT00450073|3614456|FG001|NOT COMPLETED|Overall Study||0
2905811|NCT00450073|3614457|FG002|NOT COMPLETED|Overall Study||1
2905812|NCT00450112|3614467|FG000|STARTED|Overall Study||125
2905813|NCT00450112|3614468|FG001|STARTED|Overall Study||77
2905814|NCT00450112|3614467|FG000|Received Injection|Overall Study||125
2905815|NCT00450112|3614468|FG001|Received Injection|Overall Study||74
2905816|NCT00450112|3614467|FG000|Analyzed Participants|Overall Study|3 subjects removed from ITT analyses because of no post treatment data (pre-defined criteria).|122
2905817|NCT00450112|3614468|FG001|Analyzed Participants|Overall Study||74
2905818|NCT00450112|3614467|FG000|COMPLETED|Overall Study||112
2905819|NCT00450112|3614468|FG001|COMPLETED|Overall Study||71
2905820|NCT00450112|3614467|FG000|NOT COMPLETED|Overall Study||13
2905821|NCT00450112|3614468|FG001|NOT COMPLETED|Overall Study||6
2905822|NCT00450177|3614476|FG000|STARTED|Overall Study||97
2905823|NCT00450177|3614477|FG001|STARTED|Overall Study||103
2905824|NCT00450177|3614476|FG000|COMPLETED|Overall Study||88
2905825|NCT00450177|3614477|FG001|COMPLETED|Overall Study||92
2905826|NCT00450177|3614476|FG000|NOT COMPLETED|Overall Study||9
2905827|NCT00450177|3614477|FG001|NOT COMPLETED|Overall Study||11
2905828|NCT00450190|3614483|FG000|STARTED|Overall Study||20
2905829|NCT00450190|3614483|FG000|COMPLETED|Overall Study||18
2905830|NCT00450190|3614483|FG000|NOT COMPLETED|Overall Study||2
2905831|NCT00450216|3614489|FG000|STARTED|Overall Study||607
2905832|NCT00450216|3614490|FG001|STARTED|Overall Study||299
2905833|NCT00450216|3614489|FG000|COMPLETED|Overall Study||433
2905834|NCT00450216|3614490|FG001|COMPLETED|Overall Study||170
2905835|NCT00450216|3614489|FG000|NOT COMPLETED|Overall Study||174
2905836|NCT00450216|3614490|FG001|NOT COMPLETED|Overall Study||129
2905837|NCT00450242|3614498|FG000|STARTED|Overall Study||7
2905838|NCT00450242|3614499|FG001|STARTED|Overall Study||7
2905839|NCT00450242|3614498|FG000|COMPLETED|Overall Study||4
2905840|NCT00450242|3614499|FG001|COMPLETED|Overall Study||6
2905841|NCT00450242|3614498|FG000|NOT COMPLETED|Overall Study||3
2905842|NCT00450242|3614499|FG001|NOT COMPLETED|Overall Study||1
2905843|NCT00450255|3614507|FG000|STARTED|Overall Study||41
2905844|NCT00450255|3614507|FG000|COMPLETED|Overall Study||40
2905845|NCT00450255|3614507|FG000|NOT COMPLETED|Overall Study||1
2905846|NCT00450294|3614512|FG000|STARTED|Overall Study||10
2905847|NCT00450294|3614512|FG000|COMPLETED|Overall Study||10
2905848|NCT00450294|3614512|FG000|NOT COMPLETED|Overall Study||0
2905849|NCT00450372|3614517|FG000|STARTED|Overall Study||38
2905850|NCT00450372|3614517|FG000|COMPLETED|Overall Study||37
2905851|NCT00450372|3614517|FG000|NOT COMPLETED|Overall Study||1
2905852|NCT00450385|3614524|FG000|STARTED|Overall Study||57
2905853|NCT00450385|3614524|FG000|COMPLETED|Overall Study||44
2905854|NCT00450385|3614524|FG000|NOT COMPLETED|Overall Study||13
2905855|NCT00450411|3614529|FG000|STARTED|Overall Study||100
2905856|NCT00450411|3614529|FG000|Eligible and Started Protocol Treatment|Overall Study||92
2905857|NCT00450411|3614529|FG000|COMPLETED|Overall Study||92
2905858|NCT00450411|3614529|FG000|NOT COMPLETED|Overall Study||8
2905859|NCT00450424|3614535|FG000|STARTED|Overall Study||122
2905860|NCT00450424|3614536|FG001|STARTED|Overall Study||117
2905861|NCT00450424|3614535|FG000|COMPLETED|Overall Study||102
2905862|NCT00450424|3614536|FG001|COMPLETED|Overall Study||106
2905863|NCT00450424|3614535|FG000|NOT COMPLETED|Overall Study||20
2905864|NCT00450424|3614536|FG001|NOT COMPLETED|Overall Study||11
2905865|NCT00450437|3614544|FG000|STARTED|Overall Study||1640
2905866|NCT00450437|3614545|FG001|STARTED|Overall Study||540
2905867|NCT00450437|3614546|FG002|STARTED|Overall Study||1023
2905868|NCT00450437|3614547|FG003|STARTED|Overall Study||336
2905869|NCT00450437|3614544|FG000|COMPLETED|Overall Study||1594
2905870|NCT00450437|3614545|FG001|COMPLETED|Overall Study||524
2905871|NCT00450437|3614546|FG002|COMPLETED|Overall Study||999
2905872|NCT00450437|3614547|FG003|COMPLETED|Overall Study||325
2905873|NCT00450437|3614544|FG000|NOT COMPLETED|Overall Study||46
2905874|NCT00450437|3614545|FG001|NOT COMPLETED|Overall Study||16
2905875|NCT00450437|3614546|FG002|NOT COMPLETED|Overall Study||24
2905876|NCT00450437|3614547|FG003|NOT COMPLETED|Overall Study||11
2905877|NCT00450450|3614563|FG000|STARTED|Overall Study||13
2905878|NCT00450450|3614564|FG001|STARTED|Overall Study||14
2905879|NCT00450450|3614563|FG000|COMPLETED|Overall Study||8
2905880|NCT00450450|3614564|FG001|COMPLETED|Overall Study||11
2905881|NCT00450450|3614563|FG000|NOT COMPLETED|Overall Study||5
2905882|NCT00450450|3614564|FG001|NOT COMPLETED|Overall Study||3
2905883|NCT00450463|3614572|FG000|STARTED|Initial Drug Administration||33
2905884|NCT00450463|3614573|FG001|STARTED|Initial Drug Administration||31
2905885|NCT00450463|3614572|FG000|COMPLETED|Initial Drug Administration||33
2905886|NCT00450463|3614573|FG001|COMPLETED|Initial Drug Administration||31
2905887|NCT00450463|3614572|FG000|NOT COMPLETED|Initial Drug Administration||0
2905888|NCT00450463|3614573|FG001|NOT COMPLETED|Initial Drug Administration||0
2905889|NCT00450463|3614572|FG000|STARTED|Progressed to Receive Vaccine Alone||11
2905890|NCT00450463|3614573|FG001|STARTED|Progressed to Receive Vaccine Alone||0
2905891|NCT00450463|3614572|FG000|COMPLETED|Progressed to Receive Vaccine Alone||11
2905892|NCT00450463|3614573|FG001|COMPLETED|Progressed to Receive Vaccine Alone||0
2905893|NCT00450463|3614572|FG000|NOT COMPLETED|Progressed to Receive Vaccine Alone||0
2905894|NCT00450463|3614573|FG001|NOT COMPLETED|Progressed to Receive Vaccine Alone||0
2905895|NCT00450580|3614584|FG000|STARTED|Overall Study||106
2905896|NCT00450580|3614585|FG001|STARTED|Overall Study||106
2905897|NCT00450580|3614584|FG000|COMPLETED|Overall Study||90
2905898|NCT00450580|3614585|FG001|COMPLETED|Overall Study||90
2905899|NCT00450580|3614584|FG000|NOT COMPLETED|Overall Study||16
2905900|NCT00450580|3614585|FG001|NOT COMPLETED|Overall Study||16
2905901|NCT00450619|3614593|FG000|STARTED|Overall Study||22
2905902|NCT00450619|3614594|FG001|STARTED|Overall Study||22
2905903|NCT00450619|3614593|FG000|COMPLETED|Overall Study||18
2905904|NCT00450619|3614594|FG001|COMPLETED|Overall Study||21
2905905|NCT00450619|3614593|FG000|NOT COMPLETED|Overall Study||4
2905906|NCT00450619|3614594|FG001|NOT COMPLETED|Overall Study||1
2905907|NCT00450658|3614603|FG000|STARTED|Overall Study||415
2905908|NCT00450658|3614604|FG001|STARTED|Overall Study||212
2905909|NCT00450658|3614603|FG000|COMPLETED|Overall Study||272
2905910|NCT00450658|3614604|FG001|COMPLETED|Overall Study||122
2905911|NCT00450658|3614603|FG000|NOT COMPLETED|Overall Study||143
2905912|NCT00450658|3614604|FG001|NOT COMPLETED|Overall Study||90
2920419|NCT00536913|3630940|FG000|STARTED|Overall Study||55
2920420|NCT00536913|3630941|FG001|STARTED|Overall Study||52
2920421|NCT00536913|3630940|FG000|COMPLETED|Overall Study||55
2920422|NCT00536913|3630941|FG001|COMPLETED|Overall Study||52
2920423|NCT00536913|3630940|FG000|NOT COMPLETED|Overall Study||0
2920424|NCT00536913|3630941|FG001|NOT COMPLETED|Overall Study||0
2920425|NCT00536939|3630947|FG000|STARTED|Overall Study||2
2920426|NCT00536939|3630948|FG001|STARTED|Overall Study||0
2920427|NCT00536939|3630947|FG000|Entered Safety lead-in|Overall Study||2
2920428|NCT00536939|3630948|FG001|Entered Safety lead-in|Overall Study||0
2920429|NCT00536939|3630947|FG000|Randomized|Overall Study||0
2920430|NCT00536939|3630948|FG001|Randomized|Overall Study||0
2920431|NCT00536939|3630947|FG000|COMPLETED|Overall Study||0
2920432|NCT00536939|3630948|FG001|COMPLETED|Overall Study||0
2920433|NCT00536939|3630947|FG000|NOT COMPLETED|Overall Study||2
2920434|NCT00536939|3630948|FG001|NOT COMPLETED|Overall Study||0
2920435|NCT00536991|3630953|FG000|STARTED|Overall Study||51
2920436|NCT00536991|3630953|FG000|COMPLETED|Overall Study||38
2920437|NCT00536991|3630953|FG000|NOT COMPLETED|Overall Study||13
2920438|NCT00537017|3630958|FG000|STARTED|Treatment Phase||140
2920439|NCT00537017|3630958|FG000|COMPLETED|Treatment Phase||106
2920440|NCT00537017|3630958|FG000|NOT COMPLETED|Treatment Phase||34
2920441|NCT00537017|3630958|FG000|STARTED|Follow-up Phase|All TP participants were eligible for FUP entry. 5 participants completing TP did not enter FUP.|135
2920442|NCT00537017|3630958|FG000|COMPLETED|Follow-up Phase||126
2920443|NCT00537017|3630958|FG000|NOT COMPLETED|Follow-up Phase||9
2920444|NCT00537030|3630962|FG000|STARTED|Overall Study||59
2920445|NCT00537030|3630962|FG000|COMPLETED|Overall Study||43
2920446|NCT00537030|3630962|FG000|NOT COMPLETED|Overall Study||16
2920447|NCT00537056|3630966|FG000|STARTED|Baseline PET/CT||17
2920448|NCT00537056|3630966|FG000|COMPLETED|Baseline PET/CT||17
2920449|NCT00537056|3630966|FG000|NOT COMPLETED|Baseline PET/CT||0
2920450|NCT00537056|3630966|FG000|STARTED|Interim PET/CT||17
2920451|NCT00537056|3630966|FG000|COMPLETED|Interim PET/CT||12
2920452|NCT00537056|3630966|FG000|NOT COMPLETED|Interim PET/CT||5
2905913|NCT00450723|3614610|FG000|STARTED|Overall Study||39
2905914|NCT00450723|3614610|FG000|COMPLETED|Overall Study||34
2905915|NCT00450723|3614610|FG000|NOT COMPLETED|Overall Study||5
2905916|NCT00450749|3614618|FG000|STARTED|Overall Study||3
2905917|NCT00450749|3614619|FG001|STARTED|Overall Study||3
2905918|NCT00450749|3614620|FG002|STARTED|Overall Study||4
2905919|NCT00450749|3614618|FG000|COMPLETED|Overall Study||3
2905920|NCT00450749|3614619|FG001|COMPLETED|Overall Study||2
2905921|NCT00450749|3614620|FG002|COMPLETED|Overall Study||2
2905922|NCT00450749|3614618|FG000|NOT COMPLETED|Overall Study||0
2905923|NCT00450749|3614619|FG001|NOT COMPLETED|Overall Study||1
2905924|NCT00450749|3614620|FG002|NOT COMPLETED|Overall Study||2
2905925|NCT00450801|3614628|FG000|STARTED|Overall Study||22
2905926|NCT00450801|3614628|FG000|COMPLETED|Overall Study||21
2905927|NCT00450801|3614628|FG000|NOT COMPLETED|Overall Study||1
2905928|NCT00450814|3614647|FG000|STARTED|Overall Study||3
2905929|NCT00450814|3614648|FG001|STARTED|Overall Study||3
2905930|NCT00450814|3614649|FG002|STARTED|Overall Study||3
2905931|NCT00450814|3614650|FG003|STARTED|Overall Study||4
2905932|NCT00450814|3614651|FG004|STARTED|Overall Study||4
2905933|NCT00450814|3614652|FG005|STARTED|Overall Study||7
2905934|NCT00450814|3614653|FG006|STARTED|Overall Study||3
2905935|NCT00450814|3614654|FG007|STARTED|Overall Study||3
2905936|NCT00450814|3614655|FG008|STARTED|Overall Study||2
2905937|NCT00450814|3614656|FG009|STARTED|Overall Study||12
2905938|NCT00450814|3614657|FG010|STARTED|Overall Study||4
2905939|NCT00450814|3614647|FG000|COMPLETED|Overall Study||3
2905940|NCT00450814|3614648|FG001|COMPLETED|Overall Study||3
2905941|NCT00450814|3614649|FG002|COMPLETED|Overall Study||3
2905942|NCT00450814|3614650|FG003|COMPLETED|Overall Study||3
2905943|NCT00450814|3614651|FG004|COMPLETED|Overall Study||3
2905944|NCT00450814|3614652|FG005|COMPLETED|Overall Study||6
2905945|NCT00450814|3614653|FG006|COMPLETED|Overall Study||3
2905946|NCT00450814|3614654|FG007|COMPLETED|Overall Study||3
2905947|NCT00450814|3614655|FG008|COMPLETED|Overall Study||2
2905948|NCT00450814|3614656|FG009|COMPLETED|Overall Study||11
2905949|NCT00450814|3614657|FG010|COMPLETED|Overall Study||4
2905950|NCT00450814|3614647|FG000|NOT COMPLETED|Overall Study||0
2905951|NCT00450814|3614648|FG001|NOT COMPLETED|Overall Study||0
2905952|NCT00450814|3614649|FG002|NOT COMPLETED|Overall Study||0
2905953|NCT00450814|3614650|FG003|NOT COMPLETED|Overall Study||1
2905954|NCT00450814|3614651|FG004|NOT COMPLETED|Overall Study||1
2905955|NCT00450814|3614652|FG005|NOT COMPLETED|Overall Study||1
2905956|NCT00450814|3614653|FG006|NOT COMPLETED|Overall Study||0
2905957|NCT00450814|3614654|FG007|NOT COMPLETED|Overall Study||0
2905958|NCT00450814|3614655|FG008|NOT COMPLETED|Overall Study||0
2905959|NCT00450814|3614656|FG009|NOT COMPLETED|Overall Study||1
2905960|NCT00450814|3614657|FG010|NOT COMPLETED|Overall Study||0
2905961|NCT00450866|3614682|FG000|STARTED|Overall Study||45
2905962|NCT00450866|3614683|FG001|STARTED|Overall Study||10
2905963|NCT00450866|3614682|FG000|COMPLETED|Overall Study||38
2905964|NCT00450866|3614683|FG001|COMPLETED|Overall Study||7
2905965|NCT00450866|3614682|FG000|NOT COMPLETED|Overall Study||7
2905966|NCT00450866|3614683|FG001|NOT COMPLETED|Overall Study||3
2905967|NCT00450983|3614689|FG000|STARTED|Overall Study||1
2905968|NCT00450983|3614689|FG000|COMPLETED|Overall Study||1
2905969|NCT00450983|3614689|FG000|NOT COMPLETED|Overall Study||0
2905970|NCT00451035|3614693|FG000|STARTED|Overall Study||29
2905971|NCT00451035|3614693|FG000|COMPLETED|Overall Study||12
2905972|NCT00451035|3614693|FG000|NOT COMPLETED|Overall Study||17
2905973|NCT00451048|3614698|FG000|STARTED|Overall Study||10
2905974|NCT00451048|3614698|FG000|COMPLETED|Overall Study||10
2905975|NCT00451048|3614698|FG000|NOT COMPLETED|Overall Study||0
2905976|NCT00451178|3614704|FG000|STARTED|Chemotherapy (Up To Six 21-Day Cycles)||58
2905977|NCT00451178|3614705|FG001|STARTED|Chemotherapy (Up To Six 21-Day Cycles)||43
2905978|NCT00451178|3614704|FG000|Received At Least 1 Dose Study Treatment|Chemotherapy (Up To Six 21-Day Cycles)||57
2905979|NCT00451178|3614705|FG001|Received At Least 1 Dose Study Treatment|Chemotherapy (Up To Six 21-Day Cycles)||43
2905980|NCT00451178|3614704|FG000|COMPLETED|Chemotherapy (Up To Six 21-Day Cycles)||40
2905981|NCT00451178|3614705|FG001|COMPLETED|Chemotherapy (Up To Six 21-Day Cycles)||26
2905982|NCT00451178|3614704|FG000|NOT COMPLETED|Chemotherapy (Up To Six 21-Day Cycles)||18
2905983|NCT00451178|3614705|FG001|NOT COMPLETED|Chemotherapy (Up To Six 21-Day Cycles)||17
2905984|NCT00451178|3614704|FG000|STARTED|Prior to Maintenance Therapy||40
2905985|NCT00451178|3614705|FG001|STARTED|Prior to Maintenance Therapy|R-CHOP participants were excluded from maintenance therapy and went directly to long-term follow-up.|0
2905986|NCT00451178|3614704|FG000|COMPLETED|Prior to Maintenance Therapy||36
2905987|NCT00451178|3614705|FG001|COMPLETED|Prior to Maintenance Therapy||0
2905988|NCT00451178|3614704|FG000|NOT COMPLETED|Prior to Maintenance Therapy||4
2905989|NCT00451178|3614705|FG001|NOT COMPLETED|Prior to Maintenance Therapy||0
2905990|NCT00451178|3614704|FG000|STARTED|Maintenance Therapy (up to 3 Years)||36
2905991|NCT00451178|3614705|FG001|STARTED|Maintenance Therapy (up to 3 Years)|R-CHOP participants were excluded from maintenance therapy and went directly to long-term follow-up.|0
2905992|NCT00451178|3614704|FG000|COMPLETED|Maintenance Therapy (up to 3 Years)||6
2905993|NCT00451178|3614705|FG001|COMPLETED|Maintenance Therapy (up to 3 Years)||0
2905994|NCT00451178|3614704|FG000|NOT COMPLETED|Maintenance Therapy (up to 3 Years)||30
2905995|NCT00451178|3614705|FG001|NOT COMPLETED|Maintenance Therapy (up to 3 Years)||0
2905996|NCT00451178|3614704|FG000|STARTED|Long-Term Follow-Up (Up to 2 Years)||6
2905997|NCT00451178|3614705|FG001|STARTED|Long-Term Follow-Up (Up to 2 Years)||26
2905998|NCT00451178|3614704|FG000|COMPLETED|Long-Term Follow-Up (Up to 2 Years)||0
2905999|NCT00451178|3614705|FG001|COMPLETED|Long-Term Follow-Up (Up to 2 Years)||0
2906000|NCT00451178|3614704|FG000|NOT COMPLETED|Long-Term Follow-Up (Up to 2 Years)||6
2906001|NCT00451178|3614705|FG001|NOT COMPLETED|Long-Term Follow-Up (Up to 2 Years)||26
2906002|NCT00451191|3614717|FG000|STARTED|Overall Study||68
2906003|NCT00451191|3614718|FG001|STARTED|Overall Study||66
2906004|NCT00451191|3614717|FG000|COMPLETED|Overall Study||53
2906005|NCT00451191|3614718|FG001|COMPLETED|Overall Study||55
2906006|NCT00451191|3614717|FG000|NOT COMPLETED|Overall Study||15
2906007|NCT00451191|3614718|FG001|NOT COMPLETED|Overall Study||11
2906008|NCT00451204|3614726|FG000|STARTED|Overall Study||82
2906009|NCT00451204|3614727|FG001|STARTED|Overall Study||76
2906010|NCT00451204|3614726|FG000|COMPLETED|Overall Study|60 completed the study but 3 stopped study drug(s) early|60
2906011|NCT00451204|3614727|FG001|COMPLETED|Overall Study||56
2906012|NCT00451204|3614726|FG000|NOT COMPLETED|Overall Study||22
2906013|NCT00451204|3614727|FG001|NOT COMPLETED|Overall Study||20
2906014|NCT00451217|3614740|FG000|STARTED|Overall Study||49
2906015|NCT00451217|3614741|FG001|STARTED|Overall Study||49
2906016|NCT00451217|3614742|FG002|STARTED|Overall Study||51
2906017|NCT00451217|3614743|FG003|STARTED|Overall Study||49
2906018|NCT00451217|3614740|FG000|Treated|Overall Study||48
2906019|NCT00451217|3614741|FG001|Treated|Overall Study||48
2906020|NCT00451217|3614742|FG002|Treated|Overall Study||48
2906021|NCT00451217|3614743|FG003|Treated|Overall Study||45
2906022|NCT00451217|3614740|FG000|COMPLETED|Overall Study||47
2906023|NCT00451217|3614741|FG001|COMPLETED|Overall Study||47
2906024|NCT00451217|3614742|FG002|COMPLETED|Overall Study||47
2906025|NCT00451217|3614743|FG003|COMPLETED|Overall Study||44
2906026|NCT00451217|3614740|FG000|NOT COMPLETED|Overall Study||2
2906027|NCT00451217|3614741|FG001|NOT COMPLETED|Overall Study||2
2906028|NCT00451217|3614742|FG002|NOT COMPLETED|Overall Study||4
2906029|NCT00451217|3614743|FG003|NOT COMPLETED|Overall Study||5
2906030|NCT00451282|3614755|FG000|STARTED|Overall Study||46
2906031|NCT00451282|3614756|FG001|STARTED|Overall Study||39
2906032|NCT00451282|3614755|FG000|COMPLETED|Overall Study||40
2906033|NCT00451282|3614756|FG001|COMPLETED|Overall Study||34
2906034|NCT00451282|3614755|FG000|NOT COMPLETED|Overall Study||6
2906035|NCT00451282|3614756|FG001|NOT COMPLETED|Overall Study||5
2906036|NCT00451321|3614770|FG000|STARTED|Overall Study||8
2906037|NCT00451321|3614771|FG001|STARTED|Overall Study||15
2906038|NCT00451321|3614772|FG002|STARTED|Overall Study||18
2906039|NCT00451321|3614773|FG003|STARTED|Overall Study||19
2906040|NCT00451321|3614774|FG004|STARTED|Overall Study||7
2906041|NCT00451321|3614775|FG005|STARTED|Overall Study||9
2906042|NCT00451321|3614776|FG006|STARTED|Overall Study||6
2906043|NCT00451321|3614777|FG007|STARTED|Overall Study||6
2906044|NCT00451321|3614770|FG000|COMPLETED|Overall Study||1
2906045|NCT00451321|3614771|FG001|COMPLETED|Overall Study||10
2906046|NCT00451321|3614772|FG002|COMPLETED|Overall Study||0
2906047|NCT00451321|3614773|FG003|COMPLETED|Overall Study||7
2906048|NCT00451321|3614774|FG004|COMPLETED|Overall Study||0
2906049|NCT00451321|3614775|FG005|COMPLETED|Overall Study||0
2906050|NCT00451321|3614776|FG006|COMPLETED|Overall Study||0
2906051|NCT00451321|3614777|FG007|COMPLETED|Overall Study||0
2906052|NCT00451321|3614770|FG000|NOT COMPLETED|Overall Study||7
2906053|NCT00451321|3614771|FG001|NOT COMPLETED|Overall Study||5
2906054|NCT00451321|3614772|FG002|NOT COMPLETED|Overall Study||18
2906055|NCT00451321|3614773|FG003|NOT COMPLETED|Overall Study||12
2906056|NCT00451321|3614774|FG004|NOT COMPLETED|Overall Study||7
2906057|NCT00451321|3614775|FG005|NOT COMPLETED|Overall Study||9
2906058|NCT00451321|3614776|FG006|NOT COMPLETED|Overall Study||6
2906059|NCT00451321|3614777|FG007|NOT COMPLETED|Overall Study||6
2906060|NCT00451451|3614799|FG000|STARTED|Overall Study|363 participants were dosed; 363 participants were randomized|363
2906061|NCT00451451|3614800|FG001|STARTED|Overall Study|359 participants were dosed; 362 participants were randomized|359
2906062|NCT00451451|3614801|FG002|STARTED|Overall Study|345 participants were dosed; 345 participants were randomized|345
2906063|NCT00451451|3614802|FG003|STARTED|Overall Study|350 participants were dosed; 360 participants were randomized|350
2906064|NCT00451451|3614799|FG000|COMPLETED|Overall Study||278
2906065|NCT00451451|3614800|FG001|COMPLETED|Overall Study||284
2906066|NCT00451451|3614801|FG002|COMPLETED|Overall Study||273
2906067|NCT00451451|3614802|FG003|COMPLETED|Overall Study||292
2906068|NCT00451451|3614799|FG000|NOT COMPLETED|Overall Study||85
2906069|NCT00451451|3614800|FG001|NOT COMPLETED|Overall Study||75
2906070|NCT00451451|3614801|FG002|NOT COMPLETED|Overall Study||72
2906071|NCT00451451|3614802|FG003|NOT COMPLETED|Overall Study||58
2906072|NCT00451555|3614817|FG000|STARTED|Overall Study||96
2906073|NCT00451555|3614818|FG001|STARTED|Overall Study||60
2906074|NCT00451555|3614817|FG000|Received at Least One Dose of Study Drug|Overall Study||94
2906075|NCT00451555|3614818|FG001|Received at Least One Dose of Study Drug|Overall Study||58
2906076|NCT00451555|3614817|FG000|Enzastaurin Twice Daily Dosing (BID)|Overall Study||39
2906077|NCT00451555|3614818|FG001|Enzastaurin Twice Daily Dosing (BID)|Overall Study||0
2906078|NCT00451555|3614817|FG000|Enzastaurin Once Daily Dosing (QD)|Overall Study||55
2906079|NCT00451555|3614818|FG001|Enzastaurin Once Daily Dosing (QD)|Overall Study||0
2906080|NCT00451555|3614817|FG000|Progressive Disease|Overall Study||75
2906081|NCT00451555|3614818|FG001|Progressive Disease|Overall Study||54
2906082|NCT00451555|3614817|FG000|Death|Overall Study||2
2906083|NCT00451555|3614818|FG001|Death|Overall Study||0
2906084|NCT00451555|3614817|FG000|COMPLETED|Overall Study||83
2906085|NCT00451555|3614818|FG001|COMPLETED|Overall Study||56
2906086|NCT00451555|3614817|FG000|NOT COMPLETED|Overall Study||13
2906087|NCT00451555|3614818|FG001|NOT COMPLETED|Overall Study||4
2906088|NCT00451698|3614835|FG000|STARTED|Overall Study||3
2906089|NCT00451698|3614836|FG001|STARTED|Overall Study||6
2906090|NCT00451698|3614835|FG000|COMPLETED|Overall Study||3
2906091|NCT00451698|3614836|FG001|COMPLETED|Overall Study||6
2906092|NCT00451698|3614835|FG000|NOT COMPLETED|Overall Study||0
2906093|NCT00451698|3614836|FG001|NOT COMPLETED|Overall Study||0
2906094|NCT00451906|3614844|FG000|STARTED|Overall Study||2252
2906095|NCT00451906|3614844|FG000|COMPLETED|Overall Study||13
2906096|NCT00451906|3614844|FG000|NOT COMPLETED|Overall Study||2239
2906097|NCT00451958|3614852|FG000|STARTED|CS21 (NCT00295750)|CS21 intention-to-treat (ITT) population.|210
2906098|NCT00451958|3614853|FG001|STARTED|CS21 (NCT00295750)|CS21 ITT population.|206
2906099|NCT00451958|3614854|FG002|STARTED|CS21 (NCT00295750)|Participants were switched from the leuprolide 7.5 mg group when CS21 was completed.|0
2906100|NCT00451958|3614855|FG003|STARTED|CS21 (NCT00295750)|Participants were switched from the leuprolide 7.5 mg group when CS21 was completed.|0
2906101|NCT00451958|3614856|FG004|STARTED|CS21 (NCT00295750)||204
2906102|NCT00451958|3614852|FG000|COMPLETED|CS21 (NCT00295750)||169
2906103|NCT00451958|3614853|FG001|COMPLETED|CS21 (NCT00295750)||163
2906104|NCT00451958|3614854|FG002|COMPLETED|CS21 (NCT00295750)||0
2906105|NCT00451958|3614855|FG003|COMPLETED|CS21 (NCT00295750)||0
2906106|NCT00451958|3614856|FG004|COMPLETED|CS21 (NCT00295750)||172
2906107|NCT00451958|3614852|FG000|NOT COMPLETED|CS21 (NCT00295750)||41
2906108|NCT00451958|3614853|FG001|NOT COMPLETED|CS21 (NCT00295750)||43
2906109|NCT00451958|3614854|FG002|NOT COMPLETED|CS21 (NCT00295750)||0
2906110|NCT00451958|3614855|FG003|NOT COMPLETED|CS21 (NCT00295750)||0
2906111|NCT00451958|3614856|FG004|NOT COMPLETED|CS21 (NCT00295750)||32
2906112|NCT00451958|3614852|FG000|STARTED|CS21A (NCT00451958)|CS21A intention-to-treat (ITT) population.|125
2906113|NCT00451958|3614853|FG001|STARTED|CS21A (NCT00451958)|CS21A ITT population.|126
2906114|NCT00451958|3614854|FG002|STARTED|CS21A (NCT00451958)|CS21A ITT population.|69
2906115|NCT00451958|3614855|FG003|STARTED|CS21A (NCT00451958)|One of the enrolled participants never received any treatment, i.e. the CS21A ITT population=65.|66
2906116|NCT00451958|3614856|FG004|STARTED|CS21A (NCT00451958)|Participants were switched to the degarelix groups when CS21 was completed.|0
2906117|NCT00451958|3614852|FG000|COMPLETED|CS21A (NCT00451958)||60
2906118|NCT00451958|3614853|FG001|COMPLETED|CS21A (NCT00451958)||49
2906119|NCT00451958|3614854|FG002|COMPLETED|CS21A (NCT00451958)||27
2906120|NCT00451958|3614855|FG003|COMPLETED|CS21A (NCT00451958)||27
2906121|NCT00451958|3614856|FG004|COMPLETED|CS21A (NCT00451958)||0
2906122|NCT00451958|3614852|FG000|NOT COMPLETED|CS21A (NCT00451958)||65
2906123|NCT00451958|3614853|FG001|NOT COMPLETED|CS21A (NCT00451958)||77
2906124|NCT00451958|3614854|FG002|NOT COMPLETED|CS21A (NCT00451958)||42
2906125|NCT00451958|3614855|FG003|NOT COMPLETED|CS21A (NCT00451958)||39
2906126|NCT00451958|3614856|FG004|NOT COMPLETED|CS21A (NCT00451958)||0
2906127|NCT00452114|3614872|FG000|STARTED|Overall Study||15
2906128|NCT00452114|3614873|FG001|STARTED|Overall Study||13
2906129|NCT00452114|3614872|FG000|COMPLETED|Overall Study||12
2906130|NCT00452114|3614873|FG001|COMPLETED|Overall Study||10
2906131|NCT00452114|3614872|FG000|NOT COMPLETED|Overall Study||3
2906132|NCT00452114|3614873|FG001|NOT COMPLETED|Overall Study||3
2906133|NCT00452335|3614882|FG000|STARTED|Overall Study||27
2906134|NCT00452335|3614883|FG001|STARTED|Overall Study||65
2906135|NCT00452335|3614884|FG002|STARTED|Overall Study||32
2906136|NCT00452335|3614882|FG000|COMPLETED|Overall Study||25
2906137|NCT00452335|3614883|FG001|COMPLETED|Overall Study||61
2906138|NCT00452335|3614884|FG002|COMPLETED|Overall Study||23
2906139|NCT00452335|3614882|FG000|NOT COMPLETED|Overall Study||2
2906140|NCT00452335|3614883|FG001|NOT COMPLETED|Overall Study||4
2906141|NCT00452335|3614884|FG002|NOT COMPLETED|Overall Study||9
2906142|NCT00452348|3614897|FG000|STARTED|Overall Study||310
2906143|NCT00452348|3614898|FG001|STARTED|Overall Study||318
2906144|NCT00452348|3614897|FG000|COMPLETED|Overall Study||231
2906145|NCT00452348|3614898|FG001|COMPLETED|Overall Study||234
2906146|NCT00452348|3614897|FG000|NOT COMPLETED|Overall Study||79
2906147|NCT00452348|3614898|FG001|NOT COMPLETED|Overall Study||84
3171382|NCT01933789|3898533|FG001|Completed After-visit Survey|Overall Study|Number reflects individual clinicians who returned surveys for up to 6 enrolled patients|64
3171383|NCT01933789|3898534|FG002|Completed After-visit Survey|Overall Study|Number reflects individual IP Team members who returned surveys for up to 6 enrolled patients|2
3171802|NCT01937299|3899008|FG001|STARTED|Overall Study||116
3316178|NCT03107611|4049464|FG001|COMPLETED|Overall Study||212
3316179|NCT03107611|4049465|FG002|COMPLETED|Overall Study||212
3316180|NCT03107611|4049463|FG000|NOT COMPLETED|Overall Study||7
2906148|NCT00452374|3614904|FG000|STARTED|Overall Study||48
2906149|NCT00452374|3614904|FG000|COMPLETED|Overall Study||48
2906150|NCT00452374|3614904|FG000|NOT COMPLETED|Overall Study||0
2906151|NCT00452387|3614908|FG000|STARTED|Overall Study||22
2906152|NCT00452387|3614908|FG000|COMPLETED|Overall Study||22
2906153|NCT00452387|3614908|FG000|NOT COMPLETED|Overall Study||0
2906154|NCT00452400|3614919|FG000|STARTED|Overall Study||79
2906155|NCT00452400|3614920|FG001|STARTED|Overall Study||81
2906156|NCT00452400|3614921|FG002|STARTED|Overall Study||80
2906157|NCT00452400|3614922|FG003|STARTED|Overall Study||86
2906158|NCT00452400|3614923|FG004|STARTED|Overall Study||79
2906159|NCT00452400|3614919|FG000|COMPLETED|Overall Study||74
2906160|NCT00452400|3614920|FG001|COMPLETED|Overall Study||80
2906161|NCT00452400|3614921|FG002|COMPLETED|Overall Study||73
2906162|NCT00452400|3614922|FG003|COMPLETED|Overall Study||85
2906163|NCT00452400|3614923|FG004|COMPLETED|Overall Study||76
2906164|NCT00452400|3614919|FG000|NOT COMPLETED|Overall Study||5
2906165|NCT00452400|3614920|FG001|NOT COMPLETED|Overall Study||1
2906166|NCT00452400|3614921|FG002|NOT COMPLETED|Overall Study||7
2906167|NCT00452400|3614922|FG003|NOT COMPLETED|Overall Study||1
2906168|NCT00452400|3614923|FG004|NOT COMPLETED|Overall Study||3
2906169|NCT00452413|3614938|FG000|STARTED|Overall Study||4
2906170|NCT00452413|3614939|FG001|STARTED|Overall Study||12
2906171|NCT00452413|3614940|FG002|STARTED|Overall Study||49
2906172|NCT00452413|3614938|FG000|Received at Least 1 Dose of Study Drug|Overall Study||4
2906173|NCT00452413|3614939|FG001|Received at Least 1 Dose of Study Drug|Overall Study||12
2906174|NCT00452413|3614940|FG002|Received at Least 1 Dose of Study Drug|Overall Study||49
2906175|NCT00452413|3614938|FG000|COMPLETED|Overall Study||0
2906176|NCT00452413|3614939|FG001|COMPLETED|Overall Study||0
2906177|NCT00452413|3614940|FG002|COMPLETED|Overall Study||0
2906178|NCT00452413|3614938|FG000|NOT COMPLETED|Overall Study||4
2906179|NCT00452413|3614939|FG001|NOT COMPLETED|Overall Study||12
2906180|NCT00452413|3614940|FG002|NOT COMPLETED|Overall Study||49
2906181|NCT00452426|3614951|FG000|STARTED|Overall Study||496
2906182|NCT00452426|3614952|FG001|STARTED|Overall Study||504
2906183|NCT00452426|3614951|FG000|COMPLETED|Overall Study||489
2906184|NCT00452426|3614952|FG001|COMPLETED|Overall Study||493
2906185|NCT00452426|3614951|FG000|NOT COMPLETED|Overall Study||7
2906186|NCT00452426|3614952|FG001|NOT COMPLETED|Overall Study||11
2906187|NCT00452439|3614960|FG000|STARTED|Overall Study||36
2906188|NCT00452439|3614961|FG001|STARTED|Overall Study||36
2906189|NCT00452439|3614960|FG000|COMPLETED|Overall Study||22
2906190|NCT00452439|3614961|FG001|COMPLETED|Overall Study||29
2906191|NCT00452439|3614960|FG000|NOT COMPLETED|Overall Study||14
2906192|NCT00452439|3614961|FG001|NOT COMPLETED|Overall Study||7
2906193|NCT00452452|3614970|FG000|STARTED|Overall Study||90
2906194|NCT00452452|3614971|FG001|STARTED|Overall Study||112
2906195|NCT00452452|3614972|FG002|STARTED|Overall Study||153
2906196|NCT00452452|3614970|FG000|Vaccinated Dose 1|Overall Study||90
2906197|NCT00452452|3614971|FG001|Vaccinated Dose 1|Overall Study||112
2906198|NCT00452452|3614972|FG002|Vaccinated Dose 1|Overall Study||152
2906199|NCT00452452|3614970|FG000|Vaccinated Dose 2|Overall Study||90
2906200|NCT00452452|3614971|FG001|Vaccinated Dose 2|Overall Study||112
2906201|NCT00452452|3614972|FG002|Vaccinated Dose 2|Overall Study||0
2906202|NCT00452452|3614970|FG000|Vaccinated Dose 3|Overall Study||89
2906203|NCT00452452|3614971|FG001|Vaccinated Dose 3|Overall Study||0
2906204|NCT00452452|3614972|FG002|Vaccinated Dose 3|Overall Study||0
2906205|NCT00452452|3614970|FG000|COMPLETED|Overall Study||88
2906206|NCT00452452|3614971|FG001|COMPLETED|Overall Study||112
2906207|NCT00452452|3614972|FG002|COMPLETED|Overall Study||152
2906208|NCT00452452|3614970|FG000|NOT COMPLETED|Overall Study||2
2906209|NCT00452452|3614971|FG001|NOT COMPLETED|Overall Study||0
2906210|NCT00452452|3614972|FG002|NOT COMPLETED|Overall Study||1
2906211|NCT00452530|3614988|FG000|STARTED|Overall Study|Randomized|1528
2906212|NCT00452530|3614989|FG001|STARTED|Overall Study|Randomized|1529
2906213|NCT00452530|3614988|FG000|Received Treatment|Overall Study||1501
2906214|NCT00452530|3614989|FG001|Received Treatment|Overall Study||1508
2906215|NCT00452530|3614988|FG000|Evaluable Participants|Overall Study||907
2906216|NCT00452530|3614989|FG001|Evaluable Participants|Overall Study||921
2906217|NCT00452530|3614988|FG000|Primary Participants|Overall Study||976
2906218|NCT00452530|3614989|FG001|Primary Participants|Overall Study||997
2906219|NCT00452530|3614988|FG000|COMPLETED|Overall Study||1392
2906220|NCT00452530|3614989|FG001|COMPLETED|Overall Study||1393
2906221|NCT00452530|3614988|FG000|NOT COMPLETED|Overall Study||136
2906222|NCT00452530|3614989|FG001|NOT COMPLETED|Overall Study||136
2906223|NCT00452543|3615001|FG000|STARTED|Overall Study||12
2906224|NCT00452543|3615002|FG001|STARTED|Overall Study||11
2906225|NCT00452543|3615001|FG000|COMPLETED|Overall Study||7
2906226|NCT00452543|3615002|FG001|COMPLETED|Overall Study||5
2906227|NCT00452543|3615001|FG000|NOT COMPLETED|Overall Study||5
2906228|NCT00452543|3615002|FG001|NOT COMPLETED|Overall Study||6
2906229|NCT00452673|3615012|FG000|STARTED|Dose Escalation Period||7
2906230|NCT00452673|3615013|FG001|STARTED|Dose Escalation Period||9
2906231|NCT00452673|3615014|FG002|STARTED|Dose Escalation Period||6
3316181|NCT03107611|4049464|FG001|NOT COMPLETED|Overall Study||4
3316182|NCT03107611|4049465|FG002|NOT COMPLETED|Overall Study||9
3316183|NCT03107715|4049475|FG000|STARTED|Overall Study||132
3316184|NCT03107715|4049476|FG001|STARTED|Overall Study||111
3316185|NCT03107715|4049475|FG000|COMPLETED|Overall Study||128
3316186|NCT03107715|4049476|FG001|COMPLETED|Overall Study||104
3316187|NCT03107715|4049475|FG000|NOT COMPLETED|Overall Study||4
2906232|NCT00452673|3615015|FG003|STARTED|Dose Escalation Period||9
2906233|NCT00452673|3615016|FG004|STARTED|Dose Escalation Period||0
2906234|NCT00452673|3615012|FG000|COMPLETED|Dose Escalation Period||0
2906235|NCT00452673|3615013|FG001|COMPLETED|Dose Escalation Period||0
2906236|NCT00452673|3615014|FG002|COMPLETED|Dose Escalation Period||0
2906237|NCT00452673|3615015|FG003|COMPLETED|Dose Escalation Period||0
2906238|NCT00452673|3615016|FG004|COMPLETED|Dose Escalation Period||0
2906239|NCT00452673|3615012|FG000|NOT COMPLETED|Dose Escalation Period||7
2906240|NCT00452673|3615013|FG001|NOT COMPLETED|Dose Escalation Period||9
2906241|NCT00452673|3615014|FG002|NOT COMPLETED|Dose Escalation Period||6
2906242|NCT00452673|3615015|FG003|NOT COMPLETED|Dose Escalation Period||9
2906243|NCT00452673|3615016|FG004|NOT COMPLETED|Dose Escalation Period||0
2906244|NCT00452673|3615012|FG000|STARTED|Dose Expansion Period||0
2906245|NCT00452673|3615013|FG001|STARTED|Dose Expansion Period||0
2906246|NCT00452673|3615014|FG002|STARTED|Dose Expansion Period||0
2906247|NCT00452673|3615015|FG003|STARTED|Dose Expansion Period||0
2906248|NCT00452673|3615016|FG004|STARTED|Dose Expansion Period|The last dose level arm in the escalation period was selected for the dose expansion period.|21
2906249|NCT00452673|3615012|FG000|COMPLETED|Dose Expansion Period||0
2906250|NCT00452673|3615013|FG001|COMPLETED|Dose Expansion Period||0
2906251|NCT00452673|3615014|FG002|COMPLETED|Dose Expansion Period||0
2906252|NCT00452673|3615015|FG003|COMPLETED|Dose Expansion Period||0
2906253|NCT00452673|3615016|FG004|COMPLETED|Dose Expansion Period||0
2906254|NCT00452673|3615012|FG000|NOT COMPLETED|Dose Expansion Period||0
2906255|NCT00452673|3615013|FG001|NOT COMPLETED|Dose Expansion Period||0
2906256|NCT00452673|3615014|FG002|NOT COMPLETED|Dose Expansion Period||0
2906257|NCT00452673|3615015|FG003|NOT COMPLETED|Dose Expansion Period||0
2906258|NCT00452673|3615016|FG004|NOT COMPLETED|Dose Expansion Period||21
2906259|NCT00452699|3615029|FG000|STARTED|Overall Study||306
2906260|NCT00452699|3615030|FG001|STARTED|Overall Study||315
2906261|NCT00452699|3615029|FG000|COMPLETED|Overall Study||225
2906262|NCT00452699|3615030|FG001|COMPLETED|Overall Study||242
2906263|NCT00452699|3615029|FG000|NOT COMPLETED|Overall Study||81
2906264|NCT00452699|3615030|FG001|NOT COMPLETED|Overall Study||73
2906265|NCT00452790|3615038|FG000|STARTED|Infant Series||354
2906266|NCT00452790|3615039|FG001|STARTED|Infant Series||355
2906267|NCT00452790|3615038|FG000|Vaccinated Dose 1|Infant Series||353
2906268|NCT00452790|3615039|FG001|Vaccinated Dose 1|Infant Series||353
2906269|NCT00452790|3615038|FG000|Vaccinated Dose 2|Infant Series||300
2906270|NCT00452790|3615039|FG001|Vaccinated Dose 2|Infant Series||300
2906271|NCT00452790|3615038|FG000|Vaccinated Dose 3|Infant Series||221
2906272|NCT00452790|3615039|FG001|Vaccinated Dose 3|Infant Series||218
2906273|NCT00452790|3615038|FG000|COMPLETED|Infant Series||219
2906274|NCT00452790|3615039|FG001|COMPLETED|Infant Series||214
2906275|NCT00452790|3615038|FG000|NOT COMPLETED|Infant Series||135
2906276|NCT00452790|3615039|FG001|NOT COMPLETED|Infant Series||141
2906277|NCT00452790|3615038|FG000|STARTED|After Infant Series||219
2906278|NCT00452790|3615039|FG001|STARTED|After Infant Series||214
2906279|NCT00452790|3615038|FG000|COMPLETED|After Infant Series||198
2906280|NCT00452790|3615039|FG001|COMPLETED|After Infant Series||200
2906281|NCT00452790|3615038|FG000|NOT COMPLETED|After Infant Series||21
2906282|NCT00452790|3615039|FG001|NOT COMPLETED|After Infant Series||14
2906283|NCT00452790|3615038|FG000|STARTED|Toddler Dose||198
2906284|NCT00452790|3615039|FG001|STARTED|Toddler Dose||200
2906285|NCT00452790|3615038|FG000|COMPLETED|Toddler Dose||198
2906286|NCT00452790|3615039|FG001|COMPLETED|Toddler Dose||198
2906287|NCT00452790|3615038|FG000|NOT COMPLETED|Toddler Dose||0
2906288|NCT00452790|3615039|FG001|NOT COMPLETED|Toddler Dose||2
2906289|NCT00452868|3615049|FG000|STARTED|Overall Study||13
2906290|NCT00452868|3615049|FG000|COMPLETED|Overall Study||11
2906291|NCT00452868|3615049|FG000|NOT COMPLETED|Overall Study||2
2906292|NCT00453102|3615053|FG000|STARTED|Overall Study||18
2906293|NCT00453102|3615053|FG000|COMPLETED|Overall Study||16
2906294|NCT00453102|3615053|FG000|NOT COMPLETED|Overall Study||2
2906295|NCT00453154|3615060|FG000|STARTED|Combination Chemotherapy||12
2906296|NCT00453154|3615061|FG001|STARTED|Combination Chemotherapy||144
2906297|NCT00453154|3615062|FG002|STARTED|Combination Chemotherapy||0
2906298|NCT00453154|3615063|FG003|STARTED|Combination Chemotherapy||0
2906299|NCT00453154|3615060|FG000|COMPLETED|Combination Chemotherapy||12
2906300|NCT00453154|3615061|FG001|COMPLETED|Combination Chemotherapy||95
2906301|NCT00453154|3615062|FG002|COMPLETED|Combination Chemotherapy||0
2906302|NCT00453154|3615063|FG003|COMPLETED|Combination Chemotherapy||0
2906303|NCT00453154|3615060|FG000|NOT COMPLETED|Combination Chemotherapy||0
2906304|NCT00453154|3615061|FG001|NOT COMPLETED|Combination Chemotherapy||49
2906305|NCT00453154|3615062|FG002|NOT COMPLETED|Combination Chemotherapy||0
2906306|NCT00453154|3615063|FG003|NOT COMPLETED|Combination Chemotherapy||0
2906307|NCT00453154|3615060|FG000|STARTED|Double BIind Maintenance||0
2906308|NCT00453154|3615061|FG001|STARTED|Double BIind Maintenance||0
2906309|NCT00453154|3615062|FG002|STARTED|Double BIind Maintenance||46
2906310|NCT00453154|3615063|FG003|STARTED|Double BIind Maintenance||49
2906311|NCT00453154|3615060|FG000|COMPLETED|Double BIind Maintenance||0
2906312|NCT00453154|3615061|FG001|COMPLETED|Double BIind Maintenance||0
2906313|NCT00453154|3615062|FG002|COMPLETED|Double BIind Maintenance||0
2906314|NCT00453154|3615063|FG003|COMPLETED|Double BIind Maintenance||0
2906315|NCT00453154|3615060|FG000|NOT COMPLETED|Double BIind Maintenance||0
2906316|NCT00453154|3615061|FG001|NOT COMPLETED|Double BIind Maintenance||0
2906317|NCT00453154|3615062|FG002|NOT COMPLETED|Double BIind Maintenance||46
2906318|NCT00453154|3615063|FG003|NOT COMPLETED|Double BIind Maintenance||49
2906319|NCT00453154|3615060|FG000|STARTED|Open Label Sunitinib Crossover||0
2906320|NCT00453154|3615061|FG001|STARTED|Open Label Sunitinib Crossover||0
2906321|NCT00453154|3615062|FG002|STARTED|Open Label Sunitinib Crossover||18
2906322|NCT00453154|3615063|FG003|STARTED|Open Label Sunitinib Crossover||0
2906323|NCT00453154|3615060|FG000|COMPLETED|Open Label Sunitinib Crossover||0
2906324|NCT00453154|3615061|FG001|COMPLETED|Open Label Sunitinib Crossover||0
2906325|NCT00453154|3615062|FG002|COMPLETED|Open Label Sunitinib Crossover||18
2906326|NCT00453154|3615063|FG003|COMPLETED|Open Label Sunitinib Crossover||0
2906327|NCT00453154|3615060|FG000|NOT COMPLETED|Open Label Sunitinib Crossover||0
2906328|NCT00453154|3615061|FG001|NOT COMPLETED|Open Label Sunitinib Crossover||0
2906329|NCT00453154|3615062|FG002|NOT COMPLETED|Open Label Sunitinib Crossover||0
2906330|NCT00453154|3615063|FG003|NOT COMPLETED|Open Label Sunitinib Crossover||0
2906331|NCT00453180|3615074|FG000|STARTED|Overall Study||16
2906332|NCT00453180|3615075|FG001|STARTED|Overall Study||15
2906333|NCT00453180|3615074|FG000|COMPLETED|Overall Study||13
2906334|NCT00453180|3615075|FG001|COMPLETED|Overall Study||12
2906335|NCT00453180|3615074|FG000|NOT COMPLETED|Overall Study||3
2906336|NCT00453180|3615075|FG001|NOT COMPLETED|Overall Study||3
2906337|NCT00453193|3615081|FG000|STARTED|Overall Study||24
2906338|NCT00453193|3615081|FG000|COMPLETED|Overall Study||24
2906339|NCT00453193|3615081|FG000|NOT COMPLETED|Overall Study||0
2906340|NCT00453206|3615085|FG000|STARTED|Overall Study||66
2906341|NCT00453206|3615085|FG000|COMPLETED|Overall Study||65
2906342|NCT00453206|3615085|FG000|NOT COMPLETED|Overall Study||1
2906343|NCT00453310|3615089|FG000|STARTED|Overall Study||10
2906344|NCT00453310|3615089|FG000|COMPLETED|Overall Study||0
2906345|NCT00453310|3615089|FG000|NOT COMPLETED|Overall Study||10
2906346|NCT00453336|3615093|FG000|STARTED|Overall Study||45
2906347|NCT00453336|3615093|FG000|COMPLETED|Overall Study||45
2906348|NCT00453336|3615093|FG000|NOT COMPLETED|Overall Study||0
2906349|NCT00453349|3615099|FG000|STARTED|Randomized||228
2906350|NCT00453349|3615100|FG001|STARTED|Randomized||232
2906351|NCT00453349|3615099|FG000|COMPLETED|Randomized||203
2906352|NCT00453349|3615100|FG001|COMPLETED|Randomized||209
2906353|NCT00453349|3615099|FG000|NOT COMPLETED|Randomized||25
2906354|NCT00453349|3615100|FG001|NOT COMPLETED|Randomized||23
2906355|NCT00453349|3615099|FG000|STARTED|Reaching of Primary Endpoint (TOC)|Subjects who attended the TOC visit or at least had a clinical evaluation at TOC|225
2906356|NCT00453349|3615100|FG001|STARTED|Reaching of Primary Endpoint (TOC)|i.e. the ITT population|230
2906357|NCT00453349|3615099|FG000|Valid for Primary Efficacy Analysis|Reaching of Primary Endpoint (TOC)||194
2906358|NCT00453349|3615100|FG001|Valid for Primary Efficacy Analysis|Reaching of Primary Endpoint (TOC)||190
2906359|NCT00453349|3615099|FG000|COMPLETED|Reaching of Primary Endpoint (TOC)|All PP patients and ITT patients with a clinical response with no missing information|215
2906360|NCT00453349|3615100|FG001|COMPLETED|Reaching of Primary Endpoint (TOC)||219
2906361|NCT00453349|3615099|FG000|NOT COMPLETED|Reaching of Primary Endpoint (TOC)||10
2906362|NCT00453349|3615100|FG001|NOT COMPLETED|Reaching of Primary Endpoint (TOC)||11
2906363|NCT00453349|3615099|FG000|STARTED|Completed Study||228
2906364|NCT00453349|3615100|FG001|STARTED|Completed Study||232
2906365|NCT00453349|3615099|FG000|Completed Study Treatment|Completed Study|25 terminated prematurely|203
2906366|NCT00453349|3615100|FG001|Completed Study Treatment|Completed Study|23 terminated prematurely|209
2906367|NCT00453349|3615099|FG000|COMPLETED|Completed Study|had follow-up assessment or alternative antibiotic assessment|201
2906368|NCT00453349|3615100|FG001|COMPLETED|Completed Study|had follow-up assessment or alternative antibiotic assessment|198
2906369|NCT00453349|3615099|FG000|NOT COMPLETED|Completed Study||27
2906370|NCT00453349|3615100|FG001|NOT COMPLETED|Completed Study||34
2906371|NCT00453362|3615106|FG000|STARTED|Overall Study|14 participants consented but did not receive drug and are not represented in the baseline data|88
2906372|NCT00453362|3615106|FG000|Treated With Erlotinib|Overall Study||74
2906373|NCT00453362|3615106|FG000|FDG-PET Evaluable|Overall Study|Participants who completed all FDG-PET scans through day 56.|51
2906374|NCT00453362|3615106|FG000|FLT-PET Evaluable|Overall Study|Participants who completed all FLT-PET scans through day 56.|50
2906375|NCT00453362|3615106|FG000|COMPLETED|Overall Study||1
2906376|NCT00453362|3615106|FG000|NOT COMPLETED|Overall Study||87
2906377|NCT00453388|3615126|FG000|STARTED|Overall Study||0
2906378|NCT00453388|3615127|FG001|STARTED|Overall Study||5
2906379|NCT00453388|3615128|FG002|STARTED|Overall Study||1
2906380|NCT00453388|3615129|FG003|STARTED|Overall Study||0
2906381|NCT00453388|3615126|FG000|COMPLETED|Overall Study||0
2906382|NCT00453388|3615127|FG001|COMPLETED|Overall Study||5
2906383|NCT00453388|3615128|FG002|COMPLETED|Overall Study||1
2906384|NCT00453388|3615129|FG003|COMPLETED|Overall Study||0
2906385|NCT00453388|3615126|FG000|NOT COMPLETED|Overall Study||0
2906386|NCT00453388|3615127|FG001|NOT COMPLETED|Overall Study||0
2906387|NCT00453388|3615128|FG002|NOT COMPLETED|Overall Study||0
2906388|NCT00453388|3615129|FG003|NOT COMPLETED|Overall Study||0
2906389|NCT00453479|3615142|FG000|STARTED|Overall Study||6
2906390|NCT00453479|3615143|FG001|STARTED|Overall Study||9
2906391|NCT00453479|3615144|FG002|STARTED|Overall Study||8
2906392|NCT00453479|3615142|FG000|COMPLETED|Overall Study||6
2906393|NCT00453479|3615143|FG001|COMPLETED|Overall Study||9
2906394|NCT00453479|3615144|FG002|COMPLETED|Overall Study||8
2906395|NCT00453479|3615142|FG000|NOT COMPLETED|Overall Study||0
2906396|NCT00453479|3615143|FG001|NOT COMPLETED|Overall Study||0
2906397|NCT00453479|3615144|FG002|NOT COMPLETED|Overall Study||0
3171384|NCT01933789|3898535|FG003|Completed After-visit Survey|Overall Study|Number reflects individual IP Team members who returned surveys for up to 6 enrolled patients|1
3171385|NCT01933789|3898536|FG004|Completed After-visit Survey|Overall Study||0
3171386|NCT01933789|3898537|FG005|Completed After-visit Survey|Overall Study||0
3171387|NCT01933789|3898538|FG006|Completed After-visit Survey|Overall Study||0
3171388|NCT01933789|3898539|FG007|Completed After-visit Survey|Overall Study||0
3171389|NCT01933789|3898540|FG008|Completed After-visit Survey|Overall Study||0
3171390|NCT01933789|3898532|FG000|Completed 2-Week Survey|Overall Study||0
3171391|NCT01933789|3898533|FG001|Completed 2-Week Survey|Overall Study||0
2906398|NCT00453895|3615154|FG000|STARTED|Overall Study||39
2906399|NCT00453895|3615154|FG000|COMPLETED|Overall Study||39
2906400|NCT00453895|3615154|FG000|NOT COMPLETED|Overall Study||0
2906401|NCT00453921|3615162|FG000|STARTED|Overall Study||19
2906402|NCT00453921|3615163|FG001|STARTED|Overall Study||18
2906403|NCT00453921|3615164|FG002|STARTED|Overall Study||20
2906404|NCT00453921|3615165|FG003|STARTED|Overall Study||19
2906405|NCT00453921|3615162|FG000|COMPLETED|Overall Study||18
2906406|NCT00453921|3615163|FG001|COMPLETED|Overall Study||17
2906407|NCT00453921|3615164|FG002|COMPLETED|Overall Study||18
2906408|NCT00453921|3615165|FG003|COMPLETED|Overall Study||18
2906409|NCT00453921|3615162|FG000|NOT COMPLETED|Overall Study||1
2906410|NCT00453921|3615163|FG001|NOT COMPLETED|Overall Study||1
2906411|NCT00453921|3615164|FG002|NOT COMPLETED|Overall Study||2
2906412|NCT00453921|3615165|FG003|NOT COMPLETED|Overall Study||1
2906413|NCT00453973|3615181|FG000|STARTED|Overall Study||51
2906414|NCT00453973|3615182|FG001|STARTED|Overall Study||63
2906415|NCT00453973|3615181|FG000|COMPLETED|Overall Study||0
2906416|NCT00453973|3615182|FG001|COMPLETED|Overall Study||15
2906417|NCT00453973|3615181|FG000|NOT COMPLETED|Overall Study||51
2906418|NCT00453973|3615182|FG001|NOT COMPLETED|Overall Study||48
2906419|NCT00453986|3615193|FG000|STARTED|Overall Study||311
2906420|NCT00453986|3615194|FG001|STARTED|Overall Study||311
2906421|NCT00453986|3615195|FG002|STARTED|Overall Study||313
2906422|NCT00453986|3615196|FG003|STARTED|Overall Study||312
2906423|NCT00453986|3615197|FG004|STARTED|Overall Study||105
2906424|NCT00453986|3615193|FG000|COMPLETED|Overall Study||305
2906425|NCT00453986|3615194|FG001|COMPLETED|Overall Study||306
2906426|NCT00453986|3615195|FG002|COMPLETED|Overall Study||307
2906427|NCT00453986|3615196|FG003|COMPLETED|Overall Study||310
2906428|NCT00453986|3615197|FG004|COMPLETED|Overall Study||105
2906429|NCT00453986|3615193|FG000|NOT COMPLETED|Overall Study||6
2906430|NCT00453986|3615194|FG001|NOT COMPLETED|Overall Study||5
2906431|NCT00453986|3615195|FG002|NOT COMPLETED|Overall Study||6
2906432|NCT00453986|3615196|FG003|NOT COMPLETED|Overall Study||2
2906433|NCT00453986|3615197|FG004|NOT COMPLETED|Overall Study||0
2906434|NCT00453999|3615216|FG000|STARTED|Overall Study||45
2906435|NCT00453999|3615217|FG001|STARTED|Overall Study||46
2906436|NCT00453999|3615218|FG002|STARTED|Overall Study||46
2906437|NCT00453999|3615216|FG000|COMPLETED|Overall Study||40
3171392|NCT01933789|3898534|FG002|Completed 2-Week Survey|Overall Study||0
3171393|NCT01933789|3898535|FG003|Completed 2-Week Survey|Overall Study||0
3171394|NCT01933789|3898536|FG004|Completed 2-Week Survey|Overall Study||184
3171395|NCT01933789|3898537|FG005|Completed 2-Week Survey|Overall Study||215
3171396|NCT01933789|3898538|FG006|Completed 2-Week Survey|Overall Study||0
3171397|NCT01933789|3898539|FG007|Completed 2-Week Survey|Overall Study||0
2906438|NCT00453999|3615217|FG001|COMPLETED|Overall Study||41
2906439|NCT00453999|3615218|FG002|COMPLETED|Overall Study||43
2906440|NCT00453999|3615216|FG000|NOT COMPLETED|Overall Study||5
2906441|NCT00453999|3615217|FG001|NOT COMPLETED|Overall Study||5
2906442|NCT00453999|3615218|FG002|NOT COMPLETED|Overall Study||3
2906443|NCT00454051|3615229|FG000|STARTED|Overall Study||20
2906444|NCT00454051|3615230|FG001|STARTED|Overall Study||11
2906445|NCT00454051|3615229|FG000|COMPLETED|Overall Study||17
2906446|NCT00454051|3615230|FG001|COMPLETED|Overall Study||8
2906447|NCT00454051|3615229|FG000|NOT COMPLETED|Overall Study||3
2906448|NCT00454051|3615230|FG001|NOT COMPLETED|Overall Study||3
2906449|NCT00454116|3615239|FG000|STARTED|Overall Study|randomised patients|35
2906450|NCT00454116|3615240|FG001|STARTED|Overall Study|randomised patients|36
2906451|NCT00454116|3615241|FG002|STARTED|Overall Study|randomised patients|35
2906452|NCT00454116|3615239|FG000|COMPLETED|Overall Study|ongoing study treatment at data cut-off|8
2906453|NCT00454116|3615240|FG001|COMPLETED|Overall Study|ongoing study treatment at data cut-off|7
2906454|NCT00454116|3615241|FG002|COMPLETED|Overall Study|ongoing study treatment at data cut-off|7
2906455|NCT00454116|3615239|FG000|NOT COMPLETED|Overall Study||27
2906456|NCT00454116|3615240|FG001|NOT COMPLETED|Overall Study||29
2906457|NCT00454116|3615241|FG002|NOT COMPLETED|Overall Study||28
3171398|NCT01933789|3898540|FG008|Completed 2-Week Survey|Overall Study||0
3171399|NCT01933789|3898532|FG000|Completed 3-Month Survey|Overall Study||0
3171400|NCT01933789|3898533|FG001|Completed 3-Month Survey|Overall Study||0
3171401|NCT01933789|3898534|FG002|Completed 3-Month Survey|Overall Study||0
3171402|NCT01933789|3898535|FG003|Completed 3-Month Survey|Overall Study||0
2906458|NCT00454142|3615249|FG000|STARTED|Overall Study||33
2906459|NCT00454142|3615249|FG000|COMPLETED|Overall Study||32
2906460|NCT00454142|3615249|FG000|NOT COMPLETED|Overall Study||1
2906461|NCT00454181|3615257|FG000|STARTED|Overall Study||45
2906462|NCT00454181|3615258|FG001|STARTED|Overall Study||14
2906463|NCT00454181|3615257|FG000|COMPLETED|Overall Study||30
2906464|NCT00454181|3615258|FG001|COMPLETED|Overall Study||11
2906465|NCT00454181|3615257|FG000|NOT COMPLETED|Overall Study||15
2906466|NCT00454181|3615258|FG001|NOT COMPLETED|Overall Study||3
2906467|NCT00454194|3615266|FG000|STARTED|Overall Study||47
2906468|NCT00454194|3615267|FG001|STARTED|Overall Study||51
2906469|NCT00454194|3615266|FG000|COMPLETED|Overall Study||25
2906470|NCT00454194|3615267|FG001|COMPLETED|Overall Study||37
2906471|NCT00454194|3615266|FG000|NOT COMPLETED|Overall Study||22
2906472|NCT00454194|3615267|FG001|NOT COMPLETED|Overall Study||14
2906473|NCT00454207|3615275|FG000|STARTED|Overall Study||21
2906474|NCT00454207|3615276|FG001|STARTED|Overall Study||23
2906475|NCT00454207|3615275|FG000|COMPLETED|Overall Study|19 participants completed Part I period. 17 of 19 participants continued from part I into Part II.|17
2906476|NCT00454207|3615276|FG001|COMPLETED|Overall Study||21
2906477|NCT00454207|3615275|FG000|NOT COMPLETED|Overall Study||4
2906478|NCT00454207|3615276|FG001|NOT COMPLETED|Overall Study||2
2906479|NCT00454246|3615297|FG000|STARTED|Overall Study||73
2906480|NCT00454246|3615298|FG001|STARTED|Overall Study||29
2906481|NCT00454246|3615299|FG002|STARTED|Overall Study||9
2906482|NCT00454246|3615297|FG000|COMPLETED|Overall Study||0
2906483|NCT00454246|3615298|FG001|COMPLETED|Overall Study||0
2906484|NCT00454246|3615299|FG002|COMPLETED|Overall Study||0
2906485|NCT00454246|3615297|FG000|NOT COMPLETED|Overall Study||73
2906486|NCT00454246|3615298|FG001|NOT COMPLETED|Overall Study||29
2906487|NCT00454246|3615299|FG002|NOT COMPLETED|Overall Study||9
2906488|NCT00454324|3615309|FG000|STARTED|Overall Study||14
2906489|NCT00454324|3615310|FG001|STARTED|Overall Study||13
2906490|NCT00454324|3615309|FG000|COMPLETED|Overall Study||14
2906491|NCT00454324|3615310|FG001|COMPLETED|Overall Study||13
2906492|NCT00454324|3615309|FG000|NOT COMPLETED|Overall Study||0
2906493|NCT00454324|3615310|FG001|NOT COMPLETED|Overall Study||0
2906494|NCT00454363|3615318|FG000|STARTED|Overall Study||20
2906495|NCT00454363|3615319|FG001|STARTED|Overall Study||31
2906496|NCT00454363|3615318|FG000|COMPLETED|Overall Study||15
2906497|NCT00454363|3615319|FG001|COMPLETED|Overall Study||29
2906498|NCT00454363|3615318|FG000|NOT COMPLETED|Overall Study||5
2906499|NCT00454363|3615319|FG001|NOT COMPLETED|Overall Study||2
2906500|NCT00454532|3615328|FG000|STARTED|Overall Study||11
2906501|NCT00454532|3615329|FG001|STARTED|Overall Study||6
2906502|NCT00454532|3615330|FG002|STARTED|Overall Study||3
2906503|NCT00454532|3615331|FG003|STARTED|Overall Study||7
2906504|NCT00454532|3615328|FG000|COMPLETED|Overall Study||11
2906505|NCT00454532|3615329|FG001|COMPLETED|Overall Study||6
2906506|NCT00454532|3615330|FG002|COMPLETED|Overall Study||3
2906507|NCT00454532|3615331|FG003|COMPLETED|Overall Study||7
2906508|NCT00454532|3615328|FG000|NOT COMPLETED|Overall Study||0
2906509|NCT00454532|3615329|FG001|NOT COMPLETED|Overall Study||0
2906510|NCT00454532|3615330|FG002|NOT COMPLETED|Overall Study||0
2906511|NCT00454532|3615331|FG003|NOT COMPLETED|Overall Study||0
2906512|NCT00454584|3615344|FG000|STARTED|Controlled Period||347
2906513|NCT00454584|3615345|FG001|STARTED|Controlled Period||209
2906514|NCT00454584|3615346|FG002|STARTED|Controlled Period||347
2906515|NCT00454584|3615347|FG003|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
2906516|NCT00454584|3615348|FG004|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
2906517|NCT00454584|3615349|FG005|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
2906518|NCT00454584|3615344|FG000|COMPLETED|Controlled Period||336
2906519|NCT00454584|3615345|FG001|COMPLETED|Controlled Period||201
2906520|NCT00454584|3615346|FG002|COMPLETED|Controlled Period||342
2906521|NCT00454584|3615347|FG003|COMPLETED|Controlled Period||0
2906522|NCT00454584|3615348|FG004|COMPLETED|Controlled Period||0
2906523|NCT00454584|3615349|FG005|COMPLETED|Controlled Period||0
2906524|NCT00454584|3615344|FG000|NOT COMPLETED|Controlled Period||11
2906525|NCT00454584|3615345|FG001|NOT COMPLETED|Controlled Period||8
2906526|NCT00454584|3615346|FG002|NOT COMPLETED|Controlled Period||5
2906527|NCT00454584|3615347|FG003|NOT COMPLETED|Controlled Period||0
2906528|NCT00454584|3615348|FG004|NOT COMPLETED|Controlled Period||0
2906529|NCT00454584|3615349|FG005|NOT COMPLETED|Controlled Period||0
2906530|NCT00454584|3615344|FG000|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
2906531|NCT00454584|3615345|FG001|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
2906532|NCT00454584|3615346|FG002|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
2906533|NCT00454584|3615347|FG003|STARTED|After Controlled Period||336
3171403|NCT01933789|3898536|FG004|Completed 3-Month Survey|Overall Study||176
3171404|NCT01933789|3898537|FG005|Completed 3-Month Survey|Overall Study||211
3171405|NCT01933789|3898538|FG006|Completed 3-Month Survey|Overall Study||37
3171406|NCT01933789|3898539|FG007|Completed 3-Month Survey|Overall Study||43
3171407|NCT01933789|3898540|FG008|Completed 3-Month Survey|Overall Study||0
2906534|NCT00454584|3615348|FG004|STARTED|After Controlled Period||201
2906535|NCT00454584|3615349|FG005|STARTED|After Controlled Period||342
2906536|NCT00454584|3615344|FG000|COMPLETED|After Controlled Period||0
2906537|NCT00454584|3615345|FG001|COMPLETED|After Controlled Period||0
2906538|NCT00454584|3615346|FG002|COMPLETED|After Controlled Period||0
2906539|NCT00454584|3615347|FG003|COMPLETED|After Controlled Period||310
2906540|NCT00454584|3615348|FG004|COMPLETED|After Controlled Period||189
2906541|NCT00454584|3615349|FG005|COMPLETED|After Controlled Period||310
2906542|NCT00454584|3615344|FG000|NOT COMPLETED|After Controlled Period||0
2906543|NCT00454584|3615345|FG001|NOT COMPLETED|After Controlled Period||0
2906544|NCT00454584|3615346|FG002|NOT COMPLETED|After Controlled Period||0
2906545|NCT00454584|3615347|FG003|NOT COMPLETED|After Controlled Period||26
2906546|NCT00454584|3615348|FG004|NOT COMPLETED|After Controlled Period||12
2906547|NCT00454584|3615349|FG005|NOT COMPLETED|After Controlled Period||32
2906548|NCT00454636|3615367|FG000|STARTED|Overall Study||41
2906549|NCT00454636|3615368|FG001|STARTED|Overall Study||32
2906550|NCT00454636|3615369|FG002|STARTED|Overall Study||27
2906551|NCT00454636|3615370|FG003|STARTED|Overall Study||58
2906552|NCT00454636|3615367|FG000|COMPLETED|Overall Study||10
2906553|NCT00454636|3615368|FG001|COMPLETED|Overall Study||9
2906554|NCT00454636|3615369|FG002|COMPLETED|Overall Study||7
2906555|NCT00454636|3615370|FG003|COMPLETED|Overall Study||26
2906556|NCT00454636|3615367|FG000|NOT COMPLETED|Overall Study||31
2906557|NCT00454636|3615368|FG001|NOT COMPLETED|Overall Study||23
2906558|NCT00454636|3615369|FG002|NOT COMPLETED|Overall Study||20
2906559|NCT00454636|3615370|FG003|NOT COMPLETED|Overall Study||32
2906560|NCT00454649|3615390|FG000|STARTED|Overall Study||3
2906561|NCT00454649|3615391|FG001|STARTED|Overall Study||5
2906562|NCT00454649|3615392|FG002|STARTED|Overall Study||20
2906563|NCT00454649|3615393|FG003|STARTED|Overall Study||7
2906564|NCT00454649|3615394|FG004|STARTED|Overall Study||1
2906565|NCT00454649|3615395|FG005|STARTED|Overall Study||7
2906566|NCT00454649|3615396|FG006|STARTED|Overall Study||9
2906567|NCT00454649|3615397|FG007|STARTED|Overall Study||19
2906568|NCT00454649|3615398|FG008|STARTED|Overall Study||21
2906569|NCT00454649|3615399|FG009|STARTED|Overall Study||6
2906570|NCT00454649|3615390|FG000|COMPLETED|Overall Study||0
2906571|NCT00454649|3615391|FG001|COMPLETED|Overall Study||1
2906572|NCT00454649|3615392|FG002|COMPLETED|Overall Study||1
2906573|NCT00454649|3615393|FG003|COMPLETED|Overall Study||1
2906574|NCT00454649|3615394|FG004|COMPLETED|Overall Study||0
2906575|NCT00454649|3615395|FG005|COMPLETED|Overall Study||0
2906576|NCT00454649|3615396|FG006|COMPLETED|Overall Study||0
2906577|NCT00454649|3615397|FG007|COMPLETED|Overall Study||0
2906578|NCT00454649|3615398|FG008|COMPLETED|Overall Study||1
2906579|NCT00454649|3615399|FG009|COMPLETED|Overall Study||1
2906580|NCT00454649|3615390|FG000|NOT COMPLETED|Overall Study||3
2906581|NCT00454649|3615391|FG001|NOT COMPLETED|Overall Study||4
2906582|NCT00454649|3615392|FG002|NOT COMPLETED|Overall Study||19
2906583|NCT00454649|3615393|FG003|NOT COMPLETED|Overall Study||6
2906584|NCT00454649|3615394|FG004|NOT COMPLETED|Overall Study||1
2906585|NCT00454649|3615395|FG005|NOT COMPLETED|Overall Study||7
2906586|NCT00454649|3615396|FG006|NOT COMPLETED|Overall Study||9
2906587|NCT00454649|3615397|FG007|NOT COMPLETED|Overall Study||19
2906588|NCT00454649|3615398|FG008|NOT COMPLETED|Overall Study||20
2906589|NCT00454649|3615399|FG009|NOT COMPLETED|Overall Study||5
2906590|NCT00454779|3615442|FG000|STARTED|First-line Treatment Phase||56
2906591|NCT00454779|3615443|FG001|STARTED|First-line Treatment Phase||57
2906592|NCT00454779|3615442|FG000|Received Study Medication|First-line Treatment Phase||56
2906593|NCT00454779|3615443|FG001|Received Study Medication|First-line Treatment Phase||55
2906594|NCT00454779|3615442|FG000|COMPLETED|First-line Treatment Phase|Disease progression (radiographically determined) or death|51
2906595|NCT00454779|3615443|FG001|COMPLETED|First-line Treatment Phase|Disease progression (radiographically determined) or death|49
2906596|NCT00454779|3615442|FG000|NOT COMPLETED|First-line Treatment Phase||5
2906597|NCT00454779|3615443|FG001|NOT COMPLETED|First-line Treatment Phase||8
2906598|NCT00454779|3615442|FG000|STARTED|Second-line Treatment Phase|Subjects in this arm do not have second-line treatment period|0
2906599|NCT00454779|3615443|FG001|STARTED|Second-line Treatment Phase|Second-line Panitumumab Monotherapy|30
2906600|NCT00454779|3615442|FG000|COMPLETED|Second-line Treatment Phase|Disease progression (radiographically determined) or death|0
2906601|NCT00454779|3615443|FG001|COMPLETED|Second-line Treatment Phase|Disease progression (radiographically determined) or death|27
2906602|NCT00454779|3615442|FG000|NOT COMPLETED|Second-line Treatment Phase||0
2906603|NCT00454779|3615443|FG001|NOT COMPLETED|Second-line Treatment Phase||3
2906604|NCT00454805|3615451|FG000|STARTED|Overall Study|Randomised|31
2906605|NCT00454805|3615452|FG001|STARTED|Overall Study|Randomised|31
2906606|NCT00454805|3615451|FG000|COMPLETED|Overall Study|Ongoing at data cut-off|5
2906607|NCT00454805|3615452|FG001|COMPLETED|Overall Study|Ongoing at data cut-off|8
2906608|NCT00454805|3615451|FG000|NOT COMPLETED|Overall Study||26
2906609|NCT00454805|3615452|FG001|NOT COMPLETED|Overall Study||23
2906610|NCT00454818|3615466|FG000|STARTED|Phase I: Open-label Dose-escalation||3
2906611|NCT00454818|3615467|FG001|STARTED|Phase I: Open-label Dose-escalation||3
2906612|NCT00454818|3615468|FG002|STARTED|Phase I: Open-label Dose-escalation||3
2906613|NCT00454818|3615469|FG003|STARTED|Phase I: Open-label Dose-escalation||3
2906614|NCT00454818|3615470|FG004|STARTED|Phase I: Open-label Dose-escalation||0
2906615|NCT00454818|3615466|FG000|COMPLETED|Phase I: Open-label Dose-escalation||2
2906616|NCT00454818|3615467|FG001|COMPLETED|Phase I: Open-label Dose-escalation||2
2906617|NCT00454818|3615468|FG002|COMPLETED|Phase I: Open-label Dose-escalation||2
2906618|NCT00454818|3615469|FG003|COMPLETED|Phase I: Open-label Dose-escalation||2
2906619|NCT00454818|3615470|FG004|COMPLETED|Phase I: Open-label Dose-escalation||0
2906620|NCT00454818|3615466|FG000|NOT COMPLETED|Phase I: Open-label Dose-escalation||1
2906621|NCT00454818|3615467|FG001|NOT COMPLETED|Phase I: Open-label Dose-escalation||1
2906622|NCT00454818|3615468|FG002|NOT COMPLETED|Phase I: Open-label Dose-escalation||1
2906623|NCT00454818|3615469|FG003|NOT COMPLETED|Phase I: Open-label Dose-escalation||1
2906624|NCT00454818|3615470|FG004|NOT COMPLETED|Phase I: Open-label Dose-escalation||0
2906625|NCT00454818|3615466|FG000|STARTED|Phase 2: Randomized Double-blind||0
2906626|NCT00454818|3615467|FG001|STARTED|Phase 2: Randomized Double-blind||8
3171408|NCT01933789|3898532|FG000|Completed 6-Month Survey|Overall Study||0
3171409|NCT01933789|3898533|FG001|Completed 6-Month Survey|Overall Study||0
2906627|NCT00454818|3615468|FG002|STARTED|Phase 2: Randomized Double-blind||8
2906628|NCT00454818|3615469|FG003|STARTED|Phase 2: Randomized Double-blind||9
2906629|NCT00454818|3615470|FG004|STARTED|Phase 2: Randomized Double-blind||14
2906630|NCT00454818|3615466|FG000|COMPLETED|Phase 2: Randomized Double-blind||0
2906631|NCT00454818|3615467|FG001|COMPLETED|Phase 2: Randomized Double-blind||6
2906632|NCT00454818|3615468|FG002|COMPLETED|Phase 2: Randomized Double-blind||5
2906633|NCT00454818|3615469|FG003|COMPLETED|Phase 2: Randomized Double-blind||8
2906634|NCT00454818|3615470|FG004|COMPLETED|Phase 2: Randomized Double-blind||10
2906635|NCT00454818|3615466|FG000|NOT COMPLETED|Phase 2: Randomized Double-blind||0
2906636|NCT00454818|3615467|FG001|NOT COMPLETED|Phase 2: Randomized Double-blind||2
2906637|NCT00454818|3615468|FG002|NOT COMPLETED|Phase 2: Randomized Double-blind||3
2906638|NCT00454818|3615469|FG003|NOT COMPLETED|Phase 2: Randomized Double-blind||1
2906639|NCT00454818|3615470|FG004|NOT COMPLETED|Phase 2: Randomized Double-blind||4
2906640|NCT00454857|3615487|FG000|STARTED|Overall Study||326
2906641|NCT00454857|3615487|FG000|Completed Retrospective Chart Review|Overall Study||324
2906642|NCT00454857|3615487|FG000|Completed ≥1 Observational Study Visit|Overall Study||319
2906643|NCT00454857|3615487|FG000|COMPLETED|Overall Study||272
2906644|NCT00454857|3615487|FG000|NOT COMPLETED|Overall Study||54
2906645|NCT00454909|3615494|FG000|STARTED|Overall Study||587
2906646|NCT00454909|3615495|FG001|STARTED|Overall Study||197
2906647|NCT00454909|3615496|FG002|STARTED|Overall Study||88
2906648|NCT00454909|3615494|FG000|COMPLETED|Overall Study||580
2906649|NCT00454909|3615495|FG001|COMPLETED|Overall Study||194
2906650|NCT00454909|3615496|FG002|COMPLETED|Overall Study||86
2906651|NCT00454909|3615494|FG000|NOT COMPLETED|Overall Study||7
2906652|NCT00454909|3615495|FG001|NOT COMPLETED|Overall Study||3
2906653|NCT00454909|3615496|FG002|NOT COMPLETED|Overall Study||2
2906654|NCT00454987|3615508|FG000|STARTED|Booster Period (NCT00258700)||359
2906655|NCT00454987|3615509|FG001|STARTED|Booster Period (NCT00258700)||117
2906656|NCT00454987|3615510|FG002|STARTED|Booster Period (NCT00258700)||0
2906657|NCT00454987|3615508|FG000|COMPLETED|Booster Period (NCT00258700)||357
2906658|NCT00454987|3615509|FG001|COMPLETED|Booster Period (NCT00258700)||116
2906659|NCT00454987|3615510|FG002|COMPLETED|Booster Period (NCT00258700)||0
2906660|NCT00454987|3615508|FG000|NOT COMPLETED|Booster Period (NCT00258700)||2
2906661|NCT00454987|3615509|FG001|NOT COMPLETED|Booster Period (NCT00258700)||1
2906662|NCT00454987|3615510|FG002|NOT COMPLETED|Booster Period (NCT00258700)||0
2906663|NCT00454987|3615508|FG000|STARTED|Year 1 (NCT00454987)||221
2906664|NCT00454987|3615509|FG001|STARTED|Year 1 (NCT00454987)||67
2906665|NCT00454987|3615510|FG002|STARTED|Year 1 (NCT00454987)||0
2906666|NCT00454987|3615508|FG000|COMPLETED|Year 1 (NCT00454987)||221
2906667|NCT00454987|3615509|FG001|COMPLETED|Year 1 (NCT00454987)||67
2906668|NCT00454987|3615510|FG002|COMPLETED|Year 1 (NCT00454987)||0
2906669|NCT00454987|3615508|FG000|NOT COMPLETED|Year 1 (NCT00454987)||0
2906670|NCT00454987|3615509|FG001|NOT COMPLETED|Year 1 (NCT00454987)||0
2906671|NCT00454987|3615510|FG002|NOT COMPLETED|Year 1 (NCT00454987)||0
2906672|NCT00454987|3615508|FG000|STARTED|Year 2 (NCT00454987)||235
2906673|NCT00454987|3615509|FG001|STARTED|Year 2 (NCT00454987)||77
2906674|NCT00454987|3615510|FG002|STARTED|Year 2 (NCT00454987)||74
2906675|NCT00454987|3615508|FG000|COMPLETED|Year 2 (NCT00454987)||235
2906676|NCT00454987|3615509|FG001|COMPLETED|Year 2 (NCT00454987)||77
2906677|NCT00454987|3615510|FG002|COMPLETED|Year 2 (NCT00454987)||74
2906678|NCT00454987|3615508|FG000|NOT COMPLETED|Year 2 (NCT00454987)||0
2906679|NCT00454987|3615509|FG001|NOT COMPLETED|Year 2 (NCT00454987)||0
2906680|NCT00454987|3615510|FG002|NOT COMPLETED|Year 2 (NCT00454987)||0
2906681|NCT00454987|3615508|FG000|STARTED|Year 4 (NCT00454987)||206
2906682|NCT00454987|3615509|FG001|STARTED|Year 4 (NCT00454987)||62
2906683|NCT00454987|3615510|FG002|STARTED|Year 4 (NCT00454987)||0
2906684|NCT00454987|3615508|FG000|COMPLETED|Year 4 (NCT00454987)||206
2906685|NCT00454987|3615509|FG001|COMPLETED|Year 4 (NCT00454987)||62
2906686|NCT00454987|3615510|FG002|COMPLETED|Year 4 (NCT00454987)||0
2906687|NCT00454987|3615508|FG000|NOT COMPLETED|Year 4 (NCT00454987)||0
2906688|NCT00454987|3615509|FG001|NOT COMPLETED|Year 4 (NCT00454987)||0
2906689|NCT00454987|3615510|FG002|NOT COMPLETED|Year 4 (NCT00454987)||0
2906690|NCT00455013|3615522|FG000|STARTED|Short Term Period|35 randomized, 33 transplanted and treated.|33
2906691|NCT00455013|3615523|FG001|STARTED|Short Term Period|27 randomized, 26 transplanted and treated.|26
2906692|NCT00455013|3615524|FG002|STARTED|Short Term Period|31 randomized, 30 transplanted and treated|30
2906693|NCT00455013|3615522|FG000|COMPLETED|Short Term Period|5 discontinued belatacept by Month 6 (1 more by Month 12), 2 switched from MMF to sirolimus.|27
2906694|NCT00455013|3615523|FG001|COMPLETED|Short Term Period|5 discontinued belatacept by Month 6; 10 additional switched from sirolimus to MMF.|21
2906695|NCT00455013|3615524|FG002|COMPLETED|Short Term Period|1 discontinued tacrolimus by Month 6 and 2 discontinued by Month 12 (1 more by Month 12)|28
2906696|NCT00455013|3615522|FG000|NOT COMPLETED|Short Term Period||6
2906697|NCT00455013|3615523|FG001|NOT COMPLETED|Short Term Period||5
2906698|NCT00455013|3615524|FG002|NOT COMPLETED|Short Term Period||2
2906699|NCT00455013|3615522|FG000|STARTED|Long Term Extension (LTE)||27
2906700|NCT00455013|3615523|FG001|STARTED|Long Term Extension (LTE)|2 Participants chose not to enter the LTE.|19
2906701|NCT00455013|3615524|FG002|STARTED|Long Term Extension (LTE)|1 Participant chose not to enter the LTE.|27
2906702|NCT00455013|3615522|FG000|COMPLETED|Long Term Extension (LTE)||25
2906703|NCT00455013|3615523|FG001|COMPLETED|Long Term Extension (LTE)||16
2906704|NCT00455013|3615524|FG002|COMPLETED|Long Term Extension (LTE)||20
2906705|NCT00455013|3615522|FG000|NOT COMPLETED|Long Term Extension (LTE)||2
2906706|NCT00455013|3615523|FG001|NOT COMPLETED|Long Term Extension (LTE)||3
2906707|NCT00455013|3615524|FG002|NOT COMPLETED|Long Term Extension (LTE)||7
2906708|NCT00455195|3615534|FG000|STARTED|Double-blind Study AGLU02704|Patients randomized to alglucosidase alfa treatment group in AGLU02704 (NCT00158600).|60
2906709|NCT00455195|3615535|FG001|STARTED|Double-blind Study AGLU02704|See study AGLU02704 (NCT00158600) for results while on placebo.|30
2906710|NCT00455195|3615534|FG000|COMPLETED|Double-blind Study AGLU02704||55
2906711|NCT00455195|3615535|FG001|COMPLETED|Double-blind Study AGLU02704||26
2906712|NCT00455195|3615534|FG000|NOT COMPLETED|Double-blind Study AGLU02704||5
2906713|NCT00455195|3615535|FG001|NOT COMPLETED|Double-blind Study AGLU02704||4
2906714|NCT00455195|3615534|FG000|STARTED|Extension Study AGLU03206||55
2906715|NCT00455195|3615535|FG001|STARTED|Extension Study AGLU03206|These 26 participants completed placebo double-blind treatment in the AGLU02704 (NCT00158600) study.|26
2906716|NCT00455195|3615534|FG000|COMPLETED|Extension Study AGLU03206||55
2906717|NCT00455195|3615535|FG001|COMPLETED|Extension Study AGLU03206||26
2906718|NCT00455195|3615534|FG000|NOT COMPLETED|Extension Study AGLU03206||0
2906719|NCT00455195|3615535|FG001|NOT COMPLETED|Extension Study AGLU03206||0
2906720|NCT00455312|3615543|FG000|STARTED|Overall Study||15
2906721|NCT00455312|3615544|FG001|STARTED|Overall Study||21
2906722|NCT00455312|3615543|FG000|COMPLETED|Overall Study||15
2906723|NCT00455312|3615544|FG001|COMPLETED|Overall Study||20
2906724|NCT00455312|3615543|FG000|NOT COMPLETED|Overall Study||0
2906725|NCT00455312|3615544|FG001|NOT COMPLETED|Overall Study||1
2906726|NCT00455429|3615554|FG000|STARTED|Overall Study||18
2906727|NCT00455429|3615555|FG001|STARTED|Overall Study||15
2906728|NCT00455429|3615556|FG002|STARTED|Overall Study||17
2906729|NCT00455429|3615557|FG003|STARTED|Overall Study||34
2906730|NCT00455429|3615554|FG000|Treated|Overall Study||18
2906731|NCT00455429|3615555|FG001|Treated|Overall Study||15
2906732|NCT00455429|3615556|FG002|Treated|Overall Study||17
2906733|NCT00455429|3615557|FG003|Treated|Overall Study||32
2906734|NCT00455429|3615554|FG000|COMPLETED|Overall Study||16
2906735|NCT00455429|3615555|FG001|COMPLETED|Overall Study||10
2906736|NCT00455429|3615556|FG002|COMPLETED|Overall Study||16
2906737|NCT00455429|3615557|FG003|COMPLETED|Overall Study||20
2906738|NCT00455429|3615554|FG000|NOT COMPLETED|Overall Study||2
2906739|NCT00455429|3615555|FG001|NOT COMPLETED|Overall Study||5
2906740|NCT00455429|3615556|FG002|NOT COMPLETED|Overall Study||1
2906741|NCT00455429|3615557|FG003|NOT COMPLETED|Overall Study||14
2906742|NCT00455455|3615570|FG000|STARTED|Washout||25
2906743|NCT00455455|3615571|FG001|STARTED|Washout||25
2906744|NCT00455455|3615570|FG000|COMPLETED|Washout||25
2906745|NCT00455455|3615571|FG001|COMPLETED|Washout||24
2906746|NCT00455455|3615570|FG000|NOT COMPLETED|Washout||0
2906747|NCT00455455|3615571|FG001|NOT COMPLETED|Washout||1
2906748|NCT00455455|3615570|FG000|STARTED|First Intervention||25
2906749|NCT00455455|3615571|FG001|STARTED|First Intervention||24
2906750|NCT00455455|3615570|FG000|COMPLETED|First Intervention||25
2906751|NCT00455455|3615571|FG001|COMPLETED|First Intervention||24
2906752|NCT00455455|3615570|FG000|NOT COMPLETED|First Intervention||0
3171410|NCT01933789|3898534|FG002|Completed 6-Month Survey|Overall Study||0
3171411|NCT01933789|3898535|FG003|Completed 6-Month Survey|Overall Study||0
3171412|NCT01933789|3898536|FG004|Completed 6-Month Survey|Overall Study||160
3171413|NCT01933789|3898537|FG005|Completed 6-Month Survey|Overall Study||188
2906753|NCT00455455|3615571|FG001|NOT COMPLETED|First Intervention||0
2906754|NCT00455455|3615570|FG000|STARTED|Washout||25
2906755|NCT00455455|3615571|FG001|STARTED|Washout||24
2906756|NCT00455455|3615570|FG000|COMPLETED|Washout||24
2906757|NCT00455455|3615571|FG001|COMPLETED|Washout||24
2906758|NCT00455455|3615570|FG000|NOT COMPLETED|Washout||1
2906759|NCT00455455|3615571|FG001|NOT COMPLETED|Washout||0
2906760|NCT00455455|3615570|FG000|STARTED|Second Intervention||24
2906761|NCT00455455|3615571|FG001|STARTED|Second Intervention||24
2906762|NCT00455455|3615570|FG000|COMPLETED|Second Intervention||24
2906763|NCT00455455|3615571|FG001|COMPLETED|Second Intervention||24
2906764|NCT00455455|3615570|FG000|NOT COMPLETED|Second Intervention||0
2906765|NCT00455455|3615571|FG001|NOT COMPLETED|Second Intervention||0
2906766|NCT00455520|3615582|FG000|STARTED|Open Label Tapentadol Extended Release||591
2906767|NCT00455520|3615583|FG001|STARTED|Open Label Tapentadol Extended Release||0
2906768|NCT00455520|3615582|FG000|COMPLETED|Open Label Tapentadol Extended Release||395
2906769|NCT00455520|3615583|FG001|COMPLETED|Open Label Tapentadol Extended Release||0
2906770|NCT00455520|3615582|FG000|NOT COMPLETED|Open Label Tapentadol Extended Release||196
2906771|NCT00455520|3615583|FG001|NOT COMPLETED|Open Label Tapentadol Extended Release||0
2906772|NCT00455520|3615582|FG000|STARTED|Double Blind Tapentadol ER vs Placebo|2 subjects enrolled two separate times in this study, 1 subject did not receive study medication|196
2906773|NCT00455520|3615583|FG001|STARTED|Double Blind Tapentadol ER vs Placebo|1 subject enrolled two separate times in this study, 2 subjects did not receive study medication|193
2906774|NCT00455520|3615582|FG000|COMPLETED|Double Blind Tapentadol ER vs Placebo||133
2906775|NCT00455520|3615583|FG001|COMPLETED|Double Blind Tapentadol ER vs Placebo||131
2906776|NCT00455520|3615582|FG000|NOT COMPLETED|Double Blind Tapentadol ER vs Placebo||63
2906777|NCT00455520|3615583|FG001|NOT COMPLETED|Double Blind Tapentadol ER vs Placebo||62
2906778|NCT00455533|3615591|FG000|STARTED|Period One: Initial Chemotherapy||313
2906779|NCT00455533|3615592|FG001|STARTED|Period One: Initial Chemotherapy||0
2906780|NCT00455533|3615593|FG002|STARTED|Period One: Initial Chemotherapy||0
2906781|NCT00455533|3615591|FG000|COMPLETED|Period One: Initial Chemotherapy||295
2906782|NCT00455533|3615592|FG001|COMPLETED|Period One: Initial Chemotherapy||0
2906783|NCT00455533|3615593|FG002|COMPLETED|Period One: Initial Chemotherapy||0
2906784|NCT00455533|3615591|FG000|NOT COMPLETED|Period One: Initial Chemotherapy||18
2906785|NCT00455533|3615592|FG001|NOT COMPLETED|Period One: Initial Chemotherapy||0
2906786|NCT00455533|3615593|FG002|NOT COMPLETED|Period One: Initial Chemotherapy||0
2906787|NCT00455533|3615591|FG000|STARTED|Period Two: Randomized Period||0
2906788|NCT00455533|3615592|FG001|STARTED|Period Two: Randomized Period|148 randomized, 145 randomized and treated with ixabepilone|145
2906789|NCT00455533|3615593|FG002|STARTED|Period Two: Randomized Period|147 randomized, 144 randomized and treated with paclitaxel|144
2906790|NCT00455533|3615591|FG000|COMPLETED|Period Two: Randomized Period||0
2906791|NCT00455533|3615592|FG001|COMPLETED|Period Two: Randomized Period||139
2906792|NCT00455533|3615593|FG002|COMPLETED|Period Two: Randomized Period||138
2906793|NCT00455533|3615591|FG000|NOT COMPLETED|Period Two: Randomized Period||0
2906794|NCT00455533|3615592|FG001|NOT COMPLETED|Period Two: Randomized Period||6
2906795|NCT00455533|3615593|FG002|NOT COMPLETED|Period Two: Randomized Period||6
2906796|NCT00455650|3615603|FG000|STARTED|Week 1||10
2906797|NCT00455650|3615604|FG001|STARTED|Week 1||10
2906798|NCT00455650|3615605|FG002|STARTED|Week 1||10
2906799|NCT00455650|3615606|FG003|STARTED|Week 1||14
2906800|NCT00455650|3615607|FG004|STARTED|Week 1||14
2906801|NCT00455650|3615608|FG005|STARTED|Week 1||13
2906802|NCT00455650|3615603|FG000|COMPLETED|Week 1||10
2906803|NCT00455650|3615604|FG001|COMPLETED|Week 1||10
2906804|NCT00455650|3615605|FG002|COMPLETED|Week 1||10
2906805|NCT00455650|3615606|FG003|COMPLETED|Week 1||14
2906806|NCT00455650|3615607|FG004|COMPLETED|Week 1||14
2906807|NCT00455650|3615608|FG005|COMPLETED|Week 1||13
2906808|NCT00455650|3615603|FG000|NOT COMPLETED|Week 1||0
2906809|NCT00455650|3615604|FG001|NOT COMPLETED|Week 1||0
2906810|NCT00455650|3615605|FG002|NOT COMPLETED|Week 1||0
2906811|NCT00455650|3615606|FG003|NOT COMPLETED|Week 1||0
2906812|NCT00455650|3615607|FG004|NOT COMPLETED|Week 1||0
2906813|NCT00455650|3615608|FG005|NOT COMPLETED|Week 1||0
2906814|NCT00455650|3615603|FG000|STARTED|Week 2||10
2906815|NCT00455650|3615604|FG001|STARTED|Week 2||10
2906816|NCT00455650|3615605|FG002|STARTED|Week 2||10
2906817|NCT00455650|3615606|FG003|STARTED|Week 2||14
2906818|NCT00455650|3615607|FG004|STARTED|Week 2||14
2906819|NCT00455650|3615608|FG005|STARTED|Week 2||13
2906820|NCT00455650|3615603|FG000|COMPLETED|Week 2||10
2906821|NCT00455650|3615604|FG001|COMPLETED|Week 2||10
2906822|NCT00455650|3615605|FG002|COMPLETED|Week 2||10
2906823|NCT00455650|3615606|FG003|COMPLETED|Week 2||14
2906824|NCT00455650|3615607|FG004|COMPLETED|Week 2||14
2906825|NCT00455650|3615608|FG005|COMPLETED|Week 2||13
2906826|NCT00455650|3615603|FG000|NOT COMPLETED|Week 2||0
2906827|NCT00455650|3615604|FG001|NOT COMPLETED|Week 2||0
2906828|NCT00455650|3615605|FG002|NOT COMPLETED|Week 2||0
2906829|NCT00455650|3615606|FG003|NOT COMPLETED|Week 2||0
2906830|NCT00455650|3615607|FG004|NOT COMPLETED|Week 2||0
2906831|NCT00455650|3615608|FG005|NOT COMPLETED|Week 2||0
2906832|NCT00455650|3615603|FG000|STARTED|Week 3||10
2906833|NCT00455650|3615604|FG001|STARTED|Week 3||10
2906834|NCT00455650|3615605|FG002|STARTED|Week 3||10
2906835|NCT00455650|3615606|FG003|STARTED|Week 3||14
2906836|NCT00455650|3615607|FG004|STARTED|Week 3||14
2906837|NCT00455650|3615608|FG005|STARTED|Week 3||13
2906838|NCT00455650|3615603|FG000|COMPLETED|Week 3||10
2906839|NCT00455650|3615604|FG001|COMPLETED|Week 3||10
2906840|NCT00455650|3615605|FG002|COMPLETED|Week 3||10
2906841|NCT00455650|3615606|FG003|COMPLETED|Week 3||14
2906842|NCT00455650|3615607|FG004|COMPLETED|Week 3||14
2906843|NCT00455650|3615608|FG005|COMPLETED|Week 3||13
2906844|NCT00455650|3615603|FG000|NOT COMPLETED|Week 3||0
2906845|NCT00455650|3615604|FG001|NOT COMPLETED|Week 3||0
2906846|NCT00455650|3615605|FG002|NOT COMPLETED|Week 3||0
2906847|NCT00455650|3615606|FG003|NOT COMPLETED|Week 3||0
2906848|NCT00455650|3615607|FG004|NOT COMPLETED|Week 3||0
2906849|NCT00455650|3615608|FG005|NOT COMPLETED|Week 3||0
2906850|NCT00455663|3615621|FG000|STARTED|Overall Study||37
2906851|NCT00455663|3615622|FG001|STARTED|Overall Study||36
2906852|NCT00455663|3615623|FG002|STARTED|Overall Study||32
2906853|NCT00455663|3615621|FG000|COMPLETED|Overall Study||34
2906854|NCT00455663|3615622|FG001|COMPLETED|Overall Study||32
2906855|NCT00455663|3615623|FG002|COMPLETED|Overall Study||29
2906856|NCT00455663|3615621|FG000|NOT COMPLETED|Overall Study||3
2906857|NCT00455663|3615622|FG001|NOT COMPLETED|Overall Study||4
2906858|NCT00455663|3615623|FG002|NOT COMPLETED|Overall Study||3
2906859|NCT00455689|3615637|FG000|STARTED|Overall Study||14
2906860|NCT00455689|3615638|FG001|STARTED|Overall Study||6
2906861|NCT00455689|3615637|FG000|COMPLETED|Overall Study||14
3171414|NCT01933789|3898538|FG006|Completed 6-Month Survey|Overall Study||35
3171415|NCT01933789|3898539|FG007|Completed 6-Month Survey|Overall Study||40
3171416|NCT01933789|3898540|FG008|Completed 6-Month Survey|Overall Study||0
3171417|NCT01933789|3898532|FG000|Qualitative Interviews|Overall Study||0
3171418|NCT01933789|3898533|FG001|Qualitative Interviews|Overall Study||0
2906862|NCT00455689|3615638|FG001|COMPLETED|Overall Study||6
2906863|NCT00455689|3615637|FG000|NOT COMPLETED|Overall Study||0
2906864|NCT00455689|3615638|FG001|NOT COMPLETED|Overall Study||0
2906865|NCT00455702|3615645|FG000|STARTED|Overall Study||19
2906866|NCT00455702|3615646|FG001|STARTED|Overall Study||19
2906867|NCT00455702|3615645|FG000|COMPLETED|Overall Study||16
2906868|NCT00455702|3615646|FG001|COMPLETED|Overall Study||16
2906869|NCT00455702|3615645|FG000|NOT COMPLETED|Overall Study||3
2906870|NCT00455702|3615646|FG001|NOT COMPLETED|Overall Study||3
2906871|NCT00455741|3615656|FG000|STARTED|Overall Study||13
2906872|NCT00455741|3615657|FG001|STARTED|Overall Study||12
2906873|NCT00455741|3615656|FG000|COMPLETED|Overall Study||13
2906874|NCT00455741|3615657|FG001|COMPLETED|Overall Study||11
2906875|NCT00455741|3615656|FG000|NOT COMPLETED|Overall Study||0
2906876|NCT00455741|3615657|FG001|NOT COMPLETED|Overall Study||1
2906877|NCT00455858|3615673|FG000|STARTED|Overall Study|Enrolled in study and exposed to study drug|87
2906878|NCT00455858|3615673|FG000|COMPLETED|Overall Study||81
2906879|NCT00455858|3615673|FG000|NOT COMPLETED|Overall Study||6
2906880|NCT00455923|3615679|FG000|STARTED|Overall Study||50
2906881|NCT00455923|3615680|FG001|STARTED|Overall Study||50
2906882|NCT00455923|3615679|FG000|COMPLETED|Overall Study||47
2906883|NCT00455923|3615680|FG001|COMPLETED|Overall Study||47
2906884|NCT00455923|3615679|FG000|NOT COMPLETED|Overall Study||3
2906885|NCT00455923|3615680|FG001|NOT COMPLETED|Overall Study||3
2906886|NCT00455962|3615688|FG000|STARTED|Overall Study||10
2906887|NCT00455962|3615689|FG001|STARTED|Overall Study||13
2906888|NCT00455962|3615688|FG000|COMPLETED|Overall Study||10
2906889|NCT00455962|3615689|FG001|COMPLETED|Overall Study||13
2906890|NCT00455962|3615688|FG000|NOT COMPLETED|Overall Study||0
2906891|NCT00455962|3615689|FG001|NOT COMPLETED|Overall Study||0
2906892|NCT00455975|3615697|FG000|STARTED|Overall Study||58
2906893|NCT00455975|3615698|FG001|STARTED|Overall Study||61
2906894|NCT00455975|3615697|FG000|COMPLETED|Overall Study||40
2906895|NCT00455975|3615698|FG001|COMPLETED|Overall Study||40
2906896|NCT00455975|3615697|FG000|NOT COMPLETED|Overall Study||18
2906897|NCT00455975|3615698|FG001|NOT COMPLETED|Overall Study||21
2906898|NCT00456014|3615704|FG000|STARTED|SSRI Phase||37
2906899|NCT00456014|3615704|FG000|COMPLETED|SSRI Phase||28
2906900|NCT00456014|3615704|FG000|NOT COMPLETED|SSRI Phase||9
2906901|NCT00456014|3615704|FG000|STARTED|Tricyclic Phase|Only non-remitters from phase 1 were eligible for phase 2, and not all those eligible continued.|4
2906902|NCT00456014|3615704|FG000|COMPLETED|Tricyclic Phase||1
2906903|NCT00456014|3615704|FG000|NOT COMPLETED|Tricyclic Phase||3
2906904|NCT00456092|3615713|FG000|STARTED|Extension Phase|The Extension Phase was only open to participants enrolled after amendment 1 was in effect.|46
2906905|NCT00456092|3615714|FG001|STARTED|Extension Phase|The Extension Phase was only open to participants enrolled after amendment 1 was in effect.|40
2906906|NCT00456092|3615715|FG002|STARTED|Extension Phase||0
2906907|NCT00456092|3615716|FG003|STARTED|Extension Phase|The Extension Phase was only open to participants enrolled after amendment 1 was in effect.|20
2906908|NCT00456092|3615717|FG004|STARTED|Extension Phase|The Extension Phase was only open to participants enrolled after amendment 1 was in effect.|20
2906909|NCT00456092|3615713|FG000|COMPLETED|Extension Phase||35
2906910|NCT00456092|3615714|FG001|COMPLETED|Extension Phase||36
2906911|NCT00456092|3615715|FG002|COMPLETED|Extension Phase||0
2906912|NCT00456092|3615716|FG003|COMPLETED|Extension Phase||19
2906913|NCT00456092|3615717|FG004|COMPLETED|Extension Phase||13
2906914|NCT00456092|3615713|FG000|NOT COMPLETED|Extension Phase||11
2906915|NCT00456092|3615714|FG001|NOT COMPLETED|Extension Phase||4
2906916|NCT00456092|3615715|FG002|NOT COMPLETED|Extension Phase||0
2906917|NCT00456092|3615716|FG003|NOT COMPLETED|Extension Phase||1
2906918|NCT00456092|3615717|FG004|NOT COMPLETED|Extension Phase||7
2906919|NCT00456092|3615713|FG000|STARTED|Treatment Phase (12 Weeks)||67
2906920|NCT00456092|3615714|FG001|STARTED|Treatment Phase (12 Weeks)||69
2906921|NCT00456092|3615715|FG002|STARTED|Treatment Phase (12 Weeks)||68
2906922|NCT00456092|3615716|FG003|STARTED|Treatment Phase (12 Weeks)||0
2906923|NCT00456092|3615717|FG004|STARTED|Treatment Phase (12 Weeks)||0
2906924|NCT00456092|3615713|FG000|COMPLETED|Treatment Phase (12 Weeks)||60
2906925|NCT00456092|3615714|FG001|COMPLETED|Treatment Phase (12 Weeks)||55
2906926|NCT00456092|3615715|FG002|COMPLETED|Treatment Phase (12 Weeks)||50
2906927|NCT00456092|3615716|FG003|COMPLETED|Treatment Phase (12 Weeks)||0
2906928|NCT00456092|3615717|FG004|COMPLETED|Treatment Phase (12 Weeks)||0
2906929|NCT00456092|3615713|FG000|NOT COMPLETED|Treatment Phase (12 Weeks)||7
3316188|NCT03107715|4049476|FG001|NOT COMPLETED|Overall Study||7
3316189|NCT03107754|4049484|FG000|STARTED|Overall Study||48
3316190|NCT03107754|4049485|FG001|STARTED|Overall Study||50
3316191|NCT03107754|4049484|FG000|COMPLETED|Overall Study||48
3316192|NCT03107754|4049485|FG001|COMPLETED|Overall Study||50
3316193|NCT03107754|4049484|FG000|NOT COMPLETED|Overall Study||0
3316194|NCT03107754|4049485|FG001|NOT COMPLETED|Overall Study||0
3316195|NCT03107793|4049491|FG000|STARTED|Induction Period (16 Weeks)||500
2906930|NCT00456092|3615714|FG001|NOT COMPLETED|Treatment Phase (12 Weeks)||14
2906931|NCT00456092|3615715|FG002|NOT COMPLETED|Treatment Phase (12 Weeks)||18
2906932|NCT00456092|3615716|FG003|NOT COMPLETED|Treatment Phase (12 Weeks)||0
2906933|NCT00456092|3615717|FG004|NOT COMPLETED|Treatment Phase (12 Weeks)||0
2906934|NCT00456261|3615733|FG000|STARTED|Combination Therapy||55
2906935|NCT00456261|3615734|FG001|STARTED|Combination Therapy||55
2906936|NCT00456261|3615733|FG000|COMPLETED|Combination Therapy||3
2906937|NCT00456261|3615734|FG001|COMPLETED|Combination Therapy||29
2906938|NCT00456261|3615733|FG000|NOT COMPLETED|Combination Therapy||52
2906939|NCT00456261|3615734|FG001|NOT COMPLETED|Combination Therapy||26
2906940|NCT00456261|3615733|FG000|STARTED|Maintenance Therapy||3
2906941|NCT00456261|3615734|FG001|STARTED|Maintenance Therapy||29
2906942|NCT00456261|3615733|FG000|COMPLETED|Maintenance Therapy||3
2906943|NCT00456261|3615734|FG001|COMPLETED|Maintenance Therapy||29
2906944|NCT00456261|3615733|FG000|NOT COMPLETED|Maintenance Therapy||0
2906945|NCT00456261|3615734|FG001|NOT COMPLETED|Maintenance Therapy||0
2906946|NCT00456300|3615740|FG000|STARTED|Overall Study||5
2906947|NCT00456300|3615741|FG001|STARTED|Overall Study||4
2906948|NCT00456300|3615740|FG000|COMPLETED|Overall Study||4
2906949|NCT00456300|3615741|FG001|COMPLETED|Overall Study||4
2906950|NCT00456300|3615740|FG000|NOT COMPLETED|Overall Study||1
2906951|NCT00456300|3615741|FG001|NOT COMPLETED|Overall Study||0
2906952|NCT00456365|3615751|FG000|STARTED|Overall Study||56
2906953|NCT00456365|3615752|FG001|STARTED|Overall Study||54
2906954|NCT00456365|3615751|FG000|COMPLETED|Overall Study||49
3316196|NCT03107793|4049492|FG001|STARTED|Induction Period (16 Weeks)||0
3316197|NCT03107793|4049493|FG002|STARTED|Induction Period (16 Weeks)||0
3316198|NCT03107793|4049491|FG000|COMPLETED|Induction Period (16 Weeks)||490
2906955|NCT00456365|3615752|FG001|COMPLETED|Overall Study||42
2906956|NCT00456365|3615751|FG000|NOT COMPLETED|Overall Study||7
2906957|NCT00456365|3615752|FG001|NOT COMPLETED|Overall Study||12
2906958|NCT00456495|3615760|FG000|STARTED|Overall Study||5
2906959|NCT00456495|3615760|FG000|COMPLETED|Overall Study||3
2906960|NCT00456495|3615760|FG000|NOT COMPLETED|Overall Study||2
2906961|NCT00456508|3615765|FG000|STARTED|Overall Study||147
2906962|NCT00456508|3615765|FG000|COMPLETED|Overall Study||147
2906963|NCT00456508|3615765|FG000|NOT COMPLETED|Overall Study||0
2906964|NCT00456521|3615771|FG000|STARTED|Overall Study||591
2906965|NCT00456521|3615772|FG001|STARTED|Overall Study||202
2906966|NCT00456521|3615771|FG000|COMPLETED|Overall Study||342
2906967|NCT00456521|3615772|FG001|COMPLETED|Overall Study||118
2906968|NCT00456521|3615771|FG000|NOT COMPLETED|Overall Study||249
2906969|NCT00456521|3615772|FG001|NOT COMPLETED|Overall Study||84
2906970|NCT00456547|3615781|FG000|STARTED|Overall Study||12
2906971|NCT00456547|3615782|FG001|STARTED|Overall Study||12
2906972|NCT00456547|3615781|FG000|COMPLETED|Overall Study||12
2906973|NCT00456547|3615782|FG001|COMPLETED|Overall Study||12
2906974|NCT00456547|3615781|FG000|NOT COMPLETED|Overall Study||0
2906975|NCT00456547|3615782|FG001|NOT COMPLETED|Overall Study||0
2906976|NCT00456599|3615788|FG000|STARTED|Overall Study||71
2906977|NCT00456599|3615788|FG000|Completed Cycle 1|Overall Study|Of the 71 patients, 1 was removed for noncompliance; 2 withdrew; 2 did not complete cycle 1.|66
2906978|NCT00456599|3615788|FG000|Initiated Cycle 2|Overall Study|5 patients were removed from study prior to initiation of a second cycle.|61
2906979|NCT00456599|3615788|FG000|Completed Protocol Surgery|Overall Study|Forty-eight patients (71%) underwent laparotomy according to the protocol.|48
2906980|NCT00456599|3615788|FG000|Completed Resection|Overall Study|43 patients underwent resection.|43
2906981|NCT00456599|3615788|FG000|Post-Surgery Adjuvent Therapy|Overall Study|After resection, 26 patients (68%) initiated adjuvant therapy.|26
2906982|NCT00456599|3615788|FG000|Completed 4th Cycle of Chemotherapy|Overall Study|24 patients (63%) completed a fourth cycle of chemotherapy.|24
2906983|NCT00456599|3615788|FG000|COMPLETED|Overall Study||68
2906984|NCT00456599|3615788|FG000|NOT COMPLETED|Overall Study||3
2906985|NCT00456625|3615792|FG000|STARTED|Overall Study||76
2906986|NCT00456625|3615792|FG000|COMPLETED|Overall Study||76
2906987|NCT00456625|3615792|FG000|NOT COMPLETED|Overall Study||0
2906988|NCT00456755|3615798|FG000|STARTED|Overall Study||63
2906989|NCT00456755|3615799|FG001|STARTED|Overall Study||63
2906990|NCT00456755|3615798|FG000|COMPLETED|Overall Study||61
2906991|NCT00456755|3615799|FG001|COMPLETED|Overall Study||62
2906992|NCT00456755|3615798|FG000|NOT COMPLETED|Overall Study||2
2906993|NCT00456755|3615799|FG001|NOT COMPLETED|Overall Study||1
2906994|NCT00456807|3615807|FG000|STARTED|Overall Study||53
2906995|NCT00456807|3615808|FG001|STARTED|Overall Study||47
2906996|NCT00456807|3615807|FG000|COMPLETED|Overall Study||52
2906997|NCT00456807|3615808|FG001|COMPLETED|Overall Study||47
2906998|NCT00456807|3615807|FG000|NOT COMPLETED|Overall Study||1
2906999|NCT00456807|3615808|FG001|NOT COMPLETED|Overall Study||0
2907000|NCT00456846|3615816|FG000|STARTED|Overall Study||47
2907001|NCT00456846|3615817|FG001|STARTED|Overall Study||76
2907002|NCT00456846|3615816|FG000|COMPLETED|Overall Study|Treatment considered completed upon disease progression|31
2907003|NCT00456846|3615817|FG001|COMPLETED|Overall Study|Treatment considered completed upon disease progression|48
2907004|NCT00456846|3615816|FG000|NOT COMPLETED|Overall Study||16
3171419|NCT01933789|3898534|FG002|Qualitative Interviews|Overall Study||0
3171420|NCT01933789|3898535|FG003|Qualitative Interviews|Overall Study||0
3171421|NCT01933789|3898536|FG004|Qualitative Interviews|Overall Study||0
3171422|NCT01933789|3898537|FG005|Qualitative Interviews|Overall Study||0
3171423|NCT01933789|3898538|FG006|Qualitative Interviews|Overall Study||0
3171424|NCT01933789|3898539|FG007|Qualitative Interviews|Overall Study||0
2907005|NCT00456846|3615817|FG001|NOT COMPLETED|Overall Study||28
2920453|NCT00537056|3630966|FG000|STARTED|12-month Follow-up||17
2920454|NCT00537056|3630966|FG000|COMPLETED|12-month Follow-up||17
2920455|NCT00537056|3630966|FG000|NOT COMPLETED|12-month Follow-up||0
2920456|NCT00537082|3630975|FG000|STARTED|Overall Study||57
2920457|NCT00537082|3630976|FG001|STARTED|Overall Study||57
2920458|NCT00537082|3630977|FG002|STARTED|Overall Study||57
2920459|NCT00537082|3630975|FG000|COMPLETED|Overall Study||48
2920460|NCT00537082|3630976|FG001|COMPLETED|Overall Study||48
3171425|NCT01933789|3898540|FG008|Qualitative Interviews|Overall Study||25
3171426|NCT01933789|3898532|FG000|COMPLETED|Overall Study||59
3171427|NCT01933789|3898533|FG001|COMPLETED|Overall Study||66
3171428|NCT01933789|3898534|FG002|COMPLETED|Overall Study||2
3171429|NCT01933789|3898535|FG003|COMPLETED|Overall Study||1
3171430|NCT01933789|3898536|FG004|COMPLETED|Overall Study||190
3171431|NCT01933789|3898537|FG005|COMPLETED|Overall Study||221
3171432|NCT01933789|3898538|FG006|COMPLETED|Overall Study||43
2920461|NCT00537082|3630977|FG002|COMPLETED|Overall Study||51
2920462|NCT00537082|3630975|FG000|NOT COMPLETED|Overall Study||9
2920463|NCT00537082|3630976|FG001|NOT COMPLETED|Overall Study||9
2920464|NCT00537082|3630977|FG002|NOT COMPLETED|Overall Study||6
2920465|NCT00537095|3630987|FG000|STARTED|Overall Study||72
2920466|NCT00537095|3630988|FG001|STARTED|Overall Study||73
2920467|NCT00537095|3630987|FG000|COMPLETED|Overall Study||21
2920468|NCT00537095|3630988|FG001|COMPLETED|Overall Study||16
2920469|NCT00537095|3630987|FG000|NOT COMPLETED|Overall Study||51
2920470|NCT00537095|3630988|FG001|NOT COMPLETED|Overall Study||57
2920471|NCT00537238|3630996|FG000|STARTED|Overall Study||254
2920472|NCT00537238|3630997|FG001|STARTED|Overall Study||255
2907006|NCT00456885|3615823|FG000|STARTED|First Treatment Period, 16 Weeks||24
2907007|NCT00456885|3615824|FG001|STARTED|First Treatment Period, 16 Weeks||17
2907008|NCT00456885|3615823|FG000|COMPLETED|First Treatment Period, 16 Weeks||24
2907009|NCT00456885|3615824|FG001|COMPLETED|First Treatment Period, 16 Weeks||17
2907010|NCT00456885|3615823|FG000|NOT COMPLETED|First Treatment Period, 16 Weeks||0
2907011|NCT00456885|3615824|FG001|NOT COMPLETED|First Treatment Period, 16 Weeks||0
2907012|NCT00456885|3615823|FG000|STARTED|Washout, 3 Weeks||24
2907013|NCT00456885|3615824|FG001|STARTED|Washout, 3 Weeks||17
2907014|NCT00456885|3615823|FG000|COMPLETED|Washout, 3 Weeks||24
2907015|NCT00456885|3615824|FG001|COMPLETED|Washout, 3 Weeks||17
2907016|NCT00456885|3615823|FG000|NOT COMPLETED|Washout, 3 Weeks||0
2907017|NCT00456885|3615824|FG001|NOT COMPLETED|Washout, 3 Weeks||0
2907018|NCT00456885|3615823|FG000|STARTED|Second Treatment Period, 16 Weeks||24
2907019|NCT00456885|3615824|FG001|STARTED|Second Treatment Period, 16 Weeks||17
2907020|NCT00456885|3615823|FG000|COMPLETED|Second Treatment Period, 16 Weeks||23
2907021|NCT00456885|3615824|FG001|COMPLETED|Second Treatment Period, 16 Weeks||17
2907022|NCT00456885|3615823|FG000|NOT COMPLETED|Second Treatment Period, 16 Weeks||1
2907023|NCT00456885|3615824|FG001|NOT COMPLETED|Second Treatment Period, 16 Weeks||0
2907024|NCT00457002|3615831|FG000|STARTED|Overall Study||3255
2907025|NCT00457002|3615832|FG001|STARTED|Overall Study||3273
2907026|NCT00457002|3615831|FG000|COMPLETED|Overall Study||2442
2907027|NCT00457002|3615832|FG001|COMPLETED|Overall Study||2516
2907028|NCT00457002|3615831|FG000|NOT COMPLETED|Overall Study||813
2907029|NCT00457002|3615832|FG001|NOT COMPLETED|Overall Study||757
2907030|NCT00457015|3615840|FG000|STARTED|Overall Study||48
2907031|NCT00457015|3615841|FG001|STARTED|Overall Study||48
2907032|NCT00457015|3615840|FG000|COMPLETED|Overall Study||48
2907033|NCT00457015|3615841|FG001|COMPLETED|Overall Study||47
2907034|NCT00457015|3615840|FG000|NOT COMPLETED|Overall Study||0
2907035|NCT00457015|3615841|FG001|NOT COMPLETED|Overall Study||1
2907036|NCT00457197|3615849|FG000|STARTED|Overall Study||45
2907037|NCT00457197|3615850|FG001|STARTED|Overall Study||45
2907038|NCT00457197|3615849|FG000|COMPLETED|Overall Study||44
2907039|NCT00457197|3615850|FG001|COMPLETED|Overall Study||44
2907040|NCT00457197|3615849|FG000|NOT COMPLETED|Overall Study||1
2907041|NCT00457197|3615850|FG001|NOT COMPLETED|Overall Study||1
2907042|NCT00457249|3615858|FG000|STARTED|Overall Study||1170
2907043|NCT00457249|3615859|FG001|STARTED|Overall Study||391
2907044|NCT00457249|3615858|FG000|COMPLETED|Overall Study||1158
2907045|NCT00457249|3615859|FG001|COMPLETED|Overall Study||389
2907046|NCT00457249|3615858|FG000|NOT COMPLETED|Overall Study||12
2907047|NCT00457249|3615859|FG001|NOT COMPLETED|Overall Study||2
2907048|NCT00457301|3615869|FG000|STARTED|Overall Study||105
2907049|NCT00457301|3615870|FG001|STARTED|Overall Study||108
2907050|NCT00457301|3615869|FG000|COMPLETED|Overall Study||82
2907051|NCT00457301|3615870|FG001|COMPLETED|Overall Study||84
2907052|NCT00457301|3615869|FG000|NOT COMPLETED|Overall Study||23
2907053|NCT00457301|3615870|FG001|NOT COMPLETED|Overall Study||24
2907054|NCT00457366|3615878|FG000|STARTED|Overall Study||40
2907055|NCT00457366|3615879|FG001|STARTED|Overall Study||32
2907056|NCT00457366|3615878|FG000|COMPLETED|Overall Study||40
2907057|NCT00457366|3615879|FG001|COMPLETED|Overall Study||32
2907058|NCT00457366|3615878|FG000|NOT COMPLETED|Overall Study||0
2907059|NCT00457366|3615879|FG001|NOT COMPLETED|Overall Study||0
2907060|NCT00457392|3615887|FG000|STARTED|Overall Study||480
2907061|NCT00457392|3615888|FG001|STARTED|Overall Study||480
2907062|NCT00457392|3615887|FG000|Treated|Overall Study||473
2907063|NCT00457392|3615888|FG001|Treated|Overall Study||477
2907064|NCT00457392|3615887|FG000|COMPLETED|Overall Study||0
2907065|NCT00457392|3615888|FG001|COMPLETED|Overall Study||0
2907066|NCT00457392|3615887|FG000|NOT COMPLETED|Overall Study||480
2907067|NCT00457392|3615888|FG001|NOT COMPLETED|Overall Study||480
2907068|NCT00457418|3615894|FG000|STARTED|Pharmacokinetic (PK) Sampling Phase||32
2907069|NCT00457418|3615894|FG000|COMPLETED|Pharmacokinetic (PK) Sampling Phase||27
2907070|NCT00457418|3615894|FG000|NOT COMPLETED|Pharmacokinetic (PK) Sampling Phase||5
2907071|NCT00457418|3615894|FG000|STARTED|Post PK Maintenance|4 participants didn't complete the PK sampling phase but continued to post PK maintenance treatment.|31
2907072|NCT00457418|3615894|FG000|COMPLETED|Post PK Maintenance||3
2907073|NCT00457418|3615894|FG000|NOT COMPLETED|Post PK Maintenance||28
2907074|NCT00457626|3615898|FG000|STARTED|Overall Study||66
2907075|NCT00457626|3615898|FG000|COMPLETED|Overall Study||60
2907076|NCT00457626|3615898|FG000|NOT COMPLETED|Overall Study||6
2907077|NCT00457639|3615902|FG000|STARTED|Intervention 1 (6 Months)|6 months on Cholic Acid and crossover to Placebo for 6 months|9
2907078|NCT00457639|3615903|FG001|STARTED|Intervention 1 (6 Months)|6 months on Placebo and crossover to cholic acid for 6 months|9
2907079|NCT00457639|3615902|FG000|COMPLETED|Intervention 1 (6 Months)|Number of Patients completing Cholic Acid Phase|6
2907080|NCT00457639|3615903|FG001|COMPLETED|Intervention 1 (6 Months)|Number of patients completing Placebo Phase|7
2907081|NCT00457639|3615902|FG000|NOT COMPLETED|Intervention 1 (6 Months)||3
2907082|NCT00457639|3615903|FG001|NOT COMPLETED|Intervention 1 (6 Months)||2
2907083|NCT00457639|3615902|FG000|STARTED|Intervention 2 (6 Months)||6
2907084|NCT00457639|3615903|FG001|STARTED|Intervention 2 (6 Months)||7
2907085|NCT00457639|3615902|FG000|COMPLETED|Intervention 2 (6 Months)||6
2907086|NCT00457639|3615903|FG001|COMPLETED|Intervention 2 (6 Months)||6
2907087|NCT00457639|3615902|FG000|NOT COMPLETED|Intervention 2 (6 Months)||0
2907088|NCT00457639|3615903|FG001|NOT COMPLETED|Intervention 2 (6 Months)||1
2907089|NCT00457665|3615911|FG000|STARTED|12 Months||28
2907090|NCT00457665|3615912|FG001|STARTED|12 Months||28
2907091|NCT00457665|3615911|FG000|COMPLETED|12 Months||20
2907092|NCT00457665|3615912|FG001|COMPLETED|12 Months||19
2907093|NCT00457665|3615911|FG000|NOT COMPLETED|12 Months||8
2907094|NCT00457665|3615912|FG001|NOT COMPLETED|12 Months||9
2907095|NCT00457665|3615911|FG000|STARTED|24 Months||20
2907096|NCT00457665|3615912|FG001|STARTED|24 Months||19
2907097|NCT00457665|3615911|FG000|COMPLETED|24 Months||15
2907098|NCT00457665|3615912|FG001|COMPLETED|24 Months||11
2907099|NCT00457665|3615911|FG000|NOT COMPLETED|24 Months||5
2907100|NCT00457665|3615912|FG001|NOT COMPLETED|24 Months||8
2907101|NCT00457691|3615920|FG000|STARTED|Overall Study||386
2907102|NCT00457691|3615921|FG001|STARTED|Overall Study||382
2907103|NCT00457691|3615920|FG000|COMPLETED|Overall Study||0
2907104|NCT00457691|3615921|FG001|COMPLETED|Overall Study||0
2907105|NCT00457691|3615920|FG000|NOT COMPLETED|Overall Study||386
2907106|NCT00457691|3615921|FG001|NOT COMPLETED|Overall Study||382
2907107|NCT00457730|3615929|FG000|STARTED|Overall Study||18
3316199|NCT03107793|4049492|FG001|COMPLETED|Induction Period (16 Weeks)||0
3316200|NCT03107793|4049493|FG002|COMPLETED|Induction Period (16 Weeks)||0
3316201|NCT03107793|4049491|FG000|NOT COMPLETED|Induction Period (16 Weeks)||10
3316202|NCT03107793|4049492|FG001|NOT COMPLETED|Induction Period (16 Weeks)||0
2907108|NCT00457730|3615930|FG001|STARTED|Overall Study||20
2907109|NCT00457730|3615929|FG000|COMPLETED|Overall Study||14
2907110|NCT00457730|3615930|FG001|COMPLETED|Overall Study||19
2907111|NCT00457730|3615929|FG000|NOT COMPLETED|Overall Study||4
2907112|NCT00457730|3615930|FG001|NOT COMPLETED|Overall Study||1
2907113|NCT00457743|3615943|FG000|STARTED|Overall Study|Overall study|3
2907114|NCT00457743|3615944|FG001|STARTED|Overall Study|Overall study|30
2907115|NCT00457743|3615945|FG002|STARTED|Overall Study|Overall study|3
2907116|NCT00457743|3615943|FG000|Enrolled in Phase 1|Overall Study||3
2907117|NCT00457743|3615944|FG001|Enrolled in Phase 1|Overall Study||6
2907118|NCT00457743|3615945|FG002|Enrolled in Phase 1|Overall Study||3
2907119|NCT00457743|3615943|FG000|Completed Phase 1|Overall Study||3
2907120|NCT00457743|3615944|FG001|Completed Phase 1|Overall Study||6
2907121|NCT00457743|3615945|FG002|Completed Phase 1|Overall Study||3
2907122|NCT00457743|3615943|FG000|Enrolled in Phase 2|Overall Study|Three subjects who completed Phase 1 entered Phase 2.|3
2907123|NCT00457743|3615944|FG001|Enrolled in Phase 2|Overall Study|Six subjects who completed Phase 1 entered Phase 2, and 24 subjects were newly enrolled.|30
2907124|NCT00457743|3615945|FG002|Enrolled in Phase 2|Overall Study|Three subjects who completed Phase 1 entered Phase 2.|3
2907125|NCT00457743|3615943|FG000|COMPLETED|Overall Study|However, all 3 subjects enrolled were included in analysis (Intent-to treat population).|0
2907126|NCT00457743|3615944|FG001|COMPLETED|Overall Study|However, all 30 subjects enrolled were included in analysis(Intent-to treat population).|3
2907127|NCT00457743|3615945|FG002|COMPLETED|Overall Study|However, all 3 subjects enrolled were included in analysis(Intent-to treat population).|0
2907128|NCT00457743|3615943|FG000|NOT COMPLETED|Overall Study||3
2907129|NCT00457743|3615944|FG001|NOT COMPLETED|Overall Study||27
2907130|NCT00457743|3615945|FG002|NOT COMPLETED|Overall Study||3
2907131|NCT00457795|3615954|FG000|STARTED|Overall Study||15
2907132|NCT00457795|3615954|FG000|COMPLETED|Overall Study||15
2907133|NCT00457795|3615954|FG000|NOT COMPLETED|Overall Study||0
2907134|NCT00457821|3615966|FG000|STARTED|Part 1|Number of subjects randomized|4
2907135|NCT00457821|3615967|FG001|STARTED|Part 1|Number of subjects randomized|4
2907136|NCT00457821|3615968|FG002|STARTED|Part 1|Number of subjects randomized|5
2907137|NCT00457821|3615969|FG003|STARTED|Part 1|Number of subjects randomized|4
2907138|NCT00457821|3615970|FG004|STARTED|Part 1|Number of subjects randomized|4
2907139|NCT00457821|3615971|FG005|STARTED|Part 1|Arm in Part 2 only|0
2907140|NCT00457821|3615972|FG006|STARTED|Part 1|Arm in Part 2 only|0
2907141|NCT00457821|3615973|FG007|STARTED|Part 1|Arm in Part 2 only|0
2907142|NCT00457821|3615966|FG000|COMPLETED|Part 1||4
2907143|NCT00457821|3615967|FG001|COMPLETED|Part 1||4
2907144|NCT00457821|3615968|FG002|COMPLETED|Part 1||4
2907145|NCT00457821|3615969|FG003|COMPLETED|Part 1||4
2907146|NCT00457821|3615970|FG004|COMPLETED|Part 1||4
2907147|NCT00457821|3615971|FG005|COMPLETED|Part 1||0
2907148|NCT00457821|3615972|FG006|COMPLETED|Part 1||0
2907149|NCT00457821|3615973|FG007|COMPLETED|Part 1||0
2907150|NCT00457821|3615966|FG000|NOT COMPLETED|Part 1||0
2907151|NCT00457821|3615967|FG001|NOT COMPLETED|Part 1||0
2907152|NCT00457821|3615968|FG002|NOT COMPLETED|Part 1||1
2907153|NCT00457821|3615969|FG003|NOT COMPLETED|Part 1||0
2907154|NCT00457821|3615970|FG004|NOT COMPLETED|Part 1||0
2907155|NCT00457821|3615971|FG005|NOT COMPLETED|Part 1||0
2907156|NCT00457821|3615972|FG006|NOT COMPLETED|Part 1||0
2907157|NCT00457821|3615973|FG007|NOT COMPLETED|Part 1||0
2907158|NCT00457821|3615966|FG000|STARTED|Part 2|Arm in Part 1 only|0
2907159|NCT00457821|3615967|FG001|STARTED|Part 2|Arm in Part 1 only|0
2907160|NCT00457821|3615968|FG002|STARTED|Part 2|Arm in Part 1 only|0
2907161|NCT00457821|3615969|FG003|STARTED|Part 2|Arm in Part 1 only|0
2907162|NCT00457821|3615970|FG004|STARTED|Part 2|Arm in Part 1 only|0
2907163|NCT00457821|3615971|FG005|STARTED|Part 2|All subjects who received at least 1 dose of study drug (ivacaftor).|8
2907164|NCT00457821|3615972|FG006|STARTED|Part 2|All subjects who received at least 1 dose of study drug (ivacaftor).|7
2907165|NCT00457821|3615973|FG007|STARTED|Part 2|All subjects who received at least 1 dose of study drug (placebo).|5
2907166|NCT00457821|3615966|FG000|Completed Study Drug Treatment|Part 2||0
2907167|NCT00457821|3615967|FG001|Completed Study Drug Treatment|Part 2||0
2907168|NCT00457821|3615968|FG002|Completed Study Drug Treatment|Part 2||0
2907169|NCT00457821|3615969|FG003|Completed Study Drug Treatment|Part 2||0
2907170|NCT00457821|3615970|FG004|Completed Study Drug Treatment|Part 2||0
2907171|NCT00457821|3615971|FG005|Completed Study Drug Treatment|Part 2||8
2907172|NCT00457821|3615972|FG006|Completed Study Drug Treatment|Part 2|1 subject missed a 250-mg dose of ivacaftor on Day 28 of Part 2.|7
2907173|NCT00457821|3615973|FG007|Completed Study Drug Treatment|Part 2||4
2907174|NCT00457821|3615966|FG000|COMPLETED|Part 2||0
2907175|NCT00457821|3615967|FG001|COMPLETED|Part 2||0
2907176|NCT00457821|3615968|FG002|COMPLETED|Part 2||0
2907177|NCT00457821|3615969|FG003|COMPLETED|Part 2||0
2907178|NCT00457821|3615970|FG004|COMPLETED|Part 2||0
2907179|NCT00457821|3615971|FG005|COMPLETED|Part 2||8
2907180|NCT00457821|3615972|FG006|COMPLETED|Part 2||7
2907181|NCT00457821|3615973|FG007|COMPLETED|Part 2||4
2907182|NCT00457821|3615966|FG000|NOT COMPLETED|Part 2||0
2907183|NCT00457821|3615967|FG001|NOT COMPLETED|Part 2||0
2907184|NCT00457821|3615968|FG002|NOT COMPLETED|Part 2||0
2907185|NCT00457821|3615969|FG003|NOT COMPLETED|Part 2||0
2907186|NCT00457821|3615970|FG004|NOT COMPLETED|Part 2||0
2907187|NCT00457821|3615971|FG005|NOT COMPLETED|Part 2||0
2907188|NCT00457821|3615972|FG006|NOT COMPLETED|Part 2||0
2907189|NCT00457821|3615973|FG007|NOT COMPLETED|Part 2||1
2907190|NCT00457977|3615992|FG000|STARTED|Overall Study||90
2907191|NCT00457977|3615993|FG001|STARTED|Overall Study||91
2907192|NCT00457977|3615992|FG000|1-Month|Overall Study||88
2907193|NCT00457977|3615993|FG001|1-Month|Overall Study||87
2907194|NCT00457977|3615992|FG000|1-Year|Overall Study||69
2907195|NCT00457977|3615993|FG001|1-Year|Overall Study||76
2907196|NCT00457977|3615992|FG000|2-Year|Overall Study||62
2907197|NCT00457977|3615993|FG001|2-Year|Overall Study||66
2907198|NCT00457977|3615992|FG000|COMPLETED|Overall Study||62
2907199|NCT00457977|3615993|FG001|COMPLETED|Overall Study||66
2907200|NCT00457977|3615992|FG000|NOT COMPLETED|Overall Study||28
2907201|NCT00457977|3615993|FG001|NOT COMPLETED|Overall Study||25
2907202|NCT00458211|3615999|FG000|STARTED|Overall Study||40
2907203|NCT00458211|3615999|FG000|COMPLETED|Overall Study|12 early termination 2 protocol violation 2 ( from Rochester) withdrawn from further analysis|24
2907204|NCT00458211|3615999|FG000|NOT COMPLETED|Overall Study||16
2907205|NCT00458237|3616010|FG000|STARTED|Overall Study||3
2907206|NCT00458237|3616011|FG001|STARTED|Overall Study||3
2907207|NCT00458237|3616012|FG002|STARTED|Overall Study||5
2907208|NCT00458237|3616010|FG000|COMPLETED|Overall Study||3
2907209|NCT00458237|3616011|FG001|COMPLETED|Overall Study||3
2907210|NCT00458237|3616012|FG002|COMPLETED|Overall Study||5
2907211|NCT00458237|3616010|FG000|NOT COMPLETED|Overall Study||0
2907212|NCT00458237|3616011|FG001|NOT COMPLETED|Overall Study||0
2907213|NCT00458237|3616012|FG002|NOT COMPLETED|Overall Study||0
2907214|NCT00458302|3616023|FG000|STARTED|Overall Study||129
2907215|NCT00458302|3616024|FG001|STARTED|Overall Study||127
2907216|NCT00458302|3616023|FG000|COMPLETED|Overall Study||109
2907217|NCT00458302|3616024|FG001|COMPLETED|Overall Study||103
2907218|NCT00458302|3616023|FG000|NOT COMPLETED|Overall Study||20
2907219|NCT00458302|3616024|FG001|NOT COMPLETED|Overall Study||24
2907220|NCT00458341|3616033|FG000|STARTED|Cycle 1||15
2907221|NCT00458341|3616034|FG001|STARTED|Cycle 1||15
2907222|NCT00458341|3616033|FG000|Received at Least 1 Dose of Study Drug|Cycle 1||15
2907223|NCT00458341|3616034|FG001|Received at Least 1 Dose of Study Drug|Cycle 1||15
2907224|NCT00458341|3616033|FG000|COMPLETED|Cycle 1|1 participant did not complete Cycle 1 since all procedures were not performed due to adverse event.|14
2907225|NCT00458341|3616034|FG001|COMPLETED|Cycle 1||15
2907226|NCT00458341|3616033|FG000|NOT COMPLETED|Cycle 1||1
2907227|NCT00458341|3616034|FG001|NOT COMPLETED|Cycle 1||0
2907228|NCT00458341|3616033|FG000|STARTED|Cycle 2|The participant who did not complete Cycle 1 was eligible for Cycle 2 and completed Cycle 2.|15
2907229|NCT00458341|3616034|FG001|STARTED|Cycle 2||15
2907230|NCT00458341|3616033|FG000|Received at Least 1 Dose of Study Drug|Cycle 2||15
2907231|NCT00458341|3616034|FG001|Received at Least 1 Dose of Study Drug|Cycle 2||15
2907232|NCT00458341|3616033|FG000|COMPLETED|Cycle 2||15
2907233|NCT00458341|3616034|FG001|COMPLETED|Cycle 2||15
2907234|NCT00458341|3616033|FG000|NOT COMPLETED|Cycle 2||0
2907235|NCT00458341|3616034|FG001|NOT COMPLETED|Cycle 2||0
2907236|NCT00458393|3616042|FG000|STARTED|Overall Study||1251
2907237|NCT00458393|3616043|FG001|STARTED|Overall Study||1248
2907238|NCT00458393|3616042|FG000|COMPLETED|Overall Study||942
2907239|NCT00458393|3616043|FG001|COMPLETED|Overall Study||953
2907240|NCT00458393|3616042|FG000|NOT COMPLETED|Overall Study||309
2907241|NCT00458393|3616043|FG001|NOT COMPLETED|Overall Study||295
2907242|NCT00458406|3616053|FG000|STARTED|Month 1||43
2907243|NCT00458406|3616054|FG001|STARTED|Month 1||13
2907244|NCT00458406|3616053|FG000|COMPLETED|Month 1||43
2907245|NCT00458406|3616054|FG001|COMPLETED|Month 1||13
2907246|NCT00458406|3616053|FG000|NOT COMPLETED|Month 1||0
2907247|NCT00458406|3616054|FG001|NOT COMPLETED|Month 1||0
2907248|NCT00458406|3616053|FG000|STARTED|Month 3||43
2907249|NCT00458406|3616054|FG001|STARTED|Month 3||13
2907250|NCT00458406|3616053|FG000|COMPLETED|Month 3||43
2907251|NCT00458406|3616054|FG001|COMPLETED|Month 3||13
2907252|NCT00458406|3616053|FG000|NOT COMPLETED|Month 3||0
2907253|NCT00458406|3616054|FG001|NOT COMPLETED|Month 3||0
2907254|NCT00458484|3616074|FG000|STARTED|Overall Study||4
2907255|NCT00458484|3616075|FG001|STARTED|Overall Study||6
2907256|NCT00458484|3616076|FG002|STARTED|Overall Study||3
2907257|NCT00458484|3616077|FG003|STARTED|Overall Study||6
2907258|NCT00458484|3616078|FG004|STARTED|Overall Study||4
2907259|NCT00458484|3616079|FG005|STARTED|Overall Study||5
2907260|NCT00458484|3616080|FG006|STARTED|Overall Study||3
2907261|NCT00458484|3616074|FG000|COMPLETED|Overall Study||4
2907262|NCT00458484|3616075|FG001|COMPLETED|Overall Study||6
2907263|NCT00458484|3616076|FG002|COMPLETED|Overall Study||3
2907264|NCT00458484|3616077|FG003|COMPLETED|Overall Study||6
2907265|NCT00458484|3616078|FG004|COMPLETED|Overall Study||4
2907266|NCT00458484|3616079|FG005|COMPLETED|Overall Study||4
2907267|NCT00458484|3616080|FG006|COMPLETED|Overall Study||3
2907268|NCT00458484|3616074|FG000|NOT COMPLETED|Overall Study||0
2907269|NCT00458484|3616075|FG001|NOT COMPLETED|Overall Study||0
2907270|NCT00458484|3616076|FG002|NOT COMPLETED|Overall Study||0
2907271|NCT00458484|3616077|FG003|NOT COMPLETED|Overall Study||0
2907272|NCT00458484|3616078|FG004|NOT COMPLETED|Overall Study||0
2907273|NCT00458484|3616079|FG005|NOT COMPLETED|Overall Study||1
2907274|NCT00458484|3616080|FG006|NOT COMPLETED|Overall Study||0
2907275|NCT00458705|3616105|FG000|STARTED|Overall Study||45
2907276|NCT00458705|3616105|FG000|COMPLETED|Overall Study||40
2907277|NCT00458705|3616105|FG000|NOT COMPLETED|Overall Study||5
2907278|NCT00458783|3616111|FG000|STARTED|Overall Study||1914
2907279|NCT00458783|3616112|FG001|STARTED|Overall Study||1921
2907280|NCT00458783|3616111|FG000|COMPLETED|Overall Study||686
2907281|NCT00458783|3616112|FG001|COMPLETED|Overall Study||701
2907282|NCT00458783|3616111|FG000|NOT COMPLETED|Overall Study||1228
2907283|NCT00458783|3616112|FG001|NOT COMPLETED|Overall Study||1220
2907284|NCT00458822|3616118|FG000|STARTED|Overall Study||40
2907285|NCT00458822|3616118|FG000|COMPLETED|Overall Study||40
2907286|NCT00458822|3616118|FG000|NOT COMPLETED|Overall Study||0
2907287|NCT00458848|3616122|FG000|STARTED|Overall Study||51
2907288|NCT00458848|3616122|FG000|COMPLETED|Overall Study||51
2907289|NCT00458848|3616122|FG000|NOT COMPLETED|Overall Study||0
2907290|NCT00458952|3616128|FG000|STARTED|Overall Study||7
2907291|NCT00458952|3616129|FG001|STARTED|Overall Study||14
2907292|NCT00458952|3616128|FG000|COMPLETED|Overall Study||5
2907293|NCT00458952|3616129|FG001|COMPLETED|Overall Study||9
2907294|NCT00458952|3616128|FG000|NOT COMPLETED|Overall Study||2
2907295|NCT00458952|3616129|FG001|NOT COMPLETED|Overall Study||5
2907296|NCT00459043|3616135|FG000|STARTED|Overall Study||15
2907297|NCT00459043|3616136|FG001|STARTED|Overall Study||15
2907298|NCT00459043|3616135|FG000|COMPLETED|Overall Study||14
2907299|NCT00459043|3616136|FG001|COMPLETED|Overall Study||15
2907300|NCT00459043|3616135|FG000|NOT COMPLETED|Overall Study||1
2907301|NCT00459043|3616136|FG001|NOT COMPLETED|Overall Study||0
2907302|NCT00459056|3616144|FG000|STARTED|First Intervention (First Three Months)||10
2907303|NCT00459056|3616145|FG001|STARTED|First Intervention (First Three Months)||15
2907304|NCT00459056|3616144|FG000|COMPLETED|First Intervention (First Three Months)||9
2907305|NCT00459056|3616145|FG001|COMPLETED|First Intervention (First Three Months)||14
2907306|NCT00459056|3616144|FG000|NOT COMPLETED|First Intervention (First Three Months)||1
2907307|NCT00459056|3616145|FG001|NOT COMPLETED|First Intervention (First Three Months)||1
2907308|NCT00459056|3616144|FG000|STARTED|Washout (1 Month)||9
2907309|NCT00459056|3616145|FG001|STARTED|Washout (1 Month)||14
2907310|NCT00459056|3616144|FG000|COMPLETED|Washout (1 Month)||9
2907311|NCT00459056|3616145|FG001|COMPLETED|Washout (1 Month)||14
2907312|NCT00459056|3616144|FG000|NOT COMPLETED|Washout (1 Month)||0
2907313|NCT00459056|3616145|FG001|NOT COMPLETED|Washout (1 Month)||0
2907314|NCT00459056|3616144|FG000|STARTED|Second Intervention (Final Three Months)||9
2907315|NCT00459056|3616145|FG001|STARTED|Second Intervention (Final Three Months)||14
2907316|NCT00459056|3616144|FG000|COMPLETED|Second Intervention (Final Three Months)||9
2907317|NCT00459056|3616145|FG001|COMPLETED|Second Intervention (Final Three Months)||14
2907318|NCT00459056|3616144|FG000|NOT COMPLETED|Second Intervention (Final Three Months)||0
2907319|NCT00459056|3616145|FG001|NOT COMPLETED|Second Intervention (Final Three Months)||0
2907320|NCT00459108|3616151|FG000|STARTED|Overall Study||25
2907321|NCT00459108|3616151|FG000|COMPLETED|Overall Study||14
2907322|NCT00459108|3616151|FG000|NOT COMPLETED|Overall Study||11
2907323|NCT00459134|3616158|FG000|STARTED|Overall Study||94
2907324|NCT00459134|3616159|FG001|STARTED|Overall Study||92
2907325|NCT00459134|3616158|FG000|COMPLETED|Overall Study||71
2907326|NCT00459134|3616159|FG001|COMPLETED|Overall Study||67
2907327|NCT00459134|3616158|FG000|NOT COMPLETED|Overall Study||23
2907328|NCT00459134|3616159|FG001|NOT COMPLETED|Overall Study||25
2907329|NCT00459186|3616165|FG000|STARTED|Single Agent RAD001||19
2907330|NCT00459186|3616165|FG000|COMPLETED|Single Agent RAD001||18
2907331|NCT00459186|3616165|FG000|NOT COMPLETED|Single Agent RAD001||1
2907332|NCT00459186|3616165|FG000|STARTED|PET Imaging and Assessment||18
2907333|NCT00459186|3616165|FG000|COMPLETED|PET Imaging and Assessment||15
2907334|NCT00459186|3616165|FG000|NOT COMPLETED|PET Imaging and Assessment||3
2907335|NCT00459186|3616165|FG000|STARTED|Combination RAD001 + Docetaxel||15
2907336|NCT00459186|3616165|FG000|COMPLETED|Combination RAD001 + Docetaxel||15
2907337|NCT00459186|3616165|FG000|NOT COMPLETED|Combination RAD001 + Docetaxel||0
2907338|NCT00459290|3616169|FG000|STARTED|Overall Study||24
2907339|NCT00459290|3616169|FG000|COMPLETED|Overall Study|Patients treated until disease progression; completed defined as off treatment due to progression.|19
2907340|NCT00459290|3616169|FG000|NOT COMPLETED|Overall Study||5
2907341|NCT00459303|3616180|FG000|STARTED|Overall Study||20
2907342|NCT00459303|3616180|FG000|COMPLETED|Overall Study||20
2907343|NCT00459303|3616180|FG000|NOT COMPLETED|Overall Study||0
2907344|NCT00459316|3616192|FG000|STARTED|Steps 1 & 2||280
2907345|NCT00459316|3616193|FG001|STARTED|Steps 1 & 2||39
2907346|NCT00459316|3616194|FG002|STARTED|Steps 1 & 2||59
2907347|NCT00459316|3616192|FG000|COMPLETED|Steps 1 & 2||259
2907348|NCT00459316|3616193|FG001|COMPLETED|Steps 1 & 2||32
2907349|NCT00459316|3616194|FG002|COMPLETED|Steps 1 & 2||57
2907350|NCT00459316|3616192|FG000|NOT COMPLETED|Steps 1 & 2||21
2907351|NCT00459316|3616193|FG001|NOT COMPLETED|Steps 1 & 2||7
2907352|NCT00459316|3616194|FG002|NOT COMPLETED|Steps 1 & 2||2
2907353|NCT00459316|3616192|FG000|STARTED|Step 3|Not all participants from Steps 1/2 were eligible for Step 3|152
2907354|NCT00459316|3616193|FG001|STARTED|Step 3|Group 2 participants were not eligible for Step 3|0
2907355|NCT00459316|3616194|FG002|STARTED|Step 3|Not all participants from Steps 1/2 were eligible for Step 3|40
2907356|NCT00459316|3616192|FG000|COMPLETED|Step 3||149
2907357|NCT00459316|3616193|FG001|COMPLETED|Step 3||0
2907358|NCT00459316|3616194|FG002|COMPLETED|Step 3||39
2907359|NCT00459316|3616192|FG000|NOT COMPLETED|Step 3||3
2907360|NCT00459316|3616193|FG001|NOT COMPLETED|Step 3||0
2907361|NCT00459316|3616194|FG002|NOT COMPLETED|Step 3||1
2907362|NCT00459342|3616217|FG000|STARTED|Overall Study||35
2907363|NCT00459342|3616217|FG000|COMPLETED|Overall Study||34
2907364|NCT00459342|3616217|FG000|NOT COMPLETED|Overall Study||1
2907365|NCT00459355|3616223|FG000|STARTED|Overall Study|Includes 70 dyads, caregiver/care-recipient|140
2907366|NCT00459355|3616224|FG001|STARTED|Overall Study|Includes 57 dyads, caregiver + care-recipient|114
2907367|NCT00459355|3616223|FG000|COMPLETED|Overall Study|Includes 60 dyads, caregiver + care-recipient|120
2907368|NCT00459355|3616224|FG001|COMPLETED|Overall Study|Includes 48 dyads, caregiver + care-recipient|96
2907369|NCT00459355|3616223|FG000|NOT COMPLETED|Overall Study||20
2907370|NCT00459355|3616224|FG001|NOT COMPLETED|Overall Study||18
2907371|NCT00459368|3616236|FG000|STARTED|Overall Study||1335
2907372|NCT00459368|3616237|FG001|STARTED|Overall Study||1363
2907373|NCT00459368|3616236|FG000|COMPLETED|Overall Study||1040
2907374|NCT00459368|3616237|FG001|COMPLETED|Overall Study||1034
2907375|NCT00459368|3616236|FG000|NOT COMPLETED|Overall Study||295
2907376|NCT00459368|3616237|FG001|NOT COMPLETED|Overall Study||329
2907377|NCT00459381|3616243|FG000|STARTED|Overall Study||35
2907378|NCT00459381|3616243|FG000|COMPLETED|Overall Study||35
2907379|NCT00459381|3616243|FG000|NOT COMPLETED|Overall Study||0
2907380|NCT00459537|3616249|FG000|STARTED|Overall Study||507
2907381|NCT00459537|3616250|FG001|STARTED|Overall Study||522
2907382|NCT00459537|3616249|FG000|Safety Population|Overall Study|Participants who had at least one dose of study drug and one post-baseline safety assessment.|493
2907383|NCT00459537|3616250|FG001|Safety Population|Overall Study||512
2907384|NCT00459537|3616249|FG000|COMPLETED|Overall Study||441
2907385|NCT00459537|3616250|FG001|COMPLETED|Overall Study||446
2907386|NCT00459537|3616249|FG000|NOT COMPLETED|Overall Study||66
2907387|NCT00459537|3616250|FG001|NOT COMPLETED|Overall Study||76
2907388|NCT00459667|3616259|FG000|STARTED|Overall Study||592
2907389|NCT00459667|3616260|FG001|STARTED|Overall Study||647
2907390|NCT00459667|3616261|FG002|STARTED|Overall Study||181
2907391|NCT00459667|3616259|FG000|Study Medication Dispensed|Overall Study||586
2907392|NCT00459667|3616260|FG001|Study Medication Dispensed|Overall Study||645
2907393|NCT00459667|3616261|FG002|Study Medication Dispensed|Overall Study||180
2907394|NCT00459667|3616259|FG000|Started Treatment|Overall Study||586
2907395|NCT00459667|3616260|FG001|Started Treatment|Overall Study||644
2907396|NCT00459667|3616261|FG002|Started Treatment|Overall Study||180
2907397|NCT00459667|3616259|FG000|COMPLETED|Overall Study||554
2907398|NCT00459667|3616260|FG001|COMPLETED|Overall Study||600
2907399|NCT00459667|3616261|FG002|COMPLETED|Overall Study||161
2907400|NCT00459667|3616259|FG000|NOT COMPLETED|Overall Study||38
2907401|NCT00459667|3616260|FG001|NOT COMPLETED|Overall Study||47
2907402|NCT00459667|3616261|FG002|NOT COMPLETED|Overall Study||20
2907403|NCT00459706|3616271|FG000|STARTED|Overall Study||325
2907404|NCT00459706|3616272|FG001|STARTED|Overall Study||315
2907405|NCT00459706|3616271|FG000|MODIFIED INTENT-TO-TREAT POPULATION|Overall Study|1 participant had no evaluation after the first injection|324
2907406|NCT00459706|3616272|FG001|MODIFIED INTENT-TO-TREAT POPULATION|Overall Study|2 participants withdrew consent before the first injection|313
2907407|NCT00459706|3616271|FG000|COMPLETED|Overall Study||299
2907408|NCT00459706|3616272|FG001|COMPLETED|Overall Study||294
2907409|NCT00459706|3616271|FG000|NOT COMPLETED|Overall Study||26
2907410|NCT00459706|3616272|FG001|NOT COMPLETED|Overall Study||21
2907411|NCT00459732|3616280|FG000|STARTED|Overall Study||23
2907412|NCT00459732|3616281|FG001|STARTED|Overall Study||17
2907413|NCT00459732|3616280|FG000|COMPLETED|Overall Study|4 on zn dropped: 1 pregnant and 1 nausea after baseline, 1 lost to followup, 1 exited after 12 month|19
2907414|NCT00459732|3616281|FG001|COMPLETED|Overall Study|3 on placebo dropped: 1 pregnant after 12 mo, 1 lost to followup, one died after 12 month timepoint|14
2907415|NCT00459732|3616280|FG000|NOT COMPLETED|Overall Study||4
2907416|NCT00459732|3616281|FG001|NOT COMPLETED|Overall Study||3
2907417|NCT00459810|3616287|FG000|STARTED|Overall Study||21
2907418|NCT00459810|3616287|FG000|COMPLETED|Overall Study||21
2907419|NCT00459810|3616287|FG000|NOT COMPLETED|Overall Study||0
2907420|NCT00459862|3616291|FG000|STARTED|Overall Study||34
2907421|NCT00459862|3616291|FG000|COMPLETED|Overall Study||34
2907422|NCT00459862|3616291|FG000|NOT COMPLETED|Overall Study||0
2907423|NCT00459875|3616295|FG000|STARTED|Overall Study||24
2907424|NCT00459875|3616295|FG000|COMPLETED|Overall Study||21
2907425|NCT00459875|3616295|FG000|NOT COMPLETED|Overall Study||3
2907426|NCT00459953|3616301|FG000|STARTED|Overall Study||72
2907427|NCT00459953|3616302|FG001|STARTED|Overall Study||71
2907428|NCT00459953|3616301|FG000|COMPLETED|Overall Study||71
2907429|NCT00459953|3616302|FG001|COMPLETED|Overall Study||70
2907430|NCT00459953|3616301|FG000|NOT COMPLETED|Overall Study||1
2907431|NCT00459953|3616302|FG001|NOT COMPLETED|Overall Study||1
2907432|NCT00459979|3616308|FG000|STARTED|Overall Study||30
2907433|NCT00459979|3616308|FG000|COMPLETED|Overall Study||28
3171433|NCT01933789|3898539|FG007|COMPLETED|Overall Study||47
3171434|NCT01933789|3898540|FG008|COMPLETED|Overall Study||25
3171435|NCT01933789|3898532|FG000|NOT COMPLETED|Overall Study||6
2907434|NCT00459979|3616308|FG000|NOT COMPLETED|Overall Study||2
2907435|NCT00460031|3616312|FG000|STARTED|Overall Study||34
2907436|NCT00460031|3616312|FG000|COMPLETED|Overall Study||23
2907437|NCT00460031|3616312|FG000|NOT COMPLETED|Overall Study||11
2907438|NCT00460109|3616316|FG000|STARTED|Overall Study||24
2907439|NCT00460109|3616316|FG000|COMPLETED|Overall Study||23
2907440|NCT00460109|3616316|FG000|NOT COMPLETED|Overall Study||1
2907441|NCT00460239|3616320|FG000|STARTED|Overall Study||0
2907442|NCT00460239|3616321|FG001|STARTED|Overall Study||3
2907443|NCT00460239|3616322|FG002|STARTED|Overall Study||1
2907444|NCT00460239|3616323|FG003|STARTED|Overall Study||0
2907445|NCT00460239|3616324|FG004|STARTED|Overall Study||1
2907446|NCT00460239|3616325|FG005|STARTED|Overall Study||4
2907447|NCT00460239|3616326|FG006|STARTED|Overall Study||1
2907448|NCT00460239|3616327|FG007|STARTED|Overall Study||1
2907449|NCT00460239|3616328|FG008|STARTED|Overall Study||1
2907450|NCT00460239|3616320|FG000|COMPLETED|Overall Study||0
2907451|NCT00460239|3616321|FG001|COMPLETED|Overall Study||2
2907452|NCT00460239|3616322|FG002|COMPLETED|Overall Study||1
2907453|NCT00460239|3616323|FG003|COMPLETED|Overall Study||0
2907454|NCT00460239|3616324|FG004|COMPLETED|Overall Study||1
2907455|NCT00460239|3616325|FG005|COMPLETED|Overall Study||1
2907456|NCT00460239|3616326|FG006|COMPLETED|Overall Study||1
2907457|NCT00460239|3616327|FG007|COMPLETED|Overall Study||1
2907458|NCT00460239|3616328|FG008|COMPLETED|Overall Study||1
2907459|NCT00460239|3616320|FG000|NOT COMPLETED|Overall Study||0
2907460|NCT00460239|3616321|FG001|NOT COMPLETED|Overall Study||1
2907461|NCT00460239|3616322|FG002|NOT COMPLETED|Overall Study||0
2907462|NCT00460239|3616323|FG003|NOT COMPLETED|Overall Study||0
3171436|NCT01933789|3898533|FG001|NOT COMPLETED|Overall Study||1
3171437|NCT01933789|3898534|FG002|NOT COMPLETED|Overall Study||0
3171438|NCT01933789|3898535|FG003|NOT COMPLETED|Overall Study||1
3171439|NCT01933789|3898536|FG004|NOT COMPLETED|Overall Study||59
3171440|NCT01933789|3898537|FG005|NOT COMPLETED|Overall Study||67
2907463|NCT00460239|3616324|FG004|NOT COMPLETED|Overall Study||0
2907464|NCT00460239|3616325|FG005|NOT COMPLETED|Overall Study||3
2907465|NCT00460239|3616326|FG006|NOT COMPLETED|Overall Study||0
2907466|NCT00460239|3616327|FG007|NOT COMPLETED|Overall Study||0
2907467|NCT00460239|3616328|FG008|NOT COMPLETED|Overall Study||0
2907468|NCT00460265|3616343|FG000|STARTED|Overall Study||328
2907469|NCT00460265|3616344|FG001|STARTED|Overall Study||330
2907470|NCT00460265|3616343|FG000|Randomized While Alive|Overall Study|1 subject was randomized by error after death|327
2907471|NCT00460265|3616344|FG001|Randomized While Alive|Overall Study||330
2907472|NCT00460265|3616343|FG000|Received Study Medication|Overall Study||325
2907473|NCT00460265|3616344|FG001|Received Study Medication|Overall Study||325
2907474|NCT00460265|3616343|FG000|COMPLETED|Overall Study|Completed study=death|243
2907475|NCT00460265|3616344|FG001|COMPLETED|Overall Study|Completed study=death|241
2907476|NCT00460265|3616343|FG000|NOT COMPLETED|Overall Study||85
2907477|NCT00460265|3616344|FG001|NOT COMPLETED|Overall Study||89
2907478|NCT00460408|3616354|FG000|STARTED|Overall Study||403
2907479|NCT00460408|3616355|FG001|STARTED|Overall Study||16
2907480|NCT00460408|3616356|FG002|STARTED|Overall Study||75
2907481|NCT00460408|3616357|FG003|STARTED|Overall Study||7
2907482|NCT00460408|3616354|FG000|COMPLETED|Overall Study||336
2907483|NCT00460408|3616355|FG001|COMPLETED|Overall Study||13
2907484|NCT00460408|3616356|FG002|COMPLETED|Overall Study||69
2907485|NCT00460408|3616357|FG003|COMPLETED|Overall Study||7
2907486|NCT00460408|3616354|FG000|NOT COMPLETED|Overall Study||67
2907487|NCT00460408|3616355|FG001|NOT COMPLETED|Overall Study||3
2907488|NCT00460408|3616356|FG002|NOT COMPLETED|Overall Study||6
2907489|NCT00460408|3616357|FG003|NOT COMPLETED|Overall Study||0
2907490|NCT00460421|3616370|FG000|STARTED|Overall Study||9
2907491|NCT00460421|3616371|FG001|STARTED|Overall Study||9
2907492|NCT00460421|3616372|FG002|STARTED|Overall Study||9
2907493|NCT00460421|3616370|FG000|COMPLETED|Overall Study||9
2907494|NCT00460421|3616371|FG001|COMPLETED|Overall Study||9
2907495|NCT00460421|3616372|FG002|COMPLETED|Overall Study||9
2907496|NCT00460421|3616370|FG000|NOT COMPLETED|Overall Study||0
2907497|NCT00460421|3616371|FG001|NOT COMPLETED|Overall Study||0
2907498|NCT00460421|3616372|FG002|NOT COMPLETED|Overall Study||0
2907499|NCT00460434|3616381|FG000|STARTED|Overall Study||165
2907500|NCT00460434|3616382|FG001|STARTED|Overall Study||172
2907501|NCT00460434|3616381|FG000|3 Months|Overall Study||163
2907502|NCT00460434|3616382|FG001|3 Months|Overall Study||171
2907503|NCT00460434|3616381|FG000|12 Months|Overall Study||162
2907504|NCT00460434|3616382|FG001|12 Months|Overall Study||165
2907505|NCT00460434|3616381|FG000|COMPLETED|Overall Study||162
2907506|NCT00460434|3616382|FG001|COMPLETED|Overall Study||165
2907507|NCT00460434|3616381|FG000|NOT COMPLETED|Overall Study||3
2907508|NCT00460434|3616382|FG001|NOT COMPLETED|Overall Study||7
2907509|NCT00460525|3616390|FG000|STARTED|Overall Study||201
2907510|NCT00460525|3616391|FG001|STARTED|Overall Study||199
2907511|NCT00460525|3616390|FG000|COMPLETED|Overall Study||190
2907512|NCT00460525|3616391|FG001|COMPLETED|Overall Study||194
2907513|NCT00460525|3616390|FG000|NOT COMPLETED|Overall Study||11
2907514|NCT00460525|3616391|FG001|NOT COMPLETED|Overall Study||5
2907515|NCT00460551|3616397|FG000|STARTED|Overall Study||13
2907516|NCT00460551|3616397|FG000|COMPLETED|Overall Study|The trial was terminated after Period 1A. Only safety was measured.|13
2907517|NCT00460551|3616397|FG000|NOT COMPLETED|Overall Study||0
2907518|NCT00460564|3616405|FG000|STARTED|Double-Blind Phase (12 Weeks)||51
2907519|NCT00460564|3616406|FG001|STARTED|Double-Blind Phase (12 Weeks)||26
2907520|NCT00460564|3616407|FG002|STARTED|Double-Blind Phase (12 Weeks)||21
2907521|NCT00460564|3616408|FG003|STARTED|Double-Blind Phase (12 Weeks)||11
2907522|NCT00460564|3616409|FG004|STARTED|Double-Blind Phase (12 Weeks)||0
2907523|NCT00460564|3616410|FG005|STARTED|Double-Blind Phase (12 Weeks)||0
2907524|NCT00460564|3616411|FG006|STARTED|Double-Blind Phase (12 Weeks)||0
2907525|NCT00460564|3616412|FG007|STARTED|Double-Blind Phase (12 Weeks)||0
2907526|NCT00460564|3616405|FG000|COMPLETED|Double-Blind Phase (12 Weeks)||47
2907527|NCT00460564|3616406|FG001|COMPLETED|Double-Blind Phase (12 Weeks)||25
2907528|NCT00460564|3616407|FG002|COMPLETED|Double-Blind Phase (12 Weeks)||21
2907529|NCT00460564|3616408|FG003|COMPLETED|Double-Blind Phase (12 Weeks)||11
2907530|NCT00460564|3616409|FG004|COMPLETED|Double-Blind Phase (12 Weeks)||0
2907531|NCT00460564|3616410|FG005|COMPLETED|Double-Blind Phase (12 Weeks)||0
2907532|NCT00460564|3616411|FG006|COMPLETED|Double-Blind Phase (12 Weeks)||0
2907533|NCT00460564|3616412|FG007|COMPLETED|Double-Blind Phase (12 Weeks)||0
2907534|NCT00460564|3616405|FG000|NOT COMPLETED|Double-Blind Phase (12 Weeks)||4
2907535|NCT00460564|3616406|FG001|NOT COMPLETED|Double-Blind Phase (12 Weeks)||1
2907536|NCT00460564|3616407|FG002|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
2907537|NCT00460564|3616408|FG003|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
2907538|NCT00460564|3616409|FG004|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
2907539|NCT00460564|3616410|FG005|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
2907540|NCT00460564|3616411|FG006|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
2907541|NCT00460564|3616412|FG007|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
2907542|NCT00460564|3616405|FG000|STARTED|Open-Label Phase (36 Weeks)||0
2907543|NCT00460564|3616406|FG001|STARTED|Open-Label Phase (36 Weeks)||0
2907544|NCT00460564|3616407|FG002|STARTED|Open-Label Phase (36 Weeks)||0
2907545|NCT00460564|3616408|FG003|STARTED|Open-Label Phase (36 Weeks)||0
2907546|NCT00460564|3616409|FG004|STARTED|Open-Label Phase (36 Weeks)||47
2907547|NCT00460564|3616410|FG005|STARTED|Open-Label Phase (36 Weeks)||25
2907548|NCT00460564|3616411|FG006|STARTED|Open-Label Phase (36 Weeks)||21
2907549|NCT00460564|3616412|FG007|STARTED|Open-Label Phase (36 Weeks)||11
2907550|NCT00460564|3616405|FG000|COMPLETED|Open-Label Phase (36 Weeks)||0
2907551|NCT00460564|3616406|FG001|COMPLETED|Open-Label Phase (36 Weeks)||0
2907552|NCT00460564|3616407|FG002|COMPLETED|Open-Label Phase (36 Weeks)||0
2907553|NCT00460564|3616408|FG003|COMPLETED|Open-Label Phase (36 Weeks)||0
2907554|NCT00460564|3616409|FG004|COMPLETED|Open-Label Phase (36 Weeks)||38
2907555|NCT00460564|3616410|FG005|COMPLETED|Open-Label Phase (36 Weeks)||19
2907556|NCT00460564|3616411|FG006|COMPLETED|Open-Label Phase (36 Weeks)||19
2907557|NCT00460564|3616412|FG007|COMPLETED|Open-Label Phase (36 Weeks)||11
2907558|NCT00460564|3616405|FG000|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
2907559|NCT00460564|3616406|FG001|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
2907560|NCT00460564|3616407|FG002|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
2907561|NCT00460564|3616408|FG003|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
2907562|NCT00460564|3616409|FG004|NOT COMPLETED|Open-Label Phase (36 Weeks)||9
2907563|NCT00460564|3616410|FG005|NOT COMPLETED|Open-Label Phase (36 Weeks)||6
2907564|NCT00460564|3616411|FG006|NOT COMPLETED|Open-Label Phase (36 Weeks)||2
2907565|NCT00460564|3616412|FG007|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
2907566|NCT00460577|3616434|FG000|STARTED|Overall Study|148 patients were screened; however, 22 did not consent and 66 did not meet inclusion/exclusion.|30
2907567|NCT00460577|3616435|FG001|STARTED|Overall Study||30
2907568|NCT00460577|3616434|FG000|COMPLETED|Overall Study||28
2907569|NCT00460577|3616435|FG001|COMPLETED|Overall Study||24
2907570|NCT00460577|3616434|FG000|NOT COMPLETED|Overall Study||2
2907571|NCT00460577|3616435|FG001|NOT COMPLETED|Overall Study||6
2907572|NCT00460603|3616453|FG000|STARTED|Phase 1||6
2907573|NCT00460603|3616454|FG001|STARTED|Phase 1||6
2907574|NCT00460603|3616455|FG002|STARTED|Phase 1||4
2907575|NCT00460603|3616456|FG003|STARTED|Phase 1||8
2907576|NCT00460603|3616457|FG004|STARTED|Phase 1||6
2907577|NCT00460603|3616458|FG005|STARTED|Phase 1||4
2907578|NCT00460603|3616459|FG006|STARTED|Phase 1||6
2907579|NCT00460603|3616460|FG007|STARTED|Phase 1||3
2907580|NCT00460603|3616461|FG008|STARTED|Phase 1||18
2907581|NCT00460603|3616462|FG009|STARTED|Phase 1||0
2907582|NCT00460603|3616463|FG010|STARTED|Phase 1||0
2907583|NCT00460603|3616464|FG011|STARTED|Phase 1||0
2907584|NCT00460603|3616453|FG000|COMPLETED|Phase 1||0
2907585|NCT00460603|3616454|FG001|COMPLETED|Phase 1||0
2907586|NCT00460603|3616455|FG002|COMPLETED|Phase 1||0
2907587|NCT00460603|3616456|FG003|COMPLETED|Phase 1||0
2907588|NCT00460603|3616457|FG004|COMPLETED|Phase 1||0
2907589|NCT00460603|3616458|FG005|COMPLETED|Phase 1||0
2907590|NCT00460603|3616459|FG006|COMPLETED|Phase 1||0
2907591|NCT00460603|3616460|FG007|COMPLETED|Phase 1||0
2907592|NCT00460603|3616461|FG008|COMPLETED|Phase 1||0
2907593|NCT00460603|3616462|FG009|COMPLETED|Phase 1||0
2907594|NCT00460603|3616463|FG010|COMPLETED|Phase 1||0
2907595|NCT00460603|3616464|FG011|COMPLETED|Phase 1||0
2907596|NCT00460603|3616453|FG000|NOT COMPLETED|Phase 1||6
2907597|NCT00460603|3616454|FG001|NOT COMPLETED|Phase 1||6
2907598|NCT00460603|3616455|FG002|NOT COMPLETED|Phase 1||4
2907599|NCT00460603|3616456|FG003|NOT COMPLETED|Phase 1||8
2907600|NCT00460603|3616457|FG004|NOT COMPLETED|Phase 1||6
2907601|NCT00460603|3616458|FG005|NOT COMPLETED|Phase 1||4
2907602|NCT00460603|3616459|FG006|NOT COMPLETED|Phase 1||6
2907603|NCT00460603|3616460|FG007|NOT COMPLETED|Phase 1||3
2907604|NCT00460603|3616461|FG008|NOT COMPLETED|Phase 1||18
2907605|NCT00460603|3616462|FG009|NOT COMPLETED|Phase 1||0
2907606|NCT00460603|3616463|FG010|NOT COMPLETED|Phase 1||0
2907607|NCT00460603|3616464|FG011|NOT COMPLETED|Phase 1||0
2907608|NCT00460603|3616453|FG000|STARTED|Phase 2||0
2907609|NCT00460603|3616454|FG001|STARTED|Phase 2||0
2907610|NCT00460603|3616455|FG002|STARTED|Phase 2||0
2907611|NCT00460603|3616456|FG003|STARTED|Phase 2||0
2907612|NCT00460603|3616457|FG004|STARTED|Phase 2||0
2907613|NCT00460603|3616458|FG005|STARTED|Phase 2||0
2907614|NCT00460603|3616459|FG006|STARTED|Phase 2||0
2907615|NCT00460603|3616460|FG007|STARTED|Phase 2||0
2907616|NCT00460603|3616461|FG008|STARTED|Phase 2||0
2907617|NCT00460603|3616462|FG009|STARTED|Phase 2||42
2907618|NCT00460603|3616463|FG010|STARTED|Phase 2||43
2907619|NCT00460603|3616464|FG011|STARTED|Phase 2||41
2907620|NCT00460603|3616453|FG000|Treated|Phase 2||0
2907621|NCT00460603|3616454|FG001|Treated|Phase 2||0
2907622|NCT00460603|3616455|FG002|Treated|Phase 2||0
2907623|NCT00460603|3616456|FG003|Treated|Phase 2||0
2907624|NCT00460603|3616457|FG004|Treated|Phase 2||0
2907625|NCT00460603|3616458|FG005|Treated|Phase 2||0
2907626|NCT00460603|3616459|FG006|Treated|Phase 2||0
2907627|NCT00460603|3616460|FG007|Treated|Phase 2||0
2907628|NCT00460603|3616461|FG008|Treated|Phase 2||0
2907629|NCT00460603|3616462|FG009|Treated|Phase 2||39
2907630|NCT00460603|3616463|FG010|Treated|Phase 2||43
2907631|NCT00460603|3616464|FG011|Treated|Phase 2||41
2907632|NCT00460603|3616453|FG000|COMPLETED|Phase 2||0
2907633|NCT00460603|3616454|FG001|COMPLETED|Phase 2||0
2907634|NCT00460603|3616455|FG002|COMPLETED|Phase 2||0
2907635|NCT00460603|3616456|FG003|COMPLETED|Phase 2||0
2907636|NCT00460603|3616457|FG004|COMPLETED|Phase 2||0
2907637|NCT00460603|3616458|FG005|COMPLETED|Phase 2||0
2907638|NCT00460603|3616459|FG006|COMPLETED|Phase 2||0
2907639|NCT00460603|3616460|FG007|COMPLETED|Phase 2||0
2907640|NCT00460603|3616461|FG008|COMPLETED|Phase 2||0
2907641|NCT00460603|3616462|FG009|COMPLETED|Phase 2||0
2907642|NCT00460603|3616463|FG010|COMPLETED|Phase 2||0
2907643|NCT00460603|3616464|FG011|COMPLETED|Phase 2||0
2907644|NCT00460603|3616453|FG000|NOT COMPLETED|Phase 2||0
2907645|NCT00460603|3616454|FG001|NOT COMPLETED|Phase 2||0
2907646|NCT00460603|3616455|FG002|NOT COMPLETED|Phase 2||0
2907647|NCT00460603|3616456|FG003|NOT COMPLETED|Phase 2||0
2907648|NCT00460603|3616457|FG004|NOT COMPLETED|Phase 2||0
2907649|NCT00460603|3616458|FG005|NOT COMPLETED|Phase 2||0
2907650|NCT00460603|3616459|FG006|NOT COMPLETED|Phase 2||0
2907651|NCT00460603|3616460|FG007|NOT COMPLETED|Phase 2||0
2907652|NCT00460603|3616461|FG008|NOT COMPLETED|Phase 2||0
2907653|NCT00460603|3616462|FG009|NOT COMPLETED|Phase 2||42
2907654|NCT00460603|3616463|FG010|NOT COMPLETED|Phase 2||43
2907655|NCT00460603|3616464|FG011|NOT COMPLETED|Phase 2||41
2907656|NCT00460655|3616492|FG000|STARTED|Double-Blind Phase (12 Weeks)||58
2907657|NCT00460655|3616493|FG001|STARTED|Double-Blind Phase (12 Weeks)||62
2907658|NCT00460655|3616494|FG002|STARTED|Double-Blind Phase (12 Weeks)||0
2907659|NCT00460655|3616495|FG003|STARTED|Double-Blind Phase (12 Weeks)||0
2907660|NCT00460655|3616492|FG000|COMPLETED|Double-Blind Phase (12 Weeks)||52
2907661|NCT00460655|3616493|FG001|COMPLETED|Double-Blind Phase (12 Weeks)||61
2907662|NCT00460655|3616494|FG002|COMPLETED|Double-Blind Phase (12 Weeks)||0
2907663|NCT00460655|3616495|FG003|COMPLETED|Double-Blind Phase (12 Weeks)||0
2907664|NCT00460655|3616492|FG000|NOT COMPLETED|Double-Blind Phase (12 Weeks)||6
2907665|NCT00460655|3616493|FG001|NOT COMPLETED|Double-Blind Phase (12 Weeks)||1
2907666|NCT00460655|3616494|FG002|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
2907667|NCT00460655|3616495|FG003|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
2907668|NCT00460655|3616492|FG000|STARTED|Open-Label Phase (36 Weeks)||0
2907669|NCT00460655|3616493|FG001|STARTED|Open-Label Phase (36 Weeks)||0
2907670|NCT00460655|3616494|FG002|STARTED|Open-Label Phase (36 Weeks)||52
2907671|NCT00460655|3616495|FG003|STARTED|Open-Label Phase (36 Weeks)||61
2907672|NCT00460655|3616492|FG000|COMPLETED|Open-Label Phase (36 Weeks)||0
2907673|NCT00460655|3616493|FG001|COMPLETED|Open-Label Phase (36 Weeks)||0
2907674|NCT00460655|3616494|FG002|COMPLETED|Open-Label Phase (36 Weeks)||45
2907675|NCT00460655|3616495|FG003|COMPLETED|Open-Label Phase (36 Weeks)||52
2907676|NCT00460655|3616492|FG000|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
2907677|NCT00460655|3616493|FG001|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
2907678|NCT00460655|3616494|FG002|NOT COMPLETED|Open-Label Phase (36 Weeks)||7
2907679|NCT00460655|3616495|FG003|NOT COMPLETED|Open-Label Phase (36 Weeks)||9
2907680|NCT00460746|3616505|FG000|STARTED|Overall Study||10
2907681|NCT00460746|3616505|FG000|COMPLETED|Overall Study||8
2907682|NCT00460746|3616505|FG000|NOT COMPLETED|Overall Study||2
2907683|NCT00460798|3616509|FG000|STARTED|Overall Study||448
2907684|NCT00460798|3616509|FG000|Treated|Overall Study|Subjects with complete dosing information were recorded as 'Treated'|421
2907685|NCT00460798|3616509|FG000|COMPLETED|Overall Study||108
2907686|NCT00460798|3616509|FG000|NOT COMPLETED|Overall Study||340
2907687|NCT00460811|3616518|FG000|STARTED|Overall Study||79
2907688|NCT00460811|3616519|FG001|STARTED|Overall Study||82
2907689|NCT00460811|3616520|FG002|STARTED|Overall Study||85
2907690|NCT00460811|3616521|FG003|STARTED|Overall Study||89
2907691|NCT00460811|3616522|FG004|STARTED|Overall Study||85
2907692|NCT00460811|3616518|FG000|COMPLETED|Overall Study||63
2907693|NCT00460811|3616519|FG001|COMPLETED|Overall Study||67
2907694|NCT00460811|3616520|FG002|COMPLETED|Overall Study||71
2907695|NCT00460811|3616521|FG003|COMPLETED|Overall Study||71
2907696|NCT00460811|3616522|FG004|COMPLETED|Overall Study||65
2907697|NCT00460811|3616518|FG000|NOT COMPLETED|Overall Study||16
2907698|NCT00460811|3616519|FG001|NOT COMPLETED|Overall Study||15
2907699|NCT00460811|3616520|FG002|NOT COMPLETED|Overall Study||14
2907700|NCT00460811|3616521|FG003|NOT COMPLETED|Overall Study||18
2907701|NCT00460811|3616522|FG004|NOT COMPLETED|Overall Study||20
2907702|NCT00460993|3616541|FG000|STARTED|Phase 1 (6 Days)||14
2907703|NCT00460993|3616542|FG001|STARTED|Phase 1 (6 Days)||17
2907704|NCT00460993|3616541|FG000|COMPLETED|Phase 1 (6 Days)||14
2907705|NCT00460993|3616542|FG001|COMPLETED|Phase 1 (6 Days)||17
2907706|NCT00460993|3616541|FG000|NOT COMPLETED|Phase 1 (6 Days)||0
2907707|NCT00460993|3616542|FG001|NOT COMPLETED|Phase 1 (6 Days)||0
2907708|NCT00460993|3616541|FG000|STARTED|Phase 2 (6 Days)||14
2907709|NCT00460993|3616542|FG001|STARTED|Phase 2 (6 Days)||17
2907710|NCT00460993|3616541|FG000|COMPLETED|Phase 2 (6 Days)||14
2907711|NCT00460993|3616542|FG001|COMPLETED|Phase 2 (6 Days)||17
2907712|NCT00460993|3616541|FG000|NOT COMPLETED|Phase 2 (6 Days)||0
2907713|NCT00460993|3616542|FG001|NOT COMPLETED|Phase 2 (6 Days)||0
2907714|NCT00461045|3616548|FG000|STARTED|Overall Study||15
2907715|NCT00461045|3616548|FG000|COMPLETED|Overall Study||15
2907716|NCT00461045|3616548|FG000|NOT COMPLETED|Overall Study||0
2907717|NCT00461097|3616554|FG000|STARTED|Overall Study||40
2907718|NCT00461097|3616555|FG001|STARTED|Overall Study||15
2907719|NCT00461097|3616554|FG000|Had Month 10 (Wk 44) Oral Food Challenge|Overall Study||35
2907720|NCT00461097|3616555|FG001|Had Month 10 (Wk 44) Oral Food Challenge|Overall Study||13
2907721|NCT00461097|3616554|FG000|Had Month 22 (Wk 96) Oral Food Challenge|Overall Study||34
2907722|NCT00461097|3616555|FG001|Had Month 22 (Wk 96) Oral Food Challenge|Overall Study||1
2907723|NCT00461097|3616554|FG000|Had Year 3 (Mnth 36) Oral Food Challenge|Overall Study||16
2907724|NCT00461097|3616555|FG001|Had Year 3 (Mnth 36) Oral Food Challenge|Overall Study||0
2907725|NCT00461097|3616554|FG000|Had Year 4 (Mnth 48) Oral Food Challenge|Overall Study||7
2907726|NCT00461097|3616555|FG001|Had Year 4 (Mnth 48) Oral Food Challenge|Overall Study||0
2907727|NCT00461097|3616554|FG000|COMPLETED|Overall Study|Completed: Participants who were assessed for the primary outcome measure and outcome measure #6.|40
2907728|NCT00461097|3616555|FG001|COMPLETED|Overall Study|Completed: Participants who were assessed for the primary outcome measure.|15
2907729|NCT00461097|3616554|FG000|NOT COMPLETED|Overall Study||0
2907730|NCT00461097|3616555|FG001|NOT COMPLETED|Overall Study||0
2907731|NCT00461123|3616564|FG000|STARTED|Overall Study||25
2907732|NCT00461123|3616565|FG001|STARTED|Overall Study||25
2907733|NCT00461123|3616564|FG000|COMPLETED|Overall Study||19
2907734|NCT00461123|3616565|FG001|COMPLETED|Overall Study||19
2907735|NCT00461123|3616564|FG000|NOT COMPLETED|Overall Study||6
2907736|NCT00461123|3616565|FG001|NOT COMPLETED|Overall Study||6
2907737|NCT00461175|3616573|FG000|STARTED|Overall Study|859 patients could not be assigned to a cohort and are therefore missing in the participant flow.|43600
2907738|NCT00461175|3616574|FG001|STARTED|Overall Study|859 patients could not be assigned to a cohort and are therefore missing in the participant flow.|18735
2907739|NCT00461175|3616573|FG000|COMPLETED|Overall Study||43078
2907740|NCT00461175|3616574|FG001|COMPLETED|Overall Study||18370
2907741|NCT00461175|3616573|FG000|NOT COMPLETED|Overall Study||522
2907742|NCT00461175|3616574|FG001|NOT COMPLETED|Overall Study||365
2907743|NCT00461253|3616582|FG000|STARTED|Overall Study|Identified cases|10093
2907744|NCT00461253|3616583|FG001|STARTED|Overall Study|Identified controls|40250
2907745|NCT00461253|3616582|FG000|COMPLETED|Overall Study|Analyzed cases|5113
2907746|NCT00461253|3616583|FG001|COMPLETED|Overall Study|Analyzed controls|20452
2907747|NCT00461253|3616582|FG000|NOT COMPLETED|Overall Study||4980
2907748|NCT00461253|3616583|FG001|NOT COMPLETED|Overall Study||19798
2907749|NCT00461292|3616592|FG000|STARTED|Treatment Cycle 1||91
2907750|NCT00461292|3616593|FG001|STARTED|Treatment Cycle 1||92
2907751|NCT00461292|3616594|FG002|STARTED|Treatment Cycle 1||92
2907752|NCT00461292|3616592|FG000|COMPLETED|Treatment Cycle 1||76
2907753|NCT00461292|3616593|FG001|COMPLETED|Treatment Cycle 1||80
2907754|NCT00461292|3616594|FG002|COMPLETED|Treatment Cycle 1||81
2907755|NCT00461292|3616592|FG000|NOT COMPLETED|Treatment Cycle 1||15
2907756|NCT00461292|3616593|FG001|NOT COMPLETED|Treatment Cycle 1||12
2907757|NCT00461292|3616594|FG002|NOT COMPLETED|Treatment Cycle 1||11
2907758|NCT00461292|3616592|FG000|STARTED|Treatment Cycle 2|32 from the 300U group + 31 from the Placebo group entered Cycle 2|63
2907759|NCT00461292|3616593|FG001|STARTED|Treatment Cycle 2|42 from the 200U group + 32 from the Placebo group entered Cycle 2|74
2907760|NCT00461292|3616594|FG002|STARTED|Treatment Cycle 2|Cycle 1 Placebo pts were randomized to receive 300U or 200 U in Cycle 2|0
2907761|NCT00461292|3616592|FG000|COMPLETED|Treatment Cycle 2||58
2907762|NCT00461292|3616593|FG001|COMPLETED|Treatment Cycle 2||72
2907763|NCT00461292|3616594|FG002|COMPLETED|Treatment Cycle 2||0
2907764|NCT00461292|3616592|FG000|NOT COMPLETED|Treatment Cycle 2||5
2907765|NCT00461292|3616593|FG001|NOT COMPLETED|Treatment Cycle 2||2
2907766|NCT00461292|3616594|FG002|NOT COMPLETED|Treatment Cycle 2||0
2907767|NCT00461305|3616604|FG000|STARTED|Treatment|Enrolled|355
2907768|NCT00461305|3616605|FG001|STARTED|Treatment|Enrolled|65
2907769|NCT00461305|3616604|FG000|Subjects Dispensed Drugs|Treatment||350
2907770|NCT00461305|3616605|FG001|Subjects Dispensed Drugs|Treatment||65
2907771|NCT00461305|3616604|FG000|Subjects Received Treatment|Treatment|FAS, safety population|349
2907772|NCT00461305|3616605|FG001|Subjects Received Treatment|Treatment|FAS, safety population|65
2907773|NCT00461305|3616604|FG000|COMPLETED|Treatment||254
2907774|NCT00461305|3616605|FG001|COMPLETED|Treatment||56
2907775|NCT00461305|3616604|FG000|NOT COMPLETED|Treatment||101
2907776|NCT00461305|3616605|FG001|NOT COMPLETED|Treatment||9
2920473|NCT00537238|3630996|FG000|Completed Titration Phase|Overall Study||226
2907777|NCT00461305|3616604|FG000|STARTED|Continued Treatment|FAS, participants from previous treatment who were available to continue treatment|349
2907778|NCT00461305|3616605|FG001|STARTED|Continued Treatment|no participants were treated with the DRSP 3 mg/EE 30 μg combination beyond 6 cycles|0
2907779|NCT00461305|3616604|FG000|COMPLETED|Continued Treatment||254
2907780|NCT00461305|3616605|FG001|COMPLETED|Continued Treatment||0
2907781|NCT00461305|3616604|FG000|NOT COMPLETED|Continued Treatment||95
2907782|NCT00461305|3616605|FG001|NOT COMPLETED|Continued Treatment||0
2907783|NCT00461331|3616612|FG000|STARTED|Intervention 1||10
2907784|NCT00461331|3616613|FG001|STARTED|Intervention 1||10
2907785|NCT00461331|3616612|FG000|COMPLETED|Intervention 1||10
2907786|NCT00461331|3616613|FG001|COMPLETED|Intervention 1||10
2907787|NCT00461331|3616612|FG000|NOT COMPLETED|Intervention 1||0
2907788|NCT00461331|3616613|FG001|NOT COMPLETED|Intervention 1||0
2907789|NCT00461331|3616612|FG000|STARTED|Washout||10
2907790|NCT00461331|3616613|FG001|STARTED|Washout||10
2907791|NCT00461331|3616612|FG000|COMPLETED|Washout||10
2907792|NCT00461331|3616613|FG001|COMPLETED|Washout||10
2907793|NCT00461331|3616612|FG000|NOT COMPLETED|Washout||0
2907794|NCT00461331|3616613|FG001|NOT COMPLETED|Washout||0
2907795|NCT00461331|3616612|FG000|STARTED|Intervention 2||10
2907796|NCT00461331|3616613|FG001|STARTED|Intervention 2||10
2907797|NCT00461331|3616612|FG000|COMPLETED|Intervention 2||10
2907798|NCT00461331|3616613|FG001|COMPLETED|Intervention 2||10
2907799|NCT00461331|3616612|FG000|NOT COMPLETED|Intervention 2||0
2907800|NCT00461331|3616613|FG001|NOT COMPLETED|Intervention 2||0
2907801|NCT00461500|3616622|FG000|STARTED|Overall Study||37
2907802|NCT00461500|3616623|FG001|STARTED|Overall Study||44
2907803|NCT00461500|3616622|FG000|COMPLETED|Overall Study||30
2907804|NCT00461500|3616623|FG001|COMPLETED|Overall Study||38
2907805|NCT00461500|3616622|FG000|NOT COMPLETED|Overall Study||7
2907806|NCT00461500|3616623|FG001|NOT COMPLETED|Overall Study||6
2907807|NCT00461513|3616631|FG000|STARTED|Overall Study|6 patients dropped at time of randomization|187
2907808|NCT00461513|3616632|FG001|STARTED|Overall Study|2 patients dropped at time of randomization|197
2907809|NCT00461513|3616631|FG000|COMPLETED|Overall Study||165
2907810|NCT00461513|3616632|FG001|COMPLETED|Overall Study||172
2907811|NCT00461513|3616631|FG000|NOT COMPLETED|Overall Study||22
2907812|NCT00461513|3616632|FG001|NOT COMPLETED|Overall Study||25
2907813|NCT00461552|3616644|FG000|STARTED|Overall Study||7
2907814|NCT00461552|3616645|FG001|STARTED|Overall Study||7
2907815|NCT00461552|3616644|FG000|COMPLETED|Overall Study||7
2907816|NCT00461552|3616645|FG001|COMPLETED|Overall Study||5
2907817|NCT00461552|3616644|FG000|NOT COMPLETED|Overall Study||0
2907818|NCT00461552|3616645|FG001|NOT COMPLETED|Overall Study||2
2907819|NCT00461591|3616653|FG000|STARTED|Overall Study||406
2907820|NCT00461591|3616654|FG001|STARTED|Overall Study||396
2907821|NCT00461591|3616653|FG000|COMPLETED|Overall Study||317
2907822|NCT00461591|3616654|FG001|COMPLETED|Overall Study||311
2907823|NCT00461591|3616653|FG000|NOT COMPLETED|Overall Study||89
2907824|NCT00461591|3616654|FG001|NOT COMPLETED|Overall Study||85
2907825|NCT00461630|3616662|FG000|STARTED|Overall Study||12838
2907826|NCT00461630|3616663|FG001|STARTED|Overall Study||12835
2907827|NCT00461630|3616662|FG000|COMPLETED|Overall Study||11932
2907828|NCT00461630|3616663|FG001|COMPLETED|Overall Study||12008
2907829|NCT00461630|3616662|FG000|NOT COMPLETED|Overall Study||906
2907830|NCT00461630|3616663|FG001|NOT COMPLETED|Overall Study||827
2907831|NCT00461708|3616671|FG000|STARTED|Overall Study||115
2907832|NCT00461708|3616672|FG001|STARTED|Overall Study||38
2907833|NCT00461708|3616671|FG000|COMPLETED|Overall Study||0
2907834|NCT00461708|3616672|FG001|COMPLETED|Overall Study||0
2907835|NCT00461708|3616671|FG000|NOT COMPLETED|Overall Study||115
2907836|NCT00461708|3616672|FG001|NOT COMPLETED|Overall Study||38
2907837|NCT00461734|3616683|FG000|STARTED|Overall Study||120
2907838|NCT00461734|3616684|FG001|STARTED|Overall Study||120
2907839|NCT00461734|3616683|FG000|COMPLETED|Overall Study||62
2907840|NCT00461734|3616684|FG001|COMPLETED|Overall Study||60
2907841|NCT00461734|3616683|FG000|NOT COMPLETED|Overall Study||58
2907842|NCT00461734|3616684|FG001|NOT COMPLETED|Overall Study||60
2907843|NCT00461773|3616697|FG000|STARTED|Overall Study||3
2907844|NCT00461773|3616698|FG001|STARTED|Overall Study||2
2907845|NCT00461773|3616697|FG000|COMPLETED|Overall Study||3
2907846|NCT00461773|3616698|FG001|COMPLETED|Overall Study||2
2907847|NCT00461773|3616697|FG000|NOT COMPLETED|Overall Study||0
2907848|NCT00461773|3616698|FG001|NOT COMPLETED|Overall Study||0
2907849|NCT00461786|3616704|FG000|STARTED|Overall Study||51
2907850|NCT00461786|3616704|FG000|COMPLETED|Overall Study|Completed means the patient was evaluable for response.|48
2907851|NCT00461786|3616704|FG000|NOT COMPLETED|Overall Study||3
2907852|NCT00461851|3616708|FG000|STARTED|Overall Study||17
2907853|NCT00461851|3616708|FG000|COMPLETED|Overall Study||17
2907854|NCT00461851|3616708|FG000|NOT COMPLETED|Overall Study||0
2907855|NCT00461981|3616714|FG000|STARTED|Overall Study||50
2907856|NCT00461981|3616715|FG001|STARTED|Overall Study||51
2907857|NCT00461981|3616714|FG000|COMPLETED|Overall Study||39
2907858|NCT00461981|3616715|FG001|COMPLETED|Overall Study||42
2907859|NCT00461981|3616714|FG000|NOT COMPLETED|Overall Study||11
2907860|NCT00461981|3616715|FG001|NOT COMPLETED|Overall Study||9
2907861|NCT00462020|3616723|FG000|STARTED|Overall Study||52
2907862|NCT00462020|3616724|FG001|STARTED|Overall Study||50
2907863|NCT00462020|3616723|FG000|COMPLETED|Overall Study||52
2907864|NCT00462020|3616724|FG001|COMPLETED|Overall Study||50
2907865|NCT00462020|3616723|FG000|NOT COMPLETED|Overall Study||0
2907866|NCT00462020|3616724|FG001|NOT COMPLETED|Overall Study||0
2907867|NCT00462072|3616733|FG000|STARTED|Baseline (Week 0)||10
2907868|NCT00462072|3616734|FG001|STARTED|Baseline (Week 0)||12
2907869|NCT00462072|3616735|FG002|STARTED|Baseline (Week 0)||9
2907870|NCT00462072|3616733|FG000|COMPLETED|Baseline (Week 0)||10
2907871|NCT00462072|3616734|FG001|COMPLETED|Baseline (Week 0)||12
2907872|NCT00462072|3616735|FG002|COMPLETED|Baseline (Week 0)||9
2907873|NCT00462072|3616733|FG000|NOT COMPLETED|Baseline (Week 0)||0
2907874|NCT00462072|3616734|FG001|NOT COMPLETED|Baseline (Week 0)||0
2907875|NCT00462072|3616735|FG002|NOT COMPLETED|Baseline (Week 0)||0
2907876|NCT00462072|3616733|FG000|STARTED|Week 10||10
2907877|NCT00462072|3616734|FG001|STARTED|Week 10||12
2907878|NCT00462072|3616735|FG002|STARTED|Week 10||9
2907879|NCT00462072|3616733|FG000|COMPLETED|Week 10||10
2907880|NCT00462072|3616734|FG001|COMPLETED|Week 10||12
2907881|NCT00462072|3616735|FG002|COMPLETED|Week 10||9
2907882|NCT00462072|3616733|FG000|NOT COMPLETED|Week 10||0
2907883|NCT00462072|3616734|FG001|NOT COMPLETED|Week 10||0
2907884|NCT00462072|3616735|FG002|NOT COMPLETED|Week 10||0
2907885|NCT00462124|3616747|FG000|STARTED|Overall Study||7
2907886|NCT00462124|3616747|FG000|COMPLETED|Overall Study|One implant was misplaced and was disacitivated by puncture.|6
2907887|NCT00462124|3616747|FG000|NOT COMPLETED|Overall Study||1
2907888|NCT00462228|3616752|FG000|STARTED|Memantine or Placebo 12 Weeks||11
2907889|NCT00462228|3616752|FG000|COMPLETED|Memantine or Placebo 12 Weeks||11
2907890|NCT00462228|3616752|FG000|NOT COMPLETED|Memantine or Placebo 12 Weeks||0
2907891|NCT00462228|3616752|FG000|STARTED|No Treatment (Washout) 4 Weeks||11
2907892|NCT00462228|3616752|FG000|COMPLETED|No Treatment (Washout) 4 Weeks||11
2907893|NCT00462228|3616752|FG000|NOT COMPLETED|No Treatment (Washout) 4 Weeks||0
2907894|NCT00462228|3616752|FG000|STARTED|Placebo or Memantine 12 Weeks||11
2907895|NCT00462228|3616752|FG000|COMPLETED|Placebo or Memantine 12 Weeks||11
2907896|NCT00462228|3616752|FG000|NOT COMPLETED|Placebo or Memantine 12 Weeks||0
2907897|NCT00462228|3616752|FG000|STARTED|No Treatment (Washout) 4 Weeks||11
2907898|NCT00462228|3616752|FG000|COMPLETED|No Treatment (Washout) 4 Weeks||11
2907899|NCT00462228|3616752|FG000|NOT COMPLETED|No Treatment (Washout) 4 Weeks||0
2907900|NCT00462280|3616763|FG000|STARTED|Overall Study||34
2907901|NCT00462280|3616764|FG001|STARTED|Overall Study||32
2907902|NCT00462280|3616765|FG002|STARTED|Overall Study||7
2907903|NCT00462280|3616766|FG003|STARTED|Overall Study||7
2907904|NCT00462280|3616763|FG000|COMPLETED|Overall Study||24
2907905|NCT00462280|3616764|FG001|COMPLETED|Overall Study||25
2907906|NCT00462280|3616765|FG002|COMPLETED|Overall Study||7
2907907|NCT00462280|3616766|FG003|COMPLETED|Overall Study||4
2907908|NCT00462280|3616763|FG000|NOT COMPLETED|Overall Study||10
2907909|NCT00462280|3616764|FG001|NOT COMPLETED|Overall Study||7
2907910|NCT00462280|3616765|FG002|NOT COMPLETED|Overall Study||0
2907911|NCT00462280|3616766|FG003|NOT COMPLETED|Overall Study||3
2907912|NCT00462306|3616780|FG000|STARTED|Overall Study||4074
2907913|NCT00462306|3616781|FG001|STARTED|Overall Study||503
2907914|NCT00462306|3616780|FG000|COMPLETED|Overall Study||4074
2907915|NCT00462306|3616781|FG001|COMPLETED|Overall Study||490
2907916|NCT00462306|3616780|FG000|NOT COMPLETED|Overall Study||0
2907917|NCT00462306|3616781|FG001|NOT COMPLETED|Overall Study||13
2907918|NCT00462332|3616791|FG000|STARTED|Overall Study||45
2907919|NCT00462332|3616792|FG001|STARTED|Overall Study||41
2907920|NCT00462332|3616791|FG000|COMPLETED|Overall Study||45
2907921|NCT00462332|3616792|FG001|COMPLETED|Overall Study||41
2907922|NCT00462332|3616791|FG000|NOT COMPLETED|Overall Study||0
2907923|NCT00462332|3616792|FG001|NOT COMPLETED|Overall Study||0
2907924|NCT00462345|3616800|FG000|STARTED|Overall Study||40
2907925|NCT00462345|3616800|FG000|Completed First Course|Overall Study||38
2907926|NCT00462345|3616800|FG000|COMPLETED|Overall Study||37
2907927|NCT00462345|3616800|FG000|NOT COMPLETED|Overall Study||3
2907928|NCT00462384|3616804|FG000|STARTED|Overall Study||39
2907929|NCT00462384|3616804|FG000|COMPLETED|Overall Study||30
2907930|NCT00462384|3616804|FG000|NOT COMPLETED|Overall Study||9
2907931|NCT00462423|3616808|FG000|STARTED|Overall Study||50
2907932|NCT00462423|3616808|FG000|COMPLETED|Overall Study||50
2907933|NCT00462423|3616808|FG000|NOT COMPLETED|Overall Study||0
2907934|NCT00462449|3616815|FG000|STARTED|Overall Study||13
2907935|NCT00462449|3616816|FG001|STARTED|Overall Study||10
2907936|NCT00462449|3616815|FG000|COMPLETED|Overall Study||13
3171441|NCT01933789|3898538|FG006|NOT COMPLETED|Overall Study||15
3171442|NCT01933789|3898539|FG007|NOT COMPLETED|Overall Study||14
3171443|NCT01933789|3898540|FG008|NOT COMPLETED|Overall Study||0
3171444|NCT01933880|3898562|FG000|STARTED|Overall Study||153
3171445|NCT01933880|3898563|FG001|STARTED|Overall Study||41
3171446|NCT01933880|3898562|FG000|COMPLETED|Overall Study||123
3171447|NCT01933880|3898563|FG001|COMPLETED|Overall Study||40
3171448|NCT01933880|3898562|FG000|NOT COMPLETED|Overall Study||30
3171449|NCT01933880|3898563|FG001|NOT COMPLETED|Overall Study||1
3171450|NCT01933919|3898576|FG000|STARTED|Double-blind Placebo-controlled Phase||19
2907937|NCT00462449|3616816|FG001|COMPLETED|Overall Study||10
2907938|NCT00462449|3616815|FG000|NOT COMPLETED|Overall Study||0
2907939|NCT00462449|3616816|FG001|NOT COMPLETED|Overall Study||0
2907940|NCT00462462|3616824|FG000|STARTED|Overall Study||17
2907941|NCT00462462|3616825|FG001|STARTED|Overall Study||14
2907942|NCT00462462|3616824|FG000|COMPLETED|Overall Study||17
2907943|NCT00462462|3616825|FG001|COMPLETED|Overall Study||13
2907944|NCT00462462|3616824|FG000|NOT COMPLETED|Overall Study||0
3171451|NCT01933919|3898577|FG001|STARTED|Double-blind Placebo-controlled Phase||19
3171452|NCT01933919|3898576|FG000|Received Study Drug|Double-blind Placebo-controlled Phase||19
2907945|NCT00462462|3616825|FG001|NOT COMPLETED|Overall Study||1
2907946|NCT00462488|3616835|FG000|STARTED|Overall Study||23
2907947|NCT00462488|3616836|FG001|STARTED|Overall Study||23
2907948|NCT00462488|3616835|FG000|Completed Induction Phase|Overall Study||22
2907949|NCT00462488|3616836|FG001|Completed Induction Phase|Overall Study||23
2907950|NCT00462488|3616835|FG000|Completed Induction 2/Maintenance 1|Overall Study||18
2907951|NCT00462488|3616836|FG001|Completed Induction 2/Maintenance 1|Overall Study||9
2907952|NCT00462488|3616835|FG000|Completed Maintenance 2|Overall Study||7
2907953|NCT00462488|3616836|FG001|Completed Maintenance 2|Overall Study||6
2907954|NCT00462488|3616835|FG000|COMPLETED|Overall Study||3
2907955|NCT00462488|3616836|FG001|COMPLETED|Overall Study||6
2907956|NCT00462488|3616835|FG000|NOT COMPLETED|Overall Study||20
3171453|NCT01933919|3898577|FG001|Received Study Drug|Double-blind Placebo-controlled Phase||19
3171454|NCT01933919|3898576|FG000|COMPLETED|Double-blind Placebo-controlled Phase||19
3171455|NCT01933919|3898577|FG001|COMPLETED|Double-blind Placebo-controlled Phase||15
3171456|NCT01933919|3898576|FG000|NOT COMPLETED|Double-blind Placebo-controlled Phase||0
3171457|NCT01933919|3898577|FG001|NOT COMPLETED|Double-blind Placebo-controlled Phase||4
3171458|NCT01933919|3898576|FG000|STARTED|Open-label Long-term Phase||19
3171459|NCT01933919|3898577|FG001|STARTED|Open-label Long-term Phase||15
3171460|NCT01933919|3898576|FG000|COMPLETED|Open-label Long-term Phase||12
3171461|NCT01933919|3898577|FG001|COMPLETED|Open-label Long-term Phase||9
3171462|NCT01933919|3898576|FG000|NOT COMPLETED|Open-label Long-term Phase||7
3171463|NCT01933919|3898577|FG001|NOT COMPLETED|Open-label Long-term Phase||6
3171464|NCT01933984|3898597|FG000|STARTED|Overall Study||26
3171465|NCT01933984|3898598|FG001|STARTED|Overall Study||25
3171466|NCT01933984|3898597|FG000|COMPLETED|Overall Study||26
3171467|NCT01933984|3898598|FG001|COMPLETED|Overall Study||25
3171468|NCT01933984|3898597|FG000|NOT COMPLETED|Overall Study||0
3171469|NCT01933984|3898598|FG001|NOT COMPLETED|Overall Study||0
3171470|NCT01934010|3898611|FG000|STARTED|Overall Study||114
2907957|NCT00462488|3616836|FG001|NOT COMPLETED|Overall Study||17
2920474|NCT00537238|3630997|FG001|Completed Titration Phase|Overall Study||236
2920475|NCT00537238|3630996|FG000|Completed Maintenance Phase|Overall Study|Primary analysis drawn from the population in the maintenance phase.|208
2920476|NCT00537238|3630997|FG001|Completed Maintenance Phase|Overall Study|Primary analysis drawn from the population in the maintenance phase.|210
2920477|NCT00537238|3630996|FG000|Entered Opt Blinded Continuation Phase|Overall Study|Participants who had clinical benefit were eligible to progress into opt blinded continuation phase.|185
2920478|NCT00537238|3630997|FG001|Entered Opt Blinded Continuation Phase|Overall Study|Participants who had clinical benefit were eligible to progress into opt blinded continuation phase.|195
2920479|NCT00537238|3630996|FG000|COMPLETED|Overall Study|Completed designates participants who completed the opt blinded continuation phase.|80
2920480|NCT00537238|3630997|FG001|COMPLETED|Overall Study|Completed designates participants who completed the opt blinded continuation phase.|82
2920481|NCT00537238|3630996|FG000|NOT COMPLETED|Overall Study||174
2920482|NCT00537238|3630997|FG001|NOT COMPLETED|Overall Study||173
2920483|NCT00537277|3631003|FG000|STARTED|Overall Study||161
2920484|NCT00537277|3631003|FG000|Exposed to Trial Drug|Overall Study|One subject not exposed to trial drug, and thus not included in full analysis set (FAS)|160
2920485|NCT00537277|3631003|FG000|COMPLETED|Overall Study||112
2920486|NCT00537277|3631003|FG000|NOT COMPLETED|Overall Study||49
2920487|NCT00537290|3631007|FG000|STARTED|Overall Study||19
2920488|NCT00537290|3631007|FG000|COMPLETED|Overall Study||19
2920489|NCT00537290|3631007|FG000|NOT COMPLETED|Overall Study||0
2920490|NCT00537303|3631013|FG000|STARTED|Overall Study||146
2920491|NCT00537303|3631014|FG001|STARTED|Overall Study||150
2920492|NCT00537303|3631013|FG000|COMPLETED|Overall Study||120
2920493|NCT00537303|3631014|FG001|COMPLETED|Overall Study||125
2920494|NCT00537303|3631013|FG000|NOT COMPLETED|Overall Study||26
2920495|NCT00537303|3631014|FG001|NOT COMPLETED|Overall Study||25
2920496|NCT00537316|3631026|FG000|STARTED|Part 1||79
2920497|NCT00537316|3631027|FG001|STARTED|Part 1||80
2920498|NCT00537316|3631028|FG002|STARTED|Part 1||80
2920499|NCT00537316|3631029|FG003|STARTED|Part 1||0
2920500|NCT00537316|3631030|FG004|STARTED|Part 1||0
2920501|NCT00537316|3631031|FG005|STARTED|Part 1||0
2920502|NCT00537316|3631032|FG006|STARTED|Part 1||0
2920503|NCT00537316|3631026|FG000|COMPLETED|Part 1||65
2920504|NCT00537316|3631027|FG001|COMPLETED|Part 1||53
2920505|NCT00537316|3631028|FG002|COMPLETED|Part 1||63
2920506|NCT00537316|3631029|FG003|COMPLETED|Part 1||0
2920507|NCT00537316|3631030|FG004|COMPLETED|Part 1||0
2920508|NCT00537316|3631031|FG005|COMPLETED|Part 1||0
2920509|NCT00537316|3631032|FG006|COMPLETED|Part 1||0
2920510|NCT00537316|3631026|FG000|NOT COMPLETED|Part 1||14
2920511|NCT00537316|3631027|FG001|NOT COMPLETED|Part 1||27
2920512|NCT00537316|3631028|FG002|NOT COMPLETED|Part 1||17
2920513|NCT00537316|3631029|FG003|NOT COMPLETED|Part 1||0
2920514|NCT00537316|3631030|FG004|NOT COMPLETED|Part 1||0
2920515|NCT00537316|3631031|FG005|NOT COMPLETED|Part 1||0
2920516|NCT00537316|3631032|FG006|NOT COMPLETED|Part 1||0
2920517|NCT00537316|3631026|FG000|STARTED|Part 2||37
2920518|NCT00537316|3631027|FG001|STARTED|Part 2||10
2920519|NCT00537316|3631028|FG002|STARTED|Part 2||48
2920520|NCT00537316|3631029|FG003|STARTED|Part 2||5
2920521|NCT00537316|3631030|FG004|STARTED|Part 2||2
2920522|NCT00537316|3631031|FG005|STARTED|Part 2||4
2920523|NCT00537316|3631032|FG006|STARTED|Part 2||2
2920524|NCT00537316|3631026|FG000|COMPLETED|Part 2||11
3171471|NCT01934010|3898612|FG001|STARTED|Overall Study||67
3171472|NCT01934010|3898613|FG002|STARTED|Overall Study||76
2907958|NCT00462501|3616842|FG000|STARTED|Overall Study||35
2907959|NCT00462501|3616842|FG000|COMPLETED|Overall Study||30
2907960|NCT00462501|3616842|FG000|NOT COMPLETED|Overall Study||5
2907961|NCT00462605|3616846|FG000|STARTED|Overall Study||24
2907962|NCT00462605|3616846|FG000|COMPLETED|Overall Study||10
2907963|NCT00462605|3616846|FG000|NOT COMPLETED|Overall Study||14
2907964|NCT00462644|3616852|FG000|STARTED|Overall Study||18
2907965|NCT00462644|3616853|FG001|STARTED|Overall Study||12
2907966|NCT00462644|3616852|FG000|COMPLETED|Overall Study||18
2907967|NCT00462644|3616853|FG001|COMPLETED|Overall Study||12
2907968|NCT00462644|3616852|FG000|NOT COMPLETED|Overall Study||0
2907969|NCT00462644|3616853|FG001|NOT COMPLETED|Overall Study||0
2907970|NCT00462670|3616861|FG000|STARTED|Overall Study||57
2907971|NCT00462670|3616862|FG001|STARTED|Overall Study||53
2907972|NCT00462670|3616861|FG000|COMPLETED|Overall Study||52
2907973|NCT00462670|3616862|FG001|COMPLETED|Overall Study||46
2907974|NCT00462670|3616861|FG000|NOT COMPLETED|Overall Study||5
2907975|NCT00462670|3616862|FG001|NOT COMPLETED|Overall Study||7
2907976|NCT00462709|3616868|FG000|STARTED|Overall Study||146
2907977|NCT00462709|3616868|FG000|COMPLETED|Overall Study||79
2907978|NCT00462709|3616868|FG000|NOT COMPLETED|Overall Study||67
2907979|NCT00462722|3616875|FG000|STARTED|Overall Study||50
2907980|NCT00462722|3616876|FG001|STARTED|Overall Study||55
2907981|NCT00462722|3616877|FG002|STARTED|Overall Study||54
2907982|NCT00462722|3616875|FG000|COMPLETED|Overall Study||37
2907983|NCT00462722|3616876|FG001|COMPLETED|Overall Study||51
2907984|NCT00462722|3616877|FG002|COMPLETED|Overall Study||42
2907985|NCT00462722|3616875|FG000|NOT COMPLETED|Overall Study||13
2907986|NCT00462722|3616876|FG001|NOT COMPLETED|Overall Study||4
2907987|NCT00462722|3616877|FG002|NOT COMPLETED|Overall Study||12
2907988|NCT00462735|3616885|FG000|STARTED|Overall Study||33
2907989|NCT00462735|3616885|FG000|COMPLETED|Overall Study||33
2907990|NCT00462735|3616885|FG000|NOT COMPLETED|Overall Study||0
2907991|NCT00462761|3616890|FG000|STARTED|Overall Study||76
2907992|NCT00462761|3616890|FG000|COMPLETED|Overall Study||0
2907993|NCT00462761|3616890|FG000|NOT COMPLETED|Overall Study||76
2907994|NCT00462826|3616922|FG000|STARTED|Overall Study||49
2907995|NCT00462826|3616922|FG000|COMPLETED|Overall Study||44
2907996|NCT00462826|3616922|FG000|NOT COMPLETED|Overall Study||5
2907997|NCT00462839|3616934|FG000|STARTED|Viewed First||53
2907998|NCT00462839|3616935|FG001|STARTED|Viewed First||53
2907999|NCT00462839|3616934|FG000|COMPLETED|Viewed First||53
2908000|NCT00462839|3616935|FG001|COMPLETED|Viewed First||53
2908001|NCT00462839|3616934|FG000|NOT COMPLETED|Viewed First||0
3171473|NCT01934010|3898611|FG000|COMPLETED|Overall Study||91
3171474|NCT01934010|3898612|FG001|COMPLETED|Overall Study||56
3171475|NCT01934010|3898613|FG002|COMPLETED|Overall Study||74
3171476|NCT01934010|3898611|FG000|NOT COMPLETED|Overall Study||23
3171477|NCT01934010|3898612|FG001|NOT COMPLETED|Overall Study||11
3171478|NCT01934010|3898613|FG002|NOT COMPLETED|Overall Study||2
3171479|NCT01934140|3898632|FG000|STARTED|Persistence Phase (Year 6-10)||235
3171480|NCT01934140|3898633|FG001|STARTED|Persistence Phase (Year 6-10)||76
3171481|NCT01934140|3898632|FG000|COMPLETED|Persistence Phase (Year 6-10)|Participants completed all persistence phase visits|152
3171482|NCT01934140|3898633|FG001|COMPLETED|Persistence Phase (Year 6-10)|Participants completed all persistence phase visits|51
2908002|NCT00462839|3616935|FG001|NOT COMPLETED|Viewed First||0
2908003|NCT00462839|3616934|FG000|STARTED|Viewed Second||53
2908004|NCT00462839|3616935|FG001|STARTED|Viewed Second||53
2908005|NCT00462839|3616934|FG000|COMPLETED|Viewed Second||53
2908006|NCT00462839|3616935|FG001|COMPLETED|Viewed Second||53
2908007|NCT00462839|3616934|FG000|NOT COMPLETED|Viewed Second||0
2908008|NCT00462839|3616935|FG001|NOT COMPLETED|Viewed Second||0
2908009|NCT00462865|3616941|FG000|STARTED|Overall Study|18 pts enrolled,1 pt experienced a SAE infection normal ANC (gr 3) and did not begin study,see SAE|18
2908010|NCT00462865|3616941|FG000|COMPLETED|Overall Study||17
2908011|NCT00462865|3616941|FG000|NOT COMPLETED|Overall Study||1
2908012|NCT00462917|3616949|FG000|STARTED|Overall Study||72
2908013|NCT00462917|3616950|FG001|STARTED|Overall Study||75
2908014|NCT00462917|3616951|FG002|STARTED|Overall Study||66
2908015|NCT00462917|3616952|FG003|STARTED|Overall Study||77
2908016|NCT00462917|3616949|FG000|Met With Genetic Counselor|Overall Study||66
2908017|NCT00462917|3616950|FG001|Met With Genetic Counselor|Overall Study||71
2908018|NCT00462917|3616951|FG002|Met With Genetic Counselor|Overall Study||56
2908019|NCT00462917|3616952|FG003|Met With Genetic Counselor|Overall Study||71
2908020|NCT00462917|3616949|FG000|Received Risk Information|Overall Study||64
2908021|NCT00462917|3616950|FG001|Received Risk Information|Overall Study||70
2908022|NCT00462917|3616951|FG002|Received Risk Information|Overall Study||55
2908023|NCT00462917|3616952|FG003|Received Risk Information|Overall Study||68
2908024|NCT00462917|3616949|FG000|Completed 6 Week Follow-up|Overall Study||63
2908025|NCT00462917|3616950|FG001|Completed 6 Week Follow-up|Overall Study||70
2908026|NCT00462917|3616951|FG002|Completed 6 Week Follow-up|Overall Study||55
2908027|NCT00462917|3616952|FG003|Completed 6 Week Follow-up|Overall Study||68
2908028|NCT00462917|3616949|FG000|Completed 6 Month Follow-up|Overall Study||63
2908029|NCT00462917|3616950|FG001|Completed 6 Month Follow-up|Overall Study||68
2908030|NCT00462917|3616951|FG002|Completed 6 Month Follow-up|Overall Study||55
2908031|NCT00462917|3616952|FG003|Completed 6 Month Follow-up|Overall Study||66
2908032|NCT00462917|3616949|FG000|COMPLETED|Overall Study||62
2908033|NCT00462917|3616950|FG001|COMPLETED|Overall Study||65
2908034|NCT00462917|3616951|FG002|COMPLETED|Overall Study||54
3171483|NCT01934140|3898632|FG000|NOT COMPLETED|Persistence Phase (Year 6-10)||83
2908035|NCT00462917|3616952|FG003|COMPLETED|Overall Study||66
2908036|NCT00462917|3616949|FG000|NOT COMPLETED|Overall Study||10
2908037|NCT00462917|3616950|FG001|NOT COMPLETED|Overall Study||10
2908038|NCT00462917|3616951|FG002|NOT COMPLETED|Overall Study||12
2908039|NCT00462917|3616952|FG003|NOT COMPLETED|Overall Study||11
2908040|NCT00462982|3616962|FG000|STARTED|Overall Study||8
3171484|NCT01934140|3898633|FG001|NOT COMPLETED|Persistence Phase (Year 6-10)||25
3171485|NCT01934140|3898632|FG000|STARTED|Booster Phase (6 Months)|Eligible participants from persistence phase who provided consent, were enrolled in booster phase.|164
2908041|NCT00462982|3616962|FG000|COMPLETED|Overall Study||5
2908042|NCT00462982|3616962|FG000|NOT COMPLETED|Overall Study||3
2908043|NCT00463047|3616966|FG000|STARTED|Titration Period 1|323 subjects entered study period but 3 discontinued before being randomized to treatment|160
2908044|NCT00463047|3616967|FG001|STARTED|Titration Period 1||160
2908045|NCT00463047|3616966|FG000|COMPLETED|Titration Period 1||123
2908046|NCT00463047|3616967|FG001|COMPLETED|Titration Period 1||121
2908047|NCT00463047|3616966|FG000|NOT COMPLETED|Titration Period 1||37
2908048|NCT00463047|3616967|FG001|NOT COMPLETED|Titration Period 1||39
2908049|NCT00463047|3616966|FG000|STARTED|Titration Period 2||123
2908050|NCT00463047|3616967|FG001|STARTED|Titration Period 2||121
2908051|NCT00463047|3616966|FG000|COMPLETED|Titration Period 2||93
2908052|NCT00463047|3616967|FG001|COMPLETED|Titration Period 2||98
2908053|NCT00463047|3616966|FG000|NOT COMPLETED|Titration Period 2||30
2908054|NCT00463047|3616967|FG001|NOT COMPLETED|Titration Period 2||23
2908055|NCT00463047|3616966|FG000|STARTED|Double-Blind Treatment Period 1|After completion of titration period subjects were re-randomized to these two treatment arms|96
2908056|NCT00463047|3616967|FG001|STARTED|Double-Blind Treatment Period 1|After completion of titration period subjects were re-randomized to these two treatment arms|94
2908057|NCT00463047|3616966|FG000|COMPLETED|Double-Blind Treatment Period 1||93
2908058|NCT00463047|3616967|FG001|COMPLETED|Double-Blind Treatment Period 1||90
2908059|NCT00463047|3616966|FG000|NOT COMPLETED|Double-Blind Treatment Period 1||3
2908060|NCT00463047|3616967|FG001|NOT COMPLETED|Double-Blind Treatment Period 1||4
2908061|NCT00463047|3616966|FG000|STARTED|Double-Blind Treatment Period 2||93
2908062|NCT00463047|3616967|FG001|STARTED|Double-Blind Treatment Period 2||90
2908063|NCT00463047|3616966|FG000|COMPLETED|Double-Blind Treatment Period 2||92
2908064|NCT00463047|3616967|FG001|COMPLETED|Double-Blind Treatment Period 2||88
2908065|NCT00463047|3616966|FG000|NOT COMPLETED|Double-Blind Treatment Period 2||1
2908066|NCT00463047|3616967|FG001|NOT COMPLETED|Double-Blind Treatment Period 2||2
2908067|NCT00463060|3616976|FG000|STARTED|Phase 1-Radiation 40 Gy + Sunitinib 25mg||3
2908068|NCT00463060|3616976|FG000|COMPLETED|Phase 1-Radiation 40 Gy + Sunitinib 25mg||3
2908069|NCT00463060|3616976|FG000|NOT COMPLETED|Phase 1-Radiation 40 Gy + Sunitinib 25mg||0
2908070|NCT00463060|3616976|FG000|STARTED|Phase 1-Radiation 40 Gy+Sunitinib 37.5mg||3
2908071|NCT00463060|3616976|FG000|COMPLETED|Phase 1-Radiation 40 Gy+Sunitinib 37.5mg||3
2908072|NCT00463060|3616976|FG000|NOT COMPLETED|Phase 1-Radiation 40 Gy+Sunitinib 37.5mg||0
2908073|NCT00463060|3616976|FG000|STARTED|Phase 1-Radiation 50 Gy+Sunitinib 37.5mg||10
2908074|NCT00463060|3616976|FG000|COMPLETED|Phase 1-Radiation 50 Gy+Sunitinib 37.5mg||10
2908075|NCT00463060|3616976|FG000|NOT COMPLETED|Phase 1-Radiation 50 Gy+Sunitinib 37.5mg||0
2908076|NCT00463060|3616976|FG000|STARTED|Phase 1-Radiation 50Gy +Sunitinib 50mg||5
2908077|NCT00463060|3616976|FG000|COMPLETED|Phase 1-Radiation 50Gy +Sunitinib 50mg||0
2908078|NCT00463060|3616976|FG000|NOT COMPLETED|Phase 1-Radiation 50Gy +Sunitinib 50mg||5
2908079|NCT00463060|3616976|FG000|STARTED|Phase 2-Radiation 50Gy +Sunitinib 37.5mg|Not all patients participated in both Phase 1 and Phase II|26
2908080|NCT00463060|3616976|FG000|COMPLETED|Phase 2-Radiation 50Gy +Sunitinib 37.5mg||25
2908081|NCT00463060|3616976|FG000|NOT COMPLETED|Phase 2-Radiation 50Gy +Sunitinib 37.5mg||1
2908082|NCT00463151|3616989|FG000|STARTED|Overall Study||35
2908083|NCT00463151|3616990|FG001|STARTED|Overall Study||29
2908084|NCT00463151|3616991|FG002|STARTED|Overall Study||29
2908085|NCT00463151|3616992|FG003|STARTED|Overall Study||31
2908086|NCT00463151|3616989|FG000|COMPLETED|Overall Study||33
2908087|NCT00463151|3616990|FG001|COMPLETED|Overall Study||24
2908088|NCT00463151|3616991|FG002|COMPLETED|Overall Study||26
2908089|NCT00463151|3616992|FG003|COMPLETED|Overall Study||24
2908090|NCT00463151|3616989|FG000|NOT COMPLETED|Overall Study||2
2908091|NCT00463151|3616990|FG001|NOT COMPLETED|Overall Study||5
2908092|NCT00463151|3616991|FG002|NOT COMPLETED|Overall Study||3
2908093|NCT00463151|3616992|FG003|NOT COMPLETED|Overall Study||7
2908094|NCT00463229|3617004|FG000|STARTED|Overall Study||52
2908095|NCT00463229|3617005|FG001|STARTED|Overall Study||49
2908096|NCT00463229|3617004|FG000|COMPLETED|Overall Study||43
2908097|NCT00463229|3617005|FG001|COMPLETED|Overall Study||39
2908098|NCT00463229|3617004|FG000|NOT COMPLETED|Overall Study||9
2908099|NCT00463229|3617005|FG001|NOT COMPLETED|Overall Study||10
2908100|NCT00463346|3617014|FG000|STARTED|Overall Study||12
2908101|NCT00463346|3617015|FG001|STARTED|Overall Study||11
2908102|NCT00463346|3617014|FG000|COMPLETED|Overall Study||9
2908103|NCT00463346|3617015|FG001|COMPLETED|Overall Study||8
2908104|NCT00463346|3617014|FG000|NOT COMPLETED|Overall Study||3
2908105|NCT00463346|3617015|FG001|NOT COMPLETED|Overall Study||3
2908106|NCT00463385|3617027|FG000|STARTED|Overall Study||22
2908107|NCT00463385|3617028|FG001|STARTED|Overall Study||22
2908108|NCT00463385|3617029|FG002|STARTED|Overall Study||22
2908109|NCT00463385|3617030|FG003|STARTED|Overall Study||22
2908110|NCT00463385|3617027|FG000|Treated|Overall Study||22
2908111|NCT00463385|3617028|FG001|Treated|Overall Study||22
2908112|NCT00463385|3617029|FG002|Treated|Overall Study||19
2908113|NCT00463385|3617030|FG003|Treated|Overall Study||22
2908114|NCT00463385|3617027|FG000|COMPLETED|Overall Study||0
2908115|NCT00463385|3617028|FG001|COMPLETED|Overall Study||0
2908116|NCT00463385|3617029|FG002|COMPLETED|Overall Study||0
2908117|NCT00463385|3617030|FG003|COMPLETED|Overall Study||0
2908118|NCT00463385|3617027|FG000|NOT COMPLETED|Overall Study||22
2908119|NCT00463385|3617028|FG001|NOT COMPLETED|Overall Study||22
2908120|NCT00463385|3617029|FG002|NOT COMPLETED|Overall Study||22
2908121|NCT00463385|3617030|FG003|NOT COMPLETED|Overall Study||22
2908122|NCT00463437|3617052|FG000|STARTED|Overall Study||359
2908123|NCT00463437|3617053|FG001|STARTED|Overall Study||363
2908124|NCT00463437|3617054|FG002|STARTED|Overall Study||358
2908125|NCT00463437|3617055|FG003|STARTED|Overall Study||357
2908126|NCT00463437|3617052|FG000|COMPLETED|Overall Study||355
2908127|NCT00463437|3617053|FG001|COMPLETED|Overall Study||352
2908128|NCT00463437|3617054|FG002|COMPLETED|Overall Study||352
2908129|NCT00463437|3617055|FG003|COMPLETED|Overall Study||350
2908130|NCT00463437|3617052|FG000|NOT COMPLETED|Overall Study||4
2908131|NCT00463437|3617053|FG001|NOT COMPLETED|Overall Study||11
2908132|NCT00463437|3617054|FG002|NOT COMPLETED|Overall Study||6
2908133|NCT00463437|3617055|FG003|NOT COMPLETED|Overall Study||7
2908134|NCT00463476|3617067|FG000|STARTED|Overall Study||151
2908135|NCT00463476|3617068|FG001|STARTED|Overall Study||154
2908136|NCT00463476|3617067|FG000|COMPLETED|Overall Study||149
2908137|NCT00463476|3617068|FG001|COMPLETED|Overall Study||151
2908138|NCT00463476|3617067|FG000|NOT COMPLETED|Overall Study||2
2908139|NCT00463476|3617068|FG001|NOT COMPLETED|Overall Study||3
2908140|NCT00463567|3617081|FG000|STARTED|Overall Study|Randomized Participants|420
2908141|NCT00463567|3617082|FG001|STARTED|Overall Study||418
2908142|NCT00463567|3617083|FG002|STARTED|Overall Study||420
2908143|NCT00463567|3617084|FG003|STARTED|Overall Study||425
2908144|NCT00463567|3617085|FG004|STARTED|Overall Study||130
2908145|NCT00463567|3617086|FG005|STARTED|Overall Study||123
2908146|NCT00463567|3617087|FG006|STARTED|Overall Study||123
2908147|NCT00463567|3617081|FG000|Safety Population: Received Study Drug|Overall Study||416
2908148|NCT00463567|3617082|FG001|Safety Population: Received Study Drug|Overall Study||416
2908149|NCT00463567|3617083|FG002|Safety Population: Received Study Drug|Overall Study||415
2908150|NCT00463567|3617084|FG003|Safety Population: Received Study Drug|Overall Study||418
2908151|NCT00463567|3617085|FG004|Safety Population: Received Study Drug|Overall Study|'Completed' indicates the number of patients in the interim analysis.|127
2908152|NCT00463567|3617086|FG005|Safety Population: Received Study Drug|Overall Study|'Completed' indicates the number of patients in the interim analysis.|122
2908153|NCT00463567|3617087|FG006|Safety Population: Received Study Drug|Overall Study|'Completed' indicates the number of patients in the interim analysis.|122
2908154|NCT00463567|3617081|FG000|COMPLETED|Overall Study||325
2908155|NCT00463567|3617082|FG001|COMPLETED|Overall Study||341
2908156|NCT00463567|3617083|FG002|COMPLETED|Overall Study||331
2908157|NCT00463567|3617084|FG003|COMPLETED|Overall Study||294
2908158|NCT00463567|3617085|FG004|COMPLETED|Overall Study||107
2908159|NCT00463567|3617086|FG005|COMPLETED|Overall Study||102
2908160|NCT00463567|3617087|FG006|COMPLETED|Overall Study||112
2908161|NCT00463567|3617081|FG000|NOT COMPLETED|Overall Study||95
2908162|NCT00463567|3617082|FG001|NOT COMPLETED|Overall Study||77
2908163|NCT00463567|3617083|FG002|NOT COMPLETED|Overall Study||89
2908164|NCT00463567|3617084|FG003|NOT COMPLETED|Overall Study||131
2908165|NCT00463567|3617085|FG004|NOT COMPLETED|Overall Study||23
2908166|NCT00463567|3617086|FG005|NOT COMPLETED|Overall Study||21
2908167|NCT00463567|3617087|FG006|NOT COMPLETED|Overall Study||11
2908168|NCT00463580|3617111|FG000|STARTED|Overall Study||30
2908169|NCT00463580|3617112|FG001|STARTED|Overall Study||30
2908170|NCT00463580|3617111|FG000|COMPLETED|Overall Study||27
2908171|NCT00463580|3617112|FG001|COMPLETED|Overall Study||28
2908172|NCT00463580|3617111|FG000|NOT COMPLETED|Overall Study||3
2908173|NCT00463580|3617112|FG001|NOT COMPLETED|Overall Study||2
2908174|NCT00463606|3617127|FG000|STARTED|Overall Study||253
2908175|NCT00463606|3617128|FG001|STARTED|Overall Study||254
2908176|NCT00463606|3617129|FG002|STARTED|Overall Study||251
2908177|NCT00463606|3617127|FG000|COMPLETED|Overall Study||212
2908178|NCT00463606|3617128|FG001|COMPLETED|Overall Study||220
2908179|NCT00463606|3617129|FG002|COMPLETED|Overall Study||231
2908180|NCT00463606|3617127|FG000|NOT COMPLETED|Overall Study||41
2908181|NCT00463606|3617128|FG001|NOT COMPLETED|Overall Study||34
2908182|NCT00463606|3617129|FG002|NOT COMPLETED|Overall Study||20
2908183|NCT00463684|3617137|FG000|STARTED|Overall Study||278
2908184|NCT00463684|3617137|FG000|COMPLETED|Overall Study||274
2908185|NCT00463684|3617137|FG000|NOT COMPLETED|Overall Study||4
2908186|NCT00463788|3617143|FG000|STARTED|Overall Study||115
2908187|NCT00463788|3617144|FG001|STARTED|Overall Study||58
2908188|NCT00463788|3617143|FG000|Treated|Overall Study||114
2908189|NCT00463788|3617144|FG001|Treated|Overall Study||57
2908190|NCT00463788|3617143|FG000|COMPLETED|Overall Study||6
2908191|NCT00463788|3617144|FG001|COMPLETED|Overall Study||4
3171486|NCT01934140|3898633|FG001|STARTED|Booster Phase (6 Months)|Eligible participants from persistence phase who provided consent, were enrolled in booster phase.|56
3171487|NCT01934140|3898632|FG000|Vaccinated|Booster Phase (6 Months)||164
3171488|NCT01934140|3898633|FG001|Vaccinated|Booster Phase (6 Months)||56
3171489|NCT01934140|3898632|FG000|COMPLETED|Booster Phase (6 Months)||159
2908192|NCT00463788|3617143|FG000|NOT COMPLETED|Overall Study||109
2908193|NCT00463788|3617144|FG001|NOT COMPLETED|Overall Study||54
2908194|NCT00463801|3617151|FG000|STARTED|Overall Study||52
2908195|NCT00463801|3617151|FG000|COMPLETED|Overall Study||39
2908196|NCT00463801|3617151|FG000|NOT COMPLETED|Overall Study||13
2908197|NCT00463840|3617155|FG000|STARTED|Overall Study||24
2908198|NCT00463840|3617155|FG000|COMPLETED|Overall Study||12
2908199|NCT00463840|3617155|FG000|NOT COMPLETED|Overall Study||12
2908200|NCT00463866|3617161|FG000|STARTED|Overall Study|4203 participants randomised. Out of these, 195 had no efficacy data after randomisation.|4008
2908201|NCT00463866|3617162|FG001|STARTED|Overall Study|4221 participants randomised. Out of these, 176 had no efficacy data after randomisation.|4045
2908202|NCT00463866|3617161|FG000|COMPLETED|Overall Study||3699
2908203|NCT00463866|3617162|FG001|COMPLETED|Overall Study||3705
2908204|NCT00463866|3617161|FG000|NOT COMPLETED|Overall Study||309
2908205|NCT00463866|3617162|FG001|NOT COMPLETED|Overall Study||340
2908206|NCT00464087|3617171|FG000|STARTED|Overall Study||49
2908207|NCT00464087|3617172|FG001|STARTED|Overall Study||51
2908208|NCT00464087|3617173|FG002|STARTED|Overall Study||29
2908209|NCT00464087|3617171|FG000|COMPLETED|Overall Study||49
2908210|NCT00464087|3617172|FG001|COMPLETED|Overall Study||51
2908211|NCT00464087|3617173|FG002|COMPLETED|Overall Study||0
2908212|NCT00464087|3617171|FG000|NOT COMPLETED|Overall Study||0
2908213|NCT00464087|3617172|FG001|NOT COMPLETED|Overall Study||0
2908214|NCT00464087|3617173|FG002|NOT COMPLETED|Overall Study||29
2908215|NCT00464204|3617183|FG000|STARTED|Overall Study||100
2908216|NCT00464204|3617184|FG001|STARTED|Overall Study||96
2908217|NCT00464204|3617183|FG000|Completed Treatment|Overall Study||81
2908218|NCT00464204|3617184|FG001|Completed Treatment|Overall Study||83
2908219|NCT00464204|3617183|FG000|Day 30 Follow-up Performed|Overall Study||89
2908220|NCT00464204|3617184|FG001|Day 30 Follow-up Performed|Overall Study||83
2908221|NCT00464204|3617183|FG000|Day 90 Follow-up Performed|Overall Study||69
2908222|NCT00464204|3617184|FG001|Day 90 Follow-up Performed|Overall Study||74
2908223|NCT00464204|3617183|FG000|Withdrawal Due to Discharge From ICU|Overall Study||18
2908224|NCT00464204|3617184|FG001|Withdrawal Due to Discharge From ICU|Overall Study||11
2908225|NCT00464204|3617183|FG000|COMPLETED|Overall Study|Completed=no withdrawal until day 8.|51
2908226|NCT00464204|3617184|FG001|COMPLETED|Overall Study|Completed=no withdrawal until day 8.|64
2908227|NCT00464204|3617183|FG000|NOT COMPLETED|Overall Study||49
2908228|NCT00464204|3617184|FG001|NOT COMPLETED|Overall Study||32
2908229|NCT00464269|3617196|FG000|STARTED|Overall Study||99
2908230|NCT00464269|3617197|FG001|STARTED|Overall Study||99
2908231|NCT00464269|3617198|FG002|STARTED|Overall Study||100
2908232|NCT00464269|3617199|FG003|STARTED|Overall Study||102
2908233|NCT00464269|3617196|FG000|COMPLETED|Overall Study||93
2908234|NCT00464269|3617197|FG001|COMPLETED|Overall Study||82
2908235|NCT00464269|3617198|FG002|COMPLETED|Overall Study||93
2908236|NCT00464269|3617199|FG003|COMPLETED|Overall Study||93
2908237|NCT00464269|3617196|FG000|NOT COMPLETED|Overall Study||6
2908238|NCT00464269|3617197|FG001|NOT COMPLETED|Overall Study||17
2908239|NCT00464269|3617198|FG002|NOT COMPLETED|Overall Study||7
2908240|NCT00464269|3617199|FG003|NOT COMPLETED|Overall Study||9
2908241|NCT00464308|3617214|FG000|STARTED|Overall Study||464
2908242|NCT00464308|3617215|FG001|STARTED|Overall Study||469
2908243|NCT00464308|3617216|FG002|STARTED|Overall Study||459
2908244|NCT00464308|3617214|FG000|COMPLETED|Overall Study||395
2908245|NCT00464308|3617215|FG001|COMPLETED|Overall Study||406
2908246|NCT00464308|3617216|FG002|COMPLETED|Overall Study||400
2908247|NCT00464308|3617214|FG000|NOT COMPLETED|Overall Study||69
2908248|NCT00464308|3617215|FG001|NOT COMPLETED|Overall Study||63
2908249|NCT00464308|3617216|FG002|NOT COMPLETED|Overall Study||59
2908250|NCT00464334|3617235|FG000|STARTED|Overall Study||5
2908251|NCT00464334|3617236|FG001|STARTED|Overall Study||13
2908252|NCT00464334|3617237|FG002|STARTED|Overall Study||8
2908253|NCT00464334|3617238|FG003|STARTED|Overall Study||8
2908254|NCT00464334|3617239|FG004|STARTED|Overall Study||7
2908255|NCT00464334|3617240|FG005|STARTED|Overall Study||7
2908256|NCT00464334|3617241|FG006|STARTED|Overall Study||9
2908257|NCT00464334|3617242|FG007|STARTED|Overall Study||8
2908258|NCT00464334|3617243|FG008|STARTED|Overall Study||8
2908259|NCT00464334|3617244|FG009|STARTED|Overall Study||5
2908260|NCT00464334|3617245|FG010|STARTED|Overall Study||8
2908261|NCT00464334|3617235|FG000|COMPLETED|Overall Study||4
2908262|NCT00464334|3617236|FG001|COMPLETED|Overall Study||5
2908263|NCT00464334|3617237|FG002|COMPLETED|Overall Study||3
2908264|NCT00464334|3617238|FG003|COMPLETED|Overall Study||4
2908265|NCT00464334|3617239|FG004|COMPLETED|Overall Study||3
2908266|NCT00464334|3617240|FG005|COMPLETED|Overall Study||3
2908267|NCT00464334|3617241|FG006|COMPLETED|Overall Study||6
2908268|NCT00464334|3617242|FG007|COMPLETED|Overall Study||7
2908269|NCT00464334|3617243|FG008|COMPLETED|Overall Study||2
2908270|NCT00464334|3617244|FG009|COMPLETED|Overall Study||4
2908271|NCT00464334|3617245|FG010|COMPLETED|Overall Study||4
2908272|NCT00464334|3617235|FG000|NOT COMPLETED|Overall Study||1
2908273|NCT00464334|3617236|FG001|NOT COMPLETED|Overall Study||8
2908274|NCT00464334|3617237|FG002|NOT COMPLETED|Overall Study||5
2908275|NCT00464334|3617238|FG003|NOT COMPLETED|Overall Study||4
2908276|NCT00464334|3617239|FG004|NOT COMPLETED|Overall Study||4
2908277|NCT00464334|3617240|FG005|NOT COMPLETED|Overall Study||4
2908278|NCT00464334|3617241|FG006|NOT COMPLETED|Overall Study||3
2908279|NCT00464334|3617242|FG007|NOT COMPLETED|Overall Study||1
2908280|NCT00464334|3617243|FG008|NOT COMPLETED|Overall Study||6
2908281|NCT00464334|3617244|FG009|NOT COMPLETED|Overall Study||1
2908282|NCT00464334|3617245|FG010|NOT COMPLETED|Overall Study||4
2908283|NCT00464438|3617282|FG000|STARTED|Overall Study||85
2908284|NCT00464438|3617283|FG001|STARTED|Overall Study||86
2908285|NCT00464438|3617282|FG000|COMPLETED|Overall Study||83
2908286|NCT00464438|3617283|FG001|COMPLETED|Overall Study||80
2908287|NCT00464438|3617282|FG000|NOT COMPLETED|Overall Study||2
2908288|NCT00464438|3617283|FG001|NOT COMPLETED|Overall Study||6
2908289|NCT00464464|3617291|FG000|STARTED|Overall Study||41
2908290|NCT00464464|3617292|FG001|STARTED|Overall Study||39
2908291|NCT00464464|3617291|FG000|COMPLETED|Overall Study||36
2908292|NCT00464464|3617292|FG001|COMPLETED|Overall Study||36
2908293|NCT00464464|3617291|FG000|NOT COMPLETED|Overall Study||5
2908294|NCT00464464|3617292|FG001|NOT COMPLETED|Overall Study||3
2908295|NCT00464490|3617300|FG000|STARTED|Overall Study||21
2908296|NCT00464490|3617301|FG001|STARTED|Overall Study||21
2908297|NCT00464490|3617300|FG000|COMPLETED|Overall Study||10
2908298|NCT00464490|3617301|FG001|COMPLETED|Overall Study||10
2908299|NCT00464490|3617300|FG000|NOT COMPLETED|Overall Study||11
2908300|NCT00464490|3617301|FG001|NOT COMPLETED|Overall Study||11
2908301|NCT00464542|3617307|FG000|STARTED|Pre-treatment||12
2908302|NCT00464542|3617307|FG000|COMPLETED|Pre-treatment||10
2908303|NCT00464542|3617307|FG000|NOT COMPLETED|Pre-treatment||2
2908304|NCT00464542|3617307|FG000|STARTED|Post-treatment||10
2908305|NCT00464542|3617307|FG000|COMPLETED|Post-treatment||10
2908306|NCT00464542|3617307|FG000|NOT COMPLETED|Post-treatment||0
2908307|NCT00464568|3617311|FG000|STARTED|Overall Study||32
2908308|NCT00464568|3617311|FG000|COMPLETED|Overall Study||30
2908309|NCT00464568|3617311|FG000|NOT COMPLETED|Overall Study||2
2908310|NCT00464620|3617328|FG000|STARTED|Overall Study||50
2908311|NCT00464620|3617329|FG001|STARTED|Overall Study||200
2908312|NCT00464620|3617330|FG002|STARTED|Overall Study||116
2908313|NCT00464620|3617328|FG000|COMPLETED|Overall Study|48 patients were evaluable.|48
2908314|NCT00464620|3617329|FG001|COMPLETED|Overall Study||198
2908315|NCT00464620|3617330|FG002|COMPLETED|Overall Study||109
2908316|NCT00464620|3617328|FG000|NOT COMPLETED|Overall Study||2
2908317|NCT00464620|3617329|FG001|NOT COMPLETED|Overall Study||2
2908318|NCT00464620|3617330|FG002|NOT COMPLETED|Overall Study||7
2908319|NCT00464646|3617345|FG000|STARTED|Overall Study||76
2908320|NCT00464646|3617346|FG001|STARTED|Overall Study||29
2908321|NCT00464646|3617345|FG000|COMPLETED|Overall Study||76
2908322|NCT00464646|3617346|FG001|COMPLETED|Overall Study||29
2908323|NCT00464646|3617345|FG000|NOT COMPLETED|Overall Study||0
2908324|NCT00464646|3617346|FG001|NOT COMPLETED|Overall Study||0
2908325|NCT00464672|3617355|FG000|STARTED|Overall Study||460
2908326|NCT00464672|3617356|FG001|STARTED|Overall Study||232
2908327|NCT00464672|3617357|FG002|STARTED|Overall Study||400
2908328|NCT00464672|3617358|FG003|STARTED|Overall Study||200
2908329|NCT00464672|3617359|FG004|STARTED|Overall Study||402
2908330|NCT00464672|3617360|FG005|STARTED|Overall Study||199
2908331|NCT00464672|3617355|FG000|COMPLETED|Overall Study||435
2908332|NCT00464672|3617356|FG001|COMPLETED|Overall Study||222
2908333|NCT00464672|3617357|FG002|COMPLETED|Overall Study||400
2908334|NCT00464672|3617358|FG003|COMPLETED|Overall Study||199
2908335|NCT00464672|3617359|FG004|COMPLETED|Overall Study||392
2908336|NCT00464672|3617360|FG005|COMPLETED|Overall Study||195
2908337|NCT00464672|3617355|FG000|NOT COMPLETED|Overall Study||25
2908338|NCT00464672|3617356|FG001|NOT COMPLETED|Overall Study||10
2908339|NCT00464672|3617357|FG002|NOT COMPLETED|Overall Study||0
2908340|NCT00464672|3617358|FG003|NOT COMPLETED|Overall Study||1
2908341|NCT00464672|3617359|FG004|NOT COMPLETED|Overall Study||10
2908342|NCT00464672|3617360|FG005|NOT COMPLETED|Overall Study||4
2908343|NCT00464685|3617390|FG000|STARTED|Overall Study||126
2908344|NCT00464685|3617391|FG001|STARTED|Overall Study||127
2908345|NCT00464685|3617390|FG000|COMPLETED|Overall Study||103
2908346|NCT00464685|3617391|FG001|COMPLETED|Overall Study||94
2908347|NCT00464685|3617390|FG000|NOT COMPLETED|Overall Study||23
2908348|NCT00464685|3617391|FG001|NOT COMPLETED|Overall Study||33
2908349|NCT00464698|3617397|FG000|STARTED|Period 1: 30 mg||20
2908350|NCT00464698|3617397|FG000|COMPLETED|Period 1: 30 mg||17
2908351|NCT00464698|3617397|FG000|NOT COMPLETED|Period 1: 30 mg||3
2908352|NCT00464698|3617397|FG000|STARTED|Period 2: 60 mg||17
2908353|NCT00464698|3617397|FG000|COMPLETED|Period 2: 60 mg||17
2908354|NCT00464698|3617397|FG000|NOT COMPLETED|Period 2: 60 mg||0
2908355|NCT00464698|3617397|FG000|STARTED|Period 3: 120mg||14
2908356|NCT00464698|3617397|FG000|COMPLETED|Period 3: 120mg||12
2908357|NCT00464698|3617397|FG000|NOT COMPLETED|Period 3: 120mg||2
2908358|NCT00464711|3617403|FG000|STARTED|Overall Study||40
2908359|NCT00464711|3617403|FG000|COMPLETED|Overall Study||25
2908360|NCT00464711|3617403|FG000|NOT COMPLETED|Overall Study||15
2908361|NCT00464737|3617410|FG000|STARTED|Overall Study||82
2908362|NCT00464737|3617411|FG001|STARTED|Overall Study||74
2908363|NCT00464737|3617412|FG002|STARTED|Overall Study||74
2908364|NCT00464737|3617410|FG000|COMPLETED|Overall Study||50
2908365|NCT00464737|3617411|FG001|COMPLETED|Overall Study||42
2908366|NCT00464737|3617412|FG002|COMPLETED|Overall Study||19
2908367|NCT00464737|3617410|FG000|NOT COMPLETED|Overall Study||32
2908368|NCT00464737|3617411|FG001|NOT COMPLETED|Overall Study||32
2908369|NCT00464737|3617412|FG002|NOT COMPLETED|Overall Study||55
2908370|NCT00464815|3617422|FG000|STARTED|Overall Study||768
2908371|NCT00464815|3617423|FG001|STARTED|Overall Study||257
2908372|NCT00464815|3617422|FG000|COMPLETED|Overall Study||762
2908373|NCT00464815|3617423|FG001|COMPLETED|Overall Study||254
2908374|NCT00464815|3617422|FG000|NOT COMPLETED|Overall Study||6
2908375|NCT00464815|3617423|FG001|NOT COMPLETED|Overall Study||3
2908376|NCT00464945|3617431|FG000|STARTED|Infant Series||135
2908377|NCT00464945|3617432|FG001|STARTED|Infant Series||134
2908378|NCT00464945|3617431|FG000|Vaccinated Dose 1|Infant Series||134
2908379|NCT00464945|3617432|FG001|Vaccinated Dose 1|Infant Series||134
2908380|NCT00464945|3617431|FG000|Vaccinated Dose 2|Infant Series||132
2908381|NCT00464945|3617432|FG001|Vaccinated Dose 2|Infant Series||133
2908382|NCT00464945|3617431|FG000|Vaccinated Dose 3|Infant Series||132
2908383|NCT00464945|3617432|FG001|Vaccinated Dose 3|Infant Series||133
2908384|NCT00464945|3617431|FG000|COMPLETED|Infant Series||131
2908385|NCT00464945|3617432|FG001|COMPLETED|Infant Series||133
2908386|NCT00464945|3617431|FG000|NOT COMPLETED|Infant Series||4
2908387|NCT00464945|3617432|FG001|NOT COMPLETED|Infant Series||1
2908388|NCT00464945|3617431|FG000|STARTED|After Infant Series||131
2908389|NCT00464945|3617432|FG001|STARTED|After Infant Series||133
2908390|NCT00464945|3617431|FG000|COMPLETED|After Infant Series||131
2908391|NCT00464945|3617432|FG001|COMPLETED|After Infant Series||131
2908392|NCT00464945|3617431|FG000|NOT COMPLETED|After Infant Series||0
2908393|NCT00464945|3617432|FG001|NOT COMPLETED|After Infant Series||2
2908394|NCT00464945|3617431|FG000|STARTED|Toddler Dose||131
2908395|NCT00464945|3617432|FG001|STARTED|Toddler Dose||131
2908396|NCT00464945|3617431|FG000|COMPLETED|Toddler Dose||131
2908397|NCT00464945|3617432|FG001|COMPLETED|Toddler Dose||130
2908398|NCT00464945|3617431|FG000|NOT COMPLETED|Toddler Dose||0
2908399|NCT00464945|3617432|FG001|NOT COMPLETED|Toddler Dose||1
2908400|NCT00465088|3617456|FG000|STARTED|Overall Study|For both arms, started means treated.|114
2908401|NCT00465088|3617457|FG001|STARTED|Overall Study||79
2908402|NCT00465088|3617456|FG000|COMPLETED|Overall Study||82
2908403|NCT00465088|3617457|FG001|COMPLETED|Overall Study||70
2908404|NCT00465088|3617456|FG000|NOT COMPLETED|Overall Study||32
2908405|NCT00465088|3617457|FG001|NOT COMPLETED|Overall Study||9
2908406|NCT00465101|3617463|FG000|STARTED|Overall Study||150
2908407|NCT00465101|3617463|FG000|COMPLETED|Overall Study||91
2908408|NCT00465101|3617463|FG000|NOT COMPLETED|Overall Study||59
2908409|NCT00465179|3617489|FG000|STARTED|Overall Study||57
2908410|NCT00465179|3617489|FG000|COMPLETED|Overall Study||4
2908411|NCT00465179|3617489|FG000|NOT COMPLETED|Overall Study||53
2908412|NCT00465270|3617495|FG000|STARTED|Overall Study||499
2908413|NCT00465270|3617496|FG001|STARTED|Overall Study||481
2908414|NCT00465270|3617495|FG000|COMPLETED|Overall Study||395
2908415|NCT00465270|3617496|FG001|COMPLETED|Overall Study||321
2908416|NCT00465270|3617495|FG000|NOT COMPLETED|Overall Study||104
2908417|NCT00465270|3617496|FG001|NOT COMPLETED|Overall Study||160
2908418|NCT00465361|3617502|FG000|STARTED|Baseline Assessment||7
2908419|NCT00465361|3617502|FG000|COMPLETED|Baseline Assessment||3
2908420|NCT00465361|3617502|FG000|NOT COMPLETED|Baseline Assessment||4
2908421|NCT00465361|3617502|FG000|STARTED|Post-Intervention Assessment||3
2908422|NCT00465361|3617502|FG000|COMPLETED|Post-Intervention Assessment||3
2908423|NCT00465361|3617502|FG000|NOT COMPLETED|Post-Intervention Assessment||0
2908424|NCT00465530|3617508|FG000|STARTED|Overall Study||21
2908425|NCT00465530|3617509|FG001|STARTED|Overall Study||19
2908426|NCT00465530|3617508|FG000|COMPLETED|Overall Study||19
2908427|NCT00465530|3617509|FG001|COMPLETED|Overall Study||15
2908428|NCT00465530|3617508|FG000|NOT COMPLETED|Overall Study||2
2908429|NCT00465530|3617509|FG001|NOT COMPLETED|Overall Study||4
2908430|NCT00465569|3617517|FG000|STARTED|Overall Study||13
2908431|NCT00465569|3617518|FG001|STARTED|Overall Study||7
2908432|NCT00465569|3617517|FG000|COMPLETED|Overall Study||12
2908433|NCT00465569|3617518|FG001|COMPLETED|Overall Study||7
2908434|NCT00465569|3617517|FG000|NOT COMPLETED|Overall Study||1
2908435|NCT00465569|3617518|FG001|NOT COMPLETED|Overall Study||0
2908436|NCT00465595|3617526|FG000|STARTED|Overall Study||27
2908437|NCT00465595|3617527|FG001|STARTED|Overall Study||29
2908438|NCT00465595|3617526|FG000|COMPLETED|Overall Study||22
2908439|NCT00465595|3617527|FG001|COMPLETED|Overall Study||24
2908440|NCT00465595|3617526|FG000|NOT COMPLETED|Overall Study||5
2908441|NCT00465595|3617527|FG001|NOT COMPLETED|Overall Study||5
2908442|NCT00465647|3617543|FG000|STARTED|Overall Study||39
2908443|NCT00465647|3617544|FG001|STARTED|Overall Study||23
2908444|NCT00465647|3617545|FG002|STARTED|Overall Study||29
2908445|NCT00465647|3617546|FG003|STARTED|Overall Study||25
2908446|NCT00465647|3617543|FG000|COMPLETED|Overall Study||26
2908447|NCT00465647|3617544|FG001|COMPLETED|Overall Study||15
2908448|NCT00465647|3617545|FG002|COMPLETED|Overall Study||18
2908449|NCT00465647|3617546|FG003|COMPLETED|Overall Study||12
2908450|NCT00465647|3617543|FG000|NOT COMPLETED|Overall Study||13
2908451|NCT00465647|3617544|FG001|NOT COMPLETED|Overall Study||8
2908452|NCT00465647|3617545|FG002|NOT COMPLETED|Overall Study||11
2908453|NCT00465647|3617546|FG003|NOT COMPLETED|Overall Study||13
2908454|NCT00465738|3617568|FG000|STARTED|Overall Study||97
2908455|NCT00465738|3617569|FG001|STARTED|Overall Study||95
2908456|NCT00465738|3617568|FG000|COMPLETED|Overall Study||91
2908457|NCT00465738|3617569|FG001|COMPLETED|Overall Study||89
2908458|NCT00465738|3617568|FG000|NOT COMPLETED|Overall Study||6
2908459|NCT00465738|3617569|FG001|NOT COMPLETED|Overall Study||6
2908460|NCT00465816|3617578|FG000|STARTED|Overall Study||367
2908461|NCT00465816|3617579|FG001|STARTED|Overall Study||122
2908462|NCT00465816|3617580|FG002|STARTED|Overall Study||122
2908463|NCT00465816|3617578|FG000|COMPLETED|Overall Study||367
2908464|NCT00465816|3617579|FG001|COMPLETED|Overall Study||122
2908465|NCT00465816|3617580|FG002|COMPLETED|Overall Study||120
2908466|NCT00465816|3617578|FG000|NOT COMPLETED|Overall Study||0
2908467|NCT00465816|3617579|FG001|NOT COMPLETED|Overall Study||0
2908468|NCT00465816|3617580|FG002|NOT COMPLETED|Overall Study||2
2908469|NCT00465894|3617591|FG000|STARTED|Treatment For 12 Weeks||30
2908470|NCT00465894|3617592|FG001|STARTED|Treatment For 12 Weeks||28
2908471|NCT00465894|3617591|FG000|COMPLETED|Treatment For 12 Weeks||25
2908472|NCT00465894|3617592|FG001|COMPLETED|Treatment For 12 Weeks||25
2908473|NCT00465894|3617591|FG000|NOT COMPLETED|Treatment For 12 Weeks||5
2908474|NCT00465894|3617592|FG001|NOT COMPLETED|Treatment For 12 Weeks||3
2908475|NCT00465894|3617591|FG000|STARTED|Treatment From 12 Weeks To 24 Weeks|We included data only from participants that had complete data sets.|14
2908476|NCT00465894|3617592|FG001|STARTED|Treatment From 12 Weeks To 24 Weeks|We included data only from participants that had complete data sets.|14
2908477|NCT00465894|3617591|FG000|COMPLETED|Treatment From 12 Weeks To 24 Weeks||14
2908478|NCT00465894|3617592|FG001|COMPLETED|Treatment From 12 Weeks To 24 Weeks||14
2908479|NCT00465894|3617591|FG000|NOT COMPLETED|Treatment From 12 Weeks To 24 Weeks||0
2908480|NCT00465894|3617592|FG001|NOT COMPLETED|Treatment From 12 Weeks To 24 Weeks||0
2908481|NCT00465894|3617591|FG000|STARTED|Treatment From 24 Weeks to 52 Weeks|We included data only from participants that had complete data sets.|11
3171490|NCT01934140|3898633|FG001|COMPLETED|Booster Phase (6 Months)||53
3171491|NCT01934140|3898632|FG000|NOT COMPLETED|Booster Phase (6 Months)||5
3171492|NCT01934140|3898633|FG001|NOT COMPLETED|Booster Phase (6 Months)||3
2908482|NCT00465894|3617592|FG001|STARTED|Treatment From 24 Weeks to 52 Weeks||14
2908483|NCT00465894|3617591|FG000|COMPLETED|Treatment From 24 Weeks to 52 Weeks||11
2908484|NCT00465894|3617592|FG001|COMPLETED|Treatment From 24 Weeks to 52 Weeks||14
2908485|NCT00465894|3617591|FG000|NOT COMPLETED|Treatment From 24 Weeks to 52 Weeks||0
2908486|NCT00465894|3617592|FG001|NOT COMPLETED|Treatment From 24 Weeks to 52 Weeks||0
2908487|NCT00465972|3617616|FG000|STARTED|Overall Study||20
2908488|NCT00465972|3617617|FG001|STARTED|Overall Study||24
2908489|NCT00465972|3617616|FG000|COMPLETED|Overall Study||18
2908490|NCT00465972|3617617|FG001|COMPLETED|Overall Study||23
2908491|NCT00465972|3617616|FG000|NOT COMPLETED|Overall Study||2
2908492|NCT00465972|3617617|FG001|NOT COMPLETED|Overall Study||1
2908493|NCT00465985|3617625|FG000|STARTED|Part I - Open-label Treatment Period|All patients received treatment with ACZ885 in Part I of the study.|35
2908494|NCT00465985|3617626|FG001|STARTED|Part I - Open-label Treatment Period||0
2908495|NCT00465985|3617625|FG000|COMPLETED|Part I - Open-label Treatment Period|Only patients with a complete response completed Part I and entered Part II of the study.|31
2908496|NCT00465985|3617626|FG001|COMPLETED|Part I - Open-label Treatment Period||0
2908497|NCT00465985|3617625|FG000|NOT COMPLETED|Part I - Open-label Treatment Period||4
2908498|NCT00465985|3617626|FG001|NOT COMPLETED|Part I - Open-label Treatment Period||0
2908499|NCT00465985|3617625|FG000|STARTED|Part II - 1:1 ACZ885:Placebo|Patients with complete response to treatment entered Part II and were randomized to ACZ885 ,placebo.|15
2908500|NCT00465985|3617626|FG001|STARTED|Part II - 1:1 ACZ885:Placebo||16
2908501|NCT00465985|3617625|FG000|COMPLETED|Part II - 1:1 ACZ885:Placebo||15
2908502|NCT00465985|3617626|FG001|COMPLETED|Part II - 1:1 ACZ885:Placebo||4
2908503|NCT00465985|3617625|FG000|NOT COMPLETED|Part II - 1:1 ACZ885:Placebo||0
2908504|NCT00465985|3617626|FG001|NOT COMPLETED|Part II - 1:1 ACZ885:Placebo||12
2908505|NCT00465985|3617625|FG000|STARTED|Part III - Open-label Treatment Period|All patients received treatment with ACZ885 in Part III of the study.|31
2908506|NCT00465985|3617626|FG001|STARTED|Part III - Open-label Treatment Period||0
2908507|NCT00465985|3617625|FG000|COMPLETED|Part III - Open-label Treatment Period||29
2908508|NCT00465985|3617626|FG001|COMPLETED|Part III - Open-label Treatment Period||0
2908509|NCT00465985|3617625|FG000|NOT COMPLETED|Part III - Open-label Treatment Period||2
2908510|NCT00465985|3617626|FG001|NOT COMPLETED|Part III - Open-label Treatment Period||0
2908511|NCT00465998|3617635|FG000|STARTED|Overall Study||275
2908512|NCT00465998|3617635|FG000|COMPLETED|Overall Study||275
2908513|NCT00465998|3617635|FG000|NOT COMPLETED|Overall Study||0
2908514|NCT00466167|3617643|FG000|STARTED|Overall Study||165
2908515|NCT00466167|3617644|FG001|STARTED|Overall Study||175
2908516|NCT00466167|3617645|FG002|STARTED|Overall Study||178
2908517|NCT00466167|3617643|FG000|COMPLETED|Overall Study||145
2908518|NCT00466167|3617644|FG001|COMPLETED|Overall Study||163
2908519|NCT00466167|3617645|FG002|COMPLETED|Overall Study||157
2908520|NCT00466167|3617643|FG000|NOT COMPLETED|Overall Study||20
2908521|NCT00466167|3617644|FG001|NOT COMPLETED|Overall Study||12
2908522|NCT00466167|3617645|FG002|NOT COMPLETED|Overall Study||21
2908523|NCT00466193|3617655|FG000|STARTED|Overall Study||150
2908524|NCT00466193|3617656|FG001|STARTED|Overall Study||145
2908525|NCT00466193|3617655|FG000|COMPLETED|Overall Study||138
2908526|NCT00466193|3617656|FG001|COMPLETED|Overall Study|One patient did not report at least one Latency Sleep Onset following middle-of-the-night awakening.|137
2908527|NCT00466193|3617655|FG000|NOT COMPLETED|Overall Study||12
2908528|NCT00466193|3617656|FG001|NOT COMPLETED|Overall Study||8
2908529|NCT00466206|3617662|FG000|STARTED|Overall Study||10
3171493|NCT01934192|3898645|FG000|STARTED|Overall Study||40
3171494|NCT01934192|3898646|FG001|STARTED|Overall Study||44
3171495|NCT01934192|3898647|FG002|STARTED|Overall Study||4
3171496|NCT01934192|3898648|FG003|STARTED|Overall Study||4
3171497|NCT01934192|3898645|FG000|COMPLETED|Overall Study||31
3171498|NCT01934192|3898646|FG001|COMPLETED|Overall Study||37
3171499|NCT01934192|3898647|FG002|COMPLETED|Overall Study||3
3171500|NCT01934192|3898648|FG003|COMPLETED|Overall Study||3
3171501|NCT01934192|3898645|FG000|NOT COMPLETED|Overall Study||9
3171502|NCT01934192|3898646|FG001|NOT COMPLETED|Overall Study||7
3171503|NCT01934192|3898647|FG002|NOT COMPLETED|Overall Study||1
3384510|NCT02180217|4119614|FG002|Discontinued Prior to W48 But After W26|Overall Study||3
3384511|NCT02180217|4119612|FG000|Completed Week 48 (Core Phase)|Overall Study||36
3171504|NCT01934192|3898648|FG003|NOT COMPLETED|Overall Study||1
2908530|NCT00466206|3617662|FG000|COMPLETED|Overall Study|One of 10 patients withdrawn from study but completed treatment under Compassionate Use Designation|10
2908531|NCT00466206|3617662|FG000|NOT COMPLETED|Overall Study||0
2908532|NCT00466310|3617672|FG000|STARTED|Overall Study||20
2908533|NCT00466310|3617673|FG001|STARTED|Overall Study||20
2908534|NCT00466310|3617674|FG002|STARTED|Overall Study||31
2908535|NCT00466310|3617672|FG000|COMPLETED|Overall Study||20
2908536|NCT00466310|3617673|FG001|COMPLETED|Overall Study||20
2908537|NCT00466310|3617674|FG002|COMPLETED|Overall Study||31
2908538|NCT00466310|3617672|FG000|NOT COMPLETED|Overall Study||0
2908539|NCT00466310|3617673|FG001|NOT COMPLETED|Overall Study||0
2908540|NCT00466310|3617674|FG002|NOT COMPLETED|Overall Study||0
2908541|NCT00466323|3617684|FG000|STARTED|Overall Study||117
2908542|NCT00466323|3617685|FG001|STARTED|Overall Study||115
2908543|NCT00466323|3617684|FG000|COMPLETED|Overall Study||89
2908544|NCT00466323|3617685|FG001|COMPLETED|Overall Study||92
2908545|NCT00466323|3617684|FG000|NOT COMPLETED|Overall Study||28
2908546|NCT00466323|3617685|FG001|NOT COMPLETED|Overall Study||23
2908547|NCT00466440|3617694|FG000|STARTED|Overall Study||14
2908548|NCT00466440|3617695|FG001|STARTED|Overall Study||48
2908549|NCT00466440|3617696|FG002|STARTED|Overall Study||46
2908550|NCT00466440|3617694|FG000|Received at Least One Dose of Study Drug|Overall Study||14
2908551|NCT00466440|3617695|FG001|Received at Least One Dose of Study Drug|Overall Study||47
2908552|NCT00466440|3617696|FG002|Received at Least One Dose of Study Drug|Overall Study||41
2908553|NCT00466440|3617694|FG000|COMPLETED|Overall Study||0
2908554|NCT00466440|3617695|FG001|COMPLETED|Overall Study|Completed = completed 4 cycles of treatment|36
2908555|NCT00466440|3617696|FG002|COMPLETED|Overall Study|Completed = completed 4 cycles of treatment|34
2908556|NCT00466440|3617694|FG000|NOT COMPLETED|Overall Study||14
2908557|NCT00466440|3617695|FG001|NOT COMPLETED|Overall Study||12
2908558|NCT00466440|3617696|FG002|NOT COMPLETED|Overall Study||12
2908559|NCT00466505|3617713|FG000|STARTED|Overall Study||17
2908560|NCT00466505|3617713|FG000|COMPLETED|Overall Study||0
2908561|NCT00466505|3617713|FG000|NOT COMPLETED|Overall Study||17
2908562|NCT00466661|3617719|FG000|STARTED|Overall Study||16
2908563|NCT00466661|3617720|FG001|STARTED|Overall Study||17
2908564|NCT00466661|3617719|FG000|At Least 1 Postrandomization Visit|Overall Study||14
2908565|NCT00466661|3617720|FG001|At Least 1 Postrandomization Visit|Overall Study||16
2908566|NCT00466661|3617719|FG000|COMPLETED|Overall Study||12
2908567|NCT00466661|3617720|FG001|COMPLETED|Overall Study||11
2908568|NCT00466661|3617719|FG000|NOT COMPLETED|Overall Study||4
2908569|NCT00466661|3617720|FG001|NOT COMPLETED|Overall Study||6
2908570|NCT00466687|3617726|FG000|STARTED|Overall Study||34
3171505|NCT01934218|3898671|FG000|STARTED|Double-blind Phase||404
3171506|NCT01934218|3898672|FG001|STARTED|Double-blind Phase||410
3171507|NCT01934218|3898671|FG000|Analyzed Participants|Double-blind Phase||402
3171508|NCT01934218|3898672|FG001|Analyzed Participants|Double-blind Phase||407
3171509|NCT01934218|3898671|FG000|COMPLETED|Double-blind Phase||356
2908571|NCT00466687|3617726|FG000|COMPLETED|Overall Study||0
2908572|NCT00466687|3617726|FG000|NOT COMPLETED|Overall Study||34
2908573|NCT00466726|3617732|FG000|STARTED|Overall Study||57
2908574|NCT00466726|3617732|FG000|COMPLETED|Overall Study||43
2908575|NCT00466726|3617732|FG000|NOT COMPLETED|Overall Study||14
2908576|NCT00466752|3617738|FG000|STARTED|Overall Study||5
2908577|NCT00466752|3617739|FG001|STARTED|Overall Study||0
2908578|NCT00466752|3617738|FG000|COMPLETED|Overall Study||5
2908579|NCT00466752|3617739|FG001|COMPLETED|Overall Study||0
2908580|NCT00466752|3617738|FG000|NOT COMPLETED|Overall Study||0
2908581|NCT00466752|3617739|FG001|NOT COMPLETED|Overall Study||0
2908582|NCT00466817|3617747|FG000|STARTED|Overall Study||49
2908583|NCT00466817|3617748|FG001|STARTED|Overall Study||47
2908584|NCT00466817|3617747|FG000|COMPLETED|Overall Study||44
2908585|NCT00466817|3617748|FG001|COMPLETED|Overall Study||43
2908586|NCT00466817|3617747|FG000|NOT COMPLETED|Overall Study||5
2908587|NCT00466817|3617748|FG001|NOT COMPLETED|Overall Study||4
2908588|NCT00466921|3617763|FG000|STARTED|First 3 Cycles of Treatment|One patient completed only a few days of treatment|33
2908589|NCT00466921|3617763|FG000|Completed 1 Cycle|First 3 Cycles of Treatment||32
2908590|NCT00466921|3617763|FG000|Started Cycle 2|First 3 Cycles of Treatment||31
2908591|NCT00466921|3617763|FG000|Completed 3 Cycles|First 3 Cycles of Treatment||26
2908592|NCT00466921|3617763|FG000|COMPLETED|First 3 Cycles of Treatment||26
2908593|NCT00466921|3617763|FG000|NOT COMPLETED|First 3 Cycles of Treatment||7
2908594|NCT00466921|3617763|FG000|STARTED|Completed 4 Cycles/Reached 1st Response||26
2908595|NCT00466921|3617763|FG000|Completed 4 Cycles/1st Response|Completed 4 Cycles/Reached 1st Response||21
2908596|NCT00466921|3617763|FG000|COMPLETED|Completed 4 Cycles/Reached 1st Response||21
2908597|NCT00466921|3617763|FG000|NOT COMPLETED|Completed 4 Cycles/Reached 1st Response||5
2908598|NCT00466921|3617763|FG000|STARTED|Continued Treatment||21
2908599|NCT00466921|3617763|FG000|COMPLETED|Continued Treatment||21
2908600|NCT00466921|3617763|FG000|NOT COMPLETED|Continued Treatment||0
2908601|NCT00466921|3617763|FG000|STARTED|Follow up for a Minimum of 1 Year||33
2908602|NCT00466921|3617763|FG000|COMPLETED|Follow up for a Minimum of 1 Year||27
2908603|NCT00466921|3617763|FG000|NOT COMPLETED|Follow up for a Minimum of 1 Year||6
2908604|NCT00466947|3617769|FG000|STARTED|Primary Outcome Analysis Period||11875
2908605|NCT00466947|3617770|FG001|STARTED|Primary Outcome Analysis Period||11863
2908606|NCT00466947|3617769|FG000|Ongoing|Primary Outcome Analysis Period||11875
3171510|NCT01934218|3898672|FG001|COMPLETED|Double-blind Phase||356
3171511|NCT01934218|3898671|FG000|NOT COMPLETED|Double-blind Phase||48
2908607|NCT00466947|3617770|FG001|Ongoing|Primary Outcome Analysis Period||11863
2908608|NCT00466947|3617769|FG000|COMPLETED|Primary Outcome Analysis Period|No data on study completion and withdrawal were available at first analysis as the study was ongoing|0
2908609|NCT00466947|3617770|FG001|COMPLETED|Primary Outcome Analysis Period|No data on study completion and withdrawal were available at first analysis as the study was ongoing|0
2908610|NCT00466947|3617769|FG000|NOT COMPLETED|Primary Outcome Analysis Period||11875
2908611|NCT00466947|3617770|FG001|NOT COMPLETED|Primary Outcome Analysis Period||11863
2908612|NCT00466947|3617769|FG000|STARTED|Study End Analysis Period||11798
2908613|NCT00466947|3617770|FG001|STARTED|Study End Analysis Period||11799
2908614|NCT00466947|3617769|FG000|COMPLETED|Study End Analysis Period||9302
2908615|NCT00466947|3617770|FG001|COMPLETED|Study End Analysis Period||9265
2908616|NCT00466947|3617769|FG000|NOT COMPLETED|Study End Analysis Period||2496
3171512|NCT01934218|3898672|FG001|NOT COMPLETED|Double-blind Phase||54
3171513|NCT01934218|3898671|FG000|STARTED|Open-Label Phase||316
3171514|NCT01934218|3898672|FG001|STARTED|Open-Label Phase||328
3171515|NCT01934218|3898671|FG000|COMPLETED|Open-Label Phase||290
3171516|NCT01934218|3898672|FG001|COMPLETED|Open-Label Phase||304
3171517|NCT01934218|3898671|FG000|NOT COMPLETED|Open-Label Phase||26
3171518|NCT01934218|3898672|FG001|NOT COMPLETED|Open-Label Phase||24
3171519|NCT01934231|3898678|FG000|STARTED|Overall Study||27
3171520|NCT01934231|3898678|FG000|COMPLETED|Overall Study||27
3171521|NCT01934231|3898678|FG000|NOT COMPLETED|Overall Study||0
3171522|NCT01934335|3898684|FG000|STARTED|Overall Study||7
3171523|NCT01934335|3898685|FG001|STARTED|Overall Study||5
3171524|NCT01934335|3898684|FG000|COMPLETED|Overall Study||6
3171525|NCT01934335|3898685|FG001|COMPLETED|Overall Study||4
3171526|NCT01934335|3898684|FG000|NOT COMPLETED|Overall Study||1
3171527|NCT01934335|3898685|FG001|NOT COMPLETED|Overall Study||1
3171528|NCT01934517|3898691|FG000|STARTED|Overall Study||25
3171529|NCT01934517|3898691|FG000|COMPLETED|Overall Study||25
3316203|NCT03107793|4049493|FG002|NOT COMPLETED|Induction Period (16 Weeks)||0
3316204|NCT03107793|4049491|FG000|STARTED|Maintenance Period (16-48 Week)||0
3316205|NCT03107793|4049492|FG001|STARTED|Maintenance Period (16-48 Week)||220
2908617|NCT00466947|3617770|FG001|NOT COMPLETED|Study End Analysis Period||2534
2908618|NCT00466960|3617777|FG000|STARTED|Overall Study||21
2908619|NCT00466960|3617777|FG000|COMPLETED|Overall Study||21
2908620|NCT00466960|3617777|FG000|NOT COMPLETED|Overall Study||0
2908621|NCT00467038|3617783|FG000|STARTED|Overall Study||11
2908622|NCT00467038|3617784|FG001|STARTED|Overall Study||11
2908623|NCT00467038|3617783|FG000|COMPLETED|Overall Study||11
2908624|NCT00467038|3617784|FG001|COMPLETED|Overall Study||11
2908625|NCT00467038|3617783|FG000|NOT COMPLETED|Overall Study||0
2908626|NCT00467038|3617784|FG001|NOT COMPLETED|Overall Study||0
2908627|NCT00467051|3617791|FG000|STARTED|Overall Study||20
2908628|NCT00467051|3617791|FG000|COMPLETED|Overall Study||18
2908629|NCT00467051|3617791|FG000|NOT COMPLETED|Overall Study||2
2908630|NCT00467077|3617796|FG000|STARTED|Overall Study||21
2908631|NCT00467077|3617796|FG000|COMPLETED|Overall Study||21
2908632|NCT00467077|3617796|FG000|NOT COMPLETED|Overall Study||0
2908633|NCT00467259|3617802|FG000|STARTED|Overall Study||251
2908634|NCT00467259|3617803|FG001|STARTED|Overall Study||1020
2908635|NCT00467259|3617802|FG000|ITT Population|Overall Study||251
2908636|NCT00467259|3617803|FG001|ITT Population|Overall Study|One subject did not take any study medication and was excluded from ITT population.|1019
2908637|NCT00467259|3617802|FG000|COMPLETED|Overall Study||176
2908638|NCT00467259|3617803|FG001|COMPLETED|Overall Study||778
2908639|NCT00467259|3617802|FG000|NOT COMPLETED|Overall Study||75
3316206|NCT03107793|4049493|FG002|STARTED|Maintenance Period (16-48 Week)||221
3316207|NCT03107793|4049491|FG000|COMPLETED|Maintenance Period (16-48 Week)||0
3316208|NCT03107793|4049492|FG001|COMPLETED|Maintenance Period (16-48 Week)||174
3316209|NCT03107793|4049493|FG002|COMPLETED|Maintenance Period (16-48 Week)||193
3316210|NCT03107793|4049491|FG000|NOT COMPLETED|Maintenance Period (16-48 Week)||0
3316211|NCT03107793|4049492|FG001|NOT COMPLETED|Maintenance Period (16-48 Week)||46
3316212|NCT03107793|4049493|FG002|NOT COMPLETED|Maintenance Period (16-48 Week)||28
3316213|NCT03108027|4049500|FG000|STARTED|Period 1||7
3316214|NCT03108027|4049501|FG001|STARTED|Period 1||6
2908640|NCT00467259|3617803|FG001|NOT COMPLETED|Overall Study||242
2908641|NCT00467272|3617809|FG000|STARTED|Overall Study||41
2908642|NCT00467272|3617809|FG000|COMPLETED|Overall Study||38
2908643|NCT00467272|3617809|FG000|NOT COMPLETED|Overall Study||3
2908644|NCT00467285|3617815|FG000|STARTED|Overall Study||32
2908645|NCT00467285|3617816|FG001|STARTED|Overall Study||64
2908646|NCT00467285|3617815|FG000|COMPLETED|Overall Study||28
2908647|NCT00467285|3617816|FG001|COMPLETED|Overall Study||60
2908648|NCT00467285|3617815|FG000|NOT COMPLETED|Overall Study||4
2908649|NCT00467285|3617816|FG001|NOT COMPLETED|Overall Study||4
2908650|NCT00467298|3617826|FG000|STARTED|Overall Study||46
2908651|NCT00467298|3617827|FG001|STARTED|Overall Study||44
2908652|NCT00467298|3617826|FG000|COMPLETED|Overall Study||42
2908653|NCT00467298|3617827|FG001|COMPLETED|Overall Study||38
2908654|NCT00467298|3617826|FG000|NOT COMPLETED|Overall Study||4
2908655|NCT00467298|3617827|FG001|NOT COMPLETED|Overall Study||6
2908656|NCT00467350|3617835|FG000|STARTED|Overall Study||41
2908657|NCT00467350|3617836|FG001|STARTED|Overall Study||39
2908658|NCT00467350|3617835|FG000|COMPLETED|Overall Study||40
2908659|NCT00467350|3617836|FG001|COMPLETED|Overall Study||39
3171530|NCT01934517|3898691|FG000|NOT COMPLETED|Overall Study||0
3171531|NCT01934556|3898702|FG000|STARTED|Overall Study||30
3171532|NCT01934556|3898703|FG001|STARTED|Overall Study||60
3171533|NCT01934556|3898704|FG002|STARTED|Overall Study||60
2908660|NCT00467350|3617835|FG000|NOT COMPLETED|Overall Study||1
2908661|NCT00467350|3617836|FG001|NOT COMPLETED|Overall Study||0
2908662|NCT00467363|3617844|FG000|STARTED|Overall Study||615
2908663|NCT00467363|3617845|FG001|STARTED|Overall Study||613
2908664|NCT00467363|3617844|FG000|COMPLETED|Overall Study||535
2908665|NCT00467363|3617845|FG001|COMPLETED|Overall Study||543
2908666|NCT00467363|3617844|FG000|NOT COMPLETED|Overall Study||80
2908667|NCT00467363|3617845|FG001|NOT COMPLETED|Overall Study||70
2908668|NCT00467389|3617851|FG000|STARTED|Overall Study||6
2908669|NCT00467389|3617852|FG001|STARTED|Overall Study||6
2908670|NCT00467389|3617851|FG000|COMPLETED|Overall Study||6
2908671|NCT00467389|3617852|FG001|COMPLETED|Overall Study||6
2908672|NCT00467389|3617851|FG000|NOT COMPLETED|Overall Study||0
2908673|NCT00467389|3617852|FG001|NOT COMPLETED|Overall Study||0
2908674|NCT00467519|3617860|FG000|STARTED|Overall Study||531
2908675|NCT00467519|3617861|FG001|STARTED|Overall Study||511
2908676|NCT00467519|3617860|FG000|COMPLETED|Overall Study||517
2908677|NCT00467519|3617861|FG001|COMPLETED|Overall Study||488
2908678|NCT00467519|3617860|FG000|NOT COMPLETED|Overall Study||14
2908679|NCT00467519|3617861|FG001|NOT COMPLETED|Overall Study||23
2908680|NCT00467558|3617869|FG000|STARTED|Overall Study||4
2908681|NCT00467558|3617870|FG001|STARTED|Overall Study||3
2908682|NCT00467558|3617869|FG000|COMPLETED|Overall Study||2
2908683|NCT00467558|3617870|FG001|COMPLETED|Overall Study||3
2908684|NCT00467558|3617869|FG000|NOT COMPLETED|Overall Study||2
2908685|NCT00467558|3617870|FG001|NOT COMPLETED|Overall Study||0
2908686|NCT00467584|3617879|FG000|STARTED|Overall Study||21
2908687|NCT00467584|3617880|FG001|STARTED|Overall Study||20
2908688|NCT00467584|3617881|FG002|STARTED|Overall Study||21
2908689|NCT00467584|3617879|FG000|COMPLETED|Overall Study||17
2908690|NCT00467584|3617880|FG001|COMPLETED|Overall Study||15
2908691|NCT00467584|3617881|FG002|COMPLETED|Overall Study||20
2908692|NCT00467584|3617879|FG000|NOT COMPLETED|Overall Study||4
2908693|NCT00467584|3617880|FG001|NOT COMPLETED|Overall Study||5
2908694|NCT00467584|3617881|FG002|NOT COMPLETED|Overall Study||1
2908695|NCT00467597|3617893|FG000|STARTED|Overall Study||26
2908696|NCT00467597|3617894|FG001|STARTED|Overall Study||6
2908697|NCT00467597|3617893|FG000|COMPLETED|Overall Study||24
2908698|NCT00467597|3617894|FG001|COMPLETED|Overall Study||6
2908699|NCT00467597|3617893|FG000|NOT COMPLETED|Overall Study||2
2908700|NCT00467597|3617894|FG001|NOT COMPLETED|Overall Study||0
2908701|NCT00467610|3617904|FG000|STARTED|Overall Study||6
2908702|NCT00467610|3617904|FG000|COMPLETED|Overall Study||5
2908703|NCT00467610|3617904|FG000|NOT COMPLETED|Overall Study||1
2908704|NCT00467649|3617910|FG000|STARTED|Phase 1 (Randomized Population)|One patient randomized to the SYMLIN group withdrew consent prior to receiving the first dose|57
2908705|NCT00467649|3617911|FG001|STARTED|Phase 1 (Randomized Population)||56
2908706|NCT00467649|3617912|FG002|STARTED|Phase 1 (Randomized Population)||0
2908707|NCT00467649|3617913|FG003|STARTED|Phase 1 (Randomized Population)||0
2908708|NCT00467649|3617914|FG004|STARTED|Phase 1 (Randomized Population)||0
2908709|NCT00467649|3617915|FG005|STARTED|Phase 1 (Randomized Population)||0
2908710|NCT00467649|3617910|FG000|Intent to Treat|Phase 1 (Randomized Population)||56
2908711|NCT00467649|3617911|FG001|Intent to Treat|Phase 1 (Randomized Population)||56
2908712|NCT00467649|3617912|FG002|Intent to Treat|Phase 1 (Randomized Population)||0
2908713|NCT00467649|3617913|FG003|Intent to Treat|Phase 1 (Randomized Population)||0
2908714|NCT00467649|3617914|FG004|Intent to Treat|Phase 1 (Randomized Population)||0
2908715|NCT00467649|3617915|FG005|Intent to Treat|Phase 1 (Randomized Population)||0
2908716|NCT00467649|3617910|FG000|COMPLETED|Phase 1 (Randomized Population)||48
2908717|NCT00467649|3617911|FG001|COMPLETED|Phase 1 (Randomized Population)||50
2908718|NCT00467649|3617912|FG002|COMPLETED|Phase 1 (Randomized Population)||0
2908719|NCT00467649|3617913|FG003|COMPLETED|Phase 1 (Randomized Population)||0
2908720|NCT00467649|3617914|FG004|COMPLETED|Phase 1 (Randomized Population)||0
2908721|NCT00467649|3617915|FG005|COMPLETED|Phase 1 (Randomized Population)||0
2908722|NCT00467649|3617910|FG000|NOT COMPLETED|Phase 1 (Randomized Population)||9
2908723|NCT00467649|3617911|FG001|NOT COMPLETED|Phase 1 (Randomized Population)||6
2908724|NCT00467649|3617912|FG002|NOT COMPLETED|Phase 1 (Randomized Population)||0
2908725|NCT00467649|3617913|FG003|NOT COMPLETED|Phase 1 (Randomized Population)||0
2908726|NCT00467649|3617914|FG004|NOT COMPLETED|Phase 1 (Randomized Population)||0
2908727|NCT00467649|3617915|FG005|NOT COMPLETED|Phase 1 (Randomized Population)||0
2908728|NCT00467649|3617910|FG000|STARTED|Phase 2 (Intent-to-Treat Population)||0
2908729|NCT00467649|3617911|FG001|STARTED|Phase 2 (Intent-to-Treat Population)||0
2908730|NCT00467649|3617912|FG002|STARTED|Phase 2 (Intent-to-Treat Population)||17
2908731|NCT00467649|3617913|FG003|STARTED|Phase 2 (Intent-to-Treat Population)||31
2908732|NCT00467649|3617914|FG004|STARTED|Phase 2 (Intent-to-Treat Population)||14
2908733|NCT00467649|3617915|FG005|STARTED|Phase 2 (Intent-to-Treat Population)||36
2908734|NCT00467649|3617910|FG000|COMPLETED|Phase 2 (Intent-to-Treat Population)||0
2908735|NCT00467649|3617911|FG001|COMPLETED|Phase 2 (Intent-to-Treat Population)||0
2908736|NCT00467649|3617912|FG002|COMPLETED|Phase 2 (Intent-to-Treat Population)||17
2908737|NCT00467649|3617913|FG003|COMPLETED|Phase 2 (Intent-to-Treat Population)||29
2908738|NCT00467649|3617914|FG004|COMPLETED|Phase 2 (Intent-to-Treat Population)||14
2908739|NCT00467649|3617915|FG005|COMPLETED|Phase 2 (Intent-to-Treat Population)||35
2908740|NCT00467649|3617910|FG000|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||0
2908741|NCT00467649|3617911|FG001|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||0
2908742|NCT00467649|3617912|FG002|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||0
2908743|NCT00467649|3617913|FG003|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||2
2908744|NCT00467649|3617914|FG004|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||0
2908745|NCT00467649|3617915|FG005|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||1
2908746|NCT00467740|3617938|FG000|STARTED|Overall Study||54
2908747|NCT00467740|3617939|FG001|STARTED|Overall Study||61
2908748|NCT00467740|3617940|FG002|STARTED|Overall Study||60
2908749|NCT00467740|3617941|FG003|STARTED|Overall Study||60
3171534|NCT01934556|3898702|FG000|COMPLETED|Overall Study||25
3171535|NCT01934556|3898703|FG001|COMPLETED|Overall Study||44
3171536|NCT01934556|3898704|FG002|COMPLETED|Overall Study||50
2908750|NCT00467740|3617942|FG004|STARTED|Overall Study||61
2908751|NCT00467740|3617938|FG000|COMPLETED|Overall Study||53
2908752|NCT00467740|3617939|FG001|COMPLETED|Overall Study||58
2908753|NCT00467740|3617940|FG002|COMPLETED|Overall Study||58
2908754|NCT00467740|3617941|FG003|COMPLETED|Overall Study||59
2908755|NCT00467740|3617942|FG004|COMPLETED|Overall Study||61
2908756|NCT00467740|3617938|FG000|NOT COMPLETED|Overall Study||1
2908757|NCT00467740|3617939|FG001|NOT COMPLETED|Overall Study||3
3171537|NCT01934556|3898702|FG000|NOT COMPLETED|Overall Study||5
3171538|NCT01934556|3898703|FG001|NOT COMPLETED|Overall Study||16
2908758|NCT00467740|3617940|FG002|NOT COMPLETED|Overall Study||2
2908759|NCT00467740|3617941|FG003|NOT COMPLETED|Overall Study||1
2908760|NCT00467740|3617942|FG004|NOT COMPLETED|Overall Study||0
2908761|NCT00467779|3617969|FG000|STARTED|Stage 1||4
2908762|NCT00467779|3617970|FG001|STARTED|Stage 1||3
2908763|NCT00467779|3617971|FG002|STARTED|Stage 1||3
2908764|NCT00467779|3617972|FG003|STARTED|Stage 1||3
2908765|NCT00467779|3617973|FG004|STARTED|Stage 1||3
2908766|NCT00467779|3617974|FG005|STARTED|Stage 1||6
2908767|NCT00467779|3617975|FG006|STARTED|Stage 1||7
2908768|NCT00467779|3617976|FG007|STARTED|Stage 1||7
2908769|NCT00467779|3617977|FG008|STARTED|Stage 1||0
2908770|NCT00467779|3617978|FG009|STARTED|Stage 1||0
2908771|NCT00467779|3617979|FG010|STARTED|Stage 1||0
2908772|NCT00467779|3617980|FG011|STARTED|Stage 1||0
2908773|NCT00467779|3617981|FG012|STARTED|Stage 1||0
2908774|NCT00467779|3617982|FG013|STARTED|Stage 1||0
2908775|NCT00467779|3617983|FG014|STARTED|Stage 1||0
2908776|NCT00467779|3617969|FG000|COMPLETED|Stage 1||0
2908777|NCT00467779|3617970|FG001|COMPLETED|Stage 1||0
2908778|NCT00467779|3617971|FG002|COMPLETED|Stage 1||0
2908779|NCT00467779|3617972|FG003|COMPLETED|Stage 1||0
2908780|NCT00467779|3617973|FG004|COMPLETED|Stage 1||0
2908781|NCT00467779|3617974|FG005|COMPLETED|Stage 1||1
2908782|NCT00467779|3617975|FG006|COMPLETED|Stage 1||0
2908783|NCT00467779|3617976|FG007|COMPLETED|Stage 1||0
2908784|NCT00467779|3617977|FG008|COMPLETED|Stage 1||0
2908785|NCT00467779|3617978|FG009|COMPLETED|Stage 1||0
2908786|NCT00467779|3617979|FG010|COMPLETED|Stage 1||0
2908787|NCT00467779|3617980|FG011|COMPLETED|Stage 1||0
2908788|NCT00467779|3617981|FG012|COMPLETED|Stage 1||0
2908789|NCT00467779|3617982|FG013|COMPLETED|Stage 1||0
2908790|NCT00467779|3617983|FG014|COMPLETED|Stage 1||0
2908791|NCT00467779|3617969|FG000|NOT COMPLETED|Stage 1||4
2908792|NCT00467779|3617970|FG001|NOT COMPLETED|Stage 1||3
2908793|NCT00467779|3617971|FG002|NOT COMPLETED|Stage 1||3
2908794|NCT00467779|3617972|FG003|NOT COMPLETED|Stage 1||3
2908795|NCT00467779|3617973|FG004|NOT COMPLETED|Stage 1||3
2908796|NCT00467779|3617974|FG005|NOT COMPLETED|Stage 1||5
2908797|NCT00467779|3617975|FG006|NOT COMPLETED|Stage 1||7
2908798|NCT00467779|3617976|FG007|NOT COMPLETED|Stage 1||7
2908799|NCT00467779|3617977|FG008|NOT COMPLETED|Stage 1||0
2908800|NCT00467779|3617978|FG009|NOT COMPLETED|Stage 1||0
2908801|NCT00467779|3617979|FG010|NOT COMPLETED|Stage 1||0
2908802|NCT00467779|3617980|FG011|NOT COMPLETED|Stage 1||0
2908803|NCT00467779|3617981|FG012|NOT COMPLETED|Stage 1||0
2908804|NCT00467779|3617982|FG013|NOT COMPLETED|Stage 1||0
2908805|NCT00467779|3617983|FG014|NOT COMPLETED|Stage 1||0
2908806|NCT00467779|3617969|FG000|STARTED|Stage 1A||0
2908807|NCT00467779|3617970|FG001|STARTED|Stage 1A||0
2908808|NCT00467779|3617971|FG002|STARTED|Stage 1A||0
2908809|NCT00467779|3617972|FG003|STARTED|Stage 1A||0
2908810|NCT00467779|3617973|FG004|STARTED|Stage 1A||0
2908811|NCT00467779|3617974|FG005|STARTED|Stage 1A||0
2908812|NCT00467779|3617975|FG006|STARTED|Stage 1A||0
2908813|NCT00467779|3617976|FG007|STARTED|Stage 1A||0
2908814|NCT00467779|3617977|FG008|STARTED|Stage 1A||0
2908815|NCT00467779|3617978|FG009|STARTED|Stage 1A||3
2908816|NCT00467779|3617979|FG010|STARTED|Stage 1A||3
2908817|NCT00467779|3617980|FG011|STARTED|Stage 1A||8
2908818|NCT00467779|3617981|FG012|STARTED|Stage 1A||6
2908819|NCT00467779|3617982|FG013|STARTED|Stage 1A||0
2908820|NCT00467779|3617983|FG014|STARTED|Stage 1A||0
2908821|NCT00467779|3617969|FG000|COMPLETED|Stage 1A||0
2908822|NCT00467779|3617970|FG001|COMPLETED|Stage 1A||0
2908823|NCT00467779|3617971|FG002|COMPLETED|Stage 1A||0
2908824|NCT00467779|3617972|FG003|COMPLETED|Stage 1A||0
2908825|NCT00467779|3617973|FG004|COMPLETED|Stage 1A||0
2908826|NCT00467779|3617974|FG005|COMPLETED|Stage 1A||0
2908827|NCT00467779|3617975|FG006|COMPLETED|Stage 1A||0
2908828|NCT00467779|3617976|FG007|COMPLETED|Stage 1A||0
2908829|NCT00467779|3617977|FG008|COMPLETED|Stage 1A||0
2908830|NCT00467779|3617978|FG009|COMPLETED|Stage 1A||0
2908831|NCT00467779|3617979|FG010|COMPLETED|Stage 1A||0
2908832|NCT00467779|3617980|FG011|COMPLETED|Stage 1A||0
2908833|NCT00467779|3617981|FG012|COMPLETED|Stage 1A||0
2908834|NCT00467779|3617982|FG013|COMPLETED|Stage 1A||0
2908835|NCT00467779|3617983|FG014|COMPLETED|Stage 1A||0
2908836|NCT00467779|3617969|FG000|NOT COMPLETED|Stage 1A||0
2908837|NCT00467779|3617970|FG001|NOT COMPLETED|Stage 1A||0
2908838|NCT00467779|3617971|FG002|NOT COMPLETED|Stage 1A||0
2908839|NCT00467779|3617972|FG003|NOT COMPLETED|Stage 1A||0
2908840|NCT00467779|3617973|FG004|NOT COMPLETED|Stage 1A||0
2908841|NCT00467779|3617974|FG005|NOT COMPLETED|Stage 1A||0
2908842|NCT00467779|3617975|FG006|NOT COMPLETED|Stage 1A||0
2908843|NCT00467779|3617976|FG007|NOT COMPLETED|Stage 1A||0
2908844|NCT00467779|3617977|FG008|NOT COMPLETED|Stage 1A||0
2908845|NCT00467779|3617978|FG009|NOT COMPLETED|Stage 1A||3
2908846|NCT00467779|3617979|FG010|NOT COMPLETED|Stage 1A||3
2908847|NCT00467779|3617980|FG011|NOT COMPLETED|Stage 1A||8
2908848|NCT00467779|3617981|FG012|NOT COMPLETED|Stage 1A||6
2908849|NCT00467779|3617982|FG013|NOT COMPLETED|Stage 1A||0
2908850|NCT00467779|3617983|FG014|NOT COMPLETED|Stage 1A||0
2908851|NCT00467779|3617969|FG000|STARTED|Stage 2||0
2908852|NCT00467779|3617970|FG001|STARTED|Stage 2||0
3316215|NCT03108027|4049502|FG002|STARTED|Period 1||6
3316216|NCT03108027|4049503|FG003|STARTED|Period 1||6
3316217|NCT03108027|4049504|FG004|STARTED|Period 1||6
3316218|NCT03108027|4049505|FG005|STARTED|Period 1||6
3316219|NCT03108027|4049500|FG000|COMPLETED|Period 1||7
3316220|NCT03108027|4049501|FG001|COMPLETED|Period 1||6
3316221|NCT03108027|4049502|FG002|COMPLETED|Period 1||6
3316222|NCT03108027|4049503|FG003|COMPLETED|Period 1||4
3316223|NCT03108027|4049504|FG004|COMPLETED|Period 1||6
3316224|NCT03108027|4049505|FG005|COMPLETED|Period 1||6
3316225|NCT03108027|4049500|FG000|NOT COMPLETED|Period 1||0
3316226|NCT03108027|4049501|FG001|NOT COMPLETED|Period 1||0
3316227|NCT03108027|4049502|FG002|NOT COMPLETED|Period 1||0
3316228|NCT03108027|4049503|FG003|NOT COMPLETED|Period 1||2
3316229|NCT03108027|4049504|FG004|NOT COMPLETED|Period 1||0
3316230|NCT03108027|4049505|FG005|NOT COMPLETED|Period 1||0
3316231|NCT03108027|4049500|FG000|STARTED|Period 2||7
3316232|NCT03108027|4049501|FG001|STARTED|Period 2||6
3316233|NCT03108027|4049502|FG002|STARTED|Period 2||6
3316234|NCT03108027|4049503|FG003|STARTED|Period 2||4
3316235|NCT03108027|4049504|FG004|STARTED|Period 2||6
2908853|NCT00467779|3617971|FG002|STARTED|Stage 2||0
2908854|NCT00467779|3617972|FG003|STARTED|Stage 2||0
2908855|NCT00467779|3617973|FG004|STARTED|Stage 2||0
2908856|NCT00467779|3617974|FG005|STARTED|Stage 2||0
2908857|NCT00467779|3617975|FG006|STARTED|Stage 2||0
2908858|NCT00467779|3617976|FG007|STARTED|Stage 2||0
2908859|NCT00467779|3617977|FG008|STARTED|Stage 2||21
2908860|NCT00467779|3617978|FG009|STARTED|Stage 2||0
2908861|NCT00467779|3617979|FG010|STARTED|Stage 2||0
2908862|NCT00467779|3617980|FG011|STARTED|Stage 2||0
2908863|NCT00467779|3617981|FG012|STARTED|Stage 2||0
2908864|NCT00467779|3617982|FG013|STARTED|Stage 2||0
3171539|NCT01934556|3898704|FG002|NOT COMPLETED|Overall Study||10
3171540|NCT01934582|3898712|FG000|STARTED|Overall Study||13
3171541|NCT01934582|3898712|FG000|COMPLETED|Overall Study||13
3171542|NCT01934582|3898712|FG000|NOT COMPLETED|Overall Study||0
3171543|NCT01934790|3898718|FG000|STARTED|Treatment|Eligible for treatment|45
3316236|NCT03108027|4049505|FG005|STARTED|Period 2||6
2908865|NCT00467779|3617983|FG014|STARTED|Stage 2||0
2908866|NCT00467779|3617969|FG000|COMPLETED|Stage 2||0
2908867|NCT00467779|3617970|FG001|COMPLETED|Stage 2||0
2908868|NCT00467779|3617971|FG002|COMPLETED|Stage 2||0
2908869|NCT00467779|3617972|FG003|COMPLETED|Stage 2||0
2908870|NCT00467779|3617973|FG004|COMPLETED|Stage 2||0
2908871|NCT00467779|3617974|FG005|COMPLETED|Stage 2||0
2908872|NCT00467779|3617975|FG006|COMPLETED|Stage 2||0
2908873|NCT00467779|3617976|FG007|COMPLETED|Stage 2||0
2908874|NCT00467779|3617977|FG008|COMPLETED|Stage 2||0
2908875|NCT00467779|3617978|FG009|COMPLETED|Stage 2||0
2908876|NCT00467779|3617979|FG010|COMPLETED|Stage 2||0
2908877|NCT00467779|3617980|FG011|COMPLETED|Stage 2||0
2908878|NCT00467779|3617981|FG012|COMPLETED|Stage 2||0
2908879|NCT00467779|3617982|FG013|COMPLETED|Stage 2||0
2908880|NCT00467779|3617983|FG014|COMPLETED|Stage 2||0
2908881|NCT00467779|3617969|FG000|NOT COMPLETED|Stage 2||0
2908882|NCT00467779|3617970|FG001|NOT COMPLETED|Stage 2||0
2908883|NCT00467779|3617971|FG002|NOT COMPLETED|Stage 2||0
2908884|NCT00467779|3617972|FG003|NOT COMPLETED|Stage 2||0
3316237|NCT03108027|4049500|FG000|COMPLETED|Period 2||7
3316238|NCT03108027|4049501|FG001|COMPLETED|Period 2||6
3316239|NCT03108027|4049502|FG002|COMPLETED|Period 2||6
3316240|NCT03108027|4049503|FG003|COMPLETED|Period 2||4
3316241|NCT03108027|4049504|FG004|COMPLETED|Period 2||6
3316242|NCT03108027|4049505|FG005|COMPLETED|Period 2||6
3316243|NCT03108027|4049500|FG000|NOT COMPLETED|Period 2||0
3316244|NCT03108027|4049501|FG001|NOT COMPLETED|Period 2||0
2908885|NCT00467779|3617973|FG004|NOT COMPLETED|Stage 2||0
2908886|NCT00467779|3617974|FG005|NOT COMPLETED|Stage 2||0
2908887|NCT00467779|3617975|FG006|NOT COMPLETED|Stage 2||0
2908888|NCT00467779|3617976|FG007|NOT COMPLETED|Stage 2||0
2908889|NCT00467779|3617977|FG008|NOT COMPLETED|Stage 2||21
2908890|NCT00467779|3617978|FG009|NOT COMPLETED|Stage 2||0
2908891|NCT00467779|3617979|FG010|NOT COMPLETED|Stage 2||0
2908892|NCT00467779|3617980|FG011|NOT COMPLETED|Stage 2||0
2908893|NCT00467779|3617981|FG012|NOT COMPLETED|Stage 2||0
2908894|NCT00467779|3617982|FG013|NOT COMPLETED|Stage 2||0
2908895|NCT00467779|3617983|FG014|NOT COMPLETED|Stage 2||0
2908896|NCT00467779|3617969|FG000|STARTED|Stage 2A||0
2908897|NCT00467779|3617970|FG001|STARTED|Stage 2A||0
2908898|NCT00467779|3617971|FG002|STARTED|Stage 2A||0
3316245|NCT03108027|4049502|FG002|NOT COMPLETED|Period 2||0
3316246|NCT03108027|4049503|FG003|NOT COMPLETED|Period 2||0
3316247|NCT03108027|4049504|FG004|NOT COMPLETED|Period 2||0
2908899|NCT00467779|3617972|FG003|STARTED|Stage 2A||0
2908900|NCT00467779|3617973|FG004|STARTED|Stage 2A||0
2908901|NCT00467779|3617974|FG005|STARTED|Stage 2A||0
2908902|NCT00467779|3617975|FG006|STARTED|Stage 2A||0
2908903|NCT00467779|3617976|FG007|STARTED|Stage 2A||0
2908904|NCT00467779|3617977|FG008|STARTED|Stage 2A||0
2908905|NCT00467779|3617978|FG009|STARTED|Stage 2A||0
2908906|NCT00467779|3617979|FG010|STARTED|Stage 2A||0
2908907|NCT00467779|3617980|FG011|STARTED|Stage 2A||0
2908908|NCT00467779|3617981|FG012|STARTED|Stage 2A||0
2908909|NCT00467779|3617982|FG013|STARTED|Stage 2A||22
2908910|NCT00467779|3617983|FG014|STARTED|Stage 2A||0
2908911|NCT00467779|3617969|FG000|COMPLETED|Stage 2A||0
2908912|NCT00467779|3617970|FG001|COMPLETED|Stage 2A||0
2908913|NCT00467779|3617971|FG002|COMPLETED|Stage 2A||0
2908914|NCT00467779|3617972|FG003|COMPLETED|Stage 2A||0
2908915|NCT00467779|3617973|FG004|COMPLETED|Stage 2A||0
2908916|NCT00467779|3617974|FG005|COMPLETED|Stage 2A||0
2908917|NCT00467779|3617975|FG006|COMPLETED|Stage 2A||0
2908918|NCT00467779|3617976|FG007|COMPLETED|Stage 2A||0
2908919|NCT00467779|3617977|FG008|COMPLETED|Stage 2A||0
2908920|NCT00467779|3617978|FG009|COMPLETED|Stage 2A||0
2908921|NCT00467779|3617979|FG010|COMPLETED|Stage 2A||0
2908922|NCT00467779|3617980|FG011|COMPLETED|Stage 2A||0
2908923|NCT00467779|3617981|FG012|COMPLETED|Stage 2A||0
2908924|NCT00467779|3617982|FG013|COMPLETED|Stage 2A||1
2908925|NCT00467779|3617983|FG014|COMPLETED|Stage 2A||0
2908926|NCT00467779|3617969|FG000|NOT COMPLETED|Stage 2A||0
2908927|NCT00467779|3617970|FG001|NOT COMPLETED|Stage 2A||0
2908928|NCT00467779|3617971|FG002|NOT COMPLETED|Stage 2A||0
2908929|NCT00467779|3617972|FG003|NOT COMPLETED|Stage 2A||0
2908930|NCT00467779|3617973|FG004|NOT COMPLETED|Stage 2A||0
2908931|NCT00467779|3617974|FG005|NOT COMPLETED|Stage 2A||0
2908932|NCT00467779|3617975|FG006|NOT COMPLETED|Stage 2A||0
2908933|NCT00467779|3617976|FG007|NOT COMPLETED|Stage 2A||0
2908934|NCT00467779|3617977|FG008|NOT COMPLETED|Stage 2A||0
2908935|NCT00467779|3617978|FG009|NOT COMPLETED|Stage 2A||0
2908936|NCT00467779|3617979|FG010|NOT COMPLETED|Stage 2A||0
2908937|NCT00467779|3617980|FG011|NOT COMPLETED|Stage 2A||0
2908938|NCT00467779|3617981|FG012|NOT COMPLETED|Stage 2A||0
2908939|NCT00467779|3617982|FG013|NOT COMPLETED|Stage 2A||21
2908940|NCT00467779|3617983|FG014|NOT COMPLETED|Stage 2A||0
2908941|NCT00467779|3617969|FG000|STARTED|Stage 3||0
2908942|NCT00467779|3617970|FG001|STARTED|Stage 3||0
2908943|NCT00467779|3617971|FG002|STARTED|Stage 3||0
2908944|NCT00467779|3617972|FG003|STARTED|Stage 3||0
2908945|NCT00467779|3617973|FG004|STARTED|Stage 3||0
2908946|NCT00467779|3617974|FG005|STARTED|Stage 3||0
2908947|NCT00467779|3617975|FG006|STARTED|Stage 3||0
2908948|NCT00467779|3617976|FG007|STARTED|Stage 3||0
2908949|NCT00467779|3617977|FG008|STARTED|Stage 3||0
2908950|NCT00467779|3617978|FG009|STARTED|Stage 3||0
2908951|NCT00467779|3617979|FG010|STARTED|Stage 3||0
2908952|NCT00467779|3617980|FG011|STARTED|Stage 3||0
2908953|NCT00467779|3617981|FG012|STARTED|Stage 3||0
2908954|NCT00467779|3617982|FG013|STARTED|Stage 3||0
2908955|NCT00467779|3617983|FG014|STARTED|Stage 3||20
2908956|NCT00467779|3617969|FG000|COMPLETED|Stage 3||0
2908957|NCT00467779|3617970|FG001|COMPLETED|Stage 3||0
2908958|NCT00467779|3617971|FG002|COMPLETED|Stage 3||0
2908959|NCT00467779|3617972|FG003|COMPLETED|Stage 3||0
2908960|NCT00467779|3617973|FG004|COMPLETED|Stage 3||0
3171544|NCT01934790|3898718|FG000|Participants Received Study Treatment|Treatment||44
3171545|NCT01934790|3898718|FG000|COMPLETED|Treatment||29
3171546|NCT01934790|3898718|FG000|NOT COMPLETED|Treatment||16
3171547|NCT01934790|3898718|FG000|STARTED|Active Follow up||34
2908961|NCT00467779|3617974|FG005|COMPLETED|Stage 3||0
2908962|NCT00467779|3617975|FG006|COMPLETED|Stage 3||0
2908963|NCT00467779|3617976|FG007|COMPLETED|Stage 3||0
2908964|NCT00467779|3617977|FG008|COMPLETED|Stage 3||0
2908965|NCT00467779|3617978|FG009|COMPLETED|Stage 3||0
2908966|NCT00467779|3617979|FG010|COMPLETED|Stage 3||0
2908967|NCT00467779|3617980|FG011|COMPLETED|Stage 3||0
2908968|NCT00467779|3617981|FG012|COMPLETED|Stage 3||0
2908969|NCT00467779|3617982|FG013|COMPLETED|Stage 3||0
2908970|NCT00467779|3617983|FG014|COMPLETED|Stage 3||3
2908971|NCT00467779|3617969|FG000|NOT COMPLETED|Stage 3||0
2908972|NCT00467779|3617970|FG001|NOT COMPLETED|Stage 3||0
2908973|NCT00467779|3617971|FG002|NOT COMPLETED|Stage 3||0
2908974|NCT00467779|3617972|FG003|NOT COMPLETED|Stage 3||0
2908975|NCT00467779|3617973|FG004|NOT COMPLETED|Stage 3||0
2908976|NCT00467779|3617974|FG005|NOT COMPLETED|Stage 3||0
2908977|NCT00467779|3617975|FG006|NOT COMPLETED|Stage 3||0
2908978|NCT00467779|3617976|FG007|NOT COMPLETED|Stage 3||0
2908979|NCT00467779|3617977|FG008|NOT COMPLETED|Stage 3||0
2908980|NCT00467779|3617978|FG009|NOT COMPLETED|Stage 3||0
2908981|NCT00467779|3617979|FG010|NOT COMPLETED|Stage 3||0
2908982|NCT00467779|3617980|FG011|NOT COMPLETED|Stage 3||0
2908983|NCT00467779|3617981|FG012|NOT COMPLETED|Stage 3||0
2908984|NCT00467779|3617982|FG013|NOT COMPLETED|Stage 3||0
2908985|NCT00467779|3617983|FG014|NOT COMPLETED|Stage 3||17
2908986|NCT00467818|3618023|FG000|STARTED|Overall Study||9
2908987|NCT00467818|3618024|FG001|STARTED|Overall Study||8
2908988|NCT00467818|3618023|FG000|COMPLETED|Overall Study||6
2908989|NCT00467818|3618024|FG001|COMPLETED|Overall Study||6
2908990|NCT00467818|3618023|FG000|NOT COMPLETED|Overall Study||3
2908991|NCT00467818|3618024|FG001|NOT COMPLETED|Overall Study||2
2908992|NCT00467831|3618032|FG000|STARTED|Overall Study||3
2908993|NCT00467831|3618032|FG000|COMPLETED|Overall Study||0
3171548|NCT01934790|3898718|FG000|COMPLETED|Active Follow up||10
2908994|NCT00467831|3618032|FG000|NOT COMPLETED|Overall Study||3
2908995|NCT00467844|3618039|FG000|STARTED|Overall Study||53
2908996|NCT00467844|3618040|FG001|STARTED|Overall Study||54
2908997|NCT00467844|3618041|FG002|STARTED|Overall Study||52
2908998|NCT00467844|3618039|FG000|COMPLETED|Overall Study||34
2908999|NCT00467844|3618040|FG001|COMPLETED|Overall Study||34
2909000|NCT00467844|3618041|FG002|COMPLETED|Overall Study||38
2909001|NCT00467844|3618039|FG000|NOT COMPLETED|Overall Study||19
2909002|NCT00467844|3618040|FG001|NOT COMPLETED|Overall Study||20
2909003|NCT00467844|3618041|FG002|NOT COMPLETED|Overall Study||14
2909004|NCT00467857|3618054|FG000|STARTED|Overall Study||146
2909005|NCT00467857|3618055|FG001|STARTED|Overall Study||147
2909006|NCT00467857|3618054|FG000|COMPLETED|Overall Study||143
2909007|NCT00467857|3618055|FG001|COMPLETED|Overall Study||139
2909008|NCT00467857|3618054|FG000|NOT COMPLETED|Overall Study||3
2909009|NCT00467857|3618055|FG001|NOT COMPLETED|Overall Study||8
2920525|NCT00537316|3631027|FG001|COMPLETED|Part 2||1
2920526|NCT00537316|3631028|FG002|COMPLETED|Part 2||16
2920527|NCT00537316|3631029|FG003|COMPLETED|Part 2||2
2920528|NCT00537316|3631030|FG004|COMPLETED|Part 2||1
2920529|NCT00537316|3631031|FG005|COMPLETED|Part 2||0
2920530|NCT00537316|3631032|FG006|COMPLETED|Part 2||0
2920531|NCT00537316|3631026|FG000|NOT COMPLETED|Part 2||26
2920532|NCT00537316|3631027|FG001|NOT COMPLETED|Part 2||9
2920533|NCT00537316|3631028|FG002|NOT COMPLETED|Part 2||32
2920534|NCT00537316|3631029|FG003|NOT COMPLETED|Part 2||3
2920535|NCT00537316|3631030|FG004|NOT COMPLETED|Part 2||1
2920536|NCT00537316|3631031|FG005|NOT COMPLETED|Part 2||4
2920537|NCT00537316|3631032|FG006|NOT COMPLETED|Part 2||2
2920538|NCT00537329|3631051|FG000|STARTED|Overall Study||43
2920539|NCT00537329|3631051|FG000|COMPLETED|Overall Study||17
2920540|NCT00537329|3631051|FG000|NOT COMPLETED|Overall Study||26
2920541|NCT00537381|3631057|FG000|STARTED|Overall Study|11 Participants after disease progression switched to intetumumab alone (2) or D+P+ Intetumumab (9).|65
2920542|NCT00537381|3631058|FG001|STARTED|Overall Study||66
2920543|NCT00537381|3631057|FG000|COMPLETED|Overall Study||9
2920544|NCT00537381|3631058|FG001|COMPLETED|Overall Study||4
2920545|NCT00537381|3631057|FG000|NOT COMPLETED|Overall Study||56
2920546|NCT00537381|3631058|FG001|NOT COMPLETED|Overall Study||62
2920547|NCT00537394|3631069|FG000|STARTED|First Year of Follow-up||181
2920548|NCT00537394|3631070|FG001|STARTED|First Year of Follow-up||179
2920549|NCT00537394|3631071|FG002|STARTED|First Year of Follow-up||53
2920550|NCT00537394|3631069|FG000|COMPLETED|First Year of Follow-up|Completed refers to completing first 48 weeks of follow-up.|169
2920551|NCT00537394|3631070|FG001|COMPLETED|First Year of Follow-up|Completed refers to completing first 48 weeks of follow-up.|168
2920552|NCT00537394|3631071|FG002|COMPLETED|First Year of Follow-up||50
2920553|NCT00537394|3631069|FG000|NOT COMPLETED|First Year of Follow-up||12
2920554|NCT00537394|3631070|FG001|NOT COMPLETED|First Year of Follow-up||11
2920555|NCT00537394|3631071|FG002|NOT COMPLETED|First Year of Follow-up||3
2920556|NCT00537394|3631069|FG000|STARTED|2nd Year of Follow-up||169
2920557|NCT00537394|3631070|FG001|STARTED|2nd Year of Follow-up||168
2920558|NCT00537394|3631071|FG002|STARTED|2nd Year of Follow-up||50
2920559|NCT00537394|3631069|FG000|COMPLETED|2nd Year of Follow-up||158
2920560|NCT00537394|3631070|FG001|COMPLETED|2nd Year of Follow-up||159
2920561|NCT00537394|3631071|FG002|COMPLETED|2nd Year of Follow-up||44
2920562|NCT00537394|3631069|FG000|NOT COMPLETED|2nd Year of Follow-up||11
2920563|NCT00537394|3631070|FG001|NOT COMPLETED|2nd Year of Follow-up||9
2920564|NCT00537394|3631071|FG002|NOT COMPLETED|2nd Year of Follow-up||6
2920565|NCT00537407|3631082|FG000|STARTED|Part 1 Weeks 1-4||10
2920566|NCT00537407|3631083|FG001|STARTED|Part 1 Weeks 1-4||9
2920567|NCT00537407|3631084|FG002|STARTED|Part 1 Weeks 1-4||11
2920568|NCT00537407|3631085|FG003|STARTED|Part 1 Weeks 1-4||10
3384512|NCT02180217|4119613|FG001|Completed Week 48 (Core Phase)|Overall Study||33
3384513|NCT02180217|4119614|FG002|Completed Week 48 (Core Phase)|Overall Study||44
3384514|NCT02180217|4119612|FG000|Completed W48, Did Not Enter Ext. Phase|Overall Study||1
3384515|NCT02180217|4119613|FG001|Completed W48, Did Not Enter Ext. Phase|Overall Study||3
3384516|NCT02180217|4119614|FG002|Completed W48, Did Not Enter Ext. Phase|Overall Study||3
3384517|NCT02180217|4119612|FG000|Completed W48, Entered Ext. Phase|Overall Study||35
3384518|NCT02180217|4119613|FG001|Completed W48, Entered Ext. Phase|Overall Study||30
3384519|NCT02180217|4119614|FG002|Completed W48, Entered Ext. Phase|Overall Study||41
3384520|NCT02180217|4119612|FG000|Discontinued Extension Phase|Overall Study||12
3384521|NCT02180217|4119613|FG001|Discontinued Extension Phase|Overall Study||6
3384522|NCT02180217|4119614|FG002|Discontinued Extension Phase|Overall Study||16
3384523|NCT02180217|4119612|FG000|Completed Ext. Phase|Overall Study||23
3384524|NCT02180217|4119613|FG001|Completed Ext. Phase|Overall Study||24
3384525|NCT02180217|4119614|FG002|Completed Ext. Phase|Overall Study||25
3384526|NCT02180217|4119612|FG000|COMPLETED|Overall Study||24
3384527|NCT02180217|4119613|FG001|COMPLETED|Overall Study||27
3384528|NCT02180217|4119614|FG002|COMPLETED|Overall Study||28
3384529|NCT02180217|4119612|FG000|NOT COMPLETED|Overall Study||12
3384530|NCT02180217|4119613|FG001|NOT COMPLETED|Overall Study||8
3384531|NCT02180217|4119614|FG002|NOT COMPLETED|Overall Study||38
2920569|NCT00537407|3631086|FG004|STARTED|Part 1 Weeks 1-4||10
2920570|NCT00537407|3631082|FG000|COMPLETED|Part 1 Weeks 1-4||10
2920571|NCT00537407|3631083|FG001|COMPLETED|Part 1 Weeks 1-4||9
2920572|NCT00537407|3631084|FG002|COMPLETED|Part 1 Weeks 1-4||11
2920573|NCT00537407|3631085|FG003|COMPLETED|Part 1 Weeks 1-4||10
2920574|NCT00537407|3631086|FG004|COMPLETED|Part 1 Weeks 1-4||10
2909010|NCT00467870|3618067|FG000|STARTED|Overall Study||120
2909011|NCT00467870|3618068|FG001|STARTED|Overall Study||117
2909012|NCT00467870|3618069|FG002|STARTED|Overall Study||22
2909013|NCT00467870|3618070|FG003|STARTED|Overall Study||112
2909014|NCT00467870|3618071|FG004|STARTED|Overall Study||130
2909015|NCT00467870|3618072|FG005|STARTED|Overall Study||23
2909016|NCT00467870|3618067|FG000|COMPLETED|Overall Study||75
2909017|NCT00467870|3618068|FG001|COMPLETED|Overall Study||74
2909018|NCT00467870|3618069|FG002|COMPLETED|Overall Study||18
2909019|NCT00467870|3618070|FG003|COMPLETED|Overall Study||79
2909020|NCT00467870|3618071|FG004|COMPLETED|Overall Study||93
2909021|NCT00467870|3618072|FG005|COMPLETED|Overall Study||21
2909022|NCT00467870|3618067|FG000|NOT COMPLETED|Overall Study||45
2909023|NCT00467870|3618068|FG001|NOT COMPLETED|Overall Study||43
2909024|NCT00467870|3618069|FG002|NOT COMPLETED|Overall Study||4
2909025|NCT00467870|3618070|FG003|NOT COMPLETED|Overall Study||33
2909026|NCT00467870|3618071|FG004|NOT COMPLETED|Overall Study||37
2909027|NCT00467870|3618072|FG005|NOT COMPLETED|Overall Study||2
2909028|NCT00467896|3618082|FG000|STARTED|Overall Study||62
2909029|NCT00467896|3618082|FG000|COMPLETED|Overall Study||11
2909030|NCT00467896|3618082|FG000|NOT COMPLETED|Overall Study||51
2909031|NCT00467961|3618088|FG000|STARTED|Overall Study||31
2909032|NCT00467961|3618088|FG000|COMPLETED|Overall Study||24
2909033|NCT00467961|3618088|FG000|NOT COMPLETED|Overall Study||7
2909034|NCT00468052|3618094|FG000|STARTED|Overall Study|1 subject withdrew consent.Surgery was cancelled for 2. 4 subjects eliminated for break in protocol|68
2909035|NCT00468052|3618095|FG001|STARTED|Overall Study|One had an intraoperative complication and was withdrawn. 7 eliminated for a break in protocol.|69
2909036|NCT00468052|3618094|FG000|Target Enrollment|Overall Study||70
2909037|NCT00468052|3618095|FG001|Target Enrollment|Overall Study||70
2909038|NCT00468052|3618094|FG000|COMPLETED|Overall Study||61
2909039|NCT00468052|3618095|FG001|COMPLETED|Overall Study||61
2909040|NCT00468052|3618094|FG000|NOT COMPLETED|Overall Study||7
2909041|NCT00468052|3618095|FG001|NOT COMPLETED|Overall Study||8
2909042|NCT00468104|3618103|FG000|STARTED|First Intervention||54
2909043|NCT00468104|3618104|FG001|STARTED|First Intervention||46
2909044|NCT00468104|3618103|FG000|COMPLETED|First Intervention||45
2909045|NCT00468104|3618104|FG001|COMPLETED|First Intervention||45
2909046|NCT00468104|3618103|FG000|NOT COMPLETED|First Intervention||9
2909047|NCT00468104|3618104|FG001|NOT COMPLETED|First Intervention||1
2909048|NCT00468104|3618103|FG000|STARTED|Second Intervention|37 responded to Alteplase and did not go to the second intervention|8
2909049|NCT00468104|3618104|FG001|STARTED|Second Intervention|4 patients responded to Placebo and did not go to the second intervention|41
2909050|NCT00468104|3618103|FG000|COMPLETED|Second Intervention||3
2909051|NCT00468104|3618104|FG001|COMPLETED|Second Intervention||37
2909052|NCT00468104|3618103|FG000|NOT COMPLETED|Second Intervention||5
2909053|NCT00468104|3618104|FG001|NOT COMPLETED|Second Intervention||4
2909054|NCT00468143|3618113|FG000|STARTED|First Intervention (3 Weeks)||31
2909055|NCT00468143|3618114|FG001|STARTED|First Intervention (3 Weeks)||31
2909056|NCT00468143|3618113|FG000|COMPLETED|First Intervention (3 Weeks)||28
2909057|NCT00468143|3618114|FG001|COMPLETED|First Intervention (3 Weeks)||27
2909058|NCT00468143|3618113|FG000|NOT COMPLETED|First Intervention (3 Weeks)||3
2909059|NCT00468143|3618114|FG001|NOT COMPLETED|First Intervention (3 Weeks)||4
2909060|NCT00468143|3618113|FG000|STARTED|Second Intervention (3 Weeks)||28
2909061|NCT00468143|3618114|FG001|STARTED|Second Intervention (3 Weeks)||27
2909062|NCT00468143|3618113|FG000|COMPLETED|Second Intervention (3 Weeks)||25
2909063|NCT00468143|3618114|FG001|COMPLETED|Second Intervention (3 Weeks)||24
2909064|NCT00468143|3618113|FG000|NOT COMPLETED|Second Intervention (3 Weeks)||3
2909065|NCT00468143|3618114|FG001|NOT COMPLETED|Second Intervention (3 Weeks)||3
2909066|NCT00468169|3618122|FG000|STARTED|Overall Study||57
3384532|NCT02186457|4119631|FG000|STARTED|Overall Study||95
3384533|NCT02186457|4119632|FG001|STARTED|Overall Study||95
3384534|NCT02186457|4119631|FG000|COMPLETED|Overall Study||95
3384535|NCT02186457|4119632|FG001|COMPLETED|Overall Study||95
3384536|NCT02186457|4119631|FG000|NOT COMPLETED|Overall Study||0
3384537|NCT02186457|4119632|FG001|NOT COMPLETED|Overall Study||0
3384538|NCT02193867|4119638|FG000|STARTED|Overall Study||10
3384539|NCT02193867|4119638|FG000|Received At Least 1 Dose Of Study Drug|Overall Study||10
3384540|NCT02193867|4119638|FG000|Completed 18 Months Of Treatment|Overall Study||8
3384541|NCT02193867|4119638|FG000|COMPLETED|Overall Study||6
3384542|NCT02193867|4119638|FG000|NOT COMPLETED|Overall Study||4
3384543|NCT02215096|4119645|FG000|STARTED|Run-In Period (Up to Week 2)||37
3384544|NCT02215096|4119646|FG001|STARTED|Run-In Period (Up to Week 2)||0
3384545|NCT02215096|4119647|FG002|STARTED|Run-In Period (Up to Week 2)||0
3384546|NCT02215096|4119648|FG003|STARTED|Run-In Period (Up to Week 2)||0
3384547|NCT02215096|4119649|FG004|STARTED|Run-In Period (Up to Week 2)||0
3384548|NCT02215096|4119645|FG000|COMPLETED|Run-In Period (Up to Week 2)||36
3384549|NCT02215096|4119646|FG001|COMPLETED|Run-In Period (Up to Week 2)||0
3384550|NCT02215096|4119647|FG002|COMPLETED|Run-In Period (Up to Week 2)||0
3384551|NCT02215096|4119648|FG003|COMPLETED|Run-In Period (Up to Week 2)||0
3384552|NCT02215096|4119649|FG004|COMPLETED|Run-In Period (Up to Week 2)||0
3384553|NCT02215096|4119645|FG000|NOT COMPLETED|Run-In Period (Up to Week 2)||1
3384554|NCT02215096|4119646|FG001|NOT COMPLETED|Run-In Period (Up to Week 2)||0
2909067|NCT00468169|3618123|FG001|STARTED|Overall Study||53
2909068|NCT00468169|3618122|FG000|COMPLETED|Overall Study||56
2909069|NCT00468169|3618123|FG001|COMPLETED|Overall Study||53
3316248|NCT03108027|4049505|FG005|NOT COMPLETED|Period 2||0
3316249|NCT03108027|4049500|FG000|STARTED|Period 3||7
3316250|NCT03108027|4049501|FG001|STARTED|Period 3||6
3316251|NCT03108027|4049502|FG002|STARTED|Period 3||6
2909070|NCT00468169|3618122|FG000|NOT COMPLETED|Overall Study||1
2909071|NCT00468169|3618123|FG001|NOT COMPLETED|Overall Study||0
2909072|NCT00468208|3618131|FG000|STARTED|Overall Study||20
2909073|NCT00468208|3618131|FG000|COMPLETED|Overall Study|All patients reached common closing or early termination|20
2909074|NCT00468208|3618131|FG000|NOT COMPLETED|Overall Study||0
2909075|NCT00468286|3618137|FG000|STARTED|Overall Study|Started=Intention to treat (ITT) population.|67
2909076|NCT00468286|3618138|FG001|STARTED|Overall Study||66
2909077|NCT00468286|3618137|FG000|COMPLETED|Overall Study||60
2909078|NCT00468286|3618138|FG001|COMPLETED|Overall Study||54
2909079|NCT00468286|3618137|FG000|NOT COMPLETED|Overall Study||7
2909080|NCT00468286|3618138|FG001|NOT COMPLETED|Overall Study||12
2909081|NCT00468299|3618146|FG000|STARTED|Overall Study||9
2909082|NCT00468299|3618147|FG001|STARTED|Overall Study||8
2909083|NCT00468299|3618146|FG000|COMPLETED|Overall Study||9
2909084|NCT00468299|3618147|FG001|COMPLETED|Overall Study||7
2909085|NCT00468299|3618146|FG000|NOT COMPLETED|Overall Study||0
2909086|NCT00468299|3618147|FG001|NOT COMPLETED|Overall Study||1
2909087|NCT00468481|3618157|FG000|STARTED|Overall Study|6 of these randomized subjects did not take any study medication|291
2909088|NCT00468481|3618158|FG001|STARTED|Overall Study||94
2909089|NCT00468481|3618157|FG000|Subjects Treated|Overall Study||285
2909090|NCT00468481|3618158|FG001|Subjects Treated|Overall Study||94
2909091|NCT00468481|3618157|FG000|COMPLETED|Overall Study||203
2909092|NCT00468481|3618158|FG001|COMPLETED|Overall Study||70
2909093|NCT00468481|3618157|FG000|NOT COMPLETED|Overall Study||88
2909094|NCT00468481|3618158|FG001|NOT COMPLETED|Overall Study||24
2909095|NCT00468546|3618166|FG000|STARTED|Week 24 Analysis||208
2909096|NCT00468546|3618167|FG001|STARTED|Week 24 Analysis||308
2909097|NCT00468546|3618166|FG000|COMPLETED|Week 24 Analysis||111
2909098|NCT00468546|3618167|FG001|COMPLETED|Week 24 Analysis||253
2909099|NCT00468546|3618166|FG000|NOT COMPLETED|Week 24 Analysis||97
2909100|NCT00468546|3618167|FG001|NOT COMPLETED|Week 24 Analysis||55
2909101|NCT00468546|3618166|FG000|STARTED|Week 24 to Week 104 Analysis|Participants who completed/not completed Week (W) 24 analysis were entered in W24 to W104 analysis.|208
2909102|NCT00468546|3618167|FG001|STARTED|Week 24 to Week 104 Analysis|Participants who completed/not completed W24 analysis were entered in W24 to W104 analysis.|308
2909103|NCT00468546|3618166|FG000|COMPLETED|Week 24 to Week 104 Analysis||103
2909104|NCT00468546|3618167|FG001|COMPLETED|Week 24 to Week 104 Analysis||83
2909105|NCT00468546|3618166|FG000|NOT COMPLETED|Week 24 to Week 104 Analysis||105
2909106|NCT00468546|3618167|FG001|NOT COMPLETED|Week 24 to Week 104 Analysis||225
2909107|NCT00468559|3618175|FG000|STARTED|Open-label Treatment Phase|All participants received open-label esomeprazole during this phase of the study|98
2909108|NCT00468559|3618176|FG001|STARTED|Open-label Treatment Phase||0
2909109|NCT00468559|3618177|FG002|STARTED|Open-label Treatment Phase||0
2909110|NCT00468559|3618175|FG000|COMPLETED|Open-label Treatment Phase|18 patients discontinued (were not randomized into the double-blind treatment withdrawal phase)|80
2909111|NCT00468559|3618176|FG001|COMPLETED|Open-label Treatment Phase||0
2909112|NCT00468559|3618177|FG002|COMPLETED|Open-label Treatment Phase||0
2909113|NCT00468559|3618175|FG000|NOT COMPLETED|Open-label Treatment Phase||18
2909114|NCT00468559|3618176|FG001|NOT COMPLETED|Open-label Treatment Phase||0
2909115|NCT00468559|3618177|FG002|NOT COMPLETED|Open-label Treatment Phase||0
2909116|NCT00468559|3618175|FG000|STARTED|Double-blind, Treatment-withdrawal Phase||0
2909117|NCT00468559|3618176|FG001|STARTED|Double-blind, Treatment-withdrawal Phase||39
2909118|NCT00468559|3618177|FG002|STARTED|Double-blind, Treatment-withdrawal Phase||41
2909119|NCT00468559|3618175|FG000|COMPLETED|Double-blind, Treatment-withdrawal Phase||0
2909120|NCT00468559|3618176|FG001|COMPLETED|Double-blind, Treatment-withdrawal Phase||29
2909121|NCT00468559|3618177|FG002|COMPLETED|Double-blind, Treatment-withdrawal Phase||24
2909122|NCT00468559|3618175|FG000|NOT COMPLETED|Double-blind, Treatment-withdrawal Phase||0
2909123|NCT00468559|3618176|FG001|NOT COMPLETED|Double-blind, Treatment-withdrawal Phase||10
2909124|NCT00468559|3618177|FG002|NOT COMPLETED|Double-blind, Treatment-withdrawal Phase||17
2909125|NCT00468585|3618189|FG000|STARTED|Overall Study||4
2909126|NCT00468585|3618190|FG001|STARTED|Overall Study||3
2909127|NCT00468585|3618191|FG002|STARTED|Overall Study||50
2909128|NCT00468585|3618192|FG003|STARTED|Overall Study||6
2909129|NCT00468585|3618189|FG000|COMPLETED|Overall Study||3
2909130|NCT00468585|3618190|FG001|COMPLETED|Overall Study||3
2909131|NCT00468585|3618191|FG002|COMPLETED|Overall Study||45
2909132|NCT00468585|3618192|FG003|COMPLETED|Overall Study||5
2909133|NCT00468585|3618189|FG000|NOT COMPLETED|Overall Study||1
2909134|NCT00468585|3618190|FG001|NOT COMPLETED|Overall Study||0
2909135|NCT00468585|3618191|FG002|NOT COMPLETED|Overall Study||5
2909136|NCT00468585|3618192|FG003|NOT COMPLETED|Overall Study||1
2909137|NCT00468650|3618202|FG000|STARTED|Overall Study||117
2909138|NCT00468650|3618202|FG000|COMPLETED|Overall Study||110
2909139|NCT00468650|3618202|FG000|NOT COMPLETED|Overall Study||7
2909140|NCT00468676|3618209|FG000|STARTED|Overall Study||108
2909141|NCT00468676|3618210|FG001|STARTED|Overall Study||106
2909142|NCT00468676|3618209|FG000|COMPLETED|Overall Study||92
2909143|NCT00468676|3618210|FG001|COMPLETED|Overall Study||94
2909144|NCT00468676|3618209|FG000|NOT COMPLETED|Overall Study||16
3316252|NCT03108027|4049503|FG003|STARTED|Period 3||4
3316253|NCT03108027|4049504|FG004|STARTED|Period 3||6
3316254|NCT03108027|4049505|FG005|STARTED|Period 3||6
2909145|NCT00468676|3618210|FG001|NOT COMPLETED|Overall Study||12
2909146|NCT00468728|3618220|FG000|STARTED|Enrollment||264
2909147|NCT00468728|3618221|FG001|STARTED|Enrollment||271
2909148|NCT00468728|3618220|FG000|COMPLETED|Enrollment|1 fidaxomicin subject received vancomycin, 11 subjects didn't take drug|260
2909149|NCT00468728|3618221|FG001|COMPLETED|Enrollment|1 fidaxomicin subject received vancomycin, 11 subjects didn't take drug|264
2909150|NCT00468728|3618220|FG000|NOT COMPLETED|Enrollment||4
2909151|NCT00468728|3618221|FG001|NOT COMPLETED|Enrollment||7
2909152|NCT00468728|3618220|FG000|STARTED|Treatment||260
2909153|NCT00468728|3618221|FG001|STARTED|Treatment||264
2909154|NCT00468728|3618220|FG000|COMPLETED|Treatment||256
2909155|NCT00468728|3618221|FG001|COMPLETED|Treatment||253
2909156|NCT00468728|3618220|FG000|NOT COMPLETED|Treatment||4
2909157|NCT00468728|3618221|FG001|NOT COMPLETED|Treatment||11
2909158|NCT00468728|3618220|FG000|STARTED|Follow-up||256
2909159|NCT00468728|3618221|FG001|STARTED|Follow-up||253
2909160|NCT00468728|3618220|FG000|COMPLETED|Follow-up||222
2909161|NCT00468728|3618221|FG001|COMPLETED|Follow-up||222
2909162|NCT00468728|3618220|FG000|NOT COMPLETED|Follow-up||34
2909163|NCT00468728|3618221|FG001|NOT COMPLETED|Follow-up||31
2909164|NCT00468819|3618232|FG000|STARTED|Overall Study|Enrolled participants|48
2909165|NCT00468819|3618233|FG001|STARTED|Overall Study|Enrolled participants|44
2909166|NCT00468819|3618234|FG002|STARTED|Overall Study|Enrolled participants|48
2909167|NCT00468819|3618232|FG000|Treatment Received/ Safety Follow-up|Overall Study|FAS (Full Analysis Set)|46
2909168|NCT00468819|3618233|FG001|Treatment Received/ Safety Follow-up|Overall Study|FAS|44
2909169|NCT00468819|3618234|FG002|Treatment Received/ Safety Follow-up|Overall Study|FAS|48
2909170|NCT00468819|3618232|FG000|COMPLETED|Overall Study||42
2909171|NCT00468819|3618233|FG001|COMPLETED|Overall Study||44
2909172|NCT00468819|3618234|FG002|COMPLETED|Overall Study||46
2909173|NCT00468819|3618232|FG000|NOT COMPLETED|Overall Study||6
2909174|NCT00468819|3618233|FG001|NOT COMPLETED|Overall Study||0
2909175|NCT00468819|3618234|FG002|NOT COMPLETED|Overall Study||2
2909176|NCT00468845|3618247|FG000|STARTED|Overall Study||162
2909177|NCT00468845|3618248|FG001|STARTED|Overall Study||170
2909178|NCT00468845|3618249|FG002|STARTED|Overall Study||169
2909179|NCT00468845|3618247|FG000|Received Treatment|Overall Study||161
2909180|NCT00468845|3618248|FG001|Received Treatment|Overall Study||166
2909181|NCT00468845|3618249|FG002|Received Treatment|Overall Study||167
2909182|NCT00468845|3618247|FG000|COMPLETED|Overall Study||141
2909183|NCT00468845|3618248|FG001|COMPLETED|Overall Study||136
2909184|NCT00468845|3618249|FG002|COMPLETED|Overall Study||139
2909185|NCT00468845|3618247|FG000|NOT COMPLETED|Overall Study||21
2909186|NCT00468845|3618248|FG001|NOT COMPLETED|Overall Study||34
2909187|NCT00468845|3618249|FG002|NOT COMPLETED|Overall Study||30
2909188|NCT00468858|3618260|FG000|STARTED|Overall Study||211
2909189|NCT00468858|3618261|FG001|STARTED|Overall Study||212
2909190|NCT00468858|3618262|FG002|STARTED|Overall Study||213
2909191|NCT00468858|3618260|FG000|COMPLETED|Overall Study||202
2909192|NCT00468858|3618261|FG001|COMPLETED|Overall Study||202
2909193|NCT00468858|3618262|FG002|COMPLETED|Overall Study||199
2909194|NCT00468858|3618260|FG000|NOT COMPLETED|Overall Study||9
2909195|NCT00468858|3618261|FG001|NOT COMPLETED|Overall Study||10
2909196|NCT00468858|3618262|FG002|NOT COMPLETED|Overall Study||14
2909197|NCT00468910|3618326|FG000|STARTED|Overall Study||40
2909198|NCT00468910|3618327|FG001|STARTED|Overall Study||39
2909199|NCT00468910|3618326|FG000|Randomization|Overall Study||40
2909200|NCT00468910|3618327|FG001|Randomization|Overall Study||39
2909201|NCT00468910|3618326|FG000|Treatment|Overall Study||36
2909202|NCT00468910|3618327|FG001|Treatment|Overall Study||36
2909203|NCT00468910|3618326|FG000|Post-Treatment Biopsy|Overall Study||36
2909204|NCT00468910|3618327|FG001|Post-Treatment Biopsy|Overall Study||36
2909205|NCT00468910|3618326|FG000|Follow-up|Overall Study||36
2909206|NCT00468910|3618327|FG001|Follow-up|Overall Study||36
2909207|NCT00468910|3618326|FG000|COMPLETED|Overall Study||36
2909208|NCT00468910|3618327|FG001|COMPLETED|Overall Study||36
2909209|NCT00468910|3618326|FG000|NOT COMPLETED|Overall Study||4
2909210|NCT00468910|3618327|FG001|NOT COMPLETED|Overall Study||3
2909211|NCT00469014|3618338|FG000|STARTED|Initial Phase Randomization||5
2909212|NCT00469014|3618339|FG001|STARTED|Initial Phase Randomization||4
2909213|NCT00469014|3618340|FG002|STARTED|Initial Phase Randomization||5
2909214|NCT00469014|3618341|FG003|STARTED|Initial Phase Randomization||6
2909215|NCT00469014|3618338|FG000|COMPLETED|Initial Phase Randomization||4
2909216|NCT00469014|3618339|FG001|COMPLETED|Initial Phase Randomization||3
2909217|NCT00469014|3618340|FG002|COMPLETED|Initial Phase Randomization||4
2909218|NCT00469014|3618341|FG003|COMPLETED|Initial Phase Randomization||5
2909219|NCT00469014|3618338|FG000|NOT COMPLETED|Initial Phase Randomization||1
2909220|NCT00469014|3618339|FG001|NOT COMPLETED|Initial Phase Randomization||1
2909221|NCT00469014|3618340|FG002|NOT COMPLETED|Initial Phase Randomization||1
2909222|NCT00469014|3618341|FG003|NOT COMPLETED|Initial Phase Randomization||1
2909223|NCT00469014|3618338|FG000|STARTED|Adaptive Randomization||13
2909224|NCT00469014|3618339|FG001|STARTED|Adaptive Randomization||3
2909225|NCT00469014|3618340|FG002|STARTED|Adaptive Randomization||24
2909226|NCT00469014|3618341|FG003|STARTED|Adaptive Randomization||11
2909227|NCT00469014|3618338|FG000|COMPLETED|Adaptive Randomization||12
2909228|NCT00469014|3618339|FG001|COMPLETED|Adaptive Randomization||2
2909229|NCT00469014|3618340|FG002|COMPLETED|Adaptive Randomization||23
2909230|NCT00469014|3618341|FG003|COMPLETED|Adaptive Randomization||10
2909231|NCT00469014|3618338|FG000|NOT COMPLETED|Adaptive Randomization||1
2909232|NCT00469014|3618339|FG001|NOT COMPLETED|Adaptive Randomization||1
2909233|NCT00469014|3618340|FG002|NOT COMPLETED|Adaptive Randomization||1
2909234|NCT00469014|3618341|FG003|NOT COMPLETED|Adaptive Randomization||1
2909235|NCT00469079|3618354|FG000|STARTED|Overall Study||27
2909236|NCT00469079|3618355|FG001|STARTED|Overall Study||52
2909237|NCT00469079|3618356|FG002|STARTED|Overall Study||51
2909238|NCT00469079|3618354|FG000|COMPLETED|Overall Study||18
2909239|NCT00469079|3618355|FG001|COMPLETED|Overall Study||30
2909240|NCT00469079|3618356|FG002|COMPLETED|Overall Study||32
2909241|NCT00469079|3618354|FG000|NOT COMPLETED|Overall Study||9
2909242|NCT00469079|3618355|FG001|NOT COMPLETED|Overall Study||22
2909243|NCT00469079|3618356|FG002|NOT COMPLETED|Overall Study||19
2909244|NCT00469092|3618372|FG000|STARTED|Overall Study||239
2909245|NCT00469092|3618373|FG001|STARTED|Overall Study||241
2909246|NCT00469092|3618372|FG000|Exposed to Study Drug|Overall Study||231
2909247|NCT00469092|3618373|FG001|Exposed to Study Drug|Overall Study||238
2909248|NCT00469092|3618372|FG000|COMPLETED|Overall Study||213
2909249|NCT00469092|3618373|FG001|COMPLETED|Overall Study||220
2909250|NCT00469092|3618372|FG000|NOT COMPLETED|Overall Study||26
2909251|NCT00469092|3618373|FG001|NOT COMPLETED|Overall Study||21
2909252|NCT00469144|3618381|FG000|STARTED|Overall Study|Eight assigned to Fixed Dose without randomization.|114
2909253|NCT00469144|3618382|FG001|STARTED|Overall Study||111
2909254|NCT00469144|3618381|FG000|COMPLETED|Overall Study||108
2909255|NCT00469144|3618382|FG001|COMPLETED|Overall Study||105
2909256|NCT00469144|3618381|FG000|NOT COMPLETED|Overall Study||6
2909257|NCT00469144|3618382|FG001|NOT COMPLETED|Overall Study||6
2909258|NCT00469209|3618395|FG000|STARTED|Overall Study||20
2909259|NCT00469209|3618396|FG001|STARTED|Overall Study||20
2909260|NCT00469209|3618397|FG002|STARTED|Overall Study||20
2909261|NCT00469209|3618395|FG000|COMPLETED|Overall Study||19
2909262|NCT00469209|3618396|FG001|COMPLETED|Overall Study||20
2909263|NCT00469209|3618397|FG002|COMPLETED|Overall Study||19
2909264|NCT00469209|3618395|FG000|NOT COMPLETED|Overall Study||1
2909265|NCT00469209|3618396|FG001|NOT COMPLETED|Overall Study||0
2909266|NCT00469209|3618397|FG002|NOT COMPLETED|Overall Study||1
2909267|NCT00469274|3618407|FG000|STARTED|Overall Study||44
2909268|NCT00469274|3618408|FG001|STARTED|Overall Study||42
2909269|NCT00469274|3618407|FG000|COMPLETED|Overall Study||44
2909270|NCT00469274|3618408|FG001|COMPLETED|Overall Study||42
2909271|NCT00469274|3618407|FG000|NOT COMPLETED|Overall Study||0
2909272|NCT00469274|3618408|FG001|NOT COMPLETED|Overall Study||0
2909273|NCT00469391|3618416|FG000|STARTED|Overall Study||27
2909274|NCT00469391|3618417|FG001|STARTED|Overall Study||29
2909275|NCT00469391|3618416|FG000|Discontinued Prior to Procedure|Overall Study||2
2909276|NCT00469391|3618417|FG001|Discontinued Prior to Procedure|Overall Study||3
2909277|NCT00469391|3618416|FG000|Unsuccessful Implant Procedure|Overall Study||4
2909278|NCT00469391|3618417|FG001|Unsuccessful Implant Procedure|Overall Study||0
2909279|NCT00469391|3618416|FG000|Adverse Event|Overall Study||8
2909280|NCT00469391|3618417|FG001|Adverse Event|Overall Study||0
2909281|NCT00469391|3618416|FG000|Lost to Follow up|Overall Study||0
2909282|NCT00469391|3618417|FG001|Lost to Follow up|Overall Study||1
2909283|NCT00469391|3618416|FG000|Patient Preference|Overall Study||0
2909284|NCT00469391|3618417|FG001|Patient Preference|Overall Study||1
2909285|NCT00469391|3618416|FG000|COMPLETED|Overall Study||13
2909286|NCT00469391|3618417|FG001|COMPLETED|Overall Study||24
2909287|NCT00469391|3618416|FG000|NOT COMPLETED|Overall Study||14
2909288|NCT00469391|3618417|FG001|NOT COMPLETED|Overall Study||5
2909289|NCT00469456|3618425|FG000|STARTED|Overall Study|Safety Population defined as all patients who took at least one dose of double-blind study drug|129
2909290|NCT00469456|3618426|FG001|STARTED|Overall Study|Safety Population defined as all patients who took at least one dose of double-blind study drug.|135
2909291|NCT00469456|3618425|FG000|COMPLETED|Overall Study||120
2909292|NCT00469456|3618426|FG001|COMPLETED|Overall Study||131
2909293|NCT00469456|3618425|FG000|NOT COMPLETED|Overall Study||9
2909294|NCT00469456|3618426|FG001|NOT COMPLETED|Overall Study||4
2909295|NCT00469508|3618434|FG000|STARTED|Overall Study||34
2909296|NCT00469508|3618435|FG001|STARTED|Overall Study||37
2909297|NCT00469508|3618434|FG000|COMPLETED|Overall Study||14
2909298|NCT00469508|3618435|FG001|COMPLETED|Overall Study||13
2909299|NCT00469508|3618434|FG000|NOT COMPLETED|Overall Study||20
2909300|NCT00469508|3618435|FG001|NOT COMPLETED|Overall Study||24
2909301|NCT00469833|3618441|FG000|STARTED|Overall Study|17 subjects met inclusion criteria and consented for the study|17
2909302|NCT00469833|3618441|FG000|COMPLETED|Overall Study||15
2909303|NCT00469833|3618441|FG000|NOT COMPLETED|Overall Study||2
2909304|NCT00469859|3618453|FG000|STARTED|Overall Study||6
2909305|NCT00469859|3618454|FG001|STARTED|Overall Study||8
2909306|NCT00469859|3618453|FG000|COMPLETED|Overall Study||6
2909307|NCT00469859|3618454|FG001|COMPLETED|Overall Study||6
2909308|NCT00469859|3618453|FG000|NOT COMPLETED|Overall Study||0
2909309|NCT00469859|3618454|FG001|NOT COMPLETED|Overall Study||2
2909310|NCT00469898|3618460|FG000|STARTED|Overall Study||50
2909311|NCT00469898|3618460|FG000|COMPLETED|Overall Study||25
2909312|NCT00469898|3618460|FG000|NOT COMPLETED|Overall Study||25
2909313|NCT00469911|3618466|FG000|STARTED|Overall Study||8
2909314|NCT00469911|3618467|FG001|STARTED|Overall Study||10
2909315|NCT00469911|3618466|FG000|COMPLETED|Overall Study||8
2909316|NCT00469911|3618467|FG001|COMPLETED|Overall Study||10
2909317|NCT00469911|3618466|FG000|NOT COMPLETED|Overall Study||0
2909318|NCT00469911|3618467|FG001|NOT COMPLETED|Overall Study||0
2909319|NCT00470054|3618472|FG000|STARTED|Overall Study||44
2909320|NCT00470054|3618472|FG000|COMPLETED|Overall Study||43
2909321|NCT00470054|3618472|FG000|NOT COMPLETED|Overall Study||1
2909322|NCT00470093|3618476|FG000|STARTED|Overall Study||2
2909323|NCT00470093|3618476|FG000|COMPLETED|Overall Study||0
2909324|NCT00470093|3618476|FG000|NOT COMPLETED|Overall Study||2
2909325|NCT00470106|3618484|FG000|STARTED|Overall Study||19
2909326|NCT00470106|3618485|FG001|STARTED|Overall Study||24
2909327|NCT00470106|3618486|FG002|STARTED|Overall Study||21
2909328|NCT00470106|3618487|FG003|STARTED|Overall Study||21
2909329|NCT00470106|3618484|FG000|COMPLETED|Overall Study||16
2909330|NCT00470106|3618485|FG001|COMPLETED|Overall Study||19
2909331|NCT00470106|3618486|FG002|COMPLETED|Overall Study||14
2909332|NCT00470106|3618487|FG003|COMPLETED|Overall Study||19
2909333|NCT00470106|3618484|FG000|NOT COMPLETED|Overall Study||3
2909334|NCT00470106|3618485|FG001|NOT COMPLETED|Overall Study||5
2909335|NCT00470106|3618486|FG002|NOT COMPLETED|Overall Study||7
2909336|NCT00470106|3618487|FG003|NOT COMPLETED|Overall Study||2
2909337|NCT00470158|3618506|FG000|STARTED|Overall Study|9 children received wrong samples at enrollment and were analyzed by the supplement received.|201
2909338|NCT00470158|3618507|FG001|STARTED|Overall Study|9 children received wrong samples at enrollment and were analyzed by the supplement received.|199
2909339|NCT00470158|3618508|FG002|STARTED|Overall Study|9 children received wrong samples at enrollment and were analyzed by the supplement received.|201
2909340|NCT00470158|3618509|FG003|STARTED|Overall Study|9 children received wrong samples at enrollment and were analyzed by the supplement received.|198
2909341|NCT00470158|3618510|FG004|STARTED|Overall Study|9 children received wrong samples at enrollment and were analyzed by the supplement received.|201
2909342|NCT00470158|3618506|FG000|COMPLETED|Overall Study|Enrolled for at least 90% of total study time.|193
2909343|NCT00470158|3618507|FG001|COMPLETED|Overall Study|Enrolled for at least 90% of total study time.|191
2909344|NCT00470158|3618508|FG002|COMPLETED|Overall Study|Enrolled for at least 90% of total study time.|193
2909345|NCT00470158|3618509|FG003|COMPLETED|Overall Study|Enrolled for at least 90% of total study time.|193
2909346|NCT00470158|3618510|FG004|COMPLETED|Overall Study|Enrolled for at least 90% of total study time.|195
2909347|NCT00470158|3618506|FG000|NOT COMPLETED|Overall Study||8
2909348|NCT00470158|3618507|FG001|NOT COMPLETED|Overall Study||8
2909349|NCT00470158|3618508|FG002|NOT COMPLETED|Overall Study||8
2909350|NCT00470158|3618509|FG003|NOT COMPLETED|Overall Study||5
2909351|NCT00470158|3618510|FG004|NOT COMPLETED|Overall Study||6
2909352|NCT00470184|3618522|FG000|STARTED|Overall Study||41
2909353|NCT00470184|3618522|FG000|Treated With Study Therapy|Overall Study||36
2909354|NCT00470184|3618522|FG000|COMPLETED|Overall Study||19
2909355|NCT00470184|3618522|FG000|NOT COMPLETED|Overall Study||22
2909356|NCT00470262|3618529|FG000|STARTED|Overall Study||15
2909357|NCT00470262|3618530|FG001|STARTED|Overall Study||12
2909358|NCT00470262|3618529|FG000|COMPLETED|Overall Study||13
2909359|NCT00470262|3618530|FG001|COMPLETED|Overall Study||12
2909360|NCT00470262|3618529|FG000|NOT COMPLETED|Overall Study||2
2909361|NCT00470262|3618530|FG001|NOT COMPLETED|Overall Study||0
2909362|NCT00470275|3618537|FG000|STARTED|Overall Study||10
2909363|NCT00470275|3618537|FG000|COMPLETED|Overall Study||0
2909364|NCT00470275|3618537|FG000|NOT COMPLETED|Overall Study||10
2909365|NCT00470301|3618541|FG000|STARTED|Overall Study||60
2909366|NCT00470301|3618541|FG000|COMPLETED|Overall Study||55
2909367|NCT00470301|3618541|FG000|NOT COMPLETED|Overall Study||5
2909368|NCT00470366|3618546|FG000|STARTED|Overall Study||60
2909369|NCT00470366|3618546|FG000|COMPLETED|Overall Study||56
2909370|NCT00470366|3618546|FG000|NOT COMPLETED|Overall Study||4
2909371|NCT00470392|3618552|FG000|STARTED|Overall Study|Number of subjects enrolled, passed screening and assigned to this arm.|7
2909372|NCT00470392|3618553|FG001|STARTED|Overall Study|Number of subjects enrolled, passed screening and assigned to this arm.|2
2909373|NCT00470392|3618552|FG000|COMPLETED|Overall Study||7
2909374|NCT00470392|3618553|FG001|COMPLETED|Overall Study||2
2909375|NCT00470392|3618552|FG000|NOT COMPLETED|Overall Study||0
2909376|NCT00470392|3618553|FG001|NOT COMPLETED|Overall Study||0
2909377|NCT00470418|3618562|FG000|STARTED|Overall Study||7
2909378|NCT00470418|3618563|FG001|STARTED|Overall Study||3
2909379|NCT00470418|3618562|FG000|COMPLETED|Overall Study||6
2909380|NCT00470418|3618563|FG001|COMPLETED|Overall Study||3
2909381|NCT00470418|3618562|FG000|NOT COMPLETED|Overall Study||1
2909382|NCT00470418|3618563|FG001|NOT COMPLETED|Overall Study||0
2909383|NCT00470470|3618569|FG000|STARTED|Overall Study||30
3171549|NCT01934790|3898718|FG000|NOT COMPLETED|Active Follow up||24
3171550|NCT01934790|3898718|FG000|STARTED|Long Term Follow up||12
3171551|NCT01934790|3898718|FG000|COMPLETED|Long Term Follow up||12
3171552|NCT01934790|3898718|FG000|NOT COMPLETED|Long Term Follow up||0
3171553|NCT01934894|3898724|FG000|STARTED|Overall Study||6
2909384|NCT00470470|3618569|FG000|COMPLETED|Overall Study||25
2909385|NCT00470470|3618569|FG000|NOT COMPLETED|Overall Study||5
2909386|NCT00470535|3618573|FG000|STARTED|Overall Study||18
2909387|NCT00470535|3618573|FG000|COMPLETED|Overall Study||0
2909388|NCT00470535|3618573|FG000|NOT COMPLETED|Overall Study||18
2909389|NCT00470548|3618579|FG000|STARTED|Overall Study||3
2909390|NCT00470548|3618580|FG001|STARTED|Overall Study||3
2909391|NCT00470548|3618581|FG002|STARTED|Overall Study||6
2909392|NCT00470548|3618582|FG003|STARTED|Overall Study||37
2909393|NCT00470548|3618579|FG000|COMPLETED|Overall Study||3
2909394|NCT00470548|3618580|FG001|COMPLETED|Overall Study||3
2909395|NCT00470548|3618581|FG002|COMPLETED|Overall Study||6
2909396|NCT00470548|3618582|FG003|COMPLETED|Overall Study||37
3171554|NCT01934894|3898725|FG001|STARTED|Overall Study||5
3171555|NCT01934894|3898724|FG000|COMPLETED|Overall Study||0
3171556|NCT01934894|3898725|FG001|COMPLETED|Overall Study||0
2909397|NCT00470548|3618579|FG000|NOT COMPLETED|Overall Study||0
2909398|NCT00470548|3618580|FG001|NOT COMPLETED|Overall Study||0
2909399|NCT00470548|3618581|FG002|NOT COMPLETED|Overall Study||0
2909400|NCT00470548|3618582|FG003|NOT COMPLETED|Overall Study||0
2909401|NCT00470600|3618594|FG000|STARTED|Overall Study||86
2909402|NCT00470600|3618595|FG001|STARTED|Overall Study||99
2909403|NCT00470600|3618594|FG000|COMPLETED|Overall Study|Two subjects were randomized to incorrect stratification categories (weight).|86
2909404|NCT00470600|3618595|FG001|COMPLETED|Overall Study|One subject was randomized to incorrect stratification categories (weight).|99
2909405|NCT00470600|3618594|FG000|NOT COMPLETED|Overall Study||0
2909406|NCT00470600|3618595|FG001|NOT COMPLETED|Overall Study||0
2909407|NCT00470626|3618601|FG000|STARTED|Overall Study||129
2909408|NCT00470626|3618601|FG000|COMPLETED|Overall Study||112
2909409|NCT00470626|3618601|FG000|NOT COMPLETED|Overall Study||17
2909410|NCT00470717|3618605|FG000|STARTED|Overall Study|Each participant could be called up to 4 times weekly for 13 weeks (38x4x13)|38
2909411|NCT00470717|3618605|FG000|COMPLETED|Overall Study||38
2909412|NCT00470717|3618605|FG000|NOT COMPLETED|Overall Study||0
2909413|NCT00470834|3618611|FG000|STARTED|Treatment Period (18 Months)||65
2909414|NCT00470834|3618612|FG001|STARTED|Treatment Period (18 Months)||62
2909415|NCT00470834|3618611|FG000|COMPLETED|Treatment Period (18 Months)||27
2909416|NCT00470834|3618612|FG001|COMPLETED|Treatment Period (18 Months)||31
2909417|NCT00470834|3618611|FG000|NOT COMPLETED|Treatment Period (18 Months)||38
2909418|NCT00470834|3618612|FG001|NOT COMPLETED|Treatment Period (18 Months)||31
2909419|NCT00470834|3618611|FG000|STARTED|Extension Period (24 Months)|One participant who completed the Treatment Period did not participate in the Extension Period.|26
2909420|NCT00470834|3618612|FG001|STARTED|Extension Period (24 Months)|One participant who completed the Treatment Period did not participate in the Extension Period.|30
2909421|NCT00470834|3618611|FG000|COMPLETED|Extension Period (24 Months)||11
2909422|NCT00470834|3618612|FG001|COMPLETED|Extension Period (24 Months)||7
2909423|NCT00470834|3618611|FG000|NOT COMPLETED|Extension Period (24 Months)||15
2909424|NCT00470834|3618612|FG001|NOT COMPLETED|Extension Period (24 Months)||23
2909425|NCT00470847|3618618|FG000|STARTED|Overall Study||35
2909426|NCT00470847|3618618|FG000|COMPLETED|Overall Study||34
2909427|NCT00470847|3618618|FG000|NOT COMPLETED|Overall Study||1
2909428|NCT00471068|3618626|FG000|STARTED|Overall Study||21
2909429|NCT00471068|3618627|FG001|STARTED|Overall Study||25
2909430|NCT00471068|3618626|FG000|COMPLETED|Overall Study||20
2909431|NCT00471068|3618627|FG001|COMPLETED|Overall Study||24
2909432|NCT00471068|3618626|FG000|NOT COMPLETED|Overall Study||1
2909433|NCT00471068|3618627|FG001|NOT COMPLETED|Overall Study||1
2909434|NCT00471081|3618635|FG000|STARTED|Active Phase||160
2909435|NCT00471081|3618636|FG001|STARTED|Active Phase||189
2909436|NCT00471081|3618635|FG000|COMPLETED|Active Phase||158
2909437|NCT00471081|3618636|FG001|COMPLETED|Active Phase||176
2909438|NCT00471081|3618635|FG000|NOT COMPLETED|Active Phase||2
2909439|NCT00471081|3618636|FG001|NOT COMPLETED|Active Phase||13
2909440|NCT00471081|3618635|FG000|STARTED|Extended Safety Follow-Up||160
2909441|NCT00471081|3618636|FG001|STARTED|Extended Safety Follow-Up||189
2909442|NCT00471081|3618635|FG000|COMPLETED|Extended Safety Follow-Up||158
2909443|NCT00471081|3618636|FG001|COMPLETED|Extended Safety Follow-Up||176
2909444|NCT00471081|3618635|FG000|NOT COMPLETED|Extended Safety Follow-Up||2
2909445|NCT00471081|3618636|FG001|NOT COMPLETED|Extended Safety Follow-Up||13
2909446|NCT00471107|3618646|FG000|STARTED|Overall Study||15
2909447|NCT00471107|3618647|FG001|STARTED|Overall Study||15
2909448|NCT00471107|3618648|FG002|STARTED|Overall Study||15
2909449|NCT00471107|3618646|FG000|COMPLETED|Overall Study||12
2909450|NCT00471107|3618647|FG001|COMPLETED|Overall Study||14
2909451|NCT00471107|3618648|FG002|COMPLETED|Overall Study||12
2909452|NCT00471107|3618646|FG000|NOT COMPLETED|Overall Study||3
2909453|NCT00471107|3618647|FG001|NOT COMPLETED|Overall Study||1
2909454|NCT00471107|3618648|FG002|NOT COMPLETED|Overall Study||3
2909455|NCT00471146|3618658|FG000|STARTED|Overall Study||314
2909456|NCT00471146|3618659|FG001|STARTED|Overall Study||316
2909457|NCT00471146|3618658|FG000|Treated|Overall Study||305
2909458|NCT00471146|3618659|FG001|Treated|Overall Study||308
2909459|NCT00471146|3618658|FG000|COMPLETED|Overall Study||142
2909460|NCT00471146|3618659|FG001|COMPLETED|Overall Study||142
2909461|NCT00471146|3618658|FG000|NOT COMPLETED|Overall Study||172
2909462|NCT00471146|3618659|FG001|NOT COMPLETED|Overall Study||174
2909463|NCT00471237|3618672|FG000|STARTED|Overall Study||90
2909464|NCT00471237|3618673|FG001|STARTED|Overall Study||87
2909465|NCT00471237|3618674|FG002|STARTED|Overall Study||82
2909466|NCT00471237|3618675|FG003|STARTED|Overall Study||88
2909467|NCT00471237|3618676|FG004|STARTED|Overall Study||87
2909468|NCT00471237|3618677|FG005|STARTED|Overall Study||89
2909469|NCT00471237|3618678|FG006|STARTED|Overall Study||41
2909470|NCT00471237|3618672|FG000|COMPLETED|Overall Study||49
2909471|NCT00471237|3618673|FG001|COMPLETED|Overall Study||45
2909472|NCT00471237|3618674|FG002|COMPLETED|Overall Study||48
2909473|NCT00471237|3618675|FG003|COMPLETED|Overall Study||43
2909474|NCT00471237|3618676|FG004|COMPLETED|Overall Study||46
2909475|NCT00471237|3618677|FG005|COMPLETED|Overall Study||50
2909476|NCT00471237|3618678|FG006|COMPLETED|Overall Study||38
2909477|NCT00471237|3618672|FG000|NOT COMPLETED|Overall Study||41
2909478|NCT00471237|3618673|FG001|NOT COMPLETED|Overall Study||42
2909479|NCT00471237|3618674|FG002|NOT COMPLETED|Overall Study||34
2909480|NCT00471237|3618675|FG003|NOT COMPLETED|Overall Study||45
2909481|NCT00471237|3618676|FG004|NOT COMPLETED|Overall Study||41
2909482|NCT00471237|3618677|FG005|NOT COMPLETED|Overall Study||39
2909483|NCT00471237|3618678|FG006|NOT COMPLETED|Overall Study||3
2909484|NCT00471276|3618698|FG000|STARTED|Overall Study||83
2909485|NCT00471276|3618698|FG000|COMPLETED|Overall Study||0
2909486|NCT00471276|3618698|FG000|NOT COMPLETED|Overall Study||83
2909487|NCT00471315|3618702|FG000|STARTED|Overall Study||18
3171557|NCT01934894|3898724|FG000|NOT COMPLETED|Overall Study||6
3171558|NCT01934894|3898725|FG001|NOT COMPLETED|Overall Study||5
3171559|NCT01934972|3898736|FG000|STARTED|Overall Study||13
3171560|NCT01934972|3898737|FG001|STARTED|Overall Study||11
3171561|NCT01934972|3898736|FG000|COMPLETED|Overall Study||4
3171562|NCT01934972|3898737|FG001|COMPLETED|Overall Study||5
3171563|NCT01934972|3898736|FG000|NOT COMPLETED|Overall Study||9
3171564|NCT01934972|3898737|FG001|NOT COMPLETED|Overall Study||6
3171565|NCT01935180|3898745|FG000|STARTED|Overall Study||573
3384555|NCT02215096|4119647|FG002|NOT COMPLETED|Run-In Period (Up to Week 2)||0
3384556|NCT02215096|4119648|FG003|NOT COMPLETED|Run-In Period (Up to Week 2)||0
3384557|NCT02215096|4119649|FG004|NOT COMPLETED|Run-In Period (Up to Week 2)||0
2909488|NCT00471315|3618702|FG000|COMPLETED|Overall Study||10
2909489|NCT00471315|3618702|FG000|NOT COMPLETED|Overall Study||8
2909490|NCT00471328|3618708|FG000|STARTED|Core Phase||165
2909491|NCT00471328|3618709|FG001|STARTED|Core Phase||83
2909492|NCT00471328|3618708|FG000|Crossover to Nilotinib:Started Extension|Core Phase||0
2909493|NCT00471328|3618709|FG001|Crossover to Nilotinib:Started Extension|Core Phase||53
2909494|NCT00471328|3618708|FG000|COMPLETED|Core Phase|Ongoing on treatment during completion of core.|58
2909495|NCT00471328|3618709|FG001|COMPLETED|Core Phase|Ongoing on treatment during completion of core|16
2909496|NCT00471328|3618708|FG000|NOT COMPLETED|Core Phase||107
2909497|NCT00471328|3618709|FG001|NOT COMPLETED|Core Phase||67
2909498|NCT00471328|3618708|FG000|STARTED|Extension Phase|Out of 58 ongoing patients, 17 patients had progression or died before they could enter extension|41
2909499|NCT00471328|3618709|FG001|STARTED|Extension Phase||67
2909500|NCT00471328|3618708|FG000|Started:CrossOver Before PrimaryAnalysis|Extension Phase||0
2909501|NCT00471328|3618709|FG001|Started:CrossOver Before PrimaryAnalysis|Extension Phase||53
2909502|NCT00471328|3618708|FG000|Started:CrossOver After PrimaryAnalysis|Extension Phase||0
2909503|NCT00471328|3618709|FG001|Started:CrossOver After PrimaryAnalysis|Extension Phase||4
2909504|NCT00471328|3618708|FG000|Started:CrossOver During Extension|Extension Phase||0
2909505|NCT00471328|3618709|FG001|Started:CrossOver During Extension|Extension Phase||10
2909506|NCT00471328|3618708|FG000|COMPLETED|Extension Phase||0
2909507|NCT00471328|3618709|FG001|COMPLETED|Extension Phase||0
2909508|NCT00471328|3618708|FG000|NOT COMPLETED|Extension Phase||41
2909509|NCT00471328|3618709|FG001|NOT COMPLETED|Extension Phase||67
2909510|NCT00471354|3618717|FG000|STARTED|Overall Study||228
2909511|NCT00471354|3618717|FG000|COMPLETED|Overall Study||176
2909512|NCT00471354|3618717|FG000|NOT COMPLETED|Overall Study||52
2909513|NCT00471380|3618721|FG000|STARTED|First Intervention||22
2909514|NCT00471380|3618722|FG001|STARTED|First Intervention||24
2909515|NCT00471380|3618721|FG000|COMPLETED|First Intervention||18
2909516|NCT00471380|3618722|FG001|COMPLETED|First Intervention||20
2909517|NCT00471380|3618721|FG000|NOT COMPLETED|First Intervention||4
2909518|NCT00471380|3618722|FG001|NOT COMPLETED|First Intervention||4
2909519|NCT00471380|3618721|FG000|STARTED|Second Intervention||18
2909520|NCT00471380|3618722|FG001|STARTED|Second Intervention||20
2909521|NCT00471380|3618721|FG000|COMPLETED|Second Intervention||18
2909522|NCT00471380|3618722|FG001|COMPLETED|Second Intervention||16
2909523|NCT00471380|3618721|FG000|NOT COMPLETED|Second Intervention||0
2909524|NCT00471380|3618722|FG001|NOT COMPLETED|Second Intervention||4
2909525|NCT00471380|3618721|FG000|STARTED|Third Intervention||18
2909526|NCT00471380|3618722|FG001|STARTED|Third Intervention||16
2909527|NCT00471380|3618721|FG000|COMPLETED|Third Intervention||17
2909528|NCT00471380|3618722|FG001|COMPLETED|Third Intervention||14
2909529|NCT00471380|3618721|FG000|NOT COMPLETED|Third Intervention||1
2909530|NCT00471380|3618722|FG001|NOT COMPLETED|Third Intervention||2
2909531|NCT00471445|3618730|FG000|STARTED|Overall Study||229
2909532|NCT00471445|3618731|FG001|STARTED|Overall Study||233
2909533|NCT00471445|3618730|FG000|COMPLETED|Overall Study||227
2909534|NCT00471445|3618731|FG001|COMPLETED|Overall Study||231
2909535|NCT00471445|3618730|FG000|NOT COMPLETED|Overall Study||2
2909536|NCT00471445|3618731|FG001|NOT COMPLETED|Overall Study||2
2909537|NCT00471497|3618740|FG000|STARTED|Core Treatment Phase||283
2909538|NCT00471497|3618741|FG001|STARTED|Core Treatment Phase||282
2909539|NCT00471497|3618742|FG002|STARTED|Core Treatment Phase||281
2909540|NCT00471497|3618740|FG000|Safety Analysis Set|Core Treatment Phase|Safety set contained patients who received at least one dose of study medication.|280
3171566|NCT01935180|3898746|FG001|STARTED|Overall Study||575
3384558|NCT02215096|4119645|FG000|STARTED|Combination TP (Up to Maximum 654 Days)||0
3384559|NCT02215096|4119646|FG001|STARTED|Combination TP (Up to Maximum 654 Days)||11
3384560|NCT02215096|4119647|FG002|STARTED|Combination TP (Up to Maximum 654 Days)||11
3384561|NCT02215096|4119648|FG003|STARTED|Combination TP (Up to Maximum 654 Days)||12
3384562|NCT02215096|4119649|FG004|STARTED|Combination TP (Up to Maximum 654 Days)||2
3384563|NCT02215096|4119645|FG000|COMPLETED|Combination TP (Up to Maximum 654 Days)||0
3384564|NCT02215096|4119646|FG001|COMPLETED|Combination TP (Up to Maximum 654 Days)||9
3384565|NCT02215096|4119647|FG002|COMPLETED|Combination TP (Up to Maximum 654 Days)||10
3171567|NCT01935180|3898745|FG000|COMPLETED|Overall Study||552
3171568|NCT01935180|3898746|FG001|COMPLETED|Overall Study||561
3171569|NCT01935180|3898745|FG000|NOT COMPLETED|Overall Study||21
2909541|NCT00471497|3618741|FG001|Safety Analysis Set|Core Treatment Phase|Safety set contained patients who received at least one dose of study medication.|279
2909542|NCT00471497|3618742|FG002|Safety Analysis Set|Core Treatment Phase|Safety set contained patients who received at least one dose of study medication.|277
2909543|NCT00471497|3618740|FG000|Discon. Core/Did Not Enter Ext.|Core Treatment Phase||235
2909544|NCT00471497|3618741|FG001|Discon. Core/Did Not Enter Ext.|Core Treatment Phase||256
2909545|NCT00471497|3618742|FG002|Discon. Core/Did Not Enter Ext.|Core Treatment Phase||278
2909546|NCT00471497|3618740|FG000|Discontinued Core/Entered Ext.|Core Treatment Phase||48
2909547|NCT00471497|3618741|FG001|Discontinued Core/Entered Ext.|Core Treatment Phase||26
2909548|NCT00471497|3618742|FG002|Discontinued Core/Entered Ext.|Core Treatment Phase||3
2909549|NCT00471497|3618740|FG000|COMPLETED|Core Treatment Phase||99
2909550|NCT00471497|3618741|FG001|COMPLETED|Core Treatment Phase||107
2909551|NCT00471497|3618742|FG002|COMPLETED|Core Treatment Phase||99
2909552|NCT00471497|3618740|FG000|NOT COMPLETED|Core Treatment Phase||184
2909553|NCT00471497|3618741|FG001|NOT COMPLETED|Core Treatment Phase||175
2909554|NCT00471497|3618742|FG002|NOT COMPLETED|Core Treatment Phase||182
2909555|NCT00471497|3618740|FG000|STARTED|Extension Phase||48
2909556|NCT00471497|3618741|FG001|STARTED|Extension Phase||26
2909557|NCT00471497|3618742|FG002|STARTED|Extension Phase||3
2909558|NCT00471497|3618740|FG000|COMPLETED|Extension Phase||21
2909559|NCT00471497|3618741|FG001|COMPLETED|Extension Phase||12
2909560|NCT00471497|3618742|FG002|COMPLETED|Extension Phase||2
2909561|NCT00471497|3618740|FG000|NOT COMPLETED|Extension Phase||27
3171570|NCT01935180|3898746|FG001|NOT COMPLETED|Overall Study||14
3171571|NCT01935622|3898755|FG000|STARTED|Overall Study||3
3171572|NCT01935622|3898756|FG001|STARTED|Overall Study||3
3171573|NCT01935622|3898757|FG002|STARTED|Overall Study||4
3171574|NCT01935622|3898755|FG000|COMPLETED|Overall Study||1
3171575|NCT01935622|3898756|FG001|COMPLETED|Overall Study||1
3171576|NCT01935622|3898757|FG002|COMPLETED|Overall Study||4
3171577|NCT01935622|3898755|FG000|NOT COMPLETED|Overall Study||2
2909562|NCT00471497|3618741|FG001|NOT COMPLETED|Extension Phase||14
2909563|NCT00471497|3618742|FG002|NOT COMPLETED|Extension Phase||1
2909564|NCT00471536|3618753|FG000|STARTED|Overall Study||19
2909565|NCT00471536|3618753|FG000|COMPLETED|Overall Study||18
2909566|NCT00471536|3618753|FG000|NOT COMPLETED|Overall Study||1
2909567|NCT00471705|3618760|FG000|STARTED|Overall Study||145
2909568|NCT00471705|3618761|FG001|STARTED|Overall Study||143
2909569|NCT00471705|3618762|FG002|STARTED|Overall Study||149
2909570|NCT00471705|3618760|FG000|COMPLETED|Overall Study||121
2909571|NCT00471705|3618761|FG001|COMPLETED|Overall Study||121
2909572|NCT00471705|3618762|FG002|COMPLETED|Overall Study||134
2909573|NCT00471705|3618760|FG000|NOT COMPLETED|Overall Study||24
2909574|NCT00471705|3618761|FG001|NOT COMPLETED|Overall Study||22
2909575|NCT00471705|3618762|FG002|NOT COMPLETED|Overall Study||15
2909576|NCT00471718|3618770|FG000|STARTED|Overall Study||27
2909577|NCT00471718|3618770|FG000|COMPLETED|Overall Study||0
2909578|NCT00471718|3618770|FG000|NOT COMPLETED|Overall Study||27
2909579|NCT00471822|3618778|FG000|STARTED|Overall Study||9707
2909580|NCT00471822|3618778|FG000|Treated|Overall Study||9705
2909581|NCT00471822|3618778|FG000|COMPLETED|Overall Study||9705
2909582|NCT00471822|3618778|FG000|NOT COMPLETED|Overall Study||2
2909583|NCT00471848|3618782|FG000|STARTED|Overall Study||35
2909584|NCT00471848|3618782|FG000|COMPLETED|Overall Study|35 registered patients received the full 5-day Rabbit Antithymocyte Globuline (RATG) treatment|35
2909585|NCT00471848|3618782|FG000|NOT COMPLETED|Overall Study||0
2909586|NCT00471887|3618786|FG000|STARTED|Overall Study||32
2909587|NCT00471887|3618786|FG000|COMPLETED|Overall Study||23
2909588|NCT00471887|3618786|FG000|NOT COMPLETED|Overall Study||9
2909589|NCT00472030|3618792|FG000|STARTED|Overall Study||2
2909590|NCT00472030|3618793|FG001|STARTED|Overall Study||0
2909591|NCT00472030|3618792|FG000|COMPLETED|Overall Study||1
2909592|NCT00472030|3618793|FG001|COMPLETED|Overall Study||0
2909593|NCT00472030|3618792|FG000|NOT COMPLETED|Overall Study||1
2909594|NCT00472030|3618793|FG001|NOT COMPLETED|Overall Study||0
2909595|NCT00472056|3618807|FG000|STARTED|Overall Study||25
2909596|NCT00472056|3618808|FG001|STARTED|Overall Study||19
2909597|NCT00472056|3618809|FG002|STARTED|Overall Study||32
2909598|NCT00472056|3618810|FG003|STARTED|Overall Study||17
2909599|NCT00472056|3618807|FG000|COMPLETED|Overall Study||25
2909600|NCT00472056|3618808|FG001|COMPLETED|Overall Study||19
2909601|NCT00472056|3618809|FG002|COMPLETED|Overall Study||32
2909602|NCT00472056|3618810|FG003|COMPLETED|Overall Study||17
2909603|NCT00472056|3618807|FG000|NOT COMPLETED|Overall Study||0
2909604|NCT00472056|3618808|FG001|NOT COMPLETED|Overall Study||0
2909605|NCT00472056|3618809|FG002|NOT COMPLETED|Overall Study||0
2909606|NCT00472056|3618810|FG003|NOT COMPLETED|Overall Study||0
2909607|NCT00472199|3618820|FG000|STARTED|Overall Study||166
2909608|NCT00472199|3618821|FG001|STARTED|Overall Study||163
2909609|NCT00472199|3618820|FG000|COMPLETED|Overall Study||131
2909610|NCT00472199|3618821|FG001|COMPLETED|Overall Study||103
2909611|NCT00472199|3618820|FG000|NOT COMPLETED|Overall Study||35
2909612|NCT00472199|3618821|FG001|NOT COMPLETED|Overall Study||60
2909613|NCT00472290|3618827|FG000|STARTED|Overall Study||72
2909614|NCT00472290|3618827|FG000|COMPLETED|Overall Study||0
2909615|NCT00472290|3618827|FG000|NOT COMPLETED|Overall Study||72
2909616|NCT00472303|3618833|FG000|STARTED|Titration Phase||338
2909617|NCT00472303|3618834|FG001|STARTED|Titration Phase||158
2909618|NCT00472303|3618835|FG002|STARTED|Titration Phase|All participants in the titration phase were in the tapentadol arm during the titration phase.|0
3171578|NCT01935622|3898756|FG001|NOT COMPLETED|Overall Study||2
2909619|NCT00472303|3618833|FG000|COMPLETED|Titration Phase||279
2909620|NCT00472303|3618834|FG001|COMPLETED|Titration Phase||129
2909621|NCT00472303|3618835|FG002|COMPLETED|Titration Phase||0
2909622|NCT00472303|3618833|FG000|NOT COMPLETED|Titration Phase||59
2909623|NCT00472303|3618834|FG001|NOT COMPLETED|Titration Phase||29
2909624|NCT00472303|3618835|FG002|NOT COMPLETED|Titration Phase||0
2909625|NCT00472303|3618833|FG000|STARTED|Discontinuations After Titration Phase||279
2909626|NCT00472303|3618834|FG001|STARTED|Discontinuations After Titration Phase||129
2909627|NCT00472303|3618835|FG002|STARTED|Discontinuations After Titration Phase||0
2909628|NCT00472303|3618833|FG000|COMPLETED|Discontinuations After Titration Phase|Participants meeting stabilization criteria on days 13-15 in the titration phase were re-randomized.|218
2909629|NCT00472303|3618834|FG001|COMPLETED|Discontinuations After Titration Phase|Participants meeting stabilization criteria on days 13-15 in the titration phase were re-randomized.|109
2909630|NCT00472303|3618835|FG002|COMPLETED|Discontinuations After Titration Phase||0
2909631|NCT00472303|3618833|FG000|NOT COMPLETED|Discontinuations After Titration Phase||61
2909632|NCT00472303|3618834|FG001|NOT COMPLETED|Discontinuations After Titration Phase||20
2909633|NCT00472303|3618835|FG002|NOT COMPLETED|Discontinuations After Titration Phase||0
2909634|NCT00472303|3618833|FG000|STARTED|Maintenance Phase|106 of 218 participants in the tapentadol titration arm were re-randomized and treated.|106
2909635|NCT00472303|3618834|FG001|STARTED|Maintenance Phase||109
2909636|NCT00472303|3618835|FG002|STARTED|Maintenance Phase|112 of 218 participants in the tapentadol titration arm were re-randomized and treated.|112
2909637|NCT00472303|3618833|FG000|COMPLETED|Maintenance Phase||89
2909638|NCT00472303|3618834|FG001|COMPLETED|Maintenance Phase||93
2909639|NCT00472303|3618835|FG002|COMPLETED|Maintenance Phase||95
2909640|NCT00472303|3618833|FG000|NOT COMPLETED|Maintenance Phase||17
2909641|NCT00472303|3618834|FG001|NOT COMPLETED|Maintenance Phase||16
2909642|NCT00472303|3618835|FG002|NOT COMPLETED|Maintenance Phase||17
2909643|NCT00472420|3618863|FG000|STARTED|Induction Treatment Period||48
2909644|NCT00472420|3618863|FG000|COMPLETED|Induction Treatment Period||32
2909645|NCT00472420|3618863|FG000|NOT COMPLETED|Induction Treatment Period||16
2909646|NCT00472420|3618863|FG000|STARTED|Follow-up Period||32
2909647|NCT00472420|3618863|FG000|COMPLETED|Follow-up Period||15
2909648|NCT00472420|3618863|FG000|NOT COMPLETED|Follow-up Period||17
2909649|NCT00472446|3618871|FG000|STARTED|Overall Study||46
2909650|NCT00472446|3618872|FG001|STARTED|Overall Study||47
2909651|NCT00472446|3618873|FG002|STARTED|Overall Study||45
2909652|NCT00472446|3618874|FG003|STARTED|Overall Study||45
2909653|NCT00472446|3618871|FG000|COMPLETED|Overall Study||41
2909654|NCT00472446|3618872|FG001|COMPLETED|Overall Study||41
2909655|NCT00472446|3618873|FG002|COMPLETED|Overall Study||38
2909656|NCT00472446|3618874|FG003|COMPLETED|Overall Study||39
2909657|NCT00472446|3618871|FG000|NOT COMPLETED|Overall Study||5
2909658|NCT00472446|3618872|FG001|NOT COMPLETED|Overall Study||6
2909659|NCT00472446|3618873|FG002|NOT COMPLETED|Overall Study||7
2909660|NCT00472446|3618874|FG003|NOT COMPLETED|Overall Study||6
2909661|NCT00472576|3618886|FG000|STARTED|First Intervention||2
2909662|NCT00472576|3618887|FG001|STARTED|First Intervention||3
2909663|NCT00472576|3618886|FG000|COMPLETED|First Intervention||2
2909664|NCT00472576|3618887|FG001|COMPLETED|First Intervention||3
2909665|NCT00472576|3618886|FG000|NOT COMPLETED|First Intervention||0
2909666|NCT00472576|3618887|FG001|NOT COMPLETED|First Intervention||0
2909667|NCT00472576|3618886|FG000|STARTED|Second Intervention||2
2909668|NCT00472576|3618887|FG001|STARTED|Second Intervention||3
2909669|NCT00472576|3618886|FG000|COMPLETED|Second Intervention||2
2909670|NCT00472576|3618887|FG001|COMPLETED|Second Intervention||3
2909671|NCT00472576|3618886|FG000|NOT COMPLETED|Second Intervention||0
2909672|NCT00472576|3618887|FG001|NOT COMPLETED|Second Intervention||0
2909673|NCT00472641|3618893|FG000|STARTED|Overall Study||25
2909674|NCT00472641|3618893|FG000|COMPLETED|Overall Study||18
2909675|NCT00472641|3618893|FG000|NOT COMPLETED|Overall Study||7
2909676|NCT00472732|3618899|FG000|STARTED|Overall Study||24
2909677|NCT00472732|3618900|FG001|STARTED|Overall Study||22
2909678|NCT00472732|3618899|FG000|COMPLETED|Overall Study||24
2909679|NCT00472732|3618900|FG001|COMPLETED|Overall Study||22
2909680|NCT00472732|3618899|FG000|NOT COMPLETED|Overall Study||0
2909681|NCT00472732|3618900|FG001|NOT COMPLETED|Overall Study||0
2909682|NCT00472797|3618908|FG000|STARTED|Overall Study||119
2909683|NCT00472797|3618909|FG001|STARTED|Overall Study||113
2909684|NCT00472797|3618908|FG000|COMPLETED|Overall Study||115
2909685|NCT00472797|3618909|FG001|COMPLETED|Overall Study||112
2909686|NCT00472797|3618908|FG000|NOT COMPLETED|Overall Study||4
2909687|NCT00472797|3618909|FG001|NOT COMPLETED|Overall Study||1
2909688|NCT00472849|3618920|FG000|STARTED|Overall Study||12
2909689|NCT00472849|3618921|FG001|STARTED|Overall Study||78
2909690|NCT00472849|3618920|FG000|COMPLETED|Overall Study||12
2909691|NCT00472849|3618921|FG001|COMPLETED|Overall Study||78
2909692|NCT00472849|3618920|FG000|NOT COMPLETED|Overall Study||0
2909693|NCT00472849|3618921|FG001|NOT COMPLETED|Overall Study||0
2909694|NCT00473083|3618930|FG000|STARTED|Overall Study||50
2909695|NCT00473083|3618931|FG001|STARTED|Overall Study||50
2909696|NCT00473083|3618932|FG002|STARTED|Overall Study||50
2909697|NCT00473083|3618930|FG000|COMPLETED|Overall Study|One patient (2%) from treatment arm 1 discontinued the study drug as a result of a TEAE (dizziness)|49
2909698|NCT00473083|3618931|FG001|COMPLETED|Overall Study||50
2909699|NCT00473083|3618932|FG002|COMPLETED|Overall Study||50
2909700|NCT00473083|3618930|FG000|NOT COMPLETED|Overall Study||1
2909701|NCT00473083|3618931|FG001|NOT COMPLETED|Overall Study||0
2909702|NCT00473083|3618932|FG002|NOT COMPLETED|Overall Study||0
2909703|NCT00473265|3618943|FG000|STARTED|Overall Study||68
2909704|NCT00473265|3618943|FG000|COMPLETED|Overall Study||48
2909705|NCT00473265|3618943|FG000|NOT COMPLETED|Overall Study||20
2909706|NCT00473330|3618950|FG000|STARTED|Core Study||125
2909707|NCT00473330|3618951|FG001|STARTED|Core Study||125
2909708|NCT00473330|3618952|FG002|STARTED|Core Study||127
2909709|NCT00473330|3618950|FG000|COMPLETED|Core Study||98
2909710|NCT00473330|3618951|FG001|COMPLETED|Core Study||100
2909711|NCT00473330|3618952|FG002|COMPLETED|Core Study||86
2909712|NCT00473330|3618950|FG000|NOT COMPLETED|Core Study||27
2909713|NCT00473330|3618951|FG001|NOT COMPLETED|Core Study||25
2909714|NCT00473330|3618952|FG002|NOT COMPLETED|Core Study||41
2909715|NCT00473330|3618950|FG000|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|89
2909716|NCT00473330|3618951|FG001|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|79
2909717|NCT00473330|3618952|FG002|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|77
2909718|NCT00473330|3618950|FG000|COMPLETED|Open-label Extension Through Month 48||63
2909719|NCT00473330|3618951|FG001|COMPLETED|Open-label Extension Through Month 48||59
2909720|NCT00473330|3618952|FG002|COMPLETED|Open-label Extension Through Month 48||50
2909721|NCT00473330|3618950|FG000|NOT COMPLETED|Open-label Extension Through Month 48||26
2909722|NCT00473330|3618951|FG001|NOT COMPLETED|Open-label Extension Through Month 48||20
2909723|NCT00473330|3618952|FG002|NOT COMPLETED|Open-label Extension Through Month 48||27
2909724|NCT00473330|3618950|FG000|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|89
2909725|NCT00473330|3618951|FG001|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|79
2909726|NCT00473330|3618952|FG002|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|77
2909727|NCT00473330|3618950|FG000|COMPLETED|Open-label Extension Through Month 60||1
2909728|NCT00473330|3618951|FG001|COMPLETED|Open-label Extension Through Month 60||1
2909729|NCT00473330|3618952|FG002|COMPLETED|Open-label Extension Through Month 60||0
2909730|NCT00473330|3618950|FG000|NOT COMPLETED|Open-label Extension Through Month 60||88
2909731|NCT00473330|3618951|FG001|NOT COMPLETED|Open-label Extension Through Month 60||78
2909732|NCT00473330|3618952|FG002|NOT COMPLETED|Open-label Extension Through Month 60||77
2909733|NCT00473382|3618983|FG000|STARTED|Core Study||130
2909734|NCT00473382|3618984|FG001|STARTED|Core Study||125
2909735|NCT00473382|3618985|FG002|STARTED|Core Study||127
2909736|NCT00473382|3618983|FG000|COMPLETED|Core Study||102
2909737|NCT00473382|3618984|FG001|COMPLETED|Core Study||98
2909738|NCT00473382|3618985|FG002|COMPLETED|Core Study||98
2909739|NCT00473382|3618983|FG000|NOT COMPLETED|Core Study||28
2909740|NCT00473382|3618984|FG001|NOT COMPLETED|Core Study||27
2909741|NCT00473382|3618985|FG002|NOT COMPLETED|Core Study||29
2909742|NCT00473382|3618983|FG000|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|88
2909743|NCT00473382|3618984|FG001|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|83
2909744|NCT00473382|3618985|FG002|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|84
2909745|NCT00473382|3618983|FG000|COMPLETED|Open-label Extension Through Month 48||38
2909746|NCT00473382|3618984|FG001|COMPLETED|Open-label Extension Through Month 48||42
2909747|NCT00473382|3618985|FG002|COMPLETED|Open-label Extension Through Month 48||37
2909748|NCT00473382|3618983|FG000|NOT COMPLETED|Open-label Extension Through Month 48||50
2909749|NCT00473382|3618984|FG001|NOT COMPLETED|Open-label Extension Through Month 48||41
2909750|NCT00473382|3618985|FG002|NOT COMPLETED|Open-label Extension Through Month 48||47
2909751|NCT00473382|3618983|FG000|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|88
2909752|NCT00473382|3618984|FG001|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|83
2909753|NCT00473382|3618985|FG002|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|84
2909754|NCT00473382|3618983|FG000|COMPLETED|Open-label Extension Through Month 60||2
2909755|NCT00473382|3618984|FG001|COMPLETED|Open-label Extension Through Month 60||1
2909756|NCT00473382|3618985|FG002|COMPLETED|Open-label Extension Through Month 60||2
2909757|NCT00473382|3618983|FG000|NOT COMPLETED|Open-label Extension Through Month 60||86
2909758|NCT00473382|3618984|FG001|NOT COMPLETED|Open-label Extension Through Month 60||82
2909759|NCT00473382|3618985|FG002|NOT COMPLETED|Open-label Extension Through Month 60||82
2909760|NCT00473434|3619011|FG000|STARTED|Overall Study||64
2909761|NCT00473434|3619011|FG000|COMPLETED|Overall Study||32
2909762|NCT00473434|3619011|FG000|NOT COMPLETED|Overall Study||32
2909763|NCT00473512|3619033|FG000|STARTED|Period 1 (Phase 1)||3
2909764|NCT00473512|3619034|FG001|STARTED|Period 1 (Phase 1)||3
2909765|NCT00473512|3619035|FG002|STARTED|Period 1 (Phase 1)||3
3384566|NCT02215096|4119648|FG003|COMPLETED|Combination TP (Up to Maximum 654 Days)||10
3384567|NCT02215096|4119649|FG004|COMPLETED|Combination TP (Up to Maximum 654 Days)||1
3384568|NCT02215096|4119645|FG000|NOT COMPLETED|Combination TP (Up to Maximum 654 Days)||0
3384569|NCT02215096|4119646|FG001|NOT COMPLETED|Combination TP (Up to Maximum 654 Days)||2
3384570|NCT02215096|4119647|FG002|NOT COMPLETED|Combination TP (Up to Maximum 654 Days)||1
2909766|NCT00473512|3619036|FG003|STARTED|Period 1 (Phase 1)||42
2909767|NCT00473512|3619037|FG004|STARTED|Period 1 (Phase 1)||3
2909768|NCT00473512|3619033|FG000|COMPLETED|Period 1 (Phase 1)||2
2909769|NCT00473512|3619034|FG001|COMPLETED|Period 1 (Phase 1)||2
2909770|NCT00473512|3619035|FG002|COMPLETED|Period 1 (Phase 1)||3
2909771|NCT00473512|3619036|FG003|COMPLETED|Period 1 (Phase 1)||25
2909772|NCT00473512|3619037|FG004|COMPLETED|Period 1 (Phase 1)||2
2909773|NCT00473512|3619033|FG000|NOT COMPLETED|Period 1 (Phase 1)||1
2909774|NCT00473512|3619034|FG001|NOT COMPLETED|Period 1 (Phase 1)||1
2909775|NCT00473512|3619035|FG002|NOT COMPLETED|Period 1 (Phase 1)||0
2909776|NCT00473512|3619036|FG003|NOT COMPLETED|Period 1 (Phase 1)||17
2909777|NCT00473512|3619037|FG004|NOT COMPLETED|Period 1 (Phase 1)||1
2909778|NCT00473512|3619033|FG000|STARTED|Period 2 (Phase 2)|1 participant did not continue to Phase 2 of the study.|1
2909779|NCT00473512|3619034|FG001|STARTED|Period 2 (Phase 2)||2
2909780|NCT00473512|3619035|FG002|STARTED|Period 2 (Phase 2)|1 participant did not continue to Phase 2 of the study.|2
2909781|NCT00473512|3619036|FG003|STARTED|Period 2 (Phase 2)|2 participants did not continue to Phase 2 of the study.|23
2909782|NCT00473512|3619037|FG004|STARTED|Period 2 (Phase 2)||2
2909783|NCT00473512|3619033|FG000|COMPLETED|Period 2 (Phase 2)||0
2909784|NCT00473512|3619034|FG001|COMPLETED|Period 2 (Phase 2)||0
2909785|NCT00473512|3619035|FG002|COMPLETED|Period 2 (Phase 2)||0
2909786|NCT00473512|3619036|FG003|COMPLETED|Period 2 (Phase 2)||0
2909787|NCT00473512|3619037|FG004|COMPLETED|Period 2 (Phase 2)||0
2909788|NCT00473512|3619033|FG000|NOT COMPLETED|Period 2 (Phase 2)||1
2909789|NCT00473512|3619034|FG001|NOT COMPLETED|Period 2 (Phase 2)||2
2909790|NCT00473512|3619035|FG002|NOT COMPLETED|Period 2 (Phase 2)||2
2909791|NCT00473512|3619036|FG003|NOT COMPLETED|Period 2 (Phase 2)||23
2909792|NCT00473512|3619037|FG004|NOT COMPLETED|Period 2 (Phase 2)||2
2909793|NCT00473564|3619057|FG000|STARTED|Overall Study||170
2909794|NCT00473564|3619057|FG000|COMPLETED|Overall Study||147
2909795|NCT00473564|3619057|FG000|NOT COMPLETED|Overall Study||23
2909796|NCT00473590|3619063|FG000|STARTED|Overall Study||53
2909797|NCT00473590|3619064|FG001|STARTED|Overall Study||49
2909798|NCT00473590|3619063|FG000|Treated|Overall Study||52
2909799|NCT00473590|3619064|FG001|Treated|Overall Study||48
2909800|NCT00473590|3619063|FG000|Safety Population|Overall Study|2 patients received at least 1 bevacizumab dose & were analyzed as bevacizumab-treated patients|50
2909801|NCT00473590|3619064|FG001|Safety Population|Overall Study||50
2909802|NCT00473590|3619063|FG000|COMPLETED|Overall Study|Continuing on study as of the data cutoff date of 9 November 2009.|8
2909803|NCT00473590|3619064|FG001|COMPLETED|Overall Study|Continuing on study as of the data cutoff date of 9 November 2009.|11
2909804|NCT00473590|3619063|FG000|NOT COMPLETED|Overall Study||45
2909805|NCT00473590|3619064|FG001|NOT COMPLETED|Overall Study||38
2909806|NCT00473642|3619073|FG000|STARTED|Overall Study||10
2909807|NCT00473642|3619074|FG001|STARTED|Overall Study||11
2909808|NCT00473642|3619075|FG002|STARTED|Overall Study||10
2909809|NCT00473642|3619073|FG000|COMPLETED|Overall Study||8
2909810|NCT00473642|3619074|FG001|COMPLETED|Overall Study||10
2909811|NCT00473642|3619075|FG002|COMPLETED|Overall Study||8
2909812|NCT00473642|3619073|FG000|NOT COMPLETED|Overall Study||2
2909813|NCT00473642|3619074|FG001|NOT COMPLETED|Overall Study||1
2909814|NCT00473642|3619075|FG002|NOT COMPLETED|Overall Study||2
2909815|NCT00473655|3619089|FG000|STARTED|Overall Study|Just participants with TG above 200 mg/dl entered this period|111
2909816|NCT00473655|3619090|FG001|STARTED|Overall Study|Just participants with TG above 200 mg/dl entered this period|112
2909817|NCT00473655|3619091|FG002|STARTED|Overall Study|Just participants with TG above 200 mg/dl entered this period|111
2909818|NCT00473655|3619089|FG000|COMPLETED|Overall Study|9 participants were lost of follow up|102
2909819|NCT00473655|3619090|FG001|COMPLETED|Overall Study|5 participants were lost of follow up|107
2909820|NCT00473655|3619091|FG002|COMPLETED|Overall Study|8 participants were lost of follow up|103
2909821|NCT00473655|3619089|FG000|NOT COMPLETED|Overall Study||9
2909822|NCT00473655|3619090|FG001|NOT COMPLETED|Overall Study||5
2909823|NCT00473655|3619091|FG002|NOT COMPLETED|Overall Study||8
2909824|NCT00473668|3619102|FG000|STARTED|Overall Study||100
2909825|NCT00473668|3619103|FG001|STARTED|Overall Study||100
2909826|NCT00473668|3619104|FG002|STARTED|Overall Study||99
2909827|NCT00473668|3619102|FG000|COMPLETED|Overall Study||95
2909828|NCT00473668|3619103|FG001|COMPLETED|Overall Study||89
2909829|NCT00473668|3619104|FG002|COMPLETED|Overall Study||89
3384571|NCT02215096|4119648|FG003|NOT COMPLETED|Combination TP (Up to Maximum 654 Days)||2
3384572|NCT02215096|4119649|FG004|NOT COMPLETED|Combination TP (Up to Maximum 654 Days)||1
3386370|NCT02956434|4121661|FG000|STARTED|Overall Study||10
3386371|NCT02956434|4121662|FG001|STARTED|Overall Study||10
3386372|NCT02956434|4121663|FG002|STARTED|Overall Study||10
3386373|NCT02956434|4121664|FG003|STARTED|Overall Study||10
3386374|NCT02956434|4121661|FG000|COMPLETED|Overall Study||10
3386375|NCT02956434|4121662|FG001|COMPLETED|Overall Study||10
3386376|NCT02956434|4121663|FG002|COMPLETED|Overall Study||10
3386377|NCT02956434|4121664|FG003|COMPLETED|Overall Study||10
3386378|NCT02956434|4121661|FG000|NOT COMPLETED|Overall Study||0
3386379|NCT02956434|4121662|FG001|NOT COMPLETED|Overall Study||0
3386380|NCT02956434|4121663|FG002|NOT COMPLETED|Overall Study||0
3386381|NCT02956434|4121664|FG003|NOT COMPLETED|Overall Study||0
3386382|NCT02663622|4121676|FG000|STARTED|Overall Study||6
3386383|NCT02663622|4121677|FG001|STARTED|Overall Study||6
3386384|NCT02663622|4121678|FG002|STARTED|Overall Study||6
3386385|NCT02663622|4121679|FG003|STARTED|Overall Study||26
3386386|NCT02663622|4121676|FG000|COMPLETED|Overall Study||3
2909830|NCT00473668|3619102|FG000|NOT COMPLETED|Overall Study||5
2909831|NCT00473668|3619103|FG001|NOT COMPLETED|Overall Study||11
2909832|NCT00473668|3619104|FG002|NOT COMPLETED|Overall Study||10
2909833|NCT00473694|3619116|FG000|STARTED|Overall Study||48
2909834|NCT00473694|3619117|FG001|STARTED|Overall Study|Includes 1 participant randomized to vecuronium+sugammadex but treated with rocuronium+neostigmine|41
2909835|NCT00473694|3619118|FG002|STARTED|Overall Study||51
2909836|NCT00473694|3619119|FG003|STARTED|Overall Study||42
2909837|NCT00473694|3619116|FG000|Treated|Overall Study|Number of participants treated was based on actual treatment received.|37
2909838|NCT00473694|3619117|FG001|Treated|Overall Study|Number of participants treated was based on actual treatment received.|38
2909839|NCT00473694|3619118|FG002|Treated|Overall Study|Number of participants treated was based on actual treatment received.|46
2909840|NCT00473694|3619119|FG003|Treated|Overall Study|Number of participants treated was based on actual treatment received.|36
2909841|NCT00473694|3619116|FG000|COMPLETED|Overall Study|Number of participants completed was based on actual treatment received.|37
2909842|NCT00473694|3619117|FG001|COMPLETED|Overall Study|Number of participants completed was based on actual treatment received.|37
2909843|NCT00473694|3619118|FG002|COMPLETED|Overall Study|Number of participants completed was based on actual treatment received.|46
2909844|NCT00473694|3619119|FG003|COMPLETED|Overall Study|Number of participants completed was based on actual treatment received.|35
2909845|NCT00473694|3619116|FG000|NOT COMPLETED|Overall Study||11
2909846|NCT00473694|3619117|FG001|NOT COMPLETED|Overall Study||4
2909847|NCT00473694|3619118|FG002|NOT COMPLETED|Overall Study||5
2909848|NCT00473694|3619119|FG003|NOT COMPLETED|Overall Study||7
2909849|NCT00473746|3619137|FG000|STARTED|Period 1 (Phase 1)||6
2909850|NCT00473746|3619138|FG001|STARTED|Period 1 (Phase 1)||9
2909851|NCT00473746|3619139|FG002|STARTED|Period 1 (Phase 1)||6
2909852|NCT00473746|3619140|FG003|STARTED|Period 1 (Phase 1)||12
2909853|NCT00473746|3619141|FG004|STARTED|Period 1 (Phase 1)||0
2909854|NCT00473746|3619137|FG000|COMPLETED|Period 1 (Phase 1)||0
2909855|NCT00473746|3619138|FG001|COMPLETED|Period 1 (Phase 1)||0
2909856|NCT00473746|3619139|FG002|COMPLETED|Period 1 (Phase 1)||0
2909857|NCT00473746|3619140|FG003|COMPLETED|Period 1 (Phase 1)|Treatment ongoing|2
2909858|NCT00473746|3619141|FG004|COMPLETED|Period 1 (Phase 1)||0
2909859|NCT00473746|3619137|FG000|NOT COMPLETED|Period 1 (Phase 1)||6
2909860|NCT00473746|3619138|FG001|NOT COMPLETED|Period 1 (Phase 1)||9
2909861|NCT00473746|3619139|FG002|NOT COMPLETED|Period 1 (Phase 1)||6
2909862|NCT00473746|3619140|FG003|NOT COMPLETED|Period 1 (Phase 1)||10
2909863|NCT00473746|3619141|FG004|NOT COMPLETED|Period 1 (Phase 1)||0
2909864|NCT00473746|3619137|FG000|STARTED|Period 2 (Phase 2)||0
2909865|NCT00473746|3619138|FG001|STARTED|Period 2 (Phase 2)||0
2909866|NCT00473746|3619139|FG002|STARTED|Period 2 (Phase 2)||0
2909867|NCT00473746|3619140|FG003|STARTED|Period 2 (Phase 2)||0
2909868|NCT00473746|3619141|FG004|STARTED|Period 2 (Phase 2)||33
2909869|NCT00473746|3619137|FG000|COMPLETED|Period 2 (Phase 2)||0
2909870|NCT00473746|3619138|FG001|COMPLETED|Period 2 (Phase 2)||0
2909871|NCT00473746|3619139|FG002|COMPLETED|Period 2 (Phase 2)||0
2909872|NCT00473746|3619140|FG003|COMPLETED|Period 2 (Phase 2)||0
2909873|NCT00473746|3619141|FG004|COMPLETED|Period 2 (Phase 2)||6
2909874|NCT00473746|3619137|FG000|NOT COMPLETED|Period 2 (Phase 2)||0
2909875|NCT00473746|3619138|FG001|NOT COMPLETED|Period 2 (Phase 2)||0
2909876|NCT00473746|3619139|FG002|NOT COMPLETED|Period 2 (Phase 2)||0
2909877|NCT00473746|3619140|FG003|NOT COMPLETED|Period 2 (Phase 2)||0
2909878|NCT00473746|3619141|FG004|NOT COMPLETED|Period 2 (Phase 2)||27
2909879|NCT00473824|3619157|FG000|STARTED|Overall Study||5
2909880|NCT00473824|3619158|FG001|STARTED|Overall Study||2
2909881|NCT00473824|3619157|FG000|COMPLETED|Overall Study|Study Completion/Early Termination Date|0
2909882|NCT00473824|3619158|FG001|COMPLETED|Overall Study|Study Completion/Early Termination Date|2
2909883|NCT00473824|3619157|FG000|NOT COMPLETED|Overall Study||5
2909884|NCT00473824|3619158|FG001|NOT COMPLETED|Overall Study||0
2909885|NCT00473837|3619166|FG000|STARTED|Overall Study||50
2909886|NCT00473837|3619167|FG001|STARTED|Overall Study||46
2909887|NCT00473837|3619166|FG000|COMPLETED|Overall Study||49
2909888|NCT00473837|3619167|FG001|COMPLETED|Overall Study||43
2909889|NCT00473837|3619166|FG000|NOT COMPLETED|Overall Study||1
2909890|NCT00473837|3619167|FG001|NOT COMPLETED|Overall Study||3
2909891|NCT00473876|3619175|FG000|STARTED|Overall Study||39
2909892|NCT00473876|3619176|FG001|STARTED|Overall Study||23
2909893|NCT00473876|3619175|FG000|COMPLETED|Overall Study||36
2909894|NCT00473876|3619176|FG001|COMPLETED|Overall Study||22
2909895|NCT00473876|3619175|FG000|NOT COMPLETED|Overall Study||3
3171579|NCT01935622|3898757|FG002|NOT COMPLETED|Overall Study||0
3171580|NCT01935700|3898767|FG000|STARTED|Overall Study||14
3171581|NCT01935700|3898768|FG001|STARTED|Overall Study||86
2909896|NCT00473876|3619176|FG001|NOT COMPLETED|Overall Study||1
2909897|NCT00473889|3619186|FG000|STARTED|Overall Study||126
2909898|NCT00473889|3619187|FG001|STARTED|Overall Study||127
2909899|NCT00473889|3619186|FG000|COMPLETED|Overall Study||43
2909900|NCT00473889|3619187|FG001|COMPLETED|Overall Study||63
2909901|NCT00473889|3619186|FG000|NOT COMPLETED|Overall Study||83
2909902|NCT00473889|3619187|FG001|NOT COMPLETED|Overall Study||64
2920575|NCT00537407|3631082|FG000|NOT COMPLETED|Part 1 Weeks 1-4||0
2920576|NCT00537407|3631083|FG001|NOT COMPLETED|Part 1 Weeks 1-4||0
2920577|NCT00537407|3631084|FG002|NOT COMPLETED|Part 1 Weeks 1-4||0
2920578|NCT00537407|3631085|FG003|NOT COMPLETED|Part 1 Weeks 1-4||0
2920579|NCT00537407|3631086|FG004|NOT COMPLETED|Part 1 Weeks 1-4||0
2920580|NCT00537407|3631082|FG000|STARTED|Part 2 Weeks 5-48 or 72||10
2909903|NCT00474045|3619195|FG000|STARTED|Overall Study||233
2909904|NCT00474045|3619196|FG001|STARTED|Overall Study||237
2909905|NCT00474045|3619195|FG000|Exposed-All Subjects|Overall Study||233
2909906|NCT00474045|3619196|FG001|Exposed-All Subjects|Overall Study|5 withdrawn before treatment initiation|232
2909907|NCT00474045|3619195|FG000|Exposed-Pregnant Subjects|Overall Study||152
2909908|NCT00474045|3619196|FG001|Exposed-Pregnant Subjects|Overall Study|3 withdrawn before treatment initiation|158
2909909|NCT00474045|3619195|FG000|Pregnancies (for Exposed-pregnant)|Overall Study||152
2909910|NCT00474045|3619196|FG001|Pregnancies (for Exposed-pregnant)|Overall Study|2 subjects had spontaneous abortion and became pregnant again|160
2909911|NCT00474045|3619195|FG000|COMPLETED|Overall Study||127
2909912|NCT00474045|3619196|FG001|COMPLETED|Overall Study||136
2909913|NCT00474045|3619195|FG000|NOT COMPLETED|Overall Study||106
2909914|NCT00474045|3619196|FG001|NOT COMPLETED|Overall Study||101
2909915|NCT00474058|3619204|FG000|STARTED|Overall Study||190
2909916|NCT00474058|3619205|FG001|STARTED|Overall Study||97
2909917|NCT00474058|3619204|FG000|COMPLETED|Overall Study||166
2909918|NCT00474058|3619205|FG001|COMPLETED|Overall Study||80
2909919|NCT00474058|3619204|FG000|NOT COMPLETED|Overall Study||24
2909920|NCT00474058|3619205|FG001|NOT COMPLETED|Overall Study||17
2909921|NCT00474123|3619213|FG000|STARTED|Overall Study||38
2909922|NCT00474123|3619214|FG001|STARTED|Overall Study||40
2909923|NCT00474123|3619213|FG000|COMPLETED|Overall Study||38
2909924|NCT00474123|3619214|FG001|COMPLETED|Overall Study||40
2909925|NCT00474123|3619213|FG000|NOT COMPLETED|Overall Study||0
2909926|NCT00474123|3619214|FG001|NOT COMPLETED|Overall Study||0
2909927|NCT00474175|3619223|FG000|STARTED|Overall Study||115
2909928|NCT00474175|3619224|FG001|STARTED|Overall Study||233
2909929|NCT00474175|3619225|FG002|STARTED|Overall Study||229
2909930|NCT00474175|3619223|FG000|Treated|Overall Study||115
2909931|NCT00474175|3619224|FG001|Treated|Overall Study||233
2909932|NCT00474175|3619225|FG002|Treated|Overall Study||228
2909933|NCT00474175|3619223|FG000|COMPLETED|Overall Study||114
2909934|NCT00474175|3619224|FG001|COMPLETED|Overall Study||226
2909935|NCT00474175|3619225|FG002|COMPLETED|Overall Study||225
2909936|NCT00474175|3619223|FG000|NOT COMPLETED|Overall Study||1
2909937|NCT00474175|3619224|FG001|NOT COMPLETED|Overall Study||7
2909938|NCT00474175|3619225|FG002|NOT COMPLETED|Overall Study||4
2909939|NCT00474201|3619233|FG000|STARTED|Overall Study||15
2909940|NCT00474201|3619233|FG000|COMPLETED|Overall Study||15
2909941|NCT00474201|3619233|FG000|NOT COMPLETED|Overall Study||0
2909942|NCT00474240|3619244|FG000|STARTED|Overall Study||27
2909943|NCT00474240|3619245|FG001|STARTED|Overall Study||26
2909944|NCT00474240|3619246|FG002|STARTED|Overall Study||26
2909945|NCT00474240|3619247|FG003|STARTED|Overall Study||26
2909946|NCT00474240|3619248|FG004|STARTED|Overall Study||26
2909947|NCT00474240|3619249|FG005|STARTED|Overall Study||26
2909948|NCT00474240|3619244|FG000|COMPLETED|Overall Study||26
2909949|NCT00474240|3619245|FG001|COMPLETED|Overall Study||25
2909950|NCT00474240|3619246|FG002|COMPLETED|Overall Study||17
2909951|NCT00474240|3619247|FG003|COMPLETED|Overall Study||10
2909952|NCT00474240|3619248|FG004|COMPLETED|Overall Study||18
2909953|NCT00474240|3619249|FG005|COMPLETED|Overall Study||8
2909954|NCT00474240|3619244|FG000|NOT COMPLETED|Overall Study||1
2909955|NCT00474240|3619245|FG001|NOT COMPLETED|Overall Study||1
2909956|NCT00474240|3619246|FG002|NOT COMPLETED|Overall Study||9
2909957|NCT00474240|3619247|FG003|NOT COMPLETED|Overall Study||16
2909958|NCT00474240|3619248|FG004|NOT COMPLETED|Overall Study||8
2909959|NCT00474240|3619249|FG005|NOT COMPLETED|Overall Study||18
2909960|NCT00474253|3619265|FG000|STARTED|Overall Study|Includes 2 participants randomized to succinylcholine group who received rocuronium + sugammadex.|58
2909961|NCT00474253|3619266|FG001|STARTED|Overall Study|Includes 1 participant randomized to rocuronium + sugammadex group who received succinylcholine.|57
2909962|NCT00474253|3619265|FG000|Treated|Overall Study|Based on actual treatment received.|56
2909963|NCT00474253|3619266|FG001|Treated|Overall Study|Based on actual treatment received.|54
2909964|NCT00474253|3619265|FG000|COMPLETED|Overall Study|Based on actual treatment received.|55
2909965|NCT00474253|3619266|FG001|COMPLETED|Overall Study|Based on actual treatment received.|53
2909966|NCT00474253|3619265|FG000|NOT COMPLETED|Overall Study||3
2909967|NCT00474253|3619266|FG001|NOT COMPLETED|Overall Study||4
2909968|NCT00474266|3619276|FG000|STARTED|Overall Study||375
2909969|NCT00474266|3619277|FG001|STARTED|Overall Study||374
2909970|NCT00474266|3619278|FG002|STARTED|Overall Study||126
2909971|NCT00474266|3619279|FG003|STARTED|Overall Study||125
2909972|NCT00474266|3619276|FG000|COMPLETED|Overall Study||368
2909973|NCT00474266|3619277|FG001|COMPLETED|Overall Study||354
2909974|NCT00474266|3619278|FG002|COMPLETED|Overall Study||122
2909975|NCT00474266|3619279|FG003|COMPLETED|Overall Study||118
2909976|NCT00474266|3619276|FG000|NOT COMPLETED|Overall Study||7
2909977|NCT00474266|3619277|FG001|NOT COMPLETED|Overall Study||20
2909978|NCT00474266|3619278|FG002|NOT COMPLETED|Overall Study||4
2909979|NCT00474266|3619279|FG003|NOT COMPLETED|Overall Study||7
2909980|NCT00474383|3619292|FG000|STARTED|Main Study||47
2909981|NCT00474383|3619293|FG001|STARTED|Main Study||0
2909982|NCT00474383|3619292|FG000|COMPLETED|Main Study||11
2909983|NCT00474383|3619293|FG001|COMPLETED|Main Study||0
2909984|NCT00474383|3619292|FG000|NOT COMPLETED|Main Study||36
2909985|NCT00474383|3619293|FG001|NOT COMPLETED|Main Study||0
2909986|NCT00474383|3619292|FG000|STARTED|Between Main Study and Extension||11
2909987|NCT00474383|3619293|FG001|STARTED|Between Main Study and Extension||0
2909988|NCT00474383|3619292|FG000|COMPLETED|Between Main Study and Extension||5
2909989|NCT00474383|3619293|FG001|COMPLETED|Between Main Study and Extension||0
2909990|NCT00474383|3619292|FG000|NOT COMPLETED|Between Main Study and Extension||6
2909991|NCT00474383|3619293|FG001|NOT COMPLETED|Between Main Study and Extension||0
2909992|NCT00474383|3619292|FG000|STARTED|Extension||0
2909993|NCT00474383|3619293|FG001|STARTED|Extension||5
2909994|NCT00474383|3619292|FG000|COMPLETED|Extension||0
2909995|NCT00474383|3619293|FG001|COMPLETED|Extension||0
2909996|NCT00474383|3619292|FG000|NOT COMPLETED|Extension||0
2909997|NCT00474383|3619293|FG001|NOT COMPLETED|Extension||5
2909998|NCT00474487|3619301|FG000|STARTED|Overall Study||1606
2909999|NCT00474487|3619302|FG001|STARTED|Overall Study||217
2910000|NCT00474487|3619303|FG002|STARTED|Overall Study||899
2910001|NCT00474487|3619304|FG003|STARTED|Overall Study||109
2910002|NCT00474487|3619301|FG000|COMPLETED|Overall Study||1576
2910003|NCT00474487|3619302|FG001|COMPLETED|Overall Study||215
2910004|NCT00474487|3619303|FG002|COMPLETED|Overall Study||885
2910005|NCT00474487|3619304|FG003|COMPLETED|Overall Study||109
2910006|NCT00474487|3619301|FG000|NOT COMPLETED|Overall Study||30
2910007|NCT00474487|3619302|FG001|NOT COMPLETED|Overall Study||2
2910008|NCT00474487|3619303|FG002|NOT COMPLETED|Overall Study||14
2910009|NCT00474487|3619304|FG003|NOT COMPLETED|Overall Study||0
2910010|NCT00474526|3619331|FG000|STARTED|Overall Study||154
2910011|NCT00474526|3619332|FG001|STARTED|Overall Study||166
2910012|NCT00474526|3619333|FG002|STARTED|Overall Study||159
2910013|NCT00474526|3619334|FG003|STARTED|Overall Study||680
2910014|NCT00474526|3619335|FG004|STARTED|Overall Study||76
2910015|NCT00474526|3619336|FG005|STARTED|Overall Study||70
2910016|NCT00474526|3619337|FG006|STARTED|Overall Study||203
2910017|NCT00474526|3619338|FG007|STARTED|Overall Study||151
2910018|NCT00474526|3619339|FG008|STARTED|Overall Study||150
2910019|NCT00474526|3619340|FG009|STARTED|Overall Study||148
2910020|NCT00474526|3619341|FG010|STARTED|Overall Study||151
2910021|NCT00474526|3619342|FG011|STARTED|Overall Study||150
2910022|NCT00474526|3619343|FG012|STARTED|Overall Study||150
2910023|NCT00474526|3619344|FG013|STARTED|Overall Study||1426
2910024|NCT00474526|3619345|FG014|STARTED|Overall Study||358
2910025|NCT00474526|3619346|FG015|STARTED|Overall Study||170
2910026|NCT00474526|3619347|FG016|STARTED|Overall Study||183
2910027|NCT00474526|3619331|FG000|COMPLETED|Overall Study||121
2910028|NCT00474526|3619332|FG001|COMPLETED|Overall Study||120
2910029|NCT00474526|3619333|FG002|COMPLETED|Overall Study||110
2910030|NCT00474526|3619334|FG003|COMPLETED|Overall Study||561
2910031|NCT00474526|3619335|FG004|COMPLETED|Overall Study||8
2910032|NCT00474526|3619336|FG005|COMPLETED|Overall Study||54
2910033|NCT00474526|3619337|FG006|COMPLETED|Overall Study||178
2910034|NCT00474526|3619338|FG007|COMPLETED|Overall Study||145
2910035|NCT00474526|3619339|FG008|COMPLETED|Overall Study||144
2910036|NCT00474526|3619340|FG009|COMPLETED|Overall Study||121
2910037|NCT00474526|3619341|FG010|COMPLETED|Overall Study||141
2910038|NCT00474526|3619342|FG011|COMPLETED|Overall Study||139
2910039|NCT00474526|3619343|FG012|COMPLETED|Overall Study||135
2910040|NCT00474526|3619344|FG013|COMPLETED|Overall Study||1270
2910041|NCT00474526|3619345|FG014|COMPLETED|Overall Study||281
2910042|NCT00474526|3619346|FG015|COMPLETED|Overall Study||152
2910043|NCT00474526|3619347|FG016|COMPLETED|Overall Study||174
2910044|NCT00474526|3619331|FG000|NOT COMPLETED|Overall Study||33
3384573|NCT02218697|4119667|FG000|STARTED|Overall Study||179
3384574|NCT02218697|4119668|FG001|STARTED|Overall Study||177
3384575|NCT02218697|4119667|FG000|COMPLETED|Overall Study||177
3384576|NCT02218697|4119668|FG001|COMPLETED|Overall Study||171
3384577|NCT02218697|4119667|FG000|NOT COMPLETED|Overall Study||2
3384578|NCT02218697|4119668|FG001|NOT COMPLETED|Overall Study||6
3386387|NCT02663622|4121677|FG001|COMPLETED|Overall Study||5
3386388|NCT02663622|4121678|FG002|COMPLETED|Overall Study||5
3386389|NCT02663622|4121679|FG003|COMPLETED|Overall Study||11
3386390|NCT02663622|4121676|FG000|NOT COMPLETED|Overall Study||3
3386391|NCT02663622|4121677|FG001|NOT COMPLETED|Overall Study||1
3386392|NCT02663622|4121678|FG002|NOT COMPLETED|Overall Study||1
3386393|NCT02663622|4121679|FG003|NOT COMPLETED|Overall Study||15
3386394|NCT02609503|4121690|FG000|STARTED|Overall Study||29
3386395|NCT02609503|4121690|FG000|COMPLETED|Overall Study||25
3386396|NCT02609503|4121690|FG000|NOT COMPLETED|Overall Study||4
3386397|NCT02587598|4121708|FG000|STARTED|Overall Study||4
3386398|NCT02587598|4121709|FG001|STARTED|Overall Study||11
3386399|NCT02587598|4121710|FG002|STARTED|Overall Study||4
2910045|NCT00474526|3619332|FG001|NOT COMPLETED|Overall Study||46
2910046|NCT00474526|3619333|FG002|NOT COMPLETED|Overall Study||49
2910047|NCT00474526|3619334|FG003|NOT COMPLETED|Overall Study||119
2910048|NCT00474526|3619335|FG004|NOT COMPLETED|Overall Study||68
2910049|NCT00474526|3619336|FG005|NOT COMPLETED|Overall Study||16
2910050|NCT00474526|3619337|FG006|NOT COMPLETED|Overall Study||25
2910051|NCT00474526|3619338|FG007|NOT COMPLETED|Overall Study||6
2910052|NCT00474526|3619339|FG008|NOT COMPLETED|Overall Study||6
2910053|NCT00474526|3619340|FG009|NOT COMPLETED|Overall Study||27
2910054|NCT00474526|3619341|FG010|NOT COMPLETED|Overall Study||10
2910055|NCT00474526|3619342|FG011|NOT COMPLETED|Overall Study||11
2910056|NCT00474526|3619343|FG012|NOT COMPLETED|Overall Study||15
2910057|NCT00474526|3619344|FG013|NOT COMPLETED|Overall Study||156
2910058|NCT00474526|3619345|FG014|NOT COMPLETED|Overall Study||77
2910059|NCT00474526|3619346|FG015|NOT COMPLETED|Overall Study||18
3386400|NCT02587598|4121711|FG003|STARTED|Overall Study||21
3386401|NCT02587598|4121712|FG004|STARTED|Overall Study||12
2910060|NCT00474526|3619347|FG016|NOT COMPLETED|Overall Study||9
2910061|NCT00474539|3619435|FG000|STARTED|Infant Series|One participant was randomized to 7vPnC, but received 13vPnC.|223
2910062|NCT00474539|3619436|FG001|STARTED|Infant Series|One participant was randomized to 7vPnC, but received 13vPnC.|226
2910063|NCT00474539|3619435|FG000|Vaccinated Dose 1|Infant Series||218
2910064|NCT00474539|3619436|FG001|Vaccinated Dose 1|Infant Series||226
2910065|NCT00474539|3619435|FG000|Vaccinated Dose 2|Infant Series||217
2910066|NCT00474539|3619436|FG001|Vaccinated Dose 2|Infant Series||222
2910067|NCT00474539|3619435|FG000|Vaccinated Dose 3|Infant Series||214
2910068|NCT00474539|3619436|FG001|Vaccinated Dose 3|Infant Series||221
2910069|NCT00474539|3619435|FG000|COMPLETED|Infant Series||213
2910070|NCT00474539|3619436|FG001|COMPLETED|Infant Series||220
2910071|NCT00474539|3619435|FG000|NOT COMPLETED|Infant Series||10
2910072|NCT00474539|3619436|FG001|NOT COMPLETED|Infant Series||6
2910073|NCT00474539|3619435|FG000|STARTED|After Infant Series||213
2910074|NCT00474539|3619436|FG001|STARTED|After Infant Series||220
2910075|NCT00474539|3619435|FG000|COMPLETED|After Infant Series||209
2910076|NCT00474539|3619436|FG001|COMPLETED|After Infant Series||220
2910077|NCT00474539|3619435|FG000|NOT COMPLETED|After Infant Series||4
2910078|NCT00474539|3619436|FG001|NOT COMPLETED|After Infant Series||0
2910079|NCT00474539|3619435|FG000|STARTED|Toddler Dose||209
2910080|NCT00474539|3619436|FG001|STARTED|Toddler Dose||220
2910081|NCT00474539|3619435|FG000|COMPLETED|Toddler Dose||208
2910082|NCT00474539|3619436|FG001|COMPLETED|Toddler Dose||220
2910083|NCT00474539|3619435|FG000|NOT COMPLETED|Toddler Dose||1
2910084|NCT00474539|3619436|FG001|NOT COMPLETED|Toddler Dose||0
2910085|NCT00474617|3619470|FG000|STARTED|Overall Study||56
2910086|NCT00474617|3619471|FG001|STARTED|Overall Study||64
2910087|NCT00474617|3619472|FG002|STARTED|Overall Study||42
2910088|NCT00474617|3619470|FG000|Treated|Overall Study||48
2910089|NCT00474617|3619471|FG001|Treated|Overall Study||62
2910090|NCT00474617|3619472|FG002|Treated|Overall Study||40
2910091|NCT00474617|3619470|FG000|COMPLETED|Overall Study||48
2910092|NCT00474617|3619471|FG001|COMPLETED|Overall Study||61
2910093|NCT00474617|3619472|FG002|COMPLETED|Overall Study||40
2910094|NCT00474617|3619470|FG000|NOT COMPLETED|Overall Study||8
2910095|NCT00474617|3619471|FG001|NOT COMPLETED|Overall Study||3
2910096|NCT00474617|3619472|FG002|NOT COMPLETED|Overall Study||2
2910097|NCT00474630|3619482|FG000|STARTED|Overall Study||335
2910098|NCT00474630|3619483|FG001|STARTED|Overall Study||170
2910099|NCT00474630|3619482|FG000|COMPLETED|Overall Study||175
2910100|NCT00474630|3619483|FG001|COMPLETED|Overall Study||100
2910101|NCT00474630|3619482|FG000|NOT COMPLETED|Overall Study||160
2910102|NCT00474630|3619483|FG001|NOT COMPLETED|Overall Study||70
2910103|NCT00474708|3619492|FG000|STARTED|Overall Study||791
2910104|NCT00474708|3619493|FG001|STARTED|Overall Study||367
2910105|NCT00474708|3619492|FG000|COMPLETED|Overall Study||734
2910106|NCT00474708|3619493|FG001|COMPLETED|Overall Study||342
2910107|NCT00474708|3619492|FG000|NOT COMPLETED|Overall Study||57
2910108|NCT00474708|3619493|FG001|NOT COMPLETED|Overall Study||25
2910109|NCT00474760|3619506|FG000|STARTED|Overall Study||3
2910110|NCT00474760|3619507|FG001|STARTED|Overall Study||3
2910111|NCT00474760|3619508|FG002|STARTED|Overall Study||3
2910112|NCT00474760|3619509|FG003|STARTED|Overall Study||3
2910113|NCT00474760|3619510|FG004|STARTED|Overall Study||13
2910114|NCT00474760|3619511|FG005|STARTED|Overall Study||29
2910115|NCT00474760|3619512|FG006|STARTED|Overall Study||11
2910116|NCT00474760|3619506|FG000|COMPLETED|Overall Study||0
2910117|NCT00474760|3619507|FG001|COMPLETED|Overall Study||0
2910118|NCT00474760|3619508|FG002|COMPLETED|Overall Study||0
2910119|NCT00474760|3619509|FG003|COMPLETED|Overall Study||0
2910120|NCT00474760|3619510|FG004|COMPLETED|Overall Study||1
2910121|NCT00474760|3619511|FG005|COMPLETED|Overall Study||0
2910122|NCT00474760|3619512|FG006|COMPLETED|Overall Study||1
2910123|NCT00474760|3619506|FG000|NOT COMPLETED|Overall Study||3
2910124|NCT00474760|3619507|FG001|NOT COMPLETED|Overall Study||3
2910125|NCT00474760|3619508|FG002|NOT COMPLETED|Overall Study||3
2910126|NCT00474760|3619509|FG003|NOT COMPLETED|Overall Study||3
2910127|NCT00474760|3619510|FG004|NOT COMPLETED|Overall Study||12
2910128|NCT00474760|3619511|FG005|NOT COMPLETED|Overall Study||29
2910129|NCT00474760|3619512|FG006|NOT COMPLETED|Overall Study||10
3384579|NCT02221037|4119678|FG000|STARTED|Overall Study||5
3384580|NCT02221037|4119679|FG001|STARTED|Overall Study||11
3384581|NCT02221037|4119680|FG002|STARTED|Overall Study||8
3384582|NCT02221037|4119681|FG003|STARTED|Overall Study||9
3384583|NCT02221037|4119678|FG000|COMPLETED|Overall Study||5
3384584|NCT02221037|4119679|FG001|COMPLETED|Overall Study||11
3384585|NCT02221037|4119680|FG002|COMPLETED|Overall Study||7
3384586|NCT02221037|4119681|FG003|COMPLETED|Overall Study||9
3384587|NCT02221037|4119678|FG000|NOT COMPLETED|Overall Study||0
3384588|NCT02221037|4119679|FG001|NOT COMPLETED|Overall Study||0
3384589|NCT02221037|4119680|FG002|NOT COMPLETED|Overall Study||1
3384590|NCT02221037|4119681|FG003|NOT COMPLETED|Overall Study||0
3384594|NCT02231762|4119699|FG000|STARTED|Combination Phase||57
3384595|NCT02231762|4119700|FG001|STARTED|Combination Phase|This arm was not included in period 1 (combination phase).|0
3384596|NCT02231762|4119701|FG002|STARTED|Combination Phase|This arm was not included in period 1 (combination phase).|0
3384597|NCT02231762|4119702|FG003|STARTED|Combination Phase|This arm was not included in period 1 (combination phase).|0
2910130|NCT00474786|3619537|FG000|STARTED|Overall Study||259
2910131|NCT00474786|3619538|FG001|STARTED|Overall Study||253
2910132|NCT00474786|3619537|FG000|COMPLETED|Overall Study||0
2910133|NCT00474786|3619538|FG001|COMPLETED|Overall Study||0
2910134|NCT00474786|3619537|FG000|NOT COMPLETED|Overall Study||259
2910135|NCT00474786|3619538|FG001|NOT COMPLETED|Overall Study||253
2910136|NCT00474812|3619544|FG000|STARTED|Overall Study||51
2910137|NCT00474812|3619544|FG000|COMPLETED|Overall Study||44
2910138|NCT00474812|3619544|FG000|NOT COMPLETED|Overall Study||7
2910139|NCT00474851|3619550|FG000|STARTED|Overall Study||26
2910140|NCT00474851|3619551|FG001|STARTED|Overall Study||27
2910141|NCT00474851|3619550|FG000|Completed Baseline|Overall Study||25
2910142|NCT00474851|3619551|FG001|Completed Baseline|Overall Study||26
2910143|NCT00474851|3619550|FG000|COMPLETED|Overall Study||18
2910144|NCT00474851|3619551|FG001|COMPLETED|Overall Study||16
2910145|NCT00474851|3619550|FG000|NOT COMPLETED|Overall Study||8
2910146|NCT00474851|3619551|FG001|NOT COMPLETED|Overall Study||11
2910147|NCT00474903|3619561|FG000|STARTED|Overall Study||30
2910148|NCT00474903|3619562|FG001|STARTED|Overall Study||47
2910149|NCT00474903|3619563|FG002|STARTED|Overall Study||45
2910150|NCT00474903|3619561|FG000|COMPLETED|Overall Study||29
2910151|NCT00474903|3619562|FG001|COMPLETED|Overall Study||42
2910152|NCT00474903|3619563|FG002|COMPLETED|Overall Study||43
2910153|NCT00474903|3619561|FG000|NOT COMPLETED|Overall Study||1
2910154|NCT00474903|3619562|FG001|NOT COMPLETED|Overall Study||5
2910155|NCT00474903|3619563|FG002|NOT COMPLETED|Overall Study||2
2910156|NCT00474929|3619576|FG000|STARTED|Overall Study||6
2910157|NCT00474929|3619577|FG001|STARTED|Overall Study||6
2910158|NCT00474929|3619578|FG002|STARTED|Overall Study||7
2910159|NCT00474929|3619579|FG003|STARTED|Overall Study||7
2910160|NCT00474929|3619580|FG004|STARTED|Overall Study||77
2910161|NCT00474929|3619576|FG000|COMPLETED|Overall Study||6
2910162|NCT00474929|3619577|FG001|COMPLETED|Overall Study||5
2910163|NCT00474929|3619578|FG002|COMPLETED|Overall Study||5
2910164|NCT00474929|3619579|FG003|COMPLETED|Overall Study||5
2910165|NCT00474929|3619580|FG004|COMPLETED|Overall Study||77
2910166|NCT00474929|3619576|FG000|NOT COMPLETED|Overall Study||0
2910167|NCT00474929|3619577|FG001|NOT COMPLETED|Overall Study||1
2910168|NCT00474929|3619578|FG002|NOT COMPLETED|Overall Study||2
2910169|NCT00474929|3619579|FG003|NOT COMPLETED|Overall Study||2
2910170|NCT00474929|3619580|FG004|NOT COMPLETED|Overall Study||0
2910171|NCT00474955|3619593|FG000|STARTED|Overall Study||27
2910172|NCT00474955|3619593|FG000|COMPLETED|Overall Study||19
2910173|NCT00474955|3619593|FG000|NOT COMPLETED|Overall Study||8
2910174|NCT00474968|3619599|FG000|STARTED|Overall Study||366
2910175|NCT00474968|3619600|FG001|STARTED|Overall Study||371
2910176|NCT00474968|3619599|FG000|COMPLETED|Overall Study||348
2910177|NCT00474968|3619600|FG001|COMPLETED|Overall Study||355
2910178|NCT00474968|3619599|FG000|NOT COMPLETED|Overall Study||18
2910179|NCT00474968|3619600|FG001|NOT COMPLETED|Overall Study||16
2910180|NCT00474994|3619606|FG000|STARTED|Overall Study||53
2910181|NCT00474994|3619606|FG000|COMPLETED|Overall Study||48
2910182|NCT00474994|3619606|FG000|NOT COMPLETED|Overall Study||5
2910183|NCT00475020|3619610|FG000|STARTED|Overall Study||63
2910184|NCT00475020|3619610|FG000|COMPLETED|Overall Study||58
2910185|NCT00475020|3619610|FG000|NOT COMPLETED|Overall Study||5
2910186|NCT00475033|3619616|FG000|STARTED|Infant Series||300
2910187|NCT00475033|3619617|FG001|STARTED|Infant Series||303
2910188|NCT00475033|3619616|FG000|Vaccinated Dose 1|Infant Series||300
2910189|NCT00475033|3619617|FG001|Vaccinated Dose 1|Infant Series||303
2910190|NCT00475033|3619616|FG000|Vaccinated Dose 2|Infant Series||297
2910191|NCT00475033|3619617|FG001|Vaccinated Dose 2|Infant Series||296
2910192|NCT00475033|3619616|FG000|Vaccinated Dose 3|Infant Series||293
3171582|NCT01935700|3898767|FG000|COMPLETED|Overall Study||9
3171583|NCT01935700|3898768|FG001|COMPLETED|Overall Study||86
3171584|NCT01935700|3898767|FG000|NOT COMPLETED|Overall Study||5
3171585|NCT01935700|3898768|FG001|NOT COMPLETED|Overall Study||0
3171586|NCT01935791|3898776|FG000|STARTED|Period 1||4
3171587|NCT01935791|3898777|FG001|STARTED|Period 1||4
3171588|NCT01935791|3898778|FG002|STARTED|Period 1||3
3171589|NCT01935791|3898779|FG003|STARTED|Period 1||0
3171590|NCT01935791|3898780|FG004|STARTED|Period 1||0
3171591|NCT01935791|3898781|FG005|STARTED|Period 1||0
3171592|NCT01935791|3898782|FG006|STARTED|Period 1||0
3171593|NCT01935791|3898783|FG007|STARTED|Period 1||0
3171594|NCT01935791|3898784|FG008|STARTED|Period 1||0
3171595|NCT01935791|3898776|FG000|COMPLETED|Period 1||4
3171596|NCT01935791|3898777|FG001|COMPLETED|Period 1||4
3171597|NCT01935791|3898778|FG002|COMPLETED|Period 1||3
3171598|NCT01935791|3898779|FG003|COMPLETED|Period 1||0
3171599|NCT01935791|3898780|FG004|COMPLETED|Period 1||0
3171600|NCT01935791|3898781|FG005|COMPLETED|Period 1||0
3171601|NCT01935791|3898782|FG006|COMPLETED|Period 1||0
2910193|NCT00475033|3619617|FG001|Vaccinated Dose 3|Infant Series||294
2910194|NCT00475033|3619616|FG000|COMPLETED|Infant Series||293
2910195|NCT00475033|3619617|FG001|COMPLETED|Infant Series||290
2910196|NCT00475033|3619616|FG000|NOT COMPLETED|Infant Series||7
2910197|NCT00475033|3619617|FG001|NOT COMPLETED|Infant Series||13
2910198|NCT00475033|3619616|FG000|STARTED|After the Infant Series||293
2910199|NCT00475033|3619617|FG001|STARTED|After the Infant Series||290
2910200|NCT00475033|3619616|FG000|Withdrawn After Infant Series|After the Infant Series||6
2910201|NCT00475033|3619617|FG001|Withdrawn After Infant Series|After the Infant Series||8
2910202|NCT00475033|3619616|FG000|COMPLETED|After the Infant Series||287
2910203|NCT00475033|3619617|FG001|COMPLETED|After the Infant Series||282
2910204|NCT00475033|3619616|FG000|NOT COMPLETED|After the Infant Series||6
2910205|NCT00475033|3619617|FG001|NOT COMPLETED|After the Infant Series||8
3171602|NCT01935791|3898783|FG007|COMPLETED|Period 1||0
3171603|NCT01935791|3898784|FG008|COMPLETED|Period 1||0
3171604|NCT01935791|3898776|FG000|NOT COMPLETED|Period 1||0
3171605|NCT01935791|3898777|FG001|NOT COMPLETED|Period 1||0
3171606|NCT01935791|3898778|FG002|NOT COMPLETED|Period 1||0
3171607|NCT01935791|3898779|FG003|NOT COMPLETED|Period 1||0
3171608|NCT01935791|3898780|FG004|NOT COMPLETED|Period 1||0
3171609|NCT01935791|3898781|FG005|NOT COMPLETED|Period 1||0
3171610|NCT01935791|3898782|FG006|NOT COMPLETED|Period 1||0
3171611|NCT01935791|3898783|FG007|NOT COMPLETED|Period 1||0
3171612|NCT01935791|3898784|FG008|NOT COMPLETED|Period 1||0
3171613|NCT01935791|3898776|FG000|STARTED|Period 2||0
3171614|NCT01935791|3898777|FG001|STARTED|Period 2||0
3171615|NCT01935791|3898778|FG002|STARTED|Period 2||0
3171616|NCT01935791|3898779|FG003|STARTED|Period 2||2
3384591|NCT02224456|4119695|FG000|STARTED|Overall Study||197
3384592|NCT02224456|4119695|FG000|COMPLETED|Overall Study||161
2910206|NCT00475033|3619616|FG000|STARTED|Toddler Dose|Vaccinated Toddler Dose|287
2910207|NCT00475033|3619617|FG001|STARTED|Toddler Dose|Vaccinated Toddler Dose|282
2910208|NCT00475033|3619616|FG000|COMPLETED|Toddler Dose||283
2910209|NCT00475033|3619617|FG001|COMPLETED|Toddler Dose||282
2910210|NCT00475033|3619616|FG000|NOT COMPLETED|Toddler Dose||4
2910211|NCT00475033|3619617|FG001|NOT COMPLETED|Toddler Dose||0
2910212|NCT00475085|3619634|FG000|STARTED|Overall Study||253
2910213|NCT00475085|3619635|FG001|STARTED|Overall Study||254
2910214|NCT00475085|3619636|FG002|STARTED|Overall Study||260
3384593|NCT02224456|4119695|FG000|NOT COMPLETED|Overall Study||36
3384598|NCT02231762|4119699|FG000|COMPLETED|Combination Phase||37
3384599|NCT02231762|4119700|FG001|COMPLETED|Combination Phase||0
2910215|NCT00475085|3619637|FG003|STARTED|Overall Study||254
2910216|NCT00475085|3619634|FG000|COMPLETED|Overall Study||235
2910217|NCT00475085|3619635|FG001|COMPLETED|Overall Study||234
2910218|NCT00475085|3619636|FG002|COMPLETED|Overall Study||241
2910219|NCT00475085|3619637|FG003|COMPLETED|Overall Study||234
2910220|NCT00475085|3619634|FG000|NOT COMPLETED|Overall Study||18
2910221|NCT00475085|3619635|FG001|NOT COMPLETED|Overall Study||20
2910222|NCT00475085|3619636|FG002|NOT COMPLETED|Overall Study||19
2910223|NCT00475085|3619637|FG003|NOT COMPLETED|Overall Study||20
2910224|NCT00475150|3619649|FG000|STARTED|Overall Study||23
2910225|NCT00475150|3619650|FG001|STARTED|Overall Study||16
2910226|NCT00475150|3619649|FG000|COMPLETED|Overall Study||23
2910227|NCT00475150|3619650|FG001|COMPLETED|Overall Study||16
2910228|NCT00475150|3619649|FG000|NOT COMPLETED|Overall Study||0
2910229|NCT00475150|3619650|FG001|NOT COMPLETED|Overall Study||0
2910230|NCT00475176|3619655|FG000|STARTED|Overall Study||24
2910231|NCT00475176|3619655|FG000|COMPLETED|Overall Study||20
3384600|NCT02231762|4119701|FG002|COMPLETED|Combination Phase||0
3384601|NCT02231762|4119702|FG003|COMPLETED|Combination Phase||0
3384602|NCT02231762|4119699|FG000|NOT COMPLETED|Combination Phase||20
3384603|NCT02231762|4119700|FG001|NOT COMPLETED|Combination Phase||0
3384604|NCT02231762|4119701|FG002|NOT COMPLETED|Combination Phase||0
3384605|NCT02231762|4119702|FG003|NOT COMPLETED|Combination Phase||0
3384606|NCT02231762|4119699|FG000|STARTED|Maintenance Phase|This arm was not included in period 2 (maintenance phase).|0
3384607|NCT02231762|4119700|FG001|STARTED|Maintenance Phase|The 37 subjects completing period 1 were split between the 3 arms in period 2.|11
3384608|NCT02231762|4119701|FG002|STARTED|Maintenance Phase|The 37 subjects completing period 1 were split between the 3 arms in period 2.|14
3384609|NCT02231762|4119702|FG003|STARTED|Maintenance Phase|The 37 subjects completing period 1 were split between the 3 arms in period 2.|12
3384610|NCT02231762|4119699|FG000|COMPLETED|Maintenance Phase||0
3384611|NCT02231762|4119700|FG001|COMPLETED|Maintenance Phase||8
3384612|NCT02231762|4119701|FG002|COMPLETED|Maintenance Phase||9
3384613|NCT02231762|4119702|FG003|COMPLETED|Maintenance Phase||7
3384614|NCT02231762|4119699|FG000|NOT COMPLETED|Maintenance Phase||0
3384615|NCT02231762|4119700|FG001|NOT COMPLETED|Maintenance Phase||3
3384616|NCT02231762|4119701|FG002|NOT COMPLETED|Maintenance Phase||5
3384617|NCT02231762|4119702|FG003|NOT COMPLETED|Maintenance Phase||5
3386402|NCT02587598|4121713|FG005|STARTED|Overall Study||6
3386403|NCT02587598|4121714|FG006|STARTED|Overall Study||6
3386404|NCT02587598|4121715|FG007|STARTED|Overall Study||7
3386405|NCT02587598|4121716|FG008|STARTED|Overall Study||9
3386406|NCT02587598|4121717|FG009|STARTED|Overall Study||3
3386407|NCT02587598|4121718|FG010|STARTED|Overall Study||14
3386408|NCT02587598|4121708|FG000|COMPLETED|Overall Study|All participants discontinued study treatment and withdrew from the study.|0
3386409|NCT02587598|4121709|FG001|COMPLETED|Overall Study|All participants discontinued study treatment and withdrew from the study.|0
3386410|NCT02587598|4121710|FG002|COMPLETED|Overall Study|All participants discontinued study treatment and withdrew from the study.|0
3386411|NCT02587598|4121711|FG003|COMPLETED|Overall Study|All participants discontinued study treatment and withdrew from the study.|0
3386412|NCT02587598|4121712|FG004|COMPLETED|Overall Study|All participants discontinued study treatment and withdrew from the study.|0
3386773|NCT01047319|4122119|FG000|STARTED|Overall Study||345
2910232|NCT00475176|3619655|FG000|NOT COMPLETED|Overall Study||4
2910233|NCT00475215|3619661|FG000|STARTED|Overall Study||44
2910234|NCT00475215|3619662|FG001|STARTED|Overall Study||42
2910235|NCT00475215|3619661|FG000|Treated|Overall Study||39
2910236|NCT00475215|3619662|FG001|Treated|Overall Study||38
3171617|NCT01935791|3898780|FG004|STARTED|Period 2||3
3171618|NCT01935791|3898781|FG005|STARTED|Period 2||1
3171619|NCT01935791|3898782|FG006|STARTED|Period 2||1
3171620|NCT01935791|3898783|FG007|STARTED|Period 2||3
3171621|NCT01935791|3898784|FG008|STARTED|Period 2||1
3171622|NCT01935791|3898776|FG000|COMPLETED|Period 2||0
2910237|NCT00475215|3619661|FG000|COMPLETED|Overall Study||39
2910238|NCT00475215|3619662|FG001|COMPLETED|Overall Study||38
2910239|NCT00475215|3619661|FG000|NOT COMPLETED|Overall Study||5
2910240|NCT00475215|3619662|FG001|NOT COMPLETED|Overall Study||4
2910241|NCT00475228|3619670|FG000|STARTED|Overall Study||44
2910242|NCT00475228|3619671|FG001|STARTED|Overall Study||44
2910243|NCT00475228|3619670|FG000|COMPLETED|Overall Study||27
2910244|NCT00475228|3619671|FG001|COMPLETED|Overall Study||27
2910245|NCT00475228|3619670|FG000|NOT COMPLETED|Overall Study||17
2910246|NCT00475228|3619671|FG001|NOT COMPLETED|Overall Study||17
2910247|NCT00475241|3619683|FG000|STARTED|Overall Study||18
2910248|NCT00475241|3619684|FG001|STARTED|Overall Study||18
2910249|NCT00475241|3619683|FG000|COMPLETED|Overall Study||11
2910250|NCT00475241|3619684|FG001|COMPLETED|Overall Study||15
2910251|NCT00475241|3619683|FG000|NOT COMPLETED|Overall Study||7
2910252|NCT00475241|3619684|FG001|NOT COMPLETED|Overall Study||3
2910253|NCT00475306|3619695|FG000|STARTED|Overall Study||73
2910254|NCT00475306|3619696|FG001|STARTED|Overall Study||72
2910255|NCT00475306|3619697|FG002|STARTED|Overall Study||72
2910256|NCT00475306|3619698|FG003|STARTED|Overall Study||72
2910257|NCT00475306|3619695|FG000|COMPLETED|Overall Study|1 patient had resolution of nausea prior and did not receive the investigational medication|72
2910258|NCT00475306|3619696|FG001|COMPLETED|Overall Study|For 1 patient, data collection was incomplete and results could not be analyzed|71
2910259|NCT00475306|3619697|FG002|COMPLETED|Overall Study||72
2910260|NCT00475306|3619698|FG003|COMPLETED|Overall Study|1 patient's intravenous line infiltrated.|71
2910261|NCT00475306|3619695|FG000|NOT COMPLETED|Overall Study||1
2910262|NCT00475306|3619696|FG001|NOT COMPLETED|Overall Study||1
2910263|NCT00475306|3619697|FG002|NOT COMPLETED|Overall Study||0
2910264|NCT00475306|3619698|FG003|NOT COMPLETED|Overall Study||1
2910265|NCT00475319|3619711|FG000|STARTED|Overall Study||103
2910266|NCT00475319|3619712|FG001|STARTED|Overall Study||102
2910267|NCT00475319|3619713|FG002|STARTED|Overall Study||103
2910268|NCT00475319|3619711|FG000|COMPLETED|Overall Study||101
2910269|NCT00475319|3619712|FG001|COMPLETED|Overall Study||101
2910270|NCT00475319|3619713|FG002|COMPLETED|Overall Study||99
2910271|NCT00475319|3619711|FG000|NOT COMPLETED|Overall Study||2
2910272|NCT00475319|3619712|FG001|NOT COMPLETED|Overall Study||1
2910273|NCT00475319|3619713|FG002|NOT COMPLETED|Overall Study||4
2910274|NCT00475423|3619724|FG000|STARTED|Overall Study||122
2910275|NCT00475423|3619724|FG000|COMPLETED|Overall Study||90
2910276|NCT00475423|3619724|FG000|NOT COMPLETED|Overall Study||32
2910277|NCT00475501|3619732|FG000|STARTED|Overall Study||14
2910278|NCT00475501|3619733|FG001|STARTED|Overall Study||13
2910279|NCT00475501|3619734|FG002|STARTED|Overall Study||17
2910280|NCT00475501|3619735|FG003|STARTED|Overall Study||16
2910281|NCT00475501|3619732|FG000|COMPLETED|Overall Study||7
2910282|NCT00475501|3619733|FG001|COMPLETED|Overall Study||8
2910283|NCT00475501|3619734|FG002|COMPLETED|Overall Study||13
2910284|NCT00475501|3619735|FG003|COMPLETED|Overall Study||12
2910285|NCT00475501|3619732|FG000|NOT COMPLETED|Overall Study||7
2910286|NCT00475501|3619733|FG001|NOT COMPLETED|Overall Study||5
2910287|NCT00475501|3619734|FG002|NOT COMPLETED|Overall Study||4
2910288|NCT00475501|3619735|FG003|NOT COMPLETED|Overall Study||4
2910289|NCT00475644|3619777|FG000|STARTED|Overall Study||66
2910290|NCT00475644|3619777|FG000|Received at Least One Dose of Study Drug|Overall Study||66
2910291|NCT00475644|3619777|FG000|COMPLETED|Overall Study||53
2910292|NCT00475644|3619777|FG000|NOT COMPLETED|Overall Study||13
2910293|NCT00475670|3619783|FG000|STARTED|Overall Study||3
2910294|NCT00475670|3619784|FG001|STARTED|Overall Study||41
2910295|NCT00475670|3619783|FG000|COMPLETED|Overall Study|This cohort was closed prematurely (with only 3 participants) because of enrollment difficulties.|0
2910296|NCT00475670|3619784|FG001|COMPLETED|Overall Study||0
2910297|NCT00475670|3619783|FG000|NOT COMPLETED|Overall Study||3
2910298|NCT00475670|3619784|FG001|NOT COMPLETED|Overall Study||41
2910299|NCT00475709|3619790|FG000|STARTED|Overall Study||1022
2910300|NCT00475709|3619790|FG000|Eligible of Analysis|Overall Study|Excludes eight ineligible subjects|1014
2910301|NCT00475709|3619790|FG000|COMPLETED|Overall Study||946
2910302|NCT00475709|3619790|FG000|NOT COMPLETED|Overall Study||76
2910303|NCT00475722|3619796|FG000|STARTED|Overall Study||61
2910304|NCT00475722|3619797|FG001|STARTED|Overall Study||59
2910305|NCT00475722|3619796|FG000|COMPLETED|Overall Study||46
2910306|NCT00475722|3619797|FG001|COMPLETED|Overall Study||47
2910307|NCT00475722|3619796|FG000|NOT COMPLETED|Overall Study||15
2910308|NCT00475722|3619797|FG001|NOT COMPLETED|Overall Study||12
2910309|NCT00475735|3619809|FG000|STARTED|Treatment Period 1||14
2910310|NCT00475735|3619810|FG001|STARTED|Treatment Period 1||13
2910311|NCT00475735|3619811|FG002|STARTED|Treatment Period 1||7
2910312|NCT00475735|3619812|FG003|STARTED|Treatment Period 1||7
2910313|NCT00475735|3619813|FG004|STARTED|Treatment Period 1||16
2910314|NCT00475735|3619814|FG005|STARTED|Treatment Period 1||15
2910315|NCT00475735|3619809|FG000|COMPLETED|Treatment Period 1||10
2910316|NCT00475735|3619810|FG001|COMPLETED|Treatment Period 1||11
2910317|NCT00475735|3619811|FG002|COMPLETED|Treatment Period 1||7
2910318|NCT00475735|3619812|FG003|COMPLETED|Treatment Period 1||5
2910319|NCT00475735|3619813|FG004|COMPLETED|Treatment Period 1||14
2910320|NCT00475735|3619814|FG005|COMPLETED|Treatment Period 1||12
2910321|NCT00475735|3619809|FG000|NOT COMPLETED|Treatment Period 1||4
2910322|NCT00475735|3619810|FG001|NOT COMPLETED|Treatment Period 1||2
2910323|NCT00475735|3619811|FG002|NOT COMPLETED|Treatment Period 1||0
2910324|NCT00475735|3619812|FG003|NOT COMPLETED|Treatment Period 1||2
2910325|NCT00475735|3619813|FG004|NOT COMPLETED|Treatment Period 1||2
2910326|NCT00475735|3619814|FG005|NOT COMPLETED|Treatment Period 1||3
2910327|NCT00475735|3619809|FG000|STARTED|Treatment Washout||10
2910328|NCT00475735|3619810|FG001|STARTED|Treatment Washout|Includes 1 patient that discontinued Treatment Period 1 but continued the Study.|12
2910329|NCT00475735|3619811|FG002|STARTED|Treatment Washout||7
2910330|NCT00475735|3619812|FG003|STARTED|Treatment Washout|Includes 1 patient that discontinued Treatment Period 1 but continued the Study.|6
2910331|NCT00475735|3619813|FG004|STARTED|Treatment Washout|Includes 2 patients that discontinued Treatment Period 1 but continued the Study.|16
2910332|NCT00475735|3619814|FG005|STARTED|Treatment Washout|Includes 2 patients that discontinued Treatment Period 1 but continued the Study.|14
2910333|NCT00475735|3619809|FG000|COMPLETED|Treatment Washout||10
2910334|NCT00475735|3619810|FG001|COMPLETED|Treatment Washout||10
2910335|NCT00475735|3619811|FG002|COMPLETED|Treatment Washout||7
2910336|NCT00475735|3619812|FG003|COMPLETED|Treatment Washout||6
2910337|NCT00475735|3619813|FG004|COMPLETED|Treatment Washout||16
2910338|NCT00475735|3619814|FG005|COMPLETED|Treatment Washout||14
2910339|NCT00475735|3619809|FG000|NOT COMPLETED|Treatment Washout||0
2910340|NCT00475735|3619810|FG001|NOT COMPLETED|Treatment Washout||2
2910341|NCT00475735|3619811|FG002|NOT COMPLETED|Treatment Washout||0
2910342|NCT00475735|3619812|FG003|NOT COMPLETED|Treatment Washout||0
2910343|NCT00475735|3619813|FG004|NOT COMPLETED|Treatment Washout||0
2910344|NCT00475735|3619814|FG005|NOT COMPLETED|Treatment Washout||0
2910345|NCT00475735|3619809|FG000|STARTED|Treatment Period 2||10
2910346|NCT00475735|3619810|FG001|STARTED|Treatment Period 2||10
2910347|NCT00475735|3619811|FG002|STARTED|Treatment Period 2||7
2910348|NCT00475735|3619812|FG003|STARTED|Treatment Period 2||6
2910349|NCT00475735|3619813|FG004|STARTED|Treatment Period 2||16
2910350|NCT00475735|3619814|FG005|STARTED|Treatment Period 2||14
2910351|NCT00475735|3619809|FG000|COMPLETED|Treatment Period 2||10
2910352|NCT00475735|3619810|FG001|COMPLETED|Treatment Period 2||9
2910353|NCT00475735|3619811|FG002|COMPLETED|Treatment Period 2||7
2910354|NCT00475735|3619812|FG003|COMPLETED|Treatment Period 2||4
2910355|NCT00475735|3619813|FG004|COMPLETED|Treatment Period 2||15
2910356|NCT00475735|3619814|FG005|COMPLETED|Treatment Period 2||13
2910357|NCT00475735|3619809|FG000|NOT COMPLETED|Treatment Period 2||0
2910358|NCT00475735|3619810|FG001|NOT COMPLETED|Treatment Period 2||1
2910359|NCT00475735|3619811|FG002|NOT COMPLETED|Treatment Period 2||0
2910360|NCT00475735|3619812|FG003|NOT COMPLETED|Treatment Period 2||2
2910361|NCT00475735|3619813|FG004|NOT COMPLETED|Treatment Period 2||1
2910362|NCT00475735|3619814|FG005|NOT COMPLETED|Treatment Period 2||1
2910363|NCT00475787|3619824|FG000|STARTED|Overall Study||69
2910364|NCT00475787|3619825|FG001|STARTED|Overall Study||67
2910365|NCT00475787|3619824|FG000|COMPLETED|Overall Study||61
2910366|NCT00475787|3619825|FG001|COMPLETED|Overall Study||60
2910367|NCT00475787|3619824|FG000|NOT COMPLETED|Overall Study||8
2910368|NCT00475787|3619825|FG001|NOT COMPLETED|Overall Study||7
2910369|NCT00475852|3619835|FG000|STARTED|Overall Study||3564
2910370|NCT00475852|3619836|FG001|STARTED|Overall Study||3577
2910371|NCT00475852|3619835|FG000|COMPLETED|Overall Study||3047
2910372|NCT00475852|3619836|FG001|COMPLETED|Overall Study||3029
2910373|NCT00475852|3619835|FG000|NOT COMPLETED|Overall Study||517
2910374|NCT00475852|3619836|FG001|NOT COMPLETED|Overall Study||548
2910375|NCT00475865|3619845|FG000|STARTED|Overall Study|randomized|41
2910376|NCT00475865|3619846|FG001|STARTED|Overall Study|randomized|42
2910377|NCT00475865|3619847|FG002|STARTED|Overall Study|randomized|40
2910378|NCT00475865|3619845|FG000|Treated|Overall Study|completed treatment period|41
2910379|NCT00475865|3619846|FG001|Treated|Overall Study||42
2910380|NCT00475865|3619847|FG002|Treated|Overall Study||40
2910381|NCT00475865|3619845|FG000|COMPLETED|Overall Study||39
2910382|NCT00475865|3619846|FG001|COMPLETED|Overall Study|completed treatment period|37
2910383|NCT00475865|3619847|FG002|COMPLETED|Overall Study|completed treatment period|34
2910384|NCT00475865|3619845|FG000|NOT COMPLETED|Overall Study||2
2910385|NCT00475865|3619846|FG001|NOT COMPLETED|Overall Study||5
2910386|NCT00475865|3619847|FG002|NOT COMPLETED|Overall Study||6
2910387|NCT00475878|3619859|FG000|STARTED|Overall Study||75
2910388|NCT00475878|3619860|FG001|STARTED|Overall Study||72
2910389|NCT00475878|3619859|FG000|COMPLETED|Overall Study||75
2910390|NCT00475878|3619860|FG001|COMPLETED|Overall Study||72
2910391|NCT00475878|3619859|FG000|NOT COMPLETED|Overall Study||0
2910392|NCT00475878|3619860|FG001|NOT COMPLETED|Overall Study||0
2910393|NCT00475904|3619871|FG000|STARTED|Overall Study||140
2910394|NCT00475904|3619872|FG001|STARTED|Overall Study||144
2910395|NCT00475904|3619873|FG002|STARTED|Overall Study||76
2910396|NCT00475904|3619871|FG000|COMPLETED|Overall Study||125
2910397|NCT00475904|3619872|FG001|COMPLETED|Overall Study||131
2910398|NCT00475904|3619873|FG002|COMPLETED|Overall Study||72
2910399|NCT00475904|3619871|FG000|NOT COMPLETED|Overall Study||15
2910400|NCT00475904|3619872|FG001|NOT COMPLETED|Overall Study||13
2910401|NCT00475904|3619873|FG002|NOT COMPLETED|Overall Study||4
2910402|NCT00475982|3619883|FG000|STARTED|Overall Study||23
2910403|NCT00475982|3619884|FG001|STARTED|Overall Study||21
2910404|NCT00475982|3619883|FG000|COMPLETED|Overall Study||16
2910405|NCT00475982|3619884|FG001|COMPLETED|Overall Study||18
2910406|NCT00475982|3619883|FG000|NOT COMPLETED|Overall Study||7
2910407|NCT00475982|3619884|FG001|NOT COMPLETED|Overall Study||3
2910408|NCT00476008|3619892|FG000|STARTED|Overall Study||22
2910409|NCT00476008|3619893|FG001|STARTED|Overall Study||21
2910410|NCT00476008|3619892|FG000|6 Month Testing|Overall Study||15
2910411|NCT00476008|3619893|FG001|6 Month Testing|Overall Study||14
2910412|NCT00476008|3619892|FG000|COMPLETED|Overall Study||13
2910413|NCT00476008|3619893|FG001|COMPLETED|Overall Study||13
2910414|NCT00476008|3619892|FG000|NOT COMPLETED|Overall Study||9
2910415|NCT00476008|3619893|FG001|NOT COMPLETED|Overall Study||8
2910416|NCT00476021|3619905|FG000|STARTED|Overall Study||51
2910417|NCT00476021|3619906|FG001|STARTED|Overall Study||51
2910418|NCT00476021|3619905|FG000|COMPLETED|Overall Study||51
2910419|NCT00476021|3619906|FG001|COMPLETED|Overall Study||51
2910420|NCT00476021|3619905|FG000|NOT COMPLETED|Overall Study||0
2910421|NCT00476021|3619906|FG001|NOT COMPLETED|Overall Study||0
2910422|NCT00476047|3619918|FG000|STARTED|Overall Study||16
2910423|NCT00476047|3619918|FG000|Completed Treatment|Overall Study||16
2910424|NCT00476047|3619918|FG000|COMPLETED|Overall Study||15
2910425|NCT00476047|3619918|FG000|NOT COMPLETED|Overall Study||1
2910426|NCT00476086|3619924|FG000|STARTED|Overall Study||20
2910427|NCT00476086|3619924|FG000|Received Chemotherapy|Overall Study||19
2910428|NCT00476086|3619924|FG000|Received Radiation|Overall Study||15
2910429|NCT00476086|3619924|FG000|COMPLETED|Overall Study||15
2910430|NCT00476086|3619924|FG000|NOT COMPLETED|Overall Study||5
2910431|NCT00476151|3619932|FG000|STARTED|Overall Study||112
2910432|NCT00476151|3619933|FG001|STARTED|Overall Study||114
2910433|NCT00476151|3619932|FG000|COMPLETED|Overall Study||109
2910434|NCT00476151|3619933|FG001|COMPLETED|Overall Study||107
2910435|NCT00476151|3619932|FG000|NOT COMPLETED|Overall Study||3
2910436|NCT00476151|3619933|FG001|NOT COMPLETED|Overall Study||7
2910437|NCT00476229|3619939|FG000|STARTED|Overall Study||20
2910438|NCT00476229|3619939|FG000|COMPLETED|Overall Study||19
2910439|NCT00476229|3619939|FG000|NOT COMPLETED|Overall Study||1
2910440|NCT00476242|3619945|FG000|STARTED|Overall Study||27
2910441|NCT00476242|3619946|FG001|STARTED|Overall Study||28
2910442|NCT00476242|3619945|FG000|COMPLETED|Overall Study||19
2910443|NCT00476242|3619946|FG001|COMPLETED|Overall Study||12
2910444|NCT00476242|3619945|FG000|NOT COMPLETED|Overall Study||8
2910445|NCT00476242|3619946|FG001|NOT COMPLETED|Overall Study||16
2910446|NCT00476476|3619956|FG000|STARTED|Overall Study||17
2910447|NCT00476476|3619957|FG001|STARTED|Overall Study||24
2910448|NCT00476476|3619956|FG000|Response Evaluable|Overall Study||17
2910449|NCT00476476|3619957|FG001|Response Evaluable|Overall Study|One woman was unevaluable due to an allergic reaction that developed after the 2nd dose.|23
2910450|NCT00476476|3619956|FG000|COMPLETED|Overall Study||15
2910451|NCT00476476|3619957|FG001|COMPLETED|Overall Study|Treatment was not of fixed duration and thus pts are not considered to have 'Completed' treatment.|0
2910452|NCT00476476|3619956|FG000|NOT COMPLETED|Overall Study||2
2910453|NCT00476476|3619957|FG001|NOT COMPLETED|Overall Study||24
2910454|NCT00476593|3619966|FG000|STARTED|Overall Study||32
2910455|NCT00476593|3619967|FG001|STARTED|Overall Study||19
2910456|NCT00476593|3619968|FG002|STARTED|Overall Study||38
2910457|NCT00476593|3619969|FG003|STARTED|Overall Study||129
2910458|NCT00476593|3619966|FG000|COMPLETED|Overall Study|all subjects completed treatment in one eye. However, bilateral OCT scans included only in 22 cases|22
2910459|NCT00476593|3619967|FG001|COMPLETED|Overall Study|all subjects completed treatment in one eye. However, bilateral OCT scans included only in 17 cases|17
2910460|NCT00476593|3619968|FG002|COMPLETED|Overall Study||30
2910461|NCT00476593|3619969|FG003|COMPLETED|Overall Study||107
2910462|NCT00476593|3619966|FG000|NOT COMPLETED|Overall Study||10
2910463|NCT00476593|3619967|FG001|NOT COMPLETED|Overall Study||2
2910464|NCT00476593|3619968|FG002|NOT COMPLETED|Overall Study||8
2910465|NCT00476593|3619969|FG003|NOT COMPLETED|Overall Study||22
2910466|NCT00476645|3619979|FG000|STARTED|Overall Study||10
2910467|NCT00476645|3619979|FG000|COMPLETED|Overall Study||10
2910468|NCT00476645|3619979|FG000|NOT COMPLETED|Overall Study||0
2910469|NCT00476788|3619983|FG000|STARTED|Overall Study||14
2910470|NCT00476788|3619983|FG000|COMPLETED|Overall Study||11
2910471|NCT00476788|3619983|FG000|NOT COMPLETED|Overall Study||3
2910472|NCT00476957|3619989|FG000|STARTED|Overall Study||4357
2910473|NCT00476957|3619990|FG001|STARTED|Overall Study||4352
3384618|NCT02234843|4119726|FG000|STARTED|Overall Study||184
3384619|NCT02234843|4119727|FG001|STARTED|Overall Study||67
3384620|NCT02234843|4119728|FG002|STARTED|Overall Study||47
3384621|NCT02234843|4119729|FG003|STARTED|Overall Study||21
3384622|NCT02234843|4119730|FG004|STARTED|Overall Study||16
3384623|NCT02234843|4119731|FG005|STARTED|Overall Study||92
3384624|NCT02234843|4119732|FG006|STARTED|Overall Study||34
3384625|NCT02234843|4119733|FG007|STARTED|Overall Study||22
3384626|NCT02234843|4119734|FG008|STARTED|Overall Study||9
3384627|NCT02234843|4119735|FG009|STARTED|Overall Study||8
3384628|NCT02234843|4119726|FG000|COMPLETED|Overall Study||162
3384629|NCT02234843|4119727|FG001|COMPLETED|Overall Study||61
3384630|NCT02234843|4119728|FG002|COMPLETED|Overall Study||44
3384631|NCT02234843|4119729|FG003|COMPLETED|Overall Study||16
3384632|NCT02234843|4119730|FG004|COMPLETED|Overall Study||14
3384633|NCT02234843|4119731|FG005|COMPLETED|Overall Study||79
3384634|NCT02234843|4119732|FG006|COMPLETED|Overall Study||32
3384635|NCT02234843|4119733|FG007|COMPLETED|Overall Study||20
3384636|NCT02234843|4119734|FG008|COMPLETED|Overall Study||8
3384637|NCT02234843|4119735|FG009|COMPLETED|Overall Study||8
3384638|NCT02234843|4119726|FG000|NOT COMPLETED|Overall Study||22
3384639|NCT02234843|4119727|FG001|NOT COMPLETED|Overall Study||6
3384640|NCT02234843|4119728|FG002|NOT COMPLETED|Overall Study||3
3384641|NCT02234843|4119729|FG003|NOT COMPLETED|Overall Study||5
3384642|NCT02234843|4119730|FG004|NOT COMPLETED|Overall Study||2
3384643|NCT02234843|4119731|FG005|NOT COMPLETED|Overall Study||13
2910474|NCT00476957|3619989|FG000|COMPLETED|Overall Study||4181
2910475|NCT00476957|3619990|FG001|COMPLETED|Overall Study||4159
2910476|NCT00476957|3619989|FG000|NOT COMPLETED|Overall Study||176
2910477|NCT00476957|3619990|FG001|NOT COMPLETED|Overall Study||193
2910478|NCT00476996|3619999|FG000|STARTED|Blinded Treatment Phase (up to Week 48)||277
3171623|NCT01935791|3898777|FG001|COMPLETED|Period 2||0
3171624|NCT01935791|3898778|FG002|COMPLETED|Period 2||0
3171625|NCT01935791|3898779|FG003|COMPLETED|Period 2||2
3171626|NCT01935791|3898780|FG004|COMPLETED|Period 2||3
3171627|NCT01935791|3898781|FG005|COMPLETED|Period 2||1
3171628|NCT01935791|3898782|FG006|COMPLETED|Period 2||1
3171629|NCT01935791|3898783|FG007|COMPLETED|Period 2||3
3171630|NCT01935791|3898784|FG008|COMPLETED|Period 2||1
2910479|NCT00476996|3620000|FG001|STARTED|Blinded Treatment Phase (up to Week 48)||277
2910480|NCT00476996|3620001|FG002|STARTED|Blinded Treatment Phase (up to Week 48)||282
2910481|NCT00476996|3620002|FG003|STARTED|Blinded Treatment Phase (up to Week 48)||0
2910482|NCT00476996|3619999|FG000|COMPLETED|Blinded Treatment Phase (up to Week 48)||205
2910483|NCT00476996|3620000|FG001|COMPLETED|Blinded Treatment Phase (up to Week 48)||222
2910484|NCT00476996|3620001|FG002|COMPLETED|Blinded Treatment Phase (up to Week 48)||237
2910485|NCT00476996|3620002|FG003|COMPLETED|Blinded Treatment Phase (up to Week 48)||0
2910486|NCT00476996|3619999|FG000|NOT COMPLETED|Blinded Treatment Phase (up to Week 48)||72
2910487|NCT00476996|3620000|FG001|NOT COMPLETED|Blinded Treatment Phase (up to Week 48)||55
2910488|NCT00476996|3620001|FG002|NOT COMPLETED|Blinded Treatment Phase (up to Week 48)||45
2910489|NCT00476996|3620002|FG003|NOT COMPLETED|Blinded Treatment Phase (up to Week 48)||0
2910490|NCT00476996|3619999|FG000|STARTED|OLE Phase (From Week 48)||0
2910491|NCT00476996|3620000|FG001|STARTED|OLE Phase (From Week 48)||0
2910492|NCT00476996|3620001|FG002|STARTED|OLE Phase (From Week 48)||0
2910493|NCT00476996|3620002|FG003|STARTED|OLE Phase (From Week 48)||664
2910494|NCT00476996|3619999|FG000|COMPLETED|OLE Phase (From Week 48)||0
2910495|NCT00476996|3620000|FG001|COMPLETED|OLE Phase (From Week 48)||0
2910496|NCT00476996|3620001|FG002|COMPLETED|OLE Phase (From Week 48)||0
2910497|NCT00476996|3620002|FG003|COMPLETED|OLE Phase (From Week 48)||0
2910498|NCT00476996|3619999|FG000|NOT COMPLETED|OLE Phase (From Week 48)||0
2910499|NCT00476996|3620000|FG001|NOT COMPLETED|OLE Phase (From Week 48)||0
2910500|NCT00476996|3620001|FG002|NOT COMPLETED|OLE Phase (From Week 48)||0
2910501|NCT00476996|3620002|FG003|NOT COMPLETED|OLE Phase (From Week 48)||664
2910502|NCT00477087|3620011|FG000|STARTED|Overall Study||10
2910503|NCT00477087|3620011|FG000|COMPLETED|Overall Study||10
2910504|NCT00477087|3620011|FG000|NOT COMPLETED|Overall Study||0
2910505|NCT00477152|3620015|FG000|STARTED|Overall Study|One patient withdrawn prior to treatment, so not included in analyses.|52
2920581|NCT00537407|3631083|FG001|STARTED|Part 2 Weeks 5-48 or 72||9
3171631|NCT01935791|3898776|FG000|NOT COMPLETED|Period 2||0
3171632|NCT01935791|3898777|FG001|NOT COMPLETED|Period 2||0
3171633|NCT01935791|3898778|FG002|NOT COMPLETED|Period 2||0
3171634|NCT01935791|3898779|FG003|NOT COMPLETED|Period 2||0
3171635|NCT01935791|3898780|FG004|NOT COMPLETED|Period 2||0
3171636|NCT01935791|3898781|FG005|NOT COMPLETED|Period 2||0
3171637|NCT01935791|3898782|FG006|NOT COMPLETED|Period 2||0
3171638|NCT01935791|3898783|FG007|NOT COMPLETED|Period 2||0
3171639|NCT01935791|3898784|FG008|NOT COMPLETED|Period 2||0
3171640|NCT01935934|3898800|FG000|STARTED|Overall Study||70
3171641|NCT01935934|3898801|FG001|STARTED|Overall Study||32
3171642|NCT01935934|3898800|FG000|COMPLETED|Overall Study||70
3171643|NCT01935934|3898801|FG001|COMPLETED|Overall Study||32
3171644|NCT01935934|3898800|FG000|NOT COMPLETED|Overall Study||0
3171645|NCT01935934|3898801|FG001|NOT COMPLETED|Overall Study||0
3171646|NCT01936181|3898808|FG000|STARTED|Randomised, Double-blind||291
3171647|NCT01936181|3898809|FG001|STARTED|Randomised, Double-blind||293
3171648|NCT01936181|3898810|FG002|STARTED|Randomised, Double-blind||0
3171649|NCT01936181|3898811|FG003|STARTED|Randomised, Double-blind||0
3171650|NCT01936181|3898808|FG000|COMPLETED|Randomised, Double-blind||227
3171651|NCT01936181|3898809|FG001|COMPLETED|Randomised, Double-blind||225
3171652|NCT01936181|3898810|FG002|COMPLETED|Randomised, Double-blind||0
3384644|NCT02234843|4119732|FG006|NOT COMPLETED|Overall Study||2
3384645|NCT02234843|4119733|FG007|NOT COMPLETED|Overall Study||2
3384646|NCT02234843|4119734|FG008|NOT COMPLETED|Overall Study||1
3384647|NCT02234843|4119735|FG009|NOT COMPLETED|Overall Study||0
3386413|NCT02587598|4121713|FG005|COMPLETED|Overall Study|All participants discontinued study treatment and withdrew from the study.|0
3386414|NCT02587598|4121714|FG006|COMPLETED|Overall Study|All participants discontinued study treatment and withdrew from the study.|0
3386415|NCT02587598|4121715|FG007|COMPLETED|Overall Study|All participants discontinued study treatment and withdrew from the study.|0
3386416|NCT02587598|4121716|FG008|COMPLETED|Overall Study|All participants discontinued study treatment and withdrew from the study.|0
3386417|NCT02587598|4121717|FG009|COMPLETED|Overall Study|All participants discontinued study treatment and withdrew from the study.|0
3386418|NCT02587598|4121718|FG010|COMPLETED|Overall Study|All participants discontinued study treatment and withdrew from the study.|0
3386419|NCT02587598|4121708|FG000|NOT COMPLETED|Overall Study||4
3386420|NCT02587598|4121709|FG001|NOT COMPLETED|Overall Study||11
3386421|NCT02587598|4121710|FG002|NOT COMPLETED|Overall Study||4
3386422|NCT02587598|4121711|FG003|NOT COMPLETED|Overall Study||21
3386423|NCT02587598|4121712|FG004|NOT COMPLETED|Overall Study||12
3386424|NCT02587598|4121713|FG005|NOT COMPLETED|Overall Study||6
3386425|NCT02587598|4121714|FG006|NOT COMPLETED|Overall Study||6
3386426|NCT02587598|4121715|FG007|NOT COMPLETED|Overall Study||7
2910506|NCT00477152|3620015|FG000|COMPLETED|Overall Study|Two patients treated, but assessments incomplete. All available data included in analyses for these.|49
2910507|NCT00477152|3620015|FG000|NOT COMPLETED|Overall Study||3
2910508|NCT00477165|3620021|FG000|STARTED|Overall Study||27
2910509|NCT00477165|3620022|FG001|STARTED|Overall Study||27
2910510|NCT00477165|3620021|FG000|COMPLETED|Overall Study||20
2910511|NCT00477165|3620022|FG001|COMPLETED|Overall Study||25
2910512|NCT00477165|3620021|FG000|NOT COMPLETED|Overall Study||7
2910513|NCT00477165|3620022|FG001|NOT COMPLETED|Overall Study||2
2910514|NCT00477191|3620028|FG000|STARTED|Overall Study||18
2910515|NCT00477191|3620028|FG000|COMPLETED|Overall Study||13
2910516|NCT00477191|3620028|FG000|NOT COMPLETED|Overall Study||5
2910517|NCT00477204|3620034|FG000|STARTED|Overall Study||4
2910518|NCT00477204|3620035|FG001|STARTED|Overall Study||5
2910519|NCT00477204|3620034|FG000|COMPLETED|Overall Study||4
2910520|NCT00477204|3620035|FG001|COMPLETED|Overall Study||5
2910521|NCT00477204|3620034|FG000|NOT COMPLETED|Overall Study||0
2910522|NCT00477204|3620035|FG001|NOT COMPLETED|Overall Study||0
2910523|NCT00477269|3620043|FG000|STARTED|Core Study||28
2910524|NCT00477269|3620044|FG001|STARTED|Core Study||31
2910525|NCT00477269|3620045|FG002|STARTED|Core Study||0
2910526|NCT00477269|3620043|FG000|COMPLETED|Core Study||19
2910527|NCT00477269|3620044|FG001|COMPLETED|Core Study||23
2910528|NCT00477269|3620045|FG002|COMPLETED|Core Study||0
2910529|NCT00477269|3620043|FG000|NOT COMPLETED|Core Study||9
2910530|NCT00477269|3620044|FG001|NOT COMPLETED|Core Study||8
2910531|NCT00477269|3620045|FG002|NOT COMPLETED|Core Study||0
2910532|NCT00477269|3620043|FG000|STARTED|Open Label Extension|Arm in the Core study not extension|0
2910533|NCT00477269|3620044|FG001|STARTED|Open Label Extension|Arm in the Core study not extension|0
2910534|NCT00477269|3620045|FG002|STARTED|Open Label Extension||22
2910535|NCT00477269|3620043|FG000|COMPLETED|Open Label Extension|Arm in the Core study not extension|0
2910536|NCT00477269|3620044|FG001|COMPLETED|Open Label Extension|Arm in the Core study not extension|0
2910537|NCT00477269|3620045|FG002|COMPLETED|Open Label Extension||9
2910538|NCT00477269|3620043|FG000|NOT COMPLETED|Open Label Extension||0
2910539|NCT00477269|3620044|FG001|NOT COMPLETED|Open Label Extension||0
2910540|NCT00477269|3620045|FG002|NOT COMPLETED|Open Label Extension||13
2910541|NCT00477295|3620055|FG000|STARTED|Overall Study||282
2910542|NCT00477295|3620056|FG001|STARTED|Overall Study||301
2910543|NCT00477295|3620055|FG000|COMPLETED|Overall Study||161
2910544|NCT00477295|3620056|FG001|COMPLETED|Overall Study||192
2910545|NCT00477295|3620055|FG000|NOT COMPLETED|Overall Study||121
2910546|NCT00477295|3620056|FG001|NOT COMPLETED|Overall Study||109
2910547|NCT00477334|3620066|FG000|STARTED|Overall Study||312
2910548|NCT00477334|3620067|FG001|STARTED|Overall Study||151
2910549|NCT00477334|3620066|FG000|Randomized and Took Study Drug|Overall Study||206
2910550|NCT00477334|3620067|FG001|Randomized and Took Study Drug|Overall Study||98
2910551|NCT00477334|3620066|FG000|Intent to Treat Population|Overall Study||201
2910552|NCT00477334|3620067|FG001|Intent to Treat Population|Overall Study||98
2910553|NCT00477334|3620066|FG000|Participants Completing First Recurrence|Overall Study||187
2910554|NCT00477334|3620067|FG001|Participants Completing First Recurrence|Overall Study||92
2910555|NCT00477334|3620066|FG000|Modified Intent to Treat Population|Overall Study||152
2910556|NCT00477334|3620067|FG001|Modified Intent to Treat Population|Overall Study||78
2910557|NCT00477334|3620066|FG000|COMPLETED|Overall Study|Participants completing the first recurrence and follow-up.|142
2910558|NCT00477334|3620067|FG001|COMPLETED|Overall Study|Participants completing the first recurrence and follow-up.|75
2910559|NCT00477334|3620066|FG000|NOT COMPLETED|Overall Study||170
2910560|NCT00477334|3620067|FG001|NOT COMPLETED|Overall Study||76
2910561|NCT00477386|3620079|FG000|STARTED|Overall Study||11
2910562|NCT00477386|3620080|FG001|STARTED|Overall Study||17
2910563|NCT00477386|3620079|FG000|COMPLETED|Overall Study||0
2910564|NCT00477386|3620080|FG001|COMPLETED|Overall Study||0
2910565|NCT00477386|3620079|FG000|NOT COMPLETED|Overall Study||11
2910566|NCT00477386|3620080|FG001|NOT COMPLETED|Overall Study||17
2910567|NCT00477451|3620090|FG000|STARTED|Overall Study||20
2910568|NCT00477451|3620091|FG001|STARTED|Overall Study||20
2910569|NCT00477451|3620092|FG002|STARTED|Overall Study||7
2910570|NCT00477451|3620093|FG003|STARTED|Overall Study||2
2910571|NCT00477451|3620090|FG000|COMPLETED|Overall Study||20
2910572|NCT00477451|3620091|FG001|COMPLETED|Overall Study||20
2910573|NCT00477451|3620092|FG002|COMPLETED|Overall Study||7
2910574|NCT00477451|3620093|FG003|COMPLETED|Overall Study||2
2910575|NCT00477451|3620090|FG000|NOT COMPLETED|Overall Study||0
2910576|NCT00477451|3620091|FG001|NOT COMPLETED|Overall Study||0
2910577|NCT00477451|3620092|FG002|NOT COMPLETED|Overall Study||0
2910578|NCT00477451|3620093|FG003|NOT COMPLETED|Overall Study||0
2910579|NCT00477464|3620101|FG000|STARTED|Overall Study||51
2910580|NCT00477464|3620101|FG000|COMPLETED|Overall Study||0
2910581|NCT00477464|3620101|FG000|NOT COMPLETED|Overall Study||51
2910582|NCT00477490|3620112|FG000|STARTED|Part I: 4 Week Efficacy||160
2910583|NCT00477490|3620113|FG001|STARTED|Part I: 4 Week Efficacy||163
2910584|NCT00477490|3620114|FG002|STARTED|Part I: 4 Week Efficacy||158
2910585|NCT00477490|3620115|FG003|STARTED|Part I: 4 Week Efficacy||158
2910586|NCT00477490|3620116|FG004|STARTED|Part I: 4 Week Efficacy||160
2910587|NCT00477490|3620117|FG005|STARTED|Part I: 4 Week Efficacy||0
2910588|NCT00477490|3620118|FG006|STARTED|Part I: 4 Week Efficacy||0
2910589|NCT00477490|3620119|FG007|STARTED|Part I: 4 Week Efficacy||0
2910590|NCT00477490|3620120|FG008|STARTED|Part I: 4 Week Efficacy||0
2920582|NCT00537407|3631084|FG002|STARTED|Part 2 Weeks 5-48 or 72||11
2910591|NCT00477490|3620112|FG000|ITT Population|Part I: 4 Week Efficacy|Received at least one dose of study drug and provided at least one primary efficacy measure.|156
2910592|NCT00477490|3620113|FG001|ITT Population|Part I: 4 Week Efficacy|Received at least one dose of study drug and provided at least one primary efficacy measure.|155
2910593|NCT00477490|3620114|FG002|ITT Population|Part I: 4 Week Efficacy|Received at least one dose of study drug and provided at least one primary efficacy measure.|152
2910594|NCT00477490|3620115|FG003|ITT Population|Part I: 4 Week Efficacy|Received at least one dose of study drug and provided at least one primary efficacy measure.|148
2910595|NCT00477490|3620116|FG004|ITT Population|Part I: 4 Week Efficacy|Received at least one dose of study drug and provided at least one primary efficacy measure.|146
2910596|NCT00477490|3620117|FG005|ITT Population|Part I: 4 Week Efficacy||0
2910597|NCT00477490|3620118|FG006|ITT Population|Part I: 4 Week Efficacy||0
2910598|NCT00477490|3620119|FG007|ITT Population|Part I: 4 Week Efficacy||0
2910599|NCT00477490|3620120|FG008|ITT Population|Part I: 4 Week Efficacy||0
2910600|NCT00477490|3620112|FG000|COMPLETED|Part I: 4 Week Efficacy||145
2910601|NCT00477490|3620113|FG001|COMPLETED|Part I: 4 Week Efficacy||144
2910602|NCT00477490|3620114|FG002|COMPLETED|Part I: 4 Week Efficacy||148
2910603|NCT00477490|3620115|FG003|COMPLETED|Part I: 4 Week Efficacy||138
2910604|NCT00477490|3620116|FG004|COMPLETED|Part I: 4 Week Efficacy||135
2910605|NCT00477490|3620117|FG005|COMPLETED|Part I: 4 Week Efficacy||0
2910606|NCT00477490|3620118|FG006|COMPLETED|Part I: 4 Week Efficacy||0
2910607|NCT00477490|3620119|FG007|COMPLETED|Part I: 4 Week Efficacy||0
2910608|NCT00477490|3620120|FG008|COMPLETED|Part I: 4 Week Efficacy||0
2910609|NCT00477490|3620112|FG000|NOT COMPLETED|Part I: 4 Week Efficacy||15
2910610|NCT00477490|3620113|FG001|NOT COMPLETED|Part I: 4 Week Efficacy||19
2910611|NCT00477490|3620114|FG002|NOT COMPLETED|Part I: 4 Week Efficacy||10
2910612|NCT00477490|3620115|FG003|NOT COMPLETED|Part I: 4 Week Efficacy||20
2910613|NCT00477490|3620116|FG004|NOT COMPLETED|Part I: 4 Week Efficacy||25
2910614|NCT00477490|3620117|FG005|NOT COMPLETED|Part I: 4 Week Efficacy||0
2910615|NCT00477490|3620118|FG006|NOT COMPLETED|Part I: 4 Week Efficacy||0
2910616|NCT00477490|3620119|FG007|NOT COMPLETED|Part I: 4 Week Efficacy||0
2910617|NCT00477490|3620120|FG008|NOT COMPLETED|Part I: 4 Week Efficacy||0
2910618|NCT00477490|3620112|FG000|STARTED|Part II: Extension Week 5 up to Day 169||0
2910619|NCT00477490|3620113|FG001|STARTED|Part II: Extension Week 5 up to Day 169||135
2910620|NCT00477490|3620114|FG002|STARTED|Part II: Extension Week 5 up to Day 169||135
2910621|NCT00477490|3620115|FG003|STARTED|Part II: Extension Week 5 up to Day 169||132
2910622|NCT00477490|3620116|FG004|STARTED|Part II: Extension Week 5 up to Day 169||127
2910623|NCT00477490|3620117|FG005|STARTED|Part II: Extension Week 5 up to Day 169||31
2910624|NCT00477490|3620118|FG006|STARTED|Part II: Extension Week 5 up to Day 169||37
3384648|NCT02243306|4119770|FG000|STARTED|Overall Study||1
3384649|NCT02243306|4119771|FG001|STARTED|Overall Study||7
3384650|NCT02243306|4119770|FG000|COMPLETED|Overall Study||1
3384651|NCT02243306|4119771|FG001|COMPLETED|Overall Study||4
3384652|NCT02243306|4119770|FG000|NOT COMPLETED|Overall Study||0
3384653|NCT02243306|4119771|FG001|NOT COMPLETED|Overall Study||3
3384654|NCT02246621|4119780|FG000|STARTED|Overall Study||328
3384655|NCT02246621|4119781|FG001|STARTED|Overall Study||165
3384656|NCT02246621|4119780|FG000|Received At Least One Dose of Study Drug|Overall Study||327
3384657|NCT02246621|4119781|FG001|Received At Least One Dose of Study Drug|Overall Study||161
3384658|NCT02246621|4119780|FG000|COMPLETED|Overall Study||63
3384659|NCT02246621|4119781|FG001|COMPLETED|Overall Study||30
3384660|NCT02246621|4119780|FG000|NOT COMPLETED|Overall Study||265
3384661|NCT02246621|4119781|FG001|NOT COMPLETED|Overall Study||135
3384662|NCT02257918|4119790|FG000|STARTED|Overall Study||72
3384663|NCT02257918|4119791|FG001|STARTED|Overall Study||67
3384664|NCT02257918|4119792|FG002|STARTED|Overall Study||41
3384665|NCT02257918|4119790|FG000|Test of Cure Visit|Overall Study||72
3384666|NCT02257918|4119791|FG001|Test of Cure Visit|Overall Study||67
3384667|NCT02257918|4119792|FG002|Test of Cure Visit|Overall Study||40
3384668|NCT02257918|4119790|FG000|COMPLETED|Overall Study||68
3384669|NCT02257918|4119791|FG001|COMPLETED|Overall Study||66
3384670|NCT02257918|4119792|FG002|COMPLETED|Overall Study||39
3384671|NCT02257918|4119790|FG000|NOT COMPLETED|Overall Study||4
3384672|NCT02257918|4119791|FG001|NOT COMPLETED|Overall Study||1
3384673|NCT02257918|4119792|FG002|NOT COMPLETED|Overall Study||2
3384694|NCT02290431|4119835|FG000|STARTED|Overall Study||31
3384695|NCT02290431|4119835|FG000|Subjects. Discont. Prematurely|Overall Study||27
3384696|NCT02290431|4119835|FG000|Subjects Completed Study Per Protocol|Overall Study||8
3384697|NCT02290431|4119835|FG000|Subjs. Ntered Post-treatment Eval. Phase|Overall Study||31
3384698|NCT02290431|4119835|FG000|Subjects Entered Survival f/u Phase|Overall Study||24
3384699|NCT02290431|4119835|FG000|Entered Treatment Phase 2|Overall Study||17
3384700|NCT02290431|4119835|FG000|COMPLETED|Overall Study||4
3384701|NCT02290431|4119835|FG000|NOT COMPLETED|Overall Study||27
3384702|NCT02314923|4119849|FG000|STARTED|Overall Study||64
3384703|NCT02314923|4119850|FG001|STARTED|Overall Study||64
3384704|NCT02314923|4119851|FG002|STARTED|Overall Study||64
3384705|NCT02314923|4119852|FG003|STARTED|Overall Study||64
3384706|NCT02314923|4119853|FG004|STARTED|Overall Study||74
3384707|NCT02314923|4119854|FG005|STARTED|Overall Study||20
3384708|NCT02314923|4119855|FG006|STARTED|Overall Study||48
3384709|NCT02314923|4119856|FG007|STARTED|Overall Study||47
3384710|NCT02314923|4119857|FG008|STARTED|Overall Study||48
3384711|NCT02314923|4119858|FG009|STARTED|Overall Study||20
3384712|NCT02314923|4119849|FG000|Treated|Overall Study||64
3384713|NCT02314923|4119850|FG001|Treated|Overall Study||64
3384714|NCT02314923|4119851|FG002|Treated|Overall Study||64
2910625|NCT00477490|3620119|FG007|STARTED|Part II: Extension Week 5 up to Day 169||34
2910626|NCT00477490|3620120|FG008|STARTED|Part II: Extension Week 5 up to Day 169||34
2910627|NCT00477490|3620112|FG000|COMPLETED|Part II: Extension Week 5 up to Day 169||0
2910628|NCT00477490|3620113|FG001|COMPLETED|Part II: Extension Week 5 up to Day 169||107
2910629|NCT00477490|3620114|FG002|COMPLETED|Part II: Extension Week 5 up to Day 169||120
2910630|NCT00477490|3620115|FG003|COMPLETED|Part II: Extension Week 5 up to Day 169||120
2910631|NCT00477490|3620116|FG004|COMPLETED|Part II: Extension Week 5 up to Day 169||107
2910632|NCT00477490|3620117|FG005|COMPLETED|Part II: Extension Week 5 up to Day 169||25
2910633|NCT00477490|3620118|FG006|COMPLETED|Part II: Extension Week 5 up to Day 169||32
2910634|NCT00477490|3620119|FG007|COMPLETED|Part II: Extension Week 5 up to Day 169||29
2910635|NCT00477490|3620120|FG008|COMPLETED|Part II: Extension Week 5 up to Day 169||26
2910636|NCT00477490|3620112|FG000|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||0
2910637|NCT00477490|3620113|FG001|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||28
2910638|NCT00477490|3620114|FG002|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||15
2910639|NCT00477490|3620115|FG003|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||12
2910640|NCT00477490|3620116|FG004|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||20
2910641|NCT00477490|3620117|FG005|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||6
2910642|NCT00477490|3620118|FG006|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||5
2910643|NCT00477490|3620119|FG007|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||5
2910644|NCT00477490|3620120|FG008|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||8
2910645|NCT00477594|3620150|FG000|STARTED|Year 1 and Year 2||16
2910646|NCT00477594|3620151|FG001|STARTED|Year 1 and Year 2||5
2910647|NCT00477594|3620150|FG000|COMPLETED|Year 1 and Year 2||7
2910648|NCT00477594|3620151|FG001|COMPLETED|Year 1 and Year 2||1
2910649|NCT00477594|3620150|FG000|NOT COMPLETED|Year 1 and Year 2||9
2910650|NCT00477594|3620151|FG001|NOT COMPLETED|Year 1 and Year 2||4
2910651|NCT00477594|3620150|FG000|STARTED|Year 3||4
2910652|NCT00477594|3620151|FG001|STARTED|Year 3||0
2910653|NCT00477594|3620150|FG000|COMPLETED|Year 3||2
2910654|NCT00477594|3620151|FG001|COMPLETED|Year 3||0
2910655|NCT00477594|3620150|FG000|NOT COMPLETED|Year 3||2
2910656|NCT00477594|3620151|FG001|NOT COMPLETED|Year 3||0
2910657|NCT00477594|3620150|FG000|STARTED|Follow-up Period||16
2910658|NCT00477594|3620151|FG001|STARTED|Follow-up Period||5
2910659|NCT00477594|3620150|FG000|COMPLETED|Follow-up Period||13
2910660|NCT00477594|3620151|FG001|COMPLETED|Follow-up Period||4
2910661|NCT00477594|3620150|FG000|NOT COMPLETED|Follow-up Period||3
2910662|NCT00477594|3620151|FG001|NOT COMPLETED|Follow-up Period||1
2910663|NCT00477607|3620159|FG000|STARTED|Overall Study||19
2910664|NCT00477607|3620160|FG001|STARTED|Overall Study||20
2910665|NCT00477607|3620159|FG000|COMPLETED|Overall Study||12
2910666|NCT00477607|3620160|FG001|COMPLETED|Overall Study||13
2910667|NCT00477607|3620159|FG000|NOT COMPLETED|Overall Study||7
2910668|NCT00477607|3620160|FG001|NOT COMPLETED|Overall Study||7
2910669|NCT00477633|3620166|FG000|STARTED|Overall Study||1700
2910670|NCT00477633|3620166|FG000|COMPLETED|Overall Study||991
2910671|NCT00477633|3620166|FG000|NOT COMPLETED|Overall Study||709
3384674|NCT02258542|4119804|FG000|STARTED|Overall Study||953
3384675|NCT02258542|4119805|FG001|STARTED|Overall Study||973
3384676|NCT02258542|4119806|FG002|STARTED|Overall Study||100
3384677|NCT02258542|4119807|FG003|STARTED|Overall Study||97
3384678|NCT02258542|4119804|FG000|Treated|Overall Study||953
3384679|NCT02258542|4119805|FG001|Treated|Overall Study||971
3384680|NCT02258542|4119806|FG002|Treated|Overall Study||100
3384681|NCT02258542|4119807|FG003|Treated|Overall Study||97
3384682|NCT02258542|4119804|FG000|Adolescents Only|Overall Study||25
3384683|NCT02258542|4119805|FG001|Adolescents Only|Overall Study||61
3384684|NCT02258542|4119806|FG002|Adolescents Only|Overall Study||0
3384685|NCT02258542|4119807|FG003|Adolescents Only|Overall Study||0
3384686|NCT02258542|4119804|FG000|COMPLETED|Overall Study|170 enrolled into study MELTEMI|911
3384687|NCT02258542|4119805|FG001|COMPLETED|Overall Study|178 enrolled into study MELTEMI|924
3384688|NCT02258542|4119806|FG002|COMPLETED|Overall Study|51 enrolled into study MELTEMI|92
3384689|NCT02258542|4119807|FG003|COMPLETED|Overall Study|48 enrolled into study MELTEMI|92
3384690|NCT02258542|4119804|FG000|NOT COMPLETED|Overall Study||42
3384691|NCT02258542|4119805|FG001|NOT COMPLETED|Overall Study||49
3384692|NCT02258542|4119806|FG002|NOT COMPLETED|Overall Study||8
3384693|NCT02258542|4119807|FG003|NOT COMPLETED|Overall Study||5
3384715|NCT02314923|4119852|FG003|Treated|Overall Study||64
3384716|NCT02314923|4119853|FG004|Treated|Overall Study||74
3384717|NCT02314923|4119854|FG005|Treated|Overall Study||20
3384718|NCT02314923|4119855|FG006|Treated|Overall Study|One participant did not receive vaccination due to missing blood sample at randomization.|47
3384719|NCT02314923|4119856|FG007|Treated|Overall Study||47
3384720|NCT02314923|4119857|FG008|Treated|Overall Study||48
3384721|NCT02314923|4119858|FG009|Treated|Overall Study||20
3384722|NCT02314923|4119849|FG000|COMPLETED|Overall Study||61
3384723|NCT02314923|4119850|FG001|COMPLETED|Overall Study||60
3384724|NCT02314923|4119851|FG002|COMPLETED|Overall Study||62
3384725|NCT02314923|4119852|FG003|COMPLETED|Overall Study||63
3384726|NCT02314923|4119853|FG004|COMPLETED|Overall Study||73
3384727|NCT02314923|4119854|FG005|COMPLETED|Overall Study||19
3384728|NCT02314923|4119855|FG006|COMPLETED|Overall Study||43
3384729|NCT02314923|4119856|FG007|COMPLETED|Overall Study||42
3384730|NCT02314923|4119857|FG008|COMPLETED|Overall Study||46
3384731|NCT02314923|4119858|FG009|COMPLETED|Overall Study||20
3384732|NCT02314923|4119849|FG000|NOT COMPLETED|Overall Study||3
2910672|NCT00477659|3620170|FG000|STARTED|Overall Study||14
2910673|NCT00477659|3620170|FG000|COMPLETED|Overall Study||14
2910674|NCT00477659|3620170|FG000|NOT COMPLETED|Overall Study||0
2910675|NCT00477672|3620177|FG000|STARTED|Overall Study||98
2910676|NCT00477672|3620178|FG001|STARTED|Overall Study||101
2910677|NCT00477672|3620179|FG002|STARTED|Overall Study||99
2910678|NCT00477672|3620177|FG000|COMPLETED|Overall Study||91
2910679|NCT00477672|3620178|FG001|COMPLETED|Overall Study||85
2910680|NCT00477672|3620179|FG002|COMPLETED|Overall Study||83
2910681|NCT00477672|3620177|FG000|NOT COMPLETED|Overall Study||7
2910682|NCT00477672|3620178|FG001|NOT COMPLETED|Overall Study||16
2910683|NCT00477672|3620179|FG002|NOT COMPLETED|Overall Study||16
2910684|NCT00477685|3620187|FG000|STARTED|Overall Study||10
2910685|NCT00477685|3620187|FG000|COMPLETED|Overall Study||10
2910686|NCT00477685|3620187|FG000|NOT COMPLETED|Overall Study||0
2910687|NCT00477750|3620191|FG000|STARTED|Overall Study||26
2910688|NCT00477750|3620191|FG000|COMPLETED|Overall Study||15
2910689|NCT00477750|3620191|FG000|NOT COMPLETED|Overall Study||11
2910690|NCT00477971|3620199|FG000|STARTED|Overall Study||34
2910691|NCT00477971|3620200|FG001|STARTED|Overall Study||55
2910692|NCT00477971|3620199|FG000|COMPLETED|Overall Study||17
2910693|NCT00477971|3620200|FG001|COMPLETED|Overall Study||49
2910694|NCT00477971|3620199|FG000|NOT COMPLETED|Overall Study||17
2910695|NCT00477971|3620200|FG001|NOT COMPLETED|Overall Study||6
2910696|NCT00478023|3620211|FG000|STARTED|Overall Study||170
2910697|NCT00478023|3620212|FG001|STARTED|Overall Study||168
2910698|NCT00478023|3620213|FG002|STARTED|Overall Study||171
2910699|NCT00478023|3620214|FG003|STARTED|Overall Study||176
2910700|NCT00478023|3620215|FG004|STARTED|Overall Study||169
2910701|NCT00478023|3620211|FG000|COMPLETED|Overall Study||135
2910702|NCT00478023|3620212|FG001|COMPLETED|Overall Study||144
2910703|NCT00478023|3620213|FG002|COMPLETED|Overall Study||151
2910704|NCT00478023|3620214|FG003|COMPLETED|Overall Study||146
2910705|NCT00478023|3620215|FG004|COMPLETED|Overall Study||114
2910706|NCT00478023|3620211|FG000|NOT COMPLETED|Overall Study||35
2910707|NCT00478023|3620212|FG001|NOT COMPLETED|Overall Study||24
2910708|NCT00478023|3620213|FG002|NOT COMPLETED|Overall Study||20
2910709|NCT00478023|3620214|FG003|NOT COMPLETED|Overall Study||30
2910710|NCT00478023|3620215|FG004|NOT COMPLETED|Overall Study||55
2910711|NCT00478036|3620230|FG000|STARTED|Overall Study||10
2910712|NCT00478036|3620231|FG001|STARTED|Overall Study||7
2910713|NCT00478036|3620232|FG002|STARTED|Overall Study||14
2910714|NCT00478036|3620230|FG000|COMPLETED|Overall Study||10
2910715|NCT00478036|3620231|FG001|COMPLETED|Overall Study||7
2910716|NCT00478036|3620232|FG002|COMPLETED|Overall Study||14
3384733|NCT02314923|4119850|FG001|NOT COMPLETED|Overall Study||4
3384734|NCT02314923|4119851|FG002|NOT COMPLETED|Overall Study||2
3384735|NCT02314923|4119852|FG003|NOT COMPLETED|Overall Study||1
3384736|NCT02314923|4119853|FG004|NOT COMPLETED|Overall Study||1
3384737|NCT02314923|4119854|FG005|NOT COMPLETED|Overall Study||1
3384738|NCT02314923|4119855|FG006|NOT COMPLETED|Overall Study||5
3384739|NCT02314923|4119856|FG007|NOT COMPLETED|Overall Study||5
3384740|NCT02314923|4119857|FG008|NOT COMPLETED|Overall Study||2
3384741|NCT02314923|4119858|FG009|NOT COMPLETED|Overall Study||0
3386427|NCT02587598|4121716|FG008|NOT COMPLETED|Overall Study||9
3386428|NCT02587598|4121717|FG009|NOT COMPLETED|Overall Study||3
3386429|NCT02587598|4121718|FG010|NOT COMPLETED|Overall Study||14
3386430|NCT02485574|4121754|FG000|STARTED|Overall Study||69
3386431|NCT02485574|4121754|FG000|COMPLETED|Overall Study||65
3386432|NCT02485574|4121754|FG000|NOT COMPLETED|Overall Study||4
3386433|NCT02214160|4121766|FG000|STARTED|Overall Study||24
3386434|NCT02214160|4121767|FG001|STARTED|Overall Study||37
3386435|NCT02214160|4121768|FG002|STARTED|Overall Study||33
3386436|NCT02214160|4121766|FG000|COMPLETED|Overall Study||20
3386437|NCT02214160|4121767|FG001|COMPLETED|Overall Study||29
3386438|NCT02214160|4121768|FG002|COMPLETED|Overall Study||23
3386439|NCT02214160|4121766|FG000|NOT COMPLETED|Overall Study||4
3386440|NCT02214160|4121767|FG001|NOT COMPLETED|Overall Study||8
3386441|NCT02214160|4121768|FG002|NOT COMPLETED|Overall Study||10
3386442|NCT02032823|4121782|FG000|STARTED|Overall Study||921
3386443|NCT02032823|4121783|FG001|STARTED|Overall Study||915
3386444|NCT02032823|4121782|FG000|COMPLETED|Overall Study||0
3386445|NCT02032823|4121783|FG001|COMPLETED|Overall Study||0
3386446|NCT02032823|4121782|FG000|NOT COMPLETED|Overall Study||921
3386447|NCT02032823|4121783|FG001|NOT COMPLETED|Overall Study||915
3386448|NCT01899261|4121789|FG000|STARTED|Overall Study||20
3386449|NCT01899261|4121789|FG000|COMPLETED|Overall Study||20
3386450|NCT01899261|4121789|FG000|NOT COMPLETED|Overall Study||0
3386451|NCT01612351|4121793|FG000|STARTED|Chemotherapy||40
3386452|NCT01612351|4121793|FG000|COMPLETED|Chemotherapy||40
3386453|NCT01612351|4121793|FG000|NOT COMPLETED|Chemotherapy||0
3386454|NCT01612351|4121793|FG000|STARTED|Transoral Surgery|One patient completed chemotherapy then withdrew before surgery.|39
3386455|NCT01612351|4121793|FG000|COMPLETED|Transoral Surgery||39
3386456|NCT01612351|4121793|FG000|NOT COMPLETED|Transoral Surgery||0
3386457|NCT01612351|4121793|FG000|STARTED|Post-Operative Treatment||39
3386458|NCT01612351|4121793|FG000|COMPLETED|Post-Operative Treatment|One patient completed chemotherapy then withdrew before surgery.|39
3386459|NCT01612351|4121793|FG000|NOT COMPLETED|Post-Operative Treatment||0
3386460|NCT01595503|4121800|FG000|STARTED|Overall Study||5
3386461|NCT01595503|4121800|FG000|COMPLETED|Overall Study||5
3386462|NCT01595503|4121800|FG000|NOT COMPLETED|Overall Study||0
2910717|NCT00478036|3620230|FG000|NOT COMPLETED|Overall Study||0
2910718|NCT00478036|3620231|FG001|NOT COMPLETED|Overall Study||0
2910719|NCT00478036|3620232|FG002|NOT COMPLETED|Overall Study||0
2910720|NCT00478140|3620240|FG000|STARTED|Overall Study||4
2910721|NCT00478140|3620240|FG000|COMPLETED|Overall Study||3
2910722|NCT00478140|3620240|FG000|NOT COMPLETED|Overall Study||1
2910723|NCT00478192|3620247|FG000|STARTED|Overall Study||20
2910724|NCT00478192|3620248|FG001|STARTED|Overall Study||20
2910725|NCT00478192|3620249|FG002|STARTED|Overall Study||10
2910726|NCT00478192|3620247|FG000|Full Analysis Set / Safety Analysis Set|Overall Study||20
2910727|NCT00478192|3620248|FG001|Full Analysis Set / Safety Analysis Set|Overall Study||20
2910728|NCT00478192|3620249|FG002|Full Analysis Set / Safety Analysis Set|Overall Study||9
2910729|NCT00478192|3620247|FG000|End of Treatment|Overall Study||18
2910730|NCT00478192|3620248|FG001|End of Treatment|Overall Study||16
2910731|NCT00478192|3620249|FG002|End of Treatment|Overall Study||8
2910732|NCT00478192|3620247|FG000|COMPLETED|Overall Study||16
2910733|NCT00478192|3620248|FG001|COMPLETED|Overall Study||15
2910734|NCT00478192|3620249|FG002|COMPLETED|Overall Study||8
2910735|NCT00478192|3620247|FG000|NOT COMPLETED|Overall Study||4
2910736|NCT00478192|3620248|FG001|NOT COMPLETED|Overall Study||5
2910737|NCT00478192|3620249|FG002|NOT COMPLETED|Overall Study||2
2910738|NCT00478205|3620260|FG000|STARTED|Overall Study||981
2910739|NCT00478205|3620261|FG001|STARTED|Overall Study||486
2910740|NCT00478205|3620260|FG000|COMPLETED|Overall Study||685
2910741|NCT00478205|3620261|FG001|COMPLETED|Overall Study||399
2910742|NCT00478205|3620260|FG000|NOT COMPLETED|Overall Study||296
2910743|NCT00478205|3620261|FG001|NOT COMPLETED|Overall Study||87
2910744|NCT00478218|3620269|FG000|STARTED|Overall Study||34
2910745|NCT00478218|3620270|FG001|STARTED|Overall Study||19
2910746|NCT00478218|3620269|FG000|COMPLETED|Overall Study||34
2910747|NCT00478218|3620270|FG001|COMPLETED|Overall Study||19
2910748|NCT00478218|3620269|FG000|NOT COMPLETED|Overall Study||0
2910749|NCT00478218|3620270|FG001|NOT COMPLETED|Overall Study||0
2910750|NCT00478231|3620276|FG000|STARTED|Overall Study||209
2910751|NCT00478231|3620276|FG000|Treated|Overall Study||206
2910752|NCT00478231|3620276|FG000|COMPLETED|Overall Study||125
2910753|NCT00478231|3620276|FG000|NOT COMPLETED|Overall Study||84
2910754|NCT00478244|3620280|FG000|STARTED|Overall Study||7
2910755|NCT00478244|3620280|FG000|COMPLETED|Overall Study||6
2910756|NCT00478244|3620280|FG000|NOT COMPLETED|Overall Study||1
2910757|NCT00478257|3620286|FG000|STARTED|Overall Study||23
2910758|NCT00478257|3620287|FG001|STARTED|Overall Study||16
2910759|NCT00478257|3620286|FG000|COMPLETED|Overall Study||15
2910760|NCT00478257|3620287|FG001|COMPLETED|Overall Study||13
2910761|NCT00478257|3620286|FG000|NOT COMPLETED|Overall Study||8
3171653|NCT01936181|3898811|FG003|COMPLETED|Randomised, Double-blind||0
3384742|NCT04821362|4119884|FG000|STARTED|Overall Study||90
3384743|NCT04821362|4119885|FG001|STARTED|Overall Study||90
3384744|NCT04821362|4119886|FG002|STARTED|Overall Study||90
3384745|NCT04821362|4119884|FG000|COMPLETED|Overall Study||90
3384746|NCT04821362|4119885|FG001|COMPLETED|Overall Study||90
3384747|NCT04821362|4119886|FG002|COMPLETED|Overall Study||90
3384748|NCT04821362|4119884|FG000|NOT COMPLETED|Overall Study||0
3384749|NCT04821362|4119885|FG001|NOT COMPLETED|Overall Study||0
3384750|NCT04821362|4119886|FG002|NOT COMPLETED|Overall Study||0
3384751|NCT04524507|4119899|FG000|STARTED|Overall Study||15
3384752|NCT04524507|4119900|FG001|STARTED|Overall Study||41
3384753|NCT04524507|4119899|FG000|Received Intervention|Overall Study||14
3384754|NCT04524507|4119900|FG001|Received Intervention|Overall Study||41
3384755|NCT04524507|4119899|FG000|Hospital Discharge|Overall Study||13
3384756|NCT04524507|4119900|FG001|Hospital Discharge|Overall Study||27
3384757|NCT04524507|4119899|FG000|COMPLETED|Overall Study||9
3384758|NCT04524507|4119900|FG001|COMPLETED|Overall Study||18
3384759|NCT04524507|4119899|FG000|NOT COMPLETED|Overall Study||6
3384760|NCT04524507|4119900|FG001|NOT COMPLETED|Overall Study||23
3384761|NCT04382924|4119909|FG000|STARTED|Overall Study||52
3384762|NCT04382924|4119910|FG001|STARTED|Overall Study||56
3384763|NCT04382924|4119911|FG002|STARTED|Overall Study||60
3384764|NCT04382924|4119909|FG000|COMPLETED|Overall Study||44
3384765|NCT04382924|4119910|FG001|COMPLETED|Overall Study||46
3384766|NCT04382924|4119911|FG002|COMPLETED|Overall Study||48
3384767|NCT04382924|4119909|FG000|NOT COMPLETED|Overall Study||8
3384768|NCT04382924|4119910|FG001|NOT COMPLETED|Overall Study||10
3384769|NCT04382924|4119911|FG002|NOT COMPLETED|Overall Study||12
3384770|NCT04166214|4119921|FG000|STARTED|Overall Study||12
3384771|NCT04166214|4119922|FG001|STARTED|Overall Study||39
3384772|NCT04166214|4119921|FG000|COMPLETED|Overall Study||12
3384773|NCT04166214|4119922|FG001|COMPLETED|Overall Study||39
3384774|NCT04166214|4119921|FG000|NOT COMPLETED|Overall Study||0
3384775|NCT04166214|4119922|FG001|NOT COMPLETED|Overall Study||0
3384776|NCT03947788|4119930|FG000|STARTED|Overall Study||69
3384777|NCT03947788|4119931|FG001|STARTED|Overall Study||74
3384778|NCT03947788|4119930|FG000|COMPLETED|Overall Study||69
3384779|NCT03947788|4119931|FG001|COMPLETED|Overall Study||74
3384780|NCT03947788|4119930|FG000|NOT COMPLETED|Overall Study||0
3384781|NCT03947788|4119931|FG001|NOT COMPLETED|Overall Study||0
3384782|NCT03842436|4119942|FG000|STARTED|Overall Study||16
3384783|NCT03842436|4119942|FG000|COMPLETED|Overall Study||15
3384784|NCT03842436|4119942|FG000|NOT COMPLETED|Overall Study||1
3384785|NCT03646162|4119949|FG000|STARTED|Overall Study||31
3384786|NCT03646162|4119950|FG001|STARTED|Overall Study||31
3384787|NCT03646162|4119951|FG002|STARTED|Overall Study||31
3171654|NCT01936181|3898808|FG000|NOT COMPLETED|Randomised, Double-blind||64
2910762|NCT00478257|3620287|FG001|NOT COMPLETED|Overall Study||3
2910763|NCT00478335|3620295|FG000|STARTED|Period 1 (4 Days)||2
2910764|NCT00478335|3620296|FG001|STARTED|Period 1 (4 Days)||2
2910765|NCT00478335|3620295|FG000|COMPLETED|Period 1 (4 Days)||2
2910766|NCT00478335|3620296|FG001|COMPLETED|Period 1 (4 Days)||2
2910767|NCT00478335|3620295|FG000|NOT COMPLETED|Period 1 (4 Days)||0
2910768|NCT00478335|3620296|FG001|NOT COMPLETED|Period 1 (4 Days)||0
2910769|NCT00478335|3620295|FG000|STARTED|Period 2 (4 Days)||2
2910770|NCT00478335|3620296|FG001|STARTED|Period 2 (4 Days)||2
2910771|NCT00478335|3620295|FG000|COMPLETED|Period 2 (4 Days)||2
2910772|NCT00478335|3620296|FG001|COMPLETED|Period 2 (4 Days)||2
2910773|NCT00478335|3620295|FG000|NOT COMPLETED|Period 2 (4 Days)||0
2910774|NCT00478335|3620296|FG001|NOT COMPLETED|Period 2 (4 Days)||0
2910775|NCT00478361|3620302|FG000|STARTED|Overall Study||39
2910776|NCT00478361|3620302|FG000|COMPLETED|Overall Study||39
2910777|NCT00478361|3620302|FG000|NOT COMPLETED|Overall Study||0
2910778|NCT00478426|3620306|FG000|STARTED|Overall Study||34
2910779|NCT00478426|3620306|FG000|COMPLETED|Overall Study||33
2910780|NCT00478426|3620306|FG000|NOT COMPLETED|Overall Study||1
2910781|NCT00478556|3620312|FG000|STARTED|Overall Study||151
2910782|NCT00478556|3620313|FG001|STARTED|Overall Study||149
2910783|NCT00478556|3620312|FG000|COMPLETED|Overall Study||151
2910784|NCT00478556|3620313|FG001|COMPLETED|Overall Study||149
2910785|NCT00478556|3620312|FG000|NOT COMPLETED|Overall Study||0
2910786|NCT00478556|3620313|FG001|NOT COMPLETED|Overall Study||0
2910787|NCT00478569|3620319|FG000|STARTED|Overall Study||1170
3384788|NCT03646162|4119949|FG000|COMPLETED|Overall Study||26
3384789|NCT03646162|4119950|FG001|COMPLETED|Overall Study||27
3384790|NCT03646162|4119951|FG002|COMPLETED|Overall Study||30
3384791|NCT03646162|4119949|FG000|NOT COMPLETED|Overall Study||5
3384792|NCT03646162|4119950|FG001|NOT COMPLETED|Overall Study||4
3384793|NCT03646162|4119951|FG002|NOT COMPLETED|Overall Study||1
3384794|NCT03462030|4119963|FG000|STARTED|Overall Study||15
3384795|NCT03462030|4119964|FG001|STARTED|Overall Study||15
3384796|NCT03462030|4119963|FG000|End of Build-up|Overall Study||14
3384797|NCT03462030|4119964|FG001|End of Build-up|Overall Study||14
3384798|NCT03462030|4119963|FG000|Month 12 Food Challenge|Overall Study||14
3384799|NCT03462030|4119964|FG001|Month 12 Food Challenge|Overall Study||14
3384800|NCT03462030|4119963|FG000|COMPLETED|Overall Study||14
3384801|NCT03462030|4119964|FG001|COMPLETED|Overall Study||14
3384802|NCT03462030|4119963|FG000|NOT COMPLETED|Overall Study||1
3384803|NCT03462030|4119964|FG001|NOT COMPLETED|Overall Study||1
3384804|NCT03446768|4119972|FG000|STARTED|Overall Study||141
3384805|NCT03446768|4119973|FG001|STARTED|Overall Study||153
3384806|NCT03446768|4119972|FG000|COMPLETED|Overall Study||141
3384807|NCT03446768|4119973|FG001|COMPLETED|Overall Study||152
3384808|NCT03446768|4119972|FG000|NOT COMPLETED|Overall Study||0
3384809|NCT03446768|4119973|FG001|NOT COMPLETED|Overall Study||1
3384810|NCT03405714|4119983|FG000|STARTED|Overall Study||12
3384811|NCT03405714|4119984|FG001|STARTED|Overall Study||12
3384812|NCT03405714|4119985|FG002|STARTED|Overall Study||13
3384813|NCT03405714|4119986|FG003|STARTED|Overall Study||13
3384814|NCT03405714|4119983|FG000|COMPLETED|Overall Study||12
3384815|NCT03405714|4119984|FG001|COMPLETED|Overall Study||12
3384816|NCT03405714|4119985|FG002|COMPLETED|Overall Study||13
3384817|NCT03405714|4119986|FG003|COMPLETED|Overall Study||13
3384818|NCT03405714|4119983|FG000|NOT COMPLETED|Overall Study||0
3384819|NCT03405714|4119984|FG001|NOT COMPLETED|Overall Study||0
3384820|NCT03405714|4119985|FG002|NOT COMPLETED|Overall Study||0
3384821|NCT03405714|4119986|FG003|NOT COMPLETED|Overall Study||0
3384822|NCT03348514|4120010|FG000|STARTED|Overall Study||1
3384823|NCT03348514|4120011|FG001|STARTED|Overall Study||1
3384824|NCT03348514|4120012|FG002|STARTED|Overall Study||1
3384825|NCT03348514|4120013|FG003|STARTED|Overall Study||1
3384826|NCT03348514|4120014|FG004|STARTED|Overall Study||3
3384827|NCT03348514|4120015|FG005|STARTED|Overall Study||4
3384828|NCT03348514|4120016|FG006|STARTED|Overall Study||6
3384829|NCT03348514|4120017|FG007|STARTED|Overall Study||2
3384830|NCT03348514|4120010|FG000|COMPLETED|Overall Study||1
3384831|NCT03348514|4120011|FG001|COMPLETED|Overall Study||1
3384832|NCT03348514|4120012|FG002|COMPLETED|Overall Study||1
3384833|NCT03348514|4120013|FG003|COMPLETED|Overall Study||1
3384834|NCT03348514|4120014|FG004|COMPLETED|Overall Study||3
3384835|NCT03348514|4120015|FG005|COMPLETED|Overall Study||4
3384836|NCT03348514|4120016|FG006|COMPLETED|Overall Study||6
3384837|NCT03348514|4120017|FG007|COMPLETED|Overall Study||2
3384838|NCT03348514|4120010|FG000|NOT COMPLETED|Overall Study||0
3384839|NCT03348514|4120011|FG001|NOT COMPLETED|Overall Study||0
3384840|NCT03348514|4120012|FG002|NOT COMPLETED|Overall Study||0
3384841|NCT03348514|4120013|FG003|NOT COMPLETED|Overall Study||0
3384842|NCT03348514|4120014|FG004|NOT COMPLETED|Overall Study||0
3384843|NCT03348514|4120015|FG005|NOT COMPLETED|Overall Study||0
3384844|NCT03348514|4120016|FG006|NOT COMPLETED|Overall Study||0
3384845|NCT03348514|4120017|FG007|NOT COMPLETED|Overall Study||0
3384846|NCT03253393|4120041|FG000|STARTED|First Intervention||12
3384847|NCT03253393|4120042|FG001|STARTED|First Intervention||13
3384848|NCT03253393|4120043|FG002|STARTED|First Intervention||0
3384849|NCT03253393|4120041|FG000|COMPLETED|First Intervention||12
3384850|NCT03253393|4120042|FG001|COMPLETED|First Intervention||13
3384851|NCT03253393|4120043|FG002|COMPLETED|First Intervention||0
3384852|NCT03253393|4120041|FG000|NOT COMPLETED|First Intervention||0
2910788|NCT00478569|3620319|FG000|COMPLETED|Overall Study||761
2910789|NCT00478569|3620319|FG000|NOT COMPLETED|Overall Study||409
2910790|NCT00478608|3620331|FG000|STARTED|Overall Study||79
2910791|NCT00478608|3620331|FG000|COMPLETED|Overall Study||59
2910792|NCT00478608|3620331|FG000|NOT COMPLETED|Overall Study||20
2910793|NCT00478647|3620335|FG000|STARTED|Overall Study||40
2910794|NCT00478647|3620335|FG000|COMPLETED|Overall Study|Intent-to-Treat (ITT)=participants who have received at least 1 full or partial dose of study drug.|38
2910795|NCT00478647|3620335|FG000|NOT COMPLETED|Overall Study||2
2910796|NCT00478673|3620339|FG000|STARTED|30-Days Post-Procedure||298
2910797|NCT00478673|3620339|FG000|COMPLETED|30-Days Post-Procedure|"7 participants who did not complete this Period due to Missed Visit still continued on to Period 2"|288
2910798|NCT00478673|3620339|FG000|NOT COMPLETED|30-Days Post-Procedure||10
2910799|NCT00478673|3620339|FG000|STARTED|12-Months Post-Procedure|3 participants who did not complete Period 1 due to death (2) and withdrawal (1) are not included.|295
2910800|NCT00478673|3620339|FG000|COMPLETED|12-Months Post-Procedure||231
2910801|NCT00478673|3620339|FG000|NOT COMPLETED|12-Months Post-Procedure||64
2910802|NCT00478777|3620343|FG000|STARTED|Overall Study||150
2910803|NCT00478777|3620343|FG000|Safety and Full Analysis Set (FAS)|Overall Study|6 enrolled participants did not receive lenalidomide.|144
2910804|NCT00478777|3620343|FG000|COMPLETED|Overall Study|10 participants had >= 6 months and 63 participants < 6 months treatment prior to study termination.|73
2910805|NCT00478777|3620343|FG000|NOT COMPLETED|Overall Study||77
2910806|NCT00478881|3620349|FG000|STARTED|Overall Study||199
2910807|NCT00478881|3620350|FG001|STARTED|Overall Study||198
2910808|NCT00478881|3620349|FG000|Received Medication|Overall Study||198
2910809|NCT00478881|3620350|FG001|Received Medication|Overall Study||198
2910810|NCT00478881|3620349|FG000|COMPLETED|Overall Study||160
2910811|NCT00478881|3620350|FG001|COMPLETED|Overall Study||176
2910812|NCT00478881|3620349|FG000|NOT COMPLETED|Overall Study||39
2910813|NCT00478881|3620350|FG001|NOT COMPLETED|Overall Study||22
2910814|NCT00478933|3620356|FG000|STARTED|Overall Study||1223
2910815|NCT00478933|3620356|FG000|COMPLETED|Overall Study||1145
2910816|NCT00478933|3620356|FG000|NOT COMPLETED|Overall Study||78
2920583|NCT00537407|3631085|FG003|STARTED|Part 2 Weeks 5-48 or 72||10
2920584|NCT00537407|3631086|FG004|STARTED|Part 2 Weeks 5-48 or 72||10
2920585|NCT00537407|3631082|FG000|COMPLETED|Part 2 Weeks 5-48 or 72||2
2920586|NCT00537407|3631083|FG001|COMPLETED|Part 2 Weeks 5-48 or 72||1
2920587|NCT00537407|3631084|FG002|COMPLETED|Part 2 Weeks 5-48 or 72||2
2920588|NCT00537407|3631085|FG003|COMPLETED|Part 2 Weeks 5-48 or 72||4
3171655|NCT01936181|3898809|FG001|NOT COMPLETED|Randomised, Double-blind||68
3171656|NCT01936181|3898810|FG002|NOT COMPLETED|Randomised, Double-blind||0
3171657|NCT01936181|3898811|FG003|NOT COMPLETED|Randomised, Double-blind||0
3171658|NCT01936181|3898808|FG000|STARTED|Transition-extension||201
3171659|NCT01936181|3898809|FG001|STARTED|Transition-extension||0
3171660|NCT01936181|3898810|FG002|STARTED|Transition-extension||94
3171661|NCT01936181|3898811|FG003|STARTED|Transition-extension||101
3384853|NCT03253393|4120042|FG001|NOT COMPLETED|First Intervention||0
3384854|NCT03253393|4120043|FG002|NOT COMPLETED|First Intervention||0
3384855|NCT03253393|4120041|FG000|STARTED|Washout (Minimum 48 Hours)||12
3384856|NCT03253393|4120042|FG001|STARTED|Washout (Minimum 48 Hours)||13
3384857|NCT03253393|4120043|FG002|STARTED|Washout (Minimum 48 Hours)|Participants in this group were only assigned to one visit/intervention|0
3384858|NCT03253393|4120041|FG000|COMPLETED|Washout (Minimum 48 Hours)||12
3384859|NCT03253393|4120042|FG001|COMPLETED|Washout (Minimum 48 Hours)||13
3384860|NCT03253393|4120043|FG002|COMPLETED|Washout (Minimum 48 Hours)|Participants in this group were only assigned to one visit/intervention|0
3384861|NCT03253393|4120041|FG000|NOT COMPLETED|Washout (Minimum 48 Hours)||0
3384862|NCT03253393|4120042|FG001|NOT COMPLETED|Washout (Minimum 48 Hours)||0
3384863|NCT03253393|4120043|FG002|NOT COMPLETED|Washout (Minimum 48 Hours)||0
3384864|NCT03253393|4120041|FG000|STARTED|Second Intervention||12
3171662|NCT01936181|3898808|FG000|COMPLETED|Transition-extension||186
3384865|NCT03253393|4120042|FG001|STARTED|Second Intervention||13
3384866|NCT03253393|4120043|FG002|STARTED|Second Intervention|Participants in this group were only assigned to one visit/intervention|0
3384867|NCT03253393|4120041|FG000|COMPLETED|Second Intervention||12
3384868|NCT03253393|4120042|FG001|COMPLETED|Second Intervention||13
3384869|NCT03253393|4120043|FG002|COMPLETED|Second Intervention|Participants in this group were only assigned to one visit/intervention|0
3384870|NCT03253393|4120041|FG000|NOT COMPLETED|Second Intervention||0
3384871|NCT03253393|4120042|FG001|NOT COMPLETED|Second Intervention||0
3384872|NCT03253393|4120043|FG002|NOT COMPLETED|Second Intervention||0
3384873|NCT03253393|4120041|FG000|STARTED|Washout (Minimum 48 Hours)||12
3384874|NCT03253393|4120042|FG001|STARTED|Washout (Minimum 48 Hours)||13
3384875|NCT03253393|4120043|FG002|STARTED|Washout (Minimum 48 Hours)|Participants in this group were only assigned to one visit/intervention|0
3384876|NCT03253393|4120041|FG000|COMPLETED|Washout (Minimum 48 Hours)||6
3384877|NCT03253393|4120042|FG001|COMPLETED|Washout (Minimum 48 Hours)||6
3384878|NCT03253393|4120043|FG002|COMPLETED|Washout (Minimum 48 Hours)|Participants in this group were only assigned to one visit/intervention|0
3384879|NCT03253393|4120041|FG000|NOT COMPLETED|Washout (Minimum 48 Hours)||6
3384880|NCT03253393|4120042|FG001|NOT COMPLETED|Washout (Minimum 48 Hours)||7
3384881|NCT03253393|4120043|FG002|NOT COMPLETED|Washout (Minimum 48 Hours)||0
3384882|NCT03253393|4120041|FG000|STARTED|Third Intervention||6
3384883|NCT03253393|4120042|FG001|STARTED|Third Intervention||6
3384884|NCT03253393|4120043|FG002|STARTED|Third Intervention|Participants in this group were only assigned to one visit/intervention|13
3384885|NCT03253393|4120041|FG000|COMPLETED|Third Intervention||6
3384886|NCT03253393|4120042|FG001|COMPLETED|Third Intervention||6
2910817|NCT00479037|3620382|FG000|STARTED|Overall Study||41
2910818|NCT00479037|3620383|FG001|STARTED|Overall Study||40
2910819|NCT00479037|3620382|FG000|COMPLETED|Overall Study||38
2910820|NCT00479037|3620383|FG001|COMPLETED|Overall Study||34
2910821|NCT00479037|3620382|FG000|NOT COMPLETED|Overall Study||3
2910822|NCT00479037|3620383|FG001|NOT COMPLETED|Overall Study||6
2910823|NCT00479089|3620391|FG000|STARTED|Overall Study||25
2910824|NCT00479089|3620392|FG001|STARTED|Overall Study||25
2910825|NCT00479089|3620391|FG000|COMPLETED|Overall Study||25
2910826|NCT00479089|3620392|FG001|COMPLETED|Overall Study||25
2910827|NCT00479089|3620391|FG000|NOT COMPLETED|Overall Study||0
2910828|NCT00479089|3620392|FG001|NOT COMPLETED|Overall Study||0
2910829|NCT00479115|3620398|FG000|STARTED|Overall Study||1
2910830|NCT00479115|3620398|FG000|COMPLETED|Overall Study||1
2910831|NCT00479115|3620398|FG000|NOT COMPLETED|Overall Study||0
2910832|NCT00479154|3620404|FG000|STARTED|Overall Study||3
2910833|NCT00479154|3620405|FG001|STARTED|Overall Study||3
2910834|NCT00479154|3620404|FG000|COMPLETED|Overall Study||3
2910835|NCT00479154|3620405|FG001|COMPLETED|Overall Study||3
2910836|NCT00479154|3620404|FG000|NOT COMPLETED|Overall Study||0
2910837|NCT00479154|3620405|FG001|NOT COMPLETED|Overall Study||0
2910838|NCT00479232|3620413|FG000|STARTED|Overall Study||3
3384887|NCT03253393|4120043|FG002|COMPLETED|Third Intervention|Participants in this group were only assigned to one visit/intervention|13
3384888|NCT03253393|4120041|FG000|NOT COMPLETED|Third Intervention||0
3384889|NCT03253393|4120042|FG001|NOT COMPLETED|Third Intervention||0
3384890|NCT03253393|4120043|FG002|NOT COMPLETED|Third Intervention||0
3384891|NCT03188822|4120057|FG000|STARTED|Overall Study||9
3384892|NCT03188822|4120057|FG000|COMPLETED|Overall Study||2
3384893|NCT03188822|4120057|FG000|NOT COMPLETED|Overall Study||7
3384894|NCT03128671|4120063|FG000|STARTED|Enrollment||89
3384895|NCT03128671|4120064|FG001|STARTED|Enrollment||89
3384896|NCT03128671|4120063|FG000|COMPLETED|Enrollment||89
3384897|NCT03128671|4120064|FG001|COMPLETED|Enrollment||89
3384898|NCT03128671|4120063|FG000|NOT COMPLETED|Enrollment||0
3384899|NCT03128671|4120064|FG001|NOT COMPLETED|Enrollment||0
3384900|NCT03128671|4120063|FG000|STARTED|Allocation||89
3384901|NCT03128671|4120064|FG001|STARTED|Allocation||89
3384902|NCT03128671|4120063|FG000|COMPLETED|Allocation||80
3384903|NCT03128671|4120064|FG001|COMPLETED|Allocation||89
3384904|NCT03128671|4120063|FG000|NOT COMPLETED|Allocation||9
3384905|NCT03128671|4120064|FG001|NOT COMPLETED|Allocation||0
3384906|NCT03128671|4120063|FG000|STARTED|Intervention||80
3384907|NCT03128671|4120064|FG001|STARTED|Intervention||89
3384908|NCT03128671|4120063|FG000|COMPLETED|Intervention||44
3384909|NCT03128671|4120064|FG001|COMPLETED|Intervention||55
3384910|NCT03128671|4120063|FG000|NOT COMPLETED|Intervention||36
3384911|NCT03128671|4120064|FG001|NOT COMPLETED|Intervention||34
3384912|NCT03111732|4120070|FG000|STARTED|Overall Study||11
3384913|NCT03111732|4120070|FG000|COMPLETED|Overall Study||6
3384914|NCT03111732|4120070|FG000|NOT COMPLETED|Overall Study||5
3384915|NCT03065244|4120081|FG000|STARTED|Overall Study||50
3384916|NCT03065244|4120082|FG001|STARTED|Overall Study||55
3384917|NCT03065244|4120081|FG000|Participants Who Failed 1st Treatment and Crossed Over to Receive Other Treatment|Overall Study||22
3384918|NCT03065244|4120082|FG001|Participants Who Failed 1st Treatment and Crossed Over to Receive Other Treatment|Overall Study||9
3384919|NCT03065244|4120081|FG000|COMPLETED|Overall Study||47
3384920|NCT03065244|4120082|FG001|COMPLETED|Overall Study||51
3384921|NCT03065244|4120081|FG000|NOT COMPLETED|Overall Study||3
3384922|NCT03065244|4120082|FG001|NOT COMPLETED|Overall Study||4
3384923|NCT02879305|4120090|FG000|STARTED|Overall Study||1487
3384924|NCT02879305|4120091|FG001|STARTED|Overall Study||1477
3384925|NCT02879305|4120090|FG000|COMPLETED|Overall Study||1370
3384926|NCT02879305|4120091|FG001|COMPLETED|Overall Study||1366
3384927|NCT02879305|4120090|FG000|NOT COMPLETED|Overall Study||117
3384928|NCT02879305|4120091|FG001|NOT COMPLETED|Overall Study||111
3384929|NCT02816736|4120099|FG000|STARTED|Overall Study||179
3384930|NCT02816736|4120100|FG001|STARTED|Overall Study||186
3384931|NCT02816736|4120099|FG000|COMPLETED|Overall Study||164
3384932|NCT02816736|4120100|FG001|COMPLETED|Overall Study||166
3384933|NCT02816736|4120099|FG000|NOT COMPLETED|Overall Study||15
3384934|NCT02816736|4120100|FG001|NOT COMPLETED|Overall Study||20
3384935|NCT02787850|4120108|FG000|STARTED|Overall Study||10
3384936|NCT02787850|4120109|FG001|STARTED|Overall Study||10
3384937|NCT02787850|4120108|FG000|COMPLETED|Overall Study||10
3384938|NCT02787850|4120109|FG001|COMPLETED|Overall Study||9
3384939|NCT02787850|4120108|FG000|NOT COMPLETED|Overall Study||0
3384940|NCT02787850|4120109|FG001|NOT COMPLETED|Overall Study||1
3384941|NCT02713373|4120124|FG000|STARTED|Overall Study||44
3384942|NCT02713373|4120124|FG000|COMPLETED|Overall Study||44
3384943|NCT02713373|4120124|FG000|NOT COMPLETED|Overall Study||0
3384944|NCT02676284|4120128|FG000|STARTED|Overall Study||36
3384945|NCT02676284|4120128|FG000|COMPLETED|Overall Study||35
2910839|NCT00479232|3620414|FG001|STARTED|Overall Study||3
2910840|NCT00479232|3620415|FG002|STARTED|Overall Study||28
2910841|NCT00479232|3620416|FG003|STARTED|Overall Study||3
2910842|NCT00479232|3620417|FG004|STARTED|Overall Study||4
3384946|NCT02676284|4120128|FG000|NOT COMPLETED|Overall Study||1
3384947|NCT02632409|4120134|FG000|STARTED|Randomized||356
3384948|NCT02632409|4120135|FG001|STARTED|Randomized||353
2910843|NCT00479232|3620418|FG005|STARTED|Overall Study||30
2910844|NCT00479232|3620413|FG000|COMPLETED|Overall Study||0
2910845|NCT00479232|3620414|FG001|COMPLETED|Overall Study||0
2910846|NCT00479232|3620415|FG002|COMPLETED|Overall Study||0
2910847|NCT00479232|3620416|FG003|COMPLETED|Overall Study||0
2910848|NCT00479232|3620417|FG004|COMPLETED|Overall Study||0
2910849|NCT00479232|3620418|FG005|COMPLETED|Overall Study||0
3384949|NCT02632409|4120134|FG000|COMPLETED|Randomized||348
3384950|NCT02632409|4120135|FG001|COMPLETED|Randomized||351
3384951|NCT02632409|4120134|FG000|NOT COMPLETED|Randomized||8
3384952|NCT02632409|4120135|FG001|NOT COMPLETED|Randomized||2
3384953|NCT02632409|4120134|FG000|STARTED|Treatment Period||348
3384954|NCT02632409|4120135|FG001|STARTED|Treatment Period||351
3384955|NCT02632409|4120134|FG000|COMPLETED|Treatment Period||132
3384956|NCT02632409|4120135|FG001|COMPLETED|Treatment Period||143
3384957|NCT02632409|4120134|FG000|NOT COMPLETED|Treatment Period||216
3384958|NCT02632409|4120135|FG001|NOT COMPLETED|Treatment Period||208
3384959|NCT02516241|4120144|FG000|STARTED|Overall Study||342
3384960|NCT02516241|4120145|FG001|STARTED|Overall Study||346
3384961|NCT02516241|4120146|FG002|STARTED|Overall Study||344
3384962|NCT02516241|4120144|FG000|Received Treatment|Overall Study||340
3384963|NCT02516241|4120145|FG001|Received Treatment|Overall Study||345
3384964|NCT02516241|4120146|FG002|Received Treatment|Overall Study||313
3384965|NCT02516241|4120144|FG000|COMPLETED|Overall Study||0
3384966|NCT02516241|4120145|FG001|COMPLETED|Overall Study||0
3384967|NCT02516241|4120146|FG002|COMPLETED|Overall Study||0
3384968|NCT02516241|4120144|FG000|NOT COMPLETED|Overall Study||342
3384969|NCT02516241|4120145|FG001|NOT COMPLETED|Overall Study||346
3384970|NCT02516241|4120146|FG002|NOT COMPLETED|Overall Study||344
3386463|NCT01460160|4121804|FG000|STARTED|Treatment Phase||106
3386464|NCT01460160|4121804|FG000|COMPLETED|Treatment Phase||78
3386465|NCT01460160|4121804|FG000|NOT COMPLETED|Treatment Phase||28
3386466|NCT01460160|4121804|FG000|STARTED|Follow-up Phase|Some of the participants who did not completed the Treatment Phase were still moved to the Follow-up Phase|100
3386467|NCT01460160|4121804|FG000|COMPLETED|Follow-up Phase||0
3386468|NCT01460160|4121804|FG000|NOT COMPLETED|Follow-up Phase||100
3386469|NCT01413399|4121810|FG000|STARTED|Overall Study||208
3386470|NCT01413399|4121811|FG001|STARTED|Overall Study||334
3386471|NCT01413399|4121810|FG000|COMPLETED|Overall Study||208
3386472|NCT01413399|4121811|FG001|COMPLETED|Overall Study||334
3386473|NCT01413399|4121810|FG000|NOT COMPLETED|Overall Study||0
3386474|NCT01413399|4121811|FG001|NOT COMPLETED|Overall Study||0
3386475|NCT01170702|4121821|FG000|STARTED|Overall Study||34
3386476|NCT01170702|4121822|FG001|STARTED|Overall Study||32
3386477|NCT01170702|4121823|FG002|STARTED|Overall Study||25
3386478|NCT01170702|4121824|FG003|STARTED|Overall Study||29
3386479|NCT01170702|4121821|FG000|COMPLETED|Overall Study||33
3386480|NCT01170702|4121822|FG001|COMPLETED|Overall Study||30
3386481|NCT01170702|4121823|FG002|COMPLETED|Overall Study||25
3386482|NCT01170702|4121824|FG003|COMPLETED|Overall Study||27
3386483|NCT01170702|4121821|FG000|NOT COMPLETED|Overall Study||1
3386484|NCT01170702|4121822|FG001|NOT COMPLETED|Overall Study||2
3386485|NCT01170702|4121823|FG002|NOT COMPLETED|Overall Study||0
3386486|NCT01170702|4121824|FG003|NOT COMPLETED|Overall Study||2
3386487|NCT01018563|4121834|FG000|STARTED|Overall Study||2
3386488|NCT01018563|4121835|FG001|STARTED|Overall Study||1
3386489|NCT01018563|4121834|FG000|COMPLETED|Overall Study||0
3386490|NCT01018563|4121835|FG001|COMPLETED|Overall Study||0
3386491|NCT01018563|4121834|FG000|NOT COMPLETED|Overall Study||2
3386492|NCT01018563|4121835|FG001|NOT COMPLETED|Overall Study||1
3386493|NCT00805961|4121845|FG000|STARTED|Modality Therapy||68
3386494|NCT00805961|4121845|FG000|COMPLETED|Modality Therapy||64
3386495|NCT00805961|4121845|FG000|NOT COMPLETED|Modality Therapy||4
3386496|NCT00805961|4121845|FG000|STARTED|Treatment-Free Interval||64
3386497|NCT00805961|4121845|FG000|COMPLETED|Treatment-Free Interval||57
3386498|NCT00805961|4121845|FG000|NOT COMPLETED|Treatment-Free Interval||7
3386499|NCT00805961|4121845|FG000|STARTED|Maintenance Treatment||57
3386500|NCT00805961|4121845|FG000|COMPLETED|Maintenance Treatment||23
3386501|NCT00805961|4121845|FG000|NOT COMPLETED|Maintenance Treatment||34
3386774|NCT01047319|4122120|FG001|STARTED|Overall Study||350
3386775|NCT01047319|4122121|FG002|STARTED|Overall Study||352
3386776|NCT01047319|4122119|FG000|COMPLETED|Overall Study||0
3386777|NCT01047319|4122120|FG001|COMPLETED|Overall Study||0
3386778|NCT01047319|4122121|FG002|COMPLETED|Overall Study||0
3386779|NCT01047319|4122119|FG000|NOT COMPLETED|Overall Study||345
3386780|NCT01047319|4122120|FG001|NOT COMPLETED|Overall Study||350
3386781|NCT01047319|4122121|FG002|NOT COMPLETED|Overall Study||352
3386782|NCT00988052|4122131|FG000|STARTED|Overall Study||423
3386783|NCT00988052|4122132|FG001|STARTED|Overall Study||416
3386784|NCT00988052|4122131|FG000|COMPLETED|Overall Study||0
3386785|NCT00988052|4122132|FG001|COMPLETED|Overall Study||0
3386786|NCT00988052|4122131|FG000|NOT COMPLETED|Overall Study||423
3386787|NCT00988052|4122132|FG001|NOT COMPLETED|Overall Study||416
3386788|NCT00861705|4122142|FG000|STARTED|Overall Study||115
3386789|NCT00861705|4122143|FG001|STARTED|Overall Study||113
3386790|NCT00861705|4122144|FG002|STARTED|Overall Study||113
3386791|NCT00861705|4122145|FG003|STARTED|Overall Study||113
3386792|NCT00861705|4122142|FG000|COMPLETED|Overall Study||108
3386793|NCT00861705|4122143|FG001|COMPLETED|Overall Study||110
3386794|NCT00861705|4122144|FG002|COMPLETED|Overall Study||113
2910850|NCT00479232|3620413|FG000|NOT COMPLETED|Overall Study||3
2910851|NCT00479232|3620414|FG001|NOT COMPLETED|Overall Study||3
2910852|NCT00479232|3620415|FG002|NOT COMPLETED|Overall Study||28
3386795|NCT00861705|4122145|FG003|COMPLETED|Overall Study||112
3386796|NCT00861705|4122142|FG000|NOT COMPLETED|Overall Study||7
3386797|NCT00861705|4122143|FG001|NOT COMPLETED|Overall Study||3
2910853|NCT00479232|3620416|FG003|NOT COMPLETED|Overall Study||3
2910854|NCT00479232|3620417|FG004|NOT COMPLETED|Overall Study||4
2910855|NCT00479232|3620418|FG005|NOT COMPLETED|Overall Study||30
2910856|NCT00479336|3620440|FG000|STARTED|Overall Study||27
2910857|NCT00479336|3620441|FG001|STARTED|Overall Study||26
2910858|NCT00479336|3620442|FG002|STARTED|Overall Study||25
2910859|NCT00479336|3620443|FG003|STARTED|Overall Study||26
2910860|NCT00479336|3620440|FG000|COMPLETED|Overall Study||23
2910861|NCT00479336|3620441|FG001|COMPLETED|Overall Study||20
2910862|NCT00479336|3620442|FG002|COMPLETED|Overall Study||24
2910863|NCT00479336|3620443|FG003|COMPLETED|Overall Study||21
2910864|NCT00479336|3620440|FG000|NOT COMPLETED|Overall Study||4
2910865|NCT00479336|3620441|FG001|NOT COMPLETED|Overall Study||6
2910866|NCT00479336|3620442|FG002|NOT COMPLETED|Overall Study||1
2910867|NCT00479336|3620443|FG003|NOT COMPLETED|Overall Study||5
2910868|NCT00479388|3620455|FG000|STARTED|Overall Study||606
2910869|NCT00479388|3620456|FG001|STARTED|Overall Study||610
2910870|NCT00479388|3620455|FG000|COMPLETED|Overall Study||474
2910871|NCT00479388|3620456|FG001|COMPLETED|Overall Study||537
2910872|NCT00479388|3620455|FG000|NOT COMPLETED|Overall Study||132
2910873|NCT00479388|3620456|FG001|NOT COMPLETED|Overall Study||73
2910874|NCT00479401|3620465|FG000|STARTED|Overall Study||223
2910875|NCT00479401|3620466|FG001|STARTED|Overall Study||213
2910876|NCT00479401|3620467|FG002|STARTED|Overall Study||103
2910877|NCT00479401|3620465|FG000|COMPLETED|Overall Study||174
2910878|NCT00479401|3620466|FG001|COMPLETED|Overall Study||176
2910879|NCT00479401|3620467|FG002|COMPLETED|Overall Study||91
2910880|NCT00479401|3620465|FG000|NOT COMPLETED|Overall Study||49
2910881|NCT00479401|3620466|FG001|NOT COMPLETED|Overall Study||37
2910882|NCT00479401|3620467|FG002|NOT COMPLETED|Overall Study||12
2910883|NCT00479466|3620481|FG000|STARTED|Overall Study||57
2910884|NCT00479466|3620482|FG001|STARTED|Overall Study||57
2910885|NCT00479466|3620483|FG002|STARTED|Overall Study||57
2910886|NCT00479466|3620484|FG003|STARTED|Overall Study||58
2910887|NCT00479466|3620485|FG004|STARTED|Overall Study||56
2910888|NCT00479466|3620486|FG005|STARTED|Overall Study||57
2910889|NCT00479466|3620481|FG000|COMPLETED|Overall Study||44
2910890|NCT00479466|3620482|FG001|COMPLETED|Overall Study||49
2910891|NCT00479466|3620483|FG002|COMPLETED|Overall Study||54
2910892|NCT00479466|3620484|FG003|COMPLETED|Overall Study||55
2910893|NCT00479466|3620485|FG004|COMPLETED|Overall Study||48
2910894|NCT00479466|3620486|FG005|COMPLETED|Overall Study||53
2910895|NCT00479466|3620481|FG000|NOT COMPLETED|Overall Study||13
2910896|NCT00479466|3620482|FG001|NOT COMPLETED|Overall Study||8
2910897|NCT00479466|3620483|FG002|NOT COMPLETED|Overall Study||3
2910898|NCT00479466|3620484|FG003|NOT COMPLETED|Overall Study||3
2910899|NCT00479466|3620485|FG004|NOT COMPLETED|Overall Study||8
2910900|NCT00479466|3620486|FG005|NOT COMPLETED|Overall Study||4
2910901|NCT00479557|3620507|FG000|STARTED|Overall Study||36
2910902|NCT00479557|3620508|FG001|STARTED|Overall Study||61
2910903|NCT00479557|3620509|FG002|STARTED|Overall Study||40
2910904|NCT00479557|3620510|FG003|STARTED|Overall Study||35
2910905|NCT00479557|3620511|FG004|STARTED|Overall Study||12
2910906|NCT00479557|3620512|FG005|STARTED|Overall Study||44
2910907|NCT00479557|3620513|FG006|STARTED|Overall Study||17
2910908|NCT00479557|3620507|FG000|Treated|Overall Study||36
2910909|NCT00479557|3620508|FG001|Treated|Overall Study|One participant discontinued due to an AE, with an outcome of death.|60
2910910|NCT00479557|3620509|FG002|Treated|Overall Study||40
3316255|NCT03108027|4049500|FG000|COMPLETED|Period 3||7
3316256|NCT03108027|4049501|FG001|COMPLETED|Period 3||5
3316257|NCT03108027|4049502|FG002|COMPLETED|Period 3||6
3316258|NCT03108027|4049503|FG003|COMPLETED|Period 3||4
3316259|NCT03108027|4049504|FG004|COMPLETED|Period 3||6
3316260|NCT03108027|4049505|FG005|COMPLETED|Period 3||6
3316261|NCT03108027|4049500|FG000|NOT COMPLETED|Period 3||0
3316262|NCT03108027|4049501|FG001|NOT COMPLETED|Period 3||1
3316263|NCT03108027|4049502|FG002|NOT COMPLETED|Period 3||0
3316264|NCT03108027|4049503|FG003|NOT COMPLETED|Period 3||0
3316265|NCT03108027|4049504|FG004|NOT COMPLETED|Period 3||0
3316266|NCT03108027|4049505|FG005|NOT COMPLETED|Period 3||0
3316267|NCT03108157|4049515|FG000|STARTED|Overall Study||176
3384971|NCT02431702|4120159|FG000|STARTED|Part 1: 2-Month Oral Run-in Phase||273
3384972|NCT02431702|4120160|FG001|STARTED|Part 1: 2-Month Oral Run-in Phase||0
3384973|NCT02431702|4120161|FG002|STARTED|Part 1: 2-Month Oral Run-in Phase||0
3384974|NCT02431702|4120162|FG003|STARTED|Part 1: 2-Month Oral Run-in Phase||0
3384975|NCT02431702|4120163|FG004|STARTED|Part 1: 2-Month Oral Run-in Phase||0
3384976|NCT02431702|4120164|FG005|STARTED|Part 1: 2-Month Oral Run-in Phase||0
3384977|NCT02431702|4120165|FG006|STARTED|Part 1: 2-Month Oral Run-in Phase||64
3384978|NCT02431702|4120159|FG000|COMPLETED|Part 1: 2-Month Oral Run-in Phase||239
2910911|NCT00479557|3620510|FG003|Treated|Overall Study||35
2910912|NCT00479557|3620511|FG004|Treated|Overall Study||12
2910913|NCT00479557|3620512|FG005|Treated|Overall Study||44
2910914|NCT00479557|3620513|FG006|Treated|Overall Study||17
2910915|NCT00479557|3620507|FG000|COMPLETED|Overall Study||26
2910916|NCT00479557|3620508|FG001|COMPLETED|Overall Study||51
2910917|NCT00479557|3620509|FG002|COMPLETED|Overall Study||32
2910918|NCT00479557|3620510|FG003|COMPLETED|Overall Study||30
2910919|NCT00479557|3620511|FG004|COMPLETED|Overall Study||8
2910920|NCT00479557|3620512|FG005|COMPLETED|Overall Study||31
2910921|NCT00479557|3620513|FG006|COMPLETED|Overall Study||15
2910922|NCT00479557|3620507|FG000|NOT COMPLETED|Overall Study||10
3316268|NCT03108157|4049516|FG001|STARTED|Overall Study||176
2910923|NCT00479557|3620508|FG001|NOT COMPLETED|Overall Study||10
2910924|NCT00479557|3620509|FG002|NOT COMPLETED|Overall Study||8
2910925|NCT00479557|3620510|FG003|NOT COMPLETED|Overall Study||5
2910926|NCT00479557|3620511|FG004|NOT COMPLETED|Overall Study||4
2910927|NCT00479557|3620512|FG005|NOT COMPLETED|Overall Study||13
2910928|NCT00479557|3620513|FG006|NOT COMPLETED|Overall Study||2
2910929|NCT00479674|3620535|FG000|STARTED|Overall Study||41
2910930|NCT00479674|3620535|FG000|COMPLETED|Overall Study||0
2910931|NCT00479674|3620535|FG000|NOT COMPLETED|Overall Study||41
2910932|NCT00479687|3620541|FG000|STARTED|Ph 1: Blinded, Randomized, Controlled||150
2910933|NCT00479687|3620542|FG001|STARTED|Ph 1: Blinded, Randomized, Controlled||150
2910934|NCT00479687|3620543|FG002|STARTED|Ph 1: Blinded, Randomized, Controlled||0
2910935|NCT00479687|3620541|FG000|COMPLETED|Ph 1: Blinded, Randomized, Controlled||125
2910936|NCT00479687|3620542|FG001|COMPLETED|Ph 1: Blinded, Randomized, Controlled||131
2910937|NCT00479687|3620543|FG002|COMPLETED|Ph 1: Blinded, Randomized, Controlled||0
2910938|NCT00479687|3620541|FG000|NOT COMPLETED|Ph 1: Blinded, Randomized, Controlled||25
2910939|NCT00479687|3620542|FG001|NOT COMPLETED|Ph 1: Blinded, Randomized, Controlled||19
2910940|NCT00479687|3620543|FG002|NOT COMPLETED|Ph 1: Blinded, Randomized, Controlled||0
2910941|NCT00479687|3620541|FG000|STARTED|Ph 2: Open Label, Single (Supartz) Arm||0
2910942|NCT00479687|3620542|FG001|STARTED|Ph 2: Open Label, Single (Supartz) Arm||0
2910943|NCT00479687|3620543|FG002|STARTED|Ph 2: Open Label, Single (Supartz) Arm|Four did not continue to Ph2; 224 received at least 1 inj. and 28 received no trt. (only follow-up)|224
2910944|NCT00479687|3620541|FG000|COMPLETED|Ph 2: Open Label, Single (Supartz) Arm||0
2910945|NCT00479687|3620542|FG001|COMPLETED|Ph 2: Open Label, Single (Supartz) Arm||0
2910946|NCT00479687|3620543|FG002|COMPLETED|Ph 2: Open Label, Single (Supartz) Arm||215
2910947|NCT00479687|3620541|FG000|NOT COMPLETED|Ph 2: Open Label, Single (Supartz) Arm||0
2910948|NCT00479687|3620542|FG001|NOT COMPLETED|Ph 2: Open Label, Single (Supartz) Arm||0
3384979|NCT02431702|4120160|FG001|COMPLETED|Part 1: 2-Month Oral Run-in Phase||0
3384980|NCT02431702|4120161|FG002|COMPLETED|Part 1: 2-Month Oral Run-in Phase||0
3384981|NCT02431702|4120162|FG003|COMPLETED|Part 1: 2-Month Oral Run-in Phase||0
3384982|NCT02431702|4120163|FG004|COMPLETED|Part 1: 2-Month Oral Run-in Phase||0
3384983|NCT02431702|4120164|FG005|COMPLETED|Part 1: 2-Month Oral Run-in Phase||0
3384984|NCT02431702|4120165|FG006|COMPLETED|Part 1: 2-Month Oral Run-in Phase||32
3384985|NCT02431702|4120159|FG000|NOT COMPLETED|Part 1: 2-Month Oral Run-in Phase||34
3384986|NCT02431702|4120160|FG001|NOT COMPLETED|Part 1: 2-Month Oral Run-in Phase||0
3384987|NCT02431702|4120161|FG002|NOT COMPLETED|Part 1: 2-Month Oral Run-in Phase||0
3384988|NCT02431702|4120162|FG003|NOT COMPLETED|Part 1: 2-Month Oral Run-in Phase||0
3384989|NCT02431702|4120163|FG004|NOT COMPLETED|Part 1: 2-Month Oral Run-in Phase||0
3384990|NCT02431702|4120164|FG005|NOT COMPLETED|Part 1: 2-Month Oral Run-in Phase||0
3384991|NCT02431702|4120165|FG006|NOT COMPLETED|Part 1: 2-Month Oral Run-in Phase||32
3384992|NCT02431702|4120159|FG000|STARTED|Part 2: 9Month Disease Progression Phase||0
3384993|NCT02431702|4120160|FG001|STARTED|Part 2: 9Month Disease Progression Phase|Participants who completed Part 1 and were eligible to be randomized in this group.|78
3384994|NCT02431702|4120161|FG002|STARTED|Part 2: 9Month Disease Progression Phase|Participants who completed Part 1 and were eligible to be randomized in this group.|157
3384995|NCT02431702|4120162|FG003|STARTED|Part 2: 9Month Disease Progression Phase||0
3384996|NCT02431702|4120163|FG004|STARTED|Part 2: 9Month Disease Progression Phase||0
3384997|NCT02431702|4120164|FG005|STARTED|Part 2: 9Month Disease Progression Phase||0
3384998|NCT02431702|4120165|FG006|STARTED|Part 2: 9Month Disease Progression Phase||0
3384999|NCT02431702|4120159|FG000|COMPLETED|Part 2: 9Month Disease Progression Phase||0
3385000|NCT02431702|4120160|FG001|COMPLETED|Part 2: 9Month Disease Progression Phase||52
3385001|NCT02431702|4120161|FG002|COMPLETED|Part 2: 9Month Disease Progression Phase||128
3385002|NCT02431702|4120162|FG003|COMPLETED|Part 2: 9Month Disease Progression Phase||0
3385003|NCT02431702|4120163|FG004|COMPLETED|Part 2: 9Month Disease Progression Phase||0
3385004|NCT02431702|4120164|FG005|COMPLETED|Part 2: 9Month Disease Progression Phase||0
3385005|NCT02431702|4120165|FG006|COMPLETED|Part 2: 9Month Disease Progression Phase||0
3385006|NCT02431702|4120159|FG000|NOT COMPLETED|Part 2: 9Month Disease Progression Phase||0
3385007|NCT02431702|4120160|FG001|NOT COMPLETED|Part 2: 9Month Disease Progression Phase||26
3385008|NCT02431702|4120161|FG002|NOT COMPLETED|Part 2: 9Month Disease Progression Phase||29
3385009|NCT02431702|4120162|FG003|NOT COMPLETED|Part 2: 9Month Disease Progression Phase||0
3385010|NCT02431702|4120163|FG004|NOT COMPLETED|Part 2: 9Month Disease Progression Phase||0
3385011|NCT02431702|4120164|FG005|NOT COMPLETED|Part 2: 9Month Disease Progression Phase||0
3385012|NCT02431702|4120165|FG006|NOT COMPLETED|Part 2: 9Month Disease Progression Phase||0
3385013|NCT02431702|4120159|FG000|STARTED|Part 3: 9 Month of Additional Treatment||0
3385014|NCT02431702|4120160|FG001|STARTED|Part 3: 9 Month of Additional Treatment||0
3385015|NCT02431702|4120161|FG002|STARTED|Part 3: 9 Month of Additional Treatment||0
3385016|NCT02431702|4120162|FG003|STARTED|Part 3: 9 Month of Additional Treatment|Participants who completed Part 2 and were eligible to continue treatment in this group.|49
3385017|NCT02431702|4120163|FG004|STARTED|Part 3: 9 Month of Additional Treatment|Participants who completed Part 2 and were eligible to be re-randomized in this group.|57
3385018|NCT02431702|4120164|FG005|STARTED|Part 3: 9 Month of Additional Treatment|Participants who completed Part 2 and were eligible to be re-randomized in this group.|63
3385019|NCT02431702|4120165|FG006|STARTED|Part 3: 9 Month of Additional Treatment||0
3385020|NCT02431702|4120159|FG000|COMPLETED|Part 3: 9 Month of Additional Treatment||0
2910949|NCT00479687|3620543|FG002|NOT COMPLETED|Ph 2: Open Label, Single (Supartz) Arm||9
2910950|NCT00479765|3620550|FG000|STARTED|Overall Study||4
2910951|NCT00479765|3620550|FG000|COMPLETED|Overall Study||0
2910952|NCT00479765|3620550|FG000|NOT COMPLETED|Overall Study||4
2910953|NCT00479856|3620554|FG000|STARTED|Overall Study||9
2910954|NCT00479856|3620554|FG000|COMPLETED|Overall Study||6
2910955|NCT00479856|3620554|FG000|NOT COMPLETED|Overall Study||3
2910956|NCT00479882|3620562|FG000|STARTED|Precrossover: Periods I/II (Weeks 1-12)||610
2910957|NCT00479882|3620563|FG001|STARTED|Precrossover: Periods I/II (Weeks 1-12)||602
2910958|NCT00479882|3620564|FG002|STARTED|Precrossover: Periods I/II (Weeks 1-12)||597
2910959|NCT00479882|3620565|FG003|STARTED|Precrossover: Periods I/II (Weeks 1-12)||605
2910960|NCT00479882|3620562|FG000|COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||472
2910961|NCT00479882|3620563|FG001|COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||440
2910962|NCT00479882|3620564|FG002|COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||440
2910963|NCT00479882|3620565|FG003|COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||465
2910964|NCT00479882|3620562|FG000|NOT COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||138
2910965|NCT00479882|3620563|FG001|NOT COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||162
2910966|NCT00479882|3620564|FG002|NOT COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||157
2910967|NCT00479882|3620565|FG003|NOT COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||140
2910968|NCT00479882|3620562|FG000|STARTED|Crossover: Period III (Weeks 13-20)||472
2910969|NCT00479882|3620563|FG001|STARTED|Crossover: Period III (Weeks 13-20)||440
2910970|NCT00479882|3620564|FG002|STARTED|Crossover: Period III (Weeks 13-20)||440
2910971|NCT00479882|3620565|FG003|STARTED|Crossover: Period III (Weeks 13-20)||465
2910972|NCT00479882|3620562|FG000|COMPLETED|Crossover: Period III (Weeks 13-20)||447
2910973|NCT00479882|3620563|FG001|COMPLETED|Crossover: Period III (Weeks 13-20)||419
2910974|NCT00479882|3620564|FG002|COMPLETED|Crossover: Period III (Weeks 13-20)||420
2910975|NCT00479882|3620565|FG003|COMPLETED|Crossover: Period III (Weeks 13-20)||447
2910976|NCT00479882|3620562|FG000|NOT COMPLETED|Crossover: Period III (Weeks 13-20)||25
2910977|NCT00479882|3620563|FG001|NOT COMPLETED|Crossover: Period III (Weeks 13-20)||21
2910978|NCT00479882|3620564|FG002|NOT COMPLETED|Crossover: Period III (Weeks 13-20)||20
2910979|NCT00479882|3620565|FG003|NOT COMPLETED|Crossover: Period III (Weeks 13-20)||18
2910980|NCT00480025|3620593|FG000|STARTED|Overall Study||1515
2910981|NCT00480025|3620594|FG001|STARTED|Overall Study||757
2910982|NCT00480025|3620593|FG000|COMPLETED|Overall Study||763
2910983|NCT00480025|3620594|FG001|COMPLETED|Overall Study||388
2910984|NCT00480025|3620593|FG000|NOT COMPLETED|Overall Study||752
2910985|NCT00480025|3620594|FG001|NOT COMPLETED|Overall Study||369
2910986|NCT00480077|3620608|FG000|STARTED|Overall Study||168
2910987|NCT00480077|3620609|FG001|STARTED|Overall Study||167
2910988|NCT00480077|3620608|FG000|COMPLETED|Overall Study||137
2910989|NCT00480077|3620609|FG001|COMPLETED|Overall Study||141
3171663|NCT01936181|3898809|FG001|COMPLETED|Transition-extension||0
3171664|NCT01936181|3898810|FG002|COMPLETED|Transition-extension||88
3171665|NCT01936181|3898811|FG003|COMPLETED|Transition-extension||96
3171666|NCT01936181|3898808|FG000|NOT COMPLETED|Transition-extension||15
3385021|NCT02431702|4120160|FG001|COMPLETED|Part 3: 9 Month of Additional Treatment||0
3385022|NCT02431702|4120161|FG002|COMPLETED|Part 3: 9 Month of Additional Treatment||0
2910990|NCT00480077|3620608|FG000|NOT COMPLETED|Overall Study||31
2910991|NCT00480077|3620609|FG001|NOT COMPLETED|Overall Study||26
2910992|NCT00480324|3620617|FG000|STARTED|Overall Study||508
2910993|NCT00480324|3620618|FG001|STARTED|Overall Study||257
2910994|NCT00480324|3620617|FG000|COMPLETED|Overall Study||476
2910995|NCT00480324|3620618|FG001|COMPLETED|Overall Study||241
2910996|NCT00480324|3620617|FG000|NOT COMPLETED|Overall Study||32
2910997|NCT00480324|3620618|FG001|NOT COMPLETED|Overall Study||16
2910998|NCT00480441|3620626|FG000|STARTED|Screening||61
3385023|NCT02431702|4120162|FG003|COMPLETED|Part 3: 9 Month of Additional Treatment||40
3385024|NCT02431702|4120163|FG004|COMPLETED|Part 3: 9 Month of Additional Treatment||47
3385025|NCT02431702|4120164|FG005|COMPLETED|Part 3: 9 Month of Additional Treatment||46
3385026|NCT02431702|4120165|FG006|COMPLETED|Part 3: 9 Month of Additional Treatment||0
3385027|NCT02431702|4120159|FG000|NOT COMPLETED|Part 3: 9 Month of Additional Treatment||0
3385028|NCT02431702|4120160|FG001|NOT COMPLETED|Part 3: 9 Month of Additional Treatment||0
3385029|NCT02431702|4120161|FG002|NOT COMPLETED|Part 3: 9 Month of Additional Treatment||0
3385030|NCT02431702|4120162|FG003|NOT COMPLETED|Part 3: 9 Month of Additional Treatment||9
3385031|NCT02431702|4120163|FG004|NOT COMPLETED|Part 3: 9 Month of Additional Treatment||10
3385032|NCT02431702|4120164|FG005|NOT COMPLETED|Part 3: 9 Month of Additional Treatment||17
3385033|NCT02431702|4120165|FG006|NOT COMPLETED|Part 3: 9 Month of Additional Treatment||0
3385034|NCT02368002|4120185|FG000|STARTED|Stage 1 Intervention (Up to 20 Weeks)||233
3385035|NCT02368002|4120186|FG001|STARTED|Stage 1 Intervention (Up to 20 Weeks)||0
3385036|NCT02368002|4120187|FG002|STARTED|Stage 1 Intervention (Up to 20 Weeks)||0
3385037|NCT02368002|4120188|FG003|STARTED|Stage 1 Intervention (Up to 20 Weeks)||235
3385038|NCT02368002|4120189|FG004|STARTED|Stage 1 Intervention (Up to 20 Weeks)||0
3385039|NCT02368002|4120190|FG005|STARTED|Stage 1 Intervention (Up to 20 Weeks)||0
3385040|NCT02368002|4120185|FG000|COMPLETED|Stage 1 Intervention (Up to 20 Weeks)||228
3385041|NCT02368002|4120186|FG001|COMPLETED|Stage 1 Intervention (Up to 20 Weeks)||0
2910999|NCT00480441|3620627|FG001|STARTED|Screening|"Participants did not enter this arm until period 3 randomization"|0
2911000|NCT00480441|3620628|FG002|STARTED|Screening|"Participants did not enter this arm until period 3 randomization"|0
2911001|NCT00480441|3620626|FG000|COMPLETED|Screening||24
2911002|NCT00480441|3620627|FG001|COMPLETED|Screening|"Participants did not enter this arm until period 3 randomization"|0
2920589|NCT00537407|3631086|FG004|COMPLETED|Part 2 Weeks 5-48 or 72||3
2911003|NCT00480441|3620628|FG002|COMPLETED|Screening|"Participants did not enter this arm until period 3 randomization"|0
2911004|NCT00480441|3620626|FG000|NOT COMPLETED|Screening||37
2911005|NCT00480441|3620627|FG001|NOT COMPLETED|Screening||0
2911006|NCT00480441|3620628|FG002|NOT COMPLETED|Screening||0
2911007|NCT00480441|3620626|FG000|STARTED|Baseline Functional MRI|All non-randomized participants who also met specific eligibility for baseline functional MRI|24
2911008|NCT00480441|3620627|FG001|STARTED|Baseline Functional MRI|"Participants did not enter this arm until period 3 randomization"|0
2911009|NCT00480441|3620628|FG002|STARTED|Baseline Functional MRI|"Participants did not enter this arm until period 3 randomization"|0
2911010|NCT00480441|3620626|FG000|COMPLETED|Baseline Functional MRI||12
2911011|NCT00480441|3620627|FG001|COMPLETED|Baseline Functional MRI|"Participants did not enter this arm until period 3 randomization"|0
2911012|NCT00480441|3620628|FG002|COMPLETED|Baseline Functional MRI|"Participants did not enter this arm until period 3 randomization"|0
2911013|NCT00480441|3620626|FG000|NOT COMPLETED|Baseline Functional MRI||12
2911014|NCT00480441|3620627|FG001|NOT COMPLETED|Baseline Functional MRI||0
2911015|NCT00480441|3620628|FG002|NOT COMPLETED|Baseline Functional MRI||0
2911016|NCT00480441|3620626|FG000|STARTED|Randomization||0
2911017|NCT00480441|3620627|FG001|STARTED|Randomization||13
2911018|NCT00480441|3620628|FG002|STARTED|Randomization||11
2911019|NCT00480441|3620626|FG000|COMPLETED|Randomization||0
2911020|NCT00480441|3620627|FG001|COMPLETED|Randomization||6
2911021|NCT00480441|3620628|FG002|COMPLETED|Randomization||9
2911022|NCT00480441|3620626|FG000|NOT COMPLETED|Randomization||0
2911023|NCT00480441|3620627|FG001|NOT COMPLETED|Randomization||7
2911024|NCT00480441|3620628|FG002|NOT COMPLETED|Randomization||2
2911025|NCT00480493|3620637|FG000|STARTED|Overall Study||32
2911026|NCT00480493|3620638|FG001|STARTED|Overall Study||28
2911027|NCT00480493|3620637|FG000|Randomized|Overall Study||32
2911028|NCT00480493|3620638|FG001|Randomized|Overall Study||28
2911029|NCT00480493|3620637|FG000|COMPLETED|Overall Study||30
2911030|NCT00480493|3620638|FG001|COMPLETED|Overall Study||21
2911031|NCT00480493|3620637|FG000|NOT COMPLETED|Overall Study||2
2911032|NCT00480493|3620638|FG001|NOT COMPLETED|Overall Study||7
2911033|NCT00480532|3620650|FG000|STARTED|Overall Study||33
2911034|NCT00480532|3620651|FG001|STARTED|Overall Study||33
2911035|NCT00480532|3620652|FG002|STARTED|Overall Study||33
2911036|NCT00480532|3620653|FG003|STARTED|Overall Study||32
2911037|NCT00480532|3620650|FG000|COMPLETED|Overall Study||31
2911038|NCT00480532|3620651|FG001|COMPLETED|Overall Study||29
2911039|NCT00480532|3620652|FG002|COMPLETED|Overall Study||29
2911040|NCT00480532|3620653|FG003|COMPLETED|Overall Study||31
2911041|NCT00480532|3620650|FG000|NOT COMPLETED|Overall Study||2
2911042|NCT00480532|3620651|FG001|NOT COMPLETED|Overall Study||4
2911043|NCT00480532|3620652|FG002|NOT COMPLETED|Overall Study||4
2911044|NCT00480532|3620653|FG003|NOT COMPLETED|Overall Study||1
2911045|NCT00480636|3620663|FG000|STARTED|Overall Study||102
2911046|NCT00480636|3620663|FG000|COMPLETED|Overall Study||83
2911047|NCT00480636|3620663|FG000|NOT COMPLETED|Overall Study||19
2911048|NCT00480740|3620670|FG000|STARTED|Overall Study||26
2911049|NCT00480740|3620671|FG001|STARTED|Overall Study||9
2911050|NCT00480740|3620672|FG002|STARTED|Overall Study||6
2911051|NCT00480740|3620670|FG000|COMPLETED|Overall Study||26
2911052|NCT00480740|3620671|FG001|COMPLETED|Overall Study||9
2911053|NCT00480740|3620672|FG002|COMPLETED|Overall Study||6
2911054|NCT00480740|3620670|FG000|NOT COMPLETED|Overall Study||0
2911055|NCT00480740|3620671|FG001|NOT COMPLETED|Overall Study||0
2911056|NCT00480740|3620672|FG002|NOT COMPLETED|Overall Study||0
2911057|NCT00480779|3620682|FG000|STARTED|Overall Study||26
2911058|NCT00480779|3620683|FG001|STARTED|Overall Study||22
2911059|NCT00480779|3620682|FG000|COMPLETED|Overall Study||24
2911060|NCT00480779|3620683|FG001|COMPLETED|Overall Study||19
2911061|NCT00480779|3620682|FG000|NOT COMPLETED|Overall Study||2
2911062|NCT00480779|3620683|FG001|NOT COMPLETED|Overall Study||3
2911063|NCT00480857|3620689|FG000|STARTED|Overall Study||19
2911064|NCT00480857|3620689|FG000|COMPLETED|Overall Study||17
2911065|NCT00480857|3620689|FG000|NOT COMPLETED|Overall Study||2
2911066|NCT00480987|3620693|FG000|STARTED|Overall Study||27
2911067|NCT00480987|3620693|FG000|COMPLETED|Overall Study||27
2911068|NCT00480987|3620693|FG000|NOT COMPLETED|Overall Study||0
2911069|NCT00481065|3620705|FG000|STARTED|Overall Study||51
2911070|NCT00481065|3620706|FG001|STARTED|Overall Study||50
2911071|NCT00481065|3620707|FG002|STARTED|Overall Study||51
2911072|NCT00481065|3620708|FG003|STARTED|Overall Study||52
2911073|NCT00481065|3620709|FG004|STARTED|Overall Study||51
2911074|NCT00481065|3620710|FG005|STARTED|Overall Study||51
2911075|NCT00481065|3620711|FG006|STARTED|Overall Study||50
2911076|NCT00481065|3620712|FG007|STARTED|Overall Study||49
2911077|NCT00481065|3620705|FG000|COMPLETED|Overall Study||29
2911078|NCT00481065|3620706|FG001|COMPLETED|Overall Study||33
2911079|NCT00481065|3620707|FG002|COMPLETED|Overall Study||32
2911080|NCT00481065|3620708|FG003|COMPLETED|Overall Study||37
2911081|NCT00481065|3620709|FG004|COMPLETED|Overall Study||28
2911082|NCT00481065|3620710|FG005|COMPLETED|Overall Study||27
2911083|NCT00481065|3620711|FG006|COMPLETED|Overall Study||34
2911084|NCT00481065|3620712|FG007|COMPLETED|Overall Study||30
2911085|NCT00481065|3620705|FG000|NOT COMPLETED|Overall Study||22
2911086|NCT00481065|3620706|FG001|NOT COMPLETED|Overall Study||17
2911087|NCT00481065|3620707|FG002|NOT COMPLETED|Overall Study||19
2911088|NCT00481065|3620708|FG003|NOT COMPLETED|Overall Study||15
2911089|NCT00481065|3620709|FG004|NOT COMPLETED|Overall Study||23
2911090|NCT00481065|3620710|FG005|NOT COMPLETED|Overall Study||24
2911091|NCT00481065|3620711|FG006|NOT COMPLETED|Overall Study||16
2911092|NCT00481065|3620712|FG007|NOT COMPLETED|Overall Study||19
2911093|NCT00481078|3620734|FG000|STARTED|Overall Study||62
2911094|NCT00481078|3620735|FG001|STARTED|Overall Study||32
2911095|NCT00481078|3620734|FG000|COMPLETED|Overall Study||20
2911096|NCT00481078|3620735|FG001|COMPLETED|Overall Study||12
2911097|NCT00481078|3620734|FG000|NOT COMPLETED|Overall Study||42
2911098|NCT00481078|3620735|FG001|NOT COMPLETED|Overall Study||20
2911099|NCT00481195|3620743|FG000|STARTED|Overall Study|Two of these subjects were randomized but never received study medication.|128
2911100|NCT00481195|3620744|FG001|STARTED|Overall Study|Four of these subjects were randomized but never received study medication.|129
2911101|NCT00481195|3620743|FG000|COMPLETED|Overall Study||89
2911102|NCT00481195|3620744|FG001|COMPLETED|Overall Study||90
2911103|NCT00481195|3620743|FG000|NOT COMPLETED|Overall Study||39
2911104|NCT00481195|3620744|FG001|NOT COMPLETED|Overall Study||39
2911105|NCT00481247|3620752|FG000|STARTED|Overall Study|Randomized|259
2911106|NCT00481247|3620753|FG001|STARTED|Overall Study|Randomized|260
2911107|NCT00481247|3620752|FG000|Received Treatment|Overall Study||258
2911108|NCT00481247|3620753|FG001|Received Treatment|Overall Study||258
2911109|NCT00481247|3620752|FG000|COMPLETED|Overall Study||0
2911110|NCT00481247|3620753|FG001|COMPLETED|Overall Study||0
2911111|NCT00481247|3620752|FG000|NOT COMPLETED|Overall Study||259
2911112|NCT00481247|3620753|FG001|NOT COMPLETED|Overall Study||260
2911113|NCT00481351|3620761|FG000|STARTED|Overall Study||13
2911114|NCT00481351|3620762|FG001|STARTED|Overall Study||12
2911115|NCT00481351|3620761|FG000|COMPLETED|Overall Study||13
2911116|NCT00481351|3620762|FG001|COMPLETED|Overall Study||12
2911117|NCT00481351|3620761|FG000|NOT COMPLETED|Overall Study||0
2911118|NCT00481351|3620762|FG001|NOT COMPLETED|Overall Study||0
2911119|NCT00481507|3620770|FG000|STARTED|Overall Study||64
2911120|NCT00481507|3620771|FG001|STARTED|Overall Study||61
2911121|NCT00481507|3620770|FG000|COMPLETED|Overall Study||64
2911122|NCT00481507|3620771|FG001|COMPLETED|Overall Study||61
2911123|NCT00481507|3620770|FG000|NOT COMPLETED|Overall Study||0
2911124|NCT00481507|3620771|FG001|NOT COMPLETED|Overall Study||0
2911125|NCT00481676|3620779|FG000|STARTED|Overall Study||27
2911126|NCT00481676|3620780|FG001|STARTED|Overall Study||22
2911127|NCT00481676|3620779|FG000|COMPLETED|Overall Study||25
2911128|NCT00481676|3620780|FG001|COMPLETED|Overall Study||17
2911129|NCT00481676|3620779|FG000|NOT COMPLETED|Overall Study||2
2911130|NCT00481676|3620780|FG001|NOT COMPLETED|Overall Study||5
2911131|NCT00481767|3620788|FG000|STARTED|Overall Study||450
2911132|NCT00481767|3620789|FG001|STARTED|Overall Study||226
2911133|NCT00481767|3620788|FG000|COMPLETED|Overall Study||418
2911134|NCT00481767|3620789|FG001|COMPLETED|Overall Study||205
2911135|NCT00481767|3620788|FG000|NOT COMPLETED|Overall Study||32
2911136|NCT00481767|3620789|FG001|NOT COMPLETED|Overall Study||21
2911137|NCT00481832|3620795|FG000|STARTED|Enrollment||50
2911138|NCT00481832|3620795|FG000|COMPLETED|Enrollment||40
2911139|NCT00481832|3620795|FG000|NOT COMPLETED|Enrollment||10
2911140|NCT00481832|3620795|FG000|STARTED|Autologous Hematopoietic Cell Transplant||40
3385042|NCT02368002|4120187|FG002|COMPLETED|Stage 1 Intervention (Up to 20 Weeks)||0
3385043|NCT02368002|4120188|FG003|COMPLETED|Stage 1 Intervention (Up to 20 Weeks)||214
3385044|NCT02368002|4120189|FG004|COMPLETED|Stage 1 Intervention (Up to 20 Weeks)||0
3385045|NCT02368002|4120190|FG005|COMPLETED|Stage 1 Intervention (Up to 20 Weeks)||0
3385046|NCT02368002|4120185|FG000|NOT COMPLETED|Stage 1 Intervention (Up to 20 Weeks)||5
3385047|NCT02368002|4120186|FG001|NOT COMPLETED|Stage 1 Intervention (Up to 20 Weeks)||0
3385048|NCT02368002|4120187|FG002|NOT COMPLETED|Stage 1 Intervention (Up to 20 Weeks)||0
3385049|NCT02368002|4120188|FG003|NOT COMPLETED|Stage 1 Intervention (Up to 20 Weeks)||21
3385050|NCT02368002|4120189|FG004|NOT COMPLETED|Stage 1 Intervention (Up to 20 Weeks)||0
3385051|NCT02368002|4120190|FG005|NOT COMPLETED|Stage 1 Intervention (Up to 20 Weeks)||0
3385052|NCT02368002|4120185|FG000|STARTED|Stage 2 Intervention (Up to 17 Weeks)||88
3385053|NCT02368002|4120186|FG001|STARTED|Stage 2 Intervention (Up to 17 Weeks)||70
3385054|NCT02368002|4120187|FG002|STARTED|Stage 2 Intervention (Up to 17 Weeks)||70
3385055|NCT02368002|4120188|FG003|STARTED|Stage 2 Intervention (Up to 17 Weeks)||0
3385056|NCT02368002|4120189|FG004|STARTED|Stage 2 Intervention (Up to 17 Weeks)||0
3385057|NCT02368002|4120190|FG005|STARTED|Stage 2 Intervention (Up to 17 Weeks)||0
3385058|NCT02368002|4120185|FG000|COMPLETED|Stage 2 Intervention (Up to 17 Weeks)||86
3385059|NCT02368002|4120186|FG001|COMPLETED|Stage 2 Intervention (Up to 17 Weeks)||60
3385060|NCT02368002|4120187|FG002|COMPLETED|Stage 2 Intervention (Up to 17 Weeks)||64
3385061|NCT02368002|4120188|FG003|COMPLETED|Stage 2 Intervention (Up to 17 Weeks)||0
3385062|NCT02368002|4120189|FG004|COMPLETED|Stage 2 Intervention (Up to 17 Weeks)||0
3385063|NCT02368002|4120190|FG005|COMPLETED|Stage 2 Intervention (Up to 17 Weeks)||0
3385064|NCT02368002|4120185|FG000|NOT COMPLETED|Stage 2 Intervention (Up to 17 Weeks)||2
3385065|NCT02368002|4120186|FG001|NOT COMPLETED|Stage 2 Intervention (Up to 17 Weeks)||10
2911141|NCT00481832|3620795|FG000|COMPLETED|Autologous Hematopoietic Cell Transplant||40
2911142|NCT00481832|3620795|FG000|NOT COMPLETED|Autologous Hematopoietic Cell Transplant||0
2911143|NCT00481832|3620795|FG000|STARTED|Inter-transplant Period||40
2911144|NCT00481832|3620795|FG000|COMPLETED|Inter-transplant Period||13
2911145|NCT00481832|3620795|FG000|NOT COMPLETED|Inter-transplant Period||27
2911146|NCT00481832|3620795|FG000|STARTED|Allogenic Hematopoietic Cell Transplant||13
2911147|NCT00481832|3620795|FG000|COMPLETED|Allogenic Hematopoietic Cell Transplant||13
2911148|NCT00481832|3620795|FG000|NOT COMPLETED|Allogenic Hematopoietic Cell Transplant||0
2911149|NCT00481845|3620801|FG000|STARTED|Overall Study||1
2911150|NCT00481845|3620802|FG001|STARTED|Overall Study||0
2911151|NCT00481845|3620801|FG000|COMPLETED|Overall Study||1
2911152|NCT00481845|3620802|FG001|COMPLETED|Overall Study||0
2911153|NCT00481845|3620801|FG000|NOT COMPLETED|Overall Study||0
2911154|NCT00481845|3620802|FG001|NOT COMPLETED|Overall Study||0
2911155|NCT00481871|3620813|FG000|STARTED|Overall Study||7
2911156|NCT00481871|3620814|FG001|STARTED|Overall Study||10
2911157|NCT00481871|3620815|FG002|STARTED|Overall Study||18
2911158|NCT00481871|3620816|FG003|STARTED|Overall Study||38
2911159|NCT00481871|3620817|FG004|STARTED|Overall Study||34
2911160|NCT00481871|3620813|FG000|COMPLETED|Overall Study||7
2911161|NCT00481871|3620814|FG001|COMPLETED|Overall Study||10
2911162|NCT00481871|3620815|FG002|COMPLETED|Overall Study||17
2911163|NCT00481871|3620816|FG003|COMPLETED|Overall Study||38
2911164|NCT00481871|3620817|FG004|COMPLETED|Overall Study||34
2911165|NCT00481871|3620813|FG000|NOT COMPLETED|Overall Study||0
2911166|NCT00481871|3620814|FG001|NOT COMPLETED|Overall Study||0
2911167|NCT00481871|3620815|FG002|NOT COMPLETED|Overall Study||1
2911168|NCT00481871|3620816|FG003|NOT COMPLETED|Overall Study||0
2911169|NCT00481871|3620817|FG004|NOT COMPLETED|Overall Study||0
2911170|NCT00481988|3620827|FG000|STARTED|Overall Study||12
2911171|NCT00481988|3620828|FG001|STARTED|Overall Study|one patient was dropped from the study before randomization|9
2911172|NCT00481988|3620827|FG000|Crossover|Overall Study|patient dropped out of study after 5 sessions to pursue other treatment options|11
2911173|NCT00481988|3620828|FG001|Crossover|Overall Study|patient dropped out of study after 5 sessions to illness unrelated to study|8
2911174|NCT00481988|3620827|FG000|COMPLETED|Overall Study||11
2911175|NCT00481988|3620828|FG001|COMPLETED|Overall Study||8
2911176|NCT00481988|3620827|FG000|NOT COMPLETED|Overall Study||1
2911177|NCT00481988|3620828|FG001|NOT COMPLETED|Overall Study||1
2911178|NCT00482001|3620836|FG000|STARTED|Overall Study||11
2911179|NCT00482001|3620837|FG001|STARTED|Overall Study||11
2911180|NCT00482001|3620836|FG000|COMPLETED|Overall Study||10
2911181|NCT00482001|3620837|FG001|COMPLETED|Overall Study||10
2911182|NCT00482001|3620836|FG000|NOT COMPLETED|Overall Study||1
2911183|NCT00482001|3620837|FG001|NOT COMPLETED|Overall Study||1
2911184|NCT00482014|3620849|FG000|STARTED|Overall Study||9
2911185|NCT00482014|3620850|FG001|STARTED|Overall Study||13
2911186|NCT00482014|3620851|FG002|STARTED|Overall Study||46
2911187|NCT00482014|3620852|FG003|STARTED|Overall Study||52
2911188|NCT00482014|3620849|FG000|COMPLETED|Overall Study||2
2911189|NCT00482014|3620850|FG001|COMPLETED|Overall Study||7
2911190|NCT00482014|3620851|FG002|COMPLETED|Overall Study||35
2911191|NCT00482014|3620852|FG003|COMPLETED|Overall Study||29
2911192|NCT00482014|3620849|FG000|NOT COMPLETED|Overall Study||7
2911193|NCT00482014|3620850|FG001|NOT COMPLETED|Overall Study||6
2911194|NCT00482014|3620851|FG002|NOT COMPLETED|Overall Study||11
2911195|NCT00482014|3620852|FG003|NOT COMPLETED|Overall Study||23
2911196|NCT00482053|3620864|FG000|STARTED|Autologous Peripheral Stem Cells||3
2911197|NCT00482053|3620864|FG000|COMPLETED|Autologous Peripheral Stem Cells||3
2911198|NCT00482053|3620864|FG000|NOT COMPLETED|Autologous Peripheral Stem Cells||0
2911199|NCT00482053|3620864|FG000|STARTED|Inter-treatment Period||3
2911200|NCT00482053|3620864|FG000|COMPLETED|Inter-treatment Period||2
2911201|NCT00482053|3620864|FG000|NOT COMPLETED|Inter-treatment Period||1
2911202|NCT00482053|3620864|FG000|STARTED|Allogeneic Peripheral Stem Cells||2
2911203|NCT00482053|3620864|FG000|COMPLETED|Allogeneic Peripheral Stem Cells||2
2911204|NCT00482053|3620864|FG000|NOT COMPLETED|Allogeneic Peripheral Stem Cells||0
2911205|NCT00482170|3620870|FG000|STARTED|Overall Study||207
2911206|NCT00482170|3620871|FG001|STARTED|Overall Study||214
2911207|NCT00482170|3620870|FG000|Treated|Overall Study||207
2911208|NCT00482170|3620871|FG001|Treated|Overall Study||211
2911209|NCT00482170|3620870|FG000|COMPLETED|Overall Study||192
2911210|NCT00482170|3620871|FG001|COMPLETED|Overall Study||194
2911211|NCT00482170|3620870|FG000|NOT COMPLETED|Overall Study||15
2911212|NCT00482170|3620871|FG001|NOT COMPLETED|Overall Study||20
2911213|NCT00482274|3620877|FG000|STARTED|Overall Study||3
2911214|NCT00482274|3620877|FG000|COMPLETED|Overall Study||2
2911215|NCT00482274|3620877|FG000|NOT COMPLETED|Overall Study||1
2911216|NCT00482391|3620881|FG000|STARTED|Overall Study||95
2911217|NCT00482391|3620881|FG000|COMPLETED|Overall Study||92
2911218|NCT00482391|3620881|FG000|NOT COMPLETED|Overall Study||3
2911219|NCT00482547|3620888|FG000|STARTED|Overall Study|599 subjects were enrolled in the silver-coated catheter group.|599
2911220|NCT00482547|3620889|FG001|STARTED|Overall Study|589 subjects were enrolled in the silicone-coated catheter group.|589
2911221|NCT00482547|3620888|FG000|Successful Catheterization|Overall Study|Out of the 599 AgCS subjects 565 (94.3%) had a successful catheterization.|565
2911222|NCT00482547|3620889|FG001|Successful Catheterization|Overall Study|Out of the 589 SiCS catheter subjects 568 (96.4%) had a successful catheterization.|568
2911223|NCT00482547|3620888|FG000|48 Hour Evaluation|Overall Study|426 went on to be included in the Silver-coated 48 hour efficacy evaluable population.|426
2911224|NCT00482547|3620889|FG001|48 Hour Evaluation|Overall Study|428 went on to be included in the Silicone-coated 48 hour efficacy evaluable population.|428
2911225|NCT00482547|3620888|FG000|COMPLETED|Overall Study||426
2911226|NCT00482547|3620889|FG001|COMPLETED|Overall Study||428
2911227|NCT00482547|3620888|FG000|NOT COMPLETED|Overall Study||173
2911228|NCT00482547|3620889|FG001|NOT COMPLETED|Overall Study||161
2911229|NCT00482612|3620899|FG000|STARTED|In-treatment Period||137
2911230|NCT00482612|3620900|FG001|STARTED|In-treatment Period||125
2911231|NCT00482612|3620901|FG002|STARTED|In-treatment Period||129
2911232|NCT00482612|3620902|FG003|STARTED|In-treatment Period||135
2911233|NCT00482612|3620899|FG000|Treated|In-treatment Period||137
2911234|NCT00482612|3620900|FG001|Treated|In-treatment Period||125
2911235|NCT00482612|3620901|FG002|Treated|In-treatment Period||128
2911236|NCT00482612|3620902|FG003|Treated|In-treatment Period||135
2911237|NCT00482612|3620899|FG000|COMPLETED|In-treatment Period||137
2911238|NCT00482612|3620900|FG001|COMPLETED|In-treatment Period||125
2911239|NCT00482612|3620901|FG002|COMPLETED|In-treatment Period||128
2911240|NCT00482612|3620902|FG003|COMPLETED|In-treatment Period||135
2911241|NCT00482612|3620899|FG000|NOT COMPLETED|In-treatment Period||0
2911242|NCT00482612|3620900|FG001|NOT COMPLETED|In-treatment Period||0
2911243|NCT00482612|3620901|FG002|NOT COMPLETED|In-treatment Period||1
3171667|NCT01936181|3898809|FG001|NOT COMPLETED|Transition-extension||0
3171668|NCT01936181|3898810|FG002|NOT COMPLETED|Transition-extension||6
3171669|NCT01936181|3898811|FG003|NOT COMPLETED|Transition-extension||5
3171670|NCT01936259|3898824|FG000|STARTED|Overall Study||130
3171671|NCT01936259|3898825|FG001|STARTED|Overall Study||131
3385066|NCT02368002|4120187|FG002|NOT COMPLETED|Stage 2 Intervention (Up to 17 Weeks)||6
2911244|NCT00482612|3620902|FG003|NOT COMPLETED|In-treatment Period||0
2911245|NCT00482612|3620899|FG000|STARTED|Follow-up Period||137
2911246|NCT00482612|3620900|FG001|STARTED|Follow-up Period||125
2911247|NCT00482612|3620901|FG002|STARTED|Follow-up Period||128
2911248|NCT00482612|3620902|FG003|STARTED|Follow-up Period||135
2911249|NCT00482612|3620899|FG000|COMPLETED|Follow-up Period||123
2911250|NCT00482612|3620900|FG001|COMPLETED|Follow-up Period||107
2911251|NCT00482612|3620901|FG002|COMPLETED|Follow-up Period||106
2911252|NCT00482612|3620902|FG003|COMPLETED|Follow-up Period||127
2911253|NCT00482612|3620899|FG000|NOT COMPLETED|Follow-up Period||14
2911254|NCT00482612|3620900|FG001|NOT COMPLETED|Follow-up Period||18
2911255|NCT00482612|3620901|FG002|NOT COMPLETED|Follow-up Period||22
2911256|NCT00482612|3620902|FG003|NOT COMPLETED|Follow-up Period||8
2911257|NCT00482625|3620916|FG000|STARTED|Overall Study||6
2911258|NCT00482625|3620916|FG000|COMPLETED|Overall Study||6
2911259|NCT00482625|3620916|FG000|NOT COMPLETED|Overall Study||0
2911260|NCT00482677|3620922|FG000|STARTED|Overall Study||281
2911261|NCT00482677|3620923|FG001|STARTED|Overall Study||281
2911262|NCT00482677|3620922|FG000|COMPLETED|Overall Study||281
2911263|NCT00482677|3620923|FG001|COMPLETED|Overall Study||281
3385067|NCT02368002|4120188|FG003|NOT COMPLETED|Stage 2 Intervention (Up to 17 Weeks)||0
3385068|NCT02368002|4120189|FG004|NOT COMPLETED|Stage 2 Intervention (Up to 17 Weeks)||0
3385069|NCT02368002|4120190|FG005|NOT COMPLETED|Stage 2 Intervention (Up to 17 Weeks)||0
3385070|NCT02368002|4120185|FG000|STARTED|Stage 2 Intervention (Up to 13 Weeks)||0
3385071|NCT02368002|4120186|FG001|STARTED|Stage 2 Intervention (Up to 13 Weeks)||0
3385072|NCT02368002|4120187|FG002|STARTED|Stage 2 Intervention (Up to 13 Weeks)||0
3385073|NCT02368002|4120188|FG003|STARTED|Stage 2 Intervention (Up to 13 Weeks)||95
3385074|NCT02368002|4120189|FG004|STARTED|Stage 2 Intervention (Up to 13 Weeks)||57
3385075|NCT02368002|4120190|FG005|STARTED|Stage 2 Intervention (Up to 13 Weeks)||62
3385076|NCT02368002|4120185|FG000|COMPLETED|Stage 2 Intervention (Up to 13 Weeks)||0
3385077|NCT02368002|4120186|FG001|COMPLETED|Stage 2 Intervention (Up to 13 Weeks)||0
3385078|NCT02368002|4120187|FG002|COMPLETED|Stage 2 Intervention (Up to 13 Weeks)||0
3385079|NCT02368002|4120188|FG003|COMPLETED|Stage 2 Intervention (Up to 13 Weeks)||94
3385080|NCT02368002|4120189|FG004|COMPLETED|Stage 2 Intervention (Up to 13 Weeks)||53
3385081|NCT02368002|4120190|FG005|COMPLETED|Stage 2 Intervention (Up to 13 Weeks)||59
3385082|NCT02368002|4120185|FG000|NOT COMPLETED|Stage 2 Intervention (Up to 13 Weeks)||0
3385083|NCT02368002|4120186|FG001|NOT COMPLETED|Stage 2 Intervention (Up to 13 Weeks)||0
3385084|NCT02368002|4120187|FG002|NOT COMPLETED|Stage 2 Intervention (Up to 13 Weeks)||0
3385085|NCT02368002|4120188|FG003|NOT COMPLETED|Stage 2 Intervention (Up to 13 Weeks)||1
3385086|NCT02368002|4120189|FG004|NOT COMPLETED|Stage 2 Intervention (Up to 13 Weeks)||4
3385087|NCT02368002|4120190|FG005|NOT COMPLETED|Stage 2 Intervention (Up to 13 Weeks)||3
3385088|NCT02200770|4120202|FG000|STARTED|Randomized-controlled Period (RCP)||56
3385089|NCT02200770|4120203|FG001|STARTED|Randomized-controlled Period (RCP)||175
3385090|NCT02200770|4120202|FG000|Treated|Randomized-controlled Period (RCP)||56
3385091|NCT02200770|4120203|FG001|Treated|Randomized-controlled Period (RCP)||174
3385092|NCT02200770|4120202|FG000|COMPLETED|Randomized-controlled Period (RCP)||54
3385093|NCT02200770|4120203|FG001|COMPLETED|Randomized-controlled Period (RCP)||169
3385094|NCT02200770|4120202|FG000|NOT COMPLETED|Randomized-controlled Period (RCP)||2
3385095|NCT02200770|4120203|FG001|NOT COMPLETED|Randomized-controlled Period (RCP)||6
3385096|NCT02200770|4120202|FG000|STARTED|Open-label Period (OLP)|3 participants completed RCP but did not roll over to OLP.|51
3385097|NCT02200770|4120203|FG001|STARTED|Open-label Period (OLP)|4 participants completed RCP but did not roll over to OLP.|165
3385098|NCT02200770|4120202|FG000|COMPLETED|Open-label Period (OLP)||43
3385099|NCT02200770|4120203|FG001|COMPLETED|Open-label Period (OLP)||131
3385100|NCT02200770|4120202|FG000|NOT COMPLETED|Open-label Period (OLP)||8
3385101|NCT02200770|4120203|FG001|NOT COMPLETED|Open-label Period (OLP)||34
3385102|NCT02136069|4120213|FG000|STARTED|Overall Study||199
3385103|NCT02136069|4120214|FG001|STARTED|Overall Study||198
3385104|NCT02136069|4120213|FG000|COMPLETED|Overall Study||165
3385105|NCT02136069|4120214|FG001|COMPLETED|Overall Study||170
3385106|NCT02136069|4120213|FG000|NOT COMPLETED|Overall Study||34
2911264|NCT00482677|3620922|FG000|NOT COMPLETED|Overall Study||0
2911265|NCT00482677|3620923|FG001|NOT COMPLETED|Overall Study||0
2911266|NCT00482703|3620931|FG000|STARTED|Overall Study|number enrolled, randomized and treated|11
2920590|NCT00537407|3631082|FG000|NOT COMPLETED|Part 2 Weeks 5-48 or 72||8
2911267|NCT00482703|3620932|FG001|STARTED|Overall Study|number enrolled, randomized and treated|12
2911268|NCT00482703|3620931|FG000|COMPLETED|Overall Study||10
2911269|NCT00482703|3620932|FG001|COMPLETED|Overall Study||12
2911270|NCT00482703|3620931|FG000|NOT COMPLETED|Overall Study||1
2911271|NCT00482703|3620932|FG001|NOT COMPLETED|Overall Study||0
2911272|NCT00482729|3620947|FG000|STARTED|Overall Study|Site 079011301 was identified as non-compliant and 1 patient was excluded from all analysis|626
2911273|NCT00482729|3620948|FG001|STARTED|Overall Study|Site 079011301 was identified as non-compliant and 3 patients were excluded from all analysis|624
2911274|NCT00482729|3620947|FG000|Completed Phase A|Overall Study||484
2911275|NCT00482729|3620948|FG001|Completed Phase A|Overall Study||482
2911276|NCT00482729|3620947|FG000|Completed Phase B|Overall Study||409
2911277|NCT00482729|3620948|FG001|Completed Phase B|Overall Study||406
2911278|NCT00482729|3620947|FG000|COMPLETED|Overall Study||409
2911279|NCT00482729|3620948|FG001|COMPLETED|Overall Study||406
2911280|NCT00482729|3620947|FG000|NOT COMPLETED|Overall Study||217
3171672|NCT01936259|3898824|FG000|COMPLETED|Overall Study||118
3171673|NCT01936259|3898825|FG001|COMPLETED|Overall Study||111
3171674|NCT01936259|3898824|FG000|NOT COMPLETED|Overall Study||12
3171675|NCT01936259|3898825|FG001|NOT COMPLETED|Overall Study||20
3171676|NCT01936324|3898834|FG000|STARTED|Overall Study||6
3385107|NCT02136069|4120214|FG001|NOT COMPLETED|Overall Study||28
3385108|NCT02086552|4120220|FG000|STARTED|Overall Study||28
3385109|NCT02086552|4120220|FG000|COMPLETED|Overall Study||27
3385110|NCT02086552|4120220|FG000|NOT COMPLETED|Overall Study||1
3385111|NCT01839396|4120226|FG000|STARTED|Overall Study||121
3385112|NCT01839396|4120227|FG001|STARTED|Overall Study||39
3385113|NCT01839396|4120226|FG000|COMPLETED|Overall Study||121
3385114|NCT01839396|4120227|FG001|COMPLETED|Overall Study||39
3385115|NCT01839396|4120226|FG000|NOT COMPLETED|Overall Study||0
3385116|NCT01839396|4120227|FG001|NOT COMPLETED|Overall Study||0
3385117|NCT01517659|4120233|FG000|STARTED|Overall Study||45
3385118|NCT01517659|4120233|FG000|COMPLETED|Overall Study||45
3385119|NCT01517659|4120233|FG000|NOT COMPLETED|Overall Study||0
3385120|NCT01209767|4120238|FG000|STARTED|Overall Study||22
3385121|NCT01209767|4120238|FG000|COMPLETED|Overall Study||18
3385122|NCT01209767|4120238|FG000|NOT COMPLETED|Overall Study||4
3385123|NCT01186848|4120246|FG000|STARTED|Overall Study||30
3385124|NCT01186848|4120246|FG000|COMPLETED|Overall Study||22
3385125|NCT01186848|4120246|FG000|NOT COMPLETED|Overall Study||8
3385126|NCT01040624|4120254|FG000|STARTED|Overall Study||58
3385127|NCT01040624|4120255|FG001|STARTED|Overall Study||19
3385128|NCT01040624|4120254|FG000|COMPLETED|Overall Study||58
3385129|NCT01040624|4120255|FG001|COMPLETED|Overall Study||19
3385130|NCT01040624|4120254|FG000|NOT COMPLETED|Overall Study||0
3385131|NCT01040624|4120255|FG001|NOT COMPLETED|Overall Study||0
3385132|NCT01024608|4120263|FG000|STARTED|Overall Study||169
3385133|NCT01024608|4120264|FG001|STARTED|Overall Study||171
3385134|NCT01024608|4120263|FG000|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment|167
3385135|NCT01024608|4120264|FG001|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment|171
3385136|NCT01024608|4120263|FG000|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|167
3385137|NCT01024608|4120264|FG001|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|171
3385138|NCT01024608|4120263|FG000|COMPLETED|Overall Study||165
3385139|NCT01024608|4120264|FG001|COMPLETED|Overall Study||167
3385140|NCT01024608|4120263|FG000|NOT COMPLETED|Overall Study||4
3385141|NCT01024608|4120264|FG001|NOT COMPLETED|Overall Study||4
3385142|NCT00988247|4120272|FG000|STARTED|Overall Study||418
3385143|NCT00988247|4120273|FG001|STARTED|Overall Study||111
3385144|NCT00988247|4120272|FG000|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|415
3385145|NCT00988247|4120273|FG001|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|111
3385146|NCT00988247|4120272|FG000|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment|414
3385147|NCT00988247|4120273|FG001|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment|110
3385148|NCT00988247|4120272|FG000|COMPLETED|Overall Study||335
3385149|NCT00988247|4120273|FG001|COMPLETED|Overall Study||85
3385150|NCT00988247|4120272|FG000|NOT COMPLETED|Overall Study||83
3385151|NCT00988247|4120273|FG001|NOT COMPLETED|Overall Study||26
3385152|NCT00838981|4120283|FG000|STARTED|Week 1 Days 1-3||26
3385153|NCT00838981|4120284|FG001|STARTED|Week 1 Days 1-3||19
3385154|NCT00838981|4120285|FG002|STARTED|Week 1 Days 1-3||27
3385155|NCT00838981|4120286|FG003|STARTED|Week 1 Days 1-3||19
3385156|NCT00838981|4120283|FG000|COMPLETED|Week 1 Days 1-3||26
3385157|NCT00838981|4120284|FG001|COMPLETED|Week 1 Days 1-3||19
3385158|NCT00838981|4120285|FG002|COMPLETED|Week 1 Days 1-3||27
3171677|NCT01936324|3898835|FG001|STARTED|Overall Study||53
3385159|NCT00838981|4120286|FG003|COMPLETED|Week 1 Days 1-3||19
3385160|NCT00838981|4120283|FG000|NOT COMPLETED|Week 1 Days 1-3||0
3385161|NCT00838981|4120284|FG001|NOT COMPLETED|Week 1 Days 1-3||0
3385162|NCT00838981|4120285|FG002|NOT COMPLETED|Week 1 Days 1-3||0
3385163|NCT00838981|4120286|FG003|NOT COMPLETED|Week 1 Days 1-3||0
3385164|NCT00838981|4120283|FG000|STARTED|Day 4 to Week 11||26
3385165|NCT00838981|4120284|FG001|STARTED|Day 4 to Week 11||19
3385166|NCT00838981|4120285|FG002|STARTED|Day 4 to Week 11||27
3385167|NCT00838981|4120286|FG003|STARTED|Day 4 to Week 11||19
3385168|NCT00838981|4120283|FG000|Completed Main Treatment on 400mg|Day 4 to Week 11||22
2911281|NCT00482729|3620948|FG001|NOT COMPLETED|Overall Study||218
2911282|NCT00482911|3620956|FG000|STARTED|Dosing Schedule 1: Len & Cyc|All received Dose A-QD in cycle 1|3
2911283|NCT00482911|3620957|FG001|STARTED|Dosing Schedule 1: Len & Cyc||0
2911284|NCT00482911|3620956|FG000|COMPLETED|Dosing Schedule 1: Len & Cyc||3
2911285|NCT00482911|3620957|FG001|COMPLETED|Dosing Schedule 1: Len & Cyc||0
2911286|NCT00482911|3620956|FG000|NOT COMPLETED|Dosing Schedule 1: Len & Cyc||0
2911287|NCT00482911|3620957|FG001|NOT COMPLETED|Dosing Schedule 1: Len & Cyc||0
2911288|NCT00482911|3620956|FG000|STARTED|Dosing Schedule 1: Len, Cyc, & Sun|All received Dose B-QD in cycle 2|3
2911289|NCT00482911|3620957|FG001|STARTED|Dosing Schedule 1: Len, Cyc, & Sun|All received Dose B-QD in cycle 1|2
2911290|NCT00482911|3620956|FG000|COMPLETED|Dosing Schedule 1: Len, Cyc, & Sun|1 stopped at Dose B-QD, 1 stopped at Dose C-QD, 1 stopped at Dose C-QOD|3
2911291|NCT00482911|3620957|FG001|COMPLETED|Dosing Schedule 1: Len, Cyc, & Sun|1 stopped at Dose B-QD, 1 stopped at Dose C-QOD|2
2911292|NCT00482911|3620956|FG000|NOT COMPLETED|Dosing Schedule 1: Len, Cyc, & Sun||0
2911293|NCT00482911|3620957|FG001|NOT COMPLETED|Dosing Schedule 1: Len, Cyc, & Sun||0
3385169|NCT00838981|4120284|FG001|Completed Main Treatment on 400mg|Day 4 to Week 11||13
3385170|NCT00838981|4120285|FG002|Completed Main Treatment on 400mg|Day 4 to Week 11||17
3385171|NCT00838981|4120286|FG003|Completed Main Treatment on 400mg|Day 4 to Week 11||14
3385172|NCT00838981|4120283|FG000|COMPLETED|Day 4 to Week 11||19
3385173|NCT00838981|4120284|FG001|COMPLETED|Day 4 to Week 11||11
3385174|NCT00838981|4120285|FG002|COMPLETED|Day 4 to Week 11||16
3385175|NCT00838981|4120286|FG003|COMPLETED|Day 4 to Week 11||12
3385176|NCT00838981|4120283|FG000|NOT COMPLETED|Day 4 to Week 11||7
3385177|NCT00838981|4120284|FG001|NOT COMPLETED|Day 4 to Week 11||8
3385178|NCT00838981|4120285|FG002|NOT COMPLETED|Day 4 to Week 11||11
3385179|NCT00838981|4120286|FG003|NOT COMPLETED|Day 4 to Week 11||7
3385180|NCT00730639|4120305|FG000|STARTED|Overall Study||17
3385181|NCT00730639|4120306|FG001|STARTED|Overall Study||18
3385182|NCT00730639|4120307|FG002|STARTED|Overall Study||86
3385183|NCT00730639|4120308|FG003|STARTED|Overall Study||54
3385184|NCT00730639|4120309|FG004|STARTED|Overall Study||131
3385185|NCT00730639|4120305|FG000|COMPLETED|Overall Study||0
3385186|NCT00730639|4120306|FG001|COMPLETED|Overall Study||0
3385187|NCT00730639|4120307|FG002|COMPLETED|Overall Study||0
3385188|NCT00730639|4120308|FG003|COMPLETED|Overall Study||0
3385189|NCT00730639|4120309|FG004|COMPLETED|Overall Study||0
3385190|NCT00730639|4120305|FG000|NOT COMPLETED|Overall Study||17
3385191|NCT00730639|4120306|FG001|NOT COMPLETED|Overall Study||18
3385192|NCT00730639|4120307|FG002|NOT COMPLETED|Overall Study||86
3385193|NCT00730639|4120308|FG003|NOT COMPLETED|Overall Study||54
3385194|NCT00730639|4120309|FG004|NOT COMPLETED|Overall Study||131
3385195|NCT00693238|4120334|FG000|STARTED|Overall Study||122
3385196|NCT00693238|4120335|FG001|STARTED|Overall Study||106
3385197|NCT00693238|4120334|FG000|COMPLETED|Overall Study||122
3385198|NCT00693238|4120335|FG001|COMPLETED|Overall Study||106
3385199|NCT00693238|4120334|FG000|NOT COMPLETED|Overall Study||0
3385200|NCT00693238|4120335|FG001|NOT COMPLETED|Overall Study||0
3385201|NCT00363038|4120341|FG000|STARTED|Overall Study||16
3385202|NCT00363038|4120341|FG000|COMPLETED|Overall Study||16
3385203|NCT00363038|4120341|FG000|NOT COMPLETED|Overall Study||0
3386502|NCT04056182|4121849|FG000|STARTED|Overall Study||20
3386503|NCT04056182|4121849|FG000|COMPLETED|Overall Study||3
3386504|NCT04056182|4121849|FG000|NOT COMPLETED|Overall Study||17
3386505|NCT03954106|4121855|FG000|STARTED|Part 1: Safety Lead In Phase||4
3386506|NCT03954106|4121856|FG001|STARTED|Part 1: Safety Lead In Phase||0
3386507|NCT03954106|4121855|FG000|COMPLETED|Part 1: Safety Lead In Phase||4
3386508|NCT03954106|4121856|FG001|COMPLETED|Part 1: Safety Lead In Phase||0
3386509|NCT03954106|4121855|FG000|NOT COMPLETED|Part 1: Safety Lead In Phase||0
3386510|NCT03954106|4121856|FG001|NOT COMPLETED|Part 1: Safety Lead In Phase||0
3386511|NCT03954106|4121855|FG000|STARTED|Phase 2: Treatment at RP2D||0
3386512|NCT03954106|4121856|FG001|STARTED|Phase 2: Treatment at RP2D||21
3386513|NCT03954106|4121855|FG000|COMPLETED|Phase 2: Treatment at RP2D||0
3386514|NCT03954106|4121856|FG001|COMPLETED|Phase 2: Treatment at RP2D||21
3386515|NCT03954106|4121855|FG000|NOT COMPLETED|Phase 2: Treatment at RP2D||0
3386516|NCT03954106|4121856|FG001|NOT COMPLETED|Phase 2: Treatment at RP2D||0
3386517|NCT03921424|4121866|FG000|STARTED|Overall Study||203
3386518|NCT03921424|4121867|FG001|STARTED|Overall Study||204
3386519|NCT03921424|4121866|FG000|Vaccination 1 - (Day 1)|Overall Study||203
3386520|NCT03921424|4121867|FG001|Vaccination 1 - (Day 1)|Overall Study||204
3386521|NCT03921424|4121866|FG000|Vaccination 2 - (Week 8)|Overall Study||203
3386522|NCT03921424|4121867|FG001|Vaccination 2 - (Week 8)|Overall Study|Two participants did not receive Vaccination 2.|202
3386523|NCT03921424|4121866|FG000|COMPLETED|Overall Study||203
3386524|NCT03921424|4121867|FG001|COMPLETED|Overall Study||201
3386525|NCT03921424|4121866|FG000|NOT COMPLETED|Overall Study||0
3386526|NCT03921424|4121867|FG001|NOT COMPLETED|Overall Study||3
3386527|NCT03598777|4121880|FG000|STARTED|Overall Study||13
3386528|NCT03598777|4121881|FG001|STARTED|Overall Study||8
3386529|NCT03598777|4121882|FG002|STARTED|Overall Study||8
3386530|NCT03598777|4121883|FG003|STARTED|Overall Study||14
3386531|NCT03598777|4121884|FG004|STARTED|Overall Study||17
3386532|NCT03598777|4121880|FG000|Received Treatment in Cycle 1 DB Treatment Period|Overall Study||13
3386533|NCT03598777|4121881|FG001|Received Treatment in Cycle 1 DB Treatment Period|Overall Study||8
3386534|NCT03598777|4121882|FG002|Received Treatment in Cycle 1 DB Treatment Period|Overall Study||8
3386535|NCT03598777|4121883|FG003|Received Treatment in Cycle 1 DB Treatment Period|Overall Study||14
2911294|NCT00482911|3620956|FG000|STARTED|Dosing Schedule 2: Len, Cyc, & Sun||0
2911295|NCT00482911|3620957|FG001|STARTED|Dosing Schedule 2: Len, Cyc, & Sun|All received Dose D-QD in cycle 1|7
2911296|NCT00482911|3620956|FG000|COMPLETED|Dosing Schedule 2: Len, Cyc, & Sun||0
2911297|NCT00482911|3620957|FG001|COMPLETED|Dosing Schedule 2: Len, Cyc, & Sun|5 stopped at Dose D-QOD, 2 stopped at Dose D-QD (1 after first increasing to Dose E-QD)|7
2911298|NCT00482911|3620956|FG000|NOT COMPLETED|Dosing Schedule 2: Len, Cyc, & Sun||0
2911299|NCT00482911|3620957|FG001|NOT COMPLETED|Dosing Schedule 2: Len, Cyc, & Sun||0
2911300|NCT00483002|3620963|FG000|STARTED|Overall Study||3719
2911301|NCT00483002|3620963|FG000|COMPLETED|Overall Study||1165
2911302|NCT00483002|3620963|FG000|NOT COMPLETED|Overall Study||2554
2911303|NCT00483041|3620969|FG000|STARTED|Overall Study||5
3385204|NCT04834362|4120347|FG000|STARTED|Overall Study||53
3385205|NCT04834362|4120348|FG001|STARTED|Overall Study||52
3385206|NCT04834362|4120347|FG000|COMPLETED|Overall Study||52
3385207|NCT04834362|4120348|FG001|COMPLETED|Overall Study||50
3385208|NCT04834362|4120347|FG000|NOT COMPLETED|Overall Study||1
3385209|NCT04834362|4120348|FG001|NOT COMPLETED|Overall Study||2
3385210|NCT04681482|4120358|FG000|STARTED|Overall Study||35051
3385211|NCT04681482|4120359|FG001|STARTED|Overall Study||38756
3385212|NCT04681482|4120360|FG002|STARTED|Overall Study||12148
3385213|NCT04681482|4120361|FG003|STARTED|Overall Study||21428
3385214|NCT04681482|4120358|FG000|COMPLETED|Overall Study||35051
3385215|NCT04681482|4120359|FG001|COMPLETED|Overall Study||38756
3385216|NCT04681482|4120360|FG002|COMPLETED|Overall Study||12148
3385217|NCT04681482|4120361|FG003|COMPLETED|Overall Study||21428
3385218|NCT04681482|4120358|FG000|NOT COMPLETED|Overall Study||0
3385219|NCT04681482|4120359|FG001|NOT COMPLETED|Overall Study||0
3385220|NCT04681482|4120360|FG002|NOT COMPLETED|Overall Study||0
3385221|NCT04681482|4120361|FG003|NOT COMPLETED|Overall Study||0
3385222|NCT04611789|4120374|FG000|STARTED|Overall Study||4
3385223|NCT04611789|4120375|FG001|STARTED|Overall Study||7
3385224|NCT04611789|4120376|FG002|STARTED|Overall Study||7
3385225|NCT04611789|4120374|FG000|COMPLETED|Overall Study||3
3385226|NCT04611789|4120375|FG001|COMPLETED|Overall Study||7
3385227|NCT04611789|4120376|FG002|COMPLETED|Overall Study||7
3385228|NCT04611789|4120374|FG000|NOT COMPLETED|Overall Study||1
3385229|NCT04611789|4120375|FG001|NOT COMPLETED|Overall Study||0
3385230|NCT04611789|4120376|FG002|NOT COMPLETED|Overall Study||0
3385231|NCT04540952|4120385|FG000|STARTED|Overall Study||34
3385232|NCT04540952|4120386|FG001|STARTED|Overall Study||34
3385233|NCT04540952|4120385|FG000|COMPLETED|Overall Study||34
3385234|NCT04540952|4120386|FG001|COMPLETED|Overall Study||34
3385235|NCT04540952|4120385|FG000|NOT COMPLETED|Overall Study||0
3385236|NCT04540952|4120386|FG001|NOT COMPLETED|Overall Study||0
3385237|NCT04537910|4120398|FG000|STARTED|Overall Study||6
3385238|NCT04537910|4120399|FG001|STARTED|Overall Study||5
3385239|NCT04537910|4120400|FG002|STARTED|Overall Study||7
3385240|NCT04537910|4120401|FG003|STARTED|Overall Study||7
3385241|NCT04537910|4120398|FG000|Received at Least One Dose of Study Drug|Overall Study||6
3385242|NCT04537910|4120399|FG001|Received at Least One Dose of Study Drug|Overall Study||5
3385243|NCT04537910|4120400|FG002|Received at Least One Dose of Study Drug|Overall Study||7
3385244|NCT04537910|4120401|FG003|Received at Least One Dose of Study Drug|Overall Study||7
3385245|NCT04537910|4120398|FG000|COMPLETED|Overall Study||6
3385246|NCT04537910|4120399|FG001|COMPLETED|Overall Study||5
3385247|NCT04537910|4120400|FG002|COMPLETED|Overall Study||7
3385248|NCT04537910|4120401|FG003|COMPLETED|Overall Study||7
3385249|NCT04537910|4120398|FG000|NOT COMPLETED|Overall Study||0
3385250|NCT04537910|4120399|FG001|NOT COMPLETED|Overall Study||0
3385251|NCT04537910|4120400|FG002|NOT COMPLETED|Overall Study||0
3385252|NCT04537910|4120401|FG003|NOT COMPLETED|Overall Study||0
3386536|NCT03598777|4121884|FG004|Received Treatment in Cycle 1 DB Treatment Period|Overall Study||17
3386537|NCT03598777|4121880|FG000|Retreated in Cycle 2 OL Treatment Period|Overall Study||13
3386538|NCT03598777|4121881|FG001|Retreated in Cycle 2 OL Treatment Period|Overall Study||7
3386539|NCT03598777|4121882|FG002|Retreated in Cycle 2 OL Treatment Period|Overall Study||8
3386540|NCT03598777|4121883|FG003|Retreated in Cycle 2 OL Treatment Period|Overall Study||13
3386541|NCT03598777|4121884|FG004|Retreated in Cycle 2 OL Treatment Period|Overall Study||11
3386542|NCT03598777|4121880|FG000|Retreated in Cycle 3 OL Treatment Period|Overall Study||8
3386543|NCT03598777|4121881|FG001|Retreated in Cycle 3 OL Treatment Period|Overall Study||6
3386544|NCT03598777|4121882|FG002|Retreated in Cycle 3 OL Treatment Period|Overall Study||6
3386545|NCT03598777|4121883|FG003|Retreated in Cycle 3 OL Treatment Period|Overall Study||12
3386546|NCT03598777|4121884|FG004|Retreated in Cycle 3 OL Treatment Period|Overall Study||2
3386547|NCT03598777|4121880|FG000|Retreated in Cycle 4 OL Treatment Period|Overall Study||1
3386548|NCT03598777|4121881|FG001|Retreated in Cycle 4 OL Treatment Period|Overall Study||0
3386549|NCT03598777|4121882|FG002|Retreated in Cycle 4 OL Treatment Period|Overall Study||1
3386550|NCT03598777|4121883|FG003|Retreated in Cycle 4 OL Treatment Period|Overall Study||3
3386551|NCT03598777|4121884|FG004|Retreated in Cycle 4 OL Treatment Period|Overall Study||0
3386552|NCT03598777|4121880|FG000|COMPLETED|Overall Study||7
3386553|NCT03598777|4121881|FG001|COMPLETED|Overall Study||7
3386554|NCT03598777|4121882|FG002|COMPLETED|Overall Study||8
3386555|NCT03598777|4121883|FG003|COMPLETED|Overall Study||14
3386556|NCT03598777|4121884|FG004|COMPLETED|Overall Study||2
3386557|NCT03598777|4121880|FG000|NOT COMPLETED|Overall Study||6
2911304|NCT00483041|3620970|FG001|STARTED|Overall Study||6
3386558|NCT03598777|4121881|FG001|NOT COMPLETED|Overall Study||1
3386559|NCT03598777|4121882|FG002|NOT COMPLETED|Overall Study||0
2911305|NCT00483041|3620969|FG000|COMPLETED|Overall Study||5
2911306|NCT00483041|3620970|FG001|COMPLETED|Overall Study||5
2911307|NCT00483041|3620969|FG000|NOT COMPLETED|Overall Study||0
2911308|NCT00483041|3620970|FG001|NOT COMPLETED|Overall Study||1
2911309|NCT00483184|3620979|FG000|STARTED|Overall Study||27
2911310|NCT00483184|3620980|FG001|STARTED|Overall Study||31
2911311|NCT00483184|3620981|FG002|STARTED|Overall Study||26
2911312|NCT00483184|3620979|FG000|COMPLETED|Overall Study||22
2911313|NCT00483184|3620980|FG001|COMPLETED|Overall Study||27
2911314|NCT00483184|3620981|FG002|COMPLETED|Overall Study||23
2911315|NCT00483184|3620979|FG000|NOT COMPLETED|Overall Study||5
2911316|NCT00483184|3620980|FG001|NOT COMPLETED|Overall Study||4
2911317|NCT00483184|3620981|FG002|NOT COMPLETED|Overall Study||3
2911318|NCT00483223|3620989|FG000|STARTED|Overall Study||86
2911319|NCT00483223|3620989|FG000|COMPLETED|Overall Study||86
2911320|NCT00483223|3620989|FG000|NOT COMPLETED|Overall Study||0
2911321|NCT00483262|3620995|FG000|STARTED|Overall Study||20
2911322|NCT00483262|3620996|FG001|STARTED|Overall Study||43
2911323|NCT00483262|3620995|FG000|COMPLETED|Overall Study||20
3385253|NCT04441931|4120414|FG000|STARTED|Overall Study||6
3385254|NCT04441931|4120415|FG001|STARTED|Overall Study||7
3385255|NCT04441931|4120416|FG002|STARTED|Overall Study||7
3385256|NCT04441931|4120417|FG003|STARTED|Overall Study||6
3385257|NCT04441931|4120414|FG000|Received at Least One Dose of Study Drug|Overall Study||6
3385258|NCT04441931|4120415|FG001|Received at Least One Dose of Study Drug|Overall Study||7
3385259|NCT04441931|4120416|FG002|Received at Least One Dose of Study Drug|Overall Study||7
3385260|NCT04441931|4120417|FG003|Received at Least One Dose of Study Drug|Overall Study||6
3385261|NCT04441931|4120414|FG000|COMPLETED|Overall Study||6
3385262|NCT04441931|4120415|FG001|COMPLETED|Overall Study||7
3385263|NCT04441931|4120416|FG002|COMPLETED|Overall Study||7
3385264|NCT04441931|4120417|FG003|COMPLETED|Overall Study||6
3385265|NCT04441931|4120414|FG000|NOT COMPLETED|Overall Study||0
3385266|NCT04441931|4120415|FG001|NOT COMPLETED|Overall Study||0
3385267|NCT04441931|4120416|FG002|NOT COMPLETED|Overall Study||0
3385268|NCT04441931|4120417|FG003|NOT COMPLETED|Overall Study||0
3385269|NCT04355728|4120432|FG000|STARTED|Overall Study||12
3385270|NCT04355728|4120433|FG001|STARTED|Overall Study||12
3385271|NCT04355728|4120432|FG000|COMPLETED|Overall Study||12
3385272|NCT04355728|4120433|FG001|COMPLETED|Overall Study||12
3385273|NCT04355728|4120432|FG000|NOT COMPLETED|Overall Study||0
3385274|NCT04355728|4120433|FG001|NOT COMPLETED|Overall Study||0
3385275|NCT04344535|4120441|FG000|STARTED|Overall Study||59
3385276|NCT04344535|4120442|FG001|STARTED|Overall Study||15
3385277|NCT04344535|4120441|FG000|COMPLETED|Overall Study||59
3385278|NCT04344535|4120442|FG001|COMPLETED|Overall Study||15
3385279|NCT04344535|4120441|FG000|NOT COMPLETED|Overall Study||0
3385280|NCT04344535|4120442|FG001|NOT COMPLETED|Overall Study||0
3385281|NCT04254809|4120450|FG000|STARTED|Overall Study||48
3385282|NCT04254809|4120451|FG001|STARTED|Overall Study||48
3385283|NCT04254809|4120450|FG000|COMPLETED|Overall Study||43
3385284|NCT04254809|4120451|FG001|COMPLETED|Overall Study||38
3385285|NCT04254809|4120450|FG000|NOT COMPLETED|Overall Study||5
3385286|NCT04254809|4120451|FG001|NOT COMPLETED|Overall Study||10
3385287|NCT04230122|4120459|FG000|STARTED|Overall Study||3
3385288|NCT04230122|4120460|FG001|STARTED|Overall Study||1
3385289|NCT04230122|4120459|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
3385290|NCT04230122|4120460|FG001|Received at Least 1 Dose of Study Drug|Overall Study||1
3385291|NCT04230122|4120459|FG000|COMPLETED|Overall Study||2
3385292|NCT04230122|4120460|FG001|COMPLETED|Overall Study||1
3385293|NCT04230122|4120459|FG000|NOT COMPLETED|Overall Study||1
3385294|NCT04230122|4120460|FG001|NOT COMPLETED|Overall Study||0
3385295|NCT04110366|4120468|FG000|STARTED|Overall Study||40
3385296|NCT04110366|4120469|FG001|STARTED|Overall Study||8
3385297|NCT04110366|4120468|FG000|COMPLETED|Overall Study||40
3385298|NCT04110366|4120469|FG001|COMPLETED|Overall Study||8
3385299|NCT04110366|4120468|FG000|NOT COMPLETED|Overall Study||0
3385300|NCT04110366|4120469|FG001|NOT COMPLETED|Overall Study||0
3385301|NCT04086693|4120478|FG000|STARTED|Overall Study||175
3385302|NCT04086693|4120479|FG001|STARTED|Overall Study||175
3385303|NCT04086693|4120478|FG000|COMPLETED|Overall Study||174
3385304|NCT04086693|4120479|FG001|COMPLETED|Overall Study||171
3385305|NCT04086693|4120478|FG000|NOT COMPLETED|Overall Study||1
3385306|NCT04086693|4120479|FG001|NOT COMPLETED|Overall Study||4
3385307|NCT04033068|4120489|FG000|STARTED|Overall Study||14
3385308|NCT04033068|4120490|FG001|STARTED|Overall Study||14
3385309|NCT04033068|4120491|FG002|STARTED|Overall Study||12
3385310|NCT04033068|4120492|FG003|STARTED|Overall Study||8
3385311|NCT04033068|4120489|FG000|First Dose|Overall Study||14
3385312|NCT04033068|4120490|FG001|First Dose|Overall Study||14
3385313|NCT04033068|4120491|FG002|First Dose|Overall Study||12
3385314|NCT04033068|4120492|FG003|First Dose|Overall Study||8
3385315|NCT04033068|4120489|FG000|Second Dose|Overall Study||14
3385316|NCT04033068|4120490|FG001|Second Dose|Overall Study||14
3385317|NCT04033068|4120491|FG002|Second Dose|Overall Study||11
3385318|NCT04033068|4120492|FG003|Second Dose|Overall Study||7
3385319|NCT04033068|4120489|FG000|COMPLETED|Overall Study||14
3385320|NCT04033068|4120490|FG001|COMPLETED|Overall Study||13
3385321|NCT04033068|4120491|FG002|COMPLETED|Overall Study||11
3385322|NCT04033068|4120492|FG003|COMPLETED|Overall Study||7
3385323|NCT04033068|4120489|FG000|NOT COMPLETED|Overall Study||0
3385324|NCT04033068|4120490|FG001|NOT COMPLETED|Overall Study||1
2911324|NCT00483262|3620996|FG001|COMPLETED|Overall Study||43
2911325|NCT00483262|3620995|FG000|NOT COMPLETED|Overall Study||0
2911326|NCT00483262|3620996|FG001|NOT COMPLETED|Overall Study||0
2911327|NCT00483327|3621006|FG000|STARTED|Overall Study||30
2911328|NCT00483327|3621006|FG000|COMPLETED|Overall Study||20
2911329|NCT00483327|3621006|FG000|NOT COMPLETED|Overall Study||10
2911330|NCT00483379|3621014|FG000|STARTED|Treatment Period||6
2911331|NCT00483379|3621015|FG001|STARTED|Treatment Period||7
2911332|NCT00483379|3621014|FG000|COMPLETED|Treatment Period||4
2911333|NCT00483379|3621015|FG001|COMPLETED|Treatment Period||7
2911334|NCT00483379|3621014|FG000|NOT COMPLETED|Treatment Period||2
2911335|NCT00483379|3621015|FG001|NOT COMPLETED|Treatment Period||0
2911336|NCT00483379|3621014|FG000|STARTED|Extension Period|Extension allowed late-onset participants access to treatment until commercially available.|1
2911337|NCT00483379|3621015|FG001|STARTED|Extension Period|Extension allowed late-onset participants access to treatment until commercially available.|2
2911338|NCT00483379|3621014|FG000|COMPLETED|Extension Period||1
2911339|NCT00483379|3621015|FG001|COMPLETED|Extension Period||2
2911340|NCT00483379|3621014|FG000|NOT COMPLETED|Extension Period||0
2911341|NCT00483379|3621015|FG001|NOT COMPLETED|Extension Period||0
2911342|NCT00483405|3621023|FG000|STARTED|Overall Study||28
2911343|NCT00483405|3621023|FG000|COMPLETED|Overall Study||0
2911344|NCT00483405|3621023|FG000|NOT COMPLETED|Overall Study||28
2911345|NCT00483496|3621027|FG000|STARTED|Overall Study||16
2911346|NCT00483496|3621027|FG000|COMPLETED|Overall Study||15
2911347|NCT00483496|3621027|FG000|NOT COMPLETED|Overall Study||1
2911348|NCT00483509|3621039|FG000|STARTED|Overall Study||28
2911349|NCT00483509|3621039|FG000|COMPLETED|Overall Study||28
2911350|NCT00483509|3621039|FG000|NOT COMPLETED|Overall Study||0
2911351|NCT00483548|3621045|FG000|STARTED|Overall Study||148
2911352|NCT00483548|3621046|FG001|STARTED|Overall Study||150
2911353|NCT00483548|3621045|FG000|Received Study Treatment|Overall Study|1 subject randomized but lost to follow up; no treatment data.|147
2911354|NCT00483548|3621046|FG001|Received Study Treatment|Overall Study|3 subjects randomized but not treated.|147
2911355|NCT00483548|3621045|FG000|COMPLETED|Overall Study||88
2911356|NCT00483548|3621046|FG001|COMPLETED|Overall Study||104
2911357|NCT00483548|3621045|FG000|NOT COMPLETED|Overall Study||60
2911358|NCT00483548|3621046|FG001|NOT COMPLETED|Overall Study||46
2911359|NCT00483561|3621052|FG000|STARTED|Overall Study||26
2911360|NCT00483561|3621052|FG000|COMPLETED|Overall Study||15
2911361|NCT00483561|3621052|FG000|NOT COMPLETED|Overall Study||11
3385325|NCT04033068|4120491|FG002|NOT COMPLETED|Overall Study||1
3385326|NCT04033068|4120492|FG003|NOT COMPLETED|Overall Study||1
3386560|NCT03598777|4121883|FG003|NOT COMPLETED|Overall Study||0
3386561|NCT03598777|4121884|FG004|NOT COMPLETED|Overall Study||15
3386562|NCT03406078|4121901|FG000|STARTED|Overall Study||74
3386563|NCT03406078|4121902|FG001|STARTED|Overall Study||76
3386564|NCT03406078|4121901|FG000|COMPLETED|Overall Study||68
3386565|NCT03406078|4121902|FG001|COMPLETED|Overall Study||73
3386566|NCT03406078|4121901|FG000|NOT COMPLETED|Overall Study||6
3386567|NCT03406078|4121902|FG001|NOT COMPLETED|Overall Study||3
3386568|NCT03397589|4121910|FG000|STARTED|Overall Study||211
3386569|NCT03397589|4121911|FG001|STARTED|Overall Study||209
3386570|NCT03397589|4121910|FG000|COMPLETED|Overall Study||175
3386571|NCT03397589|4121911|FG001|COMPLETED|Overall Study||187
3386572|NCT03397589|4121910|FG000|NOT COMPLETED|Overall Study||36
3386573|NCT03397589|4121911|FG001|NOT COMPLETED|Overall Study||22
3386574|NCT03368066|4121917|FG000|STARTED|Overall Study||58
3386575|NCT03368066|4121918|FG001|STARTED|Overall Study||37
3386576|NCT03368066|4121917|FG000|COMPLETED|Overall Study||58
3386577|NCT03368066|4121918|FG001|COMPLETED|Overall Study||37
3386578|NCT03368066|4121917|FG000|NOT COMPLETED|Overall Study||0
3386579|NCT03368066|4121918|FG001|NOT COMPLETED|Overall Study||0
3386580|NCT03345342|4121924|FG000|STARTED|Open-Label Phase||838
3386581|NCT03345342|4121925|FG001|STARTED|Open-Label Phase||0
3386582|NCT03345342|4121926|FG002|STARTED|Open-Label Phase||0
3386583|NCT03345342|4121927|FG003|STARTED|Open-Label Phase||0
3386584|NCT03345342|4121928|FG004|STARTED|Open-Label Phase||0
3386585|NCT03345342|4121924|FG000|COMPLETED|Open-Label Phase||702
3386586|NCT03345342|4121925|FG001|COMPLETED|Open-Label Phase||0
3386587|NCT03345342|4121926|FG002|COMPLETED|Open-Label Phase||0
3386588|NCT03345342|4121927|FG003|COMPLETED|Open-Label Phase||0
3386589|NCT03345342|4121928|FG004|COMPLETED|Open-Label Phase||0
3386590|NCT03345342|4121924|FG000|NOT COMPLETED|Open-Label Phase||136
3386591|NCT03345342|4121925|FG001|NOT COMPLETED|Open-Label Phase||0
3386592|NCT03345342|4121926|FG002|NOT COMPLETED|Open-Label Phase||0
3386593|NCT03345342|4121927|FG003|NOT COMPLETED|Open-Label Phase||0
3386594|NCT03345342|4121928|FG004|NOT COMPLETED|Open-Label Phase||0
3386595|NCT03345342|4121924|FG000|STARTED|Double-Blind Phase||0
3386596|NCT03345342|4121925|FG001|STARTED|Double-Blind Phase|Participants from the OL phase have continued in the DB phase.|224
3386597|NCT03345342|4121926|FG002|STARTED|Double-Blind Phase|Participants from the OL phase have continued in the DB phase.|478
3386598|NCT03345342|4121927|FG003|STARTED|Double-Blind Phase||0
3386599|NCT03345342|4121928|FG004|STARTED|Double-Blind Phase||0
3386600|NCT03345342|4121924|FG000|COMPLETED|Double-Blind Phase||0
3386601|NCT03345342|4121925|FG001|COMPLETED|Double-Blind Phase||202
3386602|NCT03345342|4121926|FG002|COMPLETED|Double-Blind Phase||416
3386603|NCT03345342|4121927|FG003|COMPLETED|Double-Blind Phase||0
2911362|NCT00483574|3621058|FG000|STARTED|Overall Study||1053
2911363|NCT00483574|3621059|FG001|STARTED|Overall Study||321
2911364|NCT00483574|3621058|FG000|COMPLETED|Overall Study||951
2911365|NCT00483574|3621059|FG001|COMPLETED|Overall Study||308
2911366|NCT00483574|3621058|FG000|NOT COMPLETED|Overall Study||102
2911367|NCT00483574|3621059|FG001|NOT COMPLETED|Overall Study||13
2911368|NCT00483652|3621069|FG000|STARTED|Double-blind Treatment Period||120
3171678|NCT01936324|3898836|FG002|STARTED|Overall Study||55
3385327|NCT03561597|4120502|FG000|STARTED|Overall Study|Recruited|40
3385328|NCT03561597|4120502|FG000|3 Month Follow up|Overall Study|Attended 3 month follow up|21
3385329|NCT03561597|4120502|FG000|COMPLETED|Overall Study|Attend month 6 follow up|20
3385330|NCT03561597|4120502|FG000|NOT COMPLETED|Overall Study||20
3385331|NCT03446573|4120508|FG000|STARTED|Overall Study||369
3385332|NCT03446573|4120509|FG001|STARTED|Overall Study||372
3385333|NCT03446573|4120508|FG000|COMPLETED|Overall Study||0
3385334|NCT03446573|4120509|FG001|COMPLETED|Overall Study||0
3385335|NCT03446573|4120508|FG000|NOT COMPLETED|Overall Study||369
3385336|NCT03446573|4120509|FG001|NOT COMPLETED|Overall Study||372
3385337|NCT03402607|4120520|FG000|STARTED|Overall Study||6
3385338|NCT03402607|4120521|FG001|STARTED|Overall Study||6
3385339|NCT03402607|4120520|FG000|COMPLETED|Overall Study||6
3385340|NCT03402607|4120521|FG001|COMPLETED|Overall Study||6
3385341|NCT03402607|4120520|FG000|NOT COMPLETED|Overall Study||0
3385342|NCT03402607|4120521|FG001|NOT COMPLETED|Overall Study||0
3385343|NCT03350984|4120529|FG000|STARTED|Overall Study||39
3385344|NCT03350984|4120530|FG001|STARTED|Overall Study||36
3385345|NCT03350984|4120529|FG000|COMPLETED|Overall Study||31
3385346|NCT03350984|4120530|FG001|COMPLETED|Overall Study||28
3385347|NCT03350984|4120529|FG000|NOT COMPLETED|Overall Study||8
3385348|NCT03350984|4120530|FG001|NOT COMPLETED|Overall Study||8
3385349|NCT03277261|4120538|FG000|STARTED|Overall Study||274
3385350|NCT03277261|4120539|FG001|STARTED|Overall Study||275
3171679|NCT01936324|3898834|FG000|COMPLETED|Overall Study||6
3171680|NCT01936324|3898835|FG001|COMPLETED|Overall Study||47
3171681|NCT01936324|3898836|FG002|COMPLETED|Overall Study||50
3385351|NCT03277261|4120538|FG000|COMPLETED|Overall Study||240
3385352|NCT03277261|4120539|FG001|COMPLETED|Overall Study||252
3385353|NCT03277261|4120538|FG000|NOT COMPLETED|Overall Study||34
3385354|NCT03277261|4120539|FG001|NOT COMPLETED|Overall Study||23
3385355|NCT03277248|4120548|FG000|STARTED|Overall Study||272
3385356|NCT03277248|4120549|FG001|STARTED|Overall Study||273
3385357|NCT03277248|4120548|FG000|COMPLETED|Overall Study||254
3385358|NCT03277248|4120549|FG001|COMPLETED|Overall Study||239
3385359|NCT03277248|4120548|FG000|NOT COMPLETED|Overall Study||18
3385360|NCT03277248|4120549|FG001|NOT COMPLETED|Overall Study||34
3385361|NCT03179462|4120558|FG000|STARTED|Overall Study||9
3385362|NCT03179462|4120559|FG001|STARTED|Overall Study||10
3385363|NCT03179462|4120560|FG002|STARTED|Overall Study||8
3385364|NCT03179462|4120558|FG000|COMPLETED|Overall Study||8
3385365|NCT03179462|4120559|FG001|COMPLETED|Overall Study||8
3385366|NCT03179462|4120560|FG002|COMPLETED|Overall Study||8
3385367|NCT03179462|4120558|FG000|NOT COMPLETED|Overall Study||1
3385368|NCT03179462|4120559|FG001|NOT COMPLETED|Overall Study||2
3385369|NCT03179462|4120560|FG002|NOT COMPLETED|Overall Study||0
3385370|NCT03099707|4120570|FG000|STARTED|Overall Study||43
3385371|NCT03099707|4120571|FG001|STARTED|Overall Study||41
3385372|NCT03099707|4120570|FG000|COMPLETED|Overall Study||43
3385373|NCT03099707|4120571|FG001|COMPLETED|Overall Study||37
3385374|NCT03099707|4120570|FG000|NOT COMPLETED|Overall Study||0
3385375|NCT03099707|4120571|FG001|NOT COMPLETED|Overall Study||4
3385376|NCT03064763|4120577|FG000|STARTED|Overall Study||18
3385377|NCT03064763|4120577|FG000|Received Treatment|Overall Study||18
3385378|NCT03064763|4120577|FG000|COMPLETED|Overall Study||0
3385379|NCT03064763|4120577|FG000|NOT COMPLETED|Overall Study||18
3385380|NCT03036267|4120581|FG000|STARTED|Overall Study||46
3385381|NCT03036267|4120581|FG000|COMPLETED|Overall Study||46
3385382|NCT03036267|4120581|FG000|NOT COMPLETED|Overall Study||0
3385383|NCT02941146|4120585|FG000|STARTED|Overall Study||15
3385384|NCT02941146|4120585|FG000|COMPLETED|Overall Study||15
3385385|NCT02941146|4120585|FG000|NOT COMPLETED|Overall Study||0
3385386|NCT02928224|4120593|FG000|STARTED|Overall Study||37
3385387|NCT02928224|4120594|FG001|STARTED|Overall Study||224
3385388|NCT02928224|4120595|FG002|STARTED|Overall Study||220
3385389|NCT02928224|4120596|FG003|STARTED|Overall Study||221
3385390|NCT02928224|4120593|FG000|COMPLETED|Overall Study||0
3385391|NCT02928224|4120594|FG001|COMPLETED|Overall Study||0
3385392|NCT02928224|4120595|FG002|COMPLETED|Overall Study||0
3385393|NCT02928224|4120596|FG003|COMPLETED|Overall Study||0
3385394|NCT02928224|4120593|FG000|NOT COMPLETED|Overall Study||37
3385395|NCT02928224|4120594|FG001|NOT COMPLETED|Overall Study||224
3385396|NCT02928224|4120595|FG002|NOT COMPLETED|Overall Study||220
3385397|NCT02928224|4120596|FG003|NOT COMPLETED|Overall Study||221
3385398|NCT02922985|4120613|FG000|STARTED|Overall Study||60
3385399|NCT02922985|4120614|FG001|STARTED|Overall Study||60
3385400|NCT02922985|4120613|FG000|COMPLETED|Overall Study||60
3385401|NCT02922985|4120614|FG001|COMPLETED|Overall Study||60
3385402|NCT02922985|4120613|FG000|NOT COMPLETED|Overall Study||0
3385403|NCT02922985|4120614|FG001|NOT COMPLETED|Overall Study||0
3385404|NCT02906033|4120624|FG000|STARTED|Baseline||231
3385405|NCT02906033|4120625|FG001|STARTED|Baseline||222
3385406|NCT02906033|4120624|FG000|15 D at Baseline|Baseline||211
3385407|NCT02906033|4120625|FG001|15 D at Baseline|Baseline||189
3385408|NCT02906033|4120624|FG000|STATE at Baseline|Baseline||199
3385409|NCT02906033|4120625|FG001|STATE at Baseline|Baseline||190
3385410|NCT02906033|4120624|FG000|TRAIT at Baseline|Baseline||194
3385411|NCT02906033|4120625|FG001|TRAIT at Baseline|Baseline||189
2911369|NCT00483652|3621070|FG001|STARTED|Double-blind Treatment Period||119
2911370|NCT00483652|3621069|FG000|COMPLETED|Double-blind Treatment Period||113
2911371|NCT00483652|3621070|FG001|COMPLETED|Double-blind Treatment Period||114
3385412|NCT02906033|4120624|FG000|COMPLETED|Baseline|Analyzed at baseline for 15 D and STATE anxiety and TRAIT anxiety|194
3385413|NCT02906033|4120625|FG001|COMPLETED|Baseline|Analyzed at baseline for 15 D and STATE anxiety and TRAIT anxiety.|189
3385414|NCT02906033|4120624|FG000|NOT COMPLETED|Baseline||37
3385415|NCT02906033|4120625|FG001|NOT COMPLETED|Baseline||33
3385416|NCT02906033|4120624|FG000|STARTED|Follow-up||194
3385417|NCT02906033|4120625|FG001|STARTED|Follow-up||189
3385418|NCT02906033|4120624|FG000|15 D at Follow-up|Follow-up||151
3385419|NCT02906033|4120625|FG001|15 D at Follow-up|Follow-up||135
3385420|NCT02906033|4120624|FG000|STATE at Follow-up|Follow-up||154
3385421|NCT02906033|4120625|FG001|STATE at Follow-up|Follow-up||135
3385422|NCT02906033|4120624|FG000|TRAIT at Follow-up|Follow-up||148
3385423|NCT02906033|4120625|FG001|TRAIT at Follow-up|Follow-up||127
3385424|NCT02906033|4120624|FG000|COMPLETED|Follow-up|Analyzed for 15 D and STATE anxiety and TRAIT anxiety at follow-up|148
3385425|NCT02906033|4120625|FG001|COMPLETED|Follow-up|Analyzed at follow-up 15 D and STATE anxiety and TRAIT anxiety.|127
3385426|NCT02906033|4120624|FG000|NOT COMPLETED|Follow-up||46
3385427|NCT02906033|4120625|FG001|NOT COMPLETED|Follow-up||62
3385428|NCT02837783|4120633|FG000|STARTED|Overall Study||9
3385429|NCT02837783|4120634|FG001|STARTED|Overall Study||11
3385430|NCT02837783|4120633|FG000|Received >= 1 Dose of Study Drug|Overall Study||9
3385431|NCT02837783|4120634|FG001|Received >= 1 Dose of Study Drug|Overall Study||10
3385432|NCT02837783|4120633|FG000|COMPLETED|Overall Study||7
3385433|NCT02837783|4120634|FG001|COMPLETED|Overall Study||9
3385434|NCT02837783|4120633|FG000|NOT COMPLETED|Overall Study||2
3385435|NCT02837783|4120634|FG001|NOT COMPLETED|Overall Study||2
3385436|NCT02786537|4120646|FG000|STARTED|As Randomized||56
3385437|NCT02786537|4120647|FG001|STARTED|As Randomized||644
3385438|NCT02786537|4120648|FG002|STARTED|As Randomized||15
3385439|NCT02786537|4120649|FG003|STARTED|As Randomized||413
3385440|NCT02786537|4120650|FG004|STARTED|As Randomized||99
3385441|NCT02786537|4120651|FG005|STARTED|As Randomized||48
3385442|NCT02786537|4120646|FG000|COMPLETED|As Randomized||50
3385443|NCT02786537|4120647|FG001|COMPLETED|As Randomized||582
3385444|NCT02786537|4120648|FG002|COMPLETED|As Randomized||15
3385445|NCT02786537|4120649|FG003|COMPLETED|As Randomized||378
3385446|NCT02786537|4120650|FG004|COMPLETED|As Randomized||87
3385447|NCT02786537|4120651|FG005|COMPLETED|As Randomized||41
3171682|NCT01936324|3898834|FG000|NOT COMPLETED|Overall Study||0
3171683|NCT01936324|3898835|FG001|NOT COMPLETED|Overall Study||6
3171684|NCT01936324|3898836|FG002|NOT COMPLETED|Overall Study||5
3171685|NCT01936363|3898845|FG000|STARTED|Overall Study||32
3171686|NCT01936363|3898846|FG001|STARTED|Overall Study||33
3171687|NCT01936363|3898845|FG000|COMPLETED|Overall Study||32
3171688|NCT01936363|3898846|FG001|COMPLETED|Overall Study||33
3171689|NCT01936363|3898845|FG000|NOT COMPLETED|Overall Study||0
3385448|NCT02786537|4120646|FG000|NOT COMPLETED|As Randomized||6
3385449|NCT02786537|4120647|FG001|NOT COMPLETED|As Randomized||62
3385450|NCT02786537|4120648|FG002|NOT COMPLETED|As Randomized||0
3385451|NCT02786537|4120649|FG003|NOT COMPLETED|As Randomized||35
3385452|NCT02786537|4120650|FG004|NOT COMPLETED|As Randomized||12
3385453|NCT02786537|4120651|FG005|NOT COMPLETED|As Randomized||7
3385454|NCT02786537|4120646|FG000|STARTED|As Treated||56
3385455|NCT02786537|4120647|FG001|STARTED|As Treated||664
3385456|NCT02786537|4120648|FG002|STARTED|As Treated||15
3385457|NCT02786537|4120649|FG003|STARTED|As Treated||394
3385458|NCT02786537|4120650|FG004|STARTED|As Treated||99
3385459|NCT02786537|4120651|FG005|STARTED|As Treated||47
3385460|NCT02786537|4120646|FG000|COMPLETED|As Treated||50
3385461|NCT02786537|4120647|FG001|COMPLETED|As Treated||602
3385462|NCT02786537|4120648|FG002|COMPLETED|As Treated||15
3385463|NCT02786537|4120649|FG003|COMPLETED|As Treated||359
3385464|NCT02786537|4120650|FG004|COMPLETED|As Treated||87
3385465|NCT02786537|4120651|FG005|COMPLETED|As Treated||40
3385466|NCT02786537|4120646|FG000|NOT COMPLETED|As Treated||6
3385467|NCT02786537|4120647|FG001|NOT COMPLETED|As Treated||62
3385468|NCT02786537|4120648|FG002|NOT COMPLETED|As Treated||0
3385469|NCT02786537|4120649|FG003|NOT COMPLETED|As Treated||35
3385470|NCT02786537|4120650|FG004|NOT COMPLETED|As Treated||12
3385471|NCT02786537|4120651|FG005|NOT COMPLETED|As Treated||7
3385472|NCT02740231|4120761|FG000|STARTED|Overall Study||41
3385473|NCT02740231|4120762|FG001|STARTED|Overall Study||41
3385474|NCT02740231|4120763|FG002|STARTED|Overall Study||41
3385475|NCT02740231|4120764|FG003|STARTED|Overall Study||41
3385476|NCT02740231|4120761|FG000|COMPLETED|Overall Study||39
3385477|NCT02740231|4120762|FG001|COMPLETED|Overall Study||35
3385478|NCT02740231|4120763|FG002|COMPLETED|Overall Study||40
3385479|NCT02740231|4120764|FG003|COMPLETED|Overall Study||33
3385480|NCT02740231|4120761|FG000|NOT COMPLETED|Overall Study||2
3385481|NCT02740231|4120762|FG001|NOT COMPLETED|Overall Study||6
3385482|NCT02740231|4120763|FG002|NOT COMPLETED|Overall Study||1
3385483|NCT02740231|4120764|FG003|NOT COMPLETED|Overall Study||8
3385484|NCT02710084|4120776|FG000|STARTED|First Phase - 12 Weeks||10
3385485|NCT02710084|4120777|FG001|STARTED|First Phase - 12 Weeks||8
3385486|NCT02710084|4120776|FG000|COMPLETED|First Phase - 12 Weeks||7
3385487|NCT02710084|4120777|FG001|COMPLETED|First Phase - 12 Weeks||7
3385488|NCT02710084|4120776|FG000|NOT COMPLETED|First Phase - 12 Weeks||3
3385489|NCT02710084|4120777|FG001|NOT COMPLETED|First Phase - 12 Weeks||1
3171690|NCT01936363|3898846|FG001|NOT COMPLETED|Overall Study||0
2911372|NCT00483652|3621069|FG000|NOT COMPLETED|Double-blind Treatment Period||7
2911373|NCT00483652|3621070|FG001|NOT COMPLETED|Double-blind Treatment Period||5
2911374|NCT00483652|3621069|FG000|STARTED|Post-study Follow-up||113
2911375|NCT00483652|3621070|FG001|STARTED|Post-study Follow-up||114
2911376|NCT00483652|3621069|FG000|COMPLETED|Post-study Follow-up||113
2911377|NCT00483652|3621070|FG001|COMPLETED|Post-study Follow-up||114
2911378|NCT00483652|3621069|FG000|NOT COMPLETED|Post-study Follow-up||0
2911379|NCT00483652|3621070|FG001|NOT COMPLETED|Post-study Follow-up||0
3385490|NCT02710084|4120776|FG000|STARTED|Open Label Phase: Week 12 to 24||7
3385491|NCT02710084|4120777|FG001|STARTED|Open Label Phase: Week 12 to 24||7
3385492|NCT02710084|4120776|FG000|COMPLETED|Open Label Phase: Week 12 to 24||7
3385493|NCT02710084|4120777|FG001|COMPLETED|Open Label Phase: Week 12 to 24||7
3385494|NCT02710084|4120776|FG000|NOT COMPLETED|Open Label Phase: Week 12 to 24||0
3385495|NCT02710084|4120777|FG001|NOT COMPLETED|Open Label Phase: Week 12 to 24||0
3385496|NCT02660034|4120798|FG000|STARTED|Overall Study||12
3385497|NCT02660034|4120799|FG001|STARTED|Overall Study||12
3385498|NCT02660034|4120800|FG002|STARTED|Overall Study||6
3385499|NCT02660034|4120801|FG003|STARTED|Overall Study||13
3385500|NCT02660034|4120802|FG004|STARTED|Overall Study||6
3385501|NCT02660034|4120803|FG005|STARTED|Overall Study||23
3385502|NCT02660034|4120804|FG006|STARTED|Overall Study||23
3385503|NCT02660034|4120805|FG007|STARTED|Overall Study||19
3385504|NCT02660034|4120806|FG008|STARTED|Overall Study||20
3385505|NCT02660034|4120807|FG009|STARTED|Overall Study||23
3385506|NCT02660034|4120808|FG010|STARTED|Overall Study||20
3385507|NCT02660034|4120809|FG011|STARTED|Overall Study||21
3385508|NCT02660034|4120810|FG012|STARTED|Overall Study||21
3385509|NCT02660034|4120811|FG013|STARTED|Overall Study||10
3385510|NCT02660034|4120798|FG000|Received At Least 1 Dose of Study Drug(s)|Overall Study||12
3385511|NCT02660034|4120799|FG001|Received At Least 1 Dose of Study Drug(s)|Overall Study||12
3385512|NCT02660034|4120800|FG002|Received At Least 1 Dose of Study Drug(s)|Overall Study||6
3385513|NCT02660034|4120801|FG003|Received At Least 1 Dose of Study Drug(s)|Overall Study||13
3385514|NCT02660034|4120802|FG004|Received At Least 1 Dose of Study Drug(s)|Overall Study||6
3385515|NCT02660034|4120803|FG005|Received At Least 1 Dose of Study Drug(s)|Overall Study||23
3385516|NCT02660034|4120804|FG006|Received At Least 1 Dose of Study Drug(s)|Overall Study||23
3385517|NCT02660034|4120805|FG007|Received At Least 1 Dose of Study Drug(s)|Overall Study||19
3385518|NCT02660034|4120806|FG008|Received At Least 1 Dose of Study Drug(s)|Overall Study||20
3385519|NCT02660034|4120807|FG009|Received At Least 1 Dose of Study Drug(s)|Overall Study||23
3385520|NCT02660034|4120808|FG010|Received At Least 1 Dose of Study Drug(s)|Overall Study||20
3385521|NCT02660034|4120809|FG011|Received At Least 1 Dose of Study Drug(s)|Overall Study||21
3385522|NCT02660034|4120810|FG012|Received At Least 1 Dose of Study Drug(s)|Overall Study||21
3385523|NCT02660034|4120811|FG013|Received At Least 1 Dose of Study Drug(s)|Overall Study||10
3385524|NCT02660034|4120798|FG000|COMPLETED|Overall Study||0
3385525|NCT02660034|4120799|FG001|COMPLETED|Overall Study||0
3385526|NCT02660034|4120800|FG002|COMPLETED|Overall Study||0
3385527|NCT02660034|4120801|FG003|COMPLETED|Overall Study||0
3385528|NCT02660034|4120802|FG004|COMPLETED|Overall Study||0
3385529|NCT02660034|4120803|FG005|COMPLETED|Overall Study||0
3385530|NCT02660034|4120804|FG006|COMPLETED|Overall Study||0
3385531|NCT02660034|4120805|FG007|COMPLETED|Overall Study||0
3385532|NCT02660034|4120806|FG008|COMPLETED|Overall Study||0
3385533|NCT02660034|4120807|FG009|COMPLETED|Overall Study||0
3385534|NCT02660034|4120808|FG010|COMPLETED|Overall Study||0
3385535|NCT02660034|4120809|FG011|COMPLETED|Overall Study||0
3385536|NCT02660034|4120810|FG012|COMPLETED|Overall Study||0
3385537|NCT02660034|4120811|FG013|COMPLETED|Overall Study||0
3385538|NCT02660034|4120798|FG000|NOT COMPLETED|Overall Study||12
3385539|NCT02660034|4120799|FG001|NOT COMPLETED|Overall Study||12
3385540|NCT02660034|4120800|FG002|NOT COMPLETED|Overall Study||6
3385541|NCT02660034|4120801|FG003|NOT COMPLETED|Overall Study||13
3385542|NCT02660034|4120802|FG004|NOT COMPLETED|Overall Study||6
3385543|NCT02660034|4120803|FG005|NOT COMPLETED|Overall Study||23
3385544|NCT02660034|4120804|FG006|NOT COMPLETED|Overall Study||23
3385545|NCT02660034|4120805|FG007|NOT COMPLETED|Overall Study||19
3385546|NCT02660034|4120806|FG008|NOT COMPLETED|Overall Study||20
3385547|NCT02660034|4120807|FG009|NOT COMPLETED|Overall Study||23
3385548|NCT02660034|4120808|FG010|NOT COMPLETED|Overall Study||20
3385549|NCT02660034|4120809|FG011|NOT COMPLETED|Overall Study||21
3385550|NCT02660034|4120810|FG012|NOT COMPLETED|Overall Study||21
3385551|NCT02660034|4120811|FG013|NOT COMPLETED|Overall Study||10
3385552|NCT02640625|4120845|FG000|STARTED|Overall Study||20
3385553|NCT02640625|4120845|FG000|COMPLETED|Overall Study||19
3385554|NCT02640625|4120845|FG000|NOT COMPLETED|Overall Study||1
3385555|NCT02561962|4120859|FG000|STARTED|Overall Study||3
3385556|NCT02561962|4120860|FG001|STARTED|Overall Study||3
3385557|NCT02561962|4120861|FG002|STARTED|Overall Study||3
3385558|NCT02561962|4120862|FG003|STARTED|Overall Study||3
3385559|NCT02561962|4120863|FG004|STARTED|Overall Study||6
3385560|NCT02561962|4120864|FG005|STARTED|Overall Study||6
3385561|NCT02561962|4120865|FG006|STARTED|Overall Study||5
3385562|NCT02561962|4120866|FG007|STARTED|Overall Study||11
3385563|NCT02561962|4120867|FG008|STARTED|Overall Study||2
3385564|NCT02561962|4120859|FG000|Received Treatment|Overall Study||3
3385565|NCT02561962|4120860|FG001|Received Treatment|Overall Study||3
3385566|NCT02561962|4120861|FG002|Received Treatment|Overall Study||3
3385567|NCT02561962|4120862|FG003|Received Treatment|Overall Study||3
3385568|NCT02561962|4120863|FG004|Received Treatment|Overall Study||6
3385569|NCT02561962|4120864|FG005|Received Treatment|Overall Study||6
3385570|NCT02561962|4120865|FG006|Received Treatment|Overall Study||5
3385571|NCT02561962|4120866|FG007|Received Treatment|Overall Study||9
3385572|NCT02561962|4120867|FG008|Received Treatment|Overall Study||2
3385573|NCT02561962|4120859|FG000|COMPLETED|Overall Study||1
3385574|NCT02561962|4120860|FG001|COMPLETED|Overall Study||3
3385575|NCT02561962|4120861|FG002|COMPLETED|Overall Study||3
3385576|NCT02561962|4120862|FG003|COMPLETED|Overall Study||2
3385577|NCT02561962|4120863|FG004|COMPLETED|Overall Study||4
3385578|NCT02561962|4120864|FG005|COMPLETED|Overall Study||2
3385579|NCT02561962|4120865|FG006|COMPLETED|Overall Study||3
3385580|NCT02561962|4120866|FG007|COMPLETED|Overall Study||3
3385581|NCT02561962|4120867|FG008|COMPLETED|Overall Study||1
3385582|NCT02561962|4120859|FG000|NOT COMPLETED|Overall Study||2
3385583|NCT02561962|4120860|FG001|NOT COMPLETED|Overall Study||0
3385584|NCT02561962|4120861|FG002|NOT COMPLETED|Overall Study||0
3385585|NCT02561962|4120862|FG003|NOT COMPLETED|Overall Study||1
3385586|NCT02561962|4120863|FG004|NOT COMPLETED|Overall Study||2
3385587|NCT02561962|4120864|FG005|NOT COMPLETED|Overall Study||4
3385588|NCT02561962|4120865|FG006|NOT COMPLETED|Overall Study||2
3385589|NCT02561962|4120866|FG007|NOT COMPLETED|Overall Study||8
3385590|NCT02561962|4120867|FG008|NOT COMPLETED|Overall Study||1
3385591|NCT02519348|4120896|FG000|STARTED|Overall Study||40
3385592|NCT02519348|4120897|FG001|STARTED|Overall Study||104
3385593|NCT02519348|4120898|FG002|STARTED|Overall Study||75
3385594|NCT02519348|4120899|FG003|STARTED|Overall Study||69
3385595|NCT02519348|4120900|FG004|STARTED|Overall Study||84
3385596|NCT02519348|4120901|FG005|STARTED|Overall Study||47
3385597|NCT02519348|4120902|FG006|STARTED|Overall Study||3
3385598|NCT02519348|4120903|FG007|STARTED|Overall Study||5
3385599|NCT02519348|4120904|FG008|STARTED|Overall Study||6
3385600|NCT02519348|4120896|FG000|Treated|Overall Study||40
3385601|NCT02519348|4120897|FG001|Treated|Overall Study||101
3385602|NCT02519348|4120898|FG002|Treated|Overall Study||74
3385603|NCT02519348|4120899|FG003|Treated|Overall Study||69
3385604|NCT02519348|4120900|FG004|Treated|Overall Study||82
3385605|NCT02519348|4120901|FG005|Treated|Overall Study||47
3385606|NCT02519348|4120902|FG006|Treated|Overall Study||3
3385607|NCT02519348|4120903|FG007|Treated|Overall Study||5
3385608|NCT02519348|4120904|FG008|Treated|Overall Study||5
3385609|NCT02519348|4120896|FG000|COMPLETED|Overall Study||0
3385610|NCT02519348|4120897|FG001|COMPLETED|Overall Study||0
3385611|NCT02519348|4120898|FG002|COMPLETED|Overall Study||0
3385612|NCT02519348|4120899|FG003|COMPLETED|Overall Study||0
3385613|NCT02519348|4120900|FG004|COMPLETED|Overall Study||0
3385614|NCT02519348|4120901|FG005|COMPLETED|Overall Study||0
3385615|NCT02519348|4120902|FG006|COMPLETED|Overall Study||0
3385616|NCT02519348|4120903|FG007|COMPLETED|Overall Study||0
3385617|NCT02519348|4120904|FG008|COMPLETED|Overall Study||0
3385618|NCT02519348|4120896|FG000|NOT COMPLETED|Overall Study||40
3385619|NCT02519348|4120897|FG001|NOT COMPLETED|Overall Study||104
3385620|NCT02519348|4120898|FG002|NOT COMPLETED|Overall Study||75
3385621|NCT02519348|4120899|FG003|NOT COMPLETED|Overall Study||69
3385622|NCT02519348|4120900|FG004|NOT COMPLETED|Overall Study||84
3385623|NCT02519348|4120901|FG005|NOT COMPLETED|Overall Study||47
3385624|NCT02519348|4120902|FG006|NOT COMPLETED|Overall Study||3
3385625|NCT02519348|4120903|FG007|NOT COMPLETED|Overall Study||5
3385626|NCT02519348|4120904|FG008|NOT COMPLETED|Overall Study||6
3385627|NCT02500589|4120927|FG000|STARTED|Overall Study||175
3385628|NCT02500589|4120928|FG001|STARTED|Overall Study||175
3385629|NCT02500589|4120927|FG000|COMPLETED|Overall Study||147
3385630|NCT02500589|4120928|FG001|COMPLETED|Overall Study||143
3385631|NCT02500589|4120927|FG000|NOT COMPLETED|Overall Study||28
3385632|NCT02500589|4120928|FG001|NOT COMPLETED|Overall Study||32
3385633|NCT02474329|4120938|FG000|STARTED|Overall Study|Participants (People with Parkinson's Disease) who signed a consent form.|304
3385634|NCT02474329|4120938|FG000|COMPLETED|Overall Study|Participants (People with Parkinson's Disease) who contributed data for 13 weeks.|291
3385635|NCT02474329|4120938|FG000|NOT COMPLETED|Overall Study||13
3385636|NCT02471339|4120945|FG000|STARTED|Overall Study||32
3385637|NCT02471339|4120946|FG001|STARTED|Overall Study||34
3385638|NCT02471339|4120945|FG000|COMPLETED|Overall Study||30
3385639|NCT02471339|4120946|FG001|COMPLETED|Overall Study||34
3385640|NCT02471339|4120945|FG000|NOT COMPLETED|Overall Study||2
3385641|NCT02471339|4120946|FG001|NOT COMPLETED|Overall Study||0
3385642|NCT02384993|4120954|FG000|STARTED|Overall Study||12
3385643|NCT02384993|4120955|FG001|STARTED|Overall Study||12
3385644|NCT02384993|4120954|FG000|COMPLETED|Overall Study||12
3385645|NCT02384993|4120955|FG001|COMPLETED|Overall Study||11
3385646|NCT02384993|4120954|FG000|NOT COMPLETED|Overall Study||0
3385647|NCT02384993|4120955|FG001|NOT COMPLETED|Overall Study||1
3386604|NCT03345342|4121928|FG004|COMPLETED|Double-Blind Phase||0
3386605|NCT03345342|4121924|FG000|NOT COMPLETED|Double-Blind Phase||0
3386606|NCT03345342|4121925|FG001|NOT COMPLETED|Double-Blind Phase||22
3386607|NCT03345342|4121926|FG002|NOT COMPLETED|Double-Blind Phase||62
3386608|NCT03345342|4121927|FG003|NOT COMPLETED|Double-Blind Phase||0
3386609|NCT03345342|4121928|FG004|NOT COMPLETED|Double-Blind Phase||0
3386610|NCT03345342|4121924|FG000|STARTED|Follow-Up Phase||0
3386611|NCT03345342|4121925|FG001|STARTED|Follow-Up Phase||0
3386612|NCT03345342|4121926|FG002|STARTED|Follow-Up Phase||0
3386613|NCT03345342|4121927|FG003|STARTED|Follow-Up Phase|Participants from the DB phase have continued in the FU phase.|42
3385648|NCT01976273|4120964|FG000|STARTED|Overall Study||10
3385649|NCT01976273|4120965|FG001|STARTED|Overall Study||10
3385650|NCT01976273|4120964|FG000|COMPLETED|Overall Study||9
3385651|NCT01976273|4120965|FG001|COMPLETED|Overall Study||9
3385652|NCT01976273|4120964|FG000|NOT COMPLETED|Overall Study||1
3385653|NCT01976273|4120965|FG001|NOT COMPLETED|Overall Study||1
3385654|NCT01722929|4120971|FG000|STARTED|Overall Study||4
3385655|NCT01722929|4120971|FG000|COMPLETED|Overall Study||4
3385656|NCT01722929|4120971|FG000|NOT COMPLETED|Overall Study||0
3385657|NCT01500733|4120978|FG000|STARTED|Overall Study||35
3385658|NCT01500733|4120979|FG001|STARTED|Overall Study||51
3385659|NCT01500733|4120978|FG000|COMPLETED|Overall Study||33
3385660|NCT01500733|4120979|FG001|COMPLETED|Overall Study||48
3385661|NCT01500733|4120978|FG000|NOT COMPLETED|Overall Study||2
3385662|NCT01500733|4120979|FG001|NOT COMPLETED|Overall Study||3
3385663|NCT01388491|4120987|FG000|STARTED|Overall Study|number randomized|150
3385664|NCT01388491|4120988|FG001|STARTED|Overall Study||143
3385665|NCT01388491|4120987|FG000|Safety Population|Overall Study|Safety: all randomized participants who took 1 or more doses of study drug|145
3385666|NCT01388491|4120988|FG001|Safety Population|Overall Study||142
3385667|NCT01388491|4120987|FG000|Intent-to-Treat (ITT) Population|Overall Study|ITT:participants in safety population with baseline (BL) + ≥1 post-BL prothrombin fragment 1+2 value|140
3385668|NCT01388491|4120988|FG001|Intent-to-Treat (ITT) Population|Overall Study||136
3385669|NCT01388491|4120987|FG000|Per Protocol (PP) Population|Overall Study|PP: all data from ITT participants obtained prior to any major protocol violations|125
3385670|NCT01388491|4120988|FG001|Per Protocol (PP) Population|Overall Study||121
3385671|NCT01388491|4120987|FG000|COMPLETED|Overall Study||116
3385672|NCT01388491|4120988|FG001|COMPLETED|Overall Study||114
3385673|NCT01388491|4120987|FG000|NOT COMPLETED|Overall Study||34
3385674|NCT01388491|4120988|FG001|NOT COMPLETED|Overall Study||29
3385675|NCT01373151|4121001|FG000|STARTED|Period 1||61
3385676|NCT01373151|4121002|FG001|STARTED|Period 1||59
3385677|NCT01373151|4121003|FG002|STARTED|Period 1||60
3385678|NCT01373151|4121004|FG003|STARTED|Period 1||60
3385679|NCT01373151|4121005|FG004|STARTED|Period 1||59
3385680|NCT01373151|4121006|FG005|STARTED|Period 1||60
3385681|NCT01373151|4121007|FG006|STARTED|Period 1||59
3385682|NCT01373151|4121001|FG000|COMPLETED|Period 1||56
3385683|NCT01373151|4121002|FG001|COMPLETED|Period 1||59
3385684|NCT01373151|4121003|FG002|COMPLETED|Period 1||56
3385685|NCT01373151|4121004|FG003|COMPLETED|Period 1||59
3385686|NCT01373151|4121005|FG004|COMPLETED|Period 1||54
3385687|NCT01373151|4121006|FG005|COMPLETED|Period 1||56
3385688|NCT01373151|4121007|FG006|COMPLETED|Period 1||59
3385689|NCT01373151|4121001|FG000|NOT COMPLETED|Period 1||5
3385690|NCT01373151|4121002|FG001|NOT COMPLETED|Period 1||0
3385691|NCT01373151|4121003|FG002|NOT COMPLETED|Period 1||4
3385692|NCT01373151|4121004|FG003|NOT COMPLETED|Period 1||1
3385693|NCT01373151|4121005|FG004|NOT COMPLETED|Period 1||5
3385694|NCT01373151|4121006|FG005|NOT COMPLETED|Period 1||4
3385695|NCT01373151|4121007|FG006|NOT COMPLETED|Period 1||0
3385696|NCT01373151|4121001|FG000|STARTED|Period 2||56
3385697|NCT01373151|4121002|FG001|STARTED|Period 2||58
3385698|NCT01373151|4121003|FG002|STARTED|Period 2||56
3385699|NCT01373151|4121004|FG003|STARTED|Period 2||59
3385700|NCT01373151|4121005|FG004|STARTED|Period 2||54
3385701|NCT01373151|4121006|FG005|STARTED|Period 2||55
3385702|NCT01373151|4121007|FG006|STARTED|Period 2||59
3385703|NCT01373151|4121001|FG000|COMPLETED|Period 2||47
3385704|NCT01373151|4121002|FG001|COMPLETED|Period 2||57
3385705|NCT01373151|4121003|FG002|COMPLETED|Period 2||52
3385706|NCT01373151|4121004|FG003|COMPLETED|Period 2||54
3385707|NCT01373151|4121005|FG004|COMPLETED|Period 2||52
3385708|NCT01373151|4121006|FG005|COMPLETED|Period 2||55
3385709|NCT01373151|4121007|FG006|COMPLETED|Period 2||54
3385710|NCT01373151|4121001|FG000|NOT COMPLETED|Period 2||9
3385711|NCT01373151|4121002|FG001|NOT COMPLETED|Period 2||1
3385712|NCT01373151|4121003|FG002|NOT COMPLETED|Period 2||4
3385713|NCT01373151|4121004|FG003|NOT COMPLETED|Period 2||5
3385714|NCT01373151|4121005|FG004|NOT COMPLETED|Period 2||2
3385715|NCT01373151|4121006|FG005|NOT COMPLETED|Period 2||0
3385716|NCT01373151|4121007|FG006|NOT COMPLETED|Period 2||5
3385717|NCT01328587|4121023|FG000|STARTED|Overall Study||34
3385718|NCT01328587|4121023|FG000|COMPLETED|Overall Study||34
3385719|NCT01328587|4121023|FG000|NOT COMPLETED|Overall Study||0
3385720|NCT01285947|4121029|FG000|STARTED|Overall Study||10
3385721|NCT01285947|4121030|FG001|STARTED|Overall Study||10
3385722|NCT01285947|4121029|FG000|COMPLETED|Overall Study||10
3385723|NCT01285947|4121030|FG001|COMPLETED|Overall Study||10
3385724|NCT01285947|4121029|FG000|NOT COMPLETED|Overall Study||0
3385725|NCT01285947|4121030|FG001|NOT COMPLETED|Overall Study||0
3385726|NCT01281644|4121036|FG000|STARTED|Overall Study||23
3385727|NCT01281644|4121036|FG000|COMPLETED|Overall Study||18
3385728|NCT01281644|4121036|FG000|NOT COMPLETED|Overall Study||5
3385729|NCT01274611|4121042|FG000|STARTED|Overall Study||20
3385730|NCT01274611|4121042|FG000|COMPLETED|Overall Study||20
3385731|NCT01274611|4121042|FG000|NOT COMPLETED|Overall Study||0
3385732|NCT00960297|4121048|FG000|STARTED|Overall Study||4
3385733|NCT00960297|4121048|FG000|COMPLETED|Overall Study||1
3385734|NCT00960297|4121048|FG000|NOT COMPLETED|Overall Study||3
3385735|NCT00910650|4121052|FG000|STARTED|Overall Study||14
3385736|NCT00910650|4121052|FG000|COMPLETED|Overall Study||12
3385737|NCT00910650|4121052|FG000|NOT COMPLETED|Overall Study||2
3385738|NCT00793169|4121056|FG000|STARTED|Overall Study||19
3385739|NCT00793169|4121056|FG000|COMPLETED|Overall Study||19
3385740|NCT00793169|4121056|FG000|NOT COMPLETED|Overall Study||0
3171691|NCT01936389|3898854|FG000|STARTED|Overall Study||5
3171692|NCT01936389|3898855|FG001|STARTED|Overall Study||5
3171693|NCT01936389|3898854|FG000|COMPLETED|Overall Study||4
3171694|NCT01936389|3898855|FG001|COMPLETED|Overall Study||5
3171695|NCT01936389|3898854|FG000|NOT COMPLETED|Overall Study||1
3171696|NCT01936389|3898855|FG001|NOT COMPLETED|Overall Study||0
3171697|NCT01936467|3898863|FG000|STARTED|Overall Study||60
3171698|NCT01936467|3898864|FG001|STARTED|Overall Study||61
3171699|NCT01936467|3898863|FG000|COMPLETED|Overall Study||60
3171700|NCT01936467|3898864|FG001|COMPLETED|Overall Study||61
3171701|NCT01936467|3898863|FG000|NOT COMPLETED|Overall Study||0
3171702|NCT01936467|3898864|FG001|NOT COMPLETED|Overall Study||0
3385741|NCT00703326|4121062|FG000|STARTED|Overall Study||759
3385742|NCT00703326|4121063|FG001|STARTED|Overall Study||385
3385743|NCT00703326|4121062|FG000|Received at Least 1 Dose of Study Drug|Overall Study||752
3385744|NCT00703326|4121063|FG001|Received at Least 1 Dose of Study Drug|Overall Study||382
3385745|NCT00703326|4121062|FG000|COMPLETED|Overall Study||657
3385746|NCT00703326|4121063|FG001|COMPLETED|Overall Study||347
3385747|NCT00703326|4121062|FG000|NOT COMPLETED|Overall Study||102
3385748|NCT00703326|4121063|FG001|NOT COMPLETED|Overall Study||38
3385749|NCT00602667|4121073|FG000|STARTED|Overall Study||57
3385750|NCT00602667|4121074|FG001|STARTED|Overall Study||156
3385751|NCT00602667|4121075|FG002|STARTED|Overall Study||77
3385752|NCT00602667|4121073|FG000|COMPLETED|Overall Study||38
3385753|NCT00602667|4121074|FG001|COMPLETED|Overall Study||75
3385754|NCT00602667|4121075|FG002|COMPLETED|Overall Study||14
3385755|NCT00602667|4121073|FG000|NOT COMPLETED|Overall Study||19
3385756|NCT00602667|4121074|FG001|NOT COMPLETED|Overall Study||81
3385757|NCT00602667|4121075|FG002|NOT COMPLETED|Overall Study||63
3385758|NCT00535990|4121110|FG000|STARTED|Overall Study||250
3385759|NCT00535990|4121110|FG000|COMPLETED|Overall Study||250
3385760|NCT00535990|4121110|FG000|NOT COMPLETED|Overall Study||0
3385761|NCT00472186|4121116|FG000|STARTED|Overall Study||2
3385762|NCT00472186|4121117|FG001|STARTED|Overall Study||0
3385763|NCT00472186|4121116|FG000|COMPLETED|Overall Study||1
3385764|NCT00472186|4121117|FG001|COMPLETED|Overall Study||0
3385765|NCT00472186|4121116|FG000|NOT COMPLETED|Overall Study||1
3385766|NCT00472186|4121117|FG001|NOT COMPLETED|Overall Study||0
3386614|NCT03345342|4121928|FG004|STARTED|Follow-Up Phase|Participants from the DB phase have continued in the FU phase.|109
3386615|NCT03345342|4121924|FG000|COMPLETED|Follow-Up Phase||0
3386616|NCT03345342|4121925|FG001|COMPLETED|Follow-Up Phase||0
3386617|NCT03345342|4121926|FG002|COMPLETED|Follow-Up Phase||0
3386618|NCT03345342|4121927|FG003|COMPLETED|Follow-Up Phase||34
3386619|NCT03345342|4121928|FG004|COMPLETED|Follow-Up Phase||78
3386620|NCT03345342|4121924|FG000|NOT COMPLETED|Follow-Up Phase||0
3386621|NCT03345342|4121925|FG001|NOT COMPLETED|Follow-Up Phase||0
3386622|NCT03345342|4121926|FG002|NOT COMPLETED|Follow-Up Phase||0
3386623|NCT03345342|4121927|FG003|NOT COMPLETED|Follow-Up Phase||8
3386624|NCT03345342|4121928|FG004|NOT COMPLETED|Follow-Up Phase||31
3386625|NCT03265145|4121942|FG000|STARTED|Overall Study||356
3386626|NCT03265145|4121943|FG001|STARTED|Overall Study||358
3386627|NCT03265145|4121942|FG000|COMPLETED|Overall Study||285
3386628|NCT03265145|4121943|FG001|COMPLETED|Overall Study||302
3386629|NCT03265145|4121942|FG000|NOT COMPLETED|Overall Study||71
3386630|NCT03265145|4121943|FG001|NOT COMPLETED|Overall Study||56
3386631|NCT03218995|4121950|FG000|STARTED|Overall Study||15
3386632|NCT03218995|4121950|FG000|Received at Least 1 Dose of Study Drug|Overall Study||15
3386633|NCT03218995|4121950|FG000|COMPLETED|Overall Study||15
3386634|NCT03218995|4121950|FG000|NOT COMPLETED|Overall Study||0
3386635|NCT03197935|4121958|FG000|STARTED|Overall Study||168
3386636|NCT03197935|4121959|FG001|STARTED|Overall Study||165
3386637|NCT03197935|4121958|FG000|COMPLETED|Overall Study||0
3386638|NCT03197935|4121959|FG001|COMPLETED|Overall Study||0
3386639|NCT03197935|4121958|FG000|NOT COMPLETED|Overall Study||168
3171703|NCT01936519|3898876|FG000|STARTED|Overall Study||12
3171704|NCT01936519|3898877|FG001|STARTED|Overall Study||12
3171705|NCT01936519|3898876|FG000|COMPLETED|Overall Study||11
3171706|NCT01936519|3898877|FG001|COMPLETED|Overall Study||8
3171707|NCT01936519|3898876|FG000|NOT COMPLETED|Overall Study||1
3171708|NCT01936519|3898877|FG001|NOT COMPLETED|Overall Study||4
3171709|NCT01936623|3898888|FG000|STARTED|Overall Study||40
3171710|NCT01936623|3898889|FG001|STARTED|Overall Study||40
3171711|NCT01936623|3898888|FG000|COMPLETED|Overall Study||40
3386640|NCT03197935|4121959|FG001|NOT COMPLETED|Overall Study||165
3386641|NCT03030222|4121968|FG000|STARTED|Overall Study||33
3386642|NCT03030222|4121969|FG001|STARTED|Overall Study||32
3386643|NCT03030222|4121968|FG000|COMPLETED|Overall Study||33
3386644|NCT03030222|4121969|FG001|COMPLETED|Overall Study||32
3386645|NCT03030222|4121968|FG000|NOT COMPLETED|Overall Study||0
3386646|NCT03030222|4121969|FG001|NOT COMPLETED|Overall Study||0
3386647|NCT02880241|4121981|FG000|STARTED|Overall Study|Study terminated|8
3386648|NCT02880241|4121982|FG001|STARTED|Overall Study|Study terminated|0
3386649|NCT02880241|4121983|FG002|STARTED|Overall Study|Study terminated|0
3386650|NCT02880241|4121984|FG003|STARTED|Overall Study|Study terminated|0
3386651|NCT02880241|4121985|FG004|STARTED|Overall Study|Study terminated|0
3171712|NCT01936623|3898889|FG001|COMPLETED|Overall Study||35
3386652|NCT02880241|4121986|FG005|STARTED|Overall Study|Study terminated|0
3386653|NCT02880241|4121981|FG000|COMPLETED|Overall Study|Study terminated|7
3386654|NCT02880241|4121982|FG001|COMPLETED|Overall Study|Study terminated|0
3171713|NCT01936623|3898888|FG000|NOT COMPLETED|Overall Study||0
3385767|NCT03996876|4121127|FG000|STARTED|Overall Study||14
3385768|NCT03996876|4121128|FG001|STARTED|Overall Study||14
3385769|NCT03996876|4121127|FG000|COMPLETED|Overall Study||12
3385770|NCT03996876|4121128|FG001|COMPLETED|Overall Study||10
3385771|NCT03996876|4121127|FG000|NOT COMPLETED|Overall Study||2
3385772|NCT03996876|4121128|FG001|NOT COMPLETED|Overall Study||4
3386655|NCT02880241|4121983|FG002|COMPLETED|Overall Study|Study terminated|0
3386656|NCT02880241|4121984|FG003|COMPLETED|Overall Study|Study terminated|0
3386657|NCT02880241|4121985|FG004|COMPLETED|Overall Study|Study terminated|0
3386658|NCT02880241|4121986|FG005|COMPLETED|Overall Study|Study terminated|0
3386659|NCT02880241|4121981|FG000|NOT COMPLETED|Overall Study||1
3386660|NCT02880241|4121982|FG001|NOT COMPLETED|Overall Study||0
3386661|NCT02880241|4121983|FG002|NOT COMPLETED|Overall Study||0
3386662|NCT02880241|4121984|FG003|NOT COMPLETED|Overall Study||0
3386663|NCT02880241|4121985|FG004|NOT COMPLETED|Overall Study||0
3386664|NCT02880241|4121986|FG005|NOT COMPLETED|Overall Study||0
3386665|NCT02832687|4122004|FG000|STARTED|Overall Study||41
3386666|NCT02832687|4122005|FG001|STARTED|Overall Study||47
3386667|NCT02832687|4122004|FG000|Participants Who Were Included in the Analysis|Overall Study||31
3386668|NCT02832687|4122005|FG001|Participants Who Were Included in the Analysis|Overall Study||34
3386669|NCT02832687|4122004|FG000|COMPLETED|Overall Study||41
3386670|NCT02832687|4122005|FG001|COMPLETED|Overall Study||45
3386671|NCT02832687|4122004|FG000|NOT COMPLETED|Overall Study||0
3386672|NCT02832687|4122005|FG001|NOT COMPLETED|Overall Study||2
3386673|NCT02568449|4122011|FG000|STARTED|Overall Study||20
3386674|NCT02568449|4122011|FG000|COMPLETED|Overall Study||20
3386675|NCT02568449|4122011|FG000|NOT COMPLETED|Overall Study||0
3386676|NCT02499900|4122017|FG000|STARTED|Core Study Period||430
3386677|NCT02499900|4122018|FG001|STARTED|Core Study Period||431
3386678|NCT02499900|4122017|FG000|Safety Analysis Set|Core Study Period||427
3386679|NCT02499900|4122018|FG001|Safety Analysis Set|Core Study Period||430
3386680|NCT02499900|4122017|FG000|COMPLETED|Core Study Period||395
3386681|NCT02499900|4122018|FG001|COMPLETED|Core Study Period||399
3386682|NCT02499900|4122017|FG000|NOT COMPLETED|Core Study Period||35
3386683|NCT02499900|4122018|FG001|NOT COMPLETED|Core Study Period||32
3386684|NCT02499900|4122017|FG000|STARTED|Completed Core, Continued Into Extension||395
3386685|NCT02499900|4122018|FG001|STARTED|Completed Core, Continued Into Extension||399
3386686|NCT02499900|4122017|FG000|COMPLETED|Completed Core, Continued Into Extension||392
3386687|NCT02499900|4122018|FG001|COMPLETED|Completed Core, Continued Into Extension||397
3386688|NCT02499900|4122017|FG000|NOT COMPLETED|Completed Core, Continued Into Extension||3
3386689|NCT02499900|4122018|FG001|NOT COMPLETED|Completed Core, Continued Into Extension||2
3386690|NCT02499900|4122017|FG000|STARTED|Extension Study Period||392
3386691|NCT02499900|4122018|FG001|STARTED|Extension Study Period||397
3386692|NCT02499900|4122017|FG000|Safety Analysis Set|Extension Study Period||392
3386693|NCT02499900|4122018|FG001|Safety Analysis Set|Extension Study Period|One participant was not treated in the Extension Study Period|396
3386694|NCT02499900|4122017|FG000|COMPLETED|Extension Study Period||380
3386695|NCT02499900|4122018|FG001|COMPLETED|Extension Study Period||377
3386696|NCT02499900|4122017|FG000|NOT COMPLETED|Extension Study Period||12
3386697|NCT02499900|4122018|FG001|NOT COMPLETED|Extension Study Period||20
3386698|NCT02481986|4122032|FG000|STARTED|Overall Study||108
3386699|NCT02481986|4122033|FG001|STARTED|Overall Study||115
3386700|NCT02481986|4122032|FG000|COMPLETED|Overall Study||103
3386701|NCT02481986|4122033|FG001|COMPLETED|Overall Study||106
3386702|NCT02481986|4122032|FG000|NOT COMPLETED|Overall Study||5
3386703|NCT02481986|4122033|FG001|NOT COMPLETED|Overall Study||9
3386704|NCT02394548|4122039|FG000|STARTED|Overall Study||26
3386705|NCT02394548|4122039|FG000|COMPLETED|Overall Study||25
3386706|NCT02394548|4122039|FG000|NOT COMPLETED|Overall Study||1
3386707|NCT02269917|4122045|FG000|STARTED|BL to EOE-Test and BL to Switch-Control||766
3386708|NCT02269917|4122046|FG001|STARTED|BL to EOE-Test and BL to Switch-Control||383
3386709|NCT02269917|4122047|FG002|STARTED|BL to EOE-Test and BL to Switch-Control||0
3386710|NCT02269917|4122045|FG000|Treated|BL to EOE-Test and BL to Switch-Control||763
3386711|NCT02269917|4122046|FG001|Treated|BL to EOE-Test and BL to Switch-Control||378
3386712|NCT02269917|4122047|FG002|Treated|BL to EOE-Test and BL to Switch-Control||0
3386713|NCT02269917|4122045|FG000|COMPLETED|BL to EOE-Test and BL to Switch-Control||649
3386714|NCT02269917|4122046|FG001|COMPLETED|BL to EOE-Test and BL to Switch-Control||352
3386715|NCT02269917|4122047|FG002|COMPLETED|BL to EOE-Test and BL to Switch-Control||0
3386716|NCT02269917|4122045|FG000|NOT COMPLETED|BL to EOE-Test and BL to Switch-Control||117
3386717|NCT02269917|4122046|FG001|NOT COMPLETED|BL to EOE-Test and BL to Switch-Control||31
3386718|NCT02269917|4122047|FG002|NOT COMPLETED|BL to EOE-Test and BL to Switch-Control||0
3386719|NCT02269917|4122045|FG000|STARTED|Switch to D/C/F/TAF (Until EOE)||0
3386720|NCT02269917|4122046|FG001|STARTED|Switch to D/C/F/TAF (Until EOE)||0
3386721|NCT02269917|4122047|FG002|STARTED|Switch to D/C/F/TAF (Until EOE)||352
3386722|NCT02269917|4122045|FG000|COMPLETED|Switch to D/C/F/TAF (Until EOE)||0
3386723|NCT02269917|4122046|FG001|COMPLETED|Switch to D/C/F/TAF (Until EOE)||0
3386724|NCT02269917|4122047|FG002|COMPLETED|Switch to D/C/F/TAF (Until EOE)||314
3386725|NCT02269917|4122045|FG000|NOT COMPLETED|Switch to D/C/F/TAF (Until EOE)||0
3386726|NCT02269917|4122046|FG001|NOT COMPLETED|Switch to D/C/F/TAF (Until EOE)||0
3386727|NCT02269917|4122047|FG002|NOT COMPLETED|Switch to D/C/F/TAF (Until EOE)||38
3386728|NCT02225366|4122058|FG000|STARTED|Overall Study||2
3386729|NCT02225366|4122059|FG001|STARTED|Overall Study||1
3386730|NCT02225366|4122058|FG000|COMPLETED|Overall Study||1
3386731|NCT02225366|4122059|FG001|COMPLETED|Overall Study||1
3386809|NCT04553406|4122179|FG000|STARTED|Overall Study||1
3386810|NCT04553406|4122180|FG001|STARTED|Overall Study||1
3386811|NCT04553406|4122179|FG000|COMPLETED|Overall Study||1
3386812|NCT04553406|4122180|FG001|COMPLETED|Overall Study||0
3386813|NCT04553406|4122179|FG000|NOT COMPLETED|Overall Study||0
3386814|NCT04553406|4122180|FG001|NOT COMPLETED|Overall Study||1
3386815|NCT04325906|4122188|FG000|STARTED|Overall Study||112
3386816|NCT04325906|4122189|FG001|STARTED|Overall Study||112
3386817|NCT04325906|4122188|FG000|COMPLETED|Overall Study||110
3386818|NCT04325906|4122189|FG001|COMPLETED|Overall Study||112
3386819|NCT04325906|4122188|FG000|NOT COMPLETED|Overall Study||2
3386820|NCT04325906|4122189|FG001|NOT COMPLETED|Overall Study||0
3386821|NCT04056299|4122197|FG000|STARTED|Overall Study||9
3386822|NCT04056299|4122198|FG001|STARTED|Overall Study||6
3386823|NCT04056299|4122197|FG000|COMPLETED|Overall Study||6
3386824|NCT04056299|4122198|FG001|COMPLETED|Overall Study||3
3386825|NCT04056299|4122197|FG000|NOT COMPLETED|Overall Study||3
3386826|NCT04056299|4122198|FG001|NOT COMPLETED|Overall Study||3
3386827|NCT04046939|4122208|FG000|STARTED|Screening Period||534
3386828|NCT04046939|4122209|FG001|STARTED|Screening Period||0
3386829|NCT04046939|4122210|FG002|STARTED|Screening Period||0
3386830|NCT04046939|4122211|FG003|STARTED|Screening Period||0
3386831|NCT04046939|4122208|FG000|Received Placebo During Run-In Period|Screening Period||144
3386832|NCT04046939|4122209|FG001|Received Placebo During Run-In Period|Screening Period||0
3386833|NCT04046939|4122210|FG002|Received Placebo During Run-In Period|Screening Period||0
3386834|NCT04046939|4122211|FG003|Received Placebo During Run-In Period|Screening Period||0
3386835|NCT04046939|4122208|FG000|COMPLETED|Screening Period||103
3386836|NCT04046939|4122209|FG001|COMPLETED|Screening Period||0
3386837|NCT04046939|4122210|FG002|COMPLETED|Screening Period||0
3386838|NCT04046939|4122211|FG003|COMPLETED|Screening Period||0
3386839|NCT04046939|4122208|FG000|NOT COMPLETED|Screening Period||431
3386840|NCT04046939|4122209|FG001|NOT COMPLETED|Screening Period||0
3386841|NCT04046939|4122210|FG002|NOT COMPLETED|Screening Period||0
3386842|NCT04046939|4122211|FG003|NOT COMPLETED|Screening Period||0
3386843|NCT04046939|4122208|FG000|STARTED|Primary Assessment Period||27
3386844|NCT04046939|4122209|FG001|STARTED|Primary Assessment Period||22
3386845|NCT04046939|4122210|FG002|STARTED|Primary Assessment Period||26
3386846|NCT04046939|4122211|FG003|STARTED|Primary Assessment Period||28
3386847|NCT04046939|4122208|FG000|COMPLETED|Primary Assessment Period||25
3386848|NCT04046939|4122209|FG001|COMPLETED|Primary Assessment Period||22
3386849|NCT04046939|4122210|FG002|COMPLETED|Primary Assessment Period||24
3386850|NCT04046939|4122211|FG003|COMPLETED|Primary Assessment Period||28
3386851|NCT04046939|4122208|FG000|NOT COMPLETED|Primary Assessment Period||2
3386852|NCT04046939|4122209|FG001|NOT COMPLETED|Primary Assessment Period||0
3386853|NCT04046939|4122210|FG002|NOT COMPLETED|Primary Assessment Period||2
3386854|NCT04046939|4122211|FG003|NOT COMPLETED|Primary Assessment Period||0
3386855|NCT04046939|4122208|FG000|STARTED|Eosinophil Recovery Period||25
3386856|NCT04046939|4122209|FG001|STARTED|Eosinophil Recovery Period||22
3386857|NCT04046939|4122210|FG002|STARTED|Eosinophil Recovery Period||24
3386858|NCT04046939|4122211|FG003|STARTED|Eosinophil Recovery Period||28
3386859|NCT04046939|4122208|FG000|COMPLETED|Eosinophil Recovery Period||24
3386860|NCT04046939|4122209|FG001|COMPLETED|Eosinophil Recovery Period||22
3386861|NCT04046939|4122210|FG002|COMPLETED|Eosinophil Recovery Period||24
3386862|NCT04046939|4122211|FG003|COMPLETED|Eosinophil Recovery Period||27
3386863|NCT04046939|4122208|FG000|NOT COMPLETED|Eosinophil Recovery Period||1
3386864|NCT04046939|4122209|FG001|NOT COMPLETED|Eosinophil Recovery Period||0
3386865|NCT04046939|4122210|FG002|NOT COMPLETED|Eosinophil Recovery Period||0
3386866|NCT04046939|4122211|FG003|NOT COMPLETED|Eosinophil Recovery Period||1
3386867|NCT03792750|4122227|FG000|STARTED|Overall Study||12
3386868|NCT03792750|4122227|FG000|COMPLETED|Overall Study||9
3386869|NCT03792750|4122227|FG000|NOT COMPLETED|Overall Study||3
3386870|NCT03739593|4122235|FG000|STARTED|Overall Study||5
3386871|NCT03739593|4122236|FG001|STARTED|Overall Study||22
3386872|NCT03739593|4122237|FG002|STARTED|Overall Study||22
3386873|NCT03739593|4122235|FG000|COMPLETED|Overall Study||2
3386874|NCT03739593|4122236|FG001|COMPLETED|Overall Study||16
3386875|NCT03739593|4122237|FG002|COMPLETED|Overall Study||14
3386876|NCT03739593|4122235|FG000|NOT COMPLETED|Overall Study||3
3386877|NCT03739593|4122236|FG001|NOT COMPLETED|Overall Study||6
3386878|NCT03739593|4122237|FG002|NOT COMPLETED|Overall Study||8
3386879|NCT03739138|4122248|FG000|STARTED|Overall Study||0
3386880|NCT03739138|4122249|FG001|STARTED|Overall Study||7
3386881|NCT03739138|4122250|FG002|STARTED|Overall Study||5
3386882|NCT03739138|4122251|FG003|STARTED|Overall Study||18
3386883|NCT03739138|4122252|FG004|STARTED|Overall Study||0
3386884|NCT03739138|4122248|FG000|COMPLETED|Overall Study||0
3386885|NCT03739138|4122249|FG001|COMPLETED|Overall Study||0
3386886|NCT03739138|4122250|FG002|COMPLETED|Overall Study||0
3386887|NCT03739138|4122251|FG003|COMPLETED|Overall Study||0
3386888|NCT03739138|4122252|FG004|COMPLETED|Overall Study||0
3386889|NCT03739138|4122248|FG000|NOT COMPLETED|Overall Study||0
3386890|NCT03739138|4122249|FG001|NOT COMPLETED|Overall Study||7
3386891|NCT03739138|4122250|FG002|NOT COMPLETED|Overall Study||5
3386892|NCT03739138|4122251|FG003|NOT COMPLETED|Overall Study||18
3386893|NCT03739138|4122252|FG004|NOT COMPLETED|Overall Study||0
3386894|NCT03688555|4122262|FG000|STARTED|Overall Study||7
3386895|NCT03688555|4122263|FG001|STARTED|Overall Study||3
3386896|NCT03688555|4122262|FG000|COMPLETED|Overall Study||7
3386897|NCT03688555|4122263|FG001|COMPLETED|Overall Study||2
3386898|NCT03688555|4122262|FG000|NOT COMPLETED|Overall Study||0
3386899|NCT03688555|4122263|FG001|NOT COMPLETED|Overall Study||1
3386900|NCT03518086|4122271|FG000|STARTED|Overall Study||322
3386901|NCT03518086|4122272|FG001|STARTED|Overall Study||959
3386902|NCT03518086|4122273|FG002|STARTED|Overall Study||0
3386903|NCT03518086|4122274|FG003|STARTED|Overall Study||0
3386904|NCT03518086|4122271|FG000|Received at Least One Dose of Study Drug|Overall Study||321
3386905|NCT03518086|4122272|FG001|Received at Least One Dose of Study Drug|Overall Study||958
3386906|NCT03518086|4122273|FG002|Received at Least One Dose of Study Drug|Overall Study||0
3386907|NCT03518086|4122274|FG003|Received at Least One Dose of Study Drug|Overall Study||0
3386908|NCT03518086|4122271|FG000|COMPLETED|Overall Study||285
3386909|NCT03518086|4122272|FG001|COMPLETED|Overall Study||920
3386910|NCT03518086|4122273|FG002|COMPLETED|Overall Study||0
3386911|NCT03518086|4122274|FG003|COMPLETED|Overall Study||0
3386912|NCT03518086|4122271|FG000|NOT COMPLETED|Overall Study||37
3386913|NCT03518086|4122272|FG001|NOT COMPLETED|Overall Study||39
3386914|NCT03518086|4122273|FG002|NOT COMPLETED|Overall Study||0
3386915|NCT03518086|4122274|FG003|NOT COMPLETED|Overall Study||0
3386916|NCT03468309|4122281|FG000|STARTED|Overall Study||53
3386917|NCT03468309|4122281|FG000|COMPLETED|Overall Study||47
3386918|NCT03468309|4122281|FG000|NOT COMPLETED|Overall Study||6
3386919|NCT03367910|4122285|FG000|STARTED|Overall Study||1
3386920|NCT03367910|4122285|FG000|COMPLETED|Overall Study||1
3386921|NCT03367910|4122285|FG000|NOT COMPLETED|Overall Study||0
3386922|NCT03347123|4122291|FG000|STARTED|Overall Study||5
3386923|NCT03347123|4122292|FG001|STARTED|Overall Study||6
3386924|NCT03347123|4122293|FG002|STARTED|Overall Study||0
3386925|NCT03347123|4122294|FG003|STARTED|Overall Study||0
3386926|NCT03347123|4122295|FG004|STARTED|Overall Study||0
3386927|NCT03347123|4122296|FG005|STARTED|Overall Study||0
3386928|NCT03347123|4122297|FG006|STARTED|Overall Study||0
3386929|NCT03347123|4122291|FG000|COMPLETED|Overall Study||0
3386930|NCT03347123|4122292|FG001|COMPLETED|Overall Study||0
3386931|NCT03347123|4122293|FG002|COMPLETED|Overall Study||0
3386932|NCT03347123|4122294|FG003|COMPLETED|Overall Study||0
3386933|NCT03347123|4122295|FG004|COMPLETED|Overall Study||0
3386934|NCT03347123|4122296|FG005|COMPLETED|Overall Study||0
3386935|NCT03347123|4122297|FG006|COMPLETED|Overall Study||0
3386936|NCT03347123|4122291|FG000|NOT COMPLETED|Overall Study||5
3386937|NCT03347123|4122292|FG001|NOT COMPLETED|Overall Study||6
3386938|NCT03347123|4122293|FG002|NOT COMPLETED|Overall Study||0
3386939|NCT03347123|4122294|FG003|NOT COMPLETED|Overall Study||0
3386940|NCT03347123|4122295|FG004|NOT COMPLETED|Overall Study||0
3386941|NCT03347123|4122296|FG005|NOT COMPLETED|Overall Study||0
3386942|NCT03347123|4122297|FG006|NOT COMPLETED|Overall Study||0
3386943|NCT03318523|4122312|FG000|STARTED|PC Period: Up to Year 1||100
3386944|NCT03318523|4122313|FG001|STARTED|PC Period: Up to Year 1||55
3386945|NCT03318523|4122314|FG002|STARTED|PC Period: Up to Year 1||102
3386946|NCT03318523|4122315|FG003|STARTED|PC Period: Up to Year 1||100
3386947|NCT03318523|4122316|FG004|STARTED|PC Period: Up to Year 1||0
3386948|NCT03318523|4122317|FG005|STARTED|PC Period: Up to Year 1||0
3386949|NCT03318523|4122318|FG006|STARTED|PC Period: Up to Year 1||0
3386950|NCT03318523|4122319|FG007|STARTED|PC Period: Up to Year 1||0
3386951|NCT03318523|4122320|FG008|STARTED|PC Period: Up to Year 1||0
3386952|NCT03318523|4122321|FG009|STARTED|PC Period: Up to Year 1||0
3386953|NCT03318523|4122312|FG000|COMPLETED|PC Period: Up to Year 1||96
3386954|NCT03318523|4122313|FG001|COMPLETED|PC Period: Up to Year 1||53
3386955|NCT03318523|4122314|FG002|COMPLETED|PC Period: Up to Year 1||100
3386956|NCT03318523|4122315|FG003|COMPLETED|PC Period: Up to Year 1||96
3386957|NCT03318523|4122316|FG004|COMPLETED|PC Period: Up to Year 1||0
3386958|NCT03318523|4122317|FG005|COMPLETED|PC Period: Up to Year 1||0
3386959|NCT03318523|4122318|FG006|COMPLETED|PC Period: Up to Year 1||0
3386960|NCT03318523|4122319|FG007|COMPLETED|PC Period: Up to Year 1||0
3386961|NCT03318523|4122320|FG008|COMPLETED|PC Period: Up to Year 1||0
3386962|NCT03318523|4122321|FG009|COMPLETED|PC Period: Up to Year 1||0
3386963|NCT03318523|4122312|FG000|NOT COMPLETED|PC Period: Up to Year 1||4
3386964|NCT03318523|4122313|FG001|NOT COMPLETED|PC Period: Up to Year 1||2
3386965|NCT03318523|4122314|FG002|NOT COMPLETED|PC Period: Up to Year 1||2
3386966|NCT03318523|4122315|FG003|NOT COMPLETED|PC Period: Up to Year 1||4
3386967|NCT03318523|4122316|FG004|NOT COMPLETED|PC Period: Up to Year 1||0
3386968|NCT03318523|4122317|FG005|NOT COMPLETED|PC Period: Up to Year 1||0
3386969|NCT03318523|4122318|FG006|NOT COMPLETED|PC Period: Up to Year 1||0
3386970|NCT03318523|4122319|FG007|NOT COMPLETED|PC Period: Up to Year 1||0
3386971|NCT03318523|4122320|FG008|NOT COMPLETED|PC Period: Up to Year 1||0
3386972|NCT03318523|4122321|FG009|NOT COMPLETED|PC Period: Up to Year 1||0
3386973|NCT03318523|4122312|FG000|STARTED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
3386974|NCT03318523|4122313|FG001|STARTED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
3386975|NCT03318523|4122314|FG002|STARTED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
3386976|NCT03318523|4122315|FG003|STARTED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
3386977|NCT03318523|4122316|FG004|STARTED|DBE Period:Year 2 to EOS (Up to 3 Years)||20
3386978|NCT03318523|4122317|FG005|STARTED|DBE Period:Year 2 to EOS (Up to 3 Years)||37
3386979|NCT03318523|4122318|FG006|STARTED|DBE Period:Year 2 to EOS (Up to 3 Years)||39
3386980|NCT03318523|4122319|FG007|STARTED|DBE Period:Year 2 to EOS (Up to 3 Years)||52
3386981|NCT03318523|4122320|FG008|STARTED|DBE Period:Year 2 to EOS (Up to 3 Years)||100
3386982|NCT03318523|4122321|FG009|STARTED|DBE Period:Year 2 to EOS (Up to 3 Years)||96
3386983|NCT03318523|4122312|FG000|Number of Participants Dosed|DBE Period:Year 2 to EOS (Up to 3 Years)||0
3386984|NCT03318523|4122313|FG001|Number of Participants Dosed|DBE Period:Year 2 to EOS (Up to 3 Years)||0
3386985|NCT03318523|4122314|FG002|Number of Participants Dosed|DBE Period:Year 2 to EOS (Up to 3 Years)||0
3386986|NCT03318523|4122315|FG003|Number of Participants Dosed|DBE Period:Year 2 to EOS (Up to 3 Years)||0
3386987|NCT03318523|4122316|FG004|Number of Participants Dosed|DBE Period:Year 2 to EOS (Up to 3 Years)||20
3386988|NCT03318523|4122317|FG005|Number of Participants Dosed|DBE Period:Year 2 to EOS (Up to 3 Years)||37
3386989|NCT03318523|4122318|FG006|Number of Participants Dosed|DBE Period:Year 2 to EOS (Up to 3 Years)||39
3386990|NCT03318523|4122319|FG007|Number of Participants Dosed|DBE Period:Year 2 to EOS (Up to 3 Years)||52
3386991|NCT03318523|4122320|FG008|Number of Participants Dosed|DBE Period:Year 2 to EOS (Up to 3 Years)||100
3386992|NCT03318523|4122321|FG009|Number of Participants Dosed|DBE Period:Year 2 to EOS (Up to 3 Years)||94
3386993|NCT03318523|4122312|FG000|COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
3386994|NCT03318523|4122313|FG001|COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
3386995|NCT03318523|4122314|FG002|COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
3386996|NCT03318523|4122315|FG003|COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
3386997|NCT03318523|4122316|FG004|COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
3386998|NCT03318523|4122317|FG005|COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
3386999|NCT03318523|4122318|FG006|COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
3387000|NCT03318523|4122319|FG007|COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
3387001|NCT03318523|4122320|FG008|COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
3387002|NCT03318523|4122321|FG009|COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
3387003|NCT03318523|4122312|FG000|NOT COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
3387004|NCT03318523|4122313|FG001|NOT COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
3387005|NCT03318523|4122314|FG002|NOT COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
3387006|NCT03318523|4122315|FG003|NOT COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
3387007|NCT03318523|4122316|FG004|NOT COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||20
3387008|NCT03318523|4122317|FG005|NOT COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||37
3387009|NCT03318523|4122318|FG006|NOT COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||39
3387010|NCT03318523|4122319|FG007|NOT COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||52
3387011|NCT03318523|4122320|FG008|NOT COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||100
3387012|NCT03318523|4122321|FG009|NOT COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||96
3387013|NCT03260894|4122347|FG000|STARTED|Overall Study||64
3387014|NCT03260894|4122348|FG001|STARTED|Overall Study||65
3387015|NCT03260894|4122347|FG000|Intention-to-Treat (ITT)|Overall Study||64
3387016|NCT03260894|4122348|FG001|Intention-to-Treat (ITT)|Overall Study||65
3387017|NCT03260894|4122347|FG000|All Subjects as Treated (ASaT)|Overall Study||64
3387018|NCT03260894|4122348|FG001|All Subjects as Treated (ASaT)|Overall Study||63
3387019|NCT03260894|4122347|FG000|COMPLETED|Overall Study||18
3387020|NCT03260894|4122348|FG001|COMPLETED|Overall Study||15
3387021|NCT03260894|4122347|FG000|NOT COMPLETED|Overall Study||46
3387022|NCT03260894|4122348|FG001|NOT COMPLETED|Overall Study||50
3387023|NCT03125902|4122356|FG000|STARTED|Overall Study||220
3387024|NCT03125902|4122357|FG001|STARTED|Overall Study||431
3387025|NCT03125902|4122356|FG000|COMPLETED|Overall Study||0
3387026|NCT03125902|4122357|FG001|COMPLETED|Overall Study||0
3387027|NCT03125902|4122356|FG000|NOT COMPLETED|Overall Study||220
3387028|NCT03125902|4122357|FG001|NOT COMPLETED|Overall Study||431
3387029|NCT02906020|4122374|FG000|STARTED|Part 1: Dose Escalation Period||4
3387030|NCT02906020|4122375|FG001|STARTED|Part 1: Dose Escalation Period||4
3387031|NCT02906020|4122376|FG002|STARTED|Part 1: Dose Escalation Period||5
3387032|NCT02906020|4122377|FG003|STARTED|Part 1: Dose Escalation Period||4
3387033|NCT02906020|4122378|FG004|STARTED|Part 1: Dose Escalation Period||3
3387034|NCT02906020|4122379|FG005|STARTED|Part 1: Dose Escalation Period||3
3387035|NCT02906020|4122380|FG006|STARTED|Part 1: Dose Escalation Period||3
3387036|NCT02906020|4122381|FG007|STARTED|Part 1: Dose Escalation Period||3
3387037|NCT02906020|4122382|FG008|STARTED|Part 1: Dose Escalation Period||0
3387038|NCT02906020|4122383|FG009|STARTED|Part 1: Dose Escalation Period||0
3387039|NCT02906020|4122384|FG010|STARTED|Part 1: Dose Escalation Period||0
3387040|NCT02906020|4122385|FG011|STARTED|Part 1: Dose Escalation Period||0
3387041|NCT02906020|4122386|FG012|STARTED|Part 1: Dose Escalation Period||0
3387042|NCT02906020|4122387|FG013|STARTED|Part 1: Dose Escalation Period||0
3387043|NCT02906020|4122388|FG014|STARTED|Part 1: Dose Escalation Period||0
3387044|NCT02906020|4122389|FG015|STARTED|Part 1: Dose Escalation Period||0
3171822|NCT01937351|3899028|FG001|6-Month Follow-up|Overall Study||26
3171823|NCT01937351|3899027|FG000|COMPLETED|Overall Study||125
3171824|NCT01937351|3899028|FG001|COMPLETED|Overall Study||26
3387045|NCT02906020|4122374|FG000|Treated|Part 1: Dose Escalation Period||4
3387046|NCT02906020|4122375|FG001|Treated|Part 1: Dose Escalation Period||4
3387047|NCT02906020|4122376|FG002|Treated|Part 1: Dose Escalation Period||5
3387048|NCT02906020|4122377|FG003|Treated|Part 1: Dose Escalation Period||4
3387049|NCT02906020|4122378|FG004|Treated|Part 1: Dose Escalation Period||3
3387050|NCT02906020|4122379|FG005|Treated|Part 1: Dose Escalation Period||3
3387051|NCT02906020|4122380|FG006|Treated|Part 1: Dose Escalation Period||3
3387052|NCT02906020|4122381|FG007|Treated|Part 1: Dose Escalation Period||3
3387053|NCT02906020|4122382|FG008|Treated|Part 1: Dose Escalation Period||0
3171825|NCT01937351|3899027|FG000|NOT COMPLETED|Overall Study||9
3171826|NCT01937351|3899028|FG001|NOT COMPLETED|Overall Study||2
3387054|NCT02906020|4122383|FG009|Treated|Part 1: Dose Escalation Period||0
3387055|NCT02906020|4122384|FG010|Treated|Part 1: Dose Escalation Period||0
3387056|NCT02906020|4122385|FG011|Treated|Part 1: Dose Escalation Period||0
3387057|NCT02906020|4122386|FG012|Treated|Part 1: Dose Escalation Period||0
3387058|NCT02906020|4122387|FG013|Treated|Part 1: Dose Escalation Period||0
3387059|NCT02906020|4122388|FG014|Treated|Part 1: Dose Escalation Period||0
3387060|NCT02906020|4122389|FG015|Treated|Part 1: Dose Escalation Period||0
3387061|NCT02906020|4122374|FG000|COMPLETED|Part 1: Dose Escalation Period||4
3387062|NCT02906020|4122375|FG001|COMPLETED|Part 1: Dose Escalation Period||3
3387063|NCT02906020|4122376|FG002|COMPLETED|Part 1: Dose Escalation Period||5
3387064|NCT02906020|4122377|FG003|COMPLETED|Part 1: Dose Escalation Period||3
3387065|NCT02906020|4122378|FG004|COMPLETED|Part 1: Dose Escalation Period||3
3387066|NCT02906020|4122379|FG005|COMPLETED|Part 1: Dose Escalation Period||3
3387067|NCT02906020|4122380|FG006|COMPLETED|Part 1: Dose Escalation Period||3
3387068|NCT02906020|4122381|FG007|COMPLETED|Part 1: Dose Escalation Period||3
3387069|NCT02906020|4122382|FG008|COMPLETED|Part 1: Dose Escalation Period||0
3387070|NCT02906020|4122383|FG009|COMPLETED|Part 1: Dose Escalation Period||0
3387071|NCT02906020|4122384|FG010|COMPLETED|Part 1: Dose Escalation Period||0
3387072|NCT02906020|4122385|FG011|COMPLETED|Part 1: Dose Escalation Period||0
3387073|NCT02906020|4122386|FG012|COMPLETED|Part 1: Dose Escalation Period||0
3387074|NCT02906020|4122387|FG013|COMPLETED|Part 1: Dose Escalation Period||0
3387075|NCT02906020|4122388|FG014|COMPLETED|Part 1: Dose Escalation Period||0
3387076|NCT02906020|4122389|FG015|COMPLETED|Part 1: Dose Escalation Period||0
3387077|NCT02906020|4122374|FG000|NOT COMPLETED|Part 1: Dose Escalation Period||0
3387078|NCT02906020|4122375|FG001|NOT COMPLETED|Part 1: Dose Escalation Period||1
3387079|NCT02906020|4122376|FG002|NOT COMPLETED|Part 1: Dose Escalation Period||0
3387080|NCT02906020|4122377|FG003|NOT COMPLETED|Part 1: Dose Escalation Period||1
3387081|NCT02906020|4122378|FG004|NOT COMPLETED|Part 1: Dose Escalation Period||0
3387082|NCT02906020|4122379|FG005|NOT COMPLETED|Part 1: Dose Escalation Period||0
3387083|NCT02906020|4122380|FG006|NOT COMPLETED|Part 1: Dose Escalation Period||0
3387084|NCT02906020|4122381|FG007|NOT COMPLETED|Part 1: Dose Escalation Period||0
3387085|NCT02906020|4122382|FG008|NOT COMPLETED|Part 1: Dose Escalation Period||0
3387086|NCT02906020|4122383|FG009|NOT COMPLETED|Part 1: Dose Escalation Period||0
3387087|NCT02906020|4122384|FG010|NOT COMPLETED|Part 1: Dose Escalation Period||0
3387088|NCT02906020|4122385|FG011|NOT COMPLETED|Part 1: Dose Escalation Period||0
3387089|NCT02906020|4122386|FG012|NOT COMPLETED|Part 1: Dose Escalation Period||0
3387090|NCT02906020|4122387|FG013|NOT COMPLETED|Part 1: Dose Escalation Period||0
3387091|NCT02906020|4122388|FG014|NOT COMPLETED|Part 1: Dose Escalation Period||0
3387092|NCT02906020|4122389|FG015|NOT COMPLETED|Part 1: Dose Escalation Period||0
3387093|NCT02906020|4122374|FG000|STARTED|Part 2: Double-blind Treatment Period||0
3387094|NCT02906020|4122375|FG001|STARTED|Part 2: Double-blind Treatment Period||0
3387095|NCT02906020|4122376|FG002|STARTED|Part 2: Double-blind Treatment Period||0
3387096|NCT02906020|4122377|FG003|STARTED|Part 2: Double-blind Treatment Period||0
3387097|NCT02906020|4122378|FG004|STARTED|Part 2: Double-blind Treatment Period||0
3387098|NCT02906020|4122379|FG005|STARTED|Part 2: Double-blind Treatment Period||0
3387099|NCT02906020|4122380|FG006|STARTED|Part 2: Double-blind Treatment Period||0
3387100|NCT02906020|4122381|FG007|STARTED|Part 2: Double-blind Treatment Period||0
3387101|NCT02906020|4122382|FG008|STARTED|Part 2: Double-blind Treatment Period||111
3387102|NCT02906020|4122383|FG009|STARTED|Part 2: Double-blind Treatment Period||110
3387103|NCT02906020|4122384|FG010|STARTED|Part 2: Double-blind Treatment Period||10
3387104|NCT02906020|4122385|FG011|STARTED|Part 2: Double-blind Treatment Period||13
3387105|NCT02906020|4122386|FG012|STARTED|Part 2: Double-blind Treatment Period||0
3387106|NCT02906020|4122387|FG013|STARTED|Part 2: Double-blind Treatment Period||0
3387107|NCT02906020|4122388|FG014|STARTED|Part 2: Double-blind Treatment Period||0
3387108|NCT02906020|4122389|FG015|STARTED|Part 2: Double-blind Treatment Period||0
3387109|NCT02906020|4122374|FG000|Treated|Part 2: Double-blind Treatment Period||0
3387110|NCT02906020|4122375|FG001|Treated|Part 2: Double-blind Treatment Period||0
3387111|NCT02906020|4122376|FG002|Treated|Part 2: Double-blind Treatment Period||0
3387112|NCT02906020|4122377|FG003|Treated|Part 2: Double-blind Treatment Period||0
3387113|NCT02906020|4122378|FG004|Treated|Part 2: Double-blind Treatment Period||0
3387114|NCT02906020|4122379|FG005|Treated|Part 2: Double-blind Treatment Period||0
3387115|NCT02906020|4122380|FG006|Treated|Part 2: Double-blind Treatment Period||0
3387116|NCT02906020|4122381|FG007|Treated|Part 2: Double-blind Treatment Period||0
3387117|NCT02906020|4122382|FG008|Treated|Part 2: Double-blind Treatment Period||111
3387118|NCT02906020|4122383|FG009|Treated|Part 2: Double-blind Treatment Period||110
3387119|NCT02906020|4122384|FG010|Treated|Part 2: Double-blind Treatment Period||10
3387120|NCT02906020|4122385|FG011|Treated|Part 2: Double-blind Treatment Period||13
3387121|NCT02906020|4122386|FG012|Treated|Part 2: Double-blind Treatment Period||0
3387122|NCT02906020|4122387|FG013|Treated|Part 2: Double-blind Treatment Period||0
3387123|NCT02906020|4122388|FG014|Treated|Part 2: Double-blind Treatment Period||0
3387124|NCT02906020|4122389|FG015|Treated|Part 2: Double-blind Treatment Period||0
3387125|NCT02906020|4122374|FG000|COMPLETED|Part 2: Double-blind Treatment Period||0
3387126|NCT02906020|4122375|FG001|COMPLETED|Part 2: Double-blind Treatment Period||0
3387127|NCT02906020|4122376|FG002|COMPLETED|Part 2: Double-blind Treatment Period||0
3387128|NCT02906020|4122377|FG003|COMPLETED|Part 2: Double-blind Treatment Period||0
3387129|NCT02906020|4122378|FG004|COMPLETED|Part 2: Double-blind Treatment Period||0
3387130|NCT02906020|4122379|FG005|COMPLETED|Part 2: Double-blind Treatment Period||0
3387131|NCT02906020|4122380|FG006|COMPLETED|Part 2: Double-blind Treatment Period||0
3387132|NCT02906020|4122381|FG007|COMPLETED|Part 2: Double-blind Treatment Period||0
3387133|NCT02906020|4122382|FG008|COMPLETED|Part 2: Double-blind Treatment Period||99
3387134|NCT02906020|4122383|FG009|COMPLETED|Part 2: Double-blind Treatment Period||85
3387135|NCT02906020|4122384|FG010|COMPLETED|Part 2: Double-blind Treatment Period||10
3387136|NCT02906020|4122385|FG011|COMPLETED|Part 2: Double-blind Treatment Period||13
3387137|NCT02906020|4122386|FG012|COMPLETED|Part 2: Double-blind Treatment Period||0
3387138|NCT02906020|4122387|FG013|COMPLETED|Part 2: Double-blind Treatment Period||0
3387139|NCT02906020|4122388|FG014|COMPLETED|Part 2: Double-blind Treatment Period||0
3387140|NCT02906020|4122389|FG015|COMPLETED|Part 2: Double-blind Treatment Period||0
3171827|NCT01937364|3899035|FG000|STARTED|Overall Study||9
3171828|NCT01937364|3899036|FG001|STARTED|Overall Study||8
3171829|NCT01937364|3899035|FG000|COMPLETED|Overall Study||7
3171830|NCT01937364|3899036|FG001|COMPLETED|Overall Study||7
3171831|NCT01937364|3899035|FG000|NOT COMPLETED|Overall Study||2
3387141|NCT02906020|4122374|FG000|NOT COMPLETED|Part 2: Double-blind Treatment Period||0
3387142|NCT02906020|4122375|FG001|NOT COMPLETED|Part 2: Double-blind Treatment Period||0
3387143|NCT02906020|4122376|FG002|NOT COMPLETED|Part 2: Double-blind Treatment Period||0
3387144|NCT02906020|4122377|FG003|NOT COMPLETED|Part 2: Double-blind Treatment Period||0
3387145|NCT02906020|4122378|FG004|NOT COMPLETED|Part 2: Double-blind Treatment Period||0
3387146|NCT02906020|4122379|FG005|NOT COMPLETED|Part 2: Double-blind Treatment Period||0
3387147|NCT02906020|4122380|FG006|NOT COMPLETED|Part 2: Double-blind Treatment Period||0
3387148|NCT02906020|4122381|FG007|NOT COMPLETED|Part 2: Double-blind Treatment Period||0
3387149|NCT02906020|4122382|FG008|NOT COMPLETED|Part 2: Double-blind Treatment Period||12
3387150|NCT02906020|4122383|FG009|NOT COMPLETED|Part 2: Double-blind Treatment Period||25
3387151|NCT02906020|4122384|FG010|NOT COMPLETED|Part 2: Double-blind Treatment Period||0
3387152|NCT02906020|4122385|FG011|NOT COMPLETED|Part 2: Double-blind Treatment Period||0
3387153|NCT02906020|4122386|FG012|NOT COMPLETED|Part 2: Double-blind Treatment Period||0
3387154|NCT02906020|4122387|FG013|NOT COMPLETED|Part 2: Double-blind Treatment Period||0
3387155|NCT02906020|4122388|FG014|NOT COMPLETED|Part 2: Double-blind Treatment Period||0
3387156|NCT02906020|4122389|FG015|NOT COMPLETED|Part 2: Double-blind Treatment Period||0
3387157|NCT02906020|4122374|FG000|STARTED|Part 2: Long-term Follow-up Period||0
3387158|NCT02906020|4122375|FG001|STARTED|Part 2: Long-term Follow-up Period||0
3387159|NCT02906020|4122376|FG002|STARTED|Part 2: Long-term Follow-up Period||0
3387160|NCT02906020|4122377|FG003|STARTED|Part 2: Long-term Follow-up Period||0
3387161|NCT02906020|4122378|FG004|STARTED|Part 2: Long-term Follow-up Period||0
3387162|NCT02906020|4122379|FG005|STARTED|Part 2: Long-term Follow-up Period||0
3387163|NCT02906020|4122380|FG006|STARTED|Part 2: Long-term Follow-up Period||0
3387164|NCT02906020|4122381|FG007|STARTED|Part 2: Long-term Follow-up Period||0
3387165|NCT02906020|4122382|FG008|STARTED|Part 2: Long-term Follow-up Period||0
3387166|NCT02906020|4122383|FG009|STARTED|Part 2: Long-term Follow-up Period||0
3387167|NCT02906020|4122384|FG010|STARTED|Part 2: Long-term Follow-up Period||0
3387168|NCT02906020|4122385|FG011|STARTED|Part 2: Long-term Follow-up Period||0
3387169|NCT02906020|4122386|FG012|STARTED|Part 2: Long-term Follow-up Period||99
3387170|NCT02906020|4122387|FG013|STARTED|Part 2: Long-term Follow-up Period||85
3387171|NCT02906020|4122388|FG014|STARTED|Part 2: Long-term Follow-up Period||10
3387172|NCT02906020|4122389|FG015|STARTED|Part 2: Long-term Follow-up Period|Out of 13 completed participants in the previous part 2 DB period-arm, 2 didn't enter LTFU period.|11
3387173|NCT02906020|4122374|FG000|Treated|Part 2: Long-term Follow-up Period||0
3387174|NCT02906020|4122375|FG001|Treated|Part 2: Long-term Follow-up Period||0
3387175|NCT02906020|4122376|FG002|Treated|Part 2: Long-term Follow-up Period||0
3387176|NCT02906020|4122377|FG003|Treated|Part 2: Long-term Follow-up Period||0
3387177|NCT02906020|4122378|FG004|Treated|Part 2: Long-term Follow-up Period||0
3387178|NCT02906020|4122379|FG005|Treated|Part 2: Long-term Follow-up Period||0
3387179|NCT02906020|4122380|FG006|Treated|Part 2: Long-term Follow-up Period||0
3387180|NCT02906020|4122381|FG007|Treated|Part 2: Long-term Follow-up Period||0
3387181|NCT02906020|4122382|FG008|Treated|Part 2: Long-term Follow-up Period||0
3387182|NCT02906020|4122383|FG009|Treated|Part 2: Long-term Follow-up Period||0
3387183|NCT02906020|4122384|FG010|Treated|Part 2: Long-term Follow-up Period||0
3387184|NCT02906020|4122385|FG011|Treated|Part 2: Long-term Follow-up Period||0
3387185|NCT02906020|4122386|FG012|Treated|Part 2: Long-term Follow-up Period||87
3387186|NCT02906020|4122387|FG013|Treated|Part 2: Long-term Follow-up Period||75
3387187|NCT02906020|4122388|FG014|Treated|Part 2: Long-term Follow-up Period||10
3387188|NCT02906020|4122389|FG015|Treated|Part 2: Long-term Follow-up Period||11
3387189|NCT02906020|4122374|FG000|COMPLETED|Part 2: Long-term Follow-up Period||0
3387190|NCT02906020|4122375|FG001|COMPLETED|Part 2: Long-term Follow-up Period||0
3387191|NCT02906020|4122376|FG002|COMPLETED|Part 2: Long-term Follow-up Period||0
3387192|NCT02906020|4122377|FG003|COMPLETED|Part 2: Long-term Follow-up Period||0
3387193|NCT02906020|4122378|FG004|COMPLETED|Part 2: Long-term Follow-up Period||0
3387194|NCT02906020|4122379|FG005|COMPLETED|Part 2: Long-term Follow-up Period||0
3387195|NCT02906020|4122380|FG006|COMPLETED|Part 2: Long-term Follow-up Period||0
3387196|NCT02906020|4122381|FG007|COMPLETED|Part 2: Long-term Follow-up Period||0
3038408|NCT01154101|3757844|FG003|NOT COMPLETED|Overall Study||2
3171832|NCT01937364|3899036|FG001|NOT COMPLETED|Overall Study||1
3387197|NCT02906020|4122382|FG008|COMPLETED|Part 2: Long-term Follow-up Period||0
3387198|NCT02906020|4122383|FG009|COMPLETED|Part 2: Long-term Follow-up Period||0
3387199|NCT02906020|4122384|FG010|COMPLETED|Part 2: Long-term Follow-up Period||0
3387200|NCT02906020|4122385|FG011|COMPLETED|Part 2: Long-term Follow-up Period||0
3387201|NCT02906020|4122386|FG012|COMPLETED|Part 2: Long-term Follow-up Period||0
3387202|NCT02906020|4122387|FG013|COMPLETED|Part 2: Long-term Follow-up Period||0
3387203|NCT02906020|4122388|FG014|COMPLETED|Part 2: Long-term Follow-up Period||0
3387204|NCT02906020|4122389|FG015|COMPLETED|Part 2: Long-term Follow-up Period||0
3387205|NCT02906020|4122374|FG000|NOT COMPLETED|Part 2: Long-term Follow-up Period||0
3387206|NCT02906020|4122375|FG001|NOT COMPLETED|Part 2: Long-term Follow-up Period||0
3387207|NCT02906020|4122376|FG002|NOT COMPLETED|Part 2: Long-term Follow-up Period||0
3387208|NCT02906020|4122377|FG003|NOT COMPLETED|Part 2: Long-term Follow-up Period||0
3387209|NCT02906020|4122378|FG004|NOT COMPLETED|Part 2: Long-term Follow-up Period||0
3387210|NCT02906020|4122379|FG005|NOT COMPLETED|Part 2: Long-term Follow-up Period||0
3387211|NCT02906020|4122380|FG006|NOT COMPLETED|Part 2: Long-term Follow-up Period||0
3387212|NCT02906020|4122381|FG007|NOT COMPLETED|Part 2: Long-term Follow-up Period||0
3387213|NCT02906020|4122382|FG008|NOT COMPLETED|Part 2: Long-term Follow-up Period||0
3387214|NCT02906020|4122383|FG009|NOT COMPLETED|Part 2: Long-term Follow-up Period||0
3387215|NCT02906020|4122384|FG010|NOT COMPLETED|Part 2: Long-term Follow-up Period||0
3387216|NCT02906020|4122385|FG011|NOT COMPLETED|Part 2: Long-term Follow-up Period||0
3387217|NCT02906020|4122386|FG012|NOT COMPLETED|Part 2: Long-term Follow-up Period||99
3387218|NCT02906020|4122387|FG013|NOT COMPLETED|Part 2: Long-term Follow-up Period||85
3387219|NCT02906020|4122388|FG014|NOT COMPLETED|Part 2: Long-term Follow-up Period||10
3171833|NCT01937390|3899042|FG000|STARTED|Overall Study||585
3171834|NCT01937390|3899042|FG000|COMPLETED|Overall Study||550
3171835|NCT01937390|3899042|FG000|NOT COMPLETED|Overall Study||35
3171836|NCT01937520|3899048|FG000|STARTED|Overall Study||11
3171837|NCT01937520|3899049|FG001|STARTED|Overall Study||9
3171838|NCT01937520|3899048|FG000|COMPLETED|Overall Study||11
3171839|NCT01937520|3899049|FG001|COMPLETED|Overall Study||9
3171840|NCT01937520|3899048|FG000|NOT COMPLETED|Overall Study||0
3171841|NCT01937520|3899049|FG001|NOT COMPLETED|Overall Study||0
3171842|NCT01937559|3899059|FG000|STARTED|Overall Study||61
3317287|NCT03125200|4050833|FG004|COMPLETED|Overall Study||0
3387220|NCT02906020|4122389|FG015|NOT COMPLETED|Part 2: Long-term Follow-up Period||11
3387221|NCT02899299|4122419|FG000|STARTED|Pre-treatment||303
3387222|NCT02899299|4122420|FG001|STARTED|Pre-treatment||302
3387223|NCT02899299|4122419|FG000|COMPLETED|Pre-treatment||300
3387224|NCT02899299|4122420|FG001|COMPLETED|Pre-treatment||284
3387225|NCT02899299|4122419|FG000|NOT COMPLETED|Pre-treatment||3
3387226|NCT02899299|4122420|FG001|NOT COMPLETED|Pre-treatment||18
3387227|NCT02899299|4122419|FG000|STARTED|Treatment||300
3387228|NCT02899299|4122420|FG001|STARTED|Treatment||284
3387229|NCT02899299|4122419|FG000|COMPLETED|Treatment||5
3387230|NCT02899299|4122420|FG001|COMPLETED|Treatment||0
3387231|NCT02899299|4122419|FG000|NOT COMPLETED|Treatment||295
3387232|NCT02899299|4122420|FG001|NOT COMPLETED|Treatment||284
3387233|NCT02891226|4122430|FG000|STARTED|Period 1 (Weeks 0 to 12)||64
3387234|NCT02891226|4122431|FG001|STARTED|Period 1 (Weeks 0 to 12)||31
3387235|NCT02891226|4122432|FG002|STARTED|Period 1 (Weeks 0 to 12)||32
3387236|NCT02891226|4122433|FG003|STARTED|Period 1 (Weeks 0 to 12)||64
3387237|NCT02891226|4122434|FG004|STARTED|Period 1 (Weeks 0 to 12)||0
3387238|NCT02891226|4122435|FG005|STARTED|Period 1 (Weeks 0 to 12)||0
3387239|NCT02891226|4122436|FG006|STARTED|Period 1 (Weeks 0 to 12)||0
3387240|NCT02891226|4122437|FG007|STARTED|Period 1 (Weeks 0 to 12)||0
3387241|NCT02891226|4122438|FG008|STARTED|Period 1 (Weeks 0 to 12)||0
3387242|NCT02891226|4122439|FG009|STARTED|Period 1 (Weeks 0 to 12)||0
3387243|NCT02891226|4122440|FG010|STARTED|Period 1 (Weeks 0 to 12)||0
3387244|NCT02891226|4122441|FG011|STARTED|Period 1 (Weeks 0 to 12)||0
3387245|NCT02891226|4122442|FG012|STARTED|Period 1 (Weeks 0 to 12)||0
3387246|NCT02891226|4122443|FG013|STARTED|Period 1 (Weeks 0 to 12)||0
3387247|NCT02891226|4122444|FG014|STARTED|Period 1 (Weeks 0 to 12)||0
3387248|NCT02891226|4122445|FG015|STARTED|Period 1 (Weeks 0 to 12)||0
3387249|NCT02891226|4122430|FG000|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||64
3387250|NCT02891226|4122431|FG001|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||31
3387251|NCT02891226|4122432|FG002|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||32
3387252|NCT02891226|4122433|FG003|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||64
3387253|NCT02891226|4122434|FG004|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||0
3387254|NCT02891226|4122435|FG005|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||0
3387255|NCT02891226|4122436|FG006|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||0
3387256|NCT02891226|4122437|FG007|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||0
3387257|NCT02891226|4122438|FG008|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||0
3387258|NCT02891226|4122439|FG009|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||0
3387259|NCT02891226|4122440|FG010|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||0
3387260|NCT02891226|4122441|FG011|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||0
3387261|NCT02891226|4122442|FG012|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||0
3171843|NCT01937559|3899060|FG001|STARTED|Overall Study||61
3171844|NCT01937559|3899061|FG002|STARTED|Overall Study||66
3171845|NCT01937559|3899059|FG000|COMPLETED|Overall Study||50
3387262|NCT02891226|4122443|FG013|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||0
3387263|NCT02891226|4122444|FG014|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||0
3387264|NCT02891226|4122445|FG015|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||0
3387265|NCT02891226|4122430|FG000|COMPLETED|Period 1 (Weeks 0 to 12)||59
3387266|NCT02891226|4122431|FG001|COMPLETED|Period 1 (Weeks 0 to 12)||29
3387267|NCT02891226|4122432|FG002|COMPLETED|Period 1 (Weeks 0 to 12)||28
3387268|NCT02891226|4122433|FG003|COMPLETED|Period 1 (Weeks 0 to 12)||60
3387269|NCT02891226|4122434|FG004|COMPLETED|Period 1 (Weeks 0 to 12)||0
3387270|NCT02891226|4122435|FG005|COMPLETED|Period 1 (Weeks 0 to 12)||0
3387271|NCT02891226|4122436|FG006|COMPLETED|Period 1 (Weeks 0 to 12)||0
3387272|NCT02891226|4122437|FG007|COMPLETED|Period 1 (Weeks 0 to 12)||0
3387273|NCT02891226|4122438|FG008|COMPLETED|Period 1 (Weeks 0 to 12)||0
3387274|NCT02891226|4122439|FG009|COMPLETED|Period 1 (Weeks 0 to 12)||0
3387275|NCT02891226|4122440|FG010|COMPLETED|Period 1 (Weeks 0 to 12)||0
3387276|NCT02891226|4122441|FG011|COMPLETED|Period 1 (Weeks 0 to 12)||0
3387277|NCT02891226|4122442|FG012|COMPLETED|Period 1 (Weeks 0 to 12)||0
3387278|NCT02891226|4122443|FG013|COMPLETED|Period 1 (Weeks 0 to 12)||0
3387279|NCT02891226|4122444|FG014|COMPLETED|Period 1 (Weeks 0 to 12)||0
3387280|NCT02891226|4122445|FG015|COMPLETED|Period 1 (Weeks 0 to 12)||0
3387281|NCT02891226|4122430|FG000|NOT COMPLETED|Period 1 (Weeks 0 to 12)||5
3387282|NCT02891226|4122431|FG001|NOT COMPLETED|Period 1 (Weeks 0 to 12)||2
3387283|NCT02891226|4122432|FG002|NOT COMPLETED|Period 1 (Weeks 0 to 12)||4
3387284|NCT02891226|4122433|FG003|NOT COMPLETED|Period 1 (Weeks 0 to 12)||4
3387285|NCT02891226|4122434|FG004|NOT COMPLETED|Period 1 (Weeks 0 to 12)||0
3387286|NCT02891226|4122435|FG005|NOT COMPLETED|Period 1 (Weeks 0 to 12)||0
3387287|NCT02891226|4122436|FG006|NOT COMPLETED|Period 1 (Weeks 0 to 12)||0
3387288|NCT02891226|4122437|FG007|NOT COMPLETED|Period 1 (Weeks 0 to 12)||0
3387289|NCT02891226|4122438|FG008|NOT COMPLETED|Period 1 (Weeks 0 to 12)||0
3387290|NCT02891226|4122439|FG009|NOT COMPLETED|Period 1 (Weeks 0 to 12)||0
3387291|NCT02891226|4122440|FG010|NOT COMPLETED|Period 1 (Weeks 0 to 12)||0
3387292|NCT02891226|4122441|FG011|NOT COMPLETED|Period 1 (Weeks 0 to 12)||0
3387293|NCT02891226|4122442|FG012|NOT COMPLETED|Period 1 (Weeks 0 to 12)||0
3387294|NCT02891226|4122443|FG013|NOT COMPLETED|Period 1 (Weeks 0 to 12)||0
3387295|NCT02891226|4122444|FG014|NOT COMPLETED|Period 1 (Weeks 0 to 12)||0
3387296|NCT02891226|4122445|FG015|NOT COMPLETED|Period 1 (Weeks 0 to 12)||0
3387297|NCT02891226|4122430|FG000|STARTED|Period 2 (Weeks 12 to 52)|Participants were assigned to this arm during period 1.|0
3387298|NCT02891226|4122431|FG001|STARTED|Period 2 (Weeks 12 to 52)|Participants were assigned to this arm during period 1.|0
3387299|NCT02891226|4122432|FG002|STARTED|Period 2 (Weeks 12 to 52)|Participants were assigned to this arm during period 1.|0
3387300|NCT02891226|4122433|FG003|STARTED|Period 2 (Weeks 12 to 52)|Participants were assigned to this arm during period 1.|0
3387301|NCT02891226|4122434|FG004|STARTED|Period 2 (Weeks 12 to 52)|Participants were assigned to this arm during period 2.|9
3387302|NCT02891226|4122435|FG005|STARTED|Period 2 (Weeks 12 to 52)|Participants were assigned to this arm during period 2.|9
3387303|NCT02891226|4122436|FG006|STARTED|Period 2 (Weeks 12 to 52)|Participants were assigned to this arm during period 2.|23
3387304|NCT02891226|4122437|FG007|STARTED|Period 2 (Weeks 12 to 52)|Participants were assigned to this arm during period 2.|46
3387305|NCT02891226|4122438|FG008|STARTED|Period 2 (Weeks 12 to 52)|Participants were assigned to this arm during period 2.|30
3387306|NCT02891226|4122439|FG009|STARTED|Period 2 (Weeks 12 to 52)|Participants were assigned to this arm during period 2.|59
3387307|NCT02891226|4122440|FG010|STARTED|Period 2 (Weeks 12 to 52)||0
3387308|NCT02891226|4122441|FG011|STARTED|Period 2 (Weeks 12 to 52)||0
3387309|NCT02891226|4122442|FG012|STARTED|Period 2 (Weeks 12 to 52)||0
3387310|NCT02891226|4122443|FG013|STARTED|Period 2 (Weeks 12 to 52)||0
3387311|NCT02891226|4122444|FG014|STARTED|Period 2 (Weeks 12 to 52)||0
3387312|NCT02891226|4122445|FG015|STARTED|Period 2 (Weeks 12 to 52)||0
3387313|NCT02891226|4122430|FG000|COMPLETED|Period 2 (Weeks 12 to 52)||0
3387314|NCT02891226|4122431|FG001|COMPLETED|Period 2 (Weeks 12 to 52)||0
3387315|NCT02891226|4122432|FG002|COMPLETED|Period 2 (Weeks 12 to 52)||0
3387316|NCT02891226|4122433|FG003|COMPLETED|Period 2 (Weeks 12 to 52)||0
3387317|NCT02891226|4122434|FG004|COMPLETED|Period 2 (Weeks 12 to 52)||8
3387318|NCT02891226|4122435|FG005|COMPLETED|Period 2 (Weeks 12 to 52)||8
3387319|NCT02891226|4122436|FG006|COMPLETED|Period 2 (Weeks 12 to 52)||20
3387320|NCT02891226|4122437|FG007|COMPLETED|Period 2 (Weeks 12 to 52)||41
3387321|NCT02891226|4122438|FG008|COMPLETED|Period 2 (Weeks 12 to 52)||24
3387322|NCT02891226|4122439|FG009|COMPLETED|Period 2 (Weeks 12 to 52)||42
3387323|NCT02891226|4122440|FG010|COMPLETED|Period 2 (Weeks 12 to 52)||0
3387324|NCT02891226|4122441|FG011|COMPLETED|Period 2 (Weeks 12 to 52)||0
3387325|NCT02891226|4122442|FG012|COMPLETED|Period 2 (Weeks 12 to 52)||0
3387326|NCT02891226|4122443|FG013|COMPLETED|Period 2 (Weeks 12 to 52)||0
3387327|NCT02891226|4122444|FG014|COMPLETED|Period 2 (Weeks 12 to 52)||0
3387328|NCT02891226|4122445|FG015|COMPLETED|Period 2 (Weeks 12 to 52)||0
3387329|NCT02891226|4122430|FG000|NOT COMPLETED|Period 2 (Weeks 12 to 52)||0
3387330|NCT02891226|4122431|FG001|NOT COMPLETED|Period 2 (Weeks 12 to 52)||0
3387331|NCT02891226|4122432|FG002|NOT COMPLETED|Period 2 (Weeks 12 to 52)||0
3387332|NCT02891226|4122433|FG003|NOT COMPLETED|Period 2 (Weeks 12 to 52)||0
3387333|NCT02891226|4122434|FG004|NOT COMPLETED|Period 2 (Weeks 12 to 52)||1
3387334|NCT02891226|4122435|FG005|NOT COMPLETED|Period 2 (Weeks 12 to 52)||1
3387335|NCT02891226|4122436|FG006|NOT COMPLETED|Period 2 (Weeks 12 to 52)||3
3387336|NCT02891226|4122437|FG007|NOT COMPLETED|Period 2 (Weeks 12 to 52)||5
3387337|NCT02891226|4122438|FG008|NOT COMPLETED|Period 2 (Weeks 12 to 52)||6
3387338|NCT02891226|4122439|FG009|NOT COMPLETED|Period 2 (Weeks 12 to 52)||17
3387339|NCT02891226|4122440|FG010|NOT COMPLETED|Period 2 (Weeks 12 to 52)||0
3387340|NCT02891226|4122441|FG011|NOT COMPLETED|Period 2 (Weeks 12 to 52)||0
3387341|NCT02891226|4122442|FG012|NOT COMPLETED|Period 2 (Weeks 12 to 52)||0
3387342|NCT02891226|4122443|FG013|NOT COMPLETED|Period 2 (Weeks 12 to 52)||0
3387343|NCT02891226|4122444|FG014|NOT COMPLETED|Period 2 (Weeks 12 to 52)||0
3387344|NCT02891226|4122445|FG015|NOT COMPLETED|Period 2 (Weeks 12 to 52)||0
3387345|NCT02891226|4122430|FG000|STARTED|Period 3 (Weeks 52 to 208)||0
3387346|NCT02891226|4122431|FG001|STARTED|Period 3 (Weeks 52 to 208)||0
3387347|NCT02891226|4122432|FG002|STARTED|Period 3 (Weeks 52 to 208)||0
3387348|NCT02891226|4122433|FG003|STARTED|Period 3 (Weeks 52 to 208)||0
3387349|NCT02891226|4122434|FG004|STARTED|Period 3 (Weeks 52 to 208)|Participants were assigned to this arm during period 2.|0
3387350|NCT02891226|4122435|FG005|STARTED|Period 3 (Weeks 52 to 208)|Participants were assigned to this arm during period 2.|0
3387351|NCT02891226|4122436|FG006|STARTED|Period 3 (Weeks 52 to 208)|Participants were assigned to this arm during period 2.|0
3387352|NCT02891226|4122437|FG007|STARTED|Period 3 (Weeks 52 to 208)|Participants were assigned to this arm during period 2.|0
3387353|NCT02891226|4122438|FG008|STARTED|Period 3 (Weeks 52 to 208)|Participants were assigned to this arm during period 2.|0
3387354|NCT02891226|4122439|FG009|STARTED|Period 3 (Weeks 52 to 208)|Participants were assigned to this arm during period 2.|0
3387355|NCT02891226|4122440|FG010|STARTED|Period 3 (Weeks 52 to 208)|Participants were assigned to this arm during period 3.|137
3387356|NCT02891226|4122441|FG011|STARTED|Period 3 (Weeks 52 to 208)||0
3387357|NCT02891226|4122442|FG012|STARTED|Period 3 (Weeks 52 to 208)||0
3387358|NCT02891226|4122443|FG013|STARTED|Period 3 (Weeks 52 to 208)||0
3387359|NCT02891226|4122444|FG014|STARTED|Period 3 (Weeks 52 to 208)||0
3387360|NCT02891226|4122445|FG015|STARTED|Period 3 (Weeks 52 to 208)||0
3387361|NCT02891226|4122430|FG000|COMPLETED|Period 3 (Weeks 52 to 208)||0
3387362|NCT02891226|4122431|FG001|COMPLETED|Period 3 (Weeks 52 to 208)||0
3387363|NCT02891226|4122432|FG002|COMPLETED|Period 3 (Weeks 52 to 208)||0
3387364|NCT02891226|4122433|FG003|COMPLETED|Period 3 (Weeks 52 to 208)||0
3387365|NCT02891226|4122434|FG004|COMPLETED|Period 3 (Weeks 52 to 208)||0
3387366|NCT02891226|4122435|FG005|COMPLETED|Period 3 (Weeks 52 to 208)||0
3387367|NCT02891226|4122436|FG006|COMPLETED|Period 3 (Weeks 52 to 208)||0
3387368|NCT02891226|4122437|FG007|COMPLETED|Period 3 (Weeks 52 to 208)||0
3387369|NCT02891226|4122438|FG008|COMPLETED|Period 3 (Weeks 52 to 208)||0
3387370|NCT02891226|4122439|FG009|COMPLETED|Period 3 (Weeks 52 to 208)||0
3387371|NCT02891226|4122440|FG010|COMPLETED|Period 3 (Weeks 52 to 208)||0
3387372|NCT02891226|4122441|FG011|COMPLETED|Period 3 (Weeks 52 to 208)||0
3387373|NCT02891226|4122442|FG012|COMPLETED|Period 3 (Weeks 52 to 208)||0
3387374|NCT02891226|4122443|FG013|COMPLETED|Period 3 (Weeks 52 to 208)||0
3387375|NCT02891226|4122444|FG014|COMPLETED|Period 3 (Weeks 52 to 208)||0
3387376|NCT02891226|4122445|FG015|COMPLETED|Period 3 (Weeks 52 to 208)||0
3387377|NCT02891226|4122430|FG000|NOT COMPLETED|Period 3 (Weeks 52 to 208)||0
3387378|NCT02891226|4122431|FG001|NOT COMPLETED|Period 3 (Weeks 52 to 208)||0
3387379|NCT02891226|4122432|FG002|NOT COMPLETED|Period 3 (Weeks 52 to 208)||0
3387380|NCT02891226|4122433|FG003|NOT COMPLETED|Period 3 (Weeks 52 to 208)||0
3387381|NCT02891226|4122434|FG004|NOT COMPLETED|Period 3 (Weeks 52 to 208)||0
3387382|NCT02891226|4122435|FG005|NOT COMPLETED|Period 3 (Weeks 52 to 208)||0
3387383|NCT02891226|4122436|FG006|NOT COMPLETED|Period 3 (Weeks 52 to 208)||0
3387384|NCT02891226|4122437|FG007|NOT COMPLETED|Period 3 (Weeks 52 to 208)||0
3387385|NCT02891226|4122438|FG008|NOT COMPLETED|Period 3 (Weeks 52 to 208)||0
3387386|NCT02891226|4122439|FG009|NOT COMPLETED|Period 3 (Weeks 52 to 208)||0
3387387|NCT02891226|4122440|FG010|NOT COMPLETED|Period 3 (Weeks 52 to 208)||137
3387388|NCT02891226|4122441|FG011|NOT COMPLETED|Period 3 (Weeks 52 to 208)||0
3387389|NCT02891226|4122442|FG012|NOT COMPLETED|Period 3 (Weeks 52 to 208)||0
3387390|NCT02891226|4122443|FG013|NOT COMPLETED|Period 3 (Weeks 52 to 208)||0
3171846|NCT01937559|3899060|FG001|COMPLETED|Overall Study||50
3171847|NCT01937559|3899061|FG002|COMPLETED|Overall Study||66
3387391|NCT02891226|4122444|FG014|NOT COMPLETED|Period 3 (Weeks 52 to 208)||0
3387392|NCT02891226|4122445|FG015|NOT COMPLETED|Period 3 (Weeks 52 to 208)||0
3387393|NCT02891226|4122430|FG000|STARTED|Follow-up Period||0
3387394|NCT02891226|4122431|FG001|STARTED|Follow-up Period||0
3387395|NCT02891226|4122432|FG002|STARTED|Follow-up Period||0
3387396|NCT02891226|4122433|FG003|STARTED|Follow-up Period||0
3387397|NCT02891226|4122434|FG004|STARTED|Follow-up Period||0
3387398|NCT02891226|4122435|FG005|STARTED|Follow-up Period||0
3387399|NCT02891226|4122436|FG006|STARTED|Follow-up Period||0
3387400|NCT02891226|4122437|FG007|STARTED|Follow-up Period||0
3387401|NCT02891226|4122438|FG008|STARTED|Follow-up Period||0
3387402|NCT02891226|4122439|FG009|STARTED|Follow-up Period||0
3387403|NCT02891226|4122440|FG010|STARTED|Follow-up Period||0
3387404|NCT02891226|4122441|FG011|STARTED|Follow-up Period|Participants were assigned to this arm during follow-up period.|1
3387405|NCT02891226|4122442|FG012|STARTED|Follow-up Period|Participants were assigned to this arm during follow-up period.|2
3387406|NCT02891226|4122443|FG013|STARTED|Follow-up Period|Participants were assigned to this arm during follow-up period.|1
3387407|NCT02891226|4122444|FG014|STARTED|Follow-up Period|Participants were assigned to this arm during follow-up period.|1
3387408|NCT02891226|4122445|FG015|STARTED|Follow-up Period|Participants were assigned to this arm during follow-up period.|3
3387409|NCT02891226|4122430|FG000|COMPLETED|Follow-up Period||0
3387410|NCT02891226|4122431|FG001|COMPLETED|Follow-up Period||0
3387411|NCT02891226|4122432|FG002|COMPLETED|Follow-up Period||0
3171848|NCT01937559|3899059|FG000|NOT COMPLETED|Overall Study||11
3387412|NCT02891226|4122433|FG003|COMPLETED|Follow-up Period||0
3387413|NCT02891226|4122434|FG004|COMPLETED|Follow-up Period||0
3387414|NCT02891226|4122435|FG005|COMPLETED|Follow-up Period||0
3387415|NCT02891226|4122436|FG006|COMPLETED|Follow-up Period||0
3387416|NCT02891226|4122437|FG007|COMPLETED|Follow-up Period||0
3387417|NCT02891226|4122438|FG008|COMPLETED|Follow-up Period||0
3387418|NCT02891226|4122439|FG009|COMPLETED|Follow-up Period||0
3387419|NCT02891226|4122440|FG010|COMPLETED|Follow-up Period||0
3387420|NCT02891226|4122441|FG011|COMPLETED|Follow-up Period||0
3387421|NCT02891226|4122442|FG012|COMPLETED|Follow-up Period||2
3387422|NCT02891226|4122443|FG013|COMPLETED|Follow-up Period||1
3387423|NCT02891226|4122444|FG014|COMPLETED|Follow-up Period||0
3387424|NCT02891226|4122445|FG015|COMPLETED|Follow-up Period||2
3387425|NCT02891226|4122430|FG000|NOT COMPLETED|Follow-up Period||0
3387426|NCT02891226|4122431|FG001|NOT COMPLETED|Follow-up Period||0
3387427|NCT02891226|4122432|FG002|NOT COMPLETED|Follow-up Period||0
3387428|NCT02891226|4122433|FG003|NOT COMPLETED|Follow-up Period||0
3387429|NCT02891226|4122434|FG004|NOT COMPLETED|Follow-up Period||0
3387430|NCT02891226|4122435|FG005|NOT COMPLETED|Follow-up Period||0
3387431|NCT02891226|4122436|FG006|NOT COMPLETED|Follow-up Period||0
3387432|NCT02891226|4122437|FG007|NOT COMPLETED|Follow-up Period||0
3387433|NCT02891226|4122438|FG008|NOT COMPLETED|Follow-up Period||0
3387434|NCT02891226|4122439|FG009|NOT COMPLETED|Follow-up Period||0
3387435|NCT02891226|4122440|FG010|NOT COMPLETED|Follow-up Period||0
3387436|NCT02891226|4122441|FG011|NOT COMPLETED|Follow-up Period||1
3387437|NCT02891226|4122442|FG012|NOT COMPLETED|Follow-up Period||0
3387438|NCT02891226|4122443|FG013|NOT COMPLETED|Follow-up Period||0
3387439|NCT02891226|4122444|FG014|NOT COMPLETED|Follow-up Period||1
3387440|NCT02891226|4122445|FG015|NOT COMPLETED|Follow-up Period||1
3387441|NCT02829918|4122469|FG000|STARTED|Overall Study||54
3387442|NCT02829918|4122469|FG000|COMPLETED|Overall Study||46
3387443|NCT02829918|4122469|FG000|NOT COMPLETED|Overall Study||8
3387444|NCT02703480|4122473|FG000|STARTED|Overall Study||11
3387445|NCT02703480|4122474|FG001|STARTED|Overall Study||11
3387446|NCT02703480|4122473|FG000|COMPLETED|Overall Study||10
3387447|NCT02703480|4122474|FG001|COMPLETED|Overall Study||10
3387448|NCT02703480|4122473|FG000|NOT COMPLETED|Overall Study||1
3387449|NCT02703480|4122474|FG001|NOT COMPLETED|Overall Study||1
3387450|NCT02549092|4122482|FG000|STARTED|Treatment Period||44
3387451|NCT02549092|4122483|FG001|STARTED|Treatment Period||45
3387452|NCT02549092|4122482|FG000|COMPLETED|Treatment Period||41
3387453|NCT02549092|4122483|FG001|COMPLETED|Treatment Period||38
3387454|NCT02549092|4122482|FG000|NOT COMPLETED|Treatment Period||3
3387455|NCT02549092|4122483|FG001|NOT COMPLETED|Treatment Period||7
3387456|NCT02549092|4122482|FG000|STARTED|Extension/Transition Period||10
3387457|NCT02549092|4122483|FG001|STARTED|Extension/Transition Period||14
3387458|NCT02549092|4122482|FG000|COMPLETED|Extension/Transition Period||5
3387459|NCT02549092|4122483|FG001|COMPLETED|Extension/Transition Period||5
3387460|NCT02549092|4122482|FG000|NOT COMPLETED|Extension/Transition Period||5
3387461|NCT02549092|4122483|FG001|NOT COMPLETED|Extension/Transition Period||9
3387462|NCT02506465|4122494|FG000|STARTED|Overall Study||128
3387463|NCT02506465|4122495|FG001|STARTED|Overall Study||57
3387464|NCT02506465|4122494|FG000|COMPLETED|Overall Study|78 patients reached 12 months FU visit.|78
3387465|NCT02506465|4122495|FG001|COMPLETED|Overall Study|The Sham arm was analyzed up to 3 months FU visit as primary endpoint timeframe in accordance with the FDA guideline for BPH treatments, published in 2010, the most recent guidance available at the time of the study.|57
3387466|NCT02506465|4122494|FG000|NOT COMPLETED|Overall Study||50
3387467|NCT02506465|4122495|FG001|NOT COMPLETED|Overall Study||0
3387468|NCT02323126|4122504|FG000|STARTED|Overall Study||18
3387469|NCT02323126|4122505|FG001|STARTED|Overall Study||16
3387470|NCT02323126|4122506|FG002|STARTED|Overall Study||30
3387471|NCT02323126|4122504|FG000|COMPLETED|Overall Study||0
3387472|NCT02323126|4122505|FG001|COMPLETED|Overall Study||0
3387473|NCT02323126|4122506|FG002|COMPLETED|Overall Study||0
3387474|NCT02323126|4122504|FG000|NOT COMPLETED|Overall Study||18
3387475|NCT02323126|4122505|FG001|NOT COMPLETED|Overall Study||16
3387476|NCT02323126|4122506|FG002|NOT COMPLETED|Overall Study||30
3387477|NCT01902290|4122519|FG000|STARTED|Overall Study||210
3387478|NCT01902290|4122520|FG001|STARTED|Overall Study||211
3387479|NCT01902290|4122519|FG000|Received Study Drug|Overall Study||207
3387480|NCT01902290|4122520|FG001|Received Study Drug|Overall Study||208
3387481|NCT01902290|4122519|FG000|COMPLETED|Overall Study||162
3387482|NCT01902290|4122520|FG001|COMPLETED|Overall Study||158
3387483|NCT01902290|4122519|FG000|NOT COMPLETED|Overall Study||48
3387484|NCT01902290|4122520|FG001|NOT COMPLETED|Overall Study||53
3387485|NCT01619085|4122527|FG000|STARTED|Overall Study||752
3387486|NCT01619085|4122527|FG000|Treated|Overall Study||751
3387487|NCT01619085|4122527|FG000|COMPLETED|Overall Study||227
3387488|NCT01619085|4122527|FG000|NOT COMPLETED|Overall Study||525
3387489|NCT01126749|4122542|FG000|STARTED|Phase 1b||3
3387490|NCT01126749|4122543|FG001|STARTED|Phase 1b||6
3387491|NCT01126749|4122544|FG002|STARTED|Phase 1b||0
3387492|NCT01126749|4122545|FG003|STARTED|Phase 1b||0
3387493|NCT01126749|4122542|FG000|COMPLETED|Phase 1b||0
3387494|NCT01126749|4122543|FG001|COMPLETED|Phase 1b||0
3387495|NCT01126749|4122544|FG002|COMPLETED|Phase 1b||0
3387496|NCT01126749|4122545|FG003|COMPLETED|Phase 1b||0
3387497|NCT01126749|4122542|FG000|NOT COMPLETED|Phase 1b||3
3387498|NCT01126749|4122543|FG001|NOT COMPLETED|Phase 1b||6
3387499|NCT01126749|4122544|FG002|NOT COMPLETED|Phase 1b||0
3387500|NCT01126749|4122545|FG003|NOT COMPLETED|Phase 1b||0
3387501|NCT01126749|4122542|FG000|STARTED|Phase 2||0
3387502|NCT01126749|4122543|FG001|STARTED|Phase 2||0
3387503|NCT01126749|4122544|FG002|STARTED|Phase 2||42
3387504|NCT01126749|4122545|FG003|STARTED|Phase 2||41
3387505|NCT01126749|4122542|FG000|Safety Analysis Set (SAS)/Treated|Phase 2||0
3387506|NCT01126749|4122543|FG001|Safety Analysis Set (SAS)/Treated|Phase 2||0
3387507|NCT01126749|4122544|FG002|Safety Analysis Set (SAS)/Treated|Phase 2||41
3387508|NCT01126749|4122545|FG003|Safety Analysis Set (SAS)/Treated|Phase 2||39
3387509|NCT01126749|4122542|FG000|Modified-intent-to-treat (MITT)|Phase 2||0
3387510|NCT01126749|4122543|FG001|Modified-intent-to-treat (MITT)|Phase 2||0
3387511|NCT01126749|4122544|FG002|Modified-intent-to-treat (MITT)|Phase 2||40
3387512|NCT01126749|4122545|FG003|Modified-intent-to-treat (MITT)|Phase 2||39
3387513|NCT01126749|4122542|FG000|COMPLETED|Phase 2||0
3387514|NCT01126749|4122543|FG001|COMPLETED|Phase 2||0
3387515|NCT01126749|4122544|FG002|COMPLETED|Phase 2||0
3387516|NCT01126749|4122545|FG003|COMPLETED|Phase 2||0
3387517|NCT01126749|4122542|FG000|NOT COMPLETED|Phase 2||0
3387518|NCT01126749|4122543|FG001|NOT COMPLETED|Phase 2||0
3387519|NCT01126749|4122544|FG002|NOT COMPLETED|Phase 2||42
3387520|NCT01126749|4122545|FG003|NOT COMPLETED|Phase 2||41
3387521|NCT01111110|4122557|FG000|STARTED|Overall Study||3
3387522|NCT01111110|4122558|FG001|STARTED|Overall Study||4
3387523|NCT01111110|4122557|FG000|COMPLETED|Overall Study||3
3387524|NCT01111110|4122558|FG001|COMPLETED|Overall Study||4
3387525|NCT01111110|4122557|FG000|NOT COMPLETED|Overall Study||0
3387526|NCT01111110|4122558|FG001|NOT COMPLETED|Overall Study||0
3387527|NCT01059448|4122568|FG000|STARTED|Overall Study||49
3387528|NCT01059448|4122569|FG001|STARTED|Overall Study||55
3387529|NCT01059448|4122570|FG002|STARTED|Overall Study||53
3387530|NCT01059448|4122571|FG003|STARTED|Overall Study||54
3387531|NCT01059448|4122568|FG000|COMPLETED|Overall Study||0
3387532|NCT01059448|4122569|FG001|COMPLETED|Overall Study||0
3387533|NCT01059448|4122570|FG002|COMPLETED|Overall Study||0
3387534|NCT01059448|4122571|FG003|COMPLETED|Overall Study||0
3387535|NCT01059448|4122568|FG000|NOT COMPLETED|Overall Study||49
3387536|NCT01059448|4122569|FG001|NOT COMPLETED|Overall Study||55
3387537|NCT01059448|4122570|FG002|NOT COMPLETED|Overall Study||53
3387538|NCT01059448|4122571|FG003|NOT COMPLETED|Overall Study||54
3387539|NCT01032603|4122583|FG000|STARTED|Overall Study||101
3387540|NCT01032603|4122584|FG001|STARTED|Overall Study||96
3387541|NCT01032603|4122583|FG000|COMPLETED|Overall Study||86
3387542|NCT01032603|4122584|FG001|COMPLETED|Overall Study||77
3387543|NCT01032603|4122583|FG000|NOT COMPLETED|Overall Study||15
3387544|NCT01032603|4122584|FG001|NOT COMPLETED|Overall Study||19
3387545|NCT00821587|4122592|FG000|STARTED|Overall Study||20
3387546|NCT00821587|4122593|FG001|STARTED|Overall Study||19
3387547|NCT00821587|4122592|FG000|COMPLETED|Overall Study||20
3387548|NCT00821587|4122593|FG001|COMPLETED|Overall Study||18
3387549|NCT00821587|4122592|FG000|NOT COMPLETED|Overall Study||0
3387550|NCT00821587|4122593|FG001|NOT COMPLETED|Overall Study||1
3387551|NCT00585195|4122620|FG000|STARTED|Overall Study||3
3387552|NCT00585195|4122621|FG001|STARTED|Overall Study||4
3387553|NCT00585195|4122622|FG002|STARTED|Overall Study||9
3387554|NCT00585195|4122623|FG003|STARTED|Overall Study||7
3387555|NCT00585195|4122624|FG004|STARTED|Overall Study||9
3387556|NCT00585195|4122625|FG005|STARTED|Overall Study||6
3387557|NCT00585195|4122626|FG006|STARTED|Overall Study||7
3387558|NCT00585195|4122627|FG007|STARTED|Overall Study||5
3387559|NCT00585195|4122628|FG008|STARTED|Overall Study||3
3387560|NCT00585195|4122629|FG009|STARTED|Overall Study||6
3387561|NCT00585195|4122630|FG010|STARTED|Overall Study||11
3387562|NCT00585195|4122631|FG011|STARTED|Overall Study||53
3387563|NCT00585195|4122632|FG012|STARTED|Overall Study||85
3387564|NCT00585195|4122633|FG013|STARTED|Overall Study||41
3387565|NCT00585195|4122634|FG014|STARTED|Overall Study||48
3387566|NCT00585195|4122635|FG015|STARTED|Overall Study||19
3387567|NCT00585195|4122636|FG016|STARTED|Overall Study||154
3387568|NCT00585195|4122637|FG017|STARTED|Overall Study||67
3387569|NCT00585195|4122638|FG018|STARTED|Overall Study||21
3387570|NCT00585195|4122639|FG019|STARTED|Overall Study||18
3387571|NCT00585195|4122640|FG020|STARTED|Overall Study||14
3387572|NCT00585195|4122620|FG000|Treated|Overall Study||3
3387573|NCT00585195|4122621|FG001|Treated|Overall Study||4
3387574|NCT00585195|4122622|FG002|Treated|Overall Study||8
3387575|NCT00585195|4122623|FG003|Treated|Overall Study||7
3387576|NCT00585195|4122624|FG004|Treated|Overall Study||8
3387577|NCT00585195|4122625|FG005|Treated|Overall Study||6
3387578|NCT00585195|4122626|FG006|Treated|Overall Study||6
3387579|NCT00585195|4122627|FG007|Treated|Overall Study||5
3387580|NCT00585195|4122628|FG008|Treated|Overall Study||3
3387581|NCT00585195|4122629|FG009|Treated|Overall Study||6
3387582|NCT00585195|4122630|FG010|Treated|Overall Study||9
3387583|NCT00585195|4122631|FG011|Treated|Overall Study||53
3387584|NCT00585195|4122632|FG012|Treated|Overall Study||85
3387585|NCT00585195|4122633|FG013|Treated|Overall Study||41
3387586|NCT00585195|4122634|FG014|Treated|Overall Study||48
3387587|NCT00585195|4122635|FG015|Treated|Overall Study||18
3387588|NCT00585195|4122636|FG016|Treated|Overall Study||154
3387589|NCT00585195|4122637|FG017|Treated|Overall Study||66
3387590|NCT00585195|4122638|FG018|Treated|Overall Study||18
3387591|NCT00585195|4122639|FG019|Treated|Overall Study||18
3387592|NCT00585195|4122640|FG020|Treated|Overall Study||12
3387593|NCT00585195|4122620|FG000|COMPLETED|Overall Study||0
3387594|NCT00585195|4122621|FG001|COMPLETED|Overall Study||0
3387595|NCT00585195|4122622|FG002|COMPLETED|Overall Study||0
3387596|NCT00585195|4122623|FG003|COMPLETED|Overall Study||0
3387597|NCT00585195|4122624|FG004|COMPLETED|Overall Study||0
3387598|NCT00585195|4122625|FG005|COMPLETED|Overall Study||0
3387599|NCT00585195|4122626|FG006|COMPLETED|Overall Study||0
3387600|NCT00585195|4122627|FG007|COMPLETED|Overall Study||0
3387601|NCT00585195|4122628|FG008|COMPLETED|Overall Study||0
3387602|NCT00585195|4122629|FG009|COMPLETED|Overall Study||0
3387603|NCT00585195|4122630|FG010|COMPLETED|Overall Study||0
3387604|NCT00585195|4122631|FG011|COMPLETED|Overall Study||0
3387605|NCT00585195|4122632|FG012|COMPLETED|Overall Study||0
3387606|NCT00585195|4122633|FG013|COMPLETED|Overall Study||0
3387607|NCT00585195|4122634|FG014|COMPLETED|Overall Study||0
3387608|NCT00585195|4122635|FG015|COMPLETED|Overall Study||0
3387609|NCT00585195|4122636|FG016|COMPLETED|Overall Study||0
3387610|NCT00585195|4122637|FG017|COMPLETED|Overall Study||0
3387611|NCT00585195|4122638|FG018|COMPLETED|Overall Study||0
3387612|NCT00585195|4122639|FG019|COMPLETED|Overall Study||0
3387613|NCT00585195|4122640|FG020|COMPLETED|Overall Study||0
3387614|NCT00585195|4122620|FG000|NOT COMPLETED|Overall Study||3
3387615|NCT00585195|4122621|FG001|NOT COMPLETED|Overall Study||4
3387616|NCT00585195|4122622|FG002|NOT COMPLETED|Overall Study||9
3387617|NCT00585195|4122623|FG003|NOT COMPLETED|Overall Study||7
3387618|NCT00585195|4122624|FG004|NOT COMPLETED|Overall Study||9
3387619|NCT00585195|4122625|FG005|NOT COMPLETED|Overall Study||6
3387620|NCT00585195|4122626|FG006|NOT COMPLETED|Overall Study||7
3387621|NCT00585195|4122627|FG007|NOT COMPLETED|Overall Study||5
3387622|NCT00585195|4122628|FG008|NOT COMPLETED|Overall Study||3
3387623|NCT00585195|4122629|FG009|NOT COMPLETED|Overall Study||6
3387624|NCT00585195|4122630|FG010|NOT COMPLETED|Overall Study||11
3387625|NCT00585195|4122631|FG011|NOT COMPLETED|Overall Study||53
3387626|NCT00585195|4122632|FG012|NOT COMPLETED|Overall Study||85
3387627|NCT00585195|4122633|FG013|NOT COMPLETED|Overall Study||41
3387628|NCT00585195|4122634|FG014|NOT COMPLETED|Overall Study||48
3387629|NCT00585195|4122635|FG015|NOT COMPLETED|Overall Study||19
3387630|NCT00585195|4122636|FG016|NOT COMPLETED|Overall Study||154
3387631|NCT00585195|4122637|FG017|NOT COMPLETED|Overall Study||67
3387632|NCT00585195|4122638|FG018|NOT COMPLETED|Overall Study||21
3387633|NCT00585195|4122639|FG019|NOT COMPLETED|Overall Study||18
3387634|NCT00585195|4122640|FG020|NOT COMPLETED|Overall Study||14
3387635|NCT00278915|4122723|FG000|STARTED|Overall Study|First 6 patients were dosed at 2mg/kg then increased to 4 mg/kg. Remaining 24 were dosed at 4mg/kg.|30
3387636|NCT00278915|4122723|FG000|COMPLETED|Overall Study||29
3387637|NCT00278915|4122723|FG000|NOT COMPLETED|Overall Study||1
3038409|NCT01154101|3757845|FG004|NOT COMPLETED|Overall Study||1
3171849|NCT01937559|3899060|FG001|NOT COMPLETED|Overall Study||11
3171850|NCT01937559|3899061|FG002|NOT COMPLETED|Overall Study||0
3171851|NCT01937598|3899073|FG000|STARTED|Overall Study||8
3171852|NCT01937598|3899074|FG001|STARTED|Overall Study||8
3038410|NCT01154127|3757864|FG000|STARTED|Period 1 (21 Days)||55
3171853|NCT01937598|3899073|FG000|COMPLETED|Overall Study||8
3038411|NCT01154127|3757865|FG001|STARTED|Period 1 (21 Days)||53
3317288|NCT03125200|4050834|FG005|COMPLETED|Overall Study||0
3317289|NCT03125200|4050835|FG006|COMPLETED|Overall Study||0
3317290|NCT03125200|4050829|FG000|NOT COMPLETED|Overall Study||2
3317291|NCT03125200|4050830|FG001|NOT COMPLETED|Overall Study||2
3317292|NCT03125200|4050831|FG002|NOT COMPLETED|Overall Study||2
3317293|NCT03125200|4050832|FG003|NOT COMPLETED|Overall Study||5
3317294|NCT03125200|4050833|FG004|NOT COMPLETED|Overall Study||4
3317295|NCT03125200|4050834|FG005|NOT COMPLETED|Overall Study||3
3317296|NCT03125200|4050835|FG006|NOT COMPLETED|Overall Study||3
3317297|NCT03125226|4050854|FG000|STARTED|Overall Study||12
3038412|NCT01154127|3757864|FG000|COMPLETED|Period 1 (21 Days)||52
3171854|NCT01937598|3899074|FG001|COMPLETED|Overall Study||8
3171855|NCT01937598|3899073|FG000|NOT COMPLETED|Overall Study||0
3171856|NCT01937598|3899074|FG001|NOT COMPLETED|Overall Study||0
3171857|NCT01937624|3899080|FG000|STARTED|Overall Study||51
3171858|NCT01937624|3899080|FG000|COMPLETED|Overall Study||51
3171859|NCT01937624|3899080|FG000|NOT COMPLETED|Overall Study||0
3171860|NCT01937715|3899089|FG000|STARTED|Overall Study||3
3171861|NCT01937715|3899090|FG001|STARTED|Overall Study||4
3171862|NCT01937715|3899091|FG002|STARTED|Overall Study||3
3171863|NCT01937715|3899092|FG003|STARTED|Overall Study||5
3171864|NCT01937715|3899093|FG004|STARTED|Overall Study||3
3171865|NCT01937715|3899089|FG000|COMPLETED|Overall Study||3
3171866|NCT01937715|3899090|FG001|COMPLETED|Overall Study||3
3171867|NCT01937715|3899091|FG002|COMPLETED|Overall Study||3
3171868|NCT01937715|3899092|FG003|COMPLETED|Overall Study||1
3171869|NCT01937715|3899093|FG004|COMPLETED|Overall Study||1
3038413|NCT01154127|3757865|FG001|COMPLETED|Period 1 (21 Days)||47
3171870|NCT01937715|3899089|FG000|NOT COMPLETED|Overall Study||0
3171871|NCT01937715|3899090|FG001|NOT COMPLETED|Overall Study||1
3171872|NCT01937715|3899091|FG002|NOT COMPLETED|Overall Study||0
2920805|NCT00538850|3631372|FG000|STARTED|Fentanyl Sublingual Spray - Double-blind|There were no participants in this reporting group in the double-blind period.|0
2920806|NCT00538850|3631373|FG001|STARTED|Fentanyl Sublingual Spray - Double-blind||98
2920807|NCT00538850|3631374|FG002|STARTED|Fentanyl Sublingual Spray - Double-blind|There were no participants in this reporting group in the double-blind period.|0
2920808|NCT00538850|3631372|FG000|COMPLETED|Fentanyl Sublingual Spray - Double-blind||0
2920809|NCT00538850|3631373|FG001|COMPLETED|Fentanyl Sublingual Spray - Double-blind||95
2920810|NCT00538850|3631374|FG002|COMPLETED|Fentanyl Sublingual Spray - Double-blind||0
2920811|NCT00538850|3631372|FG000|NOT COMPLETED|Fentanyl Sublingual Spray - Double-blind||0
2920812|NCT00538850|3631373|FG001|NOT COMPLETED|Fentanyl Sublingual Spray - Double-blind||3
3171873|NCT01937715|3899092|FG003|NOT COMPLETED|Overall Study||4
3171874|NCT01937715|3899093|FG004|NOT COMPLETED|Overall Study||2
3171875|NCT01937871|3899108|FG000|STARTED|Overall Study||361
3171876|NCT01937871|3899109|FG001|STARTED|Overall Study||363
3171877|NCT01937871|3899110|FG002|STARTED|Overall Study||185
3171878|NCT01937871|3899108|FG000|Received at Least One Dose of Study Drug|Overall Study||361
3171879|NCT01937871|3899109|FG001|Received at Least One Dose of Study Drug|Overall Study||362
2920813|NCT00538850|3631374|FG002|NOT COMPLETED|Fentanyl Sublingual Spray - Double-blind||0
2920814|NCT00538850|3631372|FG000|STARTED|Placebo - Double-blind|There were no participants in this reporting group in the double-blind period.|0
2920815|NCT00538850|3631373|FG001|STARTED|Placebo - Double-blind|There were no participants in this reporting group in the double-blind period.|0
2920816|NCT00538850|3631374|FG002|STARTED|Placebo - Double-blind||98
2920817|NCT00538850|3631372|FG000|COMPLETED|Placebo - Double-blind||0
2920818|NCT00538850|3631373|FG001|COMPLETED|Placebo - Double-blind||0
2920819|NCT00538850|3631374|FG002|COMPLETED|Placebo - Double-blind||95
2920820|NCT00538850|3631372|FG000|NOT COMPLETED|Placebo - Double-blind||0
2920821|NCT00538850|3631373|FG001|NOT COMPLETED|Placebo - Double-blind||0
2920822|NCT00538850|3631374|FG002|NOT COMPLETED|Placebo - Double-blind||3
2920823|NCT00538863|3631380|FG000|STARTED|Open-label Titration||229
2920824|NCT00538863|3631380|FG000|COMPLETED|Open-label Titration||184
2920825|NCT00538863|3631380|FG000|NOT COMPLETED|Open-label Titration||45
2920826|NCT00538863|3631380|FG000|STARTED|Open-label Maintenance|Five participants who completed the titration period did not start the maintenance period.|269
2920827|NCT00538863|3631380|FG000|COMPLETED|Open-label Maintenance||163
2920828|NCT00538863|3631380|FG000|NOT COMPLETED|Open-label Maintenance||106
2920829|NCT00538902|3631389|FG000|STARTED|DB Wk 0 Through 12 (Primary D/C Reasons)||60
2920830|NCT00538902|3631390|FG001|STARTED|DB Wk 0 Through 12 (Primary D/C Reasons)||121
2920831|NCT00538902|3631391|FG002|STARTED|DB Wk 0 Through 12 (Primary D/C Reasons)||121
2920832|NCT00538902|3631389|FG000|COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||59
2920833|NCT00538902|3631390|FG001|COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||119
2920834|NCT00538902|3631391|FG002|COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||116
2920835|NCT00538902|3631389|FG000|NOT COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||1
2920836|NCT00538902|3631390|FG001|NOT COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||2
2920837|NCT00538902|3631391|FG002|NOT COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||5
2920838|NCT00538902|3631389|FG000|STARTED|OL Wk 24 to End (Primary D/C Reasons)||59
2920839|NCT00538902|3631390|FG001|STARTED|OL Wk 24 to End (Primary D/C Reasons)||119
2920840|NCT00538902|3631391|FG002|STARTED|OL Wk 24 to End (Primary D/C Reasons)||116
2920841|NCT00538902|3631389|FG000|COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||23
2920842|NCT00538902|3631390|FG001|COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||55
2920843|NCT00538902|3631391|FG002|COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||52
2920844|NCT00538902|3631389|FG000|NOT COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||36
2920845|NCT00538902|3631390|FG001|NOT COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||64
2920846|NCT00538902|3631391|FG002|NOT COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||64
2920847|NCT00538915|3631401|FG000|STARTED|Overall Study||63
2920848|NCT00538915|3631401|FG000|COMPLETED|Overall Study||52
2920849|NCT00538915|3631401|FG000|NOT COMPLETED|Overall Study||11
2920850|NCT00539006|3631409|FG000|STARTED|Pre-treatment||96
2920851|NCT00539006|3631410|FG001|STARTED|Pre-treatment||95
2920852|NCT00539006|3631411|FG002|STARTED|Pre-treatment||95
3317298|NCT03125226|4050854|FG000|COMPLETED|Overall Study||12
3171880|NCT01937871|3899110|FG002|Received at Least One Dose of Study Drug|Overall Study||185
3171881|NCT01937871|3899108|FG000|COMPLETED|Overall Study||337
3171882|NCT01937871|3899109|FG001|COMPLETED|Overall Study||346
3171883|NCT01937871|3899110|FG002|COMPLETED|Overall Study||174
3171884|NCT01937871|3899108|FG000|NOT COMPLETED|Overall Study||24
3171885|NCT01937871|3899109|FG001|NOT COMPLETED|Overall Study||17
3136832|NCT01715805|3862076|FG003|NOT COMPLETED|Double-Blind or Continued Treatment||48
3136833|NCT01715831|3862084|FG000|STARTED|Overall Study||26
3136834|NCT01715831|3862084|FG000|COMPLETED|Overall Study||25
3136835|NCT01715831|3862084|FG000|NOT COMPLETED|Overall Study||1
3171886|NCT01937871|3899110|FG002|NOT COMPLETED|Overall Study||11
2920853|NCT00539006|3631412|FG003|STARTED|Pre-treatment||91
2920854|NCT00539006|3631409|FG000|COMPLETED|Pre-treatment||96
2920855|NCT00539006|3631410|FG001|COMPLETED|Pre-treatment||94
2920856|NCT00539006|3631411|FG002|COMPLETED|Pre-treatment||95
3038414|NCT01154127|3757864|FG000|NOT COMPLETED|Period 1 (21 Days)||3
3038415|NCT01154127|3757865|FG001|NOT COMPLETED|Period 1 (21 Days)||6
3038416|NCT01154127|3757864|FG000|STARTED|Washout (14 - 28 Days)||52
3038417|NCT01154127|3757865|FG001|STARTED|Washout (14 - 28 Days)||47
3038418|NCT01154127|3757864|FG000|COMPLETED|Washout (14 - 28 Days)||49
3038419|NCT01154127|3757865|FG001|COMPLETED|Washout (14 - 28 Days)||47
3038420|NCT01154127|3757864|FG000|NOT COMPLETED|Washout (14 - 28 Days)||3
3038421|NCT01154127|3757865|FG001|NOT COMPLETED|Washout (14 - 28 Days)||0
3038422|NCT01154127|3757864|FG000|STARTED|Period 2 (21 Days)||49
3038423|NCT01154127|3757865|FG001|STARTED|Period 2 (21 Days)||47
3038424|NCT01154127|3757864|FG000|COMPLETED|Period 2 (21 Days)||49
3038425|NCT01154127|3757865|FG001|COMPLETED|Period 2 (21 Days)||46
3038426|NCT01154127|3757864|FG000|NOT COMPLETED|Period 2 (21 Days)||0
3038427|NCT01154127|3757865|FG001|NOT COMPLETED|Period 2 (21 Days)||1
3038428|NCT01154140|3757873|FG000|STARTED|Overall Study||172
3038429|NCT01154140|3757874|FG001|STARTED|Overall Study||171
3038430|NCT01154140|3757873|FG000|Treated|Overall Study||171
3038431|NCT01154140|3757874|FG001|Treated|Overall Study||169
3038432|NCT01154140|3757873|FG000|COMPLETED|Overall Study||81
3038433|NCT01154140|3757874|FG001|COMPLETED|Overall Study||69
3038434|NCT01154140|3757873|FG000|NOT COMPLETED|Overall Study||91
3038435|NCT01154140|3757874|FG001|NOT COMPLETED|Overall Study||102
3038436|NCT01154153|3757882|FG000|STARTED|Overall Study||71
3038437|NCT01154153|3757883|FG001|STARTED|Overall Study||69
3038438|NCT01154153|3757882|FG000|COMPLETED|Overall Study||66
3038439|NCT01154153|3757883|FG001|COMPLETED|Overall Study||66
3038440|NCT01154153|3757882|FG000|NOT COMPLETED|Overall Study||5
3038441|NCT01154153|3757883|FG001|NOT COMPLETED|Overall Study||3
3038442|NCT01154166|3757891|FG000|STARTED|Overall Study||169
3038443|NCT01154166|3757892|FG001|STARTED|Overall Study||175
3038444|NCT01154166|3757891|FG000|COMPLETED|Overall Study||135
3038445|NCT01154166|3757892|FG001|COMPLETED|Overall Study||163
3038446|NCT01154166|3757891|FG000|NOT COMPLETED|Overall Study||34
3038447|NCT01154166|3757892|FG001|NOT COMPLETED|Overall Study||12
3038448|NCT01154192|3757901|FG000|STARTED|Overall Study||14
3038449|NCT01154192|3757902|FG001|STARTED|Overall Study||10
3038450|NCT01154192|3757903|FG002|STARTED|Overall Study||0
3038451|NCT01154192|3757901|FG000|COMPLETED|Overall Study||14
3038452|NCT01154192|3757902|FG001|COMPLETED|Overall Study||10
3038453|NCT01154192|3757903|FG002|COMPLETED|Overall Study||0
3038454|NCT01154192|3757901|FG000|NOT COMPLETED|Overall Study||0
3038455|NCT01154192|3757902|FG001|NOT COMPLETED|Overall Study||0
3038456|NCT01154192|3757903|FG002|NOT COMPLETED|Overall Study||0
3171887|NCT01937884|3899123|FG000|STARTED|Overall Study||7
3171888|NCT01937884|3899124|FG001|STARTED|Overall Study||11
3171889|NCT01937884|3899123|FG000|COMPLETED|Overall Study||6
2920857|NCT00539006|3631412|FG003|COMPLETED|Pre-treatment||91
2920858|NCT00539006|3631409|FG000|NOT COMPLETED|Pre-treatment||0
2920859|NCT00539006|3631410|FG001|NOT COMPLETED|Pre-treatment||1
2920860|NCT00539006|3631411|FG002|NOT COMPLETED|Pre-treatment||0
2920861|NCT00539006|3631412|FG003|NOT COMPLETED|Pre-treatment||0
2920862|NCT00539006|3631409|FG000|STARTED|Treatment Period 1||96
2920863|NCT00539006|3631410|FG001|STARTED|Treatment Period 1||94
2920864|NCT00539006|3631411|FG002|STARTED|Treatment Period 1||95
2920865|NCT00539006|3631412|FG003|STARTED|Treatment Period 1||91
2920866|NCT00539006|3631409|FG000|COMPLETED|Treatment Period 1||96
2920867|NCT00539006|3631410|FG001|COMPLETED|Treatment Period 1||94
2920868|NCT00539006|3631411|FG002|COMPLETED|Treatment Period 1||93
2920869|NCT00539006|3631412|FG003|COMPLETED|Treatment Period 1||90
2920870|NCT00539006|3631409|FG000|NOT COMPLETED|Treatment Period 1||0
2920871|NCT00539006|3631410|FG001|NOT COMPLETED|Treatment Period 1||0
2920872|NCT00539006|3631411|FG002|NOT COMPLETED|Treatment Period 1||2
2920873|NCT00539006|3631412|FG003|NOT COMPLETED|Treatment Period 1||1
2920874|NCT00539006|3631409|FG000|STARTED|Washout||96
2920875|NCT00539006|3631410|FG001|STARTED|Washout||94
2920876|NCT00539006|3631411|FG002|STARTED|Washout||93
2920877|NCT00539006|3631412|FG003|STARTED|Washout||90
2920878|NCT00539006|3631409|FG000|COMPLETED|Washout||76
2920879|NCT00539006|3631410|FG001|COMPLETED|Washout||84
2920880|NCT00539006|3631411|FG002|COMPLETED|Washout||77
2920881|NCT00539006|3631412|FG003|COMPLETED|Washout||81
2920882|NCT00539006|3631409|FG000|NOT COMPLETED|Washout||20
2920883|NCT00539006|3631410|FG001|NOT COMPLETED|Washout||10
2920884|NCT00539006|3631411|FG002|NOT COMPLETED|Washout||16
2920885|NCT00539006|3631412|FG003|NOT COMPLETED|Washout||9
2920886|NCT00539006|3631409|FG000|STARTED|Treatment Period 2||76
2920887|NCT00539006|3631410|FG001|STARTED|Treatment Period 2||84
2920888|NCT00539006|3631411|FG002|STARTED|Treatment Period 2||77
2920889|NCT00539006|3631412|FG003|STARTED|Treatment Period 2||81
2920890|NCT00539006|3631409|FG000|COMPLETED|Treatment Period 2||75
2920891|NCT00539006|3631410|FG001|COMPLETED|Treatment Period 2||83
2920892|NCT00539006|3631411|FG002|COMPLETED|Treatment Period 2||77
2920893|NCT00539006|3631412|FG003|COMPLETED|Treatment Period 2||81
2920894|NCT00539006|3631409|FG000|NOT COMPLETED|Treatment Period 2||1
2920895|NCT00539006|3631410|FG001|NOT COMPLETED|Treatment Period 2||1
2920896|NCT00539006|3631411|FG002|NOT COMPLETED|Treatment Period 2||0
2920897|NCT00539006|3631412|FG003|NOT COMPLETED|Treatment Period 2||0
2920898|NCT00539006|3631409|FG000|STARTED|Post-Study||75
2920899|NCT00539006|3631410|FG001|STARTED|Post-Study||83
2920900|NCT00539006|3631411|FG002|STARTED|Post-Study||77
2920901|NCT00539006|3631412|FG003|STARTED|Post-Study||81
2920902|NCT00539006|3631409|FG000|COMPLETED|Post-Study||75
2920903|NCT00539006|3631410|FG001|COMPLETED|Post-Study||83
2920904|NCT00539006|3631411|FG002|COMPLETED|Post-Study||77
2920905|NCT00539006|3631412|FG003|COMPLETED|Post-Study||81
2920906|NCT00539006|3631409|FG000|NOT COMPLETED|Post-Study||0
2920907|NCT00539006|3631410|FG001|NOT COMPLETED|Post-Study||0
2920908|NCT00539006|3631411|FG002|NOT COMPLETED|Post-Study||0
2920909|NCT00539006|3631412|FG003|NOT COMPLETED|Post-Study||0
2920910|NCT00539032|3631430|FG000|STARTED|Overall Study||153
2920911|NCT00539032|3631431|FG001|STARTED|Overall Study||85
2920912|NCT00539032|3631430|FG000|COMPLETED|Overall Study||151
2920913|NCT00539032|3631431|FG001|COMPLETED|Overall Study||84
2920914|NCT00539032|3631430|FG000|NOT COMPLETED|Overall Study||2
2920915|NCT00539032|3631431|FG001|NOT COMPLETED|Overall Study||1
2920916|NCT00539110|3631439|FG000|STARTED|Overall Study||5
2920917|NCT00539110|3631440|FG001|STARTED|Overall Study||5
2920918|NCT00539110|3631439|FG000|COMPLETED|Overall Study||5
2920919|NCT00539110|3631440|FG001|COMPLETED|Overall Study||5
2920920|NCT00539110|3631439|FG000|NOT COMPLETED|Overall Study||0
2920921|NCT00539110|3631440|FG001|NOT COMPLETED|Overall Study||0
3171890|NCT01937884|3899124|FG001|COMPLETED|Overall Study||11
3171891|NCT01937884|3899123|FG000|NOT COMPLETED|Overall Study||1
3171892|NCT01937884|3899124|FG001|NOT COMPLETED|Overall Study||0
3171893|NCT01937975|3899135|FG000|STARTED|Overall Study||8
3171894|NCT01937975|3899136|FG001|STARTED|Overall Study||8
3171895|NCT01937975|3899137|FG002|STARTED|Overall Study||8
2920922|NCT00539188|3631448|FG000|STARTED|Overall Study||4
2920923|NCT00539188|3631449|FG001|STARTED|Overall Study||2
2920924|NCT00539188|3631448|FG000|Received Allocated Intervention|Overall Study||3
2920925|NCT00539188|3631449|FG001|Received Allocated Intervention|Overall Study||2
2920926|NCT00539188|3631448|FG000|COMPLETED|Overall Study||1
2920927|NCT00539188|3631449|FG001|COMPLETED|Overall Study||1
2920928|NCT00539188|3631448|FG000|NOT COMPLETED|Overall Study||3
2920929|NCT00539188|3631449|FG001|NOT COMPLETED|Overall Study||1
2920930|NCT00539240|3631458|FG000|STARTED|Overall Study||59
2920931|NCT00539240|3631459|FG001|STARTED|Overall Study||55
2920932|NCT00539240|3631460|FG002|STARTED|Overall Study||54
2920933|NCT00539240|3631458|FG000|COMPLETED|Overall Study||53
2920934|NCT00539240|3631459|FG001|COMPLETED|Overall Study||48
2920935|NCT00539240|3631460|FG002|COMPLETED|Overall Study||39
2920936|NCT00539240|3631458|FG000|NOT COMPLETED|Overall Study||6
2920937|NCT00539240|3631459|FG001|NOT COMPLETED|Overall Study||7
2920938|NCT00539240|3631460|FG002|NOT COMPLETED|Overall Study||15
2920939|NCT00539253|3631468|FG000|STARTED|Overall Study||45
2920940|NCT00539253|3631468|FG000|COMPLETED|Overall Study||19
2920941|NCT00539253|3631468|FG000|NOT COMPLETED|Overall Study||26
2920942|NCT00539279|3631474|FG000|STARTED|Treatment||41
2920943|NCT00539279|3631475|FG001|STARTED|Treatment||46
2920944|NCT00539279|3631474|FG000|COMPLETED|Treatment||30
2920945|NCT00539279|3631475|FG001|COMPLETED|Treatment||38
2920946|NCT00539279|3631474|FG000|NOT COMPLETED|Treatment||11
2920947|NCT00539279|3631475|FG001|NOT COMPLETED|Treatment||8
2920948|NCT00539279|3631474|FG000|STARTED|Post-Treatment Assessment|Individuals eligible for post-treatment assessment (includes all individuals randomized to PE)|30
2920949|NCT00539279|3631475|FG001|STARTED|Post-Treatment Assessment|Individuals eligible for post-treatment assessment (includes all individuals randomized to RT)|38
2920950|NCT00539279|3631474|FG000|COMPLETED|Post-Treatment Assessment||18
2920951|NCT00539279|3631475|FG001|COMPLETED|Post-Treatment Assessment||29
2920952|NCT00539279|3631474|FG000|NOT COMPLETED|Post-Treatment Assessment||12
2920953|NCT00539279|3631475|FG001|NOT COMPLETED|Post-Treatment Assessment||9
2920954|NCT00539279|3631474|FG000|STARTED|6-Month Follow-Up Assessment|Individuals eligible for 6-month assessment (includes all individuals randomized to PE)|18
2920955|NCT00539279|3631475|FG001|STARTED|6-Month Follow-Up Assessment|Individuals eligible for 6-month assessment (includes all individuals randomized to RT)|29
2920956|NCT00539279|3631474|FG000|COMPLETED|6-Month Follow-Up Assessment||17
2920957|NCT00539279|3631475|FG001|COMPLETED|6-Month Follow-Up Assessment||22
2920958|NCT00539279|3631474|FG000|NOT COMPLETED|6-Month Follow-Up Assessment||1
2920959|NCT00539279|3631475|FG001|NOT COMPLETED|6-Month Follow-Up Assessment||7
2920960|NCT00539305|3631483|FG000|STARTED|Overall Study||10
2920961|NCT00539305|3631484|FG001|STARTED|Overall Study||12
2920962|NCT00539305|3631483|FG000|COMPLETED|Overall Study||9
2920963|NCT00539305|3631484|FG001|COMPLETED|Overall Study||10
2920964|NCT00539305|3631483|FG000|NOT COMPLETED|Overall Study||1
2920965|NCT00539305|3631484|FG001|NOT COMPLETED|Overall Study||2
2920966|NCT00539500|3631490|FG000|STARTED|Overall Study||3
2920967|NCT00539500|3631490|FG000|COMPLETED|Overall Study||0
2920968|NCT00539500|3631490|FG000|NOT COMPLETED|Overall Study||3
2920969|NCT00539513|3631496|FG000|STARTED|Overall Study||5
2920970|NCT00539513|3631497|FG001|STARTED|Overall Study||5
3171896|NCT01937975|3899135|FG000|COMPLETED|Overall Study||8
3171897|NCT01937975|3899136|FG001|COMPLETED|Overall Study||8
2920971|NCT00539513|3631496|FG000|Received Allocated Intervention|Overall Study||3
2920972|NCT00539513|3631497|FG001|Received Allocated Intervention|Overall Study||4
2920973|NCT00539513|3631496|FG000|COMPLETED|Overall Study||3
2920974|NCT00539513|3631497|FG001|COMPLETED|Overall Study||3
2920975|NCT00539513|3631496|FG000|NOT COMPLETED|Overall Study||2
3171898|NCT01937975|3899137|FG002|COMPLETED|Overall Study||8
3171899|NCT01937975|3899135|FG000|NOT COMPLETED|Overall Study||0
3171900|NCT01937975|3899136|FG001|NOT COMPLETED|Overall Study||0
3171901|NCT01937975|3899137|FG002|NOT COMPLETED|Overall Study||0
2920976|NCT00539513|3631497|FG001|NOT COMPLETED|Overall Study||2
2920977|NCT00539526|3631506|FG000|STARTED|Overall Study||35
2920978|NCT00539526|3631507|FG001|STARTED|Overall Study||33
2920979|NCT00539526|3631508|FG002|STARTED|Overall Study||38
2920980|NCT00539526|3631506|FG000|COMPLETED|Overall Study||32
3171902|NCT01938001|3899151|FG000|STARTED|Overall Study||178
2920981|NCT00539526|3631507|FG001|COMPLETED|Overall Study||31
3171903|NCT01938001|3899152|FG001|STARTED|Overall Study||180
3171904|NCT01938001|3899151|FG000|Participants Received Treatment|Overall Study||176
3171905|NCT01938001|3899152|FG001|Participants Received Treatment|Overall Study||180
3171906|NCT01938001|3899151|FG000|Completed Treatment|Overall Study||124
3171907|NCT01938001|3899152|FG001|Completed Treatment|Overall Study||110
3171908|NCT01938001|3899151|FG000|COMPLETED|Overall Study||135
3171909|NCT01938001|3899152|FG001|COMPLETED|Overall Study||133
3171910|NCT01938001|3899151|FG000|NOT COMPLETED|Overall Study||43
3171911|NCT01938001|3899152|FG001|NOT COMPLETED|Overall Study||47
3171912|NCT01938040|3899160|FG000|STARTED|Overall Study||28
3171913|NCT01938040|3899161|FG001|STARTED|Overall Study||27
3171914|NCT01938040|3899160|FG000|Plasma Analysis|Overall Study|complete set of blood samples could not be obtained|24
3171915|NCT01938040|3899161|FG001|Plasma Analysis|Overall Study|complete set of blood samples could not be obtained|25
3171916|NCT01938040|3899160|FG000|Behavior Metrics|Overall Study||28
3171917|NCT01938040|3899161|FG001|Behavior Metrics|Overall Study||27
3171918|NCT01938040|3899160|FG000|COMPLETED|Overall Study||28
3171919|NCT01938040|3899161|FG001|COMPLETED|Overall Study||27
3171920|NCT01938040|3899160|FG000|NOT COMPLETED|Overall Study||0
3171921|NCT01938040|3899161|FG001|NOT COMPLETED|Overall Study||0
3171922|NCT01938066|3899175|FG000|STARTED|Overall Study||15
3171923|NCT01938066|3899176|FG001|STARTED|Overall Study||15
3171924|NCT01938066|3899175|FG000|COMPLETED|Overall Study||14
3171925|NCT01938066|3899176|FG001|COMPLETED|Overall Study||13
3171926|NCT01938066|3899175|FG000|NOT COMPLETED|Overall Study||1
3171927|NCT01938066|3899176|FG001|NOT COMPLETED|Overall Study||2
3171928|NCT01938079|3899184|FG000|STARTED|Overall Study||10
3171929|NCT01938079|3899185|FG001|STARTED|Overall Study||10
3171930|NCT01938079|3899184|FG000|COMPLETED|Overall Study||10
3171931|NCT01938079|3899185|FG001|COMPLETED|Overall Study||10
2920982|NCT00539526|3631508|FG002|COMPLETED|Overall Study||36
2920983|NCT00539526|3631506|FG000|NOT COMPLETED|Overall Study||3
2920984|NCT00539526|3631507|FG001|NOT COMPLETED|Overall Study||2
2920985|NCT00539526|3631508|FG002|NOT COMPLETED|Overall Study||2
2920986|NCT00539539|3631518|FG000|STARTED|Overall Study||815
2920987|NCT00539539|3631519|FG001|STARTED|Overall Study||771
2920988|NCT00539539|3631518|FG000|COMPLETED|Overall Study||815
2920989|NCT00539539|3631519|FG001|COMPLETED|Overall Study||771
2920990|NCT00539539|3631518|FG000|NOT COMPLETED|Overall Study||0
2920991|NCT00539539|3631519|FG001|NOT COMPLETED|Overall Study||0
2920992|NCT00539591|3631528|FG000|STARTED|Overall Study||23
2920993|NCT00539591|3631529|FG001|STARTED|Overall Study||2
2920994|NCT00539591|3631530|FG002|STARTED|Overall Study||4
2920995|NCT00539591|3631528|FG000|COMPLETED|Overall Study||18
2920996|NCT00539591|3631529|FG001|COMPLETED|Overall Study||0
2920997|NCT00539591|3631530|FG002|COMPLETED|Overall Study||1
2920998|NCT00539591|3631528|FG000|NOT COMPLETED|Overall Study||5
2920999|NCT00539591|3631529|FG001|NOT COMPLETED|Overall Study||2
2921000|NCT00539591|3631530|FG002|NOT COMPLETED|Overall Study||3
2921001|NCT00539656|3631566|FG000|STARTED|Overall Study||3
2921002|NCT00539656|3631566|FG000|COMPLETED|Overall Study||3
2921003|NCT00539656|3631566|FG000|NOT COMPLETED|Overall Study||0
2921004|NCT00539695|3631570|FG000|STARTED|Overall Study||25
2921005|NCT00539695|3631570|FG000|Evaluable Patients|Overall Study|Patients who received IL-2.|22
2921006|NCT00539695|3631570|FG000|COMPLETED|Overall Study||12
2921007|NCT00539695|3631570|FG000|NOT COMPLETED|Overall Study||13
2921008|NCT00539734|3631574|FG000|STARTED|Overall Study||26
2921009|NCT00539734|3631574|FG000|COMPLETED|Overall Study||25
2921010|NCT00539734|3631574|FG000|NOT COMPLETED|Overall Study||1
2921011|NCT00539864|3631580|FG000|STARTED|Overall Study||300
2921012|NCT00539864|3631581|FG001|STARTED|Overall Study||302
2921013|NCT00539864|3631580|FG000|COMPLETED|Overall Study||299
2921014|NCT00539864|3631581|FG001|COMPLETED|Overall Study||300
2921015|NCT00539864|3631580|FG000|NOT COMPLETED|Overall Study||1
2921016|NCT00539864|3631581|FG001|NOT COMPLETED|Overall Study||2
2921017|NCT00539942|3631589|FG000|STARTED|Overall Study||4
3038457|NCT01154218|3757912|FG000|STARTED|First Intervention Period||9
3038458|NCT01154218|3757913|FG001|STARTED|First Intervention Period||9
3038459|NCT01154218|3757914|FG002|STARTED|First Intervention Period||9
3038460|NCT01154218|3757915|FG003|STARTED|First Intervention Period||9
3038461|NCT01154218|3757912|FG000|COMPLETED|First Intervention Period||9
3038462|NCT01154218|3757913|FG001|COMPLETED|First Intervention Period||9
3038463|NCT01154218|3757914|FG002|COMPLETED|First Intervention Period||9
3038464|NCT01154218|3757915|FG003|COMPLETED|First Intervention Period||9
3038465|NCT01154218|3757912|FG000|NOT COMPLETED|First Intervention Period||0
3038466|NCT01154218|3757913|FG001|NOT COMPLETED|First Intervention Period||0
3038467|NCT01154218|3757914|FG002|NOT COMPLETED|First Intervention Period||0
3038468|NCT01154218|3757915|FG003|NOT COMPLETED|First Intervention Period||0
2921018|NCT00539942|3631590|FG001|STARTED|Overall Study||3
2921019|NCT00539942|3631589|FG000|COMPLETED|Overall Study||4
2921020|NCT00539942|3631590|FG001|COMPLETED|Overall Study||3
2921021|NCT00539942|3631589|FG000|NOT COMPLETED|Overall Study||0
2921022|NCT00539942|3631590|FG001|NOT COMPLETED|Overall Study||0
2921023|NCT00539981|3631598|FG000|STARTED|Overall Study||2344
2921024|NCT00539981|3631599|FG001|STARTED|Overall Study||2304
3317299|NCT03125226|4050854|FG000|NOT COMPLETED|Overall Study||0
3317300|NCT03125395|4050858|FG000|STARTED|Overall Study||57
3317301|NCT03125395|4050858|FG000|Study 115B FAS|Overall Study||60
3317302|NCT03125395|4050858|FG000|Study 116 FAS|Overall Study||57
3317303|NCT03125395|4050858|FG000|Study 116 LCI Substudy Set|Overall Study||31
3317304|NCT03125395|4050858|FG000|COMPLETED|Overall Study||47
3317305|NCT03125395|4050858|FG000|NOT COMPLETED|Overall Study||10
3171932|NCT01938079|3899184|FG000|NOT COMPLETED|Overall Study||0
3171933|NCT01938079|3899185|FG001|NOT COMPLETED|Overall Study||0
3317306|NCT03125629|4050862|FG000|STARTED|Overall Study||53
3317307|NCT03125629|4050862|FG000|COMPLETED|Overall Study||50
3317308|NCT03125629|4050862|FG000|NOT COMPLETED|Overall Study||3
3317315|NCT03125915|4050888|FG000|STARTED|Baseline and Intervention||32
3317316|NCT03125915|4050889|FG001|STARTED|Baseline and Intervention||40
3317317|NCT03125915|4050890|FG002|STARTED|Baseline and Intervention||34
3317318|NCT03125915|4050891|FG003|STARTED|Baseline and Intervention||34
3317319|NCT03125915|4050888|FG000|COMPLETED|Baseline and Intervention||32
3317320|NCT03125915|4050889|FG001|COMPLETED|Baseline and Intervention||40
3317321|NCT03125915|4050890|FG002|COMPLETED|Baseline and Intervention||34
3317322|NCT03125915|4050891|FG003|COMPLETED|Baseline and Intervention||34
3317323|NCT03125915|4050888|FG000|NOT COMPLETED|Baseline and Intervention||0
3317324|NCT03125915|4050889|FG001|NOT COMPLETED|Baseline and Intervention||0
3317325|NCT03125915|4050890|FG002|NOT COMPLETED|Baseline and Intervention||0
3317326|NCT03125915|4050891|FG003|NOT COMPLETED|Baseline and Intervention||0
3317327|NCT03125915|4050888|FG000|STARTED|1 Month Follow up||32
3317328|NCT03125915|4050889|FG001|STARTED|1 Month Follow up||40
3317329|NCT03125915|4050890|FG002|STARTED|1 Month Follow up||34
3317330|NCT03125915|4050891|FG003|STARTED|1 Month Follow up||34
3317331|NCT03125915|4050888|FG000|COMPLETED|1 Month Follow up||29
3317332|NCT03125915|4050889|FG001|COMPLETED|1 Month Follow up||37
3317333|NCT03125915|4050890|FG002|COMPLETED|1 Month Follow up||32
3317334|NCT03125915|4050891|FG003|COMPLETED|1 Month Follow up||31
3317335|NCT03125915|4050888|FG000|NOT COMPLETED|1 Month Follow up||3
3317336|NCT03125915|4050889|FG001|NOT COMPLETED|1 Month Follow up||3
3317337|NCT03125915|4050890|FG002|NOT COMPLETED|1 Month Follow up||2
3317338|NCT03125915|4050891|FG003|NOT COMPLETED|1 Month Follow up||3
3317339|NCT03125915|4050888|FG000|STARTED|3 Month Follow-up||32
3317340|NCT03125915|4050889|FG001|STARTED|3 Month Follow-up||40
3317341|NCT03125915|4050890|FG002|STARTED|3 Month Follow-up||34
3317342|NCT03125915|4050891|FG003|STARTED|3 Month Follow-up||34
3317343|NCT03125915|4050888|FG000|COMPLETED|3 Month Follow-up||26
3317344|NCT03125915|4050889|FG001|COMPLETED|3 Month Follow-up||36
3317345|NCT03125915|4050890|FG002|COMPLETED|3 Month Follow-up||30
3317346|NCT03125915|4050891|FG003|COMPLETED|3 Month Follow-up||32
3317347|NCT03125915|4050888|FG000|NOT COMPLETED|3 Month Follow-up||6
3317348|NCT03125915|4050889|FG001|NOT COMPLETED|3 Month Follow-up||4
3317349|NCT03125915|4050890|FG002|NOT COMPLETED|3 Month Follow-up||4
3317350|NCT03125915|4050891|FG003|NOT COMPLETED|3 Month Follow-up||2
3317351|NCT03125915|4050888|FG000|STARTED|6 Month Follow-up||32
3317352|NCT03125915|4050889|FG001|STARTED|6 Month Follow-up||40
3317353|NCT03125915|4050890|FG002|STARTED|6 Month Follow-up||34
3317354|NCT03125915|4050891|FG003|STARTED|6 Month Follow-up||34
3317355|NCT03125915|4050888|FG000|COMPLETED|6 Month Follow-up||25
3317356|NCT03125915|4050889|FG001|COMPLETED|6 Month Follow-up||37
3317357|NCT03125915|4050890|FG002|COMPLETED|6 Month Follow-up||28
3317358|NCT03125915|4050891|FG003|COMPLETED|6 Month Follow-up||31
3317359|NCT03125915|4050888|FG000|NOT COMPLETED|6 Month Follow-up||7
3317360|NCT03125915|4050889|FG001|NOT COMPLETED|6 Month Follow-up||3
3317361|NCT03125915|4050890|FG002|NOT COMPLETED|6 Month Follow-up||6
3317362|NCT03125915|4050891|FG003|NOT COMPLETED|6 Month Follow-up||3
3317363|NCT03125941|4050903|FG000|STARTED|Overall Study||65
3317364|NCT03125941|4050904|FG001|STARTED|Overall Study||65
3317365|NCT03125941|4050903|FG000|Post-randomization Exclusion|Overall Study|procedure changed, did not receive intervention|1
3317366|NCT03125941|4050904|FG001|Post-randomization Exclusion|Overall Study|procedure changed, did not receive intervention|2
3317367|NCT03125941|4050903|FG000|COMPLETED|Overall Study||64
3317368|NCT03125941|4050904|FG001|COMPLETED|Overall Study||63
3317369|NCT03125941|4050903|FG000|NOT COMPLETED|Overall Study||1
3317370|NCT03125941|4050904|FG001|NOT COMPLETED|Overall Study||2
3317371|NCT03126227|4050912|FG000|STARTED|Overall Study||338
3317372|NCT03126227|4050913|FG001|STARTED|Overall Study||168
3317373|NCT03126227|4050912|FG000|COMPLETED|Overall Study||260
3317374|NCT03126227|4050913|FG001|COMPLETED|Overall Study||158
3317375|NCT03126227|4050912|FG000|NOT COMPLETED|Overall Study||78
3317376|NCT03126227|4050913|FG001|NOT COMPLETED|Overall Study||10
3317377|NCT03126344|4050922|FG000|STARTED|Overall Study||33
3317378|NCT03126344|4050923|FG001|STARTED|Overall Study||33
3317379|NCT03126344|4050924|FG002|STARTED|Overall Study||33
3317380|NCT03126344|4050922|FG000|COMPLETED|Overall Study||33
3171934|NCT01938170|3899191|FG000|STARTED|Overall Study||41
3171935|NCT01938170|3899191|FG000|COMPLETED|Overall Study||41
3171936|NCT01938170|3899191|FG000|NOT COMPLETED|Overall Study||0
3171937|NCT01938378|3899198|FG000|STARTED|Overall Study||41
3171938|NCT01938378|3899198|FG000|COMPLETED|Overall Study||41
3171939|NCT01938378|3899198|FG000|NOT COMPLETED|Overall Study||0
3171940|NCT01938391|3899216|FG000|STARTED|Baseline||25
3171941|NCT01938391|3899216|FG000|COMPLETED|Baseline||25
3171942|NCT01938391|3899216|FG000|NOT COMPLETED|Baseline||0
3171943|NCT01938391|3899216|FG000|STARTED|2 Week Follow up||25
3171944|NCT01938391|3899216|FG000|COMPLETED|2 Week Follow up||25
3171945|NCT01938391|3899216|FG000|NOT COMPLETED|2 Week Follow up||0
2921025|NCT00539981|3631598|FG000|COMPLETED|Overall Study||2049
2921026|NCT00539981|3631599|FG001|COMPLETED|Overall Study||2022
2921027|NCT00539981|3631598|FG000|NOT COMPLETED|Overall Study||295
2921028|NCT00539981|3631599|FG001|NOT COMPLETED|Overall Study||282
2921029|NCT00539994|3631611|FG000|STARTED|Overall Study||23
2921030|NCT00539994|3631612|FG001|STARTED|Overall Study||19
2921031|NCT00539994|3631613|FG002|STARTED|Overall Study||15
2921032|NCT00539994|3631611|FG000|COMPLETED|Overall Study||20
2921033|NCT00539994|3631612|FG001|COMPLETED|Overall Study||18
2921034|NCT00539994|3631613|FG002|COMPLETED|Overall Study||13
2921035|NCT00539994|3631611|FG000|NOT COMPLETED|Overall Study||3
2921036|NCT00539994|3631612|FG001|NOT COMPLETED|Overall Study||1
2921037|NCT00539994|3631613|FG002|NOT COMPLETED|Overall Study||2
2921038|NCT00540007|3631630|FG000|STARTED|Overall Study||38
2921039|NCT00540007|3631631|FG001|STARTED|Overall Study||42
2921040|NCT00540007|3631630|FG000|COMPLETED|Overall Study||38
2921041|NCT00540007|3631631|FG001|COMPLETED|Overall Study||42
2921042|NCT00540007|3631630|FG000|NOT COMPLETED|Overall Study||0
2921043|NCT00540007|3631631|FG001|NOT COMPLETED|Overall Study||0
2921044|NCT00540046|3631640|FG000|STARTED|Overall Study||104
2921045|NCT00540046|3631641|FG001|STARTED|Overall Study||111
2921046|NCT00540046|3631640|FG000|COMPLETED|Overall Study||71
2921047|NCT00540046|3631641|FG001|COMPLETED|Overall Study||88
2921048|NCT00540046|3631640|FG000|NOT COMPLETED|Overall Study||33
2921049|NCT00540046|3631641|FG001|NOT COMPLETED|Overall Study||23
2921050|NCT00540124|3631652|FG000|STARTED|Overall Study||51
2921051|NCT00540124|3631653|FG001|STARTED|Overall Study||51
2921052|NCT00540124|3631654|FG002|STARTED|Overall Study||49
2921053|NCT00540124|3631652|FG000|COMPLETED|Overall Study||47
2921054|NCT00540124|3631653|FG001|COMPLETED|Overall Study||48
2921055|NCT00540124|3631654|FG002|COMPLETED|Overall Study||48
2921056|NCT00540124|3631652|FG000|NOT COMPLETED|Overall Study||4
2921057|NCT00540124|3631653|FG001|NOT COMPLETED|Overall Study||3
2921058|NCT00540124|3631654|FG002|NOT COMPLETED|Overall Study||1
2921059|NCT00540228|3631667|FG000|STARTED|Overall Study||200
2921060|NCT00540228|3631668|FG001|STARTED|Overall Study||198
2921061|NCT00540228|3631669|FG002|STARTED|Overall Study||204
2921062|NCT00540228|3631670|FG003|STARTED|Overall Study||202
2921063|NCT00540228|3631671|FG004|STARTED|Overall Study||202
2921064|NCT00540228|3631667|FG000|COMPLETED|Overall Study||197
2921065|NCT00540228|3631668|FG001|COMPLETED|Overall Study||197
2921066|NCT00540228|3631669|FG002|COMPLETED|Overall Study||204
2921067|NCT00540228|3631670|FG003|COMPLETED|Overall Study||202
2921068|NCT00540228|3631671|FG004|COMPLETED|Overall Study||202
2921069|NCT00540228|3631667|FG000|NOT COMPLETED|Overall Study||3
2921070|NCT00540228|3631668|FG001|NOT COMPLETED|Overall Study||1
2921071|NCT00540228|3631669|FG002|NOT COMPLETED|Overall Study||0
2921072|NCT00540228|3631670|FG003|NOT COMPLETED|Overall Study||0
2921073|NCT00540228|3631671|FG004|NOT COMPLETED|Overall Study||0
2921074|NCT00540293|3631683|FG000|STARTED|Overall Study||425
2921075|NCT00540293|3631683|FG000|COMPLETED|Overall Study||390
2921076|NCT00540293|3631683|FG000|NOT COMPLETED|Overall Study||35
2921077|NCT00540423|3631695|FG000|STARTED|Double-Blind Treatment Period||8
2921078|NCT00540423|3631696|FG001|STARTED|Double-Blind Treatment Period||15
2921079|NCT00540423|3631697|FG002|STARTED|Double-Blind Treatment Period||0
2921080|NCT00540423|3631695|FG000|COMPLETED|Double-Blind Treatment Period||8
2921081|NCT00540423|3631696|FG001|COMPLETED|Double-Blind Treatment Period||14
2921082|NCT00540423|3631697|FG002|COMPLETED|Double-Blind Treatment Period||0
2921083|NCT00540423|3631695|FG000|NOT COMPLETED|Double-Blind Treatment Period||0
2921084|NCT00540423|3631696|FG001|NOT COMPLETED|Double-Blind Treatment Period||1
2921085|NCT00540423|3631697|FG002|NOT COMPLETED|Double-Blind Treatment Period||0
2921086|NCT00540423|3631695|FG000|STARTED|Open-Label Treatment Period||0
2921087|NCT00540423|3631696|FG001|STARTED|Open-Label Treatment Period||0
2921088|NCT00540423|3631697|FG002|STARTED|Open-Label Treatment Period||22
2921089|NCT00540423|3631695|FG000|COMPLETED|Open-Label Treatment Period||0
2921090|NCT00540423|3631696|FG001|COMPLETED|Open-Label Treatment Period||0
2921091|NCT00540423|3631697|FG002|COMPLETED|Open-Label Treatment Period||20
2921092|NCT00540423|3631695|FG000|NOT COMPLETED|Open-Label Treatment Period||0
2921093|NCT00540423|3631696|FG001|NOT COMPLETED|Open-Label Treatment Period||0
2921094|NCT00540423|3631697|FG002|NOT COMPLETED|Open-Label Treatment Period||2
2921095|NCT00540436|3631715|FG000|STARTED|First 12-Week Treatment Period||25
2921096|NCT00540436|3631715|FG000|COMPLETED|First 12-Week Treatment Period||22
2921097|NCT00540436|3631715|FG000|NOT COMPLETED|First 12-Week Treatment Period||3
2921098|NCT00540436|3631715|FG000|STARTED|Second 12-Week Treatment Period||22
2921099|NCT00540436|3631715|FG000|COMPLETED|Second 12-Week Treatment Period||21
2921100|NCT00540436|3631715|FG000|NOT COMPLETED|Second 12-Week Treatment Period||1
2921101|NCT00540449|3631721|FG000|STARTED|Overall Study||346
2921102|NCT00540449|3631722|FG001|STARTED|Overall Study||344
2921103|NCT00540449|3631721|FG000|COMPLETED|Overall Study||262
2921104|NCT00540449|3631722|FG001|COMPLETED|Overall Study||266
2921105|NCT00540449|3631721|FG000|NOT COMPLETED|Overall Study||84
2921106|NCT00540449|3631722|FG001|NOT COMPLETED|Overall Study||78
2921107|NCT00540514|3631730|FG000|STARTED|Overall Study|Intent-to-treat Population: all randomized patients regardless of treatment received.|521
2921108|NCT00540514|3631731|FG001|STARTED|Overall Study|Intent-to-treat Population: all randomized patients regardless of treatment received.|531
2921109|NCT00540514|3631730|FG000|Treated|Overall Study||514
2921110|NCT00540514|3631731|FG001|Treated|Overall Study||524
2921111|NCT00540514|3631730|FG000|Biomarker Population|Overall Study||35
2921112|NCT00540514|3631731|FG001|Biomarker Population|Overall Study||36
2921113|NCT00540514|3631730|FG000|COMPLETED|Overall Study|Completed defined as discontinuation due to progressive disease|275
2921114|NCT00540514|3631731|FG001|COMPLETED|Overall Study|Completed defined as discontinuation due to progressive disease|265
2921115|NCT00540514|3631730|FG000|NOT COMPLETED|Overall Study||246
2921116|NCT00540514|3631731|FG001|NOT COMPLETED|Overall Study||266
2921117|NCT00540579|3631738|FG000|STARTED|Overall Study||23
2921118|NCT00540579|3631738|FG000|COMPLETED|Overall Study||23
2921119|NCT00540579|3631738|FG000|NOT COMPLETED|Overall Study||0
2921120|NCT00540592|3631752|FG000|STARTED|Overall Study||204
2921121|NCT00540592|3631753|FG001|STARTED|Overall Study||202
2921122|NCT00540592|3631754|FG002|STARTED|Overall Study||202
2921123|NCT00540592|3631755|FG003|STARTED|Overall Study||202
2921124|NCT00540592|3631756|FG004|STARTED|Overall Study||199
2921125|NCT00540592|3631757|FG005|STARTED|Overall Study||198
2921126|NCT00540592|3631758|FG006|STARTED|Overall Study||198
2921127|NCT00540592|3631759|FG007|STARTED|Overall Study||199
2921128|NCT00540592|3631760|FG008|STARTED|Overall Study||200
2921129|NCT00540592|3631761|FG009|STARTED|Overall Study||203
2921130|NCT00540592|3631752|FG000|Completed at Day 180|Overall Study||200
2921131|NCT00540592|3631753|FG001|Completed at Day 180|Overall Study||201
2921132|NCT00540592|3631754|FG002|Completed at Day 180|Overall Study||197
2921133|NCT00540592|3631755|FG003|Completed at Day 180|Overall Study||197
2921134|NCT00540592|3631756|FG004|Completed at Day 180|Overall Study||195
2921135|NCT00540592|3631757|FG005|Completed at Day 180|Overall Study||198
2921136|NCT00540592|3631758|FG006|Completed at Day 180|Overall Study||196
2921137|NCT00540592|3631759|FG007|Completed at Day 180|Overall Study||193
2921138|NCT00540592|3631760|FG008|Completed at Day 180|Overall Study||198
2921139|NCT00540592|3631761|FG009|Completed at Day 180|Overall Study||189
2921140|NCT00540592|3631752|FG000|COMPLETED|Overall Study||202
2921141|NCT00540592|3631753|FG001|COMPLETED|Overall Study||201
2921142|NCT00540592|3631754|FG002|COMPLETED|Overall Study||201
2921143|NCT00540592|3631755|FG003|COMPLETED|Overall Study||201
2921144|NCT00540592|3631756|FG004|COMPLETED|Overall Study||198
2921145|NCT00540592|3631757|FG005|COMPLETED|Overall Study||198
2921146|NCT00540592|3631758|FG006|COMPLETED|Overall Study||198
2921147|NCT00540592|3631759|FG007|COMPLETED|Overall Study||198
2921148|NCT00540592|3631760|FG008|COMPLETED|Overall Study||199
2921149|NCT00540592|3631761|FG009|COMPLETED|Overall Study||201
2921150|NCT00540592|3631752|FG000|NOT COMPLETED|Overall Study||2
2921151|NCT00540592|3631753|FG001|NOT COMPLETED|Overall Study||1
2921152|NCT00540592|3631754|FG002|NOT COMPLETED|Overall Study||1
2921153|NCT00540592|3631755|FG003|NOT COMPLETED|Overall Study||1
2921154|NCT00540592|3631756|FG004|NOT COMPLETED|Overall Study||1
2921155|NCT00540592|3631757|FG005|NOT COMPLETED|Overall Study||0
2921156|NCT00540592|3631758|FG006|NOT COMPLETED|Overall Study||0
2921157|NCT00540592|3631759|FG007|NOT COMPLETED|Overall Study||1
2921158|NCT00540592|3631760|FG008|NOT COMPLETED|Overall Study||1
2921159|NCT00540592|3631761|FG009|NOT COMPLETED|Overall Study||2
2921160|NCT00540644|3631785|FG000|STARTED|Overall Study||48
2921161|NCT00540644|3631786|FG001|STARTED|Overall Study||22
2921162|NCT00540644|3631785|FG000|COMPLETED|Overall Study||39
3171946|NCT01938391|3899216|FG000|STARTED|6 Month Follow up||25
3171947|NCT01938391|3899216|FG000|COMPLETED|6 Month Follow up||24
3171948|NCT01938391|3899216|FG000|NOT COMPLETED|6 Month Follow up||1
3171949|NCT01938391|3899216|FG000|STARTED|12 Month Follow up||24
3171950|NCT01938391|3899216|FG000|COMPLETED|12 Month Follow up||22
3171951|NCT01938391|3899216|FG000|NOT COMPLETED|12 Month Follow up||2
3171952|NCT01938430|3899234|FG000|STARTED|Overall Study||30
3171953|NCT01938430|3899235|FG001|STARTED|Overall Study||29
3171954|NCT01938430|3899236|FG002|STARTED|Overall Study||23
3171955|NCT01938430|3899237|FG003|STARTED|Overall Study||26
3171956|NCT01938430|3899238|FG004|STARTED|Overall Study||55
3171957|NCT01938430|3899239|FG005|STARTED|Overall Study||56
3171958|NCT01938430|3899240|FG006|STARTED|Overall Study||26
3171959|NCT01938430|3899241|FG007|STARTED|Overall Study||25
3171960|NCT01938430|3899242|FG008|STARTED|Overall Study||26
3171961|NCT01938430|3899243|FG009|STARTED|Overall Study||26
3171962|NCT01938430|3899244|FG010|STARTED|Overall Study||6
3171963|NCT01938430|3899245|FG011|STARTED|Overall Study||4
3171964|NCT01938430|3899246|FG012|STARTED|Overall Study||4
3171965|NCT01938430|3899247|FG013|STARTED|Overall Study||3
3171966|NCT01938430|3899234|FG000|COMPLETED|Overall Study||26
3171967|NCT01938430|3899235|FG001|COMPLETED|Overall Study||26
3171968|NCT01938430|3899236|FG002|COMPLETED|Overall Study||18
3171969|NCT01938430|3899237|FG003|COMPLETED|Overall Study||24
3171970|NCT01938430|3899238|FG004|COMPLETED|Overall Study||55
3171971|NCT01938430|3899239|FG005|COMPLETED|Overall Study||55
3171972|NCT01938430|3899240|FG006|COMPLETED|Overall Study||24
3171973|NCT01938430|3899241|FG007|COMPLETED|Overall Study||24
3171974|NCT01938430|3899242|FG008|COMPLETED|Overall Study||22
3171975|NCT01938430|3899243|FG009|COMPLETED|Overall Study||23
3171976|NCT01938430|3899244|FG010|COMPLETED|Overall Study||3
3171977|NCT01938430|3899245|FG011|COMPLETED|Overall Study||3
3171978|NCT01938430|3899246|FG012|COMPLETED|Overall Study||4
3171979|NCT01938430|3899247|FG013|COMPLETED|Overall Study||2
3171980|NCT01938430|3899234|FG000|NOT COMPLETED|Overall Study||4
3171981|NCT01938430|3899235|FG001|NOT COMPLETED|Overall Study||3
3171982|NCT01938430|3899236|FG002|NOT COMPLETED|Overall Study||5
3171983|NCT01938430|3899237|FG003|NOT COMPLETED|Overall Study||2
3171984|NCT01938430|3899238|FG004|NOT COMPLETED|Overall Study||0
3171985|NCT01938430|3899239|FG005|NOT COMPLETED|Overall Study||1
3171986|NCT01938430|3899240|FG006|NOT COMPLETED|Overall Study||2
3171987|NCT01938430|3899241|FG007|NOT COMPLETED|Overall Study||1
3171988|NCT01938430|3899242|FG008|NOT COMPLETED|Overall Study||4
3171989|NCT01938430|3899243|FG009|NOT COMPLETED|Overall Study||3
3171990|NCT01938430|3899244|FG010|NOT COMPLETED|Overall Study||3
3171991|NCT01938430|3899245|FG011|NOT COMPLETED|Overall Study||1
3171992|NCT01938430|3899246|FG012|NOT COMPLETED|Overall Study||0
3171993|NCT01938430|3899247|FG013|NOT COMPLETED|Overall Study||1
3171994|NCT01938573|3899302|FG000|STARTED|Overall Study||15
3171995|NCT01938573|3899303|FG001|STARTED|Overall Study||6
3171996|NCT01938573|3899302|FG000|COMPLETED|Overall Study||13
3171997|NCT01938573|3899303|FG001|COMPLETED|Overall Study||6
3171998|NCT01938573|3899302|FG000|NOT COMPLETED|Overall Study||2
3317381|NCT03126344|4050923|FG001|COMPLETED|Overall Study||33
3317382|NCT03126344|4050924|FG002|COMPLETED|Overall Study||28
3317383|NCT03126344|4050922|FG000|NOT COMPLETED|Overall Study||0
3171999|NCT01938573|3899303|FG001|NOT COMPLETED|Overall Study||0
3172000|NCT01938625|3899310|FG000|STARTED|Overall Study||10
3172001|NCT01938625|3899311|FG001|STARTED|Overall Study||25
3172002|NCT01938625|3899310|FG000|COMPLETED|Overall Study||10
3172003|NCT01938625|3899311|FG001|COMPLETED|Overall Study||23
2921163|NCT00540644|3631786|FG001|COMPLETED|Overall Study||13
2921164|NCT00540644|3631785|FG000|NOT COMPLETED|Overall Study||9
2921165|NCT00540644|3631786|FG001|NOT COMPLETED|Overall Study||9
2921166|NCT00540722|3631792|FG000|STARTED|Overall Study||56
2921167|NCT00540722|3631792|FG000|COMPLETED|Overall Study||56
2921168|NCT00540722|3631792|FG000|NOT COMPLETED|Overall Study||0
2921169|NCT00540982|3631797|FG000|STARTED|Overall Study||47
2921170|NCT00540982|3631797|FG000|Normal Liver Function|Overall Study||11
2921171|NCT00540982|3631797|FG000|Mild Liver Dysfunction|Overall Study||6
2921172|NCT00540982|3631797|FG000|Moderate Liver Dysfunction|Overall Study||18
2921173|NCT00540982|3631797|FG000|Severe Liver Dysfunction|Overall Study||12
2921174|NCT00540982|3631797|FG000|COMPLETED|Overall Study||47
2921175|NCT00540982|3631797|FG000|NOT COMPLETED|Overall Study||0
2921176|NCT00540995|3631821|FG000|STARTED|Overall Study||23
2921177|NCT00540995|3631822|FG001|STARTED|Overall Study||2
2921178|NCT00540995|3631821|FG000|COMPLETED|Overall Study||23
2921179|NCT00540995|3631822|FG001|COMPLETED|Overall Study||2
2921180|NCT00540995|3631821|FG000|NOT COMPLETED|Overall Study||0
2921181|NCT00540995|3631822|FG001|NOT COMPLETED|Overall Study||0
2921182|NCT00541034|3631827|FG000|STARTED|Overall Study||49
2921183|NCT00541034|3631827|FG000|COMPLETED|Overall Study||46
2921184|NCT00541034|3631827|FG000|NOT COMPLETED|Overall Study||3
2921185|NCT00541099|3631831|FG000|STARTED|Overall Study||11
2921186|NCT00541099|3631831|FG000|COMPLETED|Overall Study||8
2921187|NCT00541099|3631831|FG000|NOT COMPLETED|Overall Study||3
2921188|NCT00541190|3631837|FG000|STARTED|Overall Study||10
2921189|NCT00541190|3631838|FG001|STARTED|Overall Study||11
2921190|NCT00541190|3631837|FG000|COMPLETED|Overall Study||10
2921191|NCT00541190|3631838|FG001|COMPLETED|Overall Study||11
2921192|NCT00541190|3631837|FG000|NOT COMPLETED|Overall Study||0
2921193|NCT00541190|3631838|FG001|NOT COMPLETED|Overall Study||0
2921194|NCT00541229|3631852|FG000|STARTED|Treatment Period I (Week 1)||17
2921195|NCT00541229|3631853|FG001|STARTED|Treatment Period I (Week 1)||16
2921196|NCT00541229|3631854|FG002|STARTED|Treatment Period I (Week 1)||20
3038469|NCT01154218|3757912|FG000|STARTED|Washout Period (at Least 14 Days)||9
3038470|NCT01154218|3757913|FG001|STARTED|Washout Period (at Least 14 Days)||9
3038471|NCT01154218|3757914|FG002|STARTED|Washout Period (at Least 14 Days)||9
3038472|NCT01154218|3757915|FG003|STARTED|Washout Period (at Least 14 Days)||9
3038473|NCT01154218|3757912|FG000|COMPLETED|Washout Period (at Least 14 Days)||9
3038474|NCT01154218|3757913|FG001|COMPLETED|Washout Period (at Least 14 Days)||9
3038475|NCT01154218|3757914|FG002|COMPLETED|Washout Period (at Least 14 Days)||9
3038476|NCT01154218|3757915|FG003|COMPLETED|Washout Period (at Least 14 Days)||9
3038477|NCT01154218|3757912|FG000|NOT COMPLETED|Washout Period (at Least 14 Days)||0
3038478|NCT01154218|3757913|FG001|NOT COMPLETED|Washout Period (at Least 14 Days)||0
3038479|NCT01154218|3757914|FG002|NOT COMPLETED|Washout Period (at Least 14 Days)||0
3038480|NCT01154218|3757915|FG003|NOT COMPLETED|Washout Period (at Least 14 Days)||0
3038481|NCT01154218|3757912|FG000|STARTED|Second Intervention Period||9
3038482|NCT01154218|3757913|FG001|STARTED|Second Intervention Period||9
3038483|NCT01154218|3757914|FG002|STARTED|Second Intervention Period||9
3038484|NCT01154218|3757915|FG003|STARTED|Second Intervention Period||9
3038485|NCT01154218|3757912|FG000|COMPLETED|Second Intervention Period||9
3038486|NCT01154218|3757913|FG001|COMPLETED|Second Intervention Period||9
3038487|NCT01154218|3757914|FG002|COMPLETED|Second Intervention Period||9
3038488|NCT01154218|3757915|FG003|COMPLETED|Second Intervention Period||9
3038489|NCT01154218|3757912|FG000|NOT COMPLETED|Second Intervention Period||0
3038490|NCT01154218|3757913|FG001|NOT COMPLETED|Second Intervention Period||0
3038491|NCT01154218|3757914|FG002|NOT COMPLETED|Second Intervention Period||0
3038492|NCT01154218|3757915|FG003|NOT COMPLETED|Second Intervention Period||0
3038493|NCT01154218|3757912|FG000|STARTED|Washout Period (at Least 14 Days)||9
3038494|NCT01154218|3757913|FG001|STARTED|Washout Period (at Least 14 Days)||9
3038495|NCT01154218|3757914|FG002|STARTED|Washout Period (at Least 14 Days)||9
3038496|NCT01154218|3757915|FG003|STARTED|Washout Period (at Least 14 Days)||9
3038497|NCT01154218|3757912|FG000|COMPLETED|Washout Period (at Least 14 Days)||9
3038498|NCT01154218|3757913|FG001|COMPLETED|Washout Period (at Least 14 Days)||9
3038499|NCT01154218|3757914|FG002|COMPLETED|Washout Period (at Least 14 Days)||9
3038500|NCT01154218|3757915|FG003|COMPLETED|Washout Period (at Least 14 Days)||9
3038501|NCT01154218|3757912|FG000|NOT COMPLETED|Washout Period (at Least 14 Days)||0
3038502|NCT01154218|3757913|FG001|NOT COMPLETED|Washout Period (at Least 14 Days)||0
3038503|NCT01154218|3757914|FG002|NOT COMPLETED|Washout Period (at Least 14 Days)||0
3038504|NCT01154218|3757915|FG003|NOT COMPLETED|Washout Period (at Least 14 Days)||0
3038505|NCT01154218|3757912|FG000|STARTED|Third Intervention Period||9
3038506|NCT01154218|3757913|FG001|STARTED|Third Intervention Period||9
3038507|NCT01154218|3757914|FG002|STARTED|Third Intervention Period||9
3038508|NCT01154218|3757915|FG003|STARTED|Third Intervention Period||9
3038509|NCT01154218|3757912|FG000|COMPLETED|Third Intervention Period||9
3038510|NCT01154218|3757913|FG001|COMPLETED|Third Intervention Period||8
3038511|NCT01154218|3757914|FG002|COMPLETED|Third Intervention Period||9
3038512|NCT01154218|3757915|FG003|COMPLETED|Third Intervention Period||9
3038513|NCT01154218|3757912|FG000|NOT COMPLETED|Third Intervention Period||0
3038514|NCT01154218|3757913|FG001|NOT COMPLETED|Third Intervention Period||1
3038515|NCT01154218|3757914|FG002|NOT COMPLETED|Third Intervention Period||0
3038516|NCT01154218|3757915|FG003|NOT COMPLETED|Third Intervention Period||0
3038517|NCT01154218|3757912|FG000|STARTED|Washout Period (at Least 14 Days)||9
3038518|NCT01154218|3757913|FG001|STARTED|Washout Period (at Least 14 Days)||8
3038519|NCT01154218|3757914|FG002|STARTED|Washout Period (at Least 14 Days)||9
3038520|NCT01154218|3757915|FG003|STARTED|Washout Period (at Least 14 Days)||9
3038521|NCT01154218|3757912|FG000|COMPLETED|Washout Period (at Least 14 Days)||9
3172004|NCT01938625|3899310|FG000|NOT COMPLETED|Overall Study||0
3317384|NCT03126344|4050923|FG001|NOT COMPLETED|Overall Study||0
2921197|NCT00541229|3631855|FG003|STARTED|Treatment Period I (Week 1)||18
3317385|NCT03126344|4050924|FG002|NOT COMPLETED|Overall Study||5
3317386|NCT03126370|4050932|FG000|STARTED|TDF With a Boosted PI||10
3317387|NCT03126370|4050932|FG000|COMPLETED|TDF With a Boosted PI||10
3317388|NCT03126370|4050932|FG000|NOT COMPLETED|TDF With a Boosted PI||0
3317389|NCT03126370|4050932|FG000|STARTED|TAF With a Boosted PI||10
3317390|NCT03126370|4050932|FG000|COMPLETED|TAF With a Boosted PI||10
3317391|NCT03126370|4050932|FG000|NOT COMPLETED|TAF With a Boosted PI||0
3317392|NCT03126370|4050932|FG000|STARTED|TAF With a Boosted PI and LDV/SOF||10
2921198|NCT00541229|3631856|FG004|STARTED|Treatment Period I (Week 1)||14
3317393|NCT03126370|4050932|FG000|COMPLETED|TAF With a Boosted PI and LDV/SOF||10
3317394|NCT03126370|4050932|FG000|NOT COMPLETED|TAF With a Boosted PI and LDV/SOF||0
3317395|NCT03126370|4050932|FG000|STARTED|TAF With a Boosted PI||10
3317396|NCT03126370|4050932|FG000|COMPLETED|TAF With a Boosted PI||10
3317397|NCT03126370|4050932|FG000|NOT COMPLETED|TAF With a Boosted PI||0
3317398|NCT03126448|4050943|FG000|STARTED|Overall Study||56
3317399|NCT03126448|4050944|FG001|STARTED|Overall Study||49
3317400|NCT03126448|4050945|FG002|STARTED|Overall Study||37
3317401|NCT03126448|4050943|FG000|COMPLETED|Overall Study||43
3317402|NCT03126448|4050944|FG001|COMPLETED|Overall Study||41
3172005|NCT01938625|3899311|FG001|NOT COMPLETED|Overall Study||2
3172006|NCT01938664|3899319|FG000|STARTED|Overall Study||20
3172007|NCT01938664|3899320|FG001|STARTED|Overall Study||10
3172008|NCT01938664|3899319|FG000|COMPLETED|Overall Study||5
3172009|NCT01938664|3899320|FG001|COMPLETED|Overall Study||0
3172010|NCT01938664|3899319|FG000|NOT COMPLETED|Overall Study||15
2921199|NCT00541229|3631857|FG005|STARTED|Treatment Period I (Week 1)||18
2921200|NCT00541229|3631852|FG000|COMPLETED|Treatment Period I (Week 1)||17
2921201|NCT00541229|3631853|FG001|COMPLETED|Treatment Period I (Week 1)||15
2921202|NCT00541229|3631854|FG002|COMPLETED|Treatment Period I (Week 1)||17
2921203|NCT00541229|3631855|FG003|COMPLETED|Treatment Period I (Week 1)||17
2921204|NCT00541229|3631856|FG004|COMPLETED|Treatment Period I (Week 1)||14
2921205|NCT00541229|3631857|FG005|COMPLETED|Treatment Period I (Week 1)||16
2921206|NCT00541229|3631852|FG000|NOT COMPLETED|Treatment Period I (Week 1)||0
2921207|NCT00541229|3631853|FG001|NOT COMPLETED|Treatment Period I (Week 1)||1
2921208|NCT00541229|3631854|FG002|NOT COMPLETED|Treatment Period I (Week 1)||3
2921209|NCT00541229|3631855|FG003|NOT COMPLETED|Treatment Period I (Week 1)||1
2921210|NCT00541229|3631856|FG004|NOT COMPLETED|Treatment Period I (Week 1)||0
2921211|NCT00541229|3631857|FG005|NOT COMPLETED|Treatment Period I (Week 1)||2
3172011|NCT01938664|3899320|FG001|NOT COMPLETED|Overall Study||10
3172012|NCT01938846|3899329|FG000|STARTED|Overall Study||41
3317403|NCT03126448|4050945|FG002|COMPLETED|Overall Study||27
3317404|NCT03126448|4050943|FG000|NOT COMPLETED|Overall Study||13
3317405|NCT03126448|4050944|FG001|NOT COMPLETED|Overall Study||8
3317406|NCT03126448|4050945|FG002|NOT COMPLETED|Overall Study||10
3317407|NCT03126539|4050955|FG000|STARTED|Overall Study||9
3317408|NCT03126539|4050956|FG001|STARTED|Overall Study||9
3317409|NCT03126539|4050957|FG002|STARTED|Overall Study||9
3317410|NCT03126539|4050958|FG003|STARTED|Overall Study|Group B was not done|0
3317411|NCT03126539|4050959|FG004|STARTED|Overall Study||0
3317412|NCT03126539|4050955|FG000|COMPLETED|Overall Study||8
3317413|NCT03126539|4050956|FG001|COMPLETED|Overall Study||8
3317414|NCT03126539|4050957|FG002|COMPLETED|Overall Study||8
3317415|NCT03126539|4050958|FG003|COMPLETED|Overall Study||0
3317416|NCT03126539|4050959|FG004|COMPLETED|Overall Study||0
3317417|NCT03126539|4050955|FG000|NOT COMPLETED|Overall Study||1
3317418|NCT03126539|4050956|FG001|NOT COMPLETED|Overall Study||1
3317419|NCT03126539|4050957|FG002|NOT COMPLETED|Overall Study||1
3317420|NCT03126539|4050958|FG003|NOT COMPLETED|Overall Study||0
3317421|NCT03126539|4050959|FG004|NOT COMPLETED|Overall Study||0
3317422|NCT03126682|4050974|FG000|STARTED|Overall Study||5
3317423|NCT03126682|4050975|FG001|STARTED|Overall Study||5
3317424|NCT03126682|4050974|FG000|COMPLETED|Overall Study||5
3317425|NCT03126682|4050975|FG001|COMPLETED|Overall Study||5
3317426|NCT03126682|4050974|FG000|NOT COMPLETED|Overall Study||0
3317427|NCT03126682|4050975|FG001|NOT COMPLETED|Overall Study||0
3317428|NCT03126760|4050983|FG000|STARTED|Overall Study||18
3317429|NCT03126760|4050984|FG001|STARTED|Overall Study||17
3317430|NCT03126760|4050983|FG000|Modified Intent to Treat (mITT)|Overall Study||18
3317431|NCT03126760|4050984|FG001|Modified Intent to Treat (mITT)|Overall Study||17
3317432|NCT03126760|4050983|FG000|Completed Treatment|Overall Study|One participant halted treatment for adverse event, but completed the study|17
3317433|NCT03126760|4050984|FG001|Completed Treatment|Overall Study||17
3317434|NCT03126760|4050983|FG000|COMPLETED|Overall Study||18
3317435|NCT03126760|4050984|FG001|COMPLETED|Overall Study||17
3317436|NCT03126760|4050983|FG000|NOT COMPLETED|Overall Study||0
3317437|NCT03126760|4050984|FG001|NOT COMPLETED|Overall Study||0
3317438|NCT03126786|4050992|FG000|STARTED|Overall Study||36
3317439|NCT03126786|4050993|FG001|STARTED|Overall Study||35
3317440|NCT03126786|4050992|FG000|COMPLETED|Overall Study||30
3317441|NCT03126786|4050993|FG001|COMPLETED|Overall Study||33
3317442|NCT03126786|4050992|FG000|NOT COMPLETED|Overall Study||6
3317443|NCT03126786|4050993|FG001|NOT COMPLETED|Overall Study||2
3317444|NCT03127228|4051001|FG000|STARTED|Overall Study||12
3317445|NCT03127228|4051002|FG001|STARTED|Overall Study||12
3317446|NCT03127228|4051001|FG000|COMPLETED|Overall Study||12
3317447|NCT03127228|4051002|FG001|COMPLETED|Overall Study||12
3317448|NCT03127228|4051001|FG000|NOT COMPLETED|Overall Study||0
3317449|NCT03127228|4051002|FG001|NOT COMPLETED|Overall Study||0
3317450|NCT03127358|4051011|FG000|STARTED|Overall Study|3/9/18:Date first participant was randomized to this arm.|3
3317451|NCT03127358|4051012|FG001|STARTED|Overall Study|3/22/18: Date first participant randomized to this arm.|3
3317452|NCT03127358|4051013|FG002|STARTED|Overall Study|3/14/18: Date first participant randomized to this arm..|5
3317453|NCT03127358|4051011|FG000|COMPLETED|Overall Study|12/26/18: Date of SVR for last participant randomized to this arm.|3
3317454|NCT03127358|4051012|FG001|COMPLETED|Overall Study|2/6/19: Date of SVR for last participant randomized to this arm.|3
3317455|NCT03127358|4051013|FG002|COMPLETED|Overall Study|11/20/18: Date of SVR for last participant randomized to this arm.|5
3317456|NCT03127358|4051011|FG000|NOT COMPLETED|Overall Study||0
3317457|NCT03127358|4051012|FG001|NOT COMPLETED|Overall Study||0
3317458|NCT03127358|4051013|FG002|NOT COMPLETED|Overall Study||0
3317459|NCT03127384|4051027|FG000|STARTED|Overall Study||49
3317460|NCT03127384|4051027|FG000|Completed 3 Month Visit|Overall Study||47
3317461|NCT03127384|4051027|FG000|COMPLETED|Overall Study||43
3317462|NCT03127384|4051027|FG000|NOT COMPLETED|Overall Study||6
3317463|NCT03127514|4051035|FG000|STARTED|Overall Study||48
3317464|NCT03127514|4051036|FG001|STARTED|Overall Study||89
3317465|NCT03127514|4051035|FG000|COMPLETED|Overall Study||38
3317466|NCT03127514|4051036|FG001|COMPLETED|Overall Study||67
3317467|NCT03127514|4051035|FG000|NOT COMPLETED|Overall Study||10
3317468|NCT03127514|4051036|FG001|NOT COMPLETED|Overall Study||22
3317469|NCT03127644|4051045|FG000|STARTED|Overall Study||34
3317470|NCT03127644|4051046|FG001|STARTED|Overall Study||36
3317471|NCT03127644|4051047|FG002|STARTED|Overall Study||33
3317472|NCT03127644|4051045|FG000|COMPLETED|Overall Study||34
3317473|NCT03127644|4051046|FG001|COMPLETED|Overall Study||36
3317474|NCT03127644|4051047|FG002|COMPLETED|Overall Study||31
3317475|NCT03127644|4051045|FG000|NOT COMPLETED|Overall Study||0
3317476|NCT03127644|4051046|FG001|NOT COMPLETED|Overall Study||0
3317477|NCT03127644|4051047|FG002|NOT COMPLETED|Overall Study||2
3317478|NCT03127943|4051057|FG000|STARTED|First Intervention||12
3317479|NCT03127943|4051058|FG001|STARTED|First Intervention||12
3317480|NCT03127943|4051057|FG000|COMPLETED|First Intervention||12
3317481|NCT03127943|4051058|FG001|COMPLETED|First Intervention||12
3317482|NCT03127943|4051057|FG000|NOT COMPLETED|First Intervention||0
3317483|NCT03127943|4051058|FG001|NOT COMPLETED|First Intervention||0
3317484|NCT03127943|4051057|FG000|STARTED|Washout (1 Week)||12
3317485|NCT03127943|4051058|FG001|STARTED|Washout (1 Week)||12
3317486|NCT03127943|4051057|FG000|COMPLETED|Washout (1 Week)||12
3172013|NCT01938846|3899330|FG001|STARTED|Overall Study||25
3172014|NCT01938846|3899331|FG002|STARTED|Overall Study||24
3172015|NCT01938846|3899329|FG000|COMPLETED|Overall Study||0
3172016|NCT01938846|3899330|FG001|COMPLETED|Overall Study||0
3172017|NCT01938846|3899331|FG002|COMPLETED|Overall Study||0
2921212|NCT00541229|3631852|FG000|STARTED|Washout Period I (Week 2-5)||17
2921213|NCT00541229|3631853|FG001|STARTED|Washout Period I (Week 2-5)||15
2921214|NCT00541229|3631854|FG002|STARTED|Washout Period I (Week 2-5)||17
3172018|NCT01938846|3899329|FG000|NOT COMPLETED|Overall Study||41
3172019|NCT01938846|3899330|FG001|NOT COMPLETED|Overall Study||25
3172020|NCT01938846|3899331|FG002|NOT COMPLETED|Overall Study||24
3172021|NCT01938989|3899372|FG000|STARTED|Overall Study||77
3172022|NCT01938989|3899373|FG001|STARTED|Overall Study||77
3172023|NCT01938989|3899372|FG000|COMPLETED|Overall Study||77
3172024|NCT01938989|3899373|FG001|COMPLETED|Overall Study||77
3172025|NCT01938989|3899372|FG000|NOT COMPLETED|Overall Study||0
3172026|NCT01938989|3899373|FG001|NOT COMPLETED|Overall Study||0
3172027|NCT01939002|3899381|FG000|STARTED|Overall Study||103
3172028|NCT01939002|3899382|FG001|STARTED|Overall Study||98
3172029|NCT01939002|3899381|FG000|COMPLETED|Overall Study||84
3172030|NCT01939002|3899382|FG001|COMPLETED|Overall Study||80
3172031|NCT01939002|3899381|FG000|NOT COMPLETED|Overall Study||19
3172032|NCT01939002|3899382|FG001|NOT COMPLETED|Overall Study||18
3172033|NCT01939028|3899393|FG000|STARTED|Overall Study||58
3172034|NCT01939028|3899393|FG000|COMPLETED|Overall Study||46
3172035|NCT01939028|3899393|FG000|NOT COMPLETED|Overall Study||12
3172036|NCT01939145|3899399|FG000|STARTED|Overall Study||49
3172037|NCT01939145|3899400|FG001|STARTED|Overall Study||51
3172038|NCT01939145|3899399|FG000|COMPLETED|Overall Study||47
3172039|NCT01939145|3899400|FG001|COMPLETED|Overall Study||44
3172040|NCT01939145|3899399|FG000|NOT COMPLETED|Overall Study||2
3172041|NCT01939145|3899400|FG001|NOT COMPLETED|Overall Study||7
3172042|NCT01939158|3899410|FG000|STARTED|Overall Study||203
3172043|NCT01939158|3899411|FG001|STARTED|Overall Study||198
3172044|NCT01939158|3899412|FG002|STARTED|Overall Study||201
3172045|NCT01939158|3899413|FG003|STARTED|Overall Study||201
3172046|NCT01939158|3899410|FG000|Vaccinated|Overall Study||203
3172047|NCT01939158|3899411|FG001|Vaccinated|Overall Study||197
3172048|NCT01939158|3899412|FG002|Vaccinated|Overall Study||201
3172049|NCT01939158|3899413|FG003|Vaccinated|Overall Study||201
3172050|NCT01939158|3899410|FG000|COMPLETED|Overall Study||156
3172051|NCT01939158|3899411|FG001|COMPLETED|Overall Study||146
3172052|NCT01939158|3899412|FG002|COMPLETED|Overall Study||160
3172053|NCT01939158|3899413|FG003|COMPLETED|Overall Study||157
3172054|NCT01939158|3899410|FG000|NOT COMPLETED|Overall Study||47
3172055|NCT01939158|3899411|FG001|NOT COMPLETED|Overall Study||52
3172056|NCT01939158|3899412|FG002|NOT COMPLETED|Overall Study||41
3172057|NCT01939158|3899413|FG003|NOT COMPLETED|Overall Study||44
3172058|NCT01939197|3899434|FG000|STARTED|Overall Study||31
3172059|NCT01939197|3899435|FG001|STARTED|Overall Study||32
3172060|NCT01939197|3899436|FG002|STARTED|Overall Study||10
3172061|NCT01939197|3899437|FG003|STARTED|Overall Study||12
2921215|NCT00541229|3631855|FG003|STARTED|Washout Period I (Week 2-5)||17
2921216|NCT00541229|3631856|FG004|STARTED|Washout Period I (Week 2-5)||14
2921217|NCT00541229|3631857|FG005|STARTED|Washout Period I (Week 2-5)||16
2921218|NCT00541229|3631852|FG000|COMPLETED|Washout Period I (Week 2-5)||13
2921219|NCT00541229|3631853|FG001|COMPLETED|Washout Period I (Week 2-5)||13
2921220|NCT00541229|3631854|FG002|COMPLETED|Washout Period I (Week 2-5)||13
2921221|NCT00541229|3631855|FG003|COMPLETED|Washout Period I (Week 2-5)||13
2921222|NCT00541229|3631856|FG004|COMPLETED|Washout Period I (Week 2-5)||13
2921223|NCT00541229|3631857|FG005|COMPLETED|Washout Period I (Week 2-5)||11
2921224|NCT00541229|3631852|FG000|NOT COMPLETED|Washout Period I (Week 2-5)||4
2921225|NCT00541229|3631853|FG001|NOT COMPLETED|Washout Period I (Week 2-5)||2
2921226|NCT00541229|3631854|FG002|NOT COMPLETED|Washout Period I (Week 2-5)||4
2921227|NCT00541229|3631855|FG003|NOT COMPLETED|Washout Period I (Week 2-5)||4
2921228|NCT00541229|3631856|FG004|NOT COMPLETED|Washout Period I (Week 2-5)||1
2921229|NCT00541229|3631857|FG005|NOT COMPLETED|Washout Period I (Week 2-5)||5
2921230|NCT00541229|3631852|FG000|STARTED|Treatment Period II (Week 6)||13
2921231|NCT00541229|3631853|FG001|STARTED|Treatment Period II (Week 6)||13
2921232|NCT00541229|3631854|FG002|STARTED|Treatment Period II (Week 6)||13
2921233|NCT00541229|3631855|FG003|STARTED|Treatment Period II (Week 6)||13
2921234|NCT00541229|3631856|FG004|STARTED|Treatment Period II (Week 6)||13
2921235|NCT00541229|3631857|FG005|STARTED|Treatment Period II (Week 6)||11
2921236|NCT00541229|3631852|FG000|COMPLETED|Treatment Period II (Week 6)||11
2921237|NCT00541229|3631853|FG001|COMPLETED|Treatment Period II (Week 6)||12
3172062|NCT01939197|3899438|FG004|STARTED|Overall Study||200
3172063|NCT01939197|3899439|FG005|STARTED|Overall Study||5
3172064|NCT01939197|3899440|FG006|STARTED|Overall Study||28
3172065|NCT01939197|3899434|FG000|COMPLETED|Overall Study||30
3172066|NCT01939197|3899435|FG001|COMPLETED|Overall Study||31
3172067|NCT01939197|3899436|FG002|COMPLETED|Overall Study||10
2921238|NCT00541229|3631854|FG002|COMPLETED|Treatment Period II (Week 6)||12
2921239|NCT00541229|3631855|FG003|COMPLETED|Treatment Period II (Week 6)||12
2921240|NCT00541229|3631856|FG004|COMPLETED|Treatment Period II (Week 6)||11
2921241|NCT00541229|3631857|FG005|COMPLETED|Treatment Period II (Week 6)||8
2921242|NCT00541229|3631852|FG000|NOT COMPLETED|Treatment Period II (Week 6)||2
2921243|NCT00541229|3631853|FG001|NOT COMPLETED|Treatment Period II (Week 6)||1
2921244|NCT00541229|3631854|FG002|NOT COMPLETED|Treatment Period II (Week 6)||1
2921245|NCT00541229|3631855|FG003|NOT COMPLETED|Treatment Period II (Week 6)||1
2921246|NCT00541229|3631856|FG004|NOT COMPLETED|Treatment Period II (Week 6)||2
3172068|NCT01939197|3899437|FG003|COMPLETED|Overall Study||11
3172069|NCT01939197|3899438|FG004|COMPLETED|Overall Study||196
3172070|NCT01939197|3899439|FG005|COMPLETED|Overall Study||4
3172071|NCT01939197|3899440|FG006|COMPLETED|Overall Study||26
3136836|NCT01715857|3862088|FG000|STARTED|Overall Study||4100
3136837|NCT01715857|3862088|FG000|COMPLETED|Overall Study||4004
3172072|NCT01939197|3899434|FG000|NOT COMPLETED|Overall Study||1
3172073|NCT01939197|3899435|FG001|NOT COMPLETED|Overall Study||1
2921247|NCT00541229|3631857|FG005|NOT COMPLETED|Treatment Period II (Week 6)||3
2921248|NCT00541229|3631852|FG000|STARTED|Washout Period II (Week 7-10)||11
2921249|NCT00541229|3631853|FG001|STARTED|Washout Period II (Week 7-10)||12
2921250|NCT00541229|3631854|FG002|STARTED|Washout Period II (Week 7-10)||12
2921251|NCT00541229|3631855|FG003|STARTED|Washout Period II (Week 7-10)||12
2921252|NCT00541229|3631856|FG004|STARTED|Washout Period II (Week 7-10)||11
2921253|NCT00541229|3631857|FG005|STARTED|Washout Period II (Week 7-10)||8
2921254|NCT00541229|3631852|FG000|COMPLETED|Washout Period II (Week 7-10)||7
2921255|NCT00541229|3631853|FG001|COMPLETED|Washout Period II (Week 7-10)||8
2921256|NCT00541229|3631854|FG002|COMPLETED|Washout Period II (Week 7-10)||10
2921257|NCT00541229|3631855|FG003|COMPLETED|Washout Period II (Week 7-10)||8
2921258|NCT00541229|3631856|FG004|COMPLETED|Washout Period II (Week 7-10)||7
2921259|NCT00541229|3631857|FG005|COMPLETED|Washout Period II (Week 7-10)||5
2921260|NCT00541229|3631852|FG000|NOT COMPLETED|Washout Period II (Week 7-10)||4
2921261|NCT00541229|3631853|FG001|NOT COMPLETED|Washout Period II (Week 7-10)||4
2921262|NCT00541229|3631854|FG002|NOT COMPLETED|Washout Period II (Week 7-10)||2
2921263|NCT00541229|3631855|FG003|NOT COMPLETED|Washout Period II (Week 7-10)||4
2921264|NCT00541229|3631856|FG004|NOT COMPLETED|Washout Period II (Week 7-10)||4
2921265|NCT00541229|3631857|FG005|NOT COMPLETED|Washout Period II (Week 7-10)||3
2921266|NCT00541229|3631852|FG000|STARTED|Treatment Period III (Week 11)||7
2921267|NCT00541229|3631853|FG001|STARTED|Treatment Period III (Week 11)||8
2921268|NCT00541229|3631854|FG002|STARTED|Treatment Period III (Week 11)||10
2921269|NCT00541229|3631855|FG003|STARTED|Treatment Period III (Week 11)||8
2921270|NCT00541229|3631856|FG004|STARTED|Treatment Period III (Week 11)||7
2921271|NCT00541229|3631857|FG005|STARTED|Treatment Period III (Week 11)||5
2921272|NCT00541229|3631852|FG000|COMPLETED|Treatment Period III (Week 11)||7
2921273|NCT00541229|3631853|FG001|COMPLETED|Treatment Period III (Week 11)||8
2921274|NCT00541229|3631854|FG002|COMPLETED|Treatment Period III (Week 11)||9
2921275|NCT00541229|3631855|FG003|COMPLETED|Treatment Period III (Week 11)||8
2921276|NCT00541229|3631856|FG004|COMPLETED|Treatment Period III (Week 11)||6
2921277|NCT00541229|3631857|FG005|COMPLETED|Treatment Period III (Week 11)||4
2921278|NCT00541229|3631852|FG000|NOT COMPLETED|Treatment Period III (Week 11)||0
2921279|NCT00541229|3631853|FG001|NOT COMPLETED|Treatment Period III (Week 11)||0
2921280|NCT00541229|3631854|FG002|NOT COMPLETED|Treatment Period III (Week 11)||1
2921281|NCT00541229|3631855|FG003|NOT COMPLETED|Treatment Period III (Week 11)||0
2921282|NCT00541229|3631856|FG004|NOT COMPLETED|Treatment Period III (Week 11)||1
2921283|NCT00541229|3631857|FG005|NOT COMPLETED|Treatment Period III (Week 11)||1
2921284|NCT00541242|3631867|FG000|STARTED|Treatment Period 1||0
2921285|NCT00541242|3631868|FG001|STARTED|Treatment Period 1|586 patients were enrolled and received open-label latanoprost for 6 weeks|586
2921286|NCT00541242|3631867|FG000|COMPLETED|Treatment Period 1||0
2921287|NCT00541242|3631868|FG001|COMPLETED|Treatment Period 1|43 of the 586 patients did not enter Treatment Period 2 (Randomized at Week 6)|586
2921288|NCT00541242|3631867|FG000|NOT COMPLETED|Treatment Period 1||0
2921289|NCT00541242|3631868|FG001|NOT COMPLETED|Treatment Period 1||0
2921290|NCT00541242|3631867|FG000|STARTED|Treatment Period 2||270
2921291|NCT00541242|3631868|FG001|STARTED|Treatment Period 2||273
3172074|NCT01939197|3899436|FG002|NOT COMPLETED|Overall Study||0
3172075|NCT01939197|3899437|FG003|NOT COMPLETED|Overall Study||1
3172076|NCT01939197|3899438|FG004|NOT COMPLETED|Overall Study||4
3172077|NCT01939197|3899439|FG005|NOT COMPLETED|Overall Study||1
3172078|NCT01939197|3899440|FG006|NOT COMPLETED|Overall Study||2
3172079|NCT01939275|3899470|FG000|STARTED|Overall Study||8
3172080|NCT01939275|3899470|FG000|COMPLETED|Overall Study||8
2921292|NCT00541242|3631867|FG000|COMPLETED|Treatment Period 2||261
2921293|NCT00541242|3631868|FG001|COMPLETED|Treatment Period 2||266
2921294|NCT00541242|3631867|FG000|NOT COMPLETED|Treatment Period 2||9
2921295|NCT00541242|3631868|FG001|NOT COMPLETED|Treatment Period 2||7
3172081|NCT01939275|3899470|FG000|NOT COMPLETED|Overall Study||0
2921296|NCT00541307|3631874|FG000|STARTED|Overall Study||119
2921297|NCT00541307|3631874|FG000|COMPLETED|Overall Study||95
2921298|NCT00541307|3631874|FG000|NOT COMPLETED|Overall Study||24
2921299|NCT00541346|3631878|FG000|STARTED|Baseline||16
2921300|NCT00541346|3631878|FG000|COMPLETED|Baseline||16
2921301|NCT00541346|3631878|FG000|NOT COMPLETED|Baseline||0
2921302|NCT00541346|3631878|FG000|STARTED|Follow-up||16
2921303|NCT00541346|3631878|FG000|COMPLETED|Follow-up||15
2921304|NCT00541346|3631878|FG000|NOT COMPLETED|Follow-up||1
2921305|NCT00541385|3631884|FG000|STARTED|Overall Study||355
2921306|NCT00541385|3631885|FG001|STARTED|Overall Study||180
2921307|NCT00541385|3631884|FG000|COMPLETED|Overall Study||274
2921308|NCT00541385|3631885|FG001|COMPLETED|Overall Study||142
2921309|NCT00541385|3631884|FG000|NOT COMPLETED|Overall Study||81
2921310|NCT00541385|3631885|FG001|NOT COMPLETED|Overall Study||38
2921311|NCT00541450|3631893|FG000|STARTED|Phase A||244
2921312|NCT00541450|3631894|FG001|STARTED|Phase A||248
2921313|NCT00541450|3631893|FG000|COMPLETED|Phase A||224
2921314|NCT00541450|3631894|FG001|COMPLETED|Phase A||231
2921315|NCT00541450|3631893|FG000|NOT COMPLETED|Phase A||20
2921316|NCT00541450|3631894|FG001|NOT COMPLETED|Phase A||17
2921317|NCT00541450|3631893|FG000|STARTED|Phase B||224
2921318|NCT00541450|3631894|FG001|STARTED|Phase B||231
2921319|NCT00541450|3631893|FG000|COMPLETED|Phase B||187
2921320|NCT00541450|3631894|FG001|COMPLETED|Phase B||200
2921321|NCT00541450|3631893|FG000|NOT COMPLETED|Phase B||37
2921322|NCT00541450|3631894|FG001|NOT COMPLETED|Phase B||31
2921323|NCT00541593|3631904|FG000|STARTED|Overall Study||5
2921324|NCT00541593|3631904|FG000|COMPLETED|Overall Study||5
2921325|NCT00541593|3631904|FG000|NOT COMPLETED|Overall Study||0
2921326|NCT00541658|3631911|FG000|STARTED|Overall Study||308
2921327|NCT00541658|3631912|FG001|STARTED|Overall Study||307
2921328|NCT00541658|3631913|FG002|STARTED|Overall Study||308
3172082|NCT01939288|3899476|FG000|STARTED|Overall Study||5
2921329|NCT00541658|3631911|FG000|ITT Population|Overall Study||307
2921330|NCT00541658|3631912|FG001|ITT Population|Overall Study||307
3172083|NCT01939288|3899477|FG001|STARTED|Overall Study||5
3172084|NCT01939288|3899476|FG000|COMPLETED|Overall Study||5
3172085|NCT01939288|3899477|FG001|COMPLETED|Overall Study||5
3172086|NCT01939288|3899476|FG000|NOT COMPLETED|Overall Study||0
3317487|NCT03127943|4051058|FG001|COMPLETED|Washout (1 Week)||12
3317488|NCT03127943|4051057|FG000|NOT COMPLETED|Washout (1 Week)||0
3317489|NCT03127943|4051058|FG001|NOT COMPLETED|Washout (1 Week)||0
3317490|NCT03127943|4051057|FG000|STARTED|Second Intervention||12
3317491|NCT03127943|4051058|FG001|STARTED|Second Intervention||12
3317492|NCT03127943|4051057|FG000|COMPLETED|Second Intervention||12
3317493|NCT03127943|4051058|FG001|COMPLETED|Second Intervention||12
3317494|NCT03127943|4051057|FG000|NOT COMPLETED|Second Intervention||0
3317495|NCT03127943|4051058|FG001|NOT COMPLETED|Second Intervention||0
3317496|NCT03127956|4051064|FG000|STARTED|Overall Study||748
3317497|NCT03127956|4051064|FG000|COMPLETED|Overall Study||431
3317498|NCT03127956|4051064|FG000|NOT COMPLETED|Overall Study||317
3317499|NCT03128008|4051068|FG000|STARTED|Overall Study||10
3317500|NCT03128008|4051068|FG000|COMPLETED|Overall Study|9 participants are in follow up|1
3317501|NCT03128008|4051068|FG000|NOT COMPLETED|Overall Study||9
3317502|NCT03128086|4051075|FG000|STARTED|Overall Study||50
3317503|NCT03128086|4051076|FG001|STARTED|Overall Study||44
3317504|NCT03128086|4051075|FG000|COMPLETED|Overall Study||50
2921331|NCT00541658|3631913|FG002|ITT Population|Overall Study||308
2921332|NCT00541658|3631911|FG000|COMPLETED|Overall Study||248
2921333|NCT00541658|3631912|FG001|COMPLETED|Overall Study||234
2921334|NCT00541658|3631913|FG002|COMPLETED|Overall Study||240
3038522|NCT01154218|3757913|FG001|COMPLETED|Washout Period (at Least 14 Days)||8
3317505|NCT03128086|4051076|FG001|COMPLETED|Overall Study||44
3317506|NCT03128086|4051075|FG000|NOT COMPLETED|Overall Study||0
3317507|NCT03128086|4051076|FG001|NOT COMPLETED|Overall Study||0
3317508|NCT03128099|4051085|FG000|STARTED|Overall Study||21
3317509|NCT03128099|4051086|FG001|STARTED|Overall Study||4
3317510|NCT03128099|4051087|FG002|STARTED|Overall Study||22
3038523|NCT01154218|3757914|FG002|COMPLETED|Washout Period (at Least 14 Days)||9
3038524|NCT01154218|3757915|FG003|COMPLETED|Washout Period (at Least 14 Days)||8
3038525|NCT01154218|3757912|FG000|NOT COMPLETED|Washout Period (at Least 14 Days)||0
3038526|NCT01154218|3757913|FG001|NOT COMPLETED|Washout Period (at Least 14 Days)||0
3038527|NCT01154218|3757914|FG002|NOT COMPLETED|Washout Period (at Least 14 Days)||0
3038528|NCT01154218|3757915|FG003|NOT COMPLETED|Washout Period (at Least 14 Days)||1
3038529|NCT01154218|3757912|FG000|STARTED|Fourth Intervention Period||9
3038530|NCT01154218|3757913|FG001|STARTED|Fourth Intervention Period||8
3038531|NCT01154218|3757914|FG002|STARTED|Fourth Intervention Period||9
3038532|NCT01154218|3757915|FG003|STARTED|Fourth Intervention Period||8
3038533|NCT01154218|3757912|FG000|COMPLETED|Fourth Intervention Period||8
3038534|NCT01154218|3757913|FG001|COMPLETED|Fourth Intervention Period||8
3038535|NCT01154218|3757914|FG002|COMPLETED|Fourth Intervention Period||9
3038536|NCT01154218|3757915|FG003|COMPLETED|Fourth Intervention Period||8
3172087|NCT01939288|3899477|FG001|NOT COMPLETED|Overall Study||0
3172088|NCT01939301|3899484|FG000|STARTED|Overall Study||39
3172089|NCT01939301|3899485|FG001|STARTED|Overall Study||39
3172090|NCT01939301|3899484|FG000|COMPLETED|Overall Study||38
3172091|NCT01939301|3899485|FG001|COMPLETED|Overall Study||38
3172092|NCT01939301|3899484|FG000|NOT COMPLETED|Overall Study||1
3172093|NCT01939301|3899485|FG001|NOT COMPLETED|Overall Study||1
3172094|NCT01939314|3899493|FG000|STARTED|Overall Study||45
3172095|NCT01939314|3899494|FG001|STARTED|Overall Study||48
3172096|NCT01939314|3899493|FG000|15 Minute Endpoint|Overall Study||41
3172097|NCT01939314|3899494|FG001|15 Minute Endpoint|Overall Study||46
3172098|NCT01939314|3899493|FG000|24 Hour Endpoint|Overall Study||36
3172099|NCT01939314|3899494|FG001|24 Hour Endpoint|Overall Study||40
3172100|NCT01939314|3899493|FG000|COMPLETED|Overall Study||36
3172101|NCT01939314|3899494|FG001|COMPLETED|Overall Study||40
3172102|NCT01939314|3899493|FG000|NOT COMPLETED|Overall Study||9
3172103|NCT01939314|3899494|FG001|NOT COMPLETED|Overall Study||8
3172104|NCT01939353|3899502|FG000|STARTED|Placebo Run-in (1 Week)||45
3172105|NCT01939353|3899502|FG000|COMPLETED|Placebo Run-in (1 Week)||41
3172106|NCT01939353|3899502|FG000|NOT COMPLETED|Placebo Run-in (1 Week)||4
3172107|NCT01939353|3899502|FG000|STARTED|CTN SR Treatment Phase (4 Weeks)||41
3172108|NCT01939353|3899502|FG000|COMPLETED|CTN SR Treatment Phase (4 Weeks)||37
3317511|NCT03128099|4051085|FG000|Hour 1 (Low Dose) Started|Overall Study||21
3317512|NCT03128099|4051086|FG001|Hour 1 (Low Dose) Started|Overall Study||4
3317513|NCT03128099|4051087|FG002|Hour 1 (Low Dose) Started|Overall Study||22
3317514|NCT03128099|4051085|FG000|Hour 1 (Low Dose) Completed|Overall Study||19
3317515|NCT03128099|4051086|FG001|Hour 1 (Low Dose) Completed|Overall Study||4
3317516|NCT03128099|4051087|FG002|Hour 1 (Low Dose) Completed|Overall Study||21
3317517|NCT03128099|4051085|FG000|Hour 2 (High Dose)Started|Overall Study|Hour 2 of training not available to these participants|0
3317518|NCT03128099|4051086|FG001|Hour 2 (High Dose)Started|Overall Study||4
3317519|NCT03128099|4051087|FG002|Hour 2 (High Dose)Started|Overall Study|Hour 2 of training not available to these participants|0
3172109|NCT01939353|3899502|FG000|NOT COMPLETED|CTN SR Treatment Phase (4 Weeks)||4
3172110|NCT01939366|3899511|FG000|STARTED|Overall Study||66
3172111|NCT01939366|3899512|FG001|STARTED|Overall Study||64
2921335|NCT00541658|3631911|FG000|NOT COMPLETED|Overall Study||60
2921336|NCT00541658|3631912|FG001|NOT COMPLETED|Overall Study||73
2921337|NCT00541658|3631913|FG002|NOT COMPLETED|Overall Study||68
2921338|NCT00541671|3631925|FG000|STARTED|Overall Study||13
2921339|NCT00541671|3631926|FG001|STARTED|Overall Study||12
3172112|NCT01939366|3899513|FG002|STARTED|Overall Study||65
3172113|NCT01939366|3899514|FG003|STARTED|Overall Study||68
3172114|NCT01939366|3899515|FG004|STARTED|Overall Study||66
2921340|NCT00541671|3631925|FG000|COMPLETED|Overall Study||13
2921341|NCT00541671|3631926|FG001|COMPLETED|Overall Study||12
2921342|NCT00541671|3631925|FG000|NOT COMPLETED|Overall Study||0
2921343|NCT00541671|3631926|FG001|NOT COMPLETED|Overall Study||0
2921344|NCT00541775|3631935|FG000|STARTED|Overall Study||94
2921345|NCT00541775|3631936|FG001|STARTED|Overall Study||87
2921346|NCT00541775|3631937|FG002|STARTED|Overall Study||92
2921347|NCT00541775|3631935|FG000|COMPLETED|Overall Study||85
2921348|NCT00541775|3631936|FG001|COMPLETED|Overall Study||85
2921349|NCT00541775|3631937|FG002|COMPLETED|Overall Study||84
2921350|NCT00541775|3631935|FG000|NOT COMPLETED|Overall Study||9
2921351|NCT00541775|3631936|FG001|NOT COMPLETED|Overall Study||2
2921352|NCT00541775|3631937|FG002|NOT COMPLETED|Overall Study||8
2921353|NCT00541866|3631950|FG000|STARTED|Overall Study|41 started, but only 39 treated|41
2921354|NCT00541866|3631951|FG001|STARTED|Overall Study||18
2921355|NCT00541866|3631952|FG002|STARTED|Overall Study||17
2921356|NCT00541866|3631953|FG003|STARTED|Overall Study||16
2921357|NCT00541866|3631954|FG004|STARTED|Overall Study||18
2921358|NCT00541866|3631950|FG000|COMPLETED|Overall Study||7
2921359|NCT00541866|3631951|FG001|COMPLETED|Overall Study||0
2921360|NCT00541866|3631952|FG002|COMPLETED|Overall Study||2
2921361|NCT00541866|3631953|FG003|COMPLETED|Overall Study||0
2921362|NCT00541866|3631954|FG004|COMPLETED|Overall Study||3
2921363|NCT00541866|3631950|FG000|NOT COMPLETED|Overall Study||34
2921364|NCT00541866|3631951|FG001|NOT COMPLETED|Overall Study||18
2921365|NCT00541866|3631952|FG002|NOT COMPLETED|Overall Study||15
2921366|NCT00541866|3631953|FG003|NOT COMPLETED|Overall Study||16
2921367|NCT00541866|3631954|FG004|NOT COMPLETED|Overall Study||15
2921368|NCT00541931|3631984|FG000|STARTED|Overall Study||22
2921369|NCT00541931|3631985|FG001|STARTED|Overall Study||15
2921370|NCT00541931|3631984|FG000|COMPLETED|Overall Study||17
2921371|NCT00541931|3631985|FG001|COMPLETED|Overall Study||11
2921372|NCT00541931|3631984|FG000|NOT COMPLETED|Overall Study||5
2921373|NCT00541931|3631985|FG001|NOT COMPLETED|Overall Study||4
2921374|NCT00541970|3631997|FG000|STARTED|Month 7||240
2921375|NCT00541970|3631998|FG001|STARTED|Month 7||241
2921376|NCT00541970|3631999|FG002|STARTED|Month 7||240
2921377|NCT00541970|3632000|FG003|STARTED|Month 7||239
2921378|NCT00541970|3631997|FG000|COMPLETED|Month 7||231
2921379|NCT00541970|3631998|FG001|COMPLETED|Month 7||228
2921380|NCT00541970|3631999|FG002|COMPLETED|Month 7||229
2921381|NCT00541970|3632000|FG003|COMPLETED|Month 7||234
2921382|NCT00541970|3631997|FG000|NOT COMPLETED|Month 7||9
2921383|NCT00541970|3631998|FG001|NOT COMPLETED|Month 7||13
2921384|NCT00541970|3631999|FG002|NOT COMPLETED|Month 7||11
2921385|NCT00541970|3632000|FG003|NOT COMPLETED|Month 7||5
2921386|NCT00541970|3631997|FG000|STARTED|Month 12||240
2921387|NCT00541970|3631998|FG001|STARTED|Month 12||241
2921388|NCT00541970|3631999|FG002|STARTED|Month 12||240
2921389|NCT00541970|3632000|FG003|STARTED|Month 12||239
2921390|NCT00541970|3631997|FG000|COMPLETED|Month 12||228
2921391|NCT00541970|3631998|FG001|COMPLETED|Month 12||219
2921392|NCT00541970|3631999|FG002|COMPLETED|Month 12||219
2921393|NCT00541970|3632000|FG003|COMPLETED|Month 12||223
2921394|NCT00541970|3631997|FG000|NOT COMPLETED|Month 12||12
2921395|NCT00541970|3631998|FG001|NOT COMPLETED|Month 12||22
2921396|NCT00541970|3631999|FG002|NOT COMPLETED|Month 12||21
2921397|NCT00541970|3632000|FG003|NOT COMPLETED|Month 12||16
2921398|NCT00541970|3631997|FG000|STARTED|Month 18||240
2921399|NCT00541970|3631998|FG001|STARTED|Month 18||241
2921400|NCT00541970|3631999|FG002|STARTED|Month 18||240
2921401|NCT00541970|3632000|FG003|STARTED|Month 18||239
2921402|NCT00541970|3631997|FG000|COMPLETED|Month 18||226
2921403|NCT00541970|3631998|FG001|COMPLETED|Month 18||217
2921404|NCT00541970|3631999|FG002|COMPLETED|Month 18||215
2921405|NCT00541970|3632000|FG003|COMPLETED|Month 18||222
2921406|NCT00541970|3631997|FG000|NOT COMPLETED|Month 18||14
2921407|NCT00541970|3631998|FG001|NOT COMPLETED|Month 18||24
2921408|NCT00541970|3631999|FG002|NOT COMPLETED|Month 18||25
2921409|NCT00541970|3632000|FG003|NOT COMPLETED|Month 18||17
2921410|NCT00541970|3631997|FG000|STARTED|Month 24||240
2921411|NCT00541970|3631998|FG001|STARTED|Month 24||241
3317520|NCT03128099|4051085|FG000|Hour 2 (High Dose) Completed|Overall Study||0
3317521|NCT03128099|4051086|FG001|Hour 2 (High Dose) Completed|Overall Study||0
2921412|NCT00541970|3631999|FG002|STARTED|Month 24||240
3317522|NCT03128099|4051087|FG002|Hour 2 (High Dose) Completed|Overall Study||0
3317523|NCT03128099|4051085|FG000|COMPLETED|Overall Study||19
3317524|NCT03128099|4051086|FG001|COMPLETED|Overall Study|hour 2 training was completed by 0 participants|0
3317525|NCT03128099|4051087|FG002|COMPLETED|Overall Study||21
3317526|NCT03128099|4051085|FG000|NOT COMPLETED|Overall Study||2
3317527|NCT03128099|4051086|FG001|NOT COMPLETED|Overall Study||4
3317528|NCT03128099|4051087|FG002|NOT COMPLETED|Overall Study||1
3317529|NCT03128307|4051093|FG000|STARTED|Overall Study||604
3172115|NCT01939366|3899511|FG000|Allocated Set Excl. Non-compliant Sites|Overall Study||64
3172116|NCT01939366|3899512|FG001|Allocated Set Excl. Non-compliant Sites|Overall Study||61
3172117|NCT01939366|3899513|FG002|Allocated Set Excl. Non-compliant Sites|Overall Study||63
3172118|NCT01939366|3899514|FG003|Allocated Set Excl. Non-compliant Sites|Overall Study||65
3317530|NCT03128307|4051093|FG000|COMPLETED|Overall Study||570
3317531|NCT03128307|4051093|FG000|NOT COMPLETED|Overall Study||34
3317532|NCT03128372|4051097|FG000|STARTED|Overall Study||32
3317533|NCT03128372|4051097|FG000|COMPLETED|Overall Study||32
3317534|NCT03128372|4051097|FG000|NOT COMPLETED|Overall Study||0
3317535|NCT03128411|4051101|FG000|STARTED|Treatment Phase||60
3317536|NCT03128411|4051101|FG000|Received Treatment|Treatment Phase||60
3317537|NCT03128411|4051101|FG000|COMPLETED|Treatment Phase||0
3317538|NCT03128411|4051101|FG000|NOT COMPLETED|Treatment Phase||60
3317539|NCT03128411|4051101|FG000|STARTED|Long Term Follow-up Phase|"Participants who discontinued treatment phase, entered this phase, except those were Ongoing."|19
3317540|NCT03128411|4051101|FG000|COMPLETED|Long Term Follow-up Phase||0
3317541|NCT03128411|4051101|FG000|NOT COMPLETED|Long Term Follow-up Phase||19
3317542|NCT03128723|4051105|FG000|STARTED|Overall Study||45
3317543|NCT03128723|4051105|FG000|COMPLETED|Overall Study||43
3317544|NCT03128723|4051105|FG000|NOT COMPLETED|Overall Study||2
3317545|NCT03128892|4051109|FG000|STARTED|Overall Study||34
3317546|NCT03128892|4051109|FG000|COMPLETED|Overall Study||31
3317547|NCT03128892|4051109|FG000|NOT COMPLETED|Overall Study||3
3317548|NCT03128931|4051113|FG000|STARTED|Overall Study||45
3317549|NCT03128931|4051113|FG000|COMPLETED|Overall Study||41
3317550|NCT03128931|4051113|FG000|NOT COMPLETED|Overall Study||4
3317551|NCT03129100|4051122|FG000|STARTED|Lead-In Period (Period 1)||350
3317552|NCT03129100|4051123|FG001|STARTED|Lead-In Period (Period 1)||423
3172119|NCT01939366|3899515|FG004|Allocated Set Excl. Non-compliant Sites|Overall Study||63
3172120|NCT01939366|3899511|FG000|Safety Set|Overall Study||64
3172121|NCT01939366|3899512|FG001|Safety Set|Overall Study||61
3172122|NCT01939366|3899513|FG002|Safety Set|Overall Study||62
3172123|NCT01939366|3899514|FG003|Safety Set|Overall Study||65
3172124|NCT01939366|3899515|FG004|Safety Set|Overall Study||62
3172125|NCT01939366|3899511|FG000|Full Analysis Set|Overall Study||64
3172126|NCT01939366|3899512|FG001|Full Analysis Set|Overall Study||60
3172127|NCT01939366|3899513|FG002|Full Analysis Set|Overall Study||61
3172128|NCT01939366|3899514|FG003|Full Analysis Set|Overall Study||65
3172129|NCT01939366|3899515|FG004|Full Analysis Set|Overall Study||62
3172130|NCT01939366|3899511|FG000|Per Protocol Set|Overall Study||58
3172131|NCT01939366|3899512|FG001|Per Protocol Set|Overall Study||55
3172132|NCT01939366|3899513|FG002|Per Protocol Set|Overall Study||50
3172133|NCT01939366|3899514|FG003|Per Protocol Set|Overall Study||51
3172134|NCT01939366|3899515|FG004|Per Protocol Set|Overall Study||49
3172135|NCT01939366|3899511|FG000|COMPLETED|Overall Study||52
3172136|NCT01939366|3899512|FG001|COMPLETED|Overall Study||41
3172137|NCT01939366|3899513|FG002|COMPLETED|Overall Study||27
3172138|NCT01939366|3899514|FG003|COMPLETED|Overall Study||51
3172139|NCT01939366|3899515|FG004|COMPLETED|Overall Study||48
3172140|NCT01939366|3899511|FG000|NOT COMPLETED|Overall Study||14
3172141|NCT01939366|3899512|FG001|NOT COMPLETED|Overall Study||23
3172142|NCT01939366|3899513|FG002|NOT COMPLETED|Overall Study||38
3172143|NCT01939366|3899514|FG003|NOT COMPLETED|Overall Study||17
3172144|NCT01939366|3899515|FG004|NOT COMPLETED|Overall Study||18
3172145|NCT01939405|3899529|FG000|STARTED|Overall Study||30
3172146|NCT01939405|3899530|FG001|STARTED|Overall Study||30
3172147|NCT01939405|3899529|FG000|COMPLETED|Overall Study||27
3172148|NCT01939405|3899530|FG001|COMPLETED|Overall Study||28
3172149|NCT01939405|3899529|FG000|NOT COMPLETED|Overall Study||3
3172150|NCT01939405|3899530|FG001|NOT COMPLETED|Overall Study||2
3172151|NCT01939496|3899539|FG000|STARTED|Overall Study||56
3172152|NCT01939496|3899540|FG001|STARTED|Overall Study||57
3317553|NCT03129100|4051124|FG002|STARTED|Lead-In Period (Period 1)||0
3317554|NCT03129100|4051125|FG003|STARTED|Lead-In Period (Period 1)||0
3317555|NCT03129100|4051126|FG004|STARTED|Lead-In Period (Period 1)||0
3317556|NCT03129100|4051127|FG005|STARTED|Lead-In Period (Period 1)||0
3317557|NCT03129100|4051128|FG006|STARTED|Lead-In Period (Period 1)||0
3172153|NCT01939496|3899541|FG002|STARTED|Overall Study||56
3172154|NCT01939496|3899539|FG000|COMPLETED|Overall Study||47
3172155|NCT01939496|3899540|FG001|COMPLETED|Overall Study||54
3172156|NCT01939496|3899541|FG002|COMPLETED|Overall Study||54
3172157|NCT01939496|3899539|FG000|NOT COMPLETED|Overall Study||9
3172158|NCT01939496|3899540|FG001|NOT COMPLETED|Overall Study||3
3172159|NCT01939496|3899541|FG002|NOT COMPLETED|Overall Study||2
3172160|NCT01939548|3899552|FG000|STARTED|Overall Study||78
3172161|NCT01939548|3899553|FG001|STARTED|Overall Study||82
3172162|NCT01939548|3899554|FG002|STARTED|Overall Study||80
3317558|NCT03129100|4051129|FG007|STARTED|Lead-In Period (Period 1)||0
3317559|NCT03129100|4051130|FG008|STARTED|Lead-In Period (Period 1)||0
3317560|NCT03129100|4051131|FG009|STARTED|Lead-In Period (Period 1)||0
3317561|NCT03129100|4051132|FG010|STARTED|Lead-In Period (Period 1)||0
3317562|NCT03129100|4051122|FG000|COMPLETED|Lead-In Period (Period 1)||335
3317563|NCT03129100|4051123|FG001|COMPLETED|Lead-In Period (Period 1)||406
3317564|NCT03129100|4051124|FG002|COMPLETED|Lead-In Period (Period 1)||0
3317565|NCT03129100|4051125|FG003|COMPLETED|Lead-In Period (Period 1)||0
3317566|NCT03129100|4051126|FG004|COMPLETED|Lead-In Period (Period 1)||0
3317567|NCT03129100|4051127|FG005|COMPLETED|Lead-In Period (Period 1)||0
3317568|NCT03129100|4051128|FG006|COMPLETED|Lead-In Period (Period 1)||0
2921413|NCT00541970|3632000|FG003|STARTED|Month 24||239
3172163|NCT01939548|3899552|FG000|COMPLETED|Overall Study||41
3172164|NCT01939548|3899553|FG001|COMPLETED|Overall Study||33
3172165|NCT01939548|3899554|FG002|COMPLETED|Overall Study||50
3172166|NCT01939548|3899552|FG000|NOT COMPLETED|Overall Study||37
3172167|NCT01939548|3899553|FG001|NOT COMPLETED|Overall Study||49
3172168|NCT01939548|3899554|FG002|NOT COMPLETED|Overall Study||30
2921414|NCT00541970|3631997|FG000|COMPLETED|Month 24||211
2921415|NCT00541970|3631998|FG001|COMPLETED|Month 24||209
2921416|NCT00541970|3631999|FG002|COMPLETED|Month 24||208
2921417|NCT00541970|3632000|FG003|COMPLETED|Month 24||217
2921418|NCT00541970|3631997|FG000|NOT COMPLETED|Month 24||29
2921419|NCT00541970|3631998|FG001|NOT COMPLETED|Month 24||32
2921420|NCT00541970|3631999|FG002|NOT COMPLETED|Month 24||32
2921421|NCT00541970|3632000|FG003|NOT COMPLETED|Month 24||22
2921422|NCT00541970|3631997|FG000|STARTED|Month 36||240
2921423|NCT00541970|3631998|FG001|STARTED|Month 36||241
2921424|NCT00541970|3631999|FG002|STARTED|Month 36||240
2921425|NCT00541970|3632000|FG003|STARTED|Month 36||239
2921426|NCT00541970|3631997|FG000|COMPLETED|Month 36||179
2921427|NCT00541970|3631998|FG001|COMPLETED|Month 36||175
2921428|NCT00541970|3631999|FG002|COMPLETED|Month 36||174
2921429|NCT00541970|3632000|FG003|COMPLETED|Month 36||179
2921430|NCT00541970|3631997|FG000|NOT COMPLETED|Month 36||61
2921431|NCT00541970|3631998|FG001|NOT COMPLETED|Month 36||66
2921432|NCT00541970|3631999|FG002|NOT COMPLETED|Month 36||66
2921433|NCT00541970|3632000|FG003|NOT COMPLETED|Month 36||60
2921434|NCT00541970|3631997|FG000|STARTED|Month 48||240
2921435|NCT00541970|3631998|FG001|STARTED|Month 48||241
2921436|NCT00541970|3631999|FG002|STARTED|Month 48||240
2921437|NCT00541970|3632000|FG003|STARTED|Month 48||239
2921438|NCT00541970|3631997|FG000|COMPLETED|Month 48||169
2921439|NCT00541970|3631998|FG001|COMPLETED|Month 48||168
2921440|NCT00541970|3631999|FG002|COMPLETED|Month 48||167
2921441|NCT00541970|3632000|FG003|COMPLETED|Month 48||164
2921442|NCT00541970|3631997|FG000|NOT COMPLETED|Month 48||71
3172169|NCT01939899|3899567|FG000|STARTED|Lead-in Dose Finding Phase||3
3172170|NCT01939899|3899568|FG001|STARTED|Lead-in Dose Finding Phase||7
3172171|NCT01939899|3899569|FG002|STARTED|Lead-in Dose Finding Phase||6
2921443|NCT00541970|3631998|FG001|NOT COMPLETED|Month 48||73
2921444|NCT00541970|3631999|FG002|NOT COMPLETED|Month 48||73
2921445|NCT00541970|3632000|FG003|NOT COMPLETED|Month 48||75
2921446|NCT00541970|3631997|FG000|STARTED|Month 60||240
3172172|NCT01939899|3899570|FG003|STARTED|Lead-in Dose Finding Phase||0
2921447|NCT00541970|3631998|FG001|STARTED|Month 60||241
2921448|NCT00541970|3631999|FG002|STARTED|Month 60||240
3172173|NCT01939899|3899571|FG004|STARTED|Lead-in Dose Finding Phase||0
3172174|NCT01939899|3899567|FG000|COMPLETED|Lead-in Dose Finding Phase||1
3172175|NCT01939899|3899568|FG001|COMPLETED|Lead-in Dose Finding Phase||0
3172176|NCT01939899|3899569|FG002|COMPLETED|Lead-in Dose Finding Phase||1
3172177|NCT01939899|3899570|FG003|COMPLETED|Lead-in Dose Finding Phase||0
3172178|NCT01939899|3899571|FG004|COMPLETED|Lead-in Dose Finding Phase||0
3172179|NCT01939899|3899567|FG000|NOT COMPLETED|Lead-in Dose Finding Phase||2
3172180|NCT01939899|3899568|FG001|NOT COMPLETED|Lead-in Dose Finding Phase||7
3172181|NCT01939899|3899569|FG002|NOT COMPLETED|Lead-in Dose Finding Phase||5
3172182|NCT01939899|3899570|FG003|NOT COMPLETED|Lead-in Dose Finding Phase||0
3172183|NCT01939899|3899571|FG004|NOT COMPLETED|Lead-in Dose Finding Phase||0
3172184|NCT01939899|3899567|FG000|STARTED|Phase 2||0
3172185|NCT01939899|3899568|FG001|STARTED|Phase 2||0
2921449|NCT00541970|3632000|FG003|STARTED|Month 60||239
2921450|NCT00541970|3631997|FG000|COMPLETED|Month 60||162
3172186|NCT01939899|3899569|FG002|STARTED|Phase 2||0
3172187|NCT01939899|3899570|FG003|STARTED|Phase 2||12
3172188|NCT01939899|3899571|FG004|STARTED|Phase 2||1
3172189|NCT01939899|3899567|FG000|COMPLETED|Phase 2||0
3172190|NCT01939899|3899568|FG001|COMPLETED|Phase 2||0
3172191|NCT01939899|3899569|FG002|COMPLETED|Phase 2||0
3172192|NCT01939899|3899570|FG003|COMPLETED|Phase 2||1
3172193|NCT01939899|3899571|FG004|COMPLETED|Phase 2||0
3172194|NCT01939899|3899567|FG000|NOT COMPLETED|Phase 2||0
3172195|NCT01939899|3899568|FG001|NOT COMPLETED|Phase 2||0
2921451|NCT00541970|3631998|FG001|COMPLETED|Month 60||164
2921452|NCT00541970|3631999|FG002|COMPLETED|Month 60||158
2921453|NCT00541970|3632000|FG003|COMPLETED|Month 60||167
2921454|NCT00541970|3631997|FG000|NOT COMPLETED|Month 60||78
2921455|NCT00541970|3631998|FG001|NOT COMPLETED|Month 60||77
2921456|NCT00541970|3631999|FG002|NOT COMPLETED|Month 60||82
2921457|NCT00541970|3632000|FG003|NOT COMPLETED|Month 60||72
2921458|NCT00542178|3632016|FG000|STARTED|Overall Study||390
2921459|NCT00542178|3632017|FG001|STARTED|Overall Study||412
2921460|NCT00542178|3632018|FG002|STARTED|Overall Study||382
2921461|NCT00542178|3632019|FG003|STARTED|Overall Study||370
2921462|NCT00542178|3632020|FG004|STARTED|Overall Study||464
2921463|NCT00542178|3632021|FG005|STARTED|Overall Study||495
2921464|NCT00542178|3632022|FG006|STARTED|Overall Study||493
2921465|NCT00542178|3632023|FG007|STARTED|Overall Study||466
2921466|NCT00542178|3632016|FG000|COMPLETED|Overall Study||315
2921467|NCT00542178|3632017|FG001|COMPLETED|Overall Study||332
2921468|NCT00542178|3632018|FG002|COMPLETED|Overall Study||308
2921469|NCT00542178|3632019|FG003|COMPLETED|Overall Study||308
2921470|NCT00542178|3632020|FG004|COMPLETED|Overall Study||400
2921471|NCT00542178|3632021|FG005|COMPLETED|Overall Study||406
2921472|NCT00542178|3632022|FG006|COMPLETED|Overall Study||406
2921473|NCT00542178|3632023|FG007|COMPLETED|Overall Study||381
2921474|NCT00542178|3632016|FG000|NOT COMPLETED|Overall Study||75
2921475|NCT00542178|3632017|FG001|NOT COMPLETED|Overall Study||80
2921476|NCT00542178|3632018|FG002|NOT COMPLETED|Overall Study||74
2921477|NCT00542178|3632019|FG003|NOT COMPLETED|Overall Study||62
2921478|NCT00542178|3632020|FG004|NOT COMPLETED|Overall Study||64
2921479|NCT00542178|3632021|FG005|NOT COMPLETED|Overall Study||89
2921480|NCT00542178|3632022|FG006|NOT COMPLETED|Overall Study||87
2921481|NCT00542178|3632023|FG007|NOT COMPLETED|Overall Study||85
2921482|NCT00542191|3632037|FG000|STARTED|Overall Study||21
2921483|NCT00542191|3632037|FG000|COMPLETED|Overall Study||18
2921484|NCT00542191|3632037|FG000|NOT COMPLETED|Overall Study||3
2921485|NCT00542269|3632044|FG000|STARTED|Overall Study||61
2921486|NCT00542269|3632045|FG001|STARTED|Overall Study||60
2921487|NCT00542269|3632046|FG002|STARTED|Overall Study||57
2921488|NCT00542269|3632044|FG000|COMPLETED|Overall Study||48
2921489|NCT00542269|3632045|FG001|COMPLETED|Overall Study||54
2921490|NCT00542269|3632046|FG002|COMPLETED|Overall Study||51
2921491|NCT00542269|3632044|FG000|NOT COMPLETED|Overall Study||13
2921492|NCT00542269|3632045|FG001|NOT COMPLETED|Overall Study||6
2921493|NCT00542269|3632046|FG002|NOT COMPLETED|Overall Study||6
2921494|NCT00542308|3632056|FG000|STARTED|Overall Study||90
2921495|NCT00542308|3632056|FG000|COMPLETED|Overall Study||90
2921496|NCT00542308|3632056|FG000|NOT COMPLETED|Overall Study||0
3172196|NCT01939899|3899569|FG002|NOT COMPLETED|Phase 2||0
3172197|NCT01939899|3899570|FG003|NOT COMPLETED|Phase 2||11
3172198|NCT01939899|3899571|FG004|NOT COMPLETED|Phase 2||1
3172199|NCT01939938|3899589|FG000|STARTED|Overall Study||10
3317569|NCT03129100|4051129|FG007|COMPLETED|Lead-In Period (Period 1)||0
2921497|NCT00542321|3632062|FG000|STARTED|Overall Study||8
2921498|NCT00542321|3632063|FG001|STARTED|Overall Study||8
2921499|NCT00542321|3632062|FG000|COMPLETED|Overall Study||8
2921500|NCT00542321|3632063|FG001|COMPLETED|Overall Study||7
2921501|NCT00542321|3632062|FG000|NOT COMPLETED|Overall Study||0
2921502|NCT00542321|3632063|FG001|NOT COMPLETED|Overall Study||1
2921503|NCT00542386|3632075|FG000|STARTED|Overall Study||104
2921504|NCT00542386|3632076|FG001|STARTED|Overall Study||102
2921505|NCT00542386|3632077|FG002|STARTED|Overall Study||99
2921506|NCT00542386|3632078|FG003|STARTED|Overall Study||103
2921507|NCT00542386|3632079|FG004|STARTED|Overall Study||102
2921508|NCT00542386|3632080|FG005|STARTED|Overall Study||132
2921509|NCT00542386|3632075|FG000|COMPLETED|Overall Study||61
3172200|NCT01939938|3899589|FG000|COMPLETED|Overall Study||10
3172201|NCT01939938|3899589|FG000|NOT COMPLETED|Overall Study||0
3317570|NCT03129100|4051130|FG008|COMPLETED|Lead-In Period (Period 1)||0
3317571|NCT03129100|4051131|FG009|COMPLETED|Lead-In Period (Period 1)||0
3317572|NCT03129100|4051132|FG010|COMPLETED|Lead-In Period (Period 1)||0
3317573|NCT03129100|4051122|FG000|NOT COMPLETED|Lead-In Period (Period 1)||15
3317574|NCT03129100|4051123|FG001|NOT COMPLETED|Lead-In Period (Period 1)||17
3317575|NCT03129100|4051124|FG002|NOT COMPLETED|Lead-In Period (Period 1)||0
3317576|NCT03129100|4051125|FG003|NOT COMPLETED|Lead-In Period (Period 1)||0
3317577|NCT03129100|4051126|FG004|NOT COMPLETED|Lead-In Period (Period 1)||0
3317578|NCT03129100|4051127|FG005|NOT COMPLETED|Lead-In Period (Period 1)||0
2921510|NCT00542386|3632076|FG001|COMPLETED|Overall Study||74
2921511|NCT00542386|3632077|FG002|COMPLETED|Overall Study||66
2921512|NCT00542386|3632078|FG003|COMPLETED|Overall Study||65
2921513|NCT00542386|3632079|FG004|COMPLETED|Overall Study||62
2921514|NCT00542386|3632080|FG005|COMPLETED|Overall Study||82
2921515|NCT00542386|3632075|FG000|NOT COMPLETED|Overall Study||43
2921516|NCT00542386|3632076|FG001|NOT COMPLETED|Overall Study||28
2921517|NCT00542386|3632077|FG002|NOT COMPLETED|Overall Study||33
2921518|NCT00542386|3632078|FG003|NOT COMPLETED|Overall Study||38
3172202|NCT01939977|3899597|FG000|STARTED|Overall Study||46
3172203|NCT01939977|3899598|FG001|STARTED|Overall Study|48 patients randomized but 1 did not meet inclusion criteria. 47 patients analyzed.|48
3317579|NCT03129100|4051128|FG006|NOT COMPLETED|Lead-In Period (Period 1)||0
3317580|NCT03129100|4051129|FG007|NOT COMPLETED|Lead-In Period (Period 1)||0
3317581|NCT03129100|4051130|FG008|NOT COMPLETED|Lead-In Period (Period 1)||0
3317582|NCT03129100|4051131|FG009|NOT COMPLETED|Lead-In Period (Period 1)||0
3317583|NCT03129100|4051132|FG010|NOT COMPLETED|Lead-In Period (Period 1)||0
3317584|NCT03129100|4051122|FG000|STARTED|Period2 Extension Period (Group A and B)|Only Extension Period participants were included.|0
3317585|NCT03129100|4051123|FG001|STARTED|Period2 Extension Period (Group A and B)|Only Extension Period participants were included.|0
3317586|NCT03129100|4051124|FG002|STARTED|Period2 Extension Period (Group A and B)|Participants who entered extension period (Group A).|255
3317587|NCT03129100|4051125|FG003|STARTED|Period2 Extension Period (Group A and B)|Participants who entered extension period (Group A).|318
3317588|NCT03129100|4051126|FG004|STARTED|Period2 Extension Period (Group A and B)|Participants who entered extension period (Group B).|48
3317589|NCT03129100|4051127|FG005|STARTED|Period2 Extension Period (Group A and B)|Participants who entered extension period (Group B).|54
3317590|NCT03129100|4051128|FG006|STARTED|Period2 Extension Period (Group A and B)|Participants who entered extension period (Group B).|53
3317591|NCT03129100|4051129|FG007|STARTED|Period2 Extension Period (Group A and B)||0
3317592|NCT03129100|4051130|FG008|STARTED|Period2 Extension Period (Group A and B)||0
3317593|NCT03129100|4051131|FG009|STARTED|Period2 Extension Period (Group A and B)||0
3317594|NCT03129100|4051132|FG010|STARTED|Period2 Extension Period (Group A and B)||0
3317595|NCT03129100|4051122|FG000|COMPLETED|Period2 Extension Period (Group A and B)||0
3317596|NCT03129100|4051123|FG001|COMPLETED|Period2 Extension Period (Group A and B)||0
3317597|NCT03129100|4051124|FG002|COMPLETED|Period2 Extension Period (Group A and B)||234
3317598|NCT03129100|4051125|FG003|COMPLETED|Period2 Extension Period (Group A and B)||312
3317599|NCT03129100|4051126|FG004|COMPLETED|Period2 Extension Period (Group A and B)||42
3317600|NCT03129100|4051127|FG005|COMPLETED|Period2 Extension Period (Group A and B)||45
3317601|NCT03129100|4051128|FG006|COMPLETED|Period2 Extension Period (Group A and B)||32
3317602|NCT03129100|4051129|FG007|COMPLETED|Period2 Extension Period (Group A and B)||0
3317603|NCT03129100|4051130|FG008|COMPLETED|Period2 Extension Period (Group A and B)||0
3317604|NCT03129100|4051131|FG009|COMPLETED|Period2 Extension Period (Group A and B)||0
3172204|NCT01939977|3899597|FG000|COMPLETED|Overall Study||37
3172205|NCT01939977|3899598|FG001|COMPLETED|Overall Study||41
3172206|NCT01939977|3899597|FG000|NOT COMPLETED|Overall Study||9
3172207|NCT01939977|3899598|FG001|NOT COMPLETED|Overall Study||7
3172208|NCT01940120|3899604|FG000|STARTED|Overall Study||78
3172209|NCT01940120|3899604|FG000|COMPLETED|Overall Study||30
3172210|NCT01940120|3899604|FG000|NOT COMPLETED|Overall Study||48
3172211|NCT01940146|3899613|FG000|STARTED|Overall Study||56
2921519|NCT00542386|3632079|FG004|NOT COMPLETED|Overall Study||40
2921520|NCT00542386|3632080|FG005|NOT COMPLETED|Overall Study||50
2921521|NCT00542425|3632099|FG000|STARTED|Initial 24 Weeks||46
2921522|NCT00542425|3632100|FG001|STARTED|Initial 24 Weeks||43
2921523|NCT00542425|3632101|FG002|STARTED|Initial 24 Weeks||43
2921524|NCT00542425|3632102|FG003|STARTED|Initial 24 Weeks||45
2921525|NCT00542425|3632103|FG004|STARTED|Initial 24 Weeks||45
2921526|NCT00542425|3632099|FG000|COMPLETED|Initial 24 Weeks||42
2921527|NCT00542425|3632100|FG001|COMPLETED|Initial 24 Weeks||33
2921528|NCT00542425|3632101|FG002|COMPLETED|Initial 24 Weeks||36
2921529|NCT00542425|3632102|FG003|COMPLETED|Initial 24 Weeks||34
2921530|NCT00542425|3632103|FG004|COMPLETED|Initial 24 Weeks||39
2921531|NCT00542425|3632099|FG000|NOT COMPLETED|Initial 24 Weeks||4
2921532|NCT00542425|3632100|FG001|NOT COMPLETED|Initial 24 Weeks||10
2921533|NCT00542425|3632101|FG002|NOT COMPLETED|Initial 24 Weeks||7
2921534|NCT00542425|3632102|FG003|NOT COMPLETED|Initial 24 Weeks||11
2921535|NCT00542425|3632103|FG004|NOT COMPLETED|Initial 24 Weeks||6
2921536|NCT00542425|3632099|FG000|STARTED|Extended 24 Weeks of Treatment|Not all patients were eligible for extension study, often due to the regulatory approval timeline.|11
2921537|NCT00542425|3632100|FG001|STARTED|Extended 24 Weeks of Treatment|Not all patients were eligible for extension study, often due to the regulatory approval timeline.|13
2921538|NCT00542425|3632101|FG002|STARTED|Extended 24 Weeks of Treatment|Not all patients were eligible for extension study, often due to the regulatory approval timeline.|10
2921539|NCT00542425|3632102|FG003|STARTED|Extended 24 Weeks of Treatment|Not all patients were eligible for extension study, often due to the regulatory approval timeline.|7
2921540|NCT00542425|3632103|FG004|STARTED|Extended 24 Weeks of Treatment|Not all patients were eligible for extension study, often due to the regulatory approval timeline.|14
2921541|NCT00542425|3632099|FG000|COMPLETED|Extended 24 Weeks of Treatment||10
2921542|NCT00542425|3632100|FG001|COMPLETED|Extended 24 Weeks of Treatment||11
2921543|NCT00542425|3632101|FG002|COMPLETED|Extended 24 Weeks of Treatment||8
2921544|NCT00542425|3632102|FG003|COMPLETED|Extended 24 Weeks of Treatment||6
2921545|NCT00542425|3632103|FG004|COMPLETED|Extended 24 Weeks of Treatment||13
2921546|NCT00542425|3632099|FG000|NOT COMPLETED|Extended 24 Weeks of Treatment||1
3038537|NCT01154218|3757912|FG000|NOT COMPLETED|Fourth Intervention Period||1
3038538|NCT01154218|3757913|FG001|NOT COMPLETED|Fourth Intervention Period||0
3038539|NCT01154218|3757914|FG002|NOT COMPLETED|Fourth Intervention Period||0
3038540|NCT01154218|3757915|FG003|NOT COMPLETED|Fourth Intervention Period||0
3038541|NCT01154231|3757925|FG000|STARTED|Overall Study||314
3038542|NCT01154231|3757925|FG000|COMPLETED|Overall Study||312
3317605|NCT03129100|4051132|FG010|COMPLETED|Period2 Extension Period (Group A and B)||0
3317606|NCT03129100|4051122|FG000|NOT COMPLETED|Period2 Extension Period (Group A and B)||0
3317607|NCT03129100|4051123|FG001|NOT COMPLETED|Period2 Extension Period (Group A and B)||0
3317608|NCT03129100|4051124|FG002|NOT COMPLETED|Period2 Extension Period (Group A and B)||21
3317609|NCT03129100|4051125|FG003|NOT COMPLETED|Period2 Extension Period (Group A and B)||6
3317610|NCT03129100|4051126|FG004|NOT COMPLETED|Period2 Extension Period (Group A and B)||6
3317611|NCT03129100|4051127|FG005|NOT COMPLETED|Period2 Extension Period (Group A and B)||9
3317612|NCT03129100|4051128|FG006|NOT COMPLETED|Period2 Extension Period (Group A and B)||21
3317613|NCT03129100|4051129|FG007|NOT COMPLETED|Period2 Extension Period (Group A and B)||0
3317614|NCT03129100|4051130|FG008|NOT COMPLETED|Period2 Extension Period (Group A and B)||0
3317615|NCT03129100|4051131|FG009|NOT COMPLETED|Period2 Extension Period (Group A and B)||0
3317616|NCT03129100|4051132|FG010|NOT COMPLETED|Period2 Extension Period (Group A and B)||0
3317617|NCT03129100|4051122|FG000|STARTED|Period 2 (Retreatment Extension Period)||0
3317618|NCT03129100|4051123|FG001|STARTED|Period 2 (Retreatment Extension Period)||0
3317619|NCT03129100|4051124|FG002|STARTED|Period 2 (Retreatment Extension Period)||0
3317620|NCT03129100|4051125|FG003|STARTED|Period 2 (Retreatment Extension Period)||0
3317621|NCT03129100|4051126|FG004|STARTED|Period 2 (Retreatment Extension Period)||0
3317622|NCT03129100|4051127|FG005|STARTED|Period 2 (Retreatment Extension Period)||0
3317623|NCT03129100|4051128|FG006|STARTED|Period 2 (Retreatment Extension Period)||0
3317624|NCT03129100|4051129|FG007|STARTED|Period 2 (Retreatment Extension Period)|Participants who experienced flare in Group B Extension period.|6
3317625|NCT03129100|4051130|FG008|STARTED|Period 2 (Retreatment Extension Period)|Participants who experienced flare in Group B Extension period.|5
3317626|NCT03129100|4051131|FG009|STARTED|Period 2 (Retreatment Extension Period)|Participants who experienced flare in Group B Extension period.|9
3317627|NCT03129100|4051132|FG010|STARTED|Period 2 (Retreatment Extension Period)|Participants who experienced flare in Group B Extension period.|10
3317628|NCT03129100|4051122|FG000|COMPLETED|Period 2 (Retreatment Extension Period)||0
3317629|NCT03129100|4051123|FG001|COMPLETED|Period 2 (Retreatment Extension Period)||0
3317630|NCT03129100|4051124|FG002|COMPLETED|Period 2 (Retreatment Extension Period)||0
3317631|NCT03129100|4051125|FG003|COMPLETED|Period 2 (Retreatment Extension Period)||0
3317632|NCT03129100|4051126|FG004|COMPLETED|Period 2 (Retreatment Extension Period)||0
3317633|NCT03129100|4051127|FG005|COMPLETED|Period 2 (Retreatment Extension Period)||0
3317634|NCT03129100|4051128|FG006|COMPLETED|Period 2 (Retreatment Extension Period)||0
3317635|NCT03129100|4051129|FG007|COMPLETED|Period 2 (Retreatment Extension Period)||6
3317636|NCT03129100|4051130|FG008|COMPLETED|Period 2 (Retreatment Extension Period)||5
3317637|NCT03129100|4051131|FG009|COMPLETED|Period 2 (Retreatment Extension Period)||8
3317638|NCT03129100|4051132|FG010|COMPLETED|Period 2 (Retreatment Extension Period)||10
3317639|NCT03129100|4051122|FG000|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
3317640|NCT03129100|4051123|FG001|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
3317641|NCT03129100|4051124|FG002|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
3317642|NCT03129100|4051125|FG003|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
3317643|NCT03129100|4051126|FG004|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
3317644|NCT03129100|4051127|FG005|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
3317645|NCT03129100|4051128|FG006|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
3317646|NCT03129100|4051129|FG007|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
3317647|NCT03129100|4051130|FG008|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
3317648|NCT03129100|4051131|FG009|NOT COMPLETED|Period 2 (Retreatment Extension Period)||1
3317649|NCT03129100|4051132|FG010|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
3317650|NCT03129178|4051156|FG000|STARTED|Overall Study||13
3172212|NCT01940146|3899614|FG001|STARTED|Overall Study||55
3172213|NCT01940146|3899615|FG002|STARTED|Overall Study||56
3172214|NCT01940146|3899616|FG003|STARTED|Overall Study||55
3172215|NCT01940146|3899613|FG000|COMPLETED|Overall Study||55
3172216|NCT01940146|3899614|FG001|COMPLETED|Overall Study||55
3172217|NCT01940146|3899615|FG002|COMPLETED|Overall Study||55
3172218|NCT01940146|3899616|FG003|COMPLETED|Overall Study||53
3172219|NCT01940146|3899613|FG000|NOT COMPLETED|Overall Study||1
3172220|NCT01940146|3899614|FG001|NOT COMPLETED|Overall Study||0
3172221|NCT01940146|3899615|FG002|NOT COMPLETED|Overall Study||1
3172222|NCT01940146|3899616|FG003|NOT COMPLETED|Overall Study||2
3172223|NCT01940276|3899628|FG000|STARTED|Overall Study||50
3172224|NCT01940276|3899629|FG001|STARTED|Overall Study||50
3172225|NCT01940276|3899628|FG000|COMPLETED|Overall Study||50
3172226|NCT01940276|3899629|FG001|COMPLETED|Overall Study||50
3172227|NCT01940276|3899628|FG000|NOT COMPLETED|Overall Study||0
2921547|NCT00542425|3632100|FG001|NOT COMPLETED|Extended 24 Weeks of Treatment||2
2921548|NCT00542425|3632101|FG002|NOT COMPLETED|Extended 24 Weeks of Treatment||2
2921549|NCT00542425|3632102|FG003|NOT COMPLETED|Extended 24 Weeks of Treatment||1
2921550|NCT00542425|3632103|FG004|NOT COMPLETED|Extended 24 Weeks of Treatment||1
2921551|NCT00542490|3632115|FG000|STARTED|Overall Study||23
2921552|NCT00542490|3632115|FG000|COMPLETED|Overall Study||21
2921553|NCT00542490|3632115|FG000|NOT COMPLETED|Overall Study||2
2921554|NCT00542620|3632121|FG000|STARTED|Overall Study||13
2921555|NCT00542620|3632122|FG001|STARTED|Overall Study||12
2921556|NCT00542620|3632121|FG000|Exposed to Drug|Overall Study|One subject randomly assigned to receive mixed injections, but received a separate injection mode|12
2921557|NCT00542620|3632122|FG001|Exposed to Drug|Overall Study|One subject randomly assigned to receive mixed injections, but received a separate injection mode|13
2921558|NCT00542620|3632121|FG000|COMPLETED|Overall Study||13
2921559|NCT00542620|3632122|FG001|COMPLETED|Overall Study||12
2921560|NCT00542620|3632121|FG000|NOT COMPLETED|Overall Study||0
2921561|NCT00542620|3632122|FG001|NOT COMPLETED|Overall Study||0
2921562|NCT00542750|3632128|FG000|STARTED|Overall Study||24
2921563|NCT00542750|3632128|FG000|COMPLETED|Overall Study||24
2921564|NCT00542750|3632128|FG000|NOT COMPLETED|Overall Study||0
2921565|NCT00542789|3632134|FG000|STARTED|Overall Study|Randomised|175
2921566|NCT00542789|3632135|FG001|STARTED|Overall Study|Randomised|168
2921567|NCT00542789|3632134|FG000|COMPLETED|Overall Study||134
2921568|NCT00542789|3632135|FG001|COMPLETED|Overall Study||90
2921569|NCT00542789|3632134|FG000|NOT COMPLETED|Overall Study||41
2921570|NCT00542789|3632135|FG001|NOT COMPLETED|Overall Study||78
2921571|NCT00542815|3632144|FG000|STARTED|Overall Study||432
2921572|NCT00542815|3632145|FG001|STARTED|Overall Study||76
2921573|NCT00542815|3632146|FG002|STARTED|Overall Study||124
2921574|NCT00542815|3632144|FG000|COMPLETED|Overall Study||326
2921575|NCT00542815|3632145|FG001|COMPLETED|Overall Study||44
2921576|NCT00542815|3632146|FG002|COMPLETED|Overall Study||92
2921577|NCT00542815|3632144|FG000|NOT COMPLETED|Overall Study||106
2921578|NCT00542815|3632145|FG001|NOT COMPLETED|Overall Study||32
2921579|NCT00542815|3632146|FG002|NOT COMPLETED|Overall Study||32
2921580|NCT00542828|3632154|FG000|STARTED|Overall Study|Number of participants enrolled in the study; of the 16 enrolled, 14 received study treatment.|16
2921581|NCT00542828|3632154|FG000|COMPLETED|Overall Study|Number of participants who completed the 12-month study period.|3
2921582|NCT00542828|3632154|FG000|NOT COMPLETED|Overall Study||13
2921583|NCT00542880|3632160|FG000|STARTED|Period 1|This was a cross-over study|217
2921584|NCT00542880|3632161|FG001|STARTED|Period 1||225
2921585|NCT00542880|3632160|FG000|COMPLETED|Period 1||211
2921586|NCT00542880|3632161|FG001|COMPLETED|Period 1||213
2921587|NCT00542880|3632160|FG000|NOT COMPLETED|Period 1||6
2921588|NCT00542880|3632161|FG001|NOT COMPLETED|Period 1||12
2921589|NCT00542880|3632160|FG000|STARTED|Period 2||211
2921590|NCT00542880|3632161|FG001|STARTED|Period 2||213
2921591|NCT00542880|3632160|FG000|COMPLETED|Period 2||204
2921592|NCT00542880|3632161|FG001|COMPLETED|Period 2||203
2921593|NCT00542880|3632160|FG000|NOT COMPLETED|Period 2||7
2921594|NCT00542880|3632161|FG001|NOT COMPLETED|Period 2||10
2921595|NCT00542880|3632160|FG000|STARTED|Period 3||204
2921596|NCT00542880|3632161|FG001|STARTED|Period 3||203
2921597|NCT00542880|3632160|FG000|COMPLETED|Period 3||204
2921598|NCT00542880|3632161|FG001|COMPLETED|Period 3||201
2921599|NCT00542880|3632160|FG000|NOT COMPLETED|Period 3||0
2921600|NCT00542880|3632161|FG001|NOT COMPLETED|Period 3||2
2921601|NCT00542919|3632171|FG000|STARTED|Overall Study||23
2921602|NCT00542919|3632172|FG001|STARTED|Overall Study||19
2921603|NCT00542919|3632173|FG002|STARTED|Overall Study||15
2921604|NCT00542919|3632171|FG000|Received At Least One Dose of Study Drug|Overall Study||23
2921605|NCT00542919|3632172|FG001|Received At Least One Dose of Study Drug|Overall Study||19
2921606|NCT00542919|3632173|FG002|Received At Least One Dose of Study Drug|Overall Study||15
2921607|NCT00542919|3632171|FG000|Progressive Disease|Overall Study||15
2921608|NCT00542919|3632172|FG001|Progressive Disease|Overall Study||11
2921609|NCT00542919|3632173|FG002|Progressive Disease|Overall Study||7
3172228|NCT01940276|3899629|FG001|NOT COMPLETED|Overall Study||0
3172229|NCT01940354|3899637|FG000|STARTED|Overall Study||110
3172230|NCT01940354|3899638|FG001|STARTED|Overall Study||110
3172231|NCT01940354|3899637|FG000|COMPLETED|Overall Study||106
3172232|NCT01940354|3899638|FG001|COMPLETED|Overall Study||108
3172233|NCT01940354|3899637|FG000|NOT COMPLETED|Overall Study||4
3172234|NCT01940354|3899638|FG001|NOT COMPLETED|Overall Study||2
3172235|NCT01940471|3899646|FG000|STARTED|Double-Blind Phase||582
3172236|NCT01940471|3899647|FG001|STARTED|Double-Blind Phase||293
3172237|NCT01940471|3899646|FG000|COMPLETED|Double-Blind Phase||14
3172238|NCT01940471|3899647|FG001|COMPLETED|Double-Blind Phase||8
3172239|NCT01940471|3899646|FG000|NOT COMPLETED|Double-Blind Phase||568
3172240|NCT01940471|3899647|FG001|NOT COMPLETED|Double-Blind Phase||285
3172241|NCT01940471|3899646|FG000|STARTED|Open-Label Extension||14
3172242|NCT01940471|3899647|FG001|STARTED|Open-Label Extension||8
3172243|NCT01940471|3899646|FG000|COMPLETED|Open-Label Extension||0
3172244|NCT01940471|3899647|FG001|COMPLETED|Open-Label Extension||0
3172245|NCT01940471|3899646|FG000|NOT COMPLETED|Open-Label Extension||14
3172246|NCT01940471|3899647|FG001|NOT COMPLETED|Open-Label Extension||8
3172247|NCT01940484|3899654|FG000|STARTED|Overall Study||98
3172248|NCT01940484|3899654|FG000|COMPLETED|Overall Study||88
3172249|NCT01940484|3899654|FG000|NOT COMPLETED|Overall Study||10
3172250|NCT01940497|3899660|FG000|STARTED|Overall Study||121
3317651|NCT03129178|4051157|FG001|STARTED|Overall Study||13
3317652|NCT03129178|4051156|FG000|COMPLETED|Overall Study||12
3317653|NCT03129178|4051157|FG001|COMPLETED|Overall Study||11
3317654|NCT03129178|4051156|FG000|NOT COMPLETED|Overall Study||1
3317655|NCT03129178|4051157|FG001|NOT COMPLETED|Overall Study||2
3172251|NCT01940497|3899661|FG001|STARTED|Overall Study||119
3317656|NCT03129321|4051167|FG000|STARTED|Overall Study||351
3317657|NCT03129321|4051168|FG001|STARTED|Overall Study||350
3317658|NCT03129321|4051169|FG002|STARTED|Overall Study||175
3317659|NCT03129321|4051167|FG000|COMPLETED|Overall Study||253
3317660|NCT03129321|4051168|FG001|COMPLETED|Overall Study||241
3317661|NCT03129321|4051169|FG002|COMPLETED|Overall Study||120
3317662|NCT03129321|4051167|FG000|NOT COMPLETED|Overall Study||98
3317663|NCT03129321|4051168|FG001|NOT COMPLETED|Overall Study||109
3317664|NCT03129321|4051169|FG002|NOT COMPLETED|Overall Study||55
3317665|NCT03129568|4051179|FG000|STARTED|Overall Study||5
3317666|NCT03129568|4051179|FG000|COMPLETED|Overall Study||5
3317667|NCT03129568|4051179|FG000|NOT COMPLETED|Overall Study||0
3317668|NCT03129945|4051185|FG000|STARTED|Overall Study||15
3172252|NCT01940497|3899660|FG000|Treated|Overall Study||115
3172253|NCT01940497|3899661|FG001|Treated|Overall Study||113
3172254|NCT01940497|3899660|FG000|Treated: Adjuvant|Overall Study||95
3172255|NCT01940497|3899661|FG001|Treated: Adjuvant|Overall Study||92
3172256|NCT01940497|3899660|FG000|Treated: Neoadjuvant|Overall Study||20
3172257|NCT01940497|3899661|FG001|Treated: Neoadjuvant|Overall Study||21
3172258|NCT01940497|3899660|FG000|COMPLETED|Overall Study||100
3172259|NCT01940497|3899661|FG001|COMPLETED|Overall Study||101
3172260|NCT01940497|3899660|FG000|NOT COMPLETED|Overall Study||21
3172261|NCT01940497|3899661|FG001|NOT COMPLETED|Overall Study||18
3172262|NCT01940510|3899678|FG000|STARTED|Overall Study||24
3172263|NCT01940510|3899678|FG000|COMPLETED|Overall Study||24
3172264|NCT01940510|3899678|FG000|NOT COMPLETED|Overall Study||0
3172265|NCT01940523|3899687|FG000|STARTED|Overall Study||320
3172266|NCT01940523|3899688|FG001|STARTED|Overall Study||320
3172267|NCT01940523|3899687|FG000|COMPLETED|Overall Study||320
3172268|NCT01940523|3899688|FG001|COMPLETED|Overall Study||320
3172269|NCT01940523|3899687|FG000|NOT COMPLETED|Overall Study||0
3172270|NCT01940523|3899688|FG001|NOT COMPLETED|Overall Study||0
3172271|NCT01940705|3899700|FG000|STARTED|Overall Study||66
3172272|NCT01940705|3899701|FG001|STARTED|Overall Study||67
3172273|NCT01940705|3899702|FG002|STARTED|Overall Study||69
3172274|NCT01940705|3899703|FG003|STARTED|Overall Study||67
3172275|NCT01940705|3899700|FG000|COMPLETED|Overall Study||62
3172276|NCT01940705|3899701|FG001|COMPLETED|Overall Study||59
3172277|NCT01940705|3899702|FG002|COMPLETED|Overall Study||61
3172278|NCT01940705|3899703|FG003|COMPLETED|Overall Study||63
3172279|NCT01940705|3899700|FG000|NOT COMPLETED|Overall Study||4
3172280|NCT01940705|3899701|FG001|NOT COMPLETED|Overall Study||8
3172281|NCT01940705|3899702|FG002|NOT COMPLETED|Overall Study||8
3172282|NCT01940705|3899703|FG003|NOT COMPLETED|Overall Study||4
3172283|NCT01940887|3899718|FG000|STARTED|Year 1||322
3172284|NCT01940887|3899719|FG001|STARTED|Year 1||320
3172285|NCT01940887|3899718|FG000|COMPLETED|Year 1||283
3172286|NCT01940887|3899719|FG001|COMPLETED|Year 1||297
3317669|NCT03129945|4051186|FG001|STARTED|Overall Study||21
3317670|NCT03129945|4051185|FG000|COMPLETED|Overall Study||15
3317671|NCT03129945|4051186|FG001|COMPLETED|Overall Study||21
3317672|NCT03129945|4051185|FG000|NOT COMPLETED|Overall Study||0
3317673|NCT03129945|4051186|FG001|NOT COMPLETED|Overall Study||0
3317674|NCT03130257|4051195|FG000|STARTED|Overall Study||172
3317675|NCT03130257|4051196|FG001|STARTED|Overall Study||170
3172287|NCT01940887|3899718|FG000|NOT COMPLETED|Year 1||39
3317676|NCT03130257|4051197|FG002|STARTED|Overall Study||168
3317677|NCT03130257|4051195|FG000|COMPLETED|Overall Study||171
3317678|NCT03130257|4051196|FG001|COMPLETED|Overall Study||170
3172288|NCT01940887|3899719|FG001|NOT COMPLETED|Year 1||23
3172289|NCT01940887|3899718|FG000|STARTED|Year 2||283
3172290|NCT01940887|3899719|FG001|STARTED|Year 2||297
3172291|NCT01940887|3899718|FG000|COMPLETED|Year 2||66
3172292|NCT01940887|3899719|FG001|COMPLETED|Year 2||75
3317679|NCT03130257|4051197|FG002|COMPLETED|Overall Study||166
3317680|NCT03130257|4051195|FG000|NOT COMPLETED|Overall Study||1
3317681|NCT03130257|4051196|FG001|NOT COMPLETED|Overall Study||0
3317682|NCT03130257|4051197|FG002|NOT COMPLETED|Overall Study||2
3317683|NCT03130738|4051208|FG000|STARTED|Overall Study||23
3317684|NCT03130738|4051209|FG001|STARTED|Overall Study||22
3317685|NCT03130738|4051210|FG002|STARTED|Overall Study||20
3317686|NCT03130738|4051208|FG000|COMPLETED|Overall Study||20
3317687|NCT03130738|4051209|FG001|COMPLETED|Overall Study||20
3317688|NCT03130738|4051210|FG002|COMPLETED|Overall Study||14
3317689|NCT03130738|4051208|FG000|NOT COMPLETED|Overall Study||3
3172293|NCT01940887|3899718|FG000|NOT COMPLETED|Year 2||217
3172294|NCT01940887|3899719|FG001|NOT COMPLETED|Year 2||222
3172295|NCT01940900|3899727|FG000|STARTED|Overall Study||311
3172296|NCT01940900|3899728|FG001|STARTED|Overall Study||315
3172297|NCT01940900|3899727|FG000|COMPLETED|Overall Study||282
3172298|NCT01940900|3899728|FG001|COMPLETED|Overall Study||284
3172299|NCT01940900|3899727|FG000|NOT COMPLETED|Overall Study||29
3172300|NCT01940900|3899728|FG001|NOT COMPLETED|Overall Study||31
3172301|NCT01940939|3899736|FG000|STARTED|Overall Study||35
3317690|NCT03130738|4051209|FG001|NOT COMPLETED|Overall Study||2
3317691|NCT03130738|4051210|FG002|NOT COMPLETED|Overall Study||6
3317692|NCT03130959|4051228|FG000|STARTED|Treatment Period||23
3317693|NCT03130959|4051229|FG001|STARTED|Treatment Period||22
3317694|NCT03130959|4051230|FG002|STARTED|Treatment Period||16
3317695|NCT03130959|4051231|FG003|STARTED|Treatment Period||15
3172302|NCT01940939|3899737|FG001|STARTED|Overall Study||35
3172303|NCT01940939|3899736|FG000|COMPLETED|Overall Study||33
3172304|NCT01940939|3899737|FG001|COMPLETED|Overall Study||27
3172305|NCT01940939|3899736|FG000|NOT COMPLETED|Overall Study||2
3172306|NCT01940939|3899737|FG001|NOT COMPLETED|Overall Study||8
3172307|NCT01941030|3899745|FG000|STARTED|Overall Study||25
3172308|NCT01941030|3899746|FG001|STARTED|Overall Study||26
3172309|NCT01941030|3899745|FG000|COMPLETED|Overall Study||12
3172310|NCT01941030|3899746|FG001|COMPLETED|Overall Study||13
3172311|NCT01941030|3899745|FG000|NOT COMPLETED|Overall Study||13
3172312|NCT01941030|3899746|FG001|NOT COMPLETED|Overall Study||13
3172313|NCT01941095|3899752|FG000|STARTED|Overall Study||97
3317696|NCT03130959|4051232|FG004|STARTED|Treatment Period||15
3317697|NCT03130959|4051233|FG005|STARTED|Treatment Period||15
3317698|NCT03130959|4051234|FG006|STARTED|Treatment Period||12
3317699|NCT03130959|4051235|FG007|STARTED|Treatment Period||10
3317700|NCT03130959|4051236|FG008|STARTED|Treatment Period||19
3317701|NCT03130959|4051237|FG009|STARTED|Treatment Period||19
3317702|NCT03130959|4051228|FG000|COMPLETED|Treatment Period||2
3317703|NCT03130959|4051229|FG001|COMPLETED|Treatment Period||1
3317704|NCT03130959|4051230|FG002|COMPLETED|Treatment Period||1
3317705|NCT03130959|4051231|FG003|COMPLETED|Treatment Period||0
3317706|NCT03130959|4051232|FG004|COMPLETED|Treatment Period||0
3317707|NCT03130959|4051233|FG005|COMPLETED|Treatment Period||0
3317708|NCT03130959|4051234|FG006|COMPLETED|Treatment Period||0
3317709|NCT03130959|4051235|FG007|COMPLETED|Treatment Period||0
3317710|NCT03130959|4051236|FG008|COMPLETED|Treatment Period||0
3317711|NCT03130959|4051237|FG009|COMPLETED|Treatment Period||1
3317712|NCT03130959|4051228|FG000|NOT COMPLETED|Treatment Period||21
3317713|NCT03130959|4051229|FG001|NOT COMPLETED|Treatment Period||21
3317714|NCT03130959|4051230|FG002|NOT COMPLETED|Treatment Period||15
3317715|NCT03130959|4051231|FG003|NOT COMPLETED|Treatment Period||15
3317716|NCT03130959|4051232|FG004|NOT COMPLETED|Treatment Period||15
3317717|NCT03130959|4051233|FG005|NOT COMPLETED|Treatment Period||15
3317718|NCT03130959|4051234|FG006|NOT COMPLETED|Treatment Period||12
3317719|NCT03130959|4051235|FG007|NOT COMPLETED|Treatment Period||10
3317720|NCT03130959|4051236|FG008|NOT COMPLETED|Treatment Period||19
3317721|NCT03130959|4051237|FG009|NOT COMPLETED|Treatment Period||18
3317722|NCT03130959|4051228|FG000|STARTED|Follow-up Period||23
3317723|NCT03130959|4051229|FG001|STARTED|Follow-up Period||22
3317724|NCT03130959|4051230|FG002|STARTED|Follow-up Period||16
3317725|NCT03130959|4051231|FG003|STARTED|Follow-up Period||15
3317726|NCT03130959|4051232|FG004|STARTED|Follow-up Period||15
3317727|NCT03130959|4051233|FG005|STARTED|Follow-up Period||15
3317728|NCT03130959|4051234|FG006|STARTED|Follow-up Period||12
3317729|NCT03130959|4051235|FG007|STARTED|Follow-up Period||10
3317730|NCT03130959|4051236|FG008|STARTED|Follow-up Period||19
3317731|NCT03130959|4051237|FG009|STARTED|Follow-up Period||19
3317732|NCT03130959|4051228|FG000|COMPLETED|Follow-up Period||3
3317733|NCT03130959|4051229|FG001|COMPLETED|Follow-up Period||2
3317734|NCT03130959|4051230|FG002|COMPLETED|Follow-up Period||4
3317735|NCT03130959|4051231|FG003|COMPLETED|Follow-up Period||1
3317736|NCT03130959|4051232|FG004|COMPLETED|Follow-up Period||1
3317737|NCT03130959|4051233|FG005|COMPLETED|Follow-up Period||5
3317738|NCT03130959|4051234|FG006|COMPLETED|Follow-up Period||3
3317739|NCT03130959|4051235|FG007|COMPLETED|Follow-up Period||2
3317740|NCT03130959|4051236|FG008|COMPLETED|Follow-up Period||1
3317741|NCT03130959|4051237|FG009|COMPLETED|Follow-up Period||3
3317742|NCT03130959|4051228|FG000|NOT COMPLETED|Follow-up Period||20
3317743|NCT03130959|4051229|FG001|NOT COMPLETED|Follow-up Period||20
3317744|NCT03130959|4051230|FG002|NOT COMPLETED|Follow-up Period||12
3317745|NCT03130959|4051231|FG003|NOT COMPLETED|Follow-up Period||14
3317746|NCT03130959|4051232|FG004|NOT COMPLETED|Follow-up Period||14
3317747|NCT03130959|4051233|FG005|NOT COMPLETED|Follow-up Period||10
3317748|NCT03130959|4051234|FG006|NOT COMPLETED|Follow-up Period||9
3172314|NCT01941095|3899752|FG000|COMPLETED|Overall Study||41
3172315|NCT01941095|3899752|FG000|NOT COMPLETED|Overall Study||56
3172316|NCT01941186|3899759|FG000|STARTED|Randomization/Allocation to Study Group||31
3172317|NCT01941186|3899760|FG001|STARTED|Randomization/Allocation to Study Group||33
3172318|NCT01941186|3899759|FG000|COMPLETED|Randomization/Allocation to Study Group||31
3172319|NCT01941186|3899760|FG001|COMPLETED|Randomization/Allocation to Study Group||33
3172320|NCT01941186|3899759|FG000|NOT COMPLETED|Randomization/Allocation to Study Group||0
3172321|NCT01941186|3899760|FG001|NOT COMPLETED|Randomization/Allocation to Study Group||0
3172322|NCT01941186|3899759|FG000|STARTED|Follow-up||31
3172323|NCT01941186|3899760|FG001|STARTED|Follow-up||33
3172324|NCT01941186|3899759|FG000|COMPLETED|Follow-up||30
3172325|NCT01941186|3899760|FG001|COMPLETED|Follow-up||33
3172326|NCT01941186|3899759|FG000|NOT COMPLETED|Follow-up||1
3172327|NCT01941186|3899760|FG001|NOT COMPLETED|Follow-up||0
3172328|NCT01941472|3899779|FG000|STARTED|Overall Study||40
3172329|NCT01941472|3899779|FG000|COMPLETED|Overall Study||40
3172330|NCT01941472|3899779|FG000|NOT COMPLETED|Overall Study||0
3172331|NCT01941485|3899783|FG000|STARTED|Overall Study||59
3172332|NCT01941485|3899783|FG000|COMPLETED|Overall Study||59
3172333|NCT01941485|3899783|FG000|NOT COMPLETED|Overall Study||0
3172334|NCT01941498|3899805|FG000|STARTED|Overall Study||97
3172335|NCT01941498|3899805|FG000|COMPLETED|Overall Study||96
3172336|NCT01941498|3899805|FG000|NOT COMPLETED|Overall Study||1
3172337|NCT01941537|3899826|FG000|STARTED|Overall Study||40
3172338|NCT01941537|3899827|FG001|STARTED|Overall Study||20
3172339|NCT01941537|3899826|FG000|COMPLETED|Overall Study||36
3172340|NCT01941537|3899827|FG001|COMPLETED|Overall Study||17
3172341|NCT01941537|3899826|FG000|NOT COMPLETED|Overall Study||4
3172342|NCT01941537|3899827|FG001|NOT COMPLETED|Overall Study||3
3172343|NCT01941628|3899836|FG000|STARTED|Overall Study||46
3172344|NCT01941628|3899837|FG001|STARTED|Overall Study||45
3172345|NCT01941628|3899836|FG000|COMPLETED|Overall Study||45
3172346|NCT01941628|3899837|FG001|COMPLETED|Overall Study||45
3172347|NCT01941628|3899836|FG000|NOT COMPLETED|Overall Study||1
3172348|NCT01941628|3899837|FG001|NOT COMPLETED|Overall Study||0
3172349|NCT01941745|3899847|FG000|STARTED|Overall Study||22
3172350|NCT01941745|3899848|FG001|STARTED|Overall Study||22
3172351|NCT01941745|3899849|FG002|STARTED|Overall Study||21
3172352|NCT01941745|3899850|FG003|STARTED|Overall Study||23
3172353|NCT01941745|3899847|FG000|COMPLETED|Overall Study||22
3172354|NCT01941745|3899848|FG001|COMPLETED|Overall Study||22
3172355|NCT01941745|3899849|FG002|COMPLETED|Overall Study||21
3172356|NCT01941745|3899850|FG003|COMPLETED|Overall Study||23
3172357|NCT01941745|3899847|FG000|NOT COMPLETED|Overall Study||0
3172358|NCT01941745|3899848|FG001|NOT COMPLETED|Overall Study||0
3172359|NCT01941745|3899849|FG002|NOT COMPLETED|Overall Study||0
3172360|NCT01941745|3899850|FG003|NOT COMPLETED|Overall Study||0
3317749|NCT03130959|4051235|FG007|NOT COMPLETED|Follow-up Period||8
3317750|NCT03130959|4051236|FG008|NOT COMPLETED|Follow-up Period||18
3317751|NCT03130959|4051237|FG009|NOT COMPLETED|Follow-up Period||16
3317752|NCT03131167|4051285|FG000|STARTED|Overall Study||6
3317753|NCT03131167|4051286|FG001|STARTED|Overall Study||5
3317754|NCT03131167|4051287|FG002|STARTED|Overall Study||5
3317755|NCT03131167|4051288|FG003|STARTED|Overall Study||5
3317756|NCT03131167|4051289|FG004|STARTED|Overall Study||6
3172361|NCT01941927|3899865|FG000|STARTED|Overall Study||10
3317757|NCT03131167|4051290|FG005|STARTED|Overall Study||5
3317758|NCT03131167|4051291|FG006|STARTED|Overall Study||5
3317759|NCT03131167|4051292|FG007|STARTED|Overall Study||5
3317760|NCT03131167|4051293|FG008|STARTED|Overall Study||2
3317761|NCT03131167|4051294|FG009|STARTED|Overall Study||5
3317762|NCT03131167|4051295|FG010|STARTED|Overall Study||4
3172362|NCT01941927|3899866|FG001|STARTED|Overall Study||10
3172363|NCT01941927|3899865|FG000|COMPLETED|Overall Study||10
3172364|NCT01941927|3899866|FG001|COMPLETED|Overall Study||10
3172365|NCT01941927|3899865|FG000|NOT COMPLETED|Overall Study||0
3172366|NCT01941927|3899866|FG001|NOT COMPLETED|Overall Study||0
3172367|NCT01941940|3899872|FG000|STARTED|Overall Study||227
3172368|NCT01941940|3899872|FG000|COMPLETED|Overall Study||194
3172369|NCT01941940|3899872|FG000|NOT COMPLETED|Overall Study||33
3172370|NCT01942148|3899876|FG000|STARTED|Overall Study||68
3172371|NCT01942148|3899876|FG000|COMPLETED|Overall Study||41
3172372|NCT01942148|3899876|FG000|NOT COMPLETED|Overall Study||27
3172373|NCT01942161|3899883|FG000|STARTED|Overall Study||35
3317763|NCT03131167|4051296|FG011|STARTED|Overall Study||5
3317764|NCT03131167|4051297|FG012|STARTED|Overall Study||5
3317765|NCT03131167|4051285|FG000|COMPLETED|Overall Study||6
3317766|NCT03131167|4051286|FG001|COMPLETED|Overall Study||5
3317767|NCT03131167|4051287|FG002|COMPLETED|Overall Study||5
3317768|NCT03131167|4051288|FG003|COMPLETED|Overall Study||5
3317769|NCT03131167|4051289|FG004|COMPLETED|Overall Study||6
3317770|NCT03131167|4051290|FG005|COMPLETED|Overall Study||4
3317771|NCT03131167|4051291|FG006|COMPLETED|Overall Study||5
3317772|NCT03131167|4051292|FG007|COMPLETED|Overall Study||5
3317773|NCT03131167|4051293|FG008|COMPLETED|Overall Study||2
3317774|NCT03131167|4051294|FG009|COMPLETED|Overall Study||5
3317775|NCT03131167|4051295|FG010|COMPLETED|Overall Study||4
3317776|NCT03131167|4051296|FG011|COMPLETED|Overall Study||5
3317777|NCT03131167|4051297|FG012|COMPLETED|Overall Study||5
3317778|NCT03131167|4051285|FG000|NOT COMPLETED|Overall Study||0
3317779|NCT03131167|4051286|FG001|NOT COMPLETED|Overall Study||0
3317780|NCT03131167|4051287|FG002|NOT COMPLETED|Overall Study||0
3317781|NCT03131167|4051288|FG003|NOT COMPLETED|Overall Study||0
3317782|NCT03131167|4051289|FG004|NOT COMPLETED|Overall Study||0
3317783|NCT03131167|4051290|FG005|NOT COMPLETED|Overall Study||1
3317784|NCT03131167|4051291|FG006|NOT COMPLETED|Overall Study||0
3317785|NCT03131167|4051292|FG007|NOT COMPLETED|Overall Study||0
3317786|NCT03131167|4051293|FG008|NOT COMPLETED|Overall Study||0
3317787|NCT03131167|4051294|FG009|NOT COMPLETED|Overall Study||0
3317788|NCT03131167|4051295|FG010|NOT COMPLETED|Overall Study||0
3317789|NCT03131167|4051296|FG011|NOT COMPLETED|Overall Study||0
3317790|NCT03131167|4051297|FG012|NOT COMPLETED|Overall Study||0
3317791|NCT03131206|4051330|FG000|STARTED|Dose Level 1 (600mg BID 7d, 900mg BID)||5
3317792|NCT03131206|4051331|FG001|STARTED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
3317793|NCT03131206|4051332|FG002|STARTED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
3317794|NCT03131206|4051333|FG003|STARTED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
3317795|NCT03131206|4051330|FG000|COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||5
3317796|NCT03131206|4051331|FG001|COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
3317797|NCT03131206|4051332|FG002|COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
3317798|NCT03131206|4051333|FG003|COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
3317799|NCT03131206|4051330|FG000|NOT COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
3317800|NCT03131206|4051331|FG001|NOT COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
3317801|NCT03131206|4051332|FG002|NOT COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
3317802|NCT03131206|4051333|FG003|NOT COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
3317803|NCT03131206|4051330|FG000|STARTED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
3317804|NCT03131206|4051331|FG001|STARTED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
3317805|NCT03131206|4051332|FG002|STARTED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
3317806|NCT03131206|4051333|FG003|STARTED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
3317807|NCT03131206|4051330|FG000|COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
3317808|NCT03131206|4051331|FG001|COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
3317809|NCT03131206|4051332|FG002|COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
3317810|NCT03131206|4051333|FG003|COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
3317811|NCT03131206|4051330|FG000|NOT COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
3317812|NCT03131206|4051331|FG001|NOT COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
3317813|NCT03131206|4051332|FG002|NOT COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
3317814|NCT03131206|4051333|FG003|NOT COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
3317815|NCT03131219|4051349|FG000|STARTED|Initial Evaluation Period||21
3317816|NCT03131219|4051350|FG001|STARTED|Initial Evaluation Period||10
2921610|NCT00542919|3632171|FG000|Death|Overall Study||1
2921611|NCT00542919|3632172|FG001|Death|Overall Study||1
2921612|NCT00542919|3632173|FG002|Death|Overall Study||2
2921613|NCT00542919|3632171|FG000|COMPLETED|Overall Study||16
2921614|NCT00542919|3632172|FG001|COMPLETED|Overall Study||12
2921615|NCT00542919|3632173|FG002|COMPLETED|Overall Study||9
2921616|NCT00542919|3632171|FG000|NOT COMPLETED|Overall Study||7
2921617|NCT00542919|3632172|FG001|NOT COMPLETED|Overall Study||7
2921618|NCT00542919|3632173|FG002|NOT COMPLETED|Overall Study||6
2921619|NCT00542971|3632196|FG000|STARTED|Overall Study||75
2921620|NCT00542971|3632196|FG000|COMPLETED|Overall Study||75
2921621|NCT00542971|3632196|FG000|NOT COMPLETED|Overall Study||0
2921622|NCT00542997|3632200|FG000|STARTED|Wash in / Wash Out Period||51
2921623|NCT00542997|3632200|FG000|COMPLETED|Wash in / Wash Out Period||46
2921624|NCT00542997|3632200|FG000|NOT COMPLETED|Wash in / Wash Out Period||5
2921625|NCT00542997|3632200|FG000|STARTED|Efficacy Period||46
2921626|NCT00542997|3632200|FG000|COMPLETED|Efficacy Period||43
2921627|NCT00542997|3632200|FG000|NOT COMPLETED|Efficacy Period||3
2921628|NCT00543062|3632207|FG000|STARTED|Overall Study||12
2921629|NCT00543062|3632208|FG001|STARTED|Overall Study||12
2921630|NCT00543062|3632209|FG002|STARTED|Overall Study||12
2921631|NCT00543062|3632210|FG003|STARTED|Overall Study||12
2921632|NCT00543062|3632207|FG000|COMPLETED|Overall Study||10
2921633|NCT00543062|3632208|FG001|COMPLETED|Overall Study||11
2921634|NCT00543062|3632209|FG002|COMPLETED|Overall Study||9
2921635|NCT00543062|3632210|FG003|COMPLETED|Overall Study||11
2921636|NCT00543062|3632207|FG000|NOT COMPLETED|Overall Study||2
2921637|NCT00543062|3632208|FG001|NOT COMPLETED|Overall Study||1
2921638|NCT00543062|3632209|FG002|NOT COMPLETED|Overall Study||3
2921639|NCT00543062|3632210|FG003|NOT COMPLETED|Overall Study||1
2921640|NCT00543101|3632230|FG000|STARTED|Overall Study||12
2921641|NCT00543101|3632231|FG001|STARTED|Overall Study||12
2921642|NCT00543101|3632230|FG000|COMPLETED|Overall Study||12
2921643|NCT00543101|3632231|FG001|COMPLETED|Overall Study||12
2921644|NCT00543101|3632230|FG000|NOT COMPLETED|Overall Study||0
2921645|NCT00543101|3632231|FG001|NOT COMPLETED|Overall Study||0
2921646|NCT00543127|3632240|FG000|STARTED|Overall Study||433
2921647|NCT00543127|3632241|FG001|STARTED|Overall Study||437
2921648|NCT00543127|3632240|FG000|COMPLETED|Overall Study||303
2921649|NCT00543127|3632241|FG001|COMPLETED|Overall Study||350
2921650|NCT00543127|3632240|FG000|NOT COMPLETED|Overall Study||130
2921651|NCT00543127|3632241|FG001|NOT COMPLETED|Overall Study||87
3038543|NCT01154231|3757925|FG000|NOT COMPLETED|Overall Study||2
3038544|NCT01154283|3757931|FG000|STARTED|0-6 Weeks||14
2921652|NCT00543140|3632247|FG000|STARTED|Overall Study||303
3317817|NCT03131219|4051349|FG000|Received At Least 1 Dose of Study Drug|Initial Evaluation Period||21
3317818|NCT03131219|4051350|FG001|Received At Least 1 Dose of Study Drug|Initial Evaluation Period||10
3317819|NCT03131219|4051349|FG000|COMPLETED|Initial Evaluation Period||17
3317820|NCT03131219|4051350|FG001|COMPLETED|Initial Evaluation Period||10
3317821|NCT03131219|4051349|FG000|NOT COMPLETED|Initial Evaluation Period||4
3317822|NCT03131219|4051350|FG001|NOT COMPLETED|Initial Evaluation Period||0
3317823|NCT03131219|4051349|FG000|STARTED|Extension Period||17
3317824|NCT03131219|4051350|FG001|STARTED|Extension Period||10
3317825|NCT03131219|4051349|FG000|Received At Least 1 Dose of Study Drug|Extension Period||17
3317826|NCT03131219|4051350|FG001|Received At Least 1 Dose of Study Drug|Extension Period||10
3317827|NCT03131219|4051349|FG000|Ongoing|Extension Period||16
3317828|NCT03131219|4051350|FG001|Ongoing|Extension Period||10
3317829|NCT03131219|4051349|FG000|COMPLETED|Extension Period||0
3317830|NCT03131219|4051350|FG001|COMPLETED|Extension Period||0
3317831|NCT03131219|4051349|FG000|NOT COMPLETED|Extension Period||17
3317832|NCT03131219|4051350|FG001|NOT COMPLETED|Extension Period||10
3317833|NCT03131453|4051359|FG000|STARTED|Overall Study||456
3317834|NCT03131453|4051360|FG001|STARTED|Overall Study||233
3317835|NCT03131453|4051361|FG002|STARTED|Overall Study||456
3317836|NCT03131453|4051359|FG000|Patient Misrandomized|Overall Study||1
3317837|NCT03131453|4051360|FG001|Patient Misrandomized|Overall Study||0
3317838|NCT03131453|4051361|FG002|Patient Misrandomized|Overall Study||0
3317839|NCT03131453|4051359|FG000|COMPLETED|Overall Study||0
3317840|NCT03131453|4051360|FG001|COMPLETED|Overall Study||0
3317841|NCT03131453|4051361|FG002|COMPLETED|Overall Study||0
3317842|NCT03131453|4051359|FG000|NOT COMPLETED|Overall Study||456
3317843|NCT03131453|4051360|FG001|NOT COMPLETED|Overall Study||233
3317844|NCT03131453|4051361|FG002|NOT COMPLETED|Overall Study||456
3317845|NCT03131479|4051374|FG000|STARTED|Overall Study||10
3317846|NCT03131479|4051375|FG001|STARTED|Overall Study||10
3317847|NCT03131479|4051376|FG002|STARTED|Overall Study||11
3317848|NCT03131479|4051377|FG003|STARTED|Overall Study||12
3317849|NCT03131479|4051378|FG004|STARTED|Overall Study||10
3317850|NCT03131479|4051374|FG000|Safety Analysis Set (SS)|Overall Study||10
3317851|NCT03131479|4051375|FG001|Safety Analysis Set (SS)|Overall Study||10
3317852|NCT03131479|4051376|FG002|Safety Analysis Set (SS)|Overall Study||11
3317853|NCT03131479|4051377|FG003|Safety Analysis Set (SS)|Overall Study||12
3317854|NCT03131479|4051378|FG004|Safety Analysis Set (SS)|Overall Study||10
3317855|NCT03131479|4051374|FG000|Pharmacokinetic Analysis Set (PAS)|Overall Study||10
3317856|NCT03131479|4051375|FG001|Pharmacokinetic Analysis Set (PAS)|Overall Study||10
3317857|NCT03131479|4051376|FG002|Pharmacokinetic Analysis Set (PAS)|Overall Study||11
3317858|NCT03131479|4051377|FG003|Pharmacokinetic Analysis Set (PAS)|Overall Study||12
3317859|NCT03131479|4051378|FG004|Pharmacokinetic Analysis Set (PAS)|Overall Study||10
3317860|NCT03131479|4051374|FG000|Pharcodynamic Analysis Set (PD)|Overall Study||10
3317861|NCT03131479|4051375|FG001|Pharcodynamic Analysis Set (PD)|Overall Study||10
3317862|NCT03131479|4051376|FG002|Pharcodynamic Analysis Set (PD)|Overall Study||11
3317863|NCT03131479|4051377|FG003|Pharcodynamic Analysis Set (PD)|Overall Study||12
3317864|NCT03131479|4051378|FG004|Pharcodynamic Analysis Set (PD)|Overall Study||10
3317865|NCT03131479|4051374|FG000|COMPLETED|Overall Study||10
3317866|NCT03131479|4051375|FG001|COMPLETED|Overall Study||10
3317867|NCT03131479|4051376|FG002|COMPLETED|Overall Study||10
3317868|NCT03131479|4051377|FG003|COMPLETED|Overall Study||10
3317869|NCT03131479|4051378|FG004|COMPLETED|Overall Study||10
3317870|NCT03131479|4051374|FG000|NOT COMPLETED|Overall Study||0
3317871|NCT03131479|4051375|FG001|NOT COMPLETED|Overall Study||0
3317872|NCT03131479|4051376|FG002|NOT COMPLETED|Overall Study||1
3317873|NCT03131479|4051377|FG003|NOT COMPLETED|Overall Study||2
3317874|NCT03131479|4051378|FG004|NOT COMPLETED|Overall Study||0
3172374|NCT01942161|3899884|FG001|STARTED|Overall Study||30
3172375|NCT01942161|3899885|FG002|STARTED|Overall Study||41
3172376|NCT01942161|3899883|FG000|COMPLETED|Overall Study||27
3172377|NCT01942161|3899884|FG001|COMPLETED|Overall Study||24
3172378|NCT01942161|3899885|FG002|COMPLETED|Overall Study||35
3172379|NCT01942161|3899883|FG000|NOT COMPLETED|Overall Study||8
3172380|NCT01942161|3899884|FG001|NOT COMPLETED|Overall Study||6
3172381|NCT01942161|3899885|FG002|NOT COMPLETED|Overall Study||6
3172382|NCT01942486|3899893|FG000|STARTED|Overall Study||35
3172383|NCT01942486|3899893|FG000|COMPLETED|Overall Study||8
3172384|NCT01942486|3899893|FG000|NOT COMPLETED|Overall Study||27
3172385|NCT01942590|3899899|FG000|STARTED|Overall Study||8
3172386|NCT01942590|3899900|FG001|STARTED|Overall Study||5
3172387|NCT01942590|3899899|FG000|COMPLETED|Overall Study||7
3172388|NCT01942590|3899900|FG001|COMPLETED|Overall Study||4
3172389|NCT01942590|3899899|FG000|NOT COMPLETED|Overall Study||1
3172390|NCT01942590|3899900|FG001|NOT COMPLETED|Overall Study||1
3172391|NCT01942668|3899912|FG000|STARTED|Overall Study||418
3317875|NCT03131570|4051392|FG000|STARTED|Overall Study||12
3317876|NCT03131570|4051393|FG001|STARTED|Overall Study||11
3317877|NCT03131570|4051392|FG000|COMPLETED|Overall Study||11
3172392|NCT01942668|3899913|FG001|STARTED|Overall Study||426
3172393|NCT01942668|3899914|FG002|STARTED|Overall Study||422
3172394|NCT01942668|3899915|FG003|STARTED|Overall Study||427
3172395|NCT01942668|3899916|FG004|STARTED|Overall Study||152
3172396|NCT01942668|3899912|FG000|COMPLETED|Overall Study||284
3172397|NCT01942668|3899913|FG001|COMPLETED|Overall Study||305
3172398|NCT01942668|3899914|FG002|COMPLETED|Overall Study||312
3172399|NCT01942668|3899915|FG003|COMPLETED|Overall Study||281
3172400|NCT01942668|3899916|FG004|COMPLETED|Overall Study||93
3172401|NCT01942668|3899912|FG000|NOT COMPLETED|Overall Study||134
3172402|NCT01942668|3899913|FG001|NOT COMPLETED|Overall Study||121
3172403|NCT01942668|3899914|FG002|NOT COMPLETED|Overall Study||110
3172404|NCT01942668|3899915|FG003|NOT COMPLETED|Overall Study||146
3172405|NCT01942668|3899916|FG004|NOT COMPLETED|Overall Study||59
3172406|NCT01942694|3899935|FG000|STARTED|Overall Study||1212
3172407|NCT01942694|3899936|FG001|STARTED|Overall Study||1211
3172408|NCT01942694|3899935|FG000|COMPLETED|Overall Study||1211
3172409|NCT01942694|3899936|FG001|COMPLETED|Overall Study||1211
3172410|NCT01942694|3899935|FG000|NOT COMPLETED|Overall Study||1
3172411|NCT01942694|3899936|FG001|NOT COMPLETED|Overall Study||0
3317878|NCT03131570|4051393|FG001|COMPLETED|Overall Study||11
3317879|NCT03131570|4051392|FG000|NOT COMPLETED|Overall Study||1
3317880|NCT03131570|4051393|FG001|NOT COMPLETED|Overall Study||0
3317881|NCT03131596|4051401|FG000|STARTED|Overall Study||100
3317882|NCT03131596|4051402|FG001|STARTED|Overall Study||100
3317883|NCT03131596|4051401|FG000|COMPLETED|Overall Study||94
3317884|NCT03131596|4051402|FG001|COMPLETED|Overall Study||97
3172412|NCT01942707|3899944|FG000|STARTED|Overall Study||23
3172413|NCT01942707|3899945|FG001|STARTED|Overall Study||23
3172414|NCT01942707|3899944|FG000|COMPLETED|Overall Study||23
3172415|NCT01942707|3899945|FG001|COMPLETED|Overall Study||23
3172416|NCT01942707|3899944|FG000|NOT COMPLETED|Overall Study||0
3172417|NCT01942707|3899945|FG001|NOT COMPLETED|Overall Study||0
3172418|NCT01942720|3899951|FG000|STARTED|Overall Study||74
3172419|NCT01942720|3899951|FG000|COMPLETED|Overall Study||53
3317885|NCT03131596|4051401|FG000|NOT COMPLETED|Overall Study||6
3317886|NCT03131596|4051402|FG001|NOT COMPLETED|Overall Study||3
3317887|NCT03131648|4051410|FG000|STARTED|Initial Treatment Period||603
3317888|NCT03131648|4051411|FG001|STARTED|Initial Treatment Period||199
3317889|NCT03131648|4051412|FG002|STARTED|Initial Treatment Period||0
3317890|NCT03131648|4051413|FG003|STARTED|Initial Treatment Period||0
3317891|NCT03131648|4051414|FG004|STARTED|Initial Treatment Period||0
3317892|NCT03131648|4051415|FG005|STARTED|Initial Treatment Period||0
3317893|NCT03131648|4051416|FG006|STARTED|Initial Treatment Period||0
3317894|NCT03131648|4051417|FG007|STARTED|Initial Treatment Period||0
3317895|NCT03131648|4051410|FG000|COMPLETED|Initial Treatment Period||550
3317896|NCT03131648|4051411|FG001|COMPLETED|Initial Treatment Period||179
3317897|NCT03131648|4051412|FG002|COMPLETED|Initial Treatment Period||0
3317898|NCT03131648|4051413|FG003|COMPLETED|Initial Treatment Period||0
3317899|NCT03131648|4051414|FG004|COMPLETED|Initial Treatment Period||0
3317900|NCT03131648|4051415|FG005|COMPLETED|Initial Treatment Period||0
3317901|NCT03131648|4051416|FG006|COMPLETED|Initial Treatment Period||0
3317902|NCT03131648|4051417|FG007|COMPLETED|Initial Treatment Period||0
3317903|NCT03131648|4051410|FG000|NOT COMPLETED|Initial Treatment Period||53
3317904|NCT03131648|4051411|FG001|NOT COMPLETED|Initial Treatment Period||20
3317905|NCT03131648|4051412|FG002|NOT COMPLETED|Initial Treatment Period||0
3317906|NCT03131648|4051413|FG003|NOT COMPLETED|Initial Treatment Period||0
3317907|NCT03131648|4051414|FG004|NOT COMPLETED|Initial Treatment Period||0
3317908|NCT03131648|4051415|FG005|NOT COMPLETED|Initial Treatment Period||0
3317909|NCT03131648|4051416|FG006|NOT COMPLETED|Initial Treatment Period||0
3317910|NCT03131648|4051417|FG007|NOT COMPLETED|Initial Treatment Period||0
3317911|NCT03131648|4051410|FG000|STARTED|Open-label Treatment||0
3317912|NCT03131648|4051411|FG001|STARTED|Open-label Treatment||0
3317913|NCT03131648|4051412|FG002|STARTED|Open-label Treatment||0
3317914|NCT03131648|4051413|FG003|STARTED|Open-label Treatment||0
3317915|NCT03131648|4051414|FG004|STARTED|Open-label Treatment||0
3317916|NCT03131648|4051415|FG005|STARTED|Open-label Treatment||0
3317917|NCT03131648|4051416|FG006|STARTED|Open-label Treatment||564
3317918|NCT03131648|4051417|FG007|STARTED|Open-label Treatment||0
3317919|NCT03131648|4051410|FG000|COMPLETED|Open-label Treatment||0
3317920|NCT03131648|4051411|FG001|COMPLETED|Open-label Treatment||0
3317921|NCT03131648|4051412|FG002|COMPLETED|Open-label Treatment||0
3317922|NCT03131648|4051413|FG003|COMPLETED|Open-label Treatment||0
3317923|NCT03131648|4051414|FG004|COMPLETED|Open-label Treatment||0
3317924|NCT03131648|4051415|FG005|COMPLETED|Open-label Treatment||0
3317925|NCT03131648|4051416|FG006|COMPLETED|Open-label Treatment||446
3317926|NCT03131648|4051417|FG007|COMPLETED|Open-label Treatment||0
3317927|NCT03131648|4051410|FG000|NOT COMPLETED|Open-label Treatment||0
3317928|NCT03131648|4051411|FG001|NOT COMPLETED|Open-label Treatment||0
3317929|NCT03131648|4051412|FG002|NOT COMPLETED|Open-label Treatment||0
3317930|NCT03131648|4051413|FG003|NOT COMPLETED|Open-label Treatment||0
3317931|NCT03131648|4051414|FG004|NOT COMPLETED|Open-label Treatment||0
3172420|NCT01942720|3899951|FG000|NOT COMPLETED|Overall Study||21
3172421|NCT01942733|3899955|FG000|STARTED|Overall Study||44
3172422|NCT01942733|3899955|FG000|COMPLETED|Overall Study||41
3172423|NCT01942733|3899955|FG000|NOT COMPLETED|Overall Study||3
3172424|NCT01942785|3899959|FG000|STARTED|Overall Study||54
3172425|NCT01942785|3899959|FG000|COMPLETED|Overall Study||50
3172426|NCT01942785|3899959|FG000|NOT COMPLETED|Overall Study||4
3172427|NCT01942993|3899965|FG000|STARTED|Overall Study||3
3172428|NCT01942993|3899965|FG000|COMPLETED|Overall Study||1
3172429|NCT01942993|3899965|FG000|NOT COMPLETED|Overall Study||2
3317932|NCT03131648|4051415|FG005|NOT COMPLETED|Open-label Treatment||0
3317933|NCT03131648|4051416|FG006|NOT COMPLETED|Open-label Treatment||118
3317934|NCT03131648|4051417|FG007|NOT COMPLETED|Open-label Treatment||0
3317935|NCT03131648|4051410|FG000|STARTED|Maintenance Treatment Period||0
3317936|NCT03131648|4051411|FG001|STARTED|Maintenance Treatment Period||0
3317937|NCT03131648|4051412|FG002|STARTED|Maintenance Treatment Period||71
3317938|NCT03131648|4051413|FG003|STARTED|Maintenance Treatment Period||78
3317939|NCT03131648|4051414|FG004|STARTED|Maintenance Treatment Period||36
3317940|NCT03131648|4051415|FG005|STARTED|Maintenance Treatment Period||29
3317941|NCT03131648|4051416|FG006|STARTED|Maintenance Treatment Period||0
3317942|NCT03131648|4051417|FG007|STARTED|Maintenance Treatment Period||0
3317943|NCT03131648|4051410|FG000|COMPLETED|Maintenance Treatment Period||0
3317944|NCT03131648|4051411|FG001|COMPLETED|Maintenance Treatment Period||0
3317945|NCT03131648|4051412|FG002|COMPLETED|Maintenance Treatment Period||44
3317946|NCT03131648|4051413|FG003|COMPLETED|Maintenance Treatment Period||53
3317947|NCT03131648|4051414|FG004|COMPLETED|Maintenance Treatment Period||21
3317948|NCT03131648|4051415|FG005|COMPLETED|Maintenance Treatment Period||15
3317949|NCT03131648|4051416|FG006|COMPLETED|Maintenance Treatment Period||0
3172430|NCT01943110|3899969|FG000|STARTED|Overall Study||30
3317950|NCT03131648|4051417|FG007|COMPLETED|Maintenance Treatment Period||0
3317951|NCT03131648|4051410|FG000|NOT COMPLETED|Maintenance Treatment Period||0
3317952|NCT03131648|4051411|FG001|NOT COMPLETED|Maintenance Treatment Period||0
3317953|NCT03131648|4051412|FG002|NOT COMPLETED|Maintenance Treatment Period||27
3317954|NCT03131648|4051413|FG003|NOT COMPLETED|Maintenance Treatment Period||25
3317955|NCT03131648|4051414|FG004|NOT COMPLETED|Maintenance Treatment Period||15
3317956|NCT03131648|4051415|FG005|NOT COMPLETED|Maintenance Treatment Period||14
3317957|NCT03131648|4051416|FG006|NOT COMPLETED|Maintenance Treatment Period||0
3317958|NCT03131648|4051417|FG007|NOT COMPLETED|Maintenance Treatment Period||0
3317959|NCT03131648|4051410|FG000|STARTED|Open-label (Short Term Extension)||0
3317960|NCT03131648|4051411|FG001|STARTED|Open-label (Short Term Extension)||0
3317961|NCT03131648|4051412|FG002|STARTED|Open-label (Short Term Extension)||0
3317962|NCT03131648|4051413|FG003|STARTED|Open-label (Short Term Extension)||0
2921653|NCT00543140|3632247|FG000|COMPLETED|Overall Study||231
2921654|NCT00543140|3632247|FG000|NOT COMPLETED|Overall Study||72
2921655|NCT00543296|3632251|FG000|STARTED|Overall Study||21
2921656|NCT00543296|3632251|FG000|COMPLETED|Overall Study||14
2921657|NCT00543296|3632251|FG000|NOT COMPLETED|Overall Study||7
2921658|NCT00543309|3632258|FG000|STARTED|Overall Study||35
2921659|NCT00543309|3632259|FG001|STARTED|Overall Study||36
2921660|NCT00543309|3632260|FG002|STARTED|Overall Study||35
2921661|NCT00543309|3632258|FG000|COMPLETED|Overall Study||35
2921662|NCT00543309|3632259|FG001|COMPLETED|Overall Study||35
2921663|NCT00543309|3632260|FG002|COMPLETED|Overall Study||35
2921664|NCT00543309|3632258|FG000|NOT COMPLETED|Overall Study||0
2921665|NCT00543309|3632259|FG001|NOT COMPLETED|Overall Study||1
2921666|NCT00543309|3632260|FG002|NOT COMPLETED|Overall Study||0
2921667|NCT00543387|3632278|FG000|STARTED|Panel 1 + Panel 2||3
2921668|NCT00543387|3632279|FG001|STARTED|Panel 1 + Panel 2||3
2921669|NCT00543387|3632280|FG002|STARTED|Panel 1 + Panel 2||3
2921670|NCT00543387|3632281|FG003|STARTED|Panel 1 + Panel 2||3
2921671|NCT00543387|3632282|FG004|STARTED|Panel 1 + Panel 2||3
2921672|NCT00543387|3632283|FG005|STARTED|Panel 1 + Panel 2||3
2921673|NCT00543387|3632284|FG006|STARTED|Panel 1 + Panel 2||6
2921674|NCT00543387|3632285|FG007|STARTED|Panel 1 + Panel 2||6
2921675|NCT00543387|3632286|FG008|STARTED|Panel 1 + Panel 2||5
2921676|NCT00543387|3632287|FG009|STARTED|Panel 1 + Panel 2||0
2921677|NCT00543387|3632288|FG010|STARTED|Panel 1 + Panel 2||0
2921678|NCT00543387|3632278|FG000|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0
2921679|NCT00543387|3632279|FG001|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||1
2921680|NCT00543387|3632280|FG002|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0
2921681|NCT00543387|3632281|FG003|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0
2921682|NCT00543387|3632282|FG004|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||2
2921683|NCT00543387|3632283|FG005|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||1
2921684|NCT00543387|3632284|FG006|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0
2921685|NCT00543387|3632285|FG007|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0
2921686|NCT00543387|3632286|FG008|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0
2921687|NCT00543387|3632287|FG009|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0
2921688|NCT00543387|3632288|FG010|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0
2921689|NCT00543387|3632278|FG000|COMPLETED|Panel 1 + Panel 2||0
2921690|NCT00543387|3632279|FG001|COMPLETED|Panel 1 + Panel 2||0
2921691|NCT00543387|3632280|FG002|COMPLETED|Panel 1 + Panel 2||0
2921692|NCT00543387|3632281|FG003|COMPLETED|Panel 1 + Panel 2||0
3172431|NCT01943110|3899969|FG000|COMPLETED|Overall Study||30
3172432|NCT01943110|3899969|FG000|NOT COMPLETED|Overall Study||0
3172433|NCT01943227|3899987|FG000|STARTED|Overall Study||10
3172434|NCT01943227|3899988|FG001|STARTED|Overall Study||10
3172435|NCT01943227|3899987|FG000|COMPLETED|Overall Study||10
3172436|NCT01943227|3899988|FG001|COMPLETED|Overall Study||10
3172437|NCT01943227|3899987|FG000|NOT COMPLETED|Overall Study||0
3317963|NCT03131648|4051414|FG004|STARTED|Open-label (Short Term Extension)||0
3317964|NCT03131648|4051415|FG005|STARTED|Open-label (Short Term Extension)||0
3317965|NCT03131648|4051416|FG006|STARTED|Open-label (Short Term Extension)||0
3317966|NCT03131648|4051417|FG007|STARTED|Open-label (Short Term Extension)||65
3317967|NCT03131648|4051410|FG000|COMPLETED|Open-label (Short Term Extension)||0
3317968|NCT03131648|4051411|FG001|COMPLETED|Open-label (Short Term Extension)||0
3317969|NCT03131648|4051412|FG002|COMPLETED|Open-label (Short Term Extension)||0
3317970|NCT03131648|4051413|FG003|COMPLETED|Open-label (Short Term Extension)||0
3172438|NCT01943227|3899988|FG001|NOT COMPLETED|Overall Study||0
3172439|NCT01943292|3899997|FG000|STARTED|Overall Study||3
3172440|NCT01943292|3899998|FG001|STARTED|Overall Study||3
3172441|NCT01943292|3899999|FG002|STARTED|Overall Study||3
3172442|NCT01943292|3899997|FG000|Completed Cycle 1|Overall Study||3
3172443|NCT01943292|3899998|FG001|Completed Cycle 1|Overall Study||3
3172444|NCT01943292|3899999|FG002|Completed Cycle 1|Overall Study||3
3172445|NCT01943292|3899997|FG000|Completed Treatment|Overall Study||3
3172446|NCT01943292|3899998|FG001|Completed Treatment|Overall Study||3
3172447|NCT01943292|3899999|FG002|Completed Treatment|Overall Study||3
3172448|NCT01943292|3899997|FG000|Completed Follow-Up|Overall Study||2
3317971|NCT03131648|4051414|FG004|COMPLETED|Open-label (Short Term Extension)||0
3317972|NCT03131648|4051415|FG005|COMPLETED|Open-label (Short Term Extension)||0
3317973|NCT03131648|4051416|FG006|COMPLETED|Open-label (Short Term Extension)||0
3317974|NCT03131648|4051417|FG007|COMPLETED|Open-label (Short Term Extension)||62
3317975|NCT03131648|4051410|FG000|NOT COMPLETED|Open-label (Short Term Extension)||0
3317976|NCT03131648|4051411|FG001|NOT COMPLETED|Open-label (Short Term Extension)||0
3317977|NCT03131648|4051412|FG002|NOT COMPLETED|Open-label (Short Term Extension)||0
3317978|NCT03131648|4051413|FG003|NOT COMPLETED|Open-label (Short Term Extension)||0
3317979|NCT03131648|4051414|FG004|NOT COMPLETED|Open-label (Short Term Extension)||0
3317980|NCT03131648|4051415|FG005|NOT COMPLETED|Open-label (Short Term Extension)||0
3317981|NCT03131648|4051416|FG006|NOT COMPLETED|Open-label (Short Term Extension)||0
3317982|NCT03131648|4051417|FG007|NOT COMPLETED|Open-label (Short Term Extension)||3
3317983|NCT03131687|4051440|FG000|STARTED|Overall Study||51
3317984|NCT03131687|4051441|FG001|STARTED|Overall Study||53
3317985|NCT03131687|4051442|FG002|STARTED|Overall Study||55
3317986|NCT03131687|4051443|FG003|STARTED|Overall Study||52
3317987|NCT03131687|4051444|FG004|STARTED|Overall Study||53
3317988|NCT03131687|4051445|FG005|STARTED|Overall Study||54
3317989|NCT03131687|4051440|FG000|Received at Least One Dose of Study Drug|Overall Study||51
3317990|NCT03131687|4051441|FG001|Received at Least One Dose of Study Drug|Overall Study||52
3317991|NCT03131687|4051442|FG002|Received at Least One Dose of Study Drug|Overall Study||55
3317992|NCT03131687|4051443|FG003|Received at Least One Dose of Study Drug|Overall Study||51
3317993|NCT03131687|4051444|FG004|Received at Least One Dose of Study Drug|Overall Study||53
3317994|NCT03131687|4051445|FG005|Received at Least One Dose of Study Drug|Overall Study||54
3317995|NCT03131687|4051440|FG000|COMPLETED|Overall Study||45
3317996|NCT03131687|4051441|FG001|COMPLETED|Overall Study||44
3317997|NCT03131687|4051442|FG002|COMPLETED|Overall Study||52
3172449|NCT01943292|3899998|FG001|Completed Follow-Up|Overall Study||3
3172450|NCT01943292|3899999|FG002|Completed Follow-Up|Overall Study||3
3172451|NCT01943292|3899997|FG000|COMPLETED|Overall Study||2
3172452|NCT01943292|3899998|FG001|COMPLETED|Overall Study||3
3172453|NCT01943292|3899999|FG002|COMPLETED|Overall Study||3
3172454|NCT01943292|3899997|FG000|NOT COMPLETED|Overall Study||1
3172455|NCT01943292|3899998|FG001|NOT COMPLETED|Overall Study||0
3172456|NCT01943292|3899999|FG002|NOT COMPLETED|Overall Study||0
3317998|NCT03131687|4051443|FG003|COMPLETED|Overall Study||48
3317999|NCT03131687|4051444|FG004|COMPLETED|Overall Study||45
3318000|NCT03131687|4051445|FG005|COMPLETED|Overall Study||49
3318001|NCT03131687|4051440|FG000|NOT COMPLETED|Overall Study||6
3318002|NCT03131687|4051441|FG001|NOT COMPLETED|Overall Study||9
3318003|NCT03131687|4051442|FG002|NOT COMPLETED|Overall Study||3
3318004|NCT03131687|4051443|FG003|NOT COMPLETED|Overall Study||4
3318005|NCT03131687|4051444|FG004|NOT COMPLETED|Overall Study||8
3318006|NCT03131687|4051445|FG005|NOT COMPLETED|Overall Study||5
3318007|NCT03131713|4051474|FG000|STARTED|Overall Study||50
3318008|NCT03131713|4051475|FG001|STARTED|Overall Study|1 intervention subject was added on after the protocol was initiated.|51
3318009|NCT03131713|4051474|FG000|COMPLETED|Overall Study||45
3318010|NCT03131713|4051475|FG001|COMPLETED|Overall Study||51
3318011|NCT03131713|4051474|FG000|NOT COMPLETED|Overall Study||5
3318012|NCT03131713|4051475|FG001|NOT COMPLETED|Overall Study||0
3318013|NCT03131895|4051485|FG000|STARTED|Intervention Period 1 (2 Days)||28
3318014|NCT03131895|4051486|FG001|STARTED|Intervention Period 1 (2 Days)||28
3318015|NCT03131895|4051487|FG002|STARTED|Intervention Period 1 (2 Days)||30
3318016|NCT03131895|4051488|FG003|STARTED|Intervention Period 1 (2 Days)||30
3318017|NCT03131895|4051485|FG000|COMPLETED|Intervention Period 1 (2 Days)||28
3318018|NCT03131895|4051486|FG001|COMPLETED|Intervention Period 1 (2 Days)||28
3318019|NCT03131895|4051487|FG002|COMPLETED|Intervention Period 1 (2 Days)||30
3318020|NCT03131895|4051488|FG003|COMPLETED|Intervention Period 1 (2 Days)||30
3318021|NCT03131895|4051485|FG000|NOT COMPLETED|Intervention Period 1 (2 Days)||0
3318022|NCT03131895|4051486|FG001|NOT COMPLETED|Intervention Period 1 (2 Days)||0
3318023|NCT03131895|4051487|FG002|NOT COMPLETED|Intervention Period 1 (2 Days)||0
3318024|NCT03131895|4051488|FG003|NOT COMPLETED|Intervention Period 1 (2 Days)||0
3318025|NCT03131895|4051485|FG000|STARTED|Washout Period (at Least 5 Days)||28
3318026|NCT03131895|4051486|FG001|STARTED|Washout Period (at Least 5 Days)||28
3318027|NCT03131895|4051487|FG002|STARTED|Washout Period (at Least 5 Days)||30
3318028|NCT03131895|4051488|FG003|STARTED|Washout Period (at Least 5 Days)||30
3318029|NCT03131895|4051485|FG000|COMPLETED|Washout Period (at Least 5 Days)||27
3318030|NCT03131895|4051486|FG001|COMPLETED|Washout Period (at Least 5 Days)||23
3318031|NCT03131895|4051487|FG002|COMPLETED|Washout Period (at Least 5 Days)||26
3318032|NCT03131895|4051488|FG003|COMPLETED|Washout Period (at Least 5 Days)||25
3318033|NCT03131895|4051485|FG000|NOT COMPLETED|Washout Period (at Least 5 Days)||1
3318034|NCT03131895|4051486|FG001|NOT COMPLETED|Washout Period (at Least 5 Days)||5
3318035|NCT03131895|4051487|FG002|NOT COMPLETED|Washout Period (at Least 5 Days)||4
3318036|NCT03131895|4051488|FG003|NOT COMPLETED|Washout Period (at Least 5 Days)||5
3318037|NCT03131895|4051485|FG000|STARTED|Intervention Period 2 (2 Days)||27
3318038|NCT03131895|4051486|FG001|STARTED|Intervention Period 2 (2 Days)||23
3318039|NCT03131895|4051487|FG002|STARTED|Intervention Period 2 (2 Days)||26
3318040|NCT03131895|4051488|FG003|STARTED|Intervention Period 2 (2 Days)||25
3318041|NCT03131895|4051485|FG000|COMPLETED|Intervention Period 2 (2 Days)||26
3318042|NCT03131895|4051486|FG001|COMPLETED|Intervention Period 2 (2 Days)||22
3318043|NCT03131895|4051487|FG002|COMPLETED|Intervention Period 2 (2 Days)||26
3318044|NCT03131895|4051488|FG003|COMPLETED|Intervention Period 2 (2 Days)||25
3318045|NCT03131895|4051485|FG000|NOT COMPLETED|Intervention Period 2 (2 Days)||1
3318046|NCT03131895|4051486|FG001|NOT COMPLETED|Intervention Period 2 (2 Days)||1
3318047|NCT03131895|4051487|FG002|NOT COMPLETED|Intervention Period 2 (2 Days)||0
3318048|NCT03131895|4051488|FG003|NOT COMPLETED|Intervention Period 2 (2 Days)||0
3318049|NCT03131960|4051500|FG000|STARTED|Overall Study|1 participant missed the day one visit (V5) but remained in the study and returned for the day 90 assessment (V7).|53
3318050|NCT03131960|4051501|FG001|STARTED|Overall Study|1 discontinued treatment due to adverse event and inability to tolerate rehabilitation.|55
3318051|NCT03131960|4051500|FG000|COMPLETED|Overall Study||53
3318052|NCT03131960|4051501|FG001|COMPLETED|Overall Study||54
3318053|NCT03131960|4051500|FG000|NOT COMPLETED|Overall Study||0
3318054|NCT03131960|4051501|FG001|NOT COMPLETED|Overall Study||1
3318055|NCT03131999|4051509|FG000|STARTED|Overall Study||8
3318056|NCT03131999|4051510|FG001|STARTED|Overall Study||8
3318057|NCT03131999|4051509|FG000|COMPLETED|Overall Study||8
3318058|NCT03131999|4051510|FG001|COMPLETED|Overall Study||7
3318059|NCT03131999|4051509|FG000|NOT COMPLETED|Overall Study||0
3318060|NCT03131999|4051510|FG001|NOT COMPLETED|Overall Study||1
3318061|NCT03132220|4051518|FG000|STARTED|Overall Study||65
3318062|NCT03132220|4051519|FG001|STARTED|Overall Study||66
3318063|NCT03132220|4051518|FG000|Began Study Sessions|Overall Study|65 participants randomized to intervention arm;17 lost to f/u prior to study start;48 began sessions|48
3318064|NCT03132220|4051519|FG001|Began Study Sessions|Overall Study|66 participants randomized to control arm;8 were lost to f/u prior to study start; 58 began sessions|58
3318065|NCT03132220|4051518|FG000|COMPLETED|Overall Study||47
3318066|NCT03132220|4051519|FG001|COMPLETED|Overall Study||54
3318067|NCT03132220|4051518|FG000|NOT COMPLETED|Overall Study||18
3318068|NCT03132220|4051519|FG001|NOT COMPLETED|Overall Study||12
3318069|NCT03132246|4051527|FG000|STARTED|Overall Study||260
3318070|NCT03132246|4051527|FG000|COMPLETED|Overall Study||156
3318071|NCT03132246|4051527|FG000|NOT COMPLETED|Overall Study||104
3318072|NCT03132298|4051536|FG000|STARTED|Overall Study||48
3318073|NCT03132298|4051537|FG001|STARTED|Overall Study||48
3318074|NCT03132298|4051536|FG000|COMPLETED|Overall Study||36
3318075|NCT03132298|4051537|FG001|COMPLETED|Overall Study||35
3318076|NCT03132298|4051536|FG000|NOT COMPLETED|Overall Study||12
3318077|NCT03132298|4051537|FG001|NOT COMPLETED|Overall Study||13
3318078|NCT03132571|4051545|FG000|STARTED|Overall Study||3
3318079|NCT03132571|4051546|FG001|STARTED|Overall Study||2
3318080|NCT03132571|4051545|FG000|COMPLETED|Overall Study||3
3318081|NCT03132571|4051546|FG001|COMPLETED|Overall Study||2
3318082|NCT03132571|4051545|FG000|NOT COMPLETED|Overall Study||0
3318083|NCT03132571|4051546|FG001|NOT COMPLETED|Overall Study||0
3318084|NCT03133481|4051554|FG000|STARTED|Overall Study||45
3318085|NCT03133481|4051555|FG001|STARTED|Overall Study||49
3318086|NCT03133481|4051554|FG000|COMPLETED|Overall Study||45
3318087|NCT03133481|4051555|FG001|COMPLETED|Overall Study||45
3318088|NCT03133481|4051554|FG000|NOT COMPLETED|Overall Study||0
3318089|NCT03133481|4051555|FG001|NOT COMPLETED|Overall Study||4
3318090|NCT03133676|4051570|FG000|STARTED|Overall Study||6
3318091|NCT03133676|4051571|FG001|STARTED|Overall Study||3
3318092|NCT03133676|4051572|FG002|STARTED|Overall Study||3
3318093|NCT03133676|4051573|FG003|STARTED|Overall Study||6
3318094|NCT03133676|4051574|FG004|STARTED|Overall Study||6
3318095|NCT03133676|4051575|FG005|STARTED|Overall Study||9
3318096|NCT03133676|4051576|FG006|STARTED|Overall Study||9
3318097|NCT03133676|4051577|FG007|STARTED|Overall Study||9
3318098|NCT03133676|4051578|FG008|STARTED|Overall Study||9
3318099|NCT03133676|4051570|FG000|COMPLETED|Overall Study||6
3318100|NCT03133676|4051571|FG001|COMPLETED|Overall Study||3
3318101|NCT03133676|4051572|FG002|COMPLETED|Overall Study||3
3318102|NCT03133676|4051573|FG003|COMPLETED|Overall Study||6
3318103|NCT03133676|4051574|FG004|COMPLETED|Overall Study||6
3318104|NCT03133676|4051575|FG005|COMPLETED|Overall Study||9
3318105|NCT03133676|4051576|FG006|COMPLETED|Overall Study||9
3318106|NCT03133676|4051577|FG007|COMPLETED|Overall Study||9
3318107|NCT03133676|4051578|FG008|COMPLETED|Overall Study||9
3318108|NCT03133676|4051570|FG000|NOT COMPLETED|Overall Study||0
3318109|NCT03133676|4051571|FG001|NOT COMPLETED|Overall Study||0
3318110|NCT03133676|4051572|FG002|NOT COMPLETED|Overall Study||0
3318111|NCT03133676|4051573|FG003|NOT COMPLETED|Overall Study||0
3318112|NCT03133676|4051574|FG004|NOT COMPLETED|Overall Study||0
3318113|NCT03133676|4051575|FG005|NOT COMPLETED|Overall Study||0
3318114|NCT03133676|4051576|FG006|NOT COMPLETED|Overall Study||0
3318115|NCT03133676|4051577|FG007|NOT COMPLETED|Overall Study||0
3318116|NCT03133676|4051578|FG008|NOT COMPLETED|Overall Study||0
3318117|NCT03133767|4051607|FG000|STARTED|Overall Study||79
3318118|NCT03133767|4051608|FG001|STARTED|Overall Study||78
3318119|NCT03133767|4051607|FG000|COMPLETED|Overall Study||41
3318120|NCT03133767|4051608|FG001|COMPLETED|Overall Study||53
3318121|NCT03133767|4051607|FG000|NOT COMPLETED|Overall Study||38
3318122|NCT03133767|4051608|FG001|NOT COMPLETED|Overall Study||25
3318123|NCT03134092|4051617|FG000|STARTED|Overall Study||434
3318124|NCT03134092|4051618|FG001|STARTED|Overall Study||435
3318125|NCT03134092|4051619|FG002|STARTED|Overall Study||433
3318126|NCT03134092|4051617|FG000|COMPLETED|Overall Study||434
3318127|NCT03134092|4051618|FG001|COMPLETED|Overall Study||435
3318128|NCT03134092|4051619|FG002|COMPLETED|Overall Study||433
3318129|NCT03134092|4051617|FG000|NOT COMPLETED|Overall Study||0
3318130|NCT03134092|4051618|FG001|NOT COMPLETED|Overall Study||0
3318131|NCT03134092|4051619|FG002|NOT COMPLETED|Overall Study||0
3318132|NCT03134144|4051633|FG000|STARTED|Overall Study||15
3318133|NCT03134144|4051634|FG001|STARTED|Overall Study||30
3318134|NCT03134144|4051633|FG000|COMPLETED|Overall Study||15
3318135|NCT03134144|4051634|FG001|COMPLETED|Overall Study||30
3318136|NCT03134144|4051633|FG000|NOT COMPLETED|Overall Study||0
3318137|NCT03134144|4051634|FG001|NOT COMPLETED|Overall Study||0
3318138|NCT03134183|4051647|FG000|STARTED|Overall Study||36
3318139|NCT03134183|4051648|FG001|STARTED|Overall Study||34
3318140|NCT03134183|4051647|FG000|COMPLETED|Overall Study||35
3318141|NCT03134183|4051648|FG001|COMPLETED|Overall Study||33
3318142|NCT03134183|4051647|FG000|NOT COMPLETED|Overall Study||1
3318143|NCT03134183|4051648|FG001|NOT COMPLETED|Overall Study||1
3318144|NCT03134209|4051657|FG000|STARTED|Overall Study||53
3318145|NCT03134209|4051658|FG001|STARTED|Overall Study||54
3318146|NCT03134209|4051659|FG002|STARTED|Overall Study||53
3318147|NCT03134209|4051657|FG000|COMPLETED|Overall Study||53
3318148|NCT03134209|4051658|FG001|COMPLETED|Overall Study||54
3318149|NCT03134209|4051659|FG002|COMPLETED|Overall Study||53
3318150|NCT03134209|4051657|FG000|NOT COMPLETED|Overall Study||0
3318151|NCT03134209|4051658|FG001|NOT COMPLETED|Overall Study||0
3318152|NCT03134209|4051659|FG002|NOT COMPLETED|Overall Study||0
3318153|NCT03134222|4051670|FG000|STARTED|Treatment Period (Up to Week 12)||19
3318154|NCT03134222|4051671|FG001|STARTED|Treatment Period (Up to Week 12)||18
3318155|NCT03134222|4051672|FG002|STARTED|Treatment Period (Up to Week 12)||10
3318156|NCT03134222|4051673|FG003|STARTED|Treatment Period (Up to Week 12)||0
3318157|NCT03134222|4051674|FG004|STARTED|Treatment Period (Up to Week 12)||0
3318158|NCT03134222|4051670|FG000|COMPLETED|Treatment Period (Up to Week 12)||14
3318159|NCT03134222|4051671|FG001|COMPLETED|Treatment Period (Up to Week 12)||14
3318160|NCT03134222|4051672|FG002|COMPLETED|Treatment Period (Up to Week 12)||8
3318161|NCT03134222|4051673|FG003|COMPLETED|Treatment Period (Up to Week 12)||0
3318162|NCT03134222|4051674|FG004|COMPLETED|Treatment Period (Up to Week 12)||0
3318163|NCT03134222|4051670|FG000|NOT COMPLETED|Treatment Period (Up to Week 12)||5
3172457|NCT01943344|3900007|FG000|STARTED|Overall Study||12
3318164|NCT03134222|4051671|FG001|NOT COMPLETED|Treatment Period (Up to Week 12)||4
3318165|NCT03134222|4051672|FG002|NOT COMPLETED|Treatment Period (Up to Week 12)||2
3318166|NCT03134222|4051673|FG003|NOT COMPLETED|Treatment Period (Up to Week 12)||0
3318167|NCT03134222|4051674|FG004|NOT COMPLETED|Treatment Period (Up to Week 12)||0
3318168|NCT03134222|4051670|FG000|STARTED|Treatment Period (Week 12 to 48)||14
3318169|NCT03134222|4051671|FG001|STARTED|Treatment Period (Week 12 to 48)||14
3318170|NCT03134222|4051672|FG002|STARTED|Treatment Period (Week 12 to 48)|Participants were rerandomized 1:1 to either Placebo to Lanraplenib or Placebo to Filgotinib arm.|0
3318171|NCT03134222|4051673|FG003|STARTED|Treatment Period (Week 12 to 48)|Participants were rerandomized from the Placebo arm.|4
3318172|NCT03134222|4051674|FG004|STARTED|Treatment Period (Week 12 to 48)|Participants were rerandomized from the Placebo arm.|4
3318173|NCT03134222|4051670|FG000|COMPLETED|Treatment Period (Week 12 to 48)||12
3318174|NCT03134222|4051671|FG001|COMPLETED|Treatment Period (Week 12 to 48)||11
3318175|NCT03134222|4051672|FG002|COMPLETED|Treatment Period (Week 12 to 48)||0
3318176|NCT03134222|4051673|FG003|COMPLETED|Treatment Period (Week 12 to 48)||3
3318177|NCT03134222|4051674|FG004|COMPLETED|Treatment Period (Week 12 to 48)||3
3318178|NCT03134222|4051670|FG000|NOT COMPLETED|Treatment Period (Week 12 to 48)||2
3318179|NCT03134222|4051671|FG001|NOT COMPLETED|Treatment Period (Week 12 to 48)||3
3318180|NCT03134222|4051672|FG002|NOT COMPLETED|Treatment Period (Week 12 to 48)||0
3318181|NCT03134222|4051673|FG003|NOT COMPLETED|Treatment Period (Week 12 to 48)||1
3318182|NCT03134222|4051674|FG004|NOT COMPLETED|Treatment Period (Week 12 to 48)||1
3318183|NCT03134248|4051684|FG000|STARTED|Week 1||7
3318184|NCT03134248|4051685|FG001|STARTED|Week 1||8
3318185|NCT03134248|4051686|FG002|STARTED|Week 1||9
3318186|NCT03134248|4051687|FG003|STARTED|Week 1||7
3318187|NCT03134248|4051688|FG004|STARTED|Week 1||9
3318188|NCT03134248|4051689|FG005|STARTED|Week 1||9
3318189|NCT03134248|4051684|FG000|COMPLETED|Week 1||7
3318190|NCT03134248|4051685|FG001|COMPLETED|Week 1||8
3318191|NCT03134248|4051686|FG002|COMPLETED|Week 1||9
3318192|NCT03134248|4051687|FG003|COMPLETED|Week 1||7
3318193|NCT03134248|4051688|FG004|COMPLETED|Week 1||9
3318194|NCT03134248|4051689|FG005|COMPLETED|Week 1||9
3318195|NCT03134248|4051684|FG000|NOT COMPLETED|Week 1||0
3172458|NCT01943344|3900007|FG000|COMPLETED|Overall Study||9
3172459|NCT01943344|3900007|FG000|NOT COMPLETED|Overall Study||3
3172460|NCT01943435|3900016|FG000|STARTED|Baseline Eligibility and Randomization||88
3172461|NCT01943435|3900017|FG001|STARTED|Baseline Eligibility and Randomization||84
3318196|NCT03134248|4051685|FG001|NOT COMPLETED|Week 1||0
3318197|NCT03134248|4051686|FG002|NOT COMPLETED|Week 1||0
3318198|NCT03134248|4051687|FG003|NOT COMPLETED|Week 1||0
3318199|NCT03134248|4051688|FG004|NOT COMPLETED|Week 1||0
3318200|NCT03134248|4051689|FG005|NOT COMPLETED|Week 1||0
3318201|NCT03134248|4051684|FG000|STARTED|Week 2||7
3318202|NCT03134248|4051685|FG001|STARTED|Week 2||8
3318203|NCT03134248|4051686|FG002|STARTED|Week 2||9
3318204|NCT03134248|4051687|FG003|STARTED|Week 2||7
3318205|NCT03134248|4051688|FG004|STARTED|Week 2||9
3318206|NCT03134248|4051689|FG005|STARTED|Week 2||9
3318207|NCT03134248|4051684|FG000|COMPLETED|Week 2||7
3318208|NCT03134248|4051685|FG001|COMPLETED|Week 2||8
3318209|NCT03134248|4051686|FG002|COMPLETED|Week 2||9
3318210|NCT03134248|4051687|FG003|COMPLETED|Week 2||7
3172462|NCT01943435|3900018|FG002|STARTED|Baseline Eligibility and Randomization||87
3172463|NCT01943435|3900016|FG000|COMPLETED|Baseline Eligibility and Randomization||84
3318211|NCT03134248|4051688|FG004|COMPLETED|Week 2||9
3318212|NCT03134248|4051689|FG005|COMPLETED|Week 2||9
3318213|NCT03134248|4051684|FG000|NOT COMPLETED|Week 2||0
3318214|NCT03134248|4051685|FG001|NOT COMPLETED|Week 2||0
3318215|NCT03134248|4051686|FG002|NOT COMPLETED|Week 2||0
3318216|NCT03134248|4051687|FG003|NOT COMPLETED|Week 2||0
3318217|NCT03134248|4051688|FG004|NOT COMPLETED|Week 2||0
3318218|NCT03134248|4051689|FG005|NOT COMPLETED|Week 2||0
3318219|NCT03134248|4051684|FG000|STARTED|Week 3||7
3318220|NCT03134248|4051685|FG001|STARTED|Week 3||8
3318221|NCT03134248|4051686|FG002|STARTED|Week 3||9
3318222|NCT03134248|4051687|FG003|STARTED|Week 3||7
3318223|NCT03134248|4051688|FG004|STARTED|Week 3||9
3318224|NCT03134248|4051689|FG005|STARTED|Week 3||9
3318225|NCT03134248|4051684|FG000|COMPLETED|Week 3||7
3318226|NCT03134248|4051685|FG001|COMPLETED|Week 3||8
3318227|NCT03134248|4051686|FG002|COMPLETED|Week 3||9
3318228|NCT03134248|4051687|FG003|COMPLETED|Week 3||7
3318229|NCT03134248|4051688|FG004|COMPLETED|Week 3||9
3318230|NCT03134248|4051689|FG005|COMPLETED|Week 3||9
3318231|NCT03134248|4051684|FG000|NOT COMPLETED|Week 3||0
3318232|NCT03134248|4051685|FG001|NOT COMPLETED|Week 3||0
3318233|NCT03134248|4051686|FG002|NOT COMPLETED|Week 3||0
3318234|NCT03134248|4051687|FG003|NOT COMPLETED|Week 3||0
3318235|NCT03134248|4051688|FG004|NOT COMPLETED|Week 3||0
3318236|NCT03134248|4051689|FG005|NOT COMPLETED|Week 3||0
3318237|NCT03134313|4051699|FG000|STARTED|Overall Study||25
3318238|NCT03134313|4051699|FG000|COMPLETED|Overall Study||25
3318239|NCT03134313|4051699|FG000|NOT COMPLETED|Overall Study||0
3318240|NCT03134326|4051703|FG000|STARTED|Overall Study||21
3318241|NCT03134326|4051703|FG000|COMPLETED|Overall Study||21
3318242|NCT03134326|4051703|FG000|NOT COMPLETED|Overall Study||0
3318243|NCT03134599|4051707|FG000|STARTED|Week 1||10
3318244|NCT03134599|4051708|FG001|STARTED|Week 1||10
3318245|NCT03134599|4051709|FG002|STARTED|Week 1||10
3318246|NCT03134599|4051710|FG003|STARTED|Week 1||11
3318247|NCT03134599|4051711|FG004|STARTED|Week 1||10
3318248|NCT03134599|4051712|FG005|STARTED|Week 1||9
3318249|NCT03134599|4051707|FG000|COMPLETED|Week 1||10
3318250|NCT03134599|4051708|FG001|COMPLETED|Week 1||10
3318251|NCT03134599|4051709|FG002|COMPLETED|Week 1||10
3318252|NCT03134599|4051710|FG003|COMPLETED|Week 1||11
3318253|NCT03134599|4051711|FG004|COMPLETED|Week 1||9
3318254|NCT03134599|4051712|FG005|COMPLETED|Week 1||9
3318255|NCT03134599|4051707|FG000|NOT COMPLETED|Week 1||0
3318256|NCT03134599|4051708|FG001|NOT COMPLETED|Week 1||0
3318257|NCT03134599|4051709|FG002|NOT COMPLETED|Week 1||0
3318258|NCT03134599|4051710|FG003|NOT COMPLETED|Week 1||0
3318259|NCT03134599|4051711|FG004|NOT COMPLETED|Week 1||1
3318260|NCT03134599|4051712|FG005|NOT COMPLETED|Week 1||0
3318261|NCT03134599|4051707|FG000|STARTED|Week 2||10
3318262|NCT03134599|4051708|FG001|STARTED|Week 2||10
3318263|NCT03134599|4051709|FG002|STARTED|Week 2||10
3318264|NCT03134599|4051710|FG003|STARTED|Week 2||11
3318265|NCT03134599|4051711|FG004|STARTED|Week 2||9
3318266|NCT03134599|4051712|FG005|STARTED|Week 2||9
3318267|NCT03134599|4051707|FG000|COMPLETED|Week 2||9
3318268|NCT03134599|4051708|FG001|COMPLETED|Week 2||10
3318269|NCT03134599|4051709|FG002|COMPLETED|Week 2||10
3318270|NCT03134599|4051710|FG003|COMPLETED|Week 2||10
3318271|NCT03134599|4051711|FG004|COMPLETED|Week 2||8
3318272|NCT03134599|4051712|FG005|COMPLETED|Week 2||9
3318273|NCT03134599|4051707|FG000|NOT COMPLETED|Week 2||1
3318274|NCT03134599|4051708|FG001|NOT COMPLETED|Week 2||0
3318275|NCT03134599|4051709|FG002|NOT COMPLETED|Week 2||0
3318276|NCT03134599|4051710|FG003|NOT COMPLETED|Week 2||1
3318277|NCT03134599|4051711|FG004|NOT COMPLETED|Week 2||1
3318278|NCT03134599|4051712|FG005|NOT COMPLETED|Week 2||0
3318279|NCT03134599|4051707|FG000|STARTED|Week 3||9
3318280|NCT03134599|4051708|FG001|STARTED|Week 3||10
3318281|NCT03134599|4051709|FG002|STARTED|Week 3||10
3318282|NCT03134599|4051710|FG003|STARTED|Week 3||10
3318283|NCT03134599|4051711|FG004|STARTED|Week 3||8
3318284|NCT03134599|4051712|FG005|STARTED|Week 3||9
3318285|NCT03134599|4051707|FG000|COMPLETED|Week 3||9
3318286|NCT03134599|4051708|FG001|COMPLETED|Week 3||10
3318287|NCT03134599|4051709|FG002|COMPLETED|Week 3||10
3318288|NCT03134599|4051710|FG003|COMPLETED|Week 3||9
3318289|NCT03134599|4051711|FG004|COMPLETED|Week 3||8
2921693|NCT00543387|3632282|FG004|COMPLETED|Panel 1 + Panel 2||0
2921694|NCT00543387|3632283|FG005|COMPLETED|Panel 1 + Panel 2||0
2921695|NCT00543387|3632284|FG006|COMPLETED|Panel 1 + Panel 2||0
2921696|NCT00543387|3632285|FG007|COMPLETED|Panel 1 + Panel 2||0
2921697|NCT00543387|3632286|FG008|COMPLETED|Panel 1 + Panel 2||0
3172464|NCT01943435|3900017|FG001|COMPLETED|Baseline Eligibility and Randomization||72
3172465|NCT01943435|3900018|FG002|COMPLETED|Baseline Eligibility and Randomization||84
3172466|NCT01943435|3900016|FG000|NOT COMPLETED|Baseline Eligibility and Randomization||4
3172467|NCT01943435|3900017|FG001|NOT COMPLETED|Baseline Eligibility and Randomization||12
3172468|NCT01943435|3900018|FG002|NOT COMPLETED|Baseline Eligibility and Randomization||3
3172469|NCT01943435|3900016|FG000|STARTED|Intervention Period||84
3172470|NCT01943435|3900017|FG001|STARTED|Intervention Period||72
3318290|NCT03134599|4051712|FG005|COMPLETED|Week 3||8
3318291|NCT03134599|4051707|FG000|NOT COMPLETED|Week 3||0
3318292|NCT03134599|4051708|FG001|NOT COMPLETED|Week 3||0
3318293|NCT03134599|4051709|FG002|NOT COMPLETED|Week 3||0
3318294|NCT03134599|4051710|FG003|NOT COMPLETED|Week 3||1
3318295|NCT03134599|4051711|FG004|NOT COMPLETED|Week 3||0
3318296|NCT03134599|4051712|FG005|NOT COMPLETED|Week 3||1
3318297|NCT03134703|4051722|FG000|STARTED|Overall Study||6
3318298|NCT03134703|4051723|FG001|STARTED|Overall Study||5
3318299|NCT03134703|4051722|FG000|COMPLETED|Overall Study||0
3318300|NCT03134703|4051723|FG001|COMPLETED|Overall Study||3
3318301|NCT03134703|4051722|FG000|NOT COMPLETED|Overall Study||6
3318302|NCT03134703|4051723|FG001|NOT COMPLETED|Overall Study||2
3172471|NCT01943435|3900018|FG002|STARTED|Intervention Period||84
3172472|NCT01943435|3900016|FG000|COMPLETED|Intervention Period||81
3172473|NCT01943435|3900017|FG001|COMPLETED|Intervention Period||69
3172474|NCT01943435|3900018|FG002|COMPLETED|Intervention Period||80
3172475|NCT01943435|3900016|FG000|NOT COMPLETED|Intervention Period||3
3172476|NCT01943435|3900017|FG001|NOT COMPLETED|Intervention Period||3
3172477|NCT01943435|3900018|FG002|NOT COMPLETED|Intervention Period||4
3172478|NCT01943435|3900016|FG000|STARTED|2 Month Follow up||81
3172479|NCT01943435|3900017|FG001|STARTED|2 Month Follow up||69
3318303|NCT03134768|4051729|FG000|STARTED|Overall Study||50
3318304|NCT03134768|4051729|FG000|COMPLETED|Overall Study||50
3318305|NCT03134768|4051729|FG000|NOT COMPLETED|Overall Study||0
3318306|NCT03134911|4051735|FG000|STARTED|Overall Study||535
3318307|NCT03134911|4051735|FG000|COMPLETED|Overall Study||501
3318308|NCT03134911|4051735|FG000|NOT COMPLETED|Overall Study||34
3318309|NCT03134963|4051747|FG000|STARTED|Overall Study||12
3318310|NCT03134963|4051748|FG001|STARTED|Overall Study||13
3318311|NCT03134963|4051749|FG002|STARTED|Overall Study||3
3318312|NCT03134963|4051750|FG003|STARTED|Overall Study||14
3318313|NCT03134963|4051747|FG000|COMPLETED|Overall Study||12
3318314|NCT03134963|4051748|FG001|COMPLETED|Overall Study||13
3318315|NCT03134963|4051749|FG002|COMPLETED|Overall Study||3
3172480|NCT01943435|3900018|FG002|STARTED|2 Month Follow up||80
3172481|NCT01943435|3900016|FG000|COMPLETED|2 Month Follow up||79
3172482|NCT01943435|3900017|FG001|COMPLETED|2 Month Follow up||66
3172483|NCT01943435|3900018|FG002|COMPLETED|2 Month Follow up||80
3172484|NCT01943435|3900016|FG000|NOT COMPLETED|2 Month Follow up||2
3172485|NCT01943435|3900017|FG001|NOT COMPLETED|2 Month Follow up||3
3172486|NCT01943435|3900018|FG002|NOT COMPLETED|2 Month Follow up||0
3172487|NCT01943435|3900016|FG000|STARTED|6 Month Follow up||79
3172488|NCT01943435|3900017|FG001|STARTED|6 Month Follow up||66
3172489|NCT01943435|3900018|FG002|STARTED|6 Month Follow up||80
3172490|NCT01943435|3900016|FG000|COMPLETED|6 Month Follow up||67
3172491|NCT01943435|3900017|FG001|COMPLETED|6 Month Follow up||59
3172492|NCT01943435|3900018|FG002|COMPLETED|6 Month Follow up||65
3172493|NCT01943435|3900016|FG000|NOT COMPLETED|6 Month Follow up||12
3172494|NCT01943435|3900017|FG001|NOT COMPLETED|6 Month Follow up||7
3172495|NCT01943435|3900018|FG002|NOT COMPLETED|6 Month Follow up||15
3172496|NCT01943461|3900030|FG000|STARTED|Overall Study||5
3172497|NCT01943461|3900031|FG001|STARTED|Overall Study||6
3318316|NCT03134963|4051750|FG003|COMPLETED|Overall Study||14
3318317|NCT03134963|4051747|FG000|NOT COMPLETED|Overall Study||0
3172498|NCT01943461|3900032|FG002|STARTED|Overall Study||6
3172499|NCT01943461|3900033|FG003|STARTED|Overall Study||40
3172500|NCT01943461|3900030|FG000|COMPLETED|Overall Study||5
3172501|NCT01943461|3900031|FG001|COMPLETED|Overall Study||6
3172502|NCT01943461|3900032|FG002|COMPLETED|Overall Study||6
3172503|NCT01943461|3900033|FG003|COMPLETED|Overall Study||40
3318318|NCT03134963|4051748|FG001|NOT COMPLETED|Overall Study||0
3318319|NCT03134963|4051749|FG002|NOT COMPLETED|Overall Study||0
3318320|NCT03134963|4051750|FG003|NOT COMPLETED|Overall Study||0
3318321|NCT03134989|4051760|FG000|STARTED|Overall Study||80
3172504|NCT01943461|3900030|FG000|NOT COMPLETED|Overall Study||0
3172505|NCT01943461|3900031|FG001|NOT COMPLETED|Overall Study||0
3172506|NCT01943461|3900032|FG002|NOT COMPLETED|Overall Study||0
3172507|NCT01943461|3900033|FG003|NOT COMPLETED|Overall Study||0
3172508|NCT01943474|3900045|FG000|STARTED|Overall Study||123
3172509|NCT01943474|3900046|FG001|STARTED|Overall Study||125
3172510|NCT01943474|3900045|FG000|COMPLETED|Overall Study||123
3172511|NCT01943474|3900046|FG001|COMPLETED|Overall Study||125
3172512|NCT01943474|3900045|FG000|NOT COMPLETED|Overall Study||0
3172513|NCT01943474|3900046|FG001|NOT COMPLETED|Overall Study||0
3172514|NCT01943539|3900052|FG000|STARTED|Overall Study||44
3172515|NCT01943539|3900053|FG001|STARTED|Overall Study||40
3172516|NCT01943539|3900052|FG000|COMPLETED|Overall Study||40
3172517|NCT01943539|3900053|FG001|COMPLETED|Overall Study||40
3172518|NCT01943539|3900052|FG000|NOT COMPLETED|Overall Study||4
3172519|NCT01943539|3900053|FG001|NOT COMPLETED|Overall Study||0
3172520|NCT01943552|3900062|FG000|STARTED|Overall Study|One patient was randomised to the placebo group, but received nebulized ipratropium bromide.|96
3172521|NCT01943552|3900063|FG001|STARTED|Overall Study||94
3318322|NCT03134989|4051760|FG000|COMPLETED|Overall Study|Clinical investigation termination date: Last Subject, Final Visit 18-Jun-2020|80
3318323|NCT03134989|4051760|FG000|NOT COMPLETED|Overall Study||0
3318324|NCT03135015|4051767|FG000|STARTED|Overall Study||11
3318325|NCT03135015|4051768|FG001|STARTED|Overall Study||11
3318326|NCT03135015|4051767|FG000|Water Control|Overall Study||9
3318327|NCT03135015|4051768|FG001|Water Control|Overall Study||11
3318328|NCT03135015|4051767|FG000|Placebo Capsules|Overall Study||9
3318329|NCT03135015|4051768|FG001|Placebo Capsules|Overall Study||11
3318330|NCT03135015|4051767|FG000|2g Capsules|Overall Study||9
3318331|NCT03135015|4051768|FG001|2g Capsules|Overall Study||11
3172522|NCT01943552|3900062|FG000|COMPLETED|Overall Study||71
3172523|NCT01943552|3900063|FG001|COMPLETED|Overall Study||69
3172524|NCT01943552|3900062|FG000|NOT COMPLETED|Overall Study||25
3172525|NCT01943552|3900063|FG001|NOT COMPLETED|Overall Study||25
3172526|NCT01943565|3900072|FG000|STARTED|Overall Study||11
3172527|NCT01943565|3900073|FG001|STARTED|Overall Study||9
3172528|NCT01943565|3900074|FG002|STARTED|Overall Study||9
3172529|NCT01943565|3900072|FG000|COMPLETED|Overall Study||11
3172530|NCT01943565|3900073|FG001|COMPLETED|Overall Study||9
3172531|NCT01943565|3900074|FG002|COMPLETED|Overall Study||9
3172532|NCT01943565|3900072|FG000|NOT COMPLETED|Overall Study||0
3172533|NCT01943565|3900073|FG001|NOT COMPLETED|Overall Study||0
3172534|NCT01943565|3900074|FG002|NOT COMPLETED|Overall Study||0
3172535|NCT01943591|3900084|FG000|STARTED|Overall Study||104
3172536|NCT01943591|3900085|FG001|STARTED|Overall Study||106
3172537|NCT01943591|3900084|FG000|COMPLETED|Overall Study||99
3172538|NCT01943591|3900085|FG001|COMPLETED|Overall Study||95
3172539|NCT01943591|3900084|FG000|NOT COMPLETED|Overall Study||5
3172540|NCT01943591|3900085|FG001|NOT COMPLETED|Overall Study||11
3172541|NCT01943799|3900095|FG000|STARTED|Overall Study||27
3172542|NCT01943799|3900096|FG001|STARTED|Overall Study||50
3172543|NCT01943799|3900097|FG002|STARTED|Overall Study|1 participant was randomized to OAV + GS-4774 2 YU but received OAV + GS-4774 10 YU.|51
3172544|NCT01943799|3900098|FG003|STARTED|Overall Study||50
3172545|NCT01943799|3900095|FG000|COMPLETED|Overall Study||22
3172546|NCT01943799|3900096|FG001|COMPLETED|Overall Study||47
3172547|NCT01943799|3900097|FG002|COMPLETED|Overall Study||49
3172548|NCT01943799|3900098|FG003|COMPLETED|Overall Study||50
3172549|NCT01943799|3900095|FG000|NOT COMPLETED|Overall Study||5
3172550|NCT01943799|3900096|FG001|NOT COMPLETED|Overall Study||3
3172551|NCT01943799|3900097|FG002|NOT COMPLETED|Overall Study||2
3172552|NCT01943799|3900098|FG003|NOT COMPLETED|Overall Study||0
3172553|NCT01943825|3900112|FG000|STARTED|Overall Study||25
3172554|NCT01943825|3900113|FG001|STARTED|Overall Study||15
3172555|NCT01943825|3900114|FG002|STARTED|Overall Study||25
3172556|NCT01943825|3900115|FG003|STARTED|Overall Study||25
3172557|NCT01943825|3900112|FG000|COMPLETED|Overall Study||15
3172558|NCT01943825|3900113|FG001|COMPLETED|Overall Study||11
3172559|NCT01943825|3900114|FG002|COMPLETED|Overall Study||10
3172560|NCT01943825|3900115|FG003|COMPLETED|Overall Study||14
3172561|NCT01943825|3900112|FG000|NOT COMPLETED|Overall Study||10
3172562|NCT01943825|3900113|FG001|NOT COMPLETED|Overall Study||4
3172563|NCT01943825|3900114|FG002|NOT COMPLETED|Overall Study||15
3172564|NCT01943825|3900115|FG003|NOT COMPLETED|Overall Study||11
3172565|NCT01943851|3900147|FG000|STARTED|Part 1 (Up to 86.9 Weeks)||1
3172566|NCT01943851|3900148|FG001|STARTED|Part 1 (Up to 86.9 Weeks)||1
3172567|NCT01943851|3900149|FG002|STARTED|Part 1 (Up to 86.9 Weeks)||1
3172568|NCT01943851|3900150|FG003|STARTED|Part 1 (Up to 86.9 Weeks)||5
3172569|NCT01943851|3900151|FG004|STARTED|Part 1 (Up to 86.9 Weeks)||1
3318332|NCT03135015|4051767|FG000|4g Capsules|Overall Study||9
3318333|NCT03135015|4051768|FG001|4g Capsules|Overall Study||11
3318334|NCT03135015|4051767|FG000|2g Tablets|Overall Study||9
3318335|NCT03135015|4051768|FG001|2g Tablets|Overall Study||11
3318336|NCT03135015|4051767|FG000|4g Tablets|Overall Study||9
3318337|NCT03135015|4051768|FG001|4g Tablets|Overall Study||11
3318338|NCT03135015|4051767|FG000|COMPLETED|Overall Study||9
3318339|NCT03135015|4051768|FG001|COMPLETED|Overall Study||11
3318340|NCT03135015|4051767|FG000|NOT COMPLETED|Overall Study||2
3318341|NCT03135015|4051768|FG001|NOT COMPLETED|Overall Study||0
3318342|NCT03135028|4051818|FG000|STARTED|Overall Study||9
3318343|NCT03135028|4051818|FG000|COMPLETED|Overall Study||0
3318344|NCT03135028|4051818|FG000|NOT COMPLETED|Overall Study||9
3318345|NCT03135210|4051824|FG000|STARTED|Overall Study||2
3318346|NCT03135210|4051825|FG001|STARTED|Overall Study||2
3318347|NCT03135210|4051824|FG000|COMPLETED|Overall Study||2
3318348|NCT03135210|4051825|FG001|COMPLETED|Overall Study||1
3318349|NCT03135210|4051824|FG000|NOT COMPLETED|Overall Study||0
3318350|NCT03135210|4051825|FG001|NOT COMPLETED|Overall Study||1
3318351|NCT03135379|4051833|FG000|STARTED|Overall Study||62
3318352|NCT03135379|4051834|FG001|STARTED|Overall Study||62
3318353|NCT03135379|4051833|FG000|COMPLETED|Overall Study||61
3318354|NCT03135379|4051834|FG001|COMPLETED|Overall Study||59
3318355|NCT03135379|4051833|FG000|NOT COMPLETED|Overall Study||1
3318356|NCT03135379|4051834|FG001|NOT COMPLETED|Overall Study||3
3318357|NCT03135431|4051842|FG000|STARTED|Overall Study||20
3318358|NCT03135431|4051843|FG001|STARTED|Overall Study||20
3318359|NCT03135431|4051842|FG000|COMPLETED|Overall Study||18
3318360|NCT03135431|4051843|FG001|COMPLETED|Overall Study||20
3318361|NCT03135431|4051842|FG000|NOT COMPLETED|Overall Study||2
3318362|NCT03135431|4051843|FG001|NOT COMPLETED|Overall Study||0
3318363|NCT03135522|4051851|FG000|STARTED|Overall Study||17
3318364|NCT03135522|4051852|FG001|STARTED|Overall Study||17
3318365|NCT03135522|4051851|FG000|COMPLETED|Overall Study||16
3318366|NCT03135522|4051852|FG001|COMPLETED|Overall Study||17
3318367|NCT03135522|4051851|FG000|NOT COMPLETED|Overall Study||1
3318368|NCT03135522|4051852|FG001|NOT COMPLETED|Overall Study||0
3318369|NCT03135535|4051858|FG000|STARTED|Overall Study||30
3318370|NCT03135535|4051858|FG000|COMPLETED|Overall Study||30
3318371|NCT03135535|4051858|FG000|NOT COMPLETED|Overall Study||0
3318372|NCT03135548|4051865|FG000|STARTED|Overall Study||19
3318373|NCT03135548|4051866|FG001|STARTED|Overall Study||19
3318374|NCT03135548|4051867|FG002|STARTED|Overall Study||21
3318375|NCT03135548|4051865|FG000|COMPLETED|Overall Study||14
3318376|NCT03135548|4051866|FG001|COMPLETED|Overall Study||15
3318377|NCT03135548|4051867|FG002|COMPLETED|Overall Study||18
3318378|NCT03135548|4051865|FG000|NOT COMPLETED|Overall Study||5
3318379|NCT03135548|4051866|FG001|NOT COMPLETED|Overall Study||4
3318380|NCT03135548|4051867|FG002|NOT COMPLETED|Overall Study||3
3318381|NCT03135899|4051883|FG000|STARTED|Overall Study||1
3318382|NCT03135899|4051884|FG001|STARTED|Overall Study||1
3318383|NCT03135899|4051885|FG002|STARTED|Overall Study||1
3318384|NCT03135899|4051886|FG003|STARTED|Overall Study||1
3318385|NCT03135899|4051887|FG004|STARTED|Overall Study||8
3318386|NCT03135899|4051888|FG005|STARTED|Overall Study||9
3318387|NCT03135899|4051889|FG006|STARTED|Overall Study||8
3318388|NCT03135899|4051890|FG007|STARTED|Overall Study||8
3318389|NCT03135899|4051883|FG000|COMPLETED|Overall Study||1
3318390|NCT03135899|4051884|FG001|COMPLETED|Overall Study||1
3318391|NCT03135899|4051885|FG002|COMPLETED|Overall Study||1
3318392|NCT03135899|4051886|FG003|COMPLETED|Overall Study||1
3318393|NCT03135899|4051887|FG004|COMPLETED|Overall Study||8
3318394|NCT03135899|4051888|FG005|COMPLETED|Overall Study||7
3318395|NCT03135899|4051889|FG006|COMPLETED|Overall Study||7
3318396|NCT03135899|4051890|FG007|COMPLETED|Overall Study||8
3318397|NCT03135899|4051883|FG000|NOT COMPLETED|Overall Study||0
3318398|NCT03135899|4051884|FG001|NOT COMPLETED|Overall Study||0
3318399|NCT03135899|4051885|FG002|NOT COMPLETED|Overall Study||0
3318400|NCT03135899|4051886|FG003|NOT COMPLETED|Overall Study||0
3318401|NCT03135899|4051887|FG004|NOT COMPLETED|Overall Study||0
3318402|NCT03135899|4051888|FG005|NOT COMPLETED|Overall Study||2
3318403|NCT03135899|4051889|FG006|NOT COMPLETED|Overall Study||1
3318404|NCT03135899|4051890|FG007|NOT COMPLETED|Overall Study||0
3318405|NCT03136068|4051906|FG000|STARTED|Overall Study||88
3318406|NCT03136068|4051907|FG001|STARTED|Overall Study||90
3318407|NCT03136068|4051906|FG000|COMPLETED|Overall Study||86
3318408|NCT03136068|4051907|FG001|COMPLETED|Overall Study||89
3318409|NCT03136068|4051906|FG000|NOT COMPLETED|Overall Study||2
3318410|NCT03136068|4051907|FG001|NOT COMPLETED|Overall Study||1
3318411|NCT03136107|4051913|FG000|STARTED|Overall Study||26
3318412|NCT03136107|4051913|FG000|Test Product|Overall Study||26
3318413|NCT03136107|4051913|FG000|Reference Product|Overall Study||26
3318414|NCT03136107|4051913|FG000|Negative Control|Overall Study||26
3318415|NCT03136107|4051913|FG000|COMPLETED|Overall Study||25
3318416|NCT03136107|4051913|FG000|NOT COMPLETED|Overall Study||1
3318417|NCT03136159|4051923|FG000|STARTED|Overall Study||190
3318418|NCT03136159|4051924|FG001|STARTED|Overall Study||190
3318419|NCT03136159|4051923|FG000|COMPLETED|Overall Study||185
3318420|NCT03136159|4051924|FG001|COMPLETED|Overall Study||190
3318421|NCT03136159|4051923|FG000|NOT COMPLETED|Overall Study||5
3318422|NCT03136159|4051924|FG001|NOT COMPLETED|Overall Study||0
3318423|NCT03136198|4051932|FG000|STARTED|Overall Study||66
3318424|NCT03136198|4051933|FG001|STARTED|Overall Study||64
2921698|NCT00543387|3632287|FG009|COMPLETED|Panel 1 + Panel 2||0
3318425|NCT03136198|4051932|FG000|COMPLETED|Overall Study||66
3318426|NCT03136198|4051933|FG001|COMPLETED|Overall Study||63
3318427|NCT03136198|4051932|FG000|NOT COMPLETED|Overall Study||0
3318428|NCT03136198|4051933|FG001|NOT COMPLETED|Overall Study||1
3318429|NCT03136328|4051939|FG000|STARTED|Overall Study||11
3318430|NCT03136328|4051939|FG000|COMPLETED|Overall Study||11
3318431|NCT03136328|4051939|FG000|NOT COMPLETED|Overall Study||0
3318432|NCT03136367|4051947|FG000|STARTED|T1 Consultation||66
3318433|NCT03136367|4051948|FG001|STARTED|T1 Consultation||248
3318434|NCT03136367|4051949|FG002|STARTED|T1 Consultation||257
3318435|NCT03136367|4051947|FG000|COMPLETED|T1 Consultation|received the intervention|64
3318436|NCT03136367|4051948|FG001|COMPLETED|T1 Consultation||241
3318437|NCT03136367|4051949|FG002|COMPLETED|T1 Consultation||256
3318438|NCT03136367|4051947|FG000|NOT COMPLETED|T1 Consultation||2
3318439|NCT03136367|4051948|FG001|NOT COMPLETED|T1 Consultation||7
3318440|NCT03136367|4051949|FG002|NOT COMPLETED|T1 Consultation||1
3318441|NCT03136367|4051947|FG000|STARTED|T2 Post-consultation||64
3318442|NCT03136367|4051948|FG001|STARTED|T2 Post-consultation||241
3318443|NCT03136367|4051949|FG002|STARTED|T2 Post-consultation||256
3318444|NCT03136367|4051947|FG000|COMPLETED|T2 Post-consultation||61
3318445|NCT03136367|4051948|FG001|COMPLETED|T2 Post-consultation||235
3318446|NCT03136367|4051949|FG002|COMPLETED|T2 Post-consultation||225
3318447|NCT03136367|4051947|FG000|NOT COMPLETED|T2 Post-consultation||3
3318448|NCT03136367|4051948|FG001|NOT COMPLETED|T2 Post-consultation||6
3318449|NCT03136367|4051949|FG002|NOT COMPLETED|T2 Post-consultation||31
3318450|NCT03136367|4051947|FG000|STARTED|T3 1 Week After Surgery||61
3318451|NCT03136367|4051948|FG001|STARTED|T3 1 Week After Surgery||235
3318452|NCT03136367|4051949|FG002|STARTED|T3 1 Week After Surgery||225
3318453|NCT03136367|4051947|FG000|COMPLETED|T3 1 Week After Surgery||51
3318454|NCT03136367|4051948|FG001|COMPLETED|T3 1 Week After Surgery||203
3318455|NCT03136367|4051949|FG002|COMPLETED|T3 1 Week After Surgery||194
3318456|NCT03136367|4051947|FG000|NOT COMPLETED|T3 1 Week After Surgery||10
3318457|NCT03136367|4051948|FG001|NOT COMPLETED|T3 1 Week After Surgery||32
3318458|NCT03136367|4051949|FG002|NOT COMPLETED|T3 1 Week After Surgery||31
3318459|NCT03136367|4051947|FG000|STARTED|T4 12 Weeks After Surgery||51
3318460|NCT03136367|4051948|FG001|STARTED|T4 12 Weeks After Surgery||203
3318461|NCT03136367|4051949|FG002|STARTED|T4 12 Weeks After Surgery||194
3318462|NCT03136367|4051947|FG000|COMPLETED|T4 12 Weeks After Surgery||49
3318463|NCT03136367|4051948|FG001|COMPLETED|T4 12 Weeks After Surgery||198
3318464|NCT03136367|4051949|FG002|COMPLETED|T4 12 Weeks After Surgery||185
3318465|NCT03136367|4051947|FG000|NOT COMPLETED|T4 12 Weeks After Surgery||2
3318466|NCT03136367|4051948|FG001|NOT COMPLETED|T4 12 Weeks After Surgery||5
3318467|NCT03136367|4051949|FG002|NOT COMPLETED|T4 12 Weeks After Surgery||9
3318468|NCT03136367|4051947|FG000|STARTED|T5 1 Year After Surgery||49
3318469|NCT03136367|4051948|FG001|STARTED|T5 1 Year After Surgery||198
3318470|NCT03136367|4051949|FG002|STARTED|T5 1 Year After Surgery||185
3318471|NCT03136367|4051947|FG000|COMPLETED|T5 1 Year After Surgery||13
3318472|NCT03136367|4051948|FG001|COMPLETED|T5 1 Year After Surgery||62
3318473|NCT03136367|4051949|FG002|COMPLETED|T5 1 Year After Surgery||56
3318474|NCT03136367|4051947|FG000|NOT COMPLETED|T5 1 Year After Surgery||36
3318475|NCT03136367|4051948|FG001|NOT COMPLETED|T5 1 Year After Surgery||136
3318476|NCT03136367|4051949|FG002|NOT COMPLETED|T5 1 Year After Surgery||129
3318477|NCT03136380|4051962|FG000|STARTED|Part 1, Period 1 (3 Days)||6
3318478|NCT03136380|4051963|FG001|STARTED|Part 1, Period 1 (3 Days)||6
3318479|NCT03136380|4051964|FG002|STARTED|Part 1, Period 1 (3 Days)||6
3318480|NCT03136380|4051965|FG003|STARTED|Part 1, Period 1 (3 Days)||0
3318481|NCT03136380|4051966|FG004|STARTED|Part 1, Period 1 (3 Days)||0
3318482|NCT03136380|4051962|FG000|COMPLETED|Part 1, Period 1 (3 Days)||6
3318483|NCT03136380|4051963|FG001|COMPLETED|Part 1, Period 1 (3 Days)||6
3318484|NCT03136380|4051964|FG002|COMPLETED|Part 1, Period 1 (3 Days)||6
3318485|NCT03136380|4051965|FG003|COMPLETED|Part 1, Period 1 (3 Days)||0
3318486|NCT03136380|4051966|FG004|COMPLETED|Part 1, Period 1 (3 Days)||0
3318487|NCT03136380|4051962|FG000|NOT COMPLETED|Part 1, Period 1 (3 Days)||0
3318488|NCT03136380|4051963|FG001|NOT COMPLETED|Part 1, Period 1 (3 Days)||0
3318489|NCT03136380|4051964|FG002|NOT COMPLETED|Part 1, Period 1 (3 Days)||0
3318490|NCT03136380|4051965|FG003|NOT COMPLETED|Part 1, Period 1 (3 Days)||0
3318491|NCT03136380|4051966|FG004|NOT COMPLETED|Part 1, Period 1 (3 Days)||0
3318492|NCT03136380|4051962|FG000|STARTED|Part 1, Washout Period 1 (7 Days)||6
3318493|NCT03136380|4051963|FG001|STARTED|Part 1, Washout Period 1 (7 Days)||6
3318494|NCT03136380|4051964|FG002|STARTED|Part 1, Washout Period 1 (7 Days)||6
3318495|NCT03136380|4051965|FG003|STARTED|Part 1, Washout Period 1 (7 Days)||0
3318496|NCT03136380|4051966|FG004|STARTED|Part 1, Washout Period 1 (7 Days)||0
3318497|NCT03136380|4051962|FG000|COMPLETED|Part 1, Washout Period 1 (7 Days)||6
3318498|NCT03136380|4051963|FG001|COMPLETED|Part 1, Washout Period 1 (7 Days)||6
3318499|NCT03136380|4051964|FG002|COMPLETED|Part 1, Washout Period 1 (7 Days)||6
3318500|NCT03136380|4051965|FG003|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
3318501|NCT03136380|4051966|FG004|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
3318502|NCT03136380|4051962|FG000|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
3318503|NCT03136380|4051963|FG001|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
3318504|NCT03136380|4051964|FG002|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
3318505|NCT03136380|4051965|FG003|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
3318506|NCT03136380|4051966|FG004|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
3318507|NCT03136380|4051962|FG000|STARTED|Part 1, Period 2 (3 Days)||6
3318508|NCT03136380|4051963|FG001|STARTED|Part 1, Period 2 (3 Days)||6
3318509|NCT03136380|4051964|FG002|STARTED|Part 1, Period 2 (3 Days)||6
3318510|NCT03136380|4051965|FG003|STARTED|Part 1, Period 2 (3 Days)||0
3318511|NCT03136380|4051966|FG004|STARTED|Part 1, Period 2 (3 Days)||0
3318512|NCT03136380|4051962|FG000|COMPLETED|Part 1, Period 2 (3 Days)||6
3318513|NCT03136380|4051963|FG001|COMPLETED|Part 1, Period 2 (3 Days)||6
3318514|NCT03136380|4051964|FG002|COMPLETED|Part 1, Period 2 (3 Days)||6
3318515|NCT03136380|4051965|FG003|COMPLETED|Part 1, Period 2 (3 Days)||0
3318516|NCT03136380|4051966|FG004|COMPLETED|Part 1, Period 2 (3 Days)||0
3318517|NCT03136380|4051962|FG000|NOT COMPLETED|Part 1, Period 2 (3 Days)||0
3318518|NCT03136380|4051963|FG001|NOT COMPLETED|Part 1, Period 2 (3 Days)||0
3318519|NCT03136380|4051964|FG002|NOT COMPLETED|Part 1, Period 2 (3 Days)||0
3318520|NCT03136380|4051965|FG003|NOT COMPLETED|Part 1, Period 2 (3 Days)||0
3318521|NCT03136380|4051966|FG004|NOT COMPLETED|Part 1, Period 2 (3 Days)||0
3318522|NCT03136380|4051962|FG000|STARTED|Part 1, Washout Period 2 (7 Days)||6
3318523|NCT03136380|4051963|FG001|STARTED|Part 1, Washout Period 2 (7 Days)||6
3318524|NCT03136380|4051964|FG002|STARTED|Part 1, Washout Period 2 (7 Days)||6
3318525|NCT03136380|4051965|FG003|STARTED|Part 1, Washout Period 2 (7 Days)||0
3318526|NCT03136380|4051966|FG004|STARTED|Part 1, Washout Period 2 (7 Days)||0
3318527|NCT03136380|4051962|FG000|COMPLETED|Part 1, Washout Period 2 (7 Days)||6
3318528|NCT03136380|4051963|FG001|COMPLETED|Part 1, Washout Period 2 (7 Days)||5
3318529|NCT03136380|4051964|FG002|COMPLETED|Part 1, Washout Period 2 (7 Days)||6
3318530|NCT03136380|4051965|FG003|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
3318531|NCT03136380|4051966|FG004|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
3318532|NCT03136380|4051962|FG000|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
3318533|NCT03136380|4051963|FG001|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||1
3318534|NCT03136380|4051964|FG002|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
3318535|NCT03136380|4051965|FG003|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
3318536|NCT03136380|4051966|FG004|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
3318537|NCT03136380|4051962|FG000|STARTED|Part 1, Period 3 (4 Days)||6
3318538|NCT03136380|4051963|FG001|STARTED|Part 1, Period 3 (4 Days)||5
3318539|NCT03136380|4051964|FG002|STARTED|Part 1, Period 3 (4 Days)||6
3318540|NCT03136380|4051965|FG003|STARTED|Part 1, Period 3 (4 Days)||0
3318541|NCT03136380|4051966|FG004|STARTED|Part 1, Period 3 (4 Days)||0
3318542|NCT03136380|4051962|FG000|COMPLETED|Part 1, Period 3 (4 Days)||6
3318543|NCT03136380|4051963|FG001|COMPLETED|Part 1, Period 3 (4 Days)||5
3318544|NCT03136380|4051964|FG002|COMPLETED|Part 1, Period 3 (4 Days)||6
3318545|NCT03136380|4051965|FG003|COMPLETED|Part 1, Period 3 (4 Days)||0
3318546|NCT03136380|4051966|FG004|COMPLETED|Part 1, Period 3 (4 Days)||0
3318547|NCT03136380|4051962|FG000|NOT COMPLETED|Part 1, Period 3 (4 Days)||0
3318548|NCT03136380|4051963|FG001|NOT COMPLETED|Part 1, Period 3 (4 Days)||0
3318549|NCT03136380|4051964|FG002|NOT COMPLETED|Part 1, Period 3 (4 Days)||0
3318550|NCT03136380|4051965|FG003|NOT COMPLETED|Part 1, Period 3 (4 Days)||0
3318551|NCT03136380|4051966|FG004|NOT COMPLETED|Part 1, Period 3 (4 Days)||0
3318552|NCT03136380|4051962|FG000|STARTED|Part 2, Period 1 (3 Days)||0
3318553|NCT03136380|4051963|FG001|STARTED|Part 2, Period 1 (3 Days)||0
3318554|NCT03136380|4051964|FG002|STARTED|Part 2, Period 1 (3 Days)||0
3318555|NCT03136380|4051965|FG003|STARTED|Part 2, Period 1 (3 Days)||8
3318556|NCT03136380|4051966|FG004|STARTED|Part 2, Period 1 (3 Days)||8
3318557|NCT03136380|4051962|FG000|COMPLETED|Part 2, Period 1 (3 Days)||0
3318558|NCT03136380|4051963|FG001|COMPLETED|Part 2, Period 1 (3 Days)||0
3318559|NCT03136380|4051964|FG002|COMPLETED|Part 2, Period 1 (3 Days)||0
3318560|NCT03136380|4051965|FG003|COMPLETED|Part 2, Period 1 (3 Days)||8
3318561|NCT03136380|4051966|FG004|COMPLETED|Part 2, Period 1 (3 Days)||8
3318562|NCT03136380|4051962|FG000|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
3318563|NCT03136380|4051963|FG001|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
3318564|NCT03136380|4051964|FG002|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
3318565|NCT03136380|4051965|FG003|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
3318566|NCT03136380|4051966|FG004|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
3318567|NCT03136380|4051962|FG000|STARTED|Part 2, Washout Period 1 (7 Days)||0
3318568|NCT03136380|4051963|FG001|STARTED|Part 2, Washout Period 1 (7 Days)||0
3318569|NCT03136380|4051964|FG002|STARTED|Part 2, Washout Period 1 (7 Days)||0
3318570|NCT03136380|4051965|FG003|STARTED|Part 2, Washout Period 1 (7 Days)||8
3318571|NCT03136380|4051966|FG004|STARTED|Part 2, Washout Period 1 (7 Days)||8
3318572|NCT03136380|4051962|FG000|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
3318573|NCT03136380|4051963|FG001|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
3318574|NCT03136380|4051964|FG002|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
3318575|NCT03136380|4051965|FG003|COMPLETED|Part 2, Washout Period 1 (7 Days)||8
3318576|NCT03136380|4051966|FG004|COMPLETED|Part 2, Washout Period 1 (7 Days)||8
3318577|NCT03136380|4051962|FG000|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
3318578|NCT03136380|4051963|FG001|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
3318579|NCT03136380|4051964|FG002|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
3318580|NCT03136380|4051965|FG003|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
3318581|NCT03136380|4051966|FG004|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
3318582|NCT03136380|4051962|FG000|STARTED|Part 2, Period 2 (3 Days)||0
3318583|NCT03136380|4051963|FG001|STARTED|Part 2, Period 2 (3 Days)||0
3318584|NCT03136380|4051964|FG002|STARTED|Part 2, Period 2 (3 Days)||0
3318585|NCT03136380|4051965|FG003|STARTED|Part 2, Period 2 (3 Days)||8
3318586|NCT03136380|4051966|FG004|STARTED|Part 2, Period 2 (3 Days)||8
3318587|NCT03136380|4051962|FG000|COMPLETED|Part 2, Period 2 (3 Days)||0
3318588|NCT03136380|4051963|FG001|COMPLETED|Part 2, Period 2 (3 Days)||0
3318589|NCT03136380|4051964|FG002|COMPLETED|Part 2, Period 2 (3 Days)||0
3318590|NCT03136380|4051965|FG003|COMPLETED|Part 2, Period 2 (3 Days)||8
3318591|NCT03136380|4051966|FG004|COMPLETED|Part 2, Period 2 (3 Days)||8
3318592|NCT03136380|4051962|FG000|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
3318593|NCT03136380|4051963|FG001|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
3318594|NCT03136380|4051964|FG002|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
3318595|NCT03136380|4051965|FG003|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
3318596|NCT03136380|4051966|FG004|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
3318597|NCT03136484|4051986|FG000|STARTED|Overall Study||394
3318598|NCT03136484|4051987|FG001|STARTED|Overall Study||394
3318599|NCT03136484|4051986|FG000|Exposed|Overall Study||392
3318600|NCT03136484|4051987|FG001|Exposed|Overall Study||394
3318601|NCT03136484|4051986|FG000|COMPLETED|Overall Study||367
3318602|NCT03136484|4051987|FG001|COMPLETED|Overall Study||372
3318603|NCT03136484|4051986|FG000|NOT COMPLETED|Overall Study||27
3318604|NCT03136484|4051987|FG001|NOT COMPLETED|Overall Study||22
3318605|NCT03136861|4052000|FG000|STARTED|Treatment Period 1 (TP1)(Baseline-Wk 8)||285
3318606|NCT03136861|4052001|FG001|STARTED|Treatment Period 1 (TP1)(Baseline-Wk 8)||95
3318607|NCT03136861|4052002|FG002|STARTED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
3318608|NCT03136861|4052003|FG003|STARTED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
3318609|NCT03136861|4052004|FG004|STARTED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
3318610|NCT03136861|4052005|FG005|STARTED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
3318611|NCT03136861|4052006|FG006|STARTED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
3318612|NCT03136861|4052000|FG000|COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||278
3318613|NCT03136861|4052001|FG001|COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||89
3318614|NCT03136861|4052002|FG002|COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
3318615|NCT03136861|4052003|FG003|COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
3318616|NCT03136861|4052004|FG004|COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
3318617|NCT03136861|4052005|FG005|COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
3318618|NCT03136861|4052006|FG006|COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
3318619|NCT03136861|4052000|FG000|NOT COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||7
3318620|NCT03136861|4052001|FG001|NOT COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||6
3318621|NCT03136861|4052002|FG002|NOT COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
3318622|NCT03136861|4052003|FG003|NOT COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
3318623|NCT03136861|4052004|FG004|NOT COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
3318624|NCT03136861|4052005|FG005|NOT COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
3318625|NCT03136861|4052006|FG006|NOT COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
3318626|NCT03136861|4052000|FG000|STARTED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||0
3318627|NCT03136861|4052001|FG001|STARTED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||0
3318628|NCT03136861|4052002|FG002|STARTED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||90
3318629|NCT03136861|4052003|FG003|STARTED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||94
3318630|NCT03136861|4052004|FG004|STARTED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||94
3318631|NCT03136861|4052005|FG005|STARTED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||45
3318632|NCT03136861|4052006|FG006|STARTED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||44
3318633|NCT03136861|4052000|FG000|COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||0
3318634|NCT03136861|4052001|FG001|COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||0
3318635|NCT03136861|4052002|FG002|COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||88
3318636|NCT03136861|4052003|FG003|COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||93
3318637|NCT03136861|4052004|FG004|COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||92
3318638|NCT03136861|4052005|FG005|COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||45
3318639|NCT03136861|4052006|FG006|COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||43
3318640|NCT03136861|4052000|FG000|NOT COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||0
3318641|NCT03136861|4052001|FG001|NOT COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||0
3318642|NCT03136861|4052002|FG002|NOT COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||2
3318643|NCT03136861|4052003|FG003|NOT COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||1
3318644|NCT03136861|4052004|FG004|NOT COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||2
3318645|NCT03136861|4052005|FG005|NOT COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||0
3318646|NCT03136861|4052006|FG006|NOT COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||1
3318647|NCT03136913|4052017|FG000|STARTED|Overall Study||13
3318648|NCT03136913|4052017|FG000|Subjects Received Both Intervention|Overall Study|10 subjects with 10 OFT and 10 CFT sites received clinical measurement before implant surgery|10
3318649|NCT03136913|4052017|FG000|COMPLETED|Overall Study|8 subjects with 8 OFT and 8 CFT sites received implant surgery|8
3318650|NCT03136913|4052017|FG000|NOT COMPLETED|Overall Study||5
3318651|NCT03137069|4052030|FG000|STARTED|Overall Study||13
3318652|NCT03137069|4052031|FG001|STARTED|Overall Study||28
3318653|NCT03137069|4052032|FG002|STARTED|Overall Study||23
3318654|NCT03137069|4052033|FG003|STARTED|Overall Study||23
3318655|NCT03137069|4052034|FG004|STARTED|Overall Study||24
3318656|NCT03137069|4052035|FG005|STARTED|Overall Study||23
3318657|NCT03137069|4052030|FG000|COMPLETED|Overall Study||12
3318658|NCT03137069|4052031|FG001|COMPLETED|Overall Study||22
3318659|NCT03137069|4052032|FG002|COMPLETED|Overall Study||20
3318660|NCT03137069|4052033|FG003|COMPLETED|Overall Study||17
3318661|NCT03137069|4052034|FG004|COMPLETED|Overall Study||22
3318662|NCT03137069|4052035|FG005|COMPLETED|Overall Study||21
3318663|NCT03137069|4052030|FG000|NOT COMPLETED|Overall Study||1
3318664|NCT03137069|4052031|FG001|NOT COMPLETED|Overall Study||6
3318665|NCT03137069|4052032|FG002|NOT COMPLETED|Overall Study||3
3318666|NCT03137069|4052033|FG003|NOT COMPLETED|Overall Study||6
3318667|NCT03137069|4052034|FG004|NOT COMPLETED|Overall Study||2
3318668|NCT03137069|4052035|FG005|NOT COMPLETED|Overall Study||2
3318669|NCT03137121|4052055|FG000|STARTED|Overall Study||15
3318670|NCT03137121|4052056|FG001|STARTED|Overall Study||15
3318671|NCT03137121|4052055|FG000|COMPLETED|Overall Study||15
3318672|NCT03137121|4052056|FG001|COMPLETED|Overall Study||14
3318673|NCT03137121|4052055|FG000|NOT COMPLETED|Overall Study||0
3318674|NCT03137121|4052056|FG001|NOT COMPLETED|Overall Study||1
3318675|NCT03137173|4052064|FG000|STARTED|Overall Study||335
3318676|NCT03137173|4052065|FG001|STARTED|Overall Study||344
3318677|NCT03137173|4052064|FG000|COMPLETED|Overall Study||309
3318678|NCT03137173|4052065|FG001|COMPLETED|Overall Study||308
3318679|NCT03137173|4052064|FG000|NOT COMPLETED|Overall Study||26
3318680|NCT03137173|4052065|FG001|NOT COMPLETED|Overall Study||36
3318681|NCT03137303|4052074|FG000|STARTED|T0: Time of Enrollment - Baseline Visit||231
3318682|NCT03137303|4052075|FG001|STARTED|T0: Time of Enrollment - Baseline Visit||171
3318683|NCT03137303|4052074|FG000|COMPLETED|T0: Time of Enrollment - Baseline Visit||231
3318684|NCT03137303|4052075|FG001|COMPLETED|T0: Time of Enrollment - Baseline Visit||171
3318685|NCT03137303|4052074|FG000|NOT COMPLETED|T0: Time of Enrollment - Baseline Visit||0
3318686|NCT03137303|4052075|FG001|NOT COMPLETED|T0: Time of Enrollment - Baseline Visit||0
3318687|NCT03137303|4052074|FG000|STARTED|T1: 3-month Follow-up||231
3318688|NCT03137303|4052075|FG001|STARTED|T1: 3-month Follow-up||171
3318689|NCT03137303|4052074|FG000|COMPLETED|T1: 3-month Follow-up||225
3318690|NCT03137303|4052075|FG001|COMPLETED|T1: 3-month Follow-up||161
3318691|NCT03137303|4052074|FG000|NOT COMPLETED|T1: 3-month Follow-up||6
3318692|NCT03137303|4052075|FG001|NOT COMPLETED|T1: 3-month Follow-up||10
3318693|NCT03137303|4052074|FG000|STARTED|T2: 6-month Follow-up||230
3318694|NCT03137303|4052075|FG001|STARTED|T2: 6-month Follow-up||167
3318695|NCT03137303|4052074|FG000|COMPLETED|T2: 6-month Follow-up||225
3318696|NCT03137303|4052075|FG001|COMPLETED|T2: 6-month Follow-up||162
3318697|NCT03137303|4052074|FG000|NOT COMPLETED|T2: 6-month Follow-up||5
3318698|NCT03137303|4052075|FG001|NOT COMPLETED|T2: 6-month Follow-up||5
3318699|NCT03137303|4052074|FG000|STARTED|T3: 9-month Follow-up||230
3318700|NCT03137303|4052075|FG001|STARTED|T3: 9-month Follow-up||167
3318701|NCT03137303|4052074|FG000|COMPLETED|T3: 9-month Follow-up||225
3318702|NCT03137303|4052075|FG001|COMPLETED|T3: 9-month Follow-up||163
3318703|NCT03137303|4052074|FG000|NOT COMPLETED|T3: 9-month Follow-up||5
3318704|NCT03137303|4052075|FG001|NOT COMPLETED|T3: 9-month Follow-up||4
3318705|NCT03137303|4052074|FG000|STARTED|T4: 12-month Follow-up||229
3318706|NCT03137303|4052075|FG001|STARTED|T4: 12-month Follow-up||167
3318707|NCT03137303|4052074|FG000|COMPLETED|T4: 12-month Follow-up||222
3318708|NCT03137303|4052075|FG001|COMPLETED|T4: 12-month Follow-up||162
3318709|NCT03137303|4052074|FG000|NOT COMPLETED|T4: 12-month Follow-up||7
3318710|NCT03137303|4052075|FG001|NOT COMPLETED|T4: 12-month Follow-up||5
3318711|NCT03137459|4052083|FG000|STARTED|2-month Assessment||455
3318712|NCT03137459|4052084|FG001|STARTED|2-month Assessment||454
3318713|NCT03137459|4052083|FG000|COMPLETED|2-month Assessment||387
3318714|NCT03137459|4052084|FG001|COMPLETED|2-month Assessment||412
3318715|NCT03137459|4052083|FG000|NOT COMPLETED|2-month Assessment||68
3318716|NCT03137459|4052084|FG001|NOT COMPLETED|2-month Assessment||42
3318717|NCT03137459|4052083|FG000|STARTED|4-month Assessment||442
3318718|NCT03137459|4052084|FG001|STARTED|4-month Assessment||451
3318719|NCT03137459|4052083|FG000|COMPLETED|4-month Assessment||364
3318720|NCT03137459|4052084|FG001|COMPLETED|4-month Assessment||405
3318721|NCT03137459|4052083|FG000|NOT COMPLETED|4-month Assessment||78
3318722|NCT03137459|4052084|FG001|NOT COMPLETED|4-month Assessment||46
3318723|NCT03137459|4052083|FG000|STARTED|6-months||434
3318724|NCT03137459|4052084|FG001|STARTED|6-months||447
3318725|NCT03137459|4052083|FG000|COMPLETED|6-months||413
3318726|NCT03137459|4052084|FG001|COMPLETED|6-months||430
3318727|NCT03137459|4052083|FG000|NOT COMPLETED|6-months||21
3318728|NCT03137459|4052084|FG001|NOT COMPLETED|6-months||17
3318729|NCT03137693|4052091|FG000|STARTED|Overall Study||20
3318730|NCT03137693|4052091|FG000|COMPLETED|Overall Study||20
3318731|NCT03137693|4052091|FG000|NOT COMPLETED|Overall Study||0
3318732|NCT03137784|4052095|FG000|STARTED|Overall Study||24
3318733|NCT03137784|4052096|FG001|STARTED|Overall Study||25
3318734|NCT03137784|4052097|FG002|STARTED|Overall Study||25
3318735|NCT03137784|4052098|FG003|STARTED|Overall Study||24
3318736|NCT03137784|4052099|FG004|STARTED|Overall Study||25
3318737|NCT03137784|4052100|FG005|STARTED|Overall Study||25
3318738|NCT03137784|4052095|FG000|COMPLETED|Overall Study||22
3318739|NCT03137784|4052096|FG001|COMPLETED|Overall Study||24
3318740|NCT03137784|4052097|FG002|COMPLETED|Overall Study||25
3318741|NCT03137784|4052098|FG003|COMPLETED|Overall Study||24
3318742|NCT03137784|4052099|FG004|COMPLETED|Overall Study||24
3318743|NCT03137784|4052100|FG005|COMPLETED|Overall Study||25
3318744|NCT03137784|4052095|FG000|NOT COMPLETED|Overall Study||2
3318745|NCT03137784|4052096|FG001|NOT COMPLETED|Overall Study||1
3318746|NCT03137784|4052097|FG002|NOT COMPLETED|Overall Study||0
3318747|NCT03137784|4052098|FG003|NOT COMPLETED|Overall Study||0
3318748|NCT03137784|4052099|FG004|NOT COMPLETED|Overall Study||1
3318749|NCT03137784|4052100|FG005|NOT COMPLETED|Overall Study||0
3318750|NCT03137992|4052108|FG000|STARTED|Period 1 (Visit 2)||62
3318751|NCT03137992|4052109|FG001|STARTED|Period 1 (Visit 2)||63
3318752|NCT03137992|4052110|FG002|STARTED|Period 1 (Visit 2)||63
3318753|NCT03137992|4052111|FG003|STARTED|Period 1 (Visit 2)||63
3318754|NCT03137992|4052112|FG004|STARTED|Period 1 (Visit 2)||62
3318755|NCT03137992|4052113|FG005|STARTED|Period 1 (Visit 2)||61
3318756|NCT03137992|4052108|FG000|COMPLETED|Period 1 (Visit 2)||62
3318757|NCT03137992|4052109|FG001|COMPLETED|Period 1 (Visit 2)||63
3318758|NCT03137992|4052110|FG002|COMPLETED|Period 1 (Visit 2)||63
3318759|NCT03137992|4052111|FG003|COMPLETED|Period 1 (Visit 2)||63
3318760|NCT03137992|4052112|FG004|COMPLETED|Period 1 (Visit 2)||62
3318761|NCT03137992|4052113|FG005|COMPLETED|Period 1 (Visit 2)||61
3318762|NCT03137992|4052108|FG000|NOT COMPLETED|Period 1 (Visit 2)||0
3318763|NCT03137992|4052109|FG001|NOT COMPLETED|Period 1 (Visit 2)||0
3318764|NCT03137992|4052110|FG002|NOT COMPLETED|Period 1 (Visit 2)||0
3318765|NCT03137992|4052111|FG003|NOT COMPLETED|Period 1 (Visit 2)||0
3318766|NCT03137992|4052112|FG004|NOT COMPLETED|Period 1 (Visit 2)||0
3318767|NCT03137992|4052113|FG005|NOT COMPLETED|Period 1 (Visit 2)||0
3318768|NCT03137992|4052108|FG000|STARTED|Washout Period 1||62
3318769|NCT03137992|4052109|FG001|STARTED|Washout Period 1||63
3318770|NCT03137992|4052110|FG002|STARTED|Washout Period 1||63
3318771|NCT03137992|4052111|FG003|STARTED|Washout Period 1||63
3318772|NCT03137992|4052112|FG004|STARTED|Washout Period 1||62
3318773|NCT03137992|4052113|FG005|STARTED|Washout Period 1||61
3318774|NCT03137992|4052108|FG000|COMPLETED|Washout Period 1||59
3318775|NCT03137992|4052109|FG001|COMPLETED|Washout Period 1||59
3318776|NCT03137992|4052110|FG002|COMPLETED|Washout Period 1||61
3318777|NCT03137992|4052111|FG003|COMPLETED|Washout Period 1||63
3318778|NCT03137992|4052112|FG004|COMPLETED|Washout Period 1||60
3318779|NCT03137992|4052113|FG005|COMPLETED|Washout Period 1||59
3318780|NCT03137992|4052108|FG000|NOT COMPLETED|Washout Period 1||3
3318781|NCT03137992|4052109|FG001|NOT COMPLETED|Washout Period 1||4
3318782|NCT03137992|4052110|FG002|NOT COMPLETED|Washout Period 1||2
3318783|NCT03137992|4052111|FG003|NOT COMPLETED|Washout Period 1||0
3318784|NCT03137992|4052112|FG004|NOT COMPLETED|Washout Period 1||2
3318785|NCT03137992|4052113|FG005|NOT COMPLETED|Washout Period 1||2
3318786|NCT03137992|4052108|FG000|STARTED|Period 2 (Visit 3)||59
3318787|NCT03137992|4052109|FG001|STARTED|Period 2 (Visit 3)||59
3318788|NCT03137992|4052110|FG002|STARTED|Period 2 (Visit 3)||61
3318789|NCT03137992|4052111|FG003|STARTED|Period 2 (Visit 3)||63
3318790|NCT03137992|4052112|FG004|STARTED|Period 2 (Visit 3)||60
3318791|NCT03137992|4052113|FG005|STARTED|Period 2 (Visit 3)||59
3318792|NCT03137992|4052108|FG000|COMPLETED|Period 2 (Visit 3)||56
3318793|NCT03137992|4052109|FG001|COMPLETED|Period 2 (Visit 3)||52
3318794|NCT03137992|4052110|FG002|COMPLETED|Period 2 (Visit 3)||58
3318795|NCT03137992|4052111|FG003|COMPLETED|Period 2 (Visit 3)||58
3172570|NCT01943851|3900152|FG005|STARTED|Part 1 (Up to 86.9 Weeks)||4
3172571|NCT01943851|3900153|FG006|STARTED|Part 1 (Up to 86.9 Weeks)||8
3172572|NCT01943851|3900154|FG007|STARTED|Part 1 (Up to 86.9 Weeks)||18
2921699|NCT00543387|3632288|FG010|COMPLETED|Panel 1 + Panel 2||0
2921700|NCT00543387|3632278|FG000|NOT COMPLETED|Panel 1 + Panel 2||3
2921701|NCT00543387|3632279|FG001|NOT COMPLETED|Panel 1 + Panel 2||3
2921702|NCT00543387|3632280|FG002|NOT COMPLETED|Panel 1 + Panel 2||3
2921703|NCT00543387|3632281|FG003|NOT COMPLETED|Panel 1 + Panel 2||3
2921704|NCT00543387|3632282|FG004|NOT COMPLETED|Panel 1 + Panel 2||3
2921705|NCT00543387|3632283|FG005|NOT COMPLETED|Panel 1 + Panel 2||3
2921706|NCT00543387|3632284|FG006|NOT COMPLETED|Panel 1 + Panel 2||6
2921707|NCT00543387|3632285|FG007|NOT COMPLETED|Panel 1 + Panel 2||6
2921708|NCT00543387|3632286|FG008|NOT COMPLETED|Panel 1 + Panel 2||5
2921709|NCT00543387|3632287|FG009|NOT COMPLETED|Panel 1 + Panel 2||0
2921710|NCT00543387|3632288|FG010|NOT COMPLETED|Panel 1 + Panel 2||0
2921711|NCT00543387|3632278|FG000|STARTED|Crossover Participants||0
2921712|NCT00543387|3632279|FG001|STARTED|Crossover Participants||0
2921713|NCT00543387|3632280|FG002|STARTED|Crossover Participants||0
2921714|NCT00543387|3632281|FG003|STARTED|Crossover Participants||0
2921715|NCT00543387|3632282|FG004|STARTED|Crossover Participants||0
2921716|NCT00543387|3632283|FG005|STARTED|Crossover Participants||0
2921717|NCT00543387|3632284|FG006|STARTED|Crossover Participants||0
2921718|NCT00543387|3632285|FG007|STARTED|Crossover Participants||0
2921719|NCT00543387|3632286|FG008|STARTED|Crossover Participants||0
2921720|NCT00543387|3632287|FG009|STARTED|Crossover Participants|Participant originally treated in MK-5108 400 mg BID (Panel 1) in Period 1|1
2921721|NCT00543387|3632288|FG010|STARTED|Crossover Participants|3 participants originally treated with 1500 (2) and 1800 mg (1) MK-5108 in Panel 1 Period 1|3
2921722|NCT00543387|3632278|FG000|COMPLETED|Crossover Participants||0
2921723|NCT00543387|3632279|FG001|COMPLETED|Crossover Participants||0
3172573|NCT01943851|3900155|FG008|STARTED|Part 1 (Up to 86.9 Weeks)||3
3172574|NCT01943851|3900156|FG009|STARTED|Part 1 (Up to 86.9 Weeks)||8
3172575|NCT01943851|3900157|FG010|STARTED|Part 1 (Up to 86.9 Weeks)||1
3172576|NCT01943851|3900158|FG011|STARTED|Part 1 (Up to 86.9 Weeks)||7
3172577|NCT01943851|3900159|FG012|STARTED|Part 1 (Up to 86.9 Weeks)||7
3172578|NCT01943851|3900160|FG013|STARTED|Part 1 (Up to 86.9 Weeks)||16
2921724|NCT00543387|3632280|FG002|COMPLETED|Crossover Participants||0
3172579|NCT01943851|3900161|FG014|STARTED|Part 1 (Up to 86.9 Weeks)||6
3172580|NCT01943851|3900162|FG015|STARTED|Part 1 (Up to 86.9 Weeks)||0
3172581|NCT01943851|3900163|FG016|STARTED|Part 1 (Up to 86.9 Weeks)||0
3172582|NCT01943851|3900164|FG017|STARTED|Part 1 (Up to 86.9 Weeks)||0
3172583|NCT01943851|3900147|FG000|COMPLETED|Part 1 (Up to 86.9 Weeks)||1
3172584|NCT01943851|3900148|FG001|COMPLETED|Part 1 (Up to 86.9 Weeks)||1
3172585|NCT01943851|3900149|FG002|COMPLETED|Part 1 (Up to 86.9 Weeks)||1
3318796|NCT03137992|4052112|FG004|COMPLETED|Period 2 (Visit 3)||56
3318797|NCT03137992|4052113|FG005|COMPLETED|Period 2 (Visit 3)||51
2921725|NCT00543387|3632281|FG003|COMPLETED|Crossover Participants||0
2921726|NCT00543387|3632282|FG004|COMPLETED|Crossover Participants||0
2921727|NCT00543387|3632283|FG005|COMPLETED|Crossover Participants||0
2921728|NCT00543387|3632284|FG006|COMPLETED|Crossover Participants||0
2921729|NCT00543387|3632285|FG007|COMPLETED|Crossover Participants||0
2921730|NCT00543387|3632286|FG008|COMPLETED|Crossover Participants||0
2921731|NCT00543387|3632287|FG009|COMPLETED|Crossover Participants||0
2921732|NCT00543387|3632288|FG010|COMPLETED|Crossover Participants||0
2921733|NCT00543387|3632278|FG000|NOT COMPLETED|Crossover Participants||0
2921734|NCT00543387|3632279|FG001|NOT COMPLETED|Crossover Participants||0
3172586|NCT01943851|3900150|FG003|COMPLETED|Part 1 (Up to 86.9 Weeks)||4
3318798|NCT03137992|4052108|FG000|NOT COMPLETED|Period 2 (Visit 3)||3
3318799|NCT03137992|4052109|FG001|NOT COMPLETED|Period 2 (Visit 3)||7
3318800|NCT03137992|4052110|FG002|NOT COMPLETED|Period 2 (Visit 3)||3
3318801|NCT03137992|4052111|FG003|NOT COMPLETED|Period 2 (Visit 3)||5
3318802|NCT03137992|4052112|FG004|NOT COMPLETED|Period 2 (Visit 3)||4
3318803|NCT03137992|4052113|FG005|NOT COMPLETED|Period 2 (Visit 3)||8
3318804|NCT03137992|4052108|FG000|STARTED|Washout Period 2||56
3318805|NCT03137992|4052109|FG001|STARTED|Washout Period 2||52
3318806|NCT03137992|4052110|FG002|STARTED|Washout Period 2||58
3318807|NCT03137992|4052111|FG003|STARTED|Washout Period 2||58
3318808|NCT03137992|4052112|FG004|STARTED|Washout Period 2||56
3172587|NCT01943851|3900151|FG004|COMPLETED|Part 1 (Up to 86.9 Weeks)||0
3172588|NCT01943851|3900152|FG005|COMPLETED|Part 1 (Up to 86.9 Weeks)||4
3172589|NCT01943851|3900153|FG006|COMPLETED|Part 1 (Up to 86.9 Weeks)||7
3172590|NCT01943851|3900154|FG007|COMPLETED|Part 1 (Up to 86.9 Weeks)||16
3172591|NCT01943851|3900155|FG008|COMPLETED|Part 1 (Up to 86.9 Weeks)||2
3172592|NCT01943851|3900156|FG009|COMPLETED|Part 1 (Up to 86.9 Weeks)||8
3172593|NCT01943851|3900157|FG010|COMPLETED|Part 1 (Up to 86.9 Weeks)||1
3172594|NCT01943851|3900158|FG011|COMPLETED|Part 1 (Up to 86.9 Weeks)||7
3172595|NCT01943851|3900159|FG012|COMPLETED|Part 1 (Up to 86.9 Weeks)||7
3172596|NCT01943851|3900160|FG013|COMPLETED|Part 1 (Up to 86.9 Weeks)||15
3172597|NCT01943851|3900161|FG014|COMPLETED|Part 1 (Up to 86.9 Weeks)||6
3172598|NCT01943851|3900162|FG015|COMPLETED|Part 1 (Up to 86.9 Weeks)||0
3172599|NCT01943851|3900163|FG016|COMPLETED|Part 1 (Up to 86.9 Weeks)||0
3172600|NCT01943851|3900164|FG017|COMPLETED|Part 1 (Up to 86.9 Weeks)||0
3172601|NCT01943851|3900147|FG000|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||0
3172602|NCT01943851|3900148|FG001|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||0
3172603|NCT01943851|3900149|FG002|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||0
3172604|NCT01943851|3900150|FG003|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||1
3172605|NCT01943851|3900151|FG004|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||1
3172606|NCT01943851|3900152|FG005|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||0
3172607|NCT01943851|3900153|FG006|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||1
3172608|NCT01943851|3900154|FG007|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||2
3172609|NCT01943851|3900155|FG008|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||1
3172610|NCT01943851|3900156|FG009|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||0
3172611|NCT01943851|3900157|FG010|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||0
3172612|NCT01943851|3900158|FG011|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||0
3172613|NCT01943851|3900159|FG012|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||0
3172614|NCT01943851|3900160|FG013|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||1
3172615|NCT01943851|3900161|FG014|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||0
3172616|NCT01943851|3900162|FG015|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||0
3172617|NCT01943851|3900163|FG016|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||0
3172618|NCT01943851|3900164|FG017|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||0
2921735|NCT00543387|3632280|FG002|NOT COMPLETED|Crossover Participants||0
2921736|NCT00543387|3632281|FG003|NOT COMPLETED|Crossover Participants||0
2921737|NCT00543387|3632282|FG004|NOT COMPLETED|Crossover Participants||0
2921738|NCT00543387|3632283|FG005|NOT COMPLETED|Crossover Participants||0
2921739|NCT00543387|3632284|FG006|NOT COMPLETED|Crossover Participants||0
2921740|NCT00543387|3632285|FG007|NOT COMPLETED|Crossover Participants||0
2921741|NCT00543387|3632286|FG008|NOT COMPLETED|Crossover Participants||0
2921742|NCT00543387|3632287|FG009|NOT COMPLETED|Crossover Participants||1
2921743|NCT00543387|3632288|FG010|NOT COMPLETED|Crossover Participants||3
2921744|NCT00543400|3632316|FG000|STARTED|Overall Study||151
2921745|NCT00543400|3632317|FG001|STARTED|Overall Study||44
2921746|NCT00543400|3632318|FG002|STARTED|Overall Study||152
2921747|NCT00543400|3632319|FG003|STARTED|Overall Study||156
2921748|NCT00543400|3632316|FG000|COMPLETED|Overall Study||146
2921749|NCT00543400|3632317|FG001|COMPLETED|Overall Study||43
2921750|NCT00543400|3632318|FG002|COMPLETED|Overall Study||148
2921751|NCT00543400|3632319|FG003|COMPLETED|Overall Study||151
2921752|NCT00543400|3632316|FG000|NOT COMPLETED|Overall Study||5
2921753|NCT00543400|3632317|FG001|NOT COMPLETED|Overall Study||1
2921754|NCT00543400|3632318|FG002|NOT COMPLETED|Overall Study||4
2921755|NCT00543400|3632319|FG003|NOT COMPLETED|Overall Study||5
2921756|NCT00543439|3632332|FG000|STARTED|Period 1||10
2921757|NCT00543439|3632333|FG001|STARTED|Period 1||29
2921758|NCT00543439|3632334|FG002|STARTED|Period 1||27
2921759|NCT00543439|3632332|FG000|Treated|Period 1||9
2921760|NCT00543439|3632333|FG001|Treated|Period 1||29
2921761|NCT00543439|3632334|FG002|Treated|Period 1||27
2921762|NCT00543439|3632332|FG000|COMPLETED|Period 1||9
2921763|NCT00543439|3632333|FG001|COMPLETED|Period 1||26
2921764|NCT00543439|3632334|FG002|COMPLETED|Period 1||25
2921765|NCT00543439|3632332|FG000|NOT COMPLETED|Period 1||1
2921766|NCT00543439|3632333|FG001|NOT COMPLETED|Period 1||3
2921767|NCT00543439|3632334|FG002|NOT COMPLETED|Period 1||2
2921768|NCT00543439|3632332|FG000|STARTED|Period 2||9
2921769|NCT00543439|3632333|FG001|STARTED|Period 2||26
2921770|NCT00543439|3632334|FG002|STARTED|Period 2||25
2921771|NCT00543439|3632332|FG000|COMPLETED|Period 2||8
2921772|NCT00543439|3632333|FG001|COMPLETED|Period 2||25
2921773|NCT00543439|3632334|FG002|COMPLETED|Period 2||23
2921774|NCT00543439|3632332|FG000|NOT COMPLETED|Period 2||1
2921775|NCT00543439|3632333|FG001|NOT COMPLETED|Period 2||1
2921776|NCT00543439|3632334|FG002|NOT COMPLETED|Period 2||2
2921777|NCT00543543|3632355|FG000|STARTED|Base Study||315
2921778|NCT00543543|3632356|FG001|STARTED|Base Study||7106
2921779|NCT00543543|3632357|FG002|STARTED|Base Study||310
2921780|NCT00543543|3632358|FG003|STARTED|Base Study||7109
2921781|NCT00543543|3632355|FG000|Completed 3 Vaccinations|Base Study||300
2921782|NCT00543543|3632356|FG001|Completed 3 Vaccinations|Base Study||6928
2921783|NCT00543543|3632357|FG002|Completed 3 Vaccinations|Base Study||297
2921784|NCT00543543|3632358|FG003|Completed 3 Vaccinations|Base Study||6934
2921785|NCT00543543|3632355|FG000|COMPLETED|Base Study|Follow-up was up to 7 months|295
3172619|NCT01943851|3900147|FG000|STARTED|Part 2 (Up to 36.4 Weeks)||0
3172620|NCT01943851|3900148|FG001|STARTED|Part 2 (Up to 36.4 Weeks)||0
3172621|NCT01943851|3900149|FG002|STARTED|Part 2 (Up to 36.4 Weeks)||0
3172622|NCT01943851|3900150|FG003|STARTED|Part 2 (Up to 36.4 Weeks)||0
3172623|NCT01943851|3900151|FG004|STARTED|Part 2 (Up to 36.4 Weeks)||0
3172624|NCT01943851|3900152|FG005|STARTED|Part 2 (Up to 36.4 Weeks)||0
3172625|NCT01943851|3900153|FG006|STARTED|Part 2 (Up to 36.4 Weeks)||0
3172626|NCT01943851|3900154|FG007|STARTED|Part 2 (Up to 36.4 Weeks)||0
3172627|NCT01943851|3900155|FG008|STARTED|Part 2 (Up to 36.4 Weeks)||0
3172628|NCT01943851|3900156|FG009|STARTED|Part 2 (Up to 36.4 Weeks)||0
3318809|NCT03137992|4052113|FG005|STARTED|Washout Period 2||51
3318810|NCT03137992|4052108|FG000|COMPLETED|Washout Period 2||54
3172629|NCT01943851|3900157|FG010|STARTED|Part 2 (Up to 36.4 Weeks)||0
3172630|NCT01943851|3900158|FG011|STARTED|Part 2 (Up to 36.4 Weeks)||0
3172631|NCT01943851|3900159|FG012|STARTED|Part 2 (Up to 36.4 Weeks)||0
3172632|NCT01943851|3900160|FG013|STARTED|Part 2 (Up to 36.4 Weeks)||0
3172633|NCT01943851|3900161|FG014|STARTED|Part 2 (Up to 36.4 Weeks)||0
3172634|NCT01943851|3900162|FG015|STARTED|Part 2 (Up to 36.4 Weeks)||7
3172635|NCT01943851|3900163|FG016|STARTED|Part 2 (Up to 36.4 Weeks)||16
3172636|NCT01943851|3900164|FG017|STARTED|Part 2 (Up to 36.4 Weeks)||1
3172637|NCT01943851|3900147|FG000|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
3172638|NCT01943851|3900148|FG001|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
3318811|NCT03137992|4052109|FG001|COMPLETED|Washout Period 2||50
3318812|NCT03137992|4052110|FG002|COMPLETED|Washout Period 2||58
3318813|NCT03137992|4052111|FG003|COMPLETED|Washout Period 2||57
3318814|NCT03137992|4052112|FG004|COMPLETED|Washout Period 2||53
3318815|NCT03137992|4052113|FG005|COMPLETED|Washout Period 2||50
3318816|NCT03137992|4052108|FG000|NOT COMPLETED|Washout Period 2||2
3318817|NCT03137992|4052109|FG001|NOT COMPLETED|Washout Period 2||2
3318818|NCT03137992|4052110|FG002|NOT COMPLETED|Washout Period 2||0
3318819|NCT03137992|4052111|FG003|NOT COMPLETED|Washout Period 2||1
3318820|NCT03137992|4052112|FG004|NOT COMPLETED|Washout Period 2||3
3318821|NCT03137992|4052113|FG005|NOT COMPLETED|Washout Period 2||1
3318822|NCT03137992|4052108|FG000|STARTED|Period 3 (Visit 04)||54
2921786|NCT00543543|3632356|FG001|COMPLETED|Base Study|Follow-up was up to 54 months|5854
2921787|NCT00543543|3632357|FG002|COMPLETED|Base Study|Follow-up was up to 7 months|296
2921788|NCT00543543|3632358|FG003|COMPLETED|Base Study|Follow-up was up to 54 months|5887
2921789|NCT00543543|3632355|FG000|NOT COMPLETED|Base Study||20
2921790|NCT00543543|3632356|FG001|NOT COMPLETED|Base Study||1252
2921791|NCT00543543|3632357|FG002|NOT COMPLETED|Base Study||14
2921792|NCT00543543|3632358|FG003|NOT COMPLETED|Base Study||1222
2921793|NCT00543543|3632355|FG000|STARTED|Extension Study|This group did not participate in the Extension Study|0
2921794|NCT00543543|3632356|FG001|STARTED|Extension Study|Cohort 1|150
2921795|NCT00543543|3632357|FG002|STARTED|Extension Study|This group did not participate in the Extension Study|0
2921796|NCT00543543|3632358|FG003|STARTED|Extension Study|Cohort 2|3050
2921797|NCT00543543|3632355|FG000|COMPLETED|Extension Study||0
2921798|NCT00543543|3632356|FG001|COMPLETED|Extension Study||150
2921799|NCT00543543|3632357|FG002|COMPLETED|Extension Study||0
2921800|NCT00543543|3632358|FG003|COMPLETED|Extension Study||2824
2921801|NCT00543543|3632355|FG000|NOT COMPLETED|Extension Study||0
2921802|NCT00543543|3632356|FG001|NOT COMPLETED|Extension Study||0
2921803|NCT00543543|3632357|FG002|NOT COMPLETED|Extension Study||0
2921804|NCT00543543|3632358|FG003|NOT COMPLETED|Extension Study||226
2921805|NCT00543569|3632377|FG000|STARTED|Overall Study||82
2921806|NCT00543569|3632378|FG001|STARTED|Overall Study||80
2921807|NCT00543569|3632379|FG002|STARTED|Overall Study||80
2921808|NCT00543569|3632380|FG003|STARTED|Overall Study||81
2921809|NCT00543569|3632377|FG000|Received Treatment|Overall Study||79
2921810|NCT00543569|3632378|FG001|Received Treatment|Overall Study||77
2921811|NCT00543569|3632379|FG002|Received Treatment|Overall Study||75
2921812|NCT00543569|3632380|FG003|Received Treatment|Overall Study||78
2921813|NCT00543569|3632377|FG000|COMPLETED|Overall Study||70
2921814|NCT00543569|3632378|FG001|COMPLETED|Overall Study||72
2921815|NCT00543569|3632379|FG002|COMPLETED|Overall Study||60
2921816|NCT00543569|3632380|FG003|COMPLETED|Overall Study||72
2921817|NCT00543569|3632377|FG000|NOT COMPLETED|Overall Study||12
2921818|NCT00543569|3632378|FG001|NOT COMPLETED|Overall Study||8
2921819|NCT00543569|3632379|FG002|NOT COMPLETED|Overall Study||20
2921820|NCT00543569|3632380|FG003|NOT COMPLETED|Overall Study||9
2921821|NCT00543725|3632392|FG000|STARTED|Overall Study||340
2921822|NCT00543725|3632393|FG001|STARTED|Overall Study||338
2921823|NCT00543725|3632392|FG000|COMPLETED|Overall Study||272
2921824|NCT00543725|3632393|FG001|COMPLETED|Overall Study||264
3172639|NCT01943851|3900149|FG002|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
3172640|NCT01943851|3900150|FG003|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
2921825|NCT00543725|3632392|FG000|NOT COMPLETED|Overall Study||68
2921826|NCT00543725|3632393|FG001|NOT COMPLETED|Overall Study||74
2921827|NCT00543764|3632401|FG000|STARTED|Overall Study||100
2921828|NCT00543764|3632402|FG001|STARTED|Overall Study||50
2921829|NCT00543764|3632401|FG000|COMPLETED|Overall Study||100
2921830|NCT00543764|3632402|FG001|COMPLETED|Overall Study||50
2921831|NCT00543764|3632401|FG000|NOT COMPLETED|Overall Study||0
2921832|NCT00543764|3632402|FG001|NOT COMPLETED|Overall Study||0
2921833|NCT00543777|3632408|FG000|STARTED|Overall Study||44
2921834|NCT00543777|3632408|FG000|COMPLETED|Overall Study||44
2921835|NCT00543777|3632408|FG000|NOT COMPLETED|Overall Study||0
2921836|NCT00543803|3632412|FG000|STARTED|Overall Study||334
3172641|NCT01943851|3900151|FG004|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
3172642|NCT01943851|3900152|FG005|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
3172643|NCT01943851|3900153|FG006|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
3172644|NCT01943851|3900154|FG007|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
3172645|NCT01943851|3900155|FG008|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
3172646|NCT01943851|3900156|FG009|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
3172647|NCT01943851|3900157|FG010|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
3172648|NCT01943851|3900158|FG011|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
3172649|NCT01943851|3900159|FG012|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
3172650|NCT01943851|3900160|FG013|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
3172651|NCT01943851|3900161|FG014|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
3172652|NCT01943851|3900162|FG015|COMPLETED|Part 2 (Up to 36.4 Weeks)||1
3172653|NCT01943851|3900163|FG016|COMPLETED|Part 2 (Up to 36.4 Weeks)||13
3172654|NCT01943851|3900164|FG017|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
3172655|NCT01943851|3900147|FG000|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0
3172656|NCT01943851|3900148|FG001|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0
3172657|NCT01943851|3900149|FG002|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0
3172658|NCT01943851|3900150|FG003|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0
2921837|NCT00543803|3632412|FG000|COMPLETED|Overall Study||192
2921838|NCT00543803|3632412|FG000|NOT COMPLETED|Overall Study||142
2921839|NCT00543855|3632422|FG000|STARTED|Overall Study||35
2921840|NCT00543855|3632423|FG001|STARTED|Overall Study||33
2921841|NCT00543855|3632424|FG002|STARTED|Overall Study||37
2921842|NCT00543855|3632425|FG003|STARTED|Overall Study||34
2921843|NCT00543855|3632422|FG000|COMPLETED|Overall Study||31
2921844|NCT00543855|3632423|FG001|COMPLETED|Overall Study||31
2921845|NCT00543855|3632424|FG002|COMPLETED|Overall Study||31
2921846|NCT00543855|3632425|FG003|COMPLETED|Overall Study||30
2921847|NCT00543855|3632422|FG000|NOT COMPLETED|Overall Study||4
2921848|NCT00543855|3632423|FG001|NOT COMPLETED|Overall Study||2
2921849|NCT00543855|3632424|FG002|NOT COMPLETED|Overall Study||6
2921850|NCT00543855|3632425|FG003|NOT COMPLETED|Overall Study||4
2921851|NCT00543985|3632435|FG000|STARTED|Overall Study||36
2921852|NCT00543985|3632435|FG000|COMPLETED|Overall Study||32
2921853|NCT00543985|3632435|FG000|NOT COMPLETED|Overall Study||4
2921854|NCT00544076|3632445|FG000|STARTED|Overall Study||34
2921855|NCT00544076|3632446|FG001|STARTED|Overall Study||35
2921856|NCT00544076|3632447|FG002|STARTED|Overall Study||31
2921857|NCT00544076|3632445|FG000|COMPLETED|Overall Study||17
2921858|NCT00544076|3632446|FG001|COMPLETED|Overall Study||19
2921859|NCT00544076|3632447|FG002|COMPLETED|Overall Study||20
2921860|NCT00544076|3632445|FG000|NOT COMPLETED|Overall Study||17
2921861|NCT00544076|3632446|FG001|NOT COMPLETED|Overall Study||16
2921862|NCT00544076|3632447|FG002|NOT COMPLETED|Overall Study||11
2921863|NCT00544167|3632456|FG000|STARTED|Overall Study||45
2921864|NCT00544167|3632456|FG000|COMPLETED|Overall Study||16
2921865|NCT00544167|3632456|FG000|NOT COMPLETED|Overall Study||29
2921866|NCT00544440|3632460|FG000|STARTED|Overall Study||57
2921867|NCT00544440|3632460|FG000|COMPLETED|Overall Study||0
3038545|NCT01154283|3757932|FG001|STARTED|0-6 Weeks||14
3038546|NCT01154283|3757931|FG000|COMPLETED|0-6 Weeks||7
3038547|NCT01154283|3757932|FG001|COMPLETED|0-6 Weeks||11
3038548|NCT01154283|3757931|FG000|NOT COMPLETED|0-6 Weeks||7
3038549|NCT01154283|3757932|FG001|NOT COMPLETED|0-6 Weeks||3
3038550|NCT01154283|3757931|FG000|STARTED|7-12 Weeks||7
3038551|NCT01154283|3757932|FG001|STARTED|7-12 Weeks||11
3038552|NCT01154283|3757931|FG000|COMPLETED|7-12 Weeks||6
3038553|NCT01154283|3757932|FG001|COMPLETED|7-12 Weeks||10
3038554|NCT01154283|3757931|FG000|NOT COMPLETED|7-12 Weeks||1
3038555|NCT01154283|3757932|FG001|NOT COMPLETED|7-12 Weeks||1
3038556|NCT01154296|3757940|FG000|STARTED|Randomization and Intervention||2505
3038557|NCT01154296|3757941|FG001|STARTED|Randomization and Intervention||2507
3038558|NCT01154296|3757940|FG000|COMPLETED|Randomization and Intervention||2500
3038559|NCT01154296|3757941|FG001|COMPLETED|Randomization and Intervention||2505
3038560|NCT01154296|3757940|FG000|NOT COMPLETED|Randomization and Intervention||5
3038561|NCT01154296|3757941|FG001|NOT COMPLETED|Randomization and Intervention||2
3038562|NCT01154296|3757940|FG000|STARTED|6-month Follow-up||2505
3038563|NCT01154296|3757941|FG001|STARTED|6-month Follow-up||2507
3172659|NCT01943851|3900151|FG004|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0
3172660|NCT01943851|3900152|FG005|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0
3172661|NCT01943851|3900153|FG006|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0
3172662|NCT01943851|3900154|FG007|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0
3172663|NCT01943851|3900155|FG008|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0
3172664|NCT01943851|3900156|FG009|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0
3172665|NCT01943851|3900157|FG010|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0
3172666|NCT01943851|3900158|FG011|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0
3318823|NCT03137992|4052109|FG001|STARTED|Period 3 (Visit 04)||50
3318824|NCT03137992|4052110|FG002|STARTED|Period 3 (Visit 04)||58
3318825|NCT03137992|4052111|FG003|STARTED|Period 3 (Visit 04)||57
3318826|NCT03137992|4052112|FG004|STARTED|Period 3 (Visit 04)||53
3172667|NCT01943851|3900159|FG012|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0
3172668|NCT01943851|3900160|FG013|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0
3172669|NCT01943851|3900161|FG014|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0
3172670|NCT01943851|3900162|FG015|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||6
3172671|NCT01943851|3900163|FG016|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||3
3172672|NCT01943851|3900164|FG017|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||1
3172673|NCT01943864|3900205|FG000|STARTED|Overall Study||20
3318827|NCT03137992|4052113|FG005|STARTED|Period 3 (Visit 04)||50
3318828|NCT03137992|4052108|FG000|COMPLETED|Period 3 (Visit 04)||48
3318829|NCT03137992|4052109|FG001|COMPLETED|Period 3 (Visit 04)||48
3318830|NCT03137992|4052110|FG002|COMPLETED|Period 3 (Visit 04)||55
3318831|NCT03137992|4052111|FG003|COMPLETED|Period 3 (Visit 04)||57
3318832|NCT03137992|4052112|FG004|COMPLETED|Period 3 (Visit 04)||50
3318833|NCT03137992|4052113|FG005|COMPLETED|Period 3 (Visit 04)||47
3318834|NCT03137992|4052108|FG000|NOT COMPLETED|Period 3 (Visit 04)||6
3318835|NCT03137992|4052109|FG001|NOT COMPLETED|Period 3 (Visit 04)||2
3318836|NCT03137992|4052110|FG002|NOT COMPLETED|Period 3 (Visit 04)||3
3318837|NCT03137992|4052111|FG003|NOT COMPLETED|Period 3 (Visit 04)||0
3318838|NCT03137992|4052112|FG004|NOT COMPLETED|Period 3 (Visit 04)||3
3318839|NCT03137992|4052113|FG005|NOT COMPLETED|Period 3 (Visit 04)||3
3318840|NCT03137992|4052108|FG000|STARTED|Part 2 (Open-label Extension)||22
3318841|NCT03137992|4052109|FG001|STARTED|Part 2 (Open-label Extension)||17
3318842|NCT03137992|4052110|FG002|STARTED|Part 2 (Open-label Extension)||21
3318843|NCT03137992|4052111|FG003|STARTED|Part 2 (Open-label Extension)||25
3318844|NCT03137992|4052112|FG004|STARTED|Part 2 (Open-label Extension)||18
3318845|NCT03137992|4052113|FG005|STARTED|Part 2 (Open-label Extension)||22
3318846|NCT03137992|4052108|FG000|COMPLETED|Part 2 (Open-label Extension)||20
3318847|NCT03137992|4052109|FG001|COMPLETED|Part 2 (Open-label Extension)||17
3318848|NCT03137992|4052110|FG002|COMPLETED|Part 2 (Open-label Extension)||20
3318849|NCT03137992|4052111|FG003|COMPLETED|Part 2 (Open-label Extension)||24
3318850|NCT03137992|4052112|FG004|COMPLETED|Part 2 (Open-label Extension)||18
3318851|NCT03137992|4052113|FG005|COMPLETED|Part 2 (Open-label Extension)||21
3318852|NCT03137992|4052108|FG000|NOT COMPLETED|Part 2 (Open-label Extension)||2
3318853|NCT03137992|4052109|FG001|NOT COMPLETED|Part 2 (Open-label Extension)||0
3318854|NCT03137992|4052110|FG002|NOT COMPLETED|Part 2 (Open-label Extension)||1
3318855|NCT03137992|4052111|FG003|NOT COMPLETED|Part 2 (Open-label Extension)||1
3318856|NCT03137992|4052112|FG004|NOT COMPLETED|Part 2 (Open-label Extension)||0
3318857|NCT03137992|4052113|FG005|NOT COMPLETED|Part 2 (Open-label Extension)||1
3318858|NCT03138330|4052121|FG000|STARTED|Overall Study||95
3318859|NCT03138330|4052121|FG000|COMPLETED|Overall Study||91
3318860|NCT03138330|4052121|FG000|NOT COMPLETED|Overall Study||4
3318861|NCT03138382|4052127|FG000|STARTED|Overall Study||10
3318862|NCT03138382|4052128|FG001|STARTED|Overall Study||10
2921868|NCT00544440|3632460|FG000|NOT COMPLETED|Overall Study||57
2921869|NCT00544544|3632464|FG000|STARTED|Overall Study||14
2921870|NCT00544544|3632464|FG000|COMPLETED|Overall Study||11
2921871|NCT00544544|3632464|FG000|NOT COMPLETED|Overall Study||3
2921872|NCT00544557|3632468|FG000|STARTED|Overall Study||1685
2921873|NCT00544557|3632468|FG000|COMPLETED|Overall Study||1251
2921874|NCT00544557|3632468|FG000|NOT COMPLETED|Overall Study||434
2921875|NCT00544648|3632474|FG000|STARTED|Overall Study||11
2921876|NCT00544648|3632475|FG001|STARTED|Overall Study||2
2921877|NCT00544648|3632474|FG000|COMPLETED|Overall Study||8
2921878|NCT00544648|3632475|FG001|COMPLETED|Overall Study||1
2921879|NCT00544648|3632474|FG000|NOT COMPLETED|Overall Study||3
2921880|NCT00544648|3632475|FG001|NOT COMPLETED|Overall Study||1
2921881|NCT00544674|3632483|FG000|STARTED|Overall Study|1 subject registered and expired prior to dosing|5
2921882|NCT00544674|3632483|FG000|COMPLETED|Overall Study||4
2921883|NCT00544674|3632483|FG000|NOT COMPLETED|Overall Study||1
2921884|NCT00544713|3632489|FG000|STARTED|Overall Study||114
2921885|NCT00544713|3632490|FG001|STARTED|Overall Study||114
2921886|NCT00544713|3632489|FG000|COMPLETED|Overall Study||111
2921887|NCT00544713|3632490|FG001|COMPLETED|Overall Study||109
2921888|NCT00544713|3632489|FG000|NOT COMPLETED|Overall Study||3
2921889|NCT00544713|3632490|FG001|NOT COMPLETED|Overall Study||5
2921890|NCT00544778|3632496|FG000|STARTED|Overall Study||7
2921891|NCT00544778|3632496|FG000|COMPLETED|Overall Study||7
2921892|NCT00544778|3632496|FG000|NOT COMPLETED|Overall Study||0
2921893|NCT00544817|3632500|FG000|STARTED|Combined Modality||47
2921894|NCT00544817|3632500|FG000|COMPLETED|Combined Modality||40
2921895|NCT00544817|3632500|FG000|NOT COMPLETED|Combined Modality||7
2921896|NCT00544817|3632500|FG000|STARTED|No Treatment Interval||40
2921897|NCT00544817|3632500|FG000|COMPLETED|No Treatment Interval||28
2921898|NCT00544817|3632500|FG000|NOT COMPLETED|No Treatment Interval||12
2921899|NCT00544817|3632500|FG000|STARTED|Follow-up Systemic Therapy||28
2921900|NCT00544817|3632500|FG000|COMPLETED|Follow-up Systemic Therapy||9
2921901|NCT00544817|3632500|FG000|NOT COMPLETED|Follow-up Systemic Therapy||19
2921902|NCT00544869|3632507|FG000|STARTED|Overall Study||36
2921903|NCT00544869|3632508|FG001|STARTED|Overall Study||14
2921904|NCT00544869|3632509|FG002|STARTED|Overall Study||2
2921905|NCT00544869|3632507|FG000|COMPLETED|Overall Study||24
2921906|NCT00544869|3632508|FG001|COMPLETED|Overall Study||12
2921907|NCT00544869|3632509|FG002|COMPLETED|Overall Study||2
2921908|NCT00544869|3632507|FG000|NOT COMPLETED|Overall Study||12
2921909|NCT00544869|3632508|FG001|NOT COMPLETED|Overall Study||2
2921910|NCT00544869|3632509|FG002|NOT COMPLETED|Overall Study||0
2921911|NCT00544882|3632519|FG000|STARTED|Cycle 1: Run-in Cycle||61
3038564|NCT01154296|3757940|FG000|COMPLETED|6-month Follow-up||2177
3038565|NCT01154296|3757941|FG001|COMPLETED|6-month Follow-up||2179
3038566|NCT01154296|3757940|FG000|NOT COMPLETED|6-month Follow-up||328
3038567|NCT01154296|3757941|FG001|NOT COMPLETED|6-month Follow-up||328
3038568|NCT01154322|3757947|FG000|STARTED|Overall Study||16
3038569|NCT01154322|3757947|FG000|COMPLETED|Overall Study||14
3318863|NCT03138382|4052127|FG000|COMPLETED|Overall Study||10
3318864|NCT03138382|4052128|FG001|COMPLETED|Overall Study||10
3318865|NCT03138382|4052127|FG000|NOT COMPLETED|Overall Study||0
3318866|NCT03138382|4052128|FG001|NOT COMPLETED|Overall Study||0
3318867|NCT03138577|4052141|FG000|STARTED|Overall Study||3
3318868|NCT03138577|4052142|FG001|STARTED|Overall Study||3
3318869|NCT03138577|4052143|FG002|STARTED|Overall Study||3
3318870|NCT03138577|4052144|FG003|STARTED|Overall Study||3
3318871|NCT03138577|4052145|FG004|STARTED|Overall Study||3
3318872|NCT03138577|4052146|FG005|STARTED|Overall Study||3
2921912|NCT00544882|3632520|FG001|STARTED|Cycle 1: Run-in Cycle||0
2921913|NCT00544882|3632521|FG002|STARTED|Cycle 1: Run-in Cycle||0
2921914|NCT00544882|3632519|FG000|COMPLETED|Cycle 1: Run-in Cycle||58
2921915|NCT00544882|3632520|FG001|COMPLETED|Cycle 1: Run-in Cycle||0
2921916|NCT00544882|3632521|FG002|COMPLETED|Cycle 1: Run-in Cycle||0
2921917|NCT00544882|3632519|FG000|NOT COMPLETED|Cycle 1: Run-in Cycle||3
2921918|NCT00544882|3632520|FG001|NOT COMPLETED|Cycle 1: Run-in Cycle||0
2921919|NCT00544882|3632521|FG002|NOT COMPLETED|Cycle 1: Run-in Cycle||0
2921920|NCT00544882|3632519|FG000|STARTED|Cycle 2: Randomized Treatment Cycle||0
2921921|NCT00544882|3632520|FG001|STARTED|Cycle 2: Randomized Treatment Cycle||29
2921922|NCT00544882|3632521|FG002|STARTED|Cycle 2: Randomized Treatment Cycle||29
2921923|NCT00544882|3632519|FG000|Treated|Cycle 2: Randomized Treatment Cycle||0
2921924|NCT00544882|3632520|FG001|Treated|Cycle 2: Randomized Treatment Cycle|One participant withdrew prior to treatment|28
2921925|NCT00544882|3632521|FG002|Treated|Cycle 2: Randomized Treatment Cycle|One participant was dropped from the study due to noncompliance prior to treatment.|28
2921926|NCT00544882|3632519|FG000|COMPLETED|Cycle 2: Randomized Treatment Cycle||0
2921927|NCT00544882|3632520|FG001|COMPLETED|Cycle 2: Randomized Treatment Cycle||28
2921928|NCT00544882|3632521|FG002|COMPLETED|Cycle 2: Randomized Treatment Cycle||28
2921929|NCT00544882|3632519|FG000|NOT COMPLETED|Cycle 2: Randomized Treatment Cycle||0
2921930|NCT00544882|3632520|FG001|NOT COMPLETED|Cycle 2: Randomized Treatment Cycle||1
2921931|NCT00544882|3632521|FG002|NOT COMPLETED|Cycle 2: Randomized Treatment Cycle||1
2921932|NCT00544882|3632519|FG000|STARTED|Cycle 3: Follow-up||0
2921933|NCT00544882|3632520|FG001|STARTED|Cycle 3: Follow-up||28
2921934|NCT00544882|3632521|FG002|STARTED|Cycle 3: Follow-up||28
2921935|NCT00544882|3632519|FG000|COMPLETED|Cycle 3: Follow-up||0
2921936|NCT00544882|3632520|FG001|COMPLETED|Cycle 3: Follow-up|Completed 21 days of Cycle 3|26
2921937|NCT00544882|3632521|FG002|COMPLETED|Cycle 3: Follow-up|Completed 21 days of Cycle 3|28
2921938|NCT00544882|3632519|FG000|NOT COMPLETED|Cycle 3: Follow-up||0
2921939|NCT00544882|3632520|FG001|NOT COMPLETED|Cycle 3: Follow-up||2
2921940|NCT00544882|3632521|FG002|NOT COMPLETED|Cycle 3: Follow-up||0
2921941|NCT00544908|3632527|FG000|STARTED|Overall Study||7
2921942|NCT00544908|3632527|FG000|COMPLETED|Overall Study||7
2921943|NCT00544908|3632527|FG000|NOT COMPLETED|Overall Study||0
2921944|NCT00545025|3632533|FG000|STARTED|Overall Study||160
2921945|NCT00545025|3632534|FG001|STARTED|Overall Study||83
2921946|NCT00545025|3632533|FG000|COMPLETED|Overall Study||160
2921947|NCT00545025|3632534|FG001|COMPLETED|Overall Study||83
2921948|NCT00545025|3632533|FG000|NOT COMPLETED|Overall Study||0
2921949|NCT00545025|3632534|FG001|NOT COMPLETED|Overall Study||0
2921950|NCT00545051|3632542|FG000|STARTED|Overall Study||68
2921951|NCT00545051|3632543|FG001|STARTED|Overall Study||72
2921952|NCT00545051|3632542|FG000|COMPLETED|Overall Study||59
2921953|NCT00545051|3632543|FG001|COMPLETED|Overall Study||65
2921954|NCT00545051|3632542|FG000|NOT COMPLETED|Overall Study||9
2921955|NCT00545051|3632543|FG001|NOT COMPLETED|Overall Study||7
2921956|NCT00545064|3632549|FG000|STARTED|Overall Study||178
2921957|NCT00545064|3632549|FG000|Visit 1 (Baseline)|Overall Study||178
2921958|NCT00545064|3632549|FG000|Visit 2 (Week 4)|Overall Study||169
2921959|NCT00545064|3632549|FG000|Visit 3 (Week 8)|Overall Study|8 patients didn't complete the 8-week period. 6 were retrieved and considered as Visit 3 (Week 8)|176
2921960|NCT00545064|3632549|FG000|COMPLETED|Overall Study||170
2921961|NCT00545064|3632549|FG000|NOT COMPLETED|Overall Study||8
2921962|NCT00545077|3632557|FG000|STARTED|Overall Study||189
3172674|NCT01943864|3900205|FG000|COMPLETED|Overall Study|Death or 1 year from randomization after progression was considered completion; 20 participants died|20
3172675|NCT01943864|3900205|FG000|NOT COMPLETED|Overall Study||0
3172676|NCT01943916|3900209|FG000|STARTED|Overall Study||2105
3172677|NCT01943916|3900209|FG000|COMPLETED|Overall Study||1739
3172678|NCT01943916|3900209|FG000|NOT COMPLETED|Overall Study||366
3318873|NCT03138577|4052147|FG006|STARTED|Overall Study||3
2921963|NCT00545077|3632558|FG001|STARTED|Overall Study||191
3318874|NCT03138577|4052141|FG000|COMPLETED|Overall Study||3
3172679|NCT01944046|3900220|FG000|STARTED|Randomized to DB||146
3172680|NCT01944046|3900221|FG001|STARTED|Randomized to DB||144
3172681|NCT01944046|3900220|FG000|COMPLETED|Randomized to DB||125
3172682|NCT01944046|3900221|FG001|COMPLETED|Randomized to DB||125
3172683|NCT01944046|3900220|FG000|NOT COMPLETED|Randomized to DB||21
3172684|NCT01944046|3900221|FG001|NOT COMPLETED|Randomized to DB||19
2921964|NCT00545077|3632557|FG000|COMPLETED|Overall Study||41
2921965|NCT00545077|3632558|FG001|COMPLETED|Overall Study||36
2921966|NCT00545077|3632557|FG000|NOT COMPLETED|Overall Study||148
2921967|NCT00545077|3632558|FG001|NOT COMPLETED|Overall Study||155
2921968|NCT00545103|3632568|FG000|STARTED|Overall Study||148
2921969|NCT00545103|3632569|FG001|STARTED|Overall Study||148
2921970|NCT00545103|3632570|FG002|STARTED|Overall Study||150
2921971|NCT00545103|3632571|FG003|STARTED|Overall Study||146
2921972|NCT00545103|3632568|FG000|COMPLETED|Overall Study||73
3172685|NCT01944046|3900220|FG000|STARTED|Open Label Eligible and Consented||124
3318875|NCT03138577|4052142|FG001|COMPLETED|Overall Study||3
3318876|NCT03138577|4052143|FG002|COMPLETED|Overall Study||3
3318877|NCT03138577|4052144|FG003|COMPLETED|Overall Study||3
3318878|NCT03138577|4052145|FG004|COMPLETED|Overall Study||3
3318879|NCT03138577|4052146|FG005|COMPLETED|Overall Study||3
3318880|NCT03138577|4052147|FG006|COMPLETED|Overall Study||3
3318881|NCT03138577|4052141|FG000|NOT COMPLETED|Overall Study||0
3318882|NCT03138577|4052142|FG001|NOT COMPLETED|Overall Study||0
3318883|NCT03138577|4052143|FG002|NOT COMPLETED|Overall Study||0
3318884|NCT03138577|4052144|FG003|NOT COMPLETED|Overall Study||0
3318885|NCT03138577|4052145|FG004|NOT COMPLETED|Overall Study||0
3318886|NCT03138577|4052146|FG005|NOT COMPLETED|Overall Study||0
3318887|NCT03138577|4052147|FG006|NOT COMPLETED|Overall Study||0
3318888|NCT03138655|4052173|FG000|STARTED|Overall Study||10
3318889|NCT03138655|4052174|FG001|STARTED|Overall Study||9
3318890|NCT03138655|4052175|FG002|STARTED|Overall Study||11
3318891|NCT03138655|4052176|FG003|STARTED|Overall Study||10
3318892|NCT03138655|4052177|FG004|STARTED|Overall Study||13
3318893|NCT03138655|4052178|FG005|STARTED|Overall Study||12
3318894|NCT03138655|4052179|FG006|STARTED|Overall Study||12
3318895|NCT03138655|4052180|FG007|STARTED|Overall Study||12
3318896|NCT03138655|4052173|FG000|COMPLETED|Overall Study||7
3318897|NCT03138655|4052174|FG001|COMPLETED|Overall Study||7
3318898|NCT03138655|4052175|FG002|COMPLETED|Overall Study||9
3318899|NCT03138655|4052176|FG003|COMPLETED|Overall Study||7
3318900|NCT03138655|4052177|FG004|COMPLETED|Overall Study||11
3318901|NCT03138655|4052178|FG005|COMPLETED|Overall Study||7
3318902|NCT03138655|4052179|FG006|COMPLETED|Overall Study||9
3318903|NCT03138655|4052180|FG007|COMPLETED|Overall Study||10
3318904|NCT03138655|4052173|FG000|NOT COMPLETED|Overall Study||3
3318905|NCT03138655|4052174|FG001|NOT COMPLETED|Overall Study||2
3318906|NCT03138655|4052175|FG002|NOT COMPLETED|Overall Study||2
3318907|NCT03138655|4052176|FG003|NOT COMPLETED|Overall Study||3
3318908|NCT03138655|4052177|FG004|NOT COMPLETED|Overall Study||2
3318909|NCT03138655|4052178|FG005|NOT COMPLETED|Overall Study||5
3318910|NCT03138655|4052179|FG006|NOT COMPLETED|Overall Study||3
3318911|NCT03138655|4052180|FG007|NOT COMPLETED|Overall Study||2
3318912|NCT03138798|4052204|FG000|STARTED|Overall Study||173
2921973|NCT00545103|3632569|FG001|COMPLETED|Overall Study||70
2921974|NCT00545103|3632570|FG002|COMPLETED|Overall Study||74
2921975|NCT00545103|3632571|FG003|COMPLETED|Overall Study||76
2921976|NCT00545103|3632568|FG000|NOT COMPLETED|Overall Study||75
2921977|NCT00545103|3632569|FG001|NOT COMPLETED|Overall Study||78
2921978|NCT00545103|3632570|FG002|NOT COMPLETED|Overall Study||76
2921979|NCT00545103|3632571|FG003|NOT COMPLETED|Overall Study||70
2921980|NCT00545155|3632581|FG000|STARTED|Overall Study||187
2921981|NCT00545155|3632581|FG000|COMPLETED|Overall Study||187
2921982|NCT00545155|3632581|FG000|NOT COMPLETED|Overall Study||0
2921983|NCT00545168|3632588|FG000|STARTED|Overall Study||203
2921984|NCT00545168|3632589|FG001|STARTED|Overall Study||63
2921985|NCT00545168|3632590|FG002|STARTED|Overall Study||214
2921986|NCT00545168|3632588|FG000|COMPLETED|Overall Study||187
2921987|NCT00545168|3632589|FG001|COMPLETED|Overall Study||58
2921988|NCT00545168|3632590|FG002|COMPLETED|Overall Study||193
2921989|NCT00545168|3632588|FG000|NOT COMPLETED|Overall Study||16
2921990|NCT00545168|3632589|FG001|NOT COMPLETED|Overall Study||5
2921991|NCT00545168|3632590|FG002|NOT COMPLETED|Overall Study||21
2921992|NCT00545181|3632601|FG000|STARTED|Overall Study||29
2921993|NCT00545181|3632602|FG001|STARTED|Overall Study||25
2921994|NCT00545181|3632601|FG000|COMPLETED|Overall Study||29
2921995|NCT00545181|3632602|FG001|COMPLETED|Overall Study||25
2921996|NCT00545181|3632601|FG000|NOT COMPLETED|Overall Study||0
2921997|NCT00545181|3632602|FG001|NOT COMPLETED|Overall Study||0
2921998|NCT00545233|3632610|FG000|STARTED|Overall Study||79
2921999|NCT00545233|3632611|FG001|STARTED|Overall Study||76
2922000|NCT00545233|3632610|FG000|Safety Set|Overall Study||77
2922001|NCT00545233|3632611|FG001|Safety Set|Overall Study||75
2922002|NCT00545233|3632610|FG000|Intent-to-Treat (ITT)|Overall Study||77
2922003|NCT00545233|3632611|FG001|Intent-to-Treat (ITT)|Overall Study||73
2922004|NCT00545233|3632610|FG000|COMPLETED|Overall Study||33
2922005|NCT00545233|3632611|FG001|COMPLETED|Overall Study||41
2922006|NCT00545233|3632610|FG000|NOT COMPLETED|Overall Study||46
2922007|NCT00545233|3632611|FG001|NOT COMPLETED|Overall Study||35
2922008|NCT00545272|3632624|FG000|STARTED|Overall Study||61
2922009|NCT00545272|3632625|FG001|STARTED|Overall Study||68
2922010|NCT00545272|3632626|FG002|STARTED|Overall Study||65
2922011|NCT00545272|3632627|FG003|STARTED|Overall Study||72
2922012|NCT00545272|3632628|FG004|STARTED|Overall Study||64
2922013|NCT00545272|3632629|FG005|STARTED|Overall Study||62
2922014|NCT00545272|3632624|FG000|COMPLETED|Overall Study||61
2922015|NCT00545272|3632625|FG001|COMPLETED|Overall Study||67
2922016|NCT00545272|3632626|FG002|COMPLETED|Overall Study||64
2922017|NCT00545272|3632627|FG003|COMPLETED|Overall Study||71
2922018|NCT00545272|3632628|FG004|COMPLETED|Overall Study||62
2922019|NCT00545272|3632629|FG005|COMPLETED|Overall Study||59
2922020|NCT00545272|3632624|FG000|NOT COMPLETED|Overall Study||0
2922021|NCT00545272|3632625|FG001|NOT COMPLETED|Overall Study||1
2922022|NCT00545272|3632626|FG002|NOT COMPLETED|Overall Study||1
2922023|NCT00545272|3632627|FG003|NOT COMPLETED|Overall Study||1
2922024|NCT00545272|3632628|FG004|NOT COMPLETED|Overall Study||2
2922025|NCT00545272|3632629|FG005|NOT COMPLETED|Overall Study||3
2922026|NCT00545298|3632646|FG000|STARTED|Overall Study||2
2922027|NCT00545298|3632647|FG001|STARTED|Overall Study||1
2922028|NCT00545298|3632648|FG002|STARTED|Overall Study||1
2922029|NCT00545298|3632646|FG000|COMPLETED|Overall Study||0
3172686|NCT01944046|3900221|FG001|STARTED|Open Label Eligible and Consented||124
3172687|NCT01944046|3900220|FG000|COMPLETED|Open Label Eligible and Consented||110
3172688|NCT01944046|3900221|FG001|COMPLETED|Open Label Eligible and Consented||116
3172689|NCT01944046|3900220|FG000|NOT COMPLETED|Open Label Eligible and Consented||14
3172690|NCT01944046|3900221|FG001|NOT COMPLETED|Open Label Eligible and Consented||8
3172691|NCT01944098|3900233|FG000|STARTED|Overall Study||10
3172692|NCT01944098|3900234|FG001|STARTED|Overall Study||10
3172693|NCT01944098|3900233|FG000|COMPLETED|Overall Study||9
3172694|NCT01944098|3900234|FG001|COMPLETED|Overall Study||10
2922030|NCT00545298|3632647|FG001|COMPLETED|Overall Study||1
2922031|NCT00545298|3632648|FG002|COMPLETED|Overall Study||0
2922032|NCT00545298|3632646|FG000|NOT COMPLETED|Overall Study||2
2922033|NCT00545298|3632647|FG001|NOT COMPLETED|Overall Study||0
2922034|NCT00545298|3632648|FG002|NOT COMPLETED|Overall Study||1
2922035|NCT00545363|3632661|FG000|STARTED|Overall Study||358
2922036|NCT00545363|3632662|FG001|STARTED|Overall Study||358
2922037|NCT00545363|3632661|FG000|Treated|Overall Study||354
3038570|NCT01154322|3757947|FG000|NOT COMPLETED|Overall Study||2
3038571|NCT01154335|3757955|FG000|STARTED|Overall Study||7
3038572|NCT01154335|3757956|FG001|STARTED|Overall Study||6
3038573|NCT01154335|3757957|FG002|STARTED|Overall Study||5
3172695|NCT01944098|3900233|FG000|NOT COMPLETED|Overall Study||1
3172696|NCT01944098|3900234|FG001|NOT COMPLETED|Overall Study||0
3172697|NCT01944293|3900242|FG000|STARTED|Overall Study||7
2922038|NCT00545363|3632662|FG001|Treated|Overall Study||357
2922039|NCT00545363|3632661|FG000|COMPLETED|Overall Study||339
2922040|NCT00545363|3632662|FG001|COMPLETED|Overall Study||343
2922041|NCT00545363|3632661|FG000|NOT COMPLETED|Overall Study||19
2922042|NCT00545363|3632662|FG001|NOT COMPLETED|Overall Study||15
2922043|NCT00545402|3632670|FG000|STARTED|Overall Study||90
2922044|NCT00545402|3632671|FG001|STARTED|Overall Study||90
2922045|NCT00545402|3632670|FG000|COMPLETED|Overall Study||56
2922046|NCT00545402|3632671|FG001|COMPLETED|Overall Study||61
2922047|NCT00545402|3632670|FG000|NOT COMPLETED|Overall Study||34
2922048|NCT00545402|3632671|FG001|NOT COMPLETED|Overall Study||29
2922049|NCT00545441|3632679|FG000|STARTED|Overall Study||44
2922050|NCT00545441|3632680|FG001|STARTED|Overall Study||42
2922051|NCT00545441|3632679|FG000|COMPLETED|Overall Study||26
2922052|NCT00545441|3632680|FG001|COMPLETED|Overall Study||26
2922053|NCT00545441|3632679|FG000|NOT COMPLETED|Overall Study||18
2922054|NCT00545441|3632680|FG001|NOT COMPLETED|Overall Study||16
2922055|NCT00545532|3632688|FG000|STARTED|Overall Study||105
2922056|NCT00545532|3632689|FG001|STARTED|Overall Study||110
2922057|NCT00545532|3632688|FG000|COMPLETED|Overall Study||99
2922058|NCT00545532|3632689|FG001|COMPLETED|Overall Study||100
2922059|NCT00545532|3632688|FG000|NOT COMPLETED|Overall Study||6
2922060|NCT00545532|3632689|FG001|NOT COMPLETED|Overall Study||10
2922061|NCT00545571|3632697|FG000|STARTED|Overall Study||120
2922062|NCT00545571|3632697|FG000|COMPLETED|Overall Study||53
2922063|NCT00545571|3632697|FG000|NOT COMPLETED|Overall Study||67
2922064|NCT00545584|3632704|FG000|STARTED|Overall Study||412
2922065|NCT00545584|3632705|FG001|STARTED|Overall Study||414
2922066|NCT00545584|3632706|FG002|STARTED|Overall Study|306 subjects were randomized but only 305 were treated.|306
2922067|NCT00545584|3632704|FG000|COMPLETED|Overall Study||333
2922068|NCT00545584|3632705|FG001|COMPLETED|Overall Study||334
2922069|NCT00545584|3632706|FG002|COMPLETED|Overall Study||250
2922070|NCT00545584|3632704|FG000|NOT COMPLETED|Overall Study||79
2922071|NCT00545584|3632705|FG001|NOT COMPLETED|Overall Study||80
2922072|NCT00545584|3632706|FG002|NOT COMPLETED|Overall Study||56
2922073|NCT00545623|3632718|FG000|STARTED|Overall Study||32
2922074|NCT00545623|3632719|FG001|STARTED|Overall Study||31
2922075|NCT00545623|3632720|FG002|STARTED|Overall Study||33
2922076|NCT00545623|3632721|FG003|STARTED|Overall Study||34
2922077|NCT00545623|3632718|FG000|COMPLETED|Overall Study||25
2922078|NCT00545623|3632719|FG001|COMPLETED|Overall Study||21
2922079|NCT00545623|3632720|FG002|COMPLETED|Overall Study||20
2922080|NCT00545623|3632721|FG003|COMPLETED|Overall Study||23
2922081|NCT00545623|3632718|FG000|NOT COMPLETED|Overall Study||7
2922082|NCT00545623|3632719|FG001|NOT COMPLETED|Overall Study||10
2922083|NCT00545623|3632720|FG002|NOT COMPLETED|Overall Study||13
2922084|NCT00545623|3632721|FG003|NOT COMPLETED|Overall Study||11
2922085|NCT00545662|3632733|FG000|STARTED|Overall Study||606
3172698|NCT01944293|3900243|FG001|STARTED|Overall Study||9
2922086|NCT00545662|3632734|FG001|STARTED|Overall Study||607
2922087|NCT00545662|3632733|FG000|COMPLETED|Overall Study||521
3172699|NCT01944293|3900242|FG000|COMPLETED|Overall Study||7
3172700|NCT01944293|3900243|FG001|COMPLETED|Overall Study||9
3172701|NCT01944293|3900242|FG000|NOT COMPLETED|Overall Study||0
3318913|NCT03138798|4052205|FG001|STARTED|Overall Study||175
3318914|NCT03138798|4052204|FG000|Randomized But Did Not Meet Eligibility|Overall Study||6
3172702|NCT01944293|3900243|FG001|NOT COMPLETED|Overall Study||0
3172703|NCT01944319|3900251|FG000|STARTED|Overall Study||40
3318915|NCT03138798|4052205|FG001|Randomized But Did Not Meet Eligibility|Overall Study||4
3318916|NCT03138798|4052204|FG000|COMPLETED|Overall Study||167
3318917|NCT03138798|4052205|FG001|COMPLETED|Overall Study||171
3318918|NCT03138798|4052204|FG000|NOT COMPLETED|Overall Study||6
3318919|NCT03138798|4052205|FG001|NOT COMPLETED|Overall Study||4
3172704|NCT01944319|3900252|FG001|STARTED|Overall Study||39
3172705|NCT01944319|3900251|FG000|COMPLETED|Overall Study||40
3318920|NCT03138876|4052212|FG000|STARTED|Overall Study||20
3318921|NCT03138876|4052212|FG000|COMPLETED|Overall Study||20
3318922|NCT03138876|4052212|FG000|NOT COMPLETED|Overall Study||0
3172706|NCT01944319|3900252|FG001|COMPLETED|Overall Study||39
3172707|NCT01944319|3900251|FG000|NOT COMPLETED|Overall Study||0
3172708|NCT01944319|3900252|FG001|NOT COMPLETED|Overall Study||0
3172709|NCT01944345|3900259|FG000|STARTED|Overall Study||69
2922088|NCT00545662|3632734|FG001|COMPLETED|Overall Study||528
3172710|NCT01944345|3900259|FG000|COMPLETED|Overall Study||69
3172711|NCT01944345|3900259|FG000|NOT COMPLETED|Overall Study||0
3172712|NCT01944371|3900266|FG000|STARTED|Overall Study||10
2922089|NCT00545662|3632733|FG000|NOT COMPLETED|Overall Study||85
2922090|NCT00545662|3632734|FG001|NOT COMPLETED|Overall Study||79
2922091|NCT00545688|3632744|FG000|STARTED|Neo-Adjuvant Treatment Period||107
2922092|NCT00545688|3632745|FG001|STARTED|Neo-Adjuvant Treatment Period||107
2922093|NCT00545688|3632746|FG002|STARTED|Neo-Adjuvant Treatment Period||108
2922094|NCT00545688|3632747|FG003|STARTED|Neo-Adjuvant Treatment Period||94
3172713|NCT01944371|3900267|FG001|STARTED|Overall Study||10
3172714|NCT01944371|3900268|FG002|STARTED|Overall Study||10
3172715|NCT01944371|3900266|FG000|COMPLETED|Overall Study||10
2922095|NCT00545688|3632744|FG000|COMPLETED|Neo-Adjuvant Treatment Period||103
2922096|NCT00545688|3632745|FG001|COMPLETED|Neo-Adjuvant Treatment Period||102
2922097|NCT00545688|3632746|FG002|COMPLETED|Neo-Adjuvant Treatment Period||94
2922098|NCT00545688|3632747|FG003|COMPLETED|Neo-Adjuvant Treatment Period||88
2922099|NCT00545688|3632744|FG000|NOT COMPLETED|Neo-Adjuvant Treatment Period||4
2922100|NCT00545688|3632745|FG001|NOT COMPLETED|Neo-Adjuvant Treatment Period||5
2922101|NCT00545688|3632746|FG002|NOT COMPLETED|Neo-Adjuvant Treatment Period||14
2922102|NCT00545688|3632747|FG003|NOT COMPLETED|Neo-Adjuvant Treatment Period||6
2922103|NCT00545688|3632744|FG000|STARTED|Adjuvant Treatment Period||103
2922104|NCT00545688|3632745|FG001|STARTED|Adjuvant Treatment Period||102
2922105|NCT00545688|3632746|FG002|STARTED|Adjuvant Treatment Period||94
2922106|NCT00545688|3632747|FG003|STARTED|Adjuvant Treatment Period||88
2922107|NCT00545688|3632744|FG000|COMPLETED|Adjuvant Treatment Period||98
3172716|NCT01944371|3900267|FG001|COMPLETED|Overall Study||10
3172717|NCT01944371|3900268|FG002|COMPLETED|Overall Study||10
2922108|NCT00545688|3632745|FG001|COMPLETED|Adjuvant Treatment Period||94
2922109|NCT00545688|3632746|FG002|COMPLETED|Adjuvant Treatment Period||90
2922110|NCT00545688|3632747|FG003|COMPLETED|Adjuvant Treatment Period||74
2922111|NCT00545688|3632744|FG000|NOT COMPLETED|Adjuvant Treatment Period||5
2922112|NCT00545688|3632745|FG001|NOT COMPLETED|Adjuvant Treatment Period||8
2922113|NCT00545688|3632746|FG002|NOT COMPLETED|Adjuvant Treatment Period||4
2922114|NCT00545688|3632747|FG003|NOT COMPLETED|Adjuvant Treatment Period||14
2922115|NCT00545688|3632744|FG000|STARTED|Follow-Up Period||98
3172718|NCT01944371|3900266|FG000|NOT COMPLETED|Overall Study||0
3172719|NCT01944371|3900267|FG001|NOT COMPLETED|Overall Study||0
3172720|NCT01944371|3900268|FG002|NOT COMPLETED|Overall Study||0
3172721|NCT01944423|3900278|FG000|STARTED|Overall Study||27
3172722|NCT01944423|3900279|FG001|STARTED|Overall Study||26
3172723|NCT01944423|3900278|FG000|End of Treatment|Overall Study||21
3172724|NCT01944423|3900279|FG001|End of Treatment|Overall Study||20
3172725|NCT01944423|3900278|FG000|1-month Follow-up|Overall Study||22
3172726|NCT01944423|3900279|FG001|1-month Follow-up|Overall Study||19
3172727|NCT01944423|3900278|FG000|4-month Follow-up|Overall Study||19
3172728|NCT01944423|3900279|FG001|4-month Follow-up|Overall Study||16
3172729|NCT01944423|3900278|FG000|COMPLETED|Overall Study|6-month follow-up|19
3172730|NCT01944423|3900279|FG001|COMPLETED|Overall Study|6-month follow-up|17
3172731|NCT01944423|3900278|FG000|NOT COMPLETED|Overall Study||8
3172732|NCT01944423|3900279|FG001|NOT COMPLETED|Overall Study||9
3172733|NCT01944462|3900285|FG000|STARTED|PPPP Educational Program||203
3172734|NCT01944462|3900285|FG000|Baseline|PPPP Educational Program||203
3172735|NCT01944462|3900285|FG000|Post-Test|PPPP Educational Program||187
3172736|NCT01944462|3900285|FG000|3 Month Follow-Up|PPPP Educational Program||143
3172737|NCT01944462|3900285|FG000|COMPLETED|PPPP Educational Program||143
3172738|NCT01944462|3900285|FG000|NOT COMPLETED|PPPP Educational Program||60
3172739|NCT01944462|3900285|FG000|STARTED|Optional Vaccination||20
3172740|NCT01944462|3900285|FG000|COMPLETED|Optional Vaccination||20
3172741|NCT01944462|3900285|FG000|NOT COMPLETED|Optional Vaccination||0
3172742|NCT01944631|3900292|FG000|STARTED|Overall Study||100
3172743|NCT01944631|3900293|FG001|STARTED|Overall Study||100
3172744|NCT01944631|3900292|FG000|COMPLETED|Overall Study||96
2922116|NCT00545688|3632745|FG001|STARTED|Follow-Up Period||102
3172745|NCT01944631|3900293|FG001|COMPLETED|Overall Study||98
3172746|NCT01944631|3900292|FG000|NOT COMPLETED|Overall Study||4
3172747|NCT01944631|3900293|FG001|NOT COMPLETED|Overall Study||2
3172748|NCT01944644|3900301|FG000|STARTED|Overall Study||34
3172749|NCT01944644|3900302|FG001|STARTED|Overall Study||32
3172750|NCT01944644|3900301|FG000|COMPLETED|Overall Study||34
3172751|NCT01944644|3900302|FG001|COMPLETED|Overall Study||32
3172752|NCT01944644|3900301|FG000|NOT COMPLETED|Overall Study||0
3172753|NCT01944644|3900302|FG001|NOT COMPLETED|Overall Study||0
2922117|NCT00545688|3632746|FG002|STARTED|Follow-Up Period||98
2922118|NCT00545688|3632747|FG003|STARTED|Follow-Up Period||87
2922119|NCT00545688|3632744|FG000|COMPLETED|Follow-Up Period||77
2922120|NCT00545688|3632745|FG001|COMPLETED|Follow-Up Period||83
2922121|NCT00545688|3632746|FG002|COMPLETED|Follow-Up Period||78
2922122|NCT00545688|3632747|FG003|COMPLETED|Follow-Up Period||60
2922123|NCT00545688|3632744|FG000|NOT COMPLETED|Follow-Up Period||21
2922124|NCT00545688|3632745|FG001|NOT COMPLETED|Follow-Up Period||19
2922125|NCT00545688|3632746|FG002|NOT COMPLETED|Follow-Up Period||20
2922126|NCT00545688|3632747|FG003|NOT COMPLETED|Follow-Up Period||27
2922127|NCT00545714|3632760|FG000|STARTED|Induction Phase (6 Months)||86
2922128|NCT00545714|3632760|FG000|Safety Population|Induction Phase (6 Months)||86
2922129|NCT00545714|3632760|FG000|Intent-to-Treat (ITT) Population|Induction Phase (6 Months)||84
2922130|NCT00545714|3632760|FG000|COMPLETED|Induction Phase (6 Months)||74
2922131|NCT00545714|3632760|FG000|NOT COMPLETED|Induction Phase (6 Months)||12
2922132|NCT00545714|3632760|FG000|STARTED|Maintenance Phase (36 Months)||74
2922133|NCT00545714|3632760|FG000|COMPLETED|Maintenance Phase (36 Months)||42
2922134|NCT00545714|3632760|FG000|NOT COMPLETED|Maintenance Phase (36 Months)||32
2922135|NCT00545740|3632768|FG000|STARTED|Overall Study||145
2922136|NCT00545740|3632769|FG001|STARTED|Overall Study||145
2922137|NCT00545740|3632770|FG002|STARTED|Overall Study||151
2922138|NCT00545740|3632771|FG003|STARTED|Overall Study||149
2922139|NCT00545740|3632768|FG000|COMPLETED|Overall Study||70
2922140|NCT00545740|3632769|FG001|COMPLETED|Overall Study||62
2922141|NCT00545740|3632770|FG002|COMPLETED|Overall Study||55
2922142|NCT00545740|3632771|FG003|COMPLETED|Overall Study||78
2922143|NCT00545740|3632768|FG000|NOT COMPLETED|Overall Study||75
2922144|NCT00545740|3632769|FG001|NOT COMPLETED|Overall Study||83
2922145|NCT00545740|3632770|FG002|NOT COMPLETED|Overall Study||96
2922146|NCT00545740|3632771|FG003|NOT COMPLETED|Overall Study||71
2922147|NCT00545753|3632784|FG000|STARTED|Overall Study||243
2922148|NCT00545753|3632785|FG001|STARTED|Overall Study||59
2922149|NCT00545753|3632786|FG002|STARTED|Overall Study||256
2922150|NCT00545753|3632784|FG000|COMPLETED|Overall Study||227
2922151|NCT00545753|3632785|FG001|COMPLETED|Overall Study||54
2922152|NCT00545753|3632786|FG002|COMPLETED|Overall Study||230
2922153|NCT00545753|3632784|FG000|NOT COMPLETED|Overall Study||16
2922154|NCT00545753|3632785|FG001|NOT COMPLETED|Overall Study||5
2922155|NCT00545753|3632786|FG002|NOT COMPLETED|Overall Study||26
2922156|NCT00545779|3632795|FG000|STARTED|Overall Study||677
2922157|NCT00545779|3632795|FG000|COMPLETED|Overall Study||633
2922158|NCT00545779|3632795|FG000|NOT COMPLETED|Overall Study||44
2922159|NCT00545792|3632799|FG000|STARTED|Overall Study||21
2922160|NCT00545792|3632799|FG000|COMPLETED|Overall Study||20
2922161|NCT00545792|3632799|FG000|NOT COMPLETED|Overall Study||1
2922162|NCT00545818|3632805|FG000|STARTED|Overall Study||49
2922163|NCT00545818|3632806|FG001|STARTED|Overall Study||46
2922164|NCT00545818|3632805|FG000|COMPLETED|Overall Study||46
2922165|NCT00545818|3632806|FG001|COMPLETED|Overall Study||39
2922166|NCT00545818|3632805|FG000|NOT COMPLETED|Overall Study||3
2922167|NCT00545818|3632806|FG001|NOT COMPLETED|Overall Study||7
2922168|NCT00545948|3632815|FG000|STARTED|Overall Study|Registered patients assigned to receive vinorelbine + cisplatin protocol therapy.|9
2922169|NCT00545948|3632816|FG001|STARTED|Overall Study|Registered patients assigned to receive pemetrexed + cisplatin protocol therapy.|15
2922170|NCT00545948|3632817|FG002|STARTED|Overall Study|Registered patients who were not assigned to receive protocol therapy.|7
2922171|NCT00545948|3632815|FG000|Assigned Treatment|Overall Study||9
2922172|NCT00545948|3632816|FG001|Assigned Treatment|Overall Study||15
2922173|NCT00545948|3632817|FG002|Assigned Treatment|Overall Study||0
2922174|NCT00545948|3632815|FG000|COMPLETED|Overall Study|Patients who received vinorelbine + cisplatin protocol therapy.|8
2922175|NCT00545948|3632816|FG001|COMPLETED|Overall Study|Patients who received pemetrexed + cisplatin protocol therapy.|14
2922176|NCT00545948|3632817|FG002|COMPLETED|Overall Study||0
2922177|NCT00545948|3632815|FG000|NOT COMPLETED|Overall Study||1
2922178|NCT00545948|3632816|FG001|NOT COMPLETED|Overall Study||1
2922179|NCT00545948|3632817|FG002|NOT COMPLETED|Overall Study||7
2922180|NCT00545974|3632828|FG000|STARTED|Overall Study|subjects randomized to memantine cohort|39
2922181|NCT00545974|3632829|FG001|STARTED|Overall Study|subjects randomized to placebo cohort|42
2922182|NCT00545974|3632828|FG000|COMPLETED|Overall Study|subjects completed 26 weeks treatment in memantine cohort|37
2922183|NCT00545974|3632829|FG001|COMPLETED|Overall Study|subjects completed 26 weeks treatment in placebo cohort|39
2922184|NCT00545974|3632828|FG000|NOT COMPLETED|Overall Study||2
2922185|NCT00545974|3632829|FG001|NOT COMPLETED|Overall Study||3
3172754|NCT01944670|3900308|FG000|STARTED|Overall Study||26
3172755|NCT01944670|3900308|FG000|COMPLETED|Overall Study||24
3172756|NCT01944670|3900308|FG000|NOT COMPLETED|Overall Study||2
3172757|NCT01944722|3900314|FG000|STARTED|Overall Study||33858
3318923|NCT03138967|4052218|FG000|STARTED|Overall Study||26
3318924|NCT03138967|4052219|FG001|STARTED|Overall Study||28
3318925|NCT03138967|4052218|FG000|Post-operative Day(POD) 1 Follow-up|Overall Study||25
3318926|NCT03138967|4052219|FG001|Post-operative Day(POD) 1 Follow-up|Overall Study||25
3318927|NCT03138967|4052218|FG000|Post-operative Day(POD) 7 Follow-up|Overall Study||25
3318928|NCT03138967|4052219|FG001|Post-operative Day(POD) 7 Follow-up|Overall Study||24
3318929|NCT03138967|4052218|FG000|COMPLETED|Overall Study||25
3318930|NCT03138967|4052219|FG001|COMPLETED|Overall Study||24
3318931|NCT03138967|4052218|FG000|NOT COMPLETED|Overall Study||1
3318932|NCT03138967|4052219|FG001|NOT COMPLETED|Overall Study||4
3318933|NCT03139032|4052225|FG000|STARTED|Overall Study||1
3318934|NCT03139032|4052225|FG000|COMPLETED|Overall Study||1
3318935|NCT03139032|4052225|FG000|NOT COMPLETED|Overall Study||0
3318936|NCT03139240|4052234|FG000|STARTED|Overall Study||48
3318937|NCT03139240|4052235|FG001|STARTED|Overall Study||48
3318938|NCT03139240|4052236|FG002|STARTED|Overall Study||38
3318939|NCT03139240|4052237|FG003|STARTED|Overall Study||38
3318940|NCT03139240|4052234|FG000|COMPLETED|Overall Study||48
3318941|NCT03139240|4052235|FG001|COMPLETED|Overall Study||47
3318942|NCT03139240|4052236|FG002|COMPLETED|Overall Study||37
3318943|NCT03139240|4052237|FG003|COMPLETED|Overall Study||38
3318944|NCT03139240|4052234|FG000|NOT COMPLETED|Overall Study||0
3318945|NCT03139240|4052235|FG001|NOT COMPLETED|Overall Study||1
3318946|NCT03139240|4052236|FG002|NOT COMPLETED|Overall Study||1
3318947|NCT03139240|4052237|FG003|NOT COMPLETED|Overall Study||0
3318948|NCT03139279|4052247|FG000|STARTED|Overall Study||58
3318949|NCT03139279|4052248|FG001|STARTED|Overall Study||56
3318950|NCT03139279|4052247|FG000|COMPLETED|Overall Study||51
3318951|NCT03139279|4052248|FG001|COMPLETED|Overall Study||50
3318952|NCT03139279|4052247|FG000|NOT COMPLETED|Overall Study||7
3318953|NCT03139279|4052248|FG001|NOT COMPLETED|Overall Study||6
3318954|NCT03139448|4052256|FG000|STARTED|Overall Study||85
3318955|NCT03139448|4052257|FG001|STARTED|Overall Study||89
3318956|NCT03139448|4052256|FG000|Intervention Started|Overall Study||79
3318957|NCT03139448|4052257|FG001|Intervention Started|Overall Study||70
3318958|NCT03139448|4052256|FG000|COMPLETED|Overall Study||73
3318959|NCT03139448|4052257|FG001|COMPLETED|Overall Study||63
3318960|NCT03139448|4052256|FG000|NOT COMPLETED|Overall Study||12
3318961|NCT03139448|4052257|FG001|NOT COMPLETED|Overall Study||26
3318962|NCT03139552|4052263|FG000|STARTED|Overall Study||150
3318963|NCT03139552|4052263|FG000|COMPLETED|Overall Study||147
3318964|NCT03139552|4052263|FG000|NOT COMPLETED|Overall Study||3
3318965|NCT03139578|4052274|FG000|STARTED|Period 1||12
3318966|NCT03139578|4052275|FG001|STARTED|Period 1||13
3318967|NCT03139578|4052276|FG002|STARTED|Period 1||12
3318968|NCT03139578|4052277|FG003|STARTED|Period 1||13
3318969|NCT03139578|4052274|FG000|Discontinued|Period 1||0
3318970|NCT03139578|4052275|FG001|Discontinued|Period 1||0
3318971|NCT03139578|4052276|FG002|Discontinued|Period 1||0
3318972|NCT03139578|4052277|FG003|Discontinued|Period 1||0
3318973|NCT03139578|4052274|FG000|COMPLETED|Period 1||12
3318974|NCT03139578|4052275|FG001|COMPLETED|Period 1||13
3318975|NCT03139578|4052276|FG002|COMPLETED|Period 1||12
3318976|NCT03139578|4052277|FG003|COMPLETED|Period 1||13
3318977|NCT03139578|4052274|FG000|NOT COMPLETED|Period 1||0
3318978|NCT03139578|4052275|FG001|NOT COMPLETED|Period 1||0
3318979|NCT03139578|4052276|FG002|NOT COMPLETED|Period 1||0
3318980|NCT03139578|4052277|FG003|NOT COMPLETED|Period 1||0
3318981|NCT03139578|4052274|FG000|STARTED|Period 2||12
3318982|NCT03139578|4052275|FG001|STARTED|Period 2||13
3318983|NCT03139578|4052276|FG002|STARTED|Period 2||12
3318984|NCT03139578|4052277|FG003|STARTED|Period 2||13
3318985|NCT03139578|4052274|FG000|Discontinued|Period 2||0
3318986|NCT03139578|4052275|FG001|Discontinued|Period 2||0
3318987|NCT03139578|4052276|FG002|Discontinued|Period 2||0
3318988|NCT03139578|4052277|FG003|Discontinued|Period 2||0
3318989|NCT03139578|4052274|FG000|COMPLETED|Period 2||12
3318990|NCT03139578|4052275|FG001|COMPLETED|Period 2||13
3318991|NCT03139578|4052276|FG002|COMPLETED|Period 2||12
3318992|NCT03139578|4052277|FG003|COMPLETED|Period 2||13
3318993|NCT03139578|4052274|FG000|NOT COMPLETED|Period 2||0
3318994|NCT03139578|4052275|FG001|NOT COMPLETED|Period 2||0
3318995|NCT03139578|4052276|FG002|NOT COMPLETED|Period 2||0
3318996|NCT03139578|4052277|FG003|NOT COMPLETED|Period 2||0
3318997|NCT03139604|4052289|FG000|STARTED|Overall Study||219
3318998|NCT03139604|4052290|FG001|STARTED|Overall Study||220
3318999|NCT03139604|4052289|FG000|COMPLETED|Overall Study|Participants were considered to have completed the study if they dies or discontinued study treatment for any reason|0
3319000|NCT03139604|4052290|FG001|COMPLETED|Overall Study|Participants were considered to have completed the study if they dies or discontinued study treatment for any reason|0
3319001|NCT03139604|4052289|FG000|NOT COMPLETED|Overall Study||219
3319002|NCT03139604|4052290|FG001|NOT COMPLETED|Overall Study||220
3319003|NCT03140254|4052297|FG000|STARTED|Overall Study||145
3319004|NCT03140254|4052297|FG000|Treatment IP - Groin|Overall Study||51
3319005|NCT03140254|4052297|FG000|Treatment IP - Abdomen|Overall Study||48
3319006|NCT03140254|4052297|FG000|Treatment AC - Groin|Overall Study||51
3319007|NCT03140254|4052297|FG000|Treatment AC - Abdomen|Overall Study||48
3319008|NCT03140254|4052297|FG000|Treatment VC - Groin|Overall Study||18
3319009|NCT03140254|4052297|FG000|Treatment VC - Abdomen|Overall Study||19
3319010|NCT03140254|4052297|FG000|COMPLETED|Overall Study||144
3319011|NCT03140254|4052297|FG000|NOT COMPLETED|Overall Study||1
3319012|NCT03140631|4052305|FG000|STARTED|Overall Study||73
3319013|NCT03140631|4052306|FG001|STARTED|Overall Study||77
3319014|NCT03140631|4052305|FG000|COMPLETED|Overall Study||73
3319015|NCT03140631|4052306|FG001|COMPLETED|Overall Study||77
3319016|NCT03140631|4052305|FG000|NOT COMPLETED|Overall Study||0
3319017|NCT03140631|4052306|FG001|NOT COMPLETED|Overall Study||0
3319018|NCT03140722|4052315|FG000|STARTED|Overall Study||0
3319019|NCT03140722|4052316|FG001|STARTED|Overall Study||2
3319020|NCT03140722|4052315|FG000|COMPLETED|Overall Study||0
3319021|NCT03140722|4052316|FG001|COMPLETED|Overall Study||2
3319022|NCT03140722|4052315|FG000|NOT COMPLETED|Overall Study||0
3319023|NCT03140722|4052316|FG001|NOT COMPLETED|Overall Study||0
3319024|NCT03141086|4052324|FG000|STARTED|Overall Study||7
3319025|NCT03141086|4052325|FG001|STARTED|Overall Study||17
3319026|NCT03141086|4052324|FG000|COMPLETED|Overall Study||6
3319027|NCT03141086|4052325|FG001|COMPLETED|Overall Study||12
3319028|NCT03141086|4052324|FG000|NOT COMPLETED|Overall Study||1
3319029|NCT03141086|4052325|FG001|NOT COMPLETED|Overall Study||5
3319030|NCT03141151|4052333|FG000|STARTED|Overall Study||59
3319031|NCT03141151|4052334|FG001|STARTED|Overall Study||58
3319032|NCT03141151|4052333|FG000|COMPLETED|Overall Study||53
3319033|NCT03141151|4052334|FG001|COMPLETED|Overall Study||54
3319034|NCT03141151|4052333|FG000|NOT COMPLETED|Overall Study||6
3319035|NCT03141151|4052334|FG001|NOT COMPLETED|Overall Study||4
3319036|NCT03141242|4052342|FG000|STARTED|Overall Study||55
3319037|NCT03141242|4052343|FG001|STARTED|Overall Study||55
3319038|NCT03141242|4052342|FG000|Received Allocated Intervenion|Overall Study|11 subjects didn't attend their scheduled group session; all were included in ITT analysis|44
3319039|NCT03141242|4052343|FG001|Received Allocated Intervenion|Overall Study||55
3319040|NCT03141242|4052342|FG000|6 Month Interview|Overall Study||51
3319041|NCT03141242|4052343|FG001|6 Month Interview|Overall Study||49
3319042|NCT03141242|4052342|FG000|COMPLETED|Overall Study||55
3319043|NCT03141242|4052343|FG001|COMPLETED|Overall Study||55
3319044|NCT03141242|4052342|FG000|NOT COMPLETED|Overall Study||0
3319045|NCT03141242|4052343|FG001|NOT COMPLETED|Overall Study||0
3319046|NCT03141281|4052354|FG000|STARTED|Overall Study||57
3319047|NCT03141281|4052355|FG001|STARTED|Overall Study||59
3319048|NCT03141281|4052356|FG002|STARTED|Overall Study||56
3319049|NCT03141281|4052357|FG003|STARTED|Overall Study||58
3319050|NCT03141281|4052354|FG000|Post-Test|Overall Study||50
3319051|NCT03141281|4052355|FG001|Post-Test|Overall Study||47
3319052|NCT03141281|4052356|FG002|Post-Test|Overall Study||50
3319053|NCT03141281|4052357|FG003|Post-Test|Overall Study||56
3319054|NCT03141281|4052354|FG000|COMPLETED|Overall Study||45
3319055|NCT03141281|4052355|FG001|COMPLETED|Overall Study||38
3319056|NCT03141281|4052356|FG002|COMPLETED|Overall Study||42
3319057|NCT03141281|4052357|FG003|COMPLETED|Overall Study||47
3319058|NCT03141281|4052354|FG000|NOT COMPLETED|Overall Study||12
3319059|NCT03141281|4052355|FG001|NOT COMPLETED|Overall Study||21
3319060|NCT03141281|4052356|FG002|NOT COMPLETED|Overall Study||14
3319061|NCT03141281|4052357|FG003|NOT COMPLETED|Overall Study||11
3319062|NCT03141307|4052369|FG000|STARTED|In-Hospital||471
3319063|NCT03141307|4052370|FG001|STARTED|In-Hospital||240
3319064|NCT03141307|4052369|FG000|COMPLETED|In-Hospital||467
3319065|NCT03141307|4052370|FG001|COMPLETED|In-Hospital||238
3319066|NCT03141307|4052369|FG000|NOT COMPLETED|In-Hospital||4
3319067|NCT03141307|4052370|FG001|NOT COMPLETED|In-Hospital||2
3319068|NCT03141307|4052369|FG000|STARTED|Follow-Up||467
3319069|NCT03141307|4052370|FG001|STARTED|Follow-Up||238
3319070|NCT03141307|4052369|FG000|COMPLETED|Follow-Up||370
3319071|NCT03141307|4052370|FG001|COMPLETED|Follow-Up||184
3319072|NCT03141307|4052369|FG000|NOT COMPLETED|Follow-Up||97
3319073|NCT03141307|4052370|FG001|NOT COMPLETED|Follow-Up||54
3319074|NCT03141372|4052378|FG000|STARTED|Overall Study||42
3319075|NCT03141372|4052379|FG001|STARTED|Overall Study||42
3319076|NCT03141372|4052378|FG000|COMPLETED|Overall Study||42
3319077|NCT03141372|4052379|FG001|COMPLETED|Overall Study||40
3319078|NCT03141372|4052378|FG000|NOT COMPLETED|Overall Study||0
3319079|NCT03141372|4052379|FG001|NOT COMPLETED|Overall Study||2
3319080|NCT03141528|4052389|FG000|STARTED|Overall Study||122
3319081|NCT03141528|4052390|FG001|STARTED|Overall Study||118
3319082|NCT03141528|4052389|FG000|COMPLETED|Overall Study||75
3319083|NCT03141528|4052390|FG001|COMPLETED|Overall Study||77
3319084|NCT03141528|4052389|FG000|NOT COMPLETED|Overall Study||47
3319085|NCT03141528|4052390|FG001|NOT COMPLETED|Overall Study||41
3319086|NCT03141788|4052396|FG000|STARTED|Overall Study||52
3319087|NCT03141788|4052396|FG000|COMPLETED|Overall Study||44
3319088|NCT03141788|4052396|FG000|NOT COMPLETED|Overall Study||8
3319089|NCT03141905|4052405|FG000|STARTED|Overall Study||176
3319090|NCT03141905|4052406|FG001|STARTED|Overall Study||166
3319091|NCT03141905|4052405|FG000|COMPLETED|Overall Study||152
3319092|NCT03141905|4052406|FG001|COMPLETED|Overall Study||147
3319093|NCT03141905|4052405|FG000|NOT COMPLETED|Overall Study||24
3319094|NCT03141905|4052406|FG001|NOT COMPLETED|Overall Study||19
3319095|NCT03141931|4052415|FG000|STARTED|Overall Study||61
3319096|NCT03141931|4052416|FG001|STARTED|Overall Study||58
3319097|NCT03141931|4052415|FG000|COMPLETED|Overall Study||49
3319098|NCT03141931|4052416|FG001|COMPLETED|Overall Study||52
3319099|NCT03141931|4052415|FG000|NOT COMPLETED|Overall Study||12
3319100|NCT03141931|4052416|FG001|NOT COMPLETED|Overall Study||6
3319101|NCT03142438|4052422|FG000|STARTED|Overall Study||57
3319102|NCT03142438|4052422|FG000|COMPLETED|Overall Study||57
3319103|NCT03142438|4052422|FG000|NOT COMPLETED|Overall Study||0
3319104|NCT03142451|4052428|FG000|STARTED|Overall Study||495
3319105|NCT03142451|4052429|FG001|STARTED|Overall Study||256
3319106|NCT03142451|4052428|FG000|COMPLETED|Overall Study||437
3319107|NCT03142451|4052429|FG001|COMPLETED|Overall Study||232
3319108|NCT03142451|4052428|FG000|NOT COMPLETED|Overall Study||58
3319109|NCT03142451|4052429|FG001|NOT COMPLETED|Overall Study||24
3319110|NCT03142750|4052437|FG000|STARTED|Overall Study||14
3319111|NCT03142750|4052438|FG001|STARTED|Overall Study||10
3319112|NCT03142750|4052437|FG000|COMPLETED|Overall Study||10
3319113|NCT03142750|4052438|FG001|COMPLETED|Overall Study||9
3319114|NCT03142750|4052437|FG000|NOT COMPLETED|Overall Study||4
3319115|NCT03142750|4052438|FG001|NOT COMPLETED|Overall Study||1
3319116|NCT03142932|4052450|FG000|STARTED|Overall Study||52
3319117|NCT03142932|4052451|FG001|STARTED|Overall Study||50
3319118|NCT03142932|4052450|FG000|COMPLETED|Overall Study||50
3319119|NCT03142932|4052451|FG001|COMPLETED|Overall Study||39
3319120|NCT03142932|4052450|FG000|NOT COMPLETED|Overall Study||2
3319121|NCT03142932|4052451|FG001|NOT COMPLETED|Overall Study||11
3319122|NCT03143101|4052460|FG000|STARTED|Overall Study||67
3319123|NCT03143101|4052461|FG001|STARTED|Overall Study||66
3319124|NCT03143101|4052462|FG002|STARTED|Overall Study||67
3319125|NCT03143101|4052460|FG000|COMPLETED|Overall Study||65
3319126|NCT03143101|4052461|FG001|COMPLETED|Overall Study||63
3319127|NCT03143101|4052462|FG002|COMPLETED|Overall Study||67
3319128|NCT03143101|4052460|FG000|NOT COMPLETED|Overall Study||2
3319129|NCT03143101|4052461|FG001|NOT COMPLETED|Overall Study||3
3319130|NCT03143101|4052462|FG002|NOT COMPLETED|Overall Study||0
3319131|NCT03143166|4052470|FG000|STARTED|Period 1||36
3319132|NCT03143166|4052470|FG000|COMPLETED|Period 1||36
3319133|NCT03143166|4052470|FG000|NOT COMPLETED|Period 1||0
3319134|NCT03143166|4052470|FG000|STARTED|Period 2 (Washout of at Least 4 Days)||36
3319135|NCT03143166|4052470|FG000|COMPLETED|Period 2 (Washout of at Least 4 Days)||35
3319136|NCT03143166|4052470|FG000|NOT COMPLETED|Period 2 (Washout of at Least 4 Days)||1
3319137|NCT03143569|4052478|FG000|STARTED|Overall Study||10
3319138|NCT03143569|4052479|FG001|STARTED|Overall Study||10
3319139|NCT03143569|4052478|FG000|COMPLETED|Overall Study||10
3319140|NCT03143569|4052479|FG001|COMPLETED|Overall Study||8
3319141|NCT03143569|4052478|FG000|NOT COMPLETED|Overall Study||0
3319142|NCT03143569|4052479|FG001|NOT COMPLETED|Overall Study||2
3319143|NCT03143855|4052489|FG000|STARTED|Overall Study||17
3319144|NCT03143855|4052490|FG001|STARTED|Overall Study||10
3319145|NCT03143855|4052489|FG000|COMPLETED|Overall Study||12
3319146|NCT03143855|4052490|FG001|COMPLETED|Overall Study||6
3319147|NCT03143855|4052489|FG000|NOT COMPLETED|Overall Study||5
3319148|NCT03143855|4052490|FG001|NOT COMPLETED|Overall Study||4
3319149|NCT03143894|4052498|FG000|STARTED|First Intervention (5 Days)||3
3319150|NCT03143894|4052499|FG001|STARTED|First Intervention (5 Days)||4
3319151|NCT03143894|4052498|FG000|COMPLETED|First Intervention (5 Days)||3
3319152|NCT03143894|4052499|FG001|COMPLETED|First Intervention (5 Days)||4
3319153|NCT03143894|4052498|FG000|NOT COMPLETED|First Intervention (5 Days)||0
3319154|NCT03143894|4052499|FG001|NOT COMPLETED|First Intervention (5 Days)||0
3319155|NCT03143894|4052498|FG000|STARTED|Washout (4 Weeks)||3
3319156|NCT03143894|4052499|FG001|STARTED|Washout (4 Weeks)||4
3319157|NCT03143894|4052498|FG000|COMPLETED|Washout (4 Weeks)||3
3319158|NCT03143894|4052499|FG001|COMPLETED|Washout (4 Weeks)||4
3172758|NCT01944722|3900314|FG000|COMPLETED|Overall Study||24343
3172759|NCT01944722|3900314|FG000|NOT COMPLETED|Overall Study||9515
3172760|NCT01944774|3900326|FG000|STARTED|Overall Study||69
3172761|NCT01944774|3900327|FG001|STARTED|Overall Study||68
3319159|NCT03143894|4052498|FG000|NOT COMPLETED|Washout (4 Weeks)||0
3319160|NCT03143894|4052499|FG001|NOT COMPLETED|Washout (4 Weeks)||0
3319161|NCT03143894|4052498|FG000|STARTED|Second Intervention (5 Days)||3
3319162|NCT03143894|4052499|FG001|STARTED|Second Intervention (5 Days)||4
3319163|NCT03143894|4052498|FG000|COMPLETED|Second Intervention (5 Days)||3
3319164|NCT03143894|4052499|FG001|COMPLETED|Second Intervention (5 Days)||3
3319165|NCT03143894|4052498|FG000|NOT COMPLETED|Second Intervention (5 Days)||0
3319166|NCT03143894|4052499|FG001|NOT COMPLETED|Second Intervention (5 Days)||1
3319167|NCT03144089|4052509|FG000|STARTED|Overall Study||28
3319168|NCT03144089|4052510|FG001|STARTED|Overall Study||28
3319169|NCT03144089|4052509|FG000|COMPLETED|Overall Study||28
3319170|NCT03144089|4052510|FG001|COMPLETED|Overall Study||28
3319171|NCT03144089|4052509|FG000|NOT COMPLETED|Overall Study||0
3172762|NCT01944774|3900328|FG002|STARTED|Overall Study||70
3172763|NCT01944774|3900326|FG000|Received Treatment|Overall Study||68
3319172|NCT03144089|4052510|FG001|NOT COMPLETED|Overall Study||0
3319173|NCT03144180|4052520|FG000|STARTED|Overall Study||16
3319174|NCT03144180|4052521|FG001|STARTED|Overall Study||16
3319175|NCT03144180|4052520|FG000|COMPLETED|Overall Study||14
3319176|NCT03144180|4052521|FG001|COMPLETED|Overall Study||10
3319177|NCT03144180|4052520|FG000|NOT COMPLETED|Overall Study||2
3319178|NCT03144180|4052521|FG001|NOT COMPLETED|Overall Study||6
3319179|NCT03144518|4052531|FG000|STARTED|Primary Outcome (Mood)||52
3319180|NCT03144518|4052532|FG001|STARTED|Primary Outcome (Mood)||51
3319181|NCT03144518|4052531|FG000|COMPLETED|Primary Outcome (Mood)||52
3319182|NCT03144518|4052532|FG001|COMPLETED|Primary Outcome (Mood)||51
3319183|NCT03144518|4052531|FG000|NOT COMPLETED|Primary Outcome (Mood)||0
3319184|NCT03144518|4052532|FG001|NOT COMPLETED|Primary Outcome (Mood)||0
3319185|NCT03144518|4052531|FG000|STARTED|4 Weeks Post-Vaccination||52
3319186|NCT03144518|4052532|FG001|STARTED|4 Weeks Post-Vaccination||51
3319187|NCT03144518|4052531|FG000|COMPLETED|4 Weeks Post-Vaccination||51
3319188|NCT03144518|4052532|FG001|COMPLETED|4 Weeks Post-Vaccination||51
3319189|NCT03144518|4052531|FG000|NOT COMPLETED|4 Weeks Post-Vaccination||1
3319190|NCT03144518|4052532|FG001|NOT COMPLETED|4 Weeks Post-Vaccination||0
3319191|NCT03144518|4052531|FG000|STARTED|16 Week Post-Vaccination||52
3319192|NCT03144518|4052532|FG001|STARTED|16 Week Post-Vaccination||51
3319193|NCT03144518|4052531|FG000|COMPLETED|16 Week Post-Vaccination||49
3319194|NCT03144518|4052532|FG001|COMPLETED|16 Week Post-Vaccination||49
3319195|NCT03144518|4052531|FG000|NOT COMPLETED|16 Week Post-Vaccination||3
3319196|NCT03144518|4052532|FG001|NOT COMPLETED|16 Week Post-Vaccination||2
3319197|NCT03144635|4052539|FG000|STARTED|Overall Study||80
3319198|NCT03144635|4052539|FG000|COMPLETED|Overall Study||0
3319199|NCT03144635|4052539|FG000|NOT COMPLETED|Overall Study||80
3319200|NCT03144687|4052547|FG000|STARTED|Overall Study||13
3319201|NCT03144687|4052548|FG001|STARTED|Overall Study||10
3319202|NCT03144687|4052547|FG000|COMPLETED|Overall Study||0
3319203|NCT03144687|4052548|FG001|COMPLETED|Overall Study||0
3319204|NCT03144687|4052547|FG000|NOT COMPLETED|Overall Study||13
3319205|NCT03144687|4052548|FG001|NOT COMPLETED|Overall Study||10
3319206|NCT03144804|4052558|FG000|STARTED|Overall Study||36
3319207|NCT03144804|4052558|FG000|COMPLETED|Overall Study||32
3319208|NCT03144804|4052558|FG000|NOT COMPLETED|Overall Study||4
3319209|NCT03145064|4052562|FG000|STARTED|Overall Study||41
3319210|NCT03145064|4052562|FG000|Received At Least 1 Dose of Study Drug|Overall Study||41
3319211|NCT03145064|4052562|FG000|COMPLETED|Overall Study||0
3319212|NCT03145064|4052562|FG000|NOT COMPLETED|Overall Study||41
3319213|NCT03145207|4052567|FG000|STARTED|Overall Study|The same 12 volunteers completed each of the seven study sessions.|14
3319214|NCT03145207|4052567|FG000|COMPLETED|Overall Study||12
3319215|NCT03145207|4052567|FG000|NOT COMPLETED|Overall Study||2
3172764|NCT01944774|3900327|FG001|Received Treatment|Overall Study||67
3172765|NCT01944774|3900328|FG002|Received Treatment|Overall Study||70
3172766|NCT01944774|3900326|FG000|COMPLETED|Overall Study||63
3172767|NCT01944774|3900327|FG001|COMPLETED|Overall Study||60
3172768|NCT01944774|3900328|FG002|COMPLETED|Overall Study||62
3172769|NCT01944774|3900326|FG000|NOT COMPLETED|Overall Study||6
3172770|NCT01944774|3900327|FG001|NOT COMPLETED|Overall Study||8
3172771|NCT01944774|3900328|FG002|NOT COMPLETED|Overall Study||8
3172772|NCT01944839|3900341|FG000|STARTED|Overall Study||309
3172773|NCT01944839|3900342|FG001|STARTED|Overall Study||310
3172774|NCT01944839|3900341|FG000|COMPLETED|Overall Study||287
3172775|NCT01944839|3900342|FG001|COMPLETED|Overall Study||282
3172776|NCT01944839|3900341|FG000|NOT COMPLETED|Overall Study||22
3172777|NCT01944839|3900342|FG001|NOT COMPLETED|Overall Study||28
3172778|NCT01944878|3900350|FG000|STARTED|Overall Study||127
3172779|NCT01944878|3900351|FG001|STARTED|Overall Study||328
3172780|NCT01944878|3900350|FG000|COMPLETED|Overall Study||127
3172781|NCT01944878|3900351|FG001|COMPLETED|Overall Study||328
3172782|NCT01944878|3900350|FG000|NOT COMPLETED|Overall Study||0
3172783|NCT01944878|3900351|FG001|NOT COMPLETED|Overall Study||0
3172784|NCT01944930|3900361|FG000|STARTED|Overall Study||12
3172785|NCT01944930|3900362|FG001|STARTED|Overall Study||11
3172786|NCT01944930|3900361|FG000|COMPLETED|Overall Study||10
3172787|NCT01944930|3900362|FG001|COMPLETED|Overall Study||10
3172788|NCT01944930|3900361|FG000|NOT COMPLETED|Overall Study||2
3172789|NCT01944930|3900362|FG001|NOT COMPLETED|Overall Study||1
3172790|NCT01944969|3900368|FG000|STARTED|Overall Study||26
3172791|NCT01944969|3900368|FG000|COMPLETED|Overall Study||0
3172792|NCT01944969|3900368|FG000|NOT COMPLETED|Overall Study||26
3172793|NCT01945034|3900377|FG000|STARTED|Overall Study||67
3172794|NCT01945034|3900378|FG001|STARTED|Overall Study||85
3172795|NCT01945034|3900379|FG002|STARTED|Overall Study||152
3172796|NCT01945034|3900377|FG000|COMPLETED|Overall Study||66
3319216|NCT03145259|4052582|FG000|STARTED|Overall Study||12
3319217|NCT03145259|4052582|FG000|COMPLETED|Overall Study||12
3319218|NCT03145259|4052582|FG000|NOT COMPLETED|Overall Study||0
3319219|NCT03145766|4052594|FG000|STARTED|Active Vaccination Phase (Day 0-Day 56)||80
3319220|NCT03145766|4052595|FG001|STARTED|Active Vaccination Phase (Day 0-Day 56)||80
3319221|NCT03145766|4052596|FG002|STARTED|Active Vaccination Phase (Day 0-Day 56)||80
3319222|NCT03145766|4052597|FG003|STARTED|Active Vaccination Phase (Day 0-Day 56)||40
3319223|NCT03145766|4052598|FG004|STARTED|Active Vaccination Phase (Day 0-Day 56)||40
3319224|NCT03145766|4052594|FG000|Vaccination 1|Active Vaccination Phase (Day 0-Day 56)||80
3319225|NCT03145766|4052595|FG001|Vaccination 1|Active Vaccination Phase (Day 0-Day 56)||80
3319226|NCT03145766|4052596|FG002|Vaccination 1|Active Vaccination Phase (Day 0-Day 56)||80
3319227|NCT03145766|4052597|FG003|Vaccination 1|Active Vaccination Phase (Day 0-Day 56)|1 participant of this arm received Imovax Rabies, and counted in Group 5 for safety analysis.|39
3319228|NCT03145766|4052598|FG004|Vaccination 1|Active Vaccination Phase (Day 0-Day 56)|1 participant of Group 4 received Imovax Rabies, and counted in Group 5 for safety analysis.|41
3319229|NCT03145766|4052594|FG000|Vaccination 2|Active Vaccination Phase (Day 0-Day 56)|1 participant received Group 2 vaccine: counted in Group 2 for post-vaccination 2 safety analysis.|77
3319230|NCT03145766|4052595|FG001|Vaccination 2|Active Vaccination Phase (Day 0-Day 56)|1 participant of Group 1 received Group 2 vaccine: counted in Group 2 for post-vaccination 2 safety.|81
3319231|NCT03145766|4052596|FG002|Vaccination 2|Active Vaccination Phase (Day 0-Day 56)||80
3319232|NCT03145766|4052597|FG003|Vaccination 2|Active Vaccination Phase (Day 0-Day 56)||39
3319233|NCT03145766|4052598|FG004|Vaccination 2|Active Vaccination Phase (Day 0-Day 56)||39
3319234|NCT03145766|4052594|FG000|Vaccination 3|Active Vaccination Phase (Day 0-Day 56)||78
3319235|NCT03145766|4052595|FG001|Vaccination 3|Active Vaccination Phase (Day 0-Day 56)||79
3319236|NCT03145766|4052596|FG002|Vaccination 3|Active Vaccination Phase (Day 0-Day 56)||80
3319237|NCT03145766|4052597|FG003|Vaccination 3|Active Vaccination Phase (Day 0-Day 56)||39
3319238|NCT03145766|4052598|FG004|Vaccination 3|Active Vaccination Phase (Day 0-Day 56)||38
3319239|NCT03145766|4052594|FG000|Vaccination 4|Active Vaccination Phase (Day 0-Day 56)||78
3319240|NCT03145766|4052595|FG001|Vaccination 4|Active Vaccination Phase (Day 0-Day 56)||79
3319241|NCT03145766|4052596|FG002|Vaccination 4|Active Vaccination Phase (Day 0-Day 56)||80
3319242|NCT03145766|4052597|FG003|Vaccination 4|Active Vaccination Phase (Day 0-Day 56)||38
3319243|NCT03145766|4052598|FG004|Vaccination 4|Active Vaccination Phase (Day 0-Day 56)||38
3319244|NCT03145766|4052594|FG000|Vaccination 5|Active Vaccination Phase (Day 0-Day 56)||75
3319245|NCT03145766|4052595|FG001|Vaccination 5|Active Vaccination Phase (Day 0-Day 56)||78
3319246|NCT03145766|4052596|FG002|Vaccination 5|Active Vaccination Phase (Day 0-Day 56)||79
3319247|NCT03145766|4052597|FG003|Vaccination 5|Active Vaccination Phase (Day 0-Day 56)||34
3319248|NCT03145766|4052598|FG004|Vaccination 5|Active Vaccination Phase (Day 0-Day 56)||37
3319249|NCT03145766|4052594|FG000|COMPLETED|Active Vaccination Phase (Day 0-Day 56)||74
3319250|NCT03145766|4052595|FG001|COMPLETED|Active Vaccination Phase (Day 0-Day 56)||77
3319251|NCT03145766|4052596|FG002|COMPLETED|Active Vaccination Phase (Day 0-Day 56)||78
3319252|NCT03145766|4052597|FG003|COMPLETED|Active Vaccination Phase (Day 0-Day 56)||33
3319253|NCT03145766|4052598|FG004|COMPLETED|Active Vaccination Phase (Day 0-Day 56)||37
3319254|NCT03145766|4052594|FG000|NOT COMPLETED|Active Vaccination Phase (Day 0-Day 56)||6
3319255|NCT03145766|4052595|FG001|NOT COMPLETED|Active Vaccination Phase (Day 0-Day 56)||3
3319256|NCT03145766|4052596|FG002|NOT COMPLETED|Active Vaccination Phase (Day 0-Day 56)||2
3319257|NCT03145766|4052597|FG003|NOT COMPLETED|Active Vaccination Phase (Day 0-Day 56)||7
3319258|NCT03145766|4052598|FG004|NOT COMPLETED|Active Vaccination Phase (Day 0-Day 56)||3
3319259|NCT03145766|4052594|FG000|STARTED|Follow-up Phase (Day 56 Till Month 7)||74
3319260|NCT03145766|4052595|FG001|STARTED|Follow-up Phase (Day 56 Till Month 7)||77
3319261|NCT03145766|4052596|FG002|STARTED|Follow-up Phase (Day 56 Till Month 7)||78
3319262|NCT03145766|4052597|FG003|STARTED|Follow-up Phase (Day 56 Till Month 7)||33
3319263|NCT03145766|4052598|FG004|STARTED|Follow-up Phase (Day 56 Till Month 7)||37
3319264|NCT03145766|4052594|FG000|COMPLETED|Follow-up Phase (Day 56 Till Month 7)||67
3319265|NCT03145766|4052595|FG001|COMPLETED|Follow-up Phase (Day 56 Till Month 7)||75
3319266|NCT03145766|4052596|FG002|COMPLETED|Follow-up Phase (Day 56 Till Month 7)||73
3319267|NCT03145766|4052597|FG003|COMPLETED|Follow-up Phase (Day 56 Till Month 7)||30
3319268|NCT03145766|4052598|FG004|COMPLETED|Follow-up Phase (Day 56 Till Month 7)||34
3319269|NCT03145766|4052594|FG000|NOT COMPLETED|Follow-up Phase (Day 56 Till Month 7)||7
3319270|NCT03145766|4052595|FG001|NOT COMPLETED|Follow-up Phase (Day 56 Till Month 7)||2
3319271|NCT03145766|4052596|FG002|NOT COMPLETED|Follow-up Phase (Day 56 Till Month 7)||5
3319272|NCT03145766|4052597|FG003|NOT COMPLETED|Follow-up Phase (Day 56 Till Month 7)||3
3319273|NCT03145766|4052598|FG004|NOT COMPLETED|Follow-up Phase (Day 56 Till Month 7)||3
3319274|NCT03145818|4052615|FG000|STARTED|Overall Study||99
3319275|NCT03145818|4052616|FG001|STARTED|Overall Study||8
3319276|NCT03145818|4052617|FG002|STARTED|Overall Study||10
3319277|NCT03145818|4052618|FG003|STARTED|Overall Study||9
3319278|NCT03145818|4052615|FG000|COMPLETED|Overall Study||8
3319279|NCT03145818|4052616|FG001|COMPLETED|Overall Study||0
3319280|NCT03145818|4052617|FG002|COMPLETED|Overall Study||10
3319281|NCT03145818|4052618|FG003|COMPLETED|Overall Study||9
3319282|NCT03145818|4052615|FG000|NOT COMPLETED|Overall Study||91
3319283|NCT03145818|4052616|FG001|NOT COMPLETED|Overall Study||8
3319284|NCT03145818|4052617|FG002|NOT COMPLETED|Overall Study||0
3319285|NCT03145818|4052618|FG003|NOT COMPLETED|Overall Study||0
3319286|NCT03146403|4052628|FG000|STARTED|Overall Study||16
3319287|NCT03146403|4052629|FG001|STARTED|Overall Study||17
3319288|NCT03146403|4052628|FG000|COMPLETED|Overall Study||14
3319289|NCT03146403|4052629|FG001|COMPLETED|Overall Study||14
3319290|NCT03146403|4052628|FG000|NOT COMPLETED|Overall Study||2
3319291|NCT03146403|4052629|FG001|NOT COMPLETED|Overall Study||3
3319292|NCT03146585|4052638|FG000|STARTED|Overall Study||25
3319293|NCT03146585|4052639|FG001|STARTED|Overall Study||10
3319294|NCT03146585|4052640|FG002|STARTED|Overall Study||5
3319295|NCT03146585|4052638|FG000|COMPLETED|Overall Study||25
3319296|NCT03146585|4052639|FG001|COMPLETED|Overall Study||10
3319297|NCT03146585|4052640|FG002|COMPLETED|Overall Study||5
3319298|NCT03146585|4052638|FG000|NOT COMPLETED|Overall Study||0
3319299|NCT03146585|4052639|FG001|NOT COMPLETED|Overall Study||0
3319300|NCT03146585|4052640|FG002|NOT COMPLETED|Overall Study||0
3319301|NCT03146663|4052650|FG000|STARTED|Overall Study||25
3319302|NCT03146663|4052651|FG001|STARTED|Overall Study||28
3319303|NCT03146663|4052650|FG000|COMPLETED|Overall Study||24
3319304|NCT03146663|4052651|FG001|COMPLETED|Overall Study||27
3319305|NCT03146663|4052650|FG000|NOT COMPLETED|Overall Study||1
3319306|NCT03146663|4052651|FG001|NOT COMPLETED|Overall Study||1
3319307|NCT03146741|4052658|FG000|STARTED|Overall Study||20
3319308|NCT03146741|4052658|FG000|COMPLETED|Overall Study||10
3319309|NCT03146741|4052658|FG000|NOT COMPLETED|Overall Study||10
3319310|NCT03146806|4052662|FG000|STARTED|Overall Study||10
3319311|NCT03146806|4052662|FG000|COMPLETED|Overall Study||10
3319312|NCT03146806|4052662|FG000|NOT COMPLETED|Overall Study||0
3319313|NCT03147248|4052684|FG000|STARTED|Overall Study|This cohort is only for Part 1.|13
3319314|NCT03147248|4052685|FG001|STARTED|Overall Study|This cohort is only for Part 1.|11
3319315|NCT03147248|4052686|FG002|STARTED|Overall Study|This cohort is only for Part 1.|12
3319316|NCT03147248|4052687|FG003|STARTED|Overall Study|This cohort is only for Part 1.|12
3319317|NCT03147248|4052688|FG004|STARTED|Overall Study|This arm is for Part 2. All of the participants in Part 2 were screened only for Part 2.|167
3319318|NCT03147248|4052689|FG005|STARTED|Overall Study|This arm is for Part 2. All of the participants in Part 2 were screened only for Part 2.|176
3319319|NCT03147248|4052684|FG000|COMPLETED|Overall Study||12
3319320|NCT03147248|4052685|FG001|COMPLETED|Overall Study||9
3319321|NCT03147248|4052686|FG002|COMPLETED|Overall Study||10
3319322|NCT03147248|4052687|FG003|COMPLETED|Overall Study||10
3319323|NCT03147248|4052688|FG004|COMPLETED|Overall Study||141
3319324|NCT03147248|4052689|FG005|COMPLETED|Overall Study||145
3319325|NCT03147248|4052684|FG000|NOT COMPLETED|Overall Study||1
3319326|NCT03147248|4052685|FG001|NOT COMPLETED|Overall Study||2
3319327|NCT03147248|4052686|FG002|NOT COMPLETED|Overall Study||2
3319328|NCT03147248|4052687|FG003|NOT COMPLETED|Overall Study||2
3319329|NCT03147248|4052688|FG004|NOT COMPLETED|Overall Study||26
3319330|NCT03147248|4052689|FG005|NOT COMPLETED|Overall Study||31
3319331|NCT03147495|4052705|FG000|STARTED|Overall Study||40
3319332|NCT03147495|4052706|FG001|STARTED|Overall Study||46
3319333|NCT03147495|4052705|FG000|COMPLETED|Overall Study||40
3319334|NCT03147495|4052706|FG001|COMPLETED|Overall Study||40
3319335|NCT03147495|4052705|FG000|NOT COMPLETED|Overall Study||0
3319336|NCT03147495|4052706|FG001|NOT COMPLETED|Overall Study||6
3319337|NCT03147690|4052712|FG000|STARTED|Overall Study||74
3319338|NCT03147690|4052712|FG000|COMPLETED|Overall Study||71
3319339|NCT03147690|4052712|FG000|NOT COMPLETED|Overall Study||3
3319340|NCT03148067|4052729|FG000|STARTED|Overall Study||225
3319341|NCT03148067|4052729|FG000|COMPLETED|Overall Study||221
3319342|NCT03148067|4052729|FG000|NOT COMPLETED|Overall Study||4
3319343|NCT03148236|4052736|FG000|STARTED|Overall Study||10
3319344|NCT03148236|4052737|FG001|STARTED|Overall Study||10
3319345|NCT03148236|4052736|FG000|COMPLETED|Overall Study||10
3319346|NCT03148236|4052737|FG001|COMPLETED|Overall Study||10
3319347|NCT03148236|4052736|FG000|NOT COMPLETED|Overall Study||0
3319348|NCT03148236|4052737|FG001|NOT COMPLETED|Overall Study||0
3319349|NCT03148262|4052745|FG000|STARTED|Overall Study||31
3319350|NCT03148262|4052746|FG001|STARTED|Overall Study||32
3319351|NCT03148262|4052745|FG000|COMPLETED|Overall Study||28
3319352|NCT03148262|4052746|FG001|COMPLETED|Overall Study||31
3319353|NCT03148262|4052745|FG000|NOT COMPLETED|Overall Study||3
3319354|NCT03148262|4052746|FG001|NOT COMPLETED|Overall Study||1
3319355|NCT03148470|4052754|FG000|STARTED|Overall Study|21 Participants completed the Tasks following Sham-stimulation|21
3319356|NCT03148470|4052755|FG001|STARTED|Overall Study|20 Participants completed the Tasks following Sham-stimulation|20
3319357|NCT03148470|4052754|FG000|COMPLETED|Overall Study|20 Participants completed the Tasks following iTBS-stimulation|20
3319358|NCT03148470|4052755|FG001|COMPLETED|Overall Study|20 Participants completed the Tasks following cTBS-stimulation|20
3319359|NCT03148470|4052754|FG000|NOT COMPLETED|Overall Study||1
3319360|NCT03148470|4052755|FG001|NOT COMPLETED|Overall Study||0
3319361|NCT03148691|4052772|FG000|STARTED|Overall Study||50
3319362|NCT03148691|4052773|FG001|STARTED|Overall Study||103
3319363|NCT03148691|4052774|FG002|STARTED|Overall Study||100
3319364|NCT03148691|4052772|FG000|COMPLETED|Overall Study||47
3319365|NCT03148691|4052773|FG001|COMPLETED|Overall Study||101
3319366|NCT03148691|4052774|FG002|COMPLETED|Overall Study||92
3319367|NCT03148691|4052772|FG000|NOT COMPLETED|Overall Study||3
3319368|NCT03148691|4052773|FG001|NOT COMPLETED|Overall Study||2
3319369|NCT03148691|4052774|FG002|NOT COMPLETED|Overall Study||8
3319370|NCT03148756|4052784|FG000|STARTED|Overall Study||0
3319371|NCT03148756|4052785|FG001|STARTED|Overall Study||2
3319372|NCT03148756|4052784|FG000|COMPLETED|Overall Study||0
3319373|NCT03148756|4052785|FG001|COMPLETED|Overall Study||1
3319374|NCT03148756|4052784|FG000|NOT COMPLETED|Overall Study||0
3319375|NCT03148756|4052785|FG001|NOT COMPLETED|Overall Study||1
3319376|NCT03149042|4052791|FG000|STARTED|Overall Study||75
3319377|NCT03149042|4052791|FG000|COMPLETED|Overall Study||52
3319378|NCT03149042|4052791|FG000|NOT COMPLETED|Overall Study||23
3319379|NCT03149055|4052796|FG000|STARTED|Overall Study||99
3319380|NCT03149055|4052796|FG000|COMPLETED|Overall Study||95
3319381|NCT03149055|4052796|FG000|NOT COMPLETED|Overall Study||4
3319382|NCT03149172|4052803|FG000|STARTED|Overall Study||8
3319383|NCT03149172|4052804|FG001|STARTED|Overall Study||6
3319384|NCT03149172|4052805|FG002|STARTED|Overall Study||7
3319385|NCT03149172|4052803|FG000|COMPLETED|Overall Study||6
3319386|NCT03149172|4052804|FG001|COMPLETED|Overall Study||5
3319387|NCT03149172|4052805|FG002|COMPLETED|Overall Study||5
3319388|NCT03149172|4052803|FG000|NOT COMPLETED|Overall Study||2
3319389|NCT03149172|4052804|FG001|NOT COMPLETED|Overall Study||1
3319390|NCT03149172|4052805|FG002|NOT COMPLETED|Overall Study||2
3319391|NCT03149328|4052815|FG000|STARTED|Overall Study||284
3319392|NCT03149328|4052816|FG001|STARTED|Overall Study||259
3319393|NCT03149328|4052815|FG000|COMPLETED|Overall Study||200
3319394|NCT03149328|4052816|FG001|COMPLETED|Overall Study||213
3319395|NCT03149328|4052815|FG000|NOT COMPLETED|Overall Study||84
3319396|NCT03149328|4052816|FG001|NOT COMPLETED|Overall Study||46
3319397|NCT03149848|4052822|FG000|STARTED|Period 1 (Day 1 to Day 14)||15
3319398|NCT03149848|4052822|FG000|COMPLETED|Period 1 (Day 1 to Day 14)||14
3319399|NCT03149848|4052822|FG000|NOT COMPLETED|Period 1 (Day 1 to Day 14)||1
3319400|NCT03149848|4052822|FG000|STARTED|Period 2 (Day 15 to Day 28)||14
3319401|NCT03149848|4052822|FG000|COMPLETED|Period 2 (Day 15 to Day 28)||12
3319402|NCT03149848|4052822|FG000|NOT COMPLETED|Period 2 (Day 15 to Day 28)||2
3319403|NCT03149887|4052831|FG000|STARTED|Overall Study||27
3319404|NCT03149887|4052832|FG001|STARTED|Overall Study||27
3319405|NCT03149887|4052831|FG000|COMPLETED|Overall Study||27
3319406|NCT03149887|4052832|FG001|COMPLETED|Overall Study||27
3319407|NCT03149887|4052831|FG000|NOT COMPLETED|Overall Study||0
3319408|NCT03149887|4052832|FG001|NOT COMPLETED|Overall Study||0
3319409|NCT03149991|4052840|FG000|STARTED|Overall Study||25
3319410|NCT03149991|4052841|FG001|STARTED|Overall Study||26
3319411|NCT03149991|4052840|FG000|Completed Primary Endpoint (Day 14)|Overall Study||25
3319412|NCT03149991|4052841|FG001|Completed Primary Endpoint (Day 14)|Overall Study||24
3319413|NCT03149991|4052840|FG000|Exited|Overall Study||4
3319414|NCT03149991|4052841|FG001|Exited|Overall Study||2
3319415|NCT03149991|4052840|FG000|COMPLETED|Overall Study||21
3319416|NCT03149991|4052841|FG001|COMPLETED|Overall Study||24
3319417|NCT03149991|4052840|FG000|NOT COMPLETED|Overall Study||4
3319418|NCT03149991|4052841|FG001|NOT COMPLETED|Overall Study||2
3319419|NCT03150043|4052847|FG000|STARTED|Overall Study||65
3319420|NCT03150043|4052847|FG000|COMPLETED|Overall Study||65
3319421|NCT03150043|4052847|FG000|NOT COMPLETED|Overall Study||0
3319422|NCT03150056|4052858|FG000|STARTED|Overall Study||10
3319423|NCT03150056|4052859|FG001|STARTED|Overall Study||6
3319424|NCT03150056|4052860|FG002|STARTED|Overall Study||4
3319425|NCT03150056|4052861|FG003|STARTED|Overall Study||10
3319426|NCT03150056|4052862|FG004|STARTED|Overall Study||22
3319427|NCT03150056|4052863|FG005|STARTED|Overall Study||21
3319428|NCT03150056|4052858|FG000|COMPLETED|Overall Study||0
3319429|NCT03150056|4052859|FG001|COMPLETED|Overall Study||1
3319430|NCT03150056|4052860|FG002|COMPLETED|Overall Study||0
3319431|NCT03150056|4052861|FG003|COMPLETED|Overall Study||1
3319432|NCT03150056|4052862|FG004|COMPLETED|Overall Study||6
3319433|NCT03150056|4052863|FG005|COMPLETED|Overall Study||3
3319434|NCT03150056|4052858|FG000|NOT COMPLETED|Overall Study||10
3319435|NCT03150056|4052859|FG001|NOT COMPLETED|Overall Study||5
3319436|NCT03150056|4052860|FG002|NOT COMPLETED|Overall Study||4
3319437|NCT03150056|4052861|FG003|NOT COMPLETED|Overall Study||9
3319438|NCT03150056|4052862|FG004|NOT COMPLETED|Overall Study||16
3319439|NCT03150056|4052863|FG005|NOT COMPLETED|Overall Study||18
3319440|NCT03150082|4052880|FG000|STARTED|Treatment Period 1 (Up to 4 Weeks)||13
3319441|NCT03150082|4052881|FG001|STARTED|Treatment Period 1 (Up to 4 Weeks)||13
3319442|NCT03150082|4052880|FG000|COMPLETED|Treatment Period 1 (Up to 4 Weeks)||12
3319443|NCT03150082|4052881|FG001|COMPLETED|Treatment Period 1 (Up to 4 Weeks)||13
3319444|NCT03150082|4052880|FG000|NOT COMPLETED|Treatment Period 1 (Up to 4 Weeks)||1
3319445|NCT03150082|4052881|FG001|NOT COMPLETED|Treatment Period 1 (Up to 4 Weeks)||0
3319446|NCT03150082|4052880|FG000|STARTED|Washout Period (Up to 4 Weeks)||12
3319447|NCT03150082|4052881|FG001|STARTED|Washout Period (Up to 4 Weeks)||13
3319448|NCT03150082|4052880|FG000|COMPLETED|Washout Period (Up to 4 Weeks)||12
3319449|NCT03150082|4052881|FG001|COMPLETED|Washout Period (Up to 4 Weeks)||13
3319450|NCT03150082|4052880|FG000|NOT COMPLETED|Washout Period (Up to 4 Weeks)||0
3319451|NCT03150082|4052881|FG001|NOT COMPLETED|Washout Period (Up to 4 Weeks)||0
3319452|NCT03150082|4052880|FG000|STARTED|Treatment Period 2 (Up to 4 Weeks)||12
3319453|NCT03150082|4052881|FG001|STARTED|Treatment Period 2 (Up to 4 Weeks)||13
3319454|NCT03150082|4052880|FG000|COMPLETED|Treatment Period 2 (Up to 4 Weeks)||12
3319455|NCT03150082|4052881|FG001|COMPLETED|Treatment Period 2 (Up to 4 Weeks)||13
3319456|NCT03150082|4052880|FG000|NOT COMPLETED|Treatment Period 2 (Up to 4 Weeks)||0
3172797|NCT01945034|3900378|FG001|COMPLETED|Overall Study||80
3172798|NCT01945034|3900379|FG002|COMPLETED|Overall Study||145
3172799|NCT01945034|3900377|FG000|NOT COMPLETED|Overall Study||1
3172800|NCT01945034|3900378|FG001|NOT COMPLETED|Overall Study||5
3172801|NCT01945034|3900379|FG002|NOT COMPLETED|Overall Study||7
3172802|NCT01945086|3900390|FG000|STARTED|Overall Study||27
3172803|NCT01945086|3900391|FG001|STARTED|Overall Study||24
3172804|NCT01945086|3900392|FG002|STARTED|Overall Study||28
3172805|NCT01945086|3900390|FG000|COMPLETED|Overall Study||26
3172806|NCT01945086|3900391|FG001|COMPLETED|Overall Study||24
3172807|NCT01945086|3900392|FG002|COMPLETED|Overall Study||26
3172808|NCT01945086|3900390|FG000|NOT COMPLETED|Overall Study||1
3172809|NCT01945086|3900391|FG001|NOT COMPLETED|Overall Study||0
3172810|NCT01945086|3900392|FG002|NOT COMPLETED|Overall Study||2
3172811|NCT01945112|3900400|FG000|STARTED|Overall Study|total number of sites where tape was applied|77
3319457|NCT03150082|4052881|FG001|NOT COMPLETED|Treatment Period 2 (Up to 4 Weeks)||0
2922186|NCT00546000|3632835|FG000|STARTED|Overall Study||56
3319458|NCT03150108|4052891|FG000|STARTED|Overall Study||12
3319459|NCT03150108|4052892|FG001|STARTED|Overall Study||12
3319460|NCT03150108|4052891|FG000|COMPLETED|Overall Study||12
3319461|NCT03150108|4052892|FG001|COMPLETED|Overall Study||12
3319462|NCT03150108|4052891|FG000|NOT COMPLETED|Overall Study||0
3319463|NCT03150108|4052892|FG001|NOT COMPLETED|Overall Study||0
3319464|NCT03150199|4052909|FG000|STARTED|Overall Study||30
3319465|NCT03150199|4052910|FG001|STARTED|Overall Study||30
3172812|NCT01945112|3900401|FG001|STARTED|Overall Study|total number of sites where tape was applied|51
3172813|NCT01945112|3900400|FG000|COMPLETED|Overall Study||77
3172814|NCT01945112|3900401|FG001|COMPLETED|Overall Study||51
3172815|NCT01945112|3900400|FG000|NOT COMPLETED|Overall Study||0
3172816|NCT01945112|3900401|FG001|NOT COMPLETED|Overall Study||0
3172817|NCT01945138|3900408|FG000|STARTED|Overall Study||7
3172818|NCT01945138|3900409|FG001|STARTED|Overall Study||7
3172819|NCT01945138|3900408|FG000|COMPLETED|Overall Study||7
3172820|NCT01945138|3900409|FG001|COMPLETED|Overall Study||7
3172821|NCT01945138|3900408|FG000|NOT COMPLETED|Overall Study||0
3172822|NCT01945138|3900409|FG001|NOT COMPLETED|Overall Study||0
3172823|NCT01945216|3900418|FG000|STARTED|Overall Study||3317
3172824|NCT01945216|3900418|FG000|COMPLETED|Overall Study||3218
3172825|NCT01945216|3900418|FG000|NOT COMPLETED|Overall Study||99
3172826|NCT01945242|3900428|FG000|STARTED|Overall Study||1251
3172827|NCT01945242|3900429|FG001|STARTED|Overall Study||123
3172828|NCT01945242|3900428|FG000|COMPLETED|Overall Study||1248
3172829|NCT01945242|3900429|FG001|COMPLETED|Overall Study||120
3172830|NCT01945242|3900428|FG000|NOT COMPLETED|Overall Study||3
3172831|NCT01945242|3900429|FG001|NOT COMPLETED|Overall Study||3
3172832|NCT01945281|3900438|FG000|STARTED|Overall Study||34
2922187|NCT00546000|3632835|FG000|COMPLETED|Overall Study||52
2922188|NCT00546000|3632835|FG000|NOT COMPLETED|Overall Study||4
2922189|NCT00546078|3632841|FG000|STARTED|Overall Study||65
2922190|NCT00546078|3632842|FG001|STARTED|Overall Study||50
2922191|NCT00546078|3632841|FG000|Month 18|Overall Study||61
2922192|NCT00546078|3632842|FG001|Month 18|Overall Study||45
2922193|NCT00546078|3632841|FG000|COMPLETED|Overall Study||61
2922194|NCT00546078|3632842|FG001|COMPLETED|Overall Study||43
2922195|NCT00546078|3632841|FG000|NOT COMPLETED|Overall Study||4
2922196|NCT00546078|3632842|FG001|NOT COMPLETED|Overall Study||7
2922197|NCT00546104|3632848|FG000|STARTED|Overall Study||31
2922198|NCT00546104|3632848|FG000|COMPLETED|Overall Study||31
2922199|NCT00546104|3632848|FG000|NOT COMPLETED|Overall Study||0
2922200|NCT00546117|3632854|FG000|STARTED|Overall Study||9
2922201|NCT00546117|3632855|FG001|STARTED|Overall Study||7
2922202|NCT00546117|3632854|FG000|COMPLETED|Overall Study||5
2922203|NCT00546117|3632855|FG001|COMPLETED|Overall Study||7
2922204|NCT00546117|3632854|FG000|NOT COMPLETED|Overall Study||4
2922205|NCT00546117|3632855|FG001|NOT COMPLETED|Overall Study||0
2922206|NCT00546156|3632865|FG000|STARTED|Overall Study||84
2922207|NCT00546156|3632866|FG001|STARTED|Overall Study||20
2922208|NCT00546156|3632865|FG000|COMPLETED|Overall Study||70
2922209|NCT00546156|3632866|FG001|COMPLETED|Overall Study||19
2922210|NCT00546156|3632865|FG000|NOT COMPLETED|Overall Study||14
2922211|NCT00546156|3632866|FG001|NOT COMPLETED|Overall Study||1
2922212|NCT00546260|3632873|FG000|STARTED|Overall Study||36
2922213|NCT00546260|3632874|FG001|STARTED|Overall Study||34
2922214|NCT00546260|3632873|FG000|COMPLETED|Overall Study||28
2922215|NCT00546260|3632874|FG001|COMPLETED|Overall Study||32
2922216|NCT00546260|3632873|FG000|NOT COMPLETED|Overall Study||8
2922217|NCT00546260|3632874|FG001|NOT COMPLETED|Overall Study||2
2922218|NCT00546351|3632880|FG000|STARTED|Overall Study||621
2922219|NCT00546351|3632880|FG000|COMPLETED|Overall Study||385
2922220|NCT00546351|3632880|FG000|NOT COMPLETED|Overall Study||236
2922221|NCT00546364|3632887|FG000|STARTED|Overall Study||20
2922222|NCT00546364|3632888|FG001|STARTED|Overall Study||22
2922223|NCT00546364|3632889|FG002|STARTED|Overall Study||20
2922224|NCT00546364|3632887|FG000|Never Treated|Overall Study||0
2922225|NCT00546364|3632888|FG001|Never Treated|Overall Study||0
2922226|NCT00546364|3632889|FG002|Never Treated|Overall Study||0
2922227|NCT00546364|3632887|FG000|COMPLETED|Overall Study|Still on treatment|3
2922228|NCT00546364|3632888|FG001|COMPLETED|Overall Study|Still on treatment|4
2922229|NCT00546364|3632889|FG002|COMPLETED|Overall Study|Still on treatment|3
2922230|NCT00546364|3632887|FG000|NOT COMPLETED|Overall Study||17
2922231|NCT00546364|3632888|FG001|NOT COMPLETED|Overall Study||18
2922232|NCT00546364|3632889|FG002|NOT COMPLETED|Overall Study||17
2922233|NCT00546377|3632897|FG000|STARTED|Overall Study||50
2922234|NCT00546377|3632897|FG000|COMPLETED|Overall Study||43
2922235|NCT00546377|3632897|FG000|NOT COMPLETED|Overall Study||7
2922236|NCT00546390|3632903|FG000|STARTED|Overall Study||27
3172833|NCT01945281|3900439|FG001|STARTED|Overall Study||17
3172834|NCT01945281|3900438|FG000|Treated|Overall Study||33
3319466|NCT03150199|4052909|FG000|COMPLETED|Overall Study||30
3319467|NCT03150199|4052910|FG001|COMPLETED|Overall Study||30
3319468|NCT03150199|4052909|FG000|NOT COMPLETED|Overall Study||0
3319469|NCT03150199|4052910|FG001|NOT COMPLETED|Overall Study||0
3319470|NCT03150485|4052917|FG000|STARTED|Overall Study||2
3319471|NCT03150485|4052918|FG001|STARTED|Overall Study||9
3319472|NCT03150485|4052919|FG002|STARTED|Overall Study||4
3319473|NCT03150485|4052920|FG003|STARTED|Overall Study||5
3319474|NCT03150485|4052921|FG004|STARTED|Overall Study||2
3319475|NCT03150485|4052922|FG005|STARTED|Overall Study||1
3319476|NCT03150485|4052917|FG000|COMPLETED|Overall Study||2
3319477|NCT03150485|4052918|FG001|COMPLETED|Overall Study||8
3319478|NCT03150485|4052919|FG002|COMPLETED|Overall Study||4
3319479|NCT03150485|4052920|FG003|COMPLETED|Overall Study||5
3319480|NCT03150485|4052921|FG004|COMPLETED|Overall Study||2
3319481|NCT03150485|4052922|FG005|COMPLETED|Overall Study||1
3319482|NCT03150485|4052917|FG000|NOT COMPLETED|Overall Study||0
3319483|NCT03150485|4052918|FG001|NOT COMPLETED|Overall Study||1
3319484|NCT03150485|4052919|FG002|NOT COMPLETED|Overall Study||0
3319485|NCT03150485|4052920|FG003|NOT COMPLETED|Overall Study||0
3319486|NCT03150485|4052921|FG004|NOT COMPLETED|Overall Study||0
3319487|NCT03150485|4052922|FG005|NOT COMPLETED|Overall Study||0
3319488|NCT03150589|4052929|FG000|STARTED|Overall Study||351
3319489|NCT03150589|4052930|FG001|STARTED|Overall Study||354
3319490|NCT03150589|4052929|FG000|COMPLETED|Overall Study||307
3319491|NCT03150589|4052930|FG001|COMPLETED|Overall Study||327
3319492|NCT03150589|4052929|FG000|NOT COMPLETED|Overall Study||44
3319493|NCT03150589|4052930|FG001|NOT COMPLETED|Overall Study||27
3319494|NCT03150719|4052938|FG000|STARTED|Overall Study||47
3319495|NCT03150719|4052939|FG001|STARTED|Overall Study||50
3319496|NCT03150719|4052938|FG000|COMPLETED|Overall Study||46
3319497|NCT03150719|4052939|FG001|COMPLETED|Overall Study||48
3319498|NCT03150719|4052938|FG000|NOT COMPLETED|Overall Study||1
3319499|NCT03150719|4052939|FG001|NOT COMPLETED|Overall Study||2
3319500|NCT03150758|4052945|FG000|STARTED|Overall Study||6
3319501|NCT03150758|4052945|FG000|COMPLETED|Overall Study||6
3319502|NCT03150758|4052945|FG000|NOT COMPLETED|Overall Study||0
3319503|NCT03150875|4052951|FG000|STARTED|Overall Study||145
3319504|NCT03150875|4052952|FG001|STARTED|Overall Study||145
3319505|NCT03150875|4052951|FG000|Treated|Overall Study||144
3319506|NCT03150875|4052952|FG001|Treated|Overall Study||130
3319507|NCT03150875|4052951|FG000|Crossover to Certain Treatment|Overall Study||0
3319508|NCT03150875|4052952|FG001|Crossover to Certain Treatment|Overall Study||0
3319509|NCT03150875|4052951|FG000|COMPLETED|Overall Study||0
3319510|NCT03150875|4052952|FG001|COMPLETED|Overall Study||0
3319511|NCT03150875|4052951|FG000|NOT COMPLETED|Overall Study||145
3319512|NCT03150875|4052952|FG001|NOT COMPLETED|Overall Study||145
3319513|NCT03151148|4052960|FG000|STARTED|Overall Study||36
3319514|NCT03151148|4052961|FG001|STARTED|Overall Study||18
3319515|NCT03151148|4052960|FG000|COMPLETED|Overall Study||34
3319516|NCT03151148|4052961|FG001|COMPLETED|Overall Study||18
3319517|NCT03151148|4052960|FG000|NOT COMPLETED|Overall Study||2
3319518|NCT03151148|4052961|FG001|NOT COMPLETED|Overall Study||0
3319519|NCT03151265|4052970|FG000|STARTED|Overall Study||20
3319520|NCT03151265|4052971|FG001|STARTED|Overall Study||20
3319521|NCT03151265|4052970|FG000|COMPLETED|Overall Study||20
3319522|NCT03151265|4052971|FG001|COMPLETED|Overall Study||20
3319523|NCT03151265|4052970|FG000|NOT COMPLETED|Overall Study||0
3319524|NCT03151265|4052971|FG001|NOT COMPLETED|Overall Study||0
3319525|NCT03151395|4052977|FG000|STARTED|Overall Study||197
3319526|NCT03151395|4052977|FG000|COMPLETED|Overall Study||182
3319527|NCT03151395|4052977|FG000|NOT COMPLETED|Overall Study||15
3319528|NCT03151434|4052984|FG000|STARTED|Overall Study||53
3319529|NCT03151434|4052985|FG001|STARTED|Overall Study||47
3319530|NCT03151434|4052986|FG002|STARTED|Overall Study||47
3319531|NCT03151434|4052984|FG000|COMPLETED|Overall Study||40
3319532|NCT03151434|4052985|FG001|COMPLETED|Overall Study||40
3319533|NCT03151434|4052986|FG002|COMPLETED|Overall Study||40
3319534|NCT03151434|4052984|FG000|NOT COMPLETED|Overall Study||13
3319535|NCT03151434|4052985|FG001|NOT COMPLETED|Overall Study||7
2922237|NCT00546390|3632904|FG001|STARTED|Overall Study||28
2922238|NCT00546390|3632903|FG000|COMPLETED|Overall Study||27
2922239|NCT00546390|3632904|FG001|COMPLETED|Overall Study||28
2922240|NCT00546390|3632903|FG000|NOT COMPLETED|Overall Study||0
2922241|NCT00546390|3632904|FG001|NOT COMPLETED|Overall Study||0
2922242|NCT00546429|3632911|FG000|STARTED|Overall Study|2 subjects did not have a preoperative Merle D'Aubigne score.|62
2922243|NCT00546429|3632911|FG000|COMPLETED|Overall Study||32
2922244|NCT00546429|3632911|FG000|NOT COMPLETED|Overall Study||30
2922245|NCT00546481|3632917|FG000|STARTED|Correction Phase (CERA or Epoetin Beta)||39
2922246|NCT00546481|3632918|FG001|STARTED|Correction Phase (CERA or Epoetin Beta)||41
2922247|NCT00546481|3632919|FG002|STARTED|Correction Phase (CERA or Epoetin Beta)||0
2922248|NCT00546481|3632917|FG000|COMPLETED|Correction Phase (CERA or Epoetin Beta)||33
2922249|NCT00546481|3632918|FG001|COMPLETED|Correction Phase (CERA or Epoetin Beta)||36
2922250|NCT00546481|3632919|FG002|COMPLETED|Correction Phase (CERA or Epoetin Beta)||0
2922251|NCT00546481|3632917|FG000|NOT COMPLETED|Correction Phase (CERA or Epoetin Beta)||6
2922252|NCT00546481|3632918|FG001|NOT COMPLETED|Correction Phase (CERA or Epoetin Beta)||5
2922253|NCT00546481|3632919|FG002|NOT COMPLETED|Correction Phase (CERA or Epoetin Beta)||0
2922254|NCT00546481|3632917|FG000|STARTED|Maintenance Phase (CERA)||0
2922255|NCT00546481|3632918|FG001|STARTED|Maintenance Phase (CERA)||0
2922256|NCT00546481|3632919|FG002|STARTED|Maintenance Phase (CERA)||54
2922257|NCT00546481|3632917|FG000|COMPLETED|Maintenance Phase (CERA)||0
2922258|NCT00546481|3632918|FG001|COMPLETED|Maintenance Phase (CERA)||0
2922259|NCT00546481|3632919|FG002|COMPLETED|Maintenance Phase (CERA)||50
2922260|NCT00546481|3632917|FG000|NOT COMPLETED|Maintenance Phase (CERA)||0
2922261|NCT00546481|3632918|FG001|NOT COMPLETED|Maintenance Phase (CERA)||0
2922262|NCT00546481|3632919|FG002|NOT COMPLETED|Maintenance Phase (CERA)||4
2922263|NCT00546572|3632929|FG000|STARTED|Vax 1 / Year 0||464
2922264|NCT00546572|3632930|FG001|STARTED|Vax 1 / Year 0||474
2922265|NCT00546572|3632929|FG000|Received Vax 1|Vax 1 / Year 0||463
2922266|NCT00546572|3632930|FG001|Received Vax 1|Vax 1 / Year 0||473
2922267|NCT00546572|3632929|FG000|COMPLETED|Vax 1 / Year 0||391
2922268|NCT00546572|3632930|FG001|COMPLETED|Vax 1 / Year 0||404
2922269|NCT00546572|3632929|FG000|NOT COMPLETED|Vax 1 / Year 0||73
2922270|NCT00546572|3632930|FG001|NOT COMPLETED|Vax 1 / Year 0||70
2922271|NCT00546572|3632929|FG000|STARTED|Vax 2 / Year 1||391
2922272|NCT00546572|3632930|FG001|STARTED|Vax 2 / Year 1||404
2922273|NCT00546572|3632929|FG000|Received Vax 2|Vax 2 / Year 1||391
2922274|NCT00546572|3632930|FG001|Received Vax 2|Vax 2 / Year 1||404
2922275|NCT00546572|3632929|FG000|COMPLETED|Vax 2 / Year 1||387
2922276|NCT00546572|3632930|FG001|COMPLETED|Vax 2 / Year 1||402
2922277|NCT00546572|3632929|FG000|NOT COMPLETED|Vax 2 / Year 1||4
2922278|NCT00546572|3632930|FG001|NOT COMPLETED|Vax 2 / Year 1||2
2922279|NCT00546637|3632949|FG000|STARTED|Overall Study||474
2922280|NCT00546637|3632950|FG001|STARTED|Overall Study||473
2922281|NCT00546637|3632949|FG000|Received Treatment|Overall Study||471
2922282|NCT00546637|3632950|FG001|Received Treatment|Overall Study||472
2922283|NCT00546637|3632949|FG000|COMPLETED|Overall Study||401
2922284|NCT00546637|3632950|FG001|COMPLETED|Overall Study||424
2922285|NCT00546637|3632949|FG000|NOT COMPLETED|Overall Study||73
2922286|NCT00546637|3632950|FG001|NOT COMPLETED|Overall Study||49
2922287|NCT00546715|3632960|FG000|STARTED|Overall Study||6
2922288|NCT00546715|3632961|FG001|STARTED|Overall Study||5
2922289|NCT00546715|3632962|FG002|STARTED|Overall Study||5
2922290|NCT00546715|3632963|FG003|STARTED|Overall Study||2
2922291|NCT00546715|3632960|FG000|COMPLETED|Overall Study||6
2922292|NCT00546715|3632961|FG001|COMPLETED|Overall Study||4
2922293|NCT00546715|3632962|FG002|COMPLETED|Overall Study||5
2922294|NCT00546715|3632963|FG003|COMPLETED|Overall Study||2
2922295|NCT00546715|3632960|FG000|NOT COMPLETED|Overall Study||0
2922296|NCT00546715|3632961|FG001|NOT COMPLETED|Overall Study||1
2922297|NCT00546715|3632962|FG002|NOT COMPLETED|Overall Study||0
2922298|NCT00546715|3632963|FG003|NOT COMPLETED|Overall Study||0
2922299|NCT00546728|3632975|FG000|STARTED|Overall Study||25
2922300|NCT00546728|3632976|FG001|STARTED|Overall Study||25
2922301|NCT00546728|3632975|FG000|COMPLETED|Overall Study||25
2922302|NCT00546728|3632976|FG001|COMPLETED|Overall Study||25
2922303|NCT00546728|3632975|FG000|NOT COMPLETED|Overall Study||0
2922304|NCT00546728|3632976|FG001|NOT COMPLETED|Overall Study||0
2922305|NCT00546819|3632984|FG000|STARTED|Overall Study||207
2922306|NCT00546819|3632985|FG001|STARTED|Overall Study||102
2922307|NCT00546819|3632984|FG000|VACCINATED|Overall Study||206
2922308|NCT00546819|3632985|FG001|VACCINATED|Overall Study||100
2922309|NCT00546819|3632984|FG000|COMPLETED|Overall Study||199
3172835|NCT01945281|3900439|FG001|Treated|Overall Study||16
3172836|NCT01945281|3900438|FG000|COMPLETED|Overall Study||28
3172837|NCT01945281|3900439|FG001|COMPLETED|Overall Study||13
3172838|NCT01945281|3900438|FG000|NOT COMPLETED|Overall Study||6
3172839|NCT01945281|3900439|FG001|NOT COMPLETED|Overall Study||4
3172840|NCT01945294|3900448|FG000|STARTED|Period 1: 12-Week PR + BOC Lead-In||257
3172841|NCT01945294|3900449|FG001|STARTED|Period 1: 12-Week PR + BOC Lead-In||0
3172842|NCT01945294|3900450|FG002|STARTED|Period 1: 12-Week PR + BOC Lead-In||0
3172843|NCT01945294|3900451|FG003|STARTED|Period 1: 12-Week PR + BOC Lead-In||0
3172844|NCT01945294|3900448|FG000|COMPLETED|Period 1: 12-Week PR + BOC Lead-In||236
3172845|NCT01945294|3900449|FG001|COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
3172846|NCT01945294|3900450|FG002|COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
3172847|NCT01945294|3900451|FG003|COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
3172848|NCT01945294|3900448|FG000|NOT COMPLETED|Period 1: 12-Week PR + BOC Lead-In||21
3172849|NCT01945294|3900449|FG001|NOT COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
3172850|NCT01945294|3900450|FG002|NOT COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
3172851|NCT01945294|3900451|FG003|NOT COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
3172852|NCT01945294|3900448|FG000|STARTED|Period 2: BOC+ PR Treatment & Follow-up|Participants were assigned to 1 of the 3 arms after upon the 12-week BOC + PR lead-in.|0
3172853|NCT01945294|3900449|FG001|STARTED|Period 2: BOC+ PR Treatment & Follow-up||102
3172854|NCT01945294|3900450|FG002|STARTED|Period 2: BOC+ PR Treatment & Follow-up||105
3172855|NCT01945294|3900451|FG003|STARTED|Period 2: BOC+ PR Treatment & Follow-up||29
3172856|NCT01945294|3900448|FG000|COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||0
3172857|NCT01945294|3900449|FG001|COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||97
3172858|NCT01945294|3900450|FG002|COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||97
3172859|NCT01945294|3900451|FG003|COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||23
3172860|NCT01945294|3900448|FG000|NOT COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||0
3172861|NCT01945294|3900449|FG001|NOT COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||5
3172862|NCT01945294|3900450|FG002|NOT COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||8
3172863|NCT01945294|3900451|FG003|NOT COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||6
3172864|NCT01945489|3900462|FG000|STARTED|Cycle 1||129
3172865|NCT01945489|3900463|FG001|STARTED|Cycle 1||125
3172866|NCT01945489|3900462|FG000|COMPLETED|Cycle 1||116
3172867|NCT01945489|3900463|FG001|COMPLETED|Cycle 1||121
3172868|NCT01945489|3900462|FG000|NOT COMPLETED|Cycle 1||13
3172869|NCT01945489|3900463|FG001|NOT COMPLETED|Cycle 1||4
3172870|NCT01945489|3900462|FG000|STARTED|Cycle 2|Not all participants participated in Cycle 2.|88
3172871|NCT01945489|3900463|FG001|STARTED|Cycle 2||107
3172872|NCT01945489|3900462|FG000|COMPLETED|Cycle 2||87
3172873|NCT01945489|3900463|FG001|COMPLETED|Cycle 2||106
3172874|NCT01945489|3900462|FG000|NOT COMPLETED|Cycle 2||1
3172875|NCT01945489|3900463|FG001|NOT COMPLETED|Cycle 2||1
3172876|NCT01945580|3900472|FG000|STARTED|Overall Study||228
2922310|NCT00546819|3632985|FG001|COMPLETED|Overall Study||96
2922311|NCT00546819|3632984|FG000|NOT COMPLETED|Overall Study||8
2922312|NCT00546819|3632985|FG001|NOT COMPLETED|Overall Study||6
2922313|NCT00546871|3632991|FG000|STARTED|Part 1 - IV Infusions of IGIV, PK||14
2922314|NCT00546871|3632992|FG001|STARTED|Part 1 - IV Infusions of IGIV, PK||35
2922315|NCT00546871|3632991|FG000|COMPLETED|Part 1 - IV Infusions of IGIV, PK||13
2922316|NCT00546871|3632992|FG001|COMPLETED|Part 1 - IV Infusions of IGIV, PK||35
2922317|NCT00546871|3632991|FG000|NOT COMPLETED|Part 1 - IV Infusions of IGIV, PK||1
2922318|NCT00546871|3632992|FG001|NOT COMPLETED|Part 1 - IV Infusions of IGIV, PK||0
2922319|NCT00546871|3632991|FG000|STARTED|Part 2 - Subcutaneous (SC) IGIV, PK||13
2922320|NCT00546871|3632992|FG001|STARTED|Part 2 - Subcutaneous (SC) IGIV, PK||35
2922321|NCT00546871|3632991|FG000|COMPLETED|Part 2 - Subcutaneous (SC) IGIV, PK||12
2922322|NCT00546871|3632992|FG001|COMPLETED|Part 2 - Subcutaneous (SC) IGIV, PK||32
2922323|NCT00546871|3632991|FG000|NOT COMPLETED|Part 2 - Subcutaneous (SC) IGIV, PK||1
2922324|NCT00546871|3632992|FG001|NOT COMPLETED|Part 2 - Subcutaneous (SC) IGIV, PK||3
2922325|NCT00546871|3632991|FG000|STARTED|Part 3a- SC IGIV Adjusted Dose, PK Based||12
2922326|NCT00546871|3632992|FG001|STARTED|Part 3a- SC IGIV Adjusted Dose, PK Based||32
2922327|NCT00546871|3632991|FG000|COMPLETED|Part 3a- SC IGIV Adjusted Dose, PK Based||12
2922328|NCT00546871|3632992|FG001|COMPLETED|Part 3a- SC IGIV Adjusted Dose, PK Based||32
2922329|NCT00546871|3632991|FG000|NOT COMPLETED|Part 3a- SC IGIV Adjusted Dose, PK Based||0
2922330|NCT00546871|3632992|FG001|NOT COMPLETED|Part 3a- SC IGIV Adjusted Dose, PK Based||0
2922331|NCT00546871|3632991|FG000|STARTED|Part 3b - SC IGIV 12 Weeks||12
2922332|NCT00546871|3632992|FG001|STARTED|Part 3b - SC IGIV 12 Weeks||32
3172877|NCT01945580|3900473|FG001|STARTED|Overall Study||485
3172878|NCT01945580|3900472|FG000|COMPLETED|Overall Study||176
3172879|NCT01945580|3900473|FG001|COMPLETED|Overall Study||401
3172880|NCT01945580|3900472|FG000|NOT COMPLETED|Overall Study||52
3172881|NCT01945580|3900473|FG001|NOT COMPLETED|Overall Study||84
3172882|NCT01945593|3900487|FG000|STARTED|Overall Study||3
3172883|NCT01945593|3900488|FG001|STARTED|Overall Study||64
3172884|NCT01945593|3900489|FG002|STARTED|Overall Study||26
3172885|NCT01945593|3900490|FG003|STARTED|Overall Study||125
3172886|NCT01945593|3900487|FG000|COMPLETED|Overall Study||3
3172887|NCT01945593|3900488|FG001|COMPLETED|Overall Study||56
3172888|NCT01945593|3900489|FG002|COMPLETED|Overall Study||23
3172889|NCT01945593|3900490|FG003|COMPLETED|Overall Study||105
3136838|NCT01715857|3862088|FG000|NOT COMPLETED|Overall Study||96
3136839|NCT01715883|3862092|FG000|STARTED|Overall Study||3
3136840|NCT01715883|3862092|FG000|COMPLETED|Overall Study||2
3136841|NCT01715883|3862092|FG000|NOT COMPLETED|Overall Study||1
3136842|NCT01715896|3862099|FG000|STARTED|Overall Study||68
3136843|NCT01715896|3862100|FG001|STARTED|Overall Study||70
3136844|NCT01715896|3862099|FG000|COMPLETED|Overall Study||65
3136845|NCT01715896|3862100|FG001|COMPLETED|Overall Study||59
3136846|NCT01715896|3862099|FG000|NOT COMPLETED|Overall Study||3
3136847|NCT01715896|3862100|FG001|NOT COMPLETED|Overall Study||11
3136848|NCT01715948|3862107|FG000|STARTED|Overall Study||9
3136849|NCT01715948|3862107|FG000|COMPLETED|Overall Study||8
3136850|NCT01715948|3862107|FG000|NOT COMPLETED|Overall Study||1
3136851|NCT01716013|3862128|FG000|STARTED|Overall Study||108
3136852|NCT01716013|3862129|FG001|STARTED|Overall Study||54
3136853|NCT01716013|3862128|FG000|COMPLETED|Overall Study||105
3136854|NCT01716013|3862129|FG001|COMPLETED|Overall Study||54
3136855|NCT01716013|3862128|FG000|NOT COMPLETED|Overall Study||3
3136856|NCT01716013|3862129|FG001|NOT COMPLETED|Overall Study||0
3136857|NCT01716039|3862138|FG000|STARTED|Overall Study||4
3136858|NCT01716039|3862139|FG001|STARTED|Overall Study||8
3136859|NCT01716039|3862140|FG002|STARTED|Overall Study||10
3136860|NCT01716039|3862138|FG000|COMPLETED|Overall Study||3
3136861|NCT01716039|3862139|FG001|COMPLETED|Overall Study||6
3136862|NCT01716039|3862140|FG002|COMPLETED|Overall Study||8
3136863|NCT01716039|3862138|FG000|NOT COMPLETED|Overall Study||1
3136864|NCT01716039|3862139|FG001|NOT COMPLETED|Overall Study||2
3136865|NCT01716039|3862140|FG002|NOT COMPLETED|Overall Study||2
3136866|NCT01716104|3862152|FG000|STARTED|Overall Study||125
3136867|NCT01716104|3862153|FG001|STARTED|Overall Study||124
3136868|NCT01716104|3862152|FG000|COMPLETED|Overall Study||119
3136869|NCT01716104|3862153|FG001|COMPLETED|Overall Study||117
3136870|NCT01716104|3862152|FG000|NOT COMPLETED|Overall Study||6
3136871|NCT01716104|3862153|FG001|NOT COMPLETED|Overall Study||7
3136872|NCT01716117|3862161|FG000|STARTED|Overall Study||180
3136873|NCT01716117|3862162|FG001|STARTED|Overall Study||33
3136874|NCT01716117|3862161|FG000|Discharge|Overall Study||177
3136875|NCT01716117|3862162|FG001|Discharge|Overall Study||33
3136876|NCT01716117|3862161|FG000|1-Month Visit|Overall Study||176
3136877|NCT01716117|3862162|FG001|1-Month Visit|Overall Study||33
3136878|NCT01716117|3862161|FG000|6-Month Visit|Overall Study||174
3136879|NCT01716117|3862162|FG001|6-Month Visit|Overall Study||32
3136880|NCT01716117|3862161|FG000|COMPLETED|Overall Study||173
3136881|NCT01716117|3862162|FG001|COMPLETED|Overall Study||31
3136882|NCT01716117|3862161|FG000|NOT COMPLETED|Overall Study||7
3136883|NCT01716117|3862162|FG001|NOT COMPLETED|Overall Study||2
3136884|NCT01716156|3862179|FG000|STARTED|Overall Study||9
3136885|NCT01716156|3862180|FG001|STARTED|Overall Study||4
3136886|NCT01716156|3862181|FG002|STARTED|Overall Study||13
3136887|NCT01716156|3862179|FG000|COMPLETED|Overall Study||7
3136888|NCT01716156|3862180|FG001|COMPLETED|Overall Study||3
3136889|NCT01716156|3862181|FG002|COMPLETED|Overall Study||11
3136890|NCT01716156|3862179|FG000|NOT COMPLETED|Overall Study||2
3136891|NCT01716156|3862180|FG001|NOT COMPLETED|Overall Study||1
3136892|NCT01716156|3862181|FG002|NOT COMPLETED|Overall Study||2
3136893|NCT01716169|3862193|FG000|STARTED|Overall Study||10
3136894|NCT01716169|3862193|FG000|Standard of Care Dressings Used|Overall Study||7
3136895|NCT01716169|3862193|FG000|COMPLETED|Overall Study||6
3136896|NCT01716169|3862193|FG000|NOT COMPLETED|Overall Study||4
3136897|NCT01716195|3862199|FG000|STARTED|Overall Study||18
3136898|NCT01716195|3862199|FG000|COMPLETED|Overall Study||17
3136899|NCT01716195|3862199|FG000|NOT COMPLETED|Overall Study||1
3136900|NCT01716208|3862203|FG000|STARTED|Overall Study||12
3136901|NCT01716208|3862203|FG000|COMPLETED|Overall Study||12
3136902|NCT01716208|3862203|FG000|NOT COMPLETED|Overall Study||0
3136903|NCT01716221|3862207|FG000|STARTED|Overall Study||1
3136904|NCT01716221|3862207|FG000|COMPLETED|Overall Study||1
3136905|NCT01716221|3862207|FG000|NOT COMPLETED|Overall Study||0
3172890|NCT01945593|3900487|FG000|NOT COMPLETED|Overall Study||0
3172891|NCT01945593|3900488|FG001|NOT COMPLETED|Overall Study||8
3172892|NCT01945593|3900489|FG002|NOT COMPLETED|Overall Study||3
3172893|NCT01945593|3900490|FG003|NOT COMPLETED|Overall Study||20
3172894|NCT01945710|3900512|FG000|STARTED|Overall Study||7
2922333|NCT00546871|3632991|FG000|COMPLETED|Part 3b - SC IGIV 12 Weeks||12
2922334|NCT00546871|3632992|FG001|COMPLETED|Part 3b - SC IGIV 12 Weeks||32
2922335|NCT00546871|3632991|FG000|NOT COMPLETED|Part 3b - SC IGIV 12 Weeks||0
2922336|NCT00546871|3632992|FG001|NOT COMPLETED|Part 3b - SC IGIV 12 Weeks||0
2922337|NCT00546871|3632991|FG000|STARTED|Study Extension Period|2 withdrawn after Part 3b|10
2922338|NCT00546871|3632992|FG001|STARTED|Study Extension Period|6 withdrawn after Part 3b|26
2922339|NCT00546871|3632991|FG000|COMPLETED|Study Extension Period||9
2922340|NCT00546871|3632992|FG001|COMPLETED|Study Extension Period||25
2922341|NCT00546871|3632991|FG000|NOT COMPLETED|Study Extension Period||1
2922342|NCT00546871|3632992|FG001|NOT COMPLETED|Study Extension Period||1
2922343|NCT00546884|3633023|FG000|STARTED|Overall Study||145
2922344|NCT00546884|3633024|FG001|STARTED|Overall Study||117
2922345|NCT00546884|3633023|FG000|COMPLETED|Overall Study||145
2922346|NCT00546884|3633024|FG001|COMPLETED|Overall Study||117
2922347|NCT00546884|3633023|FG000|NOT COMPLETED|Overall Study||0
3172895|NCT01945710|3900513|FG001|STARTED|Overall Study||6
3172896|NCT01945710|3900514|FG002|STARTED|Overall Study||7
3172897|NCT01945710|3900515|FG003|STARTED|Overall Study||3
3172898|NCT01945710|3900516|FG004|STARTED|Overall Study||9
3172899|NCT01945710|3900517|FG005|STARTED|Overall Study||3
3172900|NCT01945710|3900518|FG006|STARTED|Overall Study||23
3172901|NCT01945710|3900512|FG000|COMPLETED|Overall Study||0
3172902|NCT01945710|3900513|FG001|COMPLETED|Overall Study||0
3172903|NCT01945710|3900514|FG002|COMPLETED|Overall Study||0
3172904|NCT01945710|3900515|FG003|COMPLETED|Overall Study||0
3172905|NCT01945710|3900516|FG004|COMPLETED|Overall Study||0
3172906|NCT01945710|3900517|FG005|COMPLETED|Overall Study||0
3172907|NCT01945710|3900518|FG006|COMPLETED|Overall Study||0
3172908|NCT01945710|3900512|FG000|NOT COMPLETED|Overall Study||7
3172909|NCT01945710|3900513|FG001|NOT COMPLETED|Overall Study||6
3172910|NCT01945710|3900514|FG002|NOT COMPLETED|Overall Study||7
3172911|NCT01945710|3900515|FG003|NOT COMPLETED|Overall Study||3
3172912|NCT01945710|3900516|FG004|NOT COMPLETED|Overall Study||9
3172913|NCT01945710|3900517|FG005|NOT COMPLETED|Overall Study||3
3172914|NCT01945710|3900518|FG006|NOT COMPLETED|Overall Study||23
3172915|NCT01945866|3900538|FG000|STARTED|Overall Study||65
3172916|NCT01945866|3900539|FG001|STARTED|Overall Study||64
3172917|NCT01945866|3900538|FG000|COMPLETED|Overall Study||63
3136906|NCT01716234|3862230|FG000|STARTED|Overall Study||24
3136907|NCT01716234|3862231|FG001|STARTED|Overall Study||22
3136908|NCT01716234|3862232|FG002|STARTED|Overall Study||20
3136909|NCT01716234|3862233|FG003|STARTED|Overall Study||28
3136910|NCT01716234|3862234|FG004|STARTED|Overall Study||15
3136911|NCT01716234|3862235|FG005|STARTED|Overall Study||32
3136912|NCT01716234|3862236|FG006|STARTED|Overall Study||1
3136913|NCT01716234|3862230|FG000|Treated|Overall Study||22
3136914|NCT01716234|3862231|FG001|Treated|Overall Study||21
3136915|NCT01716234|3862232|FG002|Treated|Overall Study||19
3136916|NCT01716234|3862233|FG003|Treated|Overall Study||28
3136917|NCT01716234|3862234|FG004|Treated|Overall Study||15
3136918|NCT01716234|3862235|FG005|Treated|Overall Study||30
3136919|NCT01716234|3862236|FG006|Treated|Overall Study||1
3136920|NCT01716234|3862230|FG000|COMPLETED|Overall Study||14
3136921|NCT01716234|3862231|FG001|COMPLETED|Overall Study||12
3136922|NCT01716234|3862232|FG002|COMPLETED|Overall Study||15
3136923|NCT01716234|3862233|FG003|COMPLETED|Overall Study||16
3136924|NCT01716234|3862234|FG004|COMPLETED|Overall Study||10
3136925|NCT01716234|3862235|FG005|COMPLETED|Overall Study||18
3136926|NCT01716234|3862236|FG006|COMPLETED|Overall Study||1
3136927|NCT01716234|3862230|FG000|NOT COMPLETED|Overall Study||10
3136928|NCT01716234|3862231|FG001|NOT COMPLETED|Overall Study||10
3136929|NCT01716234|3862232|FG002|NOT COMPLETED|Overall Study||5
3136930|NCT01716234|3862233|FG003|NOT COMPLETED|Overall Study||12
3136931|NCT01716234|3862234|FG004|NOT COMPLETED|Overall Study||5
3136932|NCT01716234|3862235|FG005|NOT COMPLETED|Overall Study||14
3172918|NCT01945866|3900539|FG001|COMPLETED|Overall Study||64
3172919|NCT01945866|3900538|FG000|NOT COMPLETED|Overall Study||2
3172920|NCT01945866|3900539|FG001|NOT COMPLETED|Overall Study||0
3172921|NCT01945944|3900548|FG000|STARTED|Overall Study||9
3172922|NCT01945944|3900549|FG001|STARTED|Overall Study||9
3172923|NCT01945944|3900548|FG000|COMPLETED|Overall Study||8
3172924|NCT01945944|3900549|FG001|COMPLETED|Overall Study||6
3172925|NCT01945944|3900548|FG000|NOT COMPLETED|Overall Study||1
3172926|NCT01945944|3900549|FG001|NOT COMPLETED|Overall Study||3
3172927|NCT01945970|3900557|FG000|STARTED|Overall Study||5
3172928|NCT01945970|3900558|FG001|STARTED|Overall Study||5
3172929|NCT01945970|3900559|FG002|STARTED|Overall Study||5
3172930|NCT01945970|3900560|FG003|STARTED|Overall Study||5
3172931|NCT01945970|3900561|FG004|STARTED|Overall Study||5
3172932|NCT01945970|3900562|FG005|STARTED|Overall Study||5
3172933|NCT01945970|3900557|FG000|COMPLETED|Overall Study||5
3172934|NCT01945970|3900558|FG001|COMPLETED|Overall Study||5
3172935|NCT01945970|3900559|FG002|COMPLETED|Overall Study||5
3172936|NCT01945970|3900560|FG003|COMPLETED|Overall Study||5
3172937|NCT01945970|3900561|FG004|COMPLETED|Overall Study||5
3172938|NCT01945970|3900562|FG005|COMPLETED|Overall Study||5
3172939|NCT01945970|3900557|FG000|NOT COMPLETED|Overall Study||0
3172940|NCT01945970|3900558|FG001|NOT COMPLETED|Overall Study||0
3172941|NCT01945970|3900559|FG002|NOT COMPLETED|Overall Study||0
3172942|NCT01945970|3900560|FG003|NOT COMPLETED|Overall Study||0
3172943|NCT01945970|3900561|FG004|NOT COMPLETED|Overall Study||0
3172944|NCT01945970|3900562|FG005|NOT COMPLETED|Overall Study||0
3172945|NCT01945996|3900574|FG000|STARTED|Overall Study||22
3172946|NCT01945996|3900575|FG001|STARTED|Overall Study||22
3172947|NCT01945996|3900574|FG000|COMPLETED|Overall Study||19
3172948|NCT01945996|3900575|FG001|COMPLETED|Overall Study||17
3172949|NCT01945996|3900574|FG000|NOT COMPLETED|Overall Study||3
3172950|NCT01945996|3900575|FG001|NOT COMPLETED|Overall Study||5
3172951|NCT01946126|3900585|FG000|STARTED|Overall Study||184
3172952|NCT01946126|3900586|FG001|STARTED|Overall Study||275
3172953|NCT01946126|3900585|FG000|COMPLETED|Overall Study||184
3172954|NCT01946126|3900586|FG001|COMPLETED|Overall Study||275
3172955|NCT01946126|3900585|FG000|NOT COMPLETED|Overall Study||0
3172956|NCT01946126|3900586|FG001|NOT COMPLETED|Overall Study||0
3172957|NCT01946152|3900596|FG000|STARTED|Overall Study||3
3172958|NCT01946152|3900597|FG001|STARTED|Overall Study||3
3172959|NCT01946152|3900598|FG002|STARTED|Overall Study||6
3172960|NCT01946152|3900599|FG003|STARTED|Overall Study||8
3172961|NCT01946152|3900596|FG000|COMPLETED|Overall Study||2
3172962|NCT01946152|3900597|FG001|COMPLETED|Overall Study||0
3172963|NCT01946152|3900598|FG002|COMPLETED|Overall Study||0
3172964|NCT01946152|3900599|FG003|COMPLETED|Overall Study||0
3172965|NCT01946152|3900596|FG000|NOT COMPLETED|Overall Study||1
3172966|NCT01946152|3900597|FG001|NOT COMPLETED|Overall Study||3
3172967|NCT01946152|3900598|FG002|NOT COMPLETED|Overall Study||6
3172968|NCT01946152|3900599|FG003|NOT COMPLETED|Overall Study||8
3172969|NCT01946165|3900613|FG000|STARTED|Overall Study||45
3172970|NCT01946165|3900614|FG001|STARTED|Overall Study||23
3172971|NCT01946165|3900613|FG000|COMPLETED|Overall Study||43
3172972|NCT01946165|3900614|FG001|COMPLETED|Overall Study||21
3172973|NCT01946165|3900613|FG000|NOT COMPLETED|Overall Study||2
3172974|NCT01946165|3900614|FG001|NOT COMPLETED|Overall Study||2
3172975|NCT01946178|3900621|FG000|STARTED|Overall Study||73
3172976|NCT01946178|3900621|FG000|COMPLETED|Overall Study||71
3172977|NCT01946178|3900621|FG000|NOT COMPLETED|Overall Study||2
3172978|NCT01946191|3900631|FG000|STARTED|Allocation||98
3319536|NCT03151434|4052986|FG002|NOT COMPLETED|Overall Study||7
3319537|NCT03151551|4052999|FG000|STARTED|Open-Label Treatment Period||283
3319538|NCT03151551|4053000|FG001|STARTED|Open-Label Treatment Period||283
3319539|NCT03151551|4052999|FG000|Received at Least One Dose of Study Drug|Open-Label Treatment Period||283
3319540|NCT03151551|4053000|FG001|Received at Least One Dose of Study Drug|Open-Label Treatment Period||283
3319541|NCT03151551|4052999|FG000|IXE 160 mg at Baseline, 80 mg Q2W/Q4W|Open-Label Treatment Period||49
3319542|NCT03151551|4053000|FG001|IXE 160 mg at Baseline, 80 mg Q2W/Q4W|Open-Label Treatment Period|Row represents Ixekizumab data only.|0
3319543|NCT03151551|4052999|FG000|IXE 160 mg at Baseline, 80 mg Q4W|Open-Label Treatment Period||218
3319544|NCT03151551|4053000|FG001|IXE 160 mg at Baseline, 80 mg Q4W|Open-Label Treatment Period|Row represents Ixekizumab data only.|0
3319545|NCT03151551|4052999|FG000|ADA 80 mg at Baseline, 40 mg Q2W|Open-Label Treatment Period|Row represents adalimumab data only.|0
3172979|NCT01946191|3900632|FG001|STARTED|Allocation||96
3172980|NCT01946191|3900631|FG000|COMPLETED|Allocation||97
3172981|NCT01946191|3900632|FG001|COMPLETED|Allocation||95
3172982|NCT01946191|3900631|FG000|NOT COMPLETED|Allocation||1
3172983|NCT01946191|3900632|FG001|NOT COMPLETED|Allocation||1
3172984|NCT01946191|3900631|FG000|STARTED|Follow-Up, 24-mo Endpoint||97
3172985|NCT01946191|3900632|FG001|STARTED|Follow-Up, 24-mo Endpoint||95
3172986|NCT01946191|3900631|FG000|COMPLETED|Follow-Up, 24-mo Endpoint||80
3172987|NCT01946191|3900632|FG001|COMPLETED|Follow-Up, 24-mo Endpoint||77
3172988|NCT01946191|3900631|FG000|NOT COMPLETED|Follow-Up, 24-mo Endpoint||17
3172989|NCT01946191|3900632|FG001|NOT COMPLETED|Follow-Up, 24-mo Endpoint||18
3172990|NCT01946191|3900631|FG000|STARTED|Primary Outcome Analysis||98
3172991|NCT01946191|3900632|FG001|STARTED|Primary Outcome Analysis||95
3172992|NCT01946191|3900631|FG000|COMPLETED|Primary Outcome Analysis|Weight data at 24 months|80
3172993|NCT01946191|3900632|FG001|COMPLETED|Primary Outcome Analysis|Weight data at 24 months|77
3172994|NCT01946191|3900631|FG000|NOT COMPLETED|Primary Outcome Analysis||18
3172995|NCT01946191|3900632|FG001|NOT COMPLETED|Primary Outcome Analysis||18
3172996|NCT01946243|3900639|FG000|STARTED|Overall Study||96
3172997|NCT01946243|3900639|FG000|COMPLETED|Overall Study||96
3172998|NCT01946243|3900639|FG000|NOT COMPLETED|Overall Study||0
3172999|NCT01946282|3900648|FG000|STARTED|Year 1||6565
3173000|NCT01946282|3900649|FG001|STARTED|Year 1||1000
3173001|NCT01946282|3900650|FG002|STARTED|Year 1||1000
3173002|NCT01946282|3900648|FG000|COMPLETED|Year 1||2379
3173003|NCT01946282|3900649|FG001|COMPLETED|Year 1||392
3173004|NCT01946282|3900650|FG002|COMPLETED|Year 1||346
3173005|NCT01946282|3900648|FG000|NOT COMPLETED|Year 1||4186
3173006|NCT01946282|3900649|FG001|NOT COMPLETED|Year 1||608
3173007|NCT01946282|3900650|FG002|NOT COMPLETED|Year 1||654
3173008|NCT01946282|3900648|FG000|STARTED|Year 2|Patients are those with Year 1 negative FIT results, or no longer met inclusion criteria.|2051
3173009|NCT01946282|3900649|FG001|STARTED|Year 2|Patients are those with Year 1 negative FIT results, or no longer met inclusion criteria.|341
3173010|NCT01946282|3900650|FG002|STARTED|Year 2|Patients are those with Year 1 negative FIT results, or no longer met inclusion criteria.|299
3173011|NCT01946282|3900648|FG000|COMPLETED|Year 2||1248
3173012|NCT01946282|3900649|FG001|COMPLETED|Year 2||210
3173013|NCT01946282|3900650|FG002|COMPLETED|Year 2||184
3173014|NCT01946282|3900648|FG000|NOT COMPLETED|Year 2||803
3173015|NCT01946282|3900649|FG001|NOT COMPLETED|Year 2||131
3173016|NCT01946282|3900650|FG002|NOT COMPLETED|Year 2||115
3173017|NCT01946282|3900648|FG000|STARTED|Year 3|Patients are those with Year 2 negative FIT results, or no longer met inclusion criteria.|1144
3173018|NCT01946282|3900649|FG001|STARTED|Year 3|Patients are those with Year 2 negative FIT results, or no longer met inclusion criteria.|184
3173019|NCT01946282|3900650|FG002|STARTED|Year 3|Patients are those with Year 2 negative FIT results, or no longer met inclusion criteria.|170
3173020|NCT01946282|3900648|FG000|COMPLETED|Year 3||856
3173021|NCT01946282|3900649|FG001|COMPLETED|Year 3||141
3173022|NCT01946282|3900650|FG002|COMPLETED|Year 3||140
3173023|NCT01946282|3900648|FG000|NOT COMPLETED|Year 3||288
3173024|NCT01946282|3900649|FG001|NOT COMPLETED|Year 3||43
3173025|NCT01946282|3900650|FG002|NOT COMPLETED|Year 3||30
3173026|NCT01946412|3900660|FG000|STARTED|Overall Study||33
3173027|NCT01946412|3900660|FG000|COMPLETED|Overall Study||28
3173028|NCT01946412|3900660|FG000|NOT COMPLETED|Overall Study||5
3173029|NCT01946425|3900668|FG000|STARTED|Overall Study||30
3173030|NCT01946425|3900669|FG001|STARTED|Overall Study||30
3173031|NCT01946425|3900668|FG000|COMPLETED|Overall Study||28
3173032|NCT01946425|3900669|FG001|COMPLETED|Overall Study||30
3173033|NCT01946425|3900668|FG000|NOT COMPLETED|Overall Study||2
3173034|NCT01946425|3900669|FG001|NOT COMPLETED|Overall Study||0
3173035|NCT01946438|3900680|FG000|STARTED|Overall Study||52
3173036|NCT01946438|3900681|FG001|STARTED|Overall Study||52
3173037|NCT01946438|3900682|FG002|STARTED|Overall Study||52
3173038|NCT01946438|3900683|FG003|STARTED|Overall Study||52
3173039|NCT01946438|3900680|FG000|COMPLETED|Overall Study||50
3173040|NCT01946438|3900681|FG001|COMPLETED|Overall Study||52
3173041|NCT01946438|3900682|FG002|COMPLETED|Overall Study||51
3173042|NCT01946438|3900683|FG003|COMPLETED|Overall Study||51
3173043|NCT01946438|3900680|FG000|NOT COMPLETED|Overall Study||2
3173044|NCT01946438|3900681|FG001|NOT COMPLETED|Overall Study||0
3173045|NCT01946438|3900682|FG002|NOT COMPLETED|Overall Study||1
3173046|NCT01946438|3900683|FG003|NOT COMPLETED|Overall Study||1
3173047|NCT01946529|3900702|FG000|STARTED|End of Window Therapy (2 Courses)||1
3173048|NCT01946529|3900703|FG001|STARTED|End of Window Therapy (2 Courses)||17
3173049|NCT01946529|3900704|FG002|STARTED|End of Window Therapy (2 Courses)||6
3173050|NCT01946529|3900702|FG000|COMPLETED|End of Window Therapy (2 Courses)||1
3173051|NCT01946529|3900703|FG001|COMPLETED|End of Window Therapy (2 Courses)||16
3173052|NCT01946529|3900704|FG002|COMPLETED|End of Window Therapy (2 Courses)||6
3173053|NCT01946529|3900702|FG000|NOT COMPLETED|End of Window Therapy (2 Courses)||0
3173054|NCT01946529|3900703|FG001|NOT COMPLETED|End of Window Therapy (2 Courses)||1
3173055|NCT01946529|3900704|FG002|NOT COMPLETED|End of Window Therapy (2 Courses)||0
3173056|NCT01946529|3900702|FG000|STARTED|Completion of All Therapy||1
3173057|NCT01946529|3900703|FG001|STARTED|Completion of All Therapy||16
3173058|NCT01946529|3900704|FG002|STARTED|Completion of All Therapy||6
3173059|NCT01946529|3900702|FG000|COMPLETED|Completion of All Therapy||0
3173060|NCT01946529|3900703|FG001|COMPLETED|Completion of All Therapy||0
3173061|NCT01946529|3900704|FG002|COMPLETED|Completion of All Therapy||0
3173062|NCT01946529|3900702|FG000|NOT COMPLETED|Completion of All Therapy||1
3173063|NCT01946529|3900703|FG001|NOT COMPLETED|Completion of All Therapy||16
3173064|NCT01946529|3900704|FG002|NOT COMPLETED|Completion of All Therapy||6
3173065|NCT01946802|3900711|FG000|STARTED|Overall Study||44
3173066|NCT01946802|3900711|FG000|COMPLETED|Overall Study||39
3173067|NCT01946802|3900711|FG000|NOT COMPLETED|Overall Study||5
3173068|NCT01946880|3900717|FG000|STARTED|Overall Study||50
3173069|NCT01946880|3900718|FG001|STARTED|Overall Study||52
3173070|NCT01946880|3900717|FG000|COMPLETED|Overall Study||43
3173071|NCT01946880|3900718|FG001|COMPLETED|Overall Study||49
3173072|NCT01946880|3900717|FG000|NOT COMPLETED|Overall Study||7
3173073|NCT01946880|3900718|FG001|NOT COMPLETED|Overall Study||3
3173074|NCT01947127|3900726|FG000|STARTED|Overall Study||166
3173075|NCT01947127|3900727|FG001|STARTED|Overall Study||292
3173076|NCT01947127|3900726|FG000|COMPLETED|Overall Study||143
3173077|NCT01947127|3900727|FG001|COMPLETED|Overall Study||249
3173078|NCT01947127|3900726|FG000|NOT COMPLETED|Overall Study||23
3173079|NCT01947127|3900727|FG001|NOT COMPLETED|Overall Study||43
3173080|NCT01947153|3900733|FG000|STARTED|Test Period 1||18
3173081|NCT01947153|3900734|FG001|STARTED|Test Period 1||18
3173082|NCT01947153|3900733|FG000|COMPLETED|Test Period 1||18
3173083|NCT01947153|3900734|FG001|COMPLETED|Test Period 1||18
3173084|NCT01947153|3900733|FG000|NOT COMPLETED|Test Period 1||0
3173085|NCT01947153|3900734|FG001|NOT COMPLETED|Test Period 1||0
3173086|NCT01947153|3900733|FG000|STARTED|Test Period 2||18
3173087|NCT01947153|3900734|FG001|STARTED|Test Period 2||18
3173088|NCT01947153|3900733|FG000|COMPLETED|Test Period 2||18
3173089|NCT01947153|3900734|FG001|COMPLETED|Test Period 2||18
3173090|NCT01947153|3900733|FG000|NOT COMPLETED|Test Period 2||0
3173091|NCT01947153|3900734|FG001|NOT COMPLETED|Test Period 2||0
3173092|NCT01947283|3900747|FG000|STARTED|Overall Study||89
3173093|NCT01947283|3900748|FG001|STARTED|Overall Study||68
3173094|NCT01947283|3900749|FG002|STARTED|Overall Study||83
3173095|NCT01947283|3900750|FG003|STARTED|Overall Study||72
3173096|NCT01947283|3900751|FG004|STARTED|Overall Study||95
3173097|NCT01947283|3900752|FG005|STARTED|Overall Study||34
3173098|NCT01947283|3900753|FG006|STARTED|Overall Study||40
3173099|NCT01947283|3900747|FG000|Baseline Assessment|Overall Study||89
3173100|NCT01947283|3900748|FG001|Baseline Assessment|Overall Study||68
3173101|NCT01947283|3900749|FG002|Baseline Assessment|Overall Study||83
3173102|NCT01947283|3900750|FG003|Baseline Assessment|Overall Study||72
3173103|NCT01947283|3900751|FG004|Baseline Assessment|Overall Study||0
3173104|NCT01947283|3900752|FG005|Baseline Assessment|Overall Study||34
3173105|NCT01947283|3900753|FG006|Baseline Assessment|Overall Study||40
3173106|NCT01947283|3900747|FG000|Follow-up Assessment|Overall Study||64
3173107|NCT01947283|3900748|FG001|Follow-up Assessment|Overall Study||51
3173108|NCT01947283|3900749|FG002|Follow-up Assessment|Overall Study||65
3173109|NCT01947283|3900750|FG003|Follow-up Assessment|Overall Study||59
3173110|NCT01947283|3900751|FG004|Follow-up Assessment|Overall Study||0
3173111|NCT01947283|3900752|FG005|Follow-up Assessment|Overall Study||27
3173112|NCT01947283|3900753|FG006|Follow-up Assessment|Overall Study||36
3173113|NCT01947283|3900747|FG000|Clinical Recording|Overall Study||65
3173114|NCT01947283|3900748|FG001|Clinical Recording|Overall Study||54
3173115|NCT01947283|3900749|FG002|Clinical Recording|Overall Study||68
3319546|NCT03151551|4053000|FG001|ADA 80 mg at Baseline, 40 mg Q2W|Open-Label Treatment Period||51
3319547|NCT03151551|4052999|FG000|ADA 40 mg at Baseline, 40 mg Q2W|Open-Label Treatment Period|Row represents adalimumab data only.|0
3319548|NCT03151551|4053000|FG001|ADA 40 mg at Baseline, 40 mg Q2W|Open-Label Treatment Period||219
3319549|NCT03151551|4052999|FG000|COMPLETED|Open-Label Treatment Period||265
3319550|NCT03151551|4053000|FG001|COMPLETED|Open-Label Treatment Period||259
3319551|NCT03151551|4052999|FG000|NOT COMPLETED|Open-Label Treatment Period||18
3319552|NCT03151551|4053000|FG001|NOT COMPLETED|Open-Label Treatment Period||24
3173116|NCT01947283|3900750|FG003|Clinical Recording|Overall Study||57
3173117|NCT01947283|3900751|FG004|Clinical Recording|Overall Study||0
3173118|NCT01947283|3900752|FG005|Clinical Recording|Overall Study||0
3173119|NCT01947283|3900753|FG006|Clinical Recording|Overall Study||0
3173120|NCT01947283|3900747|FG000|End-of-Intervention Assessment|Overall Study||74
3173121|NCT01947283|3900748|FG001|End-of-Intervention Assessment|Overall Study||53
3173122|NCT01947283|3900749|FG002|End-of-Intervention Assessment|Overall Study||73
3173123|NCT01947283|3900750|FG003|End-of-Intervention Assessment|Overall Study||66
3173124|NCT01947283|3900751|FG004|End-of-Intervention Assessment|Overall Study||0
3173125|NCT01947283|3900752|FG005|End-of-Intervention Assessment|Overall Study||32
3173126|NCT01947283|3900753|FG006|End-of-Intervention Assessment|Overall Study||33
3173127|NCT01947283|3900747|FG000|In Analysis|Overall Study||89
3173128|NCT01947283|3900748|FG001|In Analysis|Overall Study||68
3173129|NCT01947283|3900749|FG002|In Analysis|Overall Study||83
3173130|NCT01947283|3900750|FG003|In Analysis|Overall Study||72
3173131|NCT01947283|3900751|FG004|In Analysis|Overall Study||95
3173132|NCT01947283|3900752|FG005|In Analysis|Overall Study||30
3173133|NCT01947283|3900753|FG006|In Analysis|Overall Study||38
3173134|NCT01947283|3900747|FG000|Completed NRCT Baseline Assessment|Overall Study||0
3173135|NCT01947283|3900748|FG001|Completed NRCT Baseline Assessment|Overall Study||0
3173136|NCT01947283|3900749|FG002|Completed NRCT Baseline Assessment|Overall Study||0
3173137|NCT01947283|3900750|FG003|Completed NRCT Baseline Assessment|Overall Study||0
3173138|NCT01947283|3900751|FG004|Completed NRCT Baseline Assessment|Overall Study||95
3173139|NCT01947283|3900752|FG005|Completed NRCT Baseline Assessment|Overall Study||0
3173140|NCT01947283|3900753|FG006|Completed NRCT Baseline Assessment|Overall Study||0
3173141|NCT01947283|3900747|FG000|COMPLETED|Overall Study||60
3173142|NCT01947283|3900748|FG001|COMPLETED|Overall Study||45
3173143|NCT01947283|3900749|FG002|COMPLETED|Overall Study||62
3173144|NCT01947283|3900750|FG003|COMPLETED|Overall Study||55
3173145|NCT01947283|3900751|FG004|COMPLETED|Overall Study||95
3173146|NCT01947283|3900752|FG005|COMPLETED|Overall Study||27
3173147|NCT01947283|3900753|FG006|COMPLETED|Overall Study||32
3173148|NCT01947283|3900747|FG000|NOT COMPLETED|Overall Study||29
3173149|NCT01947283|3900748|FG001|NOT COMPLETED|Overall Study||23
3173150|NCT01947283|3900749|FG002|NOT COMPLETED|Overall Study||21
3173151|NCT01947283|3900750|FG003|NOT COMPLETED|Overall Study||17
3173152|NCT01947283|3900751|FG004|NOT COMPLETED|Overall Study||0
3173153|NCT01947283|3900752|FG005|NOT COMPLETED|Overall Study||7
3173154|NCT01947283|3900753|FG006|NOT COMPLETED|Overall Study||8
3173155|NCT01947335|3900772|FG000|STARTED|Overall Study||42
3173156|NCT01947335|3900773|FG001|STARTED|Overall Study||41
3173157|NCT01947335|3900772|FG000|COMPLETED|Overall Study||42
3173158|NCT01947335|3900773|FG001|COMPLETED|Overall Study||41
3173159|NCT01947335|3900772|FG000|NOT COMPLETED|Overall Study||0
3173160|NCT01947335|3900773|FG001|NOT COMPLETED|Overall Study||0
3173161|NCT01947491|3900783|FG000|STARTED|Overall Study||174
3173162|NCT01947491|3900784|FG001|STARTED|Overall Study||87
3173163|NCT01947491|3900785|FG002|STARTED|Overall Study||90
2922348|NCT00546884|3633024|FG001|NOT COMPLETED|Overall Study||0
2922349|NCT00546897|3633032|FG000|STARTED|Overall Study||15
2922350|NCT00546897|3633033|FG001|STARTED|Overall Study||33
2922351|NCT00546897|3633032|FG000|COMPLETED|Overall Study||15
2922352|NCT00546897|3633033|FG001|COMPLETED|Overall Study||33
2922353|NCT00546897|3633032|FG000|NOT COMPLETED|Overall Study||0
2922354|NCT00546897|3633033|FG001|NOT COMPLETED|Overall Study||0
2922355|NCT00546910|3633041|FG000|STARTED|Overall Study||63
2922356|NCT00546910|3633042|FG001|STARTED|Overall Study||62
2922357|NCT00546910|3633041|FG000|COMPLETED|Overall Study||54
2922358|NCT00546910|3633042|FG001|COMPLETED|Overall Study||51
2922359|NCT00546910|3633041|FG000|NOT COMPLETED|Overall Study||9
2922360|NCT00546910|3633042|FG001|NOT COMPLETED|Overall Study||11
2922361|NCT00547105|3633048|FG000|STARTED|Overall Study||24
2922362|NCT00547105|3633048|FG000|COMPLETED|Overall Study||24
2922363|NCT00547105|3633048|FG000|NOT COMPLETED|Overall Study||0
2922364|NCT00547118|3633054|FG000|STARTED|Overall Study||8
2922365|NCT00547118|3633055|FG001|STARTED|Overall Study||9
2922366|NCT00547118|3633054|FG000|COMPLETED|Overall Study||0
2922367|NCT00547118|3633055|FG001|COMPLETED|Overall Study||0
2922368|NCT00547118|3633054|FG000|NOT COMPLETED|Overall Study||8
3173164|NCT01947491|3900786|FG003|STARTED|Overall Study||43
3173165|NCT01947491|3900783|FG000|COMPLETED|Overall Study||166
3173166|NCT01947491|3900784|FG001|COMPLETED|Overall Study||81
3173167|NCT01947491|3900785|FG002|COMPLETED|Overall Study||88
3173168|NCT01947491|3900786|FG003|COMPLETED|Overall Study||38
3173169|NCT01947491|3900783|FG000|NOT COMPLETED|Overall Study||8
3173170|NCT01947491|3900784|FG001|NOT COMPLETED|Overall Study||6
3173171|NCT01947491|3900785|FG002|NOT COMPLETED|Overall Study||2
3173172|NCT01947491|3900786|FG003|NOT COMPLETED|Overall Study||5
3173173|NCT01947517|3900798|FG000|STARTED|Overall Study||26
3173174|NCT01947517|3900799|FG001|STARTED|Overall Study||26
3173175|NCT01947517|3900798|FG000|COMPLETED|Overall Study||25
3173176|NCT01947517|3900799|FG001|COMPLETED|Overall Study||25
3173177|NCT01947517|3900798|FG000|NOT COMPLETED|Overall Study||1
3173178|NCT01947517|3900799|FG001|NOT COMPLETED|Overall Study||1
3173179|NCT01947582|3900805|FG000|STARTED|Overall Study||2
3173180|NCT01947582|3900805|FG000|COMPLETED|Overall Study||1
3173181|NCT01947582|3900805|FG000|NOT COMPLETED|Overall Study||1
3173182|NCT01947647|3900811|FG000|STARTED|Treatment Phase||46
2922369|NCT00547118|3633055|FG001|NOT COMPLETED|Overall Study||9
2922370|NCT00547157|3633065|FG000|STARTED|Overall Study||90
2922371|NCT00547157|3633066|FG001|STARTED|Overall Study||62
2922372|NCT00547157|3633065|FG000|COMPLETED|Overall Study||41
2922373|NCT00547157|3633066|FG001|COMPLETED|Overall Study||39
2922374|NCT00547157|3633065|FG000|NOT COMPLETED|Overall Study||49
2922375|NCT00547157|3633066|FG001|NOT COMPLETED|Overall Study||23
2922376|NCT00547248|3633076|FG000|STARTED|Overall Study||280
2922377|NCT00547248|3633077|FG001|STARTED|Overall Study||93
2922378|NCT00547248|3633078|FG002|STARTED|Overall Study||285
2922379|NCT00547248|3633079|FG003|STARTED|Overall Study||98
2922380|NCT00547248|3633076|FG000|COMPLETED|Overall Study||280
2922381|NCT00547248|3633077|FG001|COMPLETED|Overall Study||93
2922382|NCT00547248|3633078|FG002|COMPLETED|Overall Study||275
2922383|NCT00547248|3633079|FG003|COMPLETED|Overall Study||96
2922384|NCT00547248|3633076|FG000|NOT COMPLETED|Overall Study||0
2922385|NCT00547248|3633077|FG001|NOT COMPLETED|Overall Study||0
2922386|NCT00547248|3633078|FG002|NOT COMPLETED|Overall Study||10
2922387|NCT00547248|3633079|FG003|NOT COMPLETED|Overall Study||2
2922388|NCT00547365|3633092|FG000|STARTED|Overall Study||10
2922389|NCT00547365|3633092|FG000|COMPLETED|Overall Study||2
2922390|NCT00547365|3633092|FG000|NOT COMPLETED|Overall Study||8
2922391|NCT00547378|3633100|FG000|STARTED|Randomized Cohort||70
2922392|NCT00547378|3633101|FG001|STARTED|Randomized Cohort||77
2922393|NCT00547378|3633102|FG002|STARTED|Randomized Cohort||0
2922394|NCT00547378|3633100|FG000|Month 3|Randomized Cohort|This includes IST subjects reached Month 3 visit, regardless of implant or not.|62
2922395|NCT00547378|3633101|FG001|Month 3|Randomized Cohort|This included SMT subjects who reached SMT Month 3 visit.|72
2922396|NCT00547378|3633102|FG002|Month 3|Randomized Cohort||0
2922397|NCT00547378|3633100|FG000|Month 6|Randomized Cohort|This includes IST subjects reached Month 6 visit, regardless of implant or not.|59
2922398|NCT00547378|3633101|FG001|Month 6|Randomized Cohort|This included SMT subjects who reached SMT Month 6 visit.|71
2922399|NCT00547378|3633102|FG002|Month 6|Randomized Cohort||0
2922400|NCT00547378|3633100|FG000|COMPLETED|Randomized Cohort||59
2922401|NCT00547378|3633101|FG001|COMPLETED|Randomized Cohort||71
2922402|NCT00547378|3633102|FG002|COMPLETED|Randomized Cohort||0
2922403|NCT00547378|3633100|FG000|NOT COMPLETED|Randomized Cohort||11
2922404|NCT00547378|3633101|FG001|NOT COMPLETED|Randomized Cohort||6
2922405|NCT00547378|3633102|FG002|NOT COMPLETED|Randomized Cohort||0
2922406|NCT00547378|3633100|FG000|STARTED|All Implanted Cohort|This included subjects who received full system implant after randomized to IST.|51
2922407|NCT00547378|3633101|FG001|STARTED|All Implanted Cohort|This included SMT subjects who received full system implant after completing randomization period.|40
2922408|NCT00547378|3633102|FG002|STARTED|All Implanted Cohort|This included subjects who received full system implant from non-randomized subjects.|181
2922409|NCT00547378|3633100|FG000|Month 3|All Implanted Cohort||51
2922410|NCT00547378|3633101|FG001|Month 3|All Implanted Cohort||39
2922411|NCT00547378|3633102|FG002|Month 3|All Implanted Cohort||178
2922412|NCT00547378|3633100|FG000|Month 6|All Implanted Cohort||50
2922413|NCT00547378|3633101|FG001|Month 6|All Implanted Cohort||36
2922414|NCT00547378|3633102|FG002|Month 6|All Implanted Cohort||178
2922415|NCT00547378|3633100|FG000|Month 12|All Implanted Cohort||48
2922416|NCT00547378|3633101|FG001|Month 12|All Implanted Cohort||32
2922417|NCT00547378|3633102|FG002|Month 12|All Implanted Cohort||175
2922418|NCT00547378|3633100|FG000|Month 24|All Implanted Cohort||42
2922419|NCT00547378|3633101|FG001|Month 24|All Implanted Cohort||30
2922420|NCT00547378|3633102|FG002|Month 24|All Implanted Cohort||161
2922421|NCT00547378|3633100|FG000|Month 36|All Implanted Cohort||42
2922422|NCT00547378|3633101|FG001|Month 36|All Implanted Cohort||29
2922423|NCT00547378|3633102|FG002|Month 36|All Implanted Cohort||146
2922424|NCT00547378|3633100|FG000|Month 48|All Implanted Cohort||38
2922425|NCT00547378|3633101|FG001|Month 48|All Implanted Cohort||27
2922426|NCT00547378|3633102|FG002|Month 48|All Implanted Cohort||136
2922427|NCT00547378|3633100|FG000|Month 60|All Implanted Cohort||36
2922428|NCT00547378|3633101|FG001|Month 60|All Implanted Cohort||23
2922429|NCT00547378|3633102|FG002|Month 60|All Implanted Cohort||114
2922430|NCT00547378|3633100|FG000|COMPLETED|All Implanted Cohort||36
2922431|NCT00547378|3633101|FG001|COMPLETED|All Implanted Cohort||22
2922432|NCT00547378|3633102|FG002|COMPLETED|All Implanted Cohort||111
2922433|NCT00547378|3633100|FG000|NOT COMPLETED|All Implanted Cohort||15
2922434|NCT00547378|3633101|FG001|NOT COMPLETED|All Implanted Cohort||18
2922435|NCT00547378|3633102|FG002|NOT COMPLETED|All Implanted Cohort||70
2922436|NCT00547521|3633112|FG000|STARTED|Short Term Study (4 Months)|Number of participants treated.|51
2922437|NCT00547521|3633113|FG001|STARTED|Short Term Study (4 Months)|Number of participants treated.|49
2922438|NCT00547521|3633112|FG000|COMPLETED|Short Term Study (4 Months)||50
2922439|NCT00547521|3633113|FG001|COMPLETED|Short Term Study (4 Months)||45
2922440|NCT00547521|3633112|FG000|NOT COMPLETED|Short Term Study (4 Months)||1
2922441|NCT00547521|3633113|FG001|NOT COMPLETED|Short Term Study (4 Months)||4
2922442|NCT00547521|3633112|FG000|STARTED|Long Term Extension (LTE) Study|ST Study had 2 arms, LTE Study pooled all participants who had abatacept injection.|0
2922443|NCT00547521|3633113|FG001|STARTED|Long Term Extension (LTE) Study|ST Study had 2 arms, LTE Study pooled all participants who had abatacept injection.|90
2922444|NCT00547521|3633112|FG000|COMPLETED|Long Term Extension (LTE) Study||0
2922445|NCT00547521|3633113|FG001|COMPLETED|Long Term Extension (LTE) Study||59
2922446|NCT00547521|3633112|FG000|NOT COMPLETED|Long Term Extension (LTE) Study||0
2922447|NCT00547521|3633113|FG001|NOT COMPLETED|Long Term Extension (LTE) Study||31
2922448|NCT00547534|3633126|FG000|STARTED|Overall Study|31 patients enrolled; one patient was determined to be ineligible, and did not receive any therapy.|30
2922449|NCT00547534|3633126|FG000|COMPLETED|Overall Study|25 patients received at least 4 cycles. 29 patients were evaluable for response.|19
2922450|NCT00547534|3633126|FG000|NOT COMPLETED|Overall Study||11
2922451|NCT00547586|3633136|FG000|STARTED|Overall Study||33
2922452|NCT00547586|3633137|FG001|STARTED|Overall Study||7
2922453|NCT00547586|3633138|FG002|STARTED|Overall Study||14
2922454|NCT00547586|3633139|FG003|STARTED|Overall Study||33
2922455|NCT00547586|3633140|FG004|STARTED|Overall Study||35
2922456|NCT00547586|3633136|FG000|COMPLETED|Overall Study||28
2922457|NCT00547586|3633137|FG001|COMPLETED|Overall Study||6
2922458|NCT00547586|3633138|FG002|COMPLETED|Overall Study||13
2922459|NCT00547586|3633139|FG003|COMPLETED|Overall Study||27
2922460|NCT00547586|3633140|FG004|COMPLETED|Overall Study||32
2922461|NCT00547586|3633136|FG000|NOT COMPLETED|Overall Study||5
2922462|NCT00547586|3633137|FG001|NOT COMPLETED|Overall Study||1
2922463|NCT00547586|3633138|FG002|NOT COMPLETED|Overall Study||1
2922464|NCT00547586|3633139|FG003|NOT COMPLETED|Overall Study||6
2922465|NCT00547586|3633140|FG004|NOT COMPLETED|Overall Study||3
2922466|NCT00547638|3633154|FG000|STARTED|Overall Study||143
3173183|NCT01947647|3900812|FG001|STARTED|Treatment Phase||47
3173184|NCT01947647|3900811|FG000|COMPLETED|Treatment Phase||29
3173185|NCT01947647|3900812|FG001|COMPLETED|Treatment Phase||21
3173186|NCT01947647|3900811|FG000|NOT COMPLETED|Treatment Phase||17
3173187|NCT01947647|3900812|FG001|NOT COMPLETED|Treatment Phase||26
3173188|NCT01947647|3900811|FG000|STARTED|6-month Followup Phase||29
3173189|NCT01947647|3900812|FG001|STARTED|6-month Followup Phase||21
3173190|NCT01947647|3900811|FG000|COMPLETED|6-month Followup Phase||20
3173191|NCT01947647|3900812|FG001|COMPLETED|6-month Followup Phase||13
3173192|NCT01947647|3900811|FG000|NOT COMPLETED|6-month Followup Phase||9
2922467|NCT00547638|3633155|FG001|STARTED|Overall Study||73
2922468|NCT00547638|3633154|FG000|COMPLETED|Overall Study||119
2922469|NCT00547638|3633155|FG001|COMPLETED|Overall Study||59
2922470|NCT00547638|3633154|FG000|NOT COMPLETED|Overall Study||24
2922471|NCT00547638|3633155|FG001|NOT COMPLETED|Overall Study||14
2922472|NCT00547703|3633163|FG000|STARTED|Overall Study||4
2922473|NCT00547703|3633164|FG001|STARTED|Overall Study||1
2922474|NCT00547703|3633163|FG000|COMPLETED|Overall Study||3
2922475|NCT00547703|3633164|FG001|COMPLETED|Overall Study||1
2922476|NCT00547703|3633163|FG000|NOT COMPLETED|Overall Study||1
2922477|NCT00547703|3633164|FG001|NOT COMPLETED|Overall Study||0
2922478|NCT00547729|3633170|FG000|STARTED|Overall Study||71
2922479|NCT00547729|3633170|FG000|COMPLETED|Overall Study||71
2922480|NCT00547729|3633170|FG000|NOT COMPLETED|Overall Study||0
2922481|NCT00547898|3633178|FG000|STARTED|Overall Study||138
2922482|NCT00547898|3633179|FG001|STARTED|Overall Study||136
2922483|NCT00547898|3633180|FG002|STARTED|Overall Study||54
2922484|NCT00547898|3633181|FG003|STARTED|Overall Study||46
2922485|NCT00547898|3633178|FG000|COMPLETED|Overall Study||129
2922486|NCT00547898|3633179|FG001|COMPLETED|Overall Study||126
2922487|NCT00547898|3633180|FG002|COMPLETED|Overall Study||54
2922488|NCT00547898|3633181|FG003|COMPLETED|Overall Study||40
2922489|NCT00547898|3633178|FG000|NOT COMPLETED|Overall Study||9
2922490|NCT00547898|3633179|FG001|NOT COMPLETED|Overall Study||10
2922491|NCT00547898|3633180|FG002|NOT COMPLETED|Overall Study||0
2922492|NCT00547898|3633181|FG003|NOT COMPLETED|Overall Study||6
2922493|NCT00547911|3633197|FG000|STARTED|Overall Study||2
2922494|NCT00547911|3633198|FG001|STARTED|Overall Study||2
2922495|NCT00547911|3633199|FG002|STARTED|Overall Study||2
2922496|NCT00547911|3633200|FG003|STARTED|Overall Study||2
2922497|NCT00547911|3633201|FG004|STARTED|Overall Study||3
2922498|NCT00547911|3633202|FG005|STARTED|Overall Study||3
2922499|NCT00547911|3633197|FG000|COMPLETED|Overall Study||2
2922500|NCT00547911|3633198|FG001|COMPLETED|Overall Study||2
2922501|NCT00547911|3633199|FG002|COMPLETED|Overall Study||2
2922502|NCT00547911|3633200|FG003|COMPLETED|Overall Study||1
2922503|NCT00547911|3633201|FG004|COMPLETED|Overall Study||3
2922504|NCT00547911|3633202|FG005|COMPLETED|Overall Study||3
2922505|NCT00547911|3633197|FG000|NOT COMPLETED|Overall Study||0
2922506|NCT00547911|3633198|FG001|NOT COMPLETED|Overall Study||0
2922507|NCT00547911|3633199|FG002|NOT COMPLETED|Overall Study||0
2922508|NCT00547911|3633200|FG003|NOT COMPLETED|Overall Study||1
2922509|NCT00547911|3633201|FG004|NOT COMPLETED|Overall Study||0
2922510|NCT00547911|3633202|FG005|NOT COMPLETED|Overall Study||0
2922511|NCT00548041|3633215|FG000|STARTED|Overall Study||100
2922512|NCT00548041|3633215|FG000|COMPLETED|Overall Study||100
2922513|NCT00548041|3633215|FG000|NOT COMPLETED|Overall Study||0
2922514|NCT00548132|3633221|FG000|STARTED|Overall Study||534
2922515|NCT00548132|3633222|FG001|STARTED|Overall Study||554
2922516|NCT00548132|3633221|FG000|Consented to Study|Overall Study||534
2922517|NCT00548132|3633222|FG001|Consented to Study|Overall Study||554
2922518|NCT00548132|3633221|FG000|COMPLETED|Overall Study||534
2922519|NCT00548132|3633222|FG001|COMPLETED|Overall Study||554
2922520|NCT00548132|3633221|FG000|NOT COMPLETED|Overall Study||0
2922521|NCT00548132|3633222|FG001|NOT COMPLETED|Overall Study||0
2922522|NCT00548145|3633232|FG000|STARTED|Overall Study||18
2922523|NCT00548145|3633233|FG001|STARTED|Overall Study||20
2922524|NCT00548145|3633232|FG000|COMPLETED|Overall Study||17
2922525|NCT00548145|3633233|FG001|COMPLETED|Overall Study||16
2922526|NCT00548145|3633232|FG000|NOT COMPLETED|Overall Study||1
2922527|NCT00548145|3633233|FG001|NOT COMPLETED|Overall Study||4
2922528|NCT00548171|3633241|FG000|STARTED|Overall Study||164
2922529|NCT00548171|3633242|FG001|STARTED|Overall Study||39
2922530|NCT00548171|3633241|FG000|COMPLETED|Overall Study||164
2922531|NCT00548171|3633242|FG001|COMPLETED|Overall Study||39
2922532|NCT00548171|3633241|FG000|NOT COMPLETED|Overall Study||0
2922533|NCT00548171|3633242|FG001|NOT COMPLETED|Overall Study||0
2922534|NCT00548184|3633248|FG000|STARTED|Overall Study||65
2922535|NCT00548184|3633248|FG000|COMPLETED|Overall Study|65 patients were on treatment. 5 did not complete due to adverse events or other reasons.|60
2922536|NCT00548184|3633248|FG000|NOT COMPLETED|Overall Study||5
2922537|NCT00548197|3633254|FG000|STARTED|Overall Study||18
2922538|NCT00548197|3633255|FG001|STARTED|Overall Study||22
2922539|NCT00548197|3633254|FG000|COMPLETED|Overall Study||18
2922540|NCT00548197|3633255|FG001|COMPLETED|Overall Study||22
2922541|NCT00548197|3633254|FG000|NOT COMPLETED|Overall Study||0
2922542|NCT00548197|3633255|FG001|NOT COMPLETED|Overall Study||0
2922543|NCT00548249|3633268|FG000|STARTED|Overall Study||26
2922544|NCT00548249|3633269|FG001|STARTED|Overall Study||26
2922545|NCT00548249|3633270|FG002|STARTED|Overall Study||29
2922546|NCT00548249|3633271|FG003|STARTED|Overall Study||22
3173193|NCT01947647|3900812|FG001|NOT COMPLETED|6-month Followup Phase||8
3173194|NCT01947816|3900818|FG000|STARTED|Overall Study||1593
3173195|NCT01947816|3900818|FG000|COMPLETED|Overall Study||1523
3173196|NCT01947816|3900818|FG000|NOT COMPLETED|Overall Study||70
3173197|NCT01947855|3900825|FG000|STARTED|Overall Study||21
3173198|NCT01947855|3900826|FG001|STARTED|Overall Study||20
3173199|NCT01947855|3900827|FG002|STARTED|Overall Study||19
3173200|NCT01947855|3900825|FG000|COMPLETED|Overall Study||20
3173201|NCT01947855|3900826|FG001|COMPLETED|Overall Study||20
3173202|NCT01947855|3900827|FG002|COMPLETED|Overall Study||19
3173203|NCT01947855|3900825|FG000|NOT COMPLETED|Overall Study||1
3173204|NCT01947855|3900826|FG001|NOT COMPLETED|Overall Study||0
3173205|NCT01947855|3900827|FG002|NOT COMPLETED|Overall Study||0
3173206|NCT01947894|3900838|FG000|STARTED|Overall Study||247
3173207|NCT01947894|3900839|FG001|STARTED|Overall Study||42
2922547|NCT00548249|3633272|FG004|STARTED|Overall Study||28
2922548|NCT00548249|3633268|FG000|COMPLETED|Overall Study||10
2922549|NCT00548249|3633269|FG001|COMPLETED|Overall Study||13
2922550|NCT00548249|3633270|FG002|COMPLETED|Overall Study||9
2922551|NCT00548249|3633271|FG003|COMPLETED|Overall Study||9
2922552|NCT00548249|3633272|FG004|COMPLETED|Overall Study||7
2922553|NCT00548249|3633268|FG000|NOT COMPLETED|Overall Study||16
2922554|NCT00548249|3633269|FG001|NOT COMPLETED|Overall Study||13
2922555|NCT00548249|3633270|FG002|NOT COMPLETED|Overall Study||20
2922556|NCT00548249|3633271|FG003|NOT COMPLETED|Overall Study||13
2922557|NCT00548249|3633272|FG004|NOT COMPLETED|Overall Study||21
2922558|NCT00548262|3633284|FG000|STARTED|Overall Study|1 participant (N) had death recorded twice; reported as 1 death in reason for discontinuation (D/C)|54
2922559|NCT00548262|3633284|FG000|COMPLETED|Overall Study|1 N had D/C recorded as died and as lack of efficacy; reported as lack of efficacy in reason for D/C|22
2922560|NCT00548262|3633284|FG000|NOT COMPLETED|Overall Study||32
2922561|NCT00548340|3633291|FG000|STARTED|Overall Study||109
2922562|NCT00548340|3633292|FG001|STARTED|Overall Study||109
2922563|NCT00548340|3633293|FG002|STARTED|Overall Study||104
2922564|NCT00548340|3633291|FG000|COMPLETED|Overall Study||101
2922565|NCT00548340|3633292|FG001|COMPLETED|Overall Study||98
2922566|NCT00548340|3633293|FG002|COMPLETED|Overall Study||95
2922567|NCT00548340|3633291|FG000|NOT COMPLETED|Overall Study||8
3173208|NCT01947894|3900840|FG002|STARTED|Overall Study||88
3173209|NCT01947894|3900838|FG000|Treated|Overall Study||246
3173210|NCT01947894|3900839|FG001|Treated|Overall Study||41
3173211|NCT01947894|3900840|FG002|Treated|Overall Study||87
3173212|NCT01947894|3900838|FG000|COMPLETED|Overall Study||160
3173213|NCT01947894|3900839|FG001|COMPLETED|Overall Study||24
2922568|NCT00548340|3633292|FG001|NOT COMPLETED|Overall Study||11
2922569|NCT00548340|3633293|FG002|NOT COMPLETED|Overall Study||9
2922570|NCT00548405|3633304|FG000|STARTED|Overall Study|Randomized.|231
2922571|NCT00548405|3633305|FG001|STARTED|Overall Study|Randomized.|436
2922572|NCT00548405|3633306|FG002|STARTED|Overall Study|Randomized.|173
2922573|NCT00548405|3633304|FG000|Treated|Overall Study|All randomized participants who received at least 1 dose of study drug as per initial randomization.|202
2922574|NCT00548405|3633305|FG001|Treated|Overall Study|All randomized participants who received at least 1 dose of study drug as per initial randomization.|426
2922575|NCT00548405|3633306|FG002|Treated|Overall Study|All randomized participants who received at least 1 dose of study drug as per initial randomization.|170
2922576|NCT00548405|3633304|FG000|COMPLETED|Overall Study||175
2922577|NCT00548405|3633305|FG001|COMPLETED|Overall Study||416
2922578|NCT00548405|3633306|FG002|COMPLETED|Overall Study||164
2922579|NCT00548405|3633304|FG000|NOT COMPLETED|Overall Study||56
2922580|NCT00548405|3633305|FG001|NOT COMPLETED|Overall Study||20
2922581|NCT00548405|3633306|FG002|NOT COMPLETED|Overall Study||9
3038574|NCT01154335|3757955|FG000|COMPLETED|Overall Study|Patients continued treatment until disease progression or unacceptable toxicity occurred.|0
3038575|NCT01154335|3757956|FG001|COMPLETED|Overall Study|Patients continued treatment until disease progression or unacceptable toxicity occurred.|0
3038576|NCT01154335|3757957|FG002|COMPLETED|Overall Study|Patients continued treatment until disease progression or unacceptable toxicity occurred.|0
3038577|NCT01154335|3757955|FG000|NOT COMPLETED|Overall Study||7
3038578|NCT01154335|3757956|FG001|NOT COMPLETED|Overall Study||6
3038579|NCT01154335|3757957|FG002|NOT COMPLETED|Overall Study||5
3038580|NCT01154452|3757968|FG000|STARTED|Phase Ib||6
3038581|NCT01154452|3757969|FG001|STARTED|Phase Ib||4
3038582|NCT01154452|3757970|FG002|STARTED|Phase Ib||0
3038583|NCT01154452|3757971|FG003|STARTED|Phase Ib||0
3038584|NCT01154452|3757968|FG000|COMPLETED|Phase Ib||3
3038585|NCT01154452|3757969|FG001|COMPLETED|Phase Ib||3
3038586|NCT01154452|3757970|FG002|COMPLETED|Phase Ib||0
3038587|NCT01154452|3757971|FG003|COMPLETED|Phase Ib||0
3038588|NCT01154452|3757968|FG000|NOT COMPLETED|Phase Ib||3
3038589|NCT01154452|3757969|FG001|NOT COMPLETED|Phase Ib||1
3038590|NCT01154452|3757970|FG002|NOT COMPLETED|Phase Ib||0
3038591|NCT01154452|3757971|FG003|NOT COMPLETED|Phase Ib||0
3038592|NCT01154452|3757968|FG000|STARTED|Phase II||0
3038593|NCT01154452|3757969|FG001|STARTED|Phase II||0
3038594|NCT01154452|3757970|FG002|STARTED|Phase II||35
3038595|NCT01154452|3757971|FG003|STARTED|Phase II||33
3038596|NCT01154452|3757968|FG000|COMPLETED|Phase II||0
3038597|NCT01154452|3757969|FG001|COMPLETED|Phase II||0
3038598|NCT01154452|3757970|FG002|COMPLETED|Phase II||30
3038599|NCT01154452|3757971|FG003|COMPLETED|Phase II||27
3038600|NCT01154452|3757968|FG000|NOT COMPLETED|Phase II||0
3038601|NCT01154452|3757969|FG001|NOT COMPLETED|Phase II||0
3038602|NCT01154452|3757970|FG002|NOT COMPLETED|Phase II||5
3038603|NCT01154452|3757971|FG003|NOT COMPLETED|Phase II||6
3038604|NCT01154634|3757988|FG000|STARTED|Period 1 - First Intervention||4
3038605|NCT01154634|3757989|FG001|STARTED|Period 1 - First Intervention||7
3038606|NCT01154634|3757990|FG002|STARTED|Period 1 - First Intervention||4
3038607|NCT01154634|3757991|FG003|STARTED|Period 1 - First Intervention||5
3038608|NCT01154634|3757988|FG000|COMPLETED|Period 1 - First Intervention||4
3038609|NCT01154634|3757989|FG001|COMPLETED|Period 1 - First Intervention||7
3038610|NCT01154634|3757990|FG002|COMPLETED|Period 1 - First Intervention||4
2922582|NCT00548418|3633315|FG000|STARTED|Overall Study||27
3173214|NCT01947894|3900840|FG002|COMPLETED|Overall Study||61
3173215|NCT01947894|3900838|FG000|NOT COMPLETED|Overall Study||87
3173216|NCT01947894|3900839|FG001|NOT COMPLETED|Overall Study||18
3173217|NCT01947894|3900840|FG002|NOT COMPLETED|Overall Study||27
3173218|NCT01947907|3900852|FG000|STARTED|Overall Study||12
3173219|NCT01947907|3900853|FG001|STARTED|Overall Study||14
3173220|NCT01947907|3900854|FG002|STARTED|Overall Study||14
3173221|NCT01947907|3900855|FG003|STARTED|Overall Study||13
3173222|NCT01947907|3900852|FG000|COMPLETED|Overall Study||12
3173223|NCT01947907|3900853|FG001|COMPLETED|Overall Study||14
3173224|NCT01947907|3900854|FG002|COMPLETED|Overall Study||14
3173225|NCT01947907|3900855|FG003|COMPLETED|Overall Study||13
3173226|NCT01947907|3900852|FG000|NOT COMPLETED|Overall Study||0
3173227|NCT01947907|3900853|FG001|NOT COMPLETED|Overall Study||0
3173228|NCT01947907|3900854|FG002|NOT COMPLETED|Overall Study||0
3173229|NCT01947907|3900855|FG003|NOT COMPLETED|Overall Study||0
3173230|NCT01947946|3900868|FG000|STARTED|Overall Study||3
3173231|NCT01947946|3900869|FG001|STARTED|Overall Study||5
3173232|NCT01947946|3900870|FG002|STARTED|Overall Study||5
3173233|NCT01947946|3900868|FG000|COMPLETED|Overall Study|Study Stopped|0
3173234|NCT01947946|3900869|FG001|COMPLETED|Overall Study||0
3173235|NCT01947946|3900870|FG002|COMPLETED|Overall Study||0
3173236|NCT01947946|3900868|FG000|NOT COMPLETED|Overall Study||3
3173237|NCT01947946|3900869|FG001|NOT COMPLETED|Overall Study||5
3173238|NCT01947946|3900870|FG002|NOT COMPLETED|Overall Study||5
3173239|NCT01948050|3900880|FG000|STARTED|Overall Study||16
3173240|NCT01948050|3900881|FG001|STARTED|Overall Study||8
3173241|NCT01948050|3900880|FG000|COMPLETED|Overall Study||16
3173242|NCT01948050|3900881|FG001|COMPLETED|Overall Study||7
3173243|NCT01948050|3900880|FG000|NOT COMPLETED|Overall Study||0
3173244|NCT01948050|3900881|FG001|NOT COMPLETED|Overall Study||1
3173245|NCT01948063|3900889|FG000|STARTED|Overall Study||20
3173246|NCT01948063|3900890|FG001|STARTED|Overall Study||21
3173247|NCT01948063|3900889|FG000|COMPLETED|Overall Study||19
3173248|NCT01948063|3900890|FG001|COMPLETED|Overall Study||19
3173249|NCT01948063|3900889|FG000|NOT COMPLETED|Overall Study||1
3173250|NCT01948063|3900890|FG001|NOT COMPLETED|Overall Study||2
3173251|NCT01948076|3900898|FG000|STARTED|Overall Study||20
2922583|NCT00548418|3633315|FG000|COMPLETED|Overall Study||27
2922584|NCT00548418|3633315|FG000|NOT COMPLETED|Overall Study||0
2922585|NCT00548431|3633319|FG000|STARTED|Overall Study||38
3038611|NCT01154634|3757991|FG003|COMPLETED|Period 1 - First Intervention||5
3038612|NCT01154634|3757988|FG000|NOT COMPLETED|Period 1 - First Intervention||0
3038613|NCT01154634|3757989|FG001|NOT COMPLETED|Period 1 - First Intervention||0
3038614|NCT01154634|3757990|FG002|NOT COMPLETED|Period 1 - First Intervention||0
3038615|NCT01154634|3757991|FG003|NOT COMPLETED|Period 1 - First Intervention||0
3038616|NCT01154634|3757988|FG000|STARTED|Period 2 - Washout||4
3038617|NCT01154634|3757989|FG001|STARTED|Period 2 - Washout||7
3038618|NCT01154634|3757990|FG002|STARTED|Period 2 - Washout||4
3038619|NCT01154634|3757991|FG003|STARTED|Period 2 - Washout||5
3173252|NCT01948076|3900899|FG001|STARTED|Overall Study||20
3319553|NCT03151551|4052999|FG000|STARTED|Post-Treatment Follow-Up Period|All participants who received at least one dose of study drug could enter the follow-up period.|265
3319554|NCT03151551|4053000|FG001|STARTED|Post-Treatment Follow-Up Period|All participants who received at least one dose of study drug could enter the follow-up period.|258
3319555|NCT03151551|4052999|FG000|COMPLETED|Post-Treatment Follow-Up Period||240
3319556|NCT03151551|4053000|FG001|COMPLETED|Post-Treatment Follow-Up Period||230
3319557|NCT03151551|4052999|FG000|NOT COMPLETED|Post-Treatment Follow-Up Period||25
3319558|NCT03151551|4053000|FG001|NOT COMPLETED|Post-Treatment Follow-Up Period||28
3319559|NCT03152019|4053010|FG000|STARTED|Overall Study||25
3319560|NCT03152019|4053011|FG001|STARTED|Overall Study||25
3319561|NCT03152019|4053010|FG000|COMPLETED|Overall Study||25
3319562|NCT03152019|4053011|FG001|COMPLETED|Overall Study||24
3319563|NCT03152019|4053010|FG000|NOT COMPLETED|Overall Study||0
3319564|NCT03152019|4053011|FG001|NOT COMPLETED|Overall Study||1
3319565|NCT03152084|4053019|FG000|STARTED|Overall Study||17
3319566|NCT03152084|4053020|FG001|STARTED|Overall Study||7
3319567|NCT03152084|4053019|FG000|COMPLETED|Overall Study||17
3319568|NCT03152084|4053020|FG001|COMPLETED|Overall Study||7
3319569|NCT03152084|4053019|FG000|NOT COMPLETED|Overall Study||0
3319570|NCT03152084|4053020|FG001|NOT COMPLETED|Overall Study||0
3319571|NCT03152110|4053026|FG000|STARTED|Overall Study||10
3319572|NCT03152110|4053026|FG000|COMPLETED|Overall Study||7
3319573|NCT03152110|4053026|FG000|NOT COMPLETED|Overall Study||3
3319574|NCT03152136|4053034|FG000|STARTED|Overall Study||32
2922586|NCT00548431|3633319|FG000|COMPLETED|Overall Study||38
2922587|NCT00548431|3633319|FG000|NOT COMPLETED|Overall Study||0
2922588|NCT00548470|3633323|FG000|STARTED|Overall Study||14
2922589|NCT00548470|3633323|FG000|COMPLETED|Overall Study||12
2922590|NCT00548470|3633323|FG000|NOT COMPLETED|Overall Study||2
2922591|NCT00548548|3633329|FG000|STARTED|Overall Study||387
2922592|NCT00548548|3633330|FG001|STARTED|Overall Study||387
2922593|NCT00548548|3633329|FG000|Treated|Overall Study||383
2922594|NCT00548548|3633330|FG001|Treated|Overall Study||384
2922595|NCT00548548|3633329|FG000|Safety Population|Overall Study|Four patients randomized to placebo received single doses of bevacizumab in error.|386
2922596|NCT00548548|3633330|FG001|Safety Population|Overall Study||381
2922597|NCT00548548|3633329|FG000|COMPLETED|Overall Study|Completed treatment discontinuation form was not completed; patient was counted alive on treatment.|25
2922598|NCT00548548|3633330|FG001|COMPLETED|Overall Study||21
2922599|NCT00548548|3633329|FG000|NOT COMPLETED|Overall Study||362
2922600|NCT00548548|3633330|FG001|NOT COMPLETED|Overall Study||366
2922601|NCT00548652|3633339|FG000|STARTED|Overall Study||18
2922602|NCT00548652|3633340|FG001|STARTED|Overall Study||38
2922603|NCT00548652|3633341|FG002|STARTED|Overall Study||45
2922604|NCT00548652|3633339|FG000|COMPLETED|Overall Study||16
2922605|NCT00548652|3633340|FG001|COMPLETED|Overall Study||29
2922606|NCT00548652|3633341|FG002|COMPLETED|Overall Study||34
2922607|NCT00548652|3633339|FG000|NOT COMPLETED|Overall Study||2
2922608|NCT00548652|3633340|FG001|NOT COMPLETED|Overall Study||9
2922609|NCT00548652|3633341|FG002|NOT COMPLETED|Overall Study||11
2922610|NCT00548691|3633351|FG000|STARTED|Overall Study||258
2922611|NCT00548691|3633352|FG001|STARTED|Overall Study||259
2922612|NCT00548691|3633351|FG000|COMPLETED|Overall Study||251
2922613|NCT00548691|3633352|FG001|COMPLETED|Overall Study||250
2922614|NCT00548691|3633351|FG000|NOT COMPLETED|Overall Study||7
2922615|NCT00548691|3633352|FG001|NOT COMPLETED|Overall Study||9
2922616|NCT00548717|3633360|FG000|STARTED|Overall Study||13
2922617|NCT00548717|3633361|FG001|STARTED|Overall Study||2
2922618|NCT00548717|3633360|FG000|COMPLETED|Overall Study||4
2922619|NCT00548717|3633361|FG001|COMPLETED|Overall Study||0
2922620|NCT00548717|3633360|FG000|NOT COMPLETED|Overall Study||9
2922621|NCT00548717|3633361|FG001|NOT COMPLETED|Overall Study||2
2922622|NCT00548808|3633372|FG000|STARTED|Overall Study||214
2922623|NCT00548808|3633373|FG001|STARTED|Overall Study||212
2922624|NCT00548808|3633372|FG000|Full Analysis Set|Overall Study||211
2922625|NCT00548808|3633373|FG001|Full Analysis Set|Overall Study||212
2922626|NCT00548808|3633372|FG000|Per-Protocol Set|Overall Study||177
2922627|NCT00548808|3633373|FG001|Per-Protocol Set|Overall Study||184
2922628|NCT00548808|3633372|FG000|COMPLETED|Overall Study||172
2922629|NCT00548808|3633373|FG001|COMPLETED|Overall Study||186
2922630|NCT00548808|3633372|FG000|NOT COMPLETED|Overall Study||42
2922631|NCT00548808|3633373|FG001|NOT COMPLETED|Overall Study||26
2922632|NCT00548847|3633379|FG000|STARTED|Overall Study||15
2922633|NCT00548847|3633379|FG000|COMPLETED|Overall Study||8
2922634|NCT00548847|3633379|FG000|NOT COMPLETED|Overall Study||7
2922635|NCT00548860|3633385|FG000|STARTED|Overall Study||996
2922636|NCT00548860|3633386|FG001|STARTED|Overall Study||1022
2922637|NCT00548860|3633385|FG000|COMPLETED|Overall Study||860
2922638|NCT00548860|3633386|FG001|COMPLETED|Overall Study||847
2922639|NCT00548860|3633385|FG000|NOT COMPLETED|Overall Study||136
2922640|NCT00548860|3633386|FG001|NOT COMPLETED|Overall Study||175
2922641|NCT00549042|3633394|FG000|STARTED|Conversion and Titration Phase||459
2922642|NCT00549042|3633395|FG001|STARTED|Conversion and Titration Phase|Per the study design, no patients received placebo during this phase.|0
2922643|NCT00549042|3633394|FG000|COMPLETED|Conversion and Titration Phase||268
3038620|NCT01154634|3757988|FG000|COMPLETED|Period 2 - Washout||4
3038621|NCT01154634|3757989|FG001|COMPLETED|Period 2 - Washout||7
3038622|NCT01154634|3757990|FG002|COMPLETED|Period 2 - Washout||4
3038623|NCT01154634|3757991|FG003|COMPLETED|Period 2 - Washout||5
3038624|NCT01154634|3757988|FG000|NOT COMPLETED|Period 2 - Washout||0
3038625|NCT01154634|3757989|FG001|NOT COMPLETED|Period 2 - Washout||0
3038626|NCT01154634|3757990|FG002|NOT COMPLETED|Period 2 - Washout||0
3319575|NCT03152136|4053035|FG001|STARTED|Overall Study||15
3319576|NCT03152136|4053036|FG002|STARTED|Overall Study||15
3319577|NCT03152136|4053034|FG000|COMPLETED|Overall Study||29
3319578|NCT03152136|4053035|FG001|COMPLETED|Overall Study||15
3319579|NCT03152136|4053036|FG002|COMPLETED|Overall Study||14
3319580|NCT03152136|4053034|FG000|NOT COMPLETED|Overall Study||3
3319581|NCT03152136|4053035|FG001|NOT COMPLETED|Overall Study||0
3319582|NCT03152136|4053036|FG002|NOT COMPLETED|Overall Study||1
3319583|NCT03152552|4053048|FG000|STARTED|Treatment Period 1 (12 Weeks)||15
3319584|NCT03152552|4053049|FG001|STARTED|Treatment Period 1 (12 Weeks)||16
3319585|NCT03152552|4053050|FG002|STARTED|Treatment Period 1 (12 Weeks)||31
3319586|NCT03152552|4053051|FG003|STARTED|Treatment Period 1 (12 Weeks)||30
3319587|NCT03152552|4053052|FG004|STARTED|Treatment Period 1 (12 Weeks)||33
3319588|NCT03152552|4053048|FG000|Full Analysis Set (FAS)|Treatment Period 1 (12 Weeks)||15
3319589|NCT03152552|4053049|FG001|Full Analysis Set (FAS)|Treatment Period 1 (12 Weeks)||16
3319590|NCT03152552|4053050|FG002|Full Analysis Set (FAS)|Treatment Period 1 (12 Weeks)||30
3319591|NCT03152552|4053051|FG003|Full Analysis Set (FAS)|Treatment Period 1 (12 Weeks)||30
3319592|NCT03152552|4053052|FG004|Full Analysis Set (FAS)|Treatment Period 1 (12 Weeks)||33
3319593|NCT03152552|4053048|FG000|COMPLETED|Treatment Period 1 (12 Weeks)||7
3319594|NCT03152552|4053049|FG001|COMPLETED|Treatment Period 1 (12 Weeks)||5
3319595|NCT03152552|4053050|FG002|COMPLETED|Treatment Period 1 (12 Weeks)||10
3173253|NCT01948076|3900898|FG000|COMPLETED|Overall Study||20
3173254|NCT01948076|3900899|FG001|COMPLETED|Overall Study||19
3173255|NCT01948076|3900898|FG000|NOT COMPLETED|Overall Study||0
3173256|NCT01948076|3900899|FG001|NOT COMPLETED|Overall Study||1
3173257|NCT01948141|3900907|FG000|STARTED|Overall Study||6
3173258|NCT01948141|3900907|FG000|COMPLETED|Overall Study||6
3173259|NCT01948141|3900907|FG000|NOT COMPLETED|Overall Study||0
3038627|NCT01154634|3757991|FG003|NOT COMPLETED|Period 2 - Washout||0
3173260|NCT01948193|3900911|FG000|STARTED|Overall Study||177
3173261|NCT01948193|3900911|FG000|COMPLETED|Overall Study||168
3173262|NCT01948193|3900911|FG000|NOT COMPLETED|Overall Study||9
3173263|NCT01948258|3900916|FG000|STARTED|Overall Study||395
3173264|NCT01948258|3900916|FG000|COMPLETED|Overall Study||233
3173265|NCT01948258|3900916|FG000|NOT COMPLETED|Overall Study||162
3173266|NCT01948310|3900922|FG000|STARTED|Overall Study||19
3173267|NCT01948310|3900923|FG001|STARTED|Overall Study||18
3173268|NCT01948310|3900922|FG000|COMPLETED|Overall Study||16
3173269|NCT01948310|3900923|FG001|COMPLETED|Overall Study||13
3173270|NCT01948310|3900922|FG000|NOT COMPLETED|Overall Study||3
3173271|NCT01948310|3900923|FG001|NOT COMPLETED|Overall Study||5
3173272|NCT01948375|3900931|FG000|STARTED|Overall Study||30
3173273|NCT01948375|3900932|FG001|STARTED|Overall Study||30
3173274|NCT01948375|3900931|FG000|COMPLETED|Overall Study||30
3173275|NCT01948375|3900932|FG001|COMPLETED|Overall Study||30
3173276|NCT01948375|3900931|FG000|NOT COMPLETED|Overall Study||0
3173277|NCT01948375|3900932|FG001|NOT COMPLETED|Overall Study||0
3173278|NCT01948388|3900942|FG000|STARTED|Overall Study||10
3173279|NCT01948388|3900943|FG001|STARTED|Overall Study||10
3173280|NCT01948388|3900942|FG000|COMPLETED|Overall Study||8
3173281|NCT01948388|3900943|FG001|COMPLETED|Overall Study||9
3173282|NCT01948388|3900942|FG000|NOT COMPLETED|Overall Study||2
3173283|NCT01948388|3900943|FG001|NOT COMPLETED|Overall Study||1
3173284|NCT01948427|3900956|FG000|STARTED|Overall Study||49
3173285|NCT01948427|3900957|FG001|STARTED|Overall Study||89
3173286|NCT01948427|3900958|FG002|STARTED|Overall Study||4
3173287|NCT01948427|3900959|FG003|STARTED|Overall Study||1
3173288|NCT01948427|3900960|FG004|STARTED|Overall Study||60
3173289|NCT01948427|3900956|FG000|COMPLETED|Overall Study||42
3173290|NCT01948427|3900957|FG001|COMPLETED|Overall Study||72
3173291|NCT01948427|3900958|FG002|COMPLETED|Overall Study||4
3173292|NCT01948427|3900959|FG003|COMPLETED|Overall Study||1
3173293|NCT01948427|3900960|FG004|COMPLETED|Overall Study||46
3173294|NCT01948427|3900956|FG000|NOT COMPLETED|Overall Study||7
3173295|NCT01948427|3900957|FG001|NOT COMPLETED|Overall Study||17
3173296|NCT01948427|3900958|FG002|NOT COMPLETED|Overall Study||0
3173297|NCT01948427|3900959|FG003|NOT COMPLETED|Overall Study||0
3173298|NCT01948427|3900960|FG004|NOT COMPLETED|Overall Study||14
3173299|NCT01948518|3900977|FG000|STARTED|Overall Study||15
3173300|NCT01948518|3900977|FG000|COMPLETED|Overall Study||15
3173301|NCT01948518|3900977|FG000|NOT COMPLETED|Overall Study||0
3173302|NCT01948739|3900981|FG000|STARTED|Overall Study||18
3173303|NCT01948739|3900981|FG000|Received Intervention|Overall Study||10
3173304|NCT01948739|3900981|FG000|COMPLETED|Overall Study||10
3173305|NCT01948739|3900981|FG000|NOT COMPLETED|Overall Study||8
3173306|NCT01948791|3900985|FG000|STARTED|Overall Study||222
3173307|NCT01948791|3900985|FG000|COMPLETED|Overall Study||151
3173308|NCT01948791|3900985|FG000|NOT COMPLETED|Overall Study||71
3173309|NCT01948830|3900991|FG000|STARTED|Overall Study||323
3173310|NCT01948830|3900992|FG001|STARTED|Overall Study||327
3173311|NCT01948830|3900991|FG000|Safety Set|Overall Study||323
3173312|NCT01948830|3900992|FG001|Safety Set|Overall Study||326
3173313|NCT01948830|3900991|FG000|COMPLETED|Overall Study||290
3173314|NCT01948830|3900992|FG001|COMPLETED|Overall Study||295
3173315|NCT01948830|3900991|FG000|NOT COMPLETED|Overall Study||33
3173316|NCT01948830|3900992|FG001|NOT COMPLETED|Overall Study||32
3173317|NCT01948908|3901001|FG000|STARTED|Overall Study||33
3173318|NCT01948908|3901002|FG001|STARTED|Overall Study||33
3173319|NCT01948908|3901003|FG002|STARTED|Overall Study||33
2922644|NCT00549042|3633395|FG001|COMPLETED|Conversion and Titration Phase|Per the study design, no patients received placebo during this phase.|0
2922645|NCT00549042|3633394|FG000|NOT COMPLETED|Conversion and Titration Phase||191
2922646|NCT00549042|3633395|FG001|NOT COMPLETED|Conversion and Titration Phase||0
2922647|NCT00549042|3633394|FG000|STARTED|Double-blind Phase||134
2922648|NCT00549042|3633395|FG001|STARTED|Double-blind Phase||134
3173320|NCT01948908|3901001|FG000|COMPLETED|Overall Study||32
3173321|NCT01948908|3901002|FG001|COMPLETED|Overall Study||33
3173322|NCT01948908|3901003|FG002|COMPLETED|Overall Study||31
3173323|NCT01948908|3901001|FG000|NOT COMPLETED|Overall Study||1
3173324|NCT01948908|3901002|FG001|NOT COMPLETED|Overall Study||0
3173325|NCT01948908|3901003|FG002|NOT COMPLETED|Overall Study||2
3173326|NCT01948947|3901013|FG000|STARTED|Overall Study||14
2922649|NCT00549042|3633394|FG000|COMPLETED|Double-blind Phase||66
2922650|NCT00549042|3633395|FG001|COMPLETED|Double-blind Phase||44
2922651|NCT00549042|3633394|FG000|NOT COMPLETED|Double-blind Phase||68
2922652|NCT00549042|3633395|FG001|NOT COMPLETED|Double-blind Phase||90
2922653|NCT00549055|3633402|FG000|STARTED|Overall Study||38
2922654|NCT00549055|3633402|FG000|COMPLETED|Overall Study||3
2922655|NCT00549055|3633402|FG000|NOT COMPLETED|Overall Study||35
2922656|NCT00549172|3633408|FG000|STARTED|Overall Study||70
2922657|NCT00549172|3633409|FG001|STARTED|Overall Study||76
2922658|NCT00549172|3633408|FG000|COMPLETED|Overall Study||70
2922659|NCT00549172|3633409|FG001|COMPLETED|Overall Study||76
2922660|NCT00549172|3633408|FG000|NOT COMPLETED|Overall Study||0
2922661|NCT00549172|3633409|FG001|NOT COMPLETED|Overall Study||0
2922662|NCT00549198|3633417|FG000|STARTED|Overall Study|Three participants were randomized but were not exposed to study drug (ABC/3TC).|195
2922663|NCT00549198|3633418|FG001|STARTED|Overall Study|Four participants were randomized but were not exposed to study drug (TDF/FTC).|197
2922664|NCT00549198|3633417|FG000|COMPLETED|Overall Study||115
2922665|NCT00549198|3633418|FG001|COMPLETED|Overall Study||134
2922666|NCT00549198|3633417|FG000|NOT COMPLETED|Overall Study||80
2922667|NCT00549198|3633418|FG001|NOT COMPLETED|Overall Study||63
2922668|NCT00549302|3633426|FG000|STARTED|Double-Blind||63
2922669|NCT00549302|3633427|FG001|STARTED|Double-Blind||294
2922670|NCT00549302|3633428|FG002|STARTED|Double-Blind||0
2922671|NCT00549302|3633426|FG000|Received at Least One Dose of Study Drug|Double-Blind||63
2922672|NCT00549302|3633427|FG001|Received at Least One Dose of Study Drug|Double-Blind||294
2922673|NCT00549302|3633428|FG002|Received at Least One Dose of Study Drug|Double-Blind||0
2922674|NCT00549302|3633426|FG000|COMPLETED|Double-Blind|Participants who completed the Double-Blind Period were eligible to enter the Open-Label Period.|52
2922675|NCT00549302|3633427|FG001|COMPLETED|Double-Blind|Participants who completed the Double-Blind Period were eligible to enter the Open-Label Period.|241
2922676|NCT00549302|3633428|FG002|COMPLETED|Double-Blind||0
2922677|NCT00549302|3633426|FG000|NOT COMPLETED|Double-Blind||11
2922678|NCT00549302|3633427|FG001|NOT COMPLETED|Double-Blind||53
2922679|NCT00549302|3633428|FG002|NOT COMPLETED|Double-Blind||0
2922680|NCT00549302|3633426|FG000|STARTED|Open-Label||0
2922681|NCT00549302|3633427|FG001|STARTED|Open-Label||0
2922682|NCT00549302|3633428|FG002|STARTED|Open-Label|7 participants who completed the Double-Blind Period did not enter the Open-Label Period.|286
2922683|NCT00549302|3633426|FG000|COMPLETED|Open-Label||0
2922684|NCT00549302|3633427|FG001|COMPLETED|Open-Label||0
2922685|NCT00549302|3633428|FG002|COMPLETED|Open-Label|Another death occurred during the 30-day follow-up period after study drug discontinuation|217
2922686|NCT00549302|3633426|FG000|NOT COMPLETED|Open-Label||0
2922687|NCT00549302|3633427|FG001|NOT COMPLETED|Open-Label||0
2922688|NCT00549302|3633428|FG002|NOT COMPLETED|Open-Label||69
3173327|NCT01948947|3901014|FG001|STARTED|Overall Study||15
3173328|NCT01948947|3901013|FG000|COMPLETED|Overall Study||14
3173329|NCT01948947|3901014|FG001|COMPLETED|Overall Study||15
3173330|NCT01948947|3901013|FG000|NOT COMPLETED|Overall Study||0
3173331|NCT01948947|3901014|FG001|NOT COMPLETED|Overall Study||0
3173332|NCT01948986|3901025|FG000|STARTED|Overall Study||6
3173333|NCT01948986|3901026|FG001|STARTED|Overall Study||8
3173334|NCT01948986|3901027|FG002|STARTED|Overall Study||8
3173335|NCT01948986|3901028|FG003|STARTED|Overall Study||6
3173336|NCT01948986|3901029|FG004|STARTED|Overall Study||8
3173337|NCT01948986|3901025|FG000|COMPLETED|Overall Study||6
3173338|NCT01948986|3901026|FG001|COMPLETED|Overall Study||8
3173339|NCT01948986|3901027|FG002|COMPLETED|Overall Study||8
3173340|NCT01948986|3901028|FG003|COMPLETED|Overall Study||6
2922689|NCT00549393|3633438|FG000|STARTED|Period 1 (6 Months)|intention to treat (ITT)|1319
2922690|NCT00549393|3633439|FG001|STARTED|Period 1 (6 Months)|ITT|1199
2922691|NCT00549393|3633438|FG000|Per Protocol|Period 1 (6 Months)||880
2922692|NCT00549393|3633439|FG001|Per Protocol|Period 1 (6 Months)||1199
2922693|NCT00549393|3633438|FG000|COMPLETED|Period 1 (6 Months)||1319
2922694|NCT00549393|3633439|FG001|COMPLETED|Period 1 (6 Months)||1199
2922695|NCT00549393|3633438|FG000|NOT COMPLETED|Period 1 (6 Months)||0
2922696|NCT00549393|3633439|FG001|NOT COMPLETED|Period 1 (6 Months)||0
2922697|NCT00549393|3633438|FG000|STARTED|Period 2 Washout (2 Weeks)||0
2922698|NCT00549393|3633439|FG001|STARTED|Period 2 Washout (2 Weeks)||0
2922699|NCT00549393|3633438|FG000|COMPLETED|Period 2 Washout (2 Weeks)||0
2922700|NCT00549393|3633439|FG001|COMPLETED|Period 2 Washout (2 Weeks)||0
2922701|NCT00549393|3633438|FG000|NOT COMPLETED|Period 2 Washout (2 Weeks)||0
2922702|NCT00549393|3633439|FG001|NOT COMPLETED|Period 2 Washout (2 Weeks)||0
2922703|NCT00549393|3633438|FG000|STARTED|Period 3 (6 Months)|number not equal to period 1 due to unit cross over design|1103
2922704|NCT00549393|3633439|FG001|STARTED|Period 3 (6 Months)|number not equal to period 1 due to unit cross over design|1326
2922705|NCT00549393|3633438|FG000|Per Protocol|Period 3 (6 Months)||667
2922706|NCT00549393|3633439|FG001|Per Protocol|Period 3 (6 Months)||1326
3173341|NCT01948986|3901029|FG004|COMPLETED|Overall Study||8
3173342|NCT01948986|3901025|FG000|NOT COMPLETED|Overall Study||0
3173343|NCT01948986|3901026|FG001|NOT COMPLETED|Overall Study||0
3038628|NCT01154634|3757988|FG000|STARTED|Period 3- Second Intervention||4
3038629|NCT01154634|3757989|FG001|STARTED|Period 3- Second Intervention||7
3038630|NCT01154634|3757990|FG002|STARTED|Period 3- Second Intervention||4
3038631|NCT01154634|3757991|FG003|STARTED|Period 3- Second Intervention||5
3038632|NCT01154634|3757988|FG000|COMPLETED|Period 3- Second Intervention||4
3038633|NCT01154634|3757989|FG001|COMPLETED|Period 3- Second Intervention||7
3038634|NCT01154634|3757990|FG002|COMPLETED|Period 3- Second Intervention||4
3038635|NCT01154634|3757991|FG003|COMPLETED|Period 3- Second Intervention||5
3038636|NCT01154634|3757988|FG000|NOT COMPLETED|Period 3- Second Intervention||0
3038637|NCT01154634|3757989|FG001|NOT COMPLETED|Period 3- Second Intervention||0
3038638|NCT01154634|3757990|FG002|NOT COMPLETED|Period 3- Second Intervention||0
3136933|NCT01716234|3862236|FG006|NOT COMPLETED|Overall Study||0
3136934|NCT01716455|3862258|FG000|STARTED|Overall Study||8
3136935|NCT01716455|3862259|FG001|STARTED|Overall Study||8
3136936|NCT01716455|3862260|FG002|STARTED|Overall Study||8
3173344|NCT01948986|3901027|FG002|NOT COMPLETED|Overall Study||0
3173345|NCT01948986|3901028|FG003|NOT COMPLETED|Overall Study||0
3173346|NCT01948986|3901029|FG004|NOT COMPLETED|Overall Study||0
2922707|NCT00549393|3633438|FG000|COMPLETED|Period 3 (6 Months)||1103
2922708|NCT00549393|3633439|FG001|COMPLETED|Period 3 (6 Months)||1326
2922709|NCT00549393|3633438|FG000|NOT COMPLETED|Period 3 (6 Months)||0
2922710|NCT00549393|3633439|FG001|NOT COMPLETED|Period 3 (6 Months)||0
2922711|NCT00549445|3633449|FG000|STARTED|Overall Study||23
2922712|NCT00549445|3633450|FG001|STARTED|Overall Study||30
2922713|NCT00549445|3633449|FG000|COMPLETED|Overall Study||8
2922714|NCT00549445|3633450|FG001|COMPLETED|Overall Study||13
2922715|NCT00549445|3633449|FG000|NOT COMPLETED|Overall Study||15
2922716|NCT00549445|3633450|FG001|NOT COMPLETED|Overall Study||17
2922717|NCT00549549|3633460|FG000|STARTED|Overall Study||101
2922718|NCT00549549|3633461|FG001|STARTED|Overall Study||99
2922719|NCT00549549|3633462|FG002|STARTED|Overall Study||99
2922720|NCT00549549|3633463|FG003|STARTED|Overall Study||103
2922721|NCT00549549|3633460|FG000|Treated|Overall Study||101
2922722|NCT00549549|3633461|FG001|Treated|Overall Study||99
2922723|NCT00549549|3633462|FG002|Treated|Overall Study||98
2922724|NCT00549549|3633463|FG003|Treated|Overall Study||102
2922725|NCT00549549|3633460|FG000|COMPLETED|Overall Study||77
2922726|NCT00549549|3633461|FG001|COMPLETED|Overall Study||77
2922727|NCT00549549|3633462|FG002|COMPLETED|Overall Study||82
2922728|NCT00549549|3633463|FG003|COMPLETED|Overall Study||78
2922729|NCT00549549|3633460|FG000|NOT COMPLETED|Overall Study||24
2922730|NCT00549549|3633461|FG001|NOT COMPLETED|Overall Study||22
2922731|NCT00549549|3633462|FG002|NOT COMPLETED|Overall Study||17
2922732|NCT00549549|3633463|FG003|NOT COMPLETED|Overall Study||25
2922733|NCT00549562|3633473|FG000|STARTED|Overall Study||25
2922734|NCT00549562|3633473|FG000|COMPLETED|Overall Study||23
2922735|NCT00549562|3633473|FG000|NOT COMPLETED|Overall Study||2
2922736|NCT00549601|3633480|FG000|STARTED|Randomized||43
2922737|NCT00549601|3633481|FG001|STARTED|Randomized||48
2922738|NCT00549601|3633482|FG002|STARTED|Randomized||51
2922739|NCT00549601|3633480|FG000|COMPLETED|Randomized||43
2922740|NCT00549601|3633481|FG001|COMPLETED|Randomized||47
2922741|NCT00549601|3633482|FG002|COMPLETED|Randomized||49
2922742|NCT00549601|3633480|FG000|NOT COMPLETED|Randomized||0
2922743|NCT00549601|3633481|FG001|NOT COMPLETED|Randomized||1
2922744|NCT00549601|3633482|FG002|NOT COMPLETED|Randomized||2
2922745|NCT00549601|3633480|FG000|STARTED|Received Study Drug|Subjects who started this period (safety population) received at least 1 dose of study drug.|43
2922746|NCT00549601|3633481|FG001|STARTED|Received Study Drug|Subjects who started this period (safety population) received at least 1 dose of study drug.|47
2922747|NCT00549601|3633482|FG002|STARTED|Received Study Drug|Subjects who started this period (safety population) received at least 1 dose of study drug.|49
2922748|NCT00549601|3633480|FG000|COMPLETED|Received Study Drug||36
2922749|NCT00549601|3633481|FG001|COMPLETED|Received Study Drug||36
2922750|NCT00549601|3633482|FG002|COMPLETED|Received Study Drug||45
2922751|NCT00549601|3633480|FG000|NOT COMPLETED|Received Study Drug||7
2922752|NCT00549601|3633481|FG001|NOT COMPLETED|Received Study Drug||11
2922753|NCT00549601|3633482|FG002|NOT COMPLETED|Received Study Drug||4
2922754|NCT00549640|3633494|FG000|STARTED|Overall Study||40
2922755|NCT00549640|3633495|FG001|STARTED|Overall Study||40
2922756|NCT00549640|3633494|FG000|COMPLETED|Overall Study|For the primary endpoint, subjects who discontinued participation were assumed to be smoking.|22
2922757|NCT00549640|3633495|FG001|COMPLETED|Overall Study||24
2922758|NCT00549640|3633494|FG000|NOT COMPLETED|Overall Study||18
2922759|NCT00549640|3633495|FG001|NOT COMPLETED|Overall Study||16
2922760|NCT00549718|3633505|FG000|STARTED|Overall Study||125
2922761|NCT00549718|3633506|FG001|STARTED|Overall Study||123
2922762|NCT00549718|3633507|FG002|STARTED|Overall Study||124
2922763|NCT00549718|3633508|FG003|STARTED|Overall Study||128
2922764|NCT00549718|3633505|FG000|COMPLETED|Overall Study||84
2922765|NCT00549718|3633506|FG001|COMPLETED|Overall Study||86
2922766|NCT00549718|3633507|FG002|COMPLETED|Overall Study||85
2922767|NCT00549718|3633508|FG003|COMPLETED|Overall Study||73
2922768|NCT00549718|3633505|FG000|NOT COMPLETED|Overall Study||41
2922769|NCT00549718|3633506|FG001|NOT COMPLETED|Overall Study||37
2922770|NCT00549718|3633507|FG002|NOT COMPLETED|Overall Study||39
2922771|NCT00549718|3633508|FG003|NOT COMPLETED|Overall Study||55
2922772|NCT00549757|3633520|FG000|STARTED|Active Treatment Phase: Max. 50 Months|"Started indicates randomized patients."|4296
2922773|NCT00549757|3633521|FG001|STARTED|Active Treatment Phase: Max. 50 Months||4310
2922774|NCT00549757|3633520|FG000|Full Analysis Set|Active Treatment Phase: Max. 50 Months||4274
2922775|NCT00549757|3633521|FG001|Full Analysis Set|Active Treatment Phase: Max. 50 Months||4287
3173347|NCT01949051|3901041|FG000|STARTED|Treatment Period 1 (7 Days)||13
3173348|NCT01949051|3901042|FG001|STARTED|Treatment Period 1 (7 Days)||13
3173349|NCT01949051|3901043|FG002|STARTED|Treatment Period 1 (7 Days)||13
3173350|NCT01949051|3901044|FG003|STARTED|Treatment Period 1 (7 Days)||13
3173351|NCT01949051|3901045|FG004|STARTED|Treatment Period 1 (7 Days)||13
3173352|NCT01949051|3901046|FG005|STARTED|Treatment Period 1 (7 Days)||13
3173353|NCT01949051|3901041|FG000|COMPLETED|Treatment Period 1 (7 Days)||11
3173354|NCT01949051|3901042|FG001|COMPLETED|Treatment Period 1 (7 Days)||13
3173355|NCT01949051|3901043|FG002|COMPLETED|Treatment Period 1 (7 Days)||13
3173356|NCT01949051|3901044|FG003|COMPLETED|Treatment Period 1 (7 Days)||12
3173357|NCT01949051|3901045|FG004|COMPLETED|Treatment Period 1 (7 Days)||13
3173358|NCT01949051|3901046|FG005|COMPLETED|Treatment Period 1 (7 Days)||13
3173359|NCT01949051|3901041|FG000|NOT COMPLETED|Treatment Period 1 (7 Days)||2
3173360|NCT01949051|3901042|FG001|NOT COMPLETED|Treatment Period 1 (7 Days)||0
3319596|NCT03152552|4053051|FG003|COMPLETED|Treatment Period 1 (12 Weeks)||10
3319597|NCT03152552|4053052|FG004|COMPLETED|Treatment Period 1 (12 Weeks)||12
3319598|NCT03152552|4053048|FG000|NOT COMPLETED|Treatment Period 1 (12 Weeks)||8
3319599|NCT03152552|4053049|FG001|NOT COMPLETED|Treatment Period 1 (12 Weeks)||11
3319600|NCT03152552|4053050|FG002|NOT COMPLETED|Treatment Period 1 (12 Weeks)||21
3319601|NCT03152552|4053051|FG003|NOT COMPLETED|Treatment Period 1 (12 Weeks)||20
3319602|NCT03152552|4053052|FG004|NOT COMPLETED|Treatment Period 1 (12 Weeks)||21
3173361|NCT01949051|3901043|FG002|NOT COMPLETED|Treatment Period 1 (7 Days)||0
3173362|NCT01949051|3901044|FG003|NOT COMPLETED|Treatment Period 1 (7 Days)||1
3173363|NCT01949051|3901045|FG004|NOT COMPLETED|Treatment Period 1 (7 Days)||0
3173364|NCT01949051|3901046|FG005|NOT COMPLETED|Treatment Period 1 (7 Days)||0
3173365|NCT01949051|3901041|FG000|STARTED|Washout Period 1 (14 to 20 Days)||11
3173366|NCT01949051|3901042|FG001|STARTED|Washout Period 1 (14 to 20 Days)||13
3173367|NCT01949051|3901043|FG002|STARTED|Washout Period 1 (14 to 20 Days)||13
3173368|NCT01949051|3901044|FG003|STARTED|Washout Period 1 (14 to 20 Days)||12
3173369|NCT01949051|3901045|FG004|STARTED|Washout Period 1 (14 to 20 Days)||13
3173370|NCT01949051|3901046|FG005|STARTED|Washout Period 1 (14 to 20 Days)||13
3173371|NCT01949051|3901041|FG000|COMPLETED|Washout Period 1 (14 to 20 Days)||11
3173372|NCT01949051|3901042|FG001|COMPLETED|Washout Period 1 (14 to 20 Days)||13
3173373|NCT01949051|3901043|FG002|COMPLETED|Washout Period 1 (14 to 20 Days)||13
3173374|NCT01949051|3901044|FG003|COMPLETED|Washout Period 1 (14 to 20 Days)||12
3173375|NCT01949051|3901045|FG004|COMPLETED|Washout Period 1 (14 to 20 Days)||13
3173376|NCT01949051|3901046|FG005|COMPLETED|Washout Period 1 (14 to 20 Days)||13
3173377|NCT01949051|3901041|FG000|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
3173378|NCT01949051|3901042|FG001|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
3173379|NCT01949051|3901043|FG002|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
3173380|NCT01949051|3901044|FG003|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
3173381|NCT01949051|3901045|FG004|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
3173382|NCT01949051|3901046|FG005|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
3173383|NCT01949051|3901041|FG000|STARTED|Treatment Period 2 (7 Days)||11
3173384|NCT01949051|3901042|FG001|STARTED|Treatment Period 2 (7 Days)||13
3173385|NCT01949051|3901043|FG002|STARTED|Treatment Period 2 (7 Days)||13
3173386|NCT01949051|3901044|FG003|STARTED|Treatment Period 2 (7 Days)||12
3173387|NCT01949051|3901045|FG004|STARTED|Treatment Period 2 (7 Days)||13
3173388|NCT01949051|3901046|FG005|STARTED|Treatment Period 2 (7 Days)||13
3173389|NCT01949051|3901041|FG000|COMPLETED|Treatment Period 2 (7 Days)||11
3173390|NCT01949051|3901042|FG001|COMPLETED|Treatment Period 2 (7 Days)||12
3173391|NCT01949051|3901043|FG002|COMPLETED|Treatment Period 2 (7 Days)||12
3173392|NCT01949051|3901044|FG003|COMPLETED|Treatment Period 2 (7 Days)||12
3173393|NCT01949051|3901045|FG004|COMPLETED|Treatment Period 2 (7 Days)||13
3173394|NCT01949051|3901046|FG005|COMPLETED|Treatment Period 2 (7 Days)||12
3173395|NCT01949051|3901041|FG000|NOT COMPLETED|Treatment Period 2 (7 Days)||0
3173396|NCT01949051|3901042|FG001|NOT COMPLETED|Treatment Period 2 (7 Days)||1
3173397|NCT01949051|3901043|FG002|NOT COMPLETED|Treatment Period 2 (7 Days)||1
3173398|NCT01949051|3901044|FG003|NOT COMPLETED|Treatment Period 2 (7 Days)||0
3173399|NCT01949051|3901045|FG004|NOT COMPLETED|Treatment Period 2 (7 Days)||0
3173400|NCT01949051|3901046|FG005|NOT COMPLETED|Treatment Period 2 (7 Days)||1
3173401|NCT01949051|3901041|FG000|STARTED|Washout Period 2 (14 to 20 Days)||11
3173402|NCT01949051|3901042|FG001|STARTED|Washout Period 2 (14 to 20 Days)||12
3173403|NCT01949051|3901043|FG002|STARTED|Washout Period 2 (14 to 20 Days)||12
3173404|NCT01949051|3901044|FG003|STARTED|Washout Period 2 (14 to 20 Days)||12
3173405|NCT01949051|3901045|FG004|STARTED|Washout Period 2 (14 to 20 Days)||13
3173406|NCT01949051|3901046|FG005|STARTED|Washout Period 2 (14 to 20 Days)||12
3173407|NCT01949051|3901041|FG000|COMPLETED|Washout Period 2 (14 to 20 Days)||11
3173408|NCT01949051|3901042|FG001|COMPLETED|Washout Period 2 (14 to 20 Days)||12
3173409|NCT01949051|3901043|FG002|COMPLETED|Washout Period 2 (14 to 20 Days)||12
3173410|NCT01949051|3901044|FG003|COMPLETED|Washout Period 2 (14 to 20 Days)||12
3173411|NCT01949051|3901045|FG004|COMPLETED|Washout Period 2 (14 to 20 Days)||13
3173412|NCT01949051|3901046|FG005|COMPLETED|Washout Period 2 (14 to 20 Days)||12
3173413|NCT01949051|3901041|FG000|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
3173414|NCT01949051|3901042|FG001|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
3173415|NCT01949051|3901043|FG002|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
3173416|NCT01949051|3901044|FG003|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
3173417|NCT01949051|3901045|FG004|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
3173418|NCT01949051|3901046|FG005|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
3173419|NCT01949051|3901041|FG000|STARTED|Treatment Period 3 (7 Days)||11
3173420|NCT01949051|3901042|FG001|STARTED|Treatment Period 3 (7 Days)||12
3173421|NCT01949051|3901043|FG002|STARTED|Treatment Period 3 (7 Days)||12
3173422|NCT01949051|3901044|FG003|STARTED|Treatment Period 3 (7 Days)||12
3173423|NCT01949051|3901045|FG004|STARTED|Treatment Period 3 (7 Days)||13
3173424|NCT01949051|3901046|FG005|STARTED|Treatment Period 3 (7 Days)||12
3173425|NCT01949051|3901041|FG000|COMPLETED|Treatment Period 3 (7 Days)||11
3173426|NCT01949051|3901042|FG001|COMPLETED|Treatment Period 3 (7 Days)||12
3173427|NCT01949051|3901043|FG002|COMPLETED|Treatment Period 3 (7 Days)||12
3173428|NCT01949051|3901044|FG003|COMPLETED|Treatment Period 3 (7 Days)||12
3173429|NCT01949051|3901045|FG004|COMPLETED|Treatment Period 3 (7 Days)||13
3173430|NCT01949051|3901046|FG005|COMPLETED|Treatment Period 3 (7 Days)||12
3173431|NCT01949051|3901041|FG000|NOT COMPLETED|Treatment Period 3 (7 Days)||0
3173432|NCT01949051|3901042|FG001|NOT COMPLETED|Treatment Period 3 (7 Days)||0
3173433|NCT01949051|3901043|FG002|NOT COMPLETED|Treatment Period 3 (7 Days)||0
3173434|NCT01949051|3901044|FG003|NOT COMPLETED|Treatment Period 3 (7 Days)||0
3173435|NCT01949051|3901045|FG004|NOT COMPLETED|Treatment Period 3 (7 Days)||0
3173436|NCT01949051|3901046|FG005|NOT COMPLETED|Treatment Period 3 (7 Days)||0
3173437|NCT01949090|3901059|FG000|STARTED|Overall Study||60
3173438|NCT01949090|3901060|FG001|STARTED|Overall Study||60
3173439|NCT01949090|3901061|FG002|STARTED|Overall Study||60
3173440|NCT01949090|3901062|FG003|STARTED|Overall Study||60
3173441|NCT01949090|3901063|FG004|STARTED|Overall Study||120
3173442|NCT01949090|3901059|FG000|COMPLETED|Overall Study||56
3173443|NCT01949090|3901060|FG001|COMPLETED|Overall Study||58
3173444|NCT01949090|3901061|FG002|COMPLETED|Overall Study||58
3173445|NCT01949090|3901062|FG003|COMPLETED|Overall Study||59
3173446|NCT01949090|3901063|FG004|COMPLETED|Overall Study||116
3173447|NCT01949090|3901059|FG000|NOT COMPLETED|Overall Study||4
3173448|NCT01949090|3901060|FG001|NOT COMPLETED|Overall Study||2
3173449|NCT01949090|3901061|FG002|NOT COMPLETED|Overall Study||2
3173450|NCT01949090|3901062|FG003|NOT COMPLETED|Overall Study||1
3173451|NCT01949090|3901063|FG004|NOT COMPLETED|Overall Study||4
3173452|NCT01949116|3901078|FG000|STARTED|Overall Study||86
3173453|NCT01949116|3901079|FG001|STARTED|Overall Study||90
3173454|NCT01949116|3901078|FG000|COMPLETED|Overall Study||78
3173455|NCT01949116|3901079|FG001|COMPLETED|Overall Study||84
3173456|NCT01949116|3901078|FG000|NOT COMPLETED|Overall Study||8
3173457|NCT01949116|3901079|FG001|NOT COMPLETED|Overall Study||6
3173458|NCT01949142|3901091|FG000|STARTED|Overall Study||179
3173459|NCT01949142|3901092|FG001|STARTED|Overall Study||87
3173460|NCT01949142|3901091|FG000|COMPLETED|Overall Study||176
3173461|NCT01949142|3901092|FG001|COMPLETED|Overall Study||86
3173462|NCT01949142|3901091|FG000|NOT COMPLETED|Overall Study||3
3173463|NCT01949142|3901092|FG001|NOT COMPLETED|Overall Study||1
3173464|NCT01949155|3901101|FG000|STARTED|Overall Study||178
3173465|NCT01949155|3901102|FG001|STARTED|Overall Study||88
3173466|NCT01949155|3901101|FG000|COMPLETED|Overall Study||176
3173467|NCT01949155|3901102|FG001|COMPLETED|Overall Study||88
2922776|NCT00549757|3633520|FG000|Safety Set|Active Treatment Phase: Max. 50 Months||4272
3173468|NCT01949155|3901101|FG000|NOT COMPLETED|Overall Study||2
3173469|NCT01949155|3901102|FG001|NOT COMPLETED|Overall Study||0
3319603|NCT03152552|4053048|FG000|STARTED|Treatment Period 2 (24 Weeks)||7
3173470|NCT01949337|3901111|FG000|STARTED|Overall Study||657
3173471|NCT01949337|3901112|FG001|STARTED|Overall Study||654
3319604|NCT03152552|4053049|FG001|STARTED|Treatment Period 2 (24 Weeks)||5
3319605|NCT03152552|4053050|FG002|STARTED|Treatment Period 2 (24 Weeks)|All patients who entered Treatment Period 2 (EPOCH 4)|9
3319606|NCT03152552|4053051|FG003|STARTED|Treatment Period 2 (24 Weeks)|All patients who entered Treatment Period 2 (EPOCH 4)|9
3319607|NCT03152552|4053052|FG004|STARTED|Treatment Period 2 (24 Weeks)|All patients who entered Treatment Period 2 (EPOCH 4)|11
3319608|NCT03152552|4053048|FG000|COMPLETED|Treatment Period 2 (24 Weeks)||1
3319609|NCT03152552|4053049|FG001|COMPLETED|Treatment Period 2 (24 Weeks)||0
3319610|NCT03152552|4053050|FG002|COMPLETED|Treatment Period 2 (24 Weeks)||0
3319611|NCT03152552|4053051|FG003|COMPLETED|Treatment Period 2 (24 Weeks)||0
3319612|NCT03152552|4053052|FG004|COMPLETED|Treatment Period 2 (24 Weeks)||0
3319613|NCT03152552|4053048|FG000|NOT COMPLETED|Treatment Period 2 (24 Weeks)||6
3319614|NCT03152552|4053049|FG001|NOT COMPLETED|Treatment Period 2 (24 Weeks)||5
3319615|NCT03152552|4053050|FG002|NOT COMPLETED|Treatment Period 2 (24 Weeks)||9
3319616|NCT03152552|4053051|FG003|NOT COMPLETED|Treatment Period 2 (24 Weeks)||9
3319617|NCT03152552|4053052|FG004|NOT COMPLETED|Treatment Period 2 (24 Weeks)||11
3319618|NCT03152591|4053067|FG000|STARTED|Overall Study||15
3319619|NCT03152591|4053068|FG001|STARTED|Overall Study||14
3319620|NCT03152591|4053067|FG000|Pharmacokinetic (PK) Analysis Set|Overall Study||14
3319621|NCT03152591|4053068|FG001|Pharmacokinetic (PK) Analysis Set|Overall Study||0
3319622|NCT03152591|4053067|FG000|Pharmacodynamic (PD) Analysis Set|Overall Study||15
3319623|NCT03152591|4053068|FG001|Pharmacodynamic (PD) Analysis Set|Overall Study||14
3319624|NCT03152591|4053067|FG000|COMPLETED|Overall Study||15
3319625|NCT03152591|4053068|FG001|COMPLETED|Overall Study||14
3319626|NCT03152591|4053067|FG000|NOT COMPLETED|Overall Study||0
3319627|NCT03152591|4053068|FG001|NOT COMPLETED|Overall Study||0
3319628|NCT03153956|4053076|FG000|STARTED|Overall Study||39
3319629|NCT03153956|4053077|FG001|STARTED|Overall Study||38
3319630|NCT03153956|4053076|FG000|COMPLETED|Overall Study||39
3319631|NCT03153956|4053077|FG001|COMPLETED|Overall Study||38
3319632|NCT03153956|4053076|FG000|NOT COMPLETED|Overall Study||0
3319633|NCT03153956|4053077|FG001|NOT COMPLETED|Overall Study||0
3319634|NCT03154047|4053083|FG000|STARTED|Overall Study||80
3319635|NCT03154047|4053083|FG000|Number of Patients Dosed|Overall Study||80
3319636|NCT03154047|4053083|FG000|COMPLETED|Overall Study||0
3319637|NCT03154047|4053083|FG000|NOT COMPLETED|Overall Study||80
3319638|NCT03154086|4053102|FG000|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||2
3319639|NCT03154086|4053103|FG001|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||2
3319640|NCT03154086|4053104|FG002|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||2
3319641|NCT03154086|4053105|FG003|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||2
3319642|NCT03154086|4053106|FG004|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
3319643|NCT03154086|4053107|FG005|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
3319644|NCT03154086|4053108|FG006|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
3319645|NCT03154086|4053109|FG007|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
3319646|NCT03154086|4053110|FG008|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
3319647|NCT03154086|4053111|FG009|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
3319648|NCT03154086|4053112|FG010|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
3319649|NCT03154086|4053113|FG011|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
3319650|NCT03154086|4053114|FG012|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
3319651|NCT03154086|4053115|FG013|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
3319652|NCT03154086|4053116|FG014|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
3319653|NCT03154086|4053102|FG000|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||2
2922777|NCT00549757|3633521|FG001|Safety Set|Active Treatment Phase: Max. 50 Months||4285
2922778|NCT00549757|3633520|FG000|COMPLETED|Active Treatment Phase: Max. 50 Months||0
2922779|NCT00549757|3633521|FG001|COMPLETED|Active Treatment Phase: Max. 50 Months||0
2922780|NCT00549757|3633520|FG000|NOT COMPLETED|Active Treatment Phase: Max. 50 Months||4296
2922781|NCT00549757|3633521|FG001|NOT COMPLETED|Active Treatment Phase: Max. 50 Months||4310
2922782|NCT00549757|3633520|FG000|STARTED|Extension Period (in Average 9 Months)|"As explained in pre-assignment detail, follow up was made after drug discontinuation"|3773
2922783|NCT00549757|3633521|FG001|STARTED|Extension Period (in Average 9 Months)|"As explained in pre-assignment detail, follow up was made after drug discontinuation"|3817
2922784|NCT00549757|3633520|FG000|COMPLETED|Extension Period (in Average 9 Months)||3148
2922785|NCT00549757|3633521|FG001|COMPLETED|Extension Period (in Average 9 Months)||3182
2922786|NCT00549757|3633520|FG000|NOT COMPLETED|Extension Period (in Average 9 Months)||625
2922787|NCT00549757|3633521|FG001|NOT COMPLETED|Extension Period (in Average 9 Months)||635
2922788|NCT00549770|3633541|FG000|STARTED|Overall Study||156
2922789|NCT00549770|3633542|FG001|STARTED|Overall Study||169
2922790|NCT00549770|3633543|FG002|STARTED|Overall Study||172
2922791|NCT00549770|3633544|FG003|STARTED|Overall Study||163
2922792|NCT00549770|3633545|FG004|STARTED|Overall Study||166
2922793|NCT00549770|3633546|FG005|STARTED|Overall Study||164
2922794|NCT00549770|3633547|FG006|STARTED|Overall Study||165
3173472|NCT01949337|3901111|FG000|COMPLETED|Overall Study||657
3173473|NCT01949337|3901112|FG001|COMPLETED|Overall Study||654
3173474|NCT01949337|3901111|FG000|NOT COMPLETED|Overall Study||0
3173475|NCT01949337|3901112|FG001|NOT COMPLETED|Overall Study||0
3173476|NCT01949389|3901118|FG000|STARTED|Overall Study||51
3173477|NCT01949389|3901118|FG000|COMPLETED|Overall Study||51
2922795|NCT00549770|3633548|FG007|STARTED|Overall Study||173
2922796|NCT00549770|3633541|FG000|Intent-to-treat Population|Overall Study||154
2922797|NCT00549770|3633542|FG001|Intent-to-treat Population|Overall Study||168
2922798|NCT00549770|3633543|FG002|Intent-to-treat Population|Overall Study||170
2922799|NCT00549770|3633544|FG003|Intent-to-treat Population|Overall Study||163
2922800|NCT00549770|3633545|FG004|Intent-to-treat Population|Overall Study||163
2922801|NCT00549770|3633546|FG005|Intent-to-treat Population|Overall Study||163
2922802|NCT00549770|3633547|FG006|Intent-to-treat Population|Overall Study||164
2922803|NCT00549770|3633548|FG007|Intent-to-treat Population|Overall Study||172
2922804|NCT00549770|3633541|FG000|Ambulatory Blood Pressure Monitoring|Overall Study||48
2922805|NCT00549770|3633542|FG001|Ambulatory Blood Pressure Monitoring|Overall Study||61
2922806|NCT00549770|3633543|FG002|Ambulatory Blood Pressure Monitoring|Overall Study||53
2922807|NCT00549770|3633544|FG003|Ambulatory Blood Pressure Monitoring|Overall Study||55
2922808|NCT00549770|3633545|FG004|Ambulatory Blood Pressure Monitoring|Overall Study||49
2922809|NCT00549770|3633546|FG005|Ambulatory Blood Pressure Monitoring|Overall Study||54
2922810|NCT00549770|3633547|FG006|Ambulatory Blood Pressure Monitoring|Overall Study||50
2922811|NCT00549770|3633548|FG007|Ambulatory Blood Pressure Monitoring|Overall Study||57
2922812|NCT00549770|3633541|FG000|COMPLETED|Overall Study||149
2922813|NCT00549770|3633542|FG001|COMPLETED|Overall Study||158
2922814|NCT00549770|3633543|FG002|COMPLETED|Overall Study||162
2922815|NCT00549770|3633544|FG003|COMPLETED|Overall Study||147
2922816|NCT00549770|3633545|FG004|COMPLETED|Overall Study||149
2922817|NCT00549770|3633546|FG005|COMPLETED|Overall Study||151
2922818|NCT00549770|3633547|FG006|COMPLETED|Overall Study||151
3038639|NCT01154634|3757991|FG003|NOT COMPLETED|Period 3- Second Intervention||0
3038640|NCT01154634|3757988|FG000|STARTED|Period 4 - Washout||4
3038641|NCT01154634|3757989|FG001|STARTED|Period 4 - Washout||7
3038642|NCT01154634|3757990|FG002|STARTED|Period 4 - Washout||4
3038643|NCT01154634|3757991|FG003|STARTED|Period 4 - Washout||5
3038644|NCT01154634|3757988|FG000|COMPLETED|Period 4 - Washout||4
3038645|NCT01154634|3757989|FG001|COMPLETED|Period 4 - Washout||7
3038646|NCT01154634|3757990|FG002|COMPLETED|Period 4 - Washout||4
3038647|NCT01154634|3757991|FG003|COMPLETED|Period 4 - Washout||5
3038648|NCT01154634|3757988|FG000|NOT COMPLETED|Period 4 - Washout||0
3038649|NCT01154634|3757989|FG001|NOT COMPLETED|Period 4 - Washout||0
3319654|NCT03154086|4053103|FG001|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||2
3319655|NCT03154086|4053104|FG002|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||2
3319656|NCT03154086|4053105|FG003|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||2
3319657|NCT03154086|4053106|FG004|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
3319658|NCT03154086|4053107|FG005|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
3319659|NCT03154086|4053108|FG006|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
3319660|NCT03154086|4053109|FG007|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
3319661|NCT03154086|4053110|FG008|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
3319662|NCT03154086|4053111|FG009|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
3319663|NCT03154086|4053112|FG010|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
3319664|NCT03154086|4053113|FG011|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
3319665|NCT03154086|4053114|FG012|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
3319666|NCT03154086|4053115|FG013|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
3319667|NCT03154086|4053116|FG014|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
3319668|NCT03154086|4053102|FG000|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
3319669|NCT03154086|4053103|FG001|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
3319670|NCT03154086|4053104|FG002|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
3319671|NCT03154086|4053105|FG003|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
3319672|NCT03154086|4053106|FG004|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
3319673|NCT03154086|4053107|FG005|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
3319674|NCT03154086|4053108|FG006|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
3319675|NCT03154086|4053109|FG007|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
3319676|NCT03154086|4053110|FG008|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
3319677|NCT03154086|4053111|FG009|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
3319678|NCT03154086|4053112|FG010|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
3319679|NCT03154086|4053113|FG011|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
3319680|NCT03154086|4053114|FG012|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
3319681|NCT03154086|4053115|FG013|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
3319682|NCT03154086|4053116|FG014|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
3319683|NCT03154086|4053102|FG000|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||2
3319684|NCT03154086|4053103|FG001|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||2
3319685|NCT03154086|4053104|FG002|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||2
3319686|NCT03154086|4053105|FG003|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||2
3319687|NCT03154086|4053106|FG004|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
3319688|NCT03154086|4053107|FG005|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
3319689|NCT03154086|4053108|FG006|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
3319690|NCT03154086|4053109|FG007|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
3319691|NCT03154086|4053110|FG008|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
3319692|NCT03154086|4053111|FG009|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
3319693|NCT03154086|4053112|FG010|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
3319694|NCT03154086|4053113|FG011|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
3319695|NCT03154086|4053114|FG012|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
3319696|NCT03154086|4053115|FG013|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
3319697|NCT03154086|4053116|FG014|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
3319698|NCT03154086|4053102|FG000|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||2
3319699|NCT03154086|4053103|FG001|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||2
2922819|NCT00549770|3633548|FG007|COMPLETED|Overall Study||148
3319700|NCT03154086|4053104|FG002|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||2
3319701|NCT03154086|4053105|FG003|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||1
3319702|NCT03154086|4053106|FG004|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
2922820|NCT00549770|3633541|FG000|NOT COMPLETED|Overall Study||7
3038650|NCT01154634|3757990|FG002|NOT COMPLETED|Period 4 - Washout||0
3038651|NCT01154634|3757991|FG003|NOT COMPLETED|Period 4 - Washout||0
3038652|NCT01154634|3757988|FG000|STARTED|Period 5 - Third Intervention||4
3038653|NCT01154634|3757989|FG001|STARTED|Period 5 - Third Intervention||7
3038654|NCT01154634|3757990|FG002|STARTED|Period 5 - Third Intervention||4
3038655|NCT01154634|3757991|FG003|STARTED|Period 5 - Third Intervention||5
3038656|NCT01154634|3757988|FG000|COMPLETED|Period 5 - Third Intervention||4
3038657|NCT01154634|3757989|FG001|COMPLETED|Period 5 - Third Intervention||7
2922821|NCT00549770|3633542|FG001|NOT COMPLETED|Overall Study||11
2922822|NCT00549770|3633543|FG002|NOT COMPLETED|Overall Study||10
2922823|NCT00549770|3633544|FG003|NOT COMPLETED|Overall Study||16
2922824|NCT00549770|3633545|FG004|NOT COMPLETED|Overall Study||17
2922825|NCT00549770|3633546|FG005|NOT COMPLETED|Overall Study||13
2922826|NCT00549770|3633547|FG006|NOT COMPLETED|Overall Study||14
2922827|NCT00549770|3633548|FG007|NOT COMPLETED|Overall Study||25
2922828|NCT00549783|3633568|FG000|STARTED|Overall Study||139
2922829|NCT00549783|3633569|FG001|STARTED|Overall Study||135
2922830|NCT00549783|3633568|FG000|COMPLETED|Overall Study||131
2922831|NCT00549783|3633569|FG001|COMPLETED|Overall Study||122
2922832|NCT00549783|3633568|FG000|NOT COMPLETED|Overall Study||8
2922833|NCT00549783|3633569|FG001|NOT COMPLETED|Overall Study||13
2922834|NCT00549822|3633575|FG000|STARTED|Overall Study||3
2922835|NCT00549822|3633575|FG000|COMPLETED|Overall Study||3
2922836|NCT00549822|3633575|FG000|NOT COMPLETED|Overall Study||0
2922837|NCT00549900|3633579|FG000|STARTED|Overall Study||30
2922838|NCT00549900|3633579|FG000|COMPLETED|Overall Study||29
2922839|NCT00549900|3633579|FG000|NOT COMPLETED|Overall Study||1
2922840|NCT00549939|3633586|FG000|STARTED|12-week Double Blind Treatment Period|29 (Alfuzosin 0.1 mg/kg/day matching placebo) + 28 (Alfuzosin 0.2 mg/kg/day matching placebo)|57
2922841|NCT00549939|3633587|FG001|STARTED|12-week Double Blind Treatment Period||57
2922842|NCT00549939|3633588|FG002|STARTED|12-week Double Blind Treatment Period||58
2922843|NCT00549939|3633586|FG000|COMPLETED|12-week Double Blind Treatment Period||56
2922844|NCT00549939|3633587|FG001|COMPLETED|12-week Double Blind Treatment Period||55
2922845|NCT00549939|3633588|FG002|COMPLETED|12-week Double Blind Treatment Period||56
2922846|NCT00549939|3633586|FG000|NOT COMPLETED|12-week Double Blind Treatment Period||1
2922847|NCT00549939|3633587|FG001|NOT COMPLETED|12-week Double Blind Treatment Period||2
2922848|NCT00549939|3633588|FG002|NOT COMPLETED|12-week Double Blind Treatment Period||2
2922849|NCT00549939|3633586|FG000|STARTED|40-week Open Label Treatment Period|54 patients continued and switched to Alfuzosin: 26 to 0.1 mg/kg/day and 28 to 0.2 mg/kg/day.|0
3038658|NCT01154634|3757990|FG002|COMPLETED|Period 5 - Third Intervention||4
3136937|NCT01716455|3862261|FG003|STARTED|Overall Study||8
2922850|NCT00549939|3633587|FG001|STARTED|40-week Open Label Treatment Period|54 patients continued Alfuzosin 0.1 mg/kg/day and 26 patients started Alfuzosin 0.1 mg/kg/day.|80
2922851|NCT00549939|3633588|FG002|STARTED|40-week Open Label Treatment Period|55 patients continued Alfuzosin 0.2 mg/kg/day and 28 patients started Alfuzosin 0.2 mg/kg/day.|83
2922852|NCT00549939|3633586|FG000|COMPLETED|40-week Open Label Treatment Period||0
2922853|NCT00549939|3633587|FG001|COMPLETED|40-week Open Label Treatment Period||75
2922854|NCT00549939|3633588|FG002|COMPLETED|40-week Open Label Treatment Period||78
2922855|NCT00549939|3633586|FG000|NOT COMPLETED|40-week Open Label Treatment Period||0
2922856|NCT00549939|3633587|FG001|NOT COMPLETED|40-week Open Label Treatment Period||5
2922857|NCT00549939|3633588|FG002|NOT COMPLETED|40-week Open Label Treatment Period||5
2922858|NCT00550043|3633603|FG000|STARTED|Overall Study||9
2922859|NCT00550043|3633604|FG001|STARTED|Overall Study||12
2922860|NCT00550043|3633605|FG002|STARTED|Overall Study||9
2922861|NCT00550043|3633606|FG003|STARTED|Overall Study||10
2922862|NCT00550043|3633607|FG004|STARTED|Overall Study||10
2922863|NCT00550043|3633603|FG000|COMPLETED|Overall Study||9
2922864|NCT00550043|3633604|FG001|COMPLETED|Overall Study||9
2922865|NCT00550043|3633605|FG002|COMPLETED|Overall Study||8
3173478|NCT01949389|3901118|FG000|NOT COMPLETED|Overall Study||0
3173479|NCT01949480|3901124|FG000|STARTED|Overall Study||20
3173480|NCT01949480|3901125|FG001|STARTED|Overall Study||22
3173481|NCT01949480|3901124|FG000|COMPLETED|Overall Study||15
3173482|NCT01949480|3901125|FG001|COMPLETED|Overall Study||14
3173483|NCT01949480|3901124|FG000|NOT COMPLETED|Overall Study||5
3173484|NCT01949480|3901125|FG001|NOT COMPLETED|Overall Study||8
3173485|NCT01949532|3901133|FG000|STARTED|Overall Study||15
3173486|NCT01949532|3901134|FG001|STARTED|Overall Study||11
3173487|NCT01949532|3901133|FG000|COMPLETED|Overall Study||12
3173488|NCT01949532|3901134|FG001|COMPLETED|Overall Study||8
3319703|NCT03154086|4053107|FG005|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
3319704|NCT03154086|4053108|FG006|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
3319705|NCT03154086|4053109|FG007|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
3319706|NCT03154086|4053110|FG008|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
3319707|NCT03154086|4053111|FG009|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
3319708|NCT03154086|4053112|FG010|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
3319709|NCT03154086|4053113|FG011|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
3319710|NCT03154086|4053114|FG012|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
2922866|NCT00550043|3633606|FG003|COMPLETED|Overall Study||8
2922867|NCT00550043|3633607|FG004|COMPLETED|Overall Study||9
2922868|NCT00550043|3633603|FG000|NOT COMPLETED|Overall Study||0
2922869|NCT00550043|3633604|FG001|NOT COMPLETED|Overall Study||3
2922870|NCT00550043|3633605|FG002|NOT COMPLETED|Overall Study||1
2922871|NCT00550043|3633606|FG003|NOT COMPLETED|Overall Study||2
2922872|NCT00550043|3633607|FG004|NOT COMPLETED|Overall Study||1
2922873|NCT00550147|3633619|FG000|STARTED|OROS Methylphenidate Monotherapy||30
2922874|NCT00550147|3633619|FG000|COMPLETED|OROS Methylphenidate Monotherapy||24
2922875|NCT00550147|3633619|FG000|NOT COMPLETED|OROS Methylphenidate Monotherapy||6
2922876|NCT00550147|3633619|FG000|STARTED|Quetiapine Addition Treatment Period||24
3038659|NCT01154634|3757991|FG003|COMPLETED|Period 5 - Third Intervention||5
3173489|NCT01949532|3901133|FG000|NOT COMPLETED|Overall Study||3
3173490|NCT01949532|3901134|FG001|NOT COMPLETED|Overall Study||3
3173491|NCT01949545|3901144|FG000|STARTED|Overall Study||11
3173492|NCT01949545|3901145|FG001|STARTED|Overall Study||17
2922877|NCT00550147|3633619|FG000|COMPLETED|Quetiapine Addition Treatment Period||18
2922878|NCT00550147|3633619|FG000|NOT COMPLETED|Quetiapine Addition Treatment Period||6
2922879|NCT00550173|3633635|FG000|STARTED|Overall Study||81
2922880|NCT00550173|3633636|FG001|STARTED|Overall Study||82
2922881|NCT00550173|3633637|FG002|STARTED|Overall Study||84
2922882|NCT00550173|3633635|FG000|Qualified Participants|Overall Study|Participants with tumors of nonsquamous histology|78
2922883|NCT00550173|3633636|FG001|Qualified Participants|Overall Study|Participants with tumors of nonsquamous histology|82
2922884|NCT00550173|3633637|FG002|Qualified Participants|Overall Study|Participants with tumors of nonsquamous histology|80
2922885|NCT00550173|3633635|FG000|Not Discontinued at 18 Months|Overall Study||9
2922886|NCT00550173|3633636|FG001|Not Discontinued at 18 Months|Overall Study||19
2922887|NCT00550173|3633637|FG002|Not Discontinued at 18 Months|Overall Study||11
2922888|NCT00550173|3633635|FG000|COMPLETED|Overall Study||9
2922889|NCT00550173|3633636|FG001|COMPLETED|Overall Study||19
2922890|NCT00550173|3633637|FG002|COMPLETED|Overall Study||11
2922891|NCT00550173|3633635|FG000|NOT COMPLETED|Overall Study||72
2922892|NCT00550173|3633636|FG001|NOT COMPLETED|Overall Study||63
2922893|NCT00550173|3633637|FG002|NOT COMPLETED|Overall Study||73
2922894|NCT00550238|3633646|FG000|STARTED|Overall Study||459
2922895|NCT00550238|3633646|FG000|COMPLETED|Overall Study||0
2922896|NCT00550238|3633646|FG000|NOT COMPLETED|Overall Study||459
2922897|NCT00550277|3633650|FG000|STARTED|Overall Study||20
2922898|NCT00550277|3633650|FG000|COMPLETED|Overall Study||11
2922899|NCT00550277|3633650|FG000|NOT COMPLETED|Overall Study||9
2922900|NCT00550290|3633656|FG000|STARTED|Overall Study||10
2922901|NCT00550290|3633657|FG001|STARTED|Overall Study||8
2922902|NCT00550290|3633656|FG000|COMPLETED|Overall Study||10
2922903|NCT00550290|3633657|FG001|COMPLETED|Overall Study||8
2922904|NCT00550290|3633656|FG000|NOT COMPLETED|Overall Study||0
2922905|NCT00550290|3633657|FG001|NOT COMPLETED|Overall Study||0
2922906|NCT00550368|3633665|FG000|STARTED|Overall Study||26
2922907|NCT00550368|3633666|FG001|STARTED|Overall Study||19
2922908|NCT00550368|3633665|FG000|COMPLETED|Overall Study||26
2922909|NCT00550368|3633666|FG001|COMPLETED|Overall Study||19
2922910|NCT00550368|3633665|FG000|NOT COMPLETED|Overall Study||0
2922911|NCT00550368|3633666|FG001|NOT COMPLETED|Overall Study||0
2922912|NCT00550394|3633674|FG000|STARTED|Overall Study||21
2922913|NCT00550394|3633675|FG001|STARTED|Overall Study||18
2922914|NCT00550394|3633674|FG000|COMPLETED|Overall Study||9
2922915|NCT00550394|3633675|FG001|COMPLETED|Overall Study||5
2922916|NCT00550394|3633674|FG000|NOT COMPLETED|Overall Study||12
2922917|NCT00550394|3633675|FG001|NOT COMPLETED|Overall Study||13
2922918|NCT00550407|3633685|FG000|STARTED|8-16 Week Preliminary (Open-Label) Phase||215
2922919|NCT00550407|3633686|FG001|STARTED|8-16 Week Preliminary (Open-Label) Phase||0
2922920|NCT00550407|3633687|FG002|STARTED|8-16 Week Preliminary (Open-Label) Phase||0
2922921|NCT00550407|3633685|FG000|COMPLETED|8-16 Week Preliminary (Open-Label) Phase||103
3038660|NCT01154634|3757988|FG000|NOT COMPLETED|Period 5 - Third Intervention||0
3038661|NCT01154634|3757989|FG001|NOT COMPLETED|Period 5 - Third Intervention||0
3038662|NCT01154634|3757990|FG002|NOT COMPLETED|Period 5 - Third Intervention||0
3038663|NCT01154634|3757991|FG003|NOT COMPLETED|Period 5 - Third Intervention||0
3038664|NCT01154634|3757988|FG000|STARTED|Period 6 - Washout||4
3038665|NCT01154634|3757989|FG001|STARTED|Period 6 - Washout||7
3038666|NCT01154634|3757990|FG002|STARTED|Period 6 - Washout||4
3038667|NCT01154634|3757991|FG003|STARTED|Period 6 - Washout||5
3038668|NCT01154634|3757988|FG000|COMPLETED|Period 6 - Washout||4
3038669|NCT01154634|3757989|FG001|COMPLETED|Period 6 - Washout||7
3038670|NCT01154634|3757990|FG002|COMPLETED|Period 6 - Washout||4
3038671|NCT01154634|3757991|FG003|COMPLETED|Period 6 - Washout||5
3038672|NCT01154634|3757988|FG000|NOT COMPLETED|Period 6 - Washout||0
3038673|NCT01154634|3757989|FG001|NOT COMPLETED|Period 6 - Washout||0
3038674|NCT01154634|3757990|FG002|NOT COMPLETED|Period 6 - Washout||0
3038675|NCT01154634|3757991|FG003|NOT COMPLETED|Period 6 - Washout||0
3038676|NCT01154634|3757988|FG000|STARTED|Period 7 - Fourth Intervention||4
3038677|NCT01154634|3757989|FG001|STARTED|Period 7 - Fourth Intervention||7
3038678|NCT01154634|3757990|FG002|STARTED|Period 7 - Fourth Intervention||4
3038679|NCT01154634|3757991|FG003|STARTED|Period 7 - Fourth Intervention||5
3038680|NCT01154634|3757988|FG000|COMPLETED|Period 7 - Fourth Intervention||4
3038681|NCT01154634|3757989|FG001|COMPLETED|Period 7 - Fourth Intervention||7
3038682|NCT01154634|3757990|FG002|COMPLETED|Period 7 - Fourth Intervention||4
3173493|NCT01949545|3901146|FG002|STARTED|Overall Study||14
3173494|NCT01949545|3901147|FG003|STARTED|Overall Study||4
3173495|NCT01949545|3901144|FG000|COMPLETED|Overall Study||11
2922922|NCT00550407|3633686|FG001|COMPLETED|8-16 Week Preliminary (Open-Label) Phase||0
2922923|NCT00550407|3633687|FG002|COMPLETED|8-16 Week Preliminary (Open-Label) Phase||0
2922924|NCT00550407|3633685|FG000|NOT COMPLETED|8-16 Week Preliminary (Open-Label) Phase||112
2922925|NCT00550407|3633686|FG001|NOT COMPLETED|8-16 Week Preliminary (Open-Label) Phase||0
2922926|NCT00550407|3633687|FG002|NOT COMPLETED|8-16 Week Preliminary (Open-Label) Phase||0
2922927|NCT00550407|3633685|FG000|STARTED|26-Week Randomized Phase||0
2922928|NCT00550407|3633686|FG001|STARTED|26-Week Randomized Phase||58
2922929|NCT00550407|3633687|FG002|STARTED|26-Week Randomized Phase||45
2922930|NCT00550407|3633685|FG000|COMPLETED|26-Week Randomized Phase||0
2922931|NCT00550407|3633686|FG001|COMPLETED|26-Week Randomized Phase||15
2922932|NCT00550407|3633687|FG002|COMPLETED|26-Week Randomized Phase||21
2922933|NCT00550407|3633685|FG000|NOT COMPLETED|26-Week Randomized Phase||0
2922934|NCT00550407|3633686|FG001|NOT COMPLETED|26-Week Randomized Phase||43
2922935|NCT00550407|3633687|FG002|NOT COMPLETED|26-Week Randomized Phase||24
2922936|NCT00550420|3633695|FG000|STARTED|Overall Study||331
2922937|NCT00550420|3633695|FG000|COMPLETED|Overall Study||26
2922938|NCT00550420|3633695|FG000|NOT COMPLETED|Overall Study||305
2922939|NCT00550446|3633708|FG000|STARTED|Up To Week 12||54
2922940|NCT00550446|3633709|FG001|STARTED|Up To Week 12||52
2922941|NCT00550446|3633710|FG002|STARTED|Up To Week 12||50
2922942|NCT00550446|3633711|FG003|STARTED|Up To Week 12||61
2922943|NCT00550446|3633712|FG004|STARTED|Up To Week 12||57
2922944|NCT00550446|3633713|FG005|STARTED|Up To Week 12||53
2922945|NCT00550446|3633714|FG006|STARTED|Up To Week 12||59
2922946|NCT00550446|3633715|FG007|STARTED|Up To Week 12||0
2922947|NCT00550446|3633716|FG008|STARTED|Up To Week 12||0
2922948|NCT00550446|3633717|FG009|STARTED|Up To Week 12||0
2922949|NCT00550446|3633718|FG010|STARTED|Up To Week 12||0
2922950|NCT00550446|3633708|FG000|Treated|Up To Week 12||54
2922951|NCT00550446|3633709|FG001|Treated|Up To Week 12||51
2922952|NCT00550446|3633710|FG002|Treated|Up To Week 12||49
2922953|NCT00550446|3633711|FG003|Treated|Up To Week 12||61
2922954|NCT00550446|3633712|FG004|Treated|Up To Week 12||57
2922955|NCT00550446|3633713|FG005|Treated|Up To Week 12||53
2922956|NCT00550446|3633714|FG006|Treated|Up To Week 12||59
2922957|NCT00550446|3633715|FG007|Treated|Up To Week 12||0
2922958|NCT00550446|3633716|FG008|Treated|Up To Week 12||0
2922959|NCT00550446|3633717|FG009|Treated|Up To Week 12||0
2922960|NCT00550446|3633718|FG010|Treated|Up To Week 12||0
2922961|NCT00550446|3633708|FG000|COMPLETED|Up To Week 12||44
2922962|NCT00550446|3633709|FG001|COMPLETED|Up To Week 12||47
2922963|NCT00550446|3633710|FG002|COMPLETED|Up To Week 12||46
2922964|NCT00550446|3633711|FG003|COMPLETED|Up To Week 12||58
2922965|NCT00550446|3633712|FG004|COMPLETED|Up To Week 12||54
2922966|NCT00550446|3633713|FG005|COMPLETED|Up To Week 12||45
2922967|NCT00550446|3633714|FG006|COMPLETED|Up To Week 12||46
2922968|NCT00550446|3633715|FG007|COMPLETED|Up To Week 12||0
2922969|NCT00550446|3633716|FG008|COMPLETED|Up To Week 12||0
2922970|NCT00550446|3633717|FG009|COMPLETED|Up To Week 12||0
2922971|NCT00550446|3633718|FG010|COMPLETED|Up To Week 12||0
2922972|NCT00550446|3633708|FG000|NOT COMPLETED|Up To Week 12||10
2922973|NCT00550446|3633709|FG001|NOT COMPLETED|Up To Week 12||5
2922974|NCT00550446|3633710|FG002|NOT COMPLETED|Up To Week 12||4
3173496|NCT01949545|3901145|FG001|COMPLETED|Overall Study||17
3319711|NCT03154086|4053115|FG013|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
3319712|NCT03154086|4053116|FG014|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
3319713|NCT03154086|4053102|FG000|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
3319714|NCT03154086|4053103|FG001|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
3319715|NCT03154086|4053104|FG002|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
3319716|NCT03154086|4053105|FG003|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||1
3319717|NCT03154086|4053106|FG004|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
3319718|NCT03154086|4053107|FG005|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
3319719|NCT03154086|4053108|FG006|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
3319720|NCT03154086|4053109|FG007|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
3319721|NCT03154086|4053110|FG008|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
3319722|NCT03154086|4053111|FG009|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
3319723|NCT03154086|4053112|FG010|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
3319724|NCT03154086|4053113|FG011|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
3319725|NCT03154086|4053114|FG012|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
3319726|NCT03154086|4053115|FG013|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
3319727|NCT03154086|4053116|FG014|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
3319728|NCT03154086|4053102|FG000|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||2
3319729|NCT03154086|4053103|FG001|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||2
3319730|NCT03154086|4053104|FG002|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||2
3319731|NCT03154086|4053105|FG003|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)|One replacement participant (par) was enrolled and dosed|2
3319732|NCT03154086|4053106|FG004|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
3319733|NCT03154086|4053107|FG005|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
3319734|NCT03154086|4053108|FG006|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
3319735|NCT03154086|4053109|FG007|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
3319736|NCT03154086|4053110|FG008|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
3319737|NCT03154086|4053111|FG009|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
3319738|NCT03154086|4053112|FG010|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
3319739|NCT03154086|4053113|FG011|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
3319740|NCT03154086|4053114|FG012|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
3319741|NCT03154086|4053115|FG013|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
3319742|NCT03154086|4053116|FG014|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
3319743|NCT03154086|4053102|FG000|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||2
3319744|NCT03154086|4053103|FG001|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||2
3319745|NCT03154086|4053104|FG002|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||2
3319746|NCT03154086|4053105|FG003|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||2
3319747|NCT03154086|4053106|FG004|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
3319748|NCT03154086|4053107|FG005|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
3319749|NCT03154086|4053108|FG006|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
3319750|NCT03154086|4053109|FG007|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
3319751|NCT03154086|4053110|FG008|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
3319752|NCT03154086|4053111|FG009|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
3319753|NCT03154086|4053112|FG010|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
3319754|NCT03154086|4053113|FG011|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
3319755|NCT03154086|4053114|FG012|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
3319756|NCT03154086|4053115|FG013|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
3319757|NCT03154086|4053116|FG014|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
3319758|NCT03154086|4053102|FG000|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
3319759|NCT03154086|4053103|FG001|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
3319760|NCT03154086|4053104|FG002|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
3319761|NCT03154086|4053105|FG003|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
3319762|NCT03154086|4053106|FG004|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
3319763|NCT03154086|4053107|FG005|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
3319764|NCT03154086|4053108|FG006|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
3319765|NCT03154086|4053109|FG007|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
3319766|NCT03154086|4053110|FG008|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
3319767|NCT03154086|4053111|FG009|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
3319768|NCT03154086|4053112|FG010|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
3319769|NCT03154086|4053113|FG011|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
3319770|NCT03154086|4053114|FG012|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
3319771|NCT03154086|4053115|FG013|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
3319772|NCT03154086|4053116|FG014|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
3319773|NCT03154086|4053102|FG000|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||2
3319774|NCT03154086|4053103|FG001|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||2
3173497|NCT01949545|3901146|FG002|COMPLETED|Overall Study||14
3173498|NCT01949545|3901147|FG003|COMPLETED|Overall Study||4
3173499|NCT01949545|3901144|FG000|NOT COMPLETED|Overall Study||0
3173500|NCT01949545|3901145|FG001|NOT COMPLETED|Overall Study||0
3173501|NCT01949545|3901146|FG002|NOT COMPLETED|Overall Study||0
3173502|NCT01949545|3901147|FG003|NOT COMPLETED|Overall Study||0
3173503|NCT01949662|3901159|FG000|STARTED|Overall Study||47
3173504|NCT01949662|3901160|FG001|STARTED|Overall Study||43
3173505|NCT01949662|3901159|FG000|COMPLETED|Overall Study||29
3173506|NCT01949662|3901160|FG001|COMPLETED|Overall Study||29
3173507|NCT01949662|3901159|FG000|NOT COMPLETED|Overall Study||18
3319775|NCT03154086|4053104|FG002|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||2
3319776|NCT03154086|4053105|FG003|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||2
3319777|NCT03154086|4053106|FG004|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
3319778|NCT03154086|4053107|FG005|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
3319779|NCT03154086|4053108|FG006|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
3319780|NCT03154086|4053109|FG007|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
3319781|NCT03154086|4053110|FG008|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
3319782|NCT03154086|4053111|FG009|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
3319783|NCT03154086|4053112|FG010|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
3319784|NCT03154086|4053113|FG011|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
3319785|NCT03154086|4053114|FG012|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
2922975|NCT00550446|3633711|FG003|NOT COMPLETED|Up To Week 12||3
2922976|NCT00550446|3633712|FG004|NOT COMPLETED|Up To Week 12||3
2922977|NCT00550446|3633713|FG005|NOT COMPLETED|Up To Week 12||8
2922978|NCT00550446|3633714|FG006|NOT COMPLETED|Up To Week 12||13
2922979|NCT00550446|3633715|FG007|NOT COMPLETED|Up To Week 12||0
2922980|NCT00550446|3633716|FG008|NOT COMPLETED|Up To Week 12||0
2922981|NCT00550446|3633717|FG009|NOT COMPLETED|Up To Week 12||0
2922982|NCT00550446|3633718|FG010|NOT COMPLETED|Up To Week 12||0
2922983|NCT00550446|3633708|FG000|STARTED|Post Week 12||27
2922984|NCT00550446|3633709|FG001|STARTED|Post Week 12||30
2922985|NCT00550446|3633710|FG002|STARTED|Post Week 12||46
2922986|NCT00550446|3633711|FG003|STARTED|Post Week 12||58
2922987|NCT00550446|3633712|FG004|STARTED|Post Week 12||54
2922988|NCT00550446|3633713|FG005|STARTED|Post Week 12||1
2922989|NCT00550446|3633714|FG006|STARTED|Post Week 12||21
2922990|NCT00550446|3633715|FG007|STARTED|Post Week 12||17
2922991|NCT00550446|3633716|FG008|STARTED|Post Week 12||17
2922992|NCT00550446|3633717|FG009|STARTED|Post Week 12||44
2922993|NCT00550446|3633718|FG010|STARTED|Post Week 12||25
2922994|NCT00550446|3633708|FG000|COMPLETED|Post Week 12||24
2922995|NCT00550446|3633709|FG001|COMPLETED|Post Week 12||28
2922996|NCT00550446|3633710|FG002|COMPLETED|Post Week 12||43
2922997|NCT00550446|3633711|FG003|COMPLETED|Post Week 12||55
2922998|NCT00550446|3633712|FG004|COMPLETED|Post Week 12||52
2922999|NCT00550446|3633713|FG005|COMPLETED|Post Week 12||0
2923000|NCT00550446|3633714|FG006|COMPLETED|Post Week 12||19
2923001|NCT00550446|3633715|FG007|COMPLETED|Post Week 12||16
2923002|NCT00550446|3633716|FG008|COMPLETED|Post Week 12||15
2923003|NCT00550446|3633717|FG009|COMPLETED|Post Week 12||37
2923004|NCT00550446|3633718|FG010|COMPLETED|Post Week 12||24
2923005|NCT00550446|3633708|FG000|NOT COMPLETED|Post Week 12||3
2923006|NCT00550446|3633709|FG001|NOT COMPLETED|Post Week 12||2
2923007|NCT00550446|3633710|FG002|NOT COMPLETED|Post Week 12||3
2923008|NCT00550446|3633711|FG003|NOT COMPLETED|Post Week 12||3
2923009|NCT00550446|3633712|FG004|NOT COMPLETED|Post Week 12||2
2923010|NCT00550446|3633713|FG005|NOT COMPLETED|Post Week 12||1
2923011|NCT00550446|3633714|FG006|NOT COMPLETED|Post Week 12||2
2923012|NCT00550446|3633715|FG007|NOT COMPLETED|Post Week 12||1
2923013|NCT00550446|3633716|FG008|NOT COMPLETED|Post Week 12||2
2923014|NCT00550446|3633717|FG009|NOT COMPLETED|Post Week 12||7
2923015|NCT00550446|3633718|FG010|NOT COMPLETED|Post Week 12||1
2923016|NCT00550459|3633758|FG000|STARTED|Overall Study||28
2923017|NCT00550459|3633759|FG001|STARTED|Overall Study||29
3173508|NCT01949662|3901160|FG001|NOT COMPLETED|Overall Study||14
3173509|NCT01949779|3901166|FG000|STARTED|Overall Study||81
3173510|NCT01949779|3901166|FG000|COMPLETED|Overall Study||79
3173511|NCT01949779|3901166|FG000|NOT COMPLETED|Overall Study||2
3173512|NCT01949844|3901170|FG000|STARTED|Overall Study||44
2923018|NCT00550459|3633758|FG000|COMPLETED|Overall Study||27
2923019|NCT00550459|3633759|FG001|COMPLETED|Overall Study||26
2923020|NCT00550459|3633758|FG000|NOT COMPLETED|Overall Study||1
2923021|NCT00550459|3633759|FG001|NOT COMPLETED|Overall Study||3
2923022|NCT00550537|3633765|FG000|STARTED|Overall Study||116
2923023|NCT00550537|3633765|FG000|COMPLETED|Overall Study||12
2923024|NCT00550537|3633765|FG000|NOT COMPLETED|Overall Study||104
2923025|NCT00550550|3633776|FG000|STARTED|Overall Study||176
2923026|NCT00550550|3633777|FG001|STARTED|Overall Study||169
2923027|NCT00550550|3633776|FG000|Number Treated|Overall Study||175
2923028|NCT00550550|3633777|FG001|Number Treated|Overall Study||169
2923029|NCT00550550|3633776|FG000|COMPLETED|Overall Study||142
2923030|NCT00550550|3633777|FG001|COMPLETED|Overall Study||140
2923031|NCT00550550|3633776|FG000|NOT COMPLETED|Overall Study||34
2923032|NCT00550550|3633777|FG001|NOT COMPLETED|Overall Study||29
2923033|NCT00550589|3633783|FG000|STARTED|Overall Study||33
2923034|NCT00550589|3633783|FG000|COMPLETED|Overall Study||33
3173513|NCT01949844|3901170|FG000|COMPLETED|Overall Study||44
3173514|NCT01949844|3901170|FG000|NOT COMPLETED|Overall Study||0
3173515|NCT01949870|3901174|FG000|STARTED|Overall Study||6
3319786|NCT03154086|4053115|FG013|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
3319787|NCT03154086|4053116|FG014|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
3319788|NCT03154086|4053102|FG000|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||2
3319789|NCT03154086|4053103|FG001|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||1
3319790|NCT03154086|4053104|FG002|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||2
3319791|NCT03154086|4053105|FG003|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||2
3319792|NCT03154086|4053106|FG004|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
3319793|NCT03154086|4053107|FG005|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
3319794|NCT03154086|4053108|FG006|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
2923035|NCT00550589|3633783|FG000|NOT COMPLETED|Overall Study||0
2923036|NCT00550615|3633791|FG000|STARTED|Overall Study||3
2923037|NCT00550615|3633792|FG001|STARTED|Overall Study||3
2923038|NCT00550615|3633793|FG002|STARTED|Overall Study||10
2923039|NCT00550615|3633794|FG003|STARTED|Overall Study||22
2923040|NCT00550615|3633791|FG000|COMPLETED|Overall Study||3
2923041|NCT00550615|3633792|FG001|COMPLETED|Overall Study||3
2923042|NCT00550615|3633793|FG002|COMPLETED|Overall Study||6
2923043|NCT00550615|3633794|FG003|COMPLETED|Overall Study||12
2923044|NCT00550615|3633791|FG000|NOT COMPLETED|Overall Study||0
2923045|NCT00550615|3633792|FG001|NOT COMPLETED|Overall Study||0
2923046|NCT00550615|3633793|FG002|NOT COMPLETED|Overall Study||4
2923047|NCT00550615|3633794|FG003|NOT COMPLETED|Overall Study||10
2923048|NCT00550654|3633800|FG000|STARTED|Overall Study||1
2923049|NCT00550654|3633800|FG000|COMPLETED|Overall Study||1
2923050|NCT00550654|3633800|FG000|NOT COMPLETED|Overall Study||0
2923051|NCT00550680|3633804|FG000|STARTED|Overall Study||208
2923052|NCT00550680|3633804|FG000|COMPLETED|Overall Study||152
2923053|NCT00550680|3633804|FG000|NOT COMPLETED|Overall Study||56
2923054|NCT00550732|3633808|FG000|STARTED|Overall Study||40
2923055|NCT00550732|3633808|FG000|COMPLETED|Overall Study||29
2923056|NCT00550732|3633808|FG000|NOT COMPLETED|Overall Study||11
2923057|NCT00550745|3633815|FG000|STARTED|Overall Study||6000
2923058|NCT00550745|3633816|FG001|STARTED|Overall Study||5999
2923059|NCT00550745|3633815|FG000|COMPLETED|Overall Study||5913
2923060|NCT00550745|3633816|FG001|COMPLETED|Overall Study||5939
2923061|NCT00550745|3633815|FG000|NOT COMPLETED|Overall Study||87
2923062|NCT00550745|3633816|FG001|NOT COMPLETED|Overall Study||60
2923063|NCT00550771|3633824|FG000|STARTED|Overall Study||121
2923064|NCT00550771|3633825|FG001|STARTED|Overall Study||60
2923065|NCT00550771|3633824|FG000|COMPLETED|Overall Study||104
2923066|NCT00550771|3633825|FG001|COMPLETED|Overall Study||50
2923067|NCT00550771|3633824|FG000|NOT COMPLETED|Overall Study||17
2923068|NCT00550771|3633825|FG001|NOT COMPLETED|Overall Study||10
2923069|NCT00550836|3633833|FG000|STARTED|Overall Study||49
2923070|NCT00550836|3633834|FG001|STARTED|Overall Study||55
2923071|NCT00550836|3633833|FG000|COMPLETED|Overall Study||46
2923072|NCT00550836|3633834|FG001|COMPLETED|Overall Study||46
2923073|NCT00550836|3633833|FG000|NOT COMPLETED|Overall Study||3
2923074|NCT00550836|3633834|FG001|NOT COMPLETED|Overall Study||9
2923075|NCT00550862|3633844|FG000|STARTED|Overall Study||38
2923076|NCT00550862|3633845|FG001|STARTED|Overall Study||48
2923077|NCT00550862|3633846|FG002|STARTED|Overall Study||41
2923078|NCT00550862|3633847|FG003|STARTED|Overall Study||38
3173516|NCT01949870|3901174|FG000|Received Treatment|Overall Study||4
3173517|NCT01949870|3901174|FG000|COMPLETED|Overall Study||0
3173518|NCT01949870|3901174|FG000|NOT COMPLETED|Overall Study||6
3173519|NCT01950013|3901181|FG000|STARTED|Overall Study||15
3173520|NCT01950013|3901182|FG001|STARTED|Overall Study||15
2923079|NCT00550862|3633844|FG000|COMPLETED|Overall Study||32
2923080|NCT00550862|3633845|FG001|COMPLETED|Overall Study||42
2923081|NCT00550862|3633846|FG002|COMPLETED|Overall Study||25
2923082|NCT00550862|3633847|FG003|COMPLETED|Overall Study||37
2923083|NCT00550862|3633844|FG000|NOT COMPLETED|Overall Study||6
2923084|NCT00550862|3633845|FG001|NOT COMPLETED|Overall Study||6
2923085|NCT00550862|3633846|FG002|NOT COMPLETED|Overall Study||16
2923086|NCT00550862|3633847|FG003|NOT COMPLETED|Overall Study||1
3038683|NCT01154634|3757991|FG003|COMPLETED|Period 7 - Fourth Intervention||5
3038684|NCT01154634|3757988|FG000|NOT COMPLETED|Period 7 - Fourth Intervention||0
3038685|NCT01154634|3757989|FG001|NOT COMPLETED|Period 7 - Fourth Intervention||0
3038686|NCT01154634|3757990|FG002|NOT COMPLETED|Period 7 - Fourth Intervention||0
3038687|NCT01154634|3757991|FG003|NOT COMPLETED|Period 7 - Fourth Intervention||0
3038688|NCT01154673|3758003|FG000|STARTED|Overall Study||16
3038689|NCT01154673|3758004|FG001|STARTED|Overall Study||16
3038690|NCT01154673|3758003|FG000|COMPLETED|Overall Study||14
3038691|NCT01154673|3758004|FG001|COMPLETED|Overall Study||16
3038692|NCT01154673|3758003|FG000|NOT COMPLETED|Overall Study||2
3038693|NCT01154673|3758004|FG001|NOT COMPLETED|Overall Study||0
3038694|NCT01154699|3758012|FG000|STARTED|First Intervention (4 Weeks)||13
3038695|NCT01154699|3758013|FG001|STARTED|First Intervention (4 Weeks)||8
3038696|NCT01154699|3758012|FG000|Subjects With Asthma Only|First Intervention (4 Weeks)||7
3038697|NCT01154699|3758013|FG001|Subjects With Asthma Only|First Intervention (4 Weeks)||6
2923087|NCT00550953|3633859|FG000|STARTED|Overall Study||156
2923088|NCT00550953|3633860|FG001|STARTED|Overall Study||158
2923089|NCT00550953|3633859|FG000|COMPLETED|Overall Study||150
2923090|NCT00550953|3633860|FG001|COMPLETED|Overall Study||152
2923091|NCT00550953|3633859|FG000|NOT COMPLETED|Overall Study||6
3173521|NCT01950013|3901183|FG002|STARTED|Overall Study||15
3173522|NCT01950013|3901181|FG000|COMPLETED|Overall Study||15
3173523|NCT01950013|3901182|FG001|COMPLETED|Overall Study||13
3173524|NCT01950013|3901183|FG002|COMPLETED|Overall Study||15
3173525|NCT01950013|3901181|FG000|NOT COMPLETED|Overall Study||0
3173526|NCT01950013|3901182|FG001|NOT COMPLETED|Overall Study||2
3173527|NCT01950013|3901183|FG002|NOT COMPLETED|Overall Study||0
3173528|NCT01950039|3901193|FG000|STARTED|Overall Study||15
3173529|NCT01950039|3901194|FG001|STARTED|Overall Study||13
2923092|NCT00550953|3633860|FG001|NOT COMPLETED|Overall Study||6
2923093|NCT00551031|3633871|FG000|STARTED|Overall Study||637
2923094|NCT00551031|3633872|FG001|STARTED|Overall Study||636
2923095|NCT00551031|3633873|FG002|STARTED|Overall Study||319
2923096|NCT00551031|3633874|FG003|STARTED|Overall Study||320
2923097|NCT00551031|3633875|FG004|STARTED|Overall Study||186
2923098|NCT00551031|3633871|FG000|COMPLETED|Overall Study||635
2923099|NCT00551031|3633872|FG001|COMPLETED|Overall Study||625
2923100|NCT00551031|3633873|FG002|COMPLETED|Overall Study||317
3136938|NCT01716455|3862262|FG004|STARTED|Overall Study||26
3136939|NCT01716455|3862263|FG005|STARTED|Overall Study||8
3136940|NCT01716455|3862258|FG000|COMPLETED|Overall Study||8
3136941|NCT01716455|3862259|FG001|COMPLETED|Overall Study||8
3136942|NCT01716455|3862260|FG002|COMPLETED|Overall Study||8
3136943|NCT01716455|3862261|FG003|COMPLETED|Overall Study||8
3136944|NCT01716455|3862262|FG004|COMPLETED|Overall Study||26
3136945|NCT01716455|3862263|FG005|COMPLETED|Overall Study||8
3136946|NCT01716455|3862258|FG000|NOT COMPLETED|Overall Study||0
3136947|NCT01716455|3862259|FG001|NOT COMPLETED|Overall Study||0
3136948|NCT01716455|3862260|FG002|NOT COMPLETED|Overall Study||0
3136949|NCT01716455|3862261|FG003|NOT COMPLETED|Overall Study||0
3136950|NCT01716455|3862262|FG004|NOT COMPLETED|Overall Study||0
2923101|NCT00551031|3633874|FG003|COMPLETED|Overall Study||317
2923102|NCT00551031|3633875|FG004|COMPLETED|Overall Study||185
2923103|NCT00551031|3633871|FG000|NOT COMPLETED|Overall Study||2
2923104|NCT00551031|3633872|FG001|NOT COMPLETED|Overall Study||11
2923105|NCT00551031|3633873|FG002|NOT COMPLETED|Overall Study||2
2923106|NCT00551031|3633874|FG003|NOT COMPLETED|Overall Study||3
2923107|NCT00551031|3633875|FG004|NOT COMPLETED|Overall Study||1
2923108|NCT00551070|3633887|FG000|STARTED|Overall Study||52
2923109|NCT00551070|3633887|FG000|COMPLETED|Overall Study||52
2923110|NCT00551070|3633887|FG000|NOT COMPLETED|Overall Study||0
2923111|NCT00551135|3633895|FG000|STARTED|Overall Study||108
2923112|NCT00551135|3633896|FG001|STARTED|Overall Study||106
2923113|NCT00551135|3633897|FG002|STARTED|Overall Study||103
2923114|NCT00551135|3633898|FG003|STARTED|Overall Study||108
2923115|NCT00551135|3633895|FG000|COMPLETED|Overall Study||103
2923116|NCT00551135|3633896|FG001|COMPLETED|Overall Study||104
2923117|NCT00551135|3633897|FG002|COMPLETED|Overall Study||98
2923118|NCT00551135|3633898|FG003|COMPLETED|Overall Study||103
2923119|NCT00551135|3633895|FG000|NOT COMPLETED|Overall Study||5
2923120|NCT00551135|3633896|FG001|NOT COMPLETED|Overall Study||2
2923121|NCT00551135|3633897|FG002|NOT COMPLETED|Overall Study||5
2923122|NCT00551135|3633898|FG003|NOT COMPLETED|Overall Study||5
2923123|NCT00551161|3633908|FG000|STARTED|Overall Study||12
2923124|NCT00551161|3633908|FG000|COMPLETED|Overall Study||11
2923125|NCT00551161|3633908|FG000|NOT COMPLETED|Overall Study||1
2923126|NCT00551174|3633914|FG000|STARTED|Overall Study||381
2923127|NCT00551174|3633915|FG001|STARTED|Overall Study||400
2923128|NCT00551174|3633914|FG000|COMPLETED|Overall Study|Intent-to-Treat (ITT) Population|362
2923129|NCT00551174|3633915|FG001|COMPLETED|Overall Study|Intent-to-Treat (ITT) Population|394
2923130|NCT00551174|3633914|FG000|NOT COMPLETED|Overall Study||19
2923131|NCT00551174|3633915|FG001|NOT COMPLETED|Overall Study||6
2923132|NCT00551200|3633921|FG000|STARTED|Overall Study||14
2923133|NCT00551200|3633921|FG000|COMPLETED|Overall Study||10
2923134|NCT00551200|3633921|FG000|NOT COMPLETED|Overall Study||4
2923135|NCT00551213|3633933|FG000|STARTED|Overall Study||50
3173530|NCT01950039|3901193|FG000|Study Drug Initiated|Overall Study||14
3173531|NCT01950039|3901194|FG001|Study Drug Initiated|Overall Study||13
2923136|NCT00551213|3633934|FG001|STARTED|Overall Study||17
2923137|NCT00551213|3633933|FG000|Treated|Overall Study||49
2923138|NCT00551213|3633934|FG001|Treated|Overall Study||15
2923139|NCT00551213|3633933|FG000|COMPLETED|Overall Study||0
2923140|NCT00551213|3633934|FG001|COMPLETED|Overall Study||0
2923141|NCT00551213|3633933|FG000|NOT COMPLETED|Overall Study||50
2923142|NCT00551213|3633934|FG001|NOT COMPLETED|Overall Study||17
2923143|NCT00551291|3633940|FG000|STARTED|Overall Study||10
2923144|NCT00551291|3633940|FG000|COMPLETED|Overall Study||9
2923145|NCT00551291|3633940|FG000|NOT COMPLETED|Overall Study||1
2923146|NCT00551369|3633944|FG000|STARTED|Overall Study||33
2923147|NCT00551369|3633944|FG000|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study|26
2923148|NCT00551369|3633944|FG000|NOT COMPLETED|Overall Study||7
3173532|NCT01950039|3901193|FG000|Completed Clamp|Overall Study||13
3173533|NCT01950039|3901194|FG001|Completed Clamp|Overall Study||12
3173534|NCT01950039|3901193|FG000|Completed MRI|Overall Study||13
3173535|NCT01950039|3901194|FG001|Completed MRI|Overall Study||12
3173536|NCT01950039|3901193|FG000|Completed Endothelial Evaluation|Overall Study||14
3038698|NCT01154699|3758012|FG000|Subjects With Asthma + OSA|First Intervention (4 Weeks)||6
3038699|NCT01154699|3758013|FG001|Subjects With Asthma + OSA|First Intervention (4 Weeks)||2
3038700|NCT01154699|3758012|FG000|COMPLETED|First Intervention (4 Weeks)||13
3038701|NCT01154699|3758013|FG001|COMPLETED|First Intervention (4 Weeks)||8
3038702|NCT01154699|3758012|FG000|NOT COMPLETED|First Intervention (4 Weeks)||0
3173537|NCT01950039|3901194|FG001|Completed Endothelial Evaluation|Overall Study||12
3173538|NCT01950039|3901193|FG000|COMPLETED|Overall Study||14
3173539|NCT01950039|3901194|FG001|COMPLETED|Overall Study||13
3173540|NCT01950039|3901193|FG000|NOT COMPLETED|Overall Study||1
3173541|NCT01950039|3901194|FG001|NOT COMPLETED|Overall Study||0
3173542|NCT01950078|3901202|FG000|STARTED|Overall Study||1025
3173543|NCT01950078|3901203|FG001|STARTED|Overall Study||508
3173544|NCT01950078|3901202|FG000|COMPLETED|Overall Study||1005
3173545|NCT01950078|3901203|FG001|COMPLETED|Overall Study||496
2923149|NCT00551421|3633948|FG000|STARTED|Original Protocol, Dose Level 1||3
2923150|NCT00551421|3633948|FG000|COMPLETED|Original Protocol, Dose Level 1|1 subject developed Grade 3 diarrhea, all 3 subjects experienced significant skin toxicity.|3
2923151|NCT00551421|3633948|FG000|NOT COMPLETED|Original Protocol, Dose Level 1||0
2923152|NCT00551421|3633948|FG000|STARTED|Amended Protocol (Cetuximab-refr. mCRC)||14
2923153|NCT00551421|3633948|FG000|COMPLETED|Amended Protocol (Cetuximab-refr. mCRC)||13
2923154|NCT00551421|3633948|FG000|NOT COMPLETED|Amended Protocol (Cetuximab-refr. mCRC)||1
2923155|NCT00551460|3633953|FG000|STARTED|Overall Study||78
2923156|NCT00551460|3633953|FG000|COMPLETED|Overall Study||60
2923157|NCT00551460|3633953|FG000|NOT COMPLETED|Overall Study||18
2923158|NCT00551525|3633957|FG000|STARTED|Overall Study||67
2923159|NCT00551525|3633957|FG000|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study|62
2923160|NCT00551525|3633957|FG000|NOT COMPLETED|Overall Study||5
2923161|NCT00551642|3633963|FG000|STARTED|Treatment Period||399
2923162|NCT00551642|3633964|FG001|STARTED|Treatment Period||401
2923163|NCT00551642|3633963|FG000|Safety Population|Treatment Period||395
2923164|NCT00551642|3633964|FG001|Safety Population|Treatment Period||397
2923165|NCT00551642|3633963|FG000|COMPLETED|Treatment Period||338
2923166|NCT00551642|3633964|FG001|COMPLETED|Treatment Period||338
2923167|NCT00551642|3633963|FG000|NOT COMPLETED|Treatment Period||61
2923168|NCT00551642|3633964|FG001|NOT COMPLETED|Treatment Period||63
2923169|NCT00551642|3633963|FG000|STARTED|7-Year Follow-up||152
2923170|NCT00551642|3633964|FG001|STARTED|7-Year Follow-up||153
2923171|NCT00551642|3633963|FG000|COMPLETED|7-Year Follow-up||152
2923172|NCT00551642|3633964|FG001|COMPLETED|7-Year Follow-up||153
2923173|NCT00551642|3633963|FG000|NOT COMPLETED|7-Year Follow-up||0
2923174|NCT00551642|3633964|FG001|NOT COMPLETED|7-Year Follow-up||0
2923175|NCT00551707|3633975|FG000|STARTED|Overall Study||4
3173546|NCT01950078|3901202|FG000|NOT COMPLETED|Overall Study||20
3173547|NCT01950078|3901203|FG001|NOT COMPLETED|Overall Study||12
3173548|NCT01950169|3901212|FG000|STARTED|Overall Study||28
3173549|NCT01950169|3901213|FG001|STARTED|Overall Study||26
3173550|NCT01950169|3901214|FG002|STARTED|Overall Study||25
3173551|NCT01950169|3901212|FG000|COMPLETED|Overall Study||25
3173552|NCT01950169|3901213|FG001|COMPLETED|Overall Study||18
3173553|NCT01950169|3901214|FG002|COMPLETED|Overall Study||24
3173554|NCT01950169|3901212|FG000|NOT COMPLETED|Overall Study||3
3173555|NCT01950169|3901213|FG001|NOT COMPLETED|Overall Study||8
2923176|NCT00551707|3633976|FG001|STARTED|Overall Study||22
2923177|NCT00551707|3633977|FG002|STARTED|Overall Study||13
2923178|NCT00551707|3633978|FG003|STARTED|Overall Study||8
2923179|NCT00551707|3633979|FG004|STARTED|Overall Study||4
2923180|NCT00551707|3633975|FG000|COMPLETED|Overall Study||4
2923181|NCT00551707|3633976|FG001|COMPLETED|Overall Study||16
2923182|NCT00551707|3633977|FG002|COMPLETED|Overall Study||10
2923183|NCT00551707|3633978|FG003|COMPLETED|Overall Study||4
2923184|NCT00551707|3633979|FG004|COMPLETED|Overall Study||3
2923185|NCT00551707|3633975|FG000|NOT COMPLETED|Overall Study||0
2923186|NCT00551707|3633976|FG001|NOT COMPLETED|Overall Study||6
2923187|NCT00551707|3633977|FG002|NOT COMPLETED|Overall Study||3
2923188|NCT00551707|3633978|FG003|NOT COMPLETED|Overall Study||4
3173556|NCT01950169|3901214|FG002|NOT COMPLETED|Overall Study||1
3173557|NCT01950260|3901225|FG000|STARTED|Overall Study||30
2923189|NCT00551707|3633979|FG004|NOT COMPLETED|Overall Study||1
2923190|NCT00551746|3633995|FG000|STARTED|Overall Study||36
2923191|NCT00551746|3633996|FG001|STARTED|Overall Study||34
3173558|NCT01950260|3901226|FG001|STARTED|Overall Study||31
3173559|NCT01950260|3901225|FG000|COMPLETED|Overall Study||30
3173560|NCT01950260|3901226|FG001|COMPLETED|Overall Study||31
3173561|NCT01950260|3901225|FG000|NOT COMPLETED|Overall Study||0
3173562|NCT01950260|3901226|FG001|NOT COMPLETED|Overall Study||0
3173563|NCT01950273|3901234|FG000|STARTED|Overall Study||49
3173564|NCT01950273|3901235|FG001|STARTED|Overall Study||46
3173565|NCT01950273|3901234|FG000|COMPLETED|Overall Study||45
3173566|NCT01950273|3901235|FG001|COMPLETED|Overall Study||46
3173567|NCT01950273|3901234|FG000|NOT COMPLETED|Overall Study||4
3173568|NCT01950273|3901235|FG001|NOT COMPLETED|Overall Study||0
3173569|NCT01950299|3901244|FG000|STARTED|Overall Study||33
3173570|NCT01950299|3901245|FG001|STARTED|Overall Study||31
3173571|NCT01950299|3901246|FG002|STARTED|Overall Study||35
3173572|NCT01950299|3901244|FG000|COMPLETED|Overall Study||22
3173573|NCT01950299|3901245|FG001|COMPLETED|Overall Study||27
3173574|NCT01950299|3901246|FG002|COMPLETED|Overall Study||28
3173575|NCT01950299|3901244|FG000|NOT COMPLETED|Overall Study||11
3173576|NCT01950299|3901245|FG001|NOT COMPLETED|Overall Study||4
3173577|NCT01950299|3901246|FG002|NOT COMPLETED|Overall Study||7
3173578|NCT01950364|3901256|FG000|STARTED|Overall Study||10
3173579|NCT01950364|3901257|FG001|STARTED|Overall Study||10
3173580|NCT01950364|3901256|FG000|COMPLETED|Overall Study||0
3173581|NCT01950364|3901257|FG001|COMPLETED|Overall Study||0
3173582|NCT01950364|3901256|FG000|NOT COMPLETED|Overall Study||10
3173583|NCT01950364|3901257|FG001|NOT COMPLETED|Overall Study||10
3173584|NCT01950663|3901263|FG000|STARTED|Overall Study||468
3173585|NCT01950663|3901263|FG000|COMPLETED|Overall Study||467
3173586|NCT01950663|3901263|FG000|NOT COMPLETED|Overall Study||1
3319795|NCT03154086|4053109|FG007|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
3319796|NCT03154086|4053110|FG008|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
3319797|NCT03154086|4053111|FG009|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
3319798|NCT03154086|4053112|FG010|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
3319799|NCT03154086|4053113|FG011|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
3319800|NCT03154086|4053114|FG012|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
3319801|NCT03154086|4053115|FG013|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
3319802|NCT03154086|4053116|FG014|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
3319803|NCT03154086|4053102|FG000|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
3319804|NCT03154086|4053103|FG001|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||1
3173587|NCT01950741|3901267|FG000|STARTED|Overall Study||48
3173588|NCT01950741|3901267|FG000|COMPLETED|Overall Study||45
3173589|NCT01950741|3901267|FG000|NOT COMPLETED|Overall Study||3
3319805|NCT03154086|4053104|FG002|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
3319806|NCT03154086|4053105|FG003|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
3319807|NCT03154086|4053106|FG004|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
3319808|NCT03154086|4053107|FG005|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
3319809|NCT03154086|4053108|FG006|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
3319810|NCT03154086|4053109|FG007|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
3319811|NCT03154086|4053110|FG008|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
3319812|NCT03154086|4053111|FG009|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
3319813|NCT03154086|4053112|FG010|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
2923192|NCT00551746|3633995|FG000|COMPLETED|Overall Study||25
2923193|NCT00551746|3633996|FG001|COMPLETED|Overall Study||26
2923194|NCT00551746|3633995|FG000|NOT COMPLETED|Overall Study||11
2923195|NCT00551746|3633996|FG001|NOT COMPLETED|Overall Study||8
2923196|NCT00551759|3634002|FG000|STARTED|Overall Study||22
2923197|NCT00551759|3634002|FG000|Eligible and Began Treatment|Overall Study||21
2923198|NCT00551759|3634002|FG000|Underwent Surgery|Overall Study||17
2923199|NCT00551759|3634002|FG000|Received Adjuvant Therapy|Overall Study||12
2923200|NCT00551759|3634002|FG000|COMPLETED|Overall Study||9
2923201|NCT00551759|3634002|FG000|NOT COMPLETED|Overall Study||13
2923202|NCT00552058|3634008|FG000|STARTED|Overall Study||223
2923203|NCT00552058|3634009|FG001|STARTED|Overall Study||216
2923204|NCT00552058|3634008|FG000|COMPLETED|Overall Study||207
2923205|NCT00552058|3634009|FG001|COMPLETED|Overall Study||192
2923206|NCT00552058|3634008|FG000|NOT COMPLETED|Overall Study||16
2923207|NCT00552058|3634009|FG001|NOT COMPLETED|Overall Study||24
2923208|NCT00552071|3634017|FG000|STARTED|Overall Study||10
2923209|NCT00552071|3634018|FG001|STARTED|Overall Study||11
2923210|NCT00552071|3634017|FG000|COMPLETED|Overall Study||6
2923211|NCT00552071|3634018|FG001|COMPLETED|Overall Study||9
2923212|NCT00552071|3634017|FG000|NOT COMPLETED|Overall Study||4
2923213|NCT00552071|3634018|FG001|NOT COMPLETED|Overall Study||2
2923214|NCT00552084|3634028|FG000|STARTED|Overall Study||126
2923215|NCT00552084|3634029|FG001|STARTED|Overall Study||64
2923216|NCT00552084|3634028|FG000|COMPLETED|Overall Study||118
2923217|NCT00552084|3634029|FG001|COMPLETED|Overall Study||55
2923218|NCT00552084|3634028|FG000|NOT COMPLETED|Overall Study||8
2923219|NCT00552084|3634029|FG001|NOT COMPLETED|Overall Study||9
2923220|NCT00552110|3634040|FG000|STARTED|Overall Study|One subject was excluded from the intent to treat population because there was no record of dosing.|146
2923221|NCT00552110|3634041|FG001|STARTED|Overall Study||139
2923222|NCT00552110|3634042|FG002|STARTED|Overall Study||139
2923223|NCT00552110|3634043|FG003|STARTED|Overall Study|One subject was excluded from the intent to treat population because there was no record of dosing.|141
2923224|NCT00552110|3634044|FG004|STARTED|Overall Study||142
2923225|NCT00552110|3634040|FG000|COMPLETED|Overall Study||142
2923226|NCT00552110|3634041|FG001|COMPLETED|Overall Study||134
2923227|NCT00552110|3634042|FG002|COMPLETED|Overall Study||137
2923228|NCT00552110|3634043|FG003|COMPLETED|Overall Study||133
2923229|NCT00552110|3634044|FG004|COMPLETED|Overall Study||133
2923230|NCT00552110|3634040|FG000|NOT COMPLETED|Overall Study||4
2923231|NCT00552110|3634041|FG001|NOT COMPLETED|Overall Study||5
2923232|NCT00552110|3634042|FG002|NOT COMPLETED|Overall Study||2
2923233|NCT00552110|3634043|FG003|NOT COMPLETED|Overall Study||8
2923234|NCT00552110|3634044|FG004|NOT COMPLETED|Overall Study||9
2923235|NCT00552175|3634059|FG000|STARTED|Overall Study||167
2923236|NCT00552175|3634060|FG001|STARTED|Overall Study||86
2923237|NCT00552175|3634061|FG002|STARTED|Overall Study||86
2923238|NCT00552175|3634059|FG000|Full Analysis Set Population|Overall Study||167
2923239|NCT00552175|3634060|FG001|Full Analysis Set Population|Overall Study||85
2923240|NCT00552175|3634061|FG002|Full Analysis Set Population|Overall Study||86
2923241|NCT00552175|3634059|FG000|COMPLETED|Overall Study||150
2923242|NCT00552175|3634060|FG001|COMPLETED|Overall Study||73
2923243|NCT00552175|3634061|FG002|COMPLETED|Overall Study||72
2923244|NCT00552175|3634059|FG000|NOT COMPLETED|Overall Study||17
2923245|NCT00552175|3634060|FG001|NOT COMPLETED|Overall Study||13
2923246|NCT00552175|3634061|FG002|NOT COMPLETED|Overall Study||14
2923247|NCT00552188|3634072|FG000|STARTED|Overall Study||26
2923248|NCT00552188|3634073|FG001|STARTED|Overall Study||26
2923249|NCT00552188|3634072|FG000|COMPLETED|Overall Study||24
2923250|NCT00552188|3634073|FG001|COMPLETED|Overall Study||21
2923251|NCT00552188|3634072|FG000|NOT COMPLETED|Overall Study||2
2923252|NCT00552188|3634073|FG001|NOT COMPLETED|Overall Study||5
2923253|NCT00552240|3634081|FG000|STARTED|Overall Study|Number in Full Analysis Set (FAS)|75
2923254|NCT00552240|3634082|FG001|STARTED|Overall Study|Number in Full Analysis Set (FAS)|77
2923255|NCT00552240|3634081|FG000|COMPLETED|Overall Study||51
2923256|NCT00552240|3634082|FG001|COMPLETED|Overall Study||59
2923257|NCT00552240|3634081|FG000|NOT COMPLETED|Overall Study||24
2923258|NCT00552240|3634082|FG001|NOT COMPLETED|Overall Study||18
2923259|NCT00552279|3634090|FG000|STARTED|Overall Study||403
2923260|NCT00552279|3634091|FG001|STARTED|Overall Study||401
2923261|NCT00552279|3634090|FG000|COMPLETED|Overall Study||389
2923262|NCT00552279|3634091|FG001|COMPLETED|Overall Study||398
2923263|NCT00552279|3634090|FG000|NOT COMPLETED|Overall Study||14
2923264|NCT00552279|3634091|FG001|NOT COMPLETED|Overall Study||3
2923265|NCT00552305|3634097|FG000|STARTED|Overall Study||370
2923266|NCT00552305|3634097|FG000|COMPLETED|Overall Study||120
2923267|NCT00552305|3634097|FG000|NOT COMPLETED|Overall Study||250
2923268|NCT00552344|3634101|FG000|STARTED|Overall Study||402
2923269|NCT00552344|3634101|FG000|COMPLETED|Overall Study||87
2923270|NCT00552344|3634101|FG000|NOT COMPLETED|Overall Study||315
2923271|NCT00552396|3634113|FG000|STARTED|Overall Study||4
2923272|NCT00552396|3634114|FG001|STARTED|Overall Study||3
2923273|NCT00552396|3634115|FG002|STARTED|Overall Study||3
2923274|NCT00552396|3634116|FG003|STARTED|Overall Study||6
2923275|NCT00552396|3634117|FG004|STARTED|Overall Study||3
2923276|NCT00552396|3634118|FG005|STARTED|Overall Study||3
2923277|NCT00552396|3634119|FG006|STARTED|Overall Study||10
2923278|NCT00552396|3634113|FG000|COMPLETED|Overall Study||1
2923279|NCT00552396|3634114|FG001|COMPLETED|Overall Study||0
2923280|NCT00552396|3634115|FG002|COMPLETED|Overall Study||0
2923281|NCT00552396|3634116|FG003|COMPLETED|Overall Study||0
2923282|NCT00552396|3634117|FG004|COMPLETED|Overall Study||0
2923283|NCT00552396|3634118|FG005|COMPLETED|Overall Study||0
2923284|NCT00552396|3634119|FG006|COMPLETED|Overall Study||1
2923285|NCT00552396|3634113|FG000|NOT COMPLETED|Overall Study||3
2923286|NCT00552396|3634114|FG001|NOT COMPLETED|Overall Study||3
2923287|NCT00552396|3634115|FG002|NOT COMPLETED|Overall Study||3
2923288|NCT00552396|3634116|FG003|NOT COMPLETED|Overall Study||6
2923289|NCT00552396|3634117|FG004|NOT COMPLETED|Overall Study||3
2923290|NCT00552396|3634118|FG005|NOT COMPLETED|Overall Study||3
2923291|NCT00552396|3634119|FG006|NOT COMPLETED|Overall Study||9
2923292|NCT00552409|3634155|FG000|STARTED|Overall Study||11
2923293|NCT00552409|3634156|FG001|STARTED|Overall Study||11
2923294|NCT00552409|3634155|FG000|COMPLETED|Overall Study||10
2923295|NCT00552409|3634156|FG001|COMPLETED|Overall Study||9
2923296|NCT00552409|3634155|FG000|NOT COMPLETED|Overall Study||1
2923297|NCT00552409|3634156|FG001|NOT COMPLETED|Overall Study||2
2923298|NCT00552422|3634162|FG000|STARTED|Overall Study||6
2923299|NCT00552422|3634162|FG000|COMPLETED|Overall Study||6
2923300|NCT00552422|3634162|FG000|NOT COMPLETED|Overall Study||0
2923301|NCT00552448|3634168|FG000|STARTED|Overall Study||20
2923302|NCT00552448|3634169|FG001|STARTED|Overall Study||16
2923303|NCT00552448|3634168|FG000|COMPLETED|Overall Study||19
2923304|NCT00552448|3634169|FG001|COMPLETED|Overall Study||16
2923305|NCT00552448|3634168|FG000|NOT COMPLETED|Overall Study||1
2923306|NCT00552448|3634169|FG001|NOT COMPLETED|Overall Study||0
2923307|NCT00552513|3634177|FG000|STARTED|Overall Study||1593
2923308|NCT00552513|3634178|FG001|STARTED|Overall Study||1438
2923309|NCT00552513|3634177|FG000|COMPLETED|Overall Study||1588
2923310|NCT00552513|3634178|FG001|COMPLETED|Overall Study||1437
2923311|NCT00552513|3634177|FG000|NOT COMPLETED|Overall Study||5
2923312|NCT00552513|3634178|FG001|NOT COMPLETED|Overall Study||1
2923313|NCT00552578|3634188|FG000|STARTED|Overall Study||6
2923314|NCT00552578|3634189|FG001|STARTED|Overall Study||6
2923315|NCT00552578|3634188|FG000|COMPLETED|Overall Study||5
2923316|NCT00552578|3634189|FG001|COMPLETED|Overall Study||5
2923317|NCT00552578|3634188|FG000|NOT COMPLETED|Overall Study||1
2923318|NCT00552578|3634189|FG001|NOT COMPLETED|Overall Study||1
2923319|NCT00552617|3634205|FG000|STARTED|Overall Study||10
2923320|NCT00552617|3634206|FG001|STARTED|Overall Study||10
2923321|NCT00552617|3634207|FG002|STARTED|Overall Study||10
2923322|NCT00552617|3634208|FG003|STARTED|Overall Study||10
2923323|NCT00552617|3634209|FG004|STARTED|Overall Study||10
2923324|NCT00552617|3634210|FG005|STARTED|Overall Study||10
2923325|NCT00552617|3634211|FG006|STARTED|Overall Study||10
2923326|NCT00552617|3634212|FG007|STARTED|Overall Study||10
2923327|NCT00552617|3634213|FG008|STARTED|Overall Study||10
2923328|NCT00552617|3634214|FG009|STARTED|Overall Study||10
2923329|NCT00552617|3634205|FG000|Treated|Overall Study||10
2923330|NCT00552617|3634206|FG001|Treated|Overall Study||10
2923331|NCT00552617|3634207|FG002|Treated|Overall Study||9
2923332|NCT00552617|3634208|FG003|Treated|Overall Study||10
2923333|NCT00552617|3634209|FG004|Treated|Overall Study||10
2923334|NCT00552617|3634210|FG005|Treated|Overall Study||10
2923335|NCT00552617|3634211|FG006|Treated|Overall Study||10
2923336|NCT00552617|3634212|FG007|Treated|Overall Study||10
2923337|NCT00552617|3634213|FG008|Treated|Overall Study||10
2923338|NCT00552617|3634214|FG009|Treated|Overall Study||9
2923339|NCT00552617|3634205|FG000|COMPLETED|Overall Study||10
2923340|NCT00552617|3634206|FG001|COMPLETED|Overall Study||10
2923341|NCT00552617|3634207|FG002|COMPLETED|Overall Study||9
2923342|NCT00552617|3634208|FG003|COMPLETED|Overall Study||9
2923343|NCT00552617|3634209|FG004|COMPLETED|Overall Study||10
2923344|NCT00552617|3634210|FG005|COMPLETED|Overall Study||8
2923345|NCT00552617|3634211|FG006|COMPLETED|Overall Study||10
2923346|NCT00552617|3634212|FG007|COMPLETED|Overall Study||10
2923347|NCT00552617|3634213|FG008|COMPLETED|Overall Study||8
2923348|NCT00552617|3634214|FG009|COMPLETED|Overall Study||9
2923349|NCT00552617|3634205|FG000|NOT COMPLETED|Overall Study||0
2923350|NCT00552617|3634206|FG001|NOT COMPLETED|Overall Study||0
2923351|NCT00552617|3634207|FG002|NOT COMPLETED|Overall Study||1
2923352|NCT00552617|3634208|FG003|NOT COMPLETED|Overall Study||1
2923353|NCT00552617|3634209|FG004|NOT COMPLETED|Overall Study||0
2923354|NCT00552617|3634210|FG005|NOT COMPLETED|Overall Study||2
2923355|NCT00552617|3634211|FG006|NOT COMPLETED|Overall Study||0
2923356|NCT00552617|3634212|FG007|NOT COMPLETED|Overall Study||0
2923357|NCT00552617|3634213|FG008|NOT COMPLETED|Overall Study||2
2923358|NCT00552617|3634214|FG009|NOT COMPLETED|Overall Study||1
2923359|NCT00552669|3634238|FG000|STARTED|Overall Study|patients|100
2923360|NCT00552669|3634239|FG001|STARTED|Overall Study|patients|100
2923361|NCT00552669|3634238|FG000|COMPLETED|Overall Study|All patients were followed for 18.3 +/- 7 months.|97
2923362|NCT00552669|3634239|FG001|COMPLETED|Overall Study|All patients were followed for 18.3 +/- 7 months.|93
2923363|NCT00552669|3634238|FG000|NOT COMPLETED|Overall Study||3
2923364|NCT00552669|3634239|FG001|NOT COMPLETED|Overall Study||7
2923365|NCT00552695|3634247|FG000|STARTED|Overall Study|August 2007|22
2923366|NCT00552695|3634248|FG001|STARTED|Overall Study|August 2007|23
2923367|NCT00552695|3634247|FG000|COMPLETED|Overall Study|September 2007|22
2923368|NCT00552695|3634248|FG001|COMPLETED|Overall Study|September 2007|23
2923369|NCT00552695|3634247|FG000|NOT COMPLETED|Overall Study||0
2923370|NCT00552695|3634248|FG001|NOT COMPLETED|Overall Study||0
2923371|NCT00552760|3634256|FG000|STARTED|Overall Study||42
2923372|NCT00552760|3634257|FG001|STARTED|Overall Study||41
2923373|NCT00552760|3634256|FG000|COMPLETED|Overall Study||16
2923374|NCT00552760|3634257|FG001|COMPLETED|Overall Study||8
2923375|NCT00552760|3634256|FG000|NOT COMPLETED|Overall Study||26
2923376|NCT00552760|3634257|FG001|NOT COMPLETED|Overall Study||33
2923377|NCT00552786|3634265|FG000|STARTED|First Intervention||25
2923378|NCT00552786|3634266|FG001|STARTED|First Intervention||28
2923379|NCT00552786|3634265|FG000|Medication and Hearing Evaluation|First Intervention||25
2923380|NCT00552786|3634266|FG001|Medication and Hearing Evaluation|First Intervention||28
3173590|NCT01950780|3901271|FG000|STARTED|Overall Study||12
3173591|NCT01950780|3901271|FG000|COMPLETED|Overall Study||12
3173592|NCT01950780|3901271|FG000|NOT COMPLETED|Overall Study||0
3173593|NCT01950819|3901278|FG000|STARTED|Overall Study||1022
3173594|NCT01950819|3901279|FG001|STARTED|Overall Study||1015
3173595|NCT01950819|3901278|FG000|COMPLETED|Overall Study||893
3173596|NCT01950819|3901279|FG001|COMPLETED|Overall Study||881
2923381|NCT00552786|3634265|FG000|COMPLETED|First Intervention||25
3173597|NCT01950819|3901278|FG000|NOT COMPLETED|Overall Study||129
3173598|NCT01950819|3901279|FG001|NOT COMPLETED|Overall Study||134
3173599|NCT01951066|3901285|FG000|STARTED|First Intervention (Baseline to Week 16)||10
3173600|NCT01951066|3901286|FG001|STARTED|First Intervention (Baseline to Week 16)||10
3173601|NCT01951066|3901285|FG000|COMPLETED|First Intervention (Baseline to Week 16)||10
3173602|NCT01951066|3901286|FG001|COMPLETED|First Intervention (Baseline to Week 16)||10
3173603|NCT01951066|3901285|FG000|NOT COMPLETED|First Intervention (Baseline to Week 16)||0
3173604|NCT01951066|3901286|FG001|NOT COMPLETED|First Intervention (Baseline to Week 16)||0
3173605|NCT01951066|3901285|FG000|STARTED|Second Intervention (Week 16 to Week 32)||10
3173606|NCT01951066|3901286|FG001|STARTED|Second Intervention (Week 16 to Week 32)||10
3173607|NCT01951066|3901285|FG000|COMPLETED|Second Intervention (Week 16 to Week 32)||10
3173608|NCT01951066|3901286|FG001|COMPLETED|Second Intervention (Week 16 to Week 32)||10
3173609|NCT01951066|3901285|FG000|NOT COMPLETED|Second Intervention (Week 16 to Week 32)||0
3173610|NCT01951066|3901286|FG001|NOT COMPLETED|Second Intervention (Week 16 to Week 32)||0
3173611|NCT01951092|3901291|FG000|STARTED|Overall Study||32
3173612|NCT01951092|3901291|FG000|COMPLETED|Overall Study||20
3173613|NCT01951092|3901291|FG000|NOT COMPLETED|Overall Study||12
3173614|NCT01951105|3901298|FG000|STARTED|Overall Study||11
3173615|NCT01951105|3901299|FG001|STARTED|Overall Study||31
3173616|NCT01951105|3901300|FG002|STARTED|Overall Study||30
3173617|NCT01951105|3901298|FG000|Completed 12 Weeks Treatment|Overall Study||10
3173618|NCT01951105|3901299|FG001|Completed 12 Weeks Treatment|Overall Study||24
3173619|NCT01951105|3901300|FG002|Completed 12 Weeks Treatment|Overall Study||28
3173620|NCT01951105|3901298|FG000|COMPLETED|Overall Study||10
3319814|NCT03154086|4053113|FG011|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
3319815|NCT03154086|4053114|FG012|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
3319816|NCT03154086|4053115|FG013|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
3319817|NCT03154086|4053116|FG014|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
3319818|NCT03154086|4053102|FG000|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||2
3319819|NCT03154086|4053103|FG001|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)|One replacement par was enrolled and dosed|2
3319820|NCT03154086|4053104|FG002|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||2
3319821|NCT03154086|4053105|FG003|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||2
3319822|NCT03154086|4053106|FG004|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
3173621|NCT01951105|3901299|FG001|COMPLETED|Overall Study||21
3173622|NCT01951105|3901300|FG002|COMPLETED|Overall Study||28
3173623|NCT01951105|3901298|FG000|NOT COMPLETED|Overall Study||1
3173624|NCT01951105|3901299|FG001|NOT COMPLETED|Overall Study||10
3173625|NCT01951105|3901300|FG002|NOT COMPLETED|Overall Study||2
2923382|NCT00552786|3634266|FG001|COMPLETED|First Intervention||28
2923383|NCT00552786|3634265|FG000|NOT COMPLETED|First Intervention||0
2923384|NCT00552786|3634266|FG001|NOT COMPLETED|First Intervention||0
2923385|NCT00552786|3634265|FG000|STARTED|Washout Period of 2 Weeks||25
2923386|NCT00552786|3634266|FG001|STARTED|Washout Period of 2 Weeks||28
2923387|NCT00552786|3634265|FG000|COMPLETED|Washout Period of 2 Weeks||25
2923388|NCT00552786|3634266|FG001|COMPLETED|Washout Period of 2 Weeks||28
2923389|NCT00552786|3634265|FG000|NOT COMPLETED|Washout Period of 2 Weeks||0
2923390|NCT00552786|3634266|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0
2923391|NCT00552786|3634265|FG000|STARTED|Second Intervention||25
2923392|NCT00552786|3634266|FG001|STARTED|Second Intervention||28
2923393|NCT00552786|3634265|FG000|COMPLETED|Second Intervention||25
2923394|NCT00552786|3634266|FG001|COMPLETED|Second Intervention||28
2923395|NCT00552786|3634265|FG000|NOT COMPLETED|Second Intervention||0
2923396|NCT00552786|3634266|FG001|NOT COMPLETED|Second Intervention||0
2923397|NCT00552812|3634272|FG000|STARTED|Overall Study|168 consents, 57 failed cath criteria, 5 met criteria but received covered stent, 1 withdrew consent|105
3038703|NCT01154699|3758013|FG001|NOT COMPLETED|First Intervention (4 Weeks)||0
3038704|NCT01154699|3758012|FG000|STARTED|Washout Period (4 Weeks)||13
3038705|NCT01154699|3758013|FG001|STARTED|Washout Period (4 Weeks)||8
3038706|NCT01154699|3758012|FG000|Subjects With Asthma Only|Washout Period (4 Weeks)||7
3038707|NCT01154699|3758013|FG001|Subjects With Asthma Only|Washout Period (4 Weeks)||6
3038708|NCT01154699|3758012|FG000|Subjects With Asthma + OSA|Washout Period (4 Weeks)||6
3038709|NCT01154699|3758013|FG001|Subjects With Asthma + OSA|Washout Period (4 Weeks)||2
3038710|NCT01154699|3758012|FG000|COMPLETED|Washout Period (4 Weeks)||13
3038711|NCT01154699|3758013|FG001|COMPLETED|Washout Period (4 Weeks)||8
3038712|NCT01154699|3758012|FG000|NOT COMPLETED|Washout Period (4 Weeks)||0
3038713|NCT01154699|3758013|FG001|NOT COMPLETED|Washout Period (4 Weeks)||0
2923398|NCT00552812|3634272|FG000|COMPLETED|Overall Study|Some still remain inside the 2 year follow up window. 2 year follow up data is not yet complete.|85
2923399|NCT00552812|3634272|FG000|NOT COMPLETED|Overall Study||20
2923400|NCT00552929|3634286|FG000|STARTED|Overall Study||9
2923401|NCT00552929|3634287|FG001|STARTED|Overall Study||10
2923402|NCT00552929|3634288|FG002|STARTED|Overall Study||10
2923403|NCT00552929|3634289|FG003|STARTED|Overall Study||11
2923404|NCT00552929|3634290|FG004|STARTED|Overall Study||10
2923405|NCT00552929|3634291|FG005|STARTED|Overall Study||10
2923406|NCT00552929|3634292|FG006|STARTED|Overall Study||10
2923407|NCT00552929|3634293|FG007|STARTED|Overall Study||11
2923408|NCT00552929|3634294|FG008|STARTED|Overall Study||10
2923409|NCT00552929|3634295|FG009|STARTED|Overall Study||11
2923410|NCT00552929|3634286|FG000|Participants as Treated|Overall Study|One participant randomized to sugammadex 0.5 mg/kg received sugammadex 3.7 mg/kg (4.0 mg\kg group)|9
2923411|NCT00552929|3634287|FG001|Participants as Treated|Overall Study||10
2923412|NCT00552929|3634288|FG002|Participants as Treated|Overall Study||10
2923413|NCT00552929|3634289|FG003|Participants as Treated|Overall Study|One participant randomized to sugammadex 0.5 mg/kg received sugammadex 3.7 mg/kg (4.0 mg\kg group)|11
3038714|NCT01154699|3758012|FG000|STARTED|Second Intervention||13
2923414|NCT00552929|3634290|FG004|Participants as Treated|Overall Study||10
2923415|NCT00552929|3634291|FG005|Participants as Treated|Overall Study||9
2923416|NCT00552929|3634292|FG006|Participants as Treated|Overall Study||10
2923417|NCT00552929|3634293|FG007|Participants as Treated|Overall Study||11
2923418|NCT00552929|3634294|FG008|Participants as Treated|Overall Study||10
3173626|NCT01951118|3901314|FG000|STARTED|Overall Study||121
3173627|NCT01951118|3901314|FG000|COMPLETED|Overall Study||94
3173628|NCT01951118|3901314|FG000|NOT COMPLETED|Overall Study||27
3173629|NCT01951157|3901326|FG000|STARTED|Overall Study||22
3173630|NCT01951157|3901327|FG001|STARTED|Overall Study||22
3173631|NCT01951157|3901328|FG002|STARTED|Overall Study||25
3173632|NCT01951157|3901326|FG000|COMPLETED|Overall Study||0
3173633|NCT01951157|3901327|FG001|COMPLETED|Overall Study||0
3173634|NCT01951157|3901328|FG002|COMPLETED|Overall Study||0
3173635|NCT01951157|3901326|FG000|NOT COMPLETED|Overall Study||22
3173636|NCT01951157|3901327|FG001|NOT COMPLETED|Overall Study||22
3173637|NCT01951157|3901328|FG002|NOT COMPLETED|Overall Study||25
3173638|NCT01951170|3901337|FG000|STARTED|Overall Study||52
3173639|NCT01951170|3901337|FG000|COMPLETED|Overall Study||51
2923419|NCT00552929|3634295|FG009|Participants as Treated|Overall Study||11
3173640|NCT01951170|3901337|FG000|NOT COMPLETED|Overall Study||1
3173641|NCT01951261|3901343|FG000|STARTED|Overall Study||58
3173642|NCT01951261|3901344|FG001|STARTED|Overall Study||58
3173643|NCT01951261|3901343|FG000|Discontinued|Overall Study|"2-readmission when was at home~1-monitor failure~1-new home hospitalitation 4-missing~1-death"|9
3319823|NCT03154086|4053107|FG005|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
3319824|NCT03154086|4053108|FG006|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
3319825|NCT03154086|4053109|FG007|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
3319826|NCT03154086|4053110|FG008|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
3319827|NCT03154086|4053111|FG009|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
3319828|NCT03154086|4053112|FG010|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
3319829|NCT03154086|4053113|FG011|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
2923420|NCT00552929|3634286|FG000|COMPLETED|Overall Study||9
2923421|NCT00552929|3634287|FG001|COMPLETED|Overall Study||10
2923422|NCT00552929|3634288|FG002|COMPLETED|Overall Study||10
2923423|NCT00552929|3634289|FG003|COMPLETED|Overall Study||11
2923424|NCT00552929|3634290|FG004|COMPLETED|Overall Study||10
2923425|NCT00552929|3634291|FG005|COMPLETED|Overall Study||9
2923426|NCT00552929|3634292|FG006|COMPLETED|Overall Study||10
2923427|NCT00552929|3634293|FG007|COMPLETED|Overall Study||11
2923428|NCT00552929|3634294|FG008|COMPLETED|Overall Study||9
2923429|NCT00552929|3634295|FG009|COMPLETED|Overall Study||11
2923430|NCT00552929|3634286|FG000|NOT COMPLETED|Overall Study||0
2923431|NCT00552929|3634287|FG001|NOT COMPLETED|Overall Study||0
2923432|NCT00552929|3634288|FG002|NOT COMPLETED|Overall Study||0
2923433|NCT00552929|3634289|FG003|NOT COMPLETED|Overall Study||0
2923434|NCT00552929|3634290|FG004|NOT COMPLETED|Overall Study||0
2923435|NCT00552929|3634291|FG005|NOT COMPLETED|Overall Study||1
2923436|NCT00552929|3634292|FG006|NOT COMPLETED|Overall Study||0
2923437|NCT00552929|3634293|FG007|NOT COMPLETED|Overall Study||0
2923438|NCT00552929|3634294|FG008|NOT COMPLETED|Overall Study||1
2923439|NCT00552929|3634295|FG009|NOT COMPLETED|Overall Study||0
2923440|NCT00553059|3634319|FG000|STARTED|Overall Study||31
2923441|NCT00553059|3634320|FG001|STARTED|Overall Study||31
2923442|NCT00553059|3634319|FG000|COMPLETED|Overall Study||30
2923443|NCT00553059|3634320|FG001|COMPLETED|Overall Study||29
2923444|NCT00553059|3634319|FG000|NOT COMPLETED|Overall Study||1
2923445|NCT00553059|3634320|FG001|NOT COMPLETED|Overall Study||2
2923446|NCT00553098|3634326|FG000|STARTED|Overall Study||29
2923447|NCT00553098|3634326|FG000|COMPLETED|Overall Study||28
2923448|NCT00553098|3634326|FG000|NOT COMPLETED|Overall Study||1
2923449|NCT00553150|3634336|FG000|STARTED|Overall Study||6
2923450|NCT00553150|3634337|FG001|STARTED|Overall Study||6
2923451|NCT00553150|3634338|FG002|STARTED|Overall Study||6
2923452|NCT00553150|3634339|FG003|STARTED|Overall Study||104
2923453|NCT00553150|3634336|FG000|COMPLETED|Overall Study||6
2923454|NCT00553150|3634337|FG001|COMPLETED|Overall Study||6
2923455|NCT00553150|3634338|FG002|COMPLETED|Overall Study||6
2923456|NCT00553150|3634339|FG003|COMPLETED|Overall Study||100
2923457|NCT00553150|3634336|FG000|NOT COMPLETED|Overall Study||0
2923458|NCT00553150|3634337|FG001|NOT COMPLETED|Overall Study||0
2923459|NCT00553150|3634338|FG002|NOT COMPLETED|Overall Study||0
2923460|NCT00553150|3634339|FG003|NOT COMPLETED|Overall Study||4
2923461|NCT00553163|3634349|FG000|STARTED|Overall Study||16
2923462|NCT00553163|3634350|FG001|STARTED|Overall Study||10
2923463|NCT00553163|3634349|FG000|COMPLETED|Overall Study||16
2923464|NCT00553163|3634350|FG001|COMPLETED|Overall Study||10
2923465|NCT00553163|3634349|FG000|NOT COMPLETED|Overall Study||0
2923466|NCT00553163|3634350|FG001|NOT COMPLETED|Overall Study||0
2923467|NCT00553202|3634361|FG000|STARTED|Overall Study||158
2923468|NCT00553202|3634361|FG000|COMPLETED|Overall Study||90
2923469|NCT00553202|3634361|FG000|NOT COMPLETED|Overall Study||68
2923470|NCT00553254|3634368|FG000|STARTED|Overall Study||6
2923471|NCT00553254|3634369|FG001|STARTED|Overall Study||6
2923472|NCT00553254|3634370|FG002|STARTED|Overall Study||43
2923473|NCT00553254|3634368|FG000|COMPLETED|Overall Study||0
2923474|NCT00553254|3634369|FG001|COMPLETED|Overall Study||0
2923475|NCT00553254|3634370|FG002|COMPLETED|Overall Study||0
2923476|NCT00553254|3634368|FG000|NOT COMPLETED|Overall Study||6
2923477|NCT00553254|3634369|FG001|NOT COMPLETED|Overall Study||6
2923478|NCT00553254|3634370|FG002|NOT COMPLETED|Overall Study||43
2923479|NCT00553267|3634385|FG000|STARTED|Overall Study||315
2923480|NCT00553267|3634386|FG001|STARTED|Overall Study||315
2923481|NCT00553267|3634387|FG002|STARTED|Overall Study||317
2923482|NCT00553267|3634385|FG000|COMPLETED|Overall Study||301
2923483|NCT00553267|3634386|FG001|COMPLETED|Overall Study||297
2923484|NCT00553267|3634387|FG002|COMPLETED|Overall Study||307
2923485|NCT00553267|3634385|FG000|NOT COMPLETED|Overall Study||14
2923486|NCT00553267|3634386|FG001|NOT COMPLETED|Overall Study||18
2923487|NCT00553267|3634387|FG002|NOT COMPLETED|Overall Study||10
2923488|NCT00553280|3634395|FG000|STARTED|Overall Study||123
2923489|NCT00553280|3634395|FG000|COMPLETED|Overall Study||97
2923490|NCT00553280|3634395|FG000|NOT COMPLETED|Overall Study||26
2923491|NCT00553319|3634402|FG000|STARTED|Overall Study||43
2923492|NCT00553319|3634403|FG001|STARTED|Overall Study||40
2923493|NCT00553319|3634404|FG002|STARTED|Overall Study||43
2923494|NCT00553319|3634402|FG000|COMPLETED|Overall Study||29
2923495|NCT00553319|3634403|FG001|COMPLETED|Overall Study||30
2923496|NCT00553319|3634404|FG002|COMPLETED|Overall Study||34
2923497|NCT00553319|3634402|FG000|NOT COMPLETED|Overall Study||14
2923498|NCT00553319|3634403|FG001|NOT COMPLETED|Overall Study||10
2923499|NCT00553319|3634404|FG002|NOT COMPLETED|Overall Study||9
3038715|NCT01154699|3758013|FG001|STARTED|Second Intervention||8
3038716|NCT01154699|3758012|FG000|Subjects With Asthma Only|Second Intervention||7
3038717|NCT01154699|3758013|FG001|Subjects With Asthma Only|Second Intervention||6
3038718|NCT01154699|3758012|FG000|Subjects With Asthma + OSA|Second Intervention||6
3038719|NCT01154699|3758013|FG001|Subjects With Asthma + OSA|Second Intervention||2
3038720|NCT01154699|3758012|FG000|COMPLETED|Second Intervention||13
3038721|NCT01154699|3758013|FG001|COMPLETED|Second Intervention||8
3038722|NCT01154699|3758012|FG000|NOT COMPLETED|Second Intervention||0
3038723|NCT01154699|3758013|FG001|NOT COMPLETED|Second Intervention||0
3038724|NCT01154751|3758021|FG000|STARTED|6-month Follow-up||109
3038725|NCT01154751|3758021|FG000|COMPLETED|6-month Follow-up||98
3038726|NCT01154751|3758021|FG000|NOT COMPLETED|6-month Follow-up||11
3038727|NCT01154751|3758021|FG000|STARTED|1-year Follow-up||98
3038728|NCT01154751|3758021|FG000|COMPLETED|1-year Follow-up||93
3038729|NCT01154751|3758021|FG000|NOT COMPLETED|1-year Follow-up||5
3038730|NCT01154751|3758021|FG000|STARTED|2-year Follow-up||93
3038731|NCT01154751|3758021|FG000|COMPLETED|2-year Follow-up||83
3038732|NCT01154751|3758021|FG000|NOT COMPLETED|2-year Follow-up||10
3038733|NCT01154751|3758021|FG000|STARTED|3-year Follow-up||83
3038734|NCT01154751|3758021|FG000|COMPLETED|3-year Follow-up||34
3038735|NCT01154751|3758021|FG000|NOT COMPLETED|3-year Follow-up||49
3038736|NCT01154816|3758037|FG000|STARTED|Overall Study||20
3038737|NCT01154816|3758038|FG001|STARTED|Overall Study||12
3038738|NCT01154816|3758039|FG002|STARTED|Overall Study||10
3038739|NCT01154816|3758040|FG003|STARTED|Overall Study||10
3038740|NCT01154816|3758041|FG004|STARTED|Overall Study||10
3038741|NCT01154816|3758042|FG005|STARTED|Overall Study||8
3038742|NCT01154816|3758043|FG006|STARTED|Overall Study||6
3038743|NCT01154816|3758044|FG007|STARTED|Overall Study||7
3038744|NCT01154816|3758045|FG008|STARTED|Overall Study||10
3319830|NCT03154086|4053114|FG012|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
3319831|NCT03154086|4053115|FG013|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
3319832|NCT03154086|4053116|FG014|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
3319833|NCT03154086|4053102|FG000|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||2
3319834|NCT03154086|4053103|FG001|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||2
3319835|NCT03154086|4053104|FG002|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||2
3319836|NCT03154086|4053105|FG003|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||2
3319837|NCT03154086|4053106|FG004|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
3173644|NCT01951261|3901344|FG001|Discontinued|Overall Study|"2-readmission when was at home~1-new home hospitalitation 3-missing"|6
3173645|NCT01951261|3901343|FG000|COMPLETED|Overall Study||49
3173646|NCT01951261|3901344|FG001|COMPLETED|Overall Study||52
3173647|NCT01951261|3901343|FG000|NOT COMPLETED|Overall Study||9
3173648|NCT01951261|3901344|FG001|NOT COMPLETED|Overall Study||6
3173649|NCT01951326|3901352|FG000|STARTED|Overall Study||166
3173650|NCT01951326|3901353|FG001|STARTED|Overall Study||165
3173651|NCT01951326|3901352|FG000|COMPLETED|Overall Study||87
3173652|NCT01951326|3901353|FG001|COMPLETED|Overall Study||87
3173653|NCT01951326|3901352|FG000|NOT COMPLETED|Overall Study||79
3319838|NCT03154086|4053107|FG005|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
3319839|NCT03154086|4053108|FG006|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
3319840|NCT03154086|4053109|FG007|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
3319841|NCT03154086|4053110|FG008|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
3319842|NCT03154086|4053111|FG009|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
3319843|NCT03154086|4053112|FG010|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
3319844|NCT03154086|4053113|FG011|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
3319845|NCT03154086|4053114|FG012|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
3319846|NCT03154086|4053115|FG013|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
3319847|NCT03154086|4053116|FG014|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
3319848|NCT03154086|4053102|FG000|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
3319849|NCT03154086|4053103|FG001|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
3319850|NCT03154086|4053104|FG002|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
3319851|NCT03154086|4053105|FG003|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
3319852|NCT03154086|4053106|FG004|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
3319853|NCT03154086|4053107|FG005|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
3319854|NCT03154086|4053108|FG006|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
3319855|NCT03154086|4053109|FG007|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
3319856|NCT03154086|4053110|FG008|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
3319857|NCT03154086|4053111|FG009|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
3319858|NCT03154086|4053112|FG010|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
3319859|NCT03154086|4053113|FG011|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
3319860|NCT03154086|4053114|FG012|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
3319861|NCT03154086|4053115|FG013|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
3319862|NCT03154086|4053116|FG014|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
3319863|NCT03154086|4053102|FG000|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||2
3319864|NCT03154086|4053103|FG001|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||2
3319865|NCT03154086|4053104|FG002|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||2
3319866|NCT03154086|4053105|FG003|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||2
3319867|NCT03154086|4053106|FG004|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
3319868|NCT03154086|4053107|FG005|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
3319869|NCT03154086|4053108|FG006|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
3319870|NCT03154086|4053109|FG007|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
3319871|NCT03154086|4053110|FG008|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
3319872|NCT03154086|4053111|FG009|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
3319873|NCT03154086|4053112|FG010|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
3319874|NCT03154086|4053113|FG011|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
3319875|NCT03154086|4053114|FG012|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
3319876|NCT03154086|4053115|FG013|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
3319877|NCT03154086|4053116|FG014|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
3319878|NCT03154086|4053102|FG000|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||2
3319879|NCT03154086|4053103|FG001|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||2
3319880|NCT03154086|4053104|FG002|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||1
3319881|NCT03154086|4053105|FG003|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||2
3173654|NCT01951326|3901353|FG001|NOT COMPLETED|Overall Study||78
3173655|NCT01951339|3901362|FG000|STARTED|Overall Study||15
3173656|NCT01951339|3901363|FG001|STARTED|Overall Study||15
3173657|NCT01951339|3901362|FG000|COMPLETED|Overall Study||13
3319882|NCT03154086|4053106|FG004|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
3319883|NCT03154086|4053107|FG005|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
2923500|NCT00553332|3634412|FG000|STARTED|Overall Study||29
2923501|NCT00553332|3634412|FG000|COMPLETED|Overall Study|evaluable for response|28
3319884|NCT03154086|4053108|FG006|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
3319885|NCT03154086|4053109|FG007|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
3319886|NCT03154086|4053110|FG008|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
3319887|NCT03154086|4053111|FG009|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
2923502|NCT00553332|3634412|FG000|NOT COMPLETED|Overall Study||1
2923503|NCT00553358|3634419|FG000|STARTED|Overall Study||152
3038745|NCT01154816|3758046|FG009|STARTED|Overall Study||10
3038746|NCT01154816|3758047|FG010|STARTED|Overall Study||11
3038747|NCT01154816|3758048|FG011|STARTED|Overall Study||4
3038748|NCT01154816|3758037|FG000|COMPLETED|Overall Study||0
3038749|NCT01154816|3758038|FG001|COMPLETED|Overall Study||2
3038750|NCT01154816|3758039|FG002|COMPLETED|Overall Study||0
3038751|NCT01154816|3758040|FG003|COMPLETED|Overall Study||0
3038752|NCT01154816|3758041|FG004|COMPLETED|Overall Study||0
3038753|NCT01154816|3758042|FG005|COMPLETED|Overall Study||0
3038754|NCT01154816|3758043|FG006|COMPLETED|Overall Study||0
3038755|NCT01154816|3758044|FG007|COMPLETED|Overall Study||0
3038756|NCT01154816|3758045|FG008|COMPLETED|Overall Study||1
3038757|NCT01154816|3758046|FG009|COMPLETED|Overall Study||0
3038758|NCT01154816|3758047|FG010|COMPLETED|Overall Study||0
3038759|NCT01154816|3758048|FG011|COMPLETED|Overall Study||0
3038760|NCT01154816|3758037|FG000|NOT COMPLETED|Overall Study||20
3038761|NCT01154816|3758038|FG001|NOT COMPLETED|Overall Study||10
3173658|NCT01951339|3901363|FG001|COMPLETED|Overall Study||14
3319888|NCT03154086|4053112|FG010|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
3319889|NCT03154086|4053113|FG011|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
3319890|NCT03154086|4053114|FG012|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
3319891|NCT03154086|4053115|FG013|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
3319892|NCT03154086|4053116|FG014|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
3319893|NCT03154086|4053102|FG000|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
3319894|NCT03154086|4053103|FG001|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
3319895|NCT03154086|4053104|FG002|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||1
3319896|NCT03154086|4053105|FG003|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
3319897|NCT03154086|4053106|FG004|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
3173659|NCT01951339|3901362|FG000|NOT COMPLETED|Overall Study||2
3173660|NCT01951339|3901363|FG001|NOT COMPLETED|Overall Study||1
3173661|NCT01951352|3901369|FG000|STARTED|Overall Study||10
3173662|NCT01951352|3901369|FG000|COMPLETED|Overall Study||10
3173663|NCT01951352|3901369|FG000|NOT COMPLETED|Overall Study||0
3173664|NCT01951391|3901375|FG000|STARTED|Overall Study||5
3173665|NCT01951391|3901376|FG001|STARTED|Overall Study||5
3136951|NCT01716455|3862263|FG005|NOT COMPLETED|Overall Study||0
3136952|NCT01716468|3862274|FG000|STARTED|Overall Study||17
3136953|NCT01716468|3862274|FG000|COMPLETED|Overall Study||11
3136954|NCT01716468|3862274|FG000|NOT COMPLETED|Overall Study||6
3136955|NCT01716520|3862278|FG000|STARTED|Treatment Period 1 (14 Days)||31
3136956|NCT01716520|3862279|FG001|STARTED|Treatment Period 1 (14 Days)||30
2923504|NCT00553358|3634420|FG001|STARTED|Overall Study||154
2923505|NCT00553358|3634421|FG002|STARTED|Overall Study||149
2923506|NCT00553358|3634419|FG000|COMPLETED|Overall Study||73
2923507|NCT00553358|3634420|FG001|COMPLETED|Overall Study||58
2923508|NCT00553358|3634421|FG002|COMPLETED|Overall Study||61
2923509|NCT00553358|3634419|FG000|NOT COMPLETED|Overall Study||79
2923510|NCT00553358|3634420|FG001|NOT COMPLETED|Overall Study||96
2923511|NCT00553358|3634421|FG002|NOT COMPLETED|Overall Study||88
2923512|NCT00553410|3634437|FG000|STARTED|Overall Study||2441
2923513|NCT00553410|3634438|FG001|STARTED|Overall Study||2443
2923514|NCT00553410|3634437|FG000|COMPLETED|Overall Study||2426
3173666|NCT01951391|3901375|FG000|COMPLETED|Overall Study||5
3173667|NCT01951391|3901376|FG001|COMPLETED|Overall Study||5
3173668|NCT01951391|3901375|FG000|NOT COMPLETED|Overall Study||0
3173669|NCT01951391|3901376|FG001|NOT COMPLETED|Overall Study||0
3173670|NCT01951417|3901384|FG000|STARTED|Overall Study||81
2923515|NCT00553410|3634438|FG001|COMPLETED|Overall Study||2425
2923516|NCT00553410|3634437|FG000|NOT COMPLETED|Overall Study||15
3173671|NCT01951417|3901384|FG000|COMPLETED|Overall Study||72
3173672|NCT01951417|3901384|FG000|NOT COMPLETED|Overall Study||9
2923517|NCT00553410|3634438|FG001|NOT COMPLETED|Overall Study||18
2923518|NCT00553436|3634444|FG000|STARTED|Overall Study|20 August 2007|7
2923519|NCT00553436|3634444|FG000|COMPLETED|Overall Study|09 April 2009|6
2923520|NCT00553436|3634444|FG000|NOT COMPLETED|Overall Study||1
2923521|NCT00553462|3634448|FG000|STARTED|Overall Study||75
2923522|NCT00553462|3634448|FG000|COMPLETED|Overall Study||61
2923523|NCT00553462|3634448|FG000|NOT COMPLETED|Overall Study||14
2923524|NCT00553475|3634455|FG000|STARTED|Overall Study||135
2923525|NCT00553475|3634456|FG001|STARTED|Overall Study||134
2923526|NCT00553475|3634457|FG002|STARTED|Overall Study||45
2923527|NCT00553475|3634455|FG000|COMPLETED|Overall Study||119
2923528|NCT00553475|3634456|FG001|COMPLETED|Overall Study||114
2923529|NCT00553475|3634457|FG002|COMPLETED|Overall Study||32
2923530|NCT00553475|3634455|FG000|NOT COMPLETED|Overall Study||16
2923531|NCT00553475|3634456|FG001|NOT COMPLETED|Overall Study||20
2923532|NCT00553475|3634457|FG002|NOT COMPLETED|Overall Study||13
2923533|NCT00553501|3634467|FG000|STARTED|Overall Study||59
2923534|NCT00553501|3634467|FG000|COMPLETED|Overall Study||55
2923535|NCT00553501|3634467|FG000|NOT COMPLETED|Overall Study||4
2923536|NCT00553514|3634476|FG000|STARTED|Overall Study||14
2923537|NCT00553514|3634477|FG001|STARTED|Overall Study||14
2923538|NCT00553514|3634478|FG002|STARTED|Overall Study||15
2923539|NCT00553514|3634479|FG003|STARTED|Overall Study||13
2923540|NCT00553514|3634480|FG004|STARTED|Overall Study||15
2923541|NCT00553514|3634476|FG000|COMPLETED|Overall Study||6
2923542|NCT00553514|3634477|FG001|COMPLETED|Overall Study||6
2923543|NCT00553514|3634478|FG002|COMPLETED|Overall Study||9
2923544|NCT00553514|3634479|FG003|COMPLETED|Overall Study||6
2923545|NCT00553514|3634480|FG004|COMPLETED|Overall Study||8
2923546|NCT00553514|3634476|FG000|NOT COMPLETED|Overall Study||8
2923547|NCT00553514|3634477|FG001|NOT COMPLETED|Overall Study||8
2923548|NCT00553514|3634478|FG002|NOT COMPLETED|Overall Study||6
2923549|NCT00553514|3634479|FG003|NOT COMPLETED|Overall Study||7
2923550|NCT00553514|3634480|FG004|NOT COMPLETED|Overall Study||7
2923551|NCT00553540|3634494|FG000|STARTED|Overall Study||25
2923552|NCT00553540|3634495|FG001|STARTED|Overall Study||25
3173673|NCT01951573|3901392|FG000|STARTED|Period 1, First 9 Hours of Wear||17
3173674|NCT01951573|3901393|FG001|STARTED|Period 1, First 9 Hours of Wear||17
3173675|NCT01951573|3901392|FG000|COMPLETED|Period 1, First 9 Hours of Wear||17
3173676|NCT01951573|3901393|FG001|COMPLETED|Period 1, First 9 Hours of Wear||17
3319898|NCT03154086|4053107|FG005|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
3319899|NCT03154086|4053108|FG006|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
3319900|NCT03154086|4053109|FG007|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
3319901|NCT03154086|4053110|FG008|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
3319902|NCT03154086|4053111|FG009|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
3319903|NCT03154086|4053112|FG010|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
3319904|NCT03154086|4053113|FG011|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
3319905|NCT03154086|4053114|FG012|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
3319906|NCT03154086|4053115|FG013|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
3319907|NCT03154086|4053116|FG014|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
3319908|NCT03154086|4053102|FG000|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)|1 par was not dosed on day of dosing due to elevated lab; hence 1 replacement was enrolled and dosed|3
3319909|NCT03154086|4053103|FG001|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||2
3319910|NCT03154086|4053104|FG002|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||1
3319911|NCT03154086|4053105|FG003|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||2
3319912|NCT03154086|4053106|FG004|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
3319913|NCT03154086|4053107|FG005|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
3319914|NCT03154086|4053108|FG006|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
3319915|NCT03154086|4053109|FG007|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
3319916|NCT03154086|4053110|FG008|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
3319917|NCT03154086|4053111|FG009|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
3319918|NCT03154086|4053112|FG010|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
3319919|NCT03154086|4053113|FG011|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
3319920|NCT03154086|4053114|FG012|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
3319921|NCT03154086|4053115|FG013|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
3319922|NCT03154086|4053116|FG014|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
3319923|NCT03154086|4053102|FG000|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||2
3319924|NCT03154086|4053103|FG001|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||2
2923553|NCT00553540|3634494|FG000|COMPLETED|Overall Study||23
2923554|NCT00553540|3634495|FG001|COMPLETED|Overall Study||20
2923555|NCT00553540|3634494|FG000|NOT COMPLETED|Overall Study||2
2923556|NCT00553540|3634495|FG001|NOT COMPLETED|Overall Study||5
2923557|NCT00553605|3634503|FG000|STARTED|Overall Study||176
2923558|NCT00553605|3634504|FG001|STARTED|Overall Study||164
2923559|NCT00553605|3634503|FG000|Treated|Overall Study||174
2923560|NCT00553605|3634504|FG001|Treated|Overall Study||164
2923561|NCT00553605|3634503|FG000|COMPLETED|Overall Study||172
2923562|NCT00553605|3634504|FG001|COMPLETED|Overall Study||161
2923563|NCT00553605|3634503|FG000|NOT COMPLETED|Overall Study||4
2923564|NCT00553605|3634504|FG001|NOT COMPLETED|Overall Study||3
2923565|NCT00553631|3634512|FG000|STARTED|Overall Study|Intent-to-treat (ITT) population|17
2923566|NCT00553631|3634513|FG001|STARTED|Overall Study|Intent-to-treat (ITT) population|17
2923567|NCT00553631|3634512|FG000|COMPLETED|Overall Study||16
2923568|NCT00553631|3634513|FG001|COMPLETED|Overall Study||16
2923569|NCT00553631|3634512|FG000|NOT COMPLETED|Overall Study||1
2923570|NCT00553631|3634513|FG001|NOT COMPLETED|Overall Study||1
2923571|NCT00553644|3634519|FG000|STARTED|Overall Study||53
2923572|NCT00553644|3634519|FG000|COMPLETED|Overall Study||25
2923573|NCT00553644|3634519|FG000|NOT COMPLETED|Overall Study||28
2923574|NCT00553696|3634527|FG000|STARTED|Overall Study||4
2923575|NCT00553696|3634528|FG001|STARTED|Overall Study||16
2923576|NCT00553696|3634529|FG002|STARTED|Overall Study||6
2923577|NCT00553696|3634530|FG003|STARTED|Overall Study||1
2923578|NCT00553696|3634527|FG000|COMPLETED|Overall Study||0
2923579|NCT00553696|3634528|FG001|COMPLETED|Overall Study||0
2923580|NCT00553696|3634529|FG002|COMPLETED|Overall Study||0
2923581|NCT00553696|3634530|FG003|COMPLETED|Overall Study||0
2923582|NCT00553696|3634527|FG000|NOT COMPLETED|Overall Study||4
2923583|NCT00553696|3634528|FG001|NOT COMPLETED|Overall Study||16
2923584|NCT00553696|3634529|FG002|NOT COMPLETED|Overall Study||6
2923585|NCT00553696|3634530|FG003|NOT COMPLETED|Overall Study||1
2923586|NCT00553735|3634543|FG000|STARTED|Overall Study||8
2923587|NCT00553735|3634543|FG000|COMPLETED|Overall Study||1
2923588|NCT00553735|3634543|FG000|NOT COMPLETED|Overall Study||7
2923589|NCT00553787|3634553|FG000|STARTED|Overall Study||994
2923590|NCT00553787|3634554|FG001|STARTED|Overall Study||498
2923591|NCT00553787|3634555|FG002|STARTED|Overall Study||995
2923592|NCT00553787|3634553|FG000|COMPLETED|Overall Study||616
2923593|NCT00553787|3634554|FG001|COMPLETED|Overall Study||374
2923594|NCT00553787|3634555|FG002|COMPLETED|Overall Study||733
2923595|NCT00553787|3634553|FG000|NOT COMPLETED|Overall Study||378
2923596|NCT00553787|3634554|FG001|NOT COMPLETED|Overall Study||124
2923597|NCT00553787|3634555|FG002|NOT COMPLETED|Overall Study||262
2923598|NCT00553839|3634563|FG000|STARTED|Overall Study||21
2923599|NCT00553839|3634563|FG000|COMPLETED|Overall Study||21
2923600|NCT00553839|3634563|FG000|NOT COMPLETED|Overall Study||0
2923601|NCT00553969|3634571|FG000|STARTED|Overall Study||31
2923602|NCT00553969|3634572|FG001|STARTED|Overall Study||24
2923603|NCT00553969|3634573|FG002|STARTED|Overall Study||22
2923604|NCT00553969|3634574|FG003|STARTED|Overall Study||24
2923605|NCT00553969|3634571|FG000|COMPLETED|Overall Study||23
2923606|NCT00553969|3634572|FG001|COMPLETED|Overall Study||24
2923607|NCT00553969|3634573|FG002|COMPLETED|Overall Study||21
3038762|NCT01154816|3758039|FG002|NOT COMPLETED|Overall Study||10
3038763|NCT01154816|3758040|FG003|NOT COMPLETED|Overall Study||10
3038764|NCT01154816|3758041|FG004|NOT COMPLETED|Overall Study||10
3038765|NCT01154816|3758042|FG005|NOT COMPLETED|Overall Study||8
3038766|NCT01154816|3758043|FG006|NOT COMPLETED|Overall Study||6
3038767|NCT01154816|3758044|FG007|NOT COMPLETED|Overall Study||7
3038768|NCT01154816|3758045|FG008|NOT COMPLETED|Overall Study||9
3038769|NCT01154816|3758046|FG009|NOT COMPLETED|Overall Study||10
3038770|NCT01154816|3758047|FG010|NOT COMPLETED|Overall Study||11
3038771|NCT01154816|3758048|FG011|NOT COMPLETED|Overall Study||4
3038772|NCT01154985|3758079|FG000|STARTED|Overall Study|Randomized|75
3038773|NCT01154985|3758080|FG001|STARTED|Overall Study|Randomized|82
3038774|NCT01154985|3758081|FG002|STARTED|Overall Study|Randomized|86
3038775|NCT01154985|3758079|FG000|Full Analysis Set|Overall Study|Received at least one dose of study medication|75
3038776|NCT01154985|3758080|FG001|Full Analysis Set|Overall Study|Received at least one dose of study medication|82
3038777|NCT01154985|3758081|FG002|Full Analysis Set|Overall Study|Received at least one dose of study medication|86
3038778|NCT01154985|3758079|FG000|Valid Biopsy -Baseline and Month 12.5|Overall Study||60
3038779|NCT01154985|3758080|FG001|Valid Biopsy -Baseline and Month 12.5|Overall Study||62
3038780|NCT01154985|3758081|FG002|Valid Biopsy -Baseline and Month 12.5|Overall Study||68
3038781|NCT01154985|3758079|FG000|Efficacy Evaluable Analysis Set|Overall Study|12-months histological data, no major protocol violations; after minimum 6 months treatment|55
3038782|NCT01154985|3758080|FG001|Efficacy Evaluable Analysis Set|Overall Study|12-months histological data, no major protocol violations; after minimum 6 months treatment|55
3038783|NCT01154985|3758081|FG002|Efficacy Evaluable Analysis Set|Overall Study|12-months histological data, no major protocol violations; after minimum 6 months treatment|64
3038784|NCT01154985|3758079|FG000|COMPLETED|Overall Study||58
3038785|NCT01154985|3758080|FG001|COMPLETED|Overall Study||55
3038786|NCT01154985|3758081|FG002|COMPLETED|Overall Study||68
3038787|NCT01154985|3758079|FG000|NOT COMPLETED|Overall Study||17
3173677|NCT01951573|3901392|FG000|NOT COMPLETED|Period 1, First 9 Hours of Wear||0
3173678|NCT01951573|3901393|FG001|NOT COMPLETED|Period 1, First 9 Hours of Wear||0
3173679|NCT01951573|3901392|FG000|STARTED|Washout Period||17
3173680|NCT01951573|3901393|FG001|STARTED|Washout Period||17
3173681|NCT01951573|3901392|FG000|COMPLETED|Washout Period||17
3173682|NCT01951573|3901393|FG001|COMPLETED|Washout Period||16
3173683|NCT01951573|3901392|FG000|NOT COMPLETED|Washout Period||0
3173684|NCT01951573|3901393|FG001|NOT COMPLETED|Washout Period||1
3173685|NCT01951573|3901392|FG000|STARTED|Period 2, Second 9 Hours of Wear||17
3173686|NCT01951573|3901393|FG001|STARTED|Period 2, Second 9 Hours of Wear||16
3173687|NCT01951573|3901392|FG000|COMPLETED|Period 2, Second 9 Hours of Wear||17
3173688|NCT01951573|3901393|FG001|COMPLETED|Period 2, Second 9 Hours of Wear||16
3173689|NCT01951573|3901392|FG000|NOT COMPLETED|Period 2, Second 9 Hours of Wear||0
3173690|NCT01951573|3901393|FG001|NOT COMPLETED|Period 2, Second 9 Hours of Wear||0
3173691|NCT01951586|3901401|FG000|STARTED|Overall Study||78
3173692|NCT01951586|3901402|FG001|STARTED|Overall Study||148
3173693|NCT01951586|3901401|FG000|Received Study Drug|Overall Study||76
3173694|NCT01951586|3901402|FG001|Received Study Drug|Overall Study||145
3173695|NCT01951586|3901401|FG000|COMPLETED|Overall Study||0
3173696|NCT01951586|3901402|FG001|COMPLETED|Overall Study||0
3173697|NCT01951586|3901401|FG000|NOT COMPLETED|Overall Study||78
3173698|NCT01951586|3901402|FG001|NOT COMPLETED|Overall Study||148
3173699|NCT01951625|3901414|FG000|STARTED|Treatment Period||92
3173700|NCT01951625|3901415|FG001|STARTED|Treatment Period||91
3173701|NCT01951625|3901416|FG002|STARTED|Treatment Period||91
3173702|NCT01951625|3901417|FG003|STARTED|Treatment Period||91
3173703|NCT01951625|3901418|FG004|STARTED|Treatment Period||91
3173704|NCT01951625|3901414|FG000|COMPLETED|Treatment Period||73
3173705|NCT01951625|3901415|FG001|COMPLETED|Treatment Period||70
3173706|NCT01951625|3901416|FG002|COMPLETED|Treatment Period||76
3173707|NCT01951625|3901417|FG003|COMPLETED|Treatment Period||69
3136957|NCT01716520|3862280|FG002|STARTED|Treatment Period 1 (14 Days)||30
2923608|NCT00553969|3634574|FG003|COMPLETED|Overall Study||23
2923609|NCT00553969|3634571|FG000|NOT COMPLETED|Overall Study||8
2923610|NCT00553969|3634572|FG001|NOT COMPLETED|Overall Study||0
2923611|NCT00553969|3634573|FG002|NOT COMPLETED|Overall Study||1
2923612|NCT00553969|3634574|FG003|NOT COMPLETED|Overall Study||1
2923613|NCT00554099|3634587|FG000|STARTED|Treatment Period (12 Weeks)||41
2923614|NCT00554099|3634588|FG001|STARTED|Treatment Period (12 Weeks)||40
2923615|NCT00554099|3634589|FG002|STARTED|Treatment Period (12 Weeks)||36
2923616|NCT00554099|3634587|FG000|COMPLETED|Treatment Period (12 Weeks)||29
2923617|NCT00554099|3634588|FG001|COMPLETED|Treatment Period (12 Weeks)||32
2923618|NCT00554099|3634589|FG002|COMPLETED|Treatment Period (12 Weeks)||27
2923619|NCT00554099|3634587|FG000|NOT COMPLETED|Treatment Period (12 Weeks)||12
2923620|NCT00554099|3634588|FG001|NOT COMPLETED|Treatment Period (12 Weeks)||8
2923621|NCT00554099|3634589|FG002|NOT COMPLETED|Treatment Period (12 Weeks)||9
2923622|NCT00554099|3634587|FG000|STARTED|Non-Treatment Phase (9 Months)||29
2923623|NCT00554099|3634588|FG001|STARTED|Non-Treatment Phase (9 Months)||32
2923624|NCT00554099|3634589|FG002|STARTED|Non-Treatment Phase (9 Months)||27
2923625|NCT00554099|3634587|FG000|COMPLETED|Non-Treatment Phase (9 Months)||22
2923626|NCT00554099|3634588|FG001|COMPLETED|Non-Treatment Phase (9 Months)||27
2923627|NCT00554099|3634589|FG002|COMPLETED|Non-Treatment Phase (9 Months)||24
2923628|NCT00554099|3634587|FG000|NOT COMPLETED|Non-Treatment Phase (9 Months)||7
2923629|NCT00554099|3634588|FG001|NOT COMPLETED|Non-Treatment Phase (9 Months)||5
2923630|NCT00554099|3634589|FG002|NOT COMPLETED|Non-Treatment Phase (9 Months)||3
2923631|NCT00554216|3634600|FG000|STARTED|Overall Study||514
2923632|NCT00554216|3634601|FG001|STARTED|Overall Study||241
2923633|NCT00554216|3634602|FG002|STARTED|Overall Study||512
2923634|NCT00554216|3634600|FG000|COMPLETED|Overall Study||272
2923635|NCT00554216|3634601|FG001|COMPLETED|Overall Study||147
2923636|NCT00554216|3634602|FG002|COMPLETED|Overall Study||340
2923637|NCT00554216|3634600|FG000|NOT COMPLETED|Overall Study||242
2923638|NCT00554216|3634601|FG001|NOT COMPLETED|Overall Study||94
2923639|NCT00554216|3634602|FG002|NOT COMPLETED|Overall Study||172
2923640|NCT00554229|3634612|FG000|STARTED|Overall Study||299
2923641|NCT00554229|3634613|FG001|STARTED|Overall Study||295
2923642|NCT00554229|3634612|FG000|Patients Who Received Treatment|Overall Study||298
2923643|NCT00554229|3634613|FG001|Patients Who Received Treatment|Overall Study||295
2923644|NCT00554229|3634612|FG000|COMPLETED|Overall Study||73
2923645|NCT00554229|3634613|FG001|COMPLETED|Overall Study||70
2923646|NCT00554229|3634612|FG000|NOT COMPLETED|Overall Study||226
2923647|NCT00554229|3634613|FG001|NOT COMPLETED|Overall Study||225
2923648|NCT00554372|3634621|FG000|STARTED|Overall Study||14
2923649|NCT00554372|3634622|FG001|STARTED|Overall Study||16
2923650|NCT00554372|3634621|FG000|COMPLETED|Overall Study||14
2923651|NCT00554372|3634622|FG001|COMPLETED|Overall Study||16
2923652|NCT00554372|3634621|FG000|NOT COMPLETED|Overall Study||0
2923653|NCT00554372|3634622|FG001|NOT COMPLETED|Overall Study||0
2923654|NCT00554463|3634630|FG000|STARTED|Overall Study||5
2923655|NCT00554463|3634630|FG000|COMPLETED|Overall Study||5
2923656|NCT00554463|3634630|FG000|NOT COMPLETED|Overall Study||0
2923657|NCT00554515|3634634|FG000|STARTED|Overall Study||123
2923658|NCT00554515|3634634|FG000|Treated|Overall Study||120
2923659|NCT00554515|3634634|FG000|COMPLETED|Overall Study||5
2923660|NCT00554515|3634634|FG000|NOT COMPLETED|Overall Study||118
2923661|NCT00554619|3634659|FG000|STARTED|Overall Study||21
2923662|NCT00554619|3634659|FG000|COMPLETED|Overall Study||18
2923663|NCT00554619|3634659|FG000|NOT COMPLETED|Overall Study||3
3173708|NCT01951625|3901418|FG004|COMPLETED|Treatment Period||74
3173709|NCT01951625|3901414|FG000|NOT COMPLETED|Treatment Period||19
3319925|NCT03154086|4053104|FG002|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||1
3319926|NCT03154086|4053105|FG003|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||2
3319927|NCT03154086|4053106|FG004|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
3319928|NCT03154086|4053107|FG005|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
3319929|NCT03154086|4053108|FG006|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
3319930|NCT03154086|4053109|FG007|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
3319931|NCT03154086|4053110|FG008|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
3319932|NCT03154086|4053111|FG009|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
3319933|NCT03154086|4053112|FG010|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
3319934|NCT03154086|4053113|FG011|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
3319935|NCT03154086|4053114|FG012|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
3319936|NCT03154086|4053115|FG013|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
3319937|NCT03154086|4053116|FG014|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
3319938|NCT03154086|4053102|FG000|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||1
3319939|NCT03154086|4053103|FG001|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
3319940|NCT03154086|4053104|FG002|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
3319941|NCT03154086|4053105|FG003|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
3319942|NCT03154086|4053106|FG004|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
3319943|NCT03154086|4053107|FG005|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
3319944|NCT03154086|4053108|FG006|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
3319945|NCT03154086|4053109|FG007|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
3319946|NCT03154086|4053110|FG008|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
3319947|NCT03154086|4053111|FG009|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
3319948|NCT03154086|4053112|FG010|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
3319949|NCT03154086|4053113|FG011|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
3319950|NCT03154086|4053114|FG012|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
3319951|NCT03154086|4053115|FG013|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
3319952|NCT03154086|4053116|FG014|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
3319953|NCT03154086|4053102|FG000|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
3319954|NCT03154086|4053103|FG001|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
3319955|NCT03154086|4053104|FG002|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
3319956|NCT03154086|4053105|FG003|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
3319957|NCT03154086|4053106|FG004|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||6
3319958|NCT03154086|4053107|FG005|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||2
3319959|NCT03154086|4053108|FG006|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
3319960|NCT03154086|4053109|FG007|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
3319961|NCT03154086|4053110|FG008|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
3319962|NCT03154086|4053111|FG009|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
3319963|NCT03154086|4053112|FG010|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
3319964|NCT03154086|4053113|FG011|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
3319965|NCT03154086|4053114|FG012|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
3319966|NCT03154086|4053115|FG013|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
3319967|NCT03154086|4053116|FG014|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
3319968|NCT03154086|4053102|FG000|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
3319969|NCT03154086|4053103|FG001|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
3319970|NCT03154086|4053104|FG002|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
3319971|NCT03154086|4053105|FG003|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
3319972|NCT03154086|4053106|FG004|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||6
3319973|NCT03154086|4053107|FG005|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||2
3319974|NCT03154086|4053108|FG006|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
3319975|NCT03154086|4053109|FG007|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
3319976|NCT03154086|4053110|FG008|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
3319977|NCT03154086|4053111|FG009|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
3319978|NCT03154086|4053112|FG010|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
3319979|NCT03154086|4053113|FG011|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
3319980|NCT03154086|4053114|FG012|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
3319981|NCT03154086|4053115|FG013|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
3319982|NCT03154086|4053116|FG014|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
3319983|NCT03154086|4053102|FG000|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
3319984|NCT03154086|4053103|FG001|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
3319985|NCT03154086|4053104|FG002|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
3319986|NCT03154086|4053105|FG003|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
3319987|NCT03154086|4053106|FG004|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
2923664|NCT00554671|3634665|FG000|STARTED|Overall Study||117
2923665|NCT00554671|3634666|FG001|STARTED|Overall Study||133
2923666|NCT00554671|3634665|FG000|COMPLETED|Overall Study||97
2923667|NCT00554671|3634666|FG001|COMPLETED|Overall Study||117
2923668|NCT00554671|3634665|FG000|NOT COMPLETED|Overall Study||20
2923669|NCT00554671|3634666|FG001|NOT COMPLETED|Overall Study||16
2923670|NCT00554749|3634673|FG000|STARTED|Overall Study||7
2923671|NCT00554749|3634673|FG000|COMPLETED|Overall Study||7
2923672|NCT00554749|3634673|FG000|NOT COMPLETED|Overall Study||0
2923673|NCT00554788|3634680|FG000|STARTED|Overall Study||21
2923674|NCT00554788|3634681|FG001|STARTED|Overall Study||18
2923675|NCT00554788|3634682|FG002|STARTED|Overall Study||21
2923676|NCT00554788|3634680|FG000|COMPLETED|Overall Study||14
2923677|NCT00554788|3634681|FG001|COMPLETED|Overall Study||12
2923678|NCT00554788|3634682|FG002|COMPLETED|Overall Study||7
3173710|NCT01951625|3901415|FG001|NOT COMPLETED|Treatment Period||21
3173711|NCT01951625|3901416|FG002|NOT COMPLETED|Treatment Period||15
3173712|NCT01951625|3901417|FG003|NOT COMPLETED|Treatment Period||22
3173713|NCT01951625|3901418|FG004|NOT COMPLETED|Treatment Period||17
3319988|NCT03154086|4053107|FG005|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
3319989|NCT03154086|4053108|FG006|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
3319990|NCT03154086|4053109|FG007|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
3319991|NCT03154086|4053110|FG008|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
3173714|NCT01951625|3901414|FG000|STARTED|Follow Up Period||87
3173715|NCT01951625|3901415|FG001|STARTED|Follow Up Period||88
3173716|NCT01951625|3901416|FG002|STARTED|Follow Up Period||88
3173717|NCT01951625|3901417|FG003|STARTED|Follow Up Period||87
3173718|NCT01951625|3901418|FG004|STARTED|Follow Up Period||88
3173719|NCT01951625|3901414|FG000|COMPLETED|Follow Up Period||79
3173720|NCT01951625|3901415|FG001|COMPLETED|Follow Up Period||79
3173721|NCT01951625|3901416|FG002|COMPLETED|Follow Up Period||84
3173722|NCT01951625|3901417|FG003|COMPLETED|Follow Up Period||76
3173723|NCT01951625|3901418|FG004|COMPLETED|Follow Up Period||78
3319992|NCT03154086|4053111|FG009|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
3319993|NCT03154086|4053112|FG010|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
3173724|NCT01951625|3901414|FG000|NOT COMPLETED|Follow Up Period||8
3319994|NCT03154086|4053113|FG011|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
3319995|NCT03154086|4053114|FG012|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
3319996|NCT03154086|4053115|FG013|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
3319997|NCT03154086|4053116|FG014|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
3319998|NCT03154086|4053102|FG000|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
3319999|NCT03154086|4053103|FG001|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
3320000|NCT03154086|4053104|FG002|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
3320001|NCT03154086|4053105|FG003|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
3320002|NCT03154086|4053106|FG004|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||6
3320003|NCT03154086|4053107|FG005|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||2
3320004|NCT03154086|4053108|FG006|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
3320005|NCT03154086|4053109|FG007|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
3320006|NCT03154086|4053110|FG008|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
3320007|NCT03154086|4053111|FG009|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
3173725|NCT01951625|3901415|FG001|NOT COMPLETED|Follow Up Period||9
3173726|NCT01951625|3901416|FG002|NOT COMPLETED|Follow Up Period||4
3173727|NCT01951625|3901417|FG003|NOT COMPLETED|Follow Up Period||11
3173728|NCT01951625|3901418|FG004|NOT COMPLETED|Follow Up Period||10
3173729|NCT01951638|3901436|FG000|STARTED|Treatment Period||93
3173730|NCT01951638|3901437|FG001|STARTED|Treatment Period||96
3173731|NCT01951638|3901438|FG002|STARTED|Treatment Period||96
3173732|NCT01951638|3901439|FG003|STARTED|Treatment Period||96
3173733|NCT01951638|3901440|FG004|STARTED|Treatment Period||96
3173734|NCT01951638|3901436|FG000|COMPLETED|Treatment Period||80
3173735|NCT01951638|3901437|FG001|COMPLETED|Treatment Period||82
3173736|NCT01951638|3901438|FG002|COMPLETED|Treatment Period||83
3173737|NCT01951638|3901439|FG003|COMPLETED|Treatment Period||80
3173738|NCT01951638|3901440|FG004|COMPLETED|Treatment Period||86
3173739|NCT01951638|3901436|FG000|NOT COMPLETED|Treatment Period||13
3173740|NCT01951638|3901437|FG001|NOT COMPLETED|Treatment Period||14
3173741|NCT01951638|3901438|FG002|NOT COMPLETED|Treatment Period||13
3173742|NCT01951638|3901439|FG003|NOT COMPLETED|Treatment Period||16
3173743|NCT01951638|3901440|FG004|NOT COMPLETED|Treatment Period||10
3173744|NCT01951638|3901436|FG000|STARTED|Follow-up Period||89
3173745|NCT01951638|3901437|FG001|STARTED|Follow-up Period||95
3173746|NCT01951638|3901438|FG002|STARTED|Follow-up Period||95
3173747|NCT01951638|3901439|FG003|STARTED|Follow-up Period||88
3173748|NCT01951638|3901440|FG004|STARTED|Follow-up Period||94
3173749|NCT01951638|3901436|FG000|COMPLETED|Follow-up Period||87
3173750|NCT01951638|3901437|FG001|COMPLETED|Follow-up Period||86
3173751|NCT01951638|3901438|FG002|COMPLETED|Follow-up Period||90
3173752|NCT01951638|3901439|FG003|COMPLETED|Follow-up Period||80
3173753|NCT01951638|3901440|FG004|COMPLETED|Follow-up Period||89
3173754|NCT01951638|3901436|FG000|NOT COMPLETED|Follow-up Period||2
3173755|NCT01951638|3901437|FG001|NOT COMPLETED|Follow-up Period||9
3173756|NCT01951638|3901438|FG002|NOT COMPLETED|Follow-up Period||5
3173757|NCT01951638|3901439|FG003|NOT COMPLETED|Follow-up Period||8
3173758|NCT01951638|3901440|FG004|NOT COMPLETED|Follow-up Period||5
3173759|NCT01951651|3901454|FG000|STARTED|Overall Study||12
3173760|NCT01951651|3901455|FG001|STARTED|Overall Study||12
3173761|NCT01951651|3901454|FG000|COMPLETED|Overall Study||8
3173762|NCT01951651|3901455|FG001|COMPLETED|Overall Study||10
3173763|NCT01951651|3901454|FG000|NOT COMPLETED|Overall Study||4
3173764|NCT01951651|3901455|FG001|NOT COMPLETED|Overall Study||2
3320008|NCT03154086|4053112|FG010|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
3320009|NCT03154086|4053113|FG011|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
3320010|NCT03154086|4053114|FG012|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
3320011|NCT03154086|4053115|FG013|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
3320012|NCT03154086|4053116|FG014|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
2923679|NCT00554788|3634680|FG000|NOT COMPLETED|Overall Study||7
2923680|NCT00554788|3634681|FG001|NOT COMPLETED|Overall Study||6
2923681|NCT00554788|3634682|FG002|NOT COMPLETED|Overall Study||14
2923682|NCT00554801|3634693|FG000|STARTED|Overall Study||55
2923683|NCT00554801|3634694|FG001|STARTED|Overall Study||29
2923684|NCT00554801|3634693|FG000|COMPLETED|Overall Study||36
2923685|NCT00554801|3634694|FG001|COMPLETED|Overall Study||29
2923686|NCT00554801|3634693|FG000|NOT COMPLETED|Overall Study||19
2923687|NCT00554801|3634694|FG001|NOT COMPLETED|Overall Study||0
2923688|NCT00554840|3634704|FG000|STARTED|Overall Study||4
2923689|NCT00554840|3634705|FG001|STARTED|Overall Study||5
2923690|NCT00554840|3634704|FG000|COMPLETED|Overall Study||4
2923691|NCT00554840|3634705|FG001|COMPLETED|Overall Study||4
2923692|NCT00554840|3634704|FG000|NOT COMPLETED|Overall Study||0
2923693|NCT00554840|3634705|FG001|NOT COMPLETED|Overall Study||1
2923694|NCT00554853|3634715|FG000|STARTED|First Arm of Study||72
2923695|NCT00554853|3634716|FG001|STARTED|First Arm of Study||71
2923696|NCT00554853|3634715|FG000|COMPLETED|First Arm of Study||56
2923697|NCT00554853|3634716|FG001|COMPLETED|First Arm of Study||64
2923698|NCT00554853|3634715|FG000|NOT COMPLETED|First Arm of Study||16
2923699|NCT00554853|3634716|FG001|NOT COMPLETED|First Arm of Study||7
2923700|NCT00554853|3634715|FG000|STARTED|Washout Period (2 Weeks)||56
2923701|NCT00554853|3634716|FG001|STARTED|Washout Period (2 Weeks)||64
2923702|NCT00554853|3634715|FG000|COMPLETED|Washout Period (2 Weeks)||56
2923703|NCT00554853|3634716|FG001|COMPLETED|Washout Period (2 Weeks)||57
2923704|NCT00554853|3634715|FG000|NOT COMPLETED|Washout Period (2 Weeks)||0
2923705|NCT00554853|3634716|FG001|NOT COMPLETED|Washout Period (2 Weeks)||7
2923706|NCT00554853|3634715|FG000|STARTED|Crossover Arm (3 Months)||56
2923707|NCT00554853|3634716|FG001|STARTED|Crossover Arm (3 Months)||57
2923708|NCT00554853|3634715|FG000|COMPLETED|Crossover Arm (3 Months)||53
2923709|NCT00554853|3634716|FG001|COMPLETED|Crossover Arm (3 Months)||55
2923710|NCT00554853|3634715|FG000|NOT COMPLETED|Crossover Arm (3 Months)||3
2923711|NCT00554853|3634716|FG001|NOT COMPLETED|Crossover Arm (3 Months)||2
2923712|NCT00554970|3634732|FG000|STARTED|Period 1||8
2923713|NCT00554970|3634733|FG001|STARTED|Period 1||8
2923714|NCT00554970|3634734|FG002|STARTED|Period 1||8
2923715|NCT00554970|3634735|FG003|STARTED|Period 1||8
2923716|NCT00554970|3634732|FG000|COMPLETED|Period 1||7
2923717|NCT00554970|3634733|FG001|COMPLETED|Period 1||8
2923718|NCT00554970|3634734|FG002|COMPLETED|Period 1||8
2923719|NCT00554970|3634735|FG003|COMPLETED|Period 1||8
2923720|NCT00554970|3634732|FG000|NOT COMPLETED|Period 1||1
2923721|NCT00554970|3634733|FG001|NOT COMPLETED|Period 1||0
2923722|NCT00554970|3634734|FG002|NOT COMPLETED|Period 1||0
2923723|NCT00554970|3634735|FG003|NOT COMPLETED|Period 1||0
2923724|NCT00554970|3634732|FG000|STARTED|Period 2||7
3320013|NCT03154086|4053102|FG000|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
3320014|NCT03154086|4053103|FG001|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
3320015|NCT03154086|4053104|FG002|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
2923725|NCT00554970|3634733|FG001|STARTED|Period 2||8
2923726|NCT00554970|3634734|FG002|STARTED|Period 2||8
2923727|NCT00554970|3634735|FG003|STARTED|Period 2||8
2923728|NCT00554970|3634732|FG000|COMPLETED|Period 2||7
2923729|NCT00554970|3634733|FG001|COMPLETED|Period 2||8
2923730|NCT00554970|3634734|FG002|COMPLETED|Period 2||7
2923731|NCT00554970|3634735|FG003|COMPLETED|Period 2||8
2923732|NCT00554970|3634732|FG000|NOT COMPLETED|Period 2||0
2923733|NCT00554970|3634733|FG001|NOT COMPLETED|Period 2||0
2923734|NCT00554970|3634734|FG002|NOT COMPLETED|Period 2||1
2923735|NCT00554970|3634735|FG003|NOT COMPLETED|Period 2||0
2923736|NCT00554996|3634745|FG000|STARTED|Overall Study||10
2923737|NCT00554996|3634745|FG000|COMPLETED|Overall Study||10
2923738|NCT00554996|3634745|FG000|NOT COMPLETED|Overall Study||0
2923739|NCT00555048|3634749|FG000|STARTED|Overall Study||1
2923740|NCT00555048|3634749|FG000|COMPLETED|Overall Study||1
2923741|NCT00555048|3634749|FG000|NOT COMPLETED|Overall Study||0
2923742|NCT00555061|3634753|FG000|STARTED|Overall Study|One participant did not receive study medication and was not included in the analysis population.|87
2923743|NCT00555061|3634753|FG000|COMPLETED|Overall Study||78
2923744|NCT00555061|3634753|FG000|NOT COMPLETED|Overall Study||9
2923745|NCT00555152|3634761|FG000|STARTED|Period Open at BCM: 1/17/08-3/8/10||2
2923746|NCT00555152|3634762|FG001|STARTED|Period Open at BCM: 1/17/08-3/8/10|Participants in initial and second study registration periods reported separately.|0
2923747|NCT00555152|3634763|FG002|STARTED|Period Open at BCM: 1/17/08-3/8/10||0
2923748|NCT00555152|3634764|FG003|STARTED|Period Open at BCM: 1/17/08-3/8/10||1
2923749|NCT00555152|3634761|FG000|COMPLETED|Period Open at BCM: 1/17/08-3/8/10||2
2923750|NCT00555152|3634762|FG001|COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
2923751|NCT00555152|3634763|FG002|COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
2923752|NCT00555152|3634764|FG003|COMPLETED|Period Open at BCM: 1/17/08-3/8/10||1
2923753|NCT00555152|3634761|FG000|NOT COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
2923754|NCT00555152|3634762|FG001|NOT COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
2923755|NCT00555152|3634763|FG002|NOT COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
2923756|NCT00555152|3634764|FG003|NOT COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
2923757|NCT00555152|3634761|FG000|STARTED|Transfer to MD Anderson: 9/19/11-8/28/14|Participants in initial and second study registration periods reported separately.|0
2923758|NCT00555152|3634762|FG001|STARTED|Transfer to MD Anderson: 9/19/11-8/28/14||10
2923759|NCT00555152|3634763|FG002|STARTED|Transfer to MD Anderson: 9/19/11-8/28/14||0
2923760|NCT00555152|3634764|FG003|STARTED|Transfer to MD Anderson: 9/19/11-8/28/14||9
2923761|NCT00555152|3634761|FG000|COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
2923762|NCT00555152|3634762|FG001|COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||10
2923763|NCT00555152|3634763|FG002|COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
2923764|NCT00555152|3634764|FG003|COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||9
2923765|NCT00555152|3634761|FG000|NOT COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
2923766|NCT00555152|3634762|FG001|NOT COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
2923767|NCT00555152|3634763|FG002|NOT COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
2923768|NCT00555152|3634764|FG003|NOT COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
2923769|NCT00555217|3634776|FG000|STARTED|Overall Study||724
2923770|NCT00555217|3634777|FG001|STARTED|Overall Study||724
2923771|NCT00555217|3634776|FG000|COMPLETED|Overall Study||649
2923772|NCT00555217|3634777|FG001|COMPLETED|Overall Study||656
2923773|NCT00555217|3634776|FG000|NOT COMPLETED|Overall Study||75
2923774|NCT00555217|3634777|FG001|NOT COMPLETED|Overall Study||68
2923775|NCT00555321|3634788|FG000|STARTED|Treatment Phase up to 12-months||52
2923776|NCT00555321|3634789|FG001|STARTED|Treatment Phase up to 12-months||51
2923777|NCT00555321|3634790|FG002|STARTED|Treatment Phase up to 12-months||50
2923778|NCT00555321|3634791|FG003|STARTED|Treatment Phase up to 12-months||53
2923779|NCT00555321|3634792|FG004|STARTED|Treatment Phase up to 12-months||54
2923780|NCT00555321|3634788|FG000|Received Transplant and Treated|Treatment Phase up to 12-months||50
2923781|NCT00555321|3634789|FG001|Received Transplant and Treated|Treatment Phase up to 12-months||48
2923782|NCT00555321|3634790|FG002|Received Transplant and Treated|Treatment Phase up to 12-months||49
2923783|NCT00555321|3634791|FG003|Received Transplant and Treated|Treatment Phase up to 12-months||53
2923784|NCT00555321|3634792|FG004|Received Transplant and Treated|Treatment Phase up to 12-months||50
2923785|NCT00555321|3634788|FG000|COMPLETED|Treatment Phase up to 12-months||31
3173765|NCT01951703|3901463|FG000|STARTED|First Intervention||64
3173766|NCT01951703|3901464|FG001|STARTED|First Intervention||63
3173767|NCT01951703|3901463|FG000|COMPLETED|First Intervention||61
3038788|NCT01154985|3758080|FG001|NOT COMPLETED|Overall Study||27
3038789|NCT01154985|3758081|FG002|NOT COMPLETED|Overall Study||18
3038790|NCT01155011|3758091|FG000|STARTED|Baseline to 6 Months||151
3173768|NCT01951703|3901464|FG001|COMPLETED|First Intervention||62
3173769|NCT01951703|3901463|FG000|NOT COMPLETED|First Intervention||3
3173770|NCT01951703|3901464|FG001|NOT COMPLETED|First Intervention||1
3173771|NCT01951703|3901463|FG000|STARTED|Second Intervention||61
3173772|NCT01951703|3901464|FG001|STARTED|Second Intervention||62
3173773|NCT01951703|3901463|FG000|COMPLETED|Second Intervention||61
3173774|NCT01951703|3901464|FG001|COMPLETED|Second Intervention||60
3173775|NCT01951703|3901463|FG000|NOT COMPLETED|Second Intervention||0
3173776|NCT01951703|3901464|FG001|NOT COMPLETED|Second Intervention||2
3173777|NCT01951768|3901473|FG000|STARTED|Overall Study||43
3173778|NCT01951768|3901474|FG001|STARTED|Overall Study||45
3173779|NCT01951768|3901473|FG000|COMPLETED|Overall Study|43 patients|43
3173780|NCT01951768|3901474|FG001|COMPLETED|Overall Study|45 patients|45
3173781|NCT01951768|3901473|FG000|NOT COMPLETED|Overall Study||0
3173782|NCT01951768|3901474|FG001|NOT COMPLETED|Overall Study||0
3173783|NCT01951820|3901482|FG000|STARTED|Overall Study||34
3173784|NCT01951820|3901483|FG001|STARTED|Overall Study||30
2923786|NCT00555321|3634789|FG001|COMPLETED|Treatment Phase up to 12-months||29
2923787|NCT00555321|3634790|FG002|COMPLETED|Treatment Phase up to 12-months||26
2923788|NCT00555321|3634791|FG003|COMPLETED|Treatment Phase up to 12-months||46
2923789|NCT00555321|3634792|FG004|COMPLETED|Treatment Phase up to 12-months||32
2923790|NCT00555321|3634788|FG000|NOT COMPLETED|Treatment Phase up to 12-months||21
2923791|NCT00555321|3634789|FG001|NOT COMPLETED|Treatment Phase up to 12-months||22
2923792|NCT00555321|3634790|FG002|NOT COMPLETED|Treatment Phase up to 12-months||24
2923793|NCT00555321|3634791|FG003|NOT COMPLETED|Treatment Phase up to 12-months||7
2923794|NCT00555321|3634792|FG004|NOT COMPLETED|Treatment Phase up to 12-months||22
2923795|NCT00555321|3634788|FG000|STARTED|Long-term Extension Phase|1 participant did not enter LTE|30
2923796|NCT00555321|3634789|FG001|STARTED|Long-term Extension Phase|2 participants did not enter LTE|27
2923797|NCT00555321|3634790|FG002|STARTED|Long-term Extension Phase|2 participants did not enter LTE|24
2923798|NCT00555321|3634791|FG003|STARTED|Long-term Extension Phase|8 participants did not enter LTE|38
2923799|NCT00555321|3634792|FG004|STARTED|Long-term Extension Phase|6 participants did not enter LTE|26
2923800|NCT00555321|3634788|FG000|COMPLETED|Long-term Extension Phase||0
2923801|NCT00555321|3634789|FG001|COMPLETED|Long-term Extension Phase||0
2923802|NCT00555321|3634790|FG002|COMPLETED|Long-term Extension Phase||0
2923803|NCT00555321|3634791|FG003|COMPLETED|Long-term Extension Phase||0
3038791|NCT01155011|3758092|FG001|STARTED|Baseline to 6 Months||156
3038792|NCT01155011|3758091|FG000|COMPLETED|Baseline to 6 Months||129
3038793|NCT01155011|3758092|FG001|COMPLETED|Baseline to 6 Months||131
3038794|NCT01155011|3758091|FG000|NOT COMPLETED|Baseline to 6 Months||22
3038795|NCT01155011|3758092|FG001|NOT COMPLETED|Baseline to 6 Months||25
3038796|NCT01155011|3758091|FG000|STARTED|6 to 12 Months||129
3038797|NCT01155011|3758092|FG001|STARTED|6 to 12 Months||131
3038798|NCT01155011|3758091|FG000|COMPLETED|6 to 12 Months||120
3038799|NCT01155011|3758092|FG001|COMPLETED|6 to 12 Months||121
3038800|NCT01155011|3758091|FG000|NOT COMPLETED|6 to 12 Months||9
3038801|NCT01155011|3758092|FG001|NOT COMPLETED|6 to 12 Months||10
3038802|NCT01155024|3758102|FG000|STARTED|First Socket Intervention Fitting||5
3038803|NCT01155024|3758103|FG001|STARTED|First Socket Intervention Fitting||5
3173785|NCT01951820|3901482|FG000|COMPLETED|Overall Study||34
3173786|NCT01951820|3901483|FG001|COMPLETED|Overall Study||30
3173787|NCT01951820|3901482|FG000|NOT COMPLETED|Overall Study||0
3173788|NCT01951820|3901483|FG001|NOT COMPLETED|Overall Study||0
3173789|NCT01951950|3901491|FG000|STARTED|Overall Study||26
2923804|NCT00555321|3634792|FG004|COMPLETED|Long-term Extension Phase||0
2923805|NCT00555321|3634788|FG000|NOT COMPLETED|Long-term Extension Phase||30
2923806|NCT00555321|3634789|FG001|NOT COMPLETED|Long-term Extension Phase||27
2923807|NCT00555321|3634790|FG002|NOT COMPLETED|Long-term Extension Phase||24
2923808|NCT00555321|3634791|FG003|NOT COMPLETED|Long-term Extension Phase||38
2923809|NCT00555321|3634792|FG004|NOT COMPLETED|Long-term Extension Phase||26
2923810|NCT00555360|3634811|FG000|STARTED|Overall Study||183
2923811|NCT00555360|3634812|FG001|STARTED|Overall Study||189
2923812|NCT00555360|3634811|FG000|COMPLETED|Overall Study||156
2923813|NCT00555360|3634812|FG001|COMPLETED|Overall Study||153
2923814|NCT00555360|3634811|FG000|NOT COMPLETED|Overall Study||27
3173790|NCT01951950|3901492|FG001|STARTED|Overall Study||26
3173791|NCT01951950|3901491|FG000|COMPLETED|Overall Study||20
3173792|NCT01951950|3901492|FG001|COMPLETED|Overall Study||20
3173793|NCT01951950|3901491|FG000|NOT COMPLETED|Overall Study||6
3173794|NCT01951950|3901492|FG001|NOT COMPLETED|Overall Study||6
3320016|NCT03154086|4053105|FG003|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
2923815|NCT00555360|3634812|FG001|NOT COMPLETED|Overall Study||36
2923816|NCT00555425|3634821|FG000|STARTED|Overall Study||57
2923817|NCT00555425|3634822|FG001|STARTED|Overall Study||56
2923818|NCT00555425|3634821|FG000|COMPLETED|Overall Study||6
2923819|NCT00555425|3634822|FG001|COMPLETED|Overall Study||37
2923820|NCT00555425|3634821|FG000|NOT COMPLETED|Overall Study||51
2923821|NCT00555425|3634822|FG001|NOT COMPLETED|Overall Study||19
2923822|NCT00555438|3634828|FG000|STARTED|10 Days Post-operative||442
2923823|NCT00555438|3634828|FG000|COMPLETED|10 Days Post-operative|438 patients attended the day 10 visit (four patients died during hospitalization)|438
2923824|NCT00555438|3634828|FG000|NOT COMPLETED|10 Days Post-operative||4
2923825|NCT00555438|3634828|FG000|STARTED|Between 10 Days and 30 Days Postoperativ||438
2923826|NCT00555438|3634828|FG000|COMPLETED|Between 10 Days and 30 Days Postoperativ||433
2923827|NCT00555438|3634828|FG000|NOT COMPLETED|Between 10 Days and 30 Days Postoperativ||5
2923828|NCT00555464|3634834|FG000|STARTED|Overall Study||4
2923829|NCT00555464|3634835|FG001|STARTED|Overall Study||4
2923830|NCT00555464|3634834|FG000|COMPLETED|Overall Study||4
2923831|NCT00555464|3634835|FG001|COMPLETED|Overall Study||1
2923832|NCT00555464|3634834|FG000|NOT COMPLETED|Overall Study||0
2923833|NCT00555464|3634835|FG001|NOT COMPLETED|Overall Study||3
2923834|NCT00555477|3634843|FG000|STARTED|Overall Study||14
2923835|NCT00555477|3634844|FG001|STARTED|Overall Study||45
2923836|NCT00555477|3634843|FG000|COMPLETED|Overall Study||12
2923837|NCT00555477|3634844|FG001|COMPLETED|Overall Study||32
2923838|NCT00555477|3634843|FG000|NOT COMPLETED|Overall Study||2
2923839|NCT00555477|3634844|FG001|NOT COMPLETED|Overall Study||13
2923840|NCT00555568|3634852|FG000|STARTED|Overall Study||100
2923841|NCT00555568|3634853|FG001|STARTED|Overall Study||98
2923842|NCT00555568|3634854|FG002|STARTED|Overall Study||100
2923843|NCT00555568|3634852|FG000|COMPLETED|Overall Study||74
2923844|NCT00555568|3634853|FG001|COMPLETED|Overall Study||82
2923845|NCT00555568|3634854|FG002|COMPLETED|Overall Study||84
2923846|NCT00555568|3634852|FG000|NOT COMPLETED|Overall Study||26
2923847|NCT00555568|3634853|FG001|NOT COMPLETED|Overall Study||16
2923848|NCT00555568|3634854|FG002|NOT COMPLETED|Overall Study||16
2923849|NCT00555581|3634862|FG000|STARTED|Overall Study||30
3320017|NCT03154086|4053106|FG004|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||6
3320018|NCT03154086|4053107|FG005|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||2
3320019|NCT03154086|4053108|FG006|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
3320020|NCT03154086|4053109|FG007|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
3320021|NCT03154086|4053110|FG008|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
3320022|NCT03154086|4053111|FG009|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
3320023|NCT03154086|4053112|FG010|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
3320024|NCT03154086|4053113|FG011|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
3320025|NCT03154086|4053114|FG012|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
3320026|NCT03154086|4053115|FG013|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
3320027|NCT03154086|4053116|FG014|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
3320028|NCT03154086|4053102|FG000|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
3320029|NCT03154086|4053103|FG001|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
3320030|NCT03154086|4053104|FG002|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
3320031|NCT03154086|4053105|FG003|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
3320032|NCT03154086|4053106|FG004|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
3320033|NCT03154086|4053107|FG005|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
3320034|NCT03154086|4053108|FG006|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
3320035|NCT03154086|4053109|FG007|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
3320036|NCT03154086|4053110|FG008|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
3320037|NCT03154086|4053111|FG009|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
3320038|NCT03154086|4053112|FG010|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
3320039|NCT03154086|4053113|FG011|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
3320040|NCT03154086|4053114|FG012|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
3320041|NCT03154086|4053115|FG013|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
3320042|NCT03154086|4053116|FG014|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
3320043|NCT03154086|4053102|FG000|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
3320044|NCT03154086|4053103|FG001|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
3320045|NCT03154086|4053104|FG002|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
3320046|NCT03154086|4053105|FG003|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
3320047|NCT03154086|4053106|FG004|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||6
3320048|NCT03154086|4053107|FG005|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||2
3320049|NCT03154086|4053108|FG006|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
3320050|NCT03154086|4053109|FG007|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
3320051|NCT03154086|4053110|FG008|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
3320052|NCT03154086|4053111|FG009|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
3320053|NCT03154086|4053112|FG010|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
3320054|NCT03154086|4053113|FG011|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
3320055|NCT03154086|4053114|FG012|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
3320056|NCT03154086|4053115|FG013|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
3320057|NCT03154086|4053116|FG014|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
3320058|NCT03154086|4053102|FG000|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
3320059|NCT03154086|4053103|FG001|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
3320060|NCT03154086|4053104|FG002|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
3320061|NCT03154086|4053105|FG003|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
3320062|NCT03154086|4053106|FG004|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||6
3320063|NCT03154086|4053107|FG005|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||2
3320064|NCT03154086|4053108|FG006|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
3320065|NCT03154086|4053109|FG007|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
3320066|NCT03154086|4053110|FG008|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
3320067|NCT03154086|4053111|FG009|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
3320068|NCT03154086|4053112|FG010|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
3320069|NCT03154086|4053113|FG011|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
3320070|NCT03154086|4053114|FG012|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
3320071|NCT03154086|4053115|FG013|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
3320072|NCT03154086|4053116|FG014|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
3320073|NCT03154086|4053102|FG000|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
3320074|NCT03154086|4053103|FG001|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
3320075|NCT03154086|4053104|FG002|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
3320076|NCT03154086|4053105|FG003|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
3320077|NCT03154086|4053106|FG004|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
3320078|NCT03154086|4053107|FG005|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
3173795|NCT01951963|3901500|FG000|STARTED|Overall Study||31
3173796|NCT01951963|3901501|FG001|STARTED|Overall Study||32
3173797|NCT01951963|3901500|FG000|COMPLETED|Overall Study||31
3173798|NCT01951963|3901501|FG001|COMPLETED|Overall Study||32
2923850|NCT00555581|3634862|FG000|COMPLETED|Overall Study||24
2923851|NCT00555581|3634862|FG000|NOT COMPLETED|Overall Study||6
2923852|NCT00555620|3634872|FG000|STARTED|Overall Study||6
2923853|NCT00555620|3634873|FG001|STARTED|Overall Study||7
2923854|NCT00555620|3634874|FG002|STARTED|Overall Study||15
2923855|NCT00555620|3634875|FG003|STARTED|Overall Study||23
3173799|NCT01951963|3901500|FG000|NOT COMPLETED|Overall Study||0
2923856|NCT00555620|3634876|FG004|STARTED|Overall Study||3
3173800|NCT01951963|3901501|FG001|NOT COMPLETED|Overall Study||0
3173801|NCT01952015|3901511|FG000|STARTED|Induction||12
3173802|NCT01952015|3901511|FG000|COMPLETED|Induction||11
3173803|NCT01952015|3901511|FG000|NOT COMPLETED|Induction||1
3173804|NCT01952015|3901511|FG000|STARTED|Maintenance||11
3320079|NCT03154086|4053108|FG006|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
3320080|NCT03154086|4053109|FG007|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
3320081|NCT03154086|4053110|FG008|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
3320082|NCT03154086|4053111|FG009|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
3320083|NCT03154086|4053112|FG010|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
3320084|NCT03154086|4053113|FG011|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
3320085|NCT03154086|4053114|FG012|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
3320086|NCT03154086|4053115|FG013|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
3320087|NCT03154086|4053116|FG014|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
3320088|NCT03154086|4053102|FG000|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
3320089|NCT03154086|4053103|FG001|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
3320090|NCT03154086|4053104|FG002|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
3320091|NCT03154086|4053105|FG003|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
3320092|NCT03154086|4053106|FG004|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
3320093|NCT03154086|4053107|FG005|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
3320094|NCT03154086|4053108|FG006|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||2
3320095|NCT03154086|4053109|FG007|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||2
3320096|NCT03154086|4053110|FG008|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||4
3320097|NCT03154086|4053111|FG009|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
3320098|NCT03154086|4053112|FG010|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
3320099|NCT03154086|4053113|FG011|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
3320100|NCT03154086|4053114|FG012|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
3320101|NCT03154086|4053115|FG013|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
3320102|NCT03154086|4053116|FG014|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
3320103|NCT03154086|4053102|FG000|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
3320104|NCT03154086|4053103|FG001|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
3320105|NCT03154086|4053104|FG002|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
3320106|NCT03154086|4053105|FG003|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
3320107|NCT03154086|4053106|FG004|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
3320108|NCT03154086|4053107|FG005|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
3320109|NCT03154086|4053108|FG006|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||2
3320110|NCT03154086|4053109|FG007|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||2
3320111|NCT03154086|4053110|FG008|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||4
3320112|NCT03154086|4053111|FG009|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
3320113|NCT03154086|4053112|FG010|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
3320114|NCT03154086|4053113|FG011|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
3320115|NCT03154086|4053114|FG012|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
3320116|NCT03154086|4053115|FG013|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
3320117|NCT03154086|4053116|FG014|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
3320118|NCT03154086|4053102|FG000|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
3173805|NCT01952015|3901511|FG000|COMPLETED|Maintenance||9
3173806|NCT01952015|3901511|FG000|NOT COMPLETED|Maintenance||2
3173807|NCT01952015|3901511|FG000|STARTED|Treatment Period 3||9
3320119|NCT03154086|4053103|FG001|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
3320120|NCT03154086|4053104|FG002|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
3320121|NCT03154086|4053105|FG003|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
3173808|NCT01952015|3901511|FG000|COMPLETED|Treatment Period 3||0
3320122|NCT03154086|4053106|FG004|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
3320123|NCT03154086|4053107|FG005|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
3320124|NCT03154086|4053108|FG006|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
3320125|NCT03154086|4053109|FG007|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
3320126|NCT03154086|4053110|FG008|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
3320127|NCT03154086|4053111|FG009|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
3320128|NCT03154086|4053112|FG010|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
3320129|NCT03154086|4053113|FG011|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
3320130|NCT03154086|4053114|FG012|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
2923857|NCT00555620|3634877|FG005|STARTED|Overall Study||22
2923858|NCT00555620|3634872|FG000|COMPLETED|Overall Study||0
2923859|NCT00555620|3634873|FG001|COMPLETED|Overall Study||0
3173809|NCT01952015|3901511|FG000|NOT COMPLETED|Treatment Period 3||9
3173810|NCT01952041|3901529|FG000|STARTED|Overall Study||62
3173811|NCT01952041|3901530|FG001|STARTED|Overall Study||64
3173812|NCT01952041|3901529|FG000|COMPLETED|Overall Study||45
3320131|NCT03154086|4053115|FG013|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
3320132|NCT03154086|4053116|FG014|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
2923860|NCT00555620|3634874|FG002|COMPLETED|Overall Study||0
2923861|NCT00555620|3634875|FG003|COMPLETED|Overall Study||0
2923862|NCT00555620|3634876|FG004|COMPLETED|Overall Study||0
2923863|NCT00555620|3634877|FG005|COMPLETED|Overall Study||0
2923864|NCT00555620|3634872|FG000|NOT COMPLETED|Overall Study||6
2923865|NCT00555620|3634873|FG001|NOT COMPLETED|Overall Study||7
2923866|NCT00555620|3634874|FG002|NOT COMPLETED|Overall Study||15
2923867|NCT00555620|3634875|FG003|NOT COMPLETED|Overall Study||23
2923868|NCT00555620|3634876|FG004|NOT COMPLETED|Overall Study||3
2923869|NCT00555620|3634877|FG005|NOT COMPLETED|Overall Study||22
2923870|NCT00555672|3634897|FG000|STARTED|Overall Study||24
2923871|NCT00555672|3634898|FG001|STARTED|Overall Study||10
2923872|NCT00555672|3634897|FG000|COMPLETED|Overall Study||0
2923873|NCT00555672|3634898|FG001|COMPLETED|Overall Study||0
2923874|NCT00555672|3634897|FG000|NOT COMPLETED|Overall Study||24
2923875|NCT00555672|3634898|FG001|NOT COMPLETED|Overall Study||10
2923876|NCT00555750|3634906|FG000|STARTED|Overall Study||10
2923877|NCT00555750|3634907|FG001|STARTED|Overall Study||10
2923878|NCT00555750|3634906|FG000|COMPLETED|Overall Study||10
2923879|NCT00555750|3634907|FG001|COMPLETED|Overall Study||10
2923880|NCT00555750|3634906|FG000|NOT COMPLETED|Overall Study||0
3320133|NCT03154086|4053102|FG000|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
3320134|NCT03154086|4053103|FG001|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
3320135|NCT03154086|4053104|FG002|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
3320136|NCT03154086|4053105|FG003|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
3320137|NCT03154086|4053106|FG004|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
3320138|NCT03154086|4053107|FG005|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
3320139|NCT03154086|4053108|FG006|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||2
3320140|NCT03154086|4053109|FG007|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||2
2923881|NCT00555750|3634907|FG001|NOT COMPLETED|Overall Study||0
2923882|NCT00555880|3634915|FG000|STARTED|Treatment Period 1 (1 Day)||13
2923883|NCT00555880|3634916|FG001|STARTED|Treatment Period 1 (1 Day)||11
2923884|NCT00555880|3634915|FG000|COMPLETED|Treatment Period 1 (1 Day)||13
2923885|NCT00555880|3634916|FG001|COMPLETED|Treatment Period 1 (1 Day)||11
2923886|NCT00555880|3634915|FG000|NOT COMPLETED|Treatment Period 1 (1 Day)||0
2923887|NCT00555880|3634916|FG001|NOT COMPLETED|Treatment Period 1 (1 Day)||0
2923888|NCT00555880|3634915|FG000|STARTED|Washout (1 Day)||13
2923889|NCT00555880|3634916|FG001|STARTED|Washout (1 Day)||11
2923890|NCT00555880|3634915|FG000|COMPLETED|Washout (1 Day)||13
2923891|NCT00555880|3634916|FG001|COMPLETED|Washout (1 Day)||11
2923892|NCT00555880|3634915|FG000|NOT COMPLETED|Washout (1 Day)||0
2923893|NCT00555880|3634916|FG001|NOT COMPLETED|Washout (1 Day)||0
2923894|NCT00555880|3634915|FG000|STARTED|Treatment Period 2 (1 Day)||13
2923895|NCT00555880|3634916|FG001|STARTED|Treatment Period 2 (1 Day)||11
2923896|NCT00555880|3634915|FG000|COMPLETED|Treatment Period 2 (1 Day)||13
2923897|NCT00555880|3634916|FG001|COMPLETED|Treatment Period 2 (1 Day)||11
2923898|NCT00555880|3634915|FG000|NOT COMPLETED|Treatment Period 2 (1 Day)||0
2923899|NCT00555880|3634916|FG001|NOT COMPLETED|Treatment Period 2 (1 Day)||0
2923900|NCT00555893|3634925|FG000|STARTED|Overall Study||130
2923901|NCT00555893|3634926|FG001|STARTED|Overall Study||63
2923902|NCT00555893|3634925|FG000|Final Analysis|Overall Study|n=16 excluded from number started because >119 hrs|114
3136958|NCT01716520|3862281|FG003|STARTED|Treatment Period 1 (14 Days)||30
3320141|NCT03154086|4053110|FG008|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||4
3320142|NCT03154086|4053111|FG009|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
3320143|NCT03154086|4053112|FG010|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
3320144|NCT03154086|4053113|FG011|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
3320145|NCT03154086|4053114|FG012|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
3320146|NCT03154086|4053115|FG013|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
3320147|NCT03154086|4053116|FG014|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
3320148|NCT03154086|4053102|FG000|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
3320149|NCT03154086|4053103|FG001|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
3320150|NCT03154086|4053104|FG002|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
3320151|NCT03154086|4053105|FG003|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
3320152|NCT03154086|4053106|FG004|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
2923903|NCT00555893|3634926|FG001|Final Analysis|Overall Study|n=12 excluded from number started because >119 hrs|51
2923904|NCT00555893|3634925|FG000|COMPLETED|Overall Study||130
2923905|NCT00555893|3634926|FG001|COMPLETED|Overall Study||63
2923906|NCT00555893|3634925|FG000|NOT COMPLETED|Overall Study||0
3173813|NCT01952041|3901530|FG001|COMPLETED|Overall Study||43
3038804|NCT01155024|3758102|FG000|COMPLETED|First Socket Intervention Fitting||5
3038805|NCT01155024|3758103|FG001|COMPLETED|First Socket Intervention Fitting||5
3038806|NCT01155024|3758102|FG000|NOT COMPLETED|First Socket Intervention Fitting||0
3038807|NCT01155024|3758103|FG001|NOT COMPLETED|First Socket Intervention Fitting||0
3038808|NCT01155024|3758102|FG000|STARTED|Second Socket Intervention Fitting||5
3038809|NCT01155024|3758103|FG001|STARTED|Second Socket Intervention Fitting||5
3038810|NCT01155024|3758102|FG000|COMPLETED|Second Socket Intervention Fitting||5
3038811|NCT01155024|3758103|FG001|COMPLETED|Second Socket Intervention Fitting||5
3038812|NCT01155024|3758102|FG000|NOT COMPLETED|Second Socket Intervention Fitting||0
3038813|NCT01155024|3758103|FG001|NOT COMPLETED|Second Socket Intervention Fitting||0
3038814|NCT01155024|3758102|FG000|STARTED|Direct Manufactured Socket 3 Month Trial||0
3038815|NCT01155024|3758103|FG001|STARTED|Direct Manufactured Socket 3 Month Trial||10
3038816|NCT01155024|3758102|FG000|COMPLETED|Direct Manufactured Socket 3 Month Trial||0
3038817|NCT01155024|3758103|FG001|COMPLETED|Direct Manufactured Socket 3 Month Trial||4
3038818|NCT01155024|3758102|FG000|NOT COMPLETED|Direct Manufactured Socket 3 Month Trial||0
3038819|NCT01155024|3758103|FG001|NOT COMPLETED|Direct Manufactured Socket 3 Month Trial||6
3173814|NCT01952041|3901529|FG000|NOT COMPLETED|Overall Study||17
3173815|NCT01952041|3901530|FG001|NOT COMPLETED|Overall Study||21
3173816|NCT01952054|3901536|FG000|STARTED|Overall Study||6
3038820|NCT01155050|3758114|FG000|STARTED|Overall Study||50
3038821|NCT01155050|3758115|FG001|STARTED|Overall Study||51
3038822|NCT01155050|3758116|FG002|STARTED|Overall Study||52
3038823|NCT01155050|3758117|FG003|STARTED|Overall Study||49
3038824|NCT01155050|3758114|FG000|COMPLETED|Overall Study||35
3038825|NCT01155050|3758115|FG001|COMPLETED|Overall Study||31
3038826|NCT01155050|3758116|FG002|COMPLETED|Overall Study||33
3038827|NCT01155050|3758117|FG003|COMPLETED|Overall Study||27
3038828|NCT01155050|3758114|FG000|NOT COMPLETED|Overall Study||15
3038829|NCT01155050|3758115|FG001|NOT COMPLETED|Overall Study||20
3038830|NCT01155050|3758116|FG002|NOT COMPLETED|Overall Study||19
3038831|NCT01155050|3758117|FG003|NOT COMPLETED|Overall Study||22
3038832|NCT01155063|3758127|FG000|STARTED|Overall Study||89
3038833|NCT01155063|3758127|FG000|COMPLETED|Overall Study||0
3038834|NCT01155063|3758127|FG000|NOT COMPLETED|Overall Study||89
3038835|NCT01155141|3758131|FG000|STARTED|Overall Study||16
3038836|NCT01155141|3758131|FG000|COMPLETED|Overall Study||14
3038837|NCT01155141|3758131|FG000|NOT COMPLETED|Overall Study||2
3038838|NCT01155154|3758138|FG000|STARTED|Overall Study||25
3038839|NCT01155154|3758139|FG001|STARTED|Overall Study||24
3038840|NCT01155154|3758140|FG002|STARTED|Overall Study||24
3038841|NCT01155154|3758138|FG000|COMPLETED|Overall Study||25
3038842|NCT01155154|3758139|FG001|COMPLETED|Overall Study||24
3038843|NCT01155154|3758140|FG002|COMPLETED|Overall Study||24
3038844|NCT01155154|3758138|FG000|NOT COMPLETED|Overall Study||0
3038845|NCT01155154|3758139|FG001|NOT COMPLETED|Overall Study||0
3038846|NCT01155154|3758140|FG002|NOT COMPLETED|Overall Study||0
3038847|NCT01155167|3758150|FG000|STARTED|Overall Study||43
3173817|NCT01952054|3901536|FG000|COMPLETED|Overall Study||5
3173818|NCT01952054|3901536|FG000|NOT COMPLETED|Overall Study||1
3173819|NCT01952080|3901544|FG000|STARTED|Overall Study||5
3173820|NCT01952080|3901545|FG001|STARTED|Overall Study||8
3173821|NCT01952080|3901546|FG002|STARTED|Overall Study||14
3173822|NCT01952080|3901547|FG003|STARTED|Overall Study||15
3173823|NCT01952080|3901544|FG000|Treated|Overall Study||5
3173824|NCT01952080|3901545|FG001|Treated|Overall Study||8
3173825|NCT01952080|3901546|FG002|Treated|Overall Study||14
3173826|NCT01952080|3901547|FG003|Treated|Overall Study||15
3173827|NCT01952080|3901544|FG000|COMPLETED|Overall Study||5
3173828|NCT01952080|3901545|FG001|COMPLETED|Overall Study||7
3173829|NCT01952080|3901546|FG002|COMPLETED|Overall Study||14
3173830|NCT01952080|3901547|FG003|COMPLETED|Overall Study||14
3173831|NCT01952080|3901544|FG000|NOT COMPLETED|Overall Study||0
3173832|NCT01952080|3901545|FG001|NOT COMPLETED|Overall Study||1
3320153|NCT03154086|4053107|FG005|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
3320154|NCT03154086|4053108|FG006|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||2
3038848|NCT01155167|3758151|FG001|STARTED|Overall Study||43
3038849|NCT01155167|3758150|FG000|COMPLETED|Overall Study||40
3173833|NCT01952080|3901546|FG002|NOT COMPLETED|Overall Study||0
3173834|NCT01952080|3901547|FG003|NOT COMPLETED|Overall Study||1
3173835|NCT01952145|3901559|FG000|STARTED|Overall Study||278
3320155|NCT03154086|4053109|FG007|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||2
3320156|NCT03154086|4053110|FG008|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||4
3320157|NCT03154086|4053111|FG009|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
3320158|NCT03154086|4053112|FG010|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
3320159|NCT03154086|4053113|FG011|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
3320160|NCT03154086|4053114|FG012|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
3320161|NCT03154086|4053115|FG013|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
3038850|NCT01155167|3758151|FG001|COMPLETED|Overall Study||43
3038851|NCT01155167|3758150|FG000|NOT COMPLETED|Overall Study||3
3038852|NCT01155167|3758151|FG001|NOT COMPLETED|Overall Study||0
3038853|NCT01155180|3758159|FG000|STARTED|Overall Study||18
3038854|NCT01155180|3758160|FG001|STARTED|Overall Study||6
3038855|NCT01155180|3758159|FG000|COMPLETED|Overall Study||18
3038856|NCT01155180|3758160|FG001|COMPLETED|Overall Study||6
3038857|NCT01155180|3758159|FG000|NOT COMPLETED|Overall Study||0
3038858|NCT01155180|3758160|FG001|NOT COMPLETED|Overall Study||0
3038859|NCT01155193|3758170|FG000|STARTED|Overall Study||10924
3038860|NCT01155193|3758171|FG001|STARTED|Overall Study||3818
3038861|NCT01155193|3758172|FG002|STARTED|Overall Study||2260
3038862|NCT01155193|3758173|FG003|STARTED|Overall Study||13802
3038863|NCT01155193|3758170|FG000|COMPLETED|Overall Study|Evaluable population (participants treated between 01 September and 01 May of the following year)|10686
3038864|NCT01155193|3758171|FG001|COMPLETED|Overall Study|Evaluable population (participants treated between 01 September and 01 May of the following year)|3805
3038865|NCT01155193|3758172|FG002|COMPLETED|Overall Study|Evaluable population (participants treated between 01 September and 01 May of the following year)|2248
3038866|NCT01155193|3758173|FG003|COMPLETED|Overall Study|Evaluable population (participants treated between 01 September and 01 May of the following year)|13711
3038867|NCT01155193|3758170|FG000|NOT COMPLETED|Overall Study||238
3038868|NCT01155193|3758171|FG001|NOT COMPLETED|Overall Study||13
3038869|NCT01155193|3758172|FG002|NOT COMPLETED|Overall Study||12
3038870|NCT01155193|3758173|FG003|NOT COMPLETED|Overall Study||91
3038871|NCT01155219|3758190|FG000|STARTED|Overall Study||77
3038872|NCT01155219|3758191|FG001|STARTED|Overall Study||73
3038873|NCT01155219|3758190|FG000|COMPLETED|Overall Study||73
3038874|NCT01155219|3758191|FG001|COMPLETED|Overall Study||70
3038875|NCT01155219|3758190|FG000|NOT COMPLETED|Overall Study||4
3038876|NCT01155219|3758191|FG001|NOT COMPLETED|Overall Study||3
3038877|NCT01155284|3758199|FG000|STARTED|Overall Study||47
3038878|NCT01155284|3758200|FG001|STARTED|Overall Study||23
3038879|NCT01155284|3758199|FG000|COMPLETED|Overall Study||40
3038880|NCT01155284|3758200|FG001|COMPLETED|Overall Study||18
3173836|NCT01952145|3901560|FG001|STARTED|Overall Study||279
2923907|NCT00555893|3634926|FG001|NOT COMPLETED|Overall Study||0
2923908|NCT00555906|3634935|FG000|STARTED|Phase 1||3
2923909|NCT00555906|3634936|FG001|STARTED|Phase 1||6
2923910|NCT00555906|3634937|FG002|STARTED|Phase 1||7
2923911|NCT00555906|3634938|FG003|STARTED|Phase 1||5
2923912|NCT00555906|3634939|FG004|STARTED|Phase 1||0
2923913|NCT00555906|3634935|FG000|COMPLETED|Phase 1||0
2923914|NCT00555906|3634936|FG001|COMPLETED|Phase 1||0
2923915|NCT00555906|3634937|FG002|COMPLETED|Phase 1||0
2923916|NCT00555906|3634938|FG003|COMPLETED|Phase 1||0
2923917|NCT00555906|3634939|FG004|COMPLETED|Phase 1||0
2923918|NCT00555906|3634935|FG000|NOT COMPLETED|Phase 1||3
2923919|NCT00555906|3634936|FG001|NOT COMPLETED|Phase 1||6
2923920|NCT00555906|3634937|FG002|NOT COMPLETED|Phase 1||7
2923921|NCT00555906|3634938|FG003|NOT COMPLETED|Phase 1||5
2923922|NCT00555906|3634939|FG004|NOT COMPLETED|Phase 1||0
2923923|NCT00555906|3634935|FG000|STARTED|Phase 2||0
2923924|NCT00555906|3634936|FG001|STARTED|Phase 2||0
2923925|NCT00555906|3634937|FG002|STARTED|Phase 2||0
2923926|NCT00555906|3634938|FG003|STARTED|Phase 2||0
2923927|NCT00555906|3634939|FG004|STARTED|Phase 2||32
2923928|NCT00555906|3634935|FG000|Treated|Phase 2||0
2923929|NCT00555906|3634936|FG001|Treated|Phase 2||0
2923930|NCT00555906|3634937|FG002|Treated|Phase 2||0
2923931|NCT00555906|3634938|FG003|Treated|Phase 2||0
2923932|NCT00555906|3634939|FG004|Treated|Phase 2||30
2923933|NCT00555906|3634935|FG000|COMPLETED|Phase 2||0
2923934|NCT00555906|3634936|FG001|COMPLETED|Phase 2||0
2923935|NCT00555906|3634937|FG002|COMPLETED|Phase 2||0
2923936|NCT00555906|3634938|FG003|COMPLETED|Phase 2||0
2923937|NCT00555906|3634939|FG004|COMPLETED|Phase 2||0
2923938|NCT00555906|3634935|FG000|NOT COMPLETED|Phase 2||0
2923939|NCT00555906|3634936|FG001|NOT COMPLETED|Phase 2||0
2923940|NCT00555906|3634937|FG002|NOT COMPLETED|Phase 2||0
2923941|NCT00555906|3634938|FG003|NOT COMPLETED|Phase 2||0
2923942|NCT00555906|3634939|FG004|NOT COMPLETED|Phase 2||32
2923943|NCT00555971|3634956|FG000|STARTED|Overall Study||5
2923944|NCT00555971|3634957|FG001|STARTED|Overall Study||8
2923945|NCT00555971|3634956|FG000|COMPLETED|Overall Study||4
2923946|NCT00555971|3634957|FG001|COMPLETED|Overall Study||7
2923947|NCT00555971|3634956|FG000|NOT COMPLETED|Overall Study||1
2923948|NCT00555971|3634957|FG001|NOT COMPLETED|Overall Study||1
3173837|NCT01952145|3901559|FG000|COMPLETED|Overall Study||250
3173838|NCT01952145|3901560|FG001|COMPLETED|Overall Study||265
3173839|NCT01952145|3901559|FG000|NOT COMPLETED|Overall Study||28
3173840|NCT01952145|3901560|FG001|NOT COMPLETED|Overall Study||14
3173841|NCT01952301|3901566|FG000|STARTED|Overall Study|We designed and implemented a single-blind, randomized, controlled, split-mouth study of 30 subjects|30
2923949|NCT00555997|3634966|FG000|STARTED|Phase 1 SPCD||29
2923950|NCT00555997|3634967|FG001|STARTED|Phase 1 SPCD||91
2923951|NCT00555997|3634968|FG002|STARTED|Phase 1 SPCD||0
2923952|NCT00555997|3634969|FG003|STARTED|Phase 1 SPCD||0
2923953|NCT00555997|3634966|FG000|COMPLETED|Phase 1 SPCD||17
2923954|NCT00555997|3634967|FG001|COMPLETED|Phase 1 SPCD||76
2923955|NCT00555997|3634968|FG002|COMPLETED|Phase 1 SPCD||0
2923956|NCT00555997|3634969|FG003|COMPLETED|Phase 1 SPCD||0
2923957|NCT00555997|3634966|FG000|NOT COMPLETED|Phase 1 SPCD||12
2923958|NCT00555997|3634967|FG001|NOT COMPLETED|Phase 1 SPCD||15
2923959|NCT00555997|3634968|FG002|NOT COMPLETED|Phase 1 SPCD||0
2923960|NCT00555997|3634969|FG003|NOT COMPLETED|Phase 1 SPCD||0
3038881|NCT01155284|3758199|FG000|NOT COMPLETED|Overall Study||7
3038882|NCT01155284|3758200|FG001|NOT COMPLETED|Overall Study||5
3038883|NCT01155323|3758208|FG000|STARTED|First Intervention||60
3038884|NCT01155323|3758209|FG001|STARTED|First Intervention||58
3038885|NCT01155323|3758208|FG000|COMPLETED|First Intervention||59
3038886|NCT01155323|3758209|FG001|COMPLETED|First Intervention||57
3038887|NCT01155323|3758208|FG000|NOT COMPLETED|First Intervention||1
3038888|NCT01155323|3758209|FG001|NOT COMPLETED|First Intervention||1
3038889|NCT01155323|3758208|FG000|STARTED|Second Intervention||59
3038890|NCT01155323|3758209|FG001|STARTED|Second Intervention||57
3038891|NCT01155323|3758208|FG000|COMPLETED|Second Intervention||58
3038892|NCT01155323|3758209|FG001|COMPLETED|Second Intervention||56
3038893|NCT01155323|3758208|FG000|NOT COMPLETED|Second Intervention||1
3038894|NCT01155323|3758209|FG001|NOT COMPLETED|Second Intervention||1
3173842|NCT01952301|3901566|FG000|COMPLETED|Overall Study||30
3173843|NCT01952301|3901566|FG000|NOT COMPLETED|Overall Study||0
3173844|NCT01952366|3901572|FG000|STARTED|Overall Study||169
3173845|NCT01952366|3901572|FG000|COMPLETED|Overall Study||138
3173846|NCT01952366|3901572|FG000|NOT COMPLETED|Overall Study||31
3173847|NCT01952418|3901581|FG000|STARTED|Overall Study||910
3173848|NCT01952418|3901582|FG001|STARTED|Overall Study||895
3173849|NCT01952418|3901581|FG000|COMPLETED|Overall Study||910
3173850|NCT01952418|3901582|FG001|COMPLETED|Overall Study||895
3173851|NCT01952418|3901581|FG000|NOT COMPLETED|Overall Study||0
3173852|NCT01952418|3901582|FG001|NOT COMPLETED|Overall Study||0
3320162|NCT03154086|4053116|FG014|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
3320163|NCT03154086|4053102|FG000|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
3320164|NCT03154086|4053103|FG001|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
3320165|NCT03154086|4053104|FG002|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
3320166|NCT03154086|4053105|FG003|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
3320167|NCT03154086|4053106|FG004|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
3320168|NCT03154086|4053107|FG005|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
3320169|NCT03154086|4053108|FG006|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
3320170|NCT03154086|4053109|FG007|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
3320171|NCT03154086|4053110|FG008|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
3320172|NCT03154086|4053111|FG009|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
3320173|NCT03154086|4053112|FG010|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
3320174|NCT03154086|4053113|FG011|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
3320175|NCT03154086|4053114|FG012|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
3320176|NCT03154086|4053115|FG013|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
3320177|NCT03154086|4053116|FG014|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
3320178|NCT03154086|4053102|FG000|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
3320179|NCT03154086|4053103|FG001|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
3320180|NCT03154086|4053104|FG002|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
3320181|NCT03154086|4053105|FG003|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
3320182|NCT03154086|4053106|FG004|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
3320183|NCT03154086|4053107|FG005|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
3320184|NCT03154086|4053108|FG006|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||2
3320185|NCT03154086|4053109|FG007|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||2
3320186|NCT03154086|4053110|FG008|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)|1 par was unwell on Day-1 of Period 2 and discontinued; hence,1 replacement was enrolled and dosed|5
3320187|NCT03154086|4053111|FG009|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
3320188|NCT03154086|4053112|FG010|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
3320189|NCT03154086|4053113|FG011|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
3320190|NCT03154086|4053114|FG012|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
3320191|NCT03154086|4053115|FG013|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
3320192|NCT03154086|4053116|FG014|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
3320193|NCT03154086|4053102|FG000|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
3320194|NCT03154086|4053103|FG001|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
3320195|NCT03154086|4053104|FG002|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
3320196|NCT03154086|4053105|FG003|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
3320197|NCT03154086|4053106|FG004|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
3320198|NCT03154086|4053107|FG005|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
3320199|NCT03154086|4053108|FG006|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||2
3320200|NCT03154086|4053109|FG007|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||1
3320201|NCT03154086|4053110|FG008|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||4
3320202|NCT03154086|4053111|FG009|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
3320203|NCT03154086|4053112|FG010|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
3320204|NCT03154086|4053113|FG011|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
3320205|NCT03154086|4053114|FG012|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
3320206|NCT03154086|4053115|FG013|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
3320207|NCT03154086|4053116|FG014|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
3320208|NCT03154086|4053102|FG000|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
3320209|NCT03154086|4053103|FG001|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
3320210|NCT03154086|4053104|FG002|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
3320211|NCT03154086|4053105|FG003|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
3320212|NCT03154086|4053106|FG004|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
3320213|NCT03154086|4053107|FG005|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
3320214|NCT03154086|4053108|FG006|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
3320215|NCT03154086|4053109|FG007|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||1
3320216|NCT03154086|4053110|FG008|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||1
3320217|NCT03154086|4053111|FG009|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
3320218|NCT03154086|4053112|FG010|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
3320219|NCT03154086|4053113|FG011|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
3320220|NCT03154086|4053114|FG012|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
3320221|NCT03154086|4053115|FG013|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
3320222|NCT03154086|4053116|FG014|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
3320223|NCT03154086|4053102|FG000|STARTED|Part B (Up to 25 Days)||0
3320224|NCT03154086|4053103|FG001|STARTED|Part B (Up to 25 Days)||0
3136959|NCT01716520|3862282|FG004|STARTED|Treatment Period 1 (14 Days)||31
3320225|NCT03154086|4053104|FG002|STARTED|Part B (Up to 25 Days)||0
3320226|NCT03154086|4053105|FG003|STARTED|Part B (Up to 25 Days)||0
3320227|NCT03154086|4053106|FG004|STARTED|Part B (Up to 25 Days)||0
3320228|NCT03154086|4053107|FG005|STARTED|Part B (Up to 25 Days)||0
3320229|NCT03154086|4053108|FG006|STARTED|Part B (Up to 25 Days)||0
3320230|NCT03154086|4053109|FG007|STARTED|Part B (Up to 25 Days)||0
3320231|NCT03154086|4053110|FG008|STARTED|Part B (Up to 25 Days)||0
3320232|NCT03154086|4053111|FG009|STARTED|Part B (Up to 25 Days)||10
3320233|NCT03154086|4053112|FG010|STARTED|Part B (Up to 25 Days)||6
3320234|NCT03154086|4053113|FG011|STARTED|Part B (Up to 25 Days)||6
3320235|NCT03154086|4053114|FG012|STARTED|Part B (Up to 25 Days)||6
3320236|NCT03154086|4053115|FG013|STARTED|Part B (Up to 25 Days)||6
3320237|NCT03154086|4053116|FG014|STARTED|Part B (Up to 25 Days)||6
3320238|NCT03154086|4053102|FG000|COMPLETED|Part B (Up to 25 Days)||0
3320239|NCT03154086|4053103|FG001|COMPLETED|Part B (Up to 25 Days)||0
3320240|NCT03154086|4053104|FG002|COMPLETED|Part B (Up to 25 Days)||0
3320241|NCT03154086|4053105|FG003|COMPLETED|Part B (Up to 25 Days)||0
3320242|NCT03154086|4053106|FG004|COMPLETED|Part B (Up to 25 Days)||0
3320243|NCT03154086|4053107|FG005|COMPLETED|Part B (Up to 25 Days)||0
3320244|NCT03154086|4053108|FG006|COMPLETED|Part B (Up to 25 Days)||0
3320245|NCT03154086|4053109|FG007|COMPLETED|Part B (Up to 25 Days)||0
3320246|NCT03154086|4053110|FG008|COMPLETED|Part B (Up to 25 Days)||0
3320247|NCT03154086|4053111|FG009|COMPLETED|Part B (Up to 25 Days)||10
3320248|NCT03154086|4053112|FG010|COMPLETED|Part B (Up to 25 Days)||5
3320249|NCT03154086|4053113|FG011|COMPLETED|Part B (Up to 25 Days)||6
3320250|NCT03154086|4053114|FG012|COMPLETED|Part B (Up to 25 Days)||6
3320251|NCT03154086|4053115|FG013|COMPLETED|Part B (Up to 25 Days)||6
3320252|NCT03154086|4053116|FG014|COMPLETED|Part B (Up to 25 Days)||6
3320253|NCT03154086|4053102|FG000|NOT COMPLETED|Part B (Up to 25 Days)||0
3320254|NCT03154086|4053103|FG001|NOT COMPLETED|Part B (Up to 25 Days)||0
3320255|NCT03154086|4053104|FG002|NOT COMPLETED|Part B (Up to 25 Days)||0
3320256|NCT03154086|4053105|FG003|NOT COMPLETED|Part B (Up to 25 Days)||0
3320257|NCT03154086|4053106|FG004|NOT COMPLETED|Part B (Up to 25 Days)||0
3320258|NCT03154086|4053107|FG005|NOT COMPLETED|Part B (Up to 25 Days)||0
3320259|NCT03154086|4053108|FG006|NOT COMPLETED|Part B (Up to 25 Days)||0
3320260|NCT03154086|4053109|FG007|NOT COMPLETED|Part B (Up to 25 Days)||0
3320261|NCT03154086|4053110|FG008|NOT COMPLETED|Part B (Up to 25 Days)||0
3320262|NCT03154086|4053111|FG009|NOT COMPLETED|Part B (Up to 25 Days)||0
3320263|NCT03154086|4053112|FG010|NOT COMPLETED|Part B (Up to 25 Days)||1
3320264|NCT03154086|4053113|FG011|NOT COMPLETED|Part B (Up to 25 Days)||0
3320265|NCT03154086|4053114|FG012|NOT COMPLETED|Part B (Up to 25 Days)||0
3320266|NCT03154086|4053115|FG013|NOT COMPLETED|Part B (Up to 25 Days)||0
3320267|NCT03154086|4053116|FG014|NOT COMPLETED|Part B (Up to 25 Days)||0
3320268|NCT03154333|4053174|FG000|STARTED|Overall Study||28
3320269|NCT03154333|4053175|FG001|STARTED|Overall Study||26
3320270|NCT03154333|4053174|FG000|COMPLETED|Overall Study||21
3320271|NCT03154333|4053175|FG001|COMPLETED|Overall Study||21
3320272|NCT03154333|4053174|FG000|NOT COMPLETED|Overall Study||7
3320273|NCT03154333|4053175|FG001|NOT COMPLETED|Overall Study||5
3320274|NCT03154476|4053184|FG000|STARTED|Overall Study||10
3320275|NCT03154476|4053185|FG001|STARTED|Overall Study||10
3320276|NCT03154476|4053184|FG000|COMPLETED|Overall Study||6
3320277|NCT03154476|4053185|FG001|COMPLETED|Overall Study||6
3320278|NCT03154476|4053184|FG000|NOT COMPLETED|Overall Study||4
3320279|NCT03154476|4053185|FG001|NOT COMPLETED|Overall Study||4
3320280|NCT03154658|4053193|FG000|STARTED|Overall Study||33
3320281|NCT03154658|4053194|FG001|STARTED|Overall Study||33
3320282|NCT03154658|4053193|FG000|COMPLETED|Overall Study||32
3320283|NCT03154658|4053194|FG001|COMPLETED|Overall Study||32
3320284|NCT03154658|4053193|FG000|NOT COMPLETED|Overall Study||1
3320285|NCT03154658|4053194|FG001|NOT COMPLETED|Overall Study||1
3320286|NCT03154710|4053202|FG000|STARTED|Overall Study||27
3320287|NCT03154710|4053203|FG001|STARTED|Overall Study||25
3320288|NCT03154710|4053202|FG000|COMPLETED|Overall Study||20
3320289|NCT03154710|4053203|FG001|COMPLETED|Overall Study||20
3320290|NCT03154710|4053202|FG000|NOT COMPLETED|Overall Study||7
3320291|NCT03154710|4053203|FG001|NOT COMPLETED|Overall Study||5
3320292|NCT03155178|4053213|FG000|STARTED|Overall Study||69
3320293|NCT03155178|4053214|FG001|STARTED|Overall Study||69
3320294|NCT03155178|4053215|FG002|STARTED|Overall Study||69
3320295|NCT03155178|4053216|FG003|STARTED|Overall Study||69
3320296|NCT03155178|4053213|FG000|COMPLETED|Overall Study||62
3320297|NCT03155178|4053214|FG001|COMPLETED|Overall Study||62
3320298|NCT03155178|4053215|FG002|COMPLETED|Overall Study||62
3320299|NCT03155178|4053216|FG003|COMPLETED|Overall Study||62
3320300|NCT03155178|4053213|FG000|NOT COMPLETED|Overall Study||7
3320301|NCT03155178|4053214|FG001|NOT COMPLETED|Overall Study||7
3320302|NCT03155178|4053215|FG002|NOT COMPLETED|Overall Study||7
3320303|NCT03155178|4053216|FG003|NOT COMPLETED|Overall Study||7
3320304|NCT03155269|4053232|FG000|STARTED|Overall Study||57
3320305|NCT03155269|4053233|FG001|STARTED|Overall Study||57
3320306|NCT03155269|4053232|FG000|COMPLETED|Overall Study||52
3320307|NCT03155269|4053233|FG001|COMPLETED|Overall Study||50
3320308|NCT03155269|4053232|FG000|NOT COMPLETED|Overall Study||5
3320309|NCT03155269|4053233|FG001|NOT COMPLETED|Overall Study||7
3320310|NCT03155724|4053239|FG000|STARTED|Overall Study||53
3320311|NCT03155724|4053239|FG000|COMPLETED|Overall Study||42
3320312|NCT03155724|4053239|FG000|NOT COMPLETED|Overall Study||11
3320313|NCT03155945|4053245|FG000|STARTED|Overall Study||6
3320314|NCT03155945|4053246|FG001|STARTED|Overall Study||8
3320315|NCT03155945|4053245|FG000|COMPLETED|Overall Study||6
3320316|NCT03155945|4053246|FG001|COMPLETED|Overall Study||5
3320317|NCT03155945|4053245|FG000|NOT COMPLETED|Overall Study||0
3320318|NCT03155945|4053246|FG001|NOT COMPLETED|Overall Study||3
3320319|NCT03156270|4053252|FG000|STARTED|Overall Study||20
3320320|NCT03156270|4053252|FG000|COMPLETED|Overall Study||18
3320321|NCT03156270|4053252|FG000|NOT COMPLETED|Overall Study||2
3320322|NCT03156543|4053260|FG000|STARTED|Overall Study||9
3320323|NCT03156543|4053261|FG001|STARTED|Overall Study||23
3320324|NCT03156543|4053260|FG000|COMPLETED|Overall Study||8
3320325|NCT03156543|4053261|FG001|COMPLETED|Overall Study||23
3320326|NCT03156543|4053260|FG000|NOT COMPLETED|Overall Study||1
3320327|NCT03156543|4053261|FG001|NOT COMPLETED|Overall Study||0
3320328|NCT03156621|4053269|FG000|STARTED|Double-Blind Treatment Period (DBTP)||24
3320329|NCT03156621|4053270|FG001|STARTED|Double-Blind Treatment Period (DBTP)||45
3320330|NCT03156621|4053269|FG000|COMPLETED|Double-Blind Treatment Period (DBTP)||24
3320331|NCT03156621|4053270|FG001|COMPLETED|Double-Blind Treatment Period (DBTP)||45
3320332|NCT03156621|4053269|FG000|NOT COMPLETED|Double-Blind Treatment Period (DBTP)||0
3320333|NCT03156621|4053270|FG001|NOT COMPLETED|Double-Blind Treatment Period (DBTP)||0
3320334|NCT03156621|4053269|FG000|STARTED|Open-Label Treatment Period (OLTP)||24
3320335|NCT03156621|4053270|FG001|STARTED|Open-Label Treatment Period (OLTP)||45
3320336|NCT03156621|4053269|FG000|COMPLETED|Open-Label Treatment Period (OLTP)||24
3320337|NCT03156621|4053270|FG001|COMPLETED|Open-Label Treatment Period (OLTP)||42
3320338|NCT03156621|4053269|FG000|NOT COMPLETED|Open-Label Treatment Period (OLTP)||0
3320339|NCT03156621|4053270|FG001|NOT COMPLETED|Open-Label Treatment Period (OLTP)||3
3320340|NCT03157089|4053281|FG000|STARTED|Overall Study||12
3320341|NCT03157089|4053282|FG001|STARTED|Overall Study||12
3320342|NCT03157089|4053281|FG000|Treated|Overall Study||12
3320343|NCT03157089|4053282|FG001|Treated|Overall Study||12
3320344|NCT03157089|4053281|FG000|COMPLETED|Overall Study||0
3320345|NCT03157089|4053282|FG001|COMPLETED|Overall Study||0
3173853|NCT01952444|3901590|FG000|STARTED|Overall Study||20
3173854|NCT01952444|3901591|FG001|STARTED|Overall Study||20
3173855|NCT01952444|3901590|FG000|COMPLETED|Overall Study||20
3173856|NCT01952444|3901591|FG001|COMPLETED|Overall Study||19
3320346|NCT03157089|4053281|FG000|NOT COMPLETED|Overall Study||12
3320347|NCT03157089|4053282|FG001|NOT COMPLETED|Overall Study||12
3320348|NCT03157232|4053289|FG000|STARTED|Overall Study||18
3320349|NCT03157232|4053289|FG000|COMPLETED|Overall Study||18
3320350|NCT03157232|4053289|FG000|NOT COMPLETED|Overall Study||0
3320351|NCT03157531|4053293|FG000|STARTED|Overall Study||97
3320352|NCT03157531|4053293|FG000|Analyzed at 30 Days For MAEs|Overall Study||93
3320353|NCT03157531|4053293|FG000|COMPLETED|Overall Study||91
3320354|NCT03157531|4053293|FG000|NOT COMPLETED|Overall Study||6
3320355|NCT03157583|4053297|FG000|STARTED|Overall Study||8
3320356|NCT03157583|4053297|FG000|COMPLETED|Overall Study||7
3320357|NCT03157583|4053297|FG000|NOT COMPLETED|Overall Study||1
3320358|NCT03158012|4053317|FG000|STARTED|Overall Study||8
3320359|NCT03158012|4053318|FG001|STARTED|Overall Study||7
3320360|NCT03158012|4053317|FG000|COMPLETED|Overall Study||8
3320361|NCT03158012|4053318|FG001|COMPLETED|Overall Study||6
3320362|NCT03158012|4053317|FG000|NOT COMPLETED|Overall Study||0
3320363|NCT03158012|4053318|FG001|NOT COMPLETED|Overall Study||1
3320364|NCT03158038|4053326|FG000|STARTED|Overall Study||240
3320365|NCT03158038|4053327|FG001|STARTED|Overall Study||60
3320366|NCT03158038|4053326|FG000|COMPLETED|Overall Study||240
3320367|NCT03158038|4053327|FG001|COMPLETED|Overall Study||60
3320368|NCT03158038|4053326|FG000|NOT COMPLETED|Overall Study||0
3320369|NCT03158038|4053327|FG001|NOT COMPLETED|Overall Study||0
3320370|NCT03158116|4053333|FG000|STARTED|Overall Study||5
3320371|NCT03158116|4053333|FG000|COMPLETED|Overall Study||5
3320372|NCT03158116|4053333|FG000|NOT COMPLETED|Overall Study||0
3320373|NCT03158220|4053339|FG000|STARTED|Overall Study||570
3320374|NCT03158220|4053340|FG001|STARTED|Overall Study||642
3320375|NCT03158220|4053339|FG000|Vaccination 1|Overall Study||570
3320376|NCT03158220|4053340|FG001|Vaccination 1|Overall Study||640
3320377|NCT03158220|4053339|FG000|Vaccination 2|Overall Study||563
3320378|NCT03158220|4053340|FG001|Vaccination 2|Overall Study||635
3320379|NCT03158220|4053339|FG000|Vaccination 3|Overall Study||556
3320380|NCT03158220|4053340|FG001|Vaccination 3|Overall Study||629
3320381|NCT03158220|4053339|FG000|COMPLETED|Overall Study||553
3320382|NCT03158220|4053340|FG001|COMPLETED|Overall Study||626
3320383|NCT03158220|4053339|FG000|NOT COMPLETED|Overall Study||17
3320384|NCT03158220|4053340|FG001|NOT COMPLETED|Overall Study||16
3320385|NCT03158272|4053350|FG000|STARTED|Overall Study||3
3320386|NCT03158272|4053351|FG001|STARTED|Overall Study||4
3320387|NCT03158272|4053352|FG002|STARTED|Overall Study||6
3320388|NCT03158272|4053353|FG003|STARTED|Overall Study||6
3320389|NCT03158272|4053350|FG000|COMPLETED|Overall Study||0
3320390|NCT03158272|4053351|FG001|COMPLETED|Overall Study||0
3320391|NCT03158272|4053352|FG002|COMPLETED|Overall Study||0
3320392|NCT03158272|4053353|FG003|COMPLETED|Overall Study||0
3320393|NCT03158272|4053350|FG000|NOT COMPLETED|Overall Study||3
3320394|NCT03158272|4053351|FG001|NOT COMPLETED|Overall Study||4
3320395|NCT03158272|4053352|FG002|NOT COMPLETED|Overall Study||6
3320396|NCT03158272|4053353|FG003|NOT COMPLETED|Overall Study||6
3320397|NCT03158311|4053368|FG000|STARTED|Overall Study||474
3320398|NCT03158311|4053369|FG001|STARTED|Overall Study||476
3320399|NCT03158311|4053370|FG002|STARTED|Overall Study||476
3320400|NCT03158311|4053368|FG000|Full Analysis Set (FAS)|Overall Study||474
3320401|NCT03158311|4053369|FG001|Full Analysis Set (FAS)|Overall Study||476
3320402|NCT03158311|4053370|FG002|Full Analysis Set (FAS)|Overall Study||475
3320403|NCT03158311|4053368|FG000|Safety Set (SAF)|Overall Study||474
3320404|NCT03158311|4053369|FG001|Safety Set (SAF)|Overall Study||476
3320405|NCT03158311|4053370|FG002|Safety Set (SAF)|Overall Study||475
3320406|NCT03158311|4053368|FG000|COMPLETED|Overall Study||452
3320407|NCT03158311|4053369|FG001|COMPLETED|Overall Study||460
3320408|NCT03158311|4053370|FG002|COMPLETED|Overall Study||448
3320409|NCT03158311|4053368|FG000|NOT COMPLETED|Overall Study||22
3320410|NCT03158311|4053369|FG001|NOT COMPLETED|Overall Study||16
3320411|NCT03158311|4053370|FG002|NOT COMPLETED|Overall Study||28
3320412|NCT03158714|4053381|FG000|STARTED|Overall Study|Number of participants enrolled and Started represents number of individual participants rather than couples|626
3320413|NCT03158714|4053382|FG001|STARTED|Overall Study|Number of participants enrolled and Started represents number of individual participants rather than couples|626
3320414|NCT03158714|4053383|FG002|STARTED|Overall Study|Number of participants enrolled and Started represents number of individual participants rather than couples|606
3320415|NCT03158714|4053381|FG000|COMPLETED|Overall Study|Participated in half or more of program.|445
3320416|NCT03158714|4053382|FG001|COMPLETED|Overall Study|Participated in half or more of program.|398
3320417|NCT03158714|4053383|FG002|COMPLETED|Overall Study|All control group participants completed the control protocol (no program).|606
3320418|NCT03158714|4053381|FG000|NOT COMPLETED|Overall Study||181
3320419|NCT03158714|4053382|FG001|NOT COMPLETED|Overall Study||228
3320420|NCT03158714|4053383|FG002|NOT COMPLETED|Overall Study||0
3320421|NCT03159091|4053393|FG000|STARTED|Overall Study||121
3320422|NCT03159091|4053394|FG001|STARTED|Overall Study||117
3320423|NCT03159091|4053393|FG000|COMPLETED|Overall Study||116
3320424|NCT03159091|4053394|FG001|COMPLETED|Overall Study||113
3320425|NCT03159091|4053393|FG000|NOT COMPLETED|Overall Study||5
3320426|NCT03159091|4053394|FG001|NOT COMPLETED|Overall Study||4
3320427|NCT03159143|4053400|FG000|STARTED|Overall Study||22
3320428|NCT03159143|4053400|FG000|COMPLETED|Overall Study||22
3320429|NCT03159143|4053400|FG000|NOT COMPLETED|Overall Study||0
3320430|NCT03159195|4053406|FG000|STARTED|Overall Study||360
3320431|NCT03159195|4053407|FG001|STARTED|Overall Study||292
3320432|NCT03159195|4053406|FG000|COMPLETED|Overall Study||360
3320433|NCT03159195|4053407|FG001|COMPLETED|Overall Study||292
3320434|NCT03159195|4053406|FG000|NOT COMPLETED|Overall Study||0
2923961|NCT00555997|3634966|FG000|STARTED|Phase 2 SPCD||0
2923962|NCT00555997|3634967|FG001|STARTED|Phase 2 SPCD||0
2923963|NCT00555997|3634968|FG002|STARTED|Phase 2 SPCD||38
2923964|NCT00555997|3634969|FG003|STARTED|Phase 2 SPCD||25
2923965|NCT00555997|3634966|FG000|COMPLETED|Phase 2 SPCD||0
2923966|NCT00555997|3634967|FG001|COMPLETED|Phase 2 SPCD||0
2923967|NCT00555997|3634968|FG002|COMPLETED|Phase 2 SPCD||31
2923968|NCT00555997|3634969|FG003|COMPLETED|Phase 2 SPCD||22
2923969|NCT00555997|3634966|FG000|NOT COMPLETED|Phase 2 SPCD||0
2923970|NCT00555997|3634967|FG001|NOT COMPLETED|Phase 2 SPCD||0
2923971|NCT00555997|3634968|FG002|NOT COMPLETED|Phase 2 SPCD||7
2923972|NCT00555997|3634969|FG003|NOT COMPLETED|Phase 2 SPCD||3
2923973|NCT00556049|3634981|FG000|STARTED|Overall Study||72
2923974|NCT00556049|3634981|FG000|COMPLETED|Overall Study||72
2923975|NCT00556049|3634981|FG000|NOT COMPLETED|Overall Study||0
2923976|NCT00556140|3634985|FG000|STARTED|Overall Study||16
3320435|NCT03159195|4053407|FG001|NOT COMPLETED|Overall Study||0
3320436|NCT03159260|4053415|FG000|STARTED|Overall Study||28
3320437|NCT03159260|4053416|FG001|STARTED|Overall Study||29
3320438|NCT03159260|4053415|FG000|COMPLETED|Overall Study||25
3320439|NCT03159260|4053416|FG001|COMPLETED|Overall Study||25
3320440|NCT03159260|4053415|FG000|NOT COMPLETED|Overall Study||3
3320441|NCT03159260|4053416|FG001|NOT COMPLETED|Overall Study||4
3320442|NCT03159299|4053424|FG000|STARTED|Overall Study||26
3320443|NCT03159299|4053425|FG001|STARTED|Overall Study||21
3320444|NCT03159299|4053424|FG000|COMPLETED|Overall Study||24
3320445|NCT03159299|4053425|FG001|COMPLETED|Overall Study||20
3320446|NCT03159299|4053424|FG000|NOT COMPLETED|Overall Study||2
3320447|NCT03159299|4053425|FG001|NOT COMPLETED|Overall Study||1
3320448|NCT03159455|4053437|FG000|STARTED|Overall Study||9
3320449|NCT03159455|4053438|FG001|STARTED|Overall Study||9
3320450|NCT03159455|4053439|FG002|STARTED|Overall Study||9
3320451|NCT03159455|4053440|FG003|STARTED|Overall Study||9
3320452|NCT03159455|4053441|FG004|STARTED|Overall Study||3
3320453|NCT03159455|4053442|FG005|STARTED|Overall Study||9
3320454|NCT03159455|4053437|FG000|COMPLETED|Overall Study||9
3320455|NCT03159455|4053438|FG001|COMPLETED|Overall Study||9
3320456|NCT03159455|4053439|FG002|COMPLETED|Overall Study||9
3320457|NCT03159455|4053440|FG003|COMPLETED|Overall Study||9
3320458|NCT03159455|4053441|FG004|COMPLETED|Overall Study||3
3320459|NCT03159455|4053442|FG005|COMPLETED|Overall Study||8
3320460|NCT03159455|4053437|FG000|NOT COMPLETED|Overall Study||0
3320461|NCT03159455|4053438|FG001|NOT COMPLETED|Overall Study||0
3320462|NCT03159455|4053439|FG002|NOT COMPLETED|Overall Study||0
3320463|NCT03159455|4053440|FG003|NOT COMPLETED|Overall Study||0
3320464|NCT03159455|4053441|FG004|NOT COMPLETED|Overall Study||0
3320465|NCT03159455|4053442|FG005|NOT COMPLETED|Overall Study||1
3320466|NCT03159468|4053466|FG000|STARTED|Overall Study||35
3320467|NCT03159468|4053467|FG001|STARTED|Overall Study||35
3320468|NCT03159468|4053468|FG002|STARTED|Overall Study||37
3320469|NCT03159468|4053469|FG003|STARTED|Overall Study||34
3320470|NCT03159468|4053470|FG004|STARTED|Overall Study||34
3320471|NCT03159468|4053471|FG005|STARTED|Overall Study||34
3320472|NCT03159468|4053466|FG000|COMPLETED|Overall Study||35
3320473|NCT03159468|4053467|FG001|COMPLETED|Overall Study||35
3320474|NCT03159468|4053468|FG002|COMPLETED|Overall Study||34
3320475|NCT03159468|4053469|FG003|COMPLETED|Overall Study||34
3320476|NCT03159468|4053470|FG004|COMPLETED|Overall Study||34
2923977|NCT00556140|3634985|FG000|COMPLETED|Overall Study||13
3320477|NCT03159468|4053471|FG005|COMPLETED|Overall Study||34
3320478|NCT03159468|4053466|FG000|NOT COMPLETED|Overall Study||0
2923978|NCT00556140|3634985|FG000|NOT COMPLETED|Overall Study||3
3320479|NCT03159468|4053467|FG001|NOT COMPLETED|Overall Study||0
3320480|NCT03159468|4053468|FG002|NOT COMPLETED|Overall Study||3
3320481|NCT03159468|4053469|FG003|NOT COMPLETED|Overall Study||0
2923979|NCT00556322|3634991|FG000|STARTED|Overall Study||221
3320482|NCT03159468|4053470|FG004|NOT COMPLETED|Overall Study||0
3320483|NCT03159468|4053471|FG005|NOT COMPLETED|Overall Study||0
3320484|NCT03159611|4053487|FG000|STARTED|Overall Study||95
3320485|NCT03159611|4053488|FG001|STARTED|Overall Study||87
3320486|NCT03159611|4053487|FG000|COMPLETED|Overall Study||72
3320487|NCT03159611|4053488|FG001|COMPLETED|Overall Study||72
3320488|NCT03159611|4053487|FG000|NOT COMPLETED|Overall Study||23
3320489|NCT03159611|4053488|FG001|NOT COMPLETED|Overall Study||15
3320490|NCT03159624|4053496|FG000|STARTED|Overall Study||21
3320491|NCT03159624|4053497|FG001|STARTED|Overall Study||26
3320492|NCT03159624|4053496|FG000|COMPLETED|Overall Study||21
3320493|NCT03159624|4053497|FG001|COMPLETED|Overall Study||25
3320494|NCT03159624|4053496|FG000|NOT COMPLETED|Overall Study||0
3320495|NCT03159624|4053497|FG001|NOT COMPLETED|Overall Study||1
3320496|NCT03160027|4053507|FG000|STARTED|Overall Study||6
3320497|NCT03160027|4053508|FG001|STARTED|Overall Study||4
3320498|NCT03160027|4053509|FG002|STARTED|Overall Study||6
3320499|NCT03160027|4053510|FG003|STARTED|Overall Study||4
3320500|NCT03160027|4053507|FG000|COMPLETED|Overall Study||6
3320501|NCT03160027|4053508|FG001|COMPLETED|Overall Study||4
3320502|NCT03160027|4053509|FG002|COMPLETED|Overall Study||6
3320503|NCT03160027|4053510|FG003|COMPLETED|Overall Study||4
3320504|NCT03160027|4053507|FG000|NOT COMPLETED|Overall Study||0
3320505|NCT03160027|4053508|FG001|NOT COMPLETED|Overall Study||0
3320506|NCT03160027|4053509|FG002|NOT COMPLETED|Overall Study||0
3320507|NCT03160027|4053510|FG003|NOT COMPLETED|Overall Study||0
3320508|NCT03160170|4053523|FG000|STARTED|Overall Study||10
3320509|NCT03160170|4053524|FG001|STARTED|Overall Study||10
3320510|NCT03160170|4053523|FG000|COMPLETED|Overall Study||10
3320511|NCT03160170|4053524|FG001|COMPLETED|Overall Study||10
3320512|NCT03160170|4053523|FG000|NOT COMPLETED|Overall Study||0
3320513|NCT03160170|4053524|FG001|NOT COMPLETED|Overall Study||0
3320514|NCT03160287|4053530|FG000|STARTED|Overall Study||24
3320515|NCT03160287|4053530|FG000|COMPLETED|Overall Study||22
3320516|NCT03160287|4053530|FG000|NOT COMPLETED|Overall Study||2
3320517|NCT03160560|4053538|FG000|STARTED|First Intervention (3 Weeks)||25
3320518|NCT03160560|4053539|FG001|STARTED|First Intervention (3 Weeks)||25
3320519|NCT03160560|4053540|FG002|STARTED|First Intervention (3 Weeks)||25
3320520|NCT03160560|4053541|FG003|STARTED|First Intervention (3 Weeks)||25
3320521|NCT03160560|4053538|FG000|COMPLETED|First Intervention (3 Weeks)||23
3320522|NCT03160560|4053539|FG001|COMPLETED|First Intervention (3 Weeks)||24
3320523|NCT03160560|4053540|FG002|COMPLETED|First Intervention (3 Weeks)||24
3320524|NCT03160560|4053541|FG003|COMPLETED|First Intervention (3 Weeks)||25
3320525|NCT03160560|4053538|FG000|NOT COMPLETED|First Intervention (3 Weeks)||2
3320526|NCT03160560|4053539|FG001|NOT COMPLETED|First Intervention (3 Weeks)||1
3320527|NCT03160560|4053540|FG002|NOT COMPLETED|First Intervention (3 Weeks)||1
3320528|NCT03160560|4053541|FG003|NOT COMPLETED|First Intervention (3 Weeks)||0
3320529|NCT03160560|4053538|FG000|STARTED|Washout (2 Weeks)||23
3320530|NCT03160560|4053539|FG001|STARTED|Washout (2 Weeks)||24
3320531|NCT03160560|4053540|FG002|STARTED|Washout (2 Weeks)||24
3320532|NCT03160560|4053541|FG003|STARTED|Washout (2 Weeks)||25
3320533|NCT03160560|4053538|FG000|COMPLETED|Washout (2 Weeks)||23
3320534|NCT03160560|4053539|FG001|COMPLETED|Washout (2 Weeks)||24
3320535|NCT03160560|4053540|FG002|COMPLETED|Washout (2 Weeks)||24
3320536|NCT03160560|4053541|FG003|COMPLETED|Washout (2 Weeks)||25
3320537|NCT03160560|4053538|FG000|NOT COMPLETED|Washout (2 Weeks)||0
3320538|NCT03160560|4053539|FG001|NOT COMPLETED|Washout (2 Weeks)||0
3320539|NCT03160560|4053540|FG002|NOT COMPLETED|Washout (2 Weeks)||0
3320540|NCT03160560|4053541|FG003|NOT COMPLETED|Washout (2 Weeks)||0
3320541|NCT03160560|4053538|FG000|STARTED|Second Intervention (3 Weeks)||23
3320542|NCT03160560|4053539|FG001|STARTED|Second Intervention (3 Weeks)||24
3320543|NCT03160560|4053540|FG002|STARTED|Second Intervention (3 Weeks)||24
3320544|NCT03160560|4053541|FG003|STARTED|Second Intervention (3 Weeks)||25
3320545|NCT03160560|4053538|FG000|COMPLETED|Second Intervention (3 Weeks)||22
3320546|NCT03160560|4053539|FG001|COMPLETED|Second Intervention (3 Weeks)||24
3320547|NCT03160560|4053540|FG002|COMPLETED|Second Intervention (3 Weeks)||24
3320548|NCT03160560|4053541|FG003|COMPLETED|Second Intervention (3 Weeks)||25
3320549|NCT03160560|4053538|FG000|NOT COMPLETED|Second Intervention (3 Weeks)||1
3320550|NCT03160560|4053539|FG001|NOT COMPLETED|Second Intervention (3 Weeks)||0
3320551|NCT03160560|4053540|FG002|NOT COMPLETED|Second Intervention (3 Weeks)||0
3173857|NCT01952444|3901590|FG000|NOT COMPLETED|Overall Study||0
3173858|NCT01952444|3901591|FG001|NOT COMPLETED|Overall Study||1
3173859|NCT01952470|3901604|FG000|STARTED|Overall Study||16
3320552|NCT03160560|4053541|FG003|NOT COMPLETED|Second Intervention (3 Weeks)||0
3320553|NCT03160573|4053555|FG000|STARTED|First Sequence (3 Weeks)||23
3320554|NCT03160573|4053556|FG001|STARTED|First Sequence (3 Weeks)||26
3320555|NCT03160573|4053557|FG002|STARTED|First Sequence (3 Weeks)||25
3320556|NCT03160573|4053558|FG003|STARTED|First Sequence (3 Weeks)||25
3320557|NCT03160573|4053555|FG000|COMPLETED|First Sequence (3 Weeks)||22
3320558|NCT03160573|4053556|FG001|COMPLETED|First Sequence (3 Weeks)||23
3320559|NCT03160573|4053557|FG002|COMPLETED|First Sequence (3 Weeks)||23
3320560|NCT03160573|4053558|FG003|COMPLETED|First Sequence (3 Weeks)||23
3320561|NCT03160573|4053555|FG000|NOT COMPLETED|First Sequence (3 Weeks)||1
3320562|NCT03160573|4053556|FG001|NOT COMPLETED|First Sequence (3 Weeks)||3
3320563|NCT03160573|4053557|FG002|NOT COMPLETED|First Sequence (3 Weeks)||2
3320564|NCT03160573|4053558|FG003|NOT COMPLETED|First Sequence (3 Weeks)||2
3320565|NCT03160573|4053555|FG000|STARTED|Washout (2 Weeks)||22
3320566|NCT03160573|4053556|FG001|STARTED|Washout (2 Weeks)||23
3320567|NCT03160573|4053557|FG002|STARTED|Washout (2 Weeks)||23
3320568|NCT03160573|4053558|FG003|STARTED|Washout (2 Weeks)||23
3320569|NCT03160573|4053555|FG000|COMPLETED|Washout (2 Weeks)||22
3320570|NCT03160573|4053556|FG001|COMPLETED|Washout (2 Weeks)||23
3320571|NCT03160573|4053557|FG002|COMPLETED|Washout (2 Weeks)||23
3320572|NCT03160573|4053558|FG003|COMPLETED|Washout (2 Weeks)||23
3320573|NCT03160573|4053555|FG000|NOT COMPLETED|Washout (2 Weeks)||0
3320574|NCT03160573|4053556|FG001|NOT COMPLETED|Washout (2 Weeks)||0
3320575|NCT03160573|4053557|FG002|NOT COMPLETED|Washout (2 Weeks)||0
3320576|NCT03160573|4053558|FG003|NOT COMPLETED|Washout (2 Weeks)||0
3320577|NCT03160573|4053555|FG000|STARTED|Second Sequence (3 Weeks)||22
3320578|NCT03160573|4053556|FG001|STARTED|Second Sequence (3 Weeks)||23
3320579|NCT03160573|4053557|FG002|STARTED|Second Sequence (3 Weeks)||23
3320580|NCT03160573|4053558|FG003|STARTED|Second Sequence (3 Weeks)||23
3320581|NCT03160573|4053555|FG000|COMPLETED|Second Sequence (3 Weeks)||22
3320582|NCT03160573|4053556|FG001|COMPLETED|Second Sequence (3 Weeks)||23
3320583|NCT03160573|4053557|FG002|COMPLETED|Second Sequence (3 Weeks)||23
3320584|NCT03160573|4053558|FG003|COMPLETED|Second Sequence (3 Weeks)||23
3320585|NCT03160573|4053555|FG000|NOT COMPLETED|Second Sequence (3 Weeks)||0
3320586|NCT03160573|4053556|FG001|NOT COMPLETED|Second Sequence (3 Weeks)||0
3320587|NCT03160573|4053557|FG002|NOT COMPLETED|Second Sequence (3 Weeks)||0
3320588|NCT03160573|4053558|FG003|NOT COMPLETED|Second Sequence (3 Weeks)||0
3320589|NCT03160703|4053572|FG000|STARTED|Overall Study||55
3320590|NCT03160703|4053573|FG001|STARTED|Overall Study||55
3320591|NCT03160703|4053574|FG002|STARTED|Overall Study||55
3320592|NCT03160703|4053575|FG003|STARTED|Overall Study||55
3320593|NCT03160703|4053572|FG000|COMPLETED|Overall Study||55
3320594|NCT03160703|4053573|FG001|COMPLETED|Overall Study||55
3320595|NCT03160703|4053574|FG002|COMPLETED|Overall Study||55
3320596|NCT03160703|4053575|FG003|COMPLETED|Overall Study||54
3320597|NCT03160703|4053572|FG000|NOT COMPLETED|Overall Study||0
3320598|NCT03160703|4053573|FG001|NOT COMPLETED|Overall Study||0
3320599|NCT03160703|4053574|FG002|NOT COMPLETED|Overall Study||0
3173860|NCT01952470|3901605|FG001|STARTED|Overall Study||16
3173861|NCT01952470|3901604|FG000|ITT Analysis|Overall Study||16
3173862|NCT01952470|3901605|FG001|ITT Analysis|Overall Study||16
3173863|NCT01952470|3901604|FG000|Discontinued Intervention|Overall Study||2
3173864|NCT01952470|3901605|FG001|Discontinued Intervention|Overall Study||1
3320600|NCT03160703|4053575|FG003|NOT COMPLETED|Overall Study||1
3320601|NCT03160716|4053585|FG000|STARTED|Overall Study||60
3320602|NCT03160716|4053585|FG000|COMPLETED|Overall Study||59
3320603|NCT03160716|4053585|FG000|NOT COMPLETED|Overall Study||1
3320604|NCT03160885|4053591|FG000|STARTED|Initial Treatment Period||593
3320605|NCT03160885|4053592|FG001|STARTED|Initial Treatment Period||201
3320606|NCT03160885|4053593|FG002|STARTED|Initial Treatment Period||0
3320607|NCT03160885|4053594|FG003|STARTED|Initial Treatment Period||0
3320608|NCT03160885|4053595|FG004|STARTED|Initial Treatment Period||0
3320609|NCT03160885|4053596|FG005|STARTED|Initial Treatment Period||0
3320610|NCT03160885|4053597|FG006|STARTED|Initial Treatment Period||0
3320611|NCT03160885|4053591|FG000|COMPLETED|Initial Treatment Period||558
3320612|NCT03160885|4053592|FG001|COMPLETED|Initial Treatment Period||179
3320613|NCT03160885|4053593|FG002|COMPLETED|Initial Treatment Period||0
3320614|NCT03160885|4053594|FG003|COMPLETED|Initial Treatment Period||0
3320615|NCT03160885|4053595|FG004|COMPLETED|Initial Treatment Period||0
3320616|NCT03160885|4053596|FG005|COMPLETED|Initial Treatment Period||0
3320617|NCT03160885|4053597|FG006|COMPLETED|Initial Treatment Period||0
3320618|NCT03160885|4053591|FG000|NOT COMPLETED|Initial Treatment Period||35
3320619|NCT03160885|4053592|FG001|NOT COMPLETED|Initial Treatment Period||22
3320620|NCT03160885|4053593|FG002|NOT COMPLETED|Initial Treatment Period||0
3320621|NCT03160885|4053594|FG003|NOT COMPLETED|Initial Treatment Period||0
3320622|NCT03160885|4053595|FG004|NOT COMPLETED|Initial Treatment Period||0
3320623|NCT03160885|4053596|FG005|NOT COMPLETED|Initial Treatment Period||0
3320624|NCT03160885|4053597|FG006|NOT COMPLETED|Initial Treatment Period||0
3320625|NCT03160885|4053591|FG000|STARTED|Open-label Treatment||0
3320626|NCT03160885|4053592|FG001|STARTED|Open-label Treatment||0
3320627|NCT03160885|4053593|FG002|STARTED|Open-label Treatment||0
3320628|NCT03160885|4053594|FG003|STARTED|Open-label Treatment||0
3320629|NCT03160885|4053595|FG004|STARTED|Open-label Treatment||0
3320630|NCT03160885|4053596|FG005|STARTED|Open-label Treatment||0
3320631|NCT03160885|4053597|FG006|STARTED|Open-label Treatment||560
3320632|NCT03160885|4053591|FG000|COMPLETED|Open-label Treatment||0
3320633|NCT03160885|4053592|FG001|COMPLETED|Open-label Treatment||0
3320634|NCT03160885|4053593|FG002|COMPLETED|Open-label Treatment||0
3320635|NCT03160885|4053594|FG003|COMPLETED|Open-label Treatment||0
3320636|NCT03160885|4053595|FG004|COMPLETED|Open-label Treatment||0
3320637|NCT03160885|4053596|FG005|COMPLETED|Open-label Treatment||0
3320638|NCT03160885|4053597|FG006|COMPLETED|Open-label Treatment||423
3320639|NCT03160885|4053591|FG000|NOT COMPLETED|Open-label Treatment||0
3320640|NCT03160885|4053592|FG001|NOT COMPLETED|Open-label Treatment||0
3320641|NCT03160885|4053593|FG002|NOT COMPLETED|Open-label Treatment||0
3320642|NCT03160885|4053594|FG003|NOT COMPLETED|Open-label Treatment||0
3320643|NCT03160885|4053595|FG004|NOT COMPLETED|Open-label Treatment||0
3320644|NCT03160885|4053596|FG005|NOT COMPLETED|Open-label Treatment||0
3320645|NCT03160885|4053597|FG006|NOT COMPLETED|Open-label Treatment||137
3320646|NCT03160885|4053591|FG000|STARTED|Maintenance Treatment Period||0
3320647|NCT03160885|4053592|FG001|STARTED|Maintenance Treatment Period||0
3320648|NCT03160885|4053593|FG002|STARTED|Maintenance Treatment Period||91
3320649|NCT03160885|4053594|FG003|STARTED|Maintenance Treatment Period||90
3320650|NCT03160885|4053595|FG004|STARTED|Maintenance Treatment Period||46
3320651|NCT03160885|4053596|FG005|STARTED|Maintenance Treatment Period||31
3320652|NCT03160885|4053597|FG006|STARTED|Maintenance Treatment Period||0
3320653|NCT03160885|4053591|FG000|COMPLETED|Maintenance Treatment Period||0
3320654|NCT03160885|4053592|FG001|COMPLETED|Maintenance Treatment Period||0
3320655|NCT03160885|4053593|FG002|COMPLETED|Maintenance Treatment Period||52
3320656|NCT03160885|4053594|FG003|COMPLETED|Maintenance Treatment Period||50
3320657|NCT03160885|4053595|FG004|COMPLETED|Maintenance Treatment Period||15
2923980|NCT00556322|3634992|FG001|STARTED|Overall Study||203
2923981|NCT00556322|3634991|FG000|COMPLETED|Overall Study|Data cutoff was 01 August 2010|0
2923982|NCT00556322|3634992|FG001|COMPLETED|Overall Study|Data cutoff was 01 August 2010|0
2923983|NCT00556322|3634991|FG000|NOT COMPLETED|Overall Study||221
3038895|NCT01155336|3758217|FG000|STARTED|Overall Study|We did not complete the study.|0
3038896|NCT01155336|3758218|FG001|STARTED|Overall Study|We did not complete the study.|4
3038897|NCT01155336|3758217|FG000|COMPLETED|Overall Study|We did not complete the study.|0
3038898|NCT01155336|3758218|FG001|COMPLETED|Overall Study|We did not complete the study.|4
3038899|NCT01155336|3758217|FG000|NOT COMPLETED|Overall Study||0
3038900|NCT01155336|3758218|FG001|NOT COMPLETED|Overall Study||0
3038901|NCT01155466|3758229|FG000|STARTED|Overall Study||156
3038902|NCT01155466|3758230|FG001|STARTED|Overall Study||155
3038903|NCT01155466|3758231|FG002|STARTED|Overall Study||156
3038904|NCT01155466|3758232|FG003|STARTED|Overall Study||155
3038905|NCT01155466|3758233|FG004|STARTED|Overall Study||156
3038906|NCT01155466|3758229|FG000|Treated|Overall Study||154
3038907|NCT01155466|3758230|FG001|Treated|Overall Study||153
3038908|NCT01155466|3758231|FG002|Treated|Overall Study||153
3038909|NCT01155466|3758232|FG003|Treated|Overall Study||155
3320658|NCT03160885|4053596|FG005|COMPLETED|Maintenance Treatment Period||16
3320659|NCT03160885|4053597|FG006|COMPLETED|Maintenance Treatment Period||0
3320660|NCT03160885|4053591|FG000|NOT COMPLETED|Maintenance Treatment Period||0
3320661|NCT03160885|4053592|FG001|NOT COMPLETED|Maintenance Treatment Period||0
3320662|NCT03160885|4053593|FG002|NOT COMPLETED|Maintenance Treatment Period||39
3320663|NCT03160885|4053594|FG003|NOT COMPLETED|Maintenance Treatment Period||40
3320664|NCT03160885|4053595|FG004|NOT COMPLETED|Maintenance Treatment Period||31
3320665|NCT03160885|4053596|FG005|NOT COMPLETED|Maintenance Treatment Period||15
3320666|NCT03160885|4053597|FG006|NOT COMPLETED|Maintenance Treatment Period||0
3320667|NCT03160898|4053618|FG000|STARTED|Overall Study||115
3320668|NCT03160898|4053619|FG001|STARTED|Overall Study|1 patient withdrew consent before study drug dosing and was therefore excluded from safety analysis|113
3320669|NCT03160898|4053620|FG002|STARTED|Overall Study||113
3320670|NCT03160898|4053621|FG003|STARTED|Overall Study||117
3320671|NCT03160898|4053618|FG000|COMPLETED|Overall Study||95
3320672|NCT03160898|4053619|FG001|COMPLETED|Overall Study||100
3320673|NCT03160898|4053620|FG002|COMPLETED|Overall Study||97
3320674|NCT03160898|4053621|FG003|COMPLETED|Overall Study||98
3320675|NCT03160898|4053618|FG000|NOT COMPLETED|Overall Study||20
3320676|NCT03160898|4053619|FG001|NOT COMPLETED|Overall Study||13
3320677|NCT03160898|4053620|FG002|NOT COMPLETED|Overall Study||16
3320678|NCT03160898|4053621|FG003|NOT COMPLETED|Overall Study||19
3320679|NCT03161158|4053634|FG000|STARTED|Overall Study||18
3320680|NCT03161158|4053635|FG001|STARTED|Overall Study||19
3320681|NCT03161158|4053634|FG000|COMPLETED|Overall Study||9
3320682|NCT03161158|4053635|FG001|COMPLETED|Overall Study||13
3320683|NCT03161158|4053634|FG000|NOT COMPLETED|Overall Study||9
3320684|NCT03161158|4053635|FG001|NOT COMPLETED|Overall Study||6
3320685|NCT03161327|4053641|FG000|STARTED|Overall Study||238
3320686|NCT03161327|4053641|FG000|COMPLETED|Overall Study||238
3320687|NCT03161327|4053641|FG000|NOT COMPLETED|Overall Study||0
3320688|NCT03161405|4053646|FG000|STARTED|First Intervention Period (3 Days)||12
3320689|NCT03161405|4053646|FG000|COMPLETED|First Intervention Period (3 Days)||12
3320690|NCT03161405|4053646|FG000|NOT COMPLETED|First Intervention Period (3 Days)||0
3320691|NCT03161405|4053646|FG000|STARTED|Washout Period (at Least 4 Days)||12
3320692|NCT03161405|4053646|FG000|COMPLETED|Washout Period (at Least 4 Days)||12
3320693|NCT03161405|4053646|FG000|NOT COMPLETED|Washout Period (at Least 4 Days)||0
3320694|NCT03161405|4053646|FG000|STARTED|Second Intervention Period (6 Days)||12
3320695|NCT03161405|4053646|FG000|COMPLETED|Second Intervention Period (6 Days)||11
3320696|NCT03161405|4053646|FG000|NOT COMPLETED|Second Intervention Period (6 Days)||1
3320697|NCT03161483|4053657|FG000|STARTED|Overall Study||83
3320698|NCT03161483|4053658|FG001|STARTED|Overall Study||42
3320699|NCT03161483|4053659|FG002|STARTED|Overall Study||82
3320700|NCT03161483|4053660|FG003|STARTED|Overall Study||81
3320701|NCT03161483|4053657|FG000|COMPLETED|Overall Study||73
3320702|NCT03161483|4053658|FG001|COMPLETED|Overall Study||39
3320703|NCT03161483|4053659|FG002|COMPLETED|Overall Study||62
3320704|NCT03161483|4053660|FG003|COMPLETED|Overall Study||73
3038910|NCT01155466|3758233|FG004|Treated|Overall Study||154
3038911|NCT01155466|3758229|FG000|COMPLETED|Overall Study|Completed treatment phase|134
3320705|NCT03161483|4053657|FG000|NOT COMPLETED|Overall Study||10
3320706|NCT03161483|4053658|FG001|NOT COMPLETED|Overall Study||3
3320707|NCT03161483|4053659|FG002|NOT COMPLETED|Overall Study||20
3320708|NCT03161483|4053660|FG003|NOT COMPLETED|Overall Study||8
3320709|NCT03161938|4053672|FG000|STARTED|Overall Study||32
3320710|NCT03161938|4053673|FG001|STARTED|Overall Study||32
3320711|NCT03161938|4053672|FG000|COMPLETED|Overall Study||32
3320712|NCT03161938|4053673|FG001|COMPLETED|Overall Study||32
3320713|NCT03161938|4053672|FG000|NOT COMPLETED|Overall Study||0
3320714|NCT03161938|4053673|FG001|NOT COMPLETED|Overall Study||0
3320715|NCT03162055|4053681|FG000|STARTED|Overall Study||559
3320716|NCT03162055|4053682|FG001|STARTED|Overall Study||560
3320717|NCT03162055|4053681|FG000|Received Treatment|Overall Study||557
3320718|NCT03162055|4053682|FG001|Received Treatment|Overall Study||560
3320719|NCT03162055|4053681|FG000|Safety Analysis Set|Overall Study||552
3320720|NCT03162055|4053682|FG001|Safety Analysis Set|Overall Study||552
3320721|NCT03162055|4053681|FG000|Full Analysis Set (FAS)|Overall Study||552
3320722|NCT03162055|4053682|FG001|Full Analysis Set (FAS)|Overall Study||552
3320723|NCT03162055|4053681|FG000|Per Protocol (PP) Analysis Set|Overall Study||506
3320724|NCT03162055|4053682|FG001|Per Protocol (PP) Analysis Set|Overall Study||510
3320725|NCT03162055|4053681|FG000|COMPLETED|Overall Study||497
3320726|NCT03162055|4053682|FG001|COMPLETED|Overall Study||517
3320727|NCT03162055|4053681|FG000|NOT COMPLETED|Overall Study||62
3320728|NCT03162055|4053682|FG001|NOT COMPLETED|Overall Study||43
3320729|NCT03162328|4053688|FG000|STARTED|Screening Period||84
3320730|NCT03162328|4053689|FG001|STARTED|Screening Period||0
3320731|NCT03162328|4053690|FG002|STARTED|Screening Period||0
3320732|NCT03162328|4053688|FG000|COMPLETED|Screening Period||62
3320733|NCT03162328|4053689|FG001|COMPLETED|Screening Period||0
3320734|NCT03162328|4053690|FG002|COMPLETED|Screening Period||0
3320735|NCT03162328|4053688|FG000|NOT COMPLETED|Screening Period||22
3320736|NCT03162328|4053689|FG001|NOT COMPLETED|Screening Period||0
3320737|NCT03162328|4053690|FG002|NOT COMPLETED|Screening Period||0
3320738|NCT03162328|4053688|FG000|STARTED|Study Period||0
3320739|NCT03162328|4053689|FG001|STARTED|Study Period||30
3320740|NCT03162328|4053690|FG002|STARTED|Study Period||32
3320741|NCT03162328|4053688|FG000|COMPLETED|Study Period||0
3320742|NCT03162328|4053689|FG001|COMPLETED|Study Period||30
3320743|NCT03162328|4053690|FG002|COMPLETED|Study Period||31
3320744|NCT03162328|4053688|FG000|NOT COMPLETED|Study Period||0
3320745|NCT03162328|4053689|FG001|NOT COMPLETED|Study Period||0
3320746|NCT03162328|4053690|FG002|NOT COMPLETED|Study Period||1
3320747|NCT03162354|4053703|FG000|STARTED|Overall Study||183
3320748|NCT03162354|4053704|FG001|STARTED|Overall Study||237
3320749|NCT03162354|4053703|FG000|COMPLETED|Overall Study||183
3320750|NCT03162354|4053704|FG001|COMPLETED|Overall Study||237
3320751|NCT03162354|4053703|FG000|NOT COMPLETED|Overall Study||0
3320752|NCT03162354|4053704|FG001|NOT COMPLETED|Overall Study||0
3320753|NCT03162458|4053717|FG000|STARTED|Overall Study||71
3320754|NCT03162458|4053718|FG001|STARTED|Overall Study||71
3320755|NCT03162458|4053717|FG000|COMPLETED|Overall Study||71
3320756|NCT03162458|4053718|FG001|COMPLETED|Overall Study||71
3320757|NCT03162458|4053717|FG000|NOT COMPLETED|Overall Study||0
3320758|NCT03162458|4053718|FG001|NOT COMPLETED|Overall Study||0
3320759|NCT03162614|4053730|FG000|STARTED|Overall Study||26
3320760|NCT03162614|4053731|FG001|STARTED|Overall Study||26
3320761|NCT03162614|4053732|FG002|STARTED|Overall Study||26
3320762|NCT03162614|4053733|FG003|STARTED|Overall Study||26
3320763|NCT03162614|4053734|FG004|STARTED|Overall Study||26
3320764|NCT03162614|4053735|FG005|STARTED|Overall Study||24
3320765|NCT03162614|4053730|FG000|COMPLETED|Overall Study||20
3320766|NCT03162614|4053731|FG001|COMPLETED|Overall Study||21
3320767|NCT03162614|4053732|FG002|COMPLETED|Overall Study||22
3320768|NCT03162614|4053733|FG003|COMPLETED|Overall Study||19
3320769|NCT03162614|4053734|FG004|COMPLETED|Overall Study||21
3320770|NCT03162614|4053735|FG005|COMPLETED|Overall Study||24
3320771|NCT03162614|4053730|FG000|NOT COMPLETED|Overall Study||6
3320772|NCT03162614|4053731|FG001|NOT COMPLETED|Overall Study||5
3320773|NCT03162614|4053732|FG002|NOT COMPLETED|Overall Study||4
3320774|NCT03162614|4053733|FG003|NOT COMPLETED|Overall Study||7
3320775|NCT03162614|4053734|FG004|NOT COMPLETED|Overall Study||5
3320776|NCT03162614|4053735|FG005|NOT COMPLETED|Overall Study||0
3320777|NCT03162796|4053752|FG000|STARTED|Placebo Controlled Period: Week 0 - 24||126
3320778|NCT03162796|4053753|FG001|STARTED|Placebo Controlled Period: Week 0 - 24||127
3320779|NCT03162796|4053754|FG002|STARTED|Placebo Controlled Period: Week 0 - 24||128
3320780|NCT03162796|4053752|FG000|COMPLETED|Placebo Controlled Period: Week 0 - 24||114
3320781|NCT03162796|4053753|FG001|COMPLETED|Placebo Controlled Period: Week 0 - 24||123
3320782|NCT03162796|4053754|FG002|COMPLETED|Placebo Controlled Period: Week 0 - 24||125
3320783|NCT03162796|4053752|FG000|NOT COMPLETED|Placebo Controlled Period: Week 0 - 24||12
3320784|NCT03162796|4053753|FG001|NOT COMPLETED|Placebo Controlled Period: Week 0 - 24||4
3320785|NCT03162796|4053754|FG002|NOT COMPLETED|Placebo Controlled Period: Week 0 - 24||3
3320786|NCT03162796|4053752|FG000|STARTED|Active Treatment Period: Week 24 - 52||114
3320787|NCT03162796|4053753|FG001|STARTED|Active Treatment Period: Week 24 - 52||123
3320788|NCT03162796|4053754|FG002|STARTED|Active Treatment Period: Week 24 - 52||125
3320789|NCT03162796|4053752|FG000|COMPLETED|Active Treatment Period: Week 24 - 52||107
3320790|NCT03162796|4053753|FG001|COMPLETED|Active Treatment Period: Week 24 - 52||116
3320791|NCT03162796|4053754|FG002|COMPLETED|Active Treatment Period: Week 24 - 52||124
3320792|NCT03162796|4053752|FG000|NOT COMPLETED|Active Treatment Period: Week 24 - 52||7
3320793|NCT03162796|4053753|FG001|NOT COMPLETED|Active Treatment Period: Week 24 - 52||7
3320794|NCT03162796|4053754|FG002|NOT COMPLETED|Active Treatment Period: Week 24 - 52||1
3320795|NCT03162796|4053752|FG000|STARTED|Safety Follow-up: Week 52 - 60||107
3320796|NCT03162796|4053753|FG001|STARTED|Safety Follow-up: Week 52 - 60||116
3320797|NCT03162796|4053754|FG002|STARTED|Safety Follow-up: Week 52 - 60||124
3320798|NCT03162796|4053752|FG000|COMPLETED|Safety Follow-up: Week 52 - 60||106
3320799|NCT03162796|4053753|FG001|COMPLETED|Safety Follow-up: Week 52 - 60||114
3320800|NCT03162796|4053754|FG002|COMPLETED|Safety Follow-up: Week 52 - 60||123
3320801|NCT03162796|4053752|FG000|NOT COMPLETED|Safety Follow-up: Week 52 - 60||1
3320802|NCT03162796|4053753|FG001|NOT COMPLETED|Safety Follow-up: Week 52 - 60||2
3320803|NCT03162796|4053754|FG002|NOT COMPLETED|Safety Follow-up: Week 52 - 60||1
3320804|NCT03163017|4053767|FG000|STARTED|Overall Study||30
3320805|NCT03163017|4053767|FG000|COMPLETED|Overall Study||30
3320806|NCT03163017|4053767|FG000|NOT COMPLETED|Overall Study||0
2923984|NCT00556322|3634992|FG001|NOT COMPLETED|Overall Study||203
2923985|NCT00556374|3635003|FG000|STARTED|Overall Study||1709
2923986|NCT00556374|3635004|FG001|STARTED|Overall Study||1711
2923987|NCT00556374|3635003|FG000|Received Study Drug|Overall Study||1699
2923988|NCT00556374|3635004|FG001|Received Study Drug|Overall Study||1700
2923989|NCT00556374|3635003|FG000|COMPLETED|Overall Study|Indicates participants continuing study|1462
2923990|NCT00556374|3635004|FG001|COMPLETED|Overall Study|Indicates participants continuing study|1491
3320807|NCT03163134|4053773|FG000|STARTED|Overall Study||85
3320808|NCT03163134|4053774|FG001|STARTED|Overall Study||85
3320809|NCT03163134|4053773|FG000|COMPLETED|Overall Study||85
3320810|NCT03163134|4053774|FG001|COMPLETED|Overall Study||85
3320811|NCT03163134|4053773|FG000|NOT COMPLETED|Overall Study||0
3320812|NCT03163134|4053774|FG001|NOT COMPLETED|Overall Study||0
3320813|NCT03163303|4053782|FG000|STARTED|Overall Study||85
3320814|NCT03163303|4053783|FG001|STARTED|Overall Study||94
3320815|NCT03163303|4053782|FG000|COMPLETED|Overall Study||85
3320816|NCT03163303|4053783|FG001|COMPLETED|Overall Study||94
3320817|NCT03163303|4053782|FG000|NOT COMPLETED|Overall Study||0
3320818|NCT03163303|4053783|FG001|NOT COMPLETED|Overall Study||0
3320819|NCT03163342|4053789|FG000|STARTED|Overall Study||20
3320820|NCT03163342|4053789|FG000|COMPLETED|Overall Study||20
3320821|NCT03163342|4053789|FG000|NOT COMPLETED|Overall Study||0
3320822|NCT03163446|4053795|FG000|STARTED|Overall Study||73
3320823|NCT03163446|4053796|FG001|STARTED|Overall Study||48
3320824|NCT03163446|4053795|FG000|COMPLETED|Overall Study||45
3320825|NCT03163446|4053796|FG001|COMPLETED|Overall Study||31
3320826|NCT03163446|4053795|FG000|NOT COMPLETED|Overall Study||28
3320827|NCT03163446|4053796|FG001|NOT COMPLETED|Overall Study||17
3320828|NCT03163472|4053810|FG000|STARTED|Overall Study||15
3320829|NCT03163472|4053811|FG001|STARTED|Overall Study||15
3320830|NCT03163472|4053810|FG000|COMPLETED|Overall Study||15
3320831|NCT03163472|4053811|FG001|COMPLETED|Overall Study||15
3320832|NCT03163472|4053810|FG000|NOT COMPLETED|Overall Study||0
3320833|NCT03163472|4053811|FG001|NOT COMPLETED|Overall Study||0
3320834|NCT03163758|4053821|FG000|STARTED|Overall Study||21
3320835|NCT03163758|4053822|FG001|STARTED|Overall Study||21
3320836|NCT03163758|4053821|FG000|COMPLETED|Overall Study||13
3320837|NCT03163758|4053822|FG001|COMPLETED|Overall Study||14
3320838|NCT03163758|4053821|FG000|NOT COMPLETED|Overall Study||8
3320839|NCT03163758|4053822|FG001|NOT COMPLETED|Overall Study||7
3320840|NCT03164538|4053830|FG000|STARTED|Overall Study||35
3320841|NCT03164538|4053831|FG001|STARTED|Overall Study||35
3320842|NCT03164538|4053830|FG000|COMPLETED|Overall Study||28
3320843|NCT03164538|4053831|FG001|COMPLETED|Overall Study||29
3320844|NCT03164538|4053830|FG000|NOT COMPLETED|Overall Study||7
3320845|NCT03164538|4053831|FG001|NOT COMPLETED|Overall Study||6
3320846|NCT03164551|4053839|FG000|STARTED|Overall Study||200
3320847|NCT03164551|4053840|FG001|STARTED|Overall Study||208
3320848|NCT03164551|4053839|FG000|COMPLETED|Overall Study||171
3320849|NCT03164551|4053840|FG001|COMPLETED|Overall Study||192
3320850|NCT03164551|4053839|FG000|NOT COMPLETED|Overall Study||29
3320851|NCT03164551|4053840|FG001|NOT COMPLETED|Overall Study||16
3320852|NCT03164629|4053848|FG000|STARTED|Overall Study||25
3320853|NCT03164629|4053849|FG001|STARTED|Overall Study||25
3320854|NCT03164629|4053848|FG000|COMPLETED|Overall Study||25
3320855|NCT03164629|4053849|FG001|COMPLETED|Overall Study||25
3320856|NCT03164629|4053848|FG000|NOT COMPLETED|Overall Study||0
3320857|NCT03164629|4053849|FG001|NOT COMPLETED|Overall Study||0
3320858|NCT03165045|4053855|FG000|STARTED|Visit 1||1351
3320859|NCT03165045|4053855|FG000|COMPLETED|Visit 1||1322
3320860|NCT03165045|4053855|FG000|NOT COMPLETED|Visit 1||29
3320861|NCT03165045|4053855|FG000|STARTED|Visit 2||1322
3320862|NCT03165045|4053855|FG000|COMPLETED|Visit 2||1140
3320863|NCT03165045|4053855|FG000|NOT COMPLETED|Visit 2||182
3320864|NCT03165058|4053863|FG000|STARTED|Overall Study||21
3320865|NCT03165058|4053864|FG001|STARTED|Overall Study||11
3320866|NCT03165058|4053863|FG000|COMPLETED|Overall Study||21
3320867|NCT03165058|4053864|FG001|COMPLETED|Overall Study||11
3320868|NCT03165058|4053863|FG000|NOT COMPLETED|Overall Study||0
3320869|NCT03165058|4053864|FG001|NOT COMPLETED|Overall Study||0
3320870|NCT03165110|4053870|FG000|STARTED|Overall Study||47
3320871|NCT03165110|4053870|FG000|COMPLETED|Overall Study||46
3320872|NCT03165110|4053870|FG000|NOT COMPLETED|Overall Study||1
3320873|NCT03165175|4053876|FG000|STARTED|1-month to 3-month||41
3320874|NCT03165175|4053877|FG001|STARTED|1-month to 3-month||39
3320875|NCT03165175|4053876|FG000|COMPLETED|1-month to 3-month||35
3320876|NCT03165175|4053877|FG001|COMPLETED|1-month to 3-month||39
3320877|NCT03165175|4053876|FG000|NOT COMPLETED|1-month to 3-month||6
3320878|NCT03165175|4053877|FG001|NOT COMPLETED|1-month to 3-month||0
3320879|NCT03165175|4053876|FG000|STARTED|Baseline to 3-month||35
3320880|NCT03165175|4053877|FG001|STARTED|Baseline to 3-month||39
3320881|NCT03165175|4053876|FG000|COMPLETED|Baseline to 3-month||31
3320882|NCT03165175|4053877|FG001|COMPLETED|Baseline to 3-month||39
3320883|NCT03165175|4053876|FG000|NOT COMPLETED|Baseline to 3-month||4
3320884|NCT03165175|4053877|FG001|NOT COMPLETED|Baseline to 3-month||0
3320885|NCT03165617|4053885|FG000|STARTED|Overall Study||2258
3320886|NCT03165617|4053886|FG001|STARTED|Overall Study||2256
3320887|NCT03165617|4053885|FG000|COMPLETED|Overall Study||2249
3320888|NCT03165617|4053886|FG001|COMPLETED|Overall Study||2247
3320889|NCT03165617|4053885|FG000|NOT COMPLETED|Overall Study||9
3320890|NCT03165617|4053886|FG001|NOT COMPLETED|Overall Study||9
3320891|NCT03165955|4053910|FG000|STARTED|Screening/Baseline||31
3320892|NCT03165955|4053910|FG000|COMPLETED|Screening/Baseline||28
3320893|NCT03165955|4053910|FG000|NOT COMPLETED|Screening/Baseline||3
3320894|NCT03165955|4053910|FG000|STARTED|Treatment||28
3320895|NCT03165955|4053910|FG000|COMPLETED|Treatment||20
3320896|NCT03165955|4053910|FG000|NOT COMPLETED|Treatment||8
3320897|NCT03165981|4053916|FG000|STARTED|Overall Study||110
3320898|NCT03165981|4053917|FG001|STARTED|Overall Study||111
3320899|NCT03165981|4053916|FG000|Per Protocol Population|Overall Study||99
3320900|NCT03165981|4053917|FG001|Per Protocol Population|Overall Study||107
3320901|NCT03165981|4053916|FG000|COMPLETED|Overall Study||99
3320902|NCT03165981|4053917|FG001|COMPLETED|Overall Study||107
3320903|NCT03165981|4053916|FG000|NOT COMPLETED|Overall Study||11
3320904|NCT03165981|4053917|FG001|NOT COMPLETED|Overall Study||4
3320905|NCT03166124|4053925|FG000|STARTED|Treatment Period 1||20
3320906|NCT03166124|4053926|FG001|STARTED|Treatment Period 1||20
3320907|NCT03166124|4053927|FG002|STARTED|Treatment Period 1||19
3320908|NCT03166124|4053928|FG003|STARTED|Treatment Period 1||21
3320909|NCT03166124|4053925|FG000|Received at Least One Dose of Study Drug|Treatment Period 1||20
3320910|NCT03166124|4053926|FG001|Received at Least One Dose of Study Drug|Treatment Period 1||20
3320911|NCT03166124|4053927|FG002|Received at Least One Dose of Study Drug|Treatment Period 1||18
3320912|NCT03166124|4053928|FG003|Received at Least One Dose of Study Drug|Treatment Period 1||21
3320913|NCT03166124|4053925|FG000|COMPLETED|Treatment Period 1||20
3320914|NCT03166124|4053926|FG001|COMPLETED|Treatment Period 1||20
3320915|NCT03166124|4053927|FG002|COMPLETED|Treatment Period 1||18
3320916|NCT03166124|4053928|FG003|COMPLETED|Treatment Period 1||21
3320917|NCT03166124|4053925|FG000|NOT COMPLETED|Treatment Period 1||0
3320918|NCT03166124|4053926|FG001|NOT COMPLETED|Treatment Period 1||0
3320919|NCT03166124|4053927|FG002|NOT COMPLETED|Treatment Period 1||1
3320920|NCT03166124|4053928|FG003|NOT COMPLETED|Treatment Period 1||0
3320921|NCT03166124|4053925|FG000|STARTED|Wash-out Period||20
3320922|NCT03166124|4053926|FG001|STARTED|Wash-out Period||20
3320923|NCT03166124|4053927|FG002|STARTED|Wash-out Period||18
3320924|NCT03166124|4053928|FG003|STARTED|Wash-out Period||21
3320925|NCT03166124|4053925|FG000|COMPLETED|Wash-out Period||20
3320926|NCT03166124|4053926|FG001|COMPLETED|Wash-out Period||18
3320927|NCT03166124|4053927|FG002|COMPLETED|Wash-out Period||17
3320928|NCT03166124|4053928|FG003|COMPLETED|Wash-out Period||20
3320929|NCT03166124|4053925|FG000|NOT COMPLETED|Wash-out Period||0
3320930|NCT03166124|4053926|FG001|NOT COMPLETED|Wash-out Period||2
3320931|NCT03166124|4053927|FG002|NOT COMPLETED|Wash-out Period||1
3320932|NCT03166124|4053928|FG003|NOT COMPLETED|Wash-out Period||1
3320933|NCT03166124|4053925|FG000|STARTED|Treatment Period 2||20
3320934|NCT03166124|4053926|FG001|STARTED|Treatment Period 2||18
3320935|NCT03166124|4053927|FG002|STARTED|Treatment Period 2||17
3320936|NCT03166124|4053928|FG003|STARTED|Treatment Period 2||20
3320937|NCT03166124|4053925|FG000|COMPLETED|Treatment Period 2||20
3320938|NCT03166124|4053926|FG001|COMPLETED|Treatment Period 2||18
3320939|NCT03166124|4053927|FG002|COMPLETED|Treatment Period 2||17
3320940|NCT03166124|4053928|FG003|COMPLETED|Treatment Period 2||20
3320941|NCT03166124|4053925|FG000|NOT COMPLETED|Treatment Period 2||0
3320942|NCT03166124|4053926|FG001|NOT COMPLETED|Treatment Period 2||0
3320943|NCT03166124|4053927|FG002|NOT COMPLETED|Treatment Period 2||0
3320944|NCT03166124|4053928|FG003|NOT COMPLETED|Treatment Period 2||0
3320945|NCT03166215|4053941|FG000|STARTED|Part 1 (Double-blind TP: Days 1 - 30)||4
3320946|NCT03166215|4053942|FG001|STARTED|Part 1 (Double-blind TP: Days 1 - 30)||14
3320947|NCT03166215|4053943|FG002|STARTED|Part 1 (Double-blind TP: Days 1 - 30)||0
3320948|NCT03166215|4053941|FG000|COMPLETED|Part 1 (Double-blind TP: Days 1 - 30)||4
3320949|NCT03166215|4053942|FG001|COMPLETED|Part 1 (Double-blind TP: Days 1 - 30)||12
3320950|NCT03166215|4053943|FG002|COMPLETED|Part 1 (Double-blind TP: Days 1 - 30)||0
3320951|NCT03166215|4053941|FG000|NOT COMPLETED|Part 1 (Double-blind TP: Days 1 - 30)||0
3320952|NCT03166215|4053942|FG001|NOT COMPLETED|Part 1 (Double-blind TP: Days 1 - 30)||2
3320953|NCT03166215|4053943|FG002|NOT COMPLETED|Part 1 (Double-blind TP: Days 1 - 30)||0
3320954|NCT03166215|4053941|FG000|STARTED|Part 2 (Open-Label TP: Days 31 - 85)||0
3320955|NCT03166215|4053942|FG001|STARTED|Part 2 (Open-Label TP: Days 31 - 85)||0
3320956|NCT03166215|4053943|FG002|STARTED|Part 2 (Open-Label TP: Days 31 - 85)||16
3320957|NCT03166215|4053941|FG000|COMPLETED|Part 2 (Open-Label TP: Days 31 - 85)||0
3320958|NCT03166215|4053942|FG001|COMPLETED|Part 2 (Open-Label TP: Days 31 - 85)||0
3320959|NCT03166215|4053943|FG002|COMPLETED|Part 2 (Open-Label TP: Days 31 - 85)||14
3320960|NCT03166215|4053941|FG000|NOT COMPLETED|Part 2 (Open-Label TP: Days 31 - 85)||0
3320961|NCT03166215|4053942|FG001|NOT COMPLETED|Part 2 (Open-Label TP: Days 31 - 85)||0
3320962|NCT03166215|4053943|FG002|NOT COMPLETED|Part 2 (Open-Label TP: Days 31 - 85)||2
3320963|NCT03166735|4053959|FG000|STARTED|Overall Study||33
3320964|NCT03166735|4053960|FG001|STARTED|Overall Study||16
3320965|NCT03166735|4053961|FG002|STARTED|Overall Study||16
3320966|NCT03166735|4053962|FG003|STARTED|Overall Study||17
3320967|NCT03166735|4053963|FG004|STARTED|Overall Study||32
3320968|NCT03166735|4053959|FG000|Treated|Overall Study||32
3320969|NCT03166735|4053960|FG001|Treated|Overall Study||16
3320970|NCT03166735|4053961|FG002|Treated|Overall Study||16
3320971|NCT03166735|4053962|FG003|Treated|Overall Study||17
3320972|NCT03166735|4053963|FG004|Treated|Overall Study||32
3320973|NCT03166735|4053959|FG000|COMPLETED|Overall Study||32
3320974|NCT03166735|4053960|FG001|COMPLETED|Overall Study||13
3320975|NCT03166735|4053961|FG002|COMPLETED|Overall Study||13
3320976|NCT03166735|4053962|FG003|COMPLETED|Overall Study||16
3320977|NCT03166735|4053963|FG004|COMPLETED|Overall Study||28
3320978|NCT03166735|4053959|FG000|NOT COMPLETED|Overall Study||1
3320979|NCT03166735|4053960|FG001|NOT COMPLETED|Overall Study||3
3320980|NCT03166735|4053961|FG002|NOT COMPLETED|Overall Study||3
3320981|NCT03166735|4053962|FG003|NOT COMPLETED|Overall Study||1
3320982|NCT03166735|4053963|FG004|NOT COMPLETED|Overall Study||4
3320983|NCT03167073|4053978|FG000|STARTED|Overall Study||85
3320984|NCT03167073|4053979|FG001|STARTED|Overall Study||85
3320985|NCT03167073|4053978|FG000|COMPLETED|Overall Study||84
3320986|NCT03167073|4053979|FG001|COMPLETED|Overall Study||85
3320987|NCT03167073|4053978|FG000|NOT COMPLETED|Overall Study||1
3320988|NCT03167073|4053979|FG001|NOT COMPLETED|Overall Study||0
3320989|NCT03167151|4053988|FG000|STARTED|Overall Study||3
3320990|NCT03167151|4053989|FG001|STARTED|Overall Study||3
3320991|NCT03167151|4053990|FG002|STARTED|Overall Study||3
3320992|NCT03167151|4053988|FG000|COMPLETED|Overall Study||2
3320993|NCT03167151|4053989|FG001|COMPLETED|Overall Study||2
3320994|NCT03167151|4053990|FG002|COMPLETED|Overall Study||2
3320995|NCT03167151|4053988|FG000|NOT COMPLETED|Overall Study||1
3320996|NCT03167151|4053989|FG001|NOT COMPLETED|Overall Study||1
3320997|NCT03167151|4053990|FG002|NOT COMPLETED|Overall Study||1
3320998|NCT03167359|4053998|FG000|STARTED|Overall Study||74
3320999|NCT03167359|4053998|FG000|COMPLETED|Overall Study||72
3321000|NCT03167359|4053998|FG000|NOT COMPLETED|Overall Study||2
3321001|NCT03167411|4054004|FG000|STARTED|Overall Study||10
3321002|NCT03167411|4054005|FG001|STARTED|Overall Study||10
3321003|NCT03167411|4054004|FG000|COMPLETED|Overall Study||10
3321004|NCT03167411|4054005|FG001|COMPLETED|Overall Study||9
3321005|NCT03167411|4054004|FG000|NOT COMPLETED|Overall Study||0
3321006|NCT03167411|4054005|FG001|NOT COMPLETED|Overall Study||1
3321007|NCT03167541|4054011|FG000|STARTED|First Intervention||9
3321008|NCT03167541|4054012|FG001|STARTED|First Intervention||9
3173865|NCT01952470|3901604|FG000|Death|Overall Study||1
3173866|NCT01952470|3901605|FG001|Death|Overall Study||1
3321009|NCT03167541|4054011|FG000|COMPLETED|First Intervention||9
3321010|NCT03167541|4054012|FG001|COMPLETED|First Intervention||9
3321011|NCT03167541|4054011|FG000|NOT COMPLETED|First Intervention||0
3321012|NCT03167541|4054012|FG001|NOT COMPLETED|First Intervention||0
3321013|NCT03167541|4054011|FG000|STARTED|Washout: 5-8 Days||9
3321014|NCT03167541|4054012|FG001|STARTED|Washout: 5-8 Days||9
3321015|NCT03167541|4054011|FG000|COMPLETED|Washout: 5-8 Days||9
3321016|NCT03167541|4054012|FG001|COMPLETED|Washout: 5-8 Days||9
3321017|NCT03167541|4054011|FG000|NOT COMPLETED|Washout: 5-8 Days||0
3321018|NCT03167541|4054012|FG001|NOT COMPLETED|Washout: 5-8 Days||0
3321019|NCT03167541|4054011|FG000|STARTED|Second Intervention||9
3321020|NCT03167541|4054012|FG001|STARTED|Second Intervention||9
3321021|NCT03167541|4054011|FG000|COMPLETED|Second Intervention||9
3321022|NCT03167541|4054012|FG001|COMPLETED|Second Intervention||9
3321023|NCT03167541|4054011|FG000|NOT COMPLETED|Second Intervention||0
3321024|NCT03167541|4054012|FG001|NOT COMPLETED|Second Intervention||0
3321025|NCT03168022|4054019|FG000|STARTED|Overall Study||21
3321026|NCT03168022|4054020|FG001|STARTED|Overall Study||22
3321027|NCT03168022|4054019|FG000|COMPLETED|Overall Study||21
3321028|NCT03168022|4054020|FG001|COMPLETED|Overall Study||21
3321029|NCT03168022|4054019|FG000|NOT COMPLETED|Overall Study||0
3321030|NCT03168022|4054020|FG001|NOT COMPLETED|Overall Study||1
3321031|NCT03168295|4054031|FG000|STARTED|Overall Study||3
3321032|NCT03168295|4054032|FG001|STARTED|Overall Study||3
3321033|NCT03168295|4054033|FG002|STARTED|Overall Study||4
3321034|NCT03168295|4054034|FG003|STARTED|Overall Study||4
3321035|NCT03168295|4054035|FG004|STARTED|Overall Study||20
3321036|NCT03168295|4054031|FG000|COMPLETED|Overall Study||3
3321037|NCT03168295|4054032|FG001|COMPLETED|Overall Study||3
3321038|NCT03168295|4054033|FG002|COMPLETED|Overall Study||4
3321039|NCT03168295|4054034|FG003|COMPLETED|Overall Study||4
3321040|NCT03168295|4054035|FG004|COMPLETED|Overall Study||20
3321041|NCT03168295|4054031|FG000|NOT COMPLETED|Overall Study||0
3321042|NCT03168295|4054032|FG001|NOT COMPLETED|Overall Study||0
3321043|NCT03168295|4054033|FG002|NOT COMPLETED|Overall Study||0
3321044|NCT03168295|4054034|FG003|NOT COMPLETED|Overall Study||0
3321045|NCT03168295|4054035|FG004|NOT COMPLETED|Overall Study||0
3321046|NCT03168308|4054048|FG000|STARTED|Overall Study||48
3321047|NCT03168308|4054049|FG001|STARTED|Overall Study||44
3321048|NCT03168308|4054048|FG000|COMPLETED|Overall Study||48
3321049|NCT03168308|4054049|FG001|COMPLETED|Overall Study||44
3321050|NCT03168308|4054048|FG000|NOT COMPLETED|Overall Study||0
3321051|NCT03168308|4054049|FG001|NOT COMPLETED|Overall Study||0
3321052|NCT03168321|4054057|FG000|STARTED|Overall Study||402
3321053|NCT03168321|4054058|FG001|STARTED|Overall Study||411
3321054|NCT03168321|4054057|FG000|COMPLETED|Overall Study||347
3321055|NCT03168321|4054058|FG001|COMPLETED|Overall Study||356
3321056|NCT03168321|4054057|FG000|NOT COMPLETED|Overall Study||55
3321057|NCT03168321|4054058|FG001|NOT COMPLETED|Overall Study||55
3321058|NCT03168334|4054066|FG000|STARTED|Overall Study||397
3321059|NCT03168334|4054067|FG001|STARTED|Overall Study||404
3173867|NCT01952470|3901604|FG000|Missing Baseline LCI 2% Data.|Overall Study||0
3321060|NCT03168334|4054066|FG000|COMPLETED|Overall Study||345
3321061|NCT03168334|4054067|FG001|COMPLETED|Overall Study||366
3321062|NCT03168334|4054066|FG000|NOT COMPLETED|Overall Study||52
3321063|NCT03168334|4054067|FG001|NOT COMPLETED|Overall Study||38
3321064|NCT03168425|4054075|FG000|STARTED|Overall Study||94
3321065|NCT03168425|4054076|FG001|STARTED|Overall Study||96
3321066|NCT03168425|4054075|FG000|COMPLETED|Overall Study||87
3321067|NCT03168425|4054076|FG001|COMPLETED|Overall Study||85
3321068|NCT03168425|4054075|FG000|NOT COMPLETED|Overall Study||7
3321069|NCT03168425|4054076|FG001|NOT COMPLETED|Overall Study||11
3321070|NCT03168542|4054083|FG000|STARTED|Overall Study||7
2923991|NCT00556374|3635003|FG000|NOT COMPLETED|Overall Study||247
2923992|NCT00556374|3635004|FG001|NOT COMPLETED|Overall Study||220
2923993|NCT00556426|3635010|FG000|STARTED|Overall Study||100
2923994|NCT00556426|3635010|FG000|COMPLETED|Overall Study||91
2923995|NCT00556426|3635010|FG000|NOT COMPLETED|Overall Study||9
2923996|NCT00556439|3635019|FG000|STARTED|Study Entry to Week 12|58 signed informed consent with 9 not being eligible. The remaining 49 received study drug.|49
2923997|NCT00556439|3635020|FG001|STARTED|Study Entry to Week 12|No participants received placebo until the Week 12 Randomization|0
2923998|NCT00556439|3635021|FG002|STARTED|Study Entry to Week 12|39 signed informed consent with 5 not being eligible. The remaining 34 received study drug.|34
2923999|NCT00556439|3635022|FG003|STARTED|Study Entry to Week 12|No participants received placebo until the Week 12 Randomization|0
2924000|NCT00556439|3635019|FG000|COMPLETED|Study Entry to Week 12||41
2924001|NCT00556439|3635020|FG001|COMPLETED|Study Entry to Week 12||0
2924002|NCT00556439|3635021|FG002|COMPLETED|Study Entry to Week 12||26
2924003|NCT00556439|3635022|FG003|COMPLETED|Study Entry to Week 12||0
2924004|NCT00556439|3635019|FG000|NOT COMPLETED|Study Entry to Week 12||8
2924005|NCT00556439|3635020|FG001|NOT COMPLETED|Study Entry to Week 12||0
2924006|NCT00556439|3635021|FG002|NOT COMPLETED|Study Entry to Week 12||8
2924007|NCT00556439|3635022|FG003|NOT COMPLETED|Study Entry to Week 12||0
2924008|NCT00556439|3635019|FG000|STARTED|After Week 12 (Randomized Study Period)||20
2924009|NCT00556439|3635020|FG001|STARTED|After Week 12 (Randomized Study Period)||21
2924010|NCT00556439|3635021|FG002|STARTED|After Week 12 (Randomized Study Period)||11
2924011|NCT00556439|3635022|FG003|STARTED|After Week 12 (Randomized Study Period)||15
2924012|NCT00556439|3635019|FG000|COMPLETED|After Week 12 (Randomized Study Period)||17
2924013|NCT00556439|3635020|FG001|COMPLETED|After Week 12 (Randomized Study Period)||17
2924014|NCT00556439|3635021|FG002|COMPLETED|After Week 12 (Randomized Study Period)||11
2924015|NCT00556439|3635022|FG003|COMPLETED|After Week 12 (Randomized Study Period)||14
2924016|NCT00556439|3635019|FG000|NOT COMPLETED|After Week 12 (Randomized Study Period)||3
2924017|NCT00556439|3635020|FG001|NOT COMPLETED|After Week 12 (Randomized Study Period)||4
2924018|NCT00556439|3635021|FG002|NOT COMPLETED|After Week 12 (Randomized Study Period)||0
2924019|NCT00556439|3635022|FG003|NOT COMPLETED|After Week 12 (Randomized Study Period)||1
2924020|NCT00556452|3635035|FG000|STARTED|Overall Study||6
2924021|NCT00556452|3635036|FG001|STARTED|Overall Study||21
2924022|NCT00556452|3635037|FG002|STARTED|Overall Study||19
2924023|NCT00556452|3635035|FG000|COMPLETED|Overall Study||6
2924024|NCT00556452|3635036|FG001|COMPLETED|Overall Study||21
2924025|NCT00556452|3635037|FG002|COMPLETED|Overall Study||19
2924026|NCT00556452|3635035|FG000|NOT COMPLETED|Overall Study||0
2924027|NCT00556452|3635036|FG001|NOT COMPLETED|Overall Study||0
2924028|NCT00556452|3635037|FG002|NOT COMPLETED|Overall Study||0
2924029|NCT00556478|3635044|FG000|STARTED|Double-blind Phase||171
2924030|NCT00556478|3635045|FG001|STARTED|Double-blind Phase||85
2924031|NCT00556478|3635044|FG000|ITT|Double-blind Phase||167
2924032|NCT00556478|3635045|FG001|ITT|Double-blind Phase||82
2924033|NCT00556478|3635044|FG000|COMPLETED|Double-blind Phase||150
3321071|NCT03168542|4054084|FG001|STARTED|Overall Study||5
3321072|NCT03168542|4054085|FG002|STARTED|Overall Study||9
3321073|NCT03168542|4054083|FG000|COMPLETED|Overall Study||7
3321074|NCT03168542|4054084|FG001|COMPLETED|Overall Study||5
3321075|NCT03168542|4054085|FG002|COMPLETED|Overall Study||9
3321076|NCT03168542|4054083|FG000|NOT COMPLETED|Overall Study||0
3321077|NCT03168542|4054084|FG001|NOT COMPLETED|Overall Study||0
3321078|NCT03168542|4054085|FG002|NOT COMPLETED|Overall Study||0
3321079|NCT03168711|4054092|FG000|STARTED|Overall Study||14
3321080|NCT03168711|4054093|FG001|STARTED|Overall Study||9
3321081|NCT03168711|4054092|FG000|COMPLETED|Overall Study||12
3321082|NCT03168711|4054093|FG001|COMPLETED|Overall Study||7
3321083|NCT03168711|4054092|FG000|NOT COMPLETED|Overall Study||2
3321084|NCT03168711|4054093|FG001|NOT COMPLETED|Overall Study||2
3321085|NCT03168841|4054099|FG000|STARTED|Overall Study||40
3321086|NCT03168841|4054099|FG000|COMPLETED|Overall Study||36
3321087|NCT03168841|4054099|FG000|NOT COMPLETED|Overall Study||4
3321088|NCT03168919|4054103|FG000|STARTED|Overall Study||5
3321089|NCT03168919|4054103|FG000|COMPLETED|Overall Study||3
3321090|NCT03168919|4054103|FG000|NOT COMPLETED|Overall Study||2
3321091|NCT03169062|4054111|FG000|STARTED|Overall Study||10
3321092|NCT03169062|4054111|FG000|COMPLETED|Overall Study||10
3321093|NCT03169062|4054111|FG000|NOT COMPLETED|Overall Study||0
3321094|NCT03169153|4054115|FG000|STARTED|Period 1, First 30 Days of Wear||42
3321095|NCT03169153|4054116|FG001|STARTED|Period 1, First 30 Days of Wear||39
3321096|NCT03169153|4054115|FG000|COMPLETED|Period 1, First 30 Days of Wear||39
3321097|NCT03169153|4054116|FG001|COMPLETED|Period 1, First 30 Days of Wear||35
3321098|NCT03169153|4054115|FG000|NOT COMPLETED|Period 1, First 30 Days of Wear||3
3321099|NCT03169153|4054116|FG001|NOT COMPLETED|Period 1, First 30 Days of Wear||4
3321100|NCT03169153|4054115|FG000|STARTED|Period 2, Second 30 Days of Wear||39
3321101|NCT03169153|4054116|FG001|STARTED|Period 2, Second 30 Days of Wear|One subject discontinued after completing Period 1 and was not exposed in Period 2.|34
3321102|NCT03169153|4054115|FG000|COMPLETED|Period 2, Second 30 Days of Wear||37
3321103|NCT03169153|4054116|FG001|COMPLETED|Period 2, Second 30 Days of Wear||32
3321104|NCT03169153|4054115|FG000|NOT COMPLETED|Period 2, Second 30 Days of Wear||2
3321105|NCT03169153|4054116|FG001|NOT COMPLETED|Period 2, Second 30 Days of Wear||2
3321106|NCT03169244|4054124|FG000|STARTED|Overall Study||22
3321107|NCT03169244|4054125|FG001|STARTED|Overall Study||20
3321108|NCT03169244|4054124|FG000|Randomly Assigned|Overall Study||22
3321109|NCT03169244|4054125|FG001|Randomly Assigned|Overall Study||20
3321110|NCT03169244|4054124|FG000|Received Intervention|Overall Study||22
3321111|NCT03169244|4054125|FG001|Received Intervention|Overall Study||18
3321112|NCT03169244|4054124|FG000|COMPLETED|Overall Study||17
3321113|NCT03169244|4054125|FG001|COMPLETED|Overall Study||16
3321114|NCT03169244|4054124|FG000|NOT COMPLETED|Overall Study||5
3321115|NCT03169244|4054125|FG001|NOT COMPLETED|Overall Study||4
3321116|NCT03169816|4054133|FG000|STARTED|Overall Study||33
3321117|NCT03169816|4054134|FG001|STARTED|Overall Study||16
3321118|NCT03169816|4054133|FG000|COMPLETED|Overall Study||6
3321119|NCT03169816|4054134|FG001|COMPLETED|Overall Study||3
3321120|NCT03169816|4054133|FG000|NOT COMPLETED|Overall Study||27
3321121|NCT03169816|4054134|FG001|NOT COMPLETED|Overall Study||13
3321122|NCT03170154|4054140|FG000|STARTED|Overall Study||350
3321123|NCT03170154|4054140|FG000|Rotational Stability Sub-study|Overall Study||141
3321124|NCT03170154|4054140|FG000|COMPLETED|Overall Study||342
3321125|NCT03170154|4054140|FG000|NOT COMPLETED|Overall Study||8
3321126|NCT03170193|4054156|FG000|STARTED|Overall Study||12
3321127|NCT03170193|4054157|FG001|STARTED|Overall Study||6
3321128|NCT03170193|4054158|FG002|STARTED|Overall Study||6
3321129|NCT03170193|4054159|FG003|STARTED|Overall Study||6
3321130|NCT03170193|4054160|FG004|STARTED|Overall Study||6
3321131|NCT03170193|4054161|FG005|STARTED|Overall Study||6
3321132|NCT03170193|4054162|FG006|STARTED|Overall Study||6
3321133|NCT03170193|4054156|FG000|COMPLETED|Overall Study||11
3321134|NCT03170193|4054157|FG001|COMPLETED|Overall Study||5
3321135|NCT03170193|4054158|FG002|COMPLETED|Overall Study||6
3321136|NCT03170193|4054159|FG003|COMPLETED|Overall Study||5
3321137|NCT03170193|4054160|FG004|COMPLETED|Overall Study||6
3321138|NCT03170193|4054161|FG005|COMPLETED|Overall Study||6
3321139|NCT03170193|4054162|FG006|COMPLETED|Overall Study||6
3321140|NCT03170193|4054156|FG000|NOT COMPLETED|Overall Study||1
3321141|NCT03170193|4054157|FG001|NOT COMPLETED|Overall Study||1
3321142|NCT03170193|4054158|FG002|NOT COMPLETED|Overall Study||0
3321143|NCT03170193|4054159|FG003|NOT COMPLETED|Overall Study||1
3321144|NCT03170193|4054160|FG004|NOT COMPLETED|Overall Study||0
3321145|NCT03170193|4054161|FG005|NOT COMPLETED|Overall Study||0
3321146|NCT03170193|4054162|FG006|NOT COMPLETED|Overall Study||0
3321147|NCT03170219|4054186|FG000|STARTED|Overall Study||7
3321148|NCT03170219|4054187|FG001|STARTED|Overall Study||4
3321149|NCT03170219|4054186|FG000|COMPLETED|Overall Study||7
3321150|NCT03170219|4054187|FG001|COMPLETED|Overall Study||4
3321151|NCT03170219|4054186|FG000|NOT COMPLETED|Overall Study||0
3321152|NCT03170219|4054187|FG001|NOT COMPLETED|Overall Study||0
3321153|NCT03170232|4054195|FG000|STARTED|Overall Study||27
3321154|NCT03170232|4054196|FG001|STARTED|Overall Study||27
3321155|NCT03170232|4054195|FG000|COMPLETED|Overall Study||0
3321156|NCT03170232|4054196|FG001|COMPLETED|Overall Study||0
3321157|NCT03170232|4054195|FG000|NOT COMPLETED|Overall Study||27
3321158|NCT03170232|4054196|FG001|NOT COMPLETED|Overall Study||27
3321159|NCT03170271|4054204|FG000|STARTED|Overall Study||431
2924034|NCT00556478|3635045|FG001|COMPLETED|Double-blind Phase||77
2924035|NCT00556478|3635044|FG000|NOT COMPLETED|Double-blind Phase||21
2924036|NCT00556478|3635045|FG001|NOT COMPLETED|Double-blind Phase||8
2924037|NCT00556478|3635044|FG000|STARTED|Open-Label Phase||146
2924038|NCT00556478|3635045|FG001|STARTED|Open-Label Phase||77
2924039|NCT00556478|3635044|FG000|Treated in Open-label|Open-Label Phase||142
2924040|NCT00556478|3635045|FG001|Treated in Open-label|Open-Label Phase||71
2924041|NCT00556478|3635044|FG000|COMPLETED|Open-Label Phase||132
2924042|NCT00556478|3635045|FG001|COMPLETED|Open-Label Phase||67
2924043|NCT00556478|3635044|FG000|NOT COMPLETED|Open-Label Phase||14
3136960|NCT01716520|3862283|FG005|STARTED|Treatment Period 1 (14 Days)||30
3136961|NCT01716520|3862278|FG000|COMPLETED|Treatment Period 1 (14 Days)||29
3136962|NCT01716520|3862279|FG001|COMPLETED|Treatment Period 1 (14 Days)||29
2924044|NCT00556478|3635045|FG001|NOT COMPLETED|Open-Label Phase||10
2924045|NCT00556491|3635056|FG000|STARTED|Overall Study|January 2008|20
2924046|NCT00556491|3635057|FG001|STARTED|Overall Study||20
3321160|NCT03170271|4054205|FG001|STARTED|Overall Study||229
3321161|NCT03170271|4054204|FG000|Received Treatment|Overall Study||427
3321162|NCT03170271|4054205|FG001|Received Treatment|Overall Study||229
3321163|NCT03170271|4054204|FG000|COMPLETED|Overall Study||398
3321164|NCT03170271|4054205|FG001|COMPLETED|Overall Study||218
3321165|NCT03170271|4054204|FG000|NOT COMPLETED|Overall Study||33
3321166|NCT03170271|4054205|FG001|NOT COMPLETED|Overall Study||11
3321167|NCT03170388|4054216|FG000|STARTED|Overall Study||147
3321168|NCT03170388|4054217|FG001|STARTED|Overall Study||150
3321169|NCT03170388|4054218|FG002|STARTED|Overall Study||146
3321170|NCT03170388|4054219|FG003|STARTED|Overall Study||150
3321171|NCT03170388|4054220|FG004|STARTED|Overall Study||148
3321172|NCT03170388|4054216|FG000|COMPLETED|Overall Study||125
3321173|NCT03170388|4054217|FG001|COMPLETED|Overall Study||132
3321174|NCT03170388|4054218|FG002|COMPLETED|Overall Study||133
3321175|NCT03170388|4054219|FG003|COMPLETED|Overall Study||132
3321176|NCT03170388|4054220|FG004|COMPLETED|Overall Study||127
3321177|NCT03170388|4054216|FG000|NOT COMPLETED|Overall Study||22
3321178|NCT03170388|4054217|FG001|NOT COMPLETED|Overall Study||18
3321179|NCT03170388|4054218|FG002|NOT COMPLETED|Overall Study||13
3321180|NCT03170388|4054219|FG003|NOT COMPLETED|Overall Study||18
3321181|NCT03170388|4054220|FG004|NOT COMPLETED|Overall Study||21
3321182|NCT03170544|4054244|FG000|STARTED|Part 1||10
3321183|NCT03170544|4054245|FG001|STARTED|Part 1||6
3321184|NCT03170544|4054246|FG002|STARTED|Part 1||6
3321185|NCT03170544|4054247|FG003|STARTED|Part 1||7
3321186|NCT03170544|4054248|FG004|STARTED|Part 1||6
3321187|NCT03170544|4054249|FG005|STARTED|Part 1||6
3321188|NCT03170544|4054250|FG006|STARTED|Part 1||0
3321189|NCT03170544|4054251|FG007|STARTED|Part 1||0
3321190|NCT03170544|4054252|FG008|STARTED|Part 1||0
3321191|NCT03170544|4054253|FG009|STARTED|Part 1||0
3321192|NCT03170544|4054254|FG010|STARTED|Part 1||0
3321193|NCT03170544|4054255|FG011|STARTED|Part 1||0
3321194|NCT03170544|4054244|FG000|COMPLETED|Part 1||9
3321195|NCT03170544|4054245|FG001|COMPLETED|Part 1||6
3321196|NCT03170544|4054246|FG002|COMPLETED|Part 1||6
3321197|NCT03170544|4054247|FG003|COMPLETED|Part 1||6
3321198|NCT03170544|4054248|FG004|COMPLETED|Part 1||6
3321199|NCT03170544|4054249|FG005|COMPLETED|Part 1||6
3321200|NCT03170544|4054250|FG006|COMPLETED|Part 1||0
3321201|NCT03170544|4054251|FG007|COMPLETED|Part 1||0
3321202|NCT03170544|4054252|FG008|COMPLETED|Part 1||0
3321203|NCT03170544|4054253|FG009|COMPLETED|Part 1||0
3321204|NCT03170544|4054254|FG010|COMPLETED|Part 1||0
3321205|NCT03170544|4054255|FG011|COMPLETED|Part 1||0
3321206|NCT03170544|4054244|FG000|NOT COMPLETED|Part 1||1
3321207|NCT03170544|4054245|FG001|NOT COMPLETED|Part 1||0
3321208|NCT03170544|4054246|FG002|NOT COMPLETED|Part 1||0
3321209|NCT03170544|4054247|FG003|NOT COMPLETED|Part 1||1
3321210|NCT03170544|4054248|FG004|NOT COMPLETED|Part 1||0
3321211|NCT03170544|4054249|FG005|NOT COMPLETED|Part 1||0
3321212|NCT03170544|4054250|FG006|NOT COMPLETED|Part 1||0
3321213|NCT03170544|4054251|FG007|NOT COMPLETED|Part 1||0
3321214|NCT03170544|4054252|FG008|NOT COMPLETED|Part 1||0
3321215|NCT03170544|4054253|FG009|NOT COMPLETED|Part 1||0
3321216|NCT03170544|4054254|FG010|NOT COMPLETED|Part 1||0
3321217|NCT03170544|4054255|FG011|NOT COMPLETED|Part 1||0
3321218|NCT03170544|4054244|FG000|STARTED|Part 2||0
3321219|NCT03170544|4054245|FG001|STARTED|Part 2||0
3321220|NCT03170544|4054246|FG002|STARTED|Part 2||0
3321221|NCT03170544|4054247|FG003|STARTED|Part 2||0
3321222|NCT03170544|4054248|FG004|STARTED|Part 2||0
3321223|NCT03170544|4054249|FG005|STARTED|Part 2||0
3321224|NCT03170544|4054250|FG006|STARTED|Part 2||4
3321225|NCT03170544|4054251|FG007|STARTED|Part 2||0
3321226|NCT03170544|4054252|FG008|STARTED|Part 2||0
3321227|NCT03170544|4054253|FG009|STARTED|Part 2||0
3321228|NCT03170544|4054254|FG010|STARTED|Part 2||0
3321229|NCT03170544|4054255|FG011|STARTED|Part 2||0
3321230|NCT03170544|4054244|FG000|COMPLETED|Part 2||0
3321231|NCT03170544|4054245|FG001|COMPLETED|Part 2||0
3321232|NCT03170544|4054246|FG002|COMPLETED|Part 2||0
3321233|NCT03170544|4054247|FG003|COMPLETED|Part 2||0
3321234|NCT03170544|4054248|FG004|COMPLETED|Part 2||0
3321235|NCT03170544|4054249|FG005|COMPLETED|Part 2||0
3321236|NCT03170544|4054250|FG006|COMPLETED|Part 2||4
3321237|NCT03170544|4054251|FG007|COMPLETED|Part 2||0
3321238|NCT03170544|4054252|FG008|COMPLETED|Part 2||0
3321239|NCT03170544|4054253|FG009|COMPLETED|Part 2||0
3321240|NCT03170544|4054254|FG010|COMPLETED|Part 2||0
3321241|NCT03170544|4054255|FG011|COMPLETED|Part 2||0
3321242|NCT03170544|4054244|FG000|NOT COMPLETED|Part 2||0
3321243|NCT03170544|4054245|FG001|NOT COMPLETED|Part 2||0
3321244|NCT03170544|4054246|FG002|NOT COMPLETED|Part 2||0
3321245|NCT03170544|4054247|FG003|NOT COMPLETED|Part 2||0
3321246|NCT03170544|4054248|FG004|NOT COMPLETED|Part 2||0
3321247|NCT03170544|4054249|FG005|NOT COMPLETED|Part 2||0
3321248|NCT03170544|4054250|FG006|NOT COMPLETED|Part 2||0
3321249|NCT03170544|4054251|FG007|NOT COMPLETED|Part 2||0
3321250|NCT03170544|4054252|FG008|NOT COMPLETED|Part 2||0
3321251|NCT03170544|4054253|FG009|NOT COMPLETED|Part 2||0
3321252|NCT03170544|4054254|FG010|NOT COMPLETED|Part 2||0
3321253|NCT03170544|4054255|FG011|NOT COMPLETED|Part 2||0
3321254|NCT03170544|4054244|FG000|STARTED|Part 3||0
3321255|NCT03170544|4054245|FG001|STARTED|Part 3||0
3321256|NCT03170544|4054246|FG002|STARTED|Part 3||0
3321257|NCT03170544|4054247|FG003|STARTED|Part 3||0
3321258|NCT03170544|4054248|FG004|STARTED|Part 3||0
3321259|NCT03170544|4054249|FG005|STARTED|Part 3||0
3321260|NCT03170544|4054250|FG006|STARTED|Part 3||0
3321261|NCT03170544|4054251|FG007|STARTED|Part 3||4
3321262|NCT03170544|4054252|FG008|STARTED|Part 3||6
3321263|NCT03170544|4054253|FG009|STARTED|Part 3||6
3321264|NCT03170544|4054254|FG010|STARTED|Part 3||0
3321265|NCT03170544|4054255|FG011|STARTED|Part 3||0
3321266|NCT03170544|4054244|FG000|COMPLETED|Part 3||0
3321267|NCT03170544|4054245|FG001|COMPLETED|Part 3||0
3321268|NCT03170544|4054246|FG002|COMPLETED|Part 3||0
3321269|NCT03170544|4054247|FG003|COMPLETED|Part 3||0
3321270|NCT03170544|4054248|FG004|COMPLETED|Part 3||0
3321271|NCT03170544|4054249|FG005|COMPLETED|Part 3||0
3321272|NCT03170544|4054250|FG006|COMPLETED|Part 3||0
3321273|NCT03170544|4054251|FG007|COMPLETED|Part 3||4
3321274|NCT03170544|4054252|FG008|COMPLETED|Part 3||6
3321275|NCT03170544|4054253|FG009|COMPLETED|Part 3||6
3321276|NCT03170544|4054254|FG010|COMPLETED|Part 3||0
3321277|NCT03170544|4054255|FG011|COMPLETED|Part 3||0
3321278|NCT03170544|4054244|FG000|NOT COMPLETED|Part 3||0
3321279|NCT03170544|4054245|FG001|NOT COMPLETED|Part 3||0
3321280|NCT03170544|4054246|FG002|NOT COMPLETED|Part 3||0
3321281|NCT03170544|4054247|FG003|NOT COMPLETED|Part 3||0
3321282|NCT03170544|4054248|FG004|NOT COMPLETED|Part 3||0
3321283|NCT03170544|4054249|FG005|NOT COMPLETED|Part 3||0
3321284|NCT03170544|4054250|FG006|NOT COMPLETED|Part 3||0
3321285|NCT03170544|4054251|FG007|NOT COMPLETED|Part 3||0
3321286|NCT03170544|4054252|FG008|NOT COMPLETED|Part 3||0
3321287|NCT03170544|4054253|FG009|NOT COMPLETED|Part 3||0
3321288|NCT03170544|4054254|FG010|NOT COMPLETED|Part 3||0
3321289|NCT03170544|4054255|FG011|NOT COMPLETED|Part 3||0
3321290|NCT03170544|4054244|FG000|STARTED|Part 4||0
3321291|NCT03170544|4054245|FG001|STARTED|Part 4||0
3321292|NCT03170544|4054246|FG002|STARTED|Part 4||0
3321293|NCT03170544|4054247|FG003|STARTED|Part 4||0
3321294|NCT03170544|4054248|FG004|STARTED|Part 4||0
3321295|NCT03170544|4054249|FG005|STARTED|Part 4||0
3321296|NCT03170544|4054250|FG006|STARTED|Part 4||0
3321297|NCT03170544|4054251|FG007|STARTED|Part 4||0
3321298|NCT03170544|4054252|FG008|STARTED|Part 4||0
3321299|NCT03170544|4054253|FG009|STARTED|Part 4||0
3321300|NCT03170544|4054254|FG010|STARTED|Part 4||3
3321301|NCT03170544|4054255|FG011|STARTED|Part 4||6
3321302|NCT03170544|4054244|FG000|COMPLETED|Part 4||0
3321303|NCT03170544|4054245|FG001|COMPLETED|Part 4||0
3321304|NCT03170544|4054246|FG002|COMPLETED|Part 4||0
3321305|NCT03170544|4054247|FG003|COMPLETED|Part 4||0
3321306|NCT03170544|4054248|FG004|COMPLETED|Part 4||0
3321307|NCT03170544|4054249|FG005|COMPLETED|Part 4||0
3321308|NCT03170544|4054250|FG006|COMPLETED|Part 4||0
3321309|NCT03170544|4054251|FG007|COMPLETED|Part 4||0
3321310|NCT03170544|4054252|FG008|COMPLETED|Part 4||0
3321311|NCT03170544|4054253|FG009|COMPLETED|Part 4||0
3321312|NCT03170544|4054254|FG010|COMPLETED|Part 4||3
3321313|NCT03170544|4054255|FG011|COMPLETED|Part 4||6
3321314|NCT03170544|4054244|FG000|NOT COMPLETED|Part 4||0
3321315|NCT03170544|4054245|FG001|NOT COMPLETED|Part 4||0
3321316|NCT03170544|4054246|FG002|NOT COMPLETED|Part 4||0
3321317|NCT03170544|4054247|FG003|NOT COMPLETED|Part 4||0
3321318|NCT03170544|4054248|FG004|NOT COMPLETED|Part 4||0
3321319|NCT03170544|4054249|FG005|NOT COMPLETED|Part 4||0
3321320|NCT03170544|4054250|FG006|NOT COMPLETED|Part 4||0
3321321|NCT03170544|4054251|FG007|NOT COMPLETED|Part 4||0
3321322|NCT03170544|4054252|FG008|NOT COMPLETED|Part 4||0
3321323|NCT03170544|4054253|FG009|NOT COMPLETED|Part 4||0
3321324|NCT03170544|4054254|FG010|NOT COMPLETED|Part 4||0
3321325|NCT03170544|4054255|FG011|NOT COMPLETED|Part 4||0
3321326|NCT03170609|4054345|FG000|STARTED|Overall Study||53
3321327|NCT03170609|4054346|FG001|STARTED|Overall Study||52
3321328|NCT03170609|4054347|FG002|STARTED|Overall Study||52
3321329|NCT03170609|4054348|FG003|STARTED|Overall Study||52
3321330|NCT03170609|4054349|FG004|STARTED|Overall Study||52
3321331|NCT03170609|4054350|FG005|STARTED|Overall Study||52
3321332|NCT03170609|4054351|FG006|STARTED|Overall Study||52
3321333|NCT03170609|4054345|FG000|Vaccinated|Overall Study||52
3321334|NCT03170609|4054346|FG001|Vaccinated|Overall Study||52
3321335|NCT03170609|4054347|FG002|Vaccinated|Overall Study||52
3321336|NCT03170609|4054348|FG003|Vaccinated|Overall Study||52
3321337|NCT03170609|4054349|FG004|Vaccinated|Overall Study||52
3321338|NCT03170609|4054350|FG005|Vaccinated|Overall Study||52
3321339|NCT03170609|4054351|FG006|Vaccinated|Overall Study||52
3321340|NCT03170609|4054345|FG000|COMPLETED|Overall Study||50
3321341|NCT03170609|4054346|FG001|COMPLETED|Overall Study||50
3321342|NCT03170609|4054347|FG002|COMPLETED|Overall Study||46
3321343|NCT03170609|4054348|FG003|COMPLETED|Overall Study||50
3321344|NCT03170609|4054349|FG004|COMPLETED|Overall Study||51
3321345|NCT03170609|4054350|FG005|COMPLETED|Overall Study||50
3321346|NCT03170609|4054351|FG006|COMPLETED|Overall Study||51
3321347|NCT03170609|4054345|FG000|NOT COMPLETED|Overall Study||3
3321348|NCT03170609|4054346|FG001|NOT COMPLETED|Overall Study||2
3321349|NCT03170609|4054347|FG002|NOT COMPLETED|Overall Study||6
3321350|NCT03170609|4054348|FG003|NOT COMPLETED|Overall Study||2
3321351|NCT03170609|4054349|FG004|NOT COMPLETED|Overall Study||1
3321352|NCT03170609|4054350|FG005|NOT COMPLETED|Overall Study||2
3321353|NCT03170609|4054351|FG006|NOT COMPLETED|Overall Study||1
3321354|NCT03170661|4054369|FG000|STARTED|Overall Study||49
3321355|NCT03170661|4054370|FG001|STARTED|Overall Study||49
3321356|NCT03170661|4054369|FG000|COMPLETED|Overall Study||49
3321357|NCT03170661|4054370|FG001|COMPLETED|Overall Study||49
3321358|NCT03170661|4054369|FG000|NOT COMPLETED|Overall Study||0
3321359|NCT03170661|4054370|FG001|NOT COMPLETED|Overall Study||0
3321360|NCT03171051|4054378|FG000|STARTED|Overall Study||10
3321361|NCT03171051|4054378|FG000|COMPLETED|Overall Study||10
3321362|NCT03171051|4054378|FG000|NOT COMPLETED|Overall Study||0
3321363|NCT03171415|4054388|FG000|STARTED|Overall Study||6
3321364|NCT03171415|4054389|FG001|STARTED|Overall Study||6
3321365|NCT03171415|4054390|FG002|STARTED|Overall Study||6
3321366|NCT03171415|4054391|FG003|STARTED|Overall Study||6
3321367|NCT03171415|4054392|FG004|STARTED|Overall Study||9
3321368|NCT03171415|4054388|FG000|COMPLETED|Overall Study||6
3321369|NCT03171415|4054389|FG001|COMPLETED|Overall Study||6
3321370|NCT03171415|4054390|FG002|COMPLETED|Overall Study||6
3321371|NCT03171415|4054391|FG003|COMPLETED|Overall Study||6
3321372|NCT03171415|4054392|FG004|COMPLETED|Overall Study||7
3321373|NCT03171415|4054388|FG000|NOT COMPLETED|Overall Study||0
3321374|NCT03171415|4054389|FG001|NOT COMPLETED|Overall Study||0
3321375|NCT03171415|4054390|FG002|NOT COMPLETED|Overall Study||0
3321376|NCT03171415|4054391|FG003|NOT COMPLETED|Overall Study||0
3321377|NCT03171415|4054392|FG004|NOT COMPLETED|Overall Study||2
3321378|NCT03172130|4054417|FG000|STARTED|Overall Study||12
3321379|NCT03172130|4054418|FG001|STARTED|Overall Study||10
3321380|NCT03172130|4054417|FG000|COMPLETED|Overall Study||9
3321381|NCT03172130|4054418|FG001|COMPLETED|Overall Study||9
3321382|NCT03172130|4054417|FG000|NOT COMPLETED|Overall Study||3
3321383|NCT03172130|4054418|FG001|NOT COMPLETED|Overall Study||1
3321384|NCT03172325|4054426|FG000|STARTED|Overall Study||68
3321385|NCT03172325|4054427|FG001|STARTED|Overall Study||68
3321386|NCT03172325|4054426|FG000|COMPLETED|Overall Study||64
3321387|NCT03172325|4054427|FG001|COMPLETED|Overall Study||64
3321388|NCT03172325|4054426|FG000|NOT COMPLETED|Overall Study||4
3321389|NCT03172325|4054427|FG001|NOT COMPLETED|Overall Study||4
3321390|NCT03172364|4054435|FG000|STARTED|Overall Study||55
3321391|NCT03172364|4054436|FG001|STARTED|Overall Study||58
3321392|NCT03172364|4054435|FG000|COMPLETED|Overall Study||53
3321393|NCT03172364|4054436|FG001|COMPLETED|Overall Study||57
3321394|NCT03172364|4054435|FG000|NOT COMPLETED|Overall Study||2
3321395|NCT03172364|4054436|FG001|NOT COMPLETED|Overall Study||1
3321396|NCT03172481|4054444|FG000|STARTED|Open-label||156
3321397|NCT03172481|4054445|FG001|STARTED|Open-label||0
3321398|NCT03172481|4054444|FG000|COMPLETED|Open-label||148
3321399|NCT03172481|4054445|FG001|COMPLETED|Open-label||0
3321400|NCT03172481|4054444|FG000|NOT COMPLETED|Open-label||8
3321401|NCT03172481|4054445|FG001|NOT COMPLETED|Open-label||0
3038912|NCT01155466|3758230|FG001|COMPLETED|Overall Study|Completed treatment phase|130
3038913|NCT01155466|3758231|FG002|COMPLETED|Overall Study|Completed treatment phase|136
3038914|NCT01155466|3758232|FG003|COMPLETED|Overall Study|Completed treatment phase|134
3038915|NCT01155466|3758233|FG004|COMPLETED|Overall Study|Completed treatment phase|129
3038916|NCT01155466|3758229|FG000|NOT COMPLETED|Overall Study||22
3038917|NCT01155466|3758230|FG001|NOT COMPLETED|Overall Study||25
3038918|NCT01155466|3758231|FG002|NOT COMPLETED|Overall Study||20
3038919|NCT01155466|3758232|FG003|NOT COMPLETED|Overall Study||21
3038920|NCT01155466|3758233|FG004|NOT COMPLETED|Overall Study||27
3038921|NCT01155479|3758250|FG000|STARTED|Part I||204
3038922|NCT01155479|3758251|FG001|STARTED|Part I||204
3038923|NCT01155479|3758252|FG002|STARTED|Part I||206
3321402|NCT03172481|4054444|FG000|STARTED|Double-blind||75
3321403|NCT03172481|4054445|FG001|STARTED|Double-blind|From 148 subjects who completed the Open-label period, 73 randomly received Placebo|73
3321404|NCT03172481|4054444|FG000|COMPLETED|Double-blind||74
3321405|NCT03172481|4054445|FG001|COMPLETED|Double-blind||73
3321406|NCT03172481|4054444|FG000|NOT COMPLETED|Double-blind||1
3321407|NCT03172481|4054445|FG001|NOT COMPLETED|Double-blind||0
3321408|NCT03172494|4054454|FG000|STARTED|Overall Study||361
3321409|NCT03172494|4054455|FG001|STARTED|Overall Study||179
3321410|NCT03172494|4054456|FG002|STARTED|Overall Study||180
3321411|NCT03172494|4054454|FG000|Full Analysis Set (FAS)|Overall Study||361
3321412|NCT03172494|4054455|FG001|Full Analysis Set (FAS)|Overall Study||179
3321413|NCT03172494|4054456|FG002|Full Analysis Set (FAS)|Overall Study||180
3321414|NCT03172494|4054454|FG000|Safety Analysis Set (SAS)|Overall Study||358
3321415|NCT03172494|4054455|FG001|Safety Analysis Set (SAS)|Overall Study||175
3321416|NCT03172494|4054456|FG002|Safety Analysis Set (SAS)|Overall Study||180
3321417|NCT03172494|4054454|FG000|Exposed|Overall Study||358
3321418|NCT03172494|4054455|FG001|Exposed|Overall Study||175
3321419|NCT03172494|4054456|FG002|Exposed|Overall Study||180
3321420|NCT03172494|4054454|FG000|COMPLETED|Overall Study||341
3321421|NCT03172494|4054455|FG001|COMPLETED|Overall Study||167
3321422|NCT03172494|4054456|FG002|COMPLETED|Overall Study||151
3321423|NCT03172494|4054454|FG000|NOT COMPLETED|Overall Study||20
3321424|NCT03172494|4054455|FG001|NOT COMPLETED|Overall Study||12
3321425|NCT03172494|4054456|FG002|NOT COMPLETED|Overall Study||29
3321426|NCT03172702|4054465|FG000|STARTED|Overall Study||150
3321427|NCT03172702|4054465|FG000|Received Treatment in CP|Overall Study||150
3321428|NCT03172702|4054465|FG000|Received Treatment in MP|Overall Study||150
3321429|NCT03172702|4054465|FG000|COMPLETED|Overall Study||122
3321430|NCT03172702|4054465|FG000|NOT COMPLETED|Overall Study||28
3321431|NCT03172780|4054473|FG000|STARTED|Overall Study||406
3321432|NCT03172780|4054474|FG001|STARTED|Overall Study||409
3321433|NCT03172780|4054475|FG002|STARTED|Overall Study||405
3321434|NCT03172780|4054473|FG000|COMPLETED|Overall Study||388
3321435|NCT03172780|4054474|FG001|COMPLETED|Overall Study||389
3321436|NCT03172780|4054475|FG002|COMPLETED|Overall Study||389
3321437|NCT03172780|4054473|FG000|NOT COMPLETED|Overall Study||18
3321438|NCT03172780|4054474|FG001|NOT COMPLETED|Overall Study||20
3321439|NCT03172780|4054475|FG002|NOT COMPLETED|Overall Study||16
3321440|NCT03172884|4054487|FG000|STARTED|Overall Study||8
3321441|NCT03172884|4054488|FG001|STARTED|Overall Study||6
3321442|NCT03172884|4054489|FG002|STARTED|Overall Study||8
3321443|NCT03172884|4054490|FG003|STARTED|Overall Study||8
3321444|NCT03172884|4054487|FG000|COMPLETED|Overall Study||8
3321445|NCT03172884|4054488|FG001|COMPLETED|Overall Study||6
3321446|NCT03172884|4054489|FG002|COMPLETED|Overall Study||8
3321447|NCT03172884|4054490|FG003|COMPLETED|Overall Study||8
3321448|NCT03172884|4054487|FG000|NOT COMPLETED|Overall Study||0
3321449|NCT03172884|4054488|FG001|NOT COMPLETED|Overall Study||0
3321450|NCT03172884|4054489|FG002|NOT COMPLETED|Overall Study||0
3321451|NCT03172884|4054490|FG003|NOT COMPLETED|Overall Study||0
3321452|NCT03173170|4054500|FG000|STARTED|First Intervention Period (6 Days)||10
3321453|NCT03173170|4054500|FG000|COMPLETED|First Intervention Period (6 Days)||10
3321454|NCT03173170|4054500|FG000|NOT COMPLETED|First Intervention Period (6 Days)||0
3321455|NCT03173170|4054500|FG000|STARTED|Washout Period (at Least 7 Days)||10
3321456|NCT03173170|4054500|FG000|COMPLETED|Washout Period (at Least 7 Days)||10
3321457|NCT03173170|4054500|FG000|NOT COMPLETED|Washout Period (at Least 7 Days)||0
3321458|NCT03173170|4054500|FG000|STARTED|Intervention Period 2 (9 Days)||10
3321459|NCT03173170|4054500|FG000|COMPLETED|Intervention Period 2 (9 Days)||10
3321460|NCT03173170|4054500|FG000|NOT COMPLETED|Intervention Period 2 (9 Days)||0
3321461|NCT03173313|4054510|FG000|STARTED|Overall Study||58
3321462|NCT03173313|4054511|FG001|STARTED|Overall Study||53
3321463|NCT03173313|4054510|FG000|Informed Consent Signed|Overall Study||58
3321464|NCT03173313|4054511|FG001|Informed Consent Signed|Overall Study||53
3321465|NCT03173313|4054510|FG000|Randomized|Overall Study||58
3321466|NCT03173313|4054511|FG001|Randomized|Overall Study||53
3321467|NCT03173313|4054510|FG000|Cooled|Overall Study||54
3321468|NCT03173313|4054511|FG001|Cooled|Overall Study||0
3321469|NCT03173313|4054510|FG000|4-6 Day Follow-up|Overall Study||57
3321470|NCT03173313|4054511|FG001|4-6 Day Follow-up|Overall Study||53
3321471|NCT03173313|4054510|FG000|30-day Follow-up|Overall Study||52
3321472|NCT03173313|4054511|FG001|30-day Follow-up|Overall Study||51
3321473|NCT03173313|4054510|FG000|12-month Follow-up|Overall Study||49
3321474|NCT03173313|4054511|FG001|12-month Follow-up|Overall Study||48
3321475|NCT03173313|4054510|FG000|COMPLETED|Overall Study||49
3321476|NCT03173313|4054511|FG001|COMPLETED|Overall Study||48
3321477|NCT03173313|4054510|FG000|NOT COMPLETED|Overall Study||9
3321478|NCT03173313|4054511|FG001|NOT COMPLETED|Overall Study||5
3321479|NCT03173547|4054519|FG000|STARTED|Overall Study||40
3321480|NCT03173547|4054520|FG001|STARTED|Overall Study||40
3321481|NCT03173547|4054519|FG000|COMPLETED|Overall Study||36
3321482|NCT03173547|4054520|FG001|COMPLETED|Overall Study||38
3321483|NCT03173547|4054519|FG000|NOT COMPLETED|Overall Study||4
3321484|NCT03173547|4054520|FG001|NOT COMPLETED|Overall Study||2
3321485|NCT03173560|4054528|FG000|STARTED|Overall Study||172
3321486|NCT03173560|4054529|FG001|STARTED|Overall Study||171
3321487|NCT03173560|4054528|FG000|Treated Participants|Overall Study||172
3321488|NCT03173560|4054529|FG001|Treated Participants|Overall Study||169
3321489|NCT03173560|4054528|FG000|Safety Set|Overall Study||173
3321490|NCT03173560|4054529|FG001|Safety Set|Overall Study||168
3321491|NCT03173560|4054528|FG000|COMPLETED|Overall Study||67
3321492|NCT03173560|4054529|FG001|COMPLETED|Overall Study||54
3321493|NCT03173560|4054528|FG000|NOT COMPLETED|Overall Study||105
3321494|NCT03173560|4054529|FG001|NOT COMPLETED|Overall Study||117
3321495|NCT03174132|4054535|FG000|STARTED|Overall Study||70
3321496|NCT03174132|4054535|FG000|COMPLETED|Overall Study||70
3321497|NCT03174132|4054535|FG000|NOT COMPLETED|Overall Study||0
3321498|NCT03174158|4054543|FG000|STARTED|Overall Study||39
3321499|NCT03174158|4054544|FG001|STARTED|Overall Study||39
3173868|NCT01952470|3901605|FG001|Missing Baseline LCI 2% Data.|Overall Study||2
3173869|NCT01952470|3901604|FG000|Missing 1+3 Month LCI 2% Data.|Overall Study||2
3173870|NCT01952470|3901605|FG001|Missing 1+3 Month LCI 2% Data.|Overall Study||1
3173871|NCT01952470|3901604|FG000|Missing 3 Month LCI 2% Data.|Overall Study||1
3173872|NCT01952470|3901605|FG001|Missing 3 Month LCI 2% Data.|Overall Study||0
3173873|NCT01952470|3901604|FG000|COMPLETED|Overall Study||13
3173874|NCT01952470|3901605|FG001|COMPLETED|Overall Study||13
2924047|NCT00556491|3635056|FG000|COMPLETED|Overall Study||19
3173875|NCT01952470|3901604|FG000|NOT COMPLETED|Overall Study||3
3173876|NCT01952470|3901605|FG001|NOT COMPLETED|Overall Study||3
2924048|NCT00556491|3635057|FG001|COMPLETED|Overall Study||19
2924049|NCT00556491|3635056|FG000|NOT COMPLETED|Overall Study||1
2924050|NCT00556491|3635057|FG001|NOT COMPLETED|Overall Study||1
2924051|NCT00556504|3635075|FG000|STARTED|Overall Study||42
2924052|NCT00556504|3635076|FG001|STARTED|Overall Study||42
2924053|NCT00556504|3635075|FG000|Intend-to Treat Population|Overall Study||42
2924054|NCT00556504|3635076|FG001|Intend-to Treat Population|Overall Study||42
2924055|NCT00556504|3635075|FG000|Safety Population|Overall Study||41
2924056|NCT00556504|3635076|FG001|Safety Population|Overall Study||42
2924057|NCT00556504|3635075|FG000|COMPLETED|Overall Study||34
2924058|NCT00556504|3635076|FG001|COMPLETED|Overall Study||33
2924059|NCT00556504|3635075|FG000|NOT COMPLETED|Overall Study||8
2924060|NCT00556504|3635076|FG001|NOT COMPLETED|Overall Study||9
2924061|NCT00556543|3635082|FG000|STARTED|Overall Study||10
2924062|NCT00556543|3635082|FG000|COMPLETED|Overall Study|Subjects completed 180 days of study enrollment|10
2924063|NCT00556543|3635082|FG000|NOT COMPLETED|Overall Study||0
2924064|NCT00556673|3635091|FG000|STARTED|Overall Study||16
2924065|NCT00556673|3635092|FG001|STARTED|Overall Study||15
3038924|NCT01155479|3758253|FG003|STARTED|Part I||204
3038925|NCT01155479|3758254|FG004|STARTED|Part I||204
3038926|NCT01155479|3758250|FG000|Treated|Part I||200
3038927|NCT01155479|3758251|FG001|Treated|Part I||202
3038928|NCT01155479|3758252|FG002|Treated|Part I||204
3038929|NCT01155479|3758253|FG003|Treated|Part I||198
3038930|NCT01155479|3758254|FG004|Treated|Part I||203
3038931|NCT01155479|3758250|FG000|COMPLETED|Part I||166
3038932|NCT01155479|3758251|FG001|COMPLETED|Part I||177
3038933|NCT01155479|3758252|FG002|COMPLETED|Part I||167
3038934|NCT01155479|3758253|FG003|COMPLETED|Part I||177
3038935|NCT01155479|3758254|FG004|COMPLETED|Part I||181
3038936|NCT01155479|3758250|FG000|NOT COMPLETED|Part I||38
3038937|NCT01155479|3758251|FG001|NOT COMPLETED|Part I||27
3038938|NCT01155479|3758252|FG002|NOT COMPLETED|Part I||39
3038939|NCT01155479|3758253|FG003|NOT COMPLETED|Part I||27
3038940|NCT01155479|3758254|FG004|NOT COMPLETED|Part I||23
3038941|NCT01155479|3758250|FG000|STARTED|Part II||166
3038942|NCT01155479|3758251|FG001|STARTED|Part II||177
3038943|NCT01155479|3758252|FG002|STARTED|Part II||167
3038944|NCT01155479|3758253|FG003|STARTED|Part II||177
3038945|NCT01155479|3758254|FG004|STARTED|Part II||181
3038946|NCT01155479|3758250|FG000|COMPLETED|Part II||107
3038947|NCT01155479|3758251|FG001|COMPLETED|Part II||116
3173877|NCT01952574|3901615|FG000|STARTED|Double-blind Treatment Phase||160
3173878|NCT01952574|3901616|FG001|STARTED|Double-blind Treatment Phase||108
3173879|NCT01952574|3901617|FG002|STARTED|Double-blind Treatment Phase||108
3173880|NCT01952574|3901618|FG003|STARTED|Double-blind Treatment Phase||107
3173881|NCT01952574|3901619|FG004|STARTED|Double-blind Treatment Phase||0
2924066|NCT00556673|3635091|FG000|Pharmacodynamic (PD) Population|Overall Study|4 patients inadvertently unblinded were not included in PD analysis population.|12
2924067|NCT00556673|3635092|FG001|Pharmacodynamic (PD) Population|Overall Study|3 patients inadvertently unblinded were not included in PD analysis population.|12
2924068|NCT00556673|3635091|FG000|COMPLETED|Overall Study||13
2924069|NCT00556673|3635092|FG001|COMPLETED|Overall Study||13
2924070|NCT00556673|3635091|FG000|NOT COMPLETED|Overall Study||3
3173882|NCT01952574|3901620|FG005|STARTED|Double-blind Treatment Phase||0
3173883|NCT01952574|3901621|FG006|STARTED|Double-blind Treatment Phase||0
3173884|NCT01952574|3901615|FG000|Received Study Drug|Double-blind Treatment Phase||153
3173885|NCT01952574|3901616|FG001|Received Study Drug|Double-blind Treatment Phase||108
2924071|NCT00556673|3635092|FG001|NOT COMPLETED|Overall Study||2
2924072|NCT00556712|3635102|FG000|STARTED|Overall Study||451
2924073|NCT00556712|3635103|FG001|STARTED|Overall Study||438
2924074|NCT00556712|3635102|FG000|COMPLETED|Overall Study|Data cutoff date: 17 May 2008|0
2924075|NCT00556712|3635103|FG001|COMPLETED|Overall Study|Data cutoff date: 17 May 2008|0
2924076|NCT00556712|3635102|FG000|NOT COMPLETED|Overall Study||451
2924077|NCT00556712|3635103|FG001|NOT COMPLETED|Overall Study||438
2924078|NCT00556842|3635111|FG000|STARTED|Overall Study||749
2924079|NCT00556842|3635112|FG001|STARTED|Overall Study||746
2924080|NCT00556842|3635111|FG000|COMPLETED|Overall Study||718
2924081|NCT00556842|3635112|FG001|COMPLETED|Overall Study||723
2924082|NCT00556842|3635111|FG000|NOT COMPLETED|Overall Study||31
2924083|NCT00556842|3635112|FG001|NOT COMPLETED|Overall Study||23
2924084|NCT00556894|3635129|FG000|STARTED|Overall Study||82
2924085|NCT00556894|3635130|FG001|STARTED|Overall Study||87
2924086|NCT00556894|3635131|FG002|STARTED|Overall Study||84
2924087|NCT00556894|3635129|FG000|COMPLETED|Overall Study||66
2924088|NCT00556894|3635130|FG001|COMPLETED|Overall Study||68
2924089|NCT00556894|3635131|FG002|COMPLETED|Overall Study||65
2924090|NCT00556894|3635129|FG000|NOT COMPLETED|Overall Study||16
2924091|NCT00556894|3635130|FG001|NOT COMPLETED|Overall Study||19
2924092|NCT00556894|3635131|FG002|NOT COMPLETED|Overall Study||19
2924093|NCT00556933|3635143|FG000|STARTED|Single vs. Divided-dose rATG Induction||45
3173886|NCT01952574|3901617|FG002|Received Study Drug|Double-blind Treatment Phase||105
3173887|NCT01952574|3901618|FG003|Received Study Drug|Double-blind Treatment Phase||106
3173888|NCT01952574|3901619|FG004|Received Study Drug|Double-blind Treatment Phase||0
3173889|NCT01952574|3901620|FG005|Received Study Drug|Double-blind Treatment Phase||0
3173890|NCT01952574|3901621|FG006|Received Study Drug|Double-blind Treatment Phase||0
3173891|NCT01952574|3901615|FG000|COMPLETED|Double-blind Treatment Phase||143
3173892|NCT01952574|3901616|FG001|COMPLETED|Double-blind Treatment Phase||105
3173893|NCT01952574|3901617|FG002|COMPLETED|Double-blind Treatment Phase||99
3173894|NCT01952574|3901618|FG003|COMPLETED|Double-blind Treatment Phase||101
3173895|NCT01952574|3901619|FG004|COMPLETED|Double-blind Treatment Phase||0
2924094|NCT00556933|3635144|FG001|STARTED|Single vs. Divided-dose rATG Induction||45
2924095|NCT00556933|3635145|FG002|STARTED|Single vs. Divided-dose rATG Induction||45
2924096|NCT00556933|3635146|FG003|STARTED|Single vs. Divided-dose rATG Induction||45
2924097|NCT00556933|3635143|FG000|COMPLETED|Single vs. Divided-dose rATG Induction||43
2924098|NCT00556933|3635144|FG001|COMPLETED|Single vs. Divided-dose rATG Induction||37
2924099|NCT00556933|3635145|FG002|COMPLETED|Single vs. Divided-dose rATG Induction||39
2924100|NCT00556933|3635146|FG003|COMPLETED|Single vs. Divided-dose rATG Induction||43
2924101|NCT00556933|3635143|FG000|NOT COMPLETED|Single vs. Divided-dose rATG Induction||2
2924102|NCT00556933|3635144|FG001|NOT COMPLETED|Single vs. Divided-dose rATG Induction||8
2924103|NCT00556933|3635145|FG002|NOT COMPLETED|Single vs. Divided-dose rATG Induction||6
2924104|NCT00556933|3635146|FG003|NOT COMPLETED|Single vs. Divided-dose rATG Induction||2
2924105|NCT00556933|3635143|FG000|STARTED|CNI Withdrawal vs. Minimization||43
2924106|NCT00556933|3635144|FG001|STARTED|CNI Withdrawal vs. Minimization||37
2924107|NCT00556933|3635145|FG002|STARTED|CNI Withdrawal vs. Minimization||39
2924108|NCT00556933|3635146|FG003|STARTED|CNI Withdrawal vs. Minimization||43
2924109|NCT00556933|3635143|FG000|COMPLETED|CNI Withdrawal vs. Minimization||42
2924110|NCT00556933|3635144|FG001|COMPLETED|CNI Withdrawal vs. Minimization||33
2924111|NCT00556933|3635145|FG002|COMPLETED|CNI Withdrawal vs. Minimization||36
2924112|NCT00556933|3635146|FG003|COMPLETED|CNI Withdrawal vs. Minimization||41
2924113|NCT00556933|3635143|FG000|NOT COMPLETED|CNI Withdrawal vs. Minimization||1
2924114|NCT00556933|3635144|FG001|NOT COMPLETED|CNI Withdrawal vs. Minimization||4
2924115|NCT00556933|3635145|FG002|NOT COMPLETED|CNI Withdrawal vs. Minimization||3
2924116|NCT00556933|3635146|FG003|NOT COMPLETED|CNI Withdrawal vs. Minimization||2
2924117|NCT00556946|3635165|FG000|STARTED|Overall Study||17
2924118|NCT00556946|3635165|FG000|COMPLETED|Overall Study||16
2924119|NCT00556946|3635165|FG000|NOT COMPLETED|Overall Study||1
2924120|NCT00556972|3635169|FG000|STARTED|Overall Study||4
2924121|NCT00556972|3635169|FG000|COMPLETED|Overall Study||4
2924122|NCT00556972|3635169|FG000|NOT COMPLETED|Overall Study||0
2924123|NCT00556998|3635173|FG000|STARTED|Voriconazole Intravenous (IV)||26
2924124|NCT00556998|3635173|FG000|Treated|Voriconazole Intravenous (IV)||26
2924125|NCT00556998|3635173|FG000|COMPLETED|Voriconazole Intravenous (IV)|One participant received 2 days of oral; then received IV again before discontinuing from study.|21
2924126|NCT00556998|3635173|FG000|NOT COMPLETED|Voriconazole Intravenous (IV)||5
2924127|NCT00556998|3635173|FG000|STARTED|Voriconazole Oral|One participant received voriconazole 150 mg every 12 hours during oral phase.|22
2924128|NCT00556998|3635173|FG000|COMPLETED|Voriconazole Oral||20
2924129|NCT00556998|3635173|FG000|NOT COMPLETED|Voriconazole Oral||2
2924130|NCT00557076|3635183|FG000|STARTED|Overall Study||8
2924131|NCT00557076|3635184|FG001|STARTED|Overall Study||8
2924132|NCT00557076|3635183|FG000|COMPLETED|Overall Study||8
2924133|NCT00557076|3635184|FG001|COMPLETED|Overall Study|One participant was withdrawn due to unblinding|7
2924134|NCT00557076|3635183|FG000|NOT COMPLETED|Overall Study||0
2924135|NCT00557076|3635184|FG001|NOT COMPLETED|Overall Study||1
2924136|NCT00557193|3635190|FG000|STARTED|Induction||218
3173896|NCT01952574|3901620|FG005|COMPLETED|Double-blind Treatment Phase||0
3173897|NCT01952574|3901621|FG006|COMPLETED|Double-blind Treatment Phase||0
3173898|NCT01952574|3901615|FG000|NOT COMPLETED|Double-blind Treatment Phase||17
3173899|NCT01952574|3901616|FG001|NOT COMPLETED|Double-blind Treatment Phase||3
3173900|NCT01952574|3901617|FG002|NOT COMPLETED|Double-blind Treatment Phase||9
3038948|NCT01155479|3758252|FG002|COMPLETED|Part II||109
3038949|NCT01155479|3758253|FG003|COMPLETED|Part II||127
3038950|NCT01155479|3758254|FG004|COMPLETED|Part II||126
3038951|NCT01155479|3758250|FG000|NOT COMPLETED|Part II||59
3038952|NCT01155479|3758251|FG001|NOT COMPLETED|Part II||61
3038953|NCT01155479|3758252|FG002|NOT COMPLETED|Part II||58
3038954|NCT01155479|3758253|FG003|NOT COMPLETED|Part II||50
3173901|NCT01952574|3901618|FG003|NOT COMPLETED|Double-blind Treatment Phase||6
3173902|NCT01952574|3901619|FG004|NOT COMPLETED|Double-blind Treatment Phase||0
3173903|NCT01952574|3901620|FG005|NOT COMPLETED|Double-blind Treatment Phase||0
3173904|NCT01952574|3901621|FG006|NOT COMPLETED|Double-blind Treatment Phase||0
3173905|NCT01952574|3901615|FG000|STARTED|Open-label Treatment Phase||0
3173906|NCT01952574|3901616|FG001|STARTED|Open-label Treatment Phase||0
3173907|NCT01952574|3901617|FG002|STARTED|Open-label Treatment Phase||0
3173908|NCT01952574|3901618|FG003|STARTED|Open-label Treatment Phase||0
3173909|NCT01952574|3901619|FG004|STARTED|Open-label Treatment Phase||383
3173910|NCT01952574|3901620|FG005|STARTED|Open-label Treatment Phase||0
2924137|NCT00557193|3635191|FG001|STARTED|Induction||0
2924138|NCT00557193|3635192|FG002|STARTED|Induction||0
2924139|NCT00557193|3635193|FG003|STARTED|Induction||0
2924140|NCT00557193|3635194|FG004|STARTED|Induction||0
2924141|NCT00557193|3635195|FG005|STARTED|Induction||0
2924142|NCT00557193|3635190|FG000|COMPLETED|Induction||192
2924143|NCT00557193|3635191|FG001|COMPLETED|Induction||0
2924144|NCT00557193|3635192|FG002|COMPLETED|Induction||0
2924145|NCT00557193|3635193|FG003|COMPLETED|Induction||0
2924146|NCT00557193|3635194|FG004|COMPLETED|Induction||0
2924147|NCT00557193|3635195|FG005|COMPLETED|Induction||0
2924148|NCT00557193|3635190|FG000|NOT COMPLETED|Induction||26
2924149|NCT00557193|3635191|FG001|NOT COMPLETED|Induction||0
2924150|NCT00557193|3635192|FG002|NOT COMPLETED|Induction||0
2924151|NCT00557193|3635193|FG003|NOT COMPLETED|Induction||0
2924152|NCT00557193|3635194|FG004|NOT COMPLETED|Induction||0
2924153|NCT00557193|3635195|FG005|NOT COMPLETED|Induction||0
2924154|NCT00557193|3635190|FG000|STARTED|Post Induction Therapy by Tx Assignment||0
2924155|NCT00557193|3635191|FG001|STARTED|Post Induction Therapy by Tx Assignment||60
2924156|NCT00557193|3635192|FG002|STARTED|Post Induction Therapy by Tx Assignment||54
2924157|NCT00557193|3635193|FG003|STARTED|Post Induction Therapy by Tx Assignment||11
2924158|NCT00557193|3635194|FG004|STARTED|Post Induction Therapy by Tx Assignment||11
2924159|NCT00557193|3635195|FG005|STARTED|Post Induction Therapy by Tx Assignment||56
2924160|NCT00557193|3635190|FG000|COMPLETED|Post Induction Therapy by Tx Assignment||0
2924161|NCT00557193|3635191|FG001|COMPLETED|Post Induction Therapy by Tx Assignment||50
2924162|NCT00557193|3635192|FG002|COMPLETED|Post Induction Therapy by Tx Assignment||22
2924163|NCT00557193|3635193|FG003|COMPLETED|Post Induction Therapy by Tx Assignment||4
2924164|NCT00557193|3635194|FG004|COMPLETED|Post Induction Therapy by Tx Assignment||4
2924165|NCT00557193|3635195|FG005|COMPLETED|Post Induction Therapy by Tx Assignment||19
2924166|NCT00557193|3635190|FG000|NOT COMPLETED|Post Induction Therapy by Tx Assignment||0
2924167|NCT00557193|3635191|FG001|NOT COMPLETED|Post Induction Therapy by Tx Assignment||10
2924168|NCT00557193|3635192|FG002|NOT COMPLETED|Post Induction Therapy by Tx Assignment||32
2924169|NCT00557193|3635193|FG003|NOT COMPLETED|Post Induction Therapy by Tx Assignment||7
3321500|NCT03174158|4054545|FG002|STARTED|Overall Study||36
3321501|NCT03174158|4054546|FG003|STARTED|Overall Study||39
3321502|NCT03174158|4054543|FG000|COMPLETED|Overall Study||35
3321503|NCT03174158|4054544|FG001|COMPLETED|Overall Study||37
3321504|NCT03174158|4054545|FG002|COMPLETED|Overall Study||34
3321505|NCT03174158|4054546|FG003|COMPLETED|Overall Study||38
3321506|NCT03174158|4054543|FG000|NOT COMPLETED|Overall Study||4
3321507|NCT03174158|4054544|FG001|NOT COMPLETED|Overall Study||2
3321508|NCT03174158|4054545|FG002|NOT COMPLETED|Overall Study||2
3321509|NCT03174158|4054546|FG003|NOT COMPLETED|Overall Study||1
3321510|NCT03174366|4054564|FG000|STARTED|Overall Study||7
3321511|NCT03174366|4054564|FG000|COMPLETED|Overall Study||7
3321512|NCT03174366|4054564|FG000|NOT COMPLETED|Overall Study||0
3321513|NCT03174925|4054568|FG000|STARTED|Overall Study||55
3321514|NCT03174925|4054568|FG000|COMPLETED|Overall Study||52
3321515|NCT03174925|4054568|FG000|NOT COMPLETED|Overall Study||3
3321516|NCT03175120|4054574|FG000|STARTED|Overall Study||302
3321517|NCT03175120|4054575|FG001|STARTED|Overall Study||151
3321518|NCT03175120|4054574|FG000|Treated|Overall Study||301
3321519|NCT03175120|4054575|FG001|Treated|Overall Study||151
2924170|NCT00557193|3635194|FG004|NOT COMPLETED|Post Induction Therapy by Tx Assignment||7
3173911|NCT01952574|3901621|FG006|STARTED|Open-label Treatment Phase||0
3173912|NCT01952574|3901615|FG000|Received 70 mg Erenumab|Open-label Treatment Phase||0
3173913|NCT01952574|3901616|FG001|Received 70 mg Erenumab|Open-label Treatment Phase||0
2924171|NCT00557193|3635195|FG005|NOT COMPLETED|Post Induction Therapy by Tx Assignment||37
2924172|NCT00557245|3635223|FG000|STARTED|Overall Study||1589
2924173|NCT00557245|3635224|FG001|STARTED|Overall Study||1583
2924174|NCT00557245|3635225|FG002|STARTED|Overall Study||1586
2924175|NCT00557245|3635223|FG000|COMPLETED|Overall Study||1577
2924176|NCT00557245|3635224|FG001|COMPLETED|Overall Study||1571
3321520|NCT03175120|4054574|FG000|Full Analysis Set (FAS)|Overall Study||302
3321521|NCT03175120|4054575|FG001|Full Analysis Set (FAS)|Overall Study||151
3321522|NCT03175120|4054574|FG000|Safety Analysis Set (SAS)|Overall Study||301
3321523|NCT03175120|4054575|FG001|Safety Analysis Set (SAS)|Overall Study||151
2924177|NCT00557245|3635225|FG002|COMPLETED|Overall Study||1574
2924178|NCT00557245|3635223|FG000|NOT COMPLETED|Overall Study||12
2924179|NCT00557245|3635224|FG001|NOT COMPLETED|Overall Study||12
2924180|NCT00557245|3635225|FG002|NOT COMPLETED|Overall Study||12
2924181|NCT00557284|3635238|FG000|STARTED|Overall Study||9
2924182|NCT00557284|3635239|FG001|STARTED|Overall Study||11
2924183|NCT00557284|3635238|FG000|COMPLETED|Overall Study||9
2924184|NCT00557284|3635239|FG001|COMPLETED|Overall Study||11
2924185|NCT00557284|3635238|FG000|NOT COMPLETED|Overall Study||0
2924186|NCT00557284|3635239|FG001|NOT COMPLETED|Overall Study||0
2924187|NCT00557310|3635245|FG000|STARTED|Main Study (0 - 18 Months)||35
2924188|NCT00557310|3635245|FG000|COMPLETED|Main Study (0 - 18 Months)|One had a metal hip implant, a protocol violation, and was excluded from efficacy analyses.|30
2924189|NCT00557310|3635245|FG000|NOT COMPLETED|Main Study (0 - 18 Months)||5
2924190|NCT00557310|3635245|FG000|STARTED|Extension Phase (18 - 24 Months)||30
2924191|NCT00557310|3635245|FG000|COMPLETED|Extension Phase (18 - 24 Months)|One had a metal hip implant, a protocol violation, and was excluded from efficacy analyses.|25
2924192|NCT00557310|3635245|FG000|NOT COMPLETED|Extension Phase (18 - 24 Months)||5
2924193|NCT00557323|3635249|FG000|STARTED|Overall Study||34
2924194|NCT00557323|3635249|FG000|COMPLETED|Overall Study||27
2924195|NCT00557323|3635249|FG000|NOT COMPLETED|Overall Study||7
2924196|NCT00557349|3635255|FG000|STARTED|Overall Study|omeprazole/bicarb|22
2924197|NCT00557349|3635256|FG001|STARTED|Overall Study||18
2924198|NCT00557349|3635255|FG000|COMPLETED|Overall Study||17
2924199|NCT00557349|3635256|FG001|COMPLETED|Overall Study||13
2924200|NCT00557349|3635255|FG000|NOT COMPLETED|Overall Study||5
2924201|NCT00557349|3635256|FG001|NOT COMPLETED|Overall Study||5
2924202|NCT00557362|3635266|FG000|STARTED|Overall Study||30
2924203|NCT00557362|3635267|FG001|STARTED|Overall Study||30
2924204|NCT00557362|3635268|FG002|STARTED|Overall Study||30
2924205|NCT00557362|3635269|FG003|STARTED|Overall Study||30
2924206|NCT00557362|3635266|FG000|COMPLETED|Overall Study||28
2924207|NCT00557362|3635267|FG001|COMPLETED|Overall Study||28
2924208|NCT00557362|3635268|FG002|COMPLETED|Overall Study||26
2924209|NCT00557362|3635269|FG003|COMPLETED|Overall Study||27
2924210|NCT00557362|3635266|FG000|NOT COMPLETED|Overall Study||2
2924211|NCT00557362|3635267|FG001|NOT COMPLETED|Overall Study||2
2924212|NCT00557362|3635268|FG002|NOT COMPLETED|Overall Study||4
2924213|NCT00557362|3635269|FG003|NOT COMPLETED|Overall Study||3
2924214|NCT00557440|3635285|FG000|STARTED|Treatment Period 1||12
2924215|NCT00557440|3635286|FG001|STARTED|Treatment Period 1||12
2924216|NCT00557440|3635287|FG002|STARTED|Treatment Period 1||13
2924217|NCT00557440|3635285|FG000|COMPLETED|Treatment Period 1||12
2924218|NCT00557440|3635286|FG001|COMPLETED|Treatment Period 1||12
2924219|NCT00557440|3635287|FG002|COMPLETED|Treatment Period 1||12
2924220|NCT00557440|3635285|FG000|NOT COMPLETED|Treatment Period 1||0
2924221|NCT00557440|3635286|FG001|NOT COMPLETED|Treatment Period 1||0
2924222|NCT00557440|3635287|FG002|NOT COMPLETED|Treatment Period 1||1
2924223|NCT00557440|3635285|FG000|STARTED|Treatment Period 2||12
2924224|NCT00557440|3635286|FG001|STARTED|Treatment Period 2||12
2924225|NCT00557440|3635287|FG002|STARTED|Treatment Period 2||12
2924226|NCT00557440|3635285|FG000|COMPLETED|Treatment Period 2||12
2924227|NCT00557440|3635286|FG001|COMPLETED|Treatment Period 2||12
2924228|NCT00557440|3635287|FG002|COMPLETED|Treatment Period 2||12
2924229|NCT00557440|3635285|FG000|NOT COMPLETED|Treatment Period 2||0
2924230|NCT00557440|3635286|FG001|NOT COMPLETED|Treatment Period 2||0
2924231|NCT00557440|3635287|FG002|NOT COMPLETED|Treatment Period 2||0
2924232|NCT00557440|3635285|FG000|STARTED|Treatment Period 3||12
2924233|NCT00557440|3635286|FG001|STARTED|Treatment Period 3||12
2924234|NCT00557440|3635287|FG002|STARTED|Treatment Period 3||12
2924235|NCT00557440|3635285|FG000|COMPLETED|Treatment Period 3||12
2924236|NCT00557440|3635286|FG001|COMPLETED|Treatment Period 3||12
2924237|NCT00557440|3635287|FG002|COMPLETED|Treatment Period 3||12
2924238|NCT00557440|3635285|FG000|NOT COMPLETED|Treatment Period 3||0
3173914|NCT01952574|3901617|FG002|Received 70 mg Erenumab|Open-label Treatment Phase||0
3321524|NCT03175120|4054574|FG000|COMPLETED|Overall Study||290
3321525|NCT03175120|4054575|FG001|COMPLETED|Overall Study||139
3321526|NCT03175120|4054574|FG000|NOT COMPLETED|Overall Study||12
3321527|NCT03175120|4054575|FG001|NOT COMPLETED|Overall Study||12
3321528|NCT03175172|4054581|FG000|STARTED|Overall Study||10
2924239|NCT00557440|3635286|FG001|NOT COMPLETED|Treatment Period 3||0
2924240|NCT00557440|3635287|FG002|NOT COMPLETED|Treatment Period 3||0
2924241|NCT00557466|3635301|FG000|STARTED|Overall Study||98
2924242|NCT00557466|3635302|FG001|STARTED|Overall Study||92
3038955|NCT01155479|3758254|FG004|NOT COMPLETED|Part II||55
3038956|NCT01155531|3758286|FG000|STARTED|Overall Study||10
3038957|NCT01155531|3758287|FG001|STARTED|Overall Study||10
3038958|NCT01155531|3758288|FG002|STARTED|Overall Study||10
3038959|NCT01155531|3758289|FG003|STARTED|Overall Study||10
3038960|NCT01155531|3758286|FG000|COMPLETED|Overall Study||9
3038961|NCT01155531|3758287|FG001|COMPLETED|Overall Study||10
3038962|NCT01155531|3758288|FG002|COMPLETED|Overall Study||8
3038963|NCT01155531|3758289|FG003|COMPLETED|Overall Study||9
3038964|NCT01155531|3758286|FG000|NOT COMPLETED|Overall Study||1
3038965|NCT01155531|3758287|FG001|NOT COMPLETED|Overall Study||0
3038966|NCT01155531|3758288|FG002|NOT COMPLETED|Overall Study||2
3038967|NCT01155531|3758289|FG003|NOT COMPLETED|Overall Study||1
3038968|NCT01155570|3758299|FG000|STARTED|Overall Study|Safety Analysis Population|734
3038969|NCT01155570|3758299|FG000|Efficacy Analysis Population|Overall Study|5 received Humira off-label, 21 did not receive Humira after the first administration|708
3038970|NCT01155570|3758299|FG000|COMPLETED|Overall Study||592
3038971|NCT01155570|3758299|FG000|NOT COMPLETED|Overall Study||142
3038972|NCT01155583|3758314|FG000|STARTED|Phase I||3
3038973|NCT01155583|3758315|FG001|STARTED|Phase I||3
3038974|NCT01155583|3758316|FG002|STARTED|Phase I||4
3038975|NCT01155583|3758317|FG003|STARTED|Phase I||6
3038976|NCT01155583|3758318|FG004|STARTED|Phase I||7
3038977|NCT01155583|3758319|FG005|STARTED|Phase I||0
3038978|NCT01155583|3758320|FG006|STARTED|Phase I||3
3038979|NCT01155583|3758321|FG007|STARTED|Phase I||8
3038980|NCT01155583|3758322|FG008|STARTED|Phase I||0
3038981|NCT01155583|3758314|FG000|COMPLETED|Phase I||3
3038982|NCT01155583|3758315|FG001|COMPLETED|Phase I||3
3038983|NCT01155583|3758316|FG002|COMPLETED|Phase I||4
3038984|NCT01155583|3758317|FG003|COMPLETED|Phase I||6
3038985|NCT01155583|3758318|FG004|COMPLETED|Phase I||6
3038986|NCT01155583|3758319|FG005|COMPLETED|Phase I||0
3038987|NCT01155583|3758320|FG006|COMPLETED|Phase I||3
3038988|NCT01155583|3758321|FG007|COMPLETED|Phase I||5
3038989|NCT01155583|3758322|FG008|COMPLETED|Phase I||0
3038990|NCT01155583|3758314|FG000|NOT COMPLETED|Phase I||0
3038991|NCT01155583|3758315|FG001|NOT COMPLETED|Phase I||0
3038992|NCT01155583|3758316|FG002|NOT COMPLETED|Phase I||0
3038993|NCT01155583|3758317|FG003|NOT COMPLETED|Phase I||0
3038994|NCT01155583|3758318|FG004|NOT COMPLETED|Phase I||1
3038995|NCT01155583|3758319|FG005|NOT COMPLETED|Phase I||0
3038996|NCT01155583|3758320|FG006|NOT COMPLETED|Phase I||0
3038997|NCT01155583|3758321|FG007|NOT COMPLETED|Phase I||3
3038998|NCT01155583|3758322|FG008|NOT COMPLETED|Phase I||0
3038999|NCT01155583|3758314|FG000|STARTED|Phase II - Expansion Phase||0
3039000|NCT01155583|3758315|FG001|STARTED|Phase II - Expansion Phase||0
3039001|NCT01155583|3758316|FG002|STARTED|Phase II - Expansion Phase||0
3039002|NCT01155583|3758317|FG003|STARTED|Phase II - Expansion Phase||0
3039003|NCT01155583|3758318|FG004|STARTED|Phase II - Expansion Phase||0
3039004|NCT01155583|3758319|FG005|STARTED|Phase II - Expansion Phase||0
3039005|NCT01155583|3758320|FG006|STARTED|Phase II - Expansion Phase||0
3039006|NCT01155583|3758321|FG007|STARTED|Phase II - Expansion Phase||0
3039007|NCT01155583|3758322|FG008|STARTED|Phase II - Expansion Phase||11
3039008|NCT01155583|3758314|FG000|COMPLETED|Phase II - Expansion Phase||0
3039009|NCT01155583|3758315|FG001|COMPLETED|Phase II - Expansion Phase||0
3039010|NCT01155583|3758316|FG002|COMPLETED|Phase II - Expansion Phase||0
3039011|NCT01155583|3758317|FG003|COMPLETED|Phase II - Expansion Phase||0
3039012|NCT01155583|3758318|FG004|COMPLETED|Phase II - Expansion Phase||0
3039013|NCT01155583|3758319|FG005|COMPLETED|Phase II - Expansion Phase||0
3039014|NCT01155583|3758320|FG006|COMPLETED|Phase II - Expansion Phase||0
3039015|NCT01155583|3758321|FG007|COMPLETED|Phase II - Expansion Phase||0
3039016|NCT01155583|3758322|FG008|COMPLETED|Phase II - Expansion Phase||11
3039017|NCT01155583|3758314|FG000|NOT COMPLETED|Phase II - Expansion Phase||0
3039018|NCT01155583|3758315|FG001|NOT COMPLETED|Phase II - Expansion Phase||0
3039019|NCT01155583|3758316|FG002|NOT COMPLETED|Phase II - Expansion Phase||0
3039020|NCT01155583|3758317|FG003|NOT COMPLETED|Phase II - Expansion Phase||0
3039021|NCT01155583|3758318|FG004|NOT COMPLETED|Phase II - Expansion Phase||0
3039022|NCT01155583|3758319|FG005|NOT COMPLETED|Phase II - Expansion Phase||0
3039023|NCT01155583|3758320|FG006|NOT COMPLETED|Phase II - Expansion Phase||0
3039024|NCT01155583|3758321|FG007|NOT COMPLETED|Phase II - Expansion Phase||0
3039025|NCT01155583|3758322|FG008|NOT COMPLETED|Phase II - Expansion Phase||0
3039026|NCT01155661|3758338|FG000|STARTED|Overall Study||608
3039027|NCT01155661|3758338|FG000|COMPLETED|Overall Study||328
3039028|NCT01155661|3758338|FG000|NOT COMPLETED|Overall Study||280
3039029|NCT01155726|3758344|FG000|STARTED|Period 1, 3 Days (Masked)||24
3039030|NCT01155726|3758345|FG001|STARTED|Period 1, 3 Days (Masked)||20
3039031|NCT01155726|3758346|FG002|STARTED|Period 1, 3 Days (Masked)||30
3039032|NCT01155726|3758347|FG003|STARTED|Period 1, 3 Days (Masked)||25
3039033|NCT01155726|3758344|FG000|COMPLETED|Period 1, 3 Days (Masked)||23
3039034|NCT01155726|3758345|FG001|COMPLETED|Period 1, 3 Days (Masked)||20
3039035|NCT01155726|3758346|FG002|COMPLETED|Period 1, 3 Days (Masked)||28
3173915|NCT01952574|3901618|FG003|Received 70 mg Erenumab|Open-label Treatment Phase||0
3173916|NCT01952574|3901619|FG004|Received 70 mg Erenumab|Open-label Treatment Phase||383
3173917|NCT01952574|3901620|FG005|Received 70 mg Erenumab|Open-label Treatment Phase||0
3173918|NCT01952574|3901621|FG006|Received 70 mg Erenumab|Open-label Treatment Phase||0
3173919|NCT01952574|3901615|FG000|Received 140 mg Erenumab|Open-label Treatment Phase||0
3173920|NCT01952574|3901616|FG001|Received 140 mg Erenumab|Open-label Treatment Phase||0
3173921|NCT01952574|3901617|FG002|Received 140 mg Erenumab|Open-label Treatment Phase||0
3173922|NCT01952574|3901618|FG003|Received 140 mg Erenumab|Open-label Treatment Phase||0
3173923|NCT01952574|3901619|FG004|Received 140 mg Erenumab|Open-label Treatment Phase||250
3321529|NCT03175172|4054581|FG000|COMPLETED|Overall Study||0
3321530|NCT03175172|4054581|FG000|NOT COMPLETED|Overall Study||10
3321531|NCT03175562|4054585|FG000|STARTED|Overall Study||240
3321532|NCT03175562|4054585|FG000|Test Product|Overall Study||240
3321533|NCT03175562|4054585|FG000|Negative Control|Overall Study||240
3321534|NCT03175562|4054585|FG000|COMPLETED|Overall Study||224
3321535|NCT03175562|4054585|FG000|NOT COMPLETED|Overall Study||16
3321536|NCT03175731|4054594|FG000|STARTED|Overall Study||53
3321537|NCT03175731|4054595|FG001|STARTED|Overall Study||53
3321538|NCT03175731|4054594|FG000|COMPLETED|Overall Study||46
3321539|NCT03175731|4054595|FG001|COMPLETED|Overall Study||48
3321540|NCT03175731|4054594|FG000|NOT COMPLETED|Overall Study||7
3321541|NCT03175731|4054595|FG001|NOT COMPLETED|Overall Study||5
3321542|NCT03176238|4054603|FG000|STARTED|Overall Study||199
3321543|NCT03176238|4054604|FG001|STARTED|Overall Study||36
3173924|NCT01952574|3901620|FG005|Received 140 mg Erenumab|Open-label Treatment Phase||0
3173925|NCT01952574|3901621|FG006|Received 140 mg Erenumab|Open-label Treatment Phase||0
3173926|NCT01952574|3901615|FG000|COMPLETED|Open-label Treatment Phase||0
3173927|NCT01952574|3901616|FG001|COMPLETED|Open-label Treatment Phase||0
3173928|NCT01952574|3901617|FG002|COMPLETED|Open-label Treatment Phase||0
3321544|NCT03176238|4054603|FG000|COMPLETED|Overall Study||0
3321545|NCT03176238|4054604|FG001|COMPLETED|Overall Study||0
3321546|NCT03176238|4054603|FG000|NOT COMPLETED|Overall Study||199
3321547|NCT03176238|4054604|FG001|NOT COMPLETED|Overall Study||36
2924243|NCT00557466|3635303|FG002|STARTED|Overall Study||101
2924244|NCT00557466|3635304|FG003|STARTED|Overall Study||96
3173929|NCT01952574|3901618|FG003|COMPLETED|Open-label Treatment Phase||0
3321548|NCT03176407|4054614|FG000|STARTED|Overall Study||30
3321549|NCT03176407|4054614|FG000|COMPLETED|Overall Study||27
3321550|NCT03176407|4054614|FG000|NOT COMPLETED|Overall Study||3
3321551|NCT03176459|4054622|FG000|STARTED|Overall Study||96
3321552|NCT03176459|4054623|FG001|STARTED|Overall Study||90
3321553|NCT03176459|4054622|FG000|COMPLETED|Overall Study||91
3321554|NCT03176459|4054623|FG001|COMPLETED|Overall Study||83
3321555|NCT03176459|4054622|FG000|NOT COMPLETED|Overall Study||5
3321556|NCT03176459|4054623|FG001|NOT COMPLETED|Overall Study||7
3173930|NCT01952574|3901619|FG004|COMPLETED|Open-label Treatment Phase||221
3173931|NCT01952574|3901620|FG005|COMPLETED|Open-label Treatment Phase||0
3173932|NCT01952574|3901621|FG006|COMPLETED|Open-label Treatment Phase||0
3173933|NCT01952574|3901615|FG000|NOT COMPLETED|Open-label Treatment Phase||0
3173934|NCT01952574|3901616|FG001|NOT COMPLETED|Open-label Treatment Phase||0
3173935|NCT01952574|3901617|FG002|NOT COMPLETED|Open-label Treatment Phase||0
3173936|NCT01952574|3901618|FG003|NOT COMPLETED|Open-label Treatment Phase||0
3173937|NCT01952574|3901619|FG004|NOT COMPLETED|Open-label Treatment Phase||162
3173938|NCT01952574|3901620|FG005|NOT COMPLETED|Open-label Treatment Phase||0
3173939|NCT01952574|3901621|FG006|NOT COMPLETED|Open-label Treatment Phase||0
3173940|NCT01952574|3901615|FG000|STARTED|Clinical Home Use Substudy||0
3173941|NCT01952574|3901616|FG001|STARTED|Clinical Home Use Substudy||0
3321557|NCT03176654|4054631|FG000|STARTED|Overall Study||13
3321558|NCT03176654|4054632|FG001|STARTED|Overall Study||15
3321559|NCT03176654|4054631|FG000|COMPLETED|Overall Study||13
3321560|NCT03176654|4054632|FG001|COMPLETED|Overall Study||15
3321561|NCT03176654|4054631|FG000|NOT COMPLETED|Overall Study||0
3321562|NCT03176654|4054632|FG001|NOT COMPLETED|Overall Study||0
3321563|NCT03176784|4054642|FG000|STARTED|Overall Study||314
3321564|NCT03176784|4054643|FG001|STARTED|Overall Study||315
3321565|NCT03176784|4054644|FG002|STARTED|Overall Study||311
3321566|NCT03176784|4054645|FG003|STARTED|Overall Study||311
3321567|NCT03176784|4054642|FG000|COMPLETED|Overall Study||209
3321568|NCT03176784|4054643|FG001|COMPLETED|Overall Study||202
3321569|NCT03176784|4054644|FG002|COMPLETED|Overall Study||198
3321570|NCT03176784|4054645|FG003|COMPLETED|Overall Study||241
3321571|NCT03176784|4054642|FG000|NOT COMPLETED|Overall Study||105
3321572|NCT03176784|4054643|FG001|NOT COMPLETED|Overall Study||113
3321573|NCT03176784|4054644|FG002|NOT COMPLETED|Overall Study||113
3321574|NCT03176784|4054645|FG003|NOT COMPLETED|Overall Study||70
3173942|NCT01952574|3901617|FG002|STARTED|Clinical Home Use Substudy||0
3173943|NCT01952574|3901618|FG003|STARTED|Clinical Home Use Substudy||0
3173944|NCT01952574|3901619|FG004|STARTED|Clinical Home Use Substudy||0
3173945|NCT01952574|3901620|FG005|STARTED|Clinical Home Use Substudy||42
3173946|NCT01952574|3901621|FG006|STARTED|Clinical Home Use Substudy||41
3173947|NCT01952574|3901615|FG000|COMPLETED|Clinical Home Use Substudy||0
3173948|NCT01952574|3901616|FG001|COMPLETED|Clinical Home Use Substudy||0
2924245|NCT00557466|3635305|FG004|STARTED|Overall Study||90
2924246|NCT00557466|3635306|FG005|STARTED|Overall Study||91
2924247|NCT00557466|3635301|FG000|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|98
2924248|NCT00557466|3635302|FG001|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|92
2924249|NCT00557466|3635303|FG002|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|101
2924250|NCT00557466|3635304|FG003|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|96
2924251|NCT00557466|3635305|FG004|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|90
2924252|NCT00557466|3635306|FG005|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|91
2924253|NCT00557466|3635301|FG000|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|98
2924254|NCT00557466|3635302|FG001|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|91
2924255|NCT00557466|3635303|FG002|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|98
2924256|NCT00557466|3635304|FG003|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|93
2924257|NCT00557466|3635305|FG004|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|87
2924258|NCT00557466|3635306|FG005|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|89
2924259|NCT00557466|3635301|FG000|COMPLETED|Overall Study||94
2924260|NCT00557466|3635302|FG001|COMPLETED|Overall Study||87
2924261|NCT00557466|3635303|FG002|COMPLETED|Overall Study||95
2924262|NCT00557466|3635304|FG003|COMPLETED|Overall Study||92
2924263|NCT00557466|3635305|FG004|COMPLETED|Overall Study||87
2924264|NCT00557466|3635306|FG005|COMPLETED|Overall Study||85
2924265|NCT00557466|3635301|FG000|NOT COMPLETED|Overall Study||4
2924266|NCT00557466|3635302|FG001|NOT COMPLETED|Overall Study||5
2924267|NCT00557466|3635303|FG002|NOT COMPLETED|Overall Study||6
2924268|NCT00557466|3635304|FG003|NOT COMPLETED|Overall Study||4
2924269|NCT00557466|3635305|FG004|NOT COMPLETED|Overall Study||3
2924270|NCT00557466|3635306|FG005|NOT COMPLETED|Overall Study||6
2924271|NCT00557492|3635320|FG000|STARTED|Overall Study||59
2924272|NCT00557492|3635320|FG000|COMPLETED|Overall Study|Evaluable for outcomes|58
2924273|NCT00557492|3635320|FG000|NOT COMPLETED|Overall Study||1
2924274|NCT00557505|3635333|FG000|STARTED|Overall Study||3
2924275|NCT00557505|3635334|FG001|STARTED|Overall Study||3
2924276|NCT00557505|3635335|FG002|STARTED|Overall Study||4
2924277|NCT00557505|3635336|FG003|STARTED|Overall Study||3
2924278|NCT00557505|3635337|FG004|STARTED|Overall Study||2
2924279|NCT00557505|3635338|FG005|STARTED|Overall Study||3
2924280|NCT00557505|3635339|FG006|STARTED|Overall Study||3
2924281|NCT00557505|3635340|FG007|STARTED|Overall Study||5
2924282|NCT00557505|3635341|FG008|STARTED|Overall Study||17
2924283|NCT00557505|3635333|FG000|COMPLETED|Overall Study||0
2924284|NCT00557505|3635334|FG001|COMPLETED|Overall Study||0
2924285|NCT00557505|3635335|FG002|COMPLETED|Overall Study||0
2924286|NCT00557505|3635336|FG003|COMPLETED|Overall Study||0
3173949|NCT01952574|3901617|FG002|COMPLETED|Clinical Home Use Substudy||0
3173950|NCT01952574|3901618|FG003|COMPLETED|Clinical Home Use Substudy||0
3173951|NCT01952574|3901619|FG004|COMPLETED|Clinical Home Use Substudy||0
3173952|NCT01952574|3901620|FG005|COMPLETED|Clinical Home Use Substudy||39
3173953|NCT01952574|3901621|FG006|COMPLETED|Clinical Home Use Substudy||40
3173954|NCT01952574|3901615|FG000|NOT COMPLETED|Clinical Home Use Substudy||0
3173955|NCT01952574|3901616|FG001|NOT COMPLETED|Clinical Home Use Substudy||0
3173956|NCT01952574|3901617|FG002|NOT COMPLETED|Clinical Home Use Substudy||0
3173957|NCT01952574|3901618|FG003|NOT COMPLETED|Clinical Home Use Substudy||0
3173958|NCT01952574|3901619|FG004|NOT COMPLETED|Clinical Home Use Substudy||0
3173959|NCT01952574|3901620|FG005|NOT COMPLETED|Clinical Home Use Substudy||3
3173960|NCT01952574|3901621|FG006|NOT COMPLETED|Clinical Home Use Substudy||1
3173961|NCT01952600|3901649|FG000|STARTED|Overall Study||80
3173962|NCT01952600|3901650|FG001|STARTED|Overall Study||90
3173963|NCT01952600|3901651|FG002|STARTED|Overall Study||45
3173964|NCT01952600|3901649|FG000|COMPLETED|Overall Study||65
3173965|NCT01952600|3901650|FG001|COMPLETED|Overall Study||77
3173966|NCT01952600|3901651|FG002|COMPLETED|Overall Study||38
3321575|NCT03177395|4054659|FG000|STARTED|Overall Study||6
3321576|NCT03177395|4054660|FG001|STARTED|Overall Study||6
3321577|NCT03177395|4054661|FG002|STARTED|Overall Study||6
3321578|NCT03177395|4054662|FG003|STARTED|Overall Study||6
3321579|NCT03177395|4054659|FG000|COMPLETED|Overall Study||6
3321580|NCT03177395|4054660|FG001|COMPLETED|Overall Study||6
3321581|NCT03177395|4054661|FG002|COMPLETED|Overall Study||6
3321582|NCT03177395|4054662|FG003|COMPLETED|Overall Study||6
3321583|NCT03177395|4054659|FG000|NOT COMPLETED|Overall Study||0
3321584|NCT03177395|4054660|FG001|NOT COMPLETED|Overall Study||0
3321585|NCT03177395|4054661|FG002|NOT COMPLETED|Overall Study||0
3321586|NCT03177395|4054662|FG003|NOT COMPLETED|Overall Study||0
3321587|NCT03177512|4054676|FG000|STARTED|Overall Study||40
3321588|NCT03177512|4054677|FG001|STARTED|Overall Study||21
3321589|NCT03177512|4054676|FG000|COMPLETED|Overall Study||31
3321590|NCT03177512|4054677|FG001|COMPLETED|Overall Study||18
3321591|NCT03177512|4054676|FG000|NOT COMPLETED|Overall Study||9
3321592|NCT03177512|4054677|FG001|NOT COMPLETED|Overall Study||3
3173967|NCT01952600|3901649|FG000|NOT COMPLETED|Overall Study||15
3173968|NCT01952600|3901650|FG001|NOT COMPLETED|Overall Study||13
3173969|NCT01952600|3901651|FG002|NOT COMPLETED|Overall Study||7
3173970|NCT01952665|3901661|FG000|STARTED|Overall Study||37
3173971|NCT01952665|3901662|FG001|STARTED|Overall Study||26
3173972|NCT01952665|3901661|FG000|COMPLETED|Overall Study||31
3173973|NCT01952665|3901662|FG001|COMPLETED|Overall Study||20
3173974|NCT01952665|3901661|FG000|NOT COMPLETED|Overall Study||6
3173975|NCT01952665|3901662|FG001|NOT COMPLETED|Overall Study||6
3173976|NCT01952678|3901673|FG000|STARTED|Overall Study||102
3173977|NCT01952678|3901674|FG001|STARTED|Overall Study||102
3173978|NCT01952678|3901673|FG000|COMPLETED|Overall Study||102
3173979|NCT01952678|3901674|FG001|COMPLETED|Overall Study||102
3173980|NCT01952678|3901673|FG000|NOT COMPLETED|Overall Study||0
3173981|NCT01952678|3901674|FG001|NOT COMPLETED|Overall Study||0
3173982|NCT01952691|3901690|FG000|STARTED|Overall Study||22
3173983|NCT01952691|3901690|FG000|COMPLETED|Overall Study||20
3173984|NCT01952691|3901690|FG000|NOT COMPLETED|Overall Study||2
3136963|NCT01716520|3862280|FG002|COMPLETED|Treatment Period 1 (14 Days)||28
3136964|NCT01716520|3862281|FG003|COMPLETED|Treatment Period 1 (14 Days)||29
3136965|NCT01716520|3862282|FG004|COMPLETED|Treatment Period 1 (14 Days)||31
2924287|NCT00557505|3635337|FG004|COMPLETED|Overall Study||0
2924288|NCT00557505|3635338|FG005|COMPLETED|Overall Study||0
2924289|NCT00557505|3635339|FG006|COMPLETED|Overall Study||0
2924290|NCT00557505|3635340|FG007|COMPLETED|Overall Study||0
2924291|NCT00557505|3635341|FG008|COMPLETED|Overall Study||0
2924292|NCT00557505|3635333|FG000|NOT COMPLETED|Overall Study||3
2924293|NCT00557505|3635334|FG001|NOT COMPLETED|Overall Study||3
2924294|NCT00557505|3635335|FG002|NOT COMPLETED|Overall Study||4
2924295|NCT00557505|3635336|FG003|NOT COMPLETED|Overall Study||3
2924296|NCT00557505|3635337|FG004|NOT COMPLETED|Overall Study||2
2924297|NCT00557505|3635338|FG005|NOT COMPLETED|Overall Study||3
2924298|NCT00557505|3635339|FG006|NOT COMPLETED|Overall Study||3
2924299|NCT00557505|3635340|FG007|NOT COMPLETED|Overall Study||5
2924300|NCT00557505|3635341|FG008|NOT COMPLETED|Overall Study||17
2924301|NCT00557622|3635366|FG000|STARTED|4-Week Run-in Phase||5
2924302|NCT00557622|3635367|FG001|STARTED|4-Week Run-in Phase||0
2924303|NCT00557622|3635366|FG000|COMPLETED|4-Week Run-in Phase||3
2924304|NCT00557622|3635367|FG001|COMPLETED|4-Week Run-in Phase||0
2924305|NCT00557622|3635366|FG000|NOT COMPLETED|4-Week Run-in Phase||2
2924306|NCT00557622|3635367|FG001|NOT COMPLETED|4-Week Run-in Phase||0
2924307|NCT00557622|3635366|FG000|STARTED|12-Week Treatment Phase||1
2924308|NCT00557622|3635367|FG001|STARTED|12-Week Treatment Phase||2
2924309|NCT00557622|3635366|FG000|COMPLETED|12-Week Treatment Phase||1
2924310|NCT00557622|3635367|FG001|COMPLETED|12-Week Treatment Phase||1
2924311|NCT00557622|3635366|FG000|NOT COMPLETED|12-Week Treatment Phase||0
2924312|NCT00557622|3635367|FG001|NOT COMPLETED|12-Week Treatment Phase||1
2924313|NCT00557830|3635376|FG000|STARTED|Screening Treatment Phase||12
2924314|NCT00557830|3635377|FG001|STARTED|Screening Treatment Phase||0
2924315|NCT00557830|3635378|FG002|STARTED|Screening Treatment Phase||0
2924316|NCT00557830|3635376|FG000|COMPLETED|Screening Treatment Phase||6
2924317|NCT00557830|3635377|FG001|COMPLETED|Screening Treatment Phase||0
2924318|NCT00557830|3635378|FG002|COMPLETED|Screening Treatment Phase||0
2924319|NCT00557830|3635376|FG000|NOT COMPLETED|Screening Treatment Phase||6
2924320|NCT00557830|3635377|FG001|NOT COMPLETED|Screening Treatment Phase||0
2924321|NCT00557830|3635378|FG002|NOT COMPLETED|Screening Treatment Phase||0
2924322|NCT00557830|3635376|FG000|STARTED|Treatment Phase||0
2924323|NCT00557830|3635377|FG001|STARTED|Treatment Phase||4
2924324|NCT00557830|3635378|FG002|STARTED|Treatment Phase||2
2924325|NCT00557830|3635376|FG000|COMPLETED|Treatment Phase||0
2924326|NCT00557830|3635377|FG001|COMPLETED|Treatment Phase||4
2924327|NCT00557830|3635378|FG002|COMPLETED|Treatment Phase||2
2924328|NCT00557830|3635376|FG000|NOT COMPLETED|Treatment Phase||0
2924329|NCT00557830|3635377|FG001|NOT COMPLETED|Treatment Phase||0
3136966|NCT01716520|3862283|FG005|COMPLETED|Treatment Period 1 (14 Days)||29
3136967|NCT01716520|3862278|FG000|NOT COMPLETED|Treatment Period 1 (14 Days)||2
3173985|NCT01952834|3901694|FG000|STARTED|Overall Study||21
2924330|NCT00557830|3635378|FG002|NOT COMPLETED|Treatment Phase||0
2924331|NCT00557856|3635386|FG000|STARTED|Part 1: Dose Escalation Phase||7
2924332|NCT00557856|3635387|FG001|STARTED|Part 1: Dose Escalation Phase||5
2924333|NCT00557856|3635388|FG002|STARTED|Part 1: Dose Escalation Phase||6
2924334|NCT00557856|3635389|FG003|STARTED|Part 1: Dose Escalation Phase||3
2924335|NCT00557856|3635390|FG004|STARTED|Part 1: Dose Escalation Phase||4
2924336|NCT00557856|3635391|FG005|STARTED|Part 1: Dose Escalation Phase||8
2924337|NCT00557856|3635392|FG006|STARTED|Part 1: Dose Escalation Phase||7
2924338|NCT00557856|3635393|FG007|STARTED|Part 1: Dose Escalation Phase||6
2924339|NCT00557856|3635394|FG008|STARTED|Part 1: Dose Escalation Phase||0
2924340|NCT00557856|3635386|FG000|Treated|Part 1: Dose Escalation Phase||5
2924341|NCT00557856|3635387|FG001|Treated|Part 1: Dose Escalation Phase||5
2924342|NCT00557856|3635388|FG002|Treated|Part 1: Dose Escalation Phase||6
2924343|NCT00557856|3635389|FG003|Treated|Part 1: Dose Escalation Phase||3
2924344|NCT00557856|3635390|FG004|Treated|Part 1: Dose Escalation Phase||4
2924345|NCT00557856|3635391|FG005|Treated|Part 1: Dose Escalation Phase||8
2924346|NCT00557856|3635392|FG006|Treated|Part 1: Dose Escalation Phase||7
2924347|NCT00557856|3635393|FG007|Treated|Part 1: Dose Escalation Phase||6
2924348|NCT00557856|3635394|FG008|Treated|Part 1: Dose Escalation Phase||0
2924349|NCT00557856|3635386|FG000|COMPLETED|Part 1: Dose Escalation Phase||0
2924350|NCT00557856|3635387|FG001|COMPLETED|Part 1: Dose Escalation Phase||0
2924351|NCT00557856|3635388|FG002|COMPLETED|Part 1: Dose Escalation Phase||0
2924352|NCT00557856|3635389|FG003|COMPLETED|Part 1: Dose Escalation Phase||0
2924353|NCT00557856|3635390|FG004|COMPLETED|Part 1: Dose Escalation Phase||0
2924354|NCT00557856|3635391|FG005|COMPLETED|Part 1: Dose Escalation Phase||0
2924355|NCT00557856|3635392|FG006|COMPLETED|Part 1: Dose Escalation Phase||0
2924356|NCT00557856|3635393|FG007|COMPLETED|Part 1: Dose Escalation Phase||0
2924357|NCT00557856|3635394|FG008|COMPLETED|Part 1: Dose Escalation Phase||0
2924358|NCT00557856|3635386|FG000|NOT COMPLETED|Part 1: Dose Escalation Phase||7
2924359|NCT00557856|3635387|FG001|NOT COMPLETED|Part 1: Dose Escalation Phase||5
2924360|NCT00557856|3635388|FG002|NOT COMPLETED|Part 1: Dose Escalation Phase||6
2924361|NCT00557856|3635389|FG003|NOT COMPLETED|Part 1: Dose Escalation Phase||3
2924362|NCT00557856|3635390|FG004|NOT COMPLETED|Part 1: Dose Escalation Phase||4
2924363|NCT00557856|3635391|FG005|NOT COMPLETED|Part 1: Dose Escalation Phase||8
2924364|NCT00557856|3635392|FG006|NOT COMPLETED|Part 1: Dose Escalation Phase||7
2924365|NCT00557856|3635393|FG007|NOT COMPLETED|Part 1: Dose Escalation Phase||6
2924366|NCT00557856|3635394|FG008|NOT COMPLETED|Part 1: Dose Escalation Phase||0
2924367|NCT00557856|3635386|FG000|STARTED|Part 2: Exploratory Phase||0
2924368|NCT00557856|3635387|FG001|STARTED|Part 2: Exploratory Phase||0
2924369|NCT00557856|3635388|FG002|STARTED|Part 2: Exploratory Phase||0
2924370|NCT00557856|3635389|FG003|STARTED|Part 2: Exploratory Phase||0
2924371|NCT00557856|3635390|FG004|STARTED|Part 2: Exploratory Phase||0
2924372|NCT00557856|3635391|FG005|STARTED|Part 2: Exploratory Phase||0
2924373|NCT00557856|3635392|FG006|STARTED|Part 2: Exploratory Phase||0
2924374|NCT00557856|3635393|FG007|STARTED|Part 2: Exploratory Phase||0
2924375|NCT00557856|3635394|FG008|STARTED|Part 2: Exploratory Phase||24
2924376|NCT00557856|3635386|FG000|COMPLETED|Part 2: Exploratory Phase||0
2924377|NCT00557856|3635387|FG001|COMPLETED|Part 2: Exploratory Phase||0
2924378|NCT00557856|3635388|FG002|COMPLETED|Part 2: Exploratory Phase||0
2924379|NCT00557856|3635389|FG003|COMPLETED|Part 2: Exploratory Phase||0
2924380|NCT00557856|3635390|FG004|COMPLETED|Part 2: Exploratory Phase||0
2924381|NCT00557856|3635391|FG005|COMPLETED|Part 2: Exploratory Phase||0
2924382|NCT00557856|3635392|FG006|COMPLETED|Part 2: Exploratory Phase||0
2924383|NCT00557856|3635393|FG007|COMPLETED|Part 2: Exploratory Phase||0
2924384|NCT00557856|3635394|FG008|COMPLETED|Part 2: Exploratory Phase||0
2924385|NCT00557856|3635386|FG000|NOT COMPLETED|Part 2: Exploratory Phase||0
2924386|NCT00557856|3635387|FG001|NOT COMPLETED|Part 2: Exploratory Phase||0
2924387|NCT00557856|3635388|FG002|NOT COMPLETED|Part 2: Exploratory Phase||0
2924388|NCT00557856|3635389|FG003|NOT COMPLETED|Part 2: Exploratory Phase||0
2924389|NCT00557856|3635390|FG004|NOT COMPLETED|Part 2: Exploratory Phase||0
3039036|NCT01155726|3758347|FG003|COMPLETED|Period 1, 3 Days (Masked)||25
3039037|NCT01155726|3758344|FG000|NOT COMPLETED|Period 1, 3 Days (Masked)||1
3039038|NCT01155726|3758345|FG001|NOT COMPLETED|Period 1, 3 Days (Masked)||0
3039039|NCT01155726|3758346|FG002|NOT COMPLETED|Period 1, 3 Days (Masked)||2
3039040|NCT01155726|3758347|FG003|NOT COMPLETED|Period 1, 3 Days (Masked)||0
3039041|NCT01155726|3758344|FG000|STARTED|Period 2, 3 Days (Unmask) or (Partial)||23
3039042|NCT01155726|3758345|FG001|STARTED|Period 2, 3 Days (Unmask) or (Partial)||20
3039043|NCT01155726|3758346|FG002|STARTED|Period 2, 3 Days (Unmask) or (Partial)||28
3039044|NCT01155726|3758347|FG003|STARTED|Period 2, 3 Days (Unmask) or (Partial)||25
3039045|NCT01155726|3758344|FG000|COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||23
3173986|NCT01952834|3901694|FG000|COMPLETED|Overall Study||20
3173987|NCT01952834|3901694|FG000|NOT COMPLETED|Overall Study||1
3173988|NCT01953003|3901701|FG000|STARTED|Overall Study||56
3173989|NCT01953003|3901702|FG001|STARTED|Overall Study||56
3173990|NCT01953003|3901701|FG000|COMPLETED|Overall Study||0
3173991|NCT01953003|3901702|FG001|COMPLETED|Overall Study||1
3173992|NCT01953003|3901701|FG000|NOT COMPLETED|Overall Study||56
3173993|NCT01953003|3901702|FG001|NOT COMPLETED|Overall Study||55
3173994|NCT01953081|3901710|FG000|STARTED|Overall Study||7
3173995|NCT01953081|3901711|FG001|STARTED|Overall Study||6
3173996|NCT01953081|3901710|FG000|COMPLETED|Overall Study||5
3173997|NCT01953081|3901711|FG001|COMPLETED|Overall Study||3
3173998|NCT01953081|3901710|FG000|NOT COMPLETED|Overall Study||2
3173999|NCT01953081|3901711|FG001|NOT COMPLETED|Overall Study||3
3174000|NCT01953211|3901717|FG000|STARTED|Overall Study|completed prior to clinical trials submission|64
3174001|NCT01953211|3901717|FG000|COMPLETED|Overall Study|completed prior to clinical trials submission|64
3174002|NCT01953211|3901717|FG000|NOT COMPLETED|Overall Study||0
3174003|NCT01953224|3901725|FG000|STARTED|Overall Study||20
3174004|NCT01953224|3901726|FG001|STARTED|Overall Study||20
3174005|NCT01953224|3901725|FG000|COMPLETED|Overall Study||18
3174006|NCT01953224|3901726|FG001|COMPLETED|Overall Study||17
3174007|NCT01953224|3901725|FG000|NOT COMPLETED|Overall Study||2
3174008|NCT01953224|3901726|FG001|NOT COMPLETED|Overall Study||3
3174009|NCT01953237|3901734|FG000|STARTED|Overall Study||10
3174010|NCT01953237|3901735|FG001|STARTED|Overall Study||21
3174011|NCT01953237|3901734|FG000|COMPLETED|Overall Study||10
3174012|NCT01953237|3901735|FG001|COMPLETED|Overall Study||21
3174013|NCT01953237|3901734|FG000|NOT COMPLETED|Overall Study||0
3174014|NCT01953237|3901735|FG001|NOT COMPLETED|Overall Study||0
3174015|NCT01953328|3901749|FG000|STARTED|Overall Study||49
3174016|NCT01953328|3901750|FG001|STARTED|Overall Study||50
3174017|NCT01953328|3901751|FG002|STARTED|Overall Study||50
3321593|NCT03177603|4054687|FG000|STARTED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||4
3321594|NCT03177603|4054688|FG001|STARTED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0
3321595|NCT03177603|4054689|FG002|STARTED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0
3321596|NCT03177603|4054690|FG003|STARTED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0
3321597|NCT03177603|4054687|FG000|COMPLETED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||4
3321598|NCT03177603|4054688|FG001|COMPLETED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0
3321599|NCT03177603|4054689|FG002|COMPLETED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0
3321600|NCT03177603|4054690|FG003|COMPLETED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0
3321601|NCT03177603|4054687|FG000|NOT COMPLETED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0
3174018|NCT01953328|3901752|FG003|STARTED|Overall Study||50
3174019|NCT01953328|3901753|FG004|STARTED|Overall Study||52
3174020|NCT01953328|3901754|FG005|STARTED|Overall Study||51
2924390|NCT00557856|3635391|FG005|NOT COMPLETED|Part 2: Exploratory Phase||0
2924391|NCT00557856|3635392|FG006|NOT COMPLETED|Part 2: Exploratory Phase||0
2924392|NCT00557856|3635393|FG007|NOT COMPLETED|Part 2: Exploratory Phase||0
2924393|NCT00557856|3635394|FG008|NOT COMPLETED|Part 2: Exploratory Phase||24
2924394|NCT00557882|3635411|FG000|STARTED|Overall Study||32
2924395|NCT00557882|3635412|FG001|STARTED|Overall Study||33
2924396|NCT00557882|3635411|FG000|COMPLETED|Overall Study||27
2924397|NCT00557882|3635412|FG001|COMPLETED|Overall Study||33
2924398|NCT00557882|3635411|FG000|NOT COMPLETED|Overall Study||5
2924399|NCT00557882|3635412|FG001|NOT COMPLETED|Overall Study||0
2924400|NCT00557947|3635418|FG000|STARTED|Overall Study||83
2924401|NCT00557947|3635418|FG000|COMPLETED|Overall Study||83
2924402|NCT00557947|3635418|FG000|NOT COMPLETED|Overall Study||0
2924403|NCT00558012|3635428|FG000|STARTED|Overall Study||89
2924404|NCT00558012|3635429|FG001|STARTED|Overall Study||92
2924405|NCT00558012|3635428|FG000|COMPLETED|Overall Study||64
2924406|NCT00558012|3635429|FG001|COMPLETED|Overall Study||74
2924407|NCT00558012|3635428|FG000|NOT COMPLETED|Overall Study||25
2924408|NCT00558012|3635429|FG001|NOT COMPLETED|Overall Study||18
2924409|NCT00558025|3635437|FG000|STARTED|Overall Study||104
2924410|NCT00558025|3635438|FG001|STARTED|Overall Study||52
2924411|NCT00558025|3635437|FG000|COMPLETED|Overall Study||100
2924412|NCT00558025|3635438|FG001|COMPLETED|Overall Study||49
2924413|NCT00558025|3635437|FG000|NOT COMPLETED|Overall Study||4
2924414|NCT00558025|3635438|FG001|NOT COMPLETED|Overall Study||3
2924415|NCT00558064|3635446|FG000|STARTED|Overall Study||269
2924416|NCT00558064|3635447|FG001|STARTED|Overall Study||262
2924417|NCT00558064|3635446|FG000|COMPLETED|Overall Study||264
2924418|NCT00558064|3635447|FG001|COMPLETED|Overall Study||257
2924419|NCT00558064|3635446|FG000|NOT COMPLETED|Overall Study||5
2924420|NCT00558064|3635447|FG001|NOT COMPLETED|Overall Study||5
2924421|NCT00558103|3635458|FG000|STARTED|Randomized Treatment Phase||38
2924422|NCT00558103|3635459|FG001|STARTED|Randomized Treatment Phase||38
2924423|NCT00558103|3635460|FG002|STARTED|Randomized Treatment Phase||36
3174021|NCT01953328|3901755|FG006|STARTED|Overall Study||51
3174022|NCT01953328|3901756|FG007|STARTED|Overall Study||51
3174023|NCT01953328|3901749|FG000|Received Treatment|Overall Study||49
3174024|NCT01953328|3901750|FG001|Received Treatment|Overall Study||50
3174025|NCT01953328|3901751|FG002|Received Treatment|Overall Study||50
3174026|NCT01953328|3901752|FG003|Received Treatment|Overall Study||50
3174027|NCT01953328|3901753|FG004|Received Treatment|Overall Study||52
3174028|NCT01953328|3901754|FG005|Received Treatment|Overall Study||51
3321602|NCT03177603|4054688|FG001|NOT COMPLETED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0
3321603|NCT03177603|4054689|FG002|NOT COMPLETED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0
3321604|NCT03177603|4054690|FG003|NOT COMPLETED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0
3321605|NCT03177603|4054687|FG000|STARTED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0
3321606|NCT03177603|4054688|FG001|STARTED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||5
3321607|NCT03177603|4054689|FG002|STARTED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0
3321608|NCT03177603|4054690|FG003|STARTED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0
3321609|NCT03177603|4054687|FG000|COMPLETED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0
3321610|NCT03177603|4054688|FG001|COMPLETED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||5
3321611|NCT03177603|4054689|FG002|COMPLETED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0
3321612|NCT03177603|4054690|FG003|COMPLETED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0
3321613|NCT03177603|4054687|FG000|NOT COMPLETED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0
3321614|NCT03177603|4054688|FG001|NOT COMPLETED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0
3321615|NCT03177603|4054689|FG002|NOT COMPLETED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0
3321616|NCT03177603|4054690|FG003|NOT COMPLETED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0
3321617|NCT03177603|4054687|FG000|STARTED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0
3321618|NCT03177603|4054688|FG001|STARTED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0
3321619|NCT03177603|4054689|FG002|STARTED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||6
3321620|NCT03177603|4054690|FG003|STARTED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0
3321621|NCT03177603|4054687|FG000|COMPLETED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0
3174029|NCT01953328|3901755|FG006|Received Treatment|Overall Study||51
3174030|NCT01953328|3901756|FG007|Received Treatment|Overall Study||51
3174031|NCT01953328|3901749|FG000|COMPLETED|Overall Study||49
3174032|NCT01953328|3901750|FG001|COMPLETED|Overall Study||50
3174033|NCT01953328|3901751|FG002|COMPLETED|Overall Study||50
3174034|NCT01953328|3901752|FG003|COMPLETED|Overall Study||50
2924424|NCT00558103|3635461|FG003|STARTED|Randomized Treatment Phase||13
2924425|NCT00558103|3635462|FG004|STARTED|Randomized Treatment Phase||38
2924426|NCT00558103|3635463|FG005|STARTED|Randomized Treatment Phase||0
2924427|NCT00558103|3635458|FG000|COMPLETED|Randomized Treatment Phase||33
2924428|NCT00558103|3635459|FG001|COMPLETED|Randomized Treatment Phase||34
2924429|NCT00558103|3635460|FG002|COMPLETED|Randomized Treatment Phase||33
2924430|NCT00558103|3635461|FG003|COMPLETED|Randomized Treatment Phase||11
2924431|NCT00558103|3635462|FG004|COMPLETED|Randomized Treatment Phase||33
2924432|NCT00558103|3635463|FG005|COMPLETED|Randomized Treatment Phase||0
2924433|NCT00558103|3635458|FG000|NOT COMPLETED|Randomized Treatment Phase||5
2924434|NCT00558103|3635459|FG001|NOT COMPLETED|Randomized Treatment Phase||4
2924435|NCT00558103|3635460|FG002|NOT COMPLETED|Randomized Treatment Phase||3
2924436|NCT00558103|3635461|FG003|NOT COMPLETED|Randomized Treatment Phase||2
2924437|NCT00558103|3635462|FG004|NOT COMPLETED|Randomized Treatment Phase||5
2924438|NCT00558103|3635463|FG005|NOT COMPLETED|Randomized Treatment Phase||0
2924439|NCT00558103|3635458|FG000|STARTED|Monotherapy Extension Phase||0
2924440|NCT00558103|3635459|FG001|STARTED|Monotherapy Extension Phase||0
2924441|NCT00558103|3635460|FG002|STARTED|Monotherapy Extension Phase||0
2924442|NCT00558103|3635461|FG003|STARTED|Monotherapy Extension Phase||0
2924443|NCT00558103|3635462|FG004|STARTED|Monotherapy Extension Phase||0
2924444|NCT00558103|3635463|FG005|STARTED|Monotherapy Extension Phase|9/11 participants completing pazopanib monotherapy elected to receive lapatinib monotherapy.|9
2924445|NCT00558103|3635458|FG000|COMPLETED|Monotherapy Extension Phase||0
2924446|NCT00558103|3635459|FG001|COMPLETED|Monotherapy Extension Phase||0
2924447|NCT00558103|3635460|FG002|COMPLETED|Monotherapy Extension Phase||0
2924448|NCT00558103|3635461|FG003|COMPLETED|Monotherapy Extension Phase||0
2924449|NCT00558103|3635462|FG004|COMPLETED|Monotherapy Extension Phase||0
2924450|NCT00558103|3635463|FG005|COMPLETED|Monotherapy Extension Phase||0
2924451|NCT00558103|3635458|FG000|NOT COMPLETED|Monotherapy Extension Phase||0
2924452|NCT00558103|3635459|FG001|NOT COMPLETED|Monotherapy Extension Phase||0
2924453|NCT00558103|3635460|FG002|NOT COMPLETED|Monotherapy Extension Phase||0
2924454|NCT00558103|3635461|FG003|NOT COMPLETED|Monotherapy Extension Phase||0
2924455|NCT00558103|3635462|FG004|NOT COMPLETED|Monotherapy Extension Phase||0
2924456|NCT00558103|3635463|FG005|NOT COMPLETED|Monotherapy Extension Phase||9
2924457|NCT00558246|3635476|FG000|STARTED|Overall Study||79
2924458|NCT00558246|3635476|FG000|COMPLETED|Overall Study||79
2924459|NCT00558246|3635476|FG000|NOT COMPLETED|Overall Study||0
2924460|NCT00558259|3635485|FG000|STARTED|Overall Study|Number who started treatment. There were 4 patients randomised to Dabigatran and not treated.|681
2924461|NCT00558259|3635486|FG001|STARTED|Overall Study|Number who started treatment. There were 6 patients randomised to placebo and not treated.|662
2924462|NCT00558259|3635485|FG000|COMPLETED|Overall Study|Completed treatment.|610
2924463|NCT00558259|3635486|FG001|COMPLETED|Overall Study|Completed treatment.|563
2924464|NCT00558259|3635485|FG000|NOT COMPLETED|Overall Study||71
2924465|NCT00558259|3635486|FG001|NOT COMPLETED|Overall Study||99
2924466|NCT00558272|3635494|FG000|STARTED|Overall Study|Randomised|69
2924467|NCT00558272|3635495|FG001|STARTED|Overall Study|Randomised|70
2924468|NCT00558272|3635494|FG000|30 Days Follow-up|Overall Study|30 days after last dose|41
2924469|NCT00558272|3635495|FG001|30 Days Follow-up|Overall Study|30 days after last dose|67
2924470|NCT00558272|3635494|FG000|COMPLETED|Overall Study|4-week treatment period|56
2924471|NCT00558272|3635495|FG001|COMPLETED|Overall Study|4-week treatment period|68
2924472|NCT00558272|3635494|FG000|NOT COMPLETED|Overall Study||13
2924473|NCT00558272|3635495|FG001|NOT COMPLETED|Overall Study||2
2924474|NCT00558285|3635506|FG000|STARTED|Overall Study||50
2924475|NCT00558285|3635507|FG001|STARTED|Overall Study||51
2924476|NCT00558285|3635508|FG002|STARTED|Overall Study||51
2924477|NCT00558285|3635509|FG003|STARTED|Overall Study||52
2924478|NCT00558285|3635510|FG004|STARTED|Overall Study||53
2924479|NCT00558285|3635506|FG000|Safety: Received Study Drug|Overall Study||49
2924480|NCT00558285|3635507|FG001|Safety: Received Study Drug|Overall Study||51
2924481|NCT00558285|3635508|FG002|Safety: Received Study Drug|Overall Study||51
2924482|NCT00558285|3635509|FG003|Safety: Received Study Drug|Overall Study||51
2924483|NCT00558285|3635510|FG004|Safety: Received Study Drug|Overall Study||53
2924484|NCT00558285|3635506|FG000|COMPLETED|Overall Study||44
2924485|NCT00558285|3635507|FG001|COMPLETED|Overall Study||48
2924486|NCT00558285|3635508|FG002|COMPLETED|Overall Study||46
2924487|NCT00558285|3635509|FG003|COMPLETED|Overall Study||48
2924488|NCT00558285|3635510|FG004|COMPLETED|Overall Study||49
2924489|NCT00558285|3635506|FG000|NOT COMPLETED|Overall Study||6
2924490|NCT00558285|3635507|FG001|NOT COMPLETED|Overall Study||3
2924491|NCT00558285|3635508|FG002|NOT COMPLETED|Overall Study||5
2924492|NCT00558285|3635509|FG003|NOT COMPLETED|Overall Study||4
2924493|NCT00558285|3635510|FG004|NOT COMPLETED|Overall Study||4
2924494|NCT00558363|3635524|FG000|STARTED|Overall Study||147
2924495|NCT00558363|3635525|FG001|STARTED|Overall Study||147
2924496|NCT00558363|3635524|FG000|COMPLETED|Overall Study||76
2924497|NCT00558363|3635525|FG001|COMPLETED|Overall Study||111
2924498|NCT00558363|3635524|FG000|NOT COMPLETED|Overall Study||71
2924499|NCT00558363|3635525|FG001|NOT COMPLETED|Overall Study||36
2924500|NCT00558428|3635535|FG000|STARTED|Overall Study||267
2924501|NCT00558428|3635536|FG001|STARTED|Overall Study||276
2924502|NCT00558428|3635537|FG002|STARTED|Overall Study||277
2924503|NCT00558428|3635538|FG003|STARTED|Overall Study||277
2924504|NCT00558428|3635535|FG000|COMPLETED|Overall Study||255
3174035|NCT01953328|3901753|FG004|COMPLETED|Overall Study||50
3174036|NCT01953328|3901754|FG005|COMPLETED|Overall Study||51
3174037|NCT01953328|3901755|FG006|COMPLETED|Overall Study||51
3174038|NCT01953328|3901756|FG007|COMPLETED|Overall Study||51
3174039|NCT01953328|3901749|FG000|NOT COMPLETED|Overall Study||0
3174040|NCT01953328|3901750|FG001|NOT COMPLETED|Overall Study||0
3174041|NCT01953328|3901751|FG002|NOT COMPLETED|Overall Study||0
3174042|NCT01953328|3901752|FG003|NOT COMPLETED|Overall Study||0
3174043|NCT01953328|3901753|FG004|NOT COMPLETED|Overall Study||2
3174044|NCT01953328|3901754|FG005|NOT COMPLETED|Overall Study||0
3174045|NCT01953328|3901755|FG006|NOT COMPLETED|Overall Study||0
3174046|NCT01953328|3901756|FG007|NOT COMPLETED|Overall Study||0
3174047|NCT01953354|3901776|FG000|STARTED|Overall Study||9
3174048|NCT01953354|3901777|FG001|STARTED|Overall Study||7
3174049|NCT01953354|3901776|FG000|COMPLETED|Overall Study||8
3174050|NCT01953354|3901777|FG001|COMPLETED|Overall Study||5
3174051|NCT01953354|3901776|FG000|NOT COMPLETED|Overall Study||1
3174052|NCT01953354|3901777|FG001|NOT COMPLETED|Overall Study||2
3174053|NCT01953432|3901785|FG000|STARTED|Overall Study||22
3174054|NCT01953432|3901786|FG001|STARTED|Overall Study||21
3039046|NCT01155726|3758345|FG001|COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||20
3174055|NCT01953432|3901785|FG000|COMPLETED|Overall Study||8
3174056|NCT01953432|3901786|FG001|COMPLETED|Overall Study||6
3174057|NCT01953432|3901785|FG000|NOT COMPLETED|Overall Study||14
3174058|NCT01953432|3901786|FG001|NOT COMPLETED|Overall Study||15
3174059|NCT01953575|3901795|FG000|STARTED|Overall Study||10
3174060|NCT01953575|3901796|FG001|STARTED|Overall Study||10
3174061|NCT01953575|3901797|FG002|STARTED|Overall Study||10
3321622|NCT03177603|4054688|FG001|COMPLETED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0
3321623|NCT03177603|4054689|FG002|COMPLETED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||6
3321624|NCT03177603|4054690|FG003|COMPLETED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0
3174062|NCT01953575|3901795|FG000|COMPLETED|Overall Study||10
3174063|NCT01953575|3901796|FG001|COMPLETED|Overall Study||10
3174064|NCT01953575|3901797|FG002|COMPLETED|Overall Study||10
3321625|NCT03177603|4054687|FG000|NOT COMPLETED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0
3321626|NCT03177603|4054688|FG001|NOT COMPLETED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0
3321627|NCT03177603|4054689|FG002|NOT COMPLETED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0
3321628|NCT03177603|4054690|FG003|NOT COMPLETED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0
3321629|NCT03177603|4054687|FG000|STARTED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0
3321630|NCT03177603|4054688|FG001|STARTED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0
3321631|NCT03177603|4054689|FG002|STARTED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0
3321632|NCT03177603|4054690|FG003|STARTED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||8
3321633|NCT03177603|4054687|FG000|COMPLETED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0
3321634|NCT03177603|4054688|FG001|COMPLETED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0
3321635|NCT03177603|4054689|FG002|COMPLETED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0
3321636|NCT03177603|4054690|FG003|COMPLETED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||8
3321637|NCT03177603|4054687|FG000|NOT COMPLETED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0
3321638|NCT03177603|4054688|FG001|NOT COMPLETED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0
3321639|NCT03177603|4054689|FG002|NOT COMPLETED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0
3321640|NCT03177603|4054690|FG003|NOT COMPLETED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0
3321641|NCT03177798|4054702|FG000|STARTED|Overall Study||5
3321642|NCT03177798|4054703|FG001|STARTED|Overall Study||6
3321643|NCT03177798|4054702|FG000|Intervention 1|Overall Study||5
3174065|NCT01953575|3901795|FG000|NOT COMPLETED|Overall Study||0
3174066|NCT01953575|3901796|FG001|NOT COMPLETED|Overall Study||0
3174067|NCT01953575|3901797|FG002|NOT COMPLETED|Overall Study||0
3174068|NCT01953601|3901808|FG000|STARTED|Part 1 (Base Study)||485
3174069|NCT01953601|3901809|FG001|STARTED|Part 1 (Base Study)||484
3174070|NCT01953601|3901810|FG002|STARTED|Part 1 (Base Study)||485
3174071|NCT01953601|3901808|FG000|Treated|Part 1 (Base Study)||483
3174072|NCT01953601|3901809|FG001|Treated|Part 1 (Base Study)||484
3174073|NCT01953601|3901810|FG002|Treated|Part 1 (Base Study)||484
3174074|NCT01953601|3901808|FG000|COMPLETED|Part 1 (Base Study)||234
3174075|NCT01953601|3901809|FG001|COMPLETED|Part 1 (Base Study)||231
3174076|NCT01953601|3901810|FG002|COMPLETED|Part 1 (Base Study)||239
3174077|NCT01953601|3901808|FG000|NOT COMPLETED|Part 1 (Base Study)||251
3321644|NCT03177798|4054703|FG001|Intervention 1|Overall Study||6
3321645|NCT03177798|4054702|FG000|Washout|Overall Study||5
3321646|NCT03177798|4054703|FG001|Washout|Overall Study||6
3321647|NCT03177798|4054702|FG000|Intervention 2|Overall Study||5
3321648|NCT03177798|4054703|FG001|Intervention 2|Overall Study||6
3321649|NCT03177798|4054702|FG000|COMPLETED|Overall Study||5
3321650|NCT03177798|4054703|FG001|COMPLETED|Overall Study||6
3321651|NCT03177798|4054702|FG000|NOT COMPLETED|Overall Study||0
3321652|NCT03177798|4054703|FG001|NOT COMPLETED|Overall Study||0
3321653|NCT03178045|4054713|FG000|STARTED|Overall Study||1396
3321654|NCT03178045|4054714|FG001|STARTED|Overall Study||1397
3321655|NCT03178045|4054713|FG000|COMPLETED|Overall Study||1310
3321656|NCT03178045|4054714|FG001|COMPLETED|Overall Study||1314
3321657|NCT03178045|4054713|FG000|NOT COMPLETED|Overall Study||86
3321658|NCT03178045|4054714|FG001|NOT COMPLETED|Overall Study||83
3321659|NCT03178266|4054723|FG000|STARTED|Overall Study||21
3321660|NCT03178266|4054724|FG001|STARTED|Overall Study||20
3321661|NCT03178266|4054723|FG000|COMPLETED|Overall Study||21
3321662|NCT03178266|4054724|FG001|COMPLETED|Overall Study||16
2924505|NCT00558428|3635536|FG001|COMPLETED|Overall Study||252
2924506|NCT00558428|3635537|FG002|COMPLETED|Overall Study||273
2924507|NCT00558428|3635538|FG003|COMPLETED|Overall Study||266
2924508|NCT00558428|3635535|FG000|NOT COMPLETED|Overall Study||12
2924509|NCT00558428|3635536|FG001|NOT COMPLETED|Overall Study||24
2924510|NCT00558428|3635537|FG002|NOT COMPLETED|Overall Study||4
2924511|NCT00558428|3635538|FG003|NOT COMPLETED|Overall Study||11
2924512|NCT00558467|3635550|FG000|STARTED|Overall Study||20
2924513|NCT00558467|3635551|FG001|STARTED|Overall Study||43
2924514|NCT00558467|3635550|FG000|COMPLETED|Overall Study||19
2924515|NCT00558467|3635551|FG001|COMPLETED|Overall Study||39
2924516|NCT00558467|3635550|FG000|NOT COMPLETED|Overall Study||1
2924517|NCT00558467|3635551|FG001|NOT COMPLETED|Overall Study||4
2924518|NCT00558519|3635557|FG000|STARTED|Overall Study||318
3039047|NCT01155726|3758346|FG002|COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||28
3039048|NCT01155726|3758347|FG003|COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||25
3039049|NCT01155726|3758344|FG000|NOT COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||0
3039050|NCT01155726|3758345|FG001|NOT COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||0
3039051|NCT01155726|3758346|FG002|NOT COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||0
3174078|NCT01953601|3901809|FG001|NOT COMPLETED|Part 1 (Base Study)||253
3174079|NCT01953601|3901810|FG002|NOT COMPLETED|Part 1 (Base Study)||246
3321663|NCT03178266|4054723|FG000|NOT COMPLETED|Overall Study||0
3321664|NCT03178266|4054724|FG001|NOT COMPLETED|Overall Study||4
3321665|NCT03178344|4054730|FG000|STARTED|First Session||10
3321666|NCT03178344|4054731|FG001|STARTED|First Session||10
3321667|NCT03178344|4054730|FG000|COMPLETED|First Session||10
3321668|NCT03178344|4054731|FG001|COMPLETED|First Session||10
3321669|NCT03178344|4054730|FG000|NOT COMPLETED|First Session||0
3321670|NCT03178344|4054731|FG001|NOT COMPLETED|First Session||0
3321671|NCT03178344|4054730|FG000|STARTED|Washout Period (5-9 Days)||10
3321672|NCT03178344|4054731|FG001|STARTED|Washout Period (5-9 Days)||10
3321673|NCT03178344|4054730|FG000|COMPLETED|Washout Period (5-9 Days)||10
2924519|NCT00558519|3635557|FG000|COMPLETED|Overall Study||295
2924520|NCT00558519|3635557|FG000|NOT COMPLETED|Overall Study||23
3321674|NCT03178344|4054731|FG001|COMPLETED|Washout Period (5-9 Days)||10
3321675|NCT03178344|4054730|FG000|NOT COMPLETED|Washout Period (5-9 Days)||0
3321676|NCT03178344|4054731|FG001|NOT COMPLETED|Washout Period (5-9 Days)||0
3321677|NCT03178344|4054730|FG000|STARTED|Second Session||10
3321678|NCT03178344|4054731|FG001|STARTED|Second Session||10
3321679|NCT03178344|4054730|FG000|COMPLETED|Second Session||10
3321680|NCT03178344|4054731|FG001|COMPLETED|Second Session||10
3321681|NCT03178344|4054730|FG000|NOT COMPLETED|Second Session||0
3321682|NCT03178344|4054731|FG001|NOT COMPLETED|Second Session||0
3321683|NCT03178487|4054739|FG000|STARTED|Overall Study||94
3321684|NCT03178487|4054740|FG001|STARTED|Overall Study||93
3321685|NCT03178487|4054739|FG000|Received Treatment|Overall Study||94
3321686|NCT03178487|4054740|FG001|Received Treatment|Overall Study||93
3321687|NCT03178487|4054739|FG000|COMPLETED|Overall Study||90
3321688|NCT03178487|4054740|FG001|COMPLETED|Overall Study||89
3321689|NCT03178487|4054739|FG000|NOT COMPLETED|Overall Study||4
3321690|NCT03178487|4054740|FG001|NOT COMPLETED|Overall Study||4
3321691|NCT03178669|4054751|FG000|STARTED|Overall Study||40
3321692|NCT03178669|4054752|FG001|STARTED|Overall Study||43
3321693|NCT03178669|4054753|FG002|STARTED|Overall Study||42
3321694|NCT03178669|4054754|FG003|STARTED|Overall Study||42
3321695|NCT03178669|4054755|FG004|STARTED|Overall Study||44
3321696|NCT03178669|4054751|FG000|Completed Week 6|Overall Study||35
3321697|NCT03178669|4054752|FG001|Completed Week 6|Overall Study||42
3321698|NCT03178669|4054753|FG002|Completed Week 6|Overall Study||36
3321699|NCT03178669|4054754|FG003|Completed Week 6|Overall Study||38
3321700|NCT03178669|4054755|FG004|Completed Week 6|Overall Study||42
3321701|NCT03178669|4054751|FG000|COMPLETED|Overall Study||35
3321702|NCT03178669|4054752|FG001|COMPLETED|Overall Study||42
3321703|NCT03178669|4054753|FG002|COMPLETED|Overall Study||35
3321704|NCT03178669|4054754|FG003|COMPLETED|Overall Study||38
3321705|NCT03178669|4054755|FG004|COMPLETED|Overall Study||40
3321706|NCT03178669|4054751|FG000|NOT COMPLETED|Overall Study||5
3321707|NCT03178669|4054752|FG001|NOT COMPLETED|Overall Study||1
3321708|NCT03178669|4054753|FG002|NOT COMPLETED|Overall Study||7
3174080|NCT01953601|3901808|FG000|STARTED|Part 2 (Extension Study)|Number started refers only to participants completing Part 1, volunteering to continue to Part 2.|198
3174081|NCT01953601|3901809|FG001|STARTED|Part 2 (Extension Study)|Number started refers only to participants completing Part 1, volunteering to continue to Part 2.|191
3174082|NCT01953601|3901810|FG002|STARTED|Part 2 (Extension Study)|Number started refers only to participants completing Part 1, volunteering to continue to Part 2.|204
3174083|NCT01953601|3901808|FG000|Treated|Part 2 (Extension Study)||197
3174084|NCT01953601|3901809|FG001|Treated|Part 2 (Extension Study)||191
3174085|NCT01953601|3901810|FG002|Treated|Part 2 (Extension Study)||204
2924521|NCT00558571|3635565|FG000|STARTED|Overall Study||16
2924522|NCT00558571|3635566|FG001|STARTED|Overall Study||16
2924523|NCT00558571|3635567|FG002|STARTED|Overall Study||16
2924524|NCT00558571|3635568|FG003|STARTED|Overall Study||30
2924525|NCT00558571|3635565|FG000|COMPLETED|Overall Study||16
2924526|NCT00558571|3635566|FG001|COMPLETED|Overall Study||16
2924527|NCT00558571|3635567|FG002|COMPLETED|Overall Study||16
2924528|NCT00558571|3635568|FG003|COMPLETED|Overall Study||30
2924529|NCT00558571|3635565|FG000|NOT COMPLETED|Overall Study||0
2924530|NCT00558571|3635566|FG001|NOT COMPLETED|Overall Study||0
2924531|NCT00558571|3635567|FG002|NOT COMPLETED|Overall Study||0
2924532|NCT00558571|3635568|FG003|NOT COMPLETED|Overall Study||0
2924533|NCT00558636|3635591|FG000|STARTED|Treatment|up to 6 cycles of combination therapy|47
2924534|NCT00558636|3635592|FG001|STARTED|Treatment||44
2924535|NCT00558636|3635591|FG000|Start of Maintenance Monotherapy|Treatment|Sorafenib taken as the single agent in the Maintenance Phase|2
2924536|NCT00558636|3635592|FG001|Start of Maintenance Monotherapy|Treatment|Placebo taken as the single agent in the Maintenance Phase|2
2924537|NCT00558636|3635591|FG000|COMPLETED|Treatment|Patients still on treatment did not enter follow-up because the study was prematurely terminated|0
2924538|NCT00558636|3635592|FG001|COMPLETED|Treatment|Patients still on treatment did not enter follow-up because the study was prematurely terminated|0
2924539|NCT00558636|3635591|FG000|NOT COMPLETED|Treatment||47
2924540|NCT00558636|3635592|FG001|NOT COMPLETED|Treatment||44
2924541|NCT00558636|3635591|FG000|STARTED|Follow-up|12 subjects entered Follow-up phase before they completed the treatment phase|12
2924542|NCT00558636|3635592|FG001|STARTED|Follow-up|7 subjects entered Follow-up phase before they completed the treatment phase|7
2924543|NCT00558636|3635591|FG000|COMPLETED|Follow-up|Study was prematurely terminated|0
2924544|NCT00558636|3635592|FG001|COMPLETED|Follow-up|Study was prematurely terminated|0
2924545|NCT00558636|3635591|FG000|NOT COMPLETED|Follow-up||12
2924546|NCT00558636|3635592|FG001|NOT COMPLETED|Follow-up||7
2924547|NCT00558701|3635600|FG000|STARTED|Overall Study||15
2924548|NCT00558701|3635601|FG001|STARTED|Overall Study||15
2924549|NCT00558701|3635600|FG000|COMPLETED|Overall Study||14
2924550|NCT00558701|3635601|FG001|COMPLETED|Overall Study||11
2924551|NCT00558701|3635600|FG000|NOT COMPLETED|Overall Study||1
3174086|NCT01953601|3901808|FG000|COMPLETED|Part 2 (Extension Study)||0
3174087|NCT01953601|3901809|FG001|COMPLETED|Part 2 (Extension Study)||0
3174088|NCT01953601|3901810|FG002|COMPLETED|Part 2 (Extension Study)||0
3174089|NCT01953601|3901808|FG000|NOT COMPLETED|Part 2 (Extension Study)||198
3174090|NCT01953601|3901809|FG001|NOT COMPLETED|Part 2 (Extension Study)||191
2924552|NCT00558701|3635601|FG001|NOT COMPLETED|Overall Study||4
2924553|NCT00558753|3635609|FG000|STARTED|Overall Study||120
2924554|NCT00558753|3635610|FG001|STARTED|Overall Study||120
2924555|NCT00558753|3635609|FG000|COMPLETED|Overall Study||115
2924556|NCT00558753|3635610|FG001|COMPLETED|Overall Study||113
2924557|NCT00558753|3635609|FG000|NOT COMPLETED|Overall Study||5
2924558|NCT00558753|3635610|FG001|NOT COMPLETED|Overall Study||7
2924559|NCT00558792|3635619|FG000|STARTED|Overall Study||68
2924560|NCT00558792|3635620|FG001|STARTED|Overall Study||63
2924561|NCT00558792|3635621|FG002|STARTED|Overall Study||60
2924562|NCT00558792|3635619|FG000|COMPLETED|Overall Study||68
2924563|NCT00558792|3635620|FG001|COMPLETED|Overall Study||63
2924564|NCT00558792|3635621|FG002|COMPLETED|Overall Study||60
2924565|NCT00558792|3635619|FG000|NOT COMPLETED|Overall Study||0
2924566|NCT00558792|3635620|FG001|NOT COMPLETED|Overall Study||0
2924567|NCT00558792|3635621|FG002|NOT COMPLETED|Overall Study||0
3039052|NCT01155726|3758347|FG003|NOT COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||0
3039053|NCT01155778|3758372|FG000|STARTED|Overall Study||4
3039054|NCT01155778|3758373|FG001|STARTED|Overall Study||4
3039055|NCT01155778|3758374|FG002|STARTED|Overall Study||4
3039056|NCT01155778|3758372|FG000|COMPLETED|Overall Study||4
3039057|NCT01155778|3758373|FG001|COMPLETED|Overall Study||4
3039058|NCT01155778|3758374|FG002|COMPLETED|Overall Study||4
3039059|NCT01155778|3758372|FG000|NOT COMPLETED|Overall Study||0
3039060|NCT01155778|3758373|FG001|NOT COMPLETED|Overall Study||0
3039061|NCT01155778|3758374|FG002|NOT COMPLETED|Overall Study||0
2924568|NCT00558831|3635632|FG000|STARTED|Overall Study||11
2924569|NCT00558831|3635632|FG000|COMPLETED|Overall Study||10
2924570|NCT00558831|3635632|FG000|NOT COMPLETED|Overall Study||1
2924571|NCT00558844|3635643|FG000|STARTED|Overall Study||15
2924572|NCT00558844|3635644|FG001|STARTED|Overall Study||7
2924573|NCT00558844|3635645|FG002|STARTED|Overall Study||7
2924574|NCT00558844|3635646|FG003|STARTED|Overall Study||5
2924575|NCT00558844|3635647|FG004|STARTED|Overall Study||7
2924576|NCT00558844|3635643|FG000|COMPLETED|Overall Study||12
2924577|NCT00558844|3635644|FG001|COMPLETED|Overall Study||7
2924578|NCT00558844|3635645|FG002|COMPLETED|Overall Study||6
2924579|NCT00558844|3635646|FG003|COMPLETED|Overall Study||5
2924580|NCT00558844|3635647|FG004|COMPLETED|Overall Study||6
2924581|NCT00558844|3635643|FG000|NOT COMPLETED|Overall Study||3
2924582|NCT00558844|3635644|FG001|NOT COMPLETED|Overall Study||0
2924583|NCT00558844|3635645|FG002|NOT COMPLETED|Overall Study||1
2924584|NCT00558844|3635646|FG003|NOT COMPLETED|Overall Study||0
2924585|NCT00558844|3635647|FG004|NOT COMPLETED|Overall Study||1
2924586|NCT00558896|3635667|FG000|STARTED|Overall Study||60
2924587|NCT00558896|3635668|FG001|STARTED|Overall Study||34
2924588|NCT00558896|3635669|FG002|STARTED|Overall Study||35
2924589|NCT00558896|3635670|FG003|STARTED|Overall Study||35
2924590|NCT00558896|3635671|FG004|STARTED|Overall Study||60
2924591|NCT00558896|3635672|FG005|STARTED|Overall Study||120
2924592|NCT00558896|3635673|FG006|STARTED|Overall Study||33
2924593|NCT00558896|3635667|FG000|COMPLETED|Overall Study||39
2924594|NCT00558896|3635668|FG001|COMPLETED|Overall Study||27
2924595|NCT00558896|3635669|FG002|COMPLETED|Overall Study||30
2924596|NCT00558896|3635670|FG003|COMPLETED|Overall Study||23
2924597|NCT00558896|3635671|FG004|COMPLETED|Overall Study||37
2924598|NCT00558896|3635672|FG005|COMPLETED|Overall Study||68
2924599|NCT00558896|3635673|FG006|COMPLETED|Overall Study||9
2924600|NCT00558896|3635667|FG000|NOT COMPLETED|Overall Study||21
2924601|NCT00558896|3635668|FG001|NOT COMPLETED|Overall Study||7
2924602|NCT00558896|3635669|FG002|NOT COMPLETED|Overall Study||5
2924603|NCT00558896|3635670|FG003|NOT COMPLETED|Overall Study||12
2924604|NCT00558896|3635671|FG004|NOT COMPLETED|Overall Study||23
2924605|NCT00558896|3635672|FG005|NOT COMPLETED|Overall Study||52
2924606|NCT00558896|3635673|FG006|NOT COMPLETED|Overall Study||24
2924607|NCT00559013|3635689|FG000|STARTED|Overall Study||38
2924608|NCT00559013|3635689|FG000|COMPLETED|Overall Study||38
2924609|NCT00559013|3635689|FG000|NOT COMPLETED|Overall Study||0
2924610|NCT00559104|3635695|FG000|STARTED|Overall Study||55
2924611|NCT00559104|3635696|FG001|STARTED|Overall Study||5
2924612|NCT00559104|3635695|FG000|COMPLETED|Overall Study|Progression was the reason for off-treatment for 9 of 9 patients who went off of treatment.|46
2924613|NCT00559104|3635696|FG001|COMPLETED|Overall Study||5
2924614|NCT00559104|3635695|FG000|NOT COMPLETED|Overall Study||9
2924615|NCT00559104|3635696|FG001|NOT COMPLETED|Overall Study||0
2924616|NCT00559273|3635704|FG000|STARTED|Correction Period (20 Weeks)||153
2924617|NCT00559273|3635705|FG001|STARTED|Correction Period (20 Weeks)||154
2924618|NCT00559273|3635704|FG000|Treated|Correction Period (20 Weeks)||151
2924619|NCT00559273|3635705|FG001|Treated|Correction Period (20 Weeks)||154
2924620|NCT00559273|3635704|FG000|COMPLETED|Correction Period (20 Weeks)||144
2924621|NCT00559273|3635705|FG001|COMPLETED|Correction Period (20 Weeks)||142
2924622|NCT00559273|3635704|FG000|NOT COMPLETED|Correction Period (20 Weeks)||9
2924623|NCT00559273|3635705|FG001|NOT COMPLETED|Correction Period (20 Weeks)||12
2924624|NCT00559273|3635704|FG000|STARTED|Evaluation Period (8 Weeks)||144
2924625|NCT00559273|3635705|FG001|STARTED|Evaluation Period (8 Weeks)||142
2924626|NCT00559273|3635704|FG000|COMPLETED|Evaluation Period (8 Weeks)||141
2924627|NCT00559273|3635705|FG001|COMPLETED|Evaluation Period (8 Weeks)||137
2924628|NCT00559273|3635704|FG000|NOT COMPLETED|Evaluation Period (8 Weeks)||3
2924629|NCT00559273|3635705|FG001|NOT COMPLETED|Evaluation Period (8 Weeks)||5
2924630|NCT00559364|3635713|FG000|STARTED|Overall Study||30
2924631|NCT00559364|3635714|FG001|STARTED|Overall Study||20
2924632|NCT00559364|3635713|FG000|COMPLETED|Overall Study||29
2924633|NCT00559364|3635714|FG001|COMPLETED|Overall Study||20
2924634|NCT00559364|3635713|FG000|NOT COMPLETED|Overall Study||1
2924635|NCT00559364|3635714|FG001|NOT COMPLETED|Overall Study||0
2924636|NCT00559377|3635720|FG000|STARTED|Overall Study||16
2924637|NCT00559377|3635720|FG000|COMPLETED|Overall Study||7
2924638|NCT00559377|3635720|FG000|NOT COMPLETED|Overall Study||9
2924639|NCT00559468|3635729|FG000|STARTED|Overall Study||26
2924640|NCT00559468|3635730|FG001|STARTED|Overall Study||26
2924641|NCT00559468|3635729|FG000|Treated|Overall Study||26
2924642|NCT00559468|3635730|FG001|Treated|Overall Study||25
2924643|NCT00559468|3635729|FG000|COMPLETED|Overall Study||26
2924644|NCT00559468|3635730|FG001|COMPLETED|Overall Study||25
2924645|NCT00559468|3635729|FG000|NOT COMPLETED|Overall Study||0
2924646|NCT00559468|3635730|FG001|NOT COMPLETED|Overall Study||1
2924647|NCT00559507|3635736|FG000|STARTED|Overall Study||12
2924648|NCT00559507|3635736|FG000|COMPLETED|Overall Study||9
2924649|NCT00559507|3635736|FG000|NOT COMPLETED|Overall Study||3
2924650|NCT00559585|3635742|FG000|STARTED|Double Blind ST Period Main Study|Randomized and treated|736
2924651|NCT00559585|3635743|FG001|STARTED|Double Blind ST Period Main Study|Randomized and treated|721
2924652|NCT00559585|3635742|FG000|COMPLETED|Double Blind ST Period Main Study||693
3321709|NCT03178669|4054754|FG003|NOT COMPLETED|Overall Study||4
3321710|NCT03178669|4054755|FG004|NOT COMPLETED|Overall Study||4
3321711|NCT03178773|4054769|FG000|STARTED|Overall Study||86
3321712|NCT03178773|4054770|FG001|STARTED|Overall Study||80
3321713|NCT03178773|4054769|FG000|3month Phone Follow up|Overall Study||49
3321714|NCT03178773|4054770|FG001|3month Phone Follow up|Overall Study||51
3321715|NCT03178773|4054769|FG000|6month in Person Follow up|Overall Study||54
3321716|NCT03178773|4054770|FG001|6month in Person Follow up|Overall Study||46
3321717|NCT03178773|4054769|FG000|9month Follow up Phone|Overall Study||36
3321718|NCT03178773|4054770|FG001|9month Follow up Phone|Overall Study||51
3321719|NCT03178773|4054769|FG000|COMPLETED|Overall Study||47
3321720|NCT03178773|4054770|FG001|COMPLETED|Overall Study||40
2924653|NCT00559585|3635743|FG001|COMPLETED|Double Blind ST Period Main Study||676
2924654|NCT00559585|3635742|FG000|NOT COMPLETED|Double Blind ST Period Main Study||43
2924655|NCT00559585|3635743|FG001|NOT COMPLETED|Double Blind ST Period Main Study||45
2924656|NCT00559585|3635742|FG000|STARTED|Anti-TNF Sub-Study in ST Period|7 completed Sub-Study ST period and 6 chose to roll over into LT Period.|8
2924657|NCT00559585|3635743|FG001|STARTED|Anti-TNF Sub-Study in ST Period|9 completed Sub-Study ST Period and 9 chose to over into the LT Period.|10
2924658|NCT00559585|3635742|FG000|COMPLETED|Anti-TNF Sub-Study in ST Period||7
2924659|NCT00559585|3635743|FG001|COMPLETED|Anti-TNF Sub-Study in ST Period||9
2924660|NCT00559585|3635742|FG000|NOT COMPLETED|Anti-TNF Sub-Study in ST Period||1
2924661|NCT00559585|3635743|FG001|NOT COMPLETED|Anti-TNF Sub-Study in ST Period||1
2924662|NCT00559585|3635742|FG000|STARTED|Open Label LT Period Main + Sub-Study|1373 includes 15 participants from ST Period Sub-Study who rolled over into LT Period (6 SC + 9 IV).|1373
2924663|NCT00559585|3635743|FG001|STARTED|Open Label LT Period Main + Sub-Study|IV administration was discontinued and abatacept was only administered SC during LT Period.|0
2924664|NCT00559585|3635742|FG000|COMPLETED|Open Label LT Period Main + Sub-Study||945
2924665|NCT00559585|3635743|FG001|COMPLETED|Open Label LT Period Main + Sub-Study||0
2924666|NCT00559585|3635742|FG000|NOT COMPLETED|Open Label LT Period Main + Sub-Study||428
2924667|NCT00559585|3635743|FG001|NOT COMPLETED|Open Label LT Period Main + Sub-Study||0
2924668|NCT00559637|3635760|FG000|STARTED|Overall Study||184
2924669|NCT00559637|3635760|FG000|COMPLETED|Overall Study||130
2924670|NCT00559637|3635760|FG000|NOT COMPLETED|Overall Study||54
2924671|NCT00559754|3635764|FG000|STARTED|Overall Study||72
2924672|NCT00559754|3635764|FG000|COMPLETED|Overall Study||61
2924673|NCT00559754|3635764|FG000|NOT COMPLETED|Overall Study||11
2924674|NCT00559845|3635768|FG000|STARTED|Overall Study||56
2924675|NCT00559845|3635768|FG000|COMPLETED|Overall Study||49
2924676|NCT00559845|3635768|FG000|NOT COMPLETED|Overall Study||7
2924677|NCT00559936|3635772|FG000|STARTED|Overall Study||24
2924678|NCT00559936|3635772|FG000|COMPLETED|Overall Study||20
2924679|NCT00559936|3635772|FG000|NOT COMPLETED|Overall Study||4
2924680|NCT00559949|3635776|FG000|STARTED|Overall Study||39
3174091|NCT01953601|3901810|FG002|NOT COMPLETED|Part 2 (Extension Study)||204
3174092|NCT01953692|3901830|FG000|STARTED|Overall Study||28
3174093|NCT01953692|3901831|FG001|STARTED|Overall Study||30
3174094|NCT01953692|3901832|FG002|STARTED|Overall Study||31
3174095|NCT01953692|3901833|FG003|STARTED|Overall Study||21
3174096|NCT01953692|3901834|FG004|STARTED|Overall Study||4
3174097|NCT01953692|3901835|FG005|STARTED|Overall Study||22
2924681|NCT00559949|3635776|FG000|COMPLETED|Overall Study||32
2924682|NCT00559949|3635776|FG000|NOT COMPLETED|Overall Study||7
2924683|NCT00559962|3635788|FG000|STARTED|Overall Study||33
2924684|NCT00559962|3635789|FG001|STARTED|Overall Study||34
2924685|NCT00559962|3635790|FG002|STARTED|Overall Study||34
2924686|NCT00559962|3635791|FG003|STARTED|Overall Study||34
2924687|NCT00559962|3635792|FG004|STARTED|Overall Study||35
2924688|NCT00559962|3635793|FG005|STARTED|Overall Study||28
2924689|NCT00559962|3635794|FG006|STARTED|Overall Study||33
2924690|NCT00559962|3635795|FG007|STARTED|Overall Study||29
2924691|NCT00559962|3635788|FG000|COMPLETED|Overall Study||31
2924692|NCT00559962|3635789|FG001|COMPLETED|Overall Study||25
2924693|NCT00559962|3635790|FG002|COMPLETED|Overall Study||24
2924694|NCT00559962|3635791|FG003|COMPLETED|Overall Study||29
2924695|NCT00559962|3635792|FG004|COMPLETED|Overall Study||21
2924696|NCT00559962|3635793|FG005|COMPLETED|Overall Study||23
2924697|NCT00559962|3635794|FG006|COMPLETED|Overall Study||28
2924698|NCT00559962|3635795|FG007|COMPLETED|Overall Study||25
2924699|NCT00559962|3635788|FG000|NOT COMPLETED|Overall Study||2
2924700|NCT00559962|3635789|FG001|NOT COMPLETED|Overall Study||9
2924701|NCT00559962|3635790|FG002|NOT COMPLETED|Overall Study||10
2924702|NCT00559962|3635791|FG003|NOT COMPLETED|Overall Study||5
2924703|NCT00559962|3635792|FG004|NOT COMPLETED|Overall Study||14
2924704|NCT00559962|3635793|FG005|NOT COMPLETED|Overall Study||5
2924705|NCT00559962|3635794|FG006|NOT COMPLETED|Overall Study||5
2924706|NCT00559962|3635795|FG007|NOT COMPLETED|Overall Study||4
2924707|NCT00559988|3635816|FG000|STARTED|Overall Study||1357
2924708|NCT00559988|3635817|FG001|STARTED|Overall Study||1361
2924709|NCT00559988|3635816|FG000|COMPLETED|Overall Study||1006
2924710|NCT00559988|3635817|FG001|COMPLETED|Overall Study||1009
3039062|NCT01155830|3758385|FG000|STARTED|Overall Study||0
3039063|NCT01155830|3758386|FG001|STARTED|Overall Study||0
3039064|NCT01155830|3758387|FG002|STARTED|Overall Study||21
3039065|NCT01155830|3758385|FG000|COMPLETED|Overall Study||0
3039066|NCT01155830|3758386|FG001|COMPLETED|Overall Study||0
3039067|NCT01155830|3758387|FG002|COMPLETED|Overall Study||21
3039068|NCT01155830|3758385|FG000|NOT COMPLETED|Overall Study||0
3039069|NCT01155830|3758386|FG001|NOT COMPLETED|Overall Study||0
3039070|NCT01155830|3758387|FG002|NOT COMPLETED|Overall Study||0
3039071|NCT01155869|3758397|FG000|STARTED|Overall Study||3
3039072|NCT01155869|3758398|FG001|STARTED|Overall Study||4
3039073|NCT01155869|3758397|FG000|COMPLETED|Overall Study||0
3039074|NCT01155869|3758398|FG001|COMPLETED|Overall Study||3
3039075|NCT01155869|3758397|FG000|NOT COMPLETED|Overall Study||3
3039076|NCT01155869|3758398|FG001|NOT COMPLETED|Overall Study||1
2924711|NCT00559988|3635816|FG000|NOT COMPLETED|Overall Study||351
3039077|NCT01155999|3758406|FG000|STARTED|Overall Study||146
3039078|NCT01155999|3758407|FG001|STARTED|Overall Study||140
3039079|NCT01155999|3758406|FG000|COMPLETED|Overall Study||139
3039080|NCT01155999|3758407|FG001|COMPLETED|Overall Study||136
3174098|NCT01953692|3901836|FG006|STARTED|Overall Study||42
3174099|NCT01953692|3901837|FG007|STARTED|Overall Study||13
3174100|NCT01953692|3901838|FG008|STARTED|Overall Study||6
3321721|NCT03178773|4054769|FG000|NOT COMPLETED|Overall Study||39
3321722|NCT03178773|4054770|FG001|NOT COMPLETED|Overall Study||40
3321723|NCT03178851|4054780|FG000|STARTED|Overall Study||92
3136968|NCT01716520|3862279|FG001|NOT COMPLETED|Treatment Period 1 (14 Days)||1
3136969|NCT01716520|3862280|FG002|NOT COMPLETED|Treatment Period 1 (14 Days)||2
3136970|NCT01716520|3862281|FG003|NOT COMPLETED|Treatment Period 1 (14 Days)||1
3136971|NCT01716520|3862282|FG004|NOT COMPLETED|Treatment Period 1 (14 Days)||0
3136972|NCT01716520|3862283|FG005|NOT COMPLETED|Treatment Period 1 (14 Days)||1
3136973|NCT01716520|3862278|FG000|STARTED|Washout Period 1 (10 to 14 Days)||29
3136974|NCT01716520|3862279|FG001|STARTED|Washout Period 1 (10 to 14 Days)||29
3136975|NCT01716520|3862280|FG002|STARTED|Washout Period 1 (10 to 14 Days)||28
3136976|NCT01716520|3862281|FG003|STARTED|Washout Period 1 (10 to 14 Days)||29
3136977|NCT01716520|3862282|FG004|STARTED|Washout Period 1 (10 to 14 Days)||31
3136978|NCT01716520|3862283|FG005|STARTED|Washout Period 1 (10 to 14 Days)||29
3174101|NCT01953692|3901830|FG000|COMPLETED|Overall Study||1
3174102|NCT01953692|3901831|FG001|COMPLETED|Overall Study||5
3174103|NCT01953692|3901832|FG002|COMPLETED|Overall Study||11
3174104|NCT01953692|3901833|FG003|COMPLETED|Overall Study||7
3174105|NCT01953692|3901834|FG004|COMPLETED|Overall Study||1
3174106|NCT01953692|3901835|FG005|COMPLETED|Overall Study||4
2924712|NCT00559988|3635817|FG001|NOT COMPLETED|Overall Study||352
2924713|NCT00560066|3635825|FG000|STARTED|Overall Study||396
2924714|NCT00560066|3635826|FG001|STARTED|Overall Study||1002
2924715|NCT00560066|3635825|FG000|COMPLETED|Overall Study||390
2924716|NCT00560066|3635826|FG001|COMPLETED|Overall Study||980
2924717|NCT00560066|3635825|FG000|NOT COMPLETED|Overall Study||6
2924718|NCT00560066|3635826|FG001|NOT COMPLETED|Overall Study||22
2924719|NCT00560105|3635839|FG000|STARTED|Overall Study||20
2924720|NCT00560105|3635840|FG001|STARTED|Overall Study||20
2924721|NCT00560105|3635839|FG000|COMPLETED|Overall Study||19
2924722|NCT00560105|3635840|FG001|COMPLETED|Overall Study||18
2924723|NCT00560105|3635839|FG000|NOT COMPLETED|Overall Study||1
2924724|NCT00560105|3635840|FG001|NOT COMPLETED|Overall Study||2
2924725|NCT00560235|3635849|FG000|STARTED|Phase 1||10
2924726|NCT00560235|3635850|FG001|STARTED|Phase 1||0
2924727|NCT00560235|3635851|FG002|STARTED|Phase 1||0
2924728|NCT00560235|3635849|FG000|COMPLETED|Phase 1||2
2924729|NCT00560235|3635850|FG001|COMPLETED|Phase 1||0
2924730|NCT00560235|3635851|FG002|COMPLETED|Phase 1||0
2924731|NCT00560235|3635849|FG000|NOT COMPLETED|Phase 1||8
2924732|NCT00560235|3635850|FG001|NOT COMPLETED|Phase 1||0
2924733|NCT00560235|3635851|FG002|NOT COMPLETED|Phase 1||0
2924734|NCT00560235|3635849|FG000|STARTED|Phase 1B||0
2924735|NCT00560235|3635850|FG001|STARTED|Phase 1B||21
2924736|NCT00560235|3635851|FG002|STARTED|Phase 1B||0
2924737|NCT00560235|3635849|FG000|COMPLETED|Phase 1B||0
2924738|NCT00560235|3635850|FG001|COMPLETED|Phase 1B||2
2924739|NCT00560235|3635851|FG002|COMPLETED|Phase 1B||0
2924740|NCT00560235|3635849|FG000|NOT COMPLETED|Phase 1B||0
2924741|NCT00560235|3635850|FG001|NOT COMPLETED|Phase 1B||19
2924742|NCT00560235|3635851|FG002|NOT COMPLETED|Phase 1B||0
2924743|NCT00560235|3635849|FG000|STARTED|Phase 2||0
2924744|NCT00560235|3635850|FG001|STARTED|Phase 2||0
2924745|NCT00560235|3635851|FG002|STARTED|Phase 2||107
2924746|NCT00560235|3635849|FG000|COMPLETED|Phase 2||0
2924747|NCT00560235|3635850|FG001|COMPLETED|Phase 2||0
2924748|NCT00560235|3635851|FG002|COMPLETED|Phase 2||10
2924749|NCT00560235|3635849|FG000|NOT COMPLETED|Phase 2||0
2924750|NCT00560235|3635850|FG001|NOT COMPLETED|Phase 2||0
2924751|NCT00560235|3635851|FG002|NOT COMPLETED|Phase 2||97
2924752|NCT00560313|3635869|FG000|STARTED|Overall Study||54
2924753|NCT00560313|3635869|FG000|COMPLETED|Overall Study||48
2924754|NCT00560313|3635869|FG000|NOT COMPLETED|Overall Study||6
2924755|NCT00560352|3635891|FG000|STARTED|Overall Study||7
2924756|NCT00560352|3635892|FG001|STARTED|Overall Study||3
2924757|NCT00560352|3635893|FG002|STARTED|Overall Study||4
2924758|NCT00560352|3635891|FG000|COMPLETED|Overall Study||0
2924759|NCT00560352|3635892|FG001|COMPLETED|Overall Study||0
3321724|NCT03178851|4054781|FG001|STARTED|Overall Study||11
3321725|NCT03178851|4054782|FG002|STARTED|Overall Study||52
3321726|NCT03178851|4054780|FG000|COMPLETED|Overall Study||0
3321727|NCT03178851|4054781|FG001|COMPLETED|Overall Study||0
3321728|NCT03178851|4054782|FG002|COMPLETED|Overall Study||0
3321729|NCT03178851|4054780|FG000|NOT COMPLETED|Overall Study||92
3321730|NCT03178851|4054781|FG001|NOT COMPLETED|Overall Study||11
3321731|NCT03178851|4054782|FG002|NOT COMPLETED|Overall Study||52
3321732|NCT03178942|4054793|FG000|STARTED|Overall Study||129
3321733|NCT03178942|4054794|FG001|STARTED|Overall Study||125
3321734|NCT03178942|4054793|FG000|COMPLETED|Overall Study||126
3321735|NCT03178942|4054794|FG001|COMPLETED|Overall Study||123
3321736|NCT03178942|4054793|FG000|NOT COMPLETED|Overall Study||3
2924760|NCT00560352|3635893|FG002|COMPLETED|Overall Study||0
2924761|NCT00560352|3635891|FG000|NOT COMPLETED|Overall Study||7
2924762|NCT00560352|3635892|FG001|NOT COMPLETED|Overall Study||3
2924763|NCT00560352|3635893|FG002|NOT COMPLETED|Overall Study||4
3039081|NCT01155999|3758406|FG000|NOT COMPLETED|Overall Study||7
3174107|NCT01953692|3901836|FG006|COMPLETED|Overall Study||10
3174108|NCT01953692|3901837|FG007|COMPLETED|Overall Study||3
3174109|NCT01953692|3901838|FG008|COMPLETED|Overall Study||1
2924764|NCT00560391|3635910|FG000|STARTED|Overall Study|Participants who received treatment|6
2924765|NCT00560391|3635911|FG001|STARTED|Overall Study|Participants who received treatment|3
2924766|NCT00560391|3635912|FG002|STARTED|Overall Study|Participants who received treatment|3
2924767|NCT00560391|3635913|FG003|STARTED|Overall Study|Participants who received treatment|6
2924768|NCT00560391|3635914|FG004|STARTED|Overall Study|Participants who received treatment|17
2924769|NCT00560391|3635910|FG000|COMPLETED|Overall Study|Completed=off treatment;Disease progression-1;Death-1;Max. clinical benefit-2;Study drug toxicity-2|6
2924770|NCT00560391|3635911|FG001|COMPLETED|Overall Study|Completed=off treatment; Disease progression-1;Death-1; Unrelated AE-1|3
2924771|NCT00560391|3635912|FG002|COMPLETED|Overall Study|Completed=off treatment; Disease progression-1;Maximum clinical benefit-1; Unrelated AE-1|3
2924772|NCT00560391|3635913|FG003|COMPLETED|Overall Study|Completed=off treatment; Disease progression-2; Unrelated AE 1 and Subject request 2|5
2924773|NCT00560391|3635914|FG004|COMPLETED|Overall Study|Completed=offtreatment;Disease progression-6;Study drug toxicity-7; Unrelated AE-1,Subject request-1|15
2924774|NCT00560391|3635910|FG000|NOT COMPLETED|Overall Study||0
2924775|NCT00560391|3635911|FG001|NOT COMPLETED|Overall Study||0
2924776|NCT00560391|3635912|FG002|NOT COMPLETED|Overall Study||0
2924777|NCT00560391|3635913|FG003|NOT COMPLETED|Overall Study||1
2924778|NCT00560391|3635914|FG004|NOT COMPLETED|Overall Study||2
2924779|NCT00560404|3635929|FG000|STARTED|Overall Study||112
2924780|NCT00560404|3635930|FG001|STARTED|Overall Study||121
2924781|NCT00560404|3635929|FG000|COMPLETED|Overall Study||76
2924782|NCT00560404|3635930|FG001|COMPLETED|Overall Study||100
2924783|NCT00560404|3635929|FG000|NOT COMPLETED|Overall Study||36
2924784|NCT00560404|3635930|FG001|NOT COMPLETED|Overall Study||21
2924785|NCT00560417|3635938|FG000|STARTED|Overall Study||171
2924786|NCT00560417|3635939|FG001|STARTED|Overall Study||168
2924787|NCT00560417|3635938|FG000|Intention to Treat (ITT) Population|Overall Study||170
2924788|NCT00560417|3635939|FG001|Intention to Treat (ITT) Population|Overall Study||167
2924789|NCT00560417|3635938|FG000|COMPLETED|Overall Study||154
3321737|NCT03178942|4054794|FG001|NOT COMPLETED|Overall Study||2
3321738|NCT03179319|4054802|FG000|STARTED|Overall Study||40
3321739|NCT03179319|4054803|FG001|STARTED|Overall Study||20
3321740|NCT03179319|4054802|FG000|3 Month Visit|Overall Study||37
3321741|NCT03179319|4054803|FG001|3 Month Visit|Overall Study||20
3321742|NCT03179319|4054802|FG000|COMPLETED|Overall Study||34
3321743|NCT03179319|4054803|FG001|COMPLETED|Overall Study||20
3321744|NCT03179319|4054802|FG000|NOT COMPLETED|Overall Study||6
3321745|NCT03179319|4054803|FG001|NOT COMPLETED|Overall Study||0
3321746|NCT03179345|4054813|FG000|STARTED|Overall Study||8
3321747|NCT03179345|4054814|FG001|STARTED|Overall Study||8
3321748|NCT03179345|4054815|FG002|STARTED|Overall Study||8
3321749|NCT03179345|4054816|FG003|STARTED|Overall Study||8
3321750|NCT03179345|4054813|FG000|Received Gralise®|Overall Study||8
3321751|NCT03179345|4054814|FG001|Received Gralise®|Overall Study||7
3321752|NCT03179345|4054815|FG002|Received Gralise®|Overall Study||7
3321753|NCT03179345|4054816|FG003|Received Gralise®|Overall Study||6
3321754|NCT03179345|4054813|FG000|Received Neurontin®|Overall Study||8
3321755|NCT03179345|4054814|FG001|Received Neurontin®|Overall Study||8
3321756|NCT03179345|4054815|FG002|Received Neurontin®|Overall Study||7
3321757|NCT03179345|4054816|FG003|Received Neurontin®|Overall Study||8
3321758|NCT03179345|4054813|FG000|Received Lyrica®|Overall Study||8
3321759|NCT03179345|4054814|FG001|Received Lyrica®|Overall Study||7
3321760|NCT03179345|4054815|FG002|Received Lyrica®|Overall Study||8
3174110|NCT01953692|3901830|FG000|NOT COMPLETED|Overall Study||27
3174111|NCT01953692|3901831|FG001|NOT COMPLETED|Overall Study||25
3174112|NCT01953692|3901832|FG002|NOT COMPLETED|Overall Study||20
3174113|NCT01953692|3901833|FG003|NOT COMPLETED|Overall Study||14
3174114|NCT01953692|3901834|FG004|NOT COMPLETED|Overall Study||3
3174115|NCT01953692|3901835|FG005|NOT COMPLETED|Overall Study||18
3174116|NCT01953692|3901836|FG006|NOT COMPLETED|Overall Study||32
3174117|NCT01953692|3901837|FG007|NOT COMPLETED|Overall Study||10
3174118|NCT01953692|3901838|FG008|NOT COMPLETED|Overall Study||5
3174119|NCT01953783|3901868|FG000|STARTED|Overall Study||7
3174120|NCT01953783|3901868|FG000|COMPLETED|Overall Study||5
3174121|NCT01953783|3901868|FG000|NOT COMPLETED|Overall Study||2
3174122|NCT01953874|3901874|FG000|STARTED|Overall Study||65
3321761|NCT03179345|4054816|FG003|Received Lyrica®|Overall Study||8
3174123|NCT01953874|3901875|FG001|STARTED|Overall Study||61
3321762|NCT03179345|4054813|FG000|Received Placebo|Overall Study||8
3321763|NCT03179345|4054814|FG001|Received Placebo|Overall Study||7
3321764|NCT03179345|4054815|FG002|Received Placebo|Overall Study||7
2924790|NCT00560417|3635939|FG001|COMPLETED|Overall Study||151
2924791|NCT00560417|3635938|FG000|NOT COMPLETED|Overall Study||17
2924792|NCT00560417|3635939|FG001|NOT COMPLETED|Overall Study||17
2924793|NCT00560508|3635947|FG000|STARTED|12 Week Double-blind Period||56
2924794|NCT00560508|3635948|FG001|STARTED|12 Week Double-blind Period||56
2924795|NCT00560508|3635947|FG000|COMPLETED|12 Week Double-blind Period||51
2924796|NCT00560508|3635948|FG001|COMPLETED|12 Week Double-blind Period||53
2924797|NCT00560508|3635947|FG000|NOT COMPLETED|12 Week Double-blind Period||5
2924798|NCT00560508|3635948|FG001|NOT COMPLETED|12 Week Double-blind Period||3
2924799|NCT00560508|3635947|FG000|STARTED|52-week Open-label Period Pramipexole ER|all patients received Pramipexole ER for the 52-week open-label period|51
2924800|NCT00560508|3635948|FG001|STARTED|52-week Open-label Period Pramipexole ER|all patients received Pramipexole ER for the 52-week open-label period|53
2924801|NCT00560508|3635947|FG000|COMPLETED|52-week Open-label Period Pramipexole ER||43
2924802|NCT00560508|3635948|FG001|COMPLETED|52-week Open-label Period Pramipexole ER||42
2924803|NCT00560508|3635947|FG000|NOT COMPLETED|52-week Open-label Period Pramipexole ER||8
2924804|NCT00560508|3635948|FG001|NOT COMPLETED|52-week Open-label Period Pramipexole ER||11
2924805|NCT00560560|3635961|FG000|STARTED|Overall Study||85
2924806|NCT00560560|3635962|FG001|STARTED|Overall Study||83
2924807|NCT00560560|3635961|FG000|COMPLETED|Overall Study||0
2924808|NCT00560560|3635962|FG001|COMPLETED|Overall Study||0
2924809|NCT00560560|3635961|FG000|NOT COMPLETED|Overall Study||85
2924810|NCT00560560|3635962|FG001|NOT COMPLETED|Overall Study||83
3174124|NCT01953874|3901874|FG000|COMPLETED|Overall Study||65
3174125|NCT01953874|3901875|FG001|COMPLETED|Overall Study||61
3174126|NCT01953874|3901874|FG000|NOT COMPLETED|Overall Study||0
3174127|NCT01953874|3901875|FG001|NOT COMPLETED|Overall Study||0
3174128|NCT01953913|3901882|FG000|STARTED|Overall Study||542
3174129|NCT01953913|3901882|FG000|Treated|Overall Study||541
3174130|NCT01953913|3901882|FG000|COMPLETED|Overall Study||0
3174131|NCT01953913|3901882|FG000|NOT COMPLETED|Overall Study||542
3174132|NCT01954017|3901889|FG000|STARTED|Overall Study||36
3174133|NCT01954017|3901890|FG001|STARTED|Overall Study||33
3174134|NCT01954017|3901891|FG002|STARTED|Overall Study||34
3174135|NCT01954017|3901889|FG000|COMPLETED|Overall Study||31
3174136|NCT01954017|3901890|FG001|COMPLETED|Overall Study||25
3174137|NCT01954017|3901891|FG002|COMPLETED|Overall Study||21
3174138|NCT01954017|3901889|FG000|NOT COMPLETED|Overall Study||5
3174139|NCT01954017|3901890|FG001|NOT COMPLETED|Overall Study||8
3174140|NCT01954017|3901891|FG002|NOT COMPLETED|Overall Study||13
3174141|NCT01954056|3901927|FG000|STARTED|Birth to 60 Days of Life||6
3174142|NCT01954056|3901928|FG001|STARTED|Birth to 60 Days of Life||6
3174143|NCT01954056|3901927|FG000|COMPLETED|Birth to 60 Days of Life||6
3174144|NCT01954056|3901928|FG001|COMPLETED|Birth to 60 Days of Life||6
3174145|NCT01954056|3901927|FG000|NOT COMPLETED|Birth to 60 Days of Life||0
3174146|NCT01954056|3901928|FG001|NOT COMPLETED|Birth to 60 Days of Life||0
3174147|NCT01954056|3901927|FG000|STARTED|Birth to 22-26 Mos. Corrected GA||6
3174148|NCT01954056|3901928|FG001|STARTED|Birth to 22-26 Mos. Corrected GA||6
3174149|NCT01954056|3901927|FG000|COMPLETED|Birth to 22-26 Mos. Corrected GA||5
3174150|NCT01954056|3901928|FG001|COMPLETED|Birth to 22-26 Mos. Corrected GA||6
3174151|NCT01954056|3901927|FG000|NOT COMPLETED|Birth to 22-26 Mos. Corrected GA||1
3174152|NCT01954056|3901928|FG001|NOT COMPLETED|Birth to 22-26 Mos. Corrected GA||0
3174153|NCT01954082|3901936|FG000|STARTED|Overall Study||317
3174154|NCT01954082|3901937|FG001|STARTED|Overall Study||321
3174155|NCT01954082|3901936|FG000|Treated|Overall Study|The 4 participants who were not treated either died (3) or withdrew before treatment start (1).|313
3174156|NCT01954082|3901937|FG001|Treated|Overall Study|The 2 participants who were not treated died before treatment start.|319
3174157|NCT01954082|3901936|FG000|COMPLETED|Overall Study|There were 22 infants that received more doses than intended per protocol.|249
3321765|NCT03179345|4054816|FG003|Received Placebo|Overall Study||8
3321766|NCT03179345|4054813|FG000|COMPLETED|Overall Study||8
3321767|NCT03179345|4054814|FG001|COMPLETED|Overall Study||7
3321768|NCT03179345|4054815|FG002|COMPLETED|Overall Study||7
3321769|NCT03179345|4054816|FG003|COMPLETED|Overall Study||6
3321770|NCT03179345|4054813|FG000|NOT COMPLETED|Overall Study||0
2924811|NCT00560573|3635968|FG000|STARTED|Overall Study||6
2924812|NCT00560573|3635969|FG001|STARTED|Overall Study||3
2924813|NCT00560573|3635970|FG002|STARTED|Overall Study||6
2924814|NCT00560573|3635971|FG003|STARTED|Overall Study||10
2924815|NCT00560573|3635972|FG004|STARTED|Overall Study||8
2924816|NCT00560573|3635973|FG005|STARTED|Overall Study||13
2924817|NCT00560573|3635968|FG000|Treated|Overall Study||6
2924818|NCT00560573|3635969|FG001|Treated|Overall Study||3
2924819|NCT00560573|3635970|FG002|Treated|Overall Study||6
2924820|NCT00560573|3635971|FG003|Treated|Overall Study||10
2924821|NCT00560573|3635972|FG004|Treated|Overall Study||7
2924822|NCT00560573|3635973|FG005|Treated|Overall Study||13
2924823|NCT00560573|3635968|FG000|COMPLETED|Overall Study||0
3174158|NCT01954082|3901937|FG001|COMPLETED|Overall Study|There were 27 infants that received more doses than intended per protocol.|264
3174159|NCT01954082|3901936|FG000|NOT COMPLETED|Overall Study||68
3174160|NCT01954082|3901937|FG001|NOT COMPLETED|Overall Study||57
3174161|NCT01954121|3901945|FG000|STARTED|Overall Study||220
3174162|NCT01954121|3901946|FG001|STARTED|Overall Study||216
3174163|NCT01954121|3901945|FG000|COMPLETED|Overall Study||93
3174164|NCT01954121|3901946|FG001|COMPLETED|Overall Study||125
3174165|NCT01954121|3901945|FG000|NOT COMPLETED|Overall Study||127
3174166|NCT01954121|3901946|FG001|NOT COMPLETED|Overall Study||91
3174167|NCT01954251|3901954|FG000|STARTED|Overall Study||413
3174168|NCT01954251|3901955|FG001|STARTED|Overall Study||415
3174169|NCT01954251|3901954|FG000|COMPLETED|Overall Study||400
3174170|NCT01954251|3901955|FG001|COMPLETED|Overall Study||396
3174171|NCT01954251|3901954|FG000|NOT COMPLETED|Overall Study||13
3174172|NCT01954251|3901955|FG001|NOT COMPLETED|Overall Study||19
3174173|NCT01954264|3901962|FG000|STARTED|Overall Study||2421
3174174|NCT01954264|3901962|FG000|COMPLETED|Overall Study||2421
3174175|NCT01954264|3901962|FG000|NOT COMPLETED|Overall Study||0
3174176|NCT01954342|3901983|FG000|STARTED|Overall Study||36
3174177|NCT01954342|3901984|FG001|STARTED|Overall Study||8
3174178|NCT01954342|3901985|FG002|STARTED|Overall Study||10
3321771|NCT03179345|4054814|FG001|NOT COMPLETED|Overall Study||1
3321772|NCT03179345|4054815|FG002|NOT COMPLETED|Overall Study||1
3321773|NCT03179345|4054816|FG003|NOT COMPLETED|Overall Study||2
3321774|NCT03179410|4054832|FG000|STARTED|Overall Study||15
3321775|NCT03179410|4054832|FG000|COMPLETED|Overall Study||15
3321776|NCT03179410|4054832|FG000|NOT COMPLETED|Overall Study||0
2924824|NCT00560573|3635969|FG001|COMPLETED|Overall Study||0
2924825|NCT00560573|3635970|FG002|COMPLETED|Overall Study||0
2924826|NCT00560573|3635971|FG003|COMPLETED|Overall Study||0
2924827|NCT00560573|3635972|FG004|COMPLETED|Overall Study||1
3174179|NCT01954342|3901986|FG003|STARTED|Overall Study||18
3174180|NCT01954342|3901983|FG000|COMPLETED|Overall Study||36
3174181|NCT01954342|3901984|FG001|COMPLETED|Overall Study||8
3174182|NCT01954342|3901985|FG002|COMPLETED|Overall Study||10
3321777|NCT03179787|4054836|FG000|STARTED|Overall Study||528
3321778|NCT03179787|4054836|FG000|COMPLETED|Overall Study||510
3321779|NCT03179787|4054836|FG000|NOT COMPLETED|Overall Study||18
3321780|NCT03179891|4054840|FG000|STARTED|First Intervention||13
3321781|NCT03179891|4054841|FG001|STARTED|First Intervention||22
3321782|NCT03179891|4054840|FG000|COMPLETED|First Intervention||11
3321783|NCT03179891|4054841|FG001|COMPLETED|First Intervention||20
3321784|NCT03179891|4054840|FG000|NOT COMPLETED|First Intervention||2
3321785|NCT03179891|4054841|FG001|NOT COMPLETED|First Intervention||2
3321786|NCT03179891|4054840|FG000|STARTED|Second Intervention (After 14 Days)||11
2924828|NCT00560573|3635973|FG005|COMPLETED|Overall Study||0
2924829|NCT00560573|3635968|FG000|NOT COMPLETED|Overall Study||6
3174183|NCT01954342|3901986|FG003|COMPLETED|Overall Study||0
3174184|NCT01954342|3901983|FG000|NOT COMPLETED|Overall Study||0
3174185|NCT01954342|3901984|FG001|NOT COMPLETED|Overall Study||0
3174186|NCT01954342|3901985|FG002|NOT COMPLETED|Overall Study||0
3174187|NCT01954342|3901986|FG003|NOT COMPLETED|Overall Study||18
3321787|NCT03179891|4054841|FG001|STARTED|Second Intervention (After 14 Days)||20
3321788|NCT03179891|4054840|FG000|COMPLETED|Second Intervention (After 14 Days)||11
3321789|NCT03179891|4054841|FG001|COMPLETED|Second Intervention (After 14 Days)||20
3321790|NCT03179891|4054840|FG000|NOT COMPLETED|Second Intervention (After 14 Days)||0
3321791|NCT03179891|4054841|FG001|NOT COMPLETED|Second Intervention (After 14 Days)||0
3321792|NCT03180138|4054853|FG000|STARTED|Overall Study||204
3321793|NCT03180138|4054854|FG001|STARTED|Overall Study||201
3321794|NCT03180138|4054855|FG002|STARTED|Overall Study||203
3321795|NCT03180138|4054853|FG000|COMPLETED|Overall Study||182
3321796|NCT03180138|4054854|FG001|COMPLETED|Overall Study||188
3321797|NCT03180138|4054855|FG002|COMPLETED|Overall Study||179
3321798|NCT03180138|4054853|FG000|NOT COMPLETED|Overall Study||22
3321799|NCT03180138|4054854|FG001|NOT COMPLETED|Overall Study||13
3321800|NCT03180138|4054855|FG002|NOT COMPLETED|Overall Study||24
3321801|NCT03180385|4054865|FG000|STARTED|Overall Study||0
3321802|NCT03180385|4054866|FG001|STARTED|Overall Study||2
2924830|NCT00560573|3635969|FG001|NOT COMPLETED|Overall Study||3
2924831|NCT00560573|3635970|FG002|NOT COMPLETED|Overall Study||6
2924832|NCT00560573|3635971|FG003|NOT COMPLETED|Overall Study||10
2924833|NCT00560573|3635972|FG004|NOT COMPLETED|Overall Study||7
2924834|NCT00560573|3635973|FG005|NOT COMPLETED|Overall Study||13
2924835|NCT00560612|3636005|FG000|STARTED|Overall Study||5
2924836|NCT00560612|3636006|FG001|STARTED|Overall Study||7
2924837|NCT00560612|3636005|FG000|COMPLETED|Overall Study||5
3174188|NCT01954394|3901998|FG000|STARTED|Overall Study|Enrolled|331
3174189|NCT01954394|3901999|FG001|STARTED|Overall Study|Enrolled|655
3174190|NCT01954394|3901998|FG000|Treated|Overall Study|Safety population|330
3174191|NCT01954394|3901999|FG001|Treated|Overall Study|Safety population|655
3174192|NCT01954394|3901998|FG000|COMPLETED|Overall Study||301
3174193|NCT01954394|3901999|FG001|COMPLETED|Overall Study||598
2924838|NCT00560612|3636006|FG001|COMPLETED|Overall Study||7
2924839|NCT00560612|3636005|FG000|NOT COMPLETED|Overall Study||0
2924840|NCT00560612|3636006|FG001|NOT COMPLETED|Overall Study||0
2924841|NCT00560703|3636014|FG000|STARTED|Overall Study||46
2924842|NCT00560703|3636015|FG001|STARTED|Overall Study||24
2924843|NCT00560703|3636014|FG000|COMPLETED|Overall Study||46
2924844|NCT00560703|3636015|FG001|COMPLETED|Overall Study||18
2924845|NCT00560703|3636014|FG000|NOT COMPLETED|Overall Study||0
2924846|NCT00560703|3636015|FG001|NOT COMPLETED|Overall Study||6
2924847|NCT00560755|3636021|FG000|STARTED|Overall Study|Vaccinated (at least one ProQuad® dose)|3388
2924848|NCT00560755|3636021|FG000|ProQuad® Dose 1 and Dose 2|Overall Study||3346
2924849|NCT00560755|3636021|FG000|COMPLETED|Overall Study||3328
2924850|NCT00560755|3636021|FG000|NOT COMPLETED|Overall Study||60
2924851|NCT00560794|3636026|FG000|STARTED|Overall Study||21
2924852|NCT00560794|3636026|FG000|Completed 1 Treatment Cycle|Overall Study||20
2924853|NCT00560794|3636026|FG000|COMPLETED|Overall Study||10
2924854|NCT00560794|3636026|FG000|NOT COMPLETED|Overall Study||11
2924855|NCT00560833|3636037|FG000|STARTED|Overall Study||317
2924856|NCT00560833|3636038|FG001|STARTED|Overall Study||155
2924857|NCT00560833|3636039|FG002|STARTED|Overall Study||160
2924858|NCT00560833|3636040|FG003|STARTED|Overall Study||155
2924859|NCT00560833|3636041|FG004|STARTED|Overall Study||156
2924860|NCT00560833|3636037|FG000|Treated|Overall Study|One participant was not randomized but was treated with placebo|317
2924861|NCT00560833|3636038|FG001|Treated|Overall Study|One participant was randomized but not treated|154
2924862|NCT00560833|3636039|FG002|Treated|Overall Study||160
2924863|NCT00560833|3636040|FG003|Treated|Overall Study||155
2924864|NCT00560833|3636041|FG004|Treated|Overall Study|One participant was randomized but not treated|155
2924865|NCT00560833|3636037|FG000|COMPLETED|Overall Study||273
2924866|NCT00560833|3636038|FG001|COMPLETED|Overall Study||129
2924867|NCT00560833|3636039|FG002|COMPLETED|Overall Study||121
2924868|NCT00560833|3636040|FG003|COMPLETED|Overall Study||124
2924869|NCT00560833|3636041|FG004|COMPLETED|Overall Study||114
2924870|NCT00560833|3636037|FG000|NOT COMPLETED|Overall Study||44
2924871|NCT00560833|3636038|FG001|NOT COMPLETED|Overall Study||26
2924872|NCT00560833|3636039|FG002|NOT COMPLETED|Overall Study||39
3174194|NCT01954394|3901998|FG000|NOT COMPLETED|Overall Study||30
3174195|NCT01954394|3901999|FG001|NOT COMPLETED|Overall Study||57
3174196|NCT01954628|3902009|FG000|STARTED|Overall Study||200
3174197|NCT01954628|3902010|FG001|STARTED|Overall Study||200
3321803|NCT03180385|4054865|FG000|COMPLETED|Overall Study||0
3321804|NCT03180385|4054866|FG001|COMPLETED|Overall Study||2
3321805|NCT03180385|4054865|FG000|NOT COMPLETED|Overall Study||0
3174198|NCT01954628|3902009|FG000|Full Analysis Set (FAS)|Overall Study||200
3321806|NCT03180385|4054866|FG001|NOT COMPLETED|Overall Study||0
3321807|NCT03180489|4054874|FG000|STARTED|Overall Study||33
3321808|NCT03180489|4054875|FG001|STARTED|Overall Study||29
3321809|NCT03180489|4054874|FG000|COMPLETED|Overall Study||25
3321810|NCT03180489|4054875|FG001|COMPLETED|Overall Study||25
3321811|NCT03180489|4054874|FG000|NOT COMPLETED|Overall Study||8
3321812|NCT03180489|4054875|FG001|NOT COMPLETED|Overall Study||4
3321813|NCT03180515|4054881|FG000|STARTED|Aim 1||12
3321814|NCT03180515|4054881|FG000|COMPLETED|Aim 1||12
3321815|NCT03180515|4054881|FG000|NOT COMPLETED|Aim 1||0
3321816|NCT03180515|4054881|FG000|STARTED|Aim 2||12
3321817|NCT03180515|4054881|FG000|COMPLETED|Aim 2||12
3321818|NCT03180515|4054881|FG000|NOT COMPLETED|Aim 2||0
3321819|NCT03180515|4054881|FG000|STARTED|Aim 3||1
3174199|NCT01954628|3902010|FG001|Full Analysis Set (FAS)|Overall Study||198
3174200|NCT01954628|3902009|FG000|Safety Set|Overall Study||200
3174201|NCT01954628|3902010|FG001|Safety Set|Overall Study||200
3174202|NCT01954628|3902009|FG000|Pharmacokinetic Population|Overall Study||181
3174203|NCT01954628|3902010|FG001|Pharmacokinetic Population|Overall Study||0
3174204|NCT01954628|3902009|FG000|US 6 Month Ophthalmology Safety Visit|Overall Study||37
3174205|NCT01954628|3902010|FG001|US 6 Month Ophthalmology Safety Visit|Overall Study||32
3174206|NCT01954628|3902009|FG000|COMPLETED|Overall Study||169
3174207|NCT01954628|3902010|FG001|COMPLETED|Overall Study||173
3174208|NCT01954628|3902009|FG000|NOT COMPLETED|Overall Study||31
3174209|NCT01954628|3902010|FG001|NOT COMPLETED|Overall Study||27
3174210|NCT01954745|3902020|FG000|STARTED|Overall Study||19
2924873|NCT00560833|3636040|FG003|NOT COMPLETED|Overall Study||31
2924874|NCT00560833|3636041|FG004|NOT COMPLETED|Overall Study||42
2924875|NCT00560859|3636055|FG000|STARTED|Overall Study||226
2924876|NCT00560859|3636056|FG001|STARTED|Overall Study||227
2924877|NCT00560859|3636055|FG000|COMPLETED|Overall Study||194
2924878|NCT00560859|3636056|FG001|COMPLETED|Overall Study||203
2924879|NCT00560859|3636055|FG000|NOT COMPLETED|Overall Study||32
3174211|NCT01954745|3902020|FG000|COMPLETED|Overall Study||0
3174212|NCT01954745|3902020|FG000|NOT COMPLETED|Overall Study||19
3174213|NCT01954771|3902027|FG000|STARTED|Overall Study||29
3174214|NCT01954771|3902028|FG001|STARTED|Overall Study||32
3174215|NCT01954771|3902029|FG002|STARTED|Overall Study||28
3174216|NCT01954771|3902027|FG000|COMPLETED|Overall Study||22
3174217|NCT01954771|3902028|FG001|COMPLETED|Overall Study||29
3174218|NCT01954771|3902029|FG002|COMPLETED|Overall Study||25
3174219|NCT01954771|3902027|FG000|NOT COMPLETED|Overall Study||7
3174220|NCT01954771|3902028|FG001|NOT COMPLETED|Overall Study||3
3321820|NCT03180515|4054881|FG000|COMPLETED|Aim 3||1
3321821|NCT03180515|4054881|FG000|NOT COMPLETED|Aim 3||0
3174221|NCT01954771|3902029|FG002|NOT COMPLETED|Overall Study||3
3174222|NCT01954927|3902042|FG000|STARTED|Overall Study||45
3321822|NCT03180528|4054897|FG000|STARTED|Overall Study||30
3321823|NCT03180528|4054897|FG000|COMPLETED|Overall Study||27
3321824|NCT03180528|4054897|FG000|NOT COMPLETED|Overall Study||3
3321825|NCT03180619|4054904|FG000|STARTED|Overall Study||78
3321826|NCT03180619|4054905|FG001|STARTED|Overall Study||15
3321827|NCT03180619|4054906|FG002|STARTED|Overall Study||31
3321828|NCT03180619|4054904|FG000|COMPLETED|Overall Study||67
3321829|NCT03180619|4054905|FG001|COMPLETED|Overall Study||14
2924880|NCT00560859|3636056|FG001|NOT COMPLETED|Overall Study||24
2924881|NCT00560885|3636063|FG000|STARTED|Overall Study||55
3174223|NCT01954927|3902043|FG001|STARTED|Overall Study||45
3321830|NCT03180619|4054906|FG002|COMPLETED|Overall Study||25
3321831|NCT03180619|4054904|FG000|NOT COMPLETED|Overall Study||11
3321832|NCT03180619|4054905|FG001|NOT COMPLETED|Overall Study||1
3321833|NCT03180619|4054906|FG002|NOT COMPLETED|Overall Study||6
3321834|NCT03180645|4054924|FG000|STARTED|Overall Study||24
3321835|NCT03180645|4054925|FG001|STARTED|Overall Study||24
3321836|NCT03180645|4054926|FG002|STARTED|Overall Study||24
3321837|NCT03180645|4054924|FG000|COMPLETED|Overall Study||24
3321838|NCT03180645|4054925|FG001|COMPLETED|Overall Study||23
3321839|NCT03180645|4054926|FG002|COMPLETED|Overall Study||22
3321840|NCT03180645|4054924|FG000|NOT COMPLETED|Overall Study||0
3321841|NCT03180645|4054925|FG001|NOT COMPLETED|Overall Study||1
3321842|NCT03180645|4054926|FG002|NOT COMPLETED|Overall Study||2
3321843|NCT03180801|4054941|FG000|STARTED|Overall Study||50
3321844|NCT03180801|4054942|FG001|STARTED|Overall Study||52
3321845|NCT03180801|4054943|FG002|STARTED|Overall Study||51
3321846|NCT03180801|4054941|FG000|Safety Population|Overall Study||50
3321847|NCT03180801|4054942|FG001|Safety Population|Overall Study||52
3321848|NCT03180801|4054943|FG002|Safety Population|Overall Study||51
3321849|NCT03180801|4054941|FG000|Intention to Treat|Overall Study||42
3321850|NCT03180801|4054942|FG001|Intention to Treat|Overall Study||40
3174224|NCT01954927|3902042|FG000|COMPLETED|Overall Study||42
3174225|NCT01954927|3902043|FG001|COMPLETED|Overall Study||44
3174226|NCT01954927|3902042|FG000|NOT COMPLETED|Overall Study||3
3174227|NCT01954927|3902043|FG001|NOT COMPLETED|Overall Study||1
3174228|NCT01955005|3902051|FG000|STARTED|Overall Study||30
3174229|NCT01955005|3902052|FG001|STARTED|Overall Study||30
3321851|NCT03180801|4054943|FG002|Intention to Treat|Overall Study||41
3321852|NCT03180801|4054941|FG000|COMPLETED|Overall Study||42
3321853|NCT03180801|4054942|FG001|COMPLETED|Overall Study||40
3321854|NCT03180801|4054943|FG002|COMPLETED|Overall Study||41
3174230|NCT01955005|3902051|FG000|COMPLETED|Overall Study||27
3321855|NCT03180801|4054941|FG000|NOT COMPLETED|Overall Study||8
3321856|NCT03180801|4054942|FG001|NOT COMPLETED|Overall Study||12
3321857|NCT03180801|4054943|FG002|NOT COMPLETED|Overall Study||10
3321858|NCT03181009|4054956|FG000|STARTED|Overall Study||30
3321859|NCT03181009|4054957|FG001|STARTED|Overall Study||30
3321860|NCT03181009|4054956|FG000|COMPLETED|Overall Study||30
3321861|NCT03181009|4054957|FG001|COMPLETED|Overall Study||28
3321862|NCT03181009|4054956|FG000|NOT COMPLETED|Overall Study||0
3321863|NCT03181009|4054957|FG001|NOT COMPLETED|Overall Study||2
3174231|NCT01955005|3902052|FG001|COMPLETED|Overall Study||25
3174232|NCT01955005|3902051|FG000|NOT COMPLETED|Overall Study||3
3174233|NCT01955005|3902052|FG001|NOT COMPLETED|Overall Study||5
3174234|NCT01955044|3902061|FG000|STARTED|Overall Study||10
3174235|NCT01955044|3902062|FG001|STARTED|Overall Study||10
3174236|NCT01955044|3902063|FG002|STARTED|Overall Study||10
3174237|NCT01955044|3902061|FG000|COMPLETED|Overall Study||9
3174238|NCT01955044|3902062|FG001|COMPLETED|Overall Study||9
3174239|NCT01955044|3902063|FG002|COMPLETED|Overall Study||10
3174240|NCT01955044|3902061|FG000|NOT COMPLETED|Overall Study||1
3174241|NCT01955044|3902062|FG001|NOT COMPLETED|Overall Study||1
3174242|NCT01955044|3902063|FG002|NOT COMPLETED|Overall Study||0
3174243|NCT01955083|3902073|FG000|STARTED|Overall Study||15
3174244|NCT01955083|3902074|FG001|STARTED|Overall Study||15
3174245|NCT01955083|3902073|FG000|COMPLETED|Overall Study||14
2924882|NCT00560885|3636063|FG000|30 Day Follow-up|Overall Study|53 pts available for 30 day follow-up, 52 pts assessed|53
2924883|NCT00560885|3636063|FG000|3 Month Follow-up|Overall Study|51 pts available for 3 month follow-up, 48 pts assessed.|51
2924884|NCT00560885|3636063|FG000|6 Month Follow-up|Overall Study|50 pts available for 6 month follow-up, 50 pts assessed|50
2924885|NCT00560885|3636063|FG000|12 Month Follow-up|Overall Study|48 pts available for 12 month follow-up, 46 pts assessed|48
2924886|NCT00560885|3636063|FG000|2 Year Follow-up|Overall Study||47
2924887|NCT00560885|3636063|FG000|COMPLETED|Overall Study||47
2924888|NCT00560885|3636063|FG000|NOT COMPLETED|Overall Study||8
2924889|NCT00560937|3636069|FG000|STARTED|Overall Study||10
2924890|NCT00560937|3636070|FG001|STARTED|Overall Study||11
2924891|NCT00560937|3636069|FG000|COMPLETED|Overall Study|One participant was withdrawn after 6 weeks and data were carried forward|9
2924892|NCT00560937|3636070|FG001|COMPLETED|Overall Study||9
2924893|NCT00560937|3636069|FG000|NOT COMPLETED|Overall Study||1
2924894|NCT00560937|3636070|FG001|NOT COMPLETED|Overall Study||2
2924895|NCT00560950|3636078|FG000|STARTED|Overall Study||72
2924896|NCT00560950|3636079|FG001|STARTED|Overall Study||71
2924897|NCT00560950|3636078|FG000|COMPLETED|Overall Study||71
2924898|NCT00560950|3636079|FG001|COMPLETED|Overall Study||71
2924899|NCT00560950|3636078|FG000|NOT COMPLETED|Overall Study||1
2924900|NCT00560950|3636079|FG001|NOT COMPLETED|Overall Study||0
2924901|NCT00561002|3636089|FG000|STARTED|Overall Study||23
2924902|NCT00561002|3636090|FG001|STARTED|Overall Study||9
2924903|NCT00561002|3636089|FG000|COMPLETED|Overall Study||23
2924904|NCT00561002|3636090|FG001|COMPLETED|Overall Study||9
2924905|NCT00561002|3636089|FG000|NOT COMPLETED|Overall Study||0
2924906|NCT00561002|3636090|FG001|NOT COMPLETED|Overall Study||0
2924907|NCT00561015|3636102|FG000|STARTED|Overall Study||9
2924908|NCT00561015|3636103|FG001|STARTED|Overall Study||5
2924909|NCT00561015|3636104|FG002|STARTED|Overall Study||9
2924910|NCT00561015|3636105|FG003|STARTED|Overall Study||8
2924911|NCT00561015|3636106|FG004|STARTED|Overall Study||9
2924912|NCT00561015|3636107|FG005|STARTED|Overall Study||9
2924913|NCT00561015|3636102|FG000|COMPLETED|Overall Study||5
2924914|NCT00561015|3636103|FG001|COMPLETED|Overall Study||5
2924915|NCT00561015|3636104|FG002|COMPLETED|Overall Study||9
2924916|NCT00561015|3636105|FG003|COMPLETED|Overall Study||7
2924917|NCT00561015|3636106|FG004|COMPLETED|Overall Study||8
2924918|NCT00561015|3636107|FG005|COMPLETED|Overall Study||6
3136979|NCT01716520|3862278|FG000|COMPLETED|Washout Period 1 (10 to 14 Days)||29
3136980|NCT01716520|3862279|FG001|COMPLETED|Washout Period 1 (10 to 14 Days)||28
3136981|NCT01716520|3862280|FG002|COMPLETED|Washout Period 1 (10 to 14 Days)||27
3136982|NCT01716520|3862281|FG003|COMPLETED|Washout Period 1 (10 to 14 Days)||29
3136983|NCT01716520|3862282|FG004|COMPLETED|Washout Period 1 (10 to 14 Days)||31
3136984|NCT01716520|3862283|FG005|COMPLETED|Washout Period 1 (10 to 14 Days)||27
3136985|NCT01716520|3862278|FG000|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
3136986|NCT01716520|3862279|FG001|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||1
3136987|NCT01716520|3862280|FG002|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||1
3136988|NCT01716520|3862281|FG003|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
3136989|NCT01716520|3862282|FG004|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
3136990|NCT01716520|3862283|FG005|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||2
3136991|NCT01716520|3862278|FG000|STARTED|Treatment Period 2 (14 Days)||29
3136992|NCT01716520|3862279|FG001|STARTED|Treatment Period 2 (14 Days)||28
3321864|NCT03181308|4054965|FG000|STARTED|Overall Study||3
3321865|NCT03181308|4054966|FG001|STARTED|Overall Study||8
3321866|NCT03181308|4054965|FG000|COMPLETED|Overall Study||3
3321867|NCT03181308|4054966|FG001|COMPLETED|Overall Study||8
3321868|NCT03181308|4054965|FG000|NOT COMPLETED|Overall Study||0
3321869|NCT03181308|4054966|FG001|NOT COMPLETED|Overall Study||0
3321870|NCT03181451|4054975|FG000|STARTED|Overall Study||12
3321871|NCT03181451|4054976|FG001|STARTED|Overall Study||13
3174246|NCT01955083|3902074|FG001|COMPLETED|Overall Study||14
3174247|NCT01955083|3902073|FG000|NOT COMPLETED|Overall Study||1
3174248|NCT01955083|3902074|FG001|NOT COMPLETED|Overall Study||1
3174249|NCT01955122|3902106|FG000|STARTED|Overall Study|"Excluded (n = 5)~Included in analysis (n = 59)"|64
3174250|NCT01955122|3902107|FG001|STARTED|Overall Study|"Excluded (n = 5)~Included in analysis (n = 57)"|62
3174251|NCT01955122|3902106|FG000|No.Patients Enrolled|Overall Study||64
3174252|NCT01955122|3902107|FG001|No.Patients Enrolled|Overall Study||62
3174253|NCT01955122|3902106|FG000|No. Patients Completed Double Procedure|Overall Study||59
3174254|NCT01955122|3902107|FG001|No. Patients Completed Double Procedure|Overall Study||57
3174255|NCT01955122|3902106|FG000|COMPLETED|Overall Study||59
2924919|NCT00561015|3636102|FG000|NOT COMPLETED|Overall Study||4
2924920|NCT00561015|3636103|FG001|NOT COMPLETED|Overall Study||0
2924921|NCT00561015|3636104|FG002|NOT COMPLETED|Overall Study||0
2924922|NCT00561015|3636105|FG003|NOT COMPLETED|Overall Study||1
2924923|NCT00561015|3636106|FG004|NOT COMPLETED|Overall Study||1
2924924|NCT00561015|3636107|FG005|NOT COMPLETED|Overall Study||3
2924925|NCT00561080|3636128|FG000|STARTED|Vaccination Period (up to Month 4)||253
2924926|NCT00561080|3636129|FG001|STARTED|Vaccination Period (up to Month 4)||255
2924927|NCT00561080|3636130|FG002|STARTED|Vaccination Period (up to Month 4)||251
2924928|NCT00561080|3636128|FG000|Received at Least 1 Vaccination|Vaccination Period (up to Month 4)||253
2924929|NCT00561080|3636129|FG001|Received at Least 1 Vaccination|Vaccination Period (up to Month 4)||254
2924930|NCT00561080|3636130|FG002|Received at Least 1 Vaccination|Vaccination Period (up to Month 4)||250
2924931|NCT00561080|3636128|FG000|COMPLETED|Vaccination Period (up to Month 4)||250
2924932|NCT00561080|3636129|FG001|COMPLETED|Vaccination Period (up to Month 4)||229
2924933|NCT00561080|3636130|FG002|COMPLETED|Vaccination Period (up to Month 4)||225
2924934|NCT00561080|3636128|FG000|NOT COMPLETED|Vaccination Period (up to Month 4)||3
3174256|NCT01955122|3902107|FG001|COMPLETED|Overall Study||57
3174257|NCT01955122|3902106|FG000|NOT COMPLETED|Overall Study||5
3174258|NCT01955122|3902107|FG001|NOT COMPLETED|Overall Study||5
3174259|NCT01955161|3902122|FG000|STARTED|Overall Study||310
3174260|NCT01955161|3902123|FG001|STARTED|Overall Study||313
3174261|NCT01955161|3902124|FG002|STARTED|Overall Study||310
3174262|NCT01955161|3902122|FG000|Treated|Overall Study||308
3174263|NCT01955161|3902123|FG001|Treated|Overall Study||313
3174264|NCT01955161|3902124|FG002|Treated|Overall Study||309
3174265|NCT01955161|3902122|FG000|COMPLETED|Overall Study||283
3174266|NCT01955161|3902123|FG001|COMPLETED|Overall Study||288
3174267|NCT01955161|3902124|FG002|COMPLETED|Overall Study||275
3174268|NCT01955161|3902122|FG000|NOT COMPLETED|Overall Study||27
3174269|NCT01955161|3902123|FG001|NOT COMPLETED|Overall Study||25
3174270|NCT01955161|3902124|FG002|NOT COMPLETED|Overall Study||35
3174271|NCT01955369|3902132|FG000|STARTED|Overall Study||200
3174272|NCT01955369|3902132|FG000|COMPLETED|Overall Study||200
3174273|NCT01955369|3902132|FG000|NOT COMPLETED|Overall Study||0
3174274|NCT01955382|3902138|FG000|STARTED|Overall Study||35
3174275|NCT01955382|3902139|FG001|STARTED|Overall Study||35
2924935|NCT00561080|3636129|FG001|NOT COMPLETED|Vaccination Period (up to Month 4)||26
2924936|NCT00561080|3636130|FG002|NOT COMPLETED|Vaccination Period (up to Month 4)||26
2924937|NCT00561080|3636128|FG000|STARTED|12-month Post Last Dose Follow-up||250
2924938|NCT00561080|3636129|FG001|STARTED|12-month Post Last Dose Follow-up||229
2924939|NCT00561080|3636130|FG002|STARTED|12-month Post Last Dose Follow-up||225
2924940|NCT00561080|3636128|FG000|COMPLETED|12-month Post Last Dose Follow-up||243
2924941|NCT00561080|3636129|FG001|COMPLETED|12-month Post Last Dose Follow-up||220
2924942|NCT00561080|3636130|FG002|COMPLETED|12-month Post Last Dose Follow-up||215
2924943|NCT00561080|3636128|FG000|NOT COMPLETED|12-month Post Last Dose Follow-up||7
2924944|NCT00561080|3636129|FG001|NOT COMPLETED|12-month Post Last Dose Follow-up||9
2924945|NCT00561080|3636130|FG002|NOT COMPLETED|12-month Post Last Dose Follow-up||10
2924946|NCT00561080|3636128|FG000|STARTED|24-month Post Last Dose Follow-up|Study stopped at 1 year post last dose|0
2924947|NCT00561080|3636129|FG001|STARTED|24-month Post Last Dose Follow-up|Study stopped at 1 year post last dose|0
2924948|NCT00561080|3636130|FG002|STARTED|24-month Post Last Dose Follow-up|Study stopped at 1 year post last dose|0
2924949|NCT00561080|3636128|FG000|COMPLETED|24-month Post Last Dose Follow-up||0
2924950|NCT00561080|3636129|FG001|COMPLETED|24-month Post Last Dose Follow-up||0
2924951|NCT00561080|3636130|FG002|COMPLETED|24-month Post Last Dose Follow-up||0
2924952|NCT00561080|3636128|FG000|NOT COMPLETED|24-month Post Last Dose Follow-up||0
2924953|NCT00561080|3636129|FG001|NOT COMPLETED|24-month Post Last Dose Follow-up||0
2924954|NCT00561080|3636130|FG002|NOT COMPLETED|24-month Post Last Dose Follow-up||0
2924955|NCT00561080|3636128|FG000|STARTED|36 Month Post Last Dose Follow-up|Study stopped at 1 year post last dose|0
3174276|NCT01955382|3902138|FG000|COMPLETED|Overall Study||35
3174277|NCT01955382|3902139|FG001|COMPLETED|Overall Study||35
3174278|NCT01955382|3902138|FG000|NOT COMPLETED|Overall Study||0
3174279|NCT01955382|3902139|FG001|NOT COMPLETED|Overall Study||0
3174280|NCT01955434|3902146|FG000|STARTED|Overall Study||25
3039082|NCT01155999|3758407|FG001|NOT COMPLETED|Overall Study||4
3174281|NCT01955434|3902146|FG000|COMPLETED|Overall Study||25
3174282|NCT01955434|3902146|FG000|NOT COMPLETED|Overall Study||0
3174283|NCT01955473|3902155|FG000|STARTED|Overall Study||3
3174284|NCT01955473|3902156|FG001|STARTED|Overall Study||6
3174285|NCT01955473|3902157|FG002|STARTED|Overall Study||6
2924956|NCT00561080|3636129|FG001|STARTED|36 Month Post Last Dose Follow-up|Study stopped at 1 year post last dose|0
2924957|NCT00561080|3636130|FG002|STARTED|36 Month Post Last Dose Follow-up|Study stopped at 1 year post last dose|0
2924958|NCT00561080|3636128|FG000|COMPLETED|36 Month Post Last Dose Follow-up||0
2924959|NCT00561080|3636129|FG001|COMPLETED|36 Month Post Last Dose Follow-up||0
2924960|NCT00561080|3636130|FG002|COMPLETED|36 Month Post Last Dose Follow-up||0
2924961|NCT00561080|3636128|FG000|NOT COMPLETED|36 Month Post Last Dose Follow-up||0
2924962|NCT00561080|3636129|FG001|NOT COMPLETED|36 Month Post Last Dose Follow-up||0
2924963|NCT00561080|3636130|FG002|NOT COMPLETED|36 Month Post Last Dose Follow-up||0
2924964|NCT00561145|3636142|FG000|STARTED|Overall Study||15
2924965|NCT00561145|3636143|FG001|STARTED|Overall Study||17
3174286|NCT01955473|3902158|FG003|STARTED|Overall Study||6
3174287|NCT01955473|3902159|FG004|STARTED|Overall Study||30
3174288|NCT01955473|3902155|FG000|COMPLETED|Overall Study||3
3174289|NCT01955473|3902156|FG001|COMPLETED|Overall Study||6
3174290|NCT01955473|3902157|FG002|COMPLETED|Overall Study||6
3321872|NCT03181451|4054977|FG002|STARTED|Overall Study||12
3321873|NCT03181451|4054975|FG000|COMPLETED|Overall Study||12
3321874|NCT03181451|4054976|FG001|COMPLETED|Overall Study||11
3321875|NCT03181451|4054977|FG002|COMPLETED|Overall Study||12
3321876|NCT03181451|4054975|FG000|NOT COMPLETED|Overall Study||0
3321877|NCT03181451|4054976|FG001|NOT COMPLETED|Overall Study||2
3321878|NCT03181451|4054977|FG002|NOT COMPLETED|Overall Study||0
3321879|NCT03181503|4054989|FG000|STARTED|Overall Study||36
3321880|NCT03181503|4054990|FG001|STARTED|Overall Study||34
3321881|NCT03181503|4054989|FG000|Treated|Overall Study||36
3321882|NCT03181503|4054990|FG001|Treated|Overall Study||34
3321883|NCT03181503|4054989|FG000|COMPLETED|Overall Study||29
3321884|NCT03181503|4054990|FG001|COMPLETED|Overall Study||31
3321885|NCT03181503|4054989|FG000|NOT COMPLETED|Overall Study||7
3321886|NCT03181503|4054990|FG001|NOT COMPLETED|Overall Study||3
3321887|NCT03181594|4054999|FG000|STARTED|Initial Study Protocol (12-month FU)||100
3321888|NCT03181594|4054999|FG000|30-day Follow-up|Initial Study Protocol (12-month FU)||99
3321889|NCT03181594|4054999|FG000|90-day Follow-up|Initial Study Protocol (12-month FU)||98
3321890|NCT03181594|4054999|FG000|6-month Follow-up|Initial Study Protocol (12-month FU)||98
3321891|NCT03181594|4054999|FG000|9-month Follow-up|Initial Study Protocol (12-month FU)||95
3321892|NCT03181594|4054999|FG000|12-month Follow-up|Initial Study Protocol (12-month FU)||91
3321893|NCT03181594|4054999|FG000|COMPLETED|Initial Study Protocol (12-month FU)||91
3321894|NCT03181594|4054999|FG000|NOT COMPLETED|Initial Study Protocol (12-month FU)||9
3321895|NCT03181594|4054999|FG000|STARTED|Long-term Extension (15-24 Month FU)||62
2924966|NCT00561145|3636142|FG000|COMPLETED|Overall Study||15
2924967|NCT00561145|3636143|FG001|COMPLETED|Overall Study||17
2924968|NCT00561145|3636142|FG000|NOT COMPLETED|Overall Study||0
2924969|NCT00561145|3636143|FG001|NOT COMPLETED|Overall Study||0
2924970|NCT00561340|3636151|FG000|STARTED|Overall Study||13
2924971|NCT00561340|3636152|FG001|STARTED|Overall Study||16
2924972|NCT00561340|3636151|FG000|COMPLETED|Overall Study||7
2924973|NCT00561340|3636152|FG001|COMPLETED|Overall Study||16
3174291|NCT01955473|3902158|FG003|COMPLETED|Overall Study||6
3174292|NCT01955473|3902159|FG004|COMPLETED|Overall Study||30
3174293|NCT01955473|3902155|FG000|NOT COMPLETED|Overall Study||0
3174294|NCT01955473|3902156|FG001|NOT COMPLETED|Overall Study||0
3174295|NCT01955473|3902157|FG002|NOT COMPLETED|Overall Study||0
3174296|NCT01955473|3902158|FG003|NOT COMPLETED|Overall Study||0
3174297|NCT01955473|3902159|FG004|NOT COMPLETED|Overall Study||0
3174298|NCT01955564|3902182|FG000|STARTED|Overall Study||18
3174299|NCT01955564|3902183|FG001|STARTED|Overall Study||6
3321896|NCT03181594|4054999|FG000|15-month Follow-up|Long-term Extension (15-24 Month FU)||56
3321897|NCT03181594|4054999|FG000|18-month Follow-up|Long-term Extension (15-24 Month FU)||57
3321898|NCT03181594|4054999|FG000|21-month Follow-up|Long-term Extension (15-24 Month FU)||55
3321899|NCT03181594|4054999|FG000|24-month Follow-up|Long-term Extension (15-24 Month FU)||57
3321900|NCT03181594|4054999|FG000|COMPLETED|Long-term Extension (15-24 Month FU)||57
3321901|NCT03181594|4054999|FG000|NOT COMPLETED|Long-term Extension (15-24 Month FU)||5
3321902|NCT03181724|4055005|FG000|STARTED|Overall Study||45
3321903|NCT03181724|4055006|FG001|STARTED|Overall Study||45
3321904|NCT03181724|4055005|FG000|COMPLETED|Overall Study||45
3321905|NCT03181724|4055006|FG001|COMPLETED|Overall Study||45
3321906|NCT03181724|4055005|FG000|NOT COMPLETED|Overall Study||0
3321907|NCT03181724|4055006|FG001|NOT COMPLETED|Overall Study||0
3321908|NCT03181932|4055014|FG000|STARTED|Period 1 (Double-blind Period)||90
3321909|NCT03181932|4055015|FG001|STARTED|Period 1 (Double-blind Period)||98
3321910|NCT03181932|4055014|FG000|COMPLETED|Period 1 (Double-blind Period)||79
3321911|NCT03181932|4055015|FG001|COMPLETED|Period 1 (Double-blind Period)||85
2924974|NCT00561340|3636151|FG000|NOT COMPLETED|Overall Study||6
3174300|NCT01955564|3902184|FG002|STARTED|Overall Study||6
3174301|NCT01955564|3902185|FG003|STARTED|Overall Study||6
3174302|NCT01955564|3902186|FG004|STARTED|Overall Study||6
3174303|NCT01955564|3902187|FG005|STARTED|Overall Study||6
3174304|NCT01955564|3902188|FG006|STARTED|Overall Study||6
3174305|NCT01955564|3902182|FG000|COMPLETED|Overall Study||18
3174306|NCT01955564|3902183|FG001|COMPLETED|Overall Study||6
3174307|NCT01955564|3902184|FG002|COMPLETED|Overall Study||6
3174308|NCT01955564|3902185|FG003|COMPLETED|Overall Study||6
3174309|NCT01955564|3902186|FG004|COMPLETED|Overall Study||6
3174310|NCT01955564|3902187|FG005|COMPLETED|Overall Study||6
3174311|NCT01955564|3902188|FG006|COMPLETED|Overall Study||6
3174312|NCT01955564|3902182|FG000|NOT COMPLETED|Overall Study||0
2924975|NCT00561340|3636152|FG001|NOT COMPLETED|Overall Study||0
2924976|NCT00561353|3636168|FG000|STARTED|Overall Study||18
2924977|NCT00561353|3636169|FG001|STARTED|Overall Study||19
2924978|NCT00561353|3636170|FG002|STARTED|Overall Study||13
2924979|NCT00561353|3636171|FG003|STARTED|Overall Study||18
2924980|NCT00561353|3636172|FG004|STARTED|Overall Study||6
2924981|NCT00561353|3636173|FG005|STARTED|Overall Study||9
2924982|NCT00561353|3636174|FG006|STARTED|Overall Study||9
2924983|NCT00561353|3636175|FG007|STARTED|Overall Study||10
2924984|NCT00561353|3636176|FG008|STARTED|Overall Study||9
2924985|NCT00561353|3636177|FG009|STARTED|Overall Study||5
2924986|NCT00561353|3636168|FG000|COMPLETED|Overall Study||13
2924987|NCT00561353|3636169|FG001|COMPLETED|Overall Study||16
2924988|NCT00561353|3636170|FG002|COMPLETED|Overall Study||10
2924989|NCT00561353|3636171|FG003|COMPLETED|Overall Study||12
2924990|NCT00561353|3636172|FG004|COMPLETED|Overall Study||5
2924991|NCT00561353|3636173|FG005|COMPLETED|Overall Study||3
2924992|NCT00561353|3636174|FG006|COMPLETED|Overall Study||3
2924993|NCT00561353|3636175|FG007|COMPLETED|Overall Study||6
2924994|NCT00561353|3636176|FG008|COMPLETED|Overall Study||2
2924995|NCT00561353|3636177|FG009|COMPLETED|Overall Study||3
2924996|NCT00561353|3636168|FG000|NOT COMPLETED|Overall Study||5
2924997|NCT00561353|3636169|FG001|NOT COMPLETED|Overall Study||3
2924998|NCT00561353|3636170|FG002|NOT COMPLETED|Overall Study||3
2924999|NCT00561353|3636171|FG003|NOT COMPLETED|Overall Study||6
2925000|NCT00561353|3636172|FG004|NOT COMPLETED|Overall Study||1
2925001|NCT00561353|3636173|FG005|NOT COMPLETED|Overall Study||6
2925002|NCT00561353|3636174|FG006|NOT COMPLETED|Overall Study||6
3174313|NCT01955564|3902183|FG001|NOT COMPLETED|Overall Study||0
3174314|NCT01955564|3902184|FG002|NOT COMPLETED|Overall Study||0
2925003|NCT00561353|3636175|FG007|NOT COMPLETED|Overall Study||4
2925004|NCT00561353|3636176|FG008|NOT COMPLETED|Overall Study||7
2925005|NCT00561353|3636177|FG009|NOT COMPLETED|Overall Study||2
2925006|NCT00561392|3636239|FG000|STARTED|Overall Study||208
2925007|NCT00561392|3636239|FG000|COMPLETED|Overall Study||155
2925008|NCT00561392|3636239|FG000|NOT COMPLETED|Overall Study||53
2925009|NCT00561418|3636243|FG000|STARTED|Overall Study||23
2925010|NCT00561418|3636243|FG000|COMPLETED|Overall Study||23
2925011|NCT00561418|3636243|FG000|NOT COMPLETED|Overall Study||0
2925012|NCT00561431|3636249|FG000|STARTED|Overall Study||100
2925013|NCT00561431|3636250|FG001|STARTED|Overall Study||100
2925014|NCT00561431|3636249|FG000|COMPLETED|Overall Study||100
2925015|NCT00561431|3636250|FG001|COMPLETED|Overall Study||100
2925016|NCT00561431|3636249|FG000|NOT COMPLETED|Overall Study||0
2925017|NCT00561431|3636250|FG001|NOT COMPLETED|Overall Study||0
3174315|NCT01955564|3902185|FG003|NOT COMPLETED|Overall Study||0
3174316|NCT01955564|3902186|FG004|NOT COMPLETED|Overall Study||0
3174317|NCT01955564|3902187|FG005|NOT COMPLETED|Overall Study||0
3174318|NCT01955564|3902188|FG006|NOT COMPLETED|Overall Study||0
3174319|NCT01955629|3902210|FG000|STARTED|Overall Study||4
3174320|NCT01955629|3902210|FG000|COMPLETED|Overall Study|1 participant with DP and 3 with unacceptable toxicity were considered completed as per protocol.|4
3174321|NCT01955629|3902210|FG000|NOT COMPLETED|Overall Study||0
3174322|NCT01955707|3902216|FG000|STARTED|Overall Study||82
3174323|NCT01955707|3902217|FG001|STARTED|Overall Study||79
3174324|NCT01955707|3902216|FG000|Withdrew Prior to Dosing|Overall Study||0
3174325|NCT01955707|3902217|FG001|Withdrew Prior to Dosing|Overall Study||1
3174326|NCT01955707|3902216|FG000|Dosed|Overall Study||82
3174327|NCT01955707|3902217|FG001|Dosed|Overall Study||78
3174328|NCT01955707|3902216|FG000|Received Total Volume of Study Drug|Overall Study||82
3174329|NCT01955707|3902217|FG001|Received Total Volume of Study Drug|Overall Study||77
3174330|NCT01955707|3902216|FG000|COMPLETED|Overall Study||62
3174331|NCT01955707|3902217|FG001|COMPLETED|Overall Study||57
3174332|NCT01955707|3902216|FG000|NOT COMPLETED|Overall Study||20
3174333|NCT01955707|3902217|FG001|NOT COMPLETED|Overall Study||22
3174334|NCT01955720|3902223|FG000|STARTED|Overall Study||13
3174335|NCT01955720|3902224|FG001|STARTED|Overall Study||13
3174336|NCT01955720|3902225|FG002|STARTED|Overall Study||3
3174337|NCT01955720|3902226|FG003|STARTED|Overall Study||3
3174338|NCT01955720|3902227|FG004|STARTED|Overall Study||7
3174339|NCT01955720|3902228|FG005|STARTED|Overall Study||7
3174340|NCT01955720|3902223|FG000|Healthy Subjects Aged 45-64|Overall Study||3
3174341|NCT01955720|3902224|FG001|Healthy Subjects Aged 45-64|Overall Study||3
3174342|NCT01955720|3902225|FG002|Healthy Subjects Aged 45-64|Overall Study||3
3174343|NCT01955720|3902226|FG003|Healthy Subjects Aged 45-64|Overall Study||3
3321912|NCT03181932|4055014|FG000|NOT COMPLETED|Period 1 (Double-blind Period)||11
3321913|NCT03181932|4055015|FG001|NOT COMPLETED|Period 1 (Double-blind Period)||13
3321914|NCT03181932|4055014|FG000|STARTED|Period 2 (Open-label Period)||75
2925018|NCT00561457|3636256|FG000|STARTED|Overall Study||134
2925019|NCT00561457|3636256|FG000|COMPLETED|Overall Study||110
2925020|NCT00561457|3636256|FG000|NOT COMPLETED|Overall Study||24
2925021|NCT00561470|3636262|FG000|STARTED|Overall Study||614
2925022|NCT00561470|3636263|FG001|STARTED|Overall Study||612
2925023|NCT00561470|3636262|FG000|TREATED|Overall Study||609
2925024|NCT00561470|3636263|FG001|TREATED|Overall Study||607
2925025|NCT00561470|3636262|FG000|SAFETY POPULATION|Overall Study|Treated participants excluding 4 who received at least 1 dose of Aflibercept|605
2925026|NCT00561470|3636263|FG001|SAFETY POPULATION|Overall Study|Treated participants including 4 from Placebo/FOLFIRI who received at least 1 dose of Aflibercept|611
2925027|NCT00561470|3636262|FG000|ONGOING TREATMENT|Overall Study|Participants continuing treatment on the cutoff date of the final analysis|11
3321915|NCT03181932|4055015|FG001|STARTED|Period 2 (Open-label Period)||83
3321916|NCT03181932|4055014|FG000|COMPLETED|Period 2 (Open-label Period)||67
3321917|NCT03181932|4055015|FG001|COMPLETED|Period 2 (Open-label Period)||70
3321918|NCT03181932|4055014|FG000|NOT COMPLETED|Period 2 (Open-label Period)||8
3321919|NCT03181932|4055015|FG001|NOT COMPLETED|Period 2 (Open-label Period)||13
3321920|NCT03181958|4055025|FG000|STARTED|Overall Study||497
3321921|NCT03181958|4055026|FG001|STARTED|Overall Study||501
3321922|NCT03181958|4055027|FG002|STARTED|Overall Study||495
3321923|NCT03181958|4055025|FG000|COMPLETED|Overall Study||480
3321924|NCT03181958|4055026|FG001|COMPLETED|Overall Study||480
3321925|NCT03181958|4055027|FG002|COMPLETED|Overall Study||480
3321926|NCT03181958|4055025|FG000|NOT COMPLETED|Overall Study||17
3321927|NCT03181958|4055026|FG001|NOT COMPLETED|Overall Study||21
3321928|NCT03181958|4055027|FG002|NOT COMPLETED|Overall Study||15
3321929|NCT03182582|4055035|FG000|STARTED|Treatment 1||12
3321930|NCT03182582|4055036|FG001|STARTED|Treatment 1||10
3321931|NCT03182582|4055035|FG000|COMPLETED|Treatment 1||12
3321932|NCT03182582|4055036|FG001|COMPLETED|Treatment 1||10
3321933|NCT03182582|4055035|FG000|NOT COMPLETED|Treatment 1||0
3321934|NCT03182582|4055036|FG001|NOT COMPLETED|Treatment 1||0
3321935|NCT03182582|4055035|FG000|STARTED|Treatment 2||12
3321936|NCT03182582|4055036|FG001|STARTED|Treatment 2||10
3321937|NCT03182582|4055035|FG000|COMPLETED|Treatment 2||12
3321938|NCT03182582|4055036|FG001|COMPLETED|Treatment 2||10
3321939|NCT03182582|4055035|FG000|NOT COMPLETED|Treatment 2||0
3321940|NCT03182582|4055036|FG001|NOT COMPLETED|Treatment 2||0
3321941|NCT03182725|4055049|FG000|STARTED|Treatment Arm 1 (First Half of Study)||16
3321942|NCT03182725|4055050|FG001|STARTED|Treatment Arm 1 (First Half of Study)||10
3321943|NCT03182725|4055049|FG000|COMPLETED|Treatment Arm 1 (First Half of Study)||16
3321944|NCT03182725|4055050|FG001|COMPLETED|Treatment Arm 1 (First Half of Study)||7
3321945|NCT03182725|4055049|FG000|NOT COMPLETED|Treatment Arm 1 (First Half of Study)||0
3321946|NCT03182725|4055050|FG001|NOT COMPLETED|Treatment Arm 1 (First Half of Study)||3
3321947|NCT03182725|4055049|FG000|STARTED|Treatment Arm 2 (Second Half of Study)||16
3321948|NCT03182725|4055050|FG001|STARTED|Treatment Arm 2 (Second Half of Study)|One participant withdrew during crossover and therefore did not start Treatment Arm 2.|6
3321949|NCT03182725|4055049|FG000|COMPLETED|Treatment Arm 2 (Second Half of Study)||16
3321950|NCT03182725|4055050|FG001|COMPLETED|Treatment Arm 2 (Second Half of Study)||6
3321951|NCT03182725|4055049|FG000|NOT COMPLETED|Treatment Arm 2 (Second Half of Study)||0
3321952|NCT03182725|4055050|FG001|NOT COMPLETED|Treatment Arm 2 (Second Half of Study)||0
3321953|NCT03182738|4055058|FG000|STARTED|Overall Study||50
3174344|NCT01955720|3902227|FG004|Healthy Subjects Aged 45-64|Overall Study||0
3174345|NCT01955720|3902228|FG005|Healthy Subjects Aged 45-64|Overall Study||0
3174346|NCT01955720|3902223|FG000|Healthy Subjects Aged 65-80|Overall Study||4
3174347|NCT01955720|3902224|FG001|Healthy Subjects Aged 65-80|Overall Study||4
3174348|NCT01955720|3902225|FG002|Healthy Subjects Aged 65-80|Overall Study||0
3174349|NCT01955720|3902226|FG003|Healthy Subjects Aged 65-80|Overall Study||0
3174350|NCT01955720|3902227|FG004|Healthy Subjects Aged 65-80|Overall Study||4
3174351|NCT01955720|3902228|FG005|Healthy Subjects Aged 65-80|Overall Study||4
3174352|NCT01955720|3902223|FG000|Subjects With Mild Renal Impairment|Overall Study||3
3174353|NCT01955720|3902224|FG001|Subjects With Mild Renal Impairment|Overall Study||3
3174354|NCT01955720|3902225|FG002|Subjects With Mild Renal Impairment|Overall Study||0
3174355|NCT01955720|3902226|FG003|Subjects With Mild Renal Impairment|Overall Study||0
3321954|NCT03182738|4055059|FG001|STARTED|Overall Study||50
2925028|NCT00561470|3636263|FG001|ONGOING TREATMENT|Overall Study|Participants continuing treatment on the cutoff date of the final analysis|14
2925029|NCT00561470|3636262|FG000|COMPLETED|Overall Study|Participants met treatment discontinuation criteria or were ongoing treatment on the cutoff date|0
3039083|NCT01156012|3758415|FG000|STARTED|Overall Study||213
3039084|NCT01156012|3758416|FG001|STARTED|Overall Study||189
3039085|NCT01156012|3758415|FG000|COMPLETED|Overall Study||206
3039086|NCT01156012|3758416|FG001|COMPLETED|Overall Study||186
3039087|NCT01156012|3758415|FG000|NOT COMPLETED|Overall Study||7
3039088|NCT01156012|3758416|FG001|NOT COMPLETED|Overall Study||3
3039089|NCT01156051|3758424|FG000|STARTED|Overall Study||12
3039090|NCT01156051|3758425|FG001|STARTED|Overall Study||17
3039091|NCT01156051|3758424|FG000|COMPLETED|Overall Study||11
3039092|NCT01156051|3758425|FG001|COMPLETED|Overall Study||16
3039093|NCT01156051|3758424|FG000|NOT COMPLETED|Overall Study||1
3039094|NCT01156051|3758425|FG001|NOT COMPLETED|Overall Study||1
3039095|NCT01156116|3758433|FG000|STARTED|Overall Study||26
3039096|NCT01156116|3758434|FG001|STARTED|Overall Study||13
3039097|NCT01156116|3758433|FG000|COMPLETED|Overall Study||21
3039098|NCT01156116|3758434|FG001|COMPLETED|Overall Study||12
3039099|NCT01156116|3758433|FG000|NOT COMPLETED|Overall Study||5
3039100|NCT01156116|3758434|FG001|NOT COMPLETED|Overall Study||1
3039101|NCT01156142|3758442|FG000|STARTED|Overall Study||77
3039102|NCT01156142|3758443|FG001|STARTED|Overall Study||78
3039103|NCT01156142|3758442|FG000|COMPLETED|Overall Study||69
3039104|NCT01156142|3758443|FG001|COMPLETED|Overall Study||71
3039105|NCT01156142|3758442|FG000|NOT COMPLETED|Overall Study||8
3039106|NCT01156142|3758443|FG001|NOT COMPLETED|Overall Study||7
3039107|NCT01156311|3758451|FG000|STARTED|2-Month Monotherapy Period||59
3039108|NCT01156311|3758452|FG001|STARTED|2-Month Monotherapy Period||49
3039109|NCT01156311|3758453|FG002|STARTED|2-Month Monotherapy Period||0
3039110|NCT01156311|3758454|FG003|STARTED|2-Month Monotherapy Period||0
3039111|NCT01156311|3758451|FG000|COMPLETED|2-Month Monotherapy Period||57
3174356|NCT01955720|3902227|FG004|Subjects With Mild Renal Impairment|Overall Study||3
3174357|NCT01955720|3902228|FG005|Subjects With Mild Renal Impairment|Overall Study||3
3174358|NCT01955720|3902223|FG000|Subjects With Moderate Renal Impairment|Overall Study||3
3174359|NCT01955720|3902224|FG001|Subjects With Moderate Renal Impairment|Overall Study||3
3174360|NCT01955720|3902225|FG002|Subjects With Moderate Renal Impairment|Overall Study||0
3174361|NCT01955720|3902226|FG003|Subjects With Moderate Renal Impairment|Overall Study||0
3174362|NCT01955720|3902227|FG004|Subjects With Moderate Renal Impairment|Overall Study||0
3174363|NCT01955720|3902228|FG005|Subjects With Moderate Renal Impairment|Overall Study||0
3174364|NCT01955720|3902223|FG000|COMPLETED|Overall Study||13
3174365|NCT01955720|3902224|FG001|COMPLETED|Overall Study||13
3174366|NCT01955720|3902225|FG002|COMPLETED|Overall Study||3
3174367|NCT01955720|3902226|FG003|COMPLETED|Overall Study||3
3174368|NCT01955720|3902227|FG004|COMPLETED|Overall Study||7
3174369|NCT01955720|3902228|FG005|COMPLETED|Overall Study||7
3174370|NCT01955720|3902223|FG000|NOT COMPLETED|Overall Study||0
2925030|NCT00561470|3636263|FG001|COMPLETED|Overall Study|Participants met treatment discontinuation criteria or were ongoing treatment on the cutoff date|0
2925031|NCT00561470|3636262|FG000|NOT COMPLETED|Overall Study||614
2925032|NCT00561470|3636263|FG001|NOT COMPLETED|Overall Study||612
2925033|NCT00561574|3636273|FG000|STARTED|Overall Study||128
2925034|NCT00561574|3636274|FG001|STARTED|Overall Study||131
2925035|NCT00561574|3636273|FG000|COMPLETED|Overall Study||80
3174371|NCT01955720|3902224|FG001|NOT COMPLETED|Overall Study||0
3174372|NCT01955720|3902225|FG002|NOT COMPLETED|Overall Study||0
3174373|NCT01955720|3902226|FG003|NOT COMPLETED|Overall Study||0
3174374|NCT01955720|3902227|FG004|NOT COMPLETED|Overall Study||0
3174375|NCT01955720|3902228|FG005|NOT COMPLETED|Overall Study||0
3174376|NCT01955733|3902277|FG000|STARTED|Period 1||33
3174377|NCT01955733|3902278|FG001|STARTED|Period 1||29
3174378|NCT01955733|3902279|FG002|STARTED|Period 1||29
3174379|NCT01955733|3902277|FG000|COMPLETED|Period 1||32
3174380|NCT01955733|3902278|FG001|COMPLETED|Period 1||29
3174381|NCT01955733|3902279|FG002|COMPLETED|Period 1||29
3174382|NCT01955733|3902277|FG000|NOT COMPLETED|Period 1||1
3174383|NCT01955733|3902278|FG001|NOT COMPLETED|Period 1||0
3174384|NCT01955733|3902279|FG002|NOT COMPLETED|Period 1||0
3174385|NCT01955733|3902277|FG000|STARTED|Period 2||32
3174386|NCT01955733|3902278|FG001|STARTED|Period 2||29
3174387|NCT01955733|3902279|FG002|STARTED|Period 2||29
2925036|NCT00561574|3636274|FG001|COMPLETED|Overall Study||73
2925037|NCT00561574|3636273|FG000|NOT COMPLETED|Overall Study||48
3174388|NCT01955733|3902277|FG000|COMPLETED|Period 2||20
2925038|NCT00561574|3636274|FG001|NOT COMPLETED|Overall Study||58
2925039|NCT00561600|3636282|FG000|STARTED|Overall Study||130
2925040|NCT00561600|3636283|FG001|STARTED|Overall Study||135
2925041|NCT00561600|3636282|FG000|COMPLETED|Overall Study||112
2925042|NCT00561600|3636283|FG001|COMPLETED|Overall Study||119
2925043|NCT00561600|3636282|FG000|NOT COMPLETED|Overall Study||18
2925044|NCT00561600|3636283|FG001|NOT COMPLETED|Overall Study||16
2925045|NCT00561652|3636293|FG000|STARTED|Overall Study||10
2925046|NCT00561652|3636294|FG001|STARTED|Overall Study||20
2925047|NCT00561652|3636293|FG000|COMPLETED|Overall Study||10
2925048|NCT00561652|3636294|FG001|COMPLETED|Overall Study||19
2925049|NCT00561652|3636293|FG000|NOT COMPLETED|Overall Study||0
2925050|NCT00561652|3636294|FG001|NOT COMPLETED|Overall Study||1
2925051|NCT00561678|3636302|FG000|STARTED|Overall Study||197
2925052|NCT00561678|3636303|FG001|STARTED|Overall Study||207
2925053|NCT00561678|3636302|FG000|COMPLETED|Overall Study||189
2925054|NCT00561678|3636303|FG001|COMPLETED|Overall Study||201
2925055|NCT00561678|3636302|FG000|NOT COMPLETED|Overall Study||8
2925056|NCT00561678|3636303|FG001|NOT COMPLETED|Overall Study||6
2925057|NCT00561730|3636309|FG000|STARTED|Overall Study||1995
2925058|NCT00561730|3636309|FG000|COMPLETED|Overall Study||1986
2925059|NCT00561730|3636309|FG000|NOT COMPLETED|Overall Study||9
2925060|NCT00561821|3636319|FG000|STARTED|Overall Study||132
2925061|NCT00561821|3636320|FG001|STARTED|Overall Study||136
2925062|NCT00561821|3636321|FG002|STARTED|Overall Study||134
2925063|NCT00561821|3636322|FG003|STARTED|Overall Study||136
2925064|NCT00561821|3636319|FG000|Treated|Overall Study||132
2925065|NCT00561821|3636320|FG001|Treated|Overall Study||136
2925066|NCT00561821|3636321|FG002|Treated|Overall Study||133
2925067|NCT00561821|3636322|FG003|Treated|Overall Study||136
2925068|NCT00561821|3636319|FG000|COMPLETED|Overall Study||127
2925069|NCT00561821|3636320|FG001|COMPLETED|Overall Study||130
2925070|NCT00561821|3636321|FG002|COMPLETED|Overall Study||132
2925071|NCT00561821|3636322|FG003|COMPLETED|Overall Study||133
2925072|NCT00561821|3636319|FG000|NOT COMPLETED|Overall Study||5
2925073|NCT00561821|3636320|FG001|NOT COMPLETED|Overall Study||6
2925074|NCT00561821|3636321|FG002|NOT COMPLETED|Overall Study||2
2925075|NCT00561821|3636322|FG003|NOT COMPLETED|Overall Study||3
2925076|NCT00561834|3636332|FG000|STARTED|Overall Study||2
2925077|NCT00561834|3636332|FG000|COMPLETED|Overall Study||2
2925078|NCT00561834|3636332|FG000|NOT COMPLETED|Overall Study||0
2925079|NCT00561925|3636339|FG000|STARTED|14 Day Lead-In Period||1068
2925080|NCT00561925|3636340|FG001|STARTED|14 Day Lead-In Period||0
2925081|NCT00561925|3636341|FG002|STARTED|14 Day Lead-In Period||0
2925082|NCT00561925|3636342|FG003|STARTED|14 Day Lead-In Period||0
2925083|NCT00561925|3636343|FG004|STARTED|14 Day Lead-In Period||0
2925084|NCT00561925|3636339|FG000|COMPLETED|14 Day Lead-In Period||1013
2925085|NCT00561925|3636340|FG001|COMPLETED|14 Day Lead-In Period||0
2925086|NCT00561925|3636341|FG002|COMPLETED|14 Day Lead-In Period||0
2925087|NCT00561925|3636342|FG003|COMPLETED|14 Day Lead-In Period||0
2925088|NCT00561925|3636343|FG004|COMPLETED|14 Day Lead-In Period||0
2925089|NCT00561925|3636339|FG000|NOT COMPLETED|14 Day Lead-In Period||55
2925090|NCT00561925|3636340|FG001|NOT COMPLETED|14 Day Lead-In Period||0
2925091|NCT00561925|3636341|FG002|NOT COMPLETED|14 Day Lead-In Period||0
2925092|NCT00561925|3636342|FG003|NOT COMPLETED|14 Day Lead-In Period||0
2925093|NCT00561925|3636343|FG004|NOT COMPLETED|14 Day Lead-In Period||0
2925094|NCT00561925|3636339|FG000|STARTED|144-week Double-blind, Double-dummy||0
2925095|NCT00561925|3636340|FG001|STARTED|144-week Double-blind, Double-dummy||508
2925096|NCT00561925|3636341|FG002|STARTED|144-week Double-blind, Double-dummy||505
2925097|NCT00561925|3636342|FG003|STARTED|144-week Double-blind, Double-dummy||0
2925098|NCT00561925|3636343|FG004|STARTED|144-week Double-blind, Double-dummy||0
2925099|NCT00561925|3636339|FG000|COMPLETED|144-week Double-blind, Double-dummy||0
2925100|NCT00561925|3636340|FG001|COMPLETED|144-week Double-blind, Double-dummy||358
2925101|NCT00561925|3636341|FG002|COMPLETED|144-week Double-blind, Double-dummy||378
2925102|NCT00561925|3636342|FG003|COMPLETED|144-week Double-blind, Double-dummy||0
2925103|NCT00561925|3636343|FG004|COMPLETED|144-week Double-blind, Double-dummy||0
3321955|NCT03182738|4055058|FG000|COMPLETED|Overall Study||41
3321956|NCT03182738|4055059|FG001|COMPLETED|Overall Study||45
3321957|NCT03182738|4055058|FG000|NOT COMPLETED|Overall Study||9
3321958|NCT03182738|4055059|FG001|NOT COMPLETED|Overall Study||5
3321959|NCT03182829|4055067|FG000|STARTED|Overall Study||467
3321960|NCT03182829|4055068|FG001|STARTED|Overall Study||444
3321961|NCT03182829|4055067|FG000|COMPLETED|Overall Study||451
3321962|NCT03182829|4055068|FG001|COMPLETED|Overall Study||429
3321963|NCT03182829|4055067|FG000|NOT COMPLETED|Overall Study||16
3321964|NCT03182829|4055068|FG001|NOT COMPLETED|Overall Study||15
3174389|NCT01955733|3902278|FG001|COMPLETED|Period 2||10
3174390|NCT01955733|3902279|FG002|COMPLETED|Period 2||8
3174391|NCT01955733|3902277|FG000|NOT COMPLETED|Period 2||12
3174392|NCT01955733|3902278|FG001|NOT COMPLETED|Period 2||19
3174393|NCT01955733|3902279|FG002|NOT COMPLETED|Period 2||21
3174394|NCT01955837|3902289|FG000|STARTED|Overall Study||271
3174395|NCT01955837|3902290|FG001|STARTED|Overall Study||135
3174396|NCT01955837|3902289|FG000|COMPLETED|Overall Study||271
3174397|NCT01955837|3902290|FG001|COMPLETED|Overall Study||135
3174398|NCT01955837|3902289|FG000|NOT COMPLETED|Overall Study||0
3174399|NCT01955837|3902290|FG001|NOT COMPLETED|Overall Study||0
3174400|NCT01955954|3902296|FG000|STARTED|Overall Study||69
3174401|NCT01955954|3902296|FG000|Received Treatment|Overall Study||66
3174402|NCT01955954|3902296|FG000|Completed Treatment|Overall Study||53
3174403|NCT01955954|3902296|FG000|Completed Post-treatment Assessement|Overall Study||48
3174404|NCT01955954|3902296|FG000|Completed 2-month Assessment|Overall Study|Primary endpoint|46
3174405|NCT01955954|3902296|FG000|Completed 6-month Assessement|Overall Study||42
3174406|NCT01955954|3902296|FG000|COMPLETED|Overall Study|12-months|33
3174407|NCT01955954|3902296|FG000|NOT COMPLETED|Overall Study||36
3174408|NCT01956032|3902300|FG000|STARTED|Overall Study||15
3174409|NCT01956032|3902300|FG000|COMPLETED|Overall Study||15
3174410|NCT01956032|3902300|FG000|NOT COMPLETED|Overall Study||0
3321965|NCT03182868|4055079|FG000|STARTED|Overall Study||12
3321966|NCT03182868|4055080|FG001|STARTED|Overall Study||20
3321967|NCT03182868|4055081|FG002|STARTED|Overall Study||21
3321968|NCT03182868|4055082|FG003|STARTED|Overall Study||1
3321969|NCT03182868|4055083|FG004|STARTED|Overall Study||24
3321970|NCT03182868|4055079|FG000|COMPLETED|Overall Study||9
3321971|NCT03182868|4055080|FG001|COMPLETED|Overall Study||20
3321972|NCT03182868|4055081|FG002|COMPLETED|Overall Study||17
3321973|NCT03182868|4055082|FG003|COMPLETED|Overall Study||0
3321974|NCT03182868|4055083|FG004|COMPLETED|Overall Study||16
2925104|NCT00561925|3636339|FG000|NOT COMPLETED|144-week Double-blind, Double-dummy||0
2925105|NCT00561925|3636340|FG001|NOT COMPLETED|144-week Double-blind, Double-dummy||150
2925106|NCT00561925|3636341|FG002|NOT COMPLETED|144-week Double-blind, Double-dummy||127
2925107|NCT00561925|3636342|FG003|NOT COMPLETED|144-week Double-blind, Double-dummy||0
2925108|NCT00561925|3636343|FG004|NOT COMPLETED|144-week Double-blind, Double-dummy||0
2925109|NCT00561925|3636339|FG000|STARTED|Open-Label Extension Period||0
2925110|NCT00561925|3636340|FG001|STARTED|Open-Label Extension Period||1
2925111|NCT00561925|3636341|FG002|STARTED|Open-Label Extension Period||0
2925112|NCT00561925|3636342|FG003|STARTED|Open-Label Extension Period||358
2925113|NCT00561925|3636343|FG004|STARTED|Open-Label Extension Period||378
2925114|NCT00561925|3636339|FG000|COMPLETED|Open-Label Extension Period||0
2925115|NCT00561925|3636340|FG001|COMPLETED|Open-Label Extension Period||1
2925116|NCT00561925|3636341|FG002|COMPLETED|Open-Label Extension Period||0
2925117|NCT00561925|3636342|FG003|COMPLETED|Open-Label Extension Period||315
2925118|NCT00561925|3636343|FG004|COMPLETED|Open-Label Extension Period||328
2925119|NCT00561925|3636339|FG000|NOT COMPLETED|Open-Label Extension Period||0
2925120|NCT00561925|3636340|FG001|NOT COMPLETED|Open-Label Extension Period||0
2925121|NCT00561925|3636341|FG002|NOT COMPLETED|Open-Label Extension Period||0
2925122|NCT00561925|3636342|FG003|NOT COMPLETED|Open-Label Extension Period||43
2925123|NCT00561925|3636343|FG004|NOT COMPLETED|Open-Label Extension Period||50
2925124|NCT00561951|3636364|FG000|STARTED|Overall Study||318
2925125|NCT00561951|3636365|FG001|STARTED|Overall Study||320
2925126|NCT00561951|3636366|FG002|STARTED|Overall Study||313
2925127|NCT00561951|3636364|FG000|COMPLETED|Overall Study||285
2925128|NCT00561951|3636365|FG001|COMPLETED|Overall Study||286
2925129|NCT00561951|3636366|FG002|COMPLETED|Overall Study||281
3321975|NCT03182868|4055079|FG000|NOT COMPLETED|Overall Study||3
3321976|NCT03182868|4055080|FG001|NOT COMPLETED|Overall Study||0
3174411|NCT01956071|3902304|FG000|STARTED|Overall Study||44
3174412|NCT01956071|3902304|FG000|COMPLETED|Overall Study||44
3174413|NCT01956071|3902304|FG000|NOT COMPLETED|Overall Study||0
3174414|NCT01956097|3902311|FG000|STARTED|Overall Study||30
3174415|NCT01956097|3902312|FG001|STARTED|Overall Study||30
3174416|NCT01956097|3902313|FG002|STARTED|Overall Study||15
3174417|NCT01956097|3902311|FG000|COMPLETED|Overall Study||24
3174418|NCT01956097|3902312|FG001|COMPLETED|Overall Study||28
3174419|NCT01956097|3902313|FG002|COMPLETED|Overall Study||15
3174420|NCT01956097|3902311|FG000|NOT COMPLETED|Overall Study||6
2925130|NCT00561951|3636364|FG000|NOT COMPLETED|Overall Study||33
2925131|NCT00561951|3636365|FG001|NOT COMPLETED|Overall Study||34
2925132|NCT00561951|3636366|FG002|NOT COMPLETED|Overall Study||32
2925133|NCT00561977|3636377|FG000|STARTED|Overall Study||12
2925134|NCT00561977|3636378|FG001|STARTED|Overall Study||12
2925135|NCT00561977|3636379|FG002|STARTED|Overall Study||12
2925136|NCT00561977|3636377|FG000|COMPLETED|Overall Study||12
2925137|NCT00561977|3636378|FG001|COMPLETED|Overall Study||9
2925138|NCT00561977|3636379|FG002|COMPLETED|Overall Study||10
2925139|NCT00561977|3636377|FG000|NOT COMPLETED|Overall Study||0
2925140|NCT00561977|3636378|FG001|NOT COMPLETED|Overall Study||3
2925141|NCT00561977|3636379|FG002|NOT COMPLETED|Overall Study||2
2925142|NCT00562094|3636387|FG000|STARTED|Overall Study||8616
2925143|NCT00562094|3636387|FG000|COMPLETED|Overall Study||8554
2925144|NCT00562094|3636387|FG000|NOT COMPLETED|Overall Study||62
2925145|NCT00562120|3636395|FG000|STARTED|First Intervention Period||6
2925146|NCT00562120|3636396|FG001|STARTED|First Intervention Period||5
2925147|NCT00562120|3636397|FG002|STARTED|First Intervention Period||5
2925148|NCT00562120|3636398|FG003|STARTED|First Intervention Period||5
2925149|NCT00562120|3636395|FG000|Treated|First Intervention Period||5
2925150|NCT00562120|3636396|FG001|Treated|First Intervention Period||5
2925151|NCT00562120|3636397|FG002|Treated|First Intervention Period||5
2925152|NCT00562120|3636398|FG003|Treated|First Intervention Period||5
2925153|NCT00562120|3636395|FG000|COMPLETED|First Intervention Period||4
2925154|NCT00562120|3636396|FG001|COMPLETED|First Intervention Period||5
2925155|NCT00562120|3636397|FG002|COMPLETED|First Intervention Period||5
2925156|NCT00562120|3636398|FG003|COMPLETED|First Intervention Period||5
2925157|NCT00562120|3636395|FG000|NOT COMPLETED|First Intervention Period||2
2925158|NCT00562120|3636396|FG001|NOT COMPLETED|First Intervention Period||0
2925159|NCT00562120|3636397|FG002|NOT COMPLETED|First Intervention Period||0
2925160|NCT00562120|3636398|FG003|NOT COMPLETED|First Intervention Period||0
2925161|NCT00562120|3636395|FG000|STARTED|Washout Period 1 (At Least 14 Days)||4
2925162|NCT00562120|3636396|FG001|STARTED|Washout Period 1 (At Least 14 Days)||5
2925163|NCT00562120|3636397|FG002|STARTED|Washout Period 1 (At Least 14 Days)||5
2925164|NCT00562120|3636398|FG003|STARTED|Washout Period 1 (At Least 14 Days)||5
2925165|NCT00562120|3636395|FG000|COMPLETED|Washout Period 1 (At Least 14 Days)||4
2925166|NCT00562120|3636396|FG001|COMPLETED|Washout Period 1 (At Least 14 Days)||5
2925167|NCT00562120|3636397|FG002|COMPLETED|Washout Period 1 (At Least 14 Days)||5
2925168|NCT00562120|3636398|FG003|COMPLETED|Washout Period 1 (At Least 14 Days)||5
2925169|NCT00562120|3636395|FG000|NOT COMPLETED|Washout Period 1 (At Least 14 Days)||0
2925170|NCT00562120|3636396|FG001|NOT COMPLETED|Washout Period 1 (At Least 14 Days)||0
2925171|NCT00562120|3636397|FG002|NOT COMPLETED|Washout Period 1 (At Least 14 Days)||0
2925172|NCT00562120|3636398|FG003|NOT COMPLETED|Washout Period 1 (At Least 14 Days)||0
2925173|NCT00562120|3636395|FG000|STARTED|Second Intervention Period||4
2925174|NCT00562120|3636396|FG001|STARTED|Second Intervention Period||5
3174421|NCT01956097|3902312|FG001|NOT COMPLETED|Overall Study||2
3174422|NCT01956097|3902313|FG002|NOT COMPLETED|Overall Study||0
3174423|NCT01956123|3902323|FG000|STARTED|COS Cycle 2||252
3174424|NCT01956123|3902324|FG001|STARTED|COS Cycle 2||261
3321977|NCT03182868|4055081|FG002|NOT COMPLETED|Overall Study||4
3321978|NCT03182868|4055082|FG003|NOT COMPLETED|Overall Study||1
3321979|NCT03182868|4055083|FG004|NOT COMPLETED|Overall Study||8
3321980|NCT03182920|4055096|FG000|STARTED|Period 1||9
3321981|NCT03182920|4055097|FG001|STARTED|Period 1||9
3174425|NCT01956123|3902325|FG002|STARTED|COS Cycle 2||0
3174426|NCT01956123|3902326|FG003|STARTED|COS Cycle 2||0
3174427|NCT01956123|3902323|FG000|COMPLETED|COS Cycle 2||238
3174428|NCT01956123|3902324|FG001|COMPLETED|COS Cycle 2||254
3174429|NCT01956123|3902325|FG002|COMPLETED|COS Cycle 2||0
3174430|NCT01956123|3902326|FG003|COMPLETED|COS Cycle 2||0
3174431|NCT01956123|3902323|FG000|NOT COMPLETED|COS Cycle 2||14
3174432|NCT01956123|3902324|FG001|NOT COMPLETED|COS Cycle 2||7
3174433|NCT01956123|3902325|FG002|NOT COMPLETED|COS Cycle 2||0
3174434|NCT01956123|3902326|FG003|NOT COMPLETED|COS Cycle 2||0
3174435|NCT01956123|3902323|FG000|STARTED|COS Cycle 3||0
3174436|NCT01956123|3902324|FG001|STARTED|COS Cycle 3||0
3174437|NCT01956123|3902325|FG002|STARTED|COS Cycle 3|Subjects in COS cycle 2 who failed to achieve an ongoing pregnancy could undergo COS cycle 3|95
3321982|NCT03182920|4055098|FG002|STARTED|Period 1||17
3174438|NCT01956123|3902326|FG003|STARTED|COS Cycle 3|Subjects in COS cycle 2 who failed to achieve an ongoing pregnancy could undergo COS cycle 3|93
2925175|NCT00562120|3636397|FG002|STARTED|Second Intervention Period||5
2925176|NCT00562120|3636398|FG003|STARTED|Second Intervention Period||5
2925177|NCT00562120|3636395|FG000|COMPLETED|Second Intervention Period||4
2925178|NCT00562120|3636396|FG001|COMPLETED|Second Intervention Period||5
2925179|NCT00562120|3636397|FG002|COMPLETED|Second Intervention Period||5
2925180|NCT00562120|3636398|FG003|COMPLETED|Second Intervention Period||5
2925181|NCT00562120|3636395|FG000|NOT COMPLETED|Second Intervention Period||0
2925182|NCT00562120|3636396|FG001|NOT COMPLETED|Second Intervention Period||0
2925183|NCT00562120|3636397|FG002|NOT COMPLETED|Second Intervention Period||0
2925184|NCT00562120|3636398|FG003|NOT COMPLETED|Second Intervention Period||0
2925185|NCT00562120|3636395|FG000|STARTED|Washout Period 2 (At Least 14 Days)||4
2925186|NCT00562120|3636396|FG001|STARTED|Washout Period 2 (At Least 14 Days)||5
2925187|NCT00562120|3636397|FG002|STARTED|Washout Period 2 (At Least 14 Days)||5
2925188|NCT00562120|3636398|FG003|STARTED|Washout Period 2 (At Least 14 Days)||5
2925189|NCT00562120|3636395|FG000|COMPLETED|Washout Period 2 (At Least 14 Days)||4
3174439|NCT01956123|3902323|FG000|COMPLETED|COS Cycle 3||0
3174440|NCT01956123|3902324|FG001|COMPLETED|COS Cycle 3||0
3174441|NCT01956123|3902325|FG002|COMPLETED|COS Cycle 3||89
3174442|NCT01956123|3902326|FG003|COMPLETED|COS Cycle 3||91
3174443|NCT01956123|3902323|FG000|NOT COMPLETED|COS Cycle 3||0
3174444|NCT01956123|3902324|FG001|NOT COMPLETED|COS Cycle 3||0
3321983|NCT03182920|4055096|FG000|COMPLETED|Period 1||9
3321984|NCT03182920|4055097|FG001|COMPLETED|Period 1||9
3321985|NCT03182920|4055098|FG002|COMPLETED|Period 1||17
3321986|NCT03182920|4055096|FG000|NOT COMPLETED|Period 1||0
3321987|NCT03182920|4055097|FG001|NOT COMPLETED|Period 1||0
3321988|NCT03182920|4055098|FG002|NOT COMPLETED|Period 1||0
3321989|NCT03182920|4055096|FG000|STARTED|Washout Period||9
3321990|NCT03182920|4055097|FG001|STARTED|Washout Period||9
3321991|NCT03182920|4055098|FG002|STARTED|Washout Period||0
3321992|NCT03182920|4055096|FG000|COMPLETED|Washout Period||9
3174445|NCT01956123|3902325|FG002|NOT COMPLETED|COS Cycle 3||6
3174446|NCT01956123|3902326|FG003|NOT COMPLETED|COS Cycle 3||2
3174447|NCT01956240|3902339|FG000|STARTED|Overall Study||48
3174448|NCT01956240|3902340|FG001|STARTED|Overall Study||49
3174449|NCT01956240|3902339|FG000|COMPLETED|Overall Study||25
3174450|NCT01956240|3902340|FG001|COMPLETED|Overall Study||25
3174451|NCT01956240|3902339|FG000|NOT COMPLETED|Overall Study||23
3174452|NCT01956240|3902340|FG001|NOT COMPLETED|Overall Study||24
3174453|NCT01956279|3902348|FG000|STARTED|Overall Study||82
3174454|NCT01956279|3902349|FG001|STARTED|Overall Study||88
3174455|NCT01956279|3902348|FG000|COMPLETED|Overall Study||68
3174456|NCT01956279|3902349|FG001|COMPLETED|Overall Study||74
3321993|NCT03182920|4055097|FG001|COMPLETED|Washout Period||9
3321994|NCT03182920|4055098|FG002|COMPLETED|Washout Period||0
3321995|NCT03182920|4055096|FG000|NOT COMPLETED|Washout Period||0
3321996|NCT03182920|4055097|FG001|NOT COMPLETED|Washout Period||0
3321997|NCT03182920|4055098|FG002|NOT COMPLETED|Washout Period||0
3321998|NCT03182920|4055096|FG000|STARTED|Period 2||9
3321999|NCT03182920|4055097|FG001|STARTED|Period 2||9
3322000|NCT03182920|4055098|FG002|STARTED|Period 2|Young participants on Lasmiditan did not move to study period 2.|0
3322001|NCT03182920|4055096|FG000|COMPLETED|Period 2||9
3322002|NCT03182920|4055097|FG001|COMPLETED|Period 2||9
3322003|NCT03182920|4055098|FG002|COMPLETED|Period 2||0
3322004|NCT03182920|4055096|FG000|NOT COMPLETED|Period 2||0
3322005|NCT03182920|4055097|FG001|NOT COMPLETED|Period 2||0
3322006|NCT03182920|4055098|FG002|NOT COMPLETED|Period 2||0
3322007|NCT03182933|4055107|FG000|STARTED|Overall Study||32
3322008|NCT03182933|4055108|FG001|STARTED|Overall Study||32
3174457|NCT01956279|3902348|FG000|NOT COMPLETED|Overall Study||14
3174458|NCT01956279|3902349|FG001|NOT COMPLETED|Overall Study||14
3174459|NCT01956435|3902355|FG000|STARTED|Overall Study||3
3174460|NCT01956435|3902356|FG001|STARTED|Overall Study||3
3174461|NCT01956435|3902355|FG000|COMPLETED|Overall Study||3
3174462|NCT01956435|3902356|FG001|COMPLETED|Overall Study||3
3174463|NCT01956435|3902355|FG000|NOT COMPLETED|Overall Study||0
3174464|NCT01956435|3902356|FG001|NOT COMPLETED|Overall Study||0
3174465|NCT01956773|3902365|FG000|STARTED|Overall Study||2520
3174466|NCT01956773|3902366|FG001|STARTED|Overall Study||100
3174467|NCT01956773|3902365|FG000|COMPLETED|Overall Study||1892
3174468|NCT01956773|3902366|FG001|COMPLETED|Overall Study||99
3174469|NCT01956773|3902365|FG000|NOT COMPLETED|Overall Study||628
3174470|NCT01956773|3902366|FG001|NOT COMPLETED|Overall Study||1
3174471|NCT01957085|3902372|FG000|STARTED|Overall Study|Per Institutional Review Board requirements, exact dates are not to be reported|366
3174472|NCT01957085|3902372|FG000|COMPLETED|Overall Study|Per Institutional Review Board, exact dates are not to be reported|366
3174473|NCT01957085|3902372|FG000|NOT COMPLETED|Overall Study||0
3174474|NCT01957111|3902379|FG000|STARTED|Overall Study||16
3174475|NCT01957111|3902380|FG001|STARTED|Overall Study||16
2925190|NCT00562120|3636396|FG001|COMPLETED|Washout Period 2 (At Least 14 Days)||5
3136993|NCT01716520|3862280|FG002|STARTED|Treatment Period 2 (14 Days)||27
3136994|NCT01716520|3862281|FG003|STARTED|Treatment Period 2 (14 Days)||29
3136995|NCT01716520|3862282|FG004|STARTED|Treatment Period 2 (14 Days)||31
3136996|NCT01716520|3862283|FG005|STARTED|Treatment Period 2 (14 Days)||27
3136997|NCT01716520|3862278|FG000|COMPLETED|Treatment Period 2 (14 Days)||29
3136998|NCT01716520|3862279|FG001|COMPLETED|Treatment Period 2 (14 Days)||28
3136999|NCT01716520|3862280|FG002|COMPLETED|Treatment Period 2 (14 Days)||27
3137000|NCT01716520|3862281|FG003|COMPLETED|Treatment Period 2 (14 Days)||28
3137001|NCT01716520|3862282|FG004|COMPLETED|Treatment Period 2 (14 Days)||29
3137002|NCT01716520|3862283|FG005|COMPLETED|Treatment Period 2 (14 Days)||27
3137003|NCT01716520|3862278|FG000|NOT COMPLETED|Treatment Period 2 (14 Days)||0
2925191|NCT00562120|3636397|FG002|COMPLETED|Washout Period 2 (At Least 14 Days)||5
2925192|NCT00562120|3636398|FG003|COMPLETED|Washout Period 2 (At Least 14 Days)||5
2925193|NCT00562120|3636395|FG000|NOT COMPLETED|Washout Period 2 (At Least 14 Days)||0
2925194|NCT00562120|3636396|FG001|NOT COMPLETED|Washout Period 2 (At Least 14 Days)||0
2925195|NCT00562120|3636397|FG002|NOT COMPLETED|Washout Period 2 (At Least 14 Days)||0
3039112|NCT01156311|3758452|FG001|COMPLETED|2-Month Monotherapy Period||47
3039113|NCT01156311|3758453|FG002|COMPLETED|2-Month Monotherapy Period||0
3039114|NCT01156311|3758454|FG003|COMPLETED|2-Month Monotherapy Period||0
3039115|NCT01156311|3758451|FG000|NOT COMPLETED|2-Month Monotherapy Period||2
3039116|NCT01156311|3758452|FG001|NOT COMPLETED|2-Month Monotherapy Period||2
3039117|NCT01156311|3758453|FG002|NOT COMPLETED|2-Month Monotherapy Period||0
3039118|NCT01156311|3758454|FG003|NOT COMPLETED|2-Month Monotherapy Period||0
3039119|NCT01156311|3758451|FG000|STARTED|6-month Add-on Therapy Period||0
3039120|NCT01156311|3758452|FG001|STARTED|6-month Add-on Therapy Period||0
3039121|NCT01156311|3758453|FG002|STARTED|6-month Add-on Therapy Period||57
3137004|NCT01716520|3862279|FG001|NOT COMPLETED|Treatment Period 2 (14 Days)||0
3174476|NCT01957111|3902379|FG000|COMPLETED|Overall Study||15
3174477|NCT01957111|3902380|FG001|COMPLETED|Overall Study||15
3174478|NCT01957111|3902379|FG000|NOT COMPLETED|Overall Study||1
2925196|NCT00562120|3636398|FG003|NOT COMPLETED|Washout Period 2 (At Least 14 Days)||0
2925197|NCT00562120|3636395|FG000|STARTED|Third Intervention Period||4
2925198|NCT00562120|3636396|FG001|STARTED|Third Intervention Period||5
2925199|NCT00562120|3636397|FG002|STARTED|Third Intervention Period||5
2925200|NCT00562120|3636398|FG003|STARTED|Third Intervention Period||5
2925201|NCT00562120|3636395|FG000|COMPLETED|Third Intervention Period||4
2925202|NCT00562120|3636396|FG001|COMPLETED|Third Intervention Period||5
2925203|NCT00562120|3636397|FG002|COMPLETED|Third Intervention Period||5
2925204|NCT00562120|3636398|FG003|COMPLETED|Third Intervention Period||5
2925205|NCT00562120|3636395|FG000|NOT COMPLETED|Third Intervention Period||0
2925206|NCT00562120|3636396|FG001|NOT COMPLETED|Third Intervention Period||0
2925207|NCT00562120|3636397|FG002|NOT COMPLETED|Third Intervention Period||0
2925208|NCT00562120|3636398|FG003|NOT COMPLETED|Third Intervention Period||0
2925209|NCT00562120|3636395|FG000|STARTED|Washout Period 3 (At Least 14 Days)||4
2925210|NCT00562120|3636396|FG001|STARTED|Washout Period 3 (At Least 14 Days)||5
2925211|NCT00562120|3636397|FG002|STARTED|Washout Period 3 (At Least 14 Days)||5
2925212|NCT00562120|3636398|FG003|STARTED|Washout Period 3 (At Least 14 Days)||5
2925213|NCT00562120|3636395|FG000|COMPLETED|Washout Period 3 (At Least 14 Days)||4
2925214|NCT00562120|3636396|FG001|COMPLETED|Washout Period 3 (At Least 14 Days)||5
2925215|NCT00562120|3636397|FG002|COMPLETED|Washout Period 3 (At Least 14 Days)||5
3174479|NCT01957111|3902380|FG001|NOT COMPLETED|Overall Study||1
3174480|NCT01957137|3902386|FG000|STARTED|Randomized Portion||30
3174481|NCT01957137|3902386|FG000|Continuous Stimulation|Randomized Portion|Subjects received continuous stimulation for approximately 4 weeks.|29
3322009|NCT03182933|4055107|FG000|COMPLETED|Overall Study||31
2925216|NCT00562120|3636398|FG003|COMPLETED|Washout Period 3 (At Least 14 Days)||5
2925217|NCT00562120|3636395|FG000|NOT COMPLETED|Washout Period 3 (At Least 14 Days)||0
2925218|NCT00562120|3636396|FG001|NOT COMPLETED|Washout Period 3 (At Least 14 Days)||0
2925219|NCT00562120|3636397|FG002|NOT COMPLETED|Washout Period 3 (At Least 14 Days)||0
2925220|NCT00562120|3636398|FG003|NOT COMPLETED|Washout Period 3 (At Least 14 Days)||0
2925221|NCT00562120|3636395|FG000|STARTED|Fourth Intervention Period||4
2925222|NCT00562120|3636396|FG001|STARTED|Fourth Intervention Period||5
2925223|NCT00562120|3636397|FG002|STARTED|Fourth Intervention Period||5
2925224|NCT00562120|3636398|FG003|STARTED|Fourth Intervention Period||5
2925225|NCT00562120|3636395|FG000|COMPLETED|Fourth Intervention Period||4
2925226|NCT00562120|3636396|FG001|COMPLETED|Fourth Intervention Period||5
2925227|NCT00562120|3636397|FG002|COMPLETED|Fourth Intervention Period||5
2925228|NCT00562120|3636398|FG003|COMPLETED|Fourth Intervention Period||5
2925229|NCT00562120|3636395|FG000|NOT COMPLETED|Fourth Intervention Period||0
2925230|NCT00562120|3636396|FG001|NOT COMPLETED|Fourth Intervention Period||0
2925231|NCT00562120|3636397|FG002|NOT COMPLETED|Fourth Intervention Period||0
2925232|NCT00562120|3636398|FG003|NOT COMPLETED|Fourth Intervention Period||0
2925233|NCT00562159|3636410|FG000|STARTED|Overall Study||213
2925234|NCT00562159|3636411|FG001|STARTED|Overall Study||225
2925235|NCT00562159|3636410|FG000|COMPLETED|Overall Study||175
2925236|NCT00562159|3636411|FG001|COMPLETED|Overall Study||192
2925237|NCT00562159|3636410|FG000|NOT COMPLETED|Overall Study||38
2925238|NCT00562159|3636411|FG001|NOT COMPLETED|Overall Study||33
2925239|NCT00562302|3636420|FG000|STARTED|Overall Study||170
2925240|NCT00562302|3636421|FG001|STARTED|Overall Study||169
2925241|NCT00562302|3636420|FG000|COMPLETED|Overall Study||150
2925242|NCT00562302|3636421|FG001|COMPLETED|Overall Study||137
2925243|NCT00562302|3636420|FG000|NOT COMPLETED|Overall Study||20
2925244|NCT00562302|3636421|FG001|NOT COMPLETED|Overall Study||32
2925245|NCT00562315|3636427|FG000|STARTED|Overall Study||93
2925246|NCT00562315|3636427|FG000|COMPLETED|Overall Study||93
2925247|NCT00562315|3636427|FG000|NOT COMPLETED|Overall Study||0
3174482|NCT01957137|3902386|FG000|Cycling Parameter #1|Randomized Portion|Subjects received Cycling Parameter #1 for approximately 4 weeks.|30
3174483|NCT01957137|3902386|FG000|Cycling Parameter #2|Randomized Portion|Subjects received Cycling Parameter #2 for approximately 4 weeks.|28
3174484|NCT01957137|3902386|FG000|Cycling Parameter #3|Randomized Portion|Subjects received Cycling Parameter #3 for approximately 4 weeks.|28
3174485|NCT01957137|3902386|FG000|COMPLETED|Randomized Portion||28
2925248|NCT00562328|3636433|FG000|STARTED|Overall Study||33
2925249|NCT00562328|3636433|FG000|COMPLETED|Overall Study||33
2925250|NCT00562328|3636433|FG000|NOT COMPLETED|Overall Study||0
2925251|NCT00562354|3636439|FG000|STARTED|Overall Study||134
2925252|NCT00562354|3636440|FG001|STARTED|Overall Study||137
2925253|NCT00562354|3636439|FG000|Received Study Treatment|Overall Study||134
2925254|NCT00562354|3636440|FG001|Received Study Treatment|Overall Study||136
2925255|NCT00562354|3636439|FG000|Evaluable Immunogenicity Population|Overall Study||134
2925256|NCT00562354|3636440|FG001|Evaluable Immunogenicity Population|Overall Study||134
2925257|NCT00562354|3636439|FG000|COMPLETED|Overall Study||134
3039122|NCT01156311|3758454|FG003|STARTED|6-month Add-on Therapy Period||47
3039123|NCT01156311|3758451|FG000|Completed BG00012 Combination Therapy|6-month Add-on Therapy Period||0
3039124|NCT01156311|3758452|FG001|Completed BG00012 Combination Therapy|6-month Add-on Therapy Period||0
3039125|NCT01156311|3758453|FG002|Completed BG00012 Combination Therapy|6-month Add-on Therapy Period||45
3039126|NCT01156311|3758454|FG003|Completed BG00012 Combination Therapy|6-month Add-on Therapy Period||38
3039127|NCT01156311|3758451|FG000|COMPLETED|6-month Add-on Therapy Period||0
3039128|NCT01156311|3758452|FG001|COMPLETED|6-month Add-on Therapy Period||0
3039129|NCT01156311|3758453|FG002|COMPLETED|6-month Add-on Therapy Period||45
3039130|NCT01156311|3758454|FG003|COMPLETED|6-month Add-on Therapy Period||37
3039131|NCT01156311|3758451|FG000|NOT COMPLETED|6-month Add-on Therapy Period||0
3039132|NCT01156311|3758452|FG001|NOT COMPLETED|6-month Add-on Therapy Period||0
3174486|NCT01957137|3902386|FG000|NOT COMPLETED|Randomized Portion||2
3174487|NCT01957137|3902386|FG000|STARTED|No Stimulation|Following randomized portion, all subjects went through no stimulation for approximately 4 weeks.|28
3174488|NCT01957137|3902386|FG000|COMPLETED|No Stimulation||28
3174489|NCT01957137|3902386|FG000|NOT COMPLETED|No Stimulation||0
2925258|NCT00562354|3636440|FG001|COMPLETED|Overall Study||135
2925259|NCT00562354|3636439|FG000|NOT COMPLETED|Overall Study||0
2925260|NCT00562354|3636440|FG001|NOT COMPLETED|Overall Study||2
2925261|NCT00562484|3636450|FG000|STARTED|Overall Study||10033
2925262|NCT00562484|3636451|FG001|STARTED|Overall Study||5011
2925263|NCT00562484|3636450|FG000|COMPLETED|Overall Study||9827
2925264|NCT00562484|3636451|FG001|COMPLETED|Overall Study||4907
2925265|NCT00562484|3636450|FG000|NOT COMPLETED|Overall Study||206
2925266|NCT00562484|3636451|FG001|NOT COMPLETED|Overall Study||104
2925267|NCT00562588|3636459|FG000|STARTED|Overall Study||260
2925268|NCT00562588|3636460|FG001|STARTED|Overall Study||283
2925269|NCT00562588|3636459|FG000|COMPLETED|Overall Study||168
2925270|NCT00562588|3636460|FG001|COMPLETED|Overall Study||184
2925271|NCT00562588|3636459|FG000|NOT COMPLETED|Overall Study||92
2925272|NCT00562588|3636460|FG001|NOT COMPLETED|Overall Study||99
2925273|NCT00562627|3636469|FG000|STARTED|Overall Study||34
2925274|NCT00562627|3636470|FG001|STARTED|Overall Study||34
2925275|NCT00562627|3636471|FG002|STARTED|Overall Study||34
2925276|NCT00562627|3636469|FG000|COMPLETED|Overall Study||33
2925277|NCT00562627|3636470|FG001|COMPLETED|Overall Study||33
2925278|NCT00562627|3636471|FG002|COMPLETED|Overall Study||33
2925279|NCT00562627|3636469|FG000|NOT COMPLETED|Overall Study||1
2925280|NCT00562627|3636470|FG001|NOT COMPLETED|Overall Study||1
2925281|NCT00562627|3636471|FG002|NOT COMPLETED|Overall Study||1
2925282|NCT00562718|3636479|FG000|STARTED|Overall Study||50
2925283|NCT00562718|3636479|FG000|COMPLETED|Overall Study||39
2925284|NCT00562718|3636479|FG000|NOT COMPLETED|Overall Study||11
3174490|NCT01957150|3902400|FG000|STARTED|Overall Study||142
3174491|NCT01957150|3902401|FG001|STARTED|Overall Study||141
3174492|NCT01957150|3902400|FG000|COMPLETED|Overall Study||87
3174493|NCT01957150|3902401|FG001|COMPLETED|Overall Study||83
3174494|NCT01957150|3902400|FG000|NOT COMPLETED|Overall Study||55
3174495|NCT01957150|3902401|FG001|NOT COMPLETED|Overall Study||58
3174496|NCT01957163|3902410|FG000|STARTED|Overall Study||206
3174497|NCT01957163|3902411|FG001|STARTED|Overall Study||206
3174498|NCT01957163|3902412|FG002|STARTED|Overall Study||207
3174499|NCT01957163|3902410|FG000|COMPLETED|Overall Study||191
3174500|NCT01957163|3902411|FG001|COMPLETED|Overall Study||195
3174501|NCT01957163|3902412|FG002|COMPLETED|Overall Study||189
3174502|NCT01957163|3902410|FG000|NOT COMPLETED|Overall Study||15
3174503|NCT01957163|3902411|FG001|NOT COMPLETED|Overall Study||11
3174504|NCT01957163|3902412|FG002|NOT COMPLETED|Overall Study||18
2925285|NCT00562861|3636485|FG000|STARTED|Overall Study||60
2925286|NCT00562861|3636486|FG001|STARTED|Overall Study||59
2925287|NCT00562861|3636485|FG000|COMPLETED|Overall Study||40
2925288|NCT00562861|3636486|FG001|COMPLETED|Overall Study||48
2925289|NCT00562861|3636485|FG000|NOT COMPLETED|Overall Study||20
2925290|NCT00562861|3636486|FG001|NOT COMPLETED|Overall Study||11
2925291|NCT00562965|3636494|FG000|STARTED|Overall Study||15
2925292|NCT00562965|3636495|FG001|STARTED|Overall Study||14
2925293|NCT00562965|3636494|FG000|Treated|Overall Study||15
2925294|NCT00562965|3636495|FG001|Treated|Overall Study||13
2925295|NCT00562965|3636494|FG000|COMPLETED|Overall Study||12
2925296|NCT00562965|3636495|FG001|COMPLETED|Overall Study||8
3174505|NCT01957202|3902420|FG000|STARTED|Treatment Period 1 (8 Days)||3
3174506|NCT01957202|3902421|FG001|STARTED|Treatment Period 1 (8 Days)||6
3174507|NCT01957202|3902422|FG002|STARTED|Treatment Period 1 (8 Days)||6
3174508|NCT01957202|3902423|FG003|STARTED|Treatment Period 1 (8 Days)||3
3174509|NCT01957202|3902424|FG004|STARTED|Treatment Period 1 (8 Days)||3
2925297|NCT00562965|3636494|FG000|NOT COMPLETED|Overall Study||3
2925298|NCT00562965|3636495|FG001|NOT COMPLETED|Overall Study||6
2925299|NCT00562978|3636503|FG000|STARTED|Overall Study||6
2925300|NCT00562978|3636504|FG001|STARTED|Overall Study||48
2925301|NCT00562978|3636503|FG000|COMPLETED|Overall Study||5
2925302|NCT00562978|3636504|FG001|COMPLETED|Overall Study||37
2925303|NCT00562978|3636503|FG000|NOT COMPLETED|Overall Study||1
2925304|NCT00562978|3636504|FG001|NOT COMPLETED|Overall Study||11
2925305|NCT00563186|3636512|FG000|STARTED|Overall Study|Patients allocated to the Novel Hospital Ward|1008
2925306|NCT00563186|3636513|FG001|STARTED|Overall Study|Patients allocated to the Traditional Hospital Ward|679
2925307|NCT00563186|3636512|FG000|COMPLETED|Overall Study||910
2925308|NCT00563186|3636513|FG001|COMPLETED|Overall Study||604
2925309|NCT00563186|3636512|FG000|NOT COMPLETED|Overall Study||98
2925310|NCT00563186|3636513|FG001|NOT COMPLETED|Overall Study||75
2925311|NCT00563290|3636524|FG000|STARTED|Overall Study||3
2925312|NCT00563290|3636525|FG001|STARTED|Overall Study||4
2925313|NCT00563290|3636524|FG000|COMPLETED|Overall Study||3
2925314|NCT00563290|3636525|FG001|COMPLETED|Overall Study||4
2925315|NCT00563290|3636524|FG000|NOT COMPLETED|Overall Study||0
2925316|NCT00563290|3636525|FG001|NOT COMPLETED|Overall Study||0
2925317|NCT00563316|3636533|FG000|STARTED|Overall Study||28
2925318|NCT00563316|3636533|FG000|Received Investigational Product|Overall Study||27
2925319|NCT00563316|3636533|FG000|COMPLETED|Overall Study||16
2925320|NCT00563316|3636533|FG000|NOT COMPLETED|Overall Study||12
2925321|NCT00563368|3636548|FG000|STARTED|Overall Study||109
2925322|NCT00563368|3636549|FG001|STARTED|Overall Study||109
2925323|NCT00563368|3636550|FG002|STARTED|Overall Study||108
2925324|NCT00563368|3636551|FG003|STARTED|Overall Study||107
2925325|NCT00563368|3636552|FG004|STARTED|Overall Study||108
2925326|NCT00563368|3636553|FG005|STARTED|Overall Study||107
2925327|NCT00563368|3636554|FG006|STARTED|Overall Study||108
2925328|NCT00563368|3636548|FG000|COMPLETED|Overall Study||74
2925329|NCT00563368|3636549|FG001|COMPLETED|Overall Study||79
2925330|NCT00563368|3636550|FG002|COMPLETED|Overall Study||78
2925331|NCT00563368|3636551|FG003|COMPLETED|Overall Study||78
2925332|NCT00563368|3636552|FG004|COMPLETED|Overall Study||80
2925333|NCT00563368|3636553|FG005|COMPLETED|Overall Study||77
2925334|NCT00563368|3636554|FG006|COMPLETED|Overall Study||75
2925335|NCT00563368|3636548|FG000|NOT COMPLETED|Overall Study||35
2925336|NCT00563368|3636549|FG001|NOT COMPLETED|Overall Study||30
2925337|NCT00563368|3636550|FG002|NOT COMPLETED|Overall Study||30
2925338|NCT00563368|3636551|FG003|NOT COMPLETED|Overall Study||29
2925339|NCT00563368|3636552|FG004|NOT COMPLETED|Overall Study||28
2925340|NCT00563368|3636553|FG005|NOT COMPLETED|Overall Study||30
2925341|NCT00563368|3636554|FG006|NOT COMPLETED|Overall Study||33
2925342|NCT00563381|3636572|FG000|STARTED|Overall Study|Started treatment|3707
2925343|NCT00563381|3636573|FG001|STARTED|Overall Study|Started treatment|3669
2925344|NCT00563381|3636572|FG000|COMPLETED|Overall Study|Completed treatment|3122
2925345|NCT00563381|3636573|FG001|COMPLETED|Overall Study|Completed treatment|3021
2925346|NCT00563381|3636572|FG000|NOT COMPLETED|Overall Study||585
2925347|NCT00563381|3636573|FG001|NOT COMPLETED|Overall Study||648
2925348|NCT00563706|3636588|FG000|STARTED|DB Treatment Period (Day 1 up to Day 28)||37
2925349|NCT00563706|3636589|FG001|STARTED|DB Treatment Period (Day 1 up to Day 28)||18
2925350|NCT00563706|3636590|FG002|STARTED|DB Treatment Period (Day 1 up to Day 28)||8
2925351|NCT00563706|3636591|FG003|STARTED|DB Treatment Period (Day 1 up to Day 28)||19
2925352|NCT00563706|3636592|FG004|STARTED|DB Treatment Period (Day 1 up to Day 28)||16
2925353|NCT00563706|3636593|FG005|STARTED|DB Treatment Period (Day 1 up to Day 28)||19
3039133|NCT01156311|3758453|FG002|NOT COMPLETED|6-month Add-on Therapy Period||12
3039134|NCT01156311|3758454|FG003|NOT COMPLETED|6-month Add-on Therapy Period||10
3039135|NCT01156363|3758465|FG000|STARTED|Overall Study||86
3039136|NCT01156363|3758465|FG000|COMPLETED|Overall Study||64
3039137|NCT01156363|3758465|FG000|NOT COMPLETED|Overall Study||22
3137005|NCT01716520|3862280|FG002|NOT COMPLETED|Treatment Period 2 (14 Days)||0
3137006|NCT01716520|3862281|FG003|NOT COMPLETED|Treatment Period 2 (14 Days)||1
3174510|NCT01957202|3902425|FG005|STARTED|Treatment Period 1 (8 Days)||2
3174511|NCT01957202|3902426|FG006|STARTED|Treatment Period 1 (8 Days)||3
3174512|NCT01957202|3902427|FG007|STARTED|Treatment Period 1 (8 Days)||3
3174513|NCT01957202|3902428|FG008|STARTED|Treatment Period 1 (8 Days)||3
3174514|NCT01957202|3902429|FG009|STARTED|Treatment Period 1 (8 Days)||6
3174515|NCT01957202|3902430|FG010|STARTED|Treatment Period 1 (8 Days)||3
3174516|NCT01957202|3902431|FG011|STARTED|Treatment Period 1 (8 Days)||6
3322010|NCT03182933|4055108|FG001|COMPLETED|Overall Study||32
3322011|NCT03182933|4055107|FG000|NOT COMPLETED|Overall Study||1
3322012|NCT03182933|4055108|FG001|NOT COMPLETED|Overall Study||0
3322013|NCT03183063|4055117|FG000|STARTED|Overall Study||20
3322014|NCT03183063|4055118|FG001|STARTED|Overall Study||4
3322015|NCT03183063|4055119|FG002|STARTED|Overall Study||115
3322016|NCT03183063|4055117|FG000|COMPLETED|Overall Study||15
3322017|NCT03183063|4055118|FG001|COMPLETED|Overall Study||0
3322018|NCT03183063|4055119|FG002|COMPLETED|Overall Study||111
3322019|NCT03183063|4055117|FG000|NOT COMPLETED|Overall Study||5
3322020|NCT03183063|4055118|FG001|NOT COMPLETED|Overall Study||4
3322021|NCT03183063|4055119|FG002|NOT COMPLETED|Overall Study||4
3322022|NCT03183518|4055133|FG000|STARTED|Overall Study||36
3322023|NCT03183518|4055133|FG000|Test Product|Overall Study||36
3322024|NCT03183518|4055133|FG000|Negative Control|Overall Study||36
3322025|NCT03183518|4055133|FG000|COMPLETED|Overall Study||33
3322026|NCT03183518|4055133|FG000|NOT COMPLETED|Overall Study||3
3322027|NCT03183869|4055140|FG000|STARTED|Overall Study||4
3322028|NCT03183869|4055141|FG001|STARTED|Overall Study||7
3322029|NCT03183869|4055140|FG000|COMPLETED|Overall Study||0
3322030|NCT03183869|4055141|FG001|COMPLETED|Overall Study||2
3322031|NCT03183869|4055140|FG000|NOT COMPLETED|Overall Study||4
2925354|NCT00563706|3636594|FG006|STARTED|DB Treatment Period (Day 1 up to Day 28)||12
2925355|NCT00563706|3636595|FG007|STARTED|DB Treatment Period (Day 1 up to Day 28)||30
2925356|NCT00563706|3636596|FG008|STARTED|DB Treatment Period (Day 1 up to Day 28)||43
2925357|NCT00563706|3636588|FG000|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||20
2925358|NCT00563706|3636589|FG001|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||13
2925359|NCT00563706|3636590|FG002|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||3
2925360|NCT00563706|3636591|FG003|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||9
2925361|NCT00563706|3636592|FG004|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||11
2925362|NCT00563706|3636593|FG005|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||14
2925363|NCT00563706|3636594|FG006|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||9
2925364|NCT00563706|3636595|FG007|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||16
2925365|NCT00563706|3636596|FG008|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||32
2925366|NCT00563706|3636588|FG000|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||17
2925367|NCT00563706|3636589|FG001|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||5
2925368|NCT00563706|3636590|FG002|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||5
2925369|NCT00563706|3636591|FG003|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||10
2925370|NCT00563706|3636592|FG004|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||5
2925371|NCT00563706|3636593|FG005|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||5
2925372|NCT00563706|3636594|FG006|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||3
2925373|NCT00563706|3636595|FG007|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||14
2925374|NCT00563706|3636596|FG008|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||11
2925375|NCT00563706|3636588|FG000|STARTED|Taper Phase (Day 29 up to Day 35)||20
2925376|NCT00563706|3636589|FG001|STARTED|Taper Phase (Day 29 up to Day 35)||13
2925377|NCT00563706|3636590|FG002|STARTED|Taper Phase (Day 29 up to Day 35)||3
2925378|NCT00563706|3636591|FG003|STARTED|Taper Phase (Day 29 up to Day 35)||9
2925379|NCT00563706|3636592|FG004|STARTED|Taper Phase (Day 29 up to Day 35)||11
2925380|NCT00563706|3636593|FG005|STARTED|Taper Phase (Day 29 up to Day 35)||14
2925381|NCT00563706|3636594|FG006|STARTED|Taper Phase (Day 29 up to Day 35)||9
2925382|NCT00563706|3636595|FG007|STARTED|Taper Phase (Day 29 up to Day 35)||16
2925383|NCT00563706|3636596|FG008|STARTED|Taper Phase (Day 29 up to Day 35)||32
2925384|NCT00563706|3636588|FG000|COMPLETED|Taper Phase (Day 29 up to Day 35)||20
2925385|NCT00563706|3636589|FG001|COMPLETED|Taper Phase (Day 29 up to Day 35)||13
2925386|NCT00563706|3636590|FG002|COMPLETED|Taper Phase (Day 29 up to Day 35)||3
2925387|NCT00563706|3636591|FG003|COMPLETED|Taper Phase (Day 29 up to Day 35)||9
2925388|NCT00563706|3636592|FG004|COMPLETED|Taper Phase (Day 29 up to Day 35)||11
2925389|NCT00563706|3636593|FG005|COMPLETED|Taper Phase (Day 29 up to Day 35)||14
2925390|NCT00563706|3636594|FG006|COMPLETED|Taper Phase (Day 29 up to Day 35)||9
2925391|NCT00563706|3636595|FG007|COMPLETED|Taper Phase (Day 29 up to Day 35)||16
2925392|NCT00563706|3636596|FG008|COMPLETED|Taper Phase (Day 29 up to Day 35)||32
2925393|NCT00563706|3636588|FG000|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
2925394|NCT00563706|3636589|FG001|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
2925395|NCT00563706|3636590|FG002|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
2925396|NCT00563706|3636591|FG003|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
2925397|NCT00563706|3636592|FG004|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
2925398|NCT00563706|3636593|FG005|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
2925399|NCT00563706|3636594|FG006|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
2925400|NCT00563706|3636595|FG007|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
2925401|NCT00563706|3636596|FG008|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
2925402|NCT00563784|3636616|FG000|STARTED|Overall Study||68
2925403|NCT00563784|3636616|FG000|COMPLETED|Overall Study||46
2925404|NCT00563784|3636616|FG000|NOT COMPLETED|Overall Study||22
2925405|NCT00563797|3636622|FG000|STARTED|Overall Study||11
2925406|NCT00563797|3636623|FG001|STARTED|Overall Study||10
2925407|NCT00563797|3636622|FG000|Received Allocated Intervention|Overall Study||11
2925408|NCT00563797|3636623|FG001|Received Allocated Intervention|Overall Study||10
2925409|NCT00563797|3636622|FG000|Follow-Up|Overall Study||11
2925410|NCT00563797|3636623|FG001|Follow-Up|Overall Study||10
2925411|NCT00563797|3636622|FG000|COMPLETED|Overall Study||4
2925412|NCT00563797|3636623|FG001|COMPLETED|Overall Study||8
2925413|NCT00563797|3636622|FG000|NOT COMPLETED|Overall Study||7
2925414|NCT00563797|3636623|FG001|NOT COMPLETED|Overall Study||2
2925415|NCT00564018|3636634|FG000|STARTED|Overall Study||11
2925416|NCT00564018|3636635|FG001|STARTED|Overall Study||10
2925417|NCT00564018|3636636|FG002|STARTED|Overall Study||12
2925418|NCT00564018|3636634|FG000|COMPLETED|Overall Study||9
2925419|NCT00564018|3636635|FG001|COMPLETED|Overall Study||7
2925420|NCT00564018|3636636|FG002|COMPLETED|Overall Study||11
2925421|NCT00564018|3636634|FG000|NOT COMPLETED|Overall Study||2
2925422|NCT00564018|3636635|FG001|NOT COMPLETED|Overall Study||3
2925423|NCT00564018|3636636|FG002|NOT COMPLETED|Overall Study||1
2925424|NCT00564070|3636646|FG000|STARTED|Overall Study||42
2925425|NCT00564070|3636647|FG001|STARTED|Overall Study||45
2925426|NCT00564070|3636646|FG000|COMPLETED|Overall Study||30
2925427|NCT00564070|3636647|FG001|COMPLETED|Overall Study||38
2925428|NCT00564070|3636646|FG000|NOT COMPLETED|Overall Study||12
2925429|NCT00564070|3636647|FG001|NOT COMPLETED|Overall Study||7
2925430|NCT00564265|3636653|FG000|STARTED|Overall Study||24
2925431|NCT00564265|3636653|FG000|COMPLETED|Overall Study||24
2925432|NCT00564265|3636653|FG000|NOT COMPLETED|Overall Study||0
2925433|NCT00564278|3636659|FG000|STARTED|Overall Study||97
2925434|NCT00564278|3636660|FG001|STARTED|Overall Study||98
2925435|NCT00564278|3636659|FG000|COMPLETED|Overall Study||50
2925436|NCT00564278|3636660|FG001|COMPLETED|Overall Study||56
2925437|NCT00564278|3636659|FG000|NOT COMPLETED|Overall Study||47
2925438|NCT00564278|3636660|FG001|NOT COMPLETED|Overall Study||42
2925439|NCT00564395|3636666|FG000|STARTED|First Intervention (10 Days)||9
2925440|NCT00564395|3636667|FG001|STARTED|First Intervention (10 Days)||9
3174517|NCT01957202|3902432|FG012|STARTED|Treatment Period 1 (8 Days)||3
3174518|NCT01957202|3902433|FG013|STARTED|Treatment Period 1 (8 Days)||3
3322032|NCT03183869|4055141|FG001|NOT COMPLETED|Overall Study||5
3322033|NCT03183908|4055149|FG000|STARTED|Overall Study||378
3322034|NCT03183908|4055150|FG001|STARTED|Overall Study||379
3322035|NCT03183908|4055149|FG000|COMPLETED|Overall Study||378
3322036|NCT03183908|4055150|FG001|COMPLETED|Overall Study||377
3322037|NCT03183908|4055149|FG000|NOT COMPLETED|Overall Study||0
3322038|NCT03183908|4055150|FG001|NOT COMPLETED|Overall Study||2
3322039|NCT03184077|4055162|FG000|STARTED|Overall Study||166
3322040|NCT03184077|4055163|FG001|STARTED|Overall Study||152
3322041|NCT03184077|4055162|FG000|COMPLETED|Overall Study||145
3322042|NCT03184077|4055163|FG001|COMPLETED|Overall Study||131
3322043|NCT03184077|4055162|FG000|NOT COMPLETED|Overall Study||21
3322044|NCT03184077|4055163|FG001|NOT COMPLETED|Overall Study||21
3322045|NCT03184428|4055169|FG000|STARTED|Overall Study||3785
3322046|NCT03184428|4055169|FG000|COMPLETED|Overall Study||2963
3322047|NCT03184428|4055169|FG000|NOT COMPLETED|Overall Study||822
3174519|NCT01957202|3902434|FG014|STARTED|Treatment Period 1 (8 Days)||6
3174520|NCT01957202|3902435|FG015|STARTED|Treatment Period 1 (8 Days)||3
3174521|NCT01957202|3902436|FG016|STARTED|Treatment Period 1 (8 Days)||6
3174522|NCT01957202|3902437|FG017|STARTED|Treatment Period 1 (8 Days)||3
3174523|NCT01957202|3902420|FG000|COMPLETED|Treatment Period 1 (8 Days)||3
3174524|NCT01957202|3902421|FG001|COMPLETED|Treatment Period 1 (8 Days)||6
3174525|NCT01957202|3902422|FG002|COMPLETED|Treatment Period 1 (8 Days)||6
3174526|NCT01957202|3902423|FG003|COMPLETED|Treatment Period 1 (8 Days)||3
3174527|NCT01957202|3902424|FG004|COMPLETED|Treatment Period 1 (8 Days)||3
3174528|NCT01957202|3902425|FG005|COMPLETED|Treatment Period 1 (8 Days)||2
3174529|NCT01957202|3902426|FG006|COMPLETED|Treatment Period 1 (8 Days)||3
3174530|NCT01957202|3902427|FG007|COMPLETED|Treatment Period 1 (8 Days)||3
3322048|NCT03184441|4055185|FG000|STARTED|Overall Study||11
3174531|NCT01957202|3902428|FG008|COMPLETED|Treatment Period 1 (8 Days)||3
3174532|NCT01957202|3902429|FG009|COMPLETED|Treatment Period 1 (8 Days)||6
3174533|NCT01957202|3902430|FG010|COMPLETED|Treatment Period 1 (8 Days)||3
3174534|NCT01957202|3902431|FG011|COMPLETED|Treatment Period 1 (8 Days)||6
3174535|NCT01957202|3902432|FG012|COMPLETED|Treatment Period 1 (8 Days)||3
3174536|NCT01957202|3902433|FG013|COMPLETED|Treatment Period 1 (8 Days)||3
3174537|NCT01957202|3902434|FG014|COMPLETED|Treatment Period 1 (8 Days)||6
3174538|NCT01957202|3902435|FG015|COMPLETED|Treatment Period 1 (8 Days)||3
3174539|NCT01957202|3902436|FG016|COMPLETED|Treatment Period 1 (8 Days)||6
3174540|NCT01957202|3902437|FG017|COMPLETED|Treatment Period 1 (8 Days)||3
3174541|NCT01957202|3902420|FG000|NOT COMPLETED|Treatment Period 1 (8 Days)||0
3174542|NCT01957202|3902421|FG001|NOT COMPLETED|Treatment Period 1 (8 Days)||0
3174543|NCT01957202|3902422|FG002|NOT COMPLETED|Treatment Period 1 (8 Days)||0
3174544|NCT01957202|3902423|FG003|NOT COMPLETED|Treatment Period 1 (8 Days)||0
3174545|NCT01957202|3902424|FG004|NOT COMPLETED|Treatment Period 1 (8 Days)||0
3174546|NCT01957202|3902425|FG005|NOT COMPLETED|Treatment Period 1 (8 Days)||0
3174547|NCT01957202|3902426|FG006|NOT COMPLETED|Treatment Period 1 (8 Days)||0
3174548|NCT01957202|3902427|FG007|NOT COMPLETED|Treatment Period 1 (8 Days)||0
2925441|NCT00564395|3636666|FG000|Received Intervention|First Intervention (10 Days)||7
2925442|NCT00564395|3636667|FG001|Received Intervention|First Intervention (10 Days)||7
2925443|NCT00564395|3636666|FG000|COMPLETED|First Intervention (10 Days)||7
2925444|NCT00564395|3636667|FG001|COMPLETED|First Intervention (10 Days)||7
2925445|NCT00564395|3636666|FG000|NOT COMPLETED|First Intervention (10 Days)||2
2925446|NCT00564395|3636667|FG001|NOT COMPLETED|First Intervention (10 Days)||2
2925447|NCT00564395|3636666|FG000|STARTED|Second Intervention (10 Days)||7
2925448|NCT00564395|3636667|FG001|STARTED|Second Intervention (10 Days)||7
2925449|NCT00564395|3636666|FG000|COMPLETED|Second Intervention (10 Days)||7
2925450|NCT00564395|3636667|FG001|COMPLETED|Second Intervention (10 Days)||7
2925451|NCT00564395|3636666|FG000|NOT COMPLETED|Second Intervention (10 Days)||0
2925452|NCT00564395|3636667|FG001|NOT COMPLETED|Second Intervention (10 Days)||0
2925453|NCT00564447|3636681|FG000|STARTED|Overall Study||6
2925454|NCT00564447|3636682|FG001|STARTED|Overall Study||6
2925455|NCT00564447|3636683|FG002|STARTED|Overall Study||6
2925456|NCT00564447|3636684|FG003|STARTED|Overall Study||6
2925457|NCT00564447|3636685|FG004|STARTED|Overall Study||6
2925458|NCT00564447|3636686|FG005|STARTED|Overall Study||6
2925459|NCT00564447|3636687|FG006|STARTED|Overall Study||6
2925460|NCT00564447|3636688|FG007|STARTED|Overall Study||6
2925461|NCT00564447|3636681|FG000|COMPLETED|Overall Study||6
2925462|NCT00564447|3636682|FG001|COMPLETED|Overall Study||6
2925463|NCT00564447|3636683|FG002|COMPLETED|Overall Study||6
2925464|NCT00564447|3636684|FG003|COMPLETED|Overall Study||6
2925465|NCT00564447|3636685|FG004|COMPLETED|Overall Study||6
2925466|NCT00564447|3636686|FG005|COMPLETED|Overall Study||6
2925467|NCT00564447|3636687|FG006|COMPLETED|Overall Study||6
2925468|NCT00564447|3636688|FG007|COMPLETED|Overall Study||6
2925469|NCT00564447|3636681|FG000|NOT COMPLETED|Overall Study||0
2925470|NCT00564447|3636682|FG001|NOT COMPLETED|Overall Study||0
2925471|NCT00564447|3636683|FG002|NOT COMPLETED|Overall Study||0
2925472|NCT00564447|3636684|FG003|NOT COMPLETED|Overall Study||0
2925473|NCT00564447|3636685|FG004|NOT COMPLETED|Overall Study||0
2925474|NCT00564447|3636686|FG005|NOT COMPLETED|Overall Study||0
2925475|NCT00564447|3636687|FG006|NOT COMPLETED|Overall Study||0
2925476|NCT00564447|3636688|FG007|NOT COMPLETED|Overall Study||0
2925477|NCT00564486|3636709|FG000|STARTED|Overall Study||43
2925478|NCT00564486|3636710|FG001|STARTED|Overall Study|One subject was randomized to receive 1 g IVAPAP but was administered 650 mg IV in error|92
2925479|NCT00564486|3636711|FG002|STARTED|Overall Study|One subject randomized to receive 1 g IVAPAP but was administered 650 mg IV in error|42
2925480|NCT00564486|3636712|FG003|STARTED|Overall Study||67
2925481|NCT00564486|3636709|FG000|COMPLETED|Overall Study|Includes all subjects who returned to clinic for Day 7 visit.|36
2925482|NCT00564486|3636710|FG001|COMPLETED|Overall Study|Includes all subjects who returned to clinic for Day 7 visit.|91
2925483|NCT00564486|3636711|FG002|COMPLETED|Overall Study|Includes all subjects who returned to clinic for Day 7 visit.|39
2925484|NCT00564486|3636712|FG003|COMPLETED|Overall Study||60
2925485|NCT00564486|3636709|FG000|NOT COMPLETED|Overall Study||7
2925486|NCT00564486|3636710|FG001|NOT COMPLETED|Overall Study||1
2925487|NCT00564486|3636711|FG002|NOT COMPLETED|Overall Study||3
3039138|NCT01156376|3758479|FG000|STARTED|Overall Study||27
3039139|NCT01156376|3758480|FG001|STARTED|Overall Study||26
3039140|NCT01156376|3758481|FG002|STARTED|Overall Study||27
3039141|NCT01156376|3758479|FG000|COMPLETED|Overall Study||26
3039142|NCT01156376|3758480|FG001|COMPLETED|Overall Study||26
3039143|NCT01156376|3758481|FG002|COMPLETED|Overall Study||23
3039144|NCT01156376|3758479|FG000|NOT COMPLETED|Overall Study||1
3039145|NCT01156376|3758480|FG001|NOT COMPLETED|Overall Study||0
3039146|NCT01156376|3758481|FG002|NOT COMPLETED|Overall Study||4
3039147|NCT01156480|3758491|FG000|STARTED|Overall Study||0
3039148|NCT01156480|3758492|FG001|STARTED|Overall Study||2
3039149|NCT01156480|3758491|FG000|COMPLETED|Overall Study||0
3039150|NCT01156480|3758492|FG001|COMPLETED|Overall Study||1
3322049|NCT03184441|4055185|FG000|COMPLETED|Overall Study|Last subject completed study|10
3322050|NCT03184441|4055185|FG000|NOT COMPLETED|Overall Study||1
3322051|NCT03184519|4055192|FG000|STARTED|Overall Study||156
3322052|NCT03184519|4055192|FG000|COMPLETED|Overall Study||129
3322053|NCT03184519|4055192|FG000|NOT COMPLETED|Overall Study||27
3322054|NCT03184558|4055196|FG000|STARTED|Overall Study||29
3322055|NCT03184558|4055196|FG000|COMPLETED|Overall Study||0
3322056|NCT03184558|4055196|FG000|NOT COMPLETED|Overall Study||29
3322057|NCT03184701|4055200|FG000|STARTED|Overall Study||45
3322058|NCT03184701|4055200|FG000|COMPLETED|Overall Study||28
3322059|NCT03184701|4055200|FG000|NOT COMPLETED|Overall Study||17
3322060|NCT03184987|4055207|FG000|STARTED|Overall Study||47
3322061|NCT03184987|4055208|FG001|STARTED|Overall Study||9
3322062|NCT03184987|4055209|FG002|STARTED|Overall Study||55
3322063|NCT03184987|4055207|FG000|COMPLETED|Overall Study||46
3322064|NCT03184987|4055208|FG001|COMPLETED|Overall Study||8
3322065|NCT03184987|4055209|FG002|COMPLETED|Overall Study||51
3322066|NCT03184987|4055207|FG000|NOT COMPLETED|Overall Study||1
3322067|NCT03184987|4055208|FG001|NOT COMPLETED|Overall Study||1
3322068|NCT03184987|4055209|FG002|NOT COMPLETED|Overall Study||4
3322069|NCT03185065|4055221|FG000|STARTED|Period 1 (6 Weeks)||35
3322070|NCT03185065|4055222|FG001|STARTED|Period 1 (6 Weeks)||34
3322071|NCT03185065|4055223|FG002|STARTED|Period 1 (6 Weeks)||35
3322072|NCT03185065|4055224|FG003|STARTED|Period 1 (6 Weeks)||37
3322073|NCT03185065|4055221|FG000|COMPLETED|Period 1 (6 Weeks)||32
3322074|NCT03185065|4055222|FG001|COMPLETED|Period 1 (6 Weeks)||33
3322075|NCT03185065|4055223|FG002|COMPLETED|Period 1 (6 Weeks)||32
3322076|NCT03185065|4055224|FG003|COMPLETED|Period 1 (6 Weeks)||36
3322077|NCT03185065|4055221|FG000|NOT COMPLETED|Period 1 (6 Weeks)||3
3322078|NCT03185065|4055222|FG001|NOT COMPLETED|Period 1 (6 Weeks)||1
3322079|NCT03185065|4055223|FG002|NOT COMPLETED|Period 1 (6 Weeks)||3
3322080|NCT03185065|4055224|FG003|NOT COMPLETED|Period 1 (6 Weeks)||1
3322081|NCT03185065|4055221|FG000|STARTED|Washout (2 Weeks)||32
3322082|NCT03185065|4055222|FG001|STARTED|Washout (2 Weeks)||33
3322083|NCT03185065|4055223|FG002|STARTED|Washout (2 Weeks)||32
3322084|NCT03185065|4055224|FG003|STARTED|Washout (2 Weeks)||36
3174549|NCT01957202|3902428|FG008|NOT COMPLETED|Treatment Period 1 (8 Days)||0
3174550|NCT01957202|3902429|FG009|NOT COMPLETED|Treatment Period 1 (8 Days)||0
3174551|NCT01957202|3902430|FG010|NOT COMPLETED|Treatment Period 1 (8 Days)||0
3174552|NCT01957202|3902431|FG011|NOT COMPLETED|Treatment Period 1 (8 Days)||0
3174553|NCT01957202|3902432|FG012|NOT COMPLETED|Treatment Period 1 (8 Days)||0
3174554|NCT01957202|3902433|FG013|NOT COMPLETED|Treatment Period 1 (8 Days)||0
3174555|NCT01957202|3902434|FG014|NOT COMPLETED|Treatment Period 1 (8 Days)||0
3174556|NCT01957202|3902435|FG015|NOT COMPLETED|Treatment Period 1 (8 Days)||0
3174557|NCT01957202|3902436|FG016|NOT COMPLETED|Treatment Period 1 (8 Days)||0
3174558|NCT01957202|3902437|FG017|NOT COMPLETED|Treatment Period 1 (8 Days)||0
3174559|NCT01957202|3902420|FG000|STARTED|Washout Period 1 (14 to 28 Days)||3
3174560|NCT01957202|3902421|FG001|STARTED|Washout Period 1 (14 to 28 Days)||6
3174561|NCT01957202|3902422|FG002|STARTED|Washout Period 1 (14 to 28 Days)||6
3174562|NCT01957202|3902423|FG003|STARTED|Washout Period 1 (14 to 28 Days)||3
3174563|NCT01957202|3902424|FG004|STARTED|Washout Period 1 (14 to 28 Days)||3
3174564|NCT01957202|3902425|FG005|STARTED|Washout Period 1 (14 to 28 Days)||2
3174565|NCT01957202|3902426|FG006|STARTED|Washout Period 1 (14 to 28 Days)||3
3174566|NCT01957202|3902427|FG007|STARTED|Washout Period 1 (14 to 28 Days)||3
3174567|NCT01957202|3902428|FG008|STARTED|Washout Period 1 (14 to 28 Days)||3
3174568|NCT01957202|3902429|FG009|STARTED|Washout Period 1 (14 to 28 Days)||6
3174569|NCT01957202|3902430|FG010|STARTED|Washout Period 1 (14 to 28 Days)||3
3174570|NCT01957202|3902431|FG011|STARTED|Washout Period 1 (14 to 28 Days)||6
3174571|NCT01957202|3902432|FG012|STARTED|Washout Period 1 (14 to 28 Days)||3
3174572|NCT01957202|3902433|FG013|STARTED|Washout Period 1 (14 to 28 Days)||3
3174573|NCT01957202|3902434|FG014|STARTED|Washout Period 1 (14 to 28 Days)||6
3174574|NCT01957202|3902435|FG015|STARTED|Washout Period 1 (14 to 28 Days)||3
3174575|NCT01957202|3902436|FG016|STARTED|Washout Period 1 (14 to 28 Days)||6
3174576|NCT01957202|3902437|FG017|STARTED|Washout Period 1 (14 to 28 Days)||3
3174577|NCT01957202|3902420|FG000|COMPLETED|Washout Period 1 (14 to 28 Days)||3
3174578|NCT01957202|3902421|FG001|COMPLETED|Washout Period 1 (14 to 28 Days)||6
3174579|NCT01957202|3902422|FG002|COMPLETED|Washout Period 1 (14 to 28 Days)||6
3174580|NCT01957202|3902423|FG003|COMPLETED|Washout Period 1 (14 to 28 Days)||3
3174581|NCT01957202|3902424|FG004|COMPLETED|Washout Period 1 (14 to 28 Days)||3
3174582|NCT01957202|3902425|FG005|COMPLETED|Washout Period 1 (14 to 28 Days)||2
3174583|NCT01957202|3902426|FG006|COMPLETED|Washout Period 1 (14 to 28 Days)||3
3174584|NCT01957202|3902427|FG007|COMPLETED|Washout Period 1 (14 to 28 Days)||3
3174585|NCT01957202|3902428|FG008|COMPLETED|Washout Period 1 (14 to 28 Days)||3
3174586|NCT01957202|3902429|FG009|COMPLETED|Washout Period 1 (14 to 28 Days)||6
3174587|NCT01957202|3902430|FG010|COMPLETED|Washout Period 1 (14 to 28 Days)||3
3322085|NCT03185065|4055221|FG000|COMPLETED|Washout (2 Weeks)||32
3174588|NCT01957202|3902431|FG011|COMPLETED|Washout Period 1 (14 to 28 Days)||6
3174589|NCT01957202|3902432|FG012|COMPLETED|Washout Period 1 (14 to 28 Days)||3
3174590|NCT01957202|3902433|FG013|COMPLETED|Washout Period 1 (14 to 28 Days)||3
3174591|NCT01957202|3902434|FG014|COMPLETED|Washout Period 1 (14 to 28 Days)||6
3174592|NCT01957202|3902435|FG015|COMPLETED|Washout Period 1 (14 to 28 Days)||3
3174593|NCT01957202|3902436|FG016|COMPLETED|Washout Period 1 (14 to 28 Days)||6
2925488|NCT00564486|3636712|FG003|NOT COMPLETED|Overall Study||7
2925489|NCT00564629|3636728|FG000|STARTED|Overall Study||51
2925490|NCT00564629|3636729|FG001|STARTED|Overall Study||54
2925491|NCT00564629|3636728|FG000|COMPLETED|Overall Study||36
2925492|NCT00564629|3636729|FG001|COMPLETED|Overall Study||45
2925493|NCT00564629|3636728|FG000|NOT COMPLETED|Overall Study||15
2925494|NCT00564629|3636729|FG001|NOT COMPLETED|Overall Study||9
2925495|NCT00564681|3636739|FG000|STARTED|Overall Study||117
3174594|NCT01957202|3902437|FG017|COMPLETED|Washout Period 1 (14 to 28 Days)||3
3174595|NCT01957202|3902420|FG000|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
3174596|NCT01957202|3902421|FG001|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
3174597|NCT01957202|3902422|FG002|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
3174598|NCT01957202|3902423|FG003|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
3322086|NCT03185065|4055222|FG001|COMPLETED|Washout (2 Weeks)||31
3322087|NCT03185065|4055223|FG002|COMPLETED|Washout (2 Weeks)||32
3322088|NCT03185065|4055224|FG003|COMPLETED|Washout (2 Weeks)||35
3322089|NCT03185065|4055221|FG000|NOT COMPLETED|Washout (2 Weeks)||0
3322090|NCT03185065|4055222|FG001|NOT COMPLETED|Washout (2 Weeks)||2
3322091|NCT03185065|4055223|FG002|NOT COMPLETED|Washout (2 Weeks)||0
3322092|NCT03185065|4055224|FG003|NOT COMPLETED|Washout (2 Weeks)||1
3322093|NCT03185065|4055221|FG000|STARTED|Period 2 (6 Weeks)||32
3322094|NCT03185065|4055222|FG001|STARTED|Period 2 (6 Weeks)||31
3322095|NCT03185065|4055223|FG002|STARTED|Period 2 (6 Weeks)||32
3322096|NCT03185065|4055224|FG003|STARTED|Period 2 (6 Weeks)||35
2925496|NCT00564681|3636740|FG001|STARTED|Overall Study||61
3174599|NCT01957202|3902424|FG004|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
3322097|NCT03185065|4055221|FG000|COMPLETED|Period 2 (6 Weeks)||32
3322098|NCT03185065|4055222|FG001|COMPLETED|Period 2 (6 Weeks)||31
3322099|NCT03185065|4055223|FG002|COMPLETED|Period 2 (6 Weeks)||32
3322100|NCT03185065|4055224|FG003|COMPLETED|Period 2 (6 Weeks)||34
3322101|NCT03185065|4055221|FG000|NOT COMPLETED|Period 2 (6 Weeks)||0
3322102|NCT03185065|4055222|FG001|NOT COMPLETED|Period 2 (6 Weeks)||0
3174600|NCT01957202|3902425|FG005|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
3174601|NCT01957202|3902426|FG006|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
3174602|NCT01957202|3902427|FG007|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
3039151|NCT01156480|3758491|FG000|NOT COMPLETED|Overall Study||0
3039152|NCT01156480|3758492|FG001|NOT COMPLETED|Overall Study||1
3039153|NCT01156532|3758500|FG000|STARTED|Overall Study||30
3039154|NCT01156532|3758500|FG000|COMPLETED|Overall Study||28
3039155|NCT01156532|3758500|FG000|NOT COMPLETED|Overall Study||2
3174603|NCT01957202|3902428|FG008|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
3174604|NCT01957202|3902429|FG009|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
3174605|NCT01957202|3902430|FG010|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
3174606|NCT01957202|3902431|FG011|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
3174607|NCT01957202|3902432|FG012|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
3174608|NCT01957202|3902433|FG013|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
3322103|NCT03185065|4055223|FG002|NOT COMPLETED|Period 2 (6 Weeks)||0
3039156|NCT01156571|3758506|FG000|STARTED|Overall Study|ITT: defined as all patients randomized.|5581
3039157|NCT01156571|3758507|FG001|STARTED|Overall Study|ITT: defined as all patients randomized.|5564
3039158|NCT01156571|3758506|FG000|COMPLETED|Overall Study|Completed = ITT patients who completed scheduled visits or developed a primary endpoint event|5564
3039159|NCT01156571|3758507|FG001|COMPLETED|Overall Study|Completed = ITT patients who completed scheduled visits or developed a primary endpoint event|5545
3039160|NCT01156571|3758506|FG000|NOT COMPLETED|Overall Study||17
3174609|NCT01957202|3902434|FG014|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
3174610|NCT01957202|3902435|FG015|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
3174611|NCT01957202|3902436|FG016|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
3174612|NCT01957202|3902437|FG017|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
2925497|NCT00564681|3636741|FG002|STARTED|Overall Study||43
2925498|NCT00564681|3636742|FG003|STARTED|Overall Study||21
2925499|NCT00564681|3636739|FG000|COMPLETED|Overall Study||106
2925500|NCT00564681|3636740|FG001|COMPLETED|Overall Study||58
2925501|NCT00564681|3636741|FG002|COMPLETED|Overall Study||40
2925502|NCT00564681|3636742|FG003|COMPLETED|Overall Study||19
2925503|NCT00564681|3636739|FG000|NOT COMPLETED|Overall Study||11
2925504|NCT00564681|3636740|FG001|NOT COMPLETED|Overall Study||3
2925505|NCT00564681|3636741|FG002|NOT COMPLETED|Overall Study||3
2925506|NCT00564681|3636742|FG003|NOT COMPLETED|Overall Study||2
2925507|NCT00564733|3636751|FG000|STARTED|Overall Study||55
2925508|NCT00564733|3636751|FG000|COMPLETED|Overall Study||46
2925509|NCT00564733|3636751|FG000|NOT COMPLETED|Overall Study||9
3174613|NCT01957202|3902420|FG000|STARTED|Treatment Period 2 (8 Days)||3
3174614|NCT01957202|3902421|FG001|STARTED|Treatment Period 2 (8 Days)||6
2925510|NCT00564850|3636755|FG000|STARTED|Overall Study||37
2925511|NCT00564850|3636755|FG000|COMPLETED|Overall Study||35
2925512|NCT00564850|3636755|FG000|NOT COMPLETED|Overall Study||2
2925513|NCT00564889|3636759|FG000|STARTED|Overall Study||35
2925514|NCT00564889|3636759|FG000|COMPLETED|Overall Study||6
2925515|NCT00564889|3636759|FG000|NOT COMPLETED|Overall Study||29
2925516|NCT00564902|3636766|FG000|STARTED|Overall Study||10
2925517|NCT00564902|3636767|FG001|STARTED|Overall Study||25
2925518|NCT00564902|3636768|FG002|STARTED|Overall Study||25
2925519|NCT00564902|3636766|FG000|4 Months|Overall Study||9
2925520|NCT00564902|3636767|FG001|4 Months|Overall Study||24
2925521|NCT00564902|3636768|FG002|4 Months|Overall Study||23
2925522|NCT00564902|3636766|FG000|8 Months|Overall Study||9
2925523|NCT00564902|3636767|FG001|8 Months|Overall Study||22
2925524|NCT00564902|3636768|FG002|8 Months|Overall Study||21
2925525|NCT00564902|3636766|FG000|12 Months|Overall Study||9
2925526|NCT00564902|3636767|FG001|12 Months|Overall Study||21
2925527|NCT00564902|3636768|FG002|12 Months|Overall Study||21
2925528|NCT00564902|3636766|FG000|COMPLETED|Overall Study||9
2925529|NCT00564902|3636767|FG001|COMPLETED|Overall Study||21
2925530|NCT00564902|3636768|FG002|COMPLETED|Overall Study||21
2925531|NCT00564902|3636766|FG000|NOT COMPLETED|Overall Study||1
2925532|NCT00564902|3636767|FG001|NOT COMPLETED|Overall Study||4
2925533|NCT00564902|3636768|FG002|NOT COMPLETED|Overall Study||4
2925534|NCT00564954|3636778|FG000|STARTED|Period 1- 1 Week||44
2925535|NCT00564954|3636779|FG001|STARTED|Period 1- 1 Week||42
2925536|NCT00564954|3636778|FG000|COMPLETED|Period 1- 1 Week||44
2925537|NCT00564954|3636779|FG001|COMPLETED|Period 1- 1 Week||42
2925538|NCT00564954|3636778|FG000|NOT COMPLETED|Period 1- 1 Week||0
2925539|NCT00564954|3636779|FG001|NOT COMPLETED|Period 1- 1 Week||0
2925540|NCT00564954|3636778|FG000|STARTED|Period 2- 1 Week||44
2925541|NCT00564954|3636779|FG001|STARTED|Period 2- 1 Week||42
3174615|NCT01957202|3902422|FG002|STARTED|Treatment Period 2 (8 Days)||6
3174616|NCT01957202|3902423|FG003|STARTED|Treatment Period 2 (8 Days)||3
3174617|NCT01957202|3902424|FG004|STARTED|Treatment Period 2 (8 Days)||3
3174618|NCT01957202|3902425|FG005|STARTED|Treatment Period 2 (8 Days)||2
3174619|NCT01957202|3902426|FG006|STARTED|Treatment Period 2 (8 Days)||3
3174620|NCT01957202|3902427|FG007|STARTED|Treatment Period 2 (8 Days)||3
3174621|NCT01957202|3902428|FG008|STARTED|Treatment Period 2 (8 Days)||3
2925542|NCT00564954|3636778|FG000|COMPLETED|Period 2- 1 Week||44
2925543|NCT00564954|3636779|FG001|COMPLETED|Period 2- 1 Week||42
2925544|NCT00564954|3636778|FG000|NOT COMPLETED|Period 2- 1 Week||0
2925545|NCT00564954|3636779|FG001|NOT COMPLETED|Period 2- 1 Week||0
3039161|NCT01156571|3758507|FG001|NOT COMPLETED|Overall Study||19
3039162|NCT01156597|3758515|FG000|STARTED|Overall Study||16
3039163|NCT01156597|3758516|FG001|STARTED|Overall Study||14
3039164|NCT01156597|3758515|FG000|COMPLETED|Overall Study||13
3039165|NCT01156597|3758516|FG001|COMPLETED|Overall Study||13
3039166|NCT01156597|3758515|FG000|NOT COMPLETED|Overall Study||3
3039167|NCT01156597|3758516|FG001|NOT COMPLETED|Overall Study||1
3039168|NCT01156675|3758526|FG000|STARTED|Overall Study||107
3039169|NCT01156675|3758527|FG001|STARTED|Overall Study||106
3039170|NCT01156675|3758528|FG002|STARTED|Overall Study||2
3039171|NCT01156675|3758526|FG000|COMPLETED|Overall Study||73
3039172|NCT01156675|3758527|FG001|COMPLETED|Overall Study||81
3039173|NCT01156675|3758528|FG002|COMPLETED|Overall Study||0
3039174|NCT01156675|3758526|FG000|NOT COMPLETED|Overall Study||34
3039175|NCT01156675|3758527|FG001|NOT COMPLETED|Overall Study||25
3039176|NCT01156675|3758528|FG002|NOT COMPLETED|Overall Study||2
3039177|NCT01156701|3758537|FG000|STARTED|Overall Study||257
3039178|NCT01156701|3758538|FG001|STARTED|Overall Study||1007
3039179|NCT01156701|3758539|FG002|STARTED|Overall Study||163716
3039180|NCT01156701|3758540|FG003|STARTED|Overall Study||6725
3039181|NCT01156701|3758537|FG000|COMPLETED|Overall Study||257
3039182|NCT01156701|3758538|FG001|COMPLETED|Overall Study||1007
3039183|NCT01156701|3758539|FG002|COMPLETED|Overall Study||163716
3039184|NCT01156701|3758540|FG003|COMPLETED|Overall Study||6725
3039185|NCT01156701|3758537|FG000|NOT COMPLETED|Overall Study||0
3039186|NCT01156701|3758538|FG001|NOT COMPLETED|Overall Study||0
3039187|NCT01156701|3758539|FG002|NOT COMPLETED|Overall Study||0
3039188|NCT01156701|3758540|FG003|NOT COMPLETED|Overall Study||0
3039189|NCT01156714|3758553|FG000|STARTED|Overall Study||20
3039190|NCT01156714|3758554|FG001|STARTED|Overall Study||19
3039191|NCT01156714|3758555|FG002|STARTED|Overall Study||20
3039192|NCT01156714|3758553|FG000|COMPLETED|Overall Study||11
3039193|NCT01156714|3758554|FG001|COMPLETED|Overall Study||15
3039194|NCT01156714|3758555|FG002|COMPLETED|Overall Study||17
3039195|NCT01156714|3758553|FG000|NOT COMPLETED|Overall Study||9
3039196|NCT01156714|3758554|FG001|NOT COMPLETED|Overall Study||4
3039197|NCT01156714|3758555|FG002|NOT COMPLETED|Overall Study||3
3039198|NCT01156792|3758566|FG000|STARTED|Overall Study||162
3039199|NCT01156792|3758566|FG000|COMPLETED|Overall Study||93
3039200|NCT01156792|3758566|FG000|NOT COMPLETED|Overall Study||69
3039201|NCT01156805|3758583|FG000|STARTED|Overall Study||237
3039202|NCT01156805|3758584|FG001|STARTED|Overall Study||272
3039203|NCT01156805|3758583|FG000|COMPLETED|Overall Study||181
3039204|NCT01156805|3758584|FG001|COMPLETED|Overall Study||216
3039205|NCT01156805|3758583|FG000|NOT COMPLETED|Overall Study||56
3039206|NCT01156805|3758584|FG001|NOT COMPLETED|Overall Study||56
3039207|NCT01156844|3758594|FG000|STARTED|Overall Study|Randomized participants.|48
3039208|NCT01156844|3758595|FG001|STARTED|Overall Study||48
3039209|NCT01156844|3758596|FG002|STARTED|Overall Study||48
3039210|NCT01156844|3758597|FG003|STARTED|Overall Study||47
3039211|NCT01156844|3758594|FG000|PD & Safety Sets: Received Study Drug|Overall Study|PD=Pharmacodynamic|48
3039212|NCT01156844|3758595|FG001|PD & Safety Sets: Received Study Drug|Overall Study||47
3039213|NCT01156844|3758596|FG002|PD & Safety Sets: Received Study Drug|Overall Study||48
3039214|NCT01156844|3758597|FG003|PD & Safety Sets: Received Study Drug|Overall Study||46
3039215|NCT01156844|3758594|FG000|COMPLETED|Overall Study||46
3039216|NCT01156844|3758595|FG001|COMPLETED|Overall Study||46
3039217|NCT01156844|3758596|FG002|COMPLETED|Overall Study||42
3039218|NCT01156844|3758597|FG003|COMPLETED|Overall Study||41
3039219|NCT01156844|3758594|FG000|NOT COMPLETED|Overall Study||2
3039220|NCT01156844|3758595|FG001|NOT COMPLETED|Overall Study||2
3039221|NCT01156844|3758596|FG002|NOT COMPLETED|Overall Study||6
3039222|NCT01156844|3758597|FG003|NOT COMPLETED|Overall Study||6
3039223|NCT01156987|3758612|FG000|STARTED|Overall Study||8
3039224|NCT01156987|3758613|FG001|STARTED|Overall Study||23
3039225|NCT01156987|3758612|FG000|COMPLETED|Overall Study||8
3039226|NCT01156987|3758613|FG001|COMPLETED|Overall Study||12
3039227|NCT01156987|3758612|FG000|NOT COMPLETED|Overall Study||0
3039228|NCT01156987|3758613|FG001|NOT COMPLETED|Overall Study||11
3039229|NCT01157065|3758621|FG000|STARTED|Overall Study||38
3039230|NCT01157065|3758622|FG001|STARTED|Overall Study||11
3039231|NCT01157065|3758621|FG000|COMPLETED|Overall Study||38
3039232|NCT01157065|3758622|FG001|COMPLETED|Overall Study||10
3039233|NCT01157065|3758621|FG000|NOT COMPLETED|Overall Study||0
3039234|NCT01157065|3758622|FG001|NOT COMPLETED|Overall Study||1
3039235|NCT01157078|3758630|FG000|STARTED|Overall Study||159
3039236|NCT01157078|3758631|FG001|STARTED|Overall Study||160
3039237|NCT01157078|3758630|FG000|Received Treatment|Overall Study||157
3039238|NCT01157078|3758631|FG001|Received Treatment|Overall Study||159
3039239|NCT01157078|3758630|FG000|COMPLETED|Overall Study||124
3039240|NCT01157078|3758631|FG001|COMPLETED|Overall Study||124
3039241|NCT01157078|3758630|FG000|NOT COMPLETED|Overall Study||35
3174622|NCT01957202|3902429|FG009|STARTED|Treatment Period 2 (8 Days)||6
3174623|NCT01957202|3902430|FG010|STARTED|Treatment Period 2 (8 Days)||3
3174624|NCT01957202|3902431|FG011|STARTED|Treatment Period 2 (8 Days)||6
3174625|NCT01957202|3902432|FG012|STARTED|Treatment Period 2 (8 Days)||3
3174626|NCT01957202|3902433|FG013|STARTED|Treatment Period 2 (8 Days)||3
3174627|NCT01957202|3902434|FG014|STARTED|Treatment Period 2 (8 Days)||6
3174628|NCT01957202|3902435|FG015|STARTED|Treatment Period 2 (8 Days)||3
3322104|NCT03185065|4055224|FG003|NOT COMPLETED|Period 2 (6 Weeks)||1
3322105|NCT03185065|4055221|FG000|STARTED|Washout (2 Weeks)||32
3174629|NCT01957202|3902436|FG016|STARTED|Treatment Period 2 (8 Days)||6
3174630|NCT01957202|3902437|FG017|STARTED|Treatment Period 2 (8 Days)||3
3174631|NCT01957202|3902420|FG000|COMPLETED|Treatment Period 2 (8 Days)||3
3322106|NCT03185065|4055222|FG001|STARTED|Washout (2 Weeks)||31
3322107|NCT03185065|4055223|FG002|STARTED|Washout (2 Weeks)||32
3322108|NCT03185065|4055224|FG003|STARTED|Washout (2 Weeks)||34
3322109|NCT03185065|4055221|FG000|COMPLETED|Washout (2 Weeks)||31
3174632|NCT01957202|3902421|FG001|COMPLETED|Treatment Period 2 (8 Days)||5
3174633|NCT01957202|3902422|FG002|COMPLETED|Treatment Period 2 (8 Days)||6
3174634|NCT01957202|3902423|FG003|COMPLETED|Treatment Period 2 (8 Days)||3
3174635|NCT01957202|3902424|FG004|COMPLETED|Treatment Period 2 (8 Days)||3
3322110|NCT03185065|4055222|FG001|COMPLETED|Washout (2 Weeks)||29
3322111|NCT03185065|4055223|FG002|COMPLETED|Washout (2 Weeks)||31
3322112|NCT03185065|4055224|FG003|COMPLETED|Washout (2 Weeks)||32
3322113|NCT03185065|4055221|FG000|NOT COMPLETED|Washout (2 Weeks)||1
3174636|NCT01957202|3902425|FG005|COMPLETED|Treatment Period 2 (8 Days)||2
3174637|NCT01957202|3902426|FG006|COMPLETED|Treatment Period 2 (8 Days)||3
3322114|NCT03185065|4055222|FG001|NOT COMPLETED|Washout (2 Weeks)||2
3174638|NCT01957202|3902427|FG007|COMPLETED|Treatment Period 2 (8 Days)||3
3174639|NCT01957202|3902428|FG008|COMPLETED|Treatment Period 2 (8 Days)||3
3174640|NCT01957202|3902429|FG009|COMPLETED|Treatment Period 2 (8 Days)||6
3174641|NCT01957202|3902430|FG010|COMPLETED|Treatment Period 2 (8 Days)||3
3174642|NCT01957202|3902431|FG011|COMPLETED|Treatment Period 2 (8 Days)||6
3174643|NCT01957202|3902432|FG012|COMPLETED|Treatment Period 2 (8 Days)||3
3174644|NCT01957202|3902433|FG013|COMPLETED|Treatment Period 2 (8 Days)||3
3174645|NCT01957202|3902434|FG014|COMPLETED|Treatment Period 2 (8 Days)||6
3322115|NCT03185065|4055223|FG002|NOT COMPLETED|Washout (2 Weeks)||1
3322116|NCT03185065|4055224|FG003|NOT COMPLETED|Washout (2 Weeks)||2
3322117|NCT03185065|4055221|FG000|STARTED|Period 3 (6 Weeks)||31
3322118|NCT03185065|4055222|FG001|STARTED|Period 3 (6 Weeks)||29
3322119|NCT03185065|4055223|FG002|STARTED|Period 3 (6 Weeks)||31
3322120|NCT03185065|4055224|FG003|STARTED|Period 3 (6 Weeks)||32
3322121|NCT03185065|4055221|FG000|COMPLETED|Period 3 (6 Weeks)||31
3322122|NCT03185065|4055222|FG001|COMPLETED|Period 3 (6 Weeks)||29
3322123|NCT03185065|4055223|FG002|COMPLETED|Period 3 (6 Weeks)||29
3322124|NCT03185065|4055224|FG003|COMPLETED|Period 3 (6 Weeks)||32
3322125|NCT03185065|4055221|FG000|NOT COMPLETED|Period 3 (6 Weeks)||0
3322126|NCT03185065|4055222|FG001|NOT COMPLETED|Period 3 (6 Weeks)||0
3322127|NCT03185065|4055223|FG002|NOT COMPLETED|Period 3 (6 Weeks)||2
3322128|NCT03185065|4055224|FG003|NOT COMPLETED|Period 3 (6 Weeks)||0
3322129|NCT03185065|4055221|FG000|STARTED|Washout (2 Weeks)||31
3322130|NCT03185065|4055222|FG001|STARTED|Washout (2 Weeks)||29
3322131|NCT03185065|4055223|FG002|STARTED|Washout (2 Weeks)||29
3322132|NCT03185065|4055224|FG003|STARTED|Washout (2 Weeks)||32
3322133|NCT03185065|4055221|FG000|COMPLETED|Washout (2 Weeks)||31
3322134|NCT03185065|4055222|FG001|COMPLETED|Washout (2 Weeks)||28
3322135|NCT03185065|4055223|FG002|COMPLETED|Washout (2 Weeks)||27
3322136|NCT03185065|4055224|FG003|COMPLETED|Washout (2 Weeks)||32
3322137|NCT03185065|4055221|FG000|NOT COMPLETED|Washout (2 Weeks)||0
2925546|NCT00565045|3636787|FG000|STARTED|Overall Study||10
2925547|NCT00565045|3636788|FG001|STARTED|Overall Study||11
2925548|NCT00565045|3636787|FG000|COMPLETED|Overall Study||9
2925549|NCT00565045|3636788|FG001|COMPLETED|Overall Study||8
2925550|NCT00565045|3636787|FG000|NOT COMPLETED|Overall Study||1
2925551|NCT00565045|3636788|FG001|NOT COMPLETED|Overall Study||3
2925552|NCT00565058|3636796|FG000|STARTED|Overall Study||10
2925553|NCT00565058|3636797|FG001|STARTED|Overall Study||15
2925554|NCT00565058|3636796|FG000|COMPLETED|Overall Study||9
2925555|NCT00565058|3636797|FG001|COMPLETED|Overall Study||15
2925556|NCT00565058|3636796|FG000|NOT COMPLETED|Overall Study||1
2925557|NCT00565058|3636797|FG001|NOT COMPLETED|Overall Study||0
2925558|NCT00565084|3636803|FG000|STARTED|First Treatment Period||11
3174646|NCT01957202|3902435|FG015|COMPLETED|Treatment Period 2 (8 Days)||3
2925559|NCT00565084|3636804|FG001|STARTED|First Treatment Period||11
2925560|NCT00565084|3636805|FG002|STARTED|First Treatment Period||11
2925561|NCT00565084|3636803|FG000|COMPLETED|First Treatment Period||11
2925562|NCT00565084|3636804|FG001|COMPLETED|First Treatment Period||11
2925563|NCT00565084|3636805|FG002|COMPLETED|First Treatment Period||11
2925564|NCT00565084|3636803|FG000|NOT COMPLETED|First Treatment Period||0
2925565|NCT00565084|3636804|FG001|NOT COMPLETED|First Treatment Period||0
2925566|NCT00565084|3636805|FG002|NOT COMPLETED|First Treatment Period||0
2925567|NCT00565084|3636803|FG000|STARTED|Second Treatment Period||11
2925568|NCT00565084|3636804|FG001|STARTED|Second Treatment Period||11
2925569|NCT00565084|3636805|FG002|STARTED|Second Treatment Period||11
2925570|NCT00565084|3636803|FG000|COMPLETED|Second Treatment Period||11
2925571|NCT00565084|3636804|FG001|COMPLETED|Second Treatment Period||11
2925572|NCT00565084|3636805|FG002|COMPLETED|Second Treatment Period||11
2925573|NCT00565084|3636803|FG000|NOT COMPLETED|Second Treatment Period||0
2925574|NCT00565084|3636804|FG001|NOT COMPLETED|Second Treatment Period||0
2925575|NCT00565084|3636805|FG002|NOT COMPLETED|Second Treatment Period||0
2925576|NCT00565084|3636803|FG000|STARTED|Third Treatment Period||11
2925577|NCT00565084|3636804|FG001|STARTED|Third Treatment Period||11
3174647|NCT01957202|3902436|FG016|COMPLETED|Treatment Period 2 (8 Days)||5
3174648|NCT01957202|3902437|FG017|COMPLETED|Treatment Period 2 (8 Days)||3
3174649|NCT01957202|3902420|FG000|NOT COMPLETED|Treatment Period 2 (8 Days)||0
3174650|NCT01957202|3902421|FG001|NOT COMPLETED|Treatment Period 2 (8 Days)||1
3174651|NCT01957202|3902422|FG002|NOT COMPLETED|Treatment Period 2 (8 Days)||0
3174652|NCT01957202|3902423|FG003|NOT COMPLETED|Treatment Period 2 (8 Days)||0
3174653|NCT01957202|3902424|FG004|NOT COMPLETED|Treatment Period 2 (8 Days)||0
3174654|NCT01957202|3902425|FG005|NOT COMPLETED|Treatment Period 2 (8 Days)||0
3174655|NCT01957202|3902426|FG006|NOT COMPLETED|Treatment Period 2 (8 Days)||0
3174656|NCT01957202|3902427|FG007|NOT COMPLETED|Treatment Period 2 (8 Days)||0
3174657|NCT01957202|3902428|FG008|NOT COMPLETED|Treatment Period 2 (8 Days)||0
3174658|NCT01957202|3902429|FG009|NOT COMPLETED|Treatment Period 2 (8 Days)||0
3174659|NCT01957202|3902430|FG010|NOT COMPLETED|Treatment Period 2 (8 Days)||0
3174660|NCT01957202|3902431|FG011|NOT COMPLETED|Treatment Period 2 (8 Days)||0
3174661|NCT01957202|3902432|FG012|NOT COMPLETED|Treatment Period 2 (8 Days)||0
3174662|NCT01957202|3902433|FG013|NOT COMPLETED|Treatment Period 2 (8 Days)||0
3174663|NCT01957202|3902434|FG014|NOT COMPLETED|Treatment Period 2 (8 Days)||0
3174664|NCT01957202|3902435|FG015|NOT COMPLETED|Treatment Period 2 (8 Days)||0
3174665|NCT01957202|3902436|FG016|NOT COMPLETED|Treatment Period 2 (8 Days)||1
3174666|NCT01957202|3902437|FG017|NOT COMPLETED|Treatment Period 2 (8 Days)||0
3174667|NCT01957202|3902420|FG000|STARTED|Washout Period 2 (14 to 28 Days)||3
3174668|NCT01957202|3902421|FG001|STARTED|Washout Period 2 (14 to 28 Days)||5
3174669|NCT01957202|3902422|FG002|STARTED|Washout Period 2 (14 to 28 Days)||6
3174670|NCT01957202|3902423|FG003|STARTED|Washout Period 2 (14 to 28 Days)||3
3174671|NCT01957202|3902424|FG004|STARTED|Washout Period 2 (14 to 28 Days)||3
3174672|NCT01957202|3902425|FG005|STARTED|Washout Period 2 (14 to 28 Days)||2
3174673|NCT01957202|3902426|FG006|STARTED|Washout Period 2 (14 to 28 Days)||3
3174674|NCT01957202|3902427|FG007|STARTED|Washout Period 2 (14 to 28 Days)||3
3174675|NCT01957202|3902428|FG008|STARTED|Washout Period 2 (14 to 28 Days)||3
3174676|NCT01957202|3902429|FG009|STARTED|Washout Period 2 (14 to 28 Days)||6
3174677|NCT01957202|3902430|FG010|STARTED|Washout Period 2 (14 to 28 Days)||3
3174678|NCT01957202|3902431|FG011|STARTED|Washout Period 2 (14 to 28 Days)||6
3174679|NCT01957202|3902432|FG012|STARTED|Washout Period 2 (14 to 28 Days)||3
3174680|NCT01957202|3902433|FG013|STARTED|Washout Period 2 (14 to 28 Days)||3
3174681|NCT01957202|3902434|FG014|STARTED|Washout Period 2 (14 to 28 Days)||6
3174682|NCT01957202|3902435|FG015|STARTED|Washout Period 2 (14 to 28 Days)||3
3174683|NCT01957202|3902436|FG016|STARTED|Washout Period 2 (14 to 28 Days)||5
3174684|NCT01957202|3902437|FG017|STARTED|Washout Period 2 (14 to 28 Days)||3
3174685|NCT01957202|3902420|FG000|COMPLETED|Washout Period 2 (14 to 28 Days)||3
3174686|NCT01957202|3902421|FG001|COMPLETED|Washout Period 2 (14 to 28 Days)||5
3174687|NCT01957202|3902422|FG002|COMPLETED|Washout Period 2 (14 to 28 Days)||6
3322138|NCT03185065|4055222|FG001|NOT COMPLETED|Washout (2 Weeks)||1
3174688|NCT01957202|3902423|FG003|COMPLETED|Washout Period 2 (14 to 28 Days)||3
3174689|NCT01957202|3902424|FG004|COMPLETED|Washout Period 2 (14 to 28 Days)||3
3174690|NCT01957202|3902425|FG005|COMPLETED|Washout Period 2 (14 to 28 Days)||2
3174691|NCT01957202|3902426|FG006|COMPLETED|Washout Period 2 (14 to 28 Days)||3
3174692|NCT01957202|3902427|FG007|COMPLETED|Washout Period 2 (14 to 28 Days)||3
3174693|NCT01957202|3902428|FG008|COMPLETED|Washout Period 2 (14 to 28 Days)||3
3174694|NCT01957202|3902429|FG009|COMPLETED|Washout Period 2 (14 to 28 Days)||6
2925578|NCT00565084|3636805|FG002|STARTED|Third Treatment Period||11
2925579|NCT00565084|3636803|FG000|COMPLETED|Third Treatment Period||11
2925580|NCT00565084|3636804|FG001|COMPLETED|Third Treatment Period||11
2925581|NCT00565084|3636805|FG002|COMPLETED|Third Treatment Period||11
2925582|NCT00565084|3636803|FG000|NOT COMPLETED|Third Treatment Period||0
2925583|NCT00565084|3636804|FG001|NOT COMPLETED|Third Treatment Period||0
2925584|NCT00565084|3636805|FG002|NOT COMPLETED|Third Treatment Period||0
2925585|NCT00565110|3636815|FG000|STARTED|Overall Study||230
2925586|NCT00565110|3636816|FG001|STARTED|Overall Study||242
2925587|NCT00565110|3636815|FG000|12-Month|Overall Study||114
2925588|NCT00565110|3636816|FG001|12-Month|Overall Study||144
2925589|NCT00565110|3636815|FG000|COMPLETED|Overall Study||99
2925590|NCT00565110|3636816|FG001|COMPLETED|Overall Study||111
2925591|NCT00565110|3636815|FG000|NOT COMPLETED|Overall Study||131
2925592|NCT00565110|3636816|FG001|NOT COMPLETED|Overall Study||131
2925593|NCT00565136|3636822|FG000|STARTED|Overall Study||29
2925594|NCT00565136|3636822|FG000|COMPLETED|Overall Study||26
2925595|NCT00565136|3636822|FG000|NOT COMPLETED|Overall Study||3
2925596|NCT00565266|3636826|FG000|STARTED|Overall Study||210
2925597|NCT00565266|3636826|FG000|COMPLETED|Overall Study||174
2925598|NCT00565266|3636826|FG000|NOT COMPLETED|Overall Study||36
2925599|NCT00565370|3636834|FG000|STARTED|Overall Study||21
2925600|NCT00565370|3636834|FG000|COMPLETED|Overall Study||21
2925601|NCT00565370|3636834|FG000|NOT COMPLETED|Overall Study||0
2925602|NCT00565409|3636838|FG000|STARTED|Period 1 Open Label||834
2925603|NCT00565409|3636839|FG001|STARTED|Period 1 Open Label||0
2925604|NCT00565409|3636840|FG002|STARTED|Period 1 Open Label||0
2925605|NCT00565409|3636841|FG003|STARTED|Period 1 Open Label||0
2925606|NCT00565409|3636838|FG000|COMPLETED|Period 1 Open Label||756
2925607|NCT00565409|3636839|FG001|COMPLETED|Period 1 Open Label||0
3174695|NCT01957202|3902430|FG010|COMPLETED|Washout Period 2 (14 to 28 Days)||3
3174696|NCT01957202|3902431|FG011|COMPLETED|Washout Period 2 (14 to 28 Days)||6
3174697|NCT01957202|3902432|FG012|COMPLETED|Washout Period 2 (14 to 28 Days)||3
3174698|NCT01957202|3902433|FG013|COMPLETED|Washout Period 2 (14 to 28 Days)||3
2925608|NCT00565409|3636840|FG002|COMPLETED|Period 1 Open Label||0
2925609|NCT00565409|3636841|FG003|COMPLETED|Period 1 Open Label||0
2925610|NCT00565409|3636838|FG000|NOT COMPLETED|Period 1 Open Label||78
2925611|NCT00565409|3636839|FG001|NOT COMPLETED|Period 1 Open Label||0
2925612|NCT00565409|3636840|FG002|NOT COMPLETED|Period 1 Open Label||0
2925613|NCT00565409|3636841|FG003|NOT COMPLETED|Period 1 Open Label||0
2925614|NCT00565409|3636838|FG000|STARTED|After Period 1, Prior to Period 2||756
2925615|NCT00565409|3636839|FG001|STARTED|After Period 1, Prior to Period 2||0
2925616|NCT00565409|3636840|FG002|STARTED|After Period 1, Prior to Period 2||0
2925617|NCT00565409|3636841|FG003|STARTED|After Period 1, Prior to Period 2||0
2925618|NCT00565409|3636838|FG000|COMPLETED|After Period 1, Prior to Period 2||604
2925619|NCT00565409|3636839|FG001|COMPLETED|After Period 1, Prior to Period 2||0
2925620|NCT00565409|3636840|FG002|COMPLETED|After Period 1, Prior to Period 2||0
2925621|NCT00565409|3636841|FG003|COMPLETED|After Period 1, Prior to Period 2||0
3039242|NCT01157078|3758631|FG001|NOT COMPLETED|Overall Study||36
3039243|NCT01157117|3758640|FG000|STARTED|Overall Study||28
3039244|NCT01157117|3758641|FG001|STARTED|Overall Study||29
3039245|NCT01157117|3758642|FG002|STARTED|Overall Study||20
3039246|NCT01157117|3758640|FG000|Began Omalizumab or Placebo Dosing|Overall Study||27
3039247|NCT01157117|3758641|FG001|Began Omalizumab or Placebo Dosing|Overall Study||28
3039248|NCT01157117|3758642|FG002|Began Omalizumab or Placebo Dosing|Overall Study||0
3039249|NCT01157117|3758640|FG000|Began Milk OIT Dosing at Month 4|Overall Study||27
3039250|NCT01157117|3758641|FG001|Began Milk OIT Dosing at Month 4|Overall Study||28
2925622|NCT00565409|3636838|FG000|NOT COMPLETED|After Period 1, Prior to Period 2||152
2925623|NCT00565409|3636839|FG001|NOT COMPLETED|After Period 1, Prior to Period 2||0
2925624|NCT00565409|3636840|FG002|NOT COMPLETED|After Period 1, Prior to Period 2||0
2925625|NCT00565409|3636841|FG003|NOT COMPLETED|After Period 1, Prior to Period 2||0
2925626|NCT00565409|3636838|FG000|STARTED|Period 2 Double-Blind||0
2925627|NCT00565409|3636839|FG001|STARTED|Period 2 Double-Blind||202
2925628|NCT00565409|3636840|FG002|STARTED|Period 2 Double-Blind||202
2925629|NCT00565409|3636841|FG003|STARTED|Period 2 Double-Blind||200
2925630|NCT00565409|3636838|FG000|COMPLETED|Period 2 Double-Blind||0
2925631|NCT00565409|3636839|FG001|COMPLETED|Period 2 Double-Blind||181
2925632|NCT00565409|3636840|FG002|COMPLETED|Period 2 Double-Blind||175
2925633|NCT00565409|3636841|FG003|COMPLETED|Period 2 Double-Blind||141
2925634|NCT00565409|3636838|FG000|NOT COMPLETED|Period 2 Double-Blind||0
2925635|NCT00565409|3636839|FG001|NOT COMPLETED|Period 2 Double-Blind||21
2925636|NCT00565409|3636840|FG002|NOT COMPLETED|Period 2 Double-Blind||27
2925637|NCT00565409|3636841|FG003|NOT COMPLETED|Period 2 Double-Blind||59
2925638|NCT00565448|3636853|FG000|STARTED|Overall Study|Intent to treat (ITT) population: all randomized participants. All were treated.|50
2925639|NCT00565448|3636854|FG001|STARTED|Overall Study|ITT population: all randomized participants. All were treated.|25
2925640|NCT00565448|3636853|FG000|COMPLETED|Overall Study|Completed induction period as per protocol.|47
2925641|NCT00565448|3636854|FG001|COMPLETED|Overall Study|Completed induction period as per protocol.|23
2925642|NCT00565448|3636853|FG000|NOT COMPLETED|Overall Study||3
2925643|NCT00565448|3636854|FG001|NOT COMPLETED|Overall Study||2
2925644|NCT00565604|3636863|FG000|STARTED|Overall Study||43
2925645|NCT00565604|3636863|FG000|7 Day|Overall Study||41
2925646|NCT00565604|3636863|FG000|2 Week|Overall Study||41
3322139|NCT03185065|4055223|FG002|NOT COMPLETED|Washout (2 Weeks)||2
3174699|NCT01957202|3902434|FG014|COMPLETED|Washout Period 2 (14 to 28 Days)||6
3174700|NCT01957202|3902435|FG015|COMPLETED|Washout Period 2 (14 to 28 Days)||3
3174701|NCT01957202|3902436|FG016|COMPLETED|Washout Period 2 (14 to 28 Days)||5
3174702|NCT01957202|3902437|FG017|COMPLETED|Washout Period 2 (14 to 28 Days)||3
3174703|NCT01957202|3902420|FG000|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
3174704|NCT01957202|3902421|FG001|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
3174705|NCT01957202|3902422|FG002|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
3174706|NCT01957202|3902423|FG003|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
3174707|NCT01957202|3902424|FG004|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
3174708|NCT01957202|3902425|FG005|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
3174709|NCT01957202|3902426|FG006|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
3174710|NCT01957202|3902427|FG007|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
3174711|NCT01957202|3902428|FG008|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
2925647|NCT00565604|3636863|FG000|6 Week|Overall Study||39
2925648|NCT00565604|3636863|FG000|6 Month|Overall Study||39
2925649|NCT00565604|3636863|FG000|COMPLETED|Overall Study||39
2925650|NCT00565604|3636863|FG000|NOT COMPLETED|Overall Study||4
2925651|NCT00565617|3636867|FG000|STARTED|Overall Study||6
2925652|NCT00565617|3636867|FG000|COMPLETED|Overall Study||5
2925653|NCT00565617|3636867|FG000|NOT COMPLETED|Overall Study||1
2925654|NCT00565643|3636873|FG000|STARTED|Overall Study||380
2925655|NCT00565643|3636874|FG001|STARTED|Overall Study||373
2925656|NCT00565643|3636873|FG000|Safety Data|Overall Study||380
2925657|NCT00565643|3636874|FG001|Safety Data|Overall Study||373
2925658|NCT00565643|3636873|FG000|Primary Outcome (Subsequent Cesarean)|Overall Study||80
2925659|NCT00565643|3636874|FG001|Primary Outcome (Subsequent Cesarean)|Overall Study||92
2925660|NCT00565643|3636873|FG000|COMPLETED|Overall Study||380
2925661|NCT00565643|3636874|FG001|COMPLETED|Overall Study||373
2925662|NCT00565643|3636873|FG000|NOT COMPLETED|Overall Study||0
2925663|NCT00565643|3636874|FG001|NOT COMPLETED|Overall Study||0
2925664|NCT00565669|3636883|FG000|STARTED|Overall Study||11
2925665|NCT00565669|3636884|FG001|STARTED|Overall Study||9
2925666|NCT00565669|3636883|FG000|COMPLETED|Overall Study||11
2925667|NCT00565669|3636884|FG001|COMPLETED|Overall Study||9
2925668|NCT00565669|3636883|FG000|NOT COMPLETED|Overall Study||0
3039251|NCT01157117|3758642|FG002|Began Milk OIT Dosing at Month 4|Overall Study||0
3039252|NCT01157117|3758640|FG000|Reached Milk OIT Maintenance Dosing|Overall Study||26
3039253|NCT01157117|3758641|FG001|Reached Milk OIT Maintenance Dosing|Overall Study||26
3174712|NCT01957202|3902429|FG009|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
3174713|NCT01957202|3902430|FG010|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
3039254|NCT01157117|3758642|FG002|Reached Milk OIT Maintenance Dosing|Overall Study||0
3039255|NCT01157117|3758640|FG000|Unblinded at Month 16|Overall Study||26
3039256|NCT01157117|3758641|FG001|Unblinded at Month 16|Overall Study||26
3039257|NCT01157117|3758642|FG002|Unblinded at Month 16|Overall Study||0
3039258|NCT01157117|3758640|FG000|Completed Month 28 Desensitization OFC|Overall Study||26
3039259|NCT01157117|3758641|FG001|Completed Month 28 Desensitization OFC|Overall Study||24
3039260|NCT01157117|3758642|FG002|Completed Month 28 Desensitization OFC|Overall Study||0
3039261|NCT01157117|3758640|FG000|Discontinued Milk OIT at Month 30|Overall Study||24
3039262|NCT01157117|3758641|FG001|Discontinued Milk OIT at Month 30|Overall Study||20
3039263|NCT01157117|3758642|FG002|Discontinued Milk OIT at Month 30|Overall Study||0
3039264|NCT01157117|3758640|FG000|Completed Month 32 Tolerance OFC|Overall Study||24
3039265|NCT01157117|3758641|FG001|Completed Month 32 Tolerance OFC|Overall Study||20
3039266|NCT01157117|3758642|FG002|Completed Month 32 Tolerance OFC|Overall Study||0
3039267|NCT01157117|3758640|FG000|Completed Final Month 38 Study Visit|Overall Study||19
3039268|NCT01157117|3758641|FG001|Completed Final Month 38 Study Visit|Overall Study||18
3039269|NCT01157117|3758642|FG002|Completed Final Month 38 Study Visit|Overall Study||3
3039270|NCT01157117|3758640|FG000|COMPLETED|Overall Study|Completed final study visit at Month 38, 6 months after final Month 32 OFC.|19
3039271|NCT01157117|3758641|FG001|COMPLETED|Overall Study|Completed final study visit at Month 38, 6 months after final Month 32 OFC.|18
3039272|NCT01157117|3758642|FG002|COMPLETED|Overall Study|Completed final study visit at Month 38, 6 months after final Month 32 OFC.|5
3039273|NCT01157117|3758640|FG000|NOT COMPLETED|Overall Study||9
3039274|NCT01157117|3758641|FG001|NOT COMPLETED|Overall Study||11
3039275|NCT01157117|3758642|FG002|NOT COMPLETED|Overall Study||15
3039276|NCT01157169|3758652|FG000|STARTED|First Intervention||20
3039277|NCT01157169|3758653|FG001|STARTED|First Intervention||20
3039278|NCT01157169|3758652|FG000|COMPLETED|First Intervention||16
3039279|NCT01157169|3758653|FG001|COMPLETED|First Intervention||18
3039280|NCT01157169|3758652|FG000|NOT COMPLETED|First Intervention||4
3039281|NCT01157169|3758653|FG001|NOT COMPLETED|First Intervention||2
3039282|NCT01157169|3758652|FG000|STARTED|Washout of 10 Days||16
3039283|NCT01157169|3758653|FG001|STARTED|Washout of 10 Days||18
3039284|NCT01157169|3758652|FG000|COMPLETED|Washout of 10 Days||16
3039285|NCT01157169|3758653|FG001|COMPLETED|Washout of 10 Days||18
3039286|NCT01157169|3758652|FG000|NOT COMPLETED|Washout of 10 Days||0
2925669|NCT00565669|3636884|FG001|NOT COMPLETED|Overall Study||0
2925670|NCT00565721|3636890|FG000|STARTED|Overall Study||33
2925671|NCT00565721|3636890|FG000|COMPLETED|Overall Study||16
2925672|NCT00565721|3636890|FG000|NOT COMPLETED|Overall Study||17
2925673|NCT00565747|3636911|FG000|STARTED|Overall Study||654
2925674|NCT00565747|3636912|FG001|STARTED|Overall Study||678
2925675|NCT00565747|3636911|FG000|COMPLETED|Overall Study|Completed with an embryo transfer|587
2925676|NCT00565747|3636912|FG001|COMPLETED|Overall Study|Completed with an embryo transfer|605
2925677|NCT00565747|3636911|FG000|NOT COMPLETED|Overall Study||67
2925678|NCT00565747|3636912|FG001|NOT COMPLETED|Overall Study||73
2925679|NCT00565773|3636918|FG000|STARTED|Overall Study||40
2925680|NCT00565773|3636918|FG000|COMPLETED|Overall Study||38
2925681|NCT00565773|3636918|FG000|NOT COMPLETED|Overall Study||2
2925682|NCT00565812|3636925|FG000|STARTED|Overall Study||485
2925683|NCT00565812|3636926|FG001|STARTED|Overall Study||486
2925684|NCT00565812|3636927|FG002|STARTED|Overall Study||486
2925685|NCT00565812|3636925|FG000|COMPLETED|Overall Study||341
2925686|NCT00565812|3636926|FG001|COMPLETED|Overall Study||351
2925687|NCT00565812|3636927|FG002|COMPLETED|Overall Study||356
2925688|NCT00565812|3636925|FG000|NOT COMPLETED|Overall Study||144
2925689|NCT00565812|3636926|FG001|NOT COMPLETED|Overall Study||135
2925690|NCT00565812|3636927|FG002|NOT COMPLETED|Overall Study||130
2925691|NCT00565864|3636938|FG000|STARTED|Overall Study||58
2925692|NCT00565864|3636939|FG001|STARTED|Overall Study||59
2925693|NCT00565864|3636940|FG002|STARTED|Overall Study||56
2925694|NCT00565864|3636938|FG000|COMPLETED|Overall Study||46
2925695|NCT00565864|3636939|FG001|COMPLETED|Overall Study||47
2925696|NCT00565864|3636940|FG002|COMPLETED|Overall Study||45
2925697|NCT00565864|3636938|FG000|NOT COMPLETED|Overall Study||12
2925698|NCT00565864|3636939|FG001|NOT COMPLETED|Overall Study||12
2925699|NCT00565864|3636940|FG002|NOT COMPLETED|Overall Study||11
2925700|NCT00565916|3636952|FG000|STARTED|Overall Study||11
2925701|NCT00565916|3636953|FG001|STARTED|Overall Study||11
2925702|NCT00565916|3636952|FG000|COMPLETED|Overall Study||11
2925703|NCT00565916|3636953|FG001|COMPLETED|Overall Study||11
2925704|NCT00565916|3636952|FG000|NOT COMPLETED|Overall Study||0
2925705|NCT00565916|3636953|FG001|NOT COMPLETED|Overall Study||0
2925706|NCT00566020|3636959|FG000|STARTED|6-week Dosage Adjustment Phase||92
2925707|NCT00566020|3636960|FG001|STARTED|6-week Dosage Adjustment Phase||0
2925708|NCT00566020|3636959|FG000|COMPLETED|6-week Dosage Adjustment Phase||85
2925709|NCT00566020|3636960|FG001|COMPLETED|6-week Dosage Adjustment Phase||0
2925710|NCT00566020|3636959|FG000|NOT COMPLETED|6-week Dosage Adjustment Phase||7
2925711|NCT00566020|3636960|FG001|NOT COMPLETED|6-week Dosage Adjustment Phase||0
2925712|NCT00566020|3636959|FG000|STARTED|46-week Long-term Administration Phase||0
2925713|NCT00566020|3636960|FG001|STARTED|46-week Long-term Administration Phase||85
2925714|NCT00566020|3636959|FG000|COMPLETED|46-week Long-term Administration Phase||0
2925715|NCT00566020|3636960|FG001|COMPLETED|46-week Long-term Administration Phase||68
2925716|NCT00566020|3636959|FG000|NOT COMPLETED|46-week Long-term Administration Phase||0
2925717|NCT00566020|3636960|FG001|NOT COMPLETED|46-week Long-term Administration Phase||17
2925718|NCT00566098|3636965|FG000|STARTED|Collection of MILs||25
2925719|NCT00566098|3636965|FG000|COMPLETED|Collection of MILs||23
2925720|NCT00566098|3636965|FG000|NOT COMPLETED|Collection of MILs||2
2925721|NCT00566098|3636965|FG000|STARTED|Generation of MILs Product||23
2925722|NCT00566098|3636965|FG000|COMPLETED|Generation of MILs Product||22
2925723|NCT00566098|3636965|FG000|NOT COMPLETED|Generation of MILs Product||1
2925724|NCT00566098|3636965|FG000|STARTED|Administration of ASCT+MILs||22
2925725|NCT00566098|3636965|FG000|COMPLETED|Administration of ASCT+MILs||4
2925726|NCT00566098|3636965|FG000|NOT COMPLETED|Administration of ASCT+MILs||18
2925727|NCT00566111|3636972|FG000|STARTED|Overall Study||2
2925728|NCT00566111|3636973|FG001|STARTED|Overall Study||3
2925729|NCT00566111|3636972|FG000|COMPLETED|Overall Study||2
2925730|NCT00566111|3636973|FG001|COMPLETED|Overall Study||1
2925731|NCT00566111|3636972|FG000|NOT COMPLETED|Overall Study||0
2925732|NCT00566111|3636973|FG001|NOT COMPLETED|Overall Study||2
2925733|NCT00566150|3636981|FG000|STARTED|Overall Study||19
2925734|NCT00566150|3636982|FG001|STARTED|Overall Study||16
2925735|NCT00566150|3636981|FG000|COMPLETED|Overall Study||10
2925736|NCT00566150|3636982|FG001|COMPLETED|Overall Study||11
2925737|NCT00566150|3636981|FG000|NOT COMPLETED|Overall Study||9
2925738|NCT00566150|3636982|FG001|NOT COMPLETED|Overall Study||5
3174714|NCT01957202|3902431|FG011|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
3174715|NCT01957202|3902432|FG012|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
2925739|NCT00566228|3636990|FG000|STARTED|Overall Study||62
2925740|NCT00566228|3636991|FG001|STARTED|Overall Study||60
2925741|NCT00566228|3636990|FG000|COMPLETED|Overall Study||56
2925742|NCT00566228|3636991|FG001|COMPLETED|Overall Study||55
2925743|NCT00566228|3636990|FG000|NOT COMPLETED|Overall Study||6
2925744|NCT00566228|3636991|FG001|NOT COMPLETED|Overall Study||5
2925745|NCT00566254|3636999|FG000|STARTED|Overall Study||100
2925746|NCT00566254|3637000|FG001|STARTED|Overall Study||107
2925747|NCT00566254|3636999|FG000|COMPLETED|Overall Study||90
3174716|NCT01957202|3902433|FG013|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
3174717|NCT01957202|3902434|FG014|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
3174718|NCT01957202|3902435|FG015|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
2925748|NCT00566254|3637000|FG001|COMPLETED|Overall Study||93
2925749|NCT00566254|3636999|FG000|NOT COMPLETED|Overall Study||10
2925750|NCT00566254|3637000|FG001|NOT COMPLETED|Overall Study||14
2925751|NCT00566501|3637008|FG000|STARTED|Overall Study||570
2925752|NCT00566501|3637009|FG001|STARTED|Overall Study||332
2925753|NCT00566501|3637008|FG000|COMPLETED|Overall Study||423
2925754|NCT00566501|3637009|FG001|COMPLETED|Overall Study||210
2925755|NCT00566501|3637008|FG000|NOT COMPLETED|Overall Study||147
2925756|NCT00566501|3637009|FG001|NOT COMPLETED|Overall Study||122
2925757|NCT00566527|3637018|FG000|STARTED|Overall Study|Number randomized.|541
2925758|NCT00566527|3637019|FG001|STARTED|Overall Study|Number randomized.|540
3039287|NCT01157169|3758653|FG001|NOT COMPLETED|Washout of 10 Days||0
3039288|NCT01157169|3758652|FG000|STARTED|Second Intervention||16
3174719|NCT01957202|3902436|FG016|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
3174720|NCT01957202|3902437|FG017|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
3174721|NCT01957202|3902420|FG000|STARTED|Treatment Period 3 (8 Days)||3
3174722|NCT01957202|3902421|FG001|STARTED|Treatment Period 3 (8 Days)||5
3174723|NCT01957202|3902422|FG002|STARTED|Treatment Period 3 (8 Days)||6
3174724|NCT01957202|3902423|FG003|STARTED|Treatment Period 3 (8 Days)||3
3174725|NCT01957202|3902424|FG004|STARTED|Treatment Period 3 (8 Days)||3
3174726|NCT01957202|3902425|FG005|STARTED|Treatment Period 3 (8 Days)||2
3174727|NCT01957202|3902426|FG006|STARTED|Treatment Period 3 (8 Days)||3
3174728|NCT01957202|3902427|FG007|STARTED|Treatment Period 3 (8 Days)||3
3174729|NCT01957202|3902428|FG008|STARTED|Treatment Period 3 (8 Days)||3
3174730|NCT01957202|3902429|FG009|STARTED|Treatment Period 3 (8 Days)||6
3174731|NCT01957202|3902430|FG010|STARTED|Treatment Period 3 (8 Days)||3
3174732|NCT01957202|3902431|FG011|STARTED|Treatment Period 3 (8 Days)||6
3174733|NCT01957202|3902432|FG012|STARTED|Treatment Period 3 (8 Days)||3
3174734|NCT01957202|3902433|FG013|STARTED|Treatment Period 3 (8 Days)||3
3174735|NCT01957202|3902434|FG014|STARTED|Treatment Period 3 (8 Days)||6
3174736|NCT01957202|3902435|FG015|STARTED|Treatment Period 3 (8 Days)||3
3174737|NCT01957202|3902436|FG016|STARTED|Treatment Period 3 (8 Days)||5
3174738|NCT01957202|3902437|FG017|STARTED|Treatment Period 3 (8 Days)||3
3174739|NCT01957202|3902420|FG000|COMPLETED|Treatment Period 3 (8 Days)||3
3174740|NCT01957202|3902421|FG001|COMPLETED|Treatment Period 3 (8 Days)||5
3174741|NCT01957202|3902422|FG002|COMPLETED|Treatment Period 3 (8 Days)||6
3174742|NCT01957202|3902423|FG003|COMPLETED|Treatment Period 3 (8 Days)||3
3174743|NCT01957202|3902424|FG004|COMPLETED|Treatment Period 3 (8 Days)||3
2925759|NCT00566527|3637020|FG002|STARTED|Overall Study|Number randomized.|539
2925760|NCT00566527|3637018|FG000|Received ProQuad® Dose 1|Overall Study||529
2925761|NCT00566527|3637019|FG001|Received ProQuad® Dose 1|Overall Study||484
2925762|NCT00566527|3637020|FG002|Received ProQuad® Dose 1|Overall Study||470
2925763|NCT00566527|3637018|FG000|Received ProQuad® Dose 2|Overall Study||525
2925764|NCT00566527|3637019|FG001|Received ProQuad® Dose 2|Overall Study||478
2925765|NCT00566527|3637020|FG002|Received ProQuad® Dose 2|Overall Study||462
2925766|NCT00566527|3637018|FG000|COMPLETED|Overall Study||524
2925767|NCT00566527|3637019|FG001|COMPLETED|Overall Study||474
2925768|NCT00566527|3637020|FG002|COMPLETED|Overall Study||461
2925769|NCT00566527|3637018|FG000|NOT COMPLETED|Overall Study||17
2925770|NCT00566527|3637019|FG001|NOT COMPLETED|Overall Study||66
2925771|NCT00566527|3637020|FG002|NOT COMPLETED|Overall Study||78
2925772|NCT00566540|3637030|FG000|STARTED|Overall Study||11
2925773|NCT00566540|3637030|FG000|COMPLETED|Overall Study||11
2925774|NCT00566540|3637030|FG000|NOT COMPLETED|Overall Study||0
2925775|NCT00566579|3637036|FG000|STARTED|Overall Study||29
2925776|NCT00566579|3637037|FG001|STARTED|Overall Study||31
2925777|NCT00566579|3637036|FG000|COMPLETED|Overall Study||29
2925778|NCT00566579|3637037|FG001|COMPLETED|Overall Study||31
2925779|NCT00566579|3637036|FG000|NOT COMPLETED|Overall Study||0
2925780|NCT00566579|3637037|FG001|NOT COMPLETED|Overall Study||0
2925781|NCT00566631|3637043|FG000|STARTED|Part 1: Core Treatment Phase||294
2925782|NCT00566631|3637043|FG000|COMPLETED|Part 1: Core Treatment Phase||234
2925783|NCT00566631|3637043|FG000|NOT COMPLETED|Part 1: Core Treatment Phase||60
2925784|NCT00566631|3637043|FG000|STARTED|Between Treatment and Extension Phase||234
2925785|NCT00566631|3637043|FG000|COMPLETED|Between Treatment and Extension Phase||139
2925786|NCT00566631|3637043|FG000|NOT COMPLETED|Between Treatment and Extension Phase||95
2925787|NCT00566631|3637043|FG000|STARTED|Part 2: Extension Phase||139
2925788|NCT00566631|3637043|FG000|COMPLETED|Part 2: Extension Phase||57
2925789|NCT00566631|3637043|FG000|NOT COMPLETED|Part 2: Extension Phase||82
2925790|NCT00566696|3637047|FG000|STARTED|Overall Study||73
2925791|NCT00566696|3637047|FG000|COMPLETED|Overall Study||31
2925792|NCT00566696|3637047|FG000|NOT COMPLETED|Overall Study||42
2925793|NCT00566709|3637053|FG000|STARTED|Overall Study||51
2925794|NCT00566709|3637054|FG001|STARTED|Overall Study||51
2925795|NCT00566709|3637053|FG000|COMPLETED|Overall Study||46
2925796|NCT00566709|3637054|FG001|COMPLETED|Overall Study||51
3039289|NCT01157169|3758653|FG001|STARTED|Second Intervention||18
3039290|NCT01157169|3758652|FG000|COMPLETED|Second Intervention||16
3039291|NCT01157169|3758653|FG001|COMPLETED|Second Intervention||17
3039292|NCT01157169|3758652|FG000|NOT COMPLETED|Second Intervention||0
3039293|NCT01157169|3758653|FG001|NOT COMPLETED|Second Intervention||1
3039294|NCT01157182|3758661|FG000|STARTED|First Intervention||18
3039295|NCT01157182|3758662|FG001|STARTED|First Intervention||18
3039296|NCT01157182|3758661|FG000|COMPLETED|First Intervention||18
3039297|NCT01157182|3758662|FG001|COMPLETED|First Intervention||18
3039298|NCT01157182|3758661|FG000|NOT COMPLETED|First Intervention||0
3039299|NCT01157182|3758662|FG001|NOT COMPLETED|First Intervention||0
3039300|NCT01157182|3758661|FG000|STARTED|Washout of 28 Days||18
3039301|NCT01157182|3758662|FG001|STARTED|Washout of 28 Days||18
3039302|NCT01157182|3758661|FG000|COMPLETED|Washout of 28 Days||16
3039303|NCT01157182|3758662|FG001|COMPLETED|Washout of 28 Days||18
3039304|NCT01157182|3758661|FG000|NOT COMPLETED|Washout of 28 Days||2
3039305|NCT01157182|3758662|FG001|NOT COMPLETED|Washout of 28 Days||0
3174744|NCT01957202|3902425|FG005|COMPLETED|Treatment Period 3 (8 Days)||2
3174745|NCT01957202|3902426|FG006|COMPLETED|Treatment Period 3 (8 Days)||3
3174746|NCT01957202|3902427|FG007|COMPLETED|Treatment Period 3 (8 Days)||3
3174747|NCT01957202|3902428|FG008|COMPLETED|Treatment Period 3 (8 Days)||3
3322140|NCT03185065|4055224|FG003|NOT COMPLETED|Washout (2 Weeks)||0
3322141|NCT03185065|4055221|FG000|STARTED|Period 4 (6 Weeks)||31
3322142|NCT03185065|4055222|FG001|STARTED|Period 4 (6 Weeks)||28
3322143|NCT03185065|4055223|FG002|STARTED|Period 4 (6 Weeks)||27
3322144|NCT03185065|4055224|FG003|STARTED|Period 4 (6 Weeks)||32
3322145|NCT03185065|4055221|FG000|COMPLETED|Period 4 (6 Weeks)||31
3322146|NCT03185065|4055222|FG001|COMPLETED|Period 4 (6 Weeks)||27
3322147|NCT03185065|4055223|FG002|COMPLETED|Period 4 (6 Weeks)||26
3322148|NCT03185065|4055224|FG003|COMPLETED|Period 4 (6 Weeks)||31
3322149|NCT03185065|4055221|FG000|NOT COMPLETED|Period 4 (6 Weeks)||0
3322150|NCT03185065|4055222|FG001|NOT COMPLETED|Period 4 (6 Weeks)||1
3322151|NCT03185065|4055223|FG002|NOT COMPLETED|Period 4 (6 Weeks)||1
3322152|NCT03185065|4055224|FG003|NOT COMPLETED|Period 4 (6 Weeks)||1
3322153|NCT03185182|4055235|FG000|STARTED|Overall Study||5
3174748|NCT01957202|3902429|FG009|COMPLETED|Treatment Period 3 (8 Days)||6
3174749|NCT01957202|3902430|FG010|COMPLETED|Treatment Period 3 (8 Days)||3
3174750|NCT01957202|3902431|FG011|COMPLETED|Treatment Period 3 (8 Days)||6
3174751|NCT01957202|3902432|FG012|COMPLETED|Treatment Period 3 (8 Days)||3
3174752|NCT01957202|3902433|FG013|COMPLETED|Treatment Period 3 (8 Days)||3
3174753|NCT01957202|3902434|FG014|COMPLETED|Treatment Period 3 (8 Days)||6
3174754|NCT01957202|3902435|FG015|COMPLETED|Treatment Period 3 (8 Days)||3
3174755|NCT01957202|3902436|FG016|COMPLETED|Treatment Period 3 (8 Days)||4
3174756|NCT01957202|3902437|FG017|COMPLETED|Treatment Period 3 (8 Days)||3
3174757|NCT01957202|3902420|FG000|NOT COMPLETED|Treatment Period 3 (8 Days)||0
3174758|NCT01957202|3902421|FG001|NOT COMPLETED|Treatment Period 3 (8 Days)||0
3174759|NCT01957202|3902422|FG002|NOT COMPLETED|Treatment Period 3 (8 Days)||0
3174760|NCT01957202|3902423|FG003|NOT COMPLETED|Treatment Period 3 (8 Days)||0
3174761|NCT01957202|3902424|FG004|NOT COMPLETED|Treatment Period 3 (8 Days)||0
3174762|NCT01957202|3902425|FG005|NOT COMPLETED|Treatment Period 3 (8 Days)||0
3174763|NCT01957202|3902426|FG006|NOT COMPLETED|Treatment Period 3 (8 Days)||0
3174764|NCT01957202|3902427|FG007|NOT COMPLETED|Treatment Period 3 (8 Days)||0
3174765|NCT01957202|3902428|FG008|NOT COMPLETED|Treatment Period 3 (8 Days)||0
3174766|NCT01957202|3902429|FG009|NOT COMPLETED|Treatment Period 3 (8 Days)||0
3174767|NCT01957202|3902430|FG010|NOT COMPLETED|Treatment Period 3 (8 Days)||0
3174768|NCT01957202|3902431|FG011|NOT COMPLETED|Treatment Period 3 (8 Days)||0
3174769|NCT01957202|3902432|FG012|NOT COMPLETED|Treatment Period 3 (8 Days)||0
2925797|NCT00566709|3637053|FG000|NOT COMPLETED|Overall Study||5
3174770|NCT01957202|3902433|FG013|NOT COMPLETED|Treatment Period 3 (8 Days)||0
3174771|NCT01957202|3902434|FG014|NOT COMPLETED|Treatment Period 3 (8 Days)||0
3174772|NCT01957202|3902435|FG015|NOT COMPLETED|Treatment Period 3 (8 Days)||0
3174773|NCT01957202|3902436|FG016|NOT COMPLETED|Treatment Period 3 (8 Days)||1
2925798|NCT00566709|3637054|FG001|NOT COMPLETED|Overall Study||0
2925799|NCT00566722|3637063|FG000|STARTED|Overall Study||41
2925800|NCT00566722|3637064|FG001|STARTED|Overall Study||29
2925801|NCT00566722|3637065|FG002|STARTED|Overall Study||82
2925802|NCT00566722|3637063|FG000|COMPLETED|Overall Study||39
2925803|NCT00566722|3637064|FG001|COMPLETED|Overall Study||24
2925804|NCT00566722|3637065|FG002|COMPLETED|Overall Study||73
2925805|NCT00566722|3637063|FG000|NOT COMPLETED|Overall Study||2
2925806|NCT00566722|3637064|FG001|NOT COMPLETED|Overall Study||5
2925807|NCT00566722|3637065|FG002|NOT COMPLETED|Overall Study||9
2925808|NCT00566735|3637078|FG000|STARTED|Overall Study||20
2925809|NCT00566735|3637079|FG001|STARTED|Overall Study||19
2925810|NCT00566735|3637078|FG000|Withdrew Before Baseline Measures|Overall Study||2
2925811|NCT00566735|3637079|FG001|Withdrew Before Baseline Measures|Overall Study||7
2925812|NCT00566735|3637078|FG000|COMPLETED|Overall Study|2 participants withdrew before baselines. Therefore, 18 participants will be included in baselines.|18
2925813|NCT00566735|3637079|FG001|COMPLETED|Overall Study|7 participants withdrew before baselines. Therefore, 12 participants will be included in baselines.|12
2925814|NCT00566735|3637078|FG000|NOT COMPLETED|Overall Study||2
2925815|NCT00566735|3637079|FG001|NOT COMPLETED|Overall Study||7
2925816|NCT00566813|3637087|FG000|STARTED|Overall Study||4
2925817|NCT00566813|3637088|FG001|STARTED|Overall Study||6
2925818|NCT00566813|3637087|FG000|COMPLETED|Overall Study||4
2925819|NCT00566813|3637088|FG001|COMPLETED|Overall Study||6
2925820|NCT00566813|3637087|FG000|NOT COMPLETED|Overall Study||0
2925821|NCT00566813|3637088|FG001|NOT COMPLETED|Overall Study||0
2925822|NCT00566852|3637096|FG000|STARTED|Overall Study||278
2925823|NCT00566852|3637097|FG001|STARTED|Overall Study||276
2925824|NCT00566852|3637096|FG000|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|71
2925825|NCT00566852|3637097|FG001|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|78
2925826|NCT00566852|3637096|FG000|NOT COMPLETED|Overall Study||207
2925827|NCT00566852|3637097|FG001|NOT COMPLETED|Overall Study||198
2925828|NCT00566930|3637106|FG000|STARTED|Overall Study||29
2925829|NCT00566930|3637107|FG001|STARTED|Overall Study||36
2925830|NCT00566930|3637108|FG002|STARTED|Overall Study||33
2925831|NCT00566930|3637106|FG000|COMPLETED|Overall Study||27
2925832|NCT00566930|3637107|FG001|COMPLETED|Overall Study||32
2925833|NCT00566930|3637108|FG002|COMPLETED|Overall Study||32
2925834|NCT00566930|3637106|FG000|NOT COMPLETED|Overall Study||2
2925835|NCT00566930|3637107|FG001|NOT COMPLETED|Overall Study||4
2925836|NCT00566930|3637108|FG002|NOT COMPLETED|Overall Study||1
2925837|NCT00566943|3637118|FG000|STARTED|Overall Study||52
2925838|NCT00566943|3637119|FG001|STARTED|Overall Study||49
2925839|NCT00566943|3637118|FG000|COMPLETED|Overall Study||52
2925840|NCT00566943|3637119|FG001|COMPLETED|Overall Study||49
2925841|NCT00566943|3637118|FG000|NOT COMPLETED|Overall Study||0
2925842|NCT00566943|3637119|FG001|NOT COMPLETED|Overall Study||0
2925843|NCT00566969|3637134|FG000|STARTED|Overall Study||34
2925844|NCT00566969|3637135|FG001|STARTED|Overall Study||37
2925845|NCT00566969|3637136|FG002|STARTED|Overall Study||35
2925846|NCT00566969|3637134|FG000|COMPLETED|Overall Study||19
2925847|NCT00566969|3637135|FG001|COMPLETED|Overall Study||28
2925848|NCT00566969|3637136|FG002|COMPLETED|Overall Study||23
2925849|NCT00566969|3637134|FG000|NOT COMPLETED|Overall Study||15
2925850|NCT00566969|3637135|FG001|NOT COMPLETED|Overall Study||9
2925851|NCT00566969|3637136|FG002|NOT COMPLETED|Overall Study||12
2925852|NCT00566982|3637146|FG000|STARTED|Overall Study||63
2925853|NCT00566982|3637147|FG001|STARTED|Overall Study||363
2925854|NCT00566982|3637146|FG000|COMPLETED|Overall Study||55
3039306|NCT01157182|3758661|FG000|STARTED|Second Intervention||16
3039307|NCT01157182|3758662|FG001|STARTED|Second Intervention||18
3039308|NCT01157182|3758661|FG000|COMPLETED|Second Intervention||16
3039309|NCT01157182|3758662|FG001|COMPLETED|Second Intervention||18
3039310|NCT01157182|3758661|FG000|NOT COMPLETED|Second Intervention||0
3039311|NCT01157182|3758662|FG001|NOT COMPLETED|Second Intervention||0
3039312|NCT01157234|3758670|FG000|STARTED|Overall Study||15
3039313|NCT01157234|3758671|FG001|STARTED|Overall Study||15
3039314|NCT01157234|3758670|FG000|COMPLETED|Overall Study||14
3039315|NCT01157234|3758671|FG001|COMPLETED|Overall Study||15
3039316|NCT01157234|3758670|FG000|NOT COMPLETED|Overall Study||1
3039317|NCT01157234|3758671|FG001|NOT COMPLETED|Overall Study||0
3039318|NCT01157351|3758686|FG000|STARTED|Overall Study||230
3039319|NCT01157351|3758687|FG001|STARTED|Overall Study||220
3174774|NCT01957202|3902437|FG017|NOT COMPLETED|Treatment Period 3 (8 Days)||0
3174775|NCT01957215|3902449|FG000|STARTED|Overall Study||135
3322154|NCT03185182|4055235|FG000|COMPLETED|Overall Study||5
3174776|NCT01957215|3902450|FG001|STARTED|Overall Study||135
3174777|NCT01957215|3902449|FG000|COMPLETED|Overall Study||122
2925855|NCT00566982|3637147|FG001|COMPLETED|Overall Study||294
2925856|NCT00566982|3637146|FG000|NOT COMPLETED|Overall Study||8
2925857|NCT00566982|3637147|FG001|NOT COMPLETED|Overall Study||69
2925858|NCT00567008|3637158|FG000|STARTED|Overall Study||18
2925859|NCT00567008|3637159|FG001|STARTED|Overall Study||19
2925860|NCT00567008|3637158|FG000|COMPLETED|Overall Study||17
2925861|NCT00567008|3637159|FG001|COMPLETED|Overall Study||18
2925862|NCT00567008|3637158|FG000|NOT COMPLETED|Overall Study||1
2925863|NCT00567008|3637159|FG001|NOT COMPLETED|Overall Study||1
2925864|NCT00567112|3637165|FG000|STARTED|Treatment Period 1 (3 Days)||7
2925865|NCT00567112|3637166|FG001|STARTED|Treatment Period 1 (3 Days)||8
2925866|NCT00567112|3637167|FG002|STARTED|Treatment Period 1 (3 Days)||0
2925867|NCT00567112|3637165|FG000|COMPLETED|Treatment Period 1 (3 Days)||7
2925868|NCT00567112|3637166|FG001|COMPLETED|Treatment Period 1 (3 Days)||8
2925869|NCT00567112|3637167|FG002|COMPLETED|Treatment Period 1 (3 Days)||0
2925870|NCT00567112|3637165|FG000|NOT COMPLETED|Treatment Period 1 (3 Days)||0
2925871|NCT00567112|3637166|FG001|NOT COMPLETED|Treatment Period 1 (3 Days)||0
2925872|NCT00567112|3637167|FG002|NOT COMPLETED|Treatment Period 1 (3 Days)||0
2925873|NCT00567112|3637165|FG000|STARTED|Washout Period 1 (3 Days)||7
2925874|NCT00567112|3637166|FG001|STARTED|Washout Period 1 (3 Days)||8
2925875|NCT00567112|3637167|FG002|STARTED|Washout Period 1 (3 Days)||0
2925876|NCT00567112|3637165|FG000|COMPLETED|Washout Period 1 (3 Days)||7
2925877|NCT00567112|3637166|FG001|COMPLETED|Washout Period 1 (3 Days)||8
2925878|NCT00567112|3637167|FG002|COMPLETED|Washout Period 1 (3 Days)||0
2925879|NCT00567112|3637165|FG000|NOT COMPLETED|Washout Period 1 (3 Days)||0
2925880|NCT00567112|3637166|FG001|NOT COMPLETED|Washout Period 1 (3 Days)||0
2925881|NCT00567112|3637167|FG002|NOT COMPLETED|Washout Period 1 (3 Days)||0
2925882|NCT00567112|3637165|FG000|STARTED|Treatment Period 2 (3 Days)||7
2925883|NCT00567112|3637166|FG001|STARTED|Treatment Period 2 (3 Days)||8
2925884|NCT00567112|3637167|FG002|STARTED|Treatment Period 2 (3 Days)|3 new participants added to Treatment Group ABCD & received treatment sequence BCD for Periods 2-4|3
2925885|NCT00567112|3637165|FG000|COMPLETED|Treatment Period 2 (3 Days)||7
2925886|NCT00567112|3637166|FG001|COMPLETED|Treatment Period 2 (3 Days)||7
2925887|NCT00567112|3637167|FG002|COMPLETED|Treatment Period 2 (3 Days)||3
2925888|NCT00567112|3637165|FG000|NOT COMPLETED|Treatment Period 2 (3 Days)||0
2925889|NCT00567112|3637166|FG001|NOT COMPLETED|Treatment Period 2 (3 Days)||1
3174778|NCT01957215|3902450|FG001|COMPLETED|Overall Study||123
3174779|NCT01957215|3902449|FG000|NOT COMPLETED|Overall Study||13
3174780|NCT01957215|3902450|FG001|NOT COMPLETED|Overall Study||12
3174781|NCT01957384|3902460|FG000|STARTED|Test Period 1 (14 Days)||4
3174782|NCT01957384|3902461|FG001|STARTED|Test Period 1 (14 Days)||4
3174783|NCT01957384|3902462|FG002|STARTED|Test Period 1 (14 Days)||4
3174784|NCT01957384|3902463|FG003|STARTED|Test Period 1 (14 Days)||4
3174785|NCT01957384|3902464|FG004|STARTED|Test Period 1 (14 Days)||3
2925890|NCT00567112|3637167|FG002|NOT COMPLETED|Treatment Period 2 (3 Days)||0
2925891|NCT00567112|3637165|FG000|STARTED|Washout Period 2 (3 Days)||7
2925892|NCT00567112|3637166|FG001|STARTED|Washout Period 2 (3 Days)||7
2925893|NCT00567112|3637167|FG002|STARTED|Washout Period 2 (3 Days)||3
2925894|NCT00567112|3637165|FG000|COMPLETED|Washout Period 2 (3 Days)||7
2925895|NCT00567112|3637166|FG001|COMPLETED|Washout Period 2 (3 Days)||7
2925896|NCT00567112|3637167|FG002|COMPLETED|Washout Period 2 (3 Days)||3
2925897|NCT00567112|3637165|FG000|NOT COMPLETED|Washout Period 2 (3 Days)||0
2925898|NCT00567112|3637166|FG001|NOT COMPLETED|Washout Period 2 (3 Days)||0
2925899|NCT00567112|3637167|FG002|NOT COMPLETED|Washout Period 2 (3 Days)||0
2925900|NCT00567112|3637165|FG000|STARTED|Treatment Period 3 (3 Days)||7
2925901|NCT00567112|3637166|FG001|STARTED|Treatment Period 3 (3 Days)||7
2925902|NCT00567112|3637167|FG002|STARTED|Treatment Period 3 (3 Days)||3
2925903|NCT00567112|3637165|FG000|COMPLETED|Treatment Period 3 (3 Days)||7
3039320|NCT01157351|3758686|FG000|Treated|Overall Study||226
3039321|NCT01157351|3758687|FG001|Treated|Overall Study||218
3039322|NCT01157351|3758686|FG000|COMPLETED|Overall Study||93
3039323|NCT01157351|3758687|FG001|COMPLETED|Overall Study||88
3039324|NCT01157351|3758686|FG000|NOT COMPLETED|Overall Study||137
3039325|NCT01157351|3758687|FG001|NOT COMPLETED|Overall Study||132
3039326|NCT01157364|3758699|FG000|STARTED|Overall Study||15
3039327|NCT01157364|3758700|FG001|STARTED|Overall Study||21
3039328|NCT01157364|3758701|FG002|STARTED|Overall Study||21
3039329|NCT01157364|3758702|FG003|STARTED|Overall Study||18
3039330|NCT01157364|3758703|FG004|STARTED|Overall Study||11
3039331|NCT01157364|3758704|FG005|STARTED|Overall Study||23
3039332|NCT01157364|3758699|FG000|COMPLETED|Overall Study||13
3039333|NCT01157364|3758700|FG001|COMPLETED|Overall Study||17
3039334|NCT01157364|3758701|FG002|COMPLETED|Overall Study||17
3039335|NCT01157364|3758702|FG003|COMPLETED|Overall Study||16
3039336|NCT01157364|3758703|FG004|COMPLETED|Overall Study||9
3039337|NCT01157364|3758704|FG005|COMPLETED|Overall Study||22
3039338|NCT01157364|3758699|FG000|NOT COMPLETED|Overall Study||2
3039339|NCT01157364|3758700|FG001|NOT COMPLETED|Overall Study||4
3039340|NCT01157364|3758701|FG002|NOT COMPLETED|Overall Study||4
3039341|NCT01157364|3758702|FG003|NOT COMPLETED|Overall Study||2
3039342|NCT01157364|3758703|FG004|NOT COMPLETED|Overall Study||2
3039343|NCT01157364|3758704|FG005|NOT COMPLETED|Overall Study||1
3039344|NCT01157377|3758725|FG000|STARTED|Overall Study||23
3039345|NCT01157377|3758726|FG001|STARTED|Overall Study||23
3039346|NCT01157377|3758727|FG002|STARTED|Overall Study||27
3039347|NCT01157377|3758728|FG003|STARTED|Overall Study||15
3039348|NCT01157377|3758729|FG004|STARTED|Overall Study||20
3039349|NCT01157377|3758730|FG005|STARTED|Overall Study||19
3039350|NCT01157377|3758731|FG006|STARTED|Overall Study||29
3039351|NCT01157377|3758725|FG000|COMPLETED|Overall Study||21
3039352|NCT01157377|3758726|FG001|COMPLETED|Overall Study||20
3039353|NCT01157377|3758727|FG002|COMPLETED|Overall Study||26
3039354|NCT01157377|3758728|FG003|COMPLETED|Overall Study||14
3039355|NCT01157377|3758729|FG004|COMPLETED|Overall Study||18
3039356|NCT01157377|3758730|FG005|COMPLETED|Overall Study||16
3137007|NCT01716520|3862282|FG004|NOT COMPLETED|Treatment Period 2 (14 Days)||2
3137008|NCT01716520|3862283|FG005|NOT COMPLETED|Treatment Period 2 (14 Days)||0
3137009|NCT01716520|3862278|FG000|STARTED|Washout Period 2 (10 to 14 Days)||29
3137010|NCT01716520|3862279|FG001|STARTED|Washout Period 2 (10 to 14 Days)||28
3137011|NCT01716520|3862280|FG002|STARTED|Washout Period 2 (10 to 14 Days)||27
3137012|NCT01716520|3862281|FG003|STARTED|Washout Period 2 (10 to 14 Days)||28
3137013|NCT01716520|3862282|FG004|STARTED|Washout Period 2 (10 to 14 Days)||29
3137014|NCT01716520|3862283|FG005|STARTED|Washout Period 2 (10 to 14 Days)||27
3137015|NCT01716520|3862278|FG000|COMPLETED|Washout Period 2 (10 to 14 Days)||27
3137016|NCT01716520|3862279|FG001|COMPLETED|Washout Period 2 (10 to 14 Days)||27
3137017|NCT01716520|3862280|FG002|COMPLETED|Washout Period 2 (10 to 14 Days)||26
3137018|NCT01716520|3862281|FG003|COMPLETED|Washout Period 2 (10 to 14 Days)||28
3137019|NCT01716520|3862282|FG004|COMPLETED|Washout Period 2 (10 to 14 Days)||29
3137020|NCT01716520|3862283|FG005|COMPLETED|Washout Period 2 (10 to 14 Days)||25
3137021|NCT01716520|3862278|FG000|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||2
3137022|NCT01716520|3862279|FG001|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||1
3137023|NCT01716520|3862280|FG002|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||1
3137024|NCT01716520|3862281|FG003|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
3137025|NCT01716520|3862282|FG004|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
3137026|NCT01716520|3862283|FG005|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||2
3137027|NCT01716520|3862278|FG000|STARTED|Treatment Period 3 (14 Days)||27
3137028|NCT01716520|3862279|FG001|STARTED|Treatment Period 3 (14 Days)||27
3137029|NCT01716520|3862280|FG002|STARTED|Treatment Period 3 (14 Days)||26
3137030|NCT01716520|3862281|FG003|STARTED|Treatment Period 3 (14 Days)||28
3137031|NCT01716520|3862282|FG004|STARTED|Treatment Period 3 (14 Days)||29
3137032|NCT01716520|3862283|FG005|STARTED|Treatment Period 3 (14 Days)||25
3137033|NCT01716520|3862278|FG000|COMPLETED|Treatment Period 3 (14 Days)||27
3137034|NCT01716520|3862279|FG001|COMPLETED|Treatment Period 3 (14 Days)||27
3137035|NCT01716520|3862280|FG002|COMPLETED|Treatment Period 3 (14 Days)||25
3174786|NCT01957384|3902465|FG005|STARTED|Test Period 1 (14 Days)||3
3174787|NCT01957384|3902460|FG000|COMPLETED|Test Period 1 (14 Days)||4
3174788|NCT01957384|3902461|FG001|COMPLETED|Test Period 1 (14 Days)||4
3174789|NCT01957384|3902462|FG002|COMPLETED|Test Period 1 (14 Days)||4
3174790|NCT01957384|3902463|FG003|COMPLETED|Test Period 1 (14 Days)||4
3322155|NCT03185182|4055235|FG000|NOT COMPLETED|Overall Study||0
3174791|NCT01957384|3902464|FG004|COMPLETED|Test Period 1 (14 Days)||3
3174792|NCT01957384|3902465|FG005|COMPLETED|Test Period 1 (14 Days)||3
3174793|NCT01957384|3902460|FG000|NOT COMPLETED|Test Period 1 (14 Days)||0
3174794|NCT01957384|3902461|FG001|NOT COMPLETED|Test Period 1 (14 Days)||0
3174795|NCT01957384|3902462|FG002|NOT COMPLETED|Test Period 1 (14 Days)||0
3174796|NCT01957384|3902463|FG003|NOT COMPLETED|Test Period 1 (14 Days)||0
3174797|NCT01957384|3902464|FG004|NOT COMPLETED|Test Period 1 (14 Days)||0
2925904|NCT00567112|3637166|FG001|COMPLETED|Treatment Period 3 (3 Days)||7
2925905|NCT00567112|3637167|FG002|COMPLETED|Treatment Period 3 (3 Days)||3
2925906|NCT00567112|3637165|FG000|NOT COMPLETED|Treatment Period 3 (3 Days)||0
2925907|NCT00567112|3637166|FG001|NOT COMPLETED|Treatment Period 3 (3 Days)||0
2925908|NCT00567112|3637167|FG002|NOT COMPLETED|Treatment Period 3 (3 Days)||0
2925909|NCT00567112|3637165|FG000|STARTED|Washout Period 3 (3 Days)||7
2925910|NCT00567112|3637166|FG001|STARTED|Washout Period 3 (3 Days)||7
2925911|NCT00567112|3637167|FG002|STARTED|Washout Period 3 (3 Days)||3
2925912|NCT00567112|3637165|FG000|COMPLETED|Washout Period 3 (3 Days)||4
2925913|NCT00567112|3637166|FG001|COMPLETED|Washout Period 3 (3 Days)||7
2925914|NCT00567112|3637167|FG002|COMPLETED|Washout Period 3 (3 Days)||3
2925915|NCT00567112|3637165|FG000|NOT COMPLETED|Washout Period 3 (3 Days)||3
2925916|NCT00567112|3637166|FG001|NOT COMPLETED|Washout Period 3 (3 Days)||0
2925917|NCT00567112|3637167|FG002|NOT COMPLETED|Washout Period 3 (3 Days)||0
2925918|NCT00567112|3637165|FG000|STARTED|Treatment Period 4 (3 Days)||4
2925919|NCT00567112|3637166|FG001|STARTED|Treatment Period 4 (3 Days)||7
2925920|NCT00567112|3637167|FG002|STARTED|Treatment Period 4 (3 Days)||3
2925921|NCT00567112|3637165|FG000|COMPLETED|Treatment Period 4 (3 Days)||4
2925922|NCT00567112|3637166|FG001|COMPLETED|Treatment Period 4 (3 Days)||7
2925923|NCT00567112|3637167|FG002|COMPLETED|Treatment Period 4 (3 Days)||3
2925924|NCT00567112|3637165|FG000|NOT COMPLETED|Treatment Period 4 (3 Days)||0
2925925|NCT00567112|3637166|FG001|NOT COMPLETED|Treatment Period 4 (3 Days)||0
2925926|NCT00567112|3637167|FG002|NOT COMPLETED|Treatment Period 4 (3 Days)||0
2925927|NCT00567164|3637179|FG000|STARTED|Overall Study||1421
2925928|NCT00567164|3637180|FG001|STARTED|Overall Study||234
2925929|NCT00567164|3637181|FG002|STARTED|Overall Study||232
2925930|NCT00567164|3637179|FG000|Subjects Received Treatment|Overall Study|Full Analysis Set|1406
2925931|NCT00567164|3637180|FG001|Subjects Received Treatment|Overall Study|Full Analysis Set|232
2925932|NCT00567164|3637181|FG002|Subjects Received Treatment|Overall Study|Full Analysis Set|226
2925933|NCT00567164|3637179|FG000|COMPLETED|Overall Study||875
3174798|NCT01957384|3902465|FG005|NOT COMPLETED|Test Period 1 (14 Days)||0
3174799|NCT01957384|3902460|FG000|STARTED|Test Period 2 (14 Days)||4
3174800|NCT01957384|3902461|FG001|STARTED|Test Period 2 (14 Days)||4
2925934|NCT00567164|3637180|FG001|COMPLETED|Overall Study||161
2925935|NCT00567164|3637181|FG002|COMPLETED|Overall Study||160
2925936|NCT00567164|3637179|FG000|NOT COMPLETED|Overall Study||546
2925937|NCT00567164|3637180|FG001|NOT COMPLETED|Overall Study||73
2925938|NCT00567164|3637181|FG002|NOT COMPLETED|Overall Study||72
2925939|NCT00567190|3637195|FG000|STARTED|Overall Study||402
2925940|NCT00567190|3637196|FG001|STARTED|Overall Study||406
2925941|NCT00567190|3637195|FG000|Did Not Receive Any Study Treatment|Overall Study||2
2925942|NCT00567190|3637196|FG001|Did Not Receive Any Study Treatment|Overall Study||2
2925943|NCT00567190|3637195|FG000|Received at Least One Dose of Pertuzumab|Overall Study||399
2925944|NCT00567190|3637196|FG001|Received at Least One Dose of Pertuzumab|Overall Study|9 participants randomized to the Placebo arm actually received at least one dose of pertuzumab.|9
2925945|NCT00567190|3637195|FG000|Received at Least One Dose of Placebo|Overall Study|1 participant randomized to the Pertuzumab arm actually received placebo at every treatment cycle.|1
2925946|NCT00567190|3637196|FG001|Received at Least One Dose of Placebo|Overall Study||395
2925947|NCT00567190|3637195|FG000|Crossover From Placebo to Pertuzumab|Overall Study||0
2925948|NCT00567190|3637196|FG001|Crossover From Placebo to Pertuzumab|Overall Study|From July 2012, 50 participants randomized to Placebo arm crossed over to open-label pertuzumab.|50
2925949|NCT00567190|3637195|FG000|COMPLETED|Overall Study||119
2925950|NCT00567190|3637196|FG001|COMPLETED|Overall Study||73
2925951|NCT00567190|3637195|FG000|NOT COMPLETED|Overall Study||283
2925952|NCT00567190|3637196|FG001|NOT COMPLETED|Overall Study||333
2925953|NCT00567229|3637207|FG000|STARTED|Overall Study||3
2925954|NCT00567229|3637207|FG000|COMPLETED|Overall Study||3
2925955|NCT00567229|3637207|FG000|NOT COMPLETED|Overall Study||0
2925956|NCT00567242|3637213|FG000|STARTED|Overall Study||7
2925957|NCT00567242|3637214|FG001|STARTED|Overall Study||7
2925958|NCT00567242|3637213|FG000|COMPLETED|Overall Study||7
2925959|NCT00567242|3637214|FG001|COMPLETED|Overall Study||7
2925960|NCT00567242|3637213|FG000|NOT COMPLETED|Overall Study||0
2925961|NCT00567242|3637214|FG001|NOT COMPLETED|Overall Study||0
2925962|NCT00567255|3637222|FG000|STARTED|Overall Study||1001
3174801|NCT01957384|3902462|FG002|STARTED|Test Period 2 (14 Days)||4
3174802|NCT01957384|3902463|FG003|STARTED|Test Period 2 (14 Days)||4
3174803|NCT01957384|3902464|FG004|STARTED|Test Period 2 (14 Days)||3
3174804|NCT01957384|3902465|FG005|STARTED|Test Period 2 (14 Days)||3
3174805|NCT01957384|3902460|FG000|COMPLETED|Test Period 2 (14 Days)||4
3174806|NCT01957384|3902461|FG001|COMPLETED|Test Period 2 (14 Days)||4
3174807|NCT01957384|3902462|FG002|COMPLETED|Test Period 2 (14 Days)||4
3174808|NCT01957384|3902463|FG003|COMPLETED|Test Period 2 (14 Days)||4
3174809|NCT01957384|3902464|FG004|COMPLETED|Test Period 2 (14 Days)||3
3174810|NCT01957384|3902465|FG005|COMPLETED|Test Period 2 (14 Days)||3
3174811|NCT01957384|3902460|FG000|NOT COMPLETED|Test Period 2 (14 Days)||0
2925963|NCT00567255|3637223|FG001|STARTED|Overall Study||495
2925964|NCT00567255|3637222|FG000|COMPLETED|Overall Study||538
2925965|NCT00567255|3637223|FG001|COMPLETED|Overall Study||267
2925966|NCT00567255|3637222|FG000|NOT COMPLETED|Overall Study||463
2925967|NCT00567255|3637223|FG001|NOT COMPLETED|Overall Study||228
2925968|NCT00567268|3637229|FG000|STARTED|Overall Study||1194
2925969|NCT00567268|3637229|FG000|COMPLETED|Overall Study||1144
2925970|NCT00567268|3637229|FG000|NOT COMPLETED|Overall Study||50
2925971|NCT00567307|3637270|FG000|STARTED|Overall Study||111
2925972|NCT00567307|3637271|FG001|STARTED|Overall Study||105
2925973|NCT00567307|3637270|FG000|COMPLETED|Overall Study||99
2925974|NCT00567307|3637271|FG001|COMPLETED|Overall Study||104
2925975|NCT00567307|3637270|FG000|NOT COMPLETED|Overall Study||12
2925976|NCT00567307|3637271|FG001|NOT COMPLETED|Overall Study||1
2925977|NCT00567320|3637279|FG000|STARTED|Overall Study||13
3039357|NCT01157377|3758731|FG006|COMPLETED|Overall Study||27
3039358|NCT01157377|3758725|FG000|NOT COMPLETED|Overall Study||2
3039359|NCT01157377|3758726|FG001|NOT COMPLETED|Overall Study||3
3039360|NCT01157377|3758727|FG002|NOT COMPLETED|Overall Study||1
3039361|NCT01157377|3758728|FG003|NOT COMPLETED|Overall Study||1
3039362|NCT01157377|3758729|FG004|NOT COMPLETED|Overall Study||2
3039363|NCT01157377|3758730|FG005|NOT COMPLETED|Overall Study||3
3039364|NCT01157377|3758731|FG006|NOT COMPLETED|Overall Study||2
3039365|NCT01157416|3758749|FG000|STARTED|Overall Study||17
3039366|NCT01157416|3758750|FG001|STARTED|Overall Study||16
3039367|NCT01157416|3758749|FG000|COMPLETED|Overall Study||15
3039368|NCT01157416|3758750|FG001|COMPLETED|Overall Study||16
3039369|NCT01157416|3758749|FG000|NOT COMPLETED|Overall Study||2
3039370|NCT01157416|3758750|FG001|NOT COMPLETED|Overall Study||0
3039371|NCT01157429|3758758|FG000|STARTED|Overall Study||12
3039372|NCT01157429|3758759|FG001|STARTED|Overall Study||12
3039373|NCT01157429|3758758|FG000|COMPLETED|Overall Study||8
3039374|NCT01157429|3758759|FG001|COMPLETED|Overall Study||8
3039375|NCT01157429|3758758|FG000|NOT COMPLETED|Overall Study||4
3039376|NCT01157429|3758759|FG001|NOT COMPLETED|Overall Study||4
3039377|NCT01157676|3758767|FG000|STARTED|Enrollment||174
3039378|NCT01157676|3758768|FG001|STARTED|Enrollment||176
3039379|NCT01157676|3758767|FG000|COMPLETED|Enrollment||174
3039380|NCT01157676|3758768|FG001|COMPLETED|Enrollment||176
3039381|NCT01157676|3758767|FG000|NOT COMPLETED|Enrollment||0
3039382|NCT01157676|3758768|FG001|NOT COMPLETED|Enrollment||0
3039383|NCT01157676|3758767|FG000|STARTED|Randomization||174
3039384|NCT01157676|3758768|FG001|STARTED|Randomization||176
3039385|NCT01157676|3758767|FG000|COMPLETED|Randomization||153
3039386|NCT01157676|3758768|FG001|COMPLETED|Randomization||159
3039387|NCT01157676|3758767|FG000|NOT COMPLETED|Randomization||21
3039388|NCT01157676|3758768|FG001|NOT COMPLETED|Randomization||17
3039389|NCT01157676|3758767|FG000|STARTED|Surgery||153
3039390|NCT01157676|3758768|FG001|STARTED|Surgery||159
3039391|NCT01157676|3758767|FG000|COMPLETED|Surgery||152
3039392|NCT01157676|3758768|FG001|COMPLETED|Surgery|advanced disease=2, inadequate visualization=1, inability to tolerate position=1, colonic mass=1.|150
3039393|NCT01157676|3758767|FG000|NOT COMPLETED|Surgery||1
3039394|NCT01157676|3758768|FG001|NOT COMPLETED|Surgery||9
3039395|NCT01157845|3758780|FG000|STARTED|Overall Study||165
3039396|NCT01157845|3758780|FG000|COMPLETED|Overall Study||130
3039397|NCT01157845|3758780|FG000|NOT COMPLETED|Overall Study||35
3039398|NCT01157897|3758788|FG000|STARTED|Overall Study||10
3039399|NCT01157897|3758789|FG001|STARTED|Overall Study||10
3039400|NCT01157897|3758790|FG002|STARTED|Overall Study||10
3039401|NCT01157897|3758791|FG003|STARTED|Overall Study||6
2925978|NCT00567320|3637280|FG001|STARTED|Overall Study||18
2925979|NCT00567320|3637279|FG000|COMPLETED|Overall Study||13
2925980|NCT00567320|3637280|FG001|COMPLETED|Overall Study||18
3039402|NCT01157897|3758788|FG000|COMPLETED|Overall Study||8
3039403|NCT01157897|3758789|FG001|COMPLETED|Overall Study||8
3039404|NCT01157897|3758790|FG002|COMPLETED|Overall Study||10
3039405|NCT01157897|3758791|FG003|COMPLETED|Overall Study||5
2925981|NCT00567320|3637279|FG000|NOT COMPLETED|Overall Study||0
2925982|NCT00567320|3637280|FG001|NOT COMPLETED|Overall Study||0
2925983|NCT00567359|3637286|FG000|STARTED|Overall Study||100
2925984|NCT00567359|3637286|FG000|COMPLETED|Overall Study||99
2925985|NCT00567359|3637286|FG000|NOT COMPLETED|Overall Study||1
2925986|NCT00567398|3637292|FG000|STARTED|Overall Study||127
2925987|NCT00567398|3637293|FG001|STARTED|Overall Study||124
2925988|NCT00567398|3637292|FG000|COMPLETED|Overall Study||120
2925989|NCT00567398|3637293|FG001|COMPLETED|Overall Study||101
2925990|NCT00567398|3637292|FG000|NOT COMPLETED|Overall Study||7
2925991|NCT00567398|3637293|FG001|NOT COMPLETED|Overall Study||23
2925992|NCT00567476|3637301|FG000|STARTED|Overall Study||78
2925993|NCT00567476|3637302|FG001|STARTED|Overall Study||38
2925994|NCT00567476|3637301|FG000|COMPLETED|Overall Study||70
2925995|NCT00567476|3637302|FG001|COMPLETED|Overall Study||34
2925996|NCT00567476|3637301|FG000|NOT COMPLETED|Overall Study||8
2925997|NCT00567476|3637302|FG001|NOT COMPLETED|Overall Study||4
2925998|NCT00567489|3637310|FG000|STARTED|Overall Study||127
2925999|NCT00567489|3637311|FG001|STARTED|Overall Study||124
2926000|NCT00567489|3637310|FG000|COMPLETED|Overall Study||120
2926001|NCT00567489|3637311|FG001|COMPLETED|Overall Study||101
2926002|NCT00567489|3637310|FG000|NOT COMPLETED|Overall Study||7
2926003|NCT00567489|3637311|FG001|NOT COMPLETED|Overall Study||23
2926004|NCT00567502|3637321|FG000|STARTED|Overall Study||804
2926005|NCT00567502|3637322|FG001|STARTED|Overall Study||141
2926006|NCT00567502|3637323|FG002|STARTED|Overall Study||2666
2926007|NCT00567502|3637324|FG003|STARTED|Overall Study||110
2926008|NCT00567502|3637321|FG000|Initiated Treatment|Overall Study||804
2926009|NCT00567502|3637322|FG001|Initiated Treatment|Overall Study||141
2926010|NCT00567502|3637323|FG002|Initiated Treatment|Overall Study||2666
2926011|NCT00567502|3637324|FG003|Initiated Treatment|Overall Study||38
2926012|NCT00567502|3637321|FG000|COMPLETED|Overall Study||563
2926013|NCT00567502|3637322|FG001|COMPLETED|Overall Study||108
2926014|NCT00567502|3637323|FG002|COMPLETED|Overall Study||1758
2926015|NCT00567502|3637324|FG003|COMPLETED|Overall Study||23
2926016|NCT00567502|3637321|FG000|NOT COMPLETED|Overall Study||241
2926017|NCT00567502|3637322|FG001|NOT COMPLETED|Overall Study||33
2926018|NCT00567502|3637323|FG002|NOT COMPLETED|Overall Study||908
3174812|NCT01957384|3902461|FG001|NOT COMPLETED|Test Period 2 (14 Days)||0
3174813|NCT01957384|3902462|FG002|NOT COMPLETED|Test Period 2 (14 Days)||0
3174814|NCT01957384|3902463|FG003|NOT COMPLETED|Test Period 2 (14 Days)||0
3174815|NCT01957384|3902464|FG004|NOT COMPLETED|Test Period 2 (14 Days)||0
3174816|NCT01957384|3902465|FG005|NOT COMPLETED|Test Period 2 (14 Days)||0
3174817|NCT01957384|3902460|FG000|STARTED|Test Period 3 (14 Days)||4
3174818|NCT01957384|3902461|FG001|STARTED|Test Period 3 (14 Days)||4
3174819|NCT01957384|3902462|FG002|STARTED|Test Period 3 (14 Days)||4
2926019|NCT00567502|3637324|FG003|NOT COMPLETED|Overall Study||87
2926020|NCT00567541|3637347|FG000|STARTED|Overall Study||7
2926021|NCT00567541|3637348|FG001|STARTED|Overall Study||9
3174820|NCT01957384|3902463|FG003|STARTED|Test Period 3 (14 Days)||4
3174821|NCT01957384|3902464|FG004|STARTED|Test Period 3 (14 Days)||3
2926022|NCT00567541|3637347|FG000|COMPLETED|Overall Study||7
2926023|NCT00567541|3637348|FG001|COMPLETED|Overall Study||8
2926024|NCT00567541|3637347|FG000|NOT COMPLETED|Overall Study||0
2926025|NCT00567541|3637348|FG001|NOT COMPLETED|Overall Study||1
2926026|NCT00567593|3637354|FG000|STARTED|Overall Study||12
2926027|NCT00567593|3637354|FG000|COMPLETED|Overall Study||10
2926028|NCT00567593|3637354|FG000|NOT COMPLETED|Overall Study||2
2926029|NCT00567840|3637363|FG000|STARTED|Overall Study||15
2926030|NCT00567840|3637364|FG001|STARTED|Overall Study||15
2926031|NCT00567840|3637365|FG002|STARTED|Overall Study||16
2926032|NCT00567840|3637366|FG003|STARTED|Overall Study||15
2926033|NCT00567840|3637367|FG004|STARTED|Overall Study||8
2926034|NCT00567840|3637363|FG000|COMPLETED|Overall Study||13
2926035|NCT00567840|3637364|FG001|COMPLETED|Overall Study||15
2926036|NCT00567840|3637365|FG002|COMPLETED|Overall Study||15
2926037|NCT00567840|3637366|FG003|COMPLETED|Overall Study||14
2926038|NCT00567840|3637367|FG004|COMPLETED|Overall Study||8
2926039|NCT00567840|3637363|FG000|NOT COMPLETED|Overall Study||2
2926040|NCT00567840|3637364|FG001|NOT COMPLETED|Overall Study||0
2926041|NCT00567840|3637365|FG002|NOT COMPLETED|Overall Study||1
2926042|NCT00567840|3637366|FG003|NOT COMPLETED|Overall Study||1
2926043|NCT00567840|3637367|FG004|NOT COMPLETED|Overall Study||0
2926044|NCT00567879|3637385|FG000|STARTED|Overall Study||7
2926045|NCT00567879|3637386|FG001|STARTED|Overall Study||7
2926046|NCT00567879|3637387|FG002|STARTED|Overall Study|7 participants belonged to the dose expansion group at 20mg/m2 i.v.|21
2926047|NCT00567879|3637388|FG003|STARTED|Overall Study||6
2926048|NCT00567879|3637389|FG004|STARTED|Overall Study||12
2926049|NCT00567879|3637390|FG005|STARTED|Overall Study||3
2926050|NCT00567879|3637385|FG000|Maximum Tolerated Dose Determining Set|Overall Study||5
2926051|NCT00567879|3637386|FG001|Maximum Tolerated Dose Determining Set|Overall Study||7
3039406|NCT01157897|3758788|FG000|NOT COMPLETED|Overall Study||2
3039407|NCT01157897|3758789|FG001|NOT COMPLETED|Overall Study||2
3039408|NCT01157897|3758790|FG002|NOT COMPLETED|Overall Study||0
3039409|NCT01157897|3758791|FG003|NOT COMPLETED|Overall Study||1
3039410|NCT01158118|3758803|FG000|STARTED|Overall Study||24
3039411|NCT01158118|3758804|FG001|STARTED|Overall Study||24
3039412|NCT01158118|3758803|FG000|COMPLETED|Overall Study||23
3039413|NCT01158118|3758804|FG001|COMPLETED|Overall Study||21
3039414|NCT01158118|3758803|FG000|NOT COMPLETED|Overall Study||1
3039415|NCT01158118|3758804|FG001|NOT COMPLETED|Overall Study||3
3039416|NCT01158157|3758810|FG000|STARTED|Overall Study|61 subjects screened; 25 subjects were vaccinated; 36 subjects were not eligible.|25
3039417|NCT01158157|3758810|FG000|COMPLETED|Overall Study||25
3039418|NCT01158157|3758810|FG000|NOT COMPLETED|Overall Study||0
3039419|NCT01158222|3758814|FG000|STARTED|Overall Study||37
3039420|NCT01158222|3758814|FG000|COMPLETED|Overall Study||20
3039421|NCT01158222|3758814|FG000|NOT COMPLETED|Overall Study||17
3039422|NCT01158261|3758818|FG000|STARTED|Overall Study||300
3039423|NCT01158261|3758818|FG000|COMPLETED|Overall Study||283
3039424|NCT01158261|3758818|FG000|NOT COMPLETED|Overall Study||17
3039425|NCT01158378|3758824|FG000|STARTED|Overall Study||124
3039426|NCT01158378|3758825|FG001|STARTED|Overall Study||126
3039427|NCT01158378|3758824|FG000|COMPLETED|Overall Study||114
3039428|NCT01158378|3758825|FG001|COMPLETED|Overall Study||117
3039429|NCT01158378|3758824|FG000|NOT COMPLETED|Overall Study||10
3039430|NCT01158378|3758825|FG001|NOT COMPLETED|Overall Study||9
3039431|NCT01158404|3758840|FG000|STARTED|Overall Study||3
3039432|NCT01158404|3758841|FG001|STARTED|Overall Study||4
3039433|NCT01158404|3758842|FG002|STARTED|Overall Study||3
3039434|NCT01158404|3758843|FG003|STARTED|Overall Study||3
3039435|NCT01158404|3758844|FG004|STARTED|Overall Study||6
3039436|NCT01158404|3758845|FG005|STARTED|Overall Study||5
3039437|NCT01158404|3758846|FG006|STARTED|Overall Study||3
3039438|NCT01158404|3758847|FG007|STARTED|Overall Study||8
3039439|NCT01158404|3758840|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
3039440|NCT01158404|3758841|FG001|Received at Least 1 Dose of Study Drug|Overall Study||4
3039441|NCT01158404|3758842|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3
3039442|NCT01158404|3758843|FG003|Received at Least 1 Dose of Study Drug|Overall Study||3
3039443|NCT01158404|3758844|FG004|Received at Least 1 Dose of Study Drug|Overall Study||6
3039444|NCT01158404|3758845|FG005|Received at Least 1 Dose of Study Drug|Overall Study||5
3039445|NCT01158404|3758846|FG006|Received at Least 1 Dose of Study Drug|Overall Study||3
3174822|NCT01957384|3902465|FG005|STARTED|Test Period 3 (14 Days)||3
3174823|NCT01957384|3902460|FG000|COMPLETED|Test Period 3 (14 Days)||4
3174824|NCT01957384|3902461|FG001|COMPLETED|Test Period 3 (14 Days)||4
3174825|NCT01957384|3902462|FG002|COMPLETED|Test Period 3 (14 Days)||4
3174826|NCT01957384|3902463|FG003|COMPLETED|Test Period 3 (14 Days)||4
3174827|NCT01957384|3902464|FG004|COMPLETED|Test Period 3 (14 Days)||3
3174828|NCT01957384|3902465|FG005|COMPLETED|Test Period 3 (14 Days)||3
3174829|NCT01957384|3902460|FG000|NOT COMPLETED|Test Period 3 (14 Days)||0
3174830|NCT01957384|3902461|FG001|NOT COMPLETED|Test Period 3 (14 Days)||0
3174831|NCT01957384|3902462|FG002|NOT COMPLETED|Test Period 3 (14 Days)||0
3174832|NCT01957384|3902463|FG003|NOT COMPLETED|Test Period 3 (14 Days)||0
3174833|NCT01957384|3902464|FG004|NOT COMPLETED|Test Period 3 (14 Days)||0
3322156|NCT03185455|4055242|FG000|STARTED|Overall Study||103
3137036|NCT01716520|3862281|FG003|COMPLETED|Treatment Period 3 (14 Days)||28
3137037|NCT01716520|3862282|FG004|COMPLETED|Treatment Period 3 (14 Days)||29
3137038|NCT01716520|3862283|FG005|COMPLETED|Treatment Period 3 (14 Days)||23
3137039|NCT01716520|3862278|FG000|NOT COMPLETED|Treatment Period 3 (14 Days)||0
3174834|NCT01957384|3902465|FG005|NOT COMPLETED|Test Period 3 (14 Days)||0
3174835|NCT01957397|3902473|FG000|STARTED|Baseline Own Product||13
3174836|NCT01957397|3902474|FG001|STARTED|Baseline Own Product||13
3174837|NCT01957397|3902473|FG000|COMPLETED|Baseline Own Product||13
3174838|NCT01957397|3902474|FG001|COMPLETED|Baseline Own Product||13
3174839|NCT01957397|3902473|FG000|NOT COMPLETED|Baseline Own Product||0
3174840|NCT01957397|3902474|FG001|NOT COMPLETED|Baseline Own Product||0
3174841|NCT01957397|3902473|FG000|STARTED|Test Period 1||13
3322157|NCT03185455|4055243|FG001|STARTED|Overall Study||103
3322158|NCT03185455|4055242|FG000|COMPLETED|Overall Study||103
3322159|NCT03185455|4055243|FG001|COMPLETED|Overall Study||103
3322160|NCT03185455|4055242|FG000|NOT COMPLETED|Overall Study||0
3322161|NCT03185455|4055243|FG001|NOT COMPLETED|Overall Study||0
3322162|NCT03185481|4055249|FG000|STARTED|Overall Study||5
3322163|NCT03185481|4055249|FG000|COMPLETED|Overall Study||0
3322164|NCT03185481|4055249|FG000|NOT COMPLETED|Overall Study||5
3322165|NCT03185546|4055261|FG000|STARTED|Baseline Through Week 12||6
3322166|NCT03185546|4055262|FG001|STARTED|Baseline Through Week 12||10
3322167|NCT03185546|4055263|FG002|STARTED|Baseline Through Week 12||5
3322168|NCT03185546|4055264|FG003|STARTED|Baseline Through Week 12||5
3322169|NCT03185546|4055265|FG004|STARTED|Baseline Through Week 12||6
3322170|NCT03185546|4055266|FG005|STARTED|Baseline Through Week 12||6
3322171|NCT03185546|4055267|FG006|STARTED|Baseline Through Week 12||7
3322172|NCT03185546|4055268|FG007|STARTED|Baseline Through Week 12||5
3322173|NCT03185546|4055261|FG000|COMPLETED|Baseline Through Week 12||2
3322174|NCT03185546|4055262|FG001|COMPLETED|Baseline Through Week 12||7
3174842|NCT01957397|3902474|FG001|STARTED|Test Period 1||13
3174843|NCT01957397|3902473|FG000|COMPLETED|Test Period 1||11
3174844|NCT01957397|3902474|FG001|COMPLETED|Test Period 1||12
3174845|NCT01957397|3902473|FG000|NOT COMPLETED|Test Period 1||2
3174846|NCT01957397|3902474|FG001|NOT COMPLETED|Test Period 1||1
3174847|NCT01957397|3902473|FG000|STARTED|Test Period 2||11
3174848|NCT01957397|3902474|FG001|STARTED|Test Period 2||12
3174849|NCT01957397|3902473|FG000|COMPLETED|Test Period 2||11
3174850|NCT01957397|3902474|FG001|COMPLETED|Test Period 2||11
3174851|NCT01957397|3902473|FG000|NOT COMPLETED|Test Period 2||0
3174852|NCT01957397|3902474|FG001|NOT COMPLETED|Test Period 2||1
3174853|NCT01957397|3902473|FG000|STARTED|Test Period 3||11
3174854|NCT01957397|3902474|FG001|STARTED|Test Period 3||11
3174855|NCT01957397|3902473|FG000|COMPLETED|Test Period 3||9
3174856|NCT01957397|3902474|FG001|COMPLETED|Test Period 3||9
3174857|NCT01957397|3902473|FG000|NOT COMPLETED|Test Period 3||2
2926052|NCT00567879|3637387|FG002|Maximum Tolerated Dose Determining Set|Overall Study|6 participants belonged to the dose expansion group at 20mg/m2 i.v.|18
2926053|NCT00567879|3637388|FG003|Maximum Tolerated Dose Determining Set|Overall Study||6
2926054|NCT00567879|3637389|FG004|Maximum Tolerated Dose Determining Set|Overall Study||12
2926055|NCT00567879|3637390|FG005|Maximum Tolerated Dose Determining Set|Overall Study||3
2926056|NCT00567879|3637385|FG000|COMPLETED|Overall Study||0
2926057|NCT00567879|3637386|FG001|COMPLETED|Overall Study||0
2926058|NCT00567879|3637387|FG002|COMPLETED|Overall Study||0
3174858|NCT01957397|3902474|FG001|NOT COMPLETED|Test Period 3||2
3174859|NCT01957410|3902484|FG000|STARTED|Open Label||13
3174860|NCT01957410|3902484|FG000|COMPLETED|Open Label||13
3174861|NCT01957410|3902484|FG000|NOT COMPLETED|Open Label||0
3322175|NCT03185546|4055263|FG002|COMPLETED|Baseline Through Week 12||4
3322176|NCT03185546|4055264|FG003|COMPLETED|Baseline Through Week 12||4
3174862|NCT01957410|3902484|FG000|STARTED|Optional Open Label||13
3174863|NCT01957410|3902484|FG000|COMPLETED|Optional Open Label||13
3322177|NCT03185546|4055265|FG004|COMPLETED|Baseline Through Week 12||5
3322178|NCT03185546|4055266|FG005|COMPLETED|Baseline Through Week 12||4
3322179|NCT03185546|4055267|FG006|COMPLETED|Baseline Through Week 12||4
3322180|NCT03185546|4055268|FG007|COMPLETED|Baseline Through Week 12||2
3322181|NCT03185546|4055261|FG000|NOT COMPLETED|Baseline Through Week 12||4
3322182|NCT03185546|4055262|FG001|NOT COMPLETED|Baseline Through Week 12||3
3174864|NCT01957410|3902484|FG000|NOT COMPLETED|Optional Open Label||0
3322183|NCT03185546|4055263|FG002|NOT COMPLETED|Baseline Through Week 12||1
3322184|NCT03185546|4055264|FG003|NOT COMPLETED|Baseline Through Week 12||1
3322185|NCT03185546|4055265|FG004|NOT COMPLETED|Baseline Through Week 12||1
3322186|NCT03185546|4055266|FG005|NOT COMPLETED|Baseline Through Week 12||2
3322187|NCT03185546|4055267|FG006|NOT COMPLETED|Baseline Through Week 12||3
3322188|NCT03185546|4055268|FG007|NOT COMPLETED|Baseline Through Week 12||3
3322189|NCT03185546|4055261|FG000|STARTED|Week 12 Through Day 30 Follow up||2
3322190|NCT03185546|4055262|FG001|STARTED|Week 12 Through Day 30 Follow up||7
3322191|NCT03185546|4055263|FG002|STARTED|Week 12 Through Day 30 Follow up||4
3174865|NCT01957462|3902488|FG000|STARTED|Test Period 1||16
3174866|NCT01957462|3902489|FG001|STARTED|Test Period 1||15
3174867|NCT01957462|3902488|FG000|COMPLETED|Test Period 1||14
3174868|NCT01957462|3902489|FG001|COMPLETED|Test Period 1||15
3174869|NCT01957462|3902488|FG000|NOT COMPLETED|Test Period 1||2
3174870|NCT01957462|3902489|FG001|NOT COMPLETED|Test Period 1||0
3174871|NCT01957462|3902488|FG000|STARTED|Test Period 2||14
3174872|NCT01957462|3902489|FG001|STARTED|Test Period 2||15
3174873|NCT01957462|3902488|FG000|COMPLETED|Test Period 2||14
3174874|NCT01957462|3902489|FG001|COMPLETED|Test Period 2||15
3174875|NCT01957462|3902488|FG000|NOT COMPLETED|Test Period 2||0
3174876|NCT01957462|3902489|FG001|NOT COMPLETED|Test Period 2||0
3174877|NCT01957475|3902495|FG000|STARTED|Test Period 1||10
3174878|NCT01957475|3902496|FG001|STARTED|Test Period 1||10
3174879|NCT01957475|3902495|FG000|COMPLETED|Test Period 1||8
3174880|NCT01957475|3902496|FG001|COMPLETED|Test Period 1||9
3322192|NCT03185546|4055264|FG003|STARTED|Week 12 Through Day 30 Follow up||4
3322193|NCT03185546|4055265|FG004|STARTED|Week 12 Through Day 30 Follow up||5
3322194|NCT03185546|4055266|FG005|STARTED|Week 12 Through Day 30 Follow up||4
3322195|NCT03185546|4055267|FG006|STARTED|Week 12 Through Day 30 Follow up||4
3322196|NCT03185546|4055268|FG007|STARTED|Week 12 Through Day 30 Follow up||2
3322197|NCT03185546|4055261|FG000|COMPLETED|Week 12 Through Day 30 Follow up||2
3322198|NCT03185546|4055262|FG001|COMPLETED|Week 12 Through Day 30 Follow up||7
3174881|NCT01957475|3902495|FG000|NOT COMPLETED|Test Period 1||2
3174882|NCT01957475|3902496|FG001|NOT COMPLETED|Test Period 1||1
3174883|NCT01957475|3902495|FG000|STARTED|Test Period 2||9
3174884|NCT01957475|3902496|FG001|STARTED|Test Period 2||8
3174885|NCT01957475|3902495|FG000|COMPLETED|Test Period 2||8
3174886|NCT01957475|3902496|FG001|COMPLETED|Test Period 2||8
3174887|NCT01957475|3902495|FG000|NOT COMPLETED|Test Period 2||1
3174888|NCT01957475|3902496|FG001|NOT COMPLETED|Test Period 2||0
3174889|NCT01957488|3902502|FG000|STARTED|Test Period 1 (2 Weeks)||30
3174890|NCT01957488|3902503|FG001|STARTED|Test Period 1 (2 Weeks)||31
3174891|NCT01957488|3902504|FG002|STARTED|Test Period 1 (2 Weeks)||30
3174892|NCT01957488|3902505|FG003|STARTED|Test Period 1 (2 Weeks)||32
3174893|NCT01957488|3902506|FG004|STARTED|Test Period 1 (2 Weeks)||30
3174894|NCT01957488|3902507|FG005|STARTED|Test Period 1 (2 Weeks)||30
3322199|NCT03185546|4055263|FG002|COMPLETED|Week 12 Through Day 30 Follow up||4
3322200|NCT03185546|4055264|FG003|COMPLETED|Week 12 Through Day 30 Follow up||3
3322201|NCT03185546|4055265|FG004|COMPLETED|Week 12 Through Day 30 Follow up||5
3322202|NCT03185546|4055266|FG005|COMPLETED|Week 12 Through Day 30 Follow up||4
3322203|NCT03185546|4055267|FG006|COMPLETED|Week 12 Through Day 30 Follow up||3
3322204|NCT03185546|4055268|FG007|COMPLETED|Week 12 Through Day 30 Follow up||2
3174895|NCT01957488|3902502|FG000|COMPLETED|Test Period 1 (2 Weeks)||27
3174896|NCT01957488|3902503|FG001|COMPLETED|Test Period 1 (2 Weeks)||28
3174897|NCT01957488|3902504|FG002|COMPLETED|Test Period 1 (2 Weeks)||26
3174898|NCT01957488|3902505|FG003|COMPLETED|Test Period 1 (2 Weeks)||29
3322205|NCT03185546|4055261|FG000|NOT COMPLETED|Week 12 Through Day 30 Follow up||0
3322206|NCT03185546|4055262|FG001|NOT COMPLETED|Week 12 Through Day 30 Follow up||0
3174899|NCT01957488|3902506|FG004|COMPLETED|Test Period 1 (2 Weeks)||27
3174900|NCT01957488|3902507|FG005|COMPLETED|Test Period 1 (2 Weeks)||24
3174901|NCT01957488|3902502|FG000|NOT COMPLETED|Test Period 1 (2 Weeks)||3
3174902|NCT01957488|3902503|FG001|NOT COMPLETED|Test Period 1 (2 Weeks)||3
3174903|NCT01957488|3902504|FG002|NOT COMPLETED|Test Period 1 (2 Weeks)||4
3174904|NCT01957488|3902505|FG003|NOT COMPLETED|Test Period 1 (2 Weeks)||3
3174905|NCT01957488|3902506|FG004|NOT COMPLETED|Test Period 1 (2 Weeks)||3
3174906|NCT01957488|3902507|FG005|NOT COMPLETED|Test Period 1 (2 Weeks)||6
3174907|NCT01957488|3902502|FG000|STARTED|Test Period 2 (2 Weeks)||27
3174908|NCT01957488|3902503|FG001|STARTED|Test Period 2 (2 Weeks)||28
3174909|NCT01957488|3902504|FG002|STARTED|Test Period 2 (2 Weeks)||26
3174910|NCT01957488|3902505|FG003|STARTED|Test Period 2 (2 Weeks)||29
3174911|NCT01957488|3902506|FG004|STARTED|Test Period 2 (2 Weeks)||27
3174912|NCT01957488|3902507|FG005|STARTED|Test Period 2 (2 Weeks)||24
3174913|NCT01957488|3902502|FG000|COMPLETED|Test Period 2 (2 Weeks)||24
3174914|NCT01957488|3902503|FG001|COMPLETED|Test Period 2 (2 Weeks)||27
3174915|NCT01957488|3902504|FG002|COMPLETED|Test Period 2 (2 Weeks)||25
3174916|NCT01957488|3902505|FG003|COMPLETED|Test Period 2 (2 Weeks)||28
3174917|NCT01957488|3902506|FG004|COMPLETED|Test Period 2 (2 Weeks)||25
3174918|NCT01957488|3902507|FG005|COMPLETED|Test Period 2 (2 Weeks)||23
3174919|NCT01957488|3902502|FG000|NOT COMPLETED|Test Period 2 (2 Weeks)||3
2926059|NCT00567879|3637388|FG003|COMPLETED|Overall Study||0
2926060|NCT00567879|3637389|FG004|COMPLETED|Overall Study||0
2926061|NCT00567879|3637390|FG005|COMPLETED|Overall Study||0
2926062|NCT00567879|3637385|FG000|NOT COMPLETED|Overall Study||7
2926063|NCT00567879|3637386|FG001|NOT COMPLETED|Overall Study||7
2926064|NCT00567879|3637387|FG002|NOT COMPLETED|Overall Study||21
2926065|NCT00567879|3637388|FG003|NOT COMPLETED|Overall Study||6
2926066|NCT00567879|3637389|FG004|NOT COMPLETED|Overall Study||12
2926067|NCT00567879|3637390|FG005|NOT COMPLETED|Overall Study||3
2926068|NCT00567892|3637410|FG000|STARTED|First Treatment (2 or 4 Weeks)||7
2926069|NCT00567892|3637411|FG001|STARTED|First Treatment (2 or 4 Weeks)||7
2926070|NCT00567892|3637412|FG002|STARTED|First Treatment (2 or 4 Weeks)||10
2926071|NCT00567892|3637413|FG003|STARTED|First Treatment (2 or 4 Weeks)||10
2926072|NCT00567892|3637410|FG000|COMPLETED|First Treatment (2 or 4 Weeks)||7
2926073|NCT00567892|3637411|FG001|COMPLETED|First Treatment (2 or 4 Weeks)||7
2926074|NCT00567892|3637412|FG002|COMPLETED|First Treatment (2 or 4 Weeks)||9
2926075|NCT00567892|3637413|FG003|COMPLETED|First Treatment (2 or 4 Weeks)||6
2926076|NCT00567892|3637410|FG000|NOT COMPLETED|First Treatment (2 or 4 Weeks)||0
2926077|NCT00567892|3637411|FG001|NOT COMPLETED|First Treatment (2 or 4 Weeks)||0
2926078|NCT00567892|3637412|FG002|NOT COMPLETED|First Treatment (2 or 4 Weeks)||1
2926079|NCT00567892|3637413|FG003|NOT COMPLETED|First Treatment (2 or 4 Weeks)||4
2926080|NCT00567892|3637410|FG000|STARTED|Washout (2 Weeks)||7
2926081|NCT00567892|3637411|FG001|STARTED|Washout (2 Weeks)||7
2926082|NCT00567892|3637412|FG002|STARTED|Washout (2 Weeks)||9
2926083|NCT00567892|3637413|FG003|STARTED|Washout (2 Weeks)||6
2926084|NCT00567892|3637410|FG000|COMPLETED|Washout (2 Weeks)||7
2926085|NCT00567892|3637411|FG001|COMPLETED|Washout (2 Weeks)||7
2926086|NCT00567892|3637412|FG002|COMPLETED|Washout (2 Weeks)||9
2926087|NCT00567892|3637413|FG003|COMPLETED|Washout (2 Weeks)||6
2926088|NCT00567892|3637410|FG000|NOT COMPLETED|Washout (2 Weeks)||0
2926089|NCT00567892|3637411|FG001|NOT COMPLETED|Washout (2 Weeks)||0
2926090|NCT00567892|3637412|FG002|NOT COMPLETED|Washout (2 Weeks)||0
2926091|NCT00567892|3637413|FG003|NOT COMPLETED|Washout (2 Weeks)||0
2926092|NCT00567892|3637410|FG000|STARTED|Second Treatment (2 or 4 Weeks)||7
2926093|NCT00567892|3637411|FG001|STARTED|Second Treatment (2 or 4 Weeks)||7
2926094|NCT00567892|3637412|FG002|STARTED|Second Treatment (2 or 4 Weeks)||9
2926095|NCT00567892|3637413|FG003|STARTED|Second Treatment (2 or 4 Weeks)||6
2926096|NCT00567892|3637410|FG000|COMPLETED|Second Treatment (2 or 4 Weeks)||7
3039446|NCT01158404|3758847|FG007|Received at Least 1 Dose of Study Drug|Overall Study||8
3039447|NCT01158404|3758840|FG000|COMPLETED|Overall Study||3
3039448|NCT01158404|3758841|FG001|COMPLETED|Overall Study||3
3039449|NCT01158404|3758842|FG002|COMPLETED|Overall Study||3
3039450|NCT01158404|3758843|FG003|COMPLETED|Overall Study||3
3039451|NCT01158404|3758844|FG004|COMPLETED|Overall Study||3
3174920|NCT01957488|3902503|FG001|NOT COMPLETED|Test Period 2 (2 Weeks)||1
3174921|NCT01957488|3902504|FG002|NOT COMPLETED|Test Period 2 (2 Weeks)||1
3174922|NCT01957488|3902505|FG003|NOT COMPLETED|Test Period 2 (2 Weeks)||1
3174923|NCT01957488|3902506|FG004|NOT COMPLETED|Test Period 2 (2 Weeks)||2
3174924|NCT01957488|3902507|FG005|NOT COMPLETED|Test Period 2 (2 Weeks)||1
3174925|NCT01957488|3902502|FG000|STARTED|Test Period 3 (2 Weeks)||24
3174926|NCT01957488|3902503|FG001|STARTED|Test Period 3 (2 Weeks)||27
3174927|NCT01957488|3902504|FG002|STARTED|Test Period 3 (2 Weeks)||25
3174928|NCT01957488|3902505|FG003|STARTED|Test Period 3 (2 Weeks)||28
3174929|NCT01957488|3902506|FG004|STARTED|Test Period 3 (2 Weeks)||25
3174930|NCT01957488|3902507|FG005|STARTED|Test Period 3 (2 Weeks)||23
3174931|NCT01957488|3902502|FG000|COMPLETED|Test Period 3 (2 Weeks)||23
3174932|NCT01957488|3902503|FG001|COMPLETED|Test Period 3 (2 Weeks)||26
3174933|NCT01957488|3902504|FG002|COMPLETED|Test Period 3 (2 Weeks)||25
3174934|NCT01957488|3902505|FG003|COMPLETED|Test Period 3 (2 Weeks)||28
3174935|NCT01957488|3902506|FG004|COMPLETED|Test Period 3 (2 Weeks)||25
3174936|NCT01957488|3902507|FG005|COMPLETED|Test Period 3 (2 Weeks)||23
3174937|NCT01957488|3902502|FG000|NOT COMPLETED|Test Period 3 (2 Weeks)||1
2926097|NCT00567892|3637411|FG001|COMPLETED|Second Treatment (2 or 4 Weeks)||7
2926098|NCT00567892|3637412|FG002|COMPLETED|Second Treatment (2 or 4 Weeks)||9
2926099|NCT00567892|3637413|FG003|COMPLETED|Second Treatment (2 or 4 Weeks)||5
2926100|NCT00567892|3637410|FG000|NOT COMPLETED|Second Treatment (2 or 4 Weeks)||0
2926101|NCT00567892|3637411|FG001|NOT COMPLETED|Second Treatment (2 or 4 Weeks)||0
2926102|NCT00567892|3637412|FG002|NOT COMPLETED|Second Treatment (2 or 4 Weeks)||0
2926103|NCT00567892|3637413|FG003|NOT COMPLETED|Second Treatment (2 or 4 Weeks)||1
2926104|NCT00567996|3637428|FG000|STARTED|Overall Study|Randomized participants|333
2926105|NCT00567996|3637429|FG001|STARTED|Overall Study||334
2926106|NCT00567996|3637430|FG002|STARTED|Overall Study||335
2926107|NCT00567996|3637428|FG000|Intent-to-treat: Received Study Drug|Overall Study||330
2926108|NCT00567996|3637429|FG001|Intent-to-treat: Received Study Drug|Overall Study||333
2926109|NCT00567996|3637430|FG002|Intent-to-treat: Received Study Drug|Overall Study||335
2926110|NCT00567996|3637428|FG000|COMPLETED|Overall Study||289
2926111|NCT00567996|3637429|FG001|COMPLETED|Overall Study||284
2926112|NCT00567996|3637430|FG002|COMPLETED|Overall Study||265
2926113|NCT00567996|3637428|FG000|NOT COMPLETED|Overall Study||44
2926114|NCT00567996|3637429|FG001|NOT COMPLETED|Overall Study||50
2926115|NCT00567996|3637430|FG002|NOT COMPLETED|Overall Study||70
2926116|NCT00568022|3637441|FG000|STARTED|Overall Study||3
3322207|NCT03185546|4055263|FG002|NOT COMPLETED|Week 12 Through Day 30 Follow up||0
3322208|NCT03185546|4055264|FG003|NOT COMPLETED|Week 12 Through Day 30 Follow up||1
3322209|NCT03185546|4055265|FG004|NOT COMPLETED|Week 12 Through Day 30 Follow up||0
3322210|NCT03185546|4055266|FG005|NOT COMPLETED|Week 12 Through Day 30 Follow up||0
3322211|NCT03185546|4055267|FG006|NOT COMPLETED|Week 12 Through Day 30 Follow up||1
3322212|NCT03185546|4055268|FG007|NOT COMPLETED|Week 12 Through Day 30 Follow up||0
3322213|NCT03186261|4055289|FG000|STARTED|Overall Study||22
3174938|NCT01957488|3902503|FG001|NOT COMPLETED|Test Period 3 (2 Weeks)||1
3174939|NCT01957488|3902504|FG002|NOT COMPLETED|Test Period 3 (2 Weeks)||0
3174940|NCT01957488|3902505|FG003|NOT COMPLETED|Test Period 3 (2 Weeks)||0
3174941|NCT01957488|3902506|FG004|NOT COMPLETED|Test Period 3 (2 Weeks)||0
3322214|NCT03186261|4055290|FG001|STARTED|Overall Study||22
3322215|NCT03186261|4055289|FG000|COMPLETED|Overall Study||22
3322216|NCT03186261|4055290|FG001|COMPLETED|Overall Study||22
3322217|NCT03186261|4055289|FG000|NOT COMPLETED|Overall Study||0
3322218|NCT03186261|4055290|FG001|NOT COMPLETED|Overall Study||0
3322219|NCT03186378|4055298|FG000|STARTED|Overall Study||17
3322220|NCT03186378|4055299|FG001|STARTED|Overall Study||16
3322221|NCT03186378|4055298|FG000|COMPLETED|Overall Study||16
3322222|NCT03186378|4055299|FG001|COMPLETED|Overall Study||16
3322223|NCT03186378|4055298|FG000|NOT COMPLETED|Overall Study||1
3322224|NCT03186378|4055299|FG001|NOT COMPLETED|Overall Study||0
3322225|NCT03186677|4055310|FG000|STARTED|Period 1||3
3322226|NCT03186677|4055311|FG001|STARTED|Period 1||3
3322227|NCT03186677|4055312|FG002|STARTED|Period 1||3
3322228|NCT03186677|4055313|FG003|STARTED|Period 1||0
3322229|NCT03186677|4055314|FG004|STARTED|Period 1||0
3322230|NCT03186677|4055310|FG000|COMPLETED|Period 1||3
3322231|NCT03186677|4055311|FG001|COMPLETED|Period 1||3
3322232|NCT03186677|4055312|FG002|COMPLETED|Period 1||3
3322233|NCT03186677|4055313|FG003|COMPLETED|Period 1||0
3322234|NCT03186677|4055314|FG004|COMPLETED|Period 1||0
2926117|NCT00568022|3637442|FG001|STARTED|Overall Study||3
2926118|NCT00568022|3637443|FG002|STARTED|Overall Study||3
2926119|NCT00568022|3637441|FG000|COMPLETED|Overall Study||3
2926120|NCT00568022|3637442|FG001|COMPLETED|Overall Study||3
2926121|NCT00568022|3637443|FG002|COMPLETED|Overall Study||3
2926122|NCT00568022|3637441|FG000|NOT COMPLETED|Overall Study||0
2926123|NCT00568022|3637442|FG001|NOT COMPLETED|Overall Study||0
2926124|NCT00568022|3637443|FG002|NOT COMPLETED|Overall Study||0
2926125|NCT00568061|3637454|FG000|STARTED|Overall Study||13
2926126|NCT00568061|3637455|FG001|STARTED|Overall Study||16
2926127|NCT00568061|3637454|FG000|COMPLETED|Overall Study||8
2926128|NCT00568061|3637455|FG001|COMPLETED|Overall Study||14
2926129|NCT00568061|3637454|FG000|NOT COMPLETED|Overall Study||5
2926130|NCT00568061|3637455|FG001|NOT COMPLETED|Overall Study||2
2926131|NCT00568087|3637464|FG000|STARTED|Overall Study||22
2926132|NCT00568087|3637465|FG001|STARTED|Overall Study||24
2926133|NCT00568087|3637464|FG000|Received Intervention|Overall Study||21
2926134|NCT00568087|3637465|FG001|Received Intervention|Overall Study||23
2926135|NCT00568087|3637464|FG000|COMPLETED|Overall Study||15
2926136|NCT00568087|3637465|FG001|COMPLETED|Overall Study||17
2926137|NCT00568087|3637464|FG000|NOT COMPLETED|Overall Study||7
2926138|NCT00568087|3637465|FG001|NOT COMPLETED|Overall Study||7
2926139|NCT00568126|3637473|FG000|STARTED|Overall Study||24
2926140|NCT00568126|3637474|FG001|STARTED|Overall Study||21
2926141|NCT00568126|3637473|FG000|COMPLETED|Overall Study||13
2926142|NCT00568126|3637474|FG001|COMPLETED|Overall Study||12
2926143|NCT00568126|3637473|FG000|NOT COMPLETED|Overall Study||11
2926144|NCT00568126|3637474|FG001|NOT COMPLETED|Overall Study||9
2926145|NCT00568321|3637483|FG000|STARTED|Overall Study||33
2926146|NCT00568321|3637484|FG001|STARTED|Overall Study||33
2926147|NCT00568321|3637485|FG002|STARTED|Overall Study||33
2926148|NCT00568321|3637483|FG000|Treated|Overall Study||31
2926149|NCT00568321|3637484|FG001|Treated|Overall Study||33
2926150|NCT00568321|3637485|FG002|Treated|Overall Study||32
2926151|NCT00568321|3637483|FG000|COMPLETED|Overall Study||20
2926152|NCT00568321|3637484|FG001|COMPLETED|Overall Study||28
2926153|NCT00568321|3637485|FG002|COMPLETED|Overall Study||24
2926154|NCT00568321|3637483|FG000|NOT COMPLETED|Overall Study||13
2926155|NCT00568321|3637484|FG001|NOT COMPLETED|Overall Study||5
2926156|NCT00568321|3637485|FG002|NOT COMPLETED|Overall Study||9
3174942|NCT01957488|3902507|FG005|NOT COMPLETED|Test Period 3 (2 Weeks)||0
3174943|NCT01957553|3902515|FG000|STARTED|Test Period 1 (21 +- 1 Days)||61
3174944|NCT01957553|3902516|FG001|STARTED|Test Period 1 (21 +- 1 Days)||66
3174945|NCT01957553|3902515|FG000|COMPLETED|Test Period 1 (21 +- 1 Days)||54
3174946|NCT01957553|3902516|FG001|COMPLETED|Test Period 1 (21 +- 1 Days)||63
3174947|NCT01957553|3902515|FG000|NOT COMPLETED|Test Period 1 (21 +- 1 Days)||7
3174948|NCT01957553|3902516|FG001|NOT COMPLETED|Test Period 1 (21 +- 1 Days)||3
3174949|NCT01957553|3902515|FG000|STARTED|Test Period 2 (21 +- 1 Days)||54
3174950|NCT01957553|3902516|FG001|STARTED|Test Period 2 (21 +- 1 Days)||63
3174951|NCT01957553|3902515|FG000|COMPLETED|Test Period 2 (21 +- 1 Days)||51
3174952|NCT01957553|3902516|FG001|COMPLETED|Test Period 2 (21 +- 1 Days)||56
3174953|NCT01957553|3902515|FG000|NOT COMPLETED|Test Period 2 (21 +- 1 Days)||3
3174954|NCT01957553|3902516|FG001|NOT COMPLETED|Test Period 2 (21 +- 1 Days)||7
3174955|NCT01957579|3902526|FG000|STARTED|Overall Study||3
3174956|NCT01957579|3902527|FG001|STARTED|Overall Study||7
3174957|NCT01957579|3902528|FG002|STARTED|Overall Study||4
3174958|NCT01957579|3902529|FG003|STARTED|Overall Study||6
3174959|NCT01957579|3902526|FG000|COMPLETED|Overall Study||3
3174960|NCT01957579|3902527|FG001|COMPLETED|Overall Study||6
3174961|NCT01957579|3902528|FG002|COMPLETED|Overall Study||2
3174962|NCT01957579|3902529|FG003|COMPLETED|Overall Study||6
3174963|NCT01957579|3902526|FG000|NOT COMPLETED|Overall Study||0
3174964|NCT01957579|3902527|FG001|NOT COMPLETED|Overall Study||1
3174965|NCT01957579|3902528|FG002|NOT COMPLETED|Overall Study||2
3174966|NCT01957579|3902529|FG003|NOT COMPLETED|Overall Study||0
3174967|NCT01957644|3902561|FG000|STARTED|Overall Study||6
3174968|NCT01957644|3902562|FG001|STARTED|Overall Study||6
3174969|NCT01957644|3902563|FG002|STARTED|Overall Study||1
3174970|NCT01957644|3902564|FG003|STARTED|Overall Study||2
3174971|NCT01957644|3902565|FG004|STARTED|Overall Study||1
3174972|NCT01957644|3902561|FG000|COMPLETED|Overall Study||0
3174973|NCT01957644|3902562|FG001|COMPLETED|Overall Study||0
3174974|NCT01957644|3902563|FG002|COMPLETED|Overall Study||0
3174975|NCT01957644|3902564|FG003|COMPLETED|Overall Study||0
3174976|NCT01957644|3902565|FG004|COMPLETED|Overall Study||0
3174977|NCT01957644|3902561|FG000|NOT COMPLETED|Overall Study||6
3174978|NCT01957644|3902562|FG001|NOT COMPLETED|Overall Study||6
3174979|NCT01957644|3902563|FG002|NOT COMPLETED|Overall Study||1
3174980|NCT01957644|3902564|FG003|NOT COMPLETED|Overall Study||2
3174981|NCT01957644|3902565|FG004|NOT COMPLETED|Overall Study||1
3174982|NCT01957657|3902579|FG000|STARTED|Overall Study||4
3174983|NCT01957657|3902579|FG000|COMPLETED|Overall Study||4
3174984|NCT01957657|3902579|FG000|NOT COMPLETED|Overall Study||0
3174985|NCT01957709|3902583|FG000|STARTED|Overall Study||8
3174986|NCT01957709|3902583|FG000|COMPLETED|Overall Study||7
3174987|NCT01957709|3902583|FG000|NOT COMPLETED|Overall Study||1
3174988|NCT01957761|3902587|FG000|STARTED|Overall Study||189
3174989|NCT01957761|3902587|FG000|COMPLETED|Overall Study||189
3174990|NCT01957761|3902587|FG000|NOT COMPLETED|Overall Study||0
3322235|NCT03186677|4055310|FG000|NOT COMPLETED|Period 1||0
3322236|NCT03186677|4055311|FG001|NOT COMPLETED|Period 1||0
3322237|NCT03186677|4055312|FG002|NOT COMPLETED|Period 1||0
3322238|NCT03186677|4055313|FG003|NOT COMPLETED|Period 1||0
3322239|NCT03186677|4055314|FG004|NOT COMPLETED|Period 1||0
3322240|NCT03186677|4055310|FG000|STARTED|Period 2||0
3322241|NCT03186677|4055311|FG001|STARTED|Period 2||0
3322242|NCT03186677|4055312|FG002|STARTED|Period 2||0
3322243|NCT03186677|4055313|FG003|STARTED|Period 2||5
3322244|NCT03186677|4055314|FG004|STARTED|Period 2||2
3322245|NCT03186677|4055310|FG000|COMPLETED|Period 2||0
3322246|NCT03186677|4055311|FG001|COMPLETED|Period 2||0
3322247|NCT03186677|4055312|FG002|COMPLETED|Period 2||0
3322248|NCT03186677|4055313|FG003|COMPLETED|Period 2||5
3322249|NCT03186677|4055314|FG004|COMPLETED|Period 2||2
3322250|NCT03186677|4055310|FG000|NOT COMPLETED|Period 2||0
3322251|NCT03186677|4055311|FG001|NOT COMPLETED|Period 2||0
3322252|NCT03186677|4055312|FG002|NOT COMPLETED|Period 2||0
3322253|NCT03186677|4055313|FG003|NOT COMPLETED|Period 2||0
3322254|NCT03186677|4055314|FG004|NOT COMPLETED|Period 2||0
3322255|NCT03186781|4055332|FG000|STARTED|Overall Study||5
3174991|NCT01957787|3902591|FG000|STARTED|Overall Study|Participant who was withdrawn prior to study treatment was not included in Number of Index Tumors.|131
3174992|NCT01957787|3902591|FG000|Intent-to-Treat (ITT) Population|Overall Study||130
3174993|NCT01957787|3902591|FG000|Modified ITT (mITT) Population|Overall Study||128
3174994|NCT01957787|3902591|FG000|COMPLETED|Overall Study||95
3174995|NCT01957787|3902591|FG000|NOT COMPLETED|Overall Study||36
3174996|NCT01957865|3902598|FG000|STARTED|Overall Study||21
3174997|NCT01957865|3902599|FG001|STARTED|Overall Study||20
3174998|NCT01957865|3902600|FG002|STARTED|Overall Study||22
3174999|NCT01957865|3902598|FG000|COMPLETED|Overall Study||21
3175000|NCT01957865|3902599|FG001|COMPLETED|Overall Study||18
3175001|NCT01957865|3902600|FG002|COMPLETED|Overall Study||19
3175002|NCT01957865|3902598|FG000|NOT COMPLETED|Overall Study||0
3175003|NCT01957865|3902599|FG001|NOT COMPLETED|Overall Study||2
3175004|NCT01957865|3902600|FG002|NOT COMPLETED|Overall Study||3
3175005|NCT01957930|3902612|FG000|STARTED|Overall Study||35
3175006|NCT01957930|3902613|FG001|STARTED|Overall Study||37
3175007|NCT01957930|3902614|FG002|STARTED|Overall Study||19
3322256|NCT03186781|4055333|FG001|STARTED|Overall Study||5
3322257|NCT03186781|4055334|FG002|STARTED|Overall Study||10
3322258|NCT03186781|4055335|FG003|STARTED|Overall Study||10
3322259|NCT03186781|4055336|FG004|STARTED|Overall Study||10
3322260|NCT03186781|4055337|FG005|STARTED|Overall Study||10
3322261|NCT03186781|4055332|FG000|Received First Product Administration|Overall Study||5
3322262|NCT03186781|4055333|FG001|Received First Product Administration|Overall Study||5
3175008|NCT01957930|3902612|FG000|COMPLETED|Overall Study||35
3175009|NCT01957930|3902613|FG001|COMPLETED|Overall Study||37
3175010|NCT01957930|3902614|FG002|COMPLETED|Overall Study||19
3322263|NCT03186781|4055334|FG002|Received First Product Administration|Overall Study||10
3322264|NCT03186781|4055335|FG003|Received First Product Administration|Overall Study||10
3175011|NCT01957930|3902612|FG000|NOT COMPLETED|Overall Study||0
3175012|NCT01957930|3902613|FG001|NOT COMPLETED|Overall Study||0
2926157|NCT00568334|3637497|FG000|STARTED|Overall Study||122
2926158|NCT00568334|3637498|FG001|STARTED|Overall Study||122
2926159|NCT00568334|3637497|FG000|COMPLETED|Overall Study||121
2926160|NCT00568334|3637498|FG001|COMPLETED|Overall Study||121
2926161|NCT00568334|3637497|FG000|NOT COMPLETED|Overall Study||1
2926162|NCT00568334|3637498|FG001|NOT COMPLETED|Overall Study||1
2926163|NCT00568386|3637506|FG000|STARTED|Overall Study||20
2926164|NCT00568386|3637507|FG001|STARTED|Overall Study||20
2926165|NCT00568386|3637506|FG000|COMPLETED|Overall Study||20
2926166|NCT00568386|3637507|FG001|COMPLETED|Overall Study||20
2926167|NCT00568386|3637506|FG000|NOT COMPLETED|Overall Study||0
2926168|NCT00568386|3637507|FG001|NOT COMPLETED|Overall Study||0
2926169|NCT00568399|3637513|FG000|STARTED|Overall Study||37
2926170|NCT00568399|3637513|FG000|COMPLETED|Overall Study|Of 48 subject enrolled, 37 initiated sodium thiosulfate treatment. 22 completed the entire protocol|22
2926171|NCT00568399|3637513|FG000|NOT COMPLETED|Overall Study||15
2926172|NCT00568451|3637521|FG000|STARTED|Overall Study||0
2926173|NCT00568451|3637522|FG001|STARTED|Overall Study||0
2926174|NCT00568451|3637523|FG002|STARTED|Overall Study||2
2926175|NCT00568451|3637524|FG003|STARTED|Overall Study||9
2926176|NCT00568451|3637521|FG000|COMPLETED|Overall Study||0
2926177|NCT00568451|3637522|FG001|COMPLETED|Overall Study||0
2926178|NCT00568451|3637523|FG002|COMPLETED|Overall Study||0
2926179|NCT00568451|3637524|FG003|COMPLETED|Overall Study||2
2926180|NCT00568451|3637521|FG000|NOT COMPLETED|Overall Study||0
2926181|NCT00568451|3637522|FG001|NOT COMPLETED|Overall Study||0
2926182|NCT00568451|3637523|FG002|NOT COMPLETED|Overall Study||2
2926183|NCT00568451|3637524|FG003|NOT COMPLETED|Overall Study||7
2926184|NCT00568555|3637537|FG000|STARTED|Overall Study||16
2926185|NCT00568555|3637538|FG001|STARTED|Overall Study||15
2926186|NCT00568555|3637537|FG000|COMPLETED|Overall Study||15
2926187|NCT00568555|3637538|FG001|COMPLETED|Overall Study||14
2926188|NCT00568555|3637537|FG000|NOT COMPLETED|Overall Study||1
2926189|NCT00568555|3637538|FG001|NOT COMPLETED|Overall Study||1
2926190|NCT00568633|3637548|FG000|STARTED|Overall Study||25
2926191|NCT00568633|3637549|FG001|STARTED|Overall Study||33
2926192|NCT00568633|3637548|FG000|COMPLETED|Overall Study||25
2926193|NCT00568633|3637549|FG001|COMPLETED|Overall Study||33
2926194|NCT00568633|3637548|FG000|NOT COMPLETED|Overall Study||0
2926195|NCT00568633|3637549|FG001|NOT COMPLETED|Overall Study||0
2926196|NCT00568685|3637558|FG000|STARTED|Overall Study||51
2926197|NCT00568685|3637559|FG001|STARTED|Overall Study||51
2926198|NCT00568685|3637560|FG002|STARTED|Overall Study||51
2926199|NCT00568685|3637558|FG000|COMPLETED|Overall Study||41
2926200|NCT00568685|3637559|FG001|COMPLETED|Overall Study||46
2926201|NCT00568685|3637560|FG002|COMPLETED|Overall Study||46
2926202|NCT00568685|3637558|FG000|NOT COMPLETED|Overall Study||10
3039452|NCT01158404|3758845|FG005|COMPLETED|Overall Study||4
3039453|NCT01158404|3758846|FG006|COMPLETED|Overall Study||2
3039454|NCT01158404|3758847|FG007|COMPLETED|Overall Study||6
3039455|NCT01158404|3758840|FG000|NOT COMPLETED|Overall Study||0
3039456|NCT01158404|3758841|FG001|NOT COMPLETED|Overall Study||1
3039457|NCT01158404|3758842|FG002|NOT COMPLETED|Overall Study||0
3039458|NCT01158404|3758843|FG003|NOT COMPLETED|Overall Study||0
3039459|NCT01158404|3758844|FG004|NOT COMPLETED|Overall Study||3
3039460|NCT01158404|3758845|FG005|NOT COMPLETED|Overall Study||1
3039461|NCT01158404|3758846|FG006|NOT COMPLETED|Overall Study||1
3039462|NCT01158404|3758847|FG007|NOT COMPLETED|Overall Study||2
3039463|NCT01158521|3758867|FG000|STARTED|Overall Study||25
3039464|NCT01158521|3758867|FG000|COMPLETED|Overall Study||25
3039465|NCT01158521|3758867|FG000|NOT COMPLETED|Overall Study||0
3039466|NCT01158534|3758873|FG000|STARTED|Overall Study||17
3039467|NCT01158534|3758873|FG000|COMPLETED|Overall Study|All three pts that did not complete study had some treatment|14
3039468|NCT01158534|3758873|FG000|NOT COMPLETED|Overall Study||3
3039469|NCT01158573|3758881|FG000|STARTED|Overall Study|Aimed to recruit 160 from July 2010 to May 2013. Each subject studied on one time point only|30
3039470|NCT01158573|3758882|FG001|STARTED|Overall Study||30
3039471|NCT01158573|3758883|FG002|STARTED|Overall Study||29
3039472|NCT01158573|3758884|FG003|STARTED|Overall Study||28
3175013|NCT01957930|3902614|FG002|NOT COMPLETED|Overall Study||0
3322265|NCT03186781|4055336|FG004|Received First Product Administration|Overall Study||10
3322266|NCT03186781|4055337|FG005|Received First Product Administration|Overall Study||10
3322267|NCT03186781|4055332|FG000|Received All Product Administrations|Overall Study||5
3322268|NCT03186781|4055333|FG001|Received All Product Administrations|Overall Study||5
3322269|NCT03186781|4055334|FG002|Received All Product Administrations|Overall Study|2nd dose not given due to unrelated intercurrent illness (n=1) and lost to follow up (n=1)|8
3322270|NCT03186781|4055335|FG003|Received All Product Administrations|Overall Study|PI decided not to give 2nd dose to limit variation in environmental exposure to flu between subjects|9
3322271|NCT03186781|4055336|FG004|Received All Product Administrations|Overall Study|2nd dose not given due to subject decision to withdraw (n=2)|8
3322272|NCT03186781|4055337|FG005|Received All Product Administrations|Overall Study|PI decided not to give 2nd dose to limit variation in environmental exposure to flu between subjects|9
3322273|NCT03186781|4055332|FG000|COMPLETED|Overall Study||5
3322274|NCT03186781|4055333|FG001|COMPLETED|Overall Study||5
3322275|NCT03186781|4055334|FG002|COMPLETED|Overall Study||9
3322276|NCT03186781|4055335|FG003|COMPLETED|Overall Study||10
3322277|NCT03186781|4055336|FG004|COMPLETED|Overall Study||7
3322278|NCT03186781|4055337|FG005|COMPLETED|Overall Study||10
3322279|NCT03186781|4055332|FG000|NOT COMPLETED|Overall Study||0
3322280|NCT03186781|4055333|FG001|NOT COMPLETED|Overall Study||0
3322281|NCT03186781|4055334|FG002|NOT COMPLETED|Overall Study||1
3322282|NCT03186781|4055335|FG003|NOT COMPLETED|Overall Study||0
3322283|NCT03186781|4055336|FG004|NOT COMPLETED|Overall Study||3
3322284|NCT03186781|4055337|FG005|NOT COMPLETED|Overall Study||0
3322285|NCT03187002|4055357|FG000|STARTED|Overall Study||55
3322286|NCT03187002|4055358|FG001|STARTED|Overall Study||54
3322287|NCT03187002|4055357|FG000|COMPLETED|Overall Study||55
3322288|NCT03187002|4055358|FG001|COMPLETED|Overall Study||54
3322289|NCT03187002|4055357|FG000|NOT COMPLETED|Overall Study||0
3322290|NCT03187002|4055358|FG001|NOT COMPLETED|Overall Study||0
3322291|NCT03187119|4055366|FG000|STARTED|Overall Study||22
3322292|NCT03187119|4055367|FG001|STARTED|Overall Study||23
3322293|NCT03187119|4055366|FG000|COMPLETED|Overall Study||20
3322294|NCT03187119|4055367|FG001|COMPLETED|Overall Study||18
3322295|NCT03187119|4055366|FG000|NOT COMPLETED|Overall Study||2
3322296|NCT03187119|4055367|FG001|NOT COMPLETED|Overall Study||5
3322297|NCT03187132|4055375|FG000|STARTED|Inpatient Trauma Only||12
3322298|NCT03187132|4055376|FG001|STARTED|Inpatient Trauma Only||12
3322299|NCT03187132|4055375|FG000|COMPLETED|Inpatient Trauma Only||8
3322300|NCT03187132|4055376|FG001|COMPLETED|Inpatient Trauma Only||0
3322301|NCT03187132|4055375|FG000|NOT COMPLETED|Inpatient Trauma Only||4
3322302|NCT03187132|4055376|FG001|NOT COMPLETED|Inpatient Trauma Only||12
3322303|NCT03187132|4055375|FG000|STARTED|Inpatient Trauma+Pain Clinic, no Opioid||4
3322304|NCT03187132|4055376|FG001|STARTED|Inpatient Trauma+Pain Clinic, no Opioid||5
3322305|NCT03187132|4055375|FG000|COMPLETED|Inpatient Trauma+Pain Clinic, no Opioid||3
3322306|NCT03187132|4055376|FG001|COMPLETED|Inpatient Trauma+Pain Clinic, no Opioid||0
3322307|NCT03187132|4055375|FG000|NOT COMPLETED|Inpatient Trauma+Pain Clinic, no Opioid||1
3322308|NCT03187132|4055376|FG001|NOT COMPLETED|Inpatient Trauma+Pain Clinic, no Opioid||5
3322309|NCT03187132|4055375|FG000|STARTED|Inpatient Trauma+Pain Clinic||11
3322310|NCT03187132|4055376|FG001|STARTED|Inpatient Trauma+Pain Clinic||7
3322311|NCT03187132|4055375|FG000|COMPLETED|Inpatient Trauma+Pain Clinic||8
3322312|NCT03187132|4055376|FG001|COMPLETED|Inpatient Trauma+Pain Clinic||0
3322313|NCT03187132|4055375|FG000|NOT COMPLETED|Inpatient Trauma+Pain Clinic||3
3322314|NCT03187132|4055376|FG001|NOT COMPLETED|Inpatient Trauma+Pain Clinic||7
3322315|NCT03187132|4055375|FG000|STARTED|Pain Clinic Only, Fully Remote||76
3322316|NCT03187132|4055376|FG001|STARTED|Pain Clinic Only, Fully Remote||118
3322317|NCT03187132|4055375|FG000|COMPLETED|Pain Clinic Only, Fully Remote||43
3322318|NCT03187132|4055376|FG001|COMPLETED|Pain Clinic Only, Fully Remote||64
3175014|NCT01958008|3902625|FG000|STARTED|Overall Study||21
3175015|NCT01958008|3902626|FG001|STARTED|Overall Study||21
3175016|NCT01958008|3902627|FG002|STARTED|Overall Study||21
3175017|NCT01958008|3902628|FG003|STARTED|Overall Study||21
3175018|NCT01958008|3902625|FG000|COMPLETED|Overall Study||20
3175019|NCT01958008|3902626|FG001|COMPLETED|Overall Study||21
3175020|NCT01958008|3902627|FG002|COMPLETED|Overall Study||20
3175021|NCT01958008|3902628|FG003|COMPLETED|Overall Study||21
3175022|NCT01958008|3902625|FG000|NOT COMPLETED|Overall Study||1
2926203|NCT00568685|3637559|FG001|NOT COMPLETED|Overall Study||5
2926204|NCT00568685|3637560|FG002|NOT COMPLETED|Overall Study||5
2926205|NCT00568776|3637576|FG000|STARTED|Overall Study|One randomized patient withdrew consent and did not receive placebo|83
2926206|NCT00568776|3637577|FG001|STARTED|Overall Study|One randomized patient withdrew consent and did not receive ELND005 250 mg BID|88
2926207|NCT00568776|3637578|FG002|STARTED|Overall Study|41 patients withdrawn per interim safety review (sponsors decision); excluded in efficacy analysis.|89
3039473|NCT01158573|3758881|FG000|COMPLETED|Overall Study|Study completed at 117 subjects.|30
3175023|NCT01958008|3902626|FG001|NOT COMPLETED|Overall Study||0
3175024|NCT01958008|3902627|FG002|NOT COMPLETED|Overall Study||1
3175025|NCT01958008|3902628|FG003|NOT COMPLETED|Overall Study||0
3175026|NCT01958060|3902647|FG000|STARTED|Overall Study||10
3175027|NCT01958060|3902648|FG001|STARTED|Overall Study||6
3175028|NCT01958060|3902649|FG002|STARTED|Overall Study||6
3322319|NCT03187132|4055375|FG000|NOT COMPLETED|Pain Clinic Only, Fully Remote||33
3322320|NCT03187132|4055376|FG001|NOT COMPLETED|Pain Clinic Only, Fully Remote||54
3322321|NCT03187197|4055385|FG000|STARTED|Overall Study||153
3322322|NCT03187197|4055386|FG001|STARTED|Overall Study||1097
3322323|NCT03187197|4055387|FG002|STARTED|Overall Study||55
3322324|NCT03187197|4055385|FG000|Started (Eligible Participants as FAS)|Overall Study||139
3322325|NCT03187197|4055386|FG001|Started (Eligible Participants as FAS)|Overall Study||1052
3322326|NCT03187197|4055387|FG002|Started (Eligible Participants as FAS)|Overall Study||54
3322327|NCT03187197|4055385|FG000|COMPLETED|Overall Study||107
3322328|NCT03187197|4055386|FG001|COMPLETED|Overall Study||704
2926208|NCT00568776|3637579|FG003|STARTED|Overall Study|42 patients withdrawn per interim safety review (sponsors decision); excluded in efficacy analysis.|91
2926209|NCT00568776|3637576|FG000|COMPLETED|Overall Study||53
2926210|NCT00568776|3637577|FG001|COMPLETED|Overall Study||52
2926211|NCT00568776|3637578|FG002|COMPLETED|Overall Study||15
2926212|NCT00568776|3637579|FG003|COMPLETED|Overall Study||19
2926213|NCT00568776|3637576|FG000|NOT COMPLETED|Overall Study||30
2926214|NCT00568776|3637577|FG001|NOT COMPLETED|Overall Study||36
2926215|NCT00568776|3637578|FG002|NOT COMPLETED|Overall Study||74
2926216|NCT00568776|3637579|FG003|NOT COMPLETED|Overall Study||72
2926217|NCT00568854|3637591|FG000|STARTED|Overall Study||6
2926218|NCT00568854|3637592|FG001|STARTED|Overall Study||4
2926219|NCT00568854|3637591|FG000|COMPLETED|Overall Study||6
2926220|NCT00568854|3637592|FG001|COMPLETED|Overall Study||4
2926221|NCT00568854|3637591|FG000|NOT COMPLETED|Overall Study||0
2926222|NCT00568854|3637592|FG001|NOT COMPLETED|Overall Study||0
2926223|NCT00568958|3637600|FG000|STARTED|Allocation||70
2926224|NCT00568958|3637601|FG001|STARTED|Allocation||70
2926225|NCT00568958|3637600|FG000|COMPLETED|Allocation||61
2926226|NCT00568958|3637601|FG001|COMPLETED|Allocation||67
2926227|NCT00568958|3637600|FG000|NOT COMPLETED|Allocation||9
2926228|NCT00568958|3637601|FG001|NOT COMPLETED|Allocation||3
2926229|NCT00568958|3637600|FG000|STARTED|Follow-Up||61
2926230|NCT00568958|3637601|FG001|STARTED|Follow-Up||67
2926231|NCT00568958|3637600|FG000|COMPLETED|Follow-Up||52
2926232|NCT00568958|3637601|FG001|COMPLETED|Follow-Up||60
2926233|NCT00568958|3637600|FG000|NOT COMPLETED|Follow-Up||9
2926234|NCT00568958|3637601|FG001|NOT COMPLETED|Follow-Up||7
2926235|NCT00569010|3637611|FG000|STARTED|Overall Study||6
2926236|NCT00569010|3637612|FG001|STARTED|Overall Study||6
2926237|NCT00569010|3637613|FG002|STARTED|Overall Study||11
2926238|NCT00569010|3637614|FG003|STARTED|Overall Study||11
2926239|NCT00569010|3637611|FG000|COMPLETED|Overall Study||6
2926240|NCT00569010|3637612|FG001|COMPLETED|Overall Study||6
2926241|NCT00569010|3637613|FG002|COMPLETED|Overall Study||11
2926242|NCT00569010|3637614|FG003|COMPLETED|Overall Study||11
2926243|NCT00569010|3637611|FG000|NOT COMPLETED|Overall Study||0
3039474|NCT01158573|3758882|FG001|COMPLETED|Overall Study||30
3039475|NCT01158573|3758883|FG002|COMPLETED|Overall Study||29
3039476|NCT01158573|3758884|FG003|COMPLETED|Overall Study||28
3039477|NCT01158573|3758881|FG000|NOT COMPLETED|Overall Study||0
3039478|NCT01158573|3758882|FG001|NOT COMPLETED|Overall Study||0
3039479|NCT01158573|3758883|FG002|NOT COMPLETED|Overall Study||0
3039480|NCT01158573|3758884|FG003|NOT COMPLETED|Overall Study||0
3039481|NCT01158651|3758894|FG000|STARTED|Overall Study||23
3039482|NCT01158651|3758894|FG000|COMPLETED|Overall Study||22
3039483|NCT01158651|3758894|FG000|NOT COMPLETED|Overall Study||1
3039484|NCT01158703|3758900|FG000|STARTED|Overall Study||12
3039485|NCT01158703|3758901|FG001|STARTED|Overall Study||8
3039486|NCT01158703|3758900|FG000|COMPLETED|Overall Study||12
3039487|NCT01158703|3758901|FG001|COMPLETED|Overall Study||8
3039488|NCT01158703|3758900|FG000|NOT COMPLETED|Overall Study||0
3039489|NCT01158703|3758901|FG001|NOT COMPLETED|Overall Study||0
3039490|NCT01158716|3758909|FG000|STARTED|Overall Study||48
3039491|NCT01158716|3758910|FG001|STARTED|Overall Study||48
3039492|NCT01158716|3758909|FG000|COMPLETED|Overall Study||47
3039493|NCT01158716|3758910|FG001|COMPLETED|Overall Study||47
3039494|NCT01158716|3758909|FG000|NOT COMPLETED|Overall Study||1
3322329|NCT03187197|4055387|FG002|COMPLETED|Overall Study||32
3322330|NCT03187197|4055385|FG000|NOT COMPLETED|Overall Study||46
3322331|NCT03187197|4055386|FG001|NOT COMPLETED|Overall Study||393
3322332|NCT03187197|4055387|FG002|NOT COMPLETED|Overall Study||23
3322333|NCT03187262|4055395|FG000|STARTED|Induction||13
3322334|NCT03187262|4055395|FG000|COMPLETED|Induction||7
3322335|NCT03187262|4055395|FG000|NOT COMPLETED|Induction||6
3322336|NCT03187262|4055395|FG000|STARTED|Consolidation||7
3322337|NCT03187262|4055395|FG000|COMPLETED|Consolidation||2
3322338|NCT03187262|4055395|FG000|NOT COMPLETED|Consolidation||5
3322339|NCT03187262|4055395|FG000|STARTED|Maintenance||2
3322340|NCT03187262|4055395|FG000|COMPLETED|Maintenance||2
3322341|NCT03187262|4055395|FG000|NOT COMPLETED|Maintenance||0
3322342|NCT03187301|4055399|FG000|STARTED|Titration Period||7
3322343|NCT03187301|4055400|FG001|STARTED|Titration Period||7
3322344|NCT03187301|4055401|FG002|STARTED|Titration Period||7
3322345|NCT03187301|4055402|FG003|STARTED|Titration Period||6
3322346|NCT03187301|4055403|FG004|STARTED|Titration Period||7
3322347|NCT03187301|4055404|FG005|STARTED|Titration Period||7
3322348|NCT03187301|4055405|FG006|STARTED|Titration Period||7
3322349|NCT03187301|4055399|FG000|COMPLETED|Titration Period||7
3322350|NCT03187301|4055400|FG001|COMPLETED|Titration Period||7
3322351|NCT03187301|4055401|FG002|COMPLETED|Titration Period||7
3322352|NCT03187301|4055402|FG003|COMPLETED|Titration Period||6
3322353|NCT03187301|4055403|FG004|COMPLETED|Titration Period||7
3322354|NCT03187301|4055404|FG005|COMPLETED|Titration Period||7
3322355|NCT03187301|4055405|FG006|COMPLETED|Titration Period||0
3322356|NCT03187301|4055399|FG000|NOT COMPLETED|Titration Period||0
3322357|NCT03187301|4055400|FG001|NOT COMPLETED|Titration Period||0
3322358|NCT03187301|4055401|FG002|NOT COMPLETED|Titration Period||0
3322359|NCT03187301|4055402|FG003|NOT COMPLETED|Titration Period||0
3322360|NCT03187301|4055403|FG004|NOT COMPLETED|Titration Period||0
3322361|NCT03187301|4055404|FG005|NOT COMPLETED|Titration Period||0
3322362|NCT03187301|4055405|FG006|NOT COMPLETED|Titration Period||7
3322363|NCT03187301|4055399|FG000|STARTED|Pre-Intervention||7
3322364|NCT03187301|4055400|FG001|STARTED|Pre-Intervention||7
3322365|NCT03187301|4055401|FG002|STARTED|Pre-Intervention||7
3322366|NCT03187301|4055402|FG003|STARTED|Pre-Intervention||6
3322367|NCT03187301|4055403|FG004|STARTED|Pre-Intervention||7
3322368|NCT03187301|4055404|FG005|STARTED|Pre-Intervention||7
3322369|NCT03187301|4055405|FG006|STARTED|Pre-Intervention||0
3322370|NCT03187301|4055399|FG000|COMPLETED|Pre-Intervention||6
3322371|NCT03187301|4055400|FG001|COMPLETED|Pre-Intervention||7
3322372|NCT03187301|4055401|FG002|COMPLETED|Pre-Intervention||7
3322373|NCT03187301|4055402|FG003|COMPLETED|Pre-Intervention||6
3322374|NCT03187301|4055403|FG004|COMPLETED|Pre-Intervention||7
3322375|NCT03187301|4055404|FG005|COMPLETED|Pre-Intervention||7
3322376|NCT03187301|4055405|FG006|COMPLETED|Pre-Intervention||0
3322377|NCT03187301|4055399|FG000|NOT COMPLETED|Pre-Intervention||1
3322378|NCT03187301|4055400|FG001|NOT COMPLETED|Pre-Intervention||0
3322379|NCT03187301|4055401|FG002|NOT COMPLETED|Pre-Intervention||0
3322380|NCT03187301|4055402|FG003|NOT COMPLETED|Pre-Intervention||0
3322381|NCT03187301|4055403|FG004|NOT COMPLETED|Pre-Intervention||0
3322382|NCT03187301|4055404|FG005|NOT COMPLETED|Pre-Intervention||0
3322383|NCT03187301|4055405|FG006|NOT COMPLETED|Pre-Intervention||0
3175029|NCT01958060|3902650|FG003|STARTED|Overall Study||5
3175030|NCT01958060|3902651|FG004|STARTED|Overall Study||7
3175031|NCT01958060|3902652|FG005|STARTED|Overall Study||1
3175032|NCT01958060|3902647|FG000|COMPLETED|Overall Study||8
3175033|NCT01958060|3902648|FG001|COMPLETED|Overall Study||6
3175034|NCT01958060|3902649|FG002|COMPLETED|Overall Study||6
3175035|NCT01958060|3902650|FG003|COMPLETED|Overall Study||5
3175036|NCT01958060|3902651|FG004|COMPLETED|Overall Study|One subject in the 50 mg iv dose group did not receive complete dose of trial medication.|6
3175037|NCT01958060|3902652|FG005|COMPLETED|Overall Study|One subject in the 100 mg iv dose group did not receive complete dose of trial medication.|1
3175038|NCT01958060|3902647|FG000|NOT COMPLETED|Overall Study||2
2926244|NCT00569010|3637612|FG001|NOT COMPLETED|Overall Study||0
2926245|NCT00569010|3637613|FG002|NOT COMPLETED|Overall Study||0
2926246|NCT00569010|3637614|FG003|NOT COMPLETED|Overall Study||0
2926247|NCT00569127|3637626|FG000|STARTED|Overall Study||214
2926248|NCT00569127|3637627|FG001|STARTED|Overall Study||213
2926249|NCT00569127|3637626|FG000|Eligible|Overall Study||200
2926250|NCT00569127|3637627|FG001|Eligible|Overall Study||202
2926251|NCT00569127|3637626|FG000|COMPLETED|Overall Study||0
2926252|NCT00569127|3637627|FG001|COMPLETED|Overall Study||0
2926253|NCT00569127|3637626|FG000|NOT COMPLETED|Overall Study||214
2926254|NCT00569127|3637627|FG001|NOT COMPLETED|Overall Study||213
3175039|NCT01958060|3902648|FG001|NOT COMPLETED|Overall Study||0
3175040|NCT01958060|3902649|FG002|NOT COMPLETED|Overall Study||0
3175041|NCT01958060|3902650|FG003|NOT COMPLETED|Overall Study||0
3175042|NCT01958060|3902651|FG004|NOT COMPLETED|Overall Study||1
3322384|NCT03187301|4055399|FG000|STARTED|First Intervention||6
3322385|NCT03187301|4055400|FG001|STARTED|First Intervention||7
3322386|NCT03187301|4055401|FG002|STARTED|First Intervention||7
3322387|NCT03187301|4055402|FG003|STARTED|First Intervention||6
3322388|NCT03187301|4055403|FG004|STARTED|First Intervention||7
3322389|NCT03187301|4055404|FG005|STARTED|First Intervention||7
3322390|NCT03187301|4055405|FG006|STARTED|First Intervention||0
3322391|NCT03187301|4055399|FG000|COMPLETED|First Intervention||6
3175043|NCT01958060|3902652|FG005|NOT COMPLETED|Overall Study||0
3175044|NCT01958073|3902673|FG000|STARTED|Randomized Period||9
3175045|NCT01958073|3902674|FG001|STARTED|Randomized Period||9
3175046|NCT01958073|3902675|FG002|STARTED|Randomized Period||17
3175047|NCT01958073|3902676|FG003|STARTED|Randomized Period||0
3175048|NCT01958073|3902677|FG004|STARTED|Randomized Period||0
3175049|NCT01958073|3902673|FG000|COMPLETED|Randomized Period||7
3322392|NCT03187301|4055400|FG001|COMPLETED|First Intervention||7
3322393|NCT03187301|4055401|FG002|COMPLETED|First Intervention||7
3175050|NCT01958073|3902674|FG001|COMPLETED|Randomized Period||8
3175051|NCT01958073|3902675|FG002|COMPLETED|Randomized Period||11
3322394|NCT03187301|4055402|FG003|COMPLETED|First Intervention||6
3322395|NCT03187301|4055403|FG004|COMPLETED|First Intervention||7
3322396|NCT03187301|4055404|FG005|COMPLETED|First Intervention||7
3322397|NCT03187301|4055405|FG006|COMPLETED|First Intervention||0
3322398|NCT03187301|4055399|FG000|NOT COMPLETED|First Intervention||0
3322399|NCT03187301|4055400|FG001|NOT COMPLETED|First Intervention||0
3322400|NCT03187301|4055401|FG002|NOT COMPLETED|First Intervention||0
3322401|NCT03187301|4055402|FG003|NOT COMPLETED|First Intervention||0
3322402|NCT03187301|4055403|FG004|NOT COMPLETED|First Intervention||0
3322403|NCT03187301|4055404|FG005|NOT COMPLETED|First Intervention||0
3322404|NCT03187301|4055405|FG006|NOT COMPLETED|First Intervention||0
3322405|NCT03187301|4055399|FG000|STARTED|First Washout||6
3322406|NCT03187301|4055400|FG001|STARTED|First Washout||7
3322407|NCT03187301|4055401|FG002|STARTED|First Washout||7
3322408|NCT03187301|4055402|FG003|STARTED|First Washout||6
3322409|NCT03187301|4055403|FG004|STARTED|First Washout||7
3175052|NCT01958073|3902676|FG003|COMPLETED|Randomized Period||0
3175053|NCT01958073|3902677|FG004|COMPLETED|Randomized Period||0
3175054|NCT01958073|3902673|FG000|NOT COMPLETED|Randomized Period||2
3175055|NCT01958073|3902674|FG001|NOT COMPLETED|Randomized Period||1
3175056|NCT01958073|3902675|FG002|NOT COMPLETED|Randomized Period||6
3175057|NCT01958073|3902676|FG003|NOT COMPLETED|Randomized Period||0
3175058|NCT01958073|3902677|FG004|NOT COMPLETED|Randomized Period||0
3175059|NCT01958073|3902673|FG000|STARTED|Open Label Period||0
2926255|NCT00569166|3637636|FG000|STARTED|Overall Study||30
2926256|NCT00569166|3637637|FG001|STARTED|Overall Study||31
2926257|NCT00569166|3637638|FG002|STARTED|Overall Study||31
2926258|NCT00569166|3637636|FG000|COMPLETED|Overall Study||21
2926259|NCT00569166|3637637|FG001|COMPLETED|Overall Study||25
2926260|NCT00569166|3637638|FG002|COMPLETED|Overall Study||27
2926261|NCT00569166|3637636|FG000|NOT COMPLETED|Overall Study||9
2926262|NCT00569166|3637637|FG001|NOT COMPLETED|Overall Study||6
2926263|NCT00569166|3637638|FG002|NOT COMPLETED|Overall Study||4
2926264|NCT00569192|3637649|FG000|STARTED|Overall Study||111
2926265|NCT00569192|3637650|FG001|STARTED|Overall Study||125
2926266|NCT00569192|3637651|FG002|STARTED|Overall Study||124
2926267|NCT00569192|3637649|FG000|COMPLETED|Overall Study||88
2926268|NCT00569192|3637650|FG001|COMPLETED|Overall Study||105
2926269|NCT00569192|3637651|FG002|COMPLETED|Overall Study||99
2926270|NCT00569192|3637649|FG000|NOT COMPLETED|Overall Study||23
3322410|NCT03187301|4055404|FG005|STARTED|First Washout||7
3322411|NCT03187301|4055405|FG006|STARTED|First Washout||0
3322412|NCT03187301|4055399|FG000|COMPLETED|First Washout||6
3322413|NCT03187301|4055400|FG001|COMPLETED|First Washout||7
3322414|NCT03187301|4055401|FG002|COMPLETED|First Washout||7
3322415|NCT03187301|4055402|FG003|COMPLETED|First Washout||6
3322416|NCT03187301|4055403|FG004|COMPLETED|First Washout||7
3322417|NCT03187301|4055404|FG005|COMPLETED|First Washout||7
3322418|NCT03187301|4055405|FG006|COMPLETED|First Washout||0
3322419|NCT03187301|4055399|FG000|NOT COMPLETED|First Washout||0
3322420|NCT03187301|4055400|FG001|NOT COMPLETED|First Washout||0
3322421|NCT03187301|4055401|FG002|NOT COMPLETED|First Washout||0
3322422|NCT03187301|4055402|FG003|NOT COMPLETED|First Washout||0
3322423|NCT03187301|4055403|FG004|NOT COMPLETED|First Washout||0
3322424|NCT03187301|4055404|FG005|NOT COMPLETED|First Washout||0
3322425|NCT03187301|4055405|FG006|NOT COMPLETED|First Washout||0
3322426|NCT03187301|4055399|FG000|STARTED|Second Intervention||6
3322427|NCT03187301|4055400|FG001|STARTED|Second Intervention||7
3322428|NCT03187301|4055401|FG002|STARTED|Second Intervention||7
3322429|NCT03187301|4055402|FG003|STARTED|Second Intervention||6
3175060|NCT01958073|3902674|FG001|STARTED|Open Label Period||0
3175061|NCT01958073|3902675|FG002|STARTED|Open Label Period||0
3175062|NCT01958073|3902676|FG003|STARTED|Open Label Period||5
3175063|NCT01958073|3902677|FG004|STARTED|Open Label Period||17
3175064|NCT01958073|3902673|FG000|COMPLETED|Open Label Period||0
3175065|NCT01958073|3902674|FG001|COMPLETED|Open Label Period||0
3322430|NCT03187301|4055403|FG004|STARTED|Second Intervention||7
3322431|NCT03187301|4055404|FG005|STARTED|Second Intervention||7
3322432|NCT03187301|4055405|FG006|STARTED|Second Intervention||0
3322433|NCT03187301|4055399|FG000|COMPLETED|Second Intervention||6
3322434|NCT03187301|4055400|FG001|COMPLETED|Second Intervention||7
3322435|NCT03187301|4055401|FG002|COMPLETED|Second Intervention||7
3322436|NCT03187301|4055402|FG003|COMPLETED|Second Intervention||6
3322437|NCT03187301|4055403|FG004|COMPLETED|Second Intervention||7
3322438|NCT03187301|4055404|FG005|COMPLETED|Second Intervention||7
3322439|NCT03187301|4055405|FG006|COMPLETED|Second Intervention||0
3322440|NCT03187301|4055399|FG000|NOT COMPLETED|Second Intervention||0
3322441|NCT03187301|4055400|FG001|NOT COMPLETED|Second Intervention||0
3322442|NCT03187301|4055401|FG002|NOT COMPLETED|Second Intervention||0
3322443|NCT03187301|4055402|FG003|NOT COMPLETED|Second Intervention||0
3322444|NCT03187301|4055403|FG004|NOT COMPLETED|Second Intervention||0
3322445|NCT03187301|4055404|FG005|NOT COMPLETED|Second Intervention||0
3322446|NCT03187301|4055405|FG006|NOT COMPLETED|Second Intervention||0
3322447|NCT03187301|4055399|FG000|STARTED|Second Washout||6
3322448|NCT03187301|4055400|FG001|STARTED|Second Washout||7
3322449|NCT03187301|4055401|FG002|STARTED|Second Washout||7
3322450|NCT03187301|4055402|FG003|STARTED|Second Washout||6
3322451|NCT03187301|4055403|FG004|STARTED|Second Washout||7
3322452|NCT03187301|4055404|FG005|STARTED|Second Washout||7
3322453|NCT03187301|4055405|FG006|STARTED|Second Washout||0
3322454|NCT03187301|4055399|FG000|COMPLETED|Second Washout||6
3322455|NCT03187301|4055400|FG001|COMPLETED|Second Washout||7
3322456|NCT03187301|4055401|FG002|COMPLETED|Second Washout||7
3322457|NCT03187301|4055402|FG003|COMPLETED|Second Washout||6
3322458|NCT03187301|4055403|FG004|COMPLETED|Second Washout||7
3322459|NCT03187301|4055404|FG005|COMPLETED|Second Washout||7
3322460|NCT03187301|4055405|FG006|COMPLETED|Second Washout||0
3322461|NCT03187301|4055399|FG000|NOT COMPLETED|Second Washout||0
3322462|NCT03187301|4055400|FG001|NOT COMPLETED|Second Washout||0
3322463|NCT03187301|4055401|FG002|NOT COMPLETED|Second Washout||0
3322464|NCT03187301|4055402|FG003|NOT COMPLETED|Second Washout||0
3322465|NCT03187301|4055403|FG004|NOT COMPLETED|Second Washout||0
3322466|NCT03187301|4055404|FG005|NOT COMPLETED|Second Washout||0
3322467|NCT03187301|4055405|FG006|NOT COMPLETED|Second Washout||0
3322468|NCT03187301|4055399|FG000|STARTED|Third Intervention||6
3322469|NCT03187301|4055400|FG001|STARTED|Third Intervention||7
3322470|NCT03187301|4055401|FG002|STARTED|Third Intervention||7
3322471|NCT03187301|4055402|FG003|STARTED|Third Intervention||6
3322472|NCT03187301|4055403|FG004|STARTED|Third Intervention||7
3322473|NCT03187301|4055404|FG005|STARTED|Third Intervention||7
3322474|NCT03187301|4055405|FG006|STARTED|Third Intervention||0
3322475|NCT03187301|4055399|FG000|COMPLETED|Third Intervention||6
3322476|NCT03187301|4055400|FG001|COMPLETED|Third Intervention||7
3322477|NCT03187301|4055401|FG002|COMPLETED|Third Intervention||7
3322478|NCT03187301|4055402|FG003|COMPLETED|Third Intervention||6
3322479|NCT03187301|4055403|FG004|COMPLETED|Third Intervention||7
3322480|NCT03187301|4055404|FG005|COMPLETED|Third Intervention||7
3175066|NCT01958073|3902675|FG002|COMPLETED|Open Label Period||0
3175067|NCT01958073|3902676|FG003|COMPLETED|Open Label Period||5
3175068|NCT01958073|3902677|FG004|COMPLETED|Open Label Period||17
3175069|NCT01958073|3902673|FG000|NOT COMPLETED|Open Label Period||0
3175070|NCT01958073|3902674|FG001|NOT COMPLETED|Open Label Period||0
3175071|NCT01958073|3902675|FG002|NOT COMPLETED|Open Label Period||0
3175072|NCT01958073|3902676|FG003|NOT COMPLETED|Open Label Period||0
3175073|NCT01958073|3902677|FG004|NOT COMPLETED|Open Label Period||0
3175074|NCT01958112|3902693|FG000|STARTED|Overall Study||14
3175075|NCT01958112|3902693|FG000|COMPLETED|Overall Study||14
2926271|NCT00569192|3637650|FG001|NOT COMPLETED|Overall Study||20
2926272|NCT00569192|3637651|FG002|NOT COMPLETED|Overall Study||25
2926273|NCT00569231|3637659|FG000|STARTED|Overall Study||18
2926274|NCT00569231|3637659|FG000|COMPLETED|Overall Study||11
2926275|NCT00569231|3637659|FG000|NOT COMPLETED|Overall Study||7
2926276|NCT00569270|3637663|FG000|STARTED|Period: First Intervention|randomized cross over study|15
2926277|NCT00569270|3637664|FG001|STARTED|Period: First Intervention||15
2926278|NCT00569270|3637663|FG000|COMPLETED|Period: First Intervention||15
2926279|NCT00569270|3637664|FG001|COMPLETED|Period: First Intervention||14
2926280|NCT00569270|3637663|FG000|NOT COMPLETED|Period: First Intervention||0
2926281|NCT00569270|3637664|FG001|NOT COMPLETED|Period: First Intervention||1
2926282|NCT00569270|3637663|FG000|STARTED|Period: Second Intervention||15
2926283|NCT00569270|3637664|FG001|STARTED|Period: Second Intervention||14
2926284|NCT00569270|3637663|FG000|29 Days|Period: Second Intervention||15
2926285|NCT00569270|3637664|FG001|29 Days|Period: Second Intervention||14
2926286|NCT00569270|3637663|FG000|COMPLETED|Period: Second Intervention||15
2926287|NCT00569270|3637664|FG001|COMPLETED|Period: Second Intervention||14
2926288|NCT00569270|3637663|FG000|NOT COMPLETED|Period: Second Intervention||0
2926289|NCT00569270|3637664|FG001|NOT COMPLETED|Period: Second Intervention||0
2926290|NCT00569309|3637679|FG000|STARTED|Overall Study||30
2926291|NCT00569309|3637679|FG000|COMPLETED|Overall Study||30
2926292|NCT00569309|3637679|FG000|NOT COMPLETED|Overall Study||0
2926293|NCT00569374|3637683|FG000|STARTED|Overall Study||8
2926294|NCT00569374|3637683|FG000|COMPLETED|Overall Study||4
2926295|NCT00569374|3637683|FG000|NOT COMPLETED|Overall Study||4
2926296|NCT00569530|3637689|FG000|STARTED|Overall Study||43
2926297|NCT00569530|3637690|FG001|STARTED|Overall Study||42
2926298|NCT00569530|3637689|FG000|COMPLETED|Overall Study||43
2926299|NCT00569530|3637690|FG001|COMPLETED|Overall Study||42
2926300|NCT00569530|3637689|FG000|NOT COMPLETED|Overall Study||0
2926301|NCT00569530|3637690|FG001|NOT COMPLETED|Overall Study||0
2926302|NCT00569582|3637696|FG000|STARTED|Overall Study||50
2926303|NCT00569582|3637696|FG000|COMPLETED|Overall Study||34
2926304|NCT00569582|3637696|FG000|NOT COMPLETED|Overall Study||16
2926305|NCT00569660|3637700|FG000|STARTED|Overall Study||34
2926306|NCT00569660|3637700|FG000|COMPLETED|Overall Study||34
2926307|NCT00569660|3637700|FG000|NOT COMPLETED|Overall Study||0
2926308|NCT00569673|3637704|FG000|STARTED|Overall Study|Total number participants enrolled on study|71
2926309|NCT00569673|3637704|FG000|COMPLETED|Overall Study|Total number participants that are eligible and evaluable.|71
3175076|NCT01958112|3902693|FG000|NOT COMPLETED|Overall Study||0
3175077|NCT01958125|3902699|FG000|STARTED|Overall Study||50
2926310|NCT00569673|3637704|FG000|NOT COMPLETED|Overall Study||0
2926311|NCT00569777|3637710|FG000|STARTED|Overall Study||206
2926312|NCT00569777|3637711|FG001|STARTED|Overall Study||104
2926313|NCT00569777|3637710|FG000|COMPLETED|Overall Study||196
2926314|NCT00569777|3637711|FG001|COMPLETED|Overall Study||101
2926315|NCT00569777|3637710|FG000|NOT COMPLETED|Overall Study||10
2926316|NCT00569777|3637711|FG001|NOT COMPLETED|Overall Study||3
3322481|NCT03187301|4055405|FG006|COMPLETED|Third Intervention||0
3322482|NCT03187301|4055399|FG000|NOT COMPLETED|Third Intervention||0
3322483|NCT03187301|4055400|FG001|NOT COMPLETED|Third Intervention||0
3322484|NCT03187301|4055401|FG002|NOT COMPLETED|Third Intervention||0
3322485|NCT03187301|4055402|FG003|NOT COMPLETED|Third Intervention||0
3322486|NCT03187301|4055403|FG004|NOT COMPLETED|Third Intervention||0
3322487|NCT03187301|4055404|FG005|NOT COMPLETED|Third Intervention||0
3322488|NCT03187301|4055405|FG006|NOT COMPLETED|Third Intervention||0
3322489|NCT03187418|4055426|FG000|STARTED|Overall Study||52
3322490|NCT03187418|4055426|FG000|COMPLETED|Overall Study||52
3322491|NCT03187418|4055426|FG000|NOT COMPLETED|Overall Study||0
3322492|NCT03187678|4055430|FG000|STARTED|Period 1 (Oral Selexipag)||20
3322493|NCT03187678|4055430|FG000|COMPLETED|Period 1 (Oral Selexipag)||20
3322494|NCT03187678|4055430|FG000|NOT COMPLETED|Period 1 (Oral Selexipag)||0
3322495|NCT03187678|4055430|FG000|STARTED|Period 2 (Intravenous Selexipag)||20
3322496|NCT03187678|4055430|FG000|COMPLETED|Period 2 (Intravenous Selexipag)||20
3322497|NCT03187678|4055430|FG000|NOT COMPLETED|Period 2 (Intravenous Selexipag)||0
3322498|NCT03187678|4055430|FG000|STARTED|Period 3 (Oral Selexipag)||20
3322499|NCT03187678|4055430|FG000|COMPLETED|Period 3 (Oral Selexipag)||20
3322500|NCT03187678|4055430|FG000|NOT COMPLETED|Period 3 (Oral Selexipag)||0
3322501|NCT03187730|4055436|FG000|STARTED|Overall Study||208
3322502|NCT03187730|4055437|FG001|STARTED|Overall Study||202
3322503|NCT03187730|4055436|FG000|COMPLETED|Overall Study||129
3322504|NCT03187730|4055437|FG001|COMPLETED|Overall Study||154
3322505|NCT03187730|4055436|FG000|NOT COMPLETED|Overall Study||79
3322506|NCT03187730|4055437|FG001|NOT COMPLETED|Overall Study||48
3322507|NCT03187756|4055443|FG000|STARTED|Overall Study||6
3322508|NCT03187756|4055443|FG000|COMPLETED|Overall Study||2
3322509|NCT03187756|4055443|FG000|NOT COMPLETED|Overall Study||4
3322510|NCT03188055|4055449|FG000|STARTED|Overall Study||48
3322511|NCT03188055|4055450|FG001|STARTED|Overall Study|Family members consented (24/48 had patient enroll along with them as patient had DMC).|48
3322512|NCT03188055|4055451|FG002|STARTED|Overall Study||62
3322513|NCT03188055|4055452|FG003|STARTED|Overall Study|Family members consented (19/38 had patient enroll along with them as patient had DMC).|38
3322514|NCT03188055|4055453|FG004|STARTED|Overall Study||59
3322515|NCT03188055|4055454|FG005|STARTED|Overall Study|Anonymous survey, cannot ascertain if same participant completed it for both pre- and post-intervention.|
3322516|NCT03188055|4055449|FG000|Patients Who Provided Self-Consent|Overall Study||0
3322517|NCT03188055|4055450|FG001|Patients Who Provided Self-Consent|Overall Study||24
3322518|NCT03188055|4055451|FG002|Patients Who Provided Self-Consent|Overall Study||0
3322519|NCT03188055|4055452|FG003|Patients Who Provided Self-Consent|Overall Study||19
3322520|NCT03188055|4055453|FG004|Patients Who Provided Self-Consent|Overall Study||0
3322521|NCT03188055|4055454|FG005|Patients Who Provided Self-Consent|Overall Study||0
3322522|NCT03188055|4055449|FG000|MDS Pre-Intervention Survey Responses|Overall Study||0
3322523|NCT03188055|4055450|FG001|MDS Pre-Intervention Survey Responses|Overall Study||0
3322524|NCT03188055|4055451|FG002|MDS Pre-Intervention Survey Responses|Overall Study||0
3322525|NCT03188055|4055452|FG003|MDS Pre-Intervention Survey Responses|Overall Study||0
3322526|NCT03188055|4055453|FG004|MDS Pre-Intervention Survey Responses|Overall Study||0
3322527|NCT03188055|4055454|FG005|MDS Pre-Intervention Survey Responses|Overall Study||99
3322528|NCT03188055|4055449|FG000|MDS Post-Intervention Survey Responses|Overall Study||0
3322529|NCT03188055|4055450|FG001|MDS Post-Intervention Survey Responses|Overall Study||0
3322530|NCT03188055|4055451|FG002|MDS Post-Intervention Survey Responses|Overall Study||0
3322531|NCT03188055|4055452|FG003|MDS Post-Intervention Survey Responses|Overall Study||0
3322532|NCT03188055|4055453|FG004|MDS Post-Intervention Survey Responses|Overall Study||0
3322533|NCT03188055|4055454|FG005|MDS Post-Intervention Survey Responses|Overall Study||134
3322534|NCT03188055|4055449|FG000|Patient Survey 1|Overall Study||0
3322535|NCT03188055|4055450|FG001|Patient Survey 1|Overall Study||16
3322536|NCT03188055|4055451|FG002|Patient Survey 1|Overall Study||0
3322537|NCT03188055|4055452|FG003|Patient Survey 1|Overall Study||13
3322538|NCT03188055|4055453|FG004|Patient Survey 1|Overall Study||0
3322539|NCT03188055|4055454|FG005|Patient Survey 1|Overall Study||0
3322540|NCT03188055|4055449|FG000|Nurse Survey 1|Overall Study||0
3322541|NCT03188055|4055450|FG001|Nurse Survey 1|Overall Study||32
3322542|NCT03188055|4055451|FG002|Nurse Survey 1|Overall Study||0
3322543|NCT03188055|4055452|FG003|Nurse Survey 1|Overall Study||27
3322544|NCT03188055|4055453|FG004|Nurse Survey 1|Overall Study||0
3322545|NCT03188055|4055454|FG005|Nurse Survey 1|Overall Study||0
3322546|NCT03188055|4055449|FG000|Family Survey 1|Overall Study||0
3322547|NCT03188055|4055450|FG001|Family Survey 1|Overall Study||37
3322548|NCT03188055|4055451|FG002|Family Survey 1|Overall Study||0
3322549|NCT03188055|4055452|FG003|Family Survey 1|Overall Study||38
3322550|NCT03188055|4055453|FG004|Family Survey 1|Overall Study||0
3322551|NCT03188055|4055454|FG005|Family Survey 1|Overall Study||0
3322552|NCT03188055|4055449|FG000|Family Survey 2|Overall Study||0
3322553|NCT03188055|4055450|FG001|Family Survey 2|Overall Study||34
3322554|NCT03188055|4055451|FG002|Family Survey 2|Overall Study||0
3322555|NCT03188055|4055452|FG003|Family Survey 2|Overall Study||35
3322556|NCT03188055|4055453|FG004|Family Survey 2|Overall Study||0
3322557|NCT03188055|4055454|FG005|Family Survey 2|Overall Study||0
3322558|NCT03188055|4055449|FG000|Family Survey 3|Overall Study||0
3322559|NCT03188055|4055450|FG001|Family Survey 3|Overall Study||29
3322560|NCT03188055|4055451|FG002|Family Survey 3|Overall Study||0
3322561|NCT03188055|4055452|FG003|Family Survey 3|Overall Study||26
3322562|NCT03188055|4055453|FG004|Family Survey 3|Overall Study||0
3322563|NCT03188055|4055454|FG005|Family Survey 3|Overall Study||0
3322564|NCT03188055|4055449|FG000|COMPLETED|Overall Study||48
3322565|NCT03188055|4055450|FG001|COMPLETED|Overall Study||29
3322566|NCT03188055|4055451|FG002|COMPLETED|Overall Study||43
3175078|NCT01958125|3902700|FG001|STARTED|Overall Study||52
3175079|NCT01958125|3902699|FG000|COMPLETED|Overall Study||48
3175080|NCT01958125|3902700|FG001|COMPLETED|Overall Study||44
3175081|NCT01958125|3902699|FG000|NOT COMPLETED|Overall Study||2
3175082|NCT01958125|3902700|FG001|NOT COMPLETED|Overall Study||8
3175083|NCT01958164|3902708|FG000|STARTED|Overall Study|Randomised and treated|6
3322567|NCT03188055|4055452|FG003|COMPLETED|Overall Study||26
3322568|NCT03188055|4055453|FG004|COMPLETED|Overall Study||59
3322569|NCT03188055|4055454|FG005|COMPLETED|Overall Study|Anonymous survey, cannot ascertain if same participant completed it for both pre- and post-intervention.|
3175084|NCT01958164|3902709|FG001|STARTED|Overall Study|Randomised and treated|10
3175085|NCT01958164|3902708|FG000|COMPLETED|Overall Study||4
3322570|NCT03188055|4055449|FG000|NOT COMPLETED|Overall Study||0
3322571|NCT03188055|4055450|FG001|NOT COMPLETED|Overall Study||19
3175086|NCT01958164|3902709|FG001|COMPLETED|Overall Study||5
3175087|NCT01958164|3902708|FG000|NOT COMPLETED|Overall Study||2
3175088|NCT01958164|3902709|FG001|NOT COMPLETED|Overall Study||5
3175089|NCT01958281|3902718|FG000|STARTED|Overall Study||10
3175090|NCT01958281|3902719|FG001|STARTED|Overall Study||10
3175091|NCT01958281|3902720|FG002|STARTED|Overall Study||18
3175092|NCT01958281|3902718|FG000|COMPLETED|Overall Study||4
3175093|NCT01958281|3902719|FG001|COMPLETED|Overall Study||6
3175094|NCT01958281|3902720|FG002|COMPLETED|Overall Study||18
3175095|NCT01958281|3902718|FG000|NOT COMPLETED|Overall Study||6
3175096|NCT01958281|3902719|FG001|NOT COMPLETED|Overall Study||4
3175097|NCT01958281|3902720|FG002|NOT COMPLETED|Overall Study||0
3175098|NCT01958294|3902729|FG000|STARTED|Overall Study||12
3175099|NCT01958294|3902729|FG000|COMPLETED|Overall Study||10
3175100|NCT01958294|3902729|FG000|NOT COMPLETED|Overall Study||2
3322572|NCT03188055|4055451|FG002|NOT COMPLETED|Overall Study||19
3322573|NCT03188055|4055452|FG003|NOT COMPLETED|Overall Study||12
3322574|NCT03188055|4055453|FG004|NOT COMPLETED|Overall Study||0
3322575|NCT03188055|4055454|FG005|NOT COMPLETED|Overall Study||
3322576|NCT03188120|4055465|FG000|STARTED|Overall Study||193
3322577|NCT03188120|4055465|FG000|COMPLETED|Overall Study||146
3322578|NCT03188120|4055465|FG000|NOT COMPLETED|Overall Study||47
3322579|NCT03188185|4055471|FG000|STARTED|Stage 1||198
3322580|NCT03188185|4055472|FG001|STARTED|Stage 1||80
3322581|NCT03188185|4055473|FG002|STARTED|Stage 1||0
3322582|NCT03188185|4055474|FG003|STARTED|Stage 1||0
3322583|NCT03188185|4055471|FG000|COMPLETED|Stage 1||179
3322584|NCT03188185|4055472|FG001|COMPLETED|Stage 1||64
3322585|NCT03188185|4055473|FG002|COMPLETED|Stage 1||0
3322586|NCT03188185|4055474|FG003|COMPLETED|Stage 1||0
3322587|NCT03188185|4055471|FG000|NOT COMPLETED|Stage 1||19
3322588|NCT03188185|4055472|FG001|NOT COMPLETED|Stage 1||16
3322589|NCT03188185|4055473|FG002|NOT COMPLETED|Stage 1||0
3322590|NCT03188185|4055474|FG003|NOT COMPLETED|Stage 1||0
3322591|NCT03188185|4055471|FG000|STARTED|Stage 2||0
3322592|NCT03188185|4055472|FG001|STARTED|Stage 2||0
3322593|NCT03188185|4055473|FG002|STARTED|Stage 2||64
3175101|NCT01958320|3902735|FG000|STARTED|Overall Study||104
3175102|NCT01958320|3902736|FG001|STARTED|Overall Study||98
3175103|NCT01958320|3902735|FG000|COMPLETED|Overall Study||104
3175104|NCT01958320|3902736|FG001|COMPLETED|Overall Study||98
3175105|NCT01958320|3902735|FG000|NOT COMPLETED|Overall Study||0
3175106|NCT01958320|3902736|FG001|NOT COMPLETED|Overall Study||0
3175107|NCT01958346|3902746|FG000|STARTED|Overall Study||39
3175108|NCT01958346|3902747|FG001|STARTED|Overall Study||39
3322594|NCT03188185|4055474|FG003|STARTED|Stage 2||63
3322595|NCT03188185|4055471|FG000|COMPLETED|Stage 2||0
3322596|NCT03188185|4055472|FG001|COMPLETED|Stage 2||0
3322597|NCT03188185|4055473|FG002|COMPLETED|Stage 2||55
3175109|NCT01958346|3902746|FG000|COMPLETED|Overall Study||39
3175110|NCT01958346|3902747|FG001|COMPLETED|Overall Study||39
3322598|NCT03188185|4055474|FG003|COMPLETED|Stage 2||57
3175111|NCT01958346|3902746|FG000|NOT COMPLETED|Overall Study||0
3175112|NCT01958346|3902747|FG001|NOT COMPLETED|Overall Study||0
3175113|NCT01958437|3902755|FG000|STARTED|Overall Study||11
3175114|NCT01958437|3902756|FG001|STARTED|Overall Study||11
3175115|NCT01958437|3902757|FG002|STARTED|Overall Study||11
3175116|NCT01958437|3902758|FG003|STARTED|Overall Study||11
3175117|NCT01958437|3902755|FG000|COMPLETED|Overall Study||11
3175118|NCT01958437|3902756|FG001|COMPLETED|Overall Study||11
3175119|NCT01958437|3902757|FG002|COMPLETED|Overall Study||10
3175120|NCT01958437|3902758|FG003|COMPLETED|Overall Study||10
3175121|NCT01958437|3902755|FG000|NOT COMPLETED|Overall Study||0
3175122|NCT01958437|3902756|FG001|NOT COMPLETED|Overall Study||0
3175123|NCT01958437|3902757|FG002|NOT COMPLETED|Overall Study||1
3175124|NCT01958437|3902758|FG003|NOT COMPLETED|Overall Study||1
3175125|NCT01958476|3902777|FG000|STARTED|Overall Study||59
3175126|NCT01958476|3902778|FG001|STARTED|Overall Study||58
3175127|NCT01958476|3902777|FG000|COMPLETED|Overall Study||58
3175128|NCT01958476|3902778|FG001|COMPLETED|Overall Study||58
3175129|NCT01958476|3902777|FG000|NOT COMPLETED|Overall Study||1
3175130|NCT01958476|3902778|FG001|NOT COMPLETED|Overall Study||0
3175131|NCT01958489|3902784|FG000|STARTED|Period 1||24
3175132|NCT01958489|3902785|FG001|STARTED|Period 1||0
3175133|NCT01958489|3902784|FG000|Received at Least 1 Dose of Study Drug|Period 1||24
3175134|NCT01958489|3902785|FG001|Received at Least 1 Dose of Study Drug|Period 1||0
3175135|NCT01958489|3902784|FG000|COMPLETED|Period 1||24
3175136|NCT01958489|3902785|FG001|COMPLETED|Period 1||0
3175137|NCT01958489|3902784|FG000|NOT COMPLETED|Period 1||0
3175138|NCT01958489|3902785|FG001|NOT COMPLETED|Period 1||0
3175139|NCT01958489|3902784|FG000|STARTED|Period 2|Participants who completed Period 1 treatment crossed over to Period 2 treatment|0
3175140|NCT01958489|3902785|FG001|STARTED|Period 2|Participants who started Period 2 treatment crossed over from Period 1 treatment|24
3175141|NCT01958489|3902784|FG000|Received at Least 1 Dose of Study Drug|Period 2||0
3322599|NCT03188185|4055471|FG000|NOT COMPLETED|Stage 2||0
3322600|NCT03188185|4055472|FG001|NOT COMPLETED|Stage 2||0
3322601|NCT03188185|4055473|FG002|NOT COMPLETED|Stage 2||9
3322602|NCT03188185|4055474|FG003|NOT COMPLETED|Stage 2||6
3322603|NCT03188263|4055486|FG000|STARTED|Overall Study||10
3322604|NCT03188263|4055487|FG001|STARTED|Overall Study||0
3322605|NCT03188263|4055486|FG000|COMPLETED|Overall Study||6
3322606|NCT03188263|4055487|FG001|COMPLETED|Overall Study||0
3322607|NCT03188263|4055486|FG000|NOT COMPLETED|Overall Study||4
3322608|NCT03188263|4055487|FG001|NOT COMPLETED|Overall Study||0
3322609|NCT03188523|4055495|FG000|STARTED|Overall Study||6
3322610|NCT03188523|4055496|FG001|STARTED|Overall Study||6
3322611|NCT03188523|4055497|FG002|STARTED|Overall Study||0
3175142|NCT01958489|3902785|FG001|Received at Least 1 Dose of Study Drug|Period 2||24
3322612|NCT03188523|4055498|FG003|STARTED|Overall Study||0
3322613|NCT03188523|4055495|FG000|COMPLETED|Overall Study||6
3322614|NCT03188523|4055496|FG001|COMPLETED|Overall Study||6
3322615|NCT03188523|4055497|FG002|COMPLETED|Overall Study||0
3322616|NCT03188523|4055498|FG003|COMPLETED|Overall Study||0
3322617|NCT03188523|4055495|FG000|NOT COMPLETED|Overall Study||0
3322618|NCT03188523|4055496|FG001|NOT COMPLETED|Overall Study||0
3322619|NCT03188523|4055497|FG002|NOT COMPLETED|Overall Study||0
3322620|NCT03188523|4055498|FG003|NOT COMPLETED|Overall Study||0
3322621|NCT03188536|4055504|FG000|STARTED|Overall Study||282
3322622|NCT03188536|4055504|FG000|COMPLETED|Overall Study||276
3322623|NCT03188536|4055504|FG000|NOT COMPLETED|Overall Study||6
3322624|NCT03188718|4055508|FG000|STARTED|Overall Study||45
3322625|NCT03188718|4055508|FG000|COMPLETED|Overall Study||37
3322626|NCT03188718|4055508|FG000|NOT COMPLETED|Overall Study||8
3322627|NCT03188991|4055516|FG000|STARTED|Overall Study||3
3322628|NCT03188991|4055517|FG001|STARTED|Overall Study||3
3322629|NCT03188991|4055518|FG002|STARTED|Overall Study||3
3322630|NCT03188991|4055519|FG003|STARTED|Overall Study||11
3322631|NCT03188991|4055516|FG000|COMPLETED|Overall Study||3
3322632|NCT03188991|4055517|FG001|COMPLETED|Overall Study||3
3322633|NCT03188991|4055518|FG002|COMPLETED|Overall Study||3
3322634|NCT03188991|4055519|FG003|COMPLETED|Overall Study||10
3322635|NCT03188991|4055516|FG000|NOT COMPLETED|Overall Study||0
3322636|NCT03188991|4055517|FG001|NOT COMPLETED|Overall Study||0
3322637|NCT03188991|4055518|FG002|NOT COMPLETED|Overall Study||0
3322638|NCT03188991|4055519|FG003|NOT COMPLETED|Overall Study||1
3322639|NCT03189134|4055529|FG000|STARTED|Overall Study||6
3322640|NCT03189134|4055529|FG000|COMPLETED|Overall Study||6
3322641|NCT03189134|4055529|FG000|NOT COMPLETED|Overall Study||0
3322642|NCT03189446|4055533|FG000|STARTED|Overall Study||32
3322643|NCT03189446|4055533|FG000|COMPLETED|Overall Study||27
3322644|NCT03189446|4055533|FG000|NOT COMPLETED|Overall Study||5
3322645|NCT03189524|4055540|FG000|STARTED|Overall Study||11
3322646|NCT03189524|4055541|FG001|STARTED|Overall Study||10
3322647|NCT03189524|4055542|FG002|STARTED|Overall Study||23
3322648|NCT03189524|4055540|FG000|Received at Least 1 Dose of Study Drug|Overall Study||11
3322649|NCT03189524|4055541|FG001|Received at Least 1 Dose of Study Drug|Overall Study||10
3322650|NCT03189524|4055542|FG002|Received at Least 1 Dose of Study Drug|Overall Study||23
3322651|NCT03189524|4055540|FG000|COMPLETED|Overall Study||0
3322652|NCT03189524|4055541|FG001|COMPLETED|Overall Study||0
3322653|NCT03189524|4055542|FG002|COMPLETED|Overall Study||0
3322654|NCT03189524|4055540|FG000|NOT COMPLETED|Overall Study||11
3322655|NCT03189524|4055541|FG001|NOT COMPLETED|Overall Study||10
3175143|NCT01958489|3902784|FG000|COMPLETED|Period 2||0
3175144|NCT01958489|3902785|FG001|COMPLETED|Period 2||23
3175145|NCT01958489|3902784|FG000|NOT COMPLETED|Period 2||0
3175146|NCT01958489|3902785|FG001|NOT COMPLETED|Period 2||1
3175147|NCT01958606|3902798|FG000|STARTED|Overall Study||13
3175148|NCT01958606|3902799|FG001|STARTED|Overall Study||5
3175149|NCT01958606|3902798|FG000|COMPLETED|Overall Study||11
3175150|NCT01958606|3902799|FG001|COMPLETED|Overall Study||5
3175151|NCT01958606|3902798|FG000|NOT COMPLETED|Overall Study||2
3175152|NCT01958606|3902799|FG001|NOT COMPLETED|Overall Study||0
3175153|NCT01958619|3902809|FG000|STARTED|Overall Study||15
3175154|NCT01958619|3902810|FG001|STARTED|Overall Study||14
3175155|NCT01958619|3902811|FG002|STARTED|Overall Study||14
3175156|NCT01958619|3902812|FG003|STARTED|Overall Study||12
3175157|NCT01958619|3902809|FG000|COMPLETED|Overall Study||13
3175158|NCT01958619|3902810|FG001|COMPLETED|Overall Study||14
3175159|NCT01958619|3902811|FG002|COMPLETED|Overall Study||13
3175160|NCT01958619|3902812|FG003|COMPLETED|Overall Study||12
3175161|NCT01958619|3902809|FG000|NOT COMPLETED|Overall Study||2
3175162|NCT01958619|3902810|FG001|NOT COMPLETED|Overall Study||0
3175163|NCT01958619|3902811|FG002|NOT COMPLETED|Overall Study||1
3175164|NCT01958619|3902812|FG003|NOT COMPLETED|Overall Study||0
3175165|NCT01958645|3902825|FG000|STARTED|Overall Study||4
3175166|NCT01958645|3902826|FG001|STARTED|Overall Study||4
3175167|NCT01958645|3902827|FG002|STARTED|Overall Study||4
3175168|NCT01958645|3902825|FG000|COMPLETED|Overall Study||4
3175169|NCT01958645|3902826|FG001|COMPLETED|Overall Study||4
3175170|NCT01958645|3902827|FG002|COMPLETED|Overall Study||4
3175171|NCT01958645|3902825|FG000|NOT COMPLETED|Overall Study||0
3175172|NCT01958645|3902826|FG001|NOT COMPLETED|Overall Study||0
3175173|NCT01958645|3902827|FG002|NOT COMPLETED|Overall Study||0
3322656|NCT03189524|4055542|FG002|NOT COMPLETED|Overall Study||23
3322657|NCT03189589|4055556|FG000|STARTED|Overall Study||6
3322658|NCT03189589|4055557|FG001|STARTED|Overall Study||6
3322659|NCT03189589|4055556|FG000|COMPLETED|Overall Study||6
3322660|NCT03189589|4055557|FG001|COMPLETED|Overall Study||6
3322661|NCT03189589|4055556|FG000|NOT COMPLETED|Overall Study||0
3322662|NCT03189589|4055557|FG001|NOT COMPLETED|Overall Study||0
3322663|NCT03189745|4055565|FG000|STARTED|Overall Study||170
3322664|NCT03189745|4055566|FG001|STARTED|Overall Study||59
3322665|NCT03189745|4055565|FG000|COMPLETED|Overall Study||169
3322666|NCT03189745|4055566|FG001|COMPLETED|Overall Study||58
3322667|NCT03189745|4055565|FG000|NOT COMPLETED|Overall Study||1
3322668|NCT03189745|4055566|FG001|NOT COMPLETED|Overall Study||1
3322669|NCT03190005|4055579|FG000|STARTED|Overall Study||5
3322670|NCT03190005|4055580|FG001|STARTED|Overall Study||5
3322671|NCT03190005|4055581|FG002|STARTED|Overall Study||5
3322672|NCT03190005|4055582|FG003|STARTED|Overall Study||5
3322673|NCT03190005|4055583|FG004|STARTED|Overall Study||5
3322674|NCT03190005|4055584|FG005|STARTED|Overall Study||5
3322675|NCT03190005|4055585|FG006|STARTED|Overall Study||5
3322676|NCT03190005|4055579|FG000|COMPLETED|Overall Study||5
3322677|NCT03190005|4055580|FG001|COMPLETED|Overall Study||5
3322678|NCT03190005|4055581|FG002|COMPLETED|Overall Study||5
3322679|NCT03190005|4055582|FG003|COMPLETED|Overall Study||5
3322680|NCT03190005|4055583|FG004|COMPLETED|Overall Study||5
3322681|NCT03190005|4055584|FG005|COMPLETED|Overall Study||5
3322682|NCT03190005|4055585|FG006|COMPLETED|Overall Study||5
3322683|NCT03190005|4055579|FG000|NOT COMPLETED|Overall Study||0
3322684|NCT03190005|4055580|FG001|NOT COMPLETED|Overall Study||0
3322685|NCT03190005|4055581|FG002|NOT COMPLETED|Overall Study||0
3322686|NCT03190005|4055582|FG003|NOT COMPLETED|Overall Study||0
3322687|NCT03190005|4055583|FG004|NOT COMPLETED|Overall Study||0
3322688|NCT03190005|4055584|FG005|NOT COMPLETED|Overall Study||0
3322689|NCT03190005|4055585|FG006|NOT COMPLETED|Overall Study||0
3175174|NCT01958671|3902840|FG000|STARTED|Overall Study||156
3175175|NCT01958671|3902841|FG001|STARTED|Overall Study||152
3175176|NCT01958671|3902842|FG002|STARTED|Overall Study||153
3175177|NCT01958671|3902840|FG000|COMPLETED|Overall Study||137
3175178|NCT01958671|3902841|FG001|COMPLETED|Overall Study||128
3175179|NCT01958671|3902842|FG002|COMPLETED|Overall Study||121
3175180|NCT01958671|3902840|FG000|NOT COMPLETED|Overall Study||19
3175181|NCT01958671|3902841|FG001|NOT COMPLETED|Overall Study||24
3175182|NCT01958671|3902842|FG002|NOT COMPLETED|Overall Study||32
3175183|NCT01958788|3902854|FG000|STARTED|Overall Study||7
3175184|NCT01958788|3902854|FG000|COMPLETED|Overall Study||7
3175185|NCT01958788|3902854|FG000|NOT COMPLETED|Overall Study||0
3175186|NCT01958827|3902858|FG000|STARTED|Overall Study||28
3175187|NCT01958827|3902858|FG000|COMPLETED|Overall Study||18
3322690|NCT03190083|4055601|FG000|STARTED|Overall Study||16
3322691|NCT03190083|4055601|FG000|COMPLETED|Overall Study||16
3322692|NCT03190083|4055601|FG000|NOT COMPLETED|Overall Study||0
3322693|NCT03190213|4055605|FG000|STARTED|Overall Study||6
3322694|NCT03190213|4055605|FG000|COMPLETED|Overall Study||6
3322695|NCT03190213|4055605|FG000|NOT COMPLETED|Overall Study||0
3322696|NCT03190369|4055611|FG000|STARTED|Overall Study||220
3175188|NCT01958827|3902858|FG000|NOT COMPLETED|Overall Study||10
3175189|NCT01958918|3902864|FG000|STARTED|Overall Study||356
3175190|NCT01958918|3902865|FG001|STARTED|Overall Study||356
3175191|NCT01958918|3902864|FG000|Full Analysis Set|Overall Study||353
3175192|NCT01958918|3902865|FG001|Full Analysis Set|Overall Study||354
3175193|NCT01958918|3902864|FG000|COMPLETED|Overall Study||313
3175194|NCT01958918|3902865|FG001|COMPLETED|Overall Study||314
3175195|NCT01958918|3902864|FG000|NOT COMPLETED|Overall Study||43
3322697|NCT03190369|4055612|FG001|STARTED|Overall Study||220
3322698|NCT03190369|4055611|FG000|Treated|Overall Study||220
3175196|NCT01958918|3902865|FG001|NOT COMPLETED|Overall Study||42
3175197|NCT01959035|3902871|FG000|STARTED|Overall Study||88
3175198|NCT01959035|3902871|FG000|COMPLETED|Overall Study||77
3175199|NCT01959035|3902871|FG000|NOT COMPLETED|Overall Study||11
3175200|NCT01959048|3902875|FG000|STARTED|Overall Study||3
3175201|NCT01959048|3902875|FG000|COMPLETED|Overall Study||3
3175202|NCT01959048|3902875|FG000|NOT COMPLETED|Overall Study||0
3175203|NCT01959113|3902879|FG000|STARTED|Overall Study||5
3175204|NCT01959113|3902879|FG000|COMPLETED|Overall Study||5
3175205|NCT01959113|3902879|FG000|NOT COMPLETED|Overall Study||0
3175206|NCT01959165|3902889|FG000|STARTED|Overall Study||13
3175207|NCT01959165|3902890|FG001|STARTED|Overall Study|1 patient discontinued the study without any treatment out of 11 patients.|11
3175208|NCT01959165|3902891|FG002|STARTED|Overall Study||12
3175209|NCT01959165|3902892|FG003|STARTED|Overall Study||9
3175210|NCT01959165|3902889|FG000|COMPLETED|Overall Study||12
3175211|NCT01959165|3902890|FG001|COMPLETED|Overall Study||10
3175212|NCT01959165|3902891|FG002|COMPLETED|Overall Study||12
3175213|NCT01959165|3902892|FG003|COMPLETED|Overall Study||7
3175214|NCT01959165|3902889|FG000|NOT COMPLETED|Overall Study||1
3175215|NCT01959165|3902890|FG001|NOT COMPLETED|Overall Study||1
3175216|NCT01959165|3902891|FG002|NOT COMPLETED|Overall Study||0
3175217|NCT01959165|3902892|FG003|NOT COMPLETED|Overall Study||2
3175218|NCT01959178|3902902|FG000|STARTED|Overall Study||73
3175219|NCT01959178|3902903|FG001|STARTED|Overall Study||73
3175220|NCT01959178|3902902|FG000|COMPLETED|Overall Study||71
3175221|NCT01959178|3902903|FG001|COMPLETED|Overall Study||71
3175222|NCT01959178|3902902|FG000|NOT COMPLETED|Overall Study||2
3175223|NCT01959178|3902903|FG001|NOT COMPLETED|Overall Study||2
3175224|NCT01959230|3902911|FG000|STARTED|Overall Study||40
3175225|NCT01959230|3902912|FG001|STARTED|Overall Study||20
3175226|NCT01959230|3902911|FG000|Received at Least 1 Dose of Study Drug|Overall Study||40
3175227|NCT01959230|3902912|FG001|Received at Least 1 Dose of Study Drug|Overall Study||20
3175228|NCT01959230|3902911|FG000|COMPLETED|Overall Study||36
3175229|NCT01959230|3902912|FG001|COMPLETED|Overall Study||19
3175230|NCT01959230|3902911|FG000|NOT COMPLETED|Overall Study||4
3175231|NCT01959230|3902912|FG001|NOT COMPLETED|Overall Study||1
3175232|NCT01959243|3902920|FG000|STARTED|Overall Study||337
3175233|NCT01959243|3902921|FG001|STARTED|Overall Study||170
3175234|NCT01959243|3902920|FG000|Received at Least 1 Dose of Study Drug|Overall Study||337
3175235|NCT01959243|3902921|FG001|Received at Least 1 Dose of Study Drug|Overall Study||170
3175236|NCT01959243|3902920|FG000|COMPLETED|Overall Study||324
3175237|NCT01959243|3902921|FG001|COMPLETED|Overall Study||166
3175238|NCT01959243|3902920|FG000|NOT COMPLETED|Overall Study||13
3175239|NCT01959243|3902921|FG001|NOT COMPLETED|Overall Study||4
3175240|NCT01959334|3902929|FG000|STARTED|First Dose||26
3175241|NCT01959334|3902930|FG001|STARTED|First Dose||49
3175242|NCT01959334|3902929|FG000|COMPLETED|First Dose|Each Dosing Period separated by at least 7 calendar days.|26
3175243|NCT01959334|3902930|FG001|COMPLETED|First Dose|Each Dosing Period is separated by at least 7 calendar days.|49
3175244|NCT01959334|3902929|FG000|NOT COMPLETED|First Dose||0
3175245|NCT01959334|3902930|FG001|NOT COMPLETED|First Dose||0
3175246|NCT01959334|3902929|FG000|STARTED|Second Dose||26
3175247|NCT01959334|3902930|FG001|STARTED|Second Dose||49
3175248|NCT01959334|3902929|FG000|COMPLETED|Second Dose||25
3175249|NCT01959334|3902930|FG001|COMPLETED|Second Dose||49
3175250|NCT01959334|3902929|FG000|NOT COMPLETED|Second Dose||1
3175251|NCT01959334|3902930|FG001|NOT COMPLETED|Second Dose||0
3175252|NCT01959334|3902929|FG000|STARTED|Third Dose||25
3175253|NCT01959334|3902930|FG001|STARTED|Third Dose||49
3175254|NCT01959334|3902929|FG000|COMPLETED|Third Dose||25
3175255|NCT01959334|3902930|FG001|COMPLETED|Third Dose||48
3175256|NCT01959334|3902929|FG000|NOT COMPLETED|Third Dose||0
3175257|NCT01959334|3902930|FG001|NOT COMPLETED|Third Dose||1
3175258|NCT01959347|3902938|FG000|STARTED|Overall Study||238
3175259|NCT01959347|3902939|FG001|STARTED|Overall Study||242
3175260|NCT01959347|3902938|FG000|COMPLETED|Overall Study||229
3175261|NCT01959347|3902939|FG001|COMPLETED|Overall Study||235
3175262|NCT01959347|3902938|FG000|NOT COMPLETED|Overall Study||9
3175263|NCT01959347|3902939|FG001|NOT COMPLETED|Overall Study||7
3175264|NCT01959412|3902945|FG000|STARTED|Overall Study||15
3175265|NCT01959412|3902946|FG001|STARTED|Overall Study||15
3175266|NCT01959412|3902947|FG002|STARTED|Overall Study||15
3175267|NCT01959412|3902948|FG003|STARTED|Overall Study||15
3175268|NCT01959412|3902949|FG004|STARTED|Overall Study||16
3175269|NCT01959412|3902950|FG005|STARTED|Overall Study||15
3175270|NCT01959412|3902945|FG000|COMPLETED|Overall Study||14
3175271|NCT01959412|3902946|FG001|COMPLETED|Overall Study||14
3175272|NCT01959412|3902947|FG002|COMPLETED|Overall Study||15
3175273|NCT01959412|3902948|FG003|COMPLETED|Overall Study||13
3175274|NCT01959412|3902949|FG004|COMPLETED|Overall Study||13
3175275|NCT01959412|3902950|FG005|COMPLETED|Overall Study||15
3175276|NCT01959412|3902945|FG000|NOT COMPLETED|Overall Study||1
3175277|NCT01959412|3902946|FG001|NOT COMPLETED|Overall Study||1
3175278|NCT01959412|3902947|FG002|NOT COMPLETED|Overall Study||0
3175279|NCT01959412|3902948|FG003|NOT COMPLETED|Overall Study||2
3175280|NCT01959412|3902949|FG004|NOT COMPLETED|Overall Study||3
3175281|NCT01959412|3902950|FG005|NOT COMPLETED|Overall Study||0
3175282|NCT01959425|3902966|FG000|STARTED|Overall Study||32
3175283|NCT01959425|3902967|FG001|STARTED|Overall Study||31
3175284|NCT01959425|3902966|FG000|COMPLETED|Overall Study||20
3175285|NCT01959425|3902967|FG001|COMPLETED|Overall Study||23
3175286|NCT01959425|3902966|FG000|NOT COMPLETED|Overall Study||12
3175287|NCT01959425|3902967|FG001|NOT COMPLETED|Overall Study||8
3175288|NCT01959464|3902975|FG000|STARTED|Overall Study||10
3175289|NCT01959464|3902976|FG001|STARTED|Overall Study||10
3175290|NCT01959464|3902975|FG000|COMPLETED|Overall Study||9
3175291|NCT01959464|3902976|FG001|COMPLETED|Overall Study||10
3175292|NCT01959464|3902975|FG000|NOT COMPLETED|Overall Study||1
3175293|NCT01959464|3902976|FG001|NOT COMPLETED|Overall Study||0
3175294|NCT01959490|3902985|FG000|STARTED|Overall Study||5
3175295|NCT01959490|3902986|FG001|STARTED|Overall Study||6
3175296|NCT01959490|3902987|FG002|STARTED|Overall Study||5
3175297|NCT01959490|3902985|FG000|COMPLETED|Overall Study||5
3175298|NCT01959490|3902986|FG001|COMPLETED|Overall Study||6
3175299|NCT01959490|3902987|FG002|COMPLETED|Overall Study||5
3175300|NCT01959490|3902985|FG000|NOT COMPLETED|Overall Study||0
3175301|NCT01959490|3902986|FG001|NOT COMPLETED|Overall Study||0
3175302|NCT01959490|3902987|FG002|NOT COMPLETED|Overall Study||0
3175303|NCT01959503|3902997|FG000|STARTED|Overall Study||107
3175304|NCT01959503|3902998|FG001|STARTED|Overall Study||51
3175305|NCT01959503|3902997|FG000|COMPLETED|Overall Study||104
3175306|NCT01959503|3902998|FG001|COMPLETED|Overall Study||49
3175307|NCT01959503|3902997|FG000|NOT COMPLETED|Overall Study||3
3175308|NCT01959503|3902998|FG001|NOT COMPLETED|Overall Study||2
3175309|NCT01959516|3903004|FG000|STARTED|Epoch 1||63
3175310|NCT01959516|3903005|FG001|STARTED|Epoch 1||63
3175311|NCT01959516|3903004|FG000|Safety Population|Epoch 1||62
3175312|NCT01959516|3903005|FG001|Safety Population|Epoch 1||62
3175313|NCT01959516|3903004|FG000|ITT Population|Epoch 1||62
3175314|NCT01959516|3903005|FG001|ITT Population|Epoch 1||62
3175315|NCT01959516|3903004|FG000|COMPLETED|Epoch 1||53
3175316|NCT01959516|3903005|FG001|COMPLETED|Epoch 1||58
3175317|NCT01959516|3903004|FG000|NOT COMPLETED|Epoch 1||10
3175318|NCT01959516|3903005|FG001|NOT COMPLETED|Epoch 1||5
3175319|NCT01959516|3903004|FG000|STARTED|Epoch 2||63
3175320|NCT01959516|3903005|FG001|STARTED|Epoch 2||63
3175321|NCT01959516|3903004|FG000|COMPLETED|Epoch 2||61
3175322|NCT01959516|3903005|FG001|COMPLETED|Epoch 2||62
3175323|NCT01959516|3903004|FG000|NOT COMPLETED|Epoch 2||2
3175324|NCT01959516|3903005|FG001|NOT COMPLETED|Epoch 2||1
3175325|NCT01959529|3903013|FG000|STARTED|Overall Study||3818
3175326|NCT01959529|3903014|FG001|STARTED|Overall Study||3819
3175327|NCT01959529|3903013|FG000|Exposed|Overall Study||3809
3175328|NCT01959529|3903014|FG001|Exposed|Overall Study||3806
3175329|NCT01959529|3903013|FG000|COMPLETED|Overall Study||3742
3175330|NCT01959529|3903014|FG001|COMPLETED|Overall Study||3747
3175331|NCT01959529|3903013|FG000|NOT COMPLETED|Overall Study||76
3175332|NCT01959529|3903014|FG001|NOT COMPLETED|Overall Study||72
3175333|NCT01959542|3903020|FG000|STARTED|Overall Study||15
3175334|NCT01959542|3903020|FG000|Evaluable at Visit 1|Overall Study||12
3175335|NCT01959542|3903020|FG000|Evaluable at Visit 2|Overall Study||12
3175336|NCT01959542|3903020|FG000|COMPLETED|Overall Study||12
3175337|NCT01959542|3903020|FG000|NOT COMPLETED|Overall Study||3
3175338|NCT01959581|3903025|FG000|STARTED|Overall Study||30
3175339|NCT01959581|3903025|FG000|COMPLETED|Overall Study||25
3175340|NCT01959581|3903025|FG000|NOT COMPLETED|Overall Study||5
3175341|NCT01959607|3903031|FG000|STARTED|Washout Period of 1 Day (Day 0)||22
3175342|NCT01959607|3903032|FG001|STARTED|Washout Period of 1 Day (Day 0)||22
3175343|NCT01959607|3903033|FG002|STARTED|Washout Period of 1 Day (Day 0)||9
3175344|NCT01959607|3903034|FG003|STARTED|Washout Period of 1 Day (Day 0)||9
3175345|NCT01959607|3903031|FG000|COMPLETED|Washout Period of 1 Day (Day 0)||22
3175346|NCT01959607|3903032|FG001|COMPLETED|Washout Period of 1 Day (Day 0)||22
3175347|NCT01959607|3903033|FG002|COMPLETED|Washout Period of 1 Day (Day 0)||9
3175348|NCT01959607|3903034|FG003|COMPLETED|Washout Period of 1 Day (Day 0)||9
3175349|NCT01959607|3903031|FG000|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
3175350|NCT01959607|3903032|FG001|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
3175351|NCT01959607|3903033|FG002|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
3175352|NCT01959607|3903034|FG003|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
3175353|NCT01959607|3903031|FG000|STARTED|First Intervention (Day 1)||22
3175354|NCT01959607|3903032|FG001|STARTED|First Intervention (Day 1)||22
3175355|NCT01959607|3903033|FG002|STARTED|First Intervention (Day 1)||9
3175356|NCT01959607|3903034|FG003|STARTED|First Intervention (Day 1)||9
3175357|NCT01959607|3903031|FG000|COMPLETED|First Intervention (Day 1)||21
3175358|NCT01959607|3903032|FG001|COMPLETED|First Intervention (Day 1)||21
3175359|NCT01959607|3903033|FG002|COMPLETED|First Intervention (Day 1)||9
3175360|NCT01959607|3903034|FG003|COMPLETED|First Intervention (Day 1)||9
3175361|NCT01959607|3903031|FG000|NOT COMPLETED|First Intervention (Day 1)||1
3175362|NCT01959607|3903032|FG001|NOT COMPLETED|First Intervention (Day 1)||1
3175363|NCT01959607|3903033|FG002|NOT COMPLETED|First Intervention (Day 1)||0
3175364|NCT01959607|3903034|FG003|NOT COMPLETED|First Intervention (Day 1)||0
3175365|NCT01959607|3903031|FG000|STARTED|Washout Period of 1 Day (Day 2)||21
3175366|NCT01959607|3903032|FG001|STARTED|Washout Period of 1 Day (Day 2)||21
3175367|NCT01959607|3903033|FG002|STARTED|Washout Period of 1 Day (Day 2)||9
3175368|NCT01959607|3903034|FG003|STARTED|Washout Period of 1 Day (Day 2)||9
3175369|NCT01959607|3903031|FG000|COMPLETED|Washout Period of 1 Day (Day 2)||21
3175370|NCT01959607|3903032|FG001|COMPLETED|Washout Period of 1 Day (Day 2)||21
3175371|NCT01959607|3903033|FG002|COMPLETED|Washout Period of 1 Day (Day 2)||9
3175372|NCT01959607|3903034|FG003|COMPLETED|Washout Period of 1 Day (Day 2)||9
3175373|NCT01959607|3903031|FG000|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
3175374|NCT01959607|3903032|FG001|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
3175375|NCT01959607|3903033|FG002|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
3175376|NCT01959607|3903034|FG003|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
3175377|NCT01959607|3903031|FG000|STARTED|Second Intervention (Day 3)||21
3175378|NCT01959607|3903032|FG001|STARTED|Second Intervention (Day 3)||21
3175379|NCT01959607|3903033|FG002|STARTED|Second Intervention (Day 3)||9
3175380|NCT01959607|3903034|FG003|STARTED|Second Intervention (Day 3)||9
2926317|NCT00569803|3637725|FG000|STARTED|Overall Study||5
2926318|NCT00569803|3637726|FG001|STARTED|Overall Study||5
2926319|NCT00569803|3637727|FG002|STARTED|Overall Study||5
2926320|NCT00569803|3637728|FG003|STARTED|Overall Study||6
2926321|NCT00569803|3637729|FG004|STARTED|Overall Study||5
3175381|NCT01959607|3903031|FG000|COMPLETED|Second Intervention (Day 3)||21
3175382|NCT01959607|3903032|FG001|COMPLETED|Second Intervention (Day 3)||21
3175383|NCT01959607|3903033|FG002|COMPLETED|Second Intervention (Day 3)||9
3175384|NCT01959607|3903034|FG003|COMPLETED|Second Intervention (Day 3)||9
3175385|NCT01959607|3903031|FG000|NOT COMPLETED|Second Intervention (Day 3)||0
3175386|NCT01959607|3903032|FG001|NOT COMPLETED|Second Intervention (Day 3)||0
3175387|NCT01959607|3903033|FG002|NOT COMPLETED|Second Intervention (Day 3)||0
3175388|NCT01959607|3903034|FG003|NOT COMPLETED|Second Intervention (Day 3)||0
3175389|NCT01959672|3903043|FG000|STARTED|Overall Study||11
3175390|NCT01959672|3903043|FG000|COMPLETED|Overall Study||10
3175391|NCT01959672|3903043|FG000|NOT COMPLETED|Overall Study||1
3175392|NCT01959685|3903050|FG000|STARTED|Overall Study||9
3175393|NCT01959685|3903050|FG000|COMPLETED|Overall Study||9
3175394|NCT01959685|3903050|FG000|NOT COMPLETED|Overall Study||0
3175395|NCT01959698|3903061|FG000|STARTED|Overall Study||3
3175396|NCT01959698|3903062|FG001|STARTED|Overall Study||3
3175397|NCT01959698|3903063|FG002|STARTED|Overall Study||3
3175398|NCT01959698|3903064|FG003|STARTED|Overall Study||3
3175399|NCT01959698|3903065|FG004|STARTED|Overall Study||3
3175400|NCT01959698|3903066|FG005|STARTED|Overall Study||6
3175401|NCT01959698|3903067|FG006|STARTED|Overall Study||8
3175402|NCT01959698|3903061|FG000|COMPLETED|Overall Study||2
3175403|NCT01959698|3903062|FG001|COMPLETED|Overall Study||3
3175404|NCT01959698|3903063|FG002|COMPLETED|Overall Study||2
3175405|NCT01959698|3903064|FG003|COMPLETED|Overall Study||1
3175406|NCT01959698|3903065|FG004|COMPLETED|Overall Study||3
3175407|NCT01959698|3903066|FG005|COMPLETED|Overall Study||3
3175408|NCT01959698|3903067|FG006|COMPLETED|Overall Study||4
3175409|NCT01959698|3903061|FG000|NOT COMPLETED|Overall Study||1
3175410|NCT01959698|3903062|FG001|NOT COMPLETED|Overall Study||0
3175411|NCT01959698|3903063|FG002|NOT COMPLETED|Overall Study||1
3175412|NCT01959698|3903064|FG003|NOT COMPLETED|Overall Study||2
3175413|NCT01959698|3903065|FG004|NOT COMPLETED|Overall Study||0
3175414|NCT01959698|3903066|FG005|NOT COMPLETED|Overall Study||3
3175415|NCT01959698|3903067|FG006|NOT COMPLETED|Overall Study||4
3175416|NCT01959841|3903087|FG000|STARTED|Overall Study||252
3175417|NCT01959841|3903088|FG001|STARTED|Overall Study||250
3175418|NCT01959841|3903089|FG002|STARTED|Overall Study||249
3175419|NCT01959841|3903087|FG000|Full Analysis Set Included|Overall Study||247
3175420|NCT01959841|3903088|FG001|Full Analysis Set Included|Overall Study||243
3175421|NCT01959841|3903089|FG002|Full Analysis Set Included|Overall Study||245
3175422|NCT01959841|3903087|FG000|Full Analysis Set Excluded|Overall Study||5
3175423|NCT01959841|3903088|FG001|Full Analysis Set Excluded|Overall Study||7
3175424|NCT01959841|3903089|FG002|Full Analysis Set Excluded|Overall Study||4
3175425|NCT01959841|3903087|FG000|Reason FAS Excluding 1|Overall Study||5
3175426|NCT01959841|3903088|FG001|Reason FAS Excluding 1|Overall Study||5
3175427|NCT01959841|3903089|FG002|Reason FAS Excluding 1|Overall Study||4
3175428|NCT01959841|3903087|FG000|Reason FAS Excluding 2|Overall Study||0
3175429|NCT01959841|3903088|FG001|Reason FAS Excluding 2|Overall Study||1
3175430|NCT01959841|3903089|FG002|Reason FAS Excluding 2|Overall Study||0
3175431|NCT01959841|3903087|FG000|Reason FAS Excluding 3|Overall Study||0
3175432|NCT01959841|3903088|FG001|Reason FAS Excluding 3|Overall Study||1
3175433|NCT01959841|3903089|FG002|Reason FAS Excluding 3|Overall Study||0
3175434|NCT01959841|3903087|FG000|COMPLETED|Overall Study||209
3175435|NCT01959841|3903088|FG001|COMPLETED|Overall Study||193
3175436|NCT01959841|3903089|FG002|COMPLETED|Overall Study||206
3175437|NCT01959841|3903087|FG000|NOT COMPLETED|Overall Study||43
3175438|NCT01959841|3903088|FG001|NOT COMPLETED|Overall Study||57
3175439|NCT01959841|3903089|FG002|NOT COMPLETED|Overall Study||43
3175440|NCT01959880|3903101|FG000|STARTED|Overall Study||1132
3175441|NCT01959880|3903102|FG001|STARTED|Overall Study||369
3175442|NCT01959880|3903103|FG002|STARTED|Overall Study||209
3175443|NCT01959880|3903104|FG003|STARTED|Overall Study||181
3175444|NCT01959880|3903101|FG000|COMPLETED|Overall Study|FDA granted approval for devices leading to early study completion. One subject reached 10 years.|0
3175445|NCT01959880|3903102|FG001|COMPLETED|Overall Study|FDA granted approval for devices leading to early study completion. One subject reached 10 years.|0
3175446|NCT01959880|3903103|FG002|COMPLETED|Overall Study|FDA granted approval for devices leading to early study completion. One subject reached 10 years.|1
3175447|NCT01959880|3903104|FG003|COMPLETED|Overall Study|FDA granted approval for devices leading to early study completion. One subject reached 10 years.|0
3175448|NCT01959880|3903101|FG000|NOT COMPLETED|Overall Study||1132
3175449|NCT01959880|3903102|FG001|NOT COMPLETED|Overall Study||369
3175450|NCT01959880|3903103|FG002|NOT COMPLETED|Overall Study||208
3175451|NCT01959880|3903104|FG003|NOT COMPLETED|Overall Study||181
3175452|NCT01959919|3903114|FG000|STARTED|Overall Study||86
3175453|NCT01959919|3903114|FG000|COMPLETED|Overall Study||84
3175454|NCT01959919|3903114|FG000|NOT COMPLETED|Overall Study||2
3175455|NCT01959932|3903121|FG000|STARTED|Overall Study||80
3175456|NCT01959932|3903122|FG001|STARTED|Overall Study||41
3175457|NCT01959932|3903123|FG002|STARTED|Overall Study||39
3175458|NCT01959932|3903121|FG000|COMPLETED|Overall Study||79
3175459|NCT01959932|3903122|FG001|COMPLETED|Overall Study||41
3175460|NCT01959932|3903123|FG002|COMPLETED|Overall Study||39
3175461|NCT01959932|3903121|FG000|NOT COMPLETED|Overall Study||1
3322699|NCT03190369|4055612|FG001|Treated|Overall Study||218
3322700|NCT03190369|4055611|FG000|COMPLETED|Overall Study||219
3322701|NCT03190369|4055612|FG001|COMPLETED|Overall Study||212
3322702|NCT03190369|4055611|FG000|NOT COMPLETED|Overall Study||1
3322703|NCT03190369|4055612|FG001|NOT COMPLETED|Overall Study||8
3322704|NCT03190460|4055620|FG000|STARTED|Overall Study||40
3322705|NCT03190460|4055621|FG001|STARTED|Overall Study||20
3322706|NCT03190460|4055620|FG000|COMPLETED|Overall Study||3
3322707|NCT03190460|4055621|FG001|COMPLETED|Overall Study||2
3322708|NCT03190460|4055620|FG000|NOT COMPLETED|Overall Study||37
3322709|NCT03190460|4055621|FG001|NOT COMPLETED|Overall Study||18
3322710|NCT03190993|4055629|FG000|STARTED|Overall Study||10
3322711|NCT03190993|4055630|FG001|STARTED|Overall Study||10
3322712|NCT03190993|4055629|FG000|COMPLETED|Overall Study||10
3322713|NCT03190993|4055630|FG001|COMPLETED|Overall Study||10
3322714|NCT03190993|4055629|FG000|NOT COMPLETED|Overall Study||0
3322715|NCT03190993|4055630|FG001|NOT COMPLETED|Overall Study||0
3322716|NCT03191396|4055638|FG000|STARTED|Overall Study||290
3322717|NCT03191396|4055639|FG001|STARTED|Overall Study||287
3322718|NCT03191396|4055638|FG000|COMPLETED|Overall Study||287
3322719|NCT03191396|4055639|FG001|COMPLETED|Overall Study||282
3322720|NCT03191396|4055638|FG000|NOT COMPLETED|Overall Study||3
3322721|NCT03191396|4055639|FG001|NOT COMPLETED|Overall Study||5
3322722|NCT03191552|4055648|FG000|STARTED|Overall Study||9
3322723|NCT03191552|4055649|FG001|STARTED|Overall Study||9
3322724|NCT03191552|4055650|FG002|STARTED|Overall Study||8
3322725|NCT03191552|4055648|FG000|COMPLETED|Overall Study||8
3322726|NCT03191552|4055649|FG001|COMPLETED|Overall Study||8
3322727|NCT03191552|4055650|FG002|COMPLETED|Overall Study||8
3322728|NCT03191552|4055648|FG000|NOT COMPLETED|Overall Study||1
3322729|NCT03191552|4055649|FG001|NOT COMPLETED|Overall Study||1
3322730|NCT03191552|4055650|FG002|NOT COMPLETED|Overall Study||0
3322731|NCT03191630|4055664|FG000|STARTED|Overall Study||30
3322732|NCT03191630|4055665|FG001|STARTED|Overall Study||30
3322733|NCT03191630|4055664|FG000|COMPLETED|Overall Study||23
3322734|NCT03191630|4055665|FG001|COMPLETED|Overall Study||23
3322735|NCT03191630|4055664|FG000|NOT COMPLETED|Overall Study||7
3322736|NCT03191630|4055665|FG001|NOT COMPLETED|Overall Study||7
3322737|NCT03191799|4055673|FG000|STARTED|Overall Study||195
3322738|NCT03191799|4055673|FG000|Received at Least One Dose of Emicizumab|Overall Study||193
3322739|NCT03191799|4055673|FG000|Dose Up-Titrated to 3 mg/kg QW|Overall Study||2
3322740|NCT03191799|4055673|FG000|COMPLETED|Overall Study||186
3322741|NCT03191799|4055673|FG000|NOT COMPLETED|Overall Study||9
3175462|NCT01959932|3903122|FG001|NOT COMPLETED|Overall Study||0
3175463|NCT01959932|3903123|FG002|NOT COMPLETED|Overall Study||0
3175464|NCT01959945|3903136|FG000|STARTED|Overall Study||80
3322742|NCT03192137|4055679|FG000|STARTED|Overall Study||173
3322743|NCT03192137|4055680|FG001|STARTED|Overall Study||87
3322744|NCT03192137|4055679|FG000|COMPLETED|Overall Study||123
3322745|NCT03192137|4055680|FG001|COMPLETED|Overall Study||29
3322746|NCT03192137|4055679|FG000|NOT COMPLETED|Overall Study||50
3322747|NCT03192137|4055680|FG001|NOT COMPLETED|Overall Study||58
3322748|NCT03192150|4055688|FG000|STARTED|Overall Study||163
3322749|NCT03192150|4055689|FG001|STARTED|Overall Study||83
3322750|NCT03192150|4055688|FG000|COMPLETED|Overall Study||108
3322751|NCT03192150|4055689|FG001|COMPLETED|Overall Study||29
3322752|NCT03192150|4055688|FG000|NOT COMPLETED|Overall Study||55
3322753|NCT03192150|4055689|FG001|NOT COMPLETED|Overall Study||54
3322754|NCT03192176|4055703|FG000|STARTED|Overall Study||44
3322755|NCT03192176|4055704|FG001|STARTED|Overall Study||45
3322756|NCT03192176|4055705|FG002|STARTED|Overall Study||44
3322757|NCT03192176|4055706|FG003|STARTED|Overall Study||45
3322758|NCT03192176|4055707|FG004|STARTED|Overall Study||44
3322759|NCT03192176|4055708|FG005|STARTED|Overall Study||45
3322760|NCT03192176|4055709|FG006|STARTED|Overall Study||45
3322761|NCT03192176|4055710|FG007|STARTED|Overall Study||44
3322762|NCT03192176|4055703|FG000|Treated|Overall Study||43
3322763|NCT03192176|4055704|FG001|Treated|Overall Study||45
3322764|NCT03192176|4055705|FG002|Treated|Overall Study||43
3322765|NCT03192176|4055706|FG003|Treated|Overall Study||45
3322766|NCT03192176|4055707|FG004|Treated|Overall Study||44
3322767|NCT03192176|4055708|FG005|Treated|Overall Study||43
3322768|NCT03192176|4055709|FG006|Treated|Overall Study||45
3322769|NCT03192176|4055710|FG007|Treated|Overall Study||44
3322770|NCT03192176|4055703|FG000|COMPLETED|Overall Study||37
3322771|NCT03192176|4055704|FG001|COMPLETED|Overall Study||40
3322772|NCT03192176|4055705|FG002|COMPLETED|Overall Study||38
3322773|NCT03192176|4055706|FG003|COMPLETED|Overall Study||33
3322774|NCT03192176|4055707|FG004|COMPLETED|Overall Study||32
3322775|NCT03192176|4055708|FG005|COMPLETED|Overall Study||34
3322776|NCT03192176|4055709|FG006|COMPLETED|Overall Study||36
3322777|NCT03192176|4055710|FG007|COMPLETED|Overall Study||37
3322778|NCT03192176|4055703|FG000|NOT COMPLETED|Overall Study||7
3322779|NCT03192176|4055704|FG001|NOT COMPLETED|Overall Study||5
3322780|NCT03192176|4055705|FG002|NOT COMPLETED|Overall Study||6
3322781|NCT03192176|4055706|FG003|NOT COMPLETED|Overall Study||12
3322782|NCT03192176|4055707|FG004|NOT COMPLETED|Overall Study||12
3322783|NCT03192176|4055708|FG005|NOT COMPLETED|Overall Study||11
3322784|NCT03192176|4055709|FG006|NOT COMPLETED|Overall Study||9
3322785|NCT03192176|4055710|FG007|NOT COMPLETED|Overall Study||7
3322786|NCT03192306|4055731|FG000|STARTED|Overall Study||227
3322787|NCT03192306|4055732|FG001|STARTED|Overall Study||224
3322788|NCT03192306|4055731|FG000|Modified Intent to Treat (MITT)|Overall Study||76
3322789|NCT03192306|4055732|FG001|Modified Intent to Treat (MITT)|Overall Study||80
3322790|NCT03192306|4055731|FG000|COMPLETED|Overall Study||75
3322791|NCT03192306|4055732|FG001|COMPLETED|Overall Study||79
3322792|NCT03192306|4055731|FG000|NOT COMPLETED|Overall Study||152
3322793|NCT03192306|4055732|FG001|NOT COMPLETED|Overall Study||145
3322794|NCT03192475|4055740|FG000|STARTED|Overall Study||162
3322795|NCT03192475|4055741|FG001|STARTED|Overall Study||160
3322796|NCT03192475|4055740|FG000|COMPLETED|Overall Study||149
3322797|NCT03192475|4055741|FG001|COMPLETED|Overall Study||151
3322798|NCT03192475|4055740|FG000|NOT COMPLETED|Overall Study||13
3322799|NCT03192475|4055741|FG001|NOT COMPLETED|Overall Study||9
3322800|NCT03192488|4055748|FG000|STARTED|First Intervention (d1)||1
3322801|NCT03192488|4055749|FG001|STARTED|First Intervention (d1)||5
3322802|NCT03192488|4055750|FG002|STARTED|First Intervention (d1)||2
3322803|NCT03192488|4055751|FG003|STARTED|First Intervention (d1)||1
3322804|NCT03192488|4055752|FG004|STARTED|First Intervention (d1)||1
3322805|NCT03192488|4055753|FG005|STARTED|First Intervention (d1)||1
3322806|NCT03192488|4055748|FG000|COMPLETED|First Intervention (d1)||1
3322807|NCT03192488|4055749|FG001|COMPLETED|First Intervention (d1)||5
3322808|NCT03192488|4055750|FG002|COMPLETED|First Intervention (d1)||2
3322809|NCT03192488|4055751|FG003|COMPLETED|First Intervention (d1)||1
3322810|NCT03192488|4055752|FG004|COMPLETED|First Intervention (d1)||1
3322811|NCT03192488|4055753|FG005|COMPLETED|First Intervention (d1)||1
3322812|NCT03192488|4055748|FG000|NOT COMPLETED|First Intervention (d1)||0
3322813|NCT03192488|4055749|FG001|NOT COMPLETED|First Intervention (d1)||0
3322814|NCT03192488|4055750|FG002|NOT COMPLETED|First Intervention (d1)||0
3175465|NCT01959945|3903137|FG001|STARTED|Overall Study||78
3322815|NCT03192488|4055751|FG003|NOT COMPLETED|First Intervention (d1)||0
3322816|NCT03192488|4055752|FG004|NOT COMPLETED|First Intervention (d1)||0
3322817|NCT03192488|4055753|FG005|NOT COMPLETED|First Intervention (d1)||0
3322818|NCT03192488|4055748|FG000|STARTED|First Washout (>6d)||1
3322819|NCT03192488|4055749|FG001|STARTED|First Washout (>6d)||5
3322820|NCT03192488|4055750|FG002|STARTED|First Washout (>6d)||2
3322821|NCT03192488|4055751|FG003|STARTED|First Washout (>6d)||1
3322822|NCT03192488|4055752|FG004|STARTED|First Washout (>6d)||1
3322823|NCT03192488|4055753|FG005|STARTED|First Washout (>6d)||1
3322824|NCT03192488|4055748|FG000|COMPLETED|First Washout (>6d)||1
3322825|NCT03192488|4055749|FG001|COMPLETED|First Washout (>6d)||5
3322826|NCT03192488|4055750|FG002|COMPLETED|First Washout (>6d)||1
3322827|NCT03192488|4055751|FG003|COMPLETED|First Washout (>6d)||1
3322828|NCT03192488|4055752|FG004|COMPLETED|First Washout (>6d)||1
3322829|NCT03192488|4055753|FG005|COMPLETED|First Washout (>6d)||0
3322830|NCT03192488|4055748|FG000|NOT COMPLETED|First Washout (>6d)||0
3322831|NCT03192488|4055749|FG001|NOT COMPLETED|First Washout (>6d)||0
3322832|NCT03192488|4055750|FG002|NOT COMPLETED|First Washout (>6d)||1
3322833|NCT03192488|4055751|FG003|NOT COMPLETED|First Washout (>6d)||0
3322834|NCT03192488|4055752|FG004|NOT COMPLETED|First Washout (>6d)||0
3322835|NCT03192488|4055753|FG005|NOT COMPLETED|First Washout (>6d)||1
3322836|NCT03192488|4055748|FG000|STARTED|Second Intervention (d1)||1
3322837|NCT03192488|4055749|FG001|STARTED|Second Intervention (d1)||5
3322838|NCT03192488|4055750|FG002|STARTED|Second Intervention (d1)||1
3322839|NCT03192488|4055751|FG003|STARTED|Second Intervention (d1)||1
3322840|NCT03192488|4055752|FG004|STARTED|Second Intervention (d1)||1
3322841|NCT03192488|4055753|FG005|STARTED|Second Intervention (d1)||0
3322842|NCT03192488|4055748|FG000|COMPLETED|Second Intervention (d1)||1
3322843|NCT03192488|4055749|FG001|COMPLETED|Second Intervention (d1)||5
3322844|NCT03192488|4055750|FG002|COMPLETED|Second Intervention (d1)||1
3322845|NCT03192488|4055751|FG003|COMPLETED|Second Intervention (d1)||1
3322846|NCT03192488|4055752|FG004|COMPLETED|Second Intervention (d1)||1
3322847|NCT03192488|4055753|FG005|COMPLETED|Second Intervention (d1)||0
3322848|NCT03192488|4055748|FG000|NOT COMPLETED|Second Intervention (d1)||0
3322849|NCT03192488|4055749|FG001|NOT COMPLETED|Second Intervention (d1)||0
3322850|NCT03192488|4055750|FG002|NOT COMPLETED|Second Intervention (d1)||0
3322851|NCT03192488|4055751|FG003|NOT COMPLETED|Second Intervention (d1)||0
3322852|NCT03192488|4055752|FG004|NOT COMPLETED|Second Intervention (d1)||0
3322853|NCT03192488|4055753|FG005|NOT COMPLETED|Second Intervention (d1)||0
3322854|NCT03192488|4055748|FG000|STARTED|Second Washout (>6d)||1
3322855|NCT03192488|4055749|FG001|STARTED|Second Washout (>6d)||5
3322856|NCT03192488|4055750|FG002|STARTED|Second Washout (>6d)||1
3322857|NCT03192488|4055751|FG003|STARTED|Second Washout (>6d)||1
3322858|NCT03192488|4055752|FG004|STARTED|Second Washout (>6d)||1
3322859|NCT03192488|4055753|FG005|STARTED|Second Washout (>6d)||0
3322860|NCT03192488|4055748|FG000|COMPLETED|Second Washout (>6d)||1
3322861|NCT03192488|4055749|FG001|COMPLETED|Second Washout (>6d)||5
3322862|NCT03192488|4055750|FG002|COMPLETED|Second Washout (>6d)||1
3322863|NCT03192488|4055751|FG003|COMPLETED|Second Washout (>6d)||1
3322864|NCT03192488|4055752|FG004|COMPLETED|Second Washout (>6d)||1
3322865|NCT03192488|4055753|FG005|COMPLETED|Second Washout (>6d)||0
3322866|NCT03192488|4055748|FG000|NOT COMPLETED|Second Washout (>6d)||0
3322867|NCT03192488|4055749|FG001|NOT COMPLETED|Second Washout (>6d)||0
3322868|NCT03192488|4055750|FG002|NOT COMPLETED|Second Washout (>6d)||0
3322869|NCT03192488|4055751|FG003|NOT COMPLETED|Second Washout (>6d)||0
3322870|NCT03192488|4055752|FG004|NOT COMPLETED|Second Washout (>6d)||0
3322871|NCT03192488|4055753|FG005|NOT COMPLETED|Second Washout (>6d)||0
3322872|NCT03192488|4055748|FG000|STARTED|Third Intervention (d1)||1
3322873|NCT03192488|4055749|FG001|STARTED|Third Intervention (d1)||5
3322874|NCT03192488|4055750|FG002|STARTED|Third Intervention (d1)||1
3322875|NCT03192488|4055751|FG003|STARTED|Third Intervention (d1)||1
3322876|NCT03192488|4055752|FG004|STARTED|Third Intervention (d1)||1
3322877|NCT03192488|4055753|FG005|STARTED|Third Intervention (d1)||0
3322878|NCT03192488|4055748|FG000|COMPLETED|Third Intervention (d1)||1
3322879|NCT03192488|4055749|FG001|COMPLETED|Third Intervention (d1)||5
3322880|NCT03192488|4055750|FG002|COMPLETED|Third Intervention (d1)||1
3322881|NCT03192488|4055751|FG003|COMPLETED|Third Intervention (d1)||1
3322882|NCT03192488|4055752|FG004|COMPLETED|Third Intervention (d1)||0
3322883|NCT03192488|4055753|FG005|COMPLETED|Third Intervention (d1)||0
3322884|NCT03192488|4055748|FG000|NOT COMPLETED|Third Intervention (d1)||0
3322885|NCT03192488|4055749|FG001|NOT COMPLETED|Third Intervention (d1)||0
3322886|NCT03192488|4055750|FG002|NOT COMPLETED|Third Intervention (d1)||0
3322887|NCT03192488|4055751|FG003|NOT COMPLETED|Third Intervention (d1)||0
3322888|NCT03192488|4055752|FG004|NOT COMPLETED|Third Intervention (d1)||1
3322889|NCT03192488|4055753|FG005|NOT COMPLETED|Third Intervention (d1)||0
3322890|NCT03192826|4055770|FG000|STARTED|Overall Study||27
3322891|NCT03192826|4055771|FG001|STARTED|Overall Study||27
3322892|NCT03192826|4055772|FG002|STARTED|Overall Study||25
3322893|NCT03192826|4055770|FG000|COMPLETED|Overall Study||27
3322894|NCT03192826|4055771|FG001|COMPLETED|Overall Study||27
3322895|NCT03192826|4055772|FG002|COMPLETED|Overall Study||25
3322896|NCT03192826|4055770|FG000|NOT COMPLETED|Overall Study||0
3322897|NCT03192826|4055771|FG001|NOT COMPLETED|Overall Study||0
3322898|NCT03192826|4055772|FG002|NOT COMPLETED|Overall Study||0
3322899|NCT03192904|4055782|FG000|STARTED|Overall Study||35
3322900|NCT03192904|4055783|FG001|STARTED|Overall Study||35
3322901|NCT03192904|4055782|FG000|COMPLETED|Overall Study||32
3322902|NCT03192904|4055783|FG001|COMPLETED|Overall Study||33
3322903|NCT03192904|4055782|FG000|NOT COMPLETED|Overall Study||3
3322904|NCT03192904|4055783|FG001|NOT COMPLETED|Overall Study||2
3322905|NCT03193021|4055791|FG000|STARTED|Overall Study||100
3322906|NCT03193021|4055792|FG001|STARTED|Overall Study||104
3322907|NCT03193021|4055791|FG000|COMPLETED|Overall Study||99
3322908|NCT03193021|4055792|FG001|COMPLETED|Overall Study||103
3322909|NCT03193021|4055791|FG000|NOT COMPLETED|Overall Study||1
3322910|NCT03193021|4055792|FG001|NOT COMPLETED|Overall Study||1
3322911|NCT03193047|4055800|FG000|STARTED|Overall Study||31
3322912|NCT03193047|4055801|FG001|STARTED|Overall Study||28
3322913|NCT03193047|4055800|FG000|COMPLETED|Overall Study||29
3322914|NCT03193047|4055801|FG001|COMPLETED|Overall Study||28
3322915|NCT03193047|4055800|FG000|NOT COMPLETED|Overall Study||2
3322916|NCT03193047|4055801|FG001|NOT COMPLETED|Overall Study||0
3322917|NCT03193398|4055811|FG000|STARTED|Overall Study||53
3322918|NCT03193398|4055812|FG001|STARTED|Overall Study||51
3322919|NCT03193398|4055811|FG000|COMPLETED|Overall Study||38
3322920|NCT03193398|4055812|FG001|COMPLETED|Overall Study||35
3322921|NCT03193398|4055811|FG000|NOT COMPLETED|Overall Study||15
3322922|NCT03193398|4055812|FG001|NOT COMPLETED|Overall Study||16
3322923|NCT03193593|4055825|FG000|STARTED|Overall Study||18
3322924|NCT03193593|4055826|FG001|STARTED|Overall Study||4
3322925|NCT03193593|4055827|FG002|STARTED|Overall Study||4
3322926|NCT03193593|4055828|FG003|STARTED|Overall Study||4
3322927|NCT03193593|4055829|FG004|STARTED|Overall Study||8
3322928|NCT03193593|4055830|FG005|STARTED|Overall Study||16
3322929|NCT03193593|4055831|FG006|STARTED|Overall Study||12
3322930|NCT03193593|4055825|FG000|COMPLETED|Overall Study||14
3322931|NCT03193593|4055826|FG001|COMPLETED|Overall Study||3
3322932|NCT03193593|4055827|FG002|COMPLETED|Overall Study||3
3322933|NCT03193593|4055828|FG003|COMPLETED|Overall Study||4
3322934|NCT03193593|4055829|FG004|COMPLETED|Overall Study||7
3322935|NCT03193593|4055830|FG005|COMPLETED|Overall Study||13
3322936|NCT03193593|4055831|FG006|COMPLETED|Overall Study||8
3322937|NCT03193593|4055825|FG000|NOT COMPLETED|Overall Study||4
3322938|NCT03193593|4055826|FG001|NOT COMPLETED|Overall Study||1
3322939|NCT03193593|4055827|FG002|NOT COMPLETED|Overall Study||1
3322940|NCT03193593|4055828|FG003|NOT COMPLETED|Overall Study||0
3322941|NCT03193593|4055829|FG004|NOT COMPLETED|Overall Study||1
3322942|NCT03193593|4055830|FG005|NOT COMPLETED|Overall Study||3
3322943|NCT03193593|4055831|FG006|NOT COMPLETED|Overall Study||4
3322944|NCT03193736|4055847|FG000|STARTED|Overall Study||26
3322945|NCT03193736|4055847|FG000|Received Implant|Overall Study||25
3322946|NCT03193736|4055847|FG000|COMPLETED|Overall Study||21
3322947|NCT03193736|4055847|FG000|NOT COMPLETED|Overall Study||5
3322948|NCT03194217|4055855|FG000|STARTED|Overall Study||60
3322949|NCT03194217|4055856|FG001|STARTED|Overall Study||60
3322950|NCT03194217|4055857|FG002|STARTED|Overall Study||60
3322951|NCT03194217|4055858|FG003|STARTED|Overall Study||64
3322952|NCT03194217|4055855|FG000|COMPLETED|Overall Study||60
3322953|NCT03194217|4055856|FG001|COMPLETED|Overall Study||57
3322954|NCT03194217|4055857|FG002|COMPLETED|Overall Study||56
3322955|NCT03194217|4055858|FG003|COMPLETED|Overall Study||60
3322956|NCT03194217|4055855|FG000|NOT COMPLETED|Overall Study||0
3322957|NCT03194217|4055856|FG001|NOT COMPLETED|Overall Study||3
3322958|NCT03194217|4055857|FG002|NOT COMPLETED|Overall Study||4
3322959|NCT03194217|4055858|FG003|NOT COMPLETED|Overall Study||4
3322960|NCT03194334|4055871|FG000|STARTED|0-3 Months||10
3322961|NCT03194334|4055872|FG001|STARTED|0-3 Months||15
3322962|NCT03194334|4055873|FG002|STARTED|0-3 Months||15
3322963|NCT03194334|4055871|FG000|COMPLETED|0-3 Months||10
3322964|NCT03194334|4055872|FG001|COMPLETED|0-3 Months||15
3175466|NCT01959945|3903138|FG002|STARTED|Overall Study||28
3175467|NCT01959945|3903139|FG003|STARTED|Overall Study||31
3175468|NCT01959945|3903136|FG000|COMPLETED|Overall Study||76
3175469|NCT01959945|3903137|FG001|COMPLETED|Overall Study||75
3175470|NCT01959945|3903138|FG002|COMPLETED|Overall Study||9
3175471|NCT01959945|3903139|FG003|COMPLETED|Overall Study||15
3175472|NCT01959945|3903136|FG000|NOT COMPLETED|Overall Study||4
3322965|NCT03194334|4055873|FG002|COMPLETED|0-3 Months||14
3322966|NCT03194334|4055871|FG000|NOT COMPLETED|0-3 Months||0
3322967|NCT03194334|4055872|FG001|NOT COMPLETED|0-3 Months||0
3322968|NCT03194334|4055873|FG002|NOT COMPLETED|0-3 Months||1
3322969|NCT03194334|4055871|FG000|STARTED|3-6 Months||10
3175473|NCT01959945|3903137|FG001|NOT COMPLETED|Overall Study||3
3175474|NCT01959945|3903138|FG002|NOT COMPLETED|Overall Study||19
3175475|NCT01959945|3903139|FG003|NOT COMPLETED|Overall Study||16
3175476|NCT01960075|3903154|FG000|STARTED|Overall Study||149
3175477|NCT01960075|3903155|FG001|STARTED|Overall Study||149
3175478|NCT01960075|3903156|FG002|STARTED|Overall Study||180
3175479|NCT01960075|3903154|FG000|COMPLETED|Overall Study||141
3322970|NCT03194334|4055872|FG001|STARTED|3-6 Months||15
3322971|NCT03194334|4055873|FG002|STARTED|3-6 Months||14
3322972|NCT03194334|4055871|FG000|COMPLETED|3-6 Months||10
3322973|NCT03194334|4055872|FG001|COMPLETED|3-6 Months||15
3322974|NCT03194334|4055873|FG002|COMPLETED|3-6 Months||14
3322975|NCT03194334|4055871|FG000|NOT COMPLETED|3-6 Months||0
3322976|NCT03194334|4055872|FG001|NOT COMPLETED|3-6 Months||0
3322977|NCT03194334|4055873|FG002|NOT COMPLETED|3-6 Months||0
3322978|NCT03194373|4055882|FG000|STARTED|Overall Study||20
3322979|NCT03194373|4055882|FG000|Received Palbociclib and Carboplatin|Overall Study||19
3322980|NCT03194373|4055882|FG000|COMPLETED|Overall Study||18
3322981|NCT03194373|4055882|FG000|NOT COMPLETED|Overall Study||2
3322982|NCT03194464|4055886|FG000|STARTED|Overall Study||15
3322983|NCT03194464|4055886|FG000|COMPLETED|Overall Study||13
3322984|NCT03194464|4055886|FG000|NOT COMPLETED|Overall Study||2
3322985|NCT03194490|4055894|FG000|STARTED|Overall Study||20
3322986|NCT03194490|4055895|FG001|STARTED|Overall Study||23
3322987|NCT03194490|4055894|FG000|COMPLETED|Overall Study||18
3322988|NCT03194490|4055895|FG001|COMPLETED|Overall Study||20
3322989|NCT03194490|4055894|FG000|NOT COMPLETED|Overall Study||2
3322990|NCT03194490|4055895|FG001|NOT COMPLETED|Overall Study||3
3322991|NCT03194503|4055904|FG000|STARTED|Overall Study||458
3322992|NCT03194503|4055905|FG001|STARTED|Overall Study||1054
3322993|NCT03194503|4055904|FG000|COMPLETED|Overall Study||458
3322994|NCT03194503|4055905|FG001|COMPLETED|Overall Study||1054
3322995|NCT03194503|4055904|FG000|NOT COMPLETED|Overall Study||0
3322996|NCT03194503|4055905|FG001|NOT COMPLETED|Overall Study||0
3322997|NCT03194698|4055915|FG000|STARTED|Overall Study||10
3322998|NCT03194698|4055916|FG001|STARTED|Overall Study||10
3322999|NCT03194698|4055915|FG000|COMPLETED|Overall Study||10
3323000|NCT03194698|4055916|FG001|COMPLETED|Overall Study||10
3323001|NCT03194698|4055915|FG000|NOT COMPLETED|Overall Study||0
3323002|NCT03194698|4055916|FG001|NOT COMPLETED|Overall Study||0
3323003|NCT03194737|4055924|FG000|STARTED|Overall Study||52
3323004|NCT03194737|4055925|FG001|STARTED|Overall Study||49
3323005|NCT03194737|4055924|FG000|COMPLETED|Overall Study||47
3323006|NCT03194737|4055925|FG001|COMPLETED|Overall Study||49
3323007|NCT03194737|4055924|FG000|NOT COMPLETED|Overall Study||5
3323008|NCT03194737|4055925|FG001|NOT COMPLETED|Overall Study||0
3323009|NCT03194776|4055933|FG000|STARTED|Overall Study||23
3323010|NCT03194776|4055934|FG001|STARTED|Overall Study||23
3323011|NCT03194776|4055933|FG000|COMPLETED|Overall Study||23
3323012|NCT03194776|4055934|FG001|COMPLETED|Overall Study||23
3323013|NCT03194776|4055933|FG000|NOT COMPLETED|Overall Study||0
3323014|NCT03194776|4055934|FG001|NOT COMPLETED|Overall Study||0
3323015|NCT03195010|4055943|FG000|STARTED|Overall Study||2
3323016|NCT03195010|4055944|FG001|STARTED|Overall Study||2
3323017|NCT03195010|4055943|FG000|COMPLETED|Overall Study||2
3323018|NCT03195010|4055944|FG001|COMPLETED|Overall Study||2
3323019|NCT03195010|4055943|FG000|NOT COMPLETED|Overall Study||0
3323020|NCT03195010|4055944|FG001|NOT COMPLETED|Overall Study||0
3323021|NCT03195517|4055952|FG000|STARTED|Overall Study||33
3323022|NCT03195517|4055952|FG000|COMPLETED|Overall Study||33
3323023|NCT03195517|4055952|FG000|NOT COMPLETED|Overall Study||0
3323024|NCT03196076|4055963|FG000|STARTED|Overall Study||5
3323025|NCT03196076|4055964|FG001|STARTED|Overall Study||20
3323026|NCT03196076|4055965|FG002|STARTED|Overall Study||0
3323027|NCT03196076|4055963|FG000|COMPLETED|Overall Study||5
3323028|NCT03196076|4055964|FG001|COMPLETED|Overall Study||20
3323029|NCT03196076|4055965|FG002|COMPLETED|Overall Study||0
3323030|NCT03196076|4055963|FG000|NOT COMPLETED|Overall Study||0
3175480|NCT01960075|3903155|FG001|COMPLETED|Overall Study||146
3175481|NCT01960075|3903156|FG002|COMPLETED|Overall Study||173
3323031|NCT03196076|4055964|FG001|NOT COMPLETED|Overall Study||0
3323032|NCT03196076|4055965|FG002|NOT COMPLETED|Overall Study||0
3323033|NCT03196193|4055975|FG000|STARTED|Overall Study||121
3323034|NCT03196193|4055976|FG001|STARTED|Overall Study||119
3323035|NCT03196193|4055975|FG000|COMPLETED|Overall Study||118
3323036|NCT03196193|4055976|FG001|COMPLETED|Overall Study||119
3323037|NCT03196193|4055975|FG000|NOT COMPLETED|Overall Study||3
3323038|NCT03196193|4055976|FG001|NOT COMPLETED|Overall Study||0
3323039|NCT03196232|4055982|FG000|STARTED|Overall Study||3
3323040|NCT03196232|4055982|FG000|COMPLETED|Overall Study||3
3323041|NCT03196232|4055982|FG000|NOT COMPLETED|Overall Study||0
3323042|NCT03196284|4055988|FG000|STARTED|Main Part||17
3323043|NCT03196284|4055989|FG001|STARTED|Main Part||9
3323044|NCT03196284|4055990|FG002|STARTED|Main Part||0
3323045|NCT03196284|4055988|FG000|Concizumab 0.15 mg/kg|Main Part||15
3323046|NCT03196284|4055989|FG001|Concizumab 0.15 mg/kg|Main Part||0
3323047|NCT03196284|4055990|FG002|Concizumab 0.15 mg/kg|Main Part||0
3323048|NCT03196284|4055988|FG000|Concizumab 0.20 mg/kg|Main Part||2
3323049|NCT03196284|4055989|FG001|Concizumab 0.20 mg/kg|Main Part||0
3323050|NCT03196284|4055990|FG002|Concizumab 0.20 mg/kg|Main Part||0
3323051|NCT03196284|4055988|FG000|Concizumab 0.25 mg/kg|Main Part||0
3323052|NCT03196284|4055989|FG001|Concizumab 0.25 mg/kg|Main Part||0
3323053|NCT03196284|4055990|FG002|Concizumab 0.25 mg/kg|Main Part||0
3323054|NCT03196284|4055988|FG000|COMPLETED|Main Part||17
3323055|NCT03196284|4055989|FG001|COMPLETED|Main Part||8
3323056|NCT03196284|4055990|FG002|COMPLETED|Main Part||0
3323057|NCT03196284|4055988|FG000|NOT COMPLETED|Main Part||0
3323058|NCT03196284|4055989|FG001|NOT COMPLETED|Main Part||1
3175482|NCT01960075|3903154|FG000|NOT COMPLETED|Overall Study||8
3175483|NCT01960075|3903155|FG001|NOT COMPLETED|Overall Study||3
3175484|NCT01960075|3903156|FG002|NOT COMPLETED|Overall Study||7
3175485|NCT01960114|3903166|FG000|STARTED|Overall Study||134
3175486|NCT01960114|3903167|FG001|STARTED|Overall Study||269
3175487|NCT01960114|3903166|FG000|COMPLETED|Overall Study||133
3175488|NCT01960114|3903167|FG001|COMPLETED|Overall Study||268
3175489|NCT01960114|3903166|FG000|NOT COMPLETED|Overall Study||1
3175490|NCT01960114|3903167|FG001|NOT COMPLETED|Overall Study||1
3175491|NCT01960140|3903173|FG000|STARTED|Period 1 (Days 1-2)||40
3323059|NCT03196284|4055990|FG002|NOT COMPLETED|Main Part||0
3323060|NCT03196284|4055988|FG000|STARTED|Extension Part|Participants who completed main part are presented in separate treatment arm.|0
3323061|NCT03196284|4055989|FG001|STARTED|Extension Part|Participants switched to treatment with concizumab in the extension part of the study.|0
3323062|NCT03196284|4055990|FG002|STARTED|Extension Part|Participants who completed the main part entered the extension part of the study.|25
3323063|NCT03196284|4055988|FG000|Concizumab 0.15 mg/kg|Extension Part||0
3323064|NCT03196284|4055989|FG001|Concizumab 0.15 mg/kg|Extension Part||0
3323065|NCT03196284|4055990|FG002|Concizumab 0.15 mg/kg|Extension Part||12
3323066|NCT03196284|4055988|FG000|Concizumab 0.20 mg/kg|Extension Part||0
3323067|NCT03196284|4055989|FG001|Concizumab 0.20 mg/kg|Extension Part||0
3323068|NCT03196284|4055990|FG002|Concizumab 0.20 mg/kg|Extension Part||9
3323069|NCT03196284|4055988|FG000|Concizumab 0.25 mg/kg|Extension Part||0
3323070|NCT03196284|4055989|FG001|Concizumab 0.25 mg/kg|Extension Part||0
3323071|NCT03196284|4055990|FG002|Concizumab 0.25 mg/kg|Extension Part||4
3323072|NCT03196284|4055988|FG000|COMPLETED|Extension Part||0
3323073|NCT03196284|4055989|FG001|COMPLETED|Extension Part||0
3323074|NCT03196284|4055990|FG002|COMPLETED|Extension Part||22
3323075|NCT03196284|4055988|FG000|NOT COMPLETED|Extension Part||0
3323076|NCT03196284|4055989|FG001|NOT COMPLETED|Extension Part||0
3323077|NCT03196284|4055990|FG002|NOT COMPLETED|Extension Part||3
3323078|NCT03196297|4056010|FG000|STARTED|Main Period||36
3323079|NCT03196297|4056010|FG000|Full Analysis Set (FAS)|Main Period||36
3323080|NCT03196297|4056010|FG000|Subject Analysis Set (SAS)|Main Period||36
3323081|NCT03196297|4056010|FG000|COMPLETED|Main Period||32
3323082|NCT03196297|4056010|FG000|NOT COMPLETED|Main Period||4
3323083|NCT03196297|4056010|FG000|STARTED|Extension Period||32
3323084|NCT03196297|4056010|FG000|FAS|Extension Period||32
3323085|NCT03196297|4056010|FG000|SAS|Extension Period||32
3323086|NCT03196297|4056010|FG000|COMPLETED|Extension Period||29
3323087|NCT03196297|4056010|FG000|NOT COMPLETED|Extension Period||3
3323088|NCT03196349|4056029|FG000|STARTED|Overall Study||17
3323089|NCT03196349|4056030|FG001|STARTED|Overall Study||14
3323090|NCT03196349|4056031|FG002|STARTED|Overall Study||13
3323091|NCT03196349|4056029|FG000|COMPLETED|Overall Study||0
3323092|NCT03196349|4056030|FG001|COMPLETED|Overall Study||0
3323093|NCT03196349|4056031|FG002|COMPLETED|Overall Study||0
3323094|NCT03196349|4056029|FG000|NOT COMPLETED|Overall Study||17
3323095|NCT03196349|4056030|FG001|NOT COMPLETED|Overall Study||14
3323096|NCT03196349|4056031|FG002|NOT COMPLETED|Overall Study||13
3323097|NCT03196505|4056041|FG000|STARTED|Overall Study||115
3323098|NCT03196505|4056042|FG001|STARTED|Overall Study||116
3323099|NCT03196505|4056041|FG000|COMPLETED|Overall Study||89
3323100|NCT03196505|4056042|FG001|COMPLETED|Overall Study||90
3323101|NCT03196505|4056041|FG000|NOT COMPLETED|Overall Study||26
3323102|NCT03196505|4056042|FG001|NOT COMPLETED|Overall Study||26
3323103|NCT03196635|4056048|FG000|STARTED|Overall Study||31
3323104|NCT03196635|4056048|FG000|COMPLETED|Overall Study||30
3323105|NCT03196635|4056048|FG000|NOT COMPLETED|Overall Study||1
3323106|NCT03196791|4056068|FG000|STARTED|Overall Study||98
3323107|NCT03196791|4056069|FG001|STARTED|Overall Study||98
3323108|NCT03196791|4056068|FG000|COMPLETED|Overall Study||88
3323109|NCT03196791|4056069|FG001|COMPLETED|Overall Study||93
3323110|NCT03196791|4056068|FG000|NOT COMPLETED|Overall Study||10
3323111|NCT03196791|4056069|FG001|NOT COMPLETED|Overall Study||5
3175492|NCT01960140|3903173|FG000|Received Simvastatin|Period 1 (Days 1-2)||40
3175493|NCT01960140|3903173|FG000|COMPLETED|Period 1 (Days 1-2)||40
3323112|NCT03196973|4056078|FG000|STARTED|Overall Study||197
3323113|NCT03196973|4056079|FG001|STARTED|Overall Study||196
3323114|NCT03196973|4056080|FG002|STARTED|Overall Study||100
3323115|NCT03196973|4056078|FG000|COMPLETED|Overall Study||188
3323116|NCT03196973|4056079|FG001|COMPLETED|Overall Study||184
3323117|NCT03196973|4056080|FG002|COMPLETED|Overall Study||95
3323118|NCT03196973|4056078|FG000|NOT COMPLETED|Overall Study||9
3323119|NCT03196973|4056079|FG001|NOT COMPLETED|Overall Study||12
3323120|NCT03196973|4056080|FG002|NOT COMPLETED|Overall Study||5
3323121|NCT03197025|4056088|FG000|STARTED|Overall Study||1
3323122|NCT03197025|4056088|FG000|COMPLETED|Overall Study||1
3323123|NCT03197025|4056088|FG000|NOT COMPLETED|Overall Study||0
3323124|NCT03197038|4056094|FG000|STARTED|Overall Study||22
3323125|NCT03197038|4056095|FG001|STARTED|Overall Study||17
3323126|NCT03197038|4056094|FG000|COMPLETED|Overall Study||18
3323127|NCT03197038|4056095|FG001|COMPLETED|Overall Study||17
3323128|NCT03197038|4056094|FG000|NOT COMPLETED|Overall Study||4
3323129|NCT03197038|4056095|FG001|NOT COMPLETED|Overall Study||0
3323130|NCT03197129|4056103|FG000|STARTED|Overall Study||60
3323131|NCT03197129|4056104|FG001|STARTED|Overall Study||62
3323132|NCT03197129|4056103|FG000|COMPLETED|Overall Study||56
3323133|NCT03197129|4056104|FG001|COMPLETED|Overall Study||57
3323134|NCT03197129|4056103|FG000|NOT COMPLETED|Overall Study||4
3323135|NCT03197129|4056104|FG001|NOT COMPLETED|Overall Study||5
3323136|NCT03197324|4056112|FG000|STARTED|Overall Study||10
3323137|NCT03197324|4056113|FG001|STARTED|Overall Study||10
3323138|NCT03197324|4056112|FG000|COMPLETED|Overall Study||10
3323139|NCT03197324|4056113|FG001|COMPLETED|Overall Study||9
3323140|NCT03197324|4056112|FG000|NOT COMPLETED|Overall Study||0
3323141|NCT03197324|4056113|FG001|NOT COMPLETED|Overall Study||1
3323142|NCT03197376|4056123|FG000|STARTED|Primary and Booster Phase||502
3323143|NCT03197376|4056124|FG001|STARTED|Primary and Booster Phase||501
3323144|NCT03197376|4056125|FG002|STARTED|Primary and Booster Phase||500
3323145|NCT03197376|4056126|FG003|STARTED|Primary and Booster Phase||747
3323146|NCT03197376|4056123|FG000|Vaccinated-Dose 1|Primary and Booster Phase||502
3323147|NCT03197376|4056124|FG001|Vaccinated-Dose 1|Primary and Booster Phase||501
3323148|NCT03197376|4056125|FG002|Vaccinated-Dose 1|Primary and Booster Phase||500
3323149|NCT03197376|4056126|FG003|Vaccinated-Dose 1|Primary and Booster Phase||747
3323150|NCT03197376|4056123|FG000|Vaccinated-Dose 2|Primary and Booster Phase||495
3323151|NCT03197376|4056124|FG001|Vaccinated-Dose 2|Primary and Booster Phase||495
3323152|NCT03197376|4056125|FG002|Vaccinated-Dose 2|Primary and Booster Phase||491
3323153|NCT03197376|4056126|FG003|Vaccinated-Dose 2|Primary and Booster Phase||738
3323154|NCT03197376|4056123|FG000|Vaccinated-Dose 3|Primary and Booster Phase||492
3323155|NCT03197376|4056124|FG001|Vaccinated-Dose 3|Primary and Booster Phase||493
3323156|NCT03197376|4056125|FG002|Vaccinated-Dose 3|Primary and Booster Phase||490
3323157|NCT03197376|4056126|FG003|Vaccinated-Dose 3|Primary and Booster Phase||731
3323158|NCT03197376|4056123|FG000|Primary Reactogenicity Cohort|Primary and Booster Phase||251
3323159|NCT03197376|4056124|FG001|Primary Reactogenicity Cohort|Primary and Booster Phase||243
3323160|NCT03197376|4056125|FG002|Primary Reactogenicity Cohort|Primary and Booster Phase||257
3323161|NCT03197376|4056126|FG003|Primary Reactogenicity Cohort|Primary and Booster Phase||364
3323162|NCT03197376|4056123|FG000|Booster Cohort|Primary and Booster Phase||150
3323163|NCT03197376|4056124|FG001|Booster Cohort|Primary and Booster Phase||151
3323164|NCT03197376|4056125|FG002|Booster Cohort|Primary and Booster Phase||150
3323165|NCT03197376|4056126|FG003|Booster Cohort|Primary and Booster Phase||224
3323166|NCT03197376|4056123|FG000|Received Booster Vaccine|Primary and Booster Phase||145
3323167|NCT03197376|4056124|FG001|Received Booster Vaccine|Primary and Booster Phase||144
3323168|NCT03197376|4056125|FG002|Received Booster Vaccine|Primary and Booster Phase||139
3323169|NCT03197376|4056126|FG003|Received Booster Vaccine|Primary and Booster Phase||213
3323170|NCT03197376|4056123|FG000|COMPLETED|Primary and Booster Phase||487
3323171|NCT03197376|4056124|FG001|COMPLETED|Primary and Booster Phase||488
3323172|NCT03197376|4056125|FG002|COMPLETED|Primary and Booster Phase||480
3323173|NCT03197376|4056126|FG003|COMPLETED|Primary and Booster Phase||722
3323174|NCT03197376|4056123|FG000|NOT COMPLETED|Primary and Booster Phase||15
3323175|NCT03197376|4056124|FG001|NOT COMPLETED|Primary and Booster Phase||13
3323176|NCT03197376|4056125|FG002|NOT COMPLETED|Primary and Booster Phase||20
3323177|NCT03197376|4056126|FG003|NOT COMPLETED|Primary and Booster Phase||25
3323178|NCT03197376|4056123|FG000|STARTED|Immune Persistence Phase||132
3323179|NCT03197376|4056124|FG001|STARTED|Immune Persistence Phase||133
3323180|NCT03197376|4056125|FG002|STARTED|Immune Persistence Phase||128
3323181|NCT03197376|4056126|FG003|STARTED|Immune Persistence Phase||195
3323182|NCT03197376|4056123|FG000|COMPLETED|Immune Persistence Phase||127
3323183|NCT03197376|4056124|FG001|COMPLETED|Immune Persistence Phase||129
3323184|NCT03197376|4056125|FG002|COMPLETED|Immune Persistence Phase||123
3323185|NCT03197376|4056126|FG003|COMPLETED|Immune Persistence Phase||190
3323186|NCT03197376|4056123|FG000|NOT COMPLETED|Immune Persistence Phase||5
3323187|NCT03197376|4056124|FG001|NOT COMPLETED|Immune Persistence Phase||4
3323188|NCT03197376|4056125|FG002|NOT COMPLETED|Immune Persistence Phase||5
3323189|NCT03197376|4056126|FG003|NOT COMPLETED|Immune Persistence Phase||5
3323190|NCT03197389|4056165|FG000|STARTED|Overall Study||16
3323191|NCT03197389|4056166|FG001|STARTED|Overall Study||5
3323192|NCT03197389|4056167|FG002|STARTED|Overall Study||18
3323193|NCT03197389|4056168|FG003|STARTED|Overall Study||9
3323194|NCT03197389|4056169|FG004|STARTED|Overall Study||1
3323195|NCT03197389|4056170|FG005|STARTED|Overall Study||5
3323196|NCT03197389|4056165|FG000|COMPLETED|Overall Study||16
3323197|NCT03197389|4056166|FG001|COMPLETED|Overall Study||5
3323198|NCT03197389|4056167|FG002|COMPLETED|Overall Study||18
3323199|NCT03197389|4056168|FG003|COMPLETED|Overall Study||9
3323200|NCT03197389|4056169|FG004|COMPLETED|Overall Study||1
3323201|NCT03197389|4056170|FG005|COMPLETED|Overall Study||5
3323202|NCT03197389|4056165|FG000|NOT COMPLETED|Overall Study||0
3323203|NCT03197389|4056166|FG001|NOT COMPLETED|Overall Study||0
3323204|NCT03197389|4056167|FG002|NOT COMPLETED|Overall Study||0
3323205|NCT03197389|4056168|FG003|NOT COMPLETED|Overall Study||0
3323206|NCT03197389|4056169|FG004|NOT COMPLETED|Overall Study||0
3323207|NCT03197389|4056170|FG005|NOT COMPLETED|Overall Study||0
3323208|NCT03197558|4056184|FG000|STARTED|Overall Study||30
3323209|NCT03197558|4056184|FG000|COMPLETED|Overall Study||29
3323210|NCT03197558|4056184|FG000|NOT COMPLETED|Overall Study||1
3323211|NCT03197883|4056190|FG000|STARTED|Overall Study||50
3323212|NCT03197883|4056191|FG001|STARTED|Overall Study||50
3323213|NCT03197883|4056190|FG000|COMPLETED|Overall Study||47
3323214|NCT03197883|4056191|FG001|COMPLETED|Overall Study||44
3323215|NCT03197883|4056190|FG000|NOT COMPLETED|Overall Study||3
3323216|NCT03197883|4056191|FG001|NOT COMPLETED|Overall Study||6
3323217|NCT03198000|4056200|FG000|STARTED|Overall Study||41
3323218|NCT03198000|4056201|FG001|STARTED|Overall Study||38
3323219|NCT03198000|4056202|FG002|STARTED|Overall Study||41
3323220|NCT03198000|4056200|FG000|COMPLETED|Overall Study||41
3323221|NCT03198000|4056201|FG001|COMPLETED|Overall Study||38
3323222|NCT03198000|4056202|FG002|COMPLETED|Overall Study||41
3323223|NCT03198000|4056200|FG000|NOT COMPLETED|Overall Study||0
3323224|NCT03198000|4056201|FG001|NOT COMPLETED|Overall Study||0
3323225|NCT03198000|4056202|FG002|NOT COMPLETED|Overall Study||0
3323226|NCT03198221|4056214|FG000|STARTED|Overall Study||3
3323227|NCT03198221|4056215|FG001|STARTED|Overall Study||2
3323228|NCT03198221|4056216|FG002|STARTED|Overall Study||7
3323229|NCT03198221|4056217|FG003|STARTED|Overall Study||2
3323230|NCT03198221|4056214|FG000|COMPLETED|Overall Study||3
3323231|NCT03198221|4056215|FG001|COMPLETED|Overall Study||2
3323232|NCT03198221|4056216|FG002|COMPLETED|Overall Study||7
3323233|NCT03198221|4056217|FG003|COMPLETED|Overall Study||2
3323234|NCT03198221|4056214|FG000|NOT COMPLETED|Overall Study||0
3323235|NCT03198221|4056215|FG001|NOT COMPLETED|Overall Study||0
3323236|NCT03198221|4056216|FG002|NOT COMPLETED|Overall Study||0
3323237|NCT03198221|4056217|FG003|NOT COMPLETED|Overall Study||0
3323238|NCT03198507|4056229|FG000|STARTED|Overall Study||228
3323239|NCT03198507|4056230|FG001|STARTED|Overall Study||227
3323240|NCT03198507|4056229|FG000|COMPLETED|Overall Study||227
3323241|NCT03198507|4056230|FG001|COMPLETED|Overall Study||227
3323242|NCT03198507|4056229|FG000|NOT COMPLETED|Overall Study||1
3323243|NCT03198507|4056230|FG001|NOT COMPLETED|Overall Study||0
3323244|NCT03198520|4056236|FG000|STARTED|Overall Study||46
3323245|NCT03198520|4056236|FG000|COMPLETED|Overall Study||40
3323246|NCT03198520|4056236|FG000|NOT COMPLETED|Overall Study||6
3323247|NCT03198715|4056253|FG000|STARTED|Overall Study||6
3323248|NCT03198715|4056254|FG001|STARTED|Overall Study||12
3323249|NCT03198715|4056255|FG002|STARTED|Overall Study||12
3323250|NCT03198715|4056256|FG003|STARTED|Overall Study||3
3323251|NCT03198715|4056257|FG004|STARTED|Overall Study||9
3323252|NCT03198715|4056253|FG000|COMPLETED|Overall Study||6
3323253|NCT03198715|4056254|FG001|COMPLETED|Overall Study||11
3323254|NCT03198715|4056255|FG002|COMPLETED|Overall Study||10
3323255|NCT03198715|4056256|FG003|COMPLETED|Overall Study||3
3323256|NCT03198715|4056257|FG004|COMPLETED|Overall Study||7
3323257|NCT03198715|4056253|FG000|NOT COMPLETED|Overall Study||0
3323258|NCT03198715|4056254|FG001|NOT COMPLETED|Overall Study||1
3323259|NCT03198715|4056255|FG002|NOT COMPLETED|Overall Study||2
3323260|NCT03198715|4056256|FG003|NOT COMPLETED|Overall Study||0
3323261|NCT03198715|4056257|FG004|NOT COMPLETED|Overall Study||2
3323262|NCT03198754|4056271|FG000|STARTED|Overall Study||38
3323263|NCT03198754|4056272|FG001|STARTED|Overall Study||35
3323264|NCT03198754|4056271|FG000|COMPLETED|Overall Study||27
3323265|NCT03198754|4056272|FG001|COMPLETED|Overall Study||27
3323266|NCT03198754|4056271|FG000|NOT COMPLETED|Overall Study||11
3323267|NCT03198754|4056272|FG001|NOT COMPLETED|Overall Study||8
3323268|NCT03198767|4056285|FG000|STARTED|Overall Study||8
3323269|NCT03198767|4056286|FG001|STARTED|Overall Study||8
3323270|NCT03198767|4056287|FG002|STARTED|Overall Study||8
3323271|NCT03198767|4056288|FG003|STARTED|Overall Study||6
3323272|NCT03198767|4056289|FG004|STARTED|Overall Study||8
3323273|NCT03198767|4056290|FG005|STARTED|Overall Study||8
3323274|NCT03198767|4056291|FG006|STARTED|Overall Study||8
3323275|NCT03198767|4056285|FG000|COMPLETED|Overall Study||8
3323276|NCT03198767|4056286|FG001|COMPLETED|Overall Study||8
3323277|NCT03198767|4056287|FG002|COMPLETED|Overall Study||8
3323278|NCT03198767|4056288|FG003|COMPLETED|Overall Study||0
3323279|NCT03198767|4056289|FG004|COMPLETED|Overall Study||8
3323280|NCT03198767|4056290|FG005|COMPLETED|Overall Study||8
3323281|NCT03198767|4056291|FG006|COMPLETED|Overall Study||8
3323282|NCT03198767|4056285|FG000|NOT COMPLETED|Overall Study||0
3323283|NCT03198767|4056286|FG001|NOT COMPLETED|Overall Study||0
3323284|NCT03198767|4056287|FG002|NOT COMPLETED|Overall Study||0
3323285|NCT03198767|4056288|FG003|NOT COMPLETED|Overall Study||6
3323286|NCT03198767|4056289|FG004|NOT COMPLETED|Overall Study||0
3323287|NCT03198767|4056290|FG005|NOT COMPLETED|Overall Study||0
3323288|NCT03198767|4056291|FG006|NOT COMPLETED|Overall Study||0
3323289|NCT03198871|4056308|FG000|STARTED|Overall Study||90
3323290|NCT03198871|4056309|FG001|STARTED|Overall Study||90
3323291|NCT03198871|4056308|FG000|COMPLETED|Overall Study||76
3323292|NCT03198871|4056309|FG001|COMPLETED|Overall Study||78
3323293|NCT03198871|4056308|FG000|NOT COMPLETED|Overall Study||14
3323294|NCT03198871|4056309|FG001|NOT COMPLETED|Overall Study||12
3323295|NCT03198884|4056315|FG000|STARTED|Overall Study||20
3323296|NCT03198884|4056315|FG000|COMPLETED|Overall Study||20
3323297|NCT03198884|4056315|FG000|NOT COMPLETED|Overall Study||0
3323298|NCT03199079|4056331|FG000|STARTED|Overall Study||10
3323299|NCT03199079|4056332|FG001|STARTED|Overall Study||10
3323300|NCT03199079|4056331|FG000|COMPLETED|Overall Study||10
3323301|NCT03199079|4056332|FG001|COMPLETED|Overall Study||10
3323302|NCT03199079|4056331|FG000|NOT COMPLETED|Overall Study||0
3323303|NCT03199079|4056332|FG001|NOT COMPLETED|Overall Study||0
3323304|NCT03199118|4056340|FG000|STARTED|Overall Study||14
3323305|NCT03199118|4056341|FG001|STARTED|Overall Study||14
3323306|NCT03199118|4056340|FG000|COMPLETED|Overall Study|6 months follow-up|14
3323307|NCT03199118|4056341|FG001|COMPLETED|Overall Study|6 months follow-up|14
3323308|NCT03199118|4056340|FG000|NOT COMPLETED|Overall Study||0
3323309|NCT03199118|4056341|FG001|NOT COMPLETED|Overall Study||0
3323310|NCT03199872|4056352|FG000|STARTED|Overall Study||22
3323311|NCT03199872|4056352|FG000|COMPLETED|Overall Study||22
3323312|NCT03199872|4056352|FG000|NOT COMPLETED|Overall Study||0
3323313|NCT03199911|4056358|FG000|STARTED|Overall Study||208
3323314|NCT03199911|4056359|FG001|STARTED|Overall Study||193
3323315|NCT03199911|4056358|FG000|Did Not Proceed With Surgery|Overall Study||2
3323316|NCT03199911|4056359|FG001|Did Not Proceed With Surgery|Overall Study||1
3323317|NCT03199911|4056358|FG000|Received Allocated Treatment|Overall Study||206
3323318|NCT03199911|4056359|FG001|Received Allocated Treatment|Overall Study||192
3323319|NCT03199911|4056358|FG000|Lost to Follow-up|Overall Study||5
3323320|NCT03199911|4056359|FG001|Lost to Follow-up|Overall Study||5
3323321|NCT03199911|4056358|FG000|Primary Outcome Analyzed|Overall Study||201
3323322|NCT03199911|4056359|FG001|Primary Outcome Analyzed|Overall Study||187
3323323|NCT03199911|4056358|FG000|COMPLETED|Overall Study||201
3323324|NCT03199911|4056359|FG001|COMPLETED|Overall Study||187
3323325|NCT03199911|4056358|FG000|NOT COMPLETED|Overall Study||7
3323326|NCT03199911|4056359|FG001|NOT COMPLETED|Overall Study||6
3323327|NCT03199963|4056367|FG000|STARTED|Blinded Phase - Overall Study||149
3323328|NCT03199963|4056368|FG001|STARTED|Blinded Phase - Overall Study||74
3323329|NCT03199963|4056367|FG000|Received at Least 1 Gel Application|Blinded Phase - Overall Study||149
3323330|NCT03199963|4056368|FG001|Received at Least 1 Gel Application|Blinded Phase - Overall Study||73
3323331|NCT03199963|4056367|FG000|COMPLETED|Blinded Phase - Overall Study||16
3323332|NCT03199963|4056368|FG001|COMPLETED|Blinded Phase - Overall Study||8
3323333|NCT03199963|4056367|FG000|NOT COMPLETED|Blinded Phase - Overall Study||133
3323334|NCT03199963|4056368|FG001|NOT COMPLETED|Blinded Phase - Overall Study||66
3323335|NCT03199963|4056367|FG000|STARTED|Optional Open-Label Phase - BHR-700||7
3323336|NCT03199963|4056368|FG001|STARTED|Optional Open-Label Phase - BHR-700||6
3323337|NCT03199963|4056367|FG000|COMPLETED|Optional Open-Label Phase - BHR-700||0
3323338|NCT03199963|4056368|FG001|COMPLETED|Optional Open-Label Phase - BHR-700||0
3323339|NCT03199963|4056367|FG000|NOT COMPLETED|Optional Open-Label Phase - BHR-700||7
3323340|NCT03199963|4056368|FG001|NOT COMPLETED|Optional Open-Label Phase - BHR-700||6
3323341|NCT03200366|4056379|FG000|STARTED|Baseline Interview With Randomization||123
3323342|NCT03200366|4056380|FG001|STARTED|Baseline Interview With Randomization||120
3323343|NCT03200366|4056381|FG002|STARTED|Baseline Interview With Randomization||128
3323344|NCT03200366|4056379|FG000|COMPLETED|Baseline Interview With Randomization||123
3323345|NCT03200366|4056380|FG001|COMPLETED|Baseline Interview With Randomization||120
3323346|NCT03200366|4056381|FG002|COMPLETED|Baseline Interview With Randomization||128
3323347|NCT03200366|4056379|FG000|NOT COMPLETED|Baseline Interview With Randomization||0
3323348|NCT03200366|4056380|FG001|NOT COMPLETED|Baseline Interview With Randomization||0
3323349|NCT03200366|4056381|FG002|NOT COMPLETED|Baseline Interview With Randomization||0
3323350|NCT03200366|4056379|FG000|STARTED|Tailored DVD Intervention Given||123
3323351|NCT03200366|4056380|FG001|STARTED|Tailored DVD Intervention Given||120
3323352|NCT03200366|4056381|FG002|STARTED|Tailored DVD Intervention Given||0
3323353|NCT03200366|4056379|FG000|COMPLETED|Tailored DVD Intervention Given||123
3323354|NCT03200366|4056380|FG001|COMPLETED|Tailored DVD Intervention Given||120
3323355|NCT03200366|4056381|FG002|COMPLETED|Tailored DVD Intervention Given||0
3323356|NCT03200366|4056379|FG000|NOT COMPLETED|Tailored DVD Intervention Given||0
3323357|NCT03200366|4056380|FG001|NOT COMPLETED|Tailored DVD Intervention Given||0
3323358|NCT03200366|4056381|FG002|NOT COMPLETED|Tailored DVD Intervention Given||0
3323359|NCT03200366|4056379|FG000|STARTED|Patient Navigation Intervention Given||0
3323360|NCT03200366|4056380|FG001|STARTED|Patient Navigation Intervention Given||120
2926322|NCT00569803|3637730|FG005|STARTED|Overall Study||5
2926323|NCT00569803|3637731|FG006|STARTED|Overall Study||10
2926324|NCT00569803|3637732|FG007|STARTED|Overall Study||6
2926325|NCT00569803|3637725|FG000|COMPLETED|Overall Study||4
2926326|NCT00569803|3637726|FG001|COMPLETED|Overall Study||5
2926327|NCT00569803|3637727|FG002|COMPLETED|Overall Study||5
2926328|NCT00569803|3637728|FG003|COMPLETED|Overall Study||5
2926329|NCT00569803|3637729|FG004|COMPLETED|Overall Study||5
2926330|NCT00569803|3637730|FG005|COMPLETED|Overall Study||5
2926331|NCT00569803|3637731|FG006|COMPLETED|Overall Study||10
2926332|NCT00569803|3637732|FG007|COMPLETED|Overall Study||5
2926333|NCT00569803|3637725|FG000|NOT COMPLETED|Overall Study||1
2926334|NCT00569803|3637726|FG001|NOT COMPLETED|Overall Study||0
2926335|NCT00569803|3637727|FG002|NOT COMPLETED|Overall Study||0
2926336|NCT00569803|3637728|FG003|NOT COMPLETED|Overall Study||1
2926337|NCT00569803|3637729|FG004|NOT COMPLETED|Overall Study||0
2926338|NCT00569803|3637730|FG005|NOT COMPLETED|Overall Study||0
2926339|NCT00569803|3637731|FG006|NOT COMPLETED|Overall Study||0
2926340|NCT00569803|3637732|FG007|NOT COMPLETED|Overall Study||1
2926341|NCT00569855|3637754|FG000|STARTED|Overall Study|832 subjects enrolled; however, study records only available for analysis from 2004 =446 subjects|785
2926342|NCT00569855|3637754|FG000|COMPLETED|Overall Study|785 subjects treated with study drug|785
2926343|NCT00569855|3637754|FG000|NOT COMPLETED|Overall Study||0
2926344|NCT00569946|3637758|FG000|STARTED|Overall Study||64
2926345|NCT00569946|3637758|FG000|COMPLETED|Overall Study||5
2926346|NCT00569946|3637758|FG000|NOT COMPLETED|Overall Study||59
2926347|NCT00570037|3637764|FG000|STARTED|Overall Study||238
2926348|NCT00570037|3637765|FG001|STARTED|Overall Study||306
2926349|NCT00570037|3637764|FG000|COMPLETED|Overall Study||194
2926350|NCT00570037|3637765|FG001|COMPLETED|Overall Study||237
2926351|NCT00570037|3637764|FG000|NOT COMPLETED|Overall Study||44
2926352|NCT00570037|3637765|FG001|NOT COMPLETED|Overall Study||69
2926353|NCT00570063|3637773|FG000|STARTED|Overall Study||24
2926354|NCT00570063|3637774|FG001|STARTED|Overall Study||11
2926355|NCT00570063|3637773|FG000|COMPLETED|Overall Study||9
2926356|NCT00570063|3637774|FG001|COMPLETED|Overall Study||3
2926357|NCT00570063|3637773|FG000|NOT COMPLETED|Overall Study||15
2926358|NCT00570063|3637774|FG001|NOT COMPLETED|Overall Study||8
2926359|NCT00570089|3637780|FG000|STARTED|Period 1||10
2926360|NCT00570089|3637781|FG001|STARTED|Period 1||10
2926361|NCT00570089|3637780|FG000|COMPLETED|Period 1||10
2926362|NCT00570089|3637781|FG001|COMPLETED|Period 1||10
2926363|NCT00570089|3637780|FG000|NOT COMPLETED|Period 1||0
2926364|NCT00570089|3637781|FG001|NOT COMPLETED|Period 1||0
2926365|NCT00570089|3637780|FG000|STARTED|Perod 2||10
2926366|NCT00570089|3637781|FG001|STARTED|Perod 2||10
2926367|NCT00570089|3637780|FG000|COMPLETED|Perod 2||10
2926368|NCT00570089|3637781|FG001|COMPLETED|Perod 2||10
2926369|NCT00570089|3637780|FG000|NOT COMPLETED|Perod 2||0
2926370|NCT00570089|3637781|FG001|NOT COMPLETED|Perod 2||0
2926371|NCT00570128|3637791|FG000|STARTED|Overall Study||64
2926372|NCT00570128|3637792|FG001|STARTED|Overall Study||65
2926373|NCT00570128|3637791|FG000|Intent to Treat (ITT) Population|Overall Study||62
2926374|NCT00570128|3637792|FG001|Intent to Treat (ITT) Population|Overall Study||65
2926375|NCT00570128|3637791|FG000|COMPLETED|Overall Study||60
2926376|NCT00570128|3637792|FG001|COMPLETED|Overall Study||65
2926377|NCT00570128|3637791|FG000|NOT COMPLETED|Overall Study||4
2926378|NCT00570128|3637792|FG001|NOT COMPLETED|Overall Study||0
2926379|NCT00570141|3637798|FG000|STARTED|Overall Study||13
2926380|NCT00570141|3637798|FG000|COMPLETED|Overall Study||10
2926381|NCT00570141|3637798|FG000|NOT COMPLETED|Overall Study||3
2926382|NCT00570232|3637802|FG000|STARTED|Overall Study||31
2926383|NCT00570232|3637802|FG000|COMPLETED|Overall Study||8
2926384|NCT00570232|3637802|FG000|NOT COMPLETED|Overall Study||23
2926385|NCT00570310|3637808|FG000|STARTED|Overall Study||53
2926386|NCT00570310|3637809|FG001|STARTED|Overall Study||51
2926387|NCT00570310|3637808|FG000|COMPLETED|Overall Study||51
2926388|NCT00570310|3637809|FG001|COMPLETED|Overall Study||45
2926389|NCT00570310|3637808|FG000|NOT COMPLETED|Overall Study||2
2926390|NCT00570310|3637809|FG001|NOT COMPLETED|Overall Study||6
2926391|NCT00570323|3637817|FG000|STARTED|Started Treatment After Randomization||36
2926392|NCT00570323|3637818|FG001|STARTED|Started Treatment After Randomization||36
2926393|NCT00570323|3637817|FG000|COMPLETED|Started Treatment After Randomization||34
3175494|NCT01960140|3903173|FG000|NOT COMPLETED|Period 1 (Days 1-2)||0
3175495|NCT01960140|3903173|FG000|STARTED|Period 2 (Days 3-18)||40
3175496|NCT01960140|3903173|FG000|Received At Least 1 Dose of Baricitinib|Period 2 (Days 3-18)||40
2926394|NCT00570323|3637818|FG001|COMPLETED|Started Treatment After Randomization||35
2926395|NCT00570323|3637817|FG000|NOT COMPLETED|Started Treatment After Randomization||2
2926396|NCT00570323|3637818|FG001|NOT COMPLETED|Started Treatment After Randomization||1
2926397|NCT00570323|3637817|FG000|STARTED|Complete Study After Start||34
2926398|NCT00570323|3637818|FG001|STARTED|Complete Study After Start||35
2926399|NCT00570323|3637817|FG000|COMPLETED|Complete Study After Start||31
3175497|NCT01960140|3903173|FG000|Received Simvastatin|Period 2 (Days 3-18)||38
3175498|NCT01960140|3903173|FG000|COMPLETED|Period 2 (Days 3-18)||38
3175499|NCT01960140|3903173|FG000|NOT COMPLETED|Period 2 (Days 3-18)||2
3175500|NCT01960257|3903181|FG000|STARTED|Stage 1 (1-3 Weeks)||77
2926400|NCT00570323|3637818|FG001|COMPLETED|Complete Study After Start||34
2926401|NCT00570323|3637817|FG000|NOT COMPLETED|Complete Study After Start||3
2926402|NCT00570323|3637818|FG001|NOT COMPLETED|Complete Study After Start||1
3039495|NCT01158716|3758910|FG001|NOT COMPLETED|Overall Study||1
3039496|NCT01158820|3758918|FG000|STARTED|Overall Study||25
3039497|NCT01158820|3758919|FG001|STARTED|Overall Study||25
3175501|NCT01960257|3903182|FG001|STARTED|Stage 1 (1-3 Weeks)||0
3175502|NCT01960257|3903183|FG002|STARTED|Stage 1 (1-3 Weeks)||0
3175503|NCT01960257|3903181|FG000|COMPLETED|Stage 1 (1-3 Weeks)||61
3175504|NCT01960257|3903182|FG001|COMPLETED|Stage 1 (1-3 Weeks)||0
3175505|NCT01960257|3903183|FG002|COMPLETED|Stage 1 (1-3 Weeks)||0
3175506|NCT01960257|3903181|FG000|NOT COMPLETED|Stage 1 (1-3 Weeks)||16
2926403|NCT00570349|3637829|FG000|STARTED|Overall Study||6
2926404|NCT00570349|3637830|FG001|STARTED|Overall Study||6
2926405|NCT00570349|3637831|FG002|STARTED|Overall Study||6
2926406|NCT00570349|3637829|FG000|COMPLETED|Overall Study||6
2926407|NCT00570349|3637830|FG001|COMPLETED|Overall Study||6
2926408|NCT00570349|3637831|FG002|COMPLETED|Overall Study||6
2926409|NCT00570349|3637829|FG000|NOT COMPLETED|Overall Study||0
2926410|NCT00570349|3637830|FG001|NOT COMPLETED|Overall Study||0
2926411|NCT00570349|3637831|FG002|NOT COMPLETED|Overall Study||0
3175507|NCT01960257|3903182|FG001|NOT COMPLETED|Stage 1 (1-3 Weeks)||0
3175508|NCT01960257|3903183|FG002|NOT COMPLETED|Stage 1 (1-3 Weeks)||0
3175509|NCT01960257|3903181|FG000|STARTED|Stage 2(1-4 Months, Not to Exceed 12wks)||0
3175510|NCT01960257|3903182|FG001|STARTED|Stage 2(1-4 Months, Not to Exceed 12wks)||41
3175511|NCT01960257|3903183|FG002|STARTED|Stage 2(1-4 Months, Not to Exceed 12wks)||20
3175512|NCT01960257|3903181|FG000|COMPLETED|Stage 2(1-4 Months, Not to Exceed 12wks)||0
3175513|NCT01960257|3903182|FG001|COMPLETED|Stage 2(1-4 Months, Not to Exceed 12wks)||41
3175514|NCT01960257|3903183|FG002|COMPLETED|Stage 2(1-4 Months, Not to Exceed 12wks)||20
3175515|NCT01960257|3903181|FG000|NOT COMPLETED|Stage 2(1-4 Months, Not to Exceed 12wks)||0
3175516|NCT01960257|3903182|FG001|NOT COMPLETED|Stage 2(1-4 Months, Not to Exceed 12wks)||0
3175517|NCT01960257|3903183|FG002|NOT COMPLETED|Stage 2(1-4 Months, Not to Exceed 12wks)||0
3175518|NCT01960296|3903195|FG000|STARTED|Overall Study||23
3175519|NCT01960296|3903196|FG001|STARTED|Overall Study||25
3175520|NCT01960296|3903195|FG000|COMPLETED|Overall Study||21
3175521|NCT01960296|3903196|FG001|COMPLETED|Overall Study||22
3175522|NCT01960296|3903195|FG000|NOT COMPLETED|Overall Study||2
3175523|NCT01960296|3903196|FG001|NOT COMPLETED|Overall Study||3
3175524|NCT01960348|3903204|FG000|STARTED|Overall Study||148
3175525|NCT01960348|3903205|FG001|STARTED|Overall Study||77
3175526|NCT01960348|3903204|FG000|COMPLETED|Overall Study||138
3175527|NCT01960348|3903205|FG001|COMPLETED|Overall Study||55
3175528|NCT01960348|3903204|FG000|NOT COMPLETED|Overall Study||10
3175529|NCT01960348|3903205|FG001|NOT COMPLETED|Overall Study||22
3175530|NCT01960387|3903211|FG000|STARTED|Overall Study||2
3175531|NCT01960387|3903211|FG000|COMPLETED|Overall Study||2
3175532|NCT01960387|3903211|FG000|NOT COMPLETED|Overall Study||0
3175533|NCT01960400|3903217|FG000|STARTED|Overall Study||11
3175534|NCT01960400|3903218|FG001|STARTED|Overall Study||11
3175535|NCT01960400|3903217|FG000|COMPLETED|Overall Study||11
3175536|NCT01960400|3903218|FG001|COMPLETED|Overall Study||11
3175537|NCT01960400|3903217|FG000|NOT COMPLETED|Overall Study||0
3175538|NCT01960400|3903218|FG001|NOT COMPLETED|Overall Study||0
3175539|NCT01960413|3903226|FG000|STARTED|Overall Study||24
3175540|NCT01960413|3903227|FG001|STARTED|Overall Study||22
3175541|NCT01960413|3903226|FG000|COMPLETED|Overall Study||20
3175542|NCT01960413|3903227|FG001|COMPLETED|Overall Study||21
3175543|NCT01960413|3903226|FG000|NOT COMPLETED|Overall Study||4
3175544|NCT01960413|3903227|FG001|NOT COMPLETED|Overall Study||1
3175545|NCT01960465|3903235|FG000|STARTED|Overall Study||138
3175546|NCT01960465|3903236|FG001|STARTED|Overall Study||82
3175547|NCT01960465|3903235|FG000|COMPLETED|Overall Study||118
3175548|NCT01960465|3903236|FG001|COMPLETED|Overall Study||73
3175549|NCT01960465|3903235|FG000|NOT COMPLETED|Overall Study||20
3175550|NCT01960465|3903236|FG001|NOT COMPLETED|Overall Study||9
3175551|NCT01960530|3903242|FG000|STARTED|Overall Study||14
3175552|NCT01960530|3903242|FG000|COMPLETED|Overall Study||14
3175553|NCT01960530|3903242|FG000|NOT COMPLETED|Overall Study||0
3175554|NCT01960725|3903259|FG000|STARTED|Overall Study||33
3175555|NCT01960725|3903260|FG001|STARTED|Overall Study||33
3175556|NCT01960725|3903259|FG000|Received First Vaccine|Overall Study||33
3175557|NCT01960725|3903260|FG001|Received First Vaccine|Overall Study||33
3175558|NCT01960725|3903259|FG000|Recieved Second Vaccine|Overall Study||33
3175559|NCT01960725|3903260|FG001|Recieved Second Vaccine|Overall Study||33
3175560|NCT01960725|3903259|FG000|Received Third Vaccine|Overall Study||32
3175561|NCT01960725|3903260|FG001|Received Third Vaccine|Overall Study||32
3175562|NCT01960725|3903259|FG000|COMPLETED|Overall Study||27
3175563|NCT01960725|3903260|FG001|COMPLETED|Overall Study||28
3175564|NCT01960725|3903259|FG000|NOT COMPLETED|Overall Study||6
3323361|NCT03200366|4056381|FG002|STARTED|Patient Navigation Intervention Given||0
3323362|NCT03200366|4056379|FG000|COMPLETED|Patient Navigation Intervention Given||0
3323363|NCT03200366|4056380|FG001|COMPLETED|Patient Navigation Intervention Given||89
3323364|NCT03200366|4056381|FG002|COMPLETED|Patient Navigation Intervention Given||0
3323365|NCT03200366|4056379|FG000|NOT COMPLETED|Patient Navigation Intervention Given||0
3323366|NCT03200366|4056380|FG001|NOT COMPLETED|Patient Navigation Intervention Given||31
3323367|NCT03200366|4056381|FG002|NOT COMPLETED|Patient Navigation Intervention Given||0
3323368|NCT03200366|4056379|FG000|STARTED|6 Month Post-Baseline Interview||123
3175565|NCT01960725|3903260|FG001|NOT COMPLETED|Overall Study||5
3175566|NCT01960790|3903266|FG000|STARTED|Overall Study||473
3175567|NCT01960790|3903266|FG000|COMPLETED|Overall Study||462
3175568|NCT01960790|3903266|FG000|NOT COMPLETED|Overall Study||11
3175569|NCT01960816|3903270|FG000|STARTED|Overall Study||33
3175570|NCT01960816|3903270|FG000|COMPLETED|Overall Study||32
2926412|NCT00570362|3637841|FG000|STARTED|Overall Study||19
2926413|NCT00570362|3637842|FG001|STARTED|Overall Study||30
2926414|NCT00570362|3637841|FG000|COMPLETED|Overall Study||19
2926415|NCT00570362|3637842|FG001|COMPLETED|Overall Study||30
2926416|NCT00570362|3637841|FG000|NOT COMPLETED|Overall Study||0
2926417|NCT00570362|3637842|FG001|NOT COMPLETED|Overall Study||0
2926418|NCT00570401|3637848|FG000|STARTED|Overall Study||21
2926419|NCT00570401|3637848|FG000|COMPLETED|Overall Study||19
2926420|NCT00570401|3637848|FG000|NOT COMPLETED|Overall Study||2
2926421|NCT00570492|3637854|FG000|STARTED|16-week Single-blind Baseline Period||910
2926422|NCT00570492|3637855|FG001|STARTED|16-week Single-blind Baseline Period||0
2926423|NCT00570492|3637856|FG002|STARTED|16-week Single-blind Baseline Period||0
2926424|NCT00570492|3637854|FG000|COMPLETED|16-week Single-blind Baseline Period||474
2926425|NCT00570492|3637855|FG001|COMPLETED|16-week Single-blind Baseline Period||0
2926426|NCT00570492|3637856|FG002|COMPLETED|16-week Single-blind Baseline Period||0
2926427|NCT00570492|3637854|FG000|NOT COMPLETED|16-week Single-blind Baseline Period||436
2926428|NCT00570492|3637855|FG001|NOT COMPLETED|16-week Single-blind Baseline Period||0
2926429|NCT00570492|3637856|FG002|NOT COMPLETED|16-week Single-blind Baseline Period||0
2926430|NCT00570492|3637854|FG000|STARTED|52-week Double-blind Treatment Period||0
2926431|NCT00570492|3637855|FG001|STARTED|52-week Double-blind Treatment Period||237
2926432|NCT00570492|3637856|FG002|STARTED|52-week Double-blind Treatment Period||237
2926433|NCT00570492|3637854|FG000|COMPLETED|52-week Double-blind Treatment Period||0
2926434|NCT00570492|3637855|FG001|COMPLETED|52-week Double-blind Treatment Period||187
2926435|NCT00570492|3637856|FG002|COMPLETED|52-week Double-blind Treatment Period||186
2926436|NCT00570492|3637854|FG000|NOT COMPLETED|52-week Double-blind Treatment Period||0
2926437|NCT00570492|3637855|FG001|NOT COMPLETED|52-week Double-blind Treatment Period||50
2926438|NCT00570492|3637856|FG002|NOT COMPLETED|52-week Double-blind Treatment Period||51
2926439|NCT00570505|3637862|FG000|STARTED|Overall Study||149
2926440|NCT00570505|3637862|FG000|COMPLETED|Overall Study|The number of subjects completing the 60-month study|108
2926441|NCT00570505|3637862|FG000|NOT COMPLETED|Overall Study||41
2926442|NCT00570661|3637866|FG000|STARTED|Overall Study||17
2926443|NCT00570661|3637866|FG000|COMPLETED|Overall Study||10
2926444|NCT00570661|3637866|FG000|NOT COMPLETED|Overall Study||7
2926445|NCT00570674|3637871|FG000|STARTED|Overall Study||6
2926446|NCT00570674|3637872|FG001|STARTED|Overall Study||3
2926447|NCT00570674|3637873|FG002|STARTED|Overall Study||4
2926448|NCT00570674|3637874|FG003|STARTED|Overall Study||3
2926449|NCT00570674|3637875|FG004|STARTED|Overall Study||3
2926450|NCT00570674|3637876|FG005|STARTED|Overall Study||10
2926451|NCT00570674|3637877|FG006|STARTED|Overall Study|The study did not continue beyond phase I.|0
2926452|NCT00570674|3637871|FG000|Treated|Overall Study||6
2926453|NCT00570674|3637872|FG001|Treated|Overall Study||3
2926454|NCT00570674|3637873|FG002|Treated|Overall Study||3
2926455|NCT00570674|3637874|FG003|Treated|Overall Study||3
2926456|NCT00570674|3637875|FG004|Treated|Overall Study||3
2926457|NCT00570674|3637876|FG005|Treated|Overall Study||10
2926458|NCT00570674|3637877|FG006|Treated|Overall Study||0
2926459|NCT00570674|3637871|FG000|PEG Evaluable|Overall Study||6
2926460|NCT00570674|3637872|FG001|PEG Evaluable|Overall Study||3
2926461|NCT00570674|3637873|FG002|PEG Evaluable|Overall Study||3
2926462|NCT00570674|3637874|FG003|PEG Evaluable|Overall Study||3
2926463|NCT00570674|3637875|FG004|PEG Evaluable|Overall Study||2
2926464|NCT00570674|3637876|FG005|PEG Evaluable|Overall Study||10
2926465|NCT00570674|3637877|FG006|PEG Evaluable|Overall Study||0
2926466|NCT00570674|3637871|FG000|COMPLETED|Overall Study||6
2926467|NCT00570674|3637872|FG001|COMPLETED|Overall Study||3
2926468|NCT00570674|3637873|FG002|COMPLETED|Overall Study||3
2926469|NCT00570674|3637874|FG003|COMPLETED|Overall Study||3
2926470|NCT00570674|3637875|FG004|COMPLETED|Overall Study||3
2926471|NCT00570674|3637876|FG005|COMPLETED|Overall Study||10
2926472|NCT00570674|3637877|FG006|COMPLETED|Overall Study||0
2926473|NCT00570674|3637871|FG000|NOT COMPLETED|Overall Study||0
2926474|NCT00570674|3637872|FG001|NOT COMPLETED|Overall Study||0
2926475|NCT00570674|3637873|FG002|NOT COMPLETED|Overall Study||1
2926476|NCT00570674|3637874|FG003|NOT COMPLETED|Overall Study||0
2926477|NCT00570674|3637875|FG004|NOT COMPLETED|Overall Study||0
2926478|NCT00570674|3637876|FG005|NOT COMPLETED|Overall Study||0
2926479|NCT00570674|3637877|FG006|NOT COMPLETED|Overall Study||0
2926480|NCT00570687|3637890|FG000|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||0
2926481|NCT00570687|3637891|FG001|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||0
2926482|NCT00570687|3637892|FG002|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||0
2926483|NCT00570687|3637893|FG003|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||0
2926484|NCT00570687|3637894|FG004|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
2926485|NCT00570687|3637895|FG005|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
2926486|NCT00570687|3637896|FG006|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
2926487|NCT00570687|3637897|FG007|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
2926488|NCT00570687|3637898|FG008|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
2926489|NCT00570687|3637899|FG009|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
2926490|NCT00570687|3637890|FG000|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
2926491|NCT00570687|3637891|FG001|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
2926492|NCT00570687|3637892|FG002|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
2926493|NCT00570687|3637893|FG003|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
2926494|NCT00570687|3637894|FG004|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
2926495|NCT00570687|3637895|FG005|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
2926496|NCT00570687|3637896|FG006|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
2926497|NCT00570687|3637897|FG007|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
2926498|NCT00570687|3637898|FG008|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
2926499|NCT00570687|3637899|FG009|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
2926500|NCT00570687|3637890|FG000|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
2926501|NCT00570687|3637891|FG001|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
2926502|NCT00570687|3637892|FG002|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
2926503|NCT00570687|3637893|FG003|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
2926504|NCT00570687|3637894|FG004|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
2926505|NCT00570687|3637895|FG005|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
2926506|NCT00570687|3637896|FG006|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
2926507|NCT00570687|3637897|FG007|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
2926508|NCT00570687|3637898|FG008|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
2926509|NCT00570687|3637899|FG009|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
2926510|NCT00570687|3637890|FG000|STARTED|Washout 1 (7-21 Days) - Orig Protocol||0
2926511|NCT00570687|3637891|FG001|STARTED|Washout 1 (7-21 Days) - Orig Protocol||0
2926512|NCT00570687|3637892|FG002|STARTED|Washout 1 (7-21 Days) - Orig Protocol||0
2926513|NCT00570687|3637893|FG003|STARTED|Washout 1 (7-21 Days) - Orig Protocol||0
2926514|NCT00570687|3637894|FG004|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
2926515|NCT00570687|3637895|FG005|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
2926516|NCT00570687|3637896|FG006|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
2926517|NCT00570687|3637897|FG007|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
2926518|NCT00570687|3637898|FG008|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
2926519|NCT00570687|3637899|FG009|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
2926520|NCT00570687|3637890|FG000|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
2926521|NCT00570687|3637891|FG001|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
2926522|NCT00570687|3637892|FG002|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
2926523|NCT00570687|3637893|FG003|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
2926524|NCT00570687|3637894|FG004|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
2926525|NCT00570687|3637895|FG005|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
2926526|NCT00570687|3637896|FG006|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
2926527|NCT00570687|3637897|FG007|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
2926528|NCT00570687|3637898|FG008|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
2926529|NCT00570687|3637899|FG009|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
2926530|NCT00570687|3637890|FG000|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
2926531|NCT00570687|3637891|FG001|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
2926532|NCT00570687|3637892|FG002|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
2926533|NCT00570687|3637893|FG003|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
2926534|NCT00570687|3637894|FG004|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
2926535|NCT00570687|3637895|FG005|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
2926536|NCT00570687|3637896|FG006|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
2926537|NCT00570687|3637897|FG007|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
2926538|NCT00570687|3637898|FG008|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
2926539|NCT00570687|3637899|FG009|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
2926540|NCT00570687|3637890|FG000|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||0
2926541|NCT00570687|3637891|FG001|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||0
2926542|NCT00570687|3637892|FG002|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||0
2926543|NCT00570687|3637893|FG003|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||0
2926544|NCT00570687|3637894|FG004|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
2926545|NCT00570687|3637895|FG005|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
2926546|NCT00570687|3637896|FG006|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
3039498|NCT01158820|3758918|FG000|COMPLETED|Overall Study||25
3039499|NCT01158820|3758919|FG001|COMPLETED|Overall Study||25
3039500|NCT01158820|3758918|FG000|NOT COMPLETED|Overall Study||0
3039501|NCT01158820|3758919|FG001|NOT COMPLETED|Overall Study||0
3039502|NCT01158885|3758926|FG000|STARTED|Treatment Course 1||2
3039503|NCT01158885|3758926|FG000|COMPLETED|Treatment Course 1||2
3039504|NCT01158885|3758926|FG000|NOT COMPLETED|Treatment Course 1||0
3039505|NCT01158885|3758926|FG000|STARTED|Treatment Course 2|Neither of the patients that were treated on Treatment Course 1 were eligible to proceed to Course 2|0
3039506|NCT01158885|3758926|FG000|COMPLETED|Treatment Course 2||0
3039507|NCT01158885|3758926|FG000|NOT COMPLETED|Treatment Course 2||0
3039508|NCT01158924|3758932|FG000|STARTED|Overall Study||14
3039509|NCT01158924|3758933|FG001|STARTED|Overall Study||26
3039510|NCT01158924|3758932|FG000|COMPLETED|Overall Study||13
3039511|NCT01158924|3758933|FG001|COMPLETED|Overall Study||23
3039512|NCT01158924|3758932|FG000|NOT COMPLETED|Overall Study||1
3039513|NCT01158924|3758933|FG001|NOT COMPLETED|Overall Study||3
3039514|NCT01158950|3758939|FG000|STARTED|1st Intervention (1 Day)||13
3175571|NCT01960816|3903270|FG000|NOT COMPLETED|Overall Study||1
3175572|NCT01960842|3903274|FG000|STARTED|Overall Study||31
3175573|NCT01960842|3903274|FG000|COMPLETED|Overall Study||28
3175574|NCT01960842|3903274|FG000|NOT COMPLETED|Overall Study||3
3175575|NCT01960855|3903283|FG000|STARTED|Overall Study||56
3175576|NCT01960855|3903284|FG001|STARTED|Overall Study||55
3175577|NCT01960855|3903285|FG002|STARTED|Overall Study||55
3175578|NCT01960855|3903286|FG003|STARTED|Overall Study||55
3175579|NCT01960855|3903287|FG004|STARTED|Overall Study||55
3175580|NCT01960855|3903283|FG000|COMPLETED|Overall Study||45
3175581|NCT01960855|3903284|FG001|COMPLETED|Overall Study||51
2926547|NCT00570687|3637897|FG007|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
2926548|NCT00570687|3637898|FG008|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
2926549|NCT00570687|3637899|FG009|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
2926550|NCT00570687|3637890|FG000|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
2926551|NCT00570687|3637891|FG001|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
2926552|NCT00570687|3637892|FG002|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
2926553|NCT00570687|3637893|FG003|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
2926554|NCT00570687|3637894|FG004|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
2926555|NCT00570687|3637895|FG005|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
2926556|NCT00570687|3637896|FG006|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
2926557|NCT00570687|3637897|FG007|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
2926558|NCT00570687|3637898|FG008|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
2926559|NCT00570687|3637899|FG009|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
2926560|NCT00570687|3637890|FG000|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
2926561|NCT00570687|3637891|FG001|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
2926562|NCT00570687|3637892|FG002|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
2926563|NCT00570687|3637893|FG003|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
2926564|NCT00570687|3637894|FG004|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
2926565|NCT00570687|3637895|FG005|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
2926566|NCT00570687|3637896|FG006|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
2926567|NCT00570687|3637897|FG007|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
3137040|NCT01716520|3862279|FG001|NOT COMPLETED|Treatment Period 3 (14 Days)||0
3137041|NCT01716520|3862280|FG002|NOT COMPLETED|Treatment Period 3 (14 Days)||1
2926568|NCT00570687|3637898|FG008|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
2926569|NCT00570687|3637899|FG009|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
2926570|NCT00570687|3637890|FG000|STARTED|Washout 2 (7-21 Days) - Orig Protocol||0
2926571|NCT00570687|3637891|FG001|STARTED|Washout 2 (7-21 Days) - Orig Protocol||0
2926572|NCT00570687|3637892|FG002|STARTED|Washout 2 (7-21 Days) - Orig Protocol||0
2926573|NCT00570687|3637893|FG003|STARTED|Washout 2 (7-21 Days) - Orig Protocol||0
2926574|NCT00570687|3637894|FG004|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
2926575|NCT00570687|3637895|FG005|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
2926576|NCT00570687|3637896|FG006|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
2926577|NCT00570687|3637897|FG007|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
2926578|NCT00570687|3637898|FG008|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
2926579|NCT00570687|3637899|FG009|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
2926580|NCT00570687|3637890|FG000|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
2926581|NCT00570687|3637891|FG001|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
3323369|NCT03200366|4056380|FG001|STARTED|6 Month Post-Baseline Interview||118
3323370|NCT03200366|4056381|FG002|STARTED|6 Month Post-Baseline Interview||128
3323371|NCT03200366|4056379|FG000|COMPLETED|6 Month Post-Baseline Interview||93
3323372|NCT03200366|4056380|FG001|COMPLETED|6 Month Post-Baseline Interview||95
3323373|NCT03200366|4056381|FG002|COMPLETED|6 Month Post-Baseline Interview||109
3323374|NCT03200366|4056379|FG000|NOT COMPLETED|6 Month Post-Baseline Interview||30
3323375|NCT03200366|4056380|FG001|NOT COMPLETED|6 Month Post-Baseline Interview||23
3323376|NCT03200366|4056381|FG002|NOT COMPLETED|6 Month Post-Baseline Interview||19
3175582|NCT01960855|3903285|FG002|COMPLETED|Overall Study||46
3175583|NCT01960855|3903286|FG003|COMPLETED|Overall Study||51
3175584|NCT01960855|3903287|FG004|COMPLETED|Overall Study||50
3175585|NCT01960855|3903283|FG000|NOT COMPLETED|Overall Study||11
3323377|NCT03200366|4056379|FG000|STARTED|9 Month Post-Baseline Interview||121
3175586|NCT01960855|3903284|FG001|NOT COMPLETED|Overall Study||4
3175587|NCT01960855|3903285|FG002|NOT COMPLETED|Overall Study||9
3175588|NCT01960855|3903286|FG003|NOT COMPLETED|Overall Study||4
3175589|NCT01960855|3903287|FG004|NOT COMPLETED|Overall Study||5
3175590|NCT01960907|3903301|FG000|STARTED|Overall Study||158
3175591|NCT01960907|3903302|FG001|STARTED|Overall Study||154
3175592|NCT01960907|3903301|FG000|COMPLETED|Overall Study||122
3175593|NCT01960907|3903302|FG001|COMPLETED|Overall Study||109
3175594|NCT01960907|3903301|FG000|NOT COMPLETED|Overall Study||36
3175595|NCT01960907|3903302|FG001|NOT COMPLETED|Overall Study||45
3175596|NCT01960998|3903313|FG000|STARTED|Overall Study||101
3175597|NCT01960998|3903314|FG001|STARTED|Overall Study||96
3175598|NCT01960998|3903313|FG000|COMPLETED|Overall Study||90
2926582|NCT00570687|3637892|FG002|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
2926583|NCT00570687|3637893|FG003|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
2926584|NCT00570687|3637894|FG004|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
2926585|NCT00570687|3637895|FG005|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
2926586|NCT00570687|3637896|FG006|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
2926587|NCT00570687|3637897|FG007|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
2926588|NCT00570687|3637898|FG008|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
2926589|NCT00570687|3637899|FG009|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
2926590|NCT00570687|3637890|FG000|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
2926591|NCT00570687|3637891|FG001|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
2926592|NCT00570687|3637892|FG002|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
2926593|NCT00570687|3637893|FG003|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
2926594|NCT00570687|3637894|FG004|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
2926595|NCT00570687|3637895|FG005|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
2926596|NCT00570687|3637896|FG006|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
2926597|NCT00570687|3637897|FG007|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
2926598|NCT00570687|3637898|FG008|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
2926599|NCT00570687|3637899|FG009|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
2926600|NCT00570687|3637890|FG000|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||0
2926601|NCT00570687|3637891|FG001|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||0
2926602|NCT00570687|3637892|FG002|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||0
2926603|NCT00570687|3637893|FG003|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||0
2926604|NCT00570687|3637894|FG004|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
2926605|NCT00570687|3637895|FG005|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
2926606|NCT00570687|3637896|FG006|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
2926607|NCT00570687|3637897|FG007|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
2926608|NCT00570687|3637898|FG008|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
2926609|NCT00570687|3637899|FG009|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
2926610|NCT00570687|3637890|FG000|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
2926611|NCT00570687|3637891|FG001|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
2926612|NCT00570687|3637892|FG002|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
2926613|NCT00570687|3637893|FG003|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
2926614|NCT00570687|3637894|FG004|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
2926615|NCT00570687|3637895|FG005|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
2926616|NCT00570687|3637896|FG006|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
2926617|NCT00570687|3637897|FG007|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
2926618|NCT00570687|3637898|FG008|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
2926619|NCT00570687|3637899|FG009|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
2926620|NCT00570687|3637890|FG000|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
2926621|NCT00570687|3637891|FG001|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
3175599|NCT01960998|3903314|FG001|COMPLETED|Overall Study||85
3175600|NCT01960998|3903313|FG000|NOT COMPLETED|Overall Study||11
3175601|NCT01960998|3903314|FG001|NOT COMPLETED|Overall Study||11
3175602|NCT01961089|3903322|FG000|STARTED|Overall Study||40
3175603|NCT01961089|3903322|FG000|COMPLETED|Overall Study||40
3175604|NCT01961089|3903322|FG000|NOT COMPLETED|Overall Study||0
3175605|NCT01961115|3903329|FG000|STARTED|Overall Study||2
3175606|NCT01961115|3903330|FG001|STARTED|Overall Study||0
3175607|NCT01961115|3903331|FG002|STARTED|Overall Study||9
3175608|NCT01961115|3903329|FG000|COMPLETED|Overall Study||0
2926622|NCT00570687|3637892|FG002|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
2926623|NCT00570687|3637893|FG003|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
3039515|NCT01158950|3758940|FG001|STARTED|1st Intervention (1 Day)||13
3175609|NCT01961115|3903330|FG001|COMPLETED|Overall Study||0
3175610|NCT01961115|3903331|FG002|COMPLETED|Overall Study||5
3175611|NCT01961115|3903329|FG000|NOT COMPLETED|Overall Study||2
3175612|NCT01961115|3903330|FG001|NOT COMPLETED|Overall Study||0
3175613|NCT01961115|3903331|FG002|NOT COMPLETED|Overall Study||4
3175614|NCT01961167|3903339|FG000|STARTED|Overall Study||27
3175615|NCT01961167|3903339|FG000|COMPLETED|Overall Study||27
3175616|NCT01961167|3903339|FG000|NOT COMPLETED|Overall Study||0
3175617|NCT01961271|3903343|FG000|STARTED|Overall Study||114
3175618|NCT01961271|3903343|FG000|COMPLETED|Overall Study||64
3175619|NCT01961271|3903343|FG000|NOT COMPLETED|Overall Study||50
3175620|NCT01961297|3903349|FG000|STARTED|Overall Study||30
3175621|NCT01961297|3903350|FG001|STARTED|Overall Study||23
3175622|NCT01961297|3903349|FG000|COMPLETED|Overall Study||28
3175623|NCT01961297|3903350|FG001|COMPLETED|Overall Study||22
3175624|NCT01961297|3903349|FG000|NOT COMPLETED|Overall Study||2
3175625|NCT01961297|3903350|FG001|NOT COMPLETED|Overall Study||1
3175626|NCT01961323|3903356|FG000|STARTED|Overall Study||70
3175627|NCT01961323|3903356|FG000|COMPLETED|Overall Study||21
3175628|NCT01961323|3903356|FG000|NOT COMPLETED|Overall Study||49
3175629|NCT01961349|3903363|FG000|STARTED|Overall Study||54
3175630|NCT01961349|3903364|FG001|STARTED|Overall Study||107
3175631|NCT01961349|3903365|FG002|STARTED|Overall Study||111
3175632|NCT01961349|3903363|FG000|COMPLETED|Overall Study||51
3175633|NCT01961349|3903364|FG001|COMPLETED|Overall Study||101
3175634|NCT01961349|3903365|FG002|COMPLETED|Overall Study||109
3175635|NCT01961349|3903363|FG000|NOT COMPLETED|Overall Study||3
3175636|NCT01961349|3903364|FG001|NOT COMPLETED|Overall Study||6
3175637|NCT01961349|3903365|FG002|NOT COMPLETED|Overall Study||2
3175638|NCT01961362|3903373|FG000|STARTED|Overall Study||19
3175639|NCT01961362|3903373|FG000|COMPLETED|Overall Study||19
3175640|NCT01961362|3903373|FG000|NOT COMPLETED|Overall Study||0
3175641|NCT01961531|3903377|FG000|STARTED|Overall Study||40
3175642|NCT01961531|3903377|FG000|COMPLETED|Overall Study||40
3175643|NCT01961531|3903377|FG000|NOT COMPLETED|Overall Study||0
3175644|NCT01961544|3903381|FG000|STARTED|Overall Study||101
3175645|NCT01961544|3903381|FG000|COMPLETED|Overall Study||88
3175646|NCT01961544|3903381|FG000|NOT COMPLETED|Overall Study||13
3175647|NCT01961609|3903387|FG000|STARTED|Initiation||119
3175648|NCT01961609|3903388|FG001|STARTED|Initiation||116
3175649|NCT01961609|3903389|FG002|STARTED|Initiation||0
3175650|NCT01961609|3903390|FG003|STARTED|Initiation||0
3175651|NCT01961609|3903387|FG000|Safety Set|Initiation||118
2926624|NCT00570687|3637894|FG004|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
2926625|NCT00570687|3637895|FG005|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
2926626|NCT00570687|3637896|FG006|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
2926627|NCT00570687|3637897|FG007|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
2926628|NCT00570687|3637898|FG008|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
2926629|NCT00570687|3637899|FG009|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
2926630|NCT00570687|3637890|FG000|STARTED|Washout 3 (7-21 Days) - Orig Protocol||0
2926631|NCT00570687|3637891|FG001|STARTED|Washout 3 (7-21 Days) - Orig Protocol||0
3039516|NCT01158950|3758939|FG000|Data Collected|1st Intervention (1 Day)||12
3039517|NCT01158950|3758940|FG001|Data Collected|1st Intervention (1 Day)||11
3039518|NCT01158950|3758939|FG000|COMPLETED|1st Intervention (1 Day)||12
3039519|NCT01158950|3758940|FG001|COMPLETED|1st Intervention (1 Day)||11
3039520|NCT01158950|3758939|FG000|NOT COMPLETED|1st Intervention (1 Day)||1
3039521|NCT01158950|3758940|FG001|NOT COMPLETED|1st Intervention (1 Day)||2
3039522|NCT01158950|3758939|FG000|STARTED|Washout (1 Week)||12
3039523|NCT01158950|3758940|FG001|STARTED|Washout (1 Week)||11
3039524|NCT01158950|3758939|FG000|COMPLETED|Washout (1 Week)||12
3039525|NCT01158950|3758940|FG001|COMPLETED|Washout (1 Week)||11
3039526|NCT01158950|3758939|FG000|NOT COMPLETED|Washout (1 Week)||0
3039527|NCT01158950|3758940|FG001|NOT COMPLETED|Washout (1 Week)||0
3039528|NCT01158950|3758939|FG000|STARTED|2nd Intervention (1 Day)||12
3039529|NCT01158950|3758940|FG001|STARTED|2nd Intervention (1 Day)||11
3039530|NCT01158950|3758939|FG000|COMPLETED|2nd Intervention (1 Day)||12
3039531|NCT01158950|3758940|FG001|COMPLETED|2nd Intervention (1 Day)||11
3039532|NCT01158950|3758939|FG000|NOT COMPLETED|2nd Intervention (1 Day)||0
3039533|NCT01158950|3758940|FG001|NOT COMPLETED|2nd Intervention (1 Day)||0
3039534|NCT01158976|3758947|FG000|STARTED|Overall Study||43
3039535|NCT01158976|3758948|FG001|STARTED|Overall Study||21
3039536|NCT01158976|3758947|FG000|COMPLETED|Overall Study||34
3039537|NCT01158976|3758948|FG001|COMPLETED|Overall Study||17
3039538|NCT01158976|3758947|FG000|NOT COMPLETED|Overall Study||9
3039539|NCT01158976|3758948|FG001|NOT COMPLETED|Overall Study||4
3039540|NCT01159015|3758956|FG000|STARTED|Overall Study||357
3039541|NCT01159015|3758957|FG001|STARTED|Overall Study||177
3039542|NCT01159015|3758956|FG000|COMPLETED|Overall Study||339
3039543|NCT01159015|3758957|FG001|COMPLETED|Overall Study||170
3039544|NCT01159015|3758956|FG000|NOT COMPLETED|Overall Study||18
3039545|NCT01159015|3758957|FG001|NOT COMPLETED|Overall Study||7
3039546|NCT01159054|3758963|FG000|STARTED|Overall Study||22
3039547|NCT01159054|3758963|FG000|COMPLETED|Overall Study||2
3039548|NCT01159054|3758963|FG000|NOT COMPLETED|Overall Study||20
3039549|NCT01159067|3758967|FG000|STARTED|Overall Study||1
3039550|NCT01159067|3758967|FG000|COMPLETED|Overall Study||1
3039551|NCT01159067|3758967|FG000|NOT COMPLETED|Overall Study||0
3039552|NCT01159171|3758971|FG000|STARTED|Overall Study||50
3039553|NCT01159171|3758971|FG000|COMPLETED|Overall Study||0
3039554|NCT01159171|3758971|FG000|NOT COMPLETED|Overall Study||50
3039555|NCT01159262|3758979|FG000|STARTED|Overall Study||14
3039556|NCT01159262|3758980|FG001|STARTED|Overall Study||14
3039557|NCT01159262|3758981|FG002|STARTED|Overall Study||8
3039558|NCT01159262|3758979|FG000|COMPLETED|Overall Study||14
3039559|NCT01159262|3758980|FG001|COMPLETED|Overall Study||14
3039560|NCT01159262|3758981|FG002|COMPLETED|Overall Study||8
3039561|NCT01159262|3758979|FG000|NOT COMPLETED|Overall Study||0
3039562|NCT01159262|3758980|FG001|NOT COMPLETED|Overall Study||0
3039563|NCT01159262|3758981|FG002|NOT COMPLETED|Overall Study||0
3039564|NCT01159431|3758991|FG000|STARTED|Overall Study||25
3039565|NCT01159431|3758992|FG001|STARTED|Overall Study||25
3039566|NCT01159431|3758991|FG000|COMPLETED|Overall Study||23
3175652|NCT01961609|3903388|FG001|Safety Set|Initiation||115
3175653|NCT01961609|3903389|FG002|Safety Set|Initiation||0
3175654|NCT01961609|3903390|FG003|Safety Set|Initiation||0
3175655|NCT01961609|3903387|FG000|Full Analysis Set|Initiation||118
2926632|NCT00570687|3637892|FG002|STARTED|Washout 3 (7-21 Days) - Orig Protocol||0
2926633|NCT00570687|3637893|FG003|STARTED|Washout 3 (7-21 Days) - Orig Protocol||0
2926634|NCT00570687|3637894|FG004|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
2926635|NCT00570687|3637895|FG005|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
2926636|NCT00570687|3637896|FG006|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
2926637|NCT00570687|3637897|FG007|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
2926638|NCT00570687|3637898|FG008|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
2926639|NCT00570687|3637899|FG009|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
2926640|NCT00570687|3637890|FG000|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
2926641|NCT00570687|3637891|FG001|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
2926642|NCT00570687|3637892|FG002|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
2926643|NCT00570687|3637893|FG003|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
2926644|NCT00570687|3637894|FG004|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
2926645|NCT00570687|3637895|FG005|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
2926646|NCT00570687|3637896|FG006|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||1
2926647|NCT00570687|3637897|FG007|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
2926648|NCT00570687|3637898|FG008|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||1
2926649|NCT00570687|3637899|FG009|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
2926650|NCT00570687|3637890|FG000|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
2926651|NCT00570687|3637891|FG001|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
2926652|NCT00570687|3637892|FG002|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
2926653|NCT00570687|3637893|FG003|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
2926654|NCT00570687|3637894|FG004|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||3
2926655|NCT00570687|3637895|FG005|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||3
2926656|NCT00570687|3637896|FG006|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||2
2926657|NCT00570687|3637897|FG007|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||3
2926658|NCT00570687|3637898|FG008|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||2
2926659|NCT00570687|3637899|FG009|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||3
2926660|NCT00570687|3637890|FG000|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
2926661|NCT00570687|3637891|FG001|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
2926662|NCT00570687|3637892|FG002|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
2926663|NCT00570687|3637893|FG003|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
2926664|NCT00570687|3637894|FG004|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
2926665|NCT00570687|3637895|FG005|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
2926666|NCT00570687|3637896|FG006|STARTED|Clamp 1 (1 Day) - Orig Protocol||1
2926667|NCT00570687|3637897|FG007|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
2926668|NCT00570687|3637898|FG008|STARTED|Clamp 1 (1 Day) - Orig Protocol||1
2926669|NCT00570687|3637899|FG009|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
3039567|NCT01159431|3758992|FG001|COMPLETED|Overall Study||19
3039568|NCT01159431|3758991|FG000|NOT COMPLETED|Overall Study||2
3039569|NCT01159431|3758992|FG001|NOT COMPLETED|Overall Study||6
3039570|NCT01159535|3759008|FG000|STARTED|Overall Study||103
3039571|NCT01159535|3759009|FG001|STARTED|Overall Study||88
3039572|NCT01159535|3759010|FG002|STARTED|Overall Study||95
3039573|NCT01159535|3759008|FG000|COMPLETED|Overall Study||79
3039574|NCT01159535|3759009|FG001|COMPLETED|Overall Study||64
3039575|NCT01159535|3759010|FG002|COMPLETED|Overall Study||64
3039576|NCT01159535|3759008|FG000|NOT COMPLETED|Overall Study||24
3039577|NCT01159535|3759009|FG001|NOT COMPLETED|Overall Study||24
3039578|NCT01159535|3759010|FG002|NOT COMPLETED|Overall Study||31
3039579|NCT01159574|3759018|FG000|STARTED|Treatment Phase||121
3039580|NCT01159574|3759018|FG000|COMPLETED|Treatment Phase||100
3039581|NCT01159574|3759018|FG000|NOT COMPLETED|Treatment Phase||21
3039582|NCT01159574|3759018|FG000|STARTED|Follow Up Phase||112
3039583|NCT01159574|3759018|FG000|COMPLETED|Follow Up Phase|Completion defined as those that are no longer in long term follow up due to death.|92
3039584|NCT01159574|3759018|FG000|NOT COMPLETED|Follow Up Phase||20
3039585|NCT01159600|3759030|FG000|STARTED|Overall Study||207
3039586|NCT01159600|3759031|FG001|STARTED|Overall Study||217
3039587|NCT01159600|3759032|FG002|STARTED|Overall Study||214
3039588|NCT01159600|3759033|FG003|STARTED|Overall Study||69
3039589|NCT01159600|3759034|FG004|STARTED|Overall Study||225
3039590|NCT01159600|3759035|FG005|STARTED|Overall Study||226
3175656|NCT01961609|3903388|FG001|Full Analysis Set|Initiation||115
3175657|NCT01961609|3903389|FG002|Full Analysis Set|Initiation||0
3175658|NCT01961609|3903390|FG003|Full Analysis Set|Initiation||0
3175659|NCT01961609|3903387|FG000|COMPLETED|Initiation||107
3175660|NCT01961609|3903388|FG001|COMPLETED|Initiation||103
3175661|NCT01961609|3903389|FG002|COMPLETED|Initiation||0
3175662|NCT01961609|3903390|FG003|COMPLETED|Initiation||0
3175663|NCT01961609|3903387|FG000|NOT COMPLETED|Initiation||12
3175664|NCT01961609|3903388|FG001|NOT COMPLETED|Initiation||13
3175665|NCT01961609|3903389|FG002|NOT COMPLETED|Initiation||0
3175666|NCT01961609|3903390|FG003|NOT COMPLETED|Initiation||0
3175667|NCT01961609|3903387|FG000|STARTED|Maintenance 1 (Weeks 17 - 48)||107
3175668|NCT01961609|3903388|FG001|STARTED|Maintenance 1 (Weeks 17 - 48)||66
3175669|NCT01961609|3903389|FG002|STARTED|Maintenance 1 (Weeks 17 - 48)||37
3175670|NCT01961609|3903390|FG003|STARTED|Maintenance 1 (Weeks 17 - 48)||0
3175671|NCT01961609|3903387|FG000|Full Analysis Set|Maintenance 1 (Weeks 17 - 48)||107
3175672|NCT01961609|3903388|FG001|Full Analysis Set|Maintenance 1 (Weeks 17 - 48)||66
3175673|NCT01961609|3903389|FG002|Full Analysis Set|Maintenance 1 (Weeks 17 - 48)||37
3175674|NCT01961609|3903390|FG003|Full Analysis Set|Maintenance 1 (Weeks 17 - 48)||0
3175675|NCT01961609|3903387|FG000|Safety Set|Maintenance 1 (Weeks 17 - 48)||107
3175676|NCT01961609|3903388|FG001|Safety Set|Maintenance 1 (Weeks 17 - 48)||66
3175677|NCT01961609|3903389|FG002|Safety Set|Maintenance 1 (Weeks 17 - 48)||37
3175678|NCT01961609|3903390|FG003|Safety Set|Maintenance 1 (Weeks 17 - 48)||0
3175679|NCT01961609|3903387|FG000|COMPLETED|Maintenance 1 (Weeks 17 - 48)||84
3175680|NCT01961609|3903388|FG001|COMPLETED|Maintenance 1 (Weeks 17 - 48)||55
3175681|NCT01961609|3903389|FG002|COMPLETED|Maintenance 1 (Weeks 17 - 48)||18
2926670|NCT00570687|3637890|FG000|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
2926671|NCT00570687|3637891|FG001|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
2926672|NCT00570687|3637892|FG002|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
2926673|NCT00570687|3637893|FG003|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
2926674|NCT00570687|3637894|FG004|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
2926675|NCT00570687|3637895|FG005|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
2926676|NCT00570687|3637896|FG006|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||1
2926677|NCT00570687|3637897|FG007|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
2926678|NCT00570687|3637898|FG008|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||1
2926679|NCT00570687|3637899|FG009|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
2926680|NCT00570687|3637890|FG000|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
2926681|NCT00570687|3637891|FG001|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
2926682|NCT00570687|3637892|FG002|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
2926683|NCT00570687|3637893|FG003|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
2926684|NCT00570687|3637894|FG004|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
2926685|NCT00570687|3637895|FG005|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
2926686|NCT00570687|3637896|FG006|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
2926687|NCT00570687|3637897|FG007|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
2926688|NCT00570687|3637898|FG008|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
2926689|NCT00570687|3637899|FG009|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
2926690|NCT00570687|3637890|FG000|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
2926691|NCT00570687|3637891|FG001|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
2926692|NCT00570687|3637892|FG002|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
2926693|NCT00570687|3637893|FG003|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
2926694|NCT00570687|3637894|FG004|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
2926695|NCT00570687|3637895|FG005|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
2926696|NCT00570687|3637896|FG006|STARTED|Washout 4 (7-21 Days) - Orig Protocol||1
2926697|NCT00570687|3637897|FG007|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
2926698|NCT00570687|3637898|FG008|STARTED|Washout 4 (7-21 Days) - Orig Protocol||1
2926699|NCT00570687|3637899|FG009|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
2926700|NCT00570687|3637890|FG000|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
2926701|NCT00570687|3637891|FG001|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
2926702|NCT00570687|3637892|FG002|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
2926703|NCT00570687|3637893|FG003|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
2926704|NCT00570687|3637894|FG004|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
2926705|NCT00570687|3637895|FG005|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
2926706|NCT00570687|3637896|FG006|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||1
2926707|NCT00570687|3637897|FG007|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
2926708|NCT00570687|3637898|FG008|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
2926709|NCT00570687|3637899|FG009|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
2926710|NCT00570687|3637890|FG000|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
2926711|NCT00570687|3637891|FG001|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
2926712|NCT00570687|3637892|FG002|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
2926713|NCT00570687|3637893|FG003|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
2926714|NCT00570687|3637894|FG004|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
2926715|NCT00570687|3637895|FG005|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
2926716|NCT00570687|3637896|FG006|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
2926717|NCT00570687|3637897|FG007|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
2926718|NCT00570687|3637898|FG008|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||1
2926719|NCT00570687|3637899|FG009|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
2926720|NCT00570687|3637890|FG000|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
2926721|NCT00570687|3637891|FG001|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
2926722|NCT00570687|3637892|FG002|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
2926723|NCT00570687|3637893|FG003|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
2926724|NCT00570687|3637894|FG004|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
2926725|NCT00570687|3637895|FG005|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
2926726|NCT00570687|3637896|FG006|STARTED|Clamp 2 (1 Day) - Orig Protocol||1
2926727|NCT00570687|3637897|FG007|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
2926728|NCT00570687|3637898|FG008|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
2926729|NCT00570687|3637899|FG009|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
3175682|NCT01961609|3903390|FG003|COMPLETED|Maintenance 1 (Weeks 17 - 48)||0
3175683|NCT01961609|3903387|FG000|NOT COMPLETED|Maintenance 1 (Weeks 17 - 48)||23
3175684|NCT01961609|3903388|FG001|NOT COMPLETED|Maintenance 1 (Weeks 17 - 48)||11
3175685|NCT01961609|3903389|FG002|NOT COMPLETED|Maintenance 1 (Weeks 17 - 48)||19
3175686|NCT01961609|3903390|FG003|NOT COMPLETED|Maintenance 1 (Weeks 17 - 48)||0
3175687|NCT01961609|3903387|FG000|STARTED|Maintanence 2 (Weeks 49 - 72)||83
3175688|NCT01961609|3903388|FG001|STARTED|Maintanence 2 (Weeks 49 - 72)||31
3175689|NCT01961609|3903389|FG002|STARTED|Maintanence 2 (Weeks 49 - 72)||16
3175690|NCT01961609|3903390|FG003|STARTED|Maintanence 2 (Weeks 49 - 72)||24
3175691|NCT01961609|3903387|FG000|Safety Set|Maintanence 2 (Weeks 49 - 72)||83
3175692|NCT01961609|3903388|FG001|Safety Set|Maintanence 2 (Weeks 49 - 72)||31
3175693|NCT01961609|3903389|FG002|Safety Set|Maintanence 2 (Weeks 49 - 72)||16
3175694|NCT01961609|3903390|FG003|Safety Set|Maintanence 2 (Weeks 49 - 72)||24
3175695|NCT01961609|3903387|FG000|Full Analysis Set|Maintanence 2 (Weeks 49 - 72)||83
2926730|NCT00570687|3637890|FG000|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
3175696|NCT01961609|3903388|FG001|Full Analysis Set|Maintanence 2 (Weeks 49 - 72)||31
3175697|NCT01961609|3903389|FG002|Full Analysis Set|Maintanence 2 (Weeks 49 - 72)||16
3175698|NCT01961609|3903390|FG003|Full Analysis Set|Maintanence 2 (Weeks 49 - 72)||24
3175699|NCT01961609|3903387|FG000|COMPLETED|Maintanence 2 (Weeks 49 - 72)||71
3323378|NCT03200366|4056380|FG001|STARTED|9 Month Post-Baseline Interview||116
3323379|NCT03200366|4056381|FG002|STARTED|9 Month Post-Baseline Interview||127
3323380|NCT03200366|4056379|FG000|COMPLETED|9 Month Post-Baseline Interview||97
3175700|NCT01961609|3903388|FG001|COMPLETED|Maintanence 2 (Weeks 49 - 72)||25
3175701|NCT01961609|3903389|FG002|COMPLETED|Maintanence 2 (Weeks 49 - 72)||12
3175702|NCT01961609|3903390|FG003|COMPLETED|Maintanence 2 (Weeks 49 - 72)||17
3175703|NCT01961609|3903387|FG000|NOT COMPLETED|Maintanence 2 (Weeks 49 - 72)||12
3175704|NCT01961609|3903388|FG001|NOT COMPLETED|Maintanence 2 (Weeks 49 - 72)||6
3323381|NCT03200366|4056380|FG001|COMPLETED|9 Month Post-Baseline Interview||95
3323382|NCT03200366|4056381|FG002|COMPLETED|9 Month Post-Baseline Interview||116
3323383|NCT03200366|4056379|FG000|NOT COMPLETED|9 Month Post-Baseline Interview||24
3323384|NCT03200366|4056380|FG001|NOT COMPLETED|9 Month Post-Baseline Interview||21
3323385|NCT03200366|4056381|FG002|NOT COMPLETED|9 Month Post-Baseline Interview||11
3323386|NCT03200535|4056395|FG000|STARTED|Overall Study||1863
3323387|NCT03200535|4056396|FG001|STARTED|Overall Study||1863
3323388|NCT03200535|4056397|FG002|STARTED|Overall Study||1862
3323389|NCT03200535|4056398|FG003|STARTED|Overall Study||1000
3323390|NCT03200535|4056395|FG000|COMPLETED|Overall Study||1863
3323391|NCT03200535|4056396|FG001|COMPLETED|Overall Study||1863
3175705|NCT01961609|3903389|FG002|NOT COMPLETED|Maintanence 2 (Weeks 49 - 72)||4
3175706|NCT01961609|3903390|FG003|NOT COMPLETED|Maintanence 2 (Weeks 49 - 72)||7
3175707|NCT01961687|3903407|FG000|STARTED|Overall Study||121
3175708|NCT01961687|3903407|FG000|COMPLETED|Overall Study||60
3175709|NCT01961687|3903407|FG000|NOT COMPLETED|Overall Study||61
3175710|NCT01961882|3903413|FG000|STARTED|Overall Study||69
3175711|NCT01961882|3903414|FG001|STARTED|Overall Study||65
3175712|NCT01961882|3903413|FG000|COMPLETED|Overall Study||19
3175713|NCT01961882|3903414|FG001|COMPLETED|Overall Study||23
3175714|NCT01961882|3903413|FG000|NOT COMPLETED|Overall Study||50
3175715|NCT01961882|3903414|FG001|NOT COMPLETED|Overall Study||42
3175716|NCT01961921|3903420|FG000|STARTED|Overall Study||27
3175717|NCT01961921|3903420|FG000|COMPLETED|Overall Study||25
3175718|NCT01961921|3903420|FG000|NOT COMPLETED|Overall Study||2
3175719|NCT01962025|3903426|FG000|STARTED|Overall Study||8
3175720|NCT01962025|3903427|FG001|STARTED|Overall Study||6
3175721|NCT01962025|3903426|FG000|COMPLETED|Overall Study||8
3175722|NCT01962025|3903427|FG001|COMPLETED|Overall Study||6
3175723|NCT01962025|3903426|FG000|NOT COMPLETED|Overall Study||0
3175724|NCT01962025|3903427|FG001|NOT COMPLETED|Overall Study||0
2926731|NCT00570687|3637891|FG001|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
2926732|NCT00570687|3637892|FG002|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
2926733|NCT00570687|3637893|FG003|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
2926734|NCT00570687|3637894|FG004|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
2926735|NCT00570687|3637895|FG005|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
2926736|NCT00570687|3637896|FG006|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||1
2926737|NCT00570687|3637897|FG007|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
2926738|NCT00570687|3637898|FG008|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
2926739|NCT00570687|3637899|FG009|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
2926740|NCT00570687|3637890|FG000|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
2926741|NCT00570687|3637891|FG001|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
2926742|NCT00570687|3637892|FG002|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
2926743|NCT00570687|3637893|FG003|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
2926744|NCT00570687|3637894|FG004|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
2926745|NCT00570687|3637895|FG005|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
2926746|NCT00570687|3637896|FG006|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
2926747|NCT00570687|3637897|FG007|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
2926748|NCT00570687|3637898|FG008|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
2926749|NCT00570687|3637899|FG009|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
2926750|NCT00570687|3637890|FG000|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
2926751|NCT00570687|3637891|FG001|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
2926752|NCT00570687|3637892|FG002|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
2926753|NCT00570687|3637893|FG003|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
2926754|NCT00570687|3637894|FG004|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
2926755|NCT00570687|3637895|FG005|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
2926756|NCT00570687|3637896|FG006|STARTED|Washout 5 (7-21 Days) - Orig Protocol||1
2926757|NCT00570687|3637897|FG007|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
2926758|NCT00570687|3637898|FG008|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
2926759|NCT00570687|3637899|FG009|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
2926760|NCT00570687|3637890|FG000|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
2926761|NCT00570687|3637891|FG001|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
2926762|NCT00570687|3637892|FG002|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
2926763|NCT00570687|3637893|FG003|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
2926764|NCT00570687|3637894|FG004|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
2926765|NCT00570687|3637895|FG005|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
2926766|NCT00570687|3637896|FG006|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
2926767|NCT00570687|3637897|FG007|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
2926768|NCT00570687|3637898|FG008|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
2926769|NCT00570687|3637899|FG009|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
2926770|NCT00570687|3637890|FG000|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
2926771|NCT00570687|3637891|FG001|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
2926772|NCT00570687|3637892|FG002|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
2926773|NCT00570687|3637893|FG003|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
2926774|NCT00570687|3637894|FG004|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
2926775|NCT00570687|3637895|FG005|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
2926776|NCT00570687|3637896|FG006|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||1
2926777|NCT00570687|3637897|FG007|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
2926778|NCT00570687|3637898|FG008|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
2926779|NCT00570687|3637899|FG009|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
2926780|NCT00570687|3637890|FG000|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||4
2926781|NCT00570687|3637891|FG001|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||2
2926782|NCT00570687|3637892|FG002|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||2
2926783|NCT00570687|3637893|FG003|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||4
2926784|NCT00570687|3637894|FG004|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
2926785|NCT00570687|3637895|FG005|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
2926786|NCT00570687|3637896|FG006|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
2926787|NCT00570687|3637897|FG007|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
2926788|NCT00570687|3637898|FG008|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
2926789|NCT00570687|3637899|FG009|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
2926790|NCT00570687|3637890|FG000|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||4
2926791|NCT00570687|3637891|FG001|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||2
3175725|NCT01962103|3903444|FG000|STARTED|Phase 1||16
3175726|NCT01962103|3903445|FG001|STARTED|Phase 1||8
3175727|NCT01962103|3903446|FG002|STARTED|Phase 1||14
3175728|NCT01962103|3903447|FG003|STARTED|Phase 1||11
3175729|NCT01962103|3903448|FG004|STARTED|Phase 1||8
3175730|NCT01962103|3903449|FG005|STARTED|Phase 1||7
3175731|NCT01962103|3903450|FG006|STARTED|Phase 1||0
3175732|NCT01962103|3903451|FG007|STARTED|Phase 1||0
3175733|NCT01962103|3903452|FG008|STARTED|Phase 1||0
3175734|NCT01962103|3903444|FG000|COMPLETED|Phase 1||0
3175735|NCT01962103|3903445|FG001|COMPLETED|Phase 1||0
3175736|NCT01962103|3903446|FG002|COMPLETED|Phase 1||0
3175737|NCT01962103|3903447|FG003|COMPLETED|Phase 1||0
3175738|NCT01962103|3903448|FG004|COMPLETED|Phase 1||0
3175739|NCT01962103|3903449|FG005|COMPLETED|Phase 1||0
3175740|NCT01962103|3903450|FG006|COMPLETED|Phase 1||0
3175741|NCT01962103|3903451|FG007|COMPLETED|Phase 1||0
3175742|NCT01962103|3903452|FG008|COMPLETED|Phase 1||0
2926792|NCT00570687|3637892|FG002|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||2
2926793|NCT00570687|3637893|FG003|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||4
2926794|NCT00570687|3637894|FG004|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
2926795|NCT00570687|3637895|FG005|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
2926796|NCT00570687|3637896|FG006|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
2926797|NCT00570687|3637897|FG007|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
2926798|NCT00570687|3637898|FG008|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
2926799|NCT00570687|3637899|FG009|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
2926800|NCT00570687|3637890|FG000|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
2926801|NCT00570687|3637891|FG001|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
2926802|NCT00570687|3637892|FG002|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
2926803|NCT00570687|3637893|FG003|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
2926804|NCT00570687|3637894|FG004|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
2926805|NCT00570687|3637895|FG005|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
2926806|NCT00570687|3637896|FG006|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
2926807|NCT00570687|3637897|FG007|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
2926808|NCT00570687|3637898|FG008|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
2926809|NCT00570687|3637899|FG009|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
2926810|NCT00570687|3637890|FG000|STARTED|Washout 1 (7-21 Days) - Amendment 1||4
2926811|NCT00570687|3637891|FG001|STARTED|Washout 1 (7-21 Days) - Amendment 1||2
2926812|NCT00570687|3637892|FG002|STARTED|Washout 1 (7-21 Days) - Amendment 1||2
2926813|NCT00570687|3637893|FG003|STARTED|Washout 1 (7-21 Days) - Amendment 1||4
2926814|NCT00570687|3637894|FG004|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
2926815|NCT00570687|3637895|FG005|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
2926816|NCT00570687|3637896|FG006|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
2926817|NCT00570687|3637897|FG007|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
2926818|NCT00570687|3637898|FG008|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
2926819|NCT00570687|3637899|FG009|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
2926820|NCT00570687|3637890|FG000|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||4
2926821|NCT00570687|3637891|FG001|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||2
2926822|NCT00570687|3637892|FG002|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||2
2926823|NCT00570687|3637893|FG003|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||4
2926824|NCT00570687|3637894|FG004|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
2926825|NCT00570687|3637895|FG005|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
2926826|NCT00570687|3637896|FG006|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
2926827|NCT00570687|3637897|FG007|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
3323392|NCT03200535|4056397|FG002|COMPLETED|Overall Study||1862
3323393|NCT03200535|4056398|FG003|COMPLETED|Overall Study||1000
3323394|NCT03200535|4056395|FG000|NOT COMPLETED|Overall Study||0
3323395|NCT03200535|4056396|FG001|NOT COMPLETED|Overall Study||0
3323396|NCT03200535|4056397|FG002|NOT COMPLETED|Overall Study||0
3323397|NCT03200535|4056398|FG003|NOT COMPLETED|Overall Study||0
2926828|NCT00570687|3637898|FG008|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
2926829|NCT00570687|3637899|FG009|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
2926830|NCT00570687|3637890|FG000|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
2926831|NCT00570687|3637891|FG001|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
2926832|NCT00570687|3637892|FG002|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
2926833|NCT00570687|3637893|FG003|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
2926834|NCT00570687|3637894|FG004|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
2926835|NCT00570687|3637895|FG005|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
2926836|NCT00570687|3637896|FG006|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
2926837|NCT00570687|3637897|FG007|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
3323398|NCT03200860|4056410|FG000|STARTED|Overall Study||41
3323399|NCT03200860|4056411|FG001|STARTED|Overall Study||39
3323400|NCT03200860|4056410|FG000|COMPLETED|Overall Study||40
3323401|NCT03200860|4056411|FG001|COMPLETED|Overall Study||39
3323402|NCT03200860|4056410|FG000|NOT COMPLETED|Overall Study||1
3323403|NCT03200860|4056411|FG001|NOT COMPLETED|Overall Study||0
3323404|NCT03200912|4056420|FG000|STARTED|Overall Study||170
2926838|NCT00570687|3637898|FG008|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
2926839|NCT00570687|3637899|FG009|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
2926840|NCT00570687|3637890|FG000|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||4
2926841|NCT00570687|3637891|FG001|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||2
2926842|NCT00570687|3637892|FG002|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||2
2926843|NCT00570687|3637893|FG003|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||4
2926844|NCT00570687|3637894|FG004|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
2926845|NCT00570687|3637895|FG005|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
2926846|NCT00570687|3637896|FG006|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
2926847|NCT00570687|3637897|FG007|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
2926848|NCT00570687|3637898|FG008|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
2926849|NCT00570687|3637899|FG009|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
2926850|NCT00570687|3637890|FG000|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||4
2926851|NCT00570687|3637891|FG001|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||2
2926852|NCT00570687|3637892|FG002|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||2
2926853|NCT00570687|3637893|FG003|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||4
2926854|NCT00570687|3637894|FG004|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
2926855|NCT00570687|3637895|FG005|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
2926856|NCT00570687|3637896|FG006|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
2926857|NCT00570687|3637897|FG007|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
3039591|NCT01159600|3759036|FG006|STARTED|Overall Study||218
3039592|NCT01159600|3759037|FG007|STARTED|Overall Study||103
3039593|NCT01159600|3759030|FG000|COMPLETED|Overall Study||186
3039594|NCT01159600|3759031|FG001|COMPLETED|Overall Study||209
3039595|NCT01159600|3759032|FG002|COMPLETED|Overall Study||196
3039596|NCT01159600|3759033|FG003|COMPLETED|Overall Study||58
3039597|NCT01159600|3759034|FG004|COMPLETED|Overall Study||201
3039598|NCT01159600|3759035|FG005|COMPLETED|Overall Study||208
3039599|NCT01159600|3759036|FG006|COMPLETED|Overall Study||199
3039600|NCT01159600|3759037|FG007|COMPLETED|Overall Study||85
3039601|NCT01159600|3759030|FG000|NOT COMPLETED|Overall Study||21
3039602|NCT01159600|3759031|FG001|NOT COMPLETED|Overall Study||8
3039603|NCT01159600|3759032|FG002|NOT COMPLETED|Overall Study||18
3039604|NCT01159600|3759033|FG003|NOT COMPLETED|Overall Study||11
3039605|NCT01159600|3759034|FG004|NOT COMPLETED|Overall Study||24
3039606|NCT01159600|3759035|FG005|NOT COMPLETED|Overall Study||18
3039607|NCT01159600|3759036|FG006|NOT COMPLETED|Overall Study||19
3039608|NCT01159600|3759037|FG007|NOT COMPLETED|Overall Study||18
3039609|NCT01159665|3759062|FG000|STARTED|Overall Study||9
3039610|NCT01159665|3759063|FG001|STARTED|Overall Study||9
3039611|NCT01159665|3759064|FG002|STARTED|Overall Study||8
3039612|NCT01159665|3759065|FG003|STARTED|Overall Study||4
3039613|NCT01159665|3759066|FG004|STARTED|Overall Study||4
3039614|NCT01159665|3759067|FG005|STARTED|Overall Study||4
3175743|NCT01962103|3903444|FG000|NOT COMPLETED|Phase 1||16
3175744|NCT01962103|3903445|FG001|NOT COMPLETED|Phase 1||8
3175745|NCT01962103|3903446|FG002|NOT COMPLETED|Phase 1||14
3175746|NCT01962103|3903447|FG003|NOT COMPLETED|Phase 1||11
3175747|NCT01962103|3903448|FG004|NOT COMPLETED|Phase 1||8
3175748|NCT01962103|3903449|FG005|NOT COMPLETED|Phase 1||7
3175749|NCT01962103|3903450|FG006|NOT COMPLETED|Phase 1||0
3175750|NCT01962103|3903451|FG007|NOT COMPLETED|Phase 1||0
3175751|NCT01962103|3903452|FG008|NOT COMPLETED|Phase 1||0
3175752|NCT01962103|3903444|FG000|STARTED|Phase 2||0
3175753|NCT01962103|3903445|FG001|STARTED|Phase 2||0
3175754|NCT01962103|3903446|FG002|STARTED|Phase 2||0
3175755|NCT01962103|3903447|FG003|STARTED|Phase 2||0
3175756|NCT01962103|3903448|FG004|STARTED|Phase 2||0
3175757|NCT01962103|3903449|FG005|STARTED|Phase 2||0
3175758|NCT01962103|3903450|FG006|STARTED|Phase 2||14
3175759|NCT01962103|3903451|FG007|STARTED|Phase 2||14
3175760|NCT01962103|3903452|FG008|STARTED|Phase 2||14
3175761|NCT01962103|3903444|FG000|COMPLETED|Phase 2||0
3175762|NCT01962103|3903445|FG001|COMPLETED|Phase 2||0
3175763|NCT01962103|3903446|FG002|COMPLETED|Phase 2||0
2926858|NCT00570687|3637898|FG008|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
3175764|NCT01962103|3903447|FG003|COMPLETED|Phase 2||0
3175765|NCT01962103|3903448|FG004|COMPLETED|Phase 2||0
3175766|NCT01962103|3903449|FG005|COMPLETED|Phase 2||0
3175767|NCT01962103|3903450|FG006|COMPLETED|Phase 2|completed treatment|0
3175768|NCT01962103|3903451|FG007|COMPLETED|Phase 2|completed treatment|0
3175769|NCT01962103|3903452|FG008|COMPLETED|Phase 2|completed treatment|0
3175770|NCT01962103|3903444|FG000|NOT COMPLETED|Phase 2||0
3175771|NCT01962103|3903445|FG001|NOT COMPLETED|Phase 2||0
3175772|NCT01962103|3903446|FG002|NOT COMPLETED|Phase 2||0
3175773|NCT01962103|3903447|FG003|NOT COMPLETED|Phase 2||0
3175774|NCT01962103|3903448|FG004|NOT COMPLETED|Phase 2||0
3175775|NCT01962103|3903449|FG005|NOT COMPLETED|Phase 2||0
3175776|NCT01962103|3903450|FG006|NOT COMPLETED|Phase 2||14
3175777|NCT01962103|3903451|FG007|NOT COMPLETED|Phase 2||14
3175778|NCT01962103|3903452|FG008|NOT COMPLETED|Phase 2||14
3175779|NCT01962207|3903476|FG000|STARTED|Persistence Phase (5 Years)||76
3175780|NCT01962207|3903477|FG001|STARTED|Persistence Phase (5 Years)||23
3175781|NCT01962207|3903478|FG002|STARTED|Persistence Phase (5 Years)||115
3039615|NCT01159665|3759062|FG000|COMPLETED|Overall Study||9
3175782|NCT01962207|3903479|FG003|STARTED|Persistence Phase (5 Years)||29
3175783|NCT01962207|3903476|FG000|COMPLETED|Persistence Phase (5 Years)||47
3175784|NCT01962207|3903477|FG001|COMPLETED|Persistence Phase (5 Years)||10
3175785|NCT01962207|3903478|FG002|COMPLETED|Persistence Phase (5 Years)||71
3175786|NCT01962207|3903479|FG003|COMPLETED|Persistence Phase (5 Years)||17
3175787|NCT01962207|3903476|FG000|NOT COMPLETED|Persistence Phase (5 Years)||29
3175788|NCT01962207|3903477|FG001|NOT COMPLETED|Persistence Phase (5 Years)||13
3175789|NCT01962207|3903478|FG002|NOT COMPLETED|Persistence Phase (5 Years)||44
3323405|NCT03200912|4056421|FG001|STARTED|Overall Study||169
3323406|NCT03200912|4056422|FG002|STARTED|Overall Study||168
3323407|NCT03200912|4056420|FG000|COMPLETED|Overall Study||166
3323408|NCT03200912|4056421|FG001|COMPLETED|Overall Study||166
3323409|NCT03200912|4056422|FG002|COMPLETED|Overall Study||164
3323410|NCT03200912|4056420|FG000|NOT COMPLETED|Overall Study||4
3323411|NCT03200912|4056421|FG001|NOT COMPLETED|Overall Study||3
3323412|NCT03200912|4056422|FG002|NOT COMPLETED|Overall Study||4
3323413|NCT03200925|4056432|FG000|STARTED|Overall Study||120
3323414|NCT03200925|4056433|FG001|STARTED|Overall Study||120
3323415|NCT03200925|4056432|FG000|COMPLETED|Overall Study||120
3039616|NCT01159665|3759063|FG001|COMPLETED|Overall Study||8
3175790|NCT01962207|3903479|FG003|NOT COMPLETED|Persistence Phase (5 Years)||12
3175791|NCT01962207|3903476|FG000|STARTED|Booster Phase (6 Months)|Eligible participants from persistence phase who provided consent to get enrolled in booster phase.|67
2926859|NCT00570687|3637899|FG009|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
2926860|NCT00570687|3637890|FG000|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
2926861|NCT00570687|3637891|FG001|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
2926862|NCT00570687|3637892|FG002|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
2926863|NCT00570687|3637893|FG003|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
2926864|NCT00570687|3637894|FG004|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
2926865|NCT00570687|3637895|FG005|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
2926866|NCT00570687|3637896|FG006|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
2926867|NCT00570687|3637897|FG007|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
3175792|NCT01962207|3903477|FG001|STARTED|Booster Phase (6 Months)|Eligible participants from persistence phase who provided consent to get enrolled in booster phase.|16
3175793|NCT01962207|3903478|FG002|STARTED|Booster Phase (6 Months)|Eligible participants from persistence phase who provided consent to get enrolled in booster phase.|77
3175794|NCT01962207|3903479|FG003|STARTED|Booster Phase (6 Months)|Eligible participants from persistence phase who provided consent to get enrolled in booster phase.|21
3175795|NCT01962207|3903476|FG000|COMPLETED|Booster Phase (6 Months)||67
2926868|NCT00570687|3637898|FG008|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
2926869|NCT00570687|3637899|FG009|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
2926870|NCT00570687|3637890|FG000|STARTED|Washout 2 (8 Weeks) - Amendment 1||4
2926871|NCT00570687|3637891|FG001|STARTED|Washout 2 (8 Weeks) - Amendment 1||2
2926872|NCT00570687|3637892|FG002|STARTED|Washout 2 (8 Weeks) - Amendment 1||2
2926873|NCT00570687|3637893|FG003|STARTED|Washout 2 (8 Weeks) - Amendment 1||4
2926874|NCT00570687|3637894|FG004|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
2926875|NCT00570687|3637895|FG005|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
2926876|NCT00570687|3637896|FG006|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
2926877|NCT00570687|3637897|FG007|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
2926878|NCT00570687|3637898|FG008|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
2926879|NCT00570687|3637899|FG009|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
2926880|NCT00570687|3637890|FG000|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||4
2926881|NCT00570687|3637891|FG001|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||2
2926882|NCT00570687|3637892|FG002|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||2
2926883|NCT00570687|3637893|FG003|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||4
2926884|NCT00570687|3637894|FG004|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
2926885|NCT00570687|3637895|FG005|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
2926886|NCT00570687|3637896|FG006|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
2926887|NCT00570687|3637897|FG007|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
2926888|NCT00570687|3637898|FG008|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
2926889|NCT00570687|3637899|FG009|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
2926890|NCT00570687|3637890|FG000|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
2926891|NCT00570687|3637891|FG001|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
2926892|NCT00570687|3637892|FG002|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
2926893|NCT00570687|3637893|FG003|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
2926894|NCT00570687|3637894|FG004|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
2926895|NCT00570687|3637895|FG005|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
2926896|NCT00570687|3637896|FG006|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
3175796|NCT01962207|3903477|FG001|COMPLETED|Booster Phase (6 Months)||16
3175797|NCT01962207|3903478|FG002|COMPLETED|Booster Phase (6 Months)||77
3175798|NCT01962207|3903479|FG003|COMPLETED|Booster Phase (6 Months)||21
3175799|NCT01962207|3903476|FG000|NOT COMPLETED|Booster Phase (6 Months)||0
3175800|NCT01962207|3903477|FG001|NOT COMPLETED|Booster Phase (6 Months)||0
3175801|NCT01962207|3903478|FG002|NOT COMPLETED|Booster Phase (6 Months)||0
3175802|NCT01962207|3903479|FG003|NOT COMPLETED|Booster Phase (6 Months)||0
3175803|NCT01962298|3903498|FG000|STARTED|Overall Study||15
3175804|NCT01962298|3903499|FG001|STARTED|Overall Study||15
3175805|NCT01962298|3903500|FG002|STARTED|Overall Study||15
3175806|NCT01962298|3903501|FG003|STARTED|Overall Study||15
3175807|NCT01962298|3903502|FG004|STARTED|Overall Study||15
3323416|NCT03200925|4056433|FG001|COMPLETED|Overall Study||120
3175808|NCT01962298|3903498|FG000|Received Intervention|Overall Study|1 subject did not receive the planned intervention and received a different one for clinical reasons|14
3175809|NCT01962298|3903499|FG001|Received Intervention|Overall Study||15
3175810|NCT01962298|3903500|FG002|Received Intervention|Overall Study||15
3175811|NCT01962298|3903501|FG003|Received Intervention|Overall Study||15
3175812|NCT01962298|3903502|FG004|Received Intervention|Overall Study||15
3175813|NCT01962298|3903498|FG000|COMPLETED|Overall Study||12
3175814|NCT01962298|3903499|FG001|COMPLETED|Overall Study||11
3175815|NCT01962298|3903500|FG002|COMPLETED|Overall Study||10
3175816|NCT01962298|3903501|FG003|COMPLETED|Overall Study||13
3175817|NCT01962298|3903502|FG004|COMPLETED|Overall Study||9
3175818|NCT01962298|3903498|FG000|NOT COMPLETED|Overall Study||3
3175819|NCT01962298|3903499|FG001|NOT COMPLETED|Overall Study||4
3175820|NCT01962298|3903500|FG002|NOT COMPLETED|Overall Study||5
3175821|NCT01962298|3903501|FG003|NOT COMPLETED|Overall Study||2
3175822|NCT01962298|3903502|FG004|NOT COMPLETED|Overall Study||6
3175823|NCT01962428|3903516|FG000|STARTED|Overall Study||139
3175824|NCT01962428|3903517|FG001|STARTED|Overall Study||139
3175825|NCT01962428|3903516|FG000|COMPLETED|Overall Study||129
3175826|NCT01962428|3903517|FG001|COMPLETED|Overall Study||133
2926897|NCT00570687|3637897|FG007|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
2926898|NCT00570687|3637898|FG008|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
2926899|NCT00570687|3637899|FG009|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
2926900|NCT00570687|3637890|FG000|STARTED|Clamp 1 (1 Day) - Amendment 1||4
2926901|NCT00570687|3637891|FG001|STARTED|Clamp 1 (1 Day) - Amendment 1||2
2926902|NCT00570687|3637892|FG002|STARTED|Clamp 1 (1 Day) - Amendment 1||2
2926903|NCT00570687|3637893|FG003|STARTED|Clamp 1 (1 Day) - Amendment 1||4
2926904|NCT00570687|3637894|FG004|STARTED|Clamp 1 (1 Day) - Amendment 1||0
2926905|NCT00570687|3637895|FG005|STARTED|Clamp 1 (1 Day) - Amendment 1||0
2926906|NCT00570687|3637896|FG006|STARTED|Clamp 1 (1 Day) - Amendment 1||0
2926907|NCT00570687|3637897|FG007|STARTED|Clamp 1 (1 Day) - Amendment 1||0
2926908|NCT00570687|3637898|FG008|STARTED|Clamp 1 (1 Day) - Amendment 1||0
2926909|NCT00570687|3637899|FG009|STARTED|Clamp 1 (1 Day) - Amendment 1||0
2926910|NCT00570687|3637890|FG000|COMPLETED|Clamp 1 (1 Day) - Amendment 1||4
2926911|NCT00570687|3637891|FG001|COMPLETED|Clamp 1 (1 Day) - Amendment 1||2
2926912|NCT00570687|3637892|FG002|COMPLETED|Clamp 1 (1 Day) - Amendment 1||2
2926913|NCT00570687|3637893|FG003|COMPLETED|Clamp 1 (1 Day) - Amendment 1||4
2926914|NCT00570687|3637894|FG004|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
2926915|NCT00570687|3637895|FG005|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
2926916|NCT00570687|3637896|FG006|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
2926917|NCT00570687|3637897|FG007|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
2926918|NCT00570687|3637898|FG008|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
2926919|NCT00570687|3637899|FG009|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
2926920|NCT00570687|3637890|FG000|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
2926921|NCT00570687|3637891|FG001|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
2926922|NCT00570687|3637892|FG002|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
2926923|NCT00570687|3637893|FG003|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
2926924|NCT00570687|3637894|FG004|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
2926925|NCT00570687|3637895|FG005|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
3175827|NCT01962428|3903516|FG000|NOT COMPLETED|Overall Study||10
3175828|NCT01962428|3903517|FG001|NOT COMPLETED|Overall Study||6
3175829|NCT01962441|3903526|FG000|STARTED|Randomized Period||200
3175830|NCT01962441|3903527|FG001|STARTED|Randomized Period||201
3175831|NCT01962441|3903528|FG002|STARTED|Randomized Period||200
3175832|NCT01962441|3903526|FG000|COMPLETED|Randomized Period||190
3175833|NCT01962441|3903527|FG001|COMPLETED|Randomized Period||190
3175834|NCT01962441|3903528|FG002|COMPLETED|Randomized Period||189
3175835|NCT01962441|3903526|FG000|NOT COMPLETED|Randomized Period||10
3175836|NCT01962441|3903527|FG001|NOT COMPLETED|Randomized Period||11
3175837|NCT01962441|3903528|FG002|NOT COMPLETED|Randomized Period||11
3175838|NCT01962441|3903526|FG000|STARTED|Retreatment Substudy|20 participants who experienced virologic failure enrolled into the Retreatment Substudy.|20
3175839|NCT01962441|3903527|FG001|STARTED|Retreatment Substudy|10 participants who experienced virologic failure enrolled into the Retreatment Substudy.|10
3175840|NCT01962441|3903528|FG002|STARTED|Retreatment Substudy|Participants in the SOF+RBV+Peg-IFN group were not eligible to enroll in the Retreatment Substudy.|0
3175841|NCT01962441|3903526|FG000|COMPLETED|Retreatment Substudy||18
3175842|NCT01962441|3903527|FG001|COMPLETED|Retreatment Substudy||10
3175843|NCT01962441|3903528|FG002|COMPLETED|Retreatment Substudy||0
3175844|NCT01962441|3903526|FG000|NOT COMPLETED|Retreatment Substudy||2
2926926|NCT00570687|3637896|FG006|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
2926927|NCT00570687|3637897|FG007|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
2926928|NCT00570687|3637898|FG008|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
2926929|NCT00570687|3637899|FG009|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
2926930|NCT00570687|3637890|FG000|STARTED|Washout 3 (7-21 Days) - Amendment 1||4
2926931|NCT00570687|3637891|FG001|STARTED|Washout 3 (7-21 Days) - Amendment 1||2
2926932|NCT00570687|3637892|FG002|STARTED|Washout 3 (7-21 Days) - Amendment 1||2
2926933|NCT00570687|3637893|FG003|STARTED|Washout 3 (7-21 Days) - Amendment 1||4
2926934|NCT00570687|3637894|FG004|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
2926935|NCT00570687|3637895|FG005|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
2926936|NCT00570687|3637896|FG006|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
2926937|NCT00570687|3637897|FG007|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
2926938|NCT00570687|3637898|FG008|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
2926939|NCT00570687|3637899|FG009|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
2926940|NCT00570687|3637890|FG000|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||4
2926941|NCT00570687|3637891|FG001|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||2
2926942|NCT00570687|3637892|FG002|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||2
2926943|NCT00570687|3637893|FG003|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||4
2926944|NCT00570687|3637894|FG004|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
2926945|NCT00570687|3637895|FG005|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
2926946|NCT00570687|3637896|FG006|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
2926947|NCT00570687|3637897|FG007|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
2926948|NCT00570687|3637898|FG008|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
2926949|NCT00570687|3637899|FG009|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
2926950|NCT00570687|3637890|FG000|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
2926951|NCT00570687|3637891|FG001|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
2926952|NCT00570687|3637892|FG002|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
2926953|NCT00570687|3637893|FG003|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
2926954|NCT00570687|3637894|FG004|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
2926955|NCT00570687|3637895|FG005|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
2926956|NCT00570687|3637896|FG006|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
2926957|NCT00570687|3637897|FG007|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
2926958|NCT00570687|3637898|FG008|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
2926959|NCT00570687|3637899|FG009|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
2926960|NCT00570687|3637890|FG000|STARTED|Clamp 2 (1 Day) - Amendment 1||4
2926961|NCT00570687|3637891|FG001|STARTED|Clamp 2 (1 Day) - Amendment 1||2
2926962|NCT00570687|3637892|FG002|STARTED|Clamp 2 (1 Day) - Amendment 1||2
2926963|NCT00570687|3637893|FG003|STARTED|Clamp 2 (1 Day) - Amendment 1||4
2926964|NCT00570687|3637894|FG004|STARTED|Clamp 2 (1 Day) - Amendment 1||0
2926965|NCT00570687|3637895|FG005|STARTED|Clamp 2 (1 Day) - Amendment 1||0
2926966|NCT00570687|3637896|FG006|STARTED|Clamp 2 (1 Day) - Amendment 1||0
2926967|NCT00570687|3637897|FG007|STARTED|Clamp 2 (1 Day) - Amendment 1||0
2926968|NCT00570687|3637898|FG008|STARTED|Clamp 2 (1 Day) - Amendment 1||0
2926969|NCT00570687|3637899|FG009|STARTED|Clamp 2 (1 Day) - Amendment 1||0
2926970|NCT00570687|3637890|FG000|COMPLETED|Clamp 2 (1 Day) - Amendment 1||4
2926971|NCT00570687|3637891|FG001|COMPLETED|Clamp 2 (1 Day) - Amendment 1||2
2926972|NCT00570687|3637892|FG002|COMPLETED|Clamp 2 (1 Day) - Amendment 1||2
2926973|NCT00570687|3637893|FG003|COMPLETED|Clamp 2 (1 Day) - Amendment 1||4
2926974|NCT00570687|3637894|FG004|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
2926975|NCT00570687|3637895|FG005|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
2926976|NCT00570687|3637896|FG006|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
2926977|NCT00570687|3637897|FG007|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
2926978|NCT00570687|3637898|FG008|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
2926979|NCT00570687|3637899|FG009|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
2926980|NCT00570687|3637890|FG000|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
2926981|NCT00570687|3637891|FG001|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
2926982|NCT00570687|3637892|FG002|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
2926983|NCT00570687|3637893|FG003|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
2926984|NCT00570687|3637894|FG004|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
2926985|NCT00570687|3637895|FG005|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
2926986|NCT00570687|3637896|FG006|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
2926987|NCT00570687|3637897|FG007|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
2926988|NCT00570687|3637898|FG008|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
2926989|NCT00570687|3637899|FG009|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
2926990|NCT00570700|3637913|FG000|STARTED|Overall Study||38
2926991|NCT00570700|3637913|FG000|COMPLETED|Overall Study||27
2926992|NCT00570700|3637913|FG000|NOT COMPLETED|Overall Study||11
2926993|NCT00570713|3637919|FG000|STARTED|Overall Study||78
2926994|NCT00570713|3637920|FG001|STARTED|Overall Study||77
2926995|NCT00570713|3637919|FG000|COMPLETED|Overall Study||0
2926996|NCT00570713|3637920|FG001|COMPLETED|Overall Study||0
2926997|NCT00570713|3637919|FG000|NOT COMPLETED|Overall Study||78
3175845|NCT01962441|3903527|FG001|NOT COMPLETED|Retreatment Substudy||0
3175846|NCT01962441|3903528|FG002|NOT COMPLETED|Retreatment Substudy||0
3175847|NCT01962493|3903539|FG000|STARTED|Overall Study||78
3175848|NCT01962493|3903540|FG001|STARTED|Overall Study||82
3175849|NCT01962493|3903539|FG000|COMPLETED|Overall Study||73
3175850|NCT01962493|3903540|FG001|COMPLETED|Overall Study||77
2926998|NCT00570713|3637920|FG001|NOT COMPLETED|Overall Study||77
2926999|NCT00570739|3637930|FG000|STARTED|Overall Study||141
2927000|NCT00570739|3637931|FG001|STARTED|Overall Study||145
2927001|NCT00570739|3637932|FG002|STARTED|Overall Study||108
2927002|NCT00570739|3637933|FG003|STARTED|Overall Study||108
2927003|NCT00570739|3637930|FG000|COMPLETED|Overall Study||120
2927004|NCT00570739|3637931|FG001|COMPLETED|Overall Study||124
2927005|NCT00570739|3637932|FG002|COMPLETED|Overall Study||92
2927006|NCT00570739|3637933|FG003|COMPLETED|Overall Study||96
2927007|NCT00570739|3637930|FG000|NOT COMPLETED|Overall Study||21
2927008|NCT00570739|3637931|FG001|NOT COMPLETED|Overall Study||21
2927009|NCT00570739|3637932|FG002|NOT COMPLETED|Overall Study||16
2927010|NCT00570739|3637933|FG003|NOT COMPLETED|Overall Study||12
2927011|NCT00570765|3637966|FG000|STARTED|DB Phase||20
2927012|NCT00570765|3637967|FG001|STARTED|DB Phase||16
2927013|NCT00570765|3637968|FG002|STARTED|DB Phase||24
2927014|NCT00570765|3637969|FG003|STARTED|DB Phase||0
2927015|NCT00570765|3637966|FG000|Received at Least 1 Dose of Study Drug|DB Phase||20
2927016|NCT00570765|3637967|FG001|Received at Least 1 Dose of Study Drug|DB Phase||16
2927017|NCT00570765|3637968|FG002|Received at Least 1 Dose of Study Drug|DB Phase||23
3175851|NCT01962493|3903539|FG000|NOT COMPLETED|Overall Study||5
3175852|NCT01962493|3903540|FG001|NOT COMPLETED|Overall Study||5
3175853|NCT01962558|3903548|FG000|STARTED|Overall Study||16
3175854|NCT01962558|3903549|FG001|STARTED|Overall Study||14
3175855|NCT01962558|3903548|FG000|Acute Study|Overall Study||16
2927018|NCT00570765|3637969|FG003|Received at Least 1 Dose of Study Drug|DB Phase||0
2927019|NCT00570765|3637966|FG000|Safety Population|DB Phase||20
2927020|NCT00570765|3637967|FG001|Safety Population|DB Phase||16
2927021|NCT00570765|3637968|FG002|Safety Population|DB Phase||23
2927022|NCT00570765|3637969|FG003|Safety Population|DB Phase||0
2927023|NCT00570765|3637966|FG000|COMPLETED|DB Phase||16
2927024|NCT00570765|3637967|FG001|COMPLETED|DB Phase||9
2927025|NCT00570765|3637968|FG002|COMPLETED|DB Phase||23
2927026|NCT00570765|3637969|FG003|COMPLETED|DB Phase||0
3039617|NCT01159665|3759064|FG002|COMPLETED|Overall Study||8
3039618|NCT01159665|3759065|FG003|COMPLETED|Overall Study||4
3039619|NCT01159665|3759066|FG004|COMPLETED|Overall Study||4
3039620|NCT01159665|3759067|FG005|COMPLETED|Overall Study||4
3039621|NCT01159665|3759062|FG000|NOT COMPLETED|Overall Study||0
3039622|NCT01159665|3759063|FG001|NOT COMPLETED|Overall Study||1
3039623|NCT01159665|3759064|FG002|NOT COMPLETED|Overall Study||0
3039624|NCT01159665|3759065|FG003|NOT COMPLETED|Overall Study||0
3039625|NCT01159665|3759066|FG004|NOT COMPLETED|Overall Study||0
3039626|NCT01159665|3759067|FG005|NOT COMPLETED|Overall Study||0
3039627|NCT01159691|3759081|FG000|STARTED|Overall Study||76
3039628|NCT01159691|3759081|FG000|COMPLETED|Overall Study|Multiple discontinuation reasons were possible.|54
3039629|NCT01159691|3759081|FG000|NOT COMPLETED|Overall Study||22
3039630|NCT01159743|3759087|FG000|STARTED|Overall Study||237
3039631|NCT01159743|3759088|FG001|STARTED|Overall Study||109
3039632|NCT01159743|3759087|FG000|COMPLETED|Overall Study||237
3039633|NCT01159743|3759088|FG001|COMPLETED|Overall Study||109
3039634|NCT01159743|3759087|FG000|NOT COMPLETED|Overall Study||0
3039635|NCT01159743|3759088|FG001|NOT COMPLETED|Overall Study||0
3039636|NCT01159769|3759094|FG000|STARTED|Overall Study||215
3039637|NCT01159769|3759094|FG000|COMPLETED|Overall Study||214
3039638|NCT01159769|3759094|FG000|NOT COMPLETED|Overall Study||1
3039639|NCT01159912|3759101|FG000|STARTED|Overall Study||115
3039640|NCT01159912|3759102|FG001|STARTED|Overall Study||114
2927027|NCT00570765|3637966|FG000|NOT COMPLETED|DB Phase||4
3039641|NCT01159912|3759103|FG002|STARTED|Overall Study||114
3175856|NCT01962558|3903549|FG001|Acute Study|Overall Study||14
3175857|NCT01962558|3903548|FG000|12-Weeks|Overall Study||16
3175858|NCT01962558|3903549|FG001|12-Weeks|Overall Study||14
3175859|NCT01962558|3903548|FG000|COMPLETED|Overall Study||16
3175860|NCT01962558|3903549|FG001|COMPLETED|Overall Study||14
3175861|NCT01962558|3903548|FG000|NOT COMPLETED|Overall Study||0
3175862|NCT01962558|3903549|FG001|NOT COMPLETED|Overall Study||0
3175863|NCT01962688|3903557|FG000|STARTED|Overall Study||19
3175864|NCT01962688|3903558|FG001|STARTED|Overall Study||18
3175865|NCT01962688|3903557|FG000|COMPLETED|Overall Study||19
3175866|NCT01962688|3903558|FG001|COMPLETED|Overall Study||18
3175867|NCT01962688|3903557|FG000|NOT COMPLETED|Overall Study||0
3175868|NCT01962688|3903558|FG001|NOT COMPLETED|Overall Study||0
3323417|NCT03200925|4056432|FG000|NOT COMPLETED|Overall Study||0
3175869|NCT01962714|3903566|FG000|STARTED|Overall Study||91
3175870|NCT01962714|3903567|FG001|STARTED|Overall Study||93
3175871|NCT01962714|3903566|FG000|Immediate Post-treatment Assessment|Overall Study||63
3175872|NCT01962714|3903567|FG001|Immediate Post-treatment Assessment|Overall Study||57
3175873|NCT01962714|3903566|FG000|3-month Follow-up|Overall Study||58
3175874|NCT01962714|3903567|FG001|3-month Follow-up|Overall Study||56
2927028|NCT00570765|3637967|FG001|NOT COMPLETED|DB Phase||7
2927029|NCT00570765|3637968|FG002|NOT COMPLETED|DB Phase||1
2927030|NCT00570765|3637969|FG003|NOT COMPLETED|DB Phase||0
2927031|NCT00570765|3637966|FG000|STARTED|LTSE Phase|Eligible participants who completed the DB phase enrolled in the LTSE phase.|0
2927032|NCT00570765|3637967|FG001|STARTED|LTSE Phase|Eligible participants who completed the DB phase enrolled in the LTSE phase.|0
2927033|NCT00570765|3637968|FG002|STARTED|LTSE Phase|Eligible participants who completed the DB phase enrolled in the LTSE phase.|0
2927034|NCT00570765|3637969|FG003|STARTED|LTSE Phase|Eligible participants who completed the DB phase enrolled in the LTSE phase.|28
2927035|NCT00570765|3637966|FG000|Received at Least 1 Dose of Study Drug|LTSE Phase||0
2927036|NCT00570765|3637967|FG001|Received at Least 1 Dose of Study Drug|LTSE Phase||0
2927037|NCT00570765|3637968|FG002|Received at Least 1 Dose of Study Drug|LTSE Phase||0
2927038|NCT00570765|3637969|FG003|Received at Least 1 Dose of Study Drug|LTSE Phase||28
2927039|NCT00570765|3637966|FG000|Safety Population|LTSE Phase||0
2927040|NCT00570765|3637967|FG001|Safety Population|LTSE Phase||0
2927041|NCT00570765|3637968|FG002|Safety Population|LTSE Phase||0
2927042|NCT00570765|3637969|FG003|Safety Population|LTSE Phase||28
2927043|NCT00570765|3637966|FG000|COMPLETED|LTSE Phase||0
3175875|NCT01962714|3903566|FG000|COMPLETED|Overall Study||61
3175876|NCT01962714|3903567|FG001|COMPLETED|Overall Study||60
3175877|NCT01962714|3903566|FG000|NOT COMPLETED|Overall Study||30
3175878|NCT01962714|3903567|FG001|NOT COMPLETED|Overall Study||33
3175879|NCT01962870|3903575|FG000|STARTED|Overall Study||13
3175880|NCT01962870|3903576|FG001|STARTED|Overall Study||17
3175881|NCT01962870|3903575|FG000|COMPLETED|Overall Study||13
3175882|NCT01962870|3903576|FG001|COMPLETED|Overall Study||17
3175883|NCT01962870|3903575|FG000|NOT COMPLETED|Overall Study||0
3175884|NCT01962870|3903576|FG001|NOT COMPLETED|Overall Study||0
3175885|NCT01962896|3903582|FG000|STARTED|Overall Study||4
3175886|NCT01962896|3903582|FG000|COMPLETED|Overall Study||0
3175887|NCT01962896|3903582|FG000|NOT COMPLETED|Overall Study||4
3175888|NCT01962922|3903589|FG000|STARTED|PK Portion Day 7||27
3175889|NCT01962922|3903590|FG001|STARTED|PK Portion Day 7||23
3175890|NCT01962922|3903589|FG000|COMPLETED|PK Portion Day 7||23
3175891|NCT01962922|3903590|FG001|COMPLETED|PK Portion Day 7||23
3175892|NCT01962922|3903589|FG000|NOT COMPLETED|PK Portion Day 7||4
3175893|NCT01962922|3903590|FG001|NOT COMPLETED|PK Portion Day 7||0
3175894|NCT01962922|3903589|FG000|STARTED|PK Portion Day 14||23
2927044|NCT00570765|3637967|FG001|COMPLETED|LTSE Phase||0
2927045|NCT00570765|3637968|FG002|COMPLETED|LTSE Phase||0
3175895|NCT01962922|3903590|FG001|STARTED|PK Portion Day 14||23
3175896|NCT01962922|3903589|FG000|COMPLETED|PK Portion Day 14||23
3175897|NCT01962922|3903590|FG001|COMPLETED|PK Portion Day 14||23
3175898|NCT01962922|3903589|FG000|NOT COMPLETED|PK Portion Day 14||0
3175899|NCT01962922|3903590|FG001|NOT COMPLETED|PK Portion Day 14||0
3175900|NCT01962922|3903589|FG000|STARTED|PK Portion Day 21||23
3175901|NCT01962922|3903590|FG001|STARTED|PK Portion Day 21||23
3175902|NCT01962922|3903589|FG000|COMPLETED|PK Portion Day 21||23
3175903|NCT01962922|3903590|FG001|COMPLETED|PK Portion Day 21||23
3175904|NCT01962922|3903589|FG000|NOT COMPLETED|PK Portion Day 21||0
3175905|NCT01962922|3903590|FG001|NOT COMPLETED|PK Portion Day 21||0
3175906|NCT01962922|3903589|FG000|STARTED|Extendion Portion (up to Month 6)||23
3175907|NCT01962922|3903590|FG001|STARTED|Extendion Portion (up to Month 6)||23
2927046|NCT00570765|3637969|FG003|COMPLETED|LTSE Phase||16
2927047|NCT00570765|3637966|FG000|NOT COMPLETED|LTSE Phase||0
2927048|NCT00570765|3637967|FG001|NOT COMPLETED|LTSE Phase||0
2927049|NCT00570765|3637968|FG002|NOT COMPLETED|LTSE Phase||0
2927050|NCT00570765|3637969|FG003|NOT COMPLETED|LTSE Phase||12
2927051|NCT00570778|3637980|FG000|STARTED|Overall Study||41
2927052|NCT00570778|3637981|FG001|STARTED|Overall Study||38
2927053|NCT00570778|3637982|FG002|STARTED|Overall Study||37
2927054|NCT00570778|3637983|FG003|STARTED|Overall Study||38
2927055|NCT00570778|3637980|FG000|Safety Population: Received Study Drug|Overall Study|Safety Population included all participants who received at least 1 dose of any study drug.|41
2927056|NCT00570778|3637981|FG001|Safety Population: Received Study Drug|Overall Study||38
2927057|NCT00570778|3637982|FG002|Safety Population: Received Study Drug|Overall Study||36
2927058|NCT00570778|3637983|FG003|Safety Population: Received Study Drug|Overall Study||38
2927059|NCT00570778|3637980|FG000|Modified Intent-to-treat Population|Overall Study||40
2927060|NCT00570778|3637981|FG001|Modified Intent-to-treat Population|Overall Study||37
2927061|NCT00570778|3637982|FG002|Modified Intent-to-treat Population|Overall Study||35
2927062|NCT00570778|3637983|FG003|Modified Intent-to-treat Population|Overall Study||37
2927063|NCT00570778|3637980|FG000|COMPLETED|Overall Study||37
2927064|NCT00570778|3637981|FG001|COMPLETED|Overall Study||34
2927065|NCT00570778|3637982|FG002|COMPLETED|Overall Study||30
2927066|NCT00570778|3637983|FG003|COMPLETED|Overall Study||34
2927067|NCT00570778|3637980|FG000|NOT COMPLETED|Overall Study||4
2927068|NCT00570778|3637981|FG001|NOT COMPLETED|Overall Study||4
2927069|NCT00570778|3637982|FG002|NOT COMPLETED|Overall Study||7
2927070|NCT00570778|3637983|FG003|NOT COMPLETED|Overall Study||4
2927071|NCT00570908|3637993|FG000|STARTED|Overall Study||12
2927072|NCT00570908|3637993|FG000|COMPLETED|Overall Study|5 patients progressed during the study treatment|5
2927073|NCT00570908|3637993|FG000|NOT COMPLETED|Overall Study||7
2927074|NCT00570921|3637997|FG000|STARTED|Overall Study||33
2927075|NCT00570921|3637997|FG000|COMPLETED|Overall Study||31
2927076|NCT00570921|3637997|FG000|NOT COMPLETED|Overall Study||2
2927077|NCT00570960|3638003|FG000|STARTED|Overall Study||4
2927078|NCT00570960|3638004|FG001|STARTED|Overall Study||4
2927079|NCT00570960|3638003|FG000|COMPLETED|Overall Study||4
2927080|NCT00570960|3638004|FG001|COMPLETED|Overall Study||4
2927081|NCT00570960|3638003|FG000|NOT COMPLETED|Overall Study||0
2927082|NCT00570960|3638004|FG001|NOT COMPLETED|Overall Study||0
2927083|NCT00571038|3638012|FG000|STARTED|Overall Study||219
2927084|NCT00571038|3638013|FG001|STARTED|Overall Study||185
2927085|NCT00571038|3638012|FG000|6 Month Follow up|Overall Study||208
2927086|NCT00571038|3638013|FG001|6 Month Follow up|Overall Study||176
2927087|NCT00571038|3638012|FG000|18 Month Survey Only|Overall Study||199
2927088|NCT00571038|3638013|FG001|18 Month Survey Only|Overall Study||163
2927089|NCT00571038|3638012|FG000|COMPLETED|Overall Study|"7 died 2 moved~1 asked to be withdrawn~1 unable to reach"|208
2927090|NCT00571038|3638013|FG001|COMPLETED|Overall Study|5 died 2 moved 3 asked to be withdrawn 4 unable to reach|171
2927091|NCT00571038|3638012|FG000|NOT COMPLETED|Overall Study||11
2927092|NCT00571038|3638013|FG001|NOT COMPLETED|Overall Study||14
2927093|NCT00571064|3638019|FG000|STARTED|Overall Study||97
2927094|NCT00571064|3638019|FG000|COMPLETED|Overall Study||76
2927095|NCT00571064|3638019|FG000|NOT COMPLETED|Overall Study||21
2927096|NCT00571103|3638024|FG000|STARTED|Overall Study||28
2927097|NCT00571103|3638024|FG000|COMPLETED|Overall Study|Of the 28 participants, 1 subject withdrew and 1 was lost to follow-up after their baseline visit.|26
2927098|NCT00571103|3638024|FG000|NOT COMPLETED|Overall Study||2
2927099|NCT00571259|3638030|FG000|STARTED|Overall Study||148
2927100|NCT00571259|3638031|FG001|STARTED|Overall Study||155
2927101|NCT00571259|3638030|FG000|COMPLETED|Overall Study||4
2927102|NCT00571259|3638031|FG001|COMPLETED|Overall Study||14
2927103|NCT00571259|3638030|FG000|NOT COMPLETED|Overall Study||144
2927104|NCT00571259|3638031|FG001|NOT COMPLETED|Overall Study||141
2927105|NCT00571324|3638039|FG000|STARTED|Intervention 1 (7 Hours)||5
2927106|NCT00571324|3638040|FG001|STARTED|Intervention 1 (7 Hours)||4
2927107|NCT00571324|3638039|FG000|COMPLETED|Intervention 1 (7 Hours)||5
2927108|NCT00571324|3638040|FG001|COMPLETED|Intervention 1 (7 Hours)||4
2927109|NCT00571324|3638039|FG000|NOT COMPLETED|Intervention 1 (7 Hours)||0
2927110|NCT00571324|3638040|FG001|NOT COMPLETED|Intervention 1 (7 Hours)||0
2927111|NCT00571324|3638039|FG000|STARTED|Intervention 2 (7 Hours)||5
3323418|NCT03200925|4056433|FG001|NOT COMPLETED|Overall Study||0
3323419|NCT03201003|4056441|FG000|STARTED|Overall Study||132
3323420|NCT03201003|4056442|FG001|STARTED|Overall Study||43
3323421|NCT03201003|4056441|FG000|COMPLETED|Overall Study||106
3323422|NCT03201003|4056442|FG001|COMPLETED|Overall Study||40
3323423|NCT03201003|4056441|FG000|NOT COMPLETED|Overall Study||26
3323424|NCT03201003|4056442|FG001|NOT COMPLETED|Overall Study||3
3323425|NCT03201211|4056451|FG000|STARTED|Overall Study||27
3323426|NCT03201211|4056452|FG001|STARTED|Overall Study||26
3323427|NCT03201211|4056453|FG002|STARTED|Overall Study||28
3323428|NCT03201211|4056451|FG000|COMPLETED|Overall Study||25
2927112|NCT00571324|3638040|FG001|STARTED|Intervention 2 (7 Hours)||4
3175908|NCT01962922|3903589|FG000|COMPLETED|Extendion Portion (up to Month 6)||18
3175909|NCT01962922|3903590|FG001|COMPLETED|Extendion Portion (up to Month 6)||20
3175910|NCT01962922|3903589|FG000|NOT COMPLETED|Extendion Portion (up to Month 6)||5
3175911|NCT01962922|3903590|FG001|NOT COMPLETED|Extendion Portion (up to Month 6)||3
3175912|NCT01962961|3903599|FG000|STARTED|Overall Study||9
3175913|NCT01962961|3903600|FG001|STARTED|Overall Study||8
3175914|NCT01962961|3903601|FG002|STARTED|Overall Study||7
3175915|NCT01962961|3903599|FG000|COMPLETED|Overall Study||9
3175916|NCT01962961|3903600|FG001|COMPLETED|Overall Study||7
3175917|NCT01962961|3903601|FG002|COMPLETED|Overall Study||6
3175918|NCT01962961|3903599|FG000|NOT COMPLETED|Overall Study||0
3175919|NCT01962961|3903600|FG001|NOT COMPLETED|Overall Study||1
3175920|NCT01962961|3903601|FG002|NOT COMPLETED|Overall Study||1
3175921|NCT01962987|3903612|FG000|STARTED|Overall Study||190
3175922|NCT01962987|3903613|FG001|STARTED|Overall Study||191
3175923|NCT01962987|3903614|FG002|STARTED|Overall Study||95
3323429|NCT03201211|4056452|FG001|COMPLETED|Overall Study||25
3175924|NCT01962987|3903612|FG000|COMPLETED|Overall Study||160
3175925|NCT01962987|3903613|FG001|COMPLETED|Overall Study||163
3175926|NCT01962987|3903614|FG002|COMPLETED|Overall Study||83
3175927|NCT01962987|3903612|FG000|NOT COMPLETED|Overall Study||30
3323430|NCT03201211|4056453|FG002|COMPLETED|Overall Study||27
2927113|NCT00571324|3638039|FG000|COMPLETED|Intervention 2 (7 Hours)||5
2927114|NCT00571324|3638040|FG001|COMPLETED|Intervention 2 (7 Hours)||4
2927115|NCT00571324|3638039|FG000|NOT COMPLETED|Intervention 2 (7 Hours)||0
2927116|NCT00571324|3638040|FG001|NOT COMPLETED|Intervention 2 (7 Hours)||0
2927117|NCT00571428|3638048|FG000|STARTED|Overall Study||15
2927118|NCT00571428|3638049|FG001|STARTED|Overall Study||18
2927119|NCT00571428|3638048|FG000|COMPLETED|Overall Study||15
2927120|NCT00571428|3638049|FG001|COMPLETED|Overall Study||18
2927121|NCT00571428|3638048|FG000|NOT COMPLETED|Overall Study||0
2927122|NCT00571428|3638049|FG001|NOT COMPLETED|Overall Study||0
2927123|NCT00571493|3638055|FG000|STARTED|Overall Study||3
2927124|NCT00571493|3638056|FG001|STARTED|Overall Study||4
2927125|NCT00571493|3638057|FG002|STARTED|Overall Study||3
2927126|NCT00571493|3638058|FG003|STARTED|Overall Study||3
2927127|NCT00571493|3638059|FG004|STARTED|Overall Study||11
2927128|NCT00571493|3638060|FG005|STARTED|Overall Study||12
2927129|NCT00571493|3638061|FG006|STARTED|Overall Study||6
3175928|NCT01962987|3903613|FG001|NOT COMPLETED|Overall Study||28
3175929|NCT01962987|3903614|FG002|NOT COMPLETED|Overall Study||12
2927130|NCT00571493|3638055|FG000|COMPLETED|Overall Study||3
2927131|NCT00571493|3638056|FG001|COMPLETED|Overall Study||4
2927132|NCT00571493|3638057|FG002|COMPLETED|Overall Study||3
2927133|NCT00571493|3638058|FG003|COMPLETED|Overall Study||3
2927134|NCT00571493|3638059|FG004|COMPLETED|Overall Study||11
2927135|NCT00571493|3638060|FG005|COMPLETED|Overall Study||12
2927136|NCT00571493|3638061|FG006|COMPLETED|Overall Study||6
2927137|NCT00571493|3638055|FG000|NOT COMPLETED|Overall Study||0
2927138|NCT00571493|3638056|FG001|NOT COMPLETED|Overall Study||0
2927139|NCT00571493|3638057|FG002|NOT COMPLETED|Overall Study||0
2927140|NCT00571493|3638058|FG003|NOT COMPLETED|Overall Study||0
2927141|NCT00571493|3638059|FG004|NOT COMPLETED|Overall Study||0
2927142|NCT00571493|3638060|FG005|NOT COMPLETED|Overall Study||0
2927143|NCT00571493|3638061|FG006|NOT COMPLETED|Overall Study||0
2927144|NCT00571519|3638076|FG000|STARTED|Overall Study||3
2927145|NCT00571519|3638077|FG001|STARTED|Overall Study||9
2927146|NCT00571519|3638078|FG002|STARTED|Overall Study||12
2927147|NCT00571519|3638079|FG003|STARTED|Overall Study||27
2927148|NCT00571519|3638080|FG004|STARTED|Overall Study||9
2927149|NCT00571519|3638081|FG005|STARTED|Overall Study||10
2927150|NCT00571519|3638082|FG006|STARTED|Overall Study||24
2927151|NCT00571519|3638076|FG000|COMPLETED|Overall Study||0
3175930|NCT01963078|3903626|FG000|STARTED|Overall Study||9
3175931|NCT01963078|3903627|FG001|STARTED|Overall Study||10
3175932|NCT01963078|3903628|FG002|STARTED|Overall Study||10
3175933|NCT01963078|3903629|FG003|STARTED|Overall Study||9
3175934|NCT01963078|3903626|FG000|COMPLETED|Overall Study||8
3175935|NCT01963078|3903627|FG001|COMPLETED|Overall Study||9
3175936|NCT01963078|3903628|FG002|COMPLETED|Overall Study||9
3175937|NCT01963078|3903629|FG003|COMPLETED|Overall Study||7
3175938|NCT01963078|3903626|FG000|NOT COMPLETED|Overall Study||1
2927152|NCT00571519|3638077|FG001|COMPLETED|Overall Study||0
2927153|NCT00571519|3638078|FG002|COMPLETED|Overall Study||0
3175939|NCT01963078|3903627|FG001|NOT COMPLETED|Overall Study||1
3175940|NCT01963078|3903628|FG002|NOT COMPLETED|Overall Study||1
3175941|NCT01963078|3903629|FG003|NOT COMPLETED|Overall Study||2
2927154|NCT00571519|3638079|FG003|COMPLETED|Overall Study||0
2927155|NCT00571519|3638080|FG004|COMPLETED|Overall Study||0
2927156|NCT00571519|3638081|FG005|COMPLETED|Overall Study||0
2927157|NCT00571519|3638082|FG006|COMPLETED|Overall Study||0
2927158|NCT00571519|3638076|FG000|NOT COMPLETED|Overall Study||3
2927159|NCT00571519|3638077|FG001|NOT COMPLETED|Overall Study||9
2927160|NCT00571519|3638078|FG002|NOT COMPLETED|Overall Study||12
2927161|NCT00571519|3638079|FG003|NOT COMPLETED|Overall Study||27
2927162|NCT00571519|3638080|FG004|NOT COMPLETED|Overall Study||9
2927163|NCT00571519|3638081|FG005|NOT COMPLETED|Overall Study||10
2927164|NCT00571519|3638082|FG006|NOT COMPLETED|Overall Study||24
2927165|NCT00571649|3638100|FG000|STARTED|Treatment Period||4050
2927166|NCT00571649|3638101|FG001|STARTED|Treatment Period||4051
2927167|NCT00571649|3638100|FG000|Participants Received Treatment|Treatment Period||3997
2927168|NCT00571649|3638101|FG001|Participants Received Treatment|Treatment Period||4001
2927169|NCT00571649|3638100|FG000|Day 10|Treatment Period||3454
3175942|NCT01963091|3903641|FG000|STARTED|Overall Study||17
3175943|NCT01963091|3903642|FG001|STARTED|Overall Study||16
3175944|NCT01963091|3903641|FG000|COMPLETED|Overall Study||17
3175945|NCT01963091|3903642|FG001|COMPLETED|Overall Study||16
3175946|NCT01963091|3903641|FG000|NOT COMPLETED|Overall Study||0
3175947|NCT01963091|3903642|FG001|NOT COMPLETED|Overall Study||0
3175948|NCT01963117|3903648|FG000|STARTED|Overall Study||11
3175949|NCT01963117|3903648|FG000|COMPLETED|Overall Study||10
3175950|NCT01963117|3903648|FG000|NOT COMPLETED|Overall Study||1
3175951|NCT01963143|3903655|FG000|STARTED|Overall Study||14
3175952|NCT01963143|3903656|FG001|STARTED|Overall Study||19
3175953|NCT01963143|3903657|FG002|STARTED|Overall Study||15
3175954|NCT01963143|3903655|FG000|COMPLETED|Overall Study||14
3175955|NCT01963143|3903656|FG001|COMPLETED|Overall Study||18
3175956|NCT01963143|3903657|FG002|COMPLETED|Overall Study||14
3175957|NCT01963143|3903655|FG000|NOT COMPLETED|Overall Study||0
3175958|NCT01963143|3903656|FG001|NOT COMPLETED|Overall Study||1
3175959|NCT01963143|3903657|FG002|NOT COMPLETED|Overall Study||1
3175960|NCT01963169|3903666|FG000|STARTED|Overall Study||301
3323431|NCT03201211|4056451|FG000|NOT COMPLETED|Overall Study||2
3323432|NCT03201211|4056452|FG001|NOT COMPLETED|Overall Study||1
3323433|NCT03201211|4056453|FG002|NOT COMPLETED|Overall Study||1
3323434|NCT03201419|4056470|FG000|STARTED|Overall Study||60
3323435|NCT03201419|4056471|FG001|STARTED|Overall Study||27
3323436|NCT03201419|4056472|FG002|STARTED|Overall Study||24
3323437|NCT03201419|4056473|FG003|STARTED|Overall Study||14
3323438|NCT03201419|4056474|FG004|STARTED|Overall Study||13
3323439|NCT03201419|4056475|FG005|STARTED|Overall Study||34
3323440|NCT03201419|4056476|FG006|STARTED|Overall Study||87
3323441|NCT03201419|4056477|FG007|STARTED|Overall Study||26
2927170|NCT00571649|3638101|FG001|Day 10|Treatment Period||3499
2927171|NCT00571649|3638100|FG000|Day 35|Treatment Period||3033
2927172|NCT00571649|3638101|FG001|Day 35|Treatment Period||3115
2927173|NCT00571649|3638100|FG000|COMPLETED|Treatment Period||2958
2927174|NCT00571649|3638101|FG001|COMPLETED|Treatment Period||3047
2927175|NCT00571649|3638100|FG000|NOT COMPLETED|Treatment Period||1092
2927176|NCT00571649|3638101|FG001|NOT COMPLETED|Treatment Period||1004
2927177|NCT00571649|3638100|FG000|STARTED|Follow-up Period|Participants were required to enter follow-up even if treatment period not completed.|3583
2927178|NCT00571649|3638101|FG001|STARTED|Follow-up Period|Participants were required to enter follow-up even if treatment period not completed.|3635
2927179|NCT00571649|3638100|FG000|COMPLETED|Follow-up Period|Began day after last dose study drug; ended on Day 90 (+/- 7 days) .|3038
2927180|NCT00571649|3638101|FG001|COMPLETED|Follow-up Period|Began day after last dose study drug; ended on Day 90 (+/- 7 days) .|3107
2927181|NCT00571649|3638100|FG000|NOT COMPLETED|Follow-up Period||545
2927182|NCT00571649|3638101|FG001|NOT COMPLETED|Follow-up Period||528
2927183|NCT00571662|3638107|FG000|STARTED|Overall Study||76
2927184|NCT00571662|3638107|FG000|COMPLETED|Overall Study||68
2927185|NCT00571662|3638107|FG000|NOT COMPLETED|Overall Study||8
2927186|NCT00571688|3638115|FG000|STARTED|Overall Study||25
3039642|NCT01159912|3759101|FG000|COMPLETED|Overall Study||75
3039643|NCT01159912|3759102|FG001|COMPLETED|Overall Study||92
3039644|NCT01159912|3759103|FG002|COMPLETED|Overall Study||88
3039645|NCT01159912|3759101|FG000|NOT COMPLETED|Overall Study||40
3039646|NCT01159912|3759102|FG001|NOT COMPLETED|Overall Study||22
3039647|NCT01159912|3759103|FG002|NOT COMPLETED|Overall Study||26
3039648|NCT01159938|3759114|FG000|STARTED|First Study Period||26
3039649|NCT01159938|3759115|FG001|STARTED|First Study Period||11
3039650|NCT01159938|3759116|FG002|STARTED|First Study Period||11
3039651|NCT01159938|3759117|FG003|STARTED|First Study Period||12
3039652|NCT01159938|3759118|FG004|STARTED|First Study Period||12
3039653|NCT01159938|3759114|FG000|Received at Least 1 Dose of Study Drug|First Study Period||0
3039654|NCT01159938|3759115|FG001|Received at Least 1 Dose of Study Drug|First Study Period||11
3039655|NCT01159938|3759116|FG002|Received at Least 1 Dose of Study Drug|First Study Period||11
3039656|NCT01159938|3759117|FG003|Received at Least 1 Dose of Study Drug|First Study Period||12
3039657|NCT01159938|3759118|FG004|Received at Least 1 Dose of Study Drug|First Study Period||12
3039658|NCT01159938|3759114|FG000|Safety and Efficacy Analysis Population|First Study Period|One healthy participant completed study but was excluded from analyses (major protocol violation).|25
3039659|NCT01159938|3759115|FG001|Safety and Efficacy Analysis Population|First Study Period||11
3039660|NCT01159938|3759116|FG002|Safety and Efficacy Analysis Population|First Study Period|Microalbuminuria relaxed with protocol amendment. T2DM albuminuria participant included in analyses.|11
3039661|NCT01159938|3759117|FG003|Safety and Efficacy Analysis Population|First Study Period||12
3039662|NCT01159938|3759118|FG004|Safety and Efficacy Analysis Population|First Study Period||12
3039663|NCT01159938|3759114|FG000|COMPLETED|First Study Period||26
3039664|NCT01159938|3759115|FG001|COMPLETED|First Study Period||11
3039665|NCT01159938|3759116|FG002|COMPLETED|First Study Period||10
3039666|NCT01159938|3759117|FG003|COMPLETED|First Study Period||12
3039667|NCT01159938|3759118|FG004|COMPLETED|First Study Period||12
3039668|NCT01159938|3759114|FG000|NOT COMPLETED|First Study Period||0
3039669|NCT01159938|3759115|FG001|NOT COMPLETED|First Study Period||0
3039670|NCT01159938|3759116|FG002|NOT COMPLETED|First Study Period||1
3039671|NCT01159938|3759117|FG003|NOT COMPLETED|First Study Period||0
3039672|NCT01159938|3759118|FG004|NOT COMPLETED|First Study Period||0
3039673|NCT01159938|3759114|FG000|STARTED|Second Study Period||0
3039674|NCT01159938|3759115|FG001|STARTED|Second Study Period||11
3039675|NCT01159938|3759116|FG002|STARTED|Second Study Period||10
3039676|NCT01159938|3759117|FG003|STARTED|Second Study Period||12
3039677|NCT01159938|3759118|FG004|STARTED|Second Study Period||12
3039678|NCT01159938|3759114|FG000|COMPLETED|Second Study Period||0
3039679|NCT01159938|3759115|FG001|COMPLETED|Second Study Period||11
3039680|NCT01159938|3759116|FG002|COMPLETED|Second Study Period||10
3039681|NCT01159938|3759117|FG003|COMPLETED|Second Study Period||12
3039682|NCT01159938|3759118|FG004|COMPLETED|Second Study Period||12
3039683|NCT01159938|3759114|FG000|NOT COMPLETED|Second Study Period||0
3039684|NCT01159938|3759115|FG001|NOT COMPLETED|Second Study Period||0
3039685|NCT01159938|3759116|FG002|NOT COMPLETED|Second Study Period||0
3039686|NCT01159938|3759117|FG003|NOT COMPLETED|Second Study Period||0
3039687|NCT01159938|3759118|FG004|NOT COMPLETED|Second Study Period||0
3039688|NCT01160198|3759142|FG000|STARTED|Overall Study||89
3039689|NCT01160198|3759143|FG001|STARTED|Overall Study||91
3039690|NCT01160198|3759144|FG002|STARTED|Overall Study||90
3175961|NCT01963169|3903667|FG001|STARTED|Overall Study||302
3175962|NCT01963169|3903668|FG002|STARTED|Overall Study||263
3175963|NCT01963169|3903666|FG000|COMPLETED|Overall Study||242
3323442|NCT03201419|4056478|FG008|STARTED|Overall Study||17
3323443|NCT03201419|4056470|FG000|COMPLETED|Overall Study||52
3323444|NCT03201419|4056471|FG001|COMPLETED|Overall Study||24
3323445|NCT03201419|4056472|FG002|COMPLETED|Overall Study||22
3323446|NCT03201419|4056473|FG003|COMPLETED|Overall Study||14
3323447|NCT03201419|4056474|FG004|COMPLETED|Overall Study||12
3323448|NCT03201419|4056475|FG005|COMPLETED|Overall Study||33
3323449|NCT03201419|4056476|FG006|COMPLETED|Overall Study||81
3323450|NCT03201419|4056477|FG007|COMPLETED|Overall Study||25
3323451|NCT03201419|4056478|FG008|COMPLETED|Overall Study||15
3323452|NCT03201419|4056470|FG000|NOT COMPLETED|Overall Study||8
3323453|NCT03201419|4056471|FG001|NOT COMPLETED|Overall Study||3
3323454|NCT03201419|4056472|FG002|NOT COMPLETED|Overall Study||2
3323455|NCT03201419|4056473|FG003|NOT COMPLETED|Overall Study||0
3323456|NCT03201419|4056474|FG004|NOT COMPLETED|Overall Study||1
3323457|NCT03201419|4056475|FG005|NOT COMPLETED|Overall Study||1
3323458|NCT03201419|4056476|FG006|NOT COMPLETED|Overall Study||6
3323459|NCT03201419|4056477|FG007|NOT COMPLETED|Overall Study||1
3323460|NCT03201419|4056478|FG008|NOT COMPLETED|Overall Study||2
3323461|NCT03201562|4056515|FG000|STARTED|Overall Study||18
3323462|NCT03201562|4056516|FG001|STARTED|Overall Study||20
3323463|NCT03201562|4056517|FG002|STARTED|Overall Study||20
3323464|NCT03201562|4056515|FG000|COMPLETED|Overall Study||18
3323465|NCT03201562|4056516|FG001|COMPLETED|Overall Study||19
3323466|NCT03201562|4056517|FG002|COMPLETED|Overall Study||16
3323467|NCT03201562|4056515|FG000|NOT COMPLETED|Overall Study||0
3323468|NCT03201562|4056516|FG001|NOT COMPLETED|Overall Study||1
3323469|NCT03201562|4056517|FG002|NOT COMPLETED|Overall Study||4
3323470|NCT03201809|4056527|FG000|STARTED|Overall Study||6
3323471|NCT03201809|4056528|FG001|STARTED|Overall Study||6
3323472|NCT03201809|4056527|FG000|COMPLETED|Overall Study||4
3323473|NCT03201809|4056528|FG001|COMPLETED|Overall Study||6
3323474|NCT03201809|4056527|FG000|NOT COMPLETED|Overall Study||2
3323475|NCT03201809|4056528|FG001|NOT COMPLETED|Overall Study||0
3323476|NCT03201900|4056534|FG000|STARTED|Treatment Phase (Up to 62 Weeks)||91
3323477|NCT03201900|4056534|FG000|Treated|Treatment Phase (Up to 62 Weeks)||89
3323478|NCT03201900|4056534|FG000|COMPLETED|Treatment Phase (Up to 62 Weeks)||54
3323479|NCT03201900|4056534|FG000|NOT COMPLETED|Treatment Phase (Up to 62 Weeks)||37
3323480|NCT03201900|4056534|FG000|STARTED|Extension Phase (From Week 63 to 156)|Eligible participants who completed Treatment Phase and agreed to continue in the Extension Phase.|46
3323481|NCT03201900|4056534|FG000|COMPLETED|Extension Phase (From Week 63 to 156)||38
3323482|NCT03201900|4056534|FG000|NOT COMPLETED|Extension Phase (From Week 63 to 156)||8
3323483|NCT03202134|4056540|FG000|STARTED|Overall Study||55
3323484|NCT03202134|4056541|FG001|STARTED|Overall Study||149
3323485|NCT03202134|4056540|FG000|COMPLETED|Overall Study||55
3323486|NCT03202134|4056541|FG001|COMPLETED|Overall Study||149
3323487|NCT03202134|4056540|FG000|NOT COMPLETED|Overall Study||0
3323488|NCT03202134|4056541|FG001|NOT COMPLETED|Overall Study||0
3323489|NCT03202264|4056549|FG000|STARTED|Overall Study||30
3323490|NCT03202264|4056549|FG000|COMPLETED|Overall Study||14
3323491|NCT03202264|4056549|FG000|NOT COMPLETED|Overall Study||16
3323492|NCT03202472|4056553|FG000|STARTED|Overall Study||50
3323493|NCT03202472|4056553|FG000|COMPLETED|Overall Study||50
3323494|NCT03202472|4056553|FG000|NOT COMPLETED|Overall Study||0
3323495|NCT03202511|4056557|FG000|STARTED|Overall Study||8
3323496|NCT03202511|4056558|FG001|STARTED|Overall Study||7
3323497|NCT03202511|4056557|FG000|COMPLETED|Overall Study||7
3323498|NCT03202511|4056558|FG001|COMPLETED|Overall Study||7
3323499|NCT03202511|4056557|FG000|NOT COMPLETED|Overall Study||1
3323500|NCT03202511|4056558|FG001|NOT COMPLETED|Overall Study||0
3323501|NCT03202550|4056566|FG000|STARTED|Overall Study||13
3323502|NCT03202550|4056567|FG001|STARTED|Overall Study||11
3323503|NCT03202550|4056566|FG000|COMPLETED|Overall Study||13
3323504|NCT03202550|4056567|FG001|COMPLETED|Overall Study||11
3323505|NCT03202550|4056566|FG000|NOT COMPLETED|Overall Study||0
3323506|NCT03202550|4056567|FG001|NOT COMPLETED|Overall Study||0
3323507|NCT03203291|4056573|FG000|STARTED|Overall Study||12
3323508|NCT03203291|4056573|FG000|COMPLETED|Overall Study||11
3323509|NCT03203291|4056573|FG000|NOT COMPLETED|Overall Study||1
3323510|NCT03203447|4056579|FG000|STARTED|Overall Study|Two patients were randomized to the Active arm, but did not receive study drug.|162
3323511|NCT03203447|4056580|FG001|STARTED|Overall Study|One patient was randomized to the Control arm, but did not receive study drug.|163
3323512|NCT03203447|4056579|FG000|COMPLETED|Overall Study||0
3323513|NCT03203447|4056580|FG001|COMPLETED|Overall Study||0
3323514|NCT03203447|4056579|FG000|NOT COMPLETED|Overall Study||162
3323515|NCT03203447|4056580|FG001|NOT COMPLETED|Overall Study||163
3323516|NCT03203564|4056590|FG000|STARTED|Overall Study||8
3323517|NCT03203564|4056591|FG001|STARTED|Overall Study||8
3323518|NCT03203564|4056592|FG002|STARTED|Overall Study||8
3323519|NCT03203564|4056593|FG003|STARTED|Overall Study||9
3323520|NCT03203564|4056590|FG000|COMPLETED|Overall Study||8
3323521|NCT03203564|4056591|FG001|COMPLETED|Overall Study||8
3323522|NCT03203564|4056592|FG002|COMPLETED|Overall Study||8
2927187|NCT00571688|3638116|FG001|STARTED|Overall Study||25
3175964|NCT01963169|3903667|FG001|COMPLETED|Overall Study||220
3175965|NCT01963169|3903668|FG002|COMPLETED|Overall Study||237
3175966|NCT01963169|3903666|FG000|NOT COMPLETED|Overall Study||59
3175967|NCT01963169|3903667|FG001|NOT COMPLETED|Overall Study||82
3175968|NCT01963169|3903668|FG002|NOT COMPLETED|Overall Study||26
3175969|NCT01963234|3903679|FG000|STARTED|Overall Study||268
2927188|NCT00571688|3638115|FG000|COMPLETED|Overall Study||20
2927189|NCT00571688|3638116|FG001|COMPLETED|Overall Study||19
2927190|NCT00571688|3638115|FG000|NOT COMPLETED|Overall Study||5
2927191|NCT00571688|3638116|FG001|NOT COMPLETED|Overall Study||6
2927192|NCT00571701|3638124|FG000|STARTED|First Intervention 12 Months||19
2927193|NCT00571701|3638125|FG001|STARTED|First Intervention 12 Months||22
2927194|NCT00571701|3638124|FG000|COMPLETED|First Intervention 12 Months||16
2927195|NCT00571701|3638125|FG001|COMPLETED|First Intervention 12 Months||21
2927196|NCT00571701|3638124|FG000|NOT COMPLETED|First Intervention 12 Months||3
2927197|NCT00571701|3638125|FG001|NOT COMPLETED|First Intervention 12 Months||1
2927198|NCT00571701|3638124|FG000|STARTED|Second Intervention 12 Months||16
2927199|NCT00571701|3638125|FG001|STARTED|Second Intervention 12 Months||21
2927200|NCT00571701|3638124|FG000|COMPLETED|Second Intervention 12 Months||13
2927201|NCT00571701|3638125|FG001|COMPLETED|Second Intervention 12 Months||20
2927202|NCT00571701|3638124|FG000|NOT COMPLETED|Second Intervention 12 Months||3
2927203|NCT00571701|3638125|FG001|NOT COMPLETED|Second Intervention 12 Months||1
2927204|NCT00571948|3638151|FG000|STARTED|Overall Study||66
2927205|NCT00571948|3638152|FG001|STARTED|Overall Study||66
2927206|NCT00571948|3638151|FG000|COMPLETED|Overall Study|Excluded from analysis (n = 2) Reason: diet record for less than 75 % of days (n = 2)|55
2927207|NCT00571948|3638152|FG001|COMPLETED|Overall Study|Excluded n = 3) Reasons: diet record < 75 % of days (n = 2); blood analysis failed (n= 1)|52
2927208|NCT00571948|3638151|FG000|NOT COMPLETED|Overall Study||11
2927209|NCT00571948|3638152|FG001|NOT COMPLETED|Overall Study||14
2927210|NCT00571961|3638158|FG000|STARTED|Overall Study||12
2927211|NCT00571961|3638158|FG000|COMPLETED|Overall Study||12
2927212|NCT00571961|3638158|FG000|NOT COMPLETED|Overall Study||0
2927213|NCT00571974|3638164|FG000|STARTED|Phase I||9
2927214|NCT00571974|3638165|FG001|STARTED|Phase I||0
2927215|NCT00571974|3638164|FG000|COMPLETED|Phase I||9
2927216|NCT00571974|3638165|FG001|COMPLETED|Phase I||0
2927217|NCT00571974|3638164|FG000|NOT COMPLETED|Phase I||0
2927218|NCT00571974|3638165|FG001|NOT COMPLETED|Phase I||0
2927219|NCT00571974|3638164|FG000|STARTED|Phase II||0
2927220|NCT00571974|3638165|FG001|STARTED|Phase II|3 participants are from phase I|21
2927221|NCT00571974|3638164|FG000|COMPLETED|Phase II||0
2927222|NCT00571974|3638165|FG001|COMPLETED|Phase II||17
2927223|NCT00571974|3638164|FG000|NOT COMPLETED|Phase II||0
3175970|NCT01963234|3903680|FG001|STARTED|Overall Study||171
3175971|NCT01963234|3903679|FG000|COMPLETED|Overall Study||207
3175972|NCT01963234|3903680|FG001|COMPLETED|Overall Study||171
3175973|NCT01963234|3903679|FG000|NOT COMPLETED|Overall Study||61
3175974|NCT01963234|3903680|FG001|NOT COMPLETED|Overall Study||0
3175975|NCT01963260|3903702|FG000|STARTED|Overall Study||6
3175976|NCT01963260|3903703|FG001|STARTED|Overall Study||6
3175977|NCT01963260|3903704|FG002|STARTED|Overall Study||6
2927224|NCT00571974|3638165|FG001|NOT COMPLETED|Phase II||4
2927225|NCT00571987|3638171|FG000|STARTED|Overall Study||107
2927226|NCT00571987|3638171|FG000|COMPLETED|Overall Study||100
2927227|NCT00571987|3638171|FG000|NOT COMPLETED|Overall Study||7
2927228|NCT00572039|3638178|FG000|STARTED|Overall Study||121
2927229|NCT00572039|3638179|FG001|STARTED|Overall Study||120
2927230|NCT00572039|3638178|FG000|COMPLETED|Overall Study||105
2927231|NCT00572039|3638179|FG001|COMPLETED|Overall Study||110
2927232|NCT00572039|3638178|FG000|NOT COMPLETED|Overall Study||16
2927233|NCT00572039|3638179|FG001|NOT COMPLETED|Overall Study||10
2927234|NCT00572117|3638189|FG000|STARTED|Overall Study||5
2927235|NCT00572117|3638190|FG001|STARTED|Overall Study||7
3039691|NCT01160198|3759142|FG000|COMPLETED|Overall Study||87
3039692|NCT01160198|3759143|FG001|COMPLETED|Overall Study||88
3039693|NCT01160198|3759144|FG002|COMPLETED|Overall Study||89
3039694|NCT01160198|3759142|FG000|NOT COMPLETED|Overall Study||2
3039695|NCT01160198|3759143|FG001|NOT COMPLETED|Overall Study||3
3039696|NCT01160198|3759144|FG002|NOT COMPLETED|Overall Study||1
3039697|NCT01160211|3759155|FG000|STARTED|Overall Study||120
3039698|NCT01160211|3759156|FG001|STARTED|Overall Study||118
3039699|NCT01160211|3759157|FG002|STARTED|Overall Study||117
3039700|NCT01160211|3759155|FG000|Ongoing|Overall Study||90
3039701|NCT01160211|3759156|FG001|Ongoing|Overall Study||75
3039702|NCT01160211|3759157|FG002|Ongoing|Overall Study||79
3039703|NCT01160211|3759155|FG000|COMPLETED|Overall Study||21
3039704|NCT01160211|3759156|FG001|COMPLETED|Overall Study||31
3039705|NCT01160211|3759157|FG002|COMPLETED|Overall Study||30
3039706|NCT01160211|3759155|FG000|NOT COMPLETED|Overall Study||99
3039707|NCT01160211|3759156|FG001|NOT COMPLETED|Overall Study||87
3039708|NCT01160211|3759157|FG002|NOT COMPLETED|Overall Study||87
3039709|NCT01160237|3759169|FG000|STARTED|Overall Study||4
3039710|NCT01160237|3759170|FG001|STARTED|Overall Study||3
3039711|NCT01160237|3759171|FG002|STARTED|Overall Study||0
3039712|NCT01160237|3759169|FG000|COMPLETED|Overall Study||4
3039713|NCT01160237|3759170|FG001|COMPLETED|Overall Study||3
3039714|NCT01160237|3759171|FG002|COMPLETED|Overall Study||0
3039715|NCT01160237|3759169|FG000|NOT COMPLETED|Overall Study||0
3039716|NCT01160237|3759170|FG001|NOT COMPLETED|Overall Study||0
3039717|NCT01160237|3759171|FG002|NOT COMPLETED|Overall Study||0
3039718|NCT01160289|3759184|FG000|STARTED|Screening, Washout, and Lead-In Period||894
3039719|NCT01160289|3759185|FG001|STARTED|Screening, Washout, and Lead-In Period||0
3039720|NCT01160289|3759186|FG002|STARTED|Screening, Washout, and Lead-In Period||0
3039721|NCT01160289|3759187|FG003|STARTED|Screening, Washout, and Lead-In Period||0
3039722|NCT01160289|3759188|FG004|STARTED|Screening, Washout, and Lead-In Period||0
3039723|NCT01160289|3759189|FG005|STARTED|Screening, Washout, and Lead-In Period||0
3039724|NCT01160289|3759184|FG000|COMPLETED|Screening, Washout, and Lead-In Period||410
3039725|NCT01160289|3759185|FG001|COMPLETED|Screening, Washout, and Lead-In Period||0
3039726|NCT01160289|3759186|FG002|COMPLETED|Screening, Washout, and Lead-In Period||0
3039727|NCT01160289|3759187|FG003|COMPLETED|Screening, Washout, and Lead-In Period||0
3039728|NCT01160289|3759188|FG004|COMPLETED|Screening, Washout, and Lead-In Period||0
2927236|NCT00572117|3638189|FG000|COMPLETED|Overall Study||3
2927237|NCT00572117|3638190|FG001|COMPLETED|Overall Study||5
3175978|NCT01963260|3903705|FG003|STARTED|Overall Study||6
2927238|NCT00572117|3638189|FG000|NOT COMPLETED|Overall Study||2
2927239|NCT00572117|3638190|FG001|NOT COMPLETED|Overall Study||2
2927240|NCT00572156|3638202|FG000|STARTED|Overall Study||26
2927241|NCT00572156|3638203|FG001|STARTED|Overall Study||27
2927242|NCT00572156|3638204|FG002|STARTED|Overall Study||27
2927243|NCT00572156|3638205|FG003|STARTED|Overall Study||26
2927244|NCT00572156|3638202|FG000|COMPLETED|Overall Study||0
2927245|NCT00572156|3638203|FG001|COMPLETED|Overall Study||1
2927246|NCT00572156|3638204|FG002|COMPLETED|Overall Study||0
2927247|NCT00572156|3638205|FG003|COMPLETED|Overall Study||1
2927248|NCT00572156|3638202|FG000|NOT COMPLETED|Overall Study||26
2927249|NCT00572156|3638203|FG001|NOT COMPLETED|Overall Study||26
2927250|NCT00572156|3638204|FG002|NOT COMPLETED|Overall Study||27
2927251|NCT00572156|3638205|FG003|NOT COMPLETED|Overall Study||25
3175979|NCT01963260|3903706|FG004|STARTED|Overall Study||6
3175980|NCT01963260|3903707|FG005|STARTED|Overall Study||10
3175981|NCT01963260|3903708|FG006|STARTED|Overall Study||3
3175982|NCT01963260|3903709|FG007|STARTED|Overall Study||2
3175983|NCT01963260|3903710|FG008|STARTED|Overall Study||1
3175984|NCT01963260|3903711|FG009|STARTED|Overall Study||4
3175985|NCT01963260|3903702|FG000|Treated|Overall Study||6
2927252|NCT00572195|3638215|FG000|STARTED|Overall Study||230
3175986|NCT01963260|3903703|FG001|Treated|Overall Study||6
2927253|NCT00572195|3638215|FG000|COMPLETED|Overall Study||162
2927254|NCT00572195|3638215|FG000|NOT COMPLETED|Overall Study||68
2927255|NCT00572234|3638221|FG000|STARTED|Overall Study||19
2927256|NCT00572234|3638222|FG001|STARTED|Overall Study||21
2927257|NCT00572234|3638221|FG000|COMPLETED|Overall Study||18
2927258|NCT00572234|3638222|FG001|COMPLETED|Overall Study||16
2927259|NCT00572234|3638221|FG000|NOT COMPLETED|Overall Study||1
2927260|NCT00572234|3638222|FG001|NOT COMPLETED|Overall Study||5
2927261|NCT00572455|3638242|FG000|STARTED|Stage I (14 Days)||9
2927262|NCT00572455|3638243|FG001|STARTED|Stage I (14 Days)||9
3175987|NCT01963260|3903704|FG002|Treated|Overall Study||6
3175988|NCT01963260|3903705|FG003|Treated|Overall Study||6
3175989|NCT01963260|3903706|FG004|Treated|Overall Study||6
3175990|NCT01963260|3903707|FG005|Treated|Overall Study||10
3175991|NCT01963260|3903708|FG006|Treated|Overall Study||3
3175992|NCT01963260|3903709|FG007|Treated|Overall Study||2
3175993|NCT01963260|3903710|FG008|Treated|Overall Study||1
3175994|NCT01963260|3903711|FG009|Treated|Overall Study||4
3175995|NCT01963260|3903702|FG000|COMPLETED|Overall Study||4
3175996|NCT01963260|3903703|FG001|COMPLETED|Overall Study||6
3175997|NCT01963260|3903704|FG002|COMPLETED|Overall Study||6
3175998|NCT01963260|3903705|FG003|COMPLETED|Overall Study||5
3175999|NCT01963260|3903706|FG004|COMPLETED|Overall Study||4
3176000|NCT01963260|3903707|FG005|COMPLETED|Overall Study||10
2927263|NCT00572455|3638244|FG002|STARTED|Stage I (14 Days)||9
2927264|NCT00572455|3638245|FG003|STARTED|Stage I (14 Days)||10
2927265|NCT00572455|3638246|FG004|STARTED|Stage I (14 Days)||9
2927266|NCT00572455|3638247|FG005|STARTED|Stage I (14 Days)||9
2927267|NCT00572455|3638248|FG006|STARTED|Stage I (14 Days)||12
2927268|NCT00572455|3638249|FG007|STARTED|Stage I (14 Days)||0
2927269|NCT00572455|3638250|FG008|STARTED|Stage I (14 Days)||0
2927270|NCT00572455|3638251|FG009|STARTED|Stage I (14 Days)||0
2927271|NCT00572455|3638252|FG010|STARTED|Stage I (14 Days)||0
2927272|NCT00572455|3638253|FG011|STARTED|Stage I (14 Days)||0
2927273|NCT00572455|3638254|FG012|STARTED|Stage I (14 Days)||0
2927274|NCT00572455|3638255|FG013|STARTED|Stage I (14 Days)||0
2927275|NCT00572455|3638242|FG000|COMPLETED|Stage I (14 Days)||9
2927276|NCT00572455|3638243|FG001|COMPLETED|Stage I (14 Days)||9
2927277|NCT00572455|3638244|FG002|COMPLETED|Stage I (14 Days)||9
2927278|NCT00572455|3638245|FG003|COMPLETED|Stage I (14 Days)||10
2927279|NCT00572455|3638246|FG004|COMPLETED|Stage I (14 Days)||8
2927280|NCT00572455|3638247|FG005|COMPLETED|Stage I (14 Days)||6
2927281|NCT00572455|3638248|FG006|COMPLETED|Stage I (14 Days)||12
2927282|NCT00572455|3638249|FG007|COMPLETED|Stage I (14 Days)||0
2927283|NCT00572455|3638250|FG008|COMPLETED|Stage I (14 Days)||0
2927284|NCT00572455|3638251|FG009|COMPLETED|Stage I (14 Days)||0
2927285|NCT00572455|3638252|FG010|COMPLETED|Stage I (14 Days)||0
2927286|NCT00572455|3638253|FG011|COMPLETED|Stage I (14 Days)||0
2927287|NCT00572455|3638254|FG012|COMPLETED|Stage I (14 Days)||0
2927288|NCT00572455|3638255|FG013|COMPLETED|Stage I (14 Days)||0
2927289|NCT00572455|3638242|FG000|NOT COMPLETED|Stage I (14 Days)||0
2927290|NCT00572455|3638243|FG001|NOT COMPLETED|Stage I (14 Days)||0
2927291|NCT00572455|3638244|FG002|NOT COMPLETED|Stage I (14 Days)||0
2927292|NCT00572455|3638245|FG003|NOT COMPLETED|Stage I (14 Days)||0
2927293|NCT00572455|3638246|FG004|NOT COMPLETED|Stage I (14 Days)||1
2927294|NCT00572455|3638247|FG005|NOT COMPLETED|Stage I (14 Days)||3
2927295|NCT00572455|3638248|FG006|NOT COMPLETED|Stage I (14 Days)||0
2927296|NCT00572455|3638249|FG007|NOT COMPLETED|Stage I (14 Days)||0
2927297|NCT00572455|3638250|FG008|NOT COMPLETED|Stage I (14 Days)||0
3039729|NCT01160289|3759189|FG005|COMPLETED|Screening, Washout, and Lead-In Period||0
3039730|NCT01160289|3759184|FG000|NOT COMPLETED|Screening, Washout, and Lead-In Period||484
3176001|NCT01963260|3903708|FG006|COMPLETED|Overall Study||3
3176002|NCT01963260|3903709|FG007|COMPLETED|Overall Study||2
3176003|NCT01963260|3903710|FG008|COMPLETED|Overall Study||1
3176004|NCT01963260|3903711|FG009|COMPLETED|Overall Study||4
3176005|NCT01963260|3903702|FG000|NOT COMPLETED|Overall Study||2
3176006|NCT01963260|3903703|FG001|NOT COMPLETED|Overall Study||0
3176007|NCT01963260|3903704|FG002|NOT COMPLETED|Overall Study||0
3176008|NCT01963260|3903705|FG003|NOT COMPLETED|Overall Study||1
3176009|NCT01963260|3903706|FG004|NOT COMPLETED|Overall Study||2
3176010|NCT01963260|3903707|FG005|NOT COMPLETED|Overall Study||0
3176011|NCT01963260|3903708|FG006|NOT COMPLETED|Overall Study||0
3176012|NCT01963260|3903709|FG007|NOT COMPLETED|Overall Study||0
3176013|NCT01963260|3903710|FG008|NOT COMPLETED|Overall Study||0
3176014|NCT01963260|3903711|FG009|NOT COMPLETED|Overall Study||0
3176015|NCT01963403|3903742|FG000|STARTED|Overall Study||13
3176016|NCT01963403|3903743|FG001|STARTED|Overall Study||13
3176017|NCT01963403|3903742|FG000|COMPLETED|Overall Study|Follow-up over three months|11
3176018|NCT01963403|3903743|FG001|COMPLETED|Overall Study|Follow-up over three months|9
3176019|NCT01963403|3903742|FG000|NOT COMPLETED|Overall Study||2
3176020|NCT01963403|3903743|FG001|NOT COMPLETED|Overall Study||4
3176021|NCT01963481|3903751|FG000|STARTED|Overall Study||23
3176022|NCT01963481|3903751|FG000|COMPLETED|Overall Study||23
3176023|NCT01963481|3903751|FG000|NOT COMPLETED|Overall Study||0
2927298|NCT00572455|3638251|FG009|NOT COMPLETED|Stage I (14 Days)||0
2927299|NCT00572455|3638252|FG010|NOT COMPLETED|Stage I (14 Days)||0
2927300|NCT00572455|3638253|FG011|NOT COMPLETED|Stage I (14 Days)||0
2927301|NCT00572455|3638254|FG012|NOT COMPLETED|Stage I (14 Days)||0
2927302|NCT00572455|3638255|FG013|NOT COMPLETED|Stage I (14 Days)||0
2927303|NCT00572455|3638242|FG000|STARTED|Stage II (28 Days)||0
2927304|NCT00572455|3638243|FG001|STARTED|Stage II (28 Days)||0
2927305|NCT00572455|3638244|FG002|STARTED|Stage II (28 Days)||0
2927306|NCT00572455|3638245|FG003|STARTED|Stage II (28 Days)||0
2927307|NCT00572455|3638246|FG004|STARTED|Stage II (28 Days)||0
2927308|NCT00572455|3638247|FG005|STARTED|Stage II (28 Days)||0
2927309|NCT00572455|3638248|FG006|STARTED|Stage II (28 Days)||0
2927310|NCT00572455|3638249|FG007|STARTED|Stage II (28 Days)||35
2927311|NCT00572455|3638250|FG008|STARTED|Stage II (28 Days)||36
2927312|NCT00572455|3638251|FG009|STARTED|Stage II (28 Days)||36
2927313|NCT00572455|3638252|FG010|STARTED|Stage II (28 Days)||36
2927314|NCT00572455|3638253|FG011|STARTED|Stage II (28 Days)||36
2927315|NCT00572455|3638254|FG012|STARTED|Stage II (28 Days)||36
2927316|NCT00572455|3638255|FG013|STARTED|Stage II (28 Days)||36
2927317|NCT00572455|3638242|FG000|Treated|Stage II (28 Days)||0
2927318|NCT00572455|3638243|FG001|Treated|Stage II (28 Days)||0
2927319|NCT00572455|3638244|FG002|Treated|Stage II (28 Days)||0
2927320|NCT00572455|3638245|FG003|Treated|Stage II (28 Days)||0
2927321|NCT00572455|3638246|FG004|Treated|Stage II (28 Days)||0
2927322|NCT00572455|3638247|FG005|Treated|Stage II (28 Days)||0
2927323|NCT00572455|3638248|FG006|Treated|Stage II (28 Days)||0
2927324|NCT00572455|3638249|FG007|Treated|Stage II (28 Days)||35
2927325|NCT00572455|3638250|FG008|Treated|Stage II (28 Days)||36
2927326|NCT00572455|3638251|FG009|Treated|Stage II (28 Days)||36
2927327|NCT00572455|3638252|FG010|Treated|Stage II (28 Days)||36
2927328|NCT00572455|3638253|FG011|Treated|Stage II (28 Days)||36
2927329|NCT00572455|3638254|FG012|Treated|Stage II (28 Days)||36
2927330|NCT00572455|3638255|FG013|Treated|Stage II (28 Days)||35
2927331|NCT00572455|3638242|FG000|COMPLETED|Stage II (28 Days)||0
2927332|NCT00572455|3638243|FG001|COMPLETED|Stage II (28 Days)||0
2927333|NCT00572455|3638244|FG002|COMPLETED|Stage II (28 Days)||0
2927334|NCT00572455|3638245|FG003|COMPLETED|Stage II (28 Days)||0
2927335|NCT00572455|3638246|FG004|COMPLETED|Stage II (28 Days)||0
2927336|NCT00572455|3638247|FG005|COMPLETED|Stage II (28 Days)||0
2927337|NCT00572455|3638248|FG006|COMPLETED|Stage II (28 Days)||0
2927338|NCT00572455|3638249|FG007|COMPLETED|Stage II (28 Days)||34
2927339|NCT00572455|3638250|FG008|COMPLETED|Stage II (28 Days)||33
2927340|NCT00572455|3638251|FG009|COMPLETED|Stage II (28 Days)||33
2927341|NCT00572455|3638252|FG010|COMPLETED|Stage II (28 Days)||31
2927342|NCT00572455|3638253|FG011|COMPLETED|Stage II (28 Days)||32
2927343|NCT00572455|3638254|FG012|COMPLETED|Stage II (28 Days)||31
2927344|NCT00572455|3638255|FG013|COMPLETED|Stage II (28 Days)||34
2927345|NCT00572455|3638242|FG000|NOT COMPLETED|Stage II (28 Days)||0
2927346|NCT00572455|3638243|FG001|NOT COMPLETED|Stage II (28 Days)||0
2927347|NCT00572455|3638244|FG002|NOT COMPLETED|Stage II (28 Days)||0
2927348|NCT00572455|3638245|FG003|NOT COMPLETED|Stage II (28 Days)||0
2927349|NCT00572455|3638246|FG004|NOT COMPLETED|Stage II (28 Days)||0
2927350|NCT00572455|3638247|FG005|NOT COMPLETED|Stage II (28 Days)||0
2927351|NCT00572455|3638248|FG006|NOT COMPLETED|Stage II (28 Days)||0
2927352|NCT00572455|3638249|FG007|NOT COMPLETED|Stage II (28 Days)||1
2927353|NCT00572455|3638250|FG008|NOT COMPLETED|Stage II (28 Days)||3
2927354|NCT00572455|3638251|FG009|NOT COMPLETED|Stage II (28 Days)||3
2927355|NCT00572455|3638252|FG010|NOT COMPLETED|Stage II (28 Days)||5
2927356|NCT00572455|3638253|FG011|NOT COMPLETED|Stage II (28 Days)||4
2927357|NCT00572455|3638254|FG012|NOT COMPLETED|Stage II (28 Days)||5
2927358|NCT00572455|3638255|FG013|NOT COMPLETED|Stage II (28 Days)||2
2927359|NCT00572468|3638287|FG000|STARTED|Overall Study||22
2927360|NCT00572468|3638288|FG001|STARTED|Overall Study||20
2927361|NCT00572468|3638287|FG000|COMPLETED|Overall Study||20
2927362|NCT00572468|3638288|FG001|COMPLETED|Overall Study||16
2927363|NCT00572468|3638287|FG000|NOT COMPLETED|Overall Study||2
2927364|NCT00572468|3638288|FG001|NOT COMPLETED|Overall Study||4
2927365|NCT00572533|3638296|FG000|STARTED|Overall Study||31
2927366|NCT00572533|3638297|FG001|STARTED|Overall Study||31
2927367|NCT00572533|3638296|FG000|COMPLETED|Overall Study||24
2927368|NCT00572533|3638297|FG001|COMPLETED|Overall Study||28
2927369|NCT00572533|3638296|FG000|NOT COMPLETED|Overall Study||7
2927370|NCT00572533|3638297|FG001|NOT COMPLETED|Overall Study||3
2927371|NCT00572572|3638305|FG000|STARTED|Overall Study||35
2927372|NCT00572572|3638306|FG001|STARTED|Overall Study||34
2927373|NCT00572572|3638305|FG000|COMPLETED|Overall Study||32
2927374|NCT00572572|3638306|FG001|COMPLETED|Overall Study||28
2927375|NCT00572572|3638305|FG000|NOT COMPLETED|Overall Study||3
2927376|NCT00572572|3638306|FG001|NOT COMPLETED|Overall Study||6
2927377|NCT00572624|3638314|FG000|STARTED|Overall Study||37
2927378|NCT00572624|3638315|FG001|STARTED|Overall Study||14
2927379|NCT00572624|3638314|FG000|COMPLETED|Overall Study||20
2927380|NCT00572624|3638315|FG001|COMPLETED|Overall Study||10
2927381|NCT00572624|3638314|FG000|NOT COMPLETED|Overall Study||17
2927382|NCT00572624|3638315|FG001|NOT COMPLETED|Overall Study||4
2927383|NCT00572728|3638321|FG000|STARTED|Overall Study|Registered|90
2927384|NCT00572728|3638321|FG000|Eligible|Overall Study||87
2927385|NCT00572728|3638321|FG000|Enrolled Under Amendment 5 or Later|Overall Study||82
2927386|NCT00572728|3638321|FG000|Did Not Withdraw|Overall Study||72
2927387|NCT00572728|3638321|FG000|On Study|Overall Study||71
2927388|NCT00572728|3638321|FG000|Completed FLT1 Scan|Overall Study||67
2927389|NCT00572728|3638321|FG000|First Therapy Initiated|Overall Study||65
2927390|NCT00572728|3638321|FG000|Completed FLT2 Scan|Overall Study||60
2927391|NCT00572728|3638321|FG000|Second Chemotherapy Initiated|Overall Study||59
2927392|NCT00572728|3638321|FG000|Second Chemotherapy Initiated After FLT2|Overall Study||52
2927393|NCT00572728|3638321|FG000|Pathology Complete|Overall Study||51
2927394|NCT00572728|3638321|FG000|Completed FLT3 Scan|Overall Study|Secondary analysis milestone: 43 pts had FLT-3 performed.|43
3176024|NCT01963611|3903760|FG000|STARTED|Overall Study||51
3176025|NCT01963611|3903761|FG001|STARTED|Overall Study||49
3176026|NCT01963611|3903762|FG002|STARTED|Overall Study||52
3323523|NCT03203564|4056593|FG003|COMPLETED|Overall Study||9
3323524|NCT03203564|4056590|FG000|NOT COMPLETED|Overall Study||0
3323525|NCT03203564|4056591|FG001|NOT COMPLETED|Overall Study||0
3323526|NCT03203564|4056592|FG002|NOT COMPLETED|Overall Study||0
3323527|NCT03203564|4056593|FG003|NOT COMPLETED|Overall Study||0
3323528|NCT03203681|4056603|FG000|STARTED|Overall Study||60
3323529|NCT03203681|4056603|FG000|3 Month|Overall Study||44
3323530|NCT03203681|4056603|FG000|6 Months|Overall Study||33
3323531|NCT03203681|4056603|FG000|COMPLETED|Overall Study||33
3323532|NCT03203681|4056603|FG000|NOT COMPLETED|Overall Study||27
3323533|NCT03204279|4056609|FG000|STARTED|Overall Study||34
3323534|NCT03204279|4056610|FG001|STARTED|Overall Study||33
3323535|NCT03204279|4056609|FG000|COMPLETED|Overall Study||34
3323536|NCT03204279|4056610|FG001|COMPLETED|Overall Study||32
3323537|NCT03204279|4056609|FG000|NOT COMPLETED|Overall Study||0
3323538|NCT03204279|4056610|FG001|NOT COMPLETED|Overall Study||1
3176027|NCT01963611|3903763|FG003|STARTED|Overall Study||52
3176028|NCT01963611|3903764|FG004|STARTED|Overall Study||51
3176029|NCT01963611|3903760|FG000|Safety Analysis Set|Overall Study||51
3176030|NCT01963611|3903761|FG001|Safety Analysis Set|Overall Study||49
3176031|NCT01963611|3903762|FG002|Safety Analysis Set|Overall Study||52
3176032|NCT01963611|3903763|FG003|Safety Analysis Set|Overall Study||52
3176033|NCT01963611|3903764|FG004|Safety Analysis Set|Overall Study||50
3176034|NCT01963611|3903760|FG000|COMPLETED|Overall Study||0
3176035|NCT01963611|3903761|FG001|COMPLETED|Overall Study||0
3176036|NCT01963611|3903762|FG002|COMPLETED|Overall Study||0
3176037|NCT01963611|3903763|FG003|COMPLETED|Overall Study||0
3323539|NCT03204526|4056617|FG000|STARTED|Overall Study||15
3323540|NCT03204526|4056617|FG000|COMPLETED|Overall Study||15
3323541|NCT03204526|4056617|FG000|NOT COMPLETED|Overall Study||0
3323542|NCT03204643|4056623|FG000|STARTED|Overall Study||323
3323543|NCT03204643|4056624|FG001|STARTED|Overall Study||314
3323544|NCT03204643|4056623|FG000|COMPLETED|Overall Study||323
3323545|NCT03204643|4056624|FG001|COMPLETED|Overall Study||314
3323546|NCT03204643|4056623|FG000|NOT COMPLETED|Overall Study||0
3323547|NCT03204643|4056624|FG001|NOT COMPLETED|Overall Study||0
3323548|NCT03204942|4056633|FG000|STARTED|Overall Study||23
3323549|NCT03204942|4056634|FG001|STARTED|Overall Study||23
3323550|NCT03204942|4056635|FG002|STARTED|Overall Study||23
3323551|NCT03204942|4056633|FG000|COMPLETED|Overall Study||23
3323552|NCT03204942|4056634|FG001|COMPLETED|Overall Study||23
2927395|NCT00572728|3638321|FG000|LN Evaluation After NAC|Overall Study|Secondary:38 patients were available for histopathological LN evaluation after NAC|38
2927396|NCT00572728|3638321|FG000|RCB Evaluation|Overall Study|Secondary: histopathology was available in 35 patients for RCB evaluation|35
2927397|NCT00572728|3638321|FG000|COMPLETED|Overall Study|51 patients eligible for primary objective analysis|51
2927398|NCT00572728|3638321|FG000|NOT COMPLETED|Overall Study||39
2927399|NCT00572832|3638329|FG000|STARTED|Overall Study||100
2927400|NCT00572832|3638330|FG001|STARTED|Overall Study||100
2927401|NCT00572832|3638329|FG000|COMPLETED|Overall Study||100
2927402|NCT00572832|3638330|FG001|COMPLETED|Overall Study||88
2927403|NCT00572832|3638329|FG000|NOT COMPLETED|Overall Study||0
2927404|NCT00572832|3638330|FG001|NOT COMPLETED|Overall Study||12
2927405|NCT00572897|3638338|FG000|STARTED|Overall Study||32
2927406|NCT00572897|3638339|FG001|STARTED|Overall Study||34
2927407|NCT00572897|3638338|FG000|COMPLETED|Overall Study||32
2927408|NCT00572897|3638339|FG001|COMPLETED|Overall Study||34
2927409|NCT00572897|3638338|FG000|NOT COMPLETED|Overall Study||0
2927410|NCT00572897|3638339|FG001|NOT COMPLETED|Overall Study||0
2927411|NCT00572910|3638351|FG000|STARTED|Overall Study||19
2927412|NCT00572910|3638352|FG001|STARTED|Overall Study||18
2927413|NCT00572910|3638353|FG002|STARTED|Overall Study||19
2927414|NCT00572910|3638354|FG003|STARTED|Overall Study||18
2927415|NCT00572910|3638355|FG004|STARTED|Overall Study||19
2927416|NCT00572910|3638356|FG005|STARTED|Overall Study||19
2927417|NCT00572910|3638357|FG006|STARTED|Overall Study||19
2927418|NCT00572910|3638358|FG007|STARTED|Overall Study||19
2927419|NCT00572910|3638359|FG008|STARTED|Overall Study||19
3323553|NCT03204942|4056635|FG002|COMPLETED|Overall Study||23
3323554|NCT03204942|4056633|FG000|NOT COMPLETED|Overall Study||0
3323555|NCT03204942|4056634|FG001|NOT COMPLETED|Overall Study||0
3323556|NCT03204942|4056635|FG002|NOT COMPLETED|Overall Study||0
3323557|NCT03204981|4056648|FG000|STARTED|Overall Study||52
3323558|NCT03204981|4056648|FG000|COMPLETED|Overall Study||46
3323559|NCT03204981|4056648|FG000|NOT COMPLETED|Overall Study||6
3323560|NCT03205046|4056656|FG000|STARTED|Overall Study||13
3323561|NCT03205046|4056657|FG001|STARTED|Overall Study||12
3323562|NCT03205046|4056656|FG000|COMPLETED|Overall Study||0
3323563|NCT03205046|4056657|FG001|COMPLETED|Overall Study||2
3323564|NCT03205046|4056656|FG000|NOT COMPLETED|Overall Study||13
2927420|NCT00572910|3638360|FG009|STARTED|Overall Study||19
2927421|NCT00572910|3638361|FG010|STARTED|Overall Study||18
2927422|NCT00572910|3638351|FG000|COMPLETED|Overall Study||15
2927423|NCT00572910|3638352|FG001|COMPLETED|Overall Study||15
2927424|NCT00572910|3638353|FG002|COMPLETED|Overall Study||17
2927425|NCT00572910|3638354|FG003|COMPLETED|Overall Study||14
2927426|NCT00572910|3638355|FG004|COMPLETED|Overall Study||17
2927427|NCT00572910|3638356|FG005|COMPLETED|Overall Study||16
2927428|NCT00572910|3638357|FG006|COMPLETED|Overall Study||15
2927429|NCT00572910|3638358|FG007|COMPLETED|Overall Study||15
2927430|NCT00572910|3638359|FG008|COMPLETED|Overall Study||16
2927431|NCT00572910|3638360|FG009|COMPLETED|Overall Study||13
3176038|NCT01963611|3903764|FG004|COMPLETED|Overall Study||0
3176039|NCT01963611|3903760|FG000|NOT COMPLETED|Overall Study||51
3176040|NCT01963611|3903761|FG001|NOT COMPLETED|Overall Study||49
3176041|NCT01963611|3903762|FG002|NOT COMPLETED|Overall Study||52
3176042|NCT01963611|3903763|FG003|NOT COMPLETED|Overall Study||52
3323565|NCT03205046|4056657|FG001|NOT COMPLETED|Overall Study||10
3323566|NCT03205150|4056666|FG000|STARTED|Overall Study||43
3323567|NCT03205150|4056667|FG001|STARTED|Overall Study||43
3323568|NCT03205150|4056668|FG002|STARTED|Overall Study||21
3323569|NCT03205150|4056666|FG000|Safety Analysis Set|Overall Study||43
3323570|NCT03205150|4056667|FG001|Safety Analysis Set|Overall Study||43
3323571|NCT03205150|4056668|FG002|Safety Analysis Set|Overall Study||21
3323572|NCT03205150|4056666|FG000|Pharmacokinetics (PK) Analysis Set|Overall Study|all patients with valid PK measurements|42
3323573|NCT03205150|4056667|FG001|Pharmacokinetics (PK) Analysis Set|Overall Study|all patients with valid PK measurements|36
3323574|NCT03205150|4056668|FG002|Pharmacokinetics (PK) Analysis Set|Overall Study|Placebo patients were excluded from the PK analyses|0
3323575|NCT03205150|4056666|FG000|Pharmacodynamics (PD) Analysis Set|Overall Study|all patients with available PD data and no protocol deviations|43
3323576|NCT03205150|4056667|FG001|Pharmacodynamics (PD) Analysis Set|Overall Study|all patients with available PD data and no protocol deviations|41
3323577|NCT03205150|4056668|FG002|Pharmacodynamics (PD) Analysis Set|Overall Study|all patients with available PD data and no protocol deviations|21
3176043|NCT01963611|3903764|FG004|NOT COMPLETED|Overall Study||51
3176044|NCT01963676|3903779|FG000|STARTED|Overall Study||14
3176045|NCT01963676|3903780|FG001|STARTED|Overall Study||13
3176046|NCT01963676|3903779|FG000|COMPLETED|Overall Study||13
3176047|NCT01963676|3903780|FG001|COMPLETED|Overall Study||13
3176048|NCT01963676|3903779|FG000|NOT COMPLETED|Overall Study||1
3176049|NCT01963676|3903780|FG001|NOT COMPLETED|Overall Study||0
3176050|NCT01963767|3903788|FG000|STARTED|Overall Study||58
3176051|NCT01963767|3903789|FG001|STARTED|Overall Study||55
3176052|NCT01963767|3903788|FG000|COMPLETED|Overall Study||52
3176053|NCT01963767|3903789|FG001|COMPLETED|Overall Study||53
3176054|NCT01963767|3903788|FG000|NOT COMPLETED|Overall Study||6
3176055|NCT01963767|3903789|FG001|NOT COMPLETED|Overall Study||2
2927432|NCT00572910|3638361|FG010|COMPLETED|Overall Study||15
2927433|NCT00572910|3638351|FG000|NOT COMPLETED|Overall Study||4
2927434|NCT00572910|3638352|FG001|NOT COMPLETED|Overall Study||3
2927435|NCT00572910|3638353|FG002|NOT COMPLETED|Overall Study||2
2927436|NCT00572910|3638354|FG003|NOT COMPLETED|Overall Study||4
2927437|NCT00572910|3638355|FG004|NOT COMPLETED|Overall Study||2
2927438|NCT00572910|3638356|FG005|NOT COMPLETED|Overall Study||3
2927439|NCT00572910|3638357|FG006|NOT COMPLETED|Overall Study||4
3176056|NCT01963793|3903795|FG000|STARTED|Overall Study||20
3176057|NCT01963793|3903795|FG000|COMPLETED|Overall Study||20
3176058|NCT01963793|3903795|FG000|NOT COMPLETED|Overall Study||0
3176059|NCT01963845|3903812|FG000|STARTED|Overall Study||25
2927440|NCT00572910|3638358|FG007|NOT COMPLETED|Overall Study||4
2927441|NCT00572910|3638359|FG008|NOT COMPLETED|Overall Study||3
3176060|NCT01963845|3903813|FG001|STARTED|Overall Study||25
3176061|NCT01963845|3903812|FG000|COMPLETED|Overall Study||25
3176062|NCT01963845|3903813|FG001|COMPLETED|Overall Study||25
3176063|NCT01963845|3903812|FG000|NOT COMPLETED|Overall Study||0
3176064|NCT01963845|3903813|FG001|NOT COMPLETED|Overall Study||0
3176065|NCT01963923|3903821|FG000|STARTED|3 Weeks Post-surgery||20
3176066|NCT01963923|3903822|FG001|STARTED|3 Weeks Post-surgery||20
3176067|NCT01963923|3903821|FG000|COMPLETED|3 Weeks Post-surgery||12
3176068|NCT01963923|3903822|FG001|COMPLETED|3 Weeks Post-surgery||10
3323578|NCT03205150|4056666|FG000|COMPLETED|Overall Study||41
3323579|NCT03205150|4056667|FG001|COMPLETED|Overall Study||36
3323580|NCT03205150|4056668|FG002|COMPLETED|Overall Study||19
3323581|NCT03205150|4056666|FG000|NOT COMPLETED|Overall Study||2
3323582|NCT03205150|4056667|FG001|NOT COMPLETED|Overall Study||7
3323583|NCT03205150|4056668|FG002|NOT COMPLETED|Overall Study||2
3323584|NCT03205163|4056679|FG000|STARTED|ATP (LDC: 3 Days; HDC: 4 Days)||7
3323585|NCT03205163|4056680|FG001|STARTED|ATP (LDC: 3 Days; HDC: 4 Days)||9
3323586|NCT03205163|4056679|FG000|Safety Population|ATP (LDC: 3 Days; HDC: 4 Days)||7
3323587|NCT03205163|4056680|FG001|Safety Population|ATP (LDC: 3 Days; HDC: 4 Days)||9
3323588|NCT03205163|4056679|FG000|COMPLETED|ATP (LDC: 3 Days; HDC: 4 Days)||6
3323589|NCT03205163|4056680|FG001|COMPLETED|ATP (LDC: 3 Days; HDC: 4 Days)||9
3323590|NCT03205163|4056679|FG000|NOT COMPLETED|ATP (LDC: 3 Days; HDC: 4 Days)||1
3323591|NCT03205163|4056680|FG001|NOT COMPLETED|ATP (LDC: 3 Days; HDC: 4 Days)||0
3323592|NCT03205163|4056679|FG000|STARTED|BTP (LDC: 28 Days; HDC: 28 Days)||6
3323593|NCT03205163|4056680|FG001|STARTED|BTP (LDC: 28 Days; HDC: 28 Days)||9
3323594|NCT03205163|4056679|FG000|Safety Population|BTP (LDC: 28 Days; HDC: 28 Days)||6
3323595|NCT03205163|4056680|FG001|Safety Population|BTP (LDC: 28 Days; HDC: 28 Days)||9
3323596|NCT03205163|4056679|FG000|COMPLETED|BTP (LDC: 28 Days; HDC: 28 Days)||6
3323597|NCT03205163|4056680|FG001|COMPLETED|BTP (LDC: 28 Days; HDC: 28 Days)||9
3323598|NCT03205163|4056679|FG000|NOT COMPLETED|BTP (LDC: 28 Days; HDC: 28 Days)||0
3323599|NCT03205163|4056680|FG001|NOT COMPLETED|BTP (LDC: 28 Days; HDC: 28 Days)||0
3323600|NCT03205358|4056697|FG000|STARTED|Overall Study||94
3323601|NCT03205358|4056698|FG001|STARTED|Overall Study||94
3323602|NCT03205358|4056697|FG000|COMPLETED|Overall Study||94
3323603|NCT03205358|4056698|FG001|COMPLETED|Overall Study||94
3176069|NCT01963923|3903821|FG000|NOT COMPLETED|3 Weeks Post-surgery||8
3176070|NCT01963923|3903822|FG001|NOT COMPLETED|3 Weeks Post-surgery||10
3176071|NCT01963923|3903821|FG000|STARTED|3 Months Post-surgery||12
3176072|NCT01963923|3903822|FG001|STARTED|3 Months Post-surgery||10
3176073|NCT01963923|3903821|FG000|COMPLETED|3 Months Post-surgery||10
2927442|NCT00572910|3638360|FG009|NOT COMPLETED|Overall Study||6
2927443|NCT00572910|3638361|FG010|NOT COMPLETED|Overall Study||3
2927444|NCT00572936|3638396|FG000|STARTED|First Intervention||4
2927445|NCT00572936|3638397|FG001|STARTED|First Intervention||4
2927446|NCT00572936|3638398|FG002|STARTED|First Intervention||5
2927447|NCT00572936|3638399|FG003|STARTED|First Intervention||5
2927448|NCT00572936|3638400|FG004|STARTED|First Intervention||5
2927449|NCT00572936|3638401|FG005|STARTED|First Intervention||5
2927450|NCT00572936|3638396|FG000|COMPLETED|First Intervention||4
2927451|NCT00572936|3638397|FG001|COMPLETED|First Intervention||4
2927452|NCT00572936|3638398|FG002|COMPLETED|First Intervention||5
2927453|NCT00572936|3638399|FG003|COMPLETED|First Intervention||5
2927454|NCT00572936|3638400|FG004|COMPLETED|First Intervention||5
2927455|NCT00572936|3638401|FG005|COMPLETED|First Intervention||5
2927456|NCT00572936|3638396|FG000|NOT COMPLETED|First Intervention||0
2927457|NCT00572936|3638397|FG001|NOT COMPLETED|First Intervention||0
2927458|NCT00572936|3638398|FG002|NOT COMPLETED|First Intervention||0
2927459|NCT00572936|3638399|FG003|NOT COMPLETED|First Intervention||0
2927460|NCT00572936|3638400|FG004|NOT COMPLETED|First Intervention||0
2927461|NCT00572936|3638401|FG005|NOT COMPLETED|First Intervention||0
2927462|NCT00572936|3638396|FG000|STARTED|Second Intervention||4
2927463|NCT00572936|3638397|FG001|STARTED|Second Intervention|1 participant dropped out between the first and second intervention due to car accident|3
2927464|NCT00572936|3638398|FG002|STARTED|Second Intervention|1 participant dropped out between first intervention and second intervention due to increased IOP|4
2927465|NCT00572936|3638399|FG003|STARTED|Second Intervention||5
2927466|NCT00572936|3638400|FG004|STARTED|Second Intervention|1 participant dropped out between first intervention and second intervention due to increased IOP|4
2927467|NCT00572936|3638401|FG005|STARTED|Second Intervention||5
2927468|NCT00572936|3638396|FG000|COMPLETED|Second Intervention||4
2927469|NCT00572936|3638397|FG001|COMPLETED|Second Intervention||3
3039731|NCT01160289|3759185|FG001|NOT COMPLETED|Screening, Washout, and Lead-In Period||0
3039732|NCT01160289|3759186|FG002|NOT COMPLETED|Screening, Washout, and Lead-In Period||0
3039733|NCT01160289|3759187|FG003|NOT COMPLETED|Screening, Washout, and Lead-In Period||0
3039734|NCT01160289|3759188|FG004|NOT COMPLETED|Screening, Washout, and Lead-In Period||0
3039735|NCT01160289|3759189|FG005|NOT COMPLETED|Screening, Washout, and Lead-In Period||0
3039736|NCT01160289|3759184|FG000|STARTED|Post-Randomization Period||0
3039737|NCT01160289|3759185|FG001|STARTED|Post-Randomization Period||85
3039738|NCT01160289|3759186|FG002|STARTED|Post-Randomization Period||97
3039739|NCT01160289|3759187|FG003|STARTED|Post-Randomization Period||52
3039740|NCT01160289|3759188|FG004|STARTED|Post-Randomization Period||89
3039741|NCT01160289|3759189|FG005|STARTED|Post-Randomization Period||87
3039742|NCT01160289|3759184|FG000|Received at Least 1 Dose of Study Drug|Post-Randomization Period||0
3176074|NCT01963923|3903822|FG001|COMPLETED|3 Months Post-surgery||9
3176075|NCT01963923|3903821|FG000|NOT COMPLETED|3 Months Post-surgery||2
3323604|NCT03205358|4056697|FG000|NOT COMPLETED|Overall Study||0
3323605|NCT03205358|4056698|FG001|NOT COMPLETED|Overall Study||0
3323606|NCT03205371|4056716|FG000|STARTED|Overall Study||107
3323607|NCT03205371|4056717|FG001|STARTED|Overall Study||53
3323608|NCT03205371|4056718|FG002|STARTED|Overall Study||53
3323609|NCT03205371|4056719|FG003|STARTED|Overall Study||86
3323610|NCT03205371|4056720|FG004|STARTED|Overall Study||42
3323611|NCT03205371|4056721|FG005|STARTED|Overall Study||42
3323612|NCT03205371|4056722|FG006|STARTED|Overall Study||200
3323613|NCT03205371|4056723|FG007|STARTED|Overall Study||100
3323614|NCT03205371|4056724|FG008|STARTED|Overall Study||100
3323615|NCT03205371|4056725|FG009|STARTED|Overall Study||200
3323616|NCT03205371|4056726|FG010|STARTED|Overall Study||100
2927470|NCT00572936|3638398|FG002|COMPLETED|Second Intervention||4
2927471|NCT00572936|3638399|FG003|COMPLETED|Second Intervention||5
2927472|NCT00572936|3638400|FG004|COMPLETED|Second Intervention||4
2927473|NCT00572936|3638401|FG005|COMPLETED|Second Intervention||5
2927474|NCT00572936|3638396|FG000|NOT COMPLETED|Second Intervention||0
2927475|NCT00572936|3638397|FG001|NOT COMPLETED|Second Intervention||0
2927476|NCT00572936|3638398|FG002|NOT COMPLETED|Second Intervention||0
2927477|NCT00572936|3638399|FG003|NOT COMPLETED|Second Intervention||0
2927478|NCT00572936|3638400|FG004|NOT COMPLETED|Second Intervention||0
2927479|NCT00572936|3638401|FG005|NOT COMPLETED|Second Intervention||0
2927480|NCT00572936|3638396|FG000|STARTED|Third Intervention||4
2927481|NCT00572936|3638397|FG001|STARTED|Third Intervention||3
2927482|NCT00572936|3638398|FG002|STARTED|Third Intervention||4
2927483|NCT00572936|3638399|FG003|STARTED|Third Intervention||5
2927484|NCT00572936|3638400|FG004|STARTED|Third Intervention|1 participant dropped out between second intervention and third intervention due to increased IOP|3
2927485|NCT00572936|3638401|FG005|STARTED|Third Intervention||5
2927486|NCT00572936|3638396|FG000|COMPLETED|Third Intervention||4
2927487|NCT00572936|3638397|FG001|COMPLETED|Third Intervention||3
2927488|NCT00572936|3638398|FG002|COMPLETED|Third Intervention||4
2927489|NCT00572936|3638399|FG003|COMPLETED|Third Intervention||5
2927490|NCT00572936|3638400|FG004|COMPLETED|Third Intervention||3
2927491|NCT00572936|3638401|FG005|COMPLETED|Third Intervention||5
2927492|NCT00572936|3638396|FG000|NOT COMPLETED|Third Intervention||0
2927493|NCT00572936|3638397|FG001|NOT COMPLETED|Third Intervention||0
2927494|NCT00572936|3638398|FG002|NOT COMPLETED|Third Intervention||0
2927495|NCT00572936|3638399|FG003|NOT COMPLETED|Third Intervention||0
2927496|NCT00572936|3638400|FG004|NOT COMPLETED|Third Intervention||0
2927497|NCT00572936|3638401|FG005|NOT COMPLETED|Third Intervention||0
2927498|NCT00573066|3638409|FG000|STARTED|Overall Study||56
2927499|NCT00573066|3638409|FG000|COMPLETED|Overall Study||36
2927500|NCT00573066|3638409|FG000|NOT COMPLETED|Overall Study||20
2927501|NCT00573131|3638415|FG000|STARTED|Overall Study||72
2927502|NCT00573131|3638416|FG001|STARTED|Overall Study||65
2927503|NCT00573131|3638415|FG000|COMPLETED|Overall Study||62
2927504|NCT00573131|3638416|FG001|COMPLETED|Overall Study||57
2927505|NCT00573131|3638415|FG000|NOT COMPLETED|Overall Study||10
2927506|NCT00573131|3638416|FG001|NOT COMPLETED|Overall Study||8
2927507|NCT00573144|3638424|FG000|STARTED|Overall Study||30
2927508|NCT00573144|3638425|FG001|STARTED|Overall Study||28
2927509|NCT00573144|3638424|FG000|COMPLETED|Overall Study||28
2927510|NCT00573144|3638425|FG001|COMPLETED|Overall Study||25
2927511|NCT00573144|3638424|FG000|NOT COMPLETED|Overall Study||2
2927512|NCT00573144|3638425|FG001|NOT COMPLETED|Overall Study||3
2927513|NCT00573170|3638431|FG000|STARTED|First Treatment Period||64
2927514|NCT00573170|3638432|FG001|STARTED|First Treatment Period||60
2927515|NCT00573170|3638433|FG002|STARTED|First Treatment Period||60
3323617|NCT03205371|4056727|FG011|STARTED|Overall Study||100
3323618|NCT03205371|4056716|FG000|Safety Analysis Set (SafAS)|Overall Study||103
3323619|NCT03205371|4056717|FG001|Safety Analysis Set (SafAS)|Overall Study||52
3323620|NCT03205371|4056718|FG002|Safety Analysis Set (SafAS)|Overall Study||53
3323621|NCT03205371|4056719|FG003|Safety Analysis Set (SafAS)|Overall Study||86
3323622|NCT03205371|4056720|FG004|Safety Analysis Set (SafAS)|Overall Study||42
3323623|NCT03205371|4056721|FG005|Safety Analysis Set (SafAS)|Overall Study||42
3323624|NCT03205371|4056722|FG006|Safety Analysis Set (SafAS)|Overall Study||200
3323625|NCT03205371|4056723|FG007|Safety Analysis Set (SafAS)|Overall Study||100
3323626|NCT03205371|4056724|FG008|Safety Analysis Set (SafAS)|Overall Study||100
3323627|NCT03205371|4056725|FG009|Safety Analysis Set (SafAS)|Overall Study||200
3323628|NCT03205371|4056726|FG010|Safety Analysis Set (SafAS)|Overall Study||100
3323629|NCT03205371|4056727|FG011|Safety Analysis Set (SafAS)|Overall Study||99
3323630|NCT03205371|4056716|FG000|Per-protocol Analysis Set (PPAS)|Overall Study||92
3323631|NCT03205371|4056717|FG001|Per-protocol Analysis Set (PPAS)|Overall Study||45
3323632|NCT03205371|4056718|FG002|Per-protocol Analysis Set (PPAS)|Overall Study||50
3323633|NCT03205371|4056719|FG003|Per-protocol Analysis Set (PPAS)|Overall Study||85
3323634|NCT03205371|4056720|FG004|Per-protocol Analysis Set (PPAS)|Overall Study||42
3323635|NCT03205371|4056721|FG005|Per-protocol Analysis Set (PPAS)|Overall Study||42
3323636|NCT03205371|4056722|FG006|Per-protocol Analysis Set (PPAS)|Overall Study||155
3323637|NCT03205371|4056723|FG007|Per-protocol Analysis Set (PPAS)|Overall Study||79
3323638|NCT03205371|4056724|FG008|Per-protocol Analysis Set (PPAS)|Overall Study||68
3323639|NCT03205371|4056725|FG009|Per-protocol Analysis Set (PPAS)|Overall Study||196
3323640|NCT03205371|4056726|FG010|Per-protocol Analysis Set (PPAS)|Overall Study||96
3323641|NCT03205371|4056727|FG011|Per-protocol Analysis Set (PPAS)|Overall Study||92
3323642|NCT03205371|4056716|FG000|COMPLETED|Overall Study||103
3323643|NCT03205371|4056717|FG001|COMPLETED|Overall Study||52
3323644|NCT03205371|4056718|FG002|COMPLETED|Overall Study||53
3323645|NCT03205371|4056719|FG003|COMPLETED|Overall Study||86
3323646|NCT03205371|4056720|FG004|COMPLETED|Overall Study||42
3323647|NCT03205371|4056721|FG005|COMPLETED|Overall Study||42
3176076|NCT01963923|3903822|FG001|NOT COMPLETED|3 Months Post-surgery||1
3176077|NCT01964092|3903837|FG000|STARTED|Overall Study||229
3176078|NCT01964092|3903838|FG001|STARTED|Overall Study||181
3176079|NCT01964092|3903837|FG000|COMPLETED|Overall Study||227
3176080|NCT01964092|3903838|FG001|COMPLETED|Overall Study||181
3176081|NCT01964092|3903837|FG000|NOT COMPLETED|Overall Study||2
3176082|NCT01964092|3903838|FG001|NOT COMPLETED|Overall Study||0
3176083|NCT01964105|3903847|FG000|STARTED|Overall Study||15
3323648|NCT03205371|4056722|FG006|COMPLETED|Overall Study||190
3323649|NCT03205371|4056723|FG007|COMPLETED|Overall Study||97
3323650|NCT03205371|4056724|FG008|COMPLETED|Overall Study||95
3323651|NCT03205371|4056725|FG009|COMPLETED|Overall Study||200
3323652|NCT03205371|4056726|FG010|COMPLETED|Overall Study||100
3323653|NCT03205371|4056727|FG011|COMPLETED|Overall Study||99
3323654|NCT03205371|4056716|FG000|NOT COMPLETED|Overall Study||4
3323655|NCT03205371|4056717|FG001|NOT COMPLETED|Overall Study||1
3323656|NCT03205371|4056718|FG002|NOT COMPLETED|Overall Study||0
3323657|NCT03205371|4056719|FG003|NOT COMPLETED|Overall Study||0
3323658|NCT03205371|4056720|FG004|NOT COMPLETED|Overall Study||0
3323659|NCT03205371|4056721|FG005|NOT COMPLETED|Overall Study||0
3323660|NCT03205371|4056722|FG006|NOT COMPLETED|Overall Study||10
3323661|NCT03205371|4056723|FG007|NOT COMPLETED|Overall Study||3
3323662|NCT03205371|4056724|FG008|NOT COMPLETED|Overall Study||5
3323663|NCT03205371|4056725|FG009|NOT COMPLETED|Overall Study||0
3323664|NCT03205371|4056726|FG010|NOT COMPLETED|Overall Study||0
3323665|NCT03205371|4056727|FG011|NOT COMPLETED|Overall Study||1
3323666|NCT03205488|4056776|FG000|STARTED|Overall Study||25
3323667|NCT03205488|4056777|FG001|STARTED|Overall Study||25
3323668|NCT03205488|4056778|FG002|STARTED|Overall Study||26
3323669|NCT03205488|4056776|FG000|COMPLETED|Overall Study||24
3323670|NCT03205488|4056777|FG001|COMPLETED|Overall Study||23
3323671|NCT03205488|4056778|FG002|COMPLETED|Overall Study||21
3323672|NCT03205488|4056776|FG000|NOT COMPLETED|Overall Study||1
3323673|NCT03205488|4056777|FG001|NOT COMPLETED|Overall Study||2
3323674|NCT03205488|4056778|FG002|NOT COMPLETED|Overall Study||5
3323675|NCT03205566|4056792|FG000|STARTED|Phase 1|One participant withdrawn and replaced. Data obtained from first participant still used in analysis|19
3176084|NCT01964105|3903848|FG001|STARTED|Overall Study||75
3176085|NCT01964105|3903849|FG002|STARTED|Overall Study||10
3176086|NCT01964105|3903847|FG000|COMPLETED|Overall Study||13
3176087|NCT01964105|3903848|FG001|COMPLETED|Overall Study||62
3176088|NCT01964105|3903849|FG002|COMPLETED|Overall Study||10
3176089|NCT01964105|3903847|FG000|NOT COMPLETED|Overall Study||2
3176090|NCT01964105|3903848|FG001|NOT COMPLETED|Overall Study||13
3176091|NCT01964105|3903849|FG002|NOT COMPLETED|Overall Study||0
3176092|NCT01964222|3903859|FG000|STARTED|Overall Study||101
3176093|NCT01964222|3903860|FG001|STARTED|Overall Study||100
3176094|NCT01964222|3903859|FG000|COMPLETED|Overall Study||86
3176095|NCT01964222|3903860|FG001|COMPLETED|Overall Study||89
3176096|NCT01964222|3903859|FG000|NOT COMPLETED|Overall Study||15
3176097|NCT01964222|3903860|FG001|NOT COMPLETED|Overall Study||11
3176098|NCT01964300|3903868|FG000|STARTED|Overall Study||7
3176099|NCT01964300|3903869|FG001|STARTED|Overall Study||12
3176100|NCT01964300|3903868|FG000|COMPLETED|Overall Study||1
3176101|NCT01964300|3903869|FG001|COMPLETED|Overall Study||1
3176102|NCT01964300|3903868|FG000|NOT COMPLETED|Overall Study||6
3176103|NCT01964300|3903869|FG001|NOT COMPLETED|Overall Study||11
3176104|NCT01964326|3903875|FG000|STARTED|Overall Study||1311
3176105|NCT01964326|3903875|FG000|COMPLETED|Overall Study||1014
3176106|NCT01964326|3903875|FG000|NOT COMPLETED|Overall Study||297
3176107|NCT01964352|3903883|FG000|STARTED|Overall Study||204
3176108|NCT01964352|3903884|FG001|STARTED|Overall Study||203
3176109|NCT01964352|3903885|FG002|STARTED|Overall Study||202
3176110|NCT01964352|3903886|FG003|STARTED|Overall Study||203
3176111|NCT01964352|3903883|FG000|COMPLETED|Overall Study||178
3176112|NCT01964352|3903884|FG001|COMPLETED|Overall Study||192
3176113|NCT01964352|3903885|FG002|COMPLETED|Overall Study||196
3176114|NCT01964352|3903886|FG003|COMPLETED|Overall Study||195
3176115|NCT01964352|3903883|FG000|NOT COMPLETED|Overall Study||26
3176116|NCT01964352|3903884|FG001|NOT COMPLETED|Overall Study||11
3176117|NCT01964352|3903885|FG002|NOT COMPLETED|Overall Study||6
3176118|NCT01964352|3903886|FG003|NOT COMPLETED|Overall Study||8
3176119|NCT01964378|3903898|FG000|STARTED|Overall Study||66
3176120|NCT01964378|3903899|FG001|STARTED|Overall Study||66
3176121|NCT01964378|3903898|FG000|Participants Treated (Safety Set)|Overall Study||65
3323676|NCT03205566|4056793|FG001|STARTED|Phase 1|One participant withdrawn and replaced. Data obtained from first participant still used in analysis|19
3323677|NCT03205566|4056792|FG000|COMPLETED|Phase 1||18
3323678|NCT03205566|4056793|FG001|COMPLETED|Phase 1||18
3323679|NCT03205566|4056792|FG000|NOT COMPLETED|Phase 1||1
3323680|NCT03205566|4056793|FG001|NOT COMPLETED|Phase 1||1
3323681|NCT03205566|4056792|FG000|STARTED|Phase 2||18
3323682|NCT03205566|4056793|FG001|STARTED|Phase 2||18
3323683|NCT03205566|4056792|FG000|COMPLETED|Phase 2||18
3323684|NCT03205566|4056793|FG001|COMPLETED|Phase 2||18
3323685|NCT03205566|4056792|FG000|NOT COMPLETED|Phase 2||0
3323686|NCT03205566|4056793|FG001|NOT COMPLETED|Phase 2||0
3323687|NCT03206749|4056806|FG000|STARTED|Overall Study||80
3323688|NCT03206749|4056807|FG001|STARTED|Overall Study||81
3323689|NCT03206749|4056808|FG002|STARTED|Overall Study||82
3323690|NCT03206749|4056806|FG000|COMPLETED|Overall Study||75
3323691|NCT03206749|4056807|FG001|COMPLETED|Overall Study||78
3323692|NCT03206749|4056808|FG002|COMPLETED|Overall Study||75
3323693|NCT03206749|4056806|FG000|NOT COMPLETED|Overall Study||5
3323694|NCT03206749|4056807|FG001|NOT COMPLETED|Overall Study||3
3323695|NCT03206749|4056808|FG002|NOT COMPLETED|Overall Study||7
3323696|NCT03206788|4056819|FG000|STARTED|Overall Study||2
3323697|NCT03206788|4056820|FG001|STARTED|Overall Study||5
3176122|NCT01964378|3903899|FG001|Participants Treated (Safety Set)|Overall Study|"4 Participants died during treatment, hereof 2 with withdrawal... as primary reason for discont."|61
3176123|NCT01964378|3903898|FG000|COMPLETED|Overall Study||41
3323698|NCT03206788|4056819|FG000|COMPLETED|Overall Study||2
3323699|NCT03206788|4056820|FG001|COMPLETED|Overall Study||2
3323700|NCT03206788|4056819|FG000|NOT COMPLETED|Overall Study||0
3323701|NCT03206788|4056820|FG001|NOT COMPLETED|Overall Study||3
3323702|NCT03206918|4056826|FG000|STARTED|Overall Study||91
3323703|NCT03206918|4056826|FG000|COMPLETED|Overall Study||0
3323704|NCT03206918|4056826|FG000|NOT COMPLETED|Overall Study||91
3323705|NCT03206970|4056831|FG000|STARTED|Overall Study||86
3323706|NCT03206970|4056831|FG000|Received at Least 1 Dose of Study Drug|Overall Study||86
3323707|NCT03206970|4056831|FG000|COMPLETED|Overall Study||0
3323708|NCT03206970|4056831|FG000|NOT COMPLETED|Overall Study||86
3323709|NCT03207022|4056837|FG000|STARTED|Overall Study||12
3323710|NCT03207022|4056838|FG001|STARTED|Overall Study||12
3323711|NCT03207022|4056837|FG000|COMPLETED|Overall Study||12
3323712|NCT03207022|4056838|FG001|COMPLETED|Overall Study||12
3323713|NCT03207022|4056837|FG000|NOT COMPLETED|Overall Study||0
3323714|NCT03207022|4056838|FG001|NOT COMPLETED|Overall Study||0
3323715|NCT03207035|4056846|FG000|STARTED|Overall Study||10
3323716|NCT03207035|4056847|FG001|STARTED|Overall Study||10
3323717|NCT03207035|4056846|FG000|COMPLETED|Overall Study||10
3039743|NCT01160289|3759185|FG001|Received at Least 1 Dose of Study Drug|Post-Randomization Period||85
3039744|NCT01160289|3759186|FG002|Received at Least 1 Dose of Study Drug|Post-Randomization Period||97
3039745|NCT01160289|3759187|FG003|Received at Least 1 Dose of Study Drug|Post-Randomization Period||52
3039746|NCT01160289|3759188|FG004|Received at Least 1 Dose of Study Drug|Post-Randomization Period||89
3039747|NCT01160289|3759189|FG005|Received at Least 1 Dose of Study Drug|Post-Randomization Period||87
3039748|NCT01160289|3759184|FG000|COMPLETED|Post-Randomization Period||0
3039749|NCT01160289|3759185|FG001|COMPLETED|Post-Randomization Period||65
3039750|NCT01160289|3759186|FG002|COMPLETED|Post-Randomization Period||73
3039751|NCT01160289|3759187|FG003|COMPLETED|Post-Randomization Period||31
3176124|NCT01964378|3903899|FG001|COMPLETED|Overall Study||45
3176125|NCT01964378|3903898|FG000|NOT COMPLETED|Overall Study||25
3176126|NCT01964378|3903899|FG001|NOT COMPLETED|Overall Study||21
3039752|NCT01160289|3759188|FG004|COMPLETED|Post-Randomization Period||80
3039753|NCT01160289|3759189|FG005|COMPLETED|Post-Randomization Period||73
3039754|NCT01160289|3759184|FG000|NOT COMPLETED|Post-Randomization Period||0
3039755|NCT01160289|3759185|FG001|NOT COMPLETED|Post-Randomization Period||20
3039756|NCT01160289|3759186|FG002|NOT COMPLETED|Post-Randomization Period||24
3039757|NCT01160289|3759187|FG003|NOT COMPLETED|Post-Randomization Period||21
3176127|NCT01964430|3903907|FG000|STARTED|Overall Study||432
3176128|NCT01964430|3903908|FG001|STARTED|Overall Study||434
3176129|NCT01964430|3903907|FG000|Treated Population|Overall Study||429
3176130|NCT01964430|3903908|FG001|Treated Population|Overall Study||423
3176131|NCT01964430|3903907|FG000|COMPLETED|Overall Study||287
3176132|NCT01964430|3903908|FG001|COMPLETED|Overall Study||310
3039758|NCT01160289|3759188|FG004|NOT COMPLETED|Post-Randomization Period||9
3039759|NCT01160289|3759189|FG005|NOT COMPLETED|Post-Randomization Period||14
3039760|NCT01160354|3759205|FG000|STARTED|Overall Study||3
3323718|NCT03207035|4056847|FG001|COMPLETED|Overall Study||10
3323719|NCT03207035|4056846|FG000|NOT COMPLETED|Overall Study||0
3323720|NCT03207035|4056847|FG001|NOT COMPLETED|Overall Study||0
3323721|NCT03207074|4056853|FG000|STARTED|Overall Study||150
3323722|NCT03207074|4056853|FG000|COMPLETED|Overall Study||150
3323723|NCT03207074|4056853|FG000|NOT COMPLETED|Overall Study||0
3323724|NCT03207243|4056859|FG000|STARTED|Overall Study||82
3323725|NCT03207243|4056860|FG001|STARTED|Overall Study||83
3323726|NCT03207243|4056859|FG000|COMPLETED|Overall Study||23
3323727|NCT03207243|4056860|FG001|COMPLETED|Overall Study||39
3323728|NCT03207243|4056859|FG000|NOT COMPLETED|Overall Study||59
3323729|NCT03207243|4056860|FG001|NOT COMPLETED|Overall Study||44
3323730|NCT03207386|4056867|FG000|STARTED|Overall Study||2647
3323731|NCT03207386|4056867|FG000|COMPLETED|Overall Study||1487
3323732|NCT03207386|4056867|FG000|NOT COMPLETED|Overall Study||1160
3323733|NCT03207399|4056874|FG000|STARTED|Overall Study||1
3323734|NCT03207399|4056874|FG000|COMPLETED|Overall Study||1
3323735|NCT03207399|4056874|FG000|NOT COMPLETED|Overall Study||0
3323736|NCT03207438|4056882|FG000|STARTED|Overall Study||167
3323737|NCT03207438|4056883|FG001|STARTED|Overall Study||166
3323738|NCT03207438|4056884|FG002|STARTED|Overall Study||875
3323739|NCT03207438|4056885|FG003|STARTED|Overall Study||582
3323740|NCT03207438|4056882|FG000|COMPLETED|Overall Study||148
3323741|NCT03207438|4056883|FG001|COMPLETED|Overall Study||145
3323742|NCT03207438|4056884|FG002|COMPLETED|Overall Study||643
3323743|NCT03207438|4056885|FG003|COMPLETED|Overall Study||470
3039761|NCT01160354|3759206|FG001|STARTED|Overall Study||4
3323744|NCT03207438|4056882|FG000|NOT COMPLETED|Overall Study||19
3323745|NCT03207438|4056883|FG001|NOT COMPLETED|Overall Study||21
3323746|NCT03207438|4056884|FG002|NOT COMPLETED|Overall Study||232
3323747|NCT03207438|4056885|FG003|NOT COMPLETED|Overall Study||112
3176133|NCT01964430|3903907|FG000|NOT COMPLETED|Overall Study||145
3176134|NCT01964430|3903908|FG001|NOT COMPLETED|Overall Study||124
3176135|NCT01964521|3903914|FG000|STARTED|Overall Study||24
3176136|NCT01964521|3903914|FG000|COMPLETED|Overall Study||20
3176137|NCT01964521|3903914|FG000|NOT COMPLETED|Overall Study||4
3176138|NCT01964547|3903921|FG000|STARTED|Overall Study||62
3176139|NCT01964547|3903922|FG001|STARTED|Overall Study||59
3176140|NCT01964547|3903921|FG000|COMPLETED|Overall Study||50
3176141|NCT01964547|3903922|FG001|COMPLETED|Overall Study||48
3176142|NCT01964547|3903921|FG000|NOT COMPLETED|Overall Study||12
3176143|NCT01964547|3903922|FG001|NOT COMPLETED|Overall Study||11
3323748|NCT03207750|4056900|FG000|STARTED|Overall Study||632
3323749|NCT03207750|4056901|FG001|STARTED|Overall Study||640
3323750|NCT03207750|4056900|FG000|COMPLETED|Overall Study||574
3323751|NCT03207750|4056901|FG001|COMPLETED|Overall Study||574
3323752|NCT03207750|4056900|FG000|NOT COMPLETED|Overall Study||58
3323753|NCT03207750|4056901|FG001|NOT COMPLETED|Overall Study||66
3323754|NCT03207763|4056909|FG000|STARTED|Overall Study||8
3323755|NCT03207763|4056910|FG001|STARTED|Overall Study||25
3323756|NCT03207763|4056909|FG000|Eligible and Opted for Patches 2 and 3|Overall Study||5
3323757|NCT03207763|4056910|FG001|Eligible and Opted for Patches 2 and 3|Overall Study||23
3323758|NCT03207763|4056909|FG000|Completed Patches 2 and 3 Study|Overall Study||5
3323759|NCT03207763|4056910|FG001|Completed Patches 2 and 3 Study|Overall Study||23
3323760|NCT03207763|4056909|FG000|COMPLETED|Overall Study||7
3323761|NCT03207763|4056910|FG001|COMPLETED|Overall Study||25
3323762|NCT03207763|4056909|FG000|NOT COMPLETED|Overall Study||1
3323763|NCT03207763|4056910|FG001|NOT COMPLETED|Overall Study||0
3323764|NCT03207776|4056927|FG000|STARTED|Overall Study||2479
3323765|NCT03207776|4056928|FG001|STARTED|Overall Study||2353
3323766|NCT03207776|4056927|FG000|COMPLETED|Overall Study||2479
3323767|NCT03207776|4056928|FG001|COMPLETED|Overall Study||2353
3323768|NCT03207776|4056927|FG000|NOT COMPLETED|Overall Study||0
3323769|NCT03207776|4056928|FG001|NOT COMPLETED|Overall Study||0
3323770|NCT03208088|4056934|FG000|STARTED|Period 1||10
3323771|NCT03208088|4056935|FG001|STARTED|Period 1||9
3323772|NCT03208088|4056936|FG002|STARTED|Period 1||10
3323773|NCT03208088|4056937|FG003|STARTED|Period 1||9
3323774|NCT03208088|4056938|FG004|STARTED|Period 1||9
3323775|NCT03208088|4056939|FG005|STARTED|Period 1||9
3323776|NCT03208088|4056940|FG006|STARTED|Period 1||8
3323777|NCT03208088|4056941|FG007|STARTED|Period 1||10
3323778|NCT03208088|4056942|FG008|STARTED|Period 1||8
3323779|NCT03208088|4056943|FG009|STARTED|Period 1||9
3323780|NCT03208088|4056934|FG000|COMPLETED|Period 1||10
3323781|NCT03208088|4056935|FG001|COMPLETED|Period 1||9
3323782|NCT03208088|4056936|FG002|COMPLETED|Period 1||10
3323783|NCT03208088|4056937|FG003|COMPLETED|Period 1||9
3323784|NCT03208088|4056938|FG004|COMPLETED|Period 1||9
3323785|NCT03208088|4056939|FG005|COMPLETED|Period 1||9
3323786|NCT03208088|4056940|FG006|COMPLETED|Period 1||8
3323787|NCT03208088|4056941|FG007|COMPLETED|Period 1||10
3323788|NCT03208088|4056942|FG008|COMPLETED|Period 1||8
3323789|NCT03208088|4056943|FG009|COMPLETED|Period 1||9
3323790|NCT03208088|4056934|FG000|NOT COMPLETED|Period 1||0
3323791|NCT03208088|4056935|FG001|NOT COMPLETED|Period 1||0
3323792|NCT03208088|4056936|FG002|NOT COMPLETED|Period 1||0
3323793|NCT03208088|4056937|FG003|NOT COMPLETED|Period 1||0
3323794|NCT03208088|4056938|FG004|NOT COMPLETED|Period 1||0
3323795|NCT03208088|4056939|FG005|NOT COMPLETED|Period 1||0
3323796|NCT03208088|4056940|FG006|NOT COMPLETED|Period 1||0
3323797|NCT03208088|4056941|FG007|NOT COMPLETED|Period 1||0
3323798|NCT03208088|4056942|FG008|NOT COMPLETED|Period 1||0
3323799|NCT03208088|4056943|FG009|NOT COMPLETED|Period 1||0
3323800|NCT03208088|4056934|FG000|STARTED|Period 2||10
3323801|NCT03208088|4056935|FG001|STARTED|Period 2||9
3323802|NCT03208088|4056936|FG002|STARTED|Period 2||10
3323803|NCT03208088|4056937|FG003|STARTED|Period 2||9
3323804|NCT03208088|4056938|FG004|STARTED|Period 2||9
3323805|NCT03208088|4056939|FG005|STARTED|Period 2||9
3323806|NCT03208088|4056940|FG006|STARTED|Period 2||8
3323807|NCT03208088|4056941|FG007|STARTED|Period 2||10
3323808|NCT03208088|4056942|FG008|STARTED|Period 2||8
3323809|NCT03208088|4056943|FG009|STARTED|Period 2||9
3323810|NCT03208088|4056934|FG000|COMPLETED|Period 2||10
3176144|NCT01964716|3903930|FG000|STARTED|Overall Study||250
3323811|NCT03208088|4056935|FG001|COMPLETED|Period 2||9
3323812|NCT03208088|4056936|FG002|COMPLETED|Period 2||10
3323813|NCT03208088|4056937|FG003|COMPLETED|Period 2||9
3323814|NCT03208088|4056938|FG004|COMPLETED|Period 2||9
3323815|NCT03208088|4056939|FG005|COMPLETED|Period 2||9
3137042|NCT01716520|3862281|FG003|NOT COMPLETED|Treatment Period 3 (14 Days)||0
3137043|NCT01716520|3862282|FG004|NOT COMPLETED|Treatment Period 3 (14 Days)||0
3323816|NCT03208088|4056940|FG006|COMPLETED|Period 2||8
3323817|NCT03208088|4056941|FG007|COMPLETED|Period 2||10
3323818|NCT03208088|4056942|FG008|COMPLETED|Period 2||7
3323819|NCT03208088|4056943|FG009|COMPLETED|Period 2||9
3323820|NCT03208088|4056934|FG000|NOT COMPLETED|Period 2||0
3323821|NCT03208088|4056935|FG001|NOT COMPLETED|Period 2||0
3323822|NCT03208088|4056936|FG002|NOT COMPLETED|Period 2||0
3323823|NCT03208088|4056937|FG003|NOT COMPLETED|Period 2||0
3323824|NCT03208088|4056938|FG004|NOT COMPLETED|Period 2||0
3323825|NCT03208088|4056939|FG005|NOT COMPLETED|Period 2||0
3323826|NCT03208088|4056940|FG006|NOT COMPLETED|Period 2||0
3323827|NCT03208088|4056941|FG007|NOT COMPLETED|Period 2||0
3323828|NCT03208088|4056942|FG008|NOT COMPLETED|Period 2||1
3323829|NCT03208088|4056943|FG009|NOT COMPLETED|Period 2||0
3323830|NCT03208088|4056934|FG000|STARTED|Period 3||10
3323831|NCT03208088|4056935|FG001|STARTED|Period 3||9
3323832|NCT03208088|4056936|FG002|STARTED|Period 3||10
3323833|NCT03208088|4056937|FG003|STARTED|Period 3||9
3323834|NCT03208088|4056938|FG004|STARTED|Period 3||9
3137044|NCT01716520|3862283|FG005|NOT COMPLETED|Treatment Period 3 (14 Days)||2
3137045|NCT01716533|3862295|FG000|STARTED|Overall Study||7
3137046|NCT01716533|3862296|FG001|STARTED|Overall Study||25
3137047|NCT01716533|3862297|FG002|STARTED|Overall Study||5
3137048|NCT01716533|3862298|FG003|STARTED|Overall Study||9
3137049|NCT01716533|3862295|FG000|COMPLETED|Overall Study||7
3323835|NCT03208088|4056939|FG005|STARTED|Period 3||9
3323836|NCT03208088|4056940|FG006|STARTED|Period 3||8
3323837|NCT03208088|4056941|FG007|STARTED|Period 3||10
3323838|NCT03208088|4056942|FG008|STARTED|Period 3||7
3323839|NCT03208088|4056943|FG009|STARTED|Period 3||9
3323840|NCT03208088|4056934|FG000|COMPLETED|Period 3||10
3323841|NCT03208088|4056935|FG001|COMPLETED|Period 3||9
3323842|NCT03208088|4056936|FG002|COMPLETED|Period 3||10
3323843|NCT03208088|4056937|FG003|COMPLETED|Period 3||8
3323844|NCT03208088|4056938|FG004|COMPLETED|Period 3||9
3323845|NCT03208088|4056939|FG005|COMPLETED|Period 3||9
3323846|NCT03208088|4056940|FG006|COMPLETED|Period 3||8
3323847|NCT03208088|4056941|FG007|COMPLETED|Period 3||10
3323848|NCT03208088|4056942|FG008|COMPLETED|Period 3||7
3323849|NCT03208088|4056943|FG009|COMPLETED|Period 3||9
3323850|NCT03208088|4056934|FG000|NOT COMPLETED|Period 3||0
3323851|NCT03208088|4056935|FG001|NOT COMPLETED|Period 3||0
3323852|NCT03208088|4056936|FG002|NOT COMPLETED|Period 3||0
3323853|NCT03208088|4056937|FG003|NOT COMPLETED|Period 3||1
3323854|NCT03208088|4056938|FG004|NOT COMPLETED|Period 3||0
3323855|NCT03208088|4056939|FG005|NOT COMPLETED|Period 3||0
3323856|NCT03208088|4056940|FG006|NOT COMPLETED|Period 3||0
3323857|NCT03208088|4056941|FG007|NOT COMPLETED|Period 3||0
3323858|NCT03208088|4056942|FG008|NOT COMPLETED|Period 3||0
3323859|NCT03208088|4056943|FG009|NOT COMPLETED|Period 3||0
3323860|NCT03208088|4056934|FG000|STARTED|Period 4||10
3323861|NCT03208088|4056935|FG001|STARTED|Period 4||9
3323862|NCT03208088|4056936|FG002|STARTED|Period 4||10
3323863|NCT03208088|4056937|FG003|STARTED|Period 4||8
3137050|NCT01716533|3862296|FG001|COMPLETED|Overall Study||25
3323864|NCT03208088|4056938|FG004|STARTED|Period 4||9
3323865|NCT03208088|4056939|FG005|STARTED|Period 4||9
3323866|NCT03208088|4056940|FG006|STARTED|Period 4||8
3323867|NCT03208088|4056941|FG007|STARTED|Period 4||10
3323868|NCT03208088|4056942|FG008|STARTED|Period 4||7
3323869|NCT03208088|4056943|FG009|STARTED|Period 4||9
3323870|NCT03208088|4056934|FG000|COMPLETED|Period 4||10
3323871|NCT03208088|4056935|FG001|COMPLETED|Period 4||9
3323872|NCT03208088|4056936|FG002|COMPLETED|Period 4||10
3323873|NCT03208088|4056937|FG003|COMPLETED|Period 4||7
3323874|NCT03208088|4056938|FG004|COMPLETED|Period 4||9
3323875|NCT03208088|4056939|FG005|COMPLETED|Period 4||9
3323876|NCT03208088|4056940|FG006|COMPLETED|Period 4||8
3323877|NCT03208088|4056941|FG007|COMPLETED|Period 4||10
3323878|NCT03208088|4056942|FG008|COMPLETED|Period 4||7
3323879|NCT03208088|4056943|FG009|COMPLETED|Period 4||9
3176145|NCT01964716|3903931|FG001|STARTED|Overall Study||250
3176146|NCT01964716|3903930|FG000|Vaccinated Dose 1|Overall Study||250
3176147|NCT01964716|3903931|FG001|Vaccinated Dose 1|Overall Study||250
3176148|NCT01964716|3903930|FG000|Vaccinated Dose 2|Overall Study||249
3176149|NCT01964716|3903931|FG001|Vaccinated Dose 2|Overall Study||248
3323880|NCT03208088|4056934|FG000|NOT COMPLETED|Period 4||0
3323881|NCT03208088|4056935|FG001|NOT COMPLETED|Period 4||0
3323882|NCT03208088|4056936|FG002|NOT COMPLETED|Period 4||0
3323883|NCT03208088|4056937|FG003|NOT COMPLETED|Period 4||1
3323884|NCT03208088|4056938|FG004|NOT COMPLETED|Period 4||0
3323885|NCT03208088|4056939|FG005|NOT COMPLETED|Period 4||0
3323886|NCT03208088|4056940|FG006|NOT COMPLETED|Period 4||0
3323887|NCT03208088|4056941|FG007|NOT COMPLETED|Period 4||0
3323888|NCT03208088|4056942|FG008|NOT COMPLETED|Period 4||0
3323889|NCT03208088|4056943|FG009|NOT COMPLETED|Period 4||0
3323890|NCT03208088|4056934|FG000|STARTED|Period 5||10
3323891|NCT03208088|4056935|FG001|STARTED|Period 5||9
3323892|NCT03208088|4056936|FG002|STARTED|Period 5||10
3323893|NCT03208088|4056937|FG003|STARTED|Period 5||7
3323894|NCT03208088|4056938|FG004|STARTED|Period 5||9
3323895|NCT03208088|4056939|FG005|STARTED|Period 5||9
3323896|NCT03208088|4056940|FG006|STARTED|Period 5||8
3323897|NCT03208088|4056941|FG007|STARTED|Period 5||10
3323898|NCT03208088|4056942|FG008|STARTED|Period 5||7
3323899|NCT03208088|4056943|FG009|STARTED|Period 5||9
3323900|NCT03208088|4056934|FG000|COMPLETED|Period 5||10
3323901|NCT03208088|4056935|FG001|COMPLETED|Period 5||9
3323902|NCT03208088|4056936|FG002|COMPLETED|Period 5||10
3323903|NCT03208088|4056937|FG003|COMPLETED|Period 5||7
3323904|NCT03208088|4056938|FG004|COMPLETED|Period 5||9
3323905|NCT03208088|4056939|FG005|COMPLETED|Period 5||9
3323906|NCT03208088|4056940|FG006|COMPLETED|Period 5||8
3323907|NCT03208088|4056941|FG007|COMPLETED|Period 5||10
3323908|NCT03208088|4056942|FG008|COMPLETED|Period 5||7
3323909|NCT03208088|4056943|FG009|COMPLETED|Period 5||9
3323910|NCT03208088|4056934|FG000|NOT COMPLETED|Period 5||0
3323911|NCT03208088|4056935|FG001|NOT COMPLETED|Period 5||0
3323912|NCT03208088|4056936|FG002|NOT COMPLETED|Period 5||0
3323913|NCT03208088|4056937|FG003|NOT COMPLETED|Period 5||0
3323914|NCT03208088|4056938|FG004|NOT COMPLETED|Period 5||0
3323915|NCT03208088|4056939|FG005|NOT COMPLETED|Period 5||0
3323916|NCT03208088|4056940|FG006|NOT COMPLETED|Period 5||0
3323917|NCT03208088|4056941|FG007|NOT COMPLETED|Period 5||0
3323918|NCT03208088|4056942|FG008|NOT COMPLETED|Period 5||0
3323919|NCT03208088|4056943|FG009|NOT COMPLETED|Period 5||0
3323920|NCT03208166|4056957|FG000|STARTED|Overall Study||1
2927516|NCT00573170|3638434|FG003|STARTED|First Treatment Period||66
2927517|NCT00573170|3638435|FG004|STARTED|First Treatment Period||63
2927518|NCT00573170|3638436|FG005|STARTED|First Treatment Period||62
2927519|NCT00573170|3638431|FG000|COMPLETED|First Treatment Period||64
2927520|NCT00573170|3638432|FG001|COMPLETED|First Treatment Period||60
2927521|NCT00573170|3638433|FG002|COMPLETED|First Treatment Period||60
2927522|NCT00573170|3638434|FG003|COMPLETED|First Treatment Period||66
2927523|NCT00573170|3638435|FG004|COMPLETED|First Treatment Period||62
2927524|NCT00573170|3638436|FG005|COMPLETED|First Treatment Period||62
2927525|NCT00573170|3638431|FG000|NOT COMPLETED|First Treatment Period||0
2927526|NCT00573170|3638432|FG001|NOT COMPLETED|First Treatment Period||0
2927527|NCT00573170|3638433|FG002|NOT COMPLETED|First Treatment Period||0
2927528|NCT00573170|3638434|FG003|NOT COMPLETED|First Treatment Period||0
2927529|NCT00573170|3638435|FG004|NOT COMPLETED|First Treatment Period||1
2927530|NCT00573170|3638436|FG005|NOT COMPLETED|First Treatment Period||0
2927531|NCT00573170|3638431|FG000|STARTED|First Washout Period||64
2927532|NCT00573170|3638432|FG001|STARTED|First Washout Period||60
2927533|NCT00573170|3638433|FG002|STARTED|First Washout Period||60
2927534|NCT00573170|3638434|FG003|STARTED|First Washout Period||66
2927535|NCT00573170|3638435|FG004|STARTED|First Washout Period||62
2927536|NCT00573170|3638436|FG005|STARTED|First Washout Period||62
2927537|NCT00573170|3638431|FG000|COMPLETED|First Washout Period||56
2927538|NCT00573170|3638432|FG001|COMPLETED|First Washout Period||58
2927539|NCT00573170|3638433|FG002|COMPLETED|First Washout Period||59
2927540|NCT00573170|3638434|FG003|COMPLETED|First Washout Period||61
2927541|NCT00573170|3638435|FG004|COMPLETED|First Washout Period|Source data list 4 noncompleters; per number starting next period, there were only 3 noncompleters.|59
2927542|NCT00573170|3638436|FG005|COMPLETED|First Washout Period||55
2927543|NCT00573170|3638431|FG000|NOT COMPLETED|First Washout Period||8
2927544|NCT00573170|3638432|FG001|NOT COMPLETED|First Washout Period||2
2927545|NCT00573170|3638433|FG002|NOT COMPLETED|First Washout Period||1
2927546|NCT00573170|3638434|FG003|NOT COMPLETED|First Washout Period||5
2927547|NCT00573170|3638435|FG004|NOT COMPLETED|First Washout Period||3
2927548|NCT00573170|3638436|FG005|NOT COMPLETED|First Washout Period||7
2927549|NCT00573170|3638431|FG000|STARTED|Second Treatment Period||56
2927550|NCT00573170|3638432|FG001|STARTED|Second Treatment Period||58
2927551|NCT00573170|3638433|FG002|STARTED|Second Treatment Period||59
2927552|NCT00573170|3638434|FG003|STARTED|Second Treatment Period||61
2927553|NCT00573170|3638435|FG004|STARTED|Second Treatment Period||59
2927554|NCT00573170|3638436|FG005|STARTED|Second Treatment Period||55
2927555|NCT00573170|3638431|FG000|COMPLETED|Second Treatment Period||56
2927556|NCT00573170|3638432|FG001|COMPLETED|Second Treatment Period||58
2927557|NCT00573170|3638433|FG002|COMPLETED|Second Treatment Period||59
2927558|NCT00573170|3638434|FG003|COMPLETED|Second Treatment Period||61
2927559|NCT00573170|3638435|FG004|COMPLETED|Second Treatment Period||59
2927560|NCT00573170|3638436|FG005|COMPLETED|Second Treatment Period||55
2927561|NCT00573170|3638431|FG000|NOT COMPLETED|Second Treatment Period||0
2927562|NCT00573170|3638432|FG001|NOT COMPLETED|Second Treatment Period||0
2927563|NCT00573170|3638433|FG002|NOT COMPLETED|Second Treatment Period||0
2927564|NCT00573170|3638434|FG003|NOT COMPLETED|Second Treatment Period||0
2927565|NCT00573170|3638435|FG004|NOT COMPLETED|Second Treatment Period||0
2927566|NCT00573170|3638436|FG005|NOT COMPLETED|Second Treatment Period||0
2927567|NCT00573170|3638431|FG000|STARTED|Second Washout Period||56
2927568|NCT00573170|3638432|FG001|STARTED|Second Washout Period||58
2927569|NCT00573170|3638433|FG002|STARTED|Second Washout Period||59
2927570|NCT00573170|3638434|FG003|STARTED|Second Washout Period||61
2927571|NCT00573170|3638435|FG004|STARTED|Second Washout Period||59
2927572|NCT00573170|3638436|FG005|STARTED|Second Washout Period||55
2927573|NCT00573170|3638431|FG000|COMPLETED|Second Washout Period||51
2927574|NCT00573170|3638432|FG001|COMPLETED|Second Washout Period||54
2927575|NCT00573170|3638433|FG002|COMPLETED|Second Washout Period||55
2927576|NCT00573170|3638434|FG003|COMPLETED|Second Washout Period||56
2927577|NCT00573170|3638435|FG004|COMPLETED|Second Washout Period||51
2927578|NCT00573170|3638436|FG005|COMPLETED|Second Washout Period||53
2927579|NCT00573170|3638431|FG000|NOT COMPLETED|Second Washout Period||5
2927580|NCT00573170|3638432|FG001|NOT COMPLETED|Second Washout Period||4
2927581|NCT00573170|3638433|FG002|NOT COMPLETED|Second Washout Period||4
2927582|NCT00573170|3638434|FG003|NOT COMPLETED|Second Washout Period||5
2927583|NCT00573170|3638435|FG004|NOT COMPLETED|Second Washout Period||8
2927584|NCT00573170|3638436|FG005|NOT COMPLETED|Second Washout Period||2
2927585|NCT00573170|3638431|FG000|STARTED|Third Treatment Period||51
2927586|NCT00573170|3638432|FG001|STARTED|Third Treatment Period||54
3176150|NCT01964716|3903930|FG000|Vaccinated Dose 3|Overall Study||247
3176151|NCT01964716|3903931|FG001|Vaccinated Dose 3|Overall Study||244
3176152|NCT01964716|3903930|FG000|COMPLETED|Overall Study||245
3176153|NCT01964716|3903931|FG001|COMPLETED|Overall Study||244
3176154|NCT01964716|3903930|FG000|NOT COMPLETED|Overall Study||5
3176155|NCT01964716|3903931|FG001|NOT COMPLETED|Overall Study||6
3323921|NCT03208166|4056958|FG001|STARTED|Overall Study||1
3323922|NCT03208166|4056957|FG000|COMPLETED|Overall Study||1
3323923|NCT03208166|4056958|FG001|COMPLETED|Overall Study||1
3176156|NCT01964755|3903945|FG000|STARTED|Overall Study||6
3176157|NCT01964755|3903945|FG000|Cycle 2|Overall Study||5
3176158|NCT01964755|3903945|FG000|Cycle 3|Overall Study||4
3176159|NCT01964755|3903945|FG000|Cycle 4|Overall Study||4
3323924|NCT03208166|4056957|FG000|NOT COMPLETED|Overall Study||0
3323925|NCT03208166|4056958|FG001|NOT COMPLETED|Overall Study||0
3323926|NCT03208192|4056966|FG000|STARTED|Overall Study||32
3323927|NCT03208192|4056967|FG001|STARTED|Overall Study||36
3323928|NCT03208192|4056966|FG000|COMPLETED|Overall Study||32
3323929|NCT03208192|4056967|FG001|COMPLETED|Overall Study||36
3323930|NCT03208192|4056966|FG000|NOT COMPLETED|Overall Study||0
3323931|NCT03208192|4056967|FG001|NOT COMPLETED|Overall Study||0
3323932|NCT03208673|4056975|FG000|STARTED|Overall Study||32
3323933|NCT03208673|4056975|FG000|COMPLETED|Overall Study||32
3323934|NCT03208673|4056975|FG000|NOT COMPLETED|Overall Study||0
3323935|NCT03208933|4056979|FG000|STARTED|Overall Study||60
3323936|NCT03208933|4056979|FG000|COMPLETED|Overall Study||47
3323937|NCT03208933|4056979|FG000|NOT COMPLETED|Overall Study||13
3323938|NCT03209050|4056983|FG000|STARTED|Overall Study||30
3323939|NCT03209050|4056983|FG000|COMPLETED|Overall Study||27
3323940|NCT03209050|4056983|FG000|NOT COMPLETED|Overall Study||3
3323941|NCT03209362|4056990|FG000|STARTED|Overall Study||39
3323942|NCT03209362|4056991|FG001|STARTED|Overall Study||41
3323943|NCT03209362|4056990|FG000|COMPLETED|Overall Study||37
3323944|NCT03209362|4056991|FG001|COMPLETED|Overall Study||38
3176160|NCT01964755|3903945|FG000|Cycle 5|Overall Study||4
3323945|NCT03209362|4056990|FG000|NOT COMPLETED|Overall Study||2
3323946|NCT03209362|4056991|FG001|NOT COMPLETED|Overall Study||3
3176161|NCT01964755|3903945|FG000|COMPLETED|Overall Study||4
3323947|NCT03209492|4056997|FG000|STARTED|Overall Study||333
3323948|NCT03209492|4056997|FG000|COMPLETED|Overall Study||328
3323949|NCT03209492|4056997|FG000|NOT COMPLETED|Overall Study||5
3323950|NCT03209505|4057001|FG000|STARTED|Overall Study||10
3323951|NCT03209505|4057002|FG001|STARTED|Overall Study||10
3323952|NCT03209505|4057001|FG000|COMPLETED|Overall Study||10
3323953|NCT03209505|4057002|FG001|COMPLETED|Overall Study||10
3323954|NCT03209505|4057001|FG000|NOT COMPLETED|Overall Study||0
3323955|NCT03209505|4057002|FG001|NOT COMPLETED|Overall Study||0
3323956|NCT03209518|4057008|FG000|STARTED|Overall Study||312
3323957|NCT03209518|4057008|FG000|COMPLETED|Overall Study||310
3323958|NCT03209518|4057008|FG000|NOT COMPLETED|Overall Study||2
3323959|NCT03209570|4057014|FG000|STARTED|Overall Study||24
3323960|NCT03209570|4057015|FG001|STARTED|Overall Study||25
2927587|NCT00573170|3638433|FG002|STARTED|Third Treatment Period||55
3323961|NCT03209570|4057014|FG000|COMPLETED|Overall Study||14
3323962|NCT03209570|4057015|FG001|COMPLETED|Overall Study||12
3323963|NCT03209570|4057014|FG000|NOT COMPLETED|Overall Study||10
3323964|NCT03209570|4057015|FG001|NOT COMPLETED|Overall Study||13
3323965|NCT03209882|4057023|FG000|STARTED|Overall Study||6
3323966|NCT03209882|4057024|FG001|STARTED|Overall Study||3
3323967|NCT03209882|4057023|FG000|COMPLETED|Overall Study||6
3323968|NCT03209882|4057024|FG001|COMPLETED|Overall Study||3
3323969|NCT03209882|4057023|FG000|NOT COMPLETED|Overall Study||0
3323970|NCT03209882|4057024|FG001|NOT COMPLETED|Overall Study||0
3323971|NCT03209973|4057032|FG000|STARTED|Overall Study||70
3323972|NCT03209973|4057032|FG000|Completed Primary Outcome Period|Overall Study||66
3323973|NCT03209973|4057032|FG000|COMPLETED|Overall Study||0
3323974|NCT03209973|4057032|FG000|NOT COMPLETED|Overall Study||70
3323975|NCT03210155|4057040|FG000|STARTED|Overall Study||0
3323976|NCT03210155|4057041|FG001|STARTED|Overall Study||1
3323977|NCT03210155|4057040|FG000|COMPLETED|Overall Study||0
3323978|NCT03210155|4057041|FG001|COMPLETED|Overall Study||1
3323979|NCT03210155|4057040|FG000|NOT COMPLETED|Overall Study||0
3323980|NCT03210155|4057041|FG001|NOT COMPLETED|Overall Study||0
3323981|NCT03210220|4057049|FG000|STARTED|Overall Study||20
3323982|NCT03210220|4057050|FG001|STARTED|Overall Study||20
3323983|NCT03210220|4057049|FG000|COMPLETED|Overall Study||19
3323984|NCT03210220|4057050|FG001|COMPLETED|Overall Study||20
3323985|NCT03210220|4057049|FG000|NOT COMPLETED|Overall Study||1
2927588|NCT00573170|3638434|FG003|STARTED|Third Treatment Period||56
2927589|NCT00573170|3638435|FG004|STARTED|Third Treatment Period||51
2927590|NCT00573170|3638436|FG005|STARTED|Third Treatment Period||53
2927591|NCT00573170|3638431|FG000|COMPLETED|Third Treatment Period||50
2927592|NCT00573170|3638432|FG001|COMPLETED|Third Treatment Period||54
2927593|NCT00573170|3638433|FG002|COMPLETED|Third Treatment Period||55
2927594|NCT00573170|3638434|FG003|COMPLETED|Third Treatment Period||56
2927595|NCT00573170|3638435|FG004|COMPLETED|Third Treatment Period||51
2927596|NCT00573170|3638436|FG005|COMPLETED|Third Treatment Period||51
2927597|NCT00573170|3638431|FG000|NOT COMPLETED|Third Treatment Period||1
2927598|NCT00573170|3638432|FG001|NOT COMPLETED|Third Treatment Period||0
2927599|NCT00573170|3638433|FG002|NOT COMPLETED|Third Treatment Period||0
2927600|NCT00573170|3638434|FG003|NOT COMPLETED|Third Treatment Period||0
2927601|NCT00573170|3638435|FG004|NOT COMPLETED|Third Treatment Period||0
2927602|NCT00573170|3638436|FG005|NOT COMPLETED|Third Treatment Period||2
2927603|NCT00573183|3638455|FG000|STARTED|Overall Study||234
2927604|NCT00573183|3638456|FG001|STARTED|Overall Study||237
2927605|NCT00573183|3638455|FG000|COMPLETED|Overall Study||162
2927606|NCT00573183|3638456|FG001|COMPLETED|Overall Study||174
2927607|NCT00573183|3638455|FG000|NOT COMPLETED|Overall Study||72
2927608|NCT00573183|3638456|FG001|NOT COMPLETED|Overall Study||63
2927609|NCT00573248|3638466|FG000|STARTED|Overall Study||40
2927610|NCT00573248|3638467|FG001|STARTED|Overall Study||38
2927611|NCT00573248|3638466|FG000|Nicotine Patches and Placebo Patches|Overall Study||25
2927612|NCT00573248|3638467|FG001|Nicotine Patches and Placebo Patches|Overall Study||27
2927613|NCT00573248|3638466|FG000|COMPLETED|Overall Study||25
2927614|NCT00573248|3638467|FG001|COMPLETED|Overall Study||27
2927615|NCT00573248|3638466|FG000|NOT COMPLETED|Overall Study||15
2927616|NCT00573248|3638467|FG001|NOT COMPLETED|Overall Study||11
2927617|NCT00573261|3638475|FG000|STARTED|Overall Study||20
2927618|NCT00573261|3638476|FG001|STARTED|Overall Study||20
2927619|NCT00573261|3638475|FG000|COMPLETED|Overall Study||14
2927620|NCT00573261|3638476|FG001|COMPLETED|Overall Study||15
2927621|NCT00573261|3638475|FG000|NOT COMPLETED|Overall Study||6
2927622|NCT00573261|3638476|FG001|NOT COMPLETED|Overall Study||5
2927623|NCT00573287|3638486|FG000|STARTED|Overall Study||7
2927624|NCT00573287|3638487|FG001|STARTED|Overall Study||7
2927625|NCT00573287|3638486|FG000|COMPLETED|Overall Study||3
2927626|NCT00573287|3638487|FG001|COMPLETED|Overall Study||4
2927627|NCT00573287|3638486|FG000|NOT COMPLETED|Overall Study||4
2927628|NCT00573287|3638487|FG001|NOT COMPLETED|Overall Study||3
2927629|NCT00573313|3638497|FG000|STARTED|Overall Study|Eighteen participants recruited to start.|18
2927630|NCT00573313|3638498|FG001|STARTED|Overall Study||28
2927631|NCT00573313|3638499|FG002|STARTED|Overall Study|Nineteen recruited to start.|19
2927632|NCT00573313|3638500|FG003|STARTED|Overall Study||26
2927633|NCT00573313|3638497|FG000|COMPLETED|Overall Study||13
2927634|NCT00573313|3638498|FG001|COMPLETED|Overall Study||28
2927635|NCT00573313|3638499|FG002|COMPLETED|Overall Study||13
2927636|NCT00573313|3638500|FG003|COMPLETED|Overall Study||26
2927637|NCT00573313|3638497|FG000|NOT COMPLETED|Overall Study||5
2927638|NCT00573313|3638498|FG001|NOT COMPLETED|Overall Study||0
2927639|NCT00573313|3638499|FG002|NOT COMPLETED|Overall Study||6
2927640|NCT00573313|3638500|FG003|NOT COMPLETED|Overall Study||0
2927641|NCT00573430|3638510|FG000|STARTED|Overall Study|randomized|40
2927642|NCT00573430|3638511|FG001|STARTED|Overall Study|randomized|45
2927643|NCT00573430|3638512|FG002|STARTED|Overall Study|randomized|43
3039762|NCT01160354|3759207|FG002|STARTED|Overall Study||15
3039763|NCT01160354|3759205|FG000|COMPLETED|Overall Study||3
3039764|NCT01160354|3759206|FG001|COMPLETED|Overall Study||3
3039765|NCT01160354|3759207|FG002|COMPLETED|Overall Study||14
3323986|NCT03210220|4057050|FG001|NOT COMPLETED|Overall Study||0
3323987|NCT03210259|4057058|FG000|STARTED|12-Week Run-in Period||21
3323988|NCT03210259|4057059|FG001|STARTED|12-Week Run-in Period||118
3323989|NCT03210259|4057060|FG002|STARTED|12-Week Run-in Period||120
3323990|NCT03210259|4057058|FG000|COMPLETED|12-Week Run-in Period||0
3323991|NCT03210259|4057059|FG001|COMPLETED|12-Week Run-in Period||118
3323992|NCT03210259|4057060|FG002|COMPLETED|12-Week Run-in Period||120
3323993|NCT03210259|4057058|FG000|NOT COMPLETED|12-Week Run-in Period||21
3323994|NCT03210259|4057059|FG001|NOT COMPLETED|12-Week Run-in Period||0
3323995|NCT03210259|4057060|FG002|NOT COMPLETED|12-Week Run-in Period||0
3323996|NCT03210259|4057058|FG000|STARTED|48-Week Randomized Responder Period||0
3323997|NCT03210259|4057059|FG001|STARTED|48-Week Randomized Responder Period||118
3323998|NCT03210259|4057060|FG002|STARTED|48-Week Randomized Responder Period||120
3323999|NCT03210259|4057058|FG000|COMPLETED|48-Week Randomized Responder Period||0
3324000|NCT03210259|4057059|FG001|COMPLETED|48-Week Randomized Responder Period||107
3324001|NCT03210259|4057060|FG002|COMPLETED|48-Week Randomized Responder Period||91
3324002|NCT03210259|4057058|FG000|NOT COMPLETED|48-Week Randomized Responder Period||0
3324003|NCT03210259|4057059|FG001|NOT COMPLETED|48-Week Randomized Responder Period||11
3039766|NCT01160354|3759205|FG000|NOT COMPLETED|Overall Study||0
3039767|NCT01160354|3759206|FG001|NOT COMPLETED|Overall Study||1
3039768|NCT01160354|3759207|FG002|NOT COMPLETED|Overall Study||1
2927644|NCT00573430|3638510|FG000|COMPLETED|Overall Study||39
3324004|NCT03210259|4057060|FG002|NOT COMPLETED|48-Week Randomized Responder Period||29
3324005|NCT03210337|4057069|FG000|STARTED|Overall Study||78
3324006|NCT03210337|4057070|FG001|STARTED|Overall Study||79
3324007|NCT03210337|4057069|FG000|COMPLETED|Overall Study||70
3324008|NCT03210337|4057070|FG001|COMPLETED|Overall Study||74
3324009|NCT03210337|4057069|FG000|NOT COMPLETED|Overall Study||8
3324010|NCT03210337|4057070|FG001|NOT COMPLETED|Overall Study||5
3324011|NCT03210376|4057078|FG000|STARTED|Overall Study||50
3324012|NCT03210376|4057079|FG001|STARTED|Overall Study||50
3324013|NCT03210376|4057078|FG000|COMPLETED|Overall Study||50
3324014|NCT03210376|4057079|FG001|COMPLETED|Overall Study||50
3324015|NCT03210376|4057078|FG000|NOT COMPLETED|Overall Study||0
3324016|NCT03210376|4057079|FG001|NOT COMPLETED|Overall Study||0
3324017|NCT03210519|4057087|FG000|STARTED|Overall Study||11
3324018|NCT03210519|4057088|FG001|STARTED|Overall Study||10
3324019|NCT03210519|4057087|FG000|COMPLETED|Overall Study||9
3324020|NCT03210519|4057088|FG001|COMPLETED|Overall Study||10
3324021|NCT03210519|4057087|FG000|NOT COMPLETED|Overall Study||2
3324022|NCT03210519|4057088|FG001|NOT COMPLETED|Overall Study||0
3324023|NCT03210701|4057094|FG000|STARTED|Overall Study||123
3324024|NCT03210701|4057094|FG000|COMPLETED|Overall Study||123
3324025|NCT03210701|4057094|FG000|NOT COMPLETED|Overall Study||0
3324026|NCT03210961|4057113|FG000|STARTED|Overall Study||4
3324027|NCT03210961|4057114|FG001|STARTED|Overall Study||9
3324028|NCT03210961|4057115|FG002|STARTED|Overall Study||1
3324029|NCT03210961|4057116|FG003|STARTED|Overall Study||2
3324030|NCT03210961|4057117|FG004|STARTED|Overall Study||6
3324031|NCT03210961|4057118|FG005|STARTED|Overall Study||6
3324032|NCT03210961|4057119|FG006|STARTED|Overall Study||8
3324033|NCT03210961|4057120|FG007|STARTED|Overall Study||7
3324034|NCT03210961|4057121|FG008|STARTED|Overall Study||8
3324035|NCT03210961|4057122|FG009|STARTED|Overall Study||6
3324036|NCT03210961|4057123|FG010|STARTED|Overall Study||7
3324037|NCT03210961|4057124|FG011|STARTED|Overall Study||5
3324038|NCT03210961|4057125|FG012|STARTED|Overall Study||14
3324039|NCT03210961|4057126|FG013|STARTED|Overall Study||15
3324040|NCT03210961|4057127|FG014|STARTED|Overall Study||11
3324041|NCT03210961|4057113|FG000|COMPLETED|Overall Study||4
3324042|NCT03210961|4057114|FG001|COMPLETED|Overall Study||9
3324043|NCT03210961|4057115|FG002|COMPLETED|Overall Study||1
3324044|NCT03210961|4057116|FG003|COMPLETED|Overall Study||1
3324045|NCT03210961|4057117|FG004|COMPLETED|Overall Study||6
3324046|NCT03210961|4057118|FG005|COMPLETED|Overall Study||6
3324047|NCT03210961|4057119|FG006|COMPLETED|Overall Study||7
3324048|NCT03210961|4057120|FG007|COMPLETED|Overall Study||7
3324049|NCT03210961|4057121|FG008|COMPLETED|Overall Study||8
3324050|NCT03210961|4057122|FG009|COMPLETED|Overall Study||6
3324051|NCT03210961|4057123|FG010|COMPLETED|Overall Study||6
3324052|NCT03210961|4057124|FG011|COMPLETED|Overall Study||5
3324053|NCT03210961|4057125|FG012|COMPLETED|Overall Study||12
3324054|NCT03210961|4057126|FG013|COMPLETED|Overall Study||11
3324055|NCT03210961|4057127|FG014|COMPLETED|Overall Study||9
3324056|NCT03210961|4057113|FG000|NOT COMPLETED|Overall Study||0
3324057|NCT03210961|4057114|FG001|NOT COMPLETED|Overall Study||0
2927645|NCT00573430|3638511|FG001|COMPLETED|Overall Study||40
3324058|NCT03210961|4057115|FG002|NOT COMPLETED|Overall Study||0
3324059|NCT03210961|4057116|FG003|NOT COMPLETED|Overall Study||1
3324060|NCT03210961|4057117|FG004|NOT COMPLETED|Overall Study||0
3176162|NCT01964755|3903945|FG000|NOT COMPLETED|Overall Study||2
3176163|NCT01964898|3903951|FG000|STARTED|Overall Study||31
3176164|NCT01964898|3903952|FG001|STARTED|Overall Study||33
3176165|NCT01964898|3903951|FG000|12 Week Assessment|Overall Study||25
3176166|NCT01964898|3903952|FG001|12 Week Assessment|Overall Study||30
3176167|NCT01964898|3903951|FG000|COMPLETED|Overall Study||24
3176168|NCT01964898|3903952|FG001|COMPLETED|Overall Study||26
3176169|NCT01964898|3903951|FG000|NOT COMPLETED|Overall Study||7
3176170|NCT01964898|3903952|FG001|NOT COMPLETED|Overall Study||7
3324061|NCT03210961|4057118|FG005|NOT COMPLETED|Overall Study||0
3324062|NCT03210961|4057119|FG006|NOT COMPLETED|Overall Study||1
3324063|NCT03210961|4057120|FG007|NOT COMPLETED|Overall Study||0
3324064|NCT03210961|4057121|FG008|NOT COMPLETED|Overall Study||0
3324065|NCT03210961|4057122|FG009|NOT COMPLETED|Overall Study||0
3324066|NCT03210961|4057123|FG010|NOT COMPLETED|Overall Study||1
3324067|NCT03210961|4057124|FG011|NOT COMPLETED|Overall Study||0
3324068|NCT03210961|4057125|FG012|NOT COMPLETED|Overall Study||2
3324069|NCT03210961|4057126|FG013|NOT COMPLETED|Overall Study||4
3324070|NCT03210961|4057127|FG014|NOT COMPLETED|Overall Study||2
3324071|NCT03211117|4057178|FG000|STARTED|Overall Study||0
3324072|NCT03211117|4057179|FG001|STARTED|Overall Study||3
3324073|NCT03211117|4057178|FG000|COMPLETED|Overall Study||0
3324074|NCT03211117|4057179|FG001|COMPLETED|Overall Study||3
3324075|NCT03211117|4057178|FG000|NOT COMPLETED|Overall Study||0
3324076|NCT03211117|4057179|FG001|NOT COMPLETED|Overall Study||0
3324077|NCT03211156|4057187|FG000|STARTED|Overall Study||49
3324078|NCT03211156|4057188|FG001|STARTED|Overall Study||48
3324079|NCT03211156|4057187|FG000|Received Study Drug|Overall Study||47
3324080|NCT03211156|4057188|FG001|Received Study Drug|Overall Study||45
3324081|NCT03211156|4057187|FG000|COMPLETED|Overall Study||47
3324082|NCT03211156|4057188|FG001|COMPLETED|Overall Study||45
3324083|NCT03211156|4057187|FG000|NOT COMPLETED|Overall Study||2
3324084|NCT03211156|4057188|FG001|NOT COMPLETED|Overall Study||3
3324085|NCT03211234|4057197|FG000|STARTED|Overall Study||17
3324086|NCT03211234|4057198|FG001|STARTED|Overall Study||31
3324087|NCT03211234|4057199|FG002|STARTED|Overall Study||28
3324088|NCT03211234|4057197|FG000|COMPLETED|Overall Study||16
3324089|NCT03211234|4057198|FG001|COMPLETED|Overall Study||30
3324090|NCT03211234|4057199|FG002|COMPLETED|Overall Study||25
3324091|NCT03211234|4057197|FG000|NOT COMPLETED|Overall Study||1
3324092|NCT03211234|4057198|FG001|NOT COMPLETED|Overall Study||1
3324093|NCT03211234|4057199|FG002|NOT COMPLETED|Overall Study||3
3324094|NCT03211858|4057209|FG000|STARTED|Overall Study||301
3324095|NCT03211858|4057210|FG001|STARTED|Overall Study||296
3324096|NCT03211858|4057209|FG000|Treated|Overall Study||301
3324097|NCT03211858|4057210|FG001|Treated|Overall Study||296
3324098|NCT03211858|4057209|FG000|COMPLETED|Overall Study||264
3324099|NCT03211858|4057210|FG001|COMPLETED|Overall Study||263
3324100|NCT03211858|4057209|FG000|NOT COMPLETED|Overall Study||37
3324101|NCT03211858|4057210|FG001|NOT COMPLETED|Overall Study||33
3324102|NCT03212261|4057220|FG000|STARTED|Overall Study|Enrolled: eligible at time of approach and signed a consent.|37
3324103|NCT03212261|4057220|FG000|Remained Eligible|Overall Study||35
3324104|NCT03212261|4057220|FG000|Baseline Completion|Overall Study|Lost patients: Technology difficulties (n=2), Family Emergency (n=1), Too busy (n=3), LTFU (n=1)|30
3324105|NCT03212261|4057220|FG000|Program Initiation|Overall Study|Lost patients: Tech trouble no first visit (n=1), Too busy/no time (n=2), LTFU (n=1)|26
3324106|NCT03212261|4057220|FG000|Post-intervention Survey|Overall Study|Lost to follow up (n=4)|22
3324107|NCT03212261|4057220|FG000|One Month Follow-up|Overall Study|Lost to follow up (n=1)|21
3176171|NCT01964924|3903958|FG000|STARTED|Trametinib Monotherapy||37
3324108|NCT03212261|4057220|FG000|COMPLETED|Overall Study||21
3324109|NCT03212261|4057220|FG000|NOT COMPLETED|Overall Study||16
3324110|NCT03212326|4057225|FG000|STARTED|Overall Study||24
3324111|NCT03212326|4057225|FG000|COMPLETED|Overall Study||20
3324112|NCT03212326|4057225|FG000|NOT COMPLETED|Overall Study||4
3324113|NCT03212365|4057231|FG000|STARTED|Overall Study||151
3324114|NCT03212365|4057232|FG001|STARTED|Overall Study||144
3324115|NCT03212365|4057231|FG000|COMPLETED|Overall Study||128
3324116|NCT03212365|4057232|FG001|COMPLETED|Overall Study||130
3176172|NCT01964924|3903959|FG001|STARTED|Trametinib Monotherapy||0
3324117|NCT03212365|4057231|FG000|NOT COMPLETED|Overall Study||23
3324118|NCT03212365|4057232|FG001|NOT COMPLETED|Overall Study||14
3324119|NCT03212521|4057238|FG000|STARTED|Overall Study||230
3324120|NCT03212521|4057238|FG000|COMPLETED|Overall Study||223
3324121|NCT03212521|4057238|FG000|NOT COMPLETED|Overall Study||7
3324122|NCT03212638|4057244|FG000|STARTED|Period 1||8
3324123|NCT03212638|4057245|FG001|STARTED|Period 1||8
3324124|NCT03212638|4057246|FG002|STARTED|Period 1||8
3324125|NCT03212638|4057247|FG003|STARTED|Period 1||0
3324126|NCT03212638|4057248|FG004|STARTED|Period 1||0
3324127|NCT03212638|4057244|FG000|Received at Least 1 Dose of Study Drug|Period 1||8
3324128|NCT03212638|4057245|FG001|Received at Least 1 Dose of Study Drug|Period 1||8
3324129|NCT03212638|4057246|FG002|Received at Least 1 Dose of Study Drug|Period 1||8
3324130|NCT03212638|4057247|FG003|Received at Least 1 Dose of Study Drug|Period 1||0
3324131|NCT03212638|4057248|FG004|Received at Least 1 Dose of Study Drug|Period 1||0
3324132|NCT03212638|4057244|FG000|COMPLETED|Period 1||8
3324133|NCT03212638|4057245|FG001|COMPLETED|Period 1||8
3324134|NCT03212638|4057246|FG002|COMPLETED|Period 1||8
3324135|NCT03212638|4057247|FG003|COMPLETED|Period 1||0
3324136|NCT03212638|4057248|FG004|COMPLETED|Period 1||0
3324137|NCT03212638|4057244|FG000|NOT COMPLETED|Period 1||0
3324138|NCT03212638|4057245|FG001|NOT COMPLETED|Period 1||0
3324139|NCT03212638|4057246|FG002|NOT COMPLETED|Period 1||0
3324140|NCT03212638|4057247|FG003|NOT COMPLETED|Period 1||0
3324141|NCT03212638|4057248|FG004|NOT COMPLETED|Period 1||0
3324142|NCT03212638|4057244|FG000|STARTED|Period 2||8
3324143|NCT03212638|4057245|FG001|STARTED|Period 2||8
3324144|NCT03212638|4057246|FG002|STARTED|Period 2||8
3324145|NCT03212638|4057247|FG003|STARTED|Period 2||0
3324146|NCT03212638|4057248|FG004|STARTED|Period 2||0
3324147|NCT03212638|4057244|FG000|Received at Least 1 Dose of Study Drug|Period 2||8
3324148|NCT03212638|4057245|FG001|Received at Least 1 Dose of Study Drug|Period 2||8
3324149|NCT03212638|4057246|FG002|Received at Least 1 Dose of Study Drug|Period 2||8
3176173|NCT01964924|3903958|FG000|COMPLETED|Trametinib Monotherapy||18
3176174|NCT01964924|3903959|FG001|COMPLETED|Trametinib Monotherapy||0
3176175|NCT01964924|3903958|FG000|NOT COMPLETED|Trametinib Monotherapy||19
3176176|NCT01964924|3903959|FG001|NOT COMPLETED|Trametinib Monotherapy||0
3176177|NCT01964924|3903958|FG000|STARTED|Trametinib + GSK2141||0
3176178|NCT01964924|3903959|FG001|STARTED|Trametinib + GSK2141|Progressed in Part 1 and therefore initiated combination treatment in Part 2|19
3324150|NCT03212638|4057247|FG003|Received at Least 1 Dose of Study Drug|Period 2||0
3324151|NCT03212638|4057248|FG004|Received at Least 1 Dose of Study Drug|Period 2||0
3324152|NCT03212638|4057244|FG000|COMPLETED|Period 2||8
3324153|NCT03212638|4057245|FG001|COMPLETED|Period 2||8
3324154|NCT03212638|4057246|FG002|COMPLETED|Period 2||8
3324155|NCT03212638|4057247|FG003|COMPLETED|Period 2||0
3324156|NCT03212638|4057248|FG004|COMPLETED|Period 2||0
3324157|NCT03212638|4057244|FG000|NOT COMPLETED|Period 2||0
3324158|NCT03212638|4057245|FG001|NOT COMPLETED|Period 2||0
3324159|NCT03212638|4057246|FG002|NOT COMPLETED|Period 2||0
3324160|NCT03212638|4057247|FG003|NOT COMPLETED|Period 2||0
3324161|NCT03212638|4057248|FG004|NOT COMPLETED|Period 2||0
3324162|NCT03212638|4057244|FG000|STARTED|Period 3||8
3324163|NCT03212638|4057245|FG001|STARTED|Period 3||8
3324164|NCT03212638|4057246|FG002|STARTED|Period 3||8
3324165|NCT03212638|4057247|FG003|STARTED|Period 3||0
3324166|NCT03212638|4057248|FG004|STARTED|Period 3||0
3324167|NCT03212638|4057244|FG000|Received at Least 1 Dose of Study Drug|Period 3||8
3324168|NCT03212638|4057245|FG001|Received at Least 1 Dose of Study Drug|Period 3||8
3324169|NCT03212638|4057246|FG002|Received at Least 1 Dose of Study Drug|Period 3||8
3324170|NCT03212638|4057247|FG003|Received at Least 1 Dose of Study Drug|Period 3||0
3324171|NCT03212638|4057248|FG004|Received at Least 1 Dose of Study Drug|Period 3||0
3324172|NCT03212638|4057244|FG000|COMPLETED|Period 3||8
3324173|NCT03212638|4057245|FG001|COMPLETED|Period 3||8
3324174|NCT03212638|4057246|FG002|COMPLETED|Period 3||8
3324175|NCT03212638|4057247|FG003|COMPLETED|Period 3||0
3324176|NCT03212638|4057248|FG004|COMPLETED|Period 3||0
3324177|NCT03212638|4057244|FG000|NOT COMPLETED|Period 3||0
3324178|NCT03212638|4057245|FG001|NOT COMPLETED|Period 3||0
3324179|NCT03212638|4057246|FG002|NOT COMPLETED|Period 3||0
3324180|NCT03212638|4057247|FG003|NOT COMPLETED|Period 3||0
3324181|NCT03212638|4057248|FG004|NOT COMPLETED|Period 3||0
3324182|NCT03212638|4057244|FG000|STARTED|Period 4|Participants were not allowed to participate in Part B and have completed study.|0
3324183|NCT03212638|4057245|FG001|STARTED|Period 4|Participants were not allowed to participate in Part B and have completed study.|0
3324184|NCT03212638|4057246|FG002|STARTED|Period 4|Participants were not allowed to participate in Part B and have completed study.|0
3324185|NCT03212638|4057247|FG003|STARTED|Period 4|New Participants in Part B, no participants from Part A participated in Part B.|9
3324186|NCT03212638|4057248|FG004|STARTED|Period 4|New Participants in Part B, no participants from Part A participated in Part B.|9
2927646|NCT00573430|3638512|FG002|COMPLETED|Overall Study||33
2927647|NCT00573430|3638510|FG000|NOT COMPLETED|Overall Study||1
2927648|NCT00573430|3638511|FG001|NOT COMPLETED|Overall Study||5
2927649|NCT00573430|3638512|FG002|NOT COMPLETED|Overall Study||10
2927650|NCT00573443|3638523|FG000|STARTED|Double-Blind Phase||110
2927651|NCT00573443|3638524|FG001|STARTED|Double-Blind Phase||107
2927652|NCT00573443|3638525|FG002|STARTED|Double-Blind Phase||109
2927653|NCT00573443|3638523|FG000|Subjects With PBA Secondary to ALS|Double-Blind Phase||65
2927654|NCT00573443|3638524|FG001|Subjects With PBA Secondary to ALS|Double-Blind Phase||68
2927655|NCT00573443|3638525|FG002|Subjects With PBA Secondary to ALS|Double-Blind Phase||64
2927656|NCT00573443|3638523|FG000|Subjects With PBA Secondary to MS|Double-Blind Phase||45
2927657|NCT00573443|3638524|FG001|Subjects With PBA Secondary to MS|Double-Blind Phase||39
2927658|NCT00573443|3638525|FG002|Subjects With PBA Secondary to MS|Double-Blind Phase||45
2927659|NCT00573443|3638523|FG000|COMPLETED|Double-Blind Phase||101
2927660|NCT00573443|3638524|FG001|COMPLETED|Double-Blind Phase||88
2927661|NCT00573443|3638525|FG002|COMPLETED|Double-Blind Phase||94
2927662|NCT00573443|3638523|FG000|NOT COMPLETED|Double-Blind Phase||9
2927663|NCT00573443|3638524|FG001|NOT COMPLETED|Double-Blind Phase||19
2927664|NCT00573443|3638525|FG002|NOT COMPLETED|Double-Blind Phase||15
2927665|NCT00573443|3638523|FG000|STARTED|Open-Label Extension Phase|Subjects who completed any of the arms in the DB phase had the option to enroll in this OLE phase|253
2927666|NCT00573443|3638524|FG001|STARTED|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
2927667|NCT00573443|3638525|FG002|STARTED|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
2927668|NCT00573443|3638523|FG000|Subjects With PBA Secondary to ALS|Open-Label Extension Phase||146
2927669|NCT00573443|3638524|FG001|Subjects With PBA Secondary to ALS|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
2927670|NCT00573443|3638525|FG002|Subjects With PBA Secondary to ALS|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
2927671|NCT00573443|3638523|FG000|Subjects With PBA Secondary to MS|Open-Label Extension Phase||107
2927672|NCT00573443|3638524|FG001|Subjects With PBA Secondary to MS|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
2927673|NCT00573443|3638525|FG002|Subjects With PBA Secondary to MS|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
2927674|NCT00573443|3638523|FG000|COMPLETED|Open-Label Extension Phase||235
2927675|NCT00573443|3638524|FG001|COMPLETED|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
3039769|NCT01160380|3759217|FG000|STARTED|Overall Study||25
3039770|NCT01160380|3759218|FG001|STARTED|Overall Study||25
3039771|NCT01160380|3759217|FG000|COMPLETED|Overall Study||17
3039772|NCT01160380|3759218|FG001|COMPLETED|Overall Study||20
3039773|NCT01160380|3759217|FG000|NOT COMPLETED|Overall Study||8
3039774|NCT01160380|3759218|FG001|NOT COMPLETED|Overall Study||5
3039775|NCT01160445|3759226|FG000|STARTED|Overall Study||7
3039776|NCT01160445|3759227|FG001|STARTED|Overall Study||2
3039777|NCT01160445|3759226|FG000|COMPLETED|Overall Study||7
3039778|NCT01160445|3759227|FG001|COMPLETED|Overall Study||2
3039779|NCT01160445|3759226|FG000|NOT COMPLETED|Overall Study||0
3039780|NCT01160445|3759227|FG001|NOT COMPLETED|Overall Study||0
3039781|NCT01160458|3759233|FG000|STARTED|Overall Study||20
3039782|NCT01160458|3759233|FG000|COMPLETED|Overall Study||20
3039783|NCT01160458|3759233|FG000|NOT COMPLETED|Overall Study||0
3039784|NCT01160484|3759237|FG000|STARTED|Overall Study||40
3039785|NCT01160484|3759237|FG000|COMPLETED|Overall Study||22
3039786|NCT01160484|3759237|FG000|NOT COMPLETED|Overall Study||18
3039787|NCT01160614|3759243|FG000|STARTED|Overall Study||5
3039788|NCT01160614|3759244|FG001|STARTED|Overall Study||25
3039789|NCT01160614|3759243|FG000|COMPLETED|Overall Study||5
3039790|NCT01160614|3759244|FG001|COMPLETED|Overall Study||23
3176179|NCT01964924|3903958|FG000|COMPLETED|Trametinib + GSK2141||0
3176180|NCT01964924|3903959|FG001|COMPLETED|Trametinib + GSK2141||19
3176181|NCT01964924|3903958|FG000|NOT COMPLETED|Trametinib + GSK2141||0
3176182|NCT01964924|3903959|FG001|NOT COMPLETED|Trametinib + GSK2141||0
3176183|NCT01964950|3903970|FG000|STARTED|Overall Study|Data reports overall population,since data not collected separately per arm as specified in protocol|1101
3176184|NCT01964950|3903970|FG000|COMPLETED|Overall Study||1076
3176185|NCT01964950|3903970|FG000|NOT COMPLETED|Overall Study||25
3176186|NCT01964963|3903977|FG000|STARTED|Overall Study||19192
3176187|NCT01964963|3903977|FG000|COMPLETED|Overall Study||18249
3324187|NCT03212638|4057244|FG000|Received at Least 1 Dose of Study Drug|Period 4||0
3324188|NCT03212638|4057245|FG001|Received at Least 1 Dose of Study Drug|Period 4||0
3324189|NCT03212638|4057246|FG002|Received at Least 1 Dose of Study Drug|Period 4||0
3324190|NCT03212638|4057247|FG003|Received at Least 1 Dose of Study Drug|Period 4||9
3324191|NCT03212638|4057248|FG004|Received at Least 1 Dose of Study Drug|Period 4||9
3324192|NCT03212638|4057244|FG000|COMPLETED|Period 4||0
3324193|NCT03212638|4057245|FG001|COMPLETED|Period 4||0
3324194|NCT03212638|4057246|FG002|COMPLETED|Period 4||0
3324195|NCT03212638|4057247|FG003|COMPLETED|Period 4||9
3324196|NCT03212638|4057248|FG004|COMPLETED|Period 4||9
3324197|NCT03212638|4057244|FG000|NOT COMPLETED|Period 4||0
3324198|NCT03212638|4057245|FG001|NOT COMPLETED|Period 4||0
3324199|NCT03212638|4057246|FG002|NOT COMPLETED|Period 4||0
3324200|NCT03212638|4057247|FG003|NOT COMPLETED|Period 4||0
3324201|NCT03212638|4057248|FG004|NOT COMPLETED|Period 4||0
3324202|NCT03212638|4057244|FG000|STARTED|Period 5||0
3324203|NCT03212638|4057245|FG001|STARTED|Period 5||0
3324204|NCT03212638|4057246|FG002|STARTED|Period 5||0
3324205|NCT03212638|4057247|FG003|STARTED|Period 5||9
3324206|NCT03212638|4057248|FG004|STARTED|Period 5||9
3324207|NCT03212638|4057244|FG000|Received at Least 1 Dose of Study Drug|Period 5||0
3324208|NCT03212638|4057245|FG001|Received at Least 1 Dose of Study Drug|Period 5||0
3324209|NCT03212638|4057246|FG002|Received at Least 1 Dose of Study Drug|Period 5||0
3324210|NCT03212638|4057247|FG003|Received at Least 1 Dose of Study Drug|Period 5||9
3324211|NCT03212638|4057248|FG004|Received at Least 1 Dose of Study Drug|Period 5||9
3324212|NCT03212638|4057244|FG000|COMPLETED|Period 5||0
3324213|NCT03212638|4057245|FG001|COMPLETED|Period 5||0
3324214|NCT03212638|4057246|FG002|COMPLETED|Period 5||0
3324215|NCT03212638|4057247|FG003|COMPLETED|Period 5||9
3324216|NCT03212638|4057248|FG004|COMPLETED|Period 5||9
3324217|NCT03212638|4057244|FG000|NOT COMPLETED|Period 5||0
3324218|NCT03212638|4057245|FG001|NOT COMPLETED|Period 5||0
3324219|NCT03212638|4057246|FG002|NOT COMPLETED|Period 5||0
3324220|NCT03212638|4057247|FG003|NOT COMPLETED|Period 5||0
3324221|NCT03212638|4057248|FG004|NOT COMPLETED|Period 5||0
3324222|NCT03212690|4057260|FG000|STARTED|Overall Study||57
3324223|NCT03212690|4057260|FG000|COMPLETED|Overall Study||56
3324224|NCT03212690|4057260|FG000|NOT COMPLETED|Overall Study||1
3324225|NCT03213210|4057264|FG000|STARTED|Overall Study||5
3324226|NCT03213210|4057264|FG000|6-month Follow-up|Overall Study||3
3324227|NCT03213210|4057264|FG000|COMPLETED|Overall Study||0
3324228|NCT03213210|4057264|FG000|NOT COMPLETED|Overall Study||5
3324229|NCT03213366|4057270|FG000|STARTED|Overall Study||81
3324230|NCT03213366|4057271|FG001|STARTED|Overall Study||71
3324231|NCT03213366|4057270|FG000|COMPLETED|Overall Study||72
3324232|NCT03213366|4057271|FG001|COMPLETED|Overall Study||67
3324233|NCT03213366|4057270|FG000|NOT COMPLETED|Overall Study||9
3324234|NCT03213366|4057271|FG001|NOT COMPLETED|Overall Study||4
3324235|NCT03213405|4057281|FG000|STARTED|Overall Study||6
3324236|NCT03213405|4057282|FG001|STARTED|Overall Study||6
3324237|NCT03213405|4057283|FG002|STARTED|Overall Study||6
3324238|NCT03213405|4057284|FG003|STARTED|Overall Study||6
3324239|NCT03213405|4057281|FG000|COMPLETED|Overall Study||6
3324240|NCT03213405|4057282|FG001|COMPLETED|Overall Study||6
3324241|NCT03213405|4057283|FG002|COMPLETED|Overall Study||6
3324242|NCT03213405|4057284|FG003|COMPLETED|Overall Study||6
3324243|NCT03213405|4057281|FG000|NOT COMPLETED|Overall Study||0
3324244|NCT03213405|4057282|FG001|NOT COMPLETED|Overall Study||0
3324245|NCT03213405|4057283|FG002|NOT COMPLETED|Overall Study||0
3324246|NCT03213405|4057284|FG003|NOT COMPLETED|Overall Study||0
3324247|NCT03213509|4057296|FG000|STARTED|Overall Study||80
3324248|NCT03213509|4057297|FG001|STARTED|Overall Study||90
3324249|NCT03213509|4057296|FG000|COMPLETED|Overall Study||76
3324250|NCT03213509|4057297|FG001|COMPLETED|Overall Study||85
3324251|NCT03213509|4057296|FG000|NOT COMPLETED|Overall Study||4
3324252|NCT03213509|4057297|FG001|NOT COMPLETED|Overall Study||5
3324253|NCT03213626|4057304|FG000|STARTED|Overall Study||7
3324254|NCT03213626|4057304|FG000|COMPLETED|Overall Study||0
3324255|NCT03213626|4057304|FG000|NOT COMPLETED|Overall Study||7
3324256|NCT03213938|4057310|FG000|STARTED|Overall Study||220
3324257|NCT03213938|4057311|FG001|STARTED|Overall Study||220
3324258|NCT03213938|4057310|FG000|COMPLETED|Overall Study||206
3324259|NCT03213938|4057311|FG001|COMPLETED|Overall Study||208
3324260|NCT03213938|4057310|FG000|NOT COMPLETED|Overall Study||14
3324261|NCT03213938|4057311|FG001|NOT COMPLETED|Overall Study||12
3324262|NCT03214081|4057317|FG000|STARTED|Overall Study||1237
3324263|NCT03214081|4057317|FG000|COMPLETED|Overall Study||1174
3324264|NCT03214081|4057317|FG000|NOT COMPLETED|Overall Study||63
3324265|NCT03214094|4057321|FG000|STARTED|Overall Study||1119
3324266|NCT03214094|4057321|FG000|COMPLETED|Overall Study||1059
3324267|NCT03214094|4057321|FG000|NOT COMPLETED|Overall Study||60
3324268|NCT03214198|4057325|FG000|STARTED|Overall Study||1304
3324269|NCT03214198|4057325|FG000|COMPLETED|Overall Study||1268
3324270|NCT03214198|4057325|FG000|NOT COMPLETED|Overall Study||36
3324271|NCT03214224|4057329|FG000|STARTED|Overall Study|Subjects did both standard and remote assessments in the validation study. Total enrollment 49.|49
3324272|NCT03214224|4057329|FG000|COMPLETED|Overall Study|3 therapists enrolled. 3 ctrls enrolled (not incl. in analysis). 3 pts enr. but not completed.|40
3324273|NCT03214224|4057329|FG000|NOT COMPLETED|Overall Study||9
3324274|NCT03214367|4057339|FG000|STARTED|Lead-in Period||1316
3324275|NCT03214367|4057340|FG001|STARTED|Lead-in Period||0
3324276|NCT03214367|4057341|FG002|STARTED|Lead-in Period||0
3176188|NCT01964963|3903977|FG000|NOT COMPLETED|Overall Study||943
3176189|NCT01964976|3903983|FG000|STARTED|Overall Study|Data reports overall population,since data not collected separately per arm as specified in protocol|1096
3176190|NCT01964976|3903983|FG000|COMPLETED|Overall Study||1065
3176191|NCT01964976|3903983|FG000|NOT COMPLETED|Overall Study||31
3324277|NCT03214367|4057342|FG003|STARTED|Lead-in Period||0
3324278|NCT03214367|4057343|FG004|STARTED|Lead-in Period||76
3324279|NCT03214367|4057344|FG005|STARTED|Lead-in Period||0
3324280|NCT03214367|4057345|FG006|STARTED|Lead-in Period||0
3324281|NCT03214367|4057346|FG007|STARTED|Lead-in Period||0
3324282|NCT03214367|4057339|FG000|COMPLETED|Lead-in Period||1222
3324283|NCT03214367|4057340|FG001|COMPLETED|Lead-in Period||0
3324284|NCT03214367|4057341|FG002|COMPLETED|Lead-in Period||0
3324285|NCT03214367|4057342|FG003|COMPLETED|Lead-in Period||0
3324286|NCT03214367|4057343|FG004|COMPLETED|Lead-in Period||74
3324287|NCT03214367|4057344|FG005|COMPLETED|Lead-in Period||0
3324288|NCT03214367|4057345|FG006|COMPLETED|Lead-in Period||0
3324289|NCT03214367|4057346|FG007|COMPLETED|Lead-in Period||0
3324290|NCT03214367|4057339|FG000|NOT COMPLETED|Lead-in Period||94
3324291|NCT03214367|4057340|FG001|NOT COMPLETED|Lead-in Period||0
3324292|NCT03214367|4057341|FG002|NOT COMPLETED|Lead-in Period||0
3324293|NCT03214367|4057342|FG003|NOT COMPLETED|Lead-in Period||0
3324294|NCT03214367|4057343|FG004|NOT COMPLETED|Lead-in Period||2
3324295|NCT03214367|4057344|FG005|NOT COMPLETED|Lead-in Period||0
3324296|NCT03214367|4057345|FG006|NOT COMPLETED|Lead-in Period||0
3324297|NCT03214367|4057346|FG007|NOT COMPLETED|Lead-in Period||0
3324298|NCT03214367|4057339|FG000|STARTED|Treatment Period|Participants received Insulin Lispro during Lead-in Period.|0
2927676|NCT00573443|3638525|FG002|COMPLETED|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
2927677|NCT00573443|3638523|FG000|NOT COMPLETED|Open-Label Extension Phase||18
2927678|NCT00573443|3638524|FG001|NOT COMPLETED|Open-Label Extension Phase||0
2927679|NCT00573443|3638525|FG002|NOT COMPLETED|Open-Label Extension Phase||0
2927680|NCT00573469|3638537|FG000|STARTED|Overall Study||26
2927681|NCT00573469|3638538|FG001|STARTED|Overall Study||25
2927682|NCT00573469|3638539|FG002|STARTED|Overall Study||26
2927683|NCT00573469|3638537|FG000|COMPLETED|Overall Study||20
2927684|NCT00573469|3638538|FG001|COMPLETED|Overall Study||21
2927685|NCT00573469|3638539|FG002|COMPLETED|Overall Study||22
2927686|NCT00573469|3638537|FG000|NOT COMPLETED|Overall Study||6
2927687|NCT00573469|3638538|FG001|NOT COMPLETED|Overall Study||4
2927688|NCT00573469|3638539|FG002|NOT COMPLETED|Overall Study||4
2927689|NCT00573508|3638549|FG000|STARTED|Overall Study||382
2927690|NCT00573508|3638550|FG001|STARTED|Overall Study||386
2927691|NCT00573508|3638549|FG000|Full Analysis Set (FAS)|Overall Study|Patients who took >= 1 dose of double-blind study drug, had a baseline OAB-q & >= 1 subsequent visit|374
2927692|NCT00573508|3638550|FG001|Full Analysis Set (FAS)|Overall Study|Patients who took >= 1 dose of double-blind study drug, had a baseline OAB-q & >= 1 subsequent visit|377
2927693|NCT00573508|3638549|FG000|COMPLETED|Overall Study||318
2927694|NCT00573508|3638550|FG001|COMPLETED|Overall Study||345
2927695|NCT00573508|3638549|FG000|NOT COMPLETED|Overall Study||64
2927696|NCT00573508|3638550|FG001|NOT COMPLETED|Overall Study||41
2927697|NCT00573534|3638556|FG000|STARTED|Overall Study||8
2927698|NCT00573534|3638556|FG000|COMPLETED|Overall Study||5
2927699|NCT00573534|3638556|FG000|NOT COMPLETED|Overall Study||3
2927700|NCT00573755|3638563|FG000|STARTED|Overall Study||2
2927701|NCT00573755|3638564|FG001|STARTED|Overall Study||2
2927702|NCT00573755|3638563|FG000|COMPLETED|Overall Study||1
2927703|NCT00573755|3638564|FG001|COMPLETED|Overall Study||2
2927704|NCT00573755|3638563|FG000|NOT COMPLETED|Overall Study||1
2927705|NCT00573755|3638564|FG001|NOT COMPLETED|Overall Study||0
2927706|NCT00573768|3638573|FG000|STARTED|Overall Study||89
2927707|NCT00573768|3638574|FG001|STARTED|Overall Study||91
2927708|NCT00573768|3638575|FG002|STARTED|Overall Study||91
2927709|NCT00573768|3638573|FG000|COMPLETED|Overall Study||87
2927710|NCT00573768|3638574|FG001|COMPLETED|Overall Study||89
2927711|NCT00573768|3638575|FG002|COMPLETED|Overall Study||87
2927712|NCT00573768|3638573|FG000|NOT COMPLETED|Overall Study||2
2927713|NCT00573768|3638574|FG001|NOT COMPLETED|Overall Study||2
2927714|NCT00573768|3638575|FG002|NOT COMPLETED|Overall Study||4
2927715|NCT00573794|3638583|FG000|STARTED|Overall Study||585
2927716|NCT00573794|3638583|FG000|COMPLETED|Overall Study||255
2927717|NCT00573794|3638583|FG000|NOT COMPLETED|Overall Study||330
2927718|NCT00573833|3638587|FG000|STARTED|Overall Study||23
2927719|NCT00573833|3638587|FG000|COMPLETED|Overall Study||21
2927720|NCT00573833|3638587|FG000|NOT COMPLETED|Overall Study||2
2927721|NCT00573859|3638591|FG000|STARTED|Medication Versus Placebo||27
2927722|NCT00573859|3638591|FG000|COMPLETED|Medication Versus Placebo||15
2927723|NCT00573859|3638591|FG000|NOT COMPLETED|Medication Versus Placebo||12
2927724|NCT00573859|3638591|FG000|STARTED|Smoking Versus Abstinence||27
2927725|NCT00573859|3638591|FG000|COMPLETED|Smoking Versus Abstinence||15
2927726|NCT00573859|3638591|FG000|NOT COMPLETED|Smoking Versus Abstinence||12
2927727|NCT00573872|3638595|FG000|STARTED|Overall Study|# of patients that signed consent|43
2927728|NCT00573872|3638595|FG000|COMPLETED|Overall Study|# of patients that completed treatment|32
2927729|NCT00573872|3638595|FG000|NOT COMPLETED|Overall Study||11
2927730|NCT00573989|3638599|FG000|STARTED|Erlotinib Phase I||4
2927731|NCT00573989|3638600|FG001|STARTED|Erlotinib Phase I||6
2927732|NCT00573989|3638601|FG002|STARTED|Erlotinib Phase I||5
2927733|NCT00573989|3638602|FG003|STARTED|Erlotinib Phase I||0
2927734|NCT00573989|3638599|FG000|COMPLETED|Erlotinib Phase I||4
2927735|NCT00573989|3638600|FG001|COMPLETED|Erlotinib Phase I||6
2927736|NCT00573989|3638601|FG002|COMPLETED|Erlotinib Phase I||5
2927737|NCT00573989|3638602|FG003|COMPLETED|Erlotinib Phase I||0
2927738|NCT00573989|3638599|FG000|NOT COMPLETED|Erlotinib Phase I||0
2927739|NCT00573989|3638600|FG001|NOT COMPLETED|Erlotinib Phase I||0
2927740|NCT00573989|3638601|FG002|NOT COMPLETED|Erlotinib Phase I||0
2927741|NCT00573989|3638602|FG003|NOT COMPLETED|Erlotinib Phase I||0
2927742|NCT00573989|3638599|FG000|STARTED|Erlotinib 125mg- Phase II||0
2927743|NCT00573989|3638600|FG001|STARTED|Erlotinib 125mg- Phase II||0
2927744|NCT00573989|3638601|FG002|STARTED|Erlotinib 125mg- Phase II||0
3324299|NCT03214367|4057340|FG001|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro in Treatment Period.|442
3324300|NCT03214367|4057341|FG002|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro in Treatment Period.|451
3324301|NCT03214367|4057342|FG003|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro in Treatment Period.|329
3176192|NCT01965002|3903990|FG000|STARTED|Overall Study||5
3176193|NCT01965002|3903990|FG000|COMPLETED|Overall Study||5
3176194|NCT01965002|3903990|FG000|NOT COMPLETED|Overall Study||0
3176195|NCT01965067|3903998|FG000|STARTED|Overall Study||30
3176196|NCT01965067|3903999|FG001|STARTED|Overall Study||30
3324302|NCT03214367|4057343|FG004|STARTED|Treatment Period|Participants received Insulin Lispro during Lead-in Period.|0
3324303|NCT03214367|4057344|FG005|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro in Treatment Period.|31
3324304|NCT03214367|4057345|FG006|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro in Treatment Period.|21
3324305|NCT03214367|4057346|FG007|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro in Treatment Period.|22
3324306|NCT03214367|4057339|FG000|COMPLETED|Treatment Period||0
3324307|NCT03214367|4057340|FG001|COMPLETED|Treatment Period||408
3324308|NCT03214367|4057341|FG002|COMPLETED|Treatment Period||418
3324309|NCT03214367|4057342|FG003|COMPLETED|Treatment Period||310
3176197|NCT01965067|3903998|FG000|COMPLETED|Overall Study||30
3176198|NCT01965067|3903999|FG001|COMPLETED|Overall Study||30
3176199|NCT01965067|3903998|FG000|NOT COMPLETED|Overall Study||0
3176200|NCT01965067|3903999|FG001|NOT COMPLETED|Overall Study||0
3176201|NCT01965158|3904007|FG000|STARTED|Overall Study|Includes 1 participant enrolled at 2 different sites simultaneously|274
3176202|NCT01965158|3904008|FG001|STARTED|Overall Study|Includes 1 participant enrolled at 2 different sites simultaneously|273
3176203|NCT01965158|3904007|FG000|Received Treatment|Overall Study||272
3324310|NCT03214367|4057343|FG004|COMPLETED|Treatment Period||0
3324311|NCT03214367|4057344|FG005|COMPLETED|Treatment Period||28
3324312|NCT03214367|4057345|FG006|COMPLETED|Treatment Period||19
3324313|NCT03214367|4057346|FG007|COMPLETED|Treatment Period||21
3324314|NCT03214367|4057339|FG000|NOT COMPLETED|Treatment Period||0
3324315|NCT03214367|4057340|FG001|NOT COMPLETED|Treatment Period||34
3324316|NCT03214367|4057341|FG002|NOT COMPLETED|Treatment Period||33
3324317|NCT03214367|4057342|FG003|NOT COMPLETED|Treatment Period||19
3324318|NCT03214367|4057343|FG004|NOT COMPLETED|Treatment Period||0
3324319|NCT03214367|4057344|FG005|NOT COMPLETED|Treatment Period||3
3324320|NCT03214367|4057345|FG006|NOT COMPLETED|Treatment Period||2
3324321|NCT03214367|4057346|FG007|NOT COMPLETED|Treatment Period||1
3324322|NCT03214380|4057364|FG000|STARTED|Lead-in||750
3324323|NCT03214380|4057365|FG001|STARTED|Lead-in||0
3324324|NCT03214380|4057366|FG002|STARTED|Lead-in||0
3324325|NCT03214380|4057367|FG003|STARTED|Lead-in||183
3324326|NCT03214380|4057368|FG004|STARTED|Lead-in||0
3324327|NCT03214380|4057369|FG005|STARTED|Lead-in||0
3324328|NCT03214380|4057364|FG000|Received at Least 1 Dose Lead-in Insulin|Lead-in||750
3324329|NCT03214380|4057365|FG001|Received at Least 1 Dose Lead-in Insulin|Lead-in||0
3324330|NCT03214380|4057366|FG002|Received at Least 1 Dose Lead-in Insulin|Lead-in||0
3324331|NCT03214380|4057367|FG003|Received at Least 1 Dose Lead-in Insulin|Lead-in||183
3324332|NCT03214380|4057368|FG004|Received at Least 1 Dose Lead-in Insulin|Lead-in||0
3324333|NCT03214380|4057369|FG005|Received at Least 1 Dose Lead-in Insulin|Lead-in||0
3324334|NCT03214380|4057364|FG000|COMPLETED|Lead-in||673
3324335|NCT03214380|4057365|FG001|COMPLETED|Lead-in||0
3324336|NCT03214380|4057366|FG002|COMPLETED|Lead-in||0
3324337|NCT03214380|4057367|FG003|COMPLETED|Lead-in||164
3324338|NCT03214380|4057368|FG004|COMPLETED|Lead-in||0
3324339|NCT03214380|4057369|FG005|COMPLETED|Lead-in||0
3324340|NCT03214380|4057364|FG000|NOT COMPLETED|Lead-in||77
3324341|NCT03214380|4057365|FG001|NOT COMPLETED|Lead-in||0
3324342|NCT03214380|4057366|FG002|NOT COMPLETED|Lead-in||0
3324343|NCT03214380|4057367|FG003|NOT COMPLETED|Lead-in||19
3324344|NCT03214380|4057368|FG004|NOT COMPLETED|Lead-in||0
3324345|NCT03214380|4057369|FG005|NOT COMPLETED|Lead-in||0
3324346|NCT03214380|4057364|FG000|STARTED|Treatment Period|Participants received Insulin Lispro during Lead-in Period.|0
3324347|NCT03214380|4057365|FG001|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro for Intensive Treatment Period.|337
3324348|NCT03214380|4057366|FG002|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro for Intensive Treatment Period.|336
3324349|NCT03214380|4057367|FG003|STARTED|Treatment Period|Participants received Insulin Lispro during Lead-in Period.|0
3324350|NCT03214380|4057368|FG004|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro for Intensive Treatment Period.|82
3176204|NCT01965158|3904008|FG001|Received Treatment|Overall Study||273
3176205|NCT01965158|3904007|FG000|COMPLETED|Overall Study||233
3176206|NCT01965158|3904008|FG001|COMPLETED|Overall Study||238
3324351|NCT03214380|4057369|FG005|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro for Intensive Treatment Period.|82
3324352|NCT03214380|4057364|FG000|Received at Least 1 Dose of Study Drug|Treatment Period||0
3324353|NCT03214380|4057365|FG001|Received at Least 1 Dose of Study Drug|Treatment Period||337
3324354|NCT03214380|4057366|FG002|Received at Least 1 Dose of Study Drug|Treatment Period||336
3324355|NCT03214380|4057367|FG003|Received at Least 1 Dose of Study Drug|Treatment Period||0
3324356|NCT03214380|4057368|FG004|Received at Least 1 Dose of Study Drug|Treatment Period||82
3324357|NCT03214380|4057369|FG005|Received at Least 1 Dose of Study Drug|Treatment Period||82
3324358|NCT03214380|4057364|FG000|COMPLETED|Treatment Period||0
3324359|NCT03214380|4057365|FG001|COMPLETED|Treatment Period||319
3324360|NCT03214380|4057366|FG002|COMPLETED|Treatment Period||320
3324361|NCT03214380|4057367|FG003|COMPLETED|Treatment Period||0
3324362|NCT03214380|4057368|FG004|COMPLETED|Treatment Period||73
3324363|NCT03214380|4057369|FG005|COMPLETED|Treatment Period||71
3324364|NCT03214380|4057364|FG000|NOT COMPLETED|Treatment Period||0
3324365|NCT03214380|4057365|FG001|NOT COMPLETED|Treatment Period||18
3324366|NCT03214380|4057366|FG002|NOT COMPLETED|Treatment Period||16
3324367|NCT03214380|4057367|FG003|NOT COMPLETED|Treatment Period||0
3324368|NCT03214380|4057368|FG004|NOT COMPLETED|Treatment Period||9
3324369|NCT03214380|4057369|FG005|NOT COMPLETED|Treatment Period||11
3324370|NCT03214406|4057383|FG000|STARTED|Overall Study||88
3324371|NCT03214406|4057384|FG001|STARTED|Overall Study||93
3324372|NCT03214406|4057383|FG000|COMPLETED|Overall Study||78
3324373|NCT03214406|4057384|FG001|COMPLETED|Overall Study||78
3324374|NCT03214406|4057383|FG000|NOT COMPLETED|Overall Study||10
3324375|NCT03214406|4057384|FG001|NOT COMPLETED|Overall Study||15
3324376|NCT03214588|4057393|FG000|STARTED|Overall Study||27
3324377|NCT03214588|4057394|FG001|STARTED|Overall Study||14
3324378|NCT03214588|4057395|FG002|STARTED|Overall Study||26
3324379|NCT03214588|4057393|FG000|COMPLETED|Overall Study||26
3324380|NCT03214588|4057394|FG001|COMPLETED|Overall Study||13
3324381|NCT03214588|4057395|FG002|COMPLETED|Overall Study||24
3324382|NCT03214588|4057393|FG000|NOT COMPLETED|Overall Study||1
3324383|NCT03214588|4057394|FG001|NOT COMPLETED|Overall Study||1
3324384|NCT03214588|4057395|FG002|NOT COMPLETED|Overall Study||2
3324385|NCT03214640|4057407|FG000|STARTED|Overall Study||31
3324386|NCT03214640|4057408|FG001|STARTED|Overall Study||32
3324387|NCT03214640|4057409|FG002|STARTED|Overall Study||31
3324388|NCT03214640|4057410|FG003|STARTED|Overall Study||34
3324389|NCT03214640|4057407|FG000|COMPLETED|Overall Study||30
3324390|NCT03214640|4057408|FG001|COMPLETED|Overall Study||30
3324391|NCT03214640|4057409|FG002|COMPLETED|Overall Study||30
3324392|NCT03214640|4057410|FG003|COMPLETED|Overall Study||30
3324393|NCT03214640|4057407|FG000|NOT COMPLETED|Overall Study||1
3324394|NCT03214640|4057408|FG001|NOT COMPLETED|Overall Study||2
3324395|NCT03214640|4057409|FG002|NOT COMPLETED|Overall Study||1
3324396|NCT03214640|4057410|FG003|NOT COMPLETED|Overall Study||4
3324397|NCT03214952|4057420|FG000|STARTED|Overall Study||3183
3324398|NCT03214952|4057420|FG000|COMPLETED|Overall Study||3125
3324399|NCT03214952|4057420|FG000|NOT COMPLETED|Overall Study||58
3324400|NCT03215667|4057424|FG000|STARTED|Overall Study||9
3324401|NCT03215667|4057424|FG000|COMPLETED|Overall Study||5
3324402|NCT03215667|4057424|FG000|NOT COMPLETED|Overall Study||4
3324403|NCT03215706|4057430|FG000|STARTED|Randomization||361
3324404|NCT03215706|4057431|FG001|STARTED|Randomization||358
3324405|NCT03215706|4057430|FG000|COMPLETED|Randomization||358
3324406|NCT03215706|4057431|FG001|COMPLETED|Randomization||349
3324407|NCT03215706|4057430|FG000|NOT COMPLETED|Randomization||3
3324408|NCT03215706|4057431|FG001|NOT COMPLETED|Randomization||9
3324409|NCT03215706|4057430|FG000|STARTED|Treatment Period||358
3324410|NCT03215706|4057431|FG001|STARTED|Treatment Period||349
3324411|NCT03215706|4057430|FG000|COMPLETED|Treatment Period||16
3324412|NCT03215706|4057431|FG001|COMPLETED|Treatment Period||103
3324413|NCT03215706|4057430|FG000|NOT COMPLETED|Treatment Period||342
3324414|NCT03215706|4057431|FG001|NOT COMPLETED|Treatment Period||246
3324415|NCT03215758|4057439|FG000|STARTED|Overall Study||339
3324416|NCT03215758|4057440|FG001|STARTED|Overall Study||336
3324417|NCT03215758|4057439|FG000|COMPLETED|Overall Study||334
3324418|NCT03215758|4057440|FG001|COMPLETED|Overall Study||328
3324419|NCT03215758|4057439|FG000|NOT COMPLETED|Overall Study||5
3324420|NCT03215758|4057440|FG001|NOT COMPLETED|Overall Study||8
3324421|NCT03215771|4057446|FG000|STARTED|Overall Study||16
3324422|NCT03215771|4057446|FG000|Stroke Subjects|Overall Study||8
3324423|NCT03215771|4057446|FG000|TBI Subjects|Overall Study||8
3324424|NCT03215771|4057446|FG000|COMPLETED|Overall Study||13
3324425|NCT03215771|4057446|FG000|NOT COMPLETED|Overall Study||3
3324426|NCT03215901|4057454|FG000|STARTED|Overall Study||199
3324427|NCT03215901|4057455|FG001|STARTED|Overall Study||112
3324428|NCT03215901|4057456|FG002|STARTED|Overall Study||116
3324429|NCT03215901|4057454|FG000|COMPLETED|Overall Study||199
3324430|NCT03215901|4057455|FG001|COMPLETED|Overall Study||112
3324431|NCT03215901|4057456|FG002|COMPLETED|Overall Study||116
3324432|NCT03215901|4057454|FG000|NOT COMPLETED|Overall Study||0
3324433|NCT03215901|4057455|FG001|NOT COMPLETED|Overall Study||0
3324434|NCT03215901|4057456|FG002|NOT COMPLETED|Overall Study||0
3324435|NCT03216200|4057464|FG000|STARTED|Overall Study||5
3324436|NCT03216200|4057464|FG000|COMPLETED|Overall Study||5
3324437|NCT03216200|4057464|FG000|NOT COMPLETED|Overall Study||0
3324438|NCT03216226|4057470|FG000|STARTED|Overall Study||57
3324439|NCT03216226|4057471|FG001|STARTED|Overall Study||55
3324440|NCT03216226|4057470|FG000|Randomized and Treated|Overall Study||57
3324441|NCT03216226|4057471|FG001|Randomized and Treated|Overall Study||54
3324442|NCT03216226|4057470|FG000|COMPLETED|Overall Study||52
3324443|NCT03216226|4057471|FG001|COMPLETED|Overall Study||50
3324444|NCT03216226|4057470|FG000|NOT COMPLETED|Overall Study||5
3324445|NCT03216226|4057471|FG001|NOT COMPLETED|Overall Study||5
3324446|NCT03216265|4057480|FG000|STARTED|Overall Study||22
3324447|NCT03216265|4057481|FG001|STARTED|Overall Study||22
3324448|NCT03216265|4057482|FG002|STARTED|Overall Study||22
3324449|NCT03216265|4057480|FG000|COMPLETED|Overall Study||20
3324450|NCT03216265|4057481|FG001|COMPLETED|Overall Study||21
3324451|NCT03216265|4057482|FG002|COMPLETED|Overall Study||19
3324452|NCT03216265|4057480|FG000|NOT COMPLETED|Overall Study||2
3324453|NCT03216265|4057481|FG001|NOT COMPLETED|Overall Study||1
3324454|NCT03216265|4057482|FG002|NOT COMPLETED|Overall Study||3
3324455|NCT03216382|4057499|FG000|STARTED|Overall Study||41
3324456|NCT03216382|4057500|FG001|STARTED|Overall Study||54
3324457|NCT03216382|4057499|FG000|COMPLETED|Overall Study||34
3324458|NCT03216382|4057500|FG001|COMPLETED|Overall Study||44
3324459|NCT03216382|4057499|FG000|NOT COMPLETED|Overall Study||7
3324460|NCT03216382|4057500|FG001|NOT COMPLETED|Overall Study||10
3324461|NCT03216512|4057508|FG000|STARTED|Overall Study||17
3324462|NCT03216512|4057509|FG001|STARTED|Overall Study||14
3324463|NCT03216512|4057508|FG000|COMPLETED|Overall Study||17
3324464|NCT03216512|4057509|FG001|COMPLETED|Overall Study||13
3324465|NCT03216512|4057508|FG000|NOT COMPLETED|Overall Study||0
3324466|NCT03216512|4057509|FG001|NOT COMPLETED|Overall Study||1
3324467|NCT03216746|4057521|FG000|STARTED|Overall Study||72
3324468|NCT03216746|4057522|FG001|STARTED|Overall Study||79
3324469|NCT03216746|4057523|FG002|STARTED|Overall Study||68
3324470|NCT03216746|4057524|FG003|STARTED|Overall Study||69
3324471|NCT03216746|4057521|FG000|COMPLETED|Overall Study||66
3324472|NCT03216746|4057522|FG001|COMPLETED|Overall Study||71
3324473|NCT03216746|4057523|FG002|COMPLETED|Overall Study||63
3324474|NCT03216746|4057524|FG003|COMPLETED|Overall Study||63
3324475|NCT03216746|4057521|FG000|NOT COMPLETED|Overall Study||6
3324476|NCT03216746|4057522|FG001|NOT COMPLETED|Overall Study||8
3324477|NCT03216746|4057523|FG002|NOT COMPLETED|Overall Study||5
3324478|NCT03216746|4057524|FG003|NOT COMPLETED|Overall Study||6
3324479|NCT03216850|4057534|FG000|STARTED|Overall Study||15
3324480|NCT03216850|4057534|FG000|COMPLETED|Overall Study|6 patients did not complete the study because of the pre-analytical error.|9
3324481|NCT03216850|4057534|FG000|NOT COMPLETED|Overall Study||6
3324482|NCT03216902|4057544|FG000|STARTED|Overall Study||22
3324483|NCT03216902|4057545|FG001|STARTED|Overall Study||44
3324484|NCT03216902|4057546|FG002|STARTED|Overall Study||43
3324485|NCT03216902|4057547|FG003|STARTED|Overall Study||43
3324486|NCT03216902|4057548|FG004|STARTED|Overall Study||44
3324487|NCT03216902|4057549|FG005|STARTED|Overall Study||45
3324488|NCT03216902|4057544|FG000|COMPLETED|Overall Study||20
3324489|NCT03216902|4057545|FG001|COMPLETED|Overall Study||43
3324490|NCT03216902|4057546|FG002|COMPLETED|Overall Study||42
3324491|NCT03216902|4057547|FG003|COMPLETED|Overall Study||43
3324492|NCT03216902|4057548|FG004|COMPLETED|Overall Study||43
3324493|NCT03216902|4057549|FG005|COMPLETED|Overall Study||42
3324494|NCT03216902|4057544|FG000|NOT COMPLETED|Overall Study||2
3324495|NCT03216902|4057545|FG001|NOT COMPLETED|Overall Study||1
3324496|NCT03216902|4057546|FG002|NOT COMPLETED|Overall Study||1
3324497|NCT03216902|4057547|FG003|NOT COMPLETED|Overall Study||0
3324498|NCT03216902|4057548|FG004|NOT COMPLETED|Overall Study||1
3324499|NCT03216902|4057549|FG005|NOT COMPLETED|Overall Study||3
3324500|NCT03216954|4057571|FG000|STARTED|Overall Study||4
3324501|NCT03216954|4057572|FG001|STARTED|Overall Study||3
3324502|NCT03216954|4057573|FG002|STARTED|Overall Study||3
3324503|NCT03216954|4057574|FG003|STARTED|Overall Study||3
3324504|NCT03216954|4057575|FG004|STARTED|Overall Study||1
3324505|NCT03216954|4057571|FG000|COMPLETED|Overall Study||2
3324506|NCT03216954|4057572|FG001|COMPLETED|Overall Study||2
3324507|NCT03216954|4057573|FG002|COMPLETED|Overall Study||2
3324508|NCT03216954|4057574|FG003|COMPLETED|Overall Study||3
3324509|NCT03216954|4057575|FG004|COMPLETED|Overall Study||0
3324510|NCT03216954|4057571|FG000|NOT COMPLETED|Overall Study||2
3324511|NCT03216954|4057572|FG001|NOT COMPLETED|Overall Study||1
3324512|NCT03216954|4057573|FG002|NOT COMPLETED|Overall Study||1
3324513|NCT03216954|4057574|FG003|NOT COMPLETED|Overall Study||0
3324514|NCT03216954|4057575|FG004|NOT COMPLETED|Overall Study||1
3324515|NCT03217968|4057583|FG000|STARTED|Overall Study||59
3324516|NCT03217968|4057583|FG000|COMPLETED|Overall Study||48
3324517|NCT03217968|4057583|FG000|NOT COMPLETED|Overall Study||11
3324518|NCT03218397|4057589|FG000|STARTED|Overall Study||249
3324519|NCT03218397|4057590|FG001|STARTED|Overall Study||251
3324520|NCT03218397|4057589|FG000|COMPLETED|Overall Study||226
3324521|NCT03218397|4057590|FG001|COMPLETED|Overall Study||222
3324522|NCT03218397|4057589|FG000|NOT COMPLETED|Overall Study||23
3324523|NCT03218397|4057590|FG001|NOT COMPLETED|Overall Study||29
3324524|NCT03218566|4057596|FG000|STARTED|Overall Study||119
3324525|NCT03218566|4057596|FG000|COMPLETED|Overall Study||110
3324526|NCT03218566|4057596|FG000|NOT COMPLETED|Overall Study||9
3324527|NCT03218592|4057603|FG000|STARTED|Phase 1: 1 Dose||12
3324528|NCT03218592|4057604|FG001|STARTED|Phase 1: 1 Dose||12
3324529|NCT03218592|4057605|FG002|STARTED|Phase 1: 1 Dose||12
3324530|NCT03218592|4057603|FG000|COMPLETED|Phase 1: 1 Dose||12
3324531|NCT03218592|4057604|FG001|COMPLETED|Phase 1: 1 Dose||12
3324532|NCT03218592|4057605|FG002|COMPLETED|Phase 1: 1 Dose||12
3324533|NCT03218592|4057603|FG000|NOT COMPLETED|Phase 1: 1 Dose||0
3324534|NCT03218592|4057604|FG001|NOT COMPLETED|Phase 1: 1 Dose||0
3324535|NCT03218592|4057605|FG002|NOT COMPLETED|Phase 1: 1 Dose||0
3324536|NCT03218592|4057603|FG000|STARTED|Phase 2: Daily Doses x 28 Days||12
3324537|NCT03218592|4057604|FG001|STARTED|Phase 2: Daily Doses x 28 Days||12
3324538|NCT03218592|4057605|FG002|STARTED|Phase 2: Daily Doses x 28 Days||12
3324539|NCT03218592|4057603|FG000|COMPLETED|Phase 2: Daily Doses x 28 Days||12
3324540|NCT03218592|4057604|FG001|COMPLETED|Phase 2: Daily Doses x 28 Days||12
3324541|NCT03218592|4057605|FG002|COMPLETED|Phase 2: Daily Doses x 28 Days||12
3324542|NCT03218592|4057603|FG000|NOT COMPLETED|Phase 2: Daily Doses x 28 Days||0
3324543|NCT03218592|4057604|FG001|NOT COMPLETED|Phase 2: Daily Doses x 28 Days||0
3324544|NCT03218592|4057605|FG002|NOT COMPLETED|Phase 2: Daily Doses x 28 Days||0
3324545|NCT03218592|4057603|FG000|STARTED|Phase 3: 0 Doses Per Week||4
3324546|NCT03218592|4057604|FG001|STARTED|Phase 3: 0 Doses Per Week||4
3324547|NCT03218592|4057605|FG002|STARTED|Phase 3: 0 Doses Per Week||4
3324548|NCT03218592|4057603|FG000|4 Patients Per Group|Phase 3: 0 Doses Per Week||4
3176207|NCT01965158|3904007|FG000|NOT COMPLETED|Overall Study||41
3176208|NCT01965158|3904008|FG001|NOT COMPLETED|Overall Study||35
3324549|NCT03218592|4057604|FG001|4 Patients Per Group|Phase 3: 0 Doses Per Week||4
3324550|NCT03218592|4057605|FG002|4 Patients Per Group|Phase 3: 0 Doses Per Week||4
3324551|NCT03218592|4057603|FG000|COMPLETED|Phase 3: 0 Doses Per Week||4
3324552|NCT03218592|4057604|FG001|COMPLETED|Phase 3: 0 Doses Per Week||4
3324553|NCT03218592|4057605|FG002|COMPLETED|Phase 3: 0 Doses Per Week||4
3324554|NCT03218592|4057603|FG000|NOT COMPLETED|Phase 3: 0 Doses Per Week||0
3324555|NCT03218592|4057604|FG001|NOT COMPLETED|Phase 3: 0 Doses Per Week||0
3324556|NCT03218592|4057605|FG002|NOT COMPLETED|Phase 3: 0 Doses Per Week||0
3324557|NCT03218592|4057603|FG000|STARTED|Phase 3: 1 Dose Per Period||4
3324558|NCT03218592|4057604|FG001|STARTED|Phase 3: 1 Dose Per Period||4
3324559|NCT03218592|4057605|FG002|STARTED|Phase 3: 1 Dose Per Period||4
3324560|NCT03218592|4057603|FG000|4 Patients Per Group|Phase 3: 1 Dose Per Period||4
3324561|NCT03218592|4057604|FG001|4 Patients Per Group|Phase 3: 1 Dose Per Period||4
3324562|NCT03218592|4057605|FG002|4 Patients Per Group|Phase 3: 1 Dose Per Period||4
3324563|NCT03218592|4057603|FG000|COMPLETED|Phase 3: 1 Dose Per Period||4
3324564|NCT03218592|4057604|FG001|COMPLETED|Phase 3: 1 Dose Per Period||4
3324565|NCT03218592|4057605|FG002|COMPLETED|Phase 3: 1 Dose Per Period||4
3324566|NCT03218592|4057603|FG000|NOT COMPLETED|Phase 3: 1 Dose Per Period||0
3324567|NCT03218592|4057604|FG001|NOT COMPLETED|Phase 3: 1 Dose Per Period||0
3324568|NCT03218592|4057605|FG002|NOT COMPLETED|Phase 3: 1 Dose Per Period||0
3324569|NCT03218592|4057603|FG000|STARTED|Phase 3: 3 Doses Per Week||4
3324570|NCT03218592|4057604|FG001|STARTED|Phase 3: 3 Doses Per Week||4
3324571|NCT03218592|4057605|FG002|STARTED|Phase 3: 3 Doses Per Week||4
3324572|NCT03218592|4057603|FG000|4 Patients Per Group|Phase 3: 3 Doses Per Week||4
3324573|NCT03218592|4057604|FG001|4 Patients Per Group|Phase 3: 3 Doses Per Week||4
3324574|NCT03218592|4057605|FG002|4 Patients Per Group|Phase 3: 3 Doses Per Week||4
3324575|NCT03218592|4057603|FG000|COMPLETED|Phase 3: 3 Doses Per Week||4
3324576|NCT03218592|4057604|FG001|COMPLETED|Phase 3: 3 Doses Per Week||4
3324577|NCT03218592|4057605|FG002|COMPLETED|Phase 3: 3 Doses Per Week||4
3324578|NCT03218592|4057603|FG000|NOT COMPLETED|Phase 3: 3 Doses Per Week||0
3324579|NCT03218592|4057604|FG001|NOT COMPLETED|Phase 3: 3 Doses Per Week||0
3324580|NCT03218592|4057605|FG002|NOT COMPLETED|Phase 3: 3 Doses Per Week||0
3324581|NCT03218787|4057618|FG000|STARTED|Overall Study||2047
3324582|NCT03218787|4057618|FG000|COMPLETED|Overall Study||1841
3324583|NCT03218787|4057618|FG000|NOT COMPLETED|Overall Study||206
3324584|NCT03219216|4057624|FG000|STARTED|Overall Study||75
3324585|NCT03219216|4057625|FG001|STARTED|Overall Study||25
3324586|NCT03219216|4057624|FG000|COMPLETED|Overall Study||75
3324587|NCT03219216|4057625|FG001|COMPLETED|Overall Study||24
3324588|NCT03219216|4057624|FG000|NOT COMPLETED|Overall Study||0
3324589|NCT03219216|4057625|FG001|NOT COMPLETED|Overall Study||1
3324590|NCT03219294|4057632|FG000|STARTED|Overall Study||58
3324591|NCT03219294|4057633|FG001|STARTED|Overall Study||58
3324592|NCT03219294|4057632|FG000|COMPLETED|Overall Study||58
3324593|NCT03219294|4057633|FG001|COMPLETED|Overall Study||58
3324594|NCT03219294|4057632|FG000|NOT COMPLETED|Overall Study||0
3324595|NCT03219294|4057633|FG001|NOT COMPLETED|Overall Study||0
3324596|NCT03219320|4057643|FG000|STARTED|Overall Study||75
3324597|NCT03219320|4057644|FG001|STARTED|Overall Study||77
3324598|NCT03219320|4057645|FG002|STARTED|Overall Study||77
3324599|NCT03219320|4057646|FG003|STARTED|Overall Study||72
3324600|NCT03219320|4057643|FG000|COMPLETED|Overall Study||73
3324601|NCT03219320|4057644|FG001|COMPLETED|Overall Study||74
3324602|NCT03219320|4057645|FG002|COMPLETED|Overall Study||72
3324603|NCT03219320|4057646|FG003|COMPLETED|Overall Study||69
3324604|NCT03219320|4057643|FG000|NOT COMPLETED|Overall Study||2
3324605|NCT03219320|4057644|FG001|NOT COMPLETED|Overall Study||3
3324606|NCT03219320|4057645|FG002|NOT COMPLETED|Overall Study||5
3176209|NCT01965262|3904014|FG000|STARTED|First Intervention (7 Days)||15
3176210|NCT01965262|3904015|FG001|STARTED|First Intervention (7 Days)||15
3324607|NCT03219320|4057646|FG003|NOT COMPLETED|Overall Study||3
3324608|NCT03219723|4057656|FG000|STARTED|Overall Study||560
3324609|NCT03219723|4057656|FG000|COMPLETED|Overall Study||550
3324610|NCT03219723|4057656|FG000|NOT COMPLETED|Overall Study||10
3324611|NCT03219840|4057660|FG000|STARTED|Overall Study||38
3324612|NCT03219840|4057661|FG001|STARTED|Overall Study||31
3324613|NCT03219840|4057660|FG000|Day 1 Visit for 1st Period|Overall Study||37
3324614|NCT03219840|4057661|FG001|Day 1 Visit for 1st Period|Overall Study||31
3324615|NCT03219840|4057660|FG000|1st Intervention Period of 21 Days|Overall Study||34
3324616|NCT03219840|4057661|FG001|1st Intervention Period of 21 Days|Overall Study||31
3324617|NCT03219840|4057660|FG000|Day 22 Visit for 1st Period|Overall Study||34
3324618|NCT03219840|4057661|FG001|Day 22 Visit for 1st Period|Overall Study||31
3324619|NCT03219840|4057660|FG000|Washout Period of 21 Days|Overall Study||34
3324620|NCT03219840|4057661|FG001|Washout Period of 21 Days|Overall Study||31
3324621|NCT03219840|4057660|FG000|Day 1 Visit for 2nd Period|Overall Study||34
3324622|NCT03219840|4057661|FG001|Day 1 Visit for 2nd Period|Overall Study||31
3324623|NCT03219840|4057660|FG000|2nd Intervention Period of 21 Days|Overall Study||34
3324624|NCT03219840|4057661|FG001|2nd Intervention Period of 21 Days|Overall Study||31
3324625|NCT03219840|4057660|FG000|Day 22 Visit for 2nd Period|Overall Study||34
3324626|NCT03219840|4057661|FG001|Day 22 Visit for 2nd Period|Overall Study||31
3324627|NCT03219840|4057660|FG000|COMPLETED|Overall Study||34
3324628|NCT03219840|4057661|FG001|COMPLETED|Overall Study||31
3324629|NCT03219840|4057660|FG000|NOT COMPLETED|Overall Study||4
3324630|NCT03219840|4057661|FG001|NOT COMPLETED|Overall Study||0
3324631|NCT03219866|4057669|FG000|STARTED|Overall Study||21
3324632|NCT03219866|4057670|FG001|STARTED|Overall Study||19
3324633|NCT03219866|4057669|FG000|COMPLETED|Overall Study||21
3324634|NCT03219866|4057670|FG001|COMPLETED|Overall Study||19
3324635|NCT03219866|4057669|FG000|NOT COMPLETED|Overall Study||0
3324636|NCT03219866|4057670|FG001|NOT COMPLETED|Overall Study||0
3324637|NCT03219892|4057678|FG000|STARTED|Overall Study||20
3324638|NCT03219892|4057679|FG001|STARTED|Overall Study||10
3324639|NCT03219892|4057678|FG000|COMPLETED|Overall Study||20
3324640|NCT03219892|4057679|FG001|COMPLETED|Overall Study||10
3324641|NCT03219892|4057678|FG000|NOT COMPLETED|Overall Study||0
3324642|NCT03219892|4057679|FG001|NOT COMPLETED|Overall Study||0
3324643|NCT03220048|4057688|FG000|STARTED|Overall Study||11
3324644|NCT03220048|4057689|FG001|STARTED|Overall Study||27
3324645|NCT03220048|4057690|FG002|STARTED|Overall Study||28
3324646|NCT03220048|4057688|FG000|COMPLETED|Overall Study||11
3324647|NCT03220048|4057689|FG001|COMPLETED|Overall Study||25
3324648|NCT03220048|4057690|FG002|COMPLETED|Overall Study||27
3324649|NCT03220048|4057688|FG000|NOT COMPLETED|Overall Study||0
3324650|NCT03220048|4057689|FG001|NOT COMPLETED|Overall Study||2
3324651|NCT03220048|4057690|FG002|NOT COMPLETED|Overall Study||1
3324652|NCT03220204|4057706|FG000|STARTED|Overall Study||15
3324653|NCT03220204|4057707|FG001|STARTED|Overall Study||15
3324654|NCT03220204|4057708|FG002|STARTED|Overall Study||15
3324655|NCT03220204|4057706|FG000|COMPLETED|Overall Study||14
3324656|NCT03220204|4057707|FG001|COMPLETED|Overall Study||13
3324657|NCT03220204|4057708|FG002|COMPLETED|Overall Study||12
3324658|NCT03220204|4057706|FG000|NOT COMPLETED|Overall Study||1
3324659|NCT03220204|4057707|FG001|NOT COMPLETED|Overall Study||2
3324660|NCT03220204|4057708|FG002|NOT COMPLETED|Overall Study||3
3324661|NCT03220217|4057722|FG000|STARTED|Overall Study||8
3324662|NCT03220217|4057723|FG001|STARTED|Overall Study||10
3324663|NCT03220217|4057724|FG002|STARTED|Overall Study||11
3324664|NCT03220217|4057722|FG000|COMPLETED|Overall Study||8
3324665|NCT03220217|4057723|FG001|COMPLETED|Overall Study||9
3324666|NCT03220217|4057724|FG002|COMPLETED|Overall Study||10
3324667|NCT03220217|4057722|FG000|NOT COMPLETED|Overall Study||0
3324668|NCT03220217|4057723|FG001|NOT COMPLETED|Overall Study||1
3324669|NCT03220217|4057724|FG002|NOT COMPLETED|Overall Study||1
3324670|NCT03220230|4057753|FG000|STARTED|Overall Study||4240
3324671|NCT03220230|4057753|FG000|COMPLETED|Overall Study||4240
3324672|NCT03220230|4057753|FG000|NOT COMPLETED|Overall Study||0
3324673|NCT03220412|4057759|FG000|STARTED|Overall Study||54
3324674|NCT03220412|4057760|FG001|STARTED|Overall Study||50
3324675|NCT03220412|4057759|FG000|COMPLETED|Overall Study||54
3324676|NCT03220412|4057760|FG001|COMPLETED|Overall Study||50
3324677|NCT03220412|4057759|FG000|NOT COMPLETED|Overall Study||0
3324678|NCT03220412|4057760|FG001|NOT COMPLETED|Overall Study||0
3324679|NCT03220737|4057775|FG000|STARTED|Main Study (Day 1 - 181)||163
3324680|NCT03220737|4057776|FG001|STARTED|Main Study (Day 1 - 181)||26
3324681|NCT03220737|4057777|FG002|STARTED|Main Study (Day 1 - 181)||158
3324682|NCT03220737|4057778|FG003|STARTED|Main Study (Day 1 - 181)||27
3324683|NCT03220737|4057779|FG004|STARTED|Main Study (Day 1 - 181)||150
3324684|NCT03220737|4057780|FG005|STARTED|Main Study (Day 1 - 181)||26
3324685|NCT03220737|4057781|FG006|STARTED|Main Study (Day 1 - 181)||2688
3324686|NCT03220737|4057775|FG000|COMPLETED|Main Study (Day 1 - 181)||157
3324687|NCT03220737|4057776|FG001|COMPLETED|Main Study (Day 1 - 181)||24
3324688|NCT03220737|4057777|FG002|COMPLETED|Main Study (Day 1 - 181)||146
3324689|NCT03220737|4057778|FG003|COMPLETED|Main Study (Day 1 - 181)||24
3324690|NCT03220737|4057779|FG004|COMPLETED|Main Study (Day 1 - 181)||130
3324691|NCT03220737|4057780|FG005|COMPLETED|Main Study (Day 1 - 181)||25
3324692|NCT03220737|4057781|FG006|COMPLETED|Main Study (Day 1 - 181)||2687
3324693|NCT03220737|4057775|FG000|NOT COMPLETED|Main Study (Day 1 - 181)||6
3324694|NCT03220737|4057776|FG001|NOT COMPLETED|Main Study (Day 1 - 181)||2
3324695|NCT03220737|4057777|FG002|NOT COMPLETED|Main Study (Day 1 - 181)||12
3324696|NCT03220737|4057778|FG003|NOT COMPLETED|Main Study (Day 1 - 181)||3
3324697|NCT03220737|4057779|FG004|NOT COMPLETED|Main Study (Day 1 - 181)||20
3324698|NCT03220737|4057780|FG005|NOT COMPLETED|Main Study (Day 1 - 181)||1
3324699|NCT03220737|4057781|FG006|NOT COMPLETED|Main Study (Day 1 - 181)||1
3324700|NCT03220737|4057775|FG000|STARTED|Placebo Crossover (Day 181-365)|Only placebo subjects who opted to receive Vaxchora were included in the crossover group.|13
3324701|NCT03220737|4057776|FG001|STARTED|Placebo Crossover (Day 181-365)|Placebo subjects from Main study opted to cross over to the active group to receive Vaxchora.|0
3324702|NCT03220737|4057777|FG002|STARTED|Placebo Crossover (Day 181-365)|Only placebo subjects who opted to receive Vaxchora were included in the crossover group.|11
3324703|NCT03220737|4057778|FG003|STARTED|Placebo Crossover (Day 181-365)|Placebo subjects from Main study opted to cross over to the active group to receive Vaxchora|0
3324704|NCT03220737|4057779|FG004|STARTED|Placebo Crossover (Day 181-365)|Only placebo subjects who opted to receive Vaxchora were included in the crossover group.|7
3324705|NCT03220737|4057780|FG005|STARTED|Placebo Crossover (Day 181-365)|Placebo subjects from Main study opted to cross over to the active group to receive Vaxchora|0
3324706|NCT03220737|4057781|FG006|STARTED|Placebo Crossover (Day 181-365)||0
3324707|NCT03220737|4057775|FG000|COMPLETED|Placebo Crossover (Day 181-365)||13
3324708|NCT03220737|4057776|FG001|COMPLETED|Placebo Crossover (Day 181-365)||0
3324709|NCT03220737|4057777|FG002|COMPLETED|Placebo Crossover (Day 181-365)||11
3324710|NCT03220737|4057778|FG003|COMPLETED|Placebo Crossover (Day 181-365)||0
3324711|NCT03220737|4057779|FG004|COMPLETED|Placebo Crossover (Day 181-365)||5
3324712|NCT03220737|4057780|FG005|COMPLETED|Placebo Crossover (Day 181-365)||0
3324713|NCT03220737|4057781|FG006|COMPLETED|Placebo Crossover (Day 181-365)||0
3324714|NCT03220737|4057775|FG000|NOT COMPLETED|Placebo Crossover (Day 181-365)||0
3324715|NCT03220737|4057776|FG001|NOT COMPLETED|Placebo Crossover (Day 181-365)||0
3324716|NCT03220737|4057777|FG002|NOT COMPLETED|Placebo Crossover (Day 181-365)||0
3324717|NCT03220737|4057778|FG003|NOT COMPLETED|Placebo Crossover (Day 181-365)||0
3324718|NCT03220737|4057779|FG004|NOT COMPLETED|Placebo Crossover (Day 181-365)||2
3324719|NCT03220737|4057780|FG005|NOT COMPLETED|Placebo Crossover (Day 181-365)||0
3324720|NCT03220737|4057781|FG006|NOT COMPLETED|Placebo Crossover (Day 181-365)||0
3324721|NCT03220737|4057775|FG000|STARTED|Long-term Follow-up (Day 365-730)|Cohort 1 subjects from the main study had to opt to be included in the Long-term follow-up study.|73
3324722|NCT03220737|4057776|FG001|STARTED|Long-term Follow-up (Day 365-730)||0
3324723|NCT03220737|4057777|FG002|STARTED|Long-term Follow-up (Day 365-730)|Cohort 2 subjects were not eligible for the Long-term follow-up study.|0
3324724|NCT03220737|4057778|FG003|STARTED|Long-term Follow-up (Day 365-730)||0
3324725|NCT03220737|4057779|FG004|STARTED|Long-term Follow-up (Day 365-730)|Cohort 3 subjects were not eligible for the Long-term follow-up study.|0
3324726|NCT03220737|4057780|FG005|STARTED|Long-term Follow-up (Day 365-730)||0
3324727|NCT03220737|4057781|FG006|STARTED|Long-term Follow-up (Day 365-730)||0
3324728|NCT03220737|4057775|FG000|COMPLETED|Long-term Follow-up (Day 365-730)||62
3324729|NCT03220737|4057776|FG001|COMPLETED|Long-term Follow-up (Day 365-730)||0
3324730|NCT03220737|4057777|FG002|COMPLETED|Long-term Follow-up (Day 365-730)||0
3324731|NCT03220737|4057778|FG003|COMPLETED|Long-term Follow-up (Day 365-730)||0
3324732|NCT03220737|4057779|FG004|COMPLETED|Long-term Follow-up (Day 365-730)||0
3324733|NCT03220737|4057780|FG005|COMPLETED|Long-term Follow-up (Day 365-730)||0
3324734|NCT03220737|4057781|FG006|COMPLETED|Long-term Follow-up (Day 365-730)||0
3324735|NCT03220737|4057775|FG000|NOT COMPLETED|Long-term Follow-up (Day 365-730)||11
3324736|NCT03220737|4057776|FG001|NOT COMPLETED|Long-term Follow-up (Day 365-730)||0
3324737|NCT03220737|4057777|FG002|NOT COMPLETED|Long-term Follow-up (Day 365-730)||0
3324738|NCT03220737|4057778|FG003|NOT COMPLETED|Long-term Follow-up (Day 365-730)||0
3324739|NCT03220737|4057779|FG004|NOT COMPLETED|Long-term Follow-up (Day 365-730)||0
3324740|NCT03220737|4057780|FG005|NOT COMPLETED|Long-term Follow-up (Day 365-730)||0
3324741|NCT03220737|4057781|FG006|NOT COMPLETED|Long-term Follow-up (Day 365-730)||0
3324742|NCT03220958|4057805|FG000|STARTED|Overall Study||81
3324743|NCT03220958|4057806|FG001|STARTED|Overall Study||79
3324744|NCT03220958|4057805|FG000|COMPLETED|Overall Study||81
3324745|NCT03220958|4057806|FG001|COMPLETED|Overall Study||79
3324746|NCT03220958|4057805|FG000|NOT COMPLETED|Overall Study||0
3324747|NCT03220958|4057806|FG001|NOT COMPLETED|Overall Study||0
3324748|NCT03221192|4057812|FG000|STARTED|Overall Study||27
3324749|NCT03221192|4057812|FG000|COMPLETED|Overall Study||27
3324750|NCT03221192|4057812|FG000|NOT COMPLETED|Overall Study||0
3324751|NCT03221387|4057816|FG000|STARTED|Overall Study||30
3324752|NCT03221387|4057816|FG000|COMPLETED|Overall Study||28
3324753|NCT03221387|4057816|FG000|NOT COMPLETED|Overall Study||2
3324754|NCT03221595|4057822|FG000|STARTED|Overall Study||51
3324755|NCT03221595|4057823|FG001|STARTED|Overall Study||59
3324756|NCT03221595|4057822|FG000|COMPLETED|Overall Study||51
3324757|NCT03221595|4057823|FG001|COMPLETED|Overall Study||59
3324758|NCT03221595|4057822|FG000|NOT COMPLETED|Overall Study||0
3324759|NCT03221595|4057823|FG001|NOT COMPLETED|Overall Study||0
3324760|NCT03221660|4057829|FG000|STARTED|Overall Study||50
3324761|NCT03221660|4057829|FG000|COMPLETED|Overall Study||50
3324762|NCT03221660|4057829|FG000|NOT COMPLETED|Overall Study||0
3324763|NCT03221738|4057833|FG000|STARTED|Overall Study||10
3324764|NCT03221738|4057833|FG000|COMPLETED|Overall Study||10
3324765|NCT03221738|4057833|FG000|NOT COMPLETED|Overall Study||0
3324766|NCT03221764|4057837|FG000|STARTED|Overall Study||20
3324767|NCT03221764|4057837|FG000|COMPLETED|Overall Study||20
3324768|NCT03221764|4057837|FG000|NOT COMPLETED|Overall Study||0
3324769|NCT03222037|4057841|FG000|STARTED|Period 1||21
3324770|NCT03222037|4057842|FG001|STARTED|Period 1||22
3324771|NCT03222037|4057841|FG000|COMPLETED|Period 1||21
3324772|NCT03222037|4057842|FG001|COMPLETED|Period 1||22
3324773|NCT03222037|4057841|FG000|NOT COMPLETED|Period 1||0
3324774|NCT03222037|4057842|FG001|NOT COMPLETED|Period 1||0
3324775|NCT03222037|4057841|FG000|STARTED|Period 2||21
3324776|NCT03222037|4057842|FG001|STARTED|Period 2||22
3324777|NCT03222037|4057841|FG000|COMPLETED|Period 2||21
3324778|NCT03222037|4057842|FG001|COMPLETED|Period 2||22
3324779|NCT03222037|4057841|FG000|NOT COMPLETED|Period 2||0
3324780|NCT03222037|4057842|FG001|NOT COMPLETED|Period 2||0
3324781|NCT03222141|4057848|FG000|STARTED|Overall Study||583
3324782|NCT03222141|4057848|FG000|COMPLETED|Overall Study||565
3324783|NCT03222141|4057848|FG000|NOT COMPLETED|Overall Study||18
3324784|NCT03222349|4057853|FG000|STARTED|Overall Study||11
3324785|NCT03222349|4057854|FG001|STARTED|Overall Study||13
3324786|NCT03222349|4057853|FG000|COMPLETED|Overall Study||3
3324787|NCT03222349|4057854|FG001|COMPLETED|Overall Study||6
3324788|NCT03222349|4057853|FG000|NOT COMPLETED|Overall Study||8
3324789|NCT03222349|4057854|FG001|NOT COMPLETED|Overall Study||7
3324790|NCT03222414|4057869|FG000|STARTED|Overall Study||0
3324791|NCT03222414|4057870|FG001|STARTED|Overall Study||1
3324792|NCT03222414|4057869|FG000|COMPLETED|Overall Study||0
3324793|NCT03222414|4057870|FG001|COMPLETED|Overall Study||1
3324794|NCT03222414|4057869|FG000|NOT COMPLETED|Overall Study||0
3324795|NCT03222414|4057870|FG001|NOT COMPLETED|Overall Study||0
3324796|NCT03222427|4057876|FG000|STARTED|Overall Study||8
3324797|NCT03222427|4057876|FG000|Received One Dose of Study Drug|Overall Study||8
3324798|NCT03222427|4057876|FG000|COMPLETED|Overall Study||8
3324799|NCT03222427|4057876|FG000|NOT COMPLETED|Overall Study||0
3324800|NCT03222505|4057883|FG000|STARTED|Overall Study||5
3324801|NCT03222505|4057884|FG001|STARTED|Overall Study||7
3324802|NCT03222505|4057883|FG000|COMPLETED|Overall Study||5
3176211|NCT01965262|3904014|FG000|COMPLETED|First Intervention (7 Days)||15
3176212|NCT01965262|3904015|FG001|COMPLETED|First Intervention (7 Days)||15
3324803|NCT03222505|4057884|FG001|COMPLETED|Overall Study||7
3324804|NCT03222505|4057883|FG000|NOT COMPLETED|Overall Study||0
3324805|NCT03222505|4057884|FG001|NOT COMPLETED|Overall Study||0
3324806|NCT03222583|4057893|FG000|STARTED|Overall Study||363
3324807|NCT03222583|4057894|FG001|STARTED|Overall Study||183
3324808|NCT03222583|4057893|FG000|Received Double-blind Treatment|Overall Study||362
3324809|NCT03222583|4057894|FG001|Received Double-blind Treatment|Overall Study||183
3324810|NCT03222583|4057893|FG000|Completed Double-blind Period|Overall Study||360
3324811|NCT03222583|4057894|FG001|Completed Double-blind Period|Overall Study||183
3324812|NCT03222583|4057893|FG000|Entered Open-label Period|Overall Study||0
3324813|NCT03222583|4057894|FG001|Entered Open-label Period|Overall Study||182
3324814|NCT03222583|4057893|FG000|Completed Open-label Period|Overall Study||0
3324815|NCT03222583|4057894|FG001|Completed Open-label Period|Overall Study||181
3324816|NCT03222583|4057893|FG000|COMPLETED|Overall Study||358
3324817|NCT03222583|4057894|FG001|COMPLETED|Overall Study||177
3324818|NCT03222583|4057893|FG000|NOT COMPLETED|Overall Study||5
3324819|NCT03222583|4057894|FG001|NOT COMPLETED|Overall Study||6
3324820|NCT03223246|4057902|FG000|STARTED|48-72 Hours||83
3324821|NCT03223246|4057903|FG001|STARTED|48-72 Hours||66
3324822|NCT03223246|4057902|FG000|COMPLETED|48-72 Hours||62
3324823|NCT03223246|4057903|FG001|COMPLETED|48-72 Hours||35
3324824|NCT03223246|4057902|FG000|NOT COMPLETED|48-72 Hours||21
3324825|NCT03223246|4057903|FG001|NOT COMPLETED|48-72 Hours||31
3324826|NCT03223246|4057902|FG000|STARTED|5-7 Days||83
3324827|NCT03223246|4057903|FG001|STARTED|5-7 Days||66
3324828|NCT03223246|4057902|FG000|COMPLETED|5-7 Days||41
3324829|NCT03223246|4057903|FG001|COMPLETED|5-7 Days||35
3324830|NCT03223246|4057902|FG000|NOT COMPLETED|5-7 Days||42
3324831|NCT03223246|4057903|FG001|NOT COMPLETED|5-7 Days||31
3324832|NCT03223272|4057909|FG000|STARTED|Overall Study||7
3324833|NCT03223272|4057909|FG000|COMPLETED|Overall Study||6
3324834|NCT03223272|4057909|FG000|NOT COMPLETED|Overall Study||1
3324835|NCT03223337|4057917|FG000|STARTED|Part 1 (Up to 16 Days)||8
3324836|NCT03223337|4057918|FG001|STARTED|Part 1 (Up to 16 Days)||8
3324837|NCT03223337|4057919|FG002|STARTED|Part 1 (Up to 16 Days)||0
3324838|NCT03223337|4057920|FG003|STARTED|Part 1 (Up to 16 Days)||0
3324839|NCT03223337|4057917|FG000|COMPLETED|Part 1 (Up to 16 Days)||8
3324840|NCT03223337|4057918|FG001|COMPLETED|Part 1 (Up to 16 Days)||8
3324841|NCT03223337|4057919|FG002|COMPLETED|Part 1 (Up to 16 Days)||0
3324842|NCT03223337|4057920|FG003|COMPLETED|Part 1 (Up to 16 Days)||0
3324843|NCT03223337|4057917|FG000|NOT COMPLETED|Part 1 (Up to 16 Days)||0
3324844|NCT03223337|4057918|FG001|NOT COMPLETED|Part 1 (Up to 16 Days)||0
3324845|NCT03223337|4057919|FG002|NOT COMPLETED|Part 1 (Up to 16 Days)||0
3324846|NCT03223337|4057920|FG003|NOT COMPLETED|Part 1 (Up to 16 Days)||0
3324847|NCT03223337|4057917|FG000|STARTED|Part 2 (Up to 16 Days)||0
3324848|NCT03223337|4057918|FG001|STARTED|Part 2 (Up to 16 Days)||0
3324849|NCT03223337|4057919|FG002|STARTED|Part 2 (Up to 16 Days)||12
3324850|NCT03223337|4057920|FG003|STARTED|Part 2 (Up to 16 Days)||9
3324851|NCT03223337|4057917|FG000|COMPLETED|Part 2 (Up to 16 Days)||0
3324852|NCT03223337|4057918|FG001|COMPLETED|Part 2 (Up to 16 Days)||0
3324853|NCT03223337|4057919|FG002|COMPLETED|Part 2 (Up to 16 Days)||12
3324854|NCT03223337|4057920|FG003|COMPLETED|Part 2 (Up to 16 Days)||9
3324855|NCT03223337|4057917|FG000|NOT COMPLETED|Part 2 (Up to 16 Days)||0
3324856|NCT03223337|4057918|FG001|NOT COMPLETED|Part 2 (Up to 16 Days)||0
3324857|NCT03223337|4057919|FG002|NOT COMPLETED|Part 2 (Up to 16 Days)||0
3324858|NCT03223337|4057920|FG003|NOT COMPLETED|Part 2 (Up to 16 Days)||0
3324859|NCT03223649|4057932|FG000|STARTED|Overall Study||52
3324860|NCT03223649|4057933|FG001|STARTED|Overall Study||57
3324861|NCT03223649|4057932|FG000|COMPLETED|Overall Study||42
3324862|NCT03223649|4057933|FG001|COMPLETED|Overall Study||51
3324863|NCT03223649|4057932|FG000|NOT COMPLETED|Overall Study||10
3324864|NCT03223649|4057933|FG001|NOT COMPLETED|Overall Study||6
3324865|NCT03223909|4057942|FG000|STARTED|Overall Study||120
3324866|NCT03223909|4057943|FG001|STARTED|Overall Study||109
3324867|NCT03223909|4057944|FG002|STARTED|Overall Study||97
3324868|NCT03223909|4057942|FG000|COMPLETED|Overall Study||72
3324869|NCT03223909|4057943|FG001|COMPLETED|Overall Study||64
3324870|NCT03223909|4057944|FG002|COMPLETED|Overall Study||81
3324871|NCT03223909|4057942|FG000|NOT COMPLETED|Overall Study||48
3324872|NCT03223909|4057943|FG001|NOT COMPLETED|Overall Study||45
3324873|NCT03223909|4057944|FG002|NOT COMPLETED|Overall Study||16
3324874|NCT03224130|4057954|FG000|STARTED|Overall Study||483
3324875|NCT03224130|4057955|FG001|STARTED|Overall Study||483
3324876|NCT03224130|4057954|FG000|COMPLETED|Overall Study||483
3324877|NCT03224130|4057955|FG001|COMPLETED|Overall Study||482
3324878|NCT03224130|4057954|FG000|NOT COMPLETED|Overall Study||0
3324879|NCT03224130|4057955|FG001|NOT COMPLETED|Overall Study||1
3324880|NCT03224182|4057963|FG000|STARTED|Overall Study||81
3324881|NCT03224182|4057964|FG001|STARTED|Overall Study||37
3324882|NCT03224182|4057963|FG000|Safety Population|Overall Study||73
3324883|NCT03224182|4057964|FG001|Safety Population|Overall Study||36
3324884|NCT03224182|4057963|FG000|COMPLETED|Overall Study||0
3324885|NCT03224182|4057964|FG001|COMPLETED|Overall Study||1
3324886|NCT03224182|4057963|FG000|NOT COMPLETED|Overall Study||81
3324887|NCT03224182|4057964|FG001|NOT COMPLETED|Overall Study||36
3324888|NCT03224234|4057974|FG000|STARTED|Main Study||40
3324889|NCT03224234|4057975|FG001|STARTED|Main Study||40
3324890|NCT03224234|4057974|FG000|COMPLETED|Main Study||35
3324891|NCT03224234|4057975|FG001|COMPLETED|Main Study||35
3324892|NCT03224234|4057974|FG000|NOT COMPLETED|Main Study||5
3324893|NCT03224234|4057975|FG001|NOT COMPLETED|Main Study||5
3324894|NCT03224234|4057974|FG000|STARTED|Pilot||11
3324895|NCT03224234|4057975|FG001|STARTED|Pilot||7
3324896|NCT03224234|4057974|FG000|COMPLETED|Pilot||11
3324897|NCT03224234|4057975|FG001|COMPLETED|Pilot||7
3324898|NCT03224234|4057974|FG000|NOT COMPLETED|Pilot||0
3324899|NCT03224234|4057975|FG001|NOT COMPLETED|Pilot||0
3324900|NCT03224299|4057987|FG000|STARTED|Overall Study||131
3324901|NCT03224299|4057988|FG001|STARTED|Overall Study||424
3324902|NCT03224299|4057987|FG000|Treated With IP#1|Overall Study||65
3324903|NCT03224299|4057988|FG001|Treated With IP#1|Overall Study||101
3324904|NCT03224299|4057987|FG000|Treated With IP#2|Overall Study||66
3176213|NCT01965262|3904014|FG000|NOT COMPLETED|First Intervention (7 Days)||0
3176214|NCT01965262|3904015|FG001|NOT COMPLETED|First Intervention (7 Days)||0
3176215|NCT01965262|3904014|FG000|STARTED|Second Intervention (7 Days)||15
3176216|NCT01965262|3904015|FG001|STARTED|Second Intervention (7 Days)||15
3176217|NCT01965262|3904014|FG000|COMPLETED|Second Intervention (7 Days)||14
3176218|NCT01965262|3904015|FG001|COMPLETED|Second Intervention (7 Days)||5
3176219|NCT01965262|3904014|FG000|NOT COMPLETED|Second Intervention (7 Days)||1
3176220|NCT01965262|3904015|FG001|NOT COMPLETED|Second Intervention (7 Days)||10
3176221|NCT01965288|3904023|FG000|STARTED|Overall Study||30
3176222|NCT01965288|3904024|FG001|STARTED|Overall Study||30
3176223|NCT01965288|3904023|FG000|COMPLETED|Overall Study||30
3176224|NCT01965288|3904024|FG001|COMPLETED|Overall Study||30
3324905|NCT03224299|4057988|FG001|Treated With IP#2|Overall Study||107
3324906|NCT03224299|4057987|FG000|Treated With AC|Overall Study||66
3324907|NCT03224299|4057988|FG001|Treated With AC|Overall Study||110
3324908|NCT03224299|4057987|FG000|Treated With NC|Overall Study||65
3324909|NCT03224299|4057988|FG001|Treated With NC|Overall Study||106
3324910|NCT03224299|4057987|FG000|COMPLETED|Overall Study||131
3324911|NCT03224299|4057988|FG001|COMPLETED|Overall Study||424
3324912|NCT03224299|4057987|FG000|NOT COMPLETED|Overall Study||0
3324913|NCT03224299|4057988|FG001|NOT COMPLETED|Overall Study||0
3324914|NCT03224325|4058009|FG000|STARTED|Overall Study||13
3324915|NCT03224325|4058010|FG001|STARTED|Overall Study||6
3324916|NCT03224325|4058011|FG002|STARTED|Overall Study||6
3324917|NCT03224325|4058012|FG003|STARTED|Overall Study||6
3324918|NCT03224325|4058013|FG004|STARTED|Overall Study||6
3176225|NCT01965288|3904023|FG000|NOT COMPLETED|Overall Study||0
3176226|NCT01965288|3904024|FG001|NOT COMPLETED|Overall Study||0
3176227|NCT01965327|3904042|FG000|STARTED|Overall Study||12
3324919|NCT03224325|4058014|FG005|STARTED|Overall Study||6
3324920|NCT03224325|4058015|FG006|STARTED|Overall Study||7
3324921|NCT03224325|4058009|FG000|COMPLETED|Overall Study||12
3324922|NCT03224325|4058010|FG001|COMPLETED|Overall Study||6
3324923|NCT03224325|4058011|FG002|COMPLETED|Overall Study||6
3324924|NCT03224325|4058012|FG003|COMPLETED|Overall Study||5
3324925|NCT03224325|4058013|FG004|COMPLETED|Overall Study||6
3324926|NCT03224325|4058014|FG005|COMPLETED|Overall Study||6
3324927|NCT03224325|4058015|FG006|COMPLETED|Overall Study||6
3324928|NCT03224325|4058009|FG000|NOT COMPLETED|Overall Study||1
3324929|NCT03224325|4058010|FG001|NOT COMPLETED|Overall Study||0
3324930|NCT03224325|4058011|FG002|NOT COMPLETED|Overall Study||0
3324931|NCT03224325|4058012|FG003|NOT COMPLETED|Overall Study||1
3324932|NCT03224325|4058013|FG004|NOT COMPLETED|Overall Study||0
3324933|NCT03224325|4058014|FG005|NOT COMPLETED|Overall Study||0
3324934|NCT03224325|4058015|FG006|NOT COMPLETED|Overall Study||1
3324935|NCT03224351|4058045|FG000|STARTED|Overall Study||10
3324936|NCT03224351|4058046|FG001|STARTED|Overall Study||11
3324937|NCT03224351|4058047|FG002|STARTED|Overall Study||20
3324938|NCT03224351|4058048|FG003|STARTED|Overall Study||22
3324939|NCT03224351|4058049|FG004|STARTED|Overall Study||11
3324940|NCT03224351|4058050|FG005|STARTED|Overall Study||18
3324941|NCT03224351|4058051|FG006|STARTED|Overall Study||6
3324942|NCT03224351|4058052|FG007|STARTED|Overall Study||19
3324943|NCT03224351|4058045|FG000|COMPLETED|Overall Study||10
3324944|NCT03224351|4058046|FG001|COMPLETED|Overall Study||11
3324945|NCT03224351|4058047|FG002|COMPLETED|Overall Study||20
3324946|NCT03224351|4058048|FG003|COMPLETED|Overall Study||22
3324947|NCT03224351|4058049|FG004|COMPLETED|Overall Study||11
3324948|NCT03224351|4058050|FG005|COMPLETED|Overall Study||18
3324949|NCT03224351|4058051|FG006|COMPLETED|Overall Study||6
3324950|NCT03224351|4058052|FG007|COMPLETED|Overall Study||19
3324951|NCT03224351|4058045|FG000|NOT COMPLETED|Overall Study||0
3324952|NCT03224351|4058046|FG001|NOT COMPLETED|Overall Study||0
3324953|NCT03224351|4058047|FG002|NOT COMPLETED|Overall Study||0
3324954|NCT03224351|4058048|FG003|NOT COMPLETED|Overall Study||0
3324955|NCT03224351|4058049|FG004|NOT COMPLETED|Overall Study||0
3324956|NCT03224351|4058050|FG005|NOT COMPLETED|Overall Study||0
3324957|NCT03224351|4058051|FG006|NOT COMPLETED|Overall Study||0
3324958|NCT03224351|4058052|FG007|NOT COMPLETED|Overall Study||0
3324959|NCT03224390|4058080|FG000|STARTED|Overall Study||56
3324960|NCT03224390|4058081|FG001|STARTED|Overall Study||56
3324961|NCT03224390|4058080|FG000|COMPLETED|Overall Study||29
3324962|NCT03224390|4058081|FG001|COMPLETED|Overall Study||21
3324963|NCT03224390|4058080|FG000|NOT COMPLETED|Overall Study||27
3324964|NCT03224390|4058081|FG001|NOT COMPLETED|Overall Study||35
3324965|NCT03224403|4058093|FG000|STARTED|Overall Study||59
3324966|NCT03224403|4058094|FG001|STARTED|Overall Study||249
3324967|NCT03224403|4058095|FG002|STARTED|Overall Study||232
3324968|NCT03224403|4058096|FG003|STARTED|Overall Study||124
3324969|NCT03224403|4058093|FG000|COMPLETED|Overall Study||59
3324970|NCT03224403|4058094|FG001|COMPLETED|Overall Study||249
3324971|NCT03224403|4058095|FG002|COMPLETED|Overall Study||232
3324972|NCT03224403|4058096|FG003|COMPLETED|Overall Study||124
3324973|NCT03224403|4058093|FG000|NOT COMPLETED|Overall Study||0
3324974|NCT03224403|4058094|FG001|NOT COMPLETED|Overall Study||0
3324975|NCT03224403|4058095|FG002|NOT COMPLETED|Overall Study||0
3324976|NCT03224403|4058096|FG003|NOT COMPLETED|Overall Study||0
3324977|NCT03224520|4058110|FG000|STARTED|Overall Study||371
3324978|NCT03224520|4058111|FG001|STARTED|Overall Study||370
3324979|NCT03224520|4058112|FG002|STARTED|Overall Study||374
3324980|NCT03224520|4058113|FG003|STARTED|Overall Study||372
3324981|NCT03224520|4058110|FG000|COMPLETED|Overall Study||205
3324982|NCT03224520|4058111|FG001|COMPLETED|Overall Study||207
3324983|NCT03224520|4058112|FG002|COMPLETED|Overall Study||190
3324984|NCT03224520|4058113|FG003|COMPLETED|Overall Study||199
3324985|NCT03224520|4058110|FG000|NOT COMPLETED|Overall Study||166
3324986|NCT03224520|4058111|FG001|NOT COMPLETED|Overall Study||163
3324987|NCT03224520|4058112|FG002|NOT COMPLETED|Overall Study||184
3324988|NCT03224520|4058113|FG003|NOT COMPLETED|Overall Study||173
3324989|NCT03224585|4058125|FG000|STARTED|Overall Study||2
3324990|NCT03224585|4058126|FG001|STARTED|Overall Study||3
3324991|NCT03224585|4058125|FG000|COMPLETED|Overall Study||2
3324992|NCT03224585|4058126|FG001|COMPLETED|Overall Study||3
3324993|NCT03224585|4058125|FG000|NOT COMPLETED|Overall Study||0
3324994|NCT03224585|4058126|FG001|NOT COMPLETED|Overall Study||0
3176228|NCT01965327|3904042|FG000|COMPLETED|Overall Study|Prior to completion, 2 subjects were withdrawn by the PI for failure to adhere to study protocol.|10
3176229|NCT01965327|3904042|FG000|NOT COMPLETED|Overall Study||2
3176230|NCT01965366|3904048|FG000|STARTED|Overall Study||13
3176231|NCT01965366|3904049|FG001|STARTED|Overall Study||14
3176232|NCT01965366|3904048|FG000|COMPLETED|Overall Study||3
3176233|NCT01965366|3904049|FG001|COMPLETED|Overall Study||9
3176234|NCT01965366|3904048|FG000|NOT COMPLETED|Overall Study||10
3176235|NCT01965366|3904049|FG001|NOT COMPLETED|Overall Study||5
3176236|NCT01965431|3904055|FG000|STARTED|Overall Study|Started are actually Treated subjects|8
3176237|NCT01965431|3904056|FG001|STARTED|Overall Study||8
3324995|NCT03224598|4058134|FG000|STARTED|Overall Study||9
3324996|NCT03224598|4058135|FG001|STARTED|Overall Study||17
3324997|NCT03224598|4058136|FG002|STARTED|Overall Study||13
3324998|NCT03224598|4058134|FG000|COMPLETED|Overall Study||9
3324999|NCT03224598|4058135|FG001|COMPLETED|Overall Study||14
3325000|NCT03224598|4058136|FG002|COMPLETED|Overall Study||13
3325001|NCT03224598|4058134|FG000|NOT COMPLETED|Overall Study||0
3325002|NCT03224598|4058135|FG001|NOT COMPLETED|Overall Study||3
3325003|NCT03224598|4058136|FG002|NOT COMPLETED|Overall Study||0
3325004|NCT03225001|4058144|FG000|STARTED|Overall Study||197
3325005|NCT03225001|4058144|FG000|Valve-Implanted|Overall Study||195
3325006|NCT03225001|4058144|FG000|COMPLETED|Overall Study||188
3325007|NCT03225001|4058144|FG000|NOT COMPLETED|Overall Study||9
3325008|NCT03225313|4058151|FG000|STARTED|Overall Study|25 Patients|25
3325009|NCT03225313|4058152|FG001|STARTED|Overall Study|25 Patients|25
3325010|NCT03225313|4058153|FG002|STARTED|Overall Study|25 Patients|25
3325011|NCT03225313|4058151|FG000|COMPLETED|Overall Study|25 Patients|25
3325012|NCT03225313|4058152|FG001|COMPLETED|Overall Study|25 Patients|25
3325013|NCT03225313|4058153|FG002|COMPLETED|Overall Study|25 Patients|25
3325014|NCT03225313|4058151|FG000|NOT COMPLETED|Overall Study||0
3325015|NCT03225313|4058152|FG001|NOT COMPLETED|Overall Study||0
3325016|NCT03225313|4058153|FG002|NOT COMPLETED|Overall Study||0
3325017|NCT03225573|4058163|FG000|STARTED|Overall Study||60
3325018|NCT03225573|4058163|FG000|COMPLETED|Overall Study||60
3325019|NCT03225573|4058163|FG000|NOT COMPLETED|Overall Study||0
3325020|NCT03225599|4058167|FG000|STARTED|Overall Study||9
3325021|NCT03225599|4058167|FG000|COMPLETED|Overall Study||7
3325022|NCT03225599|4058167|FG000|NOT COMPLETED|Overall Study||2
3325023|NCT03225859|4058171|FG000|STARTED|Overall Study||12
3325024|NCT03225859|4058171|FG000|COMPLETED|Overall Study||11
3325025|NCT03225859|4058171|FG000|NOT COMPLETED|Overall Study||1
3325026|NCT03226223|4058177|FG000|STARTED|Overall Study||10
3325027|NCT03226223|4058178|FG001|STARTED|Overall Study||8
3325028|NCT03226223|4058177|FG000|COMPLETED|Overall Study||8
3325029|NCT03226223|4058178|FG001|COMPLETED|Overall Study||6
3325030|NCT03226223|4058177|FG000|NOT COMPLETED|Overall Study||2
3325031|NCT03226223|4058178|FG001|NOT COMPLETED|Overall Study||2
3325032|NCT03226249|4058184|FG000|STARTED|PEM Induction Cycles 1-3, and PET#2||30
3325033|NCT03226249|4058184|FG000|PEM Cycle 1|PEM Induction Cycles 1-3, and PET#2||30
3325034|NCT03226249|4058184|FG000|PEM Cycle 2|PEM Induction Cycles 1-3, and PET#2||30
3325035|NCT03226249|4058184|FG000|PEM Cycle 3|PEM Induction Cycles 1-3, and PET#2||30
3325036|NCT03226249|4058184|FG000|PET#2|PEM Induction Cycles 1-3, and PET#2||30
3325037|NCT03226249|4058184|FG000|COMPLETED|PEM Induction Cycles 1-3, and PET#2||30
3325038|NCT03226249|4058184|FG000|NOT COMPLETED|PEM Induction Cycles 1-3, and PET#2||0
3325039|NCT03226249|4058184|FG000|STARTED|2 Cycles of AVD + PET#3||30
3325040|NCT03226249|4058184|FG000|AVD Cycle 1|2 Cycles of AVD + PET#3||30
3325041|NCT03226249|4058184|FG000|AVD Cycle 2|2 Cycles of AVD + PET#3||30
3325042|NCT03226249|4058184|FG000|PET#3|2 Cycles of AVD + PET#3||30
3325043|NCT03226249|4058184|FG000|COMPLETED|2 Cycles of AVD + PET#3||30
3325044|NCT03226249|4058184|FG000|NOT COMPLETED|2 Cycles of AVD + PET#3||0
3325045|NCT03226249|4058184|FG000|STARTED|2-4 Cycles of AVD +/- Chemo & RT, PET#4||30
3325046|NCT03226249|4058184|FG000|2-4 Cycles of AVD +/- Chemo & RT|2-4 Cycles of AVD +/- Chemo & RT, PET#4||29
3325047|NCT03226249|4058184|FG000|PET#4|2-4 Cycles of AVD +/- Chemo & RT, PET#4||29
3325048|NCT03226249|4058184|FG000|COMPLETED|2-4 Cycles of AVD +/- Chemo & RT, PET#4||29
3325049|NCT03226249|4058184|FG000|NOT COMPLETED|2-4 Cycles of AVD +/- Chemo & RT, PET#4||1
3325050|NCT03226249|4058184|FG000|STARTED|PEM Consolidation (1-2 Years)||29
3325051|NCT03226249|4058184|FG000|COMPLETED|PEM Consolidation (1-2 Years)||0
3325052|NCT03226249|4058184|FG000|NOT COMPLETED|PEM Consolidation (1-2 Years)||29
3325053|NCT03226249|4058184|FG000|STARTED|Survival Follow-up|All patients that are treated with one dose of study drug go into follow-up.|30
3325054|NCT03226249|4058184|FG000|COMPLETED|Survival Follow-up||0
3325055|NCT03226249|4058184|FG000|NOT COMPLETED|Survival Follow-up||30
3325056|NCT03226275|4058192|FG000|STARTED|Treatment Period 1 (8 Days)||8
3325057|NCT03226275|4058193|FG001|STARTED|Treatment Period 1 (8 Days)||8
3325058|NCT03226275|4058194|FG002|STARTED|Treatment Period 1 (8 Days)||8
3325059|NCT03226275|4058195|FG003|STARTED|Treatment Period 1 (8 Days)||8
3325060|NCT03226275|4058192|FG000|COMPLETED|Treatment Period 1 (8 Days)||8
3325061|NCT03226275|4058193|FG001|COMPLETED|Treatment Period 1 (8 Days)||8
3325062|NCT03226275|4058194|FG002|COMPLETED|Treatment Period 1 (8 Days)||7
3325063|NCT03226275|4058195|FG003|COMPLETED|Treatment Period 1 (8 Days)||7
3325064|NCT03226275|4058192|FG000|NOT COMPLETED|Treatment Period 1 (8 Days)||0
3325065|NCT03226275|4058193|FG001|NOT COMPLETED|Treatment Period 1 (8 Days)||0
3325066|NCT03226275|4058194|FG002|NOT COMPLETED|Treatment Period 1 (8 Days)||1
3325067|NCT03226275|4058195|FG003|NOT COMPLETED|Treatment Period 1 (8 Days)||1
3325068|NCT03226275|4058192|FG000|STARTED|Treatment Period 2 (8 Days)||8
3325069|NCT03226275|4058193|FG001|STARTED|Treatment Period 2 (8 Days)||8
3325070|NCT03226275|4058194|FG002|STARTED|Treatment Period 2 (8 Days)||7
3325071|NCT03226275|4058195|FG003|STARTED|Treatment Period 2 (8 Days)||7
3325072|NCT03226275|4058192|FG000|COMPLETED|Treatment Period 2 (8 Days)||8
3325073|NCT03226275|4058193|FG001|COMPLETED|Treatment Period 2 (8 Days)||8
3325074|NCT03226275|4058194|FG002|COMPLETED|Treatment Period 2 (8 Days)||7
3325075|NCT03226275|4058195|FG003|COMPLETED|Treatment Period 2 (8 Days)||7
3325076|NCT03226275|4058192|FG000|NOT COMPLETED|Treatment Period 2 (8 Days)||0
3325077|NCT03226275|4058193|FG001|NOT COMPLETED|Treatment Period 2 (8 Days)||0
3325078|NCT03226275|4058194|FG002|NOT COMPLETED|Treatment Period 2 (8 Days)||0
3325079|NCT03226275|4058195|FG003|NOT COMPLETED|Treatment Period 2 (8 Days)||0
3325080|NCT03226353|4058205|FG000|STARTED|Overall Study||77
3325081|NCT03226353|4058205|FG000|Habitual Wearers of Proclear 1 Day|Overall Study||2
3325082|NCT03226353|4058205|FG000|Other Habitual Lens Types|Overall Study||75
3325083|NCT03226353|4058205|FG000|COMPLETED|Overall Study|Study participants completed includes the Omafilcon A habitual wearers.|71
3325084|NCT03226353|4058205|FG000|NOT COMPLETED|Overall Study||6
3325085|NCT03226366|4058216|FG000|STARTED|Overall Study||911
3325086|NCT03226366|4058217|FG001|STARTED|Overall Study||495
3325087|NCT03226366|4058218|FG002|STARTED|Overall Study||1183
3325088|NCT03226366|4058219|FG003|STARTED|Overall Study||641
3176238|NCT01965431|3904057|FG002|STARTED|Overall Study||8
3176239|NCT01965431|3904058|FG003|STARTED|Overall Study||8
3176240|NCT01965431|3904059|FG004|STARTED|Overall Study||8
3176241|NCT01965431|3904060|FG005|STARTED|Overall Study||8
3176242|NCT01965431|3904055|FG000|COMPLETED|Overall Study||2
3176243|NCT01965431|3904056|FG001|COMPLETED|Overall Study||2
3325089|NCT03226366|4058216|FG000|COMPLETED|Overall Study||911
3325090|NCT03226366|4058217|FG001|COMPLETED|Overall Study||495
3325091|NCT03226366|4058218|FG002|COMPLETED|Overall Study||1183
3325092|NCT03226366|4058219|FG003|COMPLETED|Overall Study||641
3325093|NCT03226366|4058216|FG000|NOT COMPLETED|Overall Study||0
3325094|NCT03226366|4058217|FG001|NOT COMPLETED|Overall Study||0
3325095|NCT03226366|4058218|FG002|NOT COMPLETED|Overall Study||0
3325096|NCT03226366|4058219|FG003|NOT COMPLETED|Overall Study||0
3325097|NCT03226392|4058231|FG000|STARTED|Overall Study||352
3325098|NCT03226392|4058232|FG001|STARTED|Overall Study||352
3325099|NCT03226392|4058231|FG000|FAS|Overall Study||352
3325100|NCT03226392|4058232|FG001|FAS|Overall Study|"2 patients in the placebo were mis-randomized, not treated, not included due to technical problems"|350
3325101|NCT03226392|4058231|FG000|COMPLETED|Overall Study||341
3325102|NCT03226392|4058232|FG001|COMPLETED|Overall Study||344
3176244|NCT01965431|3904057|FG002|COMPLETED|Overall Study||2
3176245|NCT01965431|3904058|FG003|COMPLETED|Overall Study||2
3176246|NCT01965431|3904059|FG004|COMPLETED|Overall Study||2
3325103|NCT03226392|4058231|FG000|NOT COMPLETED|Overall Study||11
3325104|NCT03226392|4058232|FG001|NOT COMPLETED|Overall Study||8
3325105|NCT03226457|4058238|FG000|STARTED|Treatment 1: 6 Weeks||12
3325106|NCT03226457|4058239|FG001|STARTED|Treatment 1: 6 Weeks||11
3325107|NCT03226457|4058238|FG000|COMPLETED|Treatment 1: 6 Weeks||12
3325108|NCT03226457|4058239|FG001|COMPLETED|Treatment 1: 6 Weeks||11
3325109|NCT03226457|4058238|FG000|NOT COMPLETED|Treatment 1: 6 Weeks||0
3325110|NCT03226457|4058239|FG001|NOT COMPLETED|Treatment 1: 6 Weeks||0
3325111|NCT03226457|4058238|FG000|STARTED|Washout Period: Minimum 2 Weeks||12
3325112|NCT03226457|4058239|FG001|STARTED|Washout Period: Minimum 2 Weeks||11
3325113|NCT03226457|4058238|FG000|COMPLETED|Washout Period: Minimum 2 Weeks||12
3325114|NCT03226457|4058239|FG001|COMPLETED|Washout Period: Minimum 2 Weeks||11
3325115|NCT03226457|4058238|FG000|NOT COMPLETED|Washout Period: Minimum 2 Weeks||0
3325116|NCT03226457|4058239|FG001|NOT COMPLETED|Washout Period: Minimum 2 Weeks||0
3325117|NCT03226457|4058238|FG000|STARTED|Treatment 2: 6 Weeks||12
3325118|NCT03226457|4058239|FG001|STARTED|Treatment 2: 6 Weeks||11
3325119|NCT03226457|4058238|FG000|COMPLETED|Treatment 2: 6 Weeks||12
3325120|NCT03226457|4058239|FG001|COMPLETED|Treatment 2: 6 Weeks||11
3325121|NCT03226457|4058238|FG000|NOT COMPLETED|Treatment 2: 6 Weeks||0
3325122|NCT03226457|4058239|FG001|NOT COMPLETED|Treatment 2: 6 Weeks||0
3325123|NCT03226652|4058245|FG000|STARTED|Overall Study||101
3325124|NCT03226652|4058245|FG000|COMPLETED|Overall Study||101
3325125|NCT03226652|4058245|FG000|NOT COMPLETED|Overall Study||0
3325126|NCT03226691|4058249|FG000|STARTED|Overall Study||15
3325127|NCT03226691|4058249|FG000|COMPLETED|Overall Study||15
3325128|NCT03226691|4058249|FG000|NOT COMPLETED|Overall Study||0
3325129|NCT03226769|4058255|FG000|STARTED|Overall Study||29
3325130|NCT03226769|4058256|FG001|STARTED|Overall Study||28
3325131|NCT03226769|4058255|FG000|COMPLETED|Overall Study||29
3325132|NCT03226769|4058256|FG001|COMPLETED|Overall Study||27
3325133|NCT03226769|4058255|FG000|NOT COMPLETED|Overall Study||0
3325134|NCT03226769|4058256|FG001|NOT COMPLETED|Overall Study||1
3325135|NCT03226899|4058264|FG000|STARTED|Overall Study||118
3325136|NCT03226899|4058265|FG001|STARTED|Overall Study||124
3325137|NCT03226899|4058264|FG000|COMPLETED|Overall Study||0
3325138|NCT03226899|4058265|FG001|COMPLETED|Overall Study||0
3325139|NCT03226899|4058264|FG000|NOT COMPLETED|Overall Study||118
3325140|NCT03226899|4058265|FG001|NOT COMPLETED|Overall Study||124
3325141|NCT03227445|4058271|FG000|STARTED|Period 1 (28 Days)||60
3325142|NCT03227445|4058272|FG001|STARTED|Period 1 (28 Days)||59
3325143|NCT03227445|4058273|FG002|STARTED|Period 1 (28 Days)||60
3325144|NCT03227445|4058274|FG003|STARTED|Period 1 (28 Days)||60
3325145|NCT03227445|4058271|FG000|COMPLETED|Period 1 (28 Days)||58
3325146|NCT03227445|4058272|FG001|COMPLETED|Period 1 (28 Days)||57
3325147|NCT03227445|4058273|FG002|COMPLETED|Period 1 (28 Days)||59
3325148|NCT03227445|4058274|FG003|COMPLETED|Period 1 (28 Days)||58
3325149|NCT03227445|4058271|FG000|NOT COMPLETED|Period 1 (28 Days)||2
3325150|NCT03227445|4058272|FG001|NOT COMPLETED|Period 1 (28 Days)||2
3325151|NCT03227445|4058273|FG002|NOT COMPLETED|Period 1 (28 Days)||1
3325152|NCT03227445|4058274|FG003|NOT COMPLETED|Period 1 (28 Days)||2
3325153|NCT03227445|4058271|FG000|STARTED|Period 2 (28 Days)||58
3325154|NCT03227445|4058272|FG001|STARTED|Period 2 (28 Days)||57
3325155|NCT03227445|4058273|FG002|STARTED|Period 2 (28 Days)||59
3325156|NCT03227445|4058274|FG003|STARTED|Period 2 (28 Days)||58
3325157|NCT03227445|4058271|FG000|COMPLETED|Period 2 (28 Days)||57
3325158|NCT03227445|4058272|FG001|COMPLETED|Period 2 (28 Days)||56
3325159|NCT03227445|4058273|FG002|COMPLETED|Period 2 (28 Days)||57
3325160|NCT03227445|4058274|FG003|COMPLETED|Period 2 (28 Days)||55
3325161|NCT03227445|4058271|FG000|NOT COMPLETED|Period 2 (28 Days)||1
3325162|NCT03227445|4058272|FG001|NOT COMPLETED|Period 2 (28 Days)||1
3325163|NCT03227445|4058273|FG002|NOT COMPLETED|Period 2 (28 Days)||2
3176247|NCT01965431|3904060|FG005|COMPLETED|Overall Study||2
3176248|NCT01965431|3904055|FG000|NOT COMPLETED|Overall Study||6
3176249|NCT01965431|3904056|FG001|NOT COMPLETED|Overall Study||6
3176250|NCT01965431|3904057|FG002|NOT COMPLETED|Overall Study||6
3176251|NCT01965431|3904058|FG003|NOT COMPLETED|Overall Study||6
3176252|NCT01965431|3904059|FG004|NOT COMPLETED|Overall Study||6
3325164|NCT03227445|4058274|FG003|NOT COMPLETED|Period 2 (28 Days)||3
3325165|NCT03227692|4058285|FG000|STARTED|Overall Study||47
3325166|NCT03227692|4058286|FG001|STARTED|Overall Study||46
3325167|NCT03227692|4058285|FG000|COMPLETED|Overall Study||42
3325168|NCT03227692|4058286|FG001|COMPLETED|Overall Study||41
3325169|NCT03227692|4058285|FG000|NOT COMPLETED|Overall Study||5
3325170|NCT03227692|4058286|FG001|NOT COMPLETED|Overall Study||5
3325171|NCT03227861|4058292|FG000|STARTED|Main Study Period (Week 0 to Week 48)||109
3325172|NCT03227861|4058292|FG000|COMPLETED|Main Study Period (Week 0 to Week 48)||97
3325173|NCT03227861|4058292|FG000|NOT COMPLETED|Main Study Period (Week 0 to Week 48)||12
3325174|NCT03227861|4058292|FG000|STARTED|Extension Period (Week 48 to Week 96)|17 participants were not willing to enter extension study and discontinued after main study.|80
3325175|NCT03227861|4058292|FG000|COMPLETED|Extension Period (Week 48 to Week 96)||0
3325176|NCT03227861|4058292|FG000|NOT COMPLETED|Extension Period (Week 48 to Week 96)||80
3325177|NCT03228017|4058300|FG000|STARTED|Overall Study||45
3325178|NCT03228017|4058301|FG001|STARTED|Overall Study||18
3325179|NCT03228017|4058300|FG000|COMPLETED|Overall Study||45
3325180|NCT03228017|4058301|FG001|COMPLETED|Overall Study||18
3325181|NCT03228017|4058300|FG000|NOT COMPLETED|Overall Study||0
3325182|NCT03228017|4058301|FG001|NOT COMPLETED|Overall Study||0
3325183|NCT03228212|4058307|FG000|STARTED|Period 1||65
3325184|NCT03228212|4058308|FG001|STARTED|Period 1||65
3325185|NCT03228212|4058307|FG000|COMPLETED|Period 1||64
3325186|NCT03228212|4058308|FG001|COMPLETED|Period 1||64
3325187|NCT03228212|4058307|FG000|NOT COMPLETED|Period 1||1
3325188|NCT03228212|4058308|FG001|NOT COMPLETED|Period 1||1
3325189|NCT03228212|4058307|FG000|STARTED|Period 2||64
3325190|NCT03228212|4058308|FG001|STARTED|Period 2||64
3325191|NCT03228212|4058307|FG000|COMPLETED|Period 2||63
3325192|NCT03228212|4058308|FG001|COMPLETED|Period 2||64
3325193|NCT03228212|4058307|FG000|NOT COMPLETED|Period 2||1
3325194|NCT03228212|4058308|FG001|NOT COMPLETED|Period 2||0
3325195|NCT03228212|4058307|FG000|STARTED|Period 3||63
3325196|NCT03228212|4058308|FG001|STARTED|Period 3||64
3325197|NCT03228212|4058307|FG000|COMPLETED|Period 3||63
3325198|NCT03228212|4058308|FG001|COMPLETED|Period 3||64
3325199|NCT03228212|4058307|FG000|NOT COMPLETED|Period 3||0
3325200|NCT03228212|4058308|FG001|NOT COMPLETED|Period 3||0
3325201|NCT03228420|4058316|FG000|STARTED|Overall Study||113
3325202|NCT03228420|4058317|FG001|STARTED|Overall Study||103
3325203|NCT03228420|4058316|FG000|Month-1|Overall Study||95
3325204|NCT03228420|4058317|FG001|Month-1|Overall Study||101
3325205|NCT03228420|4058316|FG000|Month-3|Overall Study||93
3325206|NCT03228420|4058317|FG001|Month-3|Overall Study||98
3325207|NCT03228420|4058316|FG000|COMPLETED|Overall Study||93
3325208|NCT03228420|4058317|FG001|COMPLETED|Overall Study||98
3325209|NCT03228420|4058316|FG000|NOT COMPLETED|Overall Study||20
3325210|NCT03228420|4058317|FG001|NOT COMPLETED|Overall Study||5
3325211|NCT03228433|4058329|FG000|STARTED|Overall Study||10
3325212|NCT03228433|4058330|FG001|STARTED|Overall Study||6
3325213|NCT03228433|4058331|FG002|STARTED|Overall Study||6
3325214|NCT03228433|4058332|FG003|STARTED|Overall Study||6
3325215|NCT03228433|4058333|FG004|STARTED|Overall Study||6
3325216|NCT03228433|4058334|FG005|STARTED|Overall Study||6
3325217|NCT03228433|4058329|FG000|COMPLETED|Overall Study||9
3325218|NCT03228433|4058330|FG001|COMPLETED|Overall Study||6
3325219|NCT03228433|4058331|FG002|COMPLETED|Overall Study||6
3325220|NCT03228433|4058332|FG003|COMPLETED|Overall Study||5
3325221|NCT03228433|4058333|FG004|COMPLETED|Overall Study||6
3325222|NCT03228433|4058334|FG005|COMPLETED|Overall Study||6
3325223|NCT03228433|4058329|FG000|NOT COMPLETED|Overall Study||1
3325224|NCT03228433|4058330|FG001|NOT COMPLETED|Overall Study||0
3325225|NCT03228433|4058331|FG002|NOT COMPLETED|Overall Study||0
3325226|NCT03228433|4058332|FG003|NOT COMPLETED|Overall Study||1
3325227|NCT03228433|4058333|FG004|NOT COMPLETED|Overall Study||0
3325228|NCT03228433|4058334|FG005|NOT COMPLETED|Overall Study||0
3325229|NCT03228836|4058356|FG000|STARTED|Overall Study||28
3325230|NCT03228836|4058356|FG000|Treated|Overall Study||28
3325231|NCT03228836|4058356|FG000|COMPLETED|Overall Study||11
3325232|NCT03228836|4058356|FG000|NOT COMPLETED|Overall Study||17
3325233|NCT03228914|4058360|FG000|STARTED|Overall Study||20
3325234|NCT03228914|4058361|FG001|STARTED|Overall Study||20
3325235|NCT03228914|4058360|FG000|COMPLETED|Overall Study||20
3325236|NCT03228914|4058361|FG001|COMPLETED|Overall Study||20
3325237|NCT03228914|4058360|FG000|NOT COMPLETED|Overall Study||0
3325238|NCT03228914|4058361|FG001|NOT COMPLETED|Overall Study||0
3325239|NCT03229109|4058371|FG000|STARTED|Overall Study||50
3325240|NCT03229109|4058372|FG001|STARTED|Overall Study||50
3325241|NCT03229109|4058373|FG002|STARTED|Overall Study||50
3325242|NCT03229109|4058374|FG003|STARTED|Overall Study||51
3325243|NCT03229109|4058371|FG000|COMPLETED|Overall Study||50
3325244|NCT03229109|4058372|FG001|COMPLETED|Overall Study||50
3325245|NCT03229109|4058373|FG002|COMPLETED|Overall Study||50
3325246|NCT03229109|4058374|FG003|COMPLETED|Overall Study||50
3325247|NCT03229109|4058371|FG000|NOT COMPLETED|Overall Study||0
3325248|NCT03229109|4058372|FG001|NOT COMPLETED|Overall Study||0
3325249|NCT03229109|4058373|FG002|NOT COMPLETED|Overall Study||0
3325250|NCT03229109|4058374|FG003|NOT COMPLETED|Overall Study||1
3325251|NCT03229252|4058387|FG000|STARTED|Overall Study||31
3325252|NCT03229252|4058388|FG001|STARTED|Overall Study||15
3325253|NCT03229252|4058389|FG002|STARTED|Overall Study||45
3325254|NCT03229252|4058387|FG000|COMPLETED|Overall Study||29
3325255|NCT03229252|4058388|FG001|COMPLETED|Overall Study||15
3325256|NCT03229252|4058389|FG002|COMPLETED|Overall Study||39
3325257|NCT03229252|4058387|FG000|NOT COMPLETED|Overall Study||2
3325258|NCT03229252|4058388|FG001|NOT COMPLETED|Overall Study||0
3325259|NCT03229252|4058389|FG002|NOT COMPLETED|Overall Study||6
3325260|NCT03229486|4058399|FG000|STARTED|Overall Study||20
3325261|NCT03229486|4058400|FG001|STARTED|Overall Study||20
3325262|NCT03229486|4058399|FG000|COMPLETED|Overall Study||20
3325263|NCT03229486|4058400|FG001|COMPLETED|Overall Study||19
3325264|NCT03229486|4058399|FG000|NOT COMPLETED|Overall Study||0
3325265|NCT03229486|4058400|FG001|NOT COMPLETED|Overall Study||1
3325266|NCT03229759|4058406|FG000|STARTED|Overall Study||99
3325267|NCT03229759|4058406|FG000|Participants Treated|Overall Study||69
3325268|NCT03229759|4058406|FG000|Treated With Investigational Product|Overall Study||45
3325269|NCT03229759|4058406|FG000|Treated With Vehicle Control|Overall Study||47
3325270|NCT03229759|4058406|FG000|Treated With Saline Control|Overall Study||46
3325271|NCT03229759|4058406|FG000|COMPLETED|Overall Study||69
3325272|NCT03229759|4058406|FG000|NOT COMPLETED|Overall Study||30
3325273|NCT03230175|4058412|FG000|STARTED|Overall Study||32
3325274|NCT03230175|4058412|FG000|COMPLETED|Overall Study||30
3325275|NCT03230175|4058412|FG000|NOT COMPLETED|Overall Study||2
3325276|NCT03230864|4058419|FG000|STARTED|Prospective Confirmation (PC) Period||68
3325277|NCT03230864|4058420|FG001|STARTED|Prospective Confirmation (PC) Period||51
3325278|NCT03230864|4058421|FG002|STARTED|Prospective Confirmation (PC) Period||0
3325279|NCT03230864|4058422|FG003|STARTED|Prospective Confirmation (PC) Period||0
3325280|NCT03230864|4058419|FG000|COMPLETED|Prospective Confirmation (PC) Period||36
3325281|NCT03230864|4058420|FG001|COMPLETED|Prospective Confirmation (PC) Period||32
3325282|NCT03230864|4058421|FG002|COMPLETED|Prospective Confirmation (PC) Period||0
3325283|NCT03230864|4058422|FG003|COMPLETED|Prospective Confirmation (PC) Period||0
3325284|NCT03230864|4058419|FG000|NOT COMPLETED|Prospective Confirmation (PC) Period||32
3325285|NCT03230864|4058420|FG001|NOT COMPLETED|Prospective Confirmation (PC) Period||19
3325286|NCT03230864|4058421|FG002|NOT COMPLETED|Prospective Confirmation (PC) Period||0
3325287|NCT03230864|4058422|FG003|NOT COMPLETED|Prospective Confirmation (PC) Period||0
3325288|NCT03230864|4058419|FG000|STARTED|Double Blind Treatment (DBT) Period||0
3325289|NCT03230864|4058420|FG001|STARTED|Double Blind Treatment (DBT) Period||0
3325290|NCT03230864|4058421|FG002|STARTED|Double Blind Treatment (DBT) Period||35
3325291|NCT03230864|4058422|FG003|STARTED|Double Blind Treatment (DBT) Period||33
3325292|NCT03230864|4058419|FG000|COMPLETED|Double Blind Treatment (DBT) Period||0
3176253|NCT01965431|3904060|FG005|NOT COMPLETED|Overall Study||6
3176254|NCT01965535|3904072|FG000|STARTED|Overall Study||78
3176255|NCT01965535|3904073|FG001|STARTED|Overall Study||77
3325293|NCT03230864|4058420|FG001|COMPLETED|Double Blind Treatment (DBT) Period||0
3176256|NCT01965535|3904072|FG000|COMPLETED|Overall Study||76
3325294|NCT03230864|4058421|FG002|COMPLETED|Double Blind Treatment (DBT) Period||27
3325295|NCT03230864|4058422|FG003|COMPLETED|Double Blind Treatment (DBT) Period||31
3325296|NCT03230864|4058419|FG000|NOT COMPLETED|Double Blind Treatment (DBT) Period||0
3325297|NCT03230864|4058420|FG001|NOT COMPLETED|Double Blind Treatment (DBT) Period||0
3325298|NCT03230864|4058421|FG002|NOT COMPLETED|Double Blind Treatment (DBT) Period||8
3325299|NCT03230864|4058422|FG003|NOT COMPLETED|Double Blind Treatment (DBT) Period||2
3325300|NCT03231228|4058434|FG000|STARTED|Overall Study||33
3325301|NCT03231228|4058435|FG001|STARTED|Overall Study||28
3325302|NCT03231228|4058434|FG000|COMPLETED|Overall Study||30
3325303|NCT03231228|4058435|FG001|COMPLETED|Overall Study||28
3325304|NCT03231228|4058434|FG000|NOT COMPLETED|Overall Study||3
3325305|NCT03231228|4058435|FG001|NOT COMPLETED|Overall Study||0
3325306|NCT03231345|4058441|FG000|STARTED|Overall Study||35
3325307|NCT03231345|4058441|FG000|COMPLETED|Overall Study||35
3325308|NCT03231345|4058441|FG000|NOT COMPLETED|Overall Study||0
3325309|NCT03231371|4058445|FG000|STARTED|Overall Study||22
3325310|NCT03231371|4058445|FG000|Optional and Age Limited (12 Yrs+) MRI|Overall Study||9
3325311|NCT03231371|4058445|FG000|COMPLETED|Overall Study||9
3325312|NCT03231371|4058445|FG000|NOT COMPLETED|Overall Study||13
3325313|NCT03231709|4058451|FG000|STARTED|Treatment Period 1||30
3325314|NCT03231709|4058452|FG001|STARTED|Treatment Period 1||30
3325315|NCT03231709|4058451|FG000|COMPLETED|Treatment Period 1||30
3325316|NCT03231709|4058452|FG001|COMPLETED|Treatment Period 1||29
3325317|NCT03231709|4058451|FG000|NOT COMPLETED|Treatment Period 1||0
3325318|NCT03231709|4058452|FG001|NOT COMPLETED|Treatment Period 1||1
3325319|NCT03231709|4058451|FG000|STARTED|Treatment Period 2||30
3325320|NCT03231709|4058452|FG001|STARTED|Treatment Period 2||29
3325321|NCT03231709|4058451|FG000|COMPLETED|Treatment Period 2||30
3325322|NCT03231709|4058452|FG001|COMPLETED|Treatment Period 2||28
3325323|NCT03231709|4058451|FG000|NOT COMPLETED|Treatment Period 2||0
3325324|NCT03231709|4058452|FG001|NOT COMPLETED|Treatment Period 2||1
3325325|NCT03231800|4058464|FG000|STARTED|Overall Study||48
3325326|NCT03231800|4058465|FG001|STARTED|Overall Study||47
3325327|NCT03231800|4058464|FG000|Safety Population|Overall Study||47
3325328|NCT03231800|4058465|FG001|Safety Population|Overall Study||47
3325329|NCT03231800|4058464|FG000|COMPLETED|Overall Study||45
3325330|NCT03231800|4058465|FG001|COMPLETED|Overall Study||44
3325331|NCT03231800|4058464|FG000|NOT COMPLETED|Overall Study||3
3325332|NCT03231800|4058465|FG001|NOT COMPLETED|Overall Study||3
3325333|NCT03231917|4058473|FG000|STARTED|Overall Study||60
3325334|NCT03231917|4058474|FG001|STARTED|Overall Study||61
3325335|NCT03231917|4058473|FG000|COMPLETED|Overall Study||60
3325336|NCT03231917|4058474|FG001|COMPLETED|Overall Study||61
3325337|NCT03231917|4058473|FG000|NOT COMPLETED|Overall Study||0
3325338|NCT03231917|4058474|FG001|NOT COMPLETED|Overall Study||0
3325339|NCT03231943|4058487|FG000|STARTED|Part 1, Period 1 (up to Day 15)||2
3325340|NCT03231943|4058488|FG001|STARTED|Part 1, Period 1 (up to Day 15)||2
3325341|NCT03231943|4058489|FG002|STARTED|Part 1, Period 1 (up to Day 15)||2
3325342|NCT03231943|4058490|FG003|STARTED|Part 1, Period 1 (up to Day 15)||2
3325343|NCT03231943|4058491|FG004|STARTED|Part 1, Period 1 (up to Day 15)||2
3325344|NCT03231943|4058492|FG005|STARTED|Part 1, Period 1 (up to Day 15)||2
3325345|NCT03231943|4058493|FG006|STARTED|Part 1, Period 1 (up to Day 15)||2
3325346|NCT03231943|4058494|FG007|STARTED|Part 1, Period 1 (up to Day 15)||2
3325347|NCT03231943|4058495|FG008|STARTED|Part 1, Period 1 (up to Day 15)||0
3325348|NCT03231943|4058496|FG009|STARTED|Part 1, Period 1 (up to Day 15)||0
3325349|NCT03231943|4058497|FG010|STARTED|Part 1, Period 1 (up to Day 15)||0
3325350|NCT03231943|4058498|FG011|STARTED|Part 1, Period 1 (up to Day 15)||0
3325351|NCT03231943|4058499|FG012|STARTED|Part 1, Period 1 (up to Day 15)||0
3325352|NCT03231943|4058487|FG000|COMPLETED|Part 1, Period 1 (up to Day 15)||2
3325353|NCT03231943|4058488|FG001|COMPLETED|Part 1, Period 1 (up to Day 15)||2
3325354|NCT03231943|4058489|FG002|COMPLETED|Part 1, Period 1 (up to Day 15)||2
3325355|NCT03231943|4058490|FG003|COMPLETED|Part 1, Period 1 (up to Day 15)||2
3325356|NCT03231943|4058491|FG004|COMPLETED|Part 1, Period 1 (up to Day 15)||2
3325357|NCT03231943|4058492|FG005|COMPLETED|Part 1, Period 1 (up to Day 15)||2
3325358|NCT03231943|4058493|FG006|COMPLETED|Part 1, Period 1 (up to Day 15)||2
3325359|NCT03231943|4058494|FG007|COMPLETED|Part 1, Period 1 (up to Day 15)||2
3325360|NCT03231943|4058495|FG008|COMPLETED|Part 1, Period 1 (up to Day 15)||0
3325361|NCT03231943|4058496|FG009|COMPLETED|Part 1, Period 1 (up to Day 15)||0
3325362|NCT03231943|4058497|FG010|COMPLETED|Part 1, Period 1 (up to Day 15)||0
3325363|NCT03231943|4058498|FG011|COMPLETED|Part 1, Period 1 (up to Day 15)||0
3325364|NCT03231943|4058499|FG012|COMPLETED|Part 1, Period 1 (up to Day 15)||0
3325365|NCT03231943|4058487|FG000|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
3325366|NCT03231943|4058488|FG001|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
3325367|NCT03231943|4058489|FG002|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
3325368|NCT03231943|4058490|FG003|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
3325369|NCT03231943|4058491|FG004|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
3325370|NCT03231943|4058492|FG005|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
3325371|NCT03231943|4058493|FG006|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
3325372|NCT03231943|4058494|FG007|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
3325373|NCT03231943|4058495|FG008|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
3325374|NCT03231943|4058496|FG009|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
3325375|NCT03231943|4058497|FG010|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
3325376|NCT03231943|4058498|FG011|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
3325377|NCT03231943|4058499|FG012|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
3325378|NCT03231943|4058487|FG000|STARTED|Part 1, Period 2 (up to Day 30)||2
3325379|NCT03231943|4058488|FG001|STARTED|Part 1, Period 2 (up to Day 30)||2
3325380|NCT03231943|4058489|FG002|STARTED|Part 1, Period 2 (up to Day 30)||2
3325381|NCT03231943|4058490|FG003|STARTED|Part 1, Period 2 (up to Day 30)||2
3325382|NCT03231943|4058491|FG004|STARTED|Part 1, Period 2 (up to Day 30)||2
3325383|NCT03231943|4058492|FG005|STARTED|Part 1, Period 2 (up to Day 30)||2
3325384|NCT03231943|4058493|FG006|STARTED|Part 1, Period 2 (up to Day 30)||2
3325385|NCT03231943|4058494|FG007|STARTED|Part 1, Period 2 (up to Day 30)||2
3325386|NCT03231943|4058495|FG008|STARTED|Part 1, Period 2 (up to Day 30)||0
3325387|NCT03231943|4058496|FG009|STARTED|Part 1, Period 2 (up to Day 30)||0
3325388|NCT03231943|4058497|FG010|STARTED|Part 1, Period 2 (up to Day 30)||0
3325389|NCT03231943|4058498|FG011|STARTED|Part 1, Period 2 (up to Day 30)||0
3325390|NCT03231943|4058499|FG012|STARTED|Part 1, Period 2 (up to Day 30)||0
3325391|NCT03231943|4058487|FG000|COMPLETED|Part 1, Period 2 (up to Day 30)||2
3325392|NCT03231943|4058488|FG001|COMPLETED|Part 1, Period 2 (up to Day 30)|Two participants withdrawn were replaced|0
3325393|NCT03231943|4058489|FG002|COMPLETED|Part 1, Period 2 (up to Day 30)|One participant withdrawn was replaced|1
3325394|NCT03231943|4058490|FG003|COMPLETED|Part 1, Period 2 (up to Day 30)||2
3325395|NCT03231943|4058491|FG004|COMPLETED|Part 1, Period 2 (up to Day 30)||2
3325396|NCT03231943|4058492|FG005|COMPLETED|Part 1, Period 2 (up to Day 30)||2
3325397|NCT03231943|4058493|FG006|COMPLETED|Part 1, Period 2 (up to Day 30)||2
3325398|NCT03231943|4058494|FG007|COMPLETED|Part 1, Period 2 (up to Day 30)||2
3325399|NCT03231943|4058495|FG008|COMPLETED|Part 1, Period 2 (up to Day 30)||0
3325400|NCT03231943|4058496|FG009|COMPLETED|Part 1, Period 2 (up to Day 30)||0
3325401|NCT03231943|4058497|FG010|COMPLETED|Part 1, Period 2 (up to Day 30)||0
3325402|NCT03231943|4058498|FG011|COMPLETED|Part 1, Period 2 (up to Day 30)||0
3325403|NCT03231943|4058499|FG012|COMPLETED|Part 1, Period 2 (up to Day 30)||0
3325404|NCT03231943|4058487|FG000|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
3325405|NCT03231943|4058488|FG001|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||2
3325406|NCT03231943|4058489|FG002|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||1
3325407|NCT03231943|4058490|FG003|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
3325408|NCT03231943|4058491|FG004|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
3325409|NCT03231943|4058492|FG005|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
3325410|NCT03231943|4058493|FG006|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
3325411|NCT03231943|4058494|FG007|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
3325412|NCT03231943|4058495|FG008|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
3325413|NCT03231943|4058496|FG009|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
3325414|NCT03231943|4058497|FG010|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
3325415|NCT03231943|4058498|FG011|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
3325416|NCT03231943|4058499|FG012|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
3325417|NCT03231943|4058487|FG000|STARTED|Part 1, Period 3 (up to Day 45)||2
3325418|NCT03231943|4058488|FG001|STARTED|Part 1, Period 3 (up to Day 45)||2
3325419|NCT03231943|4058489|FG002|STARTED|Part 1, Period 3 (up to Day 45)||2
3325420|NCT03231943|4058490|FG003|STARTED|Part 1, Period 3 (up to Day 45)||2
3325421|NCT03231943|4058491|FG004|STARTED|Part 1, Period 3 (up to Day 45)||2
3325422|NCT03231943|4058492|FG005|STARTED|Part 1, Period 3 (up to Day 45)||2
3325423|NCT03231943|4058493|FG006|STARTED|Part 1, Period 3 (up to Day 45)||2
3325424|NCT03231943|4058494|FG007|STARTED|Part 1, Period 3 (up to Day 45)||2
3325425|NCT03231943|4058495|FG008|STARTED|Part 1, Period 3 (up to Day 45)||0
3325426|NCT03231943|4058496|FG009|STARTED|Part 1, Period 3 (up to Day 45)||0
3325427|NCT03231943|4058497|FG010|STARTED|Part 1, Period 3 (up to Day 45)||0
3325428|NCT03231943|4058498|FG011|STARTED|Part 1, Period 3 (up to Day 45)||0
3325429|NCT03231943|4058499|FG012|STARTED|Part 1, Period 3 (up to Day 45)||0
3325430|NCT03231943|4058487|FG000|COMPLETED|Part 1, Period 3 (up to Day 45)|One participant withdrawn was replaced|1
3325431|NCT03231943|4058488|FG001|COMPLETED|Part 1, Period 3 (up to Day 45)||2
3325432|NCT03231943|4058489|FG002|COMPLETED|Part 1, Period 3 (up to Day 45)||2
3325433|NCT03231943|4058490|FG003|COMPLETED|Part 1, Period 3 (up to Day 45)||2
3325434|NCT03231943|4058491|FG004|COMPLETED|Part 1, Period 3 (up to Day 45)||2
3325435|NCT03231943|4058492|FG005|COMPLETED|Part 1, Period 3 (up to Day 45)||2
3325436|NCT03231943|4058493|FG006|COMPLETED|Part 1, Period 3 (up to Day 45)||2
3325437|NCT03231943|4058494|FG007|COMPLETED|Part 1, Period 3 (up to Day 45)||2
3325438|NCT03231943|4058495|FG008|COMPLETED|Part 1, Period 3 (up to Day 45)||0
3325439|NCT03231943|4058496|FG009|COMPLETED|Part 1, Period 3 (up to Day 45)||0
3325440|NCT03231943|4058497|FG010|COMPLETED|Part 1, Period 3 (up to Day 45)||0
3325441|NCT03231943|4058498|FG011|COMPLETED|Part 1, Period 3 (up to Day 45)||0
3325442|NCT03231943|4058499|FG012|COMPLETED|Part 1, Period 3 (up to Day 45)||0
3325443|NCT03231943|4058487|FG000|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||1
3325444|NCT03231943|4058488|FG001|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
3325445|NCT03231943|4058489|FG002|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
3325446|NCT03231943|4058490|FG003|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
3325447|NCT03231943|4058491|FG004|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
3325448|NCT03231943|4058492|FG005|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
3325449|NCT03231943|4058493|FG006|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
3325450|NCT03231943|4058494|FG007|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
3325451|NCT03231943|4058495|FG008|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
3325452|NCT03231943|4058496|FG009|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
3325453|NCT03231943|4058497|FG010|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
3325454|NCT03231943|4058498|FG011|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
3325455|NCT03231943|4058499|FG012|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
3325456|NCT03231943|4058487|FG000|STARTED|Part 1 Period 4 (up to Day 60)||2
3325457|NCT03231943|4058488|FG001|STARTED|Part 1 Period 4 (up to Day 60)||2
3325458|NCT03231943|4058489|FG002|STARTED|Part 1 Period 4 (up to Day 60)||2
3325459|NCT03231943|4058490|FG003|STARTED|Part 1 Period 4 (up to Day 60)||2
3325460|NCT03231943|4058491|FG004|STARTED|Part 1 Period 4 (up to Day 60)||2
3325461|NCT03231943|4058492|FG005|STARTED|Part 1 Period 4 (up to Day 60)||2
3325462|NCT03231943|4058493|FG006|STARTED|Part 1 Period 4 (up to Day 60)||2
3325463|NCT03231943|4058494|FG007|STARTED|Part 1 Period 4 (up to Day 60)||2
3325464|NCT03231943|4058495|FG008|STARTED|Part 1 Period 4 (up to Day 60)||0
3325465|NCT03231943|4058496|FG009|STARTED|Part 1 Period 4 (up to Day 60)||0
3325466|NCT03231943|4058497|FG010|STARTED|Part 1 Period 4 (up to Day 60)||0
3325467|NCT03231943|4058498|FG011|STARTED|Part 1 Period 4 (up to Day 60)||0
3325468|NCT03231943|4058499|FG012|STARTED|Part 1 Period 4 (up to Day 60)||0
3325469|NCT03231943|4058487|FG000|COMPLETED|Part 1 Period 4 (up to Day 60)||2
3325470|NCT03231943|4058488|FG001|COMPLETED|Part 1 Period 4 (up to Day 60)||2
3325471|NCT03231943|4058489|FG002|COMPLETED|Part 1 Period 4 (up to Day 60)||2
3325472|NCT03231943|4058490|FG003|COMPLETED|Part 1 Period 4 (up to Day 60)||2
3325473|NCT03231943|4058491|FG004|COMPLETED|Part 1 Period 4 (up to Day 60)||2
3325474|NCT03231943|4058492|FG005|COMPLETED|Part 1 Period 4 (up to Day 60)||2
3325475|NCT03231943|4058493|FG006|COMPLETED|Part 1 Period 4 (up to Day 60)||2
3325476|NCT03231943|4058494|FG007|COMPLETED|Part 1 Period 4 (up to Day 60)||2
3325477|NCT03231943|4058495|FG008|COMPLETED|Part 1 Period 4 (up to Day 60)||0
3325478|NCT03231943|4058496|FG009|COMPLETED|Part 1 Period 4 (up to Day 60)||0
3325479|NCT03231943|4058497|FG010|COMPLETED|Part 1 Period 4 (up to Day 60)||0
3325480|NCT03231943|4058498|FG011|COMPLETED|Part 1 Period 4 (up to Day 60)||0
3325481|NCT03231943|4058499|FG012|COMPLETED|Part 1 Period 4 (up to Day 60)||0
3325482|NCT03231943|4058487|FG000|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
3325483|NCT03231943|4058488|FG001|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
3325484|NCT03231943|4058489|FG002|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
3325485|NCT03231943|4058490|FG003|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
3325486|NCT03231943|4058491|FG004|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
3325487|NCT03231943|4058492|FG005|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
3325488|NCT03231943|4058493|FG006|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
3325489|NCT03231943|4058494|FG007|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
3325490|NCT03231943|4058495|FG008|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
3325491|NCT03231943|4058496|FG009|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
3325492|NCT03231943|4058497|FG010|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
3325493|NCT03231943|4058498|FG011|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
3325494|NCT03231943|4058499|FG012|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
3325495|NCT03231943|4058487|FG000|STARTED|Part 2||0
3325496|NCT03231943|4058488|FG001|STARTED|Part 2||0
3325497|NCT03231943|4058489|FG002|STARTED|Part 2||0
3325498|NCT03231943|4058490|FG003|STARTED|Part 2||0
3325499|NCT03231943|4058491|FG004|STARTED|Part 2||0
3325500|NCT03231943|4058492|FG005|STARTED|Part 2||0
3325501|NCT03231943|4058493|FG006|STARTED|Part 2||0
3325502|NCT03231943|4058494|FG007|STARTED|Part 2||0
3325503|NCT03231943|4058495|FG008|STARTED|Part 2||6
3325504|NCT03231943|4058496|FG009|STARTED|Part 2||6
3325505|NCT03231943|4058497|FG010|STARTED|Part 2||25
3325506|NCT03231943|4058498|FG011|STARTED|Part 2||7
3325507|NCT03231943|4058499|FG012|STARTED|Part 2||14
3325508|NCT03231943|4058487|FG000|COMPLETED|Part 2||0
3325509|NCT03231943|4058488|FG001|COMPLETED|Part 2||0
3325510|NCT03231943|4058489|FG002|COMPLETED|Part 2||0
3325511|NCT03231943|4058490|FG003|COMPLETED|Part 2||0
3325512|NCT03231943|4058491|FG004|COMPLETED|Part 2||0
3325513|NCT03231943|4058492|FG005|COMPLETED|Part 2||0
3325514|NCT03231943|4058493|FG006|COMPLETED|Part 2||0
3176257|NCT01965535|3904073|FG001|COMPLETED|Overall Study||76
3176258|NCT01965535|3904072|FG000|NOT COMPLETED|Overall Study||2
3176259|NCT01965535|3904073|FG001|NOT COMPLETED|Overall Study||1
3176260|NCT01965561|3904079|FG000|STARTED|Overall Study||10
3176261|NCT01965561|3904079|FG000|COMPLETED|Overall Study||10
3176262|NCT01965561|3904079|FG000|NOT COMPLETED|Overall Study||0
3325515|NCT03231943|4058494|FG007|COMPLETED|Part 2||0
3325516|NCT03231943|4058495|FG008|COMPLETED|Part 2||6
3325517|NCT03231943|4058496|FG009|COMPLETED|Part 2||6
3325518|NCT03231943|4058497|FG010|COMPLETED|Part 2||24
3325519|NCT03231943|4058498|FG011|COMPLETED|Part 2||6
3325520|NCT03231943|4058499|FG012|COMPLETED|Part 2||14
3325521|NCT03231943|4058487|FG000|NOT COMPLETED|Part 2||0
3325522|NCT03231943|4058488|FG001|NOT COMPLETED|Part 2||0
3325523|NCT03231943|4058489|FG002|NOT COMPLETED|Part 2||0
3325524|NCT03231943|4058490|FG003|NOT COMPLETED|Part 2||0
3325525|NCT03231943|4058491|FG004|NOT COMPLETED|Part 2||0
3325526|NCT03231943|4058492|FG005|NOT COMPLETED|Part 2||0
3325527|NCT03231943|4058493|FG006|NOT COMPLETED|Part 2||0
3325528|NCT03231943|4058494|FG007|NOT COMPLETED|Part 2||0
3325529|NCT03231943|4058495|FG008|NOT COMPLETED|Part 2||0
3325530|NCT03231943|4058496|FG009|NOT COMPLETED|Part 2||0
3325531|NCT03231943|4058497|FG010|NOT COMPLETED|Part 2||1
3325532|NCT03231943|4058498|FG011|NOT COMPLETED|Part 2||1
3176263|NCT01965600|3904086|FG000|STARTED|First Intervention||6
3325533|NCT03231943|4058499|FG012|NOT COMPLETED|Part 2||0
3325534|NCT03231969|4058533|FG000|STARTED|Overall Study||30
3325535|NCT03231969|4058534|FG001|STARTED|Overall Study||30
3325536|NCT03231969|4058535|FG002|STARTED|Overall Study||31
3325537|NCT03231969|4058536|FG003|STARTED|Overall Study||30
3325538|NCT03231969|4058533|FG000|COMPLETED|Overall Study||28
3325539|NCT03231969|4058534|FG001|COMPLETED|Overall Study||28
3325540|NCT03231969|4058535|FG002|COMPLETED|Overall Study||30
3325541|NCT03231969|4058536|FG003|COMPLETED|Overall Study||30
3325542|NCT03231969|4058533|FG000|NOT COMPLETED|Overall Study||2
3325543|NCT03231969|4058534|FG001|NOT COMPLETED|Overall Study||2
3325544|NCT03231969|4058535|FG002|NOT COMPLETED|Overall Study||1
3325545|NCT03231969|4058536|FG003|NOT COMPLETED|Overall Study||0
3325546|NCT03232281|4058548|FG000|STARTED|Overall Study||150
3325547|NCT03232281|4058549|FG001|STARTED|Overall Study||150
3325548|NCT03232281|4058548|FG000|Received Treatment|Overall Study||149
3325549|NCT03232281|4058549|FG001|Received Treatment|Overall Study||150
3325550|NCT03232281|4058548|FG000|Completed Week 12|Overall Study||143
3325551|NCT03232281|4058549|FG001|Completed Week 12|Overall Study||148
3325552|NCT03232281|4058548|FG000|Completed Week 24|Overall Study||143
3325553|NCT03232281|4058549|FG001|Completed Week 24|Overall Study||144
3325554|NCT03232281|4058548|FG000|COMPLETED|Overall Study||143
3325555|NCT03232281|4058549|FG001|COMPLETED|Overall Study||144
3325556|NCT03232281|4058548|FG000|NOT COMPLETED|Overall Study||7
3325557|NCT03232281|4058549|FG001|NOT COMPLETED|Overall Study||6
3325558|NCT03232333|4058555|FG000|STARTED|Overall Study||53
3325559|NCT03232333|4058555|FG000|COMPLETED|Overall Study||38
3325560|NCT03232333|4058555|FG000|NOT COMPLETED|Overall Study||15
3325561|NCT03232567|4058563|FG000|STARTED|Overall Study||15
3325562|NCT03232567|4058564|FG001|STARTED|Overall Study||15
3325563|NCT03232567|4058565|FG002|STARTED|Overall Study||15
3325564|NCT03232567|4058566|FG003|STARTED|Overall Study||15
3325565|NCT03232567|4058563|FG000|COMPLETED|Overall Study||15
3325566|NCT03232567|4058564|FG001|COMPLETED|Overall Study||14
3325567|NCT03232567|4058565|FG002|COMPLETED|Overall Study||15
3325568|NCT03232567|4058566|FG003|COMPLETED|Overall Study||15
3325569|NCT03232567|4058563|FG000|NOT COMPLETED|Overall Study||0
3325570|NCT03232567|4058564|FG001|NOT COMPLETED|Overall Study||1
3325571|NCT03232567|4058565|FG002|NOT COMPLETED|Overall Study||0
3325572|NCT03232567|4058566|FG003|NOT COMPLETED|Overall Study||0
3325573|NCT03232580|4058576|FG000|STARTED|Overall Study||5
3325574|NCT03232580|4058576|FG000|COMPLETED|Overall Study||5
3325575|NCT03232580|4058576|FG000|NOT COMPLETED|Overall Study||0
3325576|NCT03232645|4058580|FG000|STARTED|Overall Study||62
3325577|NCT03232645|4058580|FG000|COMPLETED|Overall Study||58
3325578|NCT03232645|4058580|FG000|NOT COMPLETED|Overall Study||4
3325579|NCT03232749|4058585|FG000|STARTED|Overall Study||25
3325580|NCT03232749|4058585|FG000|COMPLETED|Overall Study||21
3325581|NCT03232749|4058585|FG000|NOT COMPLETED|Overall Study||4
3325582|NCT03232827|4058589|FG000|STARTED|Flavored-sweetened (FS)||80
3325583|NCT03232827|4058589|FG000|COMPLETED|Flavored-sweetened (FS)||80
3325584|NCT03232827|4058589|FG000|NOT COMPLETED|Flavored-sweetened (FS)||0
3325585|NCT03232827|4058589|FG000|STARTED|Unflavored-sweetened (US)||86
3325586|NCT03232827|4058589|FG000|COMPLETED|Unflavored-sweetened (US)||86
3325587|NCT03232827|4058589|FG000|NOT COMPLETED|Unflavored-sweetened (US)||0
3325588|NCT03232827|4058589|FG000|STARTED|Unflavored-very Low Sweetened (UU)||66
3325589|NCT03232827|4058589|FG000|COMPLETED|Unflavored-very Low Sweetened (UU)||66
3325590|NCT03232827|4058589|FG000|NOT COMPLETED|Unflavored-very Low Sweetened (UU)||0
3325591|NCT03232827|4058589|FG000|STARTED|Flavored-very Low Sweetened||66
3325592|NCT03232827|4058589|FG000|COMPLETED|Flavored-very Low Sweetened||66
3325593|NCT03232827|4058589|FG000|NOT COMPLETED|Flavored-very Low Sweetened||0
3325594|NCT03232983|4058599|FG000|STARTED|Period 1||7
3325595|NCT03232983|4058600|FG001|STARTED|Period 1||7
3325596|NCT03232983|4058601|FG002|STARTED|Period 1||7
3325597|NCT03232983|4058602|FG003|STARTED|Period 1||7
3325598|NCT03232983|4058599|FG000|Received at Least One Dose of Study Drug|Period 1||7
3325599|NCT03232983|4058600|FG001|Received at Least One Dose of Study Drug|Period 1||7
3325600|NCT03232983|4058601|FG002|Received at Least One Dose of Study Drug|Period 1||7
3325601|NCT03232983|4058602|FG003|Received at Least One Dose of Study Drug|Period 1||7
3325602|NCT03232983|4058599|FG000|COMPLETED|Period 1||7
3325603|NCT03232983|4058600|FG001|COMPLETED|Period 1||7
3325604|NCT03232983|4058601|FG002|COMPLETED|Period 1||6
3325605|NCT03232983|4058602|FG003|COMPLETED|Period 1||7
3325606|NCT03232983|4058599|FG000|NOT COMPLETED|Period 1||0
3325607|NCT03232983|4058600|FG001|NOT COMPLETED|Period 1||0
3325608|NCT03232983|4058601|FG002|NOT COMPLETED|Period 1||1
3325609|NCT03232983|4058602|FG003|NOT COMPLETED|Period 1||0
3325610|NCT03232983|4058599|FG000|STARTED|Washout Period 1||7
3325611|NCT03232983|4058600|FG001|STARTED|Washout Period 1||7
3325612|NCT03232983|4058601|FG002|STARTED|Washout Period 1||6
3325613|NCT03232983|4058602|FG003|STARTED|Washout Period 1||7
3325614|NCT03232983|4058599|FG000|COMPLETED|Washout Period 1||7
3325615|NCT03232983|4058600|FG001|COMPLETED|Washout Period 1||7
3325616|NCT03232983|4058601|FG002|COMPLETED|Washout Period 1||6
3325617|NCT03232983|4058602|FG003|COMPLETED|Washout Period 1||7
3325618|NCT03232983|4058599|FG000|NOT COMPLETED|Washout Period 1||0
3325619|NCT03232983|4058600|FG001|NOT COMPLETED|Washout Period 1||0
3325620|NCT03232983|4058601|FG002|NOT COMPLETED|Washout Period 1||0
3325621|NCT03232983|4058602|FG003|NOT COMPLETED|Washout Period 1||0
3325622|NCT03232983|4058599|FG000|STARTED|Period 2||7
3325623|NCT03232983|4058600|FG001|STARTED|Period 2||7
3325624|NCT03232983|4058601|FG002|STARTED|Period 2||6
3325625|NCT03232983|4058602|FG003|STARTED|Period 2||7
3325626|NCT03232983|4058599|FG000|COMPLETED|Period 2||7
3325627|NCT03232983|4058600|FG001|COMPLETED|Period 2||7
3325628|NCT03232983|4058601|FG002|COMPLETED|Period 2||6
3325629|NCT03232983|4058602|FG003|COMPLETED|Period 2||7
3325630|NCT03232983|4058599|FG000|NOT COMPLETED|Period 2||0
3325631|NCT03232983|4058600|FG001|NOT COMPLETED|Period 2||0
3325632|NCT03232983|4058601|FG002|NOT COMPLETED|Period 2||0
3325633|NCT03232983|4058602|FG003|NOT COMPLETED|Period 2||0
3325634|NCT03232983|4058599|FG000|STARTED|Washout Period 2||7
3325635|NCT03232983|4058600|FG001|STARTED|Washout Period 2||7
3325636|NCT03232983|4058601|FG002|STARTED|Washout Period 2||6
3325637|NCT03232983|4058602|FG003|STARTED|Washout Period 2||7
3325638|NCT03232983|4058599|FG000|COMPLETED|Washout Period 2||7
3325639|NCT03232983|4058600|FG001|COMPLETED|Washout Period 2||7
3325640|NCT03232983|4058601|FG002|COMPLETED|Washout Period 2||5
3325641|NCT03232983|4058602|FG003|COMPLETED|Washout Period 2||6
3325642|NCT03232983|4058599|FG000|NOT COMPLETED|Washout Period 2||0
3325643|NCT03232983|4058600|FG001|NOT COMPLETED|Washout Period 2||0
3325644|NCT03232983|4058601|FG002|NOT COMPLETED|Washout Period 2||1
3325645|NCT03232983|4058602|FG003|NOT COMPLETED|Washout Period 2||1
3325646|NCT03232983|4058599|FG000|STARTED|Period 3||7
3325647|NCT03232983|4058600|FG001|STARTED|Period 3||7
3325648|NCT03232983|4058601|FG002|STARTED|Period 3||5
3325649|NCT03232983|4058602|FG003|STARTED|Period 3||6
3325650|NCT03232983|4058599|FG000|COMPLETED|Period 3||7
3325651|NCT03232983|4058600|FG001|COMPLETED|Period 3||7
3325652|NCT03232983|4058601|FG002|COMPLETED|Period 3||5
3325653|NCT03232983|4058602|FG003|COMPLETED|Period 3||6
3325654|NCT03232983|4058599|FG000|NOT COMPLETED|Period 3||0
3325655|NCT03232983|4058600|FG001|NOT COMPLETED|Period 3||0
3325656|NCT03232983|4058601|FG002|NOT COMPLETED|Period 3||0
3325657|NCT03232983|4058602|FG003|NOT COMPLETED|Period 3||0
3325658|NCT03232983|4058599|FG000|STARTED|Washout Period 3||7
3325659|NCT03232983|4058600|FG001|STARTED|Washout Period 3||7
3325660|NCT03232983|4058601|FG002|STARTED|Washout Period 3||5
3325661|NCT03232983|4058602|FG003|STARTED|Washout Period 3||6
3325662|NCT03232983|4058599|FG000|COMPLETED|Washout Period 3||7
3325663|NCT03232983|4058600|FG001|COMPLETED|Washout Period 3||7
3325664|NCT03232983|4058601|FG002|COMPLETED|Washout Period 3||5
3325665|NCT03232983|4058602|FG003|COMPLETED|Washout Period 3||6
3325666|NCT03232983|4058599|FG000|NOT COMPLETED|Washout Period 3||0
3325667|NCT03232983|4058600|FG001|NOT COMPLETED|Washout Period 3||0
3325668|NCT03232983|4058601|FG002|NOT COMPLETED|Washout Period 3||0
3325669|NCT03232983|4058602|FG003|NOT COMPLETED|Washout Period 3||0
3325670|NCT03232983|4058599|FG000|STARTED|Period 4||7
3325671|NCT03232983|4058600|FG001|STARTED|Period 4||7
3325672|NCT03232983|4058601|FG002|STARTED|Period 4||5
3325673|NCT03232983|4058602|FG003|STARTED|Period 4||6
3325674|NCT03232983|4058599|FG000|COMPLETED|Period 4||6
3325675|NCT03232983|4058600|FG001|COMPLETED|Period 4||7
3325676|NCT03232983|4058601|FG002|COMPLETED|Period 4||5
3325677|NCT03232983|4058602|FG003|COMPLETED|Period 4||6
3325678|NCT03232983|4058599|FG000|NOT COMPLETED|Period 4||1
3325679|NCT03232983|4058600|FG001|NOT COMPLETED|Period 4||0
3325680|NCT03232983|4058601|FG002|NOT COMPLETED|Period 4||0
3325681|NCT03232983|4058602|FG003|NOT COMPLETED|Period 4||0
3325682|NCT03233009|4058614|FG000|STARTED|Overall Study||40
3325683|NCT03233009|4058614|FG000|Test Product 1|Overall Study||39
3325684|NCT03233009|4058614|FG000|Test Product 2|Overall Study||39
3325685|NCT03233009|4058614|FG000|Test Product 3|Overall Study||39
3325686|NCT03233009|4058614|FG000|Test Product 4|Overall Study||39
3325687|NCT03233009|4058614|FG000|Reference Product|Overall Study||39
3325688|NCT03233009|4058614|FG000|COMPLETED|Overall Study||39
3325689|NCT03233009|4058614|FG000|NOT COMPLETED|Overall Study||1
3325690|NCT03233217|4058632|FG000|STARTED|Overall Study||5
3325691|NCT03233217|4058633|FG001|STARTED|Overall Study||5
3325692|NCT03233217|4058634|FG002|STARTED|Overall Study||55
3325693|NCT03233217|4058635|FG003|STARTED|Overall Study||55
3325694|NCT03233217|4058636|FG004|STARTED|Overall Study||55
3325695|NCT03233217|4058632|FG000|Safety Analysis Set (SafAS)|Overall Study||5
3325696|NCT03233217|4058633|FG001|Safety Analysis Set (SafAS)|Overall Study||5
3325697|NCT03233217|4058634|FG002|Safety Analysis Set (SafAS)|Overall Study||55
3325698|NCT03233217|4058635|FG003|Safety Analysis Set (SafAS)|Overall Study||55
3325699|NCT03233217|4058636|FG004|Safety Analysis Set (SafAS)|Overall Study||55
3325700|NCT03233217|4058632|FG000|Per-protocol Analysis Set (PPAS)|Overall Study||5
3325701|NCT03233217|4058633|FG001|Per-protocol Analysis Set (PPAS)|Overall Study||5
3325702|NCT03233217|4058634|FG002|Per-protocol Analysis Set (PPAS)|Overall Study||55
3325703|NCT03233217|4058635|FG003|Per-protocol Analysis Set (PPAS)|Overall Study||55
3325704|NCT03233217|4058636|FG004|Per-protocol Analysis Set (PPAS)|Overall Study||54
3325705|NCT03233217|4058632|FG000|COMPLETED|Overall Study||5
3325706|NCT03233217|4058633|FG001|COMPLETED|Overall Study||5
3325707|NCT03233217|4058634|FG002|COMPLETED|Overall Study||55
3325708|NCT03233217|4058635|FG003|COMPLETED|Overall Study||55
3325709|NCT03233217|4058636|FG004|COMPLETED|Overall Study||55
3325710|NCT03233217|4058632|FG000|NOT COMPLETED|Overall Study||0
3325711|NCT03233217|4058633|FG001|NOT COMPLETED|Overall Study||0
3325712|NCT03233217|4058634|FG002|NOT COMPLETED|Overall Study||0
3325713|NCT03233217|4058635|FG003|NOT COMPLETED|Overall Study||0
3325714|NCT03233217|4058636|FG004|NOT COMPLETED|Overall Study||0
3325715|NCT03233230|4058652|FG000|STARTED|Overall Study||97
3325716|NCT03233230|4058653|FG001|STARTED|Overall Study||98
3325717|NCT03233230|4058654|FG002|STARTED|Overall Study||96
3325718|NCT03233230|4058655|FG003|STARTED|Overall Study||99
3325719|NCT03233230|4058652|FG000|COMPLETED|Overall Study||82
3325720|NCT03233230|4058653|FG001|COMPLETED|Overall Study||83
3325721|NCT03233230|4058654|FG002|COMPLETED|Overall Study||84
3325722|NCT03233230|4058655|FG003|COMPLETED|Overall Study||91
3325723|NCT03233230|4058652|FG000|NOT COMPLETED|Overall Study||15
3325724|NCT03233230|4058653|FG001|NOT COMPLETED|Overall Study||15
3325725|NCT03233230|4058654|FG002|NOT COMPLETED|Overall Study||12
3325726|NCT03233230|4058655|FG003|NOT COMPLETED|Overall Study||8
3325727|NCT03233308|4058665|FG000|STARTED|Overall Study||20
3325728|NCT03233308|4058665|FG000|COMPLETED|Overall Study||18
3325729|NCT03233308|4058665|FG000|NOT COMPLETED|Overall Study||2
3325730|NCT03233438|4058678|FG000|STARTED|Overall Study||48
3325731|NCT03233438|4058679|FG001|STARTED|Overall Study||43
3325732|NCT03233438|4058678|FG000|COMPLETED|Overall Study||42
3325733|NCT03233438|4058679|FG001|COMPLETED|Overall Study||32
3325734|NCT03233438|4058678|FG000|NOT COMPLETED|Overall Study||6
3325735|NCT03233438|4058679|FG001|NOT COMPLETED|Overall Study||11
3325736|NCT03233529|4058685|FG000|STARTED|Double-Blind Period (Day 1 to Day 15)||40
3325737|NCT03233529|4058685|FG000|COMPLETED|Double-Blind Period (Day 1 to Day 15)||39
3325738|NCT03233529|4058685|FG000|NOT COMPLETED|Double-Blind Period (Day 1 to Day 15)||1
3325739|NCT03233529|4058685|FG000|STARTED|Open-Label Period (Day 15 to Day 71)||39
3325740|NCT03233529|4058685|FG000|COMPLETED|Open-Label Period (Day 15 to Day 71)||38
3325741|NCT03233529|4058685|FG000|NOT COMPLETED|Open-Label Period (Day 15 to Day 71)||1
3325742|NCT03233737|4058698|FG000|STARTED|Overall Study||10
3325743|NCT03233737|4058699|FG001|STARTED|Overall Study||10
3325744|NCT03233737|4058700|FG002|STARTED|Overall Study||5
3325745|NCT03233737|4058701|FG003|STARTED|Overall Study||24
3325746|NCT03233737|4058702|FG004|STARTED|Overall Study||26
3325747|NCT03233737|4058698|FG000|COMPLETED|Overall Study||10
3325748|NCT03233737|4058699|FG001|COMPLETED|Overall Study||10
3325749|NCT03233737|4058700|FG002|COMPLETED|Overall Study||5
3325750|NCT03233737|4058701|FG003|COMPLETED|Overall Study||24
3325751|NCT03233737|4058702|FG004|COMPLETED|Overall Study||26
3325752|NCT03233737|4058698|FG000|NOT COMPLETED|Overall Study||0
3325753|NCT03233737|4058699|FG001|NOT COMPLETED|Overall Study||0
3325754|NCT03233737|4058700|FG002|NOT COMPLETED|Overall Study||0
3325755|NCT03233737|4058701|FG003|NOT COMPLETED|Overall Study||0
3325756|NCT03233737|4058702|FG004|NOT COMPLETED|Overall Study||0
3325757|NCT03234036|4058718|FG000|STARTED|Part 1: Treatment Period 1(Up to 7 Days)||8
3325758|NCT03234036|4058719|FG001|STARTED|Part 1: Treatment Period 1(Up to 7 Days)||8
3325759|NCT03234036|4058720|FG002|STARTED|Part 1: Treatment Period 1(Up to 7 Days)||0
3325760|NCT03234036|4058721|FG003|STARTED|Part 1: Treatment Period 1(Up to 7 Days)||0
3325761|NCT03234036|4058718|FG000|COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||8
3325762|NCT03234036|4058719|FG001|COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||8
3325763|NCT03234036|4058720|FG002|COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||0
3325764|NCT03234036|4058721|FG003|COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||0
3325765|NCT03234036|4058718|FG000|NOT COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||0
3325766|NCT03234036|4058719|FG001|NOT COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||0
3325767|NCT03234036|4058720|FG002|NOT COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||0
3325768|NCT03234036|4058721|FG003|NOT COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||0
3325769|NCT03234036|4058718|FG000|STARTED|Part 1:Washout Period 1 (Up to 10 Days)||8
3325770|NCT03234036|4058719|FG001|STARTED|Part 1:Washout Period 1 (Up to 10 Days)||8
3325771|NCT03234036|4058720|FG002|STARTED|Part 1:Washout Period 1 (Up to 10 Days)||0
3325772|NCT03234036|4058721|FG003|STARTED|Part 1:Washout Period 1 (Up to 10 Days)||0
3325773|NCT03234036|4058718|FG000|COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||7
3325774|NCT03234036|4058719|FG001|COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||7
3325775|NCT03234036|4058720|FG002|COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||0
3325776|NCT03234036|4058721|FG003|COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||0
3325777|NCT03234036|4058718|FG000|NOT COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||1
3325778|NCT03234036|4058719|FG001|NOT COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||1
3325779|NCT03234036|4058720|FG002|NOT COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||0
3325780|NCT03234036|4058721|FG003|NOT COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||0
3325781|NCT03234036|4058718|FG000|STARTED|Part 1: Treatment Period 2(Up to 7 Days)||7
3325782|NCT03234036|4058719|FG001|STARTED|Part 1: Treatment Period 2(Up to 7 Days)||7
3325783|NCT03234036|4058720|FG002|STARTED|Part 1: Treatment Period 2(Up to 7 Days)||0
3325784|NCT03234036|4058721|FG003|STARTED|Part 1: Treatment Period 2(Up to 7 Days)||0
3325785|NCT03234036|4058718|FG000|COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||7
3325786|NCT03234036|4058719|FG001|COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||7
3325787|NCT03234036|4058720|FG002|COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||0
3325788|NCT03234036|4058721|FG003|COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||0
3325789|NCT03234036|4058718|FG000|NOT COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||0
3325790|NCT03234036|4058719|FG001|NOT COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||0
3325791|NCT03234036|4058720|FG002|NOT COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||0
3325792|NCT03234036|4058721|FG003|NOT COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||0
3325793|NCT03234036|4058718|FG000|STARTED|Part 1:Washout Period 2 (Up to 15 Days)||7
3325794|NCT03234036|4058719|FG001|STARTED|Part 1:Washout Period 2 (Up to 15 Days)||7
3325795|NCT03234036|4058720|FG002|STARTED|Part 1:Washout Period 2 (Up to 15 Days)||0
3325796|NCT03234036|4058721|FG003|STARTED|Part 1:Washout Period 2 (Up to 15 Days)||0
3325797|NCT03234036|4058718|FG000|COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||7
3325798|NCT03234036|4058719|FG001|COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||7
3325799|NCT03234036|4058720|FG002|COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||0
3325800|NCT03234036|4058721|FG003|COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||0
3325801|NCT03234036|4058718|FG000|NOT COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||0
3325802|NCT03234036|4058719|FG001|NOT COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||0
3325803|NCT03234036|4058720|FG002|NOT COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||0
3325804|NCT03234036|4058721|FG003|NOT COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||0
3325805|NCT03234036|4058718|FG000|STARTED|Part 1:Treatment Period 3 (Up to 7 Days)||7
3325806|NCT03234036|4058719|FG001|STARTED|Part 1:Treatment Period 3 (Up to 7 Days)||7
3325807|NCT03234036|4058720|FG002|STARTED|Part 1:Treatment Period 3 (Up to 7 Days)||0
3325808|NCT03234036|4058721|FG003|STARTED|Part 1:Treatment Period 3 (Up to 7 Days)||0
3325809|NCT03234036|4058718|FG000|COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||7
3325810|NCT03234036|4058719|FG001|COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||7
3325811|NCT03234036|4058720|FG002|COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||0
3325812|NCT03234036|4058721|FG003|COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||0
3325813|NCT03234036|4058718|FG000|NOT COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||0
3325814|NCT03234036|4058719|FG001|NOT COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||0
2927745|NCT00573989|3638602|FG003|STARTED|Erlotinib 125mg- Phase II||12
2927746|NCT00573989|3638599|FG000|COMPLETED|Erlotinib 125mg- Phase II||0
2927747|NCT00573989|3638600|FG001|COMPLETED|Erlotinib 125mg- Phase II||0
2927748|NCT00573989|3638601|FG002|COMPLETED|Erlotinib 125mg- Phase II||0
2927749|NCT00573989|3638602|FG003|COMPLETED|Erlotinib 125mg- Phase II||12
2927750|NCT00573989|3638599|FG000|NOT COMPLETED|Erlotinib 125mg- Phase II||0
2927751|NCT00573989|3638600|FG001|NOT COMPLETED|Erlotinib 125mg- Phase II||0
2927752|NCT00573989|3638601|FG002|NOT COMPLETED|Erlotinib 125mg- Phase II||0
2927753|NCT00573989|3638602|FG003|NOT COMPLETED|Erlotinib 125mg- Phase II||0
2927754|NCT00574067|3638613|FG000|STARTED|Overall Study||53
2927755|NCT00574067|3638614|FG001|STARTED|Overall Study||53
2927756|NCT00574067|3638615|FG002|STARTED|Overall Study||54
2927757|NCT00574067|3638616|FG003|STARTED|Overall Study||53
2927758|NCT00574067|3638613|FG000|COMPLETED|Overall Study||52
2927759|NCT00574067|3638614|FG001|COMPLETED|Overall Study||52
2927760|NCT00574067|3638615|FG002|COMPLETED|Overall Study||54
2927761|NCT00574067|3638616|FG003|COMPLETED|Overall Study||53
2927762|NCT00574067|3638613|FG000|NOT COMPLETED|Overall Study||1
2927763|NCT00574067|3638614|FG001|NOT COMPLETED|Overall Study||1
2927764|NCT00574067|3638615|FG002|NOT COMPLETED|Overall Study||0
2927765|NCT00574067|3638616|FG003|NOT COMPLETED|Overall Study||0
3325815|NCT03234036|4058720|FG002|NOT COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||0
3325816|NCT03234036|4058721|FG003|NOT COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||0
3325817|NCT03234036|4058718|FG000|STARTED|Part 2 (Up to 25 Days)||0
3325818|NCT03234036|4058719|FG001|STARTED|Part 2 (Up to 25 Days)||0
3325819|NCT03234036|4058720|FG002|STARTED|Part 2 (Up to 25 Days)||3
3325820|NCT03234036|4058721|FG003|STARTED|Part 2 (Up to 25 Days)||7
3325821|NCT03234036|4058718|FG000|COMPLETED|Part 2 (Up to 25 Days)||0
3325822|NCT03234036|4058719|FG001|COMPLETED|Part 2 (Up to 25 Days)||0
3325823|NCT03234036|4058720|FG002|COMPLETED|Part 2 (Up to 25 Days)||3
3325824|NCT03234036|4058721|FG003|COMPLETED|Part 2 (Up to 25 Days)||7
3325825|NCT03234036|4058718|FG000|NOT COMPLETED|Part 2 (Up to 25 Days)||0
3325826|NCT03234036|4058719|FG001|NOT COMPLETED|Part 2 (Up to 25 Days)||0
3325827|NCT03234036|4058720|FG002|NOT COMPLETED|Part 2 (Up to 25 Days)||0
3325828|NCT03234036|4058721|FG003|NOT COMPLETED|Part 2 (Up to 25 Days)||0
3325829|NCT03234374|4058739|FG000|STARTED|Overall Study||35
3325830|NCT03234374|4058740|FG001|STARTED|Overall Study||17
3325831|NCT03234374|4058739|FG000|COMPLETED|Overall Study||34
3325832|NCT03234374|4058740|FG001|COMPLETED|Overall Study||16
3325833|NCT03234374|4058739|FG000|NOT COMPLETED|Overall Study||1
3325834|NCT03234374|4058740|FG001|NOT COMPLETED|Overall Study||1
3325835|NCT03234465|4058748|FG000|STARTED|Overall Study||100
3325836|NCT03234465|4058749|FG001|STARTED|Overall Study||100
3325837|NCT03234465|4058748|FG000|COMPLETED|Overall Study||67
3325838|NCT03234465|4058749|FG001|COMPLETED|Overall Study||60
3325839|NCT03234465|4058748|FG000|NOT COMPLETED|Overall Study||33
3325840|NCT03234465|4058749|FG001|NOT COMPLETED|Overall Study||40
3325841|NCT03234608|4058757|FG000|STARTED|Overall Study||127
3325842|NCT03234608|4058758|FG001|STARTED|Overall Study||117
3325843|NCT03234608|4058757|FG000|COMPLETED|Overall Study||104
3325844|NCT03234608|4058758|FG001|COMPLETED|Overall Study||96
3325845|NCT03234608|4058757|FG000|NOT COMPLETED|Overall Study||23
3325846|NCT03234608|4058758|FG001|NOT COMPLETED|Overall Study||21
3325847|NCT03235050|4058769|FG000|STARTED|Overall Study||112
3325848|NCT03235050|4058770|FG001|STARTED|Overall Study||110
3325849|NCT03235050|4058771|FG002|STARTED|Overall Study||100
3325850|NCT03235050|4058772|FG003|STARTED|Overall Study||256
3325851|NCT03235050|4058773|FG004|STARTED|Overall Study||256
3325852|NCT03235050|4058769|FG000|COMPLETED|Overall Study||108
3325853|NCT03235050|4058770|FG001|COMPLETED|Overall Study||105
3325854|NCT03235050|4058771|FG002|COMPLETED|Overall Study||96
3325855|NCT03235050|4058772|FG003|COMPLETED|Overall Study||242
3325856|NCT03235050|4058773|FG004|COMPLETED|Overall Study||245
3325857|NCT03235050|4058769|FG000|NOT COMPLETED|Overall Study||4
3325858|NCT03235050|4058770|FG001|NOT COMPLETED|Overall Study||5
3325859|NCT03235050|4058771|FG002|NOT COMPLETED|Overall Study||4
3325860|NCT03235050|4058772|FG003|NOT COMPLETED|Overall Study||14
3325861|NCT03235050|4058773|FG004|NOT COMPLETED|Overall Study||11
3325862|NCT03235089|4058785|FG000|STARTED|Overall Study||31
3325863|NCT03235089|4058786|FG001|STARTED|Overall Study||31
3325864|NCT03235089|4058785|FG000|COMPLETED|Overall Study||28
3325865|NCT03235089|4058786|FG001|COMPLETED|Overall Study||28
3325866|NCT03235089|4058785|FG000|NOT COMPLETED|Overall Study||3
3325867|NCT03235089|4058786|FG001|NOT COMPLETED|Overall Study||3
3325868|NCT03235115|4058793|FG000|STARTED|First Intervention (1 Hour, Visit 2)||9
3325869|NCT03235115|4058794|FG001|STARTED|First Intervention (1 Hour, Visit 2)||6
3325870|NCT03235115|4058795|FG002|STARTED|First Intervention (1 Hour, Visit 2)||7
3325871|NCT03235115|4058796|FG003|STARTED|First Intervention (1 Hour, Visit 2)||6
3325872|NCT03235115|4058797|FG004|STARTED|First Intervention (1 Hour, Visit 2)||6
3325873|NCT03235115|4058798|FG005|STARTED|First Intervention (1 Hour, Visit 2)||6
3325874|NCT03235115|4058793|FG000|COMPLETED|First Intervention (1 Hour, Visit 2)||9
3325875|NCT03235115|4058794|FG001|COMPLETED|First Intervention (1 Hour, Visit 2)||6
3325876|NCT03235115|4058795|FG002|COMPLETED|First Intervention (1 Hour, Visit 2)||7
3325877|NCT03235115|4058796|FG003|COMPLETED|First Intervention (1 Hour, Visit 2)||6
3325878|NCT03235115|4058797|FG004|COMPLETED|First Intervention (1 Hour, Visit 2)||6
3325879|NCT03235115|4058798|FG005|COMPLETED|First Intervention (1 Hour, Visit 2)||5
3325880|NCT03235115|4058793|FG000|NOT COMPLETED|First Intervention (1 Hour, Visit 2)||0
3325881|NCT03235115|4058794|FG001|NOT COMPLETED|First Intervention (1 Hour, Visit 2)||0
3325882|NCT03235115|4058795|FG002|NOT COMPLETED|First Intervention (1 Hour, Visit 2)||0
3325883|NCT03235115|4058796|FG003|NOT COMPLETED|First Intervention (1 Hour, Visit 2)||0
3325884|NCT03235115|4058797|FG004|NOT COMPLETED|First Intervention (1 Hour, Visit 2)||0
3325885|NCT03235115|4058798|FG005|NOT COMPLETED|First Intervention (1 Hour, Visit 2)||1
3325886|NCT03235115|4058793|FG000|STARTED|Second Intervention (1 Hour, Visit 4)||9
3325887|NCT03235115|4058794|FG001|STARTED|Second Intervention (1 Hour, Visit 4)||6
3325888|NCT03235115|4058795|FG002|STARTED|Second Intervention (1 Hour, Visit 4)||7
3325889|NCT03235115|4058796|FG003|STARTED|Second Intervention (1 Hour, Visit 4)||6
3325890|NCT03235115|4058797|FG004|STARTED|Second Intervention (1 Hour, Visit 4)||6
3325891|NCT03235115|4058798|FG005|STARTED|Second Intervention (1 Hour, Visit 4)||5
3325892|NCT03235115|4058793|FG000|COMPLETED|Second Intervention (1 Hour, Visit 4)||9
3325893|NCT03235115|4058794|FG001|COMPLETED|Second Intervention (1 Hour, Visit 4)||6
3325894|NCT03235115|4058795|FG002|COMPLETED|Second Intervention (1 Hour, Visit 4)||7
3325895|NCT03235115|4058796|FG003|COMPLETED|Second Intervention (1 Hour, Visit 4)||6
3325896|NCT03235115|4058797|FG004|COMPLETED|Second Intervention (1 Hour, Visit 4)||6
3325897|NCT03235115|4058798|FG005|COMPLETED|Second Intervention (1 Hour, Visit 4)||5
3325898|NCT03235115|4058793|FG000|NOT COMPLETED|Second Intervention (1 Hour, Visit 4)||0
3325899|NCT03235115|4058794|FG001|NOT COMPLETED|Second Intervention (1 Hour, Visit 4)||0
3325900|NCT03235115|4058795|FG002|NOT COMPLETED|Second Intervention (1 Hour, Visit 4)||0
3325901|NCT03235115|4058796|FG003|NOT COMPLETED|Second Intervention (1 Hour, Visit 4)||0
3325902|NCT03235115|4058797|FG004|NOT COMPLETED|Second Intervention (1 Hour, Visit 4)||0
3325903|NCT03235115|4058798|FG005|NOT COMPLETED|Second Intervention (1 Hour, Visit 4)||0
3325904|NCT03235115|4058793|FG000|STARTED|Third Intervention ( 1 Hour, Visit 6)||9
3325905|NCT03235115|4058794|FG001|STARTED|Third Intervention ( 1 Hour, Visit 6)||6
3325906|NCT03235115|4058795|FG002|STARTED|Third Intervention ( 1 Hour, Visit 6)||7
3325907|NCT03235115|4058796|FG003|STARTED|Third Intervention ( 1 Hour, Visit 6)||6
3325908|NCT03235115|4058797|FG004|STARTED|Third Intervention ( 1 Hour, Visit 6)||6
3325909|NCT03235115|4058798|FG005|STARTED|Third Intervention ( 1 Hour, Visit 6)||5
3325910|NCT03235115|4058793|FG000|COMPLETED|Third Intervention ( 1 Hour, Visit 6)||9
3325911|NCT03235115|4058794|FG001|COMPLETED|Third Intervention ( 1 Hour, Visit 6)||6
3325912|NCT03235115|4058795|FG002|COMPLETED|Third Intervention ( 1 Hour, Visit 6)||7
3325913|NCT03235115|4058796|FG003|COMPLETED|Third Intervention ( 1 Hour, Visit 6)||6
3325914|NCT03235115|4058797|FG004|COMPLETED|Third Intervention ( 1 Hour, Visit 6)||6
3325915|NCT03235115|4058798|FG005|COMPLETED|Third Intervention ( 1 Hour, Visit 6)||5
3325916|NCT03235115|4058793|FG000|NOT COMPLETED|Third Intervention ( 1 Hour, Visit 6)||0
3325917|NCT03235115|4058794|FG001|NOT COMPLETED|Third Intervention ( 1 Hour, Visit 6)||0
3325918|NCT03235115|4058795|FG002|NOT COMPLETED|Third Intervention ( 1 Hour, Visit 6)||0
3325919|NCT03235115|4058796|FG003|NOT COMPLETED|Third Intervention ( 1 Hour, Visit 6)||0
3325920|NCT03235115|4058797|FG004|NOT COMPLETED|Third Intervention ( 1 Hour, Visit 6)||0
3325921|NCT03235115|4058798|FG005|NOT COMPLETED|Third Intervention ( 1 Hour, Visit 6)||0
3325922|NCT03235154|4058806|FG000|STARTED|Overall Study||11
3325923|NCT03235154|4058806|FG000|Completed Epclusa. Treatment|Overall Study||8
3325924|NCT03235154|4058806|FG000|12-wk Post-treatment HCV RNA Measured|Overall Study||7
3325925|NCT03235154|4058806|FG000|COMPLETED|Overall Study||7
3325926|NCT03235154|4058806|FG000|NOT COMPLETED|Overall Study||4
3325927|NCT03235180|4058812|FG000|STARTED|Overall Study||9
3325928|NCT03235180|4058812|FG000|COMPLETED|Overall Study||9
3325929|NCT03235180|4058812|FG000|NOT COMPLETED|Overall Study||0
3325930|NCT03235284|4058819|FG000|STARTED|Overall Study||15
3325931|NCT03235284|4058820|FG001|STARTED|Overall Study||15
3325932|NCT03235284|4058821|FG002|STARTED|Overall Study||15
3325933|NCT03235284|4058819|FG000|COMPLETED|Overall Study||14
3325934|NCT03235284|4058820|FG001|COMPLETED|Overall Study||13
3325935|NCT03235284|4058821|FG002|COMPLETED|Overall Study||14
3325936|NCT03235284|4058819|FG000|NOT COMPLETED|Overall Study||1
3325937|NCT03235284|4058820|FG001|NOT COMPLETED|Overall Study||2
3325938|NCT03235284|4058821|FG002|NOT COMPLETED|Overall Study||1
3325939|NCT03235349|4058829|FG000|STARTED|Overall Study||160
3325940|NCT03235349|4058829|FG000|COMPLETED|Overall Study||158
3325941|NCT03235349|4058829|FG000|NOT COMPLETED|Overall Study||2
3325942|NCT03235414|4058833|FG000|STARTED|Overall Study||101
3325943|NCT03235414|4058833|FG000|COMPLETED|Overall Study||101
3325944|NCT03235414|4058833|FG000|NOT COMPLETED|Overall Study||0
3325945|NCT03235479|4058839|FG000|STARTED|Overall Study||582
3325946|NCT03235479|4058840|FG001|STARTED|Overall Study||580
3325947|NCT03235479|4058839|FG000|Treated|Overall Study||546
3325948|NCT03235479|4058840|FG001|Treated|Overall Study||549
3325949|NCT03235479|4058839|FG000|COMPLETED|Overall Study||541
3325950|NCT03235479|4058840|FG001|COMPLETED|Overall Study||540
3325951|NCT03235479|4058839|FG000|NOT COMPLETED|Overall Study||41
3325952|NCT03235479|4058840|FG001|NOT COMPLETED|Overall Study||40
3325953|NCT03235726|4058854|FG000|STARTED|Part 1 (Cohort A 60 mg - Day 1)||6
3325954|NCT03235726|4058855|FG001|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0
3325955|NCT03235726|4058856|FG002|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0
3325956|NCT03235726|4058857|FG003|STARTED|Part 1 (Cohort A 60 mg - Day 1)||2
3325957|NCT03235726|4058858|FG004|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0
3325958|NCT03235726|4058859|FG005|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0
3325959|NCT03235726|4058860|FG006|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0
3325960|NCT03235726|4058861|FG007|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0
3325961|NCT03235726|4058862|FG008|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0
3325962|NCT03235726|4058863|FG009|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0
3325963|NCT03235726|4058854|FG000|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||6
3325964|NCT03235726|4058855|FG001|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
3325965|NCT03235726|4058856|FG002|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
3325966|NCT03235726|4058857|FG003|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||2
3176264|NCT01965600|3904087|FG001|STARTED|First Intervention||8
3176265|NCT01965600|3904088|FG002|STARTED|First Intervention||5
3176266|NCT01965600|3904089|FG003|STARTED|First Intervention||4
3176267|NCT01965600|3904086|FG000|Received at Least One Dose of Drug|First Intervention||6
3176268|NCT01965600|3904087|FG001|Received at Least One Dose of Drug|First Intervention||8
3325967|NCT03235726|4058858|FG004|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
3325968|NCT03235726|4058859|FG005|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
3325969|NCT03235726|4058860|FG006|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
3325970|NCT03235726|4058861|FG007|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
3325971|NCT03235726|4058862|FG008|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
3325972|NCT03235726|4058863|FG009|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
3325973|NCT03235726|4058854|FG000|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
3325974|NCT03235726|4058855|FG001|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
3325975|NCT03235726|4058856|FG002|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
3325976|NCT03235726|4058857|FG003|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
3325977|NCT03235726|4058858|FG004|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
3325978|NCT03235726|4058859|FG005|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
3325979|NCT03235726|4058860|FG006|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
3325980|NCT03235726|4058861|FG007|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
3325981|NCT03235726|4058862|FG008|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
3325982|NCT03235726|4058863|FG009|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
3325983|NCT03235726|4058854|FG000|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0
3325984|NCT03235726|4058855|FG001|STARTED|Part 1 (Cohort A 120 mg - Day 3)||6
3325985|NCT03235726|4058856|FG002|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0
3325986|NCT03235726|4058857|FG003|STARTED|Part 1 (Cohort A 120 mg - Day 3)||2
3325987|NCT03235726|4058858|FG004|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0
3325988|NCT03235726|4058859|FG005|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0
3325989|NCT03235726|4058860|FG006|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0
3325990|NCT03235726|4058861|FG007|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0
3325991|NCT03235726|4058862|FG008|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0
3325992|NCT03235726|4058863|FG009|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0
3325993|NCT03235726|4058854|FG000|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
3325994|NCT03235726|4058855|FG001|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||6
3325995|NCT03235726|4058856|FG002|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
3325996|NCT03235726|4058857|FG003|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||2
3325997|NCT03235726|4058858|FG004|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
3325998|NCT03235726|4058859|FG005|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
3325999|NCT03235726|4058860|FG006|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
3326000|NCT03235726|4058861|FG007|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
3326001|NCT03235726|4058862|FG008|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
3326002|NCT03235726|4058863|FG009|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
3326003|NCT03235726|4058854|FG000|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
3326004|NCT03235726|4058855|FG001|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
3326005|NCT03235726|4058856|FG002|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
3326006|NCT03235726|4058857|FG003|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
3326007|NCT03235726|4058858|FG004|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
3326008|NCT03235726|4058859|FG005|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
3326009|NCT03235726|4058860|FG006|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
3326010|NCT03235726|4058861|FG007|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
3326011|NCT03235726|4058862|FG008|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
3326012|NCT03235726|4058863|FG009|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
3326013|NCT03235726|4058854|FG000|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
3326014|NCT03235726|4058855|FG001|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
3326015|NCT03235726|4058856|FG002|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||6
3326016|NCT03235726|4058857|FG003|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||2
3326017|NCT03235726|4058858|FG004|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
3326018|NCT03235726|4058859|FG005|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
3326019|NCT03235726|4058860|FG006|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
3326020|NCT03235726|4058861|FG007|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
3326021|NCT03235726|4058862|FG008|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
3326022|NCT03235726|4058863|FG009|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
3326023|NCT03235726|4058854|FG000|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
3326024|NCT03235726|4058855|FG001|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
3326025|NCT03235726|4058856|FG002|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||6
3176269|NCT01965600|3904088|FG002|Received at Least One Dose of Drug|First Intervention||5
3176270|NCT01965600|3904089|FG003|Received at Least One Dose of Drug|First Intervention||4
3176271|NCT01965600|3904086|FG000|COMPLETED|First Intervention||6
3176272|NCT01965600|3904087|FG001|COMPLETED|First Intervention||8
3176273|NCT01965600|3904088|FG002|COMPLETED|First Intervention||5
3176274|NCT01965600|3904089|FG003|COMPLETED|First Intervention||4
3176275|NCT01965600|3904086|FG000|NOT COMPLETED|First Intervention||0
3176276|NCT01965600|3904087|FG001|NOT COMPLETED|First Intervention||0
3176277|NCT01965600|3904088|FG002|NOT COMPLETED|First Intervention||0
3176278|NCT01965600|3904089|FG003|NOT COMPLETED|First Intervention||0
3176279|NCT01965600|3904086|FG000|STARTED|Washout Period of Approximately 15 Days||6
3176280|NCT01965600|3904087|FG001|STARTED|Washout Period of Approximately 15 Days||8
3176281|NCT01965600|3904088|FG002|STARTED|Washout Period of Approximately 15 Days||5
3176282|NCT01965600|3904089|FG003|STARTED|Washout Period of Approximately 15 Days||4
3176283|NCT01965600|3904086|FG000|COMPLETED|Washout Period of Approximately 15 Days||4
3176284|NCT01965600|3904087|FG001|COMPLETED|Washout Period of Approximately 15 Days||4
3176285|NCT01965600|3904088|FG002|COMPLETED|Washout Period of Approximately 15 Days||3
3176286|NCT01965600|3904089|FG003|COMPLETED|Washout Period of Approximately 15 Days||2
3176287|NCT01965600|3904086|FG000|NOT COMPLETED|Washout Period of Approximately 15 Days||2
3176288|NCT01965600|3904087|FG001|NOT COMPLETED|Washout Period of Approximately 15 Days||4
3176289|NCT01965600|3904088|FG002|NOT COMPLETED|Washout Period of Approximately 15 Days||2
3176290|NCT01965600|3904089|FG003|NOT COMPLETED|Washout Period of Approximately 15 Days||2
3176291|NCT01965600|3904086|FG000|STARTED|Second Intervention||4
3176292|NCT01965600|3904087|FG001|STARTED|Second Intervention||4
3326026|NCT03235726|4058857|FG003|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||2
3326027|NCT03235726|4058858|FG004|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
3326028|NCT03235726|4058859|FG005|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
3326029|NCT03235726|4058860|FG006|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
3326030|NCT03235726|4058861|FG007|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
3326031|NCT03235726|4058862|FG008|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
3326032|NCT03235726|4058863|FG009|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
3326033|NCT03235726|4058854|FG000|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
3326034|NCT03235726|4058855|FG001|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
3326035|NCT03235726|4058856|FG002|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
3326036|NCT03235726|4058857|FG003|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
3326037|NCT03235726|4058858|FG004|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
3326038|NCT03235726|4058859|FG005|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
3326039|NCT03235726|4058860|FG006|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
3326040|NCT03235726|4058861|FG007|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
3326041|NCT03235726|4058862|FG008|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
3326042|NCT03235726|4058863|FG009|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
3326043|NCT03235726|4058854|FG000|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||0
3326044|NCT03235726|4058855|FG001|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||0
3326045|NCT03235726|4058856|FG002|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||0
3176293|NCT01965600|3904088|FG002|STARTED|Second Intervention||3
3176294|NCT01965600|3904089|FG003|STARTED|Second Intervention||2
3176295|NCT01965600|3904086|FG000|COMPLETED|Second Intervention||4
3176296|NCT01965600|3904087|FG001|COMPLETED|Second Intervention||4
3176297|NCT01965600|3904088|FG002|COMPLETED|Second Intervention||1
3176298|NCT01965600|3904089|FG003|COMPLETED|Second Intervention||0
3326046|NCT03235726|4058857|FG003|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||0
3326047|NCT03235726|4058858|FG004|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||12
3326048|NCT03235726|4058859|FG005|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||2
3326049|NCT03235726|4058860|FG006|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||14
3326050|NCT03235726|4058861|FG007|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||0
3326051|NCT03235726|4058862|FG008|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||0
3326052|NCT03235726|4058863|FG009|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||0
3326053|NCT03235726|4058854|FG000|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
3326054|NCT03235726|4058855|FG001|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
3326055|NCT03235726|4058856|FG002|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
3326056|NCT03235726|4058857|FG003|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
3326057|NCT03235726|4058858|FG004|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||10
3326058|NCT03235726|4058859|FG005|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||2
3326059|NCT03235726|4058860|FG006|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||14
3326060|NCT03235726|4058861|FG007|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
3326061|NCT03235726|4058862|FG008|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
3326062|NCT03235726|4058863|FG009|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
3326063|NCT03235726|4058854|FG000|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
3326064|NCT03235726|4058855|FG001|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
3326065|NCT03235726|4058856|FG002|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
3326066|NCT03235726|4058857|FG003|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
3326067|NCT03235726|4058858|FG004|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||2
3326068|NCT03235726|4058859|FG005|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
3326069|NCT03235726|4058860|FG006|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
3326070|NCT03235726|4058861|FG007|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
3176299|NCT01965600|3904086|FG000|NOT COMPLETED|Second Intervention||0
3176300|NCT01965600|3904087|FG001|NOT COMPLETED|Second Intervention||0
3176301|NCT01965600|3904088|FG002|NOT COMPLETED|Second Intervention||2
3326071|NCT03235726|4058862|FG008|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
3326072|NCT03235726|4058863|FG009|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
3326073|NCT03235726|4058854|FG000|STARTED|Part 2 (Cohort A - Day 1)||0
3326074|NCT03235726|4058855|FG001|STARTED|Part 2 (Cohort A - Day 1)||0
3326075|NCT03235726|4058856|FG002|STARTED|Part 2 (Cohort A - Day 1)||0
3326076|NCT03235726|4058857|FG003|STARTED|Part 2 (Cohort A - Day 1)||0
3176302|NCT01965600|3904089|FG003|NOT COMPLETED|Second Intervention||2
3176303|NCT01965652|3904099|FG000|STARTED|Overall Study|Includes two participants who each enrolled at two different sites|623
3326077|NCT03235726|4058858|FG004|STARTED|Part 2 (Cohort A - Day 1)||0
3326078|NCT03235726|4058859|FG005|STARTED|Part 2 (Cohort A - Day 1)||0
3326079|NCT03235726|4058860|FG006|STARTED|Part 2 (Cohort A - Day 1)||0
3326080|NCT03235726|4058861|FG007|STARTED|Part 2 (Cohort A - Day 1)||6
3326081|NCT03235726|4058862|FG008|STARTED|Part 2 (Cohort A - Day 1)||2
3326082|NCT03235726|4058863|FG009|STARTED|Part 2 (Cohort A - Day 1)||0
3326083|NCT03235726|4058854|FG000|COMPLETED|Part 2 (Cohort A - Day 1)||0
3326084|NCT03235726|4058855|FG001|COMPLETED|Part 2 (Cohort A - Day 1)||0
3326085|NCT03235726|4058856|FG002|COMPLETED|Part 2 (Cohort A - Day 1)||0
3326086|NCT03235726|4058857|FG003|COMPLETED|Part 2 (Cohort A - Day 1)||0
3326087|NCT03235726|4058858|FG004|COMPLETED|Part 2 (Cohort A - Day 1)||0
3326088|NCT03235726|4058859|FG005|COMPLETED|Part 2 (Cohort A - Day 1)||0
3326089|NCT03235726|4058860|FG006|COMPLETED|Part 2 (Cohort A - Day 1)||0
3326090|NCT03235726|4058861|FG007|COMPLETED|Part 2 (Cohort A - Day 1)||6
3326091|NCT03235726|4058862|FG008|COMPLETED|Part 2 (Cohort A - Day 1)||2
3326092|NCT03235726|4058863|FG009|COMPLETED|Part 2 (Cohort A - Day 1)||0
3326093|NCT03235726|4058854|FG000|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
3326094|NCT03235726|4058855|FG001|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
3326095|NCT03235726|4058856|FG002|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
3326096|NCT03235726|4058857|FG003|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
3326097|NCT03235726|4058858|FG004|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
3326098|NCT03235726|4058859|FG005|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
3326099|NCT03235726|4058860|FG006|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
3326100|NCT03235726|4058861|FG007|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
3326101|NCT03235726|4058862|FG008|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
3326102|NCT03235726|4058863|FG009|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
3326103|NCT03235726|4058854|FG000|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
3326104|NCT03235726|4058855|FG001|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
3326105|NCT03235726|4058856|FG002|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
3326106|NCT03235726|4058857|FG003|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
3326107|NCT03235726|4058858|FG004|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
3326108|NCT03235726|4058859|FG005|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
3326109|NCT03235726|4058860|FG006|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
3326110|NCT03235726|4058861|FG007|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
3326111|NCT03235726|4058862|FG008|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
3326112|NCT03235726|4058863|FG009|STARTED|Part 2 (Cohort B - Days 1 to 14)||8
3326113|NCT03235726|4058854|FG000|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
3326114|NCT03235726|4058855|FG001|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
3326115|NCT03235726|4058856|FG002|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
3326116|NCT03235726|4058857|FG003|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
3326117|NCT03235726|4058858|FG004|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
3326118|NCT03235726|4058859|FG005|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
3326119|NCT03235726|4058860|FG006|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
3326120|NCT03235726|4058861|FG007|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
3326121|NCT03235726|4058862|FG008|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
3326122|NCT03235726|4058863|FG009|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||8
3326123|NCT03235726|4058854|FG000|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
3326124|NCT03235726|4058855|FG001|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
3326125|NCT03235726|4058856|FG002|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
3326126|NCT03235726|4058857|FG003|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
3326127|NCT03235726|4058858|FG004|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
3326128|NCT03235726|4058859|FG005|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
3326129|NCT03235726|4058860|FG006|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
3326130|NCT03235726|4058861|FG007|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
3326131|NCT03235726|4058862|FG008|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
3326132|NCT03235726|4058863|FG009|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
3326133|NCT03235817|4058901|FG000|STARTED|Overall Study||13
3326134|NCT03235817|4058902|FG001|STARTED|Overall Study||13
3326135|NCT03235817|4058903|FG002|STARTED|Overall Study||13
3326136|NCT03235817|4058901|FG000|COMPLETED|Overall Study||10
3326137|NCT03235817|4058902|FG001|COMPLETED|Overall Study||12
3326138|NCT03235817|4058903|FG002|COMPLETED|Overall Study||11
3326139|NCT03235817|4058901|FG000|NOT COMPLETED|Overall Study||3
3326140|NCT03235817|4058902|FG001|NOT COMPLETED|Overall Study||1
3326141|NCT03235817|4058903|FG002|NOT COMPLETED|Overall Study||2
3326142|NCT03236168|4058912|FG000|STARTED|Overall Study||118
3326143|NCT03236168|4058912|FG000|COMPLETED|Overall Study||107
3326144|NCT03236168|4058912|FG000|NOT COMPLETED|Overall Study||11
3326145|NCT03236246|4058918|FG000|STARTED|24-Week Dose Titration Period||104
3326146|NCT03236246|4058919|FG001|STARTED|24-Week Dose Titration Period||102
3326147|NCT03236246|4058918|FG000|COMPLETED|24-Week Dose Titration Period||80
3326148|NCT03236246|4058919|FG001|COMPLETED|24-Week Dose Titration Period||75
3326149|NCT03236246|4058918|FG000|NOT COMPLETED|24-Week Dose Titration Period||24
3326150|NCT03236246|4058919|FG001|NOT COMPLETED|24-Week Dose Titration Period||27
3326151|NCT03236246|4058918|FG000|STARTED|24-Week Dose Maintenance Period|Not all participants completing the Dose Titration Period opted to enter the Dose Maintenance Period|76
3326152|NCT03236246|4058919|FG001|STARTED|24-Week Dose Maintenance Period|Not all participants completing the Dose Titration Period opted to enter the Dose Maintenance Period|72
3326153|NCT03236246|4058918|FG000|COMPLETED|24-Week Dose Maintenance Period||73
3326154|NCT03236246|4058919|FG001|COMPLETED|24-Week Dose Maintenance Period||66
3326155|NCT03236246|4058918|FG000|NOT COMPLETED|24-Week Dose Maintenance Period||3
3326156|NCT03236246|4058919|FG001|NOT COMPLETED|24-Week Dose Maintenance Period||6
3326157|NCT03236311|4058927|FG000|STARTED|Overall Study||5
3326158|NCT03236311|4058928|FG001|STARTED|Overall Study||5
3326159|NCT03236311|4058927|FG000|COMPLETED|Overall Study||5
3326160|NCT03236311|4058928|FG001|COMPLETED|Overall Study||2
3326161|NCT03236311|4058927|FG000|NOT COMPLETED|Overall Study||0
3326162|NCT03236311|4058928|FG001|NOT COMPLETED|Overall Study||3
3326163|NCT03236506|4058937|FG000|STARTED|Overall Study||39
3326164|NCT03236506|4058938|FG001|STARTED|Overall Study||42
3326165|NCT03236506|4058939|FG002|STARTED|Overall Study||47
3326166|NCT03236506|4058937|FG000|COMPLETED|Overall Study||33
3326167|NCT03236506|4058938|FG001|COMPLETED|Overall Study||37
3326168|NCT03236506|4058939|FG002|COMPLETED|Overall Study||40
3326169|NCT03236506|4058937|FG000|NOT COMPLETED|Overall Study||6
3326170|NCT03236506|4058938|FG001|NOT COMPLETED|Overall Study||5
3326171|NCT03236506|4058939|FG002|NOT COMPLETED|Overall Study||7
3326172|NCT03236779|4058949|FG000|STARTED|Overall Study||51
3326173|NCT03236779|4058950|FG001|STARTED|Overall Study||51
3326174|NCT03236779|4058949|FG000|COMPLETED|Overall Study||38
3326175|NCT03236779|4058950|FG001|COMPLETED|Overall Study||30
3326176|NCT03236779|4058949|FG000|NOT COMPLETED|Overall Study||13
3326177|NCT03236779|4058950|FG001|NOT COMPLETED|Overall Study||21
3326178|NCT03237013|4058961|FG000|STARTED|Baseline to Immediate Post-treatment||73
3326179|NCT03237013|4058962|FG001|STARTED|Baseline to Immediate Post-treatment||73
3326180|NCT03237013|4058963|FG002|STARTED|Baseline to Immediate Post-treatment||73
3326181|NCT03237013|4058961|FG000|COMPLETED|Baseline to Immediate Post-treatment||73
3326182|NCT03237013|4058962|FG001|COMPLETED|Baseline to Immediate Post-treatment||73
3326183|NCT03237013|4058963|FG002|COMPLETED|Baseline to Immediate Post-treatment||73
3326184|NCT03237013|4058961|FG000|NOT COMPLETED|Baseline to Immediate Post-treatment||0
3326185|NCT03237013|4058962|FG001|NOT COMPLETED|Baseline to Immediate Post-treatment||0
3326186|NCT03237013|4058963|FG002|NOT COMPLETED|Baseline to Immediate Post-treatment||0
3326187|NCT03237013|4058961|FG000|STARTED|Immediate Post-treatment to 1-mo F/u||73
3326188|NCT03237013|4058962|FG001|STARTED|Immediate Post-treatment to 1-mo F/u||73
3326189|NCT03237013|4058963|FG002|STARTED|Immediate Post-treatment to 1-mo F/u||73
3326190|NCT03237013|4058961|FG000|COMPLETED|Immediate Post-treatment to 1-mo F/u||30
3326191|NCT03237013|4058962|FG001|COMPLETED|Immediate Post-treatment to 1-mo F/u||43
3326192|NCT03237013|4058963|FG002|COMPLETED|Immediate Post-treatment to 1-mo F/u||36
3326193|NCT03237013|4058961|FG000|NOT COMPLETED|Immediate Post-treatment to 1-mo F/u||43
3326194|NCT03237013|4058962|FG001|NOT COMPLETED|Immediate Post-treatment to 1-mo F/u||30
3326195|NCT03237013|4058963|FG002|NOT COMPLETED|Immediate Post-treatment to 1-mo F/u||37
3326196|NCT03237065|4058973|FG000|STARTED|Overall Study||61
3176304|NCT01965652|3904100|FG001|STARTED|Overall Study|Includes three participants who each enrolled at two different sites|623
3326197|NCT03237065|4058974|FG001|STARTED|Overall Study||61
3326198|NCT03237065|4058973|FG000|Safety Analysis Set|Overall Study|1 subject from ferric carboxymaltose group received iron isomaltoside/ferric derisomaltose in error.|62
3326199|NCT03237065|4058974|FG001|Safety Analysis Set|Overall Study||57
3326200|NCT03237065|4058973|FG000|COMPLETED|Overall Study||57
3326201|NCT03237065|4058974|FG001|COMPLETED|Overall Study||57
3326202|NCT03237065|4058973|FG000|NOT COMPLETED|Overall Study||4
3326203|NCT03237065|4058974|FG001|NOT COMPLETED|Overall Study||4
3326204|NCT03237156|4058984|FG000|STARTED|Overall Study||6
3326205|NCT03237156|4058985|FG001|STARTED|Overall Study||6
3326206|NCT03237156|4058986|FG002|STARTED|Overall Study||6
3326207|NCT03237156|4058987|FG003|STARTED|Overall Study||6
3326208|NCT03237156|4058984|FG000|COMPLETED|Overall Study||6
3326209|NCT03237156|4058985|FG001|COMPLETED|Overall Study||6
3326210|NCT03237156|4058986|FG002|COMPLETED|Overall Study||6
3326211|NCT03237156|4058987|FG003|COMPLETED|Overall Study||6
3326212|NCT03237156|4058984|FG000|NOT COMPLETED|Overall Study||0
3326213|NCT03237156|4058985|FG001|NOT COMPLETED|Overall Study||0
3326214|NCT03237156|4058986|FG002|NOT COMPLETED|Overall Study||0
3326215|NCT03237156|4058987|FG003|NOT COMPLETED|Overall Study||0
3326216|NCT03237481|4059003|FG000|STARTED|Overall Study||164
3326217|NCT03237481|4059004|FG001|STARTED|Overall Study||172
3326218|NCT03237481|4059005|FG002|STARTED|Overall Study||82
3326219|NCT03237481|4059003|FG000|COMPLETED|Overall Study||159
3326220|NCT03237481|4059004|FG001|COMPLETED|Overall Study||170
3326221|NCT03237481|4059005|FG002|COMPLETED|Overall Study||81
3326222|NCT03237481|4059003|FG000|NOT COMPLETED|Overall Study||5
3176305|NCT01965652|3904099|FG000|Received Treatment|Overall Study||622
3176306|NCT01965652|3904100|FG001|Received Treatment|Overall Study||623
3176307|NCT01965652|3904099|FG000|COMPLETED|Overall Study||413
3176308|NCT01965652|3904100|FG001|COMPLETED|Overall Study||413
3176309|NCT01965652|3904099|FG000|NOT COMPLETED|Overall Study||210
3326223|NCT03237481|4059004|FG001|NOT COMPLETED|Overall Study||2
3326224|NCT03237481|4059005|FG002|NOT COMPLETED|Overall Study||1
3326225|NCT03237845|4059015|FG000|STARTED|Overall Study||594
3326226|NCT03237845|4059016|FG001|STARTED|Overall Study||592
3326227|NCT03237845|4059015|FG000|Treated|Overall Study||543
3326228|NCT03237845|4059016|FG001|Treated|Overall Study||543
3326229|NCT03237845|4059015|FG000|COMPLETED|Overall Study||538
3326230|NCT03237845|4059016|FG001|COMPLETED|Overall Study||542
3326231|NCT03237845|4059015|FG000|NOT COMPLETED|Overall Study||56
3326232|NCT03237845|4059016|FG001|NOT COMPLETED|Overall Study||50
3326233|NCT03237871|4059022|FG000|STARTED|Overall Study||17
3326234|NCT03237871|4059022|FG000|COMPLETED|Overall Study||11
3326235|NCT03237871|4059022|FG000|NOT COMPLETED|Overall Study||6
3326236|NCT03238001|4059026|FG000|STARTED|Visit 1 (Primary Endpoint Cohort)||436
3326237|NCT03238001|4059026|FG000|COMPLETED|Visit 1 (Primary Endpoint Cohort)||432
3326238|NCT03238001|4059026|FG000|NOT COMPLETED|Visit 1 (Primary Endpoint Cohort)||4
3326239|NCT03238001|4059026|FG000|STARTED|Visit 2 (Secondary Endpoint Cohort)||432
3326240|NCT03238001|4059026|FG000|COMPLETED|Visit 2 (Secondary Endpoint Cohort)||403
3326241|NCT03238001|4059026|FG000|NOT COMPLETED|Visit 2 (Secondary Endpoint Cohort)||29
3326242|NCT03238352|4059041|FG000|STARTED|Overall Study||43
3326243|NCT03238352|4059042|FG001|STARTED|Overall Study||23
3326244|NCT03238352|4059043|FG002|STARTED|Overall Study||23
3326245|NCT03238352|4059041|FG000|COMPLETED|Overall Study||43
3326246|NCT03238352|4059042|FG001|COMPLETED|Overall Study||20
3326247|NCT03238352|4059043|FG002|COMPLETED|Overall Study||22
3326248|NCT03238352|4059041|FG000|NOT COMPLETED|Overall Study||0
3326249|NCT03238352|4059042|FG001|NOT COMPLETED|Overall Study||3
3326250|NCT03238352|4059043|FG002|NOT COMPLETED|Overall Study||1
3326251|NCT03238417|4059053|FG000|STARTED|Overall||1330
3326252|NCT03238417|4059054|FG001|STARTED|Overall||2632
3326253|NCT03238417|4059053|FG000|COMPLETED|Overall||327
3326254|NCT03238417|4059054|FG001|COMPLETED|Overall||644
3326255|NCT03238417|4059053|FG000|NOT COMPLETED|Overall||1003
3326256|NCT03238417|4059054|FG001|NOT COMPLETED|Overall||1988
3326257|NCT03238417|4059053|FG000|STARTED|Baseline||513
3326258|NCT03238417|4059054|FG001|STARTED|Baseline||934
3326259|NCT03238417|4059053|FG000|COMPLETED|Baseline||124
3326260|NCT03238417|4059054|FG001|COMPLETED|Baseline||217
3326261|NCT03238417|4059053|FG000|NOT COMPLETED|Baseline||389
3326262|NCT03238417|4059054|FG001|NOT COMPLETED|Baseline||717
3326263|NCT03238417|4059053|FG000|STARTED|12-month||400
3326264|NCT03238417|4059054|FG001|STARTED|12-month||911
3326265|NCT03238417|4059053|FG000|COMPLETED|12-month||81
3326266|NCT03238417|4059054|FG001|COMPLETED|12-month||205
3326267|NCT03238417|4059053|FG000|NOT COMPLETED|12-month||319
3326268|NCT03238417|4059054|FG001|NOT COMPLETED|12-month||706
3326269|NCT03238417|4059053|FG000|STARTED|24-month||417
3326270|NCT03238417|4059054|FG001|STARTED|24-month||847
3326271|NCT03238417|4059053|FG000|COMPLETED|24-month||122
3326272|NCT03238417|4059054|FG001|COMPLETED|24-month||222
3326273|NCT03238417|4059053|FG000|NOT COMPLETED|24-month||295
3326274|NCT03238417|4059054|FG001|NOT COMPLETED|24-month||625
3326275|NCT03238651|4059065|FG000|STARTED|Overall Study||3
3326276|NCT03238651|4059066|FG001|STARTED|Overall Study||6
3326277|NCT03238651|4059067|FG002|STARTED|Overall Study||4
3326278|NCT03238651|4059068|FG003|STARTED|Overall Study||3
3326279|NCT03238651|4059069|FG004|STARTED|Overall Study||1
3326280|NCT03238651|4059065|FG000|COMPLETED|Overall Study||0
3326281|NCT03238651|4059066|FG001|COMPLETED|Overall Study||0
3326282|NCT03238651|4059067|FG002|COMPLETED|Overall Study||0
3326283|NCT03238651|4059068|FG003|COMPLETED|Overall Study||0
3326284|NCT03238651|4059069|FG004|COMPLETED|Overall Study||0
3326285|NCT03238651|4059065|FG000|NOT COMPLETED|Overall Study||3
3326286|NCT03238651|4059066|FG001|NOT COMPLETED|Overall Study||6
3326287|NCT03238651|4059067|FG002|NOT COMPLETED|Overall Study||4
3326288|NCT03238651|4059068|FG003|NOT COMPLETED|Overall Study||3
3326289|NCT03238651|4059069|FG004|NOT COMPLETED|Overall Study||1
3326290|NCT03238781|4059085|FG000|STARTED|Overall Study||137
3326291|NCT03238781|4059086|FG001|STARTED|Overall Study||104
3326292|NCT03238781|4059087|FG002|STARTED|Overall Study||102
3326293|NCT03238781|4059085|FG000|COMPLETED|Overall Study||111
3326294|NCT03238781|4059086|FG001|COMPLETED|Overall Study||87
3326295|NCT03238781|4059087|FG002|COMPLETED|Overall Study||82
3326296|NCT03238781|4059085|FG000|NOT COMPLETED|Overall Study||26
3326297|NCT03238781|4059086|FG001|NOT COMPLETED|Overall Study||17
3326298|NCT03238781|4059087|FG002|NOT COMPLETED|Overall Study||20
3326299|NCT03238911|4059097|FG000|STARTED|Overall Study||62
3326300|NCT03238911|4059098|FG001|STARTED|Overall Study||61
3326301|NCT03238911|4059097|FG000|Safety Analysis Set|Overall Study|1 subject from ferric carboxymaltose group received iron isomaltoside/ferric derisomaltose in error.|63
3326302|NCT03238911|4059098|FG001|Safety Analysis Set|Overall Study|1 subject from ferric carboxymaltose group received iron isomaltoside/ferric derisomaltose in error.|60
3326303|NCT03238911|4059097|FG000|COMPLETED|Overall Study||59
3326304|NCT03238911|4059098|FG001|COMPLETED|Overall Study||58
3326305|NCT03238911|4059097|FG000|NOT COMPLETED|Overall Study||3
3326306|NCT03238911|4059098|FG001|NOT COMPLETED|Overall Study||3
3326307|NCT03238924|4059107|FG000|STARTED|Overall Study||8
3326308|NCT03238924|4059108|FG001|STARTED|Overall Study||9
3326309|NCT03238924|4059107|FG000|COMPLETED|Overall Study||6
3326310|NCT03238924|4059108|FG001|COMPLETED|Overall Study||7
3326311|NCT03238924|4059107|FG000|NOT COMPLETED|Overall Study||2
3326312|NCT03238924|4059108|FG001|NOT COMPLETED|Overall Study||2
3326313|NCT03238963|4059116|FG000|STARTED|Overall Study||40
3326314|NCT03238963|4059117|FG001|STARTED|Overall Study||39
3326315|NCT03238963|4059116|FG000|COMPLETED|Overall Study||35
3326316|NCT03238963|4059117|FG001|COMPLETED|Overall Study||37
3326317|NCT03238963|4059116|FG000|NOT COMPLETED|Overall Study||5
3326318|NCT03238963|4059117|FG001|NOT COMPLETED|Overall Study||2
3326319|NCT03239106|4059123|FG000|STARTED|Overall Study||10
3326320|NCT03239106|4059123|FG000|COMPLETED|Overall Study||3
3326321|NCT03239106|4059123|FG000|NOT COMPLETED|Overall Study||7
3326322|NCT03239470|4059128|FG000|STARTED|Blood Donation||5
3326323|NCT03239470|4059129|FG001|STARTED|Blood Donation||0
3326324|NCT03239470|4059128|FG000|COMPLETED|Blood Donation||5
3326325|NCT03239470|4059129|FG001|COMPLETED|Blood Donation||0
3326326|NCT03239470|4059128|FG000|NOT COMPLETED|Blood Donation||0
3326327|NCT03239470|4059129|FG001|NOT COMPLETED|Blood Donation||0
3326328|NCT03239470|4059128|FG000|STARTED|Polyclonal Treg Infusion|Started includes all participants who completed the pre-infusion checklist at the infusion visit.|5
3326329|NCT03239470|4059129|FG001|STARTED|Polyclonal Treg Infusion||0
3326330|NCT03239470|4059128|FG000|COMPLETED|Polyclonal Treg Infusion|Participants who did not meet eligibility, per the pre-infusion checklist, did not complete study infusion.|4
3326331|NCT03239470|4059129|FG001|COMPLETED|Polyclonal Treg Infusion||0
3326332|NCT03239470|4059128|FG000|NOT COMPLETED|Polyclonal Treg Infusion||1
3326333|NCT03239470|4059129|FG001|NOT COMPLETED|Polyclonal Treg Infusion||0
3326334|NCT03239483|4059135|FG000|STARTED|Overall Study||19
3326335|NCT03239483|4059136|FG001|STARTED|Overall Study||9
3326336|NCT03239483|4059135|FG000|COMPLETED|Overall Study||17
3326337|NCT03239483|4059136|FG001|COMPLETED|Overall Study||9
3326338|NCT03239483|4059135|FG000|NOT COMPLETED|Overall Study||2
3326339|NCT03239483|4059136|FG001|NOT COMPLETED|Overall Study||0
3326340|NCT03239496|4059146|FG000|STARTED|Overall Study||200
3326341|NCT03239496|4059147|FG001|STARTED|Overall Study||178
3326342|NCT03239496|4059148|FG002|STARTED|Overall Study||178
3326343|NCT03239496|4059149|FG003|STARTED|Overall Study||217
3326344|NCT03239496|4059146|FG000|COMPLETED|Overall Study||186
3326345|NCT03239496|4059147|FG001|COMPLETED|Overall Study||168
3326346|NCT03239496|4059148|FG002|COMPLETED|Overall Study||166
3326347|NCT03239496|4059149|FG003|COMPLETED|Overall Study||203
3326348|NCT03239496|4059146|FG000|NOT COMPLETED|Overall Study||14
3326349|NCT03239496|4059147|FG001|NOT COMPLETED|Overall Study||10
3326350|NCT03239496|4059148|FG002|NOT COMPLETED|Overall Study||12
3326351|NCT03239496|4059149|FG003|NOT COMPLETED|Overall Study||14
3326352|NCT03239522|4059163|FG000|STARTED|Treatment Period 1 (Up to 7 Days)||6
3326353|NCT03239522|4059163|FG000|COMPLETED|Treatment Period 1 (Up to 7 Days)||6
3326354|NCT03239522|4059163|FG000|NOT COMPLETED|Treatment Period 1 (Up to 7 Days)||0
3326355|NCT03239522|4059163|FG000|STARTED|Washout Period (Up to 7 Days)||6
3326356|NCT03239522|4059163|FG000|COMPLETED|Washout Period (Up to 7 Days)||6
3326357|NCT03239522|4059163|FG000|NOT COMPLETED|Washout Period (Up to 7 Days)||0
3326358|NCT03239522|4059163|FG000|STARTED|Treatment Period 2 (Up to 15 Days)||6
3326359|NCT03239522|4059163|FG000|COMPLETED|Treatment Period 2 (Up to 15 Days)||6
3326360|NCT03239522|4059163|FG000|NOT COMPLETED|Treatment Period 2 (Up to 15 Days)||0
3326361|NCT03239574|4059174|FG000|STARTED|Overall Study||34
3326362|NCT03239574|4059174|FG000|COMPLETED|Overall Study||34
3326363|NCT03239574|4059174|FG000|NOT COMPLETED|Overall Study||0
3326364|NCT03239665|4059180|FG000|STARTED|Overall Study||175
3326365|NCT03239665|4059181|FG001|STARTED|Overall Study||160
3326366|NCT03239665|4059180|FG000|Met Inclusion Criteria|Overall Study||150
3326367|NCT03239665|4059181|FG001|Met Inclusion Criteria|Overall Study||144
3326368|NCT03239665|4059180|FG000|Submitted Survey Data|Overall Study||147
3326369|NCT03239665|4059181|FG001|Submitted Survey Data|Overall Study||140
3326370|NCT03239665|4059180|FG000|COMPLETED|Overall Study||147
3326371|NCT03239665|4059181|FG001|COMPLETED|Overall Study||140
3326372|NCT03239665|4059180|FG000|NOT COMPLETED|Overall Study||28
3326373|NCT03239665|4059181|FG001|NOT COMPLETED|Overall Study||20
3326374|NCT03239873|4059189|FG000|STARTED|Overall Study||300
3326375|NCT03239873|4059190|FG001|STARTED|Overall Study||300
3326376|NCT03239873|4059189|FG000|Vaccination 1|Overall Study||299
3326377|NCT03239873|4059190|FG001|Vaccination 1|Overall Study||300
3326378|NCT03239873|4059189|FG000|Vaccination 2|Overall Study||276
3326379|NCT03239873|4059190|FG001|Vaccination 2|Overall Study||282
3326380|NCT03239873|4059189|FG000|COMPLETED|Overall Study||268
3326381|NCT03239873|4059190|FG001|COMPLETED|Overall Study||273
3326382|NCT03239873|4059189|FG000|NOT COMPLETED|Overall Study||32
3326383|NCT03239873|4059190|FG001|NOT COMPLETED|Overall Study||27
3326384|NCT03240081|4059198|FG000|STARTED|Overall Study||25
3326385|NCT03240081|4059199|FG001|STARTED|Overall Study||25
3326386|NCT03240081|4059198|FG000|COMPLETED|Overall Study||25
3326387|NCT03240081|4059199|FG001|COMPLETED|Overall Study||22
3326388|NCT03240081|4059198|FG000|NOT COMPLETED|Overall Study||0
3326389|NCT03240081|4059199|FG001|NOT COMPLETED|Overall Study||3
3326390|NCT03240133|4059208|FG000|STARTED|Overall Study||33
3326391|NCT03240133|4059209|FG001|STARTED|Overall Study||14
3326392|NCT03240133|4059210|FG002|STARTED|Overall Study||11
3326393|NCT03240133|4059208|FG000|Completed Period 1|Overall Study||33
3326394|NCT03240133|4059209|FG001|Completed Period 1|Overall Study||14
3326395|NCT03240133|4059210|FG002|Completed Period 1|Overall Study||11
3326396|NCT03240133|4059208|FG000|Completed Period 2|Overall Study||32
3326397|NCT03240133|4059209|FG001|Completed Period 2|Overall Study||11
3326398|NCT03240133|4059210|FG002|Completed Period 2|Overall Study||11
3326399|NCT03240133|4059208|FG000|Completed Period 3|Overall Study||30
3326400|NCT03240133|4059209|FG001|Completed Period 3|Overall Study||11
3326401|NCT03240133|4059210|FG002|Completed Period 3|Overall Study||11
3326402|NCT03240133|4059208|FG000|COMPLETED|Overall Study||30
3326403|NCT03240133|4059209|FG001|COMPLETED|Overall Study||11
3326404|NCT03240133|4059210|FG002|COMPLETED|Overall Study||10
3326405|NCT03240133|4059208|FG000|NOT COMPLETED|Overall Study||3
3326406|NCT03240133|4059209|FG001|NOT COMPLETED|Overall Study||3
3326407|NCT03240133|4059210|FG002|NOT COMPLETED|Overall Study||1
3326408|NCT03240575|4059238|FG000|STARTED|Overall Study||146
3326409|NCT03240575|4059239|FG001|STARTED|Overall Study||145
3326410|NCT03240575|4059240|FG002|STARTED|Overall Study||6
3326411|NCT03240575|4059241|FG003|STARTED|Overall Study||5
3326412|NCT03240575|4059238|FG000|COMPLETED|Overall Study||144
3326413|NCT03240575|4059239|FG001|COMPLETED|Overall Study||131
3326414|NCT03240575|4059240|FG002|COMPLETED|Overall Study||6
3326415|NCT03240575|4059241|FG003|COMPLETED|Overall Study||3
3326416|NCT03240575|4059238|FG000|NOT COMPLETED|Overall Study||2
3326417|NCT03240575|4059239|FG001|NOT COMPLETED|Overall Study||14
3326418|NCT03240575|4059240|FG002|NOT COMPLETED|Overall Study||0
3326419|NCT03240575|4059241|FG003|NOT COMPLETED|Overall Study||2
3326420|NCT03241030|4059251|FG000|STARTED|Overall Study||50
3326421|NCT03241030|4059252|FG001|STARTED|Overall Study||52
3326422|NCT03241030|4059251|FG000|COMPLETED|Overall Study||49
3326423|NCT03241030|4059252|FG001|COMPLETED|Overall Study||51
3326424|NCT03241030|4059251|FG000|NOT COMPLETED|Overall Study||1
3326425|NCT03241030|4059252|FG001|NOT COMPLETED|Overall Study||1
3326426|NCT03241342|4059261|FG000|STARTED|Overall Study||163
3326427|NCT03241342|4059262|FG001|STARTED|Overall Study||163
3326428|NCT03241342|4059263|FG002|STARTED|Overall Study||165
3326429|NCT03241342|4059261|FG000|COMPLETED|Overall Study||141
3326430|NCT03241342|4059262|FG001|COMPLETED|Overall Study||132
3326431|NCT03241342|4059263|FG002|COMPLETED|Overall Study||138
3326432|NCT03241342|4059261|FG000|NOT COMPLETED|Overall Study||22
3326433|NCT03241342|4059262|FG001|NOT COMPLETED|Overall Study||31
3326434|NCT03241342|4059263|FG002|NOT COMPLETED|Overall Study||27
3326435|NCT03241368|4059271|FG000|STARTED|Overall Study||158
3326436|NCT03241368|4059271|FG000|COMPLETED|Overall Study||119
3326437|NCT03241368|4059271|FG000|NOT COMPLETED|Overall Study||39
3326438|NCT03241485|4059278|FG000|STARTED|Overall Study||42
3326439|NCT03241485|4059279|FG001|STARTED|Overall Study||37
3326440|NCT03241485|4059278|FG000|COMPLETED|Overall Study||37
3326441|NCT03241485|4059279|FG001|COMPLETED|Overall Study||33
3326442|NCT03241485|4059278|FG000|NOT COMPLETED|Overall Study||5
3326443|NCT03241485|4059279|FG001|NOT COMPLETED|Overall Study||4
3326444|NCT03241810|4059291|FG000|STARTED|Overall Study||11
3326445|NCT03241810|4059292|FG001|STARTED|Overall Study||11
3326446|NCT03241810|4059291|FG000|COMPLETED|Overall Study|Safety population: includes patients receiving at least one dose of study medication.|11
3326447|NCT03241810|4059292|FG001|COMPLETED|Overall Study|Safety population: includes patients receiving at least one dose of study medication.|11
3326448|NCT03241810|4059291|FG000|NOT COMPLETED|Overall Study||0
3326449|NCT03241810|4059292|FG001|NOT COMPLETED|Overall Study||0
3326450|NCT03241862|4059299|FG000|STARTED|Overall Study||20
3326451|NCT03241862|4059299|FG000|COMPLETED|Overall Study||20
3326452|NCT03241862|4059299|FG000|NOT COMPLETED|Overall Study||0
3326453|NCT03241927|4059303|FG000|STARTED|Overall Study||1
3326454|NCT03241927|4059304|FG001|STARTED|Overall Study||0
3326455|NCT03241927|4059303|FG000|COMPLETED|Overall Study||0
3326456|NCT03241927|4059304|FG001|COMPLETED|Overall Study||0
3326457|NCT03241927|4059303|FG000|NOT COMPLETED|Overall Study||1
3326458|NCT03241927|4059304|FG001|NOT COMPLETED|Overall Study||0
3326459|NCT03242018|4059313|FG000|STARTED|Overall Study||93
3326460|NCT03242018|4059314|FG001|STARTED|Overall Study||92
3326461|NCT03242018|4059315|FG002|STARTED|Overall Study||92
3326462|NCT03242018|4059313|FG000|COMPLETED|Overall Study||75
3326463|NCT03242018|4059314|FG001|COMPLETED|Overall Study||78
3326464|NCT03242018|4059315|FG002|COMPLETED|Overall Study||78
3326465|NCT03242018|4059313|FG000|NOT COMPLETED|Overall Study||18
3326466|NCT03242018|4059314|FG001|NOT COMPLETED|Overall Study||14
3326467|NCT03242018|4059315|FG002|NOT COMPLETED|Overall Study||14
3326468|NCT03242148|4059324|FG000|STARTED|Overall Study||38
3326469|NCT03242148|4059324|FG000|COMPLETED|Overall Study||38
3326470|NCT03242148|4059324|FG000|NOT COMPLETED|Overall Study||0
3326471|NCT03242252|4059331|FG000|STARTED|Overall Study||260
3326472|NCT03242252|4059332|FG001|STARTED|Overall Study||263
3326473|NCT03242252|4059333|FG002|STARTED|Overall Study||264
3326474|NCT03242252|4059331|FG000|COMPLETED|Overall Study||224
3326475|NCT03242252|4059332|FG001|COMPLETED|Overall Study||240
3326476|NCT03242252|4059333|FG002|COMPLETED|Overall Study||232
3326477|NCT03242252|4059331|FG000|NOT COMPLETED|Overall Study||36
3326478|NCT03242252|4059332|FG001|NOT COMPLETED|Overall Study||23
3326479|NCT03242252|4059333|FG002|NOT COMPLETED|Overall Study||32
3326480|NCT03242408|4059347|FG000|STARTED|Overall Study||100
3326481|NCT03242408|4059347|FG000|COMPLETED|Overall Study||98
3326482|NCT03242408|4059347|FG000|NOT COMPLETED|Overall Study||2
3326483|NCT03242434|4059353|FG000|STARTED|Overall Study||15
3326484|NCT03242434|4059354|FG001|STARTED|Overall Study||3
3326485|NCT03242434|4059353|FG000|COMPLETED|Overall Study||15
3326486|NCT03242434|4059354|FG001|COMPLETED|Overall Study||1
3326487|NCT03242434|4059353|FG000|NOT COMPLETED|Overall Study||0
3326488|NCT03242434|4059354|FG001|NOT COMPLETED|Overall Study||2
3326489|NCT03242590|4059361|FG000|STARTED|Overall Study||95
3326490|NCT03242590|4059361|FG000|COMPLETED|Overall Study||95
3326491|NCT03242590|4059361|FG000|NOT COMPLETED|Overall Study||0
3326492|NCT03242759|4059367|FG000|STARTED|Overall Study||88
3326493|NCT03242759|4059368|FG001|STARTED|Overall Study||13
3326494|NCT03242759|4059367|FG000|COMPLETED|Overall Study||53
3326495|NCT03242759|4059368|FG001|COMPLETED|Overall Study||6
3326496|NCT03242759|4059367|FG000|NOT COMPLETED|Overall Study||35
3326497|NCT03242759|4059368|FG001|NOT COMPLETED|Overall Study||7
3326498|NCT03242863|4059374|FG000|STARTED|Study Week 1||13
3326499|NCT03242863|4059375|FG001|STARTED|Study Week 1||16
3326500|NCT03242863|4059376|FG002|STARTED|Study Week 1||4
3326501|NCT03242863|4059377|FG003|STARTED|Study Week 1||4
3326502|NCT03242863|4059378|FG004|STARTED|Study Week 1||15
3326503|NCT03242863|4059379|FG005|STARTED|Study Week 1||5
3326504|NCT03242863|4059374|FG000|COMPLETED|Study Week 1||13
3326505|NCT03242863|4059375|FG001|COMPLETED|Study Week 1||15
3326506|NCT03242863|4059376|FG002|COMPLETED|Study Week 1||4
3326507|NCT03242863|4059377|FG003|COMPLETED|Study Week 1||4
3326508|NCT03242863|4059378|FG004|COMPLETED|Study Week 1||12
3326509|NCT03242863|4059379|FG005|COMPLETED|Study Week 1||5
3326510|NCT03242863|4059374|FG000|NOT COMPLETED|Study Week 1||0
3326511|NCT03242863|4059375|FG001|NOT COMPLETED|Study Week 1||1
3326512|NCT03242863|4059376|FG002|NOT COMPLETED|Study Week 1||0
3326513|NCT03242863|4059377|FG003|NOT COMPLETED|Study Week 1||0
3326514|NCT03242863|4059378|FG004|NOT COMPLETED|Study Week 1||3
3326515|NCT03242863|4059379|FG005|NOT COMPLETED|Study Week 1||0
3326516|NCT03242863|4059374|FG000|STARTED|Study Week 2||13
3326517|NCT03242863|4059375|FG001|STARTED|Study Week 2||15
3326518|NCT03242863|4059376|FG002|STARTED|Study Week 2||4
3326519|NCT03242863|4059377|FG003|STARTED|Study Week 2||4
3326520|NCT03242863|4059378|FG004|STARTED|Study Week 2||12
3326521|NCT03242863|4059379|FG005|STARTED|Study Week 2||5
3326522|NCT03242863|4059374|FG000|COMPLETED|Study Week 2||13
3326523|NCT03242863|4059375|FG001|COMPLETED|Study Week 2||15
3326524|NCT03242863|4059376|FG002|COMPLETED|Study Week 2||4
3326525|NCT03242863|4059377|FG003|COMPLETED|Study Week 2||4
3326526|NCT03242863|4059378|FG004|COMPLETED|Study Week 2||12
3326527|NCT03242863|4059379|FG005|COMPLETED|Study Week 2||5
3326528|NCT03242863|4059374|FG000|NOT COMPLETED|Study Week 2||0
3326529|NCT03242863|4059375|FG001|NOT COMPLETED|Study Week 2||0
3326530|NCT03242863|4059376|FG002|NOT COMPLETED|Study Week 2||0
3326531|NCT03242863|4059377|FG003|NOT COMPLETED|Study Week 2||0
3326532|NCT03242863|4059378|FG004|NOT COMPLETED|Study Week 2||0
3326533|NCT03242863|4059379|FG005|NOT COMPLETED|Study Week 2||0
3326534|NCT03242863|4059374|FG000|STARTED|Study Week 3||13
3326535|NCT03242863|4059375|FG001|STARTED|Study Week 3||15
3326536|NCT03242863|4059376|FG002|STARTED|Study Week 3||4
3326537|NCT03242863|4059377|FG003|STARTED|Study Week 3||4
3326538|NCT03242863|4059378|FG004|STARTED|Study Week 3||12
3326539|NCT03242863|4059379|FG005|STARTED|Study Week 3||5
3326540|NCT03242863|4059374|FG000|COMPLETED|Study Week 3||13
3326541|NCT03242863|4059375|FG001|COMPLETED|Study Week 3||15
3326542|NCT03242863|4059376|FG002|COMPLETED|Study Week 3||4
3326543|NCT03242863|4059377|FG003|COMPLETED|Study Week 3||4
3326544|NCT03242863|4059378|FG004|COMPLETED|Study Week 3||12
3326545|NCT03242863|4059379|FG005|COMPLETED|Study Week 3||5
3326546|NCT03242863|4059374|FG000|NOT COMPLETED|Study Week 3||0
3326547|NCT03242863|4059375|FG001|NOT COMPLETED|Study Week 3||0
3326548|NCT03242863|4059376|FG002|NOT COMPLETED|Study Week 3||0
3326549|NCT03242863|4059377|FG003|NOT COMPLETED|Study Week 3||0
3326550|NCT03242863|4059378|FG004|NOT COMPLETED|Study Week 3||0
3326551|NCT03242863|4059379|FG005|NOT COMPLETED|Study Week 3||0
3326552|NCT03242928|4059389|FG000|STARTED|Overall Study||31
3326553|NCT03242928|4059390|FG001|STARTED|Overall Study||37
3326554|NCT03242928|4059389|FG000|COMPLETED|Overall Study||22
3326555|NCT03242928|4059390|FG001|COMPLETED|Overall Study||32
3326556|NCT03242928|4059389|FG000|NOT COMPLETED|Overall Study||9
3326557|NCT03242928|4059390|FG001|NOT COMPLETED|Overall Study||5
3326558|NCT03242941|4059396|FG000|STARTED|Overall Study||16
3326559|NCT03242941|4059396|FG000|COMPLETED|Overall Study||14
3326560|NCT03242941|4059396|FG000|NOT COMPLETED|Overall Study||2
3326561|NCT03242954|4059405|FG000|STARTED|Overall Study||43
3326562|NCT03242954|4059406|FG001|STARTED|Overall Study||45
3326563|NCT03242954|4059407|FG002|STARTED|Overall Study||41
3326564|NCT03242954|4059408|FG003|STARTED|Overall Study||125
3326565|NCT03242954|4059405|FG000|COMPLETED|Overall Study||43
3326566|NCT03242954|4059406|FG001|COMPLETED|Overall Study||45
3326567|NCT03242954|4059407|FG002|COMPLETED|Overall Study||41
3326568|NCT03242954|4059408|FG003|COMPLETED|Overall Study||125
3326569|NCT03242954|4059405|FG000|NOT COMPLETED|Overall Study||0
3326570|NCT03242954|4059406|FG001|NOT COMPLETED|Overall Study||0
3326571|NCT03242954|4059407|FG002|NOT COMPLETED|Overall Study||0
3326572|NCT03242954|4059408|FG003|NOT COMPLETED|Overall Study||0
3326573|NCT03243084|4059420|FG000|STARTED|Session 1||11
3326574|NCT03243084|4059421|FG001|STARTED|Session 1||10
3326575|NCT03243084|4059420|FG000|COMPLETED|Session 1||11
3326576|NCT03243084|4059421|FG001|COMPLETED|Session 1||10
3326577|NCT03243084|4059420|FG000|NOT COMPLETED|Session 1||0
3326578|NCT03243084|4059421|FG001|NOT COMPLETED|Session 1||0
3326579|NCT03243084|4059420|FG000|STARTED|Washout (1-3 Weeks)||11
3326580|NCT03243084|4059421|FG001|STARTED|Washout (1-3 Weeks)||10
3326581|NCT03243084|4059420|FG000|COMPLETED|Washout (1-3 Weeks)||10
3326582|NCT03243084|4059421|FG001|COMPLETED|Washout (1-3 Weeks)||10
3326583|NCT03243084|4059420|FG000|NOT COMPLETED|Washout (1-3 Weeks)||1
3326584|NCT03243084|4059421|FG001|NOT COMPLETED|Washout (1-3 Weeks)||0
3326585|NCT03243084|4059420|FG000|STARTED|Session 2||10
3326586|NCT03243084|4059421|FG001|STARTED|Session 2||10
3326587|NCT03243084|4059420|FG000|COMPLETED|Session 2||10
3326588|NCT03243084|4059421|FG001|COMPLETED|Session 2||10
3326589|NCT03243084|4059420|FG000|NOT COMPLETED|Session 2||0
3326590|NCT03243084|4059421|FG001|NOT COMPLETED|Session 2||0
3326591|NCT03243305|4059428|FG000|STARTED|Overall Study||1384
3326592|NCT03243305|4059428|FG000|COMPLETED|Overall Study||449
3326593|NCT03243305|4059428|FG000|NOT COMPLETED|Overall Study||935
3326594|NCT03243630|4059432|FG000|STARTED|Overall Study||24
3326595|NCT03243630|4059432|FG000|Menthol E-liquid Saline|Overall Study||22
3326596|NCT03243630|4059432|FG000|Menthol E-liquid Higher|Overall Study||22
3326597|NCT03243630|4059432|FG000|Menthol E-liquid Lower|Overall Study||22
3326598|NCT03243630|4059432|FG000|Green Apple E-liquid Saline|Overall Study||20
3326599|NCT03243630|4059432|FG000|Green Apple E-liquid Higher|Overall Study||20
3326600|NCT03243630|4059432|FG000|Green Apple E-liquid Lower|Overall Study||20
3326601|NCT03243630|4059432|FG000|Green Apple and Menthol E-liquid Saline|Overall Study||21
3326602|NCT03243630|4059432|FG000|Green Apple and Menthol E-liquid Higher|Overall Study||21
3326603|NCT03243630|4059432|FG000|Green Apple and Menthol E-liquid Lower|Overall Study||21
3326604|NCT03243630|4059432|FG000|COMPLETED|Overall Study||22
3326605|NCT03243630|4059432|FG000|NOT COMPLETED|Overall Study||2
3326606|NCT03243981|4059440|FG000|STARTED|Overall Study||5
3326607|NCT03243981|4059440|FG000|COMPLETED|Overall Study||5
3326608|NCT03243981|4059440|FG000|NOT COMPLETED|Overall Study||0
3326609|NCT03244618|4059451|FG000|STARTED|Overall Study||132
3326610|NCT03244618|4059452|FG001|STARTED|Overall Study||131
3326611|NCT03244618|4059451|FG000|Week 2|Overall Study||128
3326612|NCT03244618|4059452|FG001|Week 2|Overall Study||125
3326613|NCT03244618|4059451|FG000|COMPLETED|Overall Study||125
3326614|NCT03244618|4059452|FG001|COMPLETED|Overall Study||122
3326615|NCT03244618|4059451|FG000|NOT COMPLETED|Overall Study||7
3326616|NCT03244618|4059452|FG001|NOT COMPLETED|Overall Study||9
3176310|NCT01965652|3904100|FG001|NOT COMPLETED|Overall Study||210
3176311|NCT01965665|3904106|FG000|STARTED|Overall Study||20
3326617|NCT03244800|4059462|FG000|STARTED|Overall Study||13
3326618|NCT03244800|4059463|FG001|STARTED|Overall Study||26
3326619|NCT03244800|4059464|FG002|STARTED|Overall Study||6
3326620|NCT03244800|4059465|FG003|STARTED|Overall Study||20
3326621|NCT03244800|4059462|FG000|COMPLETED|Overall Study||13
3326622|NCT03244800|4059463|FG001|COMPLETED|Overall Study||25
3326623|NCT03244800|4059464|FG002|COMPLETED|Overall Study||6
3326624|NCT03244800|4059465|FG003|COMPLETED|Overall Study||18
3326625|NCT03244800|4059462|FG000|NOT COMPLETED|Overall Study||0
3176312|NCT01965665|3904106|FG000|COMPLETED|Overall Study||19
3176313|NCT01965665|3904106|FG000|NOT COMPLETED|Overall Study||1
3176314|NCT01965756|3904112|FG000|STARTED|Overall Study||10
3326626|NCT03244800|4059463|FG001|NOT COMPLETED|Overall Study||1
3326627|NCT03244800|4059464|FG002|NOT COMPLETED|Overall Study||0
3326628|NCT03244800|4059465|FG003|NOT COMPLETED|Overall Study||2
3326629|NCT03244865|4059478|FG000|STARTED|Overall Study||35
3326630|NCT03244865|4059478|FG000|COMPLETED|Overall Study||35
3326631|NCT03244865|4059478|FG000|NOT COMPLETED|Overall Study||0
3326632|NCT03244917|4059484|FG000|STARTED|Overall Study||201
3326633|NCT03244917|4059485|FG001|STARTED|Overall Study||229
3326634|NCT03244917|4059484|FG000|COMPLETED|Overall Study||199
3326635|NCT03244917|4059485|FG001|COMPLETED|Overall Study||227
3326636|NCT03244917|4059484|FG000|NOT COMPLETED|Overall Study||2
3326637|NCT03244917|4059485|FG001|NOT COMPLETED|Overall Study||2
3326638|NCT03245372|4059493|FG000|STARTED|Overall Study||15
3326639|NCT03245372|4059494|FG001|STARTED|Overall Study||15
3326640|NCT03245372|4059493|FG000|COMPLETED|Overall Study||15
3326641|NCT03245372|4059494|FG001|COMPLETED|Overall Study||15
3326642|NCT03245372|4059493|FG000|NOT COMPLETED|Overall Study||0
3326643|NCT03245372|4059494|FG001|NOT COMPLETED|Overall Study||0
3326644|NCT03245398|4059502|FG000|STARTED|Overall Study||93
3326645|NCT03245398|4059503|FG001|STARTED|Overall Study||93
3326646|NCT03245398|4059502|FG000|COMPLETED|Overall Study||92
3326647|NCT03245398|4059503|FG001|COMPLETED|Overall Study||93
3326648|NCT03245398|4059502|FG000|NOT COMPLETED|Overall Study||1
3326649|NCT03245398|4059503|FG001|NOT COMPLETED|Overall Study||0
3176315|NCT01965756|3904113|FG001|STARTED|Overall Study||10
3176316|NCT01965756|3904112|FG000|COMPLETED|Overall Study||10
3176317|NCT01965756|3904113|FG001|COMPLETED|Overall Study||10
3326650|NCT03245463|4059513|FG000|STARTED|Overall Study||12
3326651|NCT03245463|4059514|FG001|STARTED|Overall Study||12
3326652|NCT03245463|4059513|FG000|COMPLETED|Overall Study||12
3326653|NCT03245463|4059514|FG001|COMPLETED|Overall Study||12
3326654|NCT03245463|4059513|FG000|NOT COMPLETED|Overall Study||0
3326655|NCT03245463|4059514|FG001|NOT COMPLETED|Overall Study||0
3326656|NCT03245619|4059537|FG000|STARTED|Part A (Up to Day 22)||5
3326657|NCT03245619|4059538|FG001|STARTED|Part A (Up to Day 22)||6
3326658|NCT03245619|4059539|FG002|STARTED|Part A (Up to Day 22)||6
3326659|NCT03245619|4059540|FG003|STARTED|Part A (Up to Day 22)||1
3326660|NCT03245619|4059541|FG004|STARTED|Part A (Up to Day 22)||0
3326661|NCT03245619|4059542|FG005|STARTED|Part A (Up to Day 22)||0
3326662|NCT03245619|4059543|FG006|STARTED|Part A (Up to Day 22)||0
3326663|NCT03245619|4059544|FG007|STARTED|Part A (Up to Day 22)||0
3326664|NCT03245619|4059545|FG008|STARTED|Part A (Up to Day 22)||0
3326665|NCT03245619|4059546|FG009|STARTED|Part A (Up to Day 22)||0
3326666|NCT03245619|4059547|FG010|STARTED|Part A (Up to Day 22)||0
3326667|NCT03245619|4059548|FG011|STARTED|Part A (Up to Day 22)||0
3326668|NCT03245619|4059549|FG012|STARTED|Part A (Up to Day 22)||0
3326669|NCT03245619|4059550|FG013|STARTED|Part A (Up to Day 22)||0
3326670|NCT03245619|4059551|FG014|STARTED|Part A (Up to Day 22)||0
3326671|NCT03245619|4059552|FG015|STARTED|Part A (Up to Day 22)||0
3326672|NCT03245619|4059553|FG016|STARTED|Part A (Up to Day 22)||0
3326673|NCT03245619|4059537|FG000|COMPLETED|Part A (Up to Day 22)||1
3326674|NCT03245619|4059538|FG001|COMPLETED|Part A (Up to Day 22)||0
3326675|NCT03245619|4059539|FG002|COMPLETED|Part A (Up to Day 22)||0
3326676|NCT03245619|4059540|FG003|COMPLETED|Part A (Up to Day 22)||1
3326677|NCT03245619|4059541|FG004|COMPLETED|Part A (Up to Day 22)||0
3326678|NCT03245619|4059542|FG005|COMPLETED|Part A (Up to Day 22)||0
3326679|NCT03245619|4059543|FG006|COMPLETED|Part A (Up to Day 22)||0
3326680|NCT03245619|4059544|FG007|COMPLETED|Part A (Up to Day 22)||0
3326681|NCT03245619|4059545|FG008|COMPLETED|Part A (Up to Day 22)||0
3176318|NCT01965756|3904112|FG000|NOT COMPLETED|Overall Study||0
3176319|NCT01965756|3904113|FG001|NOT COMPLETED|Overall Study||0
3326682|NCT03245619|4059546|FG009|COMPLETED|Part A (Up to Day 22)||0
3326683|NCT03245619|4059547|FG010|COMPLETED|Part A (Up to Day 22)||0
3326684|NCT03245619|4059548|FG011|COMPLETED|Part A (Up to Day 22)||0
3326685|NCT03245619|4059549|FG012|COMPLETED|Part A (Up to Day 22)||0
3326686|NCT03245619|4059550|FG013|COMPLETED|Part A (Up to Day 22)||0
3326687|NCT03245619|4059551|FG014|COMPLETED|Part A (Up to Day 22)||0
3326688|NCT03245619|4059552|FG015|COMPLETED|Part A (Up to Day 22)||0
3326689|NCT03245619|4059553|FG016|COMPLETED|Part A (Up to Day 22)||0
3326690|NCT03245619|4059537|FG000|NOT COMPLETED|Part A (Up to Day 22)||4
3326691|NCT03245619|4059538|FG001|NOT COMPLETED|Part A (Up to Day 22)||6
3326692|NCT03245619|4059539|FG002|NOT COMPLETED|Part A (Up to Day 22)||6
3326693|NCT03245619|4059540|FG003|NOT COMPLETED|Part A (Up to Day 22)||0
3326694|NCT03245619|4059541|FG004|NOT COMPLETED|Part A (Up to Day 22)||0
3326695|NCT03245619|4059542|FG005|NOT COMPLETED|Part A (Up to Day 22)||0
3326696|NCT03245619|4059543|FG006|NOT COMPLETED|Part A (Up to Day 22)||0
3326697|NCT03245619|4059544|FG007|NOT COMPLETED|Part A (Up to Day 22)||0
3326698|NCT03245619|4059545|FG008|NOT COMPLETED|Part A (Up to Day 22)||0
3326699|NCT03245619|4059546|FG009|NOT COMPLETED|Part A (Up to Day 22)||0
3326700|NCT03245619|4059547|FG010|NOT COMPLETED|Part A (Up to Day 22)||0
3326701|NCT03245619|4059548|FG011|NOT COMPLETED|Part A (Up to Day 22)||0
3326702|NCT03245619|4059549|FG012|NOT COMPLETED|Part A (Up to Day 22)||0
3326703|NCT03245619|4059550|FG013|NOT COMPLETED|Part A (Up to Day 22)||0
3326704|NCT03245619|4059551|FG014|NOT COMPLETED|Part A (Up to Day 22)||0
3326705|NCT03245619|4059552|FG015|NOT COMPLETED|Part A (Up to Day 22)||0
3326706|NCT03245619|4059553|FG016|NOT COMPLETED|Part A (Up to Day 22)||0
3326707|NCT03245619|4059537|FG000|STARTED|Part B (Up to 34 Days)||0
3326708|NCT03245619|4059538|FG001|STARTED|Part B (Up to 34 Days)||0
3326709|NCT03245619|4059539|FG002|STARTED|Part B (Up to 34 Days)||0
3326710|NCT03245619|4059540|FG003|STARTED|Part B (Up to 34 Days)||0
3326711|NCT03245619|4059541|FG004|STARTED|Part B (Up to 34 Days)||0
3176320|NCT01965834|3904123|FG000|STARTED|Overall Study||6
3176321|NCT01965834|3904123|FG000|COMPLETED|Overall Study||2
3176322|NCT01965834|3904123|FG000|NOT COMPLETED|Overall Study||4
3176323|NCT01965860|3904130|FG000|STARTED|Overall Study||11
3176324|NCT01965860|3904131|FG001|STARTED|Overall Study||10
3176325|NCT01965860|3904132|FG002|STARTED|Overall Study||11
3176326|NCT01965860|3904130|FG000|COMPLETED|Overall Study||9
3176327|NCT01965860|3904131|FG001|COMPLETED|Overall Study||10
3176328|NCT01965860|3904132|FG002|COMPLETED|Overall Study||10
3326712|NCT03245619|4059542|FG005|STARTED|Part B (Up to 34 Days)||0
3326713|NCT03245619|4059543|FG006|STARTED|Part B (Up to 34 Days)||0
3326714|NCT03245619|4059544|FG007|STARTED|Part B (Up to 34 Days)||0
3326715|NCT03245619|4059545|FG008|STARTED|Part B (Up to 34 Days)||0
3326716|NCT03245619|4059546|FG009|STARTED|Part B (Up to 34 Days)||0
3326717|NCT03245619|4059547|FG010|STARTED|Part B (Up to 34 Days)||0
3326718|NCT03245619|4059548|FG011|STARTED|Part B (Up to 34 Days)||0
3326719|NCT03245619|4059549|FG012|STARTED|Part B (Up to 34 Days)||0
3326720|NCT03245619|4059550|FG013|STARTED|Part B (Up to 34 Days)||0
3326721|NCT03245619|4059551|FG014|STARTED|Part B (Up to 34 Days)||0
3326722|NCT03245619|4059552|FG015|STARTED|Part B (Up to 34 Days)||0
3326723|NCT03245619|4059553|FG016|STARTED|Part B (Up to 34 Days)||0
3326724|NCT03245619|4059537|FG000|COMPLETED|Part B (Up to 34 Days)||0
3326725|NCT03245619|4059538|FG001|COMPLETED|Part B (Up to 34 Days)||0
3326726|NCT03245619|4059539|FG002|COMPLETED|Part B (Up to 34 Days)||0
3326727|NCT03245619|4059540|FG003|COMPLETED|Part B (Up to 34 Days)||0
3326728|NCT03245619|4059541|FG004|COMPLETED|Part B (Up to 34 Days)||0
3326729|NCT03245619|4059542|FG005|COMPLETED|Part B (Up to 34 Days)||0
3326730|NCT03245619|4059543|FG006|COMPLETED|Part B (Up to 34 Days)||0
3326731|NCT03245619|4059544|FG007|COMPLETED|Part B (Up to 34 Days)||0
3326732|NCT03245619|4059545|FG008|COMPLETED|Part B (Up to 34 Days)||0
3326733|NCT03245619|4059546|FG009|COMPLETED|Part B (Up to 34 Days)||0
3326734|NCT03245619|4059547|FG010|COMPLETED|Part B (Up to 34 Days)||0
3326735|NCT03245619|4059548|FG011|COMPLETED|Part B (Up to 34 Days)||0
3326736|NCT03245619|4059549|FG012|COMPLETED|Part B (Up to 34 Days)||0
3326737|NCT03245619|4059550|FG013|COMPLETED|Part B (Up to 34 Days)||0
3326738|NCT03245619|4059551|FG014|COMPLETED|Part B (Up to 34 Days)||0
3326739|NCT03245619|4059552|FG015|COMPLETED|Part B (Up to 34 Days)||0
3326740|NCT03245619|4059553|FG016|COMPLETED|Part B (Up to 34 Days)||0
3326741|NCT03245619|4059537|FG000|NOT COMPLETED|Part B (Up to 34 Days)||0
3326742|NCT03245619|4059538|FG001|NOT COMPLETED|Part B (Up to 34 Days)||0
3326743|NCT03245619|4059539|FG002|NOT COMPLETED|Part B (Up to 34 Days)||0
3326744|NCT03245619|4059540|FG003|NOT COMPLETED|Part B (Up to 34 Days)||0
3326745|NCT03245619|4059541|FG004|NOT COMPLETED|Part B (Up to 34 Days)||0
3326746|NCT03245619|4059542|FG005|NOT COMPLETED|Part B (Up to 34 Days)||0
3326747|NCT03245619|4059543|FG006|NOT COMPLETED|Part B (Up to 34 Days)||0
3326748|NCT03245619|4059544|FG007|NOT COMPLETED|Part B (Up to 34 Days)||0
3326749|NCT03245619|4059545|FG008|NOT COMPLETED|Part B (Up to 34 Days)||0
3326750|NCT03245619|4059546|FG009|NOT COMPLETED|Part B (Up to 34 Days)||0
3326751|NCT03245619|4059547|FG010|NOT COMPLETED|Part B (Up to 34 Days)||0
3326752|NCT03245619|4059548|FG011|NOT COMPLETED|Part B (Up to 34 Days)||0
3326753|NCT03245619|4059549|FG012|NOT COMPLETED|Part B (Up to 34 Days)||0
3326754|NCT03245619|4059550|FG013|NOT COMPLETED|Part B (Up to 34 Days)||0
3326755|NCT03245619|4059551|FG014|NOT COMPLETED|Part B (Up to 34 Days)||0
3326756|NCT03245619|4059552|FG015|NOT COMPLETED|Part B (Up to 34 Days)||0
3326757|NCT03245619|4059553|FG016|NOT COMPLETED|Part B (Up to 34 Days)||0
3326758|NCT03245619|4059537|FG000|STARTED|Part C (Up to 34 Days)||0
3326759|NCT03245619|4059538|FG001|STARTED|Part C (Up to 34 Days)||0
3326760|NCT03245619|4059539|FG002|STARTED|Part C (Up to 34 Days)||0
3176329|NCT01965860|3904130|FG000|NOT COMPLETED|Overall Study||2
3176330|NCT01965860|3904131|FG001|NOT COMPLETED|Overall Study||0
3176331|NCT01965860|3904132|FG002|NOT COMPLETED|Overall Study||1
3176332|NCT01965899|3904140|FG000|STARTED|Overall Study||151
3176333|NCT01965899|3904140|FG000|COMPLETED|Overall Study||145
3176334|NCT01965899|3904140|FG000|NOT COMPLETED|Overall Study||6
3176335|NCT01965938|3904147|FG000|STARTED|Overall Study||21
3176336|NCT01965938|3904148|FG001|STARTED|Overall Study||20
3176337|NCT01965938|3904147|FG000|COMPLETED|Overall Study||20
3176338|NCT01965938|3904148|FG001|COMPLETED|Overall Study||20
3176339|NCT01965938|3904147|FG000|NOT COMPLETED|Overall Study||1
3326761|NCT03245619|4059540|FG003|STARTED|Part C (Up to 34 Days)||0
3326762|NCT03245619|4059541|FG004|STARTED|Part C (Up to 34 Days)||0
3326763|NCT03245619|4059542|FG005|STARTED|Part C (Up to 34 Days)||0
3326764|NCT03245619|4059543|FG006|STARTED|Part C (Up to 34 Days)||0
3176340|NCT01965938|3904148|FG001|NOT COMPLETED|Overall Study||0
3326765|NCT03245619|4059544|FG007|STARTED|Part C (Up to 34 Days)||0
3326766|NCT03245619|4059545|FG008|STARTED|Part C (Up to 34 Days)||0
3326767|NCT03245619|4059546|FG009|STARTED|Part C (Up to 34 Days)||0
3326768|NCT03245619|4059547|FG010|STARTED|Part C (Up to 34 Days)||0
3326769|NCT03245619|4059548|FG011|STARTED|Part C (Up to 34 Days)||0
3326770|NCT03245619|4059549|FG012|STARTED|Part C (Up to 34 Days)||0
3326771|NCT03245619|4059550|FG013|STARTED|Part C (Up to 34 Days)||0
3326772|NCT03245619|4059551|FG014|STARTED|Part C (Up to 34 Days)||0
3326773|NCT03245619|4059552|FG015|STARTED|Part C (Up to 34 Days)||0
3326774|NCT03245619|4059553|FG016|STARTED|Part C (Up to 34 Days)||0
3326775|NCT03245619|4059537|FG000|COMPLETED|Part C (Up to 34 Days)||0
3326776|NCT03245619|4059538|FG001|COMPLETED|Part C (Up to 34 Days)||0
3326777|NCT03245619|4059539|FG002|COMPLETED|Part C (Up to 34 Days)||0
3326778|NCT03245619|4059540|FG003|COMPLETED|Part C (Up to 34 Days)||0
3326779|NCT03245619|4059541|FG004|COMPLETED|Part C (Up to 34 Days)||0
3326780|NCT03245619|4059542|FG005|COMPLETED|Part C (Up to 34 Days)||0
3326781|NCT03245619|4059543|FG006|COMPLETED|Part C (Up to 34 Days)||0
3326782|NCT03245619|4059544|FG007|COMPLETED|Part C (Up to 34 Days)||0
3326783|NCT03245619|4059545|FG008|COMPLETED|Part C (Up to 34 Days)||0
3326784|NCT03245619|4059546|FG009|COMPLETED|Part C (Up to 34 Days)||0
3326785|NCT03245619|4059547|FG010|COMPLETED|Part C (Up to 34 Days)||0
3326786|NCT03245619|4059548|FG011|COMPLETED|Part C (Up to 34 Days)||0
3326787|NCT03245619|4059549|FG012|COMPLETED|Part C (Up to 34 Days)||0
3326788|NCT03245619|4059550|FG013|COMPLETED|Part C (Up to 34 Days)||0
3176341|NCT01966003|3904158|FG000|STARTED|Overall Study||328
3176342|NCT01966003|3904159|FG001|STARTED|Overall Study||314
3176343|NCT01966003|3904158|FG000|Received Study Drug|Overall Study||324
3176344|NCT01966003|3904159|FG001|Received Study Drug|Overall Study||309
3176345|NCT01966003|3904158|FG000|COMPLETED|Overall Study||58
3326789|NCT03245619|4059551|FG014|COMPLETED|Part C (Up to 34 Days)||0
3326790|NCT03245619|4059552|FG015|COMPLETED|Part C (Up to 34 Days)||0
3326791|NCT03245619|4059553|FG016|COMPLETED|Part C (Up to 34 Days)||0
3326792|NCT03245619|4059537|FG000|NOT COMPLETED|Part C (Up to 34 Days)||0
3326793|NCT03245619|4059538|FG001|NOT COMPLETED|Part C (Up to 34 Days)||0
3326794|NCT03245619|4059539|FG002|NOT COMPLETED|Part C (Up to 34 Days)||0
3326795|NCT03245619|4059540|FG003|NOT COMPLETED|Part C (Up to 34 Days)||0
3326796|NCT03245619|4059541|FG004|NOT COMPLETED|Part C (Up to 34 Days)||0
3326797|NCT03245619|4059542|FG005|NOT COMPLETED|Part C (Up to 34 Days)||0
3326798|NCT03245619|4059543|FG006|NOT COMPLETED|Part C (Up to 34 Days)||0
3326799|NCT03245619|4059544|FG007|NOT COMPLETED|Part C (Up to 34 Days)||0
3326800|NCT03245619|4059545|FG008|NOT COMPLETED|Part C (Up to 34 Days)||0
3326801|NCT03245619|4059546|FG009|NOT COMPLETED|Part C (Up to 34 Days)||0
3326802|NCT03245619|4059547|FG010|NOT COMPLETED|Part C (Up to 34 Days)||0
3326803|NCT03245619|4059548|FG011|NOT COMPLETED|Part C (Up to 34 Days)||0
3326804|NCT03245619|4059549|FG012|NOT COMPLETED|Part C (Up to 34 Days)||0
3326805|NCT03245619|4059550|FG013|NOT COMPLETED|Part C (Up to 34 Days)||0
3326806|NCT03245619|4059551|FG014|NOT COMPLETED|Part C (Up to 34 Days)||0
3326807|NCT03245619|4059552|FG015|NOT COMPLETED|Part C (Up to 34 Days)||0
3326808|NCT03245619|4059553|FG016|NOT COMPLETED|Part C (Up to 34 Days)||0
3326809|NCT03245723|4059614|FG000|STARTED|Overall Study||32
3326810|NCT03245723|4059615|FG001|STARTED|Overall Study||18
3326811|NCT03245723|4059614|FG000|COMPLETED|Overall Study||27
3326812|NCT03245723|4059615|FG001|COMPLETED|Overall Study||17
3326813|NCT03245723|4059614|FG000|NOT COMPLETED|Overall Study||5
3326814|NCT03245723|4059615|FG001|NOT COMPLETED|Overall Study||1
3326815|NCT03245736|4059621|FG000|STARTED|Overall Study||5
3326816|NCT03245736|4059621|FG000|COMPLETED|Overall Study||0
3326817|NCT03245736|4059621|FG000|NOT COMPLETED|Overall Study||5
3326818|NCT03245762|4059627|FG000|STARTED|Overall Study||10
3326819|NCT03245762|4059628|FG001|STARTED|Overall Study||5
3326820|NCT03245762|4059627|FG000|COMPLETED|Overall Study||10
3326821|NCT03245762|4059628|FG001|COMPLETED|Overall Study||5
3326822|NCT03245762|4059627|FG000|NOT COMPLETED|Overall Study||0
3326823|NCT03245762|4059628|FG001|NOT COMPLETED|Overall Study||0
3326824|NCT03246061|4059636|FG000|STARTED|Overall Study||66
3326825|NCT03246061|4059637|FG001|STARTED|Overall Study||74
3326826|NCT03246061|4059636|FG000|Interim Analysis|Overall Study||51
3326827|NCT03246061|4059637|FG001|Interim Analysis|Overall Study||53
3326828|NCT03246061|4059636|FG000|COMPLETED|Overall Study||51
3326829|NCT03246061|4059637|FG001|COMPLETED|Overall Study||53
3326830|NCT03246061|4059636|FG000|NOT COMPLETED|Overall Study||15
3326831|NCT03246061|4059637|FG001|NOT COMPLETED|Overall Study||21
3326832|NCT03246152|4059645|FG000|STARTED|Overall Study||31
3326833|NCT03246152|4059645|FG000|COMPLETED|Overall Study||28
3326834|NCT03246152|4059645|FG000|NOT COMPLETED|Overall Study||3
3326835|NCT03246646|4059651|FG000|STARTED|Overall Study||26
3326836|NCT03246646|4059652|FG001|STARTED|Overall Study||26
3326837|NCT03246646|4059651|FG000|COMPLETED|Overall Study|15 participants completed either 6-month or 12-month follow-up or both.|15
3326838|NCT03246646|4059652|FG001|COMPLETED|Overall Study|Follow-up was limited to chart follow-up in CIC services|26
3326839|NCT03246646|4059651|FG000|NOT COMPLETED|Overall Study||11
3326840|NCT03246646|4059652|FG001|NOT COMPLETED|Overall Study||0
3326841|NCT03246672|4059658|FG000|STARTED|Overall Study||30
3326842|NCT03246672|4059658|FG000|Completed First Phone Call|Overall Study||29
3326843|NCT03246672|4059658|FG000|COMPLETED|Overall Study||28
3326844|NCT03246672|4059658|FG000|NOT COMPLETED|Overall Study||2
3326845|NCT03246724|4059666|FG000|STARTED|Overall Study||99
3176346|NCT01966003|3904159|FG001|COMPLETED|Overall Study||44
3326846|NCT03246724|4059667|FG001|STARTED|Overall Study||91
3326847|NCT03246724|4059668|FG002|STARTED|Overall Study||85
3326848|NCT03246724|4059669|FG003|STARTED|Overall Study||52
3326849|NCT03246724|4059666|FG000|COMPLETED|Overall Study||85
3326850|NCT03246724|4059667|FG001|COMPLETED|Overall Study||84
3326851|NCT03246724|4059668|FG002|COMPLETED|Overall Study||70
3326852|NCT03246724|4059669|FG003|COMPLETED|Overall Study||44
3326853|NCT03246724|4059666|FG000|NOT COMPLETED|Overall Study||14
3326854|NCT03246724|4059667|FG001|NOT COMPLETED|Overall Study||7
3326855|NCT03246724|4059668|FG002|NOT COMPLETED|Overall Study||15
3326856|NCT03246724|4059669|FG003|NOT COMPLETED|Overall Study||8
3326857|NCT03247322|4059681|FG000|STARTED|Overall Study||68
3326858|NCT03247322|4059682|FG001|STARTED|Overall Study||68
3326859|NCT03247322|4059681|FG000|COMPLETED|Overall Study||66
3326860|NCT03247322|4059682|FG001|COMPLETED|Overall Study||68
3326861|NCT03247322|4059681|FG000|NOT COMPLETED|Overall Study||2
3326862|NCT03247322|4059682|FG001|NOT COMPLETED|Overall Study||0
3326863|NCT03247517|4059693|FG000|STARTED|Overall Study||104
3326864|NCT03247517|4059694|FG001|STARTED|Overall Study||98
3326865|NCT03247517|4059695|FG002|STARTED|Overall Study|One subject randomized to the 400mg/day SPN-812 arm received 200mg/day SPN-812 during the trial|106
3326866|NCT03247517|4059693|FG000|COMPLETED|Overall Study||96
3326867|NCT03247517|4059694|FG001|COMPLETED|Overall Study||78
3326868|NCT03247517|4059695|FG002|COMPLETED|Overall Study||92
3326869|NCT03247517|4059693|FG000|NOT COMPLETED|Overall Study||8
3326870|NCT03247517|4059694|FG001|NOT COMPLETED|Overall Study||20
3326871|NCT03247517|4059695|FG002|NOT COMPLETED|Overall Study||14
3326872|NCT03247530|4059706|FG000|STARTED|Overall Study||159
3326873|NCT03247530|4059707|FG001|STARTED|Overall Study||154
3326874|NCT03247530|4059708|FG002|STARTED|Overall Study||161
3326875|NCT03247530|4059706|FG000|COMPLETED|Overall Study||132
3326876|NCT03247530|4059707|FG001|COMPLETED|Overall Study||126
3326877|NCT03247530|4059708|FG002|COMPLETED|Overall Study||141
3326878|NCT03247530|4059706|FG000|NOT COMPLETED|Overall Study||27
3326879|NCT03247530|4059707|FG001|NOT COMPLETED|Overall Study||28
3326880|NCT03247530|4059708|FG002|NOT COMPLETED|Overall Study||20
3326881|NCT03247543|4059722|FG000|STARTED|Overall Study||102
3326882|NCT03247543|4059723|FG001|STARTED|Overall Study||107
3326883|NCT03247543|4059724|FG002|STARTED|Overall Study|One subject randomized to the 400mg/day SPN-812 arm received Placebo during the trial.|101
3326884|NCT03247543|4059722|FG000|COMPLETED|Overall Study||85
3326885|NCT03247543|4059723|FG001|COMPLETED|Overall Study||88
3326886|NCT03247543|4059724|FG002|COMPLETED|Overall Study||78
3326887|NCT03247543|4059722|FG000|NOT COMPLETED|Overall Study||17
3326888|NCT03247543|4059723|FG001|NOT COMPLETED|Overall Study||19
3326889|NCT03247543|4059724|FG002|NOT COMPLETED|Overall Study||23
3326890|NCT03247556|4059737|FG000|STARTED|Overall Study||97
3326891|NCT03247556|4059738|FG001|STARTED|Overall Study||100
3326892|NCT03247556|4059739|FG002|STARTED|Overall Study||99
3326893|NCT03247556|4059737|FG000|COMPLETED|Overall Study||85
3326894|NCT03247556|4059738|FG001|COMPLETED|Overall Study||88
3326895|NCT03247556|4059739|FG002|COMPLETED|Overall Study||81
3326896|NCT03247556|4059737|FG000|NOT COMPLETED|Overall Study||12
3326897|NCT03247556|4059738|FG001|NOT COMPLETED|Overall Study||12
3326898|NCT03247556|4059739|FG002|NOT COMPLETED|Overall Study||18
3326899|NCT03247673|4059750|FG000|STARTED|Overall Study||46
3326900|NCT03247673|4059751|FG001|STARTED|Overall Study||47
3326901|NCT03247673|4059752|FG002|STARTED|Overall Study||48
3326902|NCT03247673|4059750|FG000|COMPLETED|Overall Study||45
3326903|NCT03247673|4059751|FG001|COMPLETED|Overall Study||47
3326904|NCT03247673|4059752|FG002|COMPLETED|Overall Study||44
3326905|NCT03247673|4059750|FG000|NOT COMPLETED|Overall Study||1
3326906|NCT03247673|4059751|FG001|NOT COMPLETED|Overall Study||0
3326907|NCT03247673|4059752|FG002|NOT COMPLETED|Overall Study||4
3326908|NCT03247686|4059762|FG000|STARTED|Overall Study||8
3326909|NCT03247686|4059763|FG001|STARTED|Overall Study||20
3326910|NCT03247686|4059762|FG000|COMPLETED|Overall Study||7
3326911|NCT03247686|4059763|FG001|COMPLETED|Overall Study||18
3326912|NCT03247686|4059762|FG000|NOT COMPLETED|Overall Study||1
3326913|NCT03247686|4059763|FG001|NOT COMPLETED|Overall Study||2
3326914|NCT03247738|4059774|FG000|STARTED|Overall Study||25
3326915|NCT03247738|4059775|FG001|STARTED|Overall Study||25
3326916|NCT03247738|4059774|FG000|COMPLETED|Overall Study||25
3326917|NCT03247738|4059775|FG001|COMPLETED|Overall Study||25
3326918|NCT03247738|4059774|FG000|NOT COMPLETED|Overall Study||0
3326919|NCT03247738|4059775|FG001|NOT COMPLETED|Overall Study||0
3326920|NCT03247790|4059781|FG000|STARTED|Period 1: Migraine Attack||16
3326921|NCT03247790|4059781|FG000|Received at Least One Dose of Study Drug|Period 1: Migraine Attack||16
3326922|NCT03247790|4059781|FG000|COMPLETED|Period 1: Migraine Attack||16
3326923|NCT03247790|4059781|FG000|NOT COMPLETED|Period 1: Migraine Attack||0
3326924|NCT03247790|4059781|FG000|STARTED|Period 2: Inter-ictal Period||16
3326925|NCT03247790|4059781|FG000|COMPLETED|Period 2: Inter-ictal Period||16
3326926|NCT03247790|4059781|FG000|NOT COMPLETED|Period 2: Inter-ictal Period||0
3326927|NCT03247816|4059787|FG000|STARTED|Overall Study||59
3176347|NCT01966003|3904158|FG000|NOT COMPLETED|Overall Study||270
3176348|NCT01966003|3904159|FG001|NOT COMPLETED|Overall Study||270
3176349|NCT01966042|3904165|FG000|STARTED|Overall Study||13
3326928|NCT03247816|4059787|FG000|COMPLETED|Overall Study||30
3326929|NCT03247816|4059787|FG000|NOT COMPLETED|Overall Study||29
3326930|NCT03247985|4059795|FG000|STARTED|Overall Study||19
3326931|NCT03247985|4059796|FG001|STARTED|Overall Study||19
3326932|NCT03247985|4059795|FG000|COMPLETED|Overall Study||19
3326933|NCT03247985|4059796|FG001|COMPLETED|Overall Study||19
3326934|NCT03247985|4059795|FG000|NOT COMPLETED|Overall Study||0
3326935|NCT03247985|4059796|FG001|NOT COMPLETED|Overall Study||0
3326936|NCT03248037|4059804|FG000|STARTED|Overall Study|Fellow eyes could be enrolled and were automatically assigned to the opposite treatment arm.|95
3326937|NCT03248037|4059805|FG001|STARTED|Overall Study|Fellow eyes could be enrolled and were automatically assigned to the opposite treatment arm.|96
3326938|NCT03248037|4059804|FG000|COMPLETED|Overall Study||74
3326939|NCT03248037|4059805|FG001|COMPLETED|Overall Study||87
3326940|NCT03248037|4059804|FG000|NOT COMPLETED|Overall Study||21
3326941|NCT03248037|4059805|FG001|NOT COMPLETED|Overall Study||9
3326942|NCT03248440|4059813|FG000|STARTED|Overall Study||131
3326943|NCT03248440|4059814|FG001|STARTED|Overall Study||132
3326944|NCT03248440|4059813|FG000|COMPLETED|Overall Study||116
3326945|NCT03248440|4059814|FG001|COMPLETED|Overall Study||120
3326946|NCT03248440|4059813|FG000|NOT COMPLETED|Overall Study||15
3326947|NCT03248440|4059814|FG001|NOT COMPLETED|Overall Study||12
3326948|NCT03248492|4059825|FG000|STARTED|Overall Study||50
3326949|NCT03248492|4059826|FG001|STARTED|Overall Study||48
3326950|NCT03248492|4059827|FG002|STARTED|Overall Study||21
3326951|NCT03248492|4059828|FG003|STARTED|Overall Study||130
3326952|NCT03248492|4059829|FG004|STARTED|Overall Study||4
3326953|NCT03248492|4059825|FG000|COMPLETED|Overall Study||0
3326954|NCT03248492|4059826|FG001|COMPLETED|Overall Study||0
3326955|NCT03248492|4059827|FG002|COMPLETED|Overall Study||0
3326956|NCT03248492|4059828|FG003|COMPLETED|Overall Study||0
3326957|NCT03248492|4059829|FG004|COMPLETED|Overall Study||0
3326958|NCT03248492|4059825|FG000|NOT COMPLETED|Overall Study||50
3326959|NCT03248492|4059826|FG001|NOT COMPLETED|Overall Study||48
3326960|NCT03248492|4059827|FG002|NOT COMPLETED|Overall Study||21
3326961|NCT03248492|4059828|FG003|NOT COMPLETED|Overall Study||130
3326962|NCT03248492|4059829|FG004|NOT COMPLETED|Overall Study||4
3326963|NCT03248882|4059854|FG000|STARTED|Overall Study||61
3326964|NCT03248882|4059855|FG001|STARTED|Overall Study||63
3326965|NCT03248882|4059856|FG002|STARTED|Overall Study||62
3326966|NCT03248882|4059857|FG003|STARTED|Overall Study||58
3326967|NCT03248882|4059858|FG004|STARTED|Overall Study||61
3326968|NCT03248882|4059854|FG000|Received Treatment|Overall Study||61
3326969|NCT03248882|4059855|FG001|Received Treatment|Overall Study||63
3326970|NCT03248882|4059856|FG002|Received Treatment|Overall Study||62
3326971|NCT03248882|4059857|FG003|Received Treatment|Overall Study||58
3326972|NCT03248882|4059858|FG004|Received Treatment|Overall Study||61
3326973|NCT03248882|4059854|FG000|COMPLETED|Overall Study||54
3326974|NCT03248882|4059855|FG001|COMPLETED|Overall Study||58
3326975|NCT03248882|4059856|FG002|COMPLETED|Overall Study||55
3326976|NCT03248882|4059857|FG003|COMPLETED|Overall Study||48
3326977|NCT03248882|4059858|FG004|COMPLETED|Overall Study||48
3326978|NCT03248882|4059854|FG000|NOT COMPLETED|Overall Study||7
3326979|NCT03248882|4059855|FG001|NOT COMPLETED|Overall Study||5
3326980|NCT03248882|4059856|FG002|NOT COMPLETED|Overall Study||7
3326981|NCT03248882|4059857|FG003|NOT COMPLETED|Overall Study||10
3326982|NCT03248882|4059858|FG004|NOT COMPLETED|Overall Study||13
3326983|NCT03248947|4059870|FG000|STARTED|Overall Study||71
3326984|NCT03248947|4059870|FG000|COMPLETED|Overall Study||63
3326985|NCT03248947|4059870|FG000|NOT COMPLETED|Overall Study||8
3326986|NCT03249116|4059881|FG000|STARTED|Overall Study||25
3326987|NCT03249116|4059882|FG001|STARTED|Overall Study||25
3326988|NCT03249116|4059883|FG002|STARTED|Overall Study||25
3326989|NCT03249116|4059881|FG000|COMPLETED|Overall Study||25
3326990|NCT03249116|4059882|FG001|COMPLETED|Overall Study||25
3326991|NCT03249116|4059883|FG002|COMPLETED|Overall Study||25
3326992|NCT03249116|4059881|FG000|NOT COMPLETED|Overall Study||0
3326993|NCT03249116|4059882|FG001|NOT COMPLETED|Overall Study||0
3326994|NCT03249116|4059883|FG002|NOT COMPLETED|Overall Study||0
3326995|NCT03249272|4059895|FG000|STARTED|Overall Study||19
3326996|NCT03249272|4059896|FG001|STARTED|Overall Study||6
3326997|NCT03249272|4059897|FG002|STARTED|Overall Study||6
3326998|NCT03249272|4059895|FG000|COMPLETED|Overall Study||19
3326999|NCT03249272|4059896|FG001|COMPLETED|Overall Study||6
3327000|NCT03249272|4059897|FG002|COMPLETED|Overall Study||6
3327001|NCT03249272|4059895|FG000|NOT COMPLETED|Overall Study||0
3327002|NCT03249272|4059896|FG001|NOT COMPLETED|Overall Study||0
3327003|NCT03249272|4059897|FG002|NOT COMPLETED|Overall Study||0
3327004|NCT03249454|4059917|FG000|STARTED|Overall Study||1
3327005|NCT03249454|4059918|FG001|STARTED|Overall Study||1
3327006|NCT03249454|4059919|FG002|STARTED|Overall Study||2
3327007|NCT03249454|4059920|FG003|STARTED|Overall Study||1
3327008|NCT03249454|4059921|FG004|STARTED|Overall Study||1
3327009|NCT03249454|4059922|FG005|STARTED|Overall Study||2
3327010|NCT03249454|4059923|FG006|STARTED|Overall Study||1
3327011|NCT03249454|4059924|FG007|STARTED|Overall Study||1
3327012|NCT03249454|4059925|FG008|STARTED|Overall Study||1
3327013|NCT03249454|4059926|FG009|STARTED|Overall Study||1
3327014|NCT03249454|4059927|FG010|STARTED|Overall Study||1
3327015|NCT03249454|4059917|FG000|First Intervention (1 Day)|Overall Study||1
3327016|NCT03249454|4059918|FG001|First Intervention (1 Day)|Overall Study||1
3327017|NCT03249454|4059919|FG002|First Intervention (1 Day)|Overall Study||2
3327018|NCT03249454|4059920|FG003|First Intervention (1 Day)|Overall Study||1
3327019|NCT03249454|4059921|FG004|First Intervention (1 Day)|Overall Study||1
3327020|NCT03249454|4059922|FG005|First Intervention (1 Day)|Overall Study||2
3176350|NCT01966042|3904165|FG000|COMPLETED|Overall Study||11
3176351|NCT01966042|3904165|FG000|NOT COMPLETED|Overall Study||2
3176352|NCT01966068|3904171|FG000|STARTED|Overall Study||294
3176353|NCT01966068|3904171|FG000|Used the MyAsthma Portal at Least Once|Overall Study||237
3176354|NCT01966068|3904171|FG000|Use the MyAsthma Portal More Than Once|Overall Study||156
3176355|NCT01966068|3904171|FG000|COMPLETED|Overall Study||156
3176356|NCT01966068|3904171|FG000|NOT COMPLETED|Overall Study||138
3176357|NCT01966107|3904178|FG000|STARTED|Overall Study||1812
3176358|NCT01966107|3904179|FG001|STARTED|Overall Study||1818
3176359|NCT01966107|3904178|FG000|Full Analysis Set|Overall Study||1791
3176360|NCT01966107|3904179|FG001|Full Analysis Set|Overall Study||1798
3176361|NCT01966107|3904178|FG000|COMPLETED|Overall Study||1010
3176362|NCT01966107|3904179|FG001|COMPLETED|Overall Study||937
3176363|NCT01966107|3904178|FG000|NOT COMPLETED|Overall Study||802
3176364|NCT01966107|3904179|FG001|NOT COMPLETED|Overall Study||881
3176365|NCT01966120|3904187|FG000|STARTED|Overall Study||55
3176366|NCT01966120|3904188|FG001|STARTED|Overall Study||32
3176367|NCT01966120|3904187|FG000|COMPLETED|Overall Study||54
3176368|NCT01966120|3904188|FG001|COMPLETED|Overall Study||26
3176369|NCT01966120|3904187|FG000|NOT COMPLETED|Overall Study||1
3176370|NCT01966120|3904188|FG001|NOT COMPLETED|Overall Study||6
3327021|NCT03249454|4059923|FG006|First Intervention (1 Day)|Overall Study||1
3327022|NCT03249454|4059924|FG007|First Intervention (1 Day)|Overall Study||1
3327023|NCT03249454|4059925|FG008|First Intervention (1 Day)|Overall Study||1
3327024|NCT03249454|4059926|FG009|First Intervention (1 Day)|Overall Study||0
3327025|NCT03249454|4059927|FG010|First Intervention (1 Day)|Overall Study||0
3327026|NCT03249454|4059917|FG000|Washout (1 Week)|Overall Study||1
3327027|NCT03249454|4059918|FG001|Washout (1 Week)|Overall Study||1
3327028|NCT03249454|4059919|FG002|Washout (1 Week)|Overall Study||2
3327029|NCT03249454|4059920|FG003|Washout (1 Week)|Overall Study||1
3327030|NCT03249454|4059921|FG004|Washout (1 Week)|Overall Study||1
3327031|NCT03249454|4059922|FG005|Washout (1 Week)|Overall Study||2
3327032|NCT03249454|4059923|FG006|Washout (1 Week)|Overall Study||1
3327033|NCT03249454|4059924|FG007|Washout (1 Week)|Overall Study||1
3327034|NCT03249454|4059925|FG008|Washout (1 Week)|Overall Study||1
3327035|NCT03249454|4059926|FG009|Washout (1 Week)|Overall Study||0
3327036|NCT03249454|4059927|FG010|Washout (1 Week)|Overall Study||0
3327037|NCT03249454|4059917|FG000|Second Intervention (1 Day)|Overall Study||1
3327038|NCT03249454|4059918|FG001|Second Intervention (1 Day)|Overall Study||1
3327039|NCT03249454|4059919|FG002|Second Intervention (1 Day)|Overall Study||2
3327040|NCT03249454|4059920|FG003|Second Intervention (1 Day)|Overall Study||1
3327041|NCT03249454|4059921|FG004|Second Intervention (1 Day)|Overall Study||1
3327042|NCT03249454|4059922|FG005|Second Intervention (1 Day)|Overall Study||2
3327043|NCT03249454|4059923|FG006|Second Intervention (1 Day)|Overall Study||1
3327044|NCT03249454|4059924|FG007|Second Intervention (1 Day)|Overall Study||1
3327045|NCT03249454|4059925|FG008|Second Intervention (1 Day)|Overall Study||1
3327046|NCT03249454|4059926|FG009|Second Intervention (1 Day)|Overall Study||0
3327047|NCT03249454|4059927|FG010|Second Intervention (1 Day)|Overall Study||0
3327048|NCT03249454|4059917|FG000|Washout (1 Week)|Overall Study||1
3327049|NCT03249454|4059918|FG001|Washout (1 Week)|Overall Study||1
3327050|NCT03249454|4059919|FG002|Washout (1 Week)|Overall Study||2
3327051|NCT03249454|4059920|FG003|Washout (1 Week)|Overall Study||1
3327052|NCT03249454|4059921|FG004|Washout (1 Week)|Overall Study||1
3327053|NCT03249454|4059922|FG005|Washout (1 Week)|Overall Study||2
3327054|NCT03249454|4059923|FG006|Washout (1 Week)|Overall Study||1
3327055|NCT03249454|4059924|FG007|Washout (1 Week)|Overall Study||1
3327056|NCT03249454|4059925|FG008|Washout (1 Week)|Overall Study||1
3327057|NCT03249454|4059926|FG009|Washout (1 Week)|Overall Study||0
3327058|NCT03249454|4059927|FG010|Washout (1 Week)|Overall Study||0
3327059|NCT03249454|4059917|FG000|Third Intervention (1 Day)|Overall Study||1
3327060|NCT03249454|4059918|FG001|Third Intervention (1 Day)|Overall Study||1
3327061|NCT03249454|4059919|FG002|Third Intervention (1 Day)|Overall Study||2
3327062|NCT03249454|4059920|FG003|Third Intervention (1 Day)|Overall Study||1
3327063|NCT03249454|4059921|FG004|Third Intervention (1 Day)|Overall Study||1
3327064|NCT03249454|4059922|FG005|Third Intervention (1 Day)|Overall Study||2
3327065|NCT03249454|4059923|FG006|Third Intervention (1 Day)|Overall Study||1
3327066|NCT03249454|4059924|FG007|Third Intervention (1 Day)|Overall Study||1
3327067|NCT03249454|4059925|FG008|Third Intervention (1 Day)|Overall Study||1
3327068|NCT03249454|4059926|FG009|Third Intervention (1 Day)|Overall Study||0
3327069|NCT03249454|4059927|FG010|Third Intervention (1 Day)|Overall Study||0
3327070|NCT03249454|4059917|FG000|Washout (1 Week)|Overall Study||1
3327071|NCT03249454|4059918|FG001|Washout (1 Week)|Overall Study||1
3327072|NCT03249454|4059919|FG002|Washout (1 Week)|Overall Study||2
3327073|NCT03249454|4059920|FG003|Washout (1 Week)|Overall Study||1
3327074|NCT03249454|4059921|FG004|Washout (1 Week)|Overall Study||1
3327075|NCT03249454|4059922|FG005|Washout (1 Week)|Overall Study||2
3327076|NCT03249454|4059923|FG006|Washout (1 Week)|Overall Study||1
3327077|NCT03249454|4059924|FG007|Washout (1 Week)|Overall Study||1
3327078|NCT03249454|4059925|FG008|Washout (1 Week)|Overall Study||1
3176371|NCT01966159|3904196|FG000|STARTED|Overall Study||205
3176372|NCT01966159|3904197|FG001|STARTED|Overall Study||207
3176373|NCT01966159|3904196|FG000|COMPLETED|Overall Study||205
3327079|NCT03249454|4059926|FG009|Washout (1 Week)|Overall Study||0
3327080|NCT03249454|4059927|FG010|Washout (1 Week)|Overall Study||0
3327081|NCT03249454|4059917|FG000|Fourth Intervention (1 Day)|Overall Study||1
3327082|NCT03249454|4059918|FG001|Fourth Intervention (1 Day)|Overall Study||1
3327083|NCT03249454|4059919|FG002|Fourth Intervention (1 Day)|Overall Study||2
3327084|NCT03249454|4059920|FG003|Fourth Intervention (1 Day)|Overall Study||1
3327085|NCT03249454|4059921|FG004|Fourth Intervention (1 Day)|Overall Study||1
3327086|NCT03249454|4059922|FG005|Fourth Intervention (1 Day)|Overall Study||2
3327087|NCT03249454|4059923|FG006|Fourth Intervention (1 Day)|Overall Study||1
3327088|NCT03249454|4059924|FG007|Fourth Intervention (1 Day)|Overall Study||1
3327089|NCT03249454|4059925|FG008|Fourth Intervention (1 Day)|Overall Study||1
3327090|NCT03249454|4059926|FG009|Fourth Intervention (1 Day)|Overall Study||0
3327091|NCT03249454|4059927|FG010|Fourth Intervention (1 Day)|Overall Study||0
3327092|NCT03249454|4059917|FG000|Washout (1 Week)|Overall Study||1
3327093|NCT03249454|4059918|FG001|Washout (1 Week)|Overall Study||1
3327094|NCT03249454|4059919|FG002|Washout (1 Week)|Overall Study||2
3327095|NCT03249454|4059920|FG003|Washout (1 Week)|Overall Study||1
3327096|NCT03249454|4059921|FG004|Washout (1 Week)|Overall Study||1
3327097|NCT03249454|4059922|FG005|Washout (1 Week)|Overall Study||2
3327098|NCT03249454|4059923|FG006|Washout (1 Week)|Overall Study||1
3327099|NCT03249454|4059924|FG007|Washout (1 Week)|Overall Study||1
3327100|NCT03249454|4059925|FG008|Washout (1 Week)|Overall Study||1
3327101|NCT03249454|4059926|FG009|Washout (1 Week)|Overall Study||0
3327102|NCT03249454|4059927|FG010|Washout (1 Week)|Overall Study||0
3327103|NCT03249454|4059917|FG000|Fifth Intervention (1 Day)|Overall Study||1
3327104|NCT03249454|4059918|FG001|Fifth Intervention (1 Day)|Overall Study||1
3327105|NCT03249454|4059919|FG002|Fifth Intervention (1 Day)|Overall Study||2
3327106|NCT03249454|4059920|FG003|Fifth Intervention (1 Day)|Overall Study||1
3327107|NCT03249454|4059921|FG004|Fifth Intervention (1 Day)|Overall Study||1
3327108|NCT03249454|4059922|FG005|Fifth Intervention (1 Day)|Overall Study||2
3327109|NCT03249454|4059923|FG006|Fifth Intervention (1 Day)|Overall Study||1
3327110|NCT03249454|4059924|FG007|Fifth Intervention (1 Day)|Overall Study||1
3327111|NCT03249454|4059925|FG008|Fifth Intervention (1 Day)|Overall Study||1
3327112|NCT03249454|4059926|FG009|Fifth Intervention (1 Day)|Overall Study||0
3327113|NCT03249454|4059927|FG010|Fifth Intervention (1 Day)|Overall Study||0
3327114|NCT03249454|4059917|FG000|COMPLETED|Overall Study||1
3327115|NCT03249454|4059918|FG001|COMPLETED|Overall Study||1
3327116|NCT03249454|4059919|FG002|COMPLETED|Overall Study||2
3327117|NCT03249454|4059920|FG003|COMPLETED|Overall Study||1
3327118|NCT03249454|4059921|FG004|COMPLETED|Overall Study||1
3327119|NCT03249454|4059922|FG005|COMPLETED|Overall Study||2
3327120|NCT03249454|4059923|FG006|COMPLETED|Overall Study||1
3327121|NCT03249454|4059924|FG007|COMPLETED|Overall Study||1
3327122|NCT03249454|4059925|FG008|COMPLETED|Overall Study||1
3327123|NCT03249454|4059926|FG009|COMPLETED|Overall Study||0
3327124|NCT03249454|4059927|FG010|COMPLETED|Overall Study||0
3327125|NCT03249454|4059917|FG000|NOT COMPLETED|Overall Study||0
3327126|NCT03249454|4059918|FG001|NOT COMPLETED|Overall Study||0
3327127|NCT03249454|4059919|FG002|NOT COMPLETED|Overall Study||0
3327128|NCT03249454|4059920|FG003|NOT COMPLETED|Overall Study||0
3327129|NCT03249454|4059921|FG004|NOT COMPLETED|Overall Study||0
3327130|NCT03249454|4059922|FG005|NOT COMPLETED|Overall Study||0
3327131|NCT03249454|4059923|FG006|NOT COMPLETED|Overall Study||0
3327132|NCT03249454|4059924|FG007|NOT COMPLETED|Overall Study||0
3327133|NCT03249454|4059925|FG008|NOT COMPLETED|Overall Study||0
3327134|NCT03249454|4059926|FG009|NOT COMPLETED|Overall Study||1
3327135|NCT03249454|4059927|FG010|NOT COMPLETED|Overall Study||1
3327136|NCT03249584|4059940|FG000|STARTED|Overall Study||184
3327137|NCT03249584|4059941|FG001|STARTED|Overall Study||22
3327138|NCT03249584|4059940|FG000|Month 3|Overall Study||132
3327139|NCT03249584|4059941|FG001|Month 3|Overall Study||15
3327140|NCT03249584|4059940|FG000|Month 3 Primary/Secondary Objectives|Overall Study|As prespecified, the primary objective included the first 42 Thoracic/Lumbar RF Ablation subjects to complete Month 3.|42
3327141|NCT03249584|4059941|FG001|Month 3 Primary/Secondary Objectives|Overall Study|As prespecified, the secondary objective included all Periacetabulum/Iliac Crest/Sacrum RF Ablation subjects.|15
3327142|NCT03249584|4059940|FG000|Month 6|Overall Study||101
3327143|NCT03249584|4059941|FG001|Month 6|Overall Study||13
3327144|NCT03249584|4059940|FG000|COMPLETED|Overall Study||51
3327145|NCT03249584|4059941|FG001|COMPLETED|Overall Study||8
3327146|NCT03249584|4059940|FG000|NOT COMPLETED|Overall Study||133
3327147|NCT03249584|4059941|FG001|NOT COMPLETED|Overall Study||14
3327148|NCT03249779|4059946|FG000|STARTED|Overall Study||8
3327149|NCT03249779|4059946|FG000|COMPLETED|Overall Study||8
3327150|NCT03249779|4059946|FG000|NOT COMPLETED|Overall Study||0
3327151|NCT03249909|4059953|FG000|STARTED|Overall Study||78
3327152|NCT03249909|4059954|FG001|STARTED|Overall Study||15
3327153|NCT03249909|4059955|FG002|STARTED|Overall Study||16
3327154|NCT03249909|4059953|FG000|COMPLETED|Overall Study||72
3327155|NCT03249909|4059954|FG001|COMPLETED|Overall Study||14
3327156|NCT03249909|4059955|FG002|COMPLETED|Overall Study||16
3327157|NCT03249909|4059953|FG000|NOT COMPLETED|Overall Study||6
3327158|NCT03249909|4059954|FG001|NOT COMPLETED|Overall Study||1
3327159|NCT03249909|4059955|FG002|NOT COMPLETED|Overall Study||0
3327160|NCT03249935|4059966|FG000|STARTED|Overall Study||100
3327161|NCT03249935|4059966|FG000|COMPLETED|Overall Study||55
3327162|NCT03249935|4059966|FG000|NOT COMPLETED|Overall Study||45
3327163|NCT03250182|4059972|FG000|STARTED|Overall Study||30
3327164|NCT03250182|4059972|FG000|COMPLETED|Overall Study||29
3327165|NCT03250182|4059972|FG000|NOT COMPLETED|Overall Study||1
3327166|NCT03250234|4059978|FG000|STARTED|Overall Study||6
3327167|NCT03250234|4059979|FG001|STARTED|Overall Study||6
3327168|NCT03250234|4059978|FG000|COMPLETED|Overall Study||6
3327169|NCT03250234|4059979|FG001|COMPLETED|Overall Study||6
3327170|NCT03250234|4059978|FG000|NOT COMPLETED|Overall Study||0
3327171|NCT03250234|4059979|FG001|NOT COMPLETED|Overall Study||0
3327172|NCT03250689|4059987|FG000|STARTED|Overall Study||5
3327173|NCT03250689|4059988|FG001|STARTED|Overall Study||14
3327174|NCT03250689|4059987|FG000|COMPLETED|Overall Study||5
3327175|NCT03250689|4059988|FG001|COMPLETED|Overall Study||14
3327176|NCT03250689|4059987|FG000|NOT COMPLETED|Overall Study||0
3327177|NCT03250689|4059988|FG001|NOT COMPLETED|Overall Study||0
3327178|NCT03250845|4059995|FG000|STARTED|Multigam 5% Infusion (Baseline)||30
3327179|NCT03250845|4059995|FG000|COMPLETED|Multigam 5% Infusion (Baseline)||30
3327180|NCT03250845|4059995|FG000|NOT COMPLETED|Multigam 5% Infusion (Baseline)||0
3327181|NCT03250845|4059995|FG000|STARTED|Multigam 10% Infusion (3-4 Weeks Later)||30
3327182|NCT03250845|4059995|FG000|COMPLETED|Multigam 10% Infusion (3-4 Weeks Later)||30
3327183|NCT03250845|4059995|FG000|NOT COMPLETED|Multigam 10% Infusion (3-4 Weeks Later)||0
3327184|NCT03251482|4060006|FG000|STARTED|Overall Study||39
3327185|NCT03251482|4060007|FG001|STARTED|Overall Study||41
3327186|NCT03251482|4060008|FG002|STARTED|Overall Study||43
3327187|NCT03251482|4060009|FG003|STARTED|Overall Study||122
3327188|NCT03251482|4060010|FG004|STARTED|Overall Study||63
3327189|NCT03251482|4060006|FG000|Treated|Overall Study||38
3327190|NCT03251482|4060007|FG001|Treated|Overall Study||40
3327191|NCT03251482|4060008|FG002|Treated|Overall Study||42
3327192|NCT03251482|4060009|FG003|Treated|Overall Study||122
3327193|NCT03251482|4060010|FG004|Treated|Overall Study||63
3327194|NCT03251482|4060006|FG000|COMPLETED|Overall Study||39
3327195|NCT03251482|4060007|FG001|COMPLETED|Overall Study||40
3327196|NCT03251482|4060008|FG002|COMPLETED|Overall Study||43
3327197|NCT03251482|4060009|FG003|COMPLETED|Overall Study||122
3327198|NCT03251482|4060010|FG004|COMPLETED|Overall Study||63
3327199|NCT03251482|4060006|FG000|NOT COMPLETED|Overall Study||0
3327200|NCT03251482|4060007|FG001|NOT COMPLETED|Overall Study||1
3327201|NCT03251482|4060008|FG002|NOT COMPLETED|Overall Study||0
3327202|NCT03251482|4060009|FG003|NOT COMPLETED|Overall Study||0
3327203|NCT03251482|4060010|FG004|NOT COMPLETED|Overall Study||0
3327204|NCT03251937|4060022|FG000|STARTED|Overall Study||40
3327205|NCT03251937|4060022|FG000|COMPLETED|Overall Study||37
3327206|NCT03251937|4060022|FG000|NOT COMPLETED|Overall Study||3
3327207|NCT03251963|4060028|FG000|STARTED|Overall Study||65
3327208|NCT03251963|4060029|FG001|STARTED|Overall Study||66
3327209|NCT03251963|4060028|FG000|COMPLETED|Overall Study||56
3327210|NCT03251963|4060029|FG001|COMPLETED|Overall Study||61
3327211|NCT03251963|4060028|FG000|NOT COMPLETED|Overall Study||9
3327212|NCT03251963|4060029|FG001|NOT COMPLETED|Overall Study||5
3327213|NCT03252015|4060039|FG000|STARTED|Overall Study||12
3327214|NCT03252015|4060040|FG001|STARTED|Overall Study||28
3327215|NCT03252015|4060041|FG002|STARTED|Overall Study||15
3327216|NCT03252015|4060042|FG003|STARTED|Overall Study||15
3327217|NCT03252015|4060039|FG000|Received at Least 1 Dose of Study Drug|Overall Study||12
3327218|NCT03252015|4060040|FG001|Received at Least 1 Dose of Study Drug|Overall Study||28
3327219|NCT03252015|4060041|FG002|Received at Least 1 Dose of Study Drug|Overall Study||15
3327220|NCT03252015|4060042|FG003|Received at Least 1 Dose of Study Drug|Overall Study||15
3327221|NCT03252015|4060039|FG000|COMPLETED|Overall Study||11
3327222|NCT03252015|4060040|FG001|COMPLETED|Overall Study||27
3327223|NCT03252015|4060041|FG002|COMPLETED|Overall Study||14
3327224|NCT03252015|4060042|FG003|COMPLETED|Overall Study||14
3327225|NCT03252015|4060039|FG000|NOT COMPLETED|Overall Study||1
3327226|NCT03252015|4060040|FG001|NOT COMPLETED|Overall Study||1
3327227|NCT03252015|4060041|FG002|NOT COMPLETED|Overall Study||1
3327228|NCT03252015|4060042|FG003|NOT COMPLETED|Overall Study||1
3327229|NCT03252145|4060068|FG000|STARTED|Overall Study||13
3327230|NCT03252145|4060069|FG001|STARTED|Overall Study||15
3327231|NCT03252145|4060068|FG000|COMPLETED|Overall Study||11
3327232|NCT03252145|4060069|FG001|COMPLETED|Overall Study||13
3327233|NCT03252145|4060068|FG000|NOT COMPLETED|Overall Study||2
3327234|NCT03252145|4060069|FG001|NOT COMPLETED|Overall Study||2
3327235|NCT03252353|4060077|FG000|STARTED|Overall Study||28
3327236|NCT03252353|4060078|FG001|STARTED|Overall Study||28
3327237|NCT03252353|4060077|FG000|COMPLETED|Overall Study||28
3327238|NCT03252353|4060078|FG001|COMPLETED|Overall Study||28
3327239|NCT03252353|4060077|FG000|NOT COMPLETED|Overall Study||0
3327240|NCT03252353|4060078|FG001|NOT COMPLETED|Overall Study||0
3327241|NCT03252431|4060089|FG000|STARTED|Overall Study||197
3327242|NCT03252431|4060090|FG001|STARTED|Overall Study||196
3327243|NCT03252431|4060089|FG000|COMPLETED|Overall Study||186
3327244|NCT03252431|4060090|FG001|COMPLETED|Overall Study||187
3327245|NCT03252431|4060089|FG000|NOT COMPLETED|Overall Study||11
3327246|NCT03252431|4060090|FG001|NOT COMPLETED|Overall Study||9
3327247|NCT03252964|4060096|FG000|STARTED|Overall Study||52
3327248|NCT03252964|4060096|FG000|COMPLETED|Overall Study||20
3327249|NCT03252964|4060096|FG000|NOT COMPLETED|Overall Study||32
3327250|NCT03253094|4060106|FG000|STARTED|Overall Study||32
3327251|NCT03253094|4060107|FG001|STARTED|Overall Study||30
3327252|NCT03253094|4060108|FG002|STARTED|Overall Study||28
3327253|NCT03253094|4060109|FG003|STARTED|Overall Study||32
3327254|NCT03253094|4060110|FG004|STARTED|Overall Study||32
3327255|NCT03253094|4060111|FG005|STARTED|Overall Study||32
3327256|NCT03253094|4060106|FG000|Subjects Discontinued|Overall Study||4
3327257|NCT03253094|4060107|FG001|Subjects Discontinued|Overall Study||3
3327258|NCT03253094|4060108|FG002|Subjects Discontinued|Overall Study||6
3327259|NCT03253094|4060109|FG003|Subjects Discontinued|Overall Study||4
3327260|NCT03253094|4060110|FG004|Subjects Discontinued|Overall Study||5
3327261|NCT03253094|4060111|FG005|Subjects Discontinued|Overall Study||4
3327262|NCT03253094|4060106|FG000|COMPLETED|Overall Study||28
3327263|NCT03253094|4060107|FG001|COMPLETED|Overall Study||27
3327264|NCT03253094|4060108|FG002|COMPLETED|Overall Study||22
3327265|NCT03253094|4060109|FG003|COMPLETED|Overall Study||28
3327266|NCT03253094|4060110|FG004|COMPLETED|Overall Study||27
3327267|NCT03253094|4060111|FG005|COMPLETED|Overall Study||28
3327268|NCT03253094|4060106|FG000|NOT COMPLETED|Overall Study||4
3327269|NCT03253094|4060107|FG001|NOT COMPLETED|Overall Study||3
3327270|NCT03253094|4060108|FG002|NOT COMPLETED|Overall Study||6
3327271|NCT03253094|4060109|FG003|NOT COMPLETED|Overall Study||4
3327272|NCT03253094|4060110|FG004|NOT COMPLETED|Overall Study||5
3327273|NCT03253094|4060111|FG005|NOT COMPLETED|Overall Study||4
3327274|NCT03254108|4060130|FG000|STARTED|Overall Study||13
3327275|NCT03254108|4060131|FG001|STARTED|Overall Study||12
3327276|NCT03254108|4060132|FG002|STARTED|Overall Study||12
3327277|NCT03254108|4060133|FG003|STARTED|Overall Study||12
3327278|NCT03254108|4060134|FG004|STARTED|Overall Study||12
3327279|NCT03254108|4060130|FG000|Received Treatment|Overall Study||13
3327280|NCT03254108|4060131|FG001|Received Treatment|Overall Study||12
3327281|NCT03254108|4060132|FG002|Received Treatment|Overall Study||12
3327282|NCT03254108|4060133|FG003|Received Treatment|Overall Study||11
3327283|NCT03254108|4060134|FG004|Received Treatment|Overall Study||12
3327284|NCT03254108|4060130|FG000|COMPLETED|Overall Study||13
3327285|NCT03254108|4060131|FG001|COMPLETED|Overall Study||10
3327286|NCT03254108|4060132|FG002|COMPLETED|Overall Study||12
3327287|NCT03254108|4060133|FG003|COMPLETED|Overall Study||11
3327288|NCT03254108|4060134|FG004|COMPLETED|Overall Study||9
3327289|NCT03254108|4060130|FG000|NOT COMPLETED|Overall Study||0
3327290|NCT03254108|4060131|FG001|NOT COMPLETED|Overall Study||2
3327291|NCT03254108|4060132|FG002|NOT COMPLETED|Overall Study||0
3327292|NCT03254108|4060133|FG003|NOT COMPLETED|Overall Study||1
3327293|NCT03254108|4060134|FG004|NOT COMPLETED|Overall Study||3
3327294|NCT03254134|4060148|FG000|STARTED|Overall Study||5745
3327295|NCT03254134|4060149|FG001|STARTED|Overall Study||16745
3327296|NCT03254134|4060148|FG000|COMPLETED|Overall Study||5146
3327297|NCT03254134|4060149|FG001|COMPLETED|Overall Study||13115
3327298|NCT03254134|4060148|FG000|NOT COMPLETED|Overall Study||599
3327299|NCT03254134|4060149|FG001|NOT COMPLETED|Overall Study||3630
3327300|NCT03254147|4060155|FG000|STARTED|Overall Study|The number of patients meeting the inclusion and exclusion criteria|53969
3327301|NCT03254147|4060155|FG000|COMPLETED|Overall Study||53969
3327302|NCT03254147|4060155|FG000|NOT COMPLETED|Overall Study||0
3327303|NCT03254459|4060161|FG000|STARTED|Overall Study||50
3327304|NCT03254459|4060162|FG001|STARTED|Overall Study||50
3327305|NCT03254459|4060161|FG000|COMPLETED|Overall Study||40
3327306|NCT03254459|4060162|FG001|COMPLETED|Overall Study||27
3327307|NCT03254459|4060161|FG000|NOT COMPLETED|Overall Study||10
3327308|NCT03254459|4060162|FG001|NOT COMPLETED|Overall Study||23
3327309|NCT03254602|4060168|FG000|STARTED|Overall Study||33
3327310|NCT03254602|4060168|FG000|COMPLETED|Overall Study||29
3327311|NCT03254602|4060168|FG000|NOT COMPLETED|Overall Study||4
3327312|NCT03254719|4060172|FG000|STARTED|Overall Study||40
3327313|NCT03254719|4060172|FG000|COMPLETED|Overall Study||40
3327314|NCT03254719|4060172|FG000|NOT COMPLETED|Overall Study||0
3327315|NCT03255187|4060178|FG000|STARTED|Periodfrom Enrollment to First Follow-up||35
3327316|NCT03255187|4060179|FG001|STARTED|Periodfrom Enrollment to First Follow-up||35
3327317|NCT03255187|4060178|FG000|COMPLETED|Periodfrom Enrollment to First Follow-up||34
3327318|NCT03255187|4060179|FG001|COMPLETED|Periodfrom Enrollment to First Follow-up||32
3327319|NCT03255187|4060178|FG000|NOT COMPLETED|Periodfrom Enrollment to First Follow-up||1
3327320|NCT03255187|4060179|FG001|NOT COMPLETED|Periodfrom Enrollment to First Follow-up||3
3327321|NCT03255187|4060178|FG000|STARTED|Period From First to Second Follow-up||34
3327322|NCT03255187|4060179|FG001|STARTED|Period From First to Second Follow-up||32
3327323|NCT03255187|4060178|FG000|COMPLETED|Period From First to Second Follow-up||34
3327324|NCT03255187|4060179|FG001|COMPLETED|Period From First to Second Follow-up||31
3327325|NCT03255187|4060178|FG000|NOT COMPLETED|Period From First to Second Follow-up||0
3327326|NCT03255187|4060179|FG001|NOT COMPLETED|Period From First to Second Follow-up||1
3327327|NCT03255187|4060178|FG000|STARTED|Period From Second to Third Follow-up||34
3327328|NCT03255187|4060179|FG001|STARTED|Period From Second to Third Follow-up||31
3327329|NCT03255187|4060178|FG000|COMPLETED|Period From Second to Third Follow-up||34
3327330|NCT03255187|4060179|FG001|COMPLETED|Period From Second to Third Follow-up||31
3327331|NCT03255187|4060178|FG000|NOT COMPLETED|Period From Second to Third Follow-up||0
3327332|NCT03255187|4060179|FG001|NOT COMPLETED|Period From Second to Third Follow-up||0
3327333|NCT03255187|4060178|FG000|STARTED|Period From Third to Fourth Follow-up||34
3327334|NCT03255187|4060179|FG001|STARTED|Period From Third to Fourth Follow-up||31
3327335|NCT03255187|4060178|FG000|COMPLETED|Period From Third to Fourth Follow-up||34
3327336|NCT03255187|4060179|FG001|COMPLETED|Period From Third to Fourth Follow-up||31
3327337|NCT03255187|4060178|FG000|NOT COMPLETED|Period From Third to Fourth Follow-up||0
3327338|NCT03255187|4060179|FG001|NOT COMPLETED|Period From Third to Fourth Follow-up||0
3327339|NCT03255187|4060178|FG000|STARTED|Period at Fourth Follow-up||34
3327340|NCT03255187|4060179|FG001|STARTED|Period at Fourth Follow-up||31
3327341|NCT03255187|4060178|FG000|COMPLETED|Period at Fourth Follow-up||34
3327342|NCT03255187|4060179|FG001|COMPLETED|Period at Fourth Follow-up||31
3327343|NCT03255187|4060178|FG000|NOT COMPLETED|Period at Fourth Follow-up||0
3327344|NCT03255187|4060179|FG001|NOT COMPLETED|Period at Fourth Follow-up||0
3327345|NCT03255291|4060191|FG000|STARTED|Overall Study||93
3327346|NCT03255291|4060192|FG001|STARTED|Overall Study||90
3327347|NCT03255291|4060193|FG002|STARTED|Overall Study||91
3327348|NCT03255291|4060194|FG003|STARTED|Overall Study||90
3327349|NCT03255291|4060195|FG004|STARTED|Overall Study||95
3327350|NCT03255291|4060196|FG005|STARTED|Overall Study||95
3327351|NCT03255291|4060191|FG000|COMPLETED|Overall Study||80
3327352|NCT03255291|4060192|FG001|COMPLETED|Overall Study||78
3327353|NCT03255291|4060193|FG002|COMPLETED|Overall Study||85
3327354|NCT03255291|4060194|FG003|COMPLETED|Overall Study||84
3327355|NCT03255291|4060195|FG004|COMPLETED|Overall Study||88
3327356|NCT03255291|4060196|FG005|COMPLETED|Overall Study||85
3327357|NCT03255291|4060191|FG000|NOT COMPLETED|Overall Study||13
3327358|NCT03255291|4060192|FG001|NOT COMPLETED|Overall Study||12
3327359|NCT03255291|4060193|FG002|NOT COMPLETED|Overall Study||6
3327360|NCT03255291|4060194|FG003|NOT COMPLETED|Overall Study||6
3327361|NCT03255291|4060195|FG004|NOT COMPLETED|Overall Study||7
3327362|NCT03255291|4060196|FG005|NOT COMPLETED|Overall Study||10
3327363|NCT03255382|4060216|FG000|STARTED|Overall Study||60
3327364|NCT03255382|4060217|FG001|STARTED|Overall Study||60
3327365|NCT03255382|4060216|FG000|COMPLETED|Overall Study||47
3327366|NCT03255382|4060217|FG001|COMPLETED|Overall Study||60
3327367|NCT03255382|4060216|FG000|NOT COMPLETED|Overall Study||13
3327368|NCT03255382|4060217|FG001|NOT COMPLETED|Overall Study||0
3327369|NCT03255655|4060226|FG000|STARTED|Overall Study||29
3327370|NCT03255655|4060227|FG001|STARTED|Overall Study||12
3327371|NCT03255655|4060226|FG000|COMPLETED|Overall Study||22
3327372|NCT03255655|4060227|FG001|COMPLETED|Overall Study||8
3327373|NCT03255655|4060226|FG000|NOT COMPLETED|Overall Study||7
3327374|NCT03255655|4060227|FG001|NOT COMPLETED|Overall Study||4
3327375|NCT03255733|4060233|FG000|STARTED|Overall Study||29
3327376|NCT03255733|4060233|FG000|COMPLETED|Overall Study||25
3327377|NCT03255733|4060233|FG000|NOT COMPLETED|Overall Study||4
3327378|NCT03255824|4060239|FG000|STARTED|Overall Study||69
3327379|NCT03255824|4060240|FG001|STARTED|Overall Study||75
3327380|NCT03255824|4060239|FG000|COMPLETED|Overall Study||67
3327381|NCT03255824|4060240|FG001|COMPLETED|Overall Study||74
3327382|NCT03255824|4060239|FG000|NOT COMPLETED|Overall Study||2
3327383|NCT03255824|4060240|FG001|NOT COMPLETED|Overall Study||1
3327384|NCT03255902|4060246|FG000|STARTED|Overall Study||7
3327385|NCT03255902|4060246|FG000|COMPLETED|Overall Study||5
3327386|NCT03255902|4060246|FG000|NOT COMPLETED|Overall Study||2
3327387|NCT03255941|4060254|FG000|STARTED|Overall Study||177
3327388|NCT03255941|4060255|FG001|STARTED|Overall Study||178
3327389|NCT03255941|4060256|FG002|STARTED|Overall Study||53
3176374|NCT01966159|3904197|FG001|COMPLETED|Overall Study||207
3176375|NCT01966159|3904196|FG000|NOT COMPLETED|Overall Study||0
3176376|NCT01966159|3904197|FG001|NOT COMPLETED|Overall Study||0
3176377|NCT01966354|3904206|FG000|STARTED|Overall Study||75
3176378|NCT01966354|3904207|FG001|STARTED|Overall Study||73
3176379|NCT01966354|3904208|FG002|STARTED|Overall Study||72
3176380|NCT01966354|3904206|FG000|COMPLETED|Overall Study||75
3176381|NCT01966354|3904207|FG001|COMPLETED|Overall Study||73
3176382|NCT01966354|3904208|FG002|COMPLETED|Overall Study||72
3176383|NCT01966354|3904206|FG000|NOT COMPLETED|Overall Study||0
3176384|NCT01966354|3904207|FG001|NOT COMPLETED|Overall Study||0
3176385|NCT01966354|3904208|FG002|NOT COMPLETED|Overall Study||0
3176386|NCT01966380|3904216|FG000|STARTED|Overall Study||3
3176387|NCT01966380|3904217|FG001|STARTED|Overall Study||3
3176388|NCT01966380|3904216|FG000|COMPLETED|Overall Study||3
3176389|NCT01966380|3904217|FG001|COMPLETED|Overall Study||2
3176390|NCT01966380|3904216|FG000|NOT COMPLETED|Overall Study||0
3176391|NCT01966380|3904217|FG001|NOT COMPLETED|Overall Study||1
3176392|NCT01966419|3904225|FG000|STARTED|Overall Study||115
3176393|NCT01966419|3904226|FG001|STARTED|Overall Study||116
3176394|NCT01966419|3904225|FG000|Intent to Treat Population (ITT)T)115|Overall Study||115
3176395|NCT01966419|3904226|FG001|Intent to Treat Population (ITT)T)115|Overall Study||116
3176396|NCT01966419|3904225|FG000|Safety Analysis Set (SAS)|Overall Study||112
3176397|NCT01966419|3904226|FG001|Safety Analysis Set (SAS)|Overall Study||114
3176398|NCT01966419|3904225|FG000|COMPLETED|Overall Study||74
3327390|NCT03255941|4060257|FG003|STARTED|Overall Study||52
3327391|NCT03255941|4060254|FG000|Deemed Eligible to Receive DMPA|Overall Study||140
3327392|NCT03255941|4060255|FG001|Deemed Eligible to Receive DMPA|Overall Study||134
3176399|NCT01966419|3904226|FG001|COMPLETED|Overall Study||80
3176400|NCT01966419|3904225|FG000|NOT COMPLETED|Overall Study||41
3176401|NCT01966419|3904226|FG001|NOT COMPLETED|Overall Study||36
3327393|NCT03255941|4060256|FG002|Deemed Eligible to Receive DMPA|Overall Study||48
3327394|NCT03255941|4060257|FG003|Deemed Eligible to Receive DMPA|Overall Study||46
3327395|NCT03255941|4060254|FG000|COMPLETED|Overall Study||139
3327396|NCT03255941|4060255|FG001|COMPLETED|Overall Study||132
3327397|NCT03255941|4060256|FG002|COMPLETED|Overall Study||48
3327398|NCT03255941|4060257|FG003|COMPLETED|Overall Study||46
3327399|NCT03255941|4060254|FG000|NOT COMPLETED|Overall Study||38
3327400|NCT03255941|4060255|FG001|NOT COMPLETED|Overall Study||46
3327401|NCT03255941|4060256|FG002|NOT COMPLETED|Overall Study||5
3327402|NCT03255941|4060257|FG003|NOT COMPLETED|Overall Study||6
3327403|NCT03255980|4060283|FG000|STARTED|Overall Study||20
3327404|NCT03255980|4060284|FG001|STARTED|Overall Study||20
3327405|NCT03255980|4060285|FG002|STARTED|Overall Study||20
3327406|NCT03255980|4060286|FG003|STARTED|Overall Study||20
3327407|NCT03255980|4060283|FG000|COMPLETED|Overall Study||17
3327408|NCT03255980|4060284|FG001|COMPLETED|Overall Study||12
3327409|NCT03255980|4060285|FG002|COMPLETED|Overall Study||14
3327410|NCT03255980|4060286|FG003|COMPLETED|Overall Study||8
3327411|NCT03255980|4060283|FG000|NOT COMPLETED|Overall Study||3
3327412|NCT03255980|4060284|FG001|NOT COMPLETED|Overall Study||8
3327413|NCT03255980|4060285|FG002|NOT COMPLETED|Overall Study||6
3176402|NCT01966432|3904235|FG000|STARTED|Overall Study||10
3176403|NCT01966432|3904236|FG001|STARTED|Overall Study||34
3176404|NCT01966432|3904237|FG002|STARTED|Overall Study||54
3176405|NCT01966432|3904235|FG000|COMPLETED|Overall Study||5
3176406|NCT01966432|3904236|FG001|COMPLETED|Overall Study||21
3176407|NCT01966432|3904237|FG002|COMPLETED|Overall Study||28
3176408|NCT01966432|3904235|FG000|NOT COMPLETED|Overall Study||5
3176409|NCT01966432|3904236|FG001|NOT COMPLETED|Overall Study||13
3176410|NCT01966432|3904237|FG002|NOT COMPLETED|Overall Study||26
3176411|NCT01966445|3904253|FG000|STARTED|Part1 (Median Exposure of 6.143 Weeks)||1
3176412|NCT01966445|3904254|FG001|STARTED|Part1 (Median Exposure of 6.143 Weeks)||3
3176413|NCT01966445|3904255|FG002|STARTED|Part1 (Median Exposure of 6.143 Weeks)||2
3176414|NCT01966445|3904256|FG003|STARTED|Part1 (Median Exposure of 6.143 Weeks)||5
3176415|NCT01966445|3904257|FG004|STARTED|Part1 (Median Exposure of 6.143 Weeks)||4
3176416|NCT01966445|3904258|FG005|STARTED|Part1 (Median Exposure of 6.143 Weeks)||5
3176417|NCT01966445|3904259|FG006|STARTED|Part1 (Median Exposure of 6.143 Weeks)||0
3176418|NCT01966445|3904253|FG000|COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||1
3176419|NCT01966445|3904254|FG001|COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||1
3176420|NCT01966445|3904255|FG002|COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||1
3176421|NCT01966445|3904256|FG003|COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||2
3176422|NCT01966445|3904257|FG004|COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||1
3176423|NCT01966445|3904258|FG005|COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||4
3176424|NCT01966445|3904259|FG006|COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||0
3176425|NCT01966445|3904253|FG000|NOT COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||0
3327414|NCT03255980|4060286|FG003|NOT COMPLETED|Overall Study||12
3327415|NCT03256136|4060300|FG000|STARTED|Overall Study||3
3327416|NCT03256136|4060301|FG001|STARTED|Overall Study||1
3327417|NCT03256136|4060302|FG002|STARTED|Overall Study||4
3327418|NCT03256136|4060303|FG003|STARTED|Overall Study||1
3327419|NCT03256136|4060300|FG000|COMPLETED|Overall Study||3
3327420|NCT03256136|4060301|FG001|COMPLETED|Overall Study||1
3327421|NCT03256136|4060302|FG002|COMPLETED|Overall Study||4
3327422|NCT03256136|4060303|FG003|COMPLETED|Overall Study||1
3327423|NCT03256136|4060300|FG000|NOT COMPLETED|Overall Study||0
3327424|NCT03256136|4060301|FG001|NOT COMPLETED|Overall Study||0
3327425|NCT03256136|4060302|FG002|NOT COMPLETED|Overall Study||0
3327426|NCT03256136|4060303|FG003|NOT COMPLETED|Overall Study||0
3327427|NCT03256162|4060315|FG000|STARTED|Overall Study||13
3327428|NCT03256162|4060316|FG001|STARTED|Overall Study||12
3327429|NCT03256162|4060315|FG000|COMPLETED|Overall Study||8
3327430|NCT03256162|4060316|FG001|COMPLETED|Overall Study||8
3327431|NCT03256162|4060315|FG000|NOT COMPLETED|Overall Study||5
3327432|NCT03256162|4060316|FG001|NOT COMPLETED|Overall Study||4
3327433|NCT03256253|4060322|FG000|STARTED|Overall Study||18
3327434|NCT03256253|4060322|FG000|COMPLETED|Overall Study||6
3327435|NCT03256253|4060322|FG000|NOT COMPLETED|Overall Study||12
3327436|NCT03256526|4060329|FG000|STARTED|Overall Study||19
3327437|NCT03256526|4060330|FG001|STARTED|Overall Study||17
3327438|NCT03256526|4060331|FG002|STARTED|Overall Study||17
3327439|NCT03256526|4060329|FG000|COMPLETED|Overall Study||17
3327440|NCT03256526|4060330|FG001|COMPLETED|Overall Study||17
3327441|NCT03256526|4060331|FG002|COMPLETED|Overall Study||14
3327442|NCT03256526|4060329|FG000|NOT COMPLETED|Overall Study||2
3327443|NCT03256526|4060330|FG001|NOT COMPLETED|Overall Study||0
3327444|NCT03256526|4060331|FG002|NOT COMPLETED|Overall Study||3
3327445|NCT03256552|4060339|FG000|STARTED|Overall Study||66
3327446|NCT03256552|4060339|FG000|GP MDI 28.8 µg|Overall Study||61
3327447|NCT03256552|4060339|FG000|GP MDI 14.4 µg|Overall Study||63
3327448|NCT03256552|4060339|FG000|GP MDI 7.2 µg|Overall Study||62
3327449|NCT03256552|4060339|FG000|Placebo MDI|Overall Study||65
3327450|NCT03256552|4060339|FG000|COMPLETED|Overall Study||61
3327451|NCT03256552|4060339|FG000|NOT COMPLETED|Overall Study||5
3327452|NCT03256578|4060351|FG000|STARTED|Overall Study||204
3327453|NCT03256578|4060352|FG001|STARTED|Overall Study||206
3327454|NCT03256578|4060351|FG000|COMPLETED|Overall Study||138
3327455|NCT03256578|4060352|FG001|COMPLETED|Overall Study||150
3176426|NCT01966445|3904254|FG001|NOT COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||2
3176427|NCT01966445|3904255|FG002|NOT COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||1
3176428|NCT01966445|3904256|FG003|NOT COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||3
3176429|NCT01966445|3904257|FG004|NOT COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||3
3327456|NCT03256578|4060351|FG000|NOT COMPLETED|Overall Study||66
3327457|NCT03256578|4060352|FG001|NOT COMPLETED|Overall Study||56
3327458|NCT03256695|4060358|FG000|STARTED|Overall Study||405
3327459|NCT03256695|4060358|FG000|Used ABS eMDPI at Least Once|Overall Study||390
3327460|NCT03256695|4060358|FG000|COMPLETED|Overall Study||366
3327461|NCT03256695|4060358|FG000|NOT COMPLETED|Overall Study||39
3327462|NCT03256799|4060362|FG000|STARTED|Overall Study||1
3327463|NCT03256799|4060362|FG000|COMPLETED|Overall Study||1
3327464|NCT03256799|4060362|FG000|NOT COMPLETED|Overall Study||0
3327465|NCT03256851|4060368|FG000|STARTED|Overall Study||10
3327466|NCT03256851|4060369|FG001|STARTED|Overall Study||10
3327467|NCT03256851|4060368|FG000|COMPLETED|Overall Study||9
3327468|NCT03256851|4060369|FG001|COMPLETED|Overall Study||10
3327469|NCT03256851|4060368|FG000|NOT COMPLETED|Overall Study||1
3327470|NCT03256851|4060369|FG001|NOT COMPLETED|Overall Study||0
3327471|NCT03256968|4060375|FG000|STARTED|Overall Study||1
3327472|NCT03256968|4060375|FG000|COMPLETED|Overall Study||1
3327473|NCT03256968|4060375|FG000|NOT COMPLETED|Overall Study||0
3327474|NCT03257189|4060379|FG000|STARTED|Overall Study||30
3327475|NCT03257189|4060379|FG000|COMPLETED|Overall Study||30
3327476|NCT03257189|4060379|FG000|NOT COMPLETED|Overall Study||0
3327477|NCT03257202|4060383|FG000|STARTED|Overall Study||12
3327478|NCT03257202|4060383|FG000|COMPLETED|Overall Study||12
3327479|NCT03257202|4060383|FG000|NOT COMPLETED|Overall Study||0
3327480|NCT03257358|4060395|FG000|STARTED|Overall Study||165
3327481|NCT03257358|4060396|FG001|STARTED|Overall Study||217
3327482|NCT03257358|4060395|FG000|Never Received Treatment|Overall Study||2
3327483|NCT03257358|4060396|FG001|Never Received Treatment|Overall Study||0
3327484|NCT03257358|4060395|FG000|COMPLETED|Overall Study||94
3327485|NCT03257358|4060396|FG001|COMPLETED|Overall Study||183
3327486|NCT03257358|4060395|FG000|NOT COMPLETED|Overall Study||71
3327487|NCT03257358|4060396|FG001|NOT COMPLETED|Overall Study||34
3327488|NCT03257371|4060402|FG000|STARTED|Overall Study||10
3327489|NCT03257371|4060402|FG000|COMPLETED|Overall Study||9
3327490|NCT03257371|4060402|FG000|NOT COMPLETED|Overall Study||1
3327491|NCT03257410|4060408|FG000|STARTED|Overall Study||86
3327492|NCT03257410|4060409|FG001|STARTED|Overall Study||86
3327493|NCT03257410|4060408|FG000|COMPLETED|Overall Study||65
3327494|NCT03257410|4060409|FG001|COMPLETED|Overall Study||65
3327495|NCT03257410|4060408|FG000|NOT COMPLETED|Overall Study||21
3327496|NCT03257410|4060409|FG001|NOT COMPLETED|Overall Study||21
3327497|NCT03257631|4060419|FG000|STARTED|Overall Study||11
3327498|NCT03257631|4060420|FG001|STARTED|Overall Study||9
3327499|NCT03257631|4060421|FG002|STARTED|Overall Study||23
3327500|NCT03257631|4060422|FG003|STARTED|Overall Study||10
3327501|NCT03257631|4060419|FG000|Received Study Drug|Overall Study||11
3327502|NCT03257631|4060420|FG001|Received Study Drug|Overall Study||9
3327503|NCT03257631|4060421|FG002|Received Study Drug|Overall Study||22
3327504|NCT03257631|4060422|FG003|Received Study Drug|Overall Study||10
3327505|NCT03257631|4060419|FG000|COMPLETED|Overall Study||0
3327506|NCT03257631|4060420|FG001|COMPLETED|Overall Study||0
3327507|NCT03257631|4060421|FG002|COMPLETED|Overall Study||0
3327508|NCT03257631|4060422|FG003|COMPLETED|Overall Study||0
3327509|NCT03257631|4060419|FG000|NOT COMPLETED|Overall Study||11
3327510|NCT03257631|4060420|FG001|NOT COMPLETED|Overall Study||9
3327511|NCT03257631|4060421|FG002|NOT COMPLETED|Overall Study||23
3327512|NCT03257631|4060422|FG003|NOT COMPLETED|Overall Study||10
3327513|NCT03257657|4060434|FG000|STARTED|Overall Study||22
3327514|NCT03257657|4060435|FG001|STARTED|Overall Study||20
3327515|NCT03257657|4060434|FG000|COMPLETED|Overall Study||22
3327516|NCT03257657|4060435|FG001|COMPLETED|Overall Study||15
3327517|NCT03257657|4060434|FG000|NOT COMPLETED|Overall Study||0
3327518|NCT03257657|4060435|FG001|NOT COMPLETED|Overall Study||5
3327519|NCT03257813|4060444|FG000|STARTED|Overall Study||30
3327520|NCT03257813|4060445|FG001|STARTED|Overall Study||30
3327521|NCT03257813|4060444|FG000|COMPLETED|Overall Study||24
3327522|NCT03257813|4060445|FG001|COMPLETED|Overall Study||27
3327523|NCT03257813|4060444|FG000|NOT COMPLETED|Overall Study||6
3327524|NCT03257813|4060445|FG001|NOT COMPLETED|Overall Study||3
3327525|NCT03257865|4060456|FG000|STARTED|Overall Study||163
3327526|NCT03257865|4060457|FG001|STARTED|Overall Study||170
3327527|NCT03257865|4060456|FG000|Received at Least 1 Dose of Study Drug|Overall Study||162
3327528|NCT03257865|4060457|FG001|Received at Least 1 Dose of Study Drug|Overall Study||170
3327529|NCT03257865|4060456|FG000|COMPLETED|Overall Study||128
3327530|NCT03257865|4060457|FG001|COMPLETED|Overall Study||135
3327531|NCT03257865|4060456|FG000|NOT COMPLETED|Overall Study||35
3327532|NCT03257865|4060457|FG001|NOT COMPLETED|Overall Study||35
3327533|NCT03257995|4060463|FG000|STARTED|Overall Study||9
3327534|NCT03257995|4060464|FG001|STARTED|Overall Study||9
3327535|NCT03257995|4060465|FG002|STARTED|Overall Study||9
3327536|NCT03257995|4060466|FG003|STARTED|Overall Study||9
3327537|NCT03257995|4060467|FG004|STARTED|Overall Study||9
3327538|NCT03257995|4060468|FG005|STARTED|Overall Study||9
3327539|NCT03257995|4060463|FG000|COMPLETED|Overall Study||9
3327540|NCT03257995|4060464|FG001|COMPLETED|Overall Study||8
3327541|NCT03257995|4060465|FG002|COMPLETED|Overall Study||9
3327542|NCT03257995|4060466|FG003|COMPLETED|Overall Study||9
3327543|NCT03257995|4060467|FG004|COMPLETED|Overall Study||9
3327544|NCT03257995|4060468|FG005|COMPLETED|Overall Study||7
3327545|NCT03257995|4060463|FG000|NOT COMPLETED|Overall Study||0
3327546|NCT03257995|4060464|FG001|NOT COMPLETED|Overall Study||1
3327547|NCT03257995|4060465|FG002|NOT COMPLETED|Overall Study||0
3327548|NCT03257995|4060466|FG003|NOT COMPLETED|Overall Study||0
3327549|NCT03257995|4060467|FG004|NOT COMPLETED|Overall Study||0
3327550|NCT03257995|4060468|FG005|NOT COMPLETED|Overall Study||2
3327551|NCT03258645|4060480|FG000|STARTED|Overall Study||1489
3327552|NCT03258645|4060480|FG000|COMPLETED|Overall Study||1489
3327553|NCT03258645|4060480|FG000|NOT COMPLETED|Overall Study||0
3327554|NCT03258710|4060490|FG000|STARTED|Overall Study||75
3327555|NCT03258710|4060490|FG000|COMPLETED|Overall Study||72
3327556|NCT03258710|4060490|FG000|NOT COMPLETED|Overall Study||3
3327557|NCT03258762|4060496|FG000|STARTED|Overall Study||7
3327558|NCT03258762|4060497|FG001|STARTED|Overall Study||7
3327559|NCT03258762|4060496|FG000|COMPLETED|Overall Study||7
3327560|NCT03258762|4060497|FG001|COMPLETED|Overall Study||6
3327561|NCT03258762|4060496|FG000|NOT COMPLETED|Overall Study||0
3327562|NCT03258762|4060497|FG001|NOT COMPLETED|Overall Study||1
3327563|NCT03258814|4060506|FG000|STARTED|Overall Study||4
3327564|NCT03258814|4060507|FG001|STARTED|Overall Study||3
3327565|NCT03258814|4060508|FG002|STARTED|Overall Study||10
3327566|NCT03258814|4060506|FG000|COMPLETED|Overall Study||0
3327567|NCT03258814|4060507|FG001|COMPLETED|Overall Study||0
3327568|NCT03258814|4060508|FG002|COMPLETED|Overall Study||0
3327569|NCT03258814|4060506|FG000|NOT COMPLETED|Overall Study||4
3327570|NCT03258814|4060507|FG001|NOT COMPLETED|Overall Study||3
3327571|NCT03258814|4060508|FG002|NOT COMPLETED|Overall Study||10
3327572|NCT03259087|4060520|FG000|STARTED|Part 1 and Period 1 of Part 2||8
3327573|NCT03259087|4060521|FG001|STARTED|Part 1 and Period 1 of Part 2||8
3327574|NCT03259087|4060522|FG002|STARTED|Part 1 and Period 1 of Part 2||8
3327575|NCT03259087|4060523|FG003|STARTED|Part 1 and Period 1 of Part 2||10
3327576|NCT03259087|4060524|FG004|STARTED|Part 1 and Period 1 of Part 2||8
3327577|NCT03259087|4060520|FG000|COMPLETED|Part 1 and Period 1 of Part 2||8
3327578|NCT03259087|4060521|FG001|COMPLETED|Part 1 and Period 1 of Part 2||8
3327579|NCT03259087|4060522|FG002|COMPLETED|Part 1 and Period 1 of Part 2||8
3327580|NCT03259087|4060523|FG003|COMPLETED|Part 1 and Period 1 of Part 2||10
3327581|NCT03259087|4060524|FG004|COMPLETED|Part 1 and Period 1 of Part 2||7
3327582|NCT03259087|4060520|FG000|NOT COMPLETED|Part 1 and Period 1 of Part 2||0
3327583|NCT03259087|4060521|FG001|NOT COMPLETED|Part 1 and Period 1 of Part 2||0
3327584|NCT03259087|4060522|FG002|NOT COMPLETED|Part 1 and Period 1 of Part 2||0
3327585|NCT03259087|4060523|FG003|NOT COMPLETED|Part 1 and Period 1 of Part 2||0
3327586|NCT03259087|4060524|FG004|NOT COMPLETED|Part 1 and Period 1 of Part 2||1
3327587|NCT03259087|4060520|FG000|STARTED|Period 2 of Part 2|Period 2 did not apply to Part 1 participants|0
3327588|NCT03259087|4060521|FG001|STARTED|Period 2 of Part 2|Period 2 did not apply to Part 1 participants|0
3327589|NCT03259087|4060522|FG002|STARTED|Period 2 of Part 2|Period 2 did not apply to Part 1 participants|0
3327590|NCT03259087|4060523|FG003|STARTED|Period 2 of Part 2|Period 2 did not apply to Part 1 participants|0
3327591|NCT03259087|4060524|FG004|STARTED|Period 2 of Part 2||7
3327592|NCT03259087|4060520|FG000|COMPLETED|Period 2 of Part 2||0
3327593|NCT03259087|4060521|FG001|COMPLETED|Period 2 of Part 2||0
3327594|NCT03259087|4060522|FG002|COMPLETED|Period 2 of Part 2||0
3327595|NCT03259087|4060523|FG003|COMPLETED|Period 2 of Part 2||0
3327596|NCT03259087|4060524|FG004|COMPLETED|Period 2 of Part 2||6
3327597|NCT03259087|4060520|FG000|NOT COMPLETED|Period 2 of Part 2||0
3327598|NCT03259087|4060521|FG001|NOT COMPLETED|Period 2 of Part 2||0
3327599|NCT03259087|4060522|FG002|NOT COMPLETED|Period 2 of Part 2||0
3327600|NCT03259087|4060523|FG003|NOT COMPLETED|Period 2 of Part 2||0
3327601|NCT03259087|4060524|FG004|NOT COMPLETED|Period 2 of Part 2||1
3327602|NCT03259139|4060552|FG000|STARTED|Overall Study||42
3327603|NCT03259139|4060553|FG001|STARTED|Overall Study||42
3327604|NCT03259139|4060554|FG002|STARTED|Overall Study||42
3327605|NCT03259139|4060555|FG003|STARTED|Overall Study||42
3327606|NCT03259139|4060556|FG004|STARTED|Overall Study||41
3327607|NCT03259139|4060557|FG005|STARTED|Overall Study||41
3327608|NCT03259139|4060552|FG000|Eligible|Overall Study||41
3327609|NCT03259139|4060553|FG001|Eligible|Overall Study||41
3327610|NCT03259139|4060554|FG002|Eligible|Overall Study||41
3327611|NCT03259139|4060555|FG003|Eligible|Overall Study||41
3327612|NCT03259139|4060556|FG004|Eligible|Overall Study||41
3327613|NCT03259139|4060557|FG005|Eligible|Overall Study||41
3327614|NCT03259139|4060552|FG000|Outlier Elimination|Overall Study||41
3327615|NCT03259139|4060553|FG001|Outlier Elimination|Overall Study||41
3327616|NCT03259139|4060554|FG002|Outlier Elimination|Overall Study||41
3327617|NCT03259139|4060555|FG003|Outlier Elimination|Overall Study||41
3327618|NCT03259139|4060556|FG004|Outlier Elimination|Overall Study||39
3327619|NCT03259139|4060557|FG005|Outlier Elimination|Overall Study||39
3327620|NCT03259139|4060552|FG000|Found Handgun|Overall Study||38
3327621|NCT03259139|4060553|FG001|Found Handgun|Overall Study||38
3327622|NCT03259139|4060554|FG002|Found Handgun|Overall Study||37
3327623|NCT03259139|4060555|FG003|Found Handgun|Overall Study||37
3327624|NCT03259139|4060556|FG004|Found Handgun|Overall Study||35
3327625|NCT03259139|4060557|FG005|Found Handgun|Overall Study||35
3327626|NCT03259139|4060552|FG000|COMPLETED|Overall Study||38
3327627|NCT03259139|4060553|FG001|COMPLETED|Overall Study||38
3327628|NCT03259139|4060554|FG002|COMPLETED|Overall Study||37
3327629|NCT03259139|4060555|FG003|COMPLETED|Overall Study||37
3327630|NCT03259139|4060556|FG004|COMPLETED|Overall Study||35
3327631|NCT03259139|4060557|FG005|COMPLETED|Overall Study||35
3327632|NCT03259139|4060552|FG000|NOT COMPLETED|Overall Study||4
3327633|NCT03259139|4060553|FG001|NOT COMPLETED|Overall Study||4
3327634|NCT03259139|4060554|FG002|NOT COMPLETED|Overall Study||5
3327635|NCT03259139|4060555|FG003|NOT COMPLETED|Overall Study||5
3327636|NCT03259139|4060556|FG004|NOT COMPLETED|Overall Study||6
3327637|NCT03259139|4060557|FG005|NOT COMPLETED|Overall Study||6
3327638|NCT03259308|4060577|FG000|STARTED|Overall Study||56
3327639|NCT03259308|4060578|FG001|STARTED|Overall Study||111
3327640|NCT03259308|4060579|FG002|STARTED|Overall Study||112
3327641|NCT03259308|4060577|FG000|COMPLETED|Overall Study||49
3327642|NCT03259308|4060578|FG001|COMPLETED|Overall Study||103
3327643|NCT03259308|4060579|FG002|COMPLETED|Overall Study||105
3327644|NCT03259308|4060577|FG000|NOT COMPLETED|Overall Study||7
3327645|NCT03259308|4060578|FG001|NOT COMPLETED|Overall Study||8
3327646|NCT03259308|4060579|FG002|NOT COMPLETED|Overall Study||7
3327647|NCT03259334|4060590|FG000|STARTED|Overall Study||76
3327648|NCT03259334|4060591|FG001|STARTED|Overall Study||153
3327649|NCT03259334|4060592|FG002|STARTED|Overall Study||151
3327650|NCT03259334|4060590|FG000|Treated|Overall Study||76
3327651|NCT03259334|4060591|FG001|Treated|Overall Study||151
3327652|NCT03259334|4060592|FG002|Treated|Overall Study||151
3327653|NCT03259334|4060590|FG000|COMPLETED|Overall Study||66
3327654|NCT03259334|4060591|FG001|COMPLETED|Overall Study||136
3327655|NCT03259334|4060592|FG002|COMPLETED|Overall Study||138
3327656|NCT03259334|4060590|FG000|NOT COMPLETED|Overall Study||10
3327657|NCT03259334|4060591|FG001|NOT COMPLETED|Overall Study||17
3327658|NCT03259334|4060592|FG002|NOT COMPLETED|Overall Study||13
3327659|NCT03259425|4060600|FG000|STARTED|Overall Study||7
3327660|NCT03259425|4060600|FG000|Surgery|Overall Study||6
3327661|NCT03259425|4060600|FG000|COMPLETED|Overall Study||6
3327662|NCT03259425|4060600|FG000|NOT COMPLETED|Overall Study||1
3327663|NCT03259490|4060606|FG000|STARTED|Period 1||15
3327664|NCT03259490|4060607|FG001|STARTED|Period 1||15
3327665|NCT03259490|4060606|FG000|COMPLETED|Period 1||15
3327666|NCT03259490|4060607|FG001|COMPLETED|Period 1||14
3327667|NCT03259490|4060606|FG000|NOT COMPLETED|Period 1||0
3327668|NCT03259490|4060607|FG001|NOT COMPLETED|Period 1||1
3327669|NCT03259490|4060606|FG000|STARTED|Period 2||15
3327670|NCT03259490|4060607|FG001|STARTED|Period 2||14
3327671|NCT03259490|4060606|FG000|COMPLETED|Period 2||14
3327672|NCT03259490|4060607|FG001|COMPLETED|Period 2||14
3327673|NCT03259490|4060606|FG000|NOT COMPLETED|Period 2||1
3327674|NCT03259490|4060607|FG001|NOT COMPLETED|Period 2||0
3327675|NCT03259555|4060615|FG000|STARTED|Overall Study||158
3327676|NCT03259555|4060616|FG001|STARTED|Overall Study||164
3327677|NCT03259555|4060615|FG000|Received At Least 1 Dose of Study Drug|Overall Study||158
3327678|NCT03259555|4060616|FG001|Received At Least 1 Dose of Study Drug|Overall Study||163
3327679|NCT03259555|4060615|FG000|COMPLETED|Overall Study||124
3327680|NCT03259555|4060616|FG001|COMPLETED|Overall Study||134
3327681|NCT03259555|4060615|FG000|NOT COMPLETED|Overall Study||34
3327682|NCT03259555|4060616|FG001|NOT COMPLETED|Overall Study||30
3327683|NCT03259789|4060625|FG000|STARTED|Overall Study||158
3327684|NCT03259789|4060626|FG001|STARTED|Overall Study||159
3327685|NCT03259789|4060627|FG002|STARTED|Overall Study||34
3327686|NCT03259789|4060625|FG000|COMPLETED|Overall Study||141
3327687|NCT03259789|4060626|FG001|COMPLETED|Overall Study||142
3327688|NCT03259789|4060627|FG002|COMPLETED|Overall Study||28
3327689|NCT03259789|4060625|FG000|NOT COMPLETED|Overall Study||17
3327690|NCT03259789|4060626|FG001|NOT COMPLETED|Overall Study||17
3327691|NCT03259789|4060627|FG002|NOT COMPLETED|Overall Study||6
3327692|NCT03260205|4060641|FG000|STARTED|Overall Study||46
3327693|NCT03260205|4060642|FG001|STARTED|Overall Study||40
3327694|NCT03260205|4060643|FG002|STARTED|Overall Study||37
3327695|NCT03260205|4060644|FG003|STARTED|Overall Study||37
3327696|NCT03260205|4060645|FG004|STARTED|Overall Study||39
3327697|NCT03260205|4060641|FG000|Received Treatment|Overall Study||45
3327698|NCT03260205|4060642|FG001|Received Treatment|Overall Study||39
3327699|NCT03260205|4060643|FG002|Received Treatment|Overall Study||35
3327700|NCT03260205|4060644|FG003|Received Treatment|Overall Study||34
3327701|NCT03260205|4060645|FG004|Received Treatment|Overall Study||38
3327702|NCT03260205|4060641|FG000|COMPLETED|Overall Study||37
3327703|NCT03260205|4060642|FG001|COMPLETED|Overall Study||32
3327704|NCT03260205|4060643|FG002|COMPLETED|Overall Study||26
3327705|NCT03260205|4060644|FG003|COMPLETED|Overall Study||30
3327706|NCT03260205|4060645|FG004|COMPLETED|Overall Study||25
3327707|NCT03260205|4060641|FG000|NOT COMPLETED|Overall Study||9
3327708|NCT03260205|4060642|FG001|NOT COMPLETED|Overall Study||8
3327709|NCT03260205|4060643|FG002|NOT COMPLETED|Overall Study||11
3327710|NCT03260205|4060644|FG003|NOT COMPLETED|Overall Study||7
3327711|NCT03260205|4060645|FG004|NOT COMPLETED|Overall Study||14
3327712|NCT03260426|4060664|FG000|STARTED|Overall Study||50
3327713|NCT03260426|4060665|FG001|STARTED|Overall Study||50
3327714|NCT03260426|4060664|FG000|COMPLETED|Overall Study||50
3327715|NCT03260426|4060665|FG001|COMPLETED|Overall Study||50
3327716|NCT03260426|4060664|FG000|NOT COMPLETED|Overall Study||0
3327717|NCT03260426|4060665|FG001|NOT COMPLETED|Overall Study||0
3327718|NCT03260595|4060674|FG000|STARTED|Overall Study||20
3327719|NCT03260595|4060675|FG001|STARTED|Overall Study||10
3327720|NCT03260595|4060676|FG002|STARTED|Overall Study||2
3327721|NCT03260595|4060674|FG000|COMPLETED|Overall Study||20
3327722|NCT03260595|4060675|FG001|COMPLETED|Overall Study||10
3327723|NCT03260595|4060676|FG002|COMPLETED|Overall Study||2
3327724|NCT03260595|4060674|FG000|NOT COMPLETED|Overall Study||0
3327725|NCT03260595|4060675|FG001|NOT COMPLETED|Overall Study||0
3327726|NCT03260595|4060676|FG002|NOT COMPLETED|Overall Study||0
3327727|NCT03260699|4060686|FG000|STARTED|Overall Study||5
3327728|NCT03260699|4060687|FG001|STARTED|Overall Study||4
3327729|NCT03260699|4060686|FG000|COMPLETED|Overall Study||5
3327730|NCT03260699|4060687|FG001|COMPLETED|Overall Study||2
3327731|NCT03260699|4060686|FG000|NOT COMPLETED|Overall Study||0
3327732|NCT03260699|4060687|FG001|NOT COMPLETED|Overall Study||2
3327733|NCT03260790|4060695|FG000|STARTED|Overall Study||8
3327734|NCT03260790|4060696|FG001|STARTED|Overall Study||9
3327735|NCT03260790|4060695|FG000|COMPLETED|Overall Study||8
3327736|NCT03260790|4060696|FG001|COMPLETED|Overall Study||9
3327737|NCT03260790|4060695|FG000|NOT COMPLETED|Overall Study||0
3327738|NCT03260790|4060696|FG001|NOT COMPLETED|Overall Study||0
3327739|NCT03260868|4060704|FG000|STARTED|Overall Study||8
3327740|NCT03260868|4060705|FG001|STARTED|Overall Study||7
3327741|NCT03260868|4060704|FG000|Safety Population|Overall Study||8
3327742|NCT03260868|4060705|FG001|Safety Population|Overall Study||6
3327743|NCT03260868|4060704|FG000|COMPLETED|Overall Study||5
3327744|NCT03260868|4060705|FG001|COMPLETED|Overall Study||4
3327745|NCT03260868|4060704|FG000|NOT COMPLETED|Overall Study||3
3327746|NCT03260868|4060705|FG001|NOT COMPLETED|Overall Study||3
3327757|NCT03261037|4060724|FG000|STARTED|Overall Study||68
3327758|NCT03261037|4060725|FG001|STARTED|Overall Study||62
3327759|NCT03261037|4060726|FG002|STARTED|Overall Study||9
3327760|NCT03261037|4060727|FG003|STARTED|Overall Study||39
3327761|NCT03261037|4060724|FG000|COMPLETED|Overall Study||64
3327762|NCT03261037|4060725|FG001|COMPLETED|Overall Study||41
3327763|NCT03261037|4060726|FG002|COMPLETED|Overall Study||9
3327764|NCT03261037|4060727|FG003|COMPLETED|Overall Study||11
3327765|NCT03261037|4060724|FG000|NOT COMPLETED|Overall Study||4
3327766|NCT03261037|4060725|FG001|NOT COMPLETED|Overall Study||21
3327767|NCT03261037|4060726|FG002|NOT COMPLETED|Overall Study||0
3327768|NCT03261037|4060727|FG003|NOT COMPLETED|Overall Study||28
3327769|NCT03261167|4060740|FG000|STARTED|Double Blind(Treatment cyc1,Upto Week48)||63
3327770|NCT03261167|4060741|FG001|STARTED|Double Blind(Treatment cyc1,Upto Week48)||61
3327771|NCT03261167|4060740|FG000|COMPLETED|Double Blind(Treatment cyc1,Upto Week48)||60
3327772|NCT03261167|4060741|FG001|COMPLETED|Double Blind(Treatment cyc1,Upto Week48)||57
3327773|NCT03261167|4060740|FG000|NOT COMPLETED|Double Blind(Treatment cyc1,Upto Week48)||3
3327774|NCT03261167|4060741|FG001|NOT COMPLETED|Double Blind(Treatment cyc1,Upto Week48)||4
3327775|NCT03261167|4060740|FG000|STARTED|Open-label(Treatment cycle2,Upto Week48)||60
3327776|NCT03261167|4060741|FG001|STARTED|Open-label(Treatment cycle2,Upto Week48)||57
3327777|NCT03261167|4060740|FG000|COMPLETED|Open-label(Treatment cycle2,Upto Week48)||58
3327778|NCT03261167|4060741|FG001|COMPLETED|Open-label(Treatment cycle2,Upto Week48)||57
3327779|NCT03261167|4060740|FG000|NOT COMPLETED|Open-label(Treatment cycle2,Upto Week48)||2
3327780|NCT03261167|4060741|FG001|NOT COMPLETED|Open-label(Treatment cycle2,Upto Week48)||0
3327781|NCT03261167|4060740|FG000|STARTED|Open-label(Treatment cycle3,Upto Week48)||55
3327782|NCT03261167|4060741|FG001|STARTED|Open-label(Treatment cycle3,Upto Week48)||56
3327783|NCT03261167|4060740|FG000|COMPLETED|Open-label(Treatment cycle3,Upto Week48)||54
3327784|NCT03261167|4060741|FG001|COMPLETED|Open-label(Treatment cycle3,Upto Week48)||55
3327785|NCT03261167|4060740|FG000|NOT COMPLETED|Open-label(Treatment cycle3,Upto Week48)||1
3327786|NCT03261167|4060741|FG001|NOT COMPLETED|Open-label(Treatment cycle3,Upto Week48)||1
3327787|NCT03261167|4060740|FG000|STARTED|Open-label(Treatment cycle4,Upto Week48)||43
3327788|NCT03261167|4060741|FG001|STARTED|Open-label(Treatment cycle4,Upto Week48)||40
3327789|NCT03261167|4060740|FG000|COMPLETED|Open-label(Treatment cycle4,Upto Week48)||43
3327790|NCT03261167|4060741|FG001|COMPLETED|Open-label(Treatment cycle4,Upto Week48)||40
3327791|NCT03261167|4060740|FG000|NOT COMPLETED|Open-label(Treatment cycle4,Upto Week48)||0
3327792|NCT03261167|4060741|FG001|NOT COMPLETED|Open-label(Treatment cycle4,Upto Week48)||0
3327793|NCT03261336|4060753|FG000|STARTED|Overall Study||1
3327794|NCT03261336|4060753|FG000|COMPLETED|Overall Study||0
3327795|NCT03261336|4060753|FG000|NOT COMPLETED|Overall Study||1
3327796|NCT03261947|4060762|FG000|STARTED|Overall Study||12
3327797|NCT03261947|4060763|FG001|STARTED|Overall Study||15
3327798|NCT03261947|4060764|FG002|STARTED|Overall Study||35
3327799|NCT03261947|4060765|FG003|STARTED|Overall Study||21
3327800|NCT03261947|4060766|FG004|STARTED|Overall Study||18
3327801|NCT03261947|4060762|FG000|COMPLETED|Overall Study||0
3327802|NCT03261947|4060763|FG001|COMPLETED|Overall Study||2
3327803|NCT03261947|4060764|FG002|COMPLETED|Overall Study||5
3327804|NCT03261947|4060765|FG003|COMPLETED|Overall Study||0
3327805|NCT03261947|4060766|FG004|COMPLETED|Overall Study||1
3327806|NCT03261947|4060762|FG000|NOT COMPLETED|Overall Study||12
3327807|NCT03261947|4060763|FG001|NOT COMPLETED|Overall Study||13
3327808|NCT03261947|4060764|FG002|NOT COMPLETED|Overall Study||30
3327809|NCT03261947|4060765|FG003|NOT COMPLETED|Overall Study||21
3327810|NCT03261947|4060766|FG004|NOT COMPLETED|Overall Study||17
3327811|NCT03261960|4060784|FG000|STARTED|Overall Study||190
3327812|NCT03261960|4060785|FG001|STARTED|Overall Study||199
3327813|NCT03261960|4060784|FG000|COMPLETED|Overall Study||176
3327814|NCT03261960|4060785|FG001|COMPLETED|Overall Study||185
3327815|NCT03261960|4060784|FG000|NOT COMPLETED|Overall Study||14
3327816|NCT03261960|4060785|FG001|NOT COMPLETED|Overall Study||14
3327817|NCT03261973|4060791|FG000|STARTED|Overall Study||47
3327818|NCT03261973|4060791|FG000|COMPLETED|Overall Study||43
3327819|NCT03261973|4060791|FG000|NOT COMPLETED|Overall Study||4
3327820|NCT03261999|4060795|FG000|STARTED|Overall Study||144
3327821|NCT03261999|4060795|FG000|ITT|Overall Study||144
3327822|NCT03261999|4060795|FG000|PP|Overall Study||132
3327823|NCT03261999|4060795|FG000|COMPLETED|Overall Study||129
3327824|NCT03261999|4060795|FG000|NOT COMPLETED|Overall Study||15
3327825|NCT03262012|4060803|FG000|STARTED|Overall Study||139
3327826|NCT03262012|4060804|FG001|STARTED|Overall Study||138
3327827|NCT03262012|4060805|FG002|STARTED|Overall Study||70
3327828|NCT03262012|4060806|FG003|STARTED|Overall Study||69
3327829|NCT03262012|4060803|FG000|COMPLETED|Overall Study||112
3327830|NCT03262012|4060804|FG001|COMPLETED|Overall Study||102
3327831|NCT03262012|4060805|FG002|COMPLETED|Overall Study||56
3327832|NCT03262012|4060806|FG003|COMPLETED|Overall Study||54
3327833|NCT03262012|4060803|FG000|NOT COMPLETED|Overall Study||27
3327834|NCT03262012|4060804|FG001|NOT COMPLETED|Overall Study||36
3327835|NCT03262012|4060805|FG002|NOT COMPLETED|Overall Study||14
3327836|NCT03262012|4060806|FG003|NOT COMPLETED|Overall Study||15
3327837|NCT03262038|4060818|FG000|STARTED|Overall Study||18
3327838|NCT03262038|4060819|FG001|STARTED|Overall Study||28
3327839|NCT03262038|4060818|FG000|COMPLETED|Overall Study||18
3327840|NCT03262038|4060819|FG001|COMPLETED|Overall Study||27
3327841|NCT03262038|4060818|FG000|NOT COMPLETED|Overall Study||0
3327842|NCT03262038|4060819|FG001|NOT COMPLETED|Overall Study||1
3327843|NCT03262233|4060829|FG000|STARTED|Overall Study||53
3327844|NCT03262233|4060830|FG001|STARTED|Overall Study||53
3327845|NCT03262233|4060831|FG002|STARTED|Overall Study||59
3327846|NCT03262233|4060832|FG003|STARTED|Overall Study||61
3327847|NCT03262233|4060829|FG000|COMPLETED|Overall Study||35
3327848|NCT03262233|4060830|FG001|COMPLETED|Overall Study||32
3327849|NCT03262233|4060831|FG002|COMPLETED|Overall Study||34
3327850|NCT03262233|4060832|FG003|COMPLETED|Overall Study||32
3327851|NCT03262233|4060829|FG000|NOT COMPLETED|Overall Study||18
3327852|NCT03262233|4060830|FG001|NOT COMPLETED|Overall Study||21
3327853|NCT03262233|4060831|FG002|NOT COMPLETED|Overall Study||25
3327854|NCT03262233|4060832|FG003|NOT COMPLETED|Overall Study||29
3327855|NCT03262389|4060843|FG000|STARTED|Overall Study||10
3327856|NCT03262389|4060843|FG000|COMPLETED|Overall Study||7
3327857|NCT03262389|4060843|FG000|NOT COMPLETED|Overall Study||3
3327858|NCT03262441|4060847|FG000|STARTED|Overall Study||5
3327859|NCT03262441|4060847|FG000|COMPLETED|Overall Study||4
3327860|NCT03262441|4060847|FG000|NOT COMPLETED|Overall Study||1
3327861|NCT03263442|4060853|FG000|STARTED|Inpatient Phase||30
3327862|NCT03263442|4060854|FG001|STARTED|Inpatient Phase||34
3327863|NCT03263442|4060853|FG000|COMPLETED|Inpatient Phase||28
3327864|NCT03263442|4060854|FG001|COMPLETED|Inpatient Phase||33
3327865|NCT03263442|4060853|FG000|NOT COMPLETED|Inpatient Phase||2
3327866|NCT03263442|4060854|FG001|NOT COMPLETED|Inpatient Phase||1
3327867|NCT03263442|4060853|FG000|STARTED|1-month Follow-Up||28
3327868|NCT03263442|4060854|FG001|STARTED|1-month Follow-Up||33
3327869|NCT03263442|4060853|FG000|COMPLETED|1-month Follow-Up||27
3327870|NCT03263442|4060854|FG001|COMPLETED|1-month Follow-Up||33
3327871|NCT03263442|4060853|FG000|NOT COMPLETED|1-month Follow-Up||1
3327872|NCT03263442|4060854|FG001|NOT COMPLETED|1-month Follow-Up||0
3327873|NCT03263442|4060853|FG000|STARTED|3-month Follow-Up||27
3327874|NCT03263442|4060854|FG001|STARTED|3-month Follow-Up||33
3327875|NCT03263442|4060853|FG000|COMPLETED|3-month Follow-Up||26
3327876|NCT03263442|4060854|FG001|COMPLETED|3-month Follow-Up||30
3327877|NCT03263442|4060853|FG000|NOT COMPLETED|3-month Follow-Up||1
3327878|NCT03263442|4060854|FG001|NOT COMPLETED|3-month Follow-Up||3
3327879|NCT03263442|4060853|FG000|STARTED|6-month Follow-Up||26
3327880|NCT03263442|4060854|FG001|STARTED|6-month Follow-Up||30
3327881|NCT03263442|4060853|FG000|COMPLETED|6-month Follow-Up||24
3327882|NCT03263442|4060854|FG001|COMPLETED|6-month Follow-Up||28
3327883|NCT03263442|4060853|FG000|NOT COMPLETED|6-month Follow-Up||2
3327884|NCT03263442|4060854|FG001|NOT COMPLETED|6-month Follow-Up||2
3327885|NCT03263702|4060864|FG000|STARTED|Overall Study||38
3327886|NCT03263702|4060865|FG001|STARTED|Overall Study||26
3327887|NCT03263702|4060864|FG000|COMPLETED|Overall Study||35
3327888|NCT03263702|4060865|FG001|COMPLETED|Overall Study||22
3327889|NCT03263702|4060864|FG000|NOT COMPLETED|Overall Study||3
3327890|NCT03263702|4060865|FG001|NOT COMPLETED|Overall Study||4
3327891|NCT03263780|4060871|FG000|STARTED|Overall Study||21
3327892|NCT03263780|4060871|FG000|COMPLETED|Overall Study|13 evaluable for primary outcome, but 11 total completed study.|11
3327893|NCT03263780|4060871|FG000|NOT COMPLETED|Overall Study||10
3327894|NCT03264066|4060881|FG000|STARTED|Overall Study||20
3327895|NCT03264066|4060882|FG001|STARTED|Overall Study||20
3327896|NCT03264066|4060883|FG002|STARTED|Overall Study||17
3327897|NCT03264066|4060884|FG003|STARTED|Overall Study||20
3327898|NCT03264066|4060885|FG004|STARTED|Overall Study||7
3327899|NCT03264066|4060886|FG005|STARTED|Overall Study||3
3327900|NCT03264066|4060881|FG000|COMPLETED|Overall Study||0
3327901|NCT03264066|4060882|FG001|COMPLETED|Overall Study||0
3327902|NCT03264066|4060883|FG002|COMPLETED|Overall Study||0
3327903|NCT03264066|4060884|FG003|COMPLETED|Overall Study||0
3327904|NCT03264066|4060885|FG004|COMPLETED|Overall Study||0
3327905|NCT03264066|4060886|FG005|COMPLETED|Overall Study||0
3327906|NCT03264066|4060881|FG000|NOT COMPLETED|Overall Study||20
3327907|NCT03264066|4060882|FG001|NOT COMPLETED|Overall Study||20
3327908|NCT03264066|4060883|FG002|NOT COMPLETED|Overall Study||17
3327909|NCT03264066|4060884|FG003|NOT COMPLETED|Overall Study||20
3327910|NCT03264066|4060885|FG004|NOT COMPLETED|Overall Study||7
3327911|NCT03264066|4060886|FG005|NOT COMPLETED|Overall Study||3
3327912|NCT03264092|4060904|FG000|STARTED|Overall Study||17
3327913|NCT03264092|4060905|FG001|STARTED|Overall Study||20
3327914|NCT03264092|4060906|FG002|STARTED|Overall Study||18
3327915|NCT03264092|4060904|FG000|COMPLETED|Overall Study||17
3327916|NCT03264092|4060905|FG001|COMPLETED|Overall Study||20
3327917|NCT03264092|4060906|FG002|COMPLETED|Overall Study||18
3327918|NCT03264092|4060904|FG000|NOT COMPLETED|Overall Study||0
3327919|NCT03264092|4060905|FG001|NOT COMPLETED|Overall Study||0
3176430|NCT01966445|3904258|FG005|NOT COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||1
3176431|NCT01966445|3904259|FG006|NOT COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||0
3176432|NCT01966445|3904253|FG000|STARTED|Part2 (Median Exposure of 7.143 Weeks)||0
3327920|NCT03264092|4060906|FG002|NOT COMPLETED|Overall Study||0
3327921|NCT03264157|4060922|FG000|STARTED|Overall Study||81
3327922|NCT03264157|4060923|FG001|STARTED|Overall Study||81
3327923|NCT03264157|4060922|FG000|COMPLETED|Overall Study||68
3327924|NCT03264157|4060923|FG001|COMPLETED|Overall Study||74
3327925|NCT03264157|4060922|FG000|NOT COMPLETED|Overall Study||13
3327926|NCT03264157|4060923|FG001|NOT COMPLETED|Overall Study||7
3327927|NCT03264248|4060931|FG000|STARTED|Overall Study||9
3327928|NCT03264248|4060931|FG000|COMPLETED|Overall Study||9
3327929|NCT03264248|4060931|FG000|NOT COMPLETED|Overall Study||0
3327930|NCT03264456|4060935|FG000|STARTED|Overall Study||18
3327931|NCT03264456|4060935|FG000|COMPLETED|Overall Study||14
3327932|NCT03264456|4060935|FG000|NOT COMPLETED|Overall Study||4
3327933|NCT03265119|4060941|FG000|STARTED|Overall Study||34
3327934|NCT03265119|4060942|FG001|STARTED|Overall Study||35
3327935|NCT03265119|4060941|FG000|COMPLETED|Overall Study||24
3327936|NCT03265119|4060942|FG001|COMPLETED|Overall Study||28
3327937|NCT03265119|4060941|FG000|NOT COMPLETED|Overall Study||10
3327938|NCT03265119|4060942|FG001|NOT COMPLETED|Overall Study||7
3327939|NCT03265132|4060950|FG000|STARTED|Overall Study||6
3327940|NCT03265132|4060951|FG001|STARTED|Overall Study|One patient failed disease specific inclusion criteria and was excluded from efficacy analysis|6
3327941|NCT03265132|4060950|FG000|COMPLETED|Overall Study||6
3327942|NCT03265132|4060951|FG001|COMPLETED|Overall Study||0
3327943|NCT03265132|4060950|FG000|NOT COMPLETED|Overall Study||0
3327944|NCT03265132|4060951|FG001|NOT COMPLETED|Overall Study||6
3327945|NCT03265600|4060961|FG000|STARTED|Overall Study||92
3176433|NCT01966445|3904254|FG001|STARTED|Part2 (Median Exposure of 7.143 Weeks)||0
3176434|NCT01966445|3904255|FG002|STARTED|Part2 (Median Exposure of 7.143 Weeks)||0
3176435|NCT01966445|3904256|FG003|STARTED|Part2 (Median Exposure of 7.143 Weeks)||0
3176436|NCT01966445|3904257|FG004|STARTED|Part2 (Median Exposure of 7.143 Weeks)||0
3176437|NCT01966445|3904258|FG005|STARTED|Part2 (Median Exposure of 7.143 Weeks)||0
3176438|NCT01966445|3904259|FG006|STARTED|Part2 (Median Exposure of 7.143 Weeks)||9
3176439|NCT01966445|3904253|FG000|COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
3176440|NCT01966445|3904254|FG001|COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
3176441|NCT01966445|3904255|FG002|COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
3327946|NCT03265600|4060962|FG001|STARTED|Overall Study||44
3327947|NCT03265600|4060961|FG000|COMPLETED|Overall Study|Completed 8 or 9 week Action Plan Initiation Survey|68
3327948|NCT03265600|4060962|FG001|COMPLETED|Overall Study|Completed 8 or 9 week Action Plan Initiation Survey|32
3327949|NCT03265600|4060961|FG000|NOT COMPLETED|Overall Study||24
3327950|NCT03265600|4060962|FG001|NOT COMPLETED|Overall Study||12
3327951|NCT03265938|4060968|FG000|STARTED|Overall Study||100
3327952|NCT03265938|4060968|FG000|COMPLETED|Overall Study||92
3327953|NCT03265938|4060968|FG000|NOT COMPLETED|Overall Study||8
3327954|NCT03266094|4060973|FG000|STARTED|Overall Study||60
3327955|NCT03266094|4060973|FG000|COMPLETED|Overall Study||58
3327956|NCT03266094|4060973|FG000|NOT COMPLETED|Overall Study||2
3327957|NCT03266107|4060979|FG000|STARTED|Enrollment to Procedure||50
3327958|NCT03266107|4060979|FG000|COMPLETED|Enrollment to Procedure||47
3176442|NCT01966445|3904256|FG003|COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
3327959|NCT03266107|4060979|FG000|NOT COMPLETED|Enrollment to Procedure||3
3327960|NCT03266107|4060979|FG000|STARTED|3-Month Follow-up Visit||47
3327961|NCT03266107|4060979|FG000|COMPLETED|3-Month Follow-up Visit||46
3327962|NCT03266107|4060979|FG000|NOT COMPLETED|3-Month Follow-up Visit||1
3327963|NCT03266107|4060979|FG000|STARTED|12-Month Follow-up Visit||46
3327964|NCT03266107|4060979|FG000|COMPLETED|12-Month Follow-up Visit||45
3327965|NCT03266107|4060979|FG000|NOT COMPLETED|12-Month Follow-up Visit||1
3327966|NCT03266172|4060988|FG000|STARTED|Part A: Period 1(2 Days)||16
3327967|NCT03266172|4060989|FG001|STARTED|Part A: Period 1(2 Days)||0
3327968|NCT03266172|4060990|FG002|STARTED|Part A: Period 1(2 Days)||0
3327969|NCT03266172|4060988|FG000|COMPLETED|Part A: Period 1(2 Days)||15
3327970|NCT03266172|4060989|FG001|COMPLETED|Part A: Period 1(2 Days)||0
3327971|NCT03266172|4060990|FG002|COMPLETED|Part A: Period 1(2 Days)||0
3327972|NCT03266172|4060988|FG000|NOT COMPLETED|Part A: Period 1(2 Days)||1
3327973|NCT03266172|4060989|FG001|NOT COMPLETED|Part A: Period 1(2 Days)||0
3327974|NCT03266172|4060990|FG002|NOT COMPLETED|Part A: Period 1(2 Days)||0
3327975|NCT03266172|4060988|FG000|STARTED|Part A: Washout Period (7 Days)||15
3327976|NCT03266172|4060989|FG001|STARTED|Part A: Washout Period (7 Days)||0
3327977|NCT03266172|4060990|FG002|STARTED|Part A: Washout Period (7 Days)||0
3327978|NCT03266172|4060988|FG000|COMPLETED|Part A: Washout Period (7 Days)||13
3327979|NCT03266172|4060989|FG001|COMPLETED|Part A: Washout Period (7 Days)||0
3327980|NCT03266172|4060990|FG002|COMPLETED|Part A: Washout Period (7 Days)||0
3327981|NCT03266172|4060988|FG000|NOT COMPLETED|Part A: Washout Period (7 Days)||2
3327982|NCT03266172|4060989|FG001|NOT COMPLETED|Part A: Washout Period (7 Days)||0
3327983|NCT03266172|4060990|FG002|NOT COMPLETED|Part A: Washout Period (7 Days)||0
3327984|NCT03266172|4060988|FG000|STARTED|Part A: Period 2 (2 Days)||13
3327985|NCT03266172|4060989|FG001|STARTED|Part A: Period 2 (2 Days)||0
3327986|NCT03266172|4060990|FG002|STARTED|Part A: Period 2 (2 Days)||0
3327987|NCT03266172|4060988|FG000|COMPLETED|Part A: Period 2 (2 Days)||13
3327988|NCT03266172|4060989|FG001|COMPLETED|Part A: Period 2 (2 Days)||0
3327989|NCT03266172|4060990|FG002|COMPLETED|Part A: Period 2 (2 Days)||0
3327990|NCT03266172|4060988|FG000|NOT COMPLETED|Part A: Period 2 (2 Days)||0
3327991|NCT03266172|4060989|FG001|NOT COMPLETED|Part A: Period 2 (2 Days)||0
3327992|NCT03266172|4060990|FG002|NOT COMPLETED|Part A: Period 2 (2 Days)||0
3327993|NCT03266172|4060988|FG000|STARTED|Part A: Washout (7 Days)||13
3327994|NCT03266172|4060989|FG001|STARTED|Part A: Washout (7 Days)||0
3327995|NCT03266172|4060990|FG002|STARTED|Part A: Washout (7 Days)||0
3327996|NCT03266172|4060988|FG000|COMPLETED|Part A: Washout (7 Days)||13
3327997|NCT03266172|4060989|FG001|COMPLETED|Part A: Washout (7 Days)||0
3327998|NCT03266172|4060990|FG002|COMPLETED|Part A: Washout (7 Days)||0
3327999|NCT03266172|4060988|FG000|NOT COMPLETED|Part A: Washout (7 Days)||0
3328000|NCT03266172|4060989|FG001|NOT COMPLETED|Part A: Washout (7 Days)||0
3328001|NCT03266172|4060990|FG002|NOT COMPLETED|Part A: Washout (7 Days)||0
3328002|NCT03266172|4060988|FG000|STARTED|Part A: Period 3 (2 Days)|3 replacement participants were enrolled|16
3328003|NCT03266172|4060989|FG001|STARTED|Part A: Period 3 (2 Days)||0
3328004|NCT03266172|4060990|FG002|STARTED|Part A: Period 3 (2 Days)||0
3328005|NCT03266172|4060988|FG000|COMPLETED|Part A: Period 3 (2 Days)||16
3328006|NCT03266172|4060989|FG001|COMPLETED|Part A: Period 3 (2 Days)||0
3328007|NCT03266172|4060990|FG002|COMPLETED|Part A: Period 3 (2 Days)||0
3328008|NCT03266172|4060988|FG000|NOT COMPLETED|Part A: Period 3 (2 Days)||0
3328009|NCT03266172|4060989|FG001|NOT COMPLETED|Part A: Period 3 (2 Days)||0
3328010|NCT03266172|4060990|FG002|NOT COMPLETED|Part A: Period 3 (2 Days)||0
3328011|NCT03266172|4060988|FG000|STARTED|Part A: Washout (7 Days)||16
3328012|NCT03266172|4060989|FG001|STARTED|Part A: Washout (7 Days)||0
3328013|NCT03266172|4060990|FG002|STARTED|Part A: Washout (7 Days)||0
3328014|NCT03266172|4060988|FG000|COMPLETED|Part A: Washout (7 Days)||16
3328015|NCT03266172|4060989|FG001|COMPLETED|Part A: Washout (7 Days)||0
3328016|NCT03266172|4060990|FG002|COMPLETED|Part A: Washout (7 Days)||0
3328017|NCT03266172|4060988|FG000|NOT COMPLETED|Part A: Washout (7 Days)||0
3328018|NCT03266172|4060989|FG001|NOT COMPLETED|Part A: Washout (7 Days)||0
3328019|NCT03266172|4060990|FG002|NOT COMPLETED|Part A: Washout (7 Days)||0
3328020|NCT03266172|4060988|FG000|STARTED|Part A: Period 4 (2 Days)||16
3328021|NCT03266172|4060989|FG001|STARTED|Part A: Period 4 (2 Days)||0
3328022|NCT03266172|4060990|FG002|STARTED|Part A: Period 4 (2 Days)||0
3328023|NCT03266172|4060988|FG000|COMPLETED|Part A: Period 4 (2 Days)||16
3328024|NCT03266172|4060989|FG001|COMPLETED|Part A: Period 4 (2 Days)||0
3328025|NCT03266172|4060990|FG002|COMPLETED|Part A: Period 4 (2 Days)||0
3328026|NCT03266172|4060988|FG000|NOT COMPLETED|Part A: Period 4 (2 Days)||0
3328027|NCT03266172|4060989|FG001|NOT COMPLETED|Part A: Period 4 (2 Days)||0
3328028|NCT03266172|4060990|FG002|NOT COMPLETED|Part A: Period 4 (2 Days)||0
3328029|NCT03266172|4060988|FG000|STARTED|Part B: Period 1 (4 Days)|Participants from Part A did not enter Part B|0
3328030|NCT03266172|4060989|FG001|STARTED|Part B: Period 1 (4 Days)|New participants were enrolled in Part B of study|10
3328031|NCT03266172|4060990|FG002|STARTED|Part B: Period 1 (4 Days)||0
3328032|NCT03266172|4060988|FG000|COMPLETED|Part B: Period 1 (4 Days)||0
3328033|NCT03266172|4060989|FG001|COMPLETED|Part B: Period 1 (4 Days)||10
3328034|NCT03266172|4060990|FG002|COMPLETED|Part B: Period 1 (4 Days)||0
3328035|NCT03266172|4060988|FG000|NOT COMPLETED|Part B: Period 1 (4 Days)||0
3328036|NCT03266172|4060989|FG001|NOT COMPLETED|Part B: Period 1 (4 Days)||0
3328037|NCT03266172|4060990|FG002|NOT COMPLETED|Part B: Period 1 (4 Days)||0
3328038|NCT03266172|4060988|FG000|STARTED|Part B: Washout (7 Days)||0
3328039|NCT03266172|4060989|FG001|STARTED|Part B: Washout (7 Days)||10
3328040|NCT03266172|4060990|FG002|STARTED|Part B: Washout (7 Days)||0
3328041|NCT03266172|4060988|FG000|COMPLETED|Part B: Washout (7 Days)||0
3328042|NCT03266172|4060989|FG001|COMPLETED|Part B: Washout (7 Days)||10
3328043|NCT03266172|4060990|FG002|COMPLETED|Part B: Washout (7 Days)||0
3328044|NCT03266172|4060988|FG000|NOT COMPLETED|Part B: Washout (7 Days)||0
3328045|NCT03266172|4060989|FG001|NOT COMPLETED|Part B: Washout (7 Days)||0
3328046|NCT03266172|4060990|FG002|NOT COMPLETED|Part B: Washout (7 Days)||0
3328047|NCT03266172|4060988|FG000|STARTED|Part B: Period 2 (4 Days)||0
3328048|NCT03266172|4060989|FG001|STARTED|Part B: Period 2 (4 Days)||10
3328049|NCT03266172|4060990|FG002|STARTED|Part B: Period 2 (4 Days)||0
3328050|NCT03266172|4060988|FG000|COMPLETED|Part B: Period 2 (4 Days)||0
3328051|NCT03266172|4060989|FG001|COMPLETED|Part B: Period 2 (4 Days)||10
3328052|NCT03266172|4060990|FG002|COMPLETED|Part B: Period 2 (4 Days)||0
3328053|NCT03266172|4060988|FG000|NOT COMPLETED|Part B: Period 2 (4 Days)||0
3328054|NCT03266172|4060989|FG001|NOT COMPLETED|Part B: Period 2 (4 Days)||0
3328055|NCT03266172|4060990|FG002|NOT COMPLETED|Part B: Period 2 (4 Days)||0
3328056|NCT03266172|4060988|FG000|STARTED|Part B: Washout (7 Days)||0
3328057|NCT03266172|4060989|FG001|STARTED|Part B: Washout (7 Days)||10
3328058|NCT03266172|4060990|FG002|STARTED|Part B: Washout (7 Days)||0
3328059|NCT03266172|4060988|FG000|COMPLETED|Part B: Washout (7 Days)||0
3328060|NCT03266172|4060989|FG001|COMPLETED|Part B: Washout (7 Days)||8
3328061|NCT03266172|4060990|FG002|COMPLETED|Part B: Washout (7 Days)||0
3328062|NCT03266172|4060988|FG000|NOT COMPLETED|Part B: Washout (7 Days)||0
3328063|NCT03266172|4060989|FG001|NOT COMPLETED|Part B: Washout (7 Days)||2
3328064|NCT03266172|4060990|FG002|NOT COMPLETED|Part B: Washout (7 Days)||0
3328065|NCT03266172|4060988|FG000|STARTED|Part B: Period 3 (4 Days)||0
3328066|NCT03266172|4060989|FG001|STARTED|Part B: Period 3 (4 Days)|Two participants completed Washout Period but withdrew before the start of Period 3.|6
3328067|NCT03266172|4060990|FG002|STARTED|Part B: Period 3 (4 Days)||0
3328068|NCT03266172|4060988|FG000|COMPLETED|Part B: Period 3 (4 Days)||0
3328069|NCT03266172|4060989|FG001|COMPLETED|Part B: Period 3 (4 Days)||6
3328070|NCT03266172|4060990|FG002|COMPLETED|Part B: Period 3 (4 Days)||0
3328071|NCT03266172|4060988|FG000|NOT COMPLETED|Part B: Period 3 (4 Days)||0
3328072|NCT03266172|4060989|FG001|NOT COMPLETED|Part B: Period 3 (4 Days)||0
3328073|NCT03266172|4060990|FG002|NOT COMPLETED|Part B: Period 3 (4 Days)||0
3328074|NCT03266172|4060988|FG000|STARTED|Part C: Period 1(2 Days)||0
3328075|NCT03266172|4060989|FG001|STARTED|Part C: Period 1(2 Days)|Participants from Part B did not enter Part C|0
3328076|NCT03266172|4060990|FG002|STARTED|Part C: Period 1(2 Days)|New participants were enrolled in Part C of study|15
3328077|NCT03266172|4060988|FG000|COMPLETED|Part C: Period 1(2 Days)||0
3328078|NCT03266172|4060989|FG001|COMPLETED|Part C: Period 1(2 Days)||0
3328079|NCT03266172|4060990|FG002|COMPLETED|Part C: Period 1(2 Days)||15
3328080|NCT03266172|4060988|FG000|NOT COMPLETED|Part C: Period 1(2 Days)||0
3328081|NCT03266172|4060989|FG001|NOT COMPLETED|Part C: Period 1(2 Days)||0
3328082|NCT03266172|4060990|FG002|NOT COMPLETED|Part C: Period 1(2 Days)||0
3328083|NCT03266172|4060988|FG000|STARTED|Part C Washout Period (7 Days)||0
3328084|NCT03266172|4060989|FG001|STARTED|Part C Washout Period (7 Days)||0
3328085|NCT03266172|4060990|FG002|STARTED|Part C Washout Period (7 Days)||15
3328086|NCT03266172|4060988|FG000|COMPLETED|Part C Washout Period (7 Days)||0
3328087|NCT03266172|4060989|FG001|COMPLETED|Part C Washout Period (7 Days)||0
3328088|NCT03266172|4060990|FG002|COMPLETED|Part C Washout Period (7 Days)||15
3328089|NCT03266172|4060988|FG000|NOT COMPLETED|Part C Washout Period (7 Days)||0
3328090|NCT03266172|4060989|FG001|NOT COMPLETED|Part C Washout Period (7 Days)||0
3328091|NCT03266172|4060990|FG002|NOT COMPLETED|Part C Washout Period (7 Days)||0
3328092|NCT03266172|4060988|FG000|STARTED|Part C Period 2(2 Days)||0
3328093|NCT03266172|4060989|FG001|STARTED|Part C Period 2(2 Days)||0
3328094|NCT03266172|4060990|FG002|STARTED|Part C Period 2(2 Days)||15
3328095|NCT03266172|4060988|FG000|COMPLETED|Part C Period 2(2 Days)||0
3328096|NCT03266172|4060989|FG001|COMPLETED|Part C Period 2(2 Days)||0
3328097|NCT03266172|4060990|FG002|COMPLETED|Part C Period 2(2 Days)||15
3328098|NCT03266172|4060988|FG000|NOT COMPLETED|Part C Period 2(2 Days)||0
3328099|NCT03266172|4060989|FG001|NOT COMPLETED|Part C Period 2(2 Days)||0
3328100|NCT03266172|4060990|FG002|NOT COMPLETED|Part C Period 2(2 Days)||0
3328101|NCT03266172|4060988|FG000|STARTED|Part C Washout Period (7 Days)||0
3328102|NCT03266172|4060989|FG001|STARTED|Part C Washout Period (7 Days)||0
3328103|NCT03266172|4060990|FG002|STARTED|Part C Washout Period (7 Days)||15
3328104|NCT03266172|4060988|FG000|COMPLETED|Part C Washout Period (7 Days)||0
3328105|NCT03266172|4060989|FG001|COMPLETED|Part C Washout Period (7 Days)||0
3328106|NCT03266172|4060990|FG002|COMPLETED|Part C Washout Period (7 Days)||15
3328107|NCT03266172|4060988|FG000|NOT COMPLETED|Part C Washout Period (7 Days)||0
3328108|NCT03266172|4060989|FG001|NOT COMPLETED|Part C Washout Period (7 Days)||0
3328109|NCT03266172|4060990|FG002|NOT COMPLETED|Part C Washout Period (7 Days)||0
3328110|NCT03266172|4060988|FG000|STARTED|Part C Period 3(2 Days)||0
3328111|NCT03266172|4060989|FG001|STARTED|Part C Period 3(2 Days)||0
3328112|NCT03266172|4060990|FG002|STARTED|Part C Period 3(2 Days)|1 replacement participant enrolled|16
3328113|NCT03266172|4060988|FG000|COMPLETED|Part C Period 3(2 Days)||0
3328114|NCT03266172|4060989|FG001|COMPLETED|Part C Period 3(2 Days)||0
3328115|NCT03266172|4060990|FG002|COMPLETED|Part C Period 3(2 Days)||16
3328116|NCT03266172|4060988|FG000|NOT COMPLETED|Part C Period 3(2 Days)||0
3328117|NCT03266172|4060989|FG001|NOT COMPLETED|Part C Period 3(2 Days)||0
3328118|NCT03266172|4060990|FG002|NOT COMPLETED|Part C Period 3(2 Days)||0
3328119|NCT03266172|4060988|FG000|STARTED|Part C Washout Period (7 Days)||0
3328120|NCT03266172|4060989|FG001|STARTED|Part C Washout Period (7 Days)||0
3328121|NCT03266172|4060990|FG002|STARTED|Part C Washout Period (7 Days)||16
3328122|NCT03266172|4060988|FG000|COMPLETED|Part C Washout Period (7 Days)||0
3328123|NCT03266172|4060989|FG001|COMPLETED|Part C Washout Period (7 Days)||0
3328124|NCT03266172|4060990|FG002|COMPLETED|Part C Washout Period (7 Days)||16
3328125|NCT03266172|4060988|FG000|NOT COMPLETED|Part C Washout Period (7 Days)||0
3328126|NCT03266172|4060989|FG001|NOT COMPLETED|Part C Washout Period (7 Days)||0
3328127|NCT03266172|4060990|FG002|NOT COMPLETED|Part C Washout Period (7 Days)||0
3328128|NCT03266172|4060988|FG000|STARTED|Part C Period 4(2 Days)||0
3328129|NCT03266172|4060989|FG001|STARTED|Part C Period 4(2 Days)||0
3328130|NCT03266172|4060990|FG002|STARTED|Part C Period 4(2 Days)||16
3328131|NCT03266172|4060988|FG000|COMPLETED|Part C Period 4(2 Days)||0
3328132|NCT03266172|4060989|FG001|COMPLETED|Part C Period 4(2 Days)||0
3328133|NCT03266172|4060990|FG002|COMPLETED|Part C Period 4(2 Days)||16
3328134|NCT03266172|4060988|FG000|NOT COMPLETED|Part C Period 4(2 Days)||0
3328135|NCT03266172|4060989|FG001|NOT COMPLETED|Part C Period 4(2 Days)||0
3328136|NCT03266172|4060990|FG002|NOT COMPLETED|Part C Period 4(2 Days)||0
3328137|NCT03266172|4060988|FG000|STARTED|Part C Washout Period (7 Days)||0
3328138|NCT03266172|4060989|FG001|STARTED|Part C Washout Period (7 Days)||0
3328139|NCT03266172|4060990|FG002|STARTED|Part C Washout Period (7 Days)||16
3328140|NCT03266172|4060988|FG000|COMPLETED|Part C Washout Period (7 Days)||0
3328141|NCT03266172|4060989|FG001|COMPLETED|Part C Washout Period (7 Days)||0
3328142|NCT03266172|4060990|FG002|COMPLETED|Part C Washout Period (7 Days)||15
3328143|NCT03266172|4060988|FG000|NOT COMPLETED|Part C Washout Period (7 Days)||0
3328144|NCT03266172|4060989|FG001|NOT COMPLETED|Part C Washout Period (7 Days)||0
3328145|NCT03266172|4060990|FG002|NOT COMPLETED|Part C Washout Period (7 Days)||1
3328146|NCT03266172|4060988|FG000|STARTED|Part C Period 5(2 Days)||0
3328147|NCT03266172|4060989|FG001|STARTED|Part C Period 5(2 Days)||0
3328148|NCT03266172|4060990|FG002|STARTED|Part C Period 5(2 Days)||15
3328149|NCT03266172|4060988|FG000|COMPLETED|Part C Period 5(2 Days)||0
3328150|NCT03266172|4060989|FG001|COMPLETED|Part C Period 5(2 Days)||0
3328151|NCT03266172|4060990|FG002|COMPLETED|Part C Period 5(2 Days)||15
3328152|NCT03266172|4060988|FG000|NOT COMPLETED|Part C Period 5(2 Days)||0
3328153|NCT03266172|4060989|FG001|NOT COMPLETED|Part C Period 5(2 Days)||0
3328154|NCT03266172|4060990|FG002|NOT COMPLETED|Part C Period 5(2 Days)||0
3328155|NCT03266172|4060988|FG000|STARTED|Part C Washout Period (7 Days)||0
3328156|NCT03266172|4060989|FG001|STARTED|Part C Washout Period (7 Days)||0
3328157|NCT03266172|4060990|FG002|STARTED|Part C Washout Period (7 Days)||15
3328158|NCT03266172|4060988|FG000|COMPLETED|Part C Washout Period (7 Days)||0
3328159|NCT03266172|4060989|FG001|COMPLETED|Part C Washout Period (7 Days)||0
3328160|NCT03266172|4060990|FG002|COMPLETED|Part C Washout Period (7 Days)||14
3328161|NCT03266172|4060988|FG000|NOT COMPLETED|Part C Washout Period (7 Days)||0
3328162|NCT03266172|4060989|FG001|NOT COMPLETED|Part C Washout Period (7 Days)||0
3328163|NCT03266172|4060990|FG002|NOT COMPLETED|Part C Washout Period (7 Days)||1
3328164|NCT03266172|4060988|FG000|STARTED|Part C Period 6(2 Days)||0
3328165|NCT03266172|4060989|FG001|STARTED|Part C Period 6(2 Days)||0
3328166|NCT03266172|4060990|FG002|STARTED|Part C Period 6(2 Days)||14
3328167|NCT03266172|4060988|FG000|COMPLETED|Part C Period 6(2 Days)||0
3328168|NCT03266172|4060989|FG001|COMPLETED|Part C Period 6(2 Days)||0
3328169|NCT03266172|4060990|FG002|COMPLETED|Part C Period 6(2 Days)||14
3328170|NCT03266172|4060988|FG000|NOT COMPLETED|Part C Period 6(2 Days)||0
3328171|NCT03266172|4060989|FG001|NOT COMPLETED|Part C Period 6(2 Days)||0
3328172|NCT03266172|4060990|FG002|NOT COMPLETED|Part C Period 6(2 Days)||0
3328173|NCT03266419|4061042|FG000|STARTED|Overall Study||51
3328174|NCT03266419|4061043|FG001|STARTED|Overall Study||49
3328175|NCT03266419|4061042|FG000|COMPLETED|Overall Study||51
3328176|NCT03266419|4061043|FG001|COMPLETED|Overall Study||49
3328177|NCT03266419|4061042|FG000|NOT COMPLETED|Overall Study||0
3328178|NCT03266419|4061043|FG001|NOT COMPLETED|Overall Study||0
3328179|NCT03266588|4061052|FG000|STARTED|Observational Period||1605
3328180|NCT03266588|4061053|FG001|STARTED|Observational Period||786
3328181|NCT03266588|4061054|FG002|STARTED|Observational Period||476
3328182|NCT03266588|4061052|FG000|COMPLETED|Observational Period||1089
3328183|NCT03266588|4061053|FG001|COMPLETED|Observational Period||511
3328184|NCT03266588|4061054|FG002|COMPLETED|Observational Period||308
3328185|NCT03266588|4061052|FG000|NOT COMPLETED|Observational Period||516
3328186|NCT03266588|4061053|FG001|NOT COMPLETED|Observational Period||275
3328187|NCT03266588|4061054|FG002|NOT COMPLETED|Observational Period||168
3328188|NCT03266588|4061052|FG000|STARTED|Long-term Treatment Period||1089
3328189|NCT03266588|4061053|FG001|STARTED|Long-term Treatment Period||511
3328190|NCT03266588|4061054|FG002|STARTED|Long-term Treatment Period||308
3328191|NCT03266588|4061052|FG000|Treated|Long-term Treatment Period||1033
3328192|NCT03266588|4061053|FG001|Treated|Long-term Treatment Period||481
3176443|NCT01966445|3904257|FG004|COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
3176444|NCT01966445|3904258|FG005|COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
3176445|NCT01966445|3904259|FG006|COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||4
3176446|NCT01966445|3904253|FG000|NOT COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
3176447|NCT01966445|3904254|FG001|NOT COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
3176448|NCT01966445|3904255|FG002|NOT COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
3328193|NCT03266588|4061054|FG002|Treated|Long-term Treatment Period||286
3328194|NCT03266588|4061052|FG000|COMPLETED|Long-term Treatment Period||683
3328195|NCT03266588|4061053|FG001|COMPLETED|Long-term Treatment Period||271
3328196|NCT03266588|4061054|FG002|COMPLETED|Long-term Treatment Period||243
3328197|NCT03266588|4061052|FG000|NOT COMPLETED|Long-term Treatment Period||406
3328198|NCT03266588|4061053|FG001|NOT COMPLETED|Long-term Treatment Period||240
3328199|NCT03266588|4061054|FG002|NOT COMPLETED|Long-term Treatment Period||65
3328200|NCT03267212|4061062|FG000|STARTED|First Intervention|Non-invasive ventilation|6
3328201|NCT03267212|4061063|FG001|STARTED|First Intervention|"First Intervention (1 day), Washout (2 days), and Second Intervention (1 day)"|9
3328202|NCT03267212|4061062|FG000|High SCI|First Intervention||2
3328203|NCT03267212|4061063|FG001|High SCI|First Intervention||5
3328204|NCT03267212|4061062|FG000|Low SCI|First Intervention||4
3328205|NCT03267212|4061063|FG001|Low SCI|First Intervention||4
3328206|NCT03267212|4061062|FG000|COMPLETED|First Intervention||5
3328207|NCT03267212|4061063|FG001|COMPLETED|First Intervention||6
3328208|NCT03267212|4061062|FG000|NOT COMPLETED|First Intervention||1
3328209|NCT03267212|4061063|FG001|NOT COMPLETED|First Intervention||3
3328210|NCT03267212|4061062|FG000|STARTED|Washout (Min 2 Days / Max 7 Days)||5
3328211|NCT03267212|4061063|FG001|STARTED|Washout (Min 2 Days / Max 7 Days)||6
3328212|NCT03267212|4061062|FG000|COMPLETED|Washout (Min 2 Days / Max 7 Days)||4
3328213|NCT03267212|4061063|FG001|COMPLETED|Washout (Min 2 Days / Max 7 Days)||6
3328214|NCT03267212|4061062|FG000|NOT COMPLETED|Washout (Min 2 Days / Max 7 Days)||1
3328215|NCT03267212|4061063|FG001|NOT COMPLETED|Washout (Min 2 Days / Max 7 Days)||0
3328216|NCT03267212|4061062|FG000|STARTED|Second Intervention||4
3328217|NCT03267212|4061063|FG001|STARTED|Second Intervention||6
3328218|NCT03267212|4061062|FG000|COMPLETED|Second Intervention||4
3328219|NCT03267212|4061063|FG001|COMPLETED|Second Intervention||6
3328220|NCT03267212|4061062|FG000|NOT COMPLETED|Second Intervention||0
3328221|NCT03267212|4061063|FG001|NOT COMPLETED|Second Intervention||0
3328222|NCT03267264|4061073|FG000|STARTED|Overall Study||66
3328223|NCT03267264|4061074|FG001|STARTED|Overall Study||49
3328224|NCT03267264|4061075|FG002|STARTED|Overall Study||68
3328225|NCT03267264|4061076|FG003|STARTED|Overall Study||65
3328226|NCT03267264|4061073|FG000|Sequence A(Nucleus)|Overall Study||34
3328227|NCT03267264|4061074|FG001|Sequence A(Nucleus)|Overall Study||25
3328228|NCT03267264|4061075|FG002|Sequence A(Nucleus)|Overall Study||33
3328229|NCT03267264|4061076|FG003|Sequence A(Nucleus)|Overall Study||33
3328230|NCT03267264|4061073|FG000|Sequence B(Comparator)|Overall Study||32
3328231|NCT03267264|4061074|FG001|Sequence B(Comparator)|Overall Study||24
3328232|NCT03267264|4061075|FG002|Sequence B(Comparator)|Overall Study||33
3328233|NCT03267264|4061076|FG003|Sequence B(Comparator)|Overall Study||32
3328234|NCT03267264|4061073|FG000|COMPLETED|Overall Study||65
3328235|NCT03267264|4061074|FG001|COMPLETED|Overall Study||49
3328236|NCT03267264|4061075|FG002|COMPLETED|Overall Study||66
3328237|NCT03267264|4061076|FG003|COMPLETED|Overall Study||61
3328238|NCT03267264|4061073|FG000|NOT COMPLETED|Overall Study||1
3328239|NCT03267264|4061074|FG001|NOT COMPLETED|Overall Study||0
3328240|NCT03267264|4061075|FG002|NOT COMPLETED|Overall Study||2
3176449|NCT01966445|3904256|FG003|NOT COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
3176450|NCT01966445|3904257|FG004|NOT COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
3328241|NCT03267264|4061076|FG003|NOT COMPLETED|Overall Study||4
3328242|NCT03267511|4061093|FG000|STARTED|Overall Study||31
3328243|NCT03267511|4061094|FG001|STARTED|Overall Study||31
3328244|NCT03267511|4061095|FG002|STARTED|Overall Study||30
3328245|NCT03267511|4061096|FG003|STARTED|Overall Study||31
3328246|NCT03267511|4061093|FG000|COMPLETED|Overall Study||31
3328247|NCT03267511|4061094|FG001|COMPLETED|Overall Study||31
3328248|NCT03267511|4061095|FG002|COMPLETED|Overall Study||30
3328249|NCT03267511|4061096|FG003|COMPLETED|Overall Study||30
3328250|NCT03267511|4061093|FG000|NOT COMPLETED|Overall Study||0
3328251|NCT03267511|4061094|FG001|NOT COMPLETED|Overall Study||0
3328252|NCT03267511|4061095|FG002|NOT COMPLETED|Overall Study||0
3328253|NCT03267511|4061096|FG003|NOT COMPLETED|Overall Study||1
3328254|NCT03267576|4061110|FG000|STARTED|Period 1: Day 0 to 27||31
3328255|NCT03267576|4061111|FG001|STARTED|Period 1: Day 0 to 27||32
3328256|NCT03267576|4061110|FG000|COMPLETED|Period 1: Day 0 to 27||31
3328257|NCT03267576|4061111|FG001|COMPLETED|Period 1: Day 0 to 27||32
3328258|NCT03267576|4061110|FG000|NOT COMPLETED|Period 1: Day 0 to 27||0
3328259|NCT03267576|4061111|FG001|NOT COMPLETED|Period 1: Day 0 to 27||0
3328260|NCT03267576|4061110|FG000|STARTED|Washout Period: 16 Days||31
3328261|NCT03267576|4061111|FG001|STARTED|Washout Period: 16 Days||32
3328262|NCT03267576|4061110|FG000|COMPLETED|Washout Period: 16 Days||31
3328263|NCT03267576|4061111|FG001|COMPLETED|Washout Period: 16 Days||32
3328264|NCT03267576|4061110|FG000|NOT COMPLETED|Washout Period: 16 Days||0
3328265|NCT03267576|4061111|FG001|NOT COMPLETED|Washout Period: 16 Days||0
3328266|NCT03267576|4061110|FG000|STARTED|Period 2: Day 44 to 71||31
3328267|NCT03267576|4061111|FG001|STARTED|Period 2: Day 44 to 71||32
3328268|NCT03267576|4061110|FG000|COMPLETED|Period 2: Day 44 to 71||30
3328269|NCT03267576|4061111|FG001|COMPLETED|Period 2: Day 44 to 71||30
3328270|NCT03267576|4061110|FG000|NOT COMPLETED|Period 2: Day 44 to 71||1
3328271|NCT03267576|4061111|FG001|NOT COMPLETED|Period 2: Day 44 to 71||2
3328272|NCT03267940|4061123|FG000|STARTED|Run-in Portion (Max. Exposure: 508 Days)||9
3328273|NCT03267940|4061124|FG001|STARTED|Run-in Portion (Max. Exposure: 508 Days)||9
3328274|NCT03267940|4061125|FG002|STARTED|Run-in Portion (Max. Exposure: 508 Days)||0
3328275|NCT03267940|4061126|FG003|STARTED|Run-in Portion (Max. Exposure: 508 Days)||0
3328276|NCT03267940|4061127|FG004|STARTED|Run-in Portion (Max. Exposure: 508 Days)||0
3328277|NCT03267940|4061128|FG005|STARTED|Run-in Portion (Max. Exposure: 508 Days)||0
3328278|NCT03267940|4061123|FG000|Received at Least 1 Dose of Study Drug|Run-in Portion (Max. Exposure: 508 Days)||9
3328279|NCT03267940|4061124|FG001|Received at Least 1 Dose of Study Drug|Run-in Portion (Max. Exposure: 508 Days)||9
3328280|NCT03267940|4061125|FG002|Received at Least 1 Dose of Study Drug|Run-in Portion (Max. Exposure: 508 Days)||0
3328281|NCT03267940|4061126|FG003|Received at Least 1 Dose of Study Drug|Run-in Portion (Max. Exposure: 508 Days)||0
3328282|NCT03267940|4061127|FG004|Received at Least 1 Dose of Study Drug|Run-in Portion (Max. Exposure: 508 Days)||0
3328283|NCT03267940|4061128|FG005|Received at Least 1 Dose of Study Drug|Run-in Portion (Max. Exposure: 508 Days)||0
3328284|NCT03267940|4061123|FG000|COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||1
3328285|NCT03267940|4061124|FG001|COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||2
3328286|NCT03267940|4061125|FG002|COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||0
3328287|NCT03267940|4061126|FG003|COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||0
3328288|NCT03267940|4061127|FG004|COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||0
3328289|NCT03267940|4061128|FG005|COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||0
3328290|NCT03267940|4061123|FG000|NOT COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||8
3328291|NCT03267940|4061124|FG001|NOT COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||7
3328292|NCT03267940|4061125|FG002|NOT COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||0
3328293|NCT03267940|4061126|FG003|NOT COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||0
3328294|NCT03267940|4061127|FG004|NOT COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||0
3328295|NCT03267940|4061128|FG005|NOT COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||0
3328296|NCT03267940|4061123|FG000|STARTED|Expansion (Maximum Exposure: 421 Days)||0
3328297|NCT03267940|4061124|FG001|STARTED|Expansion (Maximum Exposure: 421 Days)||0
3328298|NCT03267940|4061125|FG002|STARTED|Expansion (Maximum Exposure: 421 Days)||24
3328299|NCT03267940|4061126|FG003|STARTED|Expansion (Maximum Exposure: 421 Days)||22
3328300|NCT03267940|4061127|FG004|STARTED|Expansion (Maximum Exposure: 421 Days)||11
3328301|NCT03267940|4061128|FG005|STARTED|Expansion (Maximum Exposure: 421 Days)||10
3328302|NCT03267940|4061123|FG000|Received at Least 1 Dose of Study Drug|Expansion (Maximum Exposure: 421 Days)||0
3328303|NCT03267940|4061124|FG001|Received at Least 1 Dose of Study Drug|Expansion (Maximum Exposure: 421 Days)||0
3328304|NCT03267940|4061125|FG002|Received at Least 1 Dose of Study Drug|Expansion (Maximum Exposure: 421 Days)||24
3328305|NCT03267940|4061126|FG003|Received at Least 1 Dose of Study Drug|Expansion (Maximum Exposure: 421 Days)||22
3328306|NCT03267940|4061127|FG004|Received at Least 1 Dose of Study Drug|Expansion (Maximum Exposure: 421 Days)||11
3328307|NCT03267940|4061128|FG005|Received at Least 1 Dose of Study Drug|Expansion (Maximum Exposure: 421 Days)||10
3328308|NCT03267940|4061123|FG000|COMPLETED|Expansion (Maximum Exposure: 421 Days)||0
3328309|NCT03267940|4061124|FG001|COMPLETED|Expansion (Maximum Exposure: 421 Days)||0
3328310|NCT03267940|4061125|FG002|COMPLETED|Expansion (Maximum Exposure: 421 Days)||3
3328311|NCT03267940|4061126|FG003|COMPLETED|Expansion (Maximum Exposure: 421 Days)||0
3328312|NCT03267940|4061127|FG004|COMPLETED|Expansion (Maximum Exposure: 421 Days)||1
3328313|NCT03267940|4061128|FG005|COMPLETED|Expansion (Maximum Exposure: 421 Days)||0
3328314|NCT03267940|4061123|FG000|NOT COMPLETED|Expansion (Maximum Exposure: 421 Days)||0
3328315|NCT03267940|4061124|FG001|NOT COMPLETED|Expansion (Maximum Exposure: 421 Days)||0
3328316|NCT03267940|4061125|FG002|NOT COMPLETED|Expansion (Maximum Exposure: 421 Days)||21
3328317|NCT03267940|4061126|FG003|NOT COMPLETED|Expansion (Maximum Exposure: 421 Days)||22
3328318|NCT03267940|4061127|FG004|NOT COMPLETED|Expansion (Maximum Exposure: 421 Days)||10
3328319|NCT03267940|4061128|FG005|NOT COMPLETED|Expansion (Maximum Exposure: 421 Days)||10
3328320|NCT03268343|4061146|FG000|STARTED|Overall Study||12
3328321|NCT03268343|4061147|FG001|STARTED|Overall Study||12
3328322|NCT03268343|4061146|FG000|COMPLETED|Overall Study||12
3328323|NCT03268343|4061147|FG001|COMPLETED|Overall Study||12
3328324|NCT03268343|4061146|FG000|NOT COMPLETED|Overall Study||0
3328325|NCT03268343|4061147|FG001|NOT COMPLETED|Overall Study||0
3328326|NCT03268590|4061154|FG000|STARTED|Overall Study||33
3328327|NCT03268590|4061154|FG000|COMPLETED|Overall Study|One participant did not complete MRI due to a previously undiagnosed subdermal metal shard in scalp.|32
3328328|NCT03268590|4061154|FG000|NOT COMPLETED|Overall Study||1
3328329|NCT03268746|4061161|FG000|STARTED|Overall Study||45
3328330|NCT03268746|4061161|FG000|COMPLETED|Overall Study||44
3328331|NCT03268746|4061161|FG000|NOT COMPLETED|Overall Study||1
3328332|NCT03268941|4061176|FG000|STARTED|Part 1 (Days 1 to 9)||12
3328333|NCT03268941|4061177|FG001|STARTED|Part 1 (Days 1 to 9)||14
3328334|NCT03268941|4061178|FG002|STARTED|Part 1 (Days 1 to 9)||12
3328335|NCT03268941|4061179|FG003|STARTED|Part 1 (Days 1 to 9)||13
3328336|NCT03268941|4061180|FG004|STARTED|Part 1 (Days 1 to 9)||0
3328337|NCT03268941|4061181|FG005|STARTED|Part 1 (Days 1 to 9)||0
3328338|NCT03268941|4061182|FG006|STARTED|Part 1 (Days 1 to 9)||0
3328339|NCT03268941|4061176|FG000|COMPLETED|Part 1 (Days 1 to 9)||11
3328340|NCT03268941|4061177|FG001|COMPLETED|Part 1 (Days 1 to 9)||14
3328341|NCT03268941|4061178|FG002|COMPLETED|Part 1 (Days 1 to 9)||12
3328342|NCT03268941|4061179|FG003|COMPLETED|Part 1 (Days 1 to 9)||11
3328343|NCT03268941|4061180|FG004|COMPLETED|Part 1 (Days 1 to 9)||0
3328344|NCT03268941|4061181|FG005|COMPLETED|Part 1 (Days 1 to 9)||0
3328345|NCT03268941|4061182|FG006|COMPLETED|Part 1 (Days 1 to 9)||0
3328346|NCT03268941|4061176|FG000|NOT COMPLETED|Part 1 (Days 1 to 9)||1
3328347|NCT03268941|4061177|FG001|NOT COMPLETED|Part 1 (Days 1 to 9)||0
3328348|NCT03268941|4061178|FG002|NOT COMPLETED|Part 1 (Days 1 to 9)||0
3328349|NCT03268941|4061179|FG003|NOT COMPLETED|Part 1 (Days 1 to 9)||2
3328350|NCT03268941|4061180|FG004|NOT COMPLETED|Part 1 (Days 1 to 9)||0
3328351|NCT03268941|4061181|FG005|NOT COMPLETED|Part 1 (Days 1 to 9)||0
3328352|NCT03268941|4061182|FG006|NOT COMPLETED|Part 1 (Days 1 to 9)||0
3328353|NCT03268941|4061176|FG000|STARTED|Part 2: Days 17 to 25||0
3328354|NCT03268941|4061177|FG001|STARTED|Part 2: Days 17 to 25||0
3328355|NCT03268941|4061178|FG002|STARTED|Part 2: Days 17 to 25||0
3328356|NCT03268941|4061179|FG003|STARTED|Part 2: Days 17 to 25||0
3328357|NCT03268941|4061180|FG004|STARTED|Part 2: Days 17 to 25||6
3328358|NCT03268941|4061181|FG005|STARTED|Part 2: Days 17 to 25||0
3328359|NCT03268941|4061182|FG006|STARTED|Part 2: Days 17 to 25||15
3328360|NCT03268941|4061176|FG000|Treated|Part 2: Days 17 to 25||0
3328361|NCT03268941|4061177|FG001|Treated|Part 2: Days 17 to 25||0
3328362|NCT03268941|4061178|FG002|Treated|Part 2: Days 17 to 25||0
3328363|NCT03268941|4061179|FG003|Treated|Part 2: Days 17 to 25||0
3328364|NCT03268941|4061180|FG004|Treated|Part 2: Days 17 to 25||6
3328365|NCT03268941|4061181|FG005|Treated|Part 2: Days 17 to 25||0
3328366|NCT03268941|4061182|FG006|Treated|Part 2: Days 17 to 25||13
3328367|NCT03268941|4061176|FG000|COMPLETED|Part 2: Days 17 to 25||0
3328368|NCT03268941|4061177|FG001|COMPLETED|Part 2: Days 17 to 25||0
3328369|NCT03268941|4061178|FG002|COMPLETED|Part 2: Days 17 to 25||0
3328370|NCT03268941|4061179|FG003|COMPLETED|Part 2: Days 17 to 25||0
3328371|NCT03268941|4061180|FG004|COMPLETED|Part 2: Days 17 to 25||6
3328372|NCT03268941|4061181|FG005|COMPLETED|Part 2: Days 17 to 25||0
3328373|NCT03268941|4061182|FG006|COMPLETED|Part 2: Days 17 to 25||13
3328374|NCT03268941|4061176|FG000|NOT COMPLETED|Part 2: Days 17 to 25||0
3328375|NCT03268941|4061177|FG001|NOT COMPLETED|Part 2: Days 17 to 25||0
3328376|NCT03268941|4061178|FG002|NOT COMPLETED|Part 2: Days 17 to 25||0
3328377|NCT03268941|4061179|FG003|NOT COMPLETED|Part 2: Days 17 to 25||0
3328378|NCT03268941|4061180|FG004|NOT COMPLETED|Part 2: Days 17 to 25||0
3176451|NCT01966445|3904258|FG005|NOT COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
3176452|NCT01966445|3904259|FG006|NOT COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||5
3176453|NCT01966458|3904277|FG000|STARTED|Overall Study||308
3328379|NCT03268941|4061181|FG005|NOT COMPLETED|Part 2: Days 17 to 25||0
3328380|NCT03268941|4061182|FG006|NOT COMPLETED|Part 2: Days 17 to 25||2
3328381|NCT03268941|4061176|FG000|STARTED|Part 2: Period 2: Fasted (Day 25)||0
3328382|NCT03268941|4061177|FG001|STARTED|Part 2: Period 2: Fasted (Day 25)||0
3328383|NCT03268941|4061178|FG002|STARTED|Part 2: Period 2: Fasted (Day 25)||0
3328384|NCT03268941|4061179|FG003|STARTED|Part 2: Period 2: Fasted (Day 25)||0
3328385|NCT03268941|4061180|FG004|STARTED|Part 2: Period 2: Fasted (Day 25)||0
3328386|NCT03268941|4061181|FG005|STARTED|Part 2: Period 2: Fasted (Day 25)||6
3328387|NCT03268941|4061182|FG006|STARTED|Part 2: Period 2: Fasted (Day 25)||0
3328388|NCT03268941|4061176|FG000|COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
3328389|NCT03268941|4061177|FG001|COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
3328390|NCT03268941|4061178|FG002|COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
3328391|NCT03268941|4061179|FG003|COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
3328392|NCT03268941|4061180|FG004|COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
3328393|NCT03268941|4061181|FG005|COMPLETED|Part 2: Period 2: Fasted (Day 25)||6
3328394|NCT03268941|4061182|FG006|COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
3328395|NCT03268941|4061176|FG000|NOT COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
3328396|NCT03268941|4061177|FG001|NOT COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
3328397|NCT03268941|4061178|FG002|NOT COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
3328398|NCT03268941|4061179|FG003|NOT COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
3328399|NCT03268941|4061180|FG004|NOT COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
3328400|NCT03268941|4061181|FG005|NOT COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
3328401|NCT03268941|4061182|FG006|NOT COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
3328402|NCT03269435|4061203|FG000|STARTED|Overall Study||51
3328403|NCT03269435|4061204|FG001|STARTED|Overall Study||48
3328404|NCT03269435|4061203|FG000|COMPLETED|Overall Study||51
3328405|NCT03269435|4061204|FG001|COMPLETED|Overall Study||48
3328406|NCT03269435|4061203|FG000|NOT COMPLETED|Overall Study||0
3328407|NCT03269435|4061204|FG001|NOT COMPLETED|Overall Study||0
3328408|NCT03269552|4061210|FG000|STARTED|Overall Study||4
3328409|NCT03269552|4061210|FG000|COMPLETED|Overall Study||2
3328410|NCT03269552|4061210|FG000|NOT COMPLETED|Overall Study||2
3328411|NCT03270085|4061217|FG000|STARTED|Overall Study||15
3328412|NCT03270085|4061218|FG001|STARTED|Overall Study||15
3328413|NCT03270085|4061217|FG000|COMPLETED|Overall Study||14
3328414|NCT03270085|4061218|FG001|COMPLETED|Overall Study||15
3328415|NCT03270085|4061217|FG000|NOT COMPLETED|Overall Study||1
3328416|NCT03270085|4061218|FG001|NOT COMPLETED|Overall Study||0
3176454|NCT01966458|3904278|FG001|STARTED|Overall Study||157
3176455|NCT01966458|3904277|FG000|COMPLETED|Overall Study||304
3176456|NCT01966458|3904278|FG001|COMPLETED|Overall Study||155
3176457|NCT01966458|3904277|FG000|NOT COMPLETED|Overall Study||4
3176458|NCT01966458|3904278|FG001|NOT COMPLETED|Overall Study||2
3176459|NCT01966718|3904284|FG000|STARTED|Overall Study||8
3328417|NCT03270332|4061226|FG000|STARTED|Overall Study||5
3328418|NCT03270332|4061227|FG001|STARTED|Overall Study||5
3328419|NCT03270332|4061226|FG000|COMPLETED|Overall Study||5
3328420|NCT03270332|4061227|FG001|COMPLETED|Overall Study||4
3328421|NCT03270332|4061226|FG000|NOT COMPLETED|Overall Study||0
3328422|NCT03270332|4061227|FG001|NOT COMPLETED|Overall Study||1
3328423|NCT03270436|4061237|FG000|STARTED|Baseline||213
3328424|NCT03270436|4061238|FG001|STARTED|Baseline||167
3328425|NCT03270436|4061237|FG000|COMPLETED|Baseline||212
3328426|NCT03270436|4061238|FG001|COMPLETED|Baseline||166
3328427|NCT03270436|4061237|FG000|NOT COMPLETED|Baseline||1
3328428|NCT03270436|4061238|FG001|NOT COMPLETED|Baseline||1
3328429|NCT03270436|4061237|FG000|STARTED|Immediate Post-Intervention||213
3328430|NCT03270436|4061238|FG001|STARTED|Immediate Post-Intervention||167
3328431|NCT03270436|4061237|FG000|COMPLETED|Immediate Post-Intervention||172
3328432|NCT03270436|4061238|FG001|COMPLETED|Immediate Post-Intervention||111
3328433|NCT03270436|4061237|FG000|NOT COMPLETED|Immediate Post-Intervention||41
3328434|NCT03270436|4061238|FG001|NOT COMPLETED|Immediate Post-Intervention||56
3328435|NCT03270436|4061237|FG000|STARTED|6 Months Post-Intervention||213
3328436|NCT03270436|4061238|FG001|STARTED|6 Months Post-Intervention||167
3328437|NCT03270436|4061237|FG000|COMPLETED|6 Months Post-Intervention||173
3328438|NCT03270436|4061238|FG001|COMPLETED|6 Months Post-Intervention||116
3328439|NCT03270436|4061237|FG000|NOT COMPLETED|6 Months Post-Intervention||40
3328440|NCT03270436|4061238|FG001|NOT COMPLETED|6 Months Post-Intervention||51
3328441|NCT03270514|4061246|FG000|STARTED|Overall Study||29
3328442|NCT03270514|4061247|FG001|STARTED|Overall Study||31
3328443|NCT03270514|4061246|FG000|COMPLETED|Overall Study||29
3328444|NCT03270514|4061247|FG001|COMPLETED|Overall Study||31
3328445|NCT03270514|4061246|FG000|NOT COMPLETED|Overall Study||0
3328446|NCT03270514|4061247|FG001|NOT COMPLETED|Overall Study||0
3328447|NCT03270644|4061253|FG000|STARTED|Day 1 Lasmiditan Reference||44
3328448|NCT03270644|4061253|FG000|Received at Least One Dose of Study Drug|Day 1 Lasmiditan Reference||44
3328449|NCT03270644|4061253|FG000|COMPLETED|Day 1 Lasmiditan Reference||43
3328450|NCT03270644|4061253|FG000|NOT COMPLETED|Day 1 Lasmiditan Reference||1
3328451|NCT03270644|4061253|FG000|STARTED|Day 4 - 10 Propranolol Reference||43
3328452|NCT03270644|4061253|FG000|Received at Least One Dose of Study Drug|Day 4 - 10 Propranolol Reference||43
3328453|NCT03270644|4061253|FG000|Day 9 Lasmiditan + Propranolol Test|Day 4 - 10 Propranolol Reference||42
3328454|NCT03270644|4061253|FG000|COMPLETED|Day 4 - 10 Propranolol Reference||42
3328455|NCT03270644|4061253|FG000|NOT COMPLETED|Day 4 - 10 Propranolol Reference||1
3328456|NCT03270657|4061264|FG000|STARTED|Overall Study||5
3328457|NCT03270657|4061264|FG000|COMPLETED|Overall Study||4
3328458|NCT03270657|4061264|FG000|NOT COMPLETED|Overall Study||1
3328459|NCT03270943|4061270|FG000|STARTED|Intervention Refinement||6
3328460|NCT03270943|4061271|FG001|STARTED|Intervention Refinement||9
3328461|NCT03270943|4061270|FG000|COMPLETED|Intervention Refinement||6
3328462|NCT03270943|4061271|FG001|COMPLETED|Intervention Refinement||6
3328463|NCT03270943|4061270|FG000|NOT COMPLETED|Intervention Refinement||0
3176460|NCT01966718|3904284|FG000|COMPLETED|Overall Study||8
3176461|NCT01966718|3904284|FG000|NOT COMPLETED|Overall Study||0
3176462|NCT01966770|3904290|FG000|STARTED|Overall Study||20
3328464|NCT03270943|4061271|FG001|NOT COMPLETED|Intervention Refinement||3
3328465|NCT03270943|4061270|FG000|STARTED|Randomized (Willingness to be)||30
3328466|NCT03270943|4061271|FG001|STARTED|Randomized (Willingness to be)||32
3328467|NCT03270943|4061270|FG000|COMPLETED|Randomized (Willingness to be)||30
3328468|NCT03270943|4061271|FG001|COMPLETED|Randomized (Willingness to be)||31
3328469|NCT03270943|4061270|FG000|NOT COMPLETED|Randomized (Willingness to be)||0
3328470|NCT03270943|4061271|FG001|NOT COMPLETED|Randomized (Willingness to be)||1
3328471|NCT03271307|4061282|FG000|STARTED|Overall Study||1951
3328472|NCT03271307|4061283|FG001|STARTED|Overall Study||1837
3328473|NCT03271307|4061284|FG002|STARTED|Overall Study||2097
3328474|NCT03271307|4061285|FG003|STARTED|Overall Study||135
3328475|NCT03271307|4061286|FG004|STARTED|Overall Study||349
3328476|NCT03271307|4061282|FG000|COMPLETED|Overall Study||1951
3328477|NCT03271307|4061283|FG001|COMPLETED|Overall Study||1837
3328478|NCT03271307|4061284|FG002|COMPLETED|Overall Study||2097
3328479|NCT03271307|4061285|FG003|COMPLETED|Overall Study||107
3328480|NCT03271307|4061286|FG004|COMPLETED|Overall Study||258
3328481|NCT03271307|4061282|FG000|NOT COMPLETED|Overall Study||0
3328482|NCT03271307|4061283|FG001|NOT COMPLETED|Overall Study||0
3328483|NCT03271307|4061284|FG002|NOT COMPLETED|Overall Study||0
3328484|NCT03271307|4061285|FG003|NOT COMPLETED|Overall Study||28
3328485|NCT03271307|4061286|FG004|NOT COMPLETED|Overall Study||91
3328486|NCT03271424|4061304|FG000|STARTED|November 2015||20
3328487|NCT03271424|4061305|FG001|STARTED|November 2015||0
3176463|NCT01966770|3904290|FG000|COMPLETED|Overall Study||20
3176464|NCT01966770|3904290|FG000|NOT COMPLETED|Overall Study||0
3176465|NCT01966796|3904328|FG000|STARTED|Overall Study||15
3176466|NCT01966796|3904329|FG001|STARTED|Overall Study||51
3176467|NCT01966796|3904330|FG002|STARTED|Overall Study||195
3176468|NCT01966796|3904331|FG003|STARTED|Overall Study||269
3328488|NCT03271424|4061306|FG002|STARTED|November 2015||0
3328489|NCT03271424|4061304|FG000|COMPLETED|November 2015||20
3328490|NCT03271424|4061305|FG001|COMPLETED|November 2015||0
3328491|NCT03271424|4061306|FG002|COMPLETED|November 2015||0
3328492|NCT03271424|4061304|FG000|NOT COMPLETED|November 2015||0
3328493|NCT03271424|4061305|FG001|NOT COMPLETED|November 2015||0
3328494|NCT03271424|4061306|FG002|NOT COMPLETED|November 2015||0
3328495|NCT03271424|4061304|FG000|STARTED|December 2015||0
3328496|NCT03271424|4061305|FG001|STARTED|December 2015||35
3328497|NCT03271424|4061306|FG002|STARTED|December 2015||0
3328498|NCT03271424|4061304|FG000|COMPLETED|December 2015||0
3176469|NCT01966796|3904328|FG000|COMPLETED|Overall Study||15
3176470|NCT01966796|3904329|FG001|COMPLETED|Overall Study||51
3328499|NCT03271424|4061305|FG001|COMPLETED|December 2015||35
3328500|NCT03271424|4061306|FG002|COMPLETED|December 2015||0
3328501|NCT03271424|4061304|FG000|NOT COMPLETED|December 2015||0
3328502|NCT03271424|4061305|FG001|NOT COMPLETED|December 2015||0
3328503|NCT03271424|4061306|FG002|NOT COMPLETED|December 2015||0
3328504|NCT03271424|4061304|FG000|STARTED|April-May 2016||0
3328505|NCT03271424|4061305|FG001|STARTED|April-May 2016||0
3328506|NCT03271424|4061306|FG002|STARTED|April-May 2016||40
3328507|NCT03271424|4061304|FG000|COMPLETED|April-May 2016||0
3328508|NCT03271424|4061305|FG001|COMPLETED|April-May 2016||0
3328509|NCT03271424|4061306|FG002|COMPLETED|April-May 2016||40
3328510|NCT03271424|4061304|FG000|NOT COMPLETED|April-May 2016||0
3328511|NCT03271424|4061305|FG001|NOT COMPLETED|April-May 2016||0
3328512|NCT03271424|4061306|FG002|NOT COMPLETED|April-May 2016||0
3328513|NCT03271528|4061318|FG000|STARTED|Medication Dispense/Exposure Period 1||13
3328514|NCT03271528|4061319|FG001|STARTED|Medication Dispense/Exposure Period 1||14
3328515|NCT03271528|4061318|FG000|COMPLETED|Medication Dispense/Exposure Period 1||11
3328516|NCT03271528|4061319|FG001|COMPLETED|Medication Dispense/Exposure Period 1||12
3328517|NCT03271528|4061318|FG000|NOT COMPLETED|Medication Dispense/Exposure Period 1||2
3328518|NCT03271528|4061319|FG001|NOT COMPLETED|Medication Dispense/Exposure Period 1||2
3328519|NCT03271528|4061318|FG000|STARTED|Alcohol Trial 1, Washout Period 1||11
3328520|NCT03271528|4061319|FG001|STARTED|Alcohol Trial 1, Washout Period 1||12
3328521|NCT03271528|4061318|FG000|COMPLETED|Alcohol Trial 1, Washout Period 1||9
3328522|NCT03271528|4061319|FG001|COMPLETED|Alcohol Trial 1, Washout Period 1||11
3328523|NCT03271528|4061318|FG000|NOT COMPLETED|Alcohol Trial 1, Washout Period 1||2
3328524|NCT03271528|4061319|FG001|NOT COMPLETED|Alcohol Trial 1, Washout Period 1||1
3328525|NCT03271528|4061318|FG000|STARTED|Medication Dispense/Exposure Period 2||9
3328526|NCT03271528|4061319|FG001|STARTED|Medication Dispense/Exposure Period 2||11
3328527|NCT03271528|4061318|FG000|COMPLETED|Medication Dispense/Exposure Period 2||8
3328528|NCT03271528|4061319|FG001|COMPLETED|Medication Dispense/Exposure Period 2||11
3328529|NCT03271528|4061318|FG000|NOT COMPLETED|Medication Dispense/Exposure Period 2||1
3328530|NCT03271528|4061319|FG001|NOT COMPLETED|Medication Dispense/Exposure Period 2||0
3328531|NCT03271528|4061318|FG000|STARTED|Alcohol Self-Administration Trial 2||8
3328532|NCT03271528|4061319|FG001|STARTED|Alcohol Self-Administration Trial 2||11
3328533|NCT03271528|4061318|FG000|COMPLETED|Alcohol Self-Administration Trial 2||8
3328534|NCT03271528|4061319|FG001|COMPLETED|Alcohol Self-Administration Trial 2||11
3328535|NCT03271528|4061318|FG000|NOT COMPLETED|Alcohol Self-Administration Trial 2||0
3328536|NCT03271528|4061319|FG001|NOT COMPLETED|Alcohol Self-Administration Trial 2||0
3328537|NCT03272139|4061327|FG000|STARTED|Overall Study||63
3328538|NCT03272139|4061328|FG001|STARTED|Overall Study||63
3328539|NCT03272139|4061327|FG000|COMPLETED|Overall Study||63
3328540|NCT03272139|4061328|FG001|COMPLETED|Overall Study||63
3328541|NCT03272139|4061327|FG000|NOT COMPLETED|Overall Study||0
3328542|NCT03272139|4061328|FG001|NOT COMPLETED|Overall Study||0
3328543|NCT03273153|4061336|FG000|STARTED|Overall Study||224
3328544|NCT03273153|4061337|FG001|STARTED|Overall Study||222
3328545|NCT03273153|4061336|FG000|COMPLETED|Overall Study||0
3328546|NCT03273153|4061337|FG001|COMPLETED|Overall Study||0
3328547|NCT03273153|4061336|FG000|NOT COMPLETED|Overall Study||224
3328548|NCT03273153|4061337|FG001|NOT COMPLETED|Overall Study||222
3328549|NCT03273166|4061343|FG000|STARTED|Overall Study||82
3328550|NCT03273166|4061343|FG000|COMPLETED|Overall Study||51
3328551|NCT03273166|4061343|FG000|NOT COMPLETED|Overall Study||31
3328552|NCT03273257|4061350|FG000|STARTED|Overall Study||7
3328553|NCT03273257|4061351|FG001|STARTED|Overall Study||7
3328554|NCT03273257|4061350|FG000|Started Treatment|Overall Study||7
3328555|NCT03273257|4061351|FG001|Started Treatment|Overall Study|Only 6 patients from the placebo group started treatment because 1 patient died after randomization (= study start), but before initiating treatment|6
3328556|NCT03273257|4061350|FG000|Underwent PEA|Overall Study||6
3328557|NCT03273257|4061351|FG001|Underwent PEA|Overall Study||5
3328558|NCT03273257|4061350|FG000|COMPLETED|Overall Study||3
3328559|NCT03273257|4061351|FG001|COMPLETED|Overall Study||3
3328560|NCT03273257|4061350|FG000|NOT COMPLETED|Overall Study||4
3328561|NCT03273257|4061351|FG001|NOT COMPLETED|Overall Study||4
3328562|NCT03273270|4061359|FG000|STARTED|Overall Study||12
3328563|NCT03273270|4061360|FG001|STARTED|Overall Study||8
3328564|NCT03273270|4061359|FG000|COMPLETED|Overall Study||12
3328565|NCT03273270|4061360|FG001|COMPLETED|Overall Study||8
3328566|NCT03273270|4061359|FG000|NOT COMPLETED|Overall Study||0
3328567|NCT03273270|4061360|FG001|NOT COMPLETED|Overall Study||0
3328568|NCT03273283|4061368|FG000|STARTED|Overall Study||99
3328569|NCT03273283|4061369|FG001|STARTED|Overall Study||101
3328570|NCT03273283|4061368|FG000|COMPLETED|Overall Study||72
3328571|NCT03273283|4061369|FG001|COMPLETED|Overall Study||81
3328572|NCT03273283|4061368|FG000|NOT COMPLETED|Overall Study||27
3328573|NCT03273283|4061369|FG001|NOT COMPLETED|Overall Study||20
3328574|NCT03273387|4061377|FG000|STARTED|Overall Study||13
3328575|NCT03273387|4061378|FG001|STARTED|Overall Study||13
3328576|NCT03273387|4061377|FG000|COMPLETED|Overall Study||10
3328577|NCT03273387|4061378|FG001|COMPLETED|Overall Study||10
3328578|NCT03273387|4061377|FG000|NOT COMPLETED|Overall Study||3
3328579|NCT03273387|4061378|FG001|NOT COMPLETED|Overall Study||3
3328580|NCT03273426|4061386|FG000|STARTED|Overall Study||20
3328581|NCT03273426|4061387|FG001|STARTED|Overall Study||20
3328582|NCT03273426|4061386|FG000|COMPLETED|Overall Study||20
3328583|NCT03273426|4061387|FG001|COMPLETED|Overall Study||20
3328584|NCT03273426|4061386|FG000|NOT COMPLETED|Overall Study||0
3328585|NCT03273426|4061387|FG001|NOT COMPLETED|Overall Study||0
3328586|NCT03273543|4061396|FG000|STARTED|Overall Study||10
3328587|NCT03273543|4061397|FG001|STARTED|Overall Study||10
3328588|NCT03273543|4061396|FG000|COMPLETED|Overall Study||10
3328589|NCT03273543|4061397|FG001|COMPLETED|Overall Study||10
3328590|NCT03273543|4061396|FG000|NOT COMPLETED|Overall Study||0
3328591|NCT03273543|4061397|FG001|NOT COMPLETED|Overall Study||0
3328592|NCT03273673|4061405|FG000|STARTED|Overall Study||18
3328593|NCT03273673|4061406|FG001|STARTED|Overall Study||22
3328594|NCT03273673|4061405|FG000|COMPLETED|Overall Study||14
3328595|NCT03273673|4061406|FG001|COMPLETED|Overall Study||22
3328596|NCT03273673|4061405|FG000|NOT COMPLETED|Overall Study||4
3328597|NCT03273673|4061406|FG001|NOT COMPLETED|Overall Study||0
3328598|NCT03273946|4061412|FG000|STARTED|Overall Study||158
3328599|NCT03273946|4061412|FG000|COMPLETED|Overall Study||149
3328600|NCT03273946|4061412|FG000|NOT COMPLETED|Overall Study||9
3328601|NCT03274076|4061418|FG000|STARTED|24 Weeks Double Blind||10
3328602|NCT03274076|4061419|FG001|STARTED|24 Weeks Double Blind||5
3328603|NCT03274076|4061420|FG002|STARTED|24 Weeks Double Blind||0
3328604|NCT03274076|4061421|FG003|STARTED|24 Weeks Double Blind||0
3328605|NCT03274076|4061418|FG000|COMPLETED|24 Weeks Double Blind||10
3328606|NCT03274076|4061419|FG001|COMPLETED|24 Weeks Double Blind||4
3328607|NCT03274076|4061420|FG002|COMPLETED|24 Weeks Double Blind||0
3328608|NCT03274076|4061421|FG003|COMPLETED|24 Weeks Double Blind||0
3328609|NCT03274076|4061418|FG000|NOT COMPLETED|24 Weeks Double Blind||0
3328610|NCT03274076|4061419|FG001|NOT COMPLETED|24 Weeks Double Blind||1
3328611|NCT03274076|4061420|FG002|NOT COMPLETED|24 Weeks Double Blind||0
3328612|NCT03274076|4061421|FG003|NOT COMPLETED|24 Weeks Double Blind||0
3328613|NCT03274076|4061418|FG000|STARTED|24 Weeks Open Label||0
3328614|NCT03274076|4061419|FG001|STARTED|24 Weeks Open Label||0
3328615|NCT03274076|4061420|FG002|STARTED|24 Weeks Open Label||10
3328616|NCT03274076|4061421|FG003|STARTED|24 Weeks Open Label||4
3328617|NCT03274076|4061418|FG000|COMPLETED|24 Weeks Open Label||0
3328618|NCT03274076|4061419|FG001|COMPLETED|24 Weeks Open Label||0
3328619|NCT03274076|4061420|FG002|COMPLETED|24 Weeks Open Label||8
3328620|NCT03274076|4061421|FG003|COMPLETED|24 Weeks Open Label||3
3328621|NCT03274076|4061418|FG000|NOT COMPLETED|24 Weeks Open Label||0
3328622|NCT03274076|4061419|FG001|NOT COMPLETED|24 Weeks Open Label||0
3328623|NCT03274076|4061420|FG002|NOT COMPLETED|24 Weeks Open Label||2
3328624|NCT03274076|4061421|FG003|NOT COMPLETED|24 Weeks Open Label||1
3328625|NCT03274440|4061440|FG000|STARTED|Overall Study||3
3328626|NCT03274440|4061441|FG001|STARTED|Overall Study||2
3328627|NCT03274440|4061442|FG002|STARTED|Overall Study||4
3328628|NCT03274440|4061443|FG003|STARTED|Overall Study||1
3328629|NCT03274440|4061444|FG004|STARTED|Overall Study||1
3328630|NCT03274440|4061445|FG005|STARTED|Overall Study||3
3328631|NCT03274440|4061440|FG000|COMPLETED|Overall Study||2
3328632|NCT03274440|4061441|FG001|COMPLETED|Overall Study||2
3328633|NCT03274440|4061442|FG002|COMPLETED|Overall Study||4
3328634|NCT03274440|4061443|FG003|COMPLETED|Overall Study||0
3328635|NCT03274440|4061444|FG004|COMPLETED|Overall Study||1
3328636|NCT03274440|4061445|FG005|COMPLETED|Overall Study||3
3328637|NCT03274440|4061440|FG000|NOT COMPLETED|Overall Study||1
3328638|NCT03274440|4061441|FG001|NOT COMPLETED|Overall Study||0
3328639|NCT03274440|4061442|FG002|NOT COMPLETED|Overall Study||0
3328640|NCT03274440|4061443|FG003|NOT COMPLETED|Overall Study||1
3328641|NCT03274440|4061444|FG004|NOT COMPLETED|Overall Study||0
3328642|NCT03274440|4061445|FG005|NOT COMPLETED|Overall Study||0
3328643|NCT03274453|4061457|FG000|STARTED|Overall Study||38
3328644|NCT03274453|4061458|FG001|STARTED|Overall Study||30
3328645|NCT03274453|4061459|FG002|STARTED|Overall Study||32
3328646|NCT03274453|4061460|FG003|STARTED|Overall Study||29
3328647|NCT03274453|4061457|FG000|COMPLETED|Overall Study||34
3328648|NCT03274453|4061458|FG001|COMPLETED|Overall Study||24
3328649|NCT03274453|4061459|FG002|COMPLETED|Overall Study||28
3328650|NCT03274453|4061460|FG003|COMPLETED|Overall Study||25
3328651|NCT03274453|4061457|FG000|NOT COMPLETED|Overall Study||4
3328652|NCT03274453|4061458|FG001|NOT COMPLETED|Overall Study||6
3328653|NCT03274453|4061459|FG002|NOT COMPLETED|Overall Study||4
3328654|NCT03274453|4061460|FG003|NOT COMPLETED|Overall Study||4
3328655|NCT03274466|4061472|FG000|STARTED|Overall Study||147
3328656|NCT03274466|4061473|FG001|STARTED|Overall Study||147
3328657|NCT03274466|4061472|FG000|COMPLETED|Overall Study||124
3328658|NCT03274466|4061473|FG001|COMPLETED|Overall Study||118
3328659|NCT03274466|4061472|FG000|NOT COMPLETED|Overall Study||23
3328660|NCT03274466|4061473|FG001|NOT COMPLETED|Overall Study||29
3328661|NCT03274518|4061481|FG000|STARTED|First Intervention||8
3328662|NCT03274518|4061482|FG001|STARTED|First Intervention|First intervention: expanded hemodialysis, for 30 days.|8
3328663|NCT03274518|4061481|FG000|COMPLETED|First Intervention||8
3328664|NCT03274518|4061482|FG001|COMPLETED|First Intervention||8
3328665|NCT03274518|4061481|FG000|NOT COMPLETED|First Intervention||0
3328666|NCT03274518|4061482|FG001|NOT COMPLETED|First Intervention||0
3328667|NCT03274518|4061481|FG000|STARTED|Washout Period||8
3328668|NCT03274518|4061482|FG001|STARTED|Washout Period|Patients returned from expanded hemodialysis to conventional hemodialysis for 15 days.|8
3328669|NCT03274518|4061481|FG000|COMPLETED|Washout Period||8
3328670|NCT03274518|4061482|FG001|COMPLETED|Washout Period||8
3328671|NCT03274518|4061481|FG000|NOT COMPLETED|Washout Period||0
3328672|NCT03274518|4061482|FG001|NOT COMPLETED|Washout Period||0
3328673|NCT03274518|4061481|FG000|STARTED|Second Intervention||8
3328674|NCT03274518|4061482|FG001|STARTED|Second Intervention|Second intervention: patients from this group underwent online hemodiafiltration for 30 days.|8
3328675|NCT03274518|4061481|FG000|COMPLETED|Second Intervention||8
3328676|NCT03274518|4061482|FG001|COMPLETED|Second Intervention||8
3328677|NCT03274518|4061481|FG000|NOT COMPLETED|Second Intervention||0
3328678|NCT03274518|4061482|FG001|NOT COMPLETED|Second Intervention||0
3328679|NCT03274804|4061488|FG000|STARTED|Overall Study||20
3328680|NCT03274804|4061488|FG000|COMPLETED|Overall Study||20
3328681|NCT03274804|4061488|FG000|NOT COMPLETED|Overall Study||0
3328682|NCT03274856|4061495|FG000|STARTED|Overall Study||10
3328683|NCT03274856|4061496|FG001|STARTED|Overall Study||9
3328684|NCT03274856|4061495|FG000|COMPLETED|Overall Study||10
3328685|NCT03274856|4061496|FG001|COMPLETED|Overall Study||9
3328686|NCT03274856|4061495|FG000|NOT COMPLETED|Overall Study||0
3328687|NCT03274856|4061496|FG001|NOT COMPLETED|Overall Study||0
3328688|NCT03274986|4061506|FG000|STARTED|Overall Study||107
3328689|NCT03274986|4061507|FG001|STARTED|Overall Study||113
3328690|NCT03274986|4061506|FG000|Successful Implantation, as Treated|Overall Study||107
3328691|NCT03274986|4061507|FG001|Successful Implantation, as Treated|Overall Study||113
3328692|NCT03274986|4061506|FG000|COMPLETED|Overall Study||107
3328693|NCT03274986|4061507|FG001|COMPLETED|Overall Study||111
3328694|NCT03274986|4061506|FG000|NOT COMPLETED|Overall Study||0
3328695|NCT03274986|4061507|FG001|NOT COMPLETED|Overall Study||2
3328696|NCT03274999|4061520|FG000|STARTED|First Intervention (Day 0)||5
3328697|NCT03274999|4061521|FG001|STARTED|First Intervention (Day 0)||5
3328698|NCT03274999|4061520|FG000|COMPLETED|First Intervention (Day 0)||5
3328699|NCT03274999|4061521|FG001|COMPLETED|First Intervention (Day 0)||5
3328700|NCT03274999|4061520|FG000|NOT COMPLETED|First Intervention (Day 0)||0
3328701|NCT03274999|4061521|FG001|NOT COMPLETED|First Intervention (Day 0)||0
3328702|NCT03274999|4061520|FG000|STARTED|Second Intervention (Day 14)||5
3328703|NCT03274999|4061521|FG001|STARTED|Second Intervention (Day 14)||5
3328704|NCT03274999|4061520|FG000|COMPLETED|Second Intervention (Day 14)||5
3328705|NCT03274999|4061521|FG001|COMPLETED|Second Intervention (Day 14)||5
3328706|NCT03274999|4061520|FG000|NOT COMPLETED|Second Intervention (Day 14)||0
3328707|NCT03274999|4061521|FG001|NOT COMPLETED|Second Intervention (Day 14)||0
3328708|NCT03275246|4061527|FG000|STARTED|Overall Study||8
3328709|NCT03275246|4061527|FG000|COMPLETED|Overall Study||2
3328710|NCT03275246|4061527|FG000|NOT COMPLETED|Overall Study||6
3328711|NCT03275389|4061541|FG000|STARTED|Overall Study||45
3328712|NCT03275389|4061542|FG001|STARTED|Overall Study||46
3328713|NCT03275389|4061543|FG002|STARTED|Overall Study||47
3328714|NCT03275389|4061544|FG003|STARTED|Overall Study||47
3328715|NCT03275389|4061545|FG004|STARTED|Overall Study||48
3328716|NCT03275389|4061546|FG005|STARTED|Overall Study||47
3328717|NCT03275389|4061547|FG006|STARTED|Overall Study||47
3328718|NCT03275389|4061548|FG007|STARTED|Overall Study||48
3328719|NCT03275389|4061549|FG008|STARTED|Overall Study||46
3328720|NCT03275389|4061550|FG009|STARTED|Overall Study||47
3328721|NCT03275389|4061541|FG000|COMPLETED|Overall Study||34
3328722|NCT03275389|4061542|FG001|COMPLETED|Overall Study||30
3328723|NCT03275389|4061543|FG002|COMPLETED|Overall Study||24
3328724|NCT03275389|4061544|FG003|COMPLETED|Overall Study||25
3328725|NCT03275389|4061545|FG004|COMPLETED|Overall Study||32
3328726|NCT03275389|4061546|FG005|COMPLETED|Overall Study||29
3328727|NCT03275389|4061547|FG006|COMPLETED|Overall Study||22
3328728|NCT03275389|4061548|FG007|COMPLETED|Overall Study||30
3328729|NCT03275389|4061549|FG008|COMPLETED|Overall Study||31
3328730|NCT03275389|4061550|FG009|COMPLETED|Overall Study||29
3328731|NCT03275389|4061541|FG000|NOT COMPLETED|Overall Study||11
3328732|NCT03275389|4061542|FG001|NOT COMPLETED|Overall Study||16
3328733|NCT03275389|4061543|FG002|NOT COMPLETED|Overall Study||23
3328734|NCT03275389|4061544|FG003|NOT COMPLETED|Overall Study||22
3328735|NCT03275389|4061545|FG004|NOT COMPLETED|Overall Study||16
3328736|NCT03275389|4061546|FG005|NOT COMPLETED|Overall Study||18
3328737|NCT03275389|4061547|FG006|NOT COMPLETED|Overall Study||25
3328738|NCT03275389|4061548|FG007|NOT COMPLETED|Overall Study||18
3328739|NCT03275389|4061549|FG008|NOT COMPLETED|Overall Study||15
3328740|NCT03275389|4061550|FG009|NOT COMPLETED|Overall Study||18
3328741|NCT03275623|4061574|FG000|STARTED|Overall Study||30
3328742|NCT03275623|4061575|FG001|STARTED|Overall Study||30
3328743|NCT03275623|4061574|FG000|COMPLETED|Overall Study||25
3328744|NCT03275623|4061575|FG001|COMPLETED|Overall Study||28
3328745|NCT03275623|4061574|FG000|NOT COMPLETED|Overall Study||5
3328746|NCT03275623|4061575|FG001|NOT COMPLETED|Overall Study||2
3328747|NCT03275766|4061585|FG000|STARTED|Overall Study||12
3328748|NCT03275766|4061586|FG001|STARTED|Overall Study||12
3328749|NCT03275766|4061587|FG002|STARTED|Overall Study||11
3328750|NCT03275766|4061588|FG003|STARTED|Overall Study||10
3328751|NCT03275766|4061585|FG000|Received Intervention|Overall Study||9
3328752|NCT03275766|4061586|FG001|Received Intervention|Overall Study||11
3328753|NCT03275766|4061587|FG002|Received Intervention|Overall Study||10
3328754|NCT03275766|4061588|FG003|Received Intervention|Overall Study||9
3328755|NCT03275766|4061585|FG000|COMPLETED|Overall Study||7
3328756|NCT03275766|4061586|FG001|COMPLETED|Overall Study||5
3328757|NCT03275766|4061587|FG002|COMPLETED|Overall Study||7
3328758|NCT03275766|4061588|FG003|COMPLETED|Overall Study||4
3328759|NCT03275766|4061585|FG000|NOT COMPLETED|Overall Study||5
3328760|NCT03275766|4061586|FG001|NOT COMPLETED|Overall Study||7
3328761|NCT03275766|4061587|FG002|NOT COMPLETED|Overall Study||4
3328762|NCT03275766|4061588|FG003|NOT COMPLETED|Overall Study||6
3328763|NCT03275870|4061598|FG000|STARTED|Overall Study||17
3328764|NCT03275870|4061598|FG000|COMPLETED|Overall Study||3
3328765|NCT03275870|4061598|FG000|NOT COMPLETED|Overall Study||14
3328766|NCT03276026|4061604|FG000|STARTED|Overall Study||35
3328767|NCT03276026|4061605|FG001|STARTED|Overall Study||33
3328768|NCT03276026|4061604|FG000|COMPLETED|Overall Study||34
3328769|NCT03276026|4061605|FG001|COMPLETED|Overall Study||33
3328770|NCT03276026|4061604|FG000|NOT COMPLETED|Overall Study||1
3328771|NCT03276026|4061605|FG001|NOT COMPLETED|Overall Study||0
3328772|NCT03276078|4061611|FG000|STARTED|Overall Study||20
3328773|NCT03276078|4061611|FG000|COMPLETED|Overall Study||19
3328774|NCT03276078|4061611|FG000|NOT COMPLETED|Overall Study||1
3328775|NCT03276494|4061615|FG000|STARTED|Overall Study||6
3328776|NCT03276494|4061615|FG000|COMPLETED|Overall Study||5
3328777|NCT03276494|4061615|FG000|NOT COMPLETED|Overall Study||1
3328778|NCT03276637|4061619|FG000|STARTED|Overall Study||93
3328779|NCT03276637|4061619|FG000|Completed Pre Survey|Overall Study||93
3328780|NCT03276637|4061619|FG000|Underwent Sequencing|Overall Study||75
3328781|NCT03276637|4061619|FG000|Completed Post Survey|Overall Study||69
3328782|NCT03276637|4061619|FG000|COMPLETED|Overall Study||69
3328783|NCT03276637|4061619|FG000|NOT COMPLETED|Overall Study||24
3328784|NCT03276871|4061626|FG000|STARTED|Overall Study||21
3328785|NCT03276871|4061627|FG001|STARTED|Overall Study||19
3328786|NCT03276871|4061626|FG000|COMPLETED|Overall Study||21
3328787|NCT03276871|4061627|FG001|COMPLETED|Overall Study||19
3328788|NCT03276871|4061626|FG000|NOT COMPLETED|Overall Study||0
3328789|NCT03276871|4061627|FG001|NOT COMPLETED|Overall Study||0
3328790|NCT03276975|4061635|FG000|STARTED|Overall Study||8
3328791|NCT03276975|4061636|FG001|STARTED|Overall Study||7
3328792|NCT03276975|4061635|FG000|Crossover At 2 Months|Overall Study||0
3328793|NCT03276975|4061636|FG001|Crossover At 2 Months|Overall Study||7
3328794|NCT03276975|4061635|FG000|COMPLETED|Overall Study||7
3328795|NCT03276975|4061636|FG001|COMPLETED|Overall Study||7
3328796|NCT03276975|4061635|FG000|NOT COMPLETED|Overall Study||1
3328797|NCT03276975|4061636|FG001|NOT COMPLETED|Overall Study||0
3328798|NCT03277274|4061645|FG000|STARTED|Overall Study||8
3328799|NCT03277274|4061646|FG001|STARTED|Overall Study||10
3328800|NCT03277274|4061647|FG002|STARTED|Overall Study||7
3328801|NCT03277274|4061645|FG000|COMPLETED|Overall Study||8
3328802|NCT03277274|4061646|FG001|COMPLETED|Overall Study||10
3328803|NCT03277274|4061647|FG002|COMPLETED|Overall Study||7
3328804|NCT03277274|4061645|FG000|NOT COMPLETED|Overall Study||0
3328805|NCT03277274|4061646|FG001|NOT COMPLETED|Overall Study||0
3328806|NCT03277274|4061647|FG002|NOT COMPLETED|Overall Study||0
3328807|NCT03277352|4061655|FG000|STARTED|Overall Study||10
3328808|NCT03277352|4061655|FG000|COMPLETED|Overall Study||0
3328809|NCT03277352|4061655|FG000|NOT COMPLETED|Overall Study||10
3328810|NCT03277378|4061662|FG000|STARTED|Overall Study||135
3328811|NCT03277378|4061663|FG001|STARTED|Overall Study||135
3328812|NCT03277378|4061662|FG000|Received Lead Implant|Overall Study||129
3328813|NCT03277378|4061663|FG001|Received Lead Implant|Overall Study||123
3328814|NCT03277378|4061662|FG000|Completed Initial Trial|Overall Study||126
3328815|NCT03277378|4061663|FG001|Completed Initial Trial|Overall Study||122
3328816|NCT03277378|4061662|FG000|Qualified for Permanent Implant|Overall Study||103
3328817|NCT03277378|4061663|FG001|Qualified for Permanent Implant|Overall Study||93
3328818|NCT03277378|4061662|FG000|Not Qualified for Permanent Implant|Overall Study||19
3328819|NCT03277378|4061663|FG001|Not Qualified for Permanent Implant|Overall Study||20
3328820|NCT03277378|4061662|FG000|Completed Extended Trial With Tonic Stim|Overall Study||8
3328821|NCT03277378|4061663|FG001|Completed Extended Trial With Tonic Stim|Overall Study||12
3328822|NCT03277378|4061662|FG000|Exit Study|Overall Study||11
3328823|NCT03277378|4061663|FG001|Exit Study|Overall Study||8
3328824|NCT03277378|4061662|FG000|COMPLETED|Overall Study||111
3328825|NCT03277378|4061663|FG001|COMPLETED|Overall Study||101
3328826|NCT03277378|4061662|FG000|NOT COMPLETED|Overall Study||24
3328827|NCT03277378|4061663|FG001|NOT COMPLETED|Overall Study||34
3328828|NCT03277794|4061675|FG000|STARTED|Overall Study||31
3328829|NCT03277794|4061676|FG001|STARTED|Overall Study||34
3328830|NCT03277794|4061675|FG000|COMPLETED|Overall Study||28
3328831|NCT03277794|4061676|FG001|COMPLETED|Overall Study||30
3328832|NCT03277794|4061675|FG000|NOT COMPLETED|Overall Study||3
3328833|NCT03277794|4061676|FG001|NOT COMPLETED|Overall Study||4
3328834|NCT03277846|4061685|FG000|STARTED|Overall Study||50
3328835|NCT03277846|4061686|FG001|STARTED|Overall Study||51
3328836|NCT03277846|4061685|FG000|COMPLETED|Overall Study||38
3328837|NCT03277846|4061686|FG001|COMPLETED|Overall Study||40
3328838|NCT03277846|4061685|FG000|NOT COMPLETED|Overall Study||12
3328839|NCT03277846|4061686|FG001|NOT COMPLETED|Overall Study||11
3328840|NCT03278028|4061694|FG000|STARTED|Overall Study||81
3328841|NCT03278028|4061695|FG001|STARTED|Overall Study||78
3328842|NCT03278028|4061694|FG000|COMPLETED|Overall Study||77
3328843|NCT03278028|4061695|FG001|COMPLETED|Overall Study||76
3328844|NCT03278028|4061694|FG000|NOT COMPLETED|Overall Study||4
3328845|NCT03278028|4061695|FG001|NOT COMPLETED|Overall Study||2
3328846|NCT03278067|4061704|FG000|STARTED|Overall Study||16433
3328847|NCT03278067|4061705|FG001|STARTED|Overall Study||3310
3328848|NCT03278067|4061706|FG002|STARTED|Overall Study||4196
3328849|NCT03278067|4061704|FG000|COMPLETED|Overall Study||16433
3328850|NCT03278067|4061705|FG001|COMPLETED|Overall Study||3310
3328851|NCT03278067|4061706|FG002|COMPLETED|Overall Study||4196
3328852|NCT03278067|4061704|FG000|NOT COMPLETED|Overall Study||0
3328853|NCT03278067|4061705|FG001|NOT COMPLETED|Overall Study||0
3328854|NCT03278067|4061706|FG002|NOT COMPLETED|Overall Study||0
3328855|NCT03278106|4061719|FG000|STARTED|Overall Study||28
3328856|NCT03278106|4061719|FG000|COMPLETED|Overall Study||27
3328857|NCT03278106|4061719|FG000|NOT COMPLETED|Overall Study||1
3328858|NCT03278223|4061725|FG000|STARTED|Overall Study||125
3328859|NCT03278223|4061726|FG001|STARTED|Overall Study||69
3328860|NCT03278223|4061725|FG000|COMPLETED|Overall Study||122
3328861|NCT03278223|4061726|FG001|COMPLETED|Overall Study||65
3328862|NCT03278223|4061725|FG000|NOT COMPLETED|Overall Study||3
3328863|NCT03278223|4061726|FG001|NOT COMPLETED|Overall Study||4
3328864|NCT03278613|4061734|FG000|STARTED|Overall Study||111
3328865|NCT03278613|4061735|FG001|STARTED|Overall Study||55
3328866|NCT03278613|4061734|FG000|COMPLETED|Overall Study||108
3328867|NCT03278613|4061735|FG001|COMPLETED|Overall Study||54
3328868|NCT03278613|4061734|FG000|NOT COMPLETED|Overall Study||3
3328869|NCT03278613|4061735|FG001|NOT COMPLETED|Overall Study||1
3328870|NCT03278886|4061743|FG000|STARTED|Overall Study||8
3328871|NCT03278886|4061744|FG001|STARTED|Overall Study||3
3328872|NCT03278886|4061743|FG000|COMPLETED|Overall Study||8
3328873|NCT03278886|4061744|FG001|COMPLETED|Overall Study||2
3328874|NCT03278886|4061743|FG000|NOT COMPLETED|Overall Study||0
3328875|NCT03278886|4061744|FG001|NOT COMPLETED|Overall Study||1
3328876|NCT03279237|4061750|FG000|STARTED|Overall Study||25
3328877|NCT03279237|4061750|FG000|Chemo-radiation|Overall Study||23
3328878|NCT03279237|4061750|FG000|Surgical Resection|Overall Study||20
3328879|NCT03279237|4061750|FG000|COMPLETED|Overall Study||20
3328880|NCT03279237|4061750|FG000|NOT COMPLETED|Overall Study||5
3328881|NCT03279458|4061754|FG000|STARTED|Overall Study||40
3328882|NCT03279458|4061754|FG000|COMPLETED|Overall Study||40
3328883|NCT03279458|4061754|FG000|NOT COMPLETED|Overall Study||0
3328884|NCT03279731|4061762|FG000|STARTED|Overall Study||19
3328885|NCT03279731|4061763|FG001|STARTED|Overall Study||17
3328886|NCT03279731|4061762|FG000|COMPLETED|Overall Study||13
3328887|NCT03279731|4061763|FG001|COMPLETED|Overall Study||14
3328888|NCT03279731|4061762|FG000|NOT COMPLETED|Overall Study||6
3328889|NCT03279731|4061763|FG001|NOT COMPLETED|Overall Study||3
3328890|NCT03280108|4061773|FG000|STARTED|Overall Study||129
3328891|NCT03280108|4061774|FG001|STARTED|Overall Study||114
3328892|NCT03280108|4061773|FG000|COMPLETED|Overall Study||127
3328893|NCT03280108|4061774|FG001|COMPLETED|Overall Study||114
3328894|NCT03280108|4061773|FG000|NOT COMPLETED|Overall Study||2
3328895|NCT03280108|4061774|FG001|NOT COMPLETED|Overall Study||0
3328896|NCT03280121|4061785|FG000|STARTED|Overall Study||14
3328897|NCT03280121|4061785|FG000|COMPLETED|Overall Study||8
3328898|NCT03280121|4061785|FG000|NOT COMPLETED|Overall Study||6
3328899|NCT03280264|4061789|FG000|STARTED|Overall Study||18
3328900|NCT03280264|4061789|FG000|COMPLETED|Overall Study||15
3328901|NCT03280264|4061789|FG000|NOT COMPLETED|Overall Study||3
3328902|NCT03280381|4061796|FG000|STARTED|Overall Study||101
3328903|NCT03280381|4061797|FG001|STARTED|Overall Study||99
3328904|NCT03280381|4061796|FG000|COMPLETED|Overall Study||101
3328905|NCT03280381|4061797|FG001|COMPLETED|Overall Study||97
3328906|NCT03280381|4061796|FG000|NOT COMPLETED|Overall Study||0
3328907|NCT03280381|4061797|FG001|NOT COMPLETED|Overall Study||2
3328908|NCT03280537|4061806|FG000|STARTED|Overall Study||65
3328909|NCT03280537|4061807|FG001|STARTED|Overall Study||62
3328910|NCT03280537|4061806|FG000|COMPLETED|Overall Study||63
3328911|NCT03280537|4061807|FG001|COMPLETED|Overall Study||58
3328912|NCT03280537|4061806|FG000|NOT COMPLETED|Overall Study||2
3328913|NCT03280537|4061807|FG001|NOT COMPLETED|Overall Study||4
3328914|NCT03280550|4061815|FG000|STARTED|Overall Study||66
3328915|NCT03280550|4061816|FG001|STARTED|Overall Study||72
3328916|NCT03280550|4061815|FG000|COMPLETED|Overall Study||64
3328917|NCT03280550|4061816|FG001|COMPLETED|Overall Study||69
3176471|NCT01966796|3904330|FG002|COMPLETED|Overall Study||195
3176472|NCT01966796|3904331|FG003|COMPLETED|Overall Study||269
3176473|NCT01966796|3904328|FG000|NOT COMPLETED|Overall Study||0
3176474|NCT01966796|3904329|FG001|NOT COMPLETED|Overall Study||0
3176475|NCT01966796|3904330|FG002|NOT COMPLETED|Overall Study||0
3328918|NCT03280550|4061815|FG000|NOT COMPLETED|Overall Study||2
3328919|NCT03280550|4061816|FG001|NOT COMPLETED|Overall Study||3
3328920|NCT03280615|4061824|FG000|STARTED|Overall Study||50
3328921|NCT03280615|4061825|FG001|STARTED|Overall Study||50
3328922|NCT03280615|4061824|FG000|COMPLETED|Overall Study||46
3328923|NCT03280615|4061825|FG001|COMPLETED|Overall Study||45
3328924|NCT03280615|4061824|FG000|NOT COMPLETED|Overall Study||4
3328925|NCT03280615|4061825|FG001|NOT COMPLETED|Overall Study||5
3328926|NCT03281200|4061831|FG000|STARTED|Overall Study||172
3328927|NCT03281200|4061831|FG000|COMPLETED|Overall Study||172
3328928|NCT03281200|4061831|FG000|NOT COMPLETED|Overall Study||0
3328929|NCT03281304|4061837|FG000|STARTED|Overall Study||70
3328930|NCT03281304|4061838|FG001|STARTED|Overall Study||70
3328931|NCT03281304|4061837|FG000|COMPLETED|Overall Study||57
3176476|NCT01966796|3904331|FG003|NOT COMPLETED|Overall Study||0
3176477|NCT01966809|3904345|FG000|STARTED|Overall Study||1
3176478|NCT01966809|3904345|FG000|COMPLETED|Overall Study||1
3176479|NCT01966809|3904345|FG000|NOT COMPLETED|Overall Study||0
3176480|NCT01966900|3904351|FG000|STARTED|Overall Study||8
3328932|NCT03281304|4061838|FG001|COMPLETED|Overall Study||58
3328933|NCT03281304|4061837|FG000|NOT COMPLETED|Overall Study||13
3328934|NCT03281304|4061838|FG001|NOT COMPLETED|Overall Study||12
3328935|NCT03281538|4061844|FG000|STARTED|Overall Study||288
3328936|NCT03281538|4061844|FG000|COMPLETED|Overall Study||133
3328937|NCT03281538|4061844|FG000|NOT COMPLETED|Overall Study||155
3328938|NCT03281577|4061852|FG000|STARTED|Overall Study||10
3328939|NCT03281577|4061853|FG001|STARTED|Overall Study||10
3328940|NCT03281577|4061854|FG002|STARTED|Overall Study||9
3328941|NCT03281577|4061855|FG003|STARTED|Overall Study||7
3328942|NCT03281577|4061852|FG000|COMPLETED|Overall Study||9
3328943|NCT03281577|4061853|FG001|COMPLETED|Overall Study||10
3328944|NCT03281577|4061854|FG002|COMPLETED|Overall Study||9
3328945|NCT03281577|4061855|FG003|COMPLETED|Overall Study||6
3328946|NCT03281577|4061852|FG000|NOT COMPLETED|Overall Study||1
3328947|NCT03281577|4061853|FG001|NOT COMPLETED|Overall Study||0
3328948|NCT03281577|4061854|FG002|NOT COMPLETED|Overall Study||0
3328949|NCT03281577|4061855|FG003|NOT COMPLETED|Overall Study||1
3328950|NCT03281668|4061868|FG000|STARTED|Overall Study||29
3328951|NCT03281668|4061868|FG000|COMPLETED|Overall Study||21
3328952|NCT03281668|4061868|FG000|NOT COMPLETED|Overall Study||8
3328953|NCT03281876|4061874|FG000|STARTED|Overall Study||304
3328954|NCT03281876|4061875|FG001|STARTED|Overall Study||302
3328955|NCT03281876|4061874|FG000|COMPLETED|Overall Study||281
3328956|NCT03281876|4061875|FG001|COMPLETED|Overall Study||263
3328957|NCT03281876|4061874|FG000|NOT COMPLETED|Overall Study||23
3328958|NCT03281876|4061875|FG001|NOT COMPLETED|Overall Study||39
3328959|NCT03282071|4061883|FG000|STARTED|Overall Study||75
3328960|NCT03282071|4061884|FG001|STARTED|Overall Study||69
3328961|NCT03282071|4061883|FG000|COMPLETED|Overall Study||65
3328962|NCT03282071|4061884|FG001|COMPLETED|Overall Study||60
3328963|NCT03282071|4061883|FG000|NOT COMPLETED|Overall Study||10
3328964|NCT03282071|4061884|FG001|NOT COMPLETED|Overall Study||9
3328965|NCT03282227|4061892|FG000|STARTED|Overall Study||342
3328966|NCT03282227|4061892|FG000|Completed at Least 6 Months|Overall Study||257
3328967|NCT03282227|4061892|FG000|COMPLETED|Overall Study||127
3328968|NCT03282227|4061892|FG000|NOT COMPLETED|Overall Study||215
3328969|NCT03282240|4061899|FG000|STARTED|Overall Study||1777
3328970|NCT03282240|4061900|FG001|STARTED|Overall Study||443
3328971|NCT03282240|4061901|FG002|STARTED|Overall Study||450
3328972|NCT03282240|4061899|FG000|COMPLETED|Overall Study||1767
3328973|NCT03282240|4061900|FG001|COMPLETED|Overall Study||440
3328974|NCT03282240|4061901|FG002|COMPLETED|Overall Study||447
3328975|NCT03282240|4061899|FG000|NOT COMPLETED|Overall Study||10
3328976|NCT03282240|4061900|FG001|NOT COMPLETED|Overall Study||3
3328977|NCT03282240|4061901|FG002|NOT COMPLETED|Overall Study||3
3328978|NCT03282357|4061912|FG000|STARTED|Overall Study||181
3328979|NCT03282357|4061912|FG000|Safety Evaluation Set|Overall Study||176
3328980|NCT03282357|4061912|FG000|COMPLETED|Overall Study||164
3328981|NCT03282357|4061912|FG000|NOT COMPLETED|Overall Study||17
3328982|NCT03282591|4061919|FG000|STARTED|Overall Study||92
3328983|NCT03282591|4061920|FG001|STARTED|Overall Study||93
3328984|NCT03282591|4061919|FG000|COMPLETED|Overall Study||88
3328985|NCT03282591|4061920|FG001|COMPLETED|Overall Study||89
3328986|NCT03282591|4061919|FG000|NOT COMPLETED|Overall Study||4
3328987|NCT03282591|4061920|FG001|NOT COMPLETED|Overall Study||4
3328988|NCT03282682|4061930|FG000|STARTED|Overall Study||6
3328989|NCT03282682|4061931|FG001|STARTED|Overall Study||8
3328990|NCT03282682|4061932|FG002|STARTED|Overall Study||8
3328991|NCT03282682|4061930|FG000|COMPLETED|Overall Study||6
3328992|NCT03282682|4061931|FG001|COMPLETED|Overall Study||8
3328993|NCT03282682|4061932|FG002|COMPLETED|Overall Study||8
3328994|NCT03282682|4061930|FG000|NOT COMPLETED|Overall Study||0
3328995|NCT03282682|4061931|FG001|NOT COMPLETED|Overall Study||0
3328996|NCT03282682|4061932|FG002|NOT COMPLETED|Overall Study||0
3328997|NCT03283098|4061942|FG000|STARTED|Overall Study||8
3328998|NCT03283098|4061943|FG001|STARTED|Overall Study||25
3328999|NCT03283098|4061942|FG000|COMPLETED|Overall Study||8
3329000|NCT03283098|4061943|FG001|COMPLETED|Overall Study||24
3329001|NCT03283098|4061942|FG000|NOT COMPLETED|Overall Study||0
3329002|NCT03283098|4061943|FG001|NOT COMPLETED|Overall Study||1
3329003|NCT03283319|4061955|FG000|STARTED|Overall Study||62
3329004|NCT03283319|4061956|FG001|STARTED|Overall Study||60
3329005|NCT03283319|4061957|FG002|STARTED|Overall Study||62
3329006|NCT03283319|4061958|FG003|STARTED|Overall Study||61
3329007|NCT03283319|4061959|FG004|STARTED|Overall Study||60
3329008|NCT03283319|4061960|FG005|STARTED|Overall Study||61
3329009|NCT03283319|4061955|FG000|COMPLETED|Overall Study||55
3329010|NCT03283319|4061956|FG001|COMPLETED|Overall Study||54
3329011|NCT03283319|4061957|FG002|COMPLETED|Overall Study||55
3329012|NCT03283319|4061958|FG003|COMPLETED|Overall Study||54
3329013|NCT03283319|4061959|FG004|COMPLETED|Overall Study||56
3329014|NCT03283319|4061960|FG005|COMPLETED|Overall Study||57
3329015|NCT03283319|4061955|FG000|NOT COMPLETED|Overall Study||7
3329016|NCT03283319|4061956|FG001|NOT COMPLETED|Overall Study||6
3329017|NCT03283319|4061957|FG002|NOT COMPLETED|Overall Study||7
3329018|NCT03283319|4061958|FG003|NOT COMPLETED|Overall Study||7
3329019|NCT03283319|4061959|FG004|NOT COMPLETED|Overall Study||4
3329020|NCT03283319|4061960|FG005|NOT COMPLETED|Overall Study||4
3329021|NCT03283436|4061976|FG000|STARTED|Overall Study||50
3329022|NCT03283436|4061977|FG001|STARTED|Overall Study||50
3329023|NCT03283436|4061976|FG000|COMPLETED|Overall Study||44
3329024|NCT03283436|4061977|FG001|COMPLETED|Overall Study||50
3329025|NCT03283436|4061976|FG000|NOT COMPLETED|Overall Study||6
3329026|NCT03283436|4061977|FG001|NOT COMPLETED|Overall Study||0
3329027|NCT03283553|4061985|FG000|STARTED|Patient Participant Flow||69
3329028|NCT03283553|4061986|FG001|STARTED|Patient Participant Flow||63
3329029|NCT03283553|4061985|FG000|Patient Baseline Interview|Patient Participant Flow||69
3329030|NCT03283553|4061986|FG001|Patient Baseline Interview|Patient Participant Flow||62
3329031|NCT03283553|4061985|FG000|Patient 3-Month Interview|Patient Participant Flow||67
3329032|NCT03283553|4061986|FG001|Patient 3-Month Interview|Patient Participant Flow||60
3329033|NCT03283553|4061985|FG000|Patient 9-Month Interview|Patient Participant Flow||63
3329034|NCT03283553|4061986|FG001|Patient 9-Month Interview|Patient Participant Flow||57
3329035|NCT03283553|4061985|FG000|Patient 12-Month Interview|Patient Participant Flow||59
3329036|NCT03283553|4061986|FG001|Patient 12-Month Interview|Patient Participant Flow||50
3329037|NCT03283553|4061985|FG000|COMPLETED|Patient Participant Flow||59
3329038|NCT03283553|4061986|FG001|COMPLETED|Patient Participant Flow||50
3329039|NCT03283553|4061985|FG000|NOT COMPLETED|Patient Participant Flow||10
3329040|NCT03283553|4061986|FG001|NOT COMPLETED|Patient Participant Flow||13
3329041|NCT03283553|4061985|FG000|STARTED|Care Partner Participant Flow||69
3329042|NCT03283553|4061986|FG001|STARTED|Care Partner Participant Flow||63
3329043|NCT03283553|4061985|FG000|Care Partner Baseline Interview|Care Partner Participant Flow||69
3329044|NCT03283553|4061986|FG001|Care Partner Baseline Interview|Care Partner Participant Flow||63
3329045|NCT03283553|4061985|FG000|Care Partner 3-Month Interview|Care Partner Participant Flow||69
3329046|NCT03283553|4061986|FG001|Care Partner 3-Month Interview|Care Partner Participant Flow||60
3329047|NCT03283553|4061985|FG000|Care Partner 9-Month Interview|Care Partner Participant Flow||64
3329048|NCT03283553|4061986|FG001|Care Partner 9-Month Interview|Care Partner Participant Flow||55
3329049|NCT03283553|4061985|FG000|Care Partner 12-Month Interview|Care Partner Participant Flow||59
3329050|NCT03283553|4061986|FG001|Care Partner 12-Month Interview|Care Partner Participant Flow||48
3329051|NCT03283553|4061985|FG000|COMPLETED|Care Partner Participant Flow||59
3329052|NCT03283553|4061986|FG001|COMPLETED|Care Partner Participant Flow||48
3329053|NCT03283553|4061985|FG000|NOT COMPLETED|Care Partner Participant Flow||10
3329054|NCT03283553|4061986|FG001|NOT COMPLETED|Care Partner Participant Flow||15
3329055|NCT03283696|4061996|FG000|STARTED|Overall Study||16
3329056|NCT03283696|4061997|FG001|STARTED|Overall Study||8
3329057|NCT03283696|4061996|FG000|Received at Least 1 Dose of Study Drug|Overall Study||16
3329058|NCT03283696|4061997|FG001|Received at Least 1 Dose of Study Drug|Overall Study||8
3329059|NCT03283696|4061996|FG000|COMPLETED|Overall Study||9
3329060|NCT03283696|4061997|FG001|COMPLETED|Overall Study||2
3329061|NCT03283696|4061996|FG000|NOT COMPLETED|Overall Study||7
3329062|NCT03283696|4061997|FG001|NOT COMPLETED|Overall Study||6
3329063|NCT03283787|4062006|FG000|STARTED|Overall Study||20
3329064|NCT03283787|4062007|FG001|STARTED|Overall Study||20
3329065|NCT03283787|4062008|FG002|STARTED|Overall Study||20
3329066|NCT03283787|4062006|FG000|COMPLETED|Overall Study||17
3329067|NCT03283787|4062007|FG001|COMPLETED|Overall Study||13
3329068|NCT03283787|4062008|FG002|COMPLETED|Overall Study||13
3329069|NCT03283787|4062006|FG000|NOT COMPLETED|Overall Study||3
3329070|NCT03283787|4062007|FG001|NOT COMPLETED|Overall Study||7
3329071|NCT03283787|4062008|FG002|NOT COMPLETED|Overall Study||7
3329072|NCT03284229|4062019|FG000|STARTED|Overall Study||28
3329073|NCT03284229|4062019|FG000|COMPLETED|Overall Study||25
3329074|NCT03284229|4062019|FG000|NOT COMPLETED|Overall Study||3
3329075|NCT03284359|4062026|FG000|STARTED|Overall Study||93
3329076|NCT03284359|4062027|FG001|STARTED|Overall Study||89
3329077|NCT03284359|4062026|FG000|COMPLETED|Overall Study||93
3329078|NCT03284359|4062027|FG001|COMPLETED|Overall Study||89
3329079|NCT03284359|4062026|FG000|NOT COMPLETED|Overall Study||0
3329080|NCT03284359|4062027|FG001|NOT COMPLETED|Overall Study||0
3329081|NCT03284398|4062035|FG000|STARTED|Overall Study||2753
3329082|NCT03284398|4062036|FG001|STARTED|Overall Study||970
3329083|NCT03284398|4062035|FG000|COMPLETED|Overall Study||2753
3329084|NCT03284398|4062036|FG001|COMPLETED|Overall Study||970
3329085|NCT03284398|4062035|FG000|NOT COMPLETED|Overall Study||0
3329086|NCT03284398|4062036|FG001|NOT COMPLETED|Overall Study||0
3329087|NCT03284411|4062048|FG000|STARTED|Overall Study||30
3329088|NCT03284411|4062048|FG000|COMPLETED|Overall Study||30
3329089|NCT03284411|4062048|FG000|NOT COMPLETED|Overall Study||0
3329090|NCT03284424|4062055|FG000|STARTED|Overall Study||105
3329091|NCT03284424|4062056|FG001|STARTED|Overall Study||54
3329092|NCT03284424|4062055|FG000|COMPLETED|Overall Study||0
3329093|NCT03284424|4062056|FG001|COMPLETED|Overall Study||0
3329094|NCT03284424|4062055|FG000|NOT COMPLETED|Overall Study||105
3329095|NCT03284424|4062056|FG001|NOT COMPLETED|Overall Study||54
3329096|NCT03284710|4062065|FG000|STARTED|Overall Study||36
3329097|NCT03284710|4062066|FG001|STARTED|Overall Study||36
3329098|NCT03284710|4062067|FG002|STARTED|Overall Study||36
3329099|NCT03284710|4062068|FG003|STARTED|Overall Study||24
3329100|NCT03284710|4062065|FG000|Month 6.5 Immunogenicity Timepoint|Overall Study||31
3329101|NCT03284710|4062066|FG001|Month 6.5 Immunogenicity Timepoint|Overall Study||31
3329102|NCT03284710|4062067|FG002|Month 6.5 Immunogenicity Timepoint|Overall Study||31
3329103|NCT03284710|4062068|FG003|Month 6.5 Immunogenicity Timepoint|Overall Study||18
3329104|NCT03284710|4062065|FG000|Month 12 Immunogenicity Timepoint|Overall Study||30
3329105|NCT03284710|4062066|FG001|Month 12 Immunogenicity Timepoint|Overall Study||31
3329106|NCT03284710|4062067|FG002|Month 12 Immunogenicity Timepoint|Overall Study||31
3329107|NCT03284710|4062068|FG003|Month 12 Immunogenicity Timepoint|Overall Study||17
3329108|NCT03284710|4062065|FG000|Month 12.5 Immunogenicity Timepoint|Overall Study||0
3329109|NCT03284710|4062066|FG001|Month 12.5 Immunogenicity Timepoint|Overall Study||0
3329110|NCT03284710|4062067|FG002|Month 12.5 Immunogenicity Timepoint|Overall Study||0
3329111|NCT03284710|4062068|FG003|Month 12.5 Immunogenicity Timepoint|Overall Study||0
3329112|NCT03284710|4062065|FG000|Month 18 Immunogenicity Timepoint|Overall Study||0
3329113|NCT03284710|4062066|FG001|Month 18 Immunogenicity Timepoint|Overall Study||0
3329114|NCT03284710|4062067|FG002|Month 18 Immunogenicity Timepoint|Overall Study||0
3329115|NCT03284710|4062068|FG003|Month 18 Immunogenicity Timepoint|Overall Study||0
3329116|NCT03284710|4062065|FG000|COMPLETED|Overall Study||30
3329117|NCT03284710|4062066|FG001|COMPLETED|Overall Study||31
3329118|NCT03284710|4062067|FG002|COMPLETED|Overall Study||32
3329119|NCT03284710|4062068|FG003|COMPLETED|Overall Study||16
3329120|NCT03284710|4062065|FG000|NOT COMPLETED|Overall Study||6
3329121|NCT03284710|4062066|FG001|NOT COMPLETED|Overall Study||5
3329122|NCT03284710|4062067|FG002|NOT COMPLETED|Overall Study||4
3176481|NCT01966900|3904352|FG001|STARTED|Overall Study||6
3176482|NCT01966900|3904351|FG000|COMPLETED|Overall Study||6
3176483|NCT01966900|3904352|FG001|COMPLETED|Overall Study||6
3329123|NCT03284710|4062068|FG003|NOT COMPLETED|Overall Study||8
3329124|NCT03285061|4062085|FG000|STARTED|Overall Study||37
3329125|NCT03285061|4062086|FG001|STARTED|Overall Study||38
3329126|NCT03285061|4062085|FG000|COMPLETED|Overall Study||36
3329127|NCT03285061|4062086|FG001|COMPLETED|Overall Study||36
3329128|NCT03285061|4062085|FG000|NOT COMPLETED|Overall Study||1
3329129|NCT03285061|4062086|FG001|NOT COMPLETED|Overall Study||2
3329130|NCT03285113|4062092|FG000|STARTED|Overall Study||10
3329131|NCT03285113|4062092|FG000|COMPLETED|Overall Study||8
3329132|NCT03285113|4062092|FG000|NOT COMPLETED|Overall Study||2
3329133|NCT03285295|4062101|FG000|STARTED|Alinity s HBsAg||17095
3329134|NCT03285295|4062102|FG001|STARTED|Alinity s HBsAg||438
3329135|NCT03285295|4062103|FG002|STARTED|Alinity s HBsAg||403
3329136|NCT03285295|4062104|FG003|STARTED|Alinity s HBsAg||0
3329137|NCT03285295|4062105|FG004|STARTED|Alinity s HBsAg||51
3329138|NCT03285295|4062101|FG000|COMPLETED|Alinity s HBsAg||16993
3329139|NCT03285295|4062102|FG001|COMPLETED|Alinity s HBsAg||432
3329140|NCT03285295|4062103|FG002|COMPLETED|Alinity s HBsAg||403
3329141|NCT03285295|4062104|FG003|COMPLETED|Alinity s HBsAg||0
3329142|NCT03285295|4062105|FG004|COMPLETED|Alinity s HBsAg||51
3329143|NCT03285295|4062101|FG000|NOT COMPLETED|Alinity s HBsAg||102
3329144|NCT03285295|4062102|FG001|NOT COMPLETED|Alinity s HBsAg||6
3329145|NCT03285295|4062103|FG002|NOT COMPLETED|Alinity s HBsAg||0
3329146|NCT03285295|4062104|FG003|NOT COMPLETED|Alinity s HBsAg||0
3329147|NCT03285295|4062105|FG004|NOT COMPLETED|Alinity s HBsAg||0
3176484|NCT01966900|3904351|FG000|NOT COMPLETED|Overall Study||2
3329148|NCT03285295|4062101|FG000|STARTED|Alinity s HBsAg Confirmatory||8
3329149|NCT03285295|4062102|FG001|STARTED|Alinity s HBsAg Confirmatory||432
3329150|NCT03285295|4062103|FG002|STARTED|Alinity s HBsAg Confirmatory||3
3329151|NCT03285295|4062104|FG003|STARTED|Alinity s HBsAg Confirmatory||0
3329152|NCT03285295|4062105|FG004|STARTED|Alinity s HBsAg Confirmatory||0
3329153|NCT03285295|4062101|FG000|COMPLETED|Alinity s HBsAg Confirmatory||8
3329154|NCT03285295|4062102|FG001|COMPLETED|Alinity s HBsAg Confirmatory||432
3329155|NCT03285295|4062103|FG002|COMPLETED|Alinity s HBsAg Confirmatory||3
3329156|NCT03285295|4062104|FG003|COMPLETED|Alinity s HBsAg Confirmatory||0
3329157|NCT03285295|4062105|FG004|COMPLETED|Alinity s HBsAg Confirmatory||0
3329158|NCT03285295|4062101|FG000|NOT COMPLETED|Alinity s HBsAg Confirmatory||0
3329159|NCT03285295|4062102|FG001|NOT COMPLETED|Alinity s HBsAg Confirmatory||0
3329160|NCT03285295|4062103|FG002|NOT COMPLETED|Alinity s HBsAg Confirmatory||0
3329161|NCT03285295|4062104|FG003|NOT COMPLETED|Alinity s HBsAg Confirmatory||0
3329162|NCT03285295|4062105|FG004|NOT COMPLETED|Alinity s HBsAg Confirmatory||0
3329163|NCT03285295|4062101|FG000|STARTED|Alinity s HBsAg Follow-Up||0
3329164|NCT03285295|4062102|FG001|STARTED|Alinity s HBsAg Follow-Up||0
3329165|NCT03285295|4062103|FG002|STARTED|Alinity s HBsAg Follow-Up||0
3329166|NCT03285295|4062104|FG003|STARTED|Alinity s HBsAg Follow-Up||0
3329167|NCT03285295|4062105|FG004|STARTED|Alinity s HBsAg Follow-Up||0
3329168|NCT03285295|4062101|FG000|COMPLETED|Alinity s HBsAg Follow-Up||0
3329169|NCT03285295|4062102|FG001|COMPLETED|Alinity s HBsAg Follow-Up||0
3329170|NCT03285295|4062103|FG002|COMPLETED|Alinity s HBsAg Follow-Up||0
3329171|NCT03285295|4062104|FG003|COMPLETED|Alinity s HBsAg Follow-Up||0
3329172|NCT03285295|4062105|FG004|COMPLETED|Alinity s HBsAg Follow-Up||0
3329173|NCT03285295|4062101|FG000|NOT COMPLETED|Alinity s HBsAg Follow-Up||0
3329174|NCT03285295|4062102|FG001|NOT COMPLETED|Alinity s HBsAg Follow-Up||0
3329175|NCT03285295|4062103|FG002|NOT COMPLETED|Alinity s HBsAg Follow-Up||0
3329176|NCT03285295|4062104|FG003|NOT COMPLETED|Alinity s HBsAg Follow-Up||0
3176485|NCT01966900|3904352|FG001|NOT COMPLETED|Overall Study||0
3176486|NCT01966926|3904360|FG000|STARTED|Overall Study||15
3176487|NCT01966926|3904361|FG001|STARTED|Overall Study||15
3176488|NCT01966926|3904360|FG000|COMPLETED|Overall Study||15
3176489|NCT01966926|3904361|FG001|COMPLETED|Overall Study||15
3176490|NCT01966926|3904360|FG000|NOT COMPLETED|Overall Study||0
3176491|NCT01966926|3904361|FG001|NOT COMPLETED|Overall Study||0
3176492|NCT01966978|3904369|FG000|STARTED|Overall Study||61
3176493|NCT01966978|3904370|FG001|STARTED|Overall Study||59
3176494|NCT01966978|3904369|FG000|COMPLETED|Overall Study||44
3176495|NCT01966978|3904370|FG001|COMPLETED|Overall Study||46
3329177|NCT03285295|4062105|FG004|NOT COMPLETED|Alinity s HBsAg Follow-Up||0
3329178|NCT03285295|4062101|FG000|STARTED|Alinity s HTLV I/II||15968
3329179|NCT03285295|4062102|FG001|STARTED|Alinity s HTLV I/II||706
3329180|NCT03285295|4062103|FG002|STARTED|Alinity s HTLV I/II||502
3329181|NCT03285295|4062104|FG003|STARTED|Alinity s HTLV I/II||509
3329182|NCT03285295|4062105|FG004|STARTED|Alinity s HTLV I/II||0
3329183|NCT03285295|4062101|FG000|COMPLETED|Alinity s HTLV I/II||15877
3329184|NCT03285295|4062102|FG001|COMPLETED|Alinity s HTLV I/II||706
3329185|NCT03285295|4062103|FG002|COMPLETED|Alinity s HTLV I/II||502
3329186|NCT03285295|4062104|FG003|COMPLETED|Alinity s HTLV I/II||509
3329187|NCT03285295|4062105|FG004|COMPLETED|Alinity s HTLV I/II||0
3329188|NCT03285295|4062101|FG000|NOT COMPLETED|Alinity s HTLV I/II||91
3329189|NCT03285295|4062102|FG001|NOT COMPLETED|Alinity s HTLV I/II||0
3329190|NCT03285295|4062103|FG002|NOT COMPLETED|Alinity s HTLV I/II||0
3329191|NCT03285295|4062104|FG003|NOT COMPLETED|Alinity s HTLV I/II||0
3329192|NCT03285295|4062105|FG004|NOT COMPLETED|Alinity s HTLV I/II||0
3329193|NCT03285295|4062101|FG000|STARTED|Alinity s HTLV I/II Follow-Up||12
3329194|NCT03285295|4062102|FG001|STARTED|Alinity s HTLV I/II Follow-Up||0
3329195|NCT03285295|4062103|FG002|STARTED|Alinity s HTLV I/II Follow-Up||0
3329196|NCT03285295|4062104|FG003|STARTED|Alinity s HTLV I/II Follow-Up||0
3329197|NCT03285295|4062105|FG004|STARTED|Alinity s HTLV I/II Follow-Up||0
3329198|NCT03285295|4062101|FG000|COMPLETED|Alinity s HTLV I/II Follow-Up||8
3329199|NCT03285295|4062102|FG001|COMPLETED|Alinity s HTLV I/II Follow-Up||0
3329200|NCT03285295|4062103|FG002|COMPLETED|Alinity s HTLV I/II Follow-Up||0
3329201|NCT03285295|4062104|FG003|COMPLETED|Alinity s HTLV I/II Follow-Up||0
3329202|NCT03285295|4062105|FG004|COMPLETED|Alinity s HTLV I/II Follow-Up||0
3329203|NCT03285295|4062101|FG000|NOT COMPLETED|Alinity s HTLV I/II Follow-Up||4
3329204|NCT03285295|4062102|FG001|NOT COMPLETED|Alinity s HTLV I/II Follow-Up||0
3329205|NCT03285295|4062103|FG002|NOT COMPLETED|Alinity s HTLV I/II Follow-Up||0
3329206|NCT03285295|4062104|FG003|NOT COMPLETED|Alinity s HTLV I/II Follow-Up||0
3329207|NCT03285295|4062105|FG004|NOT COMPLETED|Alinity s HTLV I/II Follow-Up||0
3329208|NCT03285295|4062101|FG000|STARTED|Alinity s Anti-HCV||17095
3329209|NCT03285295|4062102|FG001|STARTED|Alinity s Anti-HCV||402
3329210|NCT03285295|4062103|FG002|STARTED|Alinity s Anti-HCV||407
3329211|NCT03285295|4062104|FG003|STARTED|Alinity s Anti-HCV||0
3329212|NCT03285295|4062105|FG004|STARTED|Alinity s Anti-HCV||0
3329213|NCT03285295|4062101|FG000|COMPLETED|Alinity s Anti-HCV||16999
3329214|NCT03285295|4062102|FG001|COMPLETED|Alinity s Anti-HCV||402
3329215|NCT03285295|4062103|FG002|COMPLETED|Alinity s Anti-HCV||407
3329216|NCT03285295|4062104|FG003|COMPLETED|Alinity s Anti-HCV||0
3329217|NCT03285295|4062105|FG004|COMPLETED|Alinity s Anti-HCV||0
3329218|NCT03285295|4062101|FG000|NOT COMPLETED|Alinity s Anti-HCV||96
3329219|NCT03285295|4062102|FG001|NOT COMPLETED|Alinity s Anti-HCV||0
3329220|NCT03285295|4062103|FG002|NOT COMPLETED|Alinity s Anti-HCV||0
3329221|NCT03285295|4062104|FG003|NOT COMPLETED|Alinity s Anti-HCV||0
3329222|NCT03285295|4062105|FG004|NOT COMPLETED|Alinity s Anti-HCV||0
3176496|NCT01966978|3904369|FG000|NOT COMPLETED|Overall Study||17
3176497|NCT01966978|3904370|FG001|NOT COMPLETED|Overall Study||13
3329223|NCT03285295|4062101|FG000|STARTED|Alinity s Anti-HCV Follow-Up||20
3329224|NCT03285295|4062102|FG001|STARTED|Alinity s Anti-HCV Follow-Up||0
3329225|NCT03285295|4062103|FG002|STARTED|Alinity s Anti-HCV Follow-Up||0
3329226|NCT03285295|4062104|FG003|STARTED|Alinity s Anti-HCV Follow-Up||0
3329227|NCT03285295|4062105|FG004|STARTED|Alinity s Anti-HCV Follow-Up||0
3329228|NCT03285295|4062101|FG000|COMPLETED|Alinity s Anti-HCV Follow-Up||2
3329229|NCT03285295|4062102|FG001|COMPLETED|Alinity s Anti-HCV Follow-Up||0
3329230|NCT03285295|4062103|FG002|COMPLETED|Alinity s Anti-HCV Follow-Up||0
3329231|NCT03285295|4062104|FG003|COMPLETED|Alinity s Anti-HCV Follow-Up||0
3329232|NCT03285295|4062105|FG004|COMPLETED|Alinity s Anti-HCV Follow-Up||0
3329233|NCT03285295|4062101|FG000|NOT COMPLETED|Alinity s Anti-HCV Follow-Up||18
3329234|NCT03285295|4062102|FG001|NOT COMPLETED|Alinity s Anti-HCV Follow-Up||0
3329235|NCT03285295|4062103|FG002|NOT COMPLETED|Alinity s Anti-HCV Follow-Up||0
3329236|NCT03285295|4062104|FG003|NOT COMPLETED|Alinity s Anti-HCV Follow-Up||0
3329237|NCT03285295|4062105|FG004|NOT COMPLETED|Alinity s Anti-HCV Follow-Up||0
3329238|NCT03285295|4062101|FG000|STARTED|Alinity s HIV Ag/Ab Combo||17095
3329239|NCT03285295|4062102|FG001|STARTED|Alinity s HIV Ag/Ab Combo||1336
3329240|NCT03285295|4062103|FG002|STARTED|Alinity s HIV Ag/Ab Combo||605
3329241|NCT03285295|4062104|FG003|STARTED|Alinity s HIV Ag/Ab Combo|Individuals at Increased Risk of HIV Infection from HIV-2 Endemic Areas|535
3329242|NCT03285295|4062105|FG004|STARTED|Alinity s HIV Ag/Ab Combo||0
3329243|NCT03285295|4062101|FG000|COMPLETED|Alinity s HIV Ag/Ab Combo||16996
3329244|NCT03285295|4062102|FG001|COMPLETED|Alinity s HIV Ag/Ab Combo||1336
3329245|NCT03285295|4062103|FG002|COMPLETED|Alinity s HIV Ag/Ab Combo||605
3329246|NCT03285295|4062104|FG003|COMPLETED|Alinity s HIV Ag/Ab Combo|Individuals at Increased Risk of HIV Infection from HIV-2 Endemic Areas|535
3329247|NCT03285295|4062105|FG004|COMPLETED|Alinity s HIV Ag/Ab Combo||0
3329248|NCT03285295|4062101|FG000|NOT COMPLETED|Alinity s HIV Ag/Ab Combo||99
3329249|NCT03285295|4062102|FG001|NOT COMPLETED|Alinity s HIV Ag/Ab Combo||0
3329250|NCT03285295|4062103|FG002|NOT COMPLETED|Alinity s HIV Ag/Ab Combo||0
3329251|NCT03285295|4062104|FG003|NOT COMPLETED|Alinity s HIV Ag/Ab Combo||0
3329252|NCT03285295|4062105|FG004|NOT COMPLETED|Alinity s HIV Ag/Ab Combo||0
3329253|NCT03285295|4062101|FG000|STARTED|Alinity s HIV Ag/Ab Combo Follow-Up||15
3329254|NCT03285295|4062102|FG001|STARTED|Alinity s HIV Ag/Ab Combo Follow-Up||0
3329255|NCT03285295|4062103|FG002|STARTED|Alinity s HIV Ag/Ab Combo Follow-Up||0
3329256|NCT03285295|4062104|FG003|STARTED|Alinity s HIV Ag/Ab Combo Follow-Up||0
3329257|NCT03285295|4062105|FG004|STARTED|Alinity s HIV Ag/Ab Combo Follow-Up||0
3329258|NCT03285295|4062101|FG000|COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||4
3329259|NCT03285295|4062102|FG001|COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0
3329260|NCT03285295|4062103|FG002|COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0
3329261|NCT03285295|4062104|FG003|COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0
3329262|NCT03285295|4062105|FG004|COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0
3329263|NCT03285295|4062101|FG000|NOT COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||11
3329264|NCT03285295|4062102|FG001|NOT COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0
3329265|NCT03285295|4062103|FG002|NOT COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0
3329266|NCT03285295|4062104|FG003|NOT COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0
3329267|NCT03285295|4062105|FG004|NOT COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0
3329268|NCT03285295|4062101|FG000|STARTED|Alinity s Anti-HBc||15968
3329269|NCT03285295|4062102|FG001|STARTED|Alinity s Anti-HBc||405
3329270|NCT03285295|4062103|FG002|STARTED|Alinity s Anti-HBc||403
3329271|NCT03285295|4062104|FG003|STARTED|Alinity s Anti-HBc||0
3329272|NCT03285295|4062105|FG004|STARTED|Alinity s Anti-HBc||0
3329273|NCT03285295|4062101|FG000|COMPLETED|Alinity s Anti-HBc||15877
3329274|NCT03285295|4062102|FG001|COMPLETED|Alinity s Anti-HBc||404
3329275|NCT03285295|4062103|FG002|COMPLETED|Alinity s Anti-HBc||403
3329276|NCT03285295|4062104|FG003|COMPLETED|Alinity s Anti-HBc||0
3329277|NCT03285295|4062105|FG004|COMPLETED|Alinity s Anti-HBc||0
3329278|NCT03285295|4062101|FG000|NOT COMPLETED|Alinity s Anti-HBc||91
3329279|NCT03285295|4062102|FG001|NOT COMPLETED|Alinity s Anti-HBc||1
3329280|NCT03285295|4062103|FG002|NOT COMPLETED|Alinity s Anti-HBc||0
3329281|NCT03285295|4062104|FG003|NOT COMPLETED|Alinity s Anti-HBc||0
3329282|NCT03285295|4062105|FG004|NOT COMPLETED|Alinity s Anti-HBc||0
3329283|NCT03285295|4062101|FG000|STARTED|Alinity s Anti-HBc Follow-Up||16
3329284|NCT03285295|4062102|FG001|STARTED|Alinity s Anti-HBc Follow-Up||0
3329285|NCT03285295|4062103|FG002|STARTED|Alinity s Anti-HBc Follow-Up||0
3329286|NCT03285295|4062104|FG003|STARTED|Alinity s Anti-HBc Follow-Up||0
3329287|NCT03285295|4062105|FG004|STARTED|Alinity s Anti-HBc Follow-Up||0
3329288|NCT03285295|4062101|FG000|COMPLETED|Alinity s Anti-HBc Follow-Up||2
3329289|NCT03285295|4062102|FG001|COMPLETED|Alinity s Anti-HBc Follow-Up||0
3329290|NCT03285295|4062103|FG002|COMPLETED|Alinity s Anti-HBc Follow-Up||0
3329291|NCT03285295|4062104|FG003|COMPLETED|Alinity s Anti-HBc Follow-Up||0
3329292|NCT03285295|4062105|FG004|COMPLETED|Alinity s Anti-HBc Follow-Up||0
3329293|NCT03285295|4062101|FG000|NOT COMPLETED|Alinity s Anti-HBc Follow-Up||14
3329294|NCT03285295|4062102|FG001|NOT COMPLETED|Alinity s Anti-HBc Follow-Up||0
3329295|NCT03285295|4062103|FG002|NOT COMPLETED|Alinity s Anti-HBc Follow-Up||0
3329296|NCT03285295|4062104|FG003|NOT COMPLETED|Alinity s Anti-HBc Follow-Up||0
3329297|NCT03285295|4062105|FG004|NOT COMPLETED|Alinity s Anti-HBc Follow-Up||0
3329298|NCT03285295|4062101|FG000|STARTED|Alinity s Chagas||16023
3329299|NCT03285295|4062102|FG001|STARTED|Alinity s Chagas||320
3329300|NCT03285295|4062103|FG002|STARTED|Alinity s Chagas||0
3329301|NCT03285295|4062104|FG003|STARTED|Alinity s Chagas||615
3329302|NCT03285295|4062105|FG004|STARTED|Alinity s Chagas||0
3329303|NCT03285295|4062101|FG000|COMPLETED|Alinity s Chagas||15804
3329304|NCT03285295|4062102|FG001|COMPLETED|Alinity s Chagas||320
3329305|NCT03285295|4062103|FG002|COMPLETED|Alinity s Chagas||0
3329306|NCT03285295|4062104|FG003|COMPLETED|Alinity s Chagas||615
3329307|NCT03285295|4062105|FG004|COMPLETED|Alinity s Chagas||0
3329308|NCT03285295|4062101|FG000|NOT COMPLETED|Alinity s Chagas||219
3329309|NCT03285295|4062102|FG001|NOT COMPLETED|Alinity s Chagas||0
3329310|NCT03285295|4062103|FG002|NOT COMPLETED|Alinity s Chagas||0
3329311|NCT03285295|4062104|FG003|NOT COMPLETED|Alinity s Chagas||0
3329312|NCT03285295|4062105|FG004|NOT COMPLETED|Alinity s Chagas||0
3329313|NCT03285295|4062101|FG000|STARTED|Alinity s Chagas Follow-Up||14
3329314|NCT03285295|4062102|FG001|STARTED|Alinity s Chagas Follow-Up||0
3329315|NCT03285295|4062103|FG002|STARTED|Alinity s Chagas Follow-Up||0
3329316|NCT03285295|4062104|FG003|STARTED|Alinity s Chagas Follow-Up||0
3329317|NCT03285295|4062105|FG004|STARTED|Alinity s Chagas Follow-Up||0
3329318|NCT03285295|4062101|FG000|COMPLETED|Alinity s Chagas Follow-Up||1
3329319|NCT03285295|4062102|FG001|COMPLETED|Alinity s Chagas Follow-Up||0
3329320|NCT03285295|4062103|FG002|COMPLETED|Alinity s Chagas Follow-Up||0
3329321|NCT03285295|4062104|FG003|COMPLETED|Alinity s Chagas Follow-Up||0
3329322|NCT03285295|4062105|FG004|COMPLETED|Alinity s Chagas Follow-Up||0
3329323|NCT03285295|4062101|FG000|NOT COMPLETED|Alinity s Chagas Follow-Up||13
3329324|NCT03285295|4062102|FG001|NOT COMPLETED|Alinity s Chagas Follow-Up||0
3329325|NCT03285295|4062103|FG002|NOT COMPLETED|Alinity s Chagas Follow-Up||0
3329326|NCT03285295|4062104|FG003|NOT COMPLETED|Alinity s Chagas Follow-Up||0
3329327|NCT03285295|4062105|FG004|NOT COMPLETED|Alinity s Chagas Follow-Up||0
3329328|NCT03285308|4062136|FG000|STARTED|Overall Study||167
3329329|NCT03285308|4062137|FG001|STARTED|Overall Study||169
3329330|NCT03285308|4062136|FG000|Safety Population|Overall Study||163
3329331|NCT03285308|4062137|FG001|Safety Population|Overall Study||163
3329332|NCT03285308|4062136|FG000|COMPLETED|Overall Study||147
3329333|NCT03285308|4062137|FG001|COMPLETED|Overall Study||146
3329334|NCT03285308|4062136|FG000|NOT COMPLETED|Overall Study||20
3329335|NCT03285308|4062137|FG001|NOT COMPLETED|Overall Study||23
3176498|NCT01967069|3904378|FG000|STARTED|Overall Study||182
3176499|NCT01967069|3904379|FG001|STARTED|Overall Study||95
3176500|NCT01967069|3904378|FG000|COMPLETED|Overall Study||174
3329336|NCT03285373|4062144|FG000|STARTED|Overall Study||314
3329337|NCT03285373|4062145|FG001|STARTED|Overall Study||253
3329338|NCT03285373|4062146|FG002|STARTED|Overall Study||266
3329339|NCT03285373|4062147|FG003|STARTED|Overall Study||130
3329340|NCT03285373|4062144|FG000|COMPLETED|Overall Study||314
3329341|NCT03285373|4062145|FG001|COMPLETED|Overall Study||253
3329342|NCT03285373|4062146|FG002|COMPLETED|Overall Study||266
3329343|NCT03285373|4062147|FG003|COMPLETED|Overall Study||130
3329344|NCT03285373|4062144|FG000|NOT COMPLETED|Overall Study||0
3329345|NCT03285373|4062145|FG001|NOT COMPLETED|Overall Study||0
3329346|NCT03285373|4062146|FG002|NOT COMPLETED|Overall Study||0
3329347|NCT03285373|4062147|FG003|NOT COMPLETED|Overall Study||0
3329348|NCT03285477|4062158|FG000|STARTED|Treatment and Response Assessment Period||176
3329349|NCT03285477|4062159|FG001|STARTED|Treatment and Response Assessment Period||175
3329350|NCT03285477|4062158|FG000|COMPLETED|Treatment and Response Assessment Period||174
3329351|NCT03285477|4062159|FG001|COMPLETED|Treatment and Response Assessment Period||175
3329352|NCT03285477|4062158|FG000|NOT COMPLETED|Treatment and Response Assessment Period||2
3329353|NCT03285477|4062159|FG001|NOT COMPLETED|Treatment and Response Assessment Period||0
3329354|NCT03285477|4062158|FG000|STARTED|Recurrence Follow-up Period||8
3329355|NCT03285477|4062159|FG001|STARTED|Recurrence Follow-up Period||77
3329356|NCT03285477|4062158|FG000|COMPLETED|Recurrence Follow-up Period||2
3329357|NCT03285477|4062159|FG001|COMPLETED|Recurrence Follow-up Period||22
3329358|NCT03285477|4062158|FG000|NOT COMPLETED|Recurrence Follow-up Period||6
3329359|NCT03285477|4062159|FG001|NOT COMPLETED|Recurrence Follow-up Period||55
3329360|NCT03285490|4062168|FG000|STARTED|Treatment and Response Assessment Period||173
3329361|NCT03285490|4062169|FG001|STARTED|Treatment and Response Assessment Period||178
3329362|NCT03285490|4062168|FG000|COMPLETED|Treatment and Response Assessment Period||173
3176501|NCT01967069|3904379|FG001|COMPLETED|Overall Study||87
3176502|NCT01967069|3904378|FG000|NOT COMPLETED|Overall Study||8
3176503|NCT01967069|3904379|FG001|NOT COMPLETED|Overall Study||8
3176504|NCT01967121|3904388|FG000|STARTED|Overall Study||25
3176505|NCT01967121|3904389|FG001|STARTED|Overall Study||25
3329363|NCT03285490|4062169|FG001|COMPLETED|Treatment and Response Assessment Period||178
3329364|NCT03285490|4062168|FG000|NOT COMPLETED|Treatment and Response Assessment Period||0
3329365|NCT03285490|4062169|FG001|NOT COMPLETED|Treatment and Response Assessment Period||0
3329366|NCT03285490|4062168|FG000|STARTED|Recurrence Follow-up Period||22
3329367|NCT03285490|4062169|FG001|STARTED|Recurrence Follow-up Period||97
3329368|NCT03285490|4062168|FG000|COMPLETED|Recurrence Follow-up Period||4
3329369|NCT03285490|4062169|FG001|COMPLETED|Recurrence Follow-up Period||36
3329370|NCT03285490|4062168|FG000|NOT COMPLETED|Recurrence Follow-up Period||18
3329371|NCT03285490|4062169|FG001|NOT COMPLETED|Recurrence Follow-up Period||61
3329372|NCT03285529|4062178|FG000|STARTED|Overall Study||30
3329373|NCT03285529|4062179|FG001|STARTED|Overall Study||30
3329374|NCT03285529|4062178|FG000|COMPLETED|Overall Study||30
3329375|NCT03285529|4062179|FG001|COMPLETED|Overall Study||30
3329376|NCT03285529|4062178|FG000|NOT COMPLETED|Overall Study||0
3329377|NCT03285529|4062179|FG001|NOT COMPLETED|Overall Study||0
3329378|NCT03285542|4062187|FG000|STARTED|Overall Study||30
3329379|NCT03285542|4062188|FG001|STARTED|Overall Study||30
3176506|NCT01967121|3904390|FG002|STARTED|Overall Study||25
3329380|NCT03285542|4062187|FG000|COMPLETED|Overall Study||30
3329381|NCT03285542|4062188|FG001|COMPLETED|Overall Study||30
3329382|NCT03285542|4062187|FG000|NOT COMPLETED|Overall Study||0
3329383|NCT03285542|4062188|FG001|NOT COMPLETED|Overall Study||0
3329384|NCT03285555|4062196|FG000|STARTED|Overall Study||30
3329385|NCT03285555|4062197|FG001|STARTED|Overall Study||30
3329386|NCT03285555|4062196|FG000|COMPLETED|Overall Study||30
3329387|NCT03285555|4062197|FG001|COMPLETED|Overall Study||30
3329388|NCT03285555|4062196|FG000|NOT COMPLETED|Overall Study||0
3329389|NCT03285555|4062197|FG001|NOT COMPLETED|Overall Study||0
3329390|NCT03285594|4062206|FG000|STARTED|Overall Study||144
3329391|NCT03285594|4062207|FG001|STARTED|Overall Study||141
3329392|NCT03285594|4062208|FG002|STARTED|Overall Study||286
3329393|NCT03285594|4062206|FG000|Treated|Overall Study||144
3329394|NCT03285594|4062207|FG001|Treated|Overall Study||141
3329395|NCT03285594|4062208|FG002|Treated|Overall Study||285
3329396|NCT03285594|4062206|FG000|COMPLETED|Overall Study||129
3329397|NCT03285594|4062207|FG001|COMPLETED|Overall Study||130
3329398|NCT03285594|4062208|FG002|COMPLETED|Overall Study||249
3329399|NCT03285594|4062206|FG000|NOT COMPLETED|Overall Study||15
3329400|NCT03285594|4062207|FG001|NOT COMPLETED|Overall Study||11
3329401|NCT03285594|4062208|FG002|NOT COMPLETED|Overall Study||37
3329402|NCT03285646|4062219|FG000|STARTED|Overall Study||32
3329403|NCT03285646|4062220|FG001|STARTED|Overall Study||31
3329404|NCT03285646|4062219|FG000|COMPLETED|Overall Study||19
3329405|NCT03285646|4062220|FG001|COMPLETED|Overall Study||27
3329406|NCT03285646|4062219|FG000|NOT COMPLETED|Overall Study||13
3329407|NCT03285646|4062220|FG001|NOT COMPLETED|Overall Study||4
3329408|NCT03285711|4062229|FG000|STARTED|Blinded Phase (Up to Week 16)||4
3329409|NCT03285711|4062230|FG001|STARTED|Blinded Phase (Up to Week 16)||5
3329410|NCT03285711|4062231|FG002|STARTED|Blinded Phase (Up to Week 16)||0
3329411|NCT03285711|4062232|FG003|STARTED|Blinded Phase (Up to Week 16)||0
3329412|NCT03285711|4062229|FG000|COMPLETED|Blinded Phase (Up to Week 16)||1
3329413|NCT03285711|4062230|FG001|COMPLETED|Blinded Phase (Up to Week 16)||4
3329414|NCT03285711|4062231|FG002|COMPLETED|Blinded Phase (Up to Week 16)||0
3329415|NCT03285711|4062232|FG003|COMPLETED|Blinded Phase (Up to Week 16)||0
3329416|NCT03285711|4062229|FG000|NOT COMPLETED|Blinded Phase (Up to Week 16)||3
3329417|NCT03285711|4062230|FG001|NOT COMPLETED|Blinded Phase (Up to Week 16)||1
3329418|NCT03285711|4062231|FG002|NOT COMPLETED|Blinded Phase (Up to Week 16)||0
3329419|NCT03285711|4062232|FG003|NOT COMPLETED|Blinded Phase (Up to Week 16)||0
3329420|NCT03285711|4062229|FG000|STARTED|Blinded Phase (Week 16 to 32)|1 participant switched treatment to filgotinib.|0
3329421|NCT03285711|4062230|FG001|STARTED|Blinded Phase (Week 16 to 32)|1 participant switched treatment to lanraplenib.|3
3329422|NCT03285711|4062231|FG002|STARTED|Blinded Phase (Week 16 to 32)|1 participant switched treatment from lanraplenib.|1
3329423|NCT03285711|4062232|FG003|STARTED|Blinded Phase (Week 16 to 32)|1 participant switched treatment from filgotinib.|1
3329424|NCT03285711|4062229|FG000|COMPLETED|Blinded Phase (Week 16 to 32)||0
3329425|NCT03285711|4062230|FG001|COMPLETED|Blinded Phase (Week 16 to 32)||3
3329426|NCT03285711|4062231|FG002|COMPLETED|Blinded Phase (Week 16 to 32)||0
3329427|NCT03285711|4062232|FG003|COMPLETED|Blinded Phase (Week 16 to 32)||1
3329428|NCT03285711|4062229|FG000|NOT COMPLETED|Blinded Phase (Week 16 to 32)||0
3329429|NCT03285711|4062230|FG001|NOT COMPLETED|Blinded Phase (Week 16 to 32)||0
3329430|NCT03285711|4062231|FG002|NOT COMPLETED|Blinded Phase (Week 16 to 32)||1
3329431|NCT03285711|4062232|FG003|NOT COMPLETED|Blinded Phase (Week 16 to 32)||0
3329432|NCT03285711|4062229|FG000|STARTED|Extended Blinded Phase (Week 32 to 52)||0
3329433|NCT03285711|4062230|FG001|STARTED|Extended Blinded Phase (Week 32 to 52)||3
3329434|NCT03285711|4062231|FG002|STARTED|Extended Blinded Phase (Week 32 to 52)||0
3329435|NCT03285711|4062232|FG003|STARTED|Extended Blinded Phase (Week 32 to 52)||1
3329436|NCT03285711|4062229|FG000|COMPLETED|Extended Blinded Phase (Week 32 to 52)||0
3329437|NCT03285711|4062230|FG001|COMPLETED|Extended Blinded Phase (Week 32 to 52)||2
3329438|NCT03285711|4062231|FG002|COMPLETED|Extended Blinded Phase (Week 32 to 52)||0
3329439|NCT03285711|4062232|FG003|COMPLETED|Extended Blinded Phase (Week 32 to 52)||1
3329440|NCT03285711|4062229|FG000|NOT COMPLETED|Extended Blinded Phase (Week 32 to 52)||0
3329441|NCT03285711|4062230|FG001|NOT COMPLETED|Extended Blinded Phase (Week 32 to 52)||1
3329442|NCT03285711|4062231|FG002|NOT COMPLETED|Extended Blinded Phase (Week 32 to 52)||0
3329443|NCT03285711|4062232|FG003|NOT COMPLETED|Extended Blinded Phase (Week 32 to 52)||0
3329444|NCT03285724|4062242|FG000|STARTED|Overall Study||1
3329445|NCT03285724|4062242|FG000|COMPLETED|Overall Study||1
3329446|NCT03285724|4062242|FG000|NOT COMPLETED|Overall Study||0
3329447|NCT03285958|4062248|FG000|STARTED|Overall Study||33
3329448|NCT03285958|4062249|FG001|STARTED|Overall Study||24
3329449|NCT03285958|4062248|FG000|COMPLETED|Overall Study||28
3329450|NCT03285958|4062249|FG001|COMPLETED|Overall Study||23
3329451|NCT03285958|4062248|FG000|NOT COMPLETED|Overall Study||5
3329452|NCT03285958|4062249|FG001|NOT COMPLETED|Overall Study||1
3329453|NCT03285984|4062256|FG000|STARTED|Overall Study||56
3329454|NCT03285984|4062256|FG000|Received Test Product 1|Overall Study||56
3329455|NCT03285984|4062256|FG000|Received Test Product 2|Overall Study||56
3329456|NCT03285984|4062256|FG000|Received Test Product 3|Overall Study||56
3329457|NCT03285984|4062256|FG000|Received Test Product 4|Overall Study||56
3329458|NCT03285984|4062256|FG000|COMPLETED|Overall Study||56
3329459|NCT03285984|4062256|FG000|NOT COMPLETED|Overall Study||0
3329460|NCT03286218|4062268|FG000|STARTED|Qualification Phase Period 1||48
3329461|NCT03286218|4062269|FG001|STARTED|Qualification Phase Period 1||48
3329462|NCT03286218|4062270|FG002|STARTED|Qualification Phase Period 1||0
3329463|NCT03286218|4062271|FG003|STARTED|Qualification Phase Period 1||0
3329464|NCT03286218|4062272|FG004|STARTED|Qualification Phase Period 1||0
3329465|NCT03286218|4062273|FG005|STARTED|Qualification Phase Period 1||0
3329466|NCT03286218|4062274|FG006|STARTED|Qualification Phase Period 1||0
3329467|NCT03286218|4062275|FG007|STARTED|Qualification Phase Period 1||0
3329468|NCT03286218|4062276|FG008|STARTED|Qualification Phase Period 1||0
3329469|NCT03286218|4062277|FG009|STARTED|Qualification Phase Period 1||0
3329470|NCT03286218|4062278|FG010|STARTED|Qualification Phase Period 1||0
3329471|NCT03286218|4062279|FG011|STARTED|Qualification Phase Period 1||0
3329472|NCT03286218|4062268|FG000|Received at Least One Dose of Study Drug|Qualification Phase Period 1||47
3329473|NCT03286218|4062269|FG001|Received at Least One Dose of Study Drug|Qualification Phase Period 1||47
3329474|NCT03286218|4062270|FG002|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
3329475|NCT03286218|4062271|FG003|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
3329476|NCT03286218|4062272|FG004|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
3329477|NCT03286218|4062273|FG005|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
3329478|NCT03286218|4062274|FG006|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
3329479|NCT03286218|4062275|FG007|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
3329480|NCT03286218|4062276|FG008|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
3329481|NCT03286218|4062277|FG009|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
3329482|NCT03286218|4062278|FG010|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
3329483|NCT03286218|4062279|FG011|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
3329484|NCT03286218|4062268|FG000|COMPLETED|Qualification Phase Period 1||47
3329485|NCT03286218|4062269|FG001|COMPLETED|Qualification Phase Period 1||47
3329486|NCT03286218|4062270|FG002|COMPLETED|Qualification Phase Period 1||0
3329487|NCT03286218|4062271|FG003|COMPLETED|Qualification Phase Period 1||0
3329488|NCT03286218|4062272|FG004|COMPLETED|Qualification Phase Period 1||0
3329489|NCT03286218|4062273|FG005|COMPLETED|Qualification Phase Period 1||0
3329490|NCT03286218|4062274|FG006|COMPLETED|Qualification Phase Period 1||0
3329491|NCT03286218|4062275|FG007|COMPLETED|Qualification Phase Period 1||0
3329492|NCT03286218|4062276|FG008|COMPLETED|Qualification Phase Period 1||0
3329493|NCT03286218|4062277|FG009|COMPLETED|Qualification Phase Period 1||0
3329494|NCT03286218|4062278|FG010|COMPLETED|Qualification Phase Period 1||0
3329495|NCT03286218|4062279|FG011|COMPLETED|Qualification Phase Period 1||0
3329496|NCT03286218|4062268|FG000|NOT COMPLETED|Qualification Phase Period 1||1
3329497|NCT03286218|4062269|FG001|NOT COMPLETED|Qualification Phase Period 1||1
3329498|NCT03286218|4062270|FG002|NOT COMPLETED|Qualification Phase Period 1||0
3329499|NCT03286218|4062271|FG003|NOT COMPLETED|Qualification Phase Period 1||0
3329500|NCT03286218|4062272|FG004|NOT COMPLETED|Qualification Phase Period 1||0
3329501|NCT03286218|4062273|FG005|NOT COMPLETED|Qualification Phase Period 1||0
3329502|NCT03286218|4062274|FG006|NOT COMPLETED|Qualification Phase Period 1||0
3329503|NCT03286218|4062275|FG007|NOT COMPLETED|Qualification Phase Period 1||0
3329504|NCT03286218|4062276|FG008|NOT COMPLETED|Qualification Phase Period 1||0
3329505|NCT03286218|4062277|FG009|NOT COMPLETED|Qualification Phase Period 1||0
3329506|NCT03286218|4062278|FG010|NOT COMPLETED|Qualification Phase Period 1||0
3329507|NCT03286218|4062279|FG011|NOT COMPLETED|Qualification Phase Period 1||0
3329508|NCT03286218|4062268|FG000|STARTED|Qualification Phase Period 2||47
3329509|NCT03286218|4062269|FG001|STARTED|Qualification Phase Period 2||47
3329510|NCT03286218|4062270|FG002|STARTED|Qualification Phase Period 2||0
3329511|NCT03286218|4062271|FG003|STARTED|Qualification Phase Period 2||0
3329512|NCT03286218|4062272|FG004|STARTED|Qualification Phase Period 2||0
3329513|NCT03286218|4062273|FG005|STARTED|Qualification Phase Period 2||0
3329514|NCT03286218|4062274|FG006|STARTED|Qualification Phase Period 2||0
3329515|NCT03286218|4062275|FG007|STARTED|Qualification Phase Period 2||0
3329516|NCT03286218|4062276|FG008|STARTED|Qualification Phase Period 2||0
3329517|NCT03286218|4062277|FG009|STARTED|Qualification Phase Period 2||0
3329518|NCT03286218|4062278|FG010|STARTED|Qualification Phase Period 2||0
3329519|NCT03286218|4062279|FG011|STARTED|Qualification Phase Period 2||0
3329520|NCT03286218|4062268|FG000|COMPLETED|Qualification Phase Period 2||30
3329521|NCT03286218|4062269|FG001|COMPLETED|Qualification Phase Period 2||28
3329522|NCT03286218|4062270|FG002|COMPLETED|Qualification Phase Period 2||0
3329523|NCT03286218|4062271|FG003|COMPLETED|Qualification Phase Period 2||0
3329524|NCT03286218|4062272|FG004|COMPLETED|Qualification Phase Period 2||0
3329525|NCT03286218|4062273|FG005|COMPLETED|Qualification Phase Period 2||0
3329526|NCT03286218|4062274|FG006|COMPLETED|Qualification Phase Period 2||0
3329527|NCT03286218|4062275|FG007|COMPLETED|Qualification Phase Period 2||0
3329528|NCT03286218|4062276|FG008|COMPLETED|Qualification Phase Period 2||0
3329529|NCT03286218|4062277|FG009|COMPLETED|Qualification Phase Period 2||0
3329530|NCT03286218|4062278|FG010|COMPLETED|Qualification Phase Period 2||0
3329531|NCT03286218|4062279|FG011|COMPLETED|Qualification Phase Period 2||0
3329532|NCT03286218|4062268|FG000|NOT COMPLETED|Qualification Phase Period 2||17
3329533|NCT03286218|4062269|FG001|NOT COMPLETED|Qualification Phase Period 2||19
3329534|NCT03286218|4062270|FG002|NOT COMPLETED|Qualification Phase Period 2||0
3329535|NCT03286218|4062271|FG003|NOT COMPLETED|Qualification Phase Period 2||0
3329536|NCT03286218|4062272|FG004|NOT COMPLETED|Qualification Phase Period 2||0
3329537|NCT03286218|4062273|FG005|NOT COMPLETED|Qualification Phase Period 2||0
3329538|NCT03286218|4062274|FG006|NOT COMPLETED|Qualification Phase Period 2||0
3329539|NCT03286218|4062275|FG007|NOT COMPLETED|Qualification Phase Period 2||0
3329540|NCT03286218|4062276|FG008|NOT COMPLETED|Qualification Phase Period 2||0
3329541|NCT03286218|4062277|FG009|NOT COMPLETED|Qualification Phase Period 2||0
3329542|NCT03286218|4062278|FG010|NOT COMPLETED|Qualification Phase Period 2||0
3329543|NCT03286218|4062279|FG011|NOT COMPLETED|Qualification Phase Period 2||0
3329544|NCT03286218|4062268|FG000|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase prior to entering the Treatment Phase.|0
3329545|NCT03286218|4062269|FG001|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase prior to entering the Treatment Phase.|0
3329546|NCT03286218|4062270|FG002|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|6
3329547|NCT03286218|4062271|FG003|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|6
3329548|NCT03286218|4062272|FG004|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|5
3329549|NCT03286218|4062273|FG005|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|6
3329550|NCT03286218|4062274|FG006|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|6
3329551|NCT03286218|4062275|FG007|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|6
3329552|NCT03286218|4062276|FG008|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|6
3329553|NCT03286218|4062277|FG009|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|6
3329554|NCT03286218|4062278|FG010|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|5
3329555|NCT03286218|4062279|FG011|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|6
3329556|NCT03286218|4062268|FG000|Received at Least One Dose of Study Drug|Treatment Phase Period 1||0
3329557|NCT03286218|4062269|FG001|Received at Least One Dose of Study Drug|Treatment Phase Period 1||0
3329558|NCT03286218|4062270|FG002|Received at Least One Dose of Study Drug|Treatment Phase Period 1||6
3329559|NCT03286218|4062271|FG003|Received at Least One Dose of Study Drug|Treatment Phase Period 1||6
3329560|NCT03286218|4062272|FG004|Received at Least One Dose of Study Drug|Treatment Phase Period 1||5
3329561|NCT03286218|4062273|FG005|Received at Least One Dose of Study Drug|Treatment Phase Period 1||6
3329562|NCT03286218|4062274|FG006|Received at Least One Dose of Study Drug|Treatment Phase Period 1||6
3329563|NCT03286218|4062275|FG007|Received at Least One Dose of Study Drug|Treatment Phase Period 1||6
3329564|NCT03286218|4062276|FG008|Received at Least One Dose of Study Drug|Treatment Phase Period 1||6
3329565|NCT03286218|4062277|FG009|Received at Least One Dose of Study Drug|Treatment Phase Period 1||6
3329566|NCT03286218|4062278|FG010|Received at Least One Dose of Study Drug|Treatment Phase Period 1||5
3329567|NCT03286218|4062279|FG011|Received at Least One Dose of Study Drug|Treatment Phase Period 1||6
3329568|NCT03286218|4062268|FG000|COMPLETED|Treatment Phase Period 1||0
3329569|NCT03286218|4062269|FG001|COMPLETED|Treatment Phase Period 1||0
3329570|NCT03286218|4062270|FG002|COMPLETED|Treatment Phase Period 1||5
3329571|NCT03286218|4062271|FG003|COMPLETED|Treatment Phase Period 1||5
3329572|NCT03286218|4062272|FG004|COMPLETED|Treatment Phase Period 1||5
3329573|NCT03286218|4062273|FG005|COMPLETED|Treatment Phase Period 1||5
3329574|NCT03286218|4062274|FG006|COMPLETED|Treatment Phase Period 1||6
3329575|NCT03286218|4062275|FG007|COMPLETED|Treatment Phase Period 1||6
3329576|NCT03286218|4062276|FG008|COMPLETED|Treatment Phase Period 1||6
3329577|NCT03286218|4062277|FG009|COMPLETED|Treatment Phase Period 1||6
3329578|NCT03286218|4062278|FG010|COMPLETED|Treatment Phase Period 1||5
3329579|NCT03286218|4062279|FG011|COMPLETED|Treatment Phase Period 1||5
3039791|NCT01160614|3759243|FG000|NOT COMPLETED|Overall Study||0
3039792|NCT01160614|3759244|FG001|NOT COMPLETED|Overall Study||2
3039793|NCT01160640|3759270|FG000|STARTED|Overall Study||117
3039794|NCT01160640|3759271|FG001|STARTED|Overall Study||116
3039795|NCT01160640|3759270|FG000|COMPLETED|Overall Study||113
3039796|NCT01160640|3759271|FG001|COMPLETED|Overall Study||110
3039797|NCT01160640|3759270|FG000|NOT COMPLETED|Overall Study||4
3039798|NCT01160640|3759271|FG001|NOT COMPLETED|Overall Study||6
3039799|NCT01160744|3759283|FG000|STARTED|Overall Study||71
3329580|NCT03286218|4062268|FG000|NOT COMPLETED|Treatment Phase Period 1||0
3329581|NCT03286218|4062269|FG001|NOT COMPLETED|Treatment Phase Period 1||0
3329582|NCT03286218|4062270|FG002|NOT COMPLETED|Treatment Phase Period 1||1
3329583|NCT03286218|4062271|FG003|NOT COMPLETED|Treatment Phase Period 1||1
3329584|NCT03286218|4062272|FG004|NOT COMPLETED|Treatment Phase Period 1||0
3329585|NCT03286218|4062273|FG005|NOT COMPLETED|Treatment Phase Period 1||1
3329586|NCT03286218|4062274|FG006|NOT COMPLETED|Treatment Phase Period 1||0
3329587|NCT03286218|4062275|FG007|NOT COMPLETED|Treatment Phase Period 1||0
3329588|NCT03286218|4062276|FG008|NOT COMPLETED|Treatment Phase Period 1||0
3329589|NCT03286218|4062277|FG009|NOT COMPLETED|Treatment Phase Period 1||0
3329590|NCT03286218|4062278|FG010|NOT COMPLETED|Treatment Phase Period 1||0
3329591|NCT03286218|4062279|FG011|NOT COMPLETED|Treatment Phase Period 1||1
3329592|NCT03286218|4062268|FG000|STARTED|Treatment Phase Period 2||0
3329593|NCT03286218|4062269|FG001|STARTED|Treatment Phase Period 2||0
3329594|NCT03286218|4062270|FG002|STARTED|Treatment Phase Period 2||5
3329595|NCT03286218|4062271|FG003|STARTED|Treatment Phase Period 2||5
3329596|NCT03286218|4062272|FG004|STARTED|Treatment Phase Period 2||5
3329597|NCT03286218|4062273|FG005|STARTED|Treatment Phase Period 2||5
3329598|NCT03286218|4062274|FG006|STARTED|Treatment Phase Period 2||6
3329599|NCT03286218|4062275|FG007|STARTED|Treatment Phase Period 2||6
3329600|NCT03286218|4062276|FG008|STARTED|Treatment Phase Period 2||6
3329601|NCT03286218|4062277|FG009|STARTED|Treatment Phase Period 2||6
3329602|NCT03286218|4062278|FG010|STARTED|Treatment Phase Period 2||5
3329603|NCT03286218|4062279|FG011|STARTED|Treatment Phase Period 2||5
3329604|NCT03286218|4062268|FG000|COMPLETED|Treatment Phase Period 2||0
3329605|NCT03286218|4062269|FG001|COMPLETED|Treatment Phase Period 2||0
3329606|NCT03286218|4062270|FG002|COMPLETED|Treatment Phase Period 2||5
3329607|NCT03286218|4062271|FG003|COMPLETED|Treatment Phase Period 2||5
3329608|NCT03286218|4062272|FG004|COMPLETED|Treatment Phase Period 2||5
3329609|NCT03286218|4062273|FG005|COMPLETED|Treatment Phase Period 2||5
3329610|NCT03286218|4062274|FG006|COMPLETED|Treatment Phase Period 2||6
3329611|NCT03286218|4062275|FG007|COMPLETED|Treatment Phase Period 2||6
3329612|NCT03286218|4062276|FG008|COMPLETED|Treatment Phase Period 2||6
3329613|NCT03286218|4062277|FG009|COMPLETED|Treatment Phase Period 2||6
3329614|NCT03286218|4062278|FG010|COMPLETED|Treatment Phase Period 2||5
3329615|NCT03286218|4062279|FG011|COMPLETED|Treatment Phase Period 2||5
3329616|NCT03286218|4062268|FG000|NOT COMPLETED|Treatment Phase Period 2||0
3329617|NCT03286218|4062269|FG001|NOT COMPLETED|Treatment Phase Period 2||0
3329618|NCT03286218|4062270|FG002|NOT COMPLETED|Treatment Phase Period 2||0
3329619|NCT03286218|4062271|FG003|NOT COMPLETED|Treatment Phase Period 2||0
3329620|NCT03286218|4062272|FG004|NOT COMPLETED|Treatment Phase Period 2||0
3329621|NCT03286218|4062273|FG005|NOT COMPLETED|Treatment Phase Period 2||0
3329622|NCT03286218|4062274|FG006|NOT COMPLETED|Treatment Phase Period 2||0
3329623|NCT03286218|4062275|FG007|NOT COMPLETED|Treatment Phase Period 2||0
3329624|NCT03286218|4062276|FG008|NOT COMPLETED|Treatment Phase Period 2||0
3329625|NCT03286218|4062277|FG009|NOT COMPLETED|Treatment Phase Period 2||0
3329626|NCT03286218|4062278|FG010|NOT COMPLETED|Treatment Phase Period 2||0
3329627|NCT03286218|4062279|FG011|NOT COMPLETED|Treatment Phase Period 2||0
3329628|NCT03286218|4062268|FG000|STARTED|Treatment Phase Period 3||0
3329629|NCT03286218|4062269|FG001|STARTED|Treatment Phase Period 3||0
3329630|NCT03286218|4062270|FG002|STARTED|Treatment Phase Period 3||5
3329631|NCT03286218|4062271|FG003|STARTED|Treatment Phase Period 3||5
3329632|NCT03286218|4062272|FG004|STARTED|Treatment Phase Period 3||5
3329633|NCT03286218|4062273|FG005|STARTED|Treatment Phase Period 3||5
3329634|NCT03286218|4062274|FG006|STARTED|Treatment Phase Period 3||6
3329635|NCT03286218|4062275|FG007|STARTED|Treatment Phase Period 3||6
3329636|NCT03286218|4062276|FG008|STARTED|Treatment Phase Period 3||6
3329637|NCT03286218|4062277|FG009|STARTED|Treatment Phase Period 3||6
3329638|NCT03286218|4062278|FG010|STARTED|Treatment Phase Period 3||5
3329639|NCT03286218|4062279|FG011|STARTED|Treatment Phase Period 3||5
3329640|NCT03286218|4062268|FG000|COMPLETED|Treatment Phase Period 3||0
3329641|NCT03286218|4062269|FG001|COMPLETED|Treatment Phase Period 3||0
3329642|NCT03286218|4062270|FG002|COMPLETED|Treatment Phase Period 3||5
3329643|NCT03286218|4062271|FG003|COMPLETED|Treatment Phase Period 3||5
3329644|NCT03286218|4062272|FG004|COMPLETED|Treatment Phase Period 3||5
3329645|NCT03286218|4062273|FG005|COMPLETED|Treatment Phase Period 3||5
3329646|NCT03286218|4062274|FG006|COMPLETED|Treatment Phase Period 3||6
3329647|NCT03286218|4062275|FG007|COMPLETED|Treatment Phase Period 3||6
3329648|NCT03286218|4062276|FG008|COMPLETED|Treatment Phase Period 3||6
3329649|NCT03286218|4062277|FG009|COMPLETED|Treatment Phase Period 3||6
3329650|NCT03286218|4062278|FG010|COMPLETED|Treatment Phase Period 3||5
3329651|NCT03286218|4062279|FG011|COMPLETED|Treatment Phase Period 3||5
3329652|NCT03286218|4062268|FG000|NOT COMPLETED|Treatment Phase Period 3||0
3329653|NCT03286218|4062269|FG001|NOT COMPLETED|Treatment Phase Period 3||0
3329654|NCT03286218|4062270|FG002|NOT COMPLETED|Treatment Phase Period 3||0
3329655|NCT03286218|4062271|FG003|NOT COMPLETED|Treatment Phase Period 3||0
3329656|NCT03286218|4062272|FG004|NOT COMPLETED|Treatment Phase Period 3||0
3329657|NCT03286218|4062273|FG005|NOT COMPLETED|Treatment Phase Period 3||0
3329658|NCT03286218|4062274|FG006|NOT COMPLETED|Treatment Phase Period 3||0
3329659|NCT03286218|4062275|FG007|NOT COMPLETED|Treatment Phase Period 3||0
3329660|NCT03286218|4062276|FG008|NOT COMPLETED|Treatment Phase Period 3||0
3329661|NCT03286218|4062277|FG009|NOT COMPLETED|Treatment Phase Period 3||0
3329662|NCT03286218|4062278|FG010|NOT COMPLETED|Treatment Phase Period 3||0
3329663|NCT03286218|4062279|FG011|NOT COMPLETED|Treatment Phase Period 3||0
3329664|NCT03286218|4062268|FG000|STARTED|Treatment Phase Period 4||0
3329665|NCT03286218|4062269|FG001|STARTED|Treatment Phase Period 4||0
3329666|NCT03286218|4062270|FG002|STARTED|Treatment Phase Period 4||5
3329667|NCT03286218|4062271|FG003|STARTED|Treatment Phase Period 4||5
3329668|NCT03286218|4062272|FG004|STARTED|Treatment Phase Period 4||5
3329669|NCT03286218|4062273|FG005|STARTED|Treatment Phase Period 4||5
3329670|NCT03286218|4062274|FG006|STARTED|Treatment Phase Period 4||6
3329671|NCT03286218|4062275|FG007|STARTED|Treatment Phase Period 4||6
3329672|NCT03286218|4062276|FG008|STARTED|Treatment Phase Period 4||6
3329673|NCT03286218|4062277|FG009|STARTED|Treatment Phase Period 4||6
3329674|NCT03286218|4062278|FG010|STARTED|Treatment Phase Period 4||5
3329675|NCT03286218|4062279|FG011|STARTED|Treatment Phase Period 4||5
3329676|NCT03286218|4062268|FG000|COMPLETED|Treatment Phase Period 4||0
3329677|NCT03286218|4062269|FG001|COMPLETED|Treatment Phase Period 4||0
3329678|NCT03286218|4062270|FG002|COMPLETED|Treatment Phase Period 4||5
3329679|NCT03286218|4062271|FG003|COMPLETED|Treatment Phase Period 4||5
3329680|NCT03286218|4062272|FG004|COMPLETED|Treatment Phase Period 4||5
3329681|NCT03286218|4062273|FG005|COMPLETED|Treatment Phase Period 4||5
3329682|NCT03286218|4062274|FG006|COMPLETED|Treatment Phase Period 4||6
3329683|NCT03286218|4062275|FG007|COMPLETED|Treatment Phase Period 4||6
3329684|NCT03286218|4062276|FG008|COMPLETED|Treatment Phase Period 4||6
3329685|NCT03286218|4062277|FG009|COMPLETED|Treatment Phase Period 4||6
3329686|NCT03286218|4062278|FG010|COMPLETED|Treatment Phase Period 4||5
3329687|NCT03286218|4062279|FG011|COMPLETED|Treatment Phase Period 4||4
3329688|NCT03286218|4062268|FG000|NOT COMPLETED|Treatment Phase Period 4||0
3329689|NCT03286218|4062269|FG001|NOT COMPLETED|Treatment Phase Period 4||0
3329690|NCT03286218|4062270|FG002|NOT COMPLETED|Treatment Phase Period 4||0
3329691|NCT03286218|4062271|FG003|NOT COMPLETED|Treatment Phase Period 4||0
3329692|NCT03286218|4062272|FG004|NOT COMPLETED|Treatment Phase Period 4||0
3329693|NCT03286218|4062273|FG005|NOT COMPLETED|Treatment Phase Period 4||0
3329694|NCT03286218|4062274|FG006|NOT COMPLETED|Treatment Phase Period 4||0
3329695|NCT03286218|4062275|FG007|NOT COMPLETED|Treatment Phase Period 4||0
3329696|NCT03286218|4062276|FG008|NOT COMPLETED|Treatment Phase Period 4||0
3329697|NCT03286218|4062277|FG009|NOT COMPLETED|Treatment Phase Period 4||0
3329698|NCT03286218|4062278|FG010|NOT COMPLETED|Treatment Phase Period 4||0
3329699|NCT03286218|4062279|FG011|NOT COMPLETED|Treatment Phase Period 4||1
3329700|NCT03286218|4062268|FG000|STARTED|Treatment Phase Period 5||0
3329701|NCT03286218|4062269|FG001|STARTED|Treatment Phase Period 5||0
3329702|NCT03286218|4062270|FG002|STARTED|Treatment Phase Period 5||5
3329703|NCT03286218|4062271|FG003|STARTED|Treatment Phase Period 5||5
3329704|NCT03286218|4062272|FG004|STARTED|Treatment Phase Period 5||5
3329705|NCT03286218|4062273|FG005|STARTED|Treatment Phase Period 5||5
3329706|NCT03286218|4062274|FG006|STARTED|Treatment Phase Period 5||6
3329707|NCT03286218|4062275|FG007|STARTED|Treatment Phase Period 5||6
3329708|NCT03286218|4062276|FG008|STARTED|Treatment Phase Period 5||6
3329709|NCT03286218|4062277|FG009|STARTED|Treatment Phase Period 5||6
3329710|NCT03286218|4062278|FG010|STARTED|Treatment Phase Period 5||5
3329711|NCT03286218|4062279|FG011|STARTED|Treatment Phase Period 5||4
3329712|NCT03286218|4062268|FG000|COMPLETED|Treatment Phase Period 5||0
3176507|NCT01967121|3904388|FG000|COMPLETED|Overall Study||25
3176508|NCT01967121|3904389|FG001|COMPLETED|Overall Study||25
3176509|NCT01967121|3904390|FG002|COMPLETED|Overall Study||25
3176510|NCT01967121|3904388|FG000|NOT COMPLETED|Overall Study||0
3176511|NCT01967121|3904389|FG001|NOT COMPLETED|Overall Study||0
3176512|NCT01967121|3904390|FG002|NOT COMPLETED|Overall Study||0
3329713|NCT03286218|4062269|FG001|COMPLETED|Treatment Phase Period 5||0
3176513|NCT01967134|3904401|FG000|STARTED|Overall Study||8
3176514|NCT01967134|3904402|FG001|STARTED|Overall Study||8
3176515|NCT01967134|3904403|FG002|STARTED|Overall Study||9
3176516|NCT01967134|3904401|FG000|COMPLETED|Overall Study||8
3176517|NCT01967134|3904402|FG001|COMPLETED|Overall Study||7
3176518|NCT01967134|3904403|FG002|COMPLETED|Overall Study||9
3176519|NCT01967134|3904401|FG000|NOT COMPLETED|Overall Study||0
3176520|NCT01967134|3904402|FG001|NOT COMPLETED|Overall Study||1
3176521|NCT01967134|3904403|FG002|NOT COMPLETED|Overall Study||0
3329714|NCT03286218|4062270|FG002|COMPLETED|Treatment Phase Period 5||5
3329715|NCT03286218|4062271|FG003|COMPLETED|Treatment Phase Period 5||5
3329716|NCT03286218|4062272|FG004|COMPLETED|Treatment Phase Period 5||5
3329717|NCT03286218|4062273|FG005|COMPLETED|Treatment Phase Period 5||5
3329718|NCT03286218|4062274|FG006|COMPLETED|Treatment Phase Period 5||6
3329719|NCT03286218|4062275|FG007|COMPLETED|Treatment Phase Period 5||6
3329720|NCT03286218|4062276|FG008|COMPLETED|Treatment Phase Period 5||6
3329721|NCT03286218|4062277|FG009|COMPLETED|Treatment Phase Period 5||6
3329722|NCT03286218|4062278|FG010|COMPLETED|Treatment Phase Period 5||5
3329723|NCT03286218|4062279|FG011|COMPLETED|Treatment Phase Period 5||4
3329724|NCT03286218|4062268|FG000|NOT COMPLETED|Treatment Phase Period 5||0
3329725|NCT03286218|4062269|FG001|NOT COMPLETED|Treatment Phase Period 5||0
3329726|NCT03286218|4062270|FG002|NOT COMPLETED|Treatment Phase Period 5||0
3176522|NCT01967147|3904413|FG000|STARTED|Overall Study||112
3176523|NCT01967147|3904414|FG001|STARTED|Overall Study||102
3176524|NCT01967147|3904413|FG000|COMPLETED|Overall Study||99
3329727|NCT03286218|4062271|FG003|NOT COMPLETED|Treatment Phase Period 5||0
3329728|NCT03286218|4062272|FG004|NOT COMPLETED|Treatment Phase Period 5||0
3329729|NCT03286218|4062273|FG005|NOT COMPLETED|Treatment Phase Period 5||0
3329730|NCT03286218|4062274|FG006|NOT COMPLETED|Treatment Phase Period 5||0
3329731|NCT03286218|4062275|FG007|NOT COMPLETED|Treatment Phase Period 5||0
3329732|NCT03286218|4062276|FG008|NOT COMPLETED|Treatment Phase Period 5||0
3329733|NCT03286218|4062277|FG009|NOT COMPLETED|Treatment Phase Period 5||0
3329734|NCT03286218|4062278|FG010|NOT COMPLETED|Treatment Phase Period 5||0
3329735|NCT03286218|4062279|FG011|NOT COMPLETED|Treatment Phase Period 5||0
3329736|NCT03286283|4062306|FG000|STARTED|Overall Study||55
3329737|NCT03286283|4062306|FG000|COMPLETED|Overall Study||55
3329738|NCT03286283|4062306|FG000|NOT COMPLETED|Overall Study||0
3329739|NCT03286400|4062310|FG000|STARTED|Overall Study||127
3329740|NCT03286400|4062310|FG000|COMPLETED|Overall Study||102
3176525|NCT01967147|3904414|FG001|COMPLETED|Overall Study||82
3176526|NCT01967147|3904413|FG000|NOT COMPLETED|Overall Study||13
3176527|NCT01967147|3904414|FG001|NOT COMPLETED|Overall Study||20
3176528|NCT01967173|3904429|FG000|STARTED|Overall Study||69
3176529|NCT01967173|3904430|FG001|STARTED|Overall Study||69
3176530|NCT01967173|3904431|FG002|STARTED|Overall Study||71
3329741|NCT03286400|4062310|FG000|NOT COMPLETED|Overall Study||25
3329742|NCT03286465|4062316|FG000|STARTED|Overall Study||100
3329743|NCT03286465|4062317|FG001|STARTED|Overall Study||100
3329744|NCT03286465|4062316|FG000|COMPLETED|Overall Study||100
3329745|NCT03286465|4062317|FG001|COMPLETED|Overall Study||100
3329746|NCT03286465|4062316|FG000|NOT COMPLETED|Overall Study||0
3329747|NCT03286465|4062317|FG001|NOT COMPLETED|Overall Study||0
3329748|NCT03286543|4062325|FG000|STARTED|Consented||47
3329749|NCT03286543|4062326|FG001|STARTED|Consented||0
3329750|NCT03286543|4062327|FG002|STARTED|Consented||0
3329751|NCT03286543|4062325|FG000|Randomized|Consented||45
3329752|NCT03286543|4062326|FG001|Randomized|Consented||0
3329753|NCT03286543|4062327|FG002|Randomized|Consented||0
3329754|NCT03286543|4062325|FG000|Enrolled|Consented||41
3329755|NCT03286543|4062326|FG001|Enrolled|Consented||0
3329756|NCT03286543|4062327|FG002|Enrolled|Consented||0
3329757|NCT03286543|4062325|FG000|Intent to Treat Set|Consented||37
3329758|NCT03286543|4062326|FG001|Intent to Treat Set|Consented||0
3329759|NCT03286543|4062327|FG002|Intent to Treat Set|Consented||0
3329760|NCT03286543|4062325|FG000|Per Protocol Set|Consented||23
3329761|NCT03286543|4062326|FG001|Per Protocol Set|Consented||0
3329762|NCT03286543|4062327|FG002|Per Protocol Set|Consented||0
3329763|NCT03286543|4062325|FG000|COMPLETED|Consented||28
3329764|NCT03286543|4062326|FG001|COMPLETED|Consented||0
3329765|NCT03286543|4062327|FG002|COMPLETED|Consented||0
3329766|NCT03286543|4062325|FG000|NOT COMPLETED|Consented||19
3329767|NCT03286543|4062326|FG001|NOT COMPLETED|Consented||0
3329768|NCT03286543|4062327|FG002|NOT COMPLETED|Consented||0
3329769|NCT03286543|4062325|FG000|STARTED|Study Enrollment||0
3329770|NCT03286543|4062326|FG001|STARTED|Study Enrollment||18
3329771|NCT03286543|4062327|FG002|STARTED|Study Enrollment||23
3329772|NCT03286543|4062325|FG000|Intent to Treat Set|Study Enrollment||0
3329773|NCT03286543|4062326|FG001|Intent to Treat Set|Study Enrollment||18
3329774|NCT03286543|4062327|FG002|Intent to Treat Set|Study Enrollment||19
3329775|NCT03286543|4062325|FG000|Per Protocol Set|Study Enrollment||0
3329776|NCT03286543|4062326|FG001|Per Protocol Set|Study Enrollment||7
3329777|NCT03286543|4062327|FG002|Per Protocol Set|Study Enrollment||16
3329778|NCT03286543|4062325|FG000|COMPLETED|Study Enrollment||0
3329779|NCT03286543|4062326|FG001|COMPLETED|Study Enrollment||12
3329780|NCT03286543|4062327|FG002|COMPLETED|Study Enrollment||16
3329781|NCT03286543|4062325|FG000|NOT COMPLETED|Study Enrollment||0
3176531|NCT01967173|3904432|FG003|STARTED|Overall Study||71
3176532|NCT01967173|3904433|FG004|STARTED|Overall Study||73
3176533|NCT01967173|3904434|FG005|STARTED|Overall Study||72
3176534|NCT01967173|3904435|FG006|STARTED|Overall Study||75
3176535|NCT01967173|3904436|FG007|STARTED|Overall Study||74
3176536|NCT01967173|3904429|FG000|Completed 1st Period|Overall Study||58
3176537|NCT01967173|3904430|FG001|Completed 1st Period|Overall Study||60
3176538|NCT01967173|3904431|FG002|Completed 1st Period|Overall Study||67
3176539|NCT01967173|3904432|FG003|Completed 1st Period|Overall Study||65
3176540|NCT01967173|3904433|FG004|Completed 1st Period|Overall Study||64
3176541|NCT01967173|3904434|FG005|Completed 1st Period|Overall Study||62
3176542|NCT01967173|3904435|FG006|Completed 1st Period|Overall Study||67
3176543|NCT01967173|3904436|FG007|Completed 1st Period|Overall Study||69
3176544|NCT01967173|3904429|FG000|Completed 2nd Period|Overall Study||52
3176545|NCT01967173|3904430|FG001|Completed 2nd Period|Overall Study||58
3176546|NCT01967173|3904431|FG002|Completed 2nd Period|Overall Study||63
3176547|NCT01967173|3904432|FG003|Completed 2nd Period|Overall Study||62
3176548|NCT01967173|3904433|FG004|Completed 2nd Period|Overall Study||63
3176549|NCT01967173|3904434|FG005|Completed 2nd Period|Overall Study||57
3329782|NCT03286543|4062326|FG001|NOT COMPLETED|Study Enrollment||6
3329783|NCT03286543|4062327|FG002|NOT COMPLETED|Study Enrollment||7
3329784|NCT03286751|4062333|FG000|STARTED|Period 1||7
3329785|NCT03286751|4062334|FG001|STARTED|Period 1||7
3329786|NCT03286751|4062335|FG002|STARTED|Period 1||7
3329787|NCT03286751|4062336|FG003|STARTED|Period 1||7
3176550|NCT01967173|3904435|FG006|Completed 2nd Period|Overall Study||63
3176551|NCT01967173|3904436|FG007|Completed 2nd Period|Overall Study||61
3329788|NCT03286751|4062337|FG004|STARTED|Period 1||7
3329789|NCT03286751|4062338|FG005|STARTED|Period 1||7
3329790|NCT03286751|4062333|FG000|Received at Least One Dose of Study Drug|Period 1||7
3329791|NCT03286751|4062334|FG001|Received at Least One Dose of Study Drug|Period 1||7
2927766|NCT00574119|3638630|FG000|STARTED|Overall Study||16
3176552|NCT01967173|3904429|FG000|Completed 3rd Period|Overall Study||48
3176553|NCT01967173|3904430|FG001|Completed 3rd Period|Overall Study||54
3176554|NCT01967173|3904431|FG002|Completed 3rd Period|Overall Study||60
3176555|NCT01967173|3904432|FG003|Completed 3rd Period|Overall Study||61
3176556|NCT01967173|3904433|FG004|Completed 3rd Period|Overall Study||59
3176557|NCT01967173|3904434|FG005|Completed 3rd Period|Overall Study||56
3176558|NCT01967173|3904435|FG006|Completed 3rd Period|Overall Study||59
3176559|NCT01967173|3904436|FG007|Completed 3rd Period|Overall Study||56
3176560|NCT01967173|3904429|FG000|Completed 4th Period|Overall Study||45
3176561|NCT01967173|3904430|FG001|Completed 4th Period|Overall Study||52
3176562|NCT01967173|3904431|FG002|Completed 4th Period|Overall Study||55
3176563|NCT01967173|3904432|FG003|Completed 4th Period|Overall Study||57
3176564|NCT01967173|3904433|FG004|Completed 4th Period|Overall Study||56
3176565|NCT01967173|3904434|FG005|Completed 4th Period|Overall Study||49
3176566|NCT01967173|3904435|FG006|Completed 4th Period|Overall Study||57
3176567|NCT01967173|3904436|FG007|Completed 4th Period|Overall Study||50
3176568|NCT01967173|3904429|FG000|COMPLETED|Overall Study||45
3176569|NCT01967173|3904430|FG001|COMPLETED|Overall Study||52
3176570|NCT01967173|3904431|FG002|COMPLETED|Overall Study||55
3176571|NCT01967173|3904432|FG003|COMPLETED|Overall Study||57
3176572|NCT01967173|3904433|FG004|COMPLETED|Overall Study||56
3176573|NCT01967173|3904434|FG005|COMPLETED|Overall Study||49
3176574|NCT01967173|3904435|FG006|COMPLETED|Overall Study||57
3176575|NCT01967173|3904436|FG007|COMPLETED|Overall Study||50
3176576|NCT01967173|3904429|FG000|NOT COMPLETED|Overall Study||24
3176577|NCT01967173|3904430|FG001|NOT COMPLETED|Overall Study||17
3329792|NCT03286751|4062335|FG002|Received at Least One Dose of Study Drug|Period 1||7
3329793|NCT03286751|4062336|FG003|Received at Least One Dose of Study Drug|Period 1||7
3329794|NCT03286751|4062337|FG004|Received at Least One Dose of Study Drug|Period 1||7
3329795|NCT03286751|4062338|FG005|Received at Least One Dose of Study Drug|Period 1||7
3329796|NCT03286751|4062333|FG000|COMPLETED|Period 1||7
3329797|NCT03286751|4062334|FG001|COMPLETED|Period 1||7
3329798|NCT03286751|4062335|FG002|COMPLETED|Period 1||7
3329799|NCT03286751|4062336|FG003|COMPLETED|Period 1||7
3329800|NCT03286751|4062337|FG004|COMPLETED|Period 1||7
3329801|NCT03286751|4062338|FG005|COMPLETED|Period 1||7
3329802|NCT03286751|4062333|FG000|NOT COMPLETED|Period 1||0
3329803|NCT03286751|4062334|FG001|NOT COMPLETED|Period 1||0
3329804|NCT03286751|4062335|FG002|NOT COMPLETED|Period 1||0
3329805|NCT03286751|4062336|FG003|NOT COMPLETED|Period 1||0
3329806|NCT03286751|4062337|FG004|NOT COMPLETED|Period 1||0
3329807|NCT03286751|4062338|FG005|NOT COMPLETED|Period 1||0
3329808|NCT03286751|4062333|FG000|STARTED|Washout Period 1||7
3329809|NCT03286751|4062334|FG001|STARTED|Washout Period 1||7
3329810|NCT03286751|4062335|FG002|STARTED|Washout Period 1||7
3329811|NCT03286751|4062336|FG003|STARTED|Washout Period 1||7
3329812|NCT03286751|4062337|FG004|STARTED|Washout Period 1||7
3329813|NCT03286751|4062338|FG005|STARTED|Washout Period 1||7
3329814|NCT03286751|4062333|FG000|COMPLETED|Washout Period 1||7
3329815|NCT03286751|4062334|FG001|COMPLETED|Washout Period 1||7
3329816|NCT03286751|4062335|FG002|COMPLETED|Washout Period 1||7
3329817|NCT03286751|4062336|FG003|COMPLETED|Washout Period 1||7
3329818|NCT03286751|4062337|FG004|COMPLETED|Washout Period 1||6
3329819|NCT03286751|4062338|FG005|COMPLETED|Washout Period 1||7
3329820|NCT03286751|4062333|FG000|NOT COMPLETED|Washout Period 1||0
3329821|NCT03286751|4062334|FG001|NOT COMPLETED|Washout Period 1||0
3329822|NCT03286751|4062335|FG002|NOT COMPLETED|Washout Period 1||0
3329823|NCT03286751|4062336|FG003|NOT COMPLETED|Washout Period 1||0
3329824|NCT03286751|4062337|FG004|NOT COMPLETED|Washout Period 1||1
3329825|NCT03286751|4062338|FG005|NOT COMPLETED|Washout Period 1||0
3329826|NCT03286751|4062333|FG000|STARTED|Period 2||7
3329827|NCT03286751|4062334|FG001|STARTED|Period 2||7
3329828|NCT03286751|4062335|FG002|STARTED|Period 2||7
3329829|NCT03286751|4062336|FG003|STARTED|Period 2||7
3329830|NCT03286751|4062337|FG004|STARTED|Period 2||6
3329831|NCT03286751|4062338|FG005|STARTED|Period 2||7
3329832|NCT03286751|4062333|FG000|COMPLETED|Period 2||7
3329833|NCT03286751|4062334|FG001|COMPLETED|Period 2||7
3329834|NCT03286751|4062335|FG002|COMPLETED|Period 2||7
3329835|NCT03286751|4062336|FG003|COMPLETED|Period 2||7
3329836|NCT03286751|4062337|FG004|COMPLETED|Period 2||6
3329837|NCT03286751|4062338|FG005|COMPLETED|Period 2||7
3329838|NCT03286751|4062333|FG000|NOT COMPLETED|Period 2||0
3329839|NCT03286751|4062334|FG001|NOT COMPLETED|Period 2||0
3329840|NCT03286751|4062335|FG002|NOT COMPLETED|Period 2||0
3329841|NCT03286751|4062336|FG003|NOT COMPLETED|Period 2||0
3329842|NCT03286751|4062337|FG004|NOT COMPLETED|Period 2||0
3329843|NCT03286751|4062338|FG005|NOT COMPLETED|Period 2||0
3329844|NCT03286751|4062333|FG000|STARTED|Washout Period 2||7
3329845|NCT03286751|4062334|FG001|STARTED|Washout Period 2||7
3329846|NCT03286751|4062335|FG002|STARTED|Washout Period 2||7
3329847|NCT03286751|4062336|FG003|STARTED|Washout Period 2||7
3329848|NCT03286751|4062337|FG004|STARTED|Washout Period 2||6
3329849|NCT03286751|4062338|FG005|STARTED|Washout Period 2||7
3329850|NCT03286751|4062333|FG000|COMPLETED|Washout Period 2||7
3329851|NCT03286751|4062334|FG001|COMPLETED|Washout Period 2||6
3329852|NCT03286751|4062335|FG002|COMPLETED|Washout Period 2||7
3329853|NCT03286751|4062336|FG003|COMPLETED|Washout Period 2||7
3329854|NCT03286751|4062337|FG004|COMPLETED|Washout Period 2||6
3329855|NCT03286751|4062338|FG005|COMPLETED|Washout Period 2||7
3329856|NCT03286751|4062333|FG000|NOT COMPLETED|Washout Period 2||0
3329857|NCT03286751|4062334|FG001|NOT COMPLETED|Washout Period 2||1
3329858|NCT03286751|4062335|FG002|NOT COMPLETED|Washout Period 2||0
3329859|NCT03286751|4062336|FG003|NOT COMPLETED|Washout Period 2||0
3329860|NCT03286751|4062337|FG004|NOT COMPLETED|Washout Period 2||0
3329861|NCT03286751|4062338|FG005|NOT COMPLETED|Washout Period 2||0
3329862|NCT03286751|4062333|FG000|STARTED|Period 3||7
3329863|NCT03286751|4062334|FG001|STARTED|Period 3||6
3329864|NCT03286751|4062335|FG002|STARTED|Period 3||7
3329865|NCT03286751|4062336|FG003|STARTED|Period 3||7
3329866|NCT03286751|4062337|FG004|STARTED|Period 3||6
3329867|NCT03286751|4062338|FG005|STARTED|Period 3||7
3329868|NCT03286751|4062333|FG000|COMPLETED|Period 3||7
3329869|NCT03286751|4062334|FG001|COMPLETED|Period 3||6
3329870|NCT03286751|4062335|FG002|COMPLETED|Period 3||7
3329871|NCT03286751|4062336|FG003|COMPLETED|Period 3||7
3329872|NCT03286751|4062337|FG004|COMPLETED|Period 3||6
3329873|NCT03286751|4062338|FG005|COMPLETED|Period 3||7
3329874|NCT03286751|4062333|FG000|NOT COMPLETED|Period 3||0
3329875|NCT03286751|4062334|FG001|NOT COMPLETED|Period 3||0
3329876|NCT03286751|4062335|FG002|NOT COMPLETED|Period 3||0
3329877|NCT03286751|4062336|FG003|NOT COMPLETED|Period 3||0
3329878|NCT03286751|4062337|FG004|NOT COMPLETED|Period 3||0
3329879|NCT03286751|4062338|FG005|NOT COMPLETED|Period 3||0
3329880|NCT03286751|4062333|FG000|STARTED|Washout Period 3||7
3329881|NCT03286751|4062334|FG001|STARTED|Washout Period 3||6
3329882|NCT03286751|4062335|FG002|STARTED|Washout Period 3||7
3329883|NCT03286751|4062336|FG003|STARTED|Washout Period 3||7
3329884|NCT03286751|4062337|FG004|STARTED|Washout Period 3||6
3329885|NCT03286751|4062338|FG005|STARTED|Washout Period 3||7
3329886|NCT03286751|4062333|FG000|COMPLETED|Washout Period 3||7
3329887|NCT03286751|4062334|FG001|COMPLETED|Washout Period 3||6
3329888|NCT03286751|4062335|FG002|COMPLETED|Washout Period 3||7
3329889|NCT03286751|4062336|FG003|COMPLETED|Washout Period 3||7
3329890|NCT03286751|4062337|FG004|COMPLETED|Washout Period 3||6
3176578|NCT01967173|3904431|FG002|NOT COMPLETED|Overall Study||16
3176579|NCT01967173|3904432|FG003|NOT COMPLETED|Overall Study||14
3176580|NCT01967173|3904433|FG004|NOT COMPLETED|Overall Study||17
3176581|NCT01967173|3904434|FG005|NOT COMPLETED|Overall Study||23
3176582|NCT01967173|3904435|FG006|NOT COMPLETED|Overall Study||18
3176583|NCT01967173|3904436|FG007|NOT COMPLETED|Overall Study||24
3176584|NCT01967225|3904452|FG000|STARTED|Overall Study||84
3176585|NCT01967225|3904453|FG001|STARTED|Overall Study||41
3176586|NCT01967225|3904452|FG000|Participants Received Treatment|Overall Study||83
3329891|NCT03286751|4062338|FG005|COMPLETED|Washout Period 3||7
3329892|NCT03286751|4062333|FG000|NOT COMPLETED|Washout Period 3||0
3329893|NCT03286751|4062334|FG001|NOT COMPLETED|Washout Period 3||0
3329894|NCT03286751|4062335|FG002|NOT COMPLETED|Washout Period 3||0
3329895|NCT03286751|4062336|FG003|NOT COMPLETED|Washout Period 3||0
3329896|NCT03286751|4062337|FG004|NOT COMPLETED|Washout Period 3||0
3329897|NCT03286751|4062338|FG005|NOT COMPLETED|Washout Period 3||0
3329898|NCT03286751|4062333|FG000|STARTED|Period 4||7
3329899|NCT03286751|4062334|FG001|STARTED|Period 4||6
3329900|NCT03286751|4062335|FG002|STARTED|Period 4||7
3329901|NCT03286751|4062336|FG003|STARTED|Period 4||7
3329902|NCT03286751|4062337|FG004|STARTED|Period 4||6
3329903|NCT03286751|4062338|FG005|STARTED|Period 4||7
3329904|NCT03286751|4062333|FG000|COMPLETED|Period 4||7
3329905|NCT03286751|4062334|FG001|COMPLETED|Period 4||6
3176587|NCT01967225|3904453|FG001|Participants Received Treatment|Overall Study||41
3176588|NCT01967225|3904452|FG000|COMPLETED|Overall Study||72
3176589|NCT01967225|3904453|FG001|COMPLETED|Overall Study||38
3176590|NCT01967225|3904452|FG000|NOT COMPLETED|Overall Study||12
3176591|NCT01967225|3904453|FG001|NOT COMPLETED|Overall Study||3
3176592|NCT01967277|3904463|FG000|STARTED|Overall Study||22
3329906|NCT03286751|4062335|FG002|COMPLETED|Period 4||7
3329907|NCT03286751|4062336|FG003|COMPLETED|Period 4||7
3329908|NCT03286751|4062337|FG004|COMPLETED|Period 4||6
3329909|NCT03286751|4062338|FG005|COMPLETED|Period 4||7
3329910|NCT03286751|4062333|FG000|NOT COMPLETED|Period 4||0
3329911|NCT03286751|4062334|FG001|NOT COMPLETED|Period 4||0
3176593|NCT01967277|3904464|FG001|STARTED|Overall Study||22
3176594|NCT01967277|3904463|FG000|COMPLETED|Overall Study||21
3176595|NCT01967277|3904464|FG001|COMPLETED|Overall Study||19
3176596|NCT01967277|3904463|FG000|NOT COMPLETED|Overall Study||1
3176597|NCT01967277|3904464|FG001|NOT COMPLETED|Overall Study||3
3329912|NCT03286751|4062335|FG002|NOT COMPLETED|Period 4||0
3176598|NCT01967342|3904473|FG000|STARTED|Overall Study||98
3176599|NCT01967342|3904474|FG001|STARTED|Overall Study||95
3329913|NCT03286751|4062336|FG003|NOT COMPLETED|Period 4||0
3329914|NCT03286751|4062337|FG004|NOT COMPLETED|Period 4||0
3329915|NCT03286751|4062338|FG005|NOT COMPLETED|Period 4||0
3329916|NCT03286751|4062333|FG000|STARTED|Washout Period 4||7
3329917|NCT03286751|4062334|FG001|STARTED|Washout Period 4||6
3329918|NCT03286751|4062335|FG002|STARTED|Washout Period 4||7
3329919|NCT03286751|4062336|FG003|STARTED|Washout Period 4||7
3329920|NCT03286751|4062337|FG004|STARTED|Washout Period 4||6
3329921|NCT03286751|4062338|FG005|STARTED|Washout Period 4||7
3329922|NCT03286751|4062333|FG000|COMPLETED|Washout Period 4||7
3329923|NCT03286751|4062334|FG001|COMPLETED|Washout Period 4||6
3329924|NCT03286751|4062335|FG002|COMPLETED|Washout Period 4||7
3329925|NCT03286751|4062336|FG003|COMPLETED|Washout Period 4||7
3329926|NCT03286751|4062337|FG004|COMPLETED|Washout Period 4||6
3329927|NCT03286751|4062338|FG005|COMPLETED|Washout Period 4||7
3329928|NCT03286751|4062333|FG000|NOT COMPLETED|Washout Period 4||0
3329929|NCT03286751|4062334|FG001|NOT COMPLETED|Washout Period 4||0
3329930|NCT03286751|4062335|FG002|NOT COMPLETED|Washout Period 4||0
3329931|NCT03286751|4062336|FG003|NOT COMPLETED|Washout Period 4||0
3329932|NCT03286751|4062337|FG004|NOT COMPLETED|Washout Period 4||0
3329933|NCT03286751|4062338|FG005|NOT COMPLETED|Washout Period 4||0
3329934|NCT03286751|4062333|FG000|STARTED|Period 5||7
3329935|NCT03286751|4062334|FG001|STARTED|Period 5||6
3329936|NCT03286751|4062335|FG002|STARTED|Period 5||7
3329937|NCT03286751|4062336|FG003|STARTED|Period 5||7
3329938|NCT03286751|4062337|FG004|STARTED|Period 5||6
3329939|NCT03286751|4062338|FG005|STARTED|Period 5||7
3329940|NCT03286751|4062333|FG000|COMPLETED|Period 5||7
3329941|NCT03286751|4062334|FG001|COMPLETED|Period 5||6
3329942|NCT03286751|4062335|FG002|COMPLETED|Period 5||7
3329943|NCT03286751|4062336|FG003|COMPLETED|Period 5||7
3329944|NCT03286751|4062337|FG004|COMPLETED|Period 5||6
3329945|NCT03286751|4062338|FG005|COMPLETED|Period 5||7
3176600|NCT01967342|3904475|FG002|STARTED|Overall Study||97
3176601|NCT01967342|3904473|FG000|5-week Follow-up|Overall Study||83
3176602|NCT01967342|3904474|FG001|5-week Follow-up|Overall Study||78
3176603|NCT01967342|3904475|FG002|5-week Follow-up|Overall Study||76
3176604|NCT01967342|3904473|FG000|10-week Follow-up|Overall Study||78
3329946|NCT03286751|4062333|FG000|NOT COMPLETED|Period 5||0
3329947|NCT03286751|4062334|FG001|NOT COMPLETED|Period 5||0
3329948|NCT03286751|4062335|FG002|NOT COMPLETED|Period 5||0
3329949|NCT03286751|4062336|FG003|NOT COMPLETED|Period 5||0
3329950|NCT03286751|4062337|FG004|NOT COMPLETED|Period 5||0
3329951|NCT03286751|4062338|FG005|NOT COMPLETED|Period 5||0
3329952|NCT03286751|4062333|FG000|STARTED|Washout Period 5||7
3329953|NCT03286751|4062334|FG001|STARTED|Washout Period 5||6
3329954|NCT03286751|4062335|FG002|STARTED|Washout Period 5||7
3329955|NCT03286751|4062336|FG003|STARTED|Washout Period 5||7
3329956|NCT03286751|4062337|FG004|STARTED|Washout Period 5||6
3329957|NCT03286751|4062338|FG005|STARTED|Washout Period 5||7
3329958|NCT03286751|4062333|FG000|COMPLETED|Washout Period 5||7
3329959|NCT03286751|4062334|FG001|COMPLETED|Washout Period 5||6
3329960|NCT03286751|4062335|FG002|COMPLETED|Washout Period 5||7
3329961|NCT03286751|4062336|FG003|COMPLETED|Washout Period 5||7
3329962|NCT03286751|4062337|FG004|COMPLETED|Washout Period 5||5
3329963|NCT03286751|4062338|FG005|COMPLETED|Washout Period 5||7
3329964|NCT03286751|4062333|FG000|NOT COMPLETED|Washout Period 5||0
3329965|NCT03286751|4062334|FG001|NOT COMPLETED|Washout Period 5||0
3329966|NCT03286751|4062335|FG002|NOT COMPLETED|Washout Period 5||0
3329967|NCT03286751|4062336|FG003|NOT COMPLETED|Washout Period 5||0
3329968|NCT03286751|4062337|FG004|NOT COMPLETED|Washout Period 5||1
3329969|NCT03286751|4062338|FG005|NOT COMPLETED|Washout Period 5||0
3329970|NCT03286751|4062333|FG000|STARTED|Period 6||7
3329971|NCT03286751|4062334|FG001|STARTED|Period 6||6
3329972|NCT03286751|4062335|FG002|STARTED|Period 6||7
3329973|NCT03286751|4062336|FG003|STARTED|Period 6||7
3329974|NCT03286751|4062337|FG004|STARTED|Period 6||5
3329975|NCT03286751|4062338|FG005|STARTED|Period 6||7
3329976|NCT03286751|4062333|FG000|COMPLETED|Period 6||7
3329977|NCT03286751|4062334|FG001|COMPLETED|Period 6||6
3329978|NCT03286751|4062335|FG002|COMPLETED|Period 6||7
3329979|NCT03286751|4062336|FG003|COMPLETED|Period 6||7
3329980|NCT03286751|4062337|FG004|COMPLETED|Period 6||5
3329981|NCT03286751|4062338|FG005|COMPLETED|Period 6||7
3329982|NCT03286751|4062333|FG000|NOT COMPLETED|Period 6||0
3329983|NCT03286751|4062334|FG001|NOT COMPLETED|Period 6||0
3329984|NCT03286751|4062335|FG002|NOT COMPLETED|Period 6||0
3329985|NCT03286751|4062336|FG003|NOT COMPLETED|Period 6||0
3329986|NCT03286751|4062337|FG004|NOT COMPLETED|Period 6||0
3329987|NCT03286751|4062338|FG005|NOT COMPLETED|Period 6||0
3329988|NCT03286829|4062356|FG000|STARTED|Overall Study||15
3329989|NCT03286829|4062357|FG001|STARTED|Overall Study||15
3329990|NCT03286829|4062358|FG002|STARTED|Overall Study||15
3329991|NCT03286829|4062359|FG003|STARTED|Overall Study||15
3329992|NCT03286829|4062356|FG000|COMPLETED|Overall Study||15
3329993|NCT03286829|4062357|FG001|COMPLETED|Overall Study||15
3329994|NCT03286829|4062358|FG002|COMPLETED|Overall Study||15
3329995|NCT03286829|4062359|FG003|COMPLETED|Overall Study||15
3329996|NCT03286829|4062356|FG000|NOT COMPLETED|Overall Study||0
3329997|NCT03286829|4062357|FG001|NOT COMPLETED|Overall Study||0
3329998|NCT03286829|4062358|FG002|NOT COMPLETED|Overall Study||0
3329999|NCT03286829|4062359|FG003|NOT COMPLETED|Overall Study||0
3330000|NCT03287089|4062373|FG000|STARTED|Overall Study||82
3330001|NCT03287089|4062374|FG001|STARTED|Overall Study||82
3330002|NCT03287089|4062373|FG000|COMPLETED|Overall Study||82
3176605|NCT01967342|3904474|FG001|10-week Follow-up|Overall Study||83
3176606|NCT01967342|3904475|FG002|10-week Follow-up|Overall Study||80
3176607|NCT01967342|3904473|FG000|COMPLETED|Overall Study||71
3176608|NCT01967342|3904474|FG001|COMPLETED|Overall Study||70
3176609|NCT01967342|3904475|FG002|COMPLETED|Overall Study||68
3176610|NCT01967342|3904473|FG000|NOT COMPLETED|Overall Study||27
3330003|NCT03287089|4062374|FG001|COMPLETED|Overall Study||76
3330004|NCT03287089|4062373|FG000|NOT COMPLETED|Overall Study||0
3330005|NCT03287089|4062374|FG001|NOT COMPLETED|Overall Study||6
3330006|NCT03287219|4062382|FG000|STARTED|Overall Study||24
3330007|NCT03287219|4062383|FG001|STARTED|Overall Study||90
3330008|NCT03287219|4062382|FG000|COMPLETED|Overall Study||24
3330009|NCT03287219|4062383|FG001|COMPLETED|Overall Study||88
3330010|NCT03287219|4062382|FG000|NOT COMPLETED|Overall Study||0
3330011|NCT03287219|4062383|FG001|NOT COMPLETED|Overall Study||2
3330012|NCT03287310|4062428|FG000|STARTED|Overall Study||12
3330013|NCT03287310|4062429|FG001|STARTED|Overall Study||6
3330014|NCT03287310|4062430|FG002|STARTED|Overall Study||6
3330015|NCT03287310|4062431|FG003|STARTED|Overall Study||9
3330016|NCT03287310|4062432|FG004|STARTED|Overall Study||9
3330017|NCT03287310|4062433|FG005|STARTED|Overall Study||6
3330018|NCT03287310|4062428|FG000|COMPLETED|Overall Study||12
3330019|NCT03287310|4062429|FG001|COMPLETED|Overall Study||6
3330020|NCT03287310|4062430|FG002|COMPLETED|Overall Study||6
3330021|NCT03287310|4062431|FG003|COMPLETED|Overall Study||9
3330022|NCT03287310|4062432|FG004|COMPLETED|Overall Study||9
3330023|NCT03287310|4062433|FG005|COMPLETED|Overall Study||6
3330024|NCT03287310|4062428|FG000|NOT COMPLETED|Overall Study||0
3330025|NCT03287310|4062429|FG001|NOT COMPLETED|Overall Study||0
3330026|NCT03287310|4062430|FG002|NOT COMPLETED|Overall Study||0
3330027|NCT03287310|4062431|FG003|NOT COMPLETED|Overall Study||0
3330028|NCT03287310|4062432|FG004|NOT COMPLETED|Overall Study||0
3330029|NCT03287310|4062433|FG005|NOT COMPLETED|Overall Study||0
3330030|NCT03287622|4062457|FG000|STARTED|Overall Study||356
3330031|NCT03287622|4062458|FG001|STARTED|Overall Study||356
3330032|NCT03287622|4062457|FG000|Sub-randomized to Nudge/NoNudge|Overall Study||253
3330033|NCT03287622|4062458|FG001|Sub-randomized to Nudge/NoNudge|Overall Study||266
3330034|NCT03287622|4062457|FG000|COMPLETED|Overall Study||298
3330035|NCT03287622|4062458|FG001|COMPLETED|Overall Study||308
3330036|NCT03287622|4062457|FG000|NOT COMPLETED|Overall Study||58
3330037|NCT03287622|4062458|FG001|NOT COMPLETED|Overall Study||48
3176611|NCT01967342|3904474|FG001|NOT COMPLETED|Overall Study||25
3330038|NCT03287635|4062471|FG000|STARTED|Overall Study||19
3330039|NCT03287635|4062471|FG000|COMPLETED|Overall Study||12
3330040|NCT03287635|4062471|FG000|NOT COMPLETED|Overall Study||7
3330041|NCT03287674|4062475|FG000|STARTED|Overall Study||7
3330042|NCT03287674|4062475|FG000|All Treated With TILs|Overall Study||6
3330043|NCT03287674|4062475|FG000|COMPLETED|Overall Study||6
3330044|NCT03287674|4062475|FG000|NOT COMPLETED|Overall Study||1
3330045|NCT03287791|4062483|FG000|STARTED|Overall Study||312
3330046|NCT03287791|4062484|FG001|STARTED|Overall Study||312
3330047|NCT03287791|4062485|FG002|STARTED|Overall Study||300
3330048|NCT03287791|4062483|FG000|Safety Population|Overall Study||306
3330049|NCT03287791|4062484|FG001|Safety Population|Overall Study||297
3330050|NCT03287791|4062485|FG002|Safety Population|Overall Study||291
3330051|NCT03287791|4062483|FG000|mITT Population|Overall Study||291
3330052|NCT03287791|4062484|FG001|mITT Population|Overall Study||291
3330053|NCT03287791|4062485|FG002|mITT Population|Overall Study||283
3330054|NCT03287791|4062483|FG000|PP Population|Overall Study||262
3330055|NCT03287791|4062484|FG001|PP Population|Overall Study||259
3330056|NCT03287791|4062485|FG002|PP Population|Overall Study||245
3330057|NCT03287791|4062483|FG000|COMPLETED|Overall Study||280
3330058|NCT03287791|4062484|FG001|COMPLETED|Overall Study||276
3330059|NCT03287791|4062485|FG002|COMPLETED|Overall Study||264
3330060|NCT03287791|4062483|FG000|NOT COMPLETED|Overall Study||32
3330061|NCT03287791|4062484|FG001|NOT COMPLETED|Overall Study||36
3330062|NCT03287791|4062485|FG002|NOT COMPLETED|Overall Study||36
3330063|NCT03287804|4062493|FG000|STARTED|Overall Study||12
3330064|NCT03287804|4062493|FG000|Leukaperesed|Overall Study||12
3330065|NCT03287804|4062493|FG000|Started Pre-conditioning Therapy|Overall Study||11
3330066|NCT03287804|4062493|FG000|Received Study Treatment|Overall Study||11
3330067|NCT03287804|4062493|FG000|COMPLETED|Overall Study||1
3330068|NCT03287804|4062493|FG000|NOT COMPLETED|Overall Study||11
3330069|NCT03287843|4062500|FG000|STARTED|Overall Study||175
3330070|NCT03287843|4062501|FG001|STARTED|Overall Study||175
3330071|NCT03287843|4062500|FG000|Excluded|Overall Study|No surgery n=5 R2 resection n=5 Stage IV n=2|12
3330072|NCT03287843|4062501|FG001|Excluded|Overall Study|No surgery n=4 R2 resection n=2 Stage IV n=2|8
3330073|NCT03287843|4062500|FG000|Lost to Follow up|Overall Study||3
3330074|NCT03287843|4062501|FG001|Lost to Follow up|Overall Study||0
3330075|NCT03287843|4062500|FG000|COMPLETED|Overall Study||160
3330076|NCT03287843|4062501|FG001|COMPLETED|Overall Study||167
3330077|NCT03287843|4062500|FG000|NOT COMPLETED|Overall Study||15
3330078|NCT03287843|4062501|FG001|NOT COMPLETED|Overall Study||8
3330079|NCT03287869|4062509|FG000|STARTED|Overall Study||188
3330080|NCT03287869|4062510|FG001|STARTED|Overall Study||193
3330081|NCT03287869|4062509|FG000|Analyzed For Safety (Safety Sample)|Overall Study||184
3330082|NCT03287869|4062510|FG001|Analyzed For Safety (Safety Sample)|Overall Study||184
3330083|NCT03287869|4062509|FG000|COMPLETED|Overall Study||105
3330084|NCT03287869|4062510|FG001|COMPLETED|Overall Study||100
3330085|NCT03287869|4062509|FG000|NOT COMPLETED|Overall Study||83
3330086|NCT03287869|4062510|FG001|NOT COMPLETED|Overall Study||93
3330087|NCT03288714|4062518|FG000|STARTED|Overall Study||59
3330088|NCT03288714|4062519|FG001|STARTED|Overall Study||62
3330089|NCT03288714|4062518|FG000|COMPLETED|Overall Study||49
3330090|NCT03288714|4062519|FG001|COMPLETED|Overall Study||59
3330091|NCT03288714|4062518|FG000|NOT COMPLETED|Overall Study||10
3330092|NCT03288714|4062519|FG001|NOT COMPLETED|Overall Study||3
3330093|NCT03288779|4062527|FG000|STARTED|Overall Study||6
3330094|NCT03288779|4062527|FG000|COMPLETED|Overall Study||3
3330095|NCT03288779|4062527|FG000|NOT COMPLETED|Overall Study||3
3330096|NCT03288987|4062533|FG000|STARTED|Overall Study||82
3330097|NCT03288987|4062534|FG001|STARTED|Overall Study||44
3330098|NCT03288987|4062533|FG000|Patients Receiving Medication|Overall Study||80
3330099|NCT03288987|4062534|FG001|Patients Receiving Medication|Overall Study||44
3330100|NCT03288987|4062533|FG000|COMPLETED|Overall Study|Per protocol population|72
3330101|NCT03288987|4062534|FG001|COMPLETED|Overall Study|Per protocol population|40
3330102|NCT03288987|4062533|FG000|NOT COMPLETED|Overall Study||10
3330103|NCT03288987|4062534|FG001|NOT COMPLETED|Overall Study||4
3330104|NCT03289052|4062543|FG000|STARTED|Overall Study||20
3330105|NCT03289052|4062544|FG001|STARTED|Overall Study||111
3330106|NCT03289052|4062545|FG002|STARTED|Overall Study||37
3330107|NCT03289052|4062543|FG000|COMPLETED|Overall Study||20
3330108|NCT03289052|4062544|FG001|COMPLETED|Overall Study||108
3330109|NCT03289052|4062545|FG002|COMPLETED|Overall Study||32
3330110|NCT03289052|4062543|FG000|NOT COMPLETED|Overall Study||0
3330111|NCT03289052|4062544|FG001|NOT COMPLETED|Overall Study||3
3330112|NCT03289052|4062545|FG002|NOT COMPLETED|Overall Study||5
3330113|NCT03289208|4062556|FG000|STARTED|Overall Study||11
3330114|NCT03289208|4062557|FG001|STARTED|Overall Study||8
3330115|NCT03289208|4062558|FG002|STARTED|Overall Study||11
3330116|NCT03289208|4062556|FG000|COMPLETED|Overall Study||10
3330117|NCT03289208|4062557|FG001|COMPLETED|Overall Study||8
3330118|NCT03289208|4062558|FG002|COMPLETED|Overall Study||11
3330119|NCT03289208|4062556|FG000|NOT COMPLETED|Overall Study||1
3330120|NCT03289208|4062557|FG001|NOT COMPLETED|Overall Study||0
3330121|NCT03289208|4062558|FG002|NOT COMPLETED|Overall Study||0
3330122|NCT03289234|4062569|FG000|STARTED|Overall Study||8
3330123|NCT03289234|4062570|FG001|STARTED|Overall Study||6
3330124|NCT03289234|4062571|FG002|STARTED|Overall Study||8
3330125|NCT03289234|4062569|FG000|COMPLETED|Overall Study||8
3330126|NCT03289234|4062570|FG001|COMPLETED|Overall Study||6
3330127|NCT03289234|4062571|FG002|COMPLETED|Overall Study||8
3330128|NCT03289234|4062569|FG000|NOT COMPLETED|Overall Study||0
3330129|NCT03289234|4062570|FG001|NOT COMPLETED|Overall Study||0
3330130|NCT03289234|4062571|FG002|NOT COMPLETED|Overall Study||0
3330131|NCT03289455|4062582|FG000|STARTED|Overall Study||4
3330132|NCT03289455|4062583|FG001|STARTED|Overall Study||5
3330133|NCT03289455|4062584|FG002|STARTED|Overall Study||6
3330134|NCT03289455|4062582|FG000|COMPLETED|Overall Study|Completed = Received AUTO3 infusion and completed 24 months visit|0
3330135|NCT03289455|4062583|FG001|COMPLETED|Overall Study|Completed = Received AUTO3 infusion and completed 24 months visit|0
3330136|NCT03289455|4062584|FG002|COMPLETED|Overall Study|Completed = Received AUTO3 infusion and completed 24 months visit|0
3330137|NCT03289455|4062582|FG000|NOT COMPLETED|Overall Study||4
3330138|NCT03289455|4062583|FG001|NOT COMPLETED|Overall Study||5
3330139|NCT03289455|4062584|FG002|NOT COMPLETED|Overall Study||6
3330140|NCT03289481|4062595|FG000|STARTED|Overall Study||6
3330141|NCT03289481|4062596|FG001|STARTED|Overall Study||7
3330142|NCT03289481|4062595|FG000|COMPLETED|Overall Study||4
3330143|NCT03289481|4062596|FG001|COMPLETED|Overall Study||5
3330144|NCT03289481|4062595|FG000|NOT COMPLETED|Overall Study||2
3330145|NCT03289481|4062596|FG001|NOT COMPLETED|Overall Study||2
3330146|NCT03289533|4062603|FG000|STARTED|Overall Study||22
3330147|NCT03289533|4062603|FG000|COMPLETED|Overall Study||0
3330148|NCT03289533|4062603|FG000|NOT COMPLETED|Overall Study||22
3330149|NCT03289676|4062609|FG000|STARTED|Overall Study||27
3330150|NCT03289676|4062610|FG001|STARTED|Overall Study||26
3330151|NCT03289676|4062609|FG000|COMPLETED|Overall Study||23
3330152|NCT03289676|4062610|FG001|COMPLETED|Overall Study|Received 80% of the allotted intervention|25
3330153|NCT03289676|4062609|FG000|NOT COMPLETED|Overall Study||4
3330154|NCT03289676|4062610|FG001|NOT COMPLETED|Overall Study||1
3330155|NCT03289858|4062618|FG000|STARTED|Overall Study||27
3330156|NCT03289858|4062619|FG001|STARTED|Overall Study||28
3330157|NCT03289858|4062618|FG000|COMPLETED|Overall Study||25
3330158|NCT03289858|4062619|FG001|COMPLETED|Overall Study||28
3330159|NCT03289858|4062618|FG000|NOT COMPLETED|Overall Study||2
3330160|NCT03289858|4062619|FG001|NOT COMPLETED|Overall Study||0
3330161|NCT03290027|4062627|FG000|STARTED|Overall Study||277
3330162|NCT03290027|4062628|FG001|STARTED|Overall Study||273
3330163|NCT03290027|4062627|FG000|COMPLETED|Overall Study||219
3330164|NCT03290027|4062628|FG001|COMPLETED|Overall Study||228
3330165|NCT03290027|4062627|FG000|NOT COMPLETED|Overall Study||58
3330166|NCT03290027|4062628|FG001|NOT COMPLETED|Overall Study||45
3330167|NCT03290300|4062634|FG000|STARTED|Overall Study||39
3330168|NCT03290300|4062634|FG000|COMPLETED|Overall Study||36
3330169|NCT03290300|4062634|FG000|NOT COMPLETED|Overall Study||3
3330170|NCT03290378|4062646|FG000|STARTED|Overall Study||140
3330171|NCT03290378|4062647|FG001|STARTED|Overall Study||133
3330172|NCT03290378|4062648|FG002|STARTED|Overall Study||136
3330173|NCT03290378|4062646|FG000|COMPLETED|Overall Study||137
3330174|NCT03290378|4062647|FG001|COMPLETED|Overall Study||123
3330175|NCT03290378|4062648|FG002|COMPLETED|Overall Study||120
3330176|NCT03290378|4062646|FG000|NOT COMPLETED|Overall Study||3
3330177|NCT03290378|4062647|FG001|NOT COMPLETED|Overall Study||10
3330178|NCT03290378|4062648|FG002|NOT COMPLETED|Overall Study||16
3330179|NCT03290768|4062656|FG000|STARTED|Overall Study||358
3330180|NCT03290768|4062656|FG000|COMPLETED|Overall Study||193
3330181|NCT03290768|4062656|FG000|NOT COMPLETED|Overall Study||165
3330182|NCT03291041|4062662|FG000|STARTED|Overall Study||13
3330183|NCT03291041|4062663|FG001|STARTED|Overall Study||12
3330184|NCT03291041|4062662|FG000|COMPLETED|Overall Study||13
3330185|NCT03291041|4062663|FG001|COMPLETED|Overall Study||12
3330186|NCT03291041|4062662|FG000|NOT COMPLETED|Overall Study||0
3330187|NCT03291041|4062663|FG001|NOT COMPLETED|Overall Study||0
3330188|NCT03291080|4062671|FG000|STARTED|First Cycle (2 Weeks)||11
3330189|NCT03291080|4062672|FG001|STARTED|First Cycle (2 Weeks)||9
3330190|NCT03291080|4062671|FG000|COMPLETED|First Cycle (2 Weeks)||11
3330191|NCT03291080|4062672|FG001|COMPLETED|First Cycle (2 Weeks)||9
3330192|NCT03291080|4062671|FG000|NOT COMPLETED|First Cycle (2 Weeks)||0
3330193|NCT03291080|4062672|FG001|NOT COMPLETED|First Cycle (2 Weeks)||0
3330194|NCT03291080|4062671|FG000|STARTED|Washout (2 Weeks)||11
3330195|NCT03291080|4062672|FG001|STARTED|Washout (2 Weeks)||9
3330196|NCT03291080|4062671|FG000|COMPLETED|Washout (2 Weeks)||11
3330197|NCT03291080|4062672|FG001|COMPLETED|Washout (2 Weeks)||9
3330198|NCT03291080|4062671|FG000|NOT COMPLETED|Washout (2 Weeks)||0
3330199|NCT03291080|4062672|FG001|NOT COMPLETED|Washout (2 Weeks)||0
3330200|NCT03291080|4062671|FG000|STARTED|Second Cylcle (2 Weeks)||9
3330201|NCT03291080|4062672|FG001|STARTED|Second Cylcle (2 Weeks)||11
3330202|NCT03291080|4062671|FG000|COMPLETED|Second Cylcle (2 Weeks)||8
3330203|NCT03291080|4062672|FG001|COMPLETED|Second Cylcle (2 Weeks)||11
3330204|NCT03291080|4062671|FG000|NOT COMPLETED|Second Cylcle (2 Weeks)||1
3330205|NCT03291080|4062672|FG001|NOT COMPLETED|Second Cylcle (2 Weeks)||0
3330206|NCT03291197|4062679|FG000|STARTED|Overall Study||5
3330207|NCT03291197|4062679|FG000|COMPLETED|Overall Study||5
3330208|NCT03291197|4062679|FG000|NOT COMPLETED|Overall Study||0
3330209|NCT03291288|4062687|FG000|STARTED|Drug-drug Interaction Phase||32
3330210|NCT03291288|4062688|FG001|STARTED|Drug-drug Interaction Phase||0
3330211|NCT03291288|4062687|FG000|COMPLETED|Drug-drug Interaction Phase||26
3330212|NCT03291288|4062688|FG001|COMPLETED|Drug-drug Interaction Phase||0
3330213|NCT03291288|4062687|FG000|NOT COMPLETED|Drug-drug Interaction Phase||6
3330214|NCT03291288|4062688|FG001|NOT COMPLETED|Drug-drug Interaction Phase||0
3330215|NCT03291288|4062687|FG000|STARTED|Pexidartinib Only|This is a crossover trial; participants who completed Part 1 continued to Part 2.|0
3330216|NCT03291288|4062688|FG001|STARTED|Pexidartinib Only||26
3330217|NCT03291288|4062687|FG000|COMPLETED|Pexidartinib Only||0
3330218|NCT03291288|4062688|FG001|COMPLETED|Pexidartinib Only||24
3330219|NCT03291288|4062687|FG000|NOT COMPLETED|Pexidartinib Only||0
3330220|NCT03291288|4062688|FG001|NOT COMPLETED|Pexidartinib Only||2
3330221|NCT03291379|4062702|FG000|STARTED|Overall Study||8
3330222|NCT03291379|4062702|FG000|COMPLETED|Overall Study||8
3330223|NCT03291379|4062702|FG000|NOT COMPLETED|Overall Study||0
3330224|NCT03291613|4062707|FG000|STARTED|Overall Study||13
3330225|NCT03291613|4062707|FG000|COMPLETED|Overall Study||12
3330226|NCT03291613|4062707|FG000|NOT COMPLETED|Overall Study||1
3330227|NCT03292016|4062717|FG000|STARTED|First Intervention||1
3330228|NCT03292016|4062718|FG001|STARTED|First Intervention||1
3330229|NCT03292016|4062719|FG002|STARTED|First Intervention||2
3330230|NCT03292016|4062720|FG003|STARTED|First Intervention||1
3330231|NCT03292016|4062721|FG004|STARTED|First Intervention||1
3330232|NCT03292016|4062722|FG005|STARTED|First Intervention||2
3330233|NCT03292016|4062717|FG000|COMPLETED|First Intervention||1
3330234|NCT03292016|4062718|FG001|COMPLETED|First Intervention||1
3330235|NCT03292016|4062719|FG002|COMPLETED|First Intervention||2
3330236|NCT03292016|4062720|FG003|COMPLETED|First Intervention||1
3330237|NCT03292016|4062721|FG004|COMPLETED|First Intervention||1
3330238|NCT03292016|4062722|FG005|COMPLETED|First Intervention||2
3330239|NCT03292016|4062717|FG000|NOT COMPLETED|First Intervention||0
3330240|NCT03292016|4062718|FG001|NOT COMPLETED|First Intervention||0
3330241|NCT03292016|4062719|FG002|NOT COMPLETED|First Intervention||0
3330242|NCT03292016|4062720|FG003|NOT COMPLETED|First Intervention||0
3330243|NCT03292016|4062721|FG004|NOT COMPLETED|First Intervention||0
3330244|NCT03292016|4062722|FG005|NOT COMPLETED|First Intervention||0
3330245|NCT03292016|4062717|FG000|STARTED|First Washout||1
3330246|NCT03292016|4062718|FG001|STARTED|First Washout||1
3330247|NCT03292016|4062719|FG002|STARTED|First Washout||2
3330248|NCT03292016|4062720|FG003|STARTED|First Washout||1
3330249|NCT03292016|4062721|FG004|STARTED|First Washout||1
3330250|NCT03292016|4062722|FG005|STARTED|First Washout||2
3330251|NCT03292016|4062717|FG000|COMPLETED|First Washout||1
3330252|NCT03292016|4062718|FG001|COMPLETED|First Washout||1
3330253|NCT03292016|4062719|FG002|COMPLETED|First Washout||2
3330254|NCT03292016|4062720|FG003|COMPLETED|First Washout||1
3330255|NCT03292016|4062721|FG004|COMPLETED|First Washout||1
3330256|NCT03292016|4062722|FG005|COMPLETED|First Washout||2
3330257|NCT03292016|4062717|FG000|NOT COMPLETED|First Washout||0
3330258|NCT03292016|4062718|FG001|NOT COMPLETED|First Washout||0
3330259|NCT03292016|4062719|FG002|NOT COMPLETED|First Washout||0
3330260|NCT03292016|4062720|FG003|NOT COMPLETED|First Washout||0
3330261|NCT03292016|4062721|FG004|NOT COMPLETED|First Washout||0
3330262|NCT03292016|4062722|FG005|NOT COMPLETED|First Washout||0
3330263|NCT03292016|4062717|FG000|STARTED|Second Intervention||1
3330264|NCT03292016|4062718|FG001|STARTED|Second Intervention||1
3330265|NCT03292016|4062719|FG002|STARTED|Second Intervention||2
3330266|NCT03292016|4062720|FG003|STARTED|Second Intervention||1
3330267|NCT03292016|4062721|FG004|STARTED|Second Intervention||1
3330268|NCT03292016|4062722|FG005|STARTED|Second Intervention||2
3330269|NCT03292016|4062717|FG000|COMPLETED|Second Intervention||1
3330270|NCT03292016|4062718|FG001|COMPLETED|Second Intervention||1
3330271|NCT03292016|4062719|FG002|COMPLETED|Second Intervention||2
3330272|NCT03292016|4062720|FG003|COMPLETED|Second Intervention||1
3330273|NCT03292016|4062721|FG004|COMPLETED|Second Intervention||1
3330274|NCT03292016|4062722|FG005|COMPLETED|Second Intervention||2
3330275|NCT03292016|4062717|FG000|NOT COMPLETED|Second Intervention||0
3330276|NCT03292016|4062718|FG001|NOT COMPLETED|Second Intervention||0
3330277|NCT03292016|4062719|FG002|NOT COMPLETED|Second Intervention||0
3330278|NCT03292016|4062720|FG003|NOT COMPLETED|Second Intervention||0
3330279|NCT03292016|4062721|FG004|NOT COMPLETED|Second Intervention||0
3330280|NCT03292016|4062722|FG005|NOT COMPLETED|Second Intervention||0
3330281|NCT03292016|4062717|FG000|STARTED|Second Washout||1
3330282|NCT03292016|4062718|FG001|STARTED|Second Washout||1
3330283|NCT03292016|4062719|FG002|STARTED|Second Washout||2
3330284|NCT03292016|4062720|FG003|STARTED|Second Washout||1
3330285|NCT03292016|4062721|FG004|STARTED|Second Washout||1
3330286|NCT03292016|4062722|FG005|STARTED|Second Washout||2
3330287|NCT03292016|4062717|FG000|COMPLETED|Second Washout||1
3330288|NCT03292016|4062718|FG001|COMPLETED|Second Washout||0
3330289|NCT03292016|4062719|FG002|COMPLETED|Second Washout||2
3330290|NCT03292016|4062720|FG003|COMPLETED|Second Washout||1
3330291|NCT03292016|4062721|FG004|COMPLETED|Second Washout||1
3330292|NCT03292016|4062722|FG005|COMPLETED|Second Washout||2
3330293|NCT03292016|4062717|FG000|NOT COMPLETED|Second Washout||0
3330294|NCT03292016|4062718|FG001|NOT COMPLETED|Second Washout||1
3330295|NCT03292016|4062719|FG002|NOT COMPLETED|Second Washout||0
3330296|NCT03292016|4062720|FG003|NOT COMPLETED|Second Washout||0
3330297|NCT03292016|4062721|FG004|NOT COMPLETED|Second Washout||0
3330298|NCT03292016|4062722|FG005|NOT COMPLETED|Second Washout||0
3330299|NCT03292016|4062717|FG000|STARTED|Third Intervention||1
3330300|NCT03292016|4062718|FG001|STARTED|Third Intervention||0
3330301|NCT03292016|4062719|FG002|STARTED|Third Intervention||2
3330302|NCT03292016|4062720|FG003|STARTED|Third Intervention||1
3330303|NCT03292016|4062721|FG004|STARTED|Third Intervention||1
3330304|NCT03292016|4062722|FG005|STARTED|Third Intervention||2
3330305|NCT03292016|4062717|FG000|COMPLETED|Third Intervention||1
3330306|NCT03292016|4062718|FG001|COMPLETED|Third Intervention||0
3330307|NCT03292016|4062719|FG002|COMPLETED|Third Intervention||2
3330308|NCT03292016|4062720|FG003|COMPLETED|Third Intervention||1
3330309|NCT03292016|4062721|FG004|COMPLETED|Third Intervention||1
3330310|NCT03292016|4062722|FG005|COMPLETED|Third Intervention||2
3330311|NCT03292016|4062717|FG000|NOT COMPLETED|Third Intervention||0
3330312|NCT03292016|4062718|FG001|NOT COMPLETED|Third Intervention||0
3330313|NCT03292016|4062719|FG002|NOT COMPLETED|Third Intervention||0
3330314|NCT03292016|4062720|FG003|NOT COMPLETED|Third Intervention||0
3330315|NCT03292016|4062721|FG004|NOT COMPLETED|Third Intervention||0
3330316|NCT03292016|4062722|FG005|NOT COMPLETED|Third Intervention||0
3330317|NCT03292406|4062733|FG000|STARTED|Overall Study||30
3330318|NCT03292406|4062734|FG001|STARTED|Overall Study||28
3330319|NCT03292406|4062735|FG002|STARTED|Overall Study||28
3330320|NCT03292406|4062733|FG000|Participants Treated|Overall Study||30
3330321|NCT03292406|4062734|FG001|Participants Treated|Overall Study||28
3330322|NCT03292406|4062735|FG002|Participants Treated|Overall Study||27
3330323|NCT03292406|4062733|FG000|COMPLETED|Overall Study||17
3330324|NCT03292406|4062734|FG001|COMPLETED|Overall Study||15
3330325|NCT03292406|4062735|FG002|COMPLETED|Overall Study||15
3330326|NCT03292406|4062733|FG000|NOT COMPLETED|Overall Study||13
3330327|NCT03292406|4062734|FG001|NOT COMPLETED|Overall Study||13
3330328|NCT03292406|4062735|FG002|NOT COMPLETED|Overall Study||13
3330329|NCT03292432|4062745|FG000|STARTED|Overall Study||46
3330330|NCT03292432|4062746|FG001|STARTED|Overall Study||43
3330331|NCT03292432|4062745|FG000|Started Study Intervention|Overall Study||45
3330332|NCT03292432|4062746|FG001|Started Study Intervention|Overall Study||43
3330333|NCT03292432|4062745|FG000|COMPLETED|Overall Study||31
3330334|NCT03292432|4062746|FG001|COMPLETED|Overall Study||32
3330335|NCT03292432|4062745|FG000|NOT COMPLETED|Overall Study||15
3330336|NCT03292432|4062746|FG001|NOT COMPLETED|Overall Study||11
3330337|NCT03292562|4062754|FG000|STARTED|Overall Study||35
3330338|NCT03292562|4062755|FG001|STARTED|Overall Study||31
3330339|NCT03292562|4062754|FG000|COMPLETED|Overall Study||29
3330340|NCT03292562|4062755|FG001|COMPLETED|Overall Study||30
3330341|NCT03292562|4062754|FG000|NOT COMPLETED|Overall Study||6
3330342|NCT03292562|4062755|FG001|NOT COMPLETED|Overall Study||1
3330343|NCT03292614|4062761|FG000|STARTED|Overall Study||25
3330344|NCT03292614|4062761|FG000|COMPLETED|Overall Study||25
3330345|NCT03292614|4062761|FG000|NOT COMPLETED|Overall Study||0
3330346|NCT03292640|4062767|FG000|STARTED|Overall Study||275
3330347|NCT03292640|4062768|FG001|STARTED|Overall Study||272
3330348|NCT03292640|4062767|FG000|COMPLETED|Overall Study||214
3330349|NCT03292640|4062768|FG001|COMPLETED|Overall Study||230
3176612|NCT01967342|3904475|FG002|NOT COMPLETED|Overall Study||29
3176613|NCT01967433|3904485|FG000|STARTED|Overall Study||61
3176614|NCT01967433|3904486|FG001|STARTED|Overall Study||59
3330350|NCT03292640|4062767|FG000|NOT COMPLETED|Overall Study||61
3330351|NCT03292640|4062768|FG001|NOT COMPLETED|Overall Study||42
3330352|NCT03292653|4062781|FG000|STARTED|Overall Study||11
3330353|NCT03292653|4062782|FG001|STARTED|Overall Study||10
3330354|NCT03292653|4062783|FG002|STARTED|Overall Study||11
3330355|NCT03292653|4062781|FG000|COMPLETED|Overall Study||10
3330356|NCT03292653|4062782|FG001|COMPLETED|Overall Study||10
3330357|NCT03292653|4062783|FG002|COMPLETED|Overall Study||10
3330358|NCT03292653|4062781|FG000|NOT COMPLETED|Overall Study||1
2927767|NCT00574119|3638630|FG000|COMPLETED|Overall Study||12
3330359|NCT03292653|4062782|FG001|NOT COMPLETED|Overall Study||0
3330360|NCT03292653|4062783|FG002|NOT COMPLETED|Overall Study||1
3330361|NCT03292692|4062794|FG000|STARTED|Overall Study||302
3330362|NCT03292692|4062795|FG001|STARTED|Overall Study||298
3330363|NCT03292692|4062794|FG000|COMPLETED|Overall Study||264
3330364|NCT03292692|4062795|FG001|COMPLETED|Overall Study||260
3330365|NCT03292692|4062794|FG000|NOT COMPLETED|Overall Study||38
3330366|NCT03292692|4062795|FG001|NOT COMPLETED|Overall Study||38
3330367|NCT03292809|4062803|FG000|STARTED|Overall Study||162
3330368|NCT03292809|4062804|FG001|STARTED|Overall Study||166
3330369|NCT03292809|4062803|FG000|COMPLETED|Overall Study||155
3330370|NCT03292809|4062804|FG001|COMPLETED|Overall Study||163
3330371|NCT03292809|4062803|FG000|NOT COMPLETED|Overall Study||7
3330372|NCT03292809|4062804|FG001|NOT COMPLETED|Overall Study||3
3330373|NCT03292952|4062812|FG000|STARTED|Open-Label Dose Optimization||155
3330374|NCT03292952|4062813|FG001|STARTED|Open-Label Dose Optimization|All subjects were treated with open-label KP415 during the Open-Label Phase|0
3330375|NCT03292952|4062814|FG002|STARTED|Open-Label Dose Optimization|All subjects were treated with open-label KP415 during the Open-Label Phase|0
3330376|NCT03292952|4062812|FG000|COMPLETED|Open-Label Dose Optimization||150
3330377|NCT03292952|4062813|FG001|COMPLETED|Open-Label Dose Optimization||0
3330378|NCT03292952|4062814|FG002|COMPLETED|Open-Label Dose Optimization||0
3330379|NCT03292952|4062812|FG000|NOT COMPLETED|Open-Label Dose Optimization||5
3330380|NCT03292952|4062813|FG001|NOT COMPLETED|Open-Label Dose Optimization||0
3330381|NCT03292952|4062814|FG002|NOT COMPLETED|Open-Label Dose Optimization||0
3330382|NCT03292952|4062812|FG000|STARTED|Double-Blind Treatment Phase|Subjects were randomized to the double-blind Treatment Phase after Open-Label Dose Optimization|0
3330383|NCT03292952|4062813|FG001|STARTED|Double-Blind Treatment Phase||74
3330384|NCT03292952|4062814|FG002|STARTED|Double-Blind Treatment Phase||76
3330385|NCT03292952|4062812|FG000|COMPLETED|Double-Blind Treatment Phase||0
3330386|NCT03292952|4062813|FG001|COMPLETED|Double-Blind Treatment Phase||74
3330387|NCT03292952|4062814|FG002|COMPLETED|Double-Blind Treatment Phase||75
3330388|NCT03292952|4062812|FG000|NOT COMPLETED|Double-Blind Treatment Phase||0
3330389|NCT03292952|4062813|FG001|NOT COMPLETED|Double-Blind Treatment Phase||0
3330390|NCT03292952|4062814|FG002|NOT COMPLETED|Double-Blind Treatment Phase||1
3330391|NCT03293238|4062827|FG000|STARTED|Overall Study||19
3330392|NCT03293238|4062828|FG001|STARTED|Overall Study||16
3330393|NCT03293238|4062829|FG002|STARTED|Overall Study||14
3330394|NCT03293238|4062830|FG003|STARTED|Overall Study||14
3330395|NCT03293238|4062827|FG000|COMPLETED|Overall Study||19
3330396|NCT03293238|4062828|FG001|COMPLETED|Overall Study||16
3330397|NCT03293238|4062829|FG002|COMPLETED|Overall Study||14
3330398|NCT03293238|4062830|FG003|COMPLETED|Overall Study||14
3330399|NCT03293238|4062827|FG000|NOT COMPLETED|Overall Study||0
3330400|NCT03293238|4062828|FG001|NOT COMPLETED|Overall Study||0
3330401|NCT03293238|4062829|FG002|NOT COMPLETED|Overall Study||0
3330402|NCT03293238|4062830|FG003|NOT COMPLETED|Overall Study||0
3330403|NCT03293394|4062842|FG000|STARTED|First Intervention (2 Weeks)||20
3330404|NCT03293394|4062843|FG001|STARTED|First Intervention (2 Weeks)||10
3330405|NCT03293394|4062842|FG000|COMPLETED|First Intervention (2 Weeks)||20
3330406|NCT03293394|4062843|FG001|COMPLETED|First Intervention (2 Weeks)||10
3330407|NCT03293394|4062842|FG000|NOT COMPLETED|First Intervention (2 Weeks)||0
3330408|NCT03293394|4062843|FG001|NOT COMPLETED|First Intervention (2 Weeks)||0
3330409|NCT03293394|4062842|FG000|STARTED|Follow-up (6 Months)||20
3330410|NCT03293394|4062843|FG001|STARTED|Follow-up (6 Months)||10
3330411|NCT03293394|4062842|FG000|COMPLETED|Follow-up (6 Months)||16
3330412|NCT03293394|4062843|FG001|COMPLETED|Follow-up (6 Months)||8
3330413|NCT03293394|4062842|FG000|NOT COMPLETED|Follow-up (6 Months)||4
3330414|NCT03293394|4062843|FG001|NOT COMPLETED|Follow-up (6 Months)||2
3330415|NCT03293485|4062849|FG000|STARTED|Overall Study||83
3330416|NCT03293485|4062849|FG000|Treated|Overall Study||81
3330417|NCT03293485|4062849|FG000|COMPLETED|Overall Study||78
3330418|NCT03293485|4062849|FG000|NOT COMPLETED|Overall Study||5
3330419|NCT03293654|4062858|FG000|STARTED|Overall Study||38
3330420|NCT03293654|4062859|FG001|STARTED|Overall Study||38
3330421|NCT03293654|4062860|FG002|STARTED|Overall Study||38
3330422|NCT03293654|4062858|FG000|COMPLETED|Overall Study||38
3176615|NCT01967433|3904485|FG000|COMPLETED|Overall Study||61
3176616|NCT01967433|3904486|FG001|COMPLETED|Overall Study||58
3176617|NCT01967433|3904485|FG000|NOT COMPLETED|Overall Study||0
3330423|NCT03293654|4062859|FG001|COMPLETED|Overall Study||37
3330424|NCT03293654|4062860|FG002|COMPLETED|Overall Study||38
3330425|NCT03293654|4062858|FG000|NOT COMPLETED|Overall Study||0
3330426|NCT03293654|4062859|FG001|NOT COMPLETED|Overall Study||1
3330427|NCT03293654|4062860|FG002|NOT COMPLETED|Overall Study||0
3330428|NCT03294213|4062868|FG000|STARTED|Overall Study||176
3330429|NCT03294213|4062868|FG000|COMPLETED|Overall Study||176
3330430|NCT03294213|4062868|FG000|NOT COMPLETED|Overall Study||0
3176618|NCT01967433|3904486|FG001|NOT COMPLETED|Overall Study||1
3330431|NCT03294317|4062872|FG000|STARTED|Overall Study||70
3330432|NCT03294317|4062872|FG000|Implanted With Lead at HIS Bundle|Overall Study||61
3330433|NCT03294317|4062872|FG000|Subjects With Available CT|Overall Study||51
3330434|NCT03294317|4062872|FG000|COMPLETED|Overall Study||50
3330435|NCT03294317|4062872|FG000|NOT COMPLETED|Overall Study||20
3330436|NCT03294538|4062879|FG000|STARTED|Overall Study||268
3330437|NCT03294538|4062880|FG001|STARTED|Overall Study||262
3330438|NCT03294538|4062881|FG002|STARTED|Overall Study||133
3330439|NCT03294538|4062879|FG000|Safety Population|Overall Study||267
3330440|NCT03294538|4062880|FG001|Safety Population|Overall Study||262
3330441|NCT03294538|4062881|FG002|Safety Population|Overall Study||132
3330442|NCT03294538|4062879|FG000|mITT Population|Overall Study||267
3330443|NCT03294538|4062880|FG001|mITT Population|Overall Study||262
3330444|NCT03294538|4062881|FG002|mITT Population|Overall Study||132
3330445|NCT03294538|4062879|FG000|PP Population|Overall Study||244
3330446|NCT03294538|4062880|FG001|PP Population|Overall Study||227
3330447|NCT03294538|4062881|FG002|PP Population|Overall Study||126
3330448|NCT03294538|4062879|FG000|COMPLETED|Overall Study||263
3330449|NCT03294538|4062880|FG001|COMPLETED|Overall Study||257
3330450|NCT03294538|4062881|FG002|COMPLETED|Overall Study||131
3330451|NCT03294538|4062879|FG000|NOT COMPLETED|Overall Study||5
3330452|NCT03294538|4062880|FG001|NOT COMPLETED|Overall Study||5
3330453|NCT03294538|4062881|FG002|NOT COMPLETED|Overall Study||2
3330454|NCT03294629|4062891|FG000|STARTED|First Intervention (2 Weeks)||16
3330455|NCT03294629|4062892|FG001|STARTED|First Intervention (2 Weeks)||19
3330456|NCT03294629|4062891|FG000|COMPLETED|First Intervention (2 Weeks)||14
3330457|NCT03294629|4062892|FG001|COMPLETED|First Intervention (2 Weeks)||15
3330458|NCT03294629|4062891|FG000|NOT COMPLETED|First Intervention (2 Weeks)||2
3330459|NCT03294629|4062892|FG001|NOT COMPLETED|First Intervention (2 Weeks)||4
3330460|NCT03294629|4062891|FG000|STARTED|Second Intervention (2 Weeks)||14
3330461|NCT03294629|4062892|FG001|STARTED|Second Intervention (2 Weeks)||15
3330462|NCT03294629|4062891|FG000|COMPLETED|Second Intervention (2 Weeks)||12
3330463|NCT03294629|4062892|FG001|COMPLETED|Second Intervention (2 Weeks)||13
3330464|NCT03294629|4062891|FG000|NOT COMPLETED|Second Intervention (2 Weeks)||2
3330465|NCT03294629|4062892|FG001|NOT COMPLETED|Second Intervention (2 Weeks)||2
3330466|NCT03294681|4062898|FG000|STARTED|Overall Study||153
3330467|NCT03294681|4062898|FG000|COMPLETED|Overall Study||152
3330468|NCT03294681|4062898|FG000|NOT COMPLETED|Overall Study||1
3330469|NCT03294850|4062904|FG000|STARTED|Overall Study||4
3330470|NCT03294850|4062905|FG001|STARTED|Overall Study||10
3330471|NCT03294850|4062904|FG000|COMPLETED|Overall Study||4
3330472|NCT03294850|4062905|FG001|COMPLETED|Overall Study||10
3330473|NCT03294850|4062904|FG000|NOT COMPLETED|Overall Study||0
3330474|NCT03294850|4062905|FG001|NOT COMPLETED|Overall Study||0
3330475|NCT03294941|4062913|FG000|STARTED|Overall Study||4
3330476|NCT03294941|4062914|FG001|STARTED|Overall Study||13
3330477|NCT03294941|4062913|FG000|COMPLETED|Overall Study||4
3330478|NCT03294941|4062914|FG001|COMPLETED|Overall Study||11
3330479|NCT03294941|4062913|FG000|NOT COMPLETED|Overall Study||0
3330480|NCT03294941|4062914|FG001|NOT COMPLETED|Overall Study||2
3330481|NCT03295201|4062923|FG000|STARTED|Overall Study||11
3330482|NCT03295201|4062924|FG001|STARTED|Overall Study||11
3330483|NCT03295201|4062923|FG000|COMPLETED|Overall Study||10
3330484|NCT03295201|4062924|FG001|COMPLETED|Overall Study||9
3330485|NCT03295201|4062923|FG000|NOT COMPLETED|Overall Study||1
3330486|NCT03295201|4062924|FG001|NOT COMPLETED|Overall Study||2
3330487|NCT03295266|4062932|FG000|STARTED|Overall Study||5
3330488|NCT03295266|4062933|FG001|STARTED|Overall Study||4
3330489|NCT03295266|4062932|FG000|COMPLETED|Overall Study||5
3330490|NCT03295266|4062933|FG001|COMPLETED|Overall Study||4
3330491|NCT03295266|4062932|FG000|NOT COMPLETED|Overall Study||0
3330492|NCT03295266|4062933|FG001|NOT COMPLETED|Overall Study||0
3330493|NCT03295318|4062942|FG000|STARTED|Overall Study||150
3330494|NCT03295318|4062943|FG001|STARTED|Overall Study||150
3330495|NCT03295318|4062944|FG002|STARTED|Overall Study||76
3330496|NCT03295318|4062942|FG000|Received First Vaccination|Overall Study|1 subject withdrew consent after randomization, but prior to vaccination.|149
3330497|NCT03295318|4062943|FG001|Received First Vaccination|Overall Study||150
3330498|NCT03295318|4062944|FG002|Received First Vaccination|Overall Study||76
3330499|NCT03295318|4062942|FG000|Received Second Vaccination|Overall Study||144
3330500|NCT03295318|4062943|FG001|Received Second Vaccination|Overall Study||145
3330501|NCT03295318|4062944|FG002|Received Second Vaccination|Overall Study||73
3330502|NCT03295318|4062942|FG000|COMPLETED|Overall Study||144
3330503|NCT03295318|4062943|FG001|COMPLETED|Overall Study||145
3330504|NCT03295318|4062944|FG002|COMPLETED|Overall Study||71
3330505|NCT03295318|4062942|FG000|NOT COMPLETED|Overall Study||6
3330506|NCT03295318|4062943|FG001|NOT COMPLETED|Overall Study||5
3330507|NCT03295318|4062944|FG002|NOT COMPLETED|Overall Study||5
3330508|NCT03295630|4062970|FG000|STARTED|Overall Study||20
3330509|NCT03295630|4062970|FG000|COMPLETED|Overall Study||20
3330510|NCT03295630|4062970|FG000|NOT COMPLETED|Overall Study||0
3330511|NCT03295721|4062978|FG000|STARTED|Overall Study||157
3330512|NCT03295721|4062979|FG001|STARTED|Overall Study||100
3330513|NCT03295721|4062980|FG002|STARTED|Overall Study||155
3330514|NCT03295721|4062978|FG000|COMPLETED|Overall Study||154
3330515|NCT03295721|4062979|FG001|COMPLETED|Overall Study||99
3330516|NCT03295721|4062980|FG002|COMPLETED|Overall Study||152
3330517|NCT03295721|4062978|FG000|NOT COMPLETED|Overall Study||3
3330518|NCT03295721|4062979|FG001|NOT COMPLETED|Overall Study||1
3330519|NCT03295721|4062980|FG002|NOT COMPLETED|Overall Study||3
3330520|NCT03296072|4062989|FG000|STARTED|Treatment Period 1||10
3330521|NCT03296072|4062990|FG001|STARTED|Treatment Period 1||11
3330522|NCT03296072|4062991|FG002|STARTED|Treatment Period 1||10
3330523|NCT03296072|4062992|FG003|STARTED|Treatment Period 1||10
3330524|NCT03296072|4062993|FG004|STARTED|Treatment Period 1||10
3330525|NCT03296072|4062994|FG005|STARTED|Treatment Period 1||11
3330526|NCT03296072|4062989|FG000|COMPLETED|Treatment Period 1||10
3330527|NCT03296072|4062990|FG001|COMPLETED|Treatment Period 1||11
3330528|NCT03296072|4062991|FG002|COMPLETED|Treatment Period 1||10
3330529|NCT03296072|4062992|FG003|COMPLETED|Treatment Period 1||10
3330530|NCT03296072|4062993|FG004|COMPLETED|Treatment Period 1||10
3330531|NCT03296072|4062994|FG005|COMPLETED|Treatment Period 1||11
3330532|NCT03296072|4062989|FG000|NOT COMPLETED|Treatment Period 1||0
3330533|NCT03296072|4062990|FG001|NOT COMPLETED|Treatment Period 1||0
3330534|NCT03296072|4062991|FG002|NOT COMPLETED|Treatment Period 1||0
3330535|NCT03296072|4062992|FG003|NOT COMPLETED|Treatment Period 1||0
3330536|NCT03296072|4062993|FG004|NOT COMPLETED|Treatment Period 1||0
3330537|NCT03296072|4062994|FG005|NOT COMPLETED|Treatment Period 1||0
3330538|NCT03296072|4062989|FG000|STARTED|Treament Period 1: Wash Out Period||10
3330539|NCT03296072|4062990|FG001|STARTED|Treament Period 1: Wash Out Period||11
3330540|NCT03296072|4062991|FG002|STARTED|Treament Period 1: Wash Out Period||10
3330541|NCT03296072|4062992|FG003|STARTED|Treament Period 1: Wash Out Period||10
3330542|NCT03296072|4062993|FG004|STARTED|Treament Period 1: Wash Out Period||10
3330543|NCT03296072|4062994|FG005|STARTED|Treament Period 1: Wash Out Period||11
3330544|NCT03296072|4062989|FG000|COMPLETED|Treament Period 1: Wash Out Period||10
3330545|NCT03296072|4062990|FG001|COMPLETED|Treament Period 1: Wash Out Period||11
3330546|NCT03296072|4062991|FG002|COMPLETED|Treament Period 1: Wash Out Period||10
3330547|NCT03296072|4062992|FG003|COMPLETED|Treament Period 1: Wash Out Period||10
3330548|NCT03296072|4062993|FG004|COMPLETED|Treament Period 1: Wash Out Period||10
3330549|NCT03296072|4062994|FG005|COMPLETED|Treament Period 1: Wash Out Period||11
3330550|NCT03296072|4062989|FG000|NOT COMPLETED|Treament Period 1: Wash Out Period||0
3330551|NCT03296072|4062990|FG001|NOT COMPLETED|Treament Period 1: Wash Out Period||0
3330552|NCT03296072|4062991|FG002|NOT COMPLETED|Treament Period 1: Wash Out Period||0
3330553|NCT03296072|4062992|FG003|NOT COMPLETED|Treament Period 1: Wash Out Period||0
3330554|NCT03296072|4062993|FG004|NOT COMPLETED|Treament Period 1: Wash Out Period||0
3330555|NCT03296072|4062994|FG005|NOT COMPLETED|Treament Period 1: Wash Out Period||0
3330556|NCT03296072|4062989|FG000|STARTED|Treament Period 2||10
3330557|NCT03296072|4062990|FG001|STARTED|Treament Period 2||11
3330558|NCT03296072|4062991|FG002|STARTED|Treament Period 2||10
3330559|NCT03296072|4062992|FG003|STARTED|Treament Period 2||10
3330560|NCT03296072|4062993|FG004|STARTED|Treament Period 2||10
3330561|NCT03296072|4062994|FG005|STARTED|Treament Period 2||11
3330562|NCT03296072|4062989|FG000|COMPLETED|Treament Period 2||10
3330563|NCT03296072|4062990|FG001|COMPLETED|Treament Period 2||11
3330564|NCT03296072|4062991|FG002|COMPLETED|Treament Period 2||10
3330565|NCT03296072|4062992|FG003|COMPLETED|Treament Period 2||10
3330566|NCT03296072|4062993|FG004|COMPLETED|Treament Period 2||10
3330567|NCT03296072|4062994|FG005|COMPLETED|Treament Period 2||11
3330568|NCT03296072|4062989|FG000|NOT COMPLETED|Treament Period 2||0
3330569|NCT03296072|4062990|FG001|NOT COMPLETED|Treament Period 2||0
3330570|NCT03296072|4062991|FG002|NOT COMPLETED|Treament Period 2||0
3330571|NCT03296072|4062992|FG003|NOT COMPLETED|Treament Period 2||0
3330572|NCT03296072|4062993|FG004|NOT COMPLETED|Treament Period 2||0
3330573|NCT03296072|4062994|FG005|NOT COMPLETED|Treament Period 2||0
3330574|NCT03296072|4062989|FG000|STARTED|Treament Period 2: Wash Out Period||10
3330575|NCT03296072|4062990|FG001|STARTED|Treament Period 2: Wash Out Period||11
3330576|NCT03296072|4062991|FG002|STARTED|Treament Period 2: Wash Out Period||10
3330577|NCT03296072|4062992|FG003|STARTED|Treament Period 2: Wash Out Period||10
3330578|NCT03296072|4062993|FG004|STARTED|Treament Period 2: Wash Out Period||10
3330579|NCT03296072|4062994|FG005|STARTED|Treament Period 2: Wash Out Period||11
3330580|NCT03296072|4062989|FG000|COMPLETED|Treament Period 2: Wash Out Period||10
3330581|NCT03296072|4062990|FG001|COMPLETED|Treament Period 2: Wash Out Period||11
3330582|NCT03296072|4062991|FG002|COMPLETED|Treament Period 2: Wash Out Period||10
3330583|NCT03296072|4062992|FG003|COMPLETED|Treament Period 2: Wash Out Period||10
3330584|NCT03296072|4062993|FG004|COMPLETED|Treament Period 2: Wash Out Period||10
3330585|NCT03296072|4062994|FG005|COMPLETED|Treament Period 2: Wash Out Period||11
3330586|NCT03296072|4062989|FG000|NOT COMPLETED|Treament Period 2: Wash Out Period||0
3330587|NCT03296072|4062990|FG001|NOT COMPLETED|Treament Period 2: Wash Out Period||0
3330588|NCT03296072|4062991|FG002|NOT COMPLETED|Treament Period 2: Wash Out Period||0
3330589|NCT03296072|4062992|FG003|NOT COMPLETED|Treament Period 2: Wash Out Period||0
3330590|NCT03296072|4062993|FG004|NOT COMPLETED|Treament Period 2: Wash Out Period||0
3330591|NCT03296072|4062994|FG005|NOT COMPLETED|Treament Period 2: Wash Out Period||0
3330592|NCT03296072|4062989|FG000|STARTED|Treament Period 3||10
3330593|NCT03296072|4062990|FG001|STARTED|Treament Period 3||11
3330594|NCT03296072|4062991|FG002|STARTED|Treament Period 3||10
3330595|NCT03296072|4062992|FG003|STARTED|Treament Period 3||10
3330596|NCT03296072|4062993|FG004|STARTED|Treament Period 3||10
3330597|NCT03296072|4062994|FG005|STARTED|Treament Period 3||11
3330598|NCT03296072|4062989|FG000|COMPLETED|Treament Period 3||10
3330599|NCT03296072|4062990|FG001|COMPLETED|Treament Period 3||11
3330600|NCT03296072|4062991|FG002|COMPLETED|Treament Period 3||10
3330601|NCT03296072|4062992|FG003|COMPLETED|Treament Period 3||10
3330602|NCT03296072|4062993|FG004|COMPLETED|Treament Period 3||10
3330603|NCT03296072|4062994|FG005|COMPLETED|Treament Period 3||11
3330604|NCT03296072|4062989|FG000|NOT COMPLETED|Treament Period 3||0
3330605|NCT03296072|4062990|FG001|NOT COMPLETED|Treament Period 3||0
3330606|NCT03296072|4062991|FG002|NOT COMPLETED|Treament Period 3||0
3330607|NCT03296072|4062992|FG003|NOT COMPLETED|Treament Period 3||0
3330608|NCT03296072|4062993|FG004|NOT COMPLETED|Treament Period 3||0
3330609|NCT03296072|4062994|FG005|NOT COMPLETED|Treament Period 3||0
3330610|NCT03296163|4063004|FG000|STARTED|Combination Therapy||315
3330611|NCT03296163|4063005|FG001|STARTED|Combination Therapy||312
3330612|NCT03296163|4063004|FG000|COMPLETED|Combination Therapy||207
3330613|NCT03296163|4063005|FG001|COMPLETED|Combination Therapy||220
3330614|NCT03296163|4063004|FG000|NOT COMPLETED|Combination Therapy||108
3330615|NCT03296163|4063005|FG001|NOT COMPLETED|Combination Therapy||92
3330616|NCT03296163|4063004|FG000|STARTED|Monotherapy||207
3330617|NCT03296163|4063005|FG001|STARTED|Monotherapy||220
3330618|NCT03296163|4063004|FG000|COMPLETED|Monotherapy||68
3330619|NCT03296163|4063005|FG001|COMPLETED|Monotherapy||74
3330620|NCT03296163|4063004|FG000|NOT COMPLETED|Monotherapy||139
3330621|NCT03296163|4063005|FG001|NOT COMPLETED|Monotherapy||146
3330622|NCT03296280|4063013|FG000|STARTED|Overall Study||73
3330623|NCT03296280|4063014|FG001|STARTED|Overall Study||43
3330624|NCT03296280|4063013|FG000|COMPLETED|Overall Study||67
3330625|NCT03296280|4063014|FG001|COMPLETED|Overall Study||36
3330626|NCT03296280|4063013|FG000|NOT COMPLETED|Overall Study||6
3330627|NCT03296280|4063014|FG001|NOT COMPLETED|Overall Study||7
3330628|NCT03296345|4063020|FG000|STARTED|Overall Study||62
3330629|NCT03296345|4063020|FG000|COMPLETED|Overall Study||62
3330630|NCT03296345|4063020|FG000|NOT COMPLETED|Overall Study||0
3330631|NCT03296527|4063028|FG000|STARTED|Overall Study||500
3330632|NCT03296527|4063029|FG001|STARTED|Overall Study||511
3330633|NCT03296527|4063028|FG000|Full Analysis Set|Overall Study||499
3330634|NCT03296527|4063029|FG001|Full Analysis Set|Overall Study||510
3330635|NCT03296527|4063028|FG000|COMPLETED|Overall Study||465
3330636|NCT03296527|4063029|FG001|COMPLETED|Overall Study||458
3330637|NCT03296527|4063028|FG000|NOT COMPLETED|Overall Study||35
3330638|NCT03296527|4063029|FG001|NOT COMPLETED|Overall Study||53
3176619|NCT01967537|3904498|FG000|STARTED|Overall Study||341
3176620|NCT01967537|3904498|FG000|COMPLETED|Overall Study||281
3176621|NCT01967537|3904498|FG000|NOT COMPLETED|Overall Study||60
3176622|NCT01967550|3904504|FG000|STARTED|Overall Study||153
3176623|NCT01967550|3904505|FG001|STARTED|Overall Study||151
3330639|NCT03296566|4063038|FG000|STARTED|Overall Study||145
3176624|NCT01967550|3904504|FG000|COMPLETED|Overall Study||148
3330640|NCT03296566|4063039|FG001|STARTED|Overall Study||152
3330641|NCT03296566|4063038|FG000|COMPLETED|Overall Study||126
3330642|NCT03296566|4063039|FG001|COMPLETED|Overall Study||103
3330643|NCT03296566|4063038|FG000|NOT COMPLETED|Overall Study||19
3330644|NCT03296566|4063039|FG001|NOT COMPLETED|Overall Study||49
3330645|NCT03296787|4063049|FG000|STARTED|Overall Study||8
3330646|NCT03296787|4063050|FG001|STARTED|Overall Study||8
3330647|NCT03296787|4063051|FG002|STARTED|Overall Study||9
3330648|NCT03296787|4063052|FG003|STARTED|Overall Study||7
3330649|NCT03296787|4063049|FG000|COMPLETED|Overall Study||8
3330650|NCT03296787|4063050|FG001|COMPLETED|Overall Study||8
3330651|NCT03296787|4063051|FG002|COMPLETED|Overall Study||9
3330652|NCT03296787|4063052|FG003|COMPLETED|Overall Study||7
3330653|NCT03296787|4063049|FG000|NOT COMPLETED|Overall Study||0
3330654|NCT03296787|4063050|FG001|NOT COMPLETED|Overall Study||0
3330655|NCT03296787|4063051|FG002|NOT COMPLETED|Overall Study||0
3330656|NCT03296787|4063052|FG003|NOT COMPLETED|Overall Study||0
3330657|NCT03296800|4063066|FG000|STARTED|Overall Study||16
3330658|NCT03296800|4063067|FG001|STARTED|Overall Study||16
3330659|NCT03296800|4063068|FG002|STARTED|Overall Study||16
3330660|NCT03296800|4063066|FG000|COMPLETED|Overall Study||16
3330661|NCT03296800|4063067|FG001|COMPLETED|Overall Study||16
3330662|NCT03296800|4063068|FG002|COMPLETED|Overall Study||16
3330663|NCT03296800|4063066|FG000|NOT COMPLETED|Overall Study||0
3330664|NCT03296800|4063067|FG001|NOT COMPLETED|Overall Study||0
3330665|NCT03296800|4063068|FG002|NOT COMPLETED|Overall Study||0
3330666|NCT03297021|4063094|FG000|STARTED|Overall Study||48
3330667|NCT03297021|4063095|FG001|STARTED|Overall Study||46
3330668|NCT03297021|4063096|FG002|STARTED|Overall Study||47
3330669|NCT03297021|4063094|FG000|COMPLETED|Overall Study||43
3330670|NCT03297021|4063095|FG001|COMPLETED|Overall Study||42
3330671|NCT03297021|4063096|FG002|COMPLETED|Overall Study||43
3330672|NCT03297021|4063094|FG000|NOT COMPLETED|Overall Study||5
3330673|NCT03297021|4063095|FG001|NOT COMPLETED|Overall Study||4
3330674|NCT03297021|4063096|FG002|NOT COMPLETED|Overall Study||4
3330675|NCT03297112|4063104|FG000|STARTED|Overall Study||12
3330676|NCT03297112|4063104|FG000|COMPLETED|Overall Study||12
3330677|NCT03297112|4063104|FG000|NOT COMPLETED|Overall Study||0
3330678|NCT03297216|4063110|FG000|STARTED|Overall Study||399
3330679|NCT03297216|4063111|FG001|STARTED|Overall Study||401
3330680|NCT03297216|4063110|FG000|Discontinued Intervention|Overall Study||5
3330681|NCT03297216|4063111|FG001|Discontinued Intervention|Overall Study||4
3330682|NCT03297216|4063110|FG000|Infants Born During Study|Overall Study||399
3330683|NCT03297216|4063111|FG001|Infants Born During Study|Overall Study||401
3330684|NCT03297216|4063110|FG000|COMPLETED|Overall Study||396
3330685|NCT03297216|4063111|FG001|COMPLETED|Overall Study||396
3330686|NCT03297216|4063110|FG000|NOT COMPLETED|Overall Study||3
3330687|NCT03297216|4063111|FG001|NOT COMPLETED|Overall Study||5
3330688|NCT03297294|4063126|FG000|STARTED|Double-Blind Treatment Period (DB)||70
3330689|NCT03297294|4063127|FG001|STARTED|Double-Blind Treatment Period (DB)||67
3330690|NCT03297294|4063128|FG002|STARTED|Double-Blind Treatment Period (DB)||0
3330691|NCT03297294|4063129|FG003|STARTED|Double-Blind Treatment Period (DB)||0
3330692|NCT03297294|4063130|FG004|STARTED|Double-Blind Treatment Period (DB)||0
3330693|NCT03297294|4063126|FG000|COMPLETED|Double-Blind Treatment Period (DB)||32
3330694|NCT03297294|4063127|FG001|COMPLETED|Double-Blind Treatment Period (DB)||30
3330695|NCT03297294|4063128|FG002|COMPLETED|Double-Blind Treatment Period (DB)||0
3330696|NCT03297294|4063129|FG003|COMPLETED|Double-Blind Treatment Period (DB)||0
3330697|NCT03297294|4063130|FG004|COMPLETED|Double-Blind Treatment Period (DB)||0
3330698|NCT03297294|4063126|FG000|NOT COMPLETED|Double-Blind Treatment Period (DB)||38
3330699|NCT03297294|4063127|FG001|NOT COMPLETED|Double-Blind Treatment Period (DB)||37
3330700|NCT03297294|4063128|FG002|NOT COMPLETED|Double-Blind Treatment Period (DB)||0
3330701|NCT03297294|4063129|FG003|NOT COMPLETED|Double-Blind Treatment Period (DB)||0
3330702|NCT03297294|4063130|FG004|NOT COMPLETED|Double-Blind Treatment Period (DB)||0
3330703|NCT03297294|4063126|FG000|STARTED|Treatment Withdrawal Period (TW)||0
3330704|NCT03297294|4063127|FG001|STARTED|Treatment Withdrawal Period (TW)||0
3330705|NCT03297294|4063128|FG002|STARTED|Treatment Withdrawal Period (TW)||14
3330706|NCT03297294|4063129|FG003|STARTED|Treatment Withdrawal Period (TW)||12
3330707|NCT03297294|4063130|FG004|STARTED|Treatment Withdrawal Period (TW)||27
3330708|NCT03297294|4063126|FG000|COMPLETED|Treatment Withdrawal Period (TW)||0
3330709|NCT03297294|4063127|FG001|COMPLETED|Treatment Withdrawal Period (TW)||0
3330710|NCT03297294|4063128|FG002|COMPLETED|Treatment Withdrawal Period (TW)||14
3330711|NCT03297294|4063129|FG003|COMPLETED|Treatment Withdrawal Period (TW)||11
3330712|NCT03297294|4063130|FG004|COMPLETED|Treatment Withdrawal Period (TW)||27
3330713|NCT03297294|4063126|FG000|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
3330714|NCT03297294|4063127|FG001|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
3330715|NCT03297294|4063128|FG002|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
3330716|NCT03297294|4063129|FG003|NOT COMPLETED|Treatment Withdrawal Period (TW)||1
3330717|NCT03297294|4063130|FG004|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
3330718|NCT03297398|4063145|FG000|STARTED|Overall Study||36
3330719|NCT03297398|4063146|FG001|STARTED|Overall Study||40
3330720|NCT03297398|4063147|FG002|STARTED|Overall Study||38
3330721|NCT03297398|4063145|FG000|COMPLETED|Overall Study||28
3330722|NCT03297398|4063146|FG001|COMPLETED|Overall Study||23
3330723|NCT03297398|4063147|FG002|COMPLETED|Overall Study||23
3330724|NCT03297398|4063145|FG000|NOT COMPLETED|Overall Study||8
3330725|NCT03297398|4063146|FG001|NOT COMPLETED|Overall Study||17
3330726|NCT03297398|4063147|FG002|NOT COMPLETED|Overall Study||15
3330727|NCT03297944|4063155|FG000|STARTED|Overall Study||15
3330728|NCT03297944|4063155|FG000|2ALP/PLC|Overall Study||15
3330729|NCT03297944|4063155|FG000|1ALP/PLC|Overall Study||15
3330730|NCT03297944|4063155|FG000|0.5ALP/PLC|Overall Study||15
3330731|NCT03297944|4063155|FG000|ZOL/PLC|Overall Study||15
3330732|NCT03297944|4063155|FG000|PLC/PLC|Overall Study||15
3330733|NCT03297944|4063155|FG000|PLC/ALP|Overall Study||15
3330734|NCT03297944|4063155|FG000|COMPLETED|Overall Study||15
3330735|NCT03297944|4063155|FG000|NOT COMPLETED|Overall Study||0
3330736|NCT03298035|4063166|FG000|STARTED|Overall Study||10
3330737|NCT03298035|4063167|FG001|STARTED|Overall Study||9
3330738|NCT03298035|4063166|FG000|Received Intervention|Overall Study||9
3330739|NCT03298035|4063167|FG001|Received Intervention|Overall Study||7
3330740|NCT03298035|4063166|FG000|COMPLETED|Overall Study||9
3330741|NCT03298035|4063167|FG001|COMPLETED|Overall Study||7
3330742|NCT03298035|4063166|FG000|NOT COMPLETED|Overall Study||1
3330743|NCT03298035|4063167|FG001|NOT COMPLETED|Overall Study||2
3330744|NCT03298048|4063176|FG000|STARTED|Overall Study||4
3176625|NCT01967550|3904505|FG001|COMPLETED|Overall Study||149
3176626|NCT01967550|3904504|FG000|NOT COMPLETED|Overall Study||5
3176627|NCT01967550|3904505|FG001|NOT COMPLETED|Overall Study||2
3330745|NCT03298048|4063177|FG001|STARTED|Overall Study||3
3330746|NCT03298048|4063178|FG002|STARTED|Overall Study||8
3330747|NCT03298048|4063176|FG000|COMPLETED|Overall Study||4
3330748|NCT03298048|4063177|FG001|COMPLETED|Overall Study||3
3330749|NCT03298048|4063178|FG002|COMPLETED|Overall Study||8
3330750|NCT03298048|4063176|FG000|NOT COMPLETED|Overall Study||0
3330751|NCT03298048|4063177|FG001|NOT COMPLETED|Overall Study||0
3330752|NCT03298048|4063178|FG002|NOT COMPLETED|Overall Study||0
3330753|NCT03298113|4063188|FG000|STARTED|Overall Study|10 subjects were treated w/ Cavilon Advanced Skin Protectant. Study terminated due to low enrollment|10
3330754|NCT03298113|4063189|FG001|STARTED|Overall Study|10 subjects were treated with IAD Hospital Standard Care. Study terminated due to low enrollment.|10
3330755|NCT03298113|4063188|FG000|IAD 1A|Overall Study||3
3330756|NCT03298113|4063189|FG001|IAD 1A|Overall Study||4
3330757|NCT03298113|4063188|FG000|IAD 2A|Overall Study||7
3330758|NCT03298113|4063189|FG001|IAD 2A|Overall Study||6
3330759|NCT03298113|4063188|FG000|COMPLETED|Overall Study||10
3330760|NCT03298113|4063189|FG001|COMPLETED|Overall Study||10
3330761|NCT03298113|4063188|FG000|NOT COMPLETED|Overall Study||0
3330762|NCT03298113|4063189|FG001|NOT COMPLETED|Overall Study||0
3330763|NCT03298412|4063195|FG000|STARTED|Run-in Period||10
3330764|NCT03298412|4063195|FG000|COMPLETED|Run-in Period||1
3330765|NCT03298412|4063195|FG000|NOT COMPLETED|Run-in Period||9
3330766|NCT03298412|4063195|FG000|STARTED|Treatment Period||1
3330767|NCT03298412|4063195|FG000|COMPLETED|Treatment Period||1
3330768|NCT03298412|4063195|FG000|NOT COMPLETED|Treatment Period||0
3330769|NCT03298841|4063201|FG000|STARTED|Overall Study||25
3330770|NCT03298841|4063202|FG001|STARTED|Overall Study||25
3330771|NCT03298841|4063201|FG000|COMPLETED|Overall Study||25
3330772|NCT03298841|4063202|FG001|COMPLETED|Overall Study||25
3330773|NCT03298841|4063201|FG000|NOT COMPLETED|Overall Study||0
3330774|NCT03298841|4063202|FG001|NOT COMPLETED|Overall Study||0
3176628|NCT01967576|3904511|FG000|STARTED|Overall Study||14
3176629|NCT01967576|3904511|FG000|COMPLETED|Overall Study||7
3176630|NCT01967576|3904511|FG000|NOT COMPLETED|Overall Study||7
3176631|NCT01967628|3904517|FG000|STARTED|Overall Study||48
3176632|NCT01967628|3904518|FG001|STARTED|Overall Study||50
3176633|NCT01967628|3904517|FG000|COMPLETED|Overall Study||21
3330775|NCT03298880|4063209|FG000|STARTED|Overall Study||75
3330776|NCT03298880|4063209|FG000|COMPLETED|Overall Study||75
3330777|NCT03298880|4063209|FG000|NOT COMPLETED|Overall Study||0
3330778|NCT03298984|4063224|FG000|STARTED|Overall Study||3
3330779|NCT03298984|4063225|FG001|STARTED|Overall Study||3
3330780|NCT03298984|4063226|FG002|STARTED|Overall Study||3
3330781|NCT03298984|4063227|FG003|STARTED|Overall Study||23
3330782|NCT03298984|4063224|FG000|COMPLETED|Overall Study||2
3330783|NCT03298984|4063225|FG001|COMPLETED|Overall Study||2
3330784|NCT03298984|4063226|FG002|COMPLETED|Overall Study||1
3330785|NCT03298984|4063227|FG003|COMPLETED|Overall Study||8
3330786|NCT03298984|4063224|FG000|NOT COMPLETED|Overall Study||1
3330787|NCT03298984|4063225|FG001|NOT COMPLETED|Overall Study||1
3330788|NCT03298984|4063226|FG002|NOT COMPLETED|Overall Study||2
3330789|NCT03298984|4063227|FG003|NOT COMPLETED|Overall Study||15
3330790|NCT03299049|4063240|FG000|STARTED|Overall Study||522
3330791|NCT03299049|4063241|FG001|STARTED|Overall Study||523
3330792|NCT03299049|4063240|FG000|COMPLETED|Overall Study||0
3330793|NCT03299049|4063241|FG001|COMPLETED|Overall Study||0
3330794|NCT03299049|4063240|FG000|NOT COMPLETED|Overall Study||522
3330795|NCT03299049|4063241|FG001|NOT COMPLETED|Overall Study||523
3330796|NCT03299101|4063254|FG000|STARTED|Overall Study||35
3330797|NCT03299101|4063254|FG000|COMPLETED|Overall Study||25
3330798|NCT03299101|4063254|FG000|NOT COMPLETED|Overall Study||10
3330799|NCT03299244|4063260|FG000|STARTED|Overall Study||317
3330800|NCT03299244|4063261|FG001|STARTED|Overall Study||320
3176634|NCT01967628|3904518|FG001|COMPLETED|Overall Study||19
3330801|NCT03299244|4063260|FG000|Received Treatment|Overall Study||315
3330802|NCT03299244|4063261|FG001|Received Treatment|Overall Study||318
3176635|NCT01967628|3904517|FG000|NOT COMPLETED|Overall Study||27
3330803|NCT03299244|4063260|FG000|COMPLETED|Overall Study||270
3330804|NCT03299244|4063261|FG001|COMPLETED|Overall Study||282
3330805|NCT03299244|4063260|FG000|NOT COMPLETED|Overall Study||47
3330806|NCT03299244|4063261|FG001|NOT COMPLETED|Overall Study||38
3330807|NCT03299686|4063270|FG000|STARTED|Treatment Epoch||70
3330808|NCT03299686|4063271|FG001|STARTED|Treatment Epoch||48
3330809|NCT03299686|4063270|FG000|PD (Pharmacodynamics) Analysis Set|Treatment Epoch||69
3330810|NCT03299686|4063271|FG001|PD (Pharmacodynamics) Analysis Set|Treatment Epoch||48
3330811|NCT03299686|4063270|FG000|COMPLETED|Treatment Epoch||59
3330812|NCT03299686|4063271|FG001|COMPLETED|Treatment Epoch||44
3330813|NCT03299686|4063270|FG000|NOT COMPLETED|Treatment Epoch||11
3330814|NCT03299686|4063271|FG001|NOT COMPLETED|Treatment Epoch||4
3330815|NCT03299686|4063270|FG000|STARTED|Follow-up Epoch||59
3330816|NCT03299686|4063271|FG001|STARTED|Follow-up Epoch||44
3330817|NCT03299686|4063270|FG000|COMPLETED|Follow-up Epoch||59
3330818|NCT03299686|4063271|FG001|COMPLETED|Follow-up Epoch||43
3330819|NCT03299686|4063270|FG000|NOT COMPLETED|Follow-up Epoch||0
3330820|NCT03299686|4063271|FG001|NOT COMPLETED|Follow-up Epoch||1
3330821|NCT03299881|4063279|FG000|STARTED|Overall Study||39
3330822|NCT03299881|4063280|FG001|STARTED|Overall Study||38
3330823|NCT03299881|4063279|FG000|COMPLETED|Overall Study||22
3330824|NCT03299881|4063280|FG001|COMPLETED|Overall Study||25
3330825|NCT03299881|4063279|FG000|NOT COMPLETED|Overall Study||17
3330826|NCT03299881|4063280|FG001|NOT COMPLETED|Overall Study||13
3330827|NCT03300050|4063291|FG000|STARTED|Overall Study||20
3330828|NCT03300050|4063292|FG001|STARTED|Overall Study||15
3330829|NCT03300050|4063293|FG002|STARTED|Overall Study||5
3330830|NCT03300050|4063294|FG003|STARTED|Overall Study||16
3330831|NCT03300050|4063295|FG004|STARTED|Overall Study||10
3330832|NCT03300050|4063291|FG000|Received Treatment|Overall Study||19
3330833|NCT03300050|4063292|FG001|Received Treatment|Overall Study||14
3330834|NCT03300050|4063293|FG002|Received Treatment|Overall Study||3
3330835|NCT03300050|4063294|FG003|Received Treatment|Overall Study||15
3330836|NCT03300050|4063295|FG004|Received Treatment|Overall Study||10
3330837|NCT03300050|4063291|FG000|Received All Scheduled Treatments|Overall Study||16
3330838|NCT03300050|4063292|FG001|Received All Scheduled Treatments|Overall Study||13
3330839|NCT03300050|4063293|FG002|Received All Scheduled Treatments|Overall Study||2
3330840|NCT03300050|4063294|FG003|Received All Scheduled Treatments|Overall Study||15
3330841|NCT03300050|4063295|FG004|Received All Scheduled Treatments|Overall Study||10
3176636|NCT01967628|3904518|FG001|NOT COMPLETED|Overall Study||31
3176637|NCT01967641|3904524|FG000|STARTED|Randomized||51
3176638|NCT01967641|3904524|FG000|COMPLETED|Randomized|Completed week 12|43
3176639|NCT01967641|3904524|FG000|NOT COMPLETED|Randomized||8
3176640|NCT01967641|3904524|FG000|STARTED|Admission to Inpatient Phase||43
3330842|NCT03300050|4063291|FG000|COMPLETED|Overall Study||17
3330843|NCT03300050|4063292|FG001|COMPLETED|Overall Study||13
3330844|NCT03300050|4063293|FG002|COMPLETED|Overall Study||2
3330845|NCT03300050|4063294|FG003|COMPLETED|Overall Study||15
3330846|NCT03300050|4063295|FG004|COMPLETED|Overall Study||9
3330847|NCT03300050|4063291|FG000|NOT COMPLETED|Overall Study||3
3330848|NCT03300050|4063292|FG001|NOT COMPLETED|Overall Study||2
3330849|NCT03300050|4063293|FG002|NOT COMPLETED|Overall Study||3
3330850|NCT03300050|4063294|FG003|NOT COMPLETED|Overall Study||1
3330851|NCT03300050|4063295|FG004|NOT COMPLETED|Overall Study||1
3330852|NCT03300466|4063309|FG000|STARTED|Overall Study||10
3330853|NCT03300466|4063310|FG001|STARTED|Overall Study||10
3330854|NCT03300466|4063309|FG000|COMPLETED|Overall Study||9
3330855|NCT03300466|4063310|FG001|COMPLETED|Overall Study||10
3330856|NCT03300466|4063309|FG000|NOT COMPLETED|Overall Study||1
3330857|NCT03300466|4063310|FG001|NOT COMPLETED|Overall Study||0
3330858|NCT03300570|4063318|FG000|STARTED|Overall Study||13
3330859|NCT03300570|4063319|FG001|STARTED|Overall Study||14
3330860|NCT03300570|4063318|FG000|COMPLETED|Overall Study||11
3330861|NCT03300570|4063319|FG001|COMPLETED|Overall Study||13
3330862|NCT03300570|4063318|FG000|NOT COMPLETED|Overall Study||2
3330863|NCT03300570|4063319|FG001|NOT COMPLETED|Overall Study||1
3330864|NCT03300674|4063328|FG000|STARTED|Overall Study||77
3330865|NCT03300674|4063329|FG001|STARTED|Overall Study||77
3330866|NCT03300674|4063328|FG000|COMPLETED|Overall Study||77
3330867|NCT03300674|4063329|FG001|COMPLETED|Overall Study||77
3330868|NCT03300674|4063328|FG000|NOT COMPLETED|Overall Study||0
3330869|NCT03300674|4063329|FG001|NOT COMPLETED|Overall Study||0
3330870|NCT03300752|4063337|FG000|STARTED|Overall Study||40
3330871|NCT03300752|4063338|FG001|STARTED|Overall Study||40
3330872|NCT03300752|4063337|FG000|COMPLETED|Overall Study||38
3330873|NCT03300752|4063338|FG001|COMPLETED|Overall Study||38
3330874|NCT03300752|4063337|FG000|NOT COMPLETED|Overall Study||2
3330875|NCT03300752|4063338|FG001|NOT COMPLETED|Overall Study||2
3330876|NCT03300843|4063344|FG000|STARTED|Overall Study||1
3330877|NCT03300843|4063344|FG000|COMPLETED|Overall Study||1
3330878|NCT03300843|4063344|FG000|NOT COMPLETED|Overall Study||0
3330879|NCT03301155|4063350|FG000|STARTED|Overall Study||528
3330880|NCT03301155|4063351|FG001|STARTED|Overall Study||508
3330881|NCT03301155|4063350|FG000|COMPLETED|Overall Study||520
3330882|NCT03301155|4063351|FG001|COMPLETED|Overall Study||501
3330883|NCT03301155|4063350|FG000|NOT COMPLETED|Overall Study||8
3330884|NCT03301155|4063351|FG001|NOT COMPLETED|Overall Study||7
3330885|NCT03301272|4063359|FG000|STARTED|First Intervention (30 Days)||7
3330886|NCT03301272|4063360|FG001|STARTED|First Intervention (30 Days)||9
3330887|NCT03301272|4063359|FG000|COMPLETED|First Intervention (30 Days)||7
3330888|NCT03301272|4063360|FG001|COMPLETED|First Intervention (30 Days)||9
3330889|NCT03301272|4063359|FG000|NOT COMPLETED|First Intervention (30 Days)||0
3330890|NCT03301272|4063360|FG001|NOT COMPLETED|First Intervention (30 Days)||0
3330891|NCT03301272|4063359|FG000|STARTED|Washout (90 Days From 1st Intervention)||7
3176641|NCT01967641|3904524|FG000|COMPLETED|Admission to Inpatient Phase|Completed 7 week inpatient phase|31
3176642|NCT01967641|3904524|FG000|NOT COMPLETED|Admission to Inpatient Phase||12
3176643|NCT01967641|3904524|FG000|STARTED|12-week Outpatient Phase||31
3176644|NCT01967641|3904524|FG000|COMPLETED|12-week Outpatient Phase|Completed week 12 of outpatient phase|18
3176645|NCT01967641|3904524|FG000|NOT COMPLETED|12-week Outpatient Phase||13
3176646|NCT01967706|3904531|FG000|STARTED|Washout Period of 1 Day (Day 0)||22
3176647|NCT01967706|3904532|FG001|STARTED|Washout Period of 1 Day (Day 0)||22
3176648|NCT01967706|3904533|FG002|STARTED|Washout Period of 1 Day (Day 0)||9
3176649|NCT01967706|3904534|FG003|STARTED|Washout Period of 1 Day (Day 0)||9
3176650|NCT01967706|3904531|FG000|COMPLETED|Washout Period of 1 Day (Day 0)||22
3330892|NCT03301272|4063360|FG001|STARTED|Washout (90 Days From 1st Intervention)||9
3330893|NCT03301272|4063359|FG000|COMPLETED|Washout (90 Days From 1st Intervention)||7
3330894|NCT03301272|4063360|FG001|COMPLETED|Washout (90 Days From 1st Intervention)||9
3330895|NCT03301272|4063359|FG000|NOT COMPLETED|Washout (90 Days From 1st Intervention)||0
3330896|NCT03301272|4063360|FG001|NOT COMPLETED|Washout (90 Days From 1st Intervention)||0
3330897|NCT03301272|4063359|FG000|STARTED|Second Intervention (30 Days)||7
3330898|NCT03301272|4063360|FG001|STARTED|Second Intervention (30 Days)||9
3330899|NCT03301272|4063359|FG000|COMPLETED|Second Intervention (30 Days)||7
3330900|NCT03301272|4063360|FG001|COMPLETED|Second Intervention (30 Days)||9
3330901|NCT03301272|4063359|FG000|NOT COMPLETED|Second Intervention (30 Days)||0
3330902|NCT03301272|4063360|FG001|NOT COMPLETED|Second Intervention (30 Days)||0
3330903|NCT03301298|4063373|FG000|STARTED|Unfed Conditions||6
3330904|NCT03301298|4063374|FG001|STARTED|Unfed Conditions||6
3330905|NCT03301298|4063375|FG002|STARTED|Unfed Conditions||6
3330906|NCT03301298|4063376|FG003|STARTED|Unfed Conditions||6
3330907|NCT03301298|4063377|FG004|STARTED|Unfed Conditions||6
3330908|NCT03301298|4063378|FG005|STARTED|Unfed Conditions||6
3330909|NCT03301298|4063379|FG006|STARTED|Unfed Conditions||12
3330910|NCT03301298|4063373|FG000|COMPLETED|Unfed Conditions||6
3330911|NCT03301298|4063374|FG001|COMPLETED|Unfed Conditions||6
3330912|NCT03301298|4063375|FG002|COMPLETED|Unfed Conditions||6
3330913|NCT03301298|4063376|FG003|COMPLETED|Unfed Conditions||6
3330914|NCT03301298|4063377|FG004|COMPLETED|Unfed Conditions||6
3330915|NCT03301298|4063378|FG005|COMPLETED|Unfed Conditions||6
3330916|NCT03301298|4063379|FG006|COMPLETED|Unfed Conditions||12
3330917|NCT03301298|4063373|FG000|NOT COMPLETED|Unfed Conditions||0
3330918|NCT03301298|4063374|FG001|NOT COMPLETED|Unfed Conditions||0
3176651|NCT01967706|3904532|FG001|COMPLETED|Washout Period of 1 Day (Day 0)||22
3330919|NCT03301298|4063375|FG002|NOT COMPLETED|Unfed Conditions||0
3330920|NCT03301298|4063376|FG003|NOT COMPLETED|Unfed Conditions||0
3330921|NCT03301298|4063377|FG004|NOT COMPLETED|Unfed Conditions||0
3330922|NCT03301298|4063378|FG005|NOT COMPLETED|Unfed Conditions||0
3330923|NCT03301298|4063379|FG006|NOT COMPLETED|Unfed Conditions||0
3330924|NCT03301298|4063373|FG000|STARTED|Fed Conditions||0
3330925|NCT03301298|4063374|FG001|STARTED|Fed Conditions||0
3330926|NCT03301298|4063375|FG002|STARTED|Fed Conditions||0
3330927|NCT03301298|4063376|FG003|STARTED|Fed Conditions||0
3330928|NCT03301298|4063377|FG004|STARTED|Fed Conditions||5
3330929|NCT03301298|4063378|FG005|STARTED|Fed Conditions||0
3330930|NCT03301298|4063379|FG006|STARTED|Fed Conditions||2
3330931|NCT03301298|4063373|FG000|COMPLETED|Fed Conditions||0
3330932|NCT03301298|4063374|FG001|COMPLETED|Fed Conditions||0
3330933|NCT03301298|4063375|FG002|COMPLETED|Fed Conditions||0
3330934|NCT03301298|4063376|FG003|COMPLETED|Fed Conditions||0
3330935|NCT03301298|4063377|FG004|COMPLETED|Fed Conditions||5
3330936|NCT03301298|4063378|FG005|COMPLETED|Fed Conditions||0
3330937|NCT03301298|4063379|FG006|COMPLETED|Fed Conditions||2
3330938|NCT03301298|4063373|FG000|NOT COMPLETED|Fed Conditions||0
3330939|NCT03301298|4063374|FG001|NOT COMPLETED|Fed Conditions||0
3330940|NCT03301298|4063375|FG002|NOT COMPLETED|Fed Conditions||0
3330941|NCT03301298|4063376|FG003|NOT COMPLETED|Fed Conditions||0
3330942|NCT03301298|4063377|FG004|NOT COMPLETED|Fed Conditions||0
3330943|NCT03301298|4063378|FG005|NOT COMPLETED|Fed Conditions||0
3330944|NCT03301298|4063379|FG006|NOT COMPLETED|Fed Conditions||0
3330945|NCT03301623|4063398|FG000|STARTED|Overall Study||462
3330946|NCT03301623|4063399|FG001|STARTED|Overall Study||521
3330947|NCT03301623|4063398|FG000|COMPLETED|Overall Study||445
3330948|NCT03301623|4063399|FG001|COMPLETED|Overall Study||506
3330949|NCT03301623|4063398|FG000|NOT COMPLETED|Overall Study||17
3330950|NCT03301623|4063399|FG001|NOT COMPLETED|Overall Study||15
3330951|NCT03301649|4063408|FG000|STARTED|Overall Study||399
3330952|NCT03301649|4063409|FG001|STARTED|Overall Study||400
3330953|NCT03301649|4063410|FG002|STARTED|Overall Study||112
3330954|NCT03301649|4063408|FG000|Safety Population|Overall Study||399
3330955|NCT03301649|4063409|FG001|Safety Population|Overall Study||400
3330956|NCT03301649|4063410|FG002|Safety Population|Overall Study||112
3330957|NCT03301649|4063408|FG000|Modified Intent-to-treat(mITT)Population|Overall Study||372
3330958|NCT03301649|4063409|FG001|Modified Intent-to-treat(mITT)Population|Overall Study||380
3330959|NCT03301649|4063410|FG002|Modified Intent-to-treat(mITT)Population|Overall Study||111
3330960|NCT03301649|4063408|FG000|Per-protocol (PP) Population|Overall Study||345
3330961|NCT03301649|4063409|FG001|Per-protocol (PP) Population|Overall Study||354
3330962|NCT03301649|4063410|FG002|Per-protocol (PP) Population|Overall Study||103
3330963|NCT03301649|4063408|FG000|COMPLETED|Overall Study||356
3330964|NCT03301649|4063409|FG001|COMPLETED|Overall Study||356
3330965|NCT03301649|4063410|FG002|COMPLETED|Overall Study||27
3330966|NCT03301649|4063408|FG000|NOT COMPLETED|Overall Study||43
3330967|NCT03301649|4063409|FG001|NOT COMPLETED|Overall Study||44
3330968|NCT03301649|4063410|FG002|NOT COMPLETED|Overall Study||85
3330969|NCT03301714|4063421|FG000|STARTED|Overall Study||60
3330970|NCT03301714|4063422|FG001|STARTED|Overall Study||60
3330971|NCT03301714|4063423|FG002|STARTED|Overall Study||60
3330972|NCT03301714|4063421|FG000|COMPLETED|Overall Study||50
3330973|NCT03301714|4063422|FG001|COMPLETED|Overall Study||54
3330974|NCT03301714|4063423|FG002|COMPLETED|Overall Study||53
3330975|NCT03301714|4063421|FG000|NOT COMPLETED|Overall Study||10
3330976|NCT03301714|4063422|FG001|NOT COMPLETED|Overall Study||6
3330977|NCT03301714|4063423|FG002|NOT COMPLETED|Overall Study||7
3330978|NCT03301740|4063436|FG000|STARTED|Phase 1 Intervention (3 Weeks)||18
3330979|NCT03301740|4063437|FG001|STARTED|Phase 1 Intervention (3 Weeks)||16
3330980|NCT03301740|4063436|FG000|COMPLETED|Phase 1 Intervention (3 Weeks)||18
3330981|NCT03301740|4063437|FG001|COMPLETED|Phase 1 Intervention (3 Weeks)||16
3330982|NCT03301740|4063436|FG000|NOT COMPLETED|Phase 1 Intervention (3 Weeks)||0
3330983|NCT03301740|4063437|FG001|NOT COMPLETED|Phase 1 Intervention (3 Weeks)||0
3330984|NCT03301740|4063436|FG000|STARTED|First Washout (1 Week)||18
3330985|NCT03301740|4063437|FG001|STARTED|First Washout (1 Week)||16
3330986|NCT03301740|4063436|FG000|COMPLETED|First Washout (1 Week)||18
3330987|NCT03301740|4063437|FG001|COMPLETED|First Washout (1 Week)||16
3330988|NCT03301740|4063436|FG000|NOT COMPLETED|First Washout (1 Week)||0
3330989|NCT03301740|4063437|FG001|NOT COMPLETED|First Washout (1 Week)||0
3330990|NCT03301740|4063436|FG000|STARTED|Phase 2 Intervention (3 Weeks)||18
3330991|NCT03301740|4063437|FG001|STARTED|Phase 2 Intervention (3 Weeks)||16
3330992|NCT03301740|4063436|FG000|COMPLETED|Phase 2 Intervention (3 Weeks)||17
3330993|NCT03301740|4063437|FG001|COMPLETED|Phase 2 Intervention (3 Weeks)||16
3330994|NCT03301740|4063436|FG000|NOT COMPLETED|Phase 2 Intervention (3 Weeks)||1
3330995|NCT03301740|4063437|FG001|NOT COMPLETED|Phase 2 Intervention (3 Weeks)||0
3330996|NCT03301740|4063436|FG000|STARTED|Second Washout (1 Week)||17
3330997|NCT03301740|4063437|FG001|STARTED|Second Washout (1 Week)||16
3330998|NCT03301740|4063436|FG000|COMPLETED|Second Washout (1 Week)||17
3330999|NCT03301740|4063437|FG001|COMPLETED|Second Washout (1 Week)||16
3331000|NCT03301740|4063436|FG000|NOT COMPLETED|Second Washout (1 Week)||0
3331001|NCT03301740|4063437|FG001|NOT COMPLETED|Second Washout (1 Week)||0
3331002|NCT03301740|4063436|FG000|STARTED|Phase 3 Intervention (3 Weeks)||17
3331003|NCT03301740|4063437|FG001|STARTED|Phase 3 Intervention (3 Weeks)||16
3331004|NCT03301740|4063436|FG000|COMPLETED|Phase 3 Intervention (3 Weeks)||17
3331005|NCT03301740|4063437|FG001|COMPLETED|Phase 3 Intervention (3 Weeks)||16
3331006|NCT03301740|4063436|FG000|NOT COMPLETED|Phase 3 Intervention (3 Weeks)||0
3331007|NCT03301740|4063437|FG001|NOT COMPLETED|Phase 3 Intervention (3 Weeks)||0
3331008|NCT03301740|4063436|FG000|STARTED|Third Washout (1 Week)||17
3331009|NCT03301740|4063437|FG001|STARTED|Third Washout (1 Week)||16
3331010|NCT03301740|4063436|FG000|COMPLETED|Third Washout (1 Week)||17
3331011|NCT03301740|4063437|FG001|COMPLETED|Third Washout (1 Week)||16
3331012|NCT03301740|4063436|FG000|NOT COMPLETED|Third Washout (1 Week)||0
3331013|NCT03301740|4063437|FG001|NOT COMPLETED|Third Washout (1 Week)||0
3331014|NCT03301740|4063436|FG000|STARTED|Phase 4 Intervention (3 Weeks)||17
3331015|NCT03301740|4063437|FG001|STARTED|Phase 4 Intervention (3 Weeks)||16
3331016|NCT03301740|4063436|FG000|COMPLETED|Phase 4 Intervention (3 Weeks)||16
3331017|NCT03301740|4063437|FG001|COMPLETED|Phase 4 Intervention (3 Weeks)||16
3331018|NCT03301740|4063436|FG000|NOT COMPLETED|Phase 4 Intervention (3 Weeks)||1
3331019|NCT03301740|4063437|FG001|NOT COMPLETED|Phase 4 Intervention (3 Weeks)||0
3331020|NCT03301779|4063443|FG000|STARTED|Overall Study||48
3331021|NCT03301779|4063444|FG001|STARTED|Overall Study||52
3331022|NCT03301779|4063443|FG000|COMPLETED|Overall Study||40
3331023|NCT03301779|4063444|FG001|COMPLETED|Overall Study||45
3331024|NCT03301779|4063443|FG000|NOT COMPLETED|Overall Study||8
3331025|NCT03301779|4063444|FG001|NOT COMPLETED|Overall Study||7
3331026|NCT03301831|4063452|FG000|STARTED|Overall Study||46
3331027|NCT03301831|4063453|FG001|STARTED|Overall Study||47
3331028|NCT03301831|4063452|FG000|COMPLETED|Overall Study||26
3331029|NCT03301831|4063453|FG001|COMPLETED|Overall Study||44
3331030|NCT03301831|4063452|FG000|NOT COMPLETED|Overall Study||20
3331031|NCT03301831|4063453|FG001|NOT COMPLETED|Overall Study||3
3331032|NCT03301844|4063461|FG000|STARTED|Overall Study|Each patient apply the Blephapad Combo wipes to one eye and standard treatment to the other eye.|19
3331033|NCT03301844|4063462|FG001|STARTED|Overall Study|Each patient apply the Blephapad Combo wipes to one eye and standard treatment to the other eye.|19
3331034|NCT03301844|4063461|FG000|COMPLETED|Overall Study||18
3331035|NCT03301844|4063462|FG001|COMPLETED|Overall Study||18
3331036|NCT03301844|4063461|FG000|NOT COMPLETED|Overall Study||1
3331037|NCT03301844|4063462|FG001|NOT COMPLETED|Overall Study||1
3331038|NCT03302091|4063470|FG000|STARTED|Overall Study||10
3331039|NCT03302091|4063471|FG001|STARTED|Overall Study||10
3331040|NCT03302091|4063470|FG000|COMPLETED|Overall Study||10
3331041|NCT03302091|4063471|FG001|COMPLETED|Overall Study||10
3331042|NCT03302091|4063470|FG000|NOT COMPLETED|Overall Study||0
3331043|NCT03302091|4063471|FG001|NOT COMPLETED|Overall Study||0
3331044|NCT03302234|4063479|FG000|STARTED|Overall Study||284
3331045|NCT03302234|4063480|FG001|STARTED|Overall Study||284
3331046|NCT03302234|4063479|FG000|COMPLETED|Overall Study||146
3331047|NCT03302234|4063480|FG001|COMPLETED|Overall Study||147
3331048|NCT03302234|4063479|FG000|NOT COMPLETED|Overall Study||138
3331049|NCT03302234|4063480|FG001|NOT COMPLETED|Overall Study||137
3331050|NCT03302416|4063487|FG000|STARTED|Overall Study||19
3331051|NCT03302416|4063487|FG000|COMPLETED|Overall Study||19
3331052|NCT03302416|4063487|FG000|NOT COMPLETED|Overall Study||0
3331053|NCT03302559|4063491|FG000|STARTED|Overall Study||29
3331054|NCT03302559|4063491|FG000|COMPLETED|Overall Study||23
3331055|NCT03302559|4063491|FG000|NOT COMPLETED|Overall Study||6
3331056|NCT03302741|4063497|FG000|STARTED|Overall Study||8
3331057|NCT03302741|4063498|FG001|STARTED|Overall Study||9
3331058|NCT03302741|4063497|FG000|COMPLETED|Overall Study||7
3331059|NCT03302741|4063498|FG001|COMPLETED|Overall Study||8
3331060|NCT03302741|4063497|FG000|NOT COMPLETED|Overall Study||1
3331061|NCT03302741|4063498|FG001|NOT COMPLETED|Overall Study||1
3331062|NCT03302767|4063504|FG000|STARTED|Overall Study||29
3331063|NCT03302767|4063504|FG000|COMPLETED|Overall Study||29
3331064|NCT03302767|4063504|FG000|NOT COMPLETED|Overall Study||0
3331065|NCT03302780|4063508|FG000|STARTED|Overall Study||3
3331066|NCT03302780|4063509|FG001|STARTED|Overall Study||3
3331067|NCT03302780|4063508|FG000|COMPLETED|Overall Study||3
3331068|NCT03302780|4063509|FG001|COMPLETED|Overall Study||3
3331069|NCT03302780|4063508|FG000|NOT COMPLETED|Overall Study||0
3331070|NCT03302780|4063509|FG001|NOT COMPLETED|Overall Study||0
3331071|NCT03302793|4063515|FG000|STARTED|Overall Study||6
3331072|NCT03302793|4063516|FG001|STARTED|Overall Study||6
3331073|NCT03302793|4063515|FG000|COMPLETED|Overall Study||6
3331074|NCT03302793|4063516|FG001|COMPLETED|Overall Study||4
3331075|NCT03302793|4063515|FG000|NOT COMPLETED|Overall Study||0
3331076|NCT03302793|4063516|FG001|NOT COMPLETED|Overall Study||2
3331077|NCT03302936|4063524|FG000|STARTED|Overall Study||49
3331078|NCT03302936|4063525|FG001|STARTED|Overall Study||49
3331079|NCT03302936|4063524|FG000|COMPLETED|Overall Study||46
3331080|NCT03302936|4063525|FG001|COMPLETED|Overall Study||45
3331081|NCT03302936|4063524|FG000|NOT COMPLETED|Overall Study||3
3331082|NCT03302936|4063525|FG001|NOT COMPLETED|Overall Study||4
3331083|NCT03302975|4063535|FG000|STARTED|Overall Study||16
3331084|NCT03302975|4063535|FG000|COMPLETED|Overall Study||12
3331085|NCT03302975|4063535|FG000|NOT COMPLETED|Overall Study||4
3331086|NCT03303079|4063542|FG000|STARTED|Overall Study||189
3331087|NCT03303079|4063543|FG001|STARTED|Overall Study||191
3331088|NCT03303079|4063544|FG002|STARTED|Overall Study||191
3331089|NCT03303079|4063542|FG000|COMPLETED|Overall Study||182
3331090|NCT03303079|4063543|FG001|COMPLETED|Overall Study||180
3331091|NCT03303079|4063544|FG002|COMPLETED|Overall Study||179
3331092|NCT03303079|4063542|FG000|NOT COMPLETED|Overall Study||7
3331093|NCT03303079|4063543|FG001|NOT COMPLETED|Overall Study||11
3331094|NCT03303079|4063544|FG002|NOT COMPLETED|Overall Study||12
3331095|NCT03303092|4063555|FG000|STARTED|Overall Study||121
3331096|NCT03303092|4063556|FG001|STARTED|Overall Study||119
3331097|NCT03303092|4063557|FG002|STARTED|Overall Study||117
3331098|NCT03303092|4063555|FG000|COMPLETED|Overall Study||118
3331099|NCT03303092|4063556|FG001|COMPLETED|Overall Study||113
3331100|NCT03303092|4063557|FG002|COMPLETED|Overall Study||112
3331101|NCT03303092|4063555|FG000|NOT COMPLETED|Overall Study||3
3331102|NCT03303092|4063556|FG001|NOT COMPLETED|Overall Study||6
3331103|NCT03303092|4063557|FG002|NOT COMPLETED|Overall Study||5
3331104|NCT03303105|4063567|FG000|STARTED|Overall Study||25
3331105|NCT03303105|4063568|FG001|STARTED|Overall Study||25
3331106|NCT03303105|4063567|FG000|COMPLETED|Overall Study||23
3331107|NCT03303105|4063568|FG001|COMPLETED|Overall Study||21
3331108|NCT03303105|4063567|FG000|NOT COMPLETED|Overall Study||2
3331109|NCT03303105|4063568|FG001|NOT COMPLETED|Overall Study||4
3331110|NCT03303144|4063574|FG000|STARTED|Triferic Via Hemodialysate (Day 3)||26
3331111|NCT03303144|4063575|FG001|STARTED|Triferic Via Hemodialysate (Day 3)||0
3331112|NCT03303144|4063576|FG002|STARTED|Triferic Via Hemodialysate (Day 3)||0
3331113|NCT03303144|4063574|FG000|COMPLETED|Triferic Via Hemodialysate (Day 3)||26
3331114|NCT03303144|4063575|FG001|COMPLETED|Triferic Via Hemodialysate (Day 3)||0
3331115|NCT03303144|4063576|FG002|COMPLETED|Triferic Via Hemodialysate (Day 3)||0
3331116|NCT03303144|4063574|FG000|NOT COMPLETED|Triferic Via Hemodialysate (Day 3)||0
3331117|NCT03303144|4063575|FG001|NOT COMPLETED|Triferic Via Hemodialysate (Day 3)||0
3331118|NCT03303144|4063576|FG002|NOT COMPLETED|Triferic Via Hemodialysate (Day 3)||0
3331119|NCT03303144|4063574|FG000|STARTED|Triferic Via IV Infusion (Day 8)||0
3331120|NCT03303144|4063575|FG001|STARTED|Triferic Via IV Infusion (Day 8)||26
3331121|NCT03303144|4063576|FG002|STARTED|Triferic Via IV Infusion (Day 8)||0
3331122|NCT03303144|4063574|FG000|COMPLETED|Triferic Via IV Infusion (Day 8)||0
3331123|NCT03303144|4063575|FG001|COMPLETED|Triferic Via IV Infusion (Day 8)||25
3331124|NCT03303144|4063576|FG002|COMPLETED|Triferic Via IV Infusion (Day 8)||0
3331125|NCT03303144|4063574|FG000|NOT COMPLETED|Triferic Via IV Infusion (Day 8)||0
3331126|NCT03303144|4063575|FG001|NOT COMPLETED|Triferic Via IV Infusion (Day 8)||1
3331127|NCT03303144|4063576|FG002|NOT COMPLETED|Triferic Via IV Infusion (Day 8)||0
3331128|NCT03303144|4063574|FG000|STARTED|Triferic Via IV Infusion (Day 10)||0
3331129|NCT03303144|4063575|FG001|STARTED|Triferic Via IV Infusion (Day 10)||0
3331130|NCT03303144|4063576|FG002|STARTED|Triferic Via IV Infusion (Day 10)||26
3331131|NCT03303144|4063574|FG000|COMPLETED|Triferic Via IV Infusion (Day 10)||0
3331132|NCT03303144|4063575|FG001|COMPLETED|Triferic Via IV Infusion (Day 10)||0
3331133|NCT03303144|4063576|FG002|COMPLETED|Triferic Via IV Infusion (Day 10)||25
3331134|NCT03303144|4063574|FG000|NOT COMPLETED|Triferic Via IV Infusion (Day 10)||0
3039800|NCT01160744|3759284|FG001|STARTED|Overall Study||69
3039801|NCT01160744|3759285|FG002|STARTED|Overall Study||69
3039802|NCT01160744|3759286|FG003|STARTED|Overall Study||71
3331135|NCT03303144|4063575|FG001|NOT COMPLETED|Triferic Via IV Infusion (Day 10)||0
3331136|NCT03303144|4063576|FG002|NOT COMPLETED|Triferic Via IV Infusion (Day 10)||1
3331137|NCT03303196|4063587|FG000|STARTED|Overall Study|Individuals who were assigned to BHBP admission then SC admission.|5
3331138|NCT03303196|4063588|FG001|STARTED|Overall Study|Individuals who were assigned to SC admission then BHBP admission.|5
3331139|NCT03303196|4063587|FG000|Washout|Overall Study||5
3331140|NCT03303196|4063588|FG001|Washout|Overall Study||5
3331141|NCT03303196|4063587|FG000|COMPLETED|Overall Study||5
3331142|NCT03303196|4063588|FG001|COMPLETED|Overall Study||5
3331143|NCT03303196|4063587|FG000|NOT COMPLETED|Overall Study||0
3331144|NCT03303196|4063588|FG001|NOT COMPLETED|Overall Study||0
3331145|NCT03303404|4063593|FG000|STARTED|Overall Study||22
3331146|NCT03303404|4063593|FG000|COMPLETED|Overall Study||22
3331147|NCT03303404|4063593|FG000|NOT COMPLETED|Overall Study||0
3331148|NCT03303417|4063597|FG000|STARTED|Overall Study||8
3331149|NCT03303417|4063598|FG001|STARTED|Overall Study||8
3331150|NCT03303417|4063597|FG000|COMPLETED|Overall Study||7
3331151|NCT03303417|4063598|FG001|COMPLETED|Overall Study||7
3331152|NCT03303417|4063597|FG000|NOT COMPLETED|Overall Study||1
3331153|NCT03303417|4063598|FG001|NOT COMPLETED|Overall Study||1
3331154|NCT03303521|4063606|FG000|STARTED|Overall Study||97
3331155|NCT03303521|4063607|FG001|STARTED|Overall Study||99
3331156|NCT03303521|4063606|FG000|COMPLETED|Overall Study||92
3331157|NCT03303521|4063607|FG001|COMPLETED|Overall Study||96
3331158|NCT03303521|4063606|FG000|NOT COMPLETED|Overall Study||5
3331159|NCT03303521|4063607|FG001|NOT COMPLETED|Overall Study||3
3331160|NCT03303794|4063615|FG000|STARTED|Overall Study||13
3331161|NCT03303794|4063616|FG001|STARTED|Overall Study||12
3331162|NCT03303794|4063615|FG000|COMPLETED|Overall Study||13
3331163|NCT03303794|4063616|FG001|COMPLETED|Overall Study||12
3331164|NCT03303794|4063615|FG000|NOT COMPLETED|Overall Study||0
3331165|NCT03303794|4063616|FG001|NOT COMPLETED|Overall Study||0
3331166|NCT03303911|4063624|FG000|STARTED|Overall Study||13
3331167|NCT03303911|4063625|FG001|STARTED|Overall Study||13
3331168|NCT03303911|4063624|FG000|COMPLETED|Overall Study||13
3331169|NCT03303911|4063625|FG001|COMPLETED|Overall Study||13
3331170|NCT03303911|4063624|FG000|NOT COMPLETED|Overall Study||0
3331171|NCT03303911|4063625|FG001|NOT COMPLETED|Overall Study||0
3331172|NCT03303950|4063631|FG000|STARTED|Overall Study||6
3331173|NCT03303950|4063631|FG000|COMPLETED|Overall Study||6
3331174|NCT03303950|4063631|FG000|NOT COMPLETED|Overall Study||0
3331175|NCT03303989|4063638|FG000|STARTED|Overall Study||24
3331176|NCT03303989|4063639|FG001|STARTED|Overall Study||11
3331177|NCT03303989|4063638|FG000|COMPLETED|Overall Study||22
3331178|NCT03303989|4063639|FG001|COMPLETED|Overall Study||10
3331179|NCT03303989|4063638|FG000|NOT COMPLETED|Overall Study||2
3331180|NCT03303989|4063639|FG001|NOT COMPLETED|Overall Study||1
3331181|NCT03304054|4063648|FG000|STARTED|Overall Study||27
3331182|NCT03304054|4063649|FG001|STARTED|Overall Study||7
3331183|NCT03304054|4063650|FG002|STARTED|Overall Study||28
3331184|NCT03304054|4063651|FG003|STARTED|Overall Study||8
3331185|NCT03304054|4063652|FG004|STARTED|Overall Study||17
3331186|NCT03304054|4063653|FG005|STARTED|Overall Study||6
3331187|NCT03304054|4063648|FG000|COMPLETED|Overall Study||27
3331188|NCT03304054|4063649|FG001|COMPLETED|Overall Study||7
3331189|NCT03304054|4063650|FG002|COMPLETED|Overall Study||27
3331190|NCT03304054|4063651|FG003|COMPLETED|Overall Study||8
3331191|NCT03304054|4063652|FG004|COMPLETED|Overall Study||0
3331192|NCT03304054|4063653|FG005|COMPLETED|Overall Study||0
3331193|NCT03304054|4063648|FG000|NOT COMPLETED|Overall Study||0
3331194|NCT03304054|4063649|FG001|NOT COMPLETED|Overall Study||0
3331195|NCT03304054|4063650|FG002|NOT COMPLETED|Overall Study||1
3331196|NCT03304054|4063651|FG003|NOT COMPLETED|Overall Study||0
3331197|NCT03304054|4063652|FG004|NOT COMPLETED|Overall Study||17
3331198|NCT03304054|4063653|FG005|NOT COMPLETED|Overall Study||6
3331199|NCT03304106|4063664|FG000|STARTED|Overall Study||44
3331200|NCT03304106|4063665|FG001|STARTED|Overall Study||58
3331201|NCT03304106|4063664|FG000|COMPLETED|Overall Study||31
3331202|NCT03304106|4063665|FG001|COMPLETED|Overall Study||56
3331203|NCT03304106|4063664|FG000|NOT COMPLETED|Overall Study||13
3331204|NCT03304106|4063665|FG001|NOT COMPLETED|Overall Study||2
3331205|NCT03304119|4063673|FG000|STARTED|Overall Study||37
3331206|NCT03304119|4063674|FG001|STARTED|Overall Study||55
3331207|NCT03304119|4063673|FG000|COMPLETED|Overall Study||37
3331208|NCT03304119|4063674|FG001|COMPLETED|Overall Study||55
3331209|NCT03304119|4063673|FG000|NOT COMPLETED|Overall Study||0
3331210|NCT03304119|4063674|FG001|NOT COMPLETED|Overall Study||0
3331211|NCT03304184|4063682|FG000|STARTED|Overall Study||15
3331212|NCT03304184|4063683|FG001|STARTED|Overall Study||9
3331213|NCT03304184|4063682|FG000|COMPLETED|Overall Study||14
3331214|NCT03304184|4063683|FG001|COMPLETED|Overall Study||7
3331215|NCT03304184|4063682|FG000|NOT COMPLETED|Overall Study||1
3331216|NCT03304184|4063683|FG001|NOT COMPLETED|Overall Study||2
3331217|NCT03304522|4063692|FG000|STARTED|Overall Study||46
3331218|NCT03304522|4063693|FG001|STARTED|Overall Study||43
3331219|NCT03304522|4063692|FG000|COMPLETED|Overall Study||45
3331220|NCT03304522|4063693|FG001|COMPLETED|Overall Study||35
3331221|NCT03304522|4063692|FG000|NOT COMPLETED|Overall Study||1
3331222|NCT03304522|4063693|FG001|NOT COMPLETED|Overall Study||8
3331223|NCT03304626|4063701|FG000|STARTED|Overall Study||20
3331224|NCT03304626|4063702|FG001|STARTED|Overall Study||20
3331225|NCT03304626|4063701|FG000|COMPLETED|Overall Study||18
3331226|NCT03304626|4063702|FG001|COMPLETED|Overall Study||19
3331227|NCT03304626|4063701|FG000|NOT COMPLETED|Overall Study||2
3331228|NCT03304626|4063702|FG001|NOT COMPLETED|Overall Study||1
3331229|NCT03304873|4063711|FG000|STARTED|Overall Study||23
3331230|NCT03304873|4063712|FG001|STARTED|Overall Study||24
3331231|NCT03304873|4063711|FG000|COMPLETED|Overall Study||22
3331232|NCT03304873|4063712|FG001|COMPLETED|Overall Study||16
3331233|NCT03304873|4063711|FG000|NOT COMPLETED|Overall Study||1
3331234|NCT03304873|4063712|FG001|NOT COMPLETED|Overall Study||8
3331235|NCT03305081|4063720|FG000|STARTED|Overall Study||25
3331236|NCT03305081|4063721|FG001|STARTED|Overall Study||20
3331237|NCT03305081|4063720|FG000|COMPLETED|Overall Study||15
3331238|NCT03305081|4063721|FG001|COMPLETED|Overall Study||5
3331239|NCT03305081|4063720|FG000|NOT COMPLETED|Overall Study||10
3331240|NCT03305081|4063721|FG001|NOT COMPLETED|Overall Study||15
3331241|NCT03305159|4063729|FG000|STARTED|Overall Study||66
3331242|NCT03305159|4063730|FG001|STARTED|Overall Study||68
3331243|NCT03305159|4063729|FG000|COMPLETED|Overall Study||63
3331244|NCT03305159|4063730|FG001|COMPLETED|Overall Study||60
3331245|NCT03305159|4063729|FG000|NOT COMPLETED|Overall Study||3
3331246|NCT03305159|4063730|FG001|NOT COMPLETED|Overall Study||8
3331247|NCT03305419|4063744|FG000|STARTED|Part A Period 1 (1Day) + Washout (7days)||3
3331248|NCT03305419|4063745|FG001|STARTED|Part A Period 1 (1Day) + Washout (7days)||3
3331249|NCT03305419|4063746|FG002|STARTED|Part A Period 1 (1Day) + Washout (7days)||3
3331250|NCT03305419|4063747|FG003|STARTED|Part A Period 1 (1Day) + Washout (7days)||3
3331251|NCT03305419|4063748|FG004|STARTED|Part A Period 1 (1Day) + Washout (7days)||0
3331252|NCT03305419|4063749|FG005|STARTED|Part A Period 1 (1Day) + Washout (7days)||0
3331253|NCT03305419|4063750|FG006|STARTED|Part A Period 1 (1Day) + Washout (7days)||0
3331254|NCT03305419|4063751|FG007|STARTED|Part A Period 1 (1Day) + Washout (7days)||0
3331255|NCT03305419|4063744|FG000|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||3
3331256|NCT03305419|4063745|FG001|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||2
3331257|NCT03305419|4063746|FG002|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||3
3331258|NCT03305419|4063747|FG003|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||3
3331259|NCT03305419|4063748|FG004|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
3331260|NCT03305419|4063749|FG005|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
3331261|NCT03305419|4063750|FG006|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
3331262|NCT03305419|4063751|FG007|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
3331263|NCT03305419|4063744|FG000|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
3331264|NCT03305419|4063745|FG001|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||1
3331265|NCT03305419|4063746|FG002|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
3331266|NCT03305419|4063747|FG003|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
3331267|NCT03305419|4063748|FG004|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
3331268|NCT03305419|4063749|FG005|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
3331269|NCT03305419|4063750|FG006|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
3331270|NCT03305419|4063751|FG007|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
3331271|NCT03305419|4063744|FG000|STARTED|Part A Period 2 (1Day) + Washout (7days)||3
3331272|NCT03305419|4063745|FG001|STARTED|Part A Period 2 (1Day) + Washout (7days)|1 participant was added to GSK2982772 120 mg TID/240 mg TID/Placebo arm|3
3331273|NCT03305419|4063746|FG002|STARTED|Part A Period 2 (1Day) + Washout (7days)||3
3331274|NCT03305419|4063747|FG003|STARTED|Part A Period 2 (1Day) + Washout (7days)||3
3331275|NCT03305419|4063748|FG004|STARTED|Part A Period 2 (1Day) + Washout (7days)||0
3331276|NCT03305419|4063749|FG005|STARTED|Part A Period 2 (1Day) + Washout (7days)||0
3331277|NCT03305419|4063750|FG006|STARTED|Part A Period 2 (1Day) + Washout (7days)||0
3331278|NCT03305419|4063751|FG007|STARTED|Part A Period 2 (1Day) + Washout (7days)||0
3331279|NCT03305419|4063744|FG000|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||1
3331280|NCT03305419|4063745|FG001|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||3
3331281|NCT03305419|4063746|FG002|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||3
3331282|NCT03305419|4063747|FG003|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||3
3331283|NCT03305419|4063748|FG004|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
3331284|NCT03305419|4063749|FG005|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
3331285|NCT03305419|4063750|FG006|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
3331286|NCT03305419|4063751|FG007|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
3331287|NCT03305419|4063744|FG000|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||2
3331288|NCT03305419|4063745|FG001|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
3331289|NCT03305419|4063746|FG002|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
3331290|NCT03305419|4063747|FG003|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
3331291|NCT03305419|4063748|FG004|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
3331292|NCT03305419|4063749|FG005|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
3331293|NCT03305419|4063750|FG006|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
3331294|NCT03305419|4063751|FG007|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
3331295|NCT03305419|4063744|FG000|STARTED|Part A Period 3 (1Day) + Washout (7days)|2 participants were added to GSK2982772 120 mg TID/240 mg TID/360 mg BID arm after Washout Period.|3
3331296|NCT03305419|4063745|FG001|STARTED|Part A Period 3 (1Day) + Washout (7days)||3
3331297|NCT03305419|4063746|FG002|STARTED|Part A Period 3 (1Day) + Washout (7days)||3
3331298|NCT03305419|4063747|FG003|STARTED|Part A Period 3 (1Day) + Washout (7days)||3
3331299|NCT03305419|4063748|FG004|STARTED|Part A Period 3 (1Day) + Washout (7days)||0
3331300|NCT03305419|4063749|FG005|STARTED|Part A Period 3 (1Day) + Washout (7days)||0
3331301|NCT03305419|4063750|FG006|STARTED|Part A Period 3 (1Day) + Washout (7days)||0
3331302|NCT03305419|4063751|FG007|STARTED|Part A Period 3 (1Day) + Washout (7days)||0
3331303|NCT03305419|4063744|FG000|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||3
3331304|NCT03305419|4063745|FG001|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||3
3331305|NCT03305419|4063746|FG002|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||3
3331306|NCT03305419|4063747|FG003|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||3
3331307|NCT03305419|4063748|FG004|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
3331308|NCT03305419|4063749|FG005|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
3331309|NCT03305419|4063750|FG006|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
3331310|NCT03305419|4063751|FG007|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
3331311|NCT03305419|4063744|FG000|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
3331312|NCT03305419|4063745|FG001|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
3331313|NCT03305419|4063746|FG002|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
3176652|NCT01967706|3904533|FG002|COMPLETED|Washout Period of 1 Day (Day 0)||9
3176653|NCT01967706|3904534|FG003|COMPLETED|Washout Period of 1 Day (Day 0)||9
3176654|NCT01967706|3904531|FG000|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
3176655|NCT01967706|3904532|FG001|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
3176656|NCT01967706|3904533|FG002|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
3176657|NCT01967706|3904534|FG003|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
3176658|NCT01967706|3904531|FG000|STARTED|First Intervention (Day 1)||22
3176659|NCT01967706|3904532|FG001|STARTED|First Intervention (Day 1)||22
3176660|NCT01967706|3904533|FG002|STARTED|First Intervention (Day 1)||9
3176661|NCT01967706|3904534|FG003|STARTED|First Intervention (Day 1)||9
3176662|NCT01967706|3904531|FG000|COMPLETED|First Intervention (Day 1)||21
3176663|NCT01967706|3904532|FG001|COMPLETED|First Intervention (Day 1)||22
3176664|NCT01967706|3904533|FG002|COMPLETED|First Intervention (Day 1)||9
3176665|NCT01967706|3904534|FG003|COMPLETED|First Intervention (Day 1)||9
3176666|NCT01967706|3904531|FG000|NOT COMPLETED|First Intervention (Day 1)||1
3176667|NCT01967706|3904532|FG001|NOT COMPLETED|First Intervention (Day 1)||0
3176668|NCT01967706|3904533|FG002|NOT COMPLETED|First Intervention (Day 1)||0
3176669|NCT01967706|3904534|FG003|NOT COMPLETED|First Intervention (Day 1)||0
3176670|NCT01967706|3904531|FG000|STARTED|Washout Period of 1 Day (Day 2)||21
3176671|NCT01967706|3904532|FG001|STARTED|Washout Period of 1 Day (Day 2)||22
3176672|NCT01967706|3904533|FG002|STARTED|Washout Period of 1 Day (Day 2)||9
3176673|NCT01967706|3904534|FG003|STARTED|Washout Period of 1 Day (Day 2)||9
3176674|NCT01967706|3904531|FG000|COMPLETED|Washout Period of 1 Day (Day 2)||21
3176675|NCT01967706|3904532|FG001|COMPLETED|Washout Period of 1 Day (Day 2)||22
3331314|NCT03305419|4063747|FG003|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
3331315|NCT03305419|4063748|FG004|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
3331316|NCT03305419|4063749|FG005|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
3331317|NCT03305419|4063750|FG006|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
3331318|NCT03305419|4063751|FG007|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
3331319|NCT03305419|4063744|FG000|STARTED|Part B (14 Days)||0
3331320|NCT03305419|4063745|FG001|STARTED|Part B (14 Days)||0
3331321|NCT03305419|4063746|FG002|STARTED|Part B (14 Days)||0
3331322|NCT03305419|4063747|FG003|STARTED|Part B (14 Days)||0
3331323|NCT03305419|4063748|FG004|STARTED|Part B (14 Days)||14
3331324|NCT03305419|4063749|FG005|STARTED|Part B (14 Days)||20
3331325|NCT03305419|4063750|FG006|STARTED|Part B (14 Days)||13
3331326|NCT03305419|4063751|FG007|STARTED|Part B (14 Days)||0
3331327|NCT03305419|4063744|FG000|COMPLETED|Part B (14 Days)||0
3331328|NCT03305419|4063745|FG001|COMPLETED|Part B (14 Days)||0
3331329|NCT03305419|4063746|FG002|COMPLETED|Part B (14 Days)||0
3331330|NCT03305419|4063747|FG003|COMPLETED|Part B (14 Days)||0
3331331|NCT03305419|4063748|FG004|COMPLETED|Part B (14 Days)||11
3331332|NCT03305419|4063749|FG005|COMPLETED|Part B (14 Days)||10
3331333|NCT03305419|4063750|FG006|COMPLETED|Part B (14 Days)||8
3331334|NCT03305419|4063751|FG007|COMPLETED|Part B (14 Days)||0
3331335|NCT03305419|4063744|FG000|NOT COMPLETED|Part B (14 Days)||0
3331336|NCT03305419|4063745|FG001|NOT COMPLETED|Part B (14 Days)||0
3331337|NCT03305419|4063746|FG002|NOT COMPLETED|Part B (14 Days)||0
3331338|NCT03305419|4063747|FG003|NOT COMPLETED|Part B (14 Days)||0
3331339|NCT03305419|4063748|FG004|NOT COMPLETED|Part B (14 Days)||3
3331340|NCT03305419|4063749|FG005|NOT COMPLETED|Part B (14 Days)||10
3331341|NCT03305419|4063750|FG006|NOT COMPLETED|Part B (14 Days)||5
3331342|NCT03305419|4063751|FG007|NOT COMPLETED|Part B (14 Days)||0
3331343|NCT03305575|4063776|FG000|STARTED|Overall Study||5
3331344|NCT03305575|4063777|FG001|STARTED|Overall Study||5
3331345|NCT03305575|4063776|FG000|COMPLETED|Overall Study||4
3331346|NCT03305575|4063777|FG001|COMPLETED|Overall Study||5
3331347|NCT03305575|4063776|FG000|NOT COMPLETED|Overall Study||1
3331348|NCT03305575|4063777|FG001|NOT COMPLETED|Overall Study||0
3331349|NCT03305653|4063783|FG000|STARTED|Overall Study||21
3331350|NCT03305653|4063783|FG000|COMPLETED|Overall Study||21
3331351|NCT03305653|4063783|FG000|NOT COMPLETED|Overall Study||0
3331352|NCT03305666|4063789|FG000|STARTED|Overall Study||18
3331353|NCT03305666|4063790|FG001|STARTED|Overall Study||18
3331354|NCT03305666|4063789|FG000|COMPLETED|Overall Study||16
3331355|NCT03305666|4063790|FG001|COMPLETED|Overall Study||18
3331356|NCT03305666|4063789|FG000|NOT COMPLETED|Overall Study||2
3331357|NCT03305666|4063790|FG001|NOT COMPLETED|Overall Study||0
3331358|NCT03305731|4063796|FG000|STARTED|Overall Study||21
3331359|NCT03305731|4063796|FG000|Week 6|Overall Study||20
3331360|NCT03305731|4063796|FG000|Week 11|Overall Study||20
3331361|NCT03305731|4063796|FG000|COMPLETED|Overall Study||20
3331362|NCT03305731|4063796|FG000|NOT COMPLETED|Overall Study||1
3331363|NCT03305770|4063802|FG000|STARTED|Overall Study||70
3331364|NCT03305770|4063803|FG001|STARTED|Overall Study||37
3331365|NCT03305770|4063802|FG000|Enrolled Dispensed Analysis Set|Overall Study||70
3331366|NCT03305770|4063803|FG001|Enrolled Dispensed Analysis Set|Overall Study||36
3331367|NCT03305770|4063802|FG000|Completed Analysis Set|Overall Study||69
3331368|NCT03305770|4063803|FG001|Completed Analysis Set|Overall Study||36
3331369|NCT03305770|4063802|FG000|COMPLETED|Overall Study||69
3331370|NCT03305770|4063803|FG001|COMPLETED|Overall Study||36
3331371|NCT03305770|4063802|FG000|NOT COMPLETED|Overall Study||1
3331372|NCT03305770|4063803|FG001|NOT COMPLETED|Overall Study||1
3331373|NCT03305809|4063815|FG000|STARTED|Overall Study||86
3331374|NCT03305809|4063816|FG001|STARTED|Overall Study||86
3331375|NCT03305809|4063817|FG002|STARTED|Overall Study||85
3331376|NCT03305809|4063818|FG003|STARTED|Overall Study||87
3331377|NCT03305809|4063815|FG000|Received at Least One Dose of Study Drug|Overall Study||86
3331378|NCT03305809|4063816|FG001|Received at Least One Dose of Study Drug|Overall Study||86
3331379|NCT03305809|4063817|FG002|Received at Least One Dose of Study Drug|Overall Study||85
3331380|NCT03305809|4063818|FG003|Received at Least One Dose of Study Drug|Overall Study||87
3331381|NCT03305809|4063815|FG000|COMPLETED|Overall Study||79
3331382|NCT03305809|4063816|FG001|COMPLETED|Overall Study||78
3331383|NCT03305809|4063817|FG002|COMPLETED|Overall Study||66
3331384|NCT03305809|4063818|FG003|COMPLETED|Overall Study||60
3331385|NCT03305809|4063815|FG000|NOT COMPLETED|Overall Study||7
3331386|NCT03305809|4063816|FG001|NOT COMPLETED|Overall Study||8
3331387|NCT03305809|4063817|FG002|NOT COMPLETED|Overall Study||19
3331388|NCT03305809|4063818|FG003|NOT COMPLETED|Overall Study||27
3331389|NCT03305822|4063831|FG000|STARTED|Period 1||20
3331390|NCT03305822|4063832|FG001|STARTED|Period 1||18
3331391|NCT03305822|4063831|FG000|Received at Least 1 Dose of Study Drug|Period 1||20
3331392|NCT03305822|4063832|FG001|Received at Least 1 Dose of Study Drug|Period 1||18
3331393|NCT03305822|4063831|FG000|COMPLETED|Period 1||20
3331394|NCT03305822|4063832|FG001|COMPLETED|Period 1||18
3331395|NCT03305822|4063831|FG000|NOT COMPLETED|Period 1||0
3331396|NCT03305822|4063832|FG001|NOT COMPLETED|Period 1||0
3331397|NCT03305822|4063831|FG000|STARTED|Washout|Cross-over study. All participants from Period 1 went on to Washout and Period 2.|20
3331398|NCT03305822|4063832|FG001|STARTED|Washout|Cross-over study. All participants from Period 1 went on to Washout and Period 2.|18
3331399|NCT03305822|4063831|FG000|COMPLETED|Washout||20
3331400|NCT03305822|4063832|FG001|COMPLETED|Washout||18
3331401|NCT03305822|4063831|FG000|NOT COMPLETED|Washout||0
3331402|NCT03305822|4063832|FG001|NOT COMPLETED|Washout||0
3331403|NCT03305822|4063831|FG000|STARTED|Period 2||20
3331404|NCT03305822|4063832|FG001|STARTED|Period 2||18
3331405|NCT03305822|4063831|FG000|Received at Least 1 Dose of Study Drug|Period 2||20
3331406|NCT03305822|4063832|FG001|Received at Least 1 Dose of Study Drug|Period 2||18
3331407|NCT03305822|4063831|FG000|COMPLETED|Period 2||20
3331408|NCT03305822|4063832|FG001|COMPLETED|Period 2||18
3331409|NCT03305822|4063831|FG000|NOT COMPLETED|Period 2||0
3331410|NCT03305822|4063832|FG001|NOT COMPLETED|Period 2||0
3331411|NCT03305887|4063840|FG000|STARTED|Overall Study||91
3331412|NCT03305887|4063841|FG001|STARTED|Overall Study||93
3331413|NCT03305887|4063840|FG000|COMPLETED|Overall Study||80
3331414|NCT03305887|4063841|FG001|COMPLETED|Overall Study||83
3331415|NCT03305887|4063840|FG000|NOT COMPLETED|Overall Study||11
3331416|NCT03305887|4063841|FG001|NOT COMPLETED|Overall Study||10
3331417|NCT03306043|4063847|FG000|STARTED|Overall Study||102
3331418|NCT03306043|4063847|FG000|COMPLETED|Overall Study||98
3331419|NCT03306043|4063847|FG000|NOT COMPLETED|Overall Study||4
3331420|NCT03306199|4063851|FG000|STARTED|Overall Study||82
3331421|NCT03306199|4063851|FG000|COMPLETED|Overall Study||67
3331422|NCT03306199|4063851|FG000|NOT COMPLETED|Overall Study||15
3331423|NCT03306277|4063855|FG000|STARTED|Overall Study||22
3331424|NCT03306277|4063855|FG000|COMPLETED|Overall Study||19
3331425|NCT03306277|4063855|FG000|NOT COMPLETED|Overall Study||3
3331426|NCT03306420|4063864|FG000|STARTED|Overall Study||3
3331427|NCT03306420|4063865|FG001|STARTED|Overall Study||3
3331428|NCT03306420|4063866|FG002|STARTED|Overall Study||3
3331429|NCT03306420|4063867|FG003|STARTED|Overall Study||3
3331430|NCT03306420|4063868|FG004|STARTED|Overall Study||3
3331431|NCT03306420|4063864|FG000|COMPLETED|Overall Study||3
3331432|NCT03306420|4063865|FG001|COMPLETED|Overall Study||3
3331433|NCT03306420|4063866|FG002|COMPLETED|Overall Study||3
3331434|NCT03306420|4063867|FG003|COMPLETED|Overall Study||3
3331435|NCT03306420|4063868|FG004|COMPLETED|Overall Study||3
3331436|NCT03306420|4063864|FG000|NOT COMPLETED|Overall Study||0
3331437|NCT03306420|4063865|FG001|NOT COMPLETED|Overall Study||0
3331438|NCT03306420|4063866|FG002|NOT COMPLETED|Overall Study||0
3331439|NCT03306420|4063867|FG003|NOT COMPLETED|Overall Study||0
3331440|NCT03306420|4063868|FG004|NOT COMPLETED|Overall Study||0
3331441|NCT03306433|4063880|FG000|STARTED|Overall Study||16
3176676|NCT01967706|3904533|FG002|COMPLETED|Washout Period of 1 Day (Day 2)||9
3176677|NCT01967706|3904534|FG003|COMPLETED|Washout Period of 1 Day (Day 2)||9
3176678|NCT01967706|3904531|FG000|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
3176679|NCT01967706|3904532|FG001|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
3176680|NCT01967706|3904533|FG002|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
3176681|NCT01967706|3904534|FG003|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
3176682|NCT01967706|3904531|FG000|STARTED|Second Intervention (Day 3)||21
3176683|NCT01967706|3904532|FG001|STARTED|Second Intervention (Day 3)||22
3176684|NCT01967706|3904533|FG002|STARTED|Second Intervention (Day 3)||9
3176685|NCT01967706|3904534|FG003|STARTED|Second Intervention (Day 3)||9
3331442|NCT03306433|4063880|FG000|UDMA-K18|Overall Study||12
3331443|NCT03306433|4063880|FG000|Adhesive Control|Overall Study||12
3331444|NCT03306433|4063880|FG000|UDMA-control|Overall Study||9
3331445|NCT03306433|4063880|FG000|COMPLETED|Overall Study||9
3331446|NCT03306433|4063880|FG000|NOT COMPLETED|Overall Study||7
3331447|NCT03306589|4063894|FG000|STARTED|Part 1 (69 Days)||2
3331448|NCT03306589|4063895|FG001|STARTED|Part 1 (69 Days)||4
3331449|NCT03306589|4063896|FG002|STARTED|Part 1 (69 Days)||2
3331450|NCT03306589|4063897|FG003|STARTED|Part 1 (69 Days)||4
3331451|NCT03306589|4063898|FG004|STARTED|Part 1 (69 Days)||0
3331452|NCT03306589|4063899|FG005|STARTED|Part 1 (69 Days)||0
3331453|NCT03306589|4063894|FG000|COMPLETED|Part 1 (69 Days)||2
3331454|NCT03306589|4063895|FG001|COMPLETED|Part 1 (69 Days)||4
3331455|NCT03306589|4063896|FG002|COMPLETED|Part 1 (69 Days)||2
3331456|NCT03306589|4063897|FG003|COMPLETED|Part 1 (69 Days)||4
3331457|NCT03306589|4063898|FG004|COMPLETED|Part 1 (69 Days)||0
3331458|NCT03306589|4063899|FG005|COMPLETED|Part 1 (69 Days)||0
3331459|NCT03306589|4063894|FG000|NOT COMPLETED|Part 1 (69 Days)||0
3331460|NCT03306589|4063895|FG001|NOT COMPLETED|Part 1 (69 Days)||0
3331461|NCT03306589|4063896|FG002|NOT COMPLETED|Part 1 (69 Days)||0
3331462|NCT03306589|4063897|FG003|NOT COMPLETED|Part 1 (69 Days)||0
3331463|NCT03306589|4063898|FG004|NOT COMPLETED|Part 1 (69 Days)||0
3331464|NCT03306589|4063899|FG005|NOT COMPLETED|Part 1 (69 Days)||0
3331465|NCT03306589|4063894|FG000|STARTED|Part 2 (69 Days)||0
3331466|NCT03306589|4063895|FG001|STARTED|Part 2 (69 Days)||0
3331467|NCT03306589|4063896|FG002|STARTED|Part 2 (69 Days)||0
3331468|NCT03306589|4063897|FG003|STARTED|Part 2 (69 Days)||0
3331469|NCT03306589|4063898|FG004|STARTED|Part 2 (69 Days)||0
3331470|NCT03306589|4063899|FG005|STARTED|Part 2 (69 Days)||0
3331471|NCT03306589|4063894|FG000|COMPLETED|Part 2 (69 Days)||0
3331472|NCT03306589|4063895|FG001|COMPLETED|Part 2 (69 Days)||0
3331473|NCT03306589|4063896|FG002|COMPLETED|Part 2 (69 Days)||0
3331474|NCT03306589|4063897|FG003|COMPLETED|Part 2 (69 Days)||0
3331475|NCT03306589|4063898|FG004|COMPLETED|Part 2 (69 Days)||0
3331476|NCT03306589|4063899|FG005|COMPLETED|Part 2 (69 Days)||0
3331477|NCT03306589|4063894|FG000|NOT COMPLETED|Part 2 (69 Days)||0
3331478|NCT03306589|4063895|FG001|NOT COMPLETED|Part 2 (69 Days)||0
3331479|NCT03306589|4063896|FG002|NOT COMPLETED|Part 2 (69 Days)||0
3331480|NCT03306589|4063897|FG003|NOT COMPLETED|Part 2 (69 Days)||0
3331481|NCT03306589|4063898|FG004|NOT COMPLETED|Part 2 (69 Days)||0
3331482|NCT03306589|4063899|FG005|NOT COMPLETED|Part 2 (69 Days)||0
3331483|NCT03306641|4063915|FG000|STARTED|First Intervention||23
3331484|NCT03306641|4063916|FG001|STARTED|First Intervention||22
3331485|NCT03306641|4063915|FG000|COMPLETED|First Intervention||23
3331486|NCT03306641|4063916|FG001|COMPLETED|First Intervention||22
3331487|NCT03306641|4063915|FG000|NOT COMPLETED|First Intervention||0
3331488|NCT03306641|4063916|FG001|NOT COMPLETED|First Intervention||0
3331489|NCT03306641|4063915|FG000|STARTED|Second Intervention||23
3176686|NCT01967706|3904531|FG000|COMPLETED|Second Intervention (Day 3)||21
3176687|NCT01967706|3904532|FG001|COMPLETED|Second Intervention (Day 3)||22
3331490|NCT03306641|4063916|FG001|STARTED|Second Intervention||22
3331491|NCT03306641|4063915|FG000|COMPLETED|Second Intervention||23
3331492|NCT03306641|4063916|FG001|COMPLETED|Second Intervention||22
3331493|NCT03306641|4063915|FG000|NOT COMPLETED|Second Intervention||0
3331494|NCT03306641|4063916|FG001|NOT COMPLETED|Second Intervention||0
3331495|NCT03307005|4063924|FG000|STARTED|Overall Study||3
3331496|NCT03307005|4063925|FG001|STARTED|Overall Study||2
3331497|NCT03307005|4063924|FG000|COMPLETED|Overall Study||3
3331498|NCT03307005|4063925|FG001|COMPLETED|Overall Study||2
3331499|NCT03307005|4063924|FG000|NOT COMPLETED|Overall Study||0
3331500|NCT03307005|4063925|FG001|NOT COMPLETED|Overall Study||0
3331501|NCT03307174|4063935|FG000|STARTED|Overall Study||60
3331502|NCT03307174|4063936|FG001|STARTED|Overall Study||60
3331503|NCT03307174|4063935|FG000|COMPLETED|Overall Study||46
3331504|NCT03307174|4063936|FG001|COMPLETED|Overall Study||53
3331505|NCT03307174|4063935|FG000|NOT COMPLETED|Overall Study||14
3331506|NCT03307174|4063936|FG001|NOT COMPLETED|Overall Study||7
3331507|NCT03307252|4063953|FG000|STARTED|Part 1, Period 1|Participants randomised in Part 1|4
3331508|NCT03307252|4063954|FG001|STARTED|Part 1, Period 1|Participants randomised in Part 1|4
3331509|NCT03307252|4063955|FG002|STARTED|Part 1, Period 1|Participants randomised in Part 1|4
3331510|NCT03307252|4063956|FG003|STARTED|Part 1, Period 1||0
3331511|NCT03307252|4063957|FG004|STARTED|Part 1, Period 1||0
3331512|NCT03307252|4063958|FG005|STARTED|Part 1, Period 1||0
3331513|NCT03307252|4063959|FG006|STARTED|Part 1, Period 1||0
3331514|NCT03307252|4063960|FG007|STARTED|Part 1, Period 1||0
3331515|NCT03307252|4063961|FG008|STARTED|Part 1, Period 1||0
3331516|NCT03307252|4063962|FG009|STARTED|Part 1, Period 1||0
3331517|NCT03307252|4063963|FG010|STARTED|Part 1, Period 1||0
3331518|NCT03307252|4063953|FG000|COMPLETED|Part 1, Period 1||4
3331519|NCT03307252|4063954|FG001|COMPLETED|Part 1, Period 1||4
3331520|NCT03307252|4063955|FG002|COMPLETED|Part 1, Period 1||4
3331521|NCT03307252|4063956|FG003|COMPLETED|Part 1, Period 1||0
3331522|NCT03307252|4063957|FG004|COMPLETED|Part 1, Period 1||0
3331523|NCT03307252|4063958|FG005|COMPLETED|Part 1, Period 1||0
3331524|NCT03307252|4063959|FG006|COMPLETED|Part 1, Period 1||0
3331525|NCT03307252|4063960|FG007|COMPLETED|Part 1, Period 1||0
3331526|NCT03307252|4063961|FG008|COMPLETED|Part 1, Period 1||0
3331527|NCT03307252|4063962|FG009|COMPLETED|Part 1, Period 1||0
3331528|NCT03307252|4063963|FG010|COMPLETED|Part 1, Period 1||0
3331529|NCT03307252|4063953|FG000|NOT COMPLETED|Part 1, Period 1||0
3331530|NCT03307252|4063954|FG001|NOT COMPLETED|Part 1, Period 1||0
3331531|NCT03307252|4063955|FG002|NOT COMPLETED|Part 1, Period 1||0
3331532|NCT03307252|4063956|FG003|NOT COMPLETED|Part 1, Period 1||0
2927768|NCT00574119|3638630|FG000|NOT COMPLETED|Overall Study||4
2927769|NCT00574145|3638636|FG000|STARTED|Overall Study||22
2927770|NCT00574145|3638637|FG001|STARTED|Overall Study||22
2927771|NCT00574145|3638636|FG000|COMPLETED|Overall Study||20
2927772|NCT00574145|3638637|FG001|COMPLETED|Overall Study||21
2927773|NCT00574145|3638636|FG000|NOT COMPLETED|Overall Study||2
2927774|NCT00574145|3638637|FG001|NOT COMPLETED|Overall Study||1
2927775|NCT00574171|3638643|FG000|STARTED|Overall Study||29
2927776|NCT00574171|3638643|FG000|COMPLETED|Overall Study||29
2927777|NCT00574171|3638643|FG000|NOT COMPLETED|Overall Study||0
2927778|NCT00574197|3638647|FG000|STARTED|Overall Study||11
2927779|NCT00574197|3638647|FG000|COMPLETED|Overall Study||6
2927780|NCT00574197|3638647|FG000|NOT COMPLETED|Overall Study||5
2927781|NCT00574236|3638651|FG000|STARTED|Overall Study||4
2927782|NCT00574236|3638651|FG000|COMPLETED|Overall Study||4
2927783|NCT00574236|3638651|FG000|NOT COMPLETED|Overall Study||0
2927784|NCT00574249|3638657|FG000|STARTED|Overall Study||364
2927785|NCT00574249|3638658|FG001|STARTED|Overall Study||366
2927786|NCT00574249|3638657|FG000|COMPLETED|Overall Study||338
2927787|NCT00574249|3638658|FG001|COMPLETED|Overall Study||338
2927788|NCT00574249|3638657|FG000|NOT COMPLETED|Overall Study||26
2927789|NCT00574249|3638658|FG001|NOT COMPLETED|Overall Study||28
2927790|NCT00574275|3638666|FG000|STARTED|Overall Study||275
2927791|NCT00574275|3638667|FG001|STARTED|Overall Study||271
2927792|NCT00574275|3638666|FG000|TREATED|Overall Study||273
2927793|NCT00574275|3638667|FG001|TREATED|Overall Study||268
2927794|NCT00574275|3638666|FG000|SAFETY POPULATION|Overall Study|Excludes 2 participants who received 1 dose of Aflibercept|271
2927795|NCT00574275|3638667|FG001|SAFETY POPULATION|Overall Study|Includes 2 participants from the Placebo and Gemcitabine arm who received 1 dose of Aflibercept|270
2927796|NCT00574275|3638666|FG000|COMPLETED|Overall Study|All participants stopped when they met treatment discontinuation criteria or by DMC recommendation|0
2927797|NCT00574275|3638667|FG001|COMPLETED|Overall Study|All participants stopped when they met treatment discontinuation criteria or by DMC recommendation|0
2927798|NCT00574275|3638666|FG000|NOT COMPLETED|Overall Study||275
2927799|NCT00574275|3638667|FG001|NOT COMPLETED|Overall Study||271
2927800|NCT00574288|3638680|FG000|STARTED|Overall Study||20
2927801|NCT00574288|3638681|FG001|STARTED|Overall Study||3
2927802|NCT00574288|3638682|FG002|STARTED|Overall Study||3
2927803|NCT00574288|3638683|FG003|STARTED|Overall Study||3
2927804|NCT00574288|3638684|FG004|STARTED|Overall Study||3
2927805|NCT00574288|3638685|FG005|STARTED|Overall Study||30
2927806|NCT00574288|3638686|FG006|STARTED|Overall Study||42
2927807|NCT00574288|3638680|FG000|COMPLETED|Overall Study||0
3331533|NCT03307252|4063957|FG004|NOT COMPLETED|Part 1, Period 1||0
3331534|NCT03307252|4063958|FG005|NOT COMPLETED|Part 1, Period 1||0
3331535|NCT03307252|4063959|FG006|NOT COMPLETED|Part 1, Period 1||0
3331536|NCT03307252|4063960|FG007|NOT COMPLETED|Part 1, Period 1||0
3331537|NCT03307252|4063961|FG008|NOT COMPLETED|Part 1, Period 1||0
3331538|NCT03307252|4063962|FG009|NOT COMPLETED|Part 1, Period 1||0
3331539|NCT03307252|4063963|FG010|NOT COMPLETED|Part 1, Period 1||0
3331540|NCT03307252|4063953|FG000|STARTED|Part 1, Washout Period 1 (13 Days)||4
3331541|NCT03307252|4063954|FG001|STARTED|Part 1, Washout Period 1 (13 Days)||4
3331542|NCT03307252|4063955|FG002|STARTED|Part 1, Washout Period 1 (13 Days)||4
3331543|NCT03307252|4063956|FG003|STARTED|Part 1, Washout Period 1 (13 Days)||0
3331544|NCT03307252|4063957|FG004|STARTED|Part 1, Washout Period 1 (13 Days)||0
3331545|NCT03307252|4063958|FG005|STARTED|Part 1, Washout Period 1 (13 Days)||0
3331546|NCT03307252|4063959|FG006|STARTED|Part 1, Washout Period 1 (13 Days)||0
3331547|NCT03307252|4063960|FG007|STARTED|Part 1, Washout Period 1 (13 Days)||0
3331548|NCT03307252|4063961|FG008|STARTED|Part 1, Washout Period 1 (13 Days)||0
3331549|NCT03307252|4063962|FG009|STARTED|Part 1, Washout Period 1 (13 Days)||0
3331550|NCT03307252|4063963|FG010|STARTED|Part 1, Washout Period 1 (13 Days)||0
3331551|NCT03307252|4063953|FG000|COMPLETED|Part 1, Washout Period 1 (13 Days)||4
3331552|NCT03307252|4063954|FG001|COMPLETED|Part 1, Washout Period 1 (13 Days)||4
3331553|NCT03307252|4063955|FG002|COMPLETED|Part 1, Washout Period 1 (13 Days)||4
3331554|NCT03307252|4063956|FG003|COMPLETED|Part 1, Washout Period 1 (13 Days)||0
3331555|NCT03307252|4063957|FG004|COMPLETED|Part 1, Washout Period 1 (13 Days)||0
3331556|NCT03307252|4063958|FG005|COMPLETED|Part 1, Washout Period 1 (13 Days)||0
3331557|NCT03307252|4063959|FG006|COMPLETED|Part 1, Washout Period 1 (13 Days)||0
3331558|NCT03307252|4063960|FG007|COMPLETED|Part 1, Washout Period 1 (13 Days)||0
3331559|NCT03307252|4063961|FG008|COMPLETED|Part 1, Washout Period 1 (13 Days)||0
3331560|NCT03307252|4063962|FG009|COMPLETED|Part 1, Washout Period 1 (13 Days)||0
3331561|NCT03307252|4063963|FG010|COMPLETED|Part 1, Washout Period 1 (13 Days)||0
3331562|NCT03307252|4063953|FG000|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
3331563|NCT03307252|4063954|FG001|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
3331564|NCT03307252|4063955|FG002|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
3331565|NCT03307252|4063956|FG003|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
3331566|NCT03307252|4063957|FG004|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
3331567|NCT03307252|4063958|FG005|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
3331568|NCT03307252|4063959|FG006|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
3331569|NCT03307252|4063960|FG007|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
3331570|NCT03307252|4063961|FG008|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
3331571|NCT03307252|4063962|FG009|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
3331572|NCT03307252|4063963|FG010|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
3331573|NCT03307252|4063953|FG000|STARTED|Part 1, Period 2|Participants randomised in Part 1|4
3331574|NCT03307252|4063954|FG001|STARTED|Part 1, Period 2|Participants randomised in Part 1|4
3331575|NCT03307252|4063955|FG002|STARTED|Part 1, Period 2|Participants randomised in Part 1|4
3331576|NCT03307252|4063956|FG003|STARTED|Part 1, Period 2||0
3331577|NCT03307252|4063957|FG004|STARTED|Part 1, Period 2||0
3331578|NCT03307252|4063958|FG005|STARTED|Part 1, Period 2||0
3331579|NCT03307252|4063959|FG006|STARTED|Part 1, Period 2||0
3331580|NCT03307252|4063960|FG007|STARTED|Part 1, Period 2||0
3331581|NCT03307252|4063961|FG008|STARTED|Part 1, Period 2||0
3331582|NCT03307252|4063962|FG009|STARTED|Part 1, Period 2||0
3331583|NCT03307252|4063963|FG010|STARTED|Part 1, Period 2||0
3331584|NCT03307252|4063953|FG000|COMPLETED|Part 1, Period 2||4
3331585|NCT03307252|4063954|FG001|COMPLETED|Part 1, Period 2||4
3331586|NCT03307252|4063955|FG002|COMPLETED|Part 1, Period 2||4
3331587|NCT03307252|4063956|FG003|COMPLETED|Part 1, Period 2||0
3331588|NCT03307252|4063957|FG004|COMPLETED|Part 1, Period 2||0
3331589|NCT03307252|4063958|FG005|COMPLETED|Part 1, Period 2||0
3331590|NCT03307252|4063959|FG006|COMPLETED|Part 1, Period 2||0
3331591|NCT03307252|4063960|FG007|COMPLETED|Part 1, Period 2||0
3331592|NCT03307252|4063961|FG008|COMPLETED|Part 1, Period 2||0
3331593|NCT03307252|4063962|FG009|COMPLETED|Part 1, Period 2||0
3331594|NCT03307252|4063963|FG010|COMPLETED|Part 1, Period 2||0
3331595|NCT03307252|4063953|FG000|NOT COMPLETED|Part 1, Period 2||0
3331596|NCT03307252|4063954|FG001|NOT COMPLETED|Part 1, Period 2||0
3331597|NCT03307252|4063955|FG002|NOT COMPLETED|Part 1, Period 2||0
3331598|NCT03307252|4063956|FG003|NOT COMPLETED|Part 1, Period 2||0
3331599|NCT03307252|4063957|FG004|NOT COMPLETED|Part 1, Period 2||0
3331600|NCT03307252|4063958|FG005|NOT COMPLETED|Part 1, Period 2||0
3331601|NCT03307252|4063959|FG006|NOT COMPLETED|Part 1, Period 2||0
3331602|NCT03307252|4063960|FG007|NOT COMPLETED|Part 1, Period 2||0
3331603|NCT03307252|4063961|FG008|NOT COMPLETED|Part 1, Period 2||0
3331604|NCT03307252|4063962|FG009|NOT COMPLETED|Part 1, Period 2||0
3331605|NCT03307252|4063963|FG010|NOT COMPLETED|Part 1, Period 2||0
3331606|NCT03307252|4063953|FG000|STARTED|Part 1, Washout Period 2 (13 Days)||4
3331607|NCT03307252|4063954|FG001|STARTED|Part 1, Washout Period 2 (13 Days)||4
3331608|NCT03307252|4063955|FG002|STARTED|Part 1, Washout Period 2 (13 Days)||4
3331609|NCT03307252|4063956|FG003|STARTED|Part 1, Washout Period 2 (13 Days)||0
3331610|NCT03307252|4063957|FG004|STARTED|Part 1, Washout Period 2 (13 Days)||0
3331611|NCT03307252|4063958|FG005|STARTED|Part 1, Washout Period 2 (13 Days)||0
3331612|NCT03307252|4063959|FG006|STARTED|Part 1, Washout Period 2 (13 Days)||0
3331613|NCT03307252|4063960|FG007|STARTED|Part 1, Washout Period 2 (13 Days)||0
3331614|NCT03307252|4063961|FG008|STARTED|Part 1, Washout Period 2 (13 Days)||0
3331615|NCT03307252|4063962|FG009|STARTED|Part 1, Washout Period 2 (13 Days)||0
3331616|NCT03307252|4063963|FG010|STARTED|Part 1, Washout Period 2 (13 Days)||0
3331617|NCT03307252|4063953|FG000|COMPLETED|Part 1, Washout Period 2 (13 Days)||4
3331618|NCT03307252|4063954|FG001|COMPLETED|Part 1, Washout Period 2 (13 Days)||4
3331619|NCT03307252|4063955|FG002|COMPLETED|Part 1, Washout Period 2 (13 Days)||4
3331620|NCT03307252|4063956|FG003|COMPLETED|Part 1, Washout Period 2 (13 Days)||0
3331621|NCT03307252|4063957|FG004|COMPLETED|Part 1, Washout Period 2 (13 Days)||0
3331622|NCT03307252|4063958|FG005|COMPLETED|Part 1, Washout Period 2 (13 Days)||0
3331623|NCT03307252|4063959|FG006|COMPLETED|Part 1, Washout Period 2 (13 Days)||0
3331624|NCT03307252|4063960|FG007|COMPLETED|Part 1, Washout Period 2 (13 Days)||0
3331625|NCT03307252|4063961|FG008|COMPLETED|Part 1, Washout Period 2 (13 Days)||0
3331626|NCT03307252|4063962|FG009|COMPLETED|Part 1, Washout Period 2 (13 Days)||0
3331627|NCT03307252|4063963|FG010|COMPLETED|Part 1, Washout Period 2 (13 Days)||0
3331628|NCT03307252|4063953|FG000|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
3331629|NCT03307252|4063954|FG001|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
3331630|NCT03307252|4063955|FG002|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
3331631|NCT03307252|4063956|FG003|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
3331632|NCT03307252|4063957|FG004|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
3331633|NCT03307252|4063958|FG005|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
3331634|NCT03307252|4063959|FG006|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
3331635|NCT03307252|4063960|FG007|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
3331636|NCT03307252|4063961|FG008|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
3331637|NCT03307252|4063962|FG009|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
3331638|NCT03307252|4063963|FG010|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
3331639|NCT03307252|4063953|FG000|STARTED|Part 1, Period 3|Participants randomised in Part 1|4
3331640|NCT03307252|4063954|FG001|STARTED|Part 1, Period 3|Participants randomised in Part 1|4
3331641|NCT03307252|4063955|FG002|STARTED|Part 1, Period 3|Participants randomised in Part 1|4
3331642|NCT03307252|4063956|FG003|STARTED|Part 1, Period 3||0
3176688|NCT01967706|3904533|FG002|COMPLETED|Second Intervention (Day 3)||9
3176689|NCT01967706|3904534|FG003|COMPLETED|Second Intervention (Day 3)||9
3176690|NCT01967706|3904531|FG000|NOT COMPLETED|Second Intervention (Day 3)||0
3331643|NCT03307252|4063957|FG004|STARTED|Part 1, Period 3||0
3331644|NCT03307252|4063958|FG005|STARTED|Part 1, Period 3||0
3331645|NCT03307252|4063959|FG006|STARTED|Part 1, Period 3||0
3331646|NCT03307252|4063960|FG007|STARTED|Part 1, Period 3||0
3331647|NCT03307252|4063961|FG008|STARTED|Part 1, Period 3||0
3331648|NCT03307252|4063962|FG009|STARTED|Part 1, Period 3||0
3331649|NCT03307252|4063963|FG010|STARTED|Part 1, Period 3||0
3331650|NCT03307252|4063953|FG000|COMPLETED|Part 1, Period 3||4
3331651|NCT03307252|4063954|FG001|COMPLETED|Part 1, Period 3||4
3331652|NCT03307252|4063955|FG002|COMPLETED|Part 1, Period 3||4
3331653|NCT03307252|4063956|FG003|COMPLETED|Part 1, Period 3||0
3331654|NCT03307252|4063957|FG004|COMPLETED|Part 1, Period 3||0
3331655|NCT03307252|4063958|FG005|COMPLETED|Part 1, Period 3||0
3331656|NCT03307252|4063959|FG006|COMPLETED|Part 1, Period 3||0
3331657|NCT03307252|4063960|FG007|COMPLETED|Part 1, Period 3||0
3331658|NCT03307252|4063961|FG008|COMPLETED|Part 1, Period 3||0
3331659|NCT03307252|4063962|FG009|COMPLETED|Part 1, Period 3||0
3331660|NCT03307252|4063963|FG010|COMPLETED|Part 1, Period 3||0
3331661|NCT03307252|4063953|FG000|NOT COMPLETED|Part 1, Period 3||0
3331662|NCT03307252|4063954|FG001|NOT COMPLETED|Part 1, Period 3||0
3331663|NCT03307252|4063955|FG002|NOT COMPLETED|Part 1, Period 3||0
3331664|NCT03307252|4063956|FG003|NOT COMPLETED|Part 1, Period 3||0
3331665|NCT03307252|4063957|FG004|NOT COMPLETED|Part 1, Period 3||0
3331666|NCT03307252|4063958|FG005|NOT COMPLETED|Part 1, Period 3||0
3331667|NCT03307252|4063959|FG006|NOT COMPLETED|Part 1, Period 3||0
3331668|NCT03307252|4063960|FG007|NOT COMPLETED|Part 1, Period 3||0
3331669|NCT03307252|4063961|FG008|NOT COMPLETED|Part 1, Period 3||0
3331670|NCT03307252|4063962|FG009|NOT COMPLETED|Part 1, Period 3||0
3331671|NCT03307252|4063963|FG010|NOT COMPLETED|Part 1, Period 3||0
3331672|NCT03307252|4063953|FG000|STARTED|Part 2, Period 1||0
3331673|NCT03307252|4063954|FG001|STARTED|Part 2, Period 1||0
3331674|NCT03307252|4063955|FG002|STARTED|Part 2, Period 1||0
3331675|NCT03307252|4063956|FG003|STARTED|Part 2, Period 1|Participants randomized in Part 2|4
3331676|NCT03307252|4063957|FG004|STARTED|Part 2, Period 1|Participants randomized in Part 2|4
3331677|NCT03307252|4063958|FG005|STARTED|Part 2, Period 1|Participants randomized in Part 2|4
3331678|NCT03307252|4063959|FG006|STARTED|Part 2, Period 1|Participants randomized in Part 2|5
3331679|NCT03307252|4063960|FG007|STARTED|Part 2, Period 1||0
3331680|NCT03307252|4063961|FG008|STARTED|Part 2, Period 1||0
3331681|NCT03307252|4063962|FG009|STARTED|Part 2, Period 1||0
3331682|NCT03307252|4063963|FG010|STARTED|Part 2, Period 1||0
3331683|NCT03307252|4063953|FG000|COMPLETED|Part 2, Period 1||0
3331684|NCT03307252|4063954|FG001|COMPLETED|Part 2, Period 1||0
3331685|NCT03307252|4063955|FG002|COMPLETED|Part 2, Period 1||0
3331686|NCT03307252|4063956|FG003|COMPLETED|Part 2, Period 1||4
3331687|NCT03307252|4063957|FG004|COMPLETED|Part 2, Period 1||4
3331688|NCT03307252|4063958|FG005|COMPLETED|Part 2, Period 1||3
3331689|NCT03307252|4063959|FG006|COMPLETED|Part 2, Period 1||5
3176691|NCT01967706|3904532|FG001|NOT COMPLETED|Second Intervention (Day 3)||0
3176692|NCT01967706|3904533|FG002|NOT COMPLETED|Second Intervention (Day 3)||0
3331690|NCT03307252|4063960|FG007|COMPLETED|Part 2, Period 1||0
3331691|NCT03307252|4063961|FG008|COMPLETED|Part 2, Period 1||0
3331692|NCT03307252|4063962|FG009|COMPLETED|Part 2, Period 1||0
3331693|NCT03307252|4063963|FG010|COMPLETED|Part 2, Period 1||0
3331694|NCT03307252|4063953|FG000|NOT COMPLETED|Part 2, Period 1||0
3331695|NCT03307252|4063954|FG001|NOT COMPLETED|Part 2, Period 1||0
3331696|NCT03307252|4063955|FG002|NOT COMPLETED|Part 2, Period 1||0
3331697|NCT03307252|4063956|FG003|NOT COMPLETED|Part 2, Period 1||0
3331698|NCT03307252|4063957|FG004|NOT COMPLETED|Part 2, Period 1||0
3331699|NCT03307252|4063958|FG005|NOT COMPLETED|Part 2, Period 1||1
3331700|NCT03307252|4063959|FG006|NOT COMPLETED|Part 2, Period 1||0
3331701|NCT03307252|4063960|FG007|NOT COMPLETED|Part 2, Period 1||0
3331702|NCT03307252|4063961|FG008|NOT COMPLETED|Part 2, Period 1||0
3331703|NCT03307252|4063962|FG009|NOT COMPLETED|Part 2, Period 1||0
3331704|NCT03307252|4063963|FG010|NOT COMPLETED|Part 2, Period 1||0
3331705|NCT03307252|4063953|FG000|STARTED|Part 2, Washout Period 1 (7 Days)||0
3331706|NCT03307252|4063954|FG001|STARTED|Part 2, Washout Period 1 (7 Days)||0
3331707|NCT03307252|4063955|FG002|STARTED|Part 2, Washout Period 1 (7 Days)||0
3331708|NCT03307252|4063956|FG003|STARTED|Part 2, Washout Period 1 (7 Days)||4
3331709|NCT03307252|4063957|FG004|STARTED|Part 2, Washout Period 1 (7 Days)||4
3331710|NCT03307252|4063958|FG005|STARTED|Part 2, Washout Period 1 (7 Days)||3
3331711|NCT03307252|4063959|FG006|STARTED|Part 2, Washout Period 1 (7 Days)||5
3331712|NCT03307252|4063960|FG007|STARTED|Part 2, Washout Period 1 (7 Days)||0
3331713|NCT03307252|4063961|FG008|STARTED|Part 2, Washout Period 1 (7 Days)||0
3331714|NCT03307252|4063962|FG009|STARTED|Part 2, Washout Period 1 (7 Days)||0
3331715|NCT03307252|4063963|FG010|STARTED|Part 2, Washout Period 1 (7 Days)||0
3331716|NCT03307252|4063953|FG000|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
3331717|NCT03307252|4063954|FG001|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
3331718|NCT03307252|4063955|FG002|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
3331719|NCT03307252|4063956|FG003|COMPLETED|Part 2, Washout Period 1 (7 Days)||4
3331720|NCT03307252|4063957|FG004|COMPLETED|Part 2, Washout Period 1 (7 Days)||4
3331721|NCT03307252|4063958|FG005|COMPLETED|Part 2, Washout Period 1 (7 Days)||3
3331722|NCT03307252|4063959|FG006|COMPLETED|Part 2, Washout Period 1 (7 Days)||5
3331723|NCT03307252|4063960|FG007|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
3331724|NCT03307252|4063961|FG008|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
3331725|NCT03307252|4063962|FG009|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
3331726|NCT03307252|4063963|FG010|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
3331727|NCT03307252|4063953|FG000|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
3331728|NCT03307252|4063954|FG001|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
3331729|NCT03307252|4063955|FG002|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
3331730|NCT03307252|4063956|FG003|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
3331731|NCT03307252|4063957|FG004|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
3331732|NCT03307252|4063958|FG005|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
3331733|NCT03307252|4063959|FG006|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
3331734|NCT03307252|4063960|FG007|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
3331735|NCT03307252|4063961|FG008|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
3331736|NCT03307252|4063962|FG009|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
3331737|NCT03307252|4063963|FG010|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
3331738|NCT03307252|4063953|FG000|STARTED|Part 2, Period 2||0
3331739|NCT03307252|4063954|FG001|STARTED|Part 2, Period 2||0
3331740|NCT03307252|4063955|FG002|STARTED|Part 2, Period 2||0
3331741|NCT03307252|4063956|FG003|STARTED|Part 2, Period 2||4
3331742|NCT03307252|4063957|FG004|STARTED|Part 2, Period 2||4
3331743|NCT03307252|4063958|FG005|STARTED|Part 2, Period 2||3
3331744|NCT03307252|4063959|FG006|STARTED|Part 2, Period 2||5
3331745|NCT03307252|4063960|FG007|STARTED|Part 2, Period 2||0
3331746|NCT03307252|4063961|FG008|STARTED|Part 2, Period 2||0
3331747|NCT03307252|4063962|FG009|STARTED|Part 2, Period 2||0
3331748|NCT03307252|4063963|FG010|STARTED|Part 2, Period 2||0
3331749|NCT03307252|4063953|FG000|COMPLETED|Part 2, Period 2||0
3331750|NCT03307252|4063954|FG001|COMPLETED|Part 2, Period 2||0
3331751|NCT03307252|4063955|FG002|COMPLETED|Part 2, Period 2||0
3331752|NCT03307252|4063956|FG003|COMPLETED|Part 2, Period 2||4
3331753|NCT03307252|4063957|FG004|COMPLETED|Part 2, Period 2||4
3331754|NCT03307252|4063958|FG005|COMPLETED|Part 2, Period 2||3
3331755|NCT03307252|4063959|FG006|COMPLETED|Part 2, Period 2||5
3331756|NCT03307252|4063960|FG007|COMPLETED|Part 2, Period 2||0
3331757|NCT03307252|4063961|FG008|COMPLETED|Part 2, Period 2||0
3331758|NCT03307252|4063962|FG009|COMPLETED|Part 2, Period 2||0
3331759|NCT03307252|4063963|FG010|COMPLETED|Part 2, Period 2||0
3331760|NCT03307252|4063953|FG000|NOT COMPLETED|Part 2, Period 2||0
3331761|NCT03307252|4063954|FG001|NOT COMPLETED|Part 2, Period 2||0
3331762|NCT03307252|4063955|FG002|NOT COMPLETED|Part 2, Period 2||0
3331763|NCT03307252|4063956|FG003|NOT COMPLETED|Part 2, Period 2||0
3331764|NCT03307252|4063957|FG004|NOT COMPLETED|Part 2, Period 2||0
3331765|NCT03307252|4063958|FG005|NOT COMPLETED|Part 2, Period 2||0
3331766|NCT03307252|4063959|FG006|NOT COMPLETED|Part 2, Period 2||0
3331767|NCT03307252|4063960|FG007|NOT COMPLETED|Part 2, Period 2||0
3331768|NCT03307252|4063961|FG008|NOT COMPLETED|Part 2, Period 2||0
3331769|NCT03307252|4063962|FG009|NOT COMPLETED|Part 2, Period 2||0
3331770|NCT03307252|4063963|FG010|NOT COMPLETED|Part 2, Period 2||0
3331771|NCT03307252|4063953|FG000|STARTED|Part 2, Washout Period 2 (7 Days)||0
3331772|NCT03307252|4063954|FG001|STARTED|Part 2, Washout Period 2 (7 Days)||0
3331773|NCT03307252|4063955|FG002|STARTED|Part 2, Washout Period 2 (7 Days)||0
3176693|NCT01967706|3904534|FG003|NOT COMPLETED|Second Intervention (Day 3)||0
3176694|NCT01967719|3904545|FG000|STARTED|Washout Period of 1 Day (Day 0)||22
3176695|NCT01967719|3904546|FG001|STARTED|Washout Period of 1 Day (Day 0)||22
3176696|NCT01967719|3904547|FG002|STARTED|Washout Period of 1 Day (Day 0)||9
3176697|NCT01967719|3904548|FG003|STARTED|Washout Period of 1 Day (Day 0)||9
3176698|NCT01967719|3904545|FG000|COMPLETED|Washout Period of 1 Day (Day 0)||22
3176699|NCT01967719|3904546|FG001|COMPLETED|Washout Period of 1 Day (Day 0)||22
3176700|NCT01967719|3904547|FG002|COMPLETED|Washout Period of 1 Day (Day 0)||9
3176701|NCT01967719|3904548|FG003|COMPLETED|Washout Period of 1 Day (Day 0)||9
3176702|NCT01967719|3904545|FG000|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
3176703|NCT01967719|3904546|FG001|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
3176704|NCT01967719|3904547|FG002|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
3176705|NCT01967719|3904548|FG003|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
3176706|NCT01967719|3904545|FG000|STARTED|First Intervention (Day 1)||22
3176707|NCT01967719|3904546|FG001|STARTED|First Intervention (Day 1)||22
3176708|NCT01967719|3904547|FG002|STARTED|First Intervention (Day 1)||9
3176709|NCT01967719|3904548|FG003|STARTED|First Intervention (Day 1)||9
3331774|NCT03307252|4063956|FG003|STARTED|Part 2, Washout Period 2 (7 Days)||4
3331775|NCT03307252|4063957|FG004|STARTED|Part 2, Washout Period 2 (7 Days)||4
3331776|NCT03307252|4063958|FG005|STARTED|Part 2, Washout Period 2 (7 Days)||3
3331777|NCT03307252|4063959|FG006|STARTED|Part 2, Washout Period 2 (7 Days)||5
3331778|NCT03307252|4063960|FG007|STARTED|Part 2, Washout Period 2 (7 Days)||0
3331779|NCT03307252|4063961|FG008|STARTED|Part 2, Washout Period 2 (7 Days)||0
3176710|NCT01967719|3904545|FG000|COMPLETED|First Intervention (Day 1)||22
3176711|NCT01967719|3904546|FG001|COMPLETED|First Intervention (Day 1)||21
3176712|NCT01967719|3904547|FG002|COMPLETED|First Intervention (Day 1)||9
3176713|NCT01967719|3904548|FG003|COMPLETED|First Intervention (Day 1)||8
3176714|NCT01967719|3904545|FG000|NOT COMPLETED|First Intervention (Day 1)||0
3176715|NCT01967719|3904546|FG001|NOT COMPLETED|First Intervention (Day 1)||1
3176716|NCT01967719|3904547|FG002|NOT COMPLETED|First Intervention (Day 1)||0
3331780|NCT03307252|4063962|FG009|STARTED|Part 2, Washout Period 2 (7 Days)||0
3331781|NCT03307252|4063963|FG010|STARTED|Part 2, Washout Period 2 (7 Days)||0
3331782|NCT03307252|4063953|FG000|COMPLETED|Part 2, Washout Period 2 (7 Days)||0
3331783|NCT03307252|4063954|FG001|COMPLETED|Part 2, Washout Period 2 (7 Days)||0
3331784|NCT03307252|4063955|FG002|COMPLETED|Part 2, Washout Period 2 (7 Days)||0
3331785|NCT03307252|4063956|FG003|COMPLETED|Part 2, Washout Period 2 (7 Days)||4
3331786|NCT03307252|4063957|FG004|COMPLETED|Part 2, Washout Period 2 (7 Days)||4
3331787|NCT03307252|4063958|FG005|COMPLETED|Part 2, Washout Period 2 (7 Days)||3
3331788|NCT03307252|4063959|FG006|COMPLETED|Part 2, Washout Period 2 (7 Days)||5
3331789|NCT03307252|4063960|FG007|COMPLETED|Part 2, Washout Period 2 (7 Days)||0
3331790|NCT03307252|4063961|FG008|COMPLETED|Part 2, Washout Period 2 (7 Days)||0
3331791|NCT03307252|4063962|FG009|COMPLETED|Part 2, Washout Period 2 (7 Days)||0
3331792|NCT03307252|4063963|FG010|COMPLETED|Part 2, Washout Period 2 (7 Days)||0
3331793|NCT03307252|4063953|FG000|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
3331794|NCT03307252|4063954|FG001|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
3331795|NCT03307252|4063955|FG002|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
3331796|NCT03307252|4063956|FG003|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
3331797|NCT03307252|4063957|FG004|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
3331798|NCT03307252|4063958|FG005|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
3331799|NCT03307252|4063959|FG006|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
3331800|NCT03307252|4063960|FG007|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
3331801|NCT03307252|4063961|FG008|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
3331802|NCT03307252|4063962|FG009|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
3331803|NCT03307252|4063963|FG010|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
3331804|NCT03307252|4063953|FG000|STARTED|Part 2, Period 3||0
3331805|NCT03307252|4063954|FG001|STARTED|Part 2, Period 3||0
3331806|NCT03307252|4063955|FG002|STARTED|Part 2, Period 3||0
3331807|NCT03307252|4063956|FG003|STARTED|Part 2, Period 3||4
3331808|NCT03307252|4063957|FG004|STARTED|Part 2, Period 3||4
3331809|NCT03307252|4063958|FG005|STARTED|Part 2, Period 3||3
3331810|NCT03307252|4063959|FG006|STARTED|Part 2, Period 3||5
3331811|NCT03307252|4063960|FG007|STARTED|Part 2, Period 3||0
3331812|NCT03307252|4063961|FG008|STARTED|Part 2, Period 3||0
3331813|NCT03307252|4063962|FG009|STARTED|Part 2, Period 3||0
3331814|NCT03307252|4063963|FG010|STARTED|Part 2, Period 3||0
3331815|NCT03307252|4063953|FG000|COMPLETED|Part 2, Period 3||0
3331816|NCT03307252|4063954|FG001|COMPLETED|Part 2, Period 3||0
3331817|NCT03307252|4063955|FG002|COMPLETED|Part 2, Period 3||0
3331818|NCT03307252|4063956|FG003|COMPLETED|Part 2, Period 3||4
3331819|NCT03307252|4063957|FG004|COMPLETED|Part 2, Period 3||3
3331820|NCT03307252|4063958|FG005|COMPLETED|Part 2, Period 3||3
3331821|NCT03307252|4063959|FG006|COMPLETED|Part 2, Period 3||5
3331822|NCT03307252|4063960|FG007|COMPLETED|Part 2, Period 3||0
3331823|NCT03307252|4063961|FG008|COMPLETED|Part 2, Period 3||0
3331824|NCT03307252|4063962|FG009|COMPLETED|Part 2, Period 3||0
3331825|NCT03307252|4063963|FG010|COMPLETED|Part 2, Period 3||0
3331826|NCT03307252|4063953|FG000|NOT COMPLETED|Part 2, Period 3||0
3331827|NCT03307252|4063954|FG001|NOT COMPLETED|Part 2, Period 3||0
3331828|NCT03307252|4063955|FG002|NOT COMPLETED|Part 2, Period 3||0
3331829|NCT03307252|4063956|FG003|NOT COMPLETED|Part 2, Period 3||0
3331830|NCT03307252|4063957|FG004|NOT COMPLETED|Part 2, Period 3||1
3331831|NCT03307252|4063958|FG005|NOT COMPLETED|Part 2, Period 3||0
3331832|NCT03307252|4063959|FG006|NOT COMPLETED|Part 2, Period 3||0
3331833|NCT03307252|4063960|FG007|NOT COMPLETED|Part 2, Period 3||0
3331834|NCT03307252|4063961|FG008|NOT COMPLETED|Part 2, Period 3||0
3331835|NCT03307252|4063962|FG009|NOT COMPLETED|Part 2, Period 3||0
3331836|NCT03307252|4063963|FG010|NOT COMPLETED|Part 2, Period 3||0
3331837|NCT03307252|4063953|FG000|STARTED|Part 2, Washout Period 3 (7 Days)||0
3331838|NCT03307252|4063954|FG001|STARTED|Part 2, Washout Period 3 (7 Days)||0
3331839|NCT03307252|4063955|FG002|STARTED|Part 2, Washout Period 3 (7 Days)||0
3331840|NCT03307252|4063956|FG003|STARTED|Part 2, Washout Period 3 (7 Days)||4
3331841|NCT03307252|4063957|FG004|STARTED|Part 2, Washout Period 3 (7 Days)||3
3331842|NCT03307252|4063958|FG005|STARTED|Part 2, Washout Period 3 (7 Days)||3
3331843|NCT03307252|4063959|FG006|STARTED|Part 2, Washout Period 3 (7 Days)||5
3331844|NCT03307252|4063960|FG007|STARTED|Part 2, Washout Period 3 (7 Days)||0
3331845|NCT03307252|4063961|FG008|STARTED|Part 2, Washout Period 3 (7 Days)||0
3331846|NCT03307252|4063962|FG009|STARTED|Part 2, Washout Period 3 (7 Days)||0
3331847|NCT03307252|4063963|FG010|STARTED|Part 2, Washout Period 3 (7 Days)||0
3331848|NCT03307252|4063953|FG000|COMPLETED|Part 2, Washout Period 3 (7 Days)||0
3331849|NCT03307252|4063954|FG001|COMPLETED|Part 2, Washout Period 3 (7 Days)||0
3331850|NCT03307252|4063955|FG002|COMPLETED|Part 2, Washout Period 3 (7 Days)||0
3331851|NCT03307252|4063956|FG003|COMPLETED|Part 2, Washout Period 3 (7 Days)||4
3331852|NCT03307252|4063957|FG004|COMPLETED|Part 2, Washout Period 3 (7 Days)||3
3331853|NCT03307252|4063958|FG005|COMPLETED|Part 2, Washout Period 3 (7 Days)||3
3331854|NCT03307252|4063959|FG006|COMPLETED|Part 2, Washout Period 3 (7 Days)||4
3331855|NCT03307252|4063960|FG007|COMPLETED|Part 2, Washout Period 3 (7 Days)||0
3331856|NCT03307252|4063961|FG008|COMPLETED|Part 2, Washout Period 3 (7 Days)||0
3331857|NCT03307252|4063962|FG009|COMPLETED|Part 2, Washout Period 3 (7 Days)||0
3331858|NCT03307252|4063963|FG010|COMPLETED|Part 2, Washout Period 3 (7 Days)||0
3331859|NCT03307252|4063953|FG000|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
3331860|NCT03307252|4063954|FG001|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
3331861|NCT03307252|4063955|FG002|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
3331862|NCT03307252|4063956|FG003|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
3331863|NCT03307252|4063957|FG004|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
3331864|NCT03307252|4063958|FG005|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
3331865|NCT03307252|4063959|FG006|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||1
3331866|NCT03307252|4063960|FG007|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
3331867|NCT03307252|4063961|FG008|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
3331868|NCT03307252|4063962|FG009|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
3331869|NCT03307252|4063963|FG010|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
3331870|NCT03307252|4063953|FG000|STARTED|Part 2, Period 4||0
3331871|NCT03307252|4063954|FG001|STARTED|Part 2, Period 4||0
3331872|NCT03307252|4063955|FG002|STARTED|Part 2, Period 4||0
3331873|NCT03307252|4063956|FG003|STARTED|Part 2, Period 4||4
3331874|NCT03307252|4063957|FG004|STARTED|Part 2, Period 4||3
3331875|NCT03307252|4063958|FG005|STARTED|Part 2, Period 4||3
3331876|NCT03307252|4063959|FG006|STARTED|Part 2, Period 4||5
3176717|NCT01967719|3904548|FG003|NOT COMPLETED|First Intervention (Day 1)||1
3176718|NCT01967719|3904545|FG000|STARTED|Washout Period of 1 Day (Day 2)||22
3176719|NCT01967719|3904546|FG001|STARTED|Washout Period of 1 Day (Day 2)||21
3176720|NCT01967719|3904547|FG002|STARTED|Washout Period of 1 Day (Day 2)||9
3176721|NCT01967719|3904548|FG003|STARTED|Washout Period of 1 Day (Day 2)||8
3176722|NCT01967719|3904545|FG000|COMPLETED|Washout Period of 1 Day (Day 2)||22
3331877|NCT03307252|4063960|FG007|STARTED|Part 2, Period 4||0
3331878|NCT03307252|4063961|FG008|STARTED|Part 2, Period 4||0
3331879|NCT03307252|4063962|FG009|STARTED|Part 2, Period 4||0
3331880|NCT03307252|4063963|FG010|STARTED|Part 2, Period 4||0
3331881|NCT03307252|4063953|FG000|COMPLETED|Part 2, Period 4||0
3331882|NCT03307252|4063954|FG001|COMPLETED|Part 2, Period 4||0
3331883|NCT03307252|4063955|FG002|COMPLETED|Part 2, Period 4||0
3331884|NCT03307252|4063956|FG003|COMPLETED|Part 2, Period 4||4
3331885|NCT03307252|4063957|FG004|COMPLETED|Part 2, Period 4||3
3331886|NCT03307252|4063958|FG005|COMPLETED|Part 2, Period 4||3
3331887|NCT03307252|4063959|FG006|COMPLETED|Part 2, Period 4||4
3331888|NCT03307252|4063960|FG007|COMPLETED|Part 2, Period 4||0
3331889|NCT03307252|4063961|FG008|COMPLETED|Part 2, Period 4||0
3331890|NCT03307252|4063962|FG009|COMPLETED|Part 2, Period 4||0
3331891|NCT03307252|4063963|FG010|COMPLETED|Part 2, Period 4||0
3331892|NCT03307252|4063953|FG000|NOT COMPLETED|Part 2, Period 4||0
3331893|NCT03307252|4063954|FG001|NOT COMPLETED|Part 2, Period 4||0
3331894|NCT03307252|4063955|FG002|NOT COMPLETED|Part 2, Period 4||0
3331895|NCT03307252|4063956|FG003|NOT COMPLETED|Part 2, Period 4||0
3331896|NCT03307252|4063957|FG004|NOT COMPLETED|Part 2, Period 4||0
3331897|NCT03307252|4063958|FG005|NOT COMPLETED|Part 2, Period 4||0
3331898|NCT03307252|4063959|FG006|NOT COMPLETED|Part 2, Period 4||1
3331899|NCT03307252|4063960|FG007|NOT COMPLETED|Part 2, Period 4||0
3331900|NCT03307252|4063961|FG008|NOT COMPLETED|Part 2, Period 4||0
3331901|NCT03307252|4063962|FG009|NOT COMPLETED|Part 2, Period 4||0
3331902|NCT03307252|4063963|FG010|NOT COMPLETED|Part 2, Period 4||0
3331903|NCT03307252|4063953|FG000|STARTED|Part 3, Period 1||0
3331904|NCT03307252|4063954|FG001|STARTED|Part 3, Period 1||0
3331905|NCT03307252|4063955|FG002|STARTED|Part 3, Period 1||0
3331906|NCT03307252|4063956|FG003|STARTED|Part 3, Period 1||0
3331907|NCT03307252|4063957|FG004|STARTED|Part 3, Period 1||0
3331908|NCT03307252|4063958|FG005|STARTED|Part 3, Period 1||0
3331909|NCT03307252|4063959|FG006|STARTED|Part 3, Period 1||0
3331910|NCT03307252|4063960|FG007|STARTED|Part 3, Period 1||4
3331911|NCT03307252|4063961|FG008|STARTED|Part 3, Period 1||4
3331912|NCT03307252|4063962|FG009|STARTED|Part 3, Period 1||4
3331913|NCT03307252|4063963|FG010|STARTED|Part 3, Period 1||4
3331914|NCT03307252|4063953|FG000|COMPLETED|Part 3, Period 1||0
3331915|NCT03307252|4063954|FG001|COMPLETED|Part 3, Period 1||0
3331916|NCT03307252|4063955|FG002|COMPLETED|Part 3, Period 1||0
3331917|NCT03307252|4063956|FG003|COMPLETED|Part 3, Period 1||0
3331918|NCT03307252|4063957|FG004|COMPLETED|Part 3, Period 1||0
3331919|NCT03307252|4063958|FG005|COMPLETED|Part 3, Period 1||0
3331920|NCT03307252|4063959|FG006|COMPLETED|Part 3, Period 1||0
3331921|NCT03307252|4063960|FG007|COMPLETED|Part 3, Period 1|Participants randomized in Part 3|4
3331922|NCT03307252|4063961|FG008|COMPLETED|Part 3, Period 1|Participants randomized in Part 3|4
3331923|NCT03307252|4063962|FG009|COMPLETED|Part 3, Period 1|Participants randomized in Part 3|4
3331924|NCT03307252|4063963|FG010|COMPLETED|Part 3, Period 1|Participants randomized in Part 3|4
3331925|NCT03307252|4063953|FG000|NOT COMPLETED|Part 3, Period 1||0
3331926|NCT03307252|4063954|FG001|NOT COMPLETED|Part 3, Period 1||0
3331927|NCT03307252|4063955|FG002|NOT COMPLETED|Part 3, Period 1||0
3331928|NCT03307252|4063956|FG003|NOT COMPLETED|Part 3, Period 1||0
3331929|NCT03307252|4063957|FG004|NOT COMPLETED|Part 3, Period 1||0
3331930|NCT03307252|4063958|FG005|NOT COMPLETED|Part 3, Period 1||0
3331931|NCT03307252|4063959|FG006|NOT COMPLETED|Part 3, Period 1||0
3331932|NCT03307252|4063960|FG007|NOT COMPLETED|Part 3, Period 1||0
3331933|NCT03307252|4063961|FG008|NOT COMPLETED|Part 3, Period 1||0
3331934|NCT03307252|4063962|FG009|NOT COMPLETED|Part 3, Period 1||0
3331935|NCT03307252|4063963|FG010|NOT COMPLETED|Part 3, Period 1||0
3331936|NCT03307252|4063953|FG000|STARTED|Part 3, Washout Period 1 (7 Days)||0
3331937|NCT03307252|4063954|FG001|STARTED|Part 3, Washout Period 1 (7 Days)||0
3331938|NCT03307252|4063955|FG002|STARTED|Part 3, Washout Period 1 (7 Days)||0
3331939|NCT03307252|4063956|FG003|STARTED|Part 3, Washout Period 1 (7 Days)||0
3331940|NCT03307252|4063957|FG004|STARTED|Part 3, Washout Period 1 (7 Days)||0
3331941|NCT03307252|4063958|FG005|STARTED|Part 3, Washout Period 1 (7 Days)||0
3331942|NCT03307252|4063959|FG006|STARTED|Part 3, Washout Period 1 (7 Days)||0
3331943|NCT03307252|4063960|FG007|STARTED|Part 3, Washout Period 1 (7 Days)||4
3331944|NCT03307252|4063961|FG008|STARTED|Part 3, Washout Period 1 (7 Days)||4
3331945|NCT03307252|4063962|FG009|STARTED|Part 3, Washout Period 1 (7 Days)||4
3331946|NCT03307252|4063963|FG010|STARTED|Part 3, Washout Period 1 (7 Days)||4
3331947|NCT03307252|4063953|FG000|COMPLETED|Part 3, Washout Period 1 (7 Days)||0
3331948|NCT03307252|4063954|FG001|COMPLETED|Part 3, Washout Period 1 (7 Days)||0
3331949|NCT03307252|4063955|FG002|COMPLETED|Part 3, Washout Period 1 (7 Days)||0
3331950|NCT03307252|4063956|FG003|COMPLETED|Part 3, Washout Period 1 (7 Days)||0
3331951|NCT03307252|4063957|FG004|COMPLETED|Part 3, Washout Period 1 (7 Days)||0
3331952|NCT03307252|4063958|FG005|COMPLETED|Part 3, Washout Period 1 (7 Days)||0
3331953|NCT03307252|4063959|FG006|COMPLETED|Part 3, Washout Period 1 (7 Days)||0
3331954|NCT03307252|4063960|FG007|COMPLETED|Part 3, Washout Period 1 (7 Days)||4
3331955|NCT03307252|4063961|FG008|COMPLETED|Part 3, Washout Period 1 (7 Days)||4
3331956|NCT03307252|4063962|FG009|COMPLETED|Part 3, Washout Period 1 (7 Days)||4
3331957|NCT03307252|4063963|FG010|COMPLETED|Part 3, Washout Period 1 (7 Days)||4
3331958|NCT03307252|4063953|FG000|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
3331959|NCT03307252|4063954|FG001|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
3331960|NCT03307252|4063955|FG002|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
3331961|NCT03307252|4063956|FG003|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
3331962|NCT03307252|4063957|FG004|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
3331963|NCT03307252|4063958|FG005|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
3331964|NCT03307252|4063959|FG006|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
3331965|NCT03307252|4063960|FG007|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
3331966|NCT03307252|4063961|FG008|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
3331967|NCT03307252|4063962|FG009|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
3331968|NCT03307252|4063963|FG010|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
3331969|NCT03307252|4063953|FG000|STARTED|Part 3, Period 2||0
3331970|NCT03307252|4063954|FG001|STARTED|Part 3, Period 2||0
3331971|NCT03307252|4063955|FG002|STARTED|Part 3, Period 2||0
3331972|NCT03307252|4063956|FG003|STARTED|Part 3, Period 2||0
3331973|NCT03307252|4063957|FG004|STARTED|Part 3, Period 2||0
3331974|NCT03307252|4063958|FG005|STARTED|Part 3, Period 2||0
3331975|NCT03307252|4063959|FG006|STARTED|Part 3, Period 2||0
3331976|NCT03307252|4063960|FG007|STARTED|Part 3, Period 2||4
3331977|NCT03307252|4063961|FG008|STARTED|Part 3, Period 2||4
3331978|NCT03307252|4063962|FG009|STARTED|Part 3, Period 2||4
3331979|NCT03307252|4063963|FG010|STARTED|Part 3, Period 2||4
3331980|NCT03307252|4063953|FG000|COMPLETED|Part 3, Period 2||0
3331981|NCT03307252|4063954|FG001|COMPLETED|Part 3, Period 2||0
3331982|NCT03307252|4063955|FG002|COMPLETED|Part 3, Period 2||0
3331983|NCT03307252|4063956|FG003|COMPLETED|Part 3, Period 2||0
3331984|NCT03307252|4063957|FG004|COMPLETED|Part 3, Period 2||0
3331985|NCT03307252|4063958|FG005|COMPLETED|Part 3, Period 2||0
3331986|NCT03307252|4063959|FG006|COMPLETED|Part 3, Period 2||0
3331987|NCT03307252|4063960|FG007|COMPLETED|Part 3, Period 2||4
3331988|NCT03307252|4063961|FG008|COMPLETED|Part 3, Period 2||4
3331989|NCT03307252|4063962|FG009|COMPLETED|Part 3, Period 2||4
3331990|NCT03307252|4063963|FG010|COMPLETED|Part 3, Period 2||4
3331991|NCT03307252|4063953|FG000|NOT COMPLETED|Part 3, Period 2||0
3331992|NCT03307252|4063954|FG001|NOT COMPLETED|Part 3, Period 2||0
3331993|NCT03307252|4063955|FG002|NOT COMPLETED|Part 3, Period 2||0
3331994|NCT03307252|4063956|FG003|NOT COMPLETED|Part 3, Period 2||0
3331995|NCT03307252|4063957|FG004|NOT COMPLETED|Part 3, Period 2||0
3331996|NCT03307252|4063958|FG005|NOT COMPLETED|Part 3, Period 2||0
3331997|NCT03307252|4063959|FG006|NOT COMPLETED|Part 3, Period 2||0
3331998|NCT03307252|4063960|FG007|NOT COMPLETED|Part 3, Period 2||0
3331999|NCT03307252|4063961|FG008|NOT COMPLETED|Part 3, Period 2||0
3332000|NCT03307252|4063962|FG009|NOT COMPLETED|Part 3, Period 2||0
3332001|NCT03307252|4063963|FG010|NOT COMPLETED|Part 3, Period 2||0
3332002|NCT03307252|4063953|FG000|STARTED|Part 3, Washout Period 2 (7 Days)||0
3332003|NCT03307252|4063954|FG001|STARTED|Part 3, Washout Period 2 (7 Days)||0
3332004|NCT03307252|4063955|FG002|STARTED|Part 3, Washout Period 2 (7 Days)||0
3332005|NCT03307252|4063956|FG003|STARTED|Part 3, Washout Period 2 (7 Days)||0
3332006|NCT03307252|4063957|FG004|STARTED|Part 3, Washout Period 2 (7 Days)||0
3332007|NCT03307252|4063958|FG005|STARTED|Part 3, Washout Period 2 (7 Days)||0
3176723|NCT01967719|3904546|FG001|COMPLETED|Washout Period of 1 Day (Day 2)||21
3176724|NCT01967719|3904547|FG002|COMPLETED|Washout Period of 1 Day (Day 2)||9
3176725|NCT01967719|3904548|FG003|COMPLETED|Washout Period of 1 Day (Day 2)||8
3176726|NCT01967719|3904545|FG000|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
3176727|NCT01967719|3904546|FG001|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
3332008|NCT03307252|4063959|FG006|STARTED|Part 3, Washout Period 2 (7 Days)||0
3332009|NCT03307252|4063960|FG007|STARTED|Part 3, Washout Period 2 (7 Days)||4
3332010|NCT03307252|4063961|FG008|STARTED|Part 3, Washout Period 2 (7 Days)||4
3332011|NCT03307252|4063962|FG009|STARTED|Part 3, Washout Period 2 (7 Days)||4
3332012|NCT03307252|4063963|FG010|STARTED|Part 3, Washout Period 2 (7 Days)||4
3332013|NCT03307252|4063953|FG000|COMPLETED|Part 3, Washout Period 2 (7 Days)||0
3332014|NCT03307252|4063954|FG001|COMPLETED|Part 3, Washout Period 2 (7 Days)||0
3332015|NCT03307252|4063955|FG002|COMPLETED|Part 3, Washout Period 2 (7 Days)||0
3332016|NCT03307252|4063956|FG003|COMPLETED|Part 3, Washout Period 2 (7 Days)||0
3332017|NCT03307252|4063957|FG004|COMPLETED|Part 3, Washout Period 2 (7 Days)||0
3332018|NCT03307252|4063958|FG005|COMPLETED|Part 3, Washout Period 2 (7 Days)||0
3332019|NCT03307252|4063959|FG006|COMPLETED|Part 3, Washout Period 2 (7 Days)||0
3332020|NCT03307252|4063960|FG007|COMPLETED|Part 3, Washout Period 2 (7 Days)||4
3332021|NCT03307252|4063961|FG008|COMPLETED|Part 3, Washout Period 2 (7 Days)||4
3332022|NCT03307252|4063962|FG009|COMPLETED|Part 3, Washout Period 2 (7 Days)||4
3332023|NCT03307252|4063963|FG010|COMPLETED|Part 3, Washout Period 2 (7 Days)||4
3332024|NCT03307252|4063953|FG000|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
3332025|NCT03307252|4063954|FG001|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
3332026|NCT03307252|4063955|FG002|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
3332027|NCT03307252|4063956|FG003|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
3332028|NCT03307252|4063957|FG004|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
3332029|NCT03307252|4063958|FG005|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
3332030|NCT03307252|4063959|FG006|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
3332031|NCT03307252|4063960|FG007|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
3332032|NCT03307252|4063961|FG008|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
3332033|NCT03307252|4063962|FG009|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
3332034|NCT03307252|4063963|FG010|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
3332035|NCT03307252|4063953|FG000|STARTED|Part 3, Period 3||0
3332036|NCT03307252|4063954|FG001|STARTED|Part 3, Period 3||0
3332037|NCT03307252|4063955|FG002|STARTED|Part 3, Period 3||0
3332038|NCT03307252|4063956|FG003|STARTED|Part 3, Period 3||0
3332039|NCT03307252|4063957|FG004|STARTED|Part 3, Period 3||0
3332040|NCT03307252|4063958|FG005|STARTED|Part 3, Period 3||0
3332041|NCT03307252|4063959|FG006|STARTED|Part 3, Period 3||0
3332042|NCT03307252|4063960|FG007|STARTED|Part 3, Period 3||4
3332043|NCT03307252|4063961|FG008|STARTED|Part 3, Period 3||4
3332044|NCT03307252|4063962|FG009|STARTED|Part 3, Period 3||4
3332045|NCT03307252|4063963|FG010|STARTED|Part 3, Period 3||4
3332046|NCT03307252|4063953|FG000|COMPLETED|Part 3, Period 3||0
3332047|NCT03307252|4063954|FG001|COMPLETED|Part 3, Period 3||0
3332048|NCT03307252|4063955|FG002|COMPLETED|Part 3, Period 3||0
3332049|NCT03307252|4063956|FG003|COMPLETED|Part 3, Period 3||0
3332050|NCT03307252|4063957|FG004|COMPLETED|Part 3, Period 3||0
3332051|NCT03307252|4063958|FG005|COMPLETED|Part 3, Period 3||0
3332052|NCT03307252|4063959|FG006|COMPLETED|Part 3, Period 3||0
3332053|NCT03307252|4063960|FG007|COMPLETED|Part 3, Period 3||4
3332054|NCT03307252|4063961|FG008|COMPLETED|Part 3, Period 3||4
3332055|NCT03307252|4063962|FG009|COMPLETED|Part 3, Period 3||4
3332056|NCT03307252|4063963|FG010|COMPLETED|Part 3, Period 3||4
3332057|NCT03307252|4063953|FG000|NOT COMPLETED|Part 3, Period 3||0
3332058|NCT03307252|4063954|FG001|NOT COMPLETED|Part 3, Period 3||0
3332059|NCT03307252|4063955|FG002|NOT COMPLETED|Part 3, Period 3||0
3332060|NCT03307252|4063956|FG003|NOT COMPLETED|Part 3, Period 3||0
3332061|NCT03307252|4063957|FG004|NOT COMPLETED|Part 3, Period 3||0
3332062|NCT03307252|4063958|FG005|NOT COMPLETED|Part 3, Period 3||0
3332063|NCT03307252|4063959|FG006|NOT COMPLETED|Part 3, Period 3||0
3332064|NCT03307252|4063960|FG007|NOT COMPLETED|Part 3, Period 3||0
3332065|NCT03307252|4063961|FG008|NOT COMPLETED|Part 3, Period 3||0
3332066|NCT03307252|4063962|FG009|NOT COMPLETED|Part 3, Period 3||0
3332067|NCT03307252|4063963|FG010|NOT COMPLETED|Part 3, Period 3||0
3332068|NCT03307252|4063953|FG000|STARTED|Part 3, Washout Period 3 (7 Days)||0
3332069|NCT03307252|4063954|FG001|STARTED|Part 3, Washout Period 3 (7 Days)||0
3332070|NCT03307252|4063955|FG002|STARTED|Part 3, Washout Period 3 (7 Days)||0
3332071|NCT03307252|4063956|FG003|STARTED|Part 3, Washout Period 3 (7 Days)||0
3332072|NCT03307252|4063957|FG004|STARTED|Part 3, Washout Period 3 (7 Days)||0
3332073|NCT03307252|4063958|FG005|STARTED|Part 3, Washout Period 3 (7 Days)||0
3332074|NCT03307252|4063959|FG006|STARTED|Part 3, Washout Period 3 (7 Days)||0
3332075|NCT03307252|4063960|FG007|STARTED|Part 3, Washout Period 3 (7 Days)||4
3332076|NCT03307252|4063961|FG008|STARTED|Part 3, Washout Period 3 (7 Days)||4
3332077|NCT03307252|4063962|FG009|STARTED|Part 3, Washout Period 3 (7 Days)||4
3332078|NCT03307252|4063963|FG010|STARTED|Part 3, Washout Period 3 (7 Days)||4
3332079|NCT03307252|4063953|FG000|COMPLETED|Part 3, Washout Period 3 (7 Days)||0
3332080|NCT03307252|4063954|FG001|COMPLETED|Part 3, Washout Period 3 (7 Days)||0
3332081|NCT03307252|4063955|FG002|COMPLETED|Part 3, Washout Period 3 (7 Days)||0
3332082|NCT03307252|4063956|FG003|COMPLETED|Part 3, Washout Period 3 (7 Days)||0
3332083|NCT03307252|4063957|FG004|COMPLETED|Part 3, Washout Period 3 (7 Days)||0
3332084|NCT03307252|4063958|FG005|COMPLETED|Part 3, Washout Period 3 (7 Days)||0
3332085|NCT03307252|4063959|FG006|COMPLETED|Part 3, Washout Period 3 (7 Days)||0
3332086|NCT03307252|4063960|FG007|COMPLETED|Part 3, Washout Period 3 (7 Days)||4
3332087|NCT03307252|4063961|FG008|COMPLETED|Part 3, Washout Period 3 (7 Days)||4
3332088|NCT03307252|4063962|FG009|COMPLETED|Part 3, Washout Period 3 (7 Days)||4
3332089|NCT03307252|4063963|FG010|COMPLETED|Part 3, Washout Period 3 (7 Days)||3
3332090|NCT03307252|4063953|FG000|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
3332091|NCT03307252|4063954|FG001|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
3332092|NCT03307252|4063955|FG002|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
3332093|NCT03307252|4063956|FG003|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
3332094|NCT03307252|4063957|FG004|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
3332095|NCT03307252|4063958|FG005|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
3332096|NCT03307252|4063959|FG006|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
3332097|NCT03307252|4063960|FG007|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
3332098|NCT03307252|4063961|FG008|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
3332099|NCT03307252|4063962|FG009|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
3332100|NCT03307252|4063963|FG010|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||1
3332101|NCT03307252|4063953|FG000|STARTED|Part 3, Period 4||0
3332102|NCT03307252|4063954|FG001|STARTED|Part 3, Period 4||0
3332103|NCT03307252|4063955|FG002|STARTED|Part 3, Period 4||0
3332104|NCT03307252|4063956|FG003|STARTED|Part 3, Period 4||0
3332105|NCT03307252|4063957|FG004|STARTED|Part 3, Period 4||0
3332106|NCT03307252|4063958|FG005|STARTED|Part 3, Period 4||0
3332107|NCT03307252|4063959|FG006|STARTED|Part 3, Period 4||0
3332108|NCT03307252|4063960|FG007|STARTED|Part 3, Period 4||4
3332109|NCT03307252|4063961|FG008|STARTED|Part 3, Period 4||4
3332110|NCT03307252|4063962|FG009|STARTED|Part 3, Period 4||4
3332111|NCT03307252|4063963|FG010|STARTED|Part 3, Period 4||3
3332112|NCT03307252|4063953|FG000|COMPLETED|Part 3, Period 4||0
3332113|NCT03307252|4063954|FG001|COMPLETED|Part 3, Period 4||0
3332114|NCT03307252|4063955|FG002|COMPLETED|Part 3, Period 4||0
3332115|NCT03307252|4063956|FG003|COMPLETED|Part 3, Period 4||0
3332116|NCT03307252|4063957|FG004|COMPLETED|Part 3, Period 4||0
3332117|NCT03307252|4063958|FG005|COMPLETED|Part 3, Period 4||0
3332118|NCT03307252|4063959|FG006|COMPLETED|Part 3, Period 4||0
3332119|NCT03307252|4063960|FG007|COMPLETED|Part 3, Period 4||4
3332120|NCT03307252|4063961|FG008|COMPLETED|Part 3, Period 4||4
3332121|NCT03307252|4063962|FG009|COMPLETED|Part 3, Period 4||4
3332122|NCT03307252|4063963|FG010|COMPLETED|Part 3, Period 4||3
3332123|NCT03307252|4063953|FG000|NOT COMPLETED|Part 3, Period 4||0
3332124|NCT03307252|4063954|FG001|NOT COMPLETED|Part 3, Period 4||0
3332125|NCT03307252|4063955|FG002|NOT COMPLETED|Part 3, Period 4||0
3332126|NCT03307252|4063956|FG003|NOT COMPLETED|Part 3, Period 4||0
3332127|NCT03307252|4063957|FG004|NOT COMPLETED|Part 3, Period 4||0
3332128|NCT03307252|4063958|FG005|NOT COMPLETED|Part 3, Period 4||0
3332129|NCT03307252|4063959|FG006|NOT COMPLETED|Part 3, Period 4||0
3332130|NCT03307252|4063960|FG007|NOT COMPLETED|Part 3, Period 4||0
3332131|NCT03307252|4063961|FG008|NOT COMPLETED|Part 3, Period 4||0
3332132|NCT03307252|4063962|FG009|NOT COMPLETED|Part 3, Period 4||0
3332133|NCT03307252|4063963|FG010|NOT COMPLETED|Part 3, Period 4||0
3332134|NCT03307785|4063990|FG000|STARTED|Part A: Up to 28.5 Months||16
3332135|NCT03307785|4063991|FG001|STARTED|Part A: Up to 28.5 Months||6
3332136|NCT03307785|4063992|FG002|STARTED|Part A: Up to 28.5 Months||0
3332137|NCT03307785|4063993|FG003|STARTED|Part A: Up to 28.5 Months||0
3332138|NCT03307785|4063994|FG004|STARTED|Part A: Up to 28.5 Months||0
3332139|NCT03307785|4063995|FG005|STARTED|Part A: Up to 28.5 Months||0
3332140|NCT03307785|4063996|FG006|STARTED|Part A: Up to 28.5 Months||0
3332141|NCT03307785|4063997|FG007|STARTED|Part A: Up to 28.5 Months||0
3332142|NCT03307785|4063998|FG008|STARTED|Part A: Up to 28.5 Months||0
3332143|NCT03307785|4063999|FG009|STARTED|Part A: Up to 28.5 Months||0
3332144|NCT03307785|4064000|FG010|STARTED|Part A: Up to 28.5 Months||0
3332145|NCT03307785|4063990|FG000|COMPLETED|Part A: Up to 28.5 Months||0
3332146|NCT03307785|4063991|FG001|COMPLETED|Part A: Up to 28.5 Months||0
3332147|NCT03307785|4063992|FG002|COMPLETED|Part A: Up to 28.5 Months||0
3332148|NCT03307785|4063993|FG003|COMPLETED|Part A: Up to 28.5 Months||0
3332149|NCT03307785|4063994|FG004|COMPLETED|Part A: Up to 28.5 Months||0
3332150|NCT03307785|4063995|FG005|COMPLETED|Part A: Up to 28.5 Months||0
3332151|NCT03307785|4063996|FG006|COMPLETED|Part A: Up to 28.5 Months||0
3332152|NCT03307785|4063997|FG007|COMPLETED|Part A: Up to 28.5 Months||0
3332153|NCT03307785|4063998|FG008|COMPLETED|Part A: Up to 28.5 Months||0
3332154|NCT03307785|4063999|FG009|COMPLETED|Part A: Up to 28.5 Months||0
3332155|NCT03307785|4064000|FG010|COMPLETED|Part A: Up to 28.5 Months||0
3332156|NCT03307785|4063990|FG000|NOT COMPLETED|Part A: Up to 28.5 Months||16
3332157|NCT03307785|4063991|FG001|NOT COMPLETED|Part A: Up to 28.5 Months||6
3332158|NCT03307785|4063992|FG002|NOT COMPLETED|Part A: Up to 28.5 Months||0
3332159|NCT03307785|4063993|FG003|NOT COMPLETED|Part A: Up to 28.5 Months||0
3332160|NCT03307785|4063994|FG004|NOT COMPLETED|Part A: Up to 28.5 Months||0
3332161|NCT03307785|4063995|FG005|NOT COMPLETED|Part A: Up to 28.5 Months||0
3332162|NCT03307785|4063996|FG006|NOT COMPLETED|Part A: Up to 28.5 Months||0
3332163|NCT03307785|4063997|FG007|NOT COMPLETED|Part A: Up to 28.5 Months||0
3332164|NCT03307785|4063998|FG008|NOT COMPLETED|Part A: Up to 28.5 Months||0
3332165|NCT03307785|4063999|FG009|NOT COMPLETED|Part A: Up to 28.5 Months||0
3332166|NCT03307785|4064000|FG010|NOT COMPLETED|Part A: Up to 28.5 Months||0
3332167|NCT03307785|4063990|FG000|STARTED|Part B: Up to 28.5 Months||0
3332168|NCT03307785|4063991|FG001|STARTED|Part B: Up to 28.5 Months||0
3332169|NCT03307785|4063992|FG002|STARTED|Part B: Up to 28.5 Months||14
3332170|NCT03307785|4063993|FG003|STARTED|Part B: Up to 28.5 Months||0
3332171|NCT03307785|4063994|FG004|STARTED|Part B: Up to 28.5 Months||0
3332172|NCT03307785|4063995|FG005|STARTED|Part B: Up to 28.5 Months||0
3332173|NCT03307785|4063996|FG006|STARTED|Part B: Up to 28.5 Months||0
3332174|NCT03307785|4063997|FG007|STARTED|Part B: Up to 28.5 Months||0
3332175|NCT03307785|4063998|FG008|STARTED|Part B: Up to 28.5 Months||0
3332176|NCT03307785|4063999|FG009|STARTED|Part B: Up to 28.5 Months||0
3332177|NCT03307785|4064000|FG010|STARTED|Part B: Up to 28.5 Months||0
3332178|NCT03307785|4063990|FG000|COMPLETED|Part B: Up to 28.5 Months||0
3332179|NCT03307785|4063991|FG001|COMPLETED|Part B: Up to 28.5 Months||0
3332180|NCT03307785|4063992|FG002|COMPLETED|Part B: Up to 28.5 Months||0
3332181|NCT03307785|4063993|FG003|COMPLETED|Part B: Up to 28.5 Months||0
3332182|NCT03307785|4063994|FG004|COMPLETED|Part B: Up to 28.5 Months||0
3332183|NCT03307785|4063995|FG005|COMPLETED|Part B: Up to 28.5 Months||0
3332184|NCT03307785|4063996|FG006|COMPLETED|Part B: Up to 28.5 Months||0
3332185|NCT03307785|4063997|FG007|COMPLETED|Part B: Up to 28.5 Months||0
3332186|NCT03307785|4063998|FG008|COMPLETED|Part B: Up to 28.5 Months||0
3332187|NCT03307785|4063999|FG009|COMPLETED|Part B: Up to 28.5 Months||0
3332188|NCT03307785|4064000|FG010|COMPLETED|Part B: Up to 28.5 Months||0
3332189|NCT03307785|4063990|FG000|NOT COMPLETED|Part B: Up to 28.5 Months||0
3332190|NCT03307785|4063991|FG001|NOT COMPLETED|Part B: Up to 28.5 Months||0
3332191|NCT03307785|4063992|FG002|NOT COMPLETED|Part B: Up to 28.5 Months||14
3332192|NCT03307785|4063993|FG003|NOT COMPLETED|Part B: Up to 28.5 Months||0
3332193|NCT03307785|4063994|FG004|NOT COMPLETED|Part B: Up to 28.5 Months||0
3332194|NCT03307785|4063995|FG005|NOT COMPLETED|Part B: Up to 28.5 Months||0
3332195|NCT03307785|4063996|FG006|NOT COMPLETED|Part B: Up to 28.5 Months||0
3332196|NCT03307785|4063997|FG007|NOT COMPLETED|Part B: Up to 28.5 Months||0
3332197|NCT03307785|4063998|FG008|NOT COMPLETED|Part B: Up to 28.5 Months||0
3332198|NCT03307785|4063999|FG009|NOT COMPLETED|Part B: Up to 28.5 Months||0
3332199|NCT03307785|4064000|FG010|NOT COMPLETED|Part B: Up to 28.5 Months||0
3332200|NCT03307785|4063990|FG000|STARTED|Part C: Up to 22.5 Months||0
3332201|NCT03307785|4063991|FG001|STARTED|Part C: Up to 22.5 Months||0
3332202|NCT03307785|4063992|FG002|STARTED|Part C: Up to 22.5 Months||0
3332203|NCT03307785|4063993|FG003|STARTED|Part C: Up to 22.5 Months||6
3332204|NCT03307785|4063994|FG004|STARTED|Part C: Up to 22.5 Months||7
3332205|NCT03307785|4063995|FG005|STARTED|Part C: Up to 22.5 Months||0
3332206|NCT03307785|4063996|FG006|STARTED|Part C: Up to 22.5 Months||0
3332207|NCT03307785|4063997|FG007|STARTED|Part C: Up to 22.5 Months||0
3332208|NCT03307785|4063998|FG008|STARTED|Part C: Up to 22.5 Months||0
3332209|NCT03307785|4063999|FG009|STARTED|Part C: Up to 22.5 Months||0
3332210|NCT03307785|4064000|FG010|STARTED|Part C: Up to 22.5 Months||0
3332211|NCT03307785|4063990|FG000|COMPLETED|Part C: Up to 22.5 Months||0
3332212|NCT03307785|4063991|FG001|COMPLETED|Part C: Up to 22.5 Months||0
3332213|NCT03307785|4063992|FG002|COMPLETED|Part C: Up to 22.5 Months||0
3332214|NCT03307785|4063993|FG003|COMPLETED|Part C: Up to 22.5 Months||0
3332215|NCT03307785|4063994|FG004|COMPLETED|Part C: Up to 22.5 Months||0
3332216|NCT03307785|4063995|FG005|COMPLETED|Part C: Up to 22.5 Months||0
3332217|NCT03307785|4063996|FG006|COMPLETED|Part C: Up to 22.5 Months||0
3332218|NCT03307785|4063997|FG007|COMPLETED|Part C: Up to 22.5 Months||0
3332219|NCT03307785|4063998|FG008|COMPLETED|Part C: Up to 22.5 Months||0
3332220|NCT03307785|4063999|FG009|COMPLETED|Part C: Up to 22.5 Months||0
3332221|NCT03307785|4064000|FG010|COMPLETED|Part C: Up to 22.5 Months||0
3332222|NCT03307785|4063990|FG000|NOT COMPLETED|Part C: Up to 22.5 Months||0
3332223|NCT03307785|4063991|FG001|NOT COMPLETED|Part C: Up to 22.5 Months||0
3332224|NCT03307785|4063992|FG002|NOT COMPLETED|Part C: Up to 22.5 Months||0
3332225|NCT03307785|4063993|FG003|NOT COMPLETED|Part C: Up to 22.5 Months||6
3332226|NCT03307785|4063994|FG004|NOT COMPLETED|Part C: Up to 22.5 Months||7
3332227|NCT03307785|4063995|FG005|NOT COMPLETED|Part C: Up to 22.5 Months||0
3332228|NCT03307785|4063996|FG006|NOT COMPLETED|Part C: Up to 22.5 Months||0
3332229|NCT03307785|4063997|FG007|NOT COMPLETED|Part C: Up to 22.5 Months||0
3332230|NCT03307785|4063998|FG008|NOT COMPLETED|Part C: Up to 22.5 Months||0
3332231|NCT03307785|4063999|FG009|NOT COMPLETED|Part C: Up to 22.5 Months||0
3332232|NCT03307785|4064000|FG010|NOT COMPLETED|Part C: Up to 22.5 Months||0
3332233|NCT03307785|4063990|FG000|STARTED|Part D: Up to 9.5 Months||0
3332234|NCT03307785|4063991|FG001|STARTED|Part D: Up to 9.5 Months||0
3332235|NCT03307785|4063992|FG002|STARTED|Part D: Up to 9.5 Months||0
3332236|NCT03307785|4063993|FG003|STARTED|Part D: Up to 9.5 Months||0
3332237|NCT03307785|4063994|FG004|STARTED|Part D: Up to 9.5 Months||0
3332238|NCT03307785|4063995|FG005|STARTED|Part D: Up to 9.5 Months||6
3332239|NCT03307785|4063996|FG006|STARTED|Part D: Up to 9.5 Months||0
3332240|NCT03307785|4063997|FG007|STARTED|Part D: Up to 9.5 Months||0
3332241|NCT03307785|4063998|FG008|STARTED|Part D: Up to 9.5 Months||0
3332242|NCT03307785|4063999|FG009|STARTED|Part D: Up to 9.5 Months||0
3332243|NCT03307785|4064000|FG010|STARTED|Part D: Up to 9.5 Months||0
3332244|NCT03307785|4063990|FG000|COMPLETED|Part D: Up to 9.5 Months||0
3332245|NCT03307785|4063991|FG001|COMPLETED|Part D: Up to 9.5 Months||0
3332246|NCT03307785|4063992|FG002|COMPLETED|Part D: Up to 9.5 Months||0
3332247|NCT03307785|4063993|FG003|COMPLETED|Part D: Up to 9.5 Months||0
3332248|NCT03307785|4063994|FG004|COMPLETED|Part D: Up to 9.5 Months||0
3332249|NCT03307785|4063995|FG005|COMPLETED|Part D: Up to 9.5 Months||3
3332250|NCT03307785|4063996|FG006|COMPLETED|Part D: Up to 9.5 Months||0
3332251|NCT03307785|4063997|FG007|COMPLETED|Part D: Up to 9.5 Months||0
3332252|NCT03307785|4063998|FG008|COMPLETED|Part D: Up to 9.5 Months||0
3332253|NCT03307785|4063999|FG009|COMPLETED|Part D: Up to 9.5 Months||0
3332254|NCT03307785|4064000|FG010|COMPLETED|Part D: Up to 9.5 Months||0
3332255|NCT03307785|4063990|FG000|NOT COMPLETED|Part D: Up to 9.5 Months||0
3332256|NCT03307785|4063991|FG001|NOT COMPLETED|Part D: Up to 9.5 Months||0
3332257|NCT03307785|4063992|FG002|NOT COMPLETED|Part D: Up to 9.5 Months||0
3332258|NCT03307785|4063993|FG003|NOT COMPLETED|Part D: Up to 9.5 Months||0
3332259|NCT03307785|4063994|FG004|NOT COMPLETED|Part D: Up to 9.5 Months||0
3332260|NCT03307785|4063995|FG005|NOT COMPLETED|Part D: Up to 9.5 Months||3
3332261|NCT03307785|4063996|FG006|NOT COMPLETED|Part D: Up to 9.5 Months||0
3332262|NCT03307785|4063997|FG007|NOT COMPLETED|Part D: Up to 9.5 Months||0
3332263|NCT03307785|4063998|FG008|NOT COMPLETED|Part D: Up to 9.5 Months||0
3332264|NCT03307785|4063999|FG009|NOT COMPLETED|Part D: Up to 9.5 Months||0
3332265|NCT03307785|4064000|FG010|NOT COMPLETED|Part D: Up to 9.5 Months||0
3332266|NCT03307785|4063990|FG000|STARTED|Part E: Up to 4.4 Months||0
3332267|NCT03307785|4063991|FG001|STARTED|Part E: Up to 4.4 Months||0
3332268|NCT03307785|4063992|FG002|STARTED|Part E: Up to 4.4 Months||0
3332269|NCT03307785|4063993|FG003|STARTED|Part E: Up to 4.4 Months||0
3332270|NCT03307785|4063994|FG004|STARTED|Part E: Up to 4.4 Months||0
3332271|NCT03307785|4063995|FG005|STARTED|Part E: Up to 4.4 Months||0
3332272|NCT03307785|4063996|FG006|STARTED|Part E: Up to 4.4 Months||2
3332273|NCT03307785|4063997|FG007|STARTED|Part E: Up to 4.4 Months||0
3332274|NCT03307785|4063998|FG008|STARTED|Part E: Up to 4.4 Months||0
3332275|NCT03307785|4063999|FG009|STARTED|Part E: Up to 4.4 Months||0
3332276|NCT03307785|4064000|FG010|STARTED|Part E: Up to 4.4 Months||0
3332277|NCT03307785|4063990|FG000|COMPLETED|Part E: Up to 4.4 Months||0
3332278|NCT03307785|4063991|FG001|COMPLETED|Part E: Up to 4.4 Months||0
3332279|NCT03307785|4063992|FG002|COMPLETED|Part E: Up to 4.4 Months||0
3332280|NCT03307785|4063993|FG003|COMPLETED|Part E: Up to 4.4 Months||0
3332281|NCT03307785|4063994|FG004|COMPLETED|Part E: Up to 4.4 Months||0
3332282|NCT03307785|4063995|FG005|COMPLETED|Part E: Up to 4.4 Months||0
3332283|NCT03307785|4063996|FG006|COMPLETED|Part E: Up to 4.4 Months||0
3176728|NCT01967719|3904547|FG002|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
3176729|NCT01967719|3904548|FG003|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
3176730|NCT01967719|3904545|FG000|STARTED|Second Intervention (Day 3)||22
3176731|NCT01967719|3904546|FG001|STARTED|Second Intervention (Day 3)||21
3176732|NCT01967719|3904547|FG002|STARTED|Second Intervention (Day 3)||9
3176733|NCT01967719|3904548|FG003|STARTED|Second Intervention (Day 3)||8
3176734|NCT01967719|3904545|FG000|COMPLETED|Second Intervention (Day 3)||22
3176735|NCT01967719|3904546|FG001|COMPLETED|Second Intervention (Day 3)||20
3332284|NCT03307785|4063997|FG007|COMPLETED|Part E: Up to 4.4 Months||0
3332285|NCT03307785|4063998|FG008|COMPLETED|Part E: Up to 4.4 Months||0
3332286|NCT03307785|4063999|FG009|COMPLETED|Part E: Up to 4.4 Months||0
3332287|NCT03307785|4064000|FG010|COMPLETED|Part E: Up to 4.4 Months||0
3332288|NCT03307785|4063990|FG000|NOT COMPLETED|Part E: Up to 4.4 Months||0
3332289|NCT03307785|4063991|FG001|NOT COMPLETED|Part E: Up to 4.4 Months||0
3332290|NCT03307785|4063992|FG002|NOT COMPLETED|Part E: Up to 4.4 Months||0
3332291|NCT03307785|4063993|FG003|NOT COMPLETED|Part E: Up to 4.4 Months||0
3332292|NCT03307785|4063994|FG004|NOT COMPLETED|Part E: Up to 4.4 Months||0
3332293|NCT03307785|4063995|FG005|NOT COMPLETED|Part E: Up to 4.4 Months||0
3332294|NCT03307785|4063996|FG006|NOT COMPLETED|Part E: Up to 4.4 Months||2
3332295|NCT03307785|4063997|FG007|NOT COMPLETED|Part E: Up to 4.4 Months||0
3332296|NCT03307785|4063998|FG008|NOT COMPLETED|Part E: Up to 4.4 Months||0
3332297|NCT03307785|4063999|FG009|NOT COMPLETED|Part E: Up to 4.4 Months||0
3332298|NCT03307785|4064000|FG010|NOT COMPLETED|Part E: Up to 4.4 Months||0
3332299|NCT03307785|4063990|FG000|STARTED|Part F: Up to 3.5 Months||0
3332300|NCT03307785|4063991|FG001|STARTED|Part F: Up to 3.5 Months||0
3332301|NCT03307785|4063992|FG002|STARTED|Part F: Up to 3.5 Months||0
3332302|NCT03307785|4063993|FG003|STARTED|Part F: Up to 3.5 Months||0
3332303|NCT03307785|4063994|FG004|STARTED|Part F: Up to 3.5 Months||0
3332304|NCT03307785|4063995|FG005|STARTED|Part F: Up to 3.5 Months||0
3332305|NCT03307785|4063996|FG006|STARTED|Part F: Up to 3.5 Months||0
3332306|NCT03307785|4063997|FG007|STARTED|Part F: Up to 3.5 Months||1
3332307|NCT03307785|4063998|FG008|STARTED|Part F: Up to 3.5 Months||0
3332308|NCT03307785|4063999|FG009|STARTED|Part F: Up to 3.5 Months||0
3332309|NCT03307785|4064000|FG010|STARTED|Part F: Up to 3.5 Months||0
3332310|NCT03307785|4063990|FG000|COMPLETED|Part F: Up to 3.5 Months||0
3332311|NCT03307785|4063991|FG001|COMPLETED|Part F: Up to 3.5 Months||0
3332312|NCT03307785|4063992|FG002|COMPLETED|Part F: Up to 3.5 Months||0
3332313|NCT03307785|4063993|FG003|COMPLETED|Part F: Up to 3.5 Months||0
3332314|NCT03307785|4063994|FG004|COMPLETED|Part F: Up to 3.5 Months||0
3332315|NCT03307785|4063995|FG005|COMPLETED|Part F: Up to 3.5 Months||0
3332316|NCT03307785|4063996|FG006|COMPLETED|Part F: Up to 3.5 Months||0
3332317|NCT03307785|4063997|FG007|COMPLETED|Part F: Up to 3.5 Months||0
3332318|NCT03307785|4063998|FG008|COMPLETED|Part F: Up to 3.5 Months||0
3332319|NCT03307785|4063999|FG009|COMPLETED|Part F: Up to 3.5 Months||0
3332320|NCT03307785|4064000|FG010|COMPLETED|Part F: Up to 3.5 Months||0
3332321|NCT03307785|4063990|FG000|NOT COMPLETED|Part F: Up to 3.5 Months||0
3332322|NCT03307785|4063991|FG001|NOT COMPLETED|Part F: Up to 3.5 Months||0
3332323|NCT03307785|4063992|FG002|NOT COMPLETED|Part F: Up to 3.5 Months||0
3332324|NCT03307785|4063993|FG003|NOT COMPLETED|Part F: Up to 3.5 Months||0
3332325|NCT03307785|4063994|FG004|NOT COMPLETED|Part F: Up to 3.5 Months||0
3332326|NCT03307785|4063995|FG005|NOT COMPLETED|Part F: Up to 3.5 Months||0
3332327|NCT03307785|4063996|FG006|NOT COMPLETED|Part F: Up to 3.5 Months||0
3332328|NCT03307785|4063997|FG007|NOT COMPLETED|Part F: Up to 3.5 Months||1
3332329|NCT03307785|4063998|FG008|NOT COMPLETED|Part F: Up to 3.5 Months||0
3332330|NCT03307785|4063999|FG009|NOT COMPLETED|Part F: Up to 3.5 Months||0
3332331|NCT03307785|4064000|FG010|NOT COMPLETED|Part F: Up to 3.5 Months||0
3332332|NCT03307785|4063990|FG000|STARTED|Part G: Up to 24 Months||0
3332333|NCT03307785|4063991|FG001|STARTED|Part G: Up to 24 Months||0
3332334|NCT03307785|4063992|FG002|STARTED|Part G: Up to 24 Months||0
3332335|NCT03307785|4063993|FG003|STARTED|Part G: Up to 24 Months||0
3332336|NCT03307785|4063994|FG004|STARTED|Part G: Up to 24 Months||0
3332337|NCT03307785|4063995|FG005|STARTED|Part G: Up to 24 Months||0
3332338|NCT03307785|4063996|FG006|STARTED|Part G: Up to 24 Months||0
3332339|NCT03307785|4063997|FG007|STARTED|Part G: Up to 24 Months||0
3332340|NCT03307785|4063998|FG008|STARTED|Part G: Up to 24 Months||0
3332341|NCT03307785|4063999|FG009|STARTED|Part G: Up to 24 Months||0
3332342|NCT03307785|4064000|FG010|STARTED|Part G: Up to 24 Months||0
3332343|NCT03307785|4063990|FG000|COMPLETED|Part G: Up to 24 Months||0
3332344|NCT03307785|4063991|FG001|COMPLETED|Part G: Up to 24 Months||0
3332345|NCT03307785|4063992|FG002|COMPLETED|Part G: Up to 24 Months||0
3332346|NCT03307785|4063993|FG003|COMPLETED|Part G: Up to 24 Months||0
3332347|NCT03307785|4063994|FG004|COMPLETED|Part G: Up to 24 Months||0
3332348|NCT03307785|4063995|FG005|COMPLETED|Part G: Up to 24 Months||0
3332349|NCT03307785|4063996|FG006|COMPLETED|Part G: Up to 24 Months||0
3332350|NCT03307785|4063997|FG007|COMPLETED|Part G: Up to 24 Months||0
3332351|NCT03307785|4063998|FG008|COMPLETED|Part G: Up to 24 Months||0
3332352|NCT03307785|4063999|FG009|COMPLETED|Part G: Up to 24 Months||0
3332353|NCT03307785|4064000|FG010|COMPLETED|Part G: Up to 24 Months||0
3332354|NCT03307785|4063990|FG000|NOT COMPLETED|Part G: Up to 24 Months||0
3332355|NCT03307785|4063991|FG001|NOT COMPLETED|Part G: Up to 24 Months||0
3332356|NCT03307785|4063992|FG002|NOT COMPLETED|Part G: Up to 24 Months||0
3332357|NCT03307785|4063993|FG003|NOT COMPLETED|Part G: Up to 24 Months||0
3332358|NCT03307785|4063994|FG004|NOT COMPLETED|Part G: Up to 24 Months||0
3332359|NCT03307785|4063995|FG005|NOT COMPLETED|Part G: Up to 24 Months||0
3332360|NCT03307785|4063996|FG006|NOT COMPLETED|Part G: Up to 24 Months||0
3332361|NCT03307785|4063997|FG007|NOT COMPLETED|Part G: Up to 24 Months||0
3176736|NCT01967719|3904547|FG002|COMPLETED|Second Intervention (Day 3)||9
3176737|NCT01967719|3904548|FG003|COMPLETED|Second Intervention (Day 3)||8
3176738|NCT01967719|3904545|FG000|NOT COMPLETED|Second Intervention (Day 3)||0
3176739|NCT01967719|3904546|FG001|NOT COMPLETED|Second Intervention (Day 3)||1
3176740|NCT01967719|3904547|FG002|NOT COMPLETED|Second Intervention (Day 3)||0
3332362|NCT03307785|4063998|FG008|NOT COMPLETED|Part G: Up to 24 Months||0
3332363|NCT03307785|4063999|FG009|NOT COMPLETED|Part G: Up to 24 Months||0
3332364|NCT03307785|4064000|FG010|NOT COMPLETED|Part G: Up to 24 Months||0
3332365|NCT03307785|4063990|FG000|STARTED|Part H: Up to 24 Months||0
3332366|NCT03307785|4063991|FG001|STARTED|Part H: Up to 24 Months||0
3332367|NCT03307785|4063992|FG002|STARTED|Part H: Up to 24 Months||0
3332368|NCT03307785|4063993|FG003|STARTED|Part H: Up to 24 Months||0
3332369|NCT03307785|4063994|FG004|STARTED|Part H: Up to 24 Months||0
3332370|NCT03307785|4063995|FG005|STARTED|Part H: Up to 24 Months||0
3332371|NCT03307785|4063996|FG006|STARTED|Part H: Up to 24 Months||0
3332372|NCT03307785|4063997|FG007|STARTED|Part H: Up to 24 Months||0
3332373|NCT03307785|4063998|FG008|STARTED|Part H: Up to 24 Months||0
3332374|NCT03307785|4063999|FG009|STARTED|Part H: Up to 24 Months||0
3332375|NCT03307785|4064000|FG010|STARTED|Part H: Up to 24 Months||0
3332376|NCT03307785|4063990|FG000|COMPLETED|Part H: Up to 24 Months||0
3332377|NCT03307785|4063991|FG001|COMPLETED|Part H: Up to 24 Months||0
3332378|NCT03307785|4063992|FG002|COMPLETED|Part H: Up to 24 Months||0
3332379|NCT03307785|4063993|FG003|COMPLETED|Part H: Up to 24 Months||0
3332380|NCT03307785|4063994|FG004|COMPLETED|Part H: Up to 24 Months||0
3332381|NCT03307785|4063995|FG005|COMPLETED|Part H: Up to 24 Months||0
3332382|NCT03307785|4063996|FG006|COMPLETED|Part H: Up to 24 Months||0
3332383|NCT03307785|4063997|FG007|COMPLETED|Part H: Up to 24 Months||0
3332384|NCT03307785|4063998|FG008|COMPLETED|Part H: Up to 24 Months||0
3332385|NCT03307785|4063999|FG009|COMPLETED|Part H: Up to 24 Months||0
3332386|NCT03307785|4064000|FG010|COMPLETED|Part H: Up to 24 Months||0
3332387|NCT03307785|4063990|FG000|NOT COMPLETED|Part H: Up to 24 Months||0
3332388|NCT03307785|4063991|FG001|NOT COMPLETED|Part H: Up to 24 Months||0
3332389|NCT03307785|4063992|FG002|NOT COMPLETED|Part H: Up to 24 Months||0
3332390|NCT03307785|4063993|FG003|NOT COMPLETED|Part H: Up to 24 Months||0
3332391|NCT03307785|4063994|FG004|NOT COMPLETED|Part H: Up to 24 Months||0
3332392|NCT03307785|4063995|FG005|NOT COMPLETED|Part H: Up to 24 Months||0
3176741|NCT01967719|3904548|FG003|NOT COMPLETED|Second Intervention (Day 3)||0
3176742|NCT01967732|3904560|FG000|STARTED|Washout Period of 1 Day (Day 0)||22
3176743|NCT01967732|3904561|FG001|STARTED|Washout Period of 1 Day (Day 0)||22
3176744|NCT01967732|3904562|FG002|STARTED|Washout Period of 1 Day (Day 0)||9
3176745|NCT01967732|3904563|FG003|STARTED|Washout Period of 1 Day (Day 0)||9
3176746|NCT01967732|3904560|FG000|COMPLETED|Washout Period of 1 Day (Day 0)||22
3332393|NCT03307785|4063996|FG006|NOT COMPLETED|Part H: Up to 24 Months||0
3332394|NCT03307785|4063997|FG007|NOT COMPLETED|Part H: Up to 24 Months||0
3332395|NCT03307785|4063998|FG008|NOT COMPLETED|Part H: Up to 24 Months||0
3332396|NCT03307785|4063999|FG009|NOT COMPLETED|Part H: Up to 24 Months||0
3332397|NCT03307785|4064000|FG010|NOT COMPLETED|Part H: Up to 24 Months||0
3332398|NCT03307785|4063990|FG000|STARTED|Part I: Up to 24 Months||0
3332399|NCT03307785|4063991|FG001|STARTED|Part I: Up to 24 Months||0
3332400|NCT03307785|4063992|FG002|STARTED|Part I: Up to 24 Months||0
3332401|NCT03307785|4063993|FG003|STARTED|Part I: Up to 24 Months||0
3332402|NCT03307785|4063994|FG004|STARTED|Part I: Up to 24 Months||0
3332403|NCT03307785|4063995|FG005|STARTED|Part I: Up to 24 Months||0
3332404|NCT03307785|4063996|FG006|STARTED|Part I: Up to 24 Months||0
3332405|NCT03307785|4063997|FG007|STARTED|Part I: Up to 24 Months||0
3332406|NCT03307785|4063998|FG008|STARTED|Part I: Up to 24 Months||0
3332407|NCT03307785|4063999|FG009|STARTED|Part I: Up to 24 Months||0
3332408|NCT03307785|4064000|FG010|STARTED|Part I: Up to 24 Months||0
3332409|NCT03307785|4063990|FG000|COMPLETED|Part I: Up to 24 Months||0
3332410|NCT03307785|4063991|FG001|COMPLETED|Part I: Up to 24 Months||0
3332411|NCT03307785|4063992|FG002|COMPLETED|Part I: Up to 24 Months||0
3332412|NCT03307785|4063993|FG003|COMPLETED|Part I: Up to 24 Months||0
3332413|NCT03307785|4063994|FG004|COMPLETED|Part I: Up to 24 Months||0
3332414|NCT03307785|4063995|FG005|COMPLETED|Part I: Up to 24 Months||0
3332415|NCT03307785|4063996|FG006|COMPLETED|Part I: Up to 24 Months||0
3332416|NCT03307785|4063997|FG007|COMPLETED|Part I: Up to 24 Months||0
3332417|NCT03307785|4063998|FG008|COMPLETED|Part I: Up to 24 Months||0
3332418|NCT03307785|4063999|FG009|COMPLETED|Part I: Up to 24 Months||0
3332419|NCT03307785|4064000|FG010|COMPLETED|Part I: Up to 24 Months||0
3332420|NCT03307785|4063990|FG000|NOT COMPLETED|Part I: Up to 24 Months||0
3332421|NCT03307785|4063991|FG001|NOT COMPLETED|Part I: Up to 24 Months||0
3332422|NCT03307785|4063992|FG002|NOT COMPLETED|Part I: Up to 24 Months||0
3332423|NCT03307785|4063993|FG003|NOT COMPLETED|Part I: Up to 24 Months||0
3332424|NCT03307785|4063994|FG004|NOT COMPLETED|Part I: Up to 24 Months||0
3332425|NCT03307785|4063995|FG005|NOT COMPLETED|Part I: Up to 24 Months||0
3332426|NCT03307785|4063996|FG006|NOT COMPLETED|Part I: Up to 24 Months||0
3332427|NCT03307785|4063997|FG007|NOT COMPLETED|Part I: Up to 24 Months||0
3332428|NCT03307785|4063998|FG008|NOT COMPLETED|Part I: Up to 24 Months||0
3332429|NCT03307785|4063999|FG009|NOT COMPLETED|Part I: Up to 24 Months||0
3332430|NCT03307785|4064000|FG010|NOT COMPLETED|Part I: Up to 24 Months||0
3332431|NCT03307837|4064027|FG000|STARTED|Overall Study||6
3332432|NCT03307837|4064028|FG001|STARTED|Overall Study||6
3332433|NCT03307837|4064029|FG002|STARTED|Overall Study||6
3332434|NCT03307837|4064030|FG003|STARTED|Overall Study||6
3332435|NCT03307837|4064031|FG004|STARTED|Overall Study||6
3332436|NCT03307837|4064032|FG005|STARTED|Overall Study||10
3332437|NCT03307837|4064027|FG000|COMPLETED|Overall Study||5
3332438|NCT03307837|4064028|FG001|COMPLETED|Overall Study||5
3332439|NCT03307837|4064029|FG002|COMPLETED|Overall Study||5
3176747|NCT01967732|3904561|FG001|COMPLETED|Washout Period of 1 Day (Day 0)||21
3332440|NCT03307837|4064030|FG003|COMPLETED|Overall Study||6
3332441|NCT03307837|4064031|FG004|COMPLETED|Overall Study||6
3332442|NCT03307837|4064032|FG005|COMPLETED|Overall Study||8
3332443|NCT03307837|4064027|FG000|NOT COMPLETED|Overall Study||1
3332444|NCT03307837|4064028|FG001|NOT COMPLETED|Overall Study||1
3332445|NCT03307837|4064029|FG002|NOT COMPLETED|Overall Study||1
3332446|NCT03307837|4064030|FG003|NOT COMPLETED|Overall Study||0
3332447|NCT03307837|4064031|FG004|NOT COMPLETED|Overall Study||0
3332448|NCT03307837|4064032|FG005|NOT COMPLETED|Overall Study||2
3332449|NCT03308058|4064053|FG000|STARTED|Overall Study||23
3332450|NCT03308058|4064054|FG001|STARTED|Overall Study||23
3332451|NCT03308058|4064053|FG000|COMPLETED|Overall Study||23
3332452|NCT03308058|4064054|FG001|COMPLETED|Overall Study||23
3332453|NCT03308058|4064053|FG000|NOT COMPLETED|Overall Study||0
3332454|NCT03308058|4064054|FG001|NOT COMPLETED|Overall Study||0
3332455|NCT03308097|4064062|FG000|STARTED|Overall Study||33
3332456|NCT03308097|4064063|FG001|STARTED|Overall Study||32
3332457|NCT03308097|4064062|FG000|COMPLETED|Overall Study||31
3332458|NCT03308097|4064063|FG001|COMPLETED|Overall Study||31
3332459|NCT03308097|4064062|FG000|NOT COMPLETED|Overall Study||2
3332460|NCT03308097|4064063|FG001|NOT COMPLETED|Overall Study||1
3332461|NCT03308669|4064071|FG000|STARTED|Overall Study||10
3332462|NCT03308669|4064072|FG001|STARTED|Overall Study||20
3332463|NCT03308669|4064071|FG000|Received at Least One Dose of Study Drug|Overall Study||10
3332464|NCT03308669|4064072|FG001|Received at Least One Dose of Study Drug|Overall Study||20
3332465|NCT03308669|4064071|FG000|COMPLETED|Overall Study||10
3332466|NCT03308669|4064072|FG001|COMPLETED|Overall Study||20
3332467|NCT03308669|4064071|FG000|NOT COMPLETED|Overall Study||0
3332468|NCT03308669|4064072|FG001|NOT COMPLETED|Overall Study||0
3332469|NCT03308799|4064093|FG000|STARTED|Overall Study||342
3332470|NCT03308799|4064094|FG001|STARTED|Overall Study||337
3332471|NCT03308799|4064095|FG002|STARTED|Overall Study||115
3332472|NCT03308799|4064093|FG000|COMPLETED|Overall Study||320
3332473|NCT03308799|4064094|FG001|COMPLETED|Overall Study||309
3332474|NCT03308799|4064095|FG002|COMPLETED|Overall Study||94
3332475|NCT03308799|4064093|FG000|NOT COMPLETED|Overall Study||22
3332476|NCT03308799|4064094|FG001|NOT COMPLETED|Overall Study||28
3332477|NCT03308799|4064095|FG002|NOT COMPLETED|Overall Study||21
3332478|NCT03308825|4064107|FG000|STARTED|Overall Study|1 child in Group 1 received a 0.5mL dose instead of a 0.25 mL dose and is included in Group 2.|59
3332479|NCT03308825|4064108|FG001|STARTED|Overall Study|1 child in Group 1 received a 0.5mL dose instead of a 0.25 mL dose and is included in Group 2.|61
3332480|NCT03308825|4064109|FG002|STARTED|Overall Study||60
3332481|NCT03308825|4064110|FG003|STARTED|Overall Study||60
3332482|NCT03308825|4064107|FG000|COMPLETED|Overall Study||57
3332483|NCT03308825|4064108|FG001|COMPLETED|Overall Study||57
3332484|NCT03308825|4064109|FG002|COMPLETED|Overall Study||59
3332485|NCT03308825|4064110|FG003|COMPLETED|Overall Study||60
3332486|NCT03308825|4064107|FG000|NOT COMPLETED|Overall Study||2
3332487|NCT03308825|4064108|FG001|NOT COMPLETED|Overall Study||4
3332488|NCT03308825|4064109|FG002|NOT COMPLETED|Overall Study||1
3332489|NCT03308825|4064110|FG003|NOT COMPLETED|Overall Study||0
3332490|NCT03308942|4064129|FG000|STARTED|Stage 1 (up to a Maximum of 29 Months)||17
3176748|NCT01967732|3904562|FG002|COMPLETED|Washout Period of 1 Day (Day 0)||9
3176749|NCT01967732|3904563|FG003|COMPLETED|Washout Period of 1 Day (Day 0)||9
3332491|NCT03308942|4064130|FG001|STARTED|Stage 1 (up to a Maximum of 29 Months)||21
3332492|NCT03308942|4064131|FG002|STARTED|Stage 1 (up to a Maximum of 29 Months)||3
3332493|NCT03308942|4064132|FG003|STARTED|Stage 1 (up to a Maximum of 29 Months)||0
3332494|NCT03308942|4064133|FG004|STARTED|Stage 1 (up to a Maximum of 29 Months)||0
3332495|NCT03308942|4064129|FG000|COMPLETED|Stage 1 (up to a Maximum of 29 Months)||0
3332496|NCT03308942|4064130|FG001|COMPLETED|Stage 1 (up to a Maximum of 29 Months)||0
3332497|NCT03308942|4064131|FG002|COMPLETED|Stage 1 (up to a Maximum of 29 Months)||0
3332498|NCT03308942|4064132|FG003|COMPLETED|Stage 1 (up to a Maximum of 29 Months)||0
3332499|NCT03308942|4064133|FG004|COMPLETED|Stage 1 (up to a Maximum of 29 Months)||0
3332500|NCT03308942|4064129|FG000|NOT COMPLETED|Stage 1 (up to a Maximum of 29 Months)||17
3332501|NCT03308942|4064130|FG001|NOT COMPLETED|Stage 1 (up to a Maximum of 29 Months)||21
3332502|NCT03308942|4064131|FG002|NOT COMPLETED|Stage 1 (up to a Maximum of 29 Months)||3
3332503|NCT03308942|4064132|FG003|NOT COMPLETED|Stage 1 (up to a Maximum of 29 Months)||0
3332504|NCT03308942|4064133|FG004|NOT COMPLETED|Stage 1 (up to a Maximum of 29 Months)||0
3332505|NCT03308942|4064129|FG000|STARTED|Stage 2 (up to a Maximum of 17 Months)||0
3332506|NCT03308942|4064130|FG001|STARTED|Stage 2 (up to a Maximum of 17 Months)||0
3332507|NCT03308942|4064131|FG002|STARTED|Stage 2 (up to a Maximum of 17 Months)||0
3332508|NCT03308942|4064132|FG003|STARTED|Stage 2 (up to a Maximum of 17 Months)||12
3332509|NCT03308942|4064133|FG004|STARTED|Stage 2 (up to a Maximum of 17 Months)||0
3332510|NCT03308942|4064129|FG000|COMPLETED|Stage 2 (up to a Maximum of 17 Months)||0
3332511|NCT03308942|4064130|FG001|COMPLETED|Stage 2 (up to a Maximum of 17 Months)||0
3332512|NCT03308942|4064131|FG002|COMPLETED|Stage 2 (up to a Maximum of 17 Months)||0
3332513|NCT03308942|4064132|FG003|COMPLETED|Stage 2 (up to a Maximum of 17 Months)||0
3332514|NCT03308942|4064133|FG004|COMPLETED|Stage 2 (up to a Maximum of 17 Months)||0
3332515|NCT03308942|4064129|FG000|NOT COMPLETED|Stage 2 (up to a Maximum of 17 Months)||0
3332516|NCT03308942|4064130|FG001|NOT COMPLETED|Stage 2 (up to a Maximum of 17 Months)||0
3332517|NCT03308942|4064131|FG002|NOT COMPLETED|Stage 2 (up to a Maximum of 17 Months)||0
3332518|NCT03308942|4064132|FG003|NOT COMPLETED|Stage 2 (up to a Maximum of 17 Months)||12
3332519|NCT03308942|4064133|FG004|NOT COMPLETED|Stage 2 (up to a Maximum of 17 Months)||0
3332520|NCT03308968|4064149|FG000|STARTED|Double-Blind Period (12 Weeks)||279
3332521|NCT03308968|4064150|FG001|STARTED|Double-Blind Period (12 Weeks)||276
3332522|NCT03308968|4064151|FG002|STARTED|Double-Blind Period (12 Weeks)||283
3332523|NCT03308968|4064149|FG000|DB Safety Analysis Set|Double-Blind Period (12 Weeks)|2 participants (1 with CM and 1 with EM) randomized to placebo but received Fremanezumab monthly.|277
3332524|NCT03308968|4064150|FG001|DB Safety Analysis Set|Double-Blind Period (12 Weeks)||276
3332525|NCT03308968|4064151|FG002|DB Safety Analysis Set|Double-Blind Period (12 Weeks)|2 participants (1 with CM and 1 with EM) randomized to placebo but received Fremanezumab monthly.|285
3332526|NCT03308968|4064149|FG000|DB Modified ITT (mITT) Analysis Set|Double-Blind Period (12 Weeks)||278
3176750|NCT01967732|3904560|FG000|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
3176751|NCT01967732|3904561|FG001|NOT COMPLETED|Washout Period of 1 Day (Day 0)||1
3176752|NCT01967732|3904562|FG002|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
3176753|NCT01967732|3904563|FG003|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
3176754|NCT01967732|3904560|FG000|STARTED|First Intervention (Day 1)||22
3176755|NCT01967732|3904561|FG001|STARTED|First Intervention (Day 1)||21
3332527|NCT03308968|4064150|FG001|DB Modified ITT (mITT) Analysis Set|Double-Blind Period (12 Weeks)||276
3332528|NCT03308968|4064151|FG002|DB Modified ITT (mITT) Analysis Set|Double-Blind Period (12 Weeks)||283
3332529|NCT03308968|4064149|FG000|COMPLETED|Double-Blind Period (12 Weeks)||264
3332530|NCT03308968|4064150|FG001|COMPLETED|Double-Blind Period (12 Weeks)||271
3332531|NCT03308968|4064151|FG002|COMPLETED|Double-Blind Period (12 Weeks)||272
3332532|NCT03308968|4064149|FG000|NOT COMPLETED|Double-Blind Period (12 Weeks)||15
3332533|NCT03308968|4064150|FG001|NOT COMPLETED|Double-Blind Period (12 Weeks)||5
3332534|NCT03308968|4064151|FG002|NOT COMPLETED|Double-Blind Period (12 Weeks)||11
3332535|NCT03308968|4064149|FG000|STARTED|Open-Label Period (12 Weeks)||264
3332536|NCT03308968|4064150|FG001|STARTED|Open-Label Period (12 Weeks)||271
3332537|NCT03308968|4064151|FG002|STARTED|Open-Label Period (12 Weeks)||272
3332538|NCT03308968|4064149|FG000|OL mITT Analysis Set|Open-Label Period (12 Weeks)||263
3332539|NCT03308968|4064150|FG001|OL mITT Analysis Set|Open-Label Period (12 Weeks)||271
3332540|NCT03308968|4064151|FG002|OL mITT Analysis Set|Open-Label Period (12 Weeks)||272
3332541|NCT03308968|4064149|FG000|COMPLETED|Open-Label Period (12 Weeks)||253
3176756|NCT01967732|3904562|FG002|STARTED|First Intervention (Day 1)||9
3332542|NCT03308968|4064150|FG001|COMPLETED|Open-Label Period (12 Weeks)||259
3332543|NCT03308968|4064151|FG002|COMPLETED|Open-Label Period (12 Weeks)||260
3332544|NCT03308968|4064149|FG000|NOT COMPLETED|Open-Label Period (12 Weeks)||11
3332545|NCT03308968|4064150|FG001|NOT COMPLETED|Open-Label Period (12 Weeks)||12
3332546|NCT03308968|4064151|FG002|NOT COMPLETED|Open-Label Period (12 Weeks)||12
3332547|NCT03309020|4064164|FG000|STARTED|Overall Study||12
3332548|NCT03309020|4064165|FG001|STARTED|Overall Study||25
3332549|NCT03309020|4064164|FG000|Underwent Cataract Surgery|Overall Study||10
3332550|NCT03309020|4064165|FG001|Underwent Cataract Surgery|Overall Study||24
3332551|NCT03309020|4064164|FG000|COMPLETED|Overall Study||9
3332552|NCT03309020|4064165|FG001|COMPLETED|Overall Study||24
3332553|NCT03309020|4064164|FG000|NOT COMPLETED|Overall Study||3
3332554|NCT03309020|4064165|FG001|NOT COMPLETED|Overall Study||1
3332555|NCT03309202|4064177|FG000|STARTED|Overall Study||6
3332556|NCT03309202|4064178|FG001|STARTED|Overall Study||6
3332557|NCT03309202|4064179|FG002|STARTED|Overall Study||6
3332558|NCT03309202|4064180|FG003|STARTED|Overall Study||6
3332559|NCT03309202|4064177|FG000|COMPLETED|Overall Study||5
3332560|NCT03309202|4064178|FG001|COMPLETED|Overall Study||6
3332561|NCT03309202|4064179|FG002|COMPLETED|Overall Study||6
3332562|NCT03309202|4064180|FG003|COMPLETED|Overall Study||6
3332563|NCT03309202|4064177|FG000|NOT COMPLETED|Overall Study||1
3332564|NCT03309202|4064178|FG001|NOT COMPLETED|Overall Study||0
3332565|NCT03309202|4064179|FG002|NOT COMPLETED|Overall Study||0
3332566|NCT03309202|4064180|FG003|NOT COMPLETED|Overall Study||0
3332567|NCT03309449|4064193|FG000|STARTED|Overall Study||46
3332568|NCT03309449|4064194|FG001|STARTED|Overall Study||46
3332569|NCT03309449|4064195|FG002|STARTED|Overall Study||46
3332570|NCT03309449|4064193|FG000|COMPLETED|Overall Study||46
3332571|NCT03309449|4064194|FG001|COMPLETED|Overall Study||46
3332572|NCT03309449|4064195|FG002|COMPLETED|Overall Study||46
3332573|NCT03309449|4064193|FG000|NOT COMPLETED|Overall Study||0
3332574|NCT03309449|4064194|FG001|NOT COMPLETED|Overall Study||0
3332575|NCT03309449|4064195|FG002|NOT COMPLETED|Overall Study||0
3332576|NCT03309605|4064211|FG000|STARTED|Overall Study||6
3332577|NCT03309605|4064212|FG001|STARTED|Overall Study||5
3332578|NCT03309605|4064213|FG002|STARTED|Overall Study||6
3332579|NCT03309605|4064214|FG003|STARTED|Overall Study||6
3332580|NCT03309605|4064215|FG004|STARTED|Overall Study||6
3332581|NCT03309605|4064216|FG005|STARTED|Overall Study||6
3332582|NCT03309605|4064217|FG006|STARTED|Overall Study||6
3332583|NCT03309605|4064218|FG007|STARTED|Overall Study||21
3332584|NCT03309605|4064211|FG000|COMPLETED|Overall Study||6
3332585|NCT03309605|4064212|FG001|COMPLETED|Overall Study||5
3332586|NCT03309605|4064213|FG002|COMPLETED|Overall Study||6
3332587|NCT03309605|4064214|FG003|COMPLETED|Overall Study||5
3332588|NCT03309605|4064215|FG004|COMPLETED|Overall Study||5
3332589|NCT03309605|4064216|FG005|COMPLETED|Overall Study||6
3332590|NCT03309605|4064217|FG006|COMPLETED|Overall Study||3
3332591|NCT03309605|4064218|FG007|COMPLETED|Overall Study||19
3332592|NCT03309605|4064211|FG000|NOT COMPLETED|Overall Study||0
3332593|NCT03309605|4064212|FG001|NOT COMPLETED|Overall Study||0
3332594|NCT03309605|4064213|FG002|NOT COMPLETED|Overall Study||0
3332595|NCT03309605|4064214|FG003|NOT COMPLETED|Overall Study||1
3332596|NCT03309605|4064215|FG004|NOT COMPLETED|Overall Study||1
3332597|NCT03309605|4064216|FG005|NOT COMPLETED|Overall Study||0
3332598|NCT03309605|4064217|FG006|NOT COMPLETED|Overall Study||3
3332599|NCT03309605|4064218|FG007|NOT COMPLETED|Overall Study||2
3332600|NCT03309657|4064232|FG000|STARTED|Overall Study||10
3332601|NCT03309657|4064232|FG000|COMPLETED|Overall Study||10
3332602|NCT03309657|4064232|FG000|NOT COMPLETED|Overall Study||0
3332603|NCT03309696|4064238|FG000|STARTED|Overall Study|All five subjects in this arm were randomize to all sham and active tDCS and rTMS interventions.|5
3332604|NCT03309696|4064239|FG001|STARTED|Overall Study|All five subjects in this arm were randomize to all sham and active tDCS and rTMS interventions.|5
3332605|NCT03309696|4064240|FG002|STARTED|Overall Study||0
3332606|NCT03309696|4064241|FG003|STARTED|Overall Study||0
3332607|NCT03309696|4064238|FG000|COMPLETED|Overall Study||5
3332608|NCT03309696|4064239|FG001|COMPLETED|Overall Study||0
3332609|NCT03309696|4064240|FG002|COMPLETED|Overall Study||0
3332610|NCT03309696|4064241|FG003|COMPLETED|Overall Study||0
3332611|NCT03309696|4064238|FG000|NOT COMPLETED|Overall Study||0
3332612|NCT03309696|4064239|FG001|NOT COMPLETED|Overall Study||5
3332613|NCT03309696|4064240|FG002|NOT COMPLETED|Overall Study||0
3332614|NCT03309696|4064241|FG003|NOT COMPLETED|Overall Study||0
3332615|NCT03309787|4064252|FG000|STARTED|Overall Study||8
3332616|NCT03309787|4064253|FG001|STARTED|Overall Study||20
3332617|NCT03309787|4064254|FG002|STARTED|Overall Study||9
3332618|NCT03309787|4064252|FG000|COMPLETED|Overall Study||6
3332619|NCT03309787|4064253|FG001|COMPLETED|Overall Study||14
3332620|NCT03309787|4064254|FG002|COMPLETED|Overall Study||7
3332621|NCT03309787|4064252|FG000|NOT COMPLETED|Overall Study||2
3332622|NCT03309787|4064253|FG001|NOT COMPLETED|Overall Study||6
3332623|NCT03309787|4064254|FG002|NOT COMPLETED|Overall Study||2
3332624|NCT03309943|4064270|FG000|STARTED|Overall Study||22
3332625|NCT03309943|4064271|FG001|STARTED|Overall Study||22
3332626|NCT03309943|4064270|FG000|COMPLETED|Overall Study||22
3332627|NCT03309943|4064271|FG001|COMPLETED|Overall Study||20
3332628|NCT03309943|4064270|FG000|NOT COMPLETED|Overall Study||0
3332629|NCT03309943|4064271|FG001|NOT COMPLETED|Overall Study||2
3332630|NCT03310021|4064297|FG000|STARTED|Overall Study||6
3332631|NCT03310021|4064298|FG001|STARTED|Overall Study||3
3332632|NCT03310021|4064299|FG002|STARTED|Overall Study||6
3332633|NCT03310021|4064300|FG003|STARTED|Overall Study||3
3332634|NCT03310021|4064301|FG004|STARTED|Overall Study||8
3332635|NCT03310021|4064302|FG005|STARTED|Overall Study||4
3332636|NCT03310021|4064303|FG006|STARTED|Overall Study||8
3332637|NCT03310021|4064304|FG007|STARTED|Overall Study||4
3332638|NCT03310021|4064305|FG008|STARTED|Overall Study||6
3332639|NCT03310021|4064306|FG009|STARTED|Overall Study||3
3332640|NCT03310021|4064307|FG010|STARTED|Overall Study||6
3332641|NCT03310021|4064308|FG011|STARTED|Overall Study||3
3332642|NCT03310021|4064309|FG012|STARTED|Overall Study||8
3332643|NCT03310021|4064310|FG013|STARTED|Overall Study||4
3332644|NCT03310021|4064311|FG014|STARTED|Overall Study||6
3332645|NCT03310021|4064312|FG015|STARTED|Overall Study||3
3332646|NCT03310021|4064313|FG016|STARTED|Overall Study||10
3332647|NCT03310021|4064314|FG017|STARTED|Overall Study||5
3332648|NCT03310021|4064315|FG018|STARTED|Overall Study||8
3332649|NCT03310021|4064316|FG019|STARTED|Overall Study||3
3332650|NCT03310021|4064297|FG000|COMPLETED|Overall Study||6
3332651|NCT03310021|4064298|FG001|COMPLETED|Overall Study||3
3332652|NCT03310021|4064299|FG002|COMPLETED|Overall Study||6
3332653|NCT03310021|4064300|FG003|COMPLETED|Overall Study||3
3332654|NCT03310021|4064301|FG004|COMPLETED|Overall Study||8
3332655|NCT03310021|4064302|FG005|COMPLETED|Overall Study||4
3332656|NCT03310021|4064303|FG006|COMPLETED|Overall Study||7
3332657|NCT03310021|4064304|FG007|COMPLETED|Overall Study||4
3332658|NCT03310021|4064305|FG008|COMPLETED|Overall Study||6
3332659|NCT03310021|4064306|FG009|COMPLETED|Overall Study||3
3332660|NCT03310021|4064307|FG010|COMPLETED|Overall Study||5
3332661|NCT03310021|4064308|FG011|COMPLETED|Overall Study||3
3332662|NCT03310021|4064309|FG012|COMPLETED|Overall Study||8
3332663|NCT03310021|4064310|FG013|COMPLETED|Overall Study||4
3332664|NCT03310021|4064311|FG014|COMPLETED|Overall Study||6
3332665|NCT03310021|4064312|FG015|COMPLETED|Overall Study||3
3332666|NCT03310021|4064313|FG016|COMPLETED|Overall Study||10
3332667|NCT03310021|4064314|FG017|COMPLETED|Overall Study||5
3332668|NCT03310021|4064315|FG018|COMPLETED|Overall Study||8
3332669|NCT03310021|4064316|FG019|COMPLETED|Overall Study||3
3332670|NCT03310021|4064297|FG000|NOT COMPLETED|Overall Study||0
3332671|NCT03310021|4064298|FG001|NOT COMPLETED|Overall Study||0
3332672|NCT03310021|4064299|FG002|NOT COMPLETED|Overall Study||0
3332673|NCT03310021|4064300|FG003|NOT COMPLETED|Overall Study||0
3332674|NCT03310021|4064301|FG004|NOT COMPLETED|Overall Study||0
3332675|NCT03310021|4064302|FG005|NOT COMPLETED|Overall Study||0
3332676|NCT03310021|4064303|FG006|NOT COMPLETED|Overall Study||1
3332677|NCT03310021|4064304|FG007|NOT COMPLETED|Overall Study||0
3332678|NCT03310021|4064305|FG008|NOT COMPLETED|Overall Study||0
3332679|NCT03310021|4064306|FG009|NOT COMPLETED|Overall Study||0
3332680|NCT03310021|4064307|FG010|NOT COMPLETED|Overall Study||1
3332681|NCT03310021|4064308|FG011|NOT COMPLETED|Overall Study||0
3332682|NCT03310021|4064309|FG012|NOT COMPLETED|Overall Study||0
3332683|NCT03310021|4064310|FG013|NOT COMPLETED|Overall Study||0
3332684|NCT03310021|4064311|FG014|NOT COMPLETED|Overall Study||0
3332685|NCT03310021|4064312|FG015|NOT COMPLETED|Overall Study||0
3332686|NCT03310021|4064313|FG016|NOT COMPLETED|Overall Study||0
3332687|NCT03310021|4064314|FG017|NOT COMPLETED|Overall Study||0
3332688|NCT03310021|4064315|FG018|NOT COMPLETED|Overall Study||0
3332689|NCT03310021|4064316|FG019|NOT COMPLETED|Overall Study||0
3332690|NCT03310268|4064361|FG000|STARTED|Overall Study||62
3332691|NCT03310268|4064362|FG001|STARTED|Overall Study||62
3332692|NCT03310268|4064363|FG002|STARTED|Overall Study||61
3332693|NCT03310268|4064361|FG000|COMPLETED|Overall Study||61
3332694|NCT03310268|4064362|FG001|COMPLETED|Overall Study||57
3332695|NCT03310268|4064363|FG002|COMPLETED|Overall Study||61
3332696|NCT03310268|4064361|FG000|NOT COMPLETED|Overall Study||1
3332697|NCT03310268|4064362|FG001|NOT COMPLETED|Overall Study||5
3332698|NCT03310268|4064363|FG002|NOT COMPLETED|Overall Study||0
3332699|NCT03310411|4064371|FG000|STARTED|Period 1||10
3332700|NCT03310411|4064372|FG001|STARTED|Period 1||10
3332701|NCT03310411|4064373|FG002|STARTED|Period 1||10
3332702|NCT03310411|4064374|FG003|STARTED|Period 1||10
3332703|NCT03310411|4064371|FG000|Received at Least 1 Dose of Study Drug|Period 1||10
3332704|NCT03310411|4064372|FG001|Received at Least 1 Dose of Study Drug|Period 1||10
3332705|NCT03310411|4064373|FG002|Received at Least 1 Dose of Study Drug|Period 1||10
3332706|NCT03310411|4064374|FG003|Received at Least 1 Dose of Study Drug|Period 1||10
3332707|NCT03310411|4064371|FG000|COMPLETED|Period 1||10
3332708|NCT03310411|4064372|FG001|COMPLETED|Period 1||10
3332709|NCT03310411|4064373|FG002|COMPLETED|Period 1||10
3332710|NCT03310411|4064374|FG003|COMPLETED|Period 1||9
3332711|NCT03310411|4064371|FG000|NOT COMPLETED|Period 1||0
3332712|NCT03310411|4064372|FG001|NOT COMPLETED|Period 1||0
3332713|NCT03310411|4064373|FG002|NOT COMPLETED|Period 1||0
3332714|NCT03310411|4064374|FG003|NOT COMPLETED|Period 1||1
3332715|NCT03310411|4064371|FG000|STARTED|Period 2||10
3332716|NCT03310411|4064372|FG001|STARTED|Period 2||10
3332717|NCT03310411|4064373|FG002|STARTED|Period 2||10
3332718|NCT03310411|4064374|FG003|STARTED|Period 2||9
3332719|NCT03310411|4064371|FG000|COMPLETED|Period 2||10
3332720|NCT03310411|4064372|FG001|COMPLETED|Period 2||10
3332721|NCT03310411|4064373|FG002|COMPLETED|Period 2||10
3332722|NCT03310411|4064374|FG003|COMPLETED|Period 2||9
3332723|NCT03310411|4064371|FG000|NOT COMPLETED|Period 2||0
3332724|NCT03310411|4064372|FG001|NOT COMPLETED|Period 2||0
3332725|NCT03310411|4064373|FG002|NOT COMPLETED|Period 2||0
3332726|NCT03310411|4064374|FG003|NOT COMPLETED|Period 2||0
3332727|NCT03310411|4064371|FG000|STARTED|Period 3||10
3332728|NCT03310411|4064372|FG001|STARTED|Period 3||10
3332729|NCT03310411|4064373|FG002|STARTED|Period 3||10
3332730|NCT03310411|4064374|FG003|STARTED|Period 3||9
3332731|NCT03310411|4064371|FG000|COMPLETED|Period 3||10
3332732|NCT03310411|4064372|FG001|COMPLETED|Period 3||10
3332733|NCT03310411|4064373|FG002|COMPLETED|Period 3||10
3332734|NCT03310411|4064374|FG003|COMPLETED|Period 3||9
3332735|NCT03310411|4064371|FG000|NOT COMPLETED|Period 3||0
3332736|NCT03310411|4064372|FG001|NOT COMPLETED|Period 3||0
3176757|NCT01967732|3904563|FG003|STARTED|First Intervention (Day 1)||9
3176758|NCT01967732|3904560|FG000|COMPLETED|First Intervention (Day 1)||22
3176759|NCT01967732|3904561|FG001|COMPLETED|First Intervention (Day 1)|Subject discontinued from the study prior to product use|20
3332737|NCT03310411|4064373|FG002|NOT COMPLETED|Period 3||0
3332738|NCT03310411|4064374|FG003|NOT COMPLETED|Period 3||0
3332739|NCT03310411|4064371|FG000|STARTED|Period Title: Period 4||10
3332740|NCT03310411|4064372|FG001|STARTED|Period Title: Period 4||10
3332741|NCT03310411|4064373|FG002|STARTED|Period Title: Period 4||10
3332742|NCT03310411|4064374|FG003|STARTED|Period Title: Period 4||9
3332743|NCT03310411|4064371|FG000|COMPLETED|Period Title: Period 4||10
3332744|NCT03310411|4064372|FG001|COMPLETED|Period Title: Period 4||10
3332745|NCT03310411|4064373|FG002|COMPLETED|Period Title: Period 4||10
3332746|NCT03310411|4064374|FG003|COMPLETED|Period Title: Period 4||9
3332747|NCT03310411|4064371|FG000|NOT COMPLETED|Period Title: Period 4||0
3332748|NCT03310411|4064372|FG001|NOT COMPLETED|Period Title: Period 4||0
3332749|NCT03310411|4064373|FG002|NOT COMPLETED|Period Title: Period 4||0
3332750|NCT03310411|4064374|FG003|NOT COMPLETED|Period Title: Period 4||0
3332751|NCT03310450|4064393|FG000|STARTED|Overall Study||32
3332752|NCT03310450|4064394|FG001|STARTED|Overall Study||34
3332753|NCT03310450|4064395|FG002|STARTED|Overall Study||28
3332754|NCT03310450|4064393|FG000|COMPLETED|Overall Study||30
3332755|NCT03310450|4064394|FG001|COMPLETED|Overall Study||30
3332756|NCT03310450|4064395|FG002|COMPLETED|Overall Study||28
3332757|NCT03310450|4064393|FG000|NOT COMPLETED|Overall Study||2
3332758|NCT03310450|4064394|FG001|NOT COMPLETED|Overall Study||4
3332759|NCT03310450|4064395|FG002|NOT COMPLETED|Overall Study||0
3332760|NCT03310580|4064409|FG000|STARTED|Overall Study||15
3332761|NCT03310580|4064410|FG001|STARTED|Overall Study||15
3332762|NCT03310580|4064411|FG002|STARTED|Overall Study||12
3332763|NCT03310580|4064409|FG000|COMPLETED|Overall Study||15
3332764|NCT03310580|4064410|FG001|COMPLETED|Overall Study||14
3332765|NCT03310580|4064411|FG002|COMPLETED|Overall Study||12
3332766|NCT03310580|4064409|FG000|NOT COMPLETED|Overall Study||0
3332767|NCT03310580|4064410|FG001|NOT COMPLETED|Overall Study||1
3332768|NCT03310580|4064411|FG002|NOT COMPLETED|Overall Study||0
3332769|NCT03310723|4064422|FG000|STARTED|Overall Study||20
3332770|NCT03310723|4064423|FG001|STARTED|Overall Study||20
3332771|NCT03310723|4064422|FG000|COMPLETED|Overall Study||20
3332772|NCT03310723|4064423|FG001|COMPLETED|Overall Study||17
3332773|NCT03310723|4064422|FG000|NOT COMPLETED|Overall Study||0
3332774|NCT03310723|4064423|FG001|NOT COMPLETED|Overall Study||3
3332775|NCT03310775|4064431|FG000|STARTED|Overall Study||19
3332776|NCT03310775|4064432|FG001|STARTED|Overall Study||18
3332777|NCT03310775|4064431|FG000|COMPLETED|Overall Study||17
3332778|NCT03310775|4064432|FG001|COMPLETED|Overall Study||14
3332779|NCT03310775|4064431|FG000|NOT COMPLETED|Overall Study||2
3332780|NCT03310775|4064432|FG001|NOT COMPLETED|Overall Study||4
3332781|NCT03310970|4064438|FG000|STARTED|Overall Study||11
3332782|NCT03310970|4064439|FG001|STARTED|Overall Study||12
3332783|NCT03310970|4064438|FG000|COMPLETED|Overall Study||11
3332784|NCT03310970|4064439|FG001|COMPLETED|Overall Study||11
3332785|NCT03310970|4064438|FG000|NOT COMPLETED|Overall Study||0
3332786|NCT03310970|4064439|FG001|NOT COMPLETED|Overall Study||1
3332787|NCT03311230|4064450|FG000|STARTED|Overall Study||151
3332788|NCT03311230|4064451|FG001|STARTED|Overall Study||151
3332789|NCT03311230|4064452|FG002|STARTED|Overall Study||150
3332790|NCT03311230|4064453|FG003|STARTED|Overall Study||150
3332791|NCT03311230|4064450|FG000|COMPLETED|Overall Study||150
3332792|NCT03311230|4064451|FG001|COMPLETED|Overall Study||146
3332793|NCT03311230|4064452|FG002|COMPLETED|Overall Study||148
3332794|NCT03311230|4064453|FG003|COMPLETED|Overall Study||143
3332795|NCT03311230|4064450|FG000|NOT COMPLETED|Overall Study||1
3332796|NCT03311230|4064451|FG001|NOT COMPLETED|Overall Study||5
3332797|NCT03311230|4064452|FG002|NOT COMPLETED|Overall Study||2
3332798|NCT03311230|4064453|FG003|NOT COMPLETED|Overall Study||7
3332799|NCT03311373|4064463|FG000|STARTED|Overall Study||56
3332800|NCT03311373|4064463|FG000|COMPLETED|Overall Study||47
3332801|NCT03311373|4064463|FG000|NOT COMPLETED|Overall Study||9
3332802|NCT03311646|4064473|FG000|STARTED|Overall Study|Number who were eligible and consented.|31
3332803|NCT03311646|4064473|FG000|COMPLETED|Overall Study|Completed VLNC Condition|16
3332804|NCT03311646|4064473|FG000|NOT COMPLETED|Overall Study||15
3332805|NCT03311659|4064478|FG000|STARTED|Overall Study||447
3332806|NCT03311659|4064478|FG000|COMPLETED|Overall Study||446
3332807|NCT03311659|4064478|FG000|NOT COMPLETED|Overall Study||1
3332808|NCT03311724|4064486|FG000|STARTED|Overall Study||26
3332809|NCT03311724|4064487|FG001|STARTED|Overall Study||29
3332810|NCT03311724|4064488|FG002|STARTED|Overall Study||28
3332811|NCT03311724|4064489|FG003|STARTED|Overall Study||28
3332812|NCT03311724|4064486|FG000|Received At Least One Dose of Study Drug|Overall Study||26
3332813|NCT03311724|4064487|FG001|Received At Least One Dose of Study Drug|Overall Study||29
3332814|NCT03311724|4064488|FG002|Received At Least One Dose of Study Drug|Overall Study||28
3332815|NCT03311724|4064489|FG003|Received At Least One Dose of Study Drug|Overall Study||28
3332816|NCT03311724|4064486|FG000|Completed Treatment|Overall Study||20
3332817|NCT03311724|4064487|FG001|Completed Treatment|Overall Study||27
3332818|NCT03311724|4064488|FG002|Completed Treatment|Overall Study||22
3332819|NCT03311724|4064489|FG003|Completed Treatment|Overall Study||26
3332820|NCT03311724|4064486|FG000|COMPLETED|Overall Study||23
3332821|NCT03311724|4064487|FG001|COMPLETED|Overall Study||28
3332822|NCT03311724|4064488|FG002|COMPLETED|Overall Study||26
3332823|NCT03311724|4064489|FG003|COMPLETED|Overall Study||27
3332824|NCT03311724|4064486|FG000|NOT COMPLETED|Overall Study||3
3176760|NCT01967732|3904562|FG002|COMPLETED|First Intervention (Day 1)||9
3176761|NCT01967732|3904563|FG003|COMPLETED|First Intervention (Day 1)||9
3176762|NCT01967732|3904560|FG000|NOT COMPLETED|First Intervention (Day 1)||0
3176763|NCT01967732|3904561|FG001|NOT COMPLETED|First Intervention (Day 1)||1
3332825|NCT03311724|4064487|FG001|NOT COMPLETED|Overall Study||1
3332826|NCT03311724|4064488|FG002|NOT COMPLETED|Overall Study||2
3332827|NCT03311724|4064489|FG003|NOT COMPLETED|Overall Study||1
3332828|NCT03311841|4064507|FG000|STARTED|Period 1||6
3332829|NCT03311841|4064508|FG001|STARTED|Period 1||7
3332830|NCT03311841|4064509|FG002|STARTED|Period 1||6
3332831|NCT03311841|4064510|FG003|STARTED|Period 1||7
3332832|NCT03311841|4064511|FG004|STARTED|Period 1||6
3332833|NCT03311841|4064507|FG000|COMPLETED|Period 1||6
3332834|NCT03311841|4064508|FG001|COMPLETED|Period 1||7
3332835|NCT03311841|4064509|FG002|COMPLETED|Period 1||6
3332836|NCT03311841|4064510|FG003|COMPLETED|Period 1||7
3332837|NCT03311841|4064511|FG004|COMPLETED|Period 1||6
3332838|NCT03311841|4064507|FG000|NOT COMPLETED|Period 1||0
3332839|NCT03311841|4064508|FG001|NOT COMPLETED|Period 1||0
3332840|NCT03311841|4064509|FG002|NOT COMPLETED|Period 1||0
3332841|NCT03311841|4064510|FG003|NOT COMPLETED|Period 1||0
3332842|NCT03311841|4064511|FG004|NOT COMPLETED|Period 1||0
3332843|NCT03311841|4064507|FG000|STARTED|14-day Wash-out||6
3332844|NCT03311841|4064508|FG001|STARTED|14-day Wash-out||7
3332845|NCT03311841|4064509|FG002|STARTED|14-day Wash-out||6
3332846|NCT03311841|4064510|FG003|STARTED|14-day Wash-out||7
3332847|NCT03311841|4064511|FG004|STARTED|14-day Wash-out||6
3332848|NCT03311841|4064507|FG000|COMPLETED|14-day Wash-out||6
3332849|NCT03311841|4064508|FG001|COMPLETED|14-day Wash-out||6
3332850|NCT03311841|4064509|FG002|COMPLETED|14-day Wash-out||6
3332851|NCT03311841|4064510|FG003|COMPLETED|14-day Wash-out||6
3332852|NCT03311841|4064511|FG004|COMPLETED|14-day Wash-out||6
3332853|NCT03311841|4064507|FG000|NOT COMPLETED|14-day Wash-out||0
3332854|NCT03311841|4064508|FG001|NOT COMPLETED|14-day Wash-out||1
3332855|NCT03311841|4064509|FG002|NOT COMPLETED|14-day Wash-out||0
3332856|NCT03311841|4064510|FG003|NOT COMPLETED|14-day Wash-out||1
3332857|NCT03311841|4064511|FG004|NOT COMPLETED|14-day Wash-out||0
3332858|NCT03311841|4064507|FG000|STARTED|Period 2||6
3332859|NCT03311841|4064508|FG001|STARTED|Period 2||6
3332860|NCT03311841|4064509|FG002|STARTED|Period 2||6
3332861|NCT03311841|4064510|FG003|STARTED|Period 2||6
3332862|NCT03311841|4064511|FG004|STARTED|Period 2||6
3332863|NCT03311841|4064507|FG000|COMPLETED|Period 2||6
3332864|NCT03311841|4064508|FG001|COMPLETED|Period 2||6
3332865|NCT03311841|4064509|FG002|COMPLETED|Period 2||6
3332866|NCT03311841|4064510|FG003|COMPLETED|Period 2||6
3332867|NCT03311841|4064511|FG004|COMPLETED|Period 2||6
3332868|NCT03311841|4064507|FG000|NOT COMPLETED|Period 2||0
3332869|NCT03311841|4064508|FG001|NOT COMPLETED|Period 2||0
3332870|NCT03311841|4064509|FG002|NOT COMPLETED|Period 2||0
3332871|NCT03311841|4064510|FG003|NOT COMPLETED|Period 2||0
3332872|NCT03311841|4064511|FG004|NOT COMPLETED|Period 2||0
3332873|NCT03312023|4064536|FG000|STARTED|Overall Study||8
3332874|NCT03312023|4064537|FG001|STARTED|Overall Study||5
3332875|NCT03312023|4064538|FG002|STARTED|Overall Study||4
3332876|NCT03312023|4064539|FG003|STARTED|Overall Study||4
3332877|NCT03312023|4064536|FG000|Completed Week 12|Overall Study||8
3332878|NCT03312023|4064537|FG001|Completed Week 12|Overall Study||5
3332879|NCT03312023|4064538|FG002|Completed Week 12|Overall Study||4
3176764|NCT01967732|3904562|FG002|NOT COMPLETED|First Intervention (Day 1)||0
3176765|NCT01967732|3904563|FG003|NOT COMPLETED|First Intervention (Day 1)||0
3176766|NCT01967732|3904560|FG000|STARTED|Washout Period of 1 Day (Day 2)||22
3176767|NCT01967732|3904561|FG001|STARTED|Washout Period of 1 Day (Day 2)||20
3176768|NCT01967732|3904562|FG002|STARTED|Washout Period of 1 Day (Day 2)||9
3332880|NCT03312023|4064539|FG003|Completed Week 12|Overall Study||4
3332881|NCT03312023|4064536|FG000|COMPLETED|Overall Study||8
3332882|NCT03312023|4064537|FG001|COMPLETED|Overall Study||5
3332883|NCT03312023|4064538|FG002|COMPLETED|Overall Study||4
3332884|NCT03312023|4064539|FG003|COMPLETED|Overall Study||4
3332885|NCT03312023|4064536|FG000|NOT COMPLETED|Overall Study||0
3332886|NCT03312023|4064537|FG001|NOT COMPLETED|Overall Study||0
3332887|NCT03312023|4064538|FG002|NOT COMPLETED|Overall Study||0
3332888|NCT03312023|4064539|FG003|NOT COMPLETED|Overall Study||0
3332889|NCT03312114|4064550|FG000|STARTED|Overall Study||5
3332890|NCT03312114|4064550|FG000|COMPLETED|Overall Study||0
3332891|NCT03312114|4064550|FG000|NOT COMPLETED|Overall Study||5
3332892|NCT03312218|4064557|FG000|STARTED|Overall Study||335
3332893|NCT03312218|4064558|FG001|STARTED|Overall Study||299
3332894|NCT03312218|4064557|FG000|COMPLETED|Overall Study||281
3332895|NCT03312218|4064558|FG001|COMPLETED|Overall Study||241
3332896|NCT03312218|4064557|FG000|NOT COMPLETED|Overall Study||54
3332897|NCT03312218|4064558|FG001|NOT COMPLETED|Overall Study||58
3332898|NCT03312231|4064569|FG000|STARTED|Overall Study||184
3332899|NCT03312231|4064570|FG001|STARTED|Overall Study||176
3332900|NCT03312231|4064571|FG002|STARTED|Overall Study||181
3332901|NCT03312231|4064572|FG003|STARTED|Overall Study||89
3332902|NCT03312231|4064573|FG004|STARTED|Overall Study||90
3332903|NCT03312231|4064569|FG000|COMPLETED|Overall Study||181
3332904|NCT03312231|4064570|FG001|COMPLETED|Overall Study||165
3332905|NCT03312231|4064571|FG002|COMPLETED|Overall Study||177
3332906|NCT03312231|4064572|FG003|COMPLETED|Overall Study||86
3332907|NCT03312231|4064573|FG004|COMPLETED|Overall Study||89
3332908|NCT03312231|4064569|FG000|NOT COMPLETED|Overall Study||3
3332909|NCT03312231|4064570|FG001|NOT COMPLETED|Overall Study||11
3332910|NCT03312231|4064571|FG002|NOT COMPLETED|Overall Study||4
3332911|NCT03312231|4064572|FG003|NOT COMPLETED|Overall Study||3
3332912|NCT03312231|4064573|FG004|NOT COMPLETED|Overall Study||1
3332913|NCT03312348|4064585|FG000|STARTED|Overall Study||30
3332914|NCT03312348|4064585|FG000|COMPLETED|Overall Study||30
3332915|NCT03312348|4064585|FG000|NOT COMPLETED|Overall Study||0
3332916|NCT03312517|4064589|FG000|STARTED|Overall Study||2
3332917|NCT03312517|4064590|FG001|STARTED|Overall Study||2
3332918|NCT03312517|4064591|FG002|STARTED|Overall Study||2
3332919|NCT03312517|4064592|FG003|STARTED|Overall Study||2
3332920|NCT03312517|4064593|FG004|STARTED|Overall Study||2
3332921|NCT03312517|4064594|FG005|STARTED|Overall Study||2
3332922|NCT03312517|4064589|FG000|COMPLETED|Overall Study||2
3332923|NCT03312517|4064590|FG001|COMPLETED|Overall Study||2
3332924|NCT03312517|4064591|FG002|COMPLETED|Overall Study||2
3332925|NCT03312517|4064592|FG003|COMPLETED|Overall Study||2
3332926|NCT03312517|4064593|FG004|COMPLETED|Overall Study||2
3332927|NCT03312517|4064594|FG005|COMPLETED|Overall Study||2
3332928|NCT03312517|4064589|FG000|NOT COMPLETED|Overall Study||0
3332929|NCT03312517|4064590|FG001|NOT COMPLETED|Overall Study||0
3332930|NCT03312517|4064591|FG002|NOT COMPLETED|Overall Study||0
3332931|NCT03312517|4064592|FG003|NOT COMPLETED|Overall Study||0
3332932|NCT03312517|4064593|FG004|NOT COMPLETED|Overall Study||0
3332933|NCT03312517|4064594|FG005|NOT COMPLETED|Overall Study||0
3332934|NCT03312543|4064604|FG000|STARTED|Before Treatment (Screening to Baseline)||61
3332935|NCT03312543|4064605|FG001|STARTED|Before Treatment (Screening to Baseline)||63
3332936|NCT03312543|4064604|FG000|COMPLETED|Before Treatment (Screening to Baseline)||60
3332937|NCT03312543|4064605|FG001|COMPLETED|Before Treatment (Screening to Baseline)||59
3332938|NCT03312543|4064604|FG000|NOT COMPLETED|Before Treatment (Screening to Baseline)||1
3332939|NCT03312543|4064605|FG001|NOT COMPLETED|Before Treatment (Screening to Baseline)||4
3332940|NCT03312543|4064604|FG000|STARTED|Treatment (Baseline to Week 12)||60
3332941|NCT03312543|4064605|FG001|STARTED|Treatment (Baseline to Week 12)||59
3332942|NCT03312543|4064604|FG000|COMPLETED|Treatment (Baseline to Week 12)||56
3332943|NCT03312543|4064605|FG001|COMPLETED|Treatment (Baseline to Week 12)||54
3332944|NCT03312543|4064604|FG000|NOT COMPLETED|Treatment (Baseline to Week 12)||4
3332945|NCT03312543|4064605|FG001|NOT COMPLETED|Treatment (Baseline to Week 12)||5
3332946|NCT03312543|4064604|FG000|STARTED|Regression (Week 12 to Week 24)||56
3332947|NCT03312543|4064605|FG001|STARTED|Regression (Week 12 to Week 24)||54
3332948|NCT03312543|4064604|FG000|COMPLETED|Regression (Week 12 to Week 24)||55
3332949|NCT03312543|4064605|FG001|COMPLETED|Regression (Week 12 to Week 24)||52
3332950|NCT03312543|4064604|FG000|NOT COMPLETED|Regression (Week 12 to Week 24)||1
3332951|NCT03312543|4064605|FG001|NOT COMPLETED|Regression (Week 12 to Week 24)||2
3332952|NCT03312595|4064611|FG000|STARTED|Overall Study||30
3332953|NCT03312595|4064611|FG000|COMPLETED|Overall Study||24
3332954|NCT03312595|4064611|FG000|NOT COMPLETED|Overall Study||6
3332955|NCT03312933|4064615|FG000|STARTED|Overall Study||100
3332956|NCT03312933|4064615|FG000|COMPLETED|Overall Study||46
3332957|NCT03312933|4064615|FG000|NOT COMPLETED|Overall Study||54
3332958|NCT03313037|4064621|FG000|STARTED|Overall Study||222
3332959|NCT03313037|4064622|FG001|STARTED|Overall Study||222
3332960|NCT03313037|4064621|FG000|Safety Population|Overall Study||221
3332961|NCT03313037|4064622|FG001|Safety Population|Overall Study||222
3332962|NCT03313037|4064621|FG000|Evaluable Immunogenicity Population(EIP)|Overall Study||210
3332963|NCT03313037|4064622|FG001|Evaluable Immunogenicity Population(EIP)|Overall Study||208
3332964|NCT03313037|4064621|FG000|COMPLETED|Overall Study||202
3332965|NCT03313037|4064622|FG001|COMPLETED|Overall Study||202
3332966|NCT03313037|4064621|FG000|NOT COMPLETED|Overall Study||20
3332967|NCT03313037|4064622|FG001|NOT COMPLETED|Overall Study||20
3332968|NCT03313050|4064632|FG000|STARTED|Stage 1: 6 Months||34
3332969|NCT03313050|4064633|FG001|STARTED|Stage 1: 6 Months||32
3332970|NCT03313050|4064634|FG002|STARTED|Stage 1: 6 Months||0
3332971|NCT03313050|4064635|FG003|STARTED|Stage 1: 6 Months||0
3332972|NCT03313050|4064632|FG000|Vaccinated|Stage 1: 6 Months||34
3332973|NCT03313050|4064633|FG001|Vaccinated|Stage 1: 6 Months||32
3332974|NCT03313050|4064634|FG002|Vaccinated|Stage 1: 6 Months||0
3332975|NCT03313050|4064635|FG003|Vaccinated|Stage 1: 6 Months||0
3332976|NCT03313050|4064632|FG000|COMPLETED|Stage 1: 6 Months||34
3332977|NCT03313050|4064633|FG001|COMPLETED|Stage 1: 6 Months||32
3332978|NCT03313050|4064634|FG002|COMPLETED|Stage 1: 6 Months||0
3332979|NCT03313050|4064635|FG003|COMPLETED|Stage 1: 6 Months||0
3332980|NCT03313050|4064632|FG000|NOT COMPLETED|Stage 1: 6 Months||0
3332981|NCT03313050|4064633|FG001|NOT COMPLETED|Stage 1: 6 Months||0
3332982|NCT03313050|4064634|FG002|NOT COMPLETED|Stage 1: 6 Months||0
3332983|NCT03313050|4064635|FG003|NOT COMPLETED|Stage 1: 6 Months||0
3332984|NCT03313050|4064632|FG000|STARTED|Stage 2: 12 Months|Stage 1 participants did not continue in Stage 2.|0
3332985|NCT03313050|4064633|FG001|STARTED|Stage 2: 12 Months|Stage 1 participants did not continue in Stage 2.|0
3332986|NCT03313050|4064634|FG002|STARTED|Stage 2: 12 Months|After Stage 1 safety was acceptable then Stage 2 followed with newer participants.|221
3332987|NCT03313050|4064635|FG003|STARTED|Stage 2: 12 Months|After Stage 1 safety was acceptable then Stage 2 followed with newer participants.|224
3332988|NCT03313050|4064632|FG000|Vaccinated|Stage 2: 12 Months||0
3332989|NCT03313050|4064633|FG001|Vaccinated|Stage 2: 12 Months||0
3332990|NCT03313050|4064634|FG002|Vaccinated|Stage 2: 12 Months||221
3332991|NCT03313050|4064635|FG003|Vaccinated|Stage 2: 12 Months||223
3332992|NCT03313050|4064632|FG000|COMPLETED|Stage 2: 12 Months||0
3332993|NCT03313050|4064633|FG001|COMPLETED|Stage 2: 12 Months||0
3332994|NCT03313050|4064634|FG002|COMPLETED|Stage 2: 12 Months||210
3176769|NCT01967732|3904563|FG003|STARTED|Washout Period of 1 Day (Day 2)||9
3176770|NCT01967732|3904560|FG000|COMPLETED|Washout Period of 1 Day (Day 2)||22
3332995|NCT03313050|4064635|FG003|COMPLETED|Stage 2: 12 Months||204
3332996|NCT03313050|4064632|FG000|NOT COMPLETED|Stage 2: 12 Months||0
3332997|NCT03313050|4064633|FG001|NOT COMPLETED|Stage 2: 12 Months||0
3332998|NCT03313050|4064634|FG002|NOT COMPLETED|Stage 2: 12 Months||11
3332999|NCT03313050|4064635|FG003|NOT COMPLETED|Stage 2: 12 Months||20
3333000|NCT03313076|4064649|FG000|STARTED|Overall Study||7
3333001|NCT03313076|4064650|FG001|STARTED|Overall Study||6
3333002|NCT03313076|4064651|FG002|STARTED|Overall Study||6
3333003|NCT03313076|4064652|FG003|STARTED|Overall Study||5
3333004|NCT03313076|4064649|FG000|COMPLETED|Overall Study||5
3333005|NCT03313076|4064650|FG001|COMPLETED|Overall Study||4
3333006|NCT03313076|4064651|FG002|COMPLETED|Overall Study||4
3333007|NCT03313076|4064652|FG003|COMPLETED|Overall Study||3
3333008|NCT03313076|4064649|FG000|NOT COMPLETED|Overall Study||2
3333009|NCT03313076|4064650|FG001|NOT COMPLETED|Overall Study||2
3333010|NCT03313076|4064651|FG002|NOT COMPLETED|Overall Study||2
3333011|NCT03313076|4064652|FG003|NOT COMPLETED|Overall Study||2
3333012|NCT03313310|4064670|FG000|STARTED|Phase 2||51
3333013|NCT03313310|4064671|FG001|STARTED|Phase 2|Phase 2 participants did not participate in Phase 3.|0
3333014|NCT03313310|4064670|FG000|COMPLETED|Phase 2||47
3333015|NCT03313310|4064671|FG001|COMPLETED|Phase 2|Phase 2 participants did not participate in Phase 3.|0
3333016|NCT03313310|4064670|FG000|NOT COMPLETED|Phase 2||4
3333017|NCT03313310|4064671|FG001|NOT COMPLETED|Phase 2||0
3333018|NCT03313310|4064670|FG000|STARTED|Phase 3|Phase 3 participants did not participate in Phase 2.|0
3333019|NCT03313310|4064671|FG001|STARTED|Phase 3||41
3333020|NCT03313310|4064670|FG000|COMPLETED|Phase 3|Phase 3 participants did not participate in Phase 2.|0
3333021|NCT03313310|4064671|FG001|COMPLETED|Phase 3||40
3333022|NCT03313310|4064670|FG000|NOT COMPLETED|Phase 3||0
3333023|NCT03313310|4064671|FG001|NOT COMPLETED|Phase 3||1
3333024|NCT03314233|4064677|FG000|STARTED|Overall Study|21 mothers provided informed consent for participation in the trial.|21
3333025|NCT03314233|4064677|FG000|COMPLETED|Overall Study|20 mothers who had provided informed consent met eligibility criteria at time of delivery.|20
3333026|NCT03314233|4064677|FG000|NOT COMPLETED|Overall Study||1
3333027|NCT03314519|4064683|FG000|STARTED|Overall Study||100
3333028|NCT03314519|4064684|FG001|STARTED|Overall Study||100
3333029|NCT03314519|4064683|FG000|COMPLETED|Overall Study||97
3333030|NCT03314519|4064684|FG001|COMPLETED|Overall Study||98
3333031|NCT03314519|4064683|FG000|NOT COMPLETED|Overall Study||3
3333032|NCT03314519|4064684|FG001|NOT COMPLETED|Overall Study||2
3333033|NCT03314662|4064693|FG000|STARTED|Overall Study||889
3333034|NCT03314662|4064694|FG001|STARTED|Overall Study||445
3333035|NCT03314662|4064695|FG002|STARTED|Overall Study||444
3333036|NCT03314662|4064693|FG000|Treated|Overall Study||888
3333037|NCT03314662|4064694|FG001|Treated|Overall Study||444
3333038|NCT03314662|4064695|FG002|Treated|Overall Study||444
3333039|NCT03314662|4064693|FG000|COMPLETED|Overall Study||881
3333040|NCT03314662|4064694|FG001|COMPLETED|Overall Study||440
3333041|NCT03314662|4064695|FG002|COMPLETED|Overall Study||439
3333042|NCT03314662|4064693|FG000|NOT COMPLETED|Overall Study||8
3333043|NCT03314662|4064694|FG001|NOT COMPLETED|Overall Study||5
3333044|NCT03314662|4064695|FG002|NOT COMPLETED|Overall Study||5
3333045|NCT03314753|4064713|FG000|STARTED|Overall Study||53
3333046|NCT03314753|4064714|FG001|STARTED|Overall Study||36
3333047|NCT03314753|4064713|FG000|COMPLETED|Overall Study||53
3333048|NCT03314753|4064714|FG001|COMPLETED|Overall Study||36
3333049|NCT03314753|4064713|FG000|NOT COMPLETED|Overall Study||0
3333050|NCT03314753|4064714|FG001|NOT COMPLETED|Overall Study||0
3333051|NCT03314857|4064720|FG000|STARTED|Overall Study||67
3333052|NCT03314857|4064720|FG000|Analysis Population|Overall Study||61
3333053|NCT03314857|4064720|FG000|COMPLETED|Overall Study|62/67 patients completed the 30-day primary endpoint visit.|62
3333054|NCT03314857|4064720|FG000|NOT COMPLETED|Overall Study||5
3333055|NCT03315104|4064727|FG000|STARTED|Overall Study||21
3333056|NCT03315104|4064728|FG001|STARTED|Overall Study||20
3333057|NCT03315104|4064729|FG002|STARTED|Overall Study||24
3333058|NCT03315104|4064727|FG000|Dosed (Safety Population)|Overall Study||19
3333059|NCT03315104|4064728|FG001|Dosed (Safety Population)|Overall Study||19
3333060|NCT03315104|4064729|FG002|Dosed (Safety Population)|Overall Study||22
3333061|NCT03315104|4064727|FG000|COMPLETED|Overall Study||18
3333062|NCT03315104|4064728|FG001|COMPLETED|Overall Study||16
3333063|NCT03315104|4064729|FG002|COMPLETED|Overall Study||19
3333064|NCT03315104|4064727|FG000|NOT COMPLETED|Overall Study||3
3333065|NCT03315104|4064728|FG001|NOT COMPLETED|Overall Study||4
3333066|NCT03315104|4064729|FG002|NOT COMPLETED|Overall Study||5
3176771|NCT01967732|3904561|FG001|COMPLETED|Washout Period of 1 Day (Day 2)||20
3176772|NCT01967732|3904562|FG002|COMPLETED|Washout Period of 1 Day (Day 2)||9
3176773|NCT01967732|3904563|FG003|COMPLETED|Washout Period of 1 Day (Day 2)||9
3333067|NCT03315208|4064739|FG000|STARTED|Overall Study||29
3333068|NCT03315208|4064740|FG001|STARTED|Overall Study||18
3333069|NCT03315208|4064739|FG000|COMPLETED|Overall Study||16
3333070|NCT03315208|4064740|FG001|COMPLETED|Overall Study||12
3333071|NCT03315208|4064739|FG000|NOT COMPLETED|Overall Study||13
3333072|NCT03315208|4064740|FG001|NOT COMPLETED|Overall Study||6
3333073|NCT03315286|4064749|FG000|STARTED|Overall Study||50
3333074|NCT03315286|4064750|FG001|STARTED|Overall Study||47
3333075|NCT03315286|4064749|FG000|COMPLETED|Overall Study||49
3333076|NCT03315286|4064750|FG001|COMPLETED|Overall Study||43
3333077|NCT03315286|4064749|FG000|NOT COMPLETED|Overall Study||1
3333078|NCT03315286|4064750|FG001|NOT COMPLETED|Overall Study||4
3333079|NCT03315559|4064756|FG000|STARTED|Treatment Period 1 (8 Days)||6
3333080|NCT03315559|4064756|FG000|COMPLETED|Treatment Period 1 (8 Days)||6
3333081|NCT03315559|4064756|FG000|NOT COMPLETED|Treatment Period 1 (8 Days)||0
3333082|NCT03315559|4064756|FG000|STARTED|Washout Period (14 Days)||6
3333083|NCT03315559|4064756|FG000|COMPLETED|Washout Period (14 Days)||6
3333084|NCT03315559|4064756|FG000|NOT COMPLETED|Washout Period (14 Days)||0
3333085|NCT03315559|4064756|FG000|STARTED|Treatment Period 2 (15 Days)||6
3333086|NCT03315559|4064756|FG000|COMPLETED|Treatment Period 2 (15 Days)||6
3333087|NCT03315559|4064756|FG000|NOT COMPLETED|Treatment Period 2 (15 Days)||0
3333088|NCT03315572|4064765|FG000|STARTED|Overall Study||14
3333089|NCT03315572|4064766|FG001|STARTED|Overall Study||14
3333090|NCT03315572|4064765|FG000|COMPLETED|Overall Study||14
3333091|NCT03315572|4064766|FG001|COMPLETED|Overall Study||14
3333092|NCT03315572|4064765|FG000|NOT COMPLETED|Overall Study||0
3333093|NCT03315572|4064766|FG001|NOT COMPLETED|Overall Study||0
3333094|NCT03315689|4064775|FG000|STARTED|Double-blind Period = 28 Days||4
3333095|NCT03315689|4064776|FG001|STARTED|Double-blind Period = 28 Days||7
3333096|NCT03315689|4064775|FG000|COMPLETED|Double-blind Period = 28 Days||3
3333097|NCT03315689|4064776|FG001|COMPLETED|Double-blind Period = 28 Days||7
3333098|NCT03315689|4064775|FG000|NOT COMPLETED|Double-blind Period = 28 Days||1
3333099|NCT03315689|4064776|FG001|NOT COMPLETED|Double-blind Period = 28 Days||0
3333100|NCT03315689|4064775|FG000|STARTED|Open Label Extension = 52 Weeks||0
3333101|NCT03315689|4064776|FG001|STARTED|Open Label Extension = 52 Weeks||10
3333102|NCT03315689|4064775|FG000|COMPLETED|Open Label Extension = 52 Weeks||0
3333103|NCT03315689|4064776|FG001|COMPLETED|Open Label Extension = 52 Weeks||7
3333104|NCT03315689|4064775|FG000|NOT COMPLETED|Open Label Extension = 52 Weeks||0
3333105|NCT03315689|4064776|FG001|NOT COMPLETED|Open Label Extension = 52 Weeks||3
3333106|NCT03315702|4064784|FG000|STARTED|Overall Study||52
3333107|NCT03315702|4064784|FG000|COMPLETED|Overall Study||52
3333108|NCT03315702|4064784|FG000|NOT COMPLETED|Overall Study||0
3333109|NCT03315780|4064789|FG000|STARTED|Period 1||6
3333110|NCT03315780|4064790|FG001|STARTED|Period 1||6
3333111|NCT03315780|4064789|FG000|Received One Dose of Study Drug|Period 1||6
3333112|NCT03315780|4064790|FG001|Received One Dose of Study Drug|Period 1||6
3333113|NCT03315780|4064789|FG000|COMPLETED|Period 1||6
3333114|NCT03315780|4064790|FG001|COMPLETED|Period 1||6
3333115|NCT03315780|4064789|FG000|NOT COMPLETED|Period 1||0
3333116|NCT03315780|4064790|FG001|NOT COMPLETED|Period 1||0
3333117|NCT03315780|4064789|FG000|STARTED|Period 2||6
3333118|NCT03315780|4064790|FG001|STARTED|Period 2||6
3333119|NCT03315780|4064789|FG000|COMPLETED|Period 2||6
3333120|NCT03315780|4064790|FG001|COMPLETED|Period 2||6
3333121|NCT03315780|4064789|FG000|NOT COMPLETED|Period 2||0
3333122|NCT03315780|4064790|FG001|NOT COMPLETED|Period 2||0
3333123|NCT03315793|4064798|FG000|STARTED|Overall Study||75
3333124|NCT03315793|4064799|FG001|STARTED|Overall Study||74
3333125|NCT03315793|4064798|FG000|Received at Least 1 Dose of Study Drug|Overall Study||75
3333126|NCT03315793|4064799|FG001|Received at Least 1 Dose of Study Drug|Overall Study||74
3333127|NCT03315793|4064798|FG000|COMPLETED|Overall Study||70
3333128|NCT03315793|4064799|FG001|COMPLETED|Overall Study||71
3333129|NCT03315793|4064798|FG000|NOT COMPLETED|Overall Study||5
3333130|NCT03315793|4064799|FG001|NOT COMPLETED|Overall Study||3
3333131|NCT03315949|4064809|FG000|STARTED|Overall Study||176
3333132|NCT03315949|4064810|FG001|STARTED|Overall Study||176
3333133|NCT03315949|4064809|FG000|COMPLETED|Overall Study||171
3333134|NCT03315949|4064810|FG001|COMPLETED|Overall Study||166
3333135|NCT03315949|4064809|FG000|NOT COMPLETED|Overall Study||5
3333136|NCT03315949|4064810|FG001|NOT COMPLETED|Overall Study||10
3333137|NCT03316131|4064816|FG000|STARTED|Treatment Period 1||18
3333138|NCT03316131|4064817|FG001|STARTED|Treatment Period 1||18
3333139|NCT03316131|4064816|FG000|COMPLETED|Treatment Period 1||18
3333140|NCT03316131|4064817|FG001|COMPLETED|Treatment Period 1||18
3333141|NCT03316131|4064816|FG000|NOT COMPLETED|Treatment Period 1||0
3333142|NCT03316131|4064817|FG001|NOT COMPLETED|Treatment Period 1||0
3333143|NCT03316131|4064816|FG000|STARTED|Treatment Period 2||18
3333144|NCT03316131|4064817|FG001|STARTED|Treatment Period 2||18
3333145|NCT03316131|4064816|FG000|COMPLETED|Treatment Period 2||17
3176774|NCT01967732|3904560|FG000|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
3333146|NCT03316131|4064817|FG001|COMPLETED|Treatment Period 2||18
3333147|NCT03316131|4064816|FG000|NOT COMPLETED|Treatment Period 2||1
3333148|NCT03316131|4064817|FG001|NOT COMPLETED|Treatment Period 2||0
3333149|NCT03316170|4064825|FG000|STARTED|Overall Study||24
3333150|NCT03316170|4064826|FG001|STARTED|Overall Study||25
3333151|NCT03316170|4064825|FG000|COMPLETED|Overall Study||17
3333152|NCT03316170|4064826|FG001|COMPLETED|Overall Study||18
3333153|NCT03316170|4064825|FG000|NOT COMPLETED|Overall Study||7
3333154|NCT03316170|4064826|FG001|NOT COMPLETED|Overall Study||7
3333155|NCT03316378|4064835|FG000|STARTED|Overall Study||23
3333156|NCT03316378|4064836|FG001|STARTED|Overall Study||23
3333157|NCT03316378|4064835|FG000|COMPLETED|Overall Study||23
3333158|NCT03316378|4064836|FG001|COMPLETED|Overall Study||23
3333159|NCT03316378|4064835|FG000|NOT COMPLETED|Overall Study||0
3333160|NCT03316378|4064836|FG001|NOT COMPLETED|Overall Study||0
3333161|NCT03316547|4064845|FG000|STARTED|Overall Study||39
3333162|NCT03316547|4064846|FG001|STARTED|Overall Study||31
3333163|NCT03316547|4064845|FG000|COMPLETED|Overall Study||21
3333164|NCT03316547|4064846|FG001|COMPLETED|Overall Study||18
3333165|NCT03316547|4064845|FG000|NOT COMPLETED|Overall Study||18
3333166|NCT03316547|4064846|FG001|NOT COMPLETED|Overall Study||13
3333167|NCT03316807|4064856|FG000|STARTED|Overall Study||91
3333168|NCT03316807|4064857|FG001|STARTED|Overall Study||91
3333169|NCT03316807|4064856|FG000|COMPLETED|Overall Study||60
3333170|NCT03316807|4064857|FG001|COMPLETED|Overall Study||65
3333171|NCT03316807|4064856|FG000|NOT COMPLETED|Overall Study||31
3333172|NCT03316807|4064857|FG001|NOT COMPLETED|Overall Study||26
3333173|NCT03316911|4064865|FG000|STARTED|Overall Study|2 did not complete baseline survey|122
3333174|NCT03316911|4064866|FG001|STARTED|Overall Study|3 did not complete baseline survey|139
3333175|NCT03316911|4064865|FG000|3-Month Follow-up Survey|Overall Study||93
3333176|NCT03316911|4064866|FG001|3-Month Follow-up Survey|Overall Study||112
3333177|NCT03316911|4064865|FG000|5-Month Follow-up Survey|Overall Study||89
3333178|NCT03316911|4064866|FG001|5-Month Follow-up Survey|Overall Study||110
3333179|NCT03316911|4064865|FG000|COMPLETED|Overall Study||89
3333180|NCT03316911|4064866|FG001|COMPLETED|Overall Study||110
3333181|NCT03316911|4064865|FG000|NOT COMPLETED|Overall Study||33
3333182|NCT03316911|4064866|FG001|NOT COMPLETED|Overall Study||29
3333183|NCT03316976|4064874|FG000|STARTED|Overall Study||20
3333184|NCT03316976|4064875|FG001|STARTED|Overall Study||20
3333185|NCT03316976|4064874|FG000|COMPLETED|Overall Study||20
3333186|NCT03316976|4064875|FG001|COMPLETED|Overall Study||20
3333187|NCT03316976|4064874|FG000|NOT COMPLETED|Overall Study||0
3176775|NCT01967732|3904561|FG001|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
3176776|NCT01967732|3904562|FG002|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
3176777|NCT01967732|3904563|FG003|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
3176778|NCT01967732|3904560|FG000|STARTED|Second Intervention (Day 3)||22
3176779|NCT01967732|3904561|FG001|STARTED|Second Intervention (Day 3)||20
3176780|NCT01967732|3904562|FG002|STARTED|Second Intervention (Day 3)||9
3176781|NCT01967732|3904563|FG003|STARTED|Second Intervention (Day 3)||9
3176782|NCT01967732|3904560|FG000|COMPLETED|Second Intervention (Day 3)||22
3176783|NCT01967732|3904561|FG001|COMPLETED|Second Intervention (Day 3)||20
3176784|NCT01967732|3904562|FG002|COMPLETED|Second Intervention (Day 3)||9
3176785|NCT01967732|3904563|FG003|COMPLETED|Second Intervention (Day 3)||9
3176786|NCT01967732|3904560|FG000|NOT COMPLETED|Second Intervention (Day 3)||0
3176787|NCT01967732|3904561|FG001|NOT COMPLETED|Second Intervention (Day 3)||0
3176788|NCT01967732|3904562|FG002|NOT COMPLETED|Second Intervention (Day 3)||0
3176789|NCT01967732|3904563|FG003|NOT COMPLETED|Second Intervention (Day 3)||0
3176790|NCT01967784|3904571|FG000|STARTED|Overall Study||100
3176791|NCT01967784|3904571|FG000|COMPLETED|Overall Study||100
3176792|NCT01967784|3904571|FG000|NOT COMPLETED|Overall Study||0
3176793|NCT01967836|3904575|FG000|STARTED|Overall Study||20
3176794|NCT01967836|3904575|FG000|COMPLETED|Overall Study||11
3176795|NCT01967836|3904575|FG000|NOT COMPLETED|Overall Study||9
3176796|NCT01967862|3904580|FG000|STARTED|Overall Study||54
3176797|NCT01967862|3904580|FG000|COMPLETED|Overall Study||54
3176798|NCT01967862|3904580|FG000|NOT COMPLETED|Overall Study||0
3176799|NCT01967888|3904586|FG000|STARTED|Overall Study||52
3333188|NCT03316976|4064875|FG001|NOT COMPLETED|Overall Study||0
3333189|NCT03317002|4064884|FG000|STARTED|Overall Study||52
3333190|NCT03317002|4064885|FG001|STARTED|Overall Study||25
3333191|NCT03317002|4064886|FG002|STARTED|Overall Study||52
3333192|NCT03317002|4064884|FG000|COMPLETED|Overall Study||50
3333193|NCT03317002|4064885|FG001|COMPLETED|Overall Study||24
3333194|NCT03317002|4064886|FG002|COMPLETED|Overall Study||51
3333195|NCT03317002|4064884|FG000|NOT COMPLETED|Overall Study||2
3333196|NCT03317002|4064885|FG001|NOT COMPLETED|Overall Study||1
3333197|NCT03317002|4064886|FG002|NOT COMPLETED|Overall Study||1
3333198|NCT03317288|4064894|FG000|STARTED|Overall Study||15
3176800|NCT01967888|3904587|FG001|STARTED|Overall Study||52
3176801|NCT01967888|3904586|FG000|COMPLETED|Overall Study||42
3176802|NCT01967888|3904587|FG001|COMPLETED|Overall Study||45
3176803|NCT01967888|3904586|FG000|NOT COMPLETED|Overall Study||10
3176804|NCT01967888|3904587|FG001|NOT COMPLETED|Overall Study||7
3176805|NCT01967940|3904596|FG000|STARTED|Part 1||12
3176806|NCT01967940|3904597|FG001|STARTED|Part 1||28
3176807|NCT01967940|3904598|FG002|STARTED|Part 1||15
3176808|NCT01967940|3904599|FG003|STARTED|Part 1||0
3176809|NCT01967940|3904596|FG000|COMPLETED|Part 1||12
3176810|NCT01967940|3904597|FG001|COMPLETED|Part 1||28
3333199|NCT03317288|4064894|FG000|COMPLETED|Overall Study||15
3333200|NCT03317288|4064894|FG000|NOT COMPLETED|Overall Study||0
3333201|NCT03317379|4064915|FG000|STARTED|Overall Study||20
3333202|NCT03317379|4064916|FG001|STARTED|Overall Study||18
3176811|NCT01967940|3904598|FG002|COMPLETED|Part 1||15
3176812|NCT01967940|3904599|FG003|COMPLETED|Part 1||0
3333203|NCT03317379|4064917|FG002|STARTED|Overall Study||22
3333204|NCT03317379|4064915|FG000|Completed Intervention|Overall Study||16
3333205|NCT03317379|4064916|FG001|Completed Intervention|Overall Study||6
3333206|NCT03317379|4064917|FG002|Completed Intervention|Overall Study||0
3333207|NCT03317379|4064915|FG000|COMPLETED|Overall Study||20
3333208|NCT03317379|4064916|FG001|COMPLETED|Overall Study||15
3333209|NCT03317379|4064917|FG002|COMPLETED|Overall Study||20
3333210|NCT03317379|4064915|FG000|NOT COMPLETED|Overall Study||0
3333211|NCT03317379|4064916|FG001|NOT COMPLETED|Overall Study||3
3333212|NCT03317379|4064917|FG002|NOT COMPLETED|Overall Study||2
3333213|NCT03317431|4064925|FG000|STARTED|Overall Study||46
3333214|NCT03317431|4064925|FG000|COMPLETED|Overall Study||46
3333215|NCT03317431|4064925|FG000|NOT COMPLETED|Overall Study||0
3333216|NCT03317444|4064931|FG000|STARTED|Overall Study||124
3333217|NCT03317444|4064932|FG001|STARTED|Overall Study||93
3333218|NCT03317444|4064931|FG000|COMPLETED|Overall Study||119
3333219|NCT03317444|4064932|FG001|COMPLETED|Overall Study||89
3333220|NCT03317444|4064931|FG000|NOT COMPLETED|Overall Study||5
3333221|NCT03317444|4064932|FG001|NOT COMPLETED|Overall Study||4
3333222|NCT03318315|4064941|FG000|STARTED|Overall Study||62
3333223|NCT03318315|4064942|FG001|STARTED|Overall Study||53
3333224|NCT03318315|4064943|FG002|STARTED|Overall Study||34
3333225|NCT03318315|4064941|FG000|Received First Vaccination|Overall Study||62
3333226|NCT03318315|4064942|FG001|Received First Vaccination|Overall Study||53
3333227|NCT03318315|4064943|FG002|Received First Vaccination|Overall Study||34
3333228|NCT03318315|4064941|FG000|Received Second Vaccination|Overall Study||59
3333229|NCT03318315|4064942|FG001|Received Second Vaccination|Overall Study||48
3333230|NCT03318315|4064943|FG002|Received Second Vaccination|Overall Study||0
3333231|NCT03318315|4064941|FG000|Received Third Vaccination|Overall Study||0
3333232|NCT03318315|4064942|FG001|Received Third Vaccination|Overall Study||46
3333233|NCT03318315|4064943|FG002|Received Third Vaccination|Overall Study||0
3333234|NCT03318315|4064941|FG000|COMPLETED|Overall Study||58
3333235|NCT03318315|4064942|FG001|COMPLETED|Overall Study||50
3176813|NCT01967940|3904596|FG000|NOT COMPLETED|Part 1||0
3176814|NCT01967940|3904597|FG001|NOT COMPLETED|Part 1||0
3333236|NCT03318315|4064943|FG002|COMPLETED|Overall Study||30
3333237|NCT03318315|4064941|FG000|NOT COMPLETED|Overall Study||4
3333238|NCT03318315|4064942|FG001|NOT COMPLETED|Overall Study||3
3333239|NCT03318315|4064943|FG002|NOT COMPLETED|Overall Study||4
3333240|NCT03318341|4064954|FG000|STARTED|Month 1||13
3333241|NCT03318341|4064955|FG001|STARTED|Month 1||13
3333242|NCT03318341|4064954|FG000|COMPLETED|Month 1||13
3333243|NCT03318341|4064955|FG001|COMPLETED|Month 1||12
3333244|NCT03318341|4064954|FG000|NOT COMPLETED|Month 1||0
3333245|NCT03318341|4064955|FG001|NOT COMPLETED|Month 1||1
3333246|NCT03318341|4064954|FG000|STARTED|Month 2||13
3333247|NCT03318341|4064955|FG001|STARTED|Month 2||12
3333248|NCT03318341|4064954|FG000|COMPLETED|Month 2||13
3333249|NCT03318341|4064955|FG001|COMPLETED|Month 2||12
3333250|NCT03318341|4064954|FG000|NOT COMPLETED|Month 2||0
3333251|NCT03318341|4064955|FG001|NOT COMPLETED|Month 2||0
3333322|NCT03318783|4065002|FG000|STARTED|Overall Study||10
3333323|NCT03318783|4065003|FG001|STARTED|Overall Study||10
3333324|NCT03318783|4065002|FG000|COMPLETED|Overall Study||10
3333325|NCT03318783|4065003|FG001|COMPLETED|Overall Study||8
3333326|NCT03318783|4065002|FG000|NOT COMPLETED|Overall Study||0
3333327|NCT03318783|4065003|FG001|NOT COMPLETED|Overall Study||2
3333328|NCT03318809|4065011|FG000|STARTED|Overall Study||6
3333329|NCT03318809|4065012|FG001|STARTED|Overall Study||6
3333330|NCT03318809|4065011|FG000|COMPLETED|Overall Study||6
3333331|NCT03318809|4065012|FG001|COMPLETED|Overall Study||6
3333332|NCT03318809|4065011|FG000|NOT COMPLETED|Overall Study||0
3333333|NCT03318809|4065012|FG001|NOT COMPLETED|Overall Study||0
3333334|NCT03319134|4065021|FG000|STARTED|Overall Study||15
3333335|NCT03319134|4065022|FG001|STARTED|Overall Study||15
3333336|NCT03319134|4065023|FG002|STARTED|Overall Study||15
3333337|NCT03319134|4065021|FG000|COMPLETED|Overall Study||15
3333338|NCT03319134|4065022|FG001|COMPLETED|Overall Study||15
3333339|NCT03319134|4065023|FG002|COMPLETED|Overall Study||15
3333340|NCT03319134|4065021|FG000|NOT COMPLETED|Overall Study||0
3333341|NCT03319134|4065022|FG001|NOT COMPLETED|Overall Study||0
3333342|NCT03319134|4065023|FG002|NOT COMPLETED|Overall Study||0
3333343|NCT03319173|4065033|FG000|STARTED|Overall Study||48
3333344|NCT03319173|4065034|FG001|STARTED|Overall Study||50
3333345|NCT03319173|4065033|FG000|COMPLETED|Overall Study||48
3333346|NCT03319173|4065034|FG001|COMPLETED|Overall Study||50
3333347|NCT03319173|4065033|FG000|NOT COMPLETED|Overall Study||0
3333348|NCT03319173|4065034|FG001|NOT COMPLETED|Overall Study||0
3333349|NCT03319212|4065046|FG000|STARTED|Overall Study||29
3333350|NCT03319212|4065047|FG001|STARTED|Overall Study||52
3333351|NCT03319212|4065046|FG000|COMPLETED|Overall Study||26
3333352|NCT03319212|4065047|FG001|COMPLETED|Overall Study||47
3333353|NCT03319212|4065046|FG000|NOT COMPLETED|Overall Study||3
3333354|NCT03319212|4065047|FG001|NOT COMPLETED|Overall Study||5
3333355|NCT03319277|4065054|FG000|STARTED|Overall Study||59
3333356|NCT03319277|4065055|FG001|STARTED|Overall Study||59
3333357|NCT03319277|4065054|FG000|COMPLETED|Overall Study||59
3333358|NCT03319277|4065055|FG001|COMPLETED|Overall Study||59
3333359|NCT03319277|4065054|FG000|NOT COMPLETED|Overall Study||0
3333360|NCT03319277|4065055|FG001|NOT COMPLETED|Overall Study||0
3333361|NCT03319719|4065061|FG000|STARTED|Overall Study||52
3333362|NCT03319719|4065061|FG000|COMPLETED|Overall Study||51
3333363|NCT03319719|4065061|FG000|NOT COMPLETED|Overall Study||1
3333364|NCT03319810|4065067|FG000|STARTED|Overall Study||5
3333365|NCT03319810|4065067|FG000|COMPLETED|Overall Study||5
3333366|NCT03319810|4065067|FG000|NOT COMPLETED|Overall Study||0
3333367|NCT03319953|4065075|FG000|STARTED|Period 1 (Day 1 to 14)||3
3333368|NCT03319953|4065076|FG001|STARTED|Period 1 (Day 1 to 14)||4
3333369|NCT03319953|4065077|FG002|STARTED|Period 1 (Day 1 to 14)||9
3333370|NCT03319953|4065078|FG003|STARTED|Period 1 (Day 1 to 14)||7
3333371|NCT03319953|4065075|FG000|COMPLETED|Period 1 (Day 1 to 14)||3
3333372|NCT03319953|4065076|FG001|COMPLETED|Period 1 (Day 1 to 14)||4
3333373|NCT03319953|4065077|FG002|COMPLETED|Period 1 (Day 1 to 14)||9
3333374|NCT03319953|4065078|FG003|COMPLETED|Period 1 (Day 1 to 14)||7
3333375|NCT03319953|4065075|FG000|NOT COMPLETED|Period 1 (Day 1 to 14)||0
3333376|NCT03319953|4065076|FG001|NOT COMPLETED|Period 1 (Day 1 to 14)||0
3333377|NCT03319953|4065077|FG002|NOT COMPLETED|Period 1 (Day 1 to 14)||0
3333378|NCT03319953|4065078|FG003|NOT COMPLETED|Period 1 (Day 1 to 14)||0
3333379|NCT03319953|4065075|FG000|STARTED|Washout Period (Day 15 to 49)||3
3333380|NCT03319953|4065076|FG001|STARTED|Washout Period (Day 15 to 49)||4
3333381|NCT03319953|4065077|FG002|STARTED|Washout Period (Day 15 to 49)||9
3333382|NCT03319953|4065078|FG003|STARTED|Washout Period (Day 15 to 49)||7
3333383|NCT03319953|4065075|FG000|COMPLETED|Washout Period (Day 15 to 49)||3
3333384|NCT03319953|4065076|FG001|COMPLETED|Washout Period (Day 15 to 49)||4
3333385|NCT03319953|4065077|FG002|COMPLETED|Washout Period (Day 15 to 49)||9
3333386|NCT03319953|4065078|FG003|COMPLETED|Washout Period (Day 15 to 49)||7
3333387|NCT03319953|4065075|FG000|NOT COMPLETED|Washout Period (Day 15 to 49)||0
3333388|NCT03319953|4065076|FG001|NOT COMPLETED|Washout Period (Day 15 to 49)||0
3333389|NCT03319953|4065077|FG002|NOT COMPLETED|Washout Period (Day 15 to 49)||0
3333390|NCT03319953|4065078|FG003|NOT COMPLETED|Washout Period (Day 15 to 49)||0
3333391|NCT03319953|4065075|FG000|STARTED|Period 2 (Day 49 to 154)||3
3333392|NCT03319953|4065076|FG001|STARTED|Period 2 (Day 49 to 154)||4
3333393|NCT03319953|4065077|FG002|STARTED|Period 2 (Day 49 to 154)||9
3333394|NCT03319953|4065078|FG003|STARTED|Period 2 (Day 49 to 154)||7
3333395|NCT03319953|4065075|FG000|Treated|Period 2 (Day 49 to 154)||2
3333396|NCT03319953|4065076|FG001|Treated|Period 2 (Day 49 to 154)||4
3333397|NCT03319953|4065077|FG002|Treated|Period 2 (Day 49 to 154)||8
3333398|NCT03319953|4065078|FG003|Treated|Period 2 (Day 49 to 154)||6
3333399|NCT03319953|4065075|FG000|COMPLETED|Period 2 (Day 49 to 154)||2
3333400|NCT03319953|4065076|FG001|COMPLETED|Period 2 (Day 49 to 154)||4
3333401|NCT03319953|4065077|FG002|COMPLETED|Period 2 (Day 49 to 154)||8
3333402|NCT03319953|4065078|FG003|COMPLETED|Period 2 (Day 49 to 154)||6
3333403|NCT03319953|4065075|FG000|NOT COMPLETED|Period 2 (Day 49 to 154)||1
3333404|NCT03319953|4065076|FG001|NOT COMPLETED|Period 2 (Day 49 to 154)||0
3333405|NCT03319953|4065077|FG002|NOT COMPLETED|Period 2 (Day 49 to 154)||1
3333406|NCT03319953|4065078|FG003|NOT COMPLETED|Period 2 (Day 49 to 154)||1
3333407|NCT03320057|4065086|FG000|STARTED|Overall Study||266
3333408|NCT03320057|4065087|FG001|STARTED|Overall Study|Includes pharmacists at study pharmacies that consented to training on mifepristone dispensing.|60
3333409|NCT03320057|4065086|FG000|Patient's Clinical Outcome Information Obtained|Overall Study||262
3333410|NCT03320057|4065087|FG001|Patient's Clinical Outcome Information Obtained|Overall Study|Clinical outcome data were not collected for pharmacists - this milestone does not apply|0
3333411|NCT03320057|4065086|FG000|Received Pharmacist Training|Overall Study||0
3333412|NCT03320057|4065087|FG001|Received Pharmacist Training|Overall Study||56
3333413|NCT03320057|4065086|FG000|Pharmacists Completed Baseline Survey|Overall Study||0
3333414|NCT03320057|4065087|FG001|Pharmacists Completed Baseline Survey|Overall Study||47
3333415|NCT03320057|4065086|FG000|COMPLETED|Overall Study||260
3333416|NCT03320057|4065087|FG001|COMPLETED|Overall Study|This includes pharmacists who completed the endline survey. Only trained pharmacists (n=56) were eligible.|43
3333417|NCT03320057|4065086|FG000|NOT COMPLETED|Overall Study||6
3333418|NCT03320057|4065087|FG001|NOT COMPLETED|Overall Study||17
3333419|NCT03320096|4065093|FG000|STARTED|Overall Study||20
3333420|NCT03320096|4065093|FG000|COMPLETED|Overall Study||20
3333421|NCT03320096|4065093|FG000|NOT COMPLETED|Overall Study||0
3333422|NCT03320369|4065097|FG000|STARTED|Overall Study||18
3333423|NCT03320369|4065097|FG000|COMPLETED|Overall Study||15
3333424|NCT03320369|4065097|FG000|NOT COMPLETED|Overall Study||3
3333425|NCT03320564|4065101|FG000|STARTED|Overall Study||2
3333426|NCT03320564|4065101|FG000|COMPLETED|Overall Study||1
3333427|NCT03320564|4065101|FG000|NOT COMPLETED|Overall Study||1
3333428|NCT03320824|4065107|FG000|STARTED|Overall Study||184
3333429|NCT03320824|4065108|FG001|STARTED|Overall Study||89
3333430|NCT03320824|4065107|FG000|COMPLETED|Overall Study||166
3333431|NCT03320824|4065108|FG001|COMPLETED|Overall Study||85
3333432|NCT03320824|4065107|FG000|NOT COMPLETED|Overall Study||18
3333433|NCT03320824|4065108|FG001|NOT COMPLETED|Overall Study||4
3333434|NCT03320850|4065124|FG000|STARTED|Overall Study||18
3333435|NCT03320850|4065125|FG001|STARTED|Overall Study||12
3333436|NCT03320850|4065126|FG002|STARTED|Overall Study||18
3333437|NCT03320850|4065127|FG003|STARTED|Overall Study||22
3333438|NCT03320850|4065128|FG004|STARTED|Overall Study||19
3333439|NCT03320850|4065129|FG005|STARTED|Overall Study||58
3333440|NCT03320850|4065130|FG006|STARTED|Overall Study||57
3333441|NCT03320850|4065131|FG007|STARTED|Overall Study||60
3333442|NCT03320850|4065132|FG008|STARTED|Overall Study||60
3333443|NCT03320850|4065133|FG009|STARTED|Overall Study||59
3333444|NCT03320850|4065124|FG000|Safety Population|Overall Study||18
3333445|NCT03320850|4065125|FG001|Safety Population|Overall Study||12
3333446|NCT03320850|4065126|FG002|Safety Population|Overall Study||18
3333447|NCT03320850|4065127|FG003|Safety Population|Overall Study||22
3333448|NCT03320850|4065128|FG004|Safety Population|Overall Study||19
3333449|NCT03320850|4065129|FG005|Safety Population|Overall Study||57
3333450|NCT03320850|4065130|FG006|Safety Population|Overall Study||57
3333451|NCT03320850|4065131|FG007|Safety Population|Overall Study||60
3333452|NCT03320850|4065132|FG008|Safety Population|Overall Study||60
3333453|NCT03320850|4065133|FG009|Safety Population|Overall Study||58
3333454|NCT03320850|4065124|FG000|COMPLETED|Overall Study||18
3333455|NCT03320850|4065125|FG001|COMPLETED|Overall Study||12
3333456|NCT03320850|4065126|FG002|COMPLETED|Overall Study||18
3333457|NCT03320850|4065127|FG003|COMPLETED|Overall Study||21
3333458|NCT03320850|4065128|FG004|COMPLETED|Overall Study||17
3333459|NCT03320850|4065129|FG005|COMPLETED|Overall Study||49
3333460|NCT03320850|4065130|FG006|COMPLETED|Overall Study||50
3333461|NCT03320850|4065131|FG007|COMPLETED|Overall Study||53
3333462|NCT03320850|4065132|FG008|COMPLETED|Overall Study||50
3333463|NCT03320850|4065133|FG009|COMPLETED|Overall Study||50
3333464|NCT03320850|4065124|FG000|NOT COMPLETED|Overall Study||0
3333465|NCT03320850|4065125|FG001|NOT COMPLETED|Overall Study||0
3333466|NCT03320850|4065126|FG002|NOT COMPLETED|Overall Study||0
3333467|NCT03320850|4065127|FG003|NOT COMPLETED|Overall Study||1
3333468|NCT03320850|4065128|FG004|NOT COMPLETED|Overall Study||2
3333469|NCT03320850|4065129|FG005|NOT COMPLETED|Overall Study||9
3333470|NCT03320850|4065130|FG006|NOT COMPLETED|Overall Study||7
3333471|NCT03320850|4065131|FG007|NOT COMPLETED|Overall Study||7
3333472|NCT03320850|4065132|FG008|NOT COMPLETED|Overall Study||10
3333473|NCT03320850|4065133|FG009|NOT COMPLETED|Overall Study||9
3333474|NCT03320941|4065165|FG000|STARTED|Overall Study||19
3333475|NCT03320941|4065166|FG001|STARTED|Overall Study||19
3333476|NCT03320941|4065167|FG002|STARTED|Overall Study||28
3333477|NCT03320941|4065168|FG003|STARTED|Overall Study||31
3333478|NCT03320941|4065169|FG004|STARTED|Overall Study||29
3333479|NCT03320941|4065165|FG000|COMPLETED|Overall Study||19
3333480|NCT03320941|4065166|FG001|COMPLETED|Overall Study||19
3333481|NCT03320941|4065167|FG002|COMPLETED|Overall Study||28
3333482|NCT03320941|4065168|FG003|COMPLETED|Overall Study||30
3333483|NCT03320941|4065169|FG004|COMPLETED|Overall Study||29
3333484|NCT03320941|4065165|FG000|NOT COMPLETED|Overall Study||0
3333485|NCT03320941|4065166|FG001|NOT COMPLETED|Overall Study||0
3333486|NCT03320941|4065167|FG002|NOT COMPLETED|Overall Study||0
3333487|NCT03320941|4065168|FG003|NOT COMPLETED|Overall Study||1
3333488|NCT03320941|4065169|FG004|NOT COMPLETED|Overall Study||0
3333489|NCT03321006|4065183|FG000|STARTED|Overall Study||14
3333490|NCT03321006|4065184|FG001|STARTED|Overall Study||11
3333491|NCT03321006|4065183|FG000|COMPLETED|Overall Study||12
3333492|NCT03321006|4065184|FG001|COMPLETED|Overall Study||11
3333493|NCT03321006|4065183|FG000|NOT COMPLETED|Overall Study||2
3333494|NCT03321006|4065184|FG001|NOT COMPLETED|Overall Study||0
3333495|NCT03321097|4065192|FG000|STARTED|Overall Study||18
3333496|NCT03321097|4065193|FG001|STARTED|Overall Study||18
3333497|NCT03321097|4065192|FG000|COMPLETED|Overall Study||18
3333498|NCT03321097|4065193|FG001|COMPLETED|Overall Study||18
3333499|NCT03321097|4065192|FG000|NOT COMPLETED|Overall Study||0
3333500|NCT03321097|4065193|FG001|NOT COMPLETED|Overall Study||0
3333501|NCT03321253|4065199|FG000|STARTED|Overall Study||38
3333502|NCT03321253|4065199|FG000|COMPLETED|Overall Study||38
3333503|NCT03321253|4065199|FG000|NOT COMPLETED|Overall Study||0
3333504|NCT03321396|4065203|FG000|STARTED|Overall Study||13
3333505|NCT03321396|4065203|FG000|COMPLETED|Overall Study||12
3333506|NCT03321396|4065203|FG000|NOT COMPLETED|Overall Study||1
3333507|NCT03321721|4065210|FG000|STARTED|Overall Study||4
3333508|NCT03321721|4065211|FG001|STARTED|Overall Study||10
3333509|NCT03321721|4065212|FG002|STARTED|Overall Study||12
3333510|NCT03321721|4065210|FG000|COMPLETED|Overall Study||0
3333511|NCT03321721|4065211|FG001|COMPLETED|Overall Study||2
3333512|NCT03321721|4065212|FG002|COMPLETED|Overall Study||1
3333513|NCT03321721|4065210|FG000|NOT COMPLETED|Overall Study||4
3333514|NCT03321721|4065211|FG001|NOT COMPLETED|Overall Study||8
3333515|NCT03321721|4065212|FG002|NOT COMPLETED|Overall Study||11
3333516|NCT03322293|4065224|FG000|STARTED|Overall Study||8
3176815|NCT01967940|3904598|FG002|NOT COMPLETED|Part 1||0
3176816|NCT01967940|3904599|FG003|NOT COMPLETED|Part 1||0
3333517|NCT03322293|4065225|FG001|STARTED|Overall Study||8
3333518|NCT03322293|4065226|FG002|STARTED|Overall Study||8
3333519|NCT03322293|4065224|FG000|COMPLETED|Overall Study||8
3333520|NCT03322293|4065225|FG001|COMPLETED|Overall Study||8
3333521|NCT03322293|4065226|FG002|COMPLETED|Overall Study||7
3333522|NCT03322293|4065224|FG000|NOT COMPLETED|Overall Study||0
3333523|NCT03322293|4065225|FG001|NOT COMPLETED|Overall Study||0
3333524|NCT03322293|4065226|FG002|NOT COMPLETED|Overall Study||1
3333525|NCT03322423|4065234|FG000|STARTED|Period 1||38
3333526|NCT03322423|4065235|FG001|STARTED|Period 1||40
3333527|NCT03322423|4065234|FG000|COMPLETED|Period 1||36
3333528|NCT03322423|4065235|FG001|COMPLETED|Period 1||38
3333529|NCT03322423|4065234|FG000|NOT COMPLETED|Period 1||2
3333530|NCT03322423|4065235|FG001|NOT COMPLETED|Period 1||2
3333531|NCT03322423|4065234|FG000|STARTED|Period 2||36
3333532|NCT03322423|4065235|FG001|STARTED|Period 2||38
3333533|NCT03322423|4065234|FG000|COMPLETED|Period 2||35
3333534|NCT03322423|4065235|FG001|COMPLETED|Period 2||36
3333535|NCT03322423|4065234|FG000|NOT COMPLETED|Period 2||1
3333536|NCT03322423|4065235|FG001|NOT COMPLETED|Period 2||2
3176817|NCT01967940|3904596|FG000|STARTED|Part 2|4 participants completed Part 1 and did not enter Part 2; 8 participants moved to the Part 2 group|0
3176818|NCT01967940|3904597|FG001|STARTED|Part 2|12 participants completed Part 1 and did not enter Part 2; 16 participants moved to the Part 2 group|0
3333537|NCT03322462|4065241|FG000|STARTED|Overall Study||155
3333538|NCT03322462|4065241|FG000|Flortaucipir PET Scan|Overall Study||155
3333539|NCT03322462|4065241|FG000|COMPLETED|Overall Study||152
3333540|NCT03322462|4065241|FG000|NOT COMPLETED|Overall Study||3
3333541|NCT03322514|4065249|FG000|STARTED|Overall Study||6
3333542|NCT03322514|4065250|FG001|STARTED|Overall Study||6
3333543|NCT03322514|4065249|FG000|COMPLETED|Overall Study||5
3333544|NCT03322514|4065250|FG001|COMPLETED|Overall Study||5
3333545|NCT03322514|4065249|FG000|NOT COMPLETED|Overall Study||1
3333546|NCT03322514|4065250|FG001|NOT COMPLETED|Overall Study||1
3333547|NCT03322657|4065258|FG000|STARTED|Overall Study||34
3333548|NCT03322657|4065259|FG001|STARTED|Overall Study||35
3333549|NCT03322657|4065258|FG000|COMPLETED|Overall Study||33
3333550|NCT03322657|4065259|FG001|COMPLETED|Overall Study||35
3333551|NCT03322657|4065258|FG000|NOT COMPLETED|Overall Study||1
3333552|NCT03322657|4065259|FG001|NOT COMPLETED|Overall Study||0
3333553|NCT03322930|4065267|FG000|STARTED|Overall Study|recruitment of 20 patients with retinitis pigmentosa|20
3333554|NCT03322930|4065268|FG001|STARTED|Overall Study|recruitment of 20 patients with macular degeneration|20
3333555|NCT03322930|4065267|FG000|COMPLETED|Overall Study||20
3333556|NCT03322930|4065268|FG001|COMPLETED|Overall Study||20
3333557|NCT03322930|4065267|FG000|NOT COMPLETED|Overall Study||0
3333558|NCT03322930|4065268|FG001|NOT COMPLETED|Overall Study||0
3333559|NCT03323086|4065276|FG000|STARTED|Overall Study||26
3333560|NCT03323086|4065277|FG001|STARTED|Overall Study||22
3333561|NCT03323086|4065276|FG000|COMPLETED|Overall Study||23
3333562|NCT03323086|4065277|FG001|COMPLETED|Overall Study||20
3333563|NCT03323086|4065276|FG000|NOT COMPLETED|Overall Study||3
3333564|NCT03323086|4065277|FG001|NOT COMPLETED|Overall Study||2
3333565|NCT03323164|4065285|FG000|STARTED|Overall Study||18
3333566|NCT03323164|4065286|FG001|STARTED|Overall Study||17
3333567|NCT03323164|4065285|FG000|COMPLETED|Overall Study||16
3333568|NCT03323164|4065286|FG001|COMPLETED|Overall Study||15
3333569|NCT03323164|4065285|FG000|NOT COMPLETED|Overall Study||2
3333570|NCT03323164|4065286|FG001|NOT COMPLETED|Overall Study||2
3333571|NCT03323307|4065296|FG000|STARTED|Overall Study||70
3333572|NCT03323307|4065296|FG000|COMPLETED|Overall Study||70
3333573|NCT03323307|4065296|FG000|NOT COMPLETED|Overall Study||0
3333574|NCT03323723|4065300|FG000|STARTED|Screening||73
3333575|NCT03323723|4065300|FG000|COMPLETED|Screening||64
3333576|NCT03323723|4065300|FG000|NOT COMPLETED|Screening||9
3333577|NCT03323723|4065300|FG000|STARTED|Baseline Phase||64
3333578|NCT03323723|4065300|FG000|COMPLETED|Baseline Phase||60
3333579|NCT03323723|4065300|FG000|NOT COMPLETED|Baseline Phase||4
3333580|NCT03323723|4065300|FG000|STARTED|Treatment Phase||60
3333581|NCT03323723|4065300|FG000|COMPLETED|Treatment Phase||51
3333582|NCT03323723|4065300|FG000|NOT COMPLETED|Treatment Phase||9
3333583|NCT03323736|4065308|FG000|STARTED|Overall Study||241
3333584|NCT03323736|4065309|FG001|STARTED|Overall Study||59
3333585|NCT03323736|4065310|FG002|STARTED|Overall Study||70
3333586|NCT03323736|4065308|FG000|Treated|Overall Study||222
3333587|NCT03323736|4065309|FG001|Treated|Overall Study||47
3333588|NCT03323736|4065310|FG002|Treated|Overall Study||68
3333589|NCT03323736|4065308|FG000|COMPLETED|Overall Study||222
3333590|NCT03323736|4065309|FG001|COMPLETED|Overall Study||47
3333591|NCT03323736|4065310|FG002|COMPLETED|Overall Study||68
3333592|NCT03323736|4065308|FG000|NOT COMPLETED|Overall Study||19
3333593|NCT03323736|4065309|FG001|NOT COMPLETED|Overall Study||12
3333594|NCT03323736|4065310|FG002|NOT COMPLETED|Overall Study||2
3333595|NCT03323801|4065320|FG000|STARTED|Overall Study||10
3333596|NCT03323801|4065320|FG000|COMPLETED|Overall Study||10
3333597|NCT03323801|4065320|FG000|NOT COMPLETED|Overall Study||0
3333598|NCT03323853|4065327|FG000|STARTED|Overall Study||213
3333599|NCT03323853|4065328|FG001|STARTED|Overall Study||238
3333600|NCT03323853|4065327|FG000|COMPLETED|Overall Study||213
3333601|NCT03323853|4065328|FG001|COMPLETED|Overall Study||238
3333602|NCT03323853|4065327|FG000|NOT COMPLETED|Overall Study||0
3333603|NCT03323853|4065328|FG001|NOT COMPLETED|Overall Study||0
3333604|NCT03324451|4065336|FG000|STARTED|Overall Study||97
3333605|NCT03324451|4065337|FG001|STARTED|Overall Study||54
3333606|NCT03324451|4065336|FG000|COMPLETED|Overall Study||65
3333607|NCT03324451|4065337|FG001|COMPLETED|Overall Study||41
3333608|NCT03324451|4065336|FG000|NOT COMPLETED|Overall Study||32
3333609|NCT03324451|4065337|FG001|NOT COMPLETED|Overall Study||13
3333610|NCT03324581|4065346|FG000|STARTED|Overall Study||77
3333611|NCT03324581|4065347|FG001|STARTED|Overall Study||80
3333612|NCT03324581|4065348|FG002|STARTED|Overall Study||82
3333613|NCT03324581|4065346|FG000|COMPLETED|Overall Study||38
3333614|NCT03324581|4065347|FG001|COMPLETED|Overall Study||44
3333615|NCT03324581|4065348|FG002|COMPLETED|Overall Study||57
3333616|NCT03324581|4065346|FG000|NOT COMPLETED|Overall Study||39
3333617|NCT03324581|4065347|FG001|NOT COMPLETED|Overall Study||36
3333618|NCT03324581|4065348|FG002|NOT COMPLETED|Overall Study||25
3333619|NCT03324607|4065356|FG000|STARTED|Overall Study||20
3333620|NCT03324607|4065356|FG000|COMPLETED|Overall Study||20
3333621|NCT03324607|4065356|FG000|NOT COMPLETED|Overall Study||0
3333622|NCT03325010|4065365|FG000|STARTED|Overall Study||64
3333623|NCT03325010|4065366|FG001|STARTED|Overall Study||63
3333624|NCT03325010|4065365|FG000|Safety Analysis Set|Overall Study||62
3333625|NCT03325010|4065366|FG001|Safety Analysis Set|Overall Study||59
3333626|NCT03325010|4065365|FG000|Full Analysis Set|Overall Study||61
3333627|NCT03325010|4065366|FG001|Full Analysis Set|Overall Study||58
3333628|NCT03325010|4065365|FG000|COMPLETED|Overall Study||55
3333629|NCT03325010|4065366|FG001|COMPLETED|Overall Study||43
3333630|NCT03325010|4065365|FG000|NOT COMPLETED|Overall Study||9
3333631|NCT03325010|4065366|FG001|NOT COMPLETED|Overall Study||20
3333632|NCT03325556|4065372|FG000|STARTED|Open-label Period||392
3333633|NCT03325556|4065373|FG001|STARTED|Open-label Period||0
3333634|NCT03325556|4065374|FG002|STARTED|Open-label Period||0
3333635|NCT03325556|4065372|FG000|COMPLETED|Open-label Period||217
3333636|NCT03325556|4065373|FG001|COMPLETED|Open-label Period||0
3333637|NCT03325556|4065374|FG002|COMPLETED|Open-label Period||0
3333638|NCT03325556|4065372|FG000|NOT COMPLETED|Open-label Period||175
3333639|NCT03325556|4065373|FG001|NOT COMPLETED|Open-label Period||0
3333640|NCT03325556|4065374|FG002|NOT COMPLETED|Open-label Period||0
3333641|NCT03325556|4065372|FG000|STARTED|Double-blind Period||0
3333642|NCT03325556|4065373|FG001|STARTED|Double-blind Period||105
3333643|NCT03325556|4065374|FG002|STARTED|Double-blind Period||112
3333644|NCT03325556|4065372|FG000|COMPLETED|Double-blind Period||0
3333645|NCT03325556|4065373|FG001|COMPLETED|Double-blind Period||44
3333646|NCT03325556|4065374|FG002|COMPLETED|Double-blind Period||35
3333647|NCT03325556|4065372|FG000|NOT COMPLETED|Double-blind Period||0
3333648|NCT03325556|4065373|FG001|NOT COMPLETED|Double-blind Period||61
3333649|NCT03325556|4065374|FG002|NOT COMPLETED|Double-blind Period||77
3333650|NCT03325673|4065383|FG000|STARTED|Overall Study||42
3333651|NCT03325673|4065384|FG001|STARTED|Overall Study||42
3333652|NCT03325673|4065383|FG000|COMPLETED|Overall Study||38
3333653|NCT03325673|4065384|FG001|COMPLETED|Overall Study||42
3333654|NCT03325673|4065383|FG000|NOT COMPLETED|Overall Study||4
3333655|NCT03325673|4065384|FG001|NOT COMPLETED|Overall Study||0
3333656|NCT03325816|4065392|FG000|STARTED|Overall Study||3
3176819|NCT01967940|3904598|FG002|STARTED|Part 2|1 participant completed Part 1 and did not enter Part 2; 14 participants moved to the Part 2 group|0
3176820|NCT01967940|3904599|FG003|STARTED|Part 2|38 participants from the Part 1 groups moved to this Part 2 E/C/F/TAF + ATV group|38
3176821|NCT01967940|3904596|FG000|COMPLETED|Part 2||0
3176822|NCT01967940|3904597|FG001|COMPLETED|Part 2||0
3176823|NCT01967940|3904598|FG002|COMPLETED|Part 2||0
3176824|NCT01967940|3904599|FG003|COMPLETED|Part 2||35
3176825|NCT01967940|3904596|FG000|NOT COMPLETED|Part 2||0
3176826|NCT01967940|3904597|FG001|NOT COMPLETED|Part 2||0
3176827|NCT01967940|3904598|FG002|NOT COMPLETED|Part 2||0
3176828|NCT01967940|3904599|FG003|NOT COMPLETED|Part 2||3
3176829|NCT01968031|3904612|FG000|STARTED|Overall Study||204
3176830|NCT01968031|3904613|FG001|STARTED|Overall Study||202
3176831|NCT01968031|3904614|FG002|STARTED|Overall Study||207
3176832|NCT01968031|3904612|FG000|Completed Week 2|Overall Study||197
3176833|NCT01968031|3904613|FG001|Completed Week 2|Overall Study||190
3176834|NCT01968031|3904614|FG002|Completed Week 2|Overall Study||199
3176835|NCT01968031|3904612|FG000|Completed Week 6|Overall Study||191
3176836|NCT01968031|3904613|FG001|Completed Week 6|Overall Study||183
3176837|NCT01968031|3904614|FG002|Completed Week 6|Overall Study||187
3176838|NCT01968031|3904612|FG000|Completed Week 10|Overall Study||187
3176839|NCT01968031|3904613|FG001|Completed Week 10|Overall Study||181
3176840|NCT01968031|3904614|FG002|Completed Week 10|Overall Study||181
3176841|NCT01968031|3904612|FG000|COMPLETED|Overall Study||186
3176842|NCT01968031|3904613|FG001|COMPLETED|Overall Study||182
3176843|NCT01968031|3904614|FG002|COMPLETED|Overall Study||178
3176844|NCT01968031|3904612|FG000|NOT COMPLETED|Overall Study||18
3176845|NCT01968031|3904613|FG001|NOT COMPLETED|Overall Study||20
3176846|NCT01968031|3904614|FG002|NOT COMPLETED|Overall Study||29
3176847|NCT01968057|3904622|FG000|STARTED|Period 1 (Day 1 to Predosing Day 4)||18
3333657|NCT03325816|4065393|FG001|STARTED|Overall Study||6
3333658|NCT03325816|4065392|FG000|COMPLETED|Overall Study||3
3333659|NCT03325816|4065393|FG001|COMPLETED|Overall Study||6
3333660|NCT03325816|4065392|FG000|NOT COMPLETED|Overall Study||0
3333661|NCT03325816|4065393|FG001|NOT COMPLETED|Overall Study||0
3333662|NCT03325881|4065403|FG000|STARTED|Overall Study||44
3333663|NCT03325881|4065404|FG001|STARTED|Overall Study||45
3333664|NCT03325881|4065403|FG000|Treated|Overall Study||43
3333665|NCT03325881|4065404|FG001|Treated|Overall Study||45
3333666|NCT03325881|4065403|FG000|COMPLETED|Overall Study||41
3333667|NCT03325881|4065404|FG001|COMPLETED|Overall Study||42
3333668|NCT03325881|4065403|FG000|NOT COMPLETED|Overall Study||3
3333669|NCT03325881|4065404|FG001|NOT COMPLETED|Overall Study||3
3333670|NCT03325894|4065414|FG000|STARTED|Overall Study||64
3333671|NCT03325894|4065415|FG001|STARTED|Overall Study||77
3333672|NCT03325894|4065414|FG000|COMPLETED|Overall Study||0
3333673|NCT03325894|4065415|FG001|COMPLETED|Overall Study||0
3333674|NCT03325894|4065414|FG000|NOT COMPLETED|Overall Study||64
3333675|NCT03325894|4065415|FG001|NOT COMPLETED|Overall Study||77
3333676|NCT03326323|4065424|FG000|STARTED|Overall Study||43
3333677|NCT03326323|4065424|FG000|COMPLETED|Overall Study||40
3333678|NCT03326323|4065424|FG000|NOT COMPLETED|Overall Study||3
3176848|NCT01968057|3904622|FG000|Received Baricitinib|Period 1 (Day 1 to Predosing Day 4)||18
3176849|NCT01968057|3904622|FG000|COMPLETED|Period 1 (Day 1 to Predosing Day 4)||18
3176850|NCT01968057|3904622|FG000|NOT COMPLETED|Period 1 (Day 1 to Predosing Day 4)||0
3176851|NCT01968057|3904622|FG000|STARTED|Period 2 (At Dosing Day 4 to Day 7)||18
3176852|NCT01968057|3904622|FG000|Received Baricitinib + Ciclosporin|Period 2 (At Dosing Day 4 to Day 7)||18
3333679|NCT03326518|4065431|FG000|STARTED|Overall Study||19
3333680|NCT03326518|4065432|FG001|STARTED|Overall Study||12
3333681|NCT03326518|4065433|FG002|STARTED|Overall Study||14
3333682|NCT03326518|4065431|FG000|COMPLETED|Overall Study||16
3333683|NCT03326518|4065432|FG001|COMPLETED|Overall Study||12
3333684|NCT03326518|4065433|FG002|COMPLETED|Overall Study||13
3333685|NCT03326518|4065431|FG000|NOT COMPLETED|Overall Study||3
3333686|NCT03326518|4065432|FG001|NOT COMPLETED|Overall Study||0
3333687|NCT03326518|4065433|FG002|NOT COMPLETED|Overall Study||1
3333688|NCT03326843|4065441|FG000|STARTED|Overall Study||4
3333689|NCT03326843|4065441|FG000|COMPLETED|Overall Study||4
3333690|NCT03326843|4065441|FG000|NOT COMPLETED|Overall Study||0
3333691|NCT03326856|4065450|FG000|STARTED|Overall Study||13
3333692|NCT03326856|4065451|FG001|STARTED|Overall Study||9
3333693|NCT03326856|4065452|FG002|STARTED|Overall Study||9
3333694|NCT03326856|4065453|FG003|STARTED|Overall Study||9
3333695|NCT03326856|4065454|FG004|STARTED|Overall Study||8
3333696|NCT03326856|4065450|FG000|COMPLETED|Overall Study||12
3333697|NCT03326856|4065451|FG001|COMPLETED|Overall Study||8
3333698|NCT03326856|4065452|FG002|COMPLETED|Overall Study||9
3333699|NCT03326856|4065453|FG003|COMPLETED|Overall Study||9
3333700|NCT03326856|4065454|FG004|COMPLETED|Overall Study||8
3333701|NCT03326856|4065450|FG000|NOT COMPLETED|Overall Study||1
3333702|NCT03326856|4065451|FG001|NOT COMPLETED|Overall Study||1
3333703|NCT03326856|4065452|FG002|NOT COMPLETED|Overall Study||0
3333704|NCT03326856|4065453|FG003|NOT COMPLETED|Overall Study||0
3333705|NCT03326856|4065454|FG004|NOT COMPLETED|Overall Study||0
3333706|NCT03326895|4065466|FG000|STARTED|Overall Study||168
3333707|NCT03326895|4065466|FG000|COMPLETED|Overall Study||168
3333708|NCT03326895|4065466|FG000|NOT COMPLETED|Overall Study||0
3333709|NCT03326986|4065473|FG000|STARTED|Overall Study||8
3333710|NCT03326986|4065474|FG001|STARTED|Overall Study||8
3333711|NCT03326986|4065475|FG002|STARTED|Overall Study||8
3333712|NCT03326986|4065473|FG000|COMPLETED|Overall Study||8
3333713|NCT03326986|4065474|FG001|COMPLETED|Overall Study||8
3333714|NCT03326986|4065475|FG002|COMPLETED|Overall Study||8
3333715|NCT03326986|4065473|FG000|NOT COMPLETED|Overall Study||0
3333716|NCT03326986|4065474|FG001|NOT COMPLETED|Overall Study||0
3333717|NCT03326986|4065475|FG002|NOT COMPLETED|Overall Study||0
3333718|NCT03326999|4065518|FG000|STARTED|Overall Study||30
3333719|NCT03326999|4065519|FG001|STARTED|Overall Study||30
3333720|NCT03326999|4065518|FG000|COMPLETED|Overall Study||30
3333721|NCT03326999|4065519|FG001|COMPLETED|Overall Study||30
3333722|NCT03326999|4065518|FG000|NOT COMPLETED|Overall Study||0
3333723|NCT03326999|4065519|FG001|NOT COMPLETED|Overall Study||0
3333724|NCT03327051|4065527|FG000|STARTED|Overall Study||19
3333725|NCT03327051|4065528|FG001|STARTED|Overall Study||20
3333726|NCT03327051|4065527|FG000|Received Treatment|Overall Study||16
3333727|NCT03327051|4065528|FG001|Received Treatment|Overall Study||16
3333728|NCT03327051|4065527|FG000|Attended Visit 2 (Week 0)|Overall Study||15
3333729|NCT03327051|4065528|FG001|Attended Visit 2 (Week 0)|Overall Study||15
3333730|NCT03327051|4065527|FG000|COMPLETED|Overall Study||14
3333731|NCT03327051|4065528|FG001|COMPLETED|Overall Study||15
3333732|NCT03327051|4065527|FG000|NOT COMPLETED|Overall Study||5
3333733|NCT03327051|4065528|FG001|NOT COMPLETED|Overall Study||5
3333734|NCT03327220|4065537|FG000|STARTED|Overall Study||62
3333735|NCT03327220|4065538|FG001|STARTED|Overall Study||62
3333736|NCT03327220|4065537|FG000|Safety Population: Received Study Treatment|Overall Study||59
3333737|NCT03327220|4065538|FG001|Safety Population: Received Study Treatment|Overall Study||60
3333738|NCT03327220|4065537|FG000|COMPLETED|Overall Study||57
3333739|NCT03327220|4065538|FG001|COMPLETED|Overall Study||58
3333740|NCT03327220|4065537|FG000|NOT COMPLETED|Overall Study||5
3333741|NCT03327220|4065538|FG001|NOT COMPLETED|Overall Study||4
3333742|NCT03327402|4065544|FG000|STARTED|Overall Study||24
3333743|NCT03327402|4065544|FG000|Rich PK Sampling Group|Overall Study||12
3333744|NCT03327402|4065544|FG000|Sparse PK Sampling Group|Overall Study||12
3333745|NCT03327402|4065544|FG000|COMPLETED|Overall Study||22
3333746|NCT03327402|4065544|FG000|NOT COMPLETED|Overall Study||2
3333747|NCT03327571|4065550|FG000|STARTED|Group 1: cHL||1598
3333748|NCT03327571|4065551|FG001|STARTED|Group 1: cHL||0
3333749|NCT03327571|4065550|FG000|COMPLETED|Group 1: cHL||1598
3333750|NCT03327571|4065551|FG001|COMPLETED|Group 1: cHL||0
3333751|NCT03327571|4065550|FG000|NOT COMPLETED|Group 1: cHL||0
3333752|NCT03327571|4065551|FG001|NOT COMPLETED|Group 1: cHL||0
3333753|NCT03327571|4065550|FG000|STARTED|Group 2: RRHL||0
3333754|NCT03327571|4065551|FG001|STARTED|Group 2: RRHL|105 RRHL only participants and 321 common participants who had CHL, and subsequently RRHL between 2010-2013.|426
3333755|NCT03327571|4065550|FG000|Participants Were Counted in Both Groups|Group 2: RRHL||0
3333756|NCT03327571|4065551|FG001|Participants Were Counted in Both Groups|Group 2: RRHL|Participants who were diagnosed with CHL, and subsequently RRHL between 2010 and 2013.|321
3333757|NCT03327571|4065550|FG000|COMPLETED|Group 2: RRHL||0
3333758|NCT03327571|4065551|FG001|COMPLETED|Group 2: RRHL||426
3333759|NCT03327571|4065550|FG000|NOT COMPLETED|Group 2: RRHL||0
3333760|NCT03327571|4065551|FG001|NOT COMPLETED|Group 2: RRHL||0
3333761|NCT03328182|4065558|FG000|STARTED|Overall Study||34
3333762|NCT03328182|4065558|FG000|COMPLETED|Overall Study||30
3333763|NCT03328182|4065558|FG000|NOT COMPLETED|Overall Study||4
3333764|NCT03328208|4065564|FG000|STARTED|Overall Study||37
3333765|NCT03328208|4065565|FG001|STARTED|Overall Study||35
3333766|NCT03328208|4065564|FG000|COMPLETED|Overall Study||37
3333767|NCT03328208|4065565|FG001|COMPLETED|Overall Study||35
3333768|NCT03328208|4065564|FG000|NOT COMPLETED|Overall Study||0
3333769|NCT03328208|4065565|FG001|NOT COMPLETED|Overall Study||0
3333770|NCT03328325|4065571|FG000|STARTED|Overall Study||152
3333771|NCT03328325|4065571|FG000|COMPLETED|Overall Study||141
3333772|NCT03328325|4065571|FG000|NOT COMPLETED|Overall Study||11
3333773|NCT03328624|4065575|FG000|STARTED|Overall Study||36
3333774|NCT03328624|4065575|FG000|COMPLETED|Overall Study||36
3333775|NCT03328624|4065575|FG000|NOT COMPLETED|Overall Study||0
3333776|NCT03328832|4065581|FG000|STARTED|Overall Study||35
3333777|NCT03328832|4065582|FG001|STARTED|Overall Study||35
3333778|NCT03328832|4065581|FG000|COMPLETED|Overall Study||35
3333779|NCT03328832|4065582|FG001|COMPLETED|Overall Study||34
3333780|NCT03328832|4065581|FG000|NOT COMPLETED|Overall Study||0
3333781|NCT03328832|4065582|FG001|NOT COMPLETED|Overall Study||1
3333782|NCT03328897|4065591|FG000|STARTED|Randomized-treatment Epoch||168
3333783|NCT03328897|4065592|FG001|STARTED|Randomized-treatment Epoch||167
3333784|NCT03328897|4065593|FG002|STARTED|Randomized-treatment Epoch||83
3333785|NCT03328897|4065591|FG000|Full Analysis Set (FAS)|Randomized-treatment Epoch||167
3333786|NCT03328897|4065592|FG001|Full Analysis Set (FAS)|Randomized-treatment Epoch||167
3333787|NCT03328897|4065593|FG002|Full Analysis Set (FAS)|Randomized-treatment Epoch||83
3333788|NCT03328897|4065591|FG000|COMPLETED|Randomized-treatment Epoch||152
3333789|NCT03328897|4065592|FG001|COMPLETED|Randomized-treatment Epoch||162
3333790|NCT03328897|4065593|FG002|COMPLETED|Randomized-treatment Epoch||81
3333791|NCT03328897|4065591|FG000|NOT COMPLETED|Randomized-treatment Epoch||16
3333792|NCT03328897|4065592|FG001|NOT COMPLETED|Randomized-treatment Epoch||5
3333793|NCT03328897|4065593|FG002|NOT COMPLETED|Randomized-treatment Epoch||2
3333794|NCT03328897|4065591|FG000|STARTED|Follow-up Epoch||161
3333795|NCT03328897|4065592|FG001|STARTED|Follow-up Epoch||163
3333796|NCT03328897|4065593|FG002|STARTED|Follow-up Epoch||81
3333797|NCT03328897|4065591|FG000|COMPLETED|Follow-up Epoch||153
3333798|NCT03328897|4065592|FG001|COMPLETED|Follow-up Epoch||160
3333799|NCT03328897|4065593|FG002|COMPLETED|Follow-up Epoch||79
3333800|NCT03328897|4065591|FG000|NOT COMPLETED|Follow-up Epoch||8
3333801|NCT03328897|4065592|FG001|NOT COMPLETED|Follow-up Epoch||3
3333802|NCT03328897|4065593|FG002|NOT COMPLETED|Follow-up Epoch||2
3333803|NCT03328949|4065601|FG000|STARTED|Overall Study||120
3333804|NCT03328949|4065601|FG000|COMPLETED|Overall Study||120
3333805|NCT03328949|4065601|FG000|NOT COMPLETED|Overall Study||0
3333806|NCT03329196|4065608|FG000|STARTED|Overall Study||151
3333807|NCT03329196|4065609|FG001|STARTED|Overall Study||153
3333808|NCT03329196|4065608|FG000|COMPLETED|Overall Study||111
3333809|NCT03329196|4065609|FG001|COMPLETED|Overall Study||123
3333810|NCT03329196|4065608|FG000|NOT COMPLETED|Overall Study||40
3333811|NCT03329196|4065609|FG001|NOT COMPLETED|Overall Study||30
3333812|NCT03329209|4065615|FG000|STARTED|Overall Study||16
3333813|NCT03329209|4065615|FG000|COMPLETED|Overall Study||16
3333814|NCT03329209|4065615|FG000|NOT COMPLETED|Overall Study||0
3333815|NCT03329352|4065619|FG000|STARTED|F&P Toffee Full Face Mask Validation||44
3333816|NCT03329352|4065619|FG000|COMPLETED|F&P Toffee Full Face Mask Validation||42
3333817|NCT03329352|4065619|FG000|NOT COMPLETED|F&P Toffee Full Face Mask Validation||2
3333818|NCT03329352|4065619|FG000|STARTED|Extension||29
3333819|NCT03329352|4065619|FG000|COMPLETED|Extension||22
3333820|NCT03329352|4065619|FG000|NOT COMPLETED|Extension||7
3333821|NCT03329573|4065629|FG000|STARTED|Treatment Period 1 (Up to 5 Days)||23
3333822|NCT03329573|4065630|FG001|STARTED|Treatment Period 1 (Up to 5 Days)||24
3176853|NCT01968057|3904622|FG000|COMPLETED|Period 2 (At Dosing Day 4 to Day 7)||18
3176854|NCT01968057|3904622|FG000|NOT COMPLETED|Period 2 (At Dosing Day 4 to Day 7)||0
3176855|NCT01968070|3904646|FG000|STARTED|Period 1||4
3176856|NCT01968070|3904647|FG001|STARTED|Period 1||4
3176857|NCT01968070|3904648|FG002|STARTED|Period 1||4
3176858|NCT01968070|3904649|FG003|STARTED|Period 1||4
3176859|NCT01968070|3904650|FG004|STARTED|Period 1||4
3176860|NCT01968070|3904651|FG005|STARTED|Period 1||4
3176861|NCT01968070|3904652|FG006|STARTED|Period 1||10
3333823|NCT03329573|4065631|FG002|STARTED|Treatment Period 1 (Up to 5 Days)||19
3333824|NCT03329573|4065632|FG003|STARTED|Treatment Period 1 (Up to 5 Days)||19
3333825|NCT03329573|4065629|FG000|COMPLETED|Treatment Period 1 (Up to 5 Days)||22
3333826|NCT03329573|4065630|FG001|COMPLETED|Treatment Period 1 (Up to 5 Days)||21
3333827|NCT03329573|4065631|FG002|COMPLETED|Treatment Period 1 (Up to 5 Days)||19
3333828|NCT03329573|4065632|FG003|COMPLETED|Treatment Period 1 (Up to 5 Days)||19
3333829|NCT03329573|4065629|FG000|NOT COMPLETED|Treatment Period 1 (Up to 5 Days)||1
3333830|NCT03329573|4065630|FG001|NOT COMPLETED|Treatment Period 1 (Up to 5 Days)||3
3333831|NCT03329573|4065631|FG002|NOT COMPLETED|Treatment Period 1 (Up to 5 Days)||0
3333832|NCT03329573|4065632|FG003|NOT COMPLETED|Treatment Period 1 (Up to 5 Days)||0
3333833|NCT03329573|4065629|FG000|STARTED|Washout Period (Day 6 to Day 11)||22
3333834|NCT03329573|4065630|FG001|STARTED|Washout Period (Day 6 to Day 11)||21
3333835|NCT03329573|4065631|FG002|STARTED|Washout Period (Day 6 to Day 11)||19
3333836|NCT03329573|4065632|FG003|STARTED|Washout Period (Day 6 to Day 11)||19
3333837|NCT03329573|4065629|FG000|COMPLETED|Washout Period (Day 6 to Day 11)||22
3333838|NCT03329573|4065630|FG001|COMPLETED|Washout Period (Day 6 to Day 11)||21
3333839|NCT03329573|4065631|FG002|COMPLETED|Washout Period (Day 6 to Day 11)||19
3333840|NCT03329573|4065632|FG003|COMPLETED|Washout Period (Day 6 to Day 11)||19
3333841|NCT03329573|4065629|FG000|NOT COMPLETED|Washout Period (Day 6 to Day 11)||0
3333842|NCT03329573|4065630|FG001|NOT COMPLETED|Washout Period (Day 6 to Day 11)||0
3333843|NCT03329573|4065631|FG002|NOT COMPLETED|Washout Period (Day 6 to Day 11)||0
3333844|NCT03329573|4065632|FG003|NOT COMPLETED|Washout Period (Day 6 to Day 11)||0
3333845|NCT03329573|4065629|FG000|STARTED|Treatment Period 2 (Day 12 to Day 26)||22
3333846|NCT03329573|4065630|FG001|STARTED|Treatment Period 2 (Day 12 to Day 26)||21
3333847|NCT03329573|4065631|FG002|STARTED|Treatment Period 2 (Day 12 to Day 26)||19
3333848|NCT03329573|4065632|FG003|STARTED|Treatment Period 2 (Day 12 to Day 26)||19
3333849|NCT03329573|4065629|FG000|COMPLETED|Treatment Period 2 (Day 12 to Day 26)||21
3333850|NCT03329573|4065630|FG001|COMPLETED|Treatment Period 2 (Day 12 to Day 26)||20
3333851|NCT03329573|4065631|FG002|COMPLETED|Treatment Period 2 (Day 12 to Day 26)||19
3333852|NCT03329573|4065632|FG003|COMPLETED|Treatment Period 2 (Day 12 to Day 26)||19
3333853|NCT03329573|4065629|FG000|NOT COMPLETED|Treatment Period 2 (Day 12 to Day 26)||1
3333854|NCT03329573|4065630|FG001|NOT COMPLETED|Treatment Period 2 (Day 12 to Day 26)||1
3333855|NCT03329573|4065631|FG002|NOT COMPLETED|Treatment Period 2 (Day 12 to Day 26)||0
3333856|NCT03329573|4065632|FG003|NOT COMPLETED|Treatment Period 2 (Day 12 to Day 26)||0
3333857|NCT03329690|4065647|FG000|STARTED|Overall Study||126
3333858|NCT03329690|4065648|FG001|STARTED|Overall Study||55
3333859|NCT03329690|4065649|FG002|STARTED|Overall Study||7
3333860|NCT03329690|4065650|FG003|STARTED|Overall Study||21
3333861|NCT03329690|4065651|FG004|STARTED|Overall Study||24
3333862|NCT03329690|4065647|FG000|Received Treatment|Overall Study||125
3333863|NCT03329690|4065648|FG001|Received Treatment|Overall Study||55
3333864|NCT03329690|4065649|FG002|Received Treatment|Overall Study||7
3333865|NCT03329690|4065650|FG003|Received Treatment|Overall Study||20
3333866|NCT03329690|4065651|FG004|Received Treatment|Overall Study||24
3333867|NCT03329690|4065647|FG000|COMPLETED|Overall Study||28
3333868|NCT03329690|4065648|FG001|COMPLETED|Overall Study||2
3333869|NCT03329690|4065649|FG002|COMPLETED|Overall Study||1
3333870|NCT03329690|4065650|FG003|COMPLETED|Overall Study||0
3333871|NCT03329690|4065651|FG004|COMPLETED|Overall Study||2
3333872|NCT03329690|4065647|FG000|NOT COMPLETED|Overall Study||98
3333873|NCT03329690|4065648|FG001|NOT COMPLETED|Overall Study||53
3333874|NCT03329690|4065649|FG002|NOT COMPLETED|Overall Study||6
3333875|NCT03329690|4065650|FG003|NOT COMPLETED|Overall Study||21
3333876|NCT03329690|4065651|FG004|NOT COMPLETED|Overall Study||22
3176862|NCT01968070|3904653|FG007|STARTED|Period 1||2
3176863|NCT01968070|3904654|FG008|STARTED|Period 1||2
3176864|NCT01968070|3904655|FG009|STARTED|Period 1||9
3176865|NCT01968070|3904656|FG010|STARTED|Period 1||2
3333877|NCT03329846|4065671|FG000|STARTED|Overall Study||10
3333878|NCT03329846|4065672|FG001|STARTED|Overall Study||10
3333879|NCT03329846|4065671|FG000|COMPLETED|Overall Study||2
3333880|NCT03329846|4065672|FG001|COMPLETED|Overall Study||1
3333881|NCT03329846|4065671|FG000|NOT COMPLETED|Overall Study||8
3333882|NCT03329846|4065672|FG001|NOT COMPLETED|Overall Study||9
3333883|NCT03329885|4065684|FG000|STARTED|Overall Study||9
3333884|NCT03329885|4065685|FG001|STARTED|Overall Study||6
3333885|NCT03329885|4065686|FG002|STARTED|Overall Study||6
3333886|NCT03329885|4065687|FG003|STARTED|Overall Study||6
3333887|NCT03329885|4065688|FG004|STARTED|Overall Study||6
3333888|NCT03329885|4065689|FG005|STARTED|Overall Study||3
3333889|NCT03329885|4065690|FG006|STARTED|Overall Study||1
3333890|NCT03329885|4065691|FG007|STARTED|Overall Study||1
3176866|NCT01968070|3904657|FG011|STARTED|Period 1||2
3176867|NCT01968070|3904658|FG012|STARTED|Period 1||9
3176868|NCT01968070|3904659|FG013|STARTED|Period 1||2
3176869|NCT01968070|3904660|FG014|STARTED|Period 1||2
3176870|NCT01968070|3904661|FG015|STARTED|Period 1||9
3333891|NCT03329885|4065692|FG008|STARTED|Overall Study|Due to early termination of study, Part C was cancelled and no patients were dosed|0
3333892|NCT03329885|4065684|FG000|COMPLETED|Overall Study||9
3333893|NCT03329885|4065685|FG001|COMPLETED|Overall Study||6
3333894|NCT03329885|4065686|FG002|COMPLETED|Overall Study||6
3333895|NCT03329885|4065687|FG003|COMPLETED|Overall Study||6
3333896|NCT03329885|4065688|FG004|COMPLETED|Overall Study||6
3333897|NCT03329885|4065689|FG005|COMPLETED|Overall Study||3
3333898|NCT03329885|4065690|FG006|COMPLETED|Overall Study||0
3333899|NCT03329885|4065691|FG007|COMPLETED|Overall Study||0
3333900|NCT03329885|4065692|FG008|COMPLETED|Overall Study||0
3333901|NCT03329885|4065684|FG000|NOT COMPLETED|Overall Study||0
3333902|NCT03329885|4065685|FG001|NOT COMPLETED|Overall Study||0
3333903|NCT03329885|4065686|FG002|NOT COMPLETED|Overall Study||0
3333904|NCT03329885|4065687|FG003|NOT COMPLETED|Overall Study||0
3333905|NCT03329885|4065688|FG004|NOT COMPLETED|Overall Study||0
3333906|NCT03329885|4065689|FG005|NOT COMPLETED|Overall Study||0
3333907|NCT03329885|4065690|FG006|NOT COMPLETED|Overall Study||1
3333908|NCT03329885|4065691|FG007|NOT COMPLETED|Overall Study||1
3333909|NCT03329885|4065692|FG008|NOT COMPLETED|Overall Study||0
3333910|NCT03329911|4065714|FG000|STARTED|Overall Study||326
3333911|NCT03329911|4065715|FG001|STARTED|Overall Study||325
3333912|NCT03329911|4065714|FG000|COMPLETED|Overall Study||209
3333913|NCT03329911|4065715|FG001|COMPLETED|Overall Study||222
3333914|NCT03329911|4065714|FG000|NOT COMPLETED|Overall Study||117
3333915|NCT03329911|4065715|FG001|NOT COMPLETED|Overall Study||103
3333916|NCT03329937|4065721|FG000|STARTED|Overall Study||21
3333917|NCT03329937|4065721|FG000|COMPLETED|Overall Study||21
3333918|NCT03329937|4065721|FG000|NOT COMPLETED|Overall Study||0
3333919|NCT03329989|4065725|FG000|STARTED|Overall Study||158
3333920|NCT03329989|4065725|FG000|COMPLETED|Overall Study||135
3333921|NCT03329989|4065725|FG000|NOT COMPLETED|Overall Study||23
3333922|NCT03330002|4065729|FG000|STARTED|Overall Study|Subjects that received the MANTA VCD|500
3333923|NCT03330002|4065729|FG000|COMPLETED|Overall Study|Subjects that received the MANTA VCD and completed 30 day follow-up visit|478
3333924|NCT03330002|4065729|FG000|NOT COMPLETED|Overall Study||22
3333925|NCT03330041|4065733|FG000|STARTED|Overall Study||50
3333926|NCT03330041|4065733|FG000|COMPLETED|Overall Study||48
3333927|NCT03330041|4065733|FG000|NOT COMPLETED|Overall Study||2
3333928|NCT03330119|4065741|FG000|STARTED|Overall Study||641
3333929|NCT03330119|4065742|FG001|STARTED|Overall Study||853
3333930|NCT03330119|4065741|FG000|COMPLETED|Overall Study||475
3333931|NCT03330119|4065742|FG001|COMPLETED|Overall Study||571
3333932|NCT03330119|4065741|FG000|NOT COMPLETED|Overall Study||166
3333933|NCT03330119|4065742|FG001|NOT COMPLETED|Overall Study||282
3333934|NCT03330236|4065750|FG000|STARTED|Overall Study||779
3333935|NCT03330236|4065751|FG001|STARTED|Overall Study||781
3333936|NCT03330236|4065750|FG000|Received Surgery|Overall Study||779
3333937|NCT03330236|4065751|FG001|Received Surgery|Overall Study||781
3333938|NCT03330236|4065750|FG000|Modified ITT|Overall Study||773
3333939|NCT03330236|4065751|FG001|Modified ITT|Overall Study||774
3333940|NCT03330236|4065750|FG000|COMPLETED|Overall Study||679
3333941|NCT03330236|4065751|FG001|COMPLETED|Overall Study||697
3333942|NCT03330236|4065750|FG000|NOT COMPLETED|Overall Study||100
3333943|NCT03330236|4065751|FG001|NOT COMPLETED|Overall Study||84
3333944|NCT03330262|4065759|FG000|STARTED|First Six Weeks||7
3333945|NCT03330262|4065760|FG001|STARTED|First Six Weeks||6
3333946|NCT03330262|4065759|FG000|COMPLETED|First Six Weeks||7
3333947|NCT03330262|4065760|FG001|COMPLETED|First Six Weeks||6
3333948|NCT03330262|4065759|FG000|NOT COMPLETED|First Six Weeks||0
3333949|NCT03330262|4065760|FG001|NOT COMPLETED|First Six Weeks||0
3333950|NCT03330262|4065759|FG000|STARTED|Second Six Weeks||7
3333951|NCT03330262|4065760|FG001|STARTED|Second Six Weeks||6
3333952|NCT03330262|4065759|FG000|COMPLETED|Second Six Weeks||5
3333953|NCT03330262|4065760|FG001|COMPLETED|Second Six Weeks||5
3333954|NCT03330262|4065759|FG000|NOT COMPLETED|Second Six Weeks||2
3333955|NCT03330262|4065760|FG001|NOT COMPLETED|Second Six Weeks||1
3333956|NCT03330275|4065769|FG000|STARTED|Visit 1 - Period 1||6
3333957|NCT03330275|4065770|FG001|STARTED|Visit 1 - Period 1||6
3333958|NCT03330275|4065771|FG002|STARTED|Visit 1 - Period 1||6
3333959|NCT03330275|4065772|FG003|STARTED|Visit 1 - Period 1||6
3333960|NCT03330275|4065773|FG004|STARTED|Visit 1 - Period 1||0
3333961|NCT03330275|4065774|FG005|STARTED|Visit 1 - Period 1||0
3333962|NCT03330275|4065775|FG006|STARTED|Visit 1 - Period 1||0
3333963|NCT03330275|4065776|FG007|STARTED|Visit 1 - Period 1||0
3333964|NCT03330275|4065777|FG008|STARTED|Visit 1 - Period 1||0
3333965|NCT03330275|4065778|FG009|STARTED|Visit 1 - Period 1||0
3333966|NCT03330275|4065769|FG000|COMPLETED|Visit 1 - Period 1||6
3333967|NCT03330275|4065770|FG001|COMPLETED|Visit 1 - Period 1||6
3333968|NCT03330275|4065771|FG002|COMPLETED|Visit 1 - Period 1||6
3333969|NCT03330275|4065772|FG003|COMPLETED|Visit 1 - Period 1||6
3333970|NCT03330275|4065773|FG004|COMPLETED|Visit 1 - Period 1||0
3333971|NCT03330275|4065774|FG005|COMPLETED|Visit 1 - Period 1||0
3333972|NCT03330275|4065775|FG006|COMPLETED|Visit 1 - Period 1||0
3333973|NCT03330275|4065776|FG007|COMPLETED|Visit 1 - Period 1||0
3333974|NCT03330275|4065777|FG008|COMPLETED|Visit 1 - Period 1||0
3333975|NCT03330275|4065778|FG009|COMPLETED|Visit 1 - Period 1||0
3333976|NCT03330275|4065769|FG000|NOT COMPLETED|Visit 1 - Period 1||0
3333977|NCT03330275|4065770|FG001|NOT COMPLETED|Visit 1 - Period 1||0
3333978|NCT03330275|4065771|FG002|NOT COMPLETED|Visit 1 - Period 1||0
3333979|NCT03330275|4065772|FG003|NOT COMPLETED|Visit 1 - Period 1||0
3333980|NCT03330275|4065773|FG004|NOT COMPLETED|Visit 1 - Period 1||0
3333981|NCT03330275|4065774|FG005|NOT COMPLETED|Visit 1 - Period 1||0
3333982|NCT03330275|4065775|FG006|NOT COMPLETED|Visit 1 - Period 1||0
3333983|NCT03330275|4065776|FG007|NOT COMPLETED|Visit 1 - Period 1||0
3333984|NCT03330275|4065777|FG008|NOT COMPLETED|Visit 1 - Period 1||0
3333985|NCT03330275|4065778|FG009|NOT COMPLETED|Visit 1 - Period 1||0
3333986|NCT03330275|4065769|FG000|STARTED|Visit 1 - Period 2||6
3333987|NCT03330275|4065770|FG001|STARTED|Visit 1 - Period 2||6
3333988|NCT03330275|4065771|FG002|STARTED|Visit 1 - Period 2||6
3333989|NCT03330275|4065772|FG003|STARTED|Visit 1 - Period 2||6
3333990|NCT03330275|4065773|FG004|STARTED|Visit 1 - Period 2||0
3333991|NCT03330275|4065774|FG005|STARTED|Visit 1 - Period 2||0
3333992|NCT03330275|4065775|FG006|STARTED|Visit 1 - Period 2||0
3333993|NCT03330275|4065776|FG007|STARTED|Visit 1 - Period 2||0
3333994|NCT03330275|4065777|FG008|STARTED|Visit 1 - Period 2||0
3333995|NCT03330275|4065778|FG009|STARTED|Visit 1 - Period 2||0
3333996|NCT03330275|4065769|FG000|COMPLETED|Visit 1 - Period 2||6
3333997|NCT03330275|4065770|FG001|COMPLETED|Visit 1 - Period 2||6
3333998|NCT03330275|4065771|FG002|COMPLETED|Visit 1 - Period 2||6
3333999|NCT03330275|4065772|FG003|COMPLETED|Visit 1 - Period 2||6
3334000|NCT03330275|4065773|FG004|COMPLETED|Visit 1 - Period 2||0
3334001|NCT03330275|4065774|FG005|COMPLETED|Visit 1 - Period 2||0
3334002|NCT03330275|4065775|FG006|COMPLETED|Visit 1 - Period 2||0
3334003|NCT03330275|4065776|FG007|COMPLETED|Visit 1 - Period 2||0
3334004|NCT03330275|4065777|FG008|COMPLETED|Visit 1 - Period 2||0
3334005|NCT03330275|4065778|FG009|COMPLETED|Visit 1 - Period 2||0
3334006|NCT03330275|4065769|FG000|NOT COMPLETED|Visit 1 - Period 2||0
3334007|NCT03330275|4065770|FG001|NOT COMPLETED|Visit 1 - Period 2||0
3334008|NCT03330275|4065771|FG002|NOT COMPLETED|Visit 1 - Period 2||0
3334009|NCT03330275|4065772|FG003|NOT COMPLETED|Visit 1 - Period 2||0
3334010|NCT03330275|4065773|FG004|NOT COMPLETED|Visit 1 - Period 2||0
3334011|NCT03330275|4065774|FG005|NOT COMPLETED|Visit 1 - Period 2||0
3334012|NCT03330275|4065775|FG006|NOT COMPLETED|Visit 1 - Period 2||0
3334013|NCT03330275|4065776|FG007|NOT COMPLETED|Visit 1 - Period 2||0
3334014|NCT03330275|4065777|FG008|NOT COMPLETED|Visit 1 - Period 2||0
3334015|NCT03330275|4065778|FG009|NOT COMPLETED|Visit 1 - Period 2||0
3334016|NCT03330275|4065769|FG000|STARTED|Visits 2, 3 and 4 - Period 1||0
3334017|NCT03330275|4065770|FG001|STARTED|Visits 2, 3 and 4 - Period 1||0
3334018|NCT03330275|4065771|FG002|STARTED|Visits 2, 3 and 4 - Period 1||0
3176871|NCT01968070|3904662|FG016|STARTED|Period 1||2
3176872|NCT01968070|3904663|FG017|STARTED|Period 1||2
3176873|NCT01968070|3904646|FG000|COMPLETED|Period 1||4
3176874|NCT01968070|3904647|FG001|COMPLETED|Period 1||3
3176875|NCT01968070|3904648|FG002|COMPLETED|Period 1||4
3176876|NCT01968070|3904649|FG003|COMPLETED|Period 1||2
3176877|NCT01968070|3904650|FG004|COMPLETED|Period 1||3
3176878|NCT01968070|3904651|FG005|COMPLETED|Period 1||4
3176879|NCT01968070|3904652|FG006|COMPLETED|Period 1||8
3334019|NCT03330275|4065772|FG003|STARTED|Visits 2, 3 and 4 - Period 1||0
3334020|NCT03330275|4065773|FG004|STARTED|Visits 2, 3 and 4 - Period 1||4
3176880|NCT01968070|3904653|FG007|COMPLETED|Period 1||2
3176881|NCT01968070|3904654|FG008|COMPLETED|Period 1||2
3176882|NCT01968070|3904655|FG009|COMPLETED|Period 1||9
3176883|NCT01968070|3904656|FG010|COMPLETED|Period 1||2
3176884|NCT01968070|3904657|FG011|COMPLETED|Period 1||1
3176885|NCT01968070|3904658|FG012|COMPLETED|Period 1||9
3176886|NCT01968070|3904659|FG013|COMPLETED|Period 1||2
3176887|NCT01968070|3904660|FG014|COMPLETED|Period 1||2
3176888|NCT01968070|3904661|FG015|COMPLETED|Period 1||8
3176889|NCT01968070|3904662|FG016|COMPLETED|Period 1||2
3176890|NCT01968070|3904663|FG017|COMPLETED|Period 1||2
3176891|NCT01968070|3904646|FG000|NOT COMPLETED|Period 1||0
3176892|NCT01968070|3904647|FG001|NOT COMPLETED|Period 1||1
3176893|NCT01968070|3904648|FG002|NOT COMPLETED|Period 1||0
3334021|NCT03330275|4065774|FG005|STARTED|Visits 2, 3 and 4 - Period 1||4
3334022|NCT03330275|4065775|FG006|STARTED|Visits 2, 3 and 4 - Period 1||4
3334023|NCT03330275|4065776|FG007|STARTED|Visits 2, 3 and 4 - Period 1||4
3334024|NCT03330275|4065777|FG008|STARTED|Visits 2, 3 and 4 - Period 1||4
3334025|NCT03330275|4065778|FG009|STARTED|Visits 2, 3 and 4 - Period 1||4
3334026|NCT03330275|4065769|FG000|COMPLETED|Visits 2, 3 and 4 - Period 1||0
3334027|NCT03330275|4065770|FG001|COMPLETED|Visits 2, 3 and 4 - Period 1||0
3334028|NCT03330275|4065771|FG002|COMPLETED|Visits 2, 3 and 4 - Period 1||0
3334029|NCT03330275|4065772|FG003|COMPLETED|Visits 2, 3 and 4 - Period 1||0
3334030|NCT03330275|4065773|FG004|COMPLETED|Visits 2, 3 and 4 - Period 1||4
3334031|NCT03330275|4065774|FG005|COMPLETED|Visits 2, 3 and 4 - Period 1||4
3334032|NCT03330275|4065775|FG006|COMPLETED|Visits 2, 3 and 4 - Period 1||4
3334033|NCT03330275|4065776|FG007|COMPLETED|Visits 2, 3 and 4 - Period 1||4
3334034|NCT03330275|4065777|FG008|COMPLETED|Visits 2, 3 and 4 - Period 1||4
3334035|NCT03330275|4065778|FG009|COMPLETED|Visits 2, 3 and 4 - Period 1||4
3334036|NCT03330275|4065769|FG000|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
3334037|NCT03330275|4065770|FG001|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
3334038|NCT03330275|4065771|FG002|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
3334039|NCT03330275|4065772|FG003|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
3334040|NCT03330275|4065773|FG004|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
3176894|NCT01968070|3904649|FG003|NOT COMPLETED|Period 1||2
3176895|NCT01968070|3904650|FG004|NOT COMPLETED|Period 1||1
3334041|NCT03330275|4065774|FG005|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
3334042|NCT03330275|4065775|FG006|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
3334043|NCT03330275|4065776|FG007|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
3334044|NCT03330275|4065777|FG008|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
3334045|NCT03330275|4065778|FG009|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
3334046|NCT03330275|4065769|FG000|STARTED|Visits 2, 3 and 4 - Period 2||0
3334047|NCT03330275|4065770|FG001|STARTED|Visits 2, 3 and 4 - Period 2||0
3334048|NCT03330275|4065771|FG002|STARTED|Visits 2, 3 and 4 - Period 2||0
3334049|NCT03330275|4065772|FG003|STARTED|Visits 2, 3 and 4 - Period 2||0
3334050|NCT03330275|4065773|FG004|STARTED|Visits 2, 3 and 4 - Period 2||4
3334051|NCT03330275|4065774|FG005|STARTED|Visits 2, 3 and 4 - Period 2||4
3334052|NCT03330275|4065775|FG006|STARTED|Visits 2, 3 and 4 - Period 2||4
3334053|NCT03330275|4065776|FG007|STARTED|Visits 2, 3 and 4 - Period 2||4
3334054|NCT03330275|4065777|FG008|STARTED|Visits 2, 3 and 4 - Period 2||4
3334055|NCT03330275|4065778|FG009|STARTED|Visits 2, 3 and 4 - Period 2||4
3334056|NCT03330275|4065769|FG000|COMPLETED|Visits 2, 3 and 4 - Period 2||0
3334057|NCT03330275|4065770|FG001|COMPLETED|Visits 2, 3 and 4 - Period 2||0
3334058|NCT03330275|4065771|FG002|COMPLETED|Visits 2, 3 and 4 - Period 2||0
3334059|NCT03330275|4065772|FG003|COMPLETED|Visits 2, 3 and 4 - Period 2||0
3334060|NCT03330275|4065773|FG004|COMPLETED|Visits 2, 3 and 4 - Period 2||4
3334061|NCT03330275|4065774|FG005|COMPLETED|Visits 2, 3 and 4 - Period 2||4
3334062|NCT03330275|4065775|FG006|COMPLETED|Visits 2, 3 and 4 - Period 2||4
3334063|NCT03330275|4065776|FG007|COMPLETED|Visits 2, 3 and 4 - Period 2||4
3334064|NCT03330275|4065777|FG008|COMPLETED|Visits 2, 3 and 4 - Period 2||4
3334065|NCT03330275|4065778|FG009|COMPLETED|Visits 2, 3 and 4 - Period 2||4
3334066|NCT03330275|4065769|FG000|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
3334067|NCT03330275|4065770|FG001|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
3334068|NCT03330275|4065771|FG002|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
3334069|NCT03330275|4065772|FG003|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
3334070|NCT03330275|4065773|FG004|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
3334071|NCT03330275|4065774|FG005|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
3334072|NCT03330275|4065775|FG006|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
3334073|NCT03330275|4065776|FG007|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
3334074|NCT03330275|4065777|FG008|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
3334075|NCT03330275|4065778|FG009|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
3334076|NCT03330275|4065769|FG000|STARTED|Visits 2, 3 and 4 - Period 3||0
3334077|NCT03330275|4065770|FG001|STARTED|Visits 2, 3 and 4 - Period 3||0
3334078|NCT03330275|4065771|FG002|STARTED|Visits 2, 3 and 4 - Period 3||0
3334079|NCT03330275|4065772|FG003|STARTED|Visits 2, 3 and 4 - Period 3||0
3334080|NCT03330275|4065773|FG004|STARTED|Visits 2, 3 and 4 - Period 3||4
3334081|NCT03330275|4065774|FG005|STARTED|Visits 2, 3 and 4 - Period 3||4
3334082|NCT03330275|4065775|FG006|STARTED|Visits 2, 3 and 4 - Period 3||4
3334083|NCT03330275|4065776|FG007|STARTED|Visits 2, 3 and 4 - Period 3||4
3334084|NCT03330275|4065777|FG008|STARTED|Visits 2, 3 and 4 - Period 3||4
3334085|NCT03330275|4065778|FG009|STARTED|Visits 2, 3 and 4 - Period 3||4
3334086|NCT03330275|4065769|FG000|COMPLETED|Visits 2, 3 and 4 - Period 3||0
3334087|NCT03330275|4065770|FG001|COMPLETED|Visits 2, 3 and 4 - Period 3||0
3334088|NCT03330275|4065771|FG002|COMPLETED|Visits 2, 3 and 4 - Period 3||0
3334089|NCT03330275|4065772|FG003|COMPLETED|Visits 2, 3 and 4 - Period 3||0
3334090|NCT03330275|4065773|FG004|COMPLETED|Visits 2, 3 and 4 - Period 3||4
3334091|NCT03330275|4065774|FG005|COMPLETED|Visits 2, 3 and 4 - Period 3||4
3334092|NCT03330275|4065775|FG006|COMPLETED|Visits 2, 3 and 4 - Period 3||4
3334093|NCT03330275|4065776|FG007|COMPLETED|Visits 2, 3 and 4 - Period 3||4
3334094|NCT03330275|4065777|FG008|COMPLETED|Visits 2, 3 and 4 - Period 3||4
3334095|NCT03330275|4065778|FG009|COMPLETED|Visits 2, 3 and 4 - Period 3||4
3334096|NCT03330275|4065769|FG000|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
3334097|NCT03330275|4065770|FG001|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
3334098|NCT03330275|4065771|FG002|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
3334099|NCT03330275|4065772|FG003|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
3334100|NCT03330275|4065773|FG004|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
3334101|NCT03330275|4065774|FG005|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
3334102|NCT03330275|4065775|FG006|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
3334103|NCT03330275|4065776|FG007|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
3334104|NCT03330275|4065777|FG008|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
3334105|NCT03330275|4065778|FG009|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
3334106|NCT03330288|4065788|FG000|STARTED|Overall Study|Enrolled|824
3334107|NCT03330288|4065789|FG001|STARTED|Overall Study|Enrolled|278
3334108|NCT03330288|4065788|FG000|COMPLETED|Overall Study||794
3334109|NCT03330288|4065789|FG001|COMPLETED|Overall Study||270
3334110|NCT03330288|4065788|FG000|NOT COMPLETED|Overall Study||30
3334111|NCT03330288|4065789|FG001|NOT COMPLETED|Overall Study||8
3334112|NCT03330457|4065799|FG000|STARTED|Overall Study||6
3334113|NCT03330457|4065800|FG001|STARTED|Overall Study||3
3334114|NCT03330457|4065801|FG002|STARTED|Overall Study||6
3334115|NCT03330457|4065802|FG003|STARTED|Overall Study||3
3334116|NCT03330457|4065799|FG000|COMPLETED|Overall Study||6
3334117|NCT03330457|4065800|FG001|COMPLETED|Overall Study||3
3334118|NCT03330457|4065801|FG002|COMPLETED|Overall Study||6
3334119|NCT03330457|4065802|FG003|COMPLETED|Overall Study||3
3334120|NCT03330457|4065799|FG000|NOT COMPLETED|Overall Study||0
3334121|NCT03330457|4065800|FG001|NOT COMPLETED|Overall Study||0
3334122|NCT03330457|4065801|FG002|NOT COMPLETED|Overall Study||0
3334123|NCT03330457|4065802|FG003|NOT COMPLETED|Overall Study||0
3334124|NCT03330834|4065812|FG000|STARTED|Overall Study||1
3334125|NCT03330834|4065812|FG000|COMPLETED|Overall Study||1
3334126|NCT03330834|4065812|FG000|NOT COMPLETED|Overall Study||0
3334127|NCT03331042|4065820|FG000|STARTED|Overall Study||22
3334128|NCT03331042|4065821|FG001|STARTED|Overall Study||21
3334129|NCT03331042|4065822|FG002|STARTED|Overall Study||21
3334130|NCT03331042|4065823|FG003|STARTED|Overall Study||21
3334131|NCT03331042|4065820|FG000|COMPLETED|Overall Study||21
3334132|NCT03331042|4065821|FG001|COMPLETED|Overall Study||21
3334133|NCT03331042|4065822|FG002|COMPLETED|Overall Study||20
3334134|NCT03331042|4065823|FG003|COMPLETED|Overall Study||20
3334135|NCT03331042|4065820|FG000|NOT COMPLETED|Overall Study||1
3334136|NCT03331042|4065821|FG001|NOT COMPLETED|Overall Study||0
3334137|NCT03331042|4065822|FG002|NOT COMPLETED|Overall Study||1
3334138|NCT03331042|4065823|FG003|NOT COMPLETED|Overall Study||1
3334139|NCT03331185|4065841|FG000|STARTED|Overall Study||14
3334140|NCT03331185|4065842|FG001|STARTED|Overall Study||12
3334141|NCT03331185|4065841|FG000|COMPLETED|Overall Study||14
3334142|NCT03331185|4065842|FG001|COMPLETED|Overall Study||12
3334143|NCT03331185|4065841|FG000|NOT COMPLETED|Overall Study||0
3334144|NCT03331185|4065842|FG001|NOT COMPLETED|Overall Study||0
3334145|NCT03331315|4065850|FG000|STARTED|Overall Study||88
3334146|NCT03331315|4065851|FG001|STARTED|Overall Study||82
3334147|NCT03331315|4065850|FG000|COMPLETED|Overall Study||70
3334148|NCT03331315|4065851|FG001|COMPLETED|Overall Study||68
3176896|NCT01968070|3904651|FG005|NOT COMPLETED|Period 1||0
3176897|NCT01968070|3904652|FG006|NOT COMPLETED|Period 1||2
3176898|NCT01968070|3904653|FG007|NOT COMPLETED|Period 1||0
3176899|NCT01968070|3904654|FG008|NOT COMPLETED|Period 1||0
3334149|NCT03331315|4065850|FG000|NOT COMPLETED|Overall Study||18
3334150|NCT03331315|4065851|FG001|NOT COMPLETED|Overall Study||14
3334151|NCT03331666|4065861|FG000|STARTED|Overall Study||2
3334152|NCT03331666|4065862|FG001|STARTED|Overall Study||2
3334153|NCT03331666|4065861|FG000|COMPLETED|Overall Study||0
3334154|NCT03331666|4065862|FG001|COMPLETED|Overall Study||0
3334155|NCT03331666|4065861|FG000|NOT COMPLETED|Overall Study||2
3334156|NCT03331666|4065862|FG001|NOT COMPLETED|Overall Study||2
3334157|NCT03331835|4065870|FG000|STARTED|Overall Study||105
3334158|NCT03331835|4065871|FG001|STARTED|Overall Study||105
3334159|NCT03331835|4065870|FG000|COMPLETED|Overall Study||91
3334160|NCT03331835|4065871|FG001|COMPLETED|Overall Study||58
3334161|NCT03331835|4065870|FG000|NOT COMPLETED|Overall Study||14
3334162|NCT03331835|4065871|FG001|NOT COMPLETED|Overall Study||47
3334163|NCT03331965|4065879|FG000|STARTED|Overall Study||55
3334164|NCT03331965|4065880|FG001|STARTED|Overall Study||55
3334165|NCT03331965|4065879|FG000|COMPLETED|Overall Study||45
3334166|NCT03331965|4065880|FG001|COMPLETED|Overall Study||51
3334167|NCT03331965|4065879|FG000|NOT COMPLETED|Overall Study||10
3334168|NCT03331965|4065880|FG001|NOT COMPLETED|Overall Study||4
3334169|NCT03332160|4065888|FG000|STARTED|Overall Study||25
3334170|NCT03332160|4065889|FG001|STARTED|Overall Study||24
3334171|NCT03332160|4065888|FG000|COMPLETED|Overall Study||24
3334172|NCT03332160|4065889|FG001|COMPLETED|Overall Study||19
3334173|NCT03332160|4065888|FG000|NOT COMPLETED|Overall Study||1
3334174|NCT03332160|4065889|FG001|NOT COMPLETED|Overall Study||5
3334175|NCT03332212|4065900|FG000|STARTED|Overall Study||19
3334176|NCT03332212|4065901|FG001|STARTED|Overall Study||18
3334177|NCT03332212|4065902|FG002|STARTED|Overall Study||17
3334178|NCT03332212|4065903|FG003|STARTED|Overall Study||18
3334179|NCT03332212|4065900|FG000|Treated|Overall Study||19
3334180|NCT03332212|4065901|FG001|Treated|Overall Study||17
3334181|NCT03332212|4065902|FG002|Treated|Overall Study||17
3334182|NCT03332212|4065903|FG003|Treated|Overall Study||18
3334183|NCT03332212|4065900|FG000|COMPLETED|Overall Study||18
3334184|NCT03332212|4065901|FG001|COMPLETED|Overall Study||16
3334185|NCT03332212|4065902|FG002|COMPLETED|Overall Study||17
3334186|NCT03332212|4065903|FG003|COMPLETED|Overall Study||17
3334187|NCT03332212|4065900|FG000|NOT COMPLETED|Overall Study||1
3334188|NCT03332212|4065901|FG001|NOT COMPLETED|Overall Study||2
3334189|NCT03332212|4065902|FG002|NOT COMPLETED|Overall Study||0
3334190|NCT03332212|4065903|FG003|NOT COMPLETED|Overall Study||1
3334191|NCT03332459|4065914|FG000|STARTED|Overall Study||3
3334192|NCT03332459|4065915|FG001|STARTED|Overall Study||1
3334193|NCT03332459|4065916|FG002|STARTED|Overall Study||3
3334194|NCT03332459|4065914|FG000|COMPLETED|Overall Study||3
3334195|NCT03332459|4065915|FG001|COMPLETED|Overall Study||1
3334196|NCT03332459|4065916|FG002|COMPLETED|Overall Study||3
3334197|NCT03332459|4065914|FG000|NOT COMPLETED|Overall Study||0
3334198|NCT03332459|4065915|FG001|NOT COMPLETED|Overall Study||0
3334199|NCT03332459|4065916|FG002|NOT COMPLETED|Overall Study||0
3334200|NCT03332628|4065924|FG000|STARTED|Overall Study||113
3334201|NCT03332628|4065924|FG000|COMPLETED|Overall Study||111
3334202|NCT03332628|4065924|FG000|NOT COMPLETED|Overall Study||2
3334203|NCT03332771|4065933|FG000|STARTED|Overall Study||159
3334204|NCT03332771|4065934|FG001|STARTED|Overall Study||317
3176900|NCT01968070|3904655|FG009|NOT COMPLETED|Period 1||0
3176901|NCT01968070|3904656|FG010|NOT COMPLETED|Period 1||0
3334205|NCT03332771|4065935|FG002|STARTED|Overall Study||160
3334206|NCT03332771|4065936|FG003|STARTED|Overall Study||318
3334207|NCT03332771|4065933|FG000|COMPLETED|Overall Study||125
3334208|NCT03332771|4065934|FG001|COMPLETED|Overall Study||266
3334209|NCT03332771|4065935|FG002|COMPLETED|Overall Study||128
3334210|NCT03332771|4065936|FG003|COMPLETED|Overall Study||270
3334211|NCT03332771|4065933|FG000|NOT COMPLETED|Overall Study||34
3334212|NCT03332771|4065934|FG001|NOT COMPLETED|Overall Study||51
3334213|NCT03332771|4065935|FG002|NOT COMPLETED|Overall Study||32
3334214|NCT03332771|4065936|FG003|NOT COMPLETED|Overall Study||48
3334215|NCT03332784|4065966|FG000|STARTED|Parts 1 and 2 - Period 1 (1 Day)||2
3334216|NCT03332784|4065967|FG001|STARTED|Parts 1 and 2 - Period 1 (1 Day)||2
3334217|NCT03332784|4065968|FG002|STARTED|Parts 1 and 2 - Period 1 (1 Day)||2
3334218|NCT03332784|4065969|FG003|STARTED|Parts 1 and 2 - Period 1 (1 Day)||2
3334219|NCT03332784|4065970|FG004|STARTED|Parts 1 and 2 - Period 1 (1 Day)||2
3334220|NCT03332784|4065971|FG005|STARTED|Parts 1 and 2 - Period 1 (1 Day)||2
3334221|NCT03332784|4065972|FG006|STARTED|Parts 1 and 2 - Period 1 (1 Day)||2
3334222|NCT03332784|4065973|FG007|STARTED|Parts 1 and 2 - Period 1 (1 Day)||2
3334223|NCT03332784|4065974|FG008|STARTED|Parts 1 and 2 - Period 1 (1 Day)||4
3334224|NCT03332784|4065975|FG009|STARTED|Parts 1 and 2 - Period 1 (1 Day)||6
3334225|NCT03332784|4065976|FG010|STARTED|Parts 1 and 2 - Period 1 (1 Day)||6
3176902|NCT01968070|3904657|FG011|NOT COMPLETED|Period 1||1
3176903|NCT01968070|3904658|FG012|NOT COMPLETED|Period 1||0
3334226|NCT03332784|4065977|FG011|STARTED|Parts 1 and 2 - Period 1 (1 Day)||2
3334227|NCT03332784|4065978|FG012|STARTED|Parts 1 and 2 - Period 1 (1 Day)||6
3334228|NCT03332784|4065979|FG013|STARTED|Parts 1 and 2 - Period 1 (1 Day)||4
3334229|NCT03332784|4065980|FG014|STARTED|Parts 1 and 2 - Period 1 (1 Day)|A washout period of 7 days was required before the dosing on Day 1 for prior medications.|2
3334230|NCT03332784|4065981|FG015|STARTED|Parts 1 and 2 - Period 1 (1 Day)|A washout period of 7 days was required before the dosing on Day 1 for prior medications.|2
3334231|NCT03332784|4065982|FG016|STARTED|Parts 1 and 2 - Period 1 (1 Day)|A washout period of 7 days was required before the dosing on Day 1 for prior medications.|2
3334232|NCT03332784|4065983|FG017|STARTED|Parts 1 and 2 - Period 1 (1 Day)|A washout period of 7 days was required before the dosing on Day 1 for prior medications.|2
3334233|NCT03332784|4065984|FG018|STARTED|Parts 1 and 2 - Period 1 (1 Day)|A washout period of 7 days was required before the dosing on Day 1 for prior medications.|3
3334234|NCT03332784|4065985|FG019|STARTED|Parts 1 and 2 - Period 1 (1 Day)|A washout period of 7 days was required before the dosing on Day 1 for prior medications.|3
3334235|NCT03332784|4065966|FG000|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2
3334236|NCT03332784|4065967|FG001|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||1
3334237|NCT03332784|4065968|FG002|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2
3334238|NCT03332784|4065969|FG003|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2
3334239|NCT03332784|4065970|FG004|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2
3334240|NCT03332784|4065971|FG005|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2
3334241|NCT03332784|4065972|FG006|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2
3334242|NCT03332784|4065973|FG007|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2
3334243|NCT03332784|4065974|FG008|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||4
3334244|NCT03332784|4065975|FG009|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||6
3334245|NCT03332784|4065976|FG010|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||6
3334246|NCT03332784|4065977|FG011|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2
3334247|NCT03332784|4065978|FG012|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||6
3334248|NCT03332784|4065979|FG013|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||4
3334249|NCT03332784|4065980|FG014|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||1
3334250|NCT03332784|4065981|FG015|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2
3176904|NCT01968070|3904659|FG013|NOT COMPLETED|Period 1||0
3334251|NCT03332784|4065982|FG016|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2
3334252|NCT03332784|4065983|FG017|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2
3334253|NCT03332784|4065984|FG018|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||3
3334254|NCT03332784|4065985|FG019|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||3
3334255|NCT03332784|4065966|FG000|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
3334256|NCT03332784|4065967|FG001|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||1
3334257|NCT03332784|4065968|FG002|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
3334258|NCT03332784|4065969|FG003|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
3334259|NCT03332784|4065970|FG004|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
3334260|NCT03332784|4065971|FG005|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
3334261|NCT03332784|4065972|FG006|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
3334262|NCT03332784|4065973|FG007|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
3334263|NCT03332784|4065974|FG008|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
3334264|NCT03332784|4065975|FG009|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
3334265|NCT03332784|4065976|FG010|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
3334266|NCT03332784|4065977|FG011|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
3334267|NCT03332784|4065978|FG012|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
3334268|NCT03332784|4065979|FG013|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
3334269|NCT03332784|4065980|FG014|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||1
3334270|NCT03332784|4065981|FG015|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
3334271|NCT03332784|4065982|FG016|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
3334272|NCT03332784|4065983|FG017|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
3334273|NCT03332784|4065984|FG018|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
3334274|NCT03332784|4065985|FG019|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
3334275|NCT03332784|4065966|FG000|STARTED|Parts 1 and 2- Period 2 (1 Day)||2
3334276|NCT03332784|4065967|FG001|STARTED|Parts 1 and 2- Period 2 (1 Day)||1
3334277|NCT03332784|4065968|FG002|STARTED|Parts 1 and 2- Period 2 (1 Day)||2
3334278|NCT03332784|4065969|FG003|STARTED|Parts 1 and 2- Period 2 (1 Day)||2
3334279|NCT03332784|4065970|FG004|STARTED|Parts 1 and 2- Period 2 (1 Day)||2
3334280|NCT03332784|4065971|FG005|STARTED|Parts 1 and 2- Period 2 (1 Day)||2
3334281|NCT03332784|4065972|FG006|STARTED|Parts 1 and 2- Period 2 (1 Day)||2
3334282|NCT03332784|4065973|FG007|STARTED|Parts 1 and 2- Period 2 (1 Day)||2
3334283|NCT03332784|4065974|FG008|STARTED|Parts 1 and 2- Period 2 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0
3334284|NCT03332784|4065975|FG009|STARTED|Parts 1 and 2- Period 2 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0
3334285|NCT03332784|4065976|FG010|STARTED|Parts 1 and 2- Period 2 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0
3334286|NCT03332784|4065977|FG011|STARTED|Parts 1 and 2- Period 2 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0
3334287|NCT03332784|4065978|FG012|STARTED|Parts 1 and 2- Period 2 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0
3334288|NCT03332784|4065979|FG013|STARTED|Parts 1 and 2- Period 2 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0
3334289|NCT03332784|4065980|FG014|STARTED|Parts 1 and 2- Period 2 (1 Day)||1
3334290|NCT03332784|4065981|FG015|STARTED|Parts 1 and 2- Period 2 (1 Day)||2
3334291|NCT03332784|4065982|FG016|STARTED|Parts 1 and 2- Period 2 (1 Day)||2
3334292|NCT03332784|4065983|FG017|STARTED|Parts 1 and 2- Period 2 (1 Day)||2
3334293|NCT03332784|4065984|FG018|STARTED|Parts 1 and 2- Period 2 (1 Day)||3
3334294|NCT03332784|4065985|FG019|STARTED|Parts 1 and 2- Period 2 (1 Day)||3
3334295|NCT03332784|4065966|FG000|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||2
3334296|NCT03332784|4065967|FG001|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||1
3334297|NCT03332784|4065968|FG002|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||2
3334298|NCT03332784|4065969|FG003|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||2
3334299|NCT03332784|4065970|FG004|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||2
3334300|NCT03332784|4065971|FG005|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||2
3334301|NCT03332784|4065972|FG006|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||2
3334302|NCT03332784|4065973|FG007|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||2
3334303|NCT03332784|4065974|FG008|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
3334304|NCT03332784|4065975|FG009|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
3334305|NCT03332784|4065976|FG010|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
3334306|NCT03332784|4065977|FG011|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
3334307|NCT03332784|4065978|FG012|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
3334308|NCT03332784|4065979|FG013|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
3334309|NCT03332784|4065980|FG014|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||1
3334310|NCT03332784|4065981|FG015|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||2
3334311|NCT03332784|4065982|FG016|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||2
3334312|NCT03332784|4065983|FG017|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||2
3334313|NCT03332784|4065984|FG018|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||3
3334314|NCT03332784|4065985|FG019|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||3
3334315|NCT03332784|4065966|FG000|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
3334316|NCT03332784|4065967|FG001|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
3334317|NCT03332784|4065968|FG002|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
3334318|NCT03332784|4065969|FG003|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
3334319|NCT03332784|4065970|FG004|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
3334320|NCT03332784|4065971|FG005|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
3334321|NCT03332784|4065972|FG006|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
3334322|NCT03332784|4065973|FG007|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
3334323|NCT03332784|4065974|FG008|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
3334324|NCT03332784|4065975|FG009|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
3334325|NCT03332784|4065976|FG010|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
3334326|NCT03332784|4065977|FG011|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
3334327|NCT03332784|4065978|FG012|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
3334328|NCT03332784|4065979|FG013|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
3334329|NCT03332784|4065980|FG014|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
3334330|NCT03332784|4065981|FG015|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
3334331|NCT03332784|4065982|FG016|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
3334332|NCT03332784|4065983|FG017|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
3334333|NCT03332784|4065984|FG018|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
3334334|NCT03332784|4065985|FG019|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
3334335|NCT03332784|4065966|FG000|STARTED|Part 1- Period 3 (1 Day)||2
3334336|NCT03332784|4065967|FG001|STARTED|Part 1- Period 3 (1 Day)||1
3334337|NCT03332784|4065968|FG002|STARTED|Part 1- Period 3 (1 Day)||2
3334338|NCT03332784|4065969|FG003|STARTED|Part 1- Period 3 (1 Day)||2
3334339|NCT03332784|4065970|FG004|STARTED|Part 1- Period 3 (1 Day)||2
3334340|NCT03332784|4065971|FG005|STARTED|Part 1- Period 3 (1 Day)||2
3334341|NCT03332784|4065972|FG006|STARTED|Part 1- Period 3 (1 Day)||2
3334342|NCT03332784|4065973|FG007|STARTED|Part 1- Period 3 (1 Day)||2
3334343|NCT03332784|4065974|FG008|STARTED|Part 1- Period 3 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0
3334344|NCT03332784|4065975|FG009|STARTED|Part 1- Period 3 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0
3334345|NCT03332784|4065976|FG010|STARTED|Part 1- Period 3 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0
3334346|NCT03332784|4065977|FG011|STARTED|Part 1- Period 3 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0
3334347|NCT03332784|4065978|FG012|STARTED|Part 1- Period 3 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0
3334348|NCT03332784|4065979|FG013|STARTED|Part 1- Period 3 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0
3334349|NCT03332784|4065980|FG014|STARTED|Part 1- Period 3 (1 Day)|Part 2 participants did not continue in subsequent periods after Period 2.|0
3334350|NCT03332784|4065981|FG015|STARTED|Part 1- Period 3 (1 Day)|Part 2 participants did not continue in subsequent periods after Period 2.|0
3334351|NCT03332784|4065982|FG016|STARTED|Part 1- Period 3 (1 Day)|Part 2 participants did not continue in subsequent periods after Period 2.|0
3334352|NCT03332784|4065983|FG017|STARTED|Part 1- Period 3 (1 Day)|Part 2 participants did not continue in subsequent periods after Period 2.|0
3334353|NCT03332784|4065984|FG018|STARTED|Part 1- Period 3 (1 Day)|Part 2 participants did not continue in subsequent periods after Period 2.|0
3334354|NCT03332784|4065985|FG019|STARTED|Part 1- Period 3 (1 Day)|Part 2 participants did not continue in subsequent periods after Period 2.|0
3334355|NCT03332784|4065966|FG000|COMPLETED|Part 1- Period 3 (1 Day)||2
3334356|NCT03332784|4065967|FG001|COMPLETED|Part 1- Period 3 (1 Day)||1
3334357|NCT03332784|4065968|FG002|COMPLETED|Part 1- Period 3 (1 Day)||2
3334358|NCT03332784|4065969|FG003|COMPLETED|Part 1- Period 3 (1 Day)||2
3334359|NCT03332784|4065970|FG004|COMPLETED|Part 1- Period 3 (1 Day)||2
3334360|NCT03332784|4065971|FG005|COMPLETED|Part 1- Period 3 (1 Day)||2
3334361|NCT03332784|4065972|FG006|COMPLETED|Part 1- Period 3 (1 Day)||2
3334362|NCT03332784|4065973|FG007|COMPLETED|Part 1- Period 3 (1 Day)||2
3334363|NCT03332784|4065974|FG008|COMPLETED|Part 1- Period 3 (1 Day)||0
3334364|NCT03332784|4065975|FG009|COMPLETED|Part 1- Period 3 (1 Day)||0
3334365|NCT03332784|4065976|FG010|COMPLETED|Part 1- Period 3 (1 Day)||0
3334366|NCT03332784|4065977|FG011|COMPLETED|Part 1- Period 3 (1 Day)||0
3334367|NCT03332784|4065978|FG012|COMPLETED|Part 1- Period 3 (1 Day)||0
3334368|NCT03332784|4065979|FG013|COMPLETED|Part 1- Period 3 (1 Day)||0
3334369|NCT03332784|4065980|FG014|COMPLETED|Part 1- Period 3 (1 Day)||0
3334370|NCT03332784|4065981|FG015|COMPLETED|Part 1- Period 3 (1 Day)||0
3334371|NCT03332784|4065982|FG016|COMPLETED|Part 1- Period 3 (1 Day)||0
3334372|NCT03332784|4065983|FG017|COMPLETED|Part 1- Period 3 (1 Day)||0
3334373|NCT03332784|4065984|FG018|COMPLETED|Part 1- Period 3 (1 Day)||0
3334374|NCT03332784|4065985|FG019|COMPLETED|Part 1- Period 3 (1 Day)||0
3334375|NCT03332784|4065966|FG000|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
3334376|NCT03332784|4065967|FG001|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
3334377|NCT03332784|4065968|FG002|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
3334378|NCT03332784|4065969|FG003|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
3334379|NCT03332784|4065970|FG004|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
3176905|NCT01968070|3904660|FG014|NOT COMPLETED|Period 1||0
3176906|NCT01968070|3904661|FG015|NOT COMPLETED|Period 1||1
3176907|NCT01968070|3904662|FG016|NOT COMPLETED|Period 1||0
3176908|NCT01968070|3904663|FG017|NOT COMPLETED|Period 1||0
3176909|NCT01968070|3904646|FG000|STARTED|Period 2||4
3176910|NCT01968070|3904647|FG001|STARTED|Period 2|1 participant was added to replace the participant who discontinued the period 1.|4
3334380|NCT03332784|4065971|FG005|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
3334381|NCT03332784|4065972|FG006|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
3334382|NCT03332784|4065973|FG007|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
3334383|NCT03332784|4065974|FG008|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
3334384|NCT03332784|4065975|FG009|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
3334385|NCT03332784|4065976|FG010|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
3334386|NCT03332784|4065977|FG011|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
3334387|NCT03332784|4065978|FG012|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
3334388|NCT03332784|4065979|FG013|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
3334389|NCT03332784|4065980|FG014|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
3334390|NCT03332784|4065981|FG015|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
3334391|NCT03332784|4065982|FG016|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
3334392|NCT03332784|4065983|FG017|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
3334393|NCT03332784|4065984|FG018|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
3334394|NCT03332784|4065985|FG019|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
3334395|NCT03332979|4066039|FG000|STARTED|Overall Study||150
3176911|NCT01968070|3904648|FG002|STARTED|Period 2||4
3334396|NCT03332979|4066039|FG000|COMPLETED|Overall Study||150
3334397|NCT03332979|4066039|FG000|NOT COMPLETED|Overall Study||0
3334398|NCT03333109|4066046|FG000|STARTED|Double-blind Treatment Period (DBTP)||338
3334399|NCT03333109|4066047|FG001|STARTED|Double-blind Treatment Period (DBTP)||224
3334400|NCT03333109|4066048|FG002|STARTED|Double-blind Treatment Period (DBTP)||338
3334401|NCT03333109|4066046|FG000|Full Analysis Set|Double-blind Treatment Period (DBTP)||329
3334402|NCT03333109|4066047|FG001|Full Analysis Set|Double-blind Treatment Period (DBTP)||219
3334403|NCT03333109|4066048|FG002|Full Analysis Set|Double-blind Treatment Period (DBTP)||330
3334404|NCT03333109|4066046|FG000|Safety Analysis Set|Double-blind Treatment Period (DBTP)||335
3334405|NCT03333109|4066047|FG001|Safety Analysis Set|Double-blind Treatment Period (DBTP)||224
3334406|NCT03333109|4066048|FG002|Safety Analysis Set|Double-blind Treatment Period (DBTP)||335
3334407|NCT03333109|4066046|FG000|COMPLETED|Double-blind Treatment Period (DBTP)||321
3334408|NCT03333109|4066047|FG001|COMPLETED|Double-blind Treatment Period (DBTP)||218
3334409|NCT03333109|4066048|FG002|COMPLETED|Double-blind Treatment Period (DBTP)||326
3334410|NCT03333109|4066046|FG000|NOT COMPLETED|Double-blind Treatment Period (DBTP)||17
3334411|NCT03333109|4066047|FG001|NOT COMPLETED|Double-blind Treatment Period (DBTP)||6
3334412|NCT03333109|4066048|FG002|NOT COMPLETED|Double-blind Treatment Period (DBTP)||12
3334413|NCT03333109|4066046|FG000|STARTED|Safety Follow-up Period|Subjects discontinued from DBTP and still entered the safety follow-up.|324
3334414|NCT03333109|4066047|FG001|STARTED|Safety Follow-up Period||218
3334415|NCT03333109|4066048|FG002|STARTED|Safety Follow-up Period|Subjects discontinued from DBTP and still entered the safety follow-up.|328
3334416|NCT03333109|4066046|FG000|COMPLETED|Safety Follow-up Period||311
3334417|NCT03333109|4066047|FG001|COMPLETED|Safety Follow-up Period||214
3334418|NCT03333109|4066048|FG002|COMPLETED|Safety Follow-up Period||315
3334419|NCT03333109|4066046|FG000|NOT COMPLETED|Safety Follow-up Period||13
3334420|NCT03333109|4066047|FG001|NOT COMPLETED|Safety Follow-up Period||4
3334421|NCT03333109|4066048|FG002|NOT COMPLETED|Safety Follow-up Period||13
3334422|NCT03333317|4066059|FG000|STARTED|Overall Study||3
3334423|NCT03333317|4066060|FG001|STARTED|Overall Study||1
3334424|NCT03333317|4066061|FG002|STARTED|Overall Study||3
3334425|NCT03333317|4066059|FG000|COMPLETED|Overall Study||3
3334426|NCT03333317|4066060|FG001|COMPLETED|Overall Study||1
3334427|NCT03333317|4066061|FG002|COMPLETED|Overall Study||3
3334428|NCT03333317|4066059|FG000|NOT COMPLETED|Overall Study||0
3334429|NCT03333317|4066060|FG001|NOT COMPLETED|Overall Study||0
3334430|NCT03333317|4066061|FG002|NOT COMPLETED|Overall Study||0
3334431|NCT03333577|4066071|FG000|STARTED|Overall Study||32
3334432|NCT03333577|4066071|FG000|COMPLETED|Overall Study||25
3334433|NCT03333577|4066071|FG000|NOT COMPLETED|Overall Study||7
3334434|NCT03333876|4066077|FG000|STARTED|Screening Period||58
3334435|NCT03333876|4066077|FG000|COMPLETED|Screening Period||54
3334436|NCT03333876|4066077|FG000|NOT COMPLETED|Screening Period||4
3334437|NCT03333876|4066077|FG000|STARTED|Nasal Dilator||54
3334438|NCT03333876|4066077|FG000|COMPLETED|Nasal Dilator||48
3334439|NCT03333876|4066077|FG000|NOT COMPLETED|Nasal Dilator||6
3334440|NCT03333876|4066077|FG000|STARTED|Mandibular Advancement||54
3334441|NCT03333876|4066077|FG000|COMPLETED|Mandibular Advancement||50
3334442|NCT03333876|4066077|FG000|NOT COMPLETED|Mandibular Advancement||4
3334443|NCT03333876|4066077|FG000|STARTED|Positional Therapy||54
3334444|NCT03333876|4066077|FG000|COMPLETED|Positional Therapy||54
3334445|NCT03333876|4066077|FG000|NOT COMPLETED|Positional Therapy||0
3334446|NCT03333941|4066090|FG000|STARTED|Overall Study||76
3334447|NCT03333941|4066090|FG000|COMPLETED|Overall Study||63
3334448|NCT03333941|4066090|FG000|NOT COMPLETED|Overall Study||13
3334449|NCT03334175|4066096|FG000|STARTED|Overall Study||8
3334450|NCT03334175|4066097|FG001|STARTED|Overall Study||10
3334451|NCT03334175|4066096|FG000|COMPLETED|Overall Study||8
3334452|NCT03334175|4066097|FG001|COMPLETED|Overall Study||9
3334453|NCT03334175|4066096|FG000|NOT COMPLETED|Overall Study||0
3334454|NCT03334175|4066097|FG001|NOT COMPLETED|Overall Study||1
3334455|NCT03334188|4066105|FG000|STARTED|Overall Study||153
3334456|NCT03334188|4066106|FG001|STARTED|Overall Study||153
3334457|NCT03334188|4066105|FG000|COMPLETED|Overall Study||145
3334458|NCT03334188|4066106|FG001|COMPLETED|Overall Study||145
3334459|NCT03334188|4066105|FG000|NOT COMPLETED|Overall Study||8
3334460|NCT03334188|4066106|FG001|NOT COMPLETED|Overall Study||8
3334461|NCT03334214|4066115|FG000|STARTED|Overall Study||15
3334462|NCT03334214|4066116|FG001|STARTED|Overall Study||29
3334463|NCT03334214|4066115|FG000|COMPLETED|Overall Study||14
3334464|NCT03334214|4066116|FG001|COMPLETED|Overall Study||27
3334465|NCT03334214|4066115|FG000|NOT COMPLETED|Overall Study||1
3334466|NCT03334214|4066116|FG001|NOT COMPLETED|Overall Study||2
3334467|NCT03334396|4066131|FG000|STARTED|Overall Study||249
3334468|NCT03334396|4066132|FG001|STARTED|Overall Study||127
3334469|NCT03334396|4066133|FG002|STARTED|Overall Study||123
3334470|NCT03334396|4066134|FG003|STARTED|Overall Study||125
3334471|NCT03334396|4066135|FG004|STARTED|Overall Study||15
3334472|NCT03334396|4066136|FG005|STARTED|Overall Study||5
3334473|NCT03334396|4066137|FG006|STARTED|Overall Study||8
3334474|NCT03334396|4066138|FG007|STARTED|Overall Study||8
3334475|NCT03334396|4066131|FG000|Received at Least One Dose of Study Drug|Overall Study||249
3334476|NCT03334396|4066132|FG001|Received at Least One Dose of Study Drug|Overall Study||127
3334477|NCT03334396|4066133|FG002|Received at Least One Dose of Study Drug|Overall Study||123
3334478|NCT03334396|4066134|FG003|Received at Least One Dose of Study Drug|Overall Study||125
3334479|NCT03334396|4066135|FG004|Received at Least One Dose of Study Drug|Overall Study||15
3334480|NCT03334396|4066136|FG005|Received at Least One Dose of Study Drug|Overall Study||5
3334481|NCT03334396|4066137|FG006|Received at Least One Dose of Study Drug|Overall Study||8
3334482|NCT03334396|4066138|FG007|Received at Least One Dose of Study Drug|Overall Study||8
3334483|NCT03334396|4066131|FG000|COMPLETED|Overall Study||226
3334484|NCT03334396|4066132|FG001|COMPLETED|Overall Study||116
3334485|NCT03334396|4066133|FG002|COMPLETED|Overall Study||113
3334486|NCT03334396|4066134|FG003|COMPLETED|Overall Study||120
3334487|NCT03334396|4066135|FG004|COMPLETED|Overall Study||12
3334488|NCT03334396|4066136|FG005|COMPLETED|Overall Study||4
3334489|NCT03334396|4066137|FG006|COMPLETED|Overall Study||5
3334490|NCT03334396|4066138|FG007|COMPLETED|Overall Study||7
3334491|NCT03334396|4066131|FG000|NOT COMPLETED|Overall Study||23
3334492|NCT03334396|4066132|FG001|NOT COMPLETED|Overall Study||11
3334493|NCT03334396|4066133|FG002|NOT COMPLETED|Overall Study||10
3334494|NCT03334396|4066134|FG003|NOT COMPLETED|Overall Study||5
3334495|NCT03334396|4066135|FG004|NOT COMPLETED|Overall Study||3
3334496|NCT03334396|4066136|FG005|NOT COMPLETED|Overall Study||1
3334497|NCT03334396|4066137|FG006|NOT COMPLETED|Overall Study||3
3334498|NCT03334396|4066138|FG007|NOT COMPLETED|Overall Study||1
3334499|NCT03334422|4066159|FG000|STARTED|Overall Study||244
3334500|NCT03334422|4066160|FG001|STARTED|Overall Study||125
3334501|NCT03334422|4066161|FG002|STARTED|Overall Study||123
3334502|NCT03334422|4066162|FG003|STARTED|Overall Study||123
3334503|NCT03334422|4066159|FG000|Received at Least One Dose of Study Drug|Overall Study||244
3334504|NCT03334422|4066160|FG001|Received at Least One Dose of Study Drug|Overall Study||124
3334505|NCT03334422|4066161|FG002|Received at Least One Dose of Study Drug|Overall Study||123
3334506|NCT03334422|4066162|FG003|Received at Least One Dose of Study Drug|Overall Study||123
3334507|NCT03334422|4066159|FG000|COMPLETED|Overall Study||225
3334508|NCT03334422|4066160|FG001|COMPLETED|Overall Study||115
3334509|NCT03334422|4066161|FG002|COMPLETED|Overall Study||113
3334510|NCT03334422|4066162|FG003|COMPLETED|Overall Study||117
3334511|NCT03334422|4066159|FG000|NOT COMPLETED|Overall Study||19
3334512|NCT03334422|4066160|FG001|NOT COMPLETED|Overall Study||10
3334513|NCT03334422|4066161|FG002|NOT COMPLETED|Overall Study||10
3334514|NCT03334422|4066162|FG003|NOT COMPLETED|Overall Study||6
3334515|NCT03334448|4066177|FG000|STARTED|Period 1||12
3334516|NCT03334448|4066178|FG001|STARTED|Period 1||12
3334517|NCT03334448|4066179|FG002|STARTED|Period 1||13
3334518|NCT03334448|4066180|FG003|STARTED|Period 1||12
3334519|NCT03334448|4066177|FG000|Received at Least 1 Dose of Study Drug|Period 1||12
3334520|NCT03334448|4066178|FG001|Received at Least 1 Dose of Study Drug|Period 1||12
3334521|NCT03334448|4066179|FG002|Received at Least 1 Dose of Study Drug|Period 1||13
3334522|NCT03334448|4066180|FG003|Received at Least 1 Dose of Study Drug|Period 1||12
3334523|NCT03334448|4066177|FG000|COMPLETED|Period 1||12
3334524|NCT03334448|4066178|FG001|COMPLETED|Period 1||12
3334525|NCT03334448|4066179|FG002|COMPLETED|Period 1||13
3334526|NCT03334448|4066180|FG003|COMPLETED|Period 1||12
3334527|NCT03334448|4066177|FG000|NOT COMPLETED|Period 1||0
3334528|NCT03334448|4066178|FG001|NOT COMPLETED|Period 1||0
3334529|NCT03334448|4066179|FG002|NOT COMPLETED|Period 1||0
3334530|NCT03334448|4066180|FG003|NOT COMPLETED|Period 1||0
3334531|NCT03334448|4066177|FG000|STARTED|Washout||12
3334532|NCT03334448|4066178|FG001|STARTED|Washout||12
3334533|NCT03334448|4066179|FG002|STARTED|Washout||13
3334534|NCT03334448|4066180|FG003|STARTED|Washout||12
3334535|NCT03334448|4066177|FG000|COMPLETED|Washout||12
3334536|NCT03334448|4066178|FG001|COMPLETED|Washout||12
3334537|NCT03334448|4066179|FG002|COMPLETED|Washout||13
3334538|NCT03334448|4066180|FG003|COMPLETED|Washout||12
3334539|NCT03334448|4066177|FG000|NOT COMPLETED|Washout||0
3334540|NCT03334448|4066178|FG001|NOT COMPLETED|Washout||0
3334541|NCT03334448|4066179|FG002|NOT COMPLETED|Washout||0
3334542|NCT03334448|4066180|FG003|NOT COMPLETED|Washout||0
3334543|NCT03334448|4066177|FG000|STARTED|Period 2||12
3334544|NCT03334448|4066178|FG001|STARTED|Period 2||12
3334545|NCT03334448|4066179|FG002|STARTED|Period 2||13
3334546|NCT03334448|4066180|FG003|STARTED|Period 2||12
3334547|NCT03334448|4066177|FG000|Received at Least 1 Dose of Study Drug|Period 2||12
3334548|NCT03334448|4066178|FG001|Received at Least 1 Dose of Study Drug|Period 2||12
3334549|NCT03334448|4066179|FG002|Received at Least 1 Dose of Study Drug|Period 2||13
3334550|NCT03334448|4066180|FG003|Received at Least 1 Dose of Study Drug|Period 2||12
3334551|NCT03334448|4066177|FG000|COMPLETED|Period 2||12
3334552|NCT03334448|4066178|FG001|COMPLETED|Period 2||12
3334553|NCT03334448|4066179|FG002|COMPLETED|Period 2||13
3334554|NCT03334448|4066180|FG003|COMPLETED|Period 2||12
3334555|NCT03334448|4066177|FG000|NOT COMPLETED|Period 2||0
3334556|NCT03334448|4066178|FG001|NOT COMPLETED|Period 2||0
3334557|NCT03334448|4066179|FG002|NOT COMPLETED|Period 2||0
3334558|NCT03334448|4066180|FG003|NOT COMPLETED|Period 2||0
3334559|NCT03334448|4066177|FG000|STARTED|Washout||12
3334560|NCT03334448|4066178|FG001|STARTED|Washout||12
3334561|NCT03334448|4066179|FG002|STARTED|Washout||13
3334562|NCT03334448|4066180|FG003|STARTED|Washout||12
3334563|NCT03334448|4066177|FG000|COMPLETED|Washout||12
3334564|NCT03334448|4066178|FG001|COMPLETED|Washout||11
3334565|NCT03334448|4066179|FG002|COMPLETED|Washout||13
3334566|NCT03334448|4066180|FG003|COMPLETED|Washout||12
3334567|NCT03334448|4066177|FG000|NOT COMPLETED|Washout||0
3334568|NCT03334448|4066178|FG001|NOT COMPLETED|Washout||1
3334569|NCT03334448|4066179|FG002|NOT COMPLETED|Washout||0
3334570|NCT03334448|4066180|FG003|NOT COMPLETED|Washout||0
3334571|NCT03334448|4066177|FG000|STARTED|Period 3||12
3334572|NCT03334448|4066178|FG001|STARTED|Period 3||11
3334573|NCT03334448|4066179|FG002|STARTED|Period 3||13
3334574|NCT03334448|4066180|FG003|STARTED|Period 3||12
3334575|NCT03334448|4066177|FG000|Received at Least 1 Dose of Study Drug|Period 3||12
3334576|NCT03334448|4066178|FG001|Received at Least 1 Dose of Study Drug|Period 3||11
3334577|NCT03334448|4066179|FG002|Received at Least 1 Dose of Study Drug|Period 3||13
3334578|NCT03334448|4066180|FG003|Received at Least 1 Dose of Study Drug|Period 3||12
3334579|NCT03334448|4066177|FG000|COMPLETED|Period 3||12
3334580|NCT03334448|4066178|FG001|COMPLETED|Period 3||11
3334581|NCT03334448|4066179|FG002|COMPLETED|Period 3||13
3334582|NCT03334448|4066180|FG003|COMPLETED|Period 3||12
3334583|NCT03334448|4066177|FG000|NOT COMPLETED|Period 3||0
3334584|NCT03334448|4066178|FG001|NOT COMPLETED|Period 3||0
3334585|NCT03334448|4066179|FG002|NOT COMPLETED|Period 3||0
3334586|NCT03334448|4066180|FG003|NOT COMPLETED|Period 3||0
3334587|NCT03334448|4066177|FG000|STARTED|Washout||12
3334588|NCT03334448|4066178|FG001|STARTED|Washout||11
3334589|NCT03334448|4066179|FG002|STARTED|Washout||13
3334590|NCT03334448|4066180|FG003|STARTED|Washout||12
3334591|NCT03334448|4066177|FG000|COMPLETED|Washout||12
3334592|NCT03334448|4066178|FG001|COMPLETED|Washout||11
3334593|NCT03334448|4066179|FG002|COMPLETED|Washout||13
3334594|NCT03334448|4066180|FG003|COMPLETED|Washout||11
3334595|NCT03334448|4066177|FG000|NOT COMPLETED|Washout||0
3334596|NCT03334448|4066178|FG001|NOT COMPLETED|Washout||0
3334597|NCT03334448|4066179|FG002|NOT COMPLETED|Washout||0
3334598|NCT03334448|4066180|FG003|NOT COMPLETED|Washout||1
3334599|NCT03334448|4066177|FG000|STARTED|Period 4||12
3334600|NCT03334448|4066178|FG001|STARTED|Period 4||11
3334601|NCT03334448|4066179|FG002|STARTED|Period 4||13
3334602|NCT03334448|4066180|FG003|STARTED|Period 4||11
3334603|NCT03334448|4066177|FG000|Received at Least 1 Dose of Study Drug|Period 4||12
3334604|NCT03334448|4066178|FG001|Received at Least 1 Dose of Study Drug|Period 4||11
3334605|NCT03334448|4066179|FG002|Received at Least 1 Dose of Study Drug|Period 4||13
3334606|NCT03334448|4066180|FG003|Received at Least 1 Dose of Study Drug|Period 4||11
3334607|NCT03334448|4066177|FG000|COMPLETED|Period 4||12
3334608|NCT03334448|4066178|FG001|COMPLETED|Period 4||11
3334609|NCT03334448|4066179|FG002|COMPLETED|Period 4||13
3334610|NCT03334448|4066180|FG003|COMPLETED|Period 4||11
3334611|NCT03334448|4066177|FG000|NOT COMPLETED|Period 4||0
3334612|NCT03334448|4066178|FG001|NOT COMPLETED|Period 4||0
3334613|NCT03334448|4066179|FG002|NOT COMPLETED|Period 4||0
3334614|NCT03334448|4066180|FG003|NOT COMPLETED|Period 4||0
3334615|NCT03334630|4066188|FG000|STARTED|Overall Study||239
3334616|NCT03334630|4066189|FG001|STARTED|Overall Study||243
3334617|NCT03334630|4066188|FG000|COMPLETED|Overall Study||225
3334618|NCT03334630|4066189|FG001|COMPLETED|Overall Study||230
3334619|NCT03334630|4066188|FG000|NOT COMPLETED|Overall Study||14
3334620|NCT03334630|4066189|FG001|NOT COMPLETED|Overall Study||13
3334621|NCT03334695|4066197|FG000|STARTED|Overall Study||31
3334622|NCT03334695|4066198|FG001|STARTED|Overall Study||32
3334623|NCT03334695|4066197|FG000|COMPLETED|Overall Study||27
3334624|NCT03334695|4066198|FG001|COMPLETED|Overall Study||26
3334625|NCT03334695|4066197|FG000|NOT COMPLETED|Overall Study||4
3334626|NCT03334695|4066198|FG001|NOT COMPLETED|Overall Study||6
3334627|NCT03334721|4066208|FG000|STARTED|Overall Study||12
3334628|NCT03334721|4066209|FG001|STARTED|Overall Study||11
3334629|NCT03334721|4066208|FG000|COMPLETED|Overall Study||10
3334630|NCT03334721|4066209|FG001|COMPLETED|Overall Study||11
3334631|NCT03334721|4066208|FG000|NOT COMPLETED|Overall Study||2
3334632|NCT03334721|4066209|FG001|NOT COMPLETED|Overall Study||0
3334633|NCT03334734|4066219|FG000|STARTED|Overall Study||4
3334634|NCT03334734|4066220|FG001|STARTED|Overall Study||4
3334635|NCT03334734|4066221|FG002|STARTED|Overall Study||7
3334636|NCT03334734|4066222|FG003|STARTED|Overall Study||1
3334637|NCT03334734|4066219|FG000|COMPLETED|Overall Study||4
3334638|NCT03334734|4066220|FG001|COMPLETED|Overall Study||4
3334639|NCT03334734|4066221|FG002|COMPLETED|Overall Study||5
3334640|NCT03334734|4066222|FG003|COMPLETED|Overall Study||1
3334641|NCT03334734|4066219|FG000|NOT COMPLETED|Overall Study||0
3334642|NCT03334734|4066220|FG001|NOT COMPLETED|Overall Study||0
3334643|NCT03334734|4066221|FG002|NOT COMPLETED|Overall Study||2
3334644|NCT03334734|4066222|FG003|NOT COMPLETED|Overall Study||0
3334645|NCT03334747|4066241|FG000|STARTED|Treatment Phase||10
3334646|NCT03334747|4066242|FG001|STARTED|Treatment Phase||10
3334647|NCT03334747|4066243|FG002|STARTED|Treatment Phase||12
3334648|NCT03334747|4066244|FG003|STARTED|Treatment Phase||20
3334649|NCT03334747|4066245|FG004|STARTED|Treatment Phase||22
3334650|NCT03334747|4066246|FG005|STARTED|Treatment Phase||20
3334651|NCT03334747|4066247|FG006|STARTED|Treatment Phase||21
3334652|NCT03334747|4066248|FG007|STARTED|Treatment Phase||22
3334653|NCT03334747|4066249|FG008|STARTED|Treatment Phase||51
3334654|NCT03334747|4066241|FG000|COMPLETED|Treatment Phase||9
3334655|NCT03334747|4066242|FG001|COMPLETED|Treatment Phase||10
3334656|NCT03334747|4066243|FG002|COMPLETED|Treatment Phase||12
3334657|NCT03334747|4066244|FG003|COMPLETED|Treatment Phase||20
3334658|NCT03334747|4066245|FG004|COMPLETED|Treatment Phase||21
3334659|NCT03334747|4066246|FG005|COMPLETED|Treatment Phase||19
3334660|NCT03334747|4066247|FG006|COMPLETED|Treatment Phase||21
3334661|NCT03334747|4066248|FG007|COMPLETED|Treatment Phase||22
3334662|NCT03334747|4066249|FG008|COMPLETED|Treatment Phase||51
3334663|NCT03334747|4066241|FG000|NOT COMPLETED|Treatment Phase||1
3334664|NCT03334747|4066242|FG001|NOT COMPLETED|Treatment Phase||0
3334665|NCT03334747|4066243|FG002|NOT COMPLETED|Treatment Phase||0
3334666|NCT03334747|4066244|FG003|NOT COMPLETED|Treatment Phase||0
3334667|NCT03334747|4066245|FG004|NOT COMPLETED|Treatment Phase||1
3334668|NCT03334747|4066246|FG005|NOT COMPLETED|Treatment Phase||1
3334669|NCT03334747|4066247|FG006|NOT COMPLETED|Treatment Phase||0
3334670|NCT03334747|4066248|FG007|NOT COMPLETED|Treatment Phase||0
3334671|NCT03334747|4066249|FG008|NOT COMPLETED|Treatment Phase||0
3334672|NCT03334747|4066241|FG000|STARTED|Follow-Up Phase||9
3334673|NCT03334747|4066242|FG001|STARTED|Follow-Up Phase||10
3334674|NCT03334747|4066243|FG002|STARTED|Follow-Up Phase||12
3334675|NCT03334747|4066244|FG003|STARTED|Follow-Up Phase||20
3334676|NCT03334747|4066245|FG004|STARTED|Follow-Up Phase||21
3334677|NCT03334747|4066246|FG005|STARTED|Follow-Up Phase||19
3334678|NCT03334747|4066247|FG006|STARTED|Follow-Up Phase||21
3334679|NCT03334747|4066248|FG007|STARTED|Follow-Up Phase||22
3334680|NCT03334747|4066249|FG008|STARTED|Follow-Up Phase||51
3334681|NCT03334747|4066241|FG000|COMPLETED|Follow-Up Phase||9
3334682|NCT03334747|4066242|FG001|COMPLETED|Follow-Up Phase||10
3334683|NCT03334747|4066243|FG002|COMPLETED|Follow-Up Phase||12
3334684|NCT03334747|4066244|FG003|COMPLETED|Follow-Up Phase||20
3334685|NCT03334747|4066245|FG004|COMPLETED|Follow-Up Phase||21
3334686|NCT03334747|4066246|FG005|COMPLETED|Follow-Up Phase||19
3334687|NCT03334747|4066247|FG006|COMPLETED|Follow-Up Phase||20
3334688|NCT03334747|4066248|FG007|COMPLETED|Follow-Up Phase||22
3334689|NCT03334747|4066249|FG008|COMPLETED|Follow-Up Phase||50
3334690|NCT03334747|4066241|FG000|NOT COMPLETED|Follow-Up Phase||0
3334691|NCT03334747|4066242|FG001|NOT COMPLETED|Follow-Up Phase||0
3334692|NCT03334747|4066243|FG002|NOT COMPLETED|Follow-Up Phase||0
3334693|NCT03334747|4066244|FG003|NOT COMPLETED|Follow-Up Phase||0
3334694|NCT03334747|4066245|FG004|NOT COMPLETED|Follow-Up Phase||0
3334695|NCT03334747|4066246|FG005|NOT COMPLETED|Follow-Up Phase||0
3334696|NCT03334747|4066247|FG006|NOT COMPLETED|Follow-Up Phase||1
3334697|NCT03334747|4066248|FG007|NOT COMPLETED|Follow-Up Phase||0
3334698|NCT03334747|4066249|FG008|NOT COMPLETED|Follow-Up Phase||1
3334699|NCT03334812|4066271|FG000|STARTED|Overall Study||9
3334700|NCT03334812|4066272|FG001|STARTED|Overall Study||5
3334701|NCT03334812|4066273|FG002|STARTED|Overall Study||0
3334702|NCT03334812|4066274|FG003|STARTED|Overall Study||0
3334703|NCT03334812|4066271|FG000|COMPLETED|Overall Study||9
3334704|NCT03334812|4066272|FG001|COMPLETED|Overall Study||5
3334705|NCT03334812|4066273|FG002|COMPLETED|Overall Study||0
3334706|NCT03334812|4066274|FG003|COMPLETED|Overall Study||0
3334707|NCT03334812|4066271|FG000|NOT COMPLETED|Overall Study||0
3334708|NCT03334812|4066272|FG001|NOT COMPLETED|Overall Study||0
3334709|NCT03334812|4066273|FG002|NOT COMPLETED|Overall Study||0
3334710|NCT03334812|4066274|FG003|NOT COMPLETED|Overall Study||0
3334711|NCT03334825|4066282|FG000|STARTED|Overall Study||119
3334712|NCT03334825|4066283|FG001|STARTED|Overall Study||117
3334713|NCT03334825|4066282|FG000|COMPLETED|Overall Study||112
3176912|NCT01968070|3904649|FG003|STARTED|Period 2|2 participants were added to replace the 2 participants who discontinued the period 1.|4
3176913|NCT01968070|3904650|FG004|STARTED|Period 2||3
3176914|NCT01968070|3904651|FG005|STARTED|Period 2||4
3334714|NCT03334825|4066283|FG001|COMPLETED|Overall Study||113
3334715|NCT03334825|4066282|FG000|NOT COMPLETED|Overall Study||7
3334716|NCT03334825|4066283|FG001|NOT COMPLETED|Overall Study||4
3334717|NCT03334903|4066291|FG000|STARTED|Overall Study||39
3334718|NCT03334903|4066292|FG001|STARTED|Overall Study||38
3334719|NCT03334903|4066291|FG000|COMPLETED|Overall Study||35
3334720|NCT03334903|4066292|FG001|COMPLETED|Overall Study||33
3334721|NCT03334903|4066291|FG000|NOT COMPLETED|Overall Study||4
3334722|NCT03334903|4066292|FG001|NOT COMPLETED|Overall Study||5
3334723|NCT03335150|4066300|FG000|STARTED|Overall Study||55
3334724|NCT03335150|4066301|FG001|STARTED|Overall Study||55
3334725|NCT03335150|4066300|FG000|Enrolled + Assigned Group|Overall Study||54
3334726|NCT03335150|4066301|FG001|Enrolled + Assigned Group|Overall Study||55
3334727|NCT03335150|4066300|FG000|PRE Testing Session|Overall Study||53
3334728|NCT03335150|4066301|FG001|PRE Testing Session|Overall Study||55
3334729|NCT03335150|4066300|FG000|Commenced Group|Overall Study||47
3334730|NCT03335150|4066301|FG001|Commenced Group|Overall Study||52
3334731|NCT03335150|4066300|FG000|POST Testing Session|Overall Study||45
3334732|NCT03335150|4066301|FG001|POST Testing Session|Overall Study||50
3334733|NCT03335150|4066300|FG000|COMPLETED|Overall Study||45
3334734|NCT03335150|4066301|FG001|COMPLETED|Overall Study||50
3334735|NCT03335150|4066300|FG000|NOT COMPLETED|Overall Study||10
3334736|NCT03335150|4066301|FG001|NOT COMPLETED|Overall Study||5
3334737|NCT03335254|4066327|FG000|STARTED|Period 1||9
3334738|NCT03335254|4066328|FG001|STARTED|Period 1||0
3334739|NCT03335254|4066329|FG002|STARTED|Period 1||0
3334740|NCT03335254|4066330|FG003|STARTED|Period 1||0
3334741|NCT03335254|4066331|FG004|STARTED|Period 1||0
3334742|NCT03335254|4066332|FG005|STARTED|Period 1||0
3334743|NCT03335254|4066333|FG006|STARTED|Period 1||0
3334744|NCT03335254|4066334|FG007|STARTED|Period 1||0
3334745|NCT03335254|4066335|FG008|STARTED|Period 1||0
3334746|NCT03335254|4066336|FG009|STARTED|Period 1||0
3334747|NCT03335254|4066337|FG010|STARTED|Period 1||0
3334748|NCT03335254|4066338|FG011|STARTED|Period 1||0
3334749|NCT03335254|4066339|FG012|STARTED|Period 1||0
3334750|NCT03335254|4066340|FG013|STARTED|Period 1||0
3334751|NCT03335254|4066341|FG014|STARTED|Period 1||0
3334752|NCT03335254|4066342|FG015|STARTED|Period 1||0
3334753|NCT03335254|4066343|FG016|STARTED|Period 1||0
3334754|NCT03335254|4066344|FG017|STARTED|Period 1||0
3334755|NCT03335254|4066345|FG018|STARTED|Period 1||0
3334756|NCT03335254|4066346|FG019|STARTED|Period 1||0
3334757|NCT03335254|4066327|FG000|COMPLETED|Period 1||9
3334758|NCT03335254|4066328|FG001|COMPLETED|Period 1||0
3334759|NCT03335254|4066329|FG002|COMPLETED|Period 1||0
3334760|NCT03335254|4066330|FG003|COMPLETED|Period 1||0
3334761|NCT03335254|4066331|FG004|COMPLETED|Period 1||0
3334762|NCT03335254|4066332|FG005|COMPLETED|Period 1||0
3334763|NCT03335254|4066333|FG006|COMPLETED|Period 1||0
3334764|NCT03335254|4066334|FG007|COMPLETED|Period 1||0
3334765|NCT03335254|4066335|FG008|COMPLETED|Period 1||0
3334766|NCT03335254|4066336|FG009|COMPLETED|Period 1||0
3334767|NCT03335254|4066337|FG010|COMPLETED|Period 1||0
3334768|NCT03335254|4066338|FG011|COMPLETED|Period 1||0
3334769|NCT03335254|4066339|FG012|COMPLETED|Period 1||0
3334770|NCT03335254|4066340|FG013|COMPLETED|Period 1||0
3334771|NCT03335254|4066341|FG014|COMPLETED|Period 1||0
3334772|NCT03335254|4066342|FG015|COMPLETED|Period 1||0
3334773|NCT03335254|4066343|FG016|COMPLETED|Period 1||0
3334774|NCT03335254|4066344|FG017|COMPLETED|Period 1||0
3334775|NCT03335254|4066345|FG018|COMPLETED|Period 1||0
3334776|NCT03335254|4066346|FG019|COMPLETED|Period 1||0
3334777|NCT03335254|4066327|FG000|NOT COMPLETED|Period 1||0
3334778|NCT03335254|4066328|FG001|NOT COMPLETED|Period 1||0
3334779|NCT03335254|4066329|FG002|NOT COMPLETED|Period 1||0
3334780|NCT03335254|4066330|FG003|NOT COMPLETED|Period 1||0
3334781|NCT03335254|4066331|FG004|NOT COMPLETED|Period 1||0
3334782|NCT03335254|4066332|FG005|NOT COMPLETED|Period 1||0
3334783|NCT03335254|4066333|FG006|NOT COMPLETED|Period 1||0
3334784|NCT03335254|4066334|FG007|NOT COMPLETED|Period 1||0
3334785|NCT03335254|4066335|FG008|NOT COMPLETED|Period 1||0
3334786|NCT03335254|4066336|FG009|NOT COMPLETED|Period 1||0
3334787|NCT03335254|4066337|FG010|NOT COMPLETED|Period 1||0
3334788|NCT03335254|4066338|FG011|NOT COMPLETED|Period 1||0
3334789|NCT03335254|4066339|FG012|NOT COMPLETED|Period 1||0
3334790|NCT03335254|4066340|FG013|NOT COMPLETED|Period 1||0
3334791|NCT03335254|4066341|FG014|NOT COMPLETED|Period 1||0
3334792|NCT03335254|4066342|FG015|NOT COMPLETED|Period 1||0
3334793|NCT03335254|4066343|FG016|NOT COMPLETED|Period 1||0
3334794|NCT03335254|4066344|FG017|NOT COMPLETED|Period 1||0
3334795|NCT03335254|4066345|FG018|NOT COMPLETED|Period 1||0
3334796|NCT03335254|4066346|FG019|NOT COMPLETED|Period 1||0
3334797|NCT03335254|4066327|FG000|STARTED|Period 2, Day 1-15||9
3334798|NCT03335254|4066328|FG001|STARTED|Period 2, Day 1-15||0
3334799|NCT03335254|4066329|FG002|STARTED|Period 2, Day 1-15||0
3334800|NCT03335254|4066330|FG003|STARTED|Period 2, Day 1-15||0
3334801|NCT03335254|4066331|FG004|STARTED|Period 2, Day 1-15||0
3334802|NCT03335254|4066332|FG005|STARTED|Period 2, Day 1-15||0
3334803|NCT03335254|4066333|FG006|STARTED|Period 2, Day 1-15||0
3334804|NCT03335254|4066334|FG007|STARTED|Period 2, Day 1-15||0
3334805|NCT03335254|4066335|FG008|STARTED|Period 2, Day 1-15||0
3334806|NCT03335254|4066336|FG009|STARTED|Period 2, Day 1-15||0
3334807|NCT03335254|4066337|FG010|STARTED|Period 2, Day 1-15||0
3334808|NCT03335254|4066338|FG011|STARTED|Period 2, Day 1-15||0
3334809|NCT03335254|4066339|FG012|STARTED|Period 2, Day 1-15||0
3334810|NCT03335254|4066340|FG013|STARTED|Period 2, Day 1-15||0
3334811|NCT03335254|4066341|FG014|STARTED|Period 2, Day 1-15||0
3334812|NCT03335254|4066342|FG015|STARTED|Period 2, Day 1-15||0
3334813|NCT03335254|4066343|FG016|STARTED|Period 2, Day 1-15||0
3334814|NCT03335254|4066344|FG017|STARTED|Period 2, Day 1-15||0
3334815|NCT03335254|4066345|FG018|STARTED|Period 2, Day 1-15||0
3334816|NCT03335254|4066346|FG019|STARTED|Period 2, Day 1-15||0
3334817|NCT03335254|4066327|FG000|COMPLETED|Period 2, Day 1-15||9
3334818|NCT03335254|4066328|FG001|COMPLETED|Period 2, Day 1-15||0
3334819|NCT03335254|4066329|FG002|COMPLETED|Period 2, Day 1-15||0
3334820|NCT03335254|4066330|FG003|COMPLETED|Period 2, Day 1-15||0
3334821|NCT03335254|4066331|FG004|COMPLETED|Period 2, Day 1-15||0
3334822|NCT03335254|4066332|FG005|COMPLETED|Period 2, Day 1-15||0
3334823|NCT03335254|4066333|FG006|COMPLETED|Period 2, Day 1-15||0
3334824|NCT03335254|4066334|FG007|COMPLETED|Period 2, Day 1-15||0
3334825|NCT03335254|4066335|FG008|COMPLETED|Period 2, Day 1-15||0
3334826|NCT03335254|4066336|FG009|COMPLETED|Period 2, Day 1-15||0
3334827|NCT03335254|4066337|FG010|COMPLETED|Period 2, Day 1-15||0
3334828|NCT03335254|4066338|FG011|COMPLETED|Period 2, Day 1-15||0
3334829|NCT03335254|4066339|FG012|COMPLETED|Period 2, Day 1-15||0
3334830|NCT03335254|4066340|FG013|COMPLETED|Period 2, Day 1-15||0
3334831|NCT03335254|4066341|FG014|COMPLETED|Period 2, Day 1-15||0
3334832|NCT03335254|4066342|FG015|COMPLETED|Period 2, Day 1-15||0
3334833|NCT03335254|4066343|FG016|COMPLETED|Period 2, Day 1-15||0
3334834|NCT03335254|4066344|FG017|COMPLETED|Period 2, Day 1-15||0
3334835|NCT03335254|4066345|FG018|COMPLETED|Period 2, Day 1-15||0
3334836|NCT03335254|4066346|FG019|COMPLETED|Period 2, Day 1-15||0
3334837|NCT03335254|4066327|FG000|NOT COMPLETED|Period 2, Day 1-15||0
3334838|NCT03335254|4066328|FG001|NOT COMPLETED|Period 2, Day 1-15||0
3334839|NCT03335254|4066329|FG002|NOT COMPLETED|Period 2, Day 1-15||0
3334840|NCT03335254|4066330|FG003|NOT COMPLETED|Period 2, Day 1-15||0
3334841|NCT03335254|4066331|FG004|NOT COMPLETED|Period 2, Day 1-15||0
3334842|NCT03335254|4066332|FG005|NOT COMPLETED|Period 2, Day 1-15||0
3334843|NCT03335254|4066333|FG006|NOT COMPLETED|Period 2, Day 1-15||0
3334844|NCT03335254|4066334|FG007|NOT COMPLETED|Period 2, Day 1-15||0
3334845|NCT03335254|4066335|FG008|NOT COMPLETED|Period 2, Day 1-15||0
3334846|NCT03335254|4066336|FG009|NOT COMPLETED|Period 2, Day 1-15||0
3334847|NCT03335254|4066337|FG010|NOT COMPLETED|Period 2, Day 1-15||0
3334848|NCT03335254|4066338|FG011|NOT COMPLETED|Period 2, Day 1-15||0
3334849|NCT03335254|4066339|FG012|NOT COMPLETED|Period 2, Day 1-15||0
3334850|NCT03335254|4066340|FG013|NOT COMPLETED|Period 2, Day 1-15||0
3334851|NCT03335254|4066341|FG014|NOT COMPLETED|Period 2, Day 1-15||0
3334852|NCT03335254|4066342|FG015|NOT COMPLETED|Period 2, Day 1-15||0
3334853|NCT03335254|4066343|FG016|NOT COMPLETED|Period 2, Day 1-15||0
3334854|NCT03335254|4066344|FG017|NOT COMPLETED|Period 2, Day 1-15||0
3334855|NCT03335254|4066345|FG018|NOT COMPLETED|Period 2, Day 1-15||0
3334856|NCT03335254|4066346|FG019|NOT COMPLETED|Period 2, Day 1-15||0
3334857|NCT03335254|4066327|FG000|STARTED|Period 3, Day 16-25||9
3334858|NCT03335254|4066328|FG001|STARTED|Period 3, Day 16-25||0
3334859|NCT03335254|4066329|FG002|STARTED|Period 3, Day 16-25||0
3334860|NCT03335254|4066330|FG003|STARTED|Period 3, Day 16-25||0
3334861|NCT03335254|4066331|FG004|STARTED|Period 3, Day 16-25||0
3334862|NCT03335254|4066332|FG005|STARTED|Period 3, Day 16-25||0
3334863|NCT03335254|4066333|FG006|STARTED|Period 3, Day 16-25||0
3334864|NCT03335254|4066334|FG007|STARTED|Period 3, Day 16-25||0
3334865|NCT03335254|4066335|FG008|STARTED|Period 3, Day 16-25||0
3334866|NCT03335254|4066336|FG009|STARTED|Period 3, Day 16-25||0
3334867|NCT03335254|4066337|FG010|STARTED|Period 3, Day 16-25||0
3334868|NCT03335254|4066338|FG011|STARTED|Period 3, Day 16-25||0
3334869|NCT03335254|4066339|FG012|STARTED|Period 3, Day 16-25||0
3334870|NCT03335254|4066340|FG013|STARTED|Period 3, Day 16-25||0
3334871|NCT03335254|4066341|FG014|STARTED|Period 3, Day 16-25||0
3334872|NCT03335254|4066342|FG015|STARTED|Period 3, Day 16-25||0
3334873|NCT03335254|4066343|FG016|STARTED|Period 3, Day 16-25||0
3334874|NCT03335254|4066344|FG017|STARTED|Period 3, Day 16-25||0
3334875|NCT03335254|4066345|FG018|STARTED|Period 3, Day 16-25||0
3334876|NCT03335254|4066346|FG019|STARTED|Period 3, Day 16-25||0
3334877|NCT03335254|4066327|FG000|COMPLETED|Period 3, Day 16-25||9
3334878|NCT03335254|4066328|FG001|COMPLETED|Period 3, Day 16-25||0
3334879|NCT03335254|4066329|FG002|COMPLETED|Period 3, Day 16-25||0
3334880|NCT03335254|4066330|FG003|COMPLETED|Period 3, Day 16-25||0
3334881|NCT03335254|4066331|FG004|COMPLETED|Period 3, Day 16-25||0
3334882|NCT03335254|4066332|FG005|COMPLETED|Period 3, Day 16-25||0
3334883|NCT03335254|4066333|FG006|COMPLETED|Period 3, Day 16-25||0
3334884|NCT03335254|4066334|FG007|COMPLETED|Period 3, Day 16-25||0
3334885|NCT03335254|4066335|FG008|COMPLETED|Period 3, Day 16-25||0
3334886|NCT03335254|4066336|FG009|COMPLETED|Period 3, Day 16-25||0
3334887|NCT03335254|4066337|FG010|COMPLETED|Period 3, Day 16-25||0
3334888|NCT03335254|4066338|FG011|COMPLETED|Period 3, Day 16-25||0
3334889|NCT03335254|4066339|FG012|COMPLETED|Period 3, Day 16-25||0
3334890|NCT03335254|4066340|FG013|COMPLETED|Period 3, Day 16-25||0
3334891|NCT03335254|4066341|FG014|COMPLETED|Period 3, Day 16-25||0
3334892|NCT03335254|4066342|FG015|COMPLETED|Period 3, Day 16-25||0
3334893|NCT03335254|4066343|FG016|COMPLETED|Period 3, Day 16-25||0
3334894|NCT03335254|4066344|FG017|COMPLETED|Period 3, Day 16-25||0
3334895|NCT03335254|4066345|FG018|COMPLETED|Period 3, Day 16-25||0
3334896|NCT03335254|4066346|FG019|COMPLETED|Period 3, Day 16-25||0
3334897|NCT03335254|4066327|FG000|NOT COMPLETED|Period 3, Day 16-25||0
3334898|NCT03335254|4066328|FG001|NOT COMPLETED|Period 3, Day 16-25||0
3334899|NCT03335254|4066329|FG002|NOT COMPLETED|Period 3, Day 16-25||0
3334900|NCT03335254|4066330|FG003|NOT COMPLETED|Period 3, Day 16-25||0
3334901|NCT03335254|4066331|FG004|NOT COMPLETED|Period 3, Day 16-25||0
3334902|NCT03335254|4066332|FG005|NOT COMPLETED|Period 3, Day 16-25||0
3334903|NCT03335254|4066333|FG006|NOT COMPLETED|Period 3, Day 16-25||0
3334904|NCT03335254|4066334|FG007|NOT COMPLETED|Period 3, Day 16-25||0
3334905|NCT03335254|4066335|FG008|NOT COMPLETED|Period 3, Day 16-25||0
3334906|NCT03335254|4066336|FG009|NOT COMPLETED|Period 3, Day 16-25||0
3334907|NCT03335254|4066337|FG010|NOT COMPLETED|Period 3, Day 16-25||0
3334908|NCT03335254|4066338|FG011|NOT COMPLETED|Period 3, Day 16-25||0
3334909|NCT03335254|4066339|FG012|NOT COMPLETED|Period 3, Day 16-25||0
3334910|NCT03335254|4066340|FG013|NOT COMPLETED|Period 3, Day 16-25||0
3334911|NCT03335254|4066341|FG014|NOT COMPLETED|Period 3, Day 16-25||0
3334912|NCT03335254|4066342|FG015|NOT COMPLETED|Period 3, Day 16-25||0
3334913|NCT03335254|4066343|FG016|NOT COMPLETED|Period 3, Day 16-25||0
3334914|NCT03335254|4066344|FG017|NOT COMPLETED|Period 3, Day 16-25||0
3334915|NCT03335254|4066345|FG018|NOT COMPLETED|Period 3, Day 16-25||0
3334916|NCT03335254|4066346|FG019|NOT COMPLETED|Period 3, Day 16-25||0
3334917|NCT03335254|4066327|FG000|STARTED|Period 3, Day 26-30||9
3334918|NCT03335254|4066328|FG001|STARTED|Period 3, Day 26-30||0
3334919|NCT03335254|4066329|FG002|STARTED|Period 3, Day 26-30||0
3334920|NCT03335254|4066330|FG003|STARTED|Period 3, Day 26-30||0
3334921|NCT03335254|4066331|FG004|STARTED|Period 3, Day 26-30||0
3334922|NCT03335254|4066332|FG005|STARTED|Period 3, Day 26-30||0
3334923|NCT03335254|4066333|FG006|STARTED|Period 3, Day 26-30||0
3334924|NCT03335254|4066334|FG007|STARTED|Period 3, Day 26-30||0
3334925|NCT03335254|4066335|FG008|STARTED|Period 3, Day 26-30||0
3334926|NCT03335254|4066336|FG009|STARTED|Period 3, Day 26-30||0
3334927|NCT03335254|4066337|FG010|STARTED|Period 3, Day 26-30||0
3334928|NCT03335254|4066338|FG011|STARTED|Period 3, Day 26-30||0
3334929|NCT03335254|4066339|FG012|STARTED|Period 3, Day 26-30||0
3334930|NCT03335254|4066340|FG013|STARTED|Period 3, Day 26-30||0
3334931|NCT03335254|4066341|FG014|STARTED|Period 3, Day 26-30||0
3334932|NCT03335254|4066342|FG015|STARTED|Period 3, Day 26-30||0
3334933|NCT03335254|4066343|FG016|STARTED|Period 3, Day 26-30||0
3334934|NCT03335254|4066344|FG017|STARTED|Period 3, Day 26-30||0
3334935|NCT03335254|4066345|FG018|STARTED|Period 3, Day 26-30||0
3334936|NCT03335254|4066346|FG019|STARTED|Period 3, Day 26-30||0
3334937|NCT03335254|4066327|FG000|COMPLETED|Period 3, Day 26-30||9
3334938|NCT03335254|4066328|FG001|COMPLETED|Period 3, Day 26-30||0
3334939|NCT03335254|4066329|FG002|COMPLETED|Period 3, Day 26-30||0
3334940|NCT03335254|4066330|FG003|COMPLETED|Period 3, Day 26-30||0
3334941|NCT03335254|4066331|FG004|COMPLETED|Period 3, Day 26-30||0
3334942|NCT03335254|4066332|FG005|COMPLETED|Period 3, Day 26-30||0
3334943|NCT03335254|4066333|FG006|COMPLETED|Period 3, Day 26-30||0
3334944|NCT03335254|4066334|FG007|COMPLETED|Period 3, Day 26-30||0
3334945|NCT03335254|4066335|FG008|COMPLETED|Period 3, Day 26-30||0
3334946|NCT03335254|4066336|FG009|COMPLETED|Period 3, Day 26-30||0
3334947|NCT03335254|4066337|FG010|COMPLETED|Period 3, Day 26-30||0
3334948|NCT03335254|4066338|FG011|COMPLETED|Period 3, Day 26-30||0
3334949|NCT03335254|4066339|FG012|COMPLETED|Period 3, Day 26-30||0
3334950|NCT03335254|4066340|FG013|COMPLETED|Period 3, Day 26-30||0
3334951|NCT03335254|4066341|FG014|COMPLETED|Period 3, Day 26-30||0
3334952|NCT03335254|4066342|FG015|COMPLETED|Period 3, Day 26-30||0
3334953|NCT03335254|4066343|FG016|COMPLETED|Period 3, Day 26-30||0
3334954|NCT03335254|4066344|FG017|COMPLETED|Period 3, Day 26-30||0
3334955|NCT03335254|4066345|FG018|COMPLETED|Period 3, Day 26-30||0
3334956|NCT03335254|4066346|FG019|COMPLETED|Period 3, Day 26-30||0
3334957|NCT03335254|4066327|FG000|NOT COMPLETED|Period 3, Day 26-30||0
3334958|NCT03335254|4066328|FG001|NOT COMPLETED|Period 3, Day 26-30||0
3334959|NCT03335254|4066329|FG002|NOT COMPLETED|Period 3, Day 26-30||0
3334960|NCT03335254|4066330|FG003|NOT COMPLETED|Period 3, Day 26-30||0
3334961|NCT03335254|4066331|FG004|NOT COMPLETED|Period 3, Day 26-30||0
3334962|NCT03335254|4066332|FG005|NOT COMPLETED|Period 3, Day 26-30||0
3334963|NCT03335254|4066333|FG006|NOT COMPLETED|Period 3, Day 26-30||0
3334964|NCT03335254|4066334|FG007|NOT COMPLETED|Period 3, Day 26-30||0
3334965|NCT03335254|4066335|FG008|NOT COMPLETED|Period 3, Day 26-30||0
3334966|NCT03335254|4066336|FG009|NOT COMPLETED|Period 3, Day 26-30||0
3334967|NCT03335254|4066337|FG010|NOT COMPLETED|Period 3, Day 26-30||0
3334968|NCT03335254|4066338|FG011|NOT COMPLETED|Period 3, Day 26-30||0
3334969|NCT03335254|4066339|FG012|NOT COMPLETED|Period 3, Day 26-30||0
3334970|NCT03335254|4066340|FG013|NOT COMPLETED|Period 3, Day 26-30||0
3334971|NCT03335254|4066341|FG014|NOT COMPLETED|Period 3, Day 26-30||0
3334972|NCT03335254|4066342|FG015|NOT COMPLETED|Period 3, Day 26-30||0
3334973|NCT03335254|4066343|FG016|NOT COMPLETED|Period 3, Day 26-30||0
3334974|NCT03335254|4066344|FG017|NOT COMPLETED|Period 3, Day 26-30||0
3334975|NCT03335254|4066345|FG018|NOT COMPLETED|Period 3, Day 26-30||0
3334976|NCT03335254|4066346|FG019|NOT COMPLETED|Period 3, Day 26-30||0
3334977|NCT03335566|4066377|FG000|STARTED|Overall Study||218
3334978|NCT03335566|4066378|FG001|STARTED|Overall Study||206
3334979|NCT03335566|4066377|FG000|COMPLETED|Overall Study||214
3334980|NCT03335566|4066378|FG001|COMPLETED|Overall Study||203
3334981|NCT03335566|4066377|FG000|NOT COMPLETED|Overall Study||4
3334982|NCT03335566|4066378|FG001|NOT COMPLETED|Overall Study||3
3334983|NCT03335761|4066387|FG000|STARTED|Overall Study||19
3334984|NCT03335761|4066388|FG001|STARTED|Overall Study||14
3334985|NCT03335761|4066389|FG002|STARTED|Overall Study||15
3334986|NCT03335761|4066387|FG000|Implanted With a Neurostimulator Device|Overall Study||18
3334987|NCT03335761|4066388|FG001|Implanted With a Neurostimulator Device|Overall Study||14
3334988|NCT03335761|4066389|FG002|Implanted With a Neurostimulator Device|Overall Study||14
3334989|NCT03335761|4066387|FG000|COMPLETED|Overall Study||17
3334990|NCT03335761|4066388|FG001|COMPLETED|Overall Study||13
3334991|NCT03335761|4066389|FG002|COMPLETED|Overall Study||13
3334992|NCT03335761|4066387|FG000|NOT COMPLETED|Overall Study||2
3334993|NCT03335761|4066388|FG001|NOT COMPLETED|Overall Study||1
3334994|NCT03335761|4066389|FG002|NOT COMPLETED|Overall Study||2
3334995|NCT03335800|4066397|FG000|STARTED|Overall Study||419927
3334996|NCT03335800|4066397|FG000|Received Irregular Pulse Notification|Overall Study||2161
3334997|NCT03335800|4066397|FG000|Attended First Study Visit|Overall Study||945
3334998|NCT03335800|4066397|FG000|ECG Patch Shipped|Overall Study||658
3334999|NCT03335800|4066397|FG000|ECG Patch Returned for Analysis|Overall Study||450
3335000|NCT03335800|4066397|FG000|Attended Second Study Visit|Overall Study||396
3335001|NCT03335800|4066397|FG000|COMPLETED|Overall Study||396
3335002|NCT03335800|4066397|FG000|NOT COMPLETED|Overall Study||419531
3335003|NCT03336450|4066401|FG000|STARTED|Overall Study||3
3335004|NCT03336450|4066401|FG000|COMPLETED|Overall Study||3
3335005|NCT03336450|4066401|FG000|NOT COMPLETED|Overall Study||0
3335006|NCT03336502|4066407|FG000|STARTED|Overall Study||30
3335007|NCT03336502|4066408|FG001|STARTED|Overall Study||40
3335008|NCT03336502|4066407|FG000|COMPLETED|Overall Study||26
3335009|NCT03336502|4066408|FG001|COMPLETED|Overall Study||31
3335010|NCT03336502|4066407|FG000|NOT COMPLETED|Overall Study||4
3335011|NCT03336502|4066408|FG001|NOT COMPLETED|Overall Study||9
3335012|NCT03336645|4066414|FG000|STARTED|Overall Study||25
3335013|NCT03336645|4066414|FG000|COMPLETED|Overall Study||25
3335014|NCT03336645|4066414|FG000|NOT COMPLETED|Overall Study||0
3335015|NCT03336853|4066420|FG000|STARTED|Overall Study||30
3335016|NCT03336853|4066421|FG001|STARTED|Overall Study||30
3335017|NCT03336853|4066420|FG000|COMPLETED|Overall Study||30
3335018|NCT03336853|4066421|FG001|COMPLETED|Overall Study||30
3335019|NCT03336853|4066420|FG000|NOT COMPLETED|Overall Study||0
3335020|NCT03336853|4066421|FG001|NOT COMPLETED|Overall Study||0
3335021|NCT03337139|4066429|FG000|STARTED|Phase I||87
3335022|NCT03337139|4066430|FG001|STARTED|Phase I|There were not two conditions in Phase I: all participants received standard group LM treatment.|0
3335023|NCT03337139|4066429|FG000|COMPLETED|Phase I||77
3335024|NCT03337139|4066430|FG001|COMPLETED|Phase I||0
3335025|NCT03337139|4066429|FG000|NOT COMPLETED|Phase I||10
3335026|NCT03337139|4066430|FG001|NOT COMPLETED|Phase I||0
3335027|NCT03337139|4066429|FG000|STARTED|Phase II||38
3335028|NCT03337139|4066430|FG001|STARTED|Phase II||39
3335029|NCT03337139|4066429|FG000|26 Week Assessment|Phase II||34
3335030|NCT03337139|4066430|FG001|26 Week Assessment|Phase II||37
3335031|NCT03337139|4066429|FG000|COMPLETED|Phase II||33
3335032|NCT03337139|4066430|FG001|COMPLETED|Phase II||36
3335033|NCT03337139|4066429|FG000|NOT COMPLETED|Phase II||5
3335034|NCT03337139|4066430|FG001|NOT COMPLETED|Phase II||3
3335035|NCT03337152|4066438|FG000|STARTED|Overall Study||24
3335036|NCT03337152|4066439|FG001|STARTED|Overall Study||24
3335037|NCT03337152|4066438|FG000|COMPLETED|Overall Study||13
3335038|NCT03337152|4066439|FG001|COMPLETED|Overall Study||13
3335039|NCT03337152|4066438|FG000|NOT COMPLETED|Overall Study||11
3335040|NCT03337152|4066439|FG001|NOT COMPLETED|Overall Study||11
3176915|NCT01968070|3904652|FG006|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
3176916|NCT01968070|3904653|FG007|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
3335041|NCT03337308|4066451|FG000|STARTED|Overall Study||108
3335042|NCT03337308|4066452|FG001|STARTED|Overall Study||110
3335043|NCT03337308|4066453|FG002|STARTED|Overall Study||109
3335044|NCT03337308|4066454|FG003|STARTED|Overall Study||55
3335045|NCT03337308|4066451|FG000|COMPLETED|Overall Study||103
3335046|NCT03337308|4066452|FG001|COMPLETED|Overall Study||103
3335047|NCT03337308|4066453|FG002|COMPLETED|Overall Study||104
3335048|NCT03337308|4066454|FG003|COMPLETED|Overall Study||53
3335049|NCT03337308|4066451|FG000|NOT COMPLETED|Overall Study||5
3335050|NCT03337308|4066452|FG001|NOT COMPLETED|Overall Study||7
3335051|NCT03337308|4066453|FG002|NOT COMPLETED|Overall Study||5
3335052|NCT03337308|4066454|FG003|NOT COMPLETED|Overall Study||2
3335053|NCT03337477|4066466|FG000|STARTED|Overall Study||33
3335054|NCT03337477|4066467|FG001|STARTED|Overall Study||37
3335055|NCT03337477|4066466|FG000|COMPLETED|Overall Study||22
3335056|NCT03337477|4066467|FG001|COMPLETED|Overall Study||24
3335057|NCT03337477|4066466|FG000|NOT COMPLETED|Overall Study||11
3335058|NCT03337477|4066467|FG001|NOT COMPLETED|Overall Study||13
3335059|NCT03337490|4066478|FG000|STARTED|Overall Study||128
3335060|NCT03337490|4066479|FG001|STARTED|Overall Study||126
3335061|NCT03337490|4066480|FG002|STARTED|Overall Study||42
3335062|NCT03337490|4066478|FG000|COMPLETED|Overall Study||117
3335063|NCT03337490|4066479|FG001|COMPLETED|Overall Study||112
3335064|NCT03337490|4066480|FG002|COMPLETED|Overall Study||7
3335065|NCT03337490|4066478|FG000|NOT COMPLETED|Overall Study||11
3335066|NCT03337490|4066479|FG001|NOT COMPLETED|Overall Study||14
3335067|NCT03337490|4066480|FG002|NOT COMPLETED|Overall Study||35
3335068|NCT03337542|4066488|FG000|STARTED|Overall Study||243
3335069|NCT03337542|4066488|FG000|Safety Population|Overall Study||242
3335070|NCT03337542|4066488|FG000|COMPLETED|Overall Study||222
3335071|NCT03337542|4066488|FG000|NOT COMPLETED|Overall Study||21
3335072|NCT03338010|4066495|FG000|STARTED|Overall Study||359
3335073|NCT03338010|4066496|FG001|STARTED|Overall Study||177
3335074|NCT03338010|4066495|FG000|Received at Least One Dose of Study Drug|Overall Study||359
3335075|NCT03338010|4066496|FG001|Received at Least One Dose of Study Drug|Overall Study||177
3335076|NCT03338010|4066495|FG000|COMPLETED|Overall Study||336
3335077|NCT03338010|4066496|FG001|COMPLETED|Overall Study||159
3335078|NCT03338010|4066495|FG000|NOT COMPLETED|Overall Study||23
3335079|NCT03338010|4066496|FG001|NOT COMPLETED|Overall Study||18
3335080|NCT03338023|4066504|FG000|STARTED|Overall Study||137
3335081|NCT03338023|4066505|FG001|STARTED|Overall Study||135
3335082|NCT03338023|4066504|FG000|Received at Least One Dose of Study Drug|Overall Study||137
3335083|NCT03338023|4066505|FG001|Received at Least One Dose of Study Drug|Overall Study||135
3335084|NCT03338023|4066504|FG000|COMPLETED|Overall Study||128
3335085|NCT03338023|4066505|FG001|COMPLETED|Overall Study||125
3335086|NCT03338023|4066504|FG000|NOT COMPLETED|Overall Study||9
3335087|NCT03338023|4066505|FG001|NOT COMPLETED|Overall Study||10
3335088|NCT03338036|4066515|FG000|STARTED|Overall Study||0
3335089|NCT03338036|4066516|FG001|STARTED|Overall Study||11
3335090|NCT03338036|4066517|FG002|STARTED|Overall Study||12
3335091|NCT03338036|4066518|FG003|STARTED|Overall Study||8
3335092|NCT03338036|4066515|FG000|COMPLETED|Overall Study||0
3335093|NCT03338036|4066516|FG001|COMPLETED|Overall Study||7
3335094|NCT03338036|4066517|FG002|COMPLETED|Overall Study||9
3335095|NCT03338036|4066518|FG003|COMPLETED|Overall Study||8
3335096|NCT03338036|4066515|FG000|NOT COMPLETED|Overall Study||0
3335097|NCT03338036|4066516|FG001|NOT COMPLETED|Overall Study||4
3335098|NCT03338036|4066517|FG002|NOT COMPLETED|Overall Study||3
3335099|NCT03338036|4066518|FG003|NOT COMPLETED|Overall Study||0
3335100|NCT03338062|4066528|FG000|STARTED|Overall Study||10
3335101|NCT03338062|4066529|FG001|STARTED|Overall Study||5
3335102|NCT03338062|4066528|FG000|COMPLETED|Overall Study||9
3335103|NCT03338062|4066529|FG001|COMPLETED|Overall Study||5
3335104|NCT03338062|4066528|FG000|NOT COMPLETED|Overall Study||1
3335105|NCT03338062|4066529|FG001|NOT COMPLETED|Overall Study||0
3335106|NCT03338296|4066538|FG000|STARTED|Overall Study||139
3335107|NCT03338296|4066539|FG001|STARTED|Overall Study||139
3335108|NCT03338296|4066538|FG000|Safety Analysis Set|Overall Study||139
3335109|NCT03338296|4066539|FG001|Safety Analysis Set|Overall Study||136
3335110|NCT03338296|4066538|FG000|COMPLETED|Overall Study||36
3335111|NCT03338296|4066539|FG001|COMPLETED|Overall Study||31
3335112|NCT03338296|4066538|FG000|NOT COMPLETED|Overall Study||103
3335113|NCT03338296|4066539|FG001|NOT COMPLETED|Overall Study||108
3335114|NCT03338400|4066547|FG000|STARTED|Overall Study||25
3335115|NCT03338400|4066548|FG001|STARTED|Overall Study||26
3335116|NCT03338400|4066547|FG000|COMPLETED|Overall Study||24
3335117|NCT03338400|4066548|FG001|COMPLETED|Overall Study||24
3335118|NCT03338400|4066547|FG000|NOT COMPLETED|Overall Study||1
3335119|NCT03338400|4066548|FG001|NOT COMPLETED|Overall Study||2
3335120|NCT03338556|4066566|FG000|STARTED|Overall Study||25
3335121|NCT03338556|4066567|FG001|STARTED|Overall Study||27
3335122|NCT03338556|4066568|FG002|STARTED|Overall Study||24
3335123|NCT03338556|4066569|FG003|STARTED|Overall Study||26
3335124|NCT03338556|4066566|FG000|COMPLETED|Overall Study||23
3335125|NCT03338556|4066567|FG001|COMPLETED|Overall Study||23
3335126|NCT03338556|4066568|FG002|COMPLETED|Overall Study||22
3335127|NCT03338556|4066569|FG003|COMPLETED|Overall Study||24
3335128|NCT03338556|4066566|FG000|NOT COMPLETED|Overall Study||2
3335129|NCT03338556|4066567|FG001|NOT COMPLETED|Overall Study||4
3335130|NCT03338556|4066568|FG002|NOT COMPLETED|Overall Study||2
3335131|NCT03338556|4066569|FG003|NOT COMPLETED|Overall Study||2
3335132|NCT03338569|4066581|FG000|STARTED|Overall Study||64
3335133|NCT03338569|4066582|FG001|STARTED|Overall Study||61
3335134|NCT03338569|4066581|FG000|COMPLETED|Overall Study||56
3335135|NCT03338569|4066582|FG001|COMPLETED|Overall Study||56
3335136|NCT03338569|4066581|FG000|NOT COMPLETED|Overall Study||8
3335137|NCT03338569|4066582|FG001|NOT COMPLETED|Overall Study||5
3335138|NCT03338673|4066590|FG000|STARTED|Overall Study||6
3335139|NCT03338673|4066591|FG001|STARTED|Overall Study||6
3335140|NCT03338673|4066590|FG000|COMPLETED|Overall Study||5
3335141|NCT03338673|4066591|FG001|COMPLETED|Overall Study||5
3335142|NCT03338673|4066590|FG000|NOT COMPLETED|Overall Study||1
3335143|NCT03338673|4066591|FG001|NOT COMPLETED|Overall Study||1
3335144|NCT03338686|4066600|FG000|STARTED|Overall Study||2
3335145|NCT03338686|4066601|FG001|STARTED|Overall Study||5
3335146|NCT03338686|4066602|FG002|STARTED|Overall Study|12 FGG implant sites and 7 CTG implant sites for this Arm/Group|7
3335147|NCT03338686|4066600|FG000|COMPLETED|Overall Study||2
3335148|NCT03338686|4066601|FG001|COMPLETED|Overall Study||5
3335149|NCT03338686|4066602|FG002|COMPLETED|Overall Study||7
3335150|NCT03338686|4066600|FG000|NOT COMPLETED|Overall Study||0
3335151|NCT03338686|4066601|FG001|NOT COMPLETED|Overall Study||0
3335152|NCT03338686|4066602|FG002|NOT COMPLETED|Overall Study||0
3335153|NCT03338803|4066609|FG000|STARTED|Overall Study||11001
3335154|NCT03338803|4066609|FG000|COMPLETED|Overall Study||11001
3335155|NCT03338803|4066609|FG000|NOT COMPLETED|Overall Study||0
3335156|NCT03338816|4066615|FG000|STARTED|6-Month Double-blind Period||46
3335157|NCT03338816|4066616|FG001|STARTED|6-Month Double-blind Period||48
3335158|NCT03338816|4066615|FG000|COMPLETED|6-Month Double-blind Period||46
3335159|NCT03338816|4066616|FG001|COMPLETED|6-Month Double-blind Period|1 participant discontinued treatment during the 6-month DB period but completed the 6-month DB Visit|47
3335160|NCT03338816|4066615|FG000|NOT COMPLETED|6-Month Double-blind Period||0
3335161|NCT03338816|4066616|FG001|NOT COMPLETED|6-Month Double-blind Period||1
3335162|NCT03338816|4066615|FG000|STARTED|Open-Label Extension Period||46
3335163|NCT03338816|4066616|FG001|STARTED|Open-Label Extension Period||47
3335164|NCT03338816|4066615|FG000|COMPLETED|Open-Label Extension Period||0
3335165|NCT03338816|4066616|FG001|COMPLETED|Open-Label Extension Period||0
3335166|NCT03338816|4066615|FG000|NOT COMPLETED|Open-Label Extension Period||46
3335167|NCT03338816|4066616|FG001|NOT COMPLETED|Open-Label Extension Period||47
3335168|NCT03338855|4066624|FG000|STARTED|Overall Study||12
3335169|NCT03338855|4066625|FG001|STARTED|Overall Study||14
3335170|NCT03338855|4066624|FG000|Received Treatment in Period 1|Overall Study||12
3335171|NCT03338855|4066625|FG001|Received Treatment in Period 1|Overall Study||14
3335172|NCT03338855|4066624|FG000|Received Treatment in Period 2|Overall Study||11
3335173|NCT03338855|4066625|FG001|Received Treatment in Period 2|Overall Study||14
3335174|NCT03338855|4066624|FG000|COMPLETED|Overall Study||11
3335175|NCT03338855|4066625|FG001|COMPLETED|Overall Study||14
3335176|NCT03338855|4066624|FG000|NOT COMPLETED|Overall Study||1
3335177|NCT03338855|4066625|FG001|NOT COMPLETED|Overall Study||0
3335178|NCT03338894|4066631|FG000|STARTED|Overall Study||66
3335179|NCT03338894|4066631|FG000|COMPLETED|Overall Study||56
3335180|NCT03338894|4066631|FG000|NOT COMPLETED|Overall Study||10
3335181|NCT03338998|4066637|FG000|STARTED|Treatment Period||16
3335182|NCT03338998|4066638|FG001|STARTED|Treatment Period||13
3335183|NCT03338998|4066637|FG000|COMPLETED|Treatment Period||8
3335184|NCT03338998|4066638|FG001|COMPLETED|Treatment Period||10
3335185|NCT03338998|4066637|FG000|NOT COMPLETED|Treatment Period||8
3335186|NCT03338998|4066638|FG001|NOT COMPLETED|Treatment Period||3
3335187|NCT03338998|4066637|FG000|STARTED|Safety Follow-Up Period||16
3335188|NCT03338998|4066638|FG001|STARTED|Safety Follow-Up Period||13
3335189|NCT03338998|4066637|FG000|COMPLETED|Safety Follow-Up Period||14
3335190|NCT03338998|4066638|FG001|COMPLETED|Safety Follow-Up Period||12
3335191|NCT03338998|4066637|FG000|NOT COMPLETED|Safety Follow-Up Period||2
3176917|NCT01968070|3904654|FG008|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
3335192|NCT03338998|4066638|FG001|NOT COMPLETED|Safety Follow-Up Period||1
3335193|NCT03339206|4066648|FG000|STARTED|Overall Study||262
3335194|NCT03339206|4066649|FG001|STARTED|Overall Study||263
3335195|NCT03339206|4066650|FG002|STARTED|Overall Study||264
3335196|NCT03339206|4066648|FG000|COMPLETED|Overall Study||262
3335197|NCT03339206|4066649|FG001|COMPLETED|Overall Study||263
3335198|NCT03339206|4066650|FG002|COMPLETED|Overall Study||264
3335199|NCT03339206|4066648|FG000|NOT COMPLETED|Overall Study||0
3335200|NCT03339206|4066649|FG001|NOT COMPLETED|Overall Study||0
3335201|NCT03339206|4066650|FG002|NOT COMPLETED|Overall Study||0
3335202|NCT03339219|4066658|FG000|STARTED|Overall Study||35
3335203|NCT03339219|4066658|FG000|COMPLETED|Overall Study||0
3335204|NCT03339219|4066658|FG000|NOT COMPLETED|Overall Study||35
3335205|NCT03339297|4066664|FG000|STARTED|Overall Study||79
3335206|NCT03339297|4066665|FG001|STARTED|Overall Study||73
3335207|NCT03339297|4066664|FG000|COMPLETED|Overall Study||56
3335208|NCT03339297|4066665|FG001|COMPLETED|Overall Study||59
3335209|NCT03339297|4066664|FG000|NOT COMPLETED|Overall Study||23
3335210|NCT03339297|4066665|FG001|NOT COMPLETED|Overall Study||14
3335211|NCT03339453|4066673|FG000|STARTED|First Visit of Glucagon Treatment||35
3335212|NCT03339453|4066674|FG001|STARTED|First Visit of Glucagon Treatment||35
3335213|NCT03339453|4066673|FG000|Received at Least 1 Dose of Study Drug|First Visit of Glucagon Treatment||35
3335214|NCT03339453|4066674|FG001|Received at Least 1 Dose of Study Drug|First Visit of Glucagon Treatment||35
3335215|NCT03339453|4066673|FG000|COMPLETED|First Visit of Glucagon Treatment||35
3335216|NCT03339453|4066674|FG001|COMPLETED|First Visit of Glucagon Treatment||34
3335217|NCT03339453|4066673|FG000|NOT COMPLETED|First Visit of Glucagon Treatment||0
3335218|NCT03339453|4066674|FG001|NOT COMPLETED|First Visit of Glucagon Treatment||1
3335219|NCT03339453|4066673|FG000|STARTED|Second Visit for Alternate Glucagon||35
3335220|NCT03339453|4066674|FG001|STARTED|Second Visit for Alternate Glucagon||34
3335221|NCT03339453|4066673|FG000|COMPLETED|Second Visit for Alternate Glucagon||35
3335222|NCT03339453|4066674|FG001|COMPLETED|Second Visit for Alternate Glucagon||34
3335223|NCT03339453|4066673|FG000|NOT COMPLETED|Second Visit for Alternate Glucagon||0
3335224|NCT03339453|4066674|FG001|NOT COMPLETED|Second Visit for Alternate Glucagon||0
3335225|NCT03339570|4066680|FG000|STARTED|Overall Study||20
3335226|NCT03339570|4066680|FG000|COMPLETED|Overall Study||16
3335227|NCT03339570|4066680|FG000|NOT COMPLETED|Overall Study||4
3335228|NCT03339583|4066695|FG000|STARTED|First Intervention (14 Days)||19
3335229|NCT03339583|4066696|FG001|STARTED|First Intervention (14 Days)||23
3335230|NCT03339583|4066695|FG000|COMPLETED|First Intervention (14 Days)||18
3335231|NCT03339583|4066696|FG001|COMPLETED|First Intervention (14 Days)||23
3335232|NCT03339583|4066695|FG000|NOT COMPLETED|First Intervention (14 Days)||1
3335233|NCT03339583|4066696|FG001|NOT COMPLETED|First Intervention (14 Days)||0
3335234|NCT03339583|4066695|FG000|STARTED|Washout (14 Days)||18
3335235|NCT03339583|4066696|FG001|STARTED|Washout (14 Days)||23
3335236|NCT03339583|4066695|FG000|COMPLETED|Washout (14 Days)||18
3335237|NCT03339583|4066696|FG001|COMPLETED|Washout (14 Days)||23
3335238|NCT03339583|4066695|FG000|NOT COMPLETED|Washout (14 Days)||0
3335239|NCT03339583|4066696|FG001|NOT COMPLETED|Washout (14 Days)||0
3335240|NCT03339583|4066695|FG000|STARTED|Second Intervention (14 Days)||18
3335241|NCT03339583|4066696|FG001|STARTED|Second Intervention (14 Days)||23
3335242|NCT03339583|4066695|FG000|COMPLETED|Second Intervention (14 Days)||18
3335243|NCT03339583|4066696|FG001|COMPLETED|Second Intervention (14 Days)||21
3335244|NCT03339583|4066695|FG000|NOT COMPLETED|Second Intervention (14 Days)||0
3335245|NCT03339583|4066696|FG001|NOT COMPLETED|Second Intervention (14 Days)||2
3335246|NCT03339583|4066695|FG000|STARTED|Follow-up (14 Days)||18
3335247|NCT03339583|4066696|FG001|STARTED|Follow-up (14 Days)||21
3335248|NCT03339583|4066695|FG000|COMPLETED|Follow-up (14 Days)||12
3176918|NCT01968070|3904655|FG009|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
3176919|NCT01968070|3904656|FG010|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
3335249|NCT03339583|4066696|FG001|COMPLETED|Follow-up (14 Days)||18
3335250|NCT03339583|4066695|FG000|NOT COMPLETED|Follow-up (14 Days)||6
3335251|NCT03339583|4066696|FG001|NOT COMPLETED|Follow-up (14 Days)||3
3335252|NCT03339713|4066706|FG000|STARTED|Overall Study||90
3335253|NCT03339713|4066707|FG001|STARTED|Overall Study||90
3335254|NCT03339713|4066706|FG000|COMPLETED|Overall Study||86
3335255|NCT03339713|4066707|FG001|COMPLETED|Overall Study||88
3335256|NCT03339713|4066706|FG000|NOT COMPLETED|Overall Study||4
3335257|NCT03339713|4066707|FG001|NOT COMPLETED|Overall Study||2
3335258|NCT03339726|4066718|FG000|STARTED|Overall Study||64
3335259|NCT03339726|4066719|FG001|STARTED|Overall Study||66
3335260|NCT03339726|4066720|FG002|STARTED|Overall Study||63
3335261|NCT03339726|4066718|FG000|COMPLETED|Overall Study||63
3335262|NCT03339726|4066719|FG001|COMPLETED|Overall Study||65
3335263|NCT03339726|4066720|FG002|COMPLETED|Overall Study||63
3335264|NCT03339726|4066718|FG000|NOT COMPLETED|Overall Study||1
3335265|NCT03339726|4066719|FG001|NOT COMPLETED|Overall Study||1
3335266|NCT03339726|4066720|FG002|NOT COMPLETED|Overall Study||0
3335267|NCT03339999|4066732|FG000|STARTED|Overall Study||7
3335268|NCT03339999|4066733|FG001|STARTED|Overall Study||6
3335269|NCT03339999|4066734|FG002|STARTED|Overall Study||6
3335270|NCT03339999|4066735|FG003|STARTED|Overall Study||5
3335271|NCT03339999|4066732|FG000|Modified Intent-to-Treat Population|Overall Study||7
3335272|NCT03339999|4066733|FG001|Modified Intent-to-Treat Population|Overall Study||6
3335273|NCT03339999|4066734|FG002|Modified Intent-to-Treat Population|Overall Study||5
3335274|NCT03339999|4066735|FG003|Modified Intent-to-Treat Population|Overall Study||4
3335275|NCT03339999|4066732|FG000|Safety Population: Received Treatment|Overall Study||7
3335276|NCT03339999|4066733|FG001|Safety Population: Received Treatment|Overall Study||6
3335277|NCT03339999|4066734|FG002|Safety Population: Received Treatment|Overall Study||6
3335278|NCT03339999|4066735|FG003|Safety Population: Received Treatment|Overall Study||4
3335279|NCT03339999|4066732|FG000|COMPLETED|Overall Study||0
3335280|NCT03339999|4066733|FG001|COMPLETED|Overall Study||0
3335281|NCT03339999|4066734|FG002|COMPLETED|Overall Study||0
3335282|NCT03339999|4066735|FG003|COMPLETED|Overall Study||0
3335283|NCT03339999|4066732|FG000|NOT COMPLETED|Overall Study||7
3335284|NCT03339999|4066733|FG001|NOT COMPLETED|Overall Study||6
3335285|NCT03339999|4066734|FG002|NOT COMPLETED|Overall Study||6
3335286|NCT03339999|4066735|FG003|NOT COMPLETED|Overall Study||5
3335287|NCT03340025|4066750|FG000|STARTED|Overall Study||11
3335288|NCT03340025|4066751|FG001|STARTED|Overall Study||9
3335289|NCT03340025|4066750|FG000|COMPLETED|Overall Study||9
3335290|NCT03340025|4066751|FG001|COMPLETED|Overall Study||7
3335291|NCT03340025|4066750|FG000|NOT COMPLETED|Overall Study||2
3335292|NCT03340025|4066751|FG001|NOT COMPLETED|Overall Study||2
3335293|NCT03340337|4066757|FG000|STARTED|Overall Study||30
3335294|NCT03340337|4066757|FG000|Received Neo-Russian|Overall Study||30
3335295|NCT03340337|4066757|FG000|Received Aussie|Overall Study||30
3335296|NCT03340337|4066757|FG000|Received RBS|Overall Study||30
3335297|NCT03340337|4066757|FG000|COMPLETED|Overall Study||30
3335298|NCT03340337|4066757|FG000|NOT COMPLETED|Overall Study||0
3335299|NCT03340350|4066772|FG000|STARTED|Overall Study||10
3335300|NCT03340350|4066772|FG000|COMPLETED|Overall Study||4
3335301|NCT03340350|4066772|FG000|NOT COMPLETED|Overall Study||6
3335302|NCT03340415|4066779|FG000|STARTED|Overall Study||29
3335303|NCT03340415|4066780|FG001|STARTED|Overall Study||24
3335304|NCT03340415|4066779|FG000|COMPLETED|Overall Study||29
3335305|NCT03340415|4066780|FG001|COMPLETED|Overall Study||21
3335306|NCT03340415|4066779|FG000|NOT COMPLETED|Overall Study||0
3335307|NCT03340415|4066780|FG001|NOT COMPLETED|Overall Study||3
3335308|NCT03340428|4066790|FG000|STARTED|Overall Study||117
3335309|NCT03340428|4066791|FG001|STARTED|Overall Study||59
3335310|NCT03340428|4066790|FG000|COMPLETED|Overall Study||116
3335311|NCT03340428|4066791|FG001|COMPLETED|Overall Study||59
3335312|NCT03340428|4066790|FG000|NOT COMPLETED|Overall Study||1
3176920|NCT01968070|3904657|FG011|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
3176921|NCT01968070|3904658|FG012|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
3176922|NCT01968070|3904659|FG013|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
3176923|NCT01968070|3904660|FG014|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
3176924|NCT01968070|3904661|FG015|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
3176925|NCT01968070|3904662|FG016|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
3176926|NCT01968070|3904663|FG017|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
3176927|NCT01968070|3904646|FG000|COMPLETED|Period 2||4
3176928|NCT01968070|3904647|FG001|COMPLETED|Period 2||4
3176929|NCT01968070|3904648|FG002|COMPLETED|Period 2||4
3176930|NCT01968070|3904649|FG003|COMPLETED|Period 2||4
3176931|NCT01968070|3904650|FG004|COMPLETED|Period 2||2
3176932|NCT01968070|3904651|FG005|COMPLETED|Period 2||4
3176933|NCT01968070|3904652|FG006|COMPLETED|Period 2||0
3176934|NCT01968070|3904653|FG007|COMPLETED|Period 2||0
3335313|NCT03340428|4066791|FG001|NOT COMPLETED|Overall Study||0
3335314|NCT03340610|4066797|FG000|STARTED|Overall Study||30
3335315|NCT03340610|4066797|FG000|COMPLETED|Overall Study||27
3335316|NCT03340610|4066797|FG000|NOT COMPLETED|Overall Study||3
3335317|NCT03340805|4066803|FG000|STARTED|Overall Study||24
3335318|NCT03340805|4066804|FG001|STARTED|Overall Study||26
3335319|NCT03340805|4066803|FG000|COMPLETED|Overall Study|1 subject withdrew early from study fluid administration but stayed in trial for outcome assessment|24
3335320|NCT03340805|4066804|FG001|COMPLETED|Overall Study||26
3335321|NCT03340805|4066803|FG000|NOT COMPLETED|Overall Study||0
3335322|NCT03340805|4066804|FG001|NOT COMPLETED|Overall Study||0
3335323|NCT03340883|4066812|FG000|STARTED|Overall Study||4
3335324|NCT03340883|4066813|FG001|STARTED|Overall Study||3
3335325|NCT03340883|4066814|FG002|STARTED|Overall Study||4
3335326|NCT03340883|4066815|FG003|STARTED|Overall Study||4
3335327|NCT03340883|4066816|FG004|STARTED|Overall Study||3
3335328|NCT03340883|4066817|FG005|STARTED|Overall Study||3
3335329|NCT03340883|4066812|FG000|COMPLETED|Overall Study||4
3335330|NCT03340883|4066813|FG001|COMPLETED|Overall Study||3
3335331|NCT03340883|4066814|FG002|COMPLETED|Overall Study||4
3335332|NCT03340883|4066815|FG003|COMPLETED|Overall Study||4
3335333|NCT03340883|4066816|FG004|COMPLETED|Overall Study||3
3335334|NCT03340883|4066817|FG005|COMPLETED|Overall Study||3
3335335|NCT03340883|4066812|FG000|NOT COMPLETED|Overall Study||0
3335336|NCT03340883|4066813|FG001|NOT COMPLETED|Overall Study||0
3335337|NCT03340883|4066814|FG002|NOT COMPLETED|Overall Study||0
3335338|NCT03340883|4066815|FG003|NOT COMPLETED|Overall Study||0
3335339|NCT03340883|4066816|FG004|NOT COMPLETED|Overall Study||0
3335340|NCT03340883|4066817|FG005|NOT COMPLETED|Overall Study||0
3335341|NCT03340961|4066835|FG000|STARTED|Overall Study||53
3335342|NCT03340961|4066836|FG001|STARTED|Overall Study||50
3335343|NCT03340961|4066837|FG002|STARTED|Overall Study||49
3335344|NCT03340961|4066838|FG003|STARTED|Overall Study||53
3335345|NCT03340961|4066835|FG000|COMPLETED|Overall Study||47
3335346|NCT03340961|4066836|FG001|COMPLETED|Overall Study||38
3335347|NCT03340961|4066837|FG002|COMPLETED|Overall Study||40
3335348|NCT03340961|4066838|FG003|COMPLETED|Overall Study||35
3335349|NCT03340961|4066835|FG000|NOT COMPLETED|Overall Study||6
3335350|NCT03340961|4066836|FG001|NOT COMPLETED|Overall Study||12
3335351|NCT03340961|4066837|FG002|NOT COMPLETED|Overall Study||9
3335352|NCT03340961|4066838|FG003|NOT COMPLETED|Overall Study||18
3335353|NCT03341273|4066850|FG000|STARTED|Overall Study||249
3335354|NCT03341273|4066851|FG001|STARTED|Overall Study||250
3335355|NCT03341273|4066850|FG000|COMPLETED|Overall Study||229
3335356|NCT03341273|4066851|FG001|COMPLETED|Overall Study||238
3335357|NCT03341273|4066850|FG000|NOT COMPLETED|Overall Study||20
3335358|NCT03341273|4066851|FG001|NOT COMPLETED|Overall Study||12
3335359|NCT03341299|4066857|FG000|STARTED|Period 1||9
3335360|NCT03341299|4066858|FG001|STARTED|Period 1||9
3335361|NCT03341299|4066859|FG002|STARTED|Period 1||9
3335362|NCT03341299|4066860|FG003|STARTED|Period 1||9
3176935|NCT01968070|3904654|FG008|COMPLETED|Period 2||0
3176936|NCT01968070|3904655|FG009|COMPLETED|Period 2||0
3176937|NCT01968070|3904656|FG010|COMPLETED|Period 2||0
3176938|NCT01968070|3904657|FG011|COMPLETED|Period 2||0
3176939|NCT01968070|3904658|FG012|COMPLETED|Period 2||0
3176940|NCT01968070|3904659|FG013|COMPLETED|Period 2||0
3335363|NCT03341299|4066857|FG000|COMPLETED|Period 1||9
3335364|NCT03341299|4066858|FG001|COMPLETED|Period 1||9
3335365|NCT03341299|4066859|FG002|COMPLETED|Period 1||9
3335366|NCT03341299|4066860|FG003|COMPLETED|Period 1||9
3335367|NCT03341299|4066857|FG000|NOT COMPLETED|Period 1||0
3335368|NCT03341299|4066858|FG001|NOT COMPLETED|Period 1||0
3335369|NCT03341299|4066859|FG002|NOT COMPLETED|Period 1||0
3335370|NCT03341299|4066860|FG003|NOT COMPLETED|Period 1||0
3335371|NCT03341299|4066857|FG000|STARTED|Washout (A Minimum of 21 Hours)||9
3335372|NCT03341299|4066858|FG001|STARTED|Washout (A Minimum of 21 Hours)||9
3335373|NCT03341299|4066859|FG002|STARTED|Washout (A Minimum of 21 Hours)||9
3335374|NCT03341299|4066860|FG003|STARTED|Washout (A Minimum of 21 Hours)||9
3335375|NCT03341299|4066857|FG000|COMPLETED|Washout (A Minimum of 21 Hours)||9
3335376|NCT03341299|4066858|FG001|COMPLETED|Washout (A Minimum of 21 Hours)||9
3335377|NCT03341299|4066859|FG002|COMPLETED|Washout (A Minimum of 21 Hours)||8
3335378|NCT03341299|4066860|FG003|COMPLETED|Washout (A Minimum of 21 Hours)||9
3335379|NCT03341299|4066857|FG000|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
3335380|NCT03341299|4066858|FG001|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
3335381|NCT03341299|4066859|FG002|NOT COMPLETED|Washout (A Minimum of 21 Hours)||1
3335382|NCT03341299|4066860|FG003|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
3335383|NCT03341299|4066857|FG000|STARTED|Period 2||9
3335384|NCT03341299|4066858|FG001|STARTED|Period 2||9
3335385|NCT03341299|4066859|FG002|STARTED|Period 2||8
3335386|NCT03341299|4066860|FG003|STARTED|Period 2||9
3335387|NCT03341299|4066857|FG000|COMPLETED|Period 2||9
3335388|NCT03341299|4066858|FG001|COMPLETED|Period 2||9
3335389|NCT03341299|4066859|FG002|COMPLETED|Period 2||8
3335390|NCT03341299|4066860|FG003|COMPLETED|Period 2||9
3335391|NCT03341299|4066857|FG000|NOT COMPLETED|Period 2||0
3335392|NCT03341299|4066858|FG001|NOT COMPLETED|Period 2||0
3335393|NCT03341299|4066859|FG002|NOT COMPLETED|Period 2||0
3335394|NCT03341299|4066860|FG003|NOT COMPLETED|Period 2||0
3335395|NCT03341299|4066857|FG000|STARTED|Washout (A Minimum of 21 Hours)||9
3335396|NCT03341299|4066858|FG001|STARTED|Washout (A Minimum of 21 Hours)||9
3335397|NCT03341299|4066859|FG002|STARTED|Washout (A Minimum of 21 Hours)||8
3335398|NCT03341299|4066860|FG003|STARTED|Washout (A Minimum of 21 Hours)||9
3335399|NCT03341299|4066857|FG000|COMPLETED|Washout (A Minimum of 21 Hours)||9
3335400|NCT03341299|4066858|FG001|COMPLETED|Washout (A Minimum of 21 Hours)||9
3335401|NCT03341299|4066859|FG002|COMPLETED|Washout (A Minimum of 21 Hours)||8
3335402|NCT03341299|4066860|FG003|COMPLETED|Washout (A Minimum of 21 Hours)||9
3335403|NCT03341299|4066857|FG000|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
3335404|NCT03341299|4066858|FG001|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
3335405|NCT03341299|4066859|FG002|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
3335406|NCT03341299|4066860|FG003|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
3335407|NCT03341299|4066857|FG000|STARTED|Period 3||9
3335408|NCT03341299|4066858|FG001|STARTED|Period 3||9
3335409|NCT03341299|4066859|FG002|STARTED|Period 3||8
3335410|NCT03341299|4066860|FG003|STARTED|Period 3||9
3335411|NCT03341299|4066857|FG000|COMPLETED|Period 3||9
3335412|NCT03341299|4066858|FG001|COMPLETED|Period 3||9
3335413|NCT03341299|4066859|FG002|COMPLETED|Period 3||8
3335414|NCT03341299|4066860|FG003|COMPLETED|Period 3||9
3335415|NCT03341299|4066857|FG000|NOT COMPLETED|Period 3||0
3335416|NCT03341299|4066858|FG001|NOT COMPLETED|Period 3||0
3335417|NCT03341299|4066859|FG002|NOT COMPLETED|Period 3||0
3335418|NCT03341299|4066860|FG003|NOT COMPLETED|Period 3||0
3335419|NCT03341299|4066857|FG000|STARTED|Washout (A Minimum of 21 Hours)||9
3335420|NCT03341299|4066858|FG001|STARTED|Washout (A Minimum of 21 Hours)||9
3335421|NCT03341299|4066859|FG002|STARTED|Washout (A Minimum of 21 Hours)||8
3335422|NCT03341299|4066860|FG003|STARTED|Washout (A Minimum of 21 Hours)||9
3335423|NCT03341299|4066857|FG000|COMPLETED|Washout (A Minimum of 21 Hours)||9
3335424|NCT03341299|4066858|FG001|COMPLETED|Washout (A Minimum of 21 Hours)||9
3335425|NCT03341299|4066859|FG002|COMPLETED|Washout (A Minimum of 21 Hours)||8
3335426|NCT03341299|4066860|FG003|COMPLETED|Washout (A Minimum of 21 Hours)||9
3335427|NCT03341299|4066857|FG000|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
3335428|NCT03341299|4066858|FG001|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
3335429|NCT03341299|4066859|FG002|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
3335430|NCT03341299|4066860|FG003|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
3335431|NCT03341299|4066857|FG000|STARTED|Period 4||9
3335432|NCT03341299|4066858|FG001|STARTED|Period 4||9
3335433|NCT03341299|4066859|FG002|STARTED|Period 4||8
3335434|NCT03341299|4066860|FG003|STARTED|Period 4||9
3335435|NCT03341299|4066857|FG000|COMPLETED|Period 4||9
3335436|NCT03341299|4066858|FG001|COMPLETED|Period 4||9
3335437|NCT03341299|4066859|FG002|COMPLETED|Period 4||8
3335438|NCT03341299|4066860|FG003|COMPLETED|Period 4||9
3335439|NCT03341299|4066857|FG000|NOT COMPLETED|Period 4||0
3335440|NCT03341299|4066858|FG001|NOT COMPLETED|Period 4||0
3335441|NCT03341299|4066859|FG002|NOT COMPLETED|Period 4||0
3335442|NCT03341299|4066860|FG003|NOT COMPLETED|Period 4||0
3335443|NCT03341312|4066872|FG000|STARTED|Period 1||9
3335444|NCT03341312|4066873|FG001|STARTED|Period 1||10
3335445|NCT03341312|4066874|FG002|STARTED|Period 1||9
3335446|NCT03341312|4066875|FG003|STARTED|Period 1||8
3335447|NCT03341312|4066872|FG000|Received at Least One Dose of Study Drug|Period 1||9
3335448|NCT03341312|4066873|FG001|Received at Least One Dose of Study Drug|Period 1||10
3335449|NCT03341312|4066874|FG002|Received at Least One Dose of Study Drug|Period 1||9
3335450|NCT03341312|4066875|FG003|Received at Least One Dose of Study Drug|Period 1||8
3335451|NCT03341312|4066872|FG000|COMPLETED|Period 1||9
3335452|NCT03341312|4066873|FG001|COMPLETED|Period 1||9
3335453|NCT03341312|4066874|FG002|COMPLETED|Period 1||9
3335454|NCT03341312|4066875|FG003|COMPLETED|Period 1||8
3335455|NCT03341312|4066872|FG000|NOT COMPLETED|Period 1||0
3335456|NCT03341312|4066873|FG001|NOT COMPLETED|Period 1||1
3335457|NCT03341312|4066874|FG002|NOT COMPLETED|Period 1||0
3335458|NCT03341312|4066875|FG003|NOT COMPLETED|Period 1||0
3335459|NCT03341312|4066872|FG000|STARTED|Period 2||9
3335460|NCT03341312|4066873|FG001|STARTED|Period 2||9
3335461|NCT03341312|4066874|FG002|STARTED|Period 2||9
3335462|NCT03341312|4066875|FG003|STARTED|Period 2||8
3335463|NCT03341312|4066872|FG000|COMPLETED|Period 2||9
3335464|NCT03341312|4066873|FG001|COMPLETED|Period 2||9
3335465|NCT03341312|4066874|FG002|COMPLETED|Period 2||9
3335466|NCT03341312|4066875|FG003|COMPLETED|Period 2||8
3335467|NCT03341312|4066872|FG000|NOT COMPLETED|Period 2||0
3335468|NCT03341312|4066873|FG001|NOT COMPLETED|Period 2||0
3335469|NCT03341312|4066874|FG002|NOT COMPLETED|Period 2||0
3335470|NCT03341312|4066875|FG003|NOT COMPLETED|Period 2||0
3335471|NCT03341312|4066872|FG000|STARTED|Period 3||9
3335472|NCT03341312|4066873|FG001|STARTED|Period 3||9
3335473|NCT03341312|4066874|FG002|STARTED|Period 3||9
3335474|NCT03341312|4066875|FG003|STARTED|Period 3||8
3335475|NCT03341312|4066872|FG000|COMPLETED|Period 3||9
3335476|NCT03341312|4066873|FG001|COMPLETED|Period 3||9
3335477|NCT03341312|4066874|FG002|COMPLETED|Period 3||9
3335478|NCT03341312|4066875|FG003|COMPLETED|Period 3||8
3335479|NCT03341312|4066872|FG000|NOT COMPLETED|Period 3||0
3335480|NCT03341312|4066873|FG001|NOT COMPLETED|Period 3||0
3335481|NCT03341312|4066874|FG002|NOT COMPLETED|Period 3||0
3335482|NCT03341312|4066875|FG003|NOT COMPLETED|Period 3||0
3335483|NCT03341312|4066872|FG000|STARTED|Period 4||9
3335484|NCT03341312|4066873|FG001|STARTED|Period 4||9
3335485|NCT03341312|4066874|FG002|STARTED|Period 4||9
3335486|NCT03341312|4066875|FG003|STARTED|Period 4||8
3335487|NCT03341312|4066872|FG000|COMPLETED|Period 4||9
3335488|NCT03341312|4066873|FG001|COMPLETED|Period 4||9
3335489|NCT03341312|4066874|FG002|COMPLETED|Period 4||9
3335490|NCT03341312|4066875|FG003|COMPLETED|Period 4||8
3335491|NCT03341312|4066872|FG000|NOT COMPLETED|Period 4||0
3335492|NCT03341312|4066873|FG001|NOT COMPLETED|Period 4||0
3335493|NCT03341312|4066874|FG002|NOT COMPLETED|Period 4||0
3335494|NCT03341312|4066875|FG003|NOT COMPLETED|Period 4||0
3335495|NCT03341507|4066887|FG000|STARTED|Overall Study||64
3335496|NCT03341507|4066887|FG000|COMPLETED|Overall Study||30
3335497|NCT03341507|4066887|FG000|NOT COMPLETED|Overall Study||34
3335498|NCT03341533|4066893|FG000|STARTED|Overall Study||72
3335499|NCT03341533|4066894|FG001|STARTED|Overall Study||70
3335500|NCT03341533|4066893|FG000|COMPLETED|Overall Study||69
3335501|NCT03341533|4066894|FG001|COMPLETED|Overall Study||68
3335502|NCT03341533|4066893|FG000|NOT COMPLETED|Overall Study||3
3335503|NCT03341533|4066894|FG001|NOT COMPLETED|Overall Study||2
3335504|NCT03341546|4066900|FG000|STARTED|Overall Study||20
3335505|NCT03341546|4066900|FG000|COMPLETED|Overall Study||20
3335506|NCT03341546|4066900|FG000|NOT COMPLETED|Overall Study||0
3335507|NCT03341637|4066906|FG000|STARTED|Overall Study||100
3335508|NCT03341637|4066907|FG001|STARTED|Overall Study||300
3335509|NCT03341637|4066906|FG000|COMPLETED|Overall Study||95
3335510|NCT03341637|4066907|FG001|COMPLETED|Overall Study||296
3335511|NCT03341637|4066906|FG000|NOT COMPLETED|Overall Study||5
3335512|NCT03341637|4066907|FG001|NOT COMPLETED|Overall Study||4
3335513|NCT03341728|4066913|FG000|STARTED|Session 1||7
3335514|NCT03341728|4066914|FG001|STARTED|Session 1||7
3335515|NCT03341728|4066913|FG000|COMPLETED|Session 1||7
3335516|NCT03341728|4066914|FG001|COMPLETED|Session 1||7
3335517|NCT03341728|4066913|FG000|NOT COMPLETED|Session 1||0
3335518|NCT03341728|4066914|FG001|NOT COMPLETED|Session 1||0
3335519|NCT03341728|4066913|FG000|STARTED|Washout (1 Week)||7
3335520|NCT03341728|4066914|FG001|STARTED|Washout (1 Week)||7
3335521|NCT03341728|4066913|FG000|COMPLETED|Washout (1 Week)||7
3335522|NCT03341728|4066914|FG001|COMPLETED|Washout (1 Week)||7
3335523|NCT03341728|4066913|FG000|NOT COMPLETED|Washout (1 Week)||0
3335524|NCT03341728|4066914|FG001|NOT COMPLETED|Washout (1 Week)||0
3335525|NCT03341728|4066913|FG000|STARTED|Session 2||7
3335526|NCT03341728|4066914|FG001|STARTED|Session 2||7
3335527|NCT03341728|4066913|FG000|COMPLETED|Session 2||7
3335528|NCT03341728|4066914|FG001|COMPLETED|Session 2||7
3335529|NCT03341728|4066913|FG000|NOT COMPLETED|Session 2||0
3335530|NCT03341728|4066914|FG001|NOT COMPLETED|Session 2||0
3335531|NCT03341910|4066924|FG000|STARTED|Overall Study||54
3335532|NCT03341910|4066925|FG001|STARTED|Overall Study||49
3335533|NCT03341910|4066926|FG002|STARTED|Overall Study||26
3335534|NCT03341910|4066927|FG003|STARTED|Overall Study||26
3335535|NCT03341910|4066924|FG000|COMPLETED|Overall Study||54
3335536|NCT03341910|4066925|FG001|COMPLETED|Overall Study||49
3335537|NCT03341910|4066926|FG002|COMPLETED|Overall Study||26
3335538|NCT03341910|4066927|FG003|COMPLETED|Overall Study||26
3335539|NCT03341910|4066924|FG000|NOT COMPLETED|Overall Study||0
3335540|NCT03341910|4066925|FG001|NOT COMPLETED|Overall Study||0
3335541|NCT03341910|4066926|FG002|NOT COMPLETED|Overall Study||0
3335542|NCT03341910|4066927|FG003|NOT COMPLETED|Overall Study||0
3335543|NCT03341923|4066937|FG000|STARTED|Period 1, First 14 Days of Wear||67
3335544|NCT03341923|4066938|FG001|STARTED|Period 1, First 14 Days of Wear||67
3335545|NCT03341923|4066937|FG000|COMPLETED|Period 1, First 14 Days of Wear||67
3335546|NCT03341923|4066938|FG001|COMPLETED|Period 1, First 14 Days of Wear||67
3335547|NCT03341923|4066937|FG000|NOT COMPLETED|Period 1, First 14 Days of Wear||0
3335548|NCT03341923|4066938|FG001|NOT COMPLETED|Period 1, First 14 Days of Wear||0
3335549|NCT03341923|4066937|FG000|STARTED|Period 2, Second 14 Days of Wear||67
3335550|NCT03341923|4066938|FG001|STARTED|Period 2, Second 14 Days of Wear|Subject completed Period 1 but was discontinued before starting Period 2.|66
3335551|NCT03341923|4066937|FG000|COMPLETED|Period 2, Second 14 Days of Wear||67
3335552|NCT03341923|4066938|FG001|COMPLETED|Period 2, Second 14 Days of Wear||65
3335553|NCT03341923|4066937|FG000|NOT COMPLETED|Period 2, Second 14 Days of Wear||0
3335554|NCT03341923|4066938|FG001|NOT COMPLETED|Period 2, Second 14 Days of Wear||1
3335555|NCT03341975|4066948|FG000|STARTED|Overall Study||44
3335556|NCT03341975|4066949|FG001|STARTED|Overall Study||47
3335557|NCT03341975|4066948|FG000|COMPLETED|Overall Study||44
3335558|NCT03341975|4066949|FG001|COMPLETED|Overall Study||47
3335559|NCT03341975|4066948|FG000|NOT COMPLETED|Overall Study||0
3335560|NCT03341975|4066949|FG001|NOT COMPLETED|Overall Study||0
3335561|NCT03342053|4066957|FG000|STARTED|Overall Study||23
3335562|NCT03342053|4066958|FG001|STARTED|Overall Study||23
3335563|NCT03342053|4066957|FG000|COMPLETED|Overall Study||21
3335564|NCT03342053|4066958|FG001|COMPLETED|Overall Study||22
3335565|NCT03342053|4066957|FG000|NOT COMPLETED|Overall Study||2
3335566|NCT03342053|4066958|FG001|NOT COMPLETED|Overall Study||1
3335567|NCT03342404|4066966|FG000|STARTED|Overall Study||96
3335568|NCT03342404|4066967|FG001|STARTED|Overall Study||49
3335569|NCT03342404|4066966|FG000|COMPLETED|Overall Study||81
3335570|NCT03342404|4066967|FG001|COMPLETED|Overall Study||18
3335571|NCT03342404|4066966|FG000|NOT COMPLETED|Overall Study||15
3335572|NCT03342404|4066967|FG001|NOT COMPLETED|Overall Study||31
3335573|NCT03342469|4066975|FG000|STARTED|Overall Study||9
3335574|NCT03342469|4066976|FG001|STARTED|Overall Study||9
3335575|NCT03342469|4066977|FG002|STARTED|Overall Study||3
3335576|NCT03342469|4066978|FG003|STARTED|Overall Study||8
3335577|NCT03342469|4066975|FG000|COMPLETED|Overall Study||9
3335578|NCT03342469|4066976|FG001|COMPLETED|Overall Study||8
3335579|NCT03342469|4066977|FG002|COMPLETED|Overall Study||3
3335580|NCT03342469|4066978|FG003|COMPLETED|Overall Study||8
3335581|NCT03342469|4066975|FG000|NOT COMPLETED|Overall Study||0
3335582|NCT03342469|4066976|FG001|NOT COMPLETED|Overall Study||1
3335583|NCT03342469|4066977|FG002|NOT COMPLETED|Overall Study||0
3335584|NCT03342469|4066978|FG003|NOT COMPLETED|Overall Study||0
3335585|NCT03342560|4066989|FG000|STARTED|Overall Study||30
3335586|NCT03342560|4066989|FG000|COMPLETED|Overall Study||28
3335587|NCT03342560|4066989|FG000|NOT COMPLETED|Overall Study||2
3335588|NCT03342690|4066997|FG000|STARTED|Overall Study||1164
3335589|NCT03342690|4066997|FG000|COMPLETED|Overall Study||1139
3335590|NCT03342690|4066997|FG000|NOT COMPLETED|Overall Study||25
3335591|NCT03342898|4067004|FG000|STARTED|Overall Study||300
3335592|NCT03342898|4067005|FG001|STARTED|Overall Study||300
3335593|NCT03342898|4067006|FG002|STARTED|Overall Study||300
3335594|NCT03342898|4067004|FG000|COMPLETED|Overall Study||246
3335595|NCT03342898|4067005|FG001|COMPLETED|Overall Study||247
3335596|NCT03342898|4067006|FG002|COMPLETED|Overall Study||246
3335597|NCT03342898|4067004|FG000|NOT COMPLETED|Overall Study||54
3335598|NCT03342898|4067005|FG001|NOT COMPLETED|Overall Study||53
3335599|NCT03342898|4067006|FG002|NOT COMPLETED|Overall Study||54
3335600|NCT03342963|4067018|FG000|STARTED|Overall Study||27
3335601|NCT03342963|4067019|FG001|STARTED|Overall Study||27
3335602|NCT03342963|4067020|FG002|STARTED|Overall Study||10
3335603|NCT03342963|4067021|FG003|STARTED|Overall Study||10
3335604|NCT03342963|4067018|FG000|COMPLETED|Overall Study||25
3335605|NCT03342963|4067019|FG001|COMPLETED|Overall Study||25
3335606|NCT03342963|4067020|FG002|COMPLETED|Overall Study||10
3335607|NCT03342963|4067021|FG003|COMPLETED|Overall Study||10
3335608|NCT03342963|4067018|FG000|NOT COMPLETED|Overall Study||2
3335609|NCT03342963|4067019|FG001|NOT COMPLETED|Overall Study||2
3335610|NCT03342963|4067020|FG002|NOT COMPLETED|Overall Study||0
3335611|NCT03342963|4067021|FG003|NOT COMPLETED|Overall Study||0
3335612|NCT03343067|4067034|FG000|STARTED|Open Label Period: Day 1 to Month 3||7
3335613|NCT03343067|4067035|FG001|STARTED|Open Label Period: Day 1 to Month 3||3
3335614|NCT03343067|4067036|FG002|STARTED|Open Label Period: Day 1 to Month 3||1
3335615|NCT03343067|4067034|FG000|COMPLETED|Open Label Period: Day 1 to Month 3||0
3335616|NCT03343067|4067035|FG001|COMPLETED|Open Label Period: Day 1 to Month 3||3
3335617|NCT03343067|4067036|FG002|COMPLETED|Open Label Period: Day 1 to Month 3||1
3335618|NCT03343067|4067034|FG000|NOT COMPLETED|Open Label Period: Day 1 to Month 3||7
3335619|NCT03343067|4067035|FG001|NOT COMPLETED|Open Label Period: Day 1 to Month 3||0
3335620|NCT03343067|4067036|FG002|NOT COMPLETED|Open Label Period: Day 1 to Month 3||0
3335621|NCT03343067|4067034|FG000|STARTED|Double Blind Period: Month 3 to Month 6||0
3335622|NCT03343067|4067035|FG001|STARTED|Double Blind Period: Month 3 to Month 6||3
3335623|NCT03343067|4067036|FG002|STARTED|Double Blind Period: Month 3 to Month 6||1
3335624|NCT03343067|4067034|FG000|COMPLETED|Double Blind Period: Month 3 to Month 6||0
3335625|NCT03343067|4067035|FG001|COMPLETED|Double Blind Period: Month 3 to Month 6||0
3335626|NCT03343067|4067036|FG002|COMPLETED|Double Blind Period: Month 3 to Month 6||0
3335627|NCT03343067|4067034|FG000|NOT COMPLETED|Double Blind Period: Month 3 to Month 6||0
3335628|NCT03343067|4067035|FG001|NOT COMPLETED|Double Blind Period: Month 3 to Month 6||3
3335629|NCT03343067|4067036|FG002|NOT COMPLETED|Double Blind Period: Month 3 to Month 6||1
3335630|NCT03343080|4067046|FG000|STARTED|Overall Study||14
3335631|NCT03343080|4067047|FG001|STARTED|Overall Study||18
3335632|NCT03343080|4067046|FG000|COMPLETED|Overall Study||14
3335633|NCT03343080|4067047|FG001|COMPLETED|Overall Study||18
3335634|NCT03343080|4067046|FG000|NOT COMPLETED|Overall Study||0
3335635|NCT03343080|4067047|FG001|NOT COMPLETED|Overall Study||0
3335636|NCT03343639|4067055|FG000|STARTED|Overall Study||102
3335637|NCT03343639|4067056|FG001|STARTED|Overall Study||102
3335638|NCT03343639|4067055|FG000|COMPLETED|Overall Study||88
3176941|NCT01968070|3904660|FG014|COMPLETED|Period 2||0
3176942|NCT01968070|3904661|FG015|COMPLETED|Period 2||0
3176943|NCT01968070|3904662|FG016|COMPLETED|Period 2||0
3335639|NCT03343639|4067056|FG001|COMPLETED|Overall Study||90
3335640|NCT03343639|4067055|FG000|NOT COMPLETED|Overall Study||14
3335641|NCT03343639|4067056|FG001|NOT COMPLETED|Overall Study||12
3335642|NCT03343704|4067064|FG000|STARTED|Overall Study||13
3335643|NCT03343704|4067065|FG001|STARTED|Overall Study||6
3335644|NCT03343704|4067064|FG000|COMPLETED|Overall Study||12
3335645|NCT03343704|4067065|FG001|COMPLETED|Overall Study||4
3335646|NCT03343704|4067064|FG000|NOT COMPLETED|Overall Study||1
3335647|NCT03343704|4067065|FG001|NOT COMPLETED|Overall Study||2
3335648|NCT03344172|4067075|FG000|STARTED|Overall Study||16
3335649|NCT03344172|4067076|FG001|STARTED|Overall Study||16
3335650|NCT03344172|4067075|FG000|COMPLETED|Overall Study||15
3335651|NCT03344172|4067076|FG001|COMPLETED|Overall Study||16
3176944|NCT01968070|3904663|FG017|COMPLETED|Period 2||0
3335652|NCT03344172|4067075|FG000|NOT COMPLETED|Overall Study||1
3335653|NCT03344172|4067076|FG001|NOT COMPLETED|Overall Study||0
3335654|NCT03344510|4067082|FG000|STARTED|First Injection (5 Minutes)||21
3335655|NCT03344510|4067083|FG001|STARTED|First Injection (5 Minutes)||26
3335656|NCT03344510|4067082|FG000|Received Injection|First Injection (5 Minutes)||21
3335657|NCT03344510|4067083|FG001|Received Injection|First Injection (5 Minutes)||26
3335658|NCT03344510|4067082|FG000|COMPLETED|First Injection (5 Minutes)||21
3335659|NCT03344510|4067083|FG001|COMPLETED|First Injection (5 Minutes)||26
3335660|NCT03344510|4067082|FG000|NOT COMPLETED|First Injection (5 Minutes)||0
3335661|NCT03344510|4067083|FG001|NOT COMPLETED|First Injection (5 Minutes)||0
3335662|NCT03344510|4067082|FG000|STARTED|Wash Out (10 Minutes||21
3335663|NCT03344510|4067083|FG001|STARTED|Wash Out (10 Minutes||26
3335664|NCT03344510|4067082|FG000|COMPLETED|Wash Out (10 Minutes||21
3335665|NCT03344510|4067083|FG001|COMPLETED|Wash Out (10 Minutes||26
3335666|NCT03344510|4067082|FG000|NOT COMPLETED|Wash Out (10 Minutes||0
3335667|NCT03344510|4067083|FG001|NOT COMPLETED|Wash Out (10 Minutes||0
3335668|NCT03344510|4067082|FG000|STARTED|Second Injection (5 Minutes)||21
3335669|NCT03344510|4067083|FG001|STARTED|Second Injection (5 Minutes)||26
3335670|NCT03344510|4067082|FG000|Received Injection|Second Injection (5 Minutes)||21
3335671|NCT03344510|4067083|FG001|Received Injection|Second Injection (5 Minutes)||26
3335672|NCT03344510|4067082|FG000|COMPLETED|Second Injection (5 Minutes)||21
3335673|NCT03344510|4067083|FG001|COMPLETED|Second Injection (5 Minutes)||26
3335674|NCT03344510|4067082|FG000|NOT COMPLETED|Second Injection (5 Minutes)||0
3335675|NCT03344510|4067083|FG001|NOT COMPLETED|Second Injection (5 Minutes)||0
3335676|NCT03344640|4067092|FG000|STARTED|Overall Study||49
3335677|NCT03344640|4067093|FG001|STARTED|Overall Study||47
3335678|NCT03344640|4067092|FG000|COMPLETED|Overall Study||46
3335679|NCT03344640|4067093|FG001|COMPLETED|Overall Study||44
3335680|NCT03344640|4067092|FG000|NOT COMPLETED|Overall Study||3
3335681|NCT03344640|4067093|FG001|NOT COMPLETED|Overall Study||3
3335682|NCT03344640|4067092|FG000|STARTED|Follow-up Epoch||46
3335683|NCT03344640|4067093|FG001|STARTED|Follow-up Epoch||44
3335684|NCT03344640|4067092|FG000|COMPLETED|Follow-up Epoch||46
3335685|NCT03344640|4067093|FG001|COMPLETED|Follow-up Epoch||42
3335686|NCT03344640|4067092|FG000|NOT COMPLETED|Follow-up Epoch||0
3335687|NCT03344640|4067093|FG001|NOT COMPLETED|Follow-up Epoch||2
3335688|NCT03344861|4067099|FG000|STARTED|Overall Study||10
3335689|NCT03344861|4067099|FG000|COMPLETED|Overall Study||10
3335690|NCT03344861|4067099|FG000|NOT COMPLETED|Overall Study||0
3335691|NCT03345108|4067103|FG000|STARTED|Period-1||8
3335692|NCT03345108|4067104|FG001|STARTED|Period-1||8
3335693|NCT03345108|4067105|FG002|STARTED|Period-1||8
3335694|NCT03345108|4067106|FG003|STARTED|Period-1||8
3335695|NCT03345108|4067107|FG004|STARTED|Period-1||8
3335696|NCT03345108|4067108|FG005|STARTED|Period-1||8
3335697|NCT03345108|4067103|FG000|COMPLETED|Period-1||8
3335698|NCT03345108|4067104|FG001|COMPLETED|Period-1||8
3335699|NCT03345108|4067105|FG002|COMPLETED|Period-1||8
3335700|NCT03345108|4067106|FG003|COMPLETED|Period-1||8
3335701|NCT03345108|4067107|FG004|COMPLETED|Period-1||8
3335702|NCT03345108|4067108|FG005|COMPLETED|Period-1||8
3335703|NCT03345108|4067103|FG000|NOT COMPLETED|Period-1||0
3335704|NCT03345108|4067104|FG001|NOT COMPLETED|Period-1||0
3335705|NCT03345108|4067105|FG002|NOT COMPLETED|Period-1||0
3335706|NCT03345108|4067106|FG003|NOT COMPLETED|Period-1||0
3335707|NCT03345108|4067107|FG004|NOT COMPLETED|Period-1||0
3335708|NCT03345108|4067108|FG005|NOT COMPLETED|Period-1||0
3335709|NCT03345108|4067103|FG000|STARTED|Period-2||8
3335710|NCT03345108|4067104|FG001|STARTED|Period-2||8
3335711|NCT03345108|4067105|FG002|STARTED|Period-2||8
3335712|NCT03345108|4067106|FG003|STARTED|Period-2||8
3335713|NCT03345108|4067107|FG004|STARTED|Period-2||8
3335714|NCT03345108|4067108|FG005|STARTED|Period-2||8
3335715|NCT03345108|4067103|FG000|COMPLETED|Period-2||8
3335716|NCT03345108|4067104|FG001|COMPLETED|Period-2||8
3335717|NCT03345108|4067105|FG002|COMPLETED|Period-2||8
3335718|NCT03345108|4067106|FG003|COMPLETED|Period-2||8
3335719|NCT03345108|4067107|FG004|COMPLETED|Period-2||8
3335720|NCT03345108|4067108|FG005|COMPLETED|Period-2||8
3335721|NCT03345108|4067103|FG000|NOT COMPLETED|Period-2||0
3335722|NCT03345108|4067104|FG001|NOT COMPLETED|Period-2||0
3335723|NCT03345108|4067105|FG002|NOT COMPLETED|Period-2||0
3335724|NCT03345108|4067106|FG003|NOT COMPLETED|Period-2||0
3335725|NCT03345108|4067107|FG004|NOT COMPLETED|Period-2||0
3335726|NCT03345108|4067108|FG005|NOT COMPLETED|Period-2||0
3335727|NCT03345108|4067103|FG000|STARTED|Period-3||7
3335728|NCT03345108|4067104|FG001|STARTED|Period-3||8
3335729|NCT03345108|4067105|FG002|STARTED|Period-3||8
3335730|NCT03345108|4067106|FG003|STARTED|Period-3||8
3335731|NCT03345108|4067107|FG004|STARTED|Period-3||8
3335732|NCT03345108|4067108|FG005|STARTED|Period-3||8
3335733|NCT03345108|4067103|FG000|COMPLETED|Period-3||7
3335734|NCT03345108|4067104|FG001|COMPLETED|Period-3||8
3335735|NCT03345108|4067105|FG002|COMPLETED|Period-3||8
3335736|NCT03345108|4067106|FG003|COMPLETED|Period-3||8
3335737|NCT03345108|4067107|FG004|COMPLETED|Period-3||8
3335738|NCT03345108|4067108|FG005|COMPLETED|Period-3||8
3335739|NCT03345108|4067103|FG000|NOT COMPLETED|Period-3||0
3335740|NCT03345108|4067104|FG001|NOT COMPLETED|Period-3||0
3335741|NCT03345108|4067105|FG002|NOT COMPLETED|Period-3||0
3335742|NCT03345108|4067106|FG003|NOT COMPLETED|Period-3||0
3335743|NCT03345108|4067107|FG004|NOT COMPLETED|Period-3||0
3335744|NCT03345108|4067108|FG005|NOT COMPLETED|Period-3||0
3335745|NCT03345160|4067116|FG000|STARTED|Overall Study||7
3335746|NCT03345160|4067116|FG000|COMPLETED|Overall Study||7
3335747|NCT03345160|4067116|FG000|NOT COMPLETED|Overall Study||0
3335748|NCT03345394|4067122|FG000|STARTED|Overall Study||48
3335749|NCT03345394|4067123|FG001|STARTED|Overall Study||50
3335750|NCT03345394|4067122|FG000|COMPLETED|Overall Study||48
3335751|NCT03345394|4067123|FG001|COMPLETED|Overall Study||50
3335752|NCT03345394|4067122|FG000|NOT COMPLETED|Overall Study||0
3335753|NCT03345394|4067123|FG001|NOT COMPLETED|Overall Study||0
3335754|NCT03345407|4067136|FG000|STARTED|Overall Study||276
3335755|NCT03345407|4067137|FG001|STARTED|Overall Study||22
3335756|NCT03345407|4067138|FG002|STARTED|Overall Study||91
3335757|NCT03345407|4067139|FG003|STARTED|Overall Study||92
3335758|NCT03345407|4067140|FG004|STARTED|Overall Study||90
3335759|NCT03345407|4067141|FG005|STARTED|Overall Study||89
3335760|NCT03345407|4067142|FG006|STARTED|Overall Study||278
3335761|NCT03345407|4067136|FG000|COMPLETED|Overall Study||244
3335762|NCT03345407|4067137|FG001|COMPLETED|Overall Study||19
3335763|NCT03345407|4067138|FG002|COMPLETED|Overall Study||79
3335764|NCT03345407|4067139|FG003|COMPLETED|Overall Study||81
3335765|NCT03345407|4067140|FG004|COMPLETED|Overall Study||75
3335766|NCT03345407|4067141|FG005|COMPLETED|Overall Study||73
3335767|NCT03345407|4067142|FG006|COMPLETED|Overall Study||233
3335768|NCT03345407|4067136|FG000|NOT COMPLETED|Overall Study||32
3335769|NCT03345407|4067137|FG001|NOT COMPLETED|Overall Study||3
3335770|NCT03345407|4067138|FG002|NOT COMPLETED|Overall Study||12
3335771|NCT03345407|4067139|FG003|NOT COMPLETED|Overall Study||11
3335772|NCT03345407|4067140|FG004|NOT COMPLETED|Overall Study||15
3335773|NCT03345407|4067141|FG005|NOT COMPLETED|Overall Study||16
3335774|NCT03345407|4067142|FG006|NOT COMPLETED|Overall Study||45
3335775|NCT03345472|4067164|FG000|STARTED|Implant to 3 Months||103
3335776|NCT03345472|4067164|FG000|COMPLETED|Implant to 3 Months||99
3335777|NCT03345472|4067164|FG000|NOT COMPLETED|Implant to 3 Months||4
3335778|NCT03345472|4067164|FG000|STARTED|3 Months to 12 Months||99
3335779|NCT03345472|4067164|FG000|COMPLETED|3 Months to 12 Months||91
3335780|NCT03345472|4067164|FG000|NOT COMPLETED|3 Months to 12 Months||8
3335781|NCT03345914|4067171|FG000|STARTED|Overall Study||123
3335782|NCT03345914|4067172|FG001|STARTED|Overall Study||122
3335783|NCT03345914|4067173|FG002|STARTED|Overall Study||122
3335784|NCT03345914|4067171|FG000|Completed Week 16 Study Treatment|Overall Study||114
3335785|NCT03345914|4067172|FG001|Completed Week 16 Study Treatment|Overall Study||118
3335786|NCT03345914|4067173|FG002|Completed Week 16 Study Treatment|Overall Study||119
3335787|NCT03345914|4067171|FG000|Completed Week 28 End of Study|Overall Study||0
3335788|NCT03345914|4067172|FG001|Completed Week 28 End of Study|Overall Study||0
3335789|NCT03345914|4067173|FG002|Completed Week 28 End of Study|Overall Study||0
3335790|NCT03345914|4067171|FG000|COMPLETED|Overall Study||0
3335791|NCT03345914|4067172|FG001|COMPLETED|Overall Study||0
3335792|NCT03345914|4067173|FG002|COMPLETED|Overall Study||0
3335793|NCT03345914|4067171|FG000|NOT COMPLETED|Overall Study||123
3335794|NCT03345914|4067172|FG001|NOT COMPLETED|Overall Study||122
3335795|NCT03345914|4067173|FG002|NOT COMPLETED|Overall Study||122
3335796|NCT03345979|4067183|FG000|STARTED|Overall Study||99
3335797|NCT03345979|4067184|FG001|STARTED|Overall Study||101
3335798|NCT03345979|4067183|FG000|COMPLETED|Overall Study||56
3335799|NCT03345979|4067184|FG001|COMPLETED|Overall Study||43
3335800|NCT03345979|4067183|FG000|NOT COMPLETED|Overall Study||43
3335801|NCT03345979|4067184|FG001|NOT COMPLETED|Overall Study||58
3335802|NCT03346057|4067194|FG000|STARTED|Overall Study||111
3335803|NCT03346057|4067195|FG001|STARTED|Overall Study||112
3335804|NCT03346057|4067196|FG002|STARTED|Overall Study||68
3335805|NCT03346057|4067197|FG003|STARTED|Overall Study||53
3335806|NCT03346057|4067194|FG000|Treated|Overall Study||105
3335807|NCT03346057|4067195|FG001|Treated|Overall Study||107
3335808|NCT03346057|4067196|FG002|Treated|Overall Study||68
3335809|NCT03346057|4067197|FG003|Treated|Overall Study||51
3335810|NCT03346057|4067194|FG000|COMPLETED|Overall Study||104
3335811|NCT03346057|4067195|FG001|COMPLETED|Overall Study||104
3335812|NCT03346057|4067196|FG002|COMPLETED|Overall Study||67
3335813|NCT03346057|4067197|FG003|COMPLETED|Overall Study||51
3335814|NCT03346057|4067194|FG000|NOT COMPLETED|Overall Study||7
3335815|NCT03346057|4067195|FG001|NOT COMPLETED|Overall Study||8
3335816|NCT03346057|4067196|FG002|NOT COMPLETED|Overall Study||1
3335817|NCT03346057|4067197|FG003|NOT COMPLETED|Overall Study||2
3335818|NCT03346070|4067212|FG000|STARTED|Overall Study||41
3335819|NCT03346070|4067213|FG001|STARTED|Overall Study||41
3335820|NCT03346070|4067214|FG002|STARTED|Overall Study||41
3335821|NCT03346070|4067215|FG003|STARTED|Overall Study||42
3335822|NCT03346070|4067216|FG004|STARTED|Overall Study||42
3335823|NCT03346070|4067212|FG000|Treated|Overall Study||38
3335824|NCT03346070|4067213|FG001|Treated|Overall Study||38
3335825|NCT03346070|4067214|FG002|Treated|Overall Study||38
3335826|NCT03346070|4067215|FG003|Treated|Overall Study||36
3335827|NCT03346070|4067216|FG004|Treated|Overall Study||38
3335828|NCT03346070|4067212|FG000|COMPLETED|Overall Study||38
3335829|NCT03346070|4067213|FG001|COMPLETED|Overall Study||37
3335830|NCT03346070|4067214|FG002|COMPLETED|Overall Study||37
3335831|NCT03346070|4067215|FG003|COMPLETED|Overall Study||36
3335832|NCT03346070|4067216|FG004|COMPLETED|Overall Study||37
3335833|NCT03346070|4067212|FG000|NOT COMPLETED|Overall Study||3
3335834|NCT03346070|4067213|FG001|NOT COMPLETED|Overall Study||4
3335835|NCT03346070|4067214|FG002|NOT COMPLETED|Overall Study||4
3335836|NCT03346070|4067215|FG003|NOT COMPLETED|Overall Study||6
3335837|NCT03346070|4067216|FG004|NOT COMPLETED|Overall Study||5
3335838|NCT03346161|4067232|FG000|STARTED|Overall Study||60
3335839|NCT03346161|4067233|FG001|STARTED|Overall Study||60
3176945|NCT01968070|3904646|FG000|NOT COMPLETED|Period 2||0
3176946|NCT01968070|3904647|FG001|NOT COMPLETED|Period 2||0
3176947|NCT01968070|3904648|FG002|NOT COMPLETED|Period 2||0
3176948|NCT01968070|3904649|FG003|NOT COMPLETED|Period 2||0
3176949|NCT01968070|3904650|FG004|NOT COMPLETED|Period 2||1
2927808|NCT00574288|3638681|FG001|COMPLETED|Overall Study||0
2927809|NCT00574288|3638682|FG002|COMPLETED|Overall Study||0
2927810|NCT00574288|3638683|FG003|COMPLETED|Overall Study||1
2927811|NCT00574288|3638684|FG004|COMPLETED|Overall Study||1
2927812|NCT00574288|3638685|FG005|COMPLETED|Overall Study||4
2927813|NCT00574288|3638686|FG006|COMPLETED|Overall Study||14
2927814|NCT00574288|3638680|FG000|NOT COMPLETED|Overall Study||20
2927815|NCT00574288|3638681|FG001|NOT COMPLETED|Overall Study||3
2927816|NCT00574288|3638682|FG002|NOT COMPLETED|Overall Study||3
2927817|NCT00574288|3638683|FG003|NOT COMPLETED|Overall Study||2
2927818|NCT00574288|3638684|FG004|NOT COMPLETED|Overall Study||2
2927819|NCT00574288|3638685|FG005|NOT COMPLETED|Overall Study||26
2927820|NCT00574288|3638686|FG006|NOT COMPLETED|Overall Study||28
2927821|NCT00574340|3638712|FG000|STARTED|Study 1 (2 Days)||10
2927822|NCT00574340|3638713|FG001|STARTED|Study 1 (2 Days)||10
2927823|NCT00574340|3638712|FG000|COMPLETED|Study 1 (2 Days)||10
2927824|NCT00574340|3638713|FG001|COMPLETED|Study 1 (2 Days)||10
2927825|NCT00574340|3638712|FG000|NOT COMPLETED|Study 1 (2 Days)||0
2927826|NCT00574340|3638713|FG001|NOT COMPLETED|Study 1 (2 Days)||0
2927827|NCT00574340|3638712|FG000|STARTED|Study 2 (2 Days)||6
2927828|NCT00574340|3638713|FG001|STARTED|Study 2 (2 Days)||6
2927829|NCT00574340|3638712|FG000|COMPLETED|Study 2 (2 Days)||6
2927830|NCT00574340|3638713|FG001|COMPLETED|Study 2 (2 Days)||6
3176950|NCT01968070|3904651|FG005|NOT COMPLETED|Period 2||0
3335840|NCT03346161|4067232|FG000|COMPLETED|Overall Study||60
3335841|NCT03346161|4067233|FG001|COMPLETED|Overall Study||60
3335842|NCT03346161|4067232|FG000|NOT COMPLETED|Overall Study||0
3335843|NCT03346161|4067233|FG001|NOT COMPLETED|Overall Study||0
3335844|NCT03346759|4067241|FG000|STARTED|Enrollment to Baseline Data Collected||15
3335845|NCT03346759|4067242|FG001|STARTED|Enrollment to Baseline Data Collected||13
3335846|NCT03346759|4067241|FG000|COMPLETED|Enrollment to Baseline Data Collected|Participants assigned to the Tampon A First arm who provided at least one vaginal microbiota sample.|13
3335847|NCT03346759|4067242|FG001|COMPLETED|Enrollment to Baseline Data Collected|Participants assigned to the Tampon B First arm who provided at least one vaginal microbiota sample.|10
3335848|NCT03346759|4067241|FG000|NOT COMPLETED|Enrollment to Baseline Data Collected||2
3335849|NCT03346759|4067242|FG001|NOT COMPLETED|Enrollment to Baseline Data Collected||3
3335850|NCT03346759|4067241|FG000|STARTED|First Menstrual Cycle||13
3335851|NCT03346759|4067242|FG001|STARTED|First Menstrual Cycle||10
3335852|NCT03346759|4067241|FG000|COMPLETED|First Menstrual Cycle||12
3335853|NCT03346759|4067242|FG001|COMPLETED|First Menstrual Cycle||10
3335854|NCT03346759|4067241|FG000|NOT COMPLETED|First Menstrual Cycle||1
3335855|NCT03346759|4067242|FG001|NOT COMPLETED|First Menstrual Cycle||0
3335856|NCT03346759|4067241|FG000|STARTED|Second Menstrual Cycle||12
3335857|NCT03346759|4067242|FG001|STARTED|Second Menstrual Cycle||10
3335858|NCT03346759|4067241|FG000|COMPLETED|Second Menstrual Cycle||11
3335859|NCT03346759|4067242|FG001|COMPLETED|Second Menstrual Cycle||10
3335860|NCT03346759|4067241|FG000|NOT COMPLETED|Second Menstrual Cycle||1
3335861|NCT03346759|4067242|FG001|NOT COMPLETED|Second Menstrual Cycle||0
3335862|NCT03346759|4067241|FG000|STARTED|Third Menstrual Cycle||11
3335863|NCT03346759|4067242|FG001|STARTED|Third Menstrual Cycle||10
3335864|NCT03346759|4067241|FG000|COMPLETED|Third Menstrual Cycle||11
3335865|NCT03346759|4067242|FG001|COMPLETED|Third Menstrual Cycle||10
3335866|NCT03346759|4067241|FG000|NOT COMPLETED|Third Menstrual Cycle||0
3335867|NCT03346759|4067242|FG001|NOT COMPLETED|Third Menstrual Cycle||0
3335868|NCT03346850|4067251|FG000|STARTED|Overall Study||20
3335869|NCT03346850|4067252|FG001|STARTED|Overall Study||20
3335870|NCT03346850|4067251|FG000|COMPLETED|Overall Study||18
3335871|NCT03346850|4067252|FG001|COMPLETED|Overall Study||17
3335872|NCT03346850|4067251|FG000|NOT COMPLETED|Overall Study||2
3335873|NCT03346850|4067252|FG001|NOT COMPLETED|Overall Study||3
3335874|NCT03346902|4067260|FG000|STARTED|Overall Study||4
3335875|NCT03346902|4067261|FG001|STARTED|Overall Study||8
3335876|NCT03346902|4067260|FG000|COMPLETED|Overall Study||4
3335877|NCT03346902|4067261|FG001|COMPLETED|Overall Study||8
3335878|NCT03346902|4067260|FG000|NOT COMPLETED|Overall Study||0
3335879|NCT03346902|4067261|FG001|NOT COMPLETED|Overall Study||0
3335880|NCT03347188|4067269|FG000|STARTED|Double-blind (DB) Period (12 Weeks)||44
3335881|NCT03347188|4067270|FG001|STARTED|Double-blind (DB) Period (12 Weeks)||43
3335882|NCT03347188|4067269|FG000|Received at Least 1 Dose of Study Drug|Double-blind (DB) Period (12 Weeks)||43
3335883|NCT03347188|4067270|FG001|Received at Least 1 Dose of Study Drug|Double-blind (DB) Period (12 Weeks)||43
3335884|NCT03347188|4067269|FG000|Full Analysis Set (FAS)|Double-blind (DB) Period (12 Weeks)||42
3335885|NCT03347188|4067270|FG001|Full Analysis Set (FAS)|Double-blind (DB) Period (12 Weeks)||43
3335886|NCT03347188|4067269|FG000|COMPLETED|Double-blind (DB) Period (12 Weeks)||29
3335887|NCT03347188|4067270|FG001|COMPLETED|Double-blind (DB) Period (12 Weeks)||26
3335888|NCT03347188|4067269|FG000|NOT COMPLETED|Double-blind (DB) Period (12 Weeks)||15
3335889|NCT03347188|4067270|FG001|NOT COMPLETED|Double-blind (DB) Period (12 Weeks)||17
3335890|NCT03347188|4067269|FG000|STARTED|Open-label (OL) Period (12 Weeks)||35
3335891|NCT03347188|4067270|FG001|STARTED|Open-label (OL) Period (12 Weeks)||35
3335892|NCT03347188|4067269|FG000|Entered in OL Period for Anti-drug Antibody (ADA) Only|Open-label (OL) Period (12 Weeks)||26
3335893|NCT03347188|4067270|FG001|Entered in OL Period for Anti-drug Antibody (ADA) Only|Open-label (OL) Period (12 Weeks)||28
3335894|NCT03347188|4067269|FG000|Received at Least 1 Dose of Study Drug|Open-label (OL) Period (12 Weeks)||9
3335895|NCT03347188|4067270|FG001|Received at Least 1 Dose of Study Drug|Open-label (OL) Period (12 Weeks)||7
3335896|NCT03347188|4067269|FG000|COMPLETED|Open-label (OL) Period (12 Weeks)||8
3335897|NCT03347188|4067270|FG001|COMPLETED|Open-label (OL) Period (12 Weeks)||6
3335898|NCT03347188|4067269|FG000|NOT COMPLETED|Open-label (OL) Period (12 Weeks)||27
3335899|NCT03347188|4067270|FG001|NOT COMPLETED|Open-label (OL) Period (12 Weeks)||29
3335900|NCT03347279|4067278|FG000|STARTED|Overall Study||529
3335901|NCT03347279|4067279|FG001|STARTED|Overall Study||532
3335902|NCT03347279|4067278|FG000|Received Treatment|Overall Study||528
3335903|NCT03347279|4067279|FG001|Received Treatment|Overall Study||531
3335904|NCT03347279|4067278|FG000|COMPLETED|Overall Study||513
3335905|NCT03347279|4067279|FG001|COMPLETED|Overall Study||509
3335906|NCT03347279|4067278|FG000|NOT COMPLETED|Overall Study||16
3335907|NCT03347279|4067279|FG001|NOT COMPLETED|Overall Study||23
3335908|NCT03347695|4067287|FG000|STARTED|Overall Study||20
3039803|NCT01160744|3759283|FG000|Received Study Drug|Overall Study||69
3039804|NCT01160744|3759284|FG001|Received Study Drug|Overall Study||67
3039805|NCT01160744|3759285|FG002|Received Study Drug|Overall Study||63
3039806|NCT01160744|3759286|FG003|Received Study Drug|Overall Study||71
3039807|NCT01160744|3759283|FG000|COMPLETED|Overall Study||60
3039808|NCT01160744|3759284|FG001|COMPLETED|Overall Study||64
3039809|NCT01160744|3759285|FG002|COMPLETED|Overall Study||62
3039810|NCT01160744|3759286|FG003|COMPLETED|Overall Study||67
3335909|NCT03347695|4067288|FG001|STARTED|Overall Study||120
3335910|NCT03347695|4067287|FG000|COMPLETED|Overall Study||20
3335911|NCT03347695|4067288|FG001|COMPLETED|Overall Study||115
3039811|NCT01160744|3759283|FG000|NOT COMPLETED|Overall Study||11
3335912|NCT03347695|4067287|FG000|NOT COMPLETED|Overall Study||0
3335913|NCT03347695|4067288|FG001|NOT COMPLETED|Overall Study||5
3335914|NCT03348683|4067298|FG000|STARTED|Overall Study||121
3335915|NCT03348683|4067299|FG001|STARTED|Overall Study||119
3335916|NCT03348683|4067298|FG000|COMPLETED|Overall Study||121
3335917|NCT03348683|4067299|FG001|COMPLETED|Overall Study||119
3335918|NCT03348683|4067298|FG000|NOT COMPLETED|Overall Study||0
3335919|NCT03348683|4067299|FG001|NOT COMPLETED|Overall Study||0
3335920|NCT03349034|4067307|FG000|STARTED|Overall Study||12
3335921|NCT03349034|4067308|FG001|STARTED|Overall Study||12
3335922|NCT03349034|4067307|FG000|COMPLETED|Overall Study||8
3335923|NCT03349034|4067308|FG001|COMPLETED|Overall Study||10
3335924|NCT03349034|4067307|FG000|NOT COMPLETED|Overall Study||4
3335925|NCT03349034|4067308|FG001|NOT COMPLETED|Overall Study||2
3335926|NCT03349060|4067319|FG000|STARTED|Overall Study||156
3335927|NCT03349060|4067320|FG001|STARTED|Overall Study||154
3335928|NCT03349060|4067321|FG002|STARTED|Overall Study||77
3335929|NCT03349060|4067319|FG000|COMPLETED|Overall Study||135
3335930|NCT03349060|4067320|FG001|COMPLETED|Overall Study||137
3335931|NCT03349060|4067321|FG002|COMPLETED|Overall Study||61
3335932|NCT03349060|4067319|FG000|NOT COMPLETED|Overall Study||21
3335933|NCT03349060|4067320|FG001|NOT COMPLETED|Overall Study||17
3335934|NCT03349060|4067321|FG002|NOT COMPLETED|Overall Study||16
3335935|NCT03349099|4067331|FG000|STARTED|Overall Study||48
3335936|NCT03349099|4067332|FG001|STARTED|Overall Study||47
3335937|NCT03349099|4067331|FG000|COMPLETED|Overall Study||44
3335938|NCT03349099|4067332|FG001|COMPLETED|Overall Study||43
3335939|NCT03349099|4067331|FG000|NOT COMPLETED|Overall Study||4
3335940|NCT03349099|4067332|FG001|NOT COMPLETED|Overall Study||4
3335941|NCT03349333|4067338|FG000|STARTED|Overall Study||71
3335942|NCT03349333|4067338|FG000|COMPLETED|Overall Study||0
3335943|NCT03349333|4067338|FG000|NOT COMPLETED|Overall Study||71
3335944|NCT03349437|4067342|FG000|STARTED|Screening||25
3335945|NCT03349437|4067343|FG001|STARTED|Screening||0
3335946|NCT03349437|4067344|FG002|STARTED|Screening||0
3335947|NCT03349437|4067342|FG000|COMPLETED|Screening||20
3335948|NCT03349437|4067343|FG001|COMPLETED|Screening||0
3335949|NCT03349437|4067344|FG002|COMPLETED|Screening||0
3335950|NCT03349437|4067342|FG000|NOT COMPLETED|Screening||5
3335951|NCT03349437|4067343|FG001|NOT COMPLETED|Screening||0
3335952|NCT03349437|4067344|FG002|NOT COMPLETED|Screening||0
3335953|NCT03349437|4067342|FG000|STARTED|Intervention||0
3335954|NCT03349437|4067343|FG001|STARTED|Intervention||10
3335955|NCT03349437|4067344|FG002|STARTED|Intervention||10
3335956|NCT03349437|4067342|FG000|COMPLETED|Intervention||0
3335957|NCT03349437|4067343|FG001|COMPLETED|Intervention||10
3335958|NCT03349437|4067344|FG002|COMPLETED|Intervention||10
3335959|NCT03349437|4067342|FG000|NOT COMPLETED|Intervention||0
3335960|NCT03349437|4067343|FG001|NOT COMPLETED|Intervention||0
3335961|NCT03349437|4067344|FG002|NOT COMPLETED|Intervention||0
3335962|NCT03349515|4067353|FG000|STARTED|Overall Study||55
3335963|NCT03349515|4067354|FG001|STARTED|Overall Study||51
3335964|NCT03349515|4067353|FG000|COMPLETED|Overall Study||50
3335965|NCT03349515|4067354|FG001|COMPLETED|Overall Study||50
3335966|NCT03349515|4067353|FG000|NOT COMPLETED|Overall Study||5
3335967|NCT03349515|4067354|FG001|NOT COMPLETED|Overall Study||1
3335968|NCT03349567|4067364|FG000|STARTED|Overall Study||2
3335969|NCT03349567|4067365|FG001|STARTED|Overall Study||2
3335970|NCT03349567|4067364|FG000|COMPLETED|Overall Study||2
3335971|NCT03349567|4067365|FG001|COMPLETED|Overall Study||2
3335972|NCT03349567|4067364|FG000|NOT COMPLETED|Overall Study||0
3335973|NCT03349567|4067365|FG001|NOT COMPLETED|Overall Study||0
3335974|NCT03349632|4067373|FG000|STARTED|Period 1, First Week of Wear||11
3335975|NCT03349632|4067374|FG001|STARTED|Period 1, First Week of Wear||11
3335976|NCT03349632|4067375|FG002|STARTED|Period 1, First Week of Wear||11
3335977|NCT03349632|4067376|FG003|STARTED|Period 1, First Week of Wear||11
3335978|NCT03349632|4067377|FG004|STARTED|Period 1, First Week of Wear||11
3335979|NCT03349632|4067378|FG005|STARTED|Period 1, First Week of Wear||11
3335980|NCT03349632|4067373|FG000|COMPLETED|Period 1, First Week of Wear||11
3335981|NCT03349632|4067374|FG001|COMPLETED|Period 1, First Week of Wear||11
3335982|NCT03349632|4067375|FG002|COMPLETED|Period 1, First Week of Wear||11
3335983|NCT03349632|4067376|FG003|COMPLETED|Period 1, First Week of Wear||11
3335984|NCT03349632|4067377|FG004|COMPLETED|Period 1, First Week of Wear||11
3335985|NCT03349632|4067378|FG005|COMPLETED|Period 1, First Week of Wear||11
3335986|NCT03349632|4067373|FG000|NOT COMPLETED|Period 1, First Week of Wear||0
3335987|NCT03349632|4067374|FG001|NOT COMPLETED|Period 1, First Week of Wear||0
3335988|NCT03349632|4067375|FG002|NOT COMPLETED|Period 1, First Week of Wear||0
3335989|NCT03349632|4067376|FG003|NOT COMPLETED|Period 1, First Week of Wear||0
3335990|NCT03349632|4067377|FG004|NOT COMPLETED|Period 1, First Week of Wear||0
3335991|NCT03349632|4067378|FG005|NOT COMPLETED|Period 1, First Week of Wear||0
3335992|NCT03349632|4067373|FG000|STARTED|Period 2, Second Week of Wear||11
3335993|NCT03349632|4067374|FG001|STARTED|Period 2, Second Week of Wear||11
3335994|NCT03349632|4067375|FG002|STARTED|Period 2, Second Week of Wear||11
3335995|NCT03349632|4067376|FG003|STARTED|Period 2, Second Week of Wear||11
3335996|NCT03349632|4067377|FG004|STARTED|Period 2, Second Week of Wear||11
3335997|NCT03349632|4067378|FG005|STARTED|Period 2, Second Week of Wear||11
3335998|NCT03349632|4067373|FG000|COMPLETED|Period 2, Second Week of Wear||11
3335999|NCT03349632|4067374|FG001|COMPLETED|Period 2, Second Week of Wear||11
3336000|NCT03349632|4067375|FG002|COMPLETED|Period 2, Second Week of Wear||11
3336001|NCT03349632|4067376|FG003|COMPLETED|Period 2, Second Week of Wear||11
3336002|NCT03349632|4067377|FG004|COMPLETED|Period 2, Second Week of Wear||11
3336003|NCT03349632|4067378|FG005|COMPLETED|Period 2, Second Week of Wear||11
3336004|NCT03349632|4067373|FG000|NOT COMPLETED|Period 2, Second Week of Wear||0
3336005|NCT03349632|4067374|FG001|NOT COMPLETED|Period 2, Second Week of Wear||0
3336006|NCT03349632|4067375|FG002|NOT COMPLETED|Period 2, Second Week of Wear||0
3336007|NCT03349632|4067376|FG003|NOT COMPLETED|Period 2, Second Week of Wear||0
3336008|NCT03349632|4067377|FG004|NOT COMPLETED|Period 2, Second Week of Wear||0
3336009|NCT03349632|4067378|FG005|NOT COMPLETED|Period 2, Second Week of Wear||0
3336010|NCT03349710|4067396|FG000|STARTED|Randomized||12
3336011|NCT03349710|4067397|FG001|STARTED|Randomized||10
3336012|NCT03349710|4067398|FG002|STARTED|Randomized||27
3336013|NCT03349710|4067399|FG003|STARTED|Randomized||25
3336014|NCT03349710|4067396|FG000|COMPLETED|Randomized||12
3336015|NCT03349710|4067397|FG001|COMPLETED|Randomized||10
3336016|NCT03349710|4067398|FG002|COMPLETED|Randomized||27
3336017|NCT03349710|4067399|FG003|COMPLETED|Randomized||24
3336018|NCT03349710|4067396|FG000|NOT COMPLETED|Randomized||0
3336019|NCT03349710|4067397|FG001|NOT COMPLETED|Randomized||0
3336020|NCT03349710|4067398|FG002|NOT COMPLETED|Randomized||0
3336021|NCT03349710|4067399|FG003|NOT COMPLETED|Randomized||1
3336022|NCT03349710|4067396|FG000|STARTED|Treatment Period||12
3336023|NCT03349710|4067397|FG001|STARTED|Treatment Period||10
3336024|NCT03349710|4067398|FG002|STARTED|Treatment Period||27
3336025|NCT03349710|4067399|FG003|STARTED|Treatment Period||24
3336026|NCT03349710|4067396|FG000|COMPLETED|Treatment Period||0
3336027|NCT03349710|4067397|FG001|COMPLETED|Treatment Period||0
3336028|NCT03349710|4067398|FG002|COMPLETED|Treatment Period||0
3336029|NCT03349710|4067399|FG003|COMPLETED|Treatment Period||0
3336030|NCT03349710|4067396|FG000|NOT COMPLETED|Treatment Period||12
3336031|NCT03349710|4067397|FG001|NOT COMPLETED|Treatment Period||10
3336032|NCT03349710|4067398|FG002|NOT COMPLETED|Treatment Period||27
3336033|NCT03349710|4067399|FG003|NOT COMPLETED|Treatment Period||24
3336034|NCT03349892|4067409|FG000|STARTED|Overall Study||1
3336035|NCT03349892|4067409|FG000|COMPLETED|Overall Study||1
3336036|NCT03349892|4067409|FG000|NOT COMPLETED|Overall Study||0
3336037|NCT03350217|4067415|FG000|STARTED|Overall Study||79
3336038|NCT03350217|4067416|FG001|STARTED|Overall Study||81
3336039|NCT03350217|4067415|FG000|COMPLETED|Overall Study||77
3336040|NCT03350217|4067416|FG001|COMPLETED|Overall Study||81
3336041|NCT03350217|4067415|FG000|NOT COMPLETED|Overall Study||2
3336042|NCT03350217|4067416|FG001|NOT COMPLETED|Overall Study||0
3336043|NCT03350256|4067422|FG000|STARTED|Overall Study||60
3336044|NCT03350256|4067422|FG000|Spinal Cord Stimulation Trial|Overall Study|Subject that underwent SCS trial|50
3336045|NCT03350256|4067422|FG000|Permanent Implant|Overall Study|subjects that underwent permanent SCS implant|35
3336046|NCT03350256|4067422|FG000|1 Month Follow up|Overall Study||30
3336047|NCT03350256|4067422|FG000|3 Month Follow up|Overall Study||27
3336048|NCT03350256|4067422|FG000|6 Month Follow up|Overall Study||24
3336049|NCT03350256|4067422|FG000|COMPLETED|Overall Study||24
3336050|NCT03350256|4067422|FG000|NOT COMPLETED|Overall Study||36
3336051|NCT03350542|4067426|FG000|STARTED|Overall Study||100
3336052|NCT03350542|4067426|FG000|Completed 12-Month Clinical F/U|Overall Study||96
3336053|NCT03350542|4067426|FG000|Death With no 12-month F/U|Overall Study||4
3336054|NCT03350542|4067426|FG000|COMPLETED|Overall Study||96
3336055|NCT03350542|4067426|FG000|NOT COMPLETED|Overall Study||4
3336056|NCT03350672|4067433|FG000|STARTED|Overall Study||17
3336057|NCT03350672|4067434|FG001|STARTED|Overall Study||10
3336058|NCT03350672|4067435|FG002|STARTED|Overall Study||10
3336059|NCT03350672|4067433|FG000|COMPLETED|Overall Study||10
3336060|NCT03350672|4067434|FG001|COMPLETED|Overall Study||10
3336061|NCT03350672|4067435|FG002|COMPLETED|Overall Study||10
3336062|NCT03350672|4067433|FG000|NOT COMPLETED|Overall Study||7
3336063|NCT03350672|4067434|FG001|NOT COMPLETED|Overall Study||0
3336064|NCT03350672|4067435|FG002|NOT COMPLETED|Overall Study||0
3336065|NCT03350724|4067445|FG000|STARTED|Overall Study||17
3336066|NCT03350724|4067446|FG001|STARTED|Overall Study||17
3336067|NCT03350724|4067445|FG000|COMPLETED|Overall Study||17
3336068|NCT03350724|4067446|FG001|COMPLETED|Overall Study||17
3336069|NCT03350724|4067445|FG000|NOT COMPLETED|Overall Study||0
3336070|NCT03350724|4067446|FG001|NOT COMPLETED|Overall Study||0
3336071|NCT03350919|4067454|FG000|STARTED|Overall Study||25
3336072|NCT03350919|4067455|FG001|STARTED|Overall Study||23
3336073|NCT03350919|4067454|FG000|COMPLETED|Overall Study||23
3336074|NCT03350919|4067455|FG001|COMPLETED|Overall Study||23
3336075|NCT03350919|4067454|FG000|NOT COMPLETED|Overall Study||2
3336076|NCT03350919|4067455|FG001|NOT COMPLETED|Overall Study||0
3336077|NCT03351101|4067465|FG000|STARTED|Overall Study||136
3336078|NCT03351101|4067466|FG001|STARTED|Overall Study||132
3336079|NCT03351101|4067465|FG000|COMPLETED|Overall Study||135
3336080|NCT03351101|4067466|FG001|COMPLETED|Overall Study||129
3336081|NCT03351101|4067465|FG000|NOT COMPLETED|Overall Study||1
3336082|NCT03351101|4067466|FG001|NOT COMPLETED|Overall Study||3
3336083|NCT03351114|4067472|FG000|STARTED|Overall Study||8
3336084|NCT03351114|4067472|FG000|COMPLETED|Overall Study||7
3336085|NCT03351114|4067472|FG000|NOT COMPLETED|Overall Study||1
3336086|NCT03351231|4067476|FG000|STARTED|Combination Therapy Period|Started = initiated and completed monotherapy, then initiated combination therapy|5
3336087|NCT03351231|4067476|FG000|COMPLETED|Combination Therapy Period|Completed = finished combination therapy|0
3336088|NCT03351231|4067476|FG000|NOT COMPLETED|Combination Therapy Period||5
3336089|NCT03351231|4067476|FG000|STARTED|Safety Follow-Up Period|Started = Initiated Safety Follow-up|3
3336090|NCT03351231|4067476|FG000|COMPLETED|Safety Follow-Up Period|Completed = Finishing safety follow-up and continuing in study|0
3336091|NCT03351231|4067476|FG000|NOT COMPLETED|Safety Follow-Up Period||3
3336092|NCT03351335|4067483|FG000|STARTED|Overall Study||21
3336093|NCT03351335|4067484|FG001|STARTED|Overall Study||19
3336094|NCT03351335|4067485|FG002|STARTED|Overall Study||20
3336095|NCT03351335|4067483|FG000|COMPLETED|Overall Study||21
3336096|NCT03351335|4067484|FG001|COMPLETED|Overall Study||19
3336097|NCT03351335|4067485|FG002|COMPLETED|Overall Study||16
3176951|NCT01968070|3904652|FG006|NOT COMPLETED|Period 2||0
3176952|NCT01968070|3904653|FG007|NOT COMPLETED|Period 2||0
3176953|NCT01968070|3904654|FG008|NOT COMPLETED|Period 2||0
3176954|NCT01968070|3904655|FG009|NOT COMPLETED|Period 2||0
3176955|NCT01968070|3904656|FG010|NOT COMPLETED|Period 2||0
3336098|NCT03351335|4067483|FG000|NOT COMPLETED|Overall Study||0
3336099|NCT03351335|4067484|FG001|NOT COMPLETED|Overall Study||0
3336100|NCT03351335|4067485|FG002|NOT COMPLETED|Overall Study||4
3176956|NCT01968070|3904657|FG011|NOT COMPLETED|Period 2||0
3336101|NCT03351478|4067496|FG000|STARTED|Overall Study||307
3336102|NCT03351478|4067497|FG001|STARTED|Overall Study||309
3336103|NCT03351478|4067498|FG002|STARTED|Overall Study||154
3336104|NCT03351478|4067496|FG000|COMPLETED|Overall Study||293
3336105|NCT03351478|4067497|FG001|COMPLETED|Overall Study||292
3336106|NCT03351478|4067498|FG002|COMPLETED|Overall Study||147
3336107|NCT03351478|4067496|FG000|NOT COMPLETED|Overall Study||14
3336108|NCT03351478|4067497|FG001|NOT COMPLETED|Overall Study||17
3336109|NCT03351478|4067498|FG002|NOT COMPLETED|Overall Study||7
3336110|NCT03351608|4067511|FG000|STARTED|Overall Study||19
3336111|NCT03351608|4067512|FG001|STARTED|Overall Study||23
3336112|NCT03351608|4067513|FG002|STARTED|Overall Study||35
3336113|NCT03351608|4067514|FG003|STARTED|Overall Study||176
3336114|NCT03351608|4067515|FG004|STARTED|Overall Study||35
3336115|NCT03351608|4067511|FG000|Treated|Overall Study||18
3336116|NCT03351608|4067512|FG001|Treated|Overall Study||22
3336117|NCT03351608|4067513|FG002|Treated|Overall Study||33
3336118|NCT03351608|4067514|FG003|Treated|Overall Study||169
3336119|NCT03351608|4067515|FG004|Treated|Overall Study||34
3336120|NCT03351608|4067511|FG000|COMPLETED|Overall Study||18
3336121|NCT03351608|4067512|FG001|COMPLETED|Overall Study||21
3336122|NCT03351608|4067513|FG002|COMPLETED|Overall Study||32
3336123|NCT03351608|4067514|FG003|COMPLETED|Overall Study||168
3336124|NCT03351608|4067515|FG004|COMPLETED|Overall Study||33
3336125|NCT03351608|4067511|FG000|NOT COMPLETED|Overall Study||1
3336126|NCT03351608|4067512|FG001|NOT COMPLETED|Overall Study||2
3336127|NCT03351608|4067513|FG002|NOT COMPLETED|Overall Study||3
3336128|NCT03351608|4067514|FG003|NOT COMPLETED|Overall Study||8
3336129|NCT03351608|4067515|FG004|NOT COMPLETED|Overall Study||2
3336130|NCT03351699|4067543|FG000|STARTED|Overall Study||6
3336131|NCT03351699|4067544|FG001|STARTED|Overall Study||6
3336132|NCT03351699|4067545|FG002|STARTED|Overall Study||6
3336133|NCT03351699|4067546|FG003|STARTED|Overall Study||6
3336134|NCT03351699|4067547|FG004|STARTED|Overall Study|Panel F did not enroll, following evaluation of earlier Panel data.|0
3336135|NCT03351699|4067543|FG000|COMPLETED|Overall Study||6
3336136|NCT03351699|4067544|FG001|COMPLETED|Overall Study||6
3336137|NCT03351699|4067545|FG002|COMPLETED|Overall Study||6
3336138|NCT03351699|4067546|FG003|COMPLETED|Overall Study||6
3336139|NCT03351699|4067547|FG004|COMPLETED|Overall Study|Panel F did not enroll, following evaluation of earlier Panel data.|0
3336140|NCT03351699|4067543|FG000|NOT COMPLETED|Overall Study||0
3336141|NCT03351699|4067544|FG001|NOT COMPLETED|Overall Study||0
3336142|NCT03351699|4067545|FG002|NOT COMPLETED|Overall Study||0
3336143|NCT03351699|4067546|FG003|NOT COMPLETED|Overall Study||0
3336144|NCT03351699|4067547|FG004|NOT COMPLETED|Overall Study||0
3336145|NCT03351738|4067571|FG000|STARTED|Overall Study||23
3336146|NCT03351738|4067572|FG001|STARTED|Overall Study||20
3336147|NCT03351738|4067573|FG002|STARTED|Overall Study||24
3336148|NCT03351738|4067574|FG003|STARTED|Overall Study||22
3336149|NCT03351738|4067575|FG004|STARTED|Overall Study||21
3336150|NCT03351738|4067576|FG005|STARTED|Overall Study||22
3336151|NCT03351738|4067571|FG000|COMPLETED|Overall Study||23
3336152|NCT03351738|4067572|FG001|COMPLETED|Overall Study||19
3336153|NCT03351738|4067573|FG002|COMPLETED|Overall Study||24
3336154|NCT03351738|4067574|FG003|COMPLETED|Overall Study||21
3336155|NCT03351738|4067575|FG004|COMPLETED|Overall Study||21
3336156|NCT03351738|4067576|FG005|COMPLETED|Overall Study||22
3336157|NCT03351738|4067571|FG000|NOT COMPLETED|Overall Study||0
3336158|NCT03351738|4067572|FG001|NOT COMPLETED|Overall Study||1
3336159|NCT03351738|4067573|FG002|NOT COMPLETED|Overall Study||0
3336160|NCT03351738|4067574|FG003|NOT COMPLETED|Overall Study||1
3336161|NCT03351738|4067575|FG004|NOT COMPLETED|Overall Study||0
3336162|NCT03351738|4067576|FG005|NOT COMPLETED|Overall Study||0
3336163|NCT03351933|4067595|FG000|STARTED|Overall Study||28
3336164|NCT03351933|4067595|FG000|COMPLETED|Overall Study||26
3336165|NCT03351933|4067595|FG000|NOT COMPLETED|Overall Study||2
3336166|NCT03352245|4067601|FG000|STARTED|Overall Study||20
3336167|NCT03352245|4067602|FG001|STARTED|Overall Study||20
3336168|NCT03352245|4067601|FG000|COMPLETED|Overall Study||20
3336169|NCT03352245|4067602|FG001|COMPLETED|Overall Study||19
3336170|NCT03352245|4067601|FG000|NOT COMPLETED|Overall Study||0
3336171|NCT03352245|4067602|FG001|NOT COMPLETED|Overall Study||1
3336172|NCT03352323|4067608|FG000|STARTED|Overall Study||50
3336173|NCT03352323|4067608|FG000|COMPLETED|Overall Study||49
3336174|NCT03352323|4067608|FG000|NOT COMPLETED|Overall Study||1
3336175|NCT03352414|4067614|FG000|STARTED|Overall Study||42
3336176|NCT03352414|4067615|FG001|STARTED|Overall Study||42
3336177|NCT03352414|4067614|FG000|Allocated|Overall Study||30
3336178|NCT03352414|4067615|FG001|Allocated|Overall Study||32
3336179|NCT03352414|4067614|FG000|COMPLETED|Overall Study||30
3336180|NCT03352414|4067615|FG001|COMPLETED|Overall Study||32
3336181|NCT03352414|4067614|FG000|NOT COMPLETED|Overall Study||12
3336182|NCT03352414|4067615|FG001|NOT COMPLETED|Overall Study||10
3336183|NCT03352453|4067625|FG000|STARTED|Overall Study||66
3336184|NCT03352453|4067626|FG001|STARTED|Overall Study||72
3336185|NCT03352453|4067625|FG000|COMPLETED|Overall Study||44
3336186|NCT03352453|4067626|FG001|COMPLETED|Overall Study||40
3336187|NCT03352453|4067625|FG000|NOT COMPLETED|Overall Study||22
3336188|NCT03352453|4067626|FG001|NOT COMPLETED|Overall Study||32
3336189|NCT03352609|4067634|FG000|STARTED|Overall Study||2
3336190|NCT03352609|4067635|FG001|STARTED|Overall Study||3
3336191|NCT03352609|4067634|FG000|COMPLETED|Overall Study||2
3336192|NCT03352609|4067635|FG001|COMPLETED|Overall Study||3
3336193|NCT03352609|4067634|FG000|NOT COMPLETED|Overall Study||0
3336194|NCT03352609|4067635|FG001|NOT COMPLETED|Overall Study||0
3336195|NCT03352713|4067641|FG000|STARTED|Overall Study||185
3336196|NCT03352713|4067641|FG000|COMPLETED|Overall Study|Participants who completed at least 1 EMA for inclusion in data analysis|159
3336197|NCT03352713|4067641|FG000|NOT COMPLETED|Overall Study||26
3336198|NCT03353220|4067645|FG000|STARTED|First Intervention (7 Days) - Phase 1||14
3336199|NCT03353220|4067646|FG001|STARTED|First Intervention (7 Days) - Phase 1||16
3336200|NCT03353220|4067645|FG000|COMPLETED|First Intervention (7 Days) - Phase 1||14
3336201|NCT03353220|4067646|FG001|COMPLETED|First Intervention (7 Days) - Phase 1||16
3336202|NCT03353220|4067645|FG000|NOT COMPLETED|First Intervention (7 Days) - Phase 1||0
3336203|NCT03353220|4067646|FG001|NOT COMPLETED|First Intervention (7 Days) - Phase 1||0
3336204|NCT03353220|4067645|FG000|STARTED|Washout (3 Weeks) - Phase 1||14
3336205|NCT03353220|4067646|FG001|STARTED|Washout (3 Weeks) - Phase 1||16
3336206|NCT03353220|4067645|FG000|COMPLETED|Washout (3 Weeks) - Phase 1||14
3336207|NCT03353220|4067646|FG001|COMPLETED|Washout (3 Weeks) - Phase 1||16
3336208|NCT03353220|4067645|FG000|NOT COMPLETED|Washout (3 Weeks) - Phase 1||0
3336209|NCT03353220|4067646|FG001|NOT COMPLETED|Washout (3 Weeks) - Phase 1||0
3336210|NCT03353220|4067645|FG000|STARTED|Second Intervention (7 Days) - Phase 1||14
3336211|NCT03353220|4067646|FG001|STARTED|Second Intervention (7 Days) - Phase 1||16
3336212|NCT03353220|4067645|FG000|COMPLETED|Second Intervention (7 Days) - Phase 1||14
3039812|NCT01160744|3759284|FG001|NOT COMPLETED|Overall Study||5
3039813|NCT01160744|3759285|FG002|NOT COMPLETED|Overall Study||7
3039814|NCT01160744|3759286|FG003|NOT COMPLETED|Overall Study||4
3039815|NCT01160770|3759298|FG000|STARTED|Overall Study||267
3039816|NCT01160770|3759298|FG000|COMPLETED|Overall Study||188
3039817|NCT01160770|3759298|FG000|NOT COMPLETED|Overall Study||79
3336213|NCT03353220|4067646|FG001|COMPLETED|Second Intervention (7 Days) - Phase 1||16
3336214|NCT03353220|4067645|FG000|NOT COMPLETED|Second Intervention (7 Days) - Phase 1||0
3336215|NCT03353220|4067646|FG001|NOT COMPLETED|Second Intervention (7 Days) - Phase 1||0
3336216|NCT03353220|4067645|FG000|STARTED|Third Intervention (6 Months) - Phase 2||14
3336217|NCT03353220|4067646|FG001|STARTED|Third Intervention (6 Months) - Phase 2||16
3336218|NCT03353220|4067645|FG000|COMPLETED|Third Intervention (6 Months) - Phase 2||10
3336219|NCT03353220|4067646|FG001|COMPLETED|Third Intervention (6 Months) - Phase 2||9
3336220|NCT03353220|4067645|FG000|NOT COMPLETED|Third Intervention (6 Months) - Phase 2||4
3336221|NCT03353220|4067646|FG001|NOT COMPLETED|Third Intervention (6 Months) - Phase 2||7
3336222|NCT03353246|4067652|FG000|STARTED|Overall Study||500
3336223|NCT03353246|4067652|FG000|COMPLETED|Overall Study||500
3336224|NCT03353246|4067652|FG000|NOT COMPLETED|Overall Study||0
3336225|NCT03353740|4067656|FG000|STARTED|Overall Study||346
3336226|NCT03353740|4067656|FG000|COMPLETED|Overall Study||294
3336227|NCT03353740|4067656|FG000|NOT COMPLETED|Overall Study||52
3336228|NCT03353753|4067662|FG000|STARTED|Overall Study||85
3336229|NCT03353753|4067663|FG001|STARTED|Overall Study|1 patient was randomized but not dosed|44
3336230|NCT03353753|4067662|FG000|COMPLETED|Overall Study||46
3336231|NCT03353753|4067663|FG001|COMPLETED|Overall Study||35
3336232|NCT03353753|4067662|FG000|NOT COMPLETED|Overall Study||39
3336233|NCT03353753|4067663|FG001|NOT COMPLETED|Overall Study||9
3336234|NCT03354325|4067671|FG000|STARTED|Overall Study||151
3336235|NCT03354325|4067672|FG001|STARTED|Overall Study||153
3336236|NCT03354325|4067671|FG000|COMPLETED|Overall Study||131
3336237|NCT03354325|4067672|FG001|COMPLETED|Overall Study||138
3336238|NCT03354325|4067671|FG000|NOT COMPLETED|Overall Study||20
3336239|NCT03354325|4067672|FG001|NOT COMPLETED|Overall Study||15
3336240|NCT03354429|4067680|FG000|STARTED|Overall Study||5523
3336241|NCT03354429|4067681|FG001|STARTED|Overall Study||5493
3336242|NCT03354429|4067680|FG000|COMPLETED|Overall Study||5514
3336243|NCT03354429|4067681|FG001|COMPLETED|Overall Study||5486
3336244|NCT03354429|4067680|FG000|NOT COMPLETED|Overall Study||9
3336245|NCT03354429|4067681|FG001|NOT COMPLETED|Overall Study||7
3336246|NCT03354598|4067689|FG000|STARTED|Overall Study||835
3336247|NCT03354598|4067690|FG001|STARTED|Overall Study||836
3336248|NCT03354598|4067689|FG000|Microbiologic Modified Intent to Treat Resistant (Micro-MITTR) Participants|Overall Study||147
3336249|NCT03354598|4067690|FG001|Microbiologic Modified Intent to Treat Resistant (Micro-MITTR) Participants|Overall Study||139
3336250|NCT03354598|4067689|FG000|Microbiologic Modified Intent to Treat Susceptible (Micro-MITTS) Participants|Overall Study||370
3336251|NCT03354598|4067690|FG001|Microbiologic Modified Intent to Treat Susceptible (Micro-MITTS) Participants|Overall Study||415
3336252|NCT03354598|4067689|FG000|Microbiologic Modified Intent to Treat (Micro-MITT) Participants|Overall Study||517
3336253|NCT03354598|4067690|FG001|Microbiologic Modified Intent to Treat (Micro-MITT) Participants|Overall Study||554
3336254|NCT03354598|4067689|FG000|Modified Intent to Treat (MITT) Participants|Overall Study||785
3336255|NCT03354598|4067690|FG001|Modified Intent to Treat (MITT) Participants|Overall Study||794
3336256|NCT03354598|4067689|FG000|Intent to Treat (ITT) Participants|Overall Study||787
3336257|NCT03354598|4067690|FG001|Intent to Treat (ITT) Participants|Overall Study||803
3336258|NCT03354598|4067689|FG000|Safety Participants|Overall Study||833
3336259|NCT03354598|4067690|FG001|Safety Participants|Overall Study||827
3336260|NCT03354598|4067689|FG000|COMPLETED|Overall Study||755
3336261|NCT03354598|4067690|FG001|COMPLETED|Overall Study||761
3336262|NCT03354598|4067689|FG000|NOT COMPLETED|Overall Study||80
3336263|NCT03354598|4067690|FG001|NOT COMPLETED|Overall Study||75
3336264|NCT03354637|4067699|FG000|STARTED|Double-blind Period||43
3336265|NCT03354637|4067700|FG001|STARTED|Double-blind Period||44
3336266|NCT03354637|4067701|FG002|STARTED|Double-blind Period||42
3336267|NCT03354637|4067699|FG000|COMPLETED|Double-blind Period||26
3336268|NCT03354637|4067700|FG001|COMPLETED|Double-blind Period||31
3336269|NCT03354637|4067701|FG002|COMPLETED|Double-blind Period||35
3336270|NCT03354637|4067699|FG000|NOT COMPLETED|Double-blind Period||17
3336271|NCT03354637|4067700|FG001|NOT COMPLETED|Double-blind Period||13
3336272|NCT03354637|4067701|FG002|NOT COMPLETED|Double-blind Period||7
3336273|NCT03354637|4067699|FG000|STARTED|Open Label Extension||0
3336274|NCT03354637|4067700|FG001|STARTED|Open Label Extension||0
3336275|NCT03354637|4067701|FG002|STARTED|Open Label Extension||61
3336276|NCT03354637|4067699|FG000|COMPLETED|Open Label Extension||0
3336277|NCT03354637|4067700|FG001|COMPLETED|Open Label Extension||0
3336278|NCT03354637|4067701|FG002|COMPLETED|Open Label Extension||33
3336279|NCT03354637|4067699|FG000|NOT COMPLETED|Open Label Extension||0
3336280|NCT03354637|4067700|FG001|NOT COMPLETED|Open Label Extension||0
3336281|NCT03354637|4067701|FG002|NOT COMPLETED|Open Label Extension||28
3336282|NCT03354663|4067710|FG000|STARTED|Enrollment to Catheter Insertion||156
3336283|NCT03354663|4067710|FG000|COMPLETED|Enrollment to Catheter Insertion||151
3336284|NCT03354663|4067710|FG000|NOT COMPLETED|Enrollment to Catheter Insertion||5
3336285|NCT03354663|4067710|FG000|STARTED|Completed 30-day Visit||151
3336286|NCT03354663|4067710|FG000|COMPLETED|Completed 30-day Visit||149
3336287|NCT03354663|4067710|FG000|NOT COMPLETED|Completed 30-day Visit||2
3336288|NCT03354754|4067720|FG000|STARTED|Overall Study||2
3336289|NCT03354754|4067721|FG001|STARTED|Overall Study||1
3336290|NCT03354754|4067720|FG000|COMPLETED|Overall Study||2
3336291|NCT03354754|4067721|FG001|COMPLETED|Overall Study||1
3336292|NCT03354754|4067720|FG000|NOT COMPLETED|Overall Study||0
3336293|NCT03354754|4067721|FG001|NOT COMPLETED|Overall Study||0
3336294|NCT03355326|4067729|FG000|STARTED|Overall Study||9
3336295|NCT03355326|4067730|FG001|STARTED|Overall Study||7
3336296|NCT03355326|4067729|FG000|COMPLETED|Overall Study||6
3336297|NCT03355326|4067730|FG001|COMPLETED|Overall Study||4
3336298|NCT03355326|4067729|FG000|NOT COMPLETED|Overall Study||3
3336299|NCT03355326|4067730|FG001|NOT COMPLETED|Overall Study||3
3336300|NCT03355742|4067736|FG000|STARTED|Overall Study||963
3336301|NCT03355742|4067736|FG000|COMPLETED|Overall Study||864
3336302|NCT03355742|4067736|FG000|NOT COMPLETED|Overall Study||99
3336303|NCT03355820|4067740|FG000|STARTED|Overall Study||227
3336304|NCT03355820|4067740|FG000|COMPLETED|Overall Study||227
3336305|NCT03355820|4067740|FG000|NOT COMPLETED|Overall Study||0
3336306|NCT03356145|4067746|FG000|STARTED|Overall Study||48
3336307|NCT03356145|4067747|FG001|STARTED|Overall Study||48
3336308|NCT03356145|4067746|FG000|Received Allocated Intervention|Overall Study||45
3336309|NCT03356145|4067747|FG001|Received Allocated Intervention|Overall Study||47
3336310|NCT03356145|4067746|FG000|COMPLETED|Overall Study||45
3336311|NCT03356145|4067747|FG001|COMPLETED|Overall Study||47
3336312|NCT03356145|4067746|FG000|NOT COMPLETED|Overall Study||3
3336313|NCT03356145|4067747|FG001|NOT COMPLETED|Overall Study||1
3336314|NCT03356977|4067753|FG000|STARTED|Overall Study||137
3336315|NCT03356977|4067753|FG000|COMPLETED|Overall Study||132
3336316|NCT03356977|4067753|FG000|NOT COMPLETED|Overall Study||5
3336317|NCT03357341|4067759|FG000|STARTED|Overall Study||96
3336318|NCT03357341|4067760|FG001|STARTED|Overall Study||98
3336319|NCT03357341|4067759|FG000|COMPLETED|Overall Study||89
3336320|NCT03357341|4067760|FG001|COMPLETED|Overall Study||86
3336321|NCT03357341|4067759|FG000|NOT COMPLETED|Overall Study||7
3336322|NCT03357341|4067760|FG001|NOT COMPLETED|Overall Study||12
3336323|NCT03357393|4067770|FG000|STARTED|Overall Study||50
3336324|NCT03357393|4067771|FG001|STARTED|Overall Study||50
3336325|NCT03357393|4067772|FG002|STARTED|Overall Study||50
3336326|NCT03357393|4067770|FG000|COMPLETED|Overall Study||50
3336327|NCT03357393|4067771|FG001|COMPLETED|Overall Study||50
3336328|NCT03357393|4067772|FG002|COMPLETED|Overall Study||50
3336329|NCT03357393|4067770|FG000|NOT COMPLETED|Overall Study||0
3336330|NCT03357393|4067771|FG001|NOT COMPLETED|Overall Study||0
3336331|NCT03357393|4067772|FG002|NOT COMPLETED|Overall Study||0
3336332|NCT03357471|4067782|FG000|STARTED|Overall Study||35
3336333|NCT03357471|4067783|FG001|STARTED|Overall Study||32
3336334|NCT03357471|4067782|FG000|COMPLETED|Overall Study||33
3336335|NCT03357471|4067783|FG001|COMPLETED|Overall Study||32
3336336|NCT03357471|4067782|FG000|NOT COMPLETED|Overall Study||2
3336337|NCT03357471|4067783|FG001|NOT COMPLETED|Overall Study||0
3336338|NCT03357614|4067791|FG000|STARTED|Overall Study||697
3336339|NCT03357614|4067792|FG001|STARTED|Overall Study||698
3336340|NCT03357614|4067791|FG000|COMPLETED|Overall Study||672
3336341|NCT03357614|4067792|FG001|COMPLETED|Overall Study||670
3336342|NCT03357614|4067791|FG000|NOT COMPLETED|Overall Study||25
3336343|NCT03357614|4067792|FG001|NOT COMPLETED|Overall Study||28
3336344|NCT03357731|4067798|FG000|STARTED|Overall Study||8
3336345|NCT03357731|4067799|FG001|STARTED|Overall Study||7
3336346|NCT03357731|4067800|FG002|STARTED|Overall Study||7
3336347|NCT03357731|4067801|FG003|STARTED|Overall Study||7
3336348|NCT03357731|4067802|FG004|STARTED|Overall Study||8
3336349|NCT03357731|4067803|FG005|STARTED|Overall Study||8
3336350|NCT03357731|4067798|FG000|Completed Period 1 (P1)|Overall Study|1 withdrew post-P1 completion/prior to P2 therapy due to acute cholecystitis, but returned for P2/P3|8
3336351|NCT03357731|4067799|FG001|Completed Period 1 (P1)|Overall Study||7
3336352|NCT03357731|4067800|FG002|Completed Period 1 (P1)|Overall Study||7
3336353|NCT03357731|4067801|FG003|Completed Period 1 (P1)|Overall Study|1 discontinued P1 due to acute bradycardia and hypotension|6
3336354|NCT03357731|4067802|FG004|Completed Period 1 (P1)|Overall Study|1 discontinued P1 due to hypotension but resumed P2/P3|7
3336355|NCT03357731|4067803|FG005|Completed Period 1 (P1)|Overall Study||8
3336356|NCT03357731|4067798|FG000|Completed Period 2 (P2)|Overall Study||8
3336357|NCT03357731|4067799|FG001|Completed Period 2 (P2)|Overall Study||7
3336358|NCT03357731|4067800|FG002|Completed Period 2 (P2)|Overall Study||7
3336359|NCT03357731|4067801|FG003|Completed Period 2 (P2)|Overall Study|"1 completed P1, did not proceed to P2/P3 (lost to follow-up);~1 discontinued P2 due to hypotension"|4
3336360|NCT03357731|4067802|FG004|Completed Period 2 (P2)|Overall Study|1 only completed P1, did not continue to P2/P3 (withdrew consent due to personal reasons)|7
3336361|NCT03357731|4067803|FG005|Completed Period 2 (P2)|Overall Study|1 discontinued P2 due to an Adverse Event (AE)|7
3336362|NCT03357731|4067798|FG000|COMPLETED|Overall Study||8
3336363|NCT03357731|4067799|FG001|COMPLETED|Overall Study||7
3336364|NCT03357731|4067800|FG002|COMPLETED|Overall Study|1 discontinuation due to hypotension|6
3336365|NCT03357731|4067801|FG003|COMPLETED|Overall Study||4
3336366|NCT03357731|4067802|FG004|COMPLETED|Overall Study||7
3336367|NCT03357731|4067803|FG005|COMPLETED|Overall Study||7
3336368|NCT03357731|4067798|FG000|NOT COMPLETED|Overall Study||0
3336369|NCT03357731|4067799|FG001|NOT COMPLETED|Overall Study||0
3336370|NCT03357731|4067800|FG002|NOT COMPLETED|Overall Study||1
3336371|NCT03357731|4067801|FG003|NOT COMPLETED|Overall Study||3
3336372|NCT03357731|4067802|FG004|NOT COMPLETED|Overall Study||1
3336373|NCT03357731|4067803|FG005|NOT COMPLETED|Overall Study||1
3336374|NCT03358147|4067816|FG000|STARTED|Overall Study||235
3336375|NCT03358147|4067817|FG001|STARTED|Overall Study||240
3336376|NCT03358147|4067818|FG002|STARTED|Overall Study||240
3336377|NCT03358147|4067819|FG003|STARTED|Overall Study||237
3336378|NCT03358147|4067820|FG004|STARTED|Overall Study||119
3336379|NCT03358147|4067816|FG000|COMPLETED|Overall Study||201
3336380|NCT03358147|4067817|FG001|COMPLETED|Overall Study||201
3336381|NCT03358147|4067818|FG002|COMPLETED|Overall Study||206
3336382|NCT03358147|4067819|FG003|COMPLETED|Overall Study||201
3336383|NCT03358147|4067820|FG004|COMPLETED|Overall Study||105
3336384|NCT03358147|4067816|FG000|NOT COMPLETED|Overall Study||34
3336385|NCT03358147|4067817|FG001|NOT COMPLETED|Overall Study||39
3336386|NCT03358147|4067818|FG002|NOT COMPLETED|Overall Study||34
3336387|NCT03358147|4067819|FG003|NOT COMPLETED|Overall Study||36
3336388|NCT03358147|4067820|FG004|NOT COMPLETED|Overall Study||14
3336389|NCT03358238|4067834|FG000|STARTED|Overall Study||23
3336390|NCT03358238|4067835|FG001|STARTED|Overall Study||25
3336391|NCT03358238|4067834|FG000|COMPLETED|Overall Study||23
3336392|NCT03358238|4067835|FG001|COMPLETED|Overall Study||24
3336393|NCT03358238|4067834|FG000|NOT COMPLETED|Overall Study||0
3336394|NCT03358238|4067835|FG001|NOT COMPLETED|Overall Study||1
3336395|NCT03358251|4067845|FG000|STARTED|Overall Study||34
3336396|NCT03358251|4067845|FG000|COMPLETED|Overall Study||34
3336397|NCT03358251|4067845|FG000|NOT COMPLETED|Overall Study||0
3336398|NCT03358290|4067857|FG000|STARTED|Overall Study||2
3336399|NCT03358290|4067858|FG001|STARTED|Overall Study||3
3336400|NCT03358290|4067859|FG002|STARTED|Overall Study||3
3336401|NCT03358290|4067860|FG003|STARTED|Overall Study||3
3336402|NCT03358290|4067861|FG004|STARTED|Overall Study||2
3336403|NCT03358290|4067857|FG000|COMPLETED|Overall Study||2
3336404|NCT03358290|4067858|FG001|COMPLETED|Overall Study||2
3336405|NCT03358290|4067859|FG002|COMPLETED|Overall Study||1
3336406|NCT03358290|4067860|FG003|COMPLETED|Overall Study||1
3336407|NCT03358290|4067861|FG004|COMPLETED|Overall Study||1
3336408|NCT03358290|4067857|FG000|NOT COMPLETED|Overall Study||0
3336409|NCT03358290|4067858|FG001|NOT COMPLETED|Overall Study||1
3336410|NCT03358290|4067859|FG002|NOT COMPLETED|Overall Study||2
3336411|NCT03358290|4067860|FG003|NOT COMPLETED|Overall Study||2
3336412|NCT03358290|4067861|FG004|NOT COMPLETED|Overall Study||1
3336413|NCT03358329|4067873|FG000|STARTED|Overall Study||50
3336414|NCT03358329|4067873|FG000|COMPLETED|Overall Study||46
3336415|NCT03358329|4067873|FG000|NOT COMPLETED|Overall Study||4
3336416|NCT03358355|4067879|FG000|STARTED|Overall Study||9
3336417|NCT03358355|4067879|FG000|COMPLETED|Overall Study||9
3336418|NCT03358355|4067879|FG000|NOT COMPLETED|Overall Study||0
3336419|NCT03358407|4067898|FG000|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||2
3336420|NCT03358407|4067899|FG001|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||2
3336421|NCT03358407|4067900|FG002|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||2
3336422|NCT03358407|4067901|FG003|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||2
3336423|NCT03358407|4067902|FG004|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||2
3336424|NCT03358407|4067903|FG005|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
3336425|NCT03358407|4067904|FG006|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
3176957|NCT01968070|3904658|FG012|NOT COMPLETED|Period 2||0
3176958|NCT01968070|3904659|FG013|NOT COMPLETED|Period 2||0
3176959|NCT01968070|3904660|FG014|NOT COMPLETED|Period 2||0
3336426|NCT03358407|4067905|FG007|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
3336427|NCT03358407|4067906|FG008|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
3336428|NCT03358407|4067907|FG009|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
3336429|NCT03358407|4067898|FG000|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||2
3336430|NCT03358407|4067899|FG001|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||2
3336431|NCT03358407|4067900|FG002|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||2
3336432|NCT03358407|4067901|FG003|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||2
3336433|NCT03358407|4067902|FG004|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||2
3336434|NCT03358407|4067903|FG005|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
3176960|NCT01968070|3904661|FG015|NOT COMPLETED|Period 2||0
3176961|NCT01968070|3904662|FG016|NOT COMPLETED|Period 2||0
3176962|NCT01968070|3904663|FG017|NOT COMPLETED|Period 2||0
3176963|NCT01968070|3904646|FG000|STARTED|Period 3||4
3176964|NCT01968070|3904647|FG001|STARTED|Period 3||4
3176965|NCT01968070|3904648|FG002|STARTED|Period 3||4
3176966|NCT01968070|3904649|FG003|STARTED|Period 3||4
3336435|NCT03358407|4067904|FG006|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
3336436|NCT03358407|4067905|FG007|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
3336437|NCT03358407|4067906|FG008|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
3336438|NCT03358407|4067907|FG009|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
3336439|NCT03358407|4067898|FG000|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
3336440|NCT03358407|4067899|FG001|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
3336441|NCT03358407|4067900|FG002|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
3336442|NCT03358407|4067901|FG003|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
3336443|NCT03358407|4067902|FG004|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
3336444|NCT03358407|4067903|FG005|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
3336445|NCT03358407|4067904|FG006|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
3336446|NCT03358407|4067905|FG007|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
3336447|NCT03358407|4067906|FG008|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
3336448|NCT03358407|4067907|FG009|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
3336449|NCT03358407|4067898|FG000|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||2
3336450|NCT03358407|4067899|FG001|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||2
3336451|NCT03358407|4067900|FG002|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||2
3336452|NCT03358407|4067901|FG003|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||2
3176967|NCT01968070|3904650|FG004|STARTED|Period 3||3
3176968|NCT01968070|3904651|FG005|STARTED|Period 3||4
3336453|NCT03358407|4067902|FG004|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||2
3336454|NCT03358407|4067903|FG005|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
3336455|NCT03358407|4067904|FG006|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
3336456|NCT03358407|4067905|FG007|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
3336457|NCT03358407|4067906|FG008|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
3336458|NCT03358407|4067907|FG009|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
3336459|NCT03358407|4067898|FG000|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||2
3336460|NCT03358407|4067899|FG001|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||2
3336461|NCT03358407|4067900|FG002|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||1
3336462|NCT03358407|4067901|FG003|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||2
3336463|NCT03358407|4067902|FG004|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||2
3336464|NCT03358407|4067903|FG005|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
3336465|NCT03358407|4067904|FG006|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
3336466|NCT03358407|4067905|FG007|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
3336467|NCT03358407|4067906|FG008|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
3336468|NCT03358407|4067907|FG009|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
3336469|NCT03358407|4067898|FG000|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
3336470|NCT03358407|4067899|FG001|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
3336471|NCT03358407|4067900|FG002|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||1
3336472|NCT03358407|4067901|FG003|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
3336473|NCT03358407|4067902|FG004|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
3336474|NCT03358407|4067903|FG005|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
3336475|NCT03358407|4067904|FG006|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
3336476|NCT03358407|4067905|FG007|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
3336477|NCT03358407|4067906|FG008|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
3336478|NCT03358407|4067907|FG009|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
3336479|NCT03358407|4067898|FG000|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||2
3336480|NCT03358407|4067899|FG001|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||2
3336481|NCT03358407|4067900|FG002|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)|1 participant was added to Part A-Cohort 1: GSK 2mg/GSK 4mg/Placebo/GSK 30mg/GSK 100mg arm|2
3336482|NCT03358407|4067901|FG003|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||2
3336483|NCT03358407|4067902|FG004|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||2
3336484|NCT03358407|4067903|FG005|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
3336485|NCT03358407|4067904|FG006|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
3336486|NCT03358407|4067905|FG007|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
3336487|NCT03358407|4067906|FG008|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
3336488|NCT03358407|4067907|FG009|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
3336489|NCT03358407|4067898|FG000|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||2
3336490|NCT03358407|4067899|FG001|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||2
3336491|NCT03358407|4067900|FG002|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||2
3336492|NCT03358407|4067901|FG003|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||2
3336493|NCT03358407|4067902|FG004|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||2
3336494|NCT03358407|4067903|FG005|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
3336495|NCT03358407|4067904|FG006|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
3336496|NCT03358407|4067905|FG007|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
3336497|NCT03358407|4067906|FG008|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
3336498|NCT03358407|4067907|FG009|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
3336499|NCT03358407|4067898|FG000|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
3336500|NCT03358407|4067899|FG001|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
3336501|NCT03358407|4067900|FG002|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
3336502|NCT03358407|4067901|FG003|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
3336503|NCT03358407|4067902|FG004|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
3336504|NCT03358407|4067903|FG005|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
3336505|NCT03358407|4067904|FG006|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
3336506|NCT03358407|4067905|FG007|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
3336507|NCT03358407|4067906|FG008|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
3336508|NCT03358407|4067907|FG009|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
3336509|NCT03358407|4067898|FG000|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||2
3336510|NCT03358407|4067899|FG001|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||2
3336511|NCT03358407|4067900|FG002|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||2
3336512|NCT03358407|4067901|FG003|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||2
3336513|NCT03358407|4067902|FG004|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||2
3336514|NCT03358407|4067903|FG005|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
3336515|NCT03358407|4067904|FG006|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
3336516|NCT03358407|4067905|FG007|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
3336517|NCT03358407|4067906|FG008|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
3336518|NCT03358407|4067907|FG009|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
3336519|NCT03358407|4067898|FG000|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||2
3336520|NCT03358407|4067899|FG001|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||2
3336521|NCT03358407|4067900|FG002|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||2
3336522|NCT03358407|4067901|FG003|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||2
3336523|NCT03358407|4067902|FG004|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||1
3336524|NCT03358407|4067903|FG005|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
3336525|NCT03358407|4067904|FG006|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
3336526|NCT03358407|4067905|FG007|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
3336527|NCT03358407|4067906|FG008|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
3336528|NCT03358407|4067907|FG009|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
3336529|NCT03358407|4067898|FG000|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
3336530|NCT03358407|4067899|FG001|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
3336531|NCT03358407|4067900|FG002|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
3336532|NCT03358407|4067901|FG003|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
3336533|NCT03358407|4067902|FG004|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||1
3336534|NCT03358407|4067903|FG005|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
3336535|NCT03358407|4067904|FG006|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
3336536|NCT03358407|4067905|FG007|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
3336537|NCT03358407|4067906|FG008|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
3336538|NCT03358407|4067907|FG009|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
3336539|NCT03358407|4067898|FG000|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||2
3336540|NCT03358407|4067899|FG001|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||2
3336541|NCT03358407|4067900|FG002|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||2
3336542|NCT03358407|4067901|FG003|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||2
3336543|NCT03358407|4067902|FG004|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)|1 participant was added to Part A-Cohort 1: GSK 2mg/GSK 4mg/GSK 10mg/GSK 30mg/Placebo arm|2
3336544|NCT03358407|4067903|FG005|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||0
3336545|NCT03358407|4067904|FG006|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||0
3336546|NCT03358407|4067905|FG007|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||0
3336547|NCT03358407|4067906|FG008|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||0
3336548|NCT03358407|4067907|FG009|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||0
3336549|NCT03358407|4067898|FG000|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||2
3336550|NCT03358407|4067899|FG001|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||2
3336551|NCT03358407|4067900|FG002|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||2
3336552|NCT03358407|4067901|FG003|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||2
3336553|NCT03358407|4067902|FG004|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||2
3336554|NCT03358407|4067903|FG005|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
3336555|NCT03358407|4067904|FG006|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
3336556|NCT03358407|4067905|FG007|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
3336557|NCT03358407|4067906|FG008|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
3336558|NCT03358407|4067907|FG009|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
3336559|NCT03358407|4067898|FG000|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
3336560|NCT03358407|4067899|FG001|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
3336561|NCT03358407|4067900|FG002|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
3336562|NCT03358407|4067901|FG003|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
3336563|NCT03358407|4067902|FG004|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
3336564|NCT03358407|4067903|FG005|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
3336565|NCT03358407|4067904|FG006|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
3336566|NCT03358407|4067905|FG007|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
3336567|NCT03358407|4067906|FG008|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
3336568|NCT03358407|4067907|FG009|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
3336569|NCT03358407|4067898|FG000|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
3336570|NCT03358407|4067899|FG001|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
3336571|NCT03358407|4067900|FG002|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
3336572|NCT03358407|4067901|FG003|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
3336573|NCT03358407|4067902|FG004|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
3336574|NCT03358407|4067903|FG005|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||3
3336575|NCT03358407|4067904|FG006|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||3
3336576|NCT03358407|4067905|FG007|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||6
3336577|NCT03358407|4067906|FG008|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
3336578|NCT03358407|4067907|FG009|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
3336579|NCT03358407|4067898|FG000|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
3336580|NCT03358407|4067899|FG001|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
3336581|NCT03358407|4067900|FG002|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
3336582|NCT03358407|4067901|FG003|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
3336583|NCT03358407|4067902|FG004|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
3336584|NCT03358407|4067903|FG005|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
3336585|NCT03358407|4067904|FG006|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||2
3336586|NCT03358407|4067905|FG007|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||3
3336587|NCT03358407|4067906|FG008|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
3336588|NCT03358407|4067907|FG009|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
3336589|NCT03358407|4067898|FG000|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
3336590|NCT03358407|4067899|FG001|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
3336591|NCT03358407|4067900|FG002|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
3336592|NCT03358407|4067901|FG003|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
3336593|NCT03358407|4067902|FG004|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
3336594|NCT03358407|4067903|FG005|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||3
3336595|NCT03358407|4067904|FG006|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||1
3336596|NCT03358407|4067905|FG007|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||3
3336597|NCT03358407|4067906|FG008|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
3336598|NCT03358407|4067907|FG009|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
3336599|NCT03358407|4067898|FG000|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)||0
3336600|NCT03358407|4067899|FG001|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)||0
3336601|NCT03358407|4067900|FG002|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)||0
3336602|NCT03358407|4067901|FG003|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)||0
3336603|NCT03358407|4067902|FG004|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)||0
3336604|NCT03358407|4067903|FG005|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)|3 participants were added to Part A-Cohort 2: Placebo/GSK 400mg arm|3
3336605|NCT03358407|4067904|FG006|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)|1 participant was added to Part A-Cohort 2: GSK 200mg/ Placebo arm|3
3336606|NCT03358407|4067905|FG007|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)|3 participants were added to Part A-Cohort 2: GSK 200mg/GSK 400mg arm|6
3336607|NCT03358407|4067906|FG008|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)||0
3336608|NCT03358407|4067907|FG009|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)||0
3336609|NCT03358407|4067898|FG000|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
3336610|NCT03358407|4067899|FG001|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
3336611|NCT03358407|4067900|FG002|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
3336612|NCT03358407|4067901|FG003|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
3336613|NCT03358407|4067902|FG004|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
3336614|NCT03358407|4067903|FG005|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
3336615|NCT03358407|4067904|FG006|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
3336616|NCT03358407|4067905|FG007|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
3336617|NCT03358407|4067906|FG008|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
3336618|NCT03358407|4067907|FG009|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
3336619|NCT03358407|4067898|FG000|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
3336620|NCT03358407|4067899|FG001|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
3336621|NCT03358407|4067900|FG002|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
3336622|NCT03358407|4067901|FG003|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
3336623|NCT03358407|4067902|FG004|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
3336624|NCT03358407|4067903|FG005|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||3
3336625|NCT03358407|4067904|FG006|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||3
3336626|NCT03358407|4067905|FG007|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||6
3336627|NCT03358407|4067906|FG008|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
3336628|NCT03358407|4067907|FG009|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
3336629|NCT03358407|4067898|FG000|STARTED|Part B: Overall Period (11 Weeks)||0
3336630|NCT03358407|4067899|FG001|STARTED|Part B: Overall Period (11 Weeks)||0
3336631|NCT03358407|4067900|FG002|STARTED|Part B: Overall Period (11 Weeks)||0
3336632|NCT03358407|4067901|FG003|STARTED|Part B: Overall Period (11 Weeks)||0
3336633|NCT03358407|4067902|FG004|STARTED|Part B: Overall Period (11 Weeks)||0
3336634|NCT03358407|4067903|FG005|STARTED|Part B: Overall Period (11 Weeks)||0
3336635|NCT03358407|4067904|FG006|STARTED|Part B: Overall Period (11 Weeks)||0
3336636|NCT03358407|4067905|FG007|STARTED|Part B: Overall Period (11 Weeks)||0
3336637|NCT03358407|4067906|FG008|STARTED|Part B: Overall Period (11 Weeks)||0
3336638|NCT03358407|4067907|FG009|STARTED|Part B: Overall Period (11 Weeks)||0
3336639|NCT03358407|4067898|FG000|COMPLETED|Part B: Overall Period (11 Weeks)||0
3336640|NCT03358407|4067899|FG001|COMPLETED|Part B: Overall Period (11 Weeks)||0
3336641|NCT03358407|4067900|FG002|COMPLETED|Part B: Overall Period (11 Weeks)||0
3336642|NCT03358407|4067901|FG003|COMPLETED|Part B: Overall Period (11 Weeks)||0
3336643|NCT03358407|4067902|FG004|COMPLETED|Part B: Overall Period (11 Weeks)||0
3336644|NCT03358407|4067903|FG005|COMPLETED|Part B: Overall Period (11 Weeks)||0
3336645|NCT03358407|4067904|FG006|COMPLETED|Part B: Overall Period (11 Weeks)||0
3336646|NCT03358407|4067905|FG007|COMPLETED|Part B: Overall Period (11 Weeks)||0
3336647|NCT03358407|4067906|FG008|COMPLETED|Part B: Overall Period (11 Weeks)||0
3336648|NCT03358407|4067907|FG009|COMPLETED|Part B: Overall Period (11 Weeks)||0
3336649|NCT03358407|4067898|FG000|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0
3336650|NCT03358407|4067899|FG001|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0
3336651|NCT03358407|4067900|FG002|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0
3336652|NCT03358407|4067901|FG003|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0
3336653|NCT03358407|4067902|FG004|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0
3336654|NCT03358407|4067903|FG005|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0
3336655|NCT03358407|4067904|FG006|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0
3336656|NCT03358407|4067905|FG007|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0
3336657|NCT03358407|4067906|FG008|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0
3336658|NCT03358407|4067907|FG009|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0
3336659|NCT03358472|4067938|FG000|STARTED|Overall Study||35
3336660|NCT03358472|4067939|FG001|STARTED|Overall Study||19
3336661|NCT03358472|4067940|FG002|STARTED|Overall Study||35
3336662|NCT03358472|4067938|FG000|Intention-to-Treat (ITT)|Overall Study||35
3336663|NCT03358472|4067939|FG001|Intention-to-Treat (ITT)|Overall Study||19
3336664|NCT03358472|4067940|FG002|Intention-to-Treat (ITT)|Overall Study||35
3336665|NCT03358472|4067938|FG000|All Participants as Treated (APaT)|Overall Study||34
3336666|NCT03358472|4067939|FG001|All Participants as Treated (APaT)|Overall Study||19
3336667|NCT03358472|4067940|FG002|All Participants as Treated (APaT)|Overall Study||34
3336668|NCT03358472|4067938|FG000|COMPLETED|Overall Study||20
3336669|NCT03358472|4067939|FG001|COMPLETED|Overall Study||9
3336670|NCT03358472|4067940|FG002|COMPLETED|Overall Study||19
3336671|NCT03358472|4067938|FG000|NOT COMPLETED|Overall Study||15
3336672|NCT03358472|4067939|FG001|NOT COMPLETED|Overall Study||10
3336673|NCT03358472|4067940|FG002|NOT COMPLETED|Overall Study||16
3336674|NCT03358576|4067950|FG000|STARTED|Overall Study||338
3336675|NCT03358576|4067951|FG001|STARTED|Overall Study||336
3336676|NCT03358576|4067950|FG000|COMPLETED|Overall Study||312
3336677|NCT03358576|4067951|FG001|COMPLETED|Overall Study||311
3336678|NCT03358576|4067950|FG000|NOT COMPLETED|Overall Study||26
3336679|NCT03358576|4067951|FG001|NOT COMPLETED|Overall Study||25
3336680|NCT03359395|4067959|FG000|STARTED|First Intervention A / B||49
3336681|NCT03359395|4067960|FG001|STARTED|First Intervention A / B||50
3336682|NCT03359395|4067959|FG000|COMPLETED|First Intervention A / B||46
3336683|NCT03359395|4067960|FG001|COMPLETED|First Intervention A / B||47
3336684|NCT03359395|4067959|FG000|NOT COMPLETED|First Intervention A / B||3
3336685|NCT03359395|4067960|FG001|NOT COMPLETED|First Intervention A / B||3
3336686|NCT03359395|4067959|FG000|STARTED|Second Intervention B/A||46
3336687|NCT03359395|4067960|FG001|STARTED|Second Intervention B/A||47
3336688|NCT03359395|4067959|FG000|COMPLETED|Second Intervention B/A||43
3336689|NCT03359395|4067960|FG001|COMPLETED|Second Intervention B/A||44
3336690|NCT03359395|4067959|FG000|NOT COMPLETED|Second Intervention B/A||3
3336691|NCT03359395|4067960|FG001|NOT COMPLETED|Second Intervention B/A||3
3336692|NCT03359473|4067970|FG000|STARTED|Overall Study||23
3336693|NCT03359473|4067971|FG001|STARTED|Overall Study||24
3336694|NCT03359473|4067972|FG002|STARTED|Overall Study||24
3336695|NCT03359473|4067973|FG003|STARTED|Overall Study||25
3336696|NCT03359473|4067970|FG000|COMPLETED|Overall Study||21
3176969|NCT01968070|3904652|FG006|STARTED|Period 3||0
3176970|NCT01968070|3904653|FG007|STARTED|Period 3||0
3176971|NCT01968070|3904654|FG008|STARTED|Period 3||0
3176972|NCT01968070|3904655|FG009|STARTED|Period 3||0
3176973|NCT01968070|3904656|FG010|STARTED|Period 3||0
3176974|NCT01968070|3904657|FG011|STARTED|Period 3||0
2927831|NCT00574340|3638712|FG000|NOT COMPLETED|Study 2 (2 Days)||0
2927832|NCT00574340|3638713|FG001|NOT COMPLETED|Study 2 (2 Days)||0
2927833|NCT00574405|3638721|FG000|STARTED|Overall Study||12
2927834|NCT00574405|3638722|FG001|STARTED|Overall Study||12
2927835|NCT00574405|3638721|FG000|COMPLETED|Overall Study||9
2927836|NCT00574405|3638722|FG001|COMPLETED|Overall Study||10
2927837|NCT00574405|3638721|FG000|NOT COMPLETED|Overall Study||3
2927838|NCT00574405|3638722|FG001|NOT COMPLETED|Overall Study||2
2927839|NCT00574548|3638730|FG000|STARTED|Overall Study||482
2927840|NCT00574548|3638731|FG001|STARTED|Overall Study||238
2927841|NCT00574548|3638730|FG000|Received Vaccination 1 (Vax 1)|Overall Study||478
2927842|NCT00574548|3638731|FG001|Received Vaccination 1 (Vax 1)|Overall Study||237
2927843|NCT00574548|3638730|FG000|Completed Vax 1 (6 Month Contact)|Overall Study||468
2927844|NCT00574548|3638731|FG001|Completed Vax 1 (6 Month Contact)|Overall Study||234
3039818|NCT01160822|3759309|FG000|STARTED|Overall Study||6
3039819|NCT01160822|3759310|FG001|STARTED|Overall Study||7
3039820|NCT01160822|3759311|FG002|STARTED|Overall Study||6
3039821|NCT01160822|3759312|FG003|STARTED|Overall Study||5
3039822|NCT01160822|3759313|FG004|STARTED|Overall Study||45
3039823|NCT01160822|3759314|FG005|STARTED|Overall Study||47
3039824|NCT01160822|3759315|FG006|STARTED|Overall Study||53
3039825|NCT01160822|3759309|FG000|COMPLETED|Overall Study||6
3039826|NCT01160822|3759310|FG001|COMPLETED|Overall Study||7
3039827|NCT01160822|3759311|FG002|COMPLETED|Overall Study||6
3039828|NCT01160822|3759312|FG003|COMPLETED|Overall Study||5
3039829|NCT01160822|3759313|FG004|COMPLETED|Overall Study||36
3039830|NCT01160822|3759314|FG005|COMPLETED|Overall Study||40
3039831|NCT01160822|3759315|FG006|COMPLETED|Overall Study||44
3039832|NCT01160822|3759309|FG000|NOT COMPLETED|Overall Study||0
3039833|NCT01160822|3759310|FG001|NOT COMPLETED|Overall Study||0
3039834|NCT01160822|3759311|FG002|NOT COMPLETED|Overall Study||0
3039835|NCT01160822|3759312|FG003|NOT COMPLETED|Overall Study||0
3039836|NCT01160822|3759313|FG004|NOT COMPLETED|Overall Study||9
3176975|NCT01968070|3904658|FG012|STARTED|Period 3||0
3336697|NCT03359473|4067971|FG001|COMPLETED|Overall Study||18
3336698|NCT03359473|4067972|FG002|COMPLETED|Overall Study||18
3336699|NCT03359473|4067973|FG003|COMPLETED|Overall Study||20
3336700|NCT03359473|4067970|FG000|NOT COMPLETED|Overall Study||2
3336701|NCT03359473|4067971|FG001|NOT COMPLETED|Overall Study||6
3336702|NCT03359473|4067972|FG002|NOT COMPLETED|Overall Study||6
3336703|NCT03359473|4067973|FG003|NOT COMPLETED|Overall Study||5
3336704|NCT03359590|4067986|FG000|STARTED|First Intervention||10
3336705|NCT03359590|4067987|FG001|STARTED|First Intervention||10
3336706|NCT03359590|4067986|FG000|Exposed|First Intervention||9
3336707|NCT03359590|4067987|FG001|Exposed|First Intervention||10
3336708|NCT03359590|4067986|FG000|Discontinued|First Intervention||1
3336709|NCT03359590|4067987|FG001|Discontinued|First Intervention||2
3336710|NCT03359590|4067986|FG000|COMPLETED|First Intervention||9
3336711|NCT03359590|4067987|FG001|COMPLETED|First Intervention||8
3336712|NCT03359590|4067986|FG000|NOT COMPLETED|First Intervention||1
3336713|NCT03359590|4067987|FG001|NOT COMPLETED|First Intervention||2
3336714|NCT03359590|4067986|FG000|STARTED|Second Intervention||9
3336715|NCT03359590|4067987|FG001|STARTED|Second Intervention||8
3336716|NCT03359590|4067986|FG000|Exposed|Second Intervention||9
3336717|NCT03359590|4067987|FG001|Exposed|Second Intervention||8
3336718|NCT03359590|4067986|FG000|Discontinued|Second Intervention||0
3336719|NCT03359590|4067987|FG001|Discontinued|Second Intervention||0
3336720|NCT03359590|4067986|FG000|COMPLETED|Second Intervention||9
3336721|NCT03359590|4067987|FG001|COMPLETED|Second Intervention||8
3336722|NCT03359590|4067986|FG000|NOT COMPLETED|Second Intervention||0
3336723|NCT03359590|4067987|FG001|NOT COMPLETED|Second Intervention||0
3336724|NCT03359629|4067995|FG000|STARTED|Overall Study||200
3336725|NCT03359629|4067996|FG001|STARTED|Overall Study||10
3336726|NCT03359629|4067995|FG000|COMPLETED|Overall Study||200
3336727|NCT03359629|4067996|FG001|COMPLETED|Overall Study||10
3336728|NCT03359629|4067995|FG000|NOT COMPLETED|Overall Study||0
3336729|NCT03359629|4067996|FG001|NOT COMPLETED|Overall Study||0
3336730|NCT03359850|4068004|FG000|STARTED|PK Phase (Up to Day 8)||9
3336731|NCT03359850|4068005|FG001|STARTED|PK Phase (Up to Day 8)||8
3336732|NCT03359850|4068004|FG000|COMPLETED|PK Phase (Up to Day 8)||8
3336733|NCT03359850|4068005|FG001|COMPLETED|PK Phase (Up to Day 8)||7
3336734|NCT03359850|4068004|FG000|NOT COMPLETED|PK Phase (Up to Day 8)||1
3336735|NCT03359850|4068005|FG001|NOT COMPLETED|PK Phase (Up to Day 8)||1
3336736|NCT03359850|4068004|FG000|STARTED|Extension Phase (Up to 28 Months)||8
3336737|NCT03359850|4068005|FG001|STARTED|Extension Phase (Up to 28 Months)||7
3336738|NCT03359850|4068004|FG000|COMPLETED|Extension Phase (Up to 28 Months)||0
3336739|NCT03359850|4068005|FG001|COMPLETED|Extension Phase (Up to 28 Months)||1
3336740|NCT03359850|4068004|FG000|NOT COMPLETED|Extension Phase (Up to 28 Months)||8
3336741|NCT03359850|4068005|FG001|NOT COMPLETED|Extension Phase (Up to 28 Months)||6
3336742|NCT03359889|4068013|FG000|STARTED|Overall Study||5
3336743|NCT03359889|4068013|FG000|COMPLETED|Overall Study||5
3336744|NCT03359889|4068013|FG000|NOT COMPLETED|Overall Study||0
3336745|NCT03360071|4068019|FG000|STARTED|Overall Study||17
3336746|NCT03360071|4068020|FG001|STARTED|Overall Study||14
3336747|NCT03360071|4068019|FG000|COMPLETED|Overall Study||16
3336748|NCT03360071|4068020|FG001|COMPLETED|Overall Study||14
3336749|NCT03360071|4068019|FG000|NOT COMPLETED|Overall Study||1
3336750|NCT03360071|4068020|FG001|NOT COMPLETED|Overall Study||0
3336751|NCT03360110|4068026|FG000|STARTED|First Intervention||27
3336752|NCT03360110|4068027|FG001|STARTED|First Intervention||26
3336753|NCT03360110|4068026|FG000|COMPLETED|First Intervention||27
3336754|NCT03360110|4068027|FG001|COMPLETED|First Intervention||26
3336755|NCT03360110|4068026|FG000|NOT COMPLETED|First Intervention||0
3336756|NCT03360110|4068027|FG001|NOT COMPLETED|First Intervention||0
3336757|NCT03360110|4068026|FG000|STARTED|Second Intervention||27
3336758|NCT03360110|4068027|FG001|STARTED|Second Intervention||26
3336759|NCT03360110|4068026|FG000|COMPLETED|Second Intervention||27
3336760|NCT03360110|4068027|FG001|COMPLETED|Second Intervention||26
3336761|NCT03360110|4068026|FG000|NOT COMPLETED|Second Intervention||0
3336762|NCT03360110|4068027|FG001|NOT COMPLETED|Second Intervention||0
3336763|NCT03360344|4068048|FG000|STARTED|Overall Study||15
3336764|NCT03360344|4068049|FG001|STARTED|Overall Study||16
3336765|NCT03360344|4068050|FG002|STARTED|Overall Study||13
3336766|NCT03360344|4068048|FG000|COMPLETED|Overall Study||15
3336767|NCT03360344|4068049|FG001|COMPLETED|Overall Study||15
3336768|NCT03360344|4068050|FG002|COMPLETED|Overall Study||12
3336769|NCT03360344|4068048|FG000|NOT COMPLETED|Overall Study||0
3336770|NCT03360344|4068049|FG001|NOT COMPLETED|Overall Study||1
3336771|NCT03360344|4068050|FG002|NOT COMPLETED|Overall Study||1
3336772|NCT03360747|4068058|FG000|STARTED|Overall Study||3
3336773|NCT03360747|4068058|FG000|COMPLETED|Overall Study||2
3336774|NCT03360747|4068058|FG000|NOT COMPLETED|Overall Study||1
3336775|NCT03361137|4068067|FG000|STARTED|Overall Study||1
3336776|NCT03361137|4068068|FG001|STARTED|Overall Study||9
3336777|NCT03361137|4068069|FG002|STARTED|Overall Study||1
3336778|NCT03361137|4068070|FG003|STARTED|Overall Study||2
3336779|NCT03361137|4068071|FG004|STARTED|Overall Study||1
3336780|NCT03361137|4068067|FG000|COMPLETED|Overall Study||0
3336781|NCT03361137|4068068|FG001|COMPLETED|Overall Study||9
3336782|NCT03361137|4068069|FG002|COMPLETED|Overall Study||1
3336783|NCT03361137|4068070|FG003|COMPLETED|Overall Study||2
3336784|NCT03361137|4068071|FG004|COMPLETED|Overall Study||1
3336785|NCT03361137|4068067|FG000|NOT COMPLETED|Overall Study||1
3336786|NCT03361137|4068068|FG001|NOT COMPLETED|Overall Study||0
3336787|NCT03361137|4068069|FG002|NOT COMPLETED|Overall Study||0
3336788|NCT03361137|4068070|FG003|NOT COMPLETED|Overall Study||0
3336789|NCT03361137|4068071|FG004|NOT COMPLETED|Overall Study||0
3336790|NCT03361176|4068087|FG000|STARTED|Overall Study||10
3336791|NCT03361176|4068088|FG001|STARTED|Overall Study||20
3336792|NCT03361176|4068087|FG000|COMPLETED|Overall Study||9
3336793|NCT03361176|4068088|FG001|COMPLETED|Overall Study||15
3336794|NCT03361176|4068087|FG000|NOT COMPLETED|Overall Study||1
3336795|NCT03361176|4068088|FG001|NOT COMPLETED|Overall Study||5
3336796|NCT03361293|4068096|FG000|STARTED|Overall Study||20
3336797|NCT03361293|4068097|FG001|STARTED|Overall Study||24
3336798|NCT03361293|4068096|FG000|COMPLETED|Overall Study||19
3336799|NCT03361293|4068097|FG001|COMPLETED|Overall Study||19
3336800|NCT03361293|4068096|FG000|NOT COMPLETED|Overall Study||1
3336801|NCT03361293|4068097|FG001|NOT COMPLETED|Overall Study||5
3336802|NCT03361423|4068105|FG000|STARTED|Overall Study||126
3336803|NCT03361423|4068106|FG001|STARTED|Overall Study||126
3336804|NCT03361423|4068105|FG000|COMPLETED|Overall Study||99
3336805|NCT03361423|4068106|FG001|COMPLETED|Overall Study||103
3336806|NCT03361423|4068105|FG000|NOT COMPLETED|Overall Study||27
3336807|NCT03361423|4068106|FG001|NOT COMPLETED|Overall Study||23
3336808|NCT03361605|4068112|FG000|STARTED|Overall Study||29
3336809|NCT03361605|4068112|FG000|COMPLETED|Overall Study||26
3336810|NCT03361605|4068112|FG000|NOT COMPLETED|Overall Study||3
3336811|NCT03361917|4068118|FG000|STARTED|Overall Study||99
3336812|NCT03361917|4068119|FG001|STARTED|Overall Study||101
3336813|NCT03361917|4068118|FG000|COMPLETED|Overall Study||99
3336814|NCT03361917|4068119|FG001|COMPLETED|Overall Study||101
3336815|NCT03361917|4068118|FG000|NOT COMPLETED|Overall Study||0
3336816|NCT03361917|4068119|FG001|NOT COMPLETED|Overall Study||0
3336817|NCT03362879|4068125|FG000|STARTED|Overall Study||409
3336818|NCT03362879|4068125|FG000|COMPLETED|Overall Study||409
3336819|NCT03362879|4068125|FG000|NOT COMPLETED|Overall Study||0
3336820|NCT03362944|4068130|FG000|STARTED|First Intervention||8
3336821|NCT03362944|4068131|FG001|STARTED|First Intervention||8
3336822|NCT03362944|4068130|FG000|COMPLETED|First Intervention||8
3336823|NCT03362944|4068131|FG001|COMPLETED|First Intervention||8
3336824|NCT03362944|4068130|FG000|NOT COMPLETED|First Intervention||0
3336825|NCT03362944|4068131|FG001|NOT COMPLETED|First Intervention||0
3336826|NCT03362944|4068130|FG000|STARTED|Single Week Washout Period||8
3336827|NCT03362944|4068131|FG001|STARTED|Single Week Washout Period||8
3336828|NCT03362944|4068130|FG000|COMPLETED|Single Week Washout Period||8
3336829|NCT03362944|4068131|FG001|COMPLETED|Single Week Washout Period||8
3336830|NCT03362944|4068130|FG000|NOT COMPLETED|Single Week Washout Period||0
3336831|NCT03362944|4068131|FG001|NOT COMPLETED|Single Week Washout Period||0
3336832|NCT03362944|4068130|FG000|STARTED|Second Intervention||8
3336833|NCT03362944|4068131|FG001|STARTED|Second Intervention||8
3336834|NCT03362944|4068130|FG000|COMPLETED|Second Intervention||8
3336835|NCT03362944|4068131|FG001|COMPLETED|Second Intervention||8
3336836|NCT03362944|4068130|FG000|NOT COMPLETED|Second Intervention||0
3336837|NCT03362944|4068131|FG001|NOT COMPLETED|Second Intervention||0
3336838|NCT03362957|4068139|FG000|STARTED|Overall Study||14
3336839|NCT03362957|4068140|FG001|STARTED|Overall Study||7
3336840|NCT03362957|4068139|FG000|Crossover to Receive GAE Procedure|Overall Study||0
3336841|NCT03362957|4068140|FG001|Crossover to Receive GAE Procedure|Overall Study||7
3336842|NCT03362957|4068139|FG000|COMPLETED|Overall Study||14
3336843|NCT03362957|4068140|FG001|COMPLETED|Overall Study||7
3336844|NCT03362957|4068139|FG000|NOT COMPLETED|Overall Study||0
3336845|NCT03362957|4068140|FG001|NOT COMPLETED|Overall Study||0
3336846|NCT03363321|4068153|FG000|STARTED|Overall Study||5
3336847|NCT03363321|4068154|FG001|STARTED|Overall Study||4
3336848|NCT03363321|4068155|FG002|STARTED|Overall Study||4
3336849|NCT03363321|4068156|FG003|STARTED|Overall Study||5
3336850|NCT03363321|4068157|FG004|STARTED|Overall Study||2
3336851|NCT03363321|4068153|FG000|COMPLETED|Overall Study||5
3336852|NCT03363321|4068154|FG001|COMPLETED|Overall Study||3
3336853|NCT03363321|4068155|FG002|COMPLETED|Overall Study||4
3336854|NCT03363321|4068156|FG003|COMPLETED|Overall Study||4
3336855|NCT03363321|4068157|FG004|COMPLETED|Overall Study||2
3336856|NCT03363321|4068153|FG000|NOT COMPLETED|Overall Study||0
3336857|NCT03363321|4068154|FG001|NOT COMPLETED|Overall Study||1
3336858|NCT03363321|4068155|FG002|NOT COMPLETED|Overall Study||0
3336859|NCT03363321|4068156|FG003|NOT COMPLETED|Overall Study||1
3336860|NCT03363321|4068157|FG004|NOT COMPLETED|Overall Study||0
3336861|NCT03363776|4068173|FG000|STARTED|Overall Study||4
3336862|NCT03363776|4068174|FG001|STARTED|Overall Study||3
3336863|NCT03363776|4068175|FG002|STARTED|Overall Study||3
3336864|NCT03363776|4068173|FG000|COMPLETED|Overall Study||1
3336865|NCT03363776|4068174|FG001|COMPLETED|Overall Study||0
3336866|NCT03363776|4068175|FG002|COMPLETED|Overall Study||1
3336867|NCT03363776|4068173|FG000|NOT COMPLETED|Overall Study||3
3336868|NCT03363776|4068174|FG001|NOT COMPLETED|Overall Study||3
3336869|NCT03363776|4068175|FG002|NOT COMPLETED|Overall Study||2
3336870|NCT03363854|4068185|FG000|STARTED|Initial Treatment Period||253
3336871|NCT03363854|4068186|FG001|STARTED|Initial Treatment Period||127
3336872|NCT03363854|4068187|FG002|STARTED|Initial Treatment Period|This treatment group applies to the continuation treatment period (see below).|0
3336873|NCT03363854|4068188|FG003|STARTED|Initial Treatment Period|This treatment group applies to the continuation treatment period (see below).|0
3336874|NCT03363854|4068189|FG004|STARTED|Initial Treatment Period|This treatment group applies to the continuation treatment period (see below).|0
3336875|NCT03363854|4068190|FG005|STARTED|Initial Treatment Period|This treatment group applies to the continuation treatment period (see below).|0
3336876|NCT03363854|4068191|FG006|STARTED|Initial Treatment Period|This treatment group applies to the continuation treatment period (see below).|0
3336877|NCT03363854|4068192|FG007|STARTED|Initial Treatment Period|This treatment group applies to the safety follow-up period (see below).|0
3336878|NCT03363854|4068185|FG000|COMPLETED|Initial Treatment Period||235
3336879|NCT03363854|4068186|FG001|COMPLETED|Initial Treatment Period||120
3336880|NCT03363854|4068187|FG002|COMPLETED|Initial Treatment Period||0
3336881|NCT03363854|4068188|FG003|COMPLETED|Initial Treatment Period||0
3336882|NCT03363854|4068189|FG004|COMPLETED|Initial Treatment Period||0
3336883|NCT03363854|4068190|FG005|COMPLETED|Initial Treatment Period||0
3336884|NCT03363854|4068191|FG006|COMPLETED|Initial Treatment Period||0
3336885|NCT03363854|4068192|FG007|COMPLETED|Initial Treatment Period||0
3336886|NCT03363854|4068185|FG000|NOT COMPLETED|Initial Treatment Period||18
3336887|NCT03363854|4068186|FG001|NOT COMPLETED|Initial Treatment Period||7
3336888|NCT03363854|4068187|FG002|NOT COMPLETED|Initial Treatment Period||0
3336889|NCT03363854|4068188|FG003|NOT COMPLETED|Initial Treatment Period||0
3336890|NCT03363854|4068189|FG004|NOT COMPLETED|Initial Treatment Period||0
3336891|NCT03363854|4068190|FG005|NOT COMPLETED|Initial Treatment Period||0
3336892|NCT03363854|4068191|FG006|NOT COMPLETED|Initial Treatment Period||0
3336893|NCT03363854|4068192|FG007|NOT COMPLETED|Initial Treatment Period||0
3336894|NCT03363854|4068185|FG000|STARTED|Continuation Treatment Period|This treatment group applies to the initial treatment period (see above).|0
3336895|NCT03363854|4068186|FG001|STARTED|Continuation Treatment Period|This treatment group applies to the initial treatment period (see above).|0
3336896|NCT03363854|4068187|FG002|STARTED|Continuation Treatment Period||69
3336897|NCT03363854|4068188|FG003|STARTED|Continuation Treatment Period||69
3336898|NCT03363854|4068189|FG004|STARTED|Continuation Treatment Period||95
3336899|NCT03363854|4068190|FG005|STARTED|Continuation Treatment Period||79
3336900|NCT03363854|4068191|FG006|STARTED|Continuation Treatment Period||41
3336901|NCT03363854|4068192|FG007|STARTED|Continuation Treatment Period|This treatment group applies to the safety follow-up period (see below).|0
3336902|NCT03363854|4068185|FG000|COMPLETED|Continuation Treatment Period||0
3336903|NCT03363854|4068186|FG001|COMPLETED|Continuation Treatment Period||0
3336904|NCT03363854|4068187|FG002|COMPLETED|Continuation Treatment Period||68
3336905|NCT03363854|4068188|FG003|COMPLETED|Continuation Treatment Period||65
3336906|NCT03363854|4068189|FG004|COMPLETED|Continuation Treatment Period||87
3336907|NCT03363854|4068190|FG005|COMPLETED|Continuation Treatment Period||72
3336908|NCT03363854|4068191|FG006|COMPLETED|Continuation Treatment Period||38
3336909|NCT03363854|4068192|FG007|COMPLETED|Continuation Treatment Period||0
3336910|NCT03363854|4068185|FG000|NOT COMPLETED|Continuation Treatment Period||0
3336911|NCT03363854|4068186|FG001|NOT COMPLETED|Continuation Treatment Period||0
3336912|NCT03363854|4068187|FG002|NOT COMPLETED|Continuation Treatment Period||1
3336913|NCT03363854|4068188|FG003|NOT COMPLETED|Continuation Treatment Period||4
3336914|NCT03363854|4068189|FG004|NOT COMPLETED|Continuation Treatment Period||8
3336915|NCT03363854|4068190|FG005|NOT COMPLETED|Continuation Treatment Period||7
3336916|NCT03363854|4068191|FG006|NOT COMPLETED|Continuation Treatment Period||3
3336917|NCT03363854|4068192|FG007|NOT COMPLETED|Continuation Treatment Period||0
3336918|NCT03363854|4068185|FG000|STARTED|Safety Follow-up Period|This treatment group applies to the initial treatment period (see above).|0
3336919|NCT03363854|4068186|FG001|STARTED|Safety Follow-up Period|This treatment group applies to the initial treatment period (see above).|0
3336920|NCT03363854|4068187|FG002|STARTED|Safety Follow-up Period|This treatment group applies to the continuation treatment period (see above).|0
3336921|NCT03363854|4068188|FG003|STARTED|Safety Follow-up Period|This treatment group applies to the continuation treatment period (see above).|0
3336922|NCT03363854|4068189|FG004|STARTED|Safety Follow-up Period|This treatment group applies to the continuation treatment period (see above).|0
3176976|NCT01968070|3904659|FG013|STARTED|Period 3||0
3176977|NCT01968070|3904660|FG014|STARTED|Period 3||0
3176978|NCT01968070|3904661|FG015|STARTED|Period 3||0
3176979|NCT01968070|3904662|FG016|STARTED|Period 3||0
3176980|NCT01968070|3904663|FG017|STARTED|Period 3||0
3176981|NCT01968070|3904646|FG000|COMPLETED|Period 3||4
3176982|NCT01968070|3904647|FG001|COMPLETED|Period 3||4
3176983|NCT01968070|3904648|FG002|COMPLETED|Period 3||4
3176984|NCT01968070|3904649|FG003|COMPLETED|Period 3||4
3176985|NCT01968070|3904650|FG004|COMPLETED|Period 3||3
3176986|NCT01968070|3904651|FG005|COMPLETED|Period 3||4
3176987|NCT01968070|3904652|FG006|COMPLETED|Period 3||0
3176988|NCT01968070|3904653|FG007|COMPLETED|Period 3||0
3176989|NCT01968070|3904654|FG008|COMPLETED|Period 3||0
3176990|NCT01968070|3904655|FG009|COMPLETED|Period 3||0
3176991|NCT01968070|3904656|FG010|COMPLETED|Period 3||0
3176992|NCT01968070|3904657|FG011|COMPLETED|Period 3||0
3336923|NCT03363854|4068190|FG005|STARTED|Safety Follow-up Period|This treatment group applies to the continuation treatment period (see above).|0
3336924|NCT03363854|4068191|FG006|STARTED|Safety Follow-up Period|This treatment group applies to the continuation treatment period (see above).|0
3336925|NCT03363854|4068192|FG007|STARTED|Safety Follow-up Period||278
3336926|NCT03363854|4068185|FG000|COMPLETED|Safety Follow-up Period||0
3336927|NCT03363854|4068186|FG001|COMPLETED|Safety Follow-up Period||0
3336928|NCT03363854|4068187|FG002|COMPLETED|Safety Follow-up Period||0
3336929|NCT03363854|4068188|FG003|COMPLETED|Safety Follow-up Period||0
3336930|NCT03363854|4068189|FG004|COMPLETED|Safety Follow-up Period||0
3336931|NCT03363854|4068190|FG005|COMPLETED|Safety Follow-up Period||0
3336932|NCT03363854|4068191|FG006|COMPLETED|Safety Follow-up Period||0
3336933|NCT03363854|4068192|FG007|COMPLETED|Safety Follow-up Period||62
3336934|NCT03363854|4068185|FG000|NOT COMPLETED|Safety Follow-up Period||0
3336935|NCT03363854|4068186|FG001|NOT COMPLETED|Safety Follow-up Period||0
3336936|NCT03363854|4068187|FG002|NOT COMPLETED|Safety Follow-up Period||0
3336937|NCT03363854|4068188|FG003|NOT COMPLETED|Safety Follow-up Period||0
3336938|NCT03363854|4068189|FG004|NOT COMPLETED|Safety Follow-up Period||0
3336939|NCT03363854|4068190|FG005|NOT COMPLETED|Safety Follow-up Period||0
3336940|NCT03363854|4068191|FG006|NOT COMPLETED|Safety Follow-up Period||0
3336941|NCT03363854|4068192|FG007|NOT COMPLETED|Safety Follow-up Period||216
3336942|NCT03363906|4068215|FG000|STARTED|Period 1 (Reference or Test)||15
3336943|NCT03363906|4068216|FG001|STARTED|Period 1 (Reference or Test)||12
3336944|NCT03363906|4068215|FG000|Received at Least One Dose of Study Drug|Period 1 (Reference or Test)||15
3336945|NCT03363906|4068216|FG001|Received at Least One Dose of Study Drug|Period 1 (Reference or Test)||11
3336946|NCT03363906|4068215|FG000|COMPLETED|Period 1 (Reference or Test)||14
3336947|NCT03363906|4068216|FG001|COMPLETED|Period 1 (Reference or Test)||10
3336948|NCT03363906|4068215|FG000|NOT COMPLETED|Period 1 (Reference or Test)||1
3336949|NCT03363906|4068216|FG001|NOT COMPLETED|Period 1 (Reference or Test)||2
3336950|NCT03363906|4068215|FG000|STARTED|Period 2 (Test or Reference)||14
3336951|NCT03363906|4068216|FG001|STARTED|Period 2 (Test or Reference)||10
3336952|NCT03363906|4068215|FG000|Received at Least One Dose of Study Drug|Period 2 (Test or Reference)||12
3336953|NCT03363906|4068216|FG001|Received at Least One Dose of Study Drug|Period 2 (Test or Reference)||9
3336954|NCT03363906|4068215|FG000|COMPLETED|Period 2 (Test or Reference)||10
3336955|NCT03363906|4068216|FG001|COMPLETED|Period 2 (Test or Reference)||9
3336956|NCT03363906|4068215|FG000|NOT COMPLETED|Period 2 (Test or Reference)||4
3336957|NCT03363906|4068216|FG001|NOT COMPLETED|Period 2 (Test or Reference)||1
3336958|NCT03364023|4068222|FG000|STARTED|Overall Study||183
3336959|NCT03364023|4068222|FG000|COMPLETED|Overall Study||166
3336960|NCT03364023|4068222|FG000|NOT COMPLETED|Overall Study||17
3336961|NCT03364036|4068226|FG000|STARTED|Overall Study||270
3336962|NCT03364036|4068226|FG000|Full Analysis Set (FAS)|Overall Study||270
3336963|NCT03364036|4068226|FG000|COMPLETED|Overall Study||264
3336964|NCT03364036|4068226|FG000|NOT COMPLETED|Overall Study||6
3336965|NCT03364049|4068234|FG000|STARTED|Overall Study||6
3336966|NCT03364049|4068235|FG001|STARTED|Overall Study||6
3336967|NCT03364049|4068236|FG002|STARTED|Overall Study||6
3336968|NCT03364049|4068237|FG003|STARTED|Overall Study||15
3336969|NCT03364049|4068234|FG000|COMPLETED|Overall Study||0
3336970|NCT03364049|4068235|FG001|COMPLETED|Overall Study||0
3336971|NCT03364049|4068236|FG002|COMPLETED|Overall Study||0
3336972|NCT03364049|4068237|FG003|COMPLETED|Overall Study||0
3336973|NCT03364049|4068234|FG000|NOT COMPLETED|Overall Study||6
3336974|NCT03364049|4068235|FG001|NOT COMPLETED|Overall Study||6
3336975|NCT03364049|4068236|FG002|NOT COMPLETED|Overall Study||6
3336976|NCT03364049|4068237|FG003|NOT COMPLETED|Overall Study||15
3336977|NCT03364192|4068247|FG000|STARTED|Overall Study||28
3336978|NCT03364192|4068247|FG000|COMPLETED|Overall Study||12
3336979|NCT03364192|4068247|FG000|NOT COMPLETED|Overall Study||16
3336980|NCT03364309|4068255|FG000|STARTED|Induction Period||88
3336981|NCT03364309|4068256|FG001|STARTED|Induction Period||174
3336982|NCT03364309|4068257|FG002|STARTED|Induction Period||176
3336983|NCT03364309|4068258|FG003|STARTED|Induction Period||0
3336984|NCT03364309|4068259|FG004|STARTED|Induction Period||0
3336985|NCT03364309|4068260|FG005|STARTED|Induction Period||0
3336986|NCT03364309|4068261|FG006|STARTED|Induction Period||0
3336987|NCT03364309|4068262|FG007|STARTED|Induction Period||0
3336988|NCT03364309|4068263|FG008|STARTED|Induction Period||0
3336989|NCT03364309|4068264|FG009|STARTED|Induction Period||0
3336990|NCT03364309|4068265|FG010|STARTED|Induction Period||0
3336991|NCT03364309|4068266|FG011|STARTED|Induction Period||0
3336992|NCT03364309|4068267|FG012|STARTED|Induction Period||0
3336993|NCT03364309|4068268|FG013|STARTED|Induction Period||0
3336994|NCT03364309|4068269|FG014|STARTED|Induction Period||0
3336995|NCT03364309|4068270|FG015|STARTED|Induction Period||0
3336996|NCT03364309|4068271|FG016|STARTED|Induction Period||0
3336997|NCT03364309|4068272|FG017|STARTED|Induction Period||0
3336998|NCT03364309|4068273|FG018|STARTED|Induction Period||0
3336999|NCT03364309|4068255|FG000|Received at Least One Dose of Study Drug|Induction Period||88
3337000|NCT03364309|4068256|FG001|Received at Least One Dose of Study Drug|Induction Period||174
3337001|NCT03364309|4068257|FG002|Received at Least One Dose of Study Drug|Induction Period||176
3337002|NCT03364309|4068258|FG003|Received at Least One Dose of Study Drug|Induction Period||0
3337003|NCT03364309|4068259|FG004|Received at Least One Dose of Study Drug|Induction Period||0
3337004|NCT03364309|4068260|FG005|Received at Least One Dose of Study Drug|Induction Period||0
3337005|NCT03364309|4068261|FG006|Received at Least One Dose of Study Drug|Induction Period||0
3337006|NCT03364309|4068262|FG007|Received at Least One Dose of Study Drug|Induction Period||0
3337007|NCT03364309|4068263|FG008|Received at Least One Dose of Study Drug|Induction Period||0
3337008|NCT03364309|4068264|FG009|Received at Least One Dose of Study Drug|Induction Period||0
3337009|NCT03364309|4068265|FG010|Received at Least One Dose of Study Drug|Induction Period||0
3337010|NCT03364309|4068266|FG011|Received at Least One Dose of Study Drug|Induction Period||0
3337011|NCT03364309|4068267|FG012|Received at Least One Dose of Study Drug|Induction Period||0
3337012|NCT03364309|4068268|FG013|Received at Least One Dose of Study Drug|Induction Period||0
3337013|NCT03364309|4068269|FG014|Received at Least One Dose of Study Drug|Induction Period||0
3337014|NCT03364309|4068270|FG015|Received at Least One Dose of Study Drug|Induction Period||0
3337015|NCT03364309|4068271|FG016|Received at Least One Dose of Study Drug|Induction Period||0
3337016|NCT03364309|4068272|FG017|Received at Least One Dose of Study Drug|Induction Period||0
3337017|NCT03364309|4068273|FG018|Received at Least One Dose of Study Drug|Induction Period||0
3337018|NCT03364309|4068255|FG000|COMPLETED|Induction Period||82
3337019|NCT03364309|4068256|FG001|COMPLETED|Induction Period||170
3337020|NCT03364309|4068257|FG002|COMPLETED|Induction Period||175
3337021|NCT03364309|4068258|FG003|COMPLETED|Induction Period||0
3337022|NCT03364309|4068259|FG004|COMPLETED|Induction Period||0
3337023|NCT03364309|4068260|FG005|COMPLETED|Induction Period||0
3337024|NCT03364309|4068261|FG006|COMPLETED|Induction Period||0
3337025|NCT03364309|4068262|FG007|COMPLETED|Induction Period||0
3337026|NCT03364309|4068263|FG008|COMPLETED|Induction Period||0
3337027|NCT03364309|4068264|FG009|COMPLETED|Induction Period||0
3337028|NCT03364309|4068265|FG010|COMPLETED|Induction Period||0
3337029|NCT03364309|4068266|FG011|COMPLETED|Induction Period||0
3337030|NCT03364309|4068267|FG012|COMPLETED|Induction Period||0
3337031|NCT03364309|4068268|FG013|COMPLETED|Induction Period||0
3337032|NCT03364309|4068269|FG014|COMPLETED|Induction Period||0
3337033|NCT03364309|4068270|FG015|COMPLETED|Induction Period||0
3337034|NCT03364309|4068271|FG016|COMPLETED|Induction Period||0
3337035|NCT03364309|4068272|FG017|COMPLETED|Induction Period||0
3337036|NCT03364309|4068273|FG018|COMPLETED|Induction Period||0
3337037|NCT03364309|4068255|FG000|NOT COMPLETED|Induction Period||6
3337038|NCT03364309|4068256|FG001|NOT COMPLETED|Induction Period||4
3337039|NCT03364309|4068257|FG002|NOT COMPLETED|Induction Period||1
3337040|NCT03364309|4068258|FG003|NOT COMPLETED|Induction Period||0
3337041|NCT03364309|4068259|FG004|NOT COMPLETED|Induction Period||0
3337042|NCT03364309|4068260|FG005|NOT COMPLETED|Induction Period||0
3337043|NCT03364309|4068261|FG006|NOT COMPLETED|Induction Period||0
3337044|NCT03364309|4068262|FG007|NOT COMPLETED|Induction Period||0
3337045|NCT03364309|4068263|FG008|NOT COMPLETED|Induction Period||0
3337046|NCT03364309|4068264|FG009|NOT COMPLETED|Induction Period||0
3337047|NCT03364309|4068265|FG010|NOT COMPLETED|Induction Period||0
3337048|NCT03364309|4068266|FG011|NOT COMPLETED|Induction Period||0
3337049|NCT03364309|4068267|FG012|NOT COMPLETED|Induction Period||0
3337050|NCT03364309|4068268|FG013|NOT COMPLETED|Induction Period||0
3337051|NCT03364309|4068269|FG014|NOT COMPLETED|Induction Period||0
3337052|NCT03364309|4068270|FG015|NOT COMPLETED|Induction Period||0
3337053|NCT03364309|4068271|FG016|NOT COMPLETED|Induction Period||0
3337054|NCT03364309|4068272|FG017|NOT COMPLETED|Induction Period||0
3337055|NCT03364309|4068273|FG018|NOT COMPLETED|Induction Period||0
3337056|NCT03364309|4068255|FG000|STARTED|Maintenance Period|This period is to report Maintenance Period participants.|0
3337057|NCT03364309|4068256|FG001|STARTED|Maintenance Period|This period is to report Maintenance Period participants.|0
3337058|NCT03364309|4068257|FG002|STARTED|Maintenance Period|This period is to report Maintenance Period participants.|0
3337059|NCT03364309|4068258|FG003|STARTED|Maintenance Period|This period is to report Maintenance Period participants.|47
3337060|NCT03364309|4068259|FG004|STARTED|Maintenance Period|This period is to report Maintenance Period participants.|92
3337061|NCT03364309|4068260|FG005|STARTED|Maintenance Period|This period is to report Maintenance Period participants.|50
3337062|NCT03364309|4068261|FG006|STARTED|Maintenance Period|This period is to report Maintenance Period participants.|100
3337063|NCT03364309|4068262|FG007|STARTED|Maintenance Period|This period is to report Maintenance Period participants.|3
3337064|NCT03364309|4068263|FG008|STARTED|Maintenance Period|This period is to report Maintenance Period participants.|79
3337065|NCT03364309|4068264|FG009|STARTED|Maintenance Period|This period is to report Maintenance Period participants.|31
3337066|NCT03364309|4068265|FG010|STARTED|Maintenance Period|This period is to report Maintenance Period participants.|23
3337067|NCT03364309|4068266|FG011|STARTED|Maintenance Period||0
3337068|NCT03364309|4068267|FG012|STARTED|Maintenance Period||0
3337069|NCT03364309|4068268|FG013|STARTED|Maintenance Period||0
3337070|NCT03364309|4068269|FG014|STARTED|Maintenance Period||0
3337071|NCT03364309|4068270|FG015|STARTED|Maintenance Period||0
3337072|NCT03364309|4068271|FG016|STARTED|Maintenance Period||0
3337073|NCT03364309|4068272|FG017|STARTED|Maintenance Period||0
3337074|NCT03364309|4068273|FG018|STARTED|Maintenance Period||0
3337075|NCT03364309|4068255|FG000|Received at Least One Dose of Study Drug|Maintenance Period||0
3337076|NCT03364309|4068256|FG001|Received at Least One Dose of Study Drug|Maintenance Period||0
3337077|NCT03364309|4068257|FG002|Received at Least One Dose of Study Drug|Maintenance Period||0
3337078|NCT03364309|4068258|FG003|Received at Least One Dose of Study Drug|Maintenance Period||47
3337079|NCT03364309|4068259|FG004|Received at Least One Dose of Study Drug|Maintenance Period||92
3337080|NCT03364309|4068260|FG005|Received at Least One Dose of Study Drug|Maintenance Period||50
3337081|NCT03364309|4068261|FG006|Received at Least One Dose of Study Drug|Maintenance Period||100
3337082|NCT03364309|4068262|FG007|Received at Least One Dose of Study Drug|Maintenance Period||3
3337083|NCT03364309|4068263|FG008|Received at Least One Dose of Study Drug|Maintenance Period||79
3337084|NCT03364309|4068264|FG009|Received at Least One Dose of Study Drug|Maintenance Period||31
3337085|NCT03364309|4068265|FG010|Received at Least One Dose of Study Drug|Maintenance Period||23
3337086|NCT03364309|4068266|FG011|Received at Least One Dose of Study Drug|Maintenance Period||0
3337087|NCT03364309|4068267|FG012|Received at Least One Dose of Study Drug|Maintenance Period||0
3337088|NCT03364309|4068268|FG013|Received at Least One Dose of Study Drug|Maintenance Period||0
3337089|NCT03364309|4068269|FG014|Received at Least One Dose of Study Drug|Maintenance Period||0
3337090|NCT03364309|4068270|FG015|Received at Least One Dose of Study Drug|Maintenance Period||0
3337091|NCT03364309|4068271|FG016|Received at Least One Dose of Study Drug|Maintenance Period||0
3337092|NCT03364309|4068272|FG017|Received at Least One Dose of Study Drug|Maintenance Period||0
3337093|NCT03364309|4068273|FG018|Received at Least One Dose of Study Drug|Maintenance Period||0
3337094|NCT03364309|4068255|FG000|COMPLETED|Maintenance Period||0
3337095|NCT03364309|4068256|FG001|COMPLETED|Maintenance Period||0
3337096|NCT03364309|4068257|FG002|COMPLETED|Maintenance Period||0
3337097|NCT03364309|4068258|FG003|COMPLETED|Maintenance Period||3
3337098|NCT03364309|4068259|FG004|COMPLETED|Maintenance Period||80
3337099|NCT03364309|4068260|FG005|COMPLETED|Maintenance Period||4
3337100|NCT03364309|4068261|FG006|COMPLETED|Maintenance Period||84
3337101|NCT03364309|4068262|FG007|COMPLETED|Maintenance Period||1
3337102|NCT03364309|4068263|FG008|COMPLETED|Maintenance Period||73
3337103|NCT03364309|4068264|FG009|COMPLETED|Maintenance Period||27
3337104|NCT03364309|4068265|FG010|COMPLETED|Maintenance Period||17
3337105|NCT03364309|4068266|FG011|COMPLETED|Maintenance Period||0
3337106|NCT03364309|4068267|FG012|COMPLETED|Maintenance Period||0
3337107|NCT03364309|4068268|FG013|COMPLETED|Maintenance Period||0
3337108|NCT03364309|4068269|FG014|COMPLETED|Maintenance Period||0
3337109|NCT03364309|4068270|FG015|COMPLETED|Maintenance Period||0
3337110|NCT03364309|4068271|FG016|COMPLETED|Maintenance Period||0
3337111|NCT03364309|4068272|FG017|COMPLETED|Maintenance Period||0
3337112|NCT03364309|4068273|FG018|COMPLETED|Maintenance Period||0
3337113|NCT03364309|4068255|FG000|NOT COMPLETED|Maintenance Period||0
3337114|NCT03364309|4068256|FG001|NOT COMPLETED|Maintenance Period||0
3337115|NCT03364309|4068257|FG002|NOT COMPLETED|Maintenance Period||0
3337116|NCT03364309|4068258|FG003|NOT COMPLETED|Maintenance Period||44
3337117|NCT03364309|4068259|FG004|NOT COMPLETED|Maintenance Period||12
3337118|NCT03364309|4068260|FG005|NOT COMPLETED|Maintenance Period||46
3337119|NCT03364309|4068261|FG006|NOT COMPLETED|Maintenance Period||16
3337120|NCT03364309|4068262|FG007|NOT COMPLETED|Maintenance Period||2
3337121|NCT03364309|4068263|FG008|NOT COMPLETED|Maintenance Period||6
3337122|NCT03364309|4068264|FG009|NOT COMPLETED|Maintenance Period||4
3337123|NCT03364309|4068265|FG010|NOT COMPLETED|Maintenance Period||6
3337124|NCT03364309|4068266|FG011|NOT COMPLETED|Maintenance Period||0
3337125|NCT03364309|4068267|FG012|NOT COMPLETED|Maintenance Period||0
3337126|NCT03364309|4068268|FG013|NOT COMPLETED|Maintenance Period||0
3337127|NCT03364309|4068269|FG014|NOT COMPLETED|Maintenance Period||0
3337128|NCT03364309|4068270|FG015|NOT COMPLETED|Maintenance Period||0
3337129|NCT03364309|4068271|FG016|NOT COMPLETED|Maintenance Period||0
3337130|NCT03364309|4068272|FG017|NOT COMPLETED|Maintenance Period||0
3337131|NCT03364309|4068273|FG018|NOT COMPLETED|Maintenance Period||0
3337132|NCT03364309|4068255|FG000|STARTED|Re-treatment (Maintenance) Period||0
3337133|NCT03364309|4068256|FG001|STARTED|Re-treatment (Maintenance) Period||0
3337134|NCT03364309|4068257|FG002|STARTED|Re-treatment (Maintenance) Period||0
3337135|NCT03364309|4068258|FG003|STARTED|Re-treatment (Maintenance) Period|This period is to report for Re-treatment (Maintenance) Period.|0
3337136|NCT03364309|4068259|FG004|STARTED|Re-treatment (Maintenance) Period|This period is to report for Re-treatment (Maintenance) Period.|0
3337137|NCT03364309|4068260|FG005|STARTED|Re-treatment (Maintenance) Period|This period is to report for Re-treatment (Maintenance) Period.|0
3337138|NCT03364309|4068261|FG006|STARTED|Re-treatment (Maintenance) Period|This period is to report for Re-treatment (Maintenance) Period.|0
3337139|NCT03364309|4068262|FG007|STARTED|Re-treatment (Maintenance) Period|This period is to report for Re-treatment (Maintenance) Period.|0
3337140|NCT03364309|4068263|FG008|STARTED|Re-treatment (Maintenance) Period|This period is to report for Re-treatment (Maintenance) Period.|0
3337141|NCT03364309|4068264|FG009|STARTED|Re-treatment (Maintenance) Period|This period is to report for Re-treatment (Maintenance) Period.|0
3337142|NCT03364309|4068265|FG010|STARTED|Re-treatment (Maintenance) Period|This period is to report for Re-treatment (Maintenance) Period.|0
3337143|NCT03364309|4068266|FG011|STARTED|Re-treatment (Maintenance) Period|This period is to report for Re-treatment (Maintenance) Period.|2
3337144|NCT03364309|4068267|FG012|STARTED|Re-treatment (Maintenance) Period|This period is to report for Re-treatment (Maintenance) Period.|43
3337145|NCT03364309|4068268|FG013|STARTED|Re-treatment (Maintenance) Period|This period is to report for Re-treatment (Maintenance) Period.|7
3337146|NCT03364309|4068269|FG014|STARTED|Re-treatment (Maintenance) Period|This period is to report for Re-treatment (Maintenance) Period.|45
3337147|NCT03364309|4068270|FG015|STARTED|Re-treatment (Maintenance) Period|This period is to report for Re-treatment (Maintenance) Period.|10
3337148|NCT03364309|4068271|FG016|STARTED|Re-treatment (Maintenance) Period||0
3337149|NCT03364309|4068272|FG017|STARTED|Re-treatment (Maintenance) Period||0
3337150|NCT03364309|4068273|FG018|STARTED|Re-treatment (Maintenance) Period||0
3337151|NCT03364309|4068255|FG000|COMPLETED|Re-treatment (Maintenance) Period||0
3337152|NCT03364309|4068256|FG001|COMPLETED|Re-treatment (Maintenance) Period||0
3337153|NCT03364309|4068257|FG002|COMPLETED|Re-treatment (Maintenance) Period||0
3337154|NCT03364309|4068258|FG003|COMPLETED|Re-treatment (Maintenance) Period||0
3337155|NCT03364309|4068259|FG004|COMPLETED|Re-treatment (Maintenance) Period||0
3337156|NCT03364309|4068260|FG005|COMPLETED|Re-treatment (Maintenance) Period||0
3337157|NCT03364309|4068261|FG006|COMPLETED|Re-treatment (Maintenance) Period||0
3337158|NCT03364309|4068262|FG007|COMPLETED|Re-treatment (Maintenance) Period||0
3337159|NCT03364309|4068263|FG008|COMPLETED|Re-treatment (Maintenance) Period||0
3337160|NCT03364309|4068264|FG009|COMPLETED|Re-treatment (Maintenance) Period||0
3337161|NCT03364309|4068265|FG010|COMPLETED|Re-treatment (Maintenance) Period||0
3337162|NCT03364309|4068266|FG011|COMPLETED|Re-treatment (Maintenance) Period||2
3337163|NCT03364309|4068267|FG012|COMPLETED|Re-treatment (Maintenance) Period||42
3337164|NCT03364309|4068268|FG013|COMPLETED|Re-treatment (Maintenance) Period||6
3337165|NCT03364309|4068269|FG014|COMPLETED|Re-treatment (Maintenance) Period||43
3337166|NCT03364309|4068270|FG015|COMPLETED|Re-treatment (Maintenance) Period||8
3337167|NCT03364309|4068271|FG016|COMPLETED|Re-treatment (Maintenance) Period||0
3337168|NCT03364309|4068272|FG017|COMPLETED|Re-treatment (Maintenance) Period||0
3337169|NCT03364309|4068273|FG018|COMPLETED|Re-treatment (Maintenance) Period||0
3337170|NCT03364309|4068255|FG000|NOT COMPLETED|Re-treatment (Maintenance) Period||0
3337171|NCT03364309|4068256|FG001|NOT COMPLETED|Re-treatment (Maintenance) Period||0
3337172|NCT03364309|4068257|FG002|NOT COMPLETED|Re-treatment (Maintenance) Period||0
3337173|NCT03364309|4068258|FG003|NOT COMPLETED|Re-treatment (Maintenance) Period||0
3337174|NCT03364309|4068259|FG004|NOT COMPLETED|Re-treatment (Maintenance) Period||0
3337175|NCT03364309|4068260|FG005|NOT COMPLETED|Re-treatment (Maintenance) Period||0
3337176|NCT03364309|4068261|FG006|NOT COMPLETED|Re-treatment (Maintenance) Period||0
3337177|NCT03364309|4068262|FG007|NOT COMPLETED|Re-treatment (Maintenance) Period||0
3337178|NCT03364309|4068263|FG008|NOT COMPLETED|Re-treatment (Maintenance) Period||0
3337179|NCT03364309|4068264|FG009|NOT COMPLETED|Re-treatment (Maintenance) Period||0
3337180|NCT03364309|4068265|FG010|NOT COMPLETED|Re-treatment (Maintenance) Period||0
3337181|NCT03364309|4068266|FG011|NOT COMPLETED|Re-treatment (Maintenance) Period||0
3337182|NCT03364309|4068267|FG012|NOT COMPLETED|Re-treatment (Maintenance) Period||1
3337183|NCT03364309|4068268|FG013|NOT COMPLETED|Re-treatment (Maintenance) Period||1
3337184|NCT03364309|4068269|FG014|NOT COMPLETED|Re-treatment (Maintenance) Period||2
3337185|NCT03364309|4068270|FG015|NOT COMPLETED|Re-treatment (Maintenance) Period||2
3337186|NCT03364309|4068271|FG016|NOT COMPLETED|Re-treatment (Maintenance) Period||0
3337187|NCT03364309|4068272|FG017|NOT COMPLETED|Re-treatment (Maintenance) Period||0
3176993|NCT01968070|3904658|FG012|COMPLETED|Period 3||0
3176994|NCT01968070|3904659|FG013|COMPLETED|Period 3||0
3176995|NCT01968070|3904660|FG014|COMPLETED|Period 3||0
3176996|NCT01968070|3904661|FG015|COMPLETED|Period 3||0
3337188|NCT03364309|4068273|FG018|NOT COMPLETED|Re-treatment (Maintenance) Period||0
3337189|NCT03364309|4068255|FG000|STARTED|Post-Treatment Followup Period||0
3337190|NCT03364309|4068256|FG001|STARTED|Post-Treatment Followup Period||0
3337191|NCT03364309|4068257|FG002|STARTED|Post-Treatment Followup Period||0
3337192|NCT03364309|4068258|FG003|STARTED|Post-Treatment Followup Period||0
3337193|NCT03364309|4068259|FG004|STARTED|Post-Treatment Followup Period||0
3337194|NCT03364309|4068260|FG005|STARTED|Post-Treatment Followup Period||0
3337195|NCT03364309|4068261|FG006|STARTED|Post-Treatment Followup Period||0
3337196|NCT03364309|4068262|FG007|STARTED|Post-Treatment Followup Period||0
3337197|NCT03364309|4068263|FG008|STARTED|Post-Treatment Followup Period||0
3337198|NCT03364309|4068264|FG009|STARTED|Post-Treatment Followup Period||0
3337199|NCT03364309|4068265|FG010|STARTED|Post-Treatment Followup Period||0
3337200|NCT03364309|4068266|FG011|STARTED|Post-Treatment Followup Period|This period is to report for Follow-up Period participants.|0
3337201|NCT03364309|4068267|FG012|STARTED|Post-Treatment Followup Period|This period is to report for Follow-up Period participants.|0
3337202|NCT03364309|4068268|FG013|STARTED|Post-Treatment Followup Period|This period is to report for Follow-up Period participants.|0
3337203|NCT03364309|4068269|FG014|STARTED|Post-Treatment Followup Period|This period is to report for Follow-up Period participants.|0
3337204|NCT03364309|4068270|FG015|STARTED|Post-Treatment Followup Period|This period is to report for Follow-up Period participants.|0
3337205|NCT03364309|4068271|FG016|STARTED|Post-Treatment Followup Period|This period is to report for Follow-up Period participants.|11
3337206|NCT03364309|4068272|FG017|STARTED|Post-Treatment Followup Period|This period is to report for Follow-up Period participants.|375
3337207|NCT03364309|4068273|FG018|STARTED|Post-Treatment Followup Period|This period is to report for Follow-up Period participants.|2
3337208|NCT03364309|4068255|FG000|COMPLETED|Post-Treatment Followup Period||0
3337209|NCT03364309|4068256|FG001|COMPLETED|Post-Treatment Followup Period||0
3337210|NCT03364309|4068257|FG002|COMPLETED|Post-Treatment Followup Period||0
3337211|NCT03364309|4068258|FG003|COMPLETED|Post-Treatment Followup Period||0
3337212|NCT03364309|4068259|FG004|COMPLETED|Post-Treatment Followup Period||0
3337213|NCT03364309|4068260|FG005|COMPLETED|Post-Treatment Followup Period||0
3337214|NCT03364309|4068261|FG006|COMPLETED|Post-Treatment Followup Period||0
3337215|NCT03364309|4068262|FG007|COMPLETED|Post-Treatment Followup Period||0
3337216|NCT03364309|4068263|FG008|COMPLETED|Post-Treatment Followup Period||0
3337217|NCT03364309|4068264|FG009|COMPLETED|Post-Treatment Followup Period||0
3337218|NCT03364309|4068265|FG010|COMPLETED|Post-Treatment Followup Period||0
3337219|NCT03364309|4068266|FG011|COMPLETED|Post-Treatment Followup Period||0
3337220|NCT03364309|4068267|FG012|COMPLETED|Post-Treatment Followup Period||0
3337221|NCT03364309|4068268|FG013|COMPLETED|Post-Treatment Followup Period||0
3337222|NCT03364309|4068269|FG014|COMPLETED|Post-Treatment Followup Period||0
3337223|NCT03364309|4068270|FG015|COMPLETED|Post-Treatment Followup Period||0
3337224|NCT03364309|4068271|FG016|COMPLETED|Post-Treatment Followup Period||6
3337225|NCT03364309|4068272|FG017|COMPLETED|Post-Treatment Followup Period||344
3337226|NCT03364309|4068273|FG018|COMPLETED|Post-Treatment Followup Period||0
3337227|NCT03364309|4068255|FG000|NOT COMPLETED|Post-Treatment Followup Period||0
3337228|NCT03364309|4068256|FG001|NOT COMPLETED|Post-Treatment Followup Period||0
3337229|NCT03364309|4068257|FG002|NOT COMPLETED|Post-Treatment Followup Period||0
3337230|NCT03364309|4068258|FG003|NOT COMPLETED|Post-Treatment Followup Period||0
3337231|NCT03364309|4068259|FG004|NOT COMPLETED|Post-Treatment Followup Period||0
3337232|NCT03364309|4068260|FG005|NOT COMPLETED|Post-Treatment Followup Period||0
3337233|NCT03364309|4068261|FG006|NOT COMPLETED|Post-Treatment Followup Period||0
3337234|NCT03364309|4068262|FG007|NOT COMPLETED|Post-Treatment Followup Period||0
3337235|NCT03364309|4068263|FG008|NOT COMPLETED|Post-Treatment Followup Period||0
3337236|NCT03364309|4068264|FG009|NOT COMPLETED|Post-Treatment Followup Period||0
3337237|NCT03364309|4068265|FG010|NOT COMPLETED|Post-Treatment Followup Period||0
3337238|NCT03364309|4068266|FG011|NOT COMPLETED|Post-Treatment Followup Period||0
3337239|NCT03364309|4068267|FG012|NOT COMPLETED|Post-Treatment Followup Period||0
3337240|NCT03364309|4068268|FG013|NOT COMPLETED|Post-Treatment Followup Period||0
3337241|NCT03364309|4068269|FG014|NOT COMPLETED|Post-Treatment Followup Period||0
3337242|NCT03364309|4068270|FG015|NOT COMPLETED|Post-Treatment Followup Period||0
3337243|NCT03364309|4068271|FG016|NOT COMPLETED|Post-Treatment Followup Period||5
3337244|NCT03364309|4068272|FG017|NOT COMPLETED|Post-Treatment Followup Period||31
3337245|NCT03364309|4068273|FG018|NOT COMPLETED|Post-Treatment Followup Period||2
3337246|NCT03364335|4068302|FG000|STARTED|Overall Study||52
3337247|NCT03364335|4068303|FG001|STARTED|Overall Study||51
3337248|NCT03364335|4068304|FG002|STARTED|Overall Study||53
3337249|NCT03364335|4068305|FG003|STARTED|Overall Study||50
3337250|NCT03364335|4068306|FG004|STARTED|Overall Study||52
3337251|NCT03364335|4068302|FG000|COMPLETED|Overall Study||42
3337252|NCT03364335|4068303|FG001|COMPLETED|Overall Study||40
3337253|NCT03364335|4068304|FG002|COMPLETED|Overall Study||42
3337254|NCT03364335|4068305|FG003|COMPLETED|Overall Study||37
3337255|NCT03364335|4068306|FG004|COMPLETED|Overall Study||41
3337256|NCT03364335|4068302|FG000|NOT COMPLETED|Overall Study||10
3337257|NCT03364335|4068303|FG001|NOT COMPLETED|Overall Study||11
3337258|NCT03364335|4068304|FG002|NOT COMPLETED|Overall Study||11
3337259|NCT03364335|4068305|FG003|NOT COMPLETED|Overall Study||13
3337260|NCT03364335|4068306|FG004|NOT COMPLETED|Overall Study||11
3337261|NCT03364608|4068318|FG000|STARTED|Overall Study||86
3337262|NCT03364608|4068318|FG000|Placebo MDI|Overall Study||82
3176997|NCT01968070|3904662|FG016|COMPLETED|Period 3||0
3337263|NCT03364608|4068318|FG000|AS MDI 90 µg|Overall Study||81
3337264|NCT03364608|4068318|FG000|AS MDI 180 µg|Overall Study||81
3337265|NCT03364608|4068318|FG000|Proventil 90 µg|Overall Study||82
3337266|NCT03364608|4068318|FG000|Proventil 180 µg|Overall Study||79
3337267|NCT03364608|4068318|FG000|COMPLETED|Overall Study||78
3337268|NCT03364608|4068318|FG000|NOT COMPLETED|Overall Study||8
3337269|NCT03364673|4068330|FG000|STARTED|Overall Study||29
3337270|NCT03364673|4068330|FG000|COMPLETED|Overall Study||24
3337271|NCT03364673|4068330|FG000|NOT COMPLETED|Overall Study||5
3337272|NCT03364738|4068334|FG000|STARTED|Overall Study||22
3337273|NCT03364738|4068334|FG000|COMPLETED|Overall Study||14
3337274|NCT03364738|4068334|FG000|NOT COMPLETED|Overall Study||8
3337275|NCT03364751|4068343|FG000|STARTED|Overall Study||70
3337276|NCT03364751|4068344|FG001|STARTED|Overall Study||84
3337277|NCT03364751|4068345|FG002|STARTED|Overall Study||17
3337278|NCT03364751|4068346|FG003|STARTED|Overall Study||1
3337279|NCT03364751|4068343|FG000|COMPLETED|Overall Study||69
3337280|NCT03364751|4068344|FG001|COMPLETED|Overall Study||83
3337281|NCT03364751|4068345|FG002|COMPLETED|Overall Study||17
3337282|NCT03364751|4068346|FG003|COMPLETED|Overall Study||1
3337283|NCT03364751|4068343|FG000|NOT COMPLETED|Overall Study||1
3337284|NCT03364751|4068344|FG001|NOT COMPLETED|Overall Study||1
3337285|NCT03364751|4068345|FG002|NOT COMPLETED|Overall Study||0
3337286|NCT03364751|4068346|FG003|NOT COMPLETED|Overall Study||0
3337287|NCT03365011|4068362|FG000|STARTED|Overall Study||20
3337288|NCT03365011|4068363|FG001|STARTED|Overall Study||20
3337289|NCT03365011|4068362|FG000|COMPLETED|Overall Study||19
3337290|NCT03365011|4068363|FG001|COMPLETED|Overall Study||18
3337291|NCT03365011|4068362|FG000|NOT COMPLETED|Overall Study||1
3337292|NCT03365011|4068363|FG001|NOT COMPLETED|Overall Study||2
3337293|NCT03365154|4068369|FG000|STARTED|Overall Study||10
3337294|NCT03365154|4068369|FG000|COMPLETED|Overall Study||10
3337295|NCT03365154|4068369|FG000|NOT COMPLETED|Overall Study||0
3337296|NCT03365778|4068376|FG000|STARTED|Overall Study||16
3337297|NCT03365778|4068377|FG001|STARTED|Overall Study||17
3337298|NCT03365778|4068378|FG002|STARTED|Overall Study||53
3337299|NCT03365778|4068376|FG000|COMPLETED|Overall Study||16
3337300|NCT03365778|4068377|FG001|COMPLETED|Overall Study||17
3337301|NCT03365778|4068378|FG002|COMPLETED|Overall Study||53
3337302|NCT03365778|4068376|FG000|NOT COMPLETED|Overall Study||0
3337303|NCT03365778|4068377|FG001|NOT COMPLETED|Overall Study||0
3337304|NCT03365778|4068378|FG002|NOT COMPLETED|Overall Study||0
3337305|NCT03365934|4068386|FG000|STARTED|Overall Study||35
3337306|NCT03365934|4068386|FG000|COMPLETED|Overall Study||33
3337307|NCT03365934|4068386|FG000|NOT COMPLETED|Overall Study||2
3337308|NCT03366207|4068395|FG000|STARTED|Overall Study||250
3337309|NCT03366207|4068395|FG000|COMPLETED|Overall Study||242
3337310|NCT03366207|4068395|FG000|NOT COMPLETED|Overall Study||8
3337311|NCT03366298|4068399|FG000|STARTED|Overall Study||3
3337312|NCT03366298|4068400|FG001|STARTED|Overall Study||3
3337313|NCT03366298|4068401|FG002|STARTED|Overall Study||3
3337314|NCT03366298|4068402|FG003|STARTED|Overall Study||3
3337315|NCT03366298|4068399|FG000|COMPLETED|Overall Study||3
3337316|NCT03366298|4068400|FG001|COMPLETED|Overall Study||3
3337317|NCT03366298|4068401|FG002|COMPLETED|Overall Study||3
3337318|NCT03366298|4068402|FG003|COMPLETED|Overall Study||3
3337319|NCT03366298|4068399|FG000|NOT COMPLETED|Overall Study||0
3337320|NCT03366298|4068400|FG001|NOT COMPLETED|Overall Study||0
3337321|NCT03366298|4068401|FG002|NOT COMPLETED|Overall Study||0
3337322|NCT03366298|4068402|FG003|NOT COMPLETED|Overall Study||0
3337323|NCT03366428|4068410|FG000|STARTED|Overall Study||51
3337324|NCT03366428|4068410|FG000|COMPLETED|Overall Study||32
3337325|NCT03366428|4068410|FG000|NOT COMPLETED|Overall Study||19
3337326|NCT03367793|4068422|FG000|STARTED|Initial Acuity at Dispense Visit (10min)||5
3337327|NCT03367793|4068423|FG001|STARTED|Initial Acuity at Dispense Visit (10min)||5
3337328|NCT03367793|4068424|FG002|STARTED|Initial Acuity at Dispense Visit (10min)||5
3337329|NCT03367793|4068425|FG003|STARTED|Initial Acuity at Dispense Visit (10min)||5
3337330|NCT03367793|4068426|FG004|STARTED|Initial Acuity at Dispense Visit (10min)||5
3337331|NCT03367793|4068427|FG005|STARTED|Initial Acuity at Dispense Visit (10min)||5
3337332|NCT03367793|4068422|FG000|COMPLETED|Initial Acuity at Dispense Visit (10min)||5
3337333|NCT03367793|4068423|FG001|COMPLETED|Initial Acuity at Dispense Visit (10min)||5
3176998|NCT01968070|3904663|FG017|COMPLETED|Period 3||0
3337334|NCT03367793|4068424|FG002|COMPLETED|Initial Acuity at Dispense Visit (10min)||5
3337335|NCT03367793|4068425|FG003|COMPLETED|Initial Acuity at Dispense Visit (10min)||5
3337336|NCT03367793|4068426|FG004|COMPLETED|Initial Acuity at Dispense Visit (10min)||5
3337337|NCT03367793|4068427|FG005|COMPLETED|Initial Acuity at Dispense Visit (10min)||5
3337338|NCT03367793|4068422|FG000|NOT COMPLETED|Initial Acuity at Dispense Visit (10min)||0
3337339|NCT03367793|4068423|FG001|NOT COMPLETED|Initial Acuity at Dispense Visit (10min)||0
3337340|NCT03367793|4068424|FG002|NOT COMPLETED|Initial Acuity at Dispense Visit (10min)||0
3337341|NCT03367793|4068425|FG003|NOT COMPLETED|Initial Acuity at Dispense Visit (10min)||0
3337342|NCT03367793|4068426|FG004|NOT COMPLETED|Initial Acuity at Dispense Visit (10min)||0
3337343|NCT03367793|4068427|FG005|NOT COMPLETED|Initial Acuity at Dispense Visit (10min)||0
3337344|NCT03367793|4068422|FG000|STARTED|Treatment 1 Dispense to 2 Months Wear||5
3337345|NCT03367793|4068423|FG001|STARTED|Treatment 1 Dispense to 2 Months Wear||5
3337346|NCT03367793|4068424|FG002|STARTED|Treatment 1 Dispense to 2 Months Wear||5
3176999|NCT01968070|3904646|FG000|NOT COMPLETED|Period 3||0
3177000|NCT01968070|3904647|FG001|NOT COMPLETED|Period 3||0
3337347|NCT03367793|4068425|FG003|STARTED|Treatment 1 Dispense to 2 Months Wear||5
3337348|NCT03367793|4068426|FG004|STARTED|Treatment 1 Dispense to 2 Months Wear||5
3337349|NCT03367793|4068427|FG005|STARTED|Treatment 1 Dispense to 2 Months Wear||5
3337350|NCT03367793|4068422|FG000|COMPLETED|Treatment 1 Dispense to 2 Months Wear||5
3337351|NCT03367793|4068423|FG001|COMPLETED|Treatment 1 Dispense to 2 Months Wear||5
3337352|NCT03367793|4068424|FG002|COMPLETED|Treatment 1 Dispense to 2 Months Wear||5
3337353|NCT03367793|4068425|FG003|COMPLETED|Treatment 1 Dispense to 2 Months Wear||5
3337354|NCT03367793|4068426|FG004|COMPLETED|Treatment 1 Dispense to 2 Months Wear||5
3337355|NCT03367793|4068427|FG005|COMPLETED|Treatment 1 Dispense to 2 Months Wear||5
3337356|NCT03367793|4068422|FG000|NOT COMPLETED|Treatment 1 Dispense to 2 Months Wear||0
3337357|NCT03367793|4068423|FG001|NOT COMPLETED|Treatment 1 Dispense to 2 Months Wear||0
3337358|NCT03367793|4068424|FG002|NOT COMPLETED|Treatment 1 Dispense to 2 Months Wear||0
3337359|NCT03367793|4068425|FG003|NOT COMPLETED|Treatment 1 Dispense to 2 Months Wear||0
3337360|NCT03367793|4068426|FG004|NOT COMPLETED|Treatment 1 Dispense to 2 Months Wear||0
3337361|NCT03367793|4068427|FG005|NOT COMPLETED|Treatment 1 Dispense to 2 Months Wear||0
3337362|NCT03367793|4068422|FG000|STARTED|Treatment 2 Dispense to 2 Months Wear||5
3337363|NCT03367793|4068423|FG001|STARTED|Treatment 2 Dispense to 2 Months Wear||5
3337364|NCT03367793|4068424|FG002|STARTED|Treatment 2 Dispense to 2 Months Wear||5
3337365|NCT03367793|4068425|FG003|STARTED|Treatment 2 Dispense to 2 Months Wear||5
3337366|NCT03367793|4068426|FG004|STARTED|Treatment 2 Dispense to 2 Months Wear||5
3337367|NCT03367793|4068427|FG005|STARTED|Treatment 2 Dispense to 2 Months Wear||5
3337368|NCT03367793|4068422|FG000|COMPLETED|Treatment 2 Dispense to 2 Months Wear||5
3337369|NCT03367793|4068423|FG001|COMPLETED|Treatment 2 Dispense to 2 Months Wear||5
3337370|NCT03367793|4068424|FG002|COMPLETED|Treatment 2 Dispense to 2 Months Wear||4
3337371|NCT03367793|4068425|FG003|COMPLETED|Treatment 2 Dispense to 2 Months Wear||5
3337372|NCT03367793|4068426|FG004|COMPLETED|Treatment 2 Dispense to 2 Months Wear||5
3337373|NCT03367793|4068427|FG005|COMPLETED|Treatment 2 Dispense to 2 Months Wear||5
3337374|NCT03367793|4068422|FG000|NOT COMPLETED|Treatment 2 Dispense to 2 Months Wear||0
3337375|NCT03367793|4068423|FG001|NOT COMPLETED|Treatment 2 Dispense to 2 Months Wear||0
3337376|NCT03367793|4068424|FG002|NOT COMPLETED|Treatment 2 Dispense to 2 Months Wear||1
3337377|NCT03367793|4068425|FG003|NOT COMPLETED|Treatment 2 Dispense to 2 Months Wear||0
3337378|NCT03367793|4068426|FG004|NOT COMPLETED|Treatment 2 Dispense to 2 Months Wear||0
3337379|NCT03367793|4068427|FG005|NOT COMPLETED|Treatment 2 Dispense to 2 Months Wear||0
3337380|NCT03367793|4068422|FG000|STARTED|Treatment 3 Dispense to 2 Months Wear||5
3337381|NCT03367793|4068423|FG001|STARTED|Treatment 3 Dispense to 2 Months Wear||5
3337382|NCT03367793|4068424|FG002|STARTED|Treatment 3 Dispense to 2 Months Wear||5
3337383|NCT03367793|4068425|FG003|STARTED|Treatment 3 Dispense to 2 Months Wear||5
3337384|NCT03367793|4068426|FG004|STARTED|Treatment 3 Dispense to 2 Months Wear||5
3337385|NCT03367793|4068427|FG005|STARTED|Treatment 3 Dispense to 2 Months Wear||5
3337386|NCT03367793|4068422|FG000|COMPLETED|Treatment 3 Dispense to 2 Months Wear||5
3337387|NCT03367793|4068423|FG001|COMPLETED|Treatment 3 Dispense to 2 Months Wear||5
3337388|NCT03367793|4068424|FG002|COMPLETED|Treatment 3 Dispense to 2 Months Wear||5
3337389|NCT03367793|4068425|FG003|COMPLETED|Treatment 3 Dispense to 2 Months Wear||5
3337390|NCT03367793|4068426|FG004|COMPLETED|Treatment 3 Dispense to 2 Months Wear||5
3337391|NCT03367793|4068427|FG005|COMPLETED|Treatment 3 Dispense to 2 Months Wear||5
3337392|NCT03367793|4068422|FG000|NOT COMPLETED|Treatment 3 Dispense to 2 Months Wear||0
3337393|NCT03367793|4068423|FG001|NOT COMPLETED|Treatment 3 Dispense to 2 Months Wear||0
3337394|NCT03367793|4068424|FG002|NOT COMPLETED|Treatment 3 Dispense to 2 Months Wear||0
3337395|NCT03367793|4068425|FG003|NOT COMPLETED|Treatment 3 Dispense to 2 Months Wear||0
3337396|NCT03367793|4068426|FG004|NOT COMPLETED|Treatment 3 Dispense to 2 Months Wear||0
3337397|NCT03367793|4068427|FG005|NOT COMPLETED|Treatment 3 Dispense to 2 Months Wear||0
3337398|NCT03368053|4068438|FG000|STARTED|Overall Study||36
3337399|NCT03368053|4068438|FG000|COMPLETED|Overall Study||36
3337400|NCT03368053|4068438|FG000|NOT COMPLETED|Overall Study||0
3337401|NCT03368170|4068444|FG000|STARTED|Overall Study||39
3337402|NCT03368170|4068445|FG001|STARTED|Overall Study||36
3337403|NCT03368170|4068444|FG000|COMPLETED|Overall Study||37
3337404|NCT03368170|4068445|FG001|COMPLETED|Overall Study||35
3337405|NCT03368170|4068444|FG000|NOT COMPLETED|Overall Study||2
3337406|NCT03368170|4068445|FG001|NOT COMPLETED|Overall Study||1
3337407|NCT03368235|4068453|FG000|STARTED|Overall Study||11
3337408|NCT03368235|4068454|FG001|STARTED|Overall Study||10
3337409|NCT03368235|4068453|FG000|COMPLETED|Overall Study||11
3337410|NCT03368235|4068454|FG001|COMPLETED|Overall Study||10
3337411|NCT03368235|4068453|FG000|NOT COMPLETED|Overall Study||0
3337412|NCT03368235|4068454|FG001|NOT COMPLETED|Overall Study||0
3337413|NCT03368807|4068460|FG000|STARTED|Period 1 (Blinded CGM)||79
3337414|NCT03368807|4068460|FG000|Received at Least 1 Dose of Study Drug|Period 1 (Blinded CGM)||78
3337415|NCT03368807|4068460|FG000|COMPLETED|Period 1 (Blinded CGM)||73
3337416|NCT03368807|4068460|FG000|NOT COMPLETED|Period 1 (Blinded CGM)||6
3337417|NCT03368807|4068460|FG000|STARTED|Period 2 (Unblinded CGM)||73
3337418|NCT03368807|4068460|FG000|COMPLETED|Period 2 (Unblinded CGM)||73
3337419|NCT03368807|4068460|FG000|NOT COMPLETED|Period 2 (Unblinded CGM)||0
3337420|NCT03368859|4068468|FG000|STARTED|Overall Study||36
3337421|NCT03368859|4068469|FG001|STARTED|Overall Study||34
3337422|NCT03368859|4068468|FG000|COMPLETED|Overall Study||0
3337423|NCT03368859|4068469|FG001|COMPLETED|Overall Study||0
3337424|NCT03368859|4068468|FG000|NOT COMPLETED|Overall Study||36
3337425|NCT03368859|4068469|FG001|NOT COMPLETED|Overall Study||34
3337426|NCT03368898|4068478|FG000|STARTED|Overall Study||37
3337427|NCT03368898|4068479|FG001|STARTED|Overall Study||33
3337428|NCT03368898|4068480|FG002|STARTED|Overall Study||34
3337429|NCT03368898|4068478|FG000|COMPLETED|Overall Study||37
3337430|NCT03368898|4068479|FG001|COMPLETED|Overall Study||33
3177001|NCT01968070|3904648|FG002|NOT COMPLETED|Period 3||0
3177002|NCT01968070|3904649|FG003|NOT COMPLETED|Period 3||0
3177003|NCT01968070|3904650|FG004|NOT COMPLETED|Period 3||0
3337431|NCT03368898|4068480|FG002|COMPLETED|Overall Study||34
3337432|NCT03368898|4068478|FG000|NOT COMPLETED|Overall Study||0
3337433|NCT03368898|4068479|FG001|NOT COMPLETED|Overall Study||0
3337434|NCT03368898|4068480|FG002|NOT COMPLETED|Overall Study||0
3337435|NCT03368937|4068488|FG000|STARTED|Overall Study||5
3337436|NCT03368937|4068488|FG000|COMPLETED|Overall Study||5
3337437|NCT03368937|4068488|FG000|NOT COMPLETED|Overall Study||0
3337438|NCT03369158|4068494|FG000|STARTED|Overall Study||14
3337439|NCT03369158|4068495|FG001|STARTED|Overall Study||15
3337440|NCT03369158|4068494|FG000|COMPLETED|Overall Study||14
3337441|NCT03369158|4068495|FG001|COMPLETED|Overall Study||15
3337442|NCT03369158|4068494|FG000|NOT COMPLETED|Overall Study||0
3337443|NCT03369158|4068495|FG001|NOT COMPLETED|Overall Study||0
3337444|NCT03369236|4068503|FG000|STARTED|Double-blind Treatment Period||6
3337445|NCT03369236|4068504|FG001|STARTED|Double-blind Treatment Period||7
3337446|NCT03369236|4068503|FG000|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||6
3337447|NCT03369236|4068504|FG001|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||7
3337448|NCT03369236|4068503|FG000|COMPLETED|Double-blind Treatment Period||6
3337449|NCT03369236|4068504|FG001|COMPLETED|Double-blind Treatment Period||6
3337450|NCT03369236|4068503|FG000|NOT COMPLETED|Double-blind Treatment Period||0
3337451|NCT03369236|4068504|FG001|NOT COMPLETED|Double-blind Treatment Period||1
3337452|NCT03369236|4068503|FG000|STARTED|Open-label Extension Period||6
3337453|NCT03369236|4068504|FG001|STARTED|Open-label Extension Period||6
3337454|NCT03369236|4068503|FG000|Received at Least 1 Dose of Study Drug|Open-label Extension Period|All participants received danicopan in the open-label extension period.|6
3177004|NCT01968070|3904651|FG005|NOT COMPLETED|Period 3||0
3177005|NCT01968070|3904652|FG006|NOT COMPLETED|Period 3||0
3177006|NCT01968070|3904653|FG007|NOT COMPLETED|Period 3||0
3177007|NCT01968070|3904654|FG008|NOT COMPLETED|Period 3||0
3177008|NCT01968070|3904655|FG009|NOT COMPLETED|Period 3||0
3177009|NCT01968070|3904656|FG010|NOT COMPLETED|Period 3||0
3177010|NCT01968070|3904657|FG011|NOT COMPLETED|Period 3||0
3177011|NCT01968070|3904658|FG012|NOT COMPLETED|Period 3||0
3177012|NCT01968070|3904659|FG013|NOT COMPLETED|Period 3||0
3177013|NCT01968070|3904660|FG014|NOT COMPLETED|Period 3||0
3177014|NCT01968070|3904661|FG015|NOT COMPLETED|Period 3||0
3177015|NCT01968070|3904662|FG016|NOT COMPLETED|Period 3||0
3177016|NCT01968070|3904663|FG017|NOT COMPLETED|Period 3||0
3337455|NCT03369236|4068504|FG001|Received at Least 1 Dose of Study Drug|Open-label Extension Period|All participants received danicopan in the open-label extension period.|6
3337456|NCT03369236|4068503|FG000|COMPLETED|Open-label Extension Period||1
3337457|NCT03369236|4068504|FG001|COMPLETED|Open-label Extension Period||0
3337458|NCT03369236|4068503|FG000|NOT COMPLETED|Open-label Extension Period||5
3337459|NCT03369236|4068504|FG001|NOT COMPLETED|Open-label Extension Period||6
3337460|NCT03369340|4068516|FG000|STARTED|Day 2||3
3337461|NCT03369340|4068517|FG001|STARTED|Day 2||3
3337462|NCT03369340|4068518|FG002|STARTED|Day 2||3
3337463|NCT03369340|4068519|FG003|STARTED|Day 2||3
3337464|NCT03369340|4068520|FG004|STARTED|Day 2||3
3337465|NCT03369340|4068521|FG005|STARTED|Day 2||3
3337466|NCT03369340|4068516|FG000|COMPLETED|Day 2||3
3337467|NCT03369340|4068517|FG001|COMPLETED|Day 2||3
3337468|NCT03369340|4068518|FG002|COMPLETED|Day 2||3
3337469|NCT03369340|4068519|FG003|COMPLETED|Day 2||3
3337470|NCT03369340|4068520|FG004|COMPLETED|Day 2||3
3337471|NCT03369340|4068521|FG005|COMPLETED|Day 2||3
3337472|NCT03369340|4068516|FG000|NOT COMPLETED|Day 2||0
3337473|NCT03369340|4068517|FG001|NOT COMPLETED|Day 2||0
3337474|NCT03369340|4068518|FG002|NOT COMPLETED|Day 2||0
3337475|NCT03369340|4068519|FG003|NOT COMPLETED|Day 2||0
3337476|NCT03369340|4068520|FG004|NOT COMPLETED|Day 2||0
3337477|NCT03369340|4068521|FG005|NOT COMPLETED|Day 2||0
3337478|NCT03369340|4068516|FG000|STARTED|Day 3||3
3337479|NCT03369340|4068517|FG001|STARTED|Day 3||3
3337480|NCT03369340|4068518|FG002|STARTED|Day 3||3
3337481|NCT03369340|4068519|FG003|STARTED|Day 3||3
3337482|NCT03369340|4068520|FG004|STARTED|Day 3||3
3337483|NCT03369340|4068521|FG005|STARTED|Day 3||3
3337484|NCT03369340|4068516|FG000|COMPLETED|Day 3||3
3337485|NCT03369340|4068517|FG001|COMPLETED|Day 3||3
3337486|NCT03369340|4068518|FG002|COMPLETED|Day 3||3
3337487|NCT03369340|4068519|FG003|COMPLETED|Day 3||3
3337488|NCT03369340|4068520|FG004|COMPLETED|Day 3||3
3337489|NCT03369340|4068521|FG005|COMPLETED|Day 3||3
3337490|NCT03369340|4068516|FG000|NOT COMPLETED|Day 3||0
3337491|NCT03369340|4068517|FG001|NOT COMPLETED|Day 3||0
3337492|NCT03369340|4068518|FG002|NOT COMPLETED|Day 3||0
3337493|NCT03369340|4068519|FG003|NOT COMPLETED|Day 3||0
3337494|NCT03369340|4068520|FG004|NOT COMPLETED|Day 3||0
3337495|NCT03369340|4068521|FG005|NOT COMPLETED|Day 3||0
3337496|NCT03369340|4068516|FG000|STARTED|Day 4||3
3337497|NCT03369340|4068517|FG001|STARTED|Day 4||3
3337498|NCT03369340|4068518|FG002|STARTED|Day 4||3
3337499|NCT03369340|4068519|FG003|STARTED|Day 4||3
3337500|NCT03369340|4068520|FG004|STARTED|Day 4||3
3337501|NCT03369340|4068521|FG005|STARTED|Day 4||3
3337502|NCT03369340|4068516|FG000|COMPLETED|Day 4||3
3337503|NCT03369340|4068517|FG001|COMPLETED|Day 4||3
3337504|NCT03369340|4068518|FG002|COMPLETED|Day 4||3
3337505|NCT03369340|4068519|FG003|COMPLETED|Day 4||3
3337506|NCT03369340|4068520|FG004|COMPLETED|Day 4||3
3337507|NCT03369340|4068521|FG005|COMPLETED|Day 4||3
3337508|NCT03369340|4068516|FG000|NOT COMPLETED|Day 4||0
3337509|NCT03369340|4068517|FG001|NOT COMPLETED|Day 4||0
3337510|NCT03369340|4068518|FG002|NOT COMPLETED|Day 4||0
3337511|NCT03369340|4068519|FG003|NOT COMPLETED|Day 4||0
3337512|NCT03369340|4068520|FG004|NOT COMPLETED|Day 4||0
3337513|NCT03369340|4068521|FG005|NOT COMPLETED|Day 4||0
3337514|NCT03369418|4068533|FG000|STARTED|Overall Study||16
3337515|NCT03369418|4068534|FG001|STARTED|Overall Study||14
3337516|NCT03369418|4068533|FG000|COMPLETED|Overall Study||13
3337517|NCT03369418|4068534|FG001|COMPLETED|Overall Study||11
3337518|NCT03369418|4068533|FG000|NOT COMPLETED|Overall Study||3
3337519|NCT03369418|4068534|FG001|NOT COMPLETED|Overall Study||3
3337520|NCT03369704|4068542|FG000|STARTED|Treatment Epoch||162
3337521|NCT03369704|4068543|FG001|STARTED|Treatment Epoch||175
3337522|NCT03369704|4068542|FG000|COMPLETED|Treatment Epoch||158
3337523|NCT03369704|4068543|FG001|COMPLETED|Treatment Epoch||172
3337524|NCT03369704|4068542|FG000|NOT COMPLETED|Treatment Epoch||4
3337525|NCT03369704|4068543|FG001|NOT COMPLETED|Treatment Epoch||3
3337526|NCT03369704|4068542|FG000|STARTED|Follow-up Epoch||161
3337527|NCT03369704|4068543|FG001|STARTED|Follow-up Epoch||174
3337528|NCT03369704|4068542|FG000|COMPLETED|Follow-up Epoch||160
3337529|NCT03369704|4068543|FG001|COMPLETED|Follow-up Epoch||174
3337530|NCT03369704|4068542|FG000|NOT COMPLETED|Follow-up Epoch||1
3337531|NCT03369704|4068543|FG001|NOT COMPLETED|Follow-up Epoch||0
3337532|NCT03369756|4068549|FG000|STARTED|Overall Study||43
3337533|NCT03369756|4068549|FG000|COMPLETED|Overall Study|36 completed 4 weeks of treatment; 40 were considered statistical completers|36
3337534|NCT03369756|4068549|FG000|NOT COMPLETED|Overall Study||7
3337535|NCT03369951|4068553|FG000|STARTED|Overall Study||58
3337536|NCT03369951|4068553|FG000|Received Study Drug|Overall Study||57
3337537|NCT03369951|4068553|FG000|COMPLETED|Overall Study||52
3337538|NCT03369951|4068553|FG000|NOT COMPLETED|Overall Study||6
3337539|NCT03370042|4068559|FG000|STARTED|Overall Study||10
3337540|NCT03370042|4068560|FG001|STARTED|Overall Study||10
3337541|NCT03370042|4068559|FG000|COMPLETED|Overall Study||10
3337542|NCT03370042|4068560|FG001|COMPLETED|Overall Study||10
3337543|NCT03370042|4068559|FG000|NOT COMPLETED|Overall Study||0
3337544|NCT03370042|4068560|FG001|NOT COMPLETED|Overall Study||0
3337545|NCT03370289|4068570|FG000|STARTED|Overall Study||55
3337546|NCT03370289|4068570|FG000|COMPLETED|Overall Study||50
3337547|NCT03370289|4068570|FG000|NOT COMPLETED|Overall Study||5
3337548|NCT03370302|4068580|FG000|STARTED|Dose Escalation Phase||3
3337549|NCT03370302|4068581|FG001|STARTED|Dose Escalation Phase||6
3337550|NCT03370302|4068582|FG002|STARTED|Dose Escalation Phase||7
3337551|NCT03370302|4068583|FG003|STARTED|Dose Escalation Phase||0
3337552|NCT03370302|4068584|FG004|STARTED|Dose Escalation Phase||3
3337553|NCT03370302|4068585|FG005|STARTED|Dose Escalation Phase||3
3337554|NCT03370302|4068580|FG000|COMPLETED|Dose Escalation Phase||0
3337555|NCT03370302|4068581|FG001|COMPLETED|Dose Escalation Phase||0
3337556|NCT03370302|4068582|FG002|COMPLETED|Dose Escalation Phase||0
3337557|NCT03370302|4068583|FG003|COMPLETED|Dose Escalation Phase||0
3337558|NCT03370302|4068584|FG004|COMPLETED|Dose Escalation Phase||0
3337559|NCT03370302|4068585|FG005|COMPLETED|Dose Escalation Phase||0
3337560|NCT03370302|4068580|FG000|NOT COMPLETED|Dose Escalation Phase||3
3337561|NCT03370302|4068581|FG001|NOT COMPLETED|Dose Escalation Phase||6
3337562|NCT03370302|4068582|FG002|NOT COMPLETED|Dose Escalation Phase||7
3337563|NCT03370302|4068583|FG003|NOT COMPLETED|Dose Escalation Phase||0
3337564|NCT03370302|4068584|FG004|NOT COMPLETED|Dose Escalation Phase||3
3337565|NCT03370302|4068585|FG005|NOT COMPLETED|Dose Escalation Phase||3
3337566|NCT03370302|4068580|FG000|STARTED|Dose Expansion Phase||0
3337567|NCT03370302|4068581|FG001|STARTED|Dose Expansion Phase||0
3337568|NCT03370302|4068582|FG002|STARTED|Dose Expansion Phase||0
3337569|NCT03370302|4068583|FG003|STARTED|Dose Expansion Phase||6
3337570|NCT03370302|4068584|FG004|STARTED|Dose Expansion Phase||0
3337571|NCT03370302|4068585|FG005|STARTED|Dose Expansion Phase||0
3337572|NCT03370302|4068580|FG000|COMPLETED|Dose Expansion Phase||0
3337573|NCT03370302|4068581|FG001|COMPLETED|Dose Expansion Phase||0
3337574|NCT03370302|4068582|FG002|COMPLETED|Dose Expansion Phase||0
3337575|NCT03370302|4068583|FG003|COMPLETED|Dose Expansion Phase||0
3337576|NCT03370302|4068584|FG004|COMPLETED|Dose Expansion Phase||0
3337577|NCT03370302|4068585|FG005|COMPLETED|Dose Expansion Phase||0
3337578|NCT03370302|4068580|FG000|NOT COMPLETED|Dose Expansion Phase||0
3337579|NCT03370302|4068581|FG001|NOT COMPLETED|Dose Expansion Phase||0
3337580|NCT03370302|4068582|FG002|NOT COMPLETED|Dose Expansion Phase||0
3337581|NCT03370302|4068583|FG003|NOT COMPLETED|Dose Expansion Phase||6
3337582|NCT03370302|4068584|FG004|NOT COMPLETED|Dose Expansion Phase||0
3337583|NCT03370302|4068585|FG005|NOT COMPLETED|Dose Expansion Phase||0
3337584|NCT03370419|4068603|FG000|STARTED|Overall Study||40
3337585|NCT03370419|4068603|FG000|COMPLETED|Overall Study||24
3337586|NCT03370419|4068603|FG000|NOT COMPLETED|Overall Study||16
3337587|NCT03370471|4068609|FG000|STARTED|Overall Study||23
3337588|NCT03370471|4068610|FG001|STARTED|Overall Study||5
3337589|NCT03370471|4068609|FG000|COMPLETED|Overall Study||16
3337590|NCT03370471|4068610|FG001|COMPLETED|Overall Study||3
3337591|NCT03370471|4068609|FG000|NOT COMPLETED|Overall Study||7
3337592|NCT03370471|4068610|FG001|NOT COMPLETED|Overall Study||2
3177017|NCT01968135|3904703|FG000|STARTED|Overall Study||16
3177018|NCT01968135|3904704|FG001|STARTED|Overall Study||16
3177019|NCT01968135|3904703|FG000|COMPLETED|Overall Study||16
3177020|NCT01968135|3904704|FG001|COMPLETED|Overall Study||16
3337593|NCT03370770|4068618|FG000|STARTED|Overall Study||204
3337594|NCT03370770|4068618|FG000|COMPLETED|Overall Study||98
3337595|NCT03370770|4068618|FG000|NOT COMPLETED|Overall Study||106
3337596|NCT03371355|4068626|FG000|STARTED|Overall Study||27
3337597|NCT03371355|4068627|FG001|STARTED|Overall Study||26
3337598|NCT03371355|4068628|FG002|STARTED|Overall Study||26
3337599|NCT03371355|4068629|FG003|STARTED|Overall Study||26
3337600|NCT03371355|4068626|FG000|COMPLETED|Overall Study||26
3337601|NCT03371355|4068627|FG001|COMPLETED|Overall Study||24
3337602|NCT03371355|4068628|FG002|COMPLETED|Overall Study||22
3337603|NCT03371355|4068629|FG003|COMPLETED|Overall Study||19
3337604|NCT03371355|4068626|FG000|NOT COMPLETED|Overall Study||1
3337605|NCT03371355|4068627|FG001|NOT COMPLETED|Overall Study||2
3337606|NCT03371355|4068628|FG002|NOT COMPLETED|Overall Study||4
3337607|NCT03371355|4068629|FG003|NOT COMPLETED|Overall Study||7
3337608|NCT03371381|4068643|FG000|STARTED|Overall Study||12
3337609|NCT03371381|4068643|FG000|COMPLETED|Overall Study||0
3337610|NCT03371381|4068643|FG000|NOT COMPLETED|Overall Study||12
3337611|NCT03371459|4068647|FG000|STARTED|Period 1||23
3337612|NCT03371459|4068648|FG001|STARTED|Period 1||23
3337613|NCT03371459|4068647|FG000|COMPLETED|Period 1||23
3337614|NCT03371459|4068648|FG001|COMPLETED|Period 1||23
3337615|NCT03371459|4068647|FG000|NOT COMPLETED|Period 1||0
3337616|NCT03371459|4068648|FG001|NOT COMPLETED|Period 1||0
3337617|NCT03371459|4068647|FG000|STARTED|Washout||23
3337618|NCT03371459|4068648|FG001|STARTED|Washout||23
3337619|NCT03371459|4068647|FG000|COMPLETED|Washout||23
3337620|NCT03371459|4068648|FG001|COMPLETED|Washout||22
3337621|NCT03371459|4068647|FG000|NOT COMPLETED|Washout||0
3337622|NCT03371459|4068648|FG001|NOT COMPLETED|Washout||1
3337623|NCT03371459|4068647|FG000|STARTED|Period 2||23
3337624|NCT03371459|4068648|FG001|STARTED|Period 2||22
3337625|NCT03371459|4068647|FG000|COMPLETED|Period 2||23
3337626|NCT03371459|4068648|FG001|COMPLETED|Period 2||22
3337627|NCT03371459|4068647|FG000|NOT COMPLETED|Period 2||0
3337628|NCT03371459|4068648|FG001|NOT COMPLETED|Period 2||0
3337629|NCT03371732|4068656|FG000|STARTED|Overall Study||51
3337630|NCT03371732|4068657|FG001|STARTED|Overall Study||53
3337631|NCT03371732|4068656|FG000|COMPLETED|Overall Study||39
3337632|NCT03371732|4068657|FG001|COMPLETED|Overall Study||46
3337633|NCT03371732|4068656|FG000|NOT COMPLETED|Overall Study||12
3337634|NCT03371732|4068657|FG001|NOT COMPLETED|Overall Study||7
3337635|NCT03371836|4068665|FG000|STARTED|Overall Study||20
3337636|NCT03371836|4068665|FG000|COMPLETED|Overall Study||18
3337637|NCT03371836|4068665|FG000|NOT COMPLETED|Overall Study||2
3337638|NCT03372083|4068669|FG000|STARTED|Overall Study||44
3337639|NCT03372083|4068669|FG000|COMPLETED|Overall Study||39
3337640|NCT03372083|4068669|FG000|NOT COMPLETED|Overall Study||5
3337641|NCT03372096|4068673|FG000|STARTED|Overall Study||18
3337642|NCT03372096|4068673|FG000|Received Intervention|Overall Study||10
3337643|NCT03372096|4068673|FG000|COMPLETED|Overall Study||10
3337644|NCT03372096|4068673|FG000|NOT COMPLETED|Overall Study||8
3337645|NCT03372369|4068682|FG000|STARTED|Qualification Period||495
3337646|NCT03372369|4068683|FG001|STARTED|Qualification Period||495
3337647|NCT03372369|4068682|FG000|COMPLETED|Qualification Period||469
3337648|NCT03372369|4068683|FG001|COMPLETED|Qualification Period||473
3337649|NCT03372369|4068682|FG000|NOT COMPLETED|Qualification Period||26
3337650|NCT03372369|4068683|FG001|NOT COMPLETED|Qualification Period||22
3337651|NCT03372369|4068682|FG000|STARTED|Intervention and Follow-Up Period||469
3337652|NCT03372369|4068683|FG001|STARTED|Intervention and Follow-Up Period||473
3337653|NCT03372369|4068682|FG000|COMPLETED|Intervention and Follow-Up Period||466
3337654|NCT03372369|4068683|FG001|COMPLETED|Intervention and Follow-Up Period||470
3337655|NCT03372369|4068682|FG000|NOT COMPLETED|Intervention and Follow-Up Period||3
3337656|NCT03372369|4068683|FG001|NOT COMPLETED|Intervention and Follow-Up Period||3
3337657|NCT03372382|4068691|FG000|STARTED|Overall Study||85
3337658|NCT03372382|4068692|FG001|STARTED|Overall Study||85
3337659|NCT03372382|4068691|FG000|COMPLETED|Overall Study||76
3337660|NCT03372382|4068692|FG001|COMPLETED|Overall Study||81
3337661|NCT03372382|4068691|FG000|NOT COMPLETED|Overall Study||9
3337662|NCT03372382|4068692|FG001|NOT COMPLETED|Overall Study||4
3337663|NCT03372434|4068703|FG000|STARTED|Overall Study||78
3337664|NCT03372434|4068704|FG001|STARTED|Overall Study||73
3337665|NCT03372434|4068705|FG002|STARTED|Overall Study||74
3337666|NCT03372434|4068703|FG000|1 Month Follow-up|Overall Study||76
3337667|NCT03372434|4068704|FG001|1 Month Follow-up|Overall Study||72
3337668|NCT03372434|4068705|FG002|1 Month Follow-up|Overall Study||73
3337669|NCT03372434|4068703|FG000|COMPLETED|Overall Study||76
3337670|NCT03372434|4068704|FG001|COMPLETED|Overall Study||70
3337671|NCT03372434|4068705|FG002|COMPLETED|Overall Study||72
3337672|NCT03372434|4068703|FG000|NOT COMPLETED|Overall Study||2
3337673|NCT03372434|4068704|FG001|NOT COMPLETED|Overall Study||3
3337674|NCT03372434|4068705|FG002|NOT COMPLETED|Overall Study||2
3337675|NCT03372551|4068713|FG000|STARTED|First Intervention (1 Week)||17
3337676|NCT03372551|4068714|FG001|STARTED|First Intervention (1 Week)||16
3337677|NCT03372551|4068713|FG000|COMPLETED|First Intervention (1 Week)||16
3337678|NCT03372551|4068714|FG001|COMPLETED|First Intervention (1 Week)||16
3337679|NCT03372551|4068713|FG000|NOT COMPLETED|First Intervention (1 Week)||1
3337680|NCT03372551|4068714|FG001|NOT COMPLETED|First Intervention (1 Week)||0
3337681|NCT03372551|4068713|FG000|STARTED|Second Intervention (1 Week)||16
3337682|NCT03372551|4068714|FG001|STARTED|Second Intervention (1 Week)||16
3337683|NCT03372551|4068713|FG000|COMPLETED|Second Intervention (1 Week)||16
3337684|NCT03372551|4068714|FG001|COMPLETED|Second Intervention (1 Week)||16
3337685|NCT03372551|4068713|FG000|NOT COMPLETED|Second Intervention (1 Week)||0
3337686|NCT03372551|4068714|FG001|NOT COMPLETED|Second Intervention (1 Week)||0
3337687|NCT03372603|4068727|FG000|STARTED|Treatment Period 1 (Up to 7 Days)||9
3337688|NCT03372603|4068728|FG001|STARTED|Treatment Period 1 (Up to 7 Days)||8
3337689|NCT03372603|4068727|FG000|COMPLETED|Treatment Period 1 (Up to 7 Days)||9
3337690|NCT03372603|4068728|FG001|COMPLETED|Treatment Period 1 (Up to 7 Days)||8
3337691|NCT03372603|4068727|FG000|NOT COMPLETED|Treatment Period 1 (Up to 7 Days)||0
3337692|NCT03372603|4068728|FG001|NOT COMPLETED|Treatment Period 1 (Up to 7 Days)||0
3337693|NCT03372603|4068727|FG000|STARTED|Wash-out Period (14-21 Days)||9
3337694|NCT03372603|4068728|FG001|STARTED|Wash-out Period (14-21 Days)||8
3337695|NCT03372603|4068727|FG000|COMPLETED|Wash-out Period (14-21 Days)||8
3337696|NCT03372603|4068728|FG001|COMPLETED|Wash-out Period (14-21 Days)||8
3337697|NCT03372603|4068727|FG000|NOT COMPLETED|Wash-out Period (14-21 Days)||1
3337698|NCT03372603|4068728|FG001|NOT COMPLETED|Wash-out Period (14-21 Days)||0
3337699|NCT03372603|4068727|FG000|STARTED|Treatment Period 2 (Up to 7 Days)||8
3337700|NCT03372603|4068728|FG001|STARTED|Treatment Period 2 (Up to 7 Days)||8
3337701|NCT03372603|4068727|FG000|COMPLETED|Treatment Period 2 (Up to 7 Days)||7
3337702|NCT03372603|4068728|FG001|COMPLETED|Treatment Period 2 (Up to 7 Days)||8
3337703|NCT03372603|4068727|FG000|NOT COMPLETED|Treatment Period 2 (Up to 7 Days)||1
3337704|NCT03372603|4068728|FG001|NOT COMPLETED|Treatment Period 2 (Up to 7 Days)||0
3337705|NCT03372928|4068734|FG000|STARTED|First Intervention (5 d Energy Deficit)||10
3337706|NCT03372928|4068735|FG001|STARTED|First Intervention (5 d Energy Deficit)||10
3337707|NCT03372928|4068734|FG000|COMPLETED|First Intervention (5 d Energy Deficit)||10
3337708|NCT03372928|4068735|FG001|COMPLETED|First Intervention (5 d Energy Deficit)||10
3337709|NCT03372928|4068734|FG000|NOT COMPLETED|First Intervention (5 d Energy Deficit)||0
3337710|NCT03372928|4068735|FG001|NOT COMPLETED|First Intervention (5 d Energy Deficit)||0
3337711|NCT03372928|4068734|FG000|STARTED|Washout (14 d)||10
3337712|NCT03372928|4068735|FG001|STARTED|Washout (14 d)||10
3337713|NCT03372928|4068734|FG000|COMPLETED|Washout (14 d)||10
3337714|NCT03372928|4068735|FG001|COMPLETED|Washout (14 d)||9
3337715|NCT03372928|4068734|FG000|NOT COMPLETED|Washout (14 d)||0
3337716|NCT03372928|4068735|FG001|NOT COMPLETED|Washout (14 d)||1
3337717|NCT03372928|4068734|FG000|STARTED|Second Intervention (5 d Energy Deficit)||10
3337718|NCT03372928|4068735|FG001|STARTED|Second Intervention (5 d Energy Deficit)||9
3337719|NCT03372928|4068734|FG000|COMPLETED|Second Intervention (5 d Energy Deficit)||10
3337720|NCT03372928|4068735|FG001|COMPLETED|Second Intervention (5 d Energy Deficit)||9
3337721|NCT03372928|4068734|FG000|NOT COMPLETED|Second Intervention (5 d Energy Deficit)||0
3337722|NCT03372928|4068735|FG001|NOT COMPLETED|Second Intervention (5 d Energy Deficit)||0
3337723|NCT03373006|4068746|FG000|STARTED|Overall Study||20
3337724|NCT03373006|4068746|FG000|COMPLETED|Overall Study||20
3337725|NCT03373006|4068746|FG000|NOT COMPLETED|Overall Study||0
3337726|NCT03373162|4068750|FG000|STARTED|Overall Study||10
3337727|NCT03373162|4068750|FG000|COMPLETED|Overall Study||10
3337728|NCT03373162|4068750|FG000|NOT COMPLETED|Overall Study||0
3337729|NCT03373240|4068757|FG000|STARTED|Overall Study||22
3337730|NCT03373240|4068758|FG001|STARTED|Overall Study||24
3337731|NCT03373240|4068757|FG000|4-week Post Treatment|Overall Study||14
3337732|NCT03373240|4068758|FG001|4-week Post Treatment|Overall Study||23
3337733|NCT03373240|4068757|FG000|COMPLETED|Overall Study|This is the 1-month post follow-up|11
3337734|NCT03373240|4068758|FG001|COMPLETED|Overall Study|This is the 1-month post follow-up|20
3337735|NCT03373240|4068757|FG000|NOT COMPLETED|Overall Study||11
3337736|NCT03373240|4068758|FG001|NOT COMPLETED|Overall Study||4
3337737|NCT03373383|4068769|FG000|STARTED|Treatment Period: Wk0-16||83
3337738|NCT03373383|4068770|FG001|STARTED|Treatment Period: Wk0-16||81
3337739|NCT03373383|4068771|FG002|STARTED|Treatment Period: Wk0-16||83
3337740|NCT03373383|4068772|FG003|STARTED|Treatment Period: Wk0-16||82
3337741|NCT03373383|4068773|FG004|STARTED|Treatment Period: Wk0-16||82
3337742|NCT03373383|4068769|FG000|Completed Titration and Stabilization|Treatment Period: Wk0-16||78
3337743|NCT03373383|4068770|FG001|Completed Titration and Stabilization|Treatment Period: Wk0-16||72
3337744|NCT03373383|4068771|FG002|Completed Titration and Stabilization|Treatment Period: Wk0-16||71
3337745|NCT03373383|4068772|FG003|Completed Titration and Stabilization|Treatment Period: Wk0-16||68
3337746|NCT03373383|4068773|FG004|Completed Titration and Stabilization|Treatment Period: Wk0-16||65
3337747|NCT03373383|4068769|FG000|Completed Maintenance Period|Treatment Period: Wk0-16||70
3337748|NCT03373383|4068770|FG001|Completed Maintenance Period|Treatment Period: Wk0-16||66
3337749|NCT03373383|4068771|FG002|Completed Maintenance Period|Treatment Period: Wk0-16||68
3337750|NCT03373383|4068772|FG003|Completed Maintenance Period|Treatment Period: Wk0-16||61
3337751|NCT03373383|4068773|FG004|Completed Maintenance Period|Treatment Period: Wk0-16||58
3337752|NCT03373383|4068769|FG000|Had Taper and Safety Follow-up|Treatment Period: Wk0-16||6
3337753|NCT03373383|4068770|FG001|Had Taper and Safety Follow-up|Treatment Period: Wk0-16||11
3337754|NCT03373383|4068771|FG002|Had Taper and Safety Follow-up|Treatment Period: Wk0-16||8
3337755|NCT03373383|4068772|FG003|Had Taper and Safety Follow-up|Treatment Period: Wk0-16||18
3337756|NCT03373383|4068773|FG004|Had Taper and Safety Follow-up|Treatment Period: Wk0-16||21
3337757|NCT03373383|4068769|FG000|COMPLETED|Treatment Period: Wk0-16||70
3337758|NCT03373383|4068770|FG001|COMPLETED|Treatment Period: Wk0-16||66
3337759|NCT03373383|4068771|FG002|COMPLETED|Treatment Period: Wk0-16||68
3337760|NCT03373383|4068772|FG003|COMPLETED|Treatment Period: Wk0-16||61
3337761|NCT03373383|4068773|FG004|COMPLETED|Treatment Period: Wk0-16||58
3337762|NCT03373383|4068769|FG000|NOT COMPLETED|Treatment Period: Wk0-16||13
3337763|NCT03373383|4068770|FG001|NOT COMPLETED|Treatment Period: Wk0-16||15
3337764|NCT03373383|4068771|FG002|NOT COMPLETED|Treatment Period: Wk0-16||15
3337765|NCT03373383|4068772|FG003|NOT COMPLETED|Treatment Period: Wk0-16||21
3337766|NCT03373383|4068773|FG004|NOT COMPLETED|Treatment Period: Wk0-16||24
3337767|NCT03373383|4068769|FG000|STARTED|Post-Treatment Period: Wk16-23||70
3337768|NCT03373383|4068770|FG001|STARTED|Post-Treatment Period: Wk16-23||66
3337769|NCT03373383|4068771|FG002|STARTED|Post-Treatment Period: Wk16-23||68
3337770|NCT03373383|4068772|FG003|STARTED|Post-Treatment Period: Wk16-23||61
3337771|NCT03373383|4068773|FG004|STARTED|Post-Treatment Period: Wk16-23||58
3337772|NCT03373383|4068769|FG000|Started Conversion Period|Post-Treatment Period: Wk16-23||69
3337773|NCT03373383|4068770|FG001|Started Conversion Period|Post-Treatment Period: Wk16-23||64
3337774|NCT03373383|4068771|FG002|Started Conversion Period|Post-Treatment Period: Wk16-23||66
3337775|NCT03373383|4068772|FG003|Started Conversion Period|Post-Treatment Period: Wk16-23||55
3337776|NCT03373383|4068773|FG004|Started Conversion Period|Post-Treatment Period: Wk16-23||57
3337777|NCT03373383|4068769|FG000|Completed Conversion Period|Post-Treatment Period: Wk16-23||68
3337778|NCT03373383|4068770|FG001|Completed Conversion Period|Post-Treatment Period: Wk16-23||64
3337779|NCT03373383|4068771|FG002|Completed Conversion Period|Post-Treatment Period: Wk16-23||66
3337780|NCT03373383|4068772|FG003|Completed Conversion Period|Post-Treatment Period: Wk16-23||55
3337781|NCT03373383|4068773|FG004|Completed Conversion Period|Post-Treatment Period: Wk16-23||57
3337782|NCT03373383|4068769|FG000|Had Taper and Safety Follow-up|Post-Treatment Period: Wk16-23||3
3337783|NCT03373383|4068770|FG001|Had Taper and Safety Follow-up|Post-Treatment Period: Wk16-23||3
3337784|NCT03373383|4068771|FG002|Had Taper and Safety Follow-up|Post-Treatment Period: Wk16-23||3
3337785|NCT03373383|4068772|FG003|Had Taper and Safety Follow-up|Post-Treatment Period: Wk16-23||6
3337786|NCT03373383|4068773|FG004|Had Taper and Safety Follow-up|Post-Treatment Period: Wk16-23||1
3337787|NCT03373383|4068769|FG000|Enrolled in EP0093|Post-Treatment Period: Wk16-23||67
3337788|NCT03373383|4068770|FG001|Enrolled in EP0093|Post-Treatment Period: Wk16-23||63
3337789|NCT03373383|4068771|FG002|Enrolled in EP0093|Post-Treatment Period: Wk16-23||65
3337790|NCT03373383|4068772|FG003|Enrolled in EP0093|Post-Treatment Period: Wk16-23||55
3337791|NCT03373383|4068773|FG004|Enrolled in EP0093|Post-Treatment Period: Wk16-23||57
3337792|NCT03373383|4068769|FG000|COMPLETED|Post-Treatment Period: Wk16-23||69
3337793|NCT03373383|4068770|FG001|COMPLETED|Post-Treatment Period: Wk16-23||66
3337794|NCT03373383|4068771|FG002|COMPLETED|Post-Treatment Period: Wk16-23||68
3337795|NCT03373383|4068772|FG003|COMPLETED|Post-Treatment Period: Wk16-23||61
3337796|NCT03373383|4068773|FG004|COMPLETED|Post-Treatment Period: Wk16-23||58
3337797|NCT03373383|4068769|FG000|NOT COMPLETED|Post-Treatment Period: Wk16-23||1
3337798|NCT03373383|4068770|FG001|NOT COMPLETED|Post-Treatment Period: Wk16-23||0
3337799|NCT03373383|4068771|FG002|NOT COMPLETED|Post-Treatment Period: Wk16-23||0
3337800|NCT03373383|4068772|FG003|NOT COMPLETED|Post-Treatment Period: Wk16-23||0
3337801|NCT03373383|4068773|FG004|NOT COMPLETED|Post-Treatment Period: Wk16-23||0
3337802|NCT03373591|4068803|FG000|STARTED|Overall Study||75
3337803|NCT03373591|4068804|FG001|STARTED|Overall Study||71
3337804|NCT03373591|4068805|FG002|STARTED|Overall Study||73
3337805|NCT03373591|4068803|FG000|COMPLETED|Overall Study||75
3337806|NCT03373591|4068804|FG001|COMPLETED|Overall Study||71
3337807|NCT03373591|4068805|FG002|COMPLETED|Overall Study||73
3337808|NCT03373591|4068803|FG000|NOT COMPLETED|Overall Study||0
3337809|NCT03373591|4068804|FG001|NOT COMPLETED|Overall Study||0
3337810|NCT03373591|4068805|FG002|NOT COMPLETED|Overall Study||0
3337811|NCT03373890|4068815|FG000|STARTED|Overall Study||6
3337812|NCT03373890|4068816|FG001|STARTED|Overall Study||6
3337813|NCT03373890|4068815|FG000|COMPLETED|Overall Study||6
3337814|NCT03373890|4068816|FG001|COMPLETED|Overall Study||6
3337815|NCT03373890|4068815|FG000|NOT COMPLETED|Overall Study||0
3337816|NCT03373890|4068816|FG001|NOT COMPLETED|Overall Study||0
3337817|NCT03374176|4068826|FG000|STARTED|Overall Study||21
3337818|NCT03374176|4068827|FG001|STARTED|Overall Study||21
3337819|NCT03374176|4068826|FG000|COMPLETED|Overall Study||21
3337820|NCT03374176|4068827|FG001|COMPLETED|Overall Study||21
3337821|NCT03374176|4068826|FG000|NOT COMPLETED|Overall Study||0
3337822|NCT03374176|4068827|FG001|NOT COMPLETED|Overall Study||0
3337823|NCT03374189|4068835|FG000|STARTED|Overall Study||40
3337824|NCT03374189|4068836|FG001|STARTED|Overall Study||39
3337825|NCT03374189|4068835|FG000|COMPLETED|Overall Study||39
3337826|NCT03374189|4068836|FG001|COMPLETED|Overall Study||39
3337827|NCT03374189|4068835|FG000|NOT COMPLETED|Overall Study||1
3337828|NCT03374189|4068836|FG001|NOT COMPLETED|Overall Study||0
3337829|NCT03374358|4068844|FG000|STARTED|Overall Study||24
3337830|NCT03374358|4068845|FG001|STARTED|Overall Study||21
3337831|NCT03374358|4068844|FG000|COMPLETED|Overall Study||24
3337832|NCT03374358|4068845|FG001|COMPLETED|Overall Study||19
3337833|NCT03374358|4068844|FG000|NOT COMPLETED|Overall Study||0
3337834|NCT03374358|4068845|FG001|NOT COMPLETED|Overall Study||2
3337835|NCT03374488|4068853|FG000|STARTED|Overall Study||42
3337836|NCT03374488|4068854|FG001|STARTED|Overall Study||42
3337837|NCT03374488|4068853|FG000|Intention-to-Treat (ITT)|Overall Study||42
3337838|NCT03374488|4068854|FG001|Intention-to-Treat (ITT)|Overall Study||42
3337839|NCT03374488|4068853|FG000|All Participants as Treated (APaT)|Overall Study||42
3337840|NCT03374488|4068854|FG001|All Participants as Treated (APaT)|Overall Study||41
3337841|NCT03374488|4068853|FG000|COMPLETED|Overall Study||23
3337842|NCT03374488|4068854|FG001|COMPLETED|Overall Study||28
3337843|NCT03374488|4068853|FG000|NOT COMPLETED|Overall Study||19
3337844|NCT03374488|4068854|FG001|NOT COMPLETED|Overall Study||14
3337845|NCT03374683|4068864|FG000|STARTED|Overall Study||148
3337846|NCT03374683|4068865|FG001|STARTED|Overall Study||150
3337847|NCT03374683|4068866|FG002|STARTED|Overall Study||153
3337848|NCT03374683|4068864|FG000|1-week Post-intervention|Overall Study||135
3337849|NCT03374683|4068865|FG001|1-week Post-intervention|Overall Study||113
3337850|NCT03374683|4068866|FG002|1-week Post-intervention|Overall Study||85
3337851|NCT03374683|4068864|FG000|COMPLETED|Overall Study||123
3337852|NCT03374683|4068865|FG001|COMPLETED|Overall Study||105
3337853|NCT03374683|4068866|FG002|COMPLETED|Overall Study||84
3337854|NCT03374683|4068864|FG000|NOT COMPLETED|Overall Study||25
3337855|NCT03374683|4068865|FG001|NOT COMPLETED|Overall Study||45
3337856|NCT03374683|4068866|FG002|NOT COMPLETED|Overall Study||69
3337857|NCT03374995|4068876|FG000|STARTED|Overall Study||13
3177021|NCT01968135|3904703|FG000|NOT COMPLETED|Overall Study||0
3177022|NCT01968135|3904704|FG001|NOT COMPLETED|Overall Study||0
3177023|NCT01968213|3904712|FG000|STARTED|Overall Study||375
3177024|NCT01968213|3904713|FG001|STARTED|Overall Study||189
3337858|NCT03374995|4068877|FG001|STARTED|Overall Study||12
3337859|NCT03374995|4068876|FG000|COMPLETED|Overall Study||13
3337860|NCT03374995|4068877|FG001|COMPLETED|Overall Study||11
3337861|NCT03374995|4068876|FG000|NOT COMPLETED|Overall Study||0
3337862|NCT03374995|4068877|FG001|NOT COMPLETED|Overall Study||1
3337863|NCT03375294|4068883|FG000|STARTED|Overall Study||3
3337864|NCT03375294|4068883|FG000|COMPLETED|Overall Study||3
3337865|NCT03375294|4068883|FG000|NOT COMPLETED|Overall Study||0
3337866|NCT03376061|4068889|FG000|STARTED|Overall Study||49
3337867|NCT03376061|4068890|FG001|STARTED|Overall Study||48
3337868|NCT03376061|4068889|FG000|COMPLETED|Overall Study||49
3337869|NCT03376061|4068890|FG001|COMPLETED|Overall Study||48
3337870|NCT03376061|4068889|FG000|NOT COMPLETED|Overall Study||0
3337871|NCT03376061|4068890|FG001|NOT COMPLETED|Overall Study||0
3337872|NCT03376256|4068899|FG000|STARTED|Overall Study||2
3337873|NCT03376256|4068900|FG001|STARTED|Overall Study||0
3337874|NCT03376256|4068899|FG000|COMPLETED|Overall Study||2
3337875|NCT03376256|4068900|FG001|COMPLETED|Overall Study||0
3337876|NCT03376256|4068899|FG000|NOT COMPLETED|Overall Study||0
3337877|NCT03376256|4068900|FG001|NOT COMPLETED|Overall Study||0
3337878|NCT03376295|4068908|FG000|STARTED|Overall Study||1977
3337879|NCT03376295|4068909|FG001|STARTED|Overall Study||1977
3337880|NCT03376295|4068908|FG000|COMPLETED|Overall Study||1977
3337881|NCT03376295|4068909|FG001|COMPLETED|Overall Study||1977
3337882|NCT03376295|4068908|FG000|NOT COMPLETED|Overall Study||0
3337883|NCT03376295|4068909|FG001|NOT COMPLETED|Overall Study||0
3337884|NCT03376321|4068917|FG000|STARTED|Overall Study||168
3337885|NCT03376321|4068918|FG001|STARTED|Overall Study||166
3337886|NCT03376321|4068917|FG000|Treated|Overall Study||163
3337887|NCT03376321|4068918|FG001|Treated|Overall Study||163
3337888|NCT03376321|4068917|FG000|COMPLETED|Overall Study||145
3337889|NCT03376321|4068918|FG001|COMPLETED|Overall Study||141
3337890|NCT03376321|4068917|FG000|NOT COMPLETED|Overall Study||23
3337891|NCT03376321|4068918|FG001|NOT COMPLETED|Overall Study||25
3177025|NCT01968213|3904712|FG000|COMPLETED|Overall Study||285
3177026|NCT01968213|3904713|FG001|COMPLETED|Overall Study||180
3177027|NCT01968213|3904712|FG000|NOT COMPLETED|Overall Study||90
3177028|NCT01968213|3904713|FG001|NOT COMPLETED|Overall Study||9
3177029|NCT01968317|3904721|FG000|STARTED|Overall Study||76
3337892|NCT03376516|4068924|FG000|STARTED|Overall Study||11
3337893|NCT03376516|4068924|FG000|Received Treatment|Overall Study||10
3337894|NCT03376516|4068924|FG000|SAF Population|Overall Study||10
3337895|NCT03376516|4068924|FG000|FAS Population|Overall Study||10
3337896|NCT03376516|4068924|FG000|PK Population|Overall Study||10
3337897|NCT03376516|4068924|FG000|PP Population|Overall Study||9
3337898|NCT03376516|4068924|FG000|SURG Population|Overall Study||2
3337899|NCT03376516|4068924|FG000|COMPLETED|Overall Study||9
3337900|NCT03376516|4068924|FG000|NOT COMPLETED|Overall Study||2
3337901|NCT03377127|4068941|FG000|STARTED|Overall Study||42
3337902|NCT03377127|4068942|FG001|STARTED|Overall Study||44
3337903|NCT03377127|4068941|FG000|COMPLETED|Overall Study||42
3337904|NCT03377127|4068942|FG001|COMPLETED|Overall Study||44
3337905|NCT03377127|4068941|FG000|NOT COMPLETED|Overall Study||0
3337906|NCT03377127|4068942|FG001|NOT COMPLETED|Overall Study||0
3337907|NCT03377244|4068951|FG000|STARTED|Baseline||19
3337908|NCT03377244|4068952|FG001|STARTED|Baseline||14
3337909|NCT03377244|4068953|FG002|STARTED|Baseline||69
3337910|NCT03377244|4068951|FG000|COMPLETED|Baseline||19
3337911|NCT03377244|4068952|FG001|COMPLETED|Baseline||14
3337912|NCT03377244|4068953|FG002|COMPLETED|Baseline||69
3337913|NCT03377244|4068951|FG000|NOT COMPLETED|Baseline||0
3337914|NCT03377244|4068952|FG001|NOT COMPLETED|Baseline||0
3337915|NCT03377244|4068953|FG002|NOT COMPLETED|Baseline||0
3337916|NCT03377244|4068951|FG000|STARTED|6 Months Post-intervention||19
3337917|NCT03377244|4068952|FG001|STARTED|6 Months Post-intervention||14
3337918|NCT03377244|4068953|FG002|STARTED|6 Months Post-intervention||69
3337919|NCT03377244|4068951|FG000|COMPLETED|6 Months Post-intervention||13
3337920|NCT03377244|4068952|FG001|COMPLETED|6 Months Post-intervention||7
3337921|NCT03377244|4068953|FG002|COMPLETED|6 Months Post-intervention||55
3337922|NCT03377244|4068951|FG000|NOT COMPLETED|6 Months Post-intervention||6
3337923|NCT03377244|4068952|FG001|NOT COMPLETED|6 Months Post-intervention||7
3337924|NCT03377244|4068953|FG002|NOT COMPLETED|6 Months Post-intervention||14
3337925|NCT03377556|4068961|FG000|STARTED|Overall Study||47
3337926|NCT03377556|4068961|FG000|Primary Analysis Population (HRRD-positive Per MDVN Criteria)|Overall Study||24
3337927|NCT03377556|4068961|FG000|COMPLETED|Overall Study||0
3337928|NCT03377556|4068961|FG000|NOT COMPLETED|Overall Study||47
3337929|NCT03377634|4068967|FG000|STARTED|Intervention Usability Testing Period||5
3337930|NCT03377634|4068968|FG001|STARTED|Intervention Usability Testing Period||0
3337931|NCT03377634|4068967|FG000|COMPLETED|Intervention Usability Testing Period||5
3337932|NCT03377634|4068968|FG001|COMPLETED|Intervention Usability Testing Period||0
3337933|NCT03377634|4068967|FG000|NOT COMPLETED|Intervention Usability Testing Period||0
3337934|NCT03377634|4068968|FG001|NOT COMPLETED|Intervention Usability Testing Period||0
3337935|NCT03377634|4068967|FG000|STARTED|Study Period||15
3337936|NCT03377634|4068968|FG001|STARTED|Study Period||13
3337937|NCT03377634|4068967|FG000|COMPLETED|Study Period||13
3337938|NCT03377634|4068968|FG001|COMPLETED|Study Period||13
3337939|NCT03377634|4068967|FG000|NOT COMPLETED|Study Period||2
3337940|NCT03377634|4068968|FG001|NOT COMPLETED|Study Period||0
3337941|NCT03378076|4068976|FG000|STARTED|Overall Study||12
3337942|NCT03378076|4068977|FG001|STARTED|Overall Study||12
3337943|NCT03378076|4068976|FG000|COMPLETED|Overall Study||12
3337944|NCT03378076|4068977|FG001|COMPLETED|Overall Study||12
3337945|NCT03378076|4068976|FG000|NOT COMPLETED|Overall Study||0
3337946|NCT03378076|4068977|FG001|NOT COMPLETED|Overall Study||0
3337947|NCT03378635|4068986|FG000|STARTED|Overall Study||84
3337948|NCT03378635|4068987|FG001|STARTED|Overall Study||43
3337949|NCT03378635|4068988|FG002|STARTED|Overall Study||43
3337950|NCT03378635|4068986|FG000|Randomized and Exposed to Treatment|Overall Study||82
3337951|NCT03378635|4068987|FG001|Randomized and Exposed to Treatment|Overall Study||43
3337952|NCT03378635|4068988|FG002|Randomized and Exposed to Treatment|Overall Study||43
3337953|NCT03378635|4068986|FG000|COMPLETED|Overall Study||82
3337954|NCT03378635|4068987|FG001|COMPLETED|Overall Study||43
3337955|NCT03378635|4068988|FG002|COMPLETED|Overall Study||43
3337956|NCT03378635|4068986|FG000|NOT COMPLETED|Overall Study||2
3337957|NCT03378635|4068987|FG001|NOT COMPLETED|Overall Study||0
3337958|NCT03378635|4068988|FG002|NOT COMPLETED|Overall Study||0
3337959|NCT03378921|4068999|FG000|STARTED|Overall Study||13
3337960|NCT03378921|4069000|FG001|STARTED|Overall Study||13
3337961|NCT03378921|4068999|FG000|COMPLETED|Overall Study||13
3337962|NCT03378921|4069000|FG001|COMPLETED|Overall Study||13
3337963|NCT03378921|4068999|FG000|NOT COMPLETED|Overall Study||0
3337964|NCT03378921|4069000|FG001|NOT COMPLETED|Overall Study||0
3337965|NCT03378973|4069008|FG000|STARTED|Overall Study||4
3337966|NCT03378973|4069009|FG001|STARTED|Overall Study||3
3337967|NCT03378973|4069008|FG000|COMPLETED|Overall Study||4
3337968|NCT03378973|4069009|FG001|COMPLETED|Overall Study||3
3337969|NCT03378973|4069008|FG000|NOT COMPLETED|Overall Study||0
3337970|NCT03378973|4069009|FG001|NOT COMPLETED|Overall Study||0
3337971|NCT03379259|4069021|FG000|STARTED|Overall Study||3
3337972|NCT03379259|4069022|FG001|STARTED|Overall Study||3
3337973|NCT03379259|4069023|FG002|STARTED|Overall Study||6
3337974|NCT03379259|4069024|FG003|STARTED|Overall Study||3
3337975|NCT03379259|4069025|FG004|STARTED|Overall Study||12
3337976|NCT03379259|4069026|FG005|STARTED|Overall Study||12
3337977|NCT03379259|4069021|FG000|COMPLETED|Overall Study||2
3337978|NCT03379259|4069022|FG001|COMPLETED|Overall Study||2
3337979|NCT03379259|4069023|FG002|COMPLETED|Overall Study||3
3337980|NCT03379259|4069024|FG003|COMPLETED|Overall Study||0
3337981|NCT03379259|4069025|FG004|COMPLETED|Overall Study||3
3337982|NCT03379259|4069026|FG005|COMPLETED|Overall Study||5
3337983|NCT03379259|4069021|FG000|NOT COMPLETED|Overall Study||1
3337984|NCT03379259|4069022|FG001|NOT COMPLETED|Overall Study||1
3337985|NCT03379259|4069023|FG002|NOT COMPLETED|Overall Study||3
3177030|NCT01968317|3904722|FG001|STARTED|Overall Study||74
3177031|NCT01968317|3904721|FG000|COMPLETED|Overall Study||76
3177032|NCT01968317|3904722|FG001|COMPLETED|Overall Study||74
3177033|NCT01968317|3904721|FG000|NOT COMPLETED|Overall Study||0
3177034|NCT01968317|3904722|FG001|NOT COMPLETED|Overall Study||0
3177035|NCT01968356|3904736|FG000|STARTED|Overall Study||101
3337986|NCT03379259|4069024|FG003|NOT COMPLETED|Overall Study||3
3337987|NCT03379259|4069025|FG004|NOT COMPLETED|Overall Study||9
3337988|NCT03379259|4069026|FG005|NOT COMPLETED|Overall Study||7
3337989|NCT03379376|4069043|FG000|STARTED|Overall Study||10
3337990|NCT03379376|4069043|FG000|COMPLETED|Overall Study||5
3337991|NCT03379376|4069043|FG000|NOT COMPLETED|Overall Study||5
3337992|NCT03379506|4069051|FG000|STARTED|Overall Study||22
3337993|NCT03379506|4069052|FG001|STARTED|Overall Study||17
3337994|NCT03379506|4069053|FG002|STARTED|Overall Study||7
3337995|NCT03379506|4069054|FG003|STARTED|Overall Study||11
3337996|NCT03379506|4069051|FG000|COMPLETED|Overall Study||22
3337997|NCT03379506|4069052|FG001|COMPLETED|Overall Study||17
3337998|NCT03379506|4069053|FG002|COMPLETED|Overall Study||7
3337999|NCT03379506|4069054|FG003|COMPLETED|Overall Study||11
3338000|NCT03379506|4069051|FG000|NOT COMPLETED|Overall Study||0
3338001|NCT03379506|4069052|FG001|NOT COMPLETED|Overall Study||0
3338002|NCT03379506|4069053|FG002|NOT COMPLETED|Overall Study||0
3338003|NCT03379506|4069054|FG003|NOT COMPLETED|Overall Study||0
3338004|NCT03379545|4069064|FG000|STARTED|Overall Study||29
3338005|NCT03379545|4069064|FG000|COMPLETED|Overall Study||29
3338006|NCT03379545|4069064|FG000|NOT COMPLETED|Overall Study||0
3338007|NCT03379662|4069071|FG000|STARTED|Overall Study||21
3338008|NCT03379662|4069072|FG001|STARTED|Overall Study||19
3338009|NCT03379662|4069071|FG000|COMPLETED|Overall Study||21
3338010|NCT03379662|4069072|FG001|COMPLETED|Overall Study||19
3338011|NCT03379662|4069071|FG000|NOT COMPLETED|Overall Study||0
3338012|NCT03379662|4069072|FG001|NOT COMPLETED|Overall Study||0
3338013|NCT03379740|4069080|FG000|STARTED|Overall Study||8
3338014|NCT03379740|4069081|FG001|STARTED|Overall Study||7
3338015|NCT03379740|4069080|FG000|COMPLETED|Overall Study||8
3338016|NCT03379740|4069081|FG001|COMPLETED|Overall Study||7
3338017|NCT03379740|4069080|FG000|NOT COMPLETED|Overall Study||0
3338018|NCT03379740|4069081|FG001|NOT COMPLETED|Overall Study||0
3338019|NCT03379753|4069096|FG000|STARTED|Overall Study||61
3338020|NCT03379753|4069097|FG001|STARTED|Overall Study||71
3338021|NCT03379753|4069096|FG000|COMPLETED|Overall Study||46
3338022|NCT03379753|4069097|FG001|COMPLETED|Overall Study||46
3338023|NCT03379753|4069096|FG000|NOT COMPLETED|Overall Study||15
3338024|NCT03379753|4069097|FG001|NOT COMPLETED|Overall Study||25
3338025|NCT03380000|4069103|FG000|STARTED|First Intervention (1day)||8
3338026|NCT03380000|4069104|FG001|STARTED|First Intervention (1day)||8
2927845|NCT00574548|3638730|FG000|Withdrawn After Vax 1 (6 Month Contact)|Overall Study||7
2927846|NCT00574548|3638731|FG001|Withdrawn After Vax 1 (6 Month Contact)|Overall Study||3
2927847|NCT00574548|3638730|FG000|Withdrawn Before Vax 2|Overall Study||41
2927848|NCT00574548|3638731|FG001|Withdrawn Before Vax 2|Overall Study||11
2927849|NCT00574548|3638730|FG000|Received Vax 2|Overall Study||427
2927850|NCT00574548|3638731|FG001|Received Vax 2|Overall Study||223
2927851|NCT00574548|3638730|FG000|Completed Vax 2 (6 Month Contact)|Overall Study||421
2927852|NCT00574548|3638731|FG001|Completed Vax 2 (6 Month Contact)|Overall Study||222
2927853|NCT00574548|3638730|FG000|COMPLETED|Overall Study||421
2927854|NCT00574548|3638731|FG001|COMPLETED|Overall Study||222
2927855|NCT00574548|3638730|FG000|NOT COMPLETED|Overall Study||61
2927856|NCT00574548|3638731|FG001|NOT COMPLETED|Overall Study||16
2927857|NCT00574587|3638759|FG000|STARTED|Overall Study||3
2927858|NCT00574587|3638760|FG001|STARTED|Overall Study||23
2927859|NCT00574587|3638761|FG002|STARTED|Overall Study||16
2927860|NCT00574587|3638762|FG003|STARTED|Overall Study||13
2927861|NCT00574587|3638759|FG000|COMPLETED|Overall Study||3
2927862|NCT00574587|3638760|FG001|COMPLETED|Overall Study||23
2927863|NCT00574587|3638761|FG002|COMPLETED|Overall Study||16
2927864|NCT00574587|3638762|FG003|COMPLETED|Overall Study||13
2927865|NCT00574587|3638759|FG000|NOT COMPLETED|Overall Study||0
2927866|NCT00574587|3638760|FG001|NOT COMPLETED|Overall Study||0
2927867|NCT00574587|3638761|FG002|NOT COMPLETED|Overall Study||0
2927868|NCT00574587|3638762|FG003|NOT COMPLETED|Overall Study||0
2927869|NCT00574704|3638777|FG000|STARTED|Overall Study||10
3338027|NCT03380000|4069103|FG000|COMPLETED|First Intervention (1day)||8
3338028|NCT03380000|4069104|FG001|COMPLETED|First Intervention (1day)||8
3338029|NCT03380000|4069103|FG000|NOT COMPLETED|First Intervention (1day)||0
3338030|NCT03380000|4069104|FG001|NOT COMPLETED|First Intervention (1day)||0
3338031|NCT03380000|4069103|FG000|STARTED|Washout (>7days)||8
3338032|NCT03380000|4069104|FG001|STARTED|Washout (>7days)||8
3338033|NCT03380000|4069103|FG000|COMPLETED|Washout (>7days)||8
3338034|NCT03380000|4069104|FG001|COMPLETED|Washout (>7days)||8
3338035|NCT03380000|4069103|FG000|NOT COMPLETED|Washout (>7days)||0
3338036|NCT03380000|4069104|FG001|NOT COMPLETED|Washout (>7days)||0
3338037|NCT03380000|4069103|FG000|STARTED|Second Intervention (1day)||8
3338038|NCT03380000|4069104|FG001|STARTED|Second Intervention (1day)||8
3338039|NCT03380000|4069103|FG000|COMPLETED|Second Intervention (1day)||8
3338040|NCT03380000|4069104|FG001|COMPLETED|Second Intervention (1day)||8
3338041|NCT03380000|4069103|FG000|NOT COMPLETED|Second Intervention (1day)||0
3338042|NCT03380000|4069104|FG001|NOT COMPLETED|Second Intervention (1day)||0
3338043|NCT03380026|4069110|FG000|STARTED|Overall Study||28
3338044|NCT03380026|4069110|FG000|Half of Body Assigned to Treatment With Valchlor Only|Overall Study||28
3338045|NCT03380026|4069110|FG000|Half of Body Assigned to Treatment With Valchlor and Triamcinolone Acetonide|Overall Study||28
3338046|NCT03380026|4069110|FG000|COMPLETED|Overall Study||25
3338047|NCT03380026|4069110|FG000|NOT COMPLETED|Overall Study||3
3338048|NCT03380091|4069119|FG000|STARTED|Overall Study||3
3338049|NCT03380091|4069120|FG001|STARTED|Overall Study||2
3338050|NCT03380091|4069119|FG000|Began Arm Treatment|Overall Study|1 participant withdrew after completing baseline measures and another withdrew just after enrolling.|1
3338051|NCT03380091|4069120|FG001|Began Arm Treatment|Overall Study|1 of the 2 participant assigned to Metformin withdrew from the study just after enrolling.|1
3338052|NCT03380091|4069119|FG000|COMPLETED|Overall Study||1
3338053|NCT03380091|4069120|FG001|COMPLETED|Overall Study||1
3338054|NCT03380091|4069119|FG000|NOT COMPLETED|Overall Study||2
3338055|NCT03380091|4069120|FG001|NOT COMPLETED|Overall Study||1
3338056|NCT03380390|4069128|FG000|STARTED|Overall Study||46
3338057|NCT03380390|4069128|FG000|COMPLETED|Overall Study||43
3338058|NCT03380390|4069128|FG000|NOT COMPLETED|Overall Study||3
3338059|NCT03380429|4069137|FG000|STARTED|Overall Study||87
3338060|NCT03380429|4069138|FG001|STARTED|Overall Study||88
3338061|NCT03380429|4069139|FG002|STARTED|Overall Study||88
3338062|NCT03380429|4069140|FG003|STARTED|Overall Study||88
3338063|NCT03380429|4069141|FG004|STARTED|Overall Study||86
3338064|NCT03380429|4069137|FG000|COMPLETED|Overall Study||82
3338065|NCT03380429|4069138|FG001|COMPLETED|Overall Study||81
3338066|NCT03380429|4069139|FG002|COMPLETED|Overall Study||77
3338067|NCT03380429|4069140|FG003|COMPLETED|Overall Study||78
3338068|NCT03380429|4069141|FG004|COMPLETED|Overall Study||81
3338069|NCT03380429|4069137|FG000|NOT COMPLETED|Overall Study||5
3338070|NCT03380429|4069138|FG001|NOT COMPLETED|Overall Study||7
3338071|NCT03380429|4069139|FG002|NOT COMPLETED|Overall Study||11
3338072|NCT03380429|4069140|FG003|NOT COMPLETED|Overall Study||10
3338073|NCT03380429|4069141|FG004|NOT COMPLETED|Overall Study||5
3338074|NCT03380572|4069160|FG000|STARTED|Overall Study||20
3338075|NCT03380572|4069161|FG001|STARTED|Overall Study||20
3338076|NCT03380572|4069160|FG000|COMPLETED|Overall Study||20
3338077|NCT03380572|4069161|FG001|COMPLETED|Overall Study||20
3338078|NCT03380572|4069160|FG000|NOT COMPLETED|Overall Study||0
3338079|NCT03380572|4069161|FG001|NOT COMPLETED|Overall Study||0
3338080|NCT03380624|4069167|FG000|STARTED|Overall Study||10
3338081|NCT03380624|4069168|FG001|STARTED|Overall Study||9
3338082|NCT03380624|4069167|FG000|COMPLETED|Overall Study||10
3338083|NCT03380624|4069168|FG001|COMPLETED|Overall Study||9
3338084|NCT03380624|4069167|FG000|NOT COMPLETED|Overall Study||0
3338085|NCT03380624|4069168|FG001|NOT COMPLETED|Overall Study||0
3338086|NCT03380780|4069174|FG000|STARTED|Overall Study||16
3338087|NCT03380780|4069174|FG000|COMPLETED|Overall Study||16
3338088|NCT03380780|4069174|FG000|NOT COMPLETED|Overall Study||0
3338089|NCT03380845|4069178|FG000|STARTED|Overall Study|Participants got bilateral face treatments with Fraxel on one side of face; Fractora on the other.|4
3338090|NCT03380845|4069178|FG000|COMPLETED|Overall Study||4
3338091|NCT03380845|4069178|FG000|NOT COMPLETED|Overall Study||0
3338092|NCT03381196|4069186|FG000|STARTED|Overall Study||276
3338093|NCT03381196|4069187|FG001|STARTED|Overall Study||277
3338094|NCT03381196|4069186|FG000|Treated|Overall Study||273
3338095|NCT03381196|4069187|FG001|Treated|Overall Study||271
3338096|NCT03381196|4069186|FG000|COMPLETED|Overall Study||260
3338097|NCT03381196|4069187|FG001|COMPLETED|Overall Study||258
3338098|NCT03381196|4069186|FG000|NOT COMPLETED|Overall Study||16
3338099|NCT03381196|4069187|FG001|NOT COMPLETED|Overall Study||19
3338100|NCT03381248|4069195|FG000|STARTED|Overall Study||89
3338101|NCT03381248|4069196|FG001|STARTED|Overall Study||88
3338102|NCT03381248|4069195|FG000|COMPLETED|Overall Study||76
3338103|NCT03381248|4069196|FG001|COMPLETED|Overall Study||82
3338104|NCT03381248|4069195|FG000|NOT COMPLETED|Overall Study||13
3338105|NCT03381248|4069196|FG001|NOT COMPLETED|Overall Study||6
3338106|NCT03381339|4069204|FG000|STARTED|Overall Study||27
3338107|NCT03381339|4069205|FG001|STARTED|Overall Study||28
3338108|NCT03381339|4069204|FG000|COMPLETED|Overall Study||23
3338109|NCT03381339|4069205|FG001|COMPLETED|Overall Study||24
3338110|NCT03381339|4069204|FG000|NOT COMPLETED|Overall Study||4
3338111|NCT03381339|4069205|FG001|NOT COMPLETED|Overall Study||4
3338112|NCT03381742|4069215|FG000|STARTED|Overall Study||525
3338113|NCT03381742|4069216|FG001|STARTED|Overall Study||501
3338114|NCT03381742|4069217|FG002|STARTED|Overall Study||1511
3338115|NCT03381742|4069218|FG003|STARTED|Overall Study||506
3338116|NCT03381742|4069215|FG000|COMPLETED|Overall Study||525
3338117|NCT03381742|4069216|FG001|COMPLETED|Overall Study||501
3338118|NCT03381742|4069217|FG002|COMPLETED|Overall Study||1511
3338119|NCT03381742|4069218|FG003|COMPLETED|Overall Study||506
3338120|NCT03381742|4069215|FG000|NOT COMPLETED|Overall Study||0
3338121|NCT03381742|4069216|FG001|NOT COMPLETED|Overall Study||0
3338122|NCT03381742|4069217|FG002|NOT COMPLETED|Overall Study||0
3338123|NCT03381742|4069218|FG003|NOT COMPLETED|Overall Study||0
3338124|NCT03381989|4069228|FG000|STARTED|Overall Study||30
3338125|NCT03381989|4069228|FG000|COMPLETED|Overall Study||22
3338126|NCT03381989|4069228|FG000|NOT COMPLETED|Overall Study||8
3338127|NCT03382262|4069237|FG000|STARTED|Overall Study||12
3338128|NCT03382262|4069238|FG001|STARTED|Overall Study||13
3338129|NCT03382262|4069239|FG002|STARTED|Overall Study||15
3338130|NCT03382262|4069240|FG003|STARTED|Overall Study||15
3338131|NCT03382262|4069237|FG000|COMPLETED|Overall Study||12
3338132|NCT03382262|4069238|FG001|COMPLETED|Overall Study||13
3338133|NCT03382262|4069239|FG002|COMPLETED|Overall Study||14
3338134|NCT03382262|4069240|FG003|COMPLETED|Overall Study||14
3338135|NCT03382262|4069237|FG000|NOT COMPLETED|Overall Study||0
3338136|NCT03382262|4069238|FG001|NOT COMPLETED|Overall Study||0
3338137|NCT03382262|4069239|FG002|NOT COMPLETED|Overall Study||1
3338138|NCT03382262|4069240|FG003|NOT COMPLETED|Overall Study||1
3338139|NCT03382418|4069253|FG000|STARTED|Overall Study||25
3338140|NCT03382418|4069254|FG001|STARTED|Overall Study||15
3338141|NCT03382418|4069255|FG002|STARTED|Overall Study||5
3338142|NCT03382418|4069253|FG000|Month .5 Immunogenicity Cohort|Overall Study||25
3338143|NCT03382418|4069254|FG001|Month .5 Immunogenicity Cohort|Overall Study||14
3338144|NCT03382418|4069255|FG002|Month .5 Immunogenicity Cohort|Overall Study||5
3338145|NCT03382418|4069253|FG000|Month 6.5 Immunogenicity Cohort|Overall Study||21
3338146|NCT03382418|4069254|FG001|Month 6.5 Immunogenicity Cohort|Overall Study||13
3338147|NCT03382418|4069255|FG002|Month 6.5 Immunogenicity Cohort|Overall Study||5
3338148|NCT03382418|4069253|FG000|COMPLETED|Overall Study||22
3338149|NCT03382418|4069254|FG001|COMPLETED|Overall Study||12
3338150|NCT03382418|4069255|FG002|COMPLETED|Overall Study||5
3338151|NCT03382418|4069253|FG000|NOT COMPLETED|Overall Study||3
3338152|NCT03382418|4069254|FG001|NOT COMPLETED|Overall Study||3
3338153|NCT03382418|4069255|FG002|NOT COMPLETED|Overall Study||0
3338154|NCT03382509|4069266|FG000|STARTED|Overall Study||8
3338155|NCT03382509|4069267|FG001|STARTED|Overall Study||8
3338156|NCT03382509|4069266|FG000|COMPLETED|Overall Study||8
3338157|NCT03382509|4069267|FG001|COMPLETED|Overall Study||8
3338158|NCT03382509|4069266|FG000|NOT COMPLETED|Overall Study||0
3338159|NCT03382509|4069267|FG001|NOT COMPLETED|Overall Study||0
3338160|NCT03382665|4069274|FG000|STARTED|Overall Study||70
3338161|NCT03382665|4069274|FG000|Actual Enrollment|Overall Study||59
3338162|NCT03382665|4069274|FG000|5 Year Follow up|Overall Study||25
3338163|NCT03382665|4069274|FG000|COMPLETED|Overall Study||25
3338164|NCT03382665|4069274|FG000|NOT COMPLETED|Overall Study||45
3338165|NCT03382821|4069284|FG000|STARTED|Overall Study||60
3338166|NCT03382821|4069285|FG001|STARTED|Overall Study||60
3338167|NCT03382821|4069284|FG000|COMPLETED|Overall Study||60
3338168|NCT03382821|4069285|FG001|COMPLETED|Overall Study||57
3338169|NCT03382821|4069284|FG000|NOT COMPLETED|Overall Study||0
3338170|NCT03382821|4069285|FG001|NOT COMPLETED|Overall Study||3
3338171|NCT03382847|4069292|FG000|STARTED|Overall Study||25
3338172|NCT03382847|4069292|FG000|COMPLETED|Overall Study||25
3338173|NCT03382847|4069292|FG000|NOT COMPLETED|Overall Study||0
3338174|NCT03382899|4069298|FG000|STARTED|Overall Study||51
3338175|NCT03382899|4069299|FG001|STARTED|Overall Study||50
3338176|NCT03382899|4069298|FG000|Received at Least 1 Dose of Study Drug|Overall Study||50
3338177|NCT03382899|4069299|FG001|Received at Least 1 Dose of Study Drug|Overall Study||48
3338178|NCT03382899|4069298|FG000|COMPLETED|Overall Study||20
3338179|NCT03382899|4069299|FG001|COMPLETED|Overall Study||15
3338180|NCT03382899|4069298|FG000|NOT COMPLETED|Overall Study||31
3338181|NCT03382899|4069299|FG001|NOT COMPLETED|Overall Study||35
3338182|NCT03382912|4069307|FG000|STARTED|Overall Study||27
3338183|NCT03382912|4069308|FG001|STARTED|Overall Study||25
3338184|NCT03382912|4069307|FG000|Received at Least 1 Dose of Study Drug|Overall Study||27
3338185|NCT03382912|4069308|FG001|Received at Least 1 Dose of Study Drug|Overall Study||24
3338186|NCT03382912|4069307|FG000|COMPLETED|Overall Study||21
3338187|NCT03382912|4069308|FG001|COMPLETED|Overall Study||13
3338188|NCT03382912|4069307|FG000|NOT COMPLETED|Overall Study||6
3338189|NCT03382912|4069308|FG001|NOT COMPLETED|Overall Study||12
3338190|NCT03383146|4069316|FG000|STARTED|Overall Study||148
3338191|NCT03383146|4069317|FG001|STARTED|Overall Study||302
3338192|NCT03383146|4069316|FG000|Safety Population|Overall Study||145
3338193|NCT03383146|4069317|FG001|Safety Population|Overall Study||299
3338194|NCT03383146|4069316|FG000|Run-in Period|Overall Study||91
3338195|NCT03383146|4069317|FG001|Run-in Period|Overall Study||207
3338196|NCT03383146|4069316|FG000|COMPLETED|Overall Study||63
3338197|NCT03383146|4069317|FG001|COMPLETED|Overall Study||118
3338198|NCT03383146|4069316|FG000|NOT COMPLETED|Overall Study||85
3338199|NCT03383146|4069317|FG001|NOT COMPLETED|Overall Study||184
3338200|NCT03383198|4069326|FG000|STARTED|Overall Study||4
3338201|NCT03383198|4069327|FG001|STARTED|Overall Study||1
3338202|NCT03383198|4069326|FG000|COMPLETED|Overall Study||4
3338203|NCT03383198|4069327|FG001|COMPLETED|Overall Study||1
3338204|NCT03383198|4069326|FG000|NOT COMPLETED|Overall Study||0
3338205|NCT03383198|4069327|FG001|NOT COMPLETED|Overall Study||0
3338206|NCT03383523|4069340|FG000|STARTED|Overall Study||11
3338207|NCT03383523|4069341|FG001|STARTED|Overall Study||11
3338208|NCT03383523|4069342|FG002|STARTED|Overall Study||10
3338209|NCT03383523|4069343|FG003|STARTED|Overall Study||12
3338210|NCT03383523|4069344|FG004|STARTED|Overall Study||11
3338211|NCT03383523|4069345|FG005|STARTED|Overall Study||12
3338212|NCT03383523|4069346|FG006|STARTED|Overall Study||10
3338213|NCT03383523|4069340|FG000|COMPLETED|Overall Study||10
3338214|NCT03383523|4069341|FG001|COMPLETED|Overall Study||11
3338215|NCT03383523|4069342|FG002|COMPLETED|Overall Study||9
3338216|NCT03383523|4069343|FG003|COMPLETED|Overall Study||12
3338217|NCT03383523|4069344|FG004|COMPLETED|Overall Study||11
3338218|NCT03383523|4069345|FG005|COMPLETED|Overall Study||12
3338219|NCT03383523|4069346|FG006|COMPLETED|Overall Study||10
3338220|NCT03383523|4069340|FG000|NOT COMPLETED|Overall Study||1
3338221|NCT03383523|4069341|FG001|NOT COMPLETED|Overall Study||0
3338222|NCT03383523|4069342|FG002|NOT COMPLETED|Overall Study||1
3338223|NCT03383523|4069343|FG003|NOT COMPLETED|Overall Study||0
3338224|NCT03383523|4069344|FG004|NOT COMPLETED|Overall Study||0
3338225|NCT03383523|4069345|FG005|NOT COMPLETED|Overall Study||0
3338226|NCT03383523|4069346|FG006|NOT COMPLETED|Overall Study||0
3338227|NCT03383588|4069365|FG000|STARTED|Overall Study||8
3177036|NCT01968356|3904737|FG001|STARTED|Overall Study||93
3177037|NCT01968356|3904738|FG002|STARTED|Overall Study||96
3177038|NCT01968356|3904739|FG003|STARTED|Overall Study||32
3338228|NCT03383588|4069366|FG001|STARTED|Overall Study||9
3338229|NCT03383588|4069367|FG002|STARTED|Overall Study||9
3338230|NCT03383588|4069365|FG000|COMPLETED|Overall Study||8
3338231|NCT03383588|4069366|FG001|COMPLETED|Overall Study||9
3338232|NCT03383588|4069367|FG002|COMPLETED|Overall Study||9
3338233|NCT03383588|4069365|FG000|NOT COMPLETED|Overall Study||0
3338234|NCT03383588|4069366|FG001|NOT COMPLETED|Overall Study||0
3338235|NCT03383588|4069367|FG002|NOT COMPLETED|Overall Study||0
3338236|NCT03383614|4069379|FG000|STARTED|Overall Study||6
3338237|NCT03383614|4069380|FG001|STARTED|Overall Study||6
3338238|NCT03383614|4069381|FG002|STARTED|Overall Study||6
3338239|NCT03383614|4069382|FG003|STARTED|Overall Study||6
3338240|NCT03383614|4069379|FG000|COMPLETED|Overall Study||6
3338241|NCT03383614|4069380|FG001|COMPLETED|Overall Study||5
3338242|NCT03383614|4069381|FG002|COMPLETED|Overall Study||6
3338243|NCT03383614|4069382|FG003|COMPLETED|Overall Study||6
3338244|NCT03383614|4069379|FG000|NOT COMPLETED|Overall Study||0
3338245|NCT03383614|4069380|FG001|NOT COMPLETED|Overall Study||1
3338246|NCT03383614|4069381|FG002|NOT COMPLETED|Overall Study||0
3338247|NCT03383614|4069382|FG003|NOT COMPLETED|Overall Study||0
3338248|NCT03383627|4069397|FG000|STARTED|Overall Study||80
3338249|NCT03383627|4069397|FG000|COMPLETED|Overall Study||80
3338250|NCT03383627|4069397|FG000|NOT COMPLETED|Overall Study||0
3338251|NCT03383692|4069403|FG000|STARTED|Overall Study||17
3338252|NCT03383692|4069404|FG001|STARTED|Overall Study||23
3338253|NCT03383692|4069403|FG000|COMPLETED|Overall Study||11
3338254|NCT03383692|4069404|FG001|COMPLETED|Overall Study||19
3338255|NCT03383692|4069403|FG000|NOT COMPLETED|Overall Study||6
3338256|NCT03383692|4069404|FG001|NOT COMPLETED|Overall Study||4
3338257|NCT03383757|4069412|FG000|STARTED|Overall Study||117
3338258|NCT03383757|4069412|FG000|TruSignal AllFit Sensor Subjects|Overall Study||56
3338259|NCT03383757|4069412|FG000|TruSignal Sensitive Sensor Subjects|Overall Study||59
3338260|NCT03383757|4069412|FG000|TruSignal AllFit Sensor Data Pairs|Overall Study||52
3338261|NCT03383757|4069412|FG000|TruSignal Sensitive Sensor Data Pairs|Overall Study||51
3338262|NCT03383757|4069412|FG000|COMPLETED|Overall Study||78
3338263|NCT03383757|4069412|FG000|NOT COMPLETED|Overall Study||39
3338264|NCT03383783|4069416|FG000|STARTED|Overall Study||27
3338265|NCT03383783|4069416|FG000|COMPLETED|Overall Study||25
3338266|NCT03383783|4069416|FG000|NOT COMPLETED|Overall Study||2
3338267|NCT03383887|4069432|FG000|STARTED|Overall Study||5
3338268|NCT03383887|4069433|FG001|STARTED|Overall Study||6
3338269|NCT03383887|4069432|FG000|COMPLETED|Overall Study||5
3338270|NCT03383887|4069433|FG001|COMPLETED|Overall Study||5
3338271|NCT03383887|4069432|FG000|NOT COMPLETED|Overall Study||0
3338272|NCT03383887|4069433|FG001|NOT COMPLETED|Overall Study||1
3338273|NCT03384173|4069441|FG000|STARTED|Overall Study||35
3338274|NCT03384173|4069441|FG000|COMPLETED|Overall Study||35
3338275|NCT03384173|4069441|FG000|NOT COMPLETED|Overall Study||0
3338276|NCT03384316|4069453|FG000|STARTED|Overall Study||6
3338277|NCT03384316|4069454|FG001|STARTED|Overall Study||5
3338278|NCT03384316|4069453|FG000|COMPLETED|Overall Study||6
3338279|NCT03384316|4069454|FG001|COMPLETED|Overall Study||4
3338280|NCT03384316|4069453|FG000|NOT COMPLETED|Overall Study||0
3177039|NCT01968356|3904740|FG004|STARTED|Overall Study||97
3177040|NCT01968356|3904741|FG005|STARTED|Overall Study||99
3177041|NCT01968356|3904742|FG006|STARTED|Overall Study||97
3177042|NCT01968356|3904743|FG007|STARTED|Overall Study||31
3177043|NCT01968356|3904736|FG000|COMPLETED|Overall Study||101
3177044|NCT01968356|3904737|FG001|COMPLETED|Overall Study||93
3177045|NCT01968356|3904738|FG002|COMPLETED|Overall Study||96
3177046|NCT01968356|3904739|FG003|COMPLETED|Overall Study||32
3177047|NCT01968356|3904740|FG004|COMPLETED|Overall Study||97
3177048|NCT01968356|3904741|FG005|COMPLETED|Overall Study||99
3177049|NCT01968356|3904742|FG006|COMPLETED|Overall Study||97
3177050|NCT01968356|3904743|FG007|COMPLETED|Overall Study||31
3338281|NCT03384316|4069454|FG001|NOT COMPLETED|Overall Study||1
3338282|NCT03384329|4069464|FG000|STARTED|Overall Study||11
3338283|NCT03384329|4069465|FG001|STARTED|Overall Study||11
3338284|NCT03384329|4069464|FG000|COMPLETED|Overall Study||11
3338285|NCT03384329|4069465|FG001|COMPLETED|Overall Study||11
3338286|NCT03384329|4069464|FG000|NOT COMPLETED|Overall Study||0
3338287|NCT03384329|4069465|FG001|NOT COMPLETED|Overall Study||0
3338288|NCT03384693|4069471|FG000|STARTED|Overall Study||25
3338289|NCT03384693|4069471|FG000|COMPLETED|Overall Study||22
3338290|NCT03384693|4069471|FG000|NOT COMPLETED|Overall Study||3
3338291|NCT03384745|4069481|FG000|STARTED|Placebo Controlled Induction (W0 - W12)||52
3338292|NCT03384745|4069482|FG001|STARTED|Placebo Controlled Induction (W0 - W12)||52
3338293|NCT03384745|4069483|FG002|STARTED|Placebo Controlled Induction (W0 - W12)||53
3338294|NCT03384745|4069484|FG003|STARTED|Placebo Controlled Induction (W0 - W12)||51
3338295|NCT03384745|4069485|FG004|STARTED|Placebo Controlled Induction (W0 - W12)||52
3338296|NCT03384745|4069486|FG005|STARTED|Placebo Controlled Induction (W0 - W12)||53
3338297|NCT03384745|4069481|FG000|COMPLETED|Placebo Controlled Induction (W0 - W12)||52
3338298|NCT03384745|4069482|FG001|COMPLETED|Placebo Controlled Induction (W0 - W12)||51
3338299|NCT03384745|4069483|FG002|COMPLETED|Placebo Controlled Induction (W0 - W12)||50
3338300|NCT03384745|4069484|FG003|COMPLETED|Placebo Controlled Induction (W0 - W12)||49
3338301|NCT03384745|4069485|FG004|COMPLETED|Placebo Controlled Induction (W0 - W12)||49
3338302|NCT03384745|4069486|FG005|COMPLETED|Placebo Controlled Induction (W0 - W12)||51
3338303|NCT03384745|4069481|FG000|NOT COMPLETED|Placebo Controlled Induction (W0 - W12)||0
3338304|NCT03384745|4069482|FG001|NOT COMPLETED|Placebo Controlled Induction (W0 - W12)||1
3338305|NCT03384745|4069483|FG002|NOT COMPLETED|Placebo Controlled Induction (W0 - W12)||3
3338306|NCT03384745|4069484|FG003|NOT COMPLETED|Placebo Controlled Induction (W0 - W12)||2
3338307|NCT03384745|4069485|FG004|NOT COMPLETED|Placebo Controlled Induction (W0 - W12)||3
3338308|NCT03384745|4069486|FG005|NOT COMPLETED|Placebo Controlled Induction (W0 - W12)||2
3338309|NCT03384745|4069481|FG000|STARTED|Maintenance/Escalation (W12-W24)||52
3338310|NCT03384745|4069482|FG001|STARTED|Maintenance/Escalation (W12-W24)||51
3338311|NCT03384745|4069483|FG002|STARTED|Maintenance/Escalation (W12-W24)||50
3338312|NCT03384745|4069484|FG003|STARTED|Maintenance/Escalation (W12-W24)||49
3338313|NCT03384745|4069485|FG004|STARTED|Maintenance/Escalation (W12-W24)||49
3338314|NCT03384745|4069486|FG005|STARTED|Maintenance/Escalation (W12-W24)||51
3338315|NCT03384745|4069481|FG000|COMPLETED|Maintenance/Escalation (W12-W24)||52
3338316|NCT03384745|4069482|FG001|COMPLETED|Maintenance/Escalation (W12-W24)||51
3338317|NCT03384745|4069483|FG002|COMPLETED|Maintenance/Escalation (W12-W24)||49
3338318|NCT03384745|4069484|FG003|COMPLETED|Maintenance/Escalation (W12-W24)||47
3338319|NCT03384745|4069485|FG004|COMPLETED|Maintenance/Escalation (W12-W24)||47
3338320|NCT03384745|4069486|FG005|COMPLETED|Maintenance/Escalation (W12-W24)||51
3338321|NCT03384745|4069481|FG000|NOT COMPLETED|Maintenance/Escalation (W12-W24)||0
3338322|NCT03384745|4069482|FG001|NOT COMPLETED|Maintenance/Escalation (W12-W24)||0
3338323|NCT03384745|4069483|FG002|NOT COMPLETED|Maintenance/Escalation (W12-W24)||1
3338324|NCT03384745|4069484|FG003|NOT COMPLETED|Maintenance/Escalation (W12-W24)||2
3338325|NCT03384745|4069485|FG004|NOT COMPLETED|Maintenance/Escalation (W12-W24)||2
3338326|NCT03384745|4069486|FG005|NOT COMPLETED|Maintenance/Escalation (W12-W24)||0
3338327|NCT03384745|4069481|FG000|STARTED|Response Assess/Dose Hold (W24-W48)||52
3338328|NCT03384745|4069482|FG001|STARTED|Response Assess/Dose Hold (W24-W48)||51
3338329|NCT03384745|4069483|FG002|STARTED|Response Assess/Dose Hold (W24-W48)||49
3338330|NCT03384745|4069484|FG003|STARTED|Response Assess/Dose Hold (W24-W48)||47
3338331|NCT03384745|4069485|FG004|STARTED|Response Assess/Dose Hold (W24-W48)||47
3338332|NCT03384745|4069486|FG005|STARTED|Response Assess/Dose Hold (W24-W48)||51
3338333|NCT03384745|4069481|FG000|COMPLETED|Response Assess/Dose Hold (W24-W48)||51
3338334|NCT03384745|4069482|FG001|COMPLETED|Response Assess/Dose Hold (W24-W48)||48
3338335|NCT03384745|4069483|FG002|COMPLETED|Response Assess/Dose Hold (W24-W48)||45
3338336|NCT03384745|4069484|FG003|COMPLETED|Response Assess/Dose Hold (W24-W48)||43
3338337|NCT03384745|4069485|FG004|COMPLETED|Response Assess/Dose Hold (W24-W48)||46
3338338|NCT03384745|4069486|FG005|COMPLETED|Response Assess/Dose Hold (W24-W48)||49
3338339|NCT03384745|4069481|FG000|NOT COMPLETED|Response Assess/Dose Hold (W24-W48)||1
3338340|NCT03384745|4069482|FG001|NOT COMPLETED|Response Assess/Dose Hold (W24-W48)||3
3338341|NCT03384745|4069483|FG002|NOT COMPLETED|Response Assess/Dose Hold (W24-W48)||4
3338342|NCT03384745|4069484|FG003|NOT COMPLETED|Response Assess/Dose Hold (W24-W48)||4
3338343|NCT03384745|4069485|FG004|NOT COMPLETED|Response Assess/Dose Hold (W24-W48)||1
3338344|NCT03384745|4069486|FG005|NOT COMPLETED|Response Assess/Dose Hold (W24-W48)||2
3338345|NCT03384940|4069509|FG000|STARTED|Overall Study||53
3338346|NCT03384940|4069510|FG001|STARTED|Overall Study||15
3338347|NCT03384940|4069511|FG002|STARTED|Overall Study||18
3338348|NCT03384940|4069509|FG000|COMPLETED|Overall Study||0
3338349|NCT03384940|4069510|FG001|COMPLETED|Overall Study||0
3338350|NCT03384940|4069511|FG002|COMPLETED|Overall Study||0
3338351|NCT03384940|4069509|FG000|NOT COMPLETED|Overall Study||53
3338352|NCT03384940|4069510|FG001|NOT COMPLETED|Overall Study||15
3338353|NCT03384940|4069511|FG002|NOT COMPLETED|Overall Study||18
3338354|NCT03384953|4069521|FG000|STARTED|Overall Study||91
3338355|NCT03384953|4069522|FG001|STARTED|Overall Study||12
3338356|NCT03384953|4069521|FG000|Completed Treatment|Overall Study||68
3338357|NCT03384953|4069522|FG001|Completed Treatment|Overall Study||6
3338358|NCT03384953|4069521|FG000|COMPLETED|Overall Study||51
3338359|NCT03384953|4069522|FG001|COMPLETED|Overall Study||4
3338360|NCT03384953|4069521|FG000|NOT COMPLETED|Overall Study||40
3338361|NCT03384953|4069522|FG001|NOT COMPLETED|Overall Study||8
3338362|NCT03384966|4069531|FG000|STARTED|Randomized at End of Screening Period||115
3338363|NCT03384966|4069532|FG001|STARTED|Randomized at End of Screening Period||115
3338364|NCT03384966|4069533|FG002|STARTED|Randomized at End of Screening Period||116
3338365|NCT03384966|4069531|FG000|COMPLETED|Randomized at End of Screening Period||114
3338366|NCT03384966|4069532|FG001|COMPLETED|Randomized at End of Screening Period||115
3338367|NCT03384966|4069533|FG002|COMPLETED|Randomized at End of Screening Period||116
3338368|NCT03384966|4069531|FG000|NOT COMPLETED|Randomized at End of Screening Period||1
3338369|NCT03384966|4069532|FG001|NOT COMPLETED|Randomized at End of Screening Period||0
3338370|NCT03384966|4069533|FG002|NOT COMPLETED|Randomized at End of Screening Period||0
3338371|NCT03384966|4069531|FG000|STARTED|Treatment Period||114
3338372|NCT03384966|4069532|FG001|STARTED|Treatment Period||115
3338373|NCT03384966|4069533|FG002|STARTED|Treatment Period||116
3338374|NCT03384966|4069531|FG000|Thigh Administration|Treatment Period||57
3338375|NCT03384966|4069532|FG001|Thigh Administration|Treatment Period||57
3338376|NCT03384966|4069533|FG002|Thigh Administration|Treatment Period||58
3338377|NCT03384966|4069531|FG000|Abdomen Administration|Treatment Period||57
3338378|NCT03384966|4069532|FG001|Abdomen Administration|Treatment Period||58
3338379|NCT03384966|4069533|FG002|Abdomen Administration|Treatment Period||58
3338380|NCT03384966|4069531|FG000|Per-protocol Analysis Set|Treatment Period||96
3338381|NCT03384966|4069532|FG001|Per-protocol Analysis Set|Treatment Period||90
3338382|NCT03384966|4069533|FG002|Per-protocol Analysis Set|Treatment Period||93
3338383|NCT03384966|4069531|FG000|Safety Analysis Set|Treatment Period||114
3338384|NCT03384966|4069532|FG001|Safety Analysis Set|Treatment Period||115
3338385|NCT03384966|4069533|FG002|Safety Analysis Set|Treatment Period||116
3338386|NCT03384966|4069531|FG000|Pharmacokinetic Analysis Set|Treatment Period||111
3338387|NCT03384966|4069532|FG001|Pharmacokinetic Analysis Set|Treatment Period||115
3338388|NCT03384966|4069533|FG002|Pharmacokinetic Analysis Set|Treatment Period||0
3338389|NCT03384966|4069531|FG000|COMPLETED|Treatment Period||114
3177051|NCT01968356|3904736|FG000|NOT COMPLETED|Overall Study||0
3177052|NCT01968356|3904737|FG001|NOT COMPLETED|Overall Study||0
3177053|NCT01968356|3904738|FG002|NOT COMPLETED|Overall Study||0
3338390|NCT03384966|4069532|FG001|COMPLETED|Treatment Period||115
3338391|NCT03384966|4069533|FG002|COMPLETED|Treatment Period||116
3338392|NCT03384966|4069531|FG000|NOT COMPLETED|Treatment Period||0
3338393|NCT03384966|4069532|FG001|NOT COMPLETED|Treatment Period||0
3338394|NCT03384966|4069533|FG002|NOT COMPLETED|Treatment Period||0
3338395|NCT03384966|4069531|FG000|STARTED|Follow-up Period||114
3338396|NCT03384966|4069532|FG001|STARTED|Follow-up Period||115
3338397|NCT03384966|4069533|FG002|STARTED|Follow-up Period||116
3338398|NCT03384966|4069531|FG000|COMPLETED|Follow-up Period||113
3338399|NCT03384966|4069532|FG001|COMPLETED|Follow-up Period||115
3338400|NCT03384966|4069533|FG002|COMPLETED|Follow-up Period||116
3338401|NCT03384966|4069531|FG000|NOT COMPLETED|Follow-up Period||1
3338402|NCT03384966|4069532|FG001|NOT COMPLETED|Follow-up Period||0
3338403|NCT03384966|4069533|FG002|NOT COMPLETED|Follow-up Period||0
3338404|NCT03386032|4069553|FG000|STARTED|Overall Study||36
3338405|NCT03386032|4069554|FG001|STARTED|Overall Study||18
3338406|NCT03386032|4069555|FG002|STARTED|Overall Study||11
3338407|NCT03386032|4069553|FG000|COMPLETED|Overall Study||18
3338408|NCT03386032|4069554|FG001|COMPLETED|Overall Study||11
3338409|NCT03386032|4069555|FG002|COMPLETED|Overall Study||11
3338410|NCT03386032|4069553|FG000|NOT COMPLETED|Overall Study||18
3338411|NCT03386032|4069554|FG001|NOT COMPLETED|Overall Study||7
3338412|NCT03386032|4069555|FG002|NOT COMPLETED|Overall Study||0
3338413|NCT03386110|4069565|FG000|STARTED|Overall Study||56
3338414|NCT03386110|4069566|FG001|STARTED|Overall Study||44
3338415|NCT03386110|4069565|FG000|COMPLETED|Overall Study||41
3338416|NCT03386110|4069566|FG001|COMPLETED|Overall Study||38
3338417|NCT03386110|4069565|FG000|NOT COMPLETED|Overall Study||15
3338418|NCT03386110|4069566|FG001|NOT COMPLETED|Overall Study||6
3338419|NCT03386344|4069575|FG000|STARTED|Overall Study||126
3338420|NCT03386344|4069576|FG001|STARTED|Overall Study||125
3338421|NCT03386344|4069577|FG002|STARTED|Overall Study||125
3338422|NCT03386344|4069575|FG000|COMPLETED|Overall Study||9
3338423|NCT03386344|4069576|FG001|COMPLETED|Overall Study||9
3338424|NCT03386344|4069577|FG002|COMPLETED|Overall Study||9
3338425|NCT03386344|4069575|FG000|NOT COMPLETED|Overall Study||117
3177054|NCT01968356|3904739|FG003|NOT COMPLETED|Overall Study||0
3177055|NCT01968356|3904740|FG004|NOT COMPLETED|Overall Study||0
3177056|NCT01968356|3904741|FG005|NOT COMPLETED|Overall Study||0
3177057|NCT01968356|3904742|FG006|NOT COMPLETED|Overall Study||0
3177058|NCT01968356|3904743|FG007|NOT COMPLETED|Overall Study||0
3177059|NCT01968382|3904772|FG000|STARTED|Overall Study||18
3177060|NCT01968382|3904773|FG001|STARTED|Overall Study||19
3177061|NCT01968382|3904774|FG002|STARTED|Overall Study||20
3177062|NCT01968382|3904772|FG000|COMPLETED|Overall Study||18
3177063|NCT01968382|3904773|FG001|COMPLETED|Overall Study||19
3177064|NCT01968382|3904774|FG002|COMPLETED|Overall Study||20
3177065|NCT01968382|3904772|FG000|NOT COMPLETED|Overall Study||0
3338426|NCT03386344|4069576|FG001|NOT COMPLETED|Overall Study||116
3338427|NCT03386344|4069577|FG002|NOT COMPLETED|Overall Study||116
3177066|NCT01968382|3904773|FG001|NOT COMPLETED|Overall Study||0
3177067|NCT01968382|3904774|FG002|NOT COMPLETED|Overall Study||0
3338428|NCT03386435|4069587|FG000|STARTED|Overall Study||80
3338429|NCT03386435|4069588|FG001|STARTED|Overall Study||80
3338430|NCT03386435|4069587|FG000|COMPLETED|Overall Study||75
3338431|NCT03386435|4069588|FG001|COMPLETED|Overall Study||73
3338432|NCT03386435|4069587|FG000|NOT COMPLETED|Overall Study||5
3338433|NCT03386435|4069588|FG001|NOT COMPLETED|Overall Study||7
3338434|NCT03386448|4069596|FG000|STARTED|Overall Study||6
3338435|NCT03386448|4069597|FG001|STARTED|Overall Study||8
3338436|NCT03386448|4069596|FG000|COMPLETED|Overall Study||6
3338437|NCT03386448|4069597|FG001|COMPLETED|Overall Study||6
3338438|NCT03386448|4069596|FG000|NOT COMPLETED|Overall Study||0
3338439|NCT03386448|4069597|FG001|NOT COMPLETED|Overall Study||2
3338440|NCT03386474|4069605|FG000|STARTED|Overall Study||107
3338441|NCT03386474|4069606|FG001|STARTED|Overall Study||43
3338442|NCT03386474|4069605|FG000|COMPLETED|Overall Study||106
3338443|NCT03386474|4069606|FG001|COMPLETED|Overall Study||42
3338444|NCT03386474|4069605|FG000|NOT COMPLETED|Overall Study||1
3338445|NCT03386474|4069606|FG001|NOT COMPLETED|Overall Study||1
3338446|NCT03386994|4069620|FG000|STARTED|Overall Study||204
3338447|NCT03386994|4069620|FG000|COMPLETED|Overall Study||166
3338448|NCT03386994|4069620|FG000|NOT COMPLETED|Overall Study||38
3338449|NCT03387020|4069638|FG000|STARTED|Overall Study||13
3338450|NCT03387020|4069639|FG001|STARTED|Overall Study||3
3338451|NCT03387020|4069640|FG002|STARTED|Overall Study||5
3338452|NCT03387020|4069638|FG000|Received Treatment|Overall Study||12
3338453|NCT03387020|4069639|FG001|Received Treatment|Overall Study||3
3338454|NCT03387020|4069640|FG002|Received Treatment|Overall Study||5
3338455|NCT03387020|4069638|FG000|COMPLETED|Overall Study||11
3338456|NCT03387020|4069639|FG001|COMPLETED|Overall Study||1
3338457|NCT03387020|4069640|FG002|COMPLETED|Overall Study||5
3338458|NCT03387020|4069638|FG000|NOT COMPLETED|Overall Study||2
3338459|NCT03387020|4069639|FG001|NOT COMPLETED|Overall Study||2
3338460|NCT03387020|4069640|FG002|NOT COMPLETED|Overall Study||0
3338461|NCT03387033|4069658|FG000|STARTED|Overall Study||20
3338462|NCT03387033|4069658|FG000|COMPLETED|Overall Study||20
3338463|NCT03387033|4069658|FG000|NOT COMPLETED|Overall Study||0
3338464|NCT03387046|4069664|FG000|STARTED|Overall Study||5
3338465|NCT03387046|4069665|FG001|STARTED|Overall Study||2
3338466|NCT03387046|4069664|FG000|COMPLETED|Overall Study||4
3338467|NCT03387046|4069665|FG001|COMPLETED|Overall Study||1
3338468|NCT03387046|4069664|FG000|NOT COMPLETED|Overall Study||1
3338469|NCT03387046|4069665|FG001|NOT COMPLETED|Overall Study||1
3338470|NCT03387267|4069671|FG000|STARTED|Overall Study||452
3338471|NCT03387267|4069671|FG000|COMPLETED|Overall Study||438
3338472|NCT03387267|4069671|FG000|NOT COMPLETED|Overall Study||14
3338473|NCT03387319|4069678|FG000|STARTED|Overall Study||25
3338474|NCT03387319|4069679|FG001|STARTED|Overall Study||25
3338475|NCT03387319|4069678|FG000|COMPLETED|Overall Study||25
3338476|NCT03387319|4069679|FG001|COMPLETED|Overall Study||25
3338477|NCT03387319|4069678|FG000|NOT COMPLETED|Overall Study||0
3338478|NCT03387319|4069679|FG001|NOT COMPLETED|Overall Study||0
3338479|NCT03387462|4069685|FG000|STARTED|Overall Study||20
3338480|NCT03387462|4069685|FG000|4 Weeks|Overall Study||20
3338481|NCT03387462|4069685|FG000|8 Weeks|Overall Study||19
3338482|NCT03387462|4069685|FG000|COMPLETED|Overall Study||19
3338483|NCT03387462|4069685|FG000|NOT COMPLETED|Overall Study||1
3338484|NCT03387683|4069691|FG000|STARTED|Overall Study||27
3338485|NCT03387683|4069692|FG001|STARTED|Overall Study||26
3338486|NCT03387683|4069691|FG000|COMPLETED|Overall Study||25
3338487|NCT03387683|4069692|FG001|COMPLETED|Overall Study||26
3338488|NCT03387683|4069691|FG000|NOT COMPLETED|Overall Study||2
3338489|NCT03387683|4069692|FG001|NOT COMPLETED|Overall Study||0
3338490|NCT03388008|4069700|FG000|STARTED|Overall Study||14
3338491|NCT03388008|4069701|FG001|STARTED|Overall Study||13
3338492|NCT03388008|4069700|FG000|COMPLETED|Overall Study||14
3338493|NCT03388008|4069701|FG001|COMPLETED|Overall Study||13
3338494|NCT03388008|4069700|FG000|NOT COMPLETED|Overall Study||0
3338495|NCT03388008|4069701|FG001|NOT COMPLETED|Overall Study||0
3338496|NCT03388164|4069709|FG000|STARTED|Overall Study||10
3338497|NCT03388164|4069710|FG001|STARTED|Overall Study||10
3338498|NCT03388164|4069709|FG000|COMPLETED|Overall Study||7
3338499|NCT03388164|4069710|FG001|COMPLETED|Overall Study||9
3338500|NCT03388164|4069709|FG000|NOT COMPLETED|Overall Study||3
3338501|NCT03388164|4069710|FG001|NOT COMPLETED|Overall Study||1
3338502|NCT03388268|4069718|FG000|STARTED|Overall Study||8
3338503|NCT03388268|4069719|FG001|STARTED|Overall Study||7
3338504|NCT03388268|4069718|FG000|COMPLETED|Overall Study||7
3338505|NCT03388268|4069719|FG001|COMPLETED|Overall Study||4
3338506|NCT03388268|4069718|FG000|NOT COMPLETED|Overall Study||1
3338507|NCT03388268|4069719|FG001|NOT COMPLETED|Overall Study||3
3338508|NCT03388294|4069727|FG000|STARTED|Overall Study||42
3338509|NCT03388294|4069728|FG001|STARTED|Overall Study||30
3338510|NCT03388294|4069727|FG000|Posttest 1|Overall Study||38
3338511|NCT03388294|4069728|FG001|Posttest 1|Overall Study||30
3338512|NCT03388294|4069727|FG000|Posttest 2|Overall Study||38
3338513|NCT03388294|4069728|FG001|Posttest 2|Overall Study||30
3338514|NCT03388294|4069727|FG000|COMPLETED|Overall Study||38
3338515|NCT03388294|4069728|FG001|COMPLETED|Overall Study||30
3338516|NCT03388294|4069727|FG000|NOT COMPLETED|Overall Study||4
3338517|NCT03388294|4069728|FG001|NOT COMPLETED|Overall Study||0
3338518|NCT03388645|4069736|FG000|STARTED|Low Dose RSV A2||4
3338519|NCT03388645|4069737|FG001|STARTED|Low Dose RSV A2||0
3338520|NCT03388645|4069736|FG000|COMPLETED|Low Dose RSV A2||4
3338521|NCT03388645|4069737|FG001|COMPLETED|Low Dose RSV A2||0
3338522|NCT03388645|4069736|FG000|NOT COMPLETED|Low Dose RSV A2||0
3338523|NCT03388645|4069737|FG001|NOT COMPLETED|Low Dose RSV A2||0
3338524|NCT03388645|4069736|FG000|STARTED|High Dose RSV A2||0
3338525|NCT03388645|4069737|FG001|STARTED|High Dose RSV A2||8
3338526|NCT03388645|4069736|FG000|COMPLETED|High Dose RSV A2||0
3338527|NCT03388645|4069737|FG001|COMPLETED|High Dose RSV A2||7
3338528|NCT03388645|4069736|FG000|NOT COMPLETED|High Dose RSV A2||0
3338529|NCT03388645|4069737|FG001|NOT COMPLETED|High Dose RSV A2||1
3338530|NCT03389308|4069743|FG000|STARTED|Overall Study||51
3338531|NCT03389308|4069743|FG000|COMPLETED|Overall Study||39
3338532|NCT03389308|4069743|FG000|NOT COMPLETED|Overall Study||12
3338533|NCT03389555|4069749|FG000|STARTED|Overall Study||103
3338534|NCT03389555|4069750|FG001|STARTED|Overall Study||102
3338535|NCT03389555|4069749|FG000|COMPLETED|Overall Study||101
3338536|NCT03389555|4069750|FG001|COMPLETED|Overall Study||99
3338537|NCT03389555|4069749|FG000|NOT COMPLETED|Overall Study||2
3338538|NCT03389555|4069750|FG001|NOT COMPLETED|Overall Study||3
3338539|NCT03389854|4069760|FG000|STARTED|Overall Study||28
3338540|NCT03389854|4069761|FG001|STARTED|Overall Study||27
3338541|NCT03389854|4069762|FG002|STARTED|Overall Study||28
3338542|NCT03389854|4069763|FG003|STARTED|Overall Study||27
3338543|NCT03389854|4069760|FG000|COMPLETED|Overall Study||27
3338544|NCT03389854|4069761|FG001|COMPLETED|Overall Study||21
3338545|NCT03389854|4069762|FG002|COMPLETED|Overall Study||23
3338546|NCT03389854|4069763|FG003|COMPLETED|Overall Study||19
3338547|NCT03389854|4069760|FG000|NOT COMPLETED|Overall Study||1
3338548|NCT03389854|4069761|FG001|NOT COMPLETED|Overall Study||6
3338549|NCT03389854|4069762|FG002|NOT COMPLETED|Overall Study||5
3338550|NCT03389854|4069763|FG003|NOT COMPLETED|Overall Study||8
3338551|NCT03389893|4069779|FG000|STARTED|Randomized Double Blind Period||46
3338552|NCT03389893|4069780|FG001|STARTED|Randomized Double Blind Period||26
3338553|NCT03389893|4069781|FG002|STARTED|Randomized Double Blind Period||0
3338554|NCT03389893|4069782|FG003|STARTED|Randomized Double Blind Period||0
3338555|NCT03389893|4069779|FG000|COMPLETED|Randomized Double Blind Period||45
3338556|NCT03389893|4069780|FG001|COMPLETED|Randomized Double Blind Period||26
3338557|NCT03389893|4069781|FG002|COMPLETED|Randomized Double Blind Period||0
3177068|NCT01968421|3904784|FG000|STARTED|Overall Study|March 1, 2015 was the date for recruiting patients|99
3177069|NCT01968421|3904785|FG001|STARTED|Overall Study|March 1, 2015 was the date for recruiting controls|97
3338558|NCT03389893|4069782|FG003|COMPLETED|Randomized Double Blind Period||0
3338559|NCT03389893|4069779|FG000|NOT COMPLETED|Randomized Double Blind Period||1
3338560|NCT03389893|4069780|FG001|NOT COMPLETED|Randomized Double Blind Period||0
3338561|NCT03389893|4069781|FG002|NOT COMPLETED|Randomized Double Blind Period||0
3338562|NCT03389893|4069782|FG003|NOT COMPLETED|Randomized Double Blind Period||0
3338563|NCT03389893|4069779|FG000|STARTED|Open Label Extension and Follow-Up||0
3338564|NCT03389893|4069780|FG001|STARTED|Open Label Extension and Follow-Up||0
3338565|NCT03389893|4069781|FG002|STARTED|Open Label Extension and Follow-Up||45
3338566|NCT03389893|4069782|FG003|STARTED|Open Label Extension and Follow-Up||26
3338567|NCT03389893|4069779|FG000|COMPLETED|Open Label Extension and Follow-Up||0
3338568|NCT03389893|4069780|FG001|COMPLETED|Open Label Extension and Follow-Up||0
3338569|NCT03389893|4069781|FG002|COMPLETED|Open Label Extension and Follow-Up||41
3338570|NCT03389893|4069782|FG003|COMPLETED|Open Label Extension and Follow-Up||25
3338571|NCT03389893|4069779|FG000|NOT COMPLETED|Open Label Extension and Follow-Up||0
3338572|NCT03389893|4069780|FG001|NOT COMPLETED|Open Label Extension and Follow-Up||0
3338573|NCT03389893|4069781|FG002|NOT COMPLETED|Open Label Extension and Follow-Up||4
3338574|NCT03389893|4069782|FG003|NOT COMPLETED|Open Label Extension and Follow-Up||1
3338575|NCT03390101|4069791|FG000|STARTED|Weeks 0-12||85
3338576|NCT03390101|4069792|FG001|STARTED|Weeks 0-12||84
3338577|NCT03390101|4069793|FG002|STARTED|Weeks 0-12||44
3338578|NCT03390101|4069791|FG000|COMPLETED|Weeks 0-12||85
3338579|NCT03390101|4069792|FG001|COMPLETED|Weeks 0-12||82
3338580|NCT03390101|4069793|FG002|COMPLETED|Weeks 0-12||43
3338581|NCT03390101|4069791|FG000|NOT COMPLETED|Weeks 0-12||0
3338582|NCT03390101|4069792|FG001|NOT COMPLETED|Weeks 0-12||2
3338583|NCT03390101|4069793|FG002|NOT COMPLETED|Weeks 0-12||1
3338584|NCT03390101|4069791|FG000|STARTED|Weeks 12-54||85
3338585|NCT03390101|4069792|FG001|STARTED|Weeks 12-54||82
3338586|NCT03390101|4069793|FG002|STARTED|Weeks 12-54||43
3338587|NCT03390101|4069791|FG000|COMPLETED|Weeks 12-54||82
3338588|NCT03390101|4069792|FG001|COMPLETED|Weeks 12-54||78
3338589|NCT03390101|4069793|FG002|COMPLETED|Weeks 12-54||41
3338590|NCT03390101|4069791|FG000|NOT COMPLETED|Weeks 12-54||3
3338591|NCT03390101|4069792|FG001|NOT COMPLETED|Weeks 12-54||4
3338592|NCT03390101|4069793|FG002|NOT COMPLETED|Weeks 12-54||2
3338593|NCT03390114|4069803|FG000|STARTED|Overall Study||10
3338594|NCT03390114|4069804|FG001|STARTED|Overall Study||10
3338595|NCT03390114|4069803|FG000|COMPLETED|Overall Study||6
3338596|NCT03390114|4069804|FG001|COMPLETED|Overall Study||8
3338597|NCT03390114|4069803|FG000|NOT COMPLETED|Overall Study||4
3338598|NCT03390114|4069804|FG001|NOT COMPLETED|Overall Study||2
3338599|NCT03390166|4069812|FG000|STARTED|Overall Study||630
3338600|NCT03390166|4069813|FG001|STARTED|Overall Study||315
3338601|NCT03390166|4069812|FG000|COMPLETED|Overall Study||618
3338602|NCT03390166|4069813|FG001|COMPLETED|Overall Study||305
3338603|NCT03390166|4069812|FG000|NOT COMPLETED|Overall Study||12
3338604|NCT03390166|4069813|FG001|NOT COMPLETED|Overall Study||10
3338605|NCT03390257|4069819|FG000|STARTED|Overall Study||14
3338606|NCT03390257|4069819|FG000|COMPLETED|Overall Study||14
3338607|NCT03390257|4069819|FG000|NOT COMPLETED|Overall Study||0
3338608|NCT03390426|4069827|FG000|STARTED|Overall Study||15
3338609|NCT03390426|4069828|FG001|STARTED|Overall Study||16
3338610|NCT03390426|4069827|FG000|COMPLETED|Overall Study||15
3338611|NCT03390426|4069828|FG001|COMPLETED|Overall Study||15
3338612|NCT03390426|4069827|FG000|NOT COMPLETED|Overall Study||0
3338613|NCT03390426|4069828|FG001|NOT COMPLETED|Overall Study||1
3338614|NCT03390842|4069836|FG000|STARTED|Overall Study||114
3338615|NCT03390842|4069837|FG001|STARTED|Overall Study||82
3338616|NCT03390842|4069836|FG000|COMPLETED|Overall Study||111
3338617|NCT03390842|4069837|FG001|COMPLETED|Overall Study||74
3338618|NCT03390842|4069836|FG000|NOT COMPLETED|Overall Study||3
3338619|NCT03390842|4069837|FG001|NOT COMPLETED|Overall Study||8
3338620|NCT03390907|4069843|FG000|STARTED|Overall Study||40
3338621|NCT03390907|4069843|FG000|COMPLETED|Overall Study||40
3338622|NCT03390907|4069843|FG000|NOT COMPLETED|Overall Study||0
3338623|NCT03391115|4069850|FG000|STARTED|Overall Study||20
3338624|NCT03391115|4069851|FG001|STARTED|Overall Study||18
3338625|NCT03391115|4069850|FG000|COMPLETED|Overall Study||20
3338626|NCT03391115|4069851|FG001|COMPLETED|Overall Study|Two Nurse participants in the dyadic patient-nurse enrollment were not successfully recruited.|18
3338627|NCT03391115|4069850|FG000|NOT COMPLETED|Overall Study||0
3338628|NCT03391115|4069851|FG001|NOT COMPLETED|Overall Study||0
3338629|NCT03391765|4069861|FG000|STARTED|Overall Study||51
3338630|NCT03391765|4069862|FG001|STARTED|Overall Study||45
3338631|NCT03391765|4069863|FG002|STARTED|Overall Study||23
3338632|NCT03391765|4069864|FG003|STARTED|Overall Study||23
3338633|NCT03391765|4069861|FG000|COMPLETED|Overall Study||0
3338634|NCT03391765|4069862|FG001|COMPLETED|Overall Study||0
3338635|NCT03391765|4069863|FG002|COMPLETED|Overall Study||0
3338636|NCT03391765|4069864|FG003|COMPLETED|Overall Study||0
3338637|NCT03391765|4069861|FG000|NOT COMPLETED|Overall Study||51
3338638|NCT03391765|4069862|FG001|NOT COMPLETED|Overall Study||45
3338639|NCT03391765|4069863|FG002|NOT COMPLETED|Overall Study||23
3338640|NCT03391765|4069864|FG003|NOT COMPLETED|Overall Study||23
3338641|NCT03391986|4069877|FG000|STARTED|Overall Study||53
3338642|NCT03391986|4069878|FG001|STARTED|Overall Study||50
3338643|NCT03391986|4069879|FG002|STARTED|Overall Study||50
3338644|NCT03391986|4069877|FG000|COMPLETED|Overall Study||53
3338645|NCT03391986|4069878|FG001|COMPLETED|Overall Study||50
3338646|NCT03391986|4069879|FG002|COMPLETED|Overall Study||50
3338647|NCT03391986|4069877|FG000|NOT COMPLETED|Overall Study||0
3338648|NCT03391986|4069878|FG001|NOT COMPLETED|Overall Study||0
3338649|NCT03391986|4069879|FG002|NOT COMPLETED|Overall Study||0
3338650|NCT03392168|4069891|FG000|STARTED|Period 1: Cohort 1||8
3338651|NCT03392168|4069892|FG001|STARTED|Period 1: Cohort 1||0
3338652|NCT03392168|4069893|FG002|STARTED|Period 1: Cohort 1||0
3338653|NCT03392168|4069894|FG003|STARTED|Period 1: Cohort 1||0
3338654|NCT03392168|4069891|FG000|COMPLETED|Period 1: Cohort 1||8
3338655|NCT03392168|4069892|FG001|COMPLETED|Period 1: Cohort 1||0
3338656|NCT03392168|4069893|FG002|COMPLETED|Period 1: Cohort 1||0
3338657|NCT03392168|4069894|FG003|COMPLETED|Period 1: Cohort 1||0
3338658|NCT03392168|4069891|FG000|NOT COMPLETED|Period 1: Cohort 1||0
3338659|NCT03392168|4069892|FG001|NOT COMPLETED|Period 1: Cohort 1||0
3338660|NCT03392168|4069893|FG002|NOT COMPLETED|Period 1: Cohort 1||0
3338661|NCT03392168|4069894|FG003|NOT COMPLETED|Period 1: Cohort 1||0
3338662|NCT03392168|4069891|FG000|STARTED|Period 2: Cohort 2||0
3338663|NCT03392168|4069892|FG001|STARTED|Period 2: Cohort 2|Includes 2 participants from Cohort 1|30
3338664|NCT03392168|4069893|FG002|STARTED|Period 2: Cohort 2|Includes 2 participants from Cohort 1|28
3338665|NCT03392168|4069894|FG003|STARTED|Period 2: Cohort 2|Includes 2 participants from Cohort 1|31
3338666|NCT03392168|4069891|FG000|COMPLETED|Period 2: Cohort 2||0
3338667|NCT03392168|4069892|FG001|COMPLETED|Period 2: Cohort 2||28
3338668|NCT03392168|4069893|FG002|COMPLETED|Period 2: Cohort 2||27
3338669|NCT03392168|4069894|FG003|COMPLETED|Period 2: Cohort 2||30
3338670|NCT03392168|4069891|FG000|NOT COMPLETED|Period 2: Cohort 2||0
3338671|NCT03392168|4069892|FG001|NOT COMPLETED|Period 2: Cohort 2||2
3338672|NCT03392168|4069893|FG002|NOT COMPLETED|Period 2: Cohort 2||1
3338673|NCT03392168|4069894|FG003|NOT COMPLETED|Period 2: Cohort 2||1
3338674|NCT03392194|4069905|FG000|STARTED|Overall Study||16
3338675|NCT03392194|4069906|FG001|STARTED|Overall Study||17
3338676|NCT03392194|4069905|FG000|COMPLETED|Overall Study||14
3338677|NCT03392194|4069906|FG001|COMPLETED|Overall Study||15
3338678|NCT03392194|4069905|FG000|NOT COMPLETED|Overall Study||2
3177070|NCT01968421|3904784|FG000|Starting Trial|Overall Study||99
3177071|NCT01968421|3904785|FG001|Starting Trial|Overall Study||97
3177072|NCT01968421|3904784|FG000|COMPLETED|Overall Study|Nov. 23, 2018 is the date for completing the trial|99
3338679|NCT03392194|4069906|FG001|NOT COMPLETED|Overall Study||2
3338680|NCT03392532|4069912|FG000|STARTED|Period 1, FIrst 30 Minutes of Wear||18
3338681|NCT03392532|4069913|FG001|STARTED|Period 1, FIrst 30 Minutes of Wear||18
3338682|NCT03392532|4069912|FG000|COMPLETED|Period 1, FIrst 30 Minutes of Wear||18
3338683|NCT03392532|4069913|FG001|COMPLETED|Period 1, FIrst 30 Minutes of Wear||18
3338684|NCT03392532|4069912|FG000|NOT COMPLETED|Period 1, FIrst 30 Minutes of Wear||0
3338685|NCT03392532|4069913|FG001|NOT COMPLETED|Period 1, FIrst 30 Minutes of Wear||0
3338686|NCT03392532|4069912|FG000|STARTED|Period 2, Second 30 Minutes of Wear||18
3338687|NCT03392532|4069913|FG001|STARTED|Period 2, Second 30 Minutes of Wear||18
3338688|NCT03392532|4069912|FG000|COMPLETED|Period 2, Second 30 Minutes of Wear||18
3338689|NCT03392532|4069913|FG001|COMPLETED|Period 2, Second 30 Minutes of Wear||18
3338690|NCT03392532|4069912|FG000|NOT COMPLETED|Period 2, Second 30 Minutes of Wear||0
3338691|NCT03392532|4069913|FG001|NOT COMPLETED|Period 2, Second 30 Minutes of Wear||0
3338692|NCT03392935|4069919|FG000|STARTED|Overall Study||37
3338693|NCT03392935|4069919|FG000|COMPLETED|Overall Study||35
3338694|NCT03392935|4069919|FG000|NOT COMPLETED|Overall Study||2
3338695|NCT03392974|4069923|FG000|STARTED|Overall Study||1
3338696|NCT03392974|4069923|FG000|COMPLETED|Overall Study||1
3338697|NCT03392974|4069923|FG000|NOT COMPLETED|Overall Study||0
3338698|NCT03393000|4069928|FG000|STARTED|Overall Study|23 subjects screened|19
3338699|NCT03393000|4069928|FG000|COMPLETED|Overall Study|19 subjects treated|5
3338700|NCT03393000|4069928|FG000|NOT COMPLETED|Overall Study||14
3338701|NCT03393208|4069936|FG000|STARTED|Treatment Period 1 (Day 1-Day 3)||13
3338702|NCT03393208|4069937|FG001|STARTED|Treatment Period 1 (Day 1-Day 3)||13
3338703|NCT03393208|4069938|FG002|STARTED|Treatment Period 1 (Day 1-Day 3)||9
3338704|NCT03393208|4069939|FG003|STARTED|Treatment Period 1 (Day 1-Day 3)||9
3338705|NCT03393208|4069936|FG000|COMPLETED|Treatment Period 1 (Day 1-Day 3)||13
3338706|NCT03393208|4069937|FG001|COMPLETED|Treatment Period 1 (Day 1-Day 3)||13
3338707|NCT03393208|4069938|FG002|COMPLETED|Treatment Period 1 (Day 1-Day 3)||9
3338708|NCT03393208|4069939|FG003|COMPLETED|Treatment Period 1 (Day 1-Day 3)||9
3338709|NCT03393208|4069936|FG000|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||0
3338710|NCT03393208|4069937|FG001|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||0
3338711|NCT03393208|4069938|FG002|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||0
3338712|NCT03393208|4069939|FG003|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||0
3338713|NCT03393208|4069936|FG000|STARTED|Treatment Period 2 (Day 8- Day 10)||13
3338714|NCT03393208|4069937|FG001|STARTED|Treatment Period 2 (Day 8- Day 10)||13
3338715|NCT03393208|4069938|FG002|STARTED|Treatment Period 2 (Day 8- Day 10)||9
3338716|NCT03393208|4069939|FG003|STARTED|Treatment Period 2 (Day 8- Day 10)||9
3338717|NCT03393208|4069936|FG000|COMPLETED|Treatment Period 2 (Day 8- Day 10)||13
3338718|NCT03393208|4069937|FG001|COMPLETED|Treatment Period 2 (Day 8- Day 10)||13
3338719|NCT03393208|4069938|FG002|COMPLETED|Treatment Period 2 (Day 8- Day 10)||9
3338720|NCT03393208|4069939|FG003|COMPLETED|Treatment Period 2 (Day 8- Day 10)||9
3338721|NCT03393208|4069936|FG000|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0
3338722|NCT03393208|4069937|FG001|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0
3338723|NCT03393208|4069938|FG002|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0
3338724|NCT03393208|4069939|FG003|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0
3338725|NCT03393494|4069954|FG000|STARTED|Overall Study||329
3338726|NCT03393494|4069955|FG001|STARTED|Overall Study||331
3338727|NCT03393494|4069956|FG002|STARTED|Overall Study||165
3338728|NCT03393494|4069954|FG000|COMPLETED|Overall Study||261
3338729|NCT03393494|4069955|FG001|COMPLETED|Overall Study||256
3338730|NCT03393494|4069956|FG002|COMPLETED|Overall Study||140
3338731|NCT03393494|4069954|FG000|NOT COMPLETED|Overall Study||68
3338732|NCT03393494|4069955|FG001|NOT COMPLETED|Overall Study||75
3338733|NCT03393494|4069956|FG002|NOT COMPLETED|Overall Study||25
3338734|NCT03393754|4069966|FG000|STARTED|Overall Study||811
3338735|NCT03393754|4069967|FG001|STARTED|Overall Study||796
3338736|NCT03393754|4069966|FG000|COMPLETED|Overall Study||785
3338737|NCT03393754|4069967|FG001|COMPLETED|Overall Study||758
3338738|NCT03393754|4069966|FG000|NOT COMPLETED|Overall Study||26
3338739|NCT03393754|4069967|FG001|NOT COMPLETED|Overall Study||38
3338740|NCT03393806|4069975|FG000|STARTED|Overall Study||9
3338741|NCT03393806|4069976|FG001|STARTED|Overall Study||8
3338742|NCT03393806|4069975|FG000|COMPLETED|Overall Study||8
3338743|NCT03393806|4069976|FG001|COMPLETED|Overall Study||8
3338744|NCT03393806|4069975|FG000|NOT COMPLETED|Overall Study||1
3177073|NCT01968421|3904785|FG001|COMPLETED|Overall Study|Nov. 23, 2018 is the date for completing the trial|97
3177074|NCT01968421|3904784|FG000|NOT COMPLETED|Overall Study||0
3177075|NCT01968421|3904785|FG001|NOT COMPLETED|Overall Study||0
3177076|NCT01968434|3904793|FG000|STARTED|Overall Study||78
3177077|NCT01968434|3904794|FG001|STARTED|Overall Study||72
3177078|NCT01968434|3904793|FG000|COMPLETED|Overall Study||75
3338745|NCT03393806|4069976|FG001|NOT COMPLETED|Overall Study||0
3338746|NCT03394391|4069985|FG000|STARTED|Overall Study||106
3338747|NCT03394391|4069986|FG001|STARTED|Overall Study||106
3338748|NCT03394391|4069985|FG000|COMPLETED|Overall Study||105
3338749|NCT03394391|4069986|FG001|COMPLETED|Overall Study||104
3338750|NCT03394391|4069985|FG000|NOT COMPLETED|Overall Study||1
3338751|NCT03394391|4069986|FG001|NOT COMPLETED|Overall Study||2
3338752|NCT03394508|4069994|FG000|STARTED|Overall Study||13
3338753|NCT03394508|4069995|FG001|STARTED|Overall Study||17
3338754|NCT03394508|4069994|FG000|COMPLETED|Overall Study||12
3338755|NCT03394508|4069995|FG001|COMPLETED|Overall Study||14
3338756|NCT03394508|4069994|FG000|NOT COMPLETED|Overall Study||1
3338757|NCT03394508|4069995|FG001|NOT COMPLETED|Overall Study||3
3338758|NCT03394768|4070005|FG000|STARTED|Overall Study||26
3338759|NCT03394768|4070005|FG000|COMPLETED|Overall Study||26
3177079|NCT01968434|3904794|FG001|COMPLETED|Overall Study||66
3338760|NCT03394768|4070005|FG000|NOT COMPLETED|Overall Study||0
3338761|NCT03394885|4070009|FG000|STARTED|Overall Study||18
3338762|NCT03394885|4070009|FG000|COMPLETED|Overall Study||3
3338763|NCT03394885|4070009|FG000|NOT COMPLETED|Overall Study||15
3338764|NCT03394924|4070016|FG000|STARTED|Overall Study||31
3338765|NCT03394924|4070017|FG001|STARTED|Overall Study||28
3338766|NCT03394924|4070018|FG002|STARTED|Overall Study||9
3338767|NCT03394924|4070016|FG000|COMPLETED|Overall Study||28
3338768|NCT03394924|4070017|FG001|COMPLETED|Overall Study||22
3338769|NCT03394924|4070018|FG002|COMPLETED|Overall Study||9
3338770|NCT03394924|4070016|FG000|NOT COMPLETED|Overall Study||3
3338771|NCT03394924|4070017|FG001|NOT COMPLETED|Overall Study||6
3338772|NCT03394924|4070018|FG002|NOT COMPLETED|Overall Study||0
3338773|NCT03395353|4070028|FG000|STARTED|Overall Study||151
3338774|NCT03395353|4070028|FG000|Received At Least 1 Dose of Study Drug|Overall Study||150
3338775|NCT03395353|4070028|FG000|COMPLETED|Overall Study||64
3338776|NCT03395353|4070028|FG000|NOT COMPLETED|Overall Study||87
3338777|NCT03395808|4070036|FG000|STARTED|Overall Study||251
3338778|NCT03395808|4070036|FG000|COMPLETED|Overall Study||251
3338779|NCT03395808|4070036|FG000|NOT COMPLETED|Overall Study||0
3338780|NCT03395886|4070042|FG000|STARTED|Overall Study||52
3338781|NCT03395886|4070043|FG001|STARTED|Overall Study||38
3338782|NCT03395886|4070042|FG000|COMPLETED|Overall Study||0
3338783|NCT03395886|4070043|FG001|COMPLETED|Overall Study||0
3338784|NCT03395886|4070042|FG000|NOT COMPLETED|Overall Study||52
3338785|NCT03395886|4070043|FG001|NOT COMPLETED|Overall Study||38
3338786|NCT03395990|4070051|FG000|STARTED|Overall Study||8
3338787|NCT03395990|4070052|FG001|STARTED|Overall Study||8
3338788|NCT03395990|4070051|FG000|COMPLETED|Overall Study||8
3338789|NCT03395990|4070052|FG001|COMPLETED|Overall Study||8
3338790|NCT03395990|4070051|FG000|NOT COMPLETED|Overall Study||0
3338791|NCT03395990|4070052|FG001|NOT COMPLETED|Overall Study||0
3338792|NCT03396432|4070060|FG000|STARTED|Overall Study||283
3338793|NCT03396432|4070061|FG001|STARTED|Overall Study||283
3338794|NCT03396432|4070060|FG000|COMPLETED|Overall Study||274
3338795|NCT03396432|4070061|FG001|COMPLETED|Overall Study||277
3177080|NCT01968434|3904793|FG000|NOT COMPLETED|Overall Study||3
3338796|NCT03396432|4070060|FG000|NOT COMPLETED|Overall Study||9
3338797|NCT03396432|4070061|FG001|NOT COMPLETED|Overall Study||6
3338798|NCT03396835|4070069|FG000|STARTED|Overall Study||16
3338799|NCT03396835|4070069|FG000|COMPLETED|Overall Study||14
3338800|NCT03396835|4070069|FG000|NOT COMPLETED|Overall Study||2
3338801|NCT03396913|4070075|FG000|STARTED|Overall Study||43
3338802|NCT03396913|4070076|FG001|STARTED|Overall Study||45
3338803|NCT03396913|4070075|FG000|COMPLETED|Overall Study||43
3338804|NCT03396913|4070076|FG001|COMPLETED|Overall Study||39
3338805|NCT03396913|4070075|FG000|NOT COMPLETED|Overall Study||0
3338806|NCT03396913|4070076|FG001|NOT COMPLETED|Overall Study||6
3338807|NCT03396952|4070082|FG000|STARTED|Overall Study||27
3338808|NCT03396952|4070082|FG000|COMPLETED|Overall Study||27
3338809|NCT03396952|4070082|FG000|NOT COMPLETED|Overall Study||0
3338810|NCT03397121|4070088|FG000|STARTED|Overall Study||242
3338811|NCT03397121|4070089|FG001|STARTED|Overall Study||240
3338812|NCT03397121|4070088|FG000|COMPLETED|Overall Study||235
3338813|NCT03397121|4070089|FG001|COMPLETED|Overall Study||231
3338814|NCT03397121|4070088|FG000|NOT COMPLETED|Overall Study||7
3338815|NCT03397121|4070089|FG001|NOT COMPLETED|Overall Study||9
3338816|NCT03397394|4070099|FG000|STARTED|Overall Study||47
3338817|NCT03397394|4070100|FG001|STARTED|Overall Study||30
3338818|NCT03397394|4070101|FG002|STARTED|Overall Study||20
3338819|NCT03397394|4070099|FG000|COMPLETED|Overall Study||47
3338820|NCT03397394|4070100|FG001|COMPLETED|Overall Study||30
3338821|NCT03397394|4070101|FG002|COMPLETED|Overall Study||20
3338822|NCT03397394|4070099|FG000|NOT COMPLETED|Overall Study||0
3338823|NCT03397394|4070100|FG001|NOT COMPLETED|Overall Study||0
3338824|NCT03397394|4070101|FG002|NOT COMPLETED|Overall Study||0
3338825|NCT03397771|4070113|FG000|STARTED|Overall Study||53
3338826|NCT03397771|4070114|FG001|STARTED|Overall Study||29
3338827|NCT03397771|4070113|FG000|COMPLETED|Overall Study||45
3338828|NCT03397771|4070114|FG001|COMPLETED|Overall Study||22
3338829|NCT03397771|4070113|FG000|NOT COMPLETED|Overall Study||8
3338830|NCT03397771|4070114|FG001|NOT COMPLETED|Overall Study||7
3338831|NCT03398213|4070123|FG000|STARTED|Overall Study||26
3338832|NCT03398213|4070124|FG001|STARTED|Overall Study||24
3338833|NCT03398213|4070125|FG002|STARTED|Overall Study||22
3338834|NCT03398213|4070123|FG000|COMPLETED|Overall Study||26
3338835|NCT03398213|4070124|FG001|COMPLETED|Overall Study||24
3338836|NCT03398213|4070125|FG002|COMPLETED|Overall Study||22
3338837|NCT03398213|4070123|FG000|NOT COMPLETED|Overall Study||0
3338838|NCT03398213|4070124|FG001|NOT COMPLETED|Overall Study||0
3338839|NCT03398213|4070125|FG002|NOT COMPLETED|Overall Study||0
3338840|NCT03398265|4070135|FG000|STARTED|Overall Study||7
3338841|NCT03398265|4070136|FG001|STARTED|Overall Study||8
3177081|NCT01968434|3904794|FG001|NOT COMPLETED|Overall Study||6
3177082|NCT01968447|3904802|FG000|STARTED|Overall Study||20
3177083|NCT01968447|3904803|FG001|STARTED|Overall Study||20
3338842|NCT03398265|4070135|FG000|COMPLETED|Overall Study||7
3338843|NCT03398265|4070136|FG001|COMPLETED|Overall Study||8
3338844|NCT03398265|4070135|FG000|NOT COMPLETED|Overall Study||0
3338845|NCT03398265|4070136|FG001|NOT COMPLETED|Overall Study||0
3338846|NCT03398278|4070145|FG000|STARTED|Period 1||19
3338847|NCT03398278|4070146|FG001|STARTED|Period 1||19
3338848|NCT03398278|4070145|FG000|COMPLETED|Period 1||18
3338849|NCT03398278|4070146|FG001|COMPLETED|Period 1||19
3338850|NCT03398278|4070145|FG000|NOT COMPLETED|Period 1||1
3338851|NCT03398278|4070146|FG001|NOT COMPLETED|Period 1||0
3338852|NCT03398278|4070145|FG000|STARTED|Period 2||18
3338853|NCT03398278|4070146|FG001|STARTED|Period 2||19
3338854|NCT03398278|4070145|FG000|COMPLETED|Period 2||16
3338855|NCT03398278|4070146|FG001|COMPLETED|Period 2||17
3338856|NCT03398278|4070145|FG000|NOT COMPLETED|Period 2||2
3338857|NCT03398278|4070146|FG001|NOT COMPLETED|Period 2||2
3338858|NCT03398330|4070168|FG000|STARTED|Period 1||21
3338859|NCT03398330|4070169|FG001|STARTED|Period 1||21
3338860|NCT03398330|4070168|FG000|COMPLETED|Period 1||20
3338861|NCT03398330|4070169|FG001|COMPLETED|Period 1||17
3338862|NCT03398330|4070168|FG000|NOT COMPLETED|Period 1||1
3338863|NCT03398330|4070169|FG001|NOT COMPLETED|Period 1||4
3338864|NCT03398330|4070168|FG000|STARTED|Period 2||20
3338865|NCT03398330|4070169|FG001|STARTED|Period 2||17
3338866|NCT03398330|4070168|FG000|COMPLETED|Period 2||19
3338867|NCT03398330|4070169|FG001|COMPLETED|Period 2||17
3338868|NCT03398330|4070168|FG000|NOT COMPLETED|Period 2||1
3177084|NCT01968447|3904802|FG000|COMPLETED|Overall Study||20
3177085|NCT01968447|3904803|FG001|COMPLETED|Overall Study||20
3177086|NCT01968447|3904802|FG000|NOT COMPLETED|Overall Study||0
3177087|NCT01968447|3904803|FG001|NOT COMPLETED|Overall Study||0
3177088|NCT01968551|3904812|FG000|STARTED|Open Label Phase (48 Weeks)||22
3338869|NCT03398330|4070169|FG001|NOT COMPLETED|Period 2||0
3338870|NCT03398356|4070192|FG000|STARTED|Before Treatment||15
3338871|NCT03398356|4070193|FG001|STARTED|Before Treatment||21
3338872|NCT03398356|4070194|FG002|STARTED|Before Treatment||11
3338873|NCT03398356|4070192|FG000|COMPLETED|Before Treatment||12
3338874|NCT03398356|4070193|FG001|COMPLETED|Before Treatment||13
3338875|NCT03398356|4070194|FG002|COMPLETED|Before Treatment|only baseline parameters were taken, this group did not participate in the further part of the study|0
3338876|NCT03398356|4070192|FG000|NOT COMPLETED|Before Treatment||3
3338877|NCT03398356|4070193|FG001|NOT COMPLETED|Before Treatment||8
3338878|NCT03398356|4070194|FG002|NOT COMPLETED|Before Treatment||11
3338879|NCT03398356|4070192|FG000|STARTED|After 6 Weeks of Treatment||12
3338880|NCT03398356|4070193|FG001|STARTED|After 6 Weeks of Treatment||13
3338881|NCT03398356|4070194|FG002|STARTED|After 6 Weeks of Treatment|control group- only initial parameters were assessed to compare, no follow-up|0
3338882|NCT03398356|4070192|FG000|COMPLETED|After 6 Weeks of Treatment||12
3338883|NCT03398356|4070193|FG001|COMPLETED|After 6 Weeks of Treatment||11
3338884|NCT03398356|4070194|FG002|COMPLETED|After 6 Weeks of Treatment|control group- only initial parameters were assessed to compare, no follow-up|0
3338885|NCT03398356|4070192|FG000|NOT COMPLETED|After 6 Weeks of Treatment||0
3338886|NCT03398356|4070193|FG001|NOT COMPLETED|After 6 Weeks of Treatment||2
3338887|NCT03398356|4070194|FG002|NOT COMPLETED|After 6 Weeks of Treatment||0
3338888|NCT03398356|4070192|FG000|STARTED|Post 6 Week Period Initial Evaluation|two of the patients were moved from group B, because of intolerance of the higher dose of the drug|14
3338889|NCT03398356|4070193|FG001|STARTED|Post 6 Week Period Initial Evaluation||11
3338890|NCT03398356|4070194|FG002|STARTED|Post 6 Week Period Initial Evaluation||0
3338891|NCT03398356|4070192|FG000|COMPLETED|Post 6 Week Period Initial Evaluation||14
3338892|NCT03398356|4070193|FG001|COMPLETED|Post 6 Week Period Initial Evaluation||11
3338893|NCT03398356|4070194|FG002|COMPLETED|Post 6 Week Period Initial Evaluation||0
3338894|NCT03398356|4070192|FG000|NOT COMPLETED|Post 6 Week Period Initial Evaluation||0
3338895|NCT03398356|4070193|FG001|NOT COMPLETED|Post 6 Week Period Initial Evaluation||0
3338896|NCT03398356|4070194|FG002|NOT COMPLETED|Post 6 Week Period Initial Evaluation||0
3338897|NCT03398356|4070192|FG000|STARTED|After 12 Weeks of Treatment||14
3338898|NCT03398356|4070193|FG001|STARTED|After 12 Weeks of Treatment||11
3338899|NCT03398356|4070194|FG002|STARTED|After 12 Weeks of Treatment|control group- only initial parameters were assessed to compare, no follow-up|0
3338900|NCT03398356|4070192|FG000|COMPLETED|After 12 Weeks of Treatment||14
3338901|NCT03398356|4070193|FG001|COMPLETED|After 12 Weeks of Treatment||11
3338902|NCT03398356|4070194|FG002|COMPLETED|After 12 Weeks of Treatment|control group- only initial parameters were assessed to compare, no follow-up|0
3338903|NCT03398356|4070192|FG000|NOT COMPLETED|After 12 Weeks of Treatment||0
3338904|NCT03398356|4070193|FG001|NOT COMPLETED|After 12 Weeks of Treatment||0
3338905|NCT03398356|4070194|FG002|NOT COMPLETED|After 12 Weeks of Treatment||0
3338906|NCT03398356|4070192|FG000|STARTED|After 15 Weeks of Treatment||14
3338907|NCT03398356|4070193|FG001|STARTED|After 15 Weeks of Treatment||11
3177089|NCT01968551|3904813|FG001|STARTED|Open Label Phase (48 Weeks)||90
3338908|NCT03398356|4070194|FG002|STARTED|After 15 Weeks of Treatment|control group- only initial parameters were assessed to compare, no follow-up|0
3338909|NCT03398356|4070192|FG000|COMPLETED|After 15 Weeks of Treatment||14
3338910|NCT03398356|4070193|FG001|COMPLETED|After 15 Weeks of Treatment||11
3338911|NCT03398356|4070194|FG002|COMPLETED|After 15 Weeks of Treatment|control group- only initial parameters were assessed to compare, no follow-up|0
3338912|NCT03398356|4070192|FG000|NOT COMPLETED|After 15 Weeks of Treatment||0
3338913|NCT03398356|4070193|FG001|NOT COMPLETED|After 15 Weeks of Treatment||0
3338914|NCT03398356|4070194|FG002|NOT COMPLETED|After 15 Weeks of Treatment||0
3338915|NCT03398421|4070202|FG000|STARTED|Treatment Period 1 (Up to 6 Days)||20
3338916|NCT03398421|4070203|FG001|STARTED|Treatment Period 1 (Up to 6 Days)||0
3338917|NCT03398421|4070202|FG000|COMPLETED|Treatment Period 1 (Up to 6 Days)||20
3338918|NCT03398421|4070203|FG001|COMPLETED|Treatment Period 1 (Up to 6 Days)||0
3338919|NCT03398421|4070202|FG000|NOT COMPLETED|Treatment Period 1 (Up to 6 Days)||0
3338920|NCT03398421|4070203|FG001|NOT COMPLETED|Treatment Period 1 (Up to 6 Days)||0
3338921|NCT03398421|4070202|FG000|STARTED|Washout Period (Up to 14 Days)||20
3338922|NCT03398421|4070203|FG001|STARTED|Washout Period (Up to 14 Days)||0
3338923|NCT03398421|4070202|FG000|COMPLETED|Washout Period (Up to 14 Days)||20
3338924|NCT03398421|4070203|FG001|COMPLETED|Washout Period (Up to 14 Days)||0
3338925|NCT03398421|4070202|FG000|NOT COMPLETED|Washout Period (Up to 14 Days)||0
3338926|NCT03398421|4070203|FG001|NOT COMPLETED|Washout Period (Up to 14 Days)||0
3338927|NCT03398421|4070202|FG000|STARTED|Treatment Period 2 (Up to 11 Days)||0
3338928|NCT03398421|4070203|FG001|STARTED|Treatment Period 2 (Up to 11 Days)||20
3338929|NCT03398421|4070202|FG000|COMPLETED|Treatment Period 2 (Up to 11 Days)||0
3338930|NCT03398421|4070203|FG001|COMPLETED|Treatment Period 2 (Up to 11 Days)||20
3338931|NCT03398421|4070202|FG000|NOT COMPLETED|Treatment Period 2 (Up to 11 Days)||0
3338932|NCT03398421|4070203|FG001|NOT COMPLETED|Treatment Period 2 (Up to 11 Days)||0
3338933|NCT03398798|4070215|FG000|STARTED|Overall Study||9
3338934|NCT03398798|4070216|FG001|STARTED|Overall Study||9
3338935|NCT03398798|4070217|FG002|STARTED|Overall Study||9
3338936|NCT03398798|4070218|FG003|STARTED|Overall Study||9
3338937|NCT03398798|4070215|FG000|COMPLETED|Overall Study||9
3338938|NCT03398798|4070216|FG001|COMPLETED|Overall Study||9
3338939|NCT03398798|4070217|FG002|COMPLETED|Overall Study||9
3338940|NCT03398798|4070218|FG003|COMPLETED|Overall Study||9
3338941|NCT03398798|4070215|FG000|NOT COMPLETED|Overall Study||0
3338942|NCT03398798|4070216|FG001|NOT COMPLETED|Overall Study||0
3177090|NCT01968551|3904814|FG002|STARTED|Open Label Phase (48 Weeks)||46
3177091|NCT01968551|3904812|FG000|COMPLETED|Open Label Phase (48 Weeks)||20
3177092|NCT01968551|3904813|FG001|COMPLETED|Open Label Phase (48 Weeks)||87
3177093|NCT01968551|3904814|FG002|COMPLETED|Open Label Phase (48 Weeks)||41
3338943|NCT03398798|4070217|FG002|NOT COMPLETED|Overall Study||0
3338944|NCT03398798|4070218|FG003|NOT COMPLETED|Overall Study||0
3338945|NCT03398928|4070230|FG000|STARTED|Overall Study||50
3338946|NCT03398928|4070231|FG001|STARTED|Overall Study||31
3338947|NCT03398928|4070230|FG000|COMPLETED|Overall Study||50
3338948|NCT03398928|4070231|FG001|COMPLETED|Overall Study||31
3338949|NCT03398928|4070230|FG000|NOT COMPLETED|Overall Study||0
3338950|NCT03398928|4070231|FG001|NOT COMPLETED|Overall Study||0
3338951|NCT03399370|4070239|FG000|STARTED|Overall Study||781
3338952|NCT03399370|4070240|FG001|STARTED|Overall Study||780
3338953|NCT03399370|4070239|FG000|COMPLETED|Overall Study||721
3338954|NCT03399370|4070240|FG001|COMPLETED|Overall Study||694
3338955|NCT03399370|4070239|FG000|NOT COMPLETED|Overall Study||60
3338956|NCT03399370|4070240|FG001|NOT COMPLETED|Overall Study||86
3338957|NCT03399786|4070249|FG000|STARTED|Double-blind Treatment Period (DBTP)||22
3338958|NCT03399786|4070250|FG001|STARTED|Double-blind Treatment Period (DBTP)||43
3338959|NCT03399786|4070251|FG002|STARTED|Double-blind Treatment Period (DBTP)||0
3338960|NCT03399786|4070252|FG003|STARTED|Double-blind Treatment Period (DBTP)||0
3338961|NCT03399786|4070249|FG000|COMPLETED|Double-blind Treatment Period (DBTP)||21
3338962|NCT03399786|4070250|FG001|COMPLETED|Double-blind Treatment Period (DBTP)||43
3338963|NCT03399786|4070251|FG002|COMPLETED|Double-blind Treatment Period (DBTP)||0
3338964|NCT03399786|4070252|FG003|COMPLETED|Double-blind Treatment Period (DBTP)||0
3338965|NCT03399786|4070249|FG000|NOT COMPLETED|Double-blind Treatment Period (DBTP)||1
3338966|NCT03399786|4070250|FG001|NOT COMPLETED|Double-blind Treatment Period (DBTP)||0
3338967|NCT03399786|4070251|FG002|NOT COMPLETED|Double-blind Treatment Period (DBTP)||0
3338968|NCT03399786|4070252|FG003|NOT COMPLETED|Double-blind Treatment Period (DBTP)||0
3338969|NCT03399786|4070249|FG000|STARTED|Open-label Treatment Period (OLTP)||0
3338970|NCT03399786|4070250|FG001|STARTED|Open-label Treatment Period (OLTP)||0
3338971|NCT03399786|4070251|FG002|STARTED|Open-label Treatment Period (OLTP)|One participant from the placebo group received evinacumab during the DBTP|20
3338972|NCT03399786|4070252|FG003|STARTED|Open-label Treatment Period (OLTP)||44
3338973|NCT03399786|4070249|FG000|COMPLETED|Open-label Treatment Period (OLTP)||0
3338974|NCT03399786|4070250|FG001|COMPLETED|Open-label Treatment Period (OLTP)||0
3338975|NCT03399786|4070251|FG002|COMPLETED|Open-label Treatment Period (OLTP)||19
3338976|NCT03399786|4070252|FG003|COMPLETED|Open-label Treatment Period (OLTP)||43
3338977|NCT03399786|4070249|FG000|NOT COMPLETED|Open-label Treatment Period (OLTP)||0
3338978|NCT03399786|4070250|FG001|NOT COMPLETED|Open-label Treatment Period (OLTP)||0
3338979|NCT03399786|4070251|FG002|NOT COMPLETED|Open-label Treatment Period (OLTP)||1
3338980|NCT03399786|4070252|FG003|NOT COMPLETED|Open-label Treatment Period (OLTP)||1
3338981|NCT03400033|4070262|FG000|STARTED|Overall Study||270
3338982|NCT03400033|4070263|FG001|STARTED|Overall Study||137
3338983|NCT03400033|4070262|FG000|COMPLETED|Overall Study||269
3338984|NCT03400033|4070263|FG001|COMPLETED|Overall Study||135
3338985|NCT03400033|4070262|FG000|NOT COMPLETED|Overall Study||1
3338986|NCT03400033|4070263|FG001|NOT COMPLETED|Overall Study||2
3338987|NCT03400163|4070280|FG000|STARTED|Treatment Period||1
3338988|NCT03400163|4070281|FG001|STARTED|Treatment Period||2
3338989|NCT03400163|4070280|FG000|COMPLETED|Treatment Period||1
3338990|NCT03400163|4070281|FG001|COMPLETED|Treatment Period||2
3338991|NCT03400163|4070280|FG000|NOT COMPLETED|Treatment Period||0
3338992|NCT03400163|4070281|FG001|NOT COMPLETED|Treatment Period||0
3338993|NCT03400163|4070280|FG000|STARTED|Follow-up Period||1
3338994|NCT03400163|4070281|FG001|STARTED|Follow-up Period||2
3338995|NCT03400163|4070280|FG000|COMPLETED|Follow-up Period||1
3338996|NCT03400163|4070281|FG001|COMPLETED|Follow-up Period||2
3338997|NCT03400163|4070280|FG000|NOT COMPLETED|Follow-up Period||0
3338998|NCT03400163|4070281|FG001|NOT COMPLETED|Follow-up Period||0
3338999|NCT03400449|4070289|FG000|STARTED|Overall Study||121
3339000|NCT03400449|4070290|FG001|STARTED|Overall Study||119
3339001|NCT03400449|4070289|FG000|COMPLETED|Overall Study||120
3339002|NCT03400449|4070290|FG001|COMPLETED|Overall Study||119
3339003|NCT03400449|4070289|FG000|NOT COMPLETED|Overall Study||1
3339004|NCT03400449|4070290|FG001|NOT COMPLETED|Overall Study||0
3339005|NCT03400475|4070300|FG000|STARTED|Overall Study||24
3339006|NCT03400475|4070301|FG001|STARTED|Overall Study||22
3339007|NCT03400475|4070300|FG000|COMPLETED|Overall Study||24
3339008|NCT03400475|4070301|FG001|COMPLETED|Overall Study||22
3339009|NCT03400475|4070300|FG000|NOT COMPLETED|Overall Study||0
3339010|NCT03400475|4070301|FG001|NOT COMPLETED|Overall Study||0
3339011|NCT03400579|4070308|FG000|STARTED|Overall Study||10
3339012|NCT03400579|4070308|FG000|COMPLETED|Overall Study||10
3339013|NCT03400579|4070308|FG000|NOT COMPLETED|Overall Study||0
3339014|NCT03400748|4070312|FG000|STARTED|Overall Study||6
3339015|NCT03400748|4070312|FG000|COMPLETED|Overall Study||6
3339016|NCT03400748|4070312|FG000|NOT COMPLETED|Overall Study||0
3339017|NCT03400787|4070318|FG000|STARTED|Overall Study||66
3339018|NCT03400787|4070319|FG001|STARTED|Overall Study||71
3339019|NCT03400787|4070318|FG000|3-Month Follow-up|Overall Study||64
3339020|NCT03400787|4070319|FG001|3-Month Follow-up|Overall Study||63
3339021|NCT03400787|4070318|FG000|COMPLETED|Overall Study||64
3339022|NCT03400787|4070319|FG001|COMPLETED|Overall Study||63
3339023|NCT03400787|4070318|FG000|NOT COMPLETED|Overall Study||2
3339024|NCT03400787|4070319|FG001|NOT COMPLETED|Overall Study||8
3339025|NCT03400800|4070327|FG000|STARTED|Overall Study||810
3339026|NCT03400800|4070328|FG001|STARTED|Overall Study||807
3339027|NCT03400800|4070327|FG000|COMPLETED|Overall Study||772
3339028|NCT03400800|4070328|FG001|COMPLETED|Overall Study||770
3339029|NCT03400800|4070327|FG000|NOT COMPLETED|Overall Study||38
3339030|NCT03400800|4070328|FG001|NOT COMPLETED|Overall Study||37
3339031|NCT03400852|4070336|FG000|STARTED|Blinded Treatment Period||29
3339032|NCT03400852|4070337|FG001|STARTED|Blinded Treatment Period||15
3339033|NCT03400852|4070338|FG002|STARTED|Blinded Treatment Period||0
3339034|NCT03400852|4070336|FG000|COMPLETED|Blinded Treatment Period||20
3339035|NCT03400852|4070337|FG001|COMPLETED|Blinded Treatment Period||9
3339036|NCT03400852|4070338|FG002|COMPLETED|Blinded Treatment Period||0
3339037|NCT03400852|4070336|FG000|NOT COMPLETED|Blinded Treatment Period||9
3339038|NCT03400852|4070337|FG001|NOT COMPLETED|Blinded Treatment Period||6
3339039|NCT03400852|4070338|FG002|NOT COMPLETED|Blinded Treatment Period||0
3339040|NCT03400852|4070336|FG000|STARTED|Open Label Period||0
3339041|NCT03400852|4070337|FG001|STARTED|Open Label Period||0
3339042|NCT03400852|4070338|FG002|STARTED|Open Label Period||24
3339043|NCT03400852|4070336|FG000|COMPLETED|Open Label Period||0
3339044|NCT03400852|4070337|FG001|COMPLETED|Open Label Period||0
3339045|NCT03400852|4070338|FG002|COMPLETED|Open Label Period||2
3339046|NCT03400852|4070336|FG000|NOT COMPLETED|Open Label Period||0
3339047|NCT03400852|4070337|FG001|NOT COMPLETED|Open Label Period||0
3339048|NCT03400852|4070338|FG002|NOT COMPLETED|Open Label Period||22
3339049|NCT03400956|4070349|FG000|STARTED|Treatment Period 1||35
3339050|NCT03400956|4070350|FG001|STARTED|Treatment Period 1||34
3339051|NCT03400956|4070351|FG002|STARTED|Treatment Period 1||34
3339052|NCT03400956|4070349|FG000|Treated|Treatment Period 1||31
3339053|NCT03400956|4070350|FG001|Treated|Treatment Period 1||30
3339054|NCT03400956|4070351|FG002|Treated|Treatment Period 1||30
3339055|NCT03400956|4070349|FG000|COMPLETED|Treatment Period 1||31
3339056|NCT03400956|4070350|FG001|COMPLETED|Treatment Period 1||26
3339057|NCT03400956|4070351|FG002|COMPLETED|Treatment Period 1||25
3339058|NCT03400956|4070349|FG000|NOT COMPLETED|Treatment Period 1||4
3339059|NCT03400956|4070350|FG001|NOT COMPLETED|Treatment Period 1||8
3339060|NCT03400956|4070351|FG002|NOT COMPLETED|Treatment Period 1||9
3339061|NCT03400956|4070349|FG000|STARTED|Post-treatment Period 1||31
3339062|NCT03400956|4070350|FG001|STARTED|Post-treatment Period 1||26
3339063|NCT03400956|4070351|FG002|STARTED|Post-treatment Period 1||25
3339064|NCT03400956|4070349|FG000|COMPLETED|Post-treatment Period 1||9
3339065|NCT03400956|4070350|FG001|COMPLETED|Post-treatment Period 1||10
3339066|NCT03400956|4070351|FG002|COMPLETED|Post-treatment Period 1||9
3339067|NCT03400956|4070349|FG000|NOT COMPLETED|Post-treatment Period 1||22
3339068|NCT03400956|4070350|FG001|NOT COMPLETED|Post-treatment Period 1||16
3339069|NCT03400956|4070351|FG002|NOT COMPLETED|Post-treatment Period 1||16
3339070|NCT03400956|4070349|FG000|STARTED|Treatment Period 2||9
3339071|NCT03400956|4070350|FG001|STARTED|Treatment Period 2||10
3339072|NCT03400956|4070351|FG002|STARTED|Treatment Period 2||9
3339073|NCT03400956|4070349|FG000|COMPLETED|Treatment Period 2||5
3339074|NCT03400956|4070350|FG001|COMPLETED|Treatment Period 2||7
3339075|NCT03400956|4070351|FG002|COMPLETED|Treatment Period 2||5
3339076|NCT03400956|4070349|FG000|NOT COMPLETED|Treatment Period 2||4
3339077|NCT03400956|4070350|FG001|NOT COMPLETED|Treatment Period 2||3
3339078|NCT03400956|4070351|FG002|NOT COMPLETED|Treatment Period 2||4
3339079|NCT03400956|4070349|FG000|STARTED|Follow-up Period||6
3339080|NCT03400956|4070350|FG001|STARTED|Follow-up Period||9
3339081|NCT03400956|4070351|FG002|STARTED|Follow-up Period||7
3339082|NCT03400956|4070349|FG000|COMPLETED|Follow-up Period||6
3339083|NCT03400956|4070350|FG001|COMPLETED|Follow-up Period||9
3339084|NCT03400956|4070351|FG002|COMPLETED|Follow-up Period||5
3339085|NCT03400956|4070349|FG000|NOT COMPLETED|Follow-up Period||0
3339086|NCT03400956|4070350|FG001|NOT COMPLETED|Follow-up Period||0
3339087|NCT03400956|4070351|FG002|NOT COMPLETED|Follow-up Period||2
3339088|NCT03401229|4070364|FG000|STARTED|Overall Study||207
3339089|NCT03401229|4070365|FG001|STARTED|Overall Study||203
3339090|NCT03401229|4070364|FG000|COMPLETED|Overall Study||167
3339091|NCT03401229|4070365|FG001|COMPLETED|Overall Study||166
3339092|NCT03401229|4070364|FG000|NOT COMPLETED|Overall Study||40
3339093|NCT03401229|4070365|FG001|NOT COMPLETED|Overall Study||37
3339094|NCT03401450|4070373|FG000|STARTED|Overall Study||33
3339095|NCT03401450|4070374|FG001|STARTED|Overall Study||36
3339096|NCT03401450|4070373|FG000|COMPLETED|Overall Study||21
3339097|NCT03401450|4070374|FG001|COMPLETED|Overall Study||23
3339098|NCT03401450|4070373|FG000|NOT COMPLETED|Overall Study||12
3339099|NCT03401450|4070374|FG001|NOT COMPLETED|Overall Study||13
3339100|NCT03401671|4070382|FG000|STARTED|Overall Study||16
3339101|NCT03401671|4070383|FG001|STARTED|Overall Study||16
3339102|NCT03401671|4070382|FG000|COMPLETED|Overall Study||16
3339103|NCT03401671|4070383|FG001|COMPLETED|Overall Study||16
3339104|NCT03401671|4070382|FG000|NOT COMPLETED|Overall Study||0
3339105|NCT03401671|4070383|FG001|NOT COMPLETED|Overall Study||0
3339106|NCT03402126|4070389|FG000|STARTED|Overall Study||138
3339107|NCT03402126|4070389|FG000|COMPLETED|Overall Study||76
3339108|NCT03402126|4070389|FG000|NOT COMPLETED|Overall Study||62
3339109|NCT03402243|4070396|FG000|STARTED|Overall Study||16
3339110|NCT03402243|4070397|FG001|STARTED|Overall Study||15
3339111|NCT03402243|4070398|FG002|STARTED|Overall Study||16
3339112|NCT03402243|4070396|FG000|COMPLETED|Overall Study||13
3339113|NCT03402243|4070397|FG001|COMPLETED|Overall Study||12
3339114|NCT03402243|4070398|FG002|COMPLETED|Overall Study||14
3339115|NCT03402243|4070396|FG000|NOT COMPLETED|Overall Study||3
3339116|NCT03402243|4070397|FG001|NOT COMPLETED|Overall Study||3
3339117|NCT03402243|4070398|FG002|NOT COMPLETED|Overall Study||2
3339118|NCT03402386|4070406|FG000|STARTED|Overall Study||42
3339119|NCT03402386|4070406|FG000|Correction Group|Overall Study||2
3339120|NCT03402386|4070406|FG000|Conversion Group|Overall Study||40
3339121|NCT03402386|4070406|FG000|COMPLETED|Overall Study||36
3339122|NCT03402386|4070406|FG000|NOT COMPLETED|Overall Study||6
3339123|NCT03402555|4070410|FG000|STARTED|Overall Study||96
3339124|NCT03402555|4070410|FG000|COMPLETED|Overall Study||91
3339125|NCT03402555|4070410|FG000|NOT COMPLETED|Overall Study||5
3339126|NCT03402659|4070416|FG000|STARTED|Overall Study||83
3339127|NCT03402659|4070417|FG001|STARTED|Overall Study||78
3339128|NCT03402659|4070416|FG000|COMPLETED|Overall Study||78
3339129|NCT03402659|4070417|FG001|COMPLETED|Overall Study||73
3339130|NCT03402659|4070416|FG000|NOT COMPLETED|Overall Study||5
3339131|NCT03402659|4070417|FG001|NOT COMPLETED|Overall Study||5
3339132|NCT03402750|4070425|FG000|STARTED|Overall Study||20
3177094|NCT01968551|3904812|FG000|NOT COMPLETED|Open Label Phase (48 Weeks)||2
3177095|NCT01968551|3904813|FG001|NOT COMPLETED|Open Label Phase (48 Weeks)||3
3339133|NCT03402750|4070426|FG001|STARTED|Overall Study||20
3339134|NCT03402750|4070425|FG000|COMPLETED|Overall Study||18
3339135|NCT03402750|4070426|FG001|COMPLETED|Overall Study||19
3339136|NCT03402750|4070425|FG000|NOT COMPLETED|Overall Study||2
3339137|NCT03402750|4070426|FG001|NOT COMPLETED|Overall Study||1
3339138|NCT03402893|4070432|FG000|STARTED|Overall Study||21
3339139|NCT03402893|4070432|FG000|COMPLETED|Overall Study||20
3339140|NCT03402893|4070432|FG000|NOT COMPLETED|Overall Study||1
3339141|NCT03402932|4070441|FG000|STARTED|Overall Study||13
3339142|NCT03402932|4070442|FG001|STARTED|Overall Study||8
3339143|NCT03402932|4070443|FG002|STARTED|Overall Study||8
3339144|NCT03402932|4070444|FG003|STARTED|Overall Study||8
3339145|NCT03402932|4070441|FG000|COMPLETED|Overall Study||13
3339146|NCT03402932|4070442|FG001|COMPLETED|Overall Study||8
3339147|NCT03402932|4070443|FG002|COMPLETED|Overall Study||8
3339148|NCT03402932|4070444|FG003|COMPLETED|Overall Study||8
3339149|NCT03402932|4070441|FG000|NOT COMPLETED|Overall Study||0
3339150|NCT03402932|4070442|FG001|NOT COMPLETED|Overall Study||0
3339151|NCT03402932|4070443|FG002|NOT COMPLETED|Overall Study||0
3339152|NCT03402932|4070444|FG003|NOT COMPLETED|Overall Study||0
3339153|NCT03403036|4070458|FG000|STARTED|Overall Study||39
3339154|NCT03403036|4070458|FG000|COMPLETED|Overall Study||34
3339155|NCT03403036|4070458|FG000|NOT COMPLETED|Overall Study||5
3339156|NCT03403192|4070466|FG000|STARTED|Overall Study||41
3339157|NCT03403192|4070467|FG001|STARTED|Overall Study||40
3339158|NCT03403192|4070468|FG002|STARTED|Overall Study||40
3339159|NCT03403192|4070469|FG003|STARTED|Overall Study||42
3339160|NCT03403192|4070466|FG000|COMPLETED|Overall Study||37
3339161|NCT03403192|4070467|FG001|COMPLETED|Overall Study||36
3339162|NCT03403192|4070468|FG002|COMPLETED|Overall Study||37
3339163|NCT03403192|4070469|FG003|COMPLETED|Overall Study||36
3339164|NCT03403192|4070466|FG000|NOT COMPLETED|Overall Study||4
3339165|NCT03403192|4070467|FG001|NOT COMPLETED|Overall Study||4
3339166|NCT03403192|4070468|FG002|NOT COMPLETED|Overall Study||3
3339167|NCT03403192|4070469|FG003|NOT COMPLETED|Overall Study||6
3339168|NCT03403231|4070495|FG000|STARTED|Overall Study||9
3339169|NCT03403231|4070496|FG001|STARTED|Overall Study||9
3339170|NCT03403231|4070497|FG002|STARTED|Overall Study||9
3339171|NCT03403231|4070498|FG003|STARTED|Overall Study||9
3339172|NCT03403231|4070499|FG004|STARTED|Overall Study||9
3339173|NCT03403231|4070500|FG005|STARTED|Overall Study||9
3339174|NCT03403231|4070501|FG006|STARTED|Overall Study||9
3339175|NCT03403231|4070502|FG007|STARTED|Overall Study||9
3339176|NCT03403231|4070503|FG008|STARTED|Overall Study||9
3339177|NCT03403231|4070504|FG009|STARTED|Overall Study||9
3339178|NCT03403231|4070505|FG010|STARTED|Overall Study||9
3339179|NCT03403231|4070506|FG011|STARTED|Overall Study||9
3339180|NCT03403231|4070507|FG012|STARTED|Overall Study||9
3339181|NCT03403231|4070508|FG013|STARTED|Overall Study||9
3339182|NCT03403231|4070509|FG014|STARTED|Overall Study||9
3339183|NCT03403231|4070510|FG015|STARTED|Overall Study||9
3339184|NCT03403231|4070495|FG000|COMPLETED|Overall Study||9
3339185|NCT03403231|4070496|FG001|COMPLETED|Overall Study||9
3339186|NCT03403231|4070497|FG002|COMPLETED|Overall Study||9
3339187|NCT03403231|4070498|FG003|COMPLETED|Overall Study||9
3339188|NCT03403231|4070499|FG004|COMPLETED|Overall Study||9
3339189|NCT03403231|4070500|FG005|COMPLETED|Overall Study||9
3339190|NCT03403231|4070501|FG006|COMPLETED|Overall Study||9
3339191|NCT03403231|4070502|FG007|COMPLETED|Overall Study||9
3339192|NCT03403231|4070503|FG008|COMPLETED|Overall Study||9
3339193|NCT03403231|4070504|FG009|COMPLETED|Overall Study||9
3339194|NCT03403231|4070505|FG010|COMPLETED|Overall Study||9
3339195|NCT03403231|4070506|FG011|COMPLETED|Overall Study||9
3339196|NCT03403231|4070507|FG012|COMPLETED|Overall Study||9
3339197|NCT03403231|4070508|FG013|COMPLETED|Overall Study||9
3339198|NCT03403231|4070509|FG014|COMPLETED|Overall Study||9
3339199|NCT03403231|4070510|FG015|COMPLETED|Overall Study||9
3339200|NCT03403231|4070495|FG000|NOT COMPLETED|Overall Study||0
3339201|NCT03403231|4070496|FG001|NOT COMPLETED|Overall Study||0
3339202|NCT03403231|4070497|FG002|NOT COMPLETED|Overall Study||0
3339203|NCT03403231|4070498|FG003|NOT COMPLETED|Overall Study||0
3339204|NCT03403231|4070499|FG004|NOT COMPLETED|Overall Study||0
3339205|NCT03403231|4070500|FG005|NOT COMPLETED|Overall Study||0
3339206|NCT03403231|4070501|FG006|NOT COMPLETED|Overall Study||0
3339207|NCT03403231|4070502|FG007|NOT COMPLETED|Overall Study||0
3339208|NCT03403231|4070503|FG008|NOT COMPLETED|Overall Study||0
3339209|NCT03403231|4070504|FG009|NOT COMPLETED|Overall Study||0
3339210|NCT03403231|4070505|FG010|NOT COMPLETED|Overall Study||0
3339211|NCT03403231|4070506|FG011|NOT COMPLETED|Overall Study||0
3339212|NCT03403231|4070507|FG012|NOT COMPLETED|Overall Study||0
3339213|NCT03403231|4070508|FG013|NOT COMPLETED|Overall Study||0
3339214|NCT03403231|4070509|FG014|NOT COMPLETED|Overall Study||0
3339215|NCT03403231|4070510|FG015|NOT COMPLETED|Overall Study||0
3339216|NCT03403374|4070544|FG000|STARTED|Overall Study||30
3339217|NCT03403374|4070544|FG000|COMPLETED|Overall Study||29
3339218|NCT03403374|4070544|FG000|NOT COMPLETED|Overall Study||1
3339219|NCT03403400|4070551|FG000|STARTED|Overall Study||5
3339220|NCT03403400|4070552|FG001|STARTED|Overall Study||6
3339221|NCT03403400|4070553|FG002|STARTED|Overall Study||6
3339222|NCT03403400|4070551|FG000|COMPLETED|Overall Study||3
3339223|NCT03403400|4070552|FG001|COMPLETED|Overall Study||6
3339224|NCT03403400|4070553|FG002|COMPLETED|Overall Study||4
3339225|NCT03403400|4070551|FG000|NOT COMPLETED|Overall Study||2
3339226|NCT03403400|4070552|FG001|NOT COMPLETED|Overall Study||0
3339227|NCT03403400|4070553|FG002|NOT COMPLETED|Overall Study||2
3339228|NCT03403413|4070576|FG000|STARTED|Overall Study||5
3339229|NCT03403413|4070576|FG000|COMPLETED|Overall Study||3
3339230|NCT03403413|4070576|FG000|NOT COMPLETED|Overall Study||2
3339231|NCT03403426|4070582|FG000|STARTED|Overall Study||85
3339232|NCT03403426|4070582|FG000|COMPLETED|Overall Study||82
3339233|NCT03403426|4070582|FG000|NOT COMPLETED|Overall Study||3
3339234|NCT03403491|4070586|FG000|STARTED|Overall Study||20
3339235|NCT03403491|4070587|FG001|STARTED|Overall Study||23
3339236|NCT03403491|4070586|FG000|COMPLETED|Overall Study||17
3339237|NCT03403491|4070587|FG001|COMPLETED|Overall Study||18
3339238|NCT03403491|4070586|FG000|NOT COMPLETED|Overall Study||3
3339239|NCT03403491|4070587|FG001|NOT COMPLETED|Overall Study||5
3339240|NCT03403504|4070596|FG000|STARTED|Period 1||12
3339241|NCT03403504|4070597|FG001|STARTED|Period 1||12
3339242|NCT03403504|4070596|FG000|COMPLETED|Period 1||12
3339243|NCT03403504|4070597|FG001|COMPLETED|Period 1||11
3339244|NCT03403504|4070596|FG000|NOT COMPLETED|Period 1||0
3339245|NCT03403504|4070597|FG001|NOT COMPLETED|Period 1||1
3339246|NCT03403504|4070596|FG000|STARTED|Period 2||12
3339247|NCT03403504|4070597|FG001|STARTED|Period 2||11
3339248|NCT03403504|4070596|FG000|COMPLETED|Period 2||12
3339249|NCT03403504|4070597|FG001|COMPLETED|Period 2||11
3339250|NCT03403504|4070596|FG000|NOT COMPLETED|Period 2||0
3339251|NCT03403504|4070597|FG001|NOT COMPLETED|Period 2||0
3339252|NCT03403517|4070619|FG000|STARTED|Overall Study||88
3339253|NCT03403517|4070620|FG001|STARTED|Overall Study||86
3339254|NCT03403517|4070619|FG000|COMPLETED|Overall Study||88
3339255|NCT03403517|4070620|FG001|COMPLETED|Overall Study||86
3339256|NCT03403517|4070619|FG000|NOT COMPLETED|Overall Study||0
3339257|NCT03403517|4070620|FG001|NOT COMPLETED|Overall Study||0
3339258|NCT03403712|4070628|FG000|STARTED|Overall Study||200
3339259|NCT03403712|4070629|FG001|STARTED|Overall Study||202
3339260|NCT03403712|4070628|FG000|COMPLETED|Overall Study||95
3339261|NCT03403712|4070629|FG001|COMPLETED|Overall Study||102
3339262|NCT03403712|4070628|FG000|NOT COMPLETED|Overall Study||105
3339263|NCT03403712|4070629|FG001|NOT COMPLETED|Overall Study||100
3137051|NCT01716533|3862297|FG002|COMPLETED|Overall Study||0
3137052|NCT01716533|3862298|FG003|COMPLETED|Overall Study||1
3137053|NCT01716533|3862295|FG000|NOT COMPLETED|Overall Study||0
3137054|NCT01716533|3862296|FG001|NOT COMPLETED|Overall Study||0
3137055|NCT01716533|3862297|FG002|NOT COMPLETED|Overall Study||5
3137056|NCT01716533|3862298|FG003|NOT COMPLETED|Overall Study||8
3339264|NCT03403725|4070646|FG000|STARTED|Overall Study||1
3339265|NCT03403725|4070647|FG001|STARTED|Overall Study||1
3339266|NCT03403725|4070648|FG002|STARTED|Overall Study||1
3339267|NCT03403725|4070649|FG003|STARTED|Overall Study||1
3339268|NCT03403725|4070650|FG004|STARTED|Overall Study||1
3339269|NCT03403725|4070651|FG005|STARTED|Overall Study||6
3339270|NCT03403725|4070652|FG006|STARTED|Overall Study||6
3339271|NCT03403725|4070653|FG007|STARTED|Overall Study||3
3339272|NCT03403725|4070654|FG008|STARTED|Overall Study||3
3339273|NCT03403725|4070655|FG009|STARTED|Overall Study||4
3339274|NCT03403725|4070656|FG010|STARTED|Overall Study||1
3339275|NCT03403725|4070646|FG000|COMPLETED|Overall Study||1
3339276|NCT03403725|4070647|FG001|COMPLETED|Overall Study||1
3339277|NCT03403725|4070648|FG002|COMPLETED|Overall Study||1
3339278|NCT03403725|4070649|FG003|COMPLETED|Overall Study||1
3339279|NCT03403725|4070650|FG004|COMPLETED|Overall Study||1
3339280|NCT03403725|4070651|FG005|COMPLETED|Overall Study||6
3339281|NCT03403725|4070652|FG006|COMPLETED|Overall Study||6
3339282|NCT03403725|4070653|FG007|COMPLETED|Overall Study||3
3339283|NCT03403725|4070654|FG008|COMPLETED|Overall Study||3
3339284|NCT03403725|4070655|FG009|COMPLETED|Overall Study||4
3339285|NCT03403725|4070656|FG010|COMPLETED|Overall Study||1
3339286|NCT03403725|4070646|FG000|NOT COMPLETED|Overall Study||0
3339287|NCT03403725|4070647|FG001|NOT COMPLETED|Overall Study||0
3339288|NCT03403725|4070648|FG002|NOT COMPLETED|Overall Study||0
3339289|NCT03403725|4070649|FG003|NOT COMPLETED|Overall Study||0
3339290|NCT03403725|4070650|FG004|NOT COMPLETED|Overall Study||0
3339291|NCT03403725|4070651|FG005|NOT COMPLETED|Overall Study||0
3339292|NCT03403725|4070652|FG006|NOT COMPLETED|Overall Study||0
3339293|NCT03403725|4070653|FG007|NOT COMPLETED|Overall Study||0
3339294|NCT03403725|4070654|FG008|NOT COMPLETED|Overall Study||0
3339295|NCT03403725|4070655|FG009|NOT COMPLETED|Overall Study||0
3339296|NCT03403725|4070656|FG010|NOT COMPLETED|Overall Study||0
3339297|NCT03403751|4070684|FG000|STARTED|Overall Study||28
3339298|NCT03403751|4070685|FG001|STARTED|Overall Study||30
3339299|NCT03403751|4070684|FG000|COMPLETED|Overall Study||21
3339300|NCT03403751|4070685|FG001|COMPLETED|Overall Study||22
3339301|NCT03403751|4070684|FG000|NOT COMPLETED|Overall Study||7
3339302|NCT03403751|4070685|FG001|NOT COMPLETED|Overall Study||8
3339303|NCT03404167|4070693|FG000|STARTED|Overall Study||8
3339304|NCT03404167|4070693|FG000|COMPLETED|Overall Study||8
3339305|NCT03404167|4070693|FG000|NOT COMPLETED|Overall Study||0
3339306|NCT03404206|4070702|FG000|STARTED|Overall Study||166
3339307|NCT03404206|4070703|FG001|STARTED|Overall Study||166
3339308|NCT03404206|4070704|FG002|STARTED|Overall Study||55
3339309|NCT03404206|4070702|FG000|COMPLETED|Overall Study||162
3339310|NCT03404206|4070703|FG001|COMPLETED|Overall Study||164
3339311|NCT03404206|4070704|FG002|COMPLETED|Overall Study||55
3339312|NCT03404206|4070702|FG000|NOT COMPLETED|Overall Study||4
3339313|NCT03404206|4070703|FG001|NOT COMPLETED|Overall Study||2
3339314|NCT03404206|4070704|FG002|NOT COMPLETED|Overall Study||0
3339315|NCT03404219|4070712|FG000|STARTED|Overall Study||31
3339316|NCT03404219|4070712|FG000|COMPLETED|Overall Study||31
3339317|NCT03404219|4070712|FG000|NOT COMPLETED|Overall Study||0
3339318|NCT03404375|4070719|FG000|STARTED|Overall Study||70
3339319|NCT03404375|4070720|FG001|STARTED|Overall Study||172
3339320|NCT03404375|4070719|FG000|COMPLETED|Overall Study||70
3339321|NCT03404375|4070720|FG001|COMPLETED|Overall Study||172
3339322|NCT03404375|4070719|FG000|NOT COMPLETED|Overall Study||0
3339323|NCT03404375|4070720|FG001|NOT COMPLETED|Overall Study||0
3339324|NCT03404401|4070728|FG000|STARTED|Overall Study||281
3339325|NCT03404401|4070729|FG001|STARTED|Overall Study||271
3339326|NCT03404401|4070728|FG000|COMPLETED|Overall Study||263
3339327|NCT03404401|4070729|FG001|COMPLETED|Overall Study||252
3339328|NCT03404401|4070728|FG000|NOT COMPLETED|Overall Study||18
3339329|NCT03404401|4070729|FG001|NOT COMPLETED|Overall Study||19
3339330|NCT03404609|4070735|FG000|STARTED|Overall Study||7
3339331|NCT03404609|4070735|FG000|COMPLETED|Overall Study||7
3339332|NCT03404609|4070735|FG000|NOT COMPLETED|Overall Study||0
3339333|NCT03404648|4070739|FG000|STARTED|Overall Study||19
3339334|NCT03404648|4070739|FG000|COMPLETED|Overall Study||19
3339335|NCT03404648|4070739|FG000|NOT COMPLETED|Overall Study||0
3137057|NCT01716559|3862312|FG000|STARTED|Overall Study||160
3137058|NCT01716559|3862312|FG000|COMPLETED|Overall Study||49
3339336|NCT03404674|4070749|FG000|STARTED|Overall Study||5
3339337|NCT03404674|4070750|FG001|STARTED|Overall Study||5
3339338|NCT03404674|4070751|FG002|STARTED|Overall Study||10
3339339|NCT03404674|4070752|FG003|STARTED|Overall Study||10
3339340|NCT03404674|4070753|FG004|STARTED|Overall Study||10
3339341|NCT03404674|4070754|FG005|STARTED|Overall Study||10
3339342|NCT03404674|4070749|FG000|Received Dose 2|Overall Study||5
3339343|NCT03404674|4070750|FG001|Received Dose 2|Overall Study||4
3339344|NCT03404674|4070751|FG002|Received Dose 2|Overall Study||10
3339345|NCT03404674|4070752|FG003|Received Dose 2|Overall Study||9
3339346|NCT03404674|4070753|FG004|Received Dose 2|Overall Study||10
3339347|NCT03404674|4070754|FG005|Received Dose 2|Overall Study||10
3339348|NCT03404674|4070749|FG000|Received Dose 3|Overall Study||5
3339349|NCT03404674|4070750|FG001|Received Dose 3|Overall Study||4
3339350|NCT03404674|4070751|FG002|Received Dose 3|Overall Study||9
3339351|NCT03404674|4070752|FG003|Received Dose 3|Overall Study||9
3339352|NCT03404674|4070753|FG004|Received Dose 3|Overall Study||10
3339353|NCT03404674|4070754|FG005|Received Dose 3|Overall Study||9
3339354|NCT03404674|4070749|FG000|COMPLETED|Overall Study||5
3339355|NCT03404674|4070750|FG001|COMPLETED|Overall Study||4
3339356|NCT03404674|4070751|FG002|COMPLETED|Overall Study||8
3339357|NCT03404674|4070752|FG003|COMPLETED|Overall Study||9
3339358|NCT03404674|4070753|FG004|COMPLETED|Overall Study||10
3339359|NCT03404674|4070754|FG005|COMPLETED|Overall Study||9
3339360|NCT03404674|4070749|FG000|NOT COMPLETED|Overall Study||0
3339361|NCT03404674|4070750|FG001|NOT COMPLETED|Overall Study||1
3339362|NCT03404674|4070751|FG002|NOT COMPLETED|Overall Study||2
3339363|NCT03404674|4070752|FG003|NOT COMPLETED|Overall Study||1
3339364|NCT03404674|4070753|FG004|NOT COMPLETED|Overall Study||0
3339365|NCT03404674|4070754|FG005|NOT COMPLETED|Overall Study||1
3339366|NCT03404843|4070771|FG000|STARTED|Overall Study||17
3339367|NCT03404843|4070772|FG001|STARTED|Overall Study||14
3339368|NCT03404843|4070771|FG000|COMPLETED|Overall Study||13
3339369|NCT03404843|4070772|FG001|COMPLETED|Overall Study||13
3339370|NCT03404843|4070771|FG000|NOT COMPLETED|Overall Study||4
3339371|NCT03404843|4070772|FG001|NOT COMPLETED|Overall Study||1
3339372|NCT03405259|4070784|FG000|STARTED|Overall Study||11
3339373|NCT03405259|4070785|FG001|STARTED|Overall Study||11
3339374|NCT03405259|4070784|FG000|COMPLETED|Overall Study||11
3339375|NCT03405259|4070785|FG001|COMPLETED|Overall Study||11
3339376|NCT03405259|4070784|FG000|NOT COMPLETED|Overall Study||0
3339377|NCT03405259|4070785|FG001|NOT COMPLETED|Overall Study||0
3177096|NCT01968551|3904814|FG002|NOT COMPLETED|Open Label Phase (48 Weeks)||5
3177097|NCT01968551|3904812|FG000|STARTED|Extension Phase||20
3177098|NCT01968551|3904813|FG001|STARTED|Extension Phase||87
3339378|NCT03405363|4070793|FG000|STARTED|Overall Study||14239
3339379|NCT03405363|4070794|FG001|STARTED|Overall Study||51167
3339380|NCT03405363|4070793|FG000|COMPLETED|Overall Study||14239
3339381|NCT03405363|4070794|FG001|COMPLETED|Overall Study||51167
3339382|NCT03405363|4070793|FG000|NOT COMPLETED|Overall Study||0
3339383|NCT03405363|4070794|FG001|NOT COMPLETED|Overall Study||0
3339384|NCT03405818|4070800|FG000|STARTED|Overall Study||55
3339385|NCT03405818|4070800|FG000|COMPLETED|Overall Study||47
3339386|NCT03405818|4070800|FG000|NOT COMPLETED|Overall Study||8
3339387|NCT03405935|4070804|FG000|STARTED|Overall Study||86
3339388|NCT03405935|4070804|FG000|COMPLETED|Overall Study||78
3339389|NCT03405935|4070804|FG000|NOT COMPLETED|Overall Study||8
3339390|NCT03406260|4070814|FG000|STARTED|Period 1||6
3339391|NCT03406260|4070815|FG001|STARTED|Period 1||6
3339392|NCT03406260|4070816|FG002|STARTED|Period 1||6
3339393|NCT03406260|4070817|FG003|STARTED|Period 1||6
3339394|NCT03406260|4070818|FG004|STARTED|Period 1||6
3339395|NCT03406260|4070819|FG005|STARTED|Period 1||6
3339396|NCT03406260|4070814|FG000|Received at Least 1 Dose of Study Drug|Period 1||6
3339397|NCT03406260|4070815|FG001|Received at Least 1 Dose of Study Drug|Period 1||6
3339398|NCT03406260|4070816|FG002|Received at Least 1 Dose of Study Drug|Period 1||6
3339399|NCT03406260|4070817|FG003|Received at Least 1 Dose of Study Drug|Period 1||6
3339400|NCT03406260|4070818|FG004|Received at Least 1 Dose of Study Drug|Period 1||6
3339401|NCT03406260|4070819|FG005|Received at Least 1 Dose of Study Drug|Period 1||6
3339402|NCT03406260|4070814|FG000|COMPLETED|Period 1||6
3339403|NCT03406260|4070815|FG001|COMPLETED|Period 1||6
3339404|NCT03406260|4070816|FG002|COMPLETED|Period 1||6
3339405|NCT03406260|4070817|FG003|COMPLETED|Period 1||6
3177099|NCT01968551|3904814|FG002|STARTED|Extension Phase|7 participant completed the Open-Label Phase, but did not enter in the Extension Phase|34
3177100|NCT01968551|3904812|FG000|COMPLETED|Extension Phase||19
3177101|NCT01968551|3904813|FG001|COMPLETED|Extension Phase||86
3177102|NCT01968551|3904814|FG002|COMPLETED|Extension Phase||30
3177103|NCT01968551|3904812|FG000|NOT COMPLETED|Extension Phase||1
3339406|NCT03406260|4070818|FG004|COMPLETED|Period 1||5
3339407|NCT03406260|4070819|FG005|COMPLETED|Period 1||6
3339408|NCT03406260|4070814|FG000|NOT COMPLETED|Period 1||0
3339409|NCT03406260|4070815|FG001|NOT COMPLETED|Period 1||0
3339410|NCT03406260|4070816|FG002|NOT COMPLETED|Period 1||0
3339411|NCT03406260|4070817|FG003|NOT COMPLETED|Period 1||0
3339412|NCT03406260|4070818|FG004|NOT COMPLETED|Period 1||1
3339413|NCT03406260|4070819|FG005|NOT COMPLETED|Period 1||0
3339414|NCT03406260|4070814|FG000|STARTED|Period 2||6
3339415|NCT03406260|4070815|FG001|STARTED|Period 2||6
3339416|NCT03406260|4070816|FG002|STARTED|Period 2||6
3339417|NCT03406260|4070817|FG003|STARTED|Period 2||6
3339418|NCT03406260|4070818|FG004|STARTED|Period 2||5
3339419|NCT03406260|4070819|FG005|STARTED|Period 2||6
3339420|NCT03406260|4070814|FG000|COMPLETED|Period 2||6
3339421|NCT03406260|4070815|FG001|COMPLETED|Period 2||6
3339422|NCT03406260|4070816|FG002|COMPLETED|Period 2||6
3339423|NCT03406260|4070817|FG003|COMPLETED|Period 2||6
3339424|NCT03406260|4070818|FG004|COMPLETED|Period 2||5
3339425|NCT03406260|4070819|FG005|COMPLETED|Period 2||6
3339426|NCT03406260|4070814|FG000|NOT COMPLETED|Period 2||0
3339427|NCT03406260|4070815|FG001|NOT COMPLETED|Period 2||0
3339428|NCT03406260|4070816|FG002|NOT COMPLETED|Period 2||0
3339429|NCT03406260|4070817|FG003|NOT COMPLETED|Period 2||0
3339430|NCT03406260|4070818|FG004|NOT COMPLETED|Period 2||0
3339431|NCT03406260|4070819|FG005|NOT COMPLETED|Period 2||0
3339432|NCT03406260|4070814|FG000|STARTED|Period 3||6
3339433|NCT03406260|4070815|FG001|STARTED|Period 3||6
3339434|NCT03406260|4070816|FG002|STARTED|Period 3||6
3339435|NCT03406260|4070817|FG003|STARTED|Period 3||6
3339436|NCT03406260|4070818|FG004|STARTED|Period 3||5
3339437|NCT03406260|4070819|FG005|STARTED|Period 3||6
3339438|NCT03406260|4070814|FG000|COMPLETED|Period 3||6
3339439|NCT03406260|4070815|FG001|COMPLETED|Period 3||6
3339440|NCT03406260|4070816|FG002|COMPLETED|Period 3||6
3339441|NCT03406260|4070817|FG003|COMPLETED|Period 3||6
3339442|NCT03406260|4070818|FG004|COMPLETED|Period 3||5
3339443|NCT03406260|4070819|FG005|COMPLETED|Period 3||6
3339444|NCT03406260|4070814|FG000|NOT COMPLETED|Period 3||0
3339445|NCT03406260|4070815|FG001|NOT COMPLETED|Period 3||0
3339446|NCT03406260|4070816|FG002|NOT COMPLETED|Period 3||0
3339447|NCT03406260|4070817|FG003|NOT COMPLETED|Period 3||0
3339448|NCT03406260|4070818|FG004|NOT COMPLETED|Period 3||0
3339449|NCT03406260|4070819|FG005|NOT COMPLETED|Period 3||0
3339450|NCT03406325|4070837|FG000|STARTED|Overall Study||12
3339451|NCT03406325|4070838|FG001|STARTED|Overall Study||1
3339452|NCT03406325|4070839|FG002|STARTED|Overall Study||1
3339453|NCT03406325|4070840|FG003|STARTED|Overall Study||1
3339454|NCT03406325|4070841|FG004|STARTED|Overall Study||1
3339455|NCT03406325|4070842|FG005|STARTED|Overall Study||1
3339456|NCT03406325|4070843|FG006|STARTED|Overall Study||1
3339457|NCT03406325|4070844|FG007|STARTED|Overall Study||1
3339458|NCT03406325|4070837|FG000|COMPLETED|Overall Study||12
3339459|NCT03406325|4070838|FG001|COMPLETED|Overall Study||1
3339460|NCT03406325|4070839|FG002|COMPLETED|Overall Study||1
3339461|NCT03406325|4070840|FG003|COMPLETED|Overall Study||1
3339462|NCT03406325|4070841|FG004|COMPLETED|Overall Study||1
3339463|NCT03406325|4070842|FG005|COMPLETED|Overall Study||1
3339464|NCT03406325|4070843|FG006|COMPLETED|Overall Study||1
3339465|NCT03406325|4070844|FG007|COMPLETED|Overall Study||1
3339466|NCT03406325|4070837|FG000|NOT COMPLETED|Overall Study||0
3339467|NCT03406325|4070838|FG001|NOT COMPLETED|Overall Study||0
3339468|NCT03406325|4070839|FG002|NOT COMPLETED|Overall Study||0
3339469|NCT03406325|4070840|FG003|NOT COMPLETED|Overall Study||0
3339470|NCT03406325|4070841|FG004|NOT COMPLETED|Overall Study||0
3339471|NCT03406325|4070842|FG005|NOT COMPLETED|Overall Study||0
3339472|NCT03406325|4070843|FG006|NOT COMPLETED|Overall Study||0
3339473|NCT03406325|4070844|FG007|NOT COMPLETED|Overall Study||0
3339474|NCT03406377|4070878|FG000|STARTED|Overall Study||41
3339475|NCT03406377|4070879|FG001|STARTED|Overall Study||72
3339476|NCT03406377|4070878|FG000|COMPLETED|Overall Study||25
3339477|NCT03406377|4070879|FG001|COMPLETED|Overall Study||51
3339478|NCT03406377|4070878|FG000|NOT COMPLETED|Overall Study||16
3339479|NCT03406377|4070879|FG001|NOT COMPLETED|Overall Study||21
3339480|NCT03406962|4070885|FG000|STARTED|Overall Study||8
3339481|NCT03406962|4070885|FG000|COMPLETED|Overall Study||5
3339482|NCT03406962|4070885|FG000|NOT COMPLETED|Overall Study||3
3339483|NCT03407053|4070892|FG000|STARTED|Overall Study||10
3339484|NCT03407053|4070893|FG001|STARTED|Overall Study||10
3339485|NCT03407053|4070892|FG000|COMPLETED|Overall Study||10
3339486|NCT03407053|4070893|FG001|COMPLETED|Overall Study||10
3339487|NCT03407053|4070892|FG000|NOT COMPLETED|Overall Study||0
3339488|NCT03407053|4070893|FG001|NOT COMPLETED|Overall Study||0
3339489|NCT03407118|4070899|FG000|STARTED|Period 1||14
3339490|NCT03407118|4070900|FG001|STARTED|Period 1||17
3339491|NCT03407118|4070899|FG000|Received at Least 1 Dose of Study Drug|Period 1||14
3339492|NCT03407118|4070900|FG001|Received at Least 1 Dose of Study Drug|Period 1||17
3339493|NCT03407118|4070899|FG000|COMPLETED|Period 1||14
3339494|NCT03407118|4070900|FG001|COMPLETED|Period 1||17
3339495|NCT03407118|4070899|FG000|NOT COMPLETED|Period 1||0
3339496|NCT03407118|4070900|FG001|NOT COMPLETED|Period 1||0
3339497|NCT03407118|4070899|FG000|STARTED|Period 2||14
3339498|NCT03407118|4070900|FG001|STARTED|Period 2||17
3339499|NCT03407118|4070899|FG000|Received at Least 1 Dose of Study Drug|Period 2||13
3339500|NCT03407118|4070900|FG001|Received at Least 1 Dose of Study Drug|Period 2||17
3339501|NCT03407118|4070899|FG000|COMPLETED|Period 2||13
3339502|NCT03407118|4070900|FG001|COMPLETED|Period 2||17
3339503|NCT03407118|4070899|FG000|NOT COMPLETED|Period 2||1
3339504|NCT03407118|4070900|FG001|NOT COMPLETED|Period 2||0
3339505|NCT03407170|4070906|FG000|STARTED|Overall Study||1
3339506|NCT03407170|4070906|FG000|COMPLETED|Overall Study||0
3339507|NCT03407170|4070906|FG000|NOT COMPLETED|Overall Study||1
3339508|NCT03407313|4070910|FG000|STARTED|Overall Study||68
3339509|NCT03407313|4070910|FG000|COMPLETED|Overall Study||66
3339510|NCT03407313|4070910|FG000|NOT COMPLETED|Overall Study||2
3339511|NCT03407430|4070916|FG000|STARTED|First Intervention||5
3339512|NCT03407430|4070917|FG001|STARTED|First Intervention||3
3339513|NCT03407430|4070916|FG000|COMPLETED|First Intervention||5
3339514|NCT03407430|4070917|FG001|COMPLETED|First Intervention||3
3339515|NCT03407430|4070916|FG000|NOT COMPLETED|First Intervention||0
3339516|NCT03407430|4070917|FG001|NOT COMPLETED|First Intervention||0
3339517|NCT03407430|4070916|FG000|STARTED|Washout||5
3339518|NCT03407430|4070917|FG001|STARTED|Washout||3
3339519|NCT03407430|4070916|FG000|COMPLETED|Washout||4
3339520|NCT03407430|4070917|FG001|COMPLETED|Washout||3
3339521|NCT03407430|4070916|FG000|NOT COMPLETED|Washout||1
3339522|NCT03407430|4070917|FG001|NOT COMPLETED|Washout||0
3339523|NCT03407430|4070916|FG000|STARTED|Second Intervention||4
3339524|NCT03407430|4070917|FG001|STARTED|Second Intervention||3
3339525|NCT03407430|4070916|FG000|COMPLETED|Second Intervention||4
3339526|NCT03407430|4070917|FG001|COMPLETED|Second Intervention||3
3339527|NCT03407430|4070916|FG000|NOT COMPLETED|Second Intervention||0
3339528|NCT03407430|4070917|FG001|NOT COMPLETED|Second Intervention||0
3339529|NCT03407482|4070930|FG000|STARTED|Overall Study||160
3339530|NCT03407482|4070930|FG000|COMPLETED|Overall Study||29
3339531|NCT03407482|4070930|FG000|NOT COMPLETED|Overall Study||131
3339532|NCT03407612|4070936|FG000|STARTED|Overall Study||19
3339533|NCT03407612|4070937|FG001|STARTED|Overall Study||23
3339534|NCT03407612|4070936|FG000|COMPLETED|Overall Study||19
3339535|NCT03407612|4070937|FG001|COMPLETED|Overall Study||23
3339536|NCT03407612|4070936|FG000|NOT COMPLETED|Overall Study||0
3339537|NCT03407612|4070937|FG001|NOT COMPLETED|Overall Study||0
3339538|NCT03407625|4070945|FG000|STARTED|Overall Study||1117
3339539|NCT03407625|4070946|FG001|STARTED|Overall Study||1110
3339540|NCT03407625|4070945|FG000|COMPLETED|Overall Study||1117
3339541|NCT03407625|4070946|FG001|COMPLETED|Overall Study||1110
3339542|NCT03407625|4070945|FG000|NOT COMPLETED|Overall Study||0
3339543|NCT03407625|4070946|FG001|NOT COMPLETED|Overall Study||0
3339544|NCT03407651|4070952|FG000|STARTED|Period 1: Part 1a||11
3339545|NCT03407651|4070952|FG000|COMPLETED|Period 1: Part 1a||10
3339546|NCT03407651|4070952|FG000|NOT COMPLETED|Period 1: Part 1a||1
3339547|NCT03407651|4070952|FG000|STARTED|Period 2: Part 1b||9
3339548|NCT03407651|4070952|FG000|COMPLETED|Period 2: Part 1b||9
3339549|NCT03407651|4070952|FG000|NOT COMPLETED|Period 2: Part 1b||0
3339550|NCT03407651|4070952|FG000|STARTED|Period 3: Part 2|The subject who discontinued after 44 daily SC doses in Part 2 elected to participate in Period 3.|11
3339551|NCT03407651|4070952|FG000|COMPLETED|Period 3: Part 2||8
3339552|NCT03407651|4070952|FG000|NOT COMPLETED|Period 3: Part 2||3
3339553|NCT03408171|4070974|FG000|STARTED|Overall Study||20
3339554|NCT03408171|4070975|FG001|STARTED|Overall Study||20
3339555|NCT03408171|4070974|FG000|COMPLETED|Overall Study||20
3339556|NCT03408171|4070975|FG001|COMPLETED|Overall Study||20
3339557|NCT03408171|4070974|FG000|NOT COMPLETED|Overall Study||0
3339558|NCT03408171|4070975|FG001|NOT COMPLETED|Overall Study||0
3339559|NCT03408392|4070981|FG000|STARTED|Treatment Period 1 (16 Days)||14
3339560|NCT03408392|4070982|FG001|STARTED|Treatment Period 1 (16 Days)||14
3339561|NCT03408392|4070981|FG000|COMPLETED|Treatment Period 1 (16 Days)||14
3339562|NCT03408392|4070982|FG001|COMPLETED|Treatment Period 1 (16 Days)||14
3339563|NCT03408392|4070981|FG000|NOT COMPLETED|Treatment Period 1 (16 Days)||0
3339564|NCT03408392|4070982|FG001|NOT COMPLETED|Treatment Period 1 (16 Days)||0
3339565|NCT03408392|4070981|FG000|STARTED|Wash-out Period (14 Days)||14
3339566|NCT03408392|4070982|FG001|STARTED|Wash-out Period (14 Days)||14
3339567|NCT03408392|4070981|FG000|COMPLETED|Wash-out Period (14 Days)||14
3339568|NCT03408392|4070982|FG001|COMPLETED|Wash-out Period (14 Days)||14
3339569|NCT03408392|4070981|FG000|NOT COMPLETED|Wash-out Period (14 Days)||0
3339570|NCT03408392|4070982|FG001|NOT COMPLETED|Wash-out Period (14 Days)||0
3339571|NCT03408392|4070981|FG000|STARTED|Treatment Period 2 (16 Days)||14
3339572|NCT03408392|4070982|FG001|STARTED|Treatment Period 2 (16 Days)||14
3339573|NCT03408392|4070981|FG000|COMPLETED|Treatment Period 2 (16 Days)||14
3339574|NCT03408392|4070982|FG001|COMPLETED|Treatment Period 2 (16 Days)||14
3339575|NCT03408392|4070981|FG000|NOT COMPLETED|Treatment Period 2 (16 Days)||0
3339576|NCT03408392|4070982|FG001|NOT COMPLETED|Treatment Period 2 (16 Days)||0
3339577|NCT03408483|4070990|FG000|STARTED|Overall Study||42
3339578|NCT03408483|4070991|FG001|STARTED|Overall Study||38
3339579|NCT03408483|4070990|FG000|COMPLETED|Overall Study||36
3339580|NCT03408483|4070991|FG001|COMPLETED|Overall Study||35
3339581|NCT03408483|4070990|FG000|NOT COMPLETED|Overall Study||6
3339582|NCT03408483|4070991|FG001|NOT COMPLETED|Overall Study||3
3339583|NCT03408639|4070999|FG000|STARTED|Overall Study||78
3339584|NCT03408639|4071000|FG001|STARTED|Overall Study||78
3339585|NCT03408639|4070999|FG000|COMPLETED|Overall Study||67
3339586|NCT03408639|4071000|FG001|COMPLETED|Overall Study||56
3339587|NCT03408639|4070999|FG000|NOT COMPLETED|Overall Study||11
3339588|NCT03408639|4071000|FG001|NOT COMPLETED|Overall Study||22
3339589|NCT03408730|4071010|FG000|STARTED|Overall Study||712
3339590|NCT03408730|4071011|FG001|STARTED|Overall Study||711
3339591|NCT03408730|4071012|FG002|STARTED|Overall Study||709
3339592|NCT03408730|4071013|FG003|STARTED|Overall Study||706
3339593|NCT03408730|4071010|FG000|COMPLETED|Overall Study||643
3339594|NCT03408730|4071011|FG001|COMPLETED|Overall Study||636
3339595|NCT03408730|4071012|FG002|COMPLETED|Overall Study||637
3339596|NCT03408730|4071013|FG003|COMPLETED|Overall Study||625
3339597|NCT03408730|4071010|FG000|NOT COMPLETED|Overall Study||69
3339598|NCT03408730|4071011|FG001|NOT COMPLETED|Overall Study||75
3339599|NCT03408730|4071012|FG002|NOT COMPLETED|Overall Study||72
3339600|NCT03408730|4071013|FG003|NOT COMPLETED|Overall Study||81
3339601|NCT03408808|4071029|FG000|STARTED|Overall Study||8
3339602|NCT03408808|4071030|FG001|STARTED|Overall Study||9
3339603|NCT03408808|4071029|FG000|COMPLETED|Overall Study||8
3339604|NCT03408808|4071030|FG001|COMPLETED|Overall Study||8
3339605|NCT03408808|4071029|FG000|NOT COMPLETED|Overall Study||0
3339606|NCT03408808|4071030|FG001|NOT COMPLETED|Overall Study||1
3339607|NCT03409107|4071038|FG000|STARTED|Overall Study||307
3339608|NCT03409107|4071039|FG001|STARTED|Overall Study||307
3339609|NCT03409107|4071038|FG000|COMPLETED|Overall Study||290
3339610|NCT03409107|4071039|FG001|COMPLETED|Overall Study||300
3339611|NCT03409107|4071038|FG000|NOT COMPLETED|Overall Study||17
3339612|NCT03409107|4071039|FG001|NOT COMPLETED|Overall Study||7
3339613|NCT03409731|4071045|FG000|STARTED|Overall Study||135
3339614|NCT03409731|4071045|FG000|COMPLETED|Overall Study||132
3339615|NCT03409731|4071045|FG000|NOT COMPLETED|Overall Study||3
3339616|NCT03409796|4071051|FG000|STARTED|Overall Study||9
3339617|NCT03409796|4071052|FG001|STARTED|Overall Study||7
3339618|NCT03409796|4071051|FG000|COMPLETED|Overall Study||7
3339619|NCT03409796|4071052|FG001|COMPLETED|Overall Study||6
3339620|NCT03409796|4071051|FG000|NOT COMPLETED|Overall Study||2
3339621|NCT03409796|4071052|FG001|NOT COMPLETED|Overall Study||1
3339622|NCT03410056|4071062|FG000|STARTED|Overall Study||8
3339623|NCT03410056|4071063|FG001|STARTED|Overall Study||6
3339624|NCT03410056|4071064|FG002|STARTED|Overall Study||11
3339625|NCT03410056|4071065|FG003|STARTED|Overall Study||11
3339626|NCT03410056|4071066|FG004|STARTED|Overall Study||0
3339627|NCT03410056|4071067|FG005|STARTED|Overall Study||0
3339628|NCT03410056|4071068|FG006|STARTED|Overall Study||0
3339629|NCT03410056|4071062|FG000|Received Treatment|Overall Study||8
3339630|NCT03410056|4071063|FG001|Received Treatment|Overall Study||6
3339631|NCT03410056|4071064|FG002|Received Treatment|Overall Study||11
3339632|NCT03410056|4071065|FG003|Received Treatment|Overall Study||11
3339633|NCT03410056|4071066|FG004|Received Treatment|Overall Study||0
3339634|NCT03410056|4071067|FG005|Received Treatment|Overall Study||0
3339635|NCT03410056|4071068|FG006|Received Treatment|Overall Study||0
3339636|NCT03410056|4071062|FG000|COMPLETED|Overall Study||8
3339637|NCT03410056|4071063|FG001|COMPLETED|Overall Study||4
3339638|NCT03410056|4071064|FG002|COMPLETED|Overall Study||3
3339639|NCT03410056|4071065|FG003|COMPLETED|Overall Study||6
3339640|NCT03410056|4071066|FG004|COMPLETED|Overall Study||0
3339641|NCT03410056|4071067|FG005|COMPLETED|Overall Study||0
3339642|NCT03410056|4071068|FG006|COMPLETED|Overall Study||0
3339643|NCT03410056|4071062|FG000|NOT COMPLETED|Overall Study||0
3339644|NCT03410056|4071063|FG001|NOT COMPLETED|Overall Study||2
3339645|NCT03410056|4071064|FG002|NOT COMPLETED|Overall Study||8
3339646|NCT03410056|4071065|FG003|NOT COMPLETED|Overall Study||5
3339647|NCT03410056|4071066|FG004|NOT COMPLETED|Overall Study||0
3339648|NCT03410056|4071067|FG005|NOT COMPLETED|Overall Study||0
3339649|NCT03410056|4071068|FG006|NOT COMPLETED|Overall Study||0
3339650|NCT03410628|4071084|FG000|STARTED|Overall Study||21
3339651|NCT03410628|4071084|FG000|COMPLETED|Overall Study||15
3339652|NCT03410628|4071084|FG000|NOT COMPLETED|Overall Study||6
3339653|NCT03410797|4071088|FG000|STARTED|Overall Study||11
3339654|NCT03410797|4071088|FG000|COMPLETED|Overall Study||11
3339655|NCT03410797|4071088|FG000|NOT COMPLETED|Overall Study||0
3339656|NCT03410862|4071095|FG000|STARTED|Overall Study||43
3339657|NCT03410862|4071096|FG001|STARTED|Overall Study||44
3339658|NCT03410862|4071095|FG000|COMPLETED|Overall Study||41
3339659|NCT03410862|4071096|FG001|COMPLETED|Overall Study||42
3339660|NCT03410862|4071095|FG000|NOT COMPLETED|Overall Study||2
3339661|NCT03410862|4071096|FG001|NOT COMPLETED|Overall Study||2
3339662|NCT03410914|4071102|FG000|STARTED|Overall Study||52
3339663|NCT03410914|4071102|FG000|COMPLETED|Overall Study||52
3339664|NCT03410914|4071102|FG000|NOT COMPLETED|Overall Study||0
3339665|NCT03410953|4071106|FG000|STARTED|Overall Study|First patient recruited|67
3339666|NCT03410953|4071106|FG000|COMPLETED|Overall Study|67 participants were enrolled in the Clinical Trial and included the analyses|67
3339667|NCT03410953|4071106|FG000|NOT COMPLETED|Overall Study||0
3339668|NCT03411902|4071112|FG000|STARTED|Overall Study||11
3339669|NCT03411902|4071113|FG001|STARTED|Overall Study||13
3339670|NCT03411902|4071112|FG000|COMPLETED|Overall Study||8
3339671|NCT03411902|4071113|FG001|COMPLETED|Overall Study||13
3339672|NCT03411902|4071112|FG000|NOT COMPLETED|Overall Study||3
3339673|NCT03411902|4071113|FG001|NOT COMPLETED|Overall Study||0
3339674|NCT03412019|4071121|FG000|STARTED|Overall Study||11
3339675|NCT03412019|4071122|FG001|STARTED|Overall Study||11
3339676|NCT03412019|4071121|FG000|COMPLETED|Overall Study||10
3339677|NCT03412019|4071122|FG001|COMPLETED|Overall Study||10
3339678|NCT03412019|4071121|FG000|NOT COMPLETED|Overall Study||1
3339679|NCT03412019|4071122|FG001|NOT COMPLETED|Overall Study||1
3339680|NCT03412084|4071130|FG000|STARTED|Overall Study||48
3339681|NCT03412084|4071131|FG001|STARTED|Overall Study||36
3339682|NCT03412084|4071130|FG000|COMPLETED|Overall Study||44
3339683|NCT03412084|4071131|FG001|COMPLETED|Overall Study||35
3339684|NCT03412084|4071130|FG000|NOT COMPLETED|Overall Study||4
3339685|NCT03412084|4071131|FG001|NOT COMPLETED|Overall Study||1
3339686|NCT03412734|4071139|FG000|STARTED|Overall Study||47
3339687|NCT03412734|4071140|FG001|STARTED|Overall Study||41
3339688|NCT03412734|4071139|FG000|COMPLETED|Overall Study||44
3339689|NCT03412734|4071140|FG001|COMPLETED|Overall Study||41
3339690|NCT03412734|4071139|FG000|NOT COMPLETED|Overall Study||3
3339691|NCT03412734|4071140|FG001|NOT COMPLETED|Overall Study||0
3339692|NCT03412929|4071146|FG000|STARTED|Overall Study||8
3339693|NCT03412929|4071146|FG000|COMPLETED|Overall Study||5
3339694|NCT03412929|4071146|FG000|NOT COMPLETED|Overall Study||3
3339695|NCT03413618|4071152|FG000|STARTED|Overall Study||45
3339696|NCT03413618|4071153|FG001|STARTED|Overall Study||45
3339697|NCT03413618|4071152|FG000|COMPLETED|Overall Study||45
3339698|NCT03413618|4071153|FG001|COMPLETED|Overall Study||45
3339699|NCT03413618|4071152|FG000|NOT COMPLETED|Overall Study||0
3339700|NCT03413618|4071153|FG001|NOT COMPLETED|Overall Study||0
3339701|NCT03414047|4071163|FG000|STARTED|Overall Study||53
3339702|NCT03414047|4071164|FG001|STARTED|Overall Study||46
3339703|NCT03414047|4071165|FG002|STARTED|Overall Study||41
3339704|NCT03414047|4071166|FG003|STARTED|Overall Study||29
3339705|NCT03414047|4071163|FG000|Received at Least One Dose of Study Drug|Overall Study||53
3339706|NCT03414047|4071164|FG001|Received at Least One Dose of Study Drug|Overall Study||46
3339707|NCT03414047|4071165|FG002|Received at Least One Dose of Study Drug|Overall Study||41
3339708|NCT03414047|4071166|FG003|Received at Least One Dose of Study Drug|Overall Study||29
3339709|NCT03414047|4071163|FG000|COMPLETED|Overall Study||51
3339710|NCT03414047|4071164|FG001|COMPLETED|Overall Study||46
3339711|NCT03414047|4071165|FG002|COMPLETED|Overall Study||38
3339712|NCT03414047|4071166|FG003|COMPLETED|Overall Study||27
3339713|NCT03414047|4071163|FG000|NOT COMPLETED|Overall Study||2
3339714|NCT03414047|4071164|FG001|NOT COMPLETED|Overall Study||0
3339715|NCT03414047|4071165|FG002|NOT COMPLETED|Overall Study||3
3339716|NCT03414047|4071166|FG003|NOT COMPLETED|Overall Study||2
3339717|NCT03414359|4071179|FG000|STARTED|Overall Study||35
3339718|NCT03414359|4071180|FG001|STARTED|Overall Study||35
3339719|NCT03414359|4071179|FG000|COMPLETED|Overall Study||34
3339720|NCT03414359|4071180|FG001|COMPLETED|Overall Study||33
3339721|NCT03414359|4071179|FG000|NOT COMPLETED|Overall Study||1
3339722|NCT03414359|4071180|FG001|NOT COMPLETED|Overall Study||2
3339723|NCT03415152|4071186|FG000|STARTED|Overall Study||3000
3339724|NCT03415152|4071186|FG000|COMPLETED|Overall Study||1975
3339725|NCT03415152|4071186|FG000|NOT COMPLETED|Overall Study||1025
3339726|NCT03415178|4071195|FG000|STARTED|Parallel-Arm Period (up to Week 4)|Randomized|34
3339727|NCT03415178|4071196|FG001|STARTED|Parallel-Arm Period (up to Week 4)|Randomized|35
3339728|NCT03415178|4071195|FG000|Treated|Parallel-Arm Period (up to Week 4)||34
3339729|NCT03415178|4071196|FG001|Treated|Parallel-Arm Period (up to Week 4)||33
3339730|NCT03415178|4071195|FG000|COMPLETED|Parallel-Arm Period (up to Week 4)|33 participants entered in single arm period & 1 participant decided not to enter single arm period.|34
3339731|NCT03415178|4071196|FG001|COMPLETED|Parallel-Arm Period (up to Week 4)|32 participants entered in single arm period & 1 participant decided not to enter single arm period.|33
3339732|NCT03415178|4071195|FG000|NOT COMPLETED|Parallel-Arm Period (up to Week 4)||0
3339733|NCT03415178|4071196|FG001|NOT COMPLETED|Parallel-Arm Period (up to Week 4)||2
3339734|NCT03415178|4071195|FG000|STARTED|Single Arm Period (up to Week 16)|Out of 34 participants from AI group, 33 participants entered entered in single arm period.|0
3339735|NCT03415178|4071196|FG001|STARTED|Single Arm Period (up to Week 16)|65 (participants completed period 1) + 1 (randomized to SYDNEY arm but not treated in period 1).|66
3339736|NCT03415178|4071195|FG000|COMPLETED|Single Arm Period (up to Week 16)||0
3339737|NCT03415178|4071196|FG001|COMPLETED|Single Arm Period (up to Week 16)||65
3339738|NCT03415178|4071195|FG000|NOT COMPLETED|Single Arm Period (up to Week 16)||0
3339739|NCT03415178|4071196|FG001|NOT COMPLETED|Single Arm Period (up to Week 16)||1
3339740|NCT03415243|4071208|FG000|STARTED|Overall Study||14
3339741|NCT03415243|4071209|FG001|STARTED|Overall Study||14
3339742|NCT03415243|4071208|FG000|COMPLETED|Overall Study||14
3339743|NCT03415243|4071209|FG001|COMPLETED|Overall Study||14
3339744|NCT03415243|4071208|FG000|NOT COMPLETED|Overall Study||0
3339745|NCT03415243|4071209|FG001|NOT COMPLETED|Overall Study||0
3339746|NCT03415581|4071217|FG000|STARTED|Overall Study||7
3339747|NCT03415581|4071218|FG001|STARTED|Overall Study||6
3339748|NCT03415581|4071217|FG000|COMPLETED|Overall Study||1
3339749|NCT03415581|4071218|FG001|COMPLETED|Overall Study||1
3339750|NCT03415581|4071217|FG000|NOT COMPLETED|Overall Study||6
3339751|NCT03415581|4071218|FG001|NOT COMPLETED|Overall Study||5
3339752|NCT03416127|4071229|FG000|STARTED|Overall Study||12
3339753|NCT03416127|4071230|FG001|STARTED|Overall Study||12
3339754|NCT03416127|4071231|FG002|STARTED|Overall Study||12
3339755|NCT03416127|4071229|FG000|COMPLETED|Overall Study||12
3339756|NCT03416127|4071230|FG001|COMPLETED|Overall Study||11
3339757|NCT03416127|4071231|FG002|COMPLETED|Overall Study||11
3339758|NCT03416127|4071229|FG000|NOT COMPLETED|Overall Study||0
3339759|NCT03416127|4071230|FG001|NOT COMPLETED|Overall Study||1
3339760|NCT03416127|4071231|FG002|NOT COMPLETED|Overall Study||1
3339761|NCT03416621|4071243|FG000|STARTED|Overall Study||13
3339762|NCT03416621|4071244|FG001|STARTED|Overall Study||12
3339763|NCT03416621|4071245|FG002|STARTED|Overall Study||6
3339764|NCT03416621|4071243|FG000|COMPLETED|Overall Study||13
3339765|NCT03416621|4071244|FG001|COMPLETED|Overall Study||11
3339766|NCT03416621|4071245|FG002|COMPLETED|Overall Study||1
3339767|NCT03416621|4071243|FG000|NOT COMPLETED|Overall Study||0
3339768|NCT03416621|4071244|FG001|NOT COMPLETED|Overall Study||1
3339769|NCT03416621|4071245|FG002|NOT COMPLETED|Overall Study||5
3339770|NCT03416946|4071257|FG000|STARTED|Overall Study||25
3339771|NCT03416946|4071258|FG001|STARTED|Overall Study||29
3339772|NCT03416946|4071257|FG000|COMPLETED|Overall Study||25
3339773|NCT03416946|4071258|FG001|COMPLETED|Overall Study||29
3339774|NCT03416946|4071257|FG000|NOT COMPLETED|Overall Study||0
3339775|NCT03416946|4071258|FG001|NOT COMPLETED|Overall Study||0
3339776|NCT03416985|4071267|FG000|STARTED|Overall Study||30
3339777|NCT03416985|4071268|FG001|STARTED|Overall Study||30
3339778|NCT03416985|4071269|FG002|STARTED|Overall Study||30
3339779|NCT03416985|4071267|FG000|COMPLETED|Overall Study||28
3339780|NCT03416985|4071268|FG001|COMPLETED|Overall Study||30
3339781|NCT03416985|4071269|FG002|COMPLETED|Overall Study||24
3339782|NCT03416985|4071267|FG000|NOT COMPLETED|Overall Study||2
3339783|NCT03416985|4071268|FG001|NOT COMPLETED|Overall Study||0
3339784|NCT03416985|4071269|FG002|NOT COMPLETED|Overall Study||6
3339785|NCT03417024|4071280|FG000|STARTED|Overall Study||13
3339786|NCT03417024|4071280|FG000|COMPLETED|Overall Study||0
3339787|NCT03417024|4071280|FG000|NOT COMPLETED|Overall Study||13
3339788|NCT03417141|4071284|FG000|STARTED|Overall Study||12
3339789|NCT03417141|4071284|FG000|COMPLETED|Overall Study||8
3339790|NCT03417141|4071284|FG000|NOT COMPLETED|Overall Study||4
3339791|NCT03417219|4071290|FG000|STARTED|Overall Study||8
3339792|NCT03417219|4071291|FG001|STARTED|Overall Study||8
3339793|NCT03417219|4071290|FG000|COMPLETED|Overall Study||8
3339794|NCT03417219|4071291|FG001|COMPLETED|Overall Study||5
3339795|NCT03417219|4071290|FG000|NOT COMPLETED|Overall Study||0
3339796|NCT03417219|4071291|FG001|NOT COMPLETED|Overall Study||3
3339797|NCT03417466|4071297|FG000|STARTED|Overall Study||66
3339798|NCT03417466|4071297|FG000|COMPLETED|Overall Study||66
3339799|NCT03417466|4071297|FG000|NOT COMPLETED|Overall Study||0
3339800|NCT03417505|4071301|FG000|STARTED|First Lens Type (30 Days)||9
3339801|NCT03417505|4071302|FG001|STARTED|First Lens Type (30 Days)||12
3339802|NCT03417505|4071301|FG000|COMPLETED|First Lens Type (30 Days)||8
3339803|NCT03417505|4071302|FG001|COMPLETED|First Lens Type (30 Days)||11
3339804|NCT03417505|4071301|FG000|NOT COMPLETED|First Lens Type (30 Days)||1
3339805|NCT03417505|4071302|FG001|NOT COMPLETED|First Lens Type (30 Days)||1
3339806|NCT03417505|4071301|FG000|STARTED|Washout Period (7 Days)||8
3339807|NCT03417505|4071302|FG001|STARTED|Washout Period (7 Days)||11
3339808|NCT03417505|4071301|FG000|COMPLETED|Washout Period (7 Days)||8
3339809|NCT03417505|4071302|FG001|COMPLETED|Washout Period (7 Days)||11
3339810|NCT03417505|4071301|FG000|NOT COMPLETED|Washout Period (7 Days)||0
3339811|NCT03417505|4071302|FG001|NOT COMPLETED|Washout Period (7 Days)||0
3339812|NCT03417505|4071301|FG000|STARTED|Second Lens Type (30 Days)||8
3339813|NCT03417505|4071302|FG001|STARTED|Second Lens Type (30 Days)||11
3339814|NCT03417505|4071301|FG000|COMPLETED|Second Lens Type (30 Days)||8
3339815|NCT03417505|4071302|FG001|COMPLETED|Second Lens Type (30 Days)||11
3177104|NCT01968551|3904813|FG001|NOT COMPLETED|Extension Phase||1
3177105|NCT01968551|3904814|FG002|NOT COMPLETED|Extension Phase||4
3339816|NCT03417505|4071301|FG000|NOT COMPLETED|Second Lens Type (30 Days)||0
3339817|NCT03417505|4071302|FG001|NOT COMPLETED|Second Lens Type (30 Days)||0
3339818|NCT03417557|4071308|FG000|STARTED|1st Intervention (3 Hours)||8
3339819|NCT03417557|4071309|FG001|STARTED|1st Intervention (3 Hours)||9
3339820|NCT03417557|4071308|FG000|COMPLETED|1st Intervention (3 Hours)||8
3339821|NCT03417557|4071309|FG001|COMPLETED|1st Intervention (3 Hours)||9
3339822|NCT03417557|4071308|FG000|NOT COMPLETED|1st Intervention (3 Hours)||0
3339823|NCT03417557|4071309|FG001|NOT COMPLETED|1st Intervention (3 Hours)||0
3339824|NCT03417557|4071308|FG000|STARTED|2nd Intervention (3 Hours)||9
3339825|NCT03417557|4071309|FG001|STARTED|2nd Intervention (3 Hours)||8
3339826|NCT03417557|4071308|FG000|COMPLETED|2nd Intervention (3 Hours)||9
3339827|NCT03417557|4071309|FG001|COMPLETED|2nd Intervention (3 Hours)||8
3339828|NCT03417557|4071308|FG000|NOT COMPLETED|2nd Intervention (3 Hours)||0
3339829|NCT03417557|4071309|FG001|NOT COMPLETED|2nd Intervention (3 Hours)||0
3339830|NCT03417713|4071315|FG000|STARTED|Overall Study||33
3339831|NCT03417713|4071315|FG000|COMPLETED|Overall Study||30
3339832|NCT03417713|4071315|FG000|NOT COMPLETED|Overall Study||3
3339833|NCT03417739|4071319|FG000|STARTED|Overall Study||13
3339834|NCT03417739|4071319|FG000|COMPLETED|Overall Study||13
3339835|NCT03417739|4071319|FG000|NOT COMPLETED|Overall Study||0
3339836|NCT03417752|4071326|FG000|STARTED|Overall Study||149
3339837|NCT03417752|4071327|FG001|STARTED|Overall Study||175
3339838|NCT03417752|4071328|FG002|STARTED|Overall Study||150
3339839|NCT03417752|4071326|FG000|COMPLETED|Overall Study||115
3339840|NCT03417752|4071327|FG001|COMPLETED|Overall Study||133
3339841|NCT03417752|4071328|FG002|COMPLETED|Overall Study||110
3339842|NCT03417752|4071326|FG000|NOT COMPLETED|Overall Study||34
3339843|NCT03417752|4071327|FG001|NOT COMPLETED|Overall Study||42
3339844|NCT03417752|4071328|FG002|NOT COMPLETED|Overall Study||40
3339845|NCT03417778|4071338|FG000|STARTED|Overall Study||10
3339846|NCT03417778|4071339|FG001|STARTED|Overall Study||10
3339847|NCT03417778|4071338|FG000|COMPLETED|Overall Study||10
3339848|NCT03417778|4071339|FG001|COMPLETED|Overall Study||10
3339849|NCT03417778|4071338|FG000|NOT COMPLETED|Overall Study||0
3339850|NCT03417778|4071339|FG001|NOT COMPLETED|Overall Study||0
3339851|NCT03417804|4071345|FG000|STARTED|Overall Study|at least 360 patients|366
3339852|NCT03417804|4071345|FG000|COMPLETED|Overall Study||366
3339853|NCT03417804|4071345|FG000|NOT COMPLETED|Overall Study||0
3339854|NCT03417830|4071352|FG000|STARTED|Part A (up to 26 Days)||2
3339855|NCT03417830|4071353|FG001|STARTED|Part A (up to 26 Days)||0
3339856|NCT03417830|4071352|FG000|COMPLETED|Part A (up to 26 Days)||1
3339857|NCT03417830|4071353|FG001|COMPLETED|Part A (up to 26 Days)||0
3339858|NCT03417830|4071352|FG000|NOT COMPLETED|Part A (up to 26 Days)||1
3177106|NCT01968694|3904828|FG000|STARTED|Visit 1 (1 Day)||10
3177107|NCT01968694|3904829|FG001|STARTED|Visit 1 (1 Day)||9
3177108|NCT01968694|3904828|FG000|COMPLETED|Visit 1 (1 Day)||10
3177109|NCT01968694|3904829|FG001|COMPLETED|Visit 1 (1 Day)||9
3339859|NCT03417830|4071353|FG001|NOT COMPLETED|Part A (up to 26 Days)||0
3339860|NCT03417830|4071352|FG000|STARTED|Part B (up to 26 Days)||0
3339861|NCT03417830|4071353|FG001|STARTED|Part B (up to 26 Days)||0
3339862|NCT03417830|4071352|FG000|COMPLETED|Part B (up to 26 Days)||0
3339863|NCT03417830|4071353|FG001|COMPLETED|Part B (up to 26 Days)||0
3339864|NCT03417830|4071352|FG000|NOT COMPLETED|Part B (up to 26 Days)||0
3339865|NCT03417830|4071353|FG001|NOT COMPLETED|Part B (up to 26 Days)||0
3339866|NCT03418051|4071363|FG000|STARTED|Overall Study||20
3339867|NCT03418051|4071364|FG001|STARTED|Overall Study||20
3339868|NCT03418051|4071365|FG002|STARTED|Overall Study||20
3339869|NCT03418051|4071363|FG000|COMPLETED|Overall Study||14
3339870|NCT03418051|4071364|FG001|COMPLETED|Overall Study||18
3339871|NCT03418051|4071365|FG002|COMPLETED|Overall Study||17
3339872|NCT03418051|4071363|FG000|NOT COMPLETED|Overall Study||6
3339873|NCT03418051|4071364|FG001|NOT COMPLETED|Overall Study||2
3339874|NCT03418051|4071365|FG002|NOT COMPLETED|Overall Study||3
3339875|NCT03418064|4071373|FG000|STARTED|First Intervention (1 Month)||21
3339876|NCT03418064|4071374|FG001|STARTED|First Intervention (1 Month)||21
3339877|NCT03418064|4071373|FG000|COMPLETED|First Intervention (1 Month)||21
3339878|NCT03418064|4071374|FG001|COMPLETED|First Intervention (1 Month)||21
3339879|NCT03418064|4071373|FG000|NOT COMPLETED|First Intervention (1 Month)||0
3339880|NCT03418064|4071374|FG001|NOT COMPLETED|First Intervention (1 Month)||0
3339881|NCT03418064|4071373|FG000|STARTED|Second Intervention (1 Month)||21
3339882|NCT03418064|4071374|FG001|STARTED|Second Intervention (1 Month)||21
3339883|NCT03418064|4071373|FG000|COMPLETED|Second Intervention (1 Month)||21
3339884|NCT03418064|4071374|FG001|COMPLETED|Second Intervention (1 Month)||21
3339885|NCT03418064|4071373|FG000|NOT COMPLETED|Second Intervention (1 Month)||0
3339886|NCT03418064|4071374|FG001|NOT COMPLETED|Second Intervention (1 Month)||0
3339887|NCT03418324|4071390|FG000|STARTED|Overall Study||3
3339888|NCT03418324|4071391|FG001|STARTED|Overall Study||8
3339889|NCT03418324|4071390|FG000|COMPLETED|Overall Study||2
3339890|NCT03418324|4071391|FG001|COMPLETED|Overall Study||6
3339891|NCT03418324|4071390|FG000|NOT COMPLETED|Overall Study||1
3339892|NCT03418324|4071391|FG001|NOT COMPLETED|Overall Study||2
3339893|NCT03418376|4071401|FG000|STARTED|Overall Study||12
3339894|NCT03418376|4071402|FG001|STARTED|Overall Study||11
3177110|NCT01968694|3904828|FG000|NOT COMPLETED|Visit 1 (1 Day)||0
3177111|NCT01968694|3904829|FG001|NOT COMPLETED|Visit 1 (1 Day)||0
3339895|NCT03418376|4071403|FG002|STARTED|Overall Study||11
3339896|NCT03418376|4071404|FG003|STARTED|Overall Study||11
3339897|NCT03418376|4071401|FG000|COMPLETED|Overall Study||11
3339898|NCT03418376|4071402|FG001|COMPLETED|Overall Study||6
3339899|NCT03418376|4071403|FG002|COMPLETED|Overall Study||8
3339900|NCT03418376|4071404|FG003|COMPLETED|Overall Study||10
3339901|NCT03418376|4071401|FG000|NOT COMPLETED|Overall Study||1
3177112|NCT01968694|3904828|FG000|STARTED|Washout (1 Month)||10
3177113|NCT01968694|3904829|FG001|STARTED|Washout (1 Month)||9
3177114|NCT01968694|3904828|FG000|COMPLETED|Washout (1 Month)||10
3177115|NCT01968694|3904829|FG001|COMPLETED|Washout (1 Month)||8
3177116|NCT01968694|3904828|FG000|NOT COMPLETED|Washout (1 Month)||0
3177117|NCT01968694|3904829|FG001|NOT COMPLETED|Washout (1 Month)||1
3177118|NCT01968694|3904828|FG000|STARTED|Visit 2 (1 Day)||10
3339902|NCT03418376|4071402|FG001|NOT COMPLETED|Overall Study||5
3339903|NCT03418376|4071403|FG002|NOT COMPLETED|Overall Study||3
3339904|NCT03418376|4071404|FG003|NOT COMPLETED|Overall Study||1
3339905|NCT03418545|4071416|FG000|STARTED|Overall Study||35
3339906|NCT03418545|4071417|FG001|STARTED|Overall Study||105
3339907|NCT03418545|4071416|FG000|Safety Population|Overall Study||34
3339908|NCT03418545|4071417|FG001|Safety Population|Overall Study||105
3339909|NCT03418545|4071416|FG000|Received Optional or Repeat Treatment|Overall Study||29
3339910|NCT03418545|4071417|FG001|Received Optional or Repeat Treatment|Overall Study||37
3339911|NCT03418545|4071416|FG000|COMPLETED|Overall Study||30
3339912|NCT03418545|4071417|FG001|COMPLETED|Overall Study||94
3339913|NCT03418545|4071416|FG000|NOT COMPLETED|Overall Study||5
3339914|NCT03418545|4071417|FG001|NOT COMPLETED|Overall Study||11
3339915|NCT03418571|4071428|FG000|STARTED|Overall Study||12
3339916|NCT03418571|4071429|FG001|STARTED|Overall Study||3
3177119|NCT01968694|3904829|FG001|STARTED|Visit 2 (1 Day)||8
3177120|NCT01968694|3904828|FG000|COMPLETED|Visit 2 (1 Day)||10
3177121|NCT01968694|3904829|FG001|COMPLETED|Visit 2 (1 Day)||8
3177122|NCT01968694|3904828|FG000|NOT COMPLETED|Visit 2 (1 Day)||0
3177123|NCT01968694|3904829|FG001|NOT COMPLETED|Visit 2 (1 Day)||0
3177124|NCT01968707|3904845|FG000|STARTED|Overall Study||247
3177125|NCT01968707|3904846|FG001|STARTED|Overall Study||74
3177126|NCT01968707|3904847|FG002|STARTED|Overall Study||246
3177127|NCT01968707|3904848|FG003|STARTED|Overall Study||245
3339917|NCT03418571|4071428|FG000|COMPLETED|Overall Study||11
3339918|NCT03418571|4071429|FG001|COMPLETED|Overall Study||3
3339919|NCT03418571|4071428|FG000|NOT COMPLETED|Overall Study||1
3339920|NCT03418571|4071429|FG001|NOT COMPLETED|Overall Study||0
3339921|NCT03418662|4071437|FG000|STARTED|Overall Study||287
3339922|NCT03418662|4071438|FG001|STARTED|Overall Study||282
3339923|NCT03418662|4071437|FG000|COMPLETED|Overall Study||284
3339924|NCT03418662|4071438|FG001|COMPLETED|Overall Study||278
3339925|NCT03418662|4071437|FG000|NOT COMPLETED|Overall Study||3
3339926|NCT03418662|4071438|FG001|NOT COMPLETED|Overall Study||4
3339927|NCT03418714|4071444|FG000|STARTED|Overall Study||13
3339928|NCT03418714|4071444|FG000|COMPLETED|Overall Study|One participant moved too much during the practice session and was therefore excluded from the scan.|12
3339929|NCT03418714|4071444|FG000|NOT COMPLETED|Overall Study||1
3339930|NCT03419078|4071451|FG000|STARTED|Overall Study||245
3339931|NCT03419078|4071452|FG001|STARTED|Overall Study||148
3339932|NCT03419078|4071453|FG002|STARTED|Overall Study||91
3339933|NCT03419078|4071451|FG000|COMPLETED|Overall Study||245
3339934|NCT03419078|4071452|FG001|COMPLETED|Overall Study||148
3339935|NCT03419078|4071453|FG002|COMPLETED|Overall Study||91
3339936|NCT03419078|4071451|FG000|NOT COMPLETED|Overall Study||0
3339937|NCT03419078|4071452|FG001|NOT COMPLETED|Overall Study||0
3339938|NCT03419078|4071453|FG002|NOT COMPLETED|Overall Study||0
3339939|NCT03419403|4071464|FG000|STARTED|Overall Study||14
3339940|NCT03419403|4071465|FG001|STARTED|Overall Study||12
3339941|NCT03419403|4071466|FG002|STARTED|Overall Study||12
3339942|NCT03419403|4071467|FG003|STARTED|Overall Study||2
3339943|NCT03419403|4071464|FG000|COMPLETED|Overall Study||2
3339944|NCT03419403|4071465|FG001|COMPLETED|Overall Study||3
3339945|NCT03419403|4071466|FG002|COMPLETED|Overall Study||0
3339946|NCT03419403|4071467|FG003|COMPLETED|Overall Study||0
3339947|NCT03419403|4071464|FG000|NOT COMPLETED|Overall Study||12
3339948|NCT03419403|4071465|FG001|NOT COMPLETED|Overall Study||9
3339949|NCT03419403|4071466|FG002|NOT COMPLETED|Overall Study||12
3339950|NCT03419403|4071467|FG003|NOT COMPLETED|Overall Study||2
3339951|NCT03419533|4071477|FG000|STARTED|Overall Study||4107
3339952|NCT03419533|4071478|FG001|STARTED|Overall Study||2695
3339953|NCT03419533|4071477|FG000|COMPLETED|Overall Study||4107
3339954|NCT03419533|4071478|FG001|COMPLETED|Overall Study||2695
3339955|NCT03419533|4071477|FG000|NOT COMPLETED|Overall Study||0
3339956|NCT03419533|4071478|FG001|NOT COMPLETED|Overall Study||0
3339957|NCT03419598|4071492|FG000|STARTED|Overall Study||30
3339958|NCT03419598|4071492|FG000|Subject Specific Tibia Models Created and Virtual Osteotomy Performed|Overall Study||28
3339959|NCT03419598|4071492|FG000|Virtual Cohort Duplicated Into A. Personalised and B. Generic Copies|Overall Study||28
3339960|NCT03419598|4071492|FG000|Finite Element (FE) Model Created for Cohort Copy Stabilised by Personalised HTO Plate|Overall Study||28
3339961|NCT03419598|4071492|FG000|FE Models Created for Cohort Copy Stabilised by Generic HTO Plate|Overall Study||28
3339962|NCT03419598|4071492|FG000|FE Models Solved for Personalised HTO Plate Stabilised Cohort Copy|Overall Study||28
3177128|NCT01968707|3904849|FG004|STARTED|Overall Study||236
3177129|NCT01968707|3904850|FG005|STARTED|Overall Study||70
3177130|NCT01968707|3904851|FG006|STARTED|Overall Study||238
3177131|NCT01968707|3904852|FG007|STARTED|Overall Study||238
3339963|NCT03419598|4071492|FG000|FE Models Solved for Generic HTO Plate Stabilised Cohort Copy|Overall Study||28
3339964|NCT03419598|4071492|FG000|COMPLETED|Overall Study||28
3339965|NCT03419598|4071492|FG000|NOT COMPLETED|Overall Study||2
3339966|NCT03419780|4071500|FG000|STARTED|Overall Study||33
3339967|NCT03419780|4071501|FG001|STARTED|Overall Study||33
3339968|NCT03419780|4071500|FG000|COMPLETED|Overall Study||33
3339969|NCT03419780|4071501|FG001|COMPLETED|Overall Study||33
3339970|NCT03419780|4071500|FG000|NOT COMPLETED|Overall Study||0
3339971|NCT03419780|4071501|FG001|NOT COMPLETED|Overall Study||0
3339972|NCT03419962|4071507|FG000|STARTED|Overall Study||1359
3339973|NCT03419962|4071507|FG000|COMPLETED|Overall Study||1322
3339974|NCT03419962|4071507|FG000|NOT COMPLETED|Overall Study||37
3339975|NCT03420300|4071511|FG000|STARTED|Overall Study||40
3339976|NCT03420300|4071511|FG000|COMPLETED|Overall Study||38
3339977|NCT03420300|4071511|FG000|NOT COMPLETED|Overall Study||2
3339978|NCT03420625|4071515|FG000|STARTED|Overall Study||10
3339979|NCT03420625|4071515|FG000|Baseline|Overall Study||10
3339980|NCT03420625|4071515|FG000|Foot IPC|Overall Study||10
3339981|NCT03420625|4071515|FG000|Rapid Calf IPC|Overall Study||10
3339982|NCT03420625|4071515|FG000|Slow Calf IPC|Overall Study||10
3339983|NCT03420625|4071515|FG000|Calf NMES|Overall Study||10
3339984|NCT03420625|4071515|FG000|COMPLETED|Overall Study||10
3339985|NCT03420625|4071515|FG000|NOT COMPLETED|Overall Study||0
3339986|NCT03421197|4071535|FG000|STARTED|Overall Study||105
3339987|NCT03421197|4071536|FG001|STARTED|Overall Study||107
3339988|NCT03421197|4071537|FG002|STARTED|Overall Study||107
3339989|NCT03421197|4071538|FG003|STARTED|Overall Study||107
3339990|NCT03421197|4071535|FG000|COMPLETED|Overall Study||67
3339991|NCT03421197|4071536|FG001|COMPLETED|Overall Study||68
3339992|NCT03421197|4071537|FG002|COMPLETED|Overall Study||56
3339993|NCT03421197|4071538|FG003|COMPLETED|Overall Study||62
3339994|NCT03421197|4071535|FG000|NOT COMPLETED|Overall Study||38
3339995|NCT03421197|4071536|FG001|NOT COMPLETED|Overall Study||39
3339996|NCT03421197|4071537|FG002|NOT COMPLETED|Overall Study||51
3339997|NCT03421197|4071538|FG003|NOT COMPLETED|Overall Study||45
3339998|NCT03421210|4071548|FG000|STARTED|Overall Study||88
3339999|NCT03421210|4071548|FG000|Received Functional Magnetic Resonance Imaging (fMRI)|Overall Study||42
3340000|NCT03421210|4071548|FG000|COMPLETED|Overall Study||35
3340001|NCT03421210|4071548|FG000|NOT COMPLETED|Overall Study||53
3340002|NCT03421379|4071554|FG000|STARTED|Period 1||34
3340003|NCT03421379|4071555|FG001|STARTED|Period 1||41
3340004|NCT03421379|4071554|FG000|Received at Least One Dose of Study Drug|Period 1||33
3340005|NCT03421379|4071555|FG001|Received at Least One Dose of Study Drug|Period 1||39
3340006|NCT03421379|4071554|FG000|COMPLETED|Period 1||32
3340007|NCT03421379|4071555|FG001|COMPLETED|Period 1||37
3340008|NCT03421379|4071554|FG000|NOT COMPLETED|Period 1||2
3340009|NCT03421379|4071555|FG001|NOT COMPLETED|Period 1||4
3340010|NCT03421379|4071554|FG000|STARTED|Washout Period (3 to 14 Days)||32
3340011|NCT03421379|4071555|FG001|STARTED|Washout Period (3 to 14 Days)||37
3340012|NCT03421379|4071554|FG000|COMPLETED|Washout Period (3 to 14 Days)||32
3340013|NCT03421379|4071555|FG001|COMPLETED|Washout Period (3 to 14 Days)||37
3340014|NCT03421379|4071554|FG000|NOT COMPLETED|Washout Period (3 to 14 Days)||0
3340015|NCT03421379|4071555|FG001|NOT COMPLETED|Washout Period (3 to 14 Days)||0
3340016|NCT03421379|4071554|FG000|STARTED|Period 2||32
3340017|NCT03421379|4071555|FG001|STARTED|Period 2||37
3340018|NCT03421379|4071554|FG000|COMPLETED|Period 2||32
3340019|NCT03421379|4071555|FG001|COMPLETED|Period 2||37
3340020|NCT03421379|4071554|FG000|NOT COMPLETED|Period 2||0
3340021|NCT03421379|4071555|FG001|NOT COMPLETED|Period 2||0
3340022|NCT03421431|4071564|FG000|STARTED|Overall Study||24
3340023|NCT03421431|4071565|FG001|STARTED|Overall Study||55
3340024|NCT03421431|4071566|FG002|STARTED|Overall Study||53
3340025|NCT03421431|4071564|FG000|COMPLETED|Overall Study||18
3340026|NCT03421431|4071565|FG001|COMPLETED|Overall Study||49
3340027|NCT03421431|4071566|FG002|COMPLETED|Overall Study||39
3340028|NCT03421431|4071564|FG000|NOT COMPLETED|Overall Study||6
3340029|NCT03421431|4071565|FG001|NOT COMPLETED|Overall Study||6
3340030|NCT03421431|4071566|FG002|NOT COMPLETED|Overall Study||14
3340031|NCT03421730|4071576|FG000|STARTED|First Intervention (Day 1, Visit 2)||1
3340032|NCT03421730|4071577|FG001|STARTED|First Intervention (Day 1, Visit 2)||3
3340033|NCT03421730|4071578|FG002|STARTED|First Intervention (Day 1, Visit 2)||1
3340034|NCT03421730|4071579|FG003|STARTED|First Intervention (Day 1, Visit 2)||1
3340035|NCT03421730|4071580|FG004|STARTED|First Intervention (Day 1, Visit 2)||3
3340036|NCT03421730|4071581|FG005|STARTED|First Intervention (Day 1, Visit 2)||1
3340037|NCT03421730|4071582|FG006|STARTED|First Intervention (Day 1, Visit 2)||1
3340038|NCT03421730|4071583|FG007|STARTED|First Intervention (Day 1, Visit 2)||1
3340039|NCT03421730|4071584|FG008|STARTED|First Intervention (Day 1, Visit 2)||1
3340040|NCT03421730|4071585|FG009|STARTED|First Intervention (Day 1, Visit 2)||2
3340041|NCT03421730|4071586|FG010|STARTED|First Intervention (Day 1, Visit 2)||1
3340042|NCT03421730|4071587|FG011|STARTED|First Intervention (Day 1, Visit 2)||1
3340043|NCT03421730|4071576|FG000|COMPLETED|First Intervention (Day 1, Visit 2)||1
3340044|NCT03421730|4071577|FG001|COMPLETED|First Intervention (Day 1, Visit 2)|Two subjects withdrew without receiving treatment with either A or C.|1
3340045|NCT03421730|4071578|FG002|COMPLETED|First Intervention (Day 1, Visit 2)||1
3340046|NCT03421730|4071579|FG003|COMPLETED|First Intervention (Day 1, Visit 2)||1
3340047|NCT03421730|4071580|FG004|COMPLETED|First Intervention (Day 1, Visit 2)||3
3340048|NCT03421730|4071581|FG005|COMPLETED|First Intervention (Day 1, Visit 2)||1
3340049|NCT03421730|4071582|FG006|COMPLETED|First Intervention (Day 1, Visit 2)||1
3340050|NCT03421730|4071583|FG007|COMPLETED|First Intervention (Day 1, Visit 2)||1
3340051|NCT03421730|4071584|FG008|COMPLETED|First Intervention (Day 1, Visit 2)||1
3340052|NCT03421730|4071585|FG009|COMPLETED|First Intervention (Day 1, Visit 2)||2
3340053|NCT03421730|4071586|FG010|COMPLETED|First Intervention (Day 1, Visit 2)||1
3340054|NCT03421730|4071587|FG011|COMPLETED|First Intervention (Day 1, Visit 2)||1
3340055|NCT03421730|4071576|FG000|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
3340056|NCT03421730|4071577|FG001|NOT COMPLETED|First Intervention (Day 1, Visit 2)||2
3340057|NCT03421730|4071578|FG002|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
3340058|NCT03421730|4071579|FG003|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
3340059|NCT03421730|4071580|FG004|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
3340060|NCT03421730|4071581|FG005|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
3340061|NCT03421730|4071582|FG006|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
3340062|NCT03421730|4071583|FG007|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
3340063|NCT03421730|4071584|FG008|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
3340064|NCT03421730|4071585|FG009|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
3340065|NCT03421730|4071586|FG010|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
3340066|NCT03421730|4071587|FG011|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
3340067|NCT03421730|4071576|FG000|STARTED|Washout (Days 4 to 10)||1
3340068|NCT03421730|4071577|FG001|STARTED|Washout (Days 4 to 10)||1
3340069|NCT03421730|4071578|FG002|STARTED|Washout (Days 4 to 10)||1
3340070|NCT03421730|4071579|FG003|STARTED|Washout (Days 4 to 10)||1
3340071|NCT03421730|4071580|FG004|STARTED|Washout (Days 4 to 10)||3
3340072|NCT03421730|4071581|FG005|STARTED|Washout (Days 4 to 10)||1
3340073|NCT03421730|4071582|FG006|STARTED|Washout (Days 4 to 10)||1
3340074|NCT03421730|4071583|FG007|STARTED|Washout (Days 4 to 10)||1
3340075|NCT03421730|4071584|FG008|STARTED|Washout (Days 4 to 10)||1
3340076|NCT03421730|4071585|FG009|STARTED|Washout (Days 4 to 10)||2
3340077|NCT03421730|4071586|FG010|STARTED|Washout (Days 4 to 10)||1
3340078|NCT03421730|4071587|FG011|STARTED|Washout (Days 4 to 10)||1
3340079|NCT03421730|4071576|FG000|COMPLETED|Washout (Days 4 to 10)||1
3340080|NCT03421730|4071577|FG001|COMPLETED|Washout (Days 4 to 10)||1
3340081|NCT03421730|4071578|FG002|COMPLETED|Washout (Days 4 to 10)||1
3340082|NCT03421730|4071579|FG003|COMPLETED|Washout (Days 4 to 10)||1
3340083|NCT03421730|4071580|FG004|COMPLETED|Washout (Days 4 to 10)|Two subjects withdrew after receiving treatment with B but before receiving treatment with C.|1
3340084|NCT03421730|4071581|FG005|COMPLETED|Washout (Days 4 to 10)||1
3340085|NCT03421730|4071582|FG006|COMPLETED|Washout (Days 4 to 10)||1
3340086|NCT03421730|4071583|FG007|COMPLETED|Washout (Days 4 to 10)||1
3340087|NCT03421730|4071584|FG008|COMPLETED|Washout (Days 4 to 10)||1
3340088|NCT03421730|4071585|FG009|COMPLETED|Washout (Days 4 to 10)||2
3340089|NCT03421730|4071586|FG010|COMPLETED|Washout (Days 4 to 10)||1
3340090|NCT03421730|4071587|FG011|COMPLETED|Washout (Days 4 to 10)||1
3340091|NCT03421730|4071576|FG000|NOT COMPLETED|Washout (Days 4 to 10)||0
3340092|NCT03421730|4071577|FG001|NOT COMPLETED|Washout (Days 4 to 10)||0
3340093|NCT03421730|4071578|FG002|NOT COMPLETED|Washout (Days 4 to 10)||0
3340094|NCT03421730|4071579|FG003|NOT COMPLETED|Washout (Days 4 to 10)||0
3340095|NCT03421730|4071580|FG004|NOT COMPLETED|Washout (Days 4 to 10)||2
3340096|NCT03421730|4071581|FG005|NOT COMPLETED|Washout (Days 4 to 10)||0
3340097|NCT03421730|4071582|FG006|NOT COMPLETED|Washout (Days 4 to 10)||0
3340098|NCT03421730|4071583|FG007|NOT COMPLETED|Washout (Days 4 to 10)||0
3340099|NCT03421730|4071584|FG008|NOT COMPLETED|Washout (Days 4 to 10)||0
3340100|NCT03421730|4071585|FG009|NOT COMPLETED|Washout (Days 4 to 10)||0
3340101|NCT03421730|4071586|FG010|NOT COMPLETED|Washout (Days 4 to 10)||0
3340102|NCT03421730|4071587|FG011|NOT COMPLETED|Washout (Days 4 to 10)||0
3340103|NCT03421730|4071576|FG000|STARTED|Second Intervention (Day 8±3, Visit 3)||1
3340104|NCT03421730|4071577|FG001|STARTED|Second Intervention (Day 8±3, Visit 3)||1
3340105|NCT03421730|4071578|FG002|STARTED|Second Intervention (Day 8±3, Visit 3)||1
3340106|NCT03421730|4071579|FG003|STARTED|Second Intervention (Day 8±3, Visit 3)||1
3340107|NCT03421730|4071580|FG004|STARTED|Second Intervention (Day 8±3, Visit 3)||1
3340108|NCT03421730|4071581|FG005|STARTED|Second Intervention (Day 8±3, Visit 3)||1
3340109|NCT03421730|4071582|FG006|STARTED|Second Intervention (Day 8±3, Visit 3)||1
3340110|NCT03421730|4071583|FG007|STARTED|Second Intervention (Day 8±3, Visit 3)||1
3340111|NCT03421730|4071584|FG008|STARTED|Second Intervention (Day 8±3, Visit 3)||1
3340112|NCT03421730|4071585|FG009|STARTED|Second Intervention (Day 8±3, Visit 3)||2
3340113|NCT03421730|4071586|FG010|STARTED|Second Intervention (Day 8±3, Visit 3)||1
3340114|NCT03421730|4071587|FG011|STARTED|Second Intervention (Day 8±3, Visit 3)||1
3340115|NCT03421730|4071576|FG000|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
3340116|NCT03421730|4071577|FG001|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
3340117|NCT03421730|4071578|FG002|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
3340118|NCT03421730|4071579|FG003|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
3340119|NCT03421730|4071580|FG004|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
3340120|NCT03421730|4071581|FG005|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
3340121|NCT03421730|4071582|FG006|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
3340122|NCT03421730|4071583|FG007|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
3340123|NCT03421730|4071584|FG008|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
3340124|NCT03421730|4071585|FG009|COMPLETED|Second Intervention (Day 8±3, Visit 3)||2
3340125|NCT03421730|4071586|FG010|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
3340126|NCT03421730|4071587|FG011|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
3340127|NCT03421730|4071576|FG000|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
3340128|NCT03421730|4071577|FG001|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
3340129|NCT03421730|4071578|FG002|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
3340130|NCT03421730|4071579|FG003|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
3340131|NCT03421730|4071580|FG004|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
3340132|NCT03421730|4071581|FG005|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
3340133|NCT03421730|4071582|FG006|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
3340134|NCT03421730|4071583|FG007|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
3340135|NCT03421730|4071584|FG008|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
3340136|NCT03421730|4071585|FG009|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
3340137|NCT03421730|4071586|FG010|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
3340138|NCT03421730|4071587|FG011|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
3340139|NCT03421886|4071603|FG000|STARTED|Overall Study||30
3340140|NCT03421886|4071604|FG001|STARTED|Overall Study||15
3340141|NCT03421886|4071603|FG000|COMPLETED|Overall Study||23
3340142|NCT03421886|4071604|FG001|COMPLETED|Overall Study||13
3340143|NCT03421886|4071603|FG000|NOT COMPLETED|Overall Study||7
3340144|NCT03421886|4071604|FG001|NOT COMPLETED|Overall Study||2
3340145|NCT03422159|4071612|FG000|STARTED|Overall Study||70
3340146|NCT03422159|4071613|FG001|STARTED|Overall Study||70
3340147|NCT03422159|4071612|FG000|COMPLETED|Overall Study||68
3340148|NCT03422159|4071613|FG001|COMPLETED|Overall Study||69
3340149|NCT03422159|4071612|FG000|NOT COMPLETED|Overall Study||2
3340150|NCT03422159|4071613|FG001|NOT COMPLETED|Overall Study||1
3340151|NCT03422172|4071621|FG000|STARTED|Oral lead-in Phase (4 Weeks)||48
3340152|NCT03422172|4071621|FG000|COMPLETED|Oral lead-in Phase (4 Weeks)||47
3340153|NCT03422172|4071621|FG000|NOT COMPLETED|Oral lead-in Phase (4 Weeks)||1
3340154|NCT03422172|4071621|FG000|STARTED|Washout (7 Days)||47
3340155|NCT03422172|4071621|FG000|COMPLETED|Washout (7 Days)||47
3340156|NCT03422172|4071621|FG000|NOT COMPLETED|Washout (7 Days)||0
3340157|NCT03422172|4071621|FG000|STARTED|Injection Phase (Week 5 to Week 41)||47
3340158|NCT03422172|4071621|FG000|COMPLETED|Injection Phase (Week 5 to Week 41)||43
3340159|NCT03422172|4071621|FG000|NOT COMPLETED|Injection Phase (Week 5 to Week 41)||4
3340160|NCT03422172|4071621|FG000|STARTED|Long Term Follow-up Phase(Upto Week 89)||43
3340161|NCT03422172|4071621|FG000|COMPLETED|Long Term Follow-up Phase(Upto Week 89)||43
3340162|NCT03422172|4071621|FG000|NOT COMPLETED|Long Term Follow-up Phase(Upto Week 89)||0
3340163|NCT03422250|4071634|FG000|STARTED|Intervention||11
3340164|NCT03422250|4071635|FG001|STARTED|Intervention||11
3340165|NCT03422250|4071636|FG002|STARTED|Intervention||12
3340166|NCT03422250|4071637|FG003|STARTED|Intervention||11
3340167|NCT03422250|4071634|FG000|COMPLETED|Intervention||10
3340168|NCT03422250|4071635|FG001|COMPLETED|Intervention||10
3340169|NCT03422250|4071636|FG002|COMPLETED|Intervention||10
3340170|NCT03422250|4071637|FG003|COMPLETED|Intervention||10
3340171|NCT03422250|4071634|FG000|NOT COMPLETED|Intervention||1
3340172|NCT03422250|4071635|FG001|NOT COMPLETED|Intervention||1
3340173|NCT03422250|4071636|FG002|NOT COMPLETED|Intervention||2
3340174|NCT03422250|4071637|FG003|NOT COMPLETED|Intervention||1
3340175|NCT03422250|4071634|FG000|STARTED|Follow-up||10
3340176|NCT03422250|4071635|FG001|STARTED|Follow-up||10
3340177|NCT03422250|4071636|FG002|STARTED|Follow-up||10
3340178|NCT03422250|4071637|FG003|STARTED|Follow-up||10
3340179|NCT03422250|4071634|FG000|COMPLETED|Follow-up||10
3340180|NCT03422250|4071635|FG001|COMPLETED|Follow-up||10
3340181|NCT03422250|4071636|FG002|COMPLETED|Follow-up||10
3340182|NCT03422250|4071637|FG003|COMPLETED|Follow-up||8
3340183|NCT03422250|4071634|FG000|NOT COMPLETED|Follow-up||0
3340184|NCT03422250|4071635|FG001|NOT COMPLETED|Follow-up||0
3340185|NCT03422250|4071636|FG002|NOT COMPLETED|Follow-up||0
3340186|NCT03422250|4071637|FG003|NOT COMPLETED|Follow-up||2
3340187|NCT03423082|4071649|FG000|STARTED|Overall Study||1
3340188|NCT03423082|4071649|FG000|COMPLETED|Overall Study||1
3340189|NCT03423082|4071649|FG000|NOT COMPLETED|Overall Study||0
3340190|NCT03423173|4071657|FG000|STARTED|Overall Study||132
3340191|NCT03423173|4071658|FG001|STARTED|Overall Study||263
3340192|NCT03423173|4071659|FG002|STARTED|Overall Study||264
3340193|NCT03423173|4071660|FG003|STARTED|Overall Study||264
3340194|NCT03423173|4071657|FG000|Received at Least 1 Dose of the IP|Overall Study||131
3340195|NCT03423173|4071658|FG001|Received at Least 1 Dose of the IP|Overall Study||263
3340196|NCT03423173|4071659|FG002|Received at Least 1 Dose of the IP|Overall Study|1 participant of TDV Lot 2 received vaccine of Lot 1 and was included in TDV Lot 1 in Safety Set.|262
3340197|NCT03423173|4071660|FG003|Received at Least 1 Dose of the IP|Overall Study||263
3340198|NCT03423173|4071657|FG000|COMPLETED|Overall Study||113
3340199|NCT03423173|4071658|FG001|COMPLETED|Overall Study||228
3340200|NCT03423173|4071659|FG002|COMPLETED|Overall Study||237
3340201|NCT03423173|4071660|FG003|COMPLETED|Overall Study||234
3340202|NCT03423173|4071657|FG000|NOT COMPLETED|Overall Study||19
3340203|NCT03423173|4071658|FG001|NOT COMPLETED|Overall Study||35
3340204|NCT03423173|4071659|FG002|NOT COMPLETED|Overall Study||27
3340205|NCT03423173|4071660|FG003|NOT COMPLETED|Overall Study||30
3340206|NCT03423186|4071672|FG000|STARTED|Overall Study||3
3340207|NCT03423186|4071673|FG001|STARTED|Overall Study||3
3340208|NCT03423186|4071672|FG000|COMPLETED|Overall Study||3
3340209|NCT03423186|4071673|FG001|COMPLETED|Overall Study||3
3340210|NCT03423186|4071672|FG000|NOT COMPLETED|Overall Study||0
3340211|NCT03423186|4071673|FG001|NOT COMPLETED|Overall Study||0
3340212|NCT03423238|4071681|FG000|STARTED|Overall Study||19
3340213|NCT03423238|4071682|FG001|STARTED|Overall Study||19
3340214|NCT03423238|4071681|FG000|COMPLETED|Overall Study||17
3340215|NCT03423238|4071682|FG001|COMPLETED|Overall Study||19
3340216|NCT03423238|4071681|FG000|NOT COMPLETED|Overall Study||2
3340217|NCT03423238|4071682|FG001|NOT COMPLETED|Overall Study||0
3340218|NCT03423641|4071691|FG000|STARTED|Overall Study||15524
3340219|NCT03423641|4071692|FG001|STARTED|Overall Study||18284
3340220|NCT03423641|4071691|FG000|COMPLETED|Overall Study||15193
3340221|NCT03423641|4071692|FG001|COMPLETED|Overall Study||10210
3340222|NCT03423641|4071691|FG000|NOT COMPLETED|Overall Study||331
3340223|NCT03423641|4071692|FG001|NOT COMPLETED|Overall Study||8074
3340224|NCT03424044|4071698|FG000|STARTED|Dexcom Training Visit (1 Week)||4
3340225|NCT03424044|4071699|FG001|STARTED|Dexcom Training Visit (1 Week)||3
3340226|NCT03424044|4071700|FG002|STARTED|Dexcom Training Visit (1 Week)||3
3340227|NCT03424044|4071701|FG003|STARTED|Dexcom Training Visit (1 Week)||3
3340228|NCT03424044|4071702|FG004|STARTED|Dexcom Training Visit (1 Week)||3
3340229|NCT03424044|4071703|FG005|STARTED|Dexcom Training Visit (1 Week)||4
3340230|NCT03424044|4071704|FG006|STARTED|Dexcom Training Visit (1 Week)||1
3340231|NCT03424044|4071705|FG007|STARTED|Dexcom Training Visit (1 Week)||1
3340232|NCT03424044|4071706|FG008|STARTED|Dexcom Training Visit (1 Week)||1
3340233|NCT03424044|4071698|FG000|COMPLETED|Dexcom Training Visit (1 Week)||4
3340234|NCT03424044|4071699|FG001|COMPLETED|Dexcom Training Visit (1 Week)||3
3340235|NCT03424044|4071700|FG002|COMPLETED|Dexcom Training Visit (1 Week)||3
3340236|NCT03424044|4071701|FG003|COMPLETED|Dexcom Training Visit (1 Week)||3
3340237|NCT03424044|4071702|FG004|COMPLETED|Dexcom Training Visit (1 Week)||3
3340238|NCT03424044|4071703|FG005|COMPLETED|Dexcom Training Visit (1 Week)||4
3340239|NCT03424044|4071704|FG006|COMPLETED|Dexcom Training Visit (1 Week)||1
3340240|NCT03424044|4071705|FG007|COMPLETED|Dexcom Training Visit (1 Week)||1
3340241|NCT03424044|4071706|FG008|COMPLETED|Dexcom Training Visit (1 Week)||1
3340242|NCT03424044|4071698|FG000|NOT COMPLETED|Dexcom Training Visit (1 Week)||0
3340243|NCT03424044|4071699|FG001|NOT COMPLETED|Dexcom Training Visit (1 Week)||0
3340244|NCT03424044|4071700|FG002|NOT COMPLETED|Dexcom Training Visit (1 Week)||0
3340245|NCT03424044|4071701|FG003|NOT COMPLETED|Dexcom Training Visit (1 Week)||0
3340246|NCT03424044|4071702|FG004|NOT COMPLETED|Dexcom Training Visit (1 Week)||0
3340247|NCT03424044|4071703|FG005|NOT COMPLETED|Dexcom Training Visit (1 Week)||0
3340248|NCT03424044|4071704|FG006|NOT COMPLETED|Dexcom Training Visit (1 Week)||0
3340249|NCT03424044|4071705|FG007|NOT COMPLETED|Dexcom Training Visit (1 Week)||0
3340250|NCT03424044|4071706|FG008|NOT COMPLETED|Dexcom Training Visit (1 Week)||0
3340251|NCT03424044|4071698|FG000|STARTED|First Rest Period (1-12 Weeks)||4
3340252|NCT03424044|4071699|FG001|STARTED|First Rest Period (1-12 Weeks)||3
3340253|NCT03424044|4071700|FG002|STARTED|First Rest Period (1-12 Weeks)||3
3340254|NCT03424044|4071701|FG003|STARTED|First Rest Period (1-12 Weeks)||3
3340255|NCT03424044|4071702|FG004|STARTED|First Rest Period (1-12 Weeks)||3
3340256|NCT03424044|4071703|FG005|STARTED|First Rest Period (1-12 Weeks)||4
3340257|NCT03424044|4071704|FG006|STARTED|First Rest Period (1-12 Weeks)||1
3340258|NCT03424044|4071705|FG007|STARTED|First Rest Period (1-12 Weeks)||1
3340259|NCT03424044|4071706|FG008|STARTED|First Rest Period (1-12 Weeks)||1
3340260|NCT03424044|4071698|FG000|COMPLETED|First Rest Period (1-12 Weeks)||4
3340261|NCT03424044|4071699|FG001|COMPLETED|First Rest Period (1-12 Weeks)||3
3340262|NCT03424044|4071700|FG002|COMPLETED|First Rest Period (1-12 Weeks)||2
3340263|NCT03424044|4071701|FG003|COMPLETED|First Rest Period (1-12 Weeks)||3
3340264|NCT03424044|4071702|FG004|COMPLETED|First Rest Period (1-12 Weeks)||3
3340265|NCT03424044|4071703|FG005|COMPLETED|First Rest Period (1-12 Weeks)||4
3340266|NCT03424044|4071704|FG006|COMPLETED|First Rest Period (1-12 Weeks)||1
3340267|NCT03424044|4071705|FG007|COMPLETED|First Rest Period (1-12 Weeks)||1
3340268|NCT03424044|4071706|FG008|COMPLETED|First Rest Period (1-12 Weeks)||1
3340269|NCT03424044|4071698|FG000|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
3340270|NCT03424044|4071699|FG001|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
3340271|NCT03424044|4071700|FG002|NOT COMPLETED|First Rest Period (1-12 Weeks)||1
3340272|NCT03424044|4071701|FG003|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
3340273|NCT03424044|4071702|FG004|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
3340274|NCT03424044|4071703|FG005|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
3340275|NCT03424044|4071704|FG006|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
3340276|NCT03424044|4071705|FG007|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
3340277|NCT03424044|4071706|FG008|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
3340278|NCT03424044|4071698|FG000|STARTED|First Intervention (76 Hours)||4
3340279|NCT03424044|4071699|FG001|STARTED|First Intervention (76 Hours)||3
3340280|NCT03424044|4071700|FG002|STARTED|First Intervention (76 Hours)||2
3340281|NCT03424044|4071701|FG003|STARTED|First Intervention (76 Hours)||3
3340282|NCT03424044|4071702|FG004|STARTED|First Intervention (76 Hours)||3
3340283|NCT03424044|4071703|FG005|STARTED|First Intervention (76 Hours)||4
3340284|NCT03424044|4071704|FG006|STARTED|First Intervention (76 Hours)||1
3340285|NCT03424044|4071705|FG007|STARTED|First Intervention (76 Hours)||1
3340286|NCT03424044|4071706|FG008|STARTED|First Intervention (76 Hours)||1
3340287|NCT03424044|4071698|FG000|COMPLETED|First Intervention (76 Hours)||4
3340288|NCT03424044|4071699|FG001|COMPLETED|First Intervention (76 Hours)||3
3340289|NCT03424044|4071700|FG002|COMPLETED|First Intervention (76 Hours)||2
2927870|NCT00574704|3638778|FG001|STARTED|Overall Study||10
3340290|NCT03424044|4071701|FG003|COMPLETED|First Intervention (76 Hours)||3
3340291|NCT03424044|4071702|FG004|COMPLETED|First Intervention (76 Hours)||2
3340292|NCT03424044|4071703|FG005|COMPLETED|First Intervention (76 Hours)||4
3340293|NCT03424044|4071704|FG006|COMPLETED|First Intervention (76 Hours)||0
3340294|NCT03424044|4071705|FG007|COMPLETED|First Intervention (76 Hours)||0
3340295|NCT03424044|4071706|FG008|COMPLETED|First Intervention (76 Hours)||0
3340296|NCT03424044|4071698|FG000|NOT COMPLETED|First Intervention (76 Hours)||0
3340297|NCT03424044|4071699|FG001|NOT COMPLETED|First Intervention (76 Hours)||0
3340298|NCT03424044|4071700|FG002|NOT COMPLETED|First Intervention (76 Hours)||0
3340299|NCT03424044|4071701|FG003|NOT COMPLETED|First Intervention (76 Hours)||0
3340300|NCT03424044|4071702|FG004|NOT COMPLETED|First Intervention (76 Hours)||1
3340301|NCT03424044|4071703|FG005|NOT COMPLETED|First Intervention (76 Hours)||0
3340302|NCT03424044|4071704|FG006|NOT COMPLETED|First Intervention (76 Hours)||1
3340303|NCT03424044|4071705|FG007|NOT COMPLETED|First Intervention (76 Hours)||1
3340304|NCT03424044|4071706|FG008|NOT COMPLETED|First Intervention (76 Hours)||1
3340305|NCT03424044|4071698|FG000|STARTED|Second Rest Period (7-45 Days)||4
3340306|NCT03424044|4071699|FG001|STARTED|Second Rest Period (7-45 Days)||3
3340307|NCT03424044|4071700|FG002|STARTED|Second Rest Period (7-45 Days)||2
3340308|NCT03424044|4071701|FG003|STARTED|Second Rest Period (7-45 Days)||3
3340309|NCT03424044|4071702|FG004|STARTED|Second Rest Period (7-45 Days)||2
3340310|NCT03424044|4071703|FG005|STARTED|Second Rest Period (7-45 Days)||4
3340311|NCT03424044|4071704|FG006|STARTED|Second Rest Period (7-45 Days)||1
3340312|NCT03424044|4071705|FG007|STARTED|Second Rest Period (7-45 Days)||1
3340313|NCT03424044|4071706|FG008|STARTED|Second Rest Period (7-45 Days)||1
3340314|NCT03424044|4071698|FG000|COMPLETED|Second Rest Period (7-45 Days)||4
3340315|NCT03424044|4071699|FG001|COMPLETED|Second Rest Period (7-45 Days)||3
3340316|NCT03424044|4071700|FG002|COMPLETED|Second Rest Period (7-45 Days)||2
3340317|NCT03424044|4071701|FG003|COMPLETED|Second Rest Period (7-45 Days)||3
3340318|NCT03424044|4071702|FG004|COMPLETED|Second Rest Period (7-45 Days)||2
3340319|NCT03424044|4071703|FG005|COMPLETED|Second Rest Period (7-45 Days)||4
3340320|NCT03424044|4071704|FG006|COMPLETED|Second Rest Period (7-45 Days)||1
3340321|NCT03424044|4071705|FG007|COMPLETED|Second Rest Period (7-45 Days)||1
3340322|NCT03424044|4071706|FG008|COMPLETED|Second Rest Period (7-45 Days)||1
3340323|NCT03424044|4071698|FG000|NOT COMPLETED|Second Rest Period (7-45 Days)||0
3340324|NCT03424044|4071699|FG001|NOT COMPLETED|Second Rest Period (7-45 Days)||0
3340325|NCT03424044|4071700|FG002|NOT COMPLETED|Second Rest Period (7-45 Days)||0
3340326|NCT03424044|4071701|FG003|NOT COMPLETED|Second Rest Period (7-45 Days)||0
3340327|NCT03424044|4071702|FG004|NOT COMPLETED|Second Rest Period (7-45 Days)||0
3340328|NCT03424044|4071703|FG005|NOT COMPLETED|Second Rest Period (7-45 Days)||0
3340329|NCT03424044|4071704|FG006|NOT COMPLETED|Second Rest Period (7-45 Days)||0
3340330|NCT03424044|4071705|FG007|NOT COMPLETED|Second Rest Period (7-45 Days)||0
3340331|NCT03424044|4071706|FG008|NOT COMPLETED|Second Rest Period (7-45 Days)||0
3340332|NCT03424044|4071698|FG000|STARTED|Second Intervention (76 Hours)||4
3340333|NCT03424044|4071699|FG001|STARTED|Second Intervention (76 Hours)||3
3177132|NCT01968707|3904845|FG000|COMPLETED|Overall Study||198
3177133|NCT01968707|3904846|FG001|COMPLETED|Overall Study||62
3177134|NCT01968707|3904847|FG002|COMPLETED|Overall Study||205
3177135|NCT01968707|3904848|FG003|COMPLETED|Overall Study||201
3177136|NCT01968707|3904849|FG004|COMPLETED|Overall Study||200
3177137|NCT01968707|3904850|FG005|COMPLETED|Overall Study||59
3340334|NCT03424044|4071700|FG002|STARTED|Second Intervention (76 Hours)||2
3340335|NCT03424044|4071701|FG003|STARTED|Second Intervention (76 Hours)||3
3340336|NCT03424044|4071702|FG004|STARTED|Second Intervention (76 Hours)||2
3340337|NCT03424044|4071703|FG005|STARTED|Second Intervention (76 Hours)||4
3340338|NCT03424044|4071704|FG006|STARTED|Second Intervention (76 Hours)||1
3340339|NCT03424044|4071705|FG007|STARTED|Second Intervention (76 Hours)||1
3340340|NCT03424044|4071706|FG008|STARTED|Second Intervention (76 Hours)||1
3340341|NCT03424044|4071698|FG000|COMPLETED|Second Intervention (76 Hours)||4
3340342|NCT03424044|4071699|FG001|COMPLETED|Second Intervention (76 Hours)||3
3340343|NCT03424044|4071700|FG002|COMPLETED|Second Intervention (76 Hours)||2
3340344|NCT03424044|4071701|FG003|COMPLETED|Second Intervention (76 Hours)||3
3340345|NCT03424044|4071702|FG004|COMPLETED|Second Intervention (76 Hours)||2
3340346|NCT03424044|4071703|FG005|COMPLETED|Second Intervention (76 Hours)||4
3340347|NCT03424044|4071704|FG006|COMPLETED|Second Intervention (76 Hours)||1
3340348|NCT03424044|4071705|FG007|COMPLETED|Second Intervention (76 Hours)||1
3340349|NCT03424044|4071706|FG008|COMPLETED|Second Intervention (76 Hours)||1
3340350|NCT03424044|4071698|FG000|NOT COMPLETED|Second Intervention (76 Hours)||0
3340351|NCT03424044|4071699|FG001|NOT COMPLETED|Second Intervention (76 Hours)||0
3340352|NCT03424044|4071700|FG002|NOT COMPLETED|Second Intervention (76 Hours)||0
3340353|NCT03424044|4071701|FG003|NOT COMPLETED|Second Intervention (76 Hours)||0
3340354|NCT03424044|4071702|FG004|NOT COMPLETED|Second Intervention (76 Hours)||0
3340355|NCT03424044|4071703|FG005|NOT COMPLETED|Second Intervention (76 Hours)||0
3340356|NCT03424044|4071704|FG006|NOT COMPLETED|Second Intervention (76 Hours)||0
3340357|NCT03424044|4071705|FG007|NOT COMPLETED|Second Intervention (76 Hours)||0
3340358|NCT03424044|4071706|FG008|NOT COMPLETED|Second Intervention (76 Hours)||0
3340359|NCT03424044|4071698|FG000|STARTED|Third Rest Period (7-45 Days)||4
3340360|NCT03424044|4071699|FG001|STARTED|Third Rest Period (7-45 Days)||3
3340361|NCT03424044|4071700|FG002|STARTED|Third Rest Period (7-45 Days)||2
3340362|NCT03424044|4071701|FG003|STARTED|Third Rest Period (7-45 Days)||3
3340363|NCT03424044|4071702|FG004|STARTED|Third Rest Period (7-45 Days)||2
3177138|NCT01968707|3904851|FG006|COMPLETED|Overall Study||204
3177139|NCT01968707|3904852|FG007|COMPLETED|Overall Study||203
3340364|NCT03424044|4071703|FG005|STARTED|Third Rest Period (7-45 Days)||4
3340365|NCT03424044|4071704|FG006|STARTED|Third Rest Period (7-45 Days)||1
3340366|NCT03424044|4071705|FG007|STARTED|Third Rest Period (7-45 Days)||1
3340367|NCT03424044|4071706|FG008|STARTED|Third Rest Period (7-45 Days)||1
3340368|NCT03424044|4071698|FG000|COMPLETED|Third Rest Period (7-45 Days)||4
3340369|NCT03424044|4071699|FG001|COMPLETED|Third Rest Period (7-45 Days)||3
3340370|NCT03424044|4071700|FG002|COMPLETED|Third Rest Period (7-45 Days)||2
3340371|NCT03424044|4071701|FG003|COMPLETED|Third Rest Period (7-45 Days)||3
3340372|NCT03424044|4071702|FG004|COMPLETED|Third Rest Period (7-45 Days)||2
3340373|NCT03424044|4071703|FG005|COMPLETED|Third Rest Period (7-45 Days)||4
3340374|NCT03424044|4071704|FG006|COMPLETED|Third Rest Period (7-45 Days)||1
3340375|NCT03424044|4071705|FG007|COMPLETED|Third Rest Period (7-45 Days)||1
3340376|NCT03424044|4071706|FG008|COMPLETED|Third Rest Period (7-45 Days)||1
3340377|NCT03424044|4071698|FG000|NOT COMPLETED|Third Rest Period (7-45 Days)||0
3340378|NCT03424044|4071699|FG001|NOT COMPLETED|Third Rest Period (7-45 Days)||0
3340379|NCT03424044|4071700|FG002|NOT COMPLETED|Third Rest Period (7-45 Days)||0
3340380|NCT03424044|4071701|FG003|NOT COMPLETED|Third Rest Period (7-45 Days)||0
3340381|NCT03424044|4071702|FG004|NOT COMPLETED|Third Rest Period (7-45 Days)||0
3340382|NCT03424044|4071703|FG005|NOT COMPLETED|Third Rest Period (7-45 Days)||0
3340383|NCT03424044|4071704|FG006|NOT COMPLETED|Third Rest Period (7-45 Days)||0
3340384|NCT03424044|4071705|FG007|NOT COMPLETED|Third Rest Period (7-45 Days)||0
3340385|NCT03424044|4071706|FG008|NOT COMPLETED|Third Rest Period (7-45 Days)||0
3340386|NCT03424044|4071698|FG000|STARTED|Third Intervention (76 Hours)||4
3340387|NCT03424044|4071699|FG001|STARTED|Third Intervention (76 Hours)||3
3340388|NCT03424044|4071700|FG002|STARTED|Third Intervention (76 Hours)||2
3340389|NCT03424044|4071701|FG003|STARTED|Third Intervention (76 Hours)||3
3340390|NCT03424044|4071702|FG004|STARTED|Third Intervention (76 Hours)||2
3340391|NCT03424044|4071703|FG005|STARTED|Third Intervention (76 Hours)||4
3340392|NCT03424044|4071704|FG006|STARTED|Third Intervention (76 Hours)||1
3340393|NCT03424044|4071705|FG007|STARTED|Third Intervention (76 Hours)||1
3340394|NCT03424044|4071706|FG008|STARTED|Third Intervention (76 Hours)||1
3340395|NCT03424044|4071698|FG000|COMPLETED|Third Intervention (76 Hours)||3
3340396|NCT03424044|4071699|FG001|COMPLETED|Third Intervention (76 Hours)||3
3340397|NCT03424044|4071700|FG002|COMPLETED|Third Intervention (76 Hours)||2
3340398|NCT03424044|4071701|FG003|COMPLETED|Third Intervention (76 Hours)||2
3340399|NCT03424044|4071702|FG004|COMPLETED|Third Intervention (76 Hours)||2
3340400|NCT03424044|4071703|FG005|COMPLETED|Third Intervention (76 Hours)||4
3340401|NCT03424044|4071704|FG006|COMPLETED|Third Intervention (76 Hours)||0
3340402|NCT03424044|4071705|FG007|COMPLETED|Third Intervention (76 Hours)||1
3340403|NCT03424044|4071706|FG008|COMPLETED|Third Intervention (76 Hours)||1
3340404|NCT03424044|4071698|FG000|NOT COMPLETED|Third Intervention (76 Hours)||1
3340405|NCT03424044|4071699|FG001|NOT COMPLETED|Third Intervention (76 Hours)||0
3340406|NCT03424044|4071700|FG002|NOT COMPLETED|Third Intervention (76 Hours)||0
3340407|NCT03424044|4071701|FG003|NOT COMPLETED|Third Intervention (76 Hours)||1
3340408|NCT03424044|4071702|FG004|NOT COMPLETED|Third Intervention (76 Hours)||0
3340409|NCT03424044|4071703|FG005|NOT COMPLETED|Third Intervention (76 Hours)||0
3340410|NCT03424044|4071704|FG006|NOT COMPLETED|Third Intervention (76 Hours)||1
3340411|NCT03424044|4071705|FG007|NOT COMPLETED|Third Intervention (76 Hours)||0
3340412|NCT03424044|4071706|FG008|NOT COMPLETED|Third Intervention (76 Hours)||0
3340413|NCT03424044|4071698|FG000|STARTED|Optional Fourth Rest Period (7-45 Days)||0
3340414|NCT03424044|4071699|FG001|STARTED|Optional Fourth Rest Period (7-45 Days)||0
3340415|NCT03424044|4071700|FG002|STARTED|Optional Fourth Rest Period (7-45 Days)||0
3340416|NCT03424044|4071701|FG003|STARTED|Optional Fourth Rest Period (7-45 Days)||0
3340417|NCT03424044|4071702|FG004|STARTED|Optional Fourth Rest Period (7-45 Days)||0
3340418|NCT03424044|4071703|FG005|STARTED|Optional Fourth Rest Period (7-45 Days)||0
3340419|NCT03424044|4071704|FG006|STARTED|Optional Fourth Rest Period (7-45 Days)||0
3340420|NCT03424044|4071705|FG007|STARTED|Optional Fourth Rest Period (7-45 Days)||1
3340421|NCT03424044|4071706|FG008|STARTED|Optional Fourth Rest Period (7-45 Days)||1
3340422|NCT03424044|4071698|FG000|COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
3340423|NCT03424044|4071699|FG001|COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
3340424|NCT03424044|4071700|FG002|COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
3340425|NCT03424044|4071701|FG003|COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
3340426|NCT03424044|4071702|FG004|COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
3340427|NCT03424044|4071703|FG005|COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
3340428|NCT03424044|4071704|FG006|COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
3340429|NCT03424044|4071705|FG007|COMPLETED|Optional Fourth Rest Period (7-45 Days)||1
3340430|NCT03424044|4071706|FG008|COMPLETED|Optional Fourth Rest Period (7-45 Days)||1
3340431|NCT03424044|4071698|FG000|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
3340432|NCT03424044|4071699|FG001|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
3340433|NCT03424044|4071700|FG002|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
3340434|NCT03424044|4071701|FG003|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
3340435|NCT03424044|4071702|FG004|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
3340436|NCT03424044|4071703|FG005|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
3340437|NCT03424044|4071704|FG006|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
3340438|NCT03424044|4071705|FG007|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
3340439|NCT03424044|4071706|FG008|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
3340440|NCT03424044|4071698|FG000|STARTED|Fourth Intervention Repeat Visit (76 hr)||0
3340441|NCT03424044|4071699|FG001|STARTED|Fourth Intervention Repeat Visit (76 hr)||0
3340442|NCT03424044|4071700|FG002|STARTED|Fourth Intervention Repeat Visit (76 hr)||0
3340443|NCT03424044|4071701|FG003|STARTED|Fourth Intervention Repeat Visit (76 hr)||0
3340444|NCT03424044|4071702|FG004|STARTED|Fourth Intervention Repeat Visit (76 hr)||0
3340445|NCT03424044|4071703|FG005|STARTED|Fourth Intervention Repeat Visit (76 hr)||0
3340446|NCT03424044|4071704|FG006|STARTED|Fourth Intervention Repeat Visit (76 hr)||0
3340447|NCT03424044|4071705|FG007|STARTED|Fourth Intervention Repeat Visit (76 hr)||1
3340448|NCT03424044|4071706|FG008|STARTED|Fourth Intervention Repeat Visit (76 hr)||1
3340449|NCT03424044|4071698|FG000|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
3340450|NCT03424044|4071699|FG001|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
3340451|NCT03424044|4071700|FG002|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
3340452|NCT03424044|4071701|FG003|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
3340453|NCT03424044|4071702|FG004|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
3340454|NCT03424044|4071703|FG005|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
3340455|NCT03424044|4071704|FG006|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
3340456|NCT03424044|4071705|FG007|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||1
3340457|NCT03424044|4071706|FG008|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||1
3340458|NCT03424044|4071698|FG000|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
3340459|NCT03424044|4071699|FG001|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
3340460|NCT03424044|4071700|FG002|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
3340461|NCT03424044|4071701|FG003|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
3340462|NCT03424044|4071702|FG004|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
3340463|NCT03424044|4071703|FG005|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
3340464|NCT03424044|4071704|FG006|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
3340465|NCT03424044|4071705|FG007|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
3340466|NCT03424044|4071706|FG008|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
3340467|NCT03424187|4071722|FG000|STARTED|Overall Study||2
3340468|NCT03424187|4071723|FG001|STARTED|Overall Study||3
3340469|NCT03424187|4071724|FG002|STARTED|Overall Study||2
3340470|NCT03424187|4071725|FG003|STARTED|Overall Study||3
3340471|NCT03424187|4071726|FG004|STARTED|Overall Study||2
3340472|NCT03424187|4071727|FG005|STARTED|Overall Study||3
3340473|NCT03424187|4071722|FG000|COMPLETED|Overall Study||2
3340474|NCT03424187|4071723|FG001|COMPLETED|Overall Study||3
3340475|NCT03424187|4071724|FG002|COMPLETED|Overall Study||2
3340476|NCT03424187|4071725|FG003|COMPLETED|Overall Study||3
3340477|NCT03424187|4071726|FG004|COMPLETED|Overall Study||2
3340478|NCT03424187|4071727|FG005|COMPLETED|Overall Study||3
3340479|NCT03424187|4071722|FG000|NOT COMPLETED|Overall Study||0
3340480|NCT03424187|4071723|FG001|NOT COMPLETED|Overall Study||0
3340481|NCT03424187|4071724|FG002|NOT COMPLETED|Overall Study||0
3340482|NCT03424187|4071725|FG003|NOT COMPLETED|Overall Study||0
3340483|NCT03424187|4071726|FG004|NOT COMPLETED|Overall Study||0
3340484|NCT03424187|4071727|FG005|NOT COMPLETED|Overall Study||0
3340485|NCT03424239|4071740|FG000|STARTED|Overall Study||6
3340486|NCT03424239|4071740|FG000|Baseline/Zoledronic Acid Administration|Overall Study||4
3340487|NCT03424239|4071740|FG000|2 Week Post-op|Overall Study||4
3340488|NCT03424239|4071740|FG000|12 Week Post-op|Overall Study||4
3340489|NCT03424239|4071740|FG000|24 Week Post-op|Overall Study||4
3340490|NCT03424239|4071740|FG000|COMPLETED|Overall Study||4
3340491|NCT03424239|4071740|FG000|NOT COMPLETED|Overall Study||2
3340492|NCT03424265|4071746|FG000|STARTED|Overall Study||29
3340493|NCT03424265|4071747|FG001|STARTED|Overall Study||34
3340494|NCT03424265|4071746|FG000|COMPLETED|Overall Study||28
3340495|NCT03424265|4071747|FG001|COMPLETED|Overall Study||32
3340496|NCT03424265|4071746|FG000|NOT COMPLETED|Overall Study||1
3340497|NCT03424265|4071747|FG001|NOT COMPLETED|Overall Study||2
3340498|NCT03424681|4071755|FG000|STARTED|Overall Study||6
3340499|NCT03424681|4071756|FG001|STARTED|Overall Study||6
3340500|NCT03424681|4071755|FG000|COMPLETED|Overall Study||6
3340501|NCT03424681|4071756|FG001|COMPLETED|Overall Study||5
3340502|NCT03424681|4071755|FG000|NOT COMPLETED|Overall Study||0
3340503|NCT03424681|4071756|FG001|NOT COMPLETED|Overall Study||1
3340504|NCT03425019|4071762|FG000|STARTED|Overall Study||20
3340505|NCT03425019|4071762|FG000|COMPLETED|Overall Study||20
3340506|NCT03425019|4071762|FG000|NOT COMPLETED|Overall Study||0
3340507|NCT03425097|4071767|FG000|STARTED|Treatment Period 1 (2 Weeks)||6
3340508|NCT03425097|4071768|FG001|STARTED|Treatment Period 1 (2 Weeks)||5
3340509|NCT03425097|4071767|FG000|COMPLETED|Treatment Period 1 (2 Weeks)||6
3340510|NCT03425097|4071768|FG001|COMPLETED|Treatment Period 1 (2 Weeks)||5
3340511|NCT03425097|4071767|FG000|NOT COMPLETED|Treatment Period 1 (2 Weeks)||0
3340512|NCT03425097|4071768|FG001|NOT COMPLETED|Treatment Period 1 (2 Weeks)||0
3340513|NCT03425097|4071767|FG000|STARTED|Washout Period (1 Week)||6
3340514|NCT03425097|4071768|FG001|STARTED|Washout Period (1 Week)||5
3340515|NCT03425097|4071767|FG000|COMPLETED|Washout Period (1 Week)||6
3340516|NCT03425097|4071768|FG001|COMPLETED|Washout Period (1 Week)||5
3340517|NCT03425097|4071767|FG000|NOT COMPLETED|Washout Period (1 Week)||0
3340518|NCT03425097|4071768|FG001|NOT COMPLETED|Washout Period (1 Week)||0
3340519|NCT03425097|4071767|FG000|STARTED|Second Treatment Period (2 Weeks)||6
3340520|NCT03425097|4071768|FG001|STARTED|Second Treatment Period (2 Weeks)||5
3340521|NCT03425097|4071767|FG000|COMPLETED|Second Treatment Period (2 Weeks)||6
3340522|NCT03425097|4071768|FG001|COMPLETED|Second Treatment Period (2 Weeks)||5
3340523|NCT03425097|4071767|FG000|NOT COMPLETED|Second Treatment Period (2 Weeks)||0
3340524|NCT03425097|4071768|FG001|NOT COMPLETED|Second Treatment Period (2 Weeks)||0
3340525|NCT03425188|4071777|FG000|STARTED|Overall Study||53
3340526|NCT03425188|4071777|FG000|COMPLETED|Overall Study||52
3340527|NCT03425188|4071777|FG000|NOT COMPLETED|Overall Study||1
3340528|NCT03425253|4071782|FG000|STARTED|Overall Study||58
3340529|NCT03425253|4071782|FG000|Safety Analysis Set|Overall Study||53
3340530|NCT03425253|4071782|FG000|FAS|Overall Study||53
3177140|NCT01968707|3904845|FG000|NOT COMPLETED|Overall Study||49
3177141|NCT01968707|3904846|FG001|NOT COMPLETED|Overall Study||12
3177142|NCT01968707|3904847|FG002|NOT COMPLETED|Overall Study||41
3177143|NCT01968707|3904848|FG003|NOT COMPLETED|Overall Study||44
3177144|NCT01968707|3904849|FG004|NOT COMPLETED|Overall Study||36
3177145|NCT01968707|3904850|FG005|NOT COMPLETED|Overall Study||11
3340531|NCT03425253|4071782|FG000|Evaluable Set (ES)|Overall Study||42
3340532|NCT03425253|4071782|FG000|COMPLETED|Overall Study||42
3340533|NCT03425253|4071782|FG000|NOT COMPLETED|Overall Study||16
3340534|NCT03425396|4071792|FG000|STARTED|Overall Study||55
3340535|NCT03425396|4071793|FG001|STARTED|Overall Study||54
3340536|NCT03425396|4071794|FG002|STARTED|Overall Study||54
3340537|NCT03425396|4071795|FG003|STARTED|Overall Study||8
3340538|NCT03425396|4071796|FG004|STARTED|Overall Study||54
3340539|NCT03425396|4071792|FG000|Completed End of Treatment Visit|Overall Study||53
3340540|NCT03425396|4071793|FG001|Completed End of Treatment Visit|Overall Study||52
3340541|NCT03425396|4071794|FG002|Completed End of Treatment Visit|Overall Study||51
3340542|NCT03425396|4071795|FG003|Completed End of Treatment Visit|Overall Study||7
3340543|NCT03425396|4071796|FG004|Completed End of Treatment Visit|Overall Study||53
3340544|NCT03425396|4071792|FG000|Completed Post-therapy Evaluation Visit|Overall Study||53
3340545|NCT03425396|4071793|FG001|Completed Post-therapy Evaluation Visit|Overall Study||49
3340546|NCT03425396|4071794|FG002|Completed Post-therapy Evaluation Visit|Overall Study||51
3340547|NCT03425396|4071795|FG003|Completed Post-therapy Evaluation Visit|Overall Study||7
3340548|NCT03425396|4071796|FG004|Completed Post-therapy Evaluation Visit|Overall Study||54
3340549|NCT03425396|4071792|FG000|Completed Final Follow-up Visit|Overall Study||53
3340550|NCT03425396|4071793|FG001|Completed Final Follow-up Visit|Overall Study||47
3340551|NCT03425396|4071794|FG002|Completed Final Follow-up Visit|Overall Study||51
3340552|NCT03425396|4071795|FG003|Completed Final Follow-up Visit|Overall Study||7
3340553|NCT03425396|4071796|FG004|Completed Final Follow-up Visit|Overall Study||53
3340554|NCT03425396|4071792|FG000|COMPLETED|Overall Study||53
3340555|NCT03425396|4071793|FG001|COMPLETED|Overall Study||47
3340556|NCT03425396|4071794|FG002|COMPLETED|Overall Study||51
3340557|NCT03425396|4071795|FG003|COMPLETED|Overall Study||7
3340558|NCT03425396|4071796|FG004|COMPLETED|Overall Study||53
3340559|NCT03425396|4071792|FG000|NOT COMPLETED|Overall Study||2
3340560|NCT03425396|4071793|FG001|NOT COMPLETED|Overall Study||7
3340561|NCT03425396|4071794|FG002|NOT COMPLETED|Overall Study||3
3340562|NCT03425396|4071795|FG003|NOT COMPLETED|Overall Study||1
3340563|NCT03425396|4071796|FG004|NOT COMPLETED|Overall Study||1
3340564|NCT03426228|4071810|FG000|STARTED|Overall Study||158
3340565|NCT03426228|4071811|FG001|STARTED|Overall Study||191
3340566|NCT03426228|4071810|FG000|COMPLETED|Overall Study||117
3340567|NCT03426228|4071811|FG001|COMPLETED|Overall Study||158
3340568|NCT03426228|4071810|FG000|NOT COMPLETED|Overall Study||41
3340569|NCT03426228|4071811|FG001|NOT COMPLETED|Overall Study||33
3177146|NCT01968707|3904851|FG006|NOT COMPLETED|Overall Study||34
3177147|NCT01968707|3904852|FG007|NOT COMPLETED|Overall Study||35
3340570|NCT03426267|4071821|FG000|STARTED|Overall Study||163
3340571|NCT03426267|4071822|FG001|STARTED|Overall Study||162
3340572|NCT03426267|4071821|FG000|Modified Intent-to-Treat Population|Overall Study||154
3340573|NCT03426267|4071822|FG001|Modified Intent-to-Treat Population|Overall Study||144
3340574|NCT03426267|4071821|FG000|COMPLETED|Overall Study||142
3340575|NCT03426267|4071822|FG001|COMPLETED|Overall Study||90
3340576|NCT03426267|4071821|FG000|NOT COMPLETED|Overall Study||21
3340577|NCT03426267|4071822|FG001|NOT COMPLETED|Overall Study||72
3340578|NCT03426345|4071830|FG000|STARTED|Overall Study||155
3340579|NCT03426345|4071831|FG001|STARTED|Overall Study||156
3340580|NCT03426345|4071830|FG000|Safety Population|Overall Study||152
3340581|NCT03426345|4071831|FG001|Safety Population|Overall Study||155
3340582|NCT03426345|4071830|FG000|COMPLETED|Overall Study||137
3340583|NCT03426345|4071831|FG001|COMPLETED|Overall Study||139
3340584|NCT03426345|4071830|FG000|NOT COMPLETED|Overall Study||18
3340585|NCT03426345|4071831|FG001|NOT COMPLETED|Overall Study||17
3340586|NCT03426436|4071838|FG000|STARTED|Overall Study||314
3340587|NCT03426436|4071838|FG000|COMPLETED|Overall Study||295
3340588|NCT03426436|4071838|FG000|NOT COMPLETED|Overall Study||19
3340589|NCT03426566|4071842|FG000|STARTED|Overall Study||974
3340590|NCT03426566|4071842|FG000|COMPLETED|Overall Study||974
3340591|NCT03426566|4071842|FG000|NOT COMPLETED|Overall Study||0
3340592|NCT03426631|4071848|FG000|STARTED|Overall Study||7
3340593|NCT03426631|4071849|FG001|STARTED|Overall Study||6
3340594|NCT03426631|4071848|FG000|COMPLETED|Overall Study||7
3340595|NCT03426631|4071849|FG001|COMPLETED|Overall Study||5
3340596|NCT03426631|4071848|FG000|NOT COMPLETED|Overall Study||0
3340597|NCT03426631|4071849|FG001|NOT COMPLETED|Overall Study||1
3340598|NCT03426787|4071855|FG000|STARTED|Overall Study||70
3340599|NCT03426787|4071855|FG000|COMPLETED|Overall Study||56
3340600|NCT03426787|4071855|FG000|NOT COMPLETED|Overall Study||14
3340601|NCT03426995|4071884|FG000|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
3340602|NCT03426995|4071885|FG001|STARTED|Part A: Cohort 1-Period 1 (Day1)||2
3340603|NCT03426995|4071886|FG002|STARTED|Part A: Cohort 1-Period 1 (Day1)||1
3340604|NCT03426995|4071887|FG003|STARTED|Part A: Cohort 1-Period 1 (Day1)||2
3340605|NCT03426995|4071888|FG004|STARTED|Part A: Cohort 1-Period 1 (Day1)||1
3340606|NCT03426995|4071889|FG005|STARTED|Part A: Cohort 1-Period 1 (Day1)||1
3340607|NCT03426995|4071890|FG006|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
3340608|NCT03426995|4071891|FG007|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
3340609|NCT03426995|4071892|FG008|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
3340610|NCT03426995|4071893|FG009|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
3340611|NCT03426995|4071894|FG010|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
3340612|NCT03426995|4071895|FG011|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
3340613|NCT03426995|4071896|FG012|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
3340614|NCT03426995|4071897|FG013|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
3340615|NCT03426995|4071898|FG014|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
3340616|NCT03426995|4071899|FG015|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
3340617|NCT03426995|4071900|FG016|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
3340618|NCT03426995|4071901|FG017|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
3340619|NCT03426995|4071902|FG018|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
3340620|NCT03426995|4071884|FG000|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
3340621|NCT03426995|4071885|FG001|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||2
3340622|NCT03426995|4071886|FG002|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
3340623|NCT03426995|4071887|FG003|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||2
3340624|NCT03426995|4071888|FG004|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||1
3340625|NCT03426995|4071889|FG005|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||1
3340626|NCT03426995|4071890|FG006|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
3340627|NCT03426995|4071891|FG007|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
3340628|NCT03426995|4071892|FG008|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
3340629|NCT03426995|4071893|FG009|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
3340630|NCT03426995|4071894|FG010|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
3340631|NCT03426995|4071895|FG011|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
3340632|NCT03426995|4071896|FG012|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
3340633|NCT03426995|4071897|FG013|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
3340634|NCT03426995|4071898|FG014|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
3340635|NCT03426995|4071899|FG015|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
3340636|NCT03426995|4071900|FG016|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
3340637|NCT03426995|4071901|FG017|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
3340638|NCT03426995|4071902|FG018|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
3340639|NCT03426995|4071884|FG000|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
3340640|NCT03426995|4071885|FG001|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
3340641|NCT03426995|4071886|FG002|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||1
3340642|NCT03426995|4071887|FG003|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
3340643|NCT03426995|4071888|FG004|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
3340644|NCT03426995|4071889|FG005|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
3340645|NCT03426995|4071890|FG006|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
3340646|NCT03426995|4071891|FG007|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
3340647|NCT03426995|4071892|FG008|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
3340648|NCT03426995|4071893|FG009|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
3340649|NCT03426995|4071894|FG010|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
3340650|NCT03426995|4071895|FG011|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
3340651|NCT03426995|4071896|FG012|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
3340652|NCT03426995|4071897|FG013|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
3340653|NCT03426995|4071898|FG014|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
3340654|NCT03426995|4071899|FG015|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
3340655|NCT03426995|4071900|FG016|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
3340656|NCT03426995|4071901|FG017|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
3340657|NCT03426995|4071902|FG018|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
3340658|NCT03426995|4071884|FG000|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
3340659|NCT03426995|4071885|FG001|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||2
3340660|NCT03426995|4071886|FG002|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
3340661|NCT03426995|4071887|FG003|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||2
3340662|NCT03426995|4071888|FG004|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||1
3340663|NCT03426995|4071889|FG005|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||1
3340664|NCT03426995|4071890|FG006|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
3340665|NCT03426995|4071891|FG007|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
3340666|NCT03426995|4071892|FG008|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
3340667|NCT03426995|4071893|FG009|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
3340668|NCT03426995|4071894|FG010|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
3340669|NCT03426995|4071895|FG011|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
3340670|NCT03426995|4071896|FG012|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
3340671|NCT03426995|4071897|FG013|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
3340672|NCT03426995|4071898|FG014|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
3340673|NCT03426995|4071899|FG015|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
3340674|NCT03426995|4071900|FG016|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
3340675|NCT03426995|4071901|FG017|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
3340676|NCT03426995|4071902|FG018|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
3340677|NCT03426995|4071884|FG000|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
3340678|NCT03426995|4071885|FG001|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||2
3340679|NCT03426995|4071886|FG002|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
3340680|NCT03426995|4071887|FG003|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||2
3340681|NCT03426995|4071888|FG004|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||1
3340682|NCT03426995|4071889|FG005|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||1
3340683|NCT03426995|4071890|FG006|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
3340684|NCT03426995|4071891|FG007|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
3340685|NCT03426995|4071892|FG008|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
3340686|NCT03426995|4071893|FG009|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
3340687|NCT03426995|4071894|FG010|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
3340688|NCT03426995|4071895|FG011|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
3340689|NCT03426995|4071896|FG012|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
3340690|NCT03426995|4071897|FG013|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
3340691|NCT03426995|4071898|FG014|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
3340692|NCT03426995|4071899|FG015|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
3340693|NCT03426995|4071900|FG016|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
3340694|NCT03426995|4071901|FG017|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
3340695|NCT03426995|4071902|FG018|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
3340696|NCT03426995|4071884|FG000|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
3340697|NCT03426995|4071885|FG001|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
3340698|NCT03426995|4071886|FG002|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
3340699|NCT03426995|4071887|FG003|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
3340700|NCT03426995|4071888|FG004|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
3340701|NCT03426995|4071889|FG005|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
3340702|NCT03426995|4071890|FG006|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
3340703|NCT03426995|4071891|FG007|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
3340704|NCT03426995|4071892|FG008|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
3340705|NCT03426995|4071893|FG009|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
3340706|NCT03426995|4071894|FG010|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
3340707|NCT03426995|4071895|FG011|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
3340708|NCT03426995|4071896|FG012|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
3340709|NCT03426995|4071897|FG013|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
3340710|NCT03426995|4071898|FG014|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
3340711|NCT03426995|4071899|FG015|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
3340712|NCT03426995|4071900|FG016|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
3340713|NCT03426995|4071901|FG017|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
3340714|NCT03426995|4071902|FG018|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
3340715|NCT03426995|4071884|FG000|STARTED|Part A: Cohort 1-Period 2 (Day1)|New participant enrolled and dosed.|1
3340716|NCT03426995|4071885|FG001|STARTED|Part A: Cohort 1-Period 2 (Day1)||2
3340717|NCT03426995|4071886|FG002|STARTED|Part A: Cohort 1-Period 2 (Day1)|New participant enrolled and dosed.|1
3340718|NCT03426995|4071887|FG003|STARTED|Part A: Cohort 1-Period 2 (Day1)||2
3340719|NCT03426995|4071888|FG004|STARTED|Part A: Cohort 1-Period 2 (Day1)||1
3340720|NCT03426995|4071889|FG005|STARTED|Part A: Cohort 1-Period 2 (Day1)|Two additional participants were enrolled and dosed.|3
3340721|NCT03426995|4071890|FG006|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
3340722|NCT03426995|4071891|FG007|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
3340723|NCT03426995|4071892|FG008|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
3340724|NCT03426995|4071893|FG009|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
3340725|NCT03426995|4071894|FG010|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
3340726|NCT03426995|4071895|FG011|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
3340727|NCT03426995|4071896|FG012|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
3340728|NCT03426995|4071897|FG013|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
3340729|NCT03426995|4071898|FG014|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
3340730|NCT03426995|4071899|FG015|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
3340731|NCT03426995|4071900|FG016|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
3340732|NCT03426995|4071901|FG017|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
3340733|NCT03426995|4071902|FG018|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
3340734|NCT03426995|4071884|FG000|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||1
3340735|NCT03426995|4071885|FG001|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||2
3340736|NCT03426995|4071886|FG002|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||1
3340737|NCT03426995|4071887|FG003|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||2
3340738|NCT03426995|4071888|FG004|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
3340739|NCT03426995|4071889|FG005|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||1
3340740|NCT03426995|4071890|FG006|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
3340741|NCT03426995|4071891|FG007|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
3340742|NCT03426995|4071892|FG008|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
3340743|NCT03426995|4071893|FG009|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
3340744|NCT03426995|4071894|FG010|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
3340745|NCT03426995|4071895|FG011|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
3340746|NCT03426995|4071896|FG012|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
3340747|NCT03426995|4071897|FG013|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
3340748|NCT03426995|4071898|FG014|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
3340749|NCT03426995|4071899|FG015|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
3340750|NCT03426995|4071900|FG016|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
3340751|NCT03426995|4071901|FG017|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
3340752|NCT03426995|4071902|FG018|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
3340753|NCT03426995|4071884|FG000|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
3340754|NCT03426995|4071885|FG001|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
3340755|NCT03426995|4071886|FG002|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
3340756|NCT03426995|4071887|FG003|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
3340757|NCT03426995|4071888|FG004|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||1
3340758|NCT03426995|4071889|FG005|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||2
3340759|NCT03426995|4071890|FG006|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
3340760|NCT03426995|4071891|FG007|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
3340761|NCT03426995|4071892|FG008|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
3340762|NCT03426995|4071893|FG009|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
3340763|NCT03426995|4071894|FG010|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
3340764|NCT03426995|4071895|FG011|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
3340765|NCT03426995|4071896|FG012|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
3340766|NCT03426995|4071897|FG013|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
3340767|NCT03426995|4071898|FG014|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
3340768|NCT03426995|4071899|FG015|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
3340769|NCT03426995|4071900|FG016|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
3340770|NCT03426995|4071901|FG017|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
3340771|NCT03426995|4071902|FG018|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
3340772|NCT03426995|4071884|FG000|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||1
3340773|NCT03426995|4071885|FG001|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||2
3340774|NCT03426995|4071886|FG002|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||1
3340775|NCT03426995|4071887|FG003|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||2
3340776|NCT03426995|4071888|FG004|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
3340777|NCT03426995|4071889|FG005|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||1
3340778|NCT03426995|4071890|FG006|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
3340779|NCT03426995|4071891|FG007|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
3340780|NCT03426995|4071892|FG008|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
3340781|NCT03426995|4071893|FG009|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
3340782|NCT03426995|4071894|FG010|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
3340783|NCT03426995|4071895|FG011|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
3340784|NCT03426995|4071896|FG012|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
3340785|NCT03426995|4071897|FG013|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
3340786|NCT03426995|4071898|FG014|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
3340787|NCT03426995|4071899|FG015|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
3340788|NCT03426995|4071900|FG016|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
3340789|NCT03426995|4071901|FG017|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
3340790|NCT03426995|4071902|FG018|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
3340791|NCT03426995|4071884|FG000|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||1
3340792|NCT03426995|4071885|FG001|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||2
3340793|NCT03426995|4071886|FG002|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||1
3340794|NCT03426995|4071887|FG003|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||2
3340795|NCT03426995|4071888|FG004|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
3340796|NCT03426995|4071889|FG005|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||1
3340797|NCT03426995|4071890|FG006|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
3340798|NCT03426995|4071891|FG007|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
3340799|NCT03426995|4071892|FG008|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
3340800|NCT03426995|4071893|FG009|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
3340801|NCT03426995|4071894|FG010|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
3340802|NCT03426995|4071895|FG011|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
3340803|NCT03426995|4071896|FG012|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
3340804|NCT03426995|4071897|FG013|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
3340805|NCT03426995|4071898|FG014|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
3340806|NCT03426995|4071899|FG015|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
3340807|NCT03426995|4071900|FG016|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
3340808|NCT03426995|4071901|FG017|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
3340809|NCT03426995|4071902|FG018|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
3340810|NCT03426995|4071884|FG000|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
3340811|NCT03426995|4071885|FG001|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
3340812|NCT03426995|4071886|FG002|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
3340813|NCT03426995|4071887|FG003|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
3340814|NCT03426995|4071888|FG004|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
3340815|NCT03426995|4071889|FG005|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
3340816|NCT03426995|4071890|FG006|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
3340817|NCT03426995|4071891|FG007|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
3340818|NCT03426995|4071892|FG008|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
3340819|NCT03426995|4071893|FG009|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
3340820|NCT03426995|4071894|FG010|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
3340821|NCT03426995|4071895|FG011|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
3340822|NCT03426995|4071896|FG012|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
3340823|NCT03426995|4071897|FG013|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
3340824|NCT03426995|4071898|FG014|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
3340825|NCT03426995|4071899|FG015|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
3340826|NCT03426995|4071900|FG016|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
3340827|NCT03426995|4071901|FG017|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
3340828|NCT03426995|4071902|FG018|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
3340829|NCT03426995|4071884|FG000|STARTED|Part A: Cohort 1-Period 3 (Day1)||1
3340830|NCT03426995|4071885|FG001|STARTED|Part A: Cohort 1-Period 3 (Day1)||2
3340831|NCT03426995|4071886|FG002|STARTED|Part A: Cohort 1-Period 3 (Day1)||1
3340832|NCT03426995|4071887|FG003|STARTED|Part A: Cohort 1-Period 3 (Day1)||2
3340833|NCT03426995|4071888|FG004|STARTED|Part A: Cohort 1-Period 3 (Day1)|New participant enrolled and dosed.|1
3340834|NCT03426995|4071889|FG005|STARTED|Part A: Cohort 1-Period 3 (Day1)|New participant enrolled and dosed.|2
3340835|NCT03426995|4071890|FG006|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
3340836|NCT03426995|4071891|FG007|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
3340837|NCT03426995|4071892|FG008|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
3340838|NCT03426995|4071893|FG009|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
3340839|NCT03426995|4071894|FG010|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
3340840|NCT03426995|4071895|FG011|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
3340841|NCT03426995|4071896|FG012|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
3340842|NCT03426995|4071897|FG013|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
3340843|NCT03426995|4071898|FG014|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
3340844|NCT03426995|4071899|FG015|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
3340845|NCT03426995|4071900|FG016|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
3340846|NCT03426995|4071901|FG017|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
3340847|NCT03426995|4071902|FG018|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
3340848|NCT03426995|4071884|FG000|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||1
3340849|NCT03426995|4071885|FG001|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||2
3340850|NCT03426995|4071886|FG002|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||1
3340851|NCT03426995|4071887|FG003|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||2
3340852|NCT03426995|4071888|FG004|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||1
3340853|NCT03426995|4071889|FG005|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||2
3340854|NCT03426995|4071890|FG006|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
3340855|NCT03426995|4071891|FG007|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
3340856|NCT03426995|4071892|FG008|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
3340857|NCT03426995|4071893|FG009|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
3340858|NCT03426995|4071894|FG010|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
3340859|NCT03426995|4071895|FG011|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
3340860|NCT03426995|4071896|FG012|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
3340861|NCT03426995|4071897|FG013|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
3340862|NCT03426995|4071898|FG014|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
3340863|NCT03426995|4071899|FG015|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
3340864|NCT03426995|4071900|FG016|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
3340865|NCT03426995|4071901|FG017|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
3340866|NCT03426995|4071902|FG018|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
3340867|NCT03426995|4071884|FG000|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
3340868|NCT03426995|4071885|FG001|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
3340869|NCT03426995|4071886|FG002|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
3340870|NCT03426995|4071887|FG003|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
3340871|NCT03426995|4071888|FG004|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
3340872|NCT03426995|4071889|FG005|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
3340873|NCT03426995|4071890|FG006|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
3340874|NCT03426995|4071891|FG007|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
3340875|NCT03426995|4071892|FG008|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
3340876|NCT03426995|4071893|FG009|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
3340877|NCT03426995|4071894|FG010|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
3340878|NCT03426995|4071895|FG011|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
3340879|NCT03426995|4071896|FG012|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
3340880|NCT03426995|4071897|FG013|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
3340881|NCT03426995|4071898|FG014|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
3340882|NCT03426995|4071899|FG015|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
3340883|NCT03426995|4071900|FG016|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
3340884|NCT03426995|4071901|FG017|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
3340885|NCT03426995|4071902|FG018|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
3340886|NCT03426995|4071884|FG000|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||1
3340887|NCT03426995|4071885|FG001|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||2
3340888|NCT03426995|4071886|FG002|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||1
3340889|NCT03426995|4071887|FG003|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||2
3340890|NCT03426995|4071888|FG004|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||1
3340891|NCT03426995|4071889|FG005|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||2
3340892|NCT03426995|4071890|FG006|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
3340893|NCT03426995|4071891|FG007|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
3340894|NCT03426995|4071892|FG008|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
3340895|NCT03426995|4071893|FG009|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
3340896|NCT03426995|4071894|FG010|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
3340897|NCT03426995|4071895|FG011|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
3340898|NCT03426995|4071896|FG012|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
3340899|NCT03426995|4071897|FG013|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
3340900|NCT03426995|4071898|FG014|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
3340901|NCT03426995|4071899|FG015|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
3340902|NCT03426995|4071900|FG016|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
3340903|NCT03426995|4071901|FG017|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
3340904|NCT03426995|4071902|FG018|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
3340905|NCT03426995|4071884|FG000|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||1
3340906|NCT03426995|4071885|FG001|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||2
3340907|NCT03426995|4071886|FG002|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||1
3340908|NCT03426995|4071887|FG003|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||2
3340909|NCT03426995|4071888|FG004|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||1
3340910|NCT03426995|4071889|FG005|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||2
3340911|NCT03426995|4071890|FG006|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
3340912|NCT03426995|4071891|FG007|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
3340913|NCT03426995|4071892|FG008|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
3340914|NCT03426995|4071893|FG009|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
3340915|NCT03426995|4071894|FG010|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
3340916|NCT03426995|4071895|FG011|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
3340917|NCT03426995|4071896|FG012|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
3340918|NCT03426995|4071897|FG013|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
3340919|NCT03426995|4071898|FG014|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
3340920|NCT03426995|4071899|FG015|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
3340921|NCT03426995|4071900|FG016|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
3340922|NCT03426995|4071901|FG017|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
3340923|NCT03426995|4071902|FG018|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
3340924|NCT03426995|4071884|FG000|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
3340925|NCT03426995|4071885|FG001|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
3340926|NCT03426995|4071886|FG002|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
3340927|NCT03426995|4071887|FG003|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
3340928|NCT03426995|4071888|FG004|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
3340929|NCT03426995|4071889|FG005|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
3340930|NCT03426995|4071890|FG006|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
3340931|NCT03426995|4071891|FG007|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
3340932|NCT03426995|4071892|FG008|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
3340933|NCT03426995|4071893|FG009|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
3340934|NCT03426995|4071894|FG010|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
3340935|NCT03426995|4071895|FG011|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
3340936|NCT03426995|4071896|FG012|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
3340937|NCT03426995|4071897|FG013|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
3340938|NCT03426995|4071898|FG014|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
3340939|NCT03426995|4071899|FG015|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
3340940|NCT03426995|4071900|FG016|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
3340941|NCT03426995|4071901|FG017|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
3340942|NCT03426995|4071902|FG018|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
3340943|NCT03426995|4071884|FG000|STARTED|Part A: Cohort 1-Period 4 (Day1)||1
3340944|NCT03426995|4071885|FG001|STARTED|Part A: Cohort 1-Period 4 (Day1)||2
3340945|NCT03426995|4071886|FG002|STARTED|Part A: Cohort 1-Period 4 (Day1)||1
3340946|NCT03426995|4071887|FG003|STARTED|Part A: Cohort 1-Period 4 (Day1)||2
3340947|NCT03426995|4071888|FG004|STARTED|Part A: Cohort 1-Period 4 (Day1)||1
3340948|NCT03426995|4071889|FG005|STARTED|Part A: Cohort 1-Period 4 (Day1)||2
3340949|NCT03426995|4071890|FG006|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
3340950|NCT03426995|4071891|FG007|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
3340951|NCT03426995|4071892|FG008|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
3340952|NCT03426995|4071893|FG009|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
3340953|NCT03426995|4071894|FG010|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
3340954|NCT03426995|4071895|FG011|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
3340955|NCT03426995|4071896|FG012|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
3340956|NCT03426995|4071897|FG013|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
3340957|NCT03426995|4071898|FG014|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
3340958|NCT03426995|4071899|FG015|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
3340959|NCT03426995|4071900|FG016|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
3340960|NCT03426995|4071901|FG017|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
3340961|NCT03426995|4071902|FG018|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
3340962|NCT03426995|4071884|FG000|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||1
3340963|NCT03426995|4071885|FG001|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||2
3340964|NCT03426995|4071886|FG002|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||1
3340965|NCT03426995|4071887|FG003|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||2
3340966|NCT03426995|4071888|FG004|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||1
3340967|NCT03426995|4071889|FG005|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||2
3340968|NCT03426995|4071890|FG006|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
3340969|NCT03426995|4071891|FG007|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
3340970|NCT03426995|4071892|FG008|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
3340971|NCT03426995|4071893|FG009|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
3340972|NCT03426995|4071894|FG010|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
3340973|NCT03426995|4071895|FG011|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
3340974|NCT03426995|4071896|FG012|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
3340975|NCT03426995|4071897|FG013|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
3340976|NCT03426995|4071898|FG014|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
3340977|NCT03426995|4071899|FG015|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
3340978|NCT03426995|4071900|FG016|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
3340979|NCT03426995|4071901|FG017|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
3340980|NCT03426995|4071902|FG018|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
3340981|NCT03426995|4071884|FG000|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
3340982|NCT03426995|4071885|FG001|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
3340983|NCT03426995|4071886|FG002|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
3340984|NCT03426995|4071887|FG003|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
3340985|NCT03426995|4071888|FG004|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
3340986|NCT03426995|4071889|FG005|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
3340987|NCT03426995|4071890|FG006|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
3340988|NCT03426995|4071891|FG007|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
3340989|NCT03426995|4071892|FG008|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
3340990|NCT03426995|4071893|FG009|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
3340991|NCT03426995|4071894|FG010|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
3340992|NCT03426995|4071895|FG011|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
3340993|NCT03426995|4071896|FG012|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
3340994|NCT03426995|4071897|FG013|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
3340995|NCT03426995|4071898|FG014|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
3177148|NCT01968811|3904885|FG000|STARTED|Overall Study||10
3177149|NCT01968811|3904885|FG000|COMPLETED|Overall Study||5
3177150|NCT01968811|3904885|FG000|NOT COMPLETED|Overall Study||5
3177151|NCT01968954|3904891|FG000|STARTED|Overall Study||354
3177152|NCT01968954|3904892|FG001|STARTED|Overall Study||357
3177153|NCT01968954|3904891|FG000|Treated|Overall Study||353
3177154|NCT01968954|3904892|FG001|Treated|Overall Study||356
3177155|NCT01968954|3904891|FG000|COMPLETED|Overall Study||314
3177156|NCT01968954|3904892|FG001|COMPLETED|Overall Study||314
3340996|NCT03426995|4071899|FG015|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
3340997|NCT03426995|4071900|FG016|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
3340998|NCT03426995|4071901|FG017|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
3340999|NCT03426995|4071902|FG018|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
3177157|NCT01968954|3904891|FG000|NOT COMPLETED|Overall Study||40
3177158|NCT01968954|3904892|FG001|NOT COMPLETED|Overall Study||43
3177159|NCT01968967|3904901|FG000|STARTED|Treatment Period||1071
3177160|NCT01968967|3904902|FG001|STARTED|Treatment Period||1068
3177161|NCT01968967|3904903|FG002|STARTED|Treatment Period||0
3177162|NCT01968967|3904904|FG003|STARTED|Treatment Period||0
3341000|NCT03426995|4071884|FG000|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
3341001|NCT03426995|4071885|FG001|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
3341002|NCT03426995|4071886|FG002|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
3341003|NCT03426995|4071887|FG003|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
3341004|NCT03426995|4071888|FG004|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
3341005|NCT03426995|4071889|FG005|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
3341006|NCT03426995|4071890|FG006|STARTED|Part A: Cohort 2-Period 1 (Day1)||1
3341007|NCT03426995|4071891|FG007|STARTED|Part A: Cohort 2-Period 1 (Day1)||2
3341008|NCT03426995|4071892|FG008|STARTED|Part A: Cohort 2-Period 1 (Day1)||1
3341009|NCT03426995|4071893|FG009|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
3341010|NCT03426995|4071894|FG010|STARTED|Part A: Cohort 2-Period 1 (Day1)||1
3341011|NCT03426995|4071895|FG011|STARTED|Part A: Cohort 2-Period 1 (Day1)||1
3341012|NCT03426995|4071896|FG012|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
3341013|NCT03426995|4071897|FG013|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
3341014|NCT03426995|4071898|FG014|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
3341015|NCT03426995|4071899|FG015|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
3341016|NCT03426995|4071900|FG016|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
3341017|NCT03426995|4071901|FG017|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
3341018|NCT03426995|4071902|FG018|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
3341019|NCT03426995|4071884|FG000|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
3341020|NCT03426995|4071885|FG001|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
3341021|NCT03426995|4071886|FG002|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
3341022|NCT03426995|4071887|FG003|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
3341023|NCT03426995|4071888|FG004|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
3341024|NCT03426995|4071889|FG005|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
3341025|NCT03426995|4071890|FG006|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||1
3341026|NCT03426995|4071891|FG007|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||2
3341027|NCT03426995|4071892|FG008|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||1
3341028|NCT03426995|4071893|FG009|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
3341029|NCT03426995|4071894|FG010|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||1
3341030|NCT03426995|4071895|FG011|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||1
3341031|NCT03426995|4071896|FG012|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
3341032|NCT03426995|4071897|FG013|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
3341033|NCT03426995|4071898|FG014|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
3341034|NCT03426995|4071899|FG015|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
3341035|NCT03426995|4071900|FG016|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
3341036|NCT03426995|4071901|FG017|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
3341037|NCT03426995|4071902|FG018|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
3341038|NCT03426995|4071884|FG000|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
3341039|NCT03426995|4071885|FG001|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
3341040|NCT03426995|4071886|FG002|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
3341041|NCT03426995|4071887|FG003|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
3341042|NCT03426995|4071888|FG004|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
3341043|NCT03426995|4071889|FG005|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
3341044|NCT03426995|4071890|FG006|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
3341045|NCT03426995|4071891|FG007|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
3341046|NCT03426995|4071892|FG008|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
3341047|NCT03426995|4071893|FG009|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
3177163|NCT01968967|3904905|FG004|STARTED|Treatment Period||0
3177164|NCT01968967|3904901|FG000|Treated|Treatment Period||1065
3177165|NCT01968967|3904902|FG001|Treated|Treatment Period||1063
3341048|NCT03426995|4071894|FG010|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
3341049|NCT03426995|4071895|FG011|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
3341050|NCT03426995|4071896|FG012|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
3341051|NCT03426995|4071897|FG013|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
3341052|NCT03426995|4071898|FG014|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
3341053|NCT03426995|4071899|FG015|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
3341054|NCT03426995|4071900|FG016|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
3341055|NCT03426995|4071901|FG017|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
3341056|NCT03426995|4071902|FG018|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
3341057|NCT03426995|4071884|FG000|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
3341058|NCT03426995|4071885|FG001|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
3341059|NCT03426995|4071886|FG002|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
3341060|NCT03426995|4071887|FG003|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
3341061|NCT03426995|4071888|FG004|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
3341062|NCT03426995|4071889|FG005|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
3341063|NCT03426995|4071890|FG006|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||1
3341064|NCT03426995|4071891|FG007|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||2
3341065|NCT03426995|4071892|FG008|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||1
3341066|NCT03426995|4071893|FG009|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
3341067|NCT03426995|4071894|FG010|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||1
3341068|NCT03426995|4071895|FG011|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||1
3341069|NCT03426995|4071896|FG012|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
3341070|NCT03426995|4071897|FG013|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
3341071|NCT03426995|4071898|FG014|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
3341072|NCT03426995|4071899|FG015|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
3341073|NCT03426995|4071900|FG016|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
3341074|NCT03426995|4071901|FG017|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
3341075|NCT03426995|4071902|FG018|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
3341076|NCT03426995|4071884|FG000|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
3341077|NCT03426995|4071885|FG001|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
3341078|NCT03426995|4071886|FG002|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
3341079|NCT03426995|4071887|FG003|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
3341080|NCT03426995|4071888|FG004|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
3341081|NCT03426995|4071889|FG005|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
3341082|NCT03426995|4071890|FG006|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||1
3341083|NCT03426995|4071891|FG007|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||2
3341084|NCT03426995|4071892|FG008|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||1
3341085|NCT03426995|4071893|FG009|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
3341086|NCT03426995|4071894|FG010|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||1
3341087|NCT03426995|4071895|FG011|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||1
3341088|NCT03426995|4071896|FG012|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
3341089|NCT03426995|4071897|FG013|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
3341090|NCT03426995|4071898|FG014|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
3341091|NCT03426995|4071899|FG015|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
3341092|NCT03426995|4071900|FG016|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
3341093|NCT03426995|4071901|FG017|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
3341094|NCT03426995|4071902|FG018|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
3341095|NCT03426995|4071884|FG000|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
3341096|NCT03426995|4071885|FG001|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
3341097|NCT03426995|4071886|FG002|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
3341098|NCT03426995|4071887|FG003|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
3341099|NCT03426995|4071888|FG004|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
3341100|NCT03426995|4071889|FG005|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
3341101|NCT03426995|4071890|FG006|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
3341102|NCT03426995|4071891|FG007|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
3177166|NCT01968967|3904903|FG002|Treated|Treatment Period||0
3177167|NCT01968967|3904904|FG003|Treated|Treatment Period||0
3177168|NCT01968967|3904905|FG004|Treated|Treatment Period||0
3177169|NCT01968967|3904901|FG000|COMPLETED|Treatment Period||925
3177170|NCT01968967|3904902|FG001|COMPLETED|Treatment Period||934
3177171|NCT01968967|3904903|FG002|COMPLETED|Treatment Period||0
3177172|NCT01968967|3904904|FG003|COMPLETED|Treatment Period||0
3177173|NCT01968967|3904905|FG004|COMPLETED|Treatment Period||0
3177174|NCT01968967|3904901|FG000|NOT COMPLETED|Treatment Period||146
3177175|NCT01968967|3904902|FG001|NOT COMPLETED|Treatment Period||134
3177176|NCT01968967|3904903|FG002|NOT COMPLETED|Treatment Period||0
3177177|NCT01968967|3904904|FG003|NOT COMPLETED|Treatment Period||0
3177178|NCT01968967|3904905|FG004|NOT COMPLETED|Treatment Period||0
3177179|NCT01968967|3904901|FG000|STARTED|Extension Period||0
3177180|NCT01968967|3904902|FG001|STARTED|Extension Period||0
3177181|NCT01968967|3904903|FG002|STARTED|Extension Period||47
3177182|NCT01968967|3904904|FG003|STARTED|Extension Period||19
3177183|NCT01968967|3904905|FG004|STARTED|Extension Period||39
3177184|NCT01968967|3904901|FG000|COMPLETED|Extension Period||0
3177185|NCT01968967|3904902|FG001|COMPLETED|Extension Period||0
3177186|NCT01968967|3904903|FG002|COMPLETED|Extension Period||45
3177187|NCT01968967|3904904|FG003|COMPLETED|Extension Period||19
3177188|NCT01968967|3904905|FG004|COMPLETED|Extension Period||34
3177189|NCT01968967|3904901|FG000|NOT COMPLETED|Extension Period||0
3177190|NCT01968967|3904902|FG001|NOT COMPLETED|Extension Period||0
3177191|NCT01968967|3904903|FG002|NOT COMPLETED|Extension Period||2
3177192|NCT01968967|3904904|FG003|NOT COMPLETED|Extension Period||0
3177193|NCT01968967|3904905|FG004|NOT COMPLETED|Extension Period||5
3177194|NCT01968980|3904921|FG000|STARTED|Overall Study||185
3177195|NCT01968980|3904922|FG001|STARTED|Overall Study||185
3177196|NCT01968980|3904921|FG000|COMPLETED|Overall Study||169
3177197|NCT01968980|3904922|FG001|COMPLETED|Overall Study||171
3177198|NCT01968980|3904921|FG000|NOT COMPLETED|Overall Study||16
3177199|NCT01968980|3904922|FG001|NOT COMPLETED|Overall Study||14
3177200|NCT01969058|3904931|FG000|STARTED|Overall Study||50
3177201|NCT01969058|3904932|FG001|STARTED|Overall Study||26
3177202|NCT01969058|3904931|FG000|COMPLETED|Overall Study||47
3177203|NCT01969058|3904932|FG001|COMPLETED|Overall Study||26
3177204|NCT01969058|3904931|FG000|NOT COMPLETED|Overall Study||3
3177205|NCT01969058|3904932|FG001|NOT COMPLETED|Overall Study||0
3177206|NCT01969084|3904940|FG000|STARTED|Overall Study||19
3177207|NCT01969084|3904941|FG001|STARTED|Overall Study||22
3177208|NCT01969084|3904940|FG000|COMPLETED|Overall Study||19
3177209|NCT01969084|3904941|FG001|COMPLETED|Overall Study|One subject withdrew due to unrelated serious adverse event|21
3177210|NCT01969084|3904940|FG000|NOT COMPLETED|Overall Study||0
3177211|NCT01969084|3904941|FG001|NOT COMPLETED|Overall Study||1
3177212|NCT01969162|3904951|FG000|STARTED|Overall Study||35
3177213|NCT01969162|3904951|FG000|COMPLETED|Overall Study||35
3177214|NCT01969162|3904951|FG000|NOT COMPLETED|Overall Study||0
3177215|NCT01969201|3904957|FG000|STARTED|Overall Study||352
3177216|NCT01969201|3904958|FG001|STARTED|Overall Study||358
3177217|NCT01969201|3904957|FG000|COMPLETED|Overall Study||307
3177218|NCT01969201|3904958|FG001|COMPLETED|Overall Study||313
3177219|NCT01969201|3904957|FG000|NOT COMPLETED|Overall Study||45
3177220|NCT01969201|3904958|FG001|NOT COMPLETED|Overall Study||45
3177221|NCT01969214|3904964|FG000|STARTED|Overall Study||101
3177222|NCT01969214|3904964|FG000|COMPLETED|Overall Study||86
3177223|NCT01969214|3904964|FG000|NOT COMPLETED|Overall Study||15
3177224|NCT01969240|3904970|FG000|STARTED|Overall Study||451
3177225|NCT01969240|3904971|FG001|STARTED|Overall Study||447
3177226|NCT01969240|3904970|FG000|COMPLETED|Overall Study||451
3177227|NCT01969240|3904971|FG001|COMPLETED|Overall Study||447
3177228|NCT01969240|3904970|FG000|NOT COMPLETED|Overall Study||0
3177229|NCT01969240|3904971|FG001|NOT COMPLETED|Overall Study||0
3177230|NCT01969435|3904979|FG000|STARTED|Overall Study||50
3177231|NCT01969435|3904979|FG000|COMPLETED|Overall Study||50
3177232|NCT01969435|3904979|FG000|NOT COMPLETED|Overall Study||0
3177233|NCT01969448|3904986|FG000|STARTED|Overall Study||55
3177234|NCT01969448|3904987|FG001|STARTED|Overall Study||24
3177235|NCT01969448|3904988|FG002|STARTED|Overall Study||0
3177236|NCT01969448|3904986|FG000|COMPLETED|Overall Study||55
3177237|NCT01969448|3904987|FG001|COMPLETED|Overall Study||24
3177238|NCT01969448|3904988|FG002|COMPLETED|Overall Study||0
3177239|NCT01969448|3904986|FG000|NOT COMPLETED|Overall Study||0
3177240|NCT01969448|3904987|FG001|NOT COMPLETED|Overall Study||0
3177241|NCT01969448|3904988|FG002|NOT COMPLETED|Overall Study||0
3177242|NCT01969500|3904998|FG000|STARTED|Overall Study||25
3341103|NCT03426995|4071892|FG008|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
3341104|NCT03426995|4071893|FG009|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
3341105|NCT03426995|4071894|FG010|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
3341106|NCT03426995|4071895|FG011|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
3341107|NCT03426995|4071896|FG012|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
3341108|NCT03426995|4071897|FG013|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
3341109|NCT03426995|4071898|FG014|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
3341110|NCT03426995|4071899|FG015|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
3341111|NCT03426995|4071900|FG016|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
3341112|NCT03426995|4071901|FG017|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
3341113|NCT03426995|4071902|FG018|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
3341114|NCT03426995|4071884|FG000|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
3341115|NCT03426995|4071885|FG001|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
3341116|NCT03426995|4071886|FG002|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
3341117|NCT03426995|4071887|FG003|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
3341118|NCT03426995|4071888|FG004|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
3341119|NCT03426995|4071889|FG005|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
3177243|NCT01969500|3904999|FG001|STARTED|Overall Study||26
3177244|NCT01969500|3904998|FG000|COMPLETED|Overall Study||24
3177245|NCT01969500|3904999|FG001|COMPLETED|Overall Study||24
3177246|NCT01969500|3904998|FG000|NOT COMPLETED|Overall Study||1
3177247|NCT01969500|3904999|FG001|NOT COMPLETED|Overall Study||2
3177248|NCT01969539|3905005|FG000|STARTED|Overall Study||11
3341120|NCT03426995|4071890|FG006|STARTED|Part A: Cohort 2-Period 2 (Day1)||1
3341121|NCT03426995|4071891|FG007|STARTED|Part A: Cohort 2-Period 2 (Day1)||2
3341122|NCT03426995|4071892|FG008|STARTED|Part A: Cohort 2-Period 2 (Day1)||1
3341123|NCT03426995|4071893|FG009|STARTED|Part A: Cohort 2-Period 2 (Day1)|Two additional participants were enrolled and dosed.|2
3341124|NCT03426995|4071894|FG010|STARTED|Part A: Cohort 2-Period 2 (Day1)||1
3341125|NCT03426995|4071895|FG011|STARTED|Part A: Cohort 2-Period 2 (Day1)|New participant enrolled and dosed.|2
3341126|NCT03426995|4071896|FG012|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
3341127|NCT03426995|4071897|FG013|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
3341128|NCT03426995|4071898|FG014|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
3341129|NCT03426995|4071899|FG015|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
3341130|NCT03426995|4071900|FG016|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
3341131|NCT03426995|4071901|FG017|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
3341132|NCT03426995|4071902|FG018|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
3341133|NCT03426995|4071884|FG000|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
3341134|NCT03426995|4071885|FG001|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
3341135|NCT03426995|4071886|FG002|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
3341136|NCT03426995|4071887|FG003|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
3341137|NCT03426995|4071888|FG004|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
3341138|NCT03426995|4071889|FG005|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
3341139|NCT03426995|4071890|FG006|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||1
3341140|NCT03426995|4071891|FG007|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||2
3341141|NCT03426995|4071892|FG008|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||1
3341142|NCT03426995|4071893|FG009|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||2
3341143|NCT03426995|4071894|FG010|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||1
3341144|NCT03426995|4071895|FG011|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||2
3341145|NCT03426995|4071896|FG012|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
3341146|NCT03426995|4071897|FG013|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
3341147|NCT03426995|4071898|FG014|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
3341148|NCT03426995|4071899|FG015|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
3341149|NCT03426995|4071900|FG016|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
3341150|NCT03426995|4071901|FG017|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
3341151|NCT03426995|4071902|FG018|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
3341152|NCT03426995|4071884|FG000|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
3341153|NCT03426995|4071885|FG001|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
3341154|NCT03426995|4071886|FG002|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
3341155|NCT03426995|4071887|FG003|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
3177249|NCT01969539|3905005|FG000|COMPLETED|Overall Study||11
3177250|NCT01969539|3905005|FG000|NOT COMPLETED|Overall Study||0
3177251|NCT01969708|3905011|FG000|STARTED|Overall Study||180
3177252|NCT01969708|3905012|FG001|STARTED|Overall Study||182
3177253|NCT01969708|3905011|FG000|COMPLETED|Overall Study||175
3177254|NCT01969708|3905012|FG001|COMPLETED|Overall Study||173
3341156|NCT03426995|4071888|FG004|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
3341157|NCT03426995|4071889|FG005|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
3341158|NCT03426995|4071890|FG006|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
3177255|NCT01969708|3905011|FG000|NOT COMPLETED|Overall Study||5
3341159|NCT03426995|4071891|FG007|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
3341160|NCT03426995|4071892|FG008|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
3341161|NCT03426995|4071893|FG009|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
3341162|NCT03426995|4071894|FG010|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
3341163|NCT03426995|4071895|FG011|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
3177256|NCT01969708|3905012|FG001|NOT COMPLETED|Overall Study||9
3177257|NCT01969721|3905018|FG000|STARTED|Overall Study||58
3177258|NCT01969721|3905019|FG001|STARTED|Overall Study||69
3341164|NCT03426995|4071896|FG012|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
3341165|NCT03426995|4071897|FG013|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
3341166|NCT03426995|4071898|FG014|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
3341167|NCT03426995|4071899|FG015|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
3341168|NCT03426995|4071900|FG016|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
3341169|NCT03426995|4071901|FG017|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
3341170|NCT03426995|4071902|FG018|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
3341171|NCT03426995|4071884|FG000|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
3341172|NCT03426995|4071885|FG001|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
3341173|NCT03426995|4071886|FG002|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
3341174|NCT03426995|4071887|FG003|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
3341175|NCT03426995|4071888|FG004|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
3341176|NCT03426995|4071889|FG005|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
3341177|NCT03426995|4071890|FG006|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||1
3341178|NCT03426995|4071891|FG007|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||2
3341179|NCT03426995|4071892|FG008|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||1
3341180|NCT03426995|4071893|FG009|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||2
3341181|NCT03426995|4071894|FG010|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||1
3341182|NCT03426995|4071895|FG011|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||2
3341183|NCT03426995|4071896|FG012|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
3341184|NCT03426995|4071897|FG013|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
3341185|NCT03426995|4071898|FG014|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
3341186|NCT03426995|4071899|FG015|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
3341187|NCT03426995|4071900|FG016|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
3177259|NCT01969721|3905020|FG002|STARTED|Overall Study||50
3177260|NCT01969721|3905021|FG003|STARTED|Overall Study||52
3177261|NCT01969721|3905018|FG000|COMPLETED|Overall Study||54
3177262|NCT01969721|3905019|FG001|COMPLETED|Overall Study||57
3177263|NCT01969721|3905020|FG002|COMPLETED|Overall Study||45
3177264|NCT01969721|3905021|FG003|COMPLETED|Overall Study||46
3177265|NCT01969721|3905018|FG000|NOT COMPLETED|Overall Study||4
3177266|NCT01969721|3905019|FG001|NOT COMPLETED|Overall Study||12
3177267|NCT01969721|3905020|FG002|NOT COMPLETED|Overall Study||5
3177268|NCT01969721|3905021|FG003|NOT COMPLETED|Overall Study||6
3177269|NCT01969747|3905035|FG000|STARTED|Overall Study||19
3177270|NCT01969747|3905036|FG001|STARTED|Overall Study||19
3177271|NCT01969747|3905037|FG002|STARTED|Overall Study||19
3177272|NCT01969747|3905038|FG003|STARTED|Overall Study||18
3177273|NCT01969747|3905035|FG000|COMPLETED|Overall Study||19
3177274|NCT01969747|3905036|FG001|COMPLETED|Overall Study||19
3177275|NCT01969747|3905037|FG002|COMPLETED|Overall Study||19
3177276|NCT01969747|3905038|FG003|COMPLETED|Overall Study||18
3177277|NCT01969747|3905035|FG000|NOT COMPLETED|Overall Study||0
3177278|NCT01969747|3905036|FG001|NOT COMPLETED|Overall Study||0
3177279|NCT01969747|3905037|FG002|NOT COMPLETED|Overall Study||0
3177280|NCT01969747|3905038|FG003|NOT COMPLETED|Overall Study||0
3177281|NCT01969799|3905050|FG000|STARTED|Overall Study||71
3177282|NCT01969799|3905051|FG001|STARTED|Overall Study||72
3177283|NCT01969799|3905050|FG000|COMPLETED|Overall Study||54
3177284|NCT01969799|3905051|FG001|COMPLETED|Overall Study||58
3177285|NCT01969799|3905050|FG000|NOT COMPLETED|Overall Study||17
3177286|NCT01969799|3905051|FG001|NOT COMPLETED|Overall Study||14
3341188|NCT03426995|4071901|FG017|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
3341189|NCT03426995|4071902|FG018|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
3341190|NCT03426995|4071884|FG000|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
3341191|NCT03426995|4071885|FG001|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
3341192|NCT03426995|4071886|FG002|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
3341193|NCT03426995|4071887|FG003|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
3341194|NCT03426995|4071888|FG004|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
3341195|NCT03426995|4071889|FG005|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
3341196|NCT03426995|4071890|FG006|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||1
3341197|NCT03426995|4071891|FG007|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||2
3341198|NCT03426995|4071892|FG008|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||1
3341199|NCT03426995|4071893|FG009|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||2
3341200|NCT03426995|4071894|FG010|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||1
3341201|NCT03426995|4071895|FG011|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||2
3341202|NCT03426995|4071896|FG012|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
3341203|NCT03426995|4071897|FG013|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
3341204|NCT03426995|4071898|FG014|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
3341205|NCT03426995|4071899|FG015|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
3341206|NCT03426995|4071900|FG016|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
3341207|NCT03426995|4071901|FG017|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
3341208|NCT03426995|4071902|FG018|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
3341209|NCT03426995|4071884|FG000|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
3177287|NCT01969812|3905059|FG000|STARTED|Overall Study||12
3177288|NCT01969812|3905060|FG001|STARTED|Overall Study||10
3177289|NCT01969812|3905059|FG000|COMPLETED|Overall Study||12
3177290|NCT01969812|3905060|FG001|COMPLETED|Overall Study||10
3177291|NCT01969812|3905059|FG000|NOT COMPLETED|Overall Study||0
3177292|NCT01969812|3905060|FG001|NOT COMPLETED|Overall Study||0
3341210|NCT03426995|4071885|FG001|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
3341211|NCT03426995|4071886|FG002|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
3341212|NCT03426995|4071887|FG003|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
3341213|NCT03426995|4071888|FG004|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
3341214|NCT03426995|4071889|FG005|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
3341215|NCT03426995|4071890|FG006|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
3341216|NCT03426995|4071891|FG007|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
3341217|NCT03426995|4071892|FG008|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
3341218|NCT03426995|4071893|FG009|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
3341219|NCT03426995|4071894|FG010|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
3341220|NCT03426995|4071895|FG011|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
3341221|NCT03426995|4071896|FG012|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
3341222|NCT03426995|4071897|FG013|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
3341223|NCT03426995|4071898|FG014|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
3341224|NCT03426995|4071899|FG015|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
3341225|NCT03426995|4071900|FG016|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
3341226|NCT03426995|4071901|FG017|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
3341227|NCT03426995|4071902|FG018|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
3341228|NCT03426995|4071884|FG000|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
3341229|NCT03426995|4071885|FG001|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
3341230|NCT03426995|4071886|FG002|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
3341231|NCT03426995|4071887|FG003|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
3341232|NCT03426995|4071888|FG004|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
3341233|NCT03426995|4071889|FG005|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
3341234|NCT03426995|4071890|FG006|STARTED|Part A: Cohort 2-Period 3 (Day1)||1
3341235|NCT03426995|4071891|FG007|STARTED|Part A: Cohort 2-Period 3 (Day1)||2
3341236|NCT03426995|4071892|FG008|STARTED|Part A: Cohort 2-Period 3 (Day1)||1
3341237|NCT03426995|4071893|FG009|STARTED|Part A: Cohort 2-Period 3 (Day1)||2
3341238|NCT03426995|4071894|FG010|STARTED|Part A: Cohort 2-Period 3 (Day1)||1
3341239|NCT03426995|4071895|FG011|STARTED|Part A: Cohort 2-Period 3 (Day1)||2
3341240|NCT03426995|4071896|FG012|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
3341241|NCT03426995|4071897|FG013|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
3341242|NCT03426995|4071898|FG014|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
3341243|NCT03426995|4071899|FG015|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
3341244|NCT03426995|4071900|FG016|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
3341245|NCT03426995|4071901|FG017|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
3341246|NCT03426995|4071902|FG018|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
3341247|NCT03426995|4071884|FG000|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
3341248|NCT03426995|4071885|FG001|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
3341249|NCT03426995|4071886|FG002|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
3341250|NCT03426995|4071887|FG003|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
3341251|NCT03426995|4071888|FG004|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
3341252|NCT03426995|4071889|FG005|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
3341253|NCT03426995|4071890|FG006|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||1
3341254|NCT03426995|4071891|FG007|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||2
3341255|NCT03426995|4071892|FG008|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||1
3341256|NCT03426995|4071893|FG009|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||2
3341257|NCT03426995|4071894|FG010|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||1
3341258|NCT03426995|4071895|FG011|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||2
3341259|NCT03426995|4071896|FG012|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
3341260|NCT03426995|4071897|FG013|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
3341261|NCT03426995|4071898|FG014|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
3341262|NCT03426995|4071899|FG015|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
3341263|NCT03426995|4071900|FG016|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
3341264|NCT03426995|4071901|FG017|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
3341265|NCT03426995|4071902|FG018|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
3341266|NCT03426995|4071884|FG000|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
3341267|NCT03426995|4071885|FG001|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
3341268|NCT03426995|4071886|FG002|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
3341269|NCT03426995|4071887|FG003|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
3341270|NCT03426995|4071888|FG004|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
3341271|NCT03426995|4071889|FG005|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
3341272|NCT03426995|4071890|FG006|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
3341273|NCT03426995|4071891|FG007|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
3341274|NCT03426995|4071892|FG008|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
3341275|NCT03426995|4071893|FG009|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
3341276|NCT03426995|4071894|FG010|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
3341277|NCT03426995|4071895|FG011|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
3341278|NCT03426995|4071896|FG012|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
3341279|NCT03426995|4071897|FG013|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
3341280|NCT03426995|4071898|FG014|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
3341281|NCT03426995|4071899|FG015|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
3341282|NCT03426995|4071900|FG016|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
3341283|NCT03426995|4071901|FG017|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
3341284|NCT03426995|4071902|FG018|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
3341285|NCT03426995|4071884|FG000|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
3341286|NCT03426995|4071885|FG001|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
3341287|NCT03426995|4071886|FG002|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
3341288|NCT03426995|4071887|FG003|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
3341289|NCT03426995|4071888|FG004|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
3341290|NCT03426995|4071889|FG005|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
3341291|NCT03426995|4071890|FG006|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||1
3341292|NCT03426995|4071891|FG007|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||2
3341293|NCT03426995|4071892|FG008|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||1
3341294|NCT03426995|4071893|FG009|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||2
3341295|NCT03426995|4071894|FG010|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||1
3341296|NCT03426995|4071895|FG011|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||2
3341297|NCT03426995|4071896|FG012|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
3341298|NCT03426995|4071897|FG013|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
3341299|NCT03426995|4071898|FG014|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
3341300|NCT03426995|4071899|FG015|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
3341301|NCT03426995|4071900|FG016|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
3341302|NCT03426995|4071901|FG017|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
3341303|NCT03426995|4071902|FG018|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
3341304|NCT03426995|4071884|FG000|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
3341305|NCT03426995|4071885|FG001|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
3341306|NCT03426995|4071886|FG002|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
3341307|NCT03426995|4071887|FG003|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
3341308|NCT03426995|4071888|FG004|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
3341309|NCT03426995|4071889|FG005|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
3341310|NCT03426995|4071890|FG006|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||1
3341311|NCT03426995|4071891|FG007|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||2
3341312|NCT03426995|4071892|FG008|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||1
3341313|NCT03426995|4071893|FG009|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||2
3341314|NCT03426995|4071894|FG010|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||1
3341315|NCT03426995|4071895|FG011|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||2
3341316|NCT03426995|4071896|FG012|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
3341317|NCT03426995|4071897|FG013|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
3341318|NCT03426995|4071898|FG014|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
3341319|NCT03426995|4071899|FG015|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
3341320|NCT03426995|4071900|FG016|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
3341321|NCT03426995|4071901|FG017|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
3341322|NCT03426995|4071902|FG018|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
3341323|NCT03426995|4071884|FG000|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
3341324|NCT03426995|4071885|FG001|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
3341325|NCT03426995|4071886|FG002|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
3341326|NCT03426995|4071887|FG003|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
3341327|NCT03426995|4071888|FG004|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
3341328|NCT03426995|4071889|FG005|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
3341329|NCT03426995|4071890|FG006|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
3341330|NCT03426995|4071891|FG007|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
3341331|NCT03426995|4071892|FG008|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
3341332|NCT03426995|4071893|FG009|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
3341333|NCT03426995|4071894|FG010|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
3341334|NCT03426995|4071895|FG011|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
3341335|NCT03426995|4071896|FG012|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
3341336|NCT03426995|4071897|FG013|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
3341337|NCT03426995|4071898|FG014|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
3341338|NCT03426995|4071899|FG015|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
3341339|NCT03426995|4071900|FG016|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
3341340|NCT03426995|4071901|FG017|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
3341341|NCT03426995|4071902|FG018|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
3341342|NCT03426995|4071884|FG000|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
3341343|NCT03426995|4071885|FG001|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
3341344|NCT03426995|4071886|FG002|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
3341345|NCT03426995|4071887|FG003|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
3341346|NCT03426995|4071888|FG004|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
3341347|NCT03426995|4071889|FG005|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
3341348|NCT03426995|4071890|FG006|STARTED|Part A: Cohort 2-Period 4 (Day1)||1
3341349|NCT03426995|4071891|FG007|STARTED|Part A: Cohort 2-Period 4 (Day1)|New participant enrolled and dosed.|3
3341350|NCT03426995|4071892|FG008|STARTED|Part A: Cohort 2-Period 4 (Day1)||1
3341351|NCT03426995|4071893|FG009|STARTED|Part A: Cohort 2-Period 4 (Day1)||2
3341352|NCT03426995|4071894|FG010|STARTED|Part A: Cohort 2-Period 4 (Day1)||1
3341353|NCT03426995|4071895|FG011|STARTED|Part A: Cohort 2-Period 4 (Day1)||2
3341354|NCT03426995|4071896|FG012|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
3341355|NCT03426995|4071897|FG013|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
3341356|NCT03426995|4071898|FG014|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
3341357|NCT03426995|4071899|FG015|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
3341358|NCT03426995|4071900|FG016|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
3341359|NCT03426995|4071901|FG017|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
3341360|NCT03426995|4071902|FG018|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
3341361|NCT03426995|4071884|FG000|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
3341362|NCT03426995|4071885|FG001|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
3341363|NCT03426995|4071886|FG002|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
3341364|NCT03426995|4071887|FG003|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
3341365|NCT03426995|4071888|FG004|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
3341366|NCT03426995|4071889|FG005|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
3341367|NCT03426995|4071890|FG006|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||1
3341368|NCT03426995|4071891|FG007|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||2
3341369|NCT03426995|4071892|FG008|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||1
3341370|NCT03426995|4071893|FG009|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||2
3341371|NCT03426995|4071894|FG010|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
3341372|NCT03426995|4071895|FG011|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||2
3341373|NCT03426995|4071896|FG012|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
3341374|NCT03426995|4071897|FG013|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
3341375|NCT03426995|4071898|FG014|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
3341376|NCT03426995|4071899|FG015|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
3341377|NCT03426995|4071900|FG016|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
3341378|NCT03426995|4071901|FG017|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
3341379|NCT03426995|4071902|FG018|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
3341380|NCT03426995|4071884|FG000|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
3341381|NCT03426995|4071885|FG001|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
3341382|NCT03426995|4071886|FG002|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
3341383|NCT03426995|4071887|FG003|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
3341384|NCT03426995|4071888|FG004|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
3341385|NCT03426995|4071889|FG005|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
3341386|NCT03426995|4071890|FG006|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
3341387|NCT03426995|4071891|FG007|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||1
3341388|NCT03426995|4071892|FG008|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
3341389|NCT03426995|4071893|FG009|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
3341390|NCT03426995|4071894|FG010|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||1
3341391|NCT03426995|4071895|FG011|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
3341392|NCT03426995|4071896|FG012|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
3341393|NCT03426995|4071897|FG013|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
3341394|NCT03426995|4071898|FG014|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
3341395|NCT03426995|4071899|FG015|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
3341396|NCT03426995|4071900|FG016|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
3341397|NCT03426995|4071901|FG017|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
3341398|NCT03426995|4071902|FG018|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
3341399|NCT03426995|4071884|FG000|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
3341400|NCT03426995|4071885|FG001|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
3341401|NCT03426995|4071886|FG002|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
3341402|NCT03426995|4071887|FG003|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
3341403|NCT03426995|4071888|FG004|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
3341404|NCT03426995|4071889|FG005|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
3341405|NCT03426995|4071890|FG006|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
3341406|NCT03426995|4071891|FG007|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
3341407|NCT03426995|4071892|FG008|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
3341408|NCT03426995|4071893|FG009|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
3341409|NCT03426995|4071894|FG010|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
3341410|NCT03426995|4071895|FG011|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
3341411|NCT03426995|4071896|FG012|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
3341412|NCT03426995|4071897|FG013|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
3341413|NCT03426995|4071898|FG014|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
3341414|NCT03426995|4071899|FG015|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
3341415|NCT03426995|4071900|FG016|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
3341416|NCT03426995|4071901|FG017|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
3341417|NCT03426995|4071902|FG018|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
3341418|NCT03426995|4071884|FG000|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
3341419|NCT03426995|4071885|FG001|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
3341420|NCT03426995|4071886|FG002|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
3341421|NCT03426995|4071887|FG003|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
3341422|NCT03426995|4071888|FG004|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
3341423|NCT03426995|4071889|FG005|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
3341424|NCT03426995|4071890|FG006|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
3341425|NCT03426995|4071891|FG007|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
3341426|NCT03426995|4071892|FG008|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
3341427|NCT03426995|4071893|FG009|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
3341428|NCT03426995|4071894|FG010|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
3341429|NCT03426995|4071895|FG011|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
3341430|NCT03426995|4071896|FG012|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
3341431|NCT03426995|4071897|FG013|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
3341432|NCT03426995|4071898|FG014|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
3341433|NCT03426995|4071899|FG015|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
3341434|NCT03426995|4071900|FG016|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
3341435|NCT03426995|4071901|FG017|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
3341436|NCT03426995|4071902|FG018|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
3341437|NCT03426995|4071884|FG000|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
3341438|NCT03426995|4071885|FG001|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
3341439|NCT03426995|4071886|FG002|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
3341440|NCT03426995|4071887|FG003|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
3341441|NCT03426995|4071888|FG004|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
3341442|NCT03426995|4071889|FG005|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
3341443|NCT03426995|4071890|FG006|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
3341444|NCT03426995|4071891|FG007|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
3341445|NCT03426995|4071892|FG008|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
3341446|NCT03426995|4071893|FG009|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
3341447|NCT03426995|4071894|FG010|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
3341448|NCT03426995|4071895|FG011|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
3341449|NCT03426995|4071896|FG012|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
3341450|NCT03426995|4071897|FG013|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
3341451|NCT03426995|4071898|FG014|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
3341452|NCT03426995|4071899|FG015|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
3341453|NCT03426995|4071900|FG016|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
3341454|NCT03426995|4071901|FG017|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
3341455|NCT03426995|4071902|FG018|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
3341456|NCT03426995|4071884|FG000|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
3341457|NCT03426995|4071885|FG001|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
3341458|NCT03426995|4071886|FG002|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
3341459|NCT03426995|4071887|FG003|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
3341460|NCT03426995|4071888|FG004|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
3341461|NCT03426995|4071889|FG005|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
3341462|NCT03426995|4071890|FG006|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
3341463|NCT03426995|4071891|FG007|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
3341464|NCT03426995|4071892|FG008|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
3341465|NCT03426995|4071893|FG009|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
3341466|NCT03426995|4071894|FG010|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
3341467|NCT03426995|4071895|FG011|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
3341468|NCT03426995|4071896|FG012|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
3341469|NCT03426995|4071897|FG013|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
3341470|NCT03426995|4071898|FG014|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
3341471|NCT03426995|4071899|FG015|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
3341472|NCT03426995|4071900|FG016|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
3341473|NCT03426995|4071901|FG017|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
3341474|NCT03426995|4071902|FG018|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
3341475|NCT03426995|4071884|FG000|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
3341476|NCT03426995|4071885|FG001|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
3341477|NCT03426995|4071886|FG002|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
3341478|NCT03426995|4071887|FG003|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
3341479|NCT03426995|4071888|FG004|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
3341480|NCT03426995|4071889|FG005|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
3341481|NCT03426995|4071890|FG006|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
3341482|NCT03426995|4071891|FG007|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
3341483|NCT03426995|4071892|FG008|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
3341484|NCT03426995|4071893|FG009|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
3341485|NCT03426995|4071894|FG010|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
3341486|NCT03426995|4071895|FG011|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
3341487|NCT03426995|4071896|FG012|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
3341488|NCT03426995|4071897|FG013|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
3341489|NCT03426995|4071898|FG014|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
3341490|NCT03426995|4071899|FG015|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
3341491|NCT03426995|4071900|FG016|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
3341492|NCT03426995|4071901|FG017|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
3341493|NCT03426995|4071902|FG018|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
3341494|NCT03426995|4071884|FG000|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
3341495|NCT03426995|4071885|FG001|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
3341496|NCT03426995|4071886|FG002|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
3341497|NCT03426995|4071887|FG003|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
3341498|NCT03426995|4071888|FG004|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
3341499|NCT03426995|4071889|FG005|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
3341500|NCT03426995|4071890|FG006|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
3341501|NCT03426995|4071891|FG007|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
3341502|NCT03426995|4071892|FG008|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
3341503|NCT03426995|4071893|FG009|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
3341504|NCT03426995|4071894|FG010|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
3341505|NCT03426995|4071895|FG011|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
3341506|NCT03426995|4071896|FG012|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
3341507|NCT03426995|4071897|FG013|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
3341508|NCT03426995|4071898|FG014|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
3341509|NCT03426995|4071899|FG015|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
3341510|NCT03426995|4071900|FG016|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
3341511|NCT03426995|4071901|FG017|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
3341512|NCT03426995|4071902|FG018|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
3341513|NCT03426995|4071884|FG000|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
3341514|NCT03426995|4071885|FG001|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
3341515|NCT03426995|4071886|FG002|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
3341516|NCT03426995|4071887|FG003|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
3341517|NCT03426995|4071888|FG004|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
3341518|NCT03426995|4071889|FG005|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
3341519|NCT03426995|4071890|FG006|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
3341520|NCT03426995|4071891|FG007|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
3341521|NCT03426995|4071892|FG008|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
3341522|NCT03426995|4071893|FG009|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
3341523|NCT03426995|4071894|FG010|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
3341524|NCT03426995|4071895|FG011|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
3341525|NCT03426995|4071896|FG012|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
3341526|NCT03426995|4071897|FG013|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
3341527|NCT03426995|4071898|FG014|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
3341528|NCT03426995|4071899|FG015|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
3341529|NCT03426995|4071900|FG016|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
3341530|NCT03426995|4071901|FG017|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
3341531|NCT03426995|4071902|FG018|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
3341532|NCT03426995|4071884|FG000|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
3341533|NCT03426995|4071885|FG001|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
3341534|NCT03426995|4071886|FG002|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
3341535|NCT03426995|4071887|FG003|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
3341536|NCT03426995|4071888|FG004|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
3341537|NCT03426995|4071889|FG005|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
3341538|NCT03426995|4071890|FG006|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
3341539|NCT03426995|4071891|FG007|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
3341540|NCT03426995|4071892|FG008|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
3341541|NCT03426995|4071893|FG009|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
3341542|NCT03426995|4071894|FG010|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
3341543|NCT03426995|4071895|FG011|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
3341544|NCT03426995|4071896|FG012|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
3341545|NCT03426995|4071897|FG013|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
3341546|NCT03426995|4071898|FG014|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
3341547|NCT03426995|4071899|FG015|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
3341548|NCT03426995|4071900|FG016|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
3341549|NCT03426995|4071901|FG017|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
3341550|NCT03426995|4071902|FG018|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
3341551|NCT03426995|4071884|FG000|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
3341552|NCT03426995|4071885|FG001|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
3341553|NCT03426995|4071886|FG002|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
3341554|NCT03426995|4071887|FG003|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
3341555|NCT03426995|4071888|FG004|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
3341556|NCT03426995|4071889|FG005|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
3341557|NCT03426995|4071890|FG006|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
3341558|NCT03426995|4071891|FG007|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
3341559|NCT03426995|4071892|FG008|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
3341560|NCT03426995|4071893|FG009|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
3341561|NCT03426995|4071894|FG010|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
3341562|NCT03426995|4071895|FG011|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
3341563|NCT03426995|4071896|FG012|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
3341564|NCT03426995|4071897|FG013|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
3341565|NCT03426995|4071898|FG014|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
3341566|NCT03426995|4071899|FG015|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
3341567|NCT03426995|4071900|FG016|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
3341568|NCT03426995|4071901|FG017|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
3341569|NCT03426995|4071902|FG018|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
3341570|NCT03426995|4071884|FG000|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
3341571|NCT03426995|4071885|FG001|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
3341572|NCT03426995|4071886|FG002|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
3341573|NCT03426995|4071887|FG003|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
3341574|NCT03426995|4071888|FG004|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
3341575|NCT03426995|4071889|FG005|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
3341576|NCT03426995|4071890|FG006|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
3341577|NCT03426995|4071891|FG007|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
3341578|NCT03426995|4071892|FG008|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
3341579|NCT03426995|4071893|FG009|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
3341580|NCT03426995|4071894|FG010|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
3341581|NCT03426995|4071895|FG011|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
3341582|NCT03426995|4071896|FG012|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
3341583|NCT03426995|4071897|FG013|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
3341584|NCT03426995|4071898|FG014|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||11
3341585|NCT03426995|4071899|FG015|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||14
3341586|NCT03426995|4071900|FG016|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
3341587|NCT03426995|4071901|FG017|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
3341588|NCT03426995|4071902|FG018|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
3341589|NCT03426995|4071884|FG000|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
3341590|NCT03426995|4071885|FG001|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
3341591|NCT03426995|4071886|FG002|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
3341592|NCT03426995|4071887|FG003|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
3341593|NCT03426995|4071888|FG004|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
3341594|NCT03426995|4071889|FG005|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
3341595|NCT03426995|4071890|FG006|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
3341596|NCT03426995|4071891|FG007|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
3341597|NCT03426995|4071892|FG008|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
3341598|NCT03426995|4071893|FG009|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
3341599|NCT03426995|4071894|FG010|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
3341600|NCT03426995|4071895|FG011|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
3341601|NCT03426995|4071896|FG012|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
3341602|NCT03426995|4071897|FG013|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
3341603|NCT03426995|4071898|FG014|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||2
3341604|NCT03426995|4071899|FG015|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||2
3341605|NCT03426995|4071900|FG016|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
3341606|NCT03426995|4071901|FG017|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
3341607|NCT03426995|4071902|FG018|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
3341608|NCT03426995|4071884|FG000|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
3341609|NCT03426995|4071885|FG001|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
3341610|NCT03426995|4071886|FG002|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
3341611|NCT03426995|4071887|FG003|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
3341612|NCT03426995|4071888|FG004|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
3341613|NCT03426995|4071889|FG005|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
3341614|NCT03426995|4071890|FG006|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
3341615|NCT03426995|4071891|FG007|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
3341616|NCT03426995|4071892|FG008|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
3341617|NCT03426995|4071893|FG009|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
3341618|NCT03426995|4071894|FG010|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
3341619|NCT03426995|4071895|FG011|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
3341620|NCT03426995|4071896|FG012|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
3341621|NCT03426995|4071897|FG013|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
3341622|NCT03426995|4071898|FG014|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||9
3341623|NCT03426995|4071899|FG015|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||12
3341624|NCT03426995|4071900|FG016|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
3341625|NCT03426995|4071901|FG017|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
3341626|NCT03426995|4071902|FG018|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
3341627|NCT03427073|4071957|FG000|STARTED|Overall Study||1
3341628|NCT03427073|4071958|FG001|STARTED|Overall Study||1
3341629|NCT03427073|4071959|FG002|STARTED|Overall Study||1
3341630|NCT03427073|4071960|FG003|STARTED|Overall Study||3
3341631|NCT03427073|4071961|FG004|STARTED|Overall Study||3
3341632|NCT03427073|4071962|FG005|STARTED|Overall Study||4
3341633|NCT03427073|4071963|FG006|STARTED|Overall Study||3
3341634|NCT03427073|4071964|FG007|STARTED|Overall Study||4
3341635|NCT03427073|4071957|FG000|COMPLETED|Overall Study||0
3341636|NCT03427073|4071958|FG001|COMPLETED|Overall Study||0
3341637|NCT03427073|4071959|FG002|COMPLETED|Overall Study||0
3341638|NCT03427073|4071960|FG003|COMPLETED|Overall Study||0
3341639|NCT03427073|4071961|FG004|COMPLETED|Overall Study||0
3341640|NCT03427073|4071962|FG005|COMPLETED|Overall Study||0
3341641|NCT03427073|4071963|FG006|COMPLETED|Overall Study||0
3341642|NCT03427073|4071964|FG007|COMPLETED|Overall Study||0
3341643|NCT03427073|4071957|FG000|NOT COMPLETED|Overall Study||1
3341644|NCT03427073|4071958|FG001|NOT COMPLETED|Overall Study||1
3341645|NCT03427073|4071959|FG002|NOT COMPLETED|Overall Study||1
3341646|NCT03427073|4071960|FG003|NOT COMPLETED|Overall Study||3
3341647|NCT03427073|4071961|FG004|NOT COMPLETED|Overall Study||3
3341648|NCT03427073|4071962|FG005|NOT COMPLETED|Overall Study||4
3341649|NCT03427073|4071963|FG006|NOT COMPLETED|Overall Study||3
3341650|NCT03427073|4071964|FG007|NOT COMPLETED|Overall Study||4
3341651|NCT03427177|4071984|FG000|STARTED|Overall Study||125
3341652|NCT03427177|4071985|FG001|STARTED|Overall Study||132
3341653|NCT03427177|4071984|FG000|COMPLETED|Overall Study||92
3341654|NCT03427177|4071985|FG001|COMPLETED|Overall Study||105
3341655|NCT03427177|4071984|FG000|NOT COMPLETED|Overall Study||33
3341656|NCT03427177|4071985|FG001|NOT COMPLETED|Overall Study||27
3341657|NCT03427268|4071991|FG000|STARTED|Overall Study||32
3341658|NCT03427268|4071991|FG000|COMPLETED|Overall Study||0
3341659|NCT03427268|4071991|FG000|NOT COMPLETED|Overall Study||32
3341660|NCT03427619|4071995|FG000|STARTED|Overall Study||275
3341661|NCT03427619|4071995|FG000|Safety Population|Overall Study||275
3341662|NCT03427619|4071995|FG000|Modified Intention to Treat Population|Overall Study||143
3341663|NCT03427619|4071995|FG000|COMPLETED|Overall Study||209
3341664|NCT03427619|4071995|FG000|NOT COMPLETED|Overall Study||66
3341665|NCT03427892|4071999|FG000|STARTED|Overall Study||21
3341666|NCT03427892|4071999|FG000|COMPLETED|Overall Study|Of the 21 recruited, 19 completed at least one post baseline visit, included in the analysis.|19
3341667|NCT03427892|4071999|FG000|NOT COMPLETED|Overall Study||2
3341668|NCT03427931|4072003|FG000|STARTED|Overall Study||7
3341669|NCT03427931|4072003|FG000|COMPLETED|Overall Study||5
3341670|NCT03427931|4072003|FG000|NOT COMPLETED|Overall Study||2
3341671|NCT03428100|4072011|FG000|STARTED|Overall Study||93
3341672|NCT03428100|4072012|FG001|STARTED|Overall Study||93
3341673|NCT03428100|4072013|FG002|STARTED|Overall Study||185
3341674|NCT03428100|4072014|FG003|STARTED|Overall Study||92
3341675|NCT03428100|4072011|FG000|Received at Least One Dose of Study Drug|Overall Study||93
3341676|NCT03428100|4072012|FG001|Received at Least One Dose of Study Drug|Overall Study||93
3341677|NCT03428100|4072013|FG002|Received at Least One Dose of Study Drug|Overall Study||184
3341678|NCT03428100|4072014|FG003|Received at Least One Dose of Study Drug|Overall Study||92
3341679|NCT03428100|4072011|FG000|COMPLETED|Overall Study||72
3341680|NCT03428100|4072012|FG001|COMPLETED|Overall Study||80
3341681|NCT03428100|4072013|FG002|COMPLETED|Overall Study||173
3341682|NCT03428100|4072014|FG003|COMPLETED|Overall Study||85
3341683|NCT03428100|4072011|FG000|NOT COMPLETED|Overall Study||21
3341684|NCT03428100|4072012|FG001|NOT COMPLETED|Overall Study||13
3341685|NCT03428100|4072013|FG002|NOT COMPLETED|Overall Study||12
3341686|NCT03428100|4072014|FG003|NOT COMPLETED|Overall Study||7
3341687|NCT03428152|4072036|FG000|STARTED|Overall Study||37
3341688|NCT03428152|4072037|FG001|STARTED|Overall Study||41
3341689|NCT03428152|4072036|FG000|COMPLETED|Overall Study||30
3341690|NCT03428152|4072037|FG001|COMPLETED|Overall Study|exclusions: epidural / TAP / wound infiltration malignity retroperitone was opened age >65|30
3341691|NCT03428152|4072036|FG000|NOT COMPLETED|Overall Study||7
2927871|NCT00574704|3638779|FG002|STARTED|Overall Study||10
2927872|NCT00574704|3638780|FG003|STARTED|Overall Study||10
2927873|NCT00574704|3638777|FG000|COMPLETED|Overall Study||10
2927874|NCT00574704|3638778|FG001|COMPLETED|Overall Study||10
2927875|NCT00574704|3638779|FG002|COMPLETED|Overall Study||9
2927876|NCT00574704|3638780|FG003|COMPLETED|Overall Study||10
2927877|NCT00574704|3638777|FG000|NOT COMPLETED|Overall Study||0
2927878|NCT00574704|3638778|FG001|NOT COMPLETED|Overall Study||0
2927879|NCT00574704|3638779|FG002|NOT COMPLETED|Overall Study||1
2927880|NCT00574704|3638780|FG003|NOT COMPLETED|Overall Study||0
2927881|NCT00574795|3638790|FG000|STARTED|Infant Series||193
2927882|NCT00574795|3638790|FG000|Vaccinated Dose 1|Infant Series||193
2927883|NCT00574795|3638790|FG000|Vaccinated Dose 2|Infant Series||190
2927884|NCT00574795|3638790|FG000|Vaccinated Dose 3|Infant Series||190
2927885|NCT00574795|3638790|FG000|COMPLETED|Infant Series||188
2927886|NCT00574795|3638790|FG000|NOT COMPLETED|Infant Series||5
2927887|NCT00574795|3638790|FG000|STARTED|After Infant Series||188
2927888|NCT00574795|3638790|FG000|COMPLETED|After Infant Series||185
2927889|NCT00574795|3638790|FG000|NOT COMPLETED|After Infant Series||3
2927890|NCT00574795|3638790|FG000|STARTED|Toddler Dose||185
2927891|NCT00574795|3638790|FG000|COMPLETED|Toddler Dose||184
2927892|NCT00574795|3638790|FG000|NOT COMPLETED|Toddler Dose||1
2927893|NCT00574834|3638808|FG000|STARTED|Overall Study||9
2927894|NCT00574834|3638809|FG001|STARTED|Overall Study||4
2927895|NCT00574834|3638810|FG002|STARTED|Overall Study||4
2927896|NCT00574834|3638808|FG000|COMPLETED|Overall Study||9
2927897|NCT00574834|3638809|FG001|COMPLETED|Overall Study||4
2927898|NCT00574834|3638810|FG002|COMPLETED|Overall Study||4
2927899|NCT00574834|3638808|FG000|NOT COMPLETED|Overall Study||0
2927900|NCT00574834|3638809|FG001|NOT COMPLETED|Overall Study||0
2927901|NCT00574834|3638810|FG002|NOT COMPLETED|Overall Study||0
2927902|NCT00574847|3638820|FG000|STARTED|Overall Study||64
2927903|NCT00574847|3638821|FG001|STARTED|Overall Study||63
2927904|NCT00574847|3638820|FG000|COMPLETED|Overall Study||56
2927905|NCT00574847|3638821|FG001|COMPLETED|Overall Study||56
2927906|NCT00574847|3638820|FG000|NOT COMPLETED|Overall Study||8
2927907|NCT00574847|3638821|FG001|NOT COMPLETED|Overall Study||7
2927908|NCT00574873|3638829|FG000|STARTED|Overall Study||250
2927909|NCT00574873|3638830|FG001|STARTED|Overall Study||252
2927910|NCT00574873|3638829|FG000|Treated|Overall Study||248
2927911|NCT00574873|3638830|FG001|Treated|Overall Study||251
2927912|NCT00574873|3638829|FG000|COMPLETED|Overall Study||12
2927913|NCT00574873|3638830|FG001|COMPLETED|Overall Study||1
2927914|NCT00574873|3638829|FG000|NOT COMPLETED|Overall Study||238
2927915|NCT00574873|3638830|FG001|NOT COMPLETED|Overall Study||251
3341692|NCT03428152|4072037|FG001|NOT COMPLETED|Overall Study||11
3341693|NCT03428230|4072047|FG000|STARTED|Overall Study||15
3341694|NCT03428230|4072048|FG001|STARTED|Overall Study||15
3341695|NCT03428230|4072049|FG002|STARTED|Overall Study||15
3341696|NCT03428230|4072050|FG003|STARTED|Overall Study||15
3341697|NCT03428230|4072047|FG000|COMPLETED|Overall Study||15
3341698|NCT03428230|4072048|FG001|COMPLETED|Overall Study||15
3341699|NCT03428230|4072049|FG002|COMPLETED|Overall Study||15
3341700|NCT03428230|4072050|FG003|COMPLETED|Overall Study||15
3341701|NCT03428230|4072047|FG000|NOT COMPLETED|Overall Study||0
3341702|NCT03428230|4072048|FG001|NOT COMPLETED|Overall Study||0
3341703|NCT03428230|4072049|FG002|NOT COMPLETED|Overall Study||0
3341704|NCT03428230|4072050|FG003|NOT COMPLETED|Overall Study||0
3341705|NCT03428360|4072060|FG000|STARTED|Overall Study||130
3177293|NCT01969851|3905069|FG000|STARTED|Overall Study||10
3177294|NCT01969851|3905070|FG001|STARTED|Overall Study||24
3177295|NCT01969851|3905071|FG002|STARTED|Overall Study||21
3177296|NCT01969851|3905069|FG000|COMPLETED|Overall Study||9
3177297|NCT01969851|3905070|FG001|COMPLETED|Overall Study||21
3341706|NCT03428360|4072060|FG000|COMPLETED|Overall Study||90
3341707|NCT03428360|4072060|FG000|NOT COMPLETED|Overall Study||40
3341708|NCT03428750|4072070|FG000|STARTED|Overall Study||210
3341709|NCT03428750|4072071|FG001|STARTED|Overall Study||213
3341710|NCT03428750|4072070|FG000|COMPLETED|Overall Study||186
3341711|NCT03428750|4072071|FG001|COMPLETED|Overall Study||192
3341712|NCT03428750|4072070|FG000|NOT COMPLETED|Overall Study||24
3341713|NCT03428750|4072071|FG001|NOT COMPLETED|Overall Study||21
3341714|NCT03428815|4072102|FG000|STARTED|Overall Study||17
3341715|NCT03428815|4072103|FG001|STARTED|Overall Study||19
3341716|NCT03428815|4072102|FG000|COMPLETED|Overall Study||7
3341717|NCT03428815|4072103|FG001|COMPLETED|Overall Study||14
3341718|NCT03428815|4072102|FG000|NOT COMPLETED|Overall Study||10
3341719|NCT03428815|4072103|FG001|NOT COMPLETED|Overall Study||5
3341720|NCT03428997|4072109|FG000|STARTED|Overall Study||24
3341721|NCT03428997|4072109|FG000|COMPLETED|Overall Study||16
3341722|NCT03428997|4072109|FG000|NOT COMPLETED|Overall Study||8
3341723|NCT03429270|4072115|FG000|STARTED|Overall Study||28
3341724|NCT03429270|4072115|FG000|COMPLETED|Overall Study||28
3341725|NCT03429270|4072115|FG000|NOT COMPLETED|Overall Study||0
3341726|NCT03429348|4072121|FG000|STARTED|Overall Study|4 participants had no additional rehab & had no corresponding sauna rehab participant to compare to.|12
3341727|NCT03429348|4072122|FG001|STARTED|Overall Study||12
3341728|NCT03429348|4072121|FG000|COMPLETED|Overall Study||12
3341729|NCT03429348|4072122|FG001|COMPLETED|Overall Study||12
3341730|NCT03429348|4072121|FG000|NOT COMPLETED|Overall Study||0
3341731|NCT03429348|4072122|FG001|NOT COMPLETED|Overall Study||0
3341732|NCT03429556|4072134|FG000|STARTED|Overall Study||12
3341733|NCT03429556|4072135|FG001|STARTED|Overall Study||4
3341734|NCT03429556|4072136|FG002|STARTED|Overall Study||4
3341735|NCT03429556|4072137|FG003|STARTED|Overall Study||3
3341736|NCT03429556|4072134|FG000|COMPLETED|Overall Study||12
3341737|NCT03429556|4072135|FG001|COMPLETED|Overall Study||3
3341738|NCT03429556|4072136|FG002|COMPLETED|Overall Study||4
3341739|NCT03429556|4072137|FG003|COMPLETED|Overall Study||3
3341740|NCT03429556|4072134|FG000|NOT COMPLETED|Overall Study||0
3341741|NCT03429556|4072135|FG001|NOT COMPLETED|Overall Study||1
3341742|NCT03429556|4072136|FG002|NOT COMPLETED|Overall Study||0
3341743|NCT03429556|4072137|FG003|NOT COMPLETED|Overall Study||0
3341744|NCT03430050|4072149|FG000|STARTED|Overall Study||3
3341745|NCT03430050|4072150|FG001|STARTED|Overall Study||5
3341746|NCT03430050|4072149|FG000|COMPLETED|Overall Study||3
3341747|NCT03430050|4072150|FG001|COMPLETED|Overall Study||5
3341748|NCT03430050|4072149|FG000|NOT COMPLETED|Overall Study||0
3341749|NCT03430050|4072150|FG001|NOT COMPLETED|Overall Study||0
3341750|NCT03430206|4072158|FG000|STARTED|Overall Study||40
3341751|NCT03430206|4072159|FG001|STARTED|Overall Study||38
3341752|NCT03430206|4072158|FG000|COMPLETED|Overall Study||18
3341753|NCT03430206|4072159|FG001|COMPLETED|Overall Study||21
3341754|NCT03430206|4072158|FG000|NOT COMPLETED|Overall Study||22
3341755|NCT03430206|4072159|FG001|NOT COMPLETED|Overall Study||17
3341756|NCT03430245|4072165|FG000|STARTED|Overall Study||16
3341757|NCT03430245|4072165|FG000|COMPLETED|Overall Study|6 subjects withdrew from study due to lengthy treatment. Treatment protocol amended.|9
3341758|NCT03430245|4072165|FG000|NOT COMPLETED|Overall Study||7
3341759|NCT03430349|4072171|FG000|STARTED|Overall Study||15
3341760|NCT03430349|4072172|FG001|STARTED|Overall Study||15
3341761|NCT03430349|4072171|FG000|Received nOPV Vaccination|Overall Study||15
3341762|NCT03430349|4072172|FG001|Received nOPV Vaccination|Overall Study||15
3341763|NCT03430349|4072171|FG000|COMPLETED|Overall Study||15
3341764|NCT03430349|4072172|FG001|COMPLETED|Overall Study||15
3341765|NCT03430349|4072171|FG000|NOT COMPLETED|Overall Study||0
2927916|NCT00574912|3638836|FG000|STARTED|Overall Study||20
3177298|NCT01969851|3905071|FG002|COMPLETED|Overall Study||14
3341766|NCT03430349|4072172|FG001|NOT COMPLETED|Overall Study||0
3177299|NCT01969851|3905069|FG000|NOT COMPLETED|Overall Study||1
3177300|NCT01969851|3905070|FG001|NOT COMPLETED|Overall Study||3
3177301|NCT01969851|3905071|FG002|NOT COMPLETED|Overall Study||7
3177302|NCT01969916|3905079|FG000|STARTED|Overall Study||150
3177303|NCT01969916|3905079|FG000|COMPLETED|Overall Study||105
3177304|NCT01969916|3905079|FG000|NOT COMPLETED|Overall Study||45
3177305|NCT01970007|3905083|FG000|STARTED|Overall Study||243
3341767|NCT03430856|4072182|FG000|STARTED|Overall Study||31
3341768|NCT03430856|4072183|FG001|STARTED|Overall Study||30
3341769|NCT03430856|4072184|FG002|STARTED|Overall Study||30
3341770|NCT03430856|4072182|FG000|Exposed|Overall Study||31
3341771|NCT03430856|4072183|FG001|Exposed|Overall Study||30
3341772|NCT03430856|4072184|FG002|Exposed|Overall Study||30
3341773|NCT03430856|4072182|FG000|COMPLETED|Overall Study||29
3341774|NCT03430856|4072183|FG001|COMPLETED|Overall Study||27
3341775|NCT03430856|4072184|FG002|COMPLETED|Overall Study||29
3341776|NCT03430856|4072182|FG000|NOT COMPLETED|Overall Study||2
3341777|NCT03430856|4072183|FG001|NOT COMPLETED|Overall Study||3
3341778|NCT03430856|4072184|FG002|NOT COMPLETED|Overall Study||1
3341779|NCT03430986|4072197|FG000|STARTED|24-week Control Period||42
3341780|NCT03430986|4072198|FG001|STARTED|24-week Control Period||122
3341781|NCT03430986|4072197|FG000|Treated as Randomized|24-week Control Period||42
3341782|NCT03430986|4072198|FG001|Treated as Randomized|24-week Control Period||120
3341783|NCT03430986|4072197|FG000|COMPLETED|24-week Control Period||34
3341784|NCT03430986|4072198|FG001|COMPLETED|24-week Control Period||118
3341785|NCT03430986|4072197|FG000|NOT COMPLETED|24-week Control Period||8
3341786|NCT03430986|4072198|FG001|NOT COMPLETED|24-week Control Period||4
3341787|NCT03430986|4072197|FG000|STARTED|24-week Post-Control Period|Not all participants received the Optional Treatment.|31
3341788|NCT03430986|4072198|FG001|STARTED|24-week Post-Control Period||118
3341789|NCT03430986|4072197|FG000|COMPLETED|24-week Post-Control Period||30
3341790|NCT03430986|4072198|FG001|COMPLETED|24-week Post-Control Period||116
3341791|NCT03430986|4072197|FG000|NOT COMPLETED|24-week Post-Control Period||1
3341792|NCT03430986|4072198|FG001|NOT COMPLETED|24-week Post-Control Period||2
3341793|NCT03431012|4072211|FG000|STARTED|Overall Study||47
3341794|NCT03431012|4072212|FG001|STARTED|Overall Study||60
3341795|NCT03431012|4072213|FG002|STARTED|Overall Study||56
3341796|NCT03431012|4072214|FG003|STARTED|Overall Study||53
3341797|NCT03431012|4072211|FG000|COMPLETED|Overall Study||47
3341798|NCT03431012|4072212|FG001|COMPLETED|Overall Study||60
3341799|NCT03431012|4072213|FG002|COMPLETED|Overall Study||56
3341800|NCT03431012|4072214|FG003|COMPLETED|Overall Study||53
3341801|NCT03431012|4072211|FG000|NOT COMPLETED|Overall Study||0
3341802|NCT03431012|4072212|FG001|NOT COMPLETED|Overall Study||0
3341803|NCT03431012|4072213|FG002|NOT COMPLETED|Overall Study||0
3341804|NCT03431012|4072214|FG003|NOT COMPLETED|Overall Study||0
3341805|NCT03431337|4072230|FG000|STARTED|Overall Study||78
3341806|NCT03431337|4072231|FG001|STARTED|Overall Study||79
3341807|NCT03431337|4072230|FG000|COMPLETED|Overall Study||49
3341808|NCT03431337|4072231|FG001|COMPLETED|Overall Study||57
3341809|NCT03431337|4072230|FG000|NOT COMPLETED|Overall Study||29
3341810|NCT03431337|4072231|FG001|NOT COMPLETED|Overall Study||22
3341811|NCT03431441|4072241|FG000|STARTED|Overall Study||24
3341812|NCT03431441|4072241|FG000|COMPLETED|Overall Study||19
3341813|NCT03431441|4072241|FG000|NOT COMPLETED|Overall Study||5
3341814|NCT03431857|4072245|FG000|STARTED|Overall Study||106
3341815|NCT03431857|4072245|FG000|COMPLETED|Overall Study|52 subjects have completed the study, and 50 had complete data (all pages of CRF visit are complete)|52
3341816|NCT03431857|4072245|FG000|NOT COMPLETED|Overall Study||54
3341817|NCT03432390|4072251|FG000|STARTED|Apnea Period||36
3341818|NCT03432390|4072252|FG001|STARTED|Apnea Period||36
3341819|NCT03432390|4072251|FG000|COMPLETED|Apnea Period||34
3341820|NCT03432390|4072252|FG001|COMPLETED|Apnea Period||34
3341821|NCT03432390|4072251|FG000|NOT COMPLETED|Apnea Period||2
3341822|NCT03432390|4072252|FG001|NOT COMPLETED|Apnea Period||2
3341823|NCT03432390|4072251|FG000|STARTED|Recovery Period||34
3341824|NCT03432390|4072252|FG001|STARTED|Recovery Period||34
3341825|NCT03432390|4072251|FG000|COMPLETED|Recovery Period||34
3341826|NCT03432390|4072252|FG001|COMPLETED|Recovery Period||34
3341827|NCT03432390|4072251|FG000|NOT COMPLETED|Recovery Period||0
3341828|NCT03432390|4072252|FG001|NOT COMPLETED|Recovery Period||0
3341829|NCT03432533|4072260|FG000|STARTED|Overall Study||141
3341830|NCT03432533|4072261|FG001|STARTED|Overall Study||142
3341831|NCT03432533|4072260|FG000|Completed 6-Month Treatment Period|Overall Study||136
3341832|NCT03432533|4072261|FG001|Completed 6-Month Treatment Period|Overall Study||137
3341833|NCT03432533|4072260|FG000|COMPLETED|Overall Study||126
3341834|NCT03432533|4072261|FG001|COMPLETED|Overall Study||131
3341835|NCT03432533|4072260|FG000|NOT COMPLETED|Overall Study||15
3341836|NCT03432533|4072261|FG001|NOT COMPLETED|Overall Study||11
3341837|NCT03432858|4072270|FG000|STARTED|Overall Study||12
3341838|NCT03432858|4072271|FG001|STARTED|Overall Study||83
3341839|NCT03432858|4072272|FG002|STARTED|Overall Study||89
3341840|NCT03432858|4072270|FG000|COMPLETED|Overall Study||10
3341841|NCT03432858|4072271|FG001|COMPLETED|Overall Study||72
3341842|NCT03432858|4072272|FG002|COMPLETED|Overall Study||72
3341843|NCT03432858|4072270|FG000|NOT COMPLETED|Overall Study||2
3341844|NCT03432858|4072271|FG001|NOT COMPLETED|Overall Study||11
3341845|NCT03432858|4072272|FG002|NOT COMPLETED|Overall Study||17
3341846|NCT03433482|4072284|FG000|STARTED|Overall Study||420
3177306|NCT01970007|3905083|FG000|COMPLETED|Overall Study||188
3177307|NCT01970007|3905083|FG000|NOT COMPLETED|Overall Study||55
3177308|NCT01970176|3905089|FG000|STARTED|Overall Study||14
3177309|NCT01970176|3905090|FG001|STARTED|Overall Study||6
3177310|NCT01970176|3905089|FG000|COMPLETED|Overall Study||14
3177311|NCT01970176|3905090|FG001|COMPLETED|Overall Study||6
3177312|NCT01970176|3905089|FG000|NOT COMPLETED|Overall Study||0
3341847|NCT03433482|4072285|FG001|STARTED|Overall Study||424
3341848|NCT03433482|4072286|FG002|STARTED|Overall Study||427
3341849|NCT03433482|4072287|FG003|STARTED|Overall Study||419
3341850|NCT03433482|4072284|FG000|COMPLETED|Overall Study||419
3341851|NCT03433482|4072285|FG001|COMPLETED|Overall Study||424
3341852|NCT03433482|4072286|FG002|COMPLETED|Overall Study||423
3341853|NCT03433482|4072287|FG003|COMPLETED|Overall Study||418
3341854|NCT03433482|4072284|FG000|NOT COMPLETED|Overall Study||1
3341855|NCT03433482|4072285|FG001|NOT COMPLETED|Overall Study||0
3341856|NCT03433482|4072286|FG002|NOT COMPLETED|Overall Study||4
3341857|NCT03433482|4072287|FG003|NOT COMPLETED|Overall Study||1
3341858|NCT03433677|4072299|FG000|STARTED|Period 1||24
3341859|NCT03433677|4072300|FG001|STARTED|Period 1||25
3341860|NCT03433677|4072299|FG000|Received at Least 1 Dose of Study Drug|Period 1||24
3341861|NCT03433677|4072300|FG001|Received at Least 1 Dose of Study Drug|Period 1||25
3177313|NCT01970176|3905090|FG001|NOT COMPLETED|Overall Study||0
3177314|NCT01970241|3905098|FG000|STARTED|Overall Study||46
3177315|NCT01970241|3905099|FG001|STARTED|Overall Study||39
3177316|NCT01970241|3905098|FG000|COMPLETED|Overall Study||29
3177317|NCT01970241|3905099|FG001|COMPLETED|Overall Study||31
3177318|NCT01970241|3905098|FG000|NOT COMPLETED|Overall Study||17
3341862|NCT03433677|4072299|FG000|COMPLETED|Period 1||23
3341863|NCT03433677|4072300|FG001|COMPLETED|Period 1||25
3341864|NCT03433677|4072299|FG000|NOT COMPLETED|Period 1||1
3341865|NCT03433677|4072300|FG001|NOT COMPLETED|Period 1||0
3341866|NCT03433677|4072299|FG000|STARTED|Period 2||23
3341867|NCT03433677|4072300|FG001|STARTED|Period 2||25
3341868|NCT03433677|4072299|FG000|Received at Least 1 Dose of Study Drug|Period 2||23
3341869|NCT03433677|4072300|FG001|Received at Least 1 Dose of Study Drug|Period 2||25
3341870|NCT03433677|4072299|FG000|COMPLETED|Period 2||22
3341871|NCT03433677|4072300|FG001|COMPLETED|Period 2||24
3341872|NCT03433677|4072299|FG000|NOT COMPLETED|Period 2||1
3341873|NCT03433677|4072300|FG001|NOT COMPLETED|Period 2||1
3341874|NCT03433703|4072307|FG000|STARTED|Overall Study||2
3341875|NCT03433703|4072307|FG000|COMPLETED|Overall Study||0
3341876|NCT03433703|4072307|FG000|NOT COMPLETED|Overall Study||2
3341877|NCT03433755|4072315|FG000|STARTED|Overall Study||42
3341878|NCT03433755|4072316|FG001|STARTED|Overall Study||41
3341879|NCT03433755|4072317|FG002|STARTED|Overall Study||79
3341880|NCT03433755|4072318|FG003|STARTED|Overall Study||80
3341881|NCT03433755|4072315|FG000|Randomized and Treated|Overall Study||41
3341882|NCT03433755|4072316|FG001|Randomized and Treated|Overall Study||41
3341883|NCT03433755|4072317|FG002|Randomized and Treated|Overall Study||79
3341884|NCT03433755|4072318|FG003|Randomized and Treated|Overall Study||80
3341885|NCT03433755|4072315|FG000|COMPLETED|Overall Study||40
3341886|NCT03433755|4072316|FG001|COMPLETED|Overall Study||41
3341887|NCT03433755|4072317|FG002|COMPLETED|Overall Study||79
3341888|NCT03433755|4072318|FG003|COMPLETED|Overall Study||80
3341889|NCT03433755|4072315|FG000|NOT COMPLETED|Overall Study||2
3341890|NCT03433755|4072316|FG001|NOT COMPLETED|Overall Study||0
3341891|NCT03433755|4072317|FG002|NOT COMPLETED|Overall Study||0
3341892|NCT03433755|4072318|FG003|NOT COMPLETED|Overall Study||0
3341893|NCT03433794|4072333|FG000|STARTED|Baseline||183
3341894|NCT03433794|4072334|FG001|STARTED|Baseline||173
3341895|NCT03433794|4072335|FG002|STARTED|Baseline||181
3341896|NCT03433794|4072333|FG000|COMPLETED|Baseline||183
3341897|NCT03433794|4072334|FG001|COMPLETED|Baseline||173
3341898|NCT03433794|4072335|FG002|COMPLETED|Baseline||181
3341899|NCT03433794|4072333|FG000|NOT COMPLETED|Baseline||0
3341900|NCT03433794|4072334|FG001|NOT COMPLETED|Baseline||0
3341901|NCT03433794|4072335|FG002|NOT COMPLETED|Baseline||0
3341902|NCT03433794|4072333|FG000|STARTED|2-Week Assessment||183
3341903|NCT03433794|4072334|FG001|STARTED|2-Week Assessment||173
3341904|NCT03433794|4072335|FG002|STARTED|2-Week Assessment||181
3341905|NCT03433794|4072333|FG000|COMPLETED|2-Week Assessment||117
3341906|NCT03433794|4072334|FG001|COMPLETED|2-Week Assessment||112
3341907|NCT03433794|4072335|FG002|COMPLETED|2-Week Assessment||109
3341908|NCT03433794|4072333|FG000|NOT COMPLETED|2-Week Assessment||66
3341909|NCT03433794|4072334|FG001|NOT COMPLETED|2-Week Assessment||61
3341910|NCT03433794|4072335|FG002|NOT COMPLETED|2-Week Assessment||72
3341911|NCT03433794|4072333|FG000|STARTED|4-Week Assessment||183
3341912|NCT03433794|4072334|FG001|STARTED|4-Week Assessment||173
3341913|NCT03433794|4072335|FG002|STARTED|4-Week Assessment||181
3341914|NCT03433794|4072333|FG000|COMPLETED|4-Week Assessment||98
3341915|NCT03433794|4072334|FG001|COMPLETED|4-Week Assessment||95
3341916|NCT03433794|4072335|FG002|COMPLETED|4-Week Assessment||91
3341917|NCT03433794|4072333|FG000|NOT COMPLETED|4-Week Assessment||85
3177319|NCT01970241|3905099|FG001|NOT COMPLETED|Overall Study||8
3177320|NCT01970371|3905110|FG000|STARTED|Overall Study||18
3177321|NCT01970371|3905111|FG001|STARTED|Overall Study||21
3177322|NCT01970371|3905112|FG002|STARTED|Overall Study||30
3177323|NCT01970371|3905110|FG000|COMPLETED|Overall Study||10
3177324|NCT01970371|3905111|FG001|COMPLETED|Overall Study||8
3177325|NCT01970371|3905112|FG002|COMPLETED|Overall Study||17
3177326|NCT01970371|3905110|FG000|NOT COMPLETED|Overall Study||8
3177327|NCT01970371|3905111|FG001|NOT COMPLETED|Overall Study||13
3341918|NCT03433794|4072334|FG001|NOT COMPLETED|4-Week Assessment||78
3341919|NCT03433794|4072335|FG002|NOT COMPLETED|4-Week Assessment||90
3341920|NCT03433794|4072333|FG000|STARTED|6-Week Assessment||183
3341921|NCT03433794|4072334|FG001|STARTED|6-Week Assessment||173
3341922|NCT03433794|4072335|FG002|STARTED|6-Week Assessment||181
3341923|NCT03433794|4072333|FG000|COMPLETED|6-Week Assessment||94
3341924|NCT03433794|4072334|FG001|COMPLETED|6-Week Assessment||85
3341925|NCT03433794|4072335|FG002|COMPLETED|6-Week Assessment||80
3341926|NCT03433794|4072333|FG000|NOT COMPLETED|6-Week Assessment||89
3341927|NCT03433794|4072334|FG001|NOT COMPLETED|6-Week Assessment||88
3341928|NCT03433794|4072335|FG002|NOT COMPLETED|6-Week Assessment||101
3341929|NCT03433794|4072333|FG000|STARTED|3-Month Assessment||183
3341930|NCT03433794|4072334|FG001|STARTED|3-Month Assessment||173
3341931|NCT03433794|4072335|FG002|STARTED|3-Month Assessment||181
3341932|NCT03433794|4072333|FG000|COMPLETED|3-Month Assessment||69
3341933|NCT03433794|4072334|FG001|COMPLETED|3-Month Assessment||73
3341934|NCT03433794|4072335|FG002|COMPLETED|3-Month Assessment||71
3341935|NCT03433794|4072333|FG000|NOT COMPLETED|3-Month Assessment||114
3341936|NCT03433794|4072334|FG001|NOT COMPLETED|3-Month Assessment||100
3341937|NCT03433794|4072335|FG002|NOT COMPLETED|3-Month Assessment||110
3341938|NCT03433794|4072333|FG000|STARTED|6-Month Assessment||183
3341939|NCT03433794|4072334|FG001|STARTED|6-Month Assessment||173
3341940|NCT03433794|4072335|FG002|STARTED|6-Month Assessment||181
3341941|NCT03433794|4072333|FG000|COMPLETED|6-Month Assessment||65
3341942|NCT03433794|4072334|FG001|COMPLETED|6-Month Assessment||58
3341943|NCT03433794|4072335|FG002|COMPLETED|6-Month Assessment||50
3341944|NCT03433794|4072333|FG000|NOT COMPLETED|6-Month Assessment||118
3341945|NCT03433794|4072334|FG001|NOT COMPLETED|6-Month Assessment||115
3341946|NCT03433794|4072335|FG002|NOT COMPLETED|6-Month Assessment||131
3341947|NCT03433794|4072333|FG000|STARTED|9-Month Assessment||183
3341948|NCT03433794|4072334|FG001|STARTED|9-Month Assessment||173
3341949|NCT03433794|4072335|FG002|STARTED|9-Month Assessment||181
3341950|NCT03433794|4072333|FG000|COMPLETED|9-Month Assessment||49
3341951|NCT03433794|4072334|FG001|COMPLETED|9-Month Assessment||52
3341952|NCT03433794|4072335|FG002|COMPLETED|9-Month Assessment||39
3341953|NCT03433794|4072333|FG000|NOT COMPLETED|9-Month Assessment||134
3341954|NCT03433794|4072334|FG001|NOT COMPLETED|9-Month Assessment||121
3341955|NCT03433794|4072335|FG002|NOT COMPLETED|9-Month Assessment||142
3341956|NCT03434119|4072345|FG000|STARTED|Overall Study||116
3341957|NCT03434119|4072346|FG001|STARTED|Overall Study||125
3341958|NCT03434119|4072345|FG000|Treated|Overall Study||115
3341959|NCT03434119|4072346|FG001|Treated|Overall Study||125
3341960|NCT03434119|4072345|FG000|COMPLETED|Overall Study||9
3341961|NCT03434119|4072346|FG001|COMPLETED|Overall Study||12
3341962|NCT03434119|4072345|FG000|NOT COMPLETED|Overall Study||107
3341963|NCT03434119|4072346|FG001|NOT COMPLETED|Overall Study||113
3341964|NCT03434249|4072354|FG000|STARTED|Overall Study||40
3341965|NCT03434249|4072355|FG001|STARTED|Overall Study||40
3341966|NCT03434249|4072354|FG000|COMPLETED|Overall Study||35
3341967|NCT03434249|4072355|FG001|COMPLETED|Overall Study||37
3341968|NCT03434249|4072354|FG000|NOT COMPLETED|Overall Study||5
3341969|NCT03434249|4072355|FG001|NOT COMPLETED|Overall Study||3
3341970|NCT03434457|4072361|FG000|STARTED|Overall Study||630
3341971|NCT03434457|4072361|FG000|COMPLETED|Overall Study||630
3341972|NCT03434457|4072361|FG000|NOT COMPLETED|Overall Study||0
3341973|NCT03434834|4072365|FG000|STARTED|Overall Study||53
3341974|NCT03434834|4072365|FG000|COMPLETED|Overall Study||37
3341975|NCT03434834|4072365|FG000|NOT COMPLETED|Overall Study||16
3341976|NCT03434977|4072371|FG000|STARTED|Intervention Period 1 (6 Days)||6
3341977|NCT03434977|4072372|FG001|STARTED|Intervention Period 1 (6 Days)||6
3341978|NCT03434977|4072371|FG000|COMPLETED|Intervention Period 1 (6 Days)||6
3341979|NCT03434977|4072372|FG001|COMPLETED|Intervention Period 1 (6 Days)||6
3341980|NCT03434977|4072371|FG000|NOT COMPLETED|Intervention Period 1 (6 Days)||0
3341981|NCT03434977|4072372|FG001|NOT COMPLETED|Intervention Period 1 (6 Days)||0
3341982|NCT03434977|4072371|FG000|STARTED|Washout Period (at Least 6 Days)||6
3341983|NCT03434977|4072372|FG001|STARTED|Washout Period (at Least 6 Days)||6
3341984|NCT03434977|4072371|FG000|COMPLETED|Washout Period (at Least 6 Days)||6
3341985|NCT03434977|4072372|FG001|COMPLETED|Washout Period (at Least 6 Days)||5
3341986|NCT03434977|4072371|FG000|NOT COMPLETED|Washout Period (at Least 6 Days)||0
3341987|NCT03434977|4072372|FG001|NOT COMPLETED|Washout Period (at Least 6 Days)||1
3341988|NCT03434977|4072371|FG000|STARTED|Intervention Period 2 (6 Days)||6
3341989|NCT03434977|4072372|FG001|STARTED|Intervention Period 2 (6 Days)||5
3341990|NCT03434977|4072371|FG000|COMPLETED|Intervention Period 2 (6 Days)||6
3341991|NCT03434977|4072372|FG001|COMPLETED|Intervention Period 2 (6 Days)||5
3341992|NCT03434977|4072371|FG000|NOT COMPLETED|Intervention Period 2 (6 Days)||0
3341993|NCT03434977|4072372|FG001|NOT COMPLETED|Intervention Period 2 (6 Days)||0
3341994|NCT03435055|4072378|FG000|STARTED|Screening||21
3341995|NCT03435055|4072378|FG000|COMPLETED|Screening||19
3341996|NCT03435055|4072378|FG000|NOT COMPLETED|Screening||2
3341997|NCT03435055|4072378|FG000|STARTED|Received Intervention||19
3341998|NCT03435055|4072378|FG000|COMPLETED|Received Intervention||16
3341999|NCT03435055|4072378|FG000|NOT COMPLETED|Received Intervention||3
3342000|NCT03435081|4072392|FG000|STARTED|Overall Study||147
3342001|NCT03435081|4072393|FG001|STARTED|Overall Study||147
3342002|NCT03435081|4072394|FG002|STARTED|Overall Study||146
3342003|NCT03435081|4072392|FG000|Received at Least One Dose of Study Drug|Overall Study||147
3342004|NCT03435081|4072393|FG001|Received at Least One Dose of Study Drug|Overall Study||147
3342005|NCT03435081|4072394|FG002|Received at Least One Dose of Study Drug|Overall Study||146
3342006|NCT03435081|4072392|FG000|COMPLETED|Overall Study||126
3342007|NCT03435081|4072393|FG001|COMPLETED|Overall Study||131
3342008|NCT03435081|4072394|FG002|COMPLETED|Overall Study||127
3342009|NCT03435081|4072392|FG000|NOT COMPLETED|Overall Study||21
3342010|NCT03435081|4072393|FG001|NOT COMPLETED|Overall Study||16
3342011|NCT03435081|4072394|FG002|NOT COMPLETED|Overall Study||19
3342012|NCT03435185|4072405|FG000|STARTED|Overall Study||44
3342013|NCT03435185|4072406|FG001|STARTED|Overall Study||43
3342014|NCT03435185|4072405|FG000|COMPLETED|Overall Study||43
3342015|NCT03435185|4072406|FG001|COMPLETED|Overall Study||28
3342016|NCT03435185|4072405|FG000|NOT COMPLETED|Overall Study||1
3342017|NCT03435185|4072406|FG001|NOT COMPLETED|Overall Study||15
3342018|NCT03435211|4072412|FG000|STARTED|Overall Study||26
3342019|NCT03435211|4072412|FG000|COMPLETED|Overall Study||25
3342020|NCT03435211|4072412|FG000|NOT COMPLETED|Overall Study||1
3342021|NCT03435224|4072416|FG000|STARTED|Overall Study||29
3342022|NCT03435224|4072416|FG000|COMPLETED|Overall Study||25
3342023|NCT03435224|4072416|FG000|NOT COMPLETED|Overall Study||4
3342024|NCT03435497|4072422|FG000|STARTED|Overall Study||51
3342025|NCT03435497|4072423|FG001|STARTED|Overall Study||47
3342026|NCT03435497|4072422|FG000|COMPLETED|Overall Study||49
3342027|NCT03435497|4072423|FG001|COMPLETED|Overall Study||41
3342028|NCT03435497|4072422|FG000|NOT COMPLETED|Overall Study||2
3342029|NCT03435497|4072423|FG001|NOT COMPLETED|Overall Study||6
3342030|NCT03435562|4072429|FG000|STARTED|Overall Study||22
3342031|NCT03435562|4072429|FG000|COMPLETED|Overall Study||18
3342032|NCT03435562|4072429|FG000|NOT COMPLETED|Overall Study||4
3342033|NCT03435614|4072442|FG000|STARTED|Overall Study||6
3342034|NCT03435614|4072443|FG001|STARTED|Overall Study||23
3342035|NCT03435614|4072442|FG000|COMPLETED|Overall Study||6
3342036|NCT03435614|4072443|FG001|COMPLETED|Overall Study||23
3342037|NCT03435614|4072442|FG000|NOT COMPLETED|Overall Study||0
3342038|NCT03435614|4072443|FG001|NOT COMPLETED|Overall Study||0
3342039|NCT03435692|4072453|FG000|STARTED|Overall Study||17
3342040|NCT03435692|4072454|FG001|STARTED|Overall Study||18
3342041|NCT03435692|4072455|FG002|STARTED|Overall Study||7
3342042|NCT03435692|4072453|FG000|COMPLETED|Overall Study|Discontinued intervention (n=2). 1) Lumbar Epidural Catheter (LEC) not working Post-Operative Day (POD) 0, Lumbar Epidural Catheter (LEC) removed and morphine infusion started - patient 1 year old. 2) Lumbar Epidural Catheter (LEC) not working Post-Operative Day (POD) 1, Lumbar Epidural Catheter (LEC) removed and Patient Controlled Analgesia (PCA) started.|15
3342043|NCT03435692|4072454|FG001|COMPLETED|Overall Study|Discontinued intervention (n=2). 1) Successful lumbar plexus injection, but unable to thread catheter, morphine infusion started (patient 1 year old). 2) Lumbar Plexus Catheter (LPC) catheter (10 cm) not long enough to reach lumbar plexus in patient weighing 136kg, Lumbar Epidural Catheter (LEC) placed instead.|16
3342044|NCT03435692|4072455|FG002|COMPLETED|Overall Study||7
3342045|NCT03435692|4072453|FG000|NOT COMPLETED|Overall Study||2
3342046|NCT03435692|4072454|FG001|NOT COMPLETED|Overall Study||2
3342047|NCT03435692|4072455|FG002|NOT COMPLETED|Overall Study||0
3342048|NCT03435783|4072469|FG000|STARTED|Overall Study||20
3342049|NCT03435783|4072470|FG001|STARTED|Overall Study||20
3342050|NCT03435783|4072469|FG000|COMPLETED|Overall Study||20
3342051|NCT03435783|4072470|FG001|COMPLETED|Overall Study||19
3342052|NCT03435783|4072469|FG000|NOT COMPLETED|Overall Study||0
3342053|NCT03435783|4072470|FG001|NOT COMPLETED|Overall Study||1
3342054|NCT03436082|4072478|FG000|STARTED|Overall Study||30
3342055|NCT03436082|4072479|FG001|STARTED|Overall Study||30
3342056|NCT03436082|4072478|FG000|COMPLETED|Overall Study|Had procedure|29
3342057|NCT03436082|4072479|FG001|COMPLETED|Overall Study|Had procedure|30
3342058|NCT03436082|4072478|FG000|NOT COMPLETED|Overall Study||1
3342059|NCT03436082|4072479|FG001|NOT COMPLETED|Overall Study||0
3342060|NCT03436147|4072487|FG000|STARTED|Overall Study||19
3342061|NCT03436147|4072488|FG001|STARTED|Overall Study||30
3342062|NCT03436147|4072487|FG000|COMPLETED|Overall Study||15
3342063|NCT03436147|4072488|FG001|COMPLETED|Overall Study||19
3342064|NCT03436147|4072487|FG000|NOT COMPLETED|Overall Study||4
3342065|NCT03436147|4072488|FG001|NOT COMPLETED|Overall Study||11
3342066|NCT03436420|4072496|FG000|STARTED|Overall Study||6
3342067|NCT03436420|4072496|FG000|COMPLETED|Overall Study||3
3342068|NCT03436420|4072496|FG000|NOT COMPLETED|Overall Study||3
3342069|NCT03436732|4072502|FG000|STARTED|Overall Study||4
3342070|NCT03436732|4072503|FG001|STARTED|Overall Study||1
3342071|NCT03436732|4072502|FG000|COMPLETED|Overall Study||0
3342072|NCT03436732|4072503|FG001|COMPLETED|Overall Study||0
3342073|NCT03436732|4072502|FG000|NOT COMPLETED|Overall Study||4
3342074|NCT03436732|4072503|FG001|NOT COMPLETED|Overall Study||1
3342075|NCT03436810|4072512|FG000|STARTED|Overall Study||20
3342076|NCT03436810|4072513|FG001|STARTED|Overall Study||20
3342077|NCT03436810|4072512|FG000|COMPLETED|Overall Study||20
3342078|NCT03436810|4072513|FG001|COMPLETED|Overall Study||20
3342079|NCT03436810|4072512|FG000|NOT COMPLETED|Overall Study||0
3342080|NCT03436810|4072513|FG001|NOT COMPLETED|Overall Study||0
3342081|NCT03437031|4072521|FG000|STARTED|Overall Study||19
3342082|NCT03437031|4072522|FG001|STARTED|Overall Study||21
3342083|NCT03437031|4072521|FG000|COMPLETED|Overall Study||19
3342084|NCT03437031|4072522|FG001|COMPLETED|Overall Study||21
3342085|NCT03437031|4072521|FG000|NOT COMPLETED|Overall Study||0
3342086|NCT03437031|4072522|FG001|NOT COMPLETED|Overall Study||0
3342087|NCT03437044|4072532|FG000|STARTED|Overall Study||20
3342088|NCT03437044|4072533|FG001|STARTED|Overall Study||20
3342089|NCT03437044|4072532|FG000|COMPLETED|Overall Study||17
3342090|NCT03437044|4072533|FG001|COMPLETED|Overall Study||18
3342091|NCT03437044|4072532|FG000|NOT COMPLETED|Overall Study||3
3342092|NCT03437044|4072533|FG001|NOT COMPLETED|Overall Study||2
3342093|NCT03437265|4072539|FG000|STARTED|Overall Study||19
3342094|NCT03437265|4072539|FG000|COMPLETED|Overall Study||13
3342095|NCT03437265|4072539|FG000|NOT COMPLETED|Overall Study||6
3342096|NCT03437278|4072546|FG000|STARTED|Overall Study||24
3342097|NCT03437278|4072547|FG001|STARTED|Overall Study||13
3342098|NCT03437278|4072548|FG002|STARTED|Overall Study||12
3342099|NCT03437278|4072546|FG000|COMPLETED|Overall Study||22
3342100|NCT03437278|4072547|FG001|COMPLETED|Overall Study||13
3342101|NCT03437278|4072548|FG002|COMPLETED|Overall Study||10
3342102|NCT03437278|4072546|FG000|NOT COMPLETED|Overall Study||2
3342103|NCT03437278|4072547|FG001|NOT COMPLETED|Overall Study||0
3342104|NCT03437278|4072548|FG002|NOT COMPLETED|Overall Study||2
3342105|NCT03437447|4072561|FG000|STARTED|Treatment Period 1||20
3342106|NCT03437447|4072562|FG001|STARTED|Treatment Period 1||20
3342107|NCT03437447|4072563|FG002|STARTED|Treatment Period 1||20
3342108|NCT03437447|4072561|FG000|COMPLETED|Treatment Period 1||20
3342109|NCT03437447|4072562|FG001|COMPLETED|Treatment Period 1||20
3342110|NCT03437447|4072563|FG002|COMPLETED|Treatment Period 1||19
3342111|NCT03437447|4072561|FG000|NOT COMPLETED|Treatment Period 1||0
3342112|NCT03437447|4072562|FG001|NOT COMPLETED|Treatment Period 1||0
3342113|NCT03437447|4072563|FG002|NOT COMPLETED|Treatment Period 1||1
3342114|NCT03437447|4072561|FG000|STARTED|Treatment Period 2||20
3342115|NCT03437447|4072562|FG001|STARTED|Treatment Period 2||20
3342116|NCT03437447|4072563|FG002|STARTED|Treatment Period 2||19
3342117|NCT03437447|4072561|FG000|COMPLETED|Treatment Period 2||20
3342118|NCT03437447|4072562|FG001|COMPLETED|Treatment Period 2||20
3342119|NCT03437447|4072563|FG002|COMPLETED|Treatment Period 2||19
3342120|NCT03437447|4072561|FG000|NOT COMPLETED|Treatment Period 2||0
3342121|NCT03437447|4072562|FG001|NOT COMPLETED|Treatment Period 2||0
3342122|NCT03437447|4072563|FG002|NOT COMPLETED|Treatment Period 2||0
3342123|NCT03437447|4072561|FG000|STARTED|Treatment Period 3||20
3342124|NCT03437447|4072562|FG001|STARTED|Treatment Period 3||20
3342125|NCT03437447|4072563|FG002|STARTED|Treatment Period 3||19
3342126|NCT03437447|4072561|FG000|COMPLETED|Treatment Period 3||20
3342127|NCT03437447|4072562|FG001|COMPLETED|Treatment Period 3||20
3342128|NCT03437447|4072563|FG002|COMPLETED|Treatment Period 3||19
3342129|NCT03437447|4072561|FG000|NOT COMPLETED|Treatment Period 3||0
3342130|NCT03437447|4072562|FG001|NOT COMPLETED|Treatment Period 3||0
3342131|NCT03437447|4072563|FG002|NOT COMPLETED|Treatment Period 3||0
3342132|NCT03437512|4072573|FG000|STARTED|Randomized||12
3342133|NCT03437512|4072574|FG001|STARTED|Randomized||13
3342134|NCT03437512|4072573|FG000|COMPLETED|Randomized||12
3342135|NCT03437512|4072574|FG001|COMPLETED|Randomized||11
3342136|NCT03437512|4072573|FG000|NOT COMPLETED|Randomized||0
3342137|NCT03437512|4072574|FG001|NOT COMPLETED|Randomized||2
3342138|NCT03437512|4072573|FG000|STARTED|Received First tDCS Session||12
3342139|NCT03437512|4072574|FG001|STARTED|Received First tDCS Session||11
3342140|NCT03437512|4072573|FG000|COMPLETED|Received First tDCS Session||12
3342141|NCT03437512|4072574|FG001|COMPLETED|Received First tDCS Session||11
3342142|NCT03437512|4072573|FG000|NOT COMPLETED|Received First tDCS Session||0
3342143|NCT03437512|4072574|FG001|NOT COMPLETED|Received First tDCS Session||0
3342144|NCT03437512|4072573|FG000|STARTED|Received Final tDCS Session||12
3342145|NCT03437512|4072574|FG001|STARTED|Received Final tDCS Session||11
3342146|NCT03437512|4072573|FG000|COMPLETED|Received Final tDCS Session||12
3342147|NCT03437512|4072574|FG001|COMPLETED|Received Final tDCS Session||11
3342148|NCT03437512|4072573|FG000|NOT COMPLETED|Received Final tDCS Session||0
3342149|NCT03437512|4072574|FG001|NOT COMPLETED|Received Final tDCS Session||0
3342150|NCT03437512|4072573|FG000|STARTED|Completed Study Follow up||12
3342151|NCT03437512|4072574|FG001|STARTED|Completed Study Follow up||11
3342152|NCT03437512|4072573|FG000|COMPLETED|Completed Study Follow up||10
3342153|NCT03437512|4072574|FG001|COMPLETED|Completed Study Follow up||10
3342154|NCT03437512|4072573|FG000|NOT COMPLETED|Completed Study Follow up||2
3342155|NCT03437512|4072574|FG001|NOT COMPLETED|Completed Study Follow up||1
3342156|NCT03437564|4072582|FG000|STARTED|Overall Study||14
3342157|NCT03437564|4072583|FG001|STARTED|Overall Study||14
3342158|NCT03437564|4072582|FG000|COMPLETED|Overall Study||14
3342159|NCT03437564|4072583|FG001|COMPLETED|Overall Study||14
3342160|NCT03437564|4072582|FG000|NOT COMPLETED|Overall Study||0
3342161|NCT03437564|4072583|FG001|NOT COMPLETED|Overall Study||0
3342162|NCT03437577|4072592|FG000|STARTED|Pre-Randomization||0
3342163|NCT03437577|4072593|FG001|STARTED|Pre-Randomization||0
3342164|NCT03437577|4072594|FG002|STARTED|Pre-Randomization||10
3342165|NCT03437577|4072592|FG000|COMPLETED|Pre-Randomization||0
3342166|NCT03437577|4072593|FG001|COMPLETED|Pre-Randomization||0
3342167|NCT03437577|4072594|FG002|COMPLETED|Pre-Randomization||0
3342168|NCT03437577|4072592|FG000|NOT COMPLETED|Pre-Randomization||0
3342169|NCT03437577|4072593|FG001|NOT COMPLETED|Pre-Randomization||0
3342170|NCT03437577|4072594|FG002|NOT COMPLETED|Pre-Randomization||10
3342171|NCT03437577|4072592|FG000|STARTED|Post-Randomization||3
3342172|NCT03437577|4072593|FG001|STARTED|Post-Randomization||5
3342173|NCT03437577|4072594|FG002|STARTED|Post-Randomization||0
3342174|NCT03437577|4072592|FG000|COMPLETED|Post-Randomization||3
3342175|NCT03437577|4072593|FG001|COMPLETED|Post-Randomization||3
3342176|NCT03437577|4072594|FG002|COMPLETED|Post-Randomization||0
3342177|NCT03437577|4072592|FG000|NOT COMPLETED|Post-Randomization||0
3342178|NCT03437577|4072593|FG001|NOT COMPLETED|Post-Randomization||2
3342179|NCT03437577|4072594|FG002|NOT COMPLETED|Post-Randomization||0
3342180|NCT03437733|4072602|FG000|STARTED|Overall Study||8
3342181|NCT03437733|4072603|FG001|STARTED|Overall Study||90
3342182|NCT03437733|4072602|FG000|Safety|Overall Study||8
3342183|NCT03437733|4072603|FG001|Safety|Overall Study||87
3342184|NCT03437733|4072602|FG000|COMPLETED|Overall Study||8
3342185|NCT03437733|4072603|FG001|COMPLETED|Overall Study||87
3342186|NCT03437733|4072602|FG000|NOT COMPLETED|Overall Study||0
3342187|NCT03437733|4072603|FG001|NOT COMPLETED|Overall Study||3
3342188|NCT03437863|4072608|FG000|STARTED|Overall Study||12
3342189|NCT03437863|4072608|FG000|COMPLETED|Overall Study||12
3342190|NCT03437863|4072608|FG000|NOT COMPLETED|Overall Study||0
3342191|NCT03438006|4072612|FG000|STARTED|Overall Study||3013
3342192|NCT03438006|4072612|FG000|COMPLETED|Overall Study||2895
3342193|NCT03438006|4072612|FG000|NOT COMPLETED|Overall Study||118
3342194|NCT03438045|4072616|FG000|STARTED|Overall Study||75
3342195|NCT03438045|4072616|FG000|COMPLETED|Overall Study||75
3342196|NCT03438045|4072616|FG000|NOT COMPLETED|Overall Study||0
3342197|NCT03438266|4072620|FG000|STARTED|Overall Study||60
3342198|NCT03438266|4072620|FG000|COMPLETED|Overall Study||60
3342199|NCT03438266|4072620|FG000|NOT COMPLETED|Overall Study||0
3342200|NCT03438383|4072628|FG000|STARTED|Overall Study||23
3342201|NCT03438383|4072629|FG001|STARTED|Overall Study||24
3342202|NCT03438383|4072628|FG000|COMPLETED|Overall Study||14
3342203|NCT03438383|4072629|FG001|COMPLETED|Overall Study||21
3342204|NCT03438383|4072628|FG000|NOT COMPLETED|Overall Study||9
3342205|NCT03438383|4072629|FG001|NOT COMPLETED|Overall Study||3
3342206|NCT03438396|4072635|FG000|STARTED|Overall Study||102
3342207|NCT03438396|4072635|FG000|Treated|Overall Study||101
3342208|NCT03438396|4072635|FG000|COMPLETED|Overall Study||0
3342209|NCT03438396|4072635|FG000|NOT COMPLETED|Overall Study||102
3342210|NCT03438539|4072645|FG000|STARTED|Overall Study||76
3342211|NCT03438539|4072646|FG001|STARTED|Overall Study||72
3342212|NCT03438539|4072647|FG002|STARTED|Overall Study||76
3342213|NCT03438539|4072648|FG003|STARTED|Overall Study||73
3342214|NCT03438539|4072649|FG004|STARTED|Overall Study||73
3342215|NCT03438539|4072650|FG005|STARTED|Overall Study||74
3342216|NCT03438539|4072645|FG000|COMPLETED|Overall Study||68
3342217|NCT03438539|4072646|FG001|COMPLETED|Overall Study||68
3342218|NCT03438539|4072647|FG002|COMPLETED|Overall Study||66
3342219|NCT03438539|4072648|FG003|COMPLETED|Overall Study||64
3342220|NCT03438539|4072649|FG004|COMPLETED|Overall Study||70
3342221|NCT03438539|4072650|FG005|COMPLETED|Overall Study||66
3342222|NCT03438539|4072645|FG000|NOT COMPLETED|Overall Study||8
3342223|NCT03438539|4072646|FG001|NOT COMPLETED|Overall Study||4
3342224|NCT03438539|4072647|FG002|NOT COMPLETED|Overall Study||10
3342225|NCT03438539|4072648|FG003|NOT COMPLETED|Overall Study||9
2927917|NCT00574912|3638836|FG000|Completed Placebo|Overall Study|12 original participants started the trial.|12
2927918|NCT00574912|3638836|FG000|Completed 0.5|Overall Study||12
2927919|NCT00574912|3638836|FG000|Completed 1.0|Overall Study||12
2927920|NCT00574912|3638836|FG000|Completed 1.5|Overall Study||12
2927921|NCT00574912|3638836|FG000|Completed 2.0|Overall Study||12
2927922|NCT00574912|3638836|FG000|COMPLETED|Overall Study||12
2927923|NCT00574912|3638836|FG000|NOT COMPLETED|Overall Study||8
3342226|NCT03438539|4072649|FG004|NOT COMPLETED|Overall Study||3
3342227|NCT03438539|4072650|FG005|NOT COMPLETED|Overall Study||8
3342228|NCT03438578|4072666|FG000|STARTED|Overall Study||100
3342229|NCT03438578|4072667|FG001|STARTED|Overall Study||100
3342230|NCT03438578|4072666|FG000|COMPLETED|Overall Study||99
3342231|NCT03438578|4072667|FG001|COMPLETED|Overall Study||96
3342232|NCT03438578|4072666|FG000|NOT COMPLETED|Overall Study||1
3342233|NCT03438578|4072667|FG001|NOT COMPLETED|Overall Study||4
3342234|NCT03439072|4072673|FG000|STARTED|Overall Study||41
3342235|NCT03439072|4072674|FG001|STARTED|Overall Study||40
3342236|NCT03439072|4072673|FG000|COMPLETED|Overall Study|1 subject dropped before G-Pen; another after G-Pen (n=40 G-Pen; N=39 Lilly Glucagon)|39
3342237|NCT03439072|4072674|FG001|COMPLETED|Overall Study|1 subject dropped before Lilly Glucagon; 3 others after Lilly Glucagon (N=39 Lilly; N=36 G-Pen)|36
3342238|NCT03439072|4072673|FG000|NOT COMPLETED|Overall Study||2
3342239|NCT03439072|4072674|FG001|NOT COMPLETED|Overall Study||4
3342240|NCT03439124|4072682|FG000|STARTED|Overall Study||94
3342241|NCT03439124|4072683|FG001|STARTED|Overall Study||44
3342242|NCT03439124|4072682|FG000|COMPLETED|Overall Study||90
3342243|NCT03439124|4072683|FG001|COMPLETED|Overall Study||44
3342244|NCT03439124|4072682|FG000|NOT COMPLETED|Overall Study||4
3342245|NCT03439124|4072683|FG001|NOT COMPLETED|Overall Study||0
3342246|NCT03439137|4072691|FG000|STARTED|Overall Study||162
3342247|NCT03439137|4072692|FG001|STARTED|Overall Study||161
3342248|NCT03439137|4072691|FG000|COMPLETED|Overall Study||120
3342249|NCT03439137|4072692|FG001|COMPLETED|Overall Study||135
3342250|NCT03439137|4072691|FG000|NOT COMPLETED|Overall Study||42
3342251|NCT03439137|4072692|FG001|NOT COMPLETED|Overall Study||26
3342252|NCT03439189|4072698|FG000|STARTED|Overall Study|Subjects performed at least one Methacetin Breath Test (MBT)|343
3342253|NCT03439189|4072698|FG000|COMPLETED|Overall Study||261
3342254|NCT03439189|4072698|FG000|NOT COMPLETED|Overall Study||82
3342255|NCT03440229|4072705|FG000|STARTED|Overall Study||9
3342256|NCT03440229|4072706|FG001|STARTED|Overall Study||7
3342257|NCT03440229|4072705|FG000|COMPLETED|Overall Study||9
3342258|NCT03440229|4072706|FG001|COMPLETED|Overall Study||7
3342259|NCT03440229|4072705|FG000|NOT COMPLETED|Overall Study||0
3342260|NCT03440229|4072706|FG001|NOT COMPLETED|Overall Study||0
3342261|NCT03440320|4072716|FG000|STARTED|Overall Study||18
3342262|NCT03440320|4072717|FG001|STARTED|Overall Study||14
3342263|NCT03440320|4072716|FG000|COMPLETED|Overall Study||18
3342264|NCT03440320|4072717|FG001|COMPLETED|Overall Study||13
3342265|NCT03440320|4072716|FG000|NOT COMPLETED|Overall Study||0
3342266|NCT03440320|4072717|FG001|NOT COMPLETED|Overall Study||1
3342267|NCT03440411|4072729|FG000|STARTED|Overall Study||3
3342268|NCT03440411|4072730|FG001|STARTED|Overall Study||1
3342269|NCT03440411|4072731|FG002|STARTED|Overall Study||2
3342270|NCT03440411|4072732|FG003|STARTED|Overall Study||2
3342271|NCT03440411|4072729|FG000|COMPLETED|Overall Study||0
3342272|NCT03440411|4072730|FG001|COMPLETED|Overall Study||0
3342273|NCT03440411|4072731|FG002|COMPLETED|Overall Study||0
3342274|NCT03440411|4072732|FG003|COMPLETED|Overall Study||0
3342275|NCT03440411|4072729|FG000|NOT COMPLETED|Overall Study||3
3342276|NCT03440411|4072730|FG001|NOT COMPLETED|Overall Study||1
3342277|NCT03440411|4072731|FG002|NOT COMPLETED|Overall Study||2
3342278|NCT03440411|4072732|FG003|NOT COMPLETED|Overall Study||2
3342279|NCT03440424|4072750|FG000|STARTED|Overall Study||8
3342280|NCT03440424|4072751|FG001|STARTED|Overall Study||8
3342281|NCT03440424|4072752|FG002|STARTED|Overall Study||8
3342282|NCT03440424|4072750|FG000|COMPLETED|Overall Study||8
3342283|NCT03440424|4072751|FG001|COMPLETED|Overall Study||8
3342284|NCT03440424|4072752|FG002|COMPLETED|Overall Study||8
3342285|NCT03440424|4072750|FG000|NOT COMPLETED|Overall Study||0
3342286|NCT03440424|4072751|FG001|NOT COMPLETED|Overall Study||0
3342287|NCT03440424|4072752|FG002|NOT COMPLETED|Overall Study||0
3342288|NCT03440619|4072760|FG000|STARTED|Overall Study||28
3342289|NCT03440619|4072760|FG000|COMPLETED|Overall Study||28
3342290|NCT03440619|4072760|FG000|NOT COMPLETED|Overall Study||0
3342291|NCT03440723|4072766|FG000|STARTED|Overall Study||21
3342292|NCT03440723|4072767|FG001|STARTED|Overall Study||21
3342293|NCT03440723|4072766|FG000|COMPLETED|Overall Study||21
3342294|NCT03440723|4072767|FG001|COMPLETED|Overall Study||21
3342295|NCT03440723|4072766|FG000|NOT COMPLETED|Overall Study||0
3342296|NCT03440723|4072767|FG001|NOT COMPLETED|Overall Study||0
3342297|NCT03440918|4072776|FG000|STARTED|Overall Study||133
3342298|NCT03440918|4072777|FG001|STARTED|Overall Study||138
3342299|NCT03440918|4072776|FG000|COMPLETED|Overall Study||133
3342300|NCT03440918|4072777|FG001|COMPLETED|Overall Study||122
3342301|NCT03440918|4072776|FG000|NOT COMPLETED|Overall Study||0
3342302|NCT03440918|4072777|FG001|NOT COMPLETED|Overall Study||16
3342303|NCT03440944|4072785|FG000|STARTED|Overall Study||9
3342304|NCT03440944|4072786|FG001|STARTED|Overall Study||9
3342305|NCT03440944|4072785|FG000|COMPLETED|Overall Study||8
3342306|NCT03440944|4072786|FG001|COMPLETED|Overall Study||8
3342307|NCT03440944|4072785|FG000|NOT COMPLETED|Overall Study||1
3342308|NCT03440944|4072786|FG001|NOT COMPLETED|Overall Study||1
3342309|NCT03441178|4072793|FG000|STARTED|Overall Study||36
3342310|NCT03441178|4072794|FG001|STARTED|Overall Study||44
3342311|NCT03441178|4072795|FG002|STARTED|Overall Study||21
3342312|NCT03441178|4072793|FG000|COMPLETED|Overall Study||36
3342313|NCT03441178|4072794|FG001|COMPLETED|Overall Study||43
3342314|NCT03441178|4072795|FG002|COMPLETED|Overall Study||20
3342315|NCT03441178|4072793|FG000|NOT COMPLETED|Overall Study||0
3342316|NCT03441178|4072794|FG001|NOT COMPLETED|Overall Study||1
3342317|NCT03441178|4072795|FG002|NOT COMPLETED|Overall Study||1
3342318|NCT03441269|4072808|FG000|STARTED|Overall Study||75
3342319|NCT03441269|4072809|FG001|STARTED|Overall Study||75
3342320|NCT03441269|4072810|FG002|STARTED|Overall Study||75
3342321|NCT03441269|4072808|FG000|COMPLETED|Overall Study||75
3342322|NCT03441269|4072809|FG001|COMPLETED|Overall Study||74
3342323|NCT03441269|4072810|FG002|COMPLETED|Overall Study||74
3342324|NCT03441269|4072808|FG000|NOT COMPLETED|Overall Study||0
3342325|NCT03441269|4072809|FG001|NOT COMPLETED|Overall Study||1
3342326|NCT03441269|4072810|FG002|NOT COMPLETED|Overall Study||1
3342327|NCT03441581|4072820|FG000|STARTED|Overall Study||12
3342328|NCT03441581|4072821|FG001|STARTED|Overall Study||12
3342329|NCT03441581|4072820|FG000|COMPLETED|Overall Study||12
3342330|NCT03441581|4072821|FG001|COMPLETED|Overall Study||12
3342331|NCT03441581|4072820|FG000|NOT COMPLETED|Overall Study||0
3342332|NCT03441581|4072821|FG001|NOT COMPLETED|Overall Study||0
3342333|NCT03441594|4072827|FG000|STARTED|Overall Study||56
3342334|NCT03441594|4072827|FG000|COMPLETED|Overall Study||56
3342335|NCT03441594|4072827|FG000|NOT COMPLETED|Overall Study||0
3342336|NCT03441633|4072841|FG000|STARTED|Overall Study||4712
3342337|NCT03441633|4072842|FG001|STARTED|Overall Study||1423
3342338|NCT03441633|4072843|FG002|STARTED|Overall Study||32212
3342339|NCT03441633|4072844|FG003|STARTED|Overall Study||192
3342340|NCT03441633|4072845|FG004|STARTED|Overall Study||2286
3342341|NCT03441633|4072846|FG005|STARTED|Overall Study||363
3342342|NCT03441633|4072847|FG006|STARTED|Overall Study||2855
3342343|NCT03441633|4072848|FG007|STARTED|Overall Study||953
3342344|NCT03441633|4072849|FG008|STARTED|Overall Study||5132
3342345|NCT03441633|4072850|FG009|STARTED|Overall Study||1562
3342346|NCT03441633|4072841|FG000|COMPLETED|Overall Study||4712
3342347|NCT03441633|4072842|FG001|COMPLETED|Overall Study||1423
3342348|NCT03441633|4072843|FG002|COMPLETED|Overall Study||32212
3342349|NCT03441633|4072844|FG003|COMPLETED|Overall Study||192
3342350|NCT03441633|4072845|FG004|COMPLETED|Overall Study||2286
3342351|NCT03441633|4072846|FG005|COMPLETED|Overall Study||363
3342352|NCT03441633|4072847|FG006|COMPLETED|Overall Study||2855
3342353|NCT03441633|4072848|FG007|COMPLETED|Overall Study||953
3342354|NCT03441633|4072849|FG008|COMPLETED|Overall Study||5132
3342355|NCT03441633|4072850|FG009|COMPLETED|Overall Study||1562
3342356|NCT03441633|4072841|FG000|NOT COMPLETED|Overall Study||0
3342357|NCT03441633|4072842|FG001|NOT COMPLETED|Overall Study||0
3342358|NCT03441633|4072843|FG002|NOT COMPLETED|Overall Study||0
3342359|NCT03441633|4072844|FG003|NOT COMPLETED|Overall Study||0
3342360|NCT03441633|4072845|FG004|NOT COMPLETED|Overall Study||0
3342361|NCT03441633|4072846|FG005|NOT COMPLETED|Overall Study||0
3342362|NCT03441633|4072847|FG006|NOT COMPLETED|Overall Study||0
3342363|NCT03441633|4072848|FG007|NOT COMPLETED|Overall Study||0
3342364|NCT03441633|4072849|FG008|NOT COMPLETED|Overall Study||0
3342365|NCT03441633|4072850|FG009|NOT COMPLETED|Overall Study||0
3342366|NCT03441789|4072878|FG000|STARTED|Overall Study||14
3342367|NCT03441789|4072879|FG001|STARTED|Overall Study||14
3342368|NCT03441789|4072878|FG000|COMPLETED|Overall Study||13
3342369|NCT03441789|4072879|FG001|COMPLETED|Overall Study||10
3342370|NCT03441789|4072878|FG000|NOT COMPLETED|Overall Study||1
3342371|NCT03441789|4072879|FG001|NOT COMPLETED|Overall Study||4
3342372|NCT03441984|4072887|FG000|STARTED|Part 1: Period 1 (Up to Day 4)||3
3342373|NCT03441984|4072888|FG001|STARTED|Part 1: Period 1 (Up to Day 4)||3
3342374|NCT03441984|4072889|FG002|STARTED|Part 1: Period 1 (Up to Day 4)||3
3342375|NCT03441984|4072890|FG003|STARTED|Part 1: Period 1 (Up to Day 4)||3
3342376|NCT03441984|4072891|FG004|STARTED|Part 1: Period 1 (Up to Day 4)||3
3342377|NCT03441984|4072892|FG005|STARTED|Part 1: Period 1 (Up to Day 4)||3
3342378|NCT03441984|4072893|FG006|STARTED|Part 1: Period 1 (Up to Day 4)||0
3342379|NCT03441984|4072894|FG007|STARTED|Part 1: Period 1 (Up to Day 4)||0
3342380|NCT03441984|4072895|FG008|STARTED|Part 1: Period 1 (Up to Day 4)||0
3342381|NCT03441984|4072896|FG009|STARTED|Part 1: Period 1 (Up to Day 4)||0
3342382|NCT03441984|4072897|FG010|STARTED|Part 1: Period 1 (Up to Day 4)||0
3342383|NCT03441984|4072898|FG011|STARTED|Part 1: Period 1 (Up to Day 4)||0
3342384|NCT03441984|4072887|FG000|COMPLETED|Part 1: Period 1 (Up to Day 4)||3
3342385|NCT03441984|4072888|FG001|COMPLETED|Part 1: Period 1 (Up to Day 4)||3
3342386|NCT03441984|4072889|FG002|COMPLETED|Part 1: Period 1 (Up to Day 4)||3
3342387|NCT03441984|4072890|FG003|COMPLETED|Part 1: Period 1 (Up to Day 4)||3
3342388|NCT03441984|4072891|FG004|COMPLETED|Part 1: Period 1 (Up to Day 4)||3
3342389|NCT03441984|4072892|FG005|COMPLETED|Part 1: Period 1 (Up to Day 4)||3
3342390|NCT03441984|4072893|FG006|COMPLETED|Part 1: Period 1 (Up to Day 4)||0
3342391|NCT03441984|4072894|FG007|COMPLETED|Part 1: Period 1 (Up to Day 4)||0
3342392|NCT03441984|4072895|FG008|COMPLETED|Part 1: Period 1 (Up to Day 4)||0
3342393|NCT03441984|4072896|FG009|COMPLETED|Part 1: Period 1 (Up to Day 4)||0
3342394|NCT03441984|4072897|FG010|COMPLETED|Part 1: Period 1 (Up to Day 4)||0
3342395|NCT03441984|4072898|FG011|COMPLETED|Part 1: Period 1 (Up to Day 4)||0
3342396|NCT03441984|4072887|FG000|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
3342397|NCT03441984|4072888|FG001|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
3342398|NCT03441984|4072889|FG002|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
3342399|NCT03441984|4072890|FG003|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
3342400|NCT03441984|4072891|FG004|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
3342401|NCT03441984|4072892|FG005|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
3342402|NCT03441984|4072893|FG006|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
3342403|NCT03441984|4072894|FG007|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
3342404|NCT03441984|4072895|FG008|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
3342405|NCT03441984|4072896|FG009|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
3342406|NCT03441984|4072897|FG010|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
3342407|NCT03441984|4072898|FG011|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
3342408|NCT03441984|4072887|FG000|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||3
3342409|NCT03441984|4072888|FG001|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||3
3342410|NCT03441984|4072889|FG002|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||3
3342411|NCT03441984|4072890|FG003|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||3
3342412|NCT03441984|4072891|FG004|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||3
3342413|NCT03441984|4072892|FG005|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||3
3342414|NCT03441984|4072893|FG006|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||0
3342415|NCT03441984|4072894|FG007|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||0
3342416|NCT03441984|4072895|FG008|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||0
3342417|NCT03441984|4072896|FG009|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||0
3342418|NCT03441984|4072897|FG010|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||0
3342419|NCT03441984|4072898|FG011|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||0
3342420|NCT03441984|4072887|FG000|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||3
3342421|NCT03441984|4072888|FG001|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||3
3342422|NCT03441984|4072889|FG002|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||3
3342423|NCT03441984|4072890|FG003|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||3
3342424|NCT03441984|4072891|FG004|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||3
3342425|NCT03441984|4072892|FG005|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||3
3342426|NCT03441984|4072893|FG006|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
3342427|NCT03441984|4072894|FG007|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
3342428|NCT03441984|4072895|FG008|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
3342429|NCT03441984|4072896|FG009|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
3342430|NCT03441984|4072897|FG010|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
3342431|NCT03441984|4072898|FG011|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
3342432|NCT03441984|4072887|FG000|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
3342433|NCT03441984|4072888|FG001|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
3342434|NCT03441984|4072889|FG002|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
3342435|NCT03441984|4072890|FG003|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
3342436|NCT03441984|4072891|FG004|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
3342437|NCT03441984|4072892|FG005|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
3342438|NCT03441984|4072893|FG006|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
3342439|NCT03441984|4072894|FG007|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
3342440|NCT03441984|4072895|FG008|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
3342441|NCT03441984|4072896|FG009|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
3342442|NCT03441984|4072897|FG010|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
3342443|NCT03441984|4072898|FG011|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
3342444|NCT03441984|4072887|FG000|STARTED|Part 1: Period 2 (Up to Day 4 )||3
3342445|NCT03441984|4072888|FG001|STARTED|Part 1: Period 2 (Up to Day 4 )||3
3342446|NCT03441984|4072889|FG002|STARTED|Part 1: Period 2 (Up to Day 4 )||3
3342447|NCT03441984|4072890|FG003|STARTED|Part 1: Period 2 (Up to Day 4 )||3
3342448|NCT03441984|4072891|FG004|STARTED|Part 1: Period 2 (Up to Day 4 )||3
3342449|NCT03441984|4072892|FG005|STARTED|Part 1: Period 2 (Up to Day 4 )||3
3342450|NCT03441984|4072893|FG006|STARTED|Part 1: Period 2 (Up to Day 4 )||0
3342451|NCT03441984|4072894|FG007|STARTED|Part 1: Period 2 (Up to Day 4 )||0
3342452|NCT03441984|4072895|FG008|STARTED|Part 1: Period 2 (Up to Day 4 )||0
3342453|NCT03441984|4072896|FG009|STARTED|Part 1: Period 2 (Up to Day 4 )||0
3342454|NCT03441984|4072897|FG010|STARTED|Part 1: Period 2 (Up to Day 4 )||0
3342455|NCT03441984|4072898|FG011|STARTED|Part 1: Period 2 (Up to Day 4 )||0
3342456|NCT03441984|4072887|FG000|COMPLETED|Part 1: Period 2 (Up to Day 4 )||3
3342457|NCT03441984|4072888|FG001|COMPLETED|Part 1: Period 2 (Up to Day 4 )||3
3342458|NCT03441984|4072889|FG002|COMPLETED|Part 1: Period 2 (Up to Day 4 )||2
3342459|NCT03441984|4072890|FG003|COMPLETED|Part 1: Period 2 (Up to Day 4 )||3
3342460|NCT03441984|4072891|FG004|COMPLETED|Part 1: Period 2 (Up to Day 4 )||3
3342461|NCT03441984|4072892|FG005|COMPLETED|Part 1: Period 2 (Up to Day 4 )||3
3342462|NCT03441984|4072893|FG006|COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
3342463|NCT03441984|4072894|FG007|COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
3342464|NCT03441984|4072895|FG008|COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
3342465|NCT03441984|4072896|FG009|COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
3342466|NCT03441984|4072897|FG010|COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
3342467|NCT03441984|4072898|FG011|COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
3342468|NCT03441984|4072887|FG000|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
3342469|NCT03441984|4072888|FG001|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
3342470|NCT03441984|4072889|FG002|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||1
3342471|NCT03441984|4072890|FG003|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
3342472|NCT03441984|4072891|FG004|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
3342473|NCT03441984|4072892|FG005|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
3342474|NCT03441984|4072893|FG006|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
3342475|NCT03441984|4072894|FG007|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
3342476|NCT03441984|4072895|FG008|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
3342477|NCT03441984|4072896|FG009|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
3342478|NCT03441984|4072897|FG010|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
3342479|NCT03441984|4072898|FG011|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
3342480|NCT03441984|4072887|FG000|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||3
3342481|NCT03441984|4072888|FG001|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||3
3342482|NCT03441984|4072889|FG002|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||2
3342483|NCT03441984|4072890|FG003|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||3
3342484|NCT03441984|4072891|FG004|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||3
3342485|NCT03441984|4072892|FG005|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||3
3342486|NCT03441984|4072893|FG006|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||0
3342487|NCT03441984|4072894|FG007|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||0
3342488|NCT03441984|4072895|FG008|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||0
3342489|NCT03441984|4072896|FG009|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||0
3342490|NCT03441984|4072897|FG010|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||0
3177328|NCT01970371|3905112|FG002|NOT COMPLETED|Overall Study||13
3177329|NCT01970397|3905124|FG000|STARTED|Overall Study||69
3177330|NCT01970397|3905125|FG001|STARTED|Overall Study||69
3177331|NCT01970397|3905124|FG000|COMPLETED|Overall Study||67
3177332|NCT01970397|3905125|FG001|COMPLETED|Overall Study||64
3177333|NCT01970397|3905124|FG000|NOT COMPLETED|Overall Study||2
3177334|NCT01970397|3905125|FG001|NOT COMPLETED|Overall Study||5
3177335|NCT01970475|3905133|FG000|STARTED|Overall Study||264
3177336|NCT01970475|3905134|FG001|STARTED|Overall Study||262
3177337|NCT01970475|3905133|FG000|COMPLETED|Overall Study||243
3177338|NCT01970475|3905134|FG001|COMPLETED|Overall Study||251
3177339|NCT01970475|3905133|FG000|NOT COMPLETED|Overall Study||21
3177340|NCT01970475|3905134|FG001|NOT COMPLETED|Overall Study||11
3177341|NCT01970488|3905142|FG000|STARTED|Part 1: Through Week 16||175
3177342|NCT01970488|3905143|FG001|STARTED|Part 1: Through Week 16||175
3177343|NCT01970488|3905144|FG002|STARTED|Part 1: Through Week 16||0
3177344|NCT01970488|3905145|FG003|STARTED|Part 1: Through Week 16||0
3177345|NCT01970488|3905146|FG004|STARTED|Part 1: Through Week 16||0
3177346|NCT01970488|3905142|FG000|Received Treatment|Part 1: Through Week 16||174
3177347|NCT01970488|3905143|FG001|Received Treatment|Part 1: Through Week 16||173
3177348|NCT01970488|3905144|FG002|Received Treatment|Part 1: Through Week 16||0
3342491|NCT03441984|4072898|FG011|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||0
3342492|NCT03441984|4072887|FG000|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||3
3342493|NCT03441984|4072888|FG001|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||3
3177349|NCT01970488|3905145|FG003|Received Treatment|Part 1: Through Week 16||0
3177350|NCT01970488|3905146|FG004|Received Treatment|Part 1: Through Week 16||0
3177351|NCT01970488|3905142|FG000|COMPLETED|Part 1: Through Week 16||164
3177352|NCT01970488|3905143|FG001|COMPLETED|Part 1: Through Week 16||162
3177353|NCT01970488|3905144|FG002|COMPLETED|Part 1: Through Week 16||0
3177354|NCT01970488|3905145|FG003|COMPLETED|Part 1: Through Week 16||0
3177355|NCT01970488|3905146|FG004|COMPLETED|Part 1: Through Week 16||0
3177356|NCT01970488|3905142|FG000|NOT COMPLETED|Part 1: Through Week 16||11
3177357|NCT01970488|3905143|FG001|NOT COMPLETED|Part 1: Through Week 16||13
3177358|NCT01970488|3905144|FG002|NOT COMPLETED|Part 1: Through Week 16||0
3177359|NCT01970488|3905145|FG003|NOT COMPLETED|Part 1: Through Week 16||0
3177360|NCT01970488|3905146|FG004|NOT COMPLETED|Part 1: Through Week 16||0
3177361|NCT01970488|3905142|FG000|STARTED|Part 2: Post Week 16||0
3177362|NCT01970488|3905143|FG001|STARTED|Part 2: Post Week 16||0
3177363|NCT01970488|3905144|FG002|STARTED|Part 2: Post Week 16|Only participants who completed week 16 and with a PASI 50 response continued in Part 2|152
3177364|NCT01970488|3905145|FG003|STARTED|Part 2: Post Week 16|Only participants who completed week 16 and with a PASI 50 response continued in Part 2|79
3177365|NCT01970488|3905146|FG004|STARTED|Part 2: Post Week 16|Only participants who completed week 16 and with a PASI 50 response continued in Part 2|77
3177366|NCT01970488|3905142|FG000|COMPLETED|Part 2: Post Week 16||0
3177367|NCT01970488|3905143|FG001|COMPLETED|Part 2: Post Week 16||0
3177368|NCT01970488|3905144|FG002|COMPLETED|Part 2: Post Week 16||135
3177369|NCT01970488|3905145|FG003|COMPLETED|Part 2: Post Week 16||71
3177370|NCT01970488|3905146|FG004|COMPLETED|Part 2: Post Week 16||69
3177371|NCT01970488|3905142|FG000|NOT COMPLETED|Part 2: Post Week 16||0
3177372|NCT01970488|3905143|FG001|NOT COMPLETED|Part 2: Post Week 16||0
3177373|NCT01970488|3905144|FG002|NOT COMPLETED|Part 2: Post Week 16||17
3177374|NCT01970488|3905145|FG003|NOT COMPLETED|Part 2: Post Week 16||8
3177375|NCT01970488|3905146|FG004|NOT COMPLETED|Part 2: Post Week 16||8
3177376|NCT01970527|3905163|FG000|STARTED|Pre-treatment/Baseline||9
3177377|NCT01970527|3905164|FG001|STARTED|Pre-treatment/Baseline||14
3177378|NCT01970527|3905163|FG000|COMPLETED|Pre-treatment/Baseline||8
3177379|NCT01970527|3905164|FG001|COMPLETED|Pre-treatment/Baseline||14
3177380|NCT01970527|3905163|FG000|NOT COMPLETED|Pre-treatment/Baseline||1
3177381|NCT01970527|3905164|FG001|NOT COMPLETED|Pre-treatment/Baseline||0
3177382|NCT01970527|3905163|FG000|STARTED|Treatment||8
3177383|NCT01970527|3905164|FG001|STARTED|Treatment||14
3177384|NCT01970527|3905163|FG000|COMPLETED|Treatment||8
3177385|NCT01970527|3905164|FG001|COMPLETED|Treatment||11
3177386|NCT01970527|3905163|FG000|NOT COMPLETED|Treatment||0
3177387|NCT01970527|3905164|FG001|NOT COMPLETED|Treatment||3
3177388|NCT01970527|3905163|FG000|STARTED|Follow-up Clinic Visit||8
3177389|NCT01970527|3905164|FG001|STARTED|Follow-up Clinic Visit||11
3177390|NCT01970527|3905163|FG000|COMPLETED|Follow-up Clinic Visit||7
3177391|NCT01970527|3905164|FG001|COMPLETED|Follow-up Clinic Visit||8
3177392|NCT01970527|3905163|FG000|NOT COMPLETED|Follow-up Clinic Visit||1
3177393|NCT01970527|3905164|FG001|NOT COMPLETED|Follow-up Clinic Visit||3
3177394|NCT01970540|3905176|FG000|STARTED|Overall Study||73
3177395|NCT01970540|3905177|FG001|STARTED|Overall Study||28
3177396|NCT01970540|3905178|FG002|STARTED|Overall Study||19
3177397|NCT01970540|3905176|FG000|COMPLETED|Overall Study||0
3177398|NCT01970540|3905177|FG001|COMPLETED|Overall Study||0
3177399|NCT01970540|3905178|FG002|COMPLETED|Overall Study||0
3177400|NCT01970540|3905176|FG000|NOT COMPLETED|Overall Study||73
3177401|NCT01970540|3905177|FG001|NOT COMPLETED|Overall Study||28
3177402|NCT01970540|3905178|FG002|NOT COMPLETED|Overall Study||19
3177403|NCT01970592|3905197|FG000|STARTED|Overall Study|Completed all training sessions|56
3177404|NCT01970592|3905197|FG000|COMPLETED|Overall Study||50
3342494|NCT03441984|4072889|FG002|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||2
3342495|NCT03441984|4072890|FG003|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||3
3342496|NCT03441984|4072891|FG004|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||3
3342497|NCT03441984|4072892|FG005|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||3
3342498|NCT03441984|4072893|FG006|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
3342499|NCT03441984|4072894|FG007|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
3342500|NCT03441984|4072895|FG008|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
3342501|NCT03441984|4072896|FG009|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
3342502|NCT03441984|4072897|FG010|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
3342503|NCT03441984|4072898|FG011|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
3342504|NCT03441984|4072887|FG000|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
3342505|NCT03441984|4072888|FG001|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
3342506|NCT03441984|4072889|FG002|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
3342507|NCT03441984|4072890|FG003|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
3342508|NCT03441984|4072891|FG004|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
3342509|NCT03441984|4072892|FG005|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
3342510|NCT03441984|4072893|FG006|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
3342511|NCT03441984|4072894|FG007|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
3342512|NCT03441984|4072895|FG008|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
3342513|NCT03441984|4072896|FG009|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
3342514|NCT03441984|4072897|FG010|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
3342515|NCT03441984|4072898|FG011|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
3342516|NCT03441984|4072887|FG000|STARTED|Part 1: Period 3 (Up to Day 4 )||3
3177405|NCT01970592|3905197|FG000|NOT COMPLETED|Overall Study||6
3177406|NCT01970787|3905201|FG000|STARTED|Overall Study||22
3177407|NCT01970787|3905201|FG000|COMPLETED|Overall Study||21
3342517|NCT03441984|4072888|FG001|STARTED|Part 1: Period 3 (Up to Day 4 )||3
3342518|NCT03441984|4072889|FG002|STARTED|Part 1: Period 3 (Up to Day 4 )||2
3342519|NCT03441984|4072890|FG003|STARTED|Part 1: Period 3 (Up to Day 4 )||3
3342520|NCT03441984|4072891|FG004|STARTED|Part 1: Period 3 (Up to Day 4 )||3
3342521|NCT03441984|4072892|FG005|STARTED|Part 1: Period 3 (Up to Day 4 )||3
3342522|NCT03441984|4072893|FG006|STARTED|Part 1: Period 3 (Up to Day 4 )||0
3342523|NCT03441984|4072894|FG007|STARTED|Part 1: Period 3 (Up to Day 4 )||0
3342524|NCT03441984|4072895|FG008|STARTED|Part 1: Period 3 (Up to Day 4 )||0
3342525|NCT03441984|4072896|FG009|STARTED|Part 1: Period 3 (Up to Day 4 )||0
3342526|NCT03441984|4072897|FG010|STARTED|Part 1: Period 3 (Up to Day 4 )||0
3342527|NCT03441984|4072898|FG011|STARTED|Part 1: Period 3 (Up to Day 4 )||0
3342528|NCT03441984|4072887|FG000|COMPLETED|Part 1: Period 3 (Up to Day 4 )||3
3342529|NCT03441984|4072888|FG001|COMPLETED|Part 1: Period 3 (Up to Day 4 )||3
3342530|NCT03441984|4072889|FG002|COMPLETED|Part 1: Period 3 (Up to Day 4 )||2
3342531|NCT03441984|4072890|FG003|COMPLETED|Part 1: Period 3 (Up to Day 4 )||3
3342532|NCT03441984|4072891|FG004|COMPLETED|Part 1: Period 3 (Up to Day 4 )||3
3342533|NCT03441984|4072892|FG005|COMPLETED|Part 1: Period 3 (Up to Day 4 )||3
3342534|NCT03441984|4072893|FG006|COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
3342535|NCT03441984|4072894|FG007|COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
3342536|NCT03441984|4072895|FG008|COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
3342537|NCT03441984|4072896|FG009|COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
3342538|NCT03441984|4072897|FG010|COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
3342539|NCT03441984|4072898|FG011|COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
3342540|NCT03441984|4072887|FG000|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
3342541|NCT03441984|4072888|FG001|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
3342542|NCT03441984|4072889|FG002|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
3342543|NCT03441984|4072890|FG003|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
3342544|NCT03441984|4072891|FG004|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
3342545|NCT03441984|4072892|FG005|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
3342546|NCT03441984|4072893|FG006|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
3342547|NCT03441984|4072894|FG007|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
3342548|NCT03441984|4072895|FG008|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
3342549|NCT03441984|4072896|FG009|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
3342550|NCT03441984|4072897|FG010|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
3342551|NCT03441984|4072898|FG011|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
3342552|NCT03441984|4072887|FG000|STARTED|Part 2: Period 1(Up to Day 4)||0
3342553|NCT03441984|4072888|FG001|STARTED|Part 2: Period 1(Up to Day 4)||0
3342554|NCT03441984|4072889|FG002|STARTED|Part 2: Period 1(Up to Day 4)||0
3342555|NCT03441984|4072890|FG003|STARTED|Part 2: Period 1(Up to Day 4)||0
3342556|NCT03441984|4072891|FG004|STARTED|Part 2: Period 1(Up to Day 4)||0
3342557|NCT03441984|4072892|FG005|STARTED|Part 2: Period 1(Up to Day 4)||0
3342558|NCT03441984|4072893|FG006|STARTED|Part 2: Period 1(Up to Day 4)||3
3342559|NCT03441984|4072894|FG007|STARTED|Part 2: Period 1(Up to Day 4)||3
3342560|NCT03441984|4072895|FG008|STARTED|Part 2: Period 1(Up to Day 4)||3
3342561|NCT03441984|4072896|FG009|STARTED|Part 2: Period 1(Up to Day 4)||3
3342562|NCT03441984|4072897|FG010|STARTED|Part 2: Period 1(Up to Day 4)||3
3342563|NCT03441984|4072898|FG011|STARTED|Part 2: Period 1(Up to Day 4)||3
3342564|NCT03441984|4072887|FG000|COMPLETED|Part 2: Period 1(Up to Day 4)||0
3342565|NCT03441984|4072888|FG001|COMPLETED|Part 2: Period 1(Up to Day 4)||0
3342566|NCT03441984|4072889|FG002|COMPLETED|Part 2: Period 1(Up to Day 4)||0
3342567|NCT03441984|4072890|FG003|COMPLETED|Part 2: Period 1(Up to Day 4)||0
3342568|NCT03441984|4072891|FG004|COMPLETED|Part 2: Period 1(Up to Day 4)||0
3342569|NCT03441984|4072892|FG005|COMPLETED|Part 2: Period 1(Up to Day 4)||0
3342570|NCT03441984|4072893|FG006|COMPLETED|Part 2: Period 1(Up to Day 4)||3
3342571|NCT03441984|4072894|FG007|COMPLETED|Part 2: Period 1(Up to Day 4)||3
3342572|NCT03441984|4072895|FG008|COMPLETED|Part 2: Period 1(Up to Day 4)||3
3342573|NCT03441984|4072896|FG009|COMPLETED|Part 2: Period 1(Up to Day 4)||3
3342574|NCT03441984|4072897|FG010|COMPLETED|Part 2: Period 1(Up to Day 4)||3
3342575|NCT03441984|4072898|FG011|COMPLETED|Part 2: Period 1(Up to Day 4)||3
3342576|NCT03441984|4072887|FG000|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
3342577|NCT03441984|4072888|FG001|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
3342578|NCT03441984|4072889|FG002|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
3342579|NCT03441984|4072890|FG003|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
3342580|NCT03441984|4072891|FG004|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
3342581|NCT03441984|4072892|FG005|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
3342582|NCT03441984|4072893|FG006|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
3342583|NCT03441984|4072894|FG007|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
3342584|NCT03441984|4072895|FG008|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
3342585|NCT03441984|4072896|FG009|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
3342586|NCT03441984|4072897|FG010|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
3342587|NCT03441984|4072898|FG011|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
3342588|NCT03441984|4072887|FG000|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||0
3342589|NCT03441984|4072888|FG001|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||0
3342590|NCT03441984|4072889|FG002|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||0
3342591|NCT03441984|4072890|FG003|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||0
3342592|NCT03441984|4072891|FG004|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||0
3342593|NCT03441984|4072892|FG005|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||0
3342594|NCT03441984|4072893|FG006|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||3
3342595|NCT03441984|4072894|FG007|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||3
3342596|NCT03441984|4072895|FG008|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||3
3342597|NCT03441984|4072896|FG009|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||3
3342598|NCT03441984|4072897|FG010|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||3
3342599|NCT03441984|4072898|FG011|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||3
3342600|NCT03441984|4072887|FG000|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
3342601|NCT03441984|4072888|FG001|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
3342602|NCT03441984|4072889|FG002|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
3342603|NCT03441984|4072890|FG003|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
3342604|NCT03441984|4072891|FG004|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
3342605|NCT03441984|4072892|FG005|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
3342606|NCT03441984|4072893|FG006|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||3
3342607|NCT03441984|4072894|FG007|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||3
3342608|NCT03441984|4072895|FG008|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||3
3342609|NCT03441984|4072896|FG009|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||3
3342610|NCT03441984|4072897|FG010|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||3
3342611|NCT03441984|4072898|FG011|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||3
3342612|NCT03441984|4072887|FG000|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
3342613|NCT03441984|4072888|FG001|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
3342614|NCT03441984|4072889|FG002|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
3342615|NCT03441984|4072890|FG003|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
3342616|NCT03441984|4072891|FG004|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
3342617|NCT03441984|4072892|FG005|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
3342618|NCT03441984|4072893|FG006|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
3342619|NCT03441984|4072894|FG007|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
3342620|NCT03441984|4072895|FG008|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
3342621|NCT03441984|4072896|FG009|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
3342622|NCT03441984|4072897|FG010|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
3342623|NCT03441984|4072898|FG011|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
3342624|NCT03441984|4072887|FG000|STARTED|Part 2: Period 2 (Up to Day 4)||0
3342625|NCT03441984|4072888|FG001|STARTED|Part 2: Period 2 (Up to Day 4)||0
3342626|NCT03441984|4072889|FG002|STARTED|Part 2: Period 2 (Up to Day 4)||0
3342627|NCT03441984|4072890|FG003|STARTED|Part 2: Period 2 (Up to Day 4)||0
3342628|NCT03441984|4072891|FG004|STARTED|Part 2: Period 2 (Up to Day 4)||0
3342629|NCT03441984|4072892|FG005|STARTED|Part 2: Period 2 (Up to Day 4)||0
3342630|NCT03441984|4072893|FG006|STARTED|Part 2: Period 2 (Up to Day 4)||3
3342631|NCT03441984|4072894|FG007|STARTED|Part 2: Period 2 (Up to Day 4)||3
3342632|NCT03441984|4072895|FG008|STARTED|Part 2: Period 2 (Up to Day 4)||3
3342633|NCT03441984|4072896|FG009|STARTED|Part 2: Period 2 (Up to Day 4)||3
3342634|NCT03441984|4072897|FG010|STARTED|Part 2: Period 2 (Up to Day 4)||3
3342635|NCT03441984|4072898|FG011|STARTED|Part 2: Period 2 (Up to Day 4)||3
3342636|NCT03441984|4072887|FG000|COMPLETED|Part 2: Period 2 (Up to Day 4)||0
3342637|NCT03441984|4072888|FG001|COMPLETED|Part 2: Period 2 (Up to Day 4)||0
3342638|NCT03441984|4072889|FG002|COMPLETED|Part 2: Period 2 (Up to Day 4)||0
3342639|NCT03441984|4072890|FG003|COMPLETED|Part 2: Period 2 (Up to Day 4)||0
3342640|NCT03441984|4072891|FG004|COMPLETED|Part 2: Period 2 (Up to Day 4)||0
3342641|NCT03441984|4072892|FG005|COMPLETED|Part 2: Period 2 (Up to Day 4)||0
3342642|NCT03441984|4072893|FG006|COMPLETED|Part 2: Period 2 (Up to Day 4)||3
3342643|NCT03441984|4072894|FG007|COMPLETED|Part 2: Period 2 (Up to Day 4)||3
3342644|NCT03441984|4072895|FG008|COMPLETED|Part 2: Period 2 (Up to Day 4)||3
3342645|NCT03441984|4072896|FG009|COMPLETED|Part 2: Period 2 (Up to Day 4)||3
3342646|NCT03441984|4072897|FG010|COMPLETED|Part 2: Period 2 (Up to Day 4)||3
3342647|NCT03441984|4072898|FG011|COMPLETED|Part 2: Period 2 (Up to Day 4)||3
3342648|NCT03441984|4072887|FG000|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
3342649|NCT03441984|4072888|FG001|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
3342650|NCT03441984|4072889|FG002|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
3342651|NCT03441984|4072890|FG003|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
3342652|NCT03441984|4072891|FG004|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
3342653|NCT03441984|4072892|FG005|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
3342654|NCT03441984|4072893|FG006|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
3342655|NCT03441984|4072894|FG007|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
3342656|NCT03441984|4072895|FG008|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
3342657|NCT03441984|4072896|FG009|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
3342658|NCT03441984|4072897|FG010|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
3342659|NCT03441984|4072898|FG011|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
3342660|NCT03441984|4072887|FG000|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||0
3342661|NCT03441984|4072888|FG001|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||0
3342662|NCT03441984|4072889|FG002|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||0
3342663|NCT03441984|4072890|FG003|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||0
3342664|NCT03441984|4072891|FG004|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||0
3342665|NCT03441984|4072892|FG005|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||0
3342666|NCT03441984|4072893|FG006|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||3
3342667|NCT03441984|4072894|FG007|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||3
3342668|NCT03441984|4072895|FG008|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||3
3342669|NCT03441984|4072896|FG009|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||3
3342670|NCT03441984|4072897|FG010|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||3
3342671|NCT03441984|4072898|FG011|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||3
3342672|NCT03441984|4072887|FG000|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
3342673|NCT03441984|4072888|FG001|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
3342674|NCT03441984|4072889|FG002|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
3342675|NCT03441984|4072890|FG003|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
3342676|NCT03441984|4072891|FG004|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
3342677|NCT03441984|4072892|FG005|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
3342678|NCT03441984|4072893|FG006|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||3
3342679|NCT03441984|4072894|FG007|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||3
3342680|NCT03441984|4072895|FG008|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||3
3342681|NCT03441984|4072896|FG009|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||3
3342682|NCT03441984|4072897|FG010|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||3
3342683|NCT03441984|4072898|FG011|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||3
3342684|NCT03441984|4072887|FG000|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
3342685|NCT03441984|4072888|FG001|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
3342686|NCT03441984|4072889|FG002|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
3342687|NCT03441984|4072890|FG003|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
3342688|NCT03441984|4072891|FG004|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
3342689|NCT03441984|4072892|FG005|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
3342690|NCT03441984|4072893|FG006|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
3342691|NCT03441984|4072894|FG007|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
3342692|NCT03441984|4072895|FG008|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
3342693|NCT03441984|4072896|FG009|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
3342694|NCT03441984|4072897|FG010|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
3342695|NCT03441984|4072898|FG011|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
3342696|NCT03441984|4072887|FG000|STARTED|Part 2: Period 3 (Up to Day 4)||0
3342697|NCT03441984|4072888|FG001|STARTED|Part 2: Period 3 (Up to Day 4)||0
3342698|NCT03441984|4072889|FG002|STARTED|Part 2: Period 3 (Up to Day 4)||0
3342699|NCT03441984|4072890|FG003|STARTED|Part 2: Period 3 (Up to Day 4)||0
3342700|NCT03441984|4072891|FG004|STARTED|Part 2: Period 3 (Up to Day 4)||0
3342701|NCT03441984|4072892|FG005|STARTED|Part 2: Period 3 (Up to Day 4)||0
3342702|NCT03441984|4072893|FG006|STARTED|Part 2: Period 3 (Up to Day 4)||3
3342703|NCT03441984|4072894|FG007|STARTED|Part 2: Period 3 (Up to Day 4)||3
3342704|NCT03441984|4072895|FG008|STARTED|Part 2: Period 3 (Up to Day 4)||3
3342705|NCT03441984|4072896|FG009|STARTED|Part 2: Period 3 (Up to Day 4)||3
3342706|NCT03441984|4072897|FG010|STARTED|Part 2: Period 3 (Up to Day 4)||3
3342707|NCT03441984|4072898|FG011|STARTED|Part 2: Period 3 (Up to Day 4)||3
3342708|NCT03441984|4072887|FG000|COMPLETED|Part 2: Period 3 (Up to Day 4)||0
3342709|NCT03441984|4072888|FG001|COMPLETED|Part 2: Period 3 (Up to Day 4)||0
3342710|NCT03441984|4072889|FG002|COMPLETED|Part 2: Period 3 (Up to Day 4)||0
3342711|NCT03441984|4072890|FG003|COMPLETED|Part 2: Period 3 (Up to Day 4)||0
3342712|NCT03441984|4072891|FG004|COMPLETED|Part 2: Period 3 (Up to Day 4)||0
3342713|NCT03441984|4072892|FG005|COMPLETED|Part 2: Period 3 (Up to Day 4)||0
3342714|NCT03441984|4072893|FG006|COMPLETED|Part 2: Period 3 (Up to Day 4)||3
3342715|NCT03441984|4072894|FG007|COMPLETED|Part 2: Period 3 (Up to Day 4)||3
3342716|NCT03441984|4072895|FG008|COMPLETED|Part 2: Period 3 (Up to Day 4)||3
3342717|NCT03441984|4072896|FG009|COMPLETED|Part 2: Period 3 (Up to Day 4)||3
3342718|NCT03441984|4072897|FG010|COMPLETED|Part 2: Period 3 (Up to Day 4)||3
3342719|NCT03441984|4072898|FG011|COMPLETED|Part 2: Period 3 (Up to Day 4)||3
3342720|NCT03441984|4072887|FG000|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
3342721|NCT03441984|4072888|FG001|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
3342722|NCT03441984|4072889|FG002|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
3342723|NCT03441984|4072890|FG003|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
3342724|NCT03441984|4072891|FG004|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
3342725|NCT03441984|4072892|FG005|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
3342726|NCT03441984|4072893|FG006|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
3342727|NCT03441984|4072894|FG007|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
3342728|NCT03441984|4072895|FG008|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
3342729|NCT03441984|4072896|FG009|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
3342730|NCT03441984|4072897|FG010|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
3342731|NCT03441984|4072898|FG011|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
3342732|NCT03442036|4072915|FG000|STARTED|Overall Study||35
3342733|NCT03442036|4072916|FG001|STARTED|Overall Study||35
3342734|NCT03442036|4072915|FG000|COMPLETED|Overall Study||35
3342735|NCT03442036|4072916|FG001|COMPLETED|Overall Study||35
3342736|NCT03442036|4072915|FG000|NOT COMPLETED|Overall Study||0
3342737|NCT03442036|4072916|FG001|NOT COMPLETED|Overall Study||0
3342738|NCT03442296|4072926|FG000|STARTED|3 Month Follow-up||78
3342739|NCT03442296|4072927|FG001|STARTED|3 Month Follow-up||73
3342740|NCT03442296|4072926|FG000|COMPLETED|3 Month Follow-up||73
3342741|NCT03442296|4072927|FG001|COMPLETED|3 Month Follow-up||70
3342742|NCT03442296|4072926|FG000|NOT COMPLETED|3 Month Follow-up||5
3342743|NCT03442296|4072927|FG001|NOT COMPLETED|3 Month Follow-up||3
3342744|NCT03442296|4072926|FG000|STARTED|12 Month Follow-up|15 participants in the immediate group did not start the 12month visit due to: death unrelated to study (3), loss to follow up (6), or withdrew consent (6)|58
3342745|NCT03442296|4072927|FG001|STARTED|12 Month Follow-up|18 participants in the delayed group did not start the 12month visit due to: death unrelated to study (3), loss to follow up (5), or withdrew consent (10)|52
3342746|NCT03442296|4072926|FG000|COMPLETED|12 Month Follow-up||57
3342747|NCT03442296|4072927|FG001|COMPLETED|12 Month Follow-up||51
3342748|NCT03442296|4072926|FG000|NOT COMPLETED|12 Month Follow-up||1
3342749|NCT03442296|4072927|FG001|NOT COMPLETED|12 Month Follow-up||1
3342750|NCT03442569|4072933|FG000|STARTED|Overall Study||56
3342751|NCT03442569|4072933|FG000|Started Treatment|Overall Study||55
3342752|NCT03442569|4072933|FG000|COMPLETED|Overall Study||55
3342753|NCT03442569|4072933|FG000|NOT COMPLETED|Overall Study||1
3342754|NCT03442595|4072939|FG000|STARTED|Overall Study||460
3342755|NCT03442595|4072940|FG001|STARTED|Overall Study||366
3342756|NCT03442595|4072939|FG000|COMPLETED|Overall Study||366
3342757|NCT03442595|4072940|FG001|COMPLETED|Overall Study||366
3342758|NCT03442595|4072939|FG000|NOT COMPLETED|Overall Study||94
3342759|NCT03442595|4072940|FG001|NOT COMPLETED|Overall Study||0
3342760|NCT03442699|4072945|FG000|STARTED|Overall Study||6
3342761|NCT03442699|4072945|FG000|COMPLETED|Overall Study||6
3342762|NCT03442699|4072945|FG000|NOT COMPLETED|Overall Study||0
3342763|NCT03442725|4072953|FG000|STARTED|Overall Study||8
3342764|NCT03442725|4072954|FG001|STARTED|Overall Study||8
3342765|NCT03442725|4072953|FG000|COMPLETED|Overall Study||8
3342766|NCT03442725|4072954|FG001|COMPLETED|Overall Study||8
3342767|NCT03442725|4072953|FG000|NOT COMPLETED|Overall Study||0
3342768|NCT03442725|4072954|FG001|NOT COMPLETED|Overall Study||0
3342769|NCT03442777|4072963|FG000|STARTED|Overall Study|All participants received at least 1 dressing|542
3342770|NCT03442777|4072964|FG001|STARTED|Overall Study|One participant received one Allevyn® Life dressing (wrong brand by mistake), besides 13 Mepilex® Border on sacrum, (0.2%) All participants received at least 1 dressing|545
3342771|NCT03442777|4072965|FG002|STARTED|Overall Study|No participants received dressings|546
3342772|NCT03442777|4072963|FG000|COMPLETED|Overall Study||534
3342773|NCT03442777|4072964|FG001|COMPLETED|Overall Study||532
3342774|NCT03442777|4072965|FG002|COMPLETED|Overall Study||539
3342775|NCT03442777|4072963|FG000|NOT COMPLETED|Overall Study||8
3342776|NCT03442777|4072964|FG001|NOT COMPLETED|Overall Study||13
3342777|NCT03442777|4072965|FG002|NOT COMPLETED|Overall Study||7
3342778|NCT03442829|4072973|FG000|STARTED|Overall Study||27
3342779|NCT03442829|4072974|FG001|STARTED|Overall Study||27
3342780|NCT03442829|4072973|FG000|COMPLETED|Overall Study||23
3342781|NCT03442829|4072974|FG001|COMPLETED|Overall Study||25
3342782|NCT03442829|4072973|FG000|NOT COMPLETED|Overall Study||4
3342783|NCT03442829|4072974|FG001|NOT COMPLETED|Overall Study||2
3342784|NCT03442868|4072980|FG000|STARTED|Overall Study||15
3342785|NCT03442868|4072980|FG000|COMPLETED|Overall Study||15
3342786|NCT03442868|4072980|FG000|NOT COMPLETED|Overall Study||0
3342787|NCT03442933|4072984|FG000|STARTED|Overall Study||20
3342788|NCT03442933|4072985|FG001|STARTED|Overall Study||20
3342789|NCT03442933|4072984|FG000|COMPLETED|Overall Study||20
3342790|NCT03442933|4072985|FG001|COMPLETED|Overall Study||20
3342791|NCT03442933|4072984|FG000|NOT COMPLETED|Overall Study||0
3342792|NCT03442933|4072985|FG001|NOT COMPLETED|Overall Study||0
3342793|NCT03443024|4072998|FG000|STARTED|Overall Study||73
3342794|NCT03443024|4072999|FG001|STARTED|Overall Study||80
3342795|NCT03443024|4073000|FG002|STARTED|Overall Study||75
3342796|NCT03443024|4073001|FG003|STARTED|Overall Study||52
3342797|NCT03443024|4072998|FG000|Received at Least One Dose of Study Drug|Overall Study||73
3342798|NCT03443024|4072999|FG001|Received at Least One Dose of Study Drug|Overall Study||80
3342799|NCT03443024|4073000|FG002|Received at Least One Dose of Study Drug|Overall Study||75
3342800|NCT03443024|4073001|FG003|Received at Least One Dose of Study Drug|Overall Study||52
3342801|NCT03443024|4072998|FG000|COMPLETED|Overall Study||52
3342802|NCT03443024|4072999|FG001|COMPLETED|Overall Study||49
3342803|NCT03443024|4073000|FG002|COMPLETED|Overall Study||56
3342804|NCT03443024|4073001|FG003|COMPLETED|Overall Study||20
3342805|NCT03443024|4072998|FG000|NOT COMPLETED|Overall Study||21
3342806|NCT03443024|4072999|FG001|NOT COMPLETED|Overall Study||31
3342807|NCT03443024|4073000|FG002|NOT COMPLETED|Overall Study||19
3342808|NCT03443024|4073001|FG003|NOT COMPLETED|Overall Study||32
3342809|NCT03443063|4073013|FG000|STARTED|Overall Study||8
3342810|NCT03443063|4073014|FG001|STARTED|Overall Study||8
3342811|NCT03443063|4073013|FG000|COMPLETED|Overall Study||8
3342812|NCT03443063|4073014|FG001|COMPLETED|Overall Study||8
3342813|NCT03443063|4073013|FG000|NOT COMPLETED|Overall Study||0
3342814|NCT03443063|4073014|FG001|NOT COMPLETED|Overall Study||0
3342815|NCT03443414|4073027|FG000|STARTED|Overall Study||82
3342816|NCT03443414|4073028|FG001|STARTED|Overall Study||81
3342817|NCT03443414|4073029|FG002|STARTED|Overall Study||82
3342818|NCT03443414|4073030|FG003|STARTED|Overall Study||80
3342819|NCT03443414|4073031|FG004|STARTED|Overall Study||80
3342820|NCT03443414|4073027|FG000|Received Treatment|Overall Study||81
3342821|NCT03443414|4073028|FG001|Received Treatment|Overall Study||81
3342822|NCT03443414|4073029|FG002|Received Treatment|Overall Study||82
3342823|NCT03443414|4073030|FG003|Received Treatment|Overall Study||80
3342824|NCT03443414|4073031|FG004|Received Treatment|Overall Study||79
3342825|NCT03443414|4073027|FG000|COMPLETED|Overall Study||71
3342826|NCT03443414|4073028|FG001|COMPLETED|Overall Study||78
3342827|NCT03443414|4073029|FG002|COMPLETED|Overall Study||76
3342828|NCT03443414|4073030|FG003|COMPLETED|Overall Study||75
3342829|NCT03443414|4073031|FG004|COMPLETED|Overall Study||75
3342830|NCT03443414|4073027|FG000|NOT COMPLETED|Overall Study||11
3342831|NCT03443414|4073028|FG001|NOT COMPLETED|Overall Study||3
3342832|NCT03443414|4073029|FG002|NOT COMPLETED|Overall Study||6
3342833|NCT03443414|4073030|FG003|NOT COMPLETED|Overall Study||5
3342834|NCT03443414|4073031|FG004|NOT COMPLETED|Overall Study||5
3342835|NCT03443427|4073045|FG000|STARTED|Overall Study||100
3342836|NCT03443427|4073046|FG001|STARTED|Overall Study||100
3342837|NCT03443427|4073045|FG000|COMPLETED|Overall Study||88
3342838|NCT03443427|4073046|FG001|COMPLETED|Overall Study||89
3342839|NCT03443427|4073045|FG000|NOT COMPLETED|Overall Study||12
3342840|NCT03443427|4073046|FG001|NOT COMPLETED|Overall Study||11
3342841|NCT03443713|4073055|FG000|STARTED|Start up Visit (2 Hours)||8
3342842|NCT03443713|4073056|FG001|STARTED|Start up Visit (2 Hours)||8
3342843|NCT03443713|4073057|FG002|STARTED|Start up Visit (2 Hours)||9
3342844|NCT03443713|4073055|FG000|COMPLETED|Start up Visit (2 Hours)||8
3342845|NCT03443713|4073056|FG001|COMPLETED|Start up Visit (2 Hours)||8
3342846|NCT03443713|4073057|FG002|COMPLETED|Start up Visit (2 Hours)||9
3342847|NCT03443713|4073055|FG000|NOT COMPLETED|Start up Visit (2 Hours)||0
3342848|NCT03443713|4073056|FG001|NOT COMPLETED|Start up Visit (2 Hours)||0
3342849|NCT03443713|4073057|FG002|NOT COMPLETED|Start up Visit (2 Hours)||0
3342850|NCT03443713|4073055|FG000|STARTED|First at Home Period (9-14 Days)||8
3342851|NCT03443713|4073056|FG001|STARTED|First at Home Period (9-14 Days)||8
3342852|NCT03443713|4073057|FG002|STARTED|First at Home Period (9-14 Days)||9
3342853|NCT03443713|4073055|FG000|COMPLETED|First at Home Period (9-14 Days)||8
3342854|NCT03443713|4073056|FG001|COMPLETED|First at Home Period (9-14 Days)||8
3342855|NCT03443713|4073057|FG002|COMPLETED|First at Home Period (9-14 Days)||8
3342856|NCT03443713|4073055|FG000|NOT COMPLETED|First at Home Period (9-14 Days)||0
3342857|NCT03443713|4073056|FG001|NOT COMPLETED|First at Home Period (9-14 Days)||0
3342858|NCT03443713|4073057|FG002|NOT COMPLETED|First at Home Period (9-14 Days)||1
3342859|NCT03443713|4073055|FG000|STARTED|First Exercise Visit (1 Hour)||8
3342860|NCT03443713|4073056|FG001|STARTED|First Exercise Visit (1 Hour)||8
3342861|NCT03443713|4073057|FG002|STARTED|First Exercise Visit (1 Hour)||8
3342862|NCT03443713|4073055|FG000|COMPLETED|First Exercise Visit (1 Hour)||8
3342863|NCT03443713|4073056|FG001|COMPLETED|First Exercise Visit (1 Hour)||8
3342864|NCT03443713|4073057|FG002|COMPLETED|First Exercise Visit (1 Hour)||8
3342865|NCT03443713|4073055|FG000|NOT COMPLETED|First Exercise Visit (1 Hour)||0
3342866|NCT03443713|4073056|FG001|NOT COMPLETED|First Exercise Visit (1 Hour)||0
3342867|NCT03443713|4073057|FG002|NOT COMPLETED|First Exercise Visit (1 Hour)||0
3342868|NCT03443713|4073055|FG000|STARTED|Dexcom Insertion Visit (30 Minutes)||8
3342869|NCT03443713|4073056|FG001|STARTED|Dexcom Insertion Visit (30 Minutes)||8
3342870|NCT03443713|4073057|FG002|STARTED|Dexcom Insertion Visit (30 Minutes)||8
3342871|NCT03443713|4073055|FG000|COMPLETED|Dexcom Insertion Visit (30 Minutes)||8
3342872|NCT03443713|4073056|FG001|COMPLETED|Dexcom Insertion Visit (30 Minutes)||8
3342873|NCT03443713|4073057|FG002|COMPLETED|Dexcom Insertion Visit (30 Minutes)||8
3342874|NCT03443713|4073055|FG000|NOT COMPLETED|Dexcom Insertion Visit (30 Minutes)||0
3342875|NCT03443713|4073056|FG001|NOT COMPLETED|Dexcom Insertion Visit (30 Minutes)||0
3342876|NCT03443713|4073057|FG002|NOT COMPLETED|Dexcom Insertion Visit (30 Minutes)||0
3342877|NCT03443713|4073055|FG000|STARTED|Second at Home Period (2-11 Days)||8
3342878|NCT03443713|4073056|FG001|STARTED|Second at Home Period (2-11 Days)||8
3342879|NCT03443713|4073057|FG002|STARTED|Second at Home Period (2-11 Days)||8
3342880|NCT03443713|4073055|FG000|COMPLETED|Second at Home Period (2-11 Days)||8
3342881|NCT03443713|4073056|FG001|COMPLETED|Second at Home Period (2-11 Days)||8
3342882|NCT03443713|4073057|FG002|COMPLETED|Second at Home Period (2-11 Days)||8
3342883|NCT03443713|4073055|FG000|NOT COMPLETED|Second at Home Period (2-11 Days)||0
3342884|NCT03443713|4073056|FG001|NOT COMPLETED|Second at Home Period (2-11 Days)||0
3342885|NCT03443713|4073057|FG002|NOT COMPLETED|Second at Home Period (2-11 Days)||0
3342886|NCT03443713|4073055|FG000|STARTED|Second Exercise Visit (1 Hour)||8
3342887|NCT03443713|4073056|FG001|STARTED|Second Exercise Visit (1 Hour)||8
3342888|NCT03443713|4073057|FG002|STARTED|Second Exercise Visit (1 Hour)||8
3342889|NCT03443713|4073055|FG000|COMPLETED|Second Exercise Visit (1 Hour)||8
3342890|NCT03443713|4073056|FG001|COMPLETED|Second Exercise Visit (1 Hour)||8
3342891|NCT03443713|4073057|FG002|COMPLETED|Second Exercise Visit (1 Hour)||8
3342892|NCT03443713|4073055|FG000|NOT COMPLETED|Second Exercise Visit (1 Hour)||0
3342893|NCT03443713|4073056|FG001|NOT COMPLETED|Second Exercise Visit (1 Hour)||0
3342894|NCT03443713|4073057|FG002|NOT COMPLETED|Second Exercise Visit (1 Hour)||0
3342895|NCT03443713|4073055|FG000|STARTED|Third at Home Period (8-12 Days)||8
3342896|NCT03443713|4073056|FG001|STARTED|Third at Home Period (8-12 Days)||8
3342897|NCT03443713|4073057|FG002|STARTED|Third at Home Period (8-12 Days)||8
3342898|NCT03443713|4073055|FG000|COMPLETED|Third at Home Period (8-12 Days)||8
3342899|NCT03443713|4073056|FG001|COMPLETED|Third at Home Period (8-12 Days)||8
3342900|NCT03443713|4073057|FG002|COMPLETED|Third at Home Period (8-12 Days)||8
3342901|NCT03443713|4073055|FG000|NOT COMPLETED|Third at Home Period (8-12 Days)||0
3342902|NCT03443713|4073056|FG001|NOT COMPLETED|Third at Home Period (8-12 Days)||0
3342903|NCT03443713|4073057|FG002|NOT COMPLETED|Third at Home Period (8-12 Days)||0
3342904|NCT03443713|4073055|FG000|STARTED|Close-out Visit (30 Minutes)||8
3342905|NCT03443713|4073056|FG001|STARTED|Close-out Visit (30 Minutes)||8
3342906|NCT03443713|4073057|FG002|STARTED|Close-out Visit (30 Minutes)||8
3342907|NCT03443713|4073055|FG000|COMPLETED|Close-out Visit (30 Minutes)||8
3342908|NCT03443713|4073056|FG001|COMPLETED|Close-out Visit (30 Minutes)||8
3342909|NCT03443713|4073057|FG002|COMPLETED|Close-out Visit (30 Minutes)||8
3342910|NCT03443713|4073055|FG000|NOT COMPLETED|Close-out Visit (30 Minutes)||0
3342911|NCT03443713|4073056|FG001|NOT COMPLETED|Close-out Visit (30 Minutes)||0
3342912|NCT03443713|4073057|FG002|NOT COMPLETED|Close-out Visit (30 Minutes)||0
3342913|NCT03444090|4073071|FG000|STARTED|Overall Study||214
3342914|NCT03444090|4073072|FG001|STARTED|Overall Study||214
3342915|NCT03444090|4073071|FG000|COMPLETED|Overall Study||211
3342916|NCT03444090|4073072|FG001|COMPLETED|Overall Study||210
3342917|NCT03444090|4073071|FG000|NOT COMPLETED|Overall Study||3
3342918|NCT03444090|4073072|FG001|NOT COMPLETED|Overall Study||4
3342919|NCT03444155|4073080|FG000|STARTED|First Intervention (6 Weeks)||15
3342920|NCT03444155|4073081|FG001|STARTED|First Intervention (6 Weeks)||15
3342921|NCT03444155|4073080|FG000|COMPLETED|First Intervention (6 Weeks)||14
3342922|NCT03444155|4073081|FG001|COMPLETED|First Intervention (6 Weeks)||15
3342923|NCT03444155|4073080|FG000|NOT COMPLETED|First Intervention (6 Weeks)||1
3342924|NCT03444155|4073081|FG001|NOT COMPLETED|First Intervention (6 Weeks)||0
3342925|NCT03444155|4073080|FG000|STARTED|Washout (2 Weeks)||14
3342926|NCT03444155|4073081|FG001|STARTED|Washout (2 Weeks)||15
3342927|NCT03444155|4073080|FG000|COMPLETED|Washout (2 Weeks)||14
3342928|NCT03444155|4073081|FG001|COMPLETED|Washout (2 Weeks)||15
3342929|NCT03444155|4073080|FG000|NOT COMPLETED|Washout (2 Weeks)||0
3342930|NCT03444155|4073081|FG001|NOT COMPLETED|Washout (2 Weeks)||0
3342931|NCT03444155|4073080|FG000|STARTED|Second Intervention (6 Weeks)||14
3342932|NCT03444155|4073081|FG001|STARTED|Second Intervention (6 Weeks)||15
3342933|NCT03444155|4073080|FG000|COMPLETED|Second Intervention (6 Weeks)||14
3342934|NCT03444155|4073081|FG001|COMPLETED|Second Intervention (6 Weeks)||15
3342935|NCT03444155|4073080|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||0
3342936|NCT03444155|4073081|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||0
3342937|NCT03444584|4073089|FG000|STARTED|Overall Study||24
3342938|NCT03444584|4073090|FG001|STARTED|Overall Study||25
3342939|NCT03444584|4073089|FG000|COMPLETED|Overall Study||24
3342940|NCT03444584|4073090|FG001|COMPLETED|Overall Study||23
3342941|NCT03444584|4073089|FG000|NOT COMPLETED|Overall Study||0
3342942|NCT03444584|4073090|FG001|NOT COMPLETED|Overall Study||2
3342943|NCT03444766|4073097|FG000|STARTED|Overall Study||100
3342944|NCT03444766|4073097|FG000|COMPLETED|Overall Study||34
3342945|NCT03444766|4073097|FG000|NOT COMPLETED|Overall Study||66
3342946|NCT03444961|4073101|FG000|STARTED|Overall Study||4
3342947|NCT03444961|4073101|FG000|COMPLETED|Overall Study||4
3342948|NCT03444961|4073101|FG000|NOT COMPLETED|Overall Study||0
3342949|NCT03445065|4073113|FG000|STARTED|Overall Study||97
3342950|NCT03445065|4073114|FG001|STARTED|Overall Study||52
3342951|NCT03445065|4073115|FG002|STARTED|Overall Study||62
3342952|NCT03445065|4073116|FG003|STARTED|Overall Study||28
3342953|NCT03445065|4073113|FG000|COMPLETED|Overall Study||90
3342954|NCT03445065|4073114|FG001|COMPLETED|Overall Study||43
3342955|NCT03445065|4073115|FG002|COMPLETED|Overall Study||57
3342956|NCT03445065|4073116|FG003|COMPLETED|Overall Study||25
3342957|NCT03445065|4073113|FG000|NOT COMPLETED|Overall Study||7
3342958|NCT03445065|4073114|FG001|NOT COMPLETED|Overall Study||9
3342959|NCT03445065|4073115|FG002|NOT COMPLETED|Overall Study||5
3342960|NCT03445065|4073116|FG003|NOT COMPLETED|Overall Study||3
3342961|NCT03445156|4073141|FG000|STARTED|Pilot Study||20
3342962|NCT03445156|4073142|FG001|STARTED|Pilot Study||20
3342963|NCT03445156|4073143|FG002|STARTED|Pilot Study||0
3342964|NCT03445156|4073141|FG000|COMPLETED|Pilot Study||20
3342965|NCT03445156|4073142|FG001|COMPLETED|Pilot Study||20
3342966|NCT03445156|4073143|FG002|COMPLETED|Pilot Study||0
3342967|NCT03445156|4073141|FG000|NOT COMPLETED|Pilot Study||0
3342968|NCT03445156|4073142|FG001|NOT COMPLETED|Pilot Study||0
3342969|NCT03445156|4073143|FG002|NOT COMPLETED|Pilot Study||0
3342970|NCT03445156|4073141|FG000|STARTED|Experiment Proper||113
3342971|NCT03445156|4073142|FG001|STARTED|Experiment Proper||115
3342972|NCT03445156|4073143|FG002|STARTED|Experiment Proper||59
3342973|NCT03445156|4073141|FG000|COMPLETED|Experiment Proper||113
3342974|NCT03445156|4073142|FG001|COMPLETED|Experiment Proper||115
3342975|NCT03445156|4073143|FG002|COMPLETED|Experiment Proper||59
3342976|NCT03445156|4073141|FG000|NOT COMPLETED|Experiment Proper||0
3342977|NCT03445156|4073142|FG001|NOT COMPLETED|Experiment Proper||0
3342978|NCT03445156|4073143|FG002|NOT COMPLETED|Experiment Proper||0
3342979|NCT03445195|4073157|FG000|STARTED|Overall Study||53
3342980|NCT03445195|4073158|FG001|STARTED|Overall Study||27
3342981|NCT03445195|4073157|FG000|COMPLETED|Overall Study||51
3342982|NCT03445195|4073158|FG001|COMPLETED|Overall Study||27
3342983|NCT03445195|4073157|FG000|NOT COMPLETED|Overall Study||2
3342984|NCT03445195|4073158|FG001|NOT COMPLETED|Overall Study||0
3342985|NCT03445390|4073164|FG000|STARTED|First Intervention||14
3342986|NCT03445390|4073165|FG001|STARTED|First Intervention||13
3342987|NCT03445390|4073164|FG000|COMPLETED|First Intervention||12
3342988|NCT03445390|4073165|FG001|COMPLETED|First Intervention||11
3342989|NCT03445390|4073164|FG000|NOT COMPLETED|First Intervention||2
3342990|NCT03445390|4073165|FG001|NOT COMPLETED|First Intervention||2
3342991|NCT03445390|4073164|FG000|STARTED|Second Intervention||12
3342992|NCT03445390|4073165|FG001|STARTED|Second Intervention||11
3342993|NCT03445390|4073164|FG000|COMPLETED|Second Intervention||10
3342994|NCT03445390|4073165|FG001|COMPLETED|Second Intervention||10
3342995|NCT03445390|4073164|FG000|NOT COMPLETED|Second Intervention||2
3342996|NCT03445390|4073165|FG001|NOT COMPLETED|Second Intervention||1
3342997|NCT03445793|4073171|FG000|STARTED|Overall Study||5
3342998|NCT03445793|4073171|FG000|COMPLETED|Overall Study||5
3342999|NCT03445793|4073171|FG000|NOT COMPLETED|Overall Study||0
3343000|NCT03446053|4073180|FG000|STARTED|Overall Study||2
3343001|NCT03446053|4073181|FG001|STARTED|Overall Study||6
3343002|NCT03446053|4073182|FG002|STARTED|Overall Study||6
3343003|NCT03446053|4073183|FG003|STARTED|Overall Study||7
3343004|NCT03446053|4073184|FG004|STARTED|Overall Study||6
3343005|NCT03446053|4073185|FG005|STARTED|Overall Study||6
3343006|NCT03446053|4073180|FG000|Randomized Set|Overall Study||2
3343007|NCT03446053|4073181|FG001|Randomized Set|Overall Study||6
3343008|NCT03446053|4073182|FG002|Randomized Set|Overall Study||6
3343009|NCT03446053|4073183|FG003|Randomized Set|Overall Study||7
3343010|NCT03446053|4073184|FG004|Randomized Set|Overall Study||6
3343011|NCT03446053|4073185|FG005|Randomized Set|Overall Study||6
3343012|NCT03446053|4073180|FG000|Safety Analysis Set|Overall Study||2
3343013|NCT03446053|4073181|FG001|Safety Analysis Set|Overall Study||6
3343014|NCT03446053|4073182|FG002|Safety Analysis Set|Overall Study||6
3343015|NCT03446053|4073183|FG003|Safety Analysis Set|Overall Study||6
3343016|NCT03446053|4073184|FG004|Safety Analysis Set|Overall Study||6
3343017|NCT03446053|4073185|FG005|Safety Analysis Set|Overall Study||6
3343018|NCT03446053|4073180|FG000|PK/PD Analysis Set|Overall Study||2
3343019|NCT03446053|4073181|FG001|PK/PD Analysis Set|Overall Study||6
3343020|NCT03446053|4073182|FG002|PK/PD Analysis Set|Overall Study||6
3343021|NCT03446053|4073183|FG003|PK/PD Analysis Set|Overall Study||6
3343022|NCT03446053|4073184|FG004|PK/PD Analysis Set|Overall Study||6
3343023|NCT03446053|4073185|FG005|PK/PD Analysis Set|Overall Study||5
3343024|NCT03446053|4073180|FG000|COMPLETED|Overall Study||2
3343025|NCT03446053|4073181|FG001|COMPLETED|Overall Study||5
3343026|NCT03446053|4073182|FG002|COMPLETED|Overall Study||6
3343027|NCT03446053|4073183|FG003|COMPLETED|Overall Study||6
3343028|NCT03446053|4073184|FG004|COMPLETED|Overall Study||6
3343029|NCT03446053|4073185|FG005|COMPLETED|Overall Study||5
3343030|NCT03446053|4073180|FG000|NOT COMPLETED|Overall Study||0
3343031|NCT03446053|4073181|FG001|NOT COMPLETED|Overall Study||1
3343032|NCT03446053|4073182|FG002|NOT COMPLETED|Overall Study||0
3343033|NCT03446053|4073183|FG003|NOT COMPLETED|Overall Study||1
3343034|NCT03446053|4073184|FG004|NOT COMPLETED|Overall Study||0
3343035|NCT03446053|4073185|FG005|NOT COMPLETED|Overall Study||1
3343036|NCT03446690|4073214|FG000|STARTED|Overall Study||33
3343037|NCT03446690|4073215|FG001|STARTED|Overall Study||29
3343038|NCT03446690|4073214|FG000|COMPLETED|Overall Study||26
3343039|NCT03446690|4073215|FG001|COMPLETED|Overall Study||29
3343040|NCT03446690|4073214|FG000|NOT COMPLETED|Overall Study||7
3343041|NCT03446690|4073215|FG001|NOT COMPLETED|Overall Study||0
3343042|NCT03446781|4073223|FG000|STARTED|Overall Study||214
3343043|NCT03446781|4073224|FG001|STARTED|Overall Study||208
3343044|NCT03446781|4073223|FG000|COMPLETED|Overall Study||186
3343045|NCT03446781|4073224|FG001|COMPLETED|Overall Study||191
3343046|NCT03446781|4073223|FG000|NOT COMPLETED|Overall Study||28
3343047|NCT03446781|4073224|FG001|NOT COMPLETED|Overall Study||17
3343048|NCT03446846|4073255|FG000|STARTED|Overall Study||90
3343049|NCT03446846|4073256|FG001|STARTED|Overall Study||92
3343050|NCT03446846|4073257|FG002|STARTED|Overall Study||178
3343051|NCT03446846|4073255|FG000|COMPLETED|Overall Study||83
3343052|NCT03446846|4073256|FG001|COMPLETED|Overall Study||87
3343053|NCT03446846|4073257|FG002|COMPLETED|Overall Study||162
3343054|NCT03446846|4073255|FG000|NOT COMPLETED|Overall Study||7
3343055|NCT03446846|4073256|FG001|NOT COMPLETED|Overall Study||5
3343056|NCT03446846|4073257|FG002|NOT COMPLETED|Overall Study||16
3343057|NCT03446885|4073265|FG000|STARTED|Overall Study||12
3343058|NCT03446885|4073266|FG001|STARTED|Overall Study||10
3343059|NCT03446885|4073265|FG000|COMPLETED|Overall Study||10
3343060|NCT03446885|4073266|FG001|COMPLETED|Overall Study||10
3343061|NCT03446885|4073265|FG000|NOT COMPLETED|Overall Study||2
3343062|NCT03446885|4073266|FG001|NOT COMPLETED|Overall Study||0
3343063|NCT03447015|4073276|FG000|STARTED|Overall Study||140
3343064|NCT03447015|4073277|FG001|STARTED|Overall Study||150
3343065|NCT03447015|4073276|FG000|COMPLETED|Overall Study||95
3343066|NCT03447015|4073277|FG001|COMPLETED|Overall Study||106
3343067|NCT03447015|4073276|FG000|NOT COMPLETED|Overall Study||45
3343068|NCT03447015|4073277|FG001|NOT COMPLETED|Overall Study||44
3343069|NCT03447249|4073285|FG000|STARTED|Overall Study||190
3343070|NCT03447249|4073286|FG001|STARTED|Overall Study||192
3343071|NCT03447249|4073285|FG000|Safety Set|Overall Study||189
3343072|NCT03447249|4073286|FG001|Safety Set|Overall Study||193
3343073|NCT03447249|4073285|FG000|COMPLETED|Overall Study||185
3343074|NCT03447249|4073286|FG001|COMPLETED|Overall Study||192
3343075|NCT03447249|4073285|FG000|NOT COMPLETED|Overall Study||5
3343076|NCT03447249|4073286|FG001|NOT COMPLETED|Overall Study||0
3343077|NCT03447314|4073312|FG000|STARTED|Part 1 (Up to 27 Months)||9
3343078|NCT03447314|4073313|FG001|STARTED|Part 1 (Up to 27 Months)||6
3343079|NCT03447314|4073314|FG002|STARTED|Part 1 (Up to 27 Months)||9
3343080|NCT03447314|4073315|FG003|STARTED|Part 1 (Up to 27 Months)||4
3343081|NCT03447314|4073316|FG004|STARTED|Part 1 (Up to 27 Months)||2
3343082|NCT03447314|4073317|FG005|STARTED|Part 1 (Up to 27 Months)||6
3343083|NCT03447314|4073318|FG006|STARTED|Part 1 (Up to 27 Months)||5
3343084|NCT03447314|4073319|FG007|STARTED|Part 1 (Up to 27 Months)||0
3343085|NCT03447314|4073320|FG008|STARTED|Part 1 (Up to 27 Months)||0
3343086|NCT03447314|4073321|FG009|STARTED|Part 1 (Up to 27 Months)||0
3343087|NCT03447314|4073322|FG010|STARTED|Part 1 (Up to 27 Months)||7
3343088|NCT03447314|4073323|FG011|STARTED|Part 1 (Up to 27 Months)||6
3343089|NCT03447314|4073324|FG012|STARTED|Part 1 (Up to 27 Months)||0
3343090|NCT03447314|4073325|FG013|STARTED|Part 1 (Up to 27 Months)||0
3343091|NCT03447314|4073326|FG014|STARTED|Part 1 (Up to 27 Months)||0
3343092|NCT03447314|4073327|FG015|STARTED|Part 1 (Up to 27 Months)||0
3343093|NCT03447314|4073328|FG016|STARTED|Part 1 (Up to 27 Months)||0
3343094|NCT03447314|4073329|FG017|STARTED|Part 1 (Up to 27 Months)||0
3343095|NCT03447314|4073312|FG000|COMPLETED|Part 1 (Up to 27 Months)||0
3343096|NCT03447314|4073313|FG001|COMPLETED|Part 1 (Up to 27 Months)||0
3343097|NCT03447314|4073314|FG002|COMPLETED|Part 1 (Up to 27 Months)||0
3343098|NCT03447314|4073315|FG003|COMPLETED|Part 1 (Up to 27 Months)||0
3343099|NCT03447314|4073316|FG004|COMPLETED|Part 1 (Up to 27 Months)||0
3343100|NCT03447314|4073317|FG005|COMPLETED|Part 1 (Up to 27 Months)||0
3343101|NCT03447314|4073318|FG006|COMPLETED|Part 1 (Up to 27 Months)||0
3343102|NCT03447314|4073319|FG007|COMPLETED|Part 1 (Up to 27 Months)||0
3343103|NCT03447314|4073320|FG008|COMPLETED|Part 1 (Up to 27 Months)||0
3343104|NCT03447314|4073321|FG009|COMPLETED|Part 1 (Up to 27 Months)||0
3343105|NCT03447314|4073322|FG010|COMPLETED|Part 1 (Up to 27 Months)||0
3343106|NCT03447314|4073323|FG011|COMPLETED|Part 1 (Up to 27 Months)||0
3343107|NCT03447314|4073324|FG012|COMPLETED|Part 1 (Up to 27 Months)||0
3343108|NCT03447314|4073325|FG013|COMPLETED|Part 1 (Up to 27 Months)||0
3343109|NCT03447314|4073326|FG014|COMPLETED|Part 1 (Up to 27 Months)||0
3343110|NCT03447314|4073327|FG015|COMPLETED|Part 1 (Up to 27 Months)||0
3343111|NCT03447314|4073328|FG016|COMPLETED|Part 1 (Up to 27 Months)||0
3343112|NCT03447314|4073329|FG017|COMPLETED|Part 1 (Up to 27 Months)||0
3343113|NCT03447314|4073312|FG000|NOT COMPLETED|Part 1 (Up to 27 Months)||9
3343114|NCT03447314|4073313|FG001|NOT COMPLETED|Part 1 (Up to 27 Months)||6
3343115|NCT03447314|4073314|FG002|NOT COMPLETED|Part 1 (Up to 27 Months)||9
3343116|NCT03447314|4073315|FG003|NOT COMPLETED|Part 1 (Up to 27 Months)||4
3343117|NCT03447314|4073316|FG004|NOT COMPLETED|Part 1 (Up to 27 Months)||2
3343118|NCT03447314|4073317|FG005|NOT COMPLETED|Part 1 (Up to 27 Months)||6
3343119|NCT03447314|4073318|FG006|NOT COMPLETED|Part 1 (Up to 27 Months)||5
3343120|NCT03447314|4073319|FG007|NOT COMPLETED|Part 1 (Up to 27 Months)||0
3343121|NCT03447314|4073320|FG008|NOT COMPLETED|Part 1 (Up to 27 Months)||0
3343122|NCT03447314|4073321|FG009|NOT COMPLETED|Part 1 (Up to 27 Months)||0
3343123|NCT03447314|4073322|FG010|NOT COMPLETED|Part 1 (Up to 27 Months)||7
3343124|NCT03447314|4073323|FG011|NOT COMPLETED|Part 1 (Up to 27 Months)||6
3343125|NCT03447314|4073324|FG012|NOT COMPLETED|Part 1 (Up to 27 Months)||0
3343126|NCT03447314|4073325|FG013|NOT COMPLETED|Part 1 (Up to 27 Months)||0
3343127|NCT03447314|4073326|FG014|NOT COMPLETED|Part 1 (Up to 27 Months)||0
3343128|NCT03447314|4073327|FG015|NOT COMPLETED|Part 1 (Up to 27 Months)||0
3343129|NCT03447314|4073328|FG016|NOT COMPLETED|Part 1 (Up to 27 Months)||0
3343130|NCT03447314|4073329|FG017|NOT COMPLETED|Part 1 (Up to 27 Months)||0
3343131|NCT03447314|4073312|FG000|STARTED|Part 2 (Up to 27 Months)||0
3343132|NCT03447314|4073313|FG001|STARTED|Part 2 (Up to 27 Months)||0
3343133|NCT03447314|4073314|FG002|STARTED|Part 2 (Up to 27 Months)||0
3343134|NCT03447314|4073315|FG003|STARTED|Part 2 (Up to 27 Months)||0
3343135|NCT03447314|4073316|FG004|STARTED|Part 2 (Up to 27 Months)||0
3343136|NCT03447314|4073317|FG005|STARTED|Part 2 (Up to 27 Months)||0
3343137|NCT03447314|4073318|FG006|STARTED|Part 2 (Up to 27 Months)||0
3343138|NCT03447314|4073319|FG007|STARTED|Part 2 (Up to 27 Months)||0
3343139|NCT03447314|4073320|FG008|STARTED|Part 2 (Up to 27 Months)||0
3343140|NCT03447314|4073321|FG009|STARTED|Part 2 (Up to 27 Months)||0
3343141|NCT03447314|4073322|FG010|STARTED|Part 2 (Up to 27 Months)||0
3343142|NCT03447314|4073323|FG011|STARTED|Part 2 (Up to 27 Months)||0
3343143|NCT03447314|4073324|FG012|STARTED|Part 2 (Up to 27 Months)||0
3343144|NCT03447314|4073325|FG013|STARTED|Part 2 (Up to 27 Months)||0
3343145|NCT03447314|4073326|FG014|STARTED|Part 2 (Up to 27 Months)||0
3343146|NCT03447314|4073327|FG015|STARTED|Part 2 (Up to 27 Months)||0
3343147|NCT03447314|4073328|FG016|STARTED|Part 2 (Up to 27 Months)||0
3343148|NCT03447314|4073329|FG017|STARTED|Part 2 (Up to 27 Months)||0
3343149|NCT03447314|4073312|FG000|COMPLETED|Part 2 (Up to 27 Months)||0
3343150|NCT03447314|4073313|FG001|COMPLETED|Part 2 (Up to 27 Months)||0
3343151|NCT03447314|4073314|FG002|COMPLETED|Part 2 (Up to 27 Months)||0
3343152|NCT03447314|4073315|FG003|COMPLETED|Part 2 (Up to 27 Months)||0
3343153|NCT03447314|4073316|FG004|COMPLETED|Part 2 (Up to 27 Months)||0
3343154|NCT03447314|4073317|FG005|COMPLETED|Part 2 (Up to 27 Months)||0
3343155|NCT03447314|4073318|FG006|COMPLETED|Part 2 (Up to 27 Months)||0
3343156|NCT03447314|4073319|FG007|COMPLETED|Part 2 (Up to 27 Months)||0
3343157|NCT03447314|4073320|FG008|COMPLETED|Part 2 (Up to 27 Months)||0
3343158|NCT03447314|4073321|FG009|COMPLETED|Part 2 (Up to 27 Months)||0
3343159|NCT03447314|4073322|FG010|COMPLETED|Part 2 (Up to 27 Months)||0
3343160|NCT03447314|4073323|FG011|COMPLETED|Part 2 (Up to 27 Months)||0
3343161|NCT03447314|4073324|FG012|COMPLETED|Part 2 (Up to 27 Months)||0
3343162|NCT03447314|4073325|FG013|COMPLETED|Part 2 (Up to 27 Months)||0
3343163|NCT03447314|4073326|FG014|COMPLETED|Part 2 (Up to 27 Months)||0
3343164|NCT03447314|4073327|FG015|COMPLETED|Part 2 (Up to 27 Months)||0
3343165|NCT03447314|4073328|FG016|COMPLETED|Part 2 (Up to 27 Months)||0
3343166|NCT03447314|4073329|FG017|COMPLETED|Part 2 (Up to 27 Months)||0
3343167|NCT03447314|4073312|FG000|NOT COMPLETED|Part 2 (Up to 27 Months)||0
3343168|NCT03447314|4073313|FG001|NOT COMPLETED|Part 2 (Up to 27 Months)||0
3343169|NCT03447314|4073314|FG002|NOT COMPLETED|Part 2 (Up to 27 Months)||0
3343170|NCT03447314|4073315|FG003|NOT COMPLETED|Part 2 (Up to 27 Months)||0
3343171|NCT03447314|4073316|FG004|NOT COMPLETED|Part 2 (Up to 27 Months)||0
3343172|NCT03447314|4073317|FG005|NOT COMPLETED|Part 2 (Up to 27 Months)||0
3343173|NCT03447314|4073318|FG006|NOT COMPLETED|Part 2 (Up to 27 Months)||0
3343174|NCT03447314|4073319|FG007|NOT COMPLETED|Part 2 (Up to 27 Months)||0
3343175|NCT03447314|4073320|FG008|NOT COMPLETED|Part 2 (Up to 27 Months)||0
3343176|NCT03447314|4073321|FG009|NOT COMPLETED|Part 2 (Up to 27 Months)||0
3343177|NCT03447314|4073322|FG010|NOT COMPLETED|Part 2 (Up to 27 Months)||0
3343178|NCT03447314|4073323|FG011|NOT COMPLETED|Part 2 (Up to 27 Months)||0
3343179|NCT03447314|4073324|FG012|NOT COMPLETED|Part 2 (Up to 27 Months)||0
3343180|NCT03447314|4073325|FG013|NOT COMPLETED|Part 2 (Up to 27 Months)||0
3343181|NCT03447314|4073326|FG014|NOT COMPLETED|Part 2 (Up to 27 Months)||0
3343182|NCT03447314|4073327|FG015|NOT COMPLETED|Part 2 (Up to 27 Months)||0
3343183|NCT03447314|4073328|FG016|NOT COMPLETED|Part 2 (Up to 27 Months)||0
3343184|NCT03447314|4073329|FG017|NOT COMPLETED|Part 2 (Up to 27 Months)||0
3343185|NCT03447353|4073370|FG000|STARTED|Overall Study||18
3343186|NCT03447353|4073370|FG000|COMPLETED|Overall Study||8
3343187|NCT03447353|4073370|FG000|NOT COMPLETED|Overall Study||10
3343188|NCT03447730|4073383|FG000|STARTED|Overall Study||6
3343189|NCT03447730|4073384|FG001|STARTED|Overall Study||9
3343190|NCT03447730|4073385|FG002|STARTED|Overall Study||8
3343191|NCT03447730|4073383|FG000|COMPLETED|Overall Study||6
3343192|NCT03447730|4073384|FG001|COMPLETED|Overall Study||7
3343193|NCT03447730|4073385|FG002|COMPLETED|Overall Study||8
3343194|NCT03447730|4073383|FG000|NOT COMPLETED|Overall Study||0
3343195|NCT03447730|4073384|FG001|NOT COMPLETED|Overall Study||2
3343196|NCT03447730|4073385|FG002|NOT COMPLETED|Overall Study||0
3343197|NCT03447821|4073396|FG000|STARTED|Overall Study||14
3343198|NCT03447821|4073397|FG001|STARTED|Overall Study||13
3343199|NCT03447821|4073398|FG002|STARTED|Overall Study||13
3343200|NCT03447821|4073396|FG000|COMPLETED|Overall Study||13
3343201|NCT03447821|4073397|FG001|COMPLETED|Overall Study||12
3343202|NCT03447821|4073398|FG002|COMPLETED|Overall Study||12
3343203|NCT03447821|4073396|FG000|NOT COMPLETED|Overall Study||1
3343204|NCT03447821|4073397|FG001|NOT COMPLETED|Overall Study||1
3343205|NCT03447821|4073398|FG002|NOT COMPLETED|Overall Study||1
3343206|NCT03448068|4073408|FG000|STARTED|Overall Study||17
3343207|NCT03448068|4073409|FG001|STARTED|Overall Study||17
3343208|NCT03448068|4073408|FG000|COMPLETED|Overall Study||17
3343209|NCT03448068|4073409|FG001|COMPLETED|Overall Study||17
3343210|NCT03448068|4073408|FG000|NOT COMPLETED|Overall Study||0
3343211|NCT03448068|4073409|FG001|NOT COMPLETED|Overall Study||0
3343212|NCT03448224|4073417|FG000|STARTED|Overall Study||28
3343213|NCT03448224|4073418|FG001|STARTED|Overall Study||26
3343214|NCT03448224|4073417|FG000|COMPLETED|Overall Study||27
3343215|NCT03448224|4073418|FG001|COMPLETED|Overall Study||26
3343216|NCT03448224|4073417|FG000|NOT COMPLETED|Overall Study||1
3343217|NCT03448224|4073418|FG001|NOT COMPLETED|Overall Study||0
3343218|NCT03448406|4073426|FG000|STARTED|Overall Study||158
3343219|NCT03448406|4073427|FG001|STARTED|Overall Study||157
3343220|NCT03448406|4073426|FG000|COMPLETED|Overall Study||147
3343221|NCT03448406|4073427|FG001|COMPLETED|Overall Study||144
3343222|NCT03448406|4073426|FG000|NOT COMPLETED|Overall Study||11
3343223|NCT03448406|4073427|FG001|NOT COMPLETED|Overall Study||13
3343224|NCT03448419|4073435|FG000|STARTED|Overall Study||156
3343225|NCT03448419|4073436|FG001|STARTED|Overall Study||156
3343226|NCT03448419|4073435|FG000|Treated|Overall Study||156
3343227|NCT03448419|4073436|FG001|Treated|Overall Study||155
3343228|NCT03448419|4073435|FG000|COMPLETED|Overall Study||143
3343229|NCT03448419|4073436|FG001|COMPLETED|Overall Study||140
3343230|NCT03448419|4073435|FG000|NOT COMPLETED|Overall Study||13
3343231|NCT03448419|4073436|FG001|NOT COMPLETED|Overall Study||16
3343232|NCT03448536|4073446|FG000|STARTED|Overall Study||100
3343233|NCT03448536|4073447|FG001|STARTED|Overall Study||101
3343234|NCT03448536|4073446|FG000|Completed First Intervention|Overall Study||83
3343235|NCT03448536|4073447|FG001|Completed First Intervention|Overall Study||78
3343236|NCT03448536|4073446|FG000|Completed First Intervention|Overall Study||95
3343237|NCT03448536|4073447|FG001|Completed First Intervention|Overall Study||97
3343238|NCT03448536|4073446|FG000|Completed Second Intervention|Overall Study||82
3343239|NCT03448536|4073447|FG001|Completed Second Intervention|Overall Study||87
3343240|NCT03448536|4073446|FG000|COMPLETED|Overall Study||88
3343241|NCT03448536|4073447|FG001|COMPLETED|Overall Study||97
3343242|NCT03448536|4073446|FG000|NOT COMPLETED|Overall Study||12
3343243|NCT03448536|4073447|FG001|NOT COMPLETED|Overall Study||4
3343244|NCT03449030|4073463|FG000|STARTED|Overall Study||1
3343245|NCT03449030|4073464|FG001|STARTED|Overall Study||1
3343246|NCT03449030|4073465|FG002|STARTED|Overall Study||1
3343247|NCT03449030|4073466|FG003|STARTED|Overall Study||5
3343248|NCT03449030|4073467|FG004|STARTED|Overall Study||7
3343249|NCT03449030|4073468|FG005|STARTED|Overall Study||7
3343250|NCT03449030|4073469|FG006|STARTED|Overall Study||2
3343251|NCT03449030|4073470|FG007|STARTED|Overall Study||3
3343252|NCT03449030|4073471|FG008|STARTED|Overall Study||3
3343253|NCT03449030|4073472|FG009|STARTED|Overall Study||1
3343254|NCT03449030|4073463|FG000|COMPLETED|Overall Study||0
3343255|NCT03449030|4073464|FG001|COMPLETED|Overall Study||0
3343256|NCT03449030|4073465|FG002|COMPLETED|Overall Study||0
3343257|NCT03449030|4073466|FG003|COMPLETED|Overall Study||0
3343258|NCT03449030|4073467|FG004|COMPLETED|Overall Study||0
3343259|NCT03449030|4073468|FG005|COMPLETED|Overall Study||0
3343260|NCT03449030|4073469|FG006|COMPLETED|Overall Study||0
3343261|NCT03449030|4073470|FG007|COMPLETED|Overall Study||0
3343262|NCT03449030|4073471|FG008|COMPLETED|Overall Study||0
3343263|NCT03449030|4073472|FG009|COMPLETED|Overall Study||0
3343264|NCT03449030|4073463|FG000|NOT COMPLETED|Overall Study||1
3343265|NCT03449030|4073464|FG001|NOT COMPLETED|Overall Study||1
3343266|NCT03449030|4073465|FG002|NOT COMPLETED|Overall Study||1
3343267|NCT03449030|4073466|FG003|NOT COMPLETED|Overall Study||5
3343268|NCT03449030|4073467|FG004|NOT COMPLETED|Overall Study||7
3343269|NCT03449030|4073468|FG005|NOT COMPLETED|Overall Study||7
3343270|NCT03449030|4073469|FG006|NOT COMPLETED|Overall Study||2
3343271|NCT03449030|4073470|FG007|NOT COMPLETED|Overall Study||3
3343272|NCT03449030|4073471|FG008|NOT COMPLETED|Overall Study||3
3343273|NCT03449030|4073472|FG009|NOT COMPLETED|Overall Study||1
3343274|NCT03449134|4073498|FG000|STARTED|52-Week Treatment Period||244
3343275|NCT03449134|4073499|FG001|STARTED|52-Week Treatment Period||244
3343276|NCT03449134|4073500|FG002|STARTED|52-Week Treatment Period||244
3343277|NCT03449134|4073498|FG000|Treated|52-Week Treatment Period||243
3343278|NCT03449134|4073499|FG001|Treated|52-Week Treatment Period||244
3343279|NCT03449134|4073500|FG002|Treated|52-Week Treatment Period||243
3343280|NCT03449134|4073498|FG000|COMPLETED|52-Week Treatment Period||199
3343281|NCT03449134|4073499|FG001|COMPLETED|52-Week Treatment Period||200
3343282|NCT03449134|4073500|FG002|COMPLETED|52-Week Treatment Period||184
3343283|NCT03449134|4073498|FG000|NOT COMPLETED|52-Week Treatment Period||45
3343284|NCT03449134|4073499|FG001|NOT COMPLETED|52-Week Treatment Period||44
3343285|NCT03449134|4073500|FG002|NOT COMPLETED|52-Week Treatment Period||60
3343286|NCT03449134|4073498|FG000|STARTED|12-Week Off-Treatment Durability Period|Not all participants continued in the optional Off-Treatment Period.|10
3343287|NCT03449134|4073499|FG001|STARTED|12-Week Off-Treatment Durability Period|Not all participants continued in the optional Off-Treatment Period.|18
3343288|NCT03449134|4073500|FG002|STARTED|12-Week Off-Treatment Durability Period|Not all participants continued in the optional Off-Treatment Period.|13
3343289|NCT03449134|4073498|FG000|COMPLETED|12-Week Off-Treatment Durability Period||10
3343290|NCT03449134|4073499|FG001|COMPLETED|12-Week Off-Treatment Durability Period||18
3343291|NCT03449134|4073500|FG002|COMPLETED|12-Week Off-Treatment Durability Period||13
3343292|NCT03449134|4073498|FG000|NOT COMPLETED|12-Week Off-Treatment Durability Period||0
3343293|NCT03449134|4073499|FG001|NOT COMPLETED|12-Week Off-Treatment Durability Period||0
3343294|NCT03449134|4073500|FG002|NOT COMPLETED|12-Week Off-Treatment Durability Period||0
3343295|NCT03449147|4073514|FG000|STARTED|52-week Treatment Period||436
3343296|NCT03449147|4073515|FG001|STARTED|52-week Treatment Period||442
3343297|NCT03449147|4073516|FG002|STARTED|52-week Treatment Period||439
3343298|NCT03449147|4073514|FG000|COMPLETED|52-week Treatment Period||382
3343299|NCT03449147|4073515|FG001|COMPLETED|52-week Treatment Period||368
3343300|NCT03449147|4073516|FG002|COMPLETED|52-week Treatment Period||355
3343301|NCT03449147|4073514|FG000|NOT COMPLETED|52-week Treatment Period||54
3343302|NCT03449147|4073515|FG001|NOT COMPLETED|52-week Treatment Period||74
3343303|NCT03449147|4073516|FG002|NOT COMPLETED|52-week Treatment Period||84
3343304|NCT03449147|4073514|FG000|STARTED|12-Week Off-Treatment Durability Period|Not all participants continued in the optional Off-Treatment Period.|48
3343305|NCT03449147|4073515|FG001|STARTED|12-Week Off-Treatment Durability Period|Not all participants continued in the optional Off-Treatment Period.|37
3343306|NCT03449147|4073516|FG002|STARTED|12-Week Off-Treatment Durability Period|Not all participants continued in the optional Off-Treatment Period.|37
3343307|NCT03449147|4073514|FG000|COMPLETED|12-Week Off-Treatment Durability Period||47
3343308|NCT03449147|4073515|FG001|COMPLETED|12-Week Off-Treatment Durability Period||36
3343309|NCT03449147|4073516|FG002|COMPLETED|12-Week Off-Treatment Durability Period||37
3343310|NCT03449147|4073514|FG000|NOT COMPLETED|12-Week Off-Treatment Durability Period||1
3343311|NCT03449147|4073515|FG001|NOT COMPLETED|12-Week Off-Treatment Durability Period||1
3343312|NCT03449147|4073516|FG002|NOT COMPLETED|12-Week Off-Treatment Durability Period||0
3343313|NCT03449342|4073530|FG000|STARTED|Overall Study||10
3343314|NCT03449342|4073531|FG001|STARTED|Overall Study||50
3343315|NCT03449342|4073530|FG000|COMPLETED|Overall Study||10
3343316|NCT03449342|4073531|FG001|COMPLETED|Overall Study||50
3343317|NCT03449342|4073530|FG000|NOT COMPLETED|Overall Study||0
3343318|NCT03449342|4073531|FG001|NOT COMPLETED|Overall Study||0
3343319|NCT03449433|4073539|FG000|STARTED|Period 1||17
3177408|NCT01970787|3905201|FG000|NOT COMPLETED|Overall Study||1
3177409|NCT01970878|3905209|FG000|STARTED|Overall Study||290
3177410|NCT01970878|3905210|FG001|STARTED|Overall Study|218 subjects were reported in the CSR, 1 had no completion status|218
3177411|NCT01970878|3905211|FG002|STARTED|Overall Study||213
3177412|NCT01970878|3905212|FG003|STARTED|Overall Study||171
3177413|NCT01970878|3905209|FG000|COMPLETED|Overall Study||253
3343320|NCT03449433|4073540|FG001|STARTED|Period 1||16
3343321|NCT03449433|4073541|FG002|STARTED|Period 1||18
3343322|NCT03449433|4073542|FG003|STARTED|Period 1||17
3343323|NCT03449433|4073543|FG004|STARTED|Period 1||12
3343324|NCT03449433|4073539|FG000|Received at Least 1 Dose of Study Drug|Period 1||17
3343325|NCT03449433|4073540|FG001|Received at Least 1 Dose of Study Drug|Period 1||16
3343326|NCT03449433|4073541|FG002|Received at Least 1 Dose of Study Drug|Period 1||18
3343327|NCT03449433|4073542|FG003|Received at Least 1 Dose of Study Drug|Period 1||17
3343328|NCT03449433|4073543|FG004|Received at Least 1 Dose of Study Drug|Period 1||0
3343329|NCT03449433|4073539|FG000|COMPLETED|Period 1||17
3343330|NCT03449433|4073540|FG001|COMPLETED|Period 1||16
3343331|NCT03449433|4073541|FG002|COMPLETED|Period 1||18
3343332|NCT03449433|4073542|FG003|COMPLETED|Period 1||17
3343333|NCT03449433|4073543|FG004|COMPLETED|Period 1||12
3343334|NCT03449433|4073539|FG000|NOT COMPLETED|Period 1||0
3343335|NCT03449433|4073540|FG001|NOT COMPLETED|Period 1||0
3343336|NCT03449433|4073541|FG002|NOT COMPLETED|Period 1||0
3343337|NCT03449433|4073542|FG003|NOT COMPLETED|Period 1||0
3343338|NCT03449433|4073543|FG004|NOT COMPLETED|Period 1||0
3343339|NCT03449433|4073539|FG000|STARTED|Period 2||17
3343340|NCT03449433|4073540|FG001|STARTED|Period 2||16
3343341|NCT03449433|4073541|FG002|STARTED|Period 2||18
3343342|NCT03449433|4073542|FG003|STARTED|Period 2||17
3343343|NCT03449433|4073543|FG004|STARTED|Period 2||12
3343344|NCT03449433|4073539|FG000|Received at Least 1 Dose of Study Drug|Period 2||17
3343345|NCT03449433|4073540|FG001|Received at Least 1 Dose of Study Drug|Period 2||16
3343346|NCT03449433|4073541|FG002|Received at Least 1 Dose of Study Drug|Period 2||18
3343347|NCT03449433|4073542|FG003|Received at Least 1 Dose of Study Drug|Period 2||17
3343348|NCT03449433|4073543|FG004|Received at Least 1 Dose of Study Drug|Period 2||0
3343349|NCT03449433|4073539|FG000|COMPLETED|Period 2||17
3177414|NCT01970878|3905210|FG001|COMPLETED|Overall Study||191
3343350|NCT03449433|4073540|FG001|COMPLETED|Period 2||16
3343351|NCT03449433|4073541|FG002|COMPLETED|Period 2||18
3343352|NCT03449433|4073542|FG003|COMPLETED|Period 2||17
3343353|NCT03449433|4073543|FG004|COMPLETED|Period 2||12
3343354|NCT03449433|4073539|FG000|NOT COMPLETED|Period 2||0
3343355|NCT03449433|4073540|FG001|NOT COMPLETED|Period 2||0
3343356|NCT03449433|4073541|FG002|NOT COMPLETED|Period 2||0
3343357|NCT03449433|4073542|FG003|NOT COMPLETED|Period 2||0
3343358|NCT03449433|4073543|FG004|NOT COMPLETED|Period 2||0
3343359|NCT03449433|4073539|FG000|STARTED|Period 3||17
3343360|NCT03449433|4073540|FG001|STARTED|Period 3||16
3343361|NCT03449433|4073541|FG002|STARTED|Period 3||18
3343362|NCT03449433|4073542|FG003|STARTED|Period 3||17
3343363|NCT03449433|4073543|FG004|STARTED|Period 3||12
3343364|NCT03449433|4073539|FG000|Received at Least 1 Dose of Study Drug|Period 3||17
3343365|NCT03449433|4073540|FG001|Received at Least 1 Dose of Study Drug|Period 3||15
3343366|NCT03449433|4073541|FG002|Received at Least 1 Dose of Study Drug|Period 3||18
3343367|NCT03449433|4073542|FG003|Received at Least 1 Dose of Study Drug|Period 3||17
3343368|NCT03449433|4073543|FG004|Received at Least 1 Dose of Study Drug|Period 3||0
3343369|NCT03449433|4073539|FG000|COMPLETED|Period 3||17
3343370|NCT03449433|4073540|FG001|COMPLETED|Period 3||15
3343371|NCT03449433|4073541|FG002|COMPLETED|Period 3||18
3343372|NCT03449433|4073542|FG003|COMPLETED|Period 3||17
3343373|NCT03449433|4073543|FG004|COMPLETED|Period 3||12
3343374|NCT03449433|4073539|FG000|NOT COMPLETED|Period 3||0
3343375|NCT03449433|4073540|FG001|NOT COMPLETED|Period 3||1
3343376|NCT03449433|4073541|FG002|NOT COMPLETED|Period 3||0
3343377|NCT03449433|4073542|FG003|NOT COMPLETED|Period 3||0
3343378|NCT03449433|4073543|FG004|NOT COMPLETED|Period 3||0
3343379|NCT03449433|4073539|FG000|STARTED|Period 4||17
3343380|NCT03449433|4073540|FG001|STARTED|Period 4||15
3343381|NCT03449433|4073541|FG002|STARTED|Period 4||18
3343382|NCT03449433|4073542|FG003|STARTED|Period 4||17
3343383|NCT03449433|4073543|FG004|STARTED|Period 4||12
3343384|NCT03449433|4073539|FG000|Received at Least 1 Dose of Study Drug|Period 4||17
3343385|NCT03449433|4073540|FG001|Received at Least 1 Dose of Study Drug|Period 4||15
3343386|NCT03449433|4073541|FG002|Received at Least 1 Dose of Study Drug|Period 4||18
3343387|NCT03449433|4073542|FG003|Received at Least 1 Dose of Study Drug|Period 4||17
3343388|NCT03449433|4073543|FG004|Received at Least 1 Dose of Study Drug|Period 4||0
3343389|NCT03449433|4073539|FG000|COMPLETED|Period 4||17
3343390|NCT03449433|4073540|FG001|COMPLETED|Period 4||15
3343391|NCT03449433|4073541|FG002|COMPLETED|Period 4||18
3343392|NCT03449433|4073542|FG003|COMPLETED|Period 4||17
3343393|NCT03449433|4073543|FG004|COMPLETED|Period 4||12
3343394|NCT03449433|4073539|FG000|NOT COMPLETED|Period 4||0
3343395|NCT03449433|4073540|FG001|NOT COMPLETED|Period 4||0
3343396|NCT03449433|4073541|FG002|NOT COMPLETED|Period 4||0
3343397|NCT03449433|4073542|FG003|NOT COMPLETED|Period 4||0
3343398|NCT03449433|4073543|FG004|NOT COMPLETED|Period 4||0
3343399|NCT03449446|4073564|FG000|STARTED|Overall Study||39
3343400|NCT03449446|4073565|FG001|STARTED|Overall Study||40
3343401|NCT03449446|4073566|FG002|STARTED|Overall Study||41
3343402|NCT03449446|4073567|FG003|STARTED|Overall Study||80
3343403|NCT03449446|4073568|FG004|STARTED|Overall Study||78
3343404|NCT03449446|4073569|FG005|STARTED|Overall Study||78
3343405|NCT03449446|4073570|FG006|STARTED|Overall Study||39
3343406|NCT03449446|4073564|FG000|COMPLETED|Overall Study||3
3343407|NCT03449446|4073565|FG001|COMPLETED|Overall Study||33
3343408|NCT03449446|4073566|FG002|COMPLETED|Overall Study||34
3343409|NCT03449446|4073567|FG003|COMPLETED|Overall Study||71
3343410|NCT03449446|4073568|FG004|COMPLETED|Overall Study||66
3343411|NCT03449446|4073569|FG005|COMPLETED|Overall Study||69
3343412|NCT03449446|4073570|FG006|COMPLETED|Overall Study||38
3343413|NCT03449446|4073564|FG000|NOT COMPLETED|Overall Study||36
3343414|NCT03449446|4073565|FG001|NOT COMPLETED|Overall Study||7
3343415|NCT03449446|4073566|FG002|NOT COMPLETED|Overall Study||7
3343416|NCT03449446|4073567|FG003|NOT COMPLETED|Overall Study||9
3177415|NCT01970878|3905211|FG002|COMPLETED|Overall Study||187
3177416|NCT01970878|3905212|FG003|COMPLETED|Overall Study||147
3177417|NCT01970878|3905209|FG000|NOT COMPLETED|Overall Study||37
3177418|NCT01970878|3905210|FG001|NOT COMPLETED|Overall Study||27
3177419|NCT01970878|3905211|FG002|NOT COMPLETED|Overall Study||26
3177420|NCT01970878|3905212|FG003|NOT COMPLETED|Overall Study||24
3177421|NCT01970943|3905222|FG000|STARTED|Overall Study||11
3343417|NCT03449446|4073568|FG004|NOT COMPLETED|Overall Study||12
3343418|NCT03449446|4073569|FG005|NOT COMPLETED|Overall Study||9
3343419|NCT03449446|4073570|FG006|NOT COMPLETED|Overall Study||1
3343420|NCT03449758|4073586|FG000|STARTED|Overall Study||84
3343421|NCT03449758|4073586|FG000|COMPLETED|Overall Study||65
3343422|NCT03449758|4073586|FG000|NOT COMPLETED|Overall Study||19
3343423|NCT03449979|4073595|FG000|STARTED|Overall Study||21
3343424|NCT03449979|4073596|FG001|STARTED|Overall Study||20
3343425|NCT03449979|4073597|FG002|STARTED|Overall Study||21
3343426|NCT03449979|4073598|FG003|STARTED|Overall Study||22
3343427|NCT03449979|4073595|FG000|COMPLETED|Overall Study||21
3343428|NCT03449979|4073596|FG001|COMPLETED|Overall Study||20
3343429|NCT03449979|4073597|FG002|COMPLETED|Overall Study||21
3177422|NCT01970943|3905223|FG001|STARTED|Overall Study||12
3177423|NCT01970943|3905222|FG000|COMPLETED|Overall Study||8
3343430|NCT03449979|4073598|FG003|COMPLETED|Overall Study||21
3343431|NCT03449979|4073595|FG000|NOT COMPLETED|Overall Study||0
3343432|NCT03449979|4073596|FG001|NOT COMPLETED|Overall Study||0
3343433|NCT03449979|4073597|FG002|NOT COMPLETED|Overall Study||0
3343434|NCT03449979|4073598|FG003|NOT COMPLETED|Overall Study||1
3343435|NCT03450070|4073608|FG000|STARTED|Overall Study||118
3343436|NCT03450070|4073608|FG000|COMPLETED|Overall Study||110
3343437|NCT03450070|4073608|FG000|NOT COMPLETED|Overall Study||8
3343438|NCT03450083|4073614|FG000|STARTED|Overall Study||12
3343439|NCT03450083|4073615|FG001|STARTED|Overall Study||12
3343440|NCT03450083|4073614|FG000|COMPLETED|Overall Study||12
3343441|NCT03450083|4073615|FG001|COMPLETED|Overall Study||12
3343442|NCT03450083|4073614|FG000|NOT COMPLETED|Overall Study||0
3343443|NCT03450083|4073615|FG001|NOT COMPLETED|Overall Study||0
3343444|NCT03450369|4073623|FG000|STARTED|Overall Study||5
3343445|NCT03450369|4073624|FG001|STARTED|Overall Study||5
3343446|NCT03450369|4073623|FG000|COMPLETED|Overall Study||5
3343447|NCT03450369|4073624|FG001|COMPLETED|Overall Study||5
3343448|NCT03450369|4073623|FG000|NOT COMPLETED|Overall Study||0
3343449|NCT03450369|4073624|FG001|NOT COMPLETED|Overall Study||0
3343450|NCT03450915|4073632|FG000|STARTED|Overall Study||6230
3343451|NCT03450915|4073633|FG001|STARTED|Overall Study||6230
3343452|NCT03450915|4073632|FG000|COMPLETED|Overall Study||5827
3343453|NCT03450915|4073633|FG001|COMPLETED|Overall Study||5855
3343454|NCT03450915|4073632|FG000|NOT COMPLETED|Overall Study||403
3343455|NCT03450915|4073633|FG001|NOT COMPLETED|Overall Study||375
3343456|NCT03451071|4073639|FG000|STARTED|First Vaccine||56
3343457|NCT03451071|4073639|FG000|COMPLETED|First Vaccine||55
3343458|NCT03451071|4073639|FG000|NOT COMPLETED|First Vaccine||1
3343459|NCT03451071|4073639|FG000|STARTED|Second Vaccine||55
3343460|NCT03451071|4073639|FG000|COMPLETED|Second Vaccine||36
3343461|NCT03451071|4073639|FG000|NOT COMPLETED|Second Vaccine||19
3343462|NCT03451071|4073639|FG000|STARTED|Third Vaccine||36
3343463|NCT03451071|4073639|FG000|COMPLETED|Third Vaccine||14
3343464|NCT03451071|4073639|FG000|NOT COMPLETED|Third Vaccine||22
3343465|NCT03451071|4073639|FG000|STARTED|Final Questionnaire and Blood Draw||14
3343466|NCT03451071|4073639|FG000|COMPLETED|Final Questionnaire and Blood Draw||10
3343467|NCT03451071|4073639|FG000|NOT COMPLETED|Final Questionnaire and Blood Draw||4
3343468|NCT03451084|4073647|FG000|STARTED|Overall Study||6
3343469|NCT03451084|4073648|FG001|STARTED|Overall Study||6
3343470|NCT03451084|4073649|FG002|STARTED|Overall Study||6
3343471|NCT03451084|4073650|FG003|STARTED|Overall Study||6
3343472|NCT03451084|4073647|FG000|COMPLETED|Overall Study||0
3343473|NCT03451084|4073648|FG001|COMPLETED|Overall Study||0
3343474|NCT03451084|4073649|FG002|COMPLETED|Overall Study||0
3343475|NCT03451084|4073650|FG003|COMPLETED|Overall Study||0
3343476|NCT03451084|4073647|FG000|NOT COMPLETED|Overall Study||6
3343477|NCT03451084|4073648|FG001|NOT COMPLETED|Overall Study||6
3343478|NCT03451084|4073649|FG002|NOT COMPLETED|Overall Study||6
3343479|NCT03451084|4073650|FG003|NOT COMPLETED|Overall Study||6
3343480|NCT03451721|4073660|FG000|STARTED|Overall Study||20
3343481|NCT03451721|4073660|FG000|COMPLETED|Overall Study||19
3343482|NCT03451721|4073660|FG000|NOT COMPLETED|Overall Study||1
3343483|NCT03451773|4073666|FG000|STARTED|Overall Study||1
3343484|NCT03451773|4073667|FG001|STARTED|Overall Study||6
3343485|NCT03451773|4073666|FG000|COMPLETED|Overall Study||0
3343486|NCT03451773|4073667|FG001|COMPLETED|Overall Study||0
3343487|NCT03451773|4073666|FG000|NOT COMPLETED|Overall Study||1
3343488|NCT03451773|4073667|FG001|NOT COMPLETED|Overall Study||6
3343489|NCT03452033|4073678|FG000|STARTED|Overall Study||21
3343490|NCT03452033|4073679|FG001|STARTED|Overall Study||22
3343491|NCT03452033|4073680|FG002|STARTED|Overall Study||22
3343492|NCT03452033|4073681|FG003|STARTED|Overall Study||22
3343493|NCT03452033|4073678|FG000|COMPLETED|Overall Study||21
3343494|NCT03452033|4073679|FG001|COMPLETED|Overall Study||22
3343495|NCT03452033|4073680|FG002|COMPLETED|Overall Study||22
3343496|NCT03452033|4073681|FG003|COMPLETED|Overall Study||22
3343497|NCT03452033|4073678|FG000|NOT COMPLETED|Overall Study||0
3343498|NCT03452033|4073679|FG001|NOT COMPLETED|Overall Study||0
3343499|NCT03452033|4073680|FG002|NOT COMPLETED|Overall Study||0
3343500|NCT03452033|4073681|FG003|NOT COMPLETED|Overall Study||0
3343501|NCT03452176|4073696|FG000|STARTED|Overall Study||11
3343502|NCT03452176|4073697|FG001|STARTED|Overall Study||11
3343503|NCT03452176|4073696|FG000|COMPLETED|Overall Study||11
3177424|NCT01970943|3905223|FG001|COMPLETED|Overall Study||11
3177425|NCT01970943|3905222|FG000|NOT COMPLETED|Overall Study||3
3343504|NCT03452176|4073697|FG001|COMPLETED|Overall Study||11
3343505|NCT03452176|4073696|FG000|NOT COMPLETED|Overall Study||0
3343506|NCT03452176|4073697|FG001|NOT COMPLETED|Overall Study||0
3343507|NCT03452189|4073711|FG000|STARTED|First Intervention (3 Months)||10
3343508|NCT03452189|4073712|FG001|STARTED|First Intervention (3 Months)||5
3343509|NCT03452189|4073711|FG000|COMPLETED|First Intervention (3 Months)||5
3343510|NCT03452189|4073712|FG001|COMPLETED|First Intervention (3 Months)||5
3343511|NCT03452189|4073711|FG000|NOT COMPLETED|First Intervention (3 Months)||5
3343512|NCT03452189|4073712|FG001|NOT COMPLETED|First Intervention (3 Months)||0
3343513|NCT03452189|4073711|FG000|STARTED|Intervention 2 (3 Months)||5
3343514|NCT03452189|4073712|FG001|STARTED|Intervention 2 (3 Months)||5
3343515|NCT03452189|4073711|FG000|COMPLETED|Intervention 2 (3 Months)||5
3177426|NCT01970943|3905223|FG001|NOT COMPLETED|Overall Study||1
3343516|NCT03452189|4073712|FG001|COMPLETED|Intervention 2 (3 Months)||5
3343517|NCT03452189|4073711|FG000|NOT COMPLETED|Intervention 2 (3 Months)||0
3343518|NCT03452189|4073712|FG001|NOT COMPLETED|Intervention 2 (3 Months)||0
3343519|NCT03452371|4073720|FG000|STARTED|Overall Study||21
3343520|NCT03452371|4073721|FG001|STARTED|Overall Study||23
3343521|NCT03452371|4073720|FG000|COMPLETED|Overall Study||21
3343522|NCT03452371|4073721|FG001|COMPLETED|Overall Study||23
3343523|NCT03452371|4073720|FG000|NOT COMPLETED|Overall Study||0
3343524|NCT03452371|4073721|FG001|NOT COMPLETED|Overall Study||0
3343525|NCT03452527|4073729|FG000|STARTED|Overall Study||7
3343526|NCT03452527|4073730|FG001|STARTED|Overall Study||8
3343527|NCT03452527|4073729|FG000|COMPLETED|Overall Study||4
3343528|NCT03452527|4073730|FG001|COMPLETED|Overall Study||4
3343529|NCT03452527|4073729|FG000|NOT COMPLETED|Overall Study||3
3343530|NCT03452527|4073730|FG001|NOT COMPLETED|Overall Study||4
3343531|NCT03452943|4073738|FG000|STARTED|Titration Period (7 Weeks)||59
3343532|NCT03452943|4073739|FG001|STARTED|Titration Period (7 Weeks)||60
3343533|NCT03452943|4073738|FG000|Safety Analysis Set|Titration Period (7 Weeks)||58
3343534|NCT03452943|4073739|FG001|Safety Analysis Set|Titration Period (7 Weeks)||59
3343535|NCT03452943|4073738|FG000|Modified ITT (mITT) Analysis Set|Titration Period (7 Weeks)||58
3343536|NCT03452943|4073739|FG001|Modified ITT (mITT) Analysis Set|Titration Period (7 Weeks)||59
3343537|NCT03452943|4073738|FG000|COMPLETED|Titration Period (7 Weeks)||54
3343538|NCT03452943|4073739|FG001|COMPLETED|Titration Period (7 Weeks)||56
3343539|NCT03452943|4073738|FG000|NOT COMPLETED|Titration Period (7 Weeks)||5
3343540|NCT03452943|4073739|FG001|NOT COMPLETED|Titration Period (7 Weeks)||4
3343541|NCT03452943|4073738|FG000|STARTED|Maintenance Period (5 Weeks)||54
3343542|NCT03452943|4073739|FG001|STARTED|Maintenance Period (5 Weeks)||56
3343543|NCT03452943|4073738|FG000|COMPLETED|Maintenance Period (5 Weeks)||51
3343544|NCT03452943|4073739|FG001|COMPLETED|Maintenance Period (5 Weeks)||56
3343545|NCT03452943|4073738|FG000|NOT COMPLETED|Maintenance Period (5 Weeks)||3
3343546|NCT03452943|4073739|FG001|NOT COMPLETED|Maintenance Period (5 Weeks)||0
3343547|NCT03453060|4073750|FG000|STARTED|Overall Study||4
3343548|NCT03453060|4073751|FG001|STARTED|Overall Study||4
3343549|NCT03453060|4073752|FG002|STARTED|Overall Study||4
3177427|NCT01970982|3905232|FG000|STARTED|Overall Study||80
3177428|NCT01970982|3905233|FG001|STARTED|Overall Study||40
3177429|NCT01970982|3905234|FG002|STARTED|Overall Study||40
3177430|NCT01970982|3905232|FG000|COMPLETED|Overall Study||80
3177431|NCT01970982|3905233|FG001|COMPLETED|Overall Study||40
3343550|NCT03453060|4073753|FG003|STARTED|Overall Study||4
3343551|NCT03453060|4073754|FG004|STARTED|Overall Study||5
3343552|NCT03453060|4073750|FG000|COMPLETED|Overall Study||4
3343553|NCT03453060|4073751|FG001|COMPLETED|Overall Study||4
3343554|NCT03453060|4073752|FG002|COMPLETED|Overall Study||4
3343555|NCT03453060|4073753|FG003|COMPLETED|Overall Study||4
3343556|NCT03453060|4073754|FG004|COMPLETED|Overall Study||5
3343557|NCT03453060|4073750|FG000|NOT COMPLETED|Overall Study||0
3343558|NCT03453060|4073751|FG001|NOT COMPLETED|Overall Study||0
3343559|NCT03453060|4073752|FG002|NOT COMPLETED|Overall Study||0
3343560|NCT03453060|4073753|FG003|NOT COMPLETED|Overall Study||0
3343561|NCT03453060|4073754|FG004|NOT COMPLETED|Overall Study||0
3343562|NCT03453151|4073766|FG000|STARTED|Overall Study||19
3343563|NCT03453151|4073766|FG000|COMPLETED|Overall Study||15
3343564|NCT03453151|4073766|FG000|NOT COMPLETED|Overall Study||4
3343565|NCT03453515|4073772|FG000|STARTED|Overall Study||113
3343566|NCT03453515|4073773|FG001|STARTED|Overall Study||113
3343567|NCT03453515|4073772|FG000|COMPLETED|Overall Study||107
3343568|NCT03453515|4073773|FG001|COMPLETED|Overall Study||100
3343569|NCT03453515|4073772|FG000|NOT COMPLETED|Overall Study||6
3343570|NCT03453515|4073773|FG001|NOT COMPLETED|Overall Study||13
3343571|NCT03454048|4073783|FG000|STARTED|Overall Study||6
3343572|NCT03454048|4073784|FG001|STARTED|Overall Study||6
3343573|NCT03454048|4073785|FG002|STARTED|Overall Study||6
3343574|NCT03454048|4073786|FG003|STARTED|Overall Study||6
3343575|NCT03454048|4073783|FG000|COMPLETED|Overall Study||6
3343576|NCT03454048|4073784|FG001|COMPLETED|Overall Study||6
3343577|NCT03454048|4073785|FG002|COMPLETED|Overall Study||6
3343578|NCT03454048|4073786|FG003|COMPLETED|Overall Study||6
3343579|NCT03454048|4073783|FG000|NOT COMPLETED|Overall Study||0
3343580|NCT03454048|4073784|FG001|NOT COMPLETED|Overall Study||0
3343581|NCT03454048|4073785|FG002|NOT COMPLETED|Overall Study||0
3343582|NCT03454048|4073786|FG003|NOT COMPLETED|Overall Study||0
3343583|NCT03454412|4073798|FG000|STARTED|Baseline Assesment||44
3343584|NCT03454412|4073798|FG000|COMPLETED|Baseline Assesment||32
3343585|NCT03454412|4073798|FG000|NOT COMPLETED|Baseline Assesment||12
3343586|NCT03454412|4073798|FG000|STARTED|Treatment Course||32
3343587|NCT03454412|4073798|FG000|COMPLETED|Treatment Course||32
3343588|NCT03454412|4073798|FG000|NOT COMPLETED|Treatment Course||0
3343589|NCT03454412|4073798|FG000|STARTED|Final Assesment||32
3343590|NCT03454412|4073798|FG000|COMPLETED|Final Assesment||32
3343591|NCT03454412|4073798|FG000|NOT COMPLETED|Final Assesment||0
3343592|NCT03454581|4073805|FG000|STARTED|Overall Study||18
3343593|NCT03454581|4073806|FG001|STARTED|Overall Study||16
3343594|NCT03454581|4073807|FG002|STARTED|Overall Study||17
3343595|NCT03454581|4073805|FG000|COMPLETED|Overall Study||14
3343596|NCT03454581|4073806|FG001|COMPLETED|Overall Study||13
3343597|NCT03454581|4073807|FG002|COMPLETED|Overall Study||14
3343598|NCT03454581|4073805|FG000|NOT COMPLETED|Overall Study||4
3343599|NCT03454581|4073806|FG001|NOT COMPLETED|Overall Study||3
3343600|NCT03454581|4073807|FG002|NOT COMPLETED|Overall Study||3
3343601|NCT03455218|4073818|FG000|STARTED|Overall Study||18
3343602|NCT03455218|4073819|FG001|STARTED|Overall Study||22
3343603|NCT03455218|4073818|FG000|COMPLETED|Overall Study||18
3177432|NCT01970982|3905234|FG002|COMPLETED|Overall Study||38
3177433|NCT01970982|3905232|FG000|NOT COMPLETED|Overall Study||0
3343604|NCT03455218|4073819|FG001|COMPLETED|Overall Study||22
3343605|NCT03455218|4073818|FG000|NOT COMPLETED|Overall Study||0
3343606|NCT03455218|4073819|FG001|NOT COMPLETED|Overall Study||0
3343607|NCT03455491|4073828|FG000|STARTED|Overall Study||40
3343608|NCT03455491|4073829|FG001|STARTED|Overall Study||40
3343609|NCT03455491|4073830|FG002|STARTED|Overall Study||40
3343610|NCT03455491|4073828|FG000|COMPLETED|Overall Study||40
3343611|NCT03455491|4073829|FG001|COMPLETED|Overall Study||40
3343612|NCT03455491|4073830|FG002|COMPLETED|Overall Study||40
3343613|NCT03455491|4073828|FG000|NOT COMPLETED|Overall Study||0
3343614|NCT03455491|4073829|FG001|NOT COMPLETED|Overall Study||0
3343615|NCT03455491|4073830|FG002|NOT COMPLETED|Overall Study||0
3343616|NCT03455543|4073840|FG000|STARTED|Part A: Randomized Treatment (17 Weeks)||92
3343617|NCT03455543|4073841|FG001|STARTED|Part A: Randomized Treatment (17 Weeks)||90
3343618|NCT03455543|4073842|FG002|STARTED|Part A: Randomized Treatment (17 Weeks)||0
3343619|NCT03455543|4073840|FG000|COMPLETED|Part A: Randomized Treatment (17 Weeks)||81
3343620|NCT03455543|4073841|FG001|COMPLETED|Part A: Randomized Treatment (17 Weeks)||83
3343621|NCT03455543|4073842|FG002|COMPLETED|Part A: Randomized Treatment (17 Weeks)||0
3177434|NCT01970982|3905233|FG001|NOT COMPLETED|Overall Study||0
3177435|NCT01970982|3905234|FG002|NOT COMPLETED|Overall Study||2
3177436|NCT01970995|3905246|FG000|STARTED|Confinement Period (Population at Day 5)||78
3177437|NCT01970995|3905247|FG001|STARTED|Confinement Period (Population at Day 5)||42
3177438|NCT01970995|3905248|FG002|STARTED|Confinement Period (Population at Day 5)||40
3177439|NCT01970995|3905246|FG000|COMPLETED|Confinement Period (Population at Day 5)||77
3177440|NCT01970995|3905247|FG001|COMPLETED|Confinement Period (Population at Day 5)||41
3177441|NCT01970995|3905248|FG002|COMPLETED|Confinement Period (Population at Day 5)||39
3177442|NCT01970995|3905246|FG000|NOT COMPLETED|Confinement Period (Population at Day 5)||1
3177443|NCT01970995|3905247|FG001|NOT COMPLETED|Confinement Period (Population at Day 5)||1
3177444|NCT01970995|3905248|FG002|NOT COMPLETED|Confinement Period (Population at Day 5)||1
3177445|NCT01970995|3905246|FG000|STARTED|End of Study (Population at Day 90)||77
3177446|NCT01970995|3905247|FG001|STARTED|End of Study (Population at Day 90)||41
3177447|NCT01970995|3905248|FG002|STARTED|End of Study (Population at Day 90)||39
3177448|NCT01970995|3905246|FG000|COMPLETED|End of Study (Population at Day 90)||76
3177449|NCT01970995|3905247|FG001|COMPLETED|End of Study (Population at Day 90)||41
3177450|NCT01970995|3905248|FG002|COMPLETED|End of Study (Population at Day 90)||38
3177451|NCT01970995|3905246|FG000|NOT COMPLETED|End of Study (Population at Day 90)||1
3177452|NCT01970995|3905247|FG001|NOT COMPLETED|End of Study (Population at Day 90)||0
3177453|NCT01970995|3905248|FG002|NOT COMPLETED|End of Study (Population at Day 90)||1
3177454|NCT01971086|3905256|FG000|STARTED|Overall Study||300
3177455|NCT01971086|3905256|FG000|COMPLETED|Overall Study||300
3177456|NCT01971086|3905256|FG000|NOT COMPLETED|Overall Study||0
3177457|NCT01971203|3905263|FG000|STARTED|Overall Study||26
3177458|NCT01971203|3905264|FG001|STARTED|Overall Study||29
3177459|NCT01971203|3905263|FG000|COMPLETED|Overall Study||17
3177460|NCT01971203|3905264|FG001|COMPLETED|Overall Study||21
3177461|NCT01971203|3905263|FG000|NOT COMPLETED|Overall Study||9
3177462|NCT01971203|3905264|FG001|NOT COMPLETED|Overall Study||8
3177463|NCT01971255|3905272|FG000|STARTED|Overall Study||32
3177464|NCT01971255|3905273|FG001|STARTED|Overall Study||42
3177465|NCT01971255|3905272|FG000|COMPLETED|Overall Study||31
3177466|NCT01971255|3905273|FG001|COMPLETED|Overall Study||40
3343622|NCT03455543|4073840|FG000|NOT COMPLETED|Part A: Randomized Treatment (17 Weeks)||11
3343623|NCT03455543|4073841|FG001|NOT COMPLETED|Part A: Randomized Treatment (17 Weeks)||7
3343624|NCT03455543|4073842|FG002|NOT COMPLETED|Part A: Randomized Treatment (17 Weeks)||0
3343625|NCT03455543|4073840|FG000|STARTED|Part B: Open-label Extension (24 Weeks)||0
3343626|NCT03455543|4073841|FG001|STARTED|Part B: Open-label Extension (24 Weeks)||0
3343627|NCT03455543|4073842|FG002|STARTED|Part B: Open-label Extension (24 Weeks)||152
3343628|NCT03455543|4073840|FG000|COMPLETED|Part B: Open-label Extension (24 Weeks)||0
3343629|NCT03455543|4073841|FG001|COMPLETED|Part B: Open-label Extension (24 Weeks)||0
3343630|NCT03455543|4073842|FG002|COMPLETED|Part B: Open-label Extension (24 Weeks)||115
3343631|NCT03455543|4073840|FG000|NOT COMPLETED|Part B: Open-label Extension (24 Weeks)||0
3343632|NCT03455543|4073841|FG001|NOT COMPLETED|Part B: Open-label Extension (24 Weeks)||0
3343633|NCT03455543|4073842|FG002|NOT COMPLETED|Part B: Open-label Extension (24 Weeks)||37
3343634|NCT03456245|4073850|FG000|STARTED|Overall Study||205
3343635|NCT03456245|4073850|FG000|COMPLETED|Overall Study||190
3343636|NCT03456245|4073850|FG000|NOT COMPLETED|Overall Study||15
3343637|NCT03456427|4073854|FG000|STARTED|Overall Study||36
3343638|NCT03456427|4073854|FG000|COMPLETED|Overall Study||33
3343639|NCT03456427|4073854|FG000|NOT COMPLETED|Overall Study||3
3343640|NCT03456700|4073859|FG000|STARTED|Overall Study||22
3343641|NCT03456700|4073859|FG000|COMPLETED|Overall Study||21
3343642|NCT03456700|4073859|FG000|NOT COMPLETED|Overall Study||1
3343643|NCT03456856|4073863|FG000|STARTED|Overall Study||30
3343644|NCT03456856|4073863|FG000|COMPLETED|Overall Study||27
3343645|NCT03456856|4073863|FG000|NOT COMPLETED|Overall Study||3
3343646|NCT03456960|4073873|FG000|STARTED|Period 1 (1 Day)||12
3343647|NCT03456960|4073874|FG001|STARTED|Period 1 (1 Day)||12
3343648|NCT03456960|4073875|FG002|STARTED|Period 1 (1 Day)||120
3343649|NCT03456960|4073876|FG003|STARTED|Period 1 (1 Day)||120
3343650|NCT03456960|4073877|FG004|STARTED|Period 1 (1 Day)||6
3343651|NCT03456960|4073878|FG005|STARTED|Period 1 (1 Day)||6
3177467|NCT01971255|3905272|FG000|NOT COMPLETED|Overall Study||1
3177468|NCT01971255|3905273|FG001|NOT COMPLETED|Overall Study||2
3343652|NCT03456960|4073873|FG000|COMPLETED|Period 1 (1 Day)||12
3343653|NCT03456960|4073874|FG001|COMPLETED|Period 1 (1 Day)||12
3343654|NCT03456960|4073875|FG002|COMPLETED|Period 1 (1 Day)||120
3343655|NCT03456960|4073876|FG003|COMPLETED|Period 1 (1 Day)||120
3343656|NCT03456960|4073877|FG004|COMPLETED|Period 1 (1 Day)||6
3343657|NCT03456960|4073878|FG005|COMPLETED|Period 1 (1 Day)||6
3343658|NCT03456960|4073873|FG000|NOT COMPLETED|Period 1 (1 Day)||0
3343659|NCT03456960|4073874|FG001|NOT COMPLETED|Period 1 (1 Day)||0
3343660|NCT03456960|4073875|FG002|NOT COMPLETED|Period 1 (1 Day)||0
3343661|NCT03456960|4073876|FG003|NOT COMPLETED|Period 1 (1 Day)||0
3343662|NCT03456960|4073877|FG004|NOT COMPLETED|Period 1 (1 Day)||0
3343663|NCT03456960|4073878|FG005|NOT COMPLETED|Period 1 (1 Day)||0
3343664|NCT03456960|4073873|FG000|STARTED|Washout Period (at Least 14 Days)||12
3343665|NCT03456960|4073874|FG001|STARTED|Washout Period (at Least 14 Days)||12
3343666|NCT03456960|4073875|FG002|STARTED|Washout Period (at Least 14 Days)||120
3343667|NCT03456960|4073876|FG003|STARTED|Washout Period (at Least 14 Days)||120
3343668|NCT03456960|4073877|FG004|STARTED|Washout Period (at Least 14 Days)||6
3343669|NCT03456960|4073878|FG005|STARTED|Washout Period (at Least 14 Days)||6
3343670|NCT03456960|4073873|FG000|COMPLETED|Washout Period (at Least 14 Days)||12
3343671|NCT03456960|4073874|FG001|COMPLETED|Washout Period (at Least 14 Days)||12
3343672|NCT03456960|4073875|FG002|COMPLETED|Washout Period (at Least 14 Days)||119
3343673|NCT03456960|4073876|FG003|COMPLETED|Washout Period (at Least 14 Days)||118
3343674|NCT03456960|4073877|FG004|COMPLETED|Washout Period (at Least 14 Days)||6
3343675|NCT03456960|4073878|FG005|COMPLETED|Washout Period (at Least 14 Days)||6
3343676|NCT03456960|4073873|FG000|NOT COMPLETED|Washout Period (at Least 14 Days)||0
3343677|NCT03456960|4073874|FG001|NOT COMPLETED|Washout Period (at Least 14 Days)||0
3343678|NCT03456960|4073875|FG002|NOT COMPLETED|Washout Period (at Least 14 Days)||1
3343679|NCT03456960|4073876|FG003|NOT COMPLETED|Washout Period (at Least 14 Days)||2
3343680|NCT03456960|4073877|FG004|NOT COMPLETED|Washout Period (at Least 14 Days)||0
3343681|NCT03456960|4073878|FG005|NOT COMPLETED|Washout Period (at Least 14 Days)||0
3343682|NCT03456960|4073873|FG000|STARTED|Period 2 (1 Day)||12
3343683|NCT03456960|4073874|FG001|STARTED|Period 2 (1 Day)||12
3343684|NCT03456960|4073875|FG002|STARTED|Period 2 (1 Day)||119
3343685|NCT03456960|4073876|FG003|STARTED|Period 2 (1 Day)||118
3343686|NCT03456960|4073877|FG004|STARTED|Period 2 (1 Day)||6
3343687|NCT03456960|4073878|FG005|STARTED|Period 2 (1 Day)||6
3343688|NCT03456960|4073873|FG000|COMPLETED|Period 2 (1 Day)||11
3343689|NCT03456960|4073874|FG001|COMPLETED|Period 2 (1 Day)||12
3343690|NCT03456960|4073875|FG002|COMPLETED|Period 2 (1 Day)||119
3343691|NCT03456960|4073876|FG003|COMPLETED|Period 2 (1 Day)||117
3343692|NCT03456960|4073877|FG004|COMPLETED|Period 2 (1 Day)||6
3343693|NCT03456960|4073878|FG005|COMPLETED|Period 2 (1 Day)||6
3343694|NCT03456960|4073873|FG000|NOT COMPLETED|Period 2 (1 Day)||1
3343695|NCT03456960|4073874|FG001|NOT COMPLETED|Period 2 (1 Day)||0
3343696|NCT03456960|4073875|FG002|NOT COMPLETED|Period 2 (1 Day)||0
3343697|NCT03456960|4073876|FG003|NOT COMPLETED|Period 2 (1 Day)||1
3343698|NCT03456960|4073877|FG004|NOT COMPLETED|Period 2 (1 Day)||0
3343699|NCT03456960|4073878|FG005|NOT COMPLETED|Period 2 (1 Day)||0
3343700|NCT03457103|4073896|FG000|STARTED|Overall Study||22
3343701|NCT03457103|4073897|FG001|STARTED|Overall Study||9
3343702|NCT03457103|4073896|FG000|COMPLETED|Overall Study||14
3343703|NCT03457103|4073897|FG001|COMPLETED|Overall Study||3
3343704|NCT03457103|4073896|FG000|NOT COMPLETED|Overall Study||8
3343705|NCT03457103|4073897|FG001|NOT COMPLETED|Overall Study||6
3343706|NCT03457116|4073905|FG000|STARTED|Overall Study||41
3343707|NCT03457116|4073906|FG001|STARTED|Overall Study||29
3343708|NCT03457116|4073905|FG000|COMPLETED|Overall Study||41
3343709|NCT03457116|4073906|FG001|COMPLETED|Overall Study||29
3343710|NCT03457116|4073905|FG000|NOT COMPLETED|Overall Study||0
3343711|NCT03457116|4073906|FG001|NOT COMPLETED|Overall Study||0
3343712|NCT03457636|4073912|FG000|STARTED|Overall Study||22
3343713|NCT03457636|4073912|FG000|COMPLETED|Overall Study||20
3343714|NCT03457636|4073912|FG000|NOT COMPLETED|Overall Study||2
3343715|NCT03457727|4073920|FG000|STARTED|Part 1, Period 1 (1 Day)||8
3343716|NCT03457727|4073921|FG001|STARTED|Part 1, Period 1 (1 Day)||8
3343717|NCT03457727|4073922|FG002|STARTED|Part 1, Period 1 (1 Day)||0
3343718|NCT03457727|4073923|FG003|STARTED|Part 1, Period 1 (1 Day)||0
3343719|NCT03457727|4073920|FG000|COMPLETED|Part 1, Period 1 (1 Day)||8
3343720|NCT03457727|4073921|FG001|COMPLETED|Part 1, Period 1 (1 Day)||8
3177469|NCT01971346|3905279|FG000|STARTED|Overall Study|Four subjects signed the informed consent and terminated the study before beginning.|50
3177470|NCT01971346|3905279|FG000|COMPLETED|Overall Study||42
3177471|NCT01971346|3905279|FG000|NOT COMPLETED|Overall Study||8
3177472|NCT01971385|3905294|FG000|STARTED|Overall Study||17
3177473|NCT01971385|3905295|FG001|STARTED|Overall Study||18
3177474|NCT01971385|3905296|FG002|STARTED|Overall Study||19
3177475|NCT01971385|3905294|FG000|COMPLETED|Overall Study||14
3177476|NCT01971385|3905295|FG001|COMPLETED|Overall Study||13
3177477|NCT01971385|3905296|FG002|COMPLETED|Overall Study||15
3177478|NCT01971385|3905294|FG000|NOT COMPLETED|Overall Study||3
3177479|NCT01971385|3905295|FG001|NOT COMPLETED|Overall Study||5
3177480|NCT01971385|3905296|FG002|NOT COMPLETED|Overall Study||4
3177481|NCT01971463|3905303|FG000|STARTED|Overall Study||81
3177482|NCT01971463|3905303|FG000|COMPLETED|Overall Study||81
3343721|NCT03457727|4073922|FG002|COMPLETED|Part 1, Period 1 (1 Day)||0
3343722|NCT03457727|4073923|FG003|COMPLETED|Part 1, Period 1 (1 Day)||0
3343723|NCT03457727|4073920|FG000|NOT COMPLETED|Part 1, Period 1 (1 Day)||0
3177483|NCT01971463|3905303|FG000|NOT COMPLETED|Overall Study||0
3177484|NCT01971476|3905310|FG000|STARTED|Cohort 1: 2 to <12 Years||3
3177485|NCT01971476|3905311|FG001|STARTED|Cohort 1: 2 to <12 Years||3
3177486|NCT01971476|3905312|FG002|STARTED|Cohort 1: 2 to <12 Years||6
3177487|NCT01971476|3905310|FG000|COMPLETED|Cohort 1: 2 to <12 Years||0
3177488|NCT01971476|3905311|FG001|COMPLETED|Cohort 1: 2 to <12 Years||0
3177489|NCT01971476|3905312|FG002|COMPLETED|Cohort 1: 2 to <12 Years||0
3177490|NCT01971476|3905310|FG000|NOT COMPLETED|Cohort 1: 2 to <12 Years||3
3177491|NCT01971476|3905311|FG001|NOT COMPLETED|Cohort 1: 2 to <12 Years||3
3177492|NCT01971476|3905312|FG002|NOT COMPLETED|Cohort 1: 2 to <12 Years||6
3177493|NCT01971476|3905310|FG000|STARTED|Cohort 2: 12 to <18 Years||6
3343724|NCT03457727|4073921|FG001|NOT COMPLETED|Part 1, Period 1 (1 Day)||0
3343725|NCT03457727|4073922|FG002|NOT COMPLETED|Part 1, Period 1 (1 Day)||0
3343726|NCT03457727|4073923|FG003|NOT COMPLETED|Part 1, Period 1 (1 Day)||0
3343727|NCT03457727|4073920|FG000|STARTED|Part 1, Washout Period 1 (5 Days)||8
3343728|NCT03457727|4073921|FG001|STARTED|Part 1, Washout Period 1 (5 Days)||8
3343729|NCT03457727|4073922|FG002|STARTED|Part 1, Washout Period 1 (5 Days)||0
3343730|NCT03457727|4073923|FG003|STARTED|Part 1, Washout Period 1 (5 Days)||0
3343731|NCT03457727|4073920|FG000|COMPLETED|Part 1, Washout Period 1 (5 Days)||8
3343732|NCT03457727|4073921|FG001|COMPLETED|Part 1, Washout Period 1 (5 Days)||8
3343733|NCT03457727|4073922|FG002|COMPLETED|Part 1, Washout Period 1 (5 Days)||0
3343734|NCT03457727|4073923|FG003|COMPLETED|Part 1, Washout Period 1 (5 Days)||0
3343735|NCT03457727|4073920|FG000|NOT COMPLETED|Part 1, Washout Period 1 (5 Days)||0
3343736|NCT03457727|4073921|FG001|NOT COMPLETED|Part 1, Washout Period 1 (5 Days)||0
3343737|NCT03457727|4073922|FG002|NOT COMPLETED|Part 1, Washout Period 1 (5 Days)||0
3343738|NCT03457727|4073923|FG003|NOT COMPLETED|Part 1, Washout Period 1 (5 Days)||0
3343739|NCT03457727|4073920|FG000|STARTED|Part 1, Period 2 (1 Day)||8
3343740|NCT03457727|4073921|FG001|STARTED|Part 1, Period 2 (1 Day)||8
3343741|NCT03457727|4073922|FG002|STARTED|Part 1, Period 2 (1 Day)||0
3343742|NCT03457727|4073923|FG003|STARTED|Part 1, Period 2 (1 Day)||0
3343743|NCT03457727|4073920|FG000|COMPLETED|Part 1, Period 2 (1 Day)||8
3343744|NCT03457727|4073921|FG001|COMPLETED|Part 1, Period 2 (1 Day)||8
3343745|NCT03457727|4073922|FG002|COMPLETED|Part 1, Period 2 (1 Day)||0
3343746|NCT03457727|4073923|FG003|COMPLETED|Part 1, Period 2 (1 Day)||0
3343747|NCT03457727|4073920|FG000|NOT COMPLETED|Part 1, Period 2 (1 Day)||0
3343748|NCT03457727|4073921|FG001|NOT COMPLETED|Part 1, Period 2 (1 Day)||0
3343749|NCT03457727|4073922|FG002|NOT COMPLETED|Part 1, Period 2 (1 Day)||0
3343750|NCT03457727|4073923|FG003|NOT COMPLETED|Part 1, Period 2 (1 Day)||0
3343751|NCT03457727|4073920|FG000|STARTED|Part 1, Washout Period 2 (5 Days)||8
3343752|NCT03457727|4073921|FG001|STARTED|Part 1, Washout Period 2 (5 Days)||8
3343753|NCT03457727|4073922|FG002|STARTED|Part 1, Washout Period 2 (5 Days)||0
3343754|NCT03457727|4073923|FG003|STARTED|Part 1, Washout Period 2 (5 Days)||0
3343755|NCT03457727|4073920|FG000|COMPLETED|Part 1, Washout Period 2 (5 Days)||8
3343756|NCT03457727|4073921|FG001|COMPLETED|Part 1, Washout Period 2 (5 Days)||8
3343757|NCT03457727|4073922|FG002|COMPLETED|Part 1, Washout Period 2 (5 Days)||0
3177494|NCT01971476|3905311|FG001|STARTED|Cohort 2: 12 to <18 Years||4
3177495|NCT01971476|3905312|FG002|STARTED|Cohort 2: 12 to <18 Years||0
3177496|NCT01971476|3905310|FG000|COMPLETED|Cohort 2: 12 to <18 Years||0
3343758|NCT03457727|4073923|FG003|COMPLETED|Part 1, Washout Period 2 (5 Days)||0
3343759|NCT03457727|4073920|FG000|NOT COMPLETED|Part 1, Washout Period 2 (5 Days)||0
3343760|NCT03457727|4073921|FG001|NOT COMPLETED|Part 1, Washout Period 2 (5 Days)||0
3343761|NCT03457727|4073922|FG002|NOT COMPLETED|Part 1, Washout Period 2 (5 Days)||0
3343762|NCT03457727|4073923|FG003|NOT COMPLETED|Part 1, Washout Period 2 (5 Days)||0
3343763|NCT03457727|4073920|FG000|STARTED|Part 1, Period 3 (1 Day)||8
3343764|NCT03457727|4073921|FG001|STARTED|Part 1, Period 3 (1 Day)||8
3343765|NCT03457727|4073922|FG002|STARTED|Part 1, Period 3 (1 Day)||0
3343766|NCT03457727|4073923|FG003|STARTED|Part 1, Period 3 (1 Day)||0
3343767|NCT03457727|4073920|FG000|COMPLETED|Part 1, Period 3 (1 Day)||8
3343768|NCT03457727|4073921|FG001|COMPLETED|Part 1, Period 3 (1 Day)||8
3343769|NCT03457727|4073922|FG002|COMPLETED|Part 1, Period 3 (1 Day)||0
3343770|NCT03457727|4073923|FG003|COMPLETED|Part 1, Period 3 (1 Day)||0
3343771|NCT03457727|4073920|FG000|NOT COMPLETED|Part 1, Period 3 (1 Day)||0
3343772|NCT03457727|4073921|FG001|NOT COMPLETED|Part 1, Period 3 (1 Day)||0
3343773|NCT03457727|4073922|FG002|NOT COMPLETED|Part 1, Period 3 (1 Day)||0
3343774|NCT03457727|4073923|FG003|NOT COMPLETED|Part 1, Period 3 (1 Day)||0
3343775|NCT03457727|4073920|FG000|STARTED|Part 1, Washout Period 3 (5 Days)||8
3343776|NCT03457727|4073921|FG001|STARTED|Part 1, Washout Period 3 (5 Days)||8
3343777|NCT03457727|4073922|FG002|STARTED|Part 1, Washout Period 3 (5 Days)||0
3343778|NCT03457727|4073923|FG003|STARTED|Part 1, Washout Period 3 (5 Days)||0
3343779|NCT03457727|4073920|FG000|COMPLETED|Part 1, Washout Period 3 (5 Days)||8
3343780|NCT03457727|4073921|FG001|COMPLETED|Part 1, Washout Period 3 (5 Days)||8
3343781|NCT03457727|4073922|FG002|COMPLETED|Part 1, Washout Period 3 (5 Days)||0
3343782|NCT03457727|4073923|FG003|COMPLETED|Part 1, Washout Period 3 (5 Days)||0
3343783|NCT03457727|4073920|FG000|NOT COMPLETED|Part 1, Washout Period 3 (5 Days)||0
3343784|NCT03457727|4073921|FG001|NOT COMPLETED|Part 1, Washout Period 3 (5 Days)||0
3343785|NCT03457727|4073922|FG002|NOT COMPLETED|Part 1, Washout Period 3 (5 Days)||0
3343786|NCT03457727|4073923|FG003|NOT COMPLETED|Part 1, Washout Period 3 (5 Days)||0
3343787|NCT03457727|4073920|FG000|STARTED|Part 1, Period 4 (1 Day)||8
3343788|NCT03457727|4073921|FG001|STARTED|Part 1, Period 4 (1 Day)||8
3343789|NCT03457727|4073922|FG002|STARTED|Part 1, Period 4 (1 Day)||0
3343790|NCT03457727|4073923|FG003|STARTED|Part 1, Period 4 (1 Day)||0
3343791|NCT03457727|4073920|FG000|COMPLETED|Part 1, Period 4 (1 Day)||8
3343792|NCT03457727|4073921|FG001|COMPLETED|Part 1, Period 4 (1 Day)||8
3343793|NCT03457727|4073922|FG002|COMPLETED|Part 1, Period 4 (1 Day)||0
3343794|NCT03457727|4073923|FG003|COMPLETED|Part 1, Period 4 (1 Day)||0
3343795|NCT03457727|4073920|FG000|NOT COMPLETED|Part 1, Period 4 (1 Day)||0
3343796|NCT03457727|4073921|FG001|NOT COMPLETED|Part 1, Period 4 (1 Day)||0
3343797|NCT03457727|4073922|FG002|NOT COMPLETED|Part 1, Period 4 (1 Day)||0
3343798|NCT03457727|4073923|FG003|NOT COMPLETED|Part 1, Period 4 (1 Day)||0
3343799|NCT03457727|4073920|FG000|STARTED|Part 2, Period 1 (1 Day)||0
3343800|NCT03457727|4073921|FG001|STARTED|Part 2, Period 1 (1 Day)||0
3343801|NCT03457727|4073922|FG002|STARTED|Part 2, Period 1 (1 Day)||12
3343802|NCT03457727|4073923|FG003|STARTED|Part 2, Period 1 (1 Day)||12
3343803|NCT03457727|4073920|FG000|COMPLETED|Part 2, Period 1 (1 Day)||0
3343804|NCT03457727|4073921|FG001|COMPLETED|Part 2, Period 1 (1 Day)||0
3343805|NCT03457727|4073922|FG002|COMPLETED|Part 2, Period 1 (1 Day)||12
3343806|NCT03457727|4073923|FG003|COMPLETED|Part 2, Period 1 (1 Day)||12
3343807|NCT03457727|4073920|FG000|NOT COMPLETED|Part 2, Period 1 (1 Day)||0
3343808|NCT03457727|4073921|FG001|NOT COMPLETED|Part 2, Period 1 (1 Day)||0
3343809|NCT03457727|4073922|FG002|NOT COMPLETED|Part 2, Period 1 (1 Day)||0
3343810|NCT03457727|4073923|FG003|NOT COMPLETED|Part 2, Period 1 (1 Day)||0
3343811|NCT03457727|4073920|FG000|STARTED|Part 2, Washout Period 1 (5 Days)||0
3343812|NCT03457727|4073921|FG001|STARTED|Part 2, Washout Period 1 (5 Days)||0
3343813|NCT03457727|4073922|FG002|STARTED|Part 2, Washout Period 1 (5 Days)||12
3343814|NCT03457727|4073923|FG003|STARTED|Part 2, Washout Period 1 (5 Days)||12
3343815|NCT03457727|4073920|FG000|COMPLETED|Part 2, Washout Period 1 (5 Days)||0
3343816|NCT03457727|4073921|FG001|COMPLETED|Part 2, Washout Period 1 (5 Days)||0
3343817|NCT03457727|4073922|FG002|COMPLETED|Part 2, Washout Period 1 (5 Days)||12
3343818|NCT03457727|4073923|FG003|COMPLETED|Part 2, Washout Period 1 (5 Days)||11
3343819|NCT03457727|4073920|FG000|NOT COMPLETED|Part 2, Washout Period 1 (5 Days)||0
3343820|NCT03457727|4073921|FG001|NOT COMPLETED|Part 2, Washout Period 1 (5 Days)||0
3343821|NCT03457727|4073922|FG002|NOT COMPLETED|Part 2, Washout Period 1 (5 Days)||0
3343822|NCT03457727|4073923|FG003|NOT COMPLETED|Part 2, Washout Period 1 (5 Days)||1
3343823|NCT03457727|4073920|FG000|STARTED|Part 2, Period 2 (1 Day)||0
3343824|NCT03457727|4073921|FG001|STARTED|Part 2, Period 2 (1 Day)||0
3343825|NCT03457727|4073922|FG002|STARTED|Part 2, Period 2 (1 Day)||12
3343826|NCT03457727|4073923|FG003|STARTED|Part 2, Period 2 (1 Day)||11
3343827|NCT03457727|4073920|FG000|COMPLETED|Part 2, Period 2 (1 Day)||0
3343828|NCT03457727|4073921|FG001|COMPLETED|Part 2, Period 2 (1 Day)||0
3343829|NCT03457727|4073922|FG002|COMPLETED|Part 2, Period 2 (1 Day)||12
3343830|NCT03457727|4073923|FG003|COMPLETED|Part 2, Period 2 (1 Day)||11
3343831|NCT03457727|4073920|FG000|NOT COMPLETED|Part 2, Period 2 (1 Day)||0
3343832|NCT03457727|4073921|FG001|NOT COMPLETED|Part 2, Period 2 (1 Day)||0
3343833|NCT03457727|4073922|FG002|NOT COMPLETED|Part 2, Period 2 (1 Day)||0
3343834|NCT03457727|4073923|FG003|NOT COMPLETED|Part 2, Period 2 (1 Day)||0
3343835|NCT03457727|4073920|FG000|STARTED|Part 2, Washout Period 2 (5 Days)||0
3343836|NCT03457727|4073921|FG001|STARTED|Part 2, Washout Period 2 (5 Days)||0
3343837|NCT03457727|4073922|FG002|STARTED|Part 2, Washout Period 2 (5 Days)||12
3343838|NCT03457727|4073923|FG003|STARTED|Part 2, Washout Period 2 (5 Days)||11
3343839|NCT03457727|4073920|FG000|COMPLETED|Part 2, Washout Period 2 (5 Days)||0
3343840|NCT03457727|4073921|FG001|COMPLETED|Part 2, Washout Period 2 (5 Days)||0
3343841|NCT03457727|4073922|FG002|COMPLETED|Part 2, Washout Period 2 (5 Days)||12
3343842|NCT03457727|4073923|FG003|COMPLETED|Part 2, Washout Period 2 (5 Days)||11
3343843|NCT03457727|4073920|FG000|NOT COMPLETED|Part 2, Washout Period 2 (5 Days)||0
3343844|NCT03457727|4073921|FG001|NOT COMPLETED|Part 2, Washout Period 2 (5 Days)||0
3343845|NCT03457727|4073922|FG002|NOT COMPLETED|Part 2, Washout Period 2 (5 Days)||0
3343846|NCT03457727|4073923|FG003|NOT COMPLETED|Part 2, Washout Period 2 (5 Days)||0
3343847|NCT03457727|4073920|FG000|STARTED|Part 2, Period 3 (1 Day)||0
3343848|NCT03457727|4073921|FG001|STARTED|Part 2, Period 3 (1 Day)||0
3343849|NCT03457727|4073922|FG002|STARTED|Part 2, Period 3 (1 Day)||12
3343850|NCT03457727|4073923|FG003|STARTED|Part 2, Period 3 (1 Day)||11
3343851|NCT03457727|4073920|FG000|COMPLETED|Part 2, Period 3 (1 Day)||0
3343852|NCT03457727|4073921|FG001|COMPLETED|Part 2, Period 3 (1 Day)||0
3343853|NCT03457727|4073922|FG002|COMPLETED|Part 2, Period 3 (1 Day)||12
3343854|NCT03457727|4073923|FG003|COMPLETED|Part 2, Period 3 (1 Day)||11
3343855|NCT03457727|4073920|FG000|NOT COMPLETED|Part 2, Period 3 (1 Day)||0
3343856|NCT03457727|4073921|FG001|NOT COMPLETED|Part 2, Period 3 (1 Day)||0
3343857|NCT03457727|4073922|FG002|NOT COMPLETED|Part 2, Period 3 (1 Day)||0
3343858|NCT03457727|4073923|FG003|NOT COMPLETED|Part 2, Period 3 (1 Day)||0
3343859|NCT03457727|4073920|FG000|STARTED|Part 2, Washout Period 3 (5 Days)||0
3343860|NCT03457727|4073921|FG001|STARTED|Part 2, Washout Period 3 (5 Days)||0
3343861|NCT03457727|4073922|FG002|STARTED|Part 2, Washout Period 3 (5 Days)||12
3343862|NCT03457727|4073923|FG003|STARTED|Part 2, Washout Period 3 (5 Days)||11
3343863|NCT03457727|4073920|FG000|COMPLETED|Part 2, Washout Period 3 (5 Days)||0
3343864|NCT03457727|4073921|FG001|COMPLETED|Part 2, Washout Period 3 (5 Days)||0
3343865|NCT03457727|4073922|FG002|COMPLETED|Part 2, Washout Period 3 (5 Days)||12
3343866|NCT03457727|4073923|FG003|COMPLETED|Part 2, Washout Period 3 (5 Days)||11
3343867|NCT03457727|4073920|FG000|NOT COMPLETED|Part 2, Washout Period 3 (5 Days)||0
3343868|NCT03457727|4073921|FG001|NOT COMPLETED|Part 2, Washout Period 3 (5 Days)||0
3343869|NCT03457727|4073922|FG002|NOT COMPLETED|Part 2, Washout Period 3 (5 Days)||0
3343870|NCT03457727|4073923|FG003|NOT COMPLETED|Part 2, Washout Period 3 (5 Days)||0
3343871|NCT03457727|4073920|FG000|STARTED|Part 2, Period 4 (1 Day)||0
3343872|NCT03457727|4073921|FG001|STARTED|Part 2, Period 4 (1 Day)||0
3343873|NCT03457727|4073922|FG002|STARTED|Part 2, Period 4 (1 Day)||12
3343874|NCT03457727|4073923|FG003|STARTED|Part 2, Period 4 (1 Day)||0
3343875|NCT03457727|4073920|FG000|COMPLETED|Part 2, Period 4 (1 Day)||0
3343876|NCT03457727|4073921|FG001|COMPLETED|Part 2, Period 4 (1 Day)||0
3343877|NCT03457727|4073922|FG002|COMPLETED|Part 2, Period 4 (1 Day)||12
3343878|NCT03457727|4073923|FG003|COMPLETED|Part 2, Period 4 (1 Day)||0
3343879|NCT03457727|4073920|FG000|NOT COMPLETED|Part 2, Period 4 (1 Day)||0
3343880|NCT03457727|4073921|FG001|NOT COMPLETED|Part 2, Period 4 (1 Day)||0
3343881|NCT03457727|4073922|FG002|NOT COMPLETED|Part 2, Period 4 (1 Day)||0
3343882|NCT03457727|4073923|FG003|NOT COMPLETED|Part 2, Period 4 (1 Day)||0
3343883|NCT03457909|4073955|FG000|STARTED|Overall Study||25
3343884|NCT03457909|4073955|FG000|COMPLETED|Overall Study||25
3343885|NCT03457909|4073955|FG000|NOT COMPLETED|Overall Study||0
3343886|NCT03458702|4073959|FG000|STARTED|Study Condition A (Yoga or Rest)||28
3343887|NCT03458702|4073960|FG001|STARTED|Study Condition A (Yoga or Rest)||28
3343888|NCT03458702|4073959|FG000|COMPLETED|Study Condition A (Yoga or Rest)||24
3343889|NCT03458702|4073960|FG001|COMPLETED|Study Condition A (Yoga or Rest)||22
3343890|NCT03458702|4073959|FG000|NOT COMPLETED|Study Condition A (Yoga or Rest)||4
3343891|NCT03458702|4073960|FG001|NOT COMPLETED|Study Condition A (Yoga or Rest)||6
3343892|NCT03458702|4073959|FG000|STARTED|Study Condition B (Yoga or Rest)||24
3343893|NCT03458702|4073960|FG001|STARTED|Study Condition B (Yoga or Rest)||22
3343894|NCT03458702|4073959|FG000|COMPLETED|Study Condition B (Yoga or Rest)||20
3343895|NCT03458702|4073960|FG001|COMPLETED|Study Condition B (Yoga or Rest)||20
3343896|NCT03458702|4073959|FG000|NOT COMPLETED|Study Condition B (Yoga or Rest)||4
3343897|NCT03458702|4073960|FG001|NOT COMPLETED|Study Condition B (Yoga or Rest)||2
3343898|NCT03458702|4073959|FG000|STARTED|Picture Rating/Body Composition||20
3343899|NCT03458702|4073960|FG001|STARTED|Picture Rating/Body Composition||20
3343900|NCT03458702|4073959|FG000|COMPLETED|Picture Rating/Body Composition||20
3343901|NCT03458702|4073960|FG001|COMPLETED|Picture Rating/Body Composition||20
3343902|NCT03458702|4073959|FG000|NOT COMPLETED|Picture Rating/Body Composition||0
3343903|NCT03458702|4073960|FG001|NOT COMPLETED|Picture Rating/Body Composition||0
3343904|NCT03458871|4073966|FG000|STARTED|Overall Study||16
3343905|NCT03458871|4073966|FG000|COMPLETED|Overall Study||16
3343906|NCT03458871|4073966|FG000|NOT COMPLETED|Overall Study||0
3343907|NCT03459040|4073970|FG000|STARTED|Overall Study||30
3343908|NCT03459040|4073970|FG000|COMPLETED|Overall Study||21
3343909|NCT03459040|4073970|FG000|NOT COMPLETED|Overall Study||9
3343910|NCT03459131|4073975|FG000|STARTED|Period 1, First 7 Days of Wear||7
3343911|NCT03459131|4073976|FG001|STARTED|Period 1, First 7 Days of Wear||8
3343912|NCT03459131|4073975|FG000|COMPLETED|Period 1, First 7 Days of Wear||7
3343913|NCT03459131|4073976|FG001|COMPLETED|Period 1, First 7 Days of Wear||8
3343914|NCT03459131|4073975|FG000|NOT COMPLETED|Period 1, First 7 Days of Wear||0
3343915|NCT03459131|4073976|FG001|NOT COMPLETED|Period 1, First 7 Days of Wear||0
3343916|NCT03459131|4073975|FG000|STARTED|Period 2, Second 7 Days of Wear||7
3343917|NCT03459131|4073976|FG001|STARTED|Period 2, Second 7 Days of Wear||8
3343918|NCT03459131|4073975|FG000|COMPLETED|Period 2, Second 7 Days of Wear||7
3343919|NCT03459131|4073976|FG001|COMPLETED|Period 2, Second 7 Days of Wear||8
3343920|NCT03459131|4073975|FG000|NOT COMPLETED|Period 2, Second 7 Days of Wear||0
3343921|NCT03459131|4073976|FG001|NOT COMPLETED|Period 2, Second 7 Days of Wear||0
3343922|NCT03459196|4073982|FG000|STARTED|Overall Study||54
3343923|NCT03459196|4073982|FG000|COMPLETED|Overall Study||52
3343924|NCT03459196|4073982|FG000|NOT COMPLETED|Overall Study||2
3343925|NCT03459612|4073990|FG000|STARTED|Period 1||17
3343926|NCT03459612|4073991|FG001|STARTED|Period 1||17
3343927|NCT03459612|4073992|FG002|STARTED|Period 1||17
3343928|NCT03459612|4073993|FG003|STARTED|Period 1||17
3343929|NCT03459612|4073990|FG000|Received at Least 1 Dose of Study Drug|Period 1||17
3177497|NCT01971476|3905311|FG001|COMPLETED|Cohort 2: 12 to <18 Years||0
3177498|NCT01971476|3905312|FG002|COMPLETED|Cohort 2: 12 to <18 Years||0
3177499|NCT01971476|3905310|FG000|NOT COMPLETED|Cohort 2: 12 to <18 Years||6
3177500|NCT01971476|3905311|FG001|NOT COMPLETED|Cohort 2: 12 to <18 Years||4
3177501|NCT01971476|3905312|FG002|NOT COMPLETED|Cohort 2: 12 to <18 Years||0
3177502|NCT01971554|3905333|FG000|STARTED|Overall Study||9
3177503|NCT01971554|3905334|FG001|STARTED|Overall Study||18
3177504|NCT01971554|3905335|FG002|STARTED|Overall Study||18
3177505|NCT01971554|3905336|FG003|STARTED|Overall Study||18
3177506|NCT01971554|3905333|FG000|COMPLETED|Overall Study||8
3343930|NCT03459612|4073991|FG001|Received at Least 1 Dose of Study Drug|Period 1||17
3343931|NCT03459612|4073992|FG002|Received at Least 1 Dose of Study Drug|Period 1||17
3343932|NCT03459612|4073993|FG003|Received at Least 1 Dose of Study Drug|Period 1||17
3343933|NCT03459612|4073990|FG000|COMPLETED|Period 1||17
3343934|NCT03459612|4073991|FG001|COMPLETED|Period 1||17
3343935|NCT03459612|4073992|FG002|COMPLETED|Period 1||17
3343936|NCT03459612|4073993|FG003|COMPLETED|Period 1||17
3343937|NCT03459612|4073990|FG000|NOT COMPLETED|Period 1||0
3343938|NCT03459612|4073991|FG001|NOT COMPLETED|Period 1||0
3343939|NCT03459612|4073992|FG002|NOT COMPLETED|Period 1||0
3343940|NCT03459612|4073993|FG003|NOT COMPLETED|Period 1||0
3343941|NCT03459612|4073990|FG000|STARTED|Period 2||17
3343942|NCT03459612|4073991|FG001|STARTED|Period 2||17
3343943|NCT03459612|4073992|FG002|STARTED|Period 2||17
3343944|NCT03459612|4073993|FG003|STARTED|Period 2||17
3177507|NCT01971554|3905334|FG001|COMPLETED|Overall Study||18
3177508|NCT01971554|3905335|FG002|COMPLETED|Overall Study||18
3177509|NCT01971554|3905336|FG003|COMPLETED|Overall Study||18
3177510|NCT01971554|3905333|FG000|NOT COMPLETED|Overall Study||1
3177511|NCT01971554|3905334|FG001|NOT COMPLETED|Overall Study||0
3177512|NCT01971554|3905335|FG002|NOT COMPLETED|Overall Study||0
3343945|NCT03459612|4073990|FG000|Received at Least 1 Dose of Study Drug|Period 2||17
3343946|NCT03459612|4073991|FG001|Received at Least 1 Dose of Study Drug|Period 2||17
3343947|NCT03459612|4073992|FG002|Received at Least 1 Dose of Study Drug|Period 2||17
3343948|NCT03459612|4073993|FG003|Received at Least 1 Dose of Study Drug|Period 2||17
3343949|NCT03459612|4073990|FG000|COMPLETED|Period 2||17
3343950|NCT03459612|4073991|FG001|COMPLETED|Period 2||17
3343951|NCT03459612|4073992|FG002|COMPLETED|Period 2||17
3343952|NCT03459612|4073993|FG003|COMPLETED|Period 2||17
3343953|NCT03459612|4073990|FG000|NOT COMPLETED|Period 2||0
3343954|NCT03459612|4073991|FG001|NOT COMPLETED|Period 2||0
3343955|NCT03459612|4073992|FG002|NOT COMPLETED|Period 2||0
3343956|NCT03459612|4073993|FG003|NOT COMPLETED|Period 2||0
3343957|NCT03459612|4073990|FG000|STARTED|Period 3||17
3343958|NCT03459612|4073991|FG001|STARTED|Period 3||17
3343959|NCT03459612|4073992|FG002|STARTED|Period 3||17
3343960|NCT03459612|4073993|FG003|STARTED|Period 3||17
3343961|NCT03459612|4073990|FG000|Received at Least 1 Dose of Study Drug|Period 3||17
3343962|NCT03459612|4073991|FG001|Received at Least 1 Dose of Study Drug|Period 3||17
3343963|NCT03459612|4073992|FG002|Received at Least 1 Dose of Study Drug|Period 3||17
3343964|NCT03459612|4073993|FG003|Received at Least 1 Dose of Study Drug|Period 3||17
3343965|NCT03459612|4073990|FG000|COMPLETED|Period 3||17
3343966|NCT03459612|4073991|FG001|COMPLETED|Period 3||17
3343967|NCT03459612|4073992|FG002|COMPLETED|Period 3||17
3343968|NCT03459612|4073993|FG003|COMPLETED|Period 3||17
3177513|NCT01971554|3905336|FG003|NOT COMPLETED|Overall Study||0
3177514|NCT01971567|3905348|FG000|STARTED|Overall Study||56
3177515|NCT01971567|3905349|FG001|STARTED|Overall Study||51
3177516|NCT01971567|3905348|FG000|COMPLETED|Overall Study||52
3177517|NCT01971567|3905349|FG001|COMPLETED|Overall Study||49
3177518|NCT01971567|3905348|FG000|NOT COMPLETED|Overall Study||4
3177519|NCT01971567|3905349|FG001|NOT COMPLETED|Overall Study||2
3177520|NCT01971580|3905357|FG000|STARTED|Overall Study||14
3177521|NCT01971580|3905358|FG001|STARTED|Overall Study||14
3177522|NCT01971580|3905357|FG000|COMPLETED|Overall Study||10
3177523|NCT01971580|3905358|FG001|COMPLETED|Overall Study||9
3177524|NCT01971580|3905357|FG000|NOT COMPLETED|Overall Study||4
3343969|NCT03459612|4073990|FG000|NOT COMPLETED|Period 3||0
3343970|NCT03459612|4073991|FG001|NOT COMPLETED|Period 3||0
3343971|NCT03459612|4073992|FG002|NOT COMPLETED|Period 3||0
3343972|NCT03459612|4073993|FG003|NOT COMPLETED|Period 3||0
3343973|NCT03459612|4073990|FG000|STARTED|Period 4||17
3343974|NCT03459612|4073991|FG001|STARTED|Period 4||17
3343975|NCT03459612|4073992|FG002|STARTED|Period 4|One participant completed period 3 and withdrew for personal reasons prior to Period 4.|16
3343976|NCT03459612|4073993|FG003|STARTED|Period 4||17
3343977|NCT03459612|4073990|FG000|Received at Least 1 Dose of Study Drug|Period 4||17
3343978|NCT03459612|4073991|FG001|Received at Least 1 Dose of Study Drug|Period 4||17
3343979|NCT03459612|4073992|FG002|Received at Least 1 Dose of Study Drug|Period 4||16
3343980|NCT03459612|4073993|FG003|Received at Least 1 Dose of Study Drug|Period 4||17
3343981|NCT03459612|4073990|FG000|COMPLETED|Period 4||17
3343982|NCT03459612|4073991|FG001|COMPLETED|Period 4||17
3343983|NCT03459612|4073992|FG002|COMPLETED|Period 4||16
3343984|NCT03459612|4073993|FG003|COMPLETED|Period 4||17
3343985|NCT03459612|4073990|FG000|NOT COMPLETED|Period 4||0
3343986|NCT03459612|4073991|FG001|NOT COMPLETED|Period 4||0
3343987|NCT03459612|4073992|FG002|NOT COMPLETED|Period 4||0
3343988|NCT03459612|4073993|FG003|NOT COMPLETED|Period 4||0
3343989|NCT03459794|4074008|FG000|STARTED|Overall Study||8
3343990|NCT03459794|4074009|FG001|STARTED|Overall Study||4
3343991|NCT03459794|4074008|FG000|COMPLETED|Overall Study||8
3343992|NCT03459794|4074009|FG001|COMPLETED|Overall Study||4
3343993|NCT03459794|4074008|FG000|NOT COMPLETED|Overall Study||0
3343994|NCT03459794|4074009|FG001|NOT COMPLETED|Overall Study||0
3343995|NCT03460587|4074021|FG000|STARTED|Overall Study||13
3343996|NCT03460587|4074021|FG000|COMPLETED|Overall Study||13
3343997|NCT03460587|4074021|FG000|NOT COMPLETED|Overall Study||0
3343998|NCT03460652|4074025|FG000|STARTED|Overall Study||282
3343999|NCT03460652|4074025|FG000|Entered Treatment Phase|Overall Study||238
3344000|NCT03460652|4074025|FG000|COMPLETED|Overall Study||155
3344001|NCT03460652|4074025|FG000|NOT COMPLETED|Overall Study||127
3344002|NCT03460899|4074030|FG000|STARTED|Euglycaemic Clamp|First Euglycaemic Clamp completed: 05. March 2018|14
3344003|NCT03460899|4074030|FG000|COMPLETED|Euglycaemic Clamp|Last Euglycaemic clamp completed: 23. May 2018|14
3344004|NCT03460899|4074030|FG000|NOT COMPLETED|Euglycaemic Clamp||0
3344005|NCT03460899|4074030|FG000|STARTED|Hyperinsulinaemic/Hypoglycaemic Clamp|First Hyperinsulinaemic/Hypoglycaemic Clamp completed: 15. March 2018|14
3344006|NCT03460899|4074030|FG000|COMPLETED|Hyperinsulinaemic/Hypoglycaemic Clamp|Last Hyperinsulinaemic/Hypoglycaemic Clamp completed: 05. June 2018|14
3344007|NCT03460899|4074030|FG000|NOT COMPLETED|Hyperinsulinaemic/Hypoglycaemic Clamp||0
3344008|NCT03460990|4074036|FG000|STARTED|Overall Study||57
3344009|NCT03460990|4074037|FG001|STARTED|Overall Study||54
3344010|NCT03460990|4074036|FG000|COMPLETED|Overall Study||57
3344011|NCT03460990|4074037|FG001|COMPLETED|Overall Study||54
3344012|NCT03460990|4074036|FG000|NOT COMPLETED|Overall Study||0
3177525|NCT01971580|3905358|FG001|NOT COMPLETED|Overall Study||5
3344013|NCT03460990|4074037|FG001|NOT COMPLETED|Overall Study||0
3344014|NCT03461146|4074043|FG000|STARTED|Overall Study||24
3344015|NCT03461146|4074043|FG000|COMPLETED|Overall Study||21
3344016|NCT03461146|4074043|FG000|NOT COMPLETED|Overall Study||3
3344017|NCT03461289|4074047|FG000|STARTED|Overall Study||33
3344018|NCT03461289|4074047|FG000|COMPLETED|Overall Study||32
3344019|NCT03461289|4074047|FG000|NOT COMPLETED|Overall Study||1
3344020|NCT03461757|4074053|FG000|STARTED|Overall Study||732
3344021|NCT03461757|4074054|FG001|STARTED|Overall Study||734
3344022|NCT03461757|4074053|FG000|Treated|Overall Study||682
3344023|NCT03461757|4074054|FG001|Treated|Overall Study||693
3344024|NCT03461757|4074053|FG000|COMPLETED|Overall Study||679
3344025|NCT03461757|4074054|FG001|COMPLETED|Overall Study||689
3344026|NCT03461757|4074053|FG000|NOT COMPLETED|Overall Study||53
3344027|NCT03461757|4074054|FG001|NOT COMPLETED|Overall Study||45
3344028|NCT03461965|4074062|FG000|STARTED|Overall Study||42
3344029|NCT03461965|4074063|FG001|STARTED|Overall Study||40
3344030|NCT03461965|4074062|FG000|COMPLETED|Overall Study||42
3344031|NCT03461965|4074063|FG001|COMPLETED|Overall Study||40
3344032|NCT03461965|4074062|FG000|NOT COMPLETED|Overall Study||0
3344033|NCT03461965|4074063|FG001|NOT COMPLETED|Overall Study||0
3344034|NCT03462082|4074069|FG000|STARTED|Study Phase (Randomized, Blinded Period)||3
3344035|NCT03462082|4074070|FG001|STARTED|Study Phase (Randomized, Blinded Period)||4
3344036|NCT03462082|4074071|FG002|STARTED|Study Phase (Randomized, Blinded Period)||4
3344037|NCT03462082|4074072|FG003|STARTED|Study Phase (Randomized, Blinded Period)||3
3344038|NCT03462082|4074073|FG004|STARTED|Study Phase (Randomized, Blinded Period)||3
3344039|NCT03462082|4074074|FG005|STARTED|Study Phase (Randomized, Blinded Period)||5
3344040|NCT03462082|4074075|FG006|STARTED|Study Phase (Randomized, Blinded Period)||0
3344041|NCT03462082|4074076|FG007|STARTED|Study Phase (Randomized, Blinded Period)||0
3344042|NCT03462082|4074069|FG000|COMPLETED|Study Phase (Randomized, Blinded Period)||3
3344043|NCT03462082|4074070|FG001|COMPLETED|Study Phase (Randomized, Blinded Period)||4
3344044|NCT03462082|4074071|FG002|COMPLETED|Study Phase (Randomized, Blinded Period)||4
3344045|NCT03462082|4074072|FG003|COMPLETED|Study Phase (Randomized, Blinded Period)||3
3344046|NCT03462082|4074073|FG004|COMPLETED|Study Phase (Randomized, Blinded Period)||3
3344047|NCT03462082|4074074|FG005|COMPLETED|Study Phase (Randomized, Blinded Period)||5
3344048|NCT03462082|4074075|FG006|COMPLETED|Study Phase (Randomized, Blinded Period)||0
3344049|NCT03462082|4074076|FG007|COMPLETED|Study Phase (Randomized, Blinded Period)||0
3344050|NCT03462082|4074069|FG000|NOT COMPLETED|Study Phase (Randomized, Blinded Period)||0
3344051|NCT03462082|4074070|FG001|NOT COMPLETED|Study Phase (Randomized, Blinded Period)||0
3344052|NCT03462082|4074071|FG002|NOT COMPLETED|Study Phase (Randomized, Blinded Period)||0
3344053|NCT03462082|4074072|FG003|NOT COMPLETED|Study Phase (Randomized, Blinded Period)||0
3344054|NCT03462082|4074073|FG004|NOT COMPLETED|Study Phase (Randomized, Blinded Period)||0
3344055|NCT03462082|4074074|FG005|NOT COMPLETED|Study Phase (Randomized, Blinded Period)||0
3344056|NCT03462082|4074075|FG006|NOT COMPLETED|Study Phase (Randomized, Blinded Period)||0
3344057|NCT03462082|4074076|FG007|NOT COMPLETED|Study Phase (Randomized, Blinded Period)||0
3344058|NCT03462082|4074069|FG000|STARTED|Open Label Phase||0
3344059|NCT03462082|4074070|FG001|STARTED|Open Label Phase||0
3344060|NCT03462082|4074071|FG002|STARTED|Open Label Phase||0
3344061|NCT03462082|4074072|FG003|STARTED|Open Label Phase||0
3344062|NCT03462082|4074073|FG004|STARTED|Open Label Phase||0
3344063|NCT03462082|4074074|FG005|STARTED|Open Label Phase||0
3344064|NCT03462082|4074075|FG006|STARTED|Open Label Phase||7
3344065|NCT03462082|4074076|FG007|STARTED|Open Label Phase||10
3344066|NCT03462082|4074069|FG000|COMPLETED|Open Label Phase||0
3344067|NCT03462082|4074070|FG001|COMPLETED|Open Label Phase||0
3344068|NCT03462082|4074071|FG002|COMPLETED|Open Label Phase||0
3344069|NCT03462082|4074072|FG003|COMPLETED|Open Label Phase||0
3344070|NCT03462082|4074073|FG004|COMPLETED|Open Label Phase||0
3344071|NCT03462082|4074074|FG005|COMPLETED|Open Label Phase||0
3344072|NCT03462082|4074075|FG006|COMPLETED|Open Label Phase||6
3344073|NCT03462082|4074076|FG007|COMPLETED|Open Label Phase||8
3344074|NCT03462082|4074069|FG000|NOT COMPLETED|Open Label Phase||0
3344075|NCT03462082|4074070|FG001|NOT COMPLETED|Open Label Phase||0
3344076|NCT03462082|4074071|FG002|NOT COMPLETED|Open Label Phase||0
3344077|NCT03462082|4074072|FG003|NOT COMPLETED|Open Label Phase||0
3344078|NCT03462082|4074073|FG004|NOT COMPLETED|Open Label Phase||0
3344079|NCT03462082|4074074|FG005|NOT COMPLETED|Open Label Phase||0
3344080|NCT03462082|4074075|FG006|NOT COMPLETED|Open Label Phase||1
3344081|NCT03462082|4074076|FG007|NOT COMPLETED|Open Label Phase||2
3344082|NCT03462576|4074089|FG000|STARTED|Overall Study||46
3344083|NCT03462576|4074090|FG001|STARTED|Overall Study||48
3344084|NCT03462576|4074091|FG002|STARTED|Overall Study||45
3344085|NCT03462576|4074089|FG000|COMPLETED|Overall Study||41
3344086|NCT03462576|4074090|FG001|COMPLETED|Overall Study||37
3344087|NCT03462576|4074091|FG002|COMPLETED|Overall Study||37
3344088|NCT03462576|4074089|FG000|NOT COMPLETED|Overall Study||5
3344089|NCT03462576|4074090|FG001|NOT COMPLETED|Overall Study||11
3344090|NCT03462576|4074091|FG002|NOT COMPLETED|Overall Study||8
3344091|NCT03462680|4074101|FG000|STARTED|Overall Study||21
3344092|NCT03462680|4074102|FG001|STARTED|Overall Study||26
3344093|NCT03462680|4074101|FG000|COMPLETED|Overall Study||18
3344094|NCT03462680|4074102|FG001|COMPLETED|Overall Study||21
3344095|NCT03462680|4074101|FG000|NOT COMPLETED|Overall Study||3
3344096|NCT03462680|4074102|FG001|NOT COMPLETED|Overall Study||5
3344097|NCT03462745|4074110|FG000|STARTED|Overall Study||92
3344098|NCT03462745|4074111|FG001|STARTED|Overall Study||92
3344099|NCT03462745|4074110|FG000|COMPLETED|Overall Study||92
3344100|NCT03462745|4074111|FG001|COMPLETED|Overall Study||92
3344101|NCT03462745|4074110|FG000|NOT COMPLETED|Overall Study||0
3344102|NCT03462745|4074111|FG001|NOT COMPLETED|Overall Study||0
3344103|NCT03462927|4074119|FG000|STARTED|Overall Study||32
3344104|NCT03462927|4074120|FG001|STARTED|Overall Study||31
3344105|NCT03462927|4074119|FG000|COMPLETED|Overall Study||26
3344106|NCT03462927|4074120|FG001|COMPLETED|Overall Study||29
3344107|NCT03462927|4074119|FG000|NOT COMPLETED|Overall Study||6
3344108|NCT03462927|4074120|FG001|NOT COMPLETED|Overall Study||2
3344109|NCT03463031|4074130|FG000|STARTED|Overall Study||225
3344110|NCT03463031|4074131|FG001|STARTED|Overall Study||221
3344111|NCT03463031|4074130|FG000|COMPLETED|Overall Study||215
3344112|NCT03463031|4074131|FG001|COMPLETED|Overall Study||216
3344113|NCT03463031|4074130|FG000|NOT COMPLETED|Overall Study||10
3344114|NCT03463031|4074131|FG001|NOT COMPLETED|Overall Study||5
3344115|NCT03463161|4074137|FG000|STARTED|Overall Study||2
3344116|NCT03463161|4074137|FG000|COMPLETED|Overall Study||2
3344117|NCT03463161|4074137|FG000|NOT COMPLETED|Overall Study||0
3344118|NCT03463512|4074143|FG000|STARTED|Overall Study||62
3344119|NCT03463512|4074144|FG001|STARTED|Overall Study||62
3344120|NCT03463512|4074143|FG000|COMPLETED|Overall Study||62
3344121|NCT03463512|4074144|FG001|COMPLETED|Overall Study||62
3344122|NCT03463512|4074143|FG000|NOT COMPLETED|Overall Study||0
3344123|NCT03463512|4074144|FG001|NOT COMPLETED|Overall Study||0
3344124|NCT03463889|4074150|FG000|STARTED|Overall Study||12
3344125|NCT03463889|4074150|FG000|COMPLETED|Overall Study||12
3344126|NCT03463889|4074150|FG000|NOT COMPLETED|Overall Study||0
3344127|NCT03463915|4074156|FG000|STARTED|Overall Study||45
3344128|NCT03463915|4074157|FG001|STARTED|Overall Study||45
3344129|NCT03463915|4074156|FG000|COMPLETED|Overall Study||35
3344130|NCT03463915|4074157|FG001|COMPLETED|Overall Study||36
3344131|NCT03463915|4074156|FG000|NOT COMPLETED|Overall Study||10
3344132|NCT03463915|4074157|FG001|NOT COMPLETED|Overall Study||9
3344133|NCT03463941|4074165|FG000|STARTED|Overall Study||80
3344134|NCT03463941|4074165|FG000|COMPLETED|Overall Study||62
3344135|NCT03463941|4074165|FG000|NOT COMPLETED|Overall Study||18
3344136|NCT03464383|4074173|FG000|STARTED|Overall Study||3
3344137|NCT03464383|4074174|FG001|STARTED|Overall Study||3
3344138|NCT03464383|4074175|FG002|STARTED|Overall Study||63
3344139|NCT03464383|4074173|FG000|COMPLETED|Overall Study||2
3344140|NCT03464383|4074174|FG001|COMPLETED|Overall Study||2
3344141|NCT03464383|4074175|FG002|COMPLETED|Overall Study||63
3344142|NCT03464383|4074173|FG000|NOT COMPLETED|Overall Study||1
3344143|NCT03464383|4074174|FG001|NOT COMPLETED|Overall Study||1
3344144|NCT03464383|4074175|FG002|NOT COMPLETED|Overall Study||0
3344145|NCT03464422|4074184|FG000|STARTED|Overall Study||21
3344146|NCT03464422|4074184|FG000|COMPLETED|Overall Study||17
3344147|NCT03464422|4074184|FG000|NOT COMPLETED|Overall Study||4
3344148|NCT03465436|4074194|FG000|STARTED|Period 1||14
3344149|NCT03465436|4074195|FG001|STARTED|Period 1||14
3344150|NCT03465436|4074196|FG002|STARTED|Period 1||14
3344151|NCT03465436|4074197|FG003|STARTED|Period 1||14
3344152|NCT03465436|4074194|FG000|Received at Least 1 Dose of Study Drug|Period 1||14
3344153|NCT03465436|4074195|FG001|Received at Least 1 Dose of Study Drug|Period 1||14
3344154|NCT03465436|4074196|FG002|Received at Least 1 Dose of Study Drug|Period 1||14
3344155|NCT03465436|4074197|FG003|Received at Least 1 Dose of Study Drug|Period 1||14
3344156|NCT03465436|4074194|FG000|COMPLETED|Period 1||14
3344157|NCT03465436|4074195|FG001|COMPLETED|Period 1||14
3344158|NCT03465436|4074196|FG002|COMPLETED|Period 1||13
3344159|NCT03465436|4074197|FG003|COMPLETED|Period 1||14
3344160|NCT03465436|4074194|FG000|NOT COMPLETED|Period 1||0
3344161|NCT03465436|4074195|FG001|NOT COMPLETED|Period 1||0
3344162|NCT03465436|4074196|FG002|NOT COMPLETED|Period 1||1
3344163|NCT03465436|4074197|FG003|NOT COMPLETED|Period 1||0
3344164|NCT03465436|4074194|FG000|STARTED|Period 2||14
3344165|NCT03465436|4074195|FG001|STARTED|Period 2||14
3344166|NCT03465436|4074196|FG002|STARTED|Period 2||13
3344167|NCT03465436|4074197|FG003|STARTED|Period 2||14
3344168|NCT03465436|4074194|FG000|Received at Least 1 Dose of Study Drug|Period 2||14
3344169|NCT03465436|4074195|FG001|Received at Least 1 Dose of Study Drug|Period 2||13
3344170|NCT03465436|4074196|FG002|Received at Least 1 Dose of Study Drug|Period 2||13
3344171|NCT03465436|4074197|FG003|Received at Least 1 Dose of Study Drug|Period 2||14
3344172|NCT03465436|4074194|FG000|COMPLETED|Period 2||14
3344173|NCT03465436|4074195|FG001|COMPLETED|Period 2||13
3344174|NCT03465436|4074196|FG002|COMPLETED|Period 2||13
3344175|NCT03465436|4074197|FG003|COMPLETED|Period 2||14
3344176|NCT03465436|4074194|FG000|NOT COMPLETED|Period 2||0
3344177|NCT03465436|4074195|FG001|NOT COMPLETED|Period 2||1
3344178|NCT03465436|4074196|FG002|NOT COMPLETED|Period 2||0
3344179|NCT03465436|4074197|FG003|NOT COMPLETED|Period 2||0
3344180|NCT03465436|4074194|FG000|STARTED|Period 3||14
3344181|NCT03465436|4074195|FG001|STARTED|Period 3||13
3344182|NCT03465436|4074196|FG002|STARTED|Period 3||13
3344183|NCT03465436|4074197|FG003|STARTED|Period 3||14
3344184|NCT03465436|4074194|FG000|Received at Least One Dose of Study Drug|Period 3||13
3344185|NCT03465436|4074195|FG001|Received at Least One Dose of Study Drug|Period 3||12
3344186|NCT03465436|4074196|FG002|Received at Least One Dose of Study Drug|Period 3||13
3344187|NCT03465436|4074197|FG003|Received at Least One Dose of Study Drug|Period 3||14
3344188|NCT03465436|4074194|FG000|COMPLETED|Period 3||13
3344189|NCT03465436|4074195|FG001|COMPLETED|Period 3||12
3344190|NCT03465436|4074196|FG002|COMPLETED|Period 3||13
3344191|NCT03465436|4074197|FG003|COMPLETED|Period 3||14
3344192|NCT03465436|4074194|FG000|NOT COMPLETED|Period 3||1
3344193|NCT03465436|4074195|FG001|NOT COMPLETED|Period 3||1
3344194|NCT03465436|4074196|FG002|NOT COMPLETED|Period 3||0
3344195|NCT03465436|4074197|FG003|NOT COMPLETED|Period 3||0
3344196|NCT03465436|4074194|FG000|STARTED|Period 4||13
3344197|NCT03465436|4074195|FG001|STARTED|Period 4||12
3344198|NCT03465436|4074196|FG002|STARTED|Period 4||13
3344199|NCT03465436|4074197|FG003|STARTED|Period 4||14
3344200|NCT03465436|4074194|FG000|Received at Least 1 Dose of Study Drug|Period 4||13
3344201|NCT03465436|4074195|FG001|Received at Least 1 Dose of Study Drug|Period 4||12
3344202|NCT03465436|4074196|FG002|Received at Least 1 Dose of Study Drug|Period 4||13
3344203|NCT03465436|4074197|FG003|Received at Least 1 Dose of Study Drug|Period 4||14
3344204|NCT03465436|4074194|FG000|COMPLETED|Period 4||13
3344205|NCT03465436|4074195|FG001|COMPLETED|Period 4||12
3344206|NCT03465436|4074196|FG002|COMPLETED|Period 4||12
3344207|NCT03465436|4074197|FG003|COMPLETED|Period 4||14
3344208|NCT03465436|4074194|FG000|NOT COMPLETED|Period 4||0
3344209|NCT03465436|4074195|FG001|NOT COMPLETED|Period 4||0
3344210|NCT03465436|4074196|FG002|NOT COMPLETED|Period 4||1
3344211|NCT03465436|4074197|FG003|NOT COMPLETED|Period 4||0
3344212|NCT03465709|4074209|FG000|STARTED|Overall Study||17
3344213|NCT03465709|4074209|FG000|COMPLETED|Overall Study||0
3344214|NCT03465709|4074209|FG000|NOT COMPLETED|Overall Study||17
3344215|NCT03465722|4074217|FG000|STARTED|End of Treatment||240
3344216|NCT03465722|4074218|FG001|STARTED|End of Treatment||236
3344217|NCT03465722|4074217|FG000|COMPLETED|End of Treatment||0
3344218|NCT03465722|4074218|FG001|COMPLETED|End of Treatment||0
3344219|NCT03465722|4074217|FG000|NOT COMPLETED|End of Treatment||240
3344220|NCT03465722|4074218|FG001|NOT COMPLETED|End of Treatment||236
3344221|NCT03465722|4074217|FG000|STARTED|End of Study||240
3344222|NCT03465722|4074218|FG001|STARTED|End of Study||236
3344223|NCT03465722|4074217|FG000|COMPLETED|End of Study||0
3344224|NCT03465722|4074218|FG001|COMPLETED|End of Study||0
3344225|NCT03465722|4074217|FG000|NOT COMPLETED|End of Study||240
3344226|NCT03465722|4074218|FG001|NOT COMPLETED|End of Study||236
3344227|NCT03465878|4074226|FG000|STARTED|Period 1-Part A First Intervention Day 1||21
3344228|NCT03465878|4074227|FG001|STARTED|Period 1-Part A First Intervention Day 1||21
3344229|NCT03465878|4074228|FG002|STARTED|Period 1-Part A First Intervention Day 1||0
3344230|NCT03465878|4074229|FG003|STARTED|Period 1-Part A First Intervention Day 1||0
3344231|NCT03465878|4074226|FG000|Received at Least 1 Dose of Study Drug|Period 1-Part A First Intervention Day 1||21
3344232|NCT03465878|4074227|FG001|Received at Least 1 Dose of Study Drug|Period 1-Part A First Intervention Day 1||21
3344233|NCT03465878|4074228|FG002|Received at Least 1 Dose of Study Drug|Period 1-Part A First Intervention Day 1||0
3344234|NCT03465878|4074229|FG003|Received at Least 1 Dose of Study Drug|Period 1-Part A First Intervention Day 1||0
3344235|NCT03465878|4074226|FG000|Children (2-11 Years)|Period 1-Part A First Intervention Day 1||7
3344236|NCT03465878|4074227|FG001|Children (2-11 Years)|Period 1-Part A First Intervention Day 1||6
3344237|NCT03465878|4074228|FG002|Children (2-11 Years)|Period 1-Part A First Intervention Day 1||0
3344238|NCT03465878|4074229|FG003|Children (2-11 Years)|Period 1-Part A First Intervention Day 1||0
3344239|NCT03465878|4074226|FG000|Adolescents (12-17 Years)|Period 1-Part A First Intervention Day 1||7
3344240|NCT03465878|4074227|FG001|Adolescents (12-17 Years)|Period 1-Part A First Intervention Day 1||7
3344241|NCT03465878|4074228|FG002|Adolescents (12-17 Years)|Period 1-Part A First Intervention Day 1||0
3344242|NCT03465878|4074229|FG003|Adolescents (12-17 Years)|Period 1-Part A First Intervention Day 1||0
3344243|NCT03465878|4074226|FG000|Adults (18-64 Years)|Period 1-Part A First Intervention Day 1||7
3344244|NCT03465878|4074227|FG001|Adults (18-64 Years)|Period 1-Part A First Intervention Day 1||8
3344245|NCT03465878|4074228|FG002|Adults (18-64 Years)|Period 1-Part A First Intervention Day 1||0
3344246|NCT03465878|4074229|FG003|Adults (18-64 Years)|Period 1-Part A First Intervention Day 1||0
3344247|NCT03465878|4074226|FG000|COMPLETED|Period 1-Part A First Intervention Day 1||21
3344248|NCT03465878|4074227|FG001|COMPLETED|Period 1-Part A First Intervention Day 1||20
3344249|NCT03465878|4074228|FG002|COMPLETED|Period 1-Part A First Intervention Day 1||0
3344250|NCT03465878|4074229|FG003|COMPLETED|Period 1-Part A First Intervention Day 1||0
3344251|NCT03465878|4074226|FG000|NOT COMPLETED|Period 1-Part A First Intervention Day 1||0
3344252|NCT03465878|4074227|FG001|NOT COMPLETED|Period 1-Part A First Intervention Day 1||1
3344253|NCT03465878|4074228|FG002|NOT COMPLETED|Period 1-Part A First Intervention Day 1||0
3344254|NCT03465878|4074229|FG003|NOT COMPLETED|Period 1-Part A First Intervention Day 1||0
3344255|NCT03465878|4074226|FG000|STARTED|Period2-Part A Second Intervention Day 1||21
3344256|NCT03465878|4074227|FG001|STARTED|Period2-Part A Second Intervention Day 1||20
3344257|NCT03465878|4074228|FG002|STARTED|Period2-Part A Second Intervention Day 1||0
3344258|NCT03465878|4074229|FG003|STARTED|Period2-Part A Second Intervention Day 1||0
3344259|NCT03465878|4074226|FG000|Children (2-11 Years)|Period2-Part A Second Intervention Day 1||7
3344260|NCT03465878|4074227|FG001|Children (2-11 Years)|Period2-Part A Second Intervention Day 1||6
3344261|NCT03465878|4074228|FG002|Children (2-11 Years)|Period2-Part A Second Intervention Day 1||0
3344262|NCT03465878|4074229|FG003|Children (2-11 Years)|Period2-Part A Second Intervention Day 1||0
3344263|NCT03465878|4074226|FG000|Adolescents (12-17 Years)|Period2-Part A Second Intervention Day 1||7
3344264|NCT03465878|4074227|FG001|Adolescents (12-17 Years)|Period2-Part A Second Intervention Day 1||7
3344265|NCT03465878|4074228|FG002|Adolescents (12-17 Years)|Period2-Part A Second Intervention Day 1||0
3344266|NCT03465878|4074229|FG003|Adolescents (12-17 Years)|Period2-Part A Second Intervention Day 1||0
3344267|NCT03465878|4074226|FG000|Adults (18-64 Years)|Period2-Part A Second Intervention Day 1||7
3344268|NCT03465878|4074227|FG001|Adults (18-64 Years)|Period2-Part A Second Intervention Day 1||7
3344269|NCT03465878|4074228|FG002|Adults (18-64 Years)|Period2-Part A Second Intervention Day 1||0
3344270|NCT03465878|4074229|FG003|Adults (18-64 Years)|Period2-Part A Second Intervention Day 1||0
3344271|NCT03465878|4074226|FG000|COMPLETED|Period2-Part A Second Intervention Day 1||21
3344272|NCT03465878|4074227|FG001|COMPLETED|Period2-Part A Second Intervention Day 1||20
3344273|NCT03465878|4074228|FG002|COMPLETED|Period2-Part A Second Intervention Day 1||0
3344274|NCT03465878|4074229|FG003|COMPLETED|Period2-Part A Second Intervention Day 1||0
3344275|NCT03465878|4074226|FG000|NOT COMPLETED|Period2-Part A Second Intervention Day 1||0
3344276|NCT03465878|4074227|FG001|NOT COMPLETED|Period2-Part A Second Intervention Day 1||0
3344277|NCT03465878|4074228|FG002|NOT COMPLETED|Period2-Part A Second Intervention Day 1||0
3344278|NCT03465878|4074229|FG003|NOT COMPLETED|Period2-Part A Second Intervention Day 1||0
3344279|NCT03465878|4074226|FG000|STARTED|Period 1-Part B First Intervention Day 1|This period is for Part B group.|0
3344280|NCT03465878|4074227|FG001|STARTED|Period 1-Part B First Intervention Day 1|This period is for Part B group.|0
3344281|NCT03465878|4074228|FG002|STARTED|Period 1-Part B First Intervention Day 1|25 pts from Part A were re-randomized to Part B, 14 new pts were randomized in Part B.|20
3344282|NCT03465878|4074229|FG003|STARTED|Period 1-Part B First Intervention Day 1|25 pts from Part A were re-randomized to Part B, 14 new pts were randomized in Part B.|19
3344283|NCT03465878|4074226|FG000|Received at Least 1 Dose of Study Drug|Period 1-Part B First Intervention Day 1||0
3344284|NCT03465878|4074227|FG001|Received at Least 1 Dose of Study Drug|Period 1-Part B First Intervention Day 1||0
3344285|NCT03465878|4074228|FG002|Received at Least 1 Dose of Study Drug|Period 1-Part B First Intervention Day 1||20
3344286|NCT03465878|4074229|FG003|Received at Least 1 Dose of Study Drug|Period 1-Part B First Intervention Day 1||17
3344287|NCT03465878|4074226|FG000|Children (2-11 Years)|Period 1-Part B First Intervention Day 1||0
3344288|NCT03465878|4074227|FG001|Children (2-11 Years)|Period 1-Part B First Intervention Day 1||0
3344289|NCT03465878|4074228|FG002|Children (2-11 Years)|Period 1-Part B First Intervention Day 1||6
3344290|NCT03465878|4074229|FG003|Children (2-11 Years)|Period 1-Part B First Intervention Day 1||6
3344291|NCT03465878|4074226|FG000|Adolescents (12-17 Years)|Period 1-Part B First Intervention Day 1||0
3344292|NCT03465878|4074227|FG001|Adolescents (12-17 Years)|Period 1-Part B First Intervention Day 1||0
3344293|NCT03465878|4074228|FG002|Adolescents (12-17 Years)|Period 1-Part B First Intervention Day 1||7
3344294|NCT03465878|4074229|FG003|Adolescents (12-17 Years)|Period 1-Part B First Intervention Day 1||6
3344295|NCT03465878|4074226|FG000|Adults (18-64 Years)|Period 1-Part B First Intervention Day 1||0
3344296|NCT03465878|4074227|FG001|Adults (18-64 Years)|Period 1-Part B First Intervention Day 1||0
3344297|NCT03465878|4074228|FG002|Adults (18-64 Years)|Period 1-Part B First Intervention Day 1||7
3344298|NCT03465878|4074229|FG003|Adults (18-64 Years)|Period 1-Part B First Intervention Day 1||5
3344299|NCT03465878|4074226|FG000|COMPLETED|Period 1-Part B First Intervention Day 1||0
3344300|NCT03465878|4074227|FG001|COMPLETED|Period 1-Part B First Intervention Day 1||0
3344301|NCT03465878|4074228|FG002|COMPLETED|Period 1-Part B First Intervention Day 1||20
3344302|NCT03465878|4074229|FG003|COMPLETED|Period 1-Part B First Intervention Day 1||17
3344303|NCT03465878|4074226|FG000|NOT COMPLETED|Period 1-Part B First Intervention Day 1||0
3344304|NCT03465878|4074227|FG001|NOT COMPLETED|Period 1-Part B First Intervention Day 1||0
3344305|NCT03465878|4074228|FG002|NOT COMPLETED|Period 1-Part B First Intervention Day 1||0
3344306|NCT03465878|4074229|FG003|NOT COMPLETED|Period 1-Part B First Intervention Day 1||2
3344307|NCT03465878|4074226|FG000|STARTED|Period2-Part B Second Intervention Day 1||0
3344308|NCT03465878|4074227|FG001|STARTED|Period2-Part B Second Intervention Day 1||0
3344309|NCT03465878|4074228|FG002|STARTED|Period2-Part B Second Intervention Day 1||20
3344310|NCT03465878|4074229|FG003|STARTED|Period2-Part B Second Intervention Day 1||17
3344311|NCT03465878|4074226|FG000|Children (2-11 Years)|Period2-Part B Second Intervention Day 1||0
3344312|NCT03465878|4074227|FG001|Children (2-11 Years)|Period2-Part B Second Intervention Day 1||0
3344313|NCT03465878|4074228|FG002|Children (2-11 Years)|Period2-Part B Second Intervention Day 1||6
3344314|NCT03465878|4074229|FG003|Children (2-11 Years)|Period2-Part B Second Intervention Day 1||6
3344315|NCT03465878|4074226|FG000|Adolescents (12-17 Years)|Period2-Part B Second Intervention Day 1||0
3344316|NCT03465878|4074227|FG001|Adolescents (12-17 Years)|Period2-Part B Second Intervention Day 1||0
3344317|NCT03465878|4074228|FG002|Adolescents (12-17 Years)|Period2-Part B Second Intervention Day 1||7
3344318|NCT03465878|4074229|FG003|Adolescents (12-17 Years)|Period2-Part B Second Intervention Day 1||6
3344319|NCT03465878|4074226|FG000|Adults (18-64 Years)|Period2-Part B Second Intervention Day 1||0
3344320|NCT03465878|4074227|FG001|Adults (18-64 Years)|Period2-Part B Second Intervention Day 1||0
3344321|NCT03465878|4074228|FG002|Adults (18-64 Years)|Period2-Part B Second Intervention Day 1||7
3344322|NCT03465878|4074229|FG003|Adults (18-64 Years)|Period2-Part B Second Intervention Day 1||5
3344323|NCT03465878|4074226|FG000|COMPLETED|Period2-Part B Second Intervention Day 1||0
3344324|NCT03465878|4074227|FG001|COMPLETED|Period2-Part B Second Intervention Day 1||0
3344325|NCT03465878|4074228|FG002|COMPLETED|Period2-Part B Second Intervention Day 1||20
3344326|NCT03465878|4074229|FG003|COMPLETED|Period2-Part B Second Intervention Day 1||17
3344327|NCT03465878|4074226|FG000|NOT COMPLETED|Period2-Part B Second Intervention Day 1||0
3344328|NCT03465878|4074227|FG001|NOT COMPLETED|Period2-Part B Second Intervention Day 1||0
3344329|NCT03465878|4074228|FG002|NOT COMPLETED|Period2-Part B Second Intervention Day 1||0
3344330|NCT03465878|4074229|FG003|NOT COMPLETED|Period2-Part B Second Intervention Day 1||0
3344331|NCT03465904|4074257|FG000|STARTED|Overall Study||298
3344332|NCT03465904|4074258|FG001|STARTED|Overall Study||303
3344333|NCT03465904|4074257|FG000|COMPLETED|Overall Study||209
3344334|NCT03465904|4074258|FG001|COMPLETED|Overall Study||237
3344335|NCT03465904|4074257|FG000|NOT COMPLETED|Overall Study||89
3344336|NCT03465904|4074258|FG001|NOT COMPLETED|Overall Study||66
3039837|NCT01160822|3759314|FG005|NOT COMPLETED|Overall Study||7
3039838|NCT01160822|3759315|FG006|NOT COMPLETED|Overall Study||9
3039839|NCT01160848|3759334|FG000|STARTED|Overall Study||12
3039840|NCT01160848|3759335|FG001|STARTED|Overall Study||8
3039841|NCT01160848|3759334|FG000|COMPLETED|Overall Study||12
3039842|NCT01160848|3759335|FG001|COMPLETED|Overall Study||8
3344337|NCT03466047|4074264|FG000|STARTED|Protein Stomach (1day)|The same 8 patients were studied in all interventions|8
3344338|NCT03466047|4074264|FG000|COMPLETED|Protein Stomach (1day)|The same 8 patients were studied in all interventions|8
3344339|NCT03466047|4074264|FG000|NOT COMPLETED|Protein Stomach (1day)||0
3344340|NCT03466047|4074264|FG000|STARTED|Protein Small Intestine (1 Day)||8
3344341|NCT03466047|4074264|FG000|COMPLETED|Protein Small Intestine (1 Day)||8
3344342|NCT03466047|4074264|FG000|NOT COMPLETED|Protein Small Intestine (1 Day)||0
3177526|NCT01971593|3905366|FG000|STARTED|Overall Study||14
3177527|NCT01971593|3905367|FG001|STARTED|Overall Study||12
3177528|NCT01971593|3905366|FG000|COMPLETED|Overall Study||9
3177529|NCT01971593|3905367|FG001|COMPLETED|Overall Study||8
3177530|NCT01971593|3905366|FG000|NOT COMPLETED|Overall Study||5
3177531|NCT01971593|3905367|FG001|NOT COMPLETED|Overall Study||4
3177532|NCT01971645|3905374|FG000|STARTED|Overall Study||25
3177533|NCT01971645|3905375|FG001|STARTED|Overall Study||27
3177534|NCT01971645|3905376|FG002|STARTED|Overall Study||25
3177535|NCT01971645|3905374|FG000|COMPLETED|Overall Study||23
3177536|NCT01971645|3905375|FG001|COMPLETED|Overall Study||27
3177537|NCT01971645|3905376|FG002|COMPLETED|Overall Study||23
3344343|NCT03466047|4074264|FG000|STARTED|CHO Stomach (1 Day)||8
3344344|NCT03466047|4074264|FG000|COMPLETED|CHO Stomach (1 Day)||8
3344345|NCT03466047|4074264|FG000|NOT COMPLETED|CHO Stomach (1 Day)||0
3177538|NCT01971645|3905374|FG000|NOT COMPLETED|Overall Study||2
3177539|NCT01971645|3905375|FG001|NOT COMPLETED|Overall Study||0
3177540|NCT01971645|3905376|FG002|NOT COMPLETED|Overall Study||2
3177541|NCT01971723|3905386|FG000|STARTED|Overall Study||16
3177542|NCT01971723|3905387|FG001|STARTED|Overall Study||16
3177543|NCT01971723|3905386|FG000|COMPLETED|Overall Study||14
3344346|NCT03466047|4074264|FG000|STARTED|CHO Small Intestine (1 Day)||8
3344347|NCT03466047|4074264|FG000|COMPLETED|CHO Small Intestine (1 Day)||8
3344348|NCT03466047|4074264|FG000|NOT COMPLETED|CHO Small Intestine (1 Day)||0
3344349|NCT03466047|4074264|FG000|STARTED|Fat Stomach (1 Day)||8
3344350|NCT03466047|4074264|FG000|COMPLETED|Fat Stomach (1 Day)||8
3344351|NCT03466047|4074264|FG000|NOT COMPLETED|Fat Stomach (1 Day)||0
3344352|NCT03466047|4074264|FG000|STARTED|Fat Small Intestine (1 Day)||8
3344353|NCT03466047|4074264|FG000|COMPLETED|Fat Small Intestine (1 Day)||8
3344354|NCT03466047|4074264|FG000|NOT COMPLETED|Fat Small Intestine (1 Day)||0
3344355|NCT03466060|4074293|FG000|STARTED|Period 1||19
3344356|NCT03466060|4074294|FG001|STARTED|Period 1||18
3344357|NCT03466060|4074295|FG002|STARTED|Period 1||20
3344358|NCT03466060|4074296|FG003|STARTED|Period 1||18
3344359|NCT03466060|4074297|FG004|STARTED|Period 1||20
3344360|NCT03466060|4074298|FG005|STARTED|Period 1||18
3344361|NCT03466060|4074293|FG000|COMPLETED|Period 1||19
3344362|NCT03466060|4074294|FG001|COMPLETED|Period 1||16
3344363|NCT03466060|4074295|FG002|COMPLETED|Period 1||17
3344364|NCT03466060|4074296|FG003|COMPLETED|Period 1||17
3344365|NCT03466060|4074297|FG004|COMPLETED|Period 1||20
3344366|NCT03466060|4074298|FG005|COMPLETED|Period 1||18
3344367|NCT03466060|4074293|FG000|NOT COMPLETED|Period 1||0
3344368|NCT03466060|4074294|FG001|NOT COMPLETED|Period 1||2
3344369|NCT03466060|4074295|FG002|NOT COMPLETED|Period 1||3
3344370|NCT03466060|4074296|FG003|NOT COMPLETED|Period 1||1
3344371|NCT03466060|4074297|FG004|NOT COMPLETED|Period 1||0
3344372|NCT03466060|4074298|FG005|NOT COMPLETED|Period 1||0
3344373|NCT03466060|4074293|FG000|STARTED|Period 2||19
3344374|NCT03466060|4074294|FG001|STARTED|Period 2||16
3344375|NCT03466060|4074295|FG002|STARTED|Period 2||17
3344376|NCT03466060|4074296|FG003|STARTED|Period 2||17
3344377|NCT03466060|4074297|FG004|STARTED|Period 2||20
3344378|NCT03466060|4074298|FG005|STARTED|Period 2||18
3344379|NCT03466060|4074293|FG000|COMPLETED|Period 2||19
3344380|NCT03466060|4074294|FG001|COMPLETED|Period 2||16
3344381|NCT03466060|4074295|FG002|COMPLETED|Period 2||16
3344382|NCT03466060|4074296|FG003|COMPLETED|Period 2||17
3344383|NCT03466060|4074297|FG004|COMPLETED|Period 2||20
3344384|NCT03466060|4074298|FG005|COMPLETED|Period 2||18
3344385|NCT03466060|4074293|FG000|NOT COMPLETED|Period 2||0
3344386|NCT03466060|4074294|FG001|NOT COMPLETED|Period 2||0
3344387|NCT03466060|4074295|FG002|NOT COMPLETED|Period 2||1
3344388|NCT03466060|4074296|FG003|NOT COMPLETED|Period 2||0
3344389|NCT03466060|4074297|FG004|NOT COMPLETED|Period 2||0
3344390|NCT03466060|4074298|FG005|NOT COMPLETED|Period 2||0
3344391|NCT03466073|4074318|FG000|STARTED|Overall Study||6
3344392|NCT03466073|4074319|FG001|STARTED|Overall Study||2
3344393|NCT03466073|4074320|FG002|STARTED|Overall Study||6
3344394|NCT03466073|4074321|FG003|STARTED|Overall Study||6
3344395|NCT03466073|4074322|FG004|STARTED|Overall Study||6
3344396|NCT03466073|4074323|FG005|STARTED|Overall Study||7
3344397|NCT03466073|4074318|FG000|COMPLETED|Overall Study||5
3344398|NCT03466073|4074319|FG001|COMPLETED|Overall Study||2
3344399|NCT03466073|4074320|FG002|COMPLETED|Overall Study||6
3344400|NCT03466073|4074321|FG003|COMPLETED|Overall Study||6
3344401|NCT03466073|4074322|FG004|COMPLETED|Overall Study||6
3344402|NCT03466073|4074323|FG005|COMPLETED|Overall Study||6
3344403|NCT03466073|4074318|FG000|NOT COMPLETED|Overall Study||1
3344404|NCT03466073|4074319|FG001|NOT COMPLETED|Overall Study||0
3344405|NCT03466073|4074320|FG002|NOT COMPLETED|Overall Study||0
3344406|NCT03466073|4074321|FG003|NOT COMPLETED|Overall Study||0
3344407|NCT03466073|4074322|FG004|NOT COMPLETED|Overall Study||0
3344408|NCT03466073|4074323|FG005|NOT COMPLETED|Overall Study||1
3344409|NCT03466086|4074344|FG000|STARTED|Period 1||28
3344410|NCT03466086|4074345|FG001|STARTED|Period 1||27
3344411|NCT03466086|4074344|FG000|COMPLETED|Period 1||26
3344412|NCT03466086|4074345|FG001|COMPLETED|Period 1||27
3344413|NCT03466086|4074344|FG000|NOT COMPLETED|Period 1||2
3344414|NCT03466086|4074345|FG001|NOT COMPLETED|Period 1||0
3344415|NCT03466086|4074344|FG000|STARTED|Period 2||26
3344416|NCT03466086|4074345|FG001|STARTED|Period 2||27
3344417|NCT03466086|4074344|FG000|COMPLETED|Period 2||26
3344418|NCT03466086|4074345|FG001|COMPLETED|Period 2||27
3344419|NCT03466086|4074344|FG000|NOT COMPLETED|Period 2||0
3344420|NCT03466086|4074345|FG001|NOT COMPLETED|Period 2||0
3344421|NCT03466099|4074354|FG000|STARTED|Overall Study||41
3344422|NCT03466099|4074355|FG001|STARTED|Overall Study||44
3344423|NCT03466099|4074356|FG002|STARTED|Overall Study|One study subject consented and was randomized, but withdrew prior to receiving any study treatments|45
3344424|NCT03466099|4074354|FG000|Treated|Overall Study||41
3344425|NCT03466099|4074355|FG001|Treated|Overall Study||44
3344426|NCT03466099|4074356|FG002|Treated|Overall Study||44
3344427|NCT03466099|4074354|FG000|COMPLETED|Overall Study||24
3344428|NCT03466099|4074355|FG001|COMPLETED|Overall Study||30
3344429|NCT03466099|4074356|FG002|COMPLETED|Overall Study||28
3344430|NCT03466099|4074354|FG000|NOT COMPLETED|Overall Study||17
3344431|NCT03466099|4074355|FG001|NOT COMPLETED|Overall Study||14
3344432|NCT03466099|4074356|FG002|NOT COMPLETED|Overall Study||17
3344433|NCT03466918|4074364|FG000|STARTED|Overall Study||58
3344434|NCT03466918|4074364|FG000|Analysis Population|Overall Study||50
3344435|NCT03466918|4074364|FG000|COMPLETED|Overall Study|All 58 patients completed the 30-day primary endpoint.|58
3344436|NCT03466918|4074364|FG000|NOT COMPLETED|Overall Study||0
3344437|NCT03467048|4074371|FG000|STARTED|Overall Study||66
3344438|NCT03467048|4074372|FG001|STARTED|Overall Study||64
3344439|NCT03467048|4074371|FG000|COMPLETED|Overall Study||66
3344440|NCT03467048|4074372|FG001|COMPLETED|Overall Study||63
3344441|NCT03467048|4074371|FG000|NOT COMPLETED|Overall Study||0
3344442|NCT03467048|4074372|FG001|NOT COMPLETED|Overall Study||1
3344443|NCT03467217|4074380|FG000|STARTED|Overall Study||43
3344444|NCT03467217|4074381|FG001|STARTED|Overall Study||40
3344445|NCT03467217|4074380|FG000|COMPLETED|Overall Study||33
3344446|NCT03467217|4074381|FG001|COMPLETED|Overall Study||34
3344447|NCT03467217|4074380|FG000|NOT COMPLETED|Overall Study||10
3344448|NCT03467217|4074381|FG001|NOT COMPLETED|Overall Study||6
3344449|NCT03467412|4074387|FG000|STARTED|Overall Study|Each unique subject will appear in 2 arms. Total sum of subjects is therefore120/2=60.|25
3344450|NCT03467412|4074388|FG001|STARTED|Overall Study|Each unique subject will appear in 2 arms. Total sum of subjects is therefore120/2=60.|25
3344451|NCT03467412|4074389|FG002|STARTED|Overall Study|Each unique subject will appear in 2 arms. Total sum of subjects is therefore120/2=60.|25
3344452|NCT03467412|4074390|FG003|STARTED|Overall Study|Each unique subject will appear in 2 arms. Total sum of subjects is therefore120/2=60.|25
3344453|NCT03467412|4074391|FG004|STARTED|Overall Study|Each unique subject will appear in 2 arms. Total sum of subjects is therefore120/2=60.|20
3344454|NCT03467412|4074387|FG000|COMPLETED|Overall Study||22
3344455|NCT03467412|4074388|FG001|COMPLETED|Overall Study||24
3344456|NCT03467412|4074389|FG002|COMPLETED|Overall Study||20
3344457|NCT03467412|4074390|FG003|COMPLETED|Overall Study||23
3344458|NCT03467412|4074391|FG004|COMPLETED|Overall Study||17
3344459|NCT03467412|4074387|FG000|NOT COMPLETED|Overall Study||3
3344460|NCT03467412|4074388|FG001|NOT COMPLETED|Overall Study||1
3344461|NCT03467412|4074389|FG002|NOT COMPLETED|Overall Study||5
3344462|NCT03467412|4074390|FG003|NOT COMPLETED|Overall Study||2
3344463|NCT03467412|4074391|FG004|NOT COMPLETED|Overall Study||3
3344464|NCT03467425|4074412|FG000|STARTED|Overall Study||1545
3344465|NCT03467425|4074413|FG001|STARTED|Overall Study||1547
3344466|NCT03467425|4074412|FG000|Randomized But Did Not Start IP|Overall Study||1
3344467|NCT03467425|4074413|FG001|Randomized But Did Not Start IP|Overall Study||0
3344468|NCT03467425|4074412|FG000|Completed IP|Overall Study||1256
3344469|NCT03467425|4074413|FG001|Completed IP|Overall Study||1359
3344470|NCT03467425|4074412|FG000|Not Completed IP|Overall Study||288
3344471|NCT03467425|4074413|FG001|Not Completed IP|Overall Study||188
3344472|NCT03467425|4074412|FG000|Withdrew IP (WIP): Lost to Follow-up|Overall Study||15
3344473|NCT03467425|4074413|FG001|Withdrew IP (WIP): Lost to Follow-up|Overall Study||24
3344474|NCT03467425|4074412|FG000|WIP: Protocol Deviation|Overall Study||0
3344475|NCT03467425|4074413|FG001|WIP: Protocol Deviation|Overall Study||2
3344476|NCT03467425|4074412|FG000|WIP: Adverse Event|Overall Study||112
3344477|NCT03467425|4074413|FG001|WIP: Adverse Event|Overall Study||29
3344478|NCT03467425|4074412|FG000|WIP: Lack of Efficacy|Overall Study||56
3344479|NCT03467425|4074413|FG001|WIP: Lack of Efficacy|Overall Study||28
3344480|NCT03467425|4074412|FG000|WIP: Physician Decision|Overall Study||14
3344481|NCT03467425|4074413|FG001|WIP: Physician Decision|Overall Study||27
3344482|NCT03467425|4074412|FG000|WIP: Withdrawal by Participant|Overall Study||91
3344483|NCT03467425|4074413|FG001|WIP: Withdrawal by Participant|Overall Study||78
3344484|NCT03467425|4074412|FG000|COMPLETED|Overall Study||1498
3344485|NCT03467425|4074413|FG001|COMPLETED|Overall Study||1493
3344486|NCT03467425|4074412|FG000|NOT COMPLETED|Overall Study||47
3344487|NCT03467425|4074413|FG001|NOT COMPLETED|Overall Study||54
3344488|NCT03467477|4074419|FG000|STARTED|Overall Study||161
3344489|NCT03467477|4074419|FG000|COMPLETED|Overall Study||161
3344490|NCT03467477|4074419|FG000|NOT COMPLETED|Overall Study||0
3344491|NCT03467685|4074428|FG000|STARTED|Overall Study||52
3344492|NCT03467685|4074429|FG001|STARTED|Overall Study||49
3344493|NCT03467685|4074428|FG000|COMPLETED|Overall Study||52
3344494|NCT03467685|4074429|FG001|COMPLETED|Overall Study||49
3344495|NCT03467685|4074428|FG000|NOT COMPLETED|Overall Study||0
3344496|NCT03467685|4074429|FG001|NOT COMPLETED|Overall Study||0
3344497|NCT03467763|4074435|FG000|STARTED|Overall Study||13
3344498|NCT03467763|4074435|FG000|Weeks 1-2|Overall Study||13
3344499|NCT03467763|4074435|FG000|Weeks 3-4|Overall Study||10
3344500|NCT03467763|4074435|FG000|Weeks 5-6|Overall Study||8
3344501|NCT03467763|4074435|FG000|Weeks 7-8|Overall Study||7
3344502|NCT03467763|4074435|FG000|Weeks 9 - 10|Overall Study||6
3344503|NCT03467763|4074435|FG000|Week 11-12|Overall Study||6
3344504|NCT03467763|4074435|FG000|Weeks 13-14|Overall Study||2
3344505|NCT03467763|4074435|FG000|Weeks 15-16|Overall Study||2
3344506|NCT03467763|4074435|FG000|COMPLETED|Overall Study||10
3344507|NCT03467763|4074435|FG000|NOT COMPLETED|Overall Study||3
3344508|NCT03467945|4074445|FG000|STARTED|Treatment Period 1||10
3344509|NCT03467945|4074446|FG001|STARTED|Treatment Period 1||10
3344510|NCT03467945|4074447|FG002|STARTED|Treatment Period 1||10
3344511|NCT03467945|4074448|FG003|STARTED|Treatment Period 1||10
3344512|NCT03467945|4074445|FG000|COMPLETED|Treatment Period 1||10
3344513|NCT03467945|4074446|FG001|COMPLETED|Treatment Period 1||10
3344514|NCT03467945|4074447|FG002|COMPLETED|Treatment Period 1||10
3344515|NCT03467945|4074448|FG003|COMPLETED|Treatment Period 1||10
3344516|NCT03467945|4074445|FG000|NOT COMPLETED|Treatment Period 1||0
3344517|NCT03467945|4074446|FG001|NOT COMPLETED|Treatment Period 1||0
3344518|NCT03467945|4074447|FG002|NOT COMPLETED|Treatment Period 1||0
3344519|NCT03467945|4074448|FG003|NOT COMPLETED|Treatment Period 1||0
3344520|NCT03467945|4074445|FG000|STARTED|Treatment Period 2||10
3344521|NCT03467945|4074446|FG001|STARTED|Treatment Period 2||10
3344522|NCT03467945|4074447|FG002|STARTED|Treatment Period 2||10
3344523|NCT03467945|4074448|FG003|STARTED|Treatment Period 2||10
3344524|NCT03467945|4074445|FG000|COMPLETED|Treatment Period 2||10
3344525|NCT03467945|4074446|FG001|COMPLETED|Treatment Period 2||9
3344526|NCT03467945|4074447|FG002|COMPLETED|Treatment Period 2||10
3344527|NCT03467945|4074448|FG003|COMPLETED|Treatment Period 2||10
3344528|NCT03467945|4074445|FG000|NOT COMPLETED|Treatment Period 2||0
3344529|NCT03467945|4074446|FG001|NOT COMPLETED|Treatment Period 2||1
3344530|NCT03467945|4074447|FG002|NOT COMPLETED|Treatment Period 2||0
3344531|NCT03467945|4074448|FG003|NOT COMPLETED|Treatment Period 2||0
3344532|NCT03467945|4074445|FG000|STARTED|Treatment Period 3||10
3344533|NCT03467945|4074446|FG001|STARTED|Treatment Period 3||9
3344534|NCT03467945|4074447|FG002|STARTED|Treatment Period 3||10
3344535|NCT03467945|4074448|FG003|STARTED|Treatment Period 3||10
3344536|NCT03467945|4074445|FG000|COMPLETED|Treatment Period 3||9
3344537|NCT03467945|4074446|FG001|COMPLETED|Treatment Period 3||9
3344538|NCT03467945|4074447|FG002|COMPLETED|Treatment Period 3||8
3344539|NCT03467945|4074448|FG003|COMPLETED|Treatment Period 3||9
3344540|NCT03467945|4074445|FG000|NOT COMPLETED|Treatment Period 3||1
3344541|NCT03467945|4074446|FG001|NOT COMPLETED|Treatment Period 3||0
3344542|NCT03467945|4074447|FG002|NOT COMPLETED|Treatment Period 3||2
3344543|NCT03467945|4074448|FG003|NOT COMPLETED|Treatment Period 3||1
3344544|NCT03467945|4074445|FG000|STARTED|Treatment Period 4||9
3344545|NCT03467945|4074446|FG001|STARTED|Treatment Period 4||9
3344546|NCT03467945|4074447|FG002|STARTED|Treatment Period 4||8
3344547|NCT03467945|4074448|FG003|STARTED|Treatment Period 4||9
3344548|NCT03467945|4074445|FG000|COMPLETED|Treatment Period 4||9
3344549|NCT03467945|4074446|FG001|COMPLETED|Treatment Period 4||9
3344550|NCT03467945|4074447|FG002|COMPLETED|Treatment Period 4||8
3344551|NCT03467945|4074448|FG003|COMPLETED|Treatment Period 4||9
3344552|NCT03467945|4074445|FG000|NOT COMPLETED|Treatment Period 4||0
3344553|NCT03467945|4074446|FG001|NOT COMPLETED|Treatment Period 4||0
3344554|NCT03467945|4074447|FG002|NOT COMPLETED|Treatment Period 4||0
3344555|NCT03467945|4074448|FG003|NOT COMPLETED|Treatment Period 4||0
3344556|NCT03467971|4074461|FG000|STARTED|Treatment Period 1||10
3344557|NCT03467971|4074462|FG001|STARTED|Treatment Period 1||11
3344558|NCT03467971|4074461|FG000|COMPLETED|Treatment Period 1||10
3344559|NCT03467971|4074462|FG001|COMPLETED|Treatment Period 1||11
3344560|NCT03467971|4074461|FG000|NOT COMPLETED|Treatment Period 1||0
3344561|NCT03467971|4074462|FG001|NOT COMPLETED|Treatment Period 1||0
3344562|NCT03467971|4074461|FG000|STARTED|Treatment Period 2||10
3344563|NCT03467971|4074462|FG001|STARTED|Treatment Period 2||11
3344564|NCT03467971|4074461|FG000|COMPLETED|Treatment Period 2||10
3344565|NCT03467971|4074462|FG001|COMPLETED|Treatment Period 2||10
3344566|NCT03467971|4074461|FG000|NOT COMPLETED|Treatment Period 2||0
3344567|NCT03467971|4074462|FG001|NOT COMPLETED|Treatment Period 2||1
3344568|NCT03468075|4074469|FG000|STARTED|Overall Study||10
3344569|NCT03468075|4074469|FG000|COMPLETED|Overall Study||10
3344570|NCT03468075|4074469|FG000|NOT COMPLETED|Overall Study||0
3344571|NCT03468179|4074473|FG000|STARTED|Overall Study||10
3344572|NCT03468179|4074473|FG000|COMPLETED|Overall Study||10
3344573|NCT03468179|4074473|FG000|NOT COMPLETED|Overall Study||0
3344574|NCT03468543|4074480|FG000|STARTED|Overall Study||3
3344575|NCT03468543|4074480|FG000|COMPLETED|Overall Study||0
3344576|NCT03468543|4074480|FG000|NOT COMPLETED|Overall Study||3
3344577|NCT03468816|4074486|FG000|STARTED|Overall Study||2
3344578|NCT03468816|4074487|FG001|STARTED|Overall Study||3
3344579|NCT03468816|4074486|FG000|COMPLETED|Overall Study||2
3344580|NCT03468816|4074487|FG001|COMPLETED|Overall Study||3
3344581|NCT03468816|4074486|FG000|NOT COMPLETED|Overall Study||0
3344582|NCT03468816|4074487|FG001|NOT COMPLETED|Overall Study||0
3344583|NCT03468855|4074495|FG000|STARTED|Overall Study||34
3344584|NCT03468855|4074495|FG000|COMPLETED|Overall Study||23
3344585|NCT03468855|4074495|FG000|NOT COMPLETED|Overall Study||11
3344586|NCT03468920|4074501|FG000|STARTED|Overall Study||60
3344587|NCT03468920|4074502|FG001|STARTED|Overall Study||60
3344588|NCT03468920|4074501|FG000|COMPLETED|Overall Study||60
3344589|NCT03468920|4074502|FG001|COMPLETED|Overall Study||60
3344590|NCT03468920|4074501|FG000|NOT COMPLETED|Overall Study||0
3344591|NCT03468920|4074502|FG001|NOT COMPLETED|Overall Study||0
3344592|NCT03468933|4074510|FG000|STARTED|Overall Study||16
3344593|NCT03468933|4074511|FG001|STARTED|Overall Study||16
3344594|NCT03468933|4074510|FG000|COMPLETED|Overall Study||16
3344595|NCT03468933|4074511|FG001|COMPLETED|Overall Study||16
3344596|NCT03468933|4074510|FG000|NOT COMPLETED|Overall Study||0
3344597|NCT03468933|4074511|FG001|NOT COMPLETED|Overall Study||0
3344598|NCT03469336|4074517|FG000|STARTED|Overall Study||18
3344599|NCT03469336|4074517|FG000|COMPLETED|Overall Study||17
3344600|NCT03469336|4074517|FG000|NOT COMPLETED|Overall Study||1
3344601|NCT03469349|4074529|FG000|STARTED|Overall Study||182
3344602|NCT03469349|4074530|FG001|STARTED|Overall Study||184
3344603|NCT03469349|4074529|FG000|COMPLETED|Overall Study||177
3344604|NCT03469349|4074530|FG001|COMPLETED|Overall Study||174
3344605|NCT03469349|4074529|FG000|NOT COMPLETED|Overall Study||5
3344606|NCT03469349|4074530|FG001|NOT COMPLETED|Overall Study||10
3344607|NCT03470012|4074536|FG000|STARTED|Overall Study||24
3344608|NCT03470012|4074536|FG000|COMPLETED|Overall Study||24
3344609|NCT03470012|4074536|FG000|NOT COMPLETED|Overall Study||0
3344610|NCT03470194|4074542|FG000|STARTED|Overall Study||49
3344611|NCT03470194|4074543|FG001|STARTED|Overall Study||57
3344612|NCT03470194|4074542|FG000|COMPLETED|Overall Study||38
3344613|NCT03470194|4074543|FG001|COMPLETED|Overall Study||40
3344614|NCT03470194|4074542|FG000|NOT COMPLETED|Overall Study||11
3344615|NCT03470194|4074543|FG001|NOT COMPLETED|Overall Study||17
3344616|NCT03470493|4074549|FG000|STARTED|Overall Study||130
3344617|NCT03470493|4074549|FG000|Met Primary Endpoint|Overall Study||80
3344618|NCT03470493|4074549|FG000|COMPLETED|Overall Study||130
3344619|NCT03470493|4074549|FG000|NOT COMPLETED|Overall Study||0
3344620|NCT03470545|4074555|FG000|STARTED|Overall Study||123
3344621|NCT03470545|4074556|FG001|STARTED|Overall Study||128
3344622|NCT03470545|4074555|FG000|COMPLETED|Overall Study||119
3344623|NCT03470545|4074556|FG001|COMPLETED|Overall Study||125
3344624|NCT03470545|4074555|FG000|NOT COMPLETED|Overall Study||4
3344625|NCT03470545|4074556|FG001|NOT COMPLETED|Overall Study||3
3344626|NCT03470740|4074565|FG000|STARTED|Overall Study||112
3344627|NCT03470740|4074566|FG001|STARTED|Overall Study||112
3344628|NCT03470740|4074565|FG000|COMPLETED|Overall Study||108
3344629|NCT03470740|4074566|FG001|COMPLETED|Overall Study||106
3344630|NCT03470740|4074565|FG000|NOT COMPLETED|Overall Study||4
3344631|NCT03470740|4074566|FG001|NOT COMPLETED|Overall Study||6
3344632|NCT03471065|4074573|FG000|STARTED|Overall Study||100
3344633|NCT03471065|4074573|FG000|COMPLETED|Overall Study||100
3344634|NCT03471065|4074573|FG000|NOT COMPLETED|Overall Study||0
3344635|NCT03471078|4074579|FG000|STARTED|Overall Study||82
3344636|NCT03471078|4074580|FG001|STARTED|Overall Study||40
3344637|NCT03471078|4074579|FG000|COMPLETED|Overall Study||61
3344638|NCT03471078|4074580|FG001|COMPLETED|Overall Study||34
3344639|NCT03471078|4074579|FG000|NOT COMPLETED|Overall Study||21
3344640|NCT03471078|4074580|FG001|NOT COMPLETED|Overall Study||6
3344641|NCT03471832|4074586|FG000|STARTED|Overall Study||40
3344642|NCT03471832|4074587|FG001|STARTED|Overall Study||40
3344643|NCT03471832|4074586|FG000|COMPLETED|Overall Study||40
3344644|NCT03471832|4074587|FG001|COMPLETED|Overall Study||40
3344645|NCT03471832|4074586|FG000|NOT COMPLETED|Overall Study||0
3344646|NCT03471832|4074587|FG001|NOT COMPLETED|Overall Study||0
3344647|NCT03471871|4074597|FG000|STARTED|Treatment Period 1(HV:1 Day, OSA:8 Days)||6
3344648|NCT03471871|4074598|FG001|STARTED|Treatment Period 1(HV:1 Day, OSA:8 Days)||5
3344649|NCT03471871|4074599|FG002|STARTED|Treatment Period 1(HV:1 Day, OSA:8 Days)||6
3344650|NCT03471871|4074600|FG003|STARTED|Treatment Period 1(HV:1 Day, OSA:8 Days)||19
3344651|NCT03471871|4074601|FG004|STARTED|Treatment Period 1(HV:1 Day, OSA:8 Days)||20
3344652|NCT03471871|4074597|FG000|Treated|Treatment Period 1(HV:1 Day, OSA:8 Days)||6
3344653|NCT03471871|4074598|FG001|Treated|Treatment Period 1(HV:1 Day, OSA:8 Days)||5
3344654|NCT03471871|4074599|FG002|Treated|Treatment Period 1(HV:1 Day, OSA:8 Days)||6
3177544|NCT01971723|3905387|FG001|COMPLETED|Overall Study||13
3344655|NCT03471871|4074600|FG003|Treated|Treatment Period 1(HV:1 Day, OSA:8 Days)||18
3344656|NCT03471871|4074601|FG004|Treated|Treatment Period 1(HV:1 Day, OSA:8 Days)||20
3344657|NCT03471871|4074597|FG000|COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||6
3344658|NCT03471871|4074598|FG001|COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||5
3344659|NCT03471871|4074599|FG002|COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||5
3344660|NCT03471871|4074600|FG003|COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||18
3344661|NCT03471871|4074601|FG004|COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||19
3344662|NCT03471871|4074597|FG000|NOT COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||0
3344663|NCT03471871|4074598|FG001|NOT COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||0
3344664|NCT03471871|4074599|FG002|NOT COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||1
3344665|NCT03471871|4074600|FG003|NOT COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||1
3344666|NCT03471871|4074601|FG004|NOT COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||1
3344667|NCT03471871|4074597|FG000|STARTED|Washout Period 1 (14 Days)||6
3344668|NCT03471871|4074598|FG001|STARTED|Washout Period 1 (14 Days)||5
3344669|NCT03471871|4074599|FG002|STARTED|Washout Period 1 (14 Days)||5
3344670|NCT03471871|4074600|FG003|STARTED|Washout Period 1 (14 Days)||18
3344671|NCT03471871|4074601|FG004|STARTED|Washout Period 1 (14 Days)||19
3344672|NCT03471871|4074597|FG000|COMPLETED|Washout Period 1 (14 Days)||6
3344673|NCT03471871|4074598|FG001|COMPLETED|Washout Period 1 (14 Days)||5
3344674|NCT03471871|4074599|FG002|COMPLETED|Washout Period 1 (14 Days)||5
3344675|NCT03471871|4074600|FG003|COMPLETED|Washout Period 1 (14 Days)||18
3344676|NCT03471871|4074601|FG004|COMPLETED|Washout Period 1 (14 Days)||19
3344677|NCT03471871|4074597|FG000|NOT COMPLETED|Washout Period 1 (14 Days)||0
3344678|NCT03471871|4074598|FG001|NOT COMPLETED|Washout Period 1 (14 Days)||0
3344679|NCT03471871|4074599|FG002|NOT COMPLETED|Washout Period 1 (14 Days)||0
3344680|NCT03471871|4074600|FG003|NOT COMPLETED|Washout Period 1 (14 Days)||0
3344681|NCT03471871|4074601|FG004|NOT COMPLETED|Washout Period 1 (14 Days)||0
3344682|NCT03471871|4074597|FG000|STARTED|Treatment Period 2(HV:1 Day, OSA:8 Days)||6
3344683|NCT03471871|4074598|FG001|STARTED|Treatment Period 2(HV:1 Day, OSA:8 Days)||5
3344684|NCT03471871|4074599|FG002|STARTED|Treatment Period 2(HV:1 Day, OSA:8 Days)||5
3344685|NCT03471871|4074600|FG003|STARTED|Treatment Period 2(HV:1 Day, OSA:8 Days)||18
3344686|NCT03471871|4074601|FG004|STARTED|Treatment Period 2(HV:1 Day, OSA:8 Days)||19
3344687|NCT03471871|4074597|FG000|COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||6
3344688|NCT03471871|4074598|FG001|COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||5
3344689|NCT03471871|4074599|FG002|COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||5
3344690|NCT03471871|4074600|FG003|COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||18
3344691|NCT03471871|4074601|FG004|COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||18
3344692|NCT03471871|4074597|FG000|NOT COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||0
3344693|NCT03471871|4074598|FG001|NOT COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||0
3344694|NCT03471871|4074599|FG002|NOT COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||0
3344695|NCT03471871|4074600|FG003|NOT COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||0
3344696|NCT03471871|4074601|FG004|NOT COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||1
3344697|NCT03471871|4074597|FG000|STARTED|Washout Period 2 (14 Days)||6
3344698|NCT03471871|4074598|FG001|STARTED|Washout Period 2 (14 Days)||5
3344699|NCT03471871|4074599|FG002|STARTED|Washout Period 2 (14 Days)||5
3344700|NCT03471871|4074600|FG003|STARTED|Washout Period 2 (14 Days)|0=not applicable, as OSA cohort was treated till Treatment Period 2, then directly followed up.|0
3344701|NCT03471871|4074601|FG004|STARTED|Washout Period 2 (14 Days)|0=not applicable, as OSA cohort was treated till Treatment Period 2, then directly followed up.|0
3344702|NCT03471871|4074597|FG000|COMPLETED|Washout Period 2 (14 Days)||6
3344703|NCT03471871|4074598|FG001|COMPLETED|Washout Period 2 (14 Days)||5
3344704|NCT03471871|4074599|FG002|COMPLETED|Washout Period 2 (14 Days)||5
3344705|NCT03471871|4074600|FG003|COMPLETED|Washout Period 2 (14 Days)||0
3344706|NCT03471871|4074601|FG004|COMPLETED|Washout Period 2 (14 Days)||0
3344707|NCT03471871|4074597|FG000|NOT COMPLETED|Washout Period 2 (14 Days)||0
3344708|NCT03471871|4074598|FG001|NOT COMPLETED|Washout Period 2 (14 Days)||0
3344709|NCT03471871|4074599|FG002|NOT COMPLETED|Washout Period 2 (14 Days)||0
3344710|NCT03471871|4074600|FG003|NOT COMPLETED|Washout Period 2 (14 Days)||0
3344711|NCT03471871|4074601|FG004|NOT COMPLETED|Washout Period 2 (14 Days)||0
3344712|NCT03471871|4074597|FG000|STARTED|Treatment Period 3: ( HV:1 Day)||6
3344713|NCT03471871|4074598|FG001|STARTED|Treatment Period 3: ( HV:1 Day)||5
3344714|NCT03471871|4074599|FG002|STARTED|Treatment Period 3: ( HV:1 Day)||5
3344715|NCT03471871|4074600|FG003|STARTED|Treatment Period 3: ( HV:1 Day)||0
3344716|NCT03471871|4074601|FG004|STARTED|Treatment Period 3: ( HV:1 Day)||0
3344717|NCT03471871|4074597|FG000|COMPLETED|Treatment Period 3: ( HV:1 Day)||6
3344718|NCT03471871|4074598|FG001|COMPLETED|Treatment Period 3: ( HV:1 Day)||5
3344719|NCT03471871|4074599|FG002|COMPLETED|Treatment Period 3: ( HV:1 Day)||5
3344720|NCT03471871|4074600|FG003|COMPLETED|Treatment Period 3: ( HV:1 Day)||0
3344721|NCT03471871|4074601|FG004|COMPLETED|Treatment Period 3: ( HV:1 Day)||0
3344722|NCT03471871|4074597|FG000|NOT COMPLETED|Treatment Period 3: ( HV:1 Day)||0
3344723|NCT03471871|4074598|FG001|NOT COMPLETED|Treatment Period 3: ( HV:1 Day)||0
3344724|NCT03471871|4074599|FG002|NOT COMPLETED|Treatment Period 3: ( HV:1 Day)||0
3344725|NCT03471871|4074600|FG003|NOT COMPLETED|Treatment Period 3: ( HV:1 Day)||0
3344726|NCT03471871|4074601|FG004|NOT COMPLETED|Treatment Period 3: ( HV:1 Day)||0
3344727|NCT03471871|4074597|FG000|STARTED|Follow Up (14 Days for Both HV and OSA)||6
3344728|NCT03471871|4074598|FG001|STARTED|Follow Up (14 Days for Both HV and OSA)||5
3344729|NCT03471871|4074599|FG002|STARTED|Follow Up (14 Days for Both HV and OSA)||5
3344730|NCT03471871|4074600|FG003|STARTED|Follow Up (14 Days for Both HV and OSA)|OSA cohort was treated till Treatment Period 2 only and then entered in follow up period.|18
3344731|NCT03471871|4074601|FG004|STARTED|Follow Up (14 Days for Both HV and OSA)|OSA cohort was treated till Treatment Period 2 only and then entered in follow up period.|18
3344732|NCT03471871|4074597|FG000|COMPLETED|Follow Up (14 Days for Both HV and OSA)||6
3344733|NCT03471871|4074598|FG001|COMPLETED|Follow Up (14 Days for Both HV and OSA)||5
3177545|NCT01971723|3905386|FG000|NOT COMPLETED|Overall Study||2
3177546|NCT01971723|3905387|FG001|NOT COMPLETED|Overall Study||3
3177547|NCT01972061|3905396|FG000|STARTED|Overall Study||1
3177548|NCT01972061|3905397|FG001|STARTED|Overall Study||23
3177549|NCT01972061|3905398|FG002|STARTED|Overall Study||20
3177550|NCT01972061|3905396|FG000|COMPLETED|Overall Study||1
3177551|NCT01972061|3905397|FG001|COMPLETED|Overall Study||23
3177552|NCT01972061|3905398|FG002|COMPLETED|Overall Study||20
3177553|NCT01972061|3905396|FG000|NOT COMPLETED|Overall Study||0
3177554|NCT01972061|3905397|FG001|NOT COMPLETED|Overall Study||0
3177555|NCT01972061|3905398|FG002|NOT COMPLETED|Overall Study||0
3177556|NCT01972074|3905409|FG000|STARTED|Overall Study||22
3177557|NCT01972074|3905410|FG001|STARTED|Overall Study||21
3177558|NCT01972074|3905411|FG002|STARTED|Overall Study||18
3177559|NCT01972074|3905409|FG000|COMPLETED|Overall Study||16
3177560|NCT01972074|3905410|FG001|COMPLETED|Overall Study||17
3177561|NCT01972074|3905411|FG002|COMPLETED|Overall Study||15
3177562|NCT01972074|3905409|FG000|NOT COMPLETED|Overall Study||6
3177563|NCT01972074|3905410|FG001|NOT COMPLETED|Overall Study||4
3177564|NCT01972074|3905411|FG002|NOT COMPLETED|Overall Study||3
3177565|NCT01972152|3905418|FG000|STARTED|First Treatment Visit||5
3177566|NCT01972152|3905419|FG001|STARTED|First Treatment Visit||5
3177567|NCT01972152|3905420|FG002|STARTED|First Treatment Visit||5
3177568|NCT01972152|3905421|FG003|STARTED|First Treatment Visit||5
3177569|NCT01972152|3905422|FG004|STARTED|First Treatment Visit||5
3177570|NCT01972152|3905423|FG005|STARTED|First Treatment Visit||5
3177571|NCT01972152|3905418|FG000|COMPLETED|First Treatment Visit||5
3177572|NCT01972152|3905419|FG001|COMPLETED|First Treatment Visit||4
3177573|NCT01972152|3905420|FG002|COMPLETED|First Treatment Visit||5
3177574|NCT01972152|3905421|FG003|COMPLETED|First Treatment Visit||5
3177575|NCT01972152|3905422|FG004|COMPLETED|First Treatment Visit||5
3177576|NCT01972152|3905423|FG005|COMPLETED|First Treatment Visit||5
3177577|NCT01972152|3905418|FG000|NOT COMPLETED|First Treatment Visit||0
3177578|NCT01972152|3905419|FG001|NOT COMPLETED|First Treatment Visit||1
3177579|NCT01972152|3905420|FG002|NOT COMPLETED|First Treatment Visit||0
3177580|NCT01972152|3905421|FG003|NOT COMPLETED|First Treatment Visit||0
3177581|NCT01972152|3905422|FG004|NOT COMPLETED|First Treatment Visit||0
3177582|NCT01972152|3905423|FG005|NOT COMPLETED|First Treatment Visit||0
3177583|NCT01972152|3905418|FG000|STARTED|Second Treatment Visit||5
3177584|NCT01972152|3905419|FG001|STARTED|Second Treatment Visit||4
3177585|NCT01972152|3905420|FG002|STARTED|Second Treatment Visit||5
3177586|NCT01972152|3905421|FG003|STARTED|Second Treatment Visit||5
3177587|NCT01972152|3905422|FG004|STARTED|Second Treatment Visit||5
3177588|NCT01972152|3905423|FG005|STARTED|Second Treatment Visit||5
3177589|NCT01972152|3905418|FG000|COMPLETED|Second Treatment Visit||5
3177590|NCT01972152|3905419|FG001|COMPLETED|Second Treatment Visit||3
3177591|NCT01972152|3905420|FG002|COMPLETED|Second Treatment Visit||5
3177592|NCT01972152|3905421|FG003|COMPLETED|Second Treatment Visit||5
3177593|NCT01972152|3905422|FG004|COMPLETED|Second Treatment Visit||5
3177594|NCT01972152|3905423|FG005|COMPLETED|Second Treatment Visit||5
3177595|NCT01972152|3905418|FG000|NOT COMPLETED|Second Treatment Visit||0
3177596|NCT01972152|3905419|FG001|NOT COMPLETED|Second Treatment Visit||1
3177597|NCT01972152|3905420|FG002|NOT COMPLETED|Second Treatment Visit||0
3177598|NCT01972152|3905421|FG003|NOT COMPLETED|Second Treatment Visit||0
3177599|NCT01972152|3905422|FG004|NOT COMPLETED|Second Treatment Visit||0
3177600|NCT01972152|3905423|FG005|NOT COMPLETED|Second Treatment Visit||0
3177601|NCT01972152|3905418|FG000|STARTED|Third Treatment Visit||5
3177602|NCT01972152|3905419|FG001|STARTED|Third Treatment Visit||3
3177603|NCT01972152|3905420|FG002|STARTED|Third Treatment Visit||5
3177604|NCT01972152|3905421|FG003|STARTED|Third Treatment Visit||5
3177605|NCT01972152|3905422|FG004|STARTED|Third Treatment Visit||5
3177606|NCT01972152|3905423|FG005|STARTED|Third Treatment Visit||5
3177607|NCT01972152|3905418|FG000|COMPLETED|Third Treatment Visit||5
3177608|NCT01972152|3905419|FG001|COMPLETED|Third Treatment Visit||3
3177609|NCT01972152|3905420|FG002|COMPLETED|Third Treatment Visit||5
3177610|NCT01972152|3905421|FG003|COMPLETED|Third Treatment Visit||5
3177611|NCT01972152|3905422|FG004|COMPLETED|Third Treatment Visit||5
3177612|NCT01972152|3905423|FG005|COMPLETED|Third Treatment Visit||5
3177613|NCT01972152|3905418|FG000|NOT COMPLETED|Third Treatment Visit||0
3177614|NCT01972152|3905419|FG001|NOT COMPLETED|Third Treatment Visit||0
3177615|NCT01972152|3905420|FG002|NOT COMPLETED|Third Treatment Visit||0
3177616|NCT01972152|3905421|FG003|NOT COMPLETED|Third Treatment Visit||0
3177617|NCT01972152|3905422|FG004|NOT COMPLETED|Third Treatment Visit||0
3177618|NCT01972152|3905423|FG005|NOT COMPLETED|Third Treatment Visit||0
3177619|NCT01972204|3905436|FG000|STARTED|Overall Study||62
3177620|NCT01972204|3905437|FG001|STARTED|Overall Study||63
3177621|NCT01972204|3905436|FG000|COMPLETED|Overall Study||58
3177622|NCT01972204|3905437|FG001|COMPLETED|Overall Study||59
3177623|NCT01972204|3905436|FG000|NOT COMPLETED|Overall Study||4
3177624|NCT01972204|3905437|FG001|NOT COMPLETED|Overall Study||4
3177625|NCT01972282|3905443|FG000|STARTED|Overall Study||1020
3177626|NCT01972282|3905443|FG000|COMPLETED|Overall Study||1005
3177627|NCT01972282|3905443|FG000|NOT COMPLETED|Overall Study||15
3177628|NCT01972308|3905449|FG000|STARTED|Overall Study||156
3177629|NCT01972308|3905450|FG001|STARTED|Overall Study||156
3177630|NCT01972308|3905449|FG000|COMPLETED|Overall Study||148
3177631|NCT01972308|3905450|FG001|COMPLETED|Overall Study||148
3177632|NCT01972308|3905449|FG000|NOT COMPLETED|Overall Study||8
3177633|NCT01972308|3905450|FG001|NOT COMPLETED|Overall Study||8
2927924|NCT00574951|3638848|FG000|STARTED|Overall Study||23
3177634|NCT01972438|3905460|FG000|STARTED|Baseline-Month 3 Crossover Period|Two participants never started IP: one died and one did not meet the inclusion criteria|9
3177635|NCT01972438|3905461|FG001|STARTED|Baseline-Month 3 Crossover Period|One participant never started IP, as unable to donate blood for preparation of ASEDs|9
3344734|NCT03471871|4074599|FG002|COMPLETED|Follow Up (14 Days for Both HV and OSA)||5
3177636|NCT01972438|3905460|FG000|COMPLETED|Baseline-Month 3 Crossover Period||6
3177637|NCT01972438|3905461|FG001|COMPLETED|Baseline-Month 3 Crossover Period||6
3177638|NCT01972438|3905460|FG000|NOT COMPLETED|Baseline-Month 3 Crossover Period||3
3177639|NCT01972438|3905461|FG001|NOT COMPLETED|Baseline-Month 3 Crossover Period||3
3177640|NCT01972438|3905460|FG000|STARTED|Months 3-6 Crossover Period||6
3177641|NCT01972438|3905461|FG001|STARTED|Months 3-6 Crossover Period|Two participants who missed Month 3 visit completed this pd but one who completed Month 3 didn't|7
3177642|NCT01972438|3905460|FG000|COMPLETED|Months 3-6 Crossover Period||6
3177643|NCT01972438|3905461|FG001|COMPLETED|Months 3-6 Crossover Period||6
3177644|NCT01972438|3905460|FG000|NOT COMPLETED|Months 3-6 Crossover Period||0
3177645|NCT01972438|3905461|FG001|NOT COMPLETED|Months 3-6 Crossover Period||1
3177646|NCT01972438|3905460|FG000|STARTED|Months 6-12 Study Period||6
3177647|NCT01972438|3905461|FG001|STARTED|Months 6-12 Study Period||6
3177648|NCT01972438|3905460|FG000|COMPLETED|Months 6-12 Study Period||3
3177649|NCT01972438|3905461|FG001|COMPLETED|Months 6-12 Study Period||4
3177650|NCT01972438|3905460|FG000|NOT COMPLETED|Months 6-12 Study Period||3
3177651|NCT01972438|3905461|FG001|NOT COMPLETED|Months 6-12 Study Period||2
3177652|NCT01972438|3905460|FG000|STARTED|Post Month 12 Study Period||3
3177653|NCT01972438|3905461|FG001|STARTED|Post Month 12 Study Period||4
3177654|NCT01972438|3905460|FG000|COMPLETED|Post Month 12 Study Period||0
3177655|NCT01972438|3905461|FG001|COMPLETED|Post Month 12 Study Period||0
3177656|NCT01972438|3905460|FG000|NOT COMPLETED|Post Month 12 Study Period||3
3177657|NCT01972438|3905461|FG001|NOT COMPLETED|Post Month 12 Study Period||4
3177658|NCT01972464|3905471|FG000|STARTED|Treatment Period (Week 1 Through Week 8)||19
3177659|NCT01972464|3905472|FG001|STARTED|Treatment Period (Week 1 Through Week 8)||22
3177660|NCT01972464|3905471|FG000|COMPLETED|Treatment Period (Week 1 Through Week 8)||16
3177661|NCT01972464|3905472|FG001|COMPLETED|Treatment Period (Week 1 Through Week 8)||18
3177662|NCT01972464|3905471|FG000|NOT COMPLETED|Treatment Period (Week 1 Through Week 8)||3
3177663|NCT01972464|3905472|FG001|NOT COMPLETED|Treatment Period (Week 1 Through Week 8)||4
3177664|NCT01972464|3905471|FG000|STARTED|3-Month Follow-Up (Week 20)||16
3177665|NCT01972464|3905472|FG001|STARTED|3-Month Follow-Up (Week 20)||18
3177666|NCT01972464|3905471|FG000|COMPLETED|3-Month Follow-Up (Week 20)||15
3177667|NCT01972464|3905472|FG001|COMPLETED|3-Month Follow-Up (Week 20)||17
3177668|NCT01972464|3905471|FG000|NOT COMPLETED|3-Month Follow-Up (Week 20)||1
3177669|NCT01972464|3905472|FG001|NOT COMPLETED|3-Month Follow-Up (Week 20)||1
3177670|NCT01972516|3905481|FG000|STARTED|Overall Study||3
3177671|NCT01972516|3905482|FG001|STARTED|Overall Study||1
3177672|NCT01972516|3905481|FG000|COMPLETED|Overall Study||3
3177673|NCT01972516|3905482|FG001|COMPLETED|Overall Study||1
3177674|NCT01972516|3905481|FG000|NOT COMPLETED|Overall Study||0
3177675|NCT01972516|3905482|FG001|NOT COMPLETED|Overall Study||0
3177676|NCT01972529|3905492|FG000|STARTED|Overall Study||48
3177677|NCT01972529|3905493|FG001|STARTED|Overall Study||90
3177678|NCT01972529|3905494|FG002|STARTED|Overall Study||34
3177679|NCT01972529|3905495|FG003|STARTED|Overall Study||59
3177680|NCT01972529|3905492|FG000|COMPLETED|Overall Study||46
3177681|NCT01972529|3905493|FG001|COMPLETED|Overall Study||85
3177682|NCT01972529|3905494|FG002|COMPLETED|Overall Study||32
3177683|NCT01972529|3905495|FG003|COMPLETED|Overall Study||55
3177684|NCT01972529|3905492|FG000|NOT COMPLETED|Overall Study||2
3177685|NCT01972529|3905493|FG001|NOT COMPLETED|Overall Study||5
3177686|NCT01972529|3905494|FG002|NOT COMPLETED|Overall Study||2
3177687|NCT01972529|3905495|FG003|NOT COMPLETED|Overall Study||4
3177688|NCT01972568|3905509|FG000|STARTED|Overall Study||102
3177689|NCT01972568|3905510|FG001|STARTED|Overall Study||104
3177690|NCT01972568|3905511|FG002|STARTED|Overall Study||100
3177691|NCT01972568|3905509|FG000|COMPLETED|Overall Study||86
3177692|NCT01972568|3905510|FG001|COMPLETED|Overall Study||92
3177693|NCT01972568|3905511|FG002|COMPLETED|Overall Study||84
3177694|NCT01972568|3905509|FG000|NOT COMPLETED|Overall Study||16
3177695|NCT01972568|3905510|FG001|NOT COMPLETED|Overall Study||12
3177696|NCT01972568|3905511|FG002|NOT COMPLETED|Overall Study||16
3177697|NCT01972659|3905521|FG000|STARTED|Overall Study||40
3177698|NCT01972659|3905522|FG001|STARTED|Overall Study||40
3177699|NCT01972659|3905521|FG000|COMPLETED|Overall Study||36
3177700|NCT01972659|3905522|FG001|COMPLETED|Overall Study||37
3177701|NCT01972659|3905521|FG000|NOT COMPLETED|Overall Study||4
3177702|NCT01972659|3905522|FG001|NOT COMPLETED|Overall Study||3
3177703|NCT01972724|3905531|FG000|STARTED|Double-Blind||19
3177704|NCT01972724|3905532|FG001|STARTED|Double-Blind||18
3177705|NCT01972724|3905533|FG002|STARTED|Double-Blind||0
3177706|NCT01972724|3905531|FG000|Intent-to-treat:Received Study Drug|Double-Blind||17
3177707|NCT01972724|3905532|FG001|Intent-to-treat:Received Study Drug|Double-Blind||17
3177708|NCT01972724|3905533|FG002|Intent-to-treat:Received Study Drug|Double-Blind||0
3177709|NCT01972724|3905531|FG000|COMPLETED|Double-Blind||10
3177710|NCT01972724|3905532|FG001|COMPLETED|Double-Blind||9
3177711|NCT01972724|3905533|FG002|COMPLETED|Double-Blind||0
3177712|NCT01972724|3905531|FG000|NOT COMPLETED|Double-Blind||9
3177713|NCT01972724|3905532|FG001|NOT COMPLETED|Double-Blind||9
3177714|NCT01972724|3905533|FG002|NOT COMPLETED|Double-Blind||0
3177715|NCT01972724|3905531|FG000|STARTED|Open-Label||0
3177716|NCT01972724|3905532|FG001|STARTED|Open-Label||0
3177717|NCT01972724|3905533|FG002|STARTED|Open-Label||77
3177718|NCT01972724|3905531|FG000|COMPLETED|Open-Label||0
3177719|NCT01972724|3905532|FG001|COMPLETED|Open-Label||0
3177720|NCT01972724|3905533|FG002|COMPLETED|Open-Label||72
3177721|NCT01972724|3905531|FG000|NOT COMPLETED|Open-Label||0
3177722|NCT01972724|3905532|FG001|NOT COMPLETED|Open-Label||0
3177723|NCT01972724|3905533|FG002|NOT COMPLETED|Open-Label||5
3177724|NCT01972776|3905547|FG000|STARTED|Part 1||6
3177725|NCT01972776|3905548|FG001|STARTED|Part 1||6
3177726|NCT01972776|3905549|FG002|STARTED|Part 1||8
3177727|NCT01972776|3905550|FG003|STARTED|Part 1||7
3177728|NCT01972776|3905551|FG004|STARTED|Part 1||0
3177729|NCT01972776|3905552|FG005|STARTED|Part 1||0
3177730|NCT01972776|3905547|FG000|COMPLETED|Part 1||6
3177731|NCT01972776|3905548|FG001|COMPLETED|Part 1||6
3177732|NCT01972776|3905549|FG002|COMPLETED|Part 1||6
3177733|NCT01972776|3905550|FG003|COMPLETED|Part 1||6
3177734|NCT01972776|3905551|FG004|COMPLETED|Part 1||0
3177735|NCT01972776|3905552|FG005|COMPLETED|Part 1||0
3177736|NCT01972776|3905547|FG000|NOT COMPLETED|Part 1||0
3177737|NCT01972776|3905548|FG001|NOT COMPLETED|Part 1||0
3177738|NCT01972776|3905549|FG002|NOT COMPLETED|Part 1||2
3177739|NCT01972776|3905550|FG003|NOT COMPLETED|Part 1||1
3177740|NCT01972776|3905551|FG004|NOT COMPLETED|Part 1||0
3177741|NCT01972776|3905552|FG005|NOT COMPLETED|Part 1||0
3177742|NCT01972776|3905547|FG000|STARTED|Part 2||0
3177743|NCT01972776|3905548|FG001|STARTED|Part 2||0
3177744|NCT01972776|3905549|FG002|STARTED|Part 2||0
3177745|NCT01972776|3905550|FG003|STARTED|Part 2||0
3177746|NCT01972776|3905551|FG004|STARTED|Part 2||14
3177747|NCT01972776|3905552|FG005|STARTED|Part 2||7
3177748|NCT01972776|3905547|FG000|COMPLETED|Part 2||0
3177749|NCT01972776|3905548|FG001|COMPLETED|Part 2||0
3177750|NCT01972776|3905549|FG002|COMPLETED|Part 2||0
3177751|NCT01972776|3905550|FG003|COMPLETED|Part 2||0
3177752|NCT01972776|3905551|FG004|COMPLETED|Part 2||1
3177753|NCT01972776|3905552|FG005|COMPLETED|Part 2||0
3177754|NCT01972776|3905547|FG000|NOT COMPLETED|Part 2||0
3177755|NCT01972776|3905548|FG001|NOT COMPLETED|Part 2||0
3177756|NCT01972776|3905549|FG002|NOT COMPLETED|Part 2||0
3177757|NCT01972776|3905550|FG003|NOT COMPLETED|Part 2||0
3177758|NCT01972776|3905551|FG004|NOT COMPLETED|Part 2||13
3177759|NCT01972776|3905552|FG005|NOT COMPLETED|Part 2||7
3177760|NCT01972789|3905568|FG000|STARTED|Overall Study||174
3177761|NCT01972789|3905569|FG001|STARTED|Overall Study||175
3177762|NCT01972789|3905568|FG000|COMPLETED|Overall Study||134
3177763|NCT01972789|3905569|FG001|COMPLETED|Overall Study||145
3177764|NCT01972789|3905568|FG000|NOT COMPLETED|Overall Study||40
3177765|NCT01972789|3905569|FG001|NOT COMPLETED|Overall Study||30
3177766|NCT01972841|3905581|FG000|STARTED|Overall Study||447
3177767|NCT01972841|3905582|FG001|STARTED|Overall Study||441
3177768|NCT01972841|3905583|FG002|STARTED|Overall Study||437
3177769|NCT01972841|3905584|FG003|STARTED|Overall Study||434
3177770|NCT01972841|3905585|FG004|STARTED|Overall Study||885
3177771|NCT01972841|3905586|FG005|STARTED|Overall Study||883
3344735|NCT03471871|4074600|FG003|COMPLETED|Follow Up (14 Days for Both HV and OSA)||17
3344736|NCT03471871|4074601|FG004|COMPLETED|Follow Up (14 Days for Both HV and OSA)||17
3344737|NCT03471871|4074597|FG000|NOT COMPLETED|Follow Up (14 Days for Both HV and OSA)||0
3344738|NCT03471871|4074598|FG001|NOT COMPLETED|Follow Up (14 Days for Both HV and OSA)||0
3344739|NCT03471871|4074599|FG002|NOT COMPLETED|Follow Up (14 Days for Both HV and OSA)||0
3344740|NCT03471871|4074600|FG003|NOT COMPLETED|Follow Up (14 Days for Both HV and OSA)||1
3344741|NCT03471871|4074601|FG004|NOT COMPLETED|Follow Up (14 Days for Both HV and OSA)||1
3344742|NCT03471975|4074615|FG000|STARTED|Overall Study||17
3344743|NCT03471975|4074616|FG001|STARTED|Overall Study||20
3344744|NCT03471975|4074615|FG000|COMPLETED|Overall Study||17
3344745|NCT03471975|4074616|FG001|COMPLETED|Overall Study||20
3344746|NCT03471975|4074615|FG000|NOT COMPLETED|Overall Study||0
3344747|NCT03471975|4074616|FG001|NOT COMPLETED|Overall Study||0
3344748|NCT03472014|4074622|FG000|STARTED|Overall Study||22
3344749|NCT03472014|4074622|FG000|COMPLETED|Overall Study||18
3344750|NCT03472014|4074622|FG000|NOT COMPLETED|Overall Study||4
3344751|NCT03472287|4074628|FG000|STARTED|Overall Study||8
3344752|NCT03472287|4074629|FG001|STARTED|Overall Study||3
3344753|NCT03472287|4074628|FG000|COMPLETED|Overall Study||8
3344754|NCT03472287|4074629|FG001|COMPLETED|Overall Study||3
3344755|NCT03472287|4074628|FG000|NOT COMPLETED|Overall Study||0
3344756|NCT03472287|4074629|FG001|NOT COMPLETED|Overall Study||0
3344757|NCT03472326|4074637|FG000|STARTED|Part 1: GS-9131 Functional Monotherapy||11
3344758|NCT03472326|4074638|FG001|STARTED|Part 1: GS-9131 Functional Monotherapy||10
3344759|NCT03472326|4074639|FG002|STARTED|Part 1: GS-9131 Functional Monotherapy||0
3344760|NCT03472326|4074640|FG003|STARTED|Part 1: GS-9131 Functional Monotherapy||0
3344761|NCT03472326|4074637|FG000|COMPLETED|Part 1: GS-9131 Functional Monotherapy||11
3344762|NCT03472326|4074638|FG001|COMPLETED|Part 1: GS-9131 Functional Monotherapy||10
3344763|NCT03472326|4074639|FG002|COMPLETED|Part 1: GS-9131 Functional Monotherapy||0
3344764|NCT03472326|4074640|FG003|COMPLETED|Part 1: GS-9131 Functional Monotherapy||0
3344765|NCT03472326|4074637|FG000|NOT COMPLETED|Part 1: GS-9131 Functional Monotherapy||0
3344766|NCT03472326|4074638|FG001|NOT COMPLETED|Part 1: GS-9131 Functional Monotherapy||0
3344767|NCT03472326|4074639|FG002|NOT COMPLETED|Part 1: GS-9131 Functional Monotherapy||0
3344768|NCT03472326|4074640|FG003|NOT COMPLETED|Part 1: GS-9131 Functional Monotherapy||0
3344769|NCT03472326|4074637|FG000|STARTED|Part 2: Combination Therapy||0
3344770|NCT03472326|4074638|FG001|STARTED|Part 2: Combination Therapy||0
3344771|NCT03472326|4074639|FG002|STARTED|Part 2: Combination Therapy|Of the participants who completed Part 1, only 1 participant entered in Part 2.|1
3344772|NCT03472326|4074640|FG003|STARTED|Part 2: Combination Therapy|Of the participants who completed Part 1, only 3 participants entered in Part 2.|3
3177772|NCT01972841|3905581|FG000|COMPLETED|Overall Study||404
3177773|NCT01972841|3905582|FG001|COMPLETED|Overall Study||397
3177774|NCT01972841|3905583|FG002|COMPLETED|Overall Study||387
3177775|NCT01972841|3905584|FG003|COMPLETED|Overall Study||397
3177776|NCT01972841|3905585|FG004|COMPLETED|Overall Study||802
3177777|NCT01972841|3905586|FG005|COMPLETED|Overall Study||798
3177778|NCT01972841|3905581|FG000|NOT COMPLETED|Overall Study||43
3344773|NCT03472326|4074637|FG000|COMPLETED|Part 2: Combination Therapy||0
3344774|NCT03472326|4074638|FG001|COMPLETED|Part 2: Combination Therapy||0
3344775|NCT03472326|4074639|FG002|COMPLETED|Part 2: Combination Therapy||0
3344776|NCT03472326|4074640|FG003|COMPLETED|Part 2: Combination Therapy||0
3344777|NCT03472326|4074637|FG000|NOT COMPLETED|Part 2: Combination Therapy||0
3344778|NCT03472326|4074638|FG001|NOT COMPLETED|Part 2: Combination Therapy||0
3344779|NCT03472326|4074639|FG002|NOT COMPLETED|Part 2: Combination Therapy||1
3344780|NCT03472326|4074640|FG003|NOT COMPLETED|Part 2: Combination Therapy||3
3344781|NCT03472469|4074651|FG000|STARTED|Overall Study||787
3344782|NCT03472469|4074652|FG001|STARTED|Overall Study||774
3344783|NCT03472469|4074651|FG000|COMPLETED|Overall Study||787
3344784|NCT03472469|4074652|FG001|COMPLETED|Overall Study||774
3344785|NCT03472469|4074651|FG000|NOT COMPLETED|Overall Study||0
3344786|NCT03472469|4074652|FG001|NOT COMPLETED|Overall Study||0
3344787|NCT03472521|4074660|FG000|STARTED|Overall Study||41
3344788|NCT03472521|4074661|FG001|STARTED|Overall Study||37
3344789|NCT03472521|4074660|FG000|Received Allocated Intervention|Overall Study||41
3344790|NCT03472521|4074661|FG001|Received Allocated Intervention|Overall Study||37
3344791|NCT03472521|4074660|FG000|COMPLETED|Overall Study||35
3344792|NCT03472521|4074661|FG001|COMPLETED|Overall Study||34
3344793|NCT03472521|4074660|FG000|NOT COMPLETED|Overall Study||6
3344794|NCT03472521|4074661|FG001|NOT COMPLETED|Overall Study||3
3344795|NCT03472534|4074667|FG000|STARTED|Overall Study|Each participant receives all 4 unit interventions.|46
3344796|NCT03472534|4074667|FG000|Diacerein 1% Ointment|Overall Study||46
3344797|NCT03472534|4074667|FG000|Vehicle Ointment|Overall Study||46
3344798|NCT03472534|4074667|FG000|0.2% Sodium Lauryl Sulfate (SLS)|Overall Study||46
3344799|NCT03472534|4074667|FG000|0.9% Saline|Overall Study||46
3344800|NCT03472534|4074667|FG000|COMPLETED|Overall Study||35
3344801|NCT03472534|4074667|FG000|NOT COMPLETED|Overall Study||11
3344802|NCT03472547|4074671|FG000|STARTED|Overall Study||234
3344803|NCT03472547|4074671|FG000|COMPLETED|Overall Study||204
3344804|NCT03472547|4074671|FG000|NOT COMPLETED|Overall Study||30
3344805|NCT03472885|4074675|FG000|STARTED|Overall Study||12
3344806|NCT03472885|4074675|FG000|Safety Population: Received at Least 1 Dose of Study Drug|Overall Study||12
3344807|NCT03472885|4074675|FG000|Efficacy Population: Received Study Drug for at Least 4 Weeks|Overall Study||11
3344808|NCT03472885|4074675|FG000|COMPLETED|Overall Study||11
3344809|NCT03472885|4074675|FG000|NOT COMPLETED|Overall Study||1
3344810|NCT03473171|4074679|FG000|STARTED|Overall Study||5
3344811|NCT03473171|4074679|FG000|COMPLETED|Overall Study||5
3344812|NCT03473171|4074679|FG000|NOT COMPLETED|Overall Study||0
3344813|NCT03473184|4074683|FG000|STARTED|Overall Study||34
3344814|NCT03473184|4074683|FG000|Diacerein 1% Ointment Irradiated|Overall Study||34
3344815|NCT03473184|4074683|FG000|Vehicle Ointment Irradiated|Overall Study||34
3344816|NCT03473184|4074683|FG000|Diacerein 1% Ointment Non-irradiated|Overall Study||34
3344817|NCT03473184|4074683|FG000|Vehicle Ointment Non-irradiated|Overall Study||34
3344818|NCT03473184|4074683|FG000|Untreated Irradiated|Overall Study||34
3344819|NCT03473184|4074683|FG000|COMPLETED|Overall Study||34
3344820|NCT03473184|4074683|FG000|NOT COMPLETED|Overall Study||0
3344821|NCT03473197|4074687|FG000|STARTED|Overall Study||61
3344822|NCT03473197|4074687|FG000|Diacerein 1% Ointment Irradiated|Overall Study||51
3344823|NCT03473197|4074687|FG000|Vehicle Ointment Irradiated|Overall Study||51
3344824|NCT03473197|4074687|FG000|Diacerein 1% Ointment Non-irradiated|Overall Study||51
3344825|NCT03473197|4074687|FG000|Vehicle Ointment Non-irradiated|Overall Study||51
3344826|NCT03473197|4074687|FG000|Untreated Irradiated|Overall Study||51
3344827|NCT03473197|4074687|FG000|COMPLETED|Overall Study||51
3344828|NCT03473197|4074687|FG000|NOT COMPLETED|Overall Study||10
3344829|NCT03473236|4074701|FG000|STARTED|Overall Study||10
3344830|NCT03473236|4074702|FG001|STARTED|Overall Study||6
3344831|NCT03473236|4074703|FG002|STARTED|Overall Study||6
3344832|NCT03473236|4074704|FG003|STARTED|Overall Study||6
3344833|NCT03473236|4074705|FG004|STARTED|Overall Study||6
3344834|NCT03473236|4074706|FG005|STARTED|Overall Study||7
3344835|NCT03473236|4074707|FG006|STARTED|Overall Study||6
3344836|NCT03473236|4074708|FG007|STARTED|Overall Study||6
3344837|NCT03473236|4074709|FG008|STARTED|Overall Study||7
3344838|NCT03473236|4074710|FG009|STARTED|Overall Study||6
3344839|NCT03473236|4074701|FG000|COMPLETED|Overall Study||10
3344840|NCT03473236|4074702|FG001|COMPLETED|Overall Study||6
3344841|NCT03473236|4074703|FG002|COMPLETED|Overall Study||6
3344842|NCT03473236|4074704|FG003|COMPLETED|Overall Study||6
3344843|NCT03473236|4074705|FG004|COMPLETED|Overall Study||6
3344844|NCT03473236|4074706|FG005|COMPLETED|Overall Study||6
3344845|NCT03473236|4074707|FG006|COMPLETED|Overall Study||6
3344846|NCT03473236|4074708|FG007|COMPLETED|Overall Study||6
3344847|NCT03473236|4074709|FG008|COMPLETED|Overall Study||6
3344848|NCT03473236|4074710|FG009|COMPLETED|Overall Study||6
3344849|NCT03473236|4074701|FG000|NOT COMPLETED|Overall Study||0
3344850|NCT03473236|4074702|FG001|NOT COMPLETED|Overall Study||0
3344851|NCT03473236|4074703|FG002|NOT COMPLETED|Overall Study||0
3344852|NCT03473236|4074704|FG003|NOT COMPLETED|Overall Study||0
3344853|NCT03473236|4074705|FG004|NOT COMPLETED|Overall Study||0
3344854|NCT03473236|4074706|FG005|NOT COMPLETED|Overall Study||1
3344855|NCT03473236|4074707|FG006|NOT COMPLETED|Overall Study||0
3344856|NCT03473236|4074708|FG007|NOT COMPLETED|Overall Study||0
3344857|NCT03473236|4074709|FG008|NOT COMPLETED|Overall Study||1
3344858|NCT03473236|4074710|FG009|NOT COMPLETED|Overall Study||0
3344859|NCT03473301|4074743|FG000|STARTED|Overall Study||31
3344860|NCT03473301|4074744|FG001|STARTED|Overall Study||29
3344861|NCT03473301|4074745|FG002|STARTED|Overall Study||31
3344862|NCT03473301|4074743|FG000|COMPLETED|Overall Study||20
3344863|NCT03473301|4074744|FG001|COMPLETED|Overall Study||23
3344864|NCT03473301|4074745|FG002|COMPLETED|Overall Study||25
3344865|NCT03473301|4074743|FG000|NOT COMPLETED|Overall Study||11
3344866|NCT03473301|4074744|FG001|NOT COMPLETED|Overall Study||6
3344867|NCT03473301|4074745|FG002|NOT COMPLETED|Overall Study||6
3344868|NCT03473665|4074755|FG000|STARTED|Overall Study||9
3344869|NCT03473665|4074755|FG000|COMPLETED|Overall Study||9
3344870|NCT03473665|4074755|FG000|NOT COMPLETED|Overall Study||0
3344871|NCT03473808|4074764|FG000|STARTED|Overall Study||5
3344872|NCT03473808|4074764|FG000|COMPLETED|Overall Study||4
3344873|NCT03473808|4074764|FG000|NOT COMPLETED|Overall Study||1
3344874|NCT03473886|4074768|FG000|STARTED|Overall Study||8
3344875|NCT03473886|4074768|FG000|COMPLETED|Overall Study||7
3344876|NCT03473886|4074768|FG000|NOT COMPLETED|Overall Study||1
3344877|NCT03474081|4074774|FG000|STARTED|Overall Study||400
3344878|NCT03474081|4074775|FG001|STARTED|Overall Study||400
3344879|NCT03474081|4074774|FG000|Received Study Treatment|Overall Study||400
3344880|NCT03474081|4074775|FG001|Received Study Treatment|Overall Study|One randomized participant withdrew consent and never received study treatment.|399
3344881|NCT03474081|4074774|FG000|COMPLETED|Overall Study||383
3344882|NCT03474081|4074775|FG001|COMPLETED|Overall Study||387
3344883|NCT03474081|4074774|FG000|NOT COMPLETED|Overall Study||17
3344884|NCT03474081|4074775|FG001|NOT COMPLETED|Overall Study||13
3344885|NCT03474172|4074783|FG000|STARTED|Overall Study||30
3344886|NCT03474172|4074784|FG001|STARTED|Overall Study||30
3344887|NCT03474172|4074783|FG000|COMPLETED|Overall Study||30
3344888|NCT03474172|4074784|FG001|COMPLETED|Overall Study||30
3344889|NCT03474172|4074783|FG000|NOT COMPLETED|Overall Study||0
3344890|NCT03474172|4074784|FG001|NOT COMPLETED|Overall Study||0
3344891|NCT03474406|4074793|FG000|STARTED|Overall Study||150
3344892|NCT03474406|4074793|FG000|COMPLETED|Overall Study||72
3344893|NCT03474406|4074793|FG000|NOT COMPLETED|Overall Study||78
3344894|NCT03474874|4074797|FG000|STARTED|Overall Study||68
3344895|NCT03474874|4074797|FG000|COMPLETED|Overall Study||54
3344896|NCT03474874|4074797|FG000|NOT COMPLETED|Overall Study||14
3344897|NCT03475056|4074805|FG000|STARTED|Overall Study||20
3344898|NCT03475056|4074806|FG001|STARTED|Overall Study||20
3344899|NCT03475056|4074805|FG000|Received Product Administration|Overall Study||20
3344900|NCT03475056|4074806|FG001|Received Product Administration|Overall Study||20
3344901|NCT03475056|4074805|FG000|COMPLETED|Overall Study||20
3344902|NCT03475056|4074806|FG001|COMPLETED|Overall Study||17
3344903|NCT03475056|4074805|FG000|NOT COMPLETED|Overall Study||0
3344904|NCT03475056|4074806|FG001|NOT COMPLETED|Overall Study||3
3344905|NCT03475316|4074815|FG000|STARTED|6 Month Intervention||13
3344906|NCT03475316|4074816|FG001|STARTED|6 Month Intervention||12
3344907|NCT03475316|4074815|FG000|COMPLETED|6 Month Intervention||8
3344908|NCT03475316|4074816|FG001|COMPLETED|6 Month Intervention||8
3344909|NCT03475316|4074815|FG000|NOT COMPLETED|6 Month Intervention||5
3344910|NCT03475316|4074816|FG001|NOT COMPLETED|6 Month Intervention||4
3344911|NCT03475316|4074815|FG000|STARTED|9 Months||8
3344912|NCT03475316|4074816|FG001|STARTED|9 Months||8
3344913|NCT03475316|4074815|FG000|COMPLETED|9 Months||5
3344914|NCT03475316|4074816|FG001|COMPLETED|9 Months||4
3344915|NCT03475316|4074815|FG000|NOT COMPLETED|9 Months||3
3344916|NCT03475316|4074816|FG001|NOT COMPLETED|9 Months||4
3344917|NCT03475875|4074822|FG000|STARTED|Period 1||46
3344918|NCT03475875|4074823|FG001|STARTED|Period 1||45
3344919|NCT03475875|4074822|FG000|COMPLETED|Period 1||43
3344920|NCT03475875|4074823|FG001|COMPLETED|Period 1||44
3344921|NCT03475875|4074822|FG000|NOT COMPLETED|Period 1||3
3344922|NCT03475875|4074823|FG001|NOT COMPLETED|Period 1||1
3344923|NCT03475875|4074822|FG000|STARTED|Period 2||43
3344924|NCT03475875|4074823|FG001|STARTED|Period 2||44
3344925|NCT03475875|4074822|FG000|COMPLETED|Period 2||40
3344926|NCT03475875|4074823|FG001|COMPLETED|Period 2||43
3344927|NCT03475875|4074822|FG000|NOT COMPLETED|Period 2||3
3344928|NCT03475875|4074823|FG001|NOT COMPLETED|Period 2||1
3344929|NCT03475875|4074822|FG000|STARTED|Period 3||40
3344930|NCT03475875|4074823|FG001|STARTED|Period 3||43
3344931|NCT03475875|4074822|FG000|COMPLETED|Period 3||40
3344932|NCT03475875|4074823|FG001|COMPLETED|Period 3||43
3344933|NCT03475875|4074822|FG000|NOT COMPLETED|Period 3||0
3344934|NCT03475875|4074823|FG001|NOT COMPLETED|Period 3||0
3344935|NCT03475992|4074832|FG000|STARTED|Overall Study||11
3344936|NCT03475992|4074833|FG001|STARTED|Overall Study||9
3344937|NCT03475992|4074834|FG002|STARTED|Overall Study||5
3344938|NCT03475992|4074832|FG000|COMPLETED|Overall Study||11
3344939|NCT03475992|4074833|FG001|COMPLETED|Overall Study||9
3344940|NCT03475992|4074834|FG002|COMPLETED|Overall Study||5
3344941|NCT03475992|4074832|FG000|NOT COMPLETED|Overall Study||0
3344942|NCT03475992|4074833|FG001|NOT COMPLETED|Overall Study||0
3344943|NCT03475992|4074834|FG002|NOT COMPLETED|Overall Study||0
3344944|NCT03476135|4074844|FG000|STARTED|Overall Study||42
3344945|NCT03476135|4074845|FG001|STARTED|Overall Study||49
3344946|NCT03476135|4074844|FG000|COMPLETED|Overall Study||42
3344947|NCT03476135|4074845|FG001|COMPLETED|Overall Study||49
3344948|NCT03476135|4074844|FG000|NOT COMPLETED|Overall Study||0
3344949|NCT03476135|4074845|FG001|NOT COMPLETED|Overall Study||0
3344950|NCT03476278|4074851|FG000|STARTED|Overall Study||300
3344951|NCT03476278|4074851|FG000|COMPLETED|Overall Study||300
3344952|NCT03476278|4074851|FG000|NOT COMPLETED|Overall Study||0
3344953|NCT03476798|4074865|FG000|STARTED|Overall Study||33
3344954|NCT03476798|4074865|FG000|COMPLETED|Overall Study||28
3344955|NCT03476798|4074865|FG000|NOT COMPLETED|Overall Study||5
3344956|NCT03476850|4074871|FG000|STARTED|Overall Study||24
3344957|NCT03476850|4074872|FG001|STARTED|Overall Study||24
3344958|NCT03476850|4074871|FG000|COMPLETED|Overall Study||24
3344959|NCT03476850|4074872|FG001|COMPLETED|Overall Study||24
3344960|NCT03476850|4074871|FG000|NOT COMPLETED|Overall Study||0
3344961|NCT03476850|4074872|FG001|NOT COMPLETED|Overall Study||0
3344962|NCT03477006|4074880|FG000|STARTED|Overall Study||40
3344963|NCT03477006|4074881|FG001|STARTED|Overall Study||46
3344964|NCT03477006|4074880|FG000|COMPLETED|Overall Study||40
3344965|NCT03477006|4074881|FG001|COMPLETED|Overall Study||46
3344966|NCT03477006|4074880|FG000|NOT COMPLETED|Overall Study||0
3344967|NCT03477006|4074881|FG001|NOT COMPLETED|Overall Study||0
3344968|NCT03477279|4074892|FG000|STARTED|Overall Study||250
3344969|NCT03477279|4074893|FG001|STARTED|Overall Study||250
3344970|NCT03477279|4074894|FG002|STARTED|Overall Study||98
3344971|NCT03477279|4074895|FG003|STARTED|Overall Study||168
3344972|NCT03477279|4074896|FG004|STARTED|Overall Study||350
3344973|NCT03477279|4074892|FG000|COMPLETED|Overall Study||203
3344974|NCT03477279|4074893|FG001|COMPLETED|Overall Study||202
3344975|NCT03477279|4074894|FG002|COMPLETED|Overall Study||98
3344976|NCT03477279|4074895|FG003|COMPLETED|Overall Study||136
3344977|NCT03477279|4074896|FG004|COMPLETED|Overall Study||349
3344978|NCT03477279|4074892|FG000|NOT COMPLETED|Overall Study||47
3344979|NCT03477279|4074893|FG001|NOT COMPLETED|Overall Study||48
3344980|NCT03477279|4074894|FG002|NOT COMPLETED|Overall Study||0
3344981|NCT03477279|4074895|FG003|NOT COMPLETED|Overall Study||32
3344982|NCT03477279|4074896|FG004|NOT COMPLETED|Overall Study||1
3344983|NCT03477838|4074909|FG000|STARTED|Overall Study||28
3344984|NCT03477838|4074909|FG000|COMPLETED|Overall Study||14
3344985|NCT03477838|4074909|FG000|NOT COMPLETED|Overall Study||14
3344986|NCT03478163|4074915|FG000|STARTED|Overall Study||5
3344987|NCT03478163|4074916|FG001|STARTED|Overall Study||6
3344988|NCT03478163|4074915|FG000|COMPLETED|Overall Study||5
3344989|NCT03478163|4074916|FG001|COMPLETED|Overall Study||6
3344990|NCT03478163|4074915|FG000|NOT COMPLETED|Overall Study||0
3344991|NCT03478163|4074916|FG001|NOT COMPLETED|Overall Study||0
3344992|NCT03478254|4074922|FG000|STARTED|Overall Study||300
3344993|NCT03478254|4074922|FG000|COMPLETED|Overall Study||300
3344994|NCT03478254|4074922|FG000|NOT COMPLETED|Overall Study||0
3344995|NCT03478371|4074927|FG000|STARTED|Overall Study||94
3344996|NCT03478371|4074927|FG000|Received Tampon D|Overall Study||91
3344997|NCT03478371|4074927|FG000|Received Tampon M|Overall Study||92
3344998|NCT03478371|4074927|FG000|Recived Tampon T|Overall Study||90
3344999|NCT03478371|4074927|FG000|Received Tampon V|Overall Study||91
3345000|NCT03478371|4074927|FG000|COMPLETED|Overall Study||89
3345001|NCT03478371|4074927|FG000|NOT COMPLETED|Overall Study||5
3345002|NCT03478644|4074939|FG000|STARTED|Phase 1|In Phase 1, only the wipe treatment was administered to eligible participants.|31
3345003|NCT03478644|4074940|FG001|STARTED|Phase 1||0
3345004|NCT03478644|4074939|FG000|COMPLETED|Phase 1|In Phase 1, only the wipe treatment was administered to eligible participants.|31
3345005|NCT03478644|4074940|FG001|COMPLETED|Phase 1||0
3345006|NCT03478644|4074939|FG000|NOT COMPLETED|Phase 1||0
3345007|NCT03478644|4074940|FG001|NOT COMPLETED|Phase 1||0
3345008|NCT03478644|4074939|FG000|STARTED|Phase 2||76
3345009|NCT03478644|4074940|FG001|STARTED|Phase 2||76
3345010|NCT03478644|4074939|FG000|COMPLETED|Phase 2||73
3345011|NCT03478644|4074940|FG001|COMPLETED|Phase 2||75
3345012|NCT03478644|4074939|FG000|NOT COMPLETED|Phase 2||3
3345013|NCT03478644|4074940|FG001|NOT COMPLETED|Phase 2||1
3345014|NCT03478657|4074948|FG000|STARTED|Overall Study||88
3345015|NCT03478657|4074949|FG001|STARTED|Overall Study||134
3345016|NCT03478657|4074948|FG000|COMPLETED|Overall Study||88
3345017|NCT03478657|4074949|FG001|COMPLETED|Overall Study||133
3345018|NCT03478657|4074948|FG000|NOT COMPLETED|Overall Study||0
3345019|NCT03478657|4074949|FG001|NOT COMPLETED|Overall Study||1
3345020|NCT03478683|4074957|FG000|STARTED|Overall Study||363
3345021|NCT03478683|4074958|FG001|STARTED|Overall Study||365
3345022|NCT03478683|4074957|FG000|COMPLETED|Overall Study||350
3345023|NCT03478683|4074958|FG001|COMPLETED|Overall Study||347
3345024|NCT03478683|4074957|FG000|NOT COMPLETED|Overall Study||13
3345025|NCT03478683|4074958|FG001|NOT COMPLETED|Overall Study||18
3345026|NCT03478696|4074966|FG000|STARTED|Overall Study||366
3345027|NCT03478696|4074967|FG001|STARTED|Overall Study||366
3345028|NCT03478696|4074966|FG000|COMPLETED|Overall Study||349
3345029|NCT03478696|4074967|FG001|COMPLETED|Overall Study||354
3345030|NCT03478696|4074966|FG000|NOT COMPLETED|Overall Study||17
3345031|NCT03478696|4074967|FG001|NOT COMPLETED|Overall Study||12
3345032|NCT03478787|4074975|FG000|STARTED|Overall Study||163
3345033|NCT03478787|4074976|FG001|STARTED|Overall Study||164
3345034|NCT03478787|4074975|FG000|COMPLETED|Overall Study||134
3345035|NCT03478787|4074976|FG001|COMPLETED|Overall Study||151
3345036|NCT03478787|4074975|FG000|NOT COMPLETED|Overall Study||29
3345037|NCT03478787|4074976|FG001|NOT COMPLETED|Overall Study||13
3345038|NCT03478891|4074985|FG000|STARTED|Overall Study||3
3345039|NCT03478891|4074986|FG001|STARTED|Overall Study||5
3345040|NCT03478891|4074987|FG002|STARTED|Overall Study||11
3345041|NCT03478891|4074985|FG000|Received MAb114|Overall Study||3
3345042|NCT03478891|4074986|FG001|Received MAb114|Overall Study||5
3345043|NCT03478891|4074987|FG002|Received MAb114|Overall Study|One Group 3 subject discontinued prior to MAb114 infusion due to inadequate venous access|10
3345044|NCT03478891|4074985|FG000|COMPLETED|Overall Study||2
3345045|NCT03478891|4074986|FG001|COMPLETED|Overall Study||5
3345046|NCT03478891|4074987|FG002|COMPLETED|Overall Study||8
3345047|NCT03478891|4074985|FG000|NOT COMPLETED|Overall Study||1
3345048|NCT03478891|4074986|FG001|NOT COMPLETED|Overall Study||0
3345049|NCT03478891|4074987|FG002|NOT COMPLETED|Overall Study||3
3345050|NCT03478904|4074999|FG000|STARTED|Overall Study||1
3345051|NCT03478904|4074999|FG000|COMPLETED|Overall Study||1
3345052|NCT03478904|4074999|FG000|NOT COMPLETED|Overall Study||0
3345053|NCT03478930|4075012|FG000|STARTED|Overall Study||126
3345054|NCT03478930|4075013|FG001|STARTED|Overall Study||123
3345055|NCT03478930|4075012|FG000|COMPLETED|Overall Study||117
3345056|NCT03478930|4075013|FG001|COMPLETED|Overall Study||114
3345057|NCT03478930|4075012|FG000|NOT COMPLETED|Overall Study||9
3345058|NCT03478930|4075013|FG001|NOT COMPLETED|Overall Study||9
3345059|NCT03478969|4075022|FG000|STARTED|Overall Study||62
3345060|NCT03478969|4075023|FG001|STARTED|Overall Study||61
3345061|NCT03478969|4075024|FG002|STARTED|Overall Study||58
3345062|NCT03478969|4075022|FG000|Participants at End of Parallel Phase|Overall Study||55
3345063|NCT03478969|4075023|FG001|Participants at End of Parallel Phase|Overall Study||58
3345064|NCT03478969|4075024|FG002|Participants at End of Parallel Phase|Overall Study||52
3345065|NCT03478969|4075022|FG000|COMPLETED|Overall Study||53
3345066|NCT03478969|4075023|FG001|COMPLETED|Overall Study||49
3345067|NCT03478969|4075024|FG002|COMPLETED|Overall Study||40
3345068|NCT03478969|4075022|FG000|NOT COMPLETED|Overall Study||9
3345069|NCT03478969|4075023|FG001|NOT COMPLETED|Overall Study||12
3345070|NCT03478969|4075024|FG002|NOT COMPLETED|Overall Study||18
3345071|NCT03478982|4075038|FG000|STARTED|Overall Study||11
3345072|NCT03478982|4075039|FG001|STARTED|Overall Study||50
3345073|NCT03478982|4075040|FG002|STARTED|Overall Study||47
3345074|NCT03478982|4075041|FG003|STARTED|Overall Study||48
3345075|NCT03478982|4075038|FG000|Enrolled Participants But Not Treated|Overall Study||3
3345076|NCT03478982|4075039|FG001|Enrolled Participants But Not Treated|Overall Study||10
3345077|NCT03478982|4075040|FG002|Enrolled Participants But Not Treated|Overall Study||9
3345078|NCT03478982|4075041|FG003|Enrolled Participants But Not Treated|Overall Study||10
3345079|NCT03478982|4075038|FG000|Intent-to-treat (ITT) Population|Overall Study||8
3345080|NCT03478982|4075039|FG001|Intent-to-treat (ITT) Population|Overall Study||40
3345081|NCT03478982|4075040|FG002|Intent-to-treat (ITT) Population|Overall Study||38
3345082|NCT03478982|4075041|FG003|Intent-to-treat (ITT) Population|Overall Study||38
3345083|NCT03478982|4075038|FG000|COMPLETED|Overall Study||11
3345084|NCT03478982|4075039|FG001|COMPLETED|Overall Study||50
3345085|NCT03478982|4075040|FG002|COMPLETED|Overall Study||47
3345086|NCT03478982|4075041|FG003|COMPLETED|Overall Study||48
3345087|NCT03478982|4075038|FG000|NOT COMPLETED|Overall Study||0
3345088|NCT03478982|4075039|FG001|NOT COMPLETED|Overall Study||0
3345089|NCT03478982|4075040|FG002|NOT COMPLETED|Overall Study||0
3177779|NCT01972841|3905582|FG001|NOT COMPLETED|Overall Study||44
3177780|NCT01972841|3905583|FG002|NOT COMPLETED|Overall Study||50
3177781|NCT01972841|3905584|FG003|NOT COMPLETED|Overall Study||37
3177782|NCT01972841|3905585|FG004|NOT COMPLETED|Overall Study||83
3177783|NCT01972841|3905586|FG005|NOT COMPLETED|Overall Study||85
3177784|NCT01973036|3905602|FG000|STARTED|Overall Study||108
3177785|NCT01973036|3905603|FG001|STARTED|Overall Study||93
3177786|NCT01973036|3905602|FG000|Received Assigned Intervention|Overall Study||113
3345090|NCT03478982|4075041|FG003|NOT COMPLETED|Overall Study||0
3345091|NCT03479216|4075053|FG000|STARTED|Overall Study||31
3345092|NCT03479216|4075054|FG001|STARTED|Overall Study||31
3345093|NCT03479216|4075053|FG000|COMPLETED|Overall Study||26
3345094|NCT03479216|4075054|FG001|COMPLETED|Overall Study||26
3345095|NCT03479216|4075053|FG000|NOT COMPLETED|Overall Study||5
3345096|NCT03479216|4075054|FG001|NOT COMPLETED|Overall Study||5
3345097|NCT03479944|4075060|FG000|STARTED|Overall Study||55
3345098|NCT03479944|4075060|FG000|FLACS|Overall Study||55
3345099|NCT03479944|4075060|FG000|Conventional|Overall Study||55
3345100|NCT03479944|4075060|FG000|Full Analysis Set|Overall Study||53
3345101|NCT03479944|4075060|FG000|COMPLETED|Overall Study||55
3345102|NCT03479944|4075060|FG000|NOT COMPLETED|Overall Study||0
3345103|NCT03480009|4075072|FG000|STARTED|Overall Study||62
3345104|NCT03480009|4075073|FG001|STARTED|Overall Study||62
3345105|NCT03480009|4075074|FG002|STARTED|Overall Study||16
3345106|NCT03480009|4075075|FG003|STARTED|Overall Study||16
3345107|NCT03480009|4075072|FG000|COMPLETED|Overall Study||58
3345108|NCT03480009|4075073|FG001|COMPLETED|Overall Study||57
3345109|NCT03480009|4075074|FG002|COMPLETED|Overall Study||12
3345110|NCT03480009|4075075|FG003|COMPLETED|Overall Study||16
3345111|NCT03480009|4075072|FG000|NOT COMPLETED|Overall Study||4
3345112|NCT03480009|4075073|FG001|NOT COMPLETED|Overall Study||5
3345113|NCT03480009|4075074|FG002|NOT COMPLETED|Overall Study||4
3345114|NCT03480009|4075075|FG003|NOT COMPLETED|Overall Study||0
3345115|NCT03480022|4075090|FG000|STARTED|Overall Study||55
3345116|NCT03480022|4075091|FG001|STARTED|Overall Study||27
3345117|NCT03480022|4075090|FG000|COMPLETED|Overall Study||44
3345118|NCT03480022|4075091|FG001|COMPLETED|Overall Study||23
3345119|NCT03480022|4075090|FG000|NOT COMPLETED|Overall Study||11
3345120|NCT03480022|4075091|FG001|NOT COMPLETED|Overall Study||4
3345121|NCT03480048|4075099|FG000|STARTED|Overall Study||28
3345122|NCT03480048|4075100|FG001|STARTED|Overall Study||25
3345123|NCT03480048|4075099|FG000|COMPLETED|Overall Study||18
3345124|NCT03480048|4075100|FG001|COMPLETED|Overall Study||17
3345125|NCT03480048|4075099|FG000|NOT COMPLETED|Overall Study||10
3345126|NCT03480048|4075100|FG001|NOT COMPLETED|Overall Study||8
3345127|NCT03480152|4075108|FG000|STARTED|Phase I||3
3345128|NCT03480152|4075109|FG001|STARTED|Phase I||2
3345129|NCT03480152|4075110|FG002|STARTED|Phase I||0
3345130|NCT03480152|4075108|FG000|Received Intervention|Phase I||2
3345131|NCT03480152|4075109|FG001|Received Intervention|Phase I||2
3345132|NCT03480152|4075110|FG002|Received Intervention|Phase I||0
3345133|NCT03480152|4075108|FG000|COMPLETED|Phase I||2
3345134|NCT03480152|4075109|FG001|COMPLETED|Phase I||2
3345135|NCT03480152|4075110|FG002|COMPLETED|Phase I||0
3345136|NCT03480152|4075108|FG000|NOT COMPLETED|Phase I||1
3345137|NCT03480152|4075109|FG001|NOT COMPLETED|Phase I||0
3345138|NCT03480152|4075110|FG002|NOT COMPLETED|Phase I||0
3345139|NCT03480152|4075108|FG000|STARTED|Phase II||0
3345140|NCT03480152|4075109|FG001|STARTED|Phase II||0
3345141|NCT03480152|4075110|FG002|STARTED|Phase II||0
3345142|NCT03480152|4075108|FG000|COMPLETED|Phase II||0
3345143|NCT03480152|4075109|FG001|COMPLETED|Phase II||0
3345144|NCT03480152|4075110|FG002|COMPLETED|Phase II||0
3345145|NCT03480152|4075108|FG000|NOT COMPLETED|Phase II||0
3345146|NCT03480152|4075109|FG001|NOT COMPLETED|Phase II||0
3345147|NCT03480152|4075110|FG002|NOT COMPLETED|Phase II||0
3345148|NCT03480243|4075118|FG000|STARTED|Padsevonil (Period 1)||28
3345149|NCT03480243|4075118|FG000|COMPLETED|Padsevonil (Period 1)||28
3345150|NCT03480243|4075118|FG000|NOT COMPLETED|Padsevonil (Period 1)||0
3345151|NCT03480243|4075118|FG000|STARTED|Padsevonil (Period 2)||28
3345152|NCT03480243|4075118|FG000|COMPLETED|Padsevonil (Period 2)||27
3345153|NCT03480243|4075118|FG000|NOT COMPLETED|Padsevonil (Period 2)||1
3345154|NCT03480243|4075118|FG000|STARTED|Erythromycin (Period 3a)||27
3345155|NCT03480243|4075118|FG000|COMPLETED|Erythromycin (Period 3a)||27
3345156|NCT03480243|4075118|FG000|NOT COMPLETED|Erythromycin (Period 3a)||0
3345157|NCT03480243|4075118|FG000|STARTED|Padsevonil and Erythromycin (Period 3b)||27
3345158|NCT03480243|4075118|FG000|COMPLETED|Padsevonil and Erythromycin (Period 3b)||26
3345159|NCT03480243|4075118|FG000|NOT COMPLETED|Padsevonil and Erythromycin (Period 3b)||1
3345160|NCT03480243|4075118|FG000|STARTED|Erythromycin (Period 3c)||26
3345161|NCT03480243|4075118|FG000|COMPLETED|Erythromycin (Period 3c)||26
3345162|NCT03480243|4075118|FG000|NOT COMPLETED|Erythromycin (Period 3c)||0
3345163|NCT03480425|4075131|FG000|STARTED|Overall Study||11
3345164|NCT03480425|4075131|FG000|COMPLETED|Overall Study||10
3345165|NCT03480425|4075131|FG000|NOT COMPLETED|Overall Study||1
3345166|NCT03480685|4075135|FG000|STARTED|Overall Study||12
3345167|NCT03480685|4075135|FG000|COMPLETED|Overall Study||12
3345168|NCT03480685|4075135|FG000|NOT COMPLETED|Overall Study||0
3345169|NCT03480750|4075147|FG000|STARTED|Overall Study||3
3345170|NCT03480750|4075148|FG001|STARTED|Overall Study||4
3345171|NCT03480750|4075149|FG002|STARTED|Overall Study||3
3345172|NCT03480750|4075150|FG003|STARTED|Overall Study||3
3345173|NCT03480750|4075151|FG004|STARTED|Overall Study||3
3345174|NCT03480750|4075152|FG005|STARTED|Overall Study||2
3345175|NCT03480750|4075147|FG000|COMPLETED|Overall Study||3
3345176|NCT03480750|4075148|FG001|COMPLETED|Overall Study||3
3345177|NCT03480750|4075149|FG002|COMPLETED|Overall Study||3
3345178|NCT03480750|4075150|FG003|COMPLETED|Overall Study||3
3345179|NCT03480750|4075151|FG004|COMPLETED|Overall Study||3
3345180|NCT03480750|4075152|FG005|COMPLETED|Overall Study||1
3345181|NCT03480750|4075147|FG000|NOT COMPLETED|Overall Study||0
3345182|NCT03480750|4075148|FG001|NOT COMPLETED|Overall Study||1
3345183|NCT03480750|4075149|FG002|NOT COMPLETED|Overall Study||0
3345184|NCT03480750|4075150|FG003|NOT COMPLETED|Overall Study||0
3345185|NCT03480750|4075151|FG004|NOT COMPLETED|Overall Study||0
3345186|NCT03480750|4075152|FG005|NOT COMPLETED|Overall Study||1
3345187|NCT03480763|4075177|FG000|STARTED|Overall Study||327
3345188|NCT03480763|4075178|FG001|STARTED|Overall Study||325
3345189|NCT03480763|4075177|FG000|Vaccination 1 - (V114 or Prevnar 13™, Day 1)|Overall Study||326
3345190|NCT03480763|4075178|FG001|Vaccination 1 - (V114 or Prevnar 13™, Day 1)|Overall Study||325
3345191|NCT03480763|4075177|FG000|Vaccination 2 - (PNEUMOVAX™23, Month 12)|Overall Study||298
3345192|NCT03480763|4075178|FG001|Vaccination 2 - (PNEUMOVAX™23, Month 12)|Overall Study||302
3345193|NCT03480763|4075177|FG000|COMPLETED|Overall Study||303
3345194|NCT03480763|4075178|FG001|COMPLETED|Overall Study||306
3345195|NCT03480763|4075177|FG000|NOT COMPLETED|Overall Study||24
3345196|NCT03480763|4075178|FG001|NOT COMPLETED|Overall Study||19
3345197|NCT03480802|4075192|FG000|STARTED|Overall Study||152
3345198|NCT03480802|4075193|FG001|STARTED|Overall Study||150
3345199|NCT03480802|4075192|FG000|Week 8|Overall Study||150
3345200|NCT03480802|4075193|FG001|Week 8|Overall Study||148
3345201|NCT03480802|4075192|FG000|COMPLETED|Overall Study||145
3345202|NCT03480802|4075193|FG001|COMPLETED|Overall Study||147
3345203|NCT03480802|4075192|FG000|NOT COMPLETED|Overall Study||7
3345204|NCT03480802|4075193|FG001|NOT COMPLETED|Overall Study||3
3345205|NCT03480841|4075201|FG000|STARTED|Overall Study||10
3345206|NCT03480841|4075201|FG000|Time 1 Data Collection (T1)|Overall Study||10
3345207|NCT03480841|4075201|FG000|LENA Baseline|Overall Study||10
3345208|NCT03480841|4075201|FG000|LENA Time 1|Overall Study||10
3345209|NCT03480841|4075201|FG000|LENA Time 2|Overall Study||10
3345210|NCT03480841|4075201|FG000|LENA Time 3|Overall Study||10
3345211|NCT03480841|4075201|FG000|LENA Time 4|Overall Study||9
3345212|NCT03480841|4075201|FG000|LENA Time 5|Overall Study||8
3345213|NCT03480841|4075201|FG000|Time 2 Data Collection (T2)|Overall Study||8
3345214|NCT03480841|4075201|FG000|COMPLETED|Overall Study||8
3345215|NCT03480841|4075201|FG000|NOT COMPLETED|Overall Study||2
3345216|NCT03480919|4075208|FG000|STARTED|Overall Study||1
3345217|NCT03480919|4075209|FG001|STARTED|Overall Study||2
3345218|NCT03480919|4075210|FG002|STARTED|Overall Study||1
3345219|NCT03480919|4075208|FG000|COMPLETED|Overall Study||1
3345220|NCT03480919|4075209|FG001|COMPLETED|Overall Study||2
3345221|NCT03480919|4075210|FG002|COMPLETED|Overall Study||1
3345222|NCT03480919|4075208|FG000|NOT COMPLETED|Overall Study||0
3345223|NCT03480919|4075209|FG001|NOT COMPLETED|Overall Study||0
3345224|NCT03480919|4075210|FG002|NOT COMPLETED|Overall Study||0
3345225|NCT03480932|4075221|FG000|STARTED|Overall Study||50
3345226|NCT03480932|4075222|FG001|STARTED|Overall Study||50
3345227|NCT03480932|4075223|FG002|STARTED|Overall Study||50
3345228|NCT03480932|4075221|FG000|COMPLETED|Overall Study||47
3345229|NCT03480932|4075222|FG001|COMPLETED|Overall Study||45
3345230|NCT03480932|4075223|FG002|COMPLETED|Overall Study||45
3345231|NCT03480932|4075221|FG000|NOT COMPLETED|Overall Study||3
3345232|NCT03480932|4075222|FG001|NOT COMPLETED|Overall Study||5
3345233|NCT03480932|4075223|FG002|NOT COMPLETED|Overall Study||5
3345234|NCT03481270|4075233|FG000|STARTED|Overall Study||324
3345235|NCT03481270|4075234|FG001|STARTED|Overall Study||313
3345236|NCT03481270|4075233|FG000|COMPLETED|Overall Study||324
3345237|NCT03481270|4075234|FG001|COMPLETED|Overall Study||313
3345238|NCT03481270|4075233|FG000|NOT COMPLETED|Overall Study||0
3345239|NCT03481270|4075234|FG001|NOT COMPLETED|Overall Study||0
3345240|NCT03481309|4075246|FG000|STARTED|First Intervention (1 Day)||4
3345241|NCT03481309|4075247|FG001|STARTED|First Intervention (1 Day)||3
3345242|NCT03481309|4075248|FG002|STARTED|First Intervention (1 Day)||3
3345243|NCT03481309|4075249|FG003|STARTED|First Intervention (1 Day)||3
3345244|NCT03481309|4075250|FG004|STARTED|First Intervention (1 Day)||3
3345245|NCT03481309|4075251|FG005|STARTED|First Intervention (1 Day)||3
3345246|NCT03481309|4075246|FG000|COMPLETED|First Intervention (1 Day)||4
3345247|NCT03481309|4075247|FG001|COMPLETED|First Intervention (1 Day)||3
3345248|NCT03481309|4075248|FG002|COMPLETED|First Intervention (1 Day)||3
3345249|NCT03481309|4075249|FG003|COMPLETED|First Intervention (1 Day)||3
3345250|NCT03481309|4075250|FG004|COMPLETED|First Intervention (1 Day)||3
3345251|NCT03481309|4075251|FG005|COMPLETED|First Intervention (1 Day)||3
3345252|NCT03481309|4075246|FG000|NOT COMPLETED|First Intervention (1 Day)||0
3345253|NCT03481309|4075247|FG001|NOT COMPLETED|First Intervention (1 Day)||0
3345254|NCT03481309|4075248|FG002|NOT COMPLETED|First Intervention (1 Day)||0
3345255|NCT03481309|4075249|FG003|NOT COMPLETED|First Intervention (1 Day)||0
3345256|NCT03481309|4075250|FG004|NOT COMPLETED|First Intervention (1 Day)||0
3345257|NCT03481309|4075251|FG005|NOT COMPLETED|First Intervention (1 Day)||0
3345258|NCT03481309|4075246|FG000|STARTED|Washout (at Least 3 Days)||4
3345259|NCT03481309|4075247|FG001|STARTED|Washout (at Least 3 Days)||3
3345260|NCT03481309|4075248|FG002|STARTED|Washout (at Least 3 Days)||3
3345261|NCT03481309|4075249|FG003|STARTED|Washout (at Least 3 Days)||3
3345262|NCT03481309|4075250|FG004|STARTED|Washout (at Least 3 Days)||3
3345263|NCT03481309|4075251|FG005|STARTED|Washout (at Least 3 Days)||3
3345264|NCT03481309|4075246|FG000|COMPLETED|Washout (at Least 3 Days)||3
3345265|NCT03481309|4075247|FG001|COMPLETED|Washout (at Least 3 Days)||3
3345266|NCT03481309|4075248|FG002|COMPLETED|Washout (at Least 3 Days)||3
3345267|NCT03481309|4075249|FG003|COMPLETED|Washout (at Least 3 Days)||3
3345268|NCT03481309|4075250|FG004|COMPLETED|Washout (at Least 3 Days)||3
3345269|NCT03481309|4075251|FG005|COMPLETED|Washout (at Least 3 Days)||3
3345270|NCT03481309|4075246|FG000|NOT COMPLETED|Washout (at Least 3 Days)||1
3345271|NCT03481309|4075247|FG001|NOT COMPLETED|Washout (at Least 3 Days)||0
3345272|NCT03481309|4075248|FG002|NOT COMPLETED|Washout (at Least 3 Days)||0
3345273|NCT03481309|4075249|FG003|NOT COMPLETED|Washout (at Least 3 Days)||0
3345274|NCT03481309|4075250|FG004|NOT COMPLETED|Washout (at Least 3 Days)||0
3345275|NCT03481309|4075251|FG005|NOT COMPLETED|Washout (at Least 3 Days)||0
3345276|NCT03481309|4075246|FG000|STARTED|Second Intervention (1 Day)||3
3345277|NCT03481309|4075247|FG001|STARTED|Second Intervention (1 Day)||3
3345278|NCT03481309|4075248|FG002|STARTED|Second Intervention (1 Day)||3
3345279|NCT03481309|4075249|FG003|STARTED|Second Intervention (1 Day)||3
3345280|NCT03481309|4075250|FG004|STARTED|Second Intervention (1 Day)||3
3345281|NCT03481309|4075251|FG005|STARTED|Second Intervention (1 Day)||3
3345282|NCT03481309|4075246|FG000|COMPLETED|Second Intervention (1 Day)||3
3345283|NCT03481309|4075247|FG001|COMPLETED|Second Intervention (1 Day)||3
3345284|NCT03481309|4075248|FG002|COMPLETED|Second Intervention (1 Day)||3
3345285|NCT03481309|4075249|FG003|COMPLETED|Second Intervention (1 Day)||3
3345286|NCT03481309|4075250|FG004|COMPLETED|Second Intervention (1 Day)||3
3345287|NCT03481309|4075251|FG005|COMPLETED|Second Intervention (1 Day)||3
3345288|NCT03481309|4075246|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
3345289|NCT03481309|4075247|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
3345290|NCT03481309|4075248|FG002|NOT COMPLETED|Second Intervention (1 Day)||0
3345291|NCT03481309|4075249|FG003|NOT COMPLETED|Second Intervention (1 Day)||0
3345292|NCT03481309|4075250|FG004|NOT COMPLETED|Second Intervention (1 Day)||0
3345293|NCT03481309|4075251|FG005|NOT COMPLETED|Second Intervention (1 Day)||0
3345294|NCT03481309|4075246|FG000|STARTED|Washout (at Least 3 Days)||3
3345295|NCT03481309|4075247|FG001|STARTED|Washout (at Least 3 Days)||3
3345296|NCT03481309|4075248|FG002|STARTED|Washout (at Least 3 Days)||3
3345297|NCT03481309|4075249|FG003|STARTED|Washout (at Least 3 Days)||3
3345298|NCT03481309|4075250|FG004|STARTED|Washout (at Least 3 Days)||3
3345299|NCT03481309|4075251|FG005|STARTED|Washout (at Least 3 Days)||3
3345300|NCT03481309|4075246|FG000|COMPLETED|Washout (at Least 3 Days)||3
3345301|NCT03481309|4075247|FG001|COMPLETED|Washout (at Least 3 Days)||3
3345302|NCT03481309|4075248|FG002|COMPLETED|Washout (at Least 3 Days)||3
3345303|NCT03481309|4075249|FG003|COMPLETED|Washout (at Least 3 Days)||3
3345304|NCT03481309|4075250|FG004|COMPLETED|Washout (at Least 3 Days)||3
3345305|NCT03481309|4075251|FG005|COMPLETED|Washout (at Least 3 Days)||3
3345306|NCT03481309|4075246|FG000|NOT COMPLETED|Washout (at Least 3 Days)||0
3345307|NCT03481309|4075247|FG001|NOT COMPLETED|Washout (at Least 3 Days)||0
3345308|NCT03481309|4075248|FG002|NOT COMPLETED|Washout (at Least 3 Days)||0
3345309|NCT03481309|4075249|FG003|NOT COMPLETED|Washout (at Least 3 Days)||0
3345310|NCT03481309|4075250|FG004|NOT COMPLETED|Washout (at Least 3 Days)||0
3345311|NCT03481309|4075251|FG005|NOT COMPLETED|Washout (at Least 3 Days)||0
3345312|NCT03481309|4075246|FG000|STARTED|Third Intervention (1 Day)||3
3345313|NCT03481309|4075247|FG001|STARTED|Third Intervention (1 Day)||3
3345314|NCT03481309|4075248|FG002|STARTED|Third Intervention (1 Day)||3
3345315|NCT03481309|4075249|FG003|STARTED|Third Intervention (1 Day)||3
3345316|NCT03481309|4075250|FG004|STARTED|Third Intervention (1 Day)||3
3345317|NCT03481309|4075251|FG005|STARTED|Third Intervention (1 Day)||3
3345318|NCT03481309|4075246|FG000|COMPLETED|Third Intervention (1 Day)||3
3345319|NCT03481309|4075247|FG001|COMPLETED|Third Intervention (1 Day)||3
3345320|NCT03481309|4075248|FG002|COMPLETED|Third Intervention (1 Day)||3
3345321|NCT03481309|4075249|FG003|COMPLETED|Third Intervention (1 Day)||3
3345322|NCT03481309|4075250|FG004|COMPLETED|Third Intervention (1 Day)||3
3345323|NCT03481309|4075251|FG005|COMPLETED|Third Intervention (1 Day)||3
3345324|NCT03481309|4075246|FG000|NOT COMPLETED|Third Intervention (1 Day)||0
3345325|NCT03481309|4075247|FG001|NOT COMPLETED|Third Intervention (1 Day)||0
3345326|NCT03481309|4075248|FG002|NOT COMPLETED|Third Intervention (1 Day)||0
3345327|NCT03481309|4075249|FG003|NOT COMPLETED|Third Intervention (1 Day)||0
3345328|NCT03481309|4075250|FG004|NOT COMPLETED|Third Intervention (1 Day)||0
3345329|NCT03481309|4075251|FG005|NOT COMPLETED|Third Intervention (1 Day)||0
3345330|NCT03481595|4075261|FG000|STARTED|Overall Study||146
3345331|NCT03481595|4075262|FG001|STARTED|Overall Study||148
3345332|NCT03481595|4075261|FG000|COMPLETED|Overall Study||143
3345333|NCT03481595|4075262|FG001|COMPLETED|Overall Study||127
3345334|NCT03481595|4075261|FG000|NOT COMPLETED|Overall Study||3
3345335|NCT03481595|4075262|FG001|NOT COMPLETED|Overall Study||21
3345336|NCT03481725|4075270|FG000|STARTED|Overall Study||31
3345337|NCT03481725|4075271|FG001|STARTED|Overall Study||34
3345338|NCT03481725|4075270|FG000|COMPLETED|Overall Study||30
3345339|NCT03481725|4075271|FG001|COMPLETED|Overall Study||34
3345340|NCT03481725|4075270|FG000|NOT COMPLETED|Overall Study||1
3345341|NCT03481725|4075271|FG001|NOT COMPLETED|Overall Study||0
3345342|NCT03481816|4075281|FG000|STARTED|Starting Dose||6
3345343|NCT03481816|4075282|FG001|STARTED|Starting Dose||0
3345344|NCT03481816|4075281|FG000|COMPLETED|Starting Dose||5
3345345|NCT03481816|4075282|FG001|COMPLETED|Starting Dose||0
3345346|NCT03481816|4075281|FG000|NOT COMPLETED|Starting Dose||1
3345347|NCT03481816|4075282|FG001|NOT COMPLETED|Starting Dose||0
3345348|NCT03481816|4075281|FG000|STARTED|Dose Expansion||0
3345349|NCT03481816|4075282|FG001|STARTED|Dose Expansion||12
3345350|NCT03481816|4075281|FG000|COMPLETED|Dose Expansion||0
3345351|NCT03481816|4075282|FG001|COMPLETED|Dose Expansion||0
3345352|NCT03481816|4075281|FG000|NOT COMPLETED|Dose Expansion||0
3345353|NCT03481816|4075282|FG001|NOT COMPLETED|Dose Expansion||12
3345354|NCT03482011|4075292|FG000|STARTED|Induction Period (16 Weeks)||107
3345355|NCT03482011|4075293|FG001|STARTED|Induction Period (16 Weeks)||423
3345356|NCT03482011|4075294|FG002|STARTED|Induction Period (16 Weeks)|Participants were assigned to this arm during maintenance period.|0
3345357|NCT03482011|4075295|FG003|STARTED|Induction Period (16 Weeks)|Participants were assigned to this arm during maintenance period.|0
3345358|NCT03482011|4075296|FG004|STARTED|Induction Period (16 Weeks)|Participants were assigned to this arm during maintenance period.|0
3345359|NCT03482011|4075297|FG005|STARTED|Induction Period (16 Weeks)|Participants were assigned to this arm during maintenance period.|0
3345360|NCT03482011|4075298|FG006|STARTED|Induction Period (16 Weeks)|Participants were assigned to this arm during maintenance period.|0
3345361|NCT03482011|4075299|FG007|STARTED|Induction Period (16 Weeks)|Participants were assigned to this arm during maintenance period.|0
3345362|NCT03482011|4075292|FG000|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||107
3345363|NCT03482011|4075293|FG001|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||422
3345364|NCT03482011|4075294|FG002|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
3345365|NCT03482011|4075295|FG003|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
3345366|NCT03482011|4075296|FG004|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
3345367|NCT03482011|4075297|FG005|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
3345368|NCT03482011|4075298|FG006|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
3345369|NCT03482011|4075299|FG007|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
3345370|NCT03482011|4075292|FG000|COMPLETED|Induction Period (16 Weeks)||101
3345371|NCT03482011|4075293|FG001|COMPLETED|Induction Period (16 Weeks)||412
3345372|NCT03482011|4075294|FG002|COMPLETED|Induction Period (16 Weeks)||0
3345373|NCT03482011|4075295|FG003|COMPLETED|Induction Period (16 Weeks)||0
3345374|NCT03482011|4075296|FG004|COMPLETED|Induction Period (16 Weeks)||0
3345375|NCT03482011|4075297|FG005|COMPLETED|Induction Period (16 Weeks)||0
3345376|NCT03482011|4075298|FG006|COMPLETED|Induction Period (16 Weeks)||0
3345377|NCT03482011|4075299|FG007|COMPLETED|Induction Period (16 Weeks)||0
3345378|NCT03482011|4075292|FG000|NOT COMPLETED|Induction Period (16 Weeks)||6
3345379|NCT03482011|4075293|FG001|NOT COMPLETED|Induction Period (16 Weeks)||11
3345380|NCT03482011|4075294|FG002|NOT COMPLETED|Induction Period (16 Weeks)||0
3345381|NCT03482011|4075295|FG003|NOT COMPLETED|Induction Period (16 Weeks)||0
3345382|NCT03482011|4075296|FG004|NOT COMPLETED|Induction Period (16 Weeks)||0
3345383|NCT03482011|4075297|FG005|NOT COMPLETED|Induction Period (16 Weeks)||0
3345384|NCT03482011|4075298|FG006|NOT COMPLETED|Induction Period (16 Weeks)||0
3345385|NCT03482011|4075299|FG007|NOT COMPLETED|Induction Period (16 Weeks)||0
3345386|NCT03482011|4075292|FG000|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during induction period.|0
3345387|NCT03482011|4075293|FG001|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during induction period.|0
3345388|NCT03482011|4075294|FG002|STARTED|Maintenance Period (36 Weeks)||7
3345389|NCT03482011|4075295|FG003|STARTED|Maintenance Period (36 Weeks)||94
3345390|NCT03482011|4075296|FG004|STARTED|Maintenance Period (36 Weeks)||91
3345391|NCT03482011|4075297|FG005|STARTED|Maintenance Period (36 Weeks)||90
3345392|NCT03482011|4075298|FG006|STARTED|Maintenance Period (36 Weeks)||91
3345393|NCT03482011|4075299|FG007|STARTED|Maintenance Period (36 Weeks)||140
3345394|NCT03482011|4075292|FG000|Relapse|Maintenance Period (36 Weeks)||0
3345395|NCT03482011|4075293|FG001|Relapse|Maintenance Period (36 Weeks)||0
3345396|NCT03482011|4075294|FG002|Relapse|Maintenance Period (36 Weeks)||1
3345397|NCT03482011|4075295|FG003|Relapse|Maintenance Period (36 Weeks)||0
3345398|NCT03482011|4075296|FG004|Relapse|Maintenance Period (36 Weeks)||41
3345399|NCT03482011|4075297|FG005|Relapse|Maintenance Period (36 Weeks)||3
3345400|NCT03482011|4075298|FG006|Relapse|Maintenance Period (36 Weeks)||2
3345401|NCT03482011|4075299|FG007|Relapse|Maintenance Period (36 Weeks)||0
3345402|NCT03482011|4075292|FG000|Roll Over to I6T-MC-AMAH (NCT03556202)|Maintenance Period (36 Weeks)||0
3345403|NCT03482011|4075293|FG001|Roll Over to I6T-MC-AMAH (NCT03556202)|Maintenance Period (36 Weeks)||0
3345404|NCT03482011|4075294|FG002|Roll Over to I6T-MC-AMAH (NCT03556202)|Maintenance Period (36 Weeks)||6
3345405|NCT03482011|4075295|FG003|Roll Over to I6T-MC-AMAH (NCT03556202)|Maintenance Period (36 Weeks)||88
3345406|NCT03482011|4075296|FG004|Roll Over to I6T-MC-AMAH (NCT03556202)|Maintenance Period (36 Weeks)||86
3345407|NCT03482011|4075297|FG005|Roll Over to I6T-MC-AMAH (NCT03556202)|Maintenance Period (36 Weeks)||85
3345408|NCT03482011|4075298|FG006|Roll Over to I6T-MC-AMAH (NCT03556202)|Maintenance Period (36 Weeks)||87
3345409|NCT03482011|4075299|FG007|Roll Over to I6T-MC-AMAH (NCT03556202)|Maintenance Period (36 Weeks)||121
3345410|NCT03482011|4075292|FG000|COMPLETED|Maintenance Period (36 Weeks)||0
3345411|NCT03482011|4075293|FG001|COMPLETED|Maintenance Period (36 Weeks)||0
3345412|NCT03482011|4075294|FG002|COMPLETED|Maintenance Period (36 Weeks)||6
3345413|NCT03482011|4075295|FG003|COMPLETED|Maintenance Period (36 Weeks)||90
3345414|NCT03482011|4075296|FG004|COMPLETED|Maintenance Period (36 Weeks)||86
3345415|NCT03482011|4075297|FG005|COMPLETED|Maintenance Period (36 Weeks)||86
3345416|NCT03482011|4075298|FG006|COMPLETED|Maintenance Period (36 Weeks)||87
3345417|NCT03482011|4075299|FG007|COMPLETED|Maintenance Period (36 Weeks)||123
3345418|NCT03482011|4075292|FG000|NOT COMPLETED|Maintenance Period (36 Weeks)||0
3345419|NCT03482011|4075293|FG001|NOT COMPLETED|Maintenance Period (36 Weeks)||0
3177787|NCT01973036|3905603|FG001|Received Assigned Intervention|Overall Study||88
3177788|NCT01973036|3905602|FG000|COMPLETED|Overall Study||108
3345420|NCT03482011|4075294|FG002|NOT COMPLETED|Maintenance Period (36 Weeks)||1
3345421|NCT03482011|4075295|FG003|NOT COMPLETED|Maintenance Period (36 Weeks)||4
3345422|NCT03482011|4075296|FG004|NOT COMPLETED|Maintenance Period (36 Weeks)||5
3345423|NCT03482011|4075297|FG005|NOT COMPLETED|Maintenance Period (36 Weeks)||4
3345424|NCT03482011|4075298|FG006|NOT COMPLETED|Maintenance Period (36 Weeks)||4
3177789|NCT01973036|3905603|FG001|COMPLETED|Overall Study||93
3177790|NCT01973036|3905602|FG000|NOT COMPLETED|Overall Study||0
3177791|NCT01973036|3905603|FG001|NOT COMPLETED|Overall Study||0
3345425|NCT03482011|4075299|FG007|NOT COMPLETED|Maintenance Period (36 Weeks)||17
3345426|NCT03482011|4075292|FG000|STARTED|Follow-up Period (12 Weeks)|Participants were assigned to this arm during induction period.|0
3345427|NCT03482011|4075293|FG001|STARTED|Follow-up Period (12 Weeks)|Participants were assigned to this arm during induction period.|0
3345428|NCT03482011|4075294|FG002|STARTED|Follow-up Period (12 Weeks)||1
3345429|NCT03482011|4075295|FG003|STARTED|Follow-up Period (12 Weeks)||10
3345430|NCT03482011|4075296|FG004|STARTED|Follow-up Period (12 Weeks)||2
3345431|NCT03482011|4075297|FG005|STARTED|Follow-up Period (12 Weeks)||4
3345432|NCT03482011|4075298|FG006|STARTED|Follow-up Period (12 Weeks)||4
3345433|NCT03482011|4075299|FG007|STARTED|Follow-up Period (12 Weeks)||21
3345434|NCT03482011|4075292|FG000|COMPLETED|Follow-up Period (12 Weeks)||0
3345435|NCT03482011|4075293|FG001|COMPLETED|Follow-up Period (12 Weeks)||0
3345436|NCT03482011|4075294|FG002|COMPLETED|Follow-up Period (12 Weeks)||0
3345437|NCT03482011|4075295|FG003|COMPLETED|Follow-up Period (12 Weeks)||5
3345438|NCT03482011|4075296|FG004|COMPLETED|Follow-up Period (12 Weeks)||2
3345439|NCT03482011|4075297|FG005|COMPLETED|Follow-up Period (12 Weeks)||3
3345440|NCT03482011|4075298|FG006|COMPLETED|Follow-up Period (12 Weeks)||2
3345441|NCT03482011|4075299|FG007|COMPLETED|Follow-up Period (12 Weeks)||4
3345442|NCT03482011|4075292|FG000|NOT COMPLETED|Follow-up Period (12 Weeks)||0
3345443|NCT03482011|4075293|FG001|NOT COMPLETED|Follow-up Period (12 Weeks)||0
3345444|NCT03482011|4075294|FG002|NOT COMPLETED|Follow-up Period (12 Weeks)||1
3345445|NCT03482011|4075295|FG003|NOT COMPLETED|Follow-up Period (12 Weeks)||5
3345446|NCT03482011|4075296|FG004|NOT COMPLETED|Follow-up Period (12 Weeks)||0
3345447|NCT03482011|4075297|FG005|NOT COMPLETED|Follow-up Period (12 Weeks)||1
3345448|NCT03482011|4075298|FG006|NOT COMPLETED|Follow-up Period (12 Weeks)||2
3345449|NCT03482011|4075299|FG007|NOT COMPLETED|Follow-up Period (12 Weeks)||17
3345450|NCT03482453|4075336|FG000|STARTED|Part 1 (1 Day)||10
3345451|NCT03482453|4075337|FG001|STARTED|Part 1 (1 Day)||6
3345452|NCT03482453|4075338|FG002|STARTED|Part 1 (1 Day)||6
3345453|NCT03482453|4075339|FG003|STARTED|Part 1 (1 Day)||6
3345454|NCT03482453|4075340|FG004|STARTED|Part 1 (1 Day)||6
3345455|NCT03482453|4075341|FG005|STARTED|Part 1 (1 Day)||6
3345456|NCT03482453|4075342|FG006|STARTED|Part 1 (1 Day)||0
3345457|NCT03482453|4075343|FG007|STARTED|Part 1 (1 Day)||0
3345458|NCT03482453|4075344|FG008|STARTED|Part 1 (1 Day)||0
3345459|NCT03482453|4075345|FG009|STARTED|Part 1 (1 Day)||0
3345460|NCT03482453|4075346|FG010|STARTED|Part 1 (1 Day)||0
3345461|NCT03482453|4075347|FG011|STARTED|Part 1 (1 Day)||0
3345462|NCT03482453|4075336|FG000|COMPLETED|Part 1 (1 Day)||10
3345463|NCT03482453|4075337|FG001|COMPLETED|Part 1 (1 Day)||6
3345464|NCT03482453|4075338|FG002|COMPLETED|Part 1 (1 Day)||6
3345465|NCT03482453|4075339|FG003|COMPLETED|Part 1 (1 Day)||6
3345466|NCT03482453|4075340|FG004|COMPLETED|Part 1 (1 Day)||6
3177792|NCT01973205|3905612|FG000|STARTED|Overall Study||453
3177793|NCT01973205|3905613|FG001|STARTED|Overall Study||447
3177794|NCT01973205|3905612|FG000|COMPLETED|Overall Study||423
3177795|NCT01973205|3905613|FG001|COMPLETED|Overall Study||425
3177796|NCT01973205|3905612|FG000|NOT COMPLETED|Overall Study||30
3177797|NCT01973205|3905613|FG001|NOT COMPLETED|Overall Study||22
3345467|NCT03482453|4075341|FG005|COMPLETED|Part 1 (1 Day)||6
3345468|NCT03482453|4075342|FG006|COMPLETED|Part 1 (1 Day)||0
3345469|NCT03482453|4075343|FG007|COMPLETED|Part 1 (1 Day)||0
3345470|NCT03482453|4075344|FG008|COMPLETED|Part 1 (1 Day)||0
3345471|NCT03482453|4075345|FG009|COMPLETED|Part 1 (1 Day)||0
3345472|NCT03482453|4075346|FG010|COMPLETED|Part 1 (1 Day)||0
3345473|NCT03482453|4075347|FG011|COMPLETED|Part 1 (1 Day)||0
3345474|NCT03482453|4075336|FG000|NOT COMPLETED|Part 1 (1 Day)||0
3345475|NCT03482453|4075337|FG001|NOT COMPLETED|Part 1 (1 Day)||0
3345476|NCT03482453|4075338|FG002|NOT COMPLETED|Part 1 (1 Day)||0
3345477|NCT03482453|4075339|FG003|NOT COMPLETED|Part 1 (1 Day)||0
3345478|NCT03482453|4075340|FG004|NOT COMPLETED|Part 1 (1 Day)||0
3345479|NCT03482453|4075341|FG005|NOT COMPLETED|Part 1 (1 Day)||0
3345480|NCT03482453|4075342|FG006|NOT COMPLETED|Part 1 (1 Day)||0
3345481|NCT03482453|4075343|FG007|NOT COMPLETED|Part 1 (1 Day)||0
3345482|NCT03482453|4075344|FG008|NOT COMPLETED|Part 1 (1 Day)||0
3345483|NCT03482453|4075345|FG009|NOT COMPLETED|Part 1 (1 Day)||0
3345484|NCT03482453|4075346|FG010|NOT COMPLETED|Part 1 (1 Day)||0
3345485|NCT03482453|4075347|FG011|NOT COMPLETED|Part 1 (1 Day)||0
3345486|NCT03482453|4075336|FG000|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||0
3345487|NCT03482453|4075337|FG001|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||0
3345488|NCT03482453|4075338|FG002|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||0
3177798|NCT01973218|3905621|FG000|STARTED|Overall Study||176
3177799|NCT01973218|3905622|FG001|STARTED|Overall Study||88
3177800|NCT01973218|3905621|FG000|COMPLETED|Overall Study||174
3177801|NCT01973218|3905622|FG001|COMPLETED|Overall Study||88
3177802|NCT01973218|3905621|FG000|NOT COMPLETED|Overall Study||2
3177803|NCT01973218|3905622|FG001|NOT COMPLETED|Overall Study||0
3345489|NCT03482453|4075339|FG003|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||0
3345490|NCT03482453|4075340|FG004|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||0
3345491|NCT03482453|4075341|FG005|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||0
3345492|NCT03482453|4075342|FG006|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||3
3345493|NCT03482453|4075343|FG007|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||3
3177804|NCT01973231|3905632|FG000|STARTED|Overall Study||202
3345494|NCT03482453|4075344|FG008|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||5
3345495|NCT03482453|4075345|FG009|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||5
3345496|NCT03482453|4075346|FG010|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||7
3345497|NCT03482453|4075347|FG011|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||6
3345498|NCT03482453|4075336|FG000|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
3345499|NCT03482453|4075337|FG001|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
3345500|NCT03482453|4075338|FG002|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
3345501|NCT03482453|4075339|FG003|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
3345502|NCT03482453|4075340|FG004|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
3345503|NCT03482453|4075341|FG005|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
3345504|NCT03482453|4075342|FG006|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||3
3345505|NCT03482453|4075343|FG007|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||3
3345506|NCT03482453|4075344|FG008|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||5
3345507|NCT03482453|4075345|FG009|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||5
3345508|NCT03482453|4075346|FG010|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||6
3345509|NCT03482453|4075347|FG011|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||6
3345510|NCT03482453|4075336|FG000|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
3345511|NCT03482453|4075337|FG001|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
3345512|NCT03482453|4075338|FG002|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
3345513|NCT03482453|4075339|FG003|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
3345514|NCT03482453|4075340|FG004|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
3345515|NCT03482453|4075341|FG005|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
3345516|NCT03482453|4075342|FG006|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
3345517|NCT03482453|4075343|FG007|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
3345518|NCT03482453|4075344|FG008|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
3345519|NCT03482453|4075345|FG009|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
3345520|NCT03482453|4075346|FG010|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||1
3345521|NCT03482453|4075347|FG011|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
3345522|NCT03482453|4075336|FG000|STARTED|Parts 2, 3 Washout Period (7 Days)||0
3345523|NCT03482453|4075337|FG001|STARTED|Parts 2, 3 Washout Period (7 Days)||0
3345524|NCT03482453|4075338|FG002|STARTED|Parts 2, 3 Washout Period (7 Days)||0
3345525|NCT03482453|4075339|FG003|STARTED|Parts 2, 3 Washout Period (7 Days)||0
3345526|NCT03482453|4075340|FG004|STARTED|Parts 2, 3 Washout Period (7 Days)||0
3345527|NCT03482453|4075341|FG005|STARTED|Parts 2, 3 Washout Period (7 Days)||0
3345528|NCT03482453|4075342|FG006|STARTED|Parts 2, 3 Washout Period (7 Days)||3
3345529|NCT03482453|4075343|FG007|STARTED|Parts 2, 3 Washout Period (7 Days)||3
3345530|NCT03482453|4075344|FG008|STARTED|Parts 2, 3 Washout Period (7 Days)||5
3345531|NCT03482453|4075345|FG009|STARTED|Parts 2, 3 Washout Period (7 Days)||5
3345532|NCT03482453|4075346|FG010|STARTED|Parts 2, 3 Washout Period (7 Days)||6
3345533|NCT03482453|4075347|FG011|STARTED|Parts 2, 3 Washout Period (7 Days)||6
3345534|NCT03482453|4075336|FG000|COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
3345535|NCT03482453|4075337|FG001|COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
3345536|NCT03482453|4075338|FG002|COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
3345537|NCT03482453|4075339|FG003|COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
3345538|NCT03482453|4075340|FG004|COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
3345539|NCT03482453|4075341|FG005|COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
3345540|NCT03482453|4075342|FG006|COMPLETED|Parts 2, 3 Washout Period (7 Days)||3
3345541|NCT03482453|4075343|FG007|COMPLETED|Parts 2, 3 Washout Period (7 Days)||3
3345542|NCT03482453|4075344|FG008|COMPLETED|Parts 2, 3 Washout Period (7 Days)||5
3345543|NCT03482453|4075345|FG009|COMPLETED|Parts 2, 3 Washout Period (7 Days)||5
3345544|NCT03482453|4075346|FG010|COMPLETED|Parts 2, 3 Washout Period (7 Days)||6
3345545|NCT03482453|4075347|FG011|COMPLETED|Parts 2, 3 Washout Period (7 Days)||6
3345546|NCT03482453|4075336|FG000|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
3345547|NCT03482453|4075337|FG001|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
3345548|NCT03482453|4075338|FG002|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
3345549|NCT03482453|4075339|FG003|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
3345550|NCT03482453|4075340|FG004|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
3345551|NCT03482453|4075341|FG005|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
3345552|NCT03482453|4075342|FG006|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
3345553|NCT03482453|4075343|FG007|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
3345554|NCT03482453|4075344|FG008|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
3345555|NCT03482453|4075345|FG009|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
3345556|NCT03482453|4075346|FG010|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
3345557|NCT03482453|4075347|FG011|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
3345558|NCT03482453|4075336|FG000|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||0
3345559|NCT03482453|4075337|FG001|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||0
3345560|NCT03482453|4075338|FG002|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||0
3345561|NCT03482453|4075339|FG003|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||0
3345562|NCT03482453|4075340|FG004|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||0
3345563|NCT03482453|4075341|FG005|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||0
3345564|NCT03482453|4075342|FG006|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||3
3345565|NCT03482453|4075343|FG007|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||3
3345566|NCT03482453|4075344|FG008|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||5
3345567|NCT03482453|4075345|FG009|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||5
3345568|NCT03482453|4075346|FG010|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||6
3345569|NCT03482453|4075347|FG011|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||6
3345570|NCT03482453|4075336|FG000|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
3345571|NCT03482453|4075337|FG001|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
3345572|NCT03482453|4075338|FG002|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
3345573|NCT03482453|4075339|FG003|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
3345574|NCT03482453|4075340|FG004|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
3345575|NCT03482453|4075341|FG005|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
3345576|NCT03482453|4075342|FG006|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||3
3345577|NCT03482453|4075343|FG007|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||3
3345578|NCT03482453|4075344|FG008|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||5
3345579|NCT03482453|4075345|FG009|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||5
3345580|NCT03482453|4075346|FG010|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||6
3345581|NCT03482453|4075347|FG011|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||6
3345582|NCT03482453|4075336|FG000|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
3345583|NCT03482453|4075337|FG001|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
3345584|NCT03482453|4075338|FG002|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
3345585|NCT03482453|4075339|FG003|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
3345586|NCT03482453|4075340|FG004|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
3345587|NCT03482453|4075341|FG005|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
3345588|NCT03482453|4075342|FG006|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
3345589|NCT03482453|4075343|FG007|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
3345590|NCT03482453|4075344|FG008|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
3345591|NCT03482453|4075345|FG009|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
3345592|NCT03482453|4075346|FG010|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
3345593|NCT03482453|4075347|FG011|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
3345594|NCT03482583|4075386|FG000|STARTED|Overall Study||37
3345595|NCT03482583|4075387|FG001|STARTED|Overall Study||14
3345596|NCT03482583|4075388|FG002|STARTED|Overall Study||39
3345597|NCT03482583|4075386|FG000|COMPLETED|Overall Study||12
3345598|NCT03482583|4075387|FG001|COMPLETED|Overall Study||5
3345599|NCT03482583|4075388|FG002|COMPLETED|Overall Study||18
3345600|NCT03482583|4075386|FG000|NOT COMPLETED|Overall Study||25
3345601|NCT03482583|4075387|FG001|NOT COMPLETED|Overall Study||9
3345602|NCT03482583|4075388|FG002|NOT COMPLETED|Overall Study||21
3345603|NCT03482635|4075401|FG000|STARTED|Overall Study||23
3345604|NCT03482635|4075402|FG001|STARTED|Overall Study||24
3345605|NCT03482635|4075403|FG002|STARTED|Overall Study||23
3345606|NCT03482635|4075404|FG003|STARTED|Overall Study||28
3345607|NCT03482635|4075401|FG000|Treated|Overall Study||23
3345608|NCT03482635|4075402|FG001|Treated|Overall Study||24
3345609|NCT03482635|4075403|FG002|Treated|Overall Study||23
3345610|NCT03482635|4075404|FG003|Treated|Overall Study||27
3345611|NCT03482635|4075401|FG000|COMPLETED|Overall Study||18
3345612|NCT03482635|4075402|FG001|COMPLETED|Overall Study||21
3345613|NCT03482635|4075403|FG002|COMPLETED|Overall Study||22
3345614|NCT03482635|4075404|FG003|COMPLETED|Overall Study||20
3345615|NCT03482635|4075401|FG000|NOT COMPLETED|Overall Study||5
3345616|NCT03482635|4075402|FG001|NOT COMPLETED|Overall Study||3
3345617|NCT03482635|4075403|FG002|NOT COMPLETED|Overall Study||1
3345618|NCT03482635|4075404|FG003|NOT COMPLETED|Overall Study||8
3345619|NCT03482713|4075416|FG000|STARTED|Overall Study||11
3345620|NCT03482713|4075417|FG001|STARTED|Overall Study||12
3345621|NCT03482713|4075416|FG000|COMPLETED|Overall Study||11
3345622|NCT03482713|4075417|FG001|COMPLETED|Overall Study||12
3345623|NCT03482713|4075416|FG000|NOT COMPLETED|Overall Study||0
3345624|NCT03482713|4075417|FG001|NOT COMPLETED|Overall Study||0
3345625|NCT03482882|4075423|FG000|STARTED|Overall Study||47
3345626|NCT03482882|4075423|FG000|COMPLETED|Overall Study||40
3345627|NCT03482882|4075423|FG000|NOT COMPLETED|Overall Study||7
3345628|NCT03482973|4075429|FG000|STARTED|Overall Study||40
3345629|NCT03482973|4075430|FG001|STARTED|Overall Study||40
3345630|NCT03482973|4075429|FG000|COMPLETED|Overall Study||40
3345631|NCT03482973|4075430|FG001|COMPLETED|Overall Study||40
3345632|NCT03482973|4075429|FG000|NOT COMPLETED|Overall Study||0
3345633|NCT03482973|4075430|FG001|NOT COMPLETED|Overall Study||0
3345634|NCT03483506|4075436|FG000|STARTED|Overall Study||12
3345635|NCT03483506|4075436|FG000|COMPLETED|Overall Study||12
3345636|NCT03483506|4075436|FG000|NOT COMPLETED|Overall Study||0
3345637|NCT03483623|4075442|FG000|STARTED|Overall Study||44
3345638|NCT03483623|4075442|FG000|Started NATO WELP|Overall Study||44
3345639|NCT03483623|4075442|FG000|Completeded NATO WELP|Overall Study|1 subject was withdrawn after the target of 43 complete sets was achieved|43
3345640|NCT03483623|4075442|FG000|Started NATO FIS|Overall Study||44
3345641|NCT03483623|4075442|FG000|Completed NATO FIS|Overall Study|1 subject was withdrawn after the target of 43 complete sets was achieved|43
3345642|NCT03483623|4075442|FG000|Started RAVEN WELP|Overall Study||44
3345643|NCT03483623|4075442|FG000|Completed RAVEN WELP|Overall Study|1 subject was withdrawn after the target of 43 complete sets was achieved|43
3345644|NCT03483623|4075442|FG000|Started RAVEN FIS|Overall Study||44
3345645|NCT03483623|4075442|FG000|Completed RAVEN FIS|Overall Study|1 subject was withdrawn after the target of 43 complete sets was achieved|43
3177805|NCT01973231|3905633|FG001|STARTED|Overall Study||202
3177806|NCT01973231|3905632|FG000|COMPLETED|Overall Study||191
3177807|NCT01973231|3905633|FG001|COMPLETED|Overall Study||190
3345646|NCT03483623|4075442|FG000|COMPLETED|Overall Study|1 subject was withdrawn after the target of 43 complete sets was achieved|43
3345647|NCT03483623|4075442|FG000|NOT COMPLETED|Overall Study||1
3345648|NCT03483675|4075448|FG000|STARTED|Overall Study||9
3345649|NCT03483675|4075449|FG001|STARTED|Overall Study||8
3345650|NCT03483675|4075448|FG000|COMPLETED|Overall Study||9
3345651|NCT03483675|4075449|FG001|COMPLETED|Overall Study||8
3345652|NCT03483675|4075448|FG000|NOT COMPLETED|Overall Study||0
3345653|NCT03483675|4075449|FG001|NOT COMPLETED|Overall Study||0
3345654|NCT03483896|4075458|FG000|STARTED|Overall Study||33
3345655|NCT03483896|4075459|FG001|STARTED|Overall Study||50
3345656|NCT03483896|4075458|FG000|COMPLETED|Overall Study||31
3345657|NCT03483896|4075459|FG001|COMPLETED|Overall Study||46
3345658|NCT03483896|4075458|FG000|NOT COMPLETED|Overall Study||2
3345659|NCT03483896|4075459|FG001|NOT COMPLETED|Overall Study||4
3345660|NCT03483935|4075467|FG000|STARTED|Stage 1: Dose Setting Study||7
3345661|NCT03483935|4075467|FG000|COMPLETED|Stage 1: Dose Setting Study||7
3345662|NCT03483935|4075467|FG000|NOT COMPLETED|Stage 1: Dose Setting Study||0
3345663|NCT03483935|4075467|FG000|STARTED|Stage 2: Randomised Controlled Trial|Participants were randomised to receiving treatment on the left or right side.|11
3345664|NCT03483935|4075467|FG000|AKs Treated|Stage 2: Randomised Controlled Trial||11
3345665|NCT03483935|4075467|FG000|AKs Not Treated|Stage 2: Randomised Controlled Trial||11
3345666|NCT03483935|4075467|FG000|COMPLETED|Stage 2: Randomised Controlled Trial||11
3345667|NCT03483935|4075467|FG000|NOT COMPLETED|Stage 2: Randomised Controlled Trial||0
3345668|NCT03483961|4075485|FG000|STARTED|Overall Study||53
3345669|NCT03483961|4075486|FG001|STARTED|Overall Study||52
3345670|NCT03483961|4075487|FG002|STARTED|Overall Study||51
3345671|NCT03483961|4075488|FG003|STARTED|Overall Study||50
3345672|NCT03483961|4075489|FG004|STARTED|Overall Study||53
3345673|NCT03483961|4075490|FG005|STARTED|Overall Study||53
3345674|NCT03483961|4075491|FG006|STARTED|Overall Study||51
3345675|NCT03483961|4075492|FG007|STARTED|Overall Study||52
3345676|NCT03483961|4075493|FG008|STARTED|Overall Study||20
3345677|NCT03483961|4075494|FG009|STARTED|Overall Study||10
3345678|NCT03483961|4075485|FG000|Exposed / Safety|Overall Study||53
3345679|NCT03483961|4075486|FG001|Exposed / Safety|Overall Study||52
3345680|NCT03483961|4075487|FG002|Exposed / Safety|Overall Study|One subject was randomized to Group 3 but treated in Group 4 due to a dispensing error.|50
3345681|NCT03483961|4075488|FG003|Exposed / Safety|Overall Study|One subject was randomized to Group 3 but treated in Group 4 due to a dispensing error.|51
3345682|NCT03483961|4075489|FG004|Exposed / Safety|Overall Study|One subject did not receive PXVX0317 but is in the Exposed / Safety population because of receipt of placebo.|53
3345683|NCT03483961|4075490|FG005|Exposed / Safety|Overall Study||53
3345684|NCT03483961|4075491|FG006|Exposed / Safety|Overall Study|One subject did not receive PXVX0317 but is in the Exposed / Safety population because of receipt of placebo.|51
3345685|NCT03483961|4075492|FG007|Exposed / Safety|Overall Study|Two subjects did not receive PXVX0317 but are in the Exposed / Safety population because of receipt of placebo.|52
3345686|NCT03483961|4075493|FG008|Exposed / Safety|Overall Study||20
3345687|NCT03483961|4075494|FG009|Exposed / Safety|Overall Study||10
3345688|NCT03483961|4075485|FG000|Immunogenicity-evaluable|Overall Study||47
3345689|NCT03483961|4075486|FG001|Immunogenicity-evaluable|Overall Study||44
3345690|NCT03483961|4075487|FG002|Immunogenicity-evaluable|Overall Study||44
3345691|NCT03483961|4075488|FG003|Immunogenicity-evaluable|Overall Study||45
3345692|NCT03483961|4075489|FG004|Immunogenicity-evaluable|Overall Study||48
3345693|NCT03483961|4075490|FG005|Immunogenicity-evaluable|Overall Study||48
3345694|NCT03483961|4075491|FG006|Immunogenicity-evaluable|Overall Study||47
3345695|NCT03483961|4075492|FG007|Immunogenicity-evaluable|Overall Study||50
3345696|NCT03483961|4075493|FG008|Immunogenicity-evaluable|Overall Study||20
3345697|NCT03483961|4075494|FG009|Immunogenicity-evaluable|Overall Study||10
3345698|NCT03483961|4075485|FG000|COMPLETED|Overall Study||42
3345699|NCT03483961|4075486|FG001|COMPLETED|Overall Study||42
3345700|NCT03483961|4075487|FG002|COMPLETED|Overall Study||39
3345701|NCT03483961|4075488|FG003|COMPLETED|Overall Study||41
3345702|NCT03483961|4075489|FG004|COMPLETED|Overall Study||43
3345703|NCT03483961|4075490|FG005|COMPLETED|Overall Study||47
3345704|NCT03483961|4075491|FG006|COMPLETED|Overall Study||46
3345705|NCT03483961|4075492|FG007|COMPLETED|Overall Study||39
3345706|NCT03483961|4075493|FG008|COMPLETED|Overall Study||18
3345707|NCT03483961|4075494|FG009|COMPLETED|Overall Study||10
3345708|NCT03483961|4075485|FG000|NOT COMPLETED|Overall Study||11
3345709|NCT03483961|4075486|FG001|NOT COMPLETED|Overall Study||10
3345710|NCT03483961|4075487|FG002|NOT COMPLETED|Overall Study||12
3345711|NCT03483961|4075488|FG003|NOT COMPLETED|Overall Study||9
3345712|NCT03483961|4075489|FG004|NOT COMPLETED|Overall Study||10
3345713|NCT03483961|4075490|FG005|NOT COMPLETED|Overall Study||6
3345714|NCT03483961|4075491|FG006|NOT COMPLETED|Overall Study||5
3345715|NCT03483961|4075492|FG007|NOT COMPLETED|Overall Study||13
3177808|NCT01973231|3905632|FG000|NOT COMPLETED|Overall Study||11
3177809|NCT01973231|3905633|FG001|NOT COMPLETED|Overall Study||12
3177810|NCT01973283|3905639|FG000|STARTED|Overall Study||100
3177811|NCT01973283|3905639|FG000|COMPLETED|Overall Study||96
3177812|NCT01973283|3905639|FG000|NOT COMPLETED|Overall Study||4
3177813|NCT01973335|3905649|FG000|STARTED|Overall Study||9
3177814|NCT01973335|3905650|FG001|STARTED|Overall Study||7
3177815|NCT01973335|3905651|FG002|STARTED|Overall Study||9
3177816|NCT01973335|3905652|FG003|STARTED|Overall Study||9
3345716|NCT03483961|4075493|FG008|NOT COMPLETED|Overall Study||2
3345717|NCT03483961|4075494|FG009|NOT COMPLETED|Overall Study||0
3345718|NCT03484273|4075515|FG000|STARTED|Overall Study|This was a crossover trial. A total of 32 participants were enrolled in this study.|32
3345719|NCT03484273|4075515|FG000|COMPLETED|Overall Study|This was a crossover trial. A total of 30 participants completed all 4 arms.|30
3345720|NCT03484273|4075515|FG000|NOT COMPLETED|Overall Study||2
3345721|NCT03484429|4075529|FG000|STARTED|Overall Study||8
3345722|NCT03484429|4075530|FG001|STARTED|Overall Study||8
3345723|NCT03484429|4075529|FG000|Postamputation Week 1-4|Overall Study||8
3345724|NCT03484429|4075530|FG001|Postamputation Week 1-4|Overall Study||8
3345725|NCT03484429|4075529|FG000|Postamputation Week 5-8|Overall Study||5
3345726|NCT03484429|4075530|FG001|Postamputation Week 5-8|Overall Study||8
3345727|NCT03484429|4075529|FG000|Postamputation Month 3|Overall Study||5
3345728|NCT03484429|4075530|FG001|Postamputation Month 3|Overall Study||7
3345729|NCT03484429|4075529|FG000|COMPLETED|Overall Study||5
3177817|NCT01973335|3905649|FG000|COMPLETED|Overall Study||9
3177818|NCT01973335|3905650|FG001|COMPLETED|Overall Study||7
3177819|NCT01973335|3905651|FG002|COMPLETED|Overall Study||9
3177820|NCT01973335|3905652|FG003|COMPLETED|Overall Study||9
3177821|NCT01973335|3905649|FG000|NOT COMPLETED|Overall Study||0
3177822|NCT01973335|3905650|FG001|NOT COMPLETED|Overall Study||0
3177823|NCT01973335|3905651|FG002|NOT COMPLETED|Overall Study||0
3177824|NCT01973335|3905652|FG003|NOT COMPLETED|Overall Study||0
3177825|NCT01973348|3905666|FG000|STARTED|Overall Study||27
3177826|NCT01973348|3905667|FG001|STARTED|Overall Study||18
3177827|NCT01973348|3905668|FG002|STARTED|Overall Study||0
3345730|NCT03484429|4075530|FG001|COMPLETED|Overall Study||8
3345731|NCT03484429|4075529|FG000|NOT COMPLETED|Overall Study||3
3345732|NCT03484429|4075530|FG001|NOT COMPLETED|Overall Study||0
3345733|NCT03485222|4075538|FG000|STARTED|Overall Study||42
3345734|NCT03485222|4075539|FG001|STARTED|Overall Study||42
3345735|NCT03485222|4075538|FG000|COMPLETED|Overall Study||40
3345736|NCT03485222|4075539|FG001|COMPLETED|Overall Study||40
3345737|NCT03485222|4075538|FG000|NOT COMPLETED|Overall Study||2
3345738|NCT03485222|4075539|FG001|NOT COMPLETED|Overall Study||2
3345739|NCT03485495|4075547|FG000|STARTED|Overall Study||65
3345740|NCT03485495|4075548|FG001|STARTED|Overall Study||59
3345741|NCT03485495|4075547|FG000|COMPLETED|Overall Study||64
3345742|NCT03485495|4075548|FG001|COMPLETED|Overall Study||59
3345743|NCT03485495|4075547|FG000|NOT COMPLETED|Overall Study||1
3345744|NCT03485495|4075548|FG001|NOT COMPLETED|Overall Study||0
3345745|NCT03485911|4075557|FG000|STARTED|Overall Study||41
3345746|NCT03485911|4075558|FG001|STARTED|Overall Study||40
3345747|NCT03485911|4075559|FG002|STARTED|Overall Study||40
3345748|NCT03485911|4075557|FG000|COMPLETED|Overall Study||40
3345749|NCT03485911|4075558|FG001|COMPLETED|Overall Study||38
3345750|NCT03485911|4075559|FG002|COMPLETED|Overall Study||36
3345751|NCT03485911|4075557|FG000|NOT COMPLETED|Overall Study||1
3345752|NCT03485911|4075558|FG001|NOT COMPLETED|Overall Study||2
3345753|NCT03485911|4075559|FG002|NOT COMPLETED|Overall Study||4
3345754|NCT03485950|4075569|FG000|STARTED|Overall Study||50
3345755|NCT03485950|4075570|FG001|STARTED|Overall Study||50
3345756|NCT03485950|4075569|FG000|COMPLETED|Overall Study||43
3345757|NCT03485950|4075570|FG001|COMPLETED|Overall Study||48
3345758|NCT03485950|4075569|FG000|NOT COMPLETED|Overall Study||7
3345759|NCT03485950|4075570|FG001|NOT COMPLETED|Overall Study||2
3345760|NCT03485976|4075576|FG000|STARTED|Overall Study||12
3345761|NCT03485976|4075576|FG000|COMPLETED|Overall Study||11
3345762|NCT03485976|4075576|FG000|NOT COMPLETED|Overall Study||1
3345763|NCT03486392|4075585|FG000|STARTED|Overall Study||60
3345764|NCT03486392|4075586|FG001|STARTED|Overall Study||59
3345765|NCT03486392|4075587|FG002|STARTED|Overall Study||118
3345766|NCT03486392|4075588|FG003|STARTED|Overall Study||118
3345767|NCT03486392|4075589|FG004|STARTED|Overall Study||119
3345768|NCT03486392|4075585|FG000|COMPLETED|Overall Study||57
3345769|NCT03486392|4075586|FG001|COMPLETED|Overall Study||59
3345770|NCT03486392|4075587|FG002|COMPLETED|Overall Study||104
3345771|NCT03486392|4075588|FG003|COMPLETED|Overall Study||109
3345772|NCT03486392|4075589|FG004|COMPLETED|Overall Study||115
3345773|NCT03486392|4075585|FG000|NOT COMPLETED|Overall Study||3
3345774|NCT03486392|4075586|FG001|NOT COMPLETED|Overall Study||0
3345775|NCT03486392|4075587|FG002|NOT COMPLETED|Overall Study||14
3345776|NCT03486392|4075588|FG003|NOT COMPLETED|Overall Study||9
3345777|NCT03486392|4075589|FG004|NOT COMPLETED|Overall Study||4
3345778|NCT03486834|4075604|FG000|STARTED|Overall Study||733
3345779|NCT03486834|4075605|FG001|STARTED|Overall Study||733
3345780|NCT03486834|4075606|FG002|STARTED|Overall Study||734
3345781|NCT03486834|4075604|FG000|Treatment 1|Overall Study||729
3345782|NCT03486834|4075605|FG001|Treatment 1|Overall Study||729
3345783|NCT03486834|4075606|FG002|Treatment 1|Overall Study||733
3345784|NCT03486834|4075604|FG000|Treatment 2|Overall Study||680
3345785|NCT03486834|4075605|FG001|Treatment 2|Overall Study||680
3345786|NCT03486834|4075606|FG002|Treatment 2|Overall Study||679
3345787|NCT03486834|4075604|FG000|Treatment 3|Overall Study||614
3345788|NCT03486834|4075605|FG001|Treatment 3|Overall Study||631
3345789|NCT03486834|4075606|FG002|Treatment 3|Overall Study||622
3177828|NCT01973348|3905669|FG003|STARTED|Overall Study||0
3177829|NCT01973348|3905666|FG000|COMPLETED|Overall Study||19
3345790|NCT03486834|4075604|FG000|COMPLETED|Overall Study||614
3345791|NCT03486834|4075605|FG001|COMPLETED|Overall Study||631
3345792|NCT03486834|4075606|FG002|COMPLETED|Overall Study||622
3177830|NCT01973348|3905667|FG001|COMPLETED|Overall Study||15
3345793|NCT03486834|4075604|FG000|NOT COMPLETED|Overall Study||119
3345794|NCT03486834|4075605|FG001|NOT COMPLETED|Overall Study||102
3345795|NCT03486834|4075606|FG002|NOT COMPLETED|Overall Study||112
3345796|NCT03486990|4075625|FG000|STARTED|Overall Study||2
3345797|NCT03486990|4075626|FG001|STARTED|Overall Study||2
3345798|NCT03486990|4075627|FG002|STARTED|Overall Study||3
3345799|NCT03486990|4075628|FG003|STARTED|Overall Study||3
3345800|NCT03486990|4075629|FG004|STARTED|Overall Study||3
3345801|NCT03486990|4075630|FG005|STARTED|Overall Study||4
3345802|NCT03486990|4075631|FG006|STARTED|Overall Study||2
3345803|NCT03486990|4075632|FG007|STARTED|Overall Study||2
3345804|NCT03486990|4075633|FG008|STARTED|Overall Study||2
3345805|NCT03486990|4075625|FG000|COMPLETED|Overall Study||2
3345806|NCT03486990|4075626|FG001|COMPLETED|Overall Study||2
3345807|NCT03486990|4075627|FG002|COMPLETED|Overall Study||3
3345808|NCT03486990|4075628|FG003|COMPLETED|Overall Study||3
3345809|NCT03486990|4075629|FG004|COMPLETED|Overall Study||3
3345810|NCT03486990|4075630|FG005|COMPLETED|Overall Study||4
3345811|NCT03486990|4075631|FG006|COMPLETED|Overall Study||2
3345812|NCT03486990|4075632|FG007|COMPLETED|Overall Study||2
3345813|NCT03486990|4075633|FG008|COMPLETED|Overall Study||2
3345814|NCT03486990|4075625|FG000|NOT COMPLETED|Overall Study||0
3345815|NCT03486990|4075626|FG001|NOT COMPLETED|Overall Study||0
3345816|NCT03486990|4075627|FG002|NOT COMPLETED|Overall Study||0
3345817|NCT03486990|4075628|FG003|NOT COMPLETED|Overall Study||0
3345818|NCT03486990|4075629|FG004|NOT COMPLETED|Overall Study||0
3345819|NCT03486990|4075630|FG005|NOT COMPLETED|Overall Study||0
3345820|NCT03486990|4075631|FG006|NOT COMPLETED|Overall Study||0
3345821|NCT03486990|4075632|FG007|NOT COMPLETED|Overall Study||0
3345822|NCT03486990|4075633|FG008|NOT COMPLETED|Overall Study||0
3345823|NCT03487276|4075674|FG000|STARTED|Main Period (16 Weeks)||37
3345824|NCT03487276|4075675|FG001|STARTED|Main Period (16 Weeks)||34
3345825|NCT03487276|4075676|FG002|STARTED|Main Period (16 Weeks)||36
3345826|NCT03487276|4075677|FG003|STARTED|Main Period (16 Weeks)||36
3345827|NCT03487276|4075678|FG004|STARTED|Main Period (16 Weeks)||36
3345828|NCT03487276|4075674|FG000|COMPLETED|Main Period (16 Weeks)||34
3345829|NCT03487276|4075675|FG001|COMPLETED|Main Period (16 Weeks)||30
3345830|NCT03487276|4075676|FG002|COMPLETED|Main Period (16 Weeks)||32
3345831|NCT03487276|4075677|FG003|COMPLETED|Main Period (16 Weeks)||30
3345832|NCT03487276|4075678|FG004|COMPLETED|Main Period (16 Weeks)|One patient completed the Main Period but was lost to follow-up afterwards and not treated in the Extension Period|31
3345833|NCT03487276|4075674|FG000|NOT COMPLETED|Main Period (16 Weeks)||3
3345834|NCT03487276|4075675|FG001|NOT COMPLETED|Main Period (16 Weeks)||4
3345835|NCT03487276|4075676|FG002|NOT COMPLETED|Main Period (16 Weeks)||4
3345836|NCT03487276|4075677|FG003|NOT COMPLETED|Main Period (16 Weeks)||6
3345837|NCT03487276|4075678|FG004|NOT COMPLETED|Main Period (16 Weeks)||5
3345838|NCT03487276|4075674|FG000|STARTED|Extension Period (28 Weeks)||0
3345839|NCT03487276|4075675|FG001|STARTED|Extension Period (28 Weeks)||0
3345840|NCT03487276|4075676|FG002|STARTED|Extension Period (28 Weeks)||72
3345841|NCT03487276|4075677|FG003|STARTED|Extension Period (28 Weeks)||84
3345842|NCT03487276|4075678|FG004|STARTED|Extension Period (28 Weeks)||0
3345843|NCT03487276|4075674|FG000|Number of Patients in Cohort 1 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0
3345844|NCT03487276|4075675|FG001|Number of Patients in Cohort 1 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0
3345845|NCT03487276|4075676|FG002|Number of Patients in Cohort 1 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||16
3345846|NCT03487276|4075677|FG003|Number of Patients in Cohort 1 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||18
3345847|NCT03487276|4075678|FG004|Number of Patients in Cohort 1 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0
3345848|NCT03487276|4075674|FG000|Number of Patients in Cohort 2 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0
3177831|NCT01973348|3905668|FG002|COMPLETED|Overall Study||0
3177832|NCT01973348|3905669|FG003|COMPLETED|Overall Study||0
3177833|NCT01973348|3905666|FG000|NOT COMPLETED|Overall Study||8
3177834|NCT01973348|3905667|FG001|NOT COMPLETED|Overall Study||3
3177835|NCT01973348|3905668|FG002|NOT COMPLETED|Overall Study||0
3177836|NCT01973348|3905669|FG003|NOT COMPLETED|Overall Study||0
3177837|NCT01973387|3905681|FG000|STARTED|Overall Study||106
3177838|NCT01973387|3905682|FG001|STARTED|Overall Study||54
3177839|NCT01973387|3905681|FG000|Treated|Overall Study||104
3177840|NCT01973387|3905682|FG001|Treated|Overall Study||52
3177841|NCT01973387|3905681|FG000|COMPLETED|Overall Study||0
3177842|NCT01973387|3905682|FG001|COMPLETED|Overall Study||36
3177843|NCT01973387|3905681|FG000|NOT COMPLETED|Overall Study||106
3177844|NCT01973387|3905682|FG001|NOT COMPLETED|Overall Study||18
3177845|NCT01973413|3905690|FG000|STARTED|Overall Study||12
3177846|NCT01973413|3905691|FG001|STARTED|Overall Study||20
3177847|NCT01973413|3905690|FG000|COMPLETED|Overall Study||11
3177848|NCT01973413|3905691|FG001|COMPLETED|Overall Study||20
3177849|NCT01973413|3905690|FG000|NOT COMPLETED|Overall Study||1
3177850|NCT01973413|3905691|FG001|NOT COMPLETED|Overall Study||0
3177851|NCT01973439|3905698|FG000|STARTED|Overall Study||23
3177852|NCT01973439|3905698|FG000|Two Evaluable PK Days|Overall Study|18 Children had two evaluable PK days|18
3177853|NCT01973439|3905698|FG000|One Evaluable PK Day Only|Overall Study|5 children had only one evaluable PK day.|5
3177854|NCT01973439|3905698|FG000|COMPLETED|Overall Study||18
3177855|NCT01973439|3905698|FG000|NOT COMPLETED|Overall Study||5
3345849|NCT03487276|4075675|FG001|Number of Patients in Cohort 2 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0
3345850|NCT03487276|4075676|FG002|Number of Patients in Cohort 2 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||12
3345851|NCT03487276|4075677|FG003|Number of Patients in Cohort 2 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||18
3345852|NCT03487276|4075678|FG004|Number of Patients in Cohort 2 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0
3345853|NCT03487276|4075674|FG000|Number of Patients in Cohort 3 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0
3345854|NCT03487276|4075675|FG001|Number of Patients in Cohort 3 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0
3345855|NCT03487276|4075676|FG002|Number of Patients in Cohort 3 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||17
3345856|NCT03487276|4075677|FG003|Number of Patients in Cohort 3 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||15
3345857|NCT03487276|4075678|FG004|Number of Patients in Cohort 3 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0
3345858|NCT03487276|4075674|FG000|Number of Patients in Cohort 4 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0
3345859|NCT03487276|4075675|FG001|Number of Patients in Cohort 4 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0
3345860|NCT03487276|4075676|FG002|Number of Patients in Cohort 4 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||12
3345861|NCT03487276|4075677|FG003|Number of Patients in Cohort 4 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||18
3345862|NCT03487276|4075678|FG004|Number of Patients in Cohort 4 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0
3345863|NCT03487276|4075674|FG000|Number of Patients in Cohort 5 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0
3345864|NCT03487276|4075675|FG001|Number of Patients in Cohort 5 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0
3345865|NCT03487276|4075676|FG002|Number of Patients in Cohort 5 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||15
3345866|NCT03487276|4075677|FG003|Number of Patients in Cohort 5 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||16
3345867|NCT03487276|4075678|FG004|Number of Patients in Cohort 5 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0
3345868|NCT03487276|4075674|FG000|COMPLETED|Extension Period (28 Weeks)||0
3345869|NCT03487276|4075675|FG001|COMPLETED|Extension Period (28 Weeks)||0
3345870|NCT03487276|4075676|FG002|COMPLETED|Extension Period (28 Weeks)||67
3345871|NCT03487276|4075677|FG003|COMPLETED|Extension Period (28 Weeks)||54
3345872|NCT03487276|4075678|FG004|COMPLETED|Extension Period (28 Weeks)||0
3345873|NCT03487276|4075674|FG000|NOT COMPLETED|Extension Period (28 Weeks)||0
3345874|NCT03487276|4075675|FG001|NOT COMPLETED|Extension Period (28 Weeks)||0
3345875|NCT03487276|4075676|FG002|NOT COMPLETED|Extension Period (28 Weeks)||5
3345876|NCT03487276|4075677|FG003|NOT COMPLETED|Extension Period (28 Weeks)||30
3345877|NCT03487276|4075678|FG004|NOT COMPLETED|Extension Period (28 Weeks)||0
3345878|NCT03487445|4075701|FG000|STARTED|Randomization||25
3345879|NCT03487445|4075702|FG001|STARTED|Randomization||23
3345880|NCT03487445|4075701|FG000|COMPLETED|Randomization||24
3345881|NCT03487445|4075702|FG001|COMPLETED|Randomization||23
3345882|NCT03487445|4075701|FG000|NOT COMPLETED|Randomization||1
3345883|NCT03487445|4075702|FG001|NOT COMPLETED|Randomization||0
3345884|NCT03487445|4075701|FG000|STARTED|Treatment Period||24
3345885|NCT03487445|4075702|FG001|STARTED|Treatment Period||23
3345886|NCT03487445|4075701|FG000|Modified Full Analysis Set (mFAS)|Treatment Period||23
3345887|NCT03487445|4075702|FG001|Modified Full Analysis Set (mFAS)|Treatment Period||22
3345888|NCT03487445|4075701|FG000|Per Protocol Set|Treatment Period||20
3345889|NCT03487445|4075702|FG001|Per Protocol Set|Treatment Period||20
3345890|NCT03487445|4075701|FG000|COMPLETED|Treatment Period||24
3345891|NCT03487445|4075702|FG001|COMPLETED|Treatment Period||23
3345892|NCT03487445|4075701|FG000|NOT COMPLETED|Treatment Period||0
3345893|NCT03487445|4075702|FG001|NOT COMPLETED|Treatment Period||0
3345894|NCT03487549|4075710|FG000|STARTED|Overall Study||21
3345895|NCT03487549|4075711|FG001|STARTED|Overall Study||35
3345896|NCT03487549|4075710|FG000|COMPLETED|Overall Study||17
3345897|NCT03487549|4075711|FG001|COMPLETED|Overall Study||33
3345898|NCT03487549|4075710|FG000|NOT COMPLETED|Overall Study||4
3345899|NCT03487549|4075711|FG001|NOT COMPLETED|Overall Study||2
3345900|NCT03487588|4075717|FG000|STARTED|Overall Study||41
3345901|NCT03487588|4075717|FG000|COMPLETED|Overall Study||41
3345902|NCT03487588|4075717|FG000|NOT COMPLETED|Overall Study||0
3345903|NCT03487718|4075723|FG000|STARTED|Overall Study||12
3345904|NCT03487718|4075724|FG001|STARTED|Overall Study||15
3345905|NCT03487718|4075723|FG000|COMPLETED|Overall Study||11
3345906|NCT03487718|4075724|FG001|COMPLETED|Overall Study||11
3345907|NCT03487718|4075723|FG000|NOT COMPLETED|Overall Study||1
3345908|NCT03487718|4075724|FG001|NOT COMPLETED|Overall Study||4
3345909|NCT03487848|4075730|FG000|STARTED|Overall Study||5
3345910|NCT03487848|4075730|FG000|COMPLETED|Overall Study||4
3345911|NCT03487848|4075730|FG000|NOT COMPLETED|Overall Study||1
3345912|NCT03488108|4075736|FG000|STARTED|First Intervention (12 Weeks)||10
3345913|NCT03488108|4075737|FG001|STARTED|First Intervention (12 Weeks)||10
3345914|NCT03488108|4075736|FG000|COMPLETED|First Intervention (12 Weeks)||10
3345915|NCT03488108|4075737|FG001|COMPLETED|First Intervention (12 Weeks)||9
3345916|NCT03488108|4075736|FG000|NOT COMPLETED|First Intervention (12 Weeks)||0
3345917|NCT03488108|4075737|FG001|NOT COMPLETED|First Intervention (12 Weeks)||1
3345918|NCT03488108|4075736|FG000|STARTED|Washout (2 Months)||10
3345919|NCT03488108|4075737|FG001|STARTED|Washout (2 Months)||9
3345920|NCT03488108|4075736|FG000|COMPLETED|Washout (2 Months)||10
3345921|NCT03488108|4075737|FG001|COMPLETED|Washout (2 Months)||9
3345922|NCT03488108|4075736|FG000|NOT COMPLETED|Washout (2 Months)||0
3345923|NCT03488108|4075737|FG001|NOT COMPLETED|Washout (2 Months)||0
3345924|NCT03488108|4075736|FG000|STARTED|Second Intervention (12 Weeks)||10
3345925|NCT03488108|4075737|FG001|STARTED|Second Intervention (12 Weeks)||9
3345926|NCT03488108|4075736|FG000|COMPLETED|Second Intervention (12 Weeks)||9
3345927|NCT03488108|4075737|FG001|COMPLETED|Second Intervention (12 Weeks)||9
3345928|NCT03488108|4075736|FG000|NOT COMPLETED|Second Intervention (12 Weeks)||1
3345929|NCT03488108|4075737|FG001|NOT COMPLETED|Second Intervention (12 Weeks)||0
3345930|NCT03488225|4075745|FG000|STARTED|Overall Study||4
3345931|NCT03488225|4075745|FG000|COMPLETED|Overall Study||0
3345932|NCT03488225|4075745|FG000|NOT COMPLETED|Overall Study||4
3177856|NCT01973491|3905702|FG000|STARTED|Baseline Control Period (8 Weeks)||37
3177857|NCT01973491|3905702|FG000|COMPLETED|Baseline Control Period (8 Weeks)||19
3177858|NCT01973491|3905702|FG000|NOT COMPLETED|Baseline Control Period (8 Weeks)||18
3177859|NCT01973491|3905702|FG000|STARTED|Titration Period(4 Weeks)||19
3177860|NCT01973491|3905702|FG000|COMPLETED|Titration Period(4 Weeks)||19
3177861|NCT01973491|3905702|FG000|NOT COMPLETED|Titration Period(4 Weeks)||0
3177862|NCT01973491|3905702|FG000|STARTED|Treatment Period (16 Weeks)||19
3345933|NCT03488238|4075749|FG000|STARTED|Overall Study||31
3345934|NCT03488238|4075749|FG000|COMPLETED|Overall Study||29
3345935|NCT03488238|4075749|FG000|NOT COMPLETED|Overall Study||2
3345936|NCT03488849|4075756|FG000|STARTED|Overall Study||10
3345937|NCT03488849|4075757|FG001|STARTED|Overall Study||8
3345938|NCT03488849|4075758|FG002|STARTED|Overall Study||6
3345939|NCT03488849|4075756|FG000|COMPLETED|Overall Study||10
3345940|NCT03488849|4075757|FG001|COMPLETED|Overall Study||8
3345941|NCT03488849|4075758|FG002|COMPLETED|Overall Study||6
3345942|NCT03488849|4075756|FG000|NOT COMPLETED|Overall Study||0
3345943|NCT03488849|4075757|FG001|NOT COMPLETED|Overall Study||0
3345944|NCT03488849|4075758|FG002|NOT COMPLETED|Overall Study||0
3345945|NCT03488927|4075769|FG000|STARTED|Overall Study||305
3345946|NCT03488927|4075770|FG001|STARTED|Overall Study||432
3345947|NCT03488927|4075771|FG002|STARTED|Overall Study||531
3345948|NCT03488927|4075769|FG000|COMPLETED|Overall Study||261
3345949|NCT03488927|4075770|FG001|COMPLETED|Overall Study||314
3345950|NCT03488927|4075771|FG002|COMPLETED|Overall Study||314
3345951|NCT03488927|4075769|FG000|NOT COMPLETED|Overall Study||44
3345952|NCT03488927|4075770|FG001|NOT COMPLETED|Overall Study||118
3345953|NCT03488927|4075771|FG002|NOT COMPLETED|Overall Study||217
3345954|NCT03489304|4075779|FG000|STARTED|Overall Study||20
3345955|NCT03489304|4075779|FG000|COMPLETED|Overall Study||16
3345956|NCT03489304|4075779|FG000|NOT COMPLETED|Overall Study||4
3345957|NCT03489343|4075790|FG000|STARTED|Overall Study||1
3345958|NCT03489343|4075791|FG001|STARTED|Overall Study||1
3345959|NCT03489343|4075792|FG002|STARTED|Overall Study||3
3345960|NCT03489343|4075793|FG003|STARTED|Overall Study||3
3345961|NCT03489343|4075794|FG004|STARTED|Overall Study||3
3345962|NCT03489343|4075795|FG005|STARTED|Overall Study||7
3345963|NCT03489343|4075796|FG006|STARTED|Overall Study||6
3345964|NCT03489343|4075790|FG000|COMPLETED|Overall Study||0
3345965|NCT03489343|4075791|FG001|COMPLETED|Overall Study||0
3345966|NCT03489343|4075792|FG002|COMPLETED|Overall Study||0
3345967|NCT03489343|4075793|FG003|COMPLETED|Overall Study||0
3345968|NCT03489343|4075794|FG004|COMPLETED|Overall Study||0
3345969|NCT03489343|4075795|FG005|COMPLETED|Overall Study||0
3345970|NCT03489343|4075796|FG006|COMPLETED|Overall Study||0
3345971|NCT03489343|4075790|FG000|NOT COMPLETED|Overall Study||1
3345972|NCT03489343|4075791|FG001|NOT COMPLETED|Overall Study||1
3345973|NCT03489343|4075792|FG002|NOT COMPLETED|Overall Study||3
3345974|NCT03489343|4075793|FG003|NOT COMPLETED|Overall Study||3
3345975|NCT03489343|4075794|FG004|NOT COMPLETED|Overall Study||3
3345976|NCT03489343|4075795|FG005|NOT COMPLETED|Overall Study||7
3345977|NCT03489343|4075796|FG006|NOT COMPLETED|Overall Study||6
3345978|NCT03489369|4075816|FG000|STARTED|Overall Study||3
3345979|NCT03489369|4075817|FG001|STARTED|Overall Study||3
3345980|NCT03489369|4075818|FG002|STARTED|Overall Study||3
3345981|NCT03489369|4075819|FG003|STARTED|Overall Study||6
3345982|NCT03489369|4075816|FG000|COMPLETED|Overall Study||0
3345983|NCT03489369|4075817|FG001|COMPLETED|Overall Study||0
3345984|NCT03489369|4075818|FG002|COMPLETED|Overall Study||0
3345985|NCT03489369|4075819|FG003|COMPLETED|Overall Study||0
3345986|NCT03489369|4075816|FG000|NOT COMPLETED|Overall Study||3
3345987|NCT03489369|4075817|FG001|NOT COMPLETED|Overall Study||3
3345988|NCT03489369|4075818|FG002|NOT COMPLETED|Overall Study||3
3345989|NCT03489369|4075819|FG003|NOT COMPLETED|Overall Study||6
3345990|NCT03489551|4075829|FG000|STARTED|Overall Study||17
3345991|NCT03489551|4075829|FG000|COMPLETED|Overall Study||15
3345992|NCT03489551|4075829|FG000|NOT COMPLETED|Overall Study||2
3345993|NCT03489720|4075835|FG000|STARTED|Overall Study||24
3345994|NCT03489720|4075836|FG001|STARTED|Overall Study||22
3345995|NCT03489720|4075835|FG000|COMPLETED|Overall Study||22
3345996|NCT03489720|4075836|FG001|COMPLETED|Overall Study||22
3345997|NCT03489720|4075835|FG000|NOT COMPLETED|Overall Study||2
3345998|NCT03489720|4075836|FG001|NOT COMPLETED|Overall Study||0
3345999|NCT03489850|4075848|FG000|STARTED|Overall Study||24
3346000|NCT03489850|4075849|FG001|STARTED|Overall Study||28
3346001|NCT03489850|4075848|FG000|COMPLETED|Overall Study||23
3346002|NCT03489850|4075849|FG001|COMPLETED|Overall Study||27
3346003|NCT03489850|4075848|FG000|NOT COMPLETED|Overall Study||1
3346004|NCT03489850|4075849|FG001|NOT COMPLETED|Overall Study||1
3346005|NCT03489863|4075857|FG000|STARTED|Overall Study||7
3346006|NCT03489863|4075858|FG001|STARTED|Overall Study||7
3346007|NCT03489863|4075857|FG000|COMPLETED|Overall Study||7
3346008|NCT03489863|4075858|FG001|COMPLETED|Overall Study||6
3346009|NCT03489863|4075857|FG000|NOT COMPLETED|Overall Study||0
3346010|NCT03489863|4075858|FG001|NOT COMPLETED|Overall Study||1
3346011|NCT03489941|4075864|FG000|STARTED|Overall Study||51
3346012|NCT03489941|4075865|FG001|STARTED|Overall Study||52
3346013|NCT03489941|4075866|FG002|STARTED|Overall Study||27
3346014|NCT03489941|4075864|FG000|COMPLETED|Overall Study||51
3346015|NCT03489941|4075865|FG001|COMPLETED|Overall Study||52
3346016|NCT03489941|4075866|FG002|COMPLETED|Overall Study||27
3346017|NCT03489941|4075864|FG000|NOT COMPLETED|Overall Study||0
3346018|NCT03489941|4075865|FG001|NOT COMPLETED|Overall Study||0
3346019|NCT03489941|4075866|FG002|NOT COMPLETED|Overall Study||0
3346020|NCT03490032|4075875|FG000|STARTED|Overall Study||6
3346021|NCT03490032|4075876|FG001|STARTED|Overall Study||12
3346022|NCT03490032|4075877|FG002|STARTED|Overall Study||12
3346023|NCT03490032|4075875|FG000|COMPLETED|Overall Study||5
3346024|NCT03490032|4075876|FG001|COMPLETED|Overall Study||12
3346025|NCT03490032|4075877|FG002|COMPLETED|Overall Study||12
3346026|NCT03490032|4075875|FG000|NOT COMPLETED|Overall Study||1
3346027|NCT03490032|4075876|FG001|NOT COMPLETED|Overall Study||0
3346028|NCT03490032|4075877|FG002|NOT COMPLETED|Overall Study||0
3346029|NCT03490110|4075888|FG000|STARTED|Overall Study||9
3346030|NCT03490110|4075889|FG001|STARTED|Overall Study||9
3346031|NCT03490110|4075888|FG000|COMPLETED|Overall Study||6
3346032|NCT03490110|4075889|FG001|COMPLETED|Overall Study||6
3346033|NCT03490110|4075888|FG000|NOT COMPLETED|Overall Study||3
3346034|NCT03490110|4075889|FG001|NOT COMPLETED|Overall Study||3
3346035|NCT03490942|4075898|FG000|STARTED|Overall Study||15
3346036|NCT03490942|4075899|FG001|STARTED|Overall Study||18
3346037|NCT03490942|4075900|FG002|STARTED|Overall Study||16
3346038|NCT03490942|4075898|FG000|COMPLETED|Overall Study||5
3346039|NCT03490942|4075899|FG001|COMPLETED|Overall Study||8
3346040|NCT03490942|4075900|FG002|COMPLETED|Overall Study||9
3346041|NCT03490942|4075898|FG000|NOT COMPLETED|Overall Study||10
3346042|NCT03490942|4075899|FG001|NOT COMPLETED|Overall Study||10
3346043|NCT03490942|4075900|FG002|NOT COMPLETED|Overall Study||7
3346044|NCT03490981|4075910|FG000|STARTED|Overall Study||15
3346045|NCT03490981|4075911|FG001|STARTED|Overall Study||15
3346046|NCT03490981|4075910|FG000|COMPLETED|Overall Study||14
3346047|NCT03490981|4075911|FG001|COMPLETED|Overall Study||13
3346048|NCT03490981|4075910|FG000|NOT COMPLETED|Overall Study||1
3346049|NCT03490981|4075911|FG001|NOT COMPLETED|Overall Study||2
3346050|NCT03491150|4075919|FG000|STARTED|Overall Study||76
3346051|NCT03491150|4075920|FG001|STARTED|Overall Study||73
3346052|NCT03491150|4075919|FG000|COMPLETED|Overall Study||0
3346053|NCT03491150|4075920|FG001|COMPLETED|Overall Study||0
3346054|NCT03491150|4075919|FG000|NOT COMPLETED|Overall Study||76
3346055|NCT03491150|4075920|FG001|NOT COMPLETED|Overall Study||73
3346056|NCT03491228|4075926|FG000|STARTED|Overall Study||107
3346057|NCT03491228|4075926|FG000|COMPLETED|Overall Study||107
3346058|NCT03491228|4075926|FG000|NOT COMPLETED|Overall Study||0
3346059|NCT03491553|4075936|FG000|STARTED|Main Study (Up to Week 48)||9
3346060|NCT03491553|4075937|FG001|STARTED|Main Study (Up to Week 48)||10
3346061|NCT03491553|4075938|FG002|STARTED|Main Study (Up to Week 48)||10
3346062|NCT03491553|4075939|FG003|STARTED|Main Study (Up to Week 48)||10
3346063|NCT03491553|4075940|FG004|STARTED|Main Study (Up to Week 48)||5
3346064|NCT03491553|4075941|FG005|STARTED|Main Study (Up to Week 48)||4
3346065|NCT03491553|4075936|FG000|COMPLETED|Main Study (Up to Week 48)||8
3346066|NCT03491553|4075937|FG001|COMPLETED|Main Study (Up to Week 48)||9
3346067|NCT03491553|4075938|FG002|COMPLETED|Main Study (Up to Week 48)||10
3346068|NCT03491553|4075939|FG003|COMPLETED|Main Study (Up to Week 48)||9
3346069|NCT03491553|4075940|FG004|COMPLETED|Main Study (Up to Week 48)||5
3346070|NCT03491553|4075941|FG005|COMPLETED|Main Study (Up to Week 48)||4
3346071|NCT03491553|4075936|FG000|NOT COMPLETED|Main Study (Up to Week 48)||1
3346072|NCT03491553|4075937|FG001|NOT COMPLETED|Main Study (Up to Week 48)||1
3346073|NCT03491553|4075938|FG002|NOT COMPLETED|Main Study (Up to Week 48)||0
3346074|NCT03491553|4075939|FG003|NOT COMPLETED|Main Study (Up to Week 48)||1
3346075|NCT03491553|4075940|FG004|NOT COMPLETED|Main Study (Up to Week 48)||0
3346076|NCT03491553|4075941|FG005|NOT COMPLETED|Main Study (Up to Week 48)||0
3346077|NCT03491553|4075936|FG000|STARTED|TFFU (Week 49 up to Additional 48 Weeks)|8 participants completed the study period up to Week 48 but did not continue in the TFFU phase.|0
3346078|NCT03491553|4075937|FG001|STARTED|TFFU (Week 49 up to Additional 48 Weeks)|9 participants completed the study period up to Week 48 but only 1 participant continued in the TFFU phase.|1
3346079|NCT03491553|4075938|FG002|STARTED|TFFU (Week 49 up to Additional 48 Weeks)|10 participants completed the study period up to Week 48 but did not continue in the TFFU phase.|0
3346080|NCT03491553|4075939|FG003|STARTED|TFFU (Week 49 up to Additional 48 Weeks)|9 participants completed the study period up to Week 48 but did not continue in the TFFU phase.|0
3346081|NCT03491553|4075940|FG004|STARTED|TFFU (Week 49 up to Additional 48 Weeks)|5 participants completed the study period up to Week 48 but did not continue in the TFFU phase.|0
3346082|NCT03491553|4075941|FG005|STARTED|TFFU (Week 49 up to Additional 48 Weeks)|4 participants completed the study period up to Week 48 but did not continue in the TFFU phase.|0
3346083|NCT03491553|4075936|FG000|COMPLETED|TFFU (Week 49 up to Additional 48 Weeks)||0
3346084|NCT03491553|4075937|FG001|COMPLETED|TFFU (Week 49 up to Additional 48 Weeks)||1
3346085|NCT03491553|4075938|FG002|COMPLETED|TFFU (Week 49 up to Additional 48 Weeks)||0
3346086|NCT03491553|4075939|FG003|COMPLETED|TFFU (Week 49 up to Additional 48 Weeks)||0
3346087|NCT03491553|4075940|FG004|COMPLETED|TFFU (Week 49 up to Additional 48 Weeks)||0
3346088|NCT03491553|4075941|FG005|COMPLETED|TFFU (Week 49 up to Additional 48 Weeks)||0
3346089|NCT03491553|4075936|FG000|NOT COMPLETED|TFFU (Week 49 up to Additional 48 Weeks)||0
3346090|NCT03491553|4075937|FG001|NOT COMPLETED|TFFU (Week 49 up to Additional 48 Weeks)||0
3346091|NCT03491553|4075938|FG002|NOT COMPLETED|TFFU (Week 49 up to Additional 48 Weeks)||0
3346092|NCT03491553|4075939|FG003|NOT COMPLETED|TFFU (Week 49 up to Additional 48 Weeks)||0
3346093|NCT03491553|4075940|FG004|NOT COMPLETED|TFFU (Week 49 up to Additional 48 Weeks)||0
3346094|NCT03491553|4075941|FG005|NOT COMPLETED|TFFU (Week 49 up to Additional 48 Weeks)||0
3346095|NCT03491800|4075960|FG000|STARTED|Overall Study||23
3177863|NCT01973491|3905702|FG000|COMPLETED|Treatment Period (16 Weeks)||18
3177864|NCT01973491|3905702|FG000|NOT COMPLETED|Treatment Period (16 Weeks)||1
3177865|NCT01973569|3905709|FG000|STARTED|Overall Study||228
3177866|NCT01973569|3905710|FG001|STARTED|Overall Study||225
3177867|NCT01973569|3905711|FG002|STARTED|Overall Study||226
3177868|NCT01973569|3905709|FG000|Received Study Drug|Overall Study||222
3177869|NCT01973569|3905710|FG001|Received Study Drug|Overall Study||222
3346096|NCT03491800|4075961|FG001|STARTED|Overall Study||23
3346097|NCT03491800|4075962|FG002|STARTED|Overall Study||7
3346098|NCT03491800|4075960|FG000|COMPLETED|Overall Study||23
3346099|NCT03491800|4075961|FG001|COMPLETED|Overall Study||23
3346100|NCT03491800|4075962|FG002|COMPLETED|Overall Study||7
3346101|NCT03491800|4075960|FG000|NOT COMPLETED|Overall Study||0
3346102|NCT03491800|4075961|FG001|NOT COMPLETED|Overall Study||0
3346103|NCT03491800|4075962|FG002|NOT COMPLETED|Overall Study||0
3346104|NCT03491891|4075973|FG000|STARTED|Overall Study||6038
3346105|NCT03491891|4075974|FG001|STARTED|Overall Study||2438
3346106|NCT03491891|4075973|FG000|COMPLETED|Overall Study||5185
3346107|NCT03491891|4075974|FG001|COMPLETED|Overall Study||2058
3346108|NCT03491891|4075973|FG000|NOT COMPLETED|Overall Study||853
3346109|NCT03491891|4075974|FG001|NOT COMPLETED|Overall Study||380
3346110|NCT03491917|4075980|FG000|STARTED|First Reading Session||50
3346111|NCT03491917|4075981|FG001|STARTED|First Reading Session||50
3346112|NCT03491917|4075980|FG000|COMPLETED|First Reading Session||50
3346113|NCT03491917|4075981|FG001|COMPLETED|First Reading Session||50
3346114|NCT03491917|4075980|FG000|NOT COMPLETED|First Reading Session||0
3346115|NCT03491917|4075981|FG001|NOT COMPLETED|First Reading Session||0
3346116|NCT03491917|4075980|FG000|STARTED|4 Week Memory Washout Period||50
3346117|NCT03491917|4075981|FG001|STARTED|4 Week Memory Washout Period||50
3346118|NCT03491917|4075980|FG000|COMPLETED|4 Week Memory Washout Period||50
3346119|NCT03491917|4075981|FG001|COMPLETED|4 Week Memory Washout Period||50
3346120|NCT03491917|4075980|FG000|NOT COMPLETED|4 Week Memory Washout Period||0
3346121|NCT03491917|4075981|FG001|NOT COMPLETED|4 Week Memory Washout Period||0
3346122|NCT03491917|4075980|FG000|STARTED|Second Reading Session||50
3346123|NCT03491917|4075981|FG001|STARTED|Second Reading Session||50
3346124|NCT03491917|4075980|FG000|COMPLETED|Second Reading Session||50
3346125|NCT03491917|4075981|FG001|COMPLETED|Second Reading Session||50
3346126|NCT03491917|4075980|FG000|NOT COMPLETED|Second Reading Session||0
3346127|NCT03491917|4075981|FG001|NOT COMPLETED|Second Reading Session||0
3346128|NCT03492099|4075987|FG000|STARTED|Overall Study||47
3346129|NCT03492099|4075987|FG000|COMPLETED|Overall Study||38
3346130|NCT03492099|4075987|FG000|NOT COMPLETED|Overall Study||9
3346131|NCT03492281|4075994|FG000|STARTED|Overall Study||540
3346132|NCT03492281|4075995|FG001|STARTED|Overall Study||547
3346133|NCT03492281|4075996|FG002|STARTED|Overall Study||431
3346134|NCT03492281|4075994|FG000|COMPLETED|Overall Study||486
3346135|NCT03492281|4075995|FG001|COMPLETED|Overall Study||502
3346136|NCT03492281|4075996|FG002|COMPLETED|Overall Study||385
3346137|NCT03492281|4075994|FG000|NOT COMPLETED|Overall Study||54
3346138|NCT03492281|4075995|FG001|NOT COMPLETED|Overall Study||45
3346139|NCT03492281|4075996|FG002|NOT COMPLETED|Overall Study||46
3346140|NCT03492398|4076016|FG000|STARTED|Overall Study||8
3346141|NCT03492398|4076017|FG001|STARTED|Overall Study||6
3346142|NCT03492398|4076018|FG002|STARTED|Overall Study||6
3346143|NCT03492398|4076019|FG003|STARTED|Overall Study||6
3346144|NCT03492398|4076020|FG004|STARTED|Overall Study||6
3346145|NCT03492398|4076021|FG005|STARTED|Overall Study||6
3346146|NCT03492398|4076022|FG006|STARTED|Overall Study||6
3346147|NCT03492398|4076023|FG007|STARTED|Overall Study||6
3346148|NCT03492398|4076024|FG008|STARTED|Overall Study||6
3346149|NCT03492398|4076016|FG000|COMPLETED|Overall Study||8
3346150|NCT03492398|4076017|FG001|COMPLETED|Overall Study||6
3346151|NCT03492398|4076018|FG002|COMPLETED|Overall Study||6
3346152|NCT03492398|4076019|FG003|COMPLETED|Overall Study||6
3346153|NCT03492398|4076020|FG004|COMPLETED|Overall Study||6
3346154|NCT03492398|4076021|FG005|COMPLETED|Overall Study||6
3346155|NCT03492398|4076022|FG006|COMPLETED|Overall Study||5
3346156|NCT03492398|4076023|FG007|COMPLETED|Overall Study||5
3346157|NCT03492398|4076024|FG008|COMPLETED|Overall Study||6
3346158|NCT03492398|4076016|FG000|NOT COMPLETED|Overall Study||0
3346159|NCT03492398|4076017|FG001|NOT COMPLETED|Overall Study||0
3346160|NCT03492398|4076018|FG002|NOT COMPLETED|Overall Study||0
3346161|NCT03492398|4076019|FG003|NOT COMPLETED|Overall Study||0
3346162|NCT03492398|4076020|FG004|NOT COMPLETED|Overall Study||0
3346163|NCT03492398|4076021|FG005|NOT COMPLETED|Overall Study||0
3346164|NCT03492398|4076022|FG006|NOT COMPLETED|Overall Study||1
3346165|NCT03492398|4076023|FG007|NOT COMPLETED|Overall Study||1
3346166|NCT03492398|4076024|FG008|NOT COMPLETED|Overall Study||0
3346167|NCT03492554|4076046|FG000|STARTED|Overall Study||301
3346168|NCT03492554|4076047|FG001|STARTED|Overall Study||301
3346169|NCT03492554|4076046|FG000|COMPLETED|Overall Study||301
3346170|NCT03492554|4076047|FG001|COMPLETED|Overall Study||287
3346171|NCT03492554|4076046|FG000|NOT COMPLETED|Overall Study||0
3346172|NCT03492554|4076047|FG001|NOT COMPLETED|Overall Study||14
3346173|NCT03493386|4076056|FG000|STARTED|Part 1, Intervention Period 1 (2 Days)||26
3346174|NCT03493386|4076057|FG001|STARTED|Part 1, Intervention Period 1 (2 Days)||26
3346175|NCT03493386|4076058|FG002|STARTED|Part 1, Intervention Period 1 (2 Days)||0
3346176|NCT03493386|4076059|FG003|STARTED|Part 1, Intervention Period 1 (2 Days)||0
3346177|NCT03493386|4076056|FG000|COMPLETED|Part 1, Intervention Period 1 (2 Days)||26
3346178|NCT03493386|4076057|FG001|COMPLETED|Part 1, Intervention Period 1 (2 Days)||26
3346179|NCT03493386|4076058|FG002|COMPLETED|Part 1, Intervention Period 1 (2 Days)||0
3346180|NCT03493386|4076059|FG003|COMPLETED|Part 1, Intervention Period 1 (2 Days)||0
3346181|NCT03493386|4076056|FG000|NOT COMPLETED|Part 1, Intervention Period 1 (2 Days)||0
3346182|NCT03493386|4076057|FG001|NOT COMPLETED|Part 1, Intervention Period 1 (2 Days)||0
3346183|NCT03493386|4076058|FG002|NOT COMPLETED|Part 1, Intervention Period 1 (2 Days)||0
3346184|NCT03493386|4076059|FG003|NOT COMPLETED|Part 1, Intervention Period 1 (2 Days)||0
3346185|NCT03493386|4076056|FG000|STARTED|Part 1, Washout Period (at Least 5 Days)||26
3346186|NCT03493386|4076057|FG001|STARTED|Part 1, Washout Period (at Least 5 Days)||26
3346187|NCT03493386|4076058|FG002|STARTED|Part 1, Washout Period (at Least 5 Days)||0
3346188|NCT03493386|4076059|FG003|STARTED|Part 1, Washout Period (at Least 5 Days)||0
3346189|NCT03493386|4076056|FG000|COMPLETED|Part 1, Washout Period (at Least 5 Days)||26
3346190|NCT03493386|4076057|FG001|COMPLETED|Part 1, Washout Period (at Least 5 Days)||25
3346191|NCT03493386|4076058|FG002|COMPLETED|Part 1, Washout Period (at Least 5 Days)||0
3346192|NCT03493386|4076059|FG003|COMPLETED|Part 1, Washout Period (at Least 5 Days)||0
3346193|NCT03493386|4076056|FG000|NOT COMPLETED|Part 1, Washout Period (at Least 5 Days)||0
3346194|NCT03493386|4076057|FG001|NOT COMPLETED|Part 1, Washout Period (at Least 5 Days)||1
3346195|NCT03493386|4076058|FG002|NOT COMPLETED|Part 1, Washout Period (at Least 5 Days)||0
3346196|NCT03493386|4076059|FG003|NOT COMPLETED|Part 1, Washout Period (at Least 5 Days)||0
3346197|NCT03493386|4076056|FG000|STARTED|Part 1, Intervention Period 2 (2 Days)||26
3346198|NCT03493386|4076057|FG001|STARTED|Part 1, Intervention Period 2 (2 Days)||25
3346199|NCT03493386|4076058|FG002|STARTED|Part 1, Intervention Period 2 (2 Days)||0
3346200|NCT03493386|4076059|FG003|STARTED|Part 1, Intervention Period 2 (2 Days)||0
3346201|NCT03493386|4076056|FG000|COMPLETED|Part 1, Intervention Period 2 (2 Days)||26
3346202|NCT03493386|4076057|FG001|COMPLETED|Part 1, Intervention Period 2 (2 Days)||25
3346203|NCT03493386|4076058|FG002|COMPLETED|Part 1, Intervention Period 2 (2 Days)||0
3346204|NCT03493386|4076059|FG003|COMPLETED|Part 1, Intervention Period 2 (2 Days)||0
3346205|NCT03493386|4076056|FG000|NOT COMPLETED|Part 1, Intervention Period 2 (2 Days)||0
3346206|NCT03493386|4076057|FG001|NOT COMPLETED|Part 1, Intervention Period 2 (2 Days)||0
3346207|NCT03493386|4076058|FG002|NOT COMPLETED|Part 1, Intervention Period 2 (2 Days)||0
3346208|NCT03493386|4076059|FG003|NOT COMPLETED|Part 1, Intervention Period 2 (2 Days)||0
3346209|NCT03493386|4076056|FG000|STARTED|Part 2, Intervention Period 1 (2 Days)||0
3346210|NCT03493386|4076057|FG001|STARTED|Part 2, Intervention Period 1 (2 Days)||0
3346211|NCT03493386|4076058|FG002|STARTED|Part 2, Intervention Period 1 (2 Days)||6
3346212|NCT03493386|4076059|FG003|STARTED|Part 2, Intervention Period 1 (2 Days)||6
3346213|NCT03493386|4076056|FG000|COMPLETED|Part 2, Intervention Period 1 (2 Days)||0
3346214|NCT03493386|4076057|FG001|COMPLETED|Part 2, Intervention Period 1 (2 Days)||0
3346215|NCT03493386|4076058|FG002|COMPLETED|Part 2, Intervention Period 1 (2 Days)||6
3346216|NCT03493386|4076059|FG003|COMPLETED|Part 2, Intervention Period 1 (2 Days)||6
3346217|NCT03493386|4076056|FG000|NOT COMPLETED|Part 2, Intervention Period 1 (2 Days)||0
3346218|NCT03493386|4076057|FG001|NOT COMPLETED|Part 2, Intervention Period 1 (2 Days)||0
3346219|NCT03493386|4076058|FG002|NOT COMPLETED|Part 2, Intervention Period 1 (2 Days)||0
3346220|NCT03493386|4076059|FG003|NOT COMPLETED|Part 2, Intervention Period 1 (2 Days)||0
3346221|NCT03493386|4076056|FG000|STARTED|Part 2, Washout Period (at Least 5 Days)||0
3346222|NCT03493386|4076057|FG001|STARTED|Part 2, Washout Period (at Least 5 Days)||0
3346223|NCT03493386|4076058|FG002|STARTED|Part 2, Washout Period (at Least 5 Days)||6
3346224|NCT03493386|4076059|FG003|STARTED|Part 2, Washout Period (at Least 5 Days)||6
3346225|NCT03493386|4076056|FG000|COMPLETED|Part 2, Washout Period (at Least 5 Days)||0
3346226|NCT03493386|4076057|FG001|COMPLETED|Part 2, Washout Period (at Least 5 Days)||0
3346227|NCT03493386|4076058|FG002|COMPLETED|Part 2, Washout Period (at Least 5 Days)||6
3346228|NCT03493386|4076059|FG003|COMPLETED|Part 2, Washout Period (at Least 5 Days)||6
3346229|NCT03493386|4076056|FG000|NOT COMPLETED|Part 2, Washout Period (at Least 5 Days)||0
3346230|NCT03493386|4076057|FG001|NOT COMPLETED|Part 2, Washout Period (at Least 5 Days)||0
3346231|NCT03493386|4076058|FG002|NOT COMPLETED|Part 2, Washout Period (at Least 5 Days)||0
3346232|NCT03493386|4076059|FG003|NOT COMPLETED|Part 2, Washout Period (at Least 5 Days)||0
3346233|NCT03493386|4076056|FG000|STARTED|Part 2, Intervention Period 2 (2 Days)||0
3346234|NCT03493386|4076057|FG001|STARTED|Part 2, Intervention Period 2 (2 Days)||0
3346235|NCT03493386|4076058|FG002|STARTED|Part 2, Intervention Period 2 (2 Days)||6
3346236|NCT03493386|4076059|FG003|STARTED|Part 2, Intervention Period 2 (2 Days)||6
3346237|NCT03493386|4076056|FG000|COMPLETED|Part 2, Intervention Period 2 (2 Days)||0
3346238|NCT03493386|4076057|FG001|COMPLETED|Part 2, Intervention Period 2 (2 Days)||0
3346239|NCT03493386|4076058|FG002|COMPLETED|Part 2, Intervention Period 2 (2 Days)||6
3346240|NCT03493386|4076059|FG003|COMPLETED|Part 2, Intervention Period 2 (2 Days)||6
3346241|NCT03493386|4076056|FG000|NOT COMPLETED|Part 2, Intervention Period 2 (2 Days)||0
3346242|NCT03493386|4076057|FG001|NOT COMPLETED|Part 2, Intervention Period 2 (2 Days)||0
3346243|NCT03493386|4076058|FG002|NOT COMPLETED|Part 2, Intervention Period 2 (2 Days)||0
3346244|NCT03493386|4076059|FG003|NOT COMPLETED|Part 2, Intervention Period 2 (2 Days)||0
3346245|NCT03493542|4076078|FG000|STARTED|Overall Study||383
3346246|NCT03493542|4076079|FG001|STARTED|Overall Study||383
3346247|NCT03493542|4076078|FG000|Vaccination 1|Overall Study||383
3346248|NCT03493542|4076079|FG001|Vaccination 1|Overall Study||383
3346249|NCT03493542|4076078|FG000|Vaccination 2|Overall Study||379
3346250|NCT03493542|4076079|FG001|Vaccination 2|Overall Study||378
3346251|NCT03493542|4076078|FG000|Vaccination 3|Overall Study||376
3346252|NCT03493542|4076079|FG001|Vaccination 3|Overall Study||374
3346253|NCT03493542|4076078|FG000|COMPLETED|Overall Study||376
3346254|NCT03493542|4076079|FG001|COMPLETED|Overall Study||374
3346255|NCT03493542|4076078|FG000|NOT COMPLETED|Overall Study||7
3346256|NCT03493542|4076079|FG001|NOT COMPLETED|Overall Study||9
3346257|NCT03493607|4076085|FG000|STARTED|Overall Study||6
3346258|NCT03493607|4076085|FG000|COMPLETED|Overall Study||6
3346259|NCT03493607|4076085|FG000|NOT COMPLETED|Overall Study||0
3346260|NCT03493698|4076089|FG000|STARTED|Treatment Period A||17
3346261|NCT03493698|4076089|FG000|COMPLETED|Treatment Period A||17
3346262|NCT03493698|4076089|FG000|NOT COMPLETED|Treatment Period A||0
3346263|NCT03493698|4076089|FG000|STARTED|Treatment Period B||17
3346264|NCT03493698|4076089|FG000|COMPLETED|Treatment Period B||17
3346265|NCT03493698|4076089|FG000|NOT COMPLETED|Treatment Period B||0
3346266|NCT03493698|4076089|FG000|STARTED|Treatment Period C||17
3346267|NCT03493698|4076089|FG000|COMPLETED|Treatment Period C||15
3346268|NCT03493698|4076089|FG000|NOT COMPLETED|Treatment Period C||2
3346269|NCT03493698|4076089|FG000|STARTED|Treatment Period D||15
3346270|NCT03493698|4076089|FG000|COMPLETED|Treatment Period D||15
3346271|NCT03493698|4076089|FG000|NOT COMPLETED|Treatment Period D||0
3346272|NCT03493815|4076105|FG000|STARTED|Overall Study||42
3346273|NCT03493815|4076106|FG001|STARTED|Overall Study||43
3346274|NCT03493815|4076105|FG000|COMPLETED|Overall Study||33
3346275|NCT03493815|4076106|FG001|COMPLETED|Overall Study||32
3346276|NCT03493815|4076105|FG000|NOT COMPLETED|Overall Study||9
3346277|NCT03493815|4076106|FG001|NOT COMPLETED|Overall Study||11
3346278|NCT03493828|4076115|FG000|STARTED|Overall Study||20
3346279|NCT03493828|4076116|FG001|STARTED|Overall Study||20
3346280|NCT03493828|4076117|FG002|STARTED|Overall Study||20
3346281|NCT03493828|4076115|FG000|COMPLETED|Overall Study||20
2927925|NCT00574951|3638848|FG000|COMPLETED|Overall Study||22
2927926|NCT00574951|3638848|FG000|NOT COMPLETED|Overall Study||1
2927927|NCT00574990|3638855|FG000|STARTED|Overall Study||12
2927928|NCT00574990|3638856|FG001|STARTED|Overall Study||19
2927929|NCT00574990|3638857|FG002|STARTED|Overall Study||8
2927930|NCT00574990|3638855|FG000|COMPLETED|Overall Study||12
2927931|NCT00574990|3638856|FG001|COMPLETED|Overall Study||19
2927932|NCT00574990|3638857|FG002|COMPLETED|Overall Study||8
2927933|NCT00574990|3638855|FG000|NOT COMPLETED|Overall Study||0
2927934|NCT00574990|3638856|FG001|NOT COMPLETED|Overall Study||0
2927935|NCT00574990|3638857|FG002|NOT COMPLETED|Overall Study||0
2927936|NCT00575016|3638872|FG000|STARTED|Treatment Cycle 1||17
2927937|NCT00575016|3638873|FG001|STARTED|Treatment Cycle 1||21
2927938|NCT00575016|3638874|FG002|STARTED|Treatment Cycle 1||19
2927939|NCT00575016|3638875|FG003|STARTED|Treatment Cycle 1|1 pt randomized to Placebo never received treatment|17
2927940|NCT00575016|3638872|FG000|COMPLETED|Treatment Cycle 1|3 pts from 200U group entered Cycle 2|8
2927941|NCT00575016|3638873|FG001|COMPLETED|Treatment Cycle 1|11 pts from 100U group entered Cycle 2|16
2927942|NCT00575016|3638874|FG002|COMPLETED|Treatment Cycle 1|8 pts from 50U group entered Cycle 2|15
2927943|NCT00575016|3638875|FG003|COMPLETED|Treatment Cycle 1|9 pts from Placebo group entered Cycle 2|12
2927944|NCT00575016|3638872|FG000|NOT COMPLETED|Treatment Cycle 1||9
2927945|NCT00575016|3638873|FG001|NOT COMPLETED|Treatment Cycle 1||5
2927946|NCT00575016|3638874|FG002|NOT COMPLETED|Treatment Cycle 1||4
2927947|NCT00575016|3638875|FG003|NOT COMPLETED|Treatment Cycle 1||5
2927948|NCT00575016|3638872|FG000|STARTED|Treatment Cycle 2|All patients received 200U in Treatment Cycle 2.|31
2927949|NCT00575016|3638873|FG001|STARTED|Treatment Cycle 2|All patients received 200U in Treatment Cycle 2.|0
3039843|NCT01160848|3759334|FG000|NOT COMPLETED|Overall Study||0
3039844|NCT01160848|3759335|FG001|NOT COMPLETED|Overall Study||0
3039845|NCT01161043|3759345|FG000|STARTED|Overall Study||83
3039846|NCT01161043|3759345|FG000|COMPLETED|Overall Study||80
3039847|NCT01161043|3759345|FG000|NOT COMPLETED|Overall Study||3
3039848|NCT01161121|3759349|FG000|STARTED|Overall Study||46
3039849|NCT01161121|3759349|FG000|COMPLETED|Overall Study||46
3039850|NCT01161121|3759349|FG000|NOT COMPLETED|Overall Study||0
3039851|NCT01161160|3759360|FG000|STARTED|Overall Study||76
3039852|NCT01161160|3759361|FG001|STARTED|Overall Study||75
3039853|NCT01161160|3759362|FG002|STARTED|Overall Study||58
3039854|NCT01161160|3759360|FG000|COMPLETED|Overall Study||76
3039855|NCT01161160|3759361|FG001|COMPLETED|Overall Study||75
3039856|NCT01161160|3759362|FG002|COMPLETED|Overall Study||58
3039857|NCT01161160|3759360|FG000|NOT COMPLETED|Overall Study||0
3039858|NCT01161160|3759361|FG001|NOT COMPLETED|Overall Study||0
3039859|NCT01161160|3759362|FG002|NOT COMPLETED|Overall Study||0
3039860|NCT01161173|3759370|FG000|STARTED|Overall Study||347
3039861|NCT01161173|3759370|FG000|COMPLETED|Overall Study||0
3039862|NCT01161173|3759370|FG000|NOT COMPLETED|Overall Study||347
3039863|NCT01161225|3759377|FG000|STARTED|Overall Study||59
3039864|NCT01161225|3759378|FG001|STARTED|Overall Study||53
3039865|NCT01161225|3759379|FG002|STARTED|Overall Study||14
3039866|NCT01161225|3759377|FG000|COMPLETED|Overall Study||45
3039867|NCT01161225|3759378|FG001|COMPLETED|Overall Study||44
3039868|NCT01161225|3759379|FG002|COMPLETED|Overall Study||12
3039869|NCT01161225|3759377|FG000|NOT COMPLETED|Overall Study||14
3039870|NCT01161225|3759378|FG001|NOT COMPLETED|Overall Study||9
3039871|NCT01161225|3759379|FG002|NOT COMPLETED|Overall Study||2
3039872|NCT01161329|3759393|FG000|STARTED|Overall Study||33
3039873|NCT01161329|3759394|FG001|STARTED|Overall Study||34
3039874|NCT01161329|3759393|FG000|COMPLETED|Overall Study||29
3039875|NCT01161329|3759394|FG001|COMPLETED|Overall Study||24
3039876|NCT01161329|3759393|FG000|NOT COMPLETED|Overall Study||4
3039877|NCT01161329|3759394|FG001|NOT COMPLETED|Overall Study||10
3039878|NCT01161407|3759403|FG000|STARTED|Overall Study||6
3039879|NCT01161407|3759404|FG001|STARTED|Overall Study||6
3346282|NCT03493828|4076116|FG001|COMPLETED|Overall Study||20
3346283|NCT03493828|4076117|FG002|COMPLETED|Overall Study||20
3346284|NCT03493828|4076115|FG000|NOT COMPLETED|Overall Study||0
3346285|NCT03493828|4076116|FG001|NOT COMPLETED|Overall Study||0
3346286|NCT03493828|4076117|FG002|NOT COMPLETED|Overall Study||0
3346287|NCT03494725|4076127|FG000|STARTED|Overall Study||60
3346288|NCT03494725|4076128|FG001|STARTED|Overall Study||60
3346289|NCT03494725|4076127|FG000|Intervention (Post 2 Weeks run-in)|Overall Study||59
3346290|NCT03494725|4076128|FG001|Intervention (Post 2 Weeks run-in)|Overall Study||59
3346291|NCT03494725|4076127|FG000|COMPLETED|Overall Study||59
3346292|NCT03494725|4076128|FG001|COMPLETED|Overall Study||58
3346293|NCT03494725|4076127|FG000|NOT COMPLETED|Overall Study||1
3346294|NCT03494725|4076128|FG001|NOT COMPLETED|Overall Study||2
3346295|NCT03494816|4076140|FG000|STARTED|Overall Study||24
3346296|NCT03494816|4076140|FG000|COMPLETED|Overall Study||18
3346297|NCT03494816|4076140|FG000|NOT COMPLETED|Overall Study||6
3346298|NCT03494985|4076152|FG000|STARTED|Overall Study||101
3346299|NCT03494985|4076153|FG001|STARTED|Overall Study||98
3346300|NCT03494985|4076154|FG002|STARTED|Overall Study||98
3346301|NCT03494985|4076155|FG003|STARTED|Overall Study||99
3346302|NCT03494985|4076152|FG000|COMPLETED|Overall Study||96
3346303|NCT03494985|4076153|FG001|COMPLETED|Overall Study||92
3346304|NCT03494985|4076154|FG002|COMPLETED|Overall Study||92
3346305|NCT03494985|4076155|FG003|COMPLETED|Overall Study||94
3346306|NCT03494985|4076152|FG000|NOT COMPLETED|Overall Study||5
3346307|NCT03494985|4076153|FG001|NOT COMPLETED|Overall Study||6
3346308|NCT03494985|4076154|FG002|NOT COMPLETED|Overall Study||6
3346309|NCT03494985|4076155|FG003|NOT COMPLETED|Overall Study||5
3346310|NCT03495102|4076168|FG000|STARTED|Overall Study||612
3346311|NCT03495102|4076169|FG001|STARTED|Overall Study||616
3346312|NCT03495102|4076170|FG002|STARTED|Overall Study||614
3346313|NCT03495102|4076168|FG000|Received at Least One Dose of Study Drug|Overall Study||612
3346314|NCT03495102|4076169|FG001|Received at Least One Dose of Study Drug|Overall Study||616
3346315|NCT03495102|4076170|FG002|Received at Least One Dose of Study Drug|Overall Study||614
3346316|NCT03495102|4076168|FG000|COMPLETED|Overall Study||556
3346317|NCT03495102|4076169|FG001|COMPLETED|Overall Study||549
3346318|NCT03495102|4076170|FG002|COMPLETED|Overall Study||560
3346319|NCT03495102|4076168|FG000|NOT COMPLETED|Overall Study||56
3346320|NCT03495102|4076169|FG001|NOT COMPLETED|Overall Study||67
3346321|NCT03495102|4076170|FG002|NOT COMPLETED|Overall Study||54
3346322|NCT03495648|4076180|FG000|STARTED|Overall Study||60
3346323|NCT03495648|4076181|FG001|STARTED|Overall Study||61
3346324|NCT03495648|4076180|FG000|COMPLETED|Overall Study||60
3346325|NCT03495648|4076181|FG001|COMPLETED|Overall Study||61
3346326|NCT03495648|4076180|FG000|NOT COMPLETED|Overall Study||0
3346327|NCT03495648|4076181|FG001|NOT COMPLETED|Overall Study||0
3346328|NCT03495817|4076187|FG000|STARTED|26 Week Open Label||31
3346329|NCT03495817|4076187|FG000|COMPLETED|26 Week Open Label||23
3346330|NCT03495817|4076187|FG000|NOT COMPLETED|26 Week Open Label||8
3346331|NCT03495817|4076187|FG000|STARTED|26 Week Extension||19
3346332|NCT03495817|4076187|FG000|COMPLETED|26 Week Extension||17
3346333|NCT03495817|4076187|FG000|NOT COMPLETED|26 Week Extension||2
3346334|NCT03495856|4076191|FG000|STARTED|Overall Study||23
3346335|NCT03495856|4076191|FG000|COMPLETED|Overall Study||22
3346336|NCT03495856|4076191|FG000|NOT COMPLETED|Overall Study||1
3346337|NCT03495869|4076199|FG000|STARTED|Overall Study||54
3346338|NCT03495869|4076200|FG001|STARTED|Overall Study||124
3346339|NCT03495869|4076201|FG002|STARTED|Overall Study||61
3346340|NCT03495869|4076202|FG003|STARTED|Overall Study||129
3346341|NCT03495869|4076199|FG000|COMPLETED|Overall Study||50
3346342|NCT03495869|4076200|FG001|COMPLETED|Overall Study||97
3346343|NCT03495869|4076201|FG002|COMPLETED|Overall Study||51
3346344|NCT03495869|4076202|FG003|COMPLETED|Overall Study||108
3346345|NCT03495869|4076199|FG000|NOT COMPLETED|Overall Study||4
3346346|NCT03495869|4076200|FG001|NOT COMPLETED|Overall Study||27
3346347|NCT03495869|4076201|FG002|NOT COMPLETED|Overall Study||10
3346348|NCT03495869|4076202|FG003|NOT COMPLETED|Overall Study||21
3346349|NCT03495908|4076214|FG000|STARTED|Overall Study||69
3346350|NCT03495908|4076215|FG001|STARTED|Overall Study||67
3346351|NCT03495908|4076214|FG000|COMPLETED|Overall Study||59
3346352|NCT03495908|4076215|FG001|COMPLETED|Overall Study||54
3346353|NCT03495908|4076214|FG000|NOT COMPLETED|Overall Study||10
3346354|NCT03495908|4076215|FG001|NOT COMPLETED|Overall Study||13
3346355|NCT03496220|4076223|FG000|STARTED|First Intervention||15
3346356|NCT03496220|4076224|FG001|STARTED|First Intervention||4
3177870|NCT01973569|3905711|FG002|Received Study Drug|Overall Study||223
3177871|NCT01973569|3905709|FG000|Did Not Receive Study Drug|Overall Study||6
3177872|NCT01973569|3905710|FG001|Did Not Receive Study Drug|Overall Study||3
3346357|NCT03496220|4076225|FG002|STARTED|First Intervention||10
3346358|NCT03496220|4076223|FG000|COMPLETED|First Intervention||15
3346359|NCT03496220|4076224|FG001|COMPLETED|First Intervention||4
3346360|NCT03496220|4076225|FG002|COMPLETED|First Intervention||10
3346361|NCT03496220|4076223|FG000|NOT COMPLETED|First Intervention||0
3346362|NCT03496220|4076224|FG001|NOT COMPLETED|First Intervention||0
3346363|NCT03496220|4076225|FG002|NOT COMPLETED|First Intervention||0
3346364|NCT03496220|4076223|FG000|STARTED|Second Intervention||17
3346365|NCT03496220|4076224|FG001|STARTED|Second Intervention||9
3346366|NCT03496220|4076225|FG002|STARTED|Second Intervention||11
3177873|NCT01973569|3905711|FG002|Did Not Receive Study Drug|Overall Study||3
3177874|NCT01973569|3905709|FG000|Discontinued Study Treatment|Overall Study||23
3346367|NCT03496220|4076223|FG000|COMPLETED|Second Intervention||17
3346368|NCT03496220|4076224|FG001|COMPLETED|Second Intervention||9
3346369|NCT03496220|4076225|FG002|COMPLETED|Second Intervention||11
3346370|NCT03496220|4076223|FG000|NOT COMPLETED|Second Intervention||0
3346371|NCT03496220|4076224|FG001|NOT COMPLETED|Second Intervention||0
3346372|NCT03496220|4076225|FG002|NOT COMPLETED|Second Intervention||0
3346373|NCT03496220|4076223|FG000|STARTED|Third Intervention||11
3346374|NCT03496220|4076224|FG001|STARTED|Third Intervention||8
3346375|NCT03496220|4076225|FG002|STARTED|Third Intervention||5
3346376|NCT03496220|4076223|FG000|COMPLETED|Third Intervention||11
3346377|NCT03496220|4076224|FG001|COMPLETED|Third Intervention||8
3346378|NCT03496220|4076225|FG002|COMPLETED|Third Intervention||5
3346379|NCT03496220|4076223|FG000|NOT COMPLETED|Third Intervention||0
3346380|NCT03496220|4076224|FG001|NOT COMPLETED|Third Intervention||0
3346381|NCT03496220|4076225|FG002|NOT COMPLETED|Third Intervention||0
3346382|NCT03496298|4076234|FG000|STARTED|Overall Study||1359
3346383|NCT03496298|4076235|FG001|STARTED|Overall Study||1359
3346384|NCT03496298|4076236|FG002|STARTED|Overall Study||1358
3346385|NCT03496298|4076234|FG000|Randomized and Treated|Overall Study||1358
3346386|NCT03496298|4076235|FG001|Randomized and Treated|Overall Study||1358
3346387|NCT03496298|4076236|FG002|Randomized and Treated|Overall Study||1357
3346388|NCT03496298|4076234|FG000|Safety Population|Overall Study|2 participants of Placebo arm received Efpeglenatide 4 mg treatment and 1 participant received Efpeglenatide 6 mg treatment. Hence, they were counted in the respective arm for safety analysis.|1355
3346389|NCT03496298|4076235|FG001|Safety Population|Overall Study|2 participants of Placebo arm received Efpeglenatide 4 mg treatment and thus counted in the 4 mg treatment arm for safety analysis.|1360
3346390|NCT03496298|4076236|FG002|Safety Population|Overall Study|1 participant of Placebo arm received Efpeglenatide 6 mg treatment and thus counted in the 6 mg treatment arm for safety analysis.|1358
3346391|NCT03496298|4076234|FG000|COMPLETED|Overall Study||42
3346392|NCT03496298|4076235|FG001|COMPLETED|Overall Study||36
3346393|NCT03496298|4076236|FG002|COMPLETED|Overall Study||23
3346394|NCT03496298|4076234|FG000|NOT COMPLETED|Overall Study||1317
3346395|NCT03496298|4076235|FG001|NOT COMPLETED|Overall Study||1323
3346396|NCT03496298|4076236|FG002|NOT COMPLETED|Overall Study||1335
3346397|NCT03496324|4076243|FG000|STARTED|Period 1||6
3346398|NCT03496324|4076244|FG001|STARTED|Period 1||6
3346399|NCT03496324|4076245|FG002|STARTED|Period 1||6
3346400|NCT03496324|4076246|FG003|STARTED|Period 1||6
3346401|NCT03496324|4076243|FG000|COMPLETED|Period 1||6
3346402|NCT03496324|4076244|FG001|COMPLETED|Period 1||6
3346403|NCT03496324|4076245|FG002|COMPLETED|Period 1||6
3346404|NCT03496324|4076246|FG003|COMPLETED|Period 1||6
3346405|NCT03496324|4076243|FG000|NOT COMPLETED|Period 1||0
3346406|NCT03496324|4076244|FG001|NOT COMPLETED|Period 1||0
3346407|NCT03496324|4076245|FG002|NOT COMPLETED|Period 1||0
3346408|NCT03496324|4076246|FG003|NOT COMPLETED|Period 1||0
3346409|NCT03496324|4076243|FG000|STARTED|Period 1: Washout (3 to 7 Days)||6
3346410|NCT03496324|4076244|FG001|STARTED|Period 1: Washout (3 to 7 Days)||6
3346411|NCT03496324|4076245|FG002|STARTED|Period 1: Washout (3 to 7 Days)||6
3346412|NCT03496324|4076246|FG003|STARTED|Period 1: Washout (3 to 7 Days)||6
3346413|NCT03496324|4076243|FG000|COMPLETED|Period 1: Washout (3 to 7 Days)||6
3346414|NCT03496324|4076244|FG001|COMPLETED|Period 1: Washout (3 to 7 Days)||6
3346415|NCT03496324|4076245|FG002|COMPLETED|Period 1: Washout (3 to 7 Days)||6
3346416|NCT03496324|4076246|FG003|COMPLETED|Period 1: Washout (3 to 7 Days)||6
3346417|NCT03496324|4076243|FG000|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
3346418|NCT03496324|4076244|FG001|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
3346419|NCT03496324|4076245|FG002|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
3346420|NCT03496324|4076246|FG003|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
3346421|NCT03496324|4076243|FG000|STARTED|Period 2||6
3346422|NCT03496324|4076244|FG001|STARTED|Period 2||6
3346423|NCT03496324|4076245|FG002|STARTED|Period 2||6
3346424|NCT03496324|4076246|FG003|STARTED|Period 2||6
3346425|NCT03496324|4076243|FG000|COMPLETED|Period 2||6
3346426|NCT03496324|4076244|FG001|COMPLETED|Period 2||6
3346427|NCT03496324|4076245|FG002|COMPLETED|Period 2||6
3346428|NCT03496324|4076246|FG003|COMPLETED|Period 2||6
3346429|NCT03496324|4076243|FG000|NOT COMPLETED|Period 2||0
3346430|NCT03496324|4076244|FG001|NOT COMPLETED|Period 2||0
3346431|NCT03496324|4076245|FG002|NOT COMPLETED|Period 2||0
3346432|NCT03496324|4076246|FG003|NOT COMPLETED|Period 2||0
3346433|NCT03496324|4076243|FG000|STARTED|Period 2: Washout (3 to 7 Days)||6
3346434|NCT03496324|4076244|FG001|STARTED|Period 2: Washout (3 to 7 Days)||6
3346435|NCT03496324|4076245|FG002|STARTED|Period 2: Washout (3 to 7 Days)||6
3346436|NCT03496324|4076246|FG003|STARTED|Period 2: Washout (3 to 7 Days)||6
3346437|NCT03496324|4076243|FG000|COMPLETED|Period 2: Washout (3 to 7 Days)||6
3346438|NCT03496324|4076244|FG001|COMPLETED|Period 2: Washout (3 to 7 Days)||6
3346439|NCT03496324|4076245|FG002|COMPLETED|Period 2: Washout (3 to 7 Days)||6
3346440|NCT03496324|4076246|FG003|COMPLETED|Period 2: Washout (3 to 7 Days)||6
3346441|NCT03496324|4076243|FG000|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||0
3346442|NCT03496324|4076244|FG001|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||0
3346443|NCT03496324|4076245|FG002|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||0
3346444|NCT03496324|4076246|FG003|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||0
3346445|NCT03496324|4076243|FG000|STARTED|Period 3||6
3346446|NCT03496324|4076244|FG001|STARTED|Period 3||6
3177875|NCT01973569|3905710|FG001|Discontinued Study Treatment|Overall Study||22
3177876|NCT01973569|3905711|FG002|Discontinued Study Treatment|Overall Study||15
3177877|NCT01973569|3905709|FG000|Discontinued Study|Overall Study||23
3177878|NCT01973569|3905710|FG001|Discontinued Study|Overall Study||22
3177879|NCT01973569|3905711|FG002|Discontinued Study|Overall Study||15
3177880|NCT01973569|3905709|FG000|COMPLETED|Overall Study||199
3177881|NCT01973569|3905710|FG001|COMPLETED|Overall Study||200
3177882|NCT01973569|3905711|FG002|COMPLETED|Overall Study||208
3177883|NCT01973569|3905709|FG000|NOT COMPLETED|Overall Study||29
3177884|NCT01973569|3905710|FG001|NOT COMPLETED|Overall Study||25
3177885|NCT01973569|3905711|FG002|NOT COMPLETED|Overall Study||18
3177886|NCT01973595|3905723|FG000|STARTED|Intervention Phase 1||15
3346447|NCT03496324|4076245|FG002|STARTED|Period 3||6
3346448|NCT03496324|4076246|FG003|STARTED|Period 3||6
3346449|NCT03496324|4076243|FG000|COMPLETED|Period 3||6
3346450|NCT03496324|4076244|FG001|COMPLETED|Period 3||6
3346451|NCT03496324|4076245|FG002|COMPLETED|Period 3||6
3346452|NCT03496324|4076246|FG003|COMPLETED|Period 3||6
3346453|NCT03496324|4076243|FG000|NOT COMPLETED|Period 3||0
3346454|NCT03496324|4076244|FG001|NOT COMPLETED|Period 3||0
3346455|NCT03496324|4076245|FG002|NOT COMPLETED|Period 3||0
3346456|NCT03496324|4076246|FG003|NOT COMPLETED|Period 3||0
3346457|NCT03496324|4076243|FG000|STARTED|Period 3: Washout (3 to 7 Days)||6
3346458|NCT03496324|4076244|FG001|STARTED|Period 3: Washout (3 to 7 Days)||6
3346459|NCT03496324|4076245|FG002|STARTED|Period 3: Washout (3 to 7 Days)||6
3346460|NCT03496324|4076246|FG003|STARTED|Period 3: Washout (3 to 7 Days)||6
3346461|NCT03496324|4076243|FG000|COMPLETED|Period 3: Washout (3 to 7 Days)||6
3346462|NCT03496324|4076244|FG001|COMPLETED|Period 3: Washout (3 to 7 Days)||6
3346463|NCT03496324|4076245|FG002|COMPLETED|Period 3: Washout (3 to 7 Days)||6
3346464|NCT03496324|4076246|FG003|COMPLETED|Period 3: Washout (3 to 7 Days)||6
3346465|NCT03496324|4076243|FG000|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
3346466|NCT03496324|4076244|FG001|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
3346467|NCT03496324|4076245|FG002|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
3346468|NCT03496324|4076246|FG003|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
3346469|NCT03496324|4076243|FG000|STARTED|Period 7: Period 4||6
3346470|NCT03496324|4076244|FG001|STARTED|Period 7: Period 4||6
3346471|NCT03496324|4076245|FG002|STARTED|Period 7: Period 4||6
3346472|NCT03496324|4076246|FG003|STARTED|Period 7: Period 4||6
3346473|NCT03496324|4076243|FG000|COMPLETED|Period 7: Period 4||6
3346474|NCT03496324|4076244|FG001|COMPLETED|Period 7: Period 4||6
3346475|NCT03496324|4076245|FG002|COMPLETED|Period 7: Period 4||6
3346476|NCT03496324|4076246|FG003|COMPLETED|Period 7: Period 4||6
3346477|NCT03496324|4076243|FG000|NOT COMPLETED|Period 7: Period 4||0
3346478|NCT03496324|4076244|FG001|NOT COMPLETED|Period 7: Period 4||0
3346479|NCT03496324|4076245|FG002|NOT COMPLETED|Period 7: Period 4||0
3346480|NCT03496324|4076246|FG003|NOT COMPLETED|Period 7: Period 4||0
3346481|NCT03496428|4076256|FG000|STARTED|Overall Study|304 locations distributed for the analyzed teeth 108 locations distributed for the implant spots|6
3346482|NCT03496428|4076256|FG000|COMPLETED|Overall Study|304 locations distributed for the analyzed teeth 108 locations distributed for the implant spots|6
3346483|NCT03496428|4076256|FG000|NOT COMPLETED|Overall Study||0
3346484|NCT03496467|4076262|FG000|STARTED|Overall Study||38
3346485|NCT03496467|4076263|FG001|STARTED|Overall Study||18
3346486|NCT03496467|4076262|FG000|COMPLETED|Overall Study||34
3346487|NCT03496467|4076263|FG001|COMPLETED|Overall Study||14
3346488|NCT03496467|4076262|FG000|NOT COMPLETED|Overall Study||4
3346489|NCT03496467|4076263|FG001|NOT COMPLETED|Overall Study||4
3346490|NCT03496545|4076271|FG000|STARTED|Overall Study||21
3346491|NCT03496545|4076272|FG001|STARTED|Overall Study||26
3346492|NCT03496545|4076271|FG000|COMPLETED|Overall Study||20
3346493|NCT03496545|4076272|FG001|COMPLETED|Overall Study||24
3346494|NCT03496545|4076271|FG000|NOT COMPLETED|Overall Study||1
3346495|NCT03496545|4076272|FG001|NOT COMPLETED|Overall Study||2
3346496|NCT03496701|4076278|FG000|STARTED|Overall Study||77
3346497|NCT03496701|4076278|FG000|COMPLETED|Overall Study||77
3346498|NCT03496701|4076278|FG000|NOT COMPLETED|Overall Study||0
3346499|NCT03496974|4076286|FG000|STARTED|Overall Study||10
3346500|NCT03496974|4076287|FG001|STARTED|Overall Study||28
3346501|NCT03496974|4076286|FG000|COMPLETED|Overall Study||9
3346502|NCT03496974|4076287|FG001|COMPLETED|Overall Study||20
3346503|NCT03496974|4076286|FG000|NOT COMPLETED|Overall Study||1
3346504|NCT03496974|4076287|FG001|NOT COMPLETED|Overall Study||8
3346505|NCT03496987|4076295|FG000|STARTED|Overall Study||49
3346506|NCT03496987|4076296|FG001|STARTED|Overall Study||51
3346507|NCT03496987|4076295|FG000|COMPLETED|Overall Study||49
3346508|NCT03496987|4076296|FG001|COMPLETED|Overall Study||51
3346509|NCT03496987|4076295|FG000|NOT COMPLETED|Overall Study||0
3346510|NCT03496987|4076296|FG001|NOT COMPLETED|Overall Study||0
3346511|NCT03497026|4076302|FG000|STARTED|Overall Study||4
3346512|NCT03497026|4076302|FG000|COMPLETED|Overall Study||4
3039880|NCT01161407|3759403|FG000|COMPLETED|Overall Study||3
3177887|NCT01973595|3905724|FG001|STARTED|Intervention Phase 1||14
3346513|NCT03497026|4076302|FG000|NOT COMPLETED|Overall Study||0
3346514|NCT03497039|4076308|FG000|STARTED|Overall Study||30
3346515|NCT03497039|4076309|FG001|STARTED|Overall Study||17
3346516|NCT03497039|4076308|FG000|Treated|Overall Study||29
3346517|NCT03497039|4076309|FG001|Treated|Overall Study||17
3346518|NCT03497039|4076308|FG000|COMPLETED|Overall Study||29
3346519|NCT03497039|4076309|FG001|COMPLETED|Overall Study||16
3346520|NCT03497039|4076308|FG000|NOT COMPLETED|Overall Study||1
3346521|NCT03497039|4076309|FG001|NOT COMPLETED|Overall Study||1
3346522|NCT03497130|4076317|FG000|STARTED|Overall Study||40
3346523|NCT03497130|4076318|FG001|STARTED|Overall Study||14
3346524|NCT03497130|4076317|FG000|COMPLETED|Overall Study||39
3346525|NCT03497130|4076318|FG001|COMPLETED|Overall Study||13
3346526|NCT03497130|4076317|FG000|NOT COMPLETED|Overall Study||1
3346527|NCT03497130|4076318|FG001|NOT COMPLETED|Overall Study||1
3346528|NCT03497429|4076326|FG000|STARTED|Overall Study||3
3346529|NCT03497429|4076327|FG001|STARTED|Overall Study||6
3346530|NCT03497429|4076326|FG000|Started|Overall Study||3
3346531|NCT03497429|4076327|FG001|Started|Overall Study||6
3346532|NCT03497429|4076326|FG000|Completed|Overall Study||0
3346533|NCT03497429|4076327|FG001|Completed|Overall Study||0
3346534|NCT03497429|4076326|FG000|COMPLETED|Overall Study||0
3346535|NCT03497429|4076327|FG001|COMPLETED|Overall Study||0
3346536|NCT03497429|4076326|FG000|NOT COMPLETED|Overall Study||3
3346537|NCT03497429|4076327|FG001|NOT COMPLETED|Overall Study||6
3346538|NCT03497585|4076333|FG000|STARTED|Overall Study|112 participants were recruited: 107 patients, plus 5 HCPs for the acceptability interviews.|112
3346539|NCT03497585|4076333|FG000|COMPLETED|Overall Study||57
3346540|NCT03497585|4076333|FG000|NOT COMPLETED|Overall Study||55
3346541|NCT03497845|4076349|FG000|STARTED|Overall Study||60
3346542|NCT03497845|4076350|FG001|STARTED|Overall Study||58
3346543|NCT03497845|4076351|FG002|STARTED|Overall Study||61
3346544|NCT03497845|4076352|FG003|STARTED|Overall Study||60
3346545|NCT03497845|4076353|FG004|STARTED|Overall Study||59
3346546|NCT03497845|4076354|FG005|STARTED|Overall Study||62
3346547|NCT03497845|4076355|FG006|STARTED|Overall Study||59
3346548|NCT03497845|4076356|FG007|STARTED|Overall Study||60
3346549|NCT03497845|4076357|FG008|STARTED|Overall Study||61
3346550|NCT03497845|4076358|FG009|STARTED|Overall Study||59
3346551|NCT03497845|4076359|FG010|STARTED|Overall Study||61
3346552|NCT03497845|4076360|FG011|STARTED|Overall Study||60
3346553|NCT03497845|4076349|FG000|COMPLETED|Overall Study|Day 142|55
3346554|NCT03497845|4076350|FG001|COMPLETED|Overall Study|Day 142|45
3346555|NCT03497845|4076351|FG002|COMPLETED|Overall Study|Day 142|50
3346556|NCT03497845|4076352|FG003|COMPLETED|Overall Study|Day 142|50
3346557|NCT03497845|4076353|FG004|COMPLETED|Overall Study|Day 262|38
3346558|NCT03497845|4076354|FG005|COMPLETED|Overall Study|Day 262|44
3346559|NCT03497845|4076355|FG006|COMPLETED|Overall Study|Day 142|51
3346560|NCT03497845|4076356|FG007|COMPLETED|Overall Study|Day 142|50
3346561|NCT03497845|4076357|FG008|COMPLETED|Overall Study|Day 142|47
3346562|NCT03497845|4076358|FG009|COMPLETED|Overall Study|Day 142|53
3346563|NCT03497845|4076359|FG010|COMPLETED|Overall Study|Day 262|46
3346564|NCT03497845|4076360|FG011|COMPLETED|Overall Study|Day 262|38
3346565|NCT03497845|4076349|FG000|NOT COMPLETED|Overall Study||5
3346566|NCT03497845|4076350|FG001|NOT COMPLETED|Overall Study||13
3346567|NCT03497845|4076351|FG002|NOT COMPLETED|Overall Study||11
3346568|NCT03497845|4076352|FG003|NOT COMPLETED|Overall Study||10
3346569|NCT03497845|4076353|FG004|NOT COMPLETED|Overall Study||21
3346570|NCT03497845|4076354|FG005|NOT COMPLETED|Overall Study||18
3346571|NCT03497845|4076355|FG006|NOT COMPLETED|Overall Study||8
3346572|NCT03497845|4076356|FG007|NOT COMPLETED|Overall Study||10
3346573|NCT03497845|4076357|FG008|NOT COMPLETED|Overall Study||14
3346574|NCT03497845|4076358|FG009|NOT COMPLETED|Overall Study||6
3346575|NCT03497845|4076359|FG010|NOT COMPLETED|Overall Study||15
3346576|NCT03497845|4076360|FG011|NOT COMPLETED|Overall Study||22
3346577|NCT03498196|4076392|FG000|STARTED|Overall Study||1
3346578|NCT03498196|4076392|FG000|COMPLETED|Overall Study||1
3346579|NCT03498196|4076392|FG000|NOT COMPLETED|Overall Study||0
3346580|NCT03498287|4076398|FG000|STARTED|Overall Study||45
3346581|NCT03498287|4076399|FG001|STARTED|Overall Study||43
3346582|NCT03498287|4076398|FG000|COMPLETED|Overall Study||42
3346583|NCT03498287|4076399|FG001|COMPLETED|Overall Study||38
3346584|NCT03498287|4076398|FG000|NOT COMPLETED|Overall Study||3
3346585|NCT03498287|4076399|FG001|NOT COMPLETED|Overall Study||5
3346586|NCT03498300|4076407|FG000|STARTED|Overall Study||21
3346587|NCT03498300|4076408|FG001|STARTED|Overall Study||21
3346588|NCT03498300|4076407|FG000|COMPLETED|Overall Study||18
3346589|NCT03498300|4076408|FG001|COMPLETED|Overall Study||13
3346590|NCT03498300|4076407|FG000|NOT COMPLETED|Overall Study||3
3346591|NCT03498300|4076408|FG001|NOT COMPLETED|Overall Study||8
3346592|NCT03498560|4076415|FG000|STARTED|Overall Study||38
3346593|NCT03498560|4076415|FG000|Completed Baseline Assessment|Overall Study||32
3346594|NCT03498560|4076415|FG000|Completed PSG|Overall Study||25
3346595|NCT03498560|4076415|FG000|COMPLETED|Overall Study||17
3346596|NCT03498560|4076415|FG000|NOT COMPLETED|Overall Study||21
3346597|NCT03499028|4076422|FG000|STARTED|Overall Study||226
3346598|NCT03499028|4076423|FG001|STARTED|Overall Study||220
3346599|NCT03499028|4076422|FG000|COMPLETED|Overall Study||204
3346600|NCT03499028|4076423|FG001|COMPLETED|Overall Study||195
3346601|NCT03499028|4076422|FG000|NOT COMPLETED|Overall Study||22
3346602|NCT03499028|4076423|FG001|NOT COMPLETED|Overall Study||25
3346603|NCT03499067|4076431|FG000|STARTED|First Intervention||27
3346604|NCT03499067|4076432|FG001|STARTED|First Intervention||31
3346605|NCT03499067|4076431|FG000|COMPLETED|First Intervention||22
3346606|NCT03499067|4076432|FG001|COMPLETED|First Intervention||24
3346607|NCT03499067|4076431|FG000|NOT COMPLETED|First Intervention||5
3346608|NCT03499067|4076432|FG001|NOT COMPLETED|First Intervention||7
3346609|NCT03499067|4076431|FG000|STARTED|Second Intervention||22
3346610|NCT03499067|4076432|FG001|STARTED|Second Intervention||24
3346611|NCT03499067|4076431|FG000|COMPLETED|Second Intervention||22
3346612|NCT03499067|4076432|FG001|COMPLETED|Second Intervention||24
3346613|NCT03499067|4076431|FG000|NOT COMPLETED|Second Intervention||0
3346614|NCT03499067|4076432|FG001|NOT COMPLETED|Second Intervention||0
3346615|NCT03499353|4076438|FG000|STARTED|Treatment||61
3346616|NCT03499353|4076438|FG000|COMPLETED|Treatment||45
3346617|NCT03499353|4076438|FG000|NOT COMPLETED|Treatment||16
3346618|NCT03499353|4076438|FG000|STARTED|Safety Follow-up||49
3346619|NCT03499353|4076438|FG000|Received Treatment|Safety Follow-up||0
3346620|NCT03499353|4076438|FG000|COMPLETED|Safety Follow-up||49
3346621|NCT03499353|4076438|FG000|NOT COMPLETED|Safety Follow-up||0
3346622|NCT03499353|4076438|FG000|STARTED|Long-Term Follow-up||58
3346623|NCT03499353|4076438|FG000|Received Treatment|Long-Term Follow-up||0
3346624|NCT03499353|4076438|FG000|COMPLETED|Long-Term Follow-up||0
3346625|NCT03499353|4076438|FG000|NOT COMPLETED|Long-Term Follow-up||58
3346626|NCT03499873|4076445|FG000|STARTED|Overall Study||183
3346627|NCT03499873|4076446|FG001|STARTED|Overall Study||182
3346628|NCT03499873|4076447|FG002|STARTED|Overall Study||83
3346629|NCT03499873|4076445|FG000|Safety Population|Overall Study||175
3346630|NCT03499873|4076446|FG001|Safety Population|Overall Study||174
3346631|NCT03499873|4076447|FG002|Safety Population|Overall Study||80
3346632|NCT03499873|4076445|FG000|Per-Protocol Population|Overall Study||144
3346633|NCT03499873|4076446|FG001|Per-Protocol Population|Overall Study||143
3346634|NCT03499873|4076447|FG002|Per-Protocol Population|Overall Study||58
3346635|NCT03499873|4076445|FG000|Modified-Intent-to-Treat|Overall Study||170
3346636|NCT03499873|4076446|FG001|Modified-Intent-to-Treat|Overall Study||168
3346637|NCT03499873|4076447|FG002|Modified-Intent-to-Treat|Overall Study||77
3346638|NCT03499873|4076445|FG000|COMPLETED|Overall Study||163
3346639|NCT03499873|4076446|FG001|COMPLETED|Overall Study||162
3346640|NCT03499873|4076447|FG002|COMPLETED|Overall Study||56
3346641|NCT03499873|4076445|FG000|NOT COMPLETED|Overall Study||20
3346642|NCT03499873|4076446|FG001|NOT COMPLETED|Overall Study||20
3346643|NCT03499873|4076447|FG002|NOT COMPLETED|Overall Study||27
3346644|NCT03500094|4076455|FG000|STARTED|Overall Study||22
3346645|NCT03500094|4076455|FG000|Received At Least 1 Dose of Study Drug|Overall Study||21
3346646|NCT03500094|4076455|FG000|COMPLETED|Overall Study||19
3346647|NCT03500094|4076455|FG000|NOT COMPLETED|Overall Study||3
3346648|NCT03500198|4076463|FG000|STARTED|Overall Study||110
3346649|NCT03500198|4076464|FG001|STARTED|Overall Study||108
3346650|NCT03500198|4076463|FG000|First Eye|Overall Study||110
3346651|NCT03500198|4076464|FG001|First Eye|Overall Study||108
3346652|NCT03500198|4076463|FG000|Second Eye|Overall Study||109
3346653|NCT03500198|4076464|FG001|Second Eye|Overall Study||108
3346654|NCT03500198|4076463|FG000|COMPLETED|Overall Study||110
3346655|NCT03500198|4076464|FG001|COMPLETED|Overall Study||107
3346656|NCT03500198|4076463|FG000|NOT COMPLETED|Overall Study||0
3346657|NCT03500198|4076464|FG001|NOT COMPLETED|Overall Study||1
3346658|NCT03500211|4076474|FG000|STARTED|Overall Study||25
3346659|NCT03500211|4076475|FG001|STARTED|Overall Study||25
3346660|NCT03500211|4076474|FG000|COMPLETED|Overall Study||24
3346661|NCT03500211|4076475|FG001|COMPLETED|Overall Study||24
3346662|NCT03500211|4076474|FG000|NOT COMPLETED|Overall Study||1
3346663|NCT03500211|4076475|FG001|NOT COMPLETED|Overall Study||1
3346664|NCT03500224|4076481|FG000|STARTED|Overall Study||6
3346665|NCT03500224|4076481|FG000|COMPLETED|Overall Study||4
3346666|NCT03500224|4076481|FG000|NOT COMPLETED|Overall Study||2
3346667|NCT03500289|4076487|FG000|STARTED|Overall Study||12
3346668|NCT03500289|4076488|FG001|STARTED|Overall Study||6
3346669|NCT03500289|4076487|FG000|COMPLETED|Overall Study||12
3346670|NCT03500289|4076488|FG001|COMPLETED|Overall Study||6
3346671|NCT03500289|4076487|FG000|NOT COMPLETED|Overall Study||0
3346672|NCT03500289|4076488|FG001|NOT COMPLETED|Overall Study||0
3346673|NCT03500302|4076494|FG000|STARTED|Overall Study||19
3346674|NCT03500302|4076494|FG000|COMPLETED|Overall Study||19
3346675|NCT03500302|4076494|FG000|NOT COMPLETED|Overall Study||0
3346676|NCT03500419|4076500|FG000|STARTED|Overall Study||27
3346677|NCT03500419|4076501|FG001|STARTED|Overall Study||55
3346678|NCT03500419|4076500|FG000|COMPLETED|Overall Study||25
3346679|NCT03500419|4076501|FG001|COMPLETED|Overall Study||30
3346680|NCT03500419|4076500|FG000|NOT COMPLETED|Overall Study||2
3346681|NCT03500419|4076501|FG001|NOT COMPLETED|Overall Study||25
3346682|NCT03500679|4076509|FG000|STARTED|Overall Study||75
3346683|NCT03500679|4076510|FG001|STARTED|Overall Study||25
3346684|NCT03500679|4076509|FG000|COMPLETED|Overall Study||66
3346685|NCT03500679|4076510|FG001|COMPLETED|Overall Study||22
3346686|NCT03500679|4076509|FG000|NOT COMPLETED|Overall Study||9
3346687|NCT03500679|4076510|FG001|NOT COMPLETED|Overall Study||3
3346688|NCT03500692|4076516|FG000|STARTED|Overall Study||500
3346689|NCT03500692|4076516|FG000|COMPLETED|Overall Study||391
3346690|NCT03500692|4076516|FG000|NOT COMPLETED|Overall Study||109
3346691|NCT03501043|4076520|FG000|STARTED|Overall Study||11
3346692|NCT03501043|4076520|FG000|COMPLETED|Overall Study||10
3346693|NCT03501043|4076520|FG000|NOT COMPLETED|Overall Study||1
3346694|NCT03501069|4076544|FG000|STARTED|Period A||2
3346695|NCT03501069|4076545|FG001|STARTED|Period A||4
3346696|NCT03501069|4076546|FG002|STARTED|Period A||2
3346697|NCT03501069|4076547|FG003|STARTED|Period A||5
3346698|NCT03501069|4076548|FG004|STARTED|Period A||1
3346699|NCT03501069|4076549|FG005|STARTED|Period A||6
3346700|NCT03501069|4076550|FG006|STARTED|Period A||6
3346701|NCT03501069|4076551|FG007|STARTED|Period A||3
3346702|NCT03501069|4076552|FG008|STARTED|Period A||3
3346703|NCT03501069|4076544|FG000|COMPLETED|Period A||2
3346704|NCT03501069|4076545|FG001|COMPLETED|Period A||4
3346705|NCT03501069|4076546|FG002|COMPLETED|Period A||2
3346706|NCT03501069|4076547|FG003|COMPLETED|Period A||5
3346707|NCT03501069|4076548|FG004|COMPLETED|Period A||1
3346708|NCT03501069|4076549|FG005|COMPLETED|Period A||6
3346709|NCT03501069|4076550|FG006|COMPLETED|Period A||6
3346710|NCT03501069|4076551|FG007|COMPLETED|Period A||3
3346711|NCT03501069|4076552|FG008|COMPLETED|Period A||3
3346712|NCT03501069|4076544|FG000|NOT COMPLETED|Period A||0
3346713|NCT03501069|4076545|FG001|NOT COMPLETED|Period A||0
3346714|NCT03501069|4076546|FG002|NOT COMPLETED|Period A||0
3346715|NCT03501069|4076547|FG003|NOT COMPLETED|Period A||0
3346716|NCT03501069|4076548|FG004|NOT COMPLETED|Period A||0
3346717|NCT03501069|4076549|FG005|NOT COMPLETED|Period A||0
3346718|NCT03501069|4076550|FG006|NOT COMPLETED|Period A||0
3346719|NCT03501069|4076551|FG007|NOT COMPLETED|Period A||0
3346720|NCT03501069|4076552|FG008|NOT COMPLETED|Period A||0
3346721|NCT03501069|4076544|FG000|STARTED|Washout Period (at Least 14 Days)||2
3346722|NCT03501069|4076545|FG001|STARTED|Washout Period (at Least 14 Days)||4
3346723|NCT03501069|4076546|FG002|STARTED|Washout Period (at Least 14 Days)||2
3346724|NCT03501069|4076547|FG003|STARTED|Washout Period (at Least 14 Days)|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
3346725|NCT03501069|4076548|FG004|STARTED|Washout Period (at Least 14 Days)|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
3346726|NCT03501069|4076549|FG005|STARTED|Washout Period (at Least 14 Days)|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
3346727|NCT03501069|4076550|FG006|STARTED|Washout Period (at Least 14 Days)|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
3346728|NCT03501069|4076551|FG007|STARTED|Washout Period (at Least 14 Days)|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
3346729|NCT03501069|4076552|FG008|STARTED|Washout Period (at Least 14 Days)|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
3346730|NCT03501069|4076544|FG000|COMPLETED|Washout Period (at Least 14 Days)||2
3346731|NCT03501069|4076545|FG001|COMPLETED|Washout Period (at Least 14 Days)||4
3346732|NCT03501069|4076546|FG002|COMPLETED|Washout Period (at Least 14 Days)||2
3346733|NCT03501069|4076547|FG003|COMPLETED|Washout Period (at Least 14 Days)||0
3346734|NCT03501069|4076548|FG004|COMPLETED|Washout Period (at Least 14 Days)||0
3346735|NCT03501069|4076549|FG005|COMPLETED|Washout Period (at Least 14 Days)||0
3346736|NCT03501069|4076550|FG006|COMPLETED|Washout Period (at Least 14 Days)||0
3346737|NCT03501069|4076551|FG007|COMPLETED|Washout Period (at Least 14 Days)||0
3346738|NCT03501069|4076552|FG008|COMPLETED|Washout Period (at Least 14 Days)||0
3346739|NCT03501069|4076544|FG000|NOT COMPLETED|Washout Period (at Least 14 Days)||0
3346740|NCT03501069|4076545|FG001|NOT COMPLETED|Washout Period (at Least 14 Days)||0
3346741|NCT03501069|4076546|FG002|NOT COMPLETED|Washout Period (at Least 14 Days)||0
3346742|NCT03501069|4076547|FG003|NOT COMPLETED|Washout Period (at Least 14 Days)||0
3346743|NCT03501069|4076548|FG004|NOT COMPLETED|Washout Period (at Least 14 Days)||0
3346744|NCT03501069|4076549|FG005|NOT COMPLETED|Washout Period (at Least 14 Days)||0
3346745|NCT03501069|4076550|FG006|NOT COMPLETED|Washout Period (at Least 14 Days)||0
3346746|NCT03501069|4076551|FG007|NOT COMPLETED|Washout Period (at Least 14 Days)||0
3346747|NCT03501069|4076552|FG008|NOT COMPLETED|Washout Period (at Least 14 Days)||0
3346748|NCT03501069|4076544|FG000|STARTED|Period B||2
3346749|NCT03501069|4076545|FG001|STARTED|Period B||4
3346750|NCT03501069|4076546|FG002|STARTED|Period B||2
3346751|NCT03501069|4076547|FG003|STARTED|Period B|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
3346752|NCT03501069|4076548|FG004|STARTED|Period B|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
3346753|NCT03501069|4076549|FG005|STARTED|Period B|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
3346754|NCT03501069|4076550|FG006|STARTED|Period B|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
3346755|NCT03501069|4076551|FG007|STARTED|Period B|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
3346756|NCT03501069|4076552|FG008|STARTED|Period B|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
3346757|NCT03501069|4076544|FG000|COMPLETED|Period B||2
3346758|NCT03501069|4076545|FG001|COMPLETED|Period B||4
3346759|NCT03501069|4076546|FG002|COMPLETED|Period B||2
3346760|NCT03501069|4076547|FG003|COMPLETED|Period B||0
3346761|NCT03501069|4076548|FG004|COMPLETED|Period B||0
3346762|NCT03501069|4076549|FG005|COMPLETED|Period B||0
3346763|NCT03501069|4076550|FG006|COMPLETED|Period B||0
3346764|NCT03501069|4076551|FG007|COMPLETED|Period B||0
3346765|NCT03501069|4076552|FG008|COMPLETED|Period B||0
3346766|NCT03501069|4076544|FG000|NOT COMPLETED|Period B||0
3346767|NCT03501069|4076545|FG001|NOT COMPLETED|Period B||0
3346768|NCT03501069|4076546|FG002|NOT COMPLETED|Period B||0
3346769|NCT03501069|4076547|FG003|NOT COMPLETED|Period B||0
3346770|NCT03501069|4076548|FG004|NOT COMPLETED|Period B||0
3346771|NCT03501069|4076549|FG005|NOT COMPLETED|Period B||0
3346772|NCT03501069|4076550|FG006|NOT COMPLETED|Period B||0
3346773|NCT03501069|4076551|FG007|NOT COMPLETED|Period B||0
3346774|NCT03501069|4076552|FG008|NOT COMPLETED|Period B||0
3346775|NCT03501264|4076582|FG000|STARTED|Overall Study||120
3346776|NCT03501264|4076583|FG001|STARTED|Overall Study||120
3346777|NCT03501264|4076582|FG000|COMPLETED|Overall Study||120
3346778|NCT03501264|4076583|FG001|COMPLETED|Overall Study||120
3346779|NCT03501264|4076582|FG000|NOT COMPLETED|Overall Study||0
3346780|NCT03501264|4076583|FG001|NOT COMPLETED|Overall Study||0
3346781|NCT03501277|4076593|FG000|STARTED|Intervention Period 1 (4 Days)||18
3346782|NCT03501277|4076594|FG001|STARTED|Intervention Period 1 (4 Days)||18
3346783|NCT03501277|4076595|FG002|STARTED|Intervention Period 1 (4 Days)||18
3346784|NCT03501277|4076596|FG003|STARTED|Intervention Period 1 (4 Days)||18
3346785|NCT03501277|4076593|FG000|Safety Analysis Set|Intervention Period 1 (4 Days)||18
3346786|NCT03501277|4076594|FG001|Safety Analysis Set|Intervention Period 1 (4 Days)||18
3346787|NCT03501277|4076595|FG002|Safety Analysis Set|Intervention Period 1 (4 Days)||17
3346788|NCT03501277|4076596|FG003|Safety Analysis Set|Intervention Period 1 (4 Days)||17
3346789|NCT03501277|4076593|FG000|COMPLETED|Intervention Period 1 (4 Days)||18
3346790|NCT03501277|4076594|FG001|COMPLETED|Intervention Period 1 (4 Days)||18
3346791|NCT03501277|4076595|FG002|COMPLETED|Intervention Period 1 (4 Days)||17
3346792|NCT03501277|4076596|FG003|COMPLETED|Intervention Period 1 (4 Days)||17
3346793|NCT03501277|4076593|FG000|NOT COMPLETED|Intervention Period 1 (4 Days)||0
3346794|NCT03501277|4076594|FG001|NOT COMPLETED|Intervention Period 1 (4 Days)||0
3346795|NCT03501277|4076595|FG002|NOT COMPLETED|Intervention Period 1 (4 Days)||1
3346796|NCT03501277|4076596|FG003|NOT COMPLETED|Intervention Period 1 (4 Days)||1
3346797|NCT03501277|4076593|FG000|STARTED|Washout Period 1 (7 Days)||18
3346798|NCT03501277|4076594|FG001|STARTED|Washout Period 1 (7 Days)||18
3346799|NCT03501277|4076595|FG002|STARTED|Washout Period 1 (7 Days)||17
3346800|NCT03501277|4076596|FG003|STARTED|Washout Period 1 (7 Days)||17
3346801|NCT03501277|4076593|FG000|COMPLETED|Washout Period 1 (7 Days)||18
3346802|NCT03501277|4076594|FG001|COMPLETED|Washout Period 1 (7 Days)||18
3346803|NCT03501277|4076595|FG002|COMPLETED|Washout Period 1 (7 Days)||17
3346804|NCT03501277|4076596|FG003|COMPLETED|Washout Period 1 (7 Days)||17
3346805|NCT03501277|4076593|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0
3346806|NCT03501277|4076594|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0
3346807|NCT03501277|4076595|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||0
3346808|NCT03501277|4076596|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||0
3346809|NCT03501277|4076593|FG000|STARTED|Intervention Period 2 (4 Days)||18
3346810|NCT03501277|4076594|FG001|STARTED|Intervention Period 2 (4 Days)||18
3346811|NCT03501277|4076595|FG002|STARTED|Intervention Period 2 (4 Days)||17
3346812|NCT03501277|4076596|FG003|STARTED|Intervention Period 2 (4 Days)||17
3346813|NCT03501277|4076593|FG000|COMPLETED|Intervention Period 2 (4 Days)||18
3346814|NCT03501277|4076594|FG001|COMPLETED|Intervention Period 2 (4 Days)||18
3346815|NCT03501277|4076595|FG002|COMPLETED|Intervention Period 2 (4 Days)||17
3346816|NCT03501277|4076596|FG003|COMPLETED|Intervention Period 2 (4 Days)||16
3346817|NCT03501277|4076593|FG000|NOT COMPLETED|Intervention Period 2 (4 Days)||0
3346818|NCT03501277|4076594|FG001|NOT COMPLETED|Intervention Period 2 (4 Days)||0
3346819|NCT03501277|4076595|FG002|NOT COMPLETED|Intervention Period 2 (4 Days)||0
3346820|NCT03501277|4076596|FG003|NOT COMPLETED|Intervention Period 2 (4 Days)||1
3346821|NCT03501277|4076593|FG000|STARTED|Washout Period 2 (7 Days)||18
3346822|NCT03501277|4076594|FG001|STARTED|Washout Period 2 (7 Days)||18
3346823|NCT03501277|4076595|FG002|STARTED|Washout Period 2 (7 Days)||17
3346824|NCT03501277|4076596|FG003|STARTED|Washout Period 2 (7 Days)||16
3346825|NCT03501277|4076593|FG000|COMPLETED|Washout Period 2 (7 Days)||18
3346826|NCT03501277|4076594|FG001|COMPLETED|Washout Period 2 (7 Days)||18
3346827|NCT03501277|4076595|FG002|COMPLETED|Washout Period 2 (7 Days)||17
3346828|NCT03501277|4076596|FG003|COMPLETED|Washout Period 2 (7 Days)||16
3346829|NCT03501277|4076593|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||0
3346830|NCT03501277|4076594|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0
3346831|NCT03501277|4076595|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0
3346832|NCT03501277|4076596|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||0
3346833|NCT03501277|4076593|FG000|STARTED|Intervention Period 3 (4 Days)||18
3346834|NCT03501277|4076594|FG001|STARTED|Intervention Period 3 (4 Days)||18
3346835|NCT03501277|4076595|FG002|STARTED|Intervention Period 3 (4 Days)||17
3346836|NCT03501277|4076596|FG003|STARTED|Intervention Period 3 (4 Days)||16
3346837|NCT03501277|4076593|FG000|COMPLETED|Intervention Period 3 (4 Days)||18
3346838|NCT03501277|4076594|FG001|COMPLETED|Intervention Period 3 (4 Days)||18
3346839|NCT03501277|4076595|FG002|COMPLETED|Intervention Period 3 (4 Days)||17
3346840|NCT03501277|4076596|FG003|COMPLETED|Intervention Period 3 (4 Days)||15
3346841|NCT03501277|4076593|FG000|NOT COMPLETED|Intervention Period 3 (4 Days)||0
3346842|NCT03501277|4076594|FG001|NOT COMPLETED|Intervention Period 3 (4 Days)||0
3346843|NCT03501277|4076595|FG002|NOT COMPLETED|Intervention Period 3 (4 Days)||0
3346844|NCT03501277|4076596|FG003|NOT COMPLETED|Intervention Period 3 (4 Days)||1
3346845|NCT03501277|4076593|FG000|STARTED|Washout Period 3 (7 Days)||18
3346846|NCT03501277|4076594|FG001|STARTED|Washout Period 3 (7 Days)||18
3346847|NCT03501277|4076595|FG002|STARTED|Washout Period 3 (7 Days)||17
3346848|NCT03501277|4076596|FG003|STARTED|Washout Period 3 (7 Days)||15
3346849|NCT03501277|4076593|FG000|COMPLETED|Washout Period 3 (7 Days)||18
3346850|NCT03501277|4076594|FG001|COMPLETED|Washout Period 3 (7 Days)||18
3346851|NCT03501277|4076595|FG002|COMPLETED|Washout Period 3 (7 Days)||17
3346852|NCT03501277|4076596|FG003|COMPLETED|Washout Period 3 (7 Days)||15
3346853|NCT03501277|4076593|FG000|NOT COMPLETED|Washout Period 3 (7 Days)||0
3346854|NCT03501277|4076594|FG001|NOT COMPLETED|Washout Period 3 (7 Days)||0
3346855|NCT03501277|4076595|FG002|NOT COMPLETED|Washout Period 3 (7 Days)||0
3346856|NCT03501277|4076596|FG003|NOT COMPLETED|Washout Period 3 (7 Days)||0
3346857|NCT03501277|4076593|FG000|STARTED|Intervention Period 4 (4 Days)||18
3346858|NCT03501277|4076594|FG001|STARTED|Intervention Period 4 (4 Days)||18
3346859|NCT03501277|4076595|FG002|STARTED|Intervention Period 4 (4 Days)||17
3346860|NCT03501277|4076596|FG003|STARTED|Intervention Period 4 (4 Days)||15
3346861|NCT03501277|4076593|FG000|COMPLETED|Intervention Period 4 (4 Days)||18
3346862|NCT03501277|4076594|FG001|COMPLETED|Intervention Period 4 (4 Days)||18
3346863|NCT03501277|4076595|FG002|COMPLETED|Intervention Period 4 (4 Days)||17
3346864|NCT03501277|4076596|FG003|COMPLETED|Intervention Period 4 (4 Days)||15
3346865|NCT03501277|4076593|FG000|NOT COMPLETED|Intervention Period 4 (4 Days)||0
3346866|NCT03501277|4076594|FG001|NOT COMPLETED|Intervention Period 4 (4 Days)||0
3346867|NCT03501277|4076595|FG002|NOT COMPLETED|Intervention Period 4 (4 Days)||0
3346868|NCT03501277|4076596|FG003|NOT COMPLETED|Intervention Period 4 (4 Days)||0
3346869|NCT03501550|4076606|FG000|STARTED|Overall Study||12
3346870|NCT03501550|4076606|FG000|COMPLETED|Overall Study||12
3346871|NCT03501550|4076606|FG000|NOT COMPLETED|Overall Study||0
3346872|NCT03501693|4076610|FG000|STARTED|First Reading Session||75
3346873|NCT03501693|4076611|FG001|STARTED|First Reading Session||75
3346874|NCT03501693|4076610|FG000|COMPLETED|First Reading Session||75
3346875|NCT03501693|4076611|FG001|COMPLETED|First Reading Session||75
3346876|NCT03501693|4076610|FG000|NOT COMPLETED|First Reading Session||0
3346877|NCT03501693|4076611|FG001|NOT COMPLETED|First Reading Session||0
3346878|NCT03501693|4076610|FG000|STARTED|4 Week Memory Washout Period||75
3346879|NCT03501693|4076611|FG001|STARTED|4 Week Memory Washout Period||75
3346880|NCT03501693|4076610|FG000|COMPLETED|4 Week Memory Washout Period||75
3346881|NCT03501693|4076611|FG001|COMPLETED|4 Week Memory Washout Period||75
3346882|NCT03501693|4076610|FG000|NOT COMPLETED|4 Week Memory Washout Period||0
3346883|NCT03501693|4076611|FG001|NOT COMPLETED|4 Week Memory Washout Period||0
3346884|NCT03501693|4076610|FG000|STARTED|Second Reading Session||75
3346885|NCT03501693|4076611|FG001|STARTED|Second Reading Session||75
3346886|NCT03501693|4076610|FG000|COMPLETED|Second Reading Session||75
3346887|NCT03501693|4076611|FG001|COMPLETED|Second Reading Session||75
3346888|NCT03501693|4076610|FG000|NOT COMPLETED|Second Reading Session||0
3346889|NCT03501693|4076611|FG001|NOT COMPLETED|Second Reading Session||0
3346890|NCT03502070|4076617|FG000|STARTED|Overall Study||47
3346891|NCT03502070|4076617|FG000|COMPLETED|Overall Study||45
3346892|NCT03502070|4076617|FG000|NOT COMPLETED|Overall Study||2
3346893|NCT03502265|4076621|FG000|STARTED|Overall Study||4
3346894|NCT03502265|4076621|FG000|COMPLETED|Overall Study||4
3346895|NCT03502265|4076621|FG000|NOT COMPLETED|Overall Study||0
3346896|NCT03502616|4076627|FG000|STARTED|Up to Week 16||134
3346897|NCT03502616|4076628|FG001|STARTED|Up to Week 16||136
3346898|NCT03502616|4076627|FG000|Treated|Up to Week 16||133
3346899|NCT03502616|4076628|FG001|Treated|Up to Week 16||136
3346900|NCT03502616|4076627|FG000|COMPLETED|Up to Week 16||132
3346901|NCT03502616|4076628|FG001|COMPLETED|Up to Week 16||133
3346902|NCT03502616|4076627|FG000|NOT COMPLETED|Up to Week 16||2
3346903|NCT03502616|4076628|FG001|NOT COMPLETED|Up to Week 16||3
3346904|NCT03502616|4076627|FG000|STARTED|Week 16 to Week 48||132
3346905|NCT03502616|4076628|FG001|STARTED|Week 16 to Week 48||133
3346906|NCT03502616|4076627|FG000|Treated|Week 16 to Week 48||132
3346907|NCT03502616|4076628|FG001|Treated|Week 16 to Week 48||133
3346908|NCT03502616|4076627|FG000|COMPLETED|Week 16 to Week 48||125
3346909|NCT03502616|4076628|FG001|COMPLETED|Week 16 to Week 48||127
3346910|NCT03502616|4076627|FG000|NOT COMPLETED|Week 16 to Week 48||7
3346911|NCT03502616|4076628|FG001|NOT COMPLETED|Week 16 to Week 48||6
3346912|NCT03502681|4076638|FG000|STARTED|Overall Study||3
3346913|NCT03502681|4076639|FG001|STARTED|Overall Study||3
3346914|NCT03502681|4076638|FG000|COMPLETED|Overall Study||0
3346915|NCT03502681|4076639|FG001|COMPLETED|Overall Study||1
3346916|NCT03502681|4076638|FG000|NOT COMPLETED|Overall Study||3
3346917|NCT03502681|4076639|FG001|NOT COMPLETED|Overall Study||2
3346918|NCT03502798|4076646|FG000|STARTED|Overall Study||5
3346919|NCT03502798|4076647|FG001|STARTED|Overall Study||40
3346920|NCT03502798|4076646|FG000|COMPLETED|Overall Study||5
3346921|NCT03502798|4076647|FG001|COMPLETED|Overall Study||33
3346922|NCT03502798|4076646|FG000|NOT COMPLETED|Overall Study||0
3346923|NCT03502798|4076647|FG001|NOT COMPLETED|Overall Study||7
3346924|NCT03502915|4076655|FG000|STARTED|Overall Study||24
3346925|NCT03502915|4076656|FG001|STARTED|Overall Study||24
3346926|NCT03502915|4076655|FG000|COMPLETED|Overall Study||24
3346927|NCT03502915|4076656|FG001|COMPLETED|Overall Study||24
3346928|NCT03502915|4076655|FG000|NOT COMPLETED|Overall Study||0
3346929|NCT03502915|4076656|FG001|NOT COMPLETED|Overall Study||0
3346930|NCT03502941|4076665|FG000|STARTED|Overall Study||3
3346931|NCT03502941|4076666|FG001|STARTED|Overall Study||5
3346932|NCT03502941|4076667|FG002|STARTED|Overall Study||8
3346933|NCT03502941|4076665|FG000|COMPLETED|Overall Study||3
3346934|NCT03502941|4076666|FG001|COMPLETED|Overall Study||5
3346935|NCT03502941|4076667|FG002|COMPLETED|Overall Study||8
3346936|NCT03502941|4076665|FG000|NOT COMPLETED|Overall Study||0
3346937|NCT03502941|4076666|FG001|NOT COMPLETED|Overall Study||0
3346938|NCT03502941|4076667|FG002|NOT COMPLETED|Overall Study||0
3346939|NCT03503162|4076675|FG000|STARTED|Overall Study||95
3346940|NCT03503162|4076675|FG000|COMPLETED|Overall Study||94
3346941|NCT03503162|4076675|FG000|NOT COMPLETED|Overall Study||1
3346942|NCT03503188|4076681|FG000|STARTED|Overall Study||128
3346943|NCT03503188|4076682|FG001|STARTED|Overall Study||146
3346944|NCT03503188|4076681|FG000|Entered in the Entire Study|Overall Study||128
3346945|NCT03503188|4076682|FG001|Entered in the Entire Study|Overall Study||145
3346946|NCT03503188|4076681|FG000|Main Study|Overall Study||99
3346947|NCT03503188|4076682|FG001|Main Study|Overall Study||101
3346948|NCT03503188|4076681|FG000|Sub-study|Overall Study||29
3346949|NCT03503188|4076682|FG001|Sub-study|Overall Study||44
3346950|NCT03503188|4076681|FG000|COMPLETED|Overall Study||128
3346951|NCT03503188|4076682|FG001|COMPLETED|Overall Study||145
3346952|NCT03503188|4076681|FG000|NOT COMPLETED|Overall Study||0
3346953|NCT03503188|4076682|FG001|NOT COMPLETED|Overall Study||1
3346954|NCT03503292|4076690|FG000|STARTED|Overall Study||2
3177888|NCT01973595|3905725|FG002|STARTED|Intervention Phase 1||15
3177889|NCT01973595|3905726|FG003|STARTED|Intervention Phase 1||14
3177890|NCT01973595|3905723|FG000|COMPLETED|Intervention Phase 1||15
3177891|NCT01973595|3905724|FG001|COMPLETED|Intervention Phase 1||14
3177892|NCT01973595|3905725|FG002|COMPLETED|Intervention Phase 1||15
3177893|NCT01973595|3905726|FG003|COMPLETED|Intervention Phase 1||14
3177894|NCT01973595|3905723|FG000|NOT COMPLETED|Intervention Phase 1||0
3177895|NCT01973595|3905724|FG001|NOT COMPLETED|Intervention Phase 1||0
3177896|NCT01973595|3905725|FG002|NOT COMPLETED|Intervention Phase 1||0
3177897|NCT01973595|3905726|FG003|NOT COMPLETED|Intervention Phase 1||0
3177898|NCT01973595|3905723|FG000|STARTED|Washout||15
3177899|NCT01973595|3905724|FG001|STARTED|Washout||14
3177900|NCT01973595|3905725|FG002|STARTED|Washout||15
3177901|NCT01973595|3905726|FG003|STARTED|Washout||14
3177902|NCT01973595|3905723|FG000|COMPLETED|Washout||14
3346955|NCT03503292|4076691|FG001|STARTED|Overall Study||90
3346956|NCT03503292|4076690|FG000|COMPLETED|Overall Study||2
3346957|NCT03503292|4076691|FG001|COMPLETED|Overall Study||90
3346958|NCT03503292|4076690|FG000|NOT COMPLETED|Overall Study||0
3346959|NCT03503292|4076691|FG001|NOT COMPLETED|Overall Study||0
3346960|NCT03503565|4076699|FG000|STARTED|Overall Study||59
3346961|NCT03503565|4076700|FG001|STARTED|Overall Study||58
3346962|NCT03503565|4076699|FG000|COMPLETED|Overall Study||59
3346963|NCT03503565|4076700|FG001|COMPLETED|Overall Study||58
3346964|NCT03503565|4076699|FG000|NOT COMPLETED|Overall Study||0
3346965|NCT03503565|4076700|FG001|NOT COMPLETED|Overall Study||0
3346966|NCT03503578|4076706|FG000|STARTED|Overall Study||12
3346967|NCT03503578|4076706|FG000|COMPLETED|Overall Study||12
3346968|NCT03503578|4076706|FG000|NOT COMPLETED|Overall Study||0
3346969|NCT03504189|4076710|FG000|STARTED|Overall Study||151
3346970|NCT03504189|4076710|FG000|COMPLETED|Overall Study||147
3346971|NCT03504189|4076710|FG000|NOT COMPLETED|Overall Study||4
3346972|NCT03504839|4076719|FG000|STARTED|Overall Study||53
3346973|NCT03504839|4076719|FG000|COMPLETED|Overall Study||49
3346974|NCT03504839|4076719|FG000|NOT COMPLETED|Overall Study||4
3346975|NCT03504852|4076726|FG000|STARTED|Overall Study||165
3346976|NCT03504852|4076727|FG001|STARTED|Overall Study||135
3346977|NCT03504852|4076728|FG002|STARTED|Overall Study||31
3346978|NCT03504852|4076726|FG000|COMPLETED|Overall Study||148
3346979|NCT03504852|4076727|FG001|COMPLETED|Overall Study||117
3346980|NCT03504852|4076728|FG002|COMPLETED|Overall Study||28
3346981|NCT03504852|4076726|FG000|NOT COMPLETED|Overall Study||17
3346982|NCT03504852|4076727|FG001|NOT COMPLETED|Overall Study||18
3177903|NCT01973595|3905724|FG001|COMPLETED|Washout||14
3177904|NCT01973595|3905725|FG002|COMPLETED|Washout||14
3346983|NCT03504852|4076728|FG002|NOT COMPLETED|Overall Study||3
3346984|NCT03504917|4076740|FG000|STARTED|Blinded Treatment Period||163
3346985|NCT03504917|4076741|FG001|STARTED|Blinded Treatment Period||158
3346986|NCT03504917|4076740|FG000|COMPLETED|Blinded Treatment Period||103
3346987|NCT03504917|4076741|FG001|COMPLETED|Blinded Treatment Period||102
3346988|NCT03504917|4076740|FG000|NOT COMPLETED|Blinded Treatment Period||60
3346989|NCT03504917|4076741|FG001|NOT COMPLETED|Blinded Treatment Period||56
3346990|NCT03504917|4076740|FG000|STARTED|Open Label Extension Treatment Period||100
3346991|NCT03504917|4076741|FG001|STARTED|Open Label Extension Treatment Period||97
3346992|NCT03504917|4076740|FG000|COMPLETED|Open Label Extension Treatment Period||0
3346993|NCT03504917|4076741|FG001|COMPLETED|Open Label Extension Treatment Period||0
3346994|NCT03504917|4076740|FG000|NOT COMPLETED|Open Label Extension Treatment Period||100
3346995|NCT03504917|4076741|FG001|NOT COMPLETED|Open Label Extension Treatment Period||97
3346996|NCT03505021|4076755|FG000|STARTED|Overall Study||329
3346997|NCT03505021|4076756|FG001|STARTED|Overall Study||167
3346998|NCT03505021|4076755|FG000|COMPLETED|Overall Study||217
3346999|NCT03505021|4076756|FG001|COMPLETED|Overall Study||112
3347000|NCT03505021|4076755|FG000|NOT COMPLETED|Overall Study||112
3347001|NCT03505021|4076756|FG001|NOT COMPLETED|Overall Study||55
3347002|NCT03505190|4076767|FG000|STARTED|Overall Study||9
3347003|NCT03505190|4076768|FG001|STARTED|Overall Study||8
3347004|NCT03505190|4076769|FG002|STARTED|Overall Study||8
3347005|NCT03505190|4076770|FG003|STARTED|Overall Study||8
3347006|NCT03505190|4076771|FG004|STARTED|Overall Study||8
3347007|NCT03505190|4076767|FG000|COMPLETED|Overall Study||9
3347008|NCT03505190|4076768|FG001|COMPLETED|Overall Study||8
3347009|NCT03505190|4076769|FG002|COMPLETED|Overall Study||8
3347010|NCT03505190|4076770|FG003|COMPLETED|Overall Study||8
3347011|NCT03505190|4076771|FG004|COMPLETED|Overall Study||8
3347012|NCT03505190|4076767|FG000|NOT COMPLETED|Overall Study||0
3347013|NCT03505190|4076768|FG001|NOT COMPLETED|Overall Study||0
3347014|NCT03505190|4076769|FG002|NOT COMPLETED|Overall Study||0
3347015|NCT03505190|4076770|FG003|NOT COMPLETED|Overall Study||0
3347016|NCT03505190|4076771|FG004|NOT COMPLETED|Overall Study||0
3347017|NCT03505593|4076783|FG000|STARTED|Overall Study||48
3347018|NCT03505593|4076783|FG000|COMPLETED|Overall Study||43
3347019|NCT03505593|4076783|FG000|NOT COMPLETED|Overall Study||5
3347020|NCT03505749|4076789|FG000|STARTED|Overall Study||38
3347021|NCT03505749|4076790|FG001|STARTED|Overall Study||45
3347022|NCT03505749|4076789|FG000|COMPLETED|Overall Study||22
3347023|NCT03505749|4076790|FG001|COMPLETED|Overall Study||28
3347024|NCT03505749|4076789|FG000|NOT COMPLETED|Overall Study||16
3347025|NCT03505749|4076790|FG001|NOT COMPLETED|Overall Study||17
3347026|NCT03506295|4076798|FG000|STARTED|Overall Study||10
3347027|NCT03506295|4076798|FG000|COMPLETED|Overall Study||10
3347028|NCT03506295|4076798|FG000|NOT COMPLETED|Overall Study||0
3347029|NCT03506347|4076806|FG000|STARTED|Overall Study||12
3347030|NCT03506347|4076807|FG001|STARTED|Overall Study||12
3347031|NCT03506347|4076806|FG000|COMPLETED|Overall Study||12
3347032|NCT03506347|4076807|FG001|COMPLETED|Overall Study||12
3347033|NCT03506347|4076806|FG000|NOT COMPLETED|Overall Study||0
3347034|NCT03506347|4076807|FG001|NOT COMPLETED|Overall Study||0
3347035|NCT03506386|4076813|FG000|STARTED|Overall Study||943
3347036|NCT03506386|4076813|FG000|COMPLETED|Overall Study||943
3347037|NCT03506386|4076813|FG000|NOT COMPLETED|Overall Study||0
3347038|NCT03506425|4076820|FG000|STARTED|Overall Study||5
3347039|NCT03506425|4076821|FG001|STARTED|Overall Study||5
3347040|NCT03506425|4076822|FG002|STARTED|Overall Study||5
3347041|NCT03506425|4076820|FG000|COMPLETED|Overall Study||3
3347042|NCT03506425|4076821|FG001|COMPLETED|Overall Study||2
3347043|NCT03506425|4076822|FG002|COMPLETED|Overall Study||4
3347044|NCT03506425|4076820|FG000|NOT COMPLETED|Overall Study||2
3347045|NCT03506425|4076821|FG001|NOT COMPLETED|Overall Study||3
3347046|NCT03506425|4076822|FG002|NOT COMPLETED|Overall Study||1
3347047|NCT03506477|4076833|FG000|STARTED|Overall Study||20
3347048|NCT03506477|4076834|FG001|STARTED|Overall Study||5
3347049|NCT03506477|4076833|FG000|COMPLETED|Overall Study||19
3347050|NCT03506477|4076834|FG001|COMPLETED|Overall Study||5
3347051|NCT03506477|4076833|FG000|NOT COMPLETED|Overall Study||1
3347052|NCT03506477|4076834|FG001|NOT COMPLETED|Overall Study||0
3347053|NCT03506724|4076842|FG000|STARTED|Overall Study||54
3347054|NCT03506724|4076843|FG001|STARTED|Overall Study||55
3347055|NCT03506724|4076842|FG000|COMPLETED|Overall Study||54
3347056|NCT03506724|4076843|FG001|COMPLETED|Overall Study||55
3347057|NCT03506724|4076842|FG000|NOT COMPLETED|Overall Study||0
3347058|NCT03506724|4076843|FG001|NOT COMPLETED|Overall Study||0
3347059|NCT03507036|4076849|FG000|STARTED|Overall Study||20
3347060|NCT03507036|4076849|FG000|COMPLETED|Overall Study||15
3347061|NCT03507036|4076849|FG000|NOT COMPLETED|Overall Study||5
3347062|NCT03507569|4076860|FG000|STARTED|Overall Study||2
3347063|NCT03507569|4076861|FG001|STARTED|Overall Study||1
3347064|NCT03507569|4076862|FG002|STARTED|Overall Study||2
3347065|NCT03507569|4076863|FG003|STARTED|Overall Study||1
3347066|NCT03507569|4076860|FG000|COMPLETED|Overall Study||2
3347067|NCT03507569|4076861|FG001|COMPLETED|Overall Study||1
3347068|NCT03507569|4076862|FG002|COMPLETED|Overall Study||2
3347069|NCT03507569|4076863|FG003|COMPLETED|Overall Study||1
3347070|NCT03507569|4076860|FG000|NOT COMPLETED|Overall Study||0
3347071|NCT03507569|4076861|FG001|NOT COMPLETED|Overall Study||0
3347072|NCT03507569|4076862|FG002|NOT COMPLETED|Overall Study||0
3347073|NCT03507569|4076863|FG003|NOT COMPLETED|Overall Study||0
3347074|NCT03508050|4076875|FG000|STARTED|Overall Study||20
3347075|NCT03508050|4076876|FG001|STARTED|Overall Study||17
3347076|NCT03508050|4076875|FG000|COMPLETED|Overall Study||15
3347077|NCT03508050|4076876|FG001|COMPLETED|Overall Study||15
3347078|NCT03508050|4076875|FG000|NOT COMPLETED|Overall Study||5
3347079|NCT03508050|4076876|FG001|NOT COMPLETED|Overall Study||2
3347080|NCT03508609|4076883|FG000|STARTED|Overall Study||20
3347081|NCT03508609|4076883|FG000|COMPLETED|Overall Study||19
3347082|NCT03508609|4076883|FG000|NOT COMPLETED|Overall Study||1
3347083|NCT03508661|4076887|FG000|STARTED|Overall Study||10
3347084|NCT03508661|4076887|FG000|COMPLETED|Overall Study||10
3347085|NCT03508661|4076887|FG000|NOT COMPLETED|Overall Study||0
3347086|NCT03508687|4076893|FG000|STARTED|Overall Study||2
3347087|NCT03508687|4076894|FG001|STARTED|Overall Study||3
3347088|NCT03508687|4076893|FG000|COMPLETED|Overall Study||2
3347089|NCT03508687|4076894|FG001|COMPLETED|Overall Study||3
3347090|NCT03508687|4076893|FG000|NOT COMPLETED|Overall Study||0
3347091|NCT03508687|4076894|FG001|NOT COMPLETED|Overall Study||0
3347092|NCT03508830|4076904|FG000|STARTED|Overall Study||46
3347093|NCT03508830|4076905|FG001|STARTED|Overall Study||45
3347094|NCT03508830|4076904|FG000|COMPLETED|Overall Study||41
3347095|NCT03508830|4076905|FG001|COMPLETED|Overall Study||39
3347096|NCT03508830|4076904|FG000|NOT COMPLETED|Overall Study||5
3347097|NCT03508830|4076905|FG001|NOT COMPLETED|Overall Study||6
3347098|NCT03508843|4076911|FG000|STARTED|Overall Study||150
3347099|NCT03508843|4076911|FG000|COMPLETED|Overall Study||147
3347100|NCT03508843|4076911|FG000|NOT COMPLETED|Overall Study||3
3347101|NCT03509350|4076917|FG000|STARTED|Overall Study||252
3347102|NCT03509350|4076918|FG001|STARTED|Overall Study||249
3347103|NCT03509350|4076917|FG000|COMPLETED|Overall Study||252
3347104|NCT03509350|4076918|FG001|COMPLETED|Overall Study||247
3347105|NCT03509350|4076917|FG000|NOT COMPLETED|Overall Study||0
3347106|NCT03509350|4076918|FG001|NOT COMPLETED|Overall Study||2
3347107|NCT03509675|4076926|FG000|STARTED|First Intervention (7 Days)||11
3347108|NCT03509675|4076927|FG001|STARTED|First Intervention (7 Days)||12
3347109|NCT03509675|4076926|FG000|COMPLETED|First Intervention (7 Days)||6
3347110|NCT03509675|4076927|FG001|COMPLETED|First Intervention (7 Days)||8
3347111|NCT03509675|4076926|FG000|NOT COMPLETED|First Intervention (7 Days)||5
3347112|NCT03509675|4076927|FG001|NOT COMPLETED|First Intervention (7 Days)||4
3347113|NCT03509675|4076926|FG000|STARTED|Washout Period (7 Days)||6
3347114|NCT03509675|4076927|FG001|STARTED|Washout Period (7 Days)||8
3347115|NCT03509675|4076926|FG000|COMPLETED|Washout Period (7 Days)||6
3347116|NCT03509675|4076927|FG001|COMPLETED|Washout Period (7 Days)||8
3347117|NCT03509675|4076926|FG000|NOT COMPLETED|Washout Period (7 Days)||0
3347118|NCT03509675|4076927|FG001|NOT COMPLETED|Washout Period (7 Days)||0
3347119|NCT03509675|4076926|FG000|STARTED|Second Intervention )7 Days)||6
3347120|NCT03509675|4076927|FG001|STARTED|Second Intervention )7 Days)||8
3347121|NCT03509675|4076926|FG000|COMPLETED|Second Intervention )7 Days)||4
3347122|NCT03509675|4076927|FG001|COMPLETED|Second Intervention )7 Days)||8
3347123|NCT03509675|4076926|FG000|NOT COMPLETED|Second Intervention )7 Days)||2
3347124|NCT03509675|4076927|FG001|NOT COMPLETED|Second Intervention )7 Days)||0
3347125|NCT03509766|4076933|FG000|STARTED|Overall Study||24
3347126|NCT03509766|4076933|FG000|COMPLETED|Overall Study||24
3347127|NCT03509766|4076933|FG000|NOT COMPLETED|Overall Study||0
3347128|NCT03509883|4076940|FG000|STARTED|Initial Treatment||15
3347129|NCT03509883|4076941|FG001|STARTED|Initial Treatment||15
3347130|NCT03509883|4076940|FG000|COMPLETED|Initial Treatment||15
3347131|NCT03509883|4076941|FG001|COMPLETED|Initial Treatment||15
3347132|NCT03509883|4076940|FG000|NOT COMPLETED|Initial Treatment||0
3347133|NCT03509883|4076941|FG001|NOT COMPLETED|Initial Treatment||0
3347134|NCT03509883|4076940|FG000|STARTED|Initial Treatment Washout||15
3347135|NCT03509883|4076941|FG001|STARTED|Initial Treatment Washout||15
3347136|NCT03509883|4076940|FG000|COMPLETED|Initial Treatment Washout||15
3347137|NCT03509883|4076941|FG001|COMPLETED|Initial Treatment Washout||15
3347138|NCT03509883|4076940|FG000|NOT COMPLETED|Initial Treatment Washout||0
3347139|NCT03509883|4076941|FG001|NOT COMPLETED|Initial Treatment Washout||0
3347140|NCT03509883|4076940|FG000|STARTED|Cross-over and Treatment||15
3347141|NCT03509883|4076941|FG001|STARTED|Cross-over and Treatment||15
3347142|NCT03509883|4076940|FG000|COMPLETED|Cross-over and Treatment||15
3347143|NCT03509883|4076941|FG001|COMPLETED|Cross-over and Treatment||15
3347144|NCT03509883|4076940|FG000|NOT COMPLETED|Cross-over and Treatment||0
3347145|NCT03509883|4076941|FG001|NOT COMPLETED|Cross-over and Treatment||0
3347146|NCT03509948|4076948|FG000|STARTED|Overall Study||6
3347147|NCT03509948|4076949|FG001|STARTED|Overall Study||7
3347148|NCT03509948|4076948|FG000|COMPLETED|Overall Study||6
3347149|NCT03509948|4076949|FG001|COMPLETED|Overall Study||6
3347150|NCT03509948|4076948|FG000|NOT COMPLETED|Overall Study||0
3347151|NCT03509948|4076949|FG001|NOT COMPLETED|Overall Study||1
3347152|NCT03509974|4076955|FG000|STARTED|Overall Study||14
3347153|NCT03509974|4076955|FG000|COMPLETED|Overall Study||14
3347154|NCT03509974|4076955|FG000|NOT COMPLETED|Overall Study||0
3347155|NCT03510182|4076959|FG000|STARTED|Overall Study||25
3347156|NCT03510182|4076959|FG000|COMPLETED|Overall Study||23
3347157|NCT03510182|4076959|FG000|NOT COMPLETED|Overall Study||2
3347158|NCT03510195|4076963|FG000|STARTED|Overall Study||267
3347159|NCT03510195|4076963|FG000|COMPLETED|Overall Study||101
3347160|NCT03510195|4076963|FG000|NOT COMPLETED|Overall Study||166
3347161|NCT03510273|4076977|FG000|STARTED|Overall Study||319
3347162|NCT03510273|4076977|FG000|Treated With Thermal Coagulation|Overall Study||319
3347163|NCT03510273|4076977|FG000|Completed 1-mth Follow-up Visit & Exited|Overall Study||192
3347164|NCT03510273|4076977|FG000|Completed 1-mth Follow-up Visit & Cont'd|Overall Study||126
3347165|NCT03510273|4076977|FG000|Completed All One-year Follow up Visits|Overall Study||118
3347166|NCT03510273|4076977|FG000|COMPLETED|Overall Study||310
3347167|NCT03510273|4076977|FG000|NOT COMPLETED|Overall Study||9
3347168|NCT03510455|4076985|FG000|STARTED|Overall Study||4
3347169|NCT03510455|4076985|FG000|Treated|Overall Study||4
3347170|NCT03510455|4076985|FG000|Extension Phase|Overall Study||1
3177905|NCT01973595|3905726|FG003|COMPLETED|Washout||14
3177906|NCT01973595|3905723|FG000|NOT COMPLETED|Washout||1
3177907|NCT01973595|3905724|FG001|NOT COMPLETED|Washout||0
3177908|NCT01973595|3905725|FG002|NOT COMPLETED|Washout||1
3177909|NCT01973595|3905726|FG003|NOT COMPLETED|Washout||0
3177910|NCT01973595|3905723|FG000|STARTED|Intervention Phase 2||14
3347171|NCT03510455|4076985|FG000|Screening Failures|Overall Study||0
3347172|NCT03510455|4076985|FG000|COMPLETED|Overall Study|3 of 4 patients completed the 24 week treatment phase of the study|3
3347173|NCT03510455|4076985|FG000|NOT COMPLETED|Overall Study||1
3347174|NCT03510481|4076995|FG000|STARTED|Year 1||69
3347175|NCT03510481|4076996|FG001|STARTED|Year 1||70
3347176|NCT03510481|4076997|FG002|STARTED|Year 1||36
3347177|NCT03510481|4076998|FG003|STARTED|Year 1||35
3347178|NCT03510481|4076995|FG000|COMPLETED|Year 1||56
3347179|NCT03510481|4076996|FG001|COMPLETED|Year 1||61
3347180|NCT03510481|4076997|FG002|COMPLETED|Year 1||34
3347181|NCT03510481|4076998|FG003|COMPLETED|Year 1||31
3347182|NCT03510481|4076995|FG000|NOT COMPLETED|Year 1||13
3347183|NCT03510481|4076996|FG001|NOT COMPLETED|Year 1||9
3347184|NCT03510481|4076997|FG002|NOT COMPLETED|Year 1||2
3347185|NCT03510481|4076998|FG003|NOT COMPLETED|Year 1||4
3347186|NCT03510481|4076995|FG000|STARTED|Year 2 - Booster Dose|10 participants who completed Period 1 did not re-consent for Period 2.|46
3347187|NCT03510481|4076996|FG001|STARTED|Year 2 - Booster Dose|9 participants who completed Period 1 did not re-consent for Period 2.|52
3347188|NCT03510481|4076997|FG002|STARTED|Year 2 - Booster Dose|9 participants who completed Period 1 did not re-consent for Period 2.|25
3347189|NCT03510481|4076998|FG003|STARTED|Year 2 - Booster Dose|12 participants who completed Period 1 did not re-consent for Period 2.|19
3347190|NCT03510481|4076995|FG000|COMPLETED|Year 2 - Booster Dose||42
3347191|NCT03510481|4076996|FG001|COMPLETED|Year 2 - Booster Dose||49
3347192|NCT03510481|4076997|FG002|COMPLETED|Year 2 - Booster Dose||23
3347193|NCT03510481|4076998|FG003|COMPLETED|Year 2 - Booster Dose||18
3347194|NCT03510481|4076995|FG000|NOT COMPLETED|Year 2 - Booster Dose||4
3347195|NCT03510481|4076996|FG001|NOT COMPLETED|Year 2 - Booster Dose||3
3347196|NCT03510481|4076997|FG002|NOT COMPLETED|Year 2 - Booster Dose||2
3347197|NCT03510481|4076998|FG003|NOT COMPLETED|Year 2 - Booster Dose||1
3347198|NCT03510663|4077018|FG000|STARTED|Overall Study||6
3347199|NCT03510663|4077019|FG001|STARTED|Overall Study||6
3347200|NCT03510663|4077020|FG002|STARTED|Overall Study||6
3347201|NCT03510663|4077021|FG003|STARTED|Overall Study||6
3347202|NCT03510663|4077022|FG004|STARTED|Overall Study||6
3347203|NCT03510663|4077023|FG005|STARTED|Overall Study||6
3347204|NCT03510663|4077024|FG006|STARTED|Overall Study||6
3347205|NCT03510663|4077025|FG007|STARTED|Overall Study||6
3347206|NCT03510663|4077018|FG000|COMPLETED|Overall Study||6
3347207|NCT03510663|4077019|FG001|COMPLETED|Overall Study||5
3347208|NCT03510663|4077020|FG002|COMPLETED|Overall Study||6
3347209|NCT03510663|4077021|FG003|COMPLETED|Overall Study||6
3177911|NCT01973595|3905724|FG001|STARTED|Intervention Phase 2||14
3347210|NCT03510663|4077022|FG004|COMPLETED|Overall Study||6
3347211|NCT03510663|4077023|FG005|COMPLETED|Overall Study||6
3347212|NCT03510663|4077024|FG006|COMPLETED|Overall Study||6
3347213|NCT03510663|4077025|FG007|COMPLETED|Overall Study||6
3347214|NCT03510663|4077018|FG000|NOT COMPLETED|Overall Study||0
3347215|NCT03510663|4077019|FG001|NOT COMPLETED|Overall Study||1
3347216|NCT03510663|4077020|FG002|NOT COMPLETED|Overall Study||0
3347217|NCT03510663|4077021|FG003|NOT COMPLETED|Overall Study||0
3347218|NCT03510663|4077022|FG004|NOT COMPLETED|Overall Study||0
3347219|NCT03510663|4077023|FG005|NOT COMPLETED|Overall Study||0
3347220|NCT03510663|4077024|FG006|NOT COMPLETED|Overall Study||0
3347221|NCT03510663|4077025|FG007|NOT COMPLETED|Overall Study||0
3347222|NCT03510715|4077037|FG000|STARTED|Overall Study||9
3347223|NCT03510715|4077038|FG001|STARTED|Overall Study||9
3347224|NCT03510715|4077037|FG000|COMPLETED|Overall Study||8
3347225|NCT03510715|4077038|FG001|COMPLETED|Overall Study||9
3347226|NCT03510715|4077037|FG000|NOT COMPLETED|Overall Study||1
3177912|NCT01973595|3905725|FG002|STARTED|Intervention Phase 2||14
3347227|NCT03510715|4077038|FG001|NOT COMPLETED|Overall Study||0
3347228|NCT03510910|4077047|FG000|STARTED|Overall Study||42
3347229|NCT03510910|4077048|FG001|STARTED|Overall Study||43
3347230|NCT03510910|4077047|FG000|COMPLETED|Overall Study||40
3347231|NCT03510910|4077048|FG001|COMPLETED|Overall Study||40
3347232|NCT03510910|4077047|FG000|NOT COMPLETED|Overall Study||2
3347233|NCT03510910|4077048|FG001|NOT COMPLETED|Overall Study||3
3347234|NCT03511001|4077056|FG000|STARTED|Overall Study||126
3347235|NCT03511001|4077057|FG001|STARTED|Overall Study||61
3347236|NCT03511001|4077056|FG000|Completers Analyzed|Overall Study|1 participant was excluded post-randomization due to not meeting race/ethnicity inclusion criteria.|114
3347237|NCT03511001|4077057|FG001|Completers Analyzed|Overall Study||61
3347238|NCT03511001|4077056|FG000|COMPLETED|Overall Study||115
3347239|NCT03511001|4077057|FG001|COMPLETED|Overall Study||54
3347240|NCT03511001|4077056|FG000|NOT COMPLETED|Overall Study||11
3347241|NCT03511001|4077057|FG001|NOT COMPLETED|Overall Study||7
3347242|NCT03511053|4077063|FG000|STARTED|Overall Study||11
3347243|NCT03511053|4077063|FG000|COMPLETED|Overall Study||10
3347244|NCT03511053|4077063|FG000|NOT COMPLETED|Overall Study||1
3347245|NCT03511105|4077069|FG000|STARTED|Overall Study||25
3347246|NCT03511105|4077070|FG001|STARTED|Overall Study||22
3347247|NCT03511105|4077069|FG000|COMPLETED|Overall Study||23
3347248|NCT03511105|4077070|FG001|COMPLETED|Overall Study||22
3347249|NCT03511105|4077069|FG000|NOT COMPLETED|Overall Study||2
3347250|NCT03511105|4077070|FG001|NOT COMPLETED|Overall Study||0
3347251|NCT03511326|4077077|FG000|STARTED|Overall Study||50
3347252|NCT03511326|4077077|FG000|COMPLETED|Overall Study||49
3347253|NCT03511326|4077077|FG000|NOT COMPLETED|Overall Study||1
3347254|NCT03511378|4077083|FG000|STARTED|Overall Study||70
3347255|NCT03511378|4077084|FG001|STARTED|Overall Study||68
3347256|NCT03511378|4077083|FG000|COMPLETED|Overall Study||67
3347257|NCT03511378|4077084|FG001|COMPLETED|Overall Study||66
3347258|NCT03511378|4077083|FG000|NOT COMPLETED|Overall Study||3
3347259|NCT03511378|4077084|FG001|NOT COMPLETED|Overall Study||2
3347260|NCT03511521|4077092|FG000|STARTED|Overall Study||2
3347261|NCT03511521|4077093|FG001|STARTED|Overall Study||1
3347262|NCT03511521|4077092|FG000|COMPLETED|Overall Study||2
3347263|NCT03511521|4077093|FG001|COMPLETED|Overall Study||1
3347264|NCT03511521|4077092|FG000|NOT COMPLETED|Overall Study||0
3347265|NCT03511521|4077093|FG001|NOT COMPLETED|Overall Study||0
3347266|NCT03511638|4077101|FG000|STARTED|Overall Study||184
3347267|NCT03511638|4077102|FG001|STARTED|Overall Study||188
3347268|NCT03511638|4077101|FG000|COMPLETED|Overall Study||182
3347269|NCT03511638|4077102|FG001|COMPLETED|Overall Study||187
3347270|NCT03511638|4077101|FG000|NOT COMPLETED|Overall Study||2
3347271|NCT03511638|4077102|FG001|NOT COMPLETED|Overall Study||1
3347272|NCT03511937|4077110|FG000|STARTED|Overall Study||200
3347273|NCT03511937|4077111|FG001|STARTED|Overall Study||200
3347274|NCT03511937|4077110|FG000|COMPLETED|Overall Study||200
3347275|NCT03511937|4077111|FG001|COMPLETED|Overall Study||200
3347276|NCT03511937|4077110|FG000|NOT COMPLETED|Overall Study||0
3347277|NCT03511937|4077111|FG001|NOT COMPLETED|Overall Study||0
3347278|NCT03512028|4077121|FG000|STARTED|Overall Study||19
3347279|NCT03512028|4077122|FG001|STARTED|Overall Study||15
3347280|NCT03512028|4077121|FG000|COMPLETED|Overall Study||15
3347281|NCT03512028|4077122|FG001|COMPLETED|Overall Study||15
3347282|NCT03512028|4077121|FG000|NOT COMPLETED|Overall Study||4
3347283|NCT03512028|4077122|FG001|NOT COMPLETED|Overall Study||0
3347284|NCT03512041|4077132|FG000|STARTED|Overall Study||10
3347285|NCT03512041|4077133|FG001|STARTED|Overall Study||10
3347286|NCT03512041|4077134|FG002|STARTED|Overall Study||11
3347287|NCT03512041|4077135|FG003|STARTED|Overall Study||9
3347288|NCT03512041|4077132|FG000|COMPLETED|Overall Study||10
3347289|NCT03512041|4077133|FG001|COMPLETED|Overall Study||10
3347290|NCT03512041|4077134|FG002|COMPLETED|Overall Study||11
3347291|NCT03512041|4077135|FG003|COMPLETED|Overall Study||9
3347292|NCT03512041|4077132|FG000|NOT COMPLETED|Overall Study||0
3347293|NCT03512041|4077133|FG001|NOT COMPLETED|Overall Study||0
3347294|NCT03512041|4077134|FG002|NOT COMPLETED|Overall Study||0
3347295|NCT03512041|4077135|FG003|NOT COMPLETED|Overall Study||0
3347296|NCT03512067|4077145|FG000|STARTED|Overall Study||1
3347297|NCT03512067|4077145|FG000|COMPLETED|Overall Study||1
3347298|NCT03512067|4077145|FG000|NOT COMPLETED|Overall Study||0
3347299|NCT03512288|4077151|FG000|STARTED|Overall Study||232
3347300|NCT03512288|4077152|FG001|STARTED|Overall Study||228
3347301|NCT03512288|4077151|FG000|Vaccination 1|Overall Study||231
3347302|NCT03512288|4077152|FG001|Vaccination 1|Overall Study||227
3347303|NCT03512288|4077151|FG000|Vaccination 2|Overall Study||222
3347304|NCT03512288|4077152|FG001|Vaccination 2|Overall Study||213
3347305|NCT03512288|4077151|FG000|Vaccination 3|Overall Study||210
3347306|NCT03512288|4077152|FG001|Vaccination 3|Overall Study||206
3347307|NCT03512288|4077151|FG000|Vaccination 4|Overall Study||197
3347308|NCT03512288|4077152|FG001|Vaccination 4|Overall Study||194
3347309|NCT03512288|4077151|FG000|COMPLETED|Overall Study||191
3347310|NCT03512288|4077152|FG001|COMPLETED|Overall Study||185
3347311|NCT03512288|4077151|FG000|NOT COMPLETED|Overall Study||41
3347312|NCT03512288|4077152|FG001|NOT COMPLETED|Overall Study||43
3347313|NCT03512353|4077158|FG000|STARTED|Overall Study||7
3347314|NCT03512353|4077158|FG000|Received Treatment|Overall Study||6
3347315|NCT03512353|4077158|FG000|COMPLETED|Overall Study||3
3347316|NCT03512353|4077158|FG000|NOT COMPLETED|Overall Study||4
3347317|NCT03512457|4077166|FG000|STARTED|Overall Study||195
3347318|NCT03512457|4077167|FG001|STARTED|Overall Study||225
3347319|NCT03512457|4077166|FG000|COMPLETED|Overall Study||161
3347320|NCT03512457|4077167|FG001|COMPLETED|Overall Study||185
3347321|NCT03512457|4077166|FG000|NOT COMPLETED|Overall Study||34
3347322|NCT03512457|4077167|FG001|NOT COMPLETED|Overall Study||40
3347323|NCT03513588|4077178|FG000|STARTED|Overall Study||16
3347324|NCT03513588|4077179|FG001|STARTED|Overall Study||17
3347325|NCT03513588|4077180|FG002|STARTED|Overall Study||15
3347326|NCT03513588|4077178|FG000|COMPLETED|Overall Study||15
3347327|NCT03513588|4077179|FG001|COMPLETED|Overall Study||15
3347328|NCT03513588|4077180|FG002|COMPLETED|Overall Study||13
3347329|NCT03513588|4077178|FG000|NOT COMPLETED|Overall Study||1
3347330|NCT03513588|4077179|FG001|NOT COMPLETED|Overall Study||2
3347331|NCT03513588|4077180|FG002|NOT COMPLETED|Overall Study||2
3347332|NCT03513757|4077192|FG000|STARTED|Overall Study||22
3347333|NCT03513757|4077193|FG001|STARTED|Overall Study||18
3347334|NCT03513757|4077192|FG000|COMPLETED|Overall Study||22
3347335|NCT03513757|4077193|FG001|COMPLETED|Overall Study||18
3347336|NCT03513757|4077192|FG000|NOT COMPLETED|Overall Study||0
3347337|NCT03513757|4077193|FG001|NOT COMPLETED|Overall Study||0
3347338|NCT03513848|4077204|FG000|STARTED|Overall Study||9
3347339|NCT03513848|4077205|FG001|STARTED|Overall Study||6
3347340|NCT03513848|4077204|FG000|COMPLETED|Overall Study||9
3347341|NCT03513848|4077205|FG001|COMPLETED|Overall Study||6
3347342|NCT03513848|4077204|FG000|NOT COMPLETED|Overall Study||0
3347343|NCT03513848|4077205|FG001|NOT COMPLETED|Overall Study||0
3347344|NCT03514277|4077214|FG000|STARTED|Overall Study||11
3347345|NCT03514277|4077215|FG001|STARTED|Overall Study||4
3347346|NCT03514277|4077216|FG002|STARTED|Overall Study||4
3347347|NCT03514277|4077214|FG000|COMPLETED|Overall Study||11
3347348|NCT03514277|4077215|FG001|COMPLETED|Overall Study||4
3347349|NCT03514277|4077216|FG002|COMPLETED|Overall Study||4
3347350|NCT03514277|4077214|FG000|NOT COMPLETED|Overall Study||0
3347351|NCT03514277|4077215|FG001|NOT COMPLETED|Overall Study||0
3347352|NCT03514277|4077216|FG002|NOT COMPLETED|Overall Study||0
3347353|NCT03514420|4077224|FG000|STARTED|Overall Study||4
3347354|NCT03514420|4077224|FG000|COMPLETED|Overall Study||4
3347355|NCT03514420|4077224|FG000|NOT COMPLETED|Overall Study||0
3347356|NCT03514641|4077232|FG000|STARTED|603A: 0-12 Week Study Period||334
3347357|NCT03514641|4077233|FG001|STARTED|603A: 0-12 Week Study Period||339
3347358|NCT03514641|4077234|FG002|STARTED|603A: 0-12 Week Study Period||0
3347359|NCT03514641|4077235|FG003|STARTED|603A: 0-12 Week Study Period||0
3347360|NCT03514641|4077232|FG000|COMPLETED|603A: 0-12 Week Study Period||307
3347361|NCT03514641|4077233|FG001|COMPLETED|603A: 0-12 Week Study Period||319
3347362|NCT03514641|4077234|FG002|COMPLETED|603A: 0-12 Week Study Period||0
3347363|NCT03514641|4077235|FG003|COMPLETED|603A: 0-12 Week Study Period||0
3347364|NCT03514641|4077232|FG000|NOT COMPLETED|603A: 0-12 Week Study Period||27
3347365|NCT03514641|4077233|FG001|NOT COMPLETED|603A: 0-12 Week Study Period||20
3347366|NCT03514641|4077234|FG002|NOT COMPLETED|603A: 0-12 Week Study Period||0
3347367|NCT03514641|4077235|FG003|NOT COMPLETED|603A: 0-12 Week Study Period||0
3347368|NCT03514641|4077232|FG000|STARTED|603B: 24-36 Week Study Period|The second part of study only applies to subjects in 603B|0
3347369|NCT03514641|4077233|FG001|STARTED|603B: 24-36 Week Study Period|The second part of study only applies to subjects in 603B|0
3347370|NCT03514641|4077234|FG002|STARTED|603B: 24-36 Week Study Period|The subjects were re-randomized in 603B|281
3347371|NCT03514641|4077235|FG003|STARTED|603B: 24-36 Week Study Period|The subjects were re-randomized in 603B|281
3347372|NCT03514641|4077232|FG000|COMPLETED|603B: 24-36 Week Study Period||0
3347373|NCT03514641|4077233|FG001|COMPLETED|603B: 24-36 Week Study Period||0
3347374|NCT03514641|4077234|FG002|COMPLETED|603B: 24-36 Week Study Period||267
3347375|NCT03514641|4077235|FG003|COMPLETED|603B: 24-36 Week Study Period||266
3347376|NCT03514641|4077232|FG000|NOT COMPLETED|603B: 24-36 Week Study Period||0
3347377|NCT03514641|4077233|FG001|NOT COMPLETED|603B: 24-36 Week Study Period||0
3347378|NCT03514641|4077234|FG002|NOT COMPLETED|603B: 24-36 Week Study Period||14
3347379|NCT03514641|4077235|FG003|NOT COMPLETED|603B: 24-36 Week Study Period||15
3347380|NCT03514966|4077249|FG000|STARTED|Overall Study||40
3347381|NCT03514966|4077250|FG001|STARTED|Overall Study||43
3347382|NCT03514966|4077249|FG000|COMPLETED|Overall Study||40
3347383|NCT03514966|4077250|FG001|COMPLETED|Overall Study||43
3347384|NCT03514966|4077249|FG000|NOT COMPLETED|Overall Study||0
3347385|NCT03514966|4077250|FG001|NOT COMPLETED|Overall Study||0
3347386|NCT03515681|4077258|FG000|STARTED|Overall Study||70
3347387|NCT03515681|4077259|FG001|STARTED|Overall Study||70
3347388|NCT03515681|4077258|FG000|Randomized|Overall Study||70
3347389|NCT03515681|4077259|FG001|Randomized|Overall Study||70
3347390|NCT03515681|4077258|FG000|Completed at 6 Months|Overall Study||61
3347391|NCT03515681|4077259|FG001|Completed at 6 Months|Overall Study||62
3347392|NCT03515681|4077258|FG000|COMPLETED|Overall Study||37
3347393|NCT03515681|4077259|FG001|COMPLETED|Overall Study||25
3347394|NCT03515681|4077258|FG000|NOT COMPLETED|Overall Study||33
3347395|NCT03515681|4077259|FG001|NOT COMPLETED|Overall Study||45
3347396|NCT03515824|4077268|FG000|STARTED|Overall Study||3
3347397|NCT03515824|4077269|FG001|STARTED|Overall Study||4
3347398|NCT03515824|4077270|FG002|STARTED|Overall Study||15
3347399|NCT03515824|4077271|FG003|STARTED|Overall Study||0
3347400|NCT03515824|4077268|FG000|COMPLETED|Overall Study||0
3347401|NCT03515824|4077269|FG001|COMPLETED|Overall Study||0
3347402|NCT03515824|4077270|FG002|COMPLETED|Overall Study||0
3347403|NCT03515824|4077271|FG003|COMPLETED|Overall Study||0
3347404|NCT03515824|4077268|FG000|NOT COMPLETED|Overall Study||3
3347405|NCT03515824|4077269|FG001|NOT COMPLETED|Overall Study||4
3347406|NCT03515824|4077270|FG002|NOT COMPLETED|Overall Study||15
3347407|NCT03515824|4077271|FG003|NOT COMPLETED|Overall Study||0
3347408|NCT03515941|4077281|FG000|STARTED|Overall Study||4
3347409|NCT03515941|4077282|FG001|STARTED|Overall Study||2
3347410|NCT03515941|4077281|FG000|COMPLETED|Overall Study||3
3347411|NCT03515941|4077282|FG001|COMPLETED|Overall Study||2
3347412|NCT03515941|4077281|FG000|NOT COMPLETED|Overall Study||1
3347413|NCT03515941|4077282|FG001|NOT COMPLETED|Overall Study||0
3347414|NCT03516227|4077290|FG000|STARTED|Overall Study||20
3347415|NCT03516227|4077291|FG001|STARTED|Overall Study||20
3347416|NCT03516227|4077290|FG000|COMPLETED|Overall Study||19
3347417|NCT03516227|4077291|FG001|COMPLETED|Overall Study||16
3347418|NCT03516227|4077290|FG000|NOT COMPLETED|Overall Study||1
3347419|NCT03516227|4077291|FG001|NOT COMPLETED|Overall Study||4
3347420|NCT03517436|4077298|FG000|STARTED|Overall Study||101
3347421|NCT03517436|4077298|FG000|COMPLETED|Overall Study||93
3347422|NCT03517436|4077298|FG000|NOT COMPLETED|Overall Study||8
3347423|NCT03517566|4077307|FG000|STARTED|Overall Study||74
3347424|NCT03517566|4077308|FG001|STARTED|Overall Study||37
3347425|NCT03517566|4077309|FG002|STARTED|Overall Study||36
3347426|NCT03517566|4077310|FG003|STARTED|Overall Study||73
3347427|NCT03517566|4077311|FG004|STARTED|Overall Study||73
3347428|NCT03517566|4077307|FG000|COMPLETED|Overall Study||42
3347429|NCT03517566|4077308|FG001|COMPLETED|Overall Study||16
3347430|NCT03517566|4077309|FG002|COMPLETED|Overall Study||21
3177913|NCT01973595|3905726|FG003|STARTED|Intervention Phase 2||14
3177914|NCT01973595|3905723|FG000|COMPLETED|Intervention Phase 2||14
3177915|NCT01973595|3905724|FG001|COMPLETED|Intervention Phase 2||14
3177916|NCT01973595|3905725|FG002|COMPLETED|Intervention Phase 2||14
3177917|NCT01973595|3905726|FG003|COMPLETED|Intervention Phase 2||14
3347431|NCT03517566|4077310|FG003|COMPLETED|Overall Study||39
3347432|NCT03517566|4077311|FG004|COMPLETED|Overall Study||41
3347433|NCT03517566|4077307|FG000|NOT COMPLETED|Overall Study||32
3347434|NCT03517566|4077308|FG001|NOT COMPLETED|Overall Study||21
3347435|NCT03517566|4077309|FG002|NOT COMPLETED|Overall Study||15
3347436|NCT03517566|4077310|FG003|NOT COMPLETED|Overall Study||34
3347437|NCT03517566|4077311|FG004|NOT COMPLETED|Overall Study||32
3347438|NCT03518008|4077324|FG000|STARTED|Period 1, First Week of Wear||11
3347439|NCT03518008|4077325|FG001|STARTED|Period 1, First Week of Wear||11
3347440|NCT03518008|4077324|FG000|COMPLETED|Period 1, First Week of Wear||11
3347441|NCT03518008|4077325|FG001|COMPLETED|Period 1, First Week of Wear||11
3347442|NCT03518008|4077324|FG000|NOT COMPLETED|Period 1, First Week of Wear||0
3347443|NCT03518008|4077325|FG001|NOT COMPLETED|Period 1, First Week of Wear||0
3347444|NCT03518008|4077324|FG000|STARTED|Period 2, Second Week of Wear||11
3347445|NCT03518008|4077325|FG001|STARTED|Period 2, Second Week of Wear||11
3347446|NCT03518008|4077324|FG000|COMPLETED|Period 2, Second Week of Wear||11
3347447|NCT03518008|4077325|FG001|COMPLETED|Period 2, Second Week of Wear||10
3347448|NCT03518008|4077324|FG000|NOT COMPLETED|Period 2, Second Week of Wear||0
3347449|NCT03518008|4077325|FG001|NOT COMPLETED|Period 2, Second Week of Wear||1
3347450|NCT03518125|4077337|FG000|STARTED|Overall Study||50
3347451|NCT03518125|4077338|FG001|STARTED|Overall Study||50
3347452|NCT03518125|4077339|FG002|STARTED|Overall Study||49
3347453|NCT03518125|4077340|FG003|STARTED|Overall Study||52
3347454|NCT03518125|4077341|FG004|STARTED|Overall Study||52
3347455|NCT03518125|4077342|FG005|STARTED|Overall Study||52
3347456|NCT03518125|4077337|FG000|COMPLETED|Overall Study||48
3347457|NCT03518125|4077338|FG001|COMPLETED|Overall Study||46
3347458|NCT03518125|4077339|FG002|COMPLETED|Overall Study||49
3347459|NCT03518125|4077340|FG003|COMPLETED|Overall Study||51
3347460|NCT03518125|4077341|FG004|COMPLETED|Overall Study||48
3347461|NCT03518125|4077342|FG005|COMPLETED|Overall Study||44
3347462|NCT03518125|4077337|FG000|NOT COMPLETED|Overall Study||2
3347463|NCT03518125|4077338|FG001|NOT COMPLETED|Overall Study||4
3347464|NCT03518125|4077339|FG002|NOT COMPLETED|Overall Study||0
3347465|NCT03518125|4077340|FG003|NOT COMPLETED|Overall Study||1
3347466|NCT03518125|4077341|FG004|NOT COMPLETED|Overall Study||4
3347467|NCT03518125|4077342|FG005|NOT COMPLETED|Overall Study||8
3347468|NCT03518658|4077359|FG000|STARTED|Overall Study|Number of patients completing device pairing survey|257
3347469|NCT03518658|4077360|FG001|STARTED|Overall Study||128607
3347470|NCT03518658|4077359|FG000|COMPLETED|Overall Study|Number of patients completing annual survey|206
3347471|NCT03518658|4077360|FG001|COMPLETED|Overall Study||128607
3347472|NCT03518658|4077359|FG000|NOT COMPLETED|Overall Study||51
3347473|NCT03518658|4077360|FG001|NOT COMPLETED|Overall Study||0
3347474|NCT03518840|4077368|FG000|STARTED|Overall Study||63
3347475|NCT03518840|4077368|FG000|COMPLETED|Overall Study||57
3347476|NCT03518840|4077368|FG000|NOT COMPLETED|Overall Study||6
3347477|NCT03519087|4077377|FG000|STARTED|Clinic Evaluation||55
3347478|NCT03519087|4077378|FG001|STARTED|Clinic Evaluation||57
3347479|NCT03519087|4077379|FG002|STARTED|Clinic Evaluation||0
3347480|NCT03519087|4077380|FG003|STARTED|Clinic Evaluation||0
3347481|NCT03519087|4077381|FG004|STARTED|Clinic Evaluation||0
3347482|NCT03519087|4077377|FG000|Received Assigned Intervention|Clinic Evaluation||54
3347483|NCT03519087|4077378|FG001|Received Assigned Intervention|Clinic Evaluation||57
3347484|NCT03519087|4077379|FG002|Received Assigned Intervention|Clinic Evaluation||0
3347485|NCT03519087|4077380|FG003|Received Assigned Intervention|Clinic Evaluation||0
3347486|NCT03519087|4077381|FG004|Received Assigned Intervention|Clinic Evaluation||0
3177918|NCT01973595|3905723|FG000|NOT COMPLETED|Intervention Phase 2||0
3347487|NCT03519087|4077377|FG000|Confirmed Diagnosis by Physician|Clinic Evaluation||39
3347488|NCT03519087|4077378|FG001|Confirmed Diagnosis by Physician|Clinic Evaluation||39
3347489|NCT03519087|4077379|FG002|Confirmed Diagnosis by Physician|Clinic Evaluation||0
3347490|NCT03519087|4077380|FG003|Confirmed Diagnosis by Physician|Clinic Evaluation||0
3347491|NCT03519087|4077381|FG004|Confirmed Diagnosis by Physician|Clinic Evaluation||0
3347492|NCT03519087|4077377|FG000|COMPLETED|Clinic Evaluation||39
3347493|NCT03519087|4077378|FG001|COMPLETED|Clinic Evaluation||39
3347494|NCT03519087|4077379|FG002|COMPLETED|Clinic Evaluation||0
3347495|NCT03519087|4077380|FG003|COMPLETED|Clinic Evaluation||0
3347496|NCT03519087|4077381|FG004|COMPLETED|Clinic Evaluation||0
3347497|NCT03519087|4077377|FG000|NOT COMPLETED|Clinic Evaluation||16
3347498|NCT03519087|4077378|FG001|NOT COMPLETED|Clinic Evaluation||18
3347499|NCT03519087|4077379|FG002|NOT COMPLETED|Clinic Evaluation||0
3347500|NCT03519087|4077380|FG003|NOT COMPLETED|Clinic Evaluation||0
3347501|NCT03519087|4077381|FG004|NOT COMPLETED|Clinic Evaluation||0
3347502|NCT03519087|4077377|FG000|STARTED|Re-randomization for Treatment||39
3347503|NCT03519087|4077378|FG001|STARTED|Re-randomization for Treatment||39
3347504|NCT03519087|4077379|FG002|STARTED|Re-randomization for Treatment||0
3347505|NCT03519087|4077380|FG003|STARTED|Re-randomization for Treatment||0
3347506|NCT03519087|4077381|FG004|STARTED|Re-randomization for Treatment||0
3347507|NCT03519087|4077377|FG000|COMPLETED|Re-randomization for Treatment||12
3347508|NCT03519087|4077378|FG001|COMPLETED|Re-randomization for Treatment||7
3347509|NCT03519087|4077379|FG002|COMPLETED|Re-randomization for Treatment||0
3347510|NCT03519087|4077380|FG003|COMPLETED|Re-randomization for Treatment||0
3347511|NCT03519087|4077381|FG004|COMPLETED|Re-randomization for Treatment||0
3347512|NCT03519087|4077377|FG000|NOT COMPLETED|Re-randomization for Treatment||27
3347513|NCT03519087|4077378|FG001|NOT COMPLETED|Re-randomization for Treatment||32
3347514|NCT03519087|4077379|FG002|NOT COMPLETED|Re-randomization for Treatment||0
3347515|NCT03519087|4077380|FG003|NOT COMPLETED|Re-randomization for Treatment||0
3347516|NCT03519087|4077381|FG004|NOT COMPLETED|Re-randomization for Treatment||0
3347517|NCT03519087|4077377|FG000|STARTED|Laboratory Testing||0
3347518|NCT03519087|4077378|FG001|STARTED|Laboratory Testing||0
3347519|NCT03519087|4077379|FG002|STARTED|Laboratory Testing|From interdisciplinary (4) or standard (2) evaluation from Period 1|6
3347520|NCT03519087|4077380|FG003|STARTED|Laboratory Testing|From interdisciplinary (4) or standard (2) evaluation from Period 1|6
3347521|NCT03519087|4077381|FG004|STARTED|Laboratory Testing|From interdisciplinary (4) or standard (3) evaluation from Period 1|7
3347522|NCT03519087|4077377|FG000|Baseline Lab Testing|Laboratory Testing||0
3347523|NCT03519087|4077378|FG001|Baseline Lab Testing|Laboratory Testing||0
3347524|NCT03519087|4077379|FG002|Baseline Lab Testing|Laboratory Testing||5
3347525|NCT03519087|4077380|FG003|Baseline Lab Testing|Laboratory Testing||4
3347526|NCT03519087|4077381|FG004|Baseline Lab Testing|Laboratory Testing||3
3347527|NCT03519087|4077377|FG000|COMPLETED|Laboratory Testing||0
3347528|NCT03519087|4077378|FG001|COMPLETED|Laboratory Testing||0
3347529|NCT03519087|4077379|FG002|COMPLETED|Laboratory Testing||4
3177919|NCT01973595|3905724|FG001|NOT COMPLETED|Intervention Phase 2||0
3177920|NCT01973595|3905725|FG002|NOT COMPLETED|Intervention Phase 2||0
3177921|NCT01973595|3905726|FG003|NOT COMPLETED|Intervention Phase 2||0
3347530|NCT03519087|4077380|FG003|COMPLETED|Laboratory Testing||2
3347531|NCT03519087|4077381|FG004|COMPLETED|Laboratory Testing||1
3347532|NCT03519087|4077377|FG000|NOT COMPLETED|Laboratory Testing||0
3347533|NCT03519087|4077378|FG001|NOT COMPLETED|Laboratory Testing||0
3347534|NCT03519087|4077379|FG002|NOT COMPLETED|Laboratory Testing||2
3347535|NCT03519087|4077380|FG003|NOT COMPLETED|Laboratory Testing||4
3347536|NCT03519087|4077381|FG004|NOT COMPLETED|Laboratory Testing||6
3347537|NCT03519204|4077399|FG000|STARTED|Overall Study|3 control participants were treated in error; 29 participants received treatment after 3 months.|43
3347538|NCT03519204|4077400|FG001|STARTED|Overall Study||133
3347539|NCT03519204|4077399|FG000|mITT Population|Overall Study||33
3347540|NCT03519204|4077400|FG001|mITT Population|Overall Study||130
3347541|NCT03519204|4077399|FG000|Safety Population|Overall Study||40
3347542|NCT03519204|4077400|FG001|Safety Population|Overall Study||136
3347543|NCT03519204|4077399|FG000|COMPLETED|Overall Study||30
3347544|NCT03519204|4077400|FG001|COMPLETED|Overall Study||118
3347545|NCT03519204|4077399|FG000|NOT COMPLETED|Overall Study||13
3347546|NCT03519204|4077400|FG001|NOT COMPLETED|Overall Study||15
3177922|NCT01973608|3905741|FG000|STARTED|Overall Study||2
3177923|NCT01973608|3905742|FG001|STARTED|Overall Study||2
3177924|NCT01973608|3905743|FG002|STARTED|Overall Study||6
3347547|NCT03519243|4077413|FG000|STARTED|Overall Study||25
3347548|NCT03519243|4077414|FG001|STARTED|Overall Study||25
3347549|NCT03519243|4077415|FG002|STARTED|Overall Study|The dose level was not studied due to the dose level l.7 µg/kg demonstrated the sufficient PD effect|0
3347550|NCT03519243|4077416|FG003|STARTED|Overall Study||25
3347551|NCT03519243|4077413|FG000|COMPLETED|Overall Study||20
3347552|NCT03519243|4077414|FG001|COMPLETED|Overall Study||21
3347553|NCT03519243|4077415|FG002|COMPLETED|Overall Study||0
3347554|NCT03519243|4077416|FG003|COMPLETED|Overall Study||24
3347555|NCT03519243|4077413|FG000|NOT COMPLETED|Overall Study||5
3347556|NCT03519243|4077414|FG001|NOT COMPLETED|Overall Study||4
3347557|NCT03519243|4077415|FG002|NOT COMPLETED|Overall Study||0
3347558|NCT03519243|4077416|FG003|NOT COMPLETED|Overall Study||1
3347559|NCT03519282|4077424|FG000|STARTED|First Intervention||5
3347560|NCT03519282|4077425|FG001|STARTED|First Intervention||5
3347561|NCT03519282|4077424|FG000|COMPLETED|First Intervention||5
3347562|NCT03519282|4077425|FG001|COMPLETED|First Intervention||5
3347563|NCT03519282|4077424|FG000|NOT COMPLETED|First Intervention||0
3347564|NCT03519282|4077425|FG001|NOT COMPLETED|First Intervention||0
3347565|NCT03519282|4077424|FG000|STARTED|Second Intervention||5
3347566|NCT03519282|4077425|FG001|STARTED|Second Intervention||5
3347567|NCT03519282|4077424|FG000|COMPLETED|Second Intervention||5
3347568|NCT03519282|4077425|FG001|COMPLETED|Second Intervention||5
3347569|NCT03519282|4077424|FG000|NOT COMPLETED|Second Intervention||0
3347570|NCT03519282|4077425|FG001|NOT COMPLETED|Second Intervention||0
3347571|NCT03519516|4077433|FG000|STARTED|Overall Study||15
3347572|NCT03519516|4077434|FG001|STARTED|Overall Study||15
3347573|NCT03519516|4077433|FG000|COMPLETED|Overall Study||15
3347574|NCT03519516|4077434|FG001|COMPLETED|Overall Study||14
3347575|NCT03519516|4077433|FG000|NOT COMPLETED|Overall Study||0
3347576|NCT03519516|4077434|FG001|NOT COMPLETED|Overall Study||1
3347577|NCT03519854|4077458|FG000|STARTED|Overall Study|N=3 randomized to Arm A. An additional N=1 (randomized to Arm C) is counted as Started in Arm A|4
3347578|NCT03519854|4077459|FG001|STARTED|Overall Study||6
3347579|NCT03519854|4077460|FG002|STARTED|Overall Study||5
3347580|NCT03519854|4077461|FG003|STARTED|Overall Study||6
3347581|NCT03519854|4077462|FG004|STARTED|Overall Study||6
3347582|NCT03519854|4077463|FG005|STARTED|Overall Study||6
3347583|NCT03519854|4077464|FG006|STARTED|Overall Study||3
3347584|NCT03519854|4077465|FG007|STARTED|Overall Study||6
3347585|NCT03519854|4077466|FG008|STARTED|Overall Study||6
3347586|NCT03519854|4077467|FG009|STARTED|Overall Study||6
3347587|NCT03519854|4077468|FG010|STARTED|Overall Study||6
3347588|NCT03519854|4077469|FG011|STARTED|Overall Study||6
3347589|NCT03519854|4077470|FG012|STARTED|Overall Study||3
3347590|NCT03519854|4077471|FG013|STARTED|Overall Study||6
3347591|NCT03519854|4077472|FG014|STARTED|Overall Study||6
3347592|NCT03519854|4077473|FG015|STARTED|Overall Study||6
3347593|NCT03519854|4077474|FG016|STARTED|Overall Study||6
3347594|NCT03519854|4077475|FG017|STARTED|Overall Study||6
3347595|NCT03519854|4077458|FG000|Treated|Overall Study|N=1 (randomized to Arm C) received placebo, 3 min after 1.2 mg/kg Esmeron®|4
3347596|NCT03519854|4077459|FG001|Treated|Overall Study||6
3347597|NCT03519854|4077460|FG002|Treated|Overall Study||4
3347598|NCT03519854|4077461|FG003|Treated|Overall Study||6
3347599|NCT03519854|4077462|FG004|Treated|Overall Study||6
3347600|NCT03519854|4077463|FG005|Treated|Overall Study||6
3347601|NCT03519854|4077464|FG006|Treated|Overall Study||3
3347602|NCT03519854|4077465|FG007|Treated|Overall Study||6
3347603|NCT03519854|4077466|FG008|Treated|Overall Study||6
3347604|NCT03519854|4077467|FG009|Treated|Overall Study||6
3347605|NCT03519854|4077468|FG010|Treated|Overall Study||6
3347606|NCT03519854|4077469|FG011|Treated|Overall Study||6
3347607|NCT03519854|4077470|FG012|Treated|Overall Study||3
3347608|NCT03519854|4077471|FG013|Treated|Overall Study||6
3347609|NCT03519854|4077472|FG014|Treated|Overall Study||6
3347610|NCT03519854|4077473|FG015|Treated|Overall Study||6
3347611|NCT03519854|4077474|FG016|Treated|Overall Study||6
3347612|NCT03519854|4077475|FG017|Treated|Overall Study||6
3347613|NCT03519854|4077458|FG000|COMPLETED|Overall Study||4
3347614|NCT03519854|4077459|FG001|COMPLETED|Overall Study||6
3347615|NCT03519854|4077460|FG002|COMPLETED|Overall Study||4
3347616|NCT03519854|4077461|FG003|COMPLETED|Overall Study||6
3347617|NCT03519854|4077462|FG004|COMPLETED|Overall Study||6
3347618|NCT03519854|4077463|FG005|COMPLETED|Overall Study||6
3347619|NCT03519854|4077464|FG006|COMPLETED|Overall Study||3
3347620|NCT03519854|4077465|FG007|COMPLETED|Overall Study||6
3347621|NCT03519854|4077466|FG008|COMPLETED|Overall Study||6
3347622|NCT03519854|4077467|FG009|COMPLETED|Overall Study||6
3347623|NCT03519854|4077468|FG010|COMPLETED|Overall Study||6
3347624|NCT03519854|4077469|FG011|COMPLETED|Overall Study||6
3347625|NCT03519854|4077470|FG012|COMPLETED|Overall Study||3
3347626|NCT03519854|4077471|FG013|COMPLETED|Overall Study||6
3347627|NCT03519854|4077472|FG014|COMPLETED|Overall Study||6
3347628|NCT03519854|4077473|FG015|COMPLETED|Overall Study||6
3347629|NCT03519854|4077474|FG016|COMPLETED|Overall Study||6
3347630|NCT03519854|4077475|FG017|COMPLETED|Overall Study||6
3347631|NCT03519854|4077458|FG000|NOT COMPLETED|Overall Study||0
3347632|NCT03519854|4077459|FG001|NOT COMPLETED|Overall Study||0
3347633|NCT03519854|4077460|FG002|NOT COMPLETED|Overall Study||1
3347634|NCT03519854|4077461|FG003|NOT COMPLETED|Overall Study||0
3347635|NCT03519854|4077462|FG004|NOT COMPLETED|Overall Study||0
3347636|NCT03519854|4077463|FG005|NOT COMPLETED|Overall Study||0
3347637|NCT03519854|4077464|FG006|NOT COMPLETED|Overall Study||0
3347638|NCT03519854|4077465|FG007|NOT COMPLETED|Overall Study||0
3347639|NCT03519854|4077466|FG008|NOT COMPLETED|Overall Study||0
3347640|NCT03519854|4077467|FG009|NOT COMPLETED|Overall Study||0
3347641|NCT03519854|4077468|FG010|NOT COMPLETED|Overall Study||0
3347642|NCT03519854|4077469|FG011|NOT COMPLETED|Overall Study||0
3347643|NCT03519854|4077470|FG012|NOT COMPLETED|Overall Study||0
3347644|NCT03519854|4077471|FG013|NOT COMPLETED|Overall Study||0
3347645|NCT03519854|4077472|FG014|NOT COMPLETED|Overall Study||0
3347646|NCT03519854|4077473|FG015|NOT COMPLETED|Overall Study||0
3347647|NCT03519854|4077474|FG016|NOT COMPLETED|Overall Study||0
3347648|NCT03519854|4077475|FG017|NOT COMPLETED|Overall Study||0
3347649|NCT03519867|4077523|FG000|STARTED|Overall Study||6
3347650|NCT03519867|4077524|FG001|STARTED|Overall Study|One participant randomized to receive MK-8616 8.0 mg/kg received MK-8616 0.8 mg/kg.|7
3347651|NCT03519867|4077525|FG002|STARTED|Overall Study||6
3347652|NCT03519867|4077526|FG003|STARTED|Overall Study||4
3347653|NCT03519867|4077527|FG004|STARTED|Overall Study||5
3347654|NCT03519867|4077528|FG005|STARTED|Overall Study||5
3347655|NCT03519867|4077529|FG006|STARTED|Overall Study||4
3347656|NCT03519867|4077530|FG007|STARTED|Overall Study||5
3347657|NCT03519867|4077531|FG008|STARTED|Overall Study||4
3347658|NCT03519867|4077532|FG009|STARTED|Overall Study||4
3347659|NCT03519867|4077523|FG000|Treated|Overall Study||5
3347660|NCT03519867|4077524|FG001|Treated|Overall Study||6
3347661|NCT03519867|4077525|FG002|Treated|Overall Study||5
3347662|NCT03519867|4077526|FG003|Treated|Overall Study||3
3347663|NCT03519867|4077527|FG004|Treated|Overall Study||5
3347664|NCT03519867|4077528|FG005|Treated|Overall Study||4
3347665|NCT03519867|4077529|FG006|Treated|Overall Study||4
3347666|NCT03519867|4077530|FG007|Treated|Overall Study||4
3347667|NCT03519867|4077531|FG008|Treated|Overall Study||3
3347668|NCT03519867|4077532|FG009|Treated|Overall Study||4
3347669|NCT03519867|4077523|FG000|COMPLETED|Overall Study||3
3347670|NCT03519867|4077524|FG001|COMPLETED|Overall Study||4
3347671|NCT03519867|4077525|FG002|COMPLETED|Overall Study||5
3347672|NCT03519867|4077526|FG003|COMPLETED|Overall Study||3
3347673|NCT03519867|4077527|FG004|COMPLETED|Overall Study||5
3347674|NCT03519867|4077528|FG005|COMPLETED|Overall Study||2
3347675|NCT03519867|4077529|FG006|COMPLETED|Overall Study||3
3347676|NCT03519867|4077530|FG007|COMPLETED|Overall Study||4
3347677|NCT03519867|4077531|FG008|COMPLETED|Overall Study||3
3347678|NCT03519867|4077532|FG009|COMPLETED|Overall Study||4
3347679|NCT03519867|4077523|FG000|NOT COMPLETED|Overall Study||3
3347680|NCT03519867|4077524|FG001|NOT COMPLETED|Overall Study||3
3347681|NCT03519867|4077525|FG002|NOT COMPLETED|Overall Study||1
3347682|NCT03519867|4077526|FG003|NOT COMPLETED|Overall Study||1
3347683|NCT03519867|4077527|FG004|NOT COMPLETED|Overall Study||0
3347684|NCT03519867|4077528|FG005|NOT COMPLETED|Overall Study||3
3347685|NCT03519867|4077529|FG006|NOT COMPLETED|Overall Study||1
3347686|NCT03519867|4077530|FG007|NOT COMPLETED|Overall Study||1
3347687|NCT03519867|4077531|FG008|NOT COMPLETED|Overall Study||1
3347688|NCT03519867|4077532|FG009|NOT COMPLETED|Overall Study||0
3347689|NCT03519919|4077554|FG000|STARTED|Overall Study||51
3347690|NCT03519919|4077554|FG000|COMPLETED|Overall Study||48
3347691|NCT03519919|4077554|FG000|NOT COMPLETED|Overall Study||3
3347692|NCT03519932|4077584|FG000|STARTED|First Intervention||24
3347693|NCT03519932|4077585|FG001|STARTED|First Intervention||25
3347694|NCT03519932|4077584|FG000|COMPLETED|First Intervention|One subject had non-significant adverse event and data not included in the analysis|23
3347695|NCT03519932|4077585|FG001|COMPLETED|First Intervention|3 subjects had non-significant adverse events and data not included in analysis.|22
3347696|NCT03519932|4077584|FG000|NOT COMPLETED|First Intervention||1
3347697|NCT03519932|4077585|FG001|NOT COMPLETED|First Intervention||3
2927950|NCT00575016|3638874|FG002|STARTED|Treatment Cycle 2|All patients received 200U in Treatment Cycle 2.|0
2927951|NCT00575016|3638875|FG003|STARTED|Treatment Cycle 2|All patients received 200U in Treatment Cycle 2.|0
2927952|NCT00575016|3638872|FG000|COMPLETED|Treatment Cycle 2||30
2927953|NCT00575016|3638873|FG001|COMPLETED|Treatment Cycle 2||0
2927954|NCT00575016|3638874|FG002|COMPLETED|Treatment Cycle 2||0
2927955|NCT00575016|3638875|FG003|COMPLETED|Treatment Cycle 2||0
2927956|NCT00575016|3638872|FG000|NOT COMPLETED|Treatment Cycle 2||1
2927957|NCT00575016|3638873|FG001|NOT COMPLETED|Treatment Cycle 2||0
2927958|NCT00575016|3638874|FG002|NOT COMPLETED|Treatment Cycle 2||0
2927959|NCT00575016|3638875|FG003|NOT COMPLETED|Treatment Cycle 2||0
2927960|NCT00575029|3638885|FG000|STARTED|Overall Study||7
2927961|NCT00575029|3638885|FG000|COMPLETED|Overall Study||7
2927962|NCT00575029|3638885|FG000|NOT COMPLETED|Overall Study||0
2927963|NCT00575042|3638889|FG000|STARTED|Overall Study||20
3039881|NCT01161407|3759404|FG001|COMPLETED|Overall Study||5
3347698|NCT03519932|4077584|FG000|STARTED|Second Intervention|Subjects who wore samfilcon A toric at 1st intervention wear comfilcon A toric at 2nd intervention|22
3347699|NCT03519932|4077585|FG001|STARTED|Second Intervention|Subjects who wore comfilcon A toric at 1st intervention wear Samfilcon A toric at 2nd intervention|23
3347700|NCT03519932|4077584|FG000|COMPLETED|Second Intervention||22
3347701|NCT03519932|4077585|FG001|COMPLETED|Second Intervention||23
3347702|NCT03519932|4077584|FG000|NOT COMPLETED|Second Intervention||0
3347703|NCT03519932|4077585|FG001|NOT COMPLETED|Second Intervention||0
3347704|NCT03520283|4077598|FG000|STARTED|Overall Study||24
3347705|NCT03520283|4077599|FG001|STARTED|Overall Study||42
3347706|NCT03520283|4077598|FG000|COMPLETED|Overall Study||24
3347707|NCT03520283|4077599|FG001|COMPLETED|Overall Study||42
3347708|NCT03520283|4077598|FG000|NOT COMPLETED|Overall Study||0
3347709|NCT03520283|4077599|FG001|NOT COMPLETED|Overall Study||0
3347710|NCT03520348|4077616|FG000|STARTED|Overall Study||12
3347711|NCT03520348|4077617|FG001|STARTED|Overall Study||12
3347712|NCT03520348|4077616|FG000|COMPLETED|Overall Study||12
3347713|NCT03520348|4077617|FG001|COMPLETED|Overall Study||12
3347714|NCT03520348|4077616|FG000|NOT COMPLETED|Overall Study||0
3347715|NCT03520348|4077617|FG001|NOT COMPLETED|Overall Study||0
3347716|NCT03520387|4077628|FG000|STARTED|Pre-Randomization||16
3347717|NCT03520387|4077629|FG001|STARTED|Pre-Randomization|Although participant flow is presented for each cell of the 2 x 2 contingency table in this factorial pilot trial, the primary analysis as originally planned focused on the main effects of (1) LRFA vs. simulated LRFA and (2) AcTIVE-CBT vs. TBSCE, unless there were indications of strong interactions between the two types of treatment. There are no participants in this group until the randomization period (until after the pre-randomization run-in period has ended).|0
3347718|NCT03520387|4077630|FG002|STARTED|Pre-Randomization|Although participant flow is presented for each cell of the 2 x 2 contingency table in this factorial pilot trial, the primary analysis as originally planned focused on the main effects of (1) LRFA vs. simulated LRFA and (2) AcTIVE-CBT vs. TBSCE, unless there were indications of strong interactions between the two types of treatment. There are no participants in this group until the randomization period (until after the pre-randomization run-in period has ended).|0
3347719|NCT03520387|4077631|FG003|STARTED|Pre-Randomization|Although participant flow is presented for each cell of the 2 x 2 contingency table in this factorial pilot trial, the primary analysis as originally planned focused on the main effects of (1) LRFA vs. simulated LRFA and (2) AcTIVE-CBT vs. TBSCE, unless there were indications of strong interactions between the two types of treatment. There are no participants in this group until the randomization period (until after the pre-randomization run-in period has ended).|0
3347720|NCT03520387|4077632|FG004|STARTED|Pre-Randomization|Although participant flow is presented for each cell of the 2 x 2 contingency table in this factorial pilot trial, the primary analysis as originally planned focused on the main effects of (1) LRFA vs. simulated LRFA and (2) AcTIVE-CBT vs. TBSCE, unless there were indications of strong interactions between the two types of treatment. There are no participants in this group until the randomization period (until after the pre-randomization run-in period has ended).|0
3347721|NCT03520387|4077628|FG000|COMPLETED|Pre-Randomization||13
3347722|NCT03520387|4077629|FG001|COMPLETED|Pre-Randomization||0
3347723|NCT03520387|4077630|FG002|COMPLETED|Pre-Randomization||0
3347724|NCT03520387|4077631|FG003|COMPLETED|Pre-Randomization||0
3347725|NCT03520387|4077632|FG004|COMPLETED|Pre-Randomization||0
3347726|NCT03520387|4077628|FG000|NOT COMPLETED|Pre-Randomization||3
3347727|NCT03520387|4077629|FG001|NOT COMPLETED|Pre-Randomization||0
3347728|NCT03520387|4077630|FG002|NOT COMPLETED|Pre-Randomization||0
3347729|NCT03520387|4077631|FG003|NOT COMPLETED|Pre-Randomization||0
3347730|NCT03520387|4077632|FG004|NOT COMPLETED|Pre-Randomization||0
3347731|NCT03520387|4077628|FG000|STARTED|Randomized|There are no participants in this group during this period, because the pre-randomization run-in period has ended.|0
3347732|NCT03520387|4077629|FG001|STARTED|Randomized|Although participant flow is presented for each cell of the 2 x 2 contingency table in this factorial pilot trial, the primary analysis as originally planned focused on the main effects of (1) LRFA vs. simulated LRFA and (2) AcTIVE-CBT vs. TBSCE, unless there were indications of strong interactions between the two types of treatment.|4
3347733|NCT03520387|4077630|FG002|STARTED|Randomized|Although participant flow is presented for each cell of the 2 x 2 contingency table in this factorial pilot trial, the primary analysis as originally planned focused on the main effects of (1) LRFA vs. simulated LRFA and (2) AcTIVE-CBT vs. TBSCE, unless there were indications of strong interactions between the two types of treatment.|3
3347734|NCT03520387|4077631|FG003|STARTED|Randomized|Although participant flow is presented for each cell of the 2 x 2 contingency table in this factorial pilot trial, the primary analysis as originally planned focused on the main effects of (1) LRFA vs. simulated LRFA and (2) AcTIVE-CBT vs. TBSCE, unless there were indications of strong interactions between the two types of treatment.|3
3347735|NCT03520387|4077632|FG004|STARTED|Randomized|Although participant flow is presented for each cell of the 2 x 2 contingency table in this factorial pilot trial, the primary analysis as originally planned focused on the main effects of (1) LRFA vs. simulated LRFA and (2) AcTIVE-CBT vs. TBSCE, unless there were indications of strong interactions between the two types of treatment.|3
3347736|NCT03520387|4077628|FG000|COMPLETED|Randomized||0
3347737|NCT03520387|4077629|FG001|COMPLETED|Randomized||4
3347738|NCT03520387|4077630|FG002|COMPLETED|Randomized||3
3347739|NCT03520387|4077631|FG003|COMPLETED|Randomized||3
3347740|NCT03520387|4077632|FG004|COMPLETED|Randomized||3
3347741|NCT03520387|4077628|FG000|NOT COMPLETED|Randomized||0
3347742|NCT03520387|4077629|FG001|NOT COMPLETED|Randomized||0
3177925|NCT01973608|3905744|FG003|STARTED|Overall Study||2
3177926|NCT01973608|3905741|FG000|COMPLETED|Overall Study||2
3177927|NCT01973608|3905742|FG001|COMPLETED|Overall Study||2
3177928|NCT01973608|3905743|FG002|COMPLETED|Overall Study||6
3177929|NCT01973608|3905744|FG003|COMPLETED|Overall Study||2
3177930|NCT01973608|3905741|FG000|NOT COMPLETED|Overall Study||0
3347743|NCT03520387|4077630|FG002|NOT COMPLETED|Randomized||0
3347744|NCT03520387|4077631|FG003|NOT COMPLETED|Randomized||0
3347745|NCT03520387|4077632|FG004|NOT COMPLETED|Randomized||0
3347746|NCT03520400|4077645|FG000|STARTED|Overall Study||37
3347747|NCT03520400|4077646|FG001|STARTED|Overall Study||14
3347748|NCT03520400|4077645|FG000|COMPLETED|Overall Study||22
3347749|NCT03520400|4077646|FG001|COMPLETED|Overall Study||7
3347750|NCT03520400|4077645|FG000|NOT COMPLETED|Overall Study||15
3347751|NCT03520400|4077646|FG001|NOT COMPLETED|Overall Study||7
3347752|NCT03520920|4077655|FG000|STARTED|Overall Study||20
3347753|NCT03520920|4077656|FG001|STARTED|Overall Study||16
3347754|NCT03520920|4077657|FG002|STARTED|Overall Study||5
3347755|NCT03520920|4077655|FG000|Received at Least 1 Dose of Study Drug|Overall Study||20
3347756|NCT03520920|4077656|FG001|Received at Least 1 Dose of Study Drug|Overall Study||16
3347757|NCT03520920|4077657|FG002|Received at Least 1 Dose of Study Drug|Overall Study||5
3347758|NCT03520920|4077655|FG000|COMPLETED|Overall Study||0
3347759|NCT03520920|4077656|FG001|COMPLETED|Overall Study||0
3347760|NCT03520920|4077657|FG002|COMPLETED|Overall Study||0
3347761|NCT03520920|4077655|FG000|NOT COMPLETED|Overall Study||20
3347762|NCT03520920|4077656|FG001|NOT COMPLETED|Overall Study||16
3347763|NCT03520920|4077657|FG002|NOT COMPLETED|Overall Study||5
3347764|NCT03520959|4077673|FG000|STARTED|Overall Study||0
3347765|NCT03520959|4077674|FG001|STARTED|Overall Study||1
3347766|NCT03520959|4077673|FG000|COMPLETED|Overall Study||0
3347767|NCT03520959|4077674|FG001|COMPLETED|Overall Study||0
3347768|NCT03520959|4077673|FG000|NOT COMPLETED|Overall Study||0
3347769|NCT03520959|4077674|FG001|NOT COMPLETED|Overall Study||1
3347770|NCT03520998|4077682|FG000|STARTED|Overall Study||24
3347771|NCT03520998|4077683|FG001|STARTED|Overall Study||23
3347772|NCT03520998|4077682|FG000|COMPLETED|Overall Study||18
3347773|NCT03520998|4077683|FG001|COMPLETED|Overall Study||21
3347774|NCT03520998|4077682|FG000|NOT COMPLETED|Overall Study||6
3347775|NCT03520998|4077683|FG001|NOT COMPLETED|Overall Study||2
3347776|NCT03521089|4077691|FG000|STARTED|Overall Study||8
3347777|NCT03521089|4077692|FG001|STARTED|Overall Study||8
3347778|NCT03521089|4077691|FG000|COMPLETED|Overall Study||8
3347779|NCT03521089|4077692|FG001|COMPLETED|Overall Study||8
3347780|NCT03521089|4077691|FG000|NOT COMPLETED|Overall Study||0
3347781|NCT03521089|4077692|FG001|NOT COMPLETED|Overall Study||0
3347782|NCT03521115|4077700|FG000|STARTED|Time 0 Baseline Surveys||206
3347783|NCT03521115|4077701|FG001|STARTED|Time 0 Baseline Surveys||205
3347784|NCT03521115|4077700|FG000|COMPLETED|Time 0 Baseline Surveys||206
3347785|NCT03521115|4077701|FG001|COMPLETED|Time 0 Baseline Surveys||205
3347786|NCT03521115|4077700|FG000|NOT COMPLETED|Time 0 Baseline Surveys||0
3347787|NCT03521115|4077701|FG001|NOT COMPLETED|Time 0 Baseline Surveys||0
3347788|NCT03521115|4077700|FG000|STARTED|Time 1 Survey (6 Months Post Baseline)||206
3347789|NCT03521115|4077701|FG001|STARTED|Time 1 Survey (6 Months Post Baseline)||205
3347790|NCT03521115|4077700|FG000|COMPLETED|Time 1 Survey (6 Months Post Baseline)||150
3347791|NCT03521115|4077701|FG001|COMPLETED|Time 1 Survey (6 Months Post Baseline)||165
3347792|NCT03521115|4077700|FG000|NOT COMPLETED|Time 1 Survey (6 Months Post Baseline)||56
3347793|NCT03521115|4077701|FG001|NOT COMPLETED|Time 1 Survey (6 Months Post Baseline)||40
3347794|NCT03521115|4077700|FG000|STARTED|Time 2 Survey (12 Months Post Baseline)||150
3347795|NCT03521115|4077701|FG001|STARTED|Time 2 Survey (12 Months Post Baseline)||165
3347796|NCT03521115|4077700|FG000|COMPLETED|Time 2 Survey (12 Months Post Baseline)||147
3347797|NCT03521115|4077701|FG001|COMPLETED|Time 2 Survey (12 Months Post Baseline)||164
3347798|NCT03521115|4077700|FG000|NOT COMPLETED|Time 2 Survey (12 Months Post Baseline)||3
3347799|NCT03521115|4077701|FG001|NOT COMPLETED|Time 2 Survey (12 Months Post Baseline)||1
3347800|NCT03521115|4077700|FG000|STARTED|Time 3 Survey (18 Months Post Baseline)||147
3347801|NCT03521115|4077701|FG001|STARTED|Time 3 Survey (18 Months Post Baseline)||164
3347802|NCT03521115|4077700|FG000|COMPLETED|Time 3 Survey (18 Months Post Baseline)||145
3347803|NCT03521115|4077701|FG001|COMPLETED|Time 3 Survey (18 Months Post Baseline)||164
3347804|NCT03521115|4077700|FG000|NOT COMPLETED|Time 3 Survey (18 Months Post Baseline)||2
3347805|NCT03521115|4077701|FG001|NOT COMPLETED|Time 3 Survey (18 Months Post Baseline)||0
3347806|NCT03521141|4077716|FG000|STARTED|Overall Study||19
3347807|NCT03521141|4077717|FG001|STARTED|Overall Study||19
3347808|NCT03521141|4077718|FG002|STARTED|Overall Study||20
3347809|NCT03521141|4077716|FG000|COMPLETED|Overall Study||18
3347810|NCT03521141|4077717|FG001|COMPLETED|Overall Study||19
3347811|NCT03521141|4077718|FG002|COMPLETED|Overall Study||19
3347812|NCT03521141|4077716|FG000|NOT COMPLETED|Overall Study||1
3347813|NCT03521141|4077717|FG001|NOT COMPLETED|Overall Study||0
3347814|NCT03521141|4077718|FG002|NOT COMPLETED|Overall Study||1
3347815|NCT03521193|4077728|FG000|STARTED|Overall Study|enrolled on the PFO closure hospitalization|78
3347816|NCT03521193|4077729|FG001|STARTED|Overall Study||12
3347817|NCT03521193|4077728|FG000|COMPLETED|Overall Study|8 pts refused to continue the study; 8 patients were non compliant to ASA treatment|62
3347818|NCT03521193|4077729|FG001|COMPLETED|Overall Study||12
3347819|NCT03521193|4077728|FG000|NOT COMPLETED|Overall Study||16
3347820|NCT03521193|4077729|FG001|NOT COMPLETED|Overall Study||0
3347821|NCT03521479|4077740|FG000|STARTED|Overall Study||10
3347822|NCT03521479|4077741|FG001|STARTED|Overall Study||10
3347823|NCT03521479|4077742|FG002|STARTED|Overall Study||10
3347824|NCT03521479|4077743|FG003|STARTED|Overall Study||10
3347825|NCT03521479|4077740|FG000|COMPLETED|Overall Study||10
3347826|NCT03521479|4077741|FG001|COMPLETED|Overall Study||10
3347827|NCT03521479|4077742|FG002|COMPLETED|Overall Study||10
3347828|NCT03521479|4077743|FG003|COMPLETED|Overall Study||10
3347829|NCT03521479|4077740|FG000|NOT COMPLETED|Overall Study||0
3347830|NCT03521479|4077741|FG001|NOT COMPLETED|Overall Study||0
3347831|NCT03521479|4077742|FG002|NOT COMPLETED|Overall Study||0
3347832|NCT03521479|4077743|FG003|NOT COMPLETED|Overall Study||0
3347833|NCT03521505|4077755|FG000|STARTED|Overall Study||25
3347834|NCT03521505|4077756|FG001|STARTED|Overall Study||25
3347835|NCT03521505|4077755|FG000|COMPLETED|Overall Study||25
3347836|NCT03521505|4077756|FG001|COMPLETED|Overall Study||25
3347837|NCT03521505|4077755|FG000|NOT COMPLETED|Overall Study||0
3347838|NCT03521505|4077756|FG001|NOT COMPLETED|Overall Study||0
3347839|NCT03521635|4077764|FG000|STARTED|Overall Study||49
3347840|NCT03521635|4077765|FG001|STARTED|Overall Study||49
3347841|NCT03521635|4077764|FG000|COMPLETED|Overall Study||45
3347842|NCT03521635|4077765|FG001|COMPLETED|Overall Study||43
3347843|NCT03521635|4077764|FG000|NOT COMPLETED|Overall Study||4
3177931|NCT01973608|3905742|FG001|NOT COMPLETED|Overall Study||0
3177932|NCT01973608|3905743|FG002|NOT COMPLETED|Overall Study||0
3177933|NCT01973608|3905744|FG003|NOT COMPLETED|Overall Study||0
3177934|NCT01973777|3905758|FG000|STARTED|Overall Study|January 2014|51
3177935|NCT01973777|3905758|FG000|One Year Follow-up|Overall Study||44
3177936|NCT01973777|3905758|FG000|COMPLETED|Overall Study||44
3177937|NCT01973777|3905758|FG000|NOT COMPLETED|Overall Study||7
3177938|NCT01973972|3905764|FG000|STARTED|Overall Study||127
3347844|NCT03521635|4077765|FG001|NOT COMPLETED|Overall Study||6
3347845|NCT03521791|4077773|FG000|STARTED|Overall Study||76
3347846|NCT03521791|4077774|FG001|STARTED|Overall Study||90
3347847|NCT03521791|4077773|FG000|COMPLETED|Overall Study||69
3347848|NCT03521791|4077774|FG001|COMPLETED|Overall Study||73
3347849|NCT03521791|4077773|FG000|NOT COMPLETED|Overall Study||7
3347850|NCT03521791|4077774|FG001|NOT COMPLETED|Overall Study||17
3347851|NCT03521817|4077782|FG000|STARTED|Overall Study||7
3347852|NCT03521817|4077783|FG001|STARTED|Overall Study||5
3347853|NCT03521817|4077782|FG000|COMPLETED|Overall Study||7
3347854|NCT03521817|4077783|FG001|COMPLETED|Overall Study|1 completer was non adherent based on weekly intervention body weight|4
3347855|NCT03521817|4077782|FG000|NOT COMPLETED|Overall Study||0
3347856|NCT03521817|4077783|FG001|NOT COMPLETED|Overall Study||1
3347857|NCT03522350|4077789|FG000|STARTED|Overall Study||18
3347858|NCT03522350|4077790|FG001|STARTED|Overall Study||18
3347859|NCT03522350|4077789|FG000|COMPLETED|Overall Study||18
3347860|NCT03522350|4077790|FG001|COMPLETED|Overall Study||18
3347861|NCT03522350|4077789|FG000|NOT COMPLETED|Overall Study||0
3347862|NCT03522350|4077790|FG001|NOT COMPLETED|Overall Study||0
3347863|NCT03522441|4077798|FG000|STARTED|Overall Study||450
3347864|NCT03522441|4077799|FG001|STARTED|Overall Study||450
3347865|NCT03522441|4077800|FG002|STARTED|Overall Study||225
3347866|NCT03522441|4077798|FG000|COMPLETED|Overall Study||424
3347867|NCT03522441|4077799|FG001|COMPLETED|Overall Study||431
3347868|NCT03522441|4077800|FG002|COMPLETED|Overall Study||214
3347869|NCT03522441|4077798|FG000|NOT COMPLETED|Overall Study||26
3347870|NCT03522441|4077799|FG001|NOT COMPLETED|Overall Study||19
3347871|NCT03522441|4077800|FG002|NOT COMPLETED|Overall Study||11
3347872|NCT03522506|4077812|FG000|STARTED|Treatment Period 1 (2 Days)||5
3347873|NCT03522506|4077813|FG001|STARTED|Treatment Period 1 (2 Days)||5
3347874|NCT03522506|4077814|FG002|STARTED|Treatment Period 1 (2 Days)||5
3347875|NCT03522506|4077815|FG003|STARTED|Treatment Period 1 (2 Days)||5
3347876|NCT03522506|4077812|FG000|COMPLETED|Treatment Period 1 (2 Days)||5
3347877|NCT03522506|4077813|FG001|COMPLETED|Treatment Period 1 (2 Days)||5
3347878|NCT03522506|4077814|FG002|COMPLETED|Treatment Period 1 (2 Days)||5
3347879|NCT03522506|4077815|FG003|COMPLETED|Treatment Period 1 (2 Days)||5
3347880|NCT03522506|4077812|FG000|NOT COMPLETED|Treatment Period 1 (2 Days)||0
3347881|NCT03522506|4077813|FG001|NOT COMPLETED|Treatment Period 1 (2 Days)||0
3347882|NCT03522506|4077814|FG002|NOT COMPLETED|Treatment Period 1 (2 Days)||0
3347883|NCT03522506|4077815|FG003|NOT COMPLETED|Treatment Period 1 (2 Days)||0
3347884|NCT03522506|4077812|FG000|STARTED|Washout Period 1 (7 Days)||5
3347885|NCT03522506|4077813|FG001|STARTED|Washout Period 1 (7 Days)||5
3347886|NCT03522506|4077814|FG002|STARTED|Washout Period 1 (7 Days)||5
3347887|NCT03522506|4077815|FG003|STARTED|Washout Period 1 (7 Days)||5
3347888|NCT03522506|4077812|FG000|COMPLETED|Washout Period 1 (7 Days)||5
3347889|NCT03522506|4077813|FG001|COMPLETED|Washout Period 1 (7 Days)||5
3347890|NCT03522506|4077814|FG002|COMPLETED|Washout Period 1 (7 Days)||5
3347891|NCT03522506|4077815|FG003|COMPLETED|Washout Period 1 (7 Days)||4
3347892|NCT03522506|4077812|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0
3347893|NCT03522506|4077813|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0
3347894|NCT03522506|4077814|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||0
3347895|NCT03522506|4077815|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||1
3347896|NCT03522506|4077812|FG000|STARTED|Treatment Period 2 (2 Days)||5
3347897|NCT03522506|4077813|FG001|STARTED|Treatment Period 2 (2 Days)||5
3347898|NCT03522506|4077814|FG002|STARTED|Treatment Period 2 (2 Days)||5
3347899|NCT03522506|4077815|FG003|STARTED|Treatment Period 2 (2 Days)||4
3347900|NCT03522506|4077812|FG000|COMPLETED|Treatment Period 2 (2 Days)||5
3347901|NCT03522506|4077813|FG001|COMPLETED|Treatment Period 2 (2 Days)||5
3347902|NCT03522506|4077814|FG002|COMPLETED|Treatment Period 2 (2 Days)||5
3347903|NCT03522506|4077815|FG003|COMPLETED|Treatment Period 2 (2 Days)||4
3347904|NCT03522506|4077812|FG000|NOT COMPLETED|Treatment Period 2 (2 Days)||0
3347905|NCT03522506|4077813|FG001|NOT COMPLETED|Treatment Period 2 (2 Days)||0
3347906|NCT03522506|4077814|FG002|NOT COMPLETED|Treatment Period 2 (2 Days)||0
3347907|NCT03522506|4077815|FG003|NOT COMPLETED|Treatment Period 2 (2 Days)||0
3347908|NCT03522506|4077812|FG000|STARTED|Washout Period 2 (7 Days)||5
3347909|NCT03522506|4077813|FG001|STARTED|Washout Period 2 (7 Days)||5
3347910|NCT03522506|4077814|FG002|STARTED|Washout Period 2 (7 Days)||5
3347911|NCT03522506|4077815|FG003|STARTED|Washout Period 2 (7 Days)||4
3347912|NCT03522506|4077812|FG000|COMPLETED|Washout Period 2 (7 Days)||5
3347913|NCT03522506|4077813|FG001|COMPLETED|Washout Period 2 (7 Days)||5
3347914|NCT03522506|4077814|FG002|COMPLETED|Washout Period 2 (7 Days)||5
3347915|NCT03522506|4077815|FG003|COMPLETED|Washout Period 2 (7 Days)||3
3347916|NCT03522506|4077812|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||0
3347917|NCT03522506|4077813|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0
3347918|NCT03522506|4077814|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0
3347919|NCT03522506|4077815|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||1
3347920|NCT03522506|4077812|FG000|STARTED|Treatment Period 3 (2 Days)||5
3347921|NCT03522506|4077813|FG001|STARTED|Treatment Period 3 (2 Days)||5
3347922|NCT03522506|4077814|FG002|STARTED|Treatment Period 3 (2 Days)||5
3347923|NCT03522506|4077815|FG003|STARTED|Treatment Period 3 (2 Days)||3
3347924|NCT03522506|4077812|FG000|COMPLETED|Treatment Period 3 (2 Days)||5
3347925|NCT03522506|4077813|FG001|COMPLETED|Treatment Period 3 (2 Days)||5
3347926|NCT03522506|4077814|FG002|COMPLETED|Treatment Period 3 (2 Days)||5
3347927|NCT03522506|4077815|FG003|COMPLETED|Treatment Period 3 (2 Days)||3
3347928|NCT03522506|4077812|FG000|NOT COMPLETED|Treatment Period 3 (2 Days)||0
3347929|NCT03522506|4077813|FG001|NOT COMPLETED|Treatment Period 3 (2 Days)||0
3347930|NCT03522506|4077814|FG002|NOT COMPLETED|Treatment Period 3 (2 Days)||0
3347931|NCT03522506|4077815|FG003|NOT COMPLETED|Treatment Period 3 (2 Days)||0
3347932|NCT03522506|4077812|FG000|STARTED|Washout Period 3 (7 Days)||5
3347933|NCT03522506|4077813|FG001|STARTED|Washout Period 3 (7 Days)||5
3347934|NCT03522506|4077814|FG002|STARTED|Washout Period 3 (7 Days)||5
3347935|NCT03522506|4077815|FG003|STARTED|Washout Period 3 (7 Days)||3
3347936|NCT03522506|4077812|FG000|COMPLETED|Washout Period 3 (7 Days)||5
3347937|NCT03522506|4077813|FG001|COMPLETED|Washout Period 3 (7 Days)||5
3347938|NCT03522506|4077814|FG002|COMPLETED|Washout Period 3 (7 Days)||5
3347939|NCT03522506|4077815|FG003|COMPLETED|Washout Period 3 (7 Days)||3
3347940|NCT03522506|4077812|FG000|NOT COMPLETED|Washout Period 3 (7 Days)||0
3347941|NCT03522506|4077813|FG001|NOT COMPLETED|Washout Period 3 (7 Days)||0
3347942|NCT03522506|4077814|FG002|NOT COMPLETED|Washout Period 3 (7 Days)||0
3347943|NCT03522506|4077815|FG003|NOT COMPLETED|Washout Period 3 (7 Days)||0
3347944|NCT03522506|4077812|FG000|STARTED|Treatment Period 4 (2 Days)||5
3347945|NCT03522506|4077813|FG001|STARTED|Treatment Period 4 (2 Days)||5
3347946|NCT03522506|4077814|FG002|STARTED|Treatment Period 4 (2 Days)||5
3347947|NCT03522506|4077815|FG003|STARTED|Treatment Period 4 (2 Days)||3
3347948|NCT03522506|4077812|FG000|COMPLETED|Treatment Period 4 (2 Days)||5
3347949|NCT03522506|4077813|FG001|COMPLETED|Treatment Period 4 (2 Days)||5
3347950|NCT03522506|4077814|FG002|COMPLETED|Treatment Period 4 (2 Days)||5
3347951|NCT03522506|4077815|FG003|COMPLETED|Treatment Period 4 (2 Days)||3
3347952|NCT03522506|4077812|FG000|NOT COMPLETED|Treatment Period 4 (2 Days)||0
3347953|NCT03522506|4077813|FG001|NOT COMPLETED|Treatment Period 4 (2 Days)||0
3347954|NCT03522506|4077814|FG002|NOT COMPLETED|Treatment Period 4 (2 Days)||0
3347955|NCT03522506|4077815|FG003|NOT COMPLETED|Treatment Period 4 (2 Days)||0
3347956|NCT03522675|4077829|FG000|STARTED|Overall Study||22
3347957|NCT03522675|4077829|FG000|COMPLETED|Overall Study||20
3347958|NCT03522675|4077829|FG000|NOT COMPLETED|Overall Study||2
3347959|NCT03522948|4077837|FG000|STARTED|Overall Study||8
3347960|NCT03522948|4077837|FG000|COMPLETED|Overall Study||7
3347961|NCT03522948|4077837|FG000|NOT COMPLETED|Overall Study||1
3347962|NCT03523715|4077843|FG000|STARTED|Overall Study||38
3347963|NCT03523715|4077844|FG001|STARTED|Overall Study||39
3347964|NCT03523715|4077843|FG000|COMPLETED|Overall Study||26
3347965|NCT03523715|4077844|FG001|COMPLETED|Overall Study||23
3347966|NCT03523715|4077843|FG000|NOT COMPLETED|Overall Study||12
3347967|NCT03523715|4077844|FG001|NOT COMPLETED|Overall Study||16
3347968|NCT03523871|4077850|FG000|STARTED|Overall Study||20
3347969|NCT03523871|4077850|FG000|COMPLETED|Overall Study||19
3347970|NCT03523871|4077850|FG000|NOT COMPLETED|Overall Study||1
3347971|NCT03523988|4077857|FG000|STARTED|Overall Study||24
3347972|NCT03523988|4077858|FG001|STARTED|Overall Study||24
3347973|NCT03523988|4077859|FG002|STARTED|Overall Study||25
3347974|NCT03523988|4077857|FG000|COMPLETED|Overall Study||7
3347975|NCT03523988|4077858|FG001|COMPLETED|Overall Study||8
3347976|NCT03523988|4077859|FG002|COMPLETED|Overall Study||7
3347977|NCT03523988|4077857|FG000|NOT COMPLETED|Overall Study||17
3347978|NCT03523988|4077858|FG001|NOT COMPLETED|Overall Study||16
3347979|NCT03523988|4077859|FG002|NOT COMPLETED|Overall Study||18
3347980|NCT03524157|4077870|FG000|STARTED|Overall Study||10
3347981|NCT03524157|4077871|FG001|STARTED|Overall Study||10
3347982|NCT03524157|4077872|FG002|STARTED|Overall Study||10
3347983|NCT03524157|4077870|FG000|COMPLETED|Overall Study||10
3347984|NCT03524157|4077871|FG001|COMPLETED|Overall Study||10
3347985|NCT03524157|4077872|FG002|COMPLETED|Overall Study||9
3347986|NCT03524157|4077870|FG000|NOT COMPLETED|Overall Study||0
3347987|NCT03524157|4077871|FG001|NOT COMPLETED|Overall Study||0
3347988|NCT03524157|4077872|FG002|NOT COMPLETED|Overall Study||1
3347989|NCT03524339|4077882|FG000|STARTED|Overall Study||66
3347990|NCT03524339|4077883|FG001|STARTED|Overall Study||66
3347991|NCT03524339|4077882|FG000|COMPLETED|Overall Study||57
3347992|NCT03524339|4077883|FG001|COMPLETED|Overall Study||62
3347993|NCT03524339|4077882|FG000|NOT COMPLETED|Overall Study||9
3347994|NCT03524339|4077883|FG001|NOT COMPLETED|Overall Study||4
3347995|NCT03525119|4077892|FG000|STARTED|Overall Study||300
3347996|NCT03525119|4077893|FG001|STARTED|Overall Study||300
3347997|NCT03525119|4077894|FG002|STARTED|Overall Study||300
3347998|NCT03525119|4077892|FG000|Safety Population|Overall Study||299
3347999|NCT03525119|4077893|FG001|Safety Population|Overall Study||300
3348000|NCT03525119|4077894|FG002|Safety Population|Overall Study||298
3348001|NCT03525119|4077892|FG000|COMPLETED|Overall Study||260
3348002|NCT03525119|4077893|FG001|COMPLETED|Overall Study||261
3348003|NCT03525119|4077894|FG002|COMPLETED|Overall Study||257
3348004|NCT03525119|4077892|FG000|NOT COMPLETED|Overall Study||40
3348005|NCT03525119|4077893|FG001|NOT COMPLETED|Overall Study||39
3348006|NCT03525119|4077894|FG002|NOT COMPLETED|Overall Study||43
3348007|NCT03525210|4077904|FG000|STARTED|Overall Study||100
3348008|NCT03525210|4077905|FG001|STARTED|Overall Study||171
3348009|NCT03525210|4077904|FG000|COMPLETED|Overall Study||96
3348010|NCT03525210|4077905|FG001|COMPLETED|Overall Study||169
3348011|NCT03525210|4077904|FG000|NOT COMPLETED|Overall Study||4
3348012|NCT03525210|4077905|FG001|NOT COMPLETED|Overall Study||2
3348013|NCT03525444|4077915|FG000|STARTED|Overall Study||203
3348014|NCT03525444|4077916|FG001|STARTED|Overall Study||200
3348015|NCT03525444|4077915|FG000|Safety Set|Overall Study||201
3348016|NCT03525444|4077916|FG001|Safety Set|Overall Study||202
3348017|NCT03525444|4077915|FG000|COMPLETED|Overall Study||203
3348018|NCT03525444|4077916|FG001|COMPLETED|Overall Study||197
3348019|NCT03525444|4077915|FG000|NOT COMPLETED|Overall Study||0
3348020|NCT03525444|4077916|FG001|NOT COMPLETED|Overall Study||3
3348021|NCT03525548|4077925|FG000|STARTED|Overall Study||52
3348022|NCT03525548|4077926|FG001|STARTED|Overall Study||55
3348023|NCT03525548|4077925|FG000|COMPLETED|Overall Study||52
3348024|NCT03525548|4077926|FG001|COMPLETED|Overall Study||55
3348025|NCT03525548|4077925|FG000|NOT COMPLETED|Overall Study||0
3348026|NCT03525548|4077926|FG001|NOT COMPLETED|Overall Study||0
3348027|NCT03525678|4077935|FG000|STARTED|Overall Study||97
3348028|NCT03525678|4077936|FG001|STARTED|Overall Study||99
3348029|NCT03525678|4077937|FG002|STARTED|Overall Study||25
3348030|NCT03525678|4077935|FG000|Received Study Treatment|Overall Study||95
3348031|NCT03525678|4077936|FG001|Received Study Treatment|Overall Study||99
3348032|NCT03525678|4077937|FG002|Received Study Treatment|Overall Study||24
3348033|NCT03525678|4077935|FG000|COMPLETED|Overall Study||0
3348034|NCT03525678|4077936|FG001|COMPLETED|Overall Study||0
3348035|NCT03525678|4077937|FG002|COMPLETED|Overall Study||0
3348036|NCT03525678|4077935|FG000|NOT COMPLETED|Overall Study||97
3348037|NCT03525678|4077936|FG001|NOT COMPLETED|Overall Study||99
3348038|NCT03525678|4077937|FG002|NOT COMPLETED|Overall Study||25
3348039|NCT03525834|4077945|FG000|STARTED|Overall Study||40
3348040|NCT03525834|4077945|FG000|COMPLETED|Overall Study||39
3348041|NCT03525834|4077945|FG000|NOT COMPLETED|Overall Study||1
3348042|NCT03526055|4077949|FG000|STARTED|Initial Program||5
3348043|NCT03526055|4077950|FG001|STARTED|Initial Program||5
3348044|NCT03526055|4077949|FG000|COMPLETED|Initial Program||5
3348045|NCT03526055|4077950|FG001|COMPLETED|Initial Program||5
3348046|NCT03526055|4077949|FG000|NOT COMPLETED|Initial Program||0
3348047|NCT03526055|4077950|FG001|NOT COMPLETED|Initial Program||0
3348048|NCT03526055|4077949|FG000|STARTED|Second Program||5
3348049|NCT03526055|4077950|FG001|STARTED|Second Program||5
3348050|NCT03526055|4077949|FG000|COMPLETED|Second Program||5
3348051|NCT03526055|4077950|FG001|COMPLETED|Second Program||5
3348052|NCT03526055|4077949|FG000|NOT COMPLETED|Second Program||0
3348053|NCT03526055|4077950|FG001|NOT COMPLETED|Second Program||0
3348054|NCT03526458|4077959|FG000|STARTED|Overall Study||20
3348055|NCT03526458|4077960|FG001|STARTED|Overall Study||20
3348056|NCT03526458|4077959|FG000|COMPLETED|Overall Study||12
3348057|NCT03526458|4077960|FG001|COMPLETED|Overall Study||15
3348058|NCT03526458|4077959|FG000|NOT COMPLETED|Overall Study||8
3348059|NCT03526458|4077960|FG001|NOT COMPLETED|Overall Study||5
3348060|NCT03526861|4077969|FG000|STARTED|Initial Treatment Period||101
3348061|NCT03526861|4077970|FG001|STARTED|Initial Treatment Period||100
3348062|NCT03526861|4077971|FG002|STARTED|Initial Treatment Period||100
3348063|NCT03526861|4077972|FG003|STARTED|Initial Treatment Period||0
3348064|NCT03526861|4077973|FG004|STARTED|Initial Treatment Period||0
3177939|NCT01973972|3905765|FG001|STARTED|Overall Study||136
3177940|NCT01973972|3905764|FG000|COMPLETED|Overall Study||109
3177941|NCT01973972|3905765|FG001|COMPLETED|Overall Study||117
3177942|NCT01973972|3905764|FG000|NOT COMPLETED|Overall Study||18
3348065|NCT03526861|4077974|FG005|STARTED|Initial Treatment Period||0
3348066|NCT03526861|4077975|FG006|STARTED|Initial Treatment Period||0
3348067|NCT03526861|4077976|FG007|STARTED|Initial Treatment Period||0
3348068|NCT03526861|4077977|FG008|STARTED|Initial Treatment Period||0
3348069|NCT03526861|4077969|FG000|COMPLETED|Initial Treatment Period||94
3348070|NCT03526861|4077970|FG001|COMPLETED|Initial Treatment Period||93
3348071|NCT03526861|4077971|FG002|COMPLETED|Initial Treatment Period||86
3348072|NCT03526861|4077972|FG003|COMPLETED|Initial Treatment Period||0
3348073|NCT03526861|4077973|FG004|COMPLETED|Initial Treatment Period||0
3348074|NCT03526861|4077974|FG005|COMPLETED|Initial Treatment Period||0
3348075|NCT03526861|4077975|FG006|COMPLETED|Initial Treatment Period||0
3348076|NCT03526861|4077976|FG007|COMPLETED|Initial Treatment Period||0
3348077|NCT03526861|4077977|FG008|COMPLETED|Initial Treatment Period||0
3348078|NCT03526861|4077969|FG000|NOT COMPLETED|Initial Treatment Period||7
3348079|NCT03526861|4077970|FG001|NOT COMPLETED|Initial Treatment Period||7
3348080|NCT03526861|4077971|FG002|NOT COMPLETED|Initial Treatment Period||14
3348081|NCT03526861|4077972|FG003|NOT COMPLETED|Initial Treatment Period||0
3348082|NCT03526861|4077973|FG004|NOT COMPLETED|Initial Treatment Period||0
3348083|NCT03526861|4077974|FG005|NOT COMPLETED|Initial Treatment Period||0
3348084|NCT03526861|4077975|FG006|NOT COMPLETED|Initial Treatment Period||0
3348085|NCT03526861|4077976|FG007|NOT COMPLETED|Initial Treatment Period||0
3348086|NCT03526861|4077977|FG008|NOT COMPLETED|Initial Treatment Period||0
3348087|NCT03526861|4077969|FG000|STARTED|Maintenance Treatment Period||0
3348088|NCT03526861|4077970|FG001|STARTED|Maintenance Treatment Period||0
3348089|NCT03526861|4077971|FG002|STARTED|Maintenance Treatment Period||0
3348090|NCT03526861|4077972|FG003|STARTED|Maintenance Treatment Period||13
3348091|NCT03526861|4077973|FG004|STARTED|Maintenance Treatment Period||14
3348092|NCT03526861|4077974|FG005|STARTED|Maintenance Treatment Period||12
3348093|NCT03526861|4077975|FG006|STARTED|Maintenance Treatment Period||14
3348094|NCT03526861|4077976|FG007|STARTED|Maintenance Treatment Period||6
3348095|NCT03526861|4077977|FG008|STARTED|Maintenance Treatment Period||0
3348096|NCT03526861|4077969|FG000|COMPLETED|Maintenance Treatment Period||0
3348097|NCT03526861|4077970|FG001|COMPLETED|Maintenance Treatment Period||0
3348098|NCT03526861|4077971|FG002|COMPLETED|Maintenance Treatment Period||0
3348099|NCT03526861|4077972|FG003|COMPLETED|Maintenance Treatment Period||5
3348100|NCT03526861|4077973|FG004|COMPLETED|Maintenance Treatment Period||8
3348101|NCT03526861|4077974|FG005|COMPLETED|Maintenance Treatment Period||8
3348102|NCT03526861|4077975|FG006|COMPLETED|Maintenance Treatment Period||8
3348103|NCT03526861|4077976|FG007|COMPLETED|Maintenance Treatment Period||4
3348104|NCT03526861|4077977|FG008|COMPLETED|Maintenance Treatment Period||0
3348105|NCT03526861|4077969|FG000|NOT COMPLETED|Maintenance Treatment Period||0
3348106|NCT03526861|4077970|FG001|NOT COMPLETED|Maintenance Treatment Period||0
3348107|NCT03526861|4077971|FG002|NOT COMPLETED|Maintenance Treatment Period||0
3348108|NCT03526861|4077972|FG003|NOT COMPLETED|Maintenance Treatment Period||8
3348109|NCT03526861|4077973|FG004|NOT COMPLETED|Maintenance Treatment Period||6
3348110|NCT03526861|4077974|FG005|NOT COMPLETED|Maintenance Treatment Period||4
3348111|NCT03526861|4077975|FG006|NOT COMPLETED|Maintenance Treatment Period||6
3348112|NCT03526861|4077976|FG007|NOT COMPLETED|Maintenance Treatment Period||2
3348113|NCT03526861|4077977|FG008|NOT COMPLETED|Maintenance Treatment Period||0
3348114|NCT03526861|4077969|FG000|STARTED|Open-label Treatment Period||0
3348115|NCT03526861|4077970|FG001|STARTED|Open-label Treatment Period||0
3348116|NCT03526861|4077971|FG002|STARTED|Open-label Treatment Period||0
3348117|NCT03526861|4077972|FG003|STARTED|Open-label Treatment Period||0
3348118|NCT03526861|4077973|FG004|STARTED|Open-label Treatment Period||0
3348119|NCT03526861|4077974|FG005|STARTED|Open-label Treatment Period||0
3348120|NCT03526861|4077975|FG006|STARTED|Open-label Treatment Period||0
3348121|NCT03526861|4077976|FG007|STARTED|Open-label Treatment Period||0
3348122|NCT03526861|4077977|FG008|STARTED|Open-label Treatment Period|226 subjects transferred to open-label treatment at Week 16. 24 subjects transferred to open-label treatment between Week 16 and Week 52.|242
3348123|NCT03526861|4077969|FG000|COMPLETED|Open-label Treatment Period||0
3348124|NCT03526861|4077970|FG001|COMPLETED|Open-label Treatment Period||0
3348125|NCT03526861|4077971|FG002|COMPLETED|Open-label Treatment Period||0
3348126|NCT03526861|4077972|FG003|COMPLETED|Open-label Treatment Period||0
3348127|NCT03526861|4077973|FG004|COMPLETED|Open-label Treatment Period||0
3348128|NCT03526861|4077974|FG005|COMPLETED|Open-label Treatment Period||0
3348129|NCT03526861|4077975|FG006|COMPLETED|Open-label Treatment Period||0
3348130|NCT03526861|4077976|FG007|COMPLETED|Open-label Treatment Period||0
3348131|NCT03526861|4077977|FG008|COMPLETED|Open-label Treatment Period||214
3348132|NCT03526861|4077969|FG000|NOT COMPLETED|Open-label Treatment Period||0
3348133|NCT03526861|4077970|FG001|NOT COMPLETED|Open-label Treatment Period||0
3348134|NCT03526861|4077971|FG002|NOT COMPLETED|Open-label Treatment Period||0
3348135|NCT03526861|4077972|FG003|NOT COMPLETED|Open-label Treatment Period||0
3348136|NCT03526861|4077973|FG004|NOT COMPLETED|Open-label Treatment Period||0
3348137|NCT03526861|4077974|FG005|NOT COMPLETED|Open-label Treatment Period||0
3348138|NCT03526861|4077975|FG006|NOT COMPLETED|Open-label Treatment Period||0
3177943|NCT01973972|3905765|FG001|NOT COMPLETED|Overall Study||19
3348139|NCT03526861|4077976|FG007|NOT COMPLETED|Open-label Treatment Period||0
3348140|NCT03526861|4077977|FG008|NOT COMPLETED|Open-label Treatment Period||28
3348141|NCT03527160|4077999|FG000|STARTED|Overall Study||134
3348142|NCT03527160|4077999|FG000|COMPLETED|Overall Study||113
3348143|NCT03527160|4077999|FG000|NOT COMPLETED|Overall Study||21
3348144|NCT03527173|4078008|FG000|STARTED|Overall Study||36
3348145|NCT03527173|4078009|FG001|STARTED|Overall Study||35
3348146|NCT03527173|4078008|FG000|COMPLETED|Overall Study||29
3348147|NCT03527173|4078009|FG001|COMPLETED|Overall Study||28
3348148|NCT03527173|4078008|FG000|NOT COMPLETED|Overall Study||7
3348149|NCT03527173|4078009|FG001|NOT COMPLETED|Overall Study||7
3348150|NCT03527550|4078017|FG000|STARTED|Overall Study||24
3348151|NCT03527550|4078018|FG001|STARTED|Overall Study||22
3348152|NCT03527550|4078017|FG000|COMPLETED|Overall Study||15
3177944|NCT01973998|3905773|FG000|STARTED|Overall Study||33
3177945|NCT01973998|3905774|FG001|STARTED|Overall Study||35
3177946|NCT01973998|3905773|FG000|COMPLETED|Overall Study||31
3348153|NCT03527550|4078018|FG001|COMPLETED|Overall Study||19
3348154|NCT03527550|4078017|FG000|NOT COMPLETED|Overall Study||9
3348155|NCT03527550|4078018|FG001|NOT COMPLETED|Overall Study||3
3348156|NCT03527745|4078052|FG000|STARTED|Overall Study||27
3348157|NCT03527745|4078053|FG001|STARTED|Overall Study||27
3348158|NCT03527745|4078054|FG002|STARTED|Overall Study||30
3348159|NCT03527745|4078055|FG003|STARTED|Overall Study||27
3348160|NCT03527745|4078056|FG004|STARTED|Overall Study||46
3348161|NCT03527745|4078057|FG005|STARTED|Overall Study||45
3348162|NCT03527745|4078058|FG006|STARTED|Overall Study||46
3348163|NCT03527745|4078059|FG007|STARTED|Overall Study||43
3348164|NCT03527745|4078060|FG008|STARTED|Overall Study||10
3348165|NCT03527745|4078061|FG009|STARTED|Overall Study||11
3348166|NCT03527745|4078062|FG010|STARTED|Overall Study||9
3348167|NCT03527745|4078063|FG011|STARTED|Overall Study||12
3348168|NCT03527745|4078064|FG012|STARTED|Overall Study|During screening, the principal investigator decided to remove the this arm due to recruitment.|0
3348169|NCT03527745|4078065|FG013|STARTED|Overall Study||13
3348170|NCT03527745|4078066|FG014|STARTED|Overall Study||13
3348171|NCT03527745|4078067|FG015|STARTED|Overall Study||12
3348172|NCT03527745|4078068|FG016|STARTED|Overall Study||24
3348173|NCT03527745|4078069|FG017|STARTED|Overall Study||27
3348174|NCT03527745|4078070|FG018|STARTED|Overall Study||27
3348175|NCT03527745|4078071|FG019|STARTED|Overall Study||29
3348176|NCT03527745|4078072|FG020|STARTED|Overall Study||26
3348177|NCT03527745|4078073|FG021|STARTED|Overall Study||40
3348178|NCT03527745|4078074|FG022|STARTED|Overall Study||41
3348179|NCT03527745|4078075|FG023|STARTED|Overall Study||38
3348180|NCT03527745|4078076|FG024|STARTED|Overall Study||40
3348181|NCT03527745|4078077|FG025|STARTED|Overall Study||37
3348182|NCT03527745|4078052|FG000|COMPLETED|Overall Study||24
3348183|NCT03527745|4078053|FG001|COMPLETED|Overall Study||21
3348184|NCT03527745|4078054|FG002|COMPLETED|Overall Study||23
3348185|NCT03527745|4078055|FG003|COMPLETED|Overall Study||18
3348186|NCT03527745|4078056|FG004|COMPLETED|Overall Study||46
3348187|NCT03527745|4078057|FG005|COMPLETED|Overall Study||43
3348188|NCT03527745|4078058|FG006|COMPLETED|Overall Study||43
3348189|NCT03527745|4078059|FG007|COMPLETED|Overall Study||41
3348190|NCT03527745|4078060|FG008|COMPLETED|Overall Study||7
3348191|NCT03527745|4078061|FG009|COMPLETED|Overall Study||9
3348192|NCT03527745|4078062|FG010|COMPLETED|Overall Study||8
3348193|NCT03527745|4078063|FG011|COMPLETED|Overall Study||11
3348194|NCT03527745|4078064|FG012|COMPLETED|Overall Study||0
3348195|NCT03527745|4078065|FG013|COMPLETED|Overall Study||13
3348196|NCT03527745|4078066|FG014|COMPLETED|Overall Study||13
3348197|NCT03527745|4078067|FG015|COMPLETED|Overall Study||12
3348198|NCT03527745|4078068|FG016|COMPLETED|Overall Study||23
3348199|NCT03527745|4078069|FG017|COMPLETED|Overall Study||27
3348200|NCT03527745|4078070|FG018|COMPLETED|Overall Study||27
3348201|NCT03527745|4078071|FG019|COMPLETED|Overall Study||28
3348202|NCT03527745|4078072|FG020|COMPLETED|Overall Study||25
3348203|NCT03527745|4078073|FG021|COMPLETED|Overall Study||35
3348204|NCT03527745|4078074|FG022|COMPLETED|Overall Study||35
3348205|NCT03527745|4078075|FG023|COMPLETED|Overall Study||30
3348206|NCT03527745|4078076|FG024|COMPLETED|Overall Study||39
3348207|NCT03527745|4078077|FG025|COMPLETED|Overall Study||34
3348208|NCT03527745|4078052|FG000|NOT COMPLETED|Overall Study||3
3348209|NCT03527745|4078053|FG001|NOT COMPLETED|Overall Study||6
3348210|NCT03527745|4078054|FG002|NOT COMPLETED|Overall Study||7
3348211|NCT03527745|4078055|FG003|NOT COMPLETED|Overall Study||9
3348212|NCT03527745|4078056|FG004|NOT COMPLETED|Overall Study||0
3348213|NCT03527745|4078057|FG005|NOT COMPLETED|Overall Study||2
3348214|NCT03527745|4078058|FG006|NOT COMPLETED|Overall Study||3
3348215|NCT03527745|4078059|FG007|NOT COMPLETED|Overall Study||2
3348216|NCT03527745|4078060|FG008|NOT COMPLETED|Overall Study||3
3348217|NCT03527745|4078061|FG009|NOT COMPLETED|Overall Study||2
3348218|NCT03527745|4078062|FG010|NOT COMPLETED|Overall Study||1
3348219|NCT03527745|4078063|FG011|NOT COMPLETED|Overall Study||1
3348220|NCT03527745|4078064|FG012|NOT COMPLETED|Overall Study||0
3348221|NCT03527745|4078065|FG013|NOT COMPLETED|Overall Study||0
3348222|NCT03527745|4078066|FG014|NOT COMPLETED|Overall Study||0
3348223|NCT03527745|4078067|FG015|NOT COMPLETED|Overall Study||0
3348224|NCT03527745|4078068|FG016|NOT COMPLETED|Overall Study||1
3177947|NCT01973998|3905774|FG001|COMPLETED|Overall Study||33
3177948|NCT01973998|3905773|FG000|NOT COMPLETED|Overall Study||2
3177949|NCT01973998|3905774|FG001|NOT COMPLETED|Overall Study||2
3348225|NCT03527745|4078069|FG017|NOT COMPLETED|Overall Study||0
3348226|NCT03527745|4078070|FG018|NOT COMPLETED|Overall Study||0
3348227|NCT03527745|4078071|FG019|NOT COMPLETED|Overall Study||1
3348228|NCT03527745|4078072|FG020|NOT COMPLETED|Overall Study||1
3348229|NCT03527745|4078073|FG021|NOT COMPLETED|Overall Study||5
3348230|NCT03527745|4078074|FG022|NOT COMPLETED|Overall Study||6
3348231|NCT03527745|4078075|FG023|NOT COMPLETED|Overall Study||8
3348232|NCT03527745|4078076|FG024|NOT COMPLETED|Overall Study||1
3348233|NCT03527745|4078077|FG025|NOT COMPLETED|Overall Study||3
3348234|NCT03527966|4078135|FG000|STARTED|Overall Study||3
3348235|NCT03527966|4078136|FG001|STARTED|Overall Study||0
3348236|NCT03527966|4078135|FG000|COMPLETED|Overall Study||0
3348237|NCT03527966|4078136|FG001|COMPLETED|Overall Study||0
3348238|NCT03527966|4078135|FG000|NOT COMPLETED|Overall Study||3
3348239|NCT03527966|4078136|FG001|NOT COMPLETED|Overall Study||0
3348240|NCT03528174|4078142|FG000|STARTED|Overall Study||10
3348241|NCT03528174|4078142|FG000|COMPLETED|Overall Study||8
3348242|NCT03528174|4078142|FG000|NOT COMPLETED|Overall Study||2
3348243|NCT03528369|4078149|FG000|STARTED|Overall Study||40
3348244|NCT03528369|4078150|FG001|STARTED|Overall Study||42
3348245|NCT03528369|4078151|FG002|STARTED|Overall Study||40
3348246|NCT03528369|4078149|FG000|COMPLETED|Overall Study||37
3348247|NCT03528369|4078150|FG001|COMPLETED|Overall Study||41
3348248|NCT03528369|4078151|FG002|COMPLETED|Overall Study||40
3348249|NCT03528369|4078149|FG000|NOT COMPLETED|Overall Study||3
3348250|NCT03528369|4078150|FG001|NOT COMPLETED|Overall Study||1
3348251|NCT03528369|4078151|FG002|NOT COMPLETED|Overall Study||0
3348252|NCT03528512|4078161|FG000|STARTED|Overall Study||3
3348253|NCT03528512|4078162|FG001|STARTED|Overall Study||2
3348254|NCT03528512|4078161|FG000|COMPLETED|Overall Study||3
3348255|NCT03528512|4078162|FG001|COMPLETED|Overall Study||2
3348256|NCT03528512|4078161|FG000|NOT COMPLETED|Overall Study||0
3348257|NCT03528512|4078162|FG001|NOT COMPLETED|Overall Study||0
3348258|NCT03528551|4078171|FG000|STARTED|Overall Study||25
3348259|NCT03528551|4078172|FG001|STARTED|Overall Study||133
3348260|NCT03528551|4078173|FG002|STARTED|Overall Study||2
3348261|NCT03528551|4078171|FG000|COMPLETED|Overall Study||23
3348262|NCT03528551|4078172|FG001|COMPLETED|Overall Study||114
3348263|NCT03528551|4078173|FG002|COMPLETED|Overall Study||2
3348264|NCT03528551|4078171|FG000|NOT COMPLETED|Overall Study||2
3348265|NCT03528551|4078172|FG001|NOT COMPLETED|Overall Study||19
3348266|NCT03528551|4078173|FG002|NOT COMPLETED|Overall Study||0
3348267|NCT03528577|4078182|FG000|STARTED|Sequence 1||128
3348268|NCT03528577|4078182|FG000|COMPLETED|Sequence 1|Per report, 119 completed the trial, and all 119 received Treatment A, B, C and D.|126
3348269|NCT03528577|4078182|FG000|NOT COMPLETED|Sequence 1||2
3348270|NCT03528577|4078182|FG000|STARTED|Sequence 2||128
3348271|NCT03528577|4078182|FG000|COMPLETED|Sequence 2||125
3348272|NCT03528577|4078182|FG000|NOT COMPLETED|Sequence 2||3
3348273|NCT03528577|4078182|FG000|STARTED|Sequence 3||128
3348274|NCT03528577|4078182|FG000|COMPLETED|Sequence 3||127
3348275|NCT03528577|4078182|FG000|NOT COMPLETED|Sequence 3||1
3348276|NCT03528577|4078182|FG000|STARTED|Sequence 4||128
3348277|NCT03528577|4078182|FG000|COMPLETED|Sequence 4||125
3348278|NCT03528577|4078182|FG000|NOT COMPLETED|Sequence 4||3
3348279|NCT03529162|4078191|FG000|STARTED|Overall Study||2
3348280|NCT03529162|4078192|FG001|STARTED|Overall Study||2
3348281|NCT03529162|4078191|FG000|COMPLETED|Overall Study||0
3348282|NCT03529162|4078192|FG001|COMPLETED|Overall Study||0
3348283|NCT03529162|4078191|FG000|NOT COMPLETED|Overall Study||2
3348284|NCT03529162|4078192|FG001|NOT COMPLETED|Overall Study||2
3348285|NCT03529409|4078203|FG000|STARTED|Randomized||30
3348286|NCT03529409|4078204|FG001|STARTED|Randomized||31
3348287|NCT03529409|4078205|FG002|STARTED|Randomized||5
3348288|NCT03529409|4078203|FG000|COMPLETED|Randomized||30
3348289|NCT03529409|4078204|FG001|COMPLETED|Randomized||31
3348290|NCT03529409|4078205|FG002|COMPLETED|Randomized||0
3348291|NCT03529409|4078203|FG000|NOT COMPLETED|Randomized||0
3348292|NCT03529409|4078204|FG001|NOT COMPLETED|Randomized||0
3348293|NCT03529409|4078205|FG002|NOT COMPLETED|Randomized||5
3348294|NCT03529409|4078203|FG000|STARTED|Post-treatment Assessment||30
3348295|NCT03529409|4078204|FG001|STARTED|Post-treatment Assessment||31
3348296|NCT03529409|4078205|FG002|STARTED|Post-treatment Assessment||0
3348297|NCT03529409|4078203|FG000|COMPLETED|Post-treatment Assessment||26
3348298|NCT03529409|4078204|FG001|COMPLETED|Post-treatment Assessment||26
3348299|NCT03529409|4078205|FG002|COMPLETED|Post-treatment Assessment||0
3348300|NCT03529409|4078203|FG000|NOT COMPLETED|Post-treatment Assessment||4
3348301|NCT03529409|4078204|FG001|NOT COMPLETED|Post-treatment Assessment||5
3348302|NCT03529409|4078205|FG002|NOT COMPLETED|Post-treatment Assessment||0
3348303|NCT03529409|4078203|FG000|STARTED|Follow-up Assessment|All participants were eligible for Follow-Up regardless of Post-Treatment attendance.|28
3348304|NCT03529409|4078204|FG001|STARTED|Follow-up Assessment|All participants (n=31) were eligible for Follow-Up regardless of Post-Treatment attendance|30
3348305|NCT03529409|4078205|FG002|STARTED|Follow-up Assessment||0
3348306|NCT03529409|4078203|FG000|COMPLETED|Follow-up Assessment||27
3348307|NCT03529409|4078204|FG001|COMPLETED|Follow-up Assessment||29
3348308|NCT03529409|4078205|FG002|COMPLETED|Follow-up Assessment||0
3348309|NCT03529409|4078203|FG000|NOT COMPLETED|Follow-up Assessment||1
3348310|NCT03529409|4078204|FG001|NOT COMPLETED|Follow-up Assessment||1
3348311|NCT03529409|4078205|FG002|NOT COMPLETED|Follow-up Assessment||0
3348312|NCT03529461|4078214|FG000|STARTED|Overall Study||28
3348313|NCT03529461|4078215|FG001|STARTED|Overall Study||28
3348314|NCT03529461|4078214|FG000|COMPLETED|Overall Study||28
3348315|NCT03529461|4078215|FG001|COMPLETED|Overall Study||28
3348316|NCT03529461|4078214|FG000|NOT COMPLETED|Overall Study||0
3348317|NCT03529461|4078215|FG001|NOT COMPLETED|Overall Study||0
3348318|NCT03529773|4078262|FG000|STARTED|Overall Study||12
3348319|NCT03529773|4078263|FG001|STARTED|Overall Study||12
3348320|NCT03529773|4078264|FG002|STARTED|Overall Study||12
3348321|NCT03529773|4078265|FG003|STARTED|Overall Study||12
3348322|NCT03529773|4078266|FG004|STARTED|Overall Study||12
3348323|NCT03529773|4078267|FG005|STARTED|Overall Study||12
3348324|NCT03529773|4078268|FG006|STARTED|Overall Study||12
3348325|NCT03529773|4078269|FG007|STARTED|Overall Study||12
3348326|NCT03529773|4078270|FG008|STARTED|Overall Study||12
3348327|NCT03529773|4078271|FG009|STARTED|Overall Study||12
3348328|NCT03529773|4078272|FG010|STARTED|Overall Study||12
3348329|NCT03529773|4078273|FG011|STARTED|Overall Study||12
3348330|NCT03529773|4078274|FG012|STARTED|Overall Study||12
3348331|NCT03529773|4078275|FG013|STARTED|Overall Study||12
3348332|NCT03529773|4078276|FG014|STARTED|Overall Study||41
3348333|NCT03529773|4078277|FG015|STARTED|Overall Study||42
3348334|NCT03529773|4078278|FG016|STARTED|Overall Study||41
3348335|NCT03529773|4078279|FG017|STARTED|Overall Study||40
3348336|NCT03529773|4078280|FG018|STARTED|Overall Study||41
3348337|NCT03529773|4078281|FG019|STARTED|Overall Study||41
3348338|NCT03529773|4078282|FG020|STARTED|Overall Study||41
3348339|NCT03529773|4078283|FG021|STARTED|Overall Study||41
3348340|NCT03529773|4078284|FG022|STARTED|Overall Study||41
3348341|NCT03529773|4078285|FG023|STARTED|Overall Study||41
3348342|NCT03529773|4078286|FG024|STARTED|Overall Study||41
3348343|NCT03529773|4078287|FG025|STARTED|Overall Study||41
3348344|NCT03529773|4078288|FG026|STARTED|Overall Study||41
3348345|NCT03529773|4078289|FG027|STARTED|Overall Study||40
3348346|NCT03529773|4078290|FG028|STARTED|Overall Study||41
3348347|NCT03529773|4078291|FG029|STARTED|Overall Study||40
3348348|NCT03529773|4078292|FG030|STARTED|Overall Study||42
3348349|NCT03529773|4078293|FG031|STARTED|Overall Study||40
3348350|NCT03529773|4078294|FG032|STARTED|Overall Study||40
3348351|NCT03529773|4078295|FG033|STARTED|Overall Study||41
3348352|NCT03529773|4078296|FG034|STARTED|Overall Study||41
3348353|NCT03529773|4078297|FG035|STARTED|Overall Study||40
3348354|NCT03529773|4078298|FG036|STARTED|Overall Study||41
3348355|NCT03529773|4078299|FG037|STARTED|Overall Study||42
3348356|NCT03529773|4078300|FG038|STARTED|Overall Study||43
3348357|NCT03529773|4078301|FG039|STARTED|Overall Study||41
3348358|NCT03529773|4078262|FG000|COMPLETED|Overall Study||12
3348359|NCT03529773|4078263|FG001|COMPLETED|Overall Study||12
3348360|NCT03529773|4078264|FG002|COMPLETED|Overall Study||11
3348361|NCT03529773|4078265|FG003|COMPLETED|Overall Study||12
3348362|NCT03529773|4078266|FG004|COMPLETED|Overall Study||11
3348363|NCT03529773|4078267|FG005|COMPLETED|Overall Study||11
3348364|NCT03529773|4078268|FG006|COMPLETED|Overall Study||12
3348365|NCT03529773|4078269|FG007|COMPLETED|Overall Study||11
3348366|NCT03529773|4078270|FG008|COMPLETED|Overall Study||12
3348367|NCT03529773|4078271|FG009|COMPLETED|Overall Study||11
3348368|NCT03529773|4078272|FG010|COMPLETED|Overall Study||11
3348369|NCT03529773|4078273|FG011|COMPLETED|Overall Study||12
3348370|NCT03529773|4078274|FG012|COMPLETED|Overall Study||10
3348371|NCT03529773|4078275|FG013|COMPLETED|Overall Study||11
3348372|NCT03529773|4078276|FG014|COMPLETED|Overall Study||35
3348373|NCT03529773|4078277|FG015|COMPLETED|Overall Study||38
3348374|NCT03529773|4078278|FG016|COMPLETED|Overall Study||40
3348375|NCT03529773|4078279|FG017|COMPLETED|Overall Study||35
3348376|NCT03529773|4078280|FG018|COMPLETED|Overall Study||37
3348377|NCT03529773|4078281|FG019|COMPLETED|Overall Study||37
3348378|NCT03529773|4078282|FG020|COMPLETED|Overall Study||34
3348379|NCT03529773|4078283|FG021|COMPLETED|Overall Study||36
3348380|NCT03529773|4078284|FG022|COMPLETED|Overall Study||36
3348381|NCT03529773|4078285|FG023|COMPLETED|Overall Study||36
3348382|NCT03529773|4078286|FG024|COMPLETED|Overall Study||34
3348383|NCT03529773|4078287|FG025|COMPLETED|Overall Study||31
3348384|NCT03529773|4078288|FG026|COMPLETED|Overall Study||33
3348385|NCT03529773|4078289|FG027|COMPLETED|Overall Study||39
3348386|NCT03529773|4078290|FG028|COMPLETED|Overall Study||40
3348387|NCT03529773|4078291|FG029|COMPLETED|Overall Study||40
3348388|NCT03529773|4078292|FG030|COMPLETED|Overall Study||39
3348389|NCT03529773|4078293|FG031|COMPLETED|Overall Study||40
3348390|NCT03529773|4078294|FG032|COMPLETED|Overall Study||40
3348391|NCT03529773|4078295|FG033|COMPLETED|Overall Study||39
3348392|NCT03529773|4078296|FG034|COMPLETED|Overall Study||37
3348393|NCT03529773|4078297|FG035|COMPLETED|Overall Study||37
3348394|NCT03529773|4078298|FG036|COMPLETED|Overall Study||40
3348395|NCT03529773|4078299|FG037|COMPLETED|Overall Study||41
3348396|NCT03529773|4078300|FG038|COMPLETED|Overall Study||43
3348397|NCT03529773|4078301|FG039|COMPLETED|Overall Study||39
3348398|NCT03529773|4078262|FG000|NOT COMPLETED|Overall Study||0
3348399|NCT03529773|4078263|FG001|NOT COMPLETED|Overall Study||0
3348400|NCT03529773|4078264|FG002|NOT COMPLETED|Overall Study||1
3348401|NCT03529773|4078265|FG003|NOT COMPLETED|Overall Study||0
3348402|NCT03529773|4078266|FG004|NOT COMPLETED|Overall Study||1
3348403|NCT03529773|4078267|FG005|NOT COMPLETED|Overall Study||1
3348404|NCT03529773|4078268|FG006|NOT COMPLETED|Overall Study||0
3348405|NCT03529773|4078269|FG007|NOT COMPLETED|Overall Study||1
3348406|NCT03529773|4078270|FG008|NOT COMPLETED|Overall Study||0
3348407|NCT03529773|4078271|FG009|NOT COMPLETED|Overall Study||1
3348408|NCT03529773|4078272|FG010|NOT COMPLETED|Overall Study||1
3348409|NCT03529773|4078273|FG011|NOT COMPLETED|Overall Study||0
3348410|NCT03529773|4078274|FG012|NOT COMPLETED|Overall Study||2
3348411|NCT03529773|4078275|FG013|NOT COMPLETED|Overall Study||1
3348412|NCT03529773|4078276|FG014|NOT COMPLETED|Overall Study||6
3348413|NCT03529773|4078277|FG015|NOT COMPLETED|Overall Study||4
3348414|NCT03529773|4078278|FG016|NOT COMPLETED|Overall Study||1
3348415|NCT03529773|4078279|FG017|NOT COMPLETED|Overall Study||5
3348416|NCT03529773|4078280|FG018|NOT COMPLETED|Overall Study||4
3348417|NCT03529773|4078281|FG019|NOT COMPLETED|Overall Study||4
3348418|NCT03529773|4078282|FG020|NOT COMPLETED|Overall Study||7
3348419|NCT03529773|4078283|FG021|NOT COMPLETED|Overall Study||5
3348420|NCT03529773|4078284|FG022|NOT COMPLETED|Overall Study||5
3348421|NCT03529773|4078285|FG023|NOT COMPLETED|Overall Study||5
3348422|NCT03529773|4078286|FG024|NOT COMPLETED|Overall Study||7
3348423|NCT03529773|4078287|FG025|NOT COMPLETED|Overall Study||10
3348424|NCT03529773|4078288|FG026|NOT COMPLETED|Overall Study||8
3348425|NCT03529773|4078289|FG027|NOT COMPLETED|Overall Study||1
3348426|NCT03529773|4078290|FG028|NOT COMPLETED|Overall Study||1
3348427|NCT03529773|4078291|FG029|NOT COMPLETED|Overall Study||0
3348428|NCT03529773|4078292|FG030|NOT COMPLETED|Overall Study||3
3348429|NCT03529773|4078293|FG031|NOT COMPLETED|Overall Study||0
3348430|NCT03529773|4078294|FG032|NOT COMPLETED|Overall Study||0
3348431|NCT03529773|4078295|FG033|NOT COMPLETED|Overall Study||2
3348432|NCT03529773|4078296|FG034|NOT COMPLETED|Overall Study||4
3348433|NCT03529773|4078297|FG035|NOT COMPLETED|Overall Study||3
3348434|NCT03529773|4078298|FG036|NOT COMPLETED|Overall Study||1
3348435|NCT03529773|4078299|FG037|NOT COMPLETED|Overall Study||1
3348436|NCT03529773|4078300|FG038|NOT COMPLETED|Overall Study||0
3348437|NCT03529773|4078301|FG039|NOT COMPLETED|Overall Study||2
3348438|NCT03530098|4078388|FG000|STARTED|Overall Study||939
3348439|NCT03530098|4078389|FG001|STARTED|Overall Study||964
3348440|NCT03530098|4078388|FG000|Ground-truth Labeled|Overall Study||741
3348441|NCT03530098|4078389|FG001|Ground-truth Labeled|Overall Study||794
3348442|NCT03530098|4078388|FG000|Primary Analysis Set|Overall Study||739
3348443|NCT03530098|4078389|FG001|Primary Analysis Set|Overall Study||792
3348444|NCT03530098|4078388|FG000|COMPLETED|Overall Study||939
3348445|NCT03530098|4078389|FG001|COMPLETED|Overall Study||964
3348446|NCT03530098|4078388|FG000|NOT COMPLETED|Overall Study||0
3348447|NCT03530098|4078389|FG001|NOT COMPLETED|Overall Study||0
3348448|NCT03530345|4078398|FG000|STARTED|Treatment Period A/Follow-up Period 1||28
3348449|NCT03530345|4078399|FG001|STARTED|Treatment Period A/Follow-up Period 1||29
3348450|NCT03530345|4078398|FG000|Treatment Period A Completers|Treatment Period A/Follow-up Period 1||26
3348451|NCT03530345|4078399|FG001|Treatment Period A Completers|Treatment Period A/Follow-up Period 1||27
3348452|NCT03530345|4078398|FG000|COMPLETED|Treatment Period A/Follow-up Period 1||7
3348453|NCT03530345|4078399|FG001|COMPLETED|Treatment Period A/Follow-up Period 1||7
3348454|NCT03530345|4078398|FG000|NOT COMPLETED|Treatment Period A/Follow-up Period 1||21
3348455|NCT03530345|4078399|FG001|NOT COMPLETED|Treatment Period A/Follow-up Period 1||22
3348456|NCT03530345|4078398|FG000|STARTED|Treatment Period B/Follow-up Period 2|2 participants completed Treatment Period A/Follow-up Period 1 but were not allocated in Period B.|5
3348457|NCT03530345|4078399|FG001|STARTED|Treatment Period B/Follow-up Period 2||7
3348458|NCT03530345|4078398|FG000|Treatment Period B Completers|Treatment Period B/Follow-up Period 2||4
3348459|NCT03530345|4078399|FG001|Treatment Period B Completers|Treatment Period B/Follow-up Period 2||6
3348460|NCT03530345|4078398|FG000|COMPLETED|Treatment Period B/Follow-up Period 2||0
3348461|NCT03530345|4078399|FG001|COMPLETED|Treatment Period B/Follow-up Period 2||0
3348462|NCT03530345|4078398|FG000|NOT COMPLETED|Treatment Period B/Follow-up Period 2||5
3348463|NCT03530345|4078399|FG001|NOT COMPLETED|Treatment Period B/Follow-up Period 2||7
3348464|NCT03530631|4078411|FG000|STARTED|Adderall/Truth||4
3348465|NCT03530631|4078411|FG000|COMPLETED|Adderall/Truth||4
3348466|NCT03530631|4078411|FG000|NOT COMPLETED|Adderall/Truth||0
3348467|NCT03530631|4078411|FG000|STARTED|Placebo/Truth||4
3348468|NCT03530631|4078411|FG000|COMPLETED|Placebo/Truth||4
3348469|NCT03530631|4078411|FG000|NOT COMPLETED|Placebo/Truth||0
3348470|NCT03530631|4078411|FG000|STARTED|Adderall/Deception||4
3348471|NCT03530631|4078411|FG000|COMPLETED|Adderall/Deception||4
3348472|NCT03530631|4078411|FG000|NOT COMPLETED|Adderall/Deception||0
3348473|NCT03530631|4078411|FG000|STARTED|Placebo/Deception||4
3348474|NCT03530631|4078411|FG000|COMPLETED|Placebo/Deception||4
3348475|NCT03530631|4078411|FG000|NOT COMPLETED|Placebo/Deception||0
3348476|NCT03530917|4078429|FG000|STARTED|Overall Study||8
3348477|NCT03530917|4078430|FG001|STARTED|Overall Study||8
3348478|NCT03530917|4078431|FG002|STARTED|Overall Study||8
3348479|NCT03530917|4078432|FG003|STARTED|Overall Study||8
3348480|NCT03530917|4078433|FG004|STARTED|Overall Study||8
3348481|NCT03530917|4078434|FG005|STARTED|Overall Study||6
3348482|NCT03530917|4078435|FG006|STARTED|Overall Study||8
3348483|NCT03530917|4078436|FG007|STARTED|Overall Study||16
3348484|NCT03530917|4078429|FG000|COMPLETED|Overall Study||8
3348485|NCT03530917|4078430|FG001|COMPLETED|Overall Study||8
3348486|NCT03530917|4078431|FG002|COMPLETED|Overall Study||8
3348487|NCT03530917|4078432|FG003|COMPLETED|Overall Study||8
3348488|NCT03530917|4078433|FG004|COMPLETED|Overall Study||8
3348489|NCT03530917|4078434|FG005|COMPLETED|Overall Study||6
3348490|NCT03530917|4078435|FG006|COMPLETED|Overall Study||8
3348491|NCT03530917|4078436|FG007|COMPLETED|Overall Study||16
3348492|NCT03530917|4078429|FG000|NOT COMPLETED|Overall Study||0
3348493|NCT03530917|4078430|FG001|NOT COMPLETED|Overall Study||0
3348494|NCT03530917|4078431|FG002|NOT COMPLETED|Overall Study||0
3348495|NCT03530917|4078432|FG003|NOT COMPLETED|Overall Study||0
3348496|NCT03530917|4078433|FG004|NOT COMPLETED|Overall Study||0
3348497|NCT03530917|4078434|FG005|NOT COMPLETED|Overall Study||0
3348498|NCT03530917|4078435|FG006|NOT COMPLETED|Overall Study||0
3348499|NCT03530917|4078436|FG007|NOT COMPLETED|Overall Study||0
3348500|NCT03530995|4078462|FG000|STARTED|Part 1 Period 1; Part 2 Period 1||35
3348501|NCT03530995|4078463|FG001|STARTED|Part 1 Period 1; Part 2 Period 1||38
3348502|NCT03530995|4078462|FG000|COMPLETED|Part 1 Period 1; Part 2 Period 1||35
3348503|NCT03530995|4078463|FG001|COMPLETED|Part 1 Period 1; Part 2 Period 1||38
3348504|NCT03530995|4078462|FG000|NOT COMPLETED|Part 1 Period 1; Part 2 Period 1||0
3348505|NCT03530995|4078463|FG001|NOT COMPLETED|Part 1 Period 1; Part 2 Period 1||0
3348506|NCT03530995|4078462|FG000|STARTED|Part 1 Period 2; Part 2 Period 2||35
3348507|NCT03530995|4078463|FG001|STARTED|Part 1 Period 2; Part 2 Period 2||38
3348508|NCT03530995|4078462|FG000|COMPLETED|Part 1 Period 2; Part 2 Period 2||35
3348509|NCT03530995|4078463|FG001|COMPLETED|Part 1 Period 2; Part 2 Period 2||38
3348510|NCT03530995|4078462|FG000|NOT COMPLETED|Part 1 Period 2; Part 2 Period 2||0
3348511|NCT03530995|4078463|FG001|NOT COMPLETED|Part 1 Period 2; Part 2 Period 2||0
3348512|NCT03530995|4078462|FG000|STARTED|Part 1 Period 3||35
3348513|NCT03530995|4078463|FG001|STARTED|Part 1 Period 3|Period 3 is not applicable to part 2 of the study.|0
3348514|NCT03530995|4078462|FG000|COMPLETED|Part 1 Period 3||32
3348515|NCT03530995|4078463|FG001|COMPLETED|Part 1 Period 3|Period 3 is not applicable to part 2 of the study.|0
3348516|NCT03530995|4078462|FG000|NOT COMPLETED|Part 1 Period 3||3
3348517|NCT03530995|4078463|FG001|NOT COMPLETED|Part 1 Period 3||0
3348518|NCT03530995|4078462|FG000|STARTED|Part 1 Period 4||32
3348519|NCT03530995|4078463|FG001|STARTED|Part 1 Period 4|Period 4 is not applicable to part 2 of the study.|0
3348520|NCT03530995|4078462|FG000|COMPLETED|Part 1 Period 4||30
3348521|NCT03530995|4078463|FG001|COMPLETED|Part 1 Period 4|Period 4 is not applicable to part 2 of the study.|0
3348522|NCT03530995|4078462|FG000|NOT COMPLETED|Part 1 Period 4||2
3348523|NCT03530995|4078463|FG001|NOT COMPLETED|Part 1 Period 4||0
3348524|NCT03531710|4078491|FG000|STARTED|Overall Study||10
3348525|NCT03531710|4078492|FG001|STARTED|Overall Study||2
3348526|NCT03531710|4078493|FG002|STARTED|Overall Study||7
3348527|NCT03531710|4078494|FG003|STARTED|Overall Study||5
3348528|NCT03531710|4078495|FG004|STARTED|Overall Study||8
3348529|NCT03531710|4078496|FG005|STARTED|Overall Study||2
3348530|NCT03531710|4078491|FG000|COMPLETED|Overall Study||8
3348531|NCT03531710|4078492|FG001|COMPLETED|Overall Study||2
3348532|NCT03531710|4078493|FG002|COMPLETED|Overall Study||7
3348533|NCT03531710|4078494|FG003|COMPLETED|Overall Study||5
3348534|NCT03531710|4078495|FG004|COMPLETED|Overall Study||8
3348535|NCT03531710|4078496|FG005|COMPLETED|Overall Study||2
3348536|NCT03531710|4078491|FG000|NOT COMPLETED|Overall Study||2
3348537|NCT03531710|4078492|FG001|NOT COMPLETED|Overall Study||0
3348538|NCT03531710|4078493|FG002|NOT COMPLETED|Overall Study||0
3348539|NCT03531710|4078494|FG003|NOT COMPLETED|Overall Study||0
3348540|NCT03531710|4078495|FG004|NOT COMPLETED|Overall Study||0
3348541|NCT03531710|4078496|FG005|NOT COMPLETED|Overall Study||0
3348542|NCT03531840|4078514|FG000|STARTED|Overall Study||5
3348543|NCT03531840|4078515|FG001|STARTED|Overall Study||6
3348544|NCT03531840|4078516|FG002|STARTED|Overall Study||8
3348545|NCT03531840|4078517|FG003|STARTED|Overall Study||4
3348546|NCT03531840|4078514|FG000|COMPLETED|Overall Study||0
3348547|NCT03531840|4078515|FG001|COMPLETED|Overall Study||1
3348548|NCT03531840|4078516|FG002|COMPLETED|Overall Study||3
3348549|NCT03531840|4078517|FG003|COMPLETED|Overall Study||1
3348550|NCT03531840|4078514|FG000|NOT COMPLETED|Overall Study||5
3348551|NCT03531840|4078515|FG001|NOT COMPLETED|Overall Study||5
3348552|NCT03531840|4078516|FG002|NOT COMPLETED|Overall Study||5
3348553|NCT03531840|4078517|FG003|NOT COMPLETED|Overall Study||3
3348554|NCT03531905|4078535|FG000|STARTED|Overall Study||81
3348555|NCT03531905|4078536|FG001|STARTED|Overall Study||81
3348556|NCT03531905|4078537|FG002|STARTED|Overall Study||80
3348557|NCT03531905|4078535|FG000|COMPLETED|Overall Study||74
3348558|NCT03531905|4078536|FG001|COMPLETED|Overall Study||76
3348559|NCT03531905|4078537|FG002|COMPLETED|Overall Study||77
3348560|NCT03531905|4078535|FG000|NOT COMPLETED|Overall Study||7
3348561|NCT03531905|4078536|FG001|NOT COMPLETED|Overall Study||5
3348562|NCT03531905|4078537|FG002|NOT COMPLETED|Overall Study||3
3348563|NCT03532009|4078549|FG000|STARTED|Overall Study||92
3348564|NCT03532009|4078550|FG001|STARTED|Overall Study||90
3348565|NCT03532009|4078549|FG000|Received Treatment|Overall Study||91
3348566|NCT03532009|4078550|FG001|Received Treatment|Overall Study||90
3348567|NCT03532009|4078549|FG000|COMPLETED|Overall Study||90
3137059|NCT01716559|3862312|FG000|NOT COMPLETED|Overall Study||111
3137060|NCT01716585|3862318|FG000|STARTED|Double-blind Treatment||477
3137061|NCT01716585|3862319|FG001|STARTED|Double-blind Treatment||159
3348568|NCT03532009|4078550|FG001|COMPLETED|Overall Study||86
3348569|NCT03532009|4078549|FG000|NOT COMPLETED|Overall Study||2
3348570|NCT03532009|4078550|FG001|NOT COMPLETED|Overall Study||4
3348571|NCT03532048|4078558|FG000|STARTED|Overall Study|68 individuals (19 fathers, 31 children & 18 mothers)|68
3348572|NCT03532048|4078559|FG001|STARTED|Overall Study|67 individuals (17 fathers, 33 children & 17 mothers)|67
3348573|NCT03532048|4078558|FG000|COMPLETED|Overall Study|49 individuals (14 fathers, 22 children, 13 mothers). 1 father only took part in interview|49
3348574|NCT03532048|4078559|FG001|COMPLETED|Overall Study|50 individuals (13 fathers, 24 children & 13 mothers)|50
3348575|NCT03532048|4078558|FG000|NOT COMPLETED|Overall Study||19
3348576|NCT03532048|4078559|FG001|NOT COMPLETED|Overall Study||17
3348577|NCT03532308|4078567|FG000|STARTED|Overall Study||10
3348578|NCT03532308|4078568|FG001|STARTED|Overall Study||9
3348579|NCT03532308|4078567|FG000|Completed Assessments|Overall Study||9
3348580|NCT03532308|4078568|FG001|Completed Assessments|Overall Study||7
3348581|NCT03532308|4078567|FG000|COMPLETED|Overall Study||10
3348582|NCT03532308|4078568|FG001|COMPLETED|Overall Study||8
3348583|NCT03532308|4078567|FG000|NOT COMPLETED|Overall Study||0
3348584|NCT03532308|4078568|FG001|NOT COMPLETED|Overall Study||1
3348585|NCT03532776|4078577|FG000|STARTED|Overall Study||201
3348586|NCT03532776|4078578|FG001|STARTED|Overall Study||198
3348587|NCT03532776|4078579|FG002|STARTED|Overall Study||67
3348588|NCT03532776|4078577|FG000|COMPLETED|Overall Study||196
3348589|NCT03532776|4078578|FG001|COMPLETED|Overall Study||194
3348590|NCT03532776|4078579|FG002|COMPLETED|Overall Study||63
3348591|NCT03532776|4078577|FG000|NOT COMPLETED|Overall Study||5
3348592|NCT03532776|4078578|FG001|NOT COMPLETED|Overall Study||4
3348593|NCT03532776|4078579|FG002|NOT COMPLETED|Overall Study||4
3348594|NCT03533036|4078590|FG000|STARTED|Overall Study||15
3348595|NCT03533036|4078591|FG001|STARTED|Overall Study||15
3348596|NCT03533036|4078590|FG000|COMPLETED|Overall Study||15
3348597|NCT03533036|4078591|FG001|COMPLETED|Overall Study||15
3348598|NCT03533036|4078590|FG000|NOT COMPLETED|Overall Study||0
3348599|NCT03533036|4078591|FG001|NOT COMPLETED|Overall Study||0
3348600|NCT03533114|4078599|FG000|STARTED|Overall||88
3348601|NCT03533114|4078600|FG001|STARTED|Overall||66
3348602|NCT03533114|4078599|FG000|COMPLETED|Overall||57
3348603|NCT03533114|4078600|FG001|COMPLETED|Overall||38
3348604|NCT03533114|4078599|FG000|NOT COMPLETED|Overall||31
3348605|NCT03533114|4078600|FG001|NOT COMPLETED|Overall||28
3348606|NCT03533114|4078599|FG000|STARTED|Open Label Titration and Optimization||88
3348607|NCT03533114|4078600|FG001|STARTED|Open Label Titration and Optimization||66
3348608|NCT03533114|4078599|FG000|COMPLETED|Open Label Titration and Optimization||72
3348609|NCT03533114|4078600|FG001|COMPLETED|Open Label Titration and Optimization||53
3348610|NCT03533114|4078599|FG000|NOT COMPLETED|Open Label Titration and Optimization||16
3348611|NCT03533114|4078600|FG001|NOT COMPLETED|Open Label Titration and Optimization||13
3348612|NCT03533114|4078599|FG000|STARTED|Stable Dose||71
3348613|NCT03533114|4078600|FG001|STARTED|Stable Dose||52
3348614|NCT03533114|4078599|FG000|COMPLETED|Stable Dose||69
3348615|NCT03533114|4078600|FG001|COMPLETED|Stable Dose||50
3348616|NCT03533114|4078599|FG000|NOT COMPLETED|Stable Dose||2
3348617|NCT03533114|4078600|FG001|NOT COMPLETED|Stable Dose||2
3348618|NCT03533114|4078599|FG000|STARTED|Double Blind Randomized-Withdrawal||69
3348619|NCT03533114|4078600|FG001|STARTED|Double Blind Randomized-Withdrawal||47
3348620|NCT03533114|4078599|FG000|JZP-258|Double Blind Randomized-Withdrawal||57
3348621|NCT03533114|4078600|FG001|JZP-258|Double Blind Randomized-Withdrawal||0
3348622|NCT03533114|4078599|FG000|Placebo|Double Blind Randomized-Withdrawal||0
3348623|NCT03533114|4078600|FG001|Placebo|Double Blind Randomized-Withdrawal||59
3348624|NCT03533114|4078599|FG000|COMPLETED|Double Blind Randomized-Withdrawal||67
3348625|NCT03533114|4078600|FG001|COMPLETED|Double Blind Randomized-Withdrawal||46
3348626|NCT03533114|4078599|FG000|NOT COMPLETED|Double Blind Randomized-Withdrawal||2
3348627|NCT03533114|4078600|FG001|NOT COMPLETED|Double Blind Randomized-Withdrawal||1
3348628|NCT03533114|4078599|FG000|STARTED|Open-Label Safety Extension||65
3348629|NCT03533114|4078600|FG001|STARTED|Open-Label Safety Extension||41
3348630|NCT03533114|4078599|FG000|COMPLETED|Open-Label Safety Extension||57
3177950|NCT01974050|3905780|FG000|STARTED|Overall Study||166
3177951|NCT01974050|3905780|FG000|COMPLETED|Overall Study||141
3348631|NCT03533114|4078600|FG001|COMPLETED|Open-Label Safety Extension||38
3348632|NCT03533114|4078599|FG000|NOT COMPLETED|Open-Label Safety Extension||8
3348633|NCT03533114|4078600|FG001|NOT COMPLETED|Open-Label Safety Extension||3
3348634|NCT03533244|4078611|FG000|STARTED|Overall Study||20
3348635|NCT03533244|4078612|FG001|STARTED|Overall Study||22
3348636|NCT03533244|4078613|FG002|STARTED|Overall Study||22
3348637|NCT03533244|4078611|FG000|COMPLETED|Overall Study||18
3348638|NCT03533244|4078612|FG001|COMPLETED|Overall Study||21
3348639|NCT03533244|4078613|FG002|COMPLETED|Overall Study||22
3348640|NCT03533244|4078611|FG000|NOT COMPLETED|Overall Study||2
3348641|NCT03533244|4078612|FG001|NOT COMPLETED|Overall Study||1
3348642|NCT03533244|4078613|FG002|NOT COMPLETED|Overall Study||0
3348643|NCT03533374|4078623|FG000|STARTED|Overall Study||54
3348644|NCT03533374|4078624|FG001|STARTED|Overall Study||46
3348645|NCT03533374|4078623|FG000|COMPLETED|Overall Study||54
3348646|NCT03533374|4078624|FG001|COMPLETED|Overall Study||46
3348647|NCT03533374|4078623|FG000|NOT COMPLETED|Overall Study||0
3348648|NCT03533374|4078624|FG001|NOT COMPLETED|Overall Study||0
3348649|NCT03533608|4078630|FG000|STARTED|Overall Study||39
3348650|NCT03533608|4078630|FG000|COMPLETED|Overall Study||34
3177952|NCT01974050|3905780|FG000|NOT COMPLETED|Overall Study||25
3348651|NCT03533608|4078630|FG000|NOT COMPLETED|Overall Study||5
3348652|NCT03533829|4078638|FG000|STARTED|Overall Study||10
3348653|NCT03533829|4078639|FG001|STARTED|Overall Study||10
3348654|NCT03533829|4078640|FG002|STARTED|Overall Study||10
3348655|NCT03533829|4078638|FG000|COMPLETED|Overall Study||10
3348656|NCT03533829|4078639|FG001|COMPLETED|Overall Study||10
3348657|NCT03533829|4078640|FG002|COMPLETED|Overall Study||10
3348658|NCT03533829|4078638|FG000|NOT COMPLETED|Overall Study||0
3348659|NCT03533829|4078639|FG001|NOT COMPLETED|Overall Study||0
3348660|NCT03533829|4078640|FG002|NOT COMPLETED|Overall Study||0
3348661|NCT03534427|4078650|FG000|STARTED|Overall Study||20
3348662|NCT03534427|4078651|FG001|STARTED|Overall Study||20
3348663|NCT03534427|4078650|FG000|COMPLETED|Overall Study||20
3348664|NCT03534427|4078651|FG001|COMPLETED|Overall Study||20
3348665|NCT03534427|4078650|FG000|NOT COMPLETED|Overall Study||0
3348666|NCT03534427|4078651|FG001|NOT COMPLETED|Overall Study||0
3348667|NCT03534986|4078660|FG000|STARTED|Overall Study||10
3348668|NCT03534986|4078661|FG001|STARTED|Overall Study||10
3348669|NCT03534986|4078662|FG002|STARTED|Overall Study||12
3348670|NCT03534986|4078660|FG000|COMPLETED|Overall Study||10
3348671|NCT03534986|4078661|FG001|COMPLETED|Overall Study||10
3348672|NCT03534986|4078662|FG002|COMPLETED|Overall Study||10
3348673|NCT03534986|4078660|FG000|NOT COMPLETED|Overall Study||0
3348674|NCT03534986|4078661|FG001|NOT COMPLETED|Overall Study||0
3348675|NCT03534986|4078662|FG002|NOT COMPLETED|Overall Study||2
3348676|NCT03535194|4078675|FG000|STARTED|Induction Period||454
3348677|NCT03535194|4078676|FG001|STARTED|Induction Period||451
3348678|NCT03535194|4078677|FG002|STARTED|Induction Period||112
3348679|NCT03535194|4078678|FG003|STARTED|Induction Period||448
3348680|NCT03535194|4078679|FG004|STARTED|Induction Period|A plaque psoriasis participant was misrandomized by the site.|19
3348681|NCT03535194|4078675|FG000|Received at Least One Dose of Study Drug|Induction Period||454
3348682|NCT03535194|4078676|FG001|Received at Least One Dose of Study Drug|Induction Period||450
3348683|NCT03535194|4078677|FG002|Received at Least One Dose of Study Drug|Induction Period||112
3348684|NCT03535194|4078678|FG003|Received at Least One Dose of Study Drug|Induction Period||448
3348685|NCT03535194|4078679|FG004|Received at Least One Dose of Study Drug|Induction Period||19
3348686|NCT03535194|4078675|FG000|COMPLETED|Induction Period||443
3348687|NCT03535194|4078676|FG001|COMPLETED|Induction Period||434
3348688|NCT03535194|4078677|FG002|COMPLETED|Induction Period||104
3348689|NCT03535194|4078678|FG003|COMPLETED|Induction Period||437
3348690|NCT03535194|4078679|FG004|COMPLETED|Induction Period||19
3348691|NCT03535194|4078675|FG000|NOT COMPLETED|Induction Period||11
3348692|NCT03535194|4078676|FG001|NOT COMPLETED|Induction Period||17
3348693|NCT03535194|4078677|FG002|NOT COMPLETED|Induction Period||8
3348694|NCT03535194|4078678|FG003|NOT COMPLETED|Induction Period||11
3348695|NCT03535194|4078679|FG004|NOT COMPLETED|Induction Period||0
3348696|NCT03535194|4078675|FG000|STARTED|Maintenance Period||443
3348697|NCT03535194|4078676|FG001|STARTED|Maintenance Period||434
3348698|NCT03535194|4078677|FG002|STARTED|Maintenance Period||104
3348699|NCT03535194|4078678|FG003|STARTED|Maintenance Period||437
3348700|NCT03535194|4078679|FG004|STARTED|Maintenance Period||19
3348701|NCT03535194|4078675|FG000|COMPLETED|Maintenance Period||421
3348702|NCT03535194|4078676|FG001|COMPLETED|Maintenance Period||418
3348703|NCT03535194|4078677|FG002|COMPLETED|Maintenance Period||96
3348704|NCT03535194|4078678|FG003|COMPLETED|Maintenance Period||400
3348705|NCT03535194|4078679|FG004|COMPLETED|Maintenance Period||13
3348706|NCT03535194|4078675|FG000|NOT COMPLETED|Maintenance Period||22
3348707|NCT03535194|4078676|FG001|NOT COMPLETED|Maintenance Period||16
3348708|NCT03535194|4078677|FG002|NOT COMPLETED|Maintenance Period||8
3348709|NCT03535194|4078678|FG003|NOT COMPLETED|Maintenance Period||37
3348710|NCT03535194|4078679|FG004|NOT COMPLETED|Maintenance Period||6
3348711|NCT03535194|4078675|FG000|STARTED|Post-Treatment Followup Period|Participants who discontinued/completed Induction/Maintenance had option to enter post-treatment|38
3348712|NCT03535194|4078676|FG001|STARTED|Post-Treatment Followup Period|Participants who discontinued/completed Induction/Maintenance had option to enter post-treatment|35
3348713|NCT03535194|4078677|FG002|STARTED|Post-Treatment Followup Period|Participants who discontinued/completed Induction/Maintenance had option to enter post-treatment|18
3348714|NCT03535194|4078678|FG003|STARTED|Post-Treatment Followup Period|Participants who discontinued/completed Induction/Maintenance had option to enter post-treatment|47
3348715|NCT03535194|4078679|FG004|STARTED|Post-Treatment Followup Period|Participants who discontinued/completed Induction/Maintenance had option to enter post-treatment|8
3348716|NCT03535194|4078675|FG000|COMPLETED|Post-Treatment Followup Period||27
3348717|NCT03535194|4078676|FG001|COMPLETED|Post-Treatment Followup Period||21
3348718|NCT03535194|4078677|FG002|COMPLETED|Post-Treatment Followup Period||7
3348719|NCT03535194|4078678|FG003|COMPLETED|Post-Treatment Followup Period||23
3348720|NCT03535194|4078679|FG004|COMPLETED|Post-Treatment Followup Period||8
3348721|NCT03535194|4078675|FG000|NOT COMPLETED|Post-Treatment Followup Period||11
3348722|NCT03535194|4078676|FG001|NOT COMPLETED|Post-Treatment Followup Period||14
3348723|NCT03535194|4078677|FG002|NOT COMPLETED|Post-Treatment Followup Period||11
3348724|NCT03535194|4078678|FG003|NOT COMPLETED|Post-Treatment Followup Period||24
3348725|NCT03535194|4078679|FG004|NOT COMPLETED|Post-Treatment Followup Period||0
3348726|NCT03535571|4078703|FG000|STARTED|Overall Study||20
3348727|NCT03535571|4078703|FG000|COMPLETED|Overall Study||19
3348728|NCT03535571|4078703|FG000|NOT COMPLETED|Overall Study||1
3348729|NCT03535649|4078709|FG000|STARTED|Overall Study||105
3348730|NCT03535649|4078709|FG000|COMPLETED|Overall Study||105
3348731|NCT03535649|4078709|FG000|NOT COMPLETED|Overall Study||0
3348732|NCT03535844|4078715|FG000|STARTED|Overall Study||22
3348733|NCT03535844|4078716|FG001|STARTED|Overall Study||19
3348734|NCT03535844|4078715|FG000|COMPLETED|Overall Study||22
3348735|NCT03535844|4078716|FG001|COMPLETED|Overall Study||18
3348736|NCT03535844|4078715|FG000|NOT COMPLETED|Overall Study||0
3348737|NCT03535844|4078716|FG001|NOT COMPLETED|Overall Study||1
3348738|NCT03535974|4078725|FG000|STARTED|First Intervention Weeks 0-6 (V1-V2)||14
3348739|NCT03535974|4078726|FG001|STARTED|First Intervention Weeks 0-6 (V1-V2)||19
3348740|NCT03535974|4078727|FG002|STARTED|First Intervention Weeks 0-6 (V1-V2)||5
3348741|NCT03535974|4078725|FG000|COMPLETED|First Intervention Weeks 0-6 (V1-V2)||12
3348742|NCT03535974|4078726|FG001|COMPLETED|First Intervention Weeks 0-6 (V1-V2)||17
3348743|NCT03535974|4078727|FG002|COMPLETED|First Intervention Weeks 0-6 (V1-V2)||5
3348744|NCT03535974|4078725|FG000|NOT COMPLETED|First Intervention Weeks 0-6 (V1-V2)||2
3348745|NCT03535974|4078726|FG001|NOT COMPLETED|First Intervention Weeks 0-6 (V1-V2)||2
3348746|NCT03535974|4078727|FG002|NOT COMPLETED|First Intervention Weeks 0-6 (V1-V2)||0
3348747|NCT03535974|4078725|FG000|STARTED|Second Intervention Weeks 6-12 (V2-V3)||12
3348748|NCT03535974|4078726|FG001|STARTED|Second Intervention Weeks 6-12 (V2-V3)||17
3348749|NCT03535974|4078727|FG002|STARTED|Second Intervention Weeks 6-12 (V2-V3)||5
3348750|NCT03535974|4078725|FG000|COMPLETED|Second Intervention Weeks 6-12 (V2-V3)||12
3348751|NCT03535974|4078726|FG001|COMPLETED|Second Intervention Weeks 6-12 (V2-V3)||17
3348752|NCT03535974|4078727|FG002|COMPLETED|Second Intervention Weeks 6-12 (V2-V3)||5
3348753|NCT03535974|4078725|FG000|NOT COMPLETED|Second Intervention Weeks 6-12 (V2-V3)||0
3348754|NCT03535974|4078726|FG001|NOT COMPLETED|Second Intervention Weeks 6-12 (V2-V3)||0
3348755|NCT03535974|4078727|FG002|NOT COMPLETED|Second Intervention Weeks 6-12 (V2-V3)||0
3348756|NCT03536663|4078735|FG000|STARTED|Optiflux||23
3348757|NCT03536663|4078735|FG000|COMPLETED|Optiflux||19
3348758|NCT03536663|4078735|FG000|NOT COMPLETED|Optiflux||4
3348759|NCT03536663|4078735|FG000|STARTED|Endexo|One subject completed the Optiflux period but missed Visit 13 and was withdrawn per protocol.|18
3348760|NCT03536663|4078735|FG000|COMPLETED|Endexo||17
3348761|NCT03536663|4078735|FG000|NOT COMPLETED|Endexo||1
3348762|NCT03536702|4078746|FG000|STARTED|Overall Study||40
3348763|NCT03536702|4078747|FG001|STARTED|Overall Study||20
3348764|NCT03536702|4078746|FG000|COMPLETED|Overall Study||26
3348765|NCT03536702|4078747|FG001|COMPLETED|Overall Study||8
3348766|NCT03536702|4078746|FG000|NOT COMPLETED|Overall Study||14
3348767|NCT03536702|4078747|FG001|NOT COMPLETED|Overall Study||12
3348768|NCT03536819|4078753|FG000|STARTED|Overall Study||20
3348769|NCT03536819|4078753|FG000|COMPLETED|Overall Study||15
3348770|NCT03536819|4078753|FG000|NOT COMPLETED|Overall Study||5
3348771|NCT03536923|4078757|FG000|STARTED|Overall Study||23
3348772|NCT03536923|4078757|FG000|COMPLETED|Overall Study||23
3348773|NCT03536923|4078757|FG000|NOT COMPLETED|Overall Study||0
3348774|NCT03536949|4078763|FG000|STARTED|Overall Study||157
3348775|NCT03536949|4078764|FG001|STARTED|Overall Study||77
3348776|NCT03536949|4078763|FG000|COMPLETED|Overall Study||143
3348777|NCT03536949|4078764|FG001|COMPLETED|Overall Study||75
3348778|NCT03536949|4078763|FG000|NOT COMPLETED|Overall Study||14
3348779|NCT03536949|4078764|FG001|NOT COMPLETED|Overall Study||2
3348780|NCT03537014|4078772|FG000|STARTED|Overall Study||46
3348781|NCT03537014|4078773|FG001|STARTED|Overall Study||45
3348782|NCT03537014|4078772|FG000|Withdrew Consent Before Dosing|Overall Study||0
3348783|NCT03537014|4078773|FG001|Withdrew Consent Before Dosing|Overall Study||1
3348784|NCT03537014|4078772|FG000|Completed First Experimental Session|Overall Study||46
3348785|NCT03537014|4078773|FG001|Completed First Experimental Session|Overall Study||44
3348786|NCT03537014|4078772|FG000|Completed Second Experimental Session|Overall Study||43
3348787|NCT03537014|4078773|FG001|Completed Second Experimental Session|Overall Study||41
3348788|NCT03537014|4078772|FG000|COMPLETED|Overall Study||42
3348789|NCT03537014|4078773|FG001|COMPLETED|Overall Study||40
3348790|NCT03537014|4078772|FG000|NOT COMPLETED|Overall Study||4
3348791|NCT03537014|4078773|FG001|NOT COMPLETED|Overall Study||5
3348792|NCT03537092|4078779|FG000|STARTED|Overall Study||64
3348793|NCT03537092|4078779|FG000|COMPLETED|Overall Study||64
3348794|NCT03537092|4078779|FG000|NOT COMPLETED|Overall Study||0
3348795|NCT03537261|4078785|FG000|STARTED|Overall Study||41
3348796|NCT03537261|4078786|FG001|STARTED|Overall Study||39
3348797|NCT03537261|4078785|FG000|Completed Baseline Assessment|Overall Study|One participant did not attend the CPI-Parent training but remained in the study.|35
3348798|NCT03537261|4078786|FG001|Completed Baseline Assessment|Overall Study||28
3348799|NCT03537261|4078785|FG000|COMPLETED|Overall Study|One participant did not attend the CPI-Parent training but remained in the study.|33
3348800|NCT03537261|4078786|FG001|COMPLETED|Overall Study||27
3348801|NCT03537261|4078785|FG000|NOT COMPLETED|Overall Study||8
3348802|NCT03537261|4078786|FG001|NOT COMPLETED|Overall Study||12
3348803|NCT03537274|4078796|FG000|STARTED|Overall Study||315
3348804|NCT03537274|4078797|FG001|STARTED|Overall Study||298
3177953|NCT01974089|3905786|FG000|STARTED|Overall Study||53
3177954|NCT01974089|3905787|FG001|STARTED|Overall Study||101
3177955|NCT01974089|3905786|FG000|COMPLETED|Overall Study||53
3177956|NCT01974089|3905787|FG001|COMPLETED|Overall Study||101
3177957|NCT01974089|3905786|FG000|NOT COMPLETED|Overall Study||0
3348805|NCT03537274|4078798|FG002|STARTED|Overall Study||304
3348806|NCT03537274|4078799|FG003|STARTED|Overall Study||307
3348807|NCT03537274|4078796|FG000|Treated|Overall Study||315
3348808|NCT03537274|4078797|FG001|Treated|Overall Study||297
3348809|NCT03537274|4078798|FG002|Treated|Overall Study||304
3348810|NCT03537274|4078799|FG003|Treated|Overall Study||303
3348811|NCT03537274|4078796|FG000|COMPLETED|Overall Study||255
3348812|NCT03537274|4078797|FG001|COMPLETED|Overall Study||229
3348813|NCT03537274|4078798|FG002|COMPLETED|Overall Study||228
3348814|NCT03537274|4078799|FG003|COMPLETED|Overall Study||231
3348815|NCT03537274|4078796|FG000|NOT COMPLETED|Overall Study||60
3348816|NCT03537274|4078797|FG001|NOT COMPLETED|Overall Study||69
3348817|NCT03537274|4078798|FG002|NOT COMPLETED|Overall Study||76
3348818|NCT03537274|4078799|FG003|NOT COMPLETED|Overall Study||76
3348819|NCT03537404|4078812|FG000|STARTED|First Intervention (A or B or C)||18
3348820|NCT03537404|4078813|FG001|STARTED|First Intervention (A or B or C)||18
3348821|NCT03537404|4078812|FG000|COMPLETED|First Intervention (A or B or C)||18
3348822|NCT03537404|4078813|FG001|COMPLETED|First Intervention (A or B or C)||18
3348823|NCT03537404|4078812|FG000|NOT COMPLETED|First Intervention (A or B or C)||0
3348824|NCT03537404|4078813|FG001|NOT COMPLETED|First Intervention (A or B or C)||0
3348825|NCT03537404|4078812|FG000|STARTED|First Washout Period (8 Days)||18
3348826|NCT03537404|4078813|FG001|STARTED|First Washout Period (8 Days)||18
3348827|NCT03537404|4078812|FG000|COMPLETED|First Washout Period (8 Days)||18
3348828|NCT03537404|4078813|FG001|COMPLETED|First Washout Period (8 Days)||18
3348829|NCT03537404|4078812|FG000|NOT COMPLETED|First Washout Period (8 Days)||0
3348830|NCT03537404|4078813|FG001|NOT COMPLETED|First Washout Period (8 Days)||0
3348831|NCT03537404|4078812|FG000|STARTED|Second Intervention (A or B or C)||18
3348832|NCT03537404|4078813|FG001|STARTED|Second Intervention (A or B or C)||18
3348833|NCT03537404|4078812|FG000|COMPLETED|Second Intervention (A or B or C)||18
3348834|NCT03537404|4078813|FG001|COMPLETED|Second Intervention (A or B or C)||18
3348835|NCT03537404|4078812|FG000|NOT COMPLETED|Second Intervention (A or B or C)||0
3348836|NCT03537404|4078813|FG001|NOT COMPLETED|Second Intervention (A or B or C)||0
3348837|NCT03537404|4078812|FG000|STARTED|Second Washout Period (8 Days)||18
3348838|NCT03537404|4078813|FG001|STARTED|Second Washout Period (8 Days)||18
3348839|NCT03537404|4078812|FG000|COMPLETED|Second Washout Period (8 Days)||18
3348840|NCT03537404|4078813|FG001|COMPLETED|Second Washout Period (8 Days)||18
3348841|NCT03537404|4078812|FG000|NOT COMPLETED|Second Washout Period (8 Days)||0
3348842|NCT03537404|4078813|FG001|NOT COMPLETED|Second Washout Period (8 Days)||0
3348843|NCT03537404|4078812|FG000|STARTED|Third Intervention (A or B or C)||18
3348844|NCT03537404|4078813|FG001|STARTED|Third Intervention (A or B or C)||18
3348845|NCT03537404|4078812|FG000|COMPLETED|Third Intervention (A or B or C)||18
3348846|NCT03537404|4078813|FG001|COMPLETED|Third Intervention (A or B or C)||18
3348847|NCT03537404|4078812|FG000|NOT COMPLETED|Third Intervention (A or B or C)||0
3348848|NCT03537404|4078813|FG001|NOT COMPLETED|Third Intervention (A or B or C)||0
3348849|NCT03537651|4078837|FG000|STARTED|Overall Study||130
3348850|NCT03537651|4078837|FG000|113B/116 FAS|Overall Study||64
3348851|NCT03537651|4078837|FG000|113B/116 LCI FAS|Overall Study||30
3348852|NCT03537651|4078837|FG000|115/116 FAS|Overall Study||66
3348853|NCT03537651|4078837|FG000|115/116 FAS (TEZ/IVA Group)|Overall Study||53
3348854|NCT03537651|4078837|FG000|COMPLETED|Overall Study||69
3348855|NCT03537651|4078837|FG000|NOT COMPLETED|Overall Study||61
3348856|NCT03537664|4078844|FG000|STARTED|Overall Study||20
3348857|NCT03537664|4078845|FG001|STARTED|Overall Study||25
3348858|NCT03537664|4078844|FG000|Metabolic Activity of Bacteria|Overall Study|5 patients were excluded from metabolic activity analysis (lost of RNA)|15
3348859|NCT03537664|4078845|FG001|Metabolic Activity of Bacteria|Overall Study||25
3177958|NCT01974089|3905787|FG001|NOT COMPLETED|Overall Study||0
3177959|NCT01974102|3905797|FG000|STARTED|Overall Study||22
3177960|NCT01974102|3905798|FG001|STARTED|Overall Study||20
3177961|NCT01974102|3905797|FG000|COMPLETED|Overall Study||15
3177962|NCT01974102|3905798|FG001|COMPLETED|Overall Study||19
3177963|NCT01974102|3905797|FG000|NOT COMPLETED|Overall Study||7
3177964|NCT01974102|3905798|FG001|NOT COMPLETED|Overall Study||1
3348860|NCT03537664|4078844|FG000|Bacterial Levels|Overall Study||20
3348861|NCT03537664|4078845|FG001|Bacterial Levels|Overall Study||25
3348862|NCT03537664|4078844|FG000|Bacterial Community Diversity|Overall Study||10
3348863|NCT03537664|4078845|FG001|Bacterial Community Diversity|Overall Study||0
3348864|NCT03537664|4078844|FG000|Endodontic Success|Overall Study||20
3348865|NCT03537664|4078845|FG001|Endodontic Success|Overall Study||10
3348866|NCT03537664|4078844|FG000|COMPLETED|Overall Study||20
3348867|NCT03537664|4078845|FG001|COMPLETED|Overall Study||25
3348868|NCT03537664|4078844|FG000|NOT COMPLETED|Overall Study||0
3348869|NCT03537664|4078845|FG001|NOT COMPLETED|Overall Study||0
3348870|NCT03538431|4078856|FG000|STARTED|Overall Study||13
3348871|NCT03538431|4078857|FG001|STARTED|Overall Study||13
3348872|NCT03538431|4078856|FG000|COMPLETED|Overall Study||12
3348873|NCT03538431|4078857|FG001|COMPLETED|Overall Study||12
3348874|NCT03538431|4078856|FG000|NOT COMPLETED|Overall Study||1
3348875|NCT03538431|4078857|FG001|NOT COMPLETED|Overall Study||1
3348876|NCT03538678|4078867|FG000|STARTED|Overall Study||20
3348877|NCT03538678|4078868|FG001|STARTED|Overall Study||20
3348878|NCT03538678|4078867|FG000|COMPLETED|Overall Study||5
3348879|NCT03538678|4078868|FG001|COMPLETED|Overall Study||9
3348880|NCT03538678|4078867|FG000|NOT COMPLETED|Overall Study||15
3348881|NCT03538678|4078868|FG001|NOT COMPLETED|Overall Study||11
3348882|NCT03538743|4078883|FG000|STARTED|Overall Study||25
3348883|NCT03538743|4078884|FG001|STARTED|Overall Study||9
3348884|NCT03538743|4078885|FG002|STARTED|Overall Study||9
3348885|NCT03538743|4078886|FG003|STARTED|Overall Study||10
3348886|NCT03538743|4078887|FG004|STARTED|Overall Study||9
3348887|NCT03538743|4078888|FG005|STARTED|Overall Study||9
3348888|NCT03538743|4078889|FG006|STARTED|Overall Study||9
3348889|NCT03538743|4078890|FG007|STARTED|Overall Study||8
3348890|NCT03538743|4078891|FG008|STARTED|Overall Study||10
3348891|NCT03538743|4078883|FG000|Received Treatment|Overall Study||25
3348892|NCT03538743|4078884|FG001|Received Treatment|Overall Study||9
3348893|NCT03538743|4078885|FG002|Received Treatment|Overall Study||9
3348894|NCT03538743|4078886|FG003|Received Treatment|Overall Study||10
3348895|NCT03538743|4078887|FG004|Received Treatment|Overall Study||9
3348896|NCT03538743|4078888|FG005|Received Treatment|Overall Study||9
3348897|NCT03538743|4078889|FG006|Received Treatment|Overall Study||9
3348898|NCT03538743|4078890|FG007|Received Treatment|Overall Study||8
3348899|NCT03538743|4078891|FG008|Received Treatment|Overall Study||10
3348900|NCT03538743|4078883|FG000|COMPLETED|Overall Study||25
3348901|NCT03538743|4078884|FG001|COMPLETED|Overall Study||9
3348902|NCT03538743|4078885|FG002|COMPLETED|Overall Study||8
3348903|NCT03538743|4078886|FG003|COMPLETED|Overall Study||8
3348904|NCT03538743|4078887|FG004|COMPLETED|Overall Study||9
3348905|NCT03538743|4078888|FG005|COMPLETED|Overall Study||9
3177965|NCT01974141|3905808|FG000|STARTED|Overall Study||1044
3177966|NCT01974141|3905809|FG001|STARTED|Overall Study||1058
3348906|NCT03538743|4078889|FG006|COMPLETED|Overall Study||9
3348907|NCT03538743|4078890|FG007|COMPLETED|Overall Study||8
3348908|NCT03538743|4078891|FG008|COMPLETED|Overall Study||7
3348909|NCT03538743|4078883|FG000|NOT COMPLETED|Overall Study||0
3348910|NCT03538743|4078884|FG001|NOT COMPLETED|Overall Study||0
3348911|NCT03538743|4078885|FG002|NOT COMPLETED|Overall Study||1
3348912|NCT03538743|4078886|FG003|NOT COMPLETED|Overall Study||2
3348913|NCT03538743|4078887|FG004|NOT COMPLETED|Overall Study||0
3348914|NCT03538743|4078888|FG005|NOT COMPLETED|Overall Study||0
3348915|NCT03538743|4078889|FG006|NOT COMPLETED|Overall Study||0
3348916|NCT03538743|4078890|FG007|NOT COMPLETED|Overall Study||0
3348917|NCT03538743|4078891|FG008|NOT COMPLETED|Overall Study||3
3348918|NCT03538795|4078919|FG000|STARTED|Overall Study||3
3348919|NCT03538795|4078919|FG000|COMPLETED|Overall Study||3
3348920|NCT03538795|4078919|FG000|NOT COMPLETED|Overall Study||0
3348921|NCT03538808|4078927|FG000|STARTED|Overall Study||20
3348922|NCT03538808|4078928|FG001|STARTED|Overall Study||20
3348923|NCT03538808|4078929|FG002|STARTED|Overall Study||20
3348924|NCT03538808|4078930|FG003|STARTED|Overall Study||20
3348925|NCT03538808|4078927|FG000|COMPLETED|Overall Study||18
3348926|NCT03538808|4078928|FG001|COMPLETED|Overall Study||20
3348927|NCT03538808|4078929|FG002|COMPLETED|Overall Study||16
3348928|NCT03538808|4078930|FG003|COMPLETED|Overall Study||18
3348929|NCT03538808|4078927|FG000|NOT COMPLETED|Overall Study||2
3348930|NCT03538808|4078928|FG001|NOT COMPLETED|Overall Study||0
3348931|NCT03538808|4078929|FG002|NOT COMPLETED|Overall Study||4
3348932|NCT03538808|4078930|FG003|NOT COMPLETED|Overall Study||2
3348933|NCT03539211|4078942|FG000|STARTED|Overall Study||16
3348934|NCT03539211|4078943|FG001|STARTED|Overall Study||15
3348935|NCT03539211|4078942|FG000|COMPLETED|Overall Study||16
3348936|NCT03539211|4078943|FG001|COMPLETED|Overall Study||15
3348937|NCT03539211|4078942|FG000|NOT COMPLETED|Overall Study||0
3348938|NCT03539211|4078943|FG001|NOT COMPLETED|Overall Study||0
3348939|NCT03539432|4078951|FG000|STARTED|Overall Study||2
3348940|NCT03539432|4078952|FG001|STARTED|Overall Study||1
3348941|NCT03539432|4078951|FG000|COMPLETED|Overall Study||2
3348942|NCT03539432|4078952|FG001|COMPLETED|Overall Study||0
2927964|NCT00575042|3638889|FG000|COMPLETED|Overall Study|2 with side effects and 1 lost to follow-up|17
2927965|NCT00575042|3638889|FG000|NOT COMPLETED|Overall Study||3
2927966|NCT00575094|3638894|FG000|STARTED|Overall Study||9
2927967|NCT00575094|3638894|FG000|COMPLETED|Overall Study||6
2927968|NCT00575094|3638894|FG000|NOT COMPLETED|Overall Study||3
2927969|NCT00575146|3638898|FG000|STARTED|Overall Study||20
2927970|NCT00575146|3638898|FG000|COMPLETED|Overall Study||17
2927971|NCT00575146|3638898|FG000|NOT COMPLETED|Overall Study||3
2927972|NCT00575159|3638902|FG000|STARTED|Overall Study||10
2927973|NCT00575159|3638902|FG000|COMPLETED|Overall Study||10
2927974|NCT00575159|3638902|FG000|NOT COMPLETED|Overall Study||0
2927975|NCT00575185|3638920|FG000|STARTED|Overall Study||12
2927976|NCT00575185|3638921|FG001|STARTED|Overall Study||11
2927977|NCT00575185|3638920|FG000|COMPLETED|Overall Study||12
2927978|NCT00575185|3638921|FG001|COMPLETED|Overall Study||11
2927979|NCT00575185|3638920|FG000|NOT COMPLETED|Overall Study||0
2927980|NCT00575185|3638921|FG001|NOT COMPLETED|Overall Study||0
2927981|NCT00575328|3638931|FG000|STARTED|Overall Study||4
2927982|NCT00575328|3638932|FG001|STARTED|Overall Study||4
2927983|NCT00575328|3638931|FG000|COMPLETED|Overall Study||1
2927984|NCT00575328|3638932|FG001|COMPLETED|Overall Study||2
2927985|NCT00575328|3638931|FG000|NOT COMPLETED|Overall Study||3
2927986|NCT00575328|3638932|FG001|NOT COMPLETED|Overall Study||2
2927987|NCT00575367|3638940|FG000|STARTED|Overall Study||19
2927988|NCT00575367|3638941|FG001|STARTED|Overall Study||18
2927989|NCT00575367|3638940|FG000|COMPLETED|Overall Study||19
2927990|NCT00575367|3638941|FG001|COMPLETED|Overall Study||18
2927991|NCT00575367|3638940|FG000|NOT COMPLETED|Overall Study||0
2927992|NCT00575367|3638941|FG001|NOT COMPLETED|Overall Study||0
2927993|NCT00575380|3638949|FG000|STARTED|Overall Study||58
2927994|NCT00575380|3638950|FG001|STARTED|Overall Study||58
2927995|NCT00575380|3638949|FG000|COMPLETED|Overall Study||57
2927996|NCT00575380|3638950|FG001|COMPLETED|Overall Study||55
3039882|NCT01161407|3759403|FG000|NOT COMPLETED|Overall Study||3
3039883|NCT01161407|3759404|FG001|NOT COMPLETED|Overall Study||1
3137062|NCT01716585|3862318|FG000|Randomized But Not Treated|Double-blind Treatment||4
3348943|NCT03539432|4078951|FG000|NOT COMPLETED|Overall Study||0
3348944|NCT03539432|4078952|FG001|NOT COMPLETED|Overall Study||1
3348945|NCT03539484|4078965|FG000|STARTED|Overall Study||1
3348946|NCT03539484|4078966|FG001|STARTED|Overall Study||1
3348947|NCT03539484|4078967|FG002|STARTED|Overall Study||1
3348948|NCT03539484|4078968|FG003|STARTED|Overall Study||3
3348949|NCT03539484|4078969|FG004|STARTED|Overall Study||13
3348950|NCT03539484|4078970|FG005|STARTED|Overall Study||5
3348951|NCT03539484|4078971|FG006|STARTED|Overall Study||2
3348952|NCT03539484|4078965|FG000|COMPLETED|Overall Study||0
3348953|NCT03539484|4078966|FG001|COMPLETED|Overall Study||0
3348954|NCT03539484|4078967|FG002|COMPLETED|Overall Study||0
3348955|NCT03539484|4078968|FG003|COMPLETED|Overall Study||0
3348956|NCT03539484|4078969|FG004|COMPLETED|Overall Study||0
3348957|NCT03539484|4078970|FG005|COMPLETED|Overall Study||0
3348958|NCT03539484|4078971|FG006|COMPLETED|Overall Study||0
3348959|NCT03539484|4078965|FG000|NOT COMPLETED|Overall Study||1
3348960|NCT03539484|4078966|FG001|NOT COMPLETED|Overall Study||1
3348961|NCT03539484|4078967|FG002|NOT COMPLETED|Overall Study||1
3348962|NCT03539484|4078968|FG003|NOT COMPLETED|Overall Study||3
3348963|NCT03539484|4078969|FG004|NOT COMPLETED|Overall Study||13
3348964|NCT03539484|4078970|FG005|NOT COMPLETED|Overall Study||5
3348965|NCT03539484|4078971|FG006|NOT COMPLETED|Overall Study||2
3348966|NCT03539549|4078992|FG000|STARTED|Overall Study||123
3348967|NCT03539549|4078992|FG000|COMPLETED|Overall Study||106
3348968|NCT03539549|4078992|FG000|NOT COMPLETED|Overall Study||17
3348969|NCT03540030|4078998|FG000|STARTED|Overall Study||48
3348970|NCT03540030|4078999|FG001|STARTED|Overall Study||38
3348971|NCT03540030|4078998|FG000|COMPLETED|Overall Study||30
3348972|NCT03540030|4078999|FG001|COMPLETED|Overall Study||35
3348973|NCT03540030|4078998|FG000|NOT COMPLETED|Overall Study||18
3348974|NCT03540030|4078999|FG001|NOT COMPLETED|Overall Study||3
3348975|NCT03540134|4079005|FG000|STARTED|Overall Study||4
3348976|NCT03540134|4079005|FG000|COMPLETED|Overall Study||4
3348977|NCT03540134|4079005|FG000|NOT COMPLETED|Overall Study||0
3348978|NCT03540147|4079009|FG000|STARTED|Overall Study||20
3348979|NCT03540147|4079009|FG000|COMPLETED|Overall Study||20
3348980|NCT03540147|4079009|FG000|NOT COMPLETED|Overall Study||0
3348981|NCT03540160|4079021|FG000|STARTED|Overall Study||558
3348982|NCT03540160|4079021|FG000|COMPLETED|Overall Study||179
3348983|NCT03540160|4079021|FG000|NOT COMPLETED|Overall Study||379
3348984|NCT03541044|4079025|FG000|STARTED|Study Period 1: Up to Day 1||23
3348985|NCT03541044|4079026|FG001|STARTED|Study Period 1: Up to Day 1||23
3348986|NCT03541044|4079025|FG000|COMPLETED|Study Period 1: Up to Day 1||23
3348987|NCT03541044|4079026|FG001|COMPLETED|Study Period 1: Up to Day 1||23
3348988|NCT03541044|4079025|FG000|NOT COMPLETED|Study Period 1: Up to Day 1||0
3348989|NCT03541044|4079026|FG001|NOT COMPLETED|Study Period 1: Up to Day 1||0
3348990|NCT03541044|4079025|FG000|STARTED|Washout Period: 5 to 7 Days||23
3348991|NCT03541044|4079026|FG001|STARTED|Washout Period: 5 to 7 Days||23
3348992|NCT03541044|4079025|FG000|COMPLETED|Washout Period: 5 to 7 Days||23
3348993|NCT03541044|4079026|FG001|COMPLETED|Washout Period: 5 to 7 Days||23
3348994|NCT03541044|4079025|FG000|NOT COMPLETED|Washout Period: 5 to 7 Days||0
3348995|NCT03541044|4079026|FG001|NOT COMPLETED|Washout Period: 5 to 7 Days||0
3348996|NCT03541044|4079025|FG000|STARTED|Study Period 2: Up to Day 8||23
3348997|NCT03541044|4079026|FG001|STARTED|Study Period 2: Up to Day 8||23
3348998|NCT03541044|4079025|FG000|COMPLETED|Study Period 2: Up to Day 8||21
3348999|NCT03541044|4079026|FG001|COMPLETED|Study Period 2: Up to Day 8||23
3349000|NCT03541044|4079025|FG000|NOT COMPLETED|Study Period 2: Up to Day 8||2
3349001|NCT03541044|4079026|FG001|NOT COMPLETED|Study Period 2: Up to Day 8||0
3349002|NCT03541356|4079039|FG000|STARTED|Overall Study||8
3349003|NCT03541356|4079040|FG001|STARTED|Overall Study||6
3349004|NCT03541356|4079041|FG002|STARTED|Overall Study||6
3349005|NCT03541356|4079042|FG003|STARTED|Overall Study||6
3349006|NCT03541356|4079043|FG004|STARTED|Overall Study||6
3349007|NCT03541356|4079039|FG000|COMPLETED|Overall Study||8
3349008|NCT03541356|4079040|FG001|COMPLETED|Overall Study||6
3349009|NCT03541356|4079041|FG002|COMPLETED|Overall Study||6
3349010|NCT03541356|4079042|FG003|COMPLETED|Overall Study||6
3349011|NCT03541356|4079043|FG004|COMPLETED|Overall Study||6
3349012|NCT03541356|4079039|FG000|NOT COMPLETED|Overall Study||0
3349013|NCT03541356|4079040|FG001|NOT COMPLETED|Overall Study||0
3349014|NCT03541356|4079041|FG002|NOT COMPLETED|Overall Study||0
3349015|NCT03541356|4079042|FG003|NOT COMPLETED|Overall Study||0
3349016|NCT03541356|4079043|FG004|NOT COMPLETED|Overall Study||0
3349017|NCT03541941|4079063|FG000|STARTED|Overall Study||57
3349018|NCT03541941|4079064|FG001|STARTED|Overall Study||55
3349019|NCT03541941|4079065|FG002|STARTED|Overall Study||52
3349020|NCT03541941|4079063|FG000|COMPLETED|Overall Study||57
3349021|NCT03541941|4079064|FG001|COMPLETED|Overall Study||55
3349022|NCT03541941|4079065|FG002|COMPLETED|Overall Study||52
3349023|NCT03541941|4079063|FG000|NOT COMPLETED|Overall Study||0
3349024|NCT03541941|4079064|FG001|NOT COMPLETED|Overall Study||0
3349025|NCT03541941|4079065|FG002|NOT COMPLETED|Overall Study||0
3349026|NCT03541980|4079075|FG000|STARTED|Overall Study||35
3349027|NCT03541980|4079076|FG001|STARTED|Overall Study||36
3349028|NCT03541980|4079075|FG000|COMPLETED|Overall Study||35
3349029|NCT03541980|4079076|FG001|COMPLETED|Overall Study||36
3349030|NCT03541980|4079075|FG000|NOT COMPLETED|Overall Study||0
3349031|NCT03541980|4079076|FG001|NOT COMPLETED|Overall Study||0
3349032|NCT03542019|4079091|FG000|STARTED|Overall Study||20
3349033|NCT03542019|4079092|FG001|STARTED|Overall Study||20
3349034|NCT03542019|4079093|FG002|STARTED|Overall Study||20
3349035|NCT03542019|4079091|FG000|COMPLETED|Overall Study||19
3349036|NCT03542019|4079092|FG001|COMPLETED|Overall Study||17
3349037|NCT03542019|4079093|FG002|COMPLETED|Overall Study||19
3349038|NCT03542019|4079091|FG000|NOT COMPLETED|Overall Study||1
3349039|NCT03542019|4079092|FG001|NOT COMPLETED|Overall Study||3
3349040|NCT03542019|4079093|FG002|NOT COMPLETED|Overall Study||1
3349041|NCT03542266|4079101|FG000|STARTED|Treatment Phase||21
3349042|NCT03542266|4079101|FG000|COMPLETED|Treatment Phase||18
3349043|NCT03542266|4079101|FG000|NOT COMPLETED|Treatment Phase||3
3349044|NCT03542266|4079101|FG000|STARTED|Post-treatment Follow-up Phase|Three subjects did not enter follow-up: 1 had PD at EOT, 2 withdrew consent|15
3349045|NCT03542266|4079101|FG000|COMPLETED|Post-treatment Follow-up Phase||0
3349046|NCT03542266|4079101|FG000|NOT COMPLETED|Post-treatment Follow-up Phase||15
3349047|NCT03542305|4079109|FG000|STARTED|Overall Study||8
3349048|NCT03542305|4079110|FG001|STARTED|Overall Study||8
3349049|NCT03542305|4079111|FG002|STARTED|Overall Study||8
3349050|NCT03542305|4079112|FG003|STARTED|Overall Study||5
3349051|NCT03542305|4079109|FG000|COMPLETED|Overall Study||8
3349052|NCT03542305|4079110|FG001|COMPLETED|Overall Study||8
3349053|NCT03542305|4079111|FG002|COMPLETED|Overall Study||8
3349054|NCT03542305|4079112|FG003|COMPLETED|Overall Study||5
3349055|NCT03542305|4079109|FG000|NOT COMPLETED|Overall Study||0
3349056|NCT03542305|4079110|FG001|NOT COMPLETED|Overall Study||0
3349057|NCT03542305|4079111|FG002|NOT COMPLETED|Overall Study||0
3349058|NCT03542305|4079112|FG003|NOT COMPLETED|Overall Study||0
3349059|NCT03542474|4079122|FG000|STARTED|Overall Study||8
3349060|NCT03542474|4079122|FG000|COMPLETED|Overall Study||8
3349061|NCT03542474|4079122|FG000|NOT COMPLETED|Overall Study||0
3349062|NCT03543085|4079126|FG000|STARTED|Overall Study||10
3349063|NCT03543085|4079126|FG000|COMPLETED|Overall Study||10
3349064|NCT03543085|4079126|FG000|NOT COMPLETED|Overall Study||0
3349065|NCT03543137|4079130|FG000|STARTED|Study Period 1: Up to Day 1||18
3349066|NCT03543137|4079131|FG001|STARTED|Study Period 1: Up to Day 1||19
3349067|NCT03543137|4079130|FG000|COMPLETED|Study Period 1: Up to Day 1||18
3349068|NCT03543137|4079131|FG001|COMPLETED|Study Period 1: Up to Day 1||19
3349069|NCT03543137|4079130|FG000|NOT COMPLETED|Study Period 1: Up to Day 1||0
3349070|NCT03543137|4079131|FG001|NOT COMPLETED|Study Period 1: Up to Day 1||0
3349071|NCT03543137|4079130|FG000|STARTED|Washout Period: 5 to 7 Days||18
3349072|NCT03543137|4079131|FG001|STARTED|Washout Period: 5 to 7 Days||19
3349073|NCT03543137|4079130|FG000|COMPLETED|Washout Period: 5 to 7 Days||18
3349074|NCT03543137|4079131|FG001|COMPLETED|Washout Period: 5 to 7 Days||19
3039884|NCT01161420|3759410|FG000|STARTED|Inspire Therapy||126
3039885|NCT01161420|3759410|FG000|COMPLETED|Inspire Therapy||124
3039886|NCT01161420|3759410|FG000|NOT COMPLETED|Inspire Therapy||2
3039887|NCT01161420|3759410|FG000|STARTED|Withdrawal Study - Maintenance||23
3039888|NCT01161420|3759410|FG000|COMPLETED|Withdrawal Study - Maintenance||23
3177967|NCT01974141|3905808|FG000|COMPLETED|Overall Study||948
3349075|NCT03543137|4079130|FG000|NOT COMPLETED|Washout Period: 5 to 7 Days||0
3349076|NCT03543137|4079131|FG001|NOT COMPLETED|Washout Period: 5 to 7 Days||0
3349077|NCT03543137|4079130|FG000|STARTED|Study Period 2: Up to Day 8||18
3349078|NCT03543137|4079131|FG001|STARTED|Study Period 2: Up to Day 8||19
3349079|NCT03543137|4079130|FG000|Treated|Study Period 2: Up to Day 8||16
3349080|NCT03543137|4079131|FG001|Treated|Study Period 2: Up to Day 8||18
3349081|NCT03543137|4079130|FG000|COMPLETED|Study Period 2: Up to Day 8||16
3349082|NCT03543137|4079131|FG001|COMPLETED|Study Period 2: Up to Day 8||18
3349083|NCT03543137|4079130|FG000|NOT COMPLETED|Study Period 2: Up to Day 8||2
3177968|NCT01974141|3905809|FG001|COMPLETED|Overall Study||976
3177969|NCT01974141|3905808|FG000|NOT COMPLETED|Overall Study||96
3177970|NCT01974141|3905809|FG001|NOT COMPLETED|Overall Study||82
3177971|NCT01974245|3905817|FG000|STARTED|Overall Study||27
3177972|NCT01974245|3905818|FG001|STARTED|Overall Study||28
3177973|NCT01974245|3905817|FG000|COMPLETED|Overall Study||18
3177974|NCT01974245|3905818|FG001|COMPLETED|Overall Study||20
3177975|NCT01974245|3905817|FG000|NOT COMPLETED|Overall Study||9
3177976|NCT01974245|3905818|FG001|NOT COMPLETED|Overall Study||8
3177977|NCT01974323|3905826|FG000|STARTED|Overall Study||1118
3177978|NCT01974323|3905827|FG001|STARTED|Overall Study||1120
3177979|NCT01974323|3905826|FG000|COMPLETED|Overall Study||1026
3177980|NCT01974323|3905827|FG001|COMPLETED|Overall Study||1027
3177981|NCT01974323|3905826|FG000|NOT COMPLETED|Overall Study||92
3177982|NCT01974323|3905827|FG001|NOT COMPLETED|Overall Study||93
3177983|NCT01974687|3905858|FG000|STARTED|Overall Study||6
3177984|NCT01974687|3905859|FG001|STARTED|Overall Study||6
3177985|NCT01974687|3905860|FG002|STARTED|Overall Study||6
3177986|NCT01974687|3905861|FG003|STARTED|Overall Study||6
3177987|NCT01974687|3905862|FG004|STARTED|Overall Study||2
3177988|NCT01974687|3905863|FG005|STARTED|Overall Study||6
3177989|NCT01974687|3905864|FG006|STARTED|Overall Study||3
3177990|NCT01974687|3905865|FG007|STARTED|Overall Study||3
3177991|NCT01974687|3905866|FG008|STARTED|Overall Study||3
3177992|NCT01974687|3905867|FG009|STARTED|Overall Study||3
3177993|NCT01974687|3905868|FG010|STARTED|Overall Study||3
3177994|NCT01974687|3905869|FG011|STARTED|Overall Study||13
3177995|NCT01974687|3905870|FG012|STARTED|Overall Study||13
3177996|NCT01974687|3905871|FG013|STARTED|Overall Study||10
3177997|NCT01974687|3905872|FG014|STARTED|Overall Study||19
3177998|NCT01974687|3905873|FG015|STARTED|Overall Study||9
3349084|NCT03543137|4079131|FG001|NOT COMPLETED|Study Period 2: Up to Day 8||1
3177999|NCT01974687|3905874|FG016|STARTED|Overall Study||9
3178000|NCT01974687|3905875|FG017|STARTED|Overall Study||11
3178001|NCT01974687|3905876|FG018|STARTED|Overall Study||9
3178002|NCT01974687|3905877|FG019|STARTED|Overall Study||3
3178003|NCT01974687|3905878|FG020|STARTED|Overall Study||3
3178004|NCT01974687|3905879|FG021|STARTED|Overall Study||8
3178005|NCT01974687|3905880|FG022|STARTED|Overall Study||8
3349085|NCT03543176|4079141|FG000|STARTED|Overall Study||392
3349086|NCT03543176|4079142|FG001|STARTED|Overall Study||397
3349087|NCT03543176|4079141|FG000|COMPLETED|Overall Study||392
3349088|NCT03543176|4079142|FG001|COMPLETED|Overall Study||397
3349089|NCT03543176|4079141|FG000|NOT COMPLETED|Overall Study||0
3349090|NCT03543176|4079142|FG001|NOT COMPLETED|Overall Study||0
3349091|NCT03543878|4079150|FG000|STARTED|Overall Study||5
3349092|NCT03543878|4079151|FG001|STARTED|Overall Study||5
3349093|NCT03543878|4079150|FG000|COMPLETED|Overall Study||5
3349094|NCT03543878|4079151|FG001|COMPLETED|Overall Study||5
3349095|NCT03543878|4079150|FG000|NOT COMPLETED|Overall Study||0
3349096|NCT03543878|4079151|FG001|NOT COMPLETED|Overall Study||0
3349097|NCT03544216|4079160|FG000|STARTED|Overall Study||42
3349098|NCT03544216|4079161|FG001|STARTED|Overall Study||42
3349099|NCT03544216|4079160|FG000|COMPLETED|Overall Study||42
3349100|NCT03544216|4079161|FG001|COMPLETED|Overall Study||42
3349101|NCT03544216|4079160|FG000|NOT COMPLETED|Overall Study||0
3349102|NCT03544216|4079161|FG001|NOT COMPLETED|Overall Study||0
3349103|NCT03544307|4079170|FG000|STARTED|Overall Study||10
3349104|NCT03544307|4079171|FG001|STARTED|Overall Study||10
3349105|NCT03544307|4079170|FG000|COMPLETED|Overall Study||10
3349106|NCT03544307|4079171|FG001|COMPLETED|Overall Study||10
3349107|NCT03544307|4079170|FG000|NOT COMPLETED|Overall Study||0
3349108|NCT03544307|4079171|FG001|NOT COMPLETED|Overall Study||0
3349109|NCT03544333|4079179|FG000|STARTED|Overall Study||3
3349110|NCT03544333|4079180|FG001|STARTED|Overall Study||2
3349111|NCT03544333|4079179|FG000|COMPLETED|Overall Study||2
3349112|NCT03544333|4079180|FG001|COMPLETED|Overall Study||2
3349113|NCT03544333|4079179|FG000|NOT COMPLETED|Overall Study||1
3349114|NCT03544333|4079180|FG001|NOT COMPLETED|Overall Study||0
3349115|NCT03544879|4079188|FG000|STARTED|Overall Study||22
3349116|NCT03544879|4079189|FG001|STARTED|Overall Study||24
3349117|NCT03544879|4079188|FG000|Completed Follow-up Physical Assessment|Overall Study||20
3349118|NCT03544879|4079189|FG001|Completed Follow-up Physical Assessment|Overall Study||21
3349119|NCT03544879|4079188|FG000|COMPLETED|Overall Study||22
3349120|NCT03544879|4079189|FG001|COMPLETED|Overall Study||23
3349121|NCT03544879|4079188|FG000|NOT COMPLETED|Overall Study||0
3349122|NCT03544879|4079189|FG001|NOT COMPLETED|Overall Study||1
3349123|NCT03545165|4079197|FG000|STARTED|Overall Study||6
3349124|NCT03545165|4079197|FG000|COMPLETED|Overall Study||6
3349125|NCT03545165|4079197|FG000|NOT COMPLETED|Overall Study||0
3349126|NCT03545412|4079201|FG000|STARTED|Overall Study||25
3349127|NCT03545412|4079201|FG000|COMPLETED|Overall Study||25
3349128|NCT03545412|4079201|FG000|NOT COMPLETED|Overall Study||0
3349129|NCT03545503|4079207|FG000|STARTED|Overall Study||208
3349130|NCT03545503|4079208|FG001|STARTED|Overall Study||220
3349131|NCT03545503|4079207|FG000|COMPLETED|Overall Study||194
3349132|NCT03545503|4079208|FG001|COMPLETED|Overall Study||204
3349133|NCT03545503|4079207|FG000|NOT COMPLETED|Overall Study||14
3349134|NCT03545503|4079208|FG001|NOT COMPLETED|Overall Study||16
3349135|NCT03545893|4079216|FG000|STARTED|Overall Study||35
3349136|NCT03545893|4079217|FG001|STARTED|Overall Study||35
3349137|NCT03545893|4079216|FG000|COMPLETED|Overall Study||35
3349138|NCT03545893|4079217|FG001|COMPLETED|Overall Study||35
3349139|NCT03545893|4079216|FG000|NOT COMPLETED|Overall Study||0
3349140|NCT03545893|4079217|FG001|NOT COMPLETED|Overall Study||0
3349141|NCT03545984|4079225|FG000|STARTED|Overall Study||24
3349142|NCT03545984|4079226|FG001|STARTED|Overall Study||24
3349143|NCT03545984|4079225|FG000|COMPLETED|Overall Study||13
3349144|NCT03545984|4079226|FG001|COMPLETED|Overall Study||15
3349145|NCT03545984|4079225|FG000|NOT COMPLETED|Overall Study||11
3349146|NCT03545984|4079226|FG001|NOT COMPLETED|Overall Study||9
3349147|NCT03546192|4079234|FG000|STARTED|Overall Study||60
3349148|NCT03546192|4079235|FG001|STARTED|Overall Study||60
3349149|NCT03546192|4079234|FG000|COMPLETED|Overall Study||60
3349150|NCT03546192|4079235|FG001|COMPLETED|Overall Study||60
3349151|NCT03546192|4079234|FG000|NOT COMPLETED|Overall Study||0
3349152|NCT03546192|4079235|FG001|NOT COMPLETED|Overall Study||0
3349153|NCT03546270|4079243|FG000|STARTED|Overall Study||52
3349154|NCT03546270|4079244|FG001|STARTED|Overall Study||48
3349155|NCT03546270|4079243|FG000|COMPLETED|Overall Study||52
3349156|NCT03546270|4079244|FG001|COMPLETED|Overall Study||48
3349157|NCT03546270|4079243|FG000|NOT COMPLETED|Overall Study||0
3349158|NCT03546270|4079244|FG001|NOT COMPLETED|Overall Study||0
3349159|NCT03546491|4079250|FG000|STARTED|Overall Study||32
3349160|NCT03546491|4079250|FG000|Recieved Test Product 1|Overall Study||32
3349161|NCT03546491|4079250|FG000|Received Test Product 2|Overall Study||32
3349162|NCT03546491|4079250|FG000|COMPLETED|Overall Study||30
3349163|NCT03546491|4079250|FG000|NOT COMPLETED|Overall Study||2
3349164|NCT03546621|4079264|FG000|STARTED|Overall Study||28
3349165|NCT03546621|4079265|FG001|STARTED|Overall Study||32
3349166|NCT03546621|4079266|FG002|STARTED|Overall Study||30
3349167|NCT03546621|4079267|FG003|STARTED|Overall Study|2 patients from Tenofovir only group withdrew from the study before treatment.|28
3349168|NCT03546621|4079264|FG000|COMPLETED|Overall Study||28
3349169|NCT03546621|4079265|FG001|COMPLETED|Overall Study||29
3349170|NCT03546621|4079266|FG002|COMPLETED|Overall Study||28
3349171|NCT03546621|4079267|FG003|COMPLETED|Overall Study||25
3349172|NCT03546621|4079264|FG000|NOT COMPLETED|Overall Study||0
3349173|NCT03546621|4079265|FG001|NOT COMPLETED|Overall Study||3
3349174|NCT03546621|4079266|FG002|NOT COMPLETED|Overall Study||2
3349175|NCT03546621|4079267|FG003|NOT COMPLETED|Overall Study||3
3349176|NCT03546647|4079277|FG000|STARTED|Overall Study||18
3349177|NCT03546647|4079278|FG001|STARTED|Overall Study|34|17
3349178|NCT03546647|4079277|FG000|COMPLETED|Overall Study||17
3349179|NCT03546647|4079278|FG001|COMPLETED|Overall Study||17
3349180|NCT03546647|4079277|FG000|NOT COMPLETED|Overall Study||1
3349181|NCT03546647|4079278|FG001|NOT COMPLETED|Overall Study||0
3349182|NCT03546816|4079286|FG000|STARTED|Overall Study||142
3349183|NCT03546816|4079287|FG001|STARTED|Overall Study||143
3349184|NCT03546816|4079286|FG000|COMPLETED|Overall Study||121
3349185|NCT03546816|4079287|FG001|COMPLETED|Overall Study||124
3349186|NCT03546816|4079286|FG000|NOT COMPLETED|Overall Study||21
3349187|NCT03546816|4079287|FG001|NOT COMPLETED|Overall Study||19
3349188|NCT03546842|4079295|FG000|STARTED|Overall Study||201
3349189|NCT03546842|4079295|FG000|Vaccination 1|Overall Study||200
3349190|NCT03546842|4079295|FG000|Vaccination 2|Overall Study||200
3349191|NCT03546842|4079295|FG000|Vaccination 3|Overall Study||198
3349192|NCT03546842|4079295|FG000|COMPLETED|Overall Study||198
3349193|NCT03546842|4079295|FG000|NOT COMPLETED|Overall Study||3
3349194|NCT03547154|4079301|FG000|STARTED|Overall Study||173
3349195|NCT03547154|4079302|FG001|STARTED|Overall Study||171
3349196|NCT03547154|4079301|FG000|COMPLETED|Overall Study||50
3349197|NCT03547154|4079302|FG001|COMPLETED|Overall Study||55
3349198|NCT03547154|4079301|FG000|NOT COMPLETED|Overall Study||123
3349199|NCT03547154|4079302|FG001|NOT COMPLETED|Overall Study||116
3349200|NCT03547167|4079310|FG000|STARTED|Overall Study||1135
3349201|NCT03547167|4079311|FG001|STARTED|Overall Study||380
3349202|NCT03547167|4079310|FG000|Vaccination 1 - (V114 or Prevnar 13™, Day 1)|Overall Study||1133
3349203|NCT03547167|4079311|FG001|Vaccination 1 - (V114 or Prevnar 13™, Day 1)|Overall Study||379
3349204|NCT03547167|4079310|FG000|Vaccination 2 - (PNEUMOVAX™23, Month 6)|Overall Study||1035
3349205|NCT03547167|4079311|FG001|Vaccination 2 - (PNEUMOVAX™23, Month 6)|Overall Study||346
3349206|NCT03547167|4079310|FG000|COMPLETED|Overall Study||1038
3349207|NCT03547167|4079311|FG001|COMPLETED|Overall Study||350
3349208|NCT03547167|4079310|FG000|NOT COMPLETED|Overall Study||97
3349209|NCT03547167|4079311|FG001|NOT COMPLETED|Overall Study||30
3349210|NCT03547531|4079323|FG000|STARTED|Overall Study||62
3349211|NCT03547531|4079324|FG001|STARTED|Overall Study||62
3349212|NCT03547531|4079323|FG000|COMPLETED|Overall Study||60
3349213|NCT03547531|4079324|FG001|COMPLETED|Overall Study||58
3349214|NCT03547531|4079323|FG000|NOT COMPLETED|Overall Study||2
3349215|NCT03547531|4079324|FG001|NOT COMPLETED|Overall Study||4
3349216|NCT03547583|4079333|FG000|STARTED|Overall Study||263
3349217|NCT03547583|4079334|FG001|STARTED|Overall Study||264
3349218|NCT03547583|4079335|FG002|STARTED|Overall Study||262
3349219|NCT03547583|4079333|FG000|Treated|Overall Study||262
3349220|NCT03547583|4079334|FG001|Treated|Overall Study||264
3349221|NCT03547583|4079335|FG002|Treated|Overall Study||262
3349222|NCT03547583|4079333|FG000|COMPLETED|Overall Study||218
3349223|NCT03547583|4079334|FG001|COMPLETED|Overall Study||224
3349224|NCT03547583|4079335|FG002|COMPLETED|Overall Study||230
3349225|NCT03547583|4079333|FG000|NOT COMPLETED|Overall Study||45
3349226|NCT03547583|4079334|FG001|NOT COMPLETED|Overall Study||40
3349227|NCT03547583|4079335|FG002|NOT COMPLETED|Overall Study||32
3349228|NCT03547635|4079349|FG000|STARTED|Overall Study||41
3349229|NCT03547635|4079350|FG001|STARTED|Overall Study||38
3349230|NCT03547635|4079351|FG002|STARTED|Overall Study||37
3349231|NCT03547635|4079349|FG000|COMPLETED|Overall Study||33
3349232|NCT03547635|4079350|FG001|COMPLETED|Overall Study||31
3349233|NCT03547635|4079351|FG002|COMPLETED|Overall Study||29
3349234|NCT03547635|4079349|FG000|NOT COMPLETED|Overall Study||8
3349235|NCT03547635|4079350|FG001|NOT COMPLETED|Overall Study||7
3349236|NCT03547635|4079351|FG002|NOT COMPLETED|Overall Study||8
3349237|NCT03547687|4079359|FG000|STARTED|Overall Study||9
3349238|NCT03547687|4079359|FG000|COMPLETED|Overall Study||7
3178006|NCT01974687|3905881|FG023|STARTED|Overall Study||6
3178007|NCT01974687|3905882|FG024|STARTED|Overall Study||10
3178008|NCT01974687|3905858|FG000|Treated|Overall Study||6
3178009|NCT01974687|3905859|FG001|Treated|Overall Study||6
3178010|NCT01974687|3905860|FG002|Treated|Overall Study||6
3349239|NCT03547687|4079359|FG000|NOT COMPLETED|Overall Study||2
3349240|NCT03548337|4079365|FG000|STARTED|Infant Series||151
3349241|NCT03548337|4079366|FG001|STARTED|Infant Series||150
3349242|NCT03548337|4079365|FG000|Vaccination 1|Infant Series||150
3349243|NCT03548337|4079366|FG001|Vaccination 1|Infant Series||150
3349244|NCT03548337|4079365|FG000|Vaccination 2|Infant Series||144
3349245|NCT03548337|4079366|FG001|Vaccination 2|Infant Series||144
3349246|NCT03548337|4079365|FG000|Vaccination 3|Infant Series||144
3349247|NCT03548337|4079366|FG001|Vaccination 3|Infant Series||141
3349248|NCT03548337|4079365|FG000|COMPLETED|Infant Series||139
3349249|NCT03548337|4079366|FG001|COMPLETED|Infant Series||139
3349250|NCT03548337|4079365|FG000|NOT COMPLETED|Infant Series||12
3349251|NCT03548337|4079366|FG001|NOT COMPLETED|Infant Series||11
3349252|NCT03548337|4079365|FG000|STARTED|Toddler Dose||139
3349253|NCT03548337|4079366|FG001|STARTED|Toddler Dose||139
3349254|NCT03548337|4079365|FG000|Vaccination 4|Toddler Dose||139
3349255|NCT03548337|4079366|FG001|Vaccination 4|Toddler Dose||139
3349256|NCT03548337|4079365|FG000|COMPLETED|Toddler Dose||138
3349257|NCT03548337|4079366|FG001|COMPLETED|Toddler Dose||138
3349258|NCT03548337|4079365|FG000|NOT COMPLETED|Toddler Dose||1
3349259|NCT03548337|4079366|FG001|NOT COMPLETED|Toddler Dose||1
3349260|NCT03548935|4079380|FG000|STARTED|Overall Study||1306
3349261|NCT03548935|4079381|FG001|STARTED|Overall Study||655
3349262|NCT03548935|4079380|FG000|Full Analysis Set (FAS)|Overall Study||1306
3349263|NCT03548935|4079381|FG001|Full Analysis Set (FAS)|Overall Study||655
3349264|NCT03548935|4079380|FG000|Safety Analysis Set (SAS)|Overall Study||1306
3349265|NCT03548935|4079381|FG001|Safety Analysis Set (SAS)|Overall Study||655
3349266|NCT03548935|4079380|FG000|COMPLETED|Overall Study||1240
3349267|NCT03548935|4079381|FG001|COMPLETED|Overall Study||609
3349268|NCT03548935|4079380|FG000|NOT COMPLETED|Overall Study||66
3349269|NCT03548935|4079381|FG001|NOT COMPLETED|Overall Study||46
3349270|NCT03549117|4079389|FG000|STARTED|Overall Study||70
3349271|NCT03549117|4079390|FG001|STARTED|Overall Study||70
3349272|NCT03549117|4079389|FG000|COMPLETED|Overall Study||69
3349273|NCT03549117|4079390|FG001|COMPLETED|Overall Study||70
3349274|NCT03549117|4079389|FG000|NOT COMPLETED|Overall Study||1
3349275|NCT03549117|4079390|FG001|NOT COMPLETED|Overall Study||0
3349276|NCT03549130|4079398|FG000|STARTED|Overall Study||64
3349277|NCT03549130|4079399|FG001|STARTED|Overall Study||66
3349278|NCT03549130|4079398|FG000|COMPLETED|Overall Study||64
3349279|NCT03549130|4079399|FG001|COMPLETED|Overall Study||64
3349280|NCT03549130|4079398|FG000|NOT COMPLETED|Overall Study||0
3349281|NCT03549130|4079399|FG001|NOT COMPLETED|Overall Study||2
3349282|NCT03549234|4079409|FG000|STARTED|Overall Study||50
3349283|NCT03549234|4079410|FG001|STARTED|Overall Study||50
3349284|NCT03549234|4079409|FG000|COMPLETED|Overall Study||50
3349285|NCT03549234|4079410|FG001|COMPLETED|Overall Study||50
3349286|NCT03549234|4079409|FG000|NOT COMPLETED|Overall Study||0
3349287|NCT03549234|4079410|FG001|NOT COMPLETED|Overall Study||0
3349288|NCT03549338|4079419|FG000|STARTED|Overall Study||1
3349289|NCT03549338|4079420|FG001|STARTED|Overall Study||1
3349290|NCT03549338|4079421|FG002|STARTED|Overall Study||0
3349291|NCT03549338|4079419|FG000|COMPLETED|Overall Study||0
3349292|NCT03549338|4079420|FG001|COMPLETED|Overall Study|Patient crossed-over to Sym004 at the EOC1 per Sponsor decision following trial termination.|0
3349293|NCT03549338|4079421|FG002|COMPLETED|Overall Study||0
3349294|NCT03549338|4079419|FG000|NOT COMPLETED|Overall Study||1
3349295|NCT03549338|4079420|FG001|NOT COMPLETED|Overall Study||1
3349296|NCT03549338|4079421|FG002|NOT COMPLETED|Overall Study||0
3349297|NCT03549429|4079429|FG000|STARTED|Overall Study||81
3349298|NCT03549429|4079430|FG001|STARTED|Overall Study||78
3349299|NCT03549429|4079429|FG000|COMPLETED|Overall Study||76
3349300|NCT03549429|4079430|FG001|COMPLETED|Overall Study||75
3349301|NCT03549429|4079429|FG000|NOT COMPLETED|Overall Study||5
3349302|NCT03549429|4079430|FG001|NOT COMPLETED|Overall Study||3
3349303|NCT03549598|4079438|FG000|STARTED|Overall Study||15
3178011|NCT01974687|3905861|FG003|Treated|Overall Study||6
3178012|NCT01974687|3905862|FG004|Treated|Overall Study||2
3178013|NCT01974687|3905863|FG005|Treated|Overall Study||6
3178014|NCT01974687|3905864|FG006|Treated|Overall Study||3
3178015|NCT01974687|3905865|FG007|Treated|Overall Study||3
3349304|NCT03549598|4079438|FG000|COMPLETED|Overall Study||15
3349305|NCT03549598|4079438|FG000|NOT COMPLETED|Overall Study||0
3349306|NCT03550066|4079446|FG000|STARTED|Overall Study||49
3349307|NCT03550066|4079447|FG001|STARTED|Overall Study||41
3349308|NCT03550066|4079446|FG000|COMPLETED|Overall Study||49
3349309|NCT03550066|4079447|FG001|COMPLETED|Overall Study||41
3349310|NCT03550066|4079446|FG000|NOT COMPLETED|Overall Study||0
3349311|NCT03550066|4079447|FG001|NOT COMPLETED|Overall Study||0
3349312|NCT03550209|4079457|FG000|STARTED|Overall Study||12
3349313|NCT03550209|4079458|FG001|STARTED|Overall Study||12
3349314|NCT03550209|4079459|FG002|STARTED|Overall Study||13
3349315|NCT03550209|4079460|FG003|STARTED|Overall Study||35
3349316|NCT03550209|4079457|FG000|COMPLETED|Overall Study||11
3349317|NCT03550209|4079458|FG001|COMPLETED|Overall Study||9
3349318|NCT03550209|4079459|FG002|COMPLETED|Overall Study||11
3349319|NCT03550209|4079460|FG003|COMPLETED|Overall Study||31
3349320|NCT03550209|4079457|FG000|NOT COMPLETED|Overall Study||1
3349321|NCT03550209|4079458|FG001|NOT COMPLETED|Overall Study||3
3349322|NCT03550209|4079459|FG002|NOT COMPLETED|Overall Study||2
3349323|NCT03550209|4079460|FG003|NOT COMPLETED|Overall Study||4
3349324|NCT03550313|4079473|FG000|STARTED|Overall Study||192
3349325|NCT03550313|4079474|FG001|STARTED|Overall Study||187
3349326|NCT03550313|4079475|FG002|STARTED|Overall Study||186
3349327|NCT03550313|4079473|FG000|Vaccinated for Dose 1|Overall Study||171
3349328|NCT03550313|4079474|FG001|Vaccinated for Dose 1|Overall Study||147
3349329|NCT03550313|4079475|FG002|Vaccinated for Dose 1|Overall Study||166
3349330|NCT03550313|4079473|FG000|Vaccinated for Dose 2|Overall Study||159
3349331|NCT03550313|4079474|FG001|Vaccinated for Dose 2|Overall Study||135
3349332|NCT03550313|4079475|FG002|Vaccinated for Dose 2|Overall Study||153
3349333|NCT03550313|4079473|FG000|Vaccinated for Dose 3|Overall Study||151
3349334|NCT03550313|4079474|FG001|Vaccinated for Dose 3|Overall Study||127
3349335|NCT03550313|4079475|FG002|Vaccinated for Dose 3|Overall Study||146
3349336|NCT03550313|4079473|FG000|COMPLETED|Overall Study||95
3349337|NCT03550313|4079474|FG001|COMPLETED|Overall Study||77
3349338|NCT03550313|4079475|FG002|COMPLETED|Overall Study||72
3349339|NCT03550313|4079473|FG000|NOT COMPLETED|Overall Study||97
3349340|NCT03550313|4079474|FG001|NOT COMPLETED|Overall Study||110
3349341|NCT03550313|4079475|FG002|NOT COMPLETED|Overall Study||114
3349342|NCT03550378|4079486|FG000|STARTED|Overall Study||20
3349343|NCT03550378|4079487|FG001|STARTED|Overall Study||21
3349344|NCT03550378|4079486|FG000|COMPLETED|Overall Study||20
3349345|NCT03550378|4079487|FG001|COMPLETED|Overall Study||20
3349346|NCT03550378|4079486|FG000|NOT COMPLETED|Overall Study||0
3349347|NCT03550378|4079487|FG001|NOT COMPLETED|Overall Study||1
3349348|NCT03550989|4079498|FG000|STARTED|Overall Study||190
3349349|NCT03550989|4079499|FG001|STARTED|Overall Study||74
3349350|NCT03550989|4079500|FG002|STARTED|Overall Study||77
3349351|NCT03550989|4079501|FG003|STARTED|Overall Study||60
3349352|NCT03550989|4079498|FG000|COMPLETED|Overall Study||188
3349353|NCT03550989|4079499|FG001|COMPLETED|Overall Study||73
3349354|NCT03550989|4079500|FG002|COMPLETED|Overall Study||76
3349355|NCT03550989|4079501|FG003|COMPLETED|Overall Study||60
3349356|NCT03550989|4079498|FG000|NOT COMPLETED|Overall Study||2
3349357|NCT03550989|4079499|FG001|NOT COMPLETED|Overall Study||1
3349358|NCT03550989|4079500|FG002|NOT COMPLETED|Overall Study||1
3349359|NCT03550989|4079501|FG003|NOT COMPLETED|Overall Study||0
3349360|NCT03551730|4079519|FG000|STARTED|Overall Study||9
3349361|NCT03551730|4079520|FG001|STARTED|Overall Study||6
3349362|NCT03551730|4079521|FG002|STARTED|Overall Study||6
3349363|NCT03551730|4079522|FG003|STARTED|Overall Study||6
3349364|NCT03551730|4079519|FG000|COMPLETED|Overall Study||8
3349365|NCT03551730|4079520|FG001|COMPLETED|Overall Study||6
3349366|NCT03551730|4079521|FG002|COMPLETED|Overall Study||6
3349367|NCT03551730|4079522|FG003|COMPLETED|Overall Study||6
3349368|NCT03551730|4079519|FG000|NOT COMPLETED|Overall Study||1
3349369|NCT03551730|4079520|FG001|NOT COMPLETED|Overall Study||0
3349370|NCT03551730|4079521|FG002|NOT COMPLETED|Overall Study||0
3349371|NCT03551730|4079522|FG003|NOT COMPLETED|Overall Study||0
3349372|NCT03551743|4079536|FG000|STARTED|Overall Study||10
3349373|NCT03551743|4079537|FG001|STARTED|Overall Study||6
3349374|NCT03551743|4079538|FG002|STARTED|Overall Study||6
3349375|NCT03551743|4079539|FG003|STARTED|Overall Study||6
3349376|NCT03551743|4079536|FG000|COMPLETED|Overall Study||8
3349377|NCT03551743|4079537|FG001|COMPLETED|Overall Study||6
3349378|NCT03551743|4079538|FG002|COMPLETED|Overall Study||6
3349379|NCT03551743|4079539|FG003|COMPLETED|Overall Study||6
3349380|NCT03551743|4079536|FG000|NOT COMPLETED|Overall Study||2
3349381|NCT03551743|4079537|FG001|NOT COMPLETED|Overall Study||0
3349382|NCT03551743|4079538|FG002|NOT COMPLETED|Overall Study||0
3349383|NCT03551743|4079539|FG003|NOT COMPLETED|Overall Study||0
3349384|NCT03551821|4079549|FG000|STARTED|Overall Study||1
3349385|NCT03551821|4079549|FG000|COMPLETED|Overall Study||1
3349386|NCT03551821|4079549|FG000|NOT COMPLETED|Overall Study||0
3349387|NCT03552198|4079557|FG000|STARTED|Overall Study||83
3349388|NCT03552198|4079558|FG001|STARTED|Overall Study||84
3349389|NCT03552198|4079559|FG002|STARTED|Overall Study||24
3349390|NCT03552198|4079560|FG003|STARTED|Overall Study||34
3349391|NCT03552198|4079557|FG000|Final Questionnaire 4 Weeks Follow-up|Overall Study||34
3349392|NCT03552198|4079558|FG001|Final Questionnaire 4 Weeks Follow-up|Overall Study||29
3349393|NCT03552198|4079559|FG002|Final Questionnaire 4 Weeks Follow-up|Overall Study||7
3349394|NCT03552198|4079560|FG003|Final Questionnaire 4 Weeks Follow-up|Overall Study||12
3349395|NCT03552198|4079557|FG000|COMPLETED|Overall Study||34
3349396|NCT03552198|4079558|FG001|COMPLETED|Overall Study||29
3349397|NCT03552198|4079559|FG002|COMPLETED|Overall Study||7
3349398|NCT03552198|4079560|FG003|COMPLETED|Overall Study||12
3349399|NCT03552198|4079557|FG000|NOT COMPLETED|Overall Study||49
3349400|NCT03552198|4079558|FG001|NOT COMPLETED|Overall Study||55
3349401|NCT03552198|4079559|FG002|NOT COMPLETED|Overall Study||17
3349402|NCT03552198|4079560|FG003|NOT COMPLETED|Overall Study||22
3349403|NCT03552289|4079572|FG000|STARTED|Overall Study||102
3349404|NCT03552289|4079573|FG001|STARTED|Overall Study||109
3349405|NCT03552289|4079572|FG000|COMPLETED|Overall Study||101
3349406|NCT03552289|4079573|FG001|COMPLETED|Overall Study||106
3349407|NCT03552289|4079572|FG000|NOT COMPLETED|Overall Study||1
3349408|NCT03552289|4079573|FG001|NOT COMPLETED|Overall Study||3
3349409|NCT03552523|4079579|FG000|STARTED|Overall Study||5
3349410|NCT03552523|4079580|FG001|STARTED|Overall Study||2
3349411|NCT03552523|4079579|FG000|COMPLETED|Overall Study||4
3349412|NCT03552523|4079580|FG001|COMPLETED|Overall Study||1
3349413|NCT03552523|4079579|FG000|NOT COMPLETED|Overall Study||1
3349414|NCT03552523|4079580|FG001|NOT COMPLETED|Overall Study||1
3349415|NCT03552536|4079589|FG000|STARTED|Overall Study||5
3349416|NCT03552536|4079590|FG001|STARTED|Overall Study||0
3349417|NCT03552536|4079591|FG002|STARTED|Overall Study||0
3349418|NCT03552536|4079589|FG000|COMPLETED|Overall Study||5
3349419|NCT03552536|4079590|FG001|COMPLETED|Overall Study||0
3349420|NCT03552536|4079591|FG002|COMPLETED|Overall Study||0
3349421|NCT03552536|4079589|FG000|NOT COMPLETED|Overall Study||0
3349422|NCT03552536|4079590|FG001|NOT COMPLETED|Overall Study||0
3349423|NCT03552536|4079591|FG002|NOT COMPLETED|Overall Study||0
3349424|NCT03552549|4079599|FG000|STARTED|Overall Study||63
3349425|NCT03552549|4079600|FG001|STARTED|Overall Study||63
3349426|NCT03552549|4079599|FG000|Treated|Overall Study||62
3349427|NCT03552549|4079600|FG001|Treated|Overall Study||62
3349428|NCT03552549|4079599|FG000|COMPLETED|Overall Study||10
3349429|NCT03552549|4079600|FG001|COMPLETED|Overall Study||11
3349430|NCT03552549|4079599|FG000|NOT COMPLETED|Overall Study||53
3349431|NCT03552549|4079600|FG001|NOT COMPLETED|Overall Study||52
3349432|NCT03552757|4079609|FG000|STARTED|Overall Study||403
3349433|NCT03552757|4079610|FG001|STARTED|Overall Study||404
3349434|NCT03552757|4079611|FG002|STARTED|Overall Study||403
3349435|NCT03552757|4079609|FG000|Exposed|Overall Study||402
3349436|NCT03552757|4079610|FG001|Exposed|Overall Study||403
3349437|NCT03552757|4079611|FG002|Exposed|Overall Study||402
3349438|NCT03552757|4079609|FG000|Full Analysis Set (FAS)|Overall Study||403
3349439|NCT03552757|4079610|FG001|Full Analysis Set (FAS)|Overall Study||404
3349440|NCT03552757|4079611|FG002|Full Analysis Set (FAS)|Overall Study||403
3349441|NCT03552757|4079609|FG000|Safety Analysis Set (SAS)|Overall Study||402
3349442|NCT03552757|4079610|FG001|Safety Analysis Set (SAS)|Overall Study||403
3349443|NCT03552757|4079611|FG002|Safety Analysis Set (SAS)|Overall Study||402
3349444|NCT03552757|4079609|FG000|COMPLETED|Overall Study||390
3349445|NCT03552757|4079610|FG001|COMPLETED|Overall Study||391
3349446|NCT03552757|4079611|FG002|COMPLETED|Overall Study||383
3349447|NCT03552757|4079609|FG000|NOT COMPLETED|Overall Study||13
3349448|NCT03552757|4079610|FG001|NOT COMPLETED|Overall Study||13
3349449|NCT03552757|4079611|FG002|NOT COMPLETED|Overall Study||20
3349450|NCT03553758|4079622|FG000|STARTED|Overall Study||16
3349451|NCT03553758|4079622|FG000|Completed Screening Visit|Overall Study||16
3349452|NCT03553758|4079622|FG000|COMPLETED|Overall Study||15
3349453|NCT03553758|4079622|FG000|NOT COMPLETED|Overall Study||1
3349454|NCT03553823|4079630|FG000|STARTED|Overall Study||20
3349455|NCT03553823|4079631|FG001|STARTED|Overall Study||20
3349456|NCT03553823|4079630|FG000|COMPLETED|Overall Study||20
3349457|NCT03553823|4079631|FG001|COMPLETED|Overall Study||19
3349458|NCT03553823|4079630|FG000|NOT COMPLETED|Overall Study||0
3349459|NCT03553823|4079631|FG001|NOT COMPLETED|Overall Study||1
3349460|NCT03553940|4079639|FG000|STARTED|Overall Study||22
3349461|NCT03553940|4079640|FG001|STARTED|Overall Study||21
3349462|NCT03553940|4079639|FG000|COMPLETED|Overall Study||22
3349463|NCT03553940|4079640|FG001|COMPLETED|Overall Study||21
3349464|NCT03553940|4079639|FG000|NOT COMPLETED|Overall Study||0
3349465|NCT03553940|4079640|FG001|NOT COMPLETED|Overall Study||0
3349466|NCT03554005|4079652|FG000|STARTED|Overall Study||1
3349467|NCT03554005|4079653|FG001|STARTED|Overall Study||2
3349468|NCT03554005|4079654|FG002|STARTED|Overall Study||2
3349469|NCT03554005|4079655|FG003|STARTED|Overall Study||2
3349470|NCT03554005|4079656|FG004|STARTED|Overall Study||11
3349471|NCT03554005|4079657|FG005|STARTED|Overall Study||11
3349472|NCT03554005|4079652|FG000|COMPLETED|Overall Study||0
3349473|NCT03554005|4079653|FG001|COMPLETED|Overall Study||1
3349474|NCT03554005|4079654|FG002|COMPLETED|Overall Study||1
3349475|NCT03554005|4079655|FG003|COMPLETED|Overall Study||1
3349476|NCT03554005|4079656|FG004|COMPLETED|Overall Study||5
3349477|NCT03554005|4079657|FG005|COMPLETED|Overall Study||0
3349478|NCT03554005|4079652|FG000|NOT COMPLETED|Overall Study||1
3349479|NCT03554005|4079653|FG001|NOT COMPLETED|Overall Study||1
3349480|NCT03554005|4079654|FG002|NOT COMPLETED|Overall Study||1
3349481|NCT03554005|4079655|FG003|NOT COMPLETED|Overall Study||1
3349482|NCT03554005|4079656|FG004|NOT COMPLETED|Overall Study||6
3349483|NCT03554005|4079657|FG005|NOT COMPLETED|Overall Study||11
3349484|NCT03554018|4079673|FG000|STARTED|Overall Study||60
3349485|NCT03554018|4079674|FG001|STARTED|Overall Study||60
3349486|NCT03554018|4079673|FG000|COMPLETED|Overall Study||57
3349487|NCT03554018|4079674|FG001|COMPLETED|Overall Study||53
3349488|NCT03554018|4079673|FG000|NOT COMPLETED|Overall Study||3
3349489|NCT03554018|4079674|FG001|NOT COMPLETED|Overall Study||7
3349490|NCT03554486|4079682|FG000|STARTED|Run-in Period (2 Weeks)||24
3349491|NCT03554486|4079683|FG001|STARTED|Run-in Period (2 Weeks)||0
3349492|NCT03554486|4079684|FG002|STARTED|Run-in Period (2 Weeks)||0
3349493|NCT03554486|4079682|FG000|COMPLETED|Run-in Period (2 Weeks)||21
3349494|NCT03554486|4079683|FG001|COMPLETED|Run-in Period (2 Weeks)||0
3349495|NCT03554486|4079684|FG002|COMPLETED|Run-in Period (2 Weeks)||0
3349496|NCT03554486|4079682|FG000|NOT COMPLETED|Run-in Period (2 Weeks)||3
3349497|NCT03554486|4079683|FG001|NOT COMPLETED|Run-in Period (2 Weeks)||0
3349498|NCT03554486|4079684|FG002|NOT COMPLETED|Run-in Period (2 Weeks)||0
3349499|NCT03554486|4079682|FG000|STARTED|Treatment Period 1 (2 Weeks)||0
3349500|NCT03554486|4079683|FG001|STARTED|Treatment Period 1 (2 Weeks)||11
3178016|NCT01974687|3905866|FG008|Treated|Overall Study||3
3178017|NCT01974687|3905867|FG009|Treated|Overall Study||3
3178018|NCT01974687|3905868|FG010|Treated|Overall Study||3
3349501|NCT03554486|4079684|FG002|STARTED|Treatment Period 1 (2 Weeks)||10
3349502|NCT03554486|4079682|FG000|COMPLETED|Treatment Period 1 (2 Weeks)||0
3349503|NCT03554486|4079683|FG001|COMPLETED|Treatment Period 1 (2 Weeks)||10
3349504|NCT03554486|4079684|FG002|COMPLETED|Treatment Period 1 (2 Weeks)||9
3349505|NCT03554486|4079682|FG000|NOT COMPLETED|Treatment Period 1 (2 Weeks)||0
3349506|NCT03554486|4079683|FG001|NOT COMPLETED|Treatment Period 1 (2 Weeks)||1
3349507|NCT03554486|4079684|FG002|NOT COMPLETED|Treatment Period 1 (2 Weeks)||1
3349508|NCT03554486|4079682|FG000|STARTED|Treatment Period 2 (2 Weeks)||0
3349509|NCT03554486|4079683|FG001|STARTED|Treatment Period 2 (2 Weeks)||10
3349510|NCT03554486|4079684|FG002|STARTED|Treatment Period 2 (2 Weeks)||9
3349511|NCT03554486|4079682|FG000|COMPLETED|Treatment Period 2 (2 Weeks)||0
3349512|NCT03554486|4079683|FG001|COMPLETED|Treatment Period 2 (2 Weeks)||10
3349513|NCT03554486|4079684|FG002|COMPLETED|Treatment Period 2 (2 Weeks)||9
3349514|NCT03554486|4079682|FG000|NOT COMPLETED|Treatment Period 2 (2 Weeks)||0
3349515|NCT03554486|4079683|FG001|NOT COMPLETED|Treatment Period 2 (2 Weeks)||0
3349516|NCT03554486|4079684|FG002|NOT COMPLETED|Treatment Period 2 (2 Weeks)||0
3349517|NCT03554629|4079691|FG000|STARTED|Overall Study|8 filterlines per participant for four scripted activities with supplemental oxygen|29
3349518|NCT03554629|4079691|FG000|COMPLETED|Overall Study|8 filterlines (CCSF) per participate for four scripted activities with supplemental oxygen.|23
3349519|NCT03554629|4079691|FG000|NOT COMPLETED|Overall Study||6
3349520|NCT03554746|4079721|FG000|STARTED|Overall Study||24
3349521|NCT03554746|4079722|FG001|STARTED|Overall Study||24
3349522|NCT03554746|4079721|FG000|COMPLETED|Overall Study||24
3349523|NCT03554746|4079722|FG001|COMPLETED|Overall Study||24
3349524|NCT03554746|4079721|FG000|NOT COMPLETED|Overall Study||0
3349525|NCT03554746|4079722|FG001|NOT COMPLETED|Overall Study||0
3349526|NCT03554772|4079732|FG000|STARTED|Overall Study||30
3349527|NCT03554772|4079733|FG001|STARTED|Overall Study||30
3349528|NCT03554772|4079734|FG002|STARTED|Overall Study||29
3349529|NCT03554772|4079735|FG003|STARTED|Overall Study||31
3349530|NCT03554772|4079732|FG000|Completed Treatment Period (8 Hours Post Dose)|Overall Study||30
3349531|NCT03554772|4079733|FG001|Completed Treatment Period (8 Hours Post Dose)|Overall Study||30
3349532|NCT03554772|4079734|FG002|Completed Treatment Period (8 Hours Post Dose)|Overall Study||29
3349533|NCT03554772|4079735|FG003|Completed Treatment Period (8 Hours Post Dose)|Overall Study||31
3349534|NCT03554772|4079732|FG000|COMPLETED|Overall Study||30
3349535|NCT03554772|4079733|FG001|COMPLETED|Overall Study||30
3349536|NCT03554772|4079734|FG002|COMPLETED|Overall Study||29
3349537|NCT03554772|4079735|FG003|COMPLETED|Overall Study||29
3349538|NCT03554772|4079732|FG000|NOT COMPLETED|Overall Study||0
3349539|NCT03554772|4079733|FG001|NOT COMPLETED|Overall Study||0
3349540|NCT03554772|4079734|FG002|NOT COMPLETED|Overall Study||0
3349541|NCT03554772|4079735|FG003|NOT COMPLETED|Overall Study||2
3349542|NCT03554954|4079745|FG000|STARTED|Overall Study||108
3349543|NCT03554954|4079745|FG000|COMPLETED|Overall Study||108
3349544|NCT03554954|4079745|FG000|NOT COMPLETED|Overall Study||0
3349545|NCT03555266|4079755|FG000|STARTED|Overall Study||32
3349546|NCT03555266|4079756|FG001|STARTED|Overall Study||31
3349547|NCT03555266|4079755|FG000|COMPLETED|Overall Study||26
3349548|NCT03555266|4079756|FG001|COMPLETED|Overall Study||27
3349549|NCT03555266|4079755|FG000|NOT COMPLETED|Overall Study||6
3349550|NCT03555266|4079756|FG001|NOT COMPLETED|Overall Study||4
3349551|NCT03555305|4079762|FG000|STARTED|Period 1||29
3349552|NCT03555305|4079763|FG001|STARTED|Period 1||29
3349553|NCT03555305|4079762|FG000|Received at Least 1 Dose of Study Drug|Period 1||29
3349554|NCT03555305|4079763|FG001|Received at Least 1 Dose of Study Drug|Period 1||29
3349555|NCT03555305|4079762|FG000|COMPLETED|Period 1||29
3349556|NCT03555305|4079763|FG001|COMPLETED|Period 1||27
3349557|NCT03555305|4079762|FG000|NOT COMPLETED|Period 1||0
3349558|NCT03555305|4079763|FG001|NOT COMPLETED|Period 1||2
3349559|NCT03555305|4079762|FG000|STARTED|Period 2||29
3349560|NCT03555305|4079763|FG001|STARTED|Period 2||27
3349561|NCT03555305|4079762|FG000|COMPLETED|Period 2||29
3349562|NCT03555305|4079763|FG001|COMPLETED|Period 2||27
3349563|NCT03555305|4079762|FG000|NOT COMPLETED|Period 2||0
3349564|NCT03555305|4079763|FG001|NOT COMPLETED|Period 2||0
3349565|NCT03555435|4079772|FG000|STARTED|Overall Study||28
3349566|NCT03555435|4079773|FG001|STARTED|Overall Study||27
3349567|NCT03555435|4079774|FG002|STARTED|Overall Study||26
3349568|NCT03555435|4079772|FG000|COMPLETED|Overall Study||11
3349569|NCT03555435|4079773|FG001|COMPLETED|Overall Study||8
3349570|NCT03555435|4079774|FG002|COMPLETED|Overall Study||18
3349571|NCT03555435|4079772|FG000|NOT COMPLETED|Overall Study||17
3349572|NCT03555435|4079773|FG001|NOT COMPLETED|Overall Study||19
3349573|NCT03555435|4079774|FG002|NOT COMPLETED|Overall Study||8
3349574|NCT03555565|4079782|FG000|STARTED|Overall Study||1026
3349575|NCT03555565|4079782|FG000|COMPLETED|Overall Study||1011
3349576|NCT03555565|4079782|FG000|NOT COMPLETED|Overall Study||15
3349577|NCT03555890|4079790|FG000|STARTED|Part 1:Treatment Period 1 (3 Days)||12
3349578|NCT03555890|4079791|FG001|STARTED|Part 1:Treatment Period 1 (3 Days)||12
3349579|NCT03555890|4079792|FG002|STARTED|Part 1:Treatment Period 1 (3 Days)||0
3349580|NCT03555890|4079793|FG003|STARTED|Part 1:Treatment Period 1 (3 Days)||0
3349581|NCT03555890|4079790|FG000|COMPLETED|Part 1:Treatment Period 1 (3 Days)||12
3349582|NCT03555890|4079791|FG001|COMPLETED|Part 1:Treatment Period 1 (3 Days)||12
3349583|NCT03555890|4079792|FG002|COMPLETED|Part 1:Treatment Period 1 (3 Days)||0
3349584|NCT03555890|4079793|FG003|COMPLETED|Part 1:Treatment Period 1 (3 Days)||0
3349585|NCT03555890|4079790|FG000|NOT COMPLETED|Part 1:Treatment Period 1 (3 Days)||0
3349586|NCT03555890|4079791|FG001|NOT COMPLETED|Part 1:Treatment Period 1 (3 Days)||0
3349587|NCT03555890|4079792|FG002|NOT COMPLETED|Part 1:Treatment Period 1 (3 Days)||0
3349588|NCT03555890|4079793|FG003|NOT COMPLETED|Part 1:Treatment Period 1 (3 Days)||0
3349589|NCT03555890|4079790|FG000|STARTED|Part 1:Washout Period (at Least 5 Days)||12
3349590|NCT03555890|4079791|FG001|STARTED|Part 1:Washout Period (at Least 5 Days)||12
3349591|NCT03555890|4079792|FG002|STARTED|Part 1:Washout Period (at Least 5 Days)||0
3349592|NCT03555890|4079793|FG003|STARTED|Part 1:Washout Period (at Least 5 Days)||0
3349593|NCT03555890|4079790|FG000|COMPLETED|Part 1:Washout Period (at Least 5 Days)||12
3349594|NCT03555890|4079791|FG001|COMPLETED|Part 1:Washout Period (at Least 5 Days)||12
3349595|NCT03555890|4079792|FG002|COMPLETED|Part 1:Washout Period (at Least 5 Days)||0
3349596|NCT03555890|4079793|FG003|COMPLETED|Part 1:Washout Period (at Least 5 Days)||0
3349597|NCT03555890|4079790|FG000|NOT COMPLETED|Part 1:Washout Period (at Least 5 Days)||0
3349598|NCT03555890|4079791|FG001|NOT COMPLETED|Part 1:Washout Period (at Least 5 Days)||0
3349599|NCT03555890|4079792|FG002|NOT COMPLETED|Part 1:Washout Period (at Least 5 Days)||0
3349600|NCT03555890|4079793|FG003|NOT COMPLETED|Part 1:Washout Period (at Least 5 Days)||0
3349601|NCT03555890|4079790|FG000|STARTED|Part 1:Treatment Period 2 (10 Days)||12
3349602|NCT03555890|4079791|FG001|STARTED|Part 1:Treatment Period 2 (10 Days)||12
3349603|NCT03555890|4079792|FG002|STARTED|Part 1:Treatment Period 2 (10 Days)||0
3349604|NCT03555890|4079793|FG003|STARTED|Part 1:Treatment Period 2 (10 Days)||0
3349605|NCT03555890|4079790|FG000|COMPLETED|Part 1:Treatment Period 2 (10 Days)||12
3349606|NCT03555890|4079791|FG001|COMPLETED|Part 1:Treatment Period 2 (10 Days)||12
3349607|NCT03555890|4079792|FG002|COMPLETED|Part 1:Treatment Period 2 (10 Days)||0
3349608|NCT03555890|4079793|FG003|COMPLETED|Part 1:Treatment Period 2 (10 Days)||0
3349609|NCT03555890|4079790|FG000|NOT COMPLETED|Part 1:Treatment Period 2 (10 Days)||0
3349610|NCT03555890|4079791|FG001|NOT COMPLETED|Part 1:Treatment Period 2 (10 Days)||0
3349611|NCT03555890|4079792|FG002|NOT COMPLETED|Part 1:Treatment Period 2 (10 Days)||0
3349612|NCT03555890|4079793|FG003|NOT COMPLETED|Part 1:Treatment Period 2 (10 Days)||0
3349613|NCT03555890|4079790|FG000|STARTED|Part 2:Treatment Period 1 (3 Days)||0
3349614|NCT03555890|4079791|FG001|STARTED|Part 2:Treatment Period 1 (3 Days)||0
3349615|NCT03555890|4079792|FG002|STARTED|Part 2:Treatment Period 1 (3 Days)||24
3349616|NCT03555890|4079793|FG003|STARTED|Part 2:Treatment Period 1 (3 Days)||24
3349617|NCT03555890|4079790|FG000|COMPLETED|Part 2:Treatment Period 1 (3 Days)||0
3349618|NCT03555890|4079791|FG001|COMPLETED|Part 2:Treatment Period 1 (3 Days)||0
3349619|NCT03555890|4079792|FG002|COMPLETED|Part 2:Treatment Period 1 (3 Days)||24
3349620|NCT03555890|4079793|FG003|COMPLETED|Part 2:Treatment Period 1 (3 Days)||24
3178019|NCT01974687|3905869|FG011|Treated|Overall Study|2 participants discontinued prior to receiving study drug|11
3178020|NCT01974687|3905870|FG012|Treated|Overall Study|3 participants discontinued prior to receiving study drug|10
3178021|NCT01974687|3905871|FG013|Treated|Overall Study|2 participants discontinued prior to receiving study drug|8
3178022|NCT01974687|3905872|FG014|Treated|Overall Study|1 participant discontinued prior to receiving study drug|18
3178023|NCT01974687|3905873|FG015|Treated|Overall Study|1 participant discontinued prior to receiving study drug|8
3178024|NCT01974687|3905874|FG016|Treated|Overall Study|1 participant discontinued prior to receiving study drug|8
3178025|NCT01974687|3905875|FG017|Treated|Overall Study|3 participants discontinued prior to receiving study drug|8
3178026|NCT01974687|3905876|FG018|Treated|Overall Study||9
3178027|NCT01974687|3905877|FG019|Treated|Overall Study||3
3178028|NCT01974687|3905878|FG020|Treated|Overall Study||3
3349621|NCT03555890|4079790|FG000|NOT COMPLETED|Part 2:Treatment Period 1 (3 Days)||0
3349622|NCT03555890|4079791|FG001|NOT COMPLETED|Part 2:Treatment Period 1 (3 Days)||0
3349623|NCT03555890|4079792|FG002|NOT COMPLETED|Part 2:Treatment Period 1 (3 Days)||0
3349624|NCT03555890|4079793|FG003|NOT COMPLETED|Part 2:Treatment Period 1 (3 Days)||0
3349625|NCT03555890|4079790|FG000|STARTED|Part 2:Washout Period (at Least 5 Days)||0
3349626|NCT03555890|4079791|FG001|STARTED|Part 2:Washout Period (at Least 5 Days)||0
3349627|NCT03555890|4079792|FG002|STARTED|Part 2:Washout Period (at Least 5 Days)||24
3349628|NCT03555890|4079793|FG003|STARTED|Part 2:Washout Period (at Least 5 Days)||24
3349629|NCT03555890|4079790|FG000|COMPLETED|Part 2:Washout Period (at Least 5 Days)||0
3349630|NCT03555890|4079791|FG001|COMPLETED|Part 2:Washout Period (at Least 5 Days)||0
3349631|NCT03555890|4079792|FG002|COMPLETED|Part 2:Washout Period (at Least 5 Days)||24
3349632|NCT03555890|4079793|FG003|COMPLETED|Part 2:Washout Period (at Least 5 Days)||23
3349633|NCT03555890|4079790|FG000|NOT COMPLETED|Part 2:Washout Period (at Least 5 Days)||0
3349634|NCT03555890|4079791|FG001|NOT COMPLETED|Part 2:Washout Period (at Least 5 Days)||0
3349635|NCT03555890|4079792|FG002|NOT COMPLETED|Part 2:Washout Period (at Least 5 Days)||0
3349636|NCT03555890|4079793|FG003|NOT COMPLETED|Part 2:Washout Period (at Least 5 Days)||1
3349637|NCT03555890|4079790|FG000|STARTED|Part 2:Treatment Period 2 (10 Days)||0
3349638|NCT03555890|4079791|FG001|STARTED|Part 2:Treatment Period 2 (10 Days)||0
3349639|NCT03555890|4079792|FG002|STARTED|Part 2:Treatment Period 2 (10 Days)||24
3349640|NCT03555890|4079793|FG003|STARTED|Part 2:Treatment Period 2 (10 Days)||23
3349641|NCT03555890|4079790|FG000|COMPLETED|Part 2:Treatment Period 2 (10 Days)||0
3349642|NCT03555890|4079791|FG001|COMPLETED|Part 2:Treatment Period 2 (10 Days)||0
3349643|NCT03555890|4079792|FG002|COMPLETED|Part 2:Treatment Period 2 (10 Days)||24
3349644|NCT03555890|4079793|FG003|COMPLETED|Part 2:Treatment Period 2 (10 Days)||23
3349645|NCT03555890|4079790|FG000|NOT COMPLETED|Part 2:Treatment Period 2 (10 Days)||0
3349646|NCT03555890|4079791|FG001|NOT COMPLETED|Part 2:Treatment Period 2 (10 Days)||0
3349647|NCT03555890|4079792|FG002|NOT COMPLETED|Part 2:Treatment Period 2 (10 Days)||0
3349648|NCT03555890|4079793|FG003|NOT COMPLETED|Part 2:Treatment Period 2 (10 Days)||0
3349649|NCT03556579|4079803|FG000|STARTED|Visit 1||16
3349650|NCT03556579|4079804|FG001|STARTED|Visit 1||14
3349651|NCT03556579|4079805|FG002|STARTED|Visit 1||14
3349652|NCT03556579|4079806|FG003|STARTED|Visit 1||16
3349653|NCT03556579|4079803|FG000|COMPLETED|Visit 1||16
3349654|NCT03556579|4079804|FG001|COMPLETED|Visit 1||14
3349655|NCT03556579|4079805|FG002|COMPLETED|Visit 1||14
3349656|NCT03556579|4079806|FG003|COMPLETED|Visit 1||16
3349657|NCT03556579|4079803|FG000|NOT COMPLETED|Visit 1||0
3349658|NCT03556579|4079804|FG001|NOT COMPLETED|Visit 1||0
3349659|NCT03556579|4079805|FG002|NOT COMPLETED|Visit 1||0
3349660|NCT03556579|4079806|FG003|NOT COMPLETED|Visit 1||0
3349661|NCT03556579|4079803|FG000|STARTED|Visit 2||16
3349662|NCT03556579|4079804|FG001|STARTED|Visit 2||14
3349663|NCT03556579|4079805|FG002|STARTED|Visit 2||14
3349664|NCT03556579|4079806|FG003|STARTED|Visit 2||16
3349665|NCT03556579|4079803|FG000|COMPLETED|Visit 2||16
3349666|NCT03556579|4079804|FG001|COMPLETED|Visit 2||14
3349667|NCT03556579|4079805|FG002|COMPLETED|Visit 2||14
3349668|NCT03556579|4079806|FG003|COMPLETED|Visit 2||16
3349669|NCT03556579|4079803|FG000|NOT COMPLETED|Visit 2||0
3349670|NCT03556579|4079804|FG001|NOT COMPLETED|Visit 2||0
3349671|NCT03556579|4079805|FG002|NOT COMPLETED|Visit 2||0
3349672|NCT03556579|4079806|FG003|NOT COMPLETED|Visit 2||0
3349673|NCT03556761|4079818|FG000|STARTED|Overall Study||192
3349674|NCT03556761|4079819|FG001|STARTED|Overall Study||192
3349675|NCT03556761|4079818|FG000|COMPLETED|Overall Study||168
3349676|NCT03556761|4079819|FG001|COMPLETED|Overall Study||163
3349677|NCT03556761|4079818|FG000|NOT COMPLETED|Overall Study||24
3349678|NCT03556761|4079819|FG001|NOT COMPLETED|Overall Study||29
3349679|NCT03556891|4079825|FG000|STARTED|Overall Study||133
3349680|NCT03556891|4079825|FG000|COMPLETED|Overall Study||120
3349681|NCT03556891|4079825|FG000|NOT COMPLETED|Overall Study||13
3349682|NCT03557034|4079831|FG000|STARTED|Overall Study||49
3349683|NCT03557034|4079832|FG001|STARTED|Overall Study||51
3178029|NCT01974687|3905879|FG021|Treated|Overall Study||8
3178030|NCT01974687|3905880|FG022|Treated|Overall Study||8
3178031|NCT01974687|3905881|FG023|Treated|Overall Study||6
3178032|NCT01974687|3905882|FG024|Treated|Overall Study||10
3178033|NCT01974687|3905858|FG000|COMPLETED|Overall Study||6
3349684|NCT03557034|4079831|FG000|Randomization|Overall Study||49
3349685|NCT03557034|4079832|FG001|Randomization|Overall Study||51
3349686|NCT03557034|4079831|FG000|COMPLETED|Overall Study||48
3349687|NCT03557034|4079832|FG001|COMPLETED|Overall Study||51
3349688|NCT03557034|4079831|FG000|NOT COMPLETED|Overall Study||1
3349689|NCT03557034|4079832|FG001|NOT COMPLETED|Overall Study||0
3349690|NCT03557086|4079840|FG000|STARTED|Overall Study||26
3349691|NCT03557086|4079841|FG001|STARTED|Overall Study||24
3349692|NCT03557086|4079840|FG000|COMPLETED|Overall Study||26
3349693|NCT03557086|4079841|FG001|COMPLETED|Overall Study||24
3349694|NCT03557086|4079840|FG000|NOT COMPLETED|Overall Study||0
3349695|NCT03557086|4079841|FG001|NOT COMPLETED|Overall Study||0
3349696|NCT03557125|4079851|FG000|STARTED|Overall Study||22
3349697|NCT03557125|4079852|FG001|STARTED|Overall Study||24
3349698|NCT03557125|4079851|FG000|COMPLETED|Overall Study||22
3349699|NCT03557125|4079852|FG001|COMPLETED|Overall Study||24
3349700|NCT03557125|4079851|FG000|NOT COMPLETED|Overall Study||0
3349701|NCT03557125|4079852|FG001|NOT COMPLETED|Overall Study||0
3349702|NCT03557333|4079858|FG000|STARTED|Overall Study||354
3349703|NCT03557333|4079858|FG000|COMPLETED|Overall Study||262
3349704|NCT03557333|4079858|FG000|NOT COMPLETED|Overall Study||92
3349705|NCT03557372|4079864|FG000|STARTED|Overall Study||14
3349706|NCT03557372|4079864|FG000|COMPLETED|Overall Study||14
3349707|NCT03557372|4079864|FG000|NOT COMPLETED|Overall Study||0
3349708|NCT03557476|4079870|FG000|STARTED|Overall Study||13
3349709|NCT03557476|4079871|FG001|STARTED|Overall Study||13
3349710|NCT03557476|4079870|FG000|COMPLETED|Overall Study||13
3349711|NCT03557476|4079871|FG001|COMPLETED|Overall Study||13
3349712|NCT03557476|4079870|FG000|NOT COMPLETED|Overall Study||0
3349713|NCT03557476|4079871|FG001|NOT COMPLETED|Overall Study||0
3349714|NCT03557658|4079879|FG000|STARTED|Overall Study||8
3349715|NCT03557658|4079880|FG001|STARTED|Overall Study||8
3349716|NCT03557658|4079879|FG000|COMPLETED|Overall Study||8
3349717|NCT03557658|4079880|FG001|COMPLETED|Overall Study||8
3349718|NCT03557658|4079879|FG000|NOT COMPLETED|Overall Study||0
3349719|NCT03557658|4079880|FG001|NOT COMPLETED|Overall Study||0
3349720|NCT03557775|4079889|FG000|STARTED|Overall Study||5
3349721|NCT03557775|4079890|FG001|STARTED|Overall Study||7
3349722|NCT03557775|4079891|FG002|STARTED|Overall Study||8
3349723|NCT03557775|4079889|FG000|COMPLETED|Overall Study||4
3349724|NCT03557775|4079890|FG001|COMPLETED|Overall Study||4
3349725|NCT03557775|4079891|FG002|COMPLETED|Overall Study||4
3349726|NCT03557775|4079889|FG000|NOT COMPLETED|Overall Study||1
3349727|NCT03557775|4079890|FG001|NOT COMPLETED|Overall Study||3
3349728|NCT03557775|4079891|FG002|NOT COMPLETED|Overall Study||4
3349729|NCT03557801|4079902|FG000|STARTED|Overall Study||34
3349730|NCT03557801|4079903|FG001|STARTED|Overall Study||33
3349731|NCT03557801|4079904|FG002|STARTED|Overall Study||33
3349732|NCT03557801|4079902|FG000|COMPLETED|Overall Study||32
3349733|NCT03557801|4079903|FG001|COMPLETED|Overall Study||32
3349734|NCT03557801|4079904|FG002|COMPLETED|Overall Study||30
3349735|NCT03557801|4079902|FG000|NOT COMPLETED|Overall Study||2
3349736|NCT03557801|4079903|FG001|NOT COMPLETED|Overall Study||1
3349737|NCT03557801|4079904|FG002|NOT COMPLETED|Overall Study||3
3349738|NCT03557931|4079915|FG000|STARTED|Overall Study||100
3349739|NCT03557931|4079916|FG001|STARTED|Overall Study||65
3349740|NCT03557931|4079917|FG002|STARTED|Overall Study||68
3349741|NCT03557931|4079915|FG000|COMPLETED|Overall Study||69
3349742|NCT03557931|4079916|FG001|COMPLETED|Overall Study||46
3349743|NCT03557931|4079917|FG002|COMPLETED|Overall Study||55
3349744|NCT03557931|4079915|FG000|NOT COMPLETED|Overall Study||31
3349745|NCT03557931|4079916|FG001|NOT COMPLETED|Overall Study||19
3349746|NCT03557931|4079917|FG002|NOT COMPLETED|Overall Study||13
3349747|NCT03558061|4079927|FG000|STARTED|Overall Study||30
3349748|NCT03558061|4079927|FG000|COMPLETED|Overall Study||29
3349749|NCT03558061|4079927|FG000|NOT COMPLETED|Overall Study||1
3349750|NCT03558074|4079931|FG000|STARTED|Overall Study||26
3349751|NCT03558074|4079931|FG000|COMPLETED|Overall Study||24
3349752|NCT03558074|4079931|FG000|NOT COMPLETED|Overall Study||2
3349753|NCT03558230|4079938|FG000|STARTED|Overall Study||7
3349754|NCT03558230|4079939|FG001|STARTED|Overall Study||6
3349755|NCT03558230|4079938|FG000|COMPLETED|Overall Study||7
3349756|NCT03558230|4079939|FG001|COMPLETED|Overall Study||6
3349757|NCT03558230|4079938|FG000|NOT COMPLETED|Overall Study||0
3349758|NCT03558230|4079939|FG001|NOT COMPLETED|Overall Study||0
3349759|NCT03558516|4079947|FG000|STARTED|Overall Study||40
3349760|NCT03558516|4079948|FG001|STARTED|Overall Study||40
3349761|NCT03558516|4079947|FG000|COMPLETED|Overall Study||38
3349762|NCT03558516|4079948|FG001|COMPLETED|Overall Study||38
3349763|NCT03558516|4079947|FG000|NOT COMPLETED|Overall Study||2
3349764|NCT03558516|4079948|FG001|NOT COMPLETED|Overall Study||2
3349765|NCT03558555|4079956|FG000|STARTED|Overall Study||58
3178034|NCT01974687|3905859|FG001|COMPLETED|Overall Study||6
3349766|NCT03558555|4079957|FG001|STARTED|Overall Study||45
3349767|NCT03558555|4079956|FG000|COMPLETED|Overall Study||56
3349768|NCT03558555|4079957|FG001|COMPLETED|Overall Study||44
3349769|NCT03558555|4079956|FG000|NOT COMPLETED|Overall Study||2
3349770|NCT03558555|4079957|FG001|NOT COMPLETED|Overall Study||1
3349771|NCT03558672|4079963|FG000|STARTED|Overall Study||18
3349772|NCT03558672|4079963|FG000|COMPLETED|Overall Study||8
3349773|NCT03558672|4079963|FG000|NOT COMPLETED|Overall Study||10
3349774|NCT03558997|4079971|FG000|STARTED|Overall Study||25
3349775|NCT03558997|4079972|FG001|STARTED|Overall Study||26
3349776|NCT03558997|4079973|FG002|STARTED|Overall Study||26
3349777|NCT03558997|4079974|FG003|STARTED|Overall Study||26
3349778|NCT03558997|4079971|FG000|COMPLETED|Overall Study||24
3349779|NCT03558997|4079972|FG001|COMPLETED|Overall Study||24
3349780|NCT03558997|4079973|FG002|COMPLETED|Overall Study||18
3349781|NCT03558997|4079974|FG003|COMPLETED|Overall Study||24
3349782|NCT03558997|4079971|FG000|NOT COMPLETED|Overall Study||1
3349783|NCT03558997|4079972|FG001|NOT COMPLETED|Overall Study||2
3349784|NCT03558997|4079973|FG002|NOT COMPLETED|Overall Study||8
3349785|NCT03558997|4079974|FG003|NOT COMPLETED|Overall Study||2
3349786|NCT03559062|4079990|FG000|STARTED|Overall Study||10
3349787|NCT03559062|4079991|FG001|STARTED|Overall Study||54
3349788|NCT03559062|4079992|FG002|STARTED|Overall Study||3
3349789|NCT03559062|4079990|FG000|COMPLETED|Overall Study||10
3349790|NCT03559062|4079991|FG001|COMPLETED|Overall Study||53
3349791|NCT03559062|4079992|FG002|COMPLETED|Overall Study||3
3349792|NCT03559062|4079990|FG000|NOT COMPLETED|Overall Study||0
3349793|NCT03559062|4079991|FG001|NOT COMPLETED|Overall Study||1
3349794|NCT03559062|4079992|FG002|NOT COMPLETED|Overall Study||0
3349795|NCT03559179|4080004|FG000|STARTED|Overall Study||8
3349796|NCT03559179|4080005|FG001|STARTED|Overall Study||24
3349797|NCT03559179|4080006|FG002|STARTED|Overall Study||23
3349798|NCT03559179|4080004|FG000|COMPLETED|Overall Study||8
3349799|NCT03559179|4080005|FG001|COMPLETED|Overall Study||23
3349800|NCT03559179|4080006|FG002|COMPLETED|Overall Study||23
3349801|NCT03559179|4080004|FG000|NOT COMPLETED|Overall Study||0
3349802|NCT03559179|4080005|FG001|NOT COMPLETED|Overall Study||1
3349803|NCT03559179|4080006|FG002|NOT COMPLETED|Overall Study||0
3349804|NCT03559205|4080025|FG000|STARTED|Overall Study||177
3349805|NCT03559205|4080026|FG001|STARTED|Overall Study||144
3349806|NCT03559205|4080025|FG000|Baseline Data|Overall Study||141
3349807|NCT03559205|4080026|FG001|Baseline Data|Overall Study||132
3349808|NCT03559205|4080025|FG000|COMPLETED|Overall Study||65
3349809|NCT03559205|4080026|FG001|COMPLETED|Overall Study||57
3349810|NCT03559205|4080025|FG000|NOT COMPLETED|Overall Study||112
3349811|NCT03559205|4080026|FG001|NOT COMPLETED|Overall Study||87
3349812|NCT03559218|4080034|FG000|STARTED|Overall Study||12
3349813|NCT03559218|4080035|FG001|STARTED|Overall Study||13
3349814|NCT03559218|4080034|FG000|COMPLETED|Overall Study||11
3349815|NCT03559218|4080035|FG001|COMPLETED|Overall Study||13
3349816|NCT03559218|4080034|FG000|NOT COMPLETED|Overall Study||1
3349817|NCT03559218|4080035|FG001|NOT COMPLETED|Overall Study||0
3349818|NCT03559257|4080043|FG000|STARTED|Double Blind Treatment Period||230
3349819|NCT03559257|4080044|FG001|STARTED|Double Blind Treatment Period||233
3349820|NCT03559257|4080043|FG000|Received at Least One Dose of Study Drug|Double Blind Treatment Period||230
3349821|NCT03559257|4080044|FG001|Received at Least One Dose of Study Drug|Double Blind Treatment Period||232
3349822|NCT03559257|4080043|FG000|COMPLETED|Double Blind Treatment Period||226
3349823|NCT03559257|4080044|FG001|COMPLETED|Double Blind Treatment Period||225
3349824|NCT03559257|4080043|FG000|NOT COMPLETED|Double Blind Treatment Period||4
3349825|NCT03559257|4080044|FG001|NOT COMPLETED|Double Blind Treatment Period||8
3349826|NCT03559257|4080043|FG000|STARTED|Open-label Treatment Period|One participant who completed double blind period has withdrawn from the study.|225
3349827|NCT03559257|4080044|FG001|STARTED|Open-label Treatment Period|One participant who completed double blind period had discontinued due to adverse event.|224
3349828|NCT03559257|4080043|FG000|COMPLETED|Open-label Treatment Period||215
3349829|NCT03559257|4080044|FG001|COMPLETED|Open-label Treatment Period||217
3349830|NCT03559257|4080043|FG000|NOT COMPLETED|Open-label Treatment Period||10
3349831|NCT03559257|4080044|FG001|NOT COMPLETED|Open-label Treatment Period||7
3349832|NCT03559517|4080056|FG000|STARTED|Overall Study||8
3349833|NCT03559517|4080057|FG001|STARTED|Overall Study||9
3349834|NCT03559517|4080058|FG002|STARTED|Overall Study||12
3349835|NCT03559517|4080056|FG000|COMPLETED|Overall Study||7
3349836|NCT03559517|4080057|FG001|COMPLETED|Overall Study||9
3349837|NCT03559517|4080058|FG002|COMPLETED|Overall Study||12
3349838|NCT03559517|4080056|FG000|NOT COMPLETED|Overall Study||1
3349839|NCT03559517|4080057|FG001|NOT COMPLETED|Overall Study||0
3349840|NCT03559517|4080058|FG002|NOT COMPLETED|Overall Study||0
3349841|NCT03559530|4080066|FG000|STARTED|Overall Study||197
3349842|NCT03559530|4080067|FG001|STARTED|Overall Study||65
3349843|NCT03559530|4080066|FG000|COMPLETED|Overall Study||106
3349844|NCT03559530|4080067|FG001|COMPLETED|Overall Study||65
3349845|NCT03559530|4080066|FG000|NOT COMPLETED|Overall Study||91
3349846|NCT03559530|4080067|FG001|NOT COMPLETED|Overall Study||0
3349847|NCT03559829|4080072|FG000|STARTED|Overall Study||20
3349848|NCT03559829|4080072|FG000|COMPLETED|Overall Study||20
3349849|NCT03559829|4080072|FG000|NOT COMPLETED|Overall Study||0
3349850|NCT03559933|4080076|FG000|STARTED|Overall Study||12
3349851|NCT03559933|4080076|FG000|COMPLETED|Overall Study||12
3349852|NCT03559933|4080076|FG000|NOT COMPLETED|Overall Study||0
3349853|NCT03560102|4080081|FG000|STARTED|Overall Study||1
3349854|NCT03560102|4080081|FG000|COMPLETED|Overall Study||1
3349855|NCT03560102|4080081|FG000|NOT COMPLETED|Overall Study||0
3349856|NCT03560128|4080087|FG000|STARTED|Overall Study||306
3349857|NCT03560128|4080088|FG001|STARTED|Overall Study||306
3349858|NCT03560128|4080087|FG000|COMPLETED|Overall Study||294
3349859|NCT03560128|4080088|FG001|COMPLETED|Overall Study||298
3349860|NCT03560128|4080087|FG000|NOT COMPLETED|Overall Study||12
3349861|NCT03560128|4080088|FG001|NOT COMPLETED|Overall Study||8
3349862|NCT03560141|4080096|FG000|STARTED|Overall Study||6
3349863|NCT03560141|4080097|FG001|STARTED|Overall Study||5
3349864|NCT03560141|4080096|FG000|COMPLETED|Overall Study||6
3349865|NCT03560141|4080097|FG001|COMPLETED|Overall Study||5
3349866|NCT03560141|4080096|FG000|NOT COMPLETED|Overall Study||0
3349867|NCT03560141|4080097|FG001|NOT COMPLETED|Overall Study||0
3349868|NCT03560245|4080107|FG000|STARTED|Overall Study||53
3349869|NCT03560245|4080108|FG001|STARTED|Overall Study||55
3349870|NCT03560245|4080107|FG000|COMPLETED|Overall Study||48
3349871|NCT03560245|4080108|FG001|COMPLETED|Overall Study||48
3349872|NCT03560245|4080107|FG000|NOT COMPLETED|Overall Study||5
3349873|NCT03560245|4080108|FG001|NOT COMPLETED|Overall Study||7
3349874|NCT03560518|4080119|FG000|STARTED|Double Blind Treatment Period||147
3349875|NCT03560518|4080120|FG001|STARTED|Double Blind Treatment Period||145
3349876|NCT03560518|4080121|FG002|STARTED|Double Blind Treatment Period||147
3349877|NCT03560518|4080119|FG000|COMPLETED|Double Blind Treatment Period||122
3349878|NCT03560518|4080120|FG001|COMPLETED|Double Blind Treatment Period||116
3349879|NCT03560518|4080121|FG002|COMPLETED|Double Blind Treatment Period||124
3349880|NCT03560518|4080119|FG000|NOT COMPLETED|Double Blind Treatment Period||25
3349881|NCT03560518|4080120|FG001|NOT COMPLETED|Double Blind Treatment Period||29
3349882|NCT03560518|4080121|FG002|NOT COMPLETED|Double Blind Treatment Period||23
3349883|NCT03560518|4080119|FG000|STARTED|Safety Follow-Up Period||10
3349884|NCT03560518|4080120|FG001|STARTED|Safety Follow-Up Period||17
3349885|NCT03560518|4080121|FG002|STARTED|Safety Follow-Up Period||22
3349886|NCT03560518|4080119|FG000|COMPLETED|Safety Follow-Up Period||10
3349887|NCT03560518|4080120|FG001|COMPLETED|Safety Follow-Up Period||17
3349888|NCT03560518|4080121|FG002|COMPLETED|Safety Follow-Up Period||22
3349889|NCT03560518|4080119|FG000|NOT COMPLETED|Safety Follow-Up Period||0
3349890|NCT03560518|4080120|FG001|NOT COMPLETED|Safety Follow-Up Period||0
3349891|NCT03560518|4080121|FG002|NOT COMPLETED|Safety Follow-Up Period||0
3349892|NCT03560739|4080133|FG000|STARTED|Overall Study||128
3349893|NCT03560739|4080134|FG001|STARTED|Overall Study||130
3349894|NCT03560739|4080135|FG002|STARTED|Overall Study||13
3349895|NCT03560739|4080136|FG003|STARTED|Overall Study||13
3349896|NCT03560739|4080133|FG000|COMPLETED|Overall Study||128
3349897|NCT03560739|4080134|FG001|COMPLETED|Overall Study||129
3349898|NCT03560739|4080135|FG002|COMPLETED|Overall Study||13
3349899|NCT03560739|4080136|FG003|COMPLETED|Overall Study||13
3349900|NCT03560739|4080133|FG000|NOT COMPLETED|Overall Study||0
3349901|NCT03560739|4080134|FG001|NOT COMPLETED|Overall Study||1
3349902|NCT03560739|4080135|FG002|NOT COMPLETED|Overall Study||0
3349903|NCT03560739|4080136|FG003|NOT COMPLETED|Overall Study||0
3349904|NCT03560869|4080146|FG000|STARTED|Overall Study||14
3349905|NCT03560869|4080147|FG001|STARTED|Overall Study||21
3349906|NCT03560869|4080146|FG000|COMPLETED|Overall Study||7
3349907|NCT03560869|4080147|FG001|COMPLETED|Overall Study||12
3349908|NCT03560869|4080146|FG000|NOT COMPLETED|Overall Study||7
3349909|NCT03560869|4080147|FG001|NOT COMPLETED|Overall Study||9
3349910|NCT03560986|4080155|FG000|STARTED|Treatment Period A/Follow-up Period 1||48
3349911|NCT03560986|4080156|FG001|STARTED|Treatment Period A/Follow-up Period 1|One additional participant was allocated to placebo but not treated.|51
3349912|NCT03560986|4080155|FG000|Treatment Period A Completers|Treatment Period A/Follow-up Period 1||45
3349913|NCT03560986|4080156|FG001|Treatment Period A Completers|Treatment Period A/Follow-up Period 1||45
3349914|NCT03560986|4080155|FG000|COMPLETED|Treatment Period A/Follow-up Period 1||12
3349915|NCT03560986|4080156|FG001|COMPLETED|Treatment Period A/Follow-up Period 1||13
3349916|NCT03560986|4080155|FG000|NOT COMPLETED|Treatment Period A/Follow-up Period 1||36
3349917|NCT03560986|4080156|FG001|NOT COMPLETED|Treatment Period A/Follow-up Period 1||38
3349918|NCT03560986|4080155|FG000|STARTED|Treatment Period B/Follow-up Period 2|3 Participants completed Treatment Period A/Follow-up Period 1 but were not allocated in Period B.|9
3349919|NCT03560986|4080156|FG001|STARTED|Treatment Period B/Follow-up Period 2|5 Part. completed Placebo Treatment Period A/Follow-up Period 1 but were not allocated in Period B.|8
3349920|NCT03560986|4080155|FG000|Treatment Period B Completers|Treatment Period B/Follow-up Period 2||8
3349921|NCT03560986|4080156|FG001|Treatment Period B Completers|Treatment Period B/Follow-up Period 2||8
3349922|NCT03560986|4080155|FG000|COMPLETED|Treatment Period B/Follow-up Period 2||1
3349923|NCT03560986|4080156|FG001|COMPLETED|Treatment Period B/Follow-up Period 2||0
3349924|NCT03560986|4080155|FG000|NOT COMPLETED|Treatment Period B/Follow-up Period 2||8
3349925|NCT03560986|4080156|FG001|NOT COMPLETED|Treatment Period B/Follow-up Period 2||8
3349926|NCT03561090|4080170|FG000|STARTED|Overall Study||247
3349927|NCT03561090|4080171|FG001|STARTED|Overall Study||248
3349928|NCT03561090|4080170|FG000|Randomized and Treated|Overall Study||246
3349929|NCT03561090|4080171|FG001|Randomized and Treated|Overall Study||247
3349930|NCT03561090|4080170|FG000|COMPLETED|Overall Study||207
3349931|NCT03561090|4080171|FG001|COMPLETED|Overall Study||212
3349932|NCT03561090|4080170|FG000|NOT COMPLETED|Overall Study||40
3349933|NCT03561090|4080171|FG001|NOT COMPLETED|Overall Study||36
3349934|NCT03561883|4080181|FG000|STARTED|Overall Study||305
3349935|NCT03561883|4080182|FG001|STARTED|Overall Study||304
3349936|NCT03561883|4080181|FG000|COMPLETED|Overall Study||259
3349937|NCT03561883|4080182|FG001|COMPLETED|Overall Study||261
3349938|NCT03561883|4080181|FG000|NOT COMPLETED|Overall Study||46
3349939|NCT03561883|4080182|FG001|NOT COMPLETED|Overall Study||43
3349940|NCT03562117|4080191|FG000|STARTED|Part 1, Up to 3 Days||8
3349941|NCT03562117|4080192|FG001|STARTED|Part 1, Up to 3 Days||8
3349942|NCT03562117|4080193|FG002|STARTED|Part 1, Up to 3 Days||0
3349943|NCT03562117|4080191|FG000|COMPLETED|Part 1, Up to 3 Days||7
3349944|NCT03562117|4080192|FG001|COMPLETED|Part 1, Up to 3 Days||8
3349945|NCT03562117|4080193|FG002|COMPLETED|Part 1, Up to 3 Days||0
3349946|NCT03562117|4080191|FG000|NOT COMPLETED|Part 1, Up to 3 Days||1
3349947|NCT03562117|4080192|FG001|NOT COMPLETED|Part 1, Up to 3 Days||0
3349948|NCT03562117|4080193|FG002|NOT COMPLETED|Part 1, Up to 3 Days||0
3349949|NCT03562117|4080191|FG000|STARTED|Part 2, Up to 3 Days|Only 1 additional participant with normal hepatic function enrolled in Part 2 received dosing|8
3349950|NCT03562117|4080192|FG001|STARTED|Part 2, Up to 3 Days||0
3349951|NCT03562117|4080193|FG002|STARTED|Part 2, Up to 3 Days||8
3349952|NCT03562117|4080191|FG000|COMPLETED|Part 2, Up to 3 Days||8
3349953|NCT03562117|4080192|FG001|COMPLETED|Part 2, Up to 3 Days||0
3349954|NCT03562117|4080193|FG002|COMPLETED|Part 2, Up to 3 Days||8
3349955|NCT03562117|4080191|FG000|NOT COMPLETED|Part 2, Up to 3 Days||0
3349956|NCT03562117|4080192|FG001|NOT COMPLETED|Part 2, Up to 3 Days||0
3349957|NCT03562117|4080193|FG002|NOT COMPLETED|Part 2, Up to 3 Days||0
3349958|NCT03562377|4080203|FG000|STARTED|Treatment Period|Number of participants assigned to treatment|107
3349959|NCT03562377|4080204|FG001|STARTED|Treatment Period|Number of participants assigned to treatment|108
3349960|NCT03562377|4080203|FG000|Safety Analysis Set|Treatment Period||107
3349961|NCT03562377|4080204|FG001|Safety Analysis Set|Treatment Period||107
3349962|NCT03562377|4080203|FG000|Per Protocol Anaysis Set|Treatment Period||88
3349963|NCT03562377|4080204|FG001|Per Protocol Anaysis Set|Treatment Period||78
3349964|NCT03562377|4080203|FG000|Full Analysis Set|Treatment Period||106
3349965|NCT03562377|4080204|FG001|Full Analysis Set|Treatment Period||108
3349966|NCT03562377|4080203|FG000|COMPLETED|Treatment Period|Number of participants attending the Week 16 visit (end of treatment visit)|100
3349967|NCT03562377|4080204|FG001|COMPLETED|Treatment Period|Number of participants attending the Week 16 visit (end of treatment visit)|89
3349968|NCT03562377|4080203|FG000|NOT COMPLETED|Treatment Period||7
3349969|NCT03562377|4080204|FG001|NOT COMPLETED|Treatment Period||19
3349970|NCT03562377|4080203|FG000|STARTED|Safety Follow-up Period|Last contact after exposure end. Main reason for not entering follow-up: transfer to extension trial|75
3349971|NCT03562377|4080204|FG001|STARTED|Safety Follow-up Period|Last contact after exposure end. Main reason for not entering follow-up: transfer to extension trial|75
3349972|NCT03562377|4080203|FG000|COMPLETED|Safety Follow-up Period|Attended Week 30 visit. Main reason for not attending was transfer to long-term extension trial.|16
3349973|NCT03562377|4080204|FG001|COMPLETED|Safety Follow-up Period|Attended Week 30 visit. Main reason for not attending was transfer to long-term extension trial.|18
3349974|NCT03562377|4080203|FG000|NOT COMPLETED|Safety Follow-up Period||59
3349975|NCT03562377|4080204|FG001|NOT COMPLETED|Safety Follow-up Period||57
3349976|NCT03562481|4080212|FG000|STARTED|First Intervention||12
3349977|NCT03562481|4080213|FG001|STARTED|First Intervention||14
3178035|NCT01974687|3905860|FG002|COMPLETED|Overall Study||6
3178036|NCT01974687|3905861|FG003|COMPLETED|Overall Study||6
3178037|NCT01974687|3905862|FG004|COMPLETED|Overall Study||2
3349978|NCT03562481|4080212|FG000|COMPLETED|First Intervention||11
3349979|NCT03562481|4080213|FG001|COMPLETED|First Intervention||14
3349980|NCT03562481|4080212|FG000|NOT COMPLETED|First Intervention||1
3349981|NCT03562481|4080213|FG001|NOT COMPLETED|First Intervention||0
3349982|NCT03562481|4080212|FG000|STARTED|Washout||11
3349983|NCT03562481|4080213|FG001|STARTED|Washout||14
3349984|NCT03562481|4080212|FG000|COMPLETED|Washout||11
3349985|NCT03562481|4080213|FG001|COMPLETED|Washout||14
3349986|NCT03562481|4080212|FG000|NOT COMPLETED|Washout||0
3349987|NCT03562481|4080213|FG001|NOT COMPLETED|Washout||0
3349988|NCT03562481|4080212|FG000|STARTED|Second Intervention||11
3349989|NCT03562481|4080213|FG001|STARTED|Second Intervention||14
3349990|NCT03562481|4080212|FG000|COMPLETED|Second Intervention||11
3349991|NCT03562481|4080213|FG001|COMPLETED|Second Intervention||14
3349992|NCT03562481|4080212|FG000|NOT COMPLETED|Second Intervention||0
3178038|NCT01974687|3905863|FG005|COMPLETED|Overall Study||6
3178039|NCT01974687|3905864|FG006|COMPLETED|Overall Study||3
3178040|NCT01974687|3905865|FG007|COMPLETED|Overall Study||3
3178041|NCT01974687|3905866|FG008|COMPLETED|Overall Study||3
3349993|NCT03562481|4080213|FG001|NOT COMPLETED|Second Intervention||0
3349994|NCT03562559|4080223|FG000|STARTED|Overall Study||40
3349995|NCT03562559|4080223|FG000|COMPLETED|Overall Study||40
3349996|NCT03562559|4080223|FG000|NOT COMPLETED|Overall Study||0
3349997|NCT03562663|4080229|FG000|STARTED|Overall Study||41
3349998|NCT03562663|4080230|FG001|STARTED|Overall Study||41
3349999|NCT03562663|4080229|FG000|COMPLETED|Overall Study||34
3350000|NCT03562663|4080230|FG001|COMPLETED|Overall Study||35
3350001|NCT03562663|4080229|FG000|NOT COMPLETED|Overall Study||7
3350002|NCT03562663|4080230|FG001|NOT COMPLETED|Overall Study||6
3350003|NCT03562988|4080236|FG000|STARTED|Overall Study||17
3350004|NCT03562988|4080237|FG001|STARTED|Overall Study||18
3350005|NCT03562988|4080236|FG000|COMPLETED|Overall Study||15
3350006|NCT03562988|4080237|FG001|COMPLETED|Overall Study||15
3350007|NCT03562988|4080236|FG000|NOT COMPLETED|Overall Study||2
3350008|NCT03562988|4080237|FG001|NOT COMPLETED|Overall Study||3
3350009|NCT03563027|4080250|FG000|STARTED|Overall Study||60
3350010|NCT03563027|4080251|FG001|STARTED|Overall Study||60
3350011|NCT03563027|4080252|FG002|STARTED|Overall Study||60
3350012|NCT03563027|4080250|FG000|COMPLETED|Overall Study||60
3350013|NCT03563027|4080251|FG001|COMPLETED|Overall Study||60
3350014|NCT03563027|4080252|FG002|COMPLETED|Overall Study||58
3350015|NCT03563027|4080250|FG000|NOT COMPLETED|Overall Study||0
3350016|NCT03563027|4080251|FG001|NOT COMPLETED|Overall Study||0
3350017|NCT03563027|4080252|FG002|NOT COMPLETED|Overall Study||2
3350018|NCT03563183|4080260|FG000|STARTED|Overall Study||26976
3350019|NCT03563183|4080260|FG000|COMPLETED|Overall Study||26976
3350020|NCT03563183|4080260|FG000|NOT COMPLETED|Overall Study||0
3350021|NCT03563209|4080279|FG000|STARTED|Overall Study||60
3350022|NCT03563209|4080279|FG000|COMPLETED|Overall Study||60
3350023|NCT03563209|4080279|FG000|NOT COMPLETED|Overall Study||0
3350024|NCT03563313|4080287|FG000|STARTED|Overall Study||112
3350025|NCT03563313|4080288|FG001|STARTED|Overall Study||56
3350026|NCT03563313|4080287|FG000|COMPLETED|Overall Study||112
3350027|NCT03563313|4080288|FG001|COMPLETED|Overall Study||56
3350028|NCT03563313|4080287|FG000|NOT COMPLETED|Overall Study||0
3350029|NCT03563313|4080288|FG001|NOT COMPLETED|Overall Study||0
3350030|NCT03563716|4080302|FG000|STARTED|Overall Study||68
3350031|NCT03563716|4080303|FG001|STARTED|Overall Study||67
3350032|NCT03563716|4080302|FG000|COMPLETED|Overall Study||0
3350033|NCT03563716|4080303|FG001|COMPLETED|Overall Study|"One participant who died had as reason for discontinuation Withdrawal by Subject"|0
3350034|NCT03563716|4080302|FG000|NOT COMPLETED|Overall Study||68
3350035|NCT03563716|4080303|FG001|NOT COMPLETED|Overall Study||67
3350036|NCT03564444|4080311|FG000|STARTED|Overall Study||60
3350037|NCT03564444|4080312|FG001|STARTED|Overall Study||240
3350038|NCT03564444|4080311|FG000|COMPLETED|Overall Study||60
3350039|NCT03564444|4080312|FG001|COMPLETED|Overall Study||240
3350040|NCT03564444|4080311|FG000|NOT COMPLETED|Overall Study||0
3350041|NCT03564444|4080312|FG001|NOT COMPLETED|Overall Study||0
3350042|NCT03564886|4080320|FG000|STARTED|Overall Study||24
3350043|NCT03564886|4080321|FG001|STARTED|Overall Study||24
3350044|NCT03564886|4080320|FG000|COMPLETED|Overall Study||23
3350045|NCT03564886|4080321|FG001|COMPLETED|Overall Study||23
3350046|NCT03564886|4080320|FG000|NOT COMPLETED|Overall Study||1
3350047|NCT03564886|4080321|FG001|NOT COMPLETED|Overall Study||1
3350048|NCT03565068|4080336|FG000|STARTED|Overall Study||12
3178042|NCT01974687|3905867|FG009|COMPLETED|Overall Study||3
3178043|NCT01974687|3905868|FG010|COMPLETED|Overall Study||3
3178044|NCT01974687|3905869|FG011|COMPLETED|Overall Study||11
3178045|NCT01974687|3905870|FG012|COMPLETED|Overall Study||10
3350049|NCT03565068|4080337|FG001|STARTED|Overall Study||4
3350050|NCT03565068|4080338|FG002|STARTED|Overall Study||12
3178046|NCT01974687|3905871|FG013|COMPLETED|Overall Study||8
3178047|NCT01974687|3905872|FG014|COMPLETED|Overall Study||18
3350051|NCT03565068|4080339|FG003|STARTED|Overall Study||4
3350052|NCT03565068|4080340|FG004|STARTED|Overall Study||12
3350053|NCT03565068|4080341|FG005|STARTED|Overall Study||1
3350054|NCT03565068|4080342|FG006|STARTED|Overall Study||4
3350055|NCT03565068|4080343|FG007|STARTED|Overall Study||17
3350056|NCT03565068|4080344|FG008|STARTED|Overall Study||9
3350057|NCT03565068|4080336|FG000|COMPLETED|Overall Study||12
3350058|NCT03565068|4080337|FG001|COMPLETED|Overall Study||4
3350059|NCT03565068|4080338|FG002|COMPLETED|Overall Study||11
3350060|NCT03565068|4080339|FG003|COMPLETED|Overall Study||4
3350061|NCT03565068|4080340|FG004|COMPLETED|Overall Study||8
3350062|NCT03565068|4080341|FG005|COMPLETED|Overall Study||0
3350063|NCT03565068|4080342|FG006|COMPLETED|Overall Study||3
3350064|NCT03565068|4080343|FG007|COMPLETED|Overall Study||9
3350065|NCT03565068|4080344|FG008|COMPLETED|Overall Study||8
3350066|NCT03565068|4080336|FG000|NOT COMPLETED|Overall Study||0
3350067|NCT03565068|4080337|FG001|NOT COMPLETED|Overall Study||0
3350068|NCT03565068|4080338|FG002|NOT COMPLETED|Overall Study||1
3350069|NCT03565068|4080339|FG003|NOT COMPLETED|Overall Study||0
3350070|NCT03565068|4080340|FG004|NOT COMPLETED|Overall Study||4
3350071|NCT03565068|4080341|FG005|NOT COMPLETED|Overall Study||1
3350072|NCT03565068|4080342|FG006|NOT COMPLETED|Overall Study||1
3350073|NCT03565068|4080343|FG007|NOT COMPLETED|Overall Study||8
3350074|NCT03565068|4080344|FG008|NOT COMPLETED|Overall Study||1
3350075|NCT03565211|4080401|FG000|STARTED|Overall Study||254
3350076|NCT03565211|4080401|FG000|Modified Intention-to-treat (mITT)|Overall Study|Had successful oocyte retrieval, received >=1 dose of IMP, and completed fresh embryo transfer|243
3350077|NCT03565211|4080401|FG000|COMPLETED|Overall Study||206
3350078|NCT03565211|4080401|FG000|NOT COMPLETED|Overall Study||48
3350079|NCT03565315|4080409|FG000|STARTED|Overall Study||3
3350080|NCT03565315|4080410|FG001|STARTED|Overall Study||3
3350081|NCT03565315|4080411|FG002|STARTED|Overall Study||1
3350082|NCT03565315|4080412|FG003|STARTED|Overall Study||2
3350083|NCT03565315|4080409|FG000|Product Administration Completed|Overall Study||3
3350084|NCT03565315|4080410|FG001|Product Administration Completed|Overall Study||0
3350085|NCT03565315|4080411|FG002|Product Administration Completed|Overall Study||1
3350086|NCT03565315|4080412|FG003|Product Administration Completed|Overall Study||0
3350087|NCT03565315|4080409|FG000|Discontinued Product Administrations|Overall Study||0
3350088|NCT03565315|4080410|FG001|Discontinued Product Administrations|Overall Study||3
3350089|NCT03565315|4080411|FG002|Discontinued Product Administrations|Overall Study||0
3350090|NCT03565315|4080412|FG003|Discontinued Product Administrations|Overall Study|One Group 4 participant enrolled but did not receive product due to IND/PI voluntary study pause.|2
3350091|NCT03565315|4080409|FG000|COMPLETED|Overall Study||3
3350092|NCT03565315|4080410|FG001|COMPLETED|Overall Study||3
3350093|NCT03565315|4080411|FG002|COMPLETED|Overall Study||1
3350094|NCT03565315|4080412|FG003|COMPLETED|Overall Study||1
3350095|NCT03565315|4080409|FG000|NOT COMPLETED|Overall Study||0
3350096|NCT03565315|4080410|FG001|NOT COMPLETED|Overall Study||0
3350097|NCT03565315|4080411|FG002|NOT COMPLETED|Overall Study||0
3350098|NCT03565315|4080412|FG003|NOT COMPLETED|Overall Study||1
3350099|NCT03565666|4080435|FG000|STARTED|Overall Study||12
3350100|NCT03565666|4080436|FG001|STARTED|Overall Study||12
3350101|NCT03565666|4080437|FG002|STARTED|Overall Study||12
3350102|NCT03565666|4080435|FG000|COMPLETED|Overall Study||12
3350103|NCT03565666|4080436|FG001|COMPLETED|Overall Study||12
3350104|NCT03565666|4080437|FG002|COMPLETED|Overall Study||11
3350105|NCT03565666|4080435|FG000|NOT COMPLETED|Overall Study||0
3350106|NCT03565666|4080436|FG001|NOT COMPLETED|Overall Study||0
3350107|NCT03565666|4080437|FG002|NOT COMPLETED|Overall Study||1
3350108|NCT03565679|4080448|FG000|STARTED|Overall Study||10
3350109|NCT03565679|4080448|FG000|COMPLETED|Overall Study||10
3350110|NCT03565679|4080448|FG000|NOT COMPLETED|Overall Study||0
3350111|NCT03565874|4080455|FG000|STARTED|Overall Study||6
3350112|NCT03565874|4080455|FG000|COMPLETED|Overall Study||4
3350113|NCT03565874|4080455|FG000|NOT COMPLETED|Overall Study||2
3350114|NCT03565887|4080461|FG000|STARTED|Overall Study||109
3350115|NCT03565887|4080462|FG001|STARTED|Overall Study||55
3350116|NCT03565887|4080461|FG000|COMPLETED|Overall Study||108
3350117|NCT03565887|4080462|FG001|COMPLETED|Overall Study||53
3350118|NCT03565887|4080461|FG000|NOT COMPLETED|Overall Study||1
3350119|NCT03565887|4080462|FG001|NOT COMPLETED|Overall Study||2
3350120|NCT03566238|4080471|FG000|STARTED|Overall Study||23
3350121|NCT03566238|4080472|FG001|STARTED|Overall Study||19
3350122|NCT03566238|4080473|FG002|STARTED|Overall Study||20
3350123|NCT03566238|4080471|FG000|Received Treatment|Overall Study||23
3350124|NCT03566238|4080472|FG001|Received Treatment|Overall Study||19
3350125|NCT03566238|4080473|FG002|Received Treatment|Overall Study||20
3350126|NCT03566238|4080471|FG000|COMPLETED|Overall Study||18
3350127|NCT03566238|4080472|FG001|COMPLETED|Overall Study||16
3350128|NCT03566238|4080473|FG002|COMPLETED|Overall Study||15
3350129|NCT03566238|4080471|FG000|NOT COMPLETED|Overall Study||5
3350130|NCT03566238|4080472|FG001|NOT COMPLETED|Overall Study||3
3350131|NCT03566238|4080473|FG002|NOT COMPLETED|Overall Study||5
3350132|NCT03566485|4080483|FG000|STARTED|Overall Study||5
3350133|NCT03566485|4080484|FG001|STARTED|Overall Study|Dose level 1 (Idasanutlin 100mg PO)|7
3350134|NCT03566485|4080483|FG000|COMPLETED|Overall Study||0
3350135|NCT03566485|4080484|FG001|COMPLETED|Overall Study||0
3350136|NCT03566485|4080483|FG000|NOT COMPLETED|Overall Study||5
3350137|NCT03566485|4080484|FG001|NOT COMPLETED|Overall Study||7
3350138|NCT03566550|4080492|FG000|STARTED|Overall Study||12
3350139|NCT03566550|4080493|FG001|STARTED|Overall Study||13
3350140|NCT03566550|4080492|FG000|COMPLETED|Overall Study||12
3350141|NCT03566550|4080493|FG001|COMPLETED|Overall Study||12
3350142|NCT03566550|4080492|FG000|NOT COMPLETED|Overall Study||0
3350143|NCT03566550|4080493|FG001|NOT COMPLETED|Overall Study||1
3350144|NCT03566680|4080499|FG000|STARTED|Overall Study||46
3350145|NCT03566680|4080499|FG000|COMPLETED|Overall Study||29
3350146|NCT03566680|4080499|FG000|NOT COMPLETED|Overall Study||17
3350147|NCT03566810|4080507|FG000|STARTED|Treatment Period 1 (Day 1-Day 3)||19
3350148|NCT03566810|4080508|FG001|STARTED|Treatment Period 1 (Day 1-Day 3)||19
3350149|NCT03566810|4080509|FG002|STARTED|Treatment Period 1 (Day 1-Day 3)||8
3350150|NCT03566810|4080510|FG003|STARTED|Treatment Period 1 (Day 1-Day 3)||8
3350151|NCT03566810|4080507|FG000|Treated|Treatment Period 1 (Day 1-Day 3)||19
3350152|NCT03566810|4080508|FG001|Treated|Treatment Period 1 (Day 1-Day 3)||18
3350153|NCT03566810|4080509|FG002|Treated|Treatment Period 1 (Day 1-Day 3)||8
3350154|NCT03566810|4080510|FG003|Treated|Treatment Period 1 (Day 1-Day 3)||8
3350155|NCT03566810|4080507|FG000|COMPLETED|Treatment Period 1 (Day 1-Day 3)||19
3350156|NCT03566810|4080508|FG001|COMPLETED|Treatment Period 1 (Day 1-Day 3)||18
3350157|NCT03566810|4080509|FG002|COMPLETED|Treatment Period 1 (Day 1-Day 3)||8
3350158|NCT03566810|4080510|FG003|COMPLETED|Treatment Period 1 (Day 1-Day 3)||8
3350159|NCT03566810|4080507|FG000|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||0
3350160|NCT03566810|4080508|FG001|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||1
3350161|NCT03566810|4080509|FG002|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||0
3350162|NCT03566810|4080510|FG003|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||0
3350163|NCT03566810|4080507|FG000|STARTED|Treatment Period 2 (Day 8- Day 10)||19
3350164|NCT03566810|4080508|FG001|STARTED|Treatment Period 2 (Day 8- Day 10)||18
3350165|NCT03566810|4080509|FG002|STARTED|Treatment Period 2 (Day 8- Day 10)||8
3350166|NCT03566810|4080510|FG003|STARTED|Treatment Period 2 (Day 8- Day 10)||8
3350167|NCT03566810|4080507|FG000|COMPLETED|Treatment Period 2 (Day 8- Day 10)||19
3350168|NCT03566810|4080508|FG001|COMPLETED|Treatment Period 2 (Day 8- Day 10)||18
3350169|NCT03566810|4080509|FG002|COMPLETED|Treatment Period 2 (Day 8- Day 10)||8
3350170|NCT03566810|4080510|FG003|COMPLETED|Treatment Period 2 (Day 8- Day 10)||8
3350171|NCT03566810|4080507|FG000|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0
3350172|NCT03566810|4080508|FG001|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0
3350173|NCT03566810|4080509|FG002|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0
3350174|NCT03566810|4080510|FG003|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0
3350175|NCT03566823|4080523|FG000|STARTED|Overall Study||6
3350176|NCT03566823|4080524|FG001|STARTED|Overall Study||15
3350177|NCT03566823|4080525|FG002|STARTED|Overall Study||13
3350178|NCT03566823|4080523|FG000|COMPLETED|Overall Study||4
3350179|NCT03566823|4080524|FG001|COMPLETED|Overall Study||12
3350180|NCT03566823|4080525|FG002|COMPLETED|Overall Study||11
3350181|NCT03566823|4080523|FG000|NOT COMPLETED|Overall Study||2
3350182|NCT03566823|4080524|FG001|NOT COMPLETED|Overall Study||3
3350183|NCT03566823|4080525|FG002|NOT COMPLETED|Overall Study||2
3350184|NCT03566979|4080537|FG000|STARTED|Overall Study||58
3350185|NCT03566979|4080538|FG001|STARTED|Overall Study||152
3350186|NCT03566979|4080539|FG002|STARTED|Overall Study||142
3350187|NCT03566979|4080540|FG003|STARTED|Overall Study||149
3350188|NCT03566979|4080537|FG000|COMPLETED|Overall Study||53
3350189|NCT03566979|4080538|FG001|COMPLETED|Overall Study||145
3350190|NCT03566979|4080539|FG002|COMPLETED|Overall Study||132
3350191|NCT03566979|4080540|FG003|COMPLETED|Overall Study||143
3350192|NCT03566979|4080537|FG000|NOT COMPLETED|Overall Study||5
3350193|NCT03566979|4080538|FG001|NOT COMPLETED|Overall Study||7
3350194|NCT03566979|4080539|FG002|NOT COMPLETED|Overall Study||10
3350195|NCT03566979|4080540|FG003|NOT COMPLETED|Overall Study||6
3350196|NCT03567005|4080550|FG000|STARTED|Period 1, First 7 Days of Wear||29
3350197|NCT03567005|4080551|FG001|STARTED|Period 1, First 7 Days of Wear||31
3350198|NCT03567005|4080550|FG000|COMPLETED|Period 1, First 7 Days of Wear||29
3350199|NCT03567005|4080551|FG001|COMPLETED|Period 1, First 7 Days of Wear||31
3350200|NCT03567005|4080550|FG000|NOT COMPLETED|Period 1, First 7 Days of Wear||0
3350201|NCT03567005|4080551|FG001|NOT COMPLETED|Period 1, First 7 Days of Wear||0
3350202|NCT03567005|4080550|FG000|STARTED|Period 2, Second 7 Days of Wear||29
3350203|NCT03567005|4080551|FG001|STARTED|Period 2, Second 7 Days of Wear||31
3350204|NCT03567005|4080550|FG000|COMPLETED|Period 2, Second 7 Days of Wear||29
3350205|NCT03567005|4080551|FG001|COMPLETED|Period 2, Second 7 Days of Wear||31
3350206|NCT03567005|4080550|FG000|NOT COMPLETED|Period 2, Second 7 Days of Wear||0
3350207|NCT03567005|4080551|FG001|NOT COMPLETED|Period 2, Second 7 Days of Wear||0
3350208|NCT03567252|4080559|FG000|STARTED|Overall Study||48
3350209|NCT03567252|4080560|FG001|STARTED|Overall Study||19
3350210|NCT03567252|4080559|FG000|COMPLETED|Overall Study||48
3350211|NCT03567252|4080560|FG001|COMPLETED|Overall Study||19
3350212|NCT03567252|4080559|FG000|NOT COMPLETED|Overall Study||0
3350213|NCT03567252|4080560|FG001|NOT COMPLETED|Overall Study||0
3350214|NCT03567291|4080566|FG000|STARTED|Period I||228
3350215|NCT03567291|4080567|FG001|STARTED|Period I||0
3350216|NCT03567291|4080568|FG002|STARTED|Period I||0
3350217|NCT03567291|4080569|FG003|STARTED|Period I||0
3350218|NCT03567291|4080566|FG000|Safety Set|Period I||227
3350219|NCT03567291|4080567|FG001|Safety Set|Period I||0
3350220|NCT03567291|4080568|FG002|Safety Set|Period I||0
3350221|NCT03567291|4080569|FG003|Safety Set|Period I||0
3350222|NCT03567291|4080566|FG000|Intent to Treat Set|Period I||228
3350223|NCT03567291|4080567|FG001|Intent to Treat Set|Period I||0
3350224|NCT03567291|4080568|FG002|Intent to Treat Set|Period I||0
3350225|NCT03567291|4080569|FG003|Intent to Treat Set|Period I||0
3350226|NCT03567291|4080566|FG000|COMPLETED|Period I||137
3350227|NCT03567291|4080567|FG001|COMPLETED|Period I||0
3350228|NCT03567291|4080568|FG002|COMPLETED|Period I||0
3350229|NCT03567291|4080569|FG003|COMPLETED|Period I||0
3350230|NCT03567291|4080566|FG000|NOT COMPLETED|Period I||91
3350231|NCT03567291|4080567|FG001|NOT COMPLETED|Period I||0
3350232|NCT03567291|4080568|FG002|NOT COMPLETED|Period I||0
3350233|NCT03567291|4080569|FG003|NOT COMPLETED|Period I||0
3350234|NCT03567291|4080566|FG000|STARTED|Period II||0
3350235|NCT03567291|4080567|FG001|STARTED|Period II||91
3350236|NCT03567291|4080568|FG002|STARTED|Period II||46
3350237|NCT03567291|4080569|FG003|STARTED|Period II||0
2927997|NCT00575380|3638949|FG000|NOT COMPLETED|Overall Study||1
2927998|NCT00575380|3638950|FG001|NOT COMPLETED|Overall Study||3
2927999|NCT00575510|3638959|FG000|STARTED|Overall Study||114
2928000|NCT00575510|3638960|FG001|STARTED|Overall Study||114
2928001|NCT00575510|3638961|FG002|STARTED|Overall Study||113
2928002|NCT00575510|3638959|FG000|COMPLETED|Overall Study||102
2928003|NCT00575510|3638960|FG001|COMPLETED|Overall Study||101
2928004|NCT00575510|3638961|FG002|COMPLETED|Overall Study||96
2928005|NCT00575510|3638959|FG000|NOT COMPLETED|Overall Study||12
2928006|NCT00575510|3638960|FG001|NOT COMPLETED|Overall Study||13
2928007|NCT00575510|3638961|FG002|NOT COMPLETED|Overall Study||17
3039889|NCT01161420|3759410|FG000|NOT COMPLETED|Withdrawal Study - Maintenance||0
3039890|NCT01161420|3759410|FG000|STARTED|Withdrawal Study - Withdrawal||23
3039891|NCT01161420|3759410|FG000|COMPLETED|Withdrawal Study - Withdrawal||23
3039892|NCT01161420|3759410|FG000|NOT COMPLETED|Withdrawal Study - Withdrawal||0
3039893|NCT01161446|3759422|FG000|STARTED|Overall Study||116
3039894|NCT01161446|3759423|FG001|STARTED|Overall Study||114
3039895|NCT01161446|3759422|FG000|COMPLETED|Overall Study||98
3039896|NCT01161446|3759423|FG001|COMPLETED|Overall Study||99
3039897|NCT01161446|3759422|FG000|NOT COMPLETED|Overall Study||18
3039898|NCT01161446|3759423|FG001|NOT COMPLETED|Overall Study||15
3039899|NCT01161472|3759429|FG000|STARTED|First Intervention Period||5
3039900|NCT01161472|3759430|FG001|STARTED|First Intervention Period||5
3039901|NCT01161472|3759431|FG002|STARTED|First Intervention Period||5
3039902|NCT01161472|3759432|FG003|STARTED|First Intervention Period||5
3039903|NCT01161472|3759429|FG000|Treated|First Intervention Period||5
3039904|NCT01161472|3759430|FG001|Treated|First Intervention Period||5
3039905|NCT01161472|3759431|FG002|Treated|First Intervention Period||5
3039906|NCT01161472|3759432|FG003|Treated|First Intervention Period||5
3039907|NCT01161472|3759429|FG000|COMPLETED|First Intervention Period||5
3039908|NCT01161472|3759430|FG001|COMPLETED|First Intervention Period||5
3039909|NCT01161472|3759431|FG002|COMPLETED|First Intervention Period||5
3039910|NCT01161472|3759432|FG003|COMPLETED|First Intervention Period||5
3039911|NCT01161472|3759429|FG000|NOT COMPLETED|First Intervention Period||0
3039912|NCT01161472|3759430|FG001|NOT COMPLETED|First Intervention Period||0
3039913|NCT01161472|3759431|FG002|NOT COMPLETED|First Intervention Period||0
3039914|NCT01161472|3759432|FG003|NOT COMPLETED|First Intervention Period||0
3039915|NCT01161472|3759429|FG000|STARTED|Washout Period (At Least 3 to 6 Days)||5
3039916|NCT01161472|3759430|FG001|STARTED|Washout Period (At Least 3 to 6 Days)||5
3039917|NCT01161472|3759431|FG002|STARTED|Washout Period (At Least 3 to 6 Days)||5
3039918|NCT01161472|3759432|FG003|STARTED|Washout Period (At Least 3 to 6 Days)||5
3039919|NCT01161472|3759429|FG000|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
3039920|NCT01161472|3759430|FG001|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
3039921|NCT01161472|3759431|FG002|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
3039922|NCT01161472|3759432|FG003|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
3039923|NCT01161472|3759429|FG000|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
3039924|NCT01161472|3759430|FG001|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
3039925|NCT01161472|3759431|FG002|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
3039926|NCT01161472|3759432|FG003|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
3039927|NCT01161472|3759429|FG000|STARTED|Second Intervention Period||5
3039928|NCT01161472|3759430|FG001|STARTED|Second Intervention Period||5
3039929|NCT01161472|3759431|FG002|STARTED|Second Intervention Period||5
3039930|NCT01161472|3759432|FG003|STARTED|Second Intervention Period||5
3039931|NCT01161472|3759429|FG000|COMPLETED|Second Intervention Period||5
3350238|NCT03567291|4080566|FG000|COMPLETED|Period II||0
3350239|NCT03567291|4080567|FG001|COMPLETED|Period II||88
3350240|NCT03567291|4080568|FG002|COMPLETED|Period II||45
3350241|NCT03567291|4080569|FG003|COMPLETED|Period II||0
3350242|NCT03567291|4080566|FG000|NOT COMPLETED|Period II||0
3350243|NCT03567291|4080567|FG001|NOT COMPLETED|Period II||3
3350244|NCT03567291|4080568|FG002|NOT COMPLETED|Period II||1
3350245|NCT03567291|4080569|FG003|NOT COMPLETED|Period II||0
3350246|NCT03567291|4080566|FG000|STARTED|Period III||0
3350247|NCT03567291|4080567|FG001|STARTED|Period III||0
3350248|NCT03567291|4080568|FG002|STARTED|Period III||0
3350249|NCT03567291|4080569|FG003|STARTED|Period III||133
3350250|NCT03567291|4080566|FG000|COMPLETED|Period III||0
3350251|NCT03567291|4080567|FG001|COMPLETED|Period III||0
3350252|NCT03567291|4080568|FG002|COMPLETED|Period III||0
3350253|NCT03567291|4080569|FG003|COMPLETED|Period III||48
3350254|NCT03567291|4080566|FG000|NOT COMPLETED|Period III||0
3350255|NCT03567291|4080567|FG001|NOT COMPLETED|Period III||0
3350256|NCT03567291|4080568|FG002|NOT COMPLETED|Period III||0
3350257|NCT03567291|4080569|FG003|NOT COMPLETED|Period III||85
3350258|NCT03567382|4080577|FG000|STARTED|Overall Study||10
3350259|NCT03567382|4080578|FG001|STARTED|Overall Study||81
3350260|NCT03567382|4080579|FG002|STARTED|Overall Study||9
3350261|NCT03567382|4080580|FG003|STARTED|Overall Study||79
3350262|NCT03567382|4080577|FG000|Received Tenofovir|Overall Study||9
3350263|NCT03567382|4080578|FG001|Received Tenofovir|Overall Study||0
3350264|NCT03567382|4080579|FG002|Received Tenofovir|Overall Study||0
3350265|NCT03567382|4080580|FG003|Received Tenofovir|Overall Study||0
3350266|NCT03567382|4080577|FG000|COMPLETED|Overall Study||7
3350267|NCT03567382|4080578|FG001|COMPLETED|Overall Study||46
3350268|NCT03567382|4080579|FG002|COMPLETED|Overall Study||7
3350269|NCT03567382|4080580|FG003|COMPLETED|Overall Study||46
3350270|NCT03567382|4080577|FG000|NOT COMPLETED|Overall Study||3
3350271|NCT03567382|4080578|FG001|NOT COMPLETED|Overall Study||35
3350272|NCT03567382|4080579|FG002|NOT COMPLETED|Overall Study||2
3350273|NCT03567382|4080580|FG003|NOT COMPLETED|Overall Study||33
3350274|NCT03567616|4080593|FG000|STARTED|Overall Study||8
3350275|NCT03567616|4080593|FG000|COMPLETED|Overall Study||0
3350276|NCT03567616|4080593|FG000|NOT COMPLETED|Overall Study||8
3350277|NCT03567980|4080600|FG000|STARTED|Overall Study||30
3350278|NCT03567980|4080600|FG000|COMPLETED|Overall Study||29
3350279|NCT03567980|4080600|FG000|NOT COMPLETED|Overall Study||1
3350280|NCT03568500|4080607|FG000|STARTED|Overall Study||18
3350281|NCT03568500|4080608|FG001|STARTED|Overall Study||20
3350282|NCT03568500|4080609|FG002|STARTED|Overall Study||6
3350283|NCT03568500|4080607|FG000|Received At Least 1 Dose of Study Drug|Overall Study||18
3350284|NCT03568500|4080608|FG001|Received At Least 1 Dose of Study Drug|Overall Study||19
3350285|NCT03568500|4080609|FG002|Received At Least 1 Dose of Study Drug|Overall Study||6
3350286|NCT03568500|4080607|FG000|COMPLETED|Overall Study||8
3350287|NCT03568500|4080608|FG001|COMPLETED|Overall Study||14
3350288|NCT03568500|4080609|FG002|COMPLETED|Overall Study||2
3350289|NCT03568500|4080607|FG000|NOT COMPLETED|Overall Study||10
3350290|NCT03568500|4080608|FG001|NOT COMPLETED|Overall Study||6
3350291|NCT03568500|4080609|FG002|NOT COMPLETED|Overall Study||4
3350292|NCT03568539|4080624|FG000|STARTED|Overall Study||3
3350293|NCT03568539|4080625|FG001|STARTED|Overall Study||36
3350294|NCT03568539|4080624|FG000|COMPLETED|Overall Study||3
3350295|NCT03568539|4080625|FG001|COMPLETED|Overall Study||36
3350296|NCT03568539|4080624|FG000|NOT COMPLETED|Overall Study||0
3350297|NCT03568539|4080625|FG001|NOT COMPLETED|Overall Study||0
3350298|NCT03568942|4080632|FG000|STARTED|Overall Study||22
3350299|NCT03568942|4080632|FG000|COMPLETED|Overall Study||20
3350300|NCT03568942|4080632|FG000|NOT COMPLETED|Overall Study||2
3350301|NCT03569020|4080638|FG000|STARTED|Period 1||22
3350302|NCT03569020|4080639|FG001|STARTED|Period 1||21
3350303|NCT03569020|4080638|FG000|COMPLETED|Period 1||22
3350304|NCT03569020|4080639|FG001|COMPLETED|Period 1||21
3350305|NCT03569020|4080638|FG000|NOT COMPLETED|Period 1||0
3350306|NCT03569020|4080639|FG001|NOT COMPLETED|Period 1||0
3350307|NCT03569020|4080638|FG000|STARTED|Period 2||22
3350308|NCT03569020|4080639|FG001|STARTED|Period 2||21
3350309|NCT03569020|4080638|FG000|COMPLETED|Period 2||22
3350310|NCT03569020|4080639|FG001|COMPLETED|Period 2||21
3350311|NCT03569020|4080638|FG000|NOT COMPLETED|Period 2||0
3350312|NCT03569020|4080639|FG001|NOT COMPLETED|Period 2||0
3350313|NCT03569033|4080651|FG000|STARTED|Overall Study||23
3350314|NCT03569033|4080652|FG001|STARTED|Overall Study||23
3350315|NCT03569033|4080651|FG000|COMPLETED|Overall Study||23
3350316|NCT03569033|4080652|FG001|COMPLETED|Overall Study||23
3350317|NCT03569033|4080651|FG000|NOT COMPLETED|Overall Study||0
3350318|NCT03569033|4080652|FG001|NOT COMPLETED|Overall Study||0
3350319|NCT03569098|4080661|FG000|STARTED|Double-Blind Treatment Cycle 1||63
3350320|NCT03569098|4080662|FG001|STARTED|Double-Blind Treatment Cycle 1||63
3350321|NCT03569098|4080663|FG002|STARTED|Double-Blind Treatment Cycle 1||60
3350322|NCT03569098|4080661|FG000|Received Study Medication|Double-Blind Treatment Cycle 1||61
3350323|NCT03569098|4080662|FG001|Received Study Medication|Double-Blind Treatment Cycle 1||63
3350324|NCT03569098|4080663|FG002|Received Study Medication|Double-Blind Treatment Cycle 1||56
3350325|NCT03569098|4080661|FG000|COMPLETED|Double-Blind Treatment Cycle 1||55
3350326|NCT03569098|4080662|FG001|COMPLETED|Double-Blind Treatment Cycle 1||53
3350327|NCT03569098|4080663|FG002|COMPLETED|Double-Blind Treatment Cycle 1||49
3350328|NCT03569098|4080661|FG000|NOT COMPLETED|Double-Blind Treatment Cycle 1||8
3350329|NCT03569098|4080662|FG001|NOT COMPLETED|Double-Blind Treatment Cycle 1||10
3350330|NCT03569098|4080663|FG002|NOT COMPLETED|Double-Blind Treatment Cycle 1||11
3350331|NCT03569098|4080661|FG000|STARTED|Open-Label Treatment Cycle 2|No participants were treated with placebo during the open-label treatment cycle 2.|0
3350332|NCT03569098|4080662|FG001|STARTED|Open-Label Treatment Cycle 2|All participants who met retreatment criteria were treated with Dysport 300 U during the open-label treatment cycle 2.|146
3350333|NCT03569098|4080663|FG002|STARTED|Open-Label Treatment Cycle 2|No participants were treated with Dysport 500 U during the open-label treatment cycle 2.|0
3350334|NCT03569098|4080661|FG000|COMPLETED|Open-Label Treatment Cycle 2||0
3350335|NCT03569098|4080662|FG001|COMPLETED|Open-Label Treatment Cycle 2||111
3350336|NCT03569098|4080663|FG002|COMPLETED|Open-Label Treatment Cycle 2||0
3350337|NCT03569098|4080661|FG000|NOT COMPLETED|Open-Label Treatment Cycle 2||0
3350338|NCT03569098|4080662|FG001|NOT COMPLETED|Open-Label Treatment Cycle 2||35
3350339|NCT03569098|4080663|FG002|NOT COMPLETED|Open-Label Treatment Cycle 2||0
3350340|NCT03569098|4080661|FG000|STARTED|Open-Label Treatment Cycle 3||0
3350341|NCT03569098|4080662|FG001|STARTED|Open-Label Treatment Cycle 3|Participants were treated with Dysport 300 U during open-label treatment cycle 3 based on investigator judgment following clinical evaluation of the participant at the time of retreatment.|8
3350342|NCT03569098|4080663|FG002|STARTED|Open-Label Treatment Cycle 3|Participants were treated with Dysport 500 U during open-label treatment cycle 3 based on investigator judgment following clinical evaluation of the participant at the time of retreatment.|56
3350343|NCT03569098|4080661|FG000|COMPLETED|Open-Label Treatment Cycle 3||0
3178048|NCT01974687|3905873|FG015|COMPLETED|Overall Study||8
3178049|NCT01974687|3905874|FG016|COMPLETED|Overall Study||8
3178050|NCT01974687|3905875|FG017|COMPLETED|Overall Study||8
3178051|NCT01974687|3905876|FG018|COMPLETED|Overall Study||9
3178052|NCT01974687|3905877|FG019|COMPLETED|Overall Study||3
3178053|NCT01974687|3905878|FG020|COMPLETED|Overall Study||3
3350344|NCT03569098|4080662|FG001|COMPLETED|Open-Label Treatment Cycle 3||7
3350345|NCT03569098|4080663|FG002|COMPLETED|Open-Label Treatment Cycle 3||50
3350346|NCT03569098|4080661|FG000|NOT COMPLETED|Open-Label Treatment Cycle 3||0
3350347|NCT03569098|4080662|FG001|NOT COMPLETED|Open-Label Treatment Cycle 3||1
3350348|NCT03569098|4080663|FG002|NOT COMPLETED|Open-Label Treatment Cycle 3||6
3350349|NCT03569202|4080676|FG000|STARTED|Part 1|Emulsion Eye Drops were used on one eye only.|3
3350350|NCT03569202|4080677|FG001|STARTED|Part 1|Control Eye Drops were not used for Part 1.|0
3350351|NCT03569202|4080676|FG000|COMPLETED|Part 1|No participant completing Part 1 was allowed to continue to Parts 2 or 3.|3
3350352|NCT03569202|4080677|FG001|COMPLETED|Part 1||0
3350353|NCT03569202|4080676|FG000|NOT COMPLETED|Part 1||0
3350354|NCT03569202|4080677|FG001|NOT COMPLETED|Part 1||0
3350355|NCT03569202|4080676|FG000|STARTED|Part 2|Emulsion Eye Drops were used on one randomized eye. Participants were different from Part 1.|9
3350356|NCT03569202|4080677|FG001|STARTED|Part 2|Control Eye Drops were used on contralateral eye. Participants were different from Part 1.|9
3350357|NCT03569202|4080676|FG000|COMPLETED|Part 2|No participant completing Part 2 was allowed to continue to Part 3.|9
3350358|NCT03569202|4080677|FG001|COMPLETED|Part 2|No participant completing Part 2 was allowed to continue to Part 3.|9
3350359|NCT03569202|4080676|FG000|NOT COMPLETED|Part 2||0
3350360|NCT03569202|4080677|FG001|NOT COMPLETED|Part 2||0
3350361|NCT03569202|4080676|FG000|STARTED|Part 3|Emulsion Eye Drops were used on both eyes. Participants were different from Parts 1 and 2.|26
3350362|NCT03569202|4080677|FG001|STARTED|Part 3|Control Eye Drops were used on both eyes. Participants were different from Parts 1 and 2.|26
3350363|NCT03569202|4080676|FG000|COMPLETED|Part 3|Per-protocol (PP) dataset. 'Not Completed' participants are included in safety and ITT datasets.|24
3350364|NCT03569202|4080677|FG001|COMPLETED|Part 3|Per-protocol (PP) dataset. 'Not Completed' participants are included in safety and ITT datasets.|25
3350365|NCT03569202|4080676|FG000|NOT COMPLETED|Part 3||2
3350366|NCT03569202|4080677|FG001|NOT COMPLETED|Part 3||1
3350367|NCT03569371|4080683|FG000|STARTED|Overall Study||10
3350368|NCT03569371|4080683|FG000|COMPLETED|Overall Study||7
3350369|NCT03569371|4080683|FG000|NOT COMPLETED|Overall Study||3
3350370|NCT03569397|4080689|FG000|STARTED|Overall Study||29
3350371|NCT03569397|4080690|FG001|STARTED|Overall Study||28
3350372|NCT03569397|4080689|FG000|COMPLETED|Overall Study||29
3350373|NCT03569397|4080690|FG001|COMPLETED|Overall Study||28
3350374|NCT03569397|4080689|FG000|NOT COMPLETED|Overall Study||0
3350375|NCT03569397|4080690|FG001|NOT COMPLETED|Overall Study||0
3350376|NCT03569618|4080697|FG000|STARTED|Overall Study||23
3178054|NCT01974687|3905879|FG021|COMPLETED|Overall Study||8
3178055|NCT01974687|3905880|FG022|COMPLETED|Overall Study||8
3178056|NCT01974687|3905881|FG023|COMPLETED|Overall Study||6
3178057|NCT01974687|3905882|FG024|COMPLETED|Overall Study||10
3178058|NCT01974687|3905858|FG000|NOT COMPLETED|Overall Study||0
3178059|NCT01974687|3905859|FG001|NOT COMPLETED|Overall Study||0
3178060|NCT01974687|3905860|FG002|NOT COMPLETED|Overall Study||0
3178061|NCT01974687|3905861|FG003|NOT COMPLETED|Overall Study||0
3178062|NCT01974687|3905862|FG004|NOT COMPLETED|Overall Study||0
3178063|NCT01974687|3905863|FG005|NOT COMPLETED|Overall Study||0
3178064|NCT01974687|3905864|FG006|NOT COMPLETED|Overall Study||0
3178065|NCT01974687|3905865|FG007|NOT COMPLETED|Overall Study||0
3178066|NCT01974687|3905866|FG008|NOT COMPLETED|Overall Study||0
3350377|NCT03569618|4080698|FG001|STARTED|Overall Study||21
3350378|NCT03569618|4080697|FG000|COMPLETED|Overall Study||20
3350379|NCT03569618|4080698|FG001|COMPLETED|Overall Study||20
3350380|NCT03569618|4080697|FG000|NOT COMPLETED|Overall Study||3
3350381|NCT03569618|4080698|FG001|NOT COMPLETED|Overall Study||1
3350382|NCT03569748|4080707|FG000|STARTED|Overall Study||110
3350383|NCT03569748|4080708|FG001|STARTED|Overall Study||110
3350384|NCT03569748|4080707|FG000|COMPLETED|Overall Study||110
3350385|NCT03569748|4080708|FG001|COMPLETED|Overall Study||101
3178067|NCT01974687|3905867|FG009|NOT COMPLETED|Overall Study||0
3350386|NCT03569748|4080707|FG000|NOT COMPLETED|Overall Study||0
3350387|NCT03569748|4080708|FG001|NOT COMPLETED|Overall Study||9
3350388|NCT03570047|4080725|FG000|STARTED|Overall Study||15902
3350389|NCT03570047|4080726|FG001|STARTED|Overall Study||22336
3350390|NCT03570047|4080727|FG002|STARTED|Overall Study||6925
3350391|NCT03570047|4080728|FG003|STARTED|Overall Study||16564
3350392|NCT03570047|4080729|FG004|STARTED|Overall Study||12262
3350393|NCT03570047|4080725|FG000|COMPLETED|Overall Study||15902
3350394|NCT03570047|4080726|FG001|COMPLETED|Overall Study||22336
3350395|NCT03570047|4080727|FG002|COMPLETED|Overall Study||6925
3350396|NCT03570047|4080728|FG003|COMPLETED|Overall Study||16564
3350397|NCT03570047|4080729|FG004|COMPLETED|Overall Study||12262
3350398|NCT03570047|4080725|FG000|NOT COMPLETED|Overall Study||0
3350399|NCT03570047|4080726|FG001|NOT COMPLETED|Overall Study||0
3350400|NCT03570047|4080727|FG002|NOT COMPLETED|Overall Study||0
3350401|NCT03570047|4080728|FG003|NOT COMPLETED|Overall Study||0
3350402|NCT03570047|4080729|FG004|NOT COMPLETED|Overall Study||0
3350403|NCT03570255|4080741|FG000|STARTED|Overall Study||28
3350404|NCT03570255|4080741|FG000|COMPLETED|Overall Study||28
3350405|NCT03570255|4080741|FG000|NOT COMPLETED|Overall Study||0
3350406|NCT03570476|4080745|FG000|STARTED|Overall Study||2
3350407|NCT03570476|4080745|FG000|COMPLETED|Overall Study||2
3350408|NCT03570476|4080745|FG000|NOT COMPLETED|Overall Study||0
3178068|NCT01974687|3905868|FG010|NOT COMPLETED|Overall Study||0
3178069|NCT01974687|3905869|FG011|NOT COMPLETED|Overall Study||2
3178070|NCT01974687|3905870|FG012|NOT COMPLETED|Overall Study||3
3178071|NCT01974687|3905871|FG013|NOT COMPLETED|Overall Study||2
3178072|NCT01974687|3905872|FG014|NOT COMPLETED|Overall Study||1
3178073|NCT01974687|3905873|FG015|NOT COMPLETED|Overall Study||1
3178074|NCT01974687|3905874|FG016|NOT COMPLETED|Overall Study||1
3178075|NCT01974687|3905875|FG017|NOT COMPLETED|Overall Study||3
3178076|NCT01974687|3905876|FG018|NOT COMPLETED|Overall Study||0
3178077|NCT01974687|3905877|FG019|NOT COMPLETED|Overall Study||0
3178078|NCT01974687|3905878|FG020|NOT COMPLETED|Overall Study||0
3178079|NCT01974687|3905879|FG021|NOT COMPLETED|Overall Study||0
3350409|NCT03570554|4080754|FG000|STARTED|Overall Study||10
3350410|NCT03570554|4080755|FG001|STARTED|Overall Study||10
3350411|NCT03570554|4080756|FG002|STARTED|Overall Study||11
3350412|NCT03570554|4080757|FG003|STARTED|Overall Study||10
3350413|NCT03570554|4080754|FG000|COMPLETED|Overall Study||10
3350414|NCT03570554|4080755|FG001|COMPLETED|Overall Study||10
3350415|NCT03570554|4080756|FG002|COMPLETED|Overall Study||10
3350416|NCT03570554|4080757|FG003|COMPLETED|Overall Study||9
3350417|NCT03570554|4080754|FG000|NOT COMPLETED|Overall Study||0
3350418|NCT03570554|4080755|FG001|NOT COMPLETED|Overall Study||0
3350419|NCT03570554|4080756|FG002|NOT COMPLETED|Overall Study||1
3350420|NCT03570554|4080757|FG003|NOT COMPLETED|Overall Study||1
3350421|NCT03570658|4080771|FG000|STARTED|Single Ascending Dose (SAD)||6
3350422|NCT03570658|4080772|FG001|STARTED|Single Ascending Dose (SAD)||2
3350423|NCT03570658|4080773|FG002|STARTED|Single Ascending Dose (SAD)||10
3350424|NCT03570658|4080774|FG003|STARTED|Single Ascending Dose (SAD)||10
3350425|NCT03570658|4080771|FG000|COMPLETED|Single Ascending Dose (SAD)||6
3350426|NCT03570658|4080772|FG001|COMPLETED|Single Ascending Dose (SAD)||2
3350427|NCT03570658|4080773|FG002|COMPLETED|Single Ascending Dose (SAD)||10
3350428|NCT03570658|4080774|FG003|COMPLETED|Single Ascending Dose (SAD)||10
3350429|NCT03570658|4080771|FG000|NOT COMPLETED|Single Ascending Dose (SAD)||0
3350430|NCT03570658|4080772|FG001|NOT COMPLETED|Single Ascending Dose (SAD)||0
3350431|NCT03570658|4080773|FG002|NOT COMPLETED|Single Ascending Dose (SAD)||0
3350432|NCT03570658|4080774|FG003|NOT COMPLETED|Single Ascending Dose (SAD)||0
3350433|NCT03570658|4080771|FG000|STARTED|Multiple Ascending Dose (MAD)||4
3350434|NCT03570658|4080772|FG001|STARTED|Multiple Ascending Dose (MAD)||0
3350435|NCT03570658|4080773|FG002|STARTED|Multiple Ascending Dose (MAD)||10
3350436|NCT03570658|4080774|FG003|STARTED|Multiple Ascending Dose (MAD)||10
3350437|NCT03570658|4080771|FG000|COMPLETED|Multiple Ascending Dose (MAD)||4
3350438|NCT03570658|4080772|FG001|COMPLETED|Multiple Ascending Dose (MAD)||0
3350439|NCT03570658|4080773|FG002|COMPLETED|Multiple Ascending Dose (MAD)||10
3350440|NCT03570658|4080774|FG003|COMPLETED|Multiple Ascending Dose (MAD)||10
3350441|NCT03570658|4080771|FG000|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
3350442|NCT03570658|4080772|FG001|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
3350443|NCT03570658|4080773|FG002|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
3350444|NCT03570658|4080774|FG003|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
3350445|NCT03570697|4080800|FG000|STARTED|Overall Study||82
3350446|NCT03570697|4080801|FG001|STARTED|Overall Study||82
3350447|NCT03570697|4080800|FG000|Received at Least 1 Dose of Study Drug|Overall Study||81
3350448|NCT03570697|4080801|FG001|Received at Least 1 Dose of Study Drug|Overall Study||80
3350449|NCT03570697|4080800|FG000|COMPLETED|Overall Study||76
3178080|NCT01974687|3905880|FG022|NOT COMPLETED|Overall Study||0
3178081|NCT01974687|3905881|FG023|NOT COMPLETED|Overall Study||0
3178082|NCT01974687|3905882|FG024|NOT COMPLETED|Overall Study||0
3350450|NCT03570697|4080801|FG001|COMPLETED|Overall Study||79
3350451|NCT03570697|4080800|FG000|NOT COMPLETED|Overall Study||6
3350452|NCT03570697|4080801|FG001|NOT COMPLETED|Overall Study||3
3350453|NCT03571256|4080810|FG000|STARTED|Overall Study||52
3350454|NCT03571256|4080811|FG001|STARTED|Overall Study||54
3350455|NCT03571256|4080812|FG002|STARTED|Overall Study||52
3350456|NCT03571256|4080810|FG000|Safety Analysis Set|Overall Study||52
3350457|NCT03571256|4080811|FG001|Safety Analysis Set|Overall Study||54
3350458|NCT03571256|4080812|FG002|Safety Analysis Set|Overall Study||51
3350459|NCT03571256|4080810|FG000|Modified ITT (mITT) Analysis Set|Overall Study||49
3350460|NCT03571256|4080811|FG001|Modified ITT (mITT) Analysis Set|Overall Study||53
3350461|NCT03571256|4080812|FG002|Modified ITT (mITT) Analysis Set|Overall Study||51
3350462|NCT03571256|4080810|FG000|COMPLETED|Overall Study||46
3350463|NCT03571256|4080811|FG001|COMPLETED|Overall Study||51
3350464|NCT03571256|4080812|FG002|COMPLETED|Overall Study||48
3350465|NCT03571256|4080810|FG000|NOT COMPLETED|Overall Study||6
3350466|NCT03571256|4080811|FG001|NOT COMPLETED|Overall Study||3
3350467|NCT03571256|4080812|FG002|NOT COMPLETED|Overall Study||4
3350468|NCT03571516|4080824|FG000|STARTED|Overall Study||5
3350469|NCT03571516|4080825|FG001|STARTED|Overall Study||5
3350470|NCT03571516|4080824|FG000|COMPLETED|Overall Study||4
3350471|NCT03571516|4080825|FG001|COMPLETED|Overall Study||4
3350472|NCT03571516|4080824|FG000|NOT COMPLETED|Overall Study||1
3350473|NCT03571516|4080825|FG001|NOT COMPLETED|Overall Study||1
3350474|NCT03571555|4080833|FG000|STARTED|Overall Study||252
3350475|NCT03571555|4080834|FG001|STARTED|Overall Study||263
3350476|NCT03571555|4080833|FG000|COMPLETED|Overall Study||177
3350477|NCT03571555|4080834|FG001|COMPLETED|Overall Study||195
3350478|NCT03571555|4080833|FG000|NOT COMPLETED|Overall Study||75
3350479|NCT03571555|4080834|FG001|NOT COMPLETED|Overall Study||68
3350480|NCT03571607|4080842|FG000|STARTED|Overall Study||53
3350481|NCT03571607|4080843|FG001|STARTED|Overall Study||153
3350482|NCT03571607|4080842|FG000|Vaccinated|Overall Study||53
3350483|NCT03571607|4080843|FG001|Vaccinated|Overall Study||153
3350484|NCT03571607|4080842|FG000|COMPLETED|Overall Study||53
3350485|NCT03571607|4080843|FG001|COMPLETED|Overall Study||153
3350486|NCT03571607|4080842|FG000|NOT COMPLETED|Overall Study||0
3350487|NCT03571607|4080843|FG001|NOT COMPLETED|Overall Study||0
3350488|NCT03571672|4080851|FG000|STARTED|Overall Study||153
3350489|NCT03571672|4080851|FG000|COMPLETED|Overall Study||148
3350490|NCT03571672|4080851|FG000|NOT COMPLETED|Overall Study||5
3350491|NCT03571724|4080861|FG000|STARTED|Week -1 (Prior to Switching)||0
3350492|NCT03571724|4080862|FG001|STARTED|Week -1 (Prior to Switching)||0
3350493|NCT03571724|4080863|FG002|STARTED|Week -1 (Prior to Switching)||72
3350494|NCT03571724|4080864|FG003|STARTED|Week -1 (Prior to Switching)||70
3350495|NCT03571724|4080861|FG000|Topography|Week -1 (Prior to Switching)||0
3350496|NCT03571724|4080862|FG001|Topography|Week -1 (Prior to Switching)||0
3350497|NCT03571724|4080863|FG002|Topography|Week -1 (Prior to Switching)|These subjects switched into VLN arms.|18
3350498|NCT03571724|4080864|FG003|Topography|Week -1 (Prior to Switching)|These subjects switched into VLN arms.|18
3350499|NCT03571724|4080861|FG000|PK Nicotine|Week -1 (Prior to Switching)||0
3350500|NCT03571724|4080862|FG001|PK Nicotine|Week -1 (Prior to Switching)||0
3350501|NCT03571724|4080863|FG002|PK Nicotine|Week -1 (Prior to Switching)|These subjects switched into VLN arms.|12
3350502|NCT03571724|4080864|FG003|PK Nicotine|Week -1 (Prior to Switching)|These subjects switched into VLN arms.|12
3350503|NCT03571724|4080861|FG000|COMPLETED|Week -1 (Prior to Switching)||0
3350504|NCT03571724|4080862|FG001|COMPLETED|Week -1 (Prior to Switching)||0
3350505|NCT03571724|4080863|FG002|COMPLETED|Week -1 (Prior to Switching)||72
3350506|NCT03571724|4080864|FG003|COMPLETED|Week -1 (Prior to Switching)||70
3350507|NCT03571724|4080861|FG000|NOT COMPLETED|Week -1 (Prior to Switching)||0
3350508|NCT03571724|4080862|FG001|NOT COMPLETED|Week -1 (Prior to Switching)||0
3350509|NCT03571724|4080863|FG002|NOT COMPLETED|Week -1 (Prior to Switching)||0
3350510|NCT03571724|4080864|FG003|NOT COMPLETED|Week -1 (Prior to Switching)||0
3350511|NCT03571724|4080861|FG000|STARTED|Week 1-6|Non-menthol VLN subjects were assigned to this arm after randomization at week 1|50
3350512|NCT03571724|4080862|FG001|STARTED|Week 1-6|Menthol VLN subjects were assigned to this arm after randomization at week 1|50
3350513|NCT03571724|4080863|FG002|STARTED|Week 1-6||22
3350514|NCT03571724|4080864|FG003|STARTED|Week 1-6||20
3350515|NCT03571724|4080861|FG000|COMPLETED|Week 1-6||43
3350516|NCT03571724|4080862|FG001|COMPLETED|Week 1-6||42
3350517|NCT03571724|4080863|FG002|COMPLETED|Week 1-6||19
3350518|NCT03571724|4080864|FG003|COMPLETED|Week 1-6||20
3350519|NCT03571724|4080861|FG000|NOT COMPLETED|Week 1-6||7
3350520|NCT03571724|4080862|FG001|NOT COMPLETED|Week 1-6||8
3350521|NCT03571724|4080863|FG002|NOT COMPLETED|Week 1-6||3
3350522|NCT03571724|4080864|FG003|NOT COMPLETED|Week 1-6||0
3350523|NCT03572062|4080895|FG000|STARTED|Overall Study||32
3350524|NCT03572062|4080896|FG001|STARTED|Overall Study||32
3350525|NCT03572062|4080897|FG002|STARTED|Overall Study||32
3350526|NCT03572062|4080898|FG003|STARTED|Overall Study||31
3350527|NCT03572062|4080899|FG004|STARTED|Overall Study||32
3350528|NCT03572062|4080900|FG005|STARTED|Overall Study||32
3350529|NCT03572062|4080901|FG006|STARTED|Overall Study||32
3350530|NCT03572062|4080902|FG007|STARTED|Overall Study||31
3350531|NCT03572062|4080903|FG008|STARTED|Overall Study||32
3350532|NCT03572062|4080904|FG009|STARTED|Overall Study||31
3350533|NCT03572062|4080895|FG000|Treated|Overall Study||32
3350534|NCT03572062|4080896|FG001|Treated|Overall Study||32
3350535|NCT03572062|4080897|FG002|Treated|Overall Study||32
3350536|NCT03572062|4080898|FG003|Treated|Overall Study||31
3350537|NCT03572062|4080899|FG004|Treated|Overall Study||31
3350538|NCT03572062|4080900|FG005|Treated|Overall Study||30
3350539|NCT03572062|4080901|FG006|Treated|Overall Study||32
3350540|NCT03572062|4080902|FG007|Treated|Overall Study||30
3350541|NCT03572062|4080903|FG008|Treated|Overall Study||32
3350542|NCT03572062|4080904|FG009|Treated|Overall Study||31
3350543|NCT03572062|4080895|FG000|COMPLETED|Overall Study||32
3178083|NCT01974700|3905964|FG000|STARTED|Overall Study||5
3178084|NCT01974700|3905965|FG001|STARTED|Overall Study||3
3178085|NCT01974700|3905964|FG000|COMPLETED|Overall Study||5
3350544|NCT03572062|4080896|FG001|COMPLETED|Overall Study||32
3350545|NCT03572062|4080897|FG002|COMPLETED|Overall Study||32
3350546|NCT03572062|4080898|FG003|COMPLETED|Overall Study||31
3350547|NCT03572062|4080899|FG004|COMPLETED|Overall Study||31
3350548|NCT03572062|4080900|FG005|COMPLETED|Overall Study||28
3350549|NCT03572062|4080901|FG006|COMPLETED|Overall Study||31
3350550|NCT03572062|4080902|FG007|COMPLETED|Overall Study||30
3350551|NCT03572062|4080903|FG008|COMPLETED|Overall Study||0
3350552|NCT03572062|4080904|FG009|COMPLETED|Overall Study||0
3350553|NCT03572062|4080895|FG000|NOT COMPLETED|Overall Study||0
3178086|NCT01974700|3905965|FG001|COMPLETED|Overall Study||3
3178087|NCT01974700|3905964|FG000|NOT COMPLETED|Overall Study||0
3178088|NCT01974700|3905965|FG001|NOT COMPLETED|Overall Study||0
3350554|NCT03572062|4080896|FG001|NOT COMPLETED|Overall Study||0
3350555|NCT03572062|4080897|FG002|NOT COMPLETED|Overall Study||0
3350556|NCT03572062|4080898|FG003|NOT COMPLETED|Overall Study||0
3350557|NCT03572062|4080899|FG004|NOT COMPLETED|Overall Study||1
3350558|NCT03572062|4080900|FG005|NOT COMPLETED|Overall Study||4
3350559|NCT03572062|4080901|FG006|NOT COMPLETED|Overall Study||1
3350560|NCT03572062|4080902|FG007|NOT COMPLETED|Overall Study||1
3350561|NCT03572062|4080903|FG008|NOT COMPLETED|Overall Study||32
3350562|NCT03572062|4080904|FG009|NOT COMPLETED|Overall Study||31
3350563|NCT03572218|4080926|FG000|STARTED|Overall Study||36
3350564|NCT03572218|4080927|FG001|STARTED|Overall Study||36
3350565|NCT03572218|4080926|FG000|Week 12|Overall Study||30
3350566|NCT03572218|4080927|FG001|Week 12|Overall Study||31
3350567|NCT03572218|4080926|FG000|Week 26|Overall Study||30
3350568|NCT03572218|4080927|FG001|Week 26|Overall Study||31
3350569|NCT03572218|4080926|FG000|COMPLETED|Overall Study||30
3350570|NCT03572218|4080927|FG001|COMPLETED|Overall Study||31
3350571|NCT03572218|4080926|FG000|NOT COMPLETED|Overall Study||6
3350572|NCT03572218|4080927|FG001|NOT COMPLETED|Overall Study||5
3350573|NCT03572478|4080933|FG000|STARTED|Overall Study||12
3350574|NCT03572478|4080933|FG000|COMPLETED|Overall Study||12
3350575|NCT03572478|4080933|FG000|NOT COMPLETED|Overall Study||0
3350576|NCT03572972|4080942|FG000|STARTED|Overall Study||10548
3350577|NCT03572972|4080943|FG001|STARTED|Overall Study||11414
3350578|NCT03572972|4080944|FG002|STARTED|Overall Study||17779
3350579|NCT03572972|4080945|FG003|STARTED|Overall Study||8648
3350580|NCT03572972|4080946|FG004|STARTED|Overall Study||16295
3350581|NCT03572972|4080942|FG000|COMPLETED|Overall Study||10548
3350582|NCT03572972|4080943|FG001|COMPLETED|Overall Study||11414
3350583|NCT03572972|4080944|FG002|COMPLETED|Overall Study||17779
3350584|NCT03572972|4080945|FG003|COMPLETED|Overall Study||8648
3350585|NCT03572972|4080946|FG004|COMPLETED|Overall Study||16295
3350586|NCT03572972|4080942|FG000|NOT COMPLETED|Overall Study||0
3350587|NCT03572972|4080943|FG001|NOT COMPLETED|Overall Study||0
3350588|NCT03572972|4080944|FG002|NOT COMPLETED|Overall Study||0
3350589|NCT03572972|4080945|FG003|NOT COMPLETED|Overall Study||0
3350590|NCT03572972|4080946|FG004|NOT COMPLETED|Overall Study||0
3350591|NCT03573206|4080966|FG000|STARTED|Overall Study||168
3350592|NCT03573206|4080966|FG000|COMPLETED|Overall Study||168
3350593|NCT03573206|4080966|FG000|NOT COMPLETED|Overall Study||0
3350594|NCT03573323|4080972|FG000|STARTED|Blinded Treatment Period (Weeks 0-24)||520
3350595|NCT03573323|4080973|FG001|STARTED|Blinded Treatment Period (Weeks 0-24)||507
3350596|NCT03573323|4080972|FG000|Received at Least One Dose of Study Drug|Blinded Treatment Period (Weeks 0-24)||519
3350597|NCT03573323|4080973|FG001|Received at Least One Dose of Study Drug|Blinded Treatment Period (Weeks 0-24)||506
3350598|NCT03573323|4080972|FG000|COMPLETED|Blinded Treatment Period (Weeks 0-24)||465
3350599|NCT03573323|4080973|FG001|COMPLETED|Blinded Treatment Period (Weeks 0-24)||459
3350600|NCT03573323|4080972|FG000|NOT COMPLETED|Blinded Treatment Period (Weeks 0-24)||55
3350601|NCT03573323|4080973|FG001|NOT COMPLETED|Blinded Treatment Period (Weeks 0-24)||48
3350602|NCT03573323|4080972|FG000|STARTED|Post-Treatment Follow Up (Weeks 25-36)||465
3350603|NCT03573323|4080973|FG001|STARTED|Post-Treatment Follow Up (Weeks 25-36)|Excludes participants who completed treatment and did not enter the PTFU.|456
3350604|NCT03573323|4080972|FG000|COMPLETED|Post-Treatment Follow Up (Weeks 25-36)||406
3350605|NCT03573323|4080973|FG001|COMPLETED|Post-Treatment Follow Up (Weeks 25-36)||399
3350606|NCT03573323|4080972|FG000|NOT COMPLETED|Post-Treatment Follow Up (Weeks 25-36)||59
3350607|NCT03573323|4080973|FG001|NOT COMPLETED|Post-Treatment Follow Up (Weeks 25-36)||57
3350608|NCT03573505|4080985|FG000|STARTED|Overall Study||52
3350609|NCT03573505|4080986|FG001|STARTED|Overall Study||54
3350610|NCT03573505|4080985|FG000|COMPLETED|Overall Study||0
3350611|NCT03573505|4080986|FG001|COMPLETED|Overall Study||0
3350612|NCT03573505|4080985|FG000|NOT COMPLETED|Overall Study||52
3350613|NCT03573505|4080986|FG001|NOT COMPLETED|Overall Study||54
3350614|NCT03573804|4080993|FG000|STARTED|Overall Study||72
3350615|NCT03573804|4080993|FG000|COMPLETED|Overall Study||62
3350616|NCT03573804|4080993|FG000|NOT COMPLETED|Overall Study||10
3350617|NCT03573830|4081005|FG000|STARTED|Overall Study||364
3350618|NCT03573830|4081006|FG001|STARTED|Overall Study||367
3350619|NCT03573830|4081005|FG000|Reviewed Assigned Material|Overall Study|All participants assigned to this arm reviewed their assigned material.|364
3350620|NCT03573830|4081006|FG001|Reviewed Assigned Material|Overall Study|360 reviewed their assigned material:Transport Canada information plus the enhanced material.|360
3350621|NCT03573830|4081005|FG000|COMPLETED|Overall Study||360
3350622|NCT03573830|4081006|FG001|COMPLETED|Overall Study||360
3350623|NCT03573830|4081005|FG000|NOT COMPLETED|Overall Study||4
3350624|NCT03573830|4081006|FG001|NOT COMPLETED|Overall Study||7
3350625|NCT03573908|4081013|FG000|STARTED|Treatment Period||308
3350626|NCT03573908|4081014|FG001|STARTED|Treatment Period||306
3350627|NCT03573908|4081015|FG002|STARTED|Treatment Period||0
3350628|NCT03573908|4081016|FG003|STARTED|Treatment Period||0
3350629|NCT03573908|4081017|FG004|STARTED|Treatment Period||0
3350630|NCT03573908|4081013|FG000|COMPLETED|Treatment Period||284
3350631|NCT03573908|4081014|FG001|COMPLETED|Treatment Period||280
3350632|NCT03573908|4081015|FG002|COMPLETED|Treatment Period||0
3350633|NCT03573908|4081016|FG003|COMPLETED|Treatment Period||0
3350634|NCT03573908|4081017|FG004|COMPLETED|Treatment Period||0
3350635|NCT03573908|4081013|FG000|NOT COMPLETED|Treatment Period||24
3350636|NCT03573908|4081014|FG001|NOT COMPLETED|Treatment Period||26
3350637|NCT03573908|4081015|FG002|NOT COMPLETED|Treatment Period||0
3350638|NCT03573908|4081016|FG003|NOT COMPLETED|Treatment Period||0
3350639|NCT03573908|4081017|FG004|NOT COMPLETED|Treatment Period||0
3350640|NCT03573908|4081013|FG000|STARTED|Randomized Withdrawal Period||0
3350641|NCT03573908|4081014|FG001|STARTED|Randomized Withdrawal Period||0
3350642|NCT03573908|4081015|FG002|STARTED|Randomized Withdrawal Period||280
3350643|NCT03573908|4081016|FG003|STARTED|Randomized Withdrawal Period||138
3350644|NCT03573908|4081017|FG004|STARTED|Randomized Withdrawal Period||139
3350645|NCT03573908|4081013|FG000|COMPLETED|Randomized Withdrawal Period||0
3350646|NCT03573908|4081014|FG001|COMPLETED|Randomized Withdrawal Period||0
3178089|NCT01974752|3905973|FG000|STARTED|Overall Study||97
3178090|NCT01974752|3905974|FG001|STARTED|Overall Study||32
3178091|NCT01974752|3905973|FG000|COMPLETED|Overall Study||60
3178092|NCT01974752|3905974|FG001|COMPLETED|Overall Study||17
2928008|NCT00575588|3638972|FG000|STARTED|Overall Study|Randomized and treated|428
2928009|NCT00575588|3638973|FG001|STARTED|Overall Study|Randomized and treated|430
2928010|NCT00575588|3638972|FG000|COMPLETED|Overall Study|Completed 104 weeks of treatment|165
3178093|NCT01974752|3905973|FG000|NOT COMPLETED|Overall Study||37
3178094|NCT01974752|3905974|FG001|NOT COMPLETED|Overall Study||15
3178095|NCT01974817|3905980|FG000|STARTED|Overall Study||25
2928011|NCT00575588|3638973|FG001|COMPLETED|Overall Study|Completed 104 weeks of treatment|147
3178096|NCT01974817|3905980|FG000|COMPLETED|Overall Study||17
3350647|NCT03573908|4081015|FG002|COMPLETED|Randomized Withdrawal Period||272
3350648|NCT03573908|4081016|FG003|COMPLETED|Randomized Withdrawal Period||136
3350649|NCT03573908|4081017|FG004|COMPLETED|Randomized Withdrawal Period||137
3350650|NCT03573908|4081013|FG000|NOT COMPLETED|Randomized Withdrawal Period||0
3350651|NCT03573908|4081014|FG001|NOT COMPLETED|Randomized Withdrawal Period||0
3350652|NCT03573908|4081015|FG002|NOT COMPLETED|Randomized Withdrawal Period||8
3350653|NCT03573908|4081016|FG003|NOT COMPLETED|Randomized Withdrawal Period||2
3350654|NCT03573908|4081017|FG004|NOT COMPLETED|Randomized Withdrawal Period||2
3350655|NCT03574181|4081026|FG000|STARTED|Overall Study||9
3350656|NCT03574181|4081026|FG000|COMPLETED|Overall Study||0
3350657|NCT03574181|4081026|FG000|NOT COMPLETED|Overall Study||9
3350658|NCT03574441|4081033|FG000|STARTED|Overall Study||31
3350659|NCT03574441|4081034|FG001|STARTED|Overall Study||30
3350660|NCT03574441|4081035|FG002|STARTED|Overall Study||30
3350661|NCT03574441|4081033|FG000|COMPLETED|Overall Study||31
3350662|NCT03574441|4081034|FG001|COMPLETED|Overall Study||30
3350663|NCT03574441|4081035|FG002|COMPLETED|Overall Study||30
3350664|NCT03574441|4081033|FG000|NOT COMPLETED|Overall Study||0
3350665|NCT03574441|4081034|FG001|NOT COMPLETED|Overall Study||0
3350666|NCT03574441|4081035|FG002|NOT COMPLETED|Overall Study||0
3350667|NCT03574753|4081043|FG000|STARTED|Overall Study||23
3350668|NCT03574753|4081043|FG000|COMPLETED|Overall Study||0
3350669|NCT03574753|4081043|FG000|NOT COMPLETED|Overall Study||23
3350670|NCT03574818|4081048|FG000|STARTED|Overall Study||1
3350671|NCT03574818|4081048|FG000|COMPLETED|Overall Study||1
3350672|NCT03574818|4081048|FG000|NOT COMPLETED|Overall Study||0
3350673|NCT03575702|4081054|FG000|STARTED|Overall Study||149
3350674|NCT03575702|4081055|FG001|STARTED|Overall Study||150
3350675|NCT03575702|4081054|FG000|COMPLETED|Overall Study||143
3350676|NCT03575702|4081055|FG001|COMPLETED|Overall Study||146
3350677|NCT03575702|4081054|FG000|NOT COMPLETED|Overall Study||6
3350678|NCT03575702|4081055|FG001|NOT COMPLETED|Overall Study||4
3350679|NCT03575754|4081063|FG000|STARTED|Overall Study||25
3350680|NCT03575754|4081064|FG001|STARTED|Overall Study||25
3350681|NCT03575754|4081063|FG000|COMPLETED|Overall Study||25
3350682|NCT03575754|4081064|FG001|COMPLETED|Overall Study||25
3350683|NCT03575754|4081063|FG000|NOT COMPLETED|Overall Study||0
3350684|NCT03575754|4081064|FG001|NOT COMPLETED|Overall Study||0
3350685|NCT03575806|4081072|FG000|STARTED|Overall Study||25
3350686|NCT03575806|4081073|FG001|STARTED|Overall Study||27
3350687|NCT03575806|4081072|FG000|COMPLETED|Overall Study||25
3350688|NCT03575806|4081073|FG001|COMPLETED|Overall Study||23
3350689|NCT03575806|4081072|FG000|NOT COMPLETED|Overall Study||0
3350690|NCT03575806|4081073|FG001|NOT COMPLETED|Overall Study||4
3350691|NCT03575871|4081082|FG000|STARTED|Overall Study||158
3350692|NCT03575871|4081083|FG001|STARTED|Overall Study||155
3350693|NCT03575871|4081084|FG002|STARTED|Overall Study||78
3350694|NCT03575871|4081082|FG000|COMPLETED|Overall Study||137
3350695|NCT03575871|4081083|FG001|COMPLETED|Overall Study||141
3350696|NCT03575871|4081084|FG002|COMPLETED|Overall Study||52
3350697|NCT03575871|4081082|FG000|NOT COMPLETED|Overall Study||21
3350698|NCT03575871|4081083|FG001|NOT COMPLETED|Overall Study||14
3350699|NCT03575871|4081084|FG002|NOT COMPLETED|Overall Study||26
3350700|NCT03575962|4081092|FG000|STARTED|Treatment Period 1 (4 Days)||7
3350701|NCT03575962|4081093|FG001|STARTED|Treatment Period 1 (4 Days)||7
3350702|NCT03575962|4081092|FG000|COMPLETED|Treatment Period 1 (4 Days)||7
3350703|NCT03575962|4081093|FG001|COMPLETED|Treatment Period 1 (4 Days)||7
3178097|NCT01974817|3905980|FG000|NOT COMPLETED|Overall Study||8
3178098|NCT01974895|3905986|FG000|STARTED|Overall Study||158
3178099|NCT01974895|3905987|FG001|STARTED|Overall Study||156
3178100|NCT01974895|3905986|FG000|COMPLETED|Overall Study||143
3178101|NCT01974895|3905987|FG001|COMPLETED|Overall Study||141
3178102|NCT01974895|3905986|FG000|NOT COMPLETED|Overall Study||15
3178103|NCT01974895|3905987|FG001|NOT COMPLETED|Overall Study||15
3178104|NCT01975090|3905993|FG000|STARTED|Overall Study||129
3178105|NCT01975090|3905993|FG000|6-month Follow-up|Overall Study||117
3350704|NCT03575962|4081092|FG000|NOT COMPLETED|Treatment Period 1 (4 Days)||0
3350705|NCT03575962|4081093|FG001|NOT COMPLETED|Treatment Period 1 (4 Days)||0
3350706|NCT03575962|4081092|FG000|STARTED|Washout Period (7 Days)||7
3350707|NCT03575962|4081093|FG001|STARTED|Washout Period (7 Days)||7
3350708|NCT03575962|4081092|FG000|COMPLETED|Washout Period (7 Days)||7
3350709|NCT03575962|4081093|FG001|COMPLETED|Washout Period (7 Days)||7
3350710|NCT03575962|4081092|FG000|NOT COMPLETED|Washout Period (7 Days)||0
3350711|NCT03575962|4081093|FG001|NOT COMPLETED|Washout Period (7 Days)||0
3350712|NCT03575962|4081092|FG000|STARTED|Treatment Period 2 (4 Days)||7
3350713|NCT03575962|4081093|FG001|STARTED|Treatment Period 2 (4 Days)||7
3350714|NCT03575962|4081092|FG000|COMPLETED|Treatment Period 2 (4 Days)||7
3350715|NCT03575962|4081093|FG001|COMPLETED|Treatment Period 2 (4 Days)||7
3350716|NCT03575962|4081092|FG000|NOT COMPLETED|Treatment Period 2 (4 Days)||0
3350717|NCT03575962|4081093|FG001|NOT COMPLETED|Treatment Period 2 (4 Days)||0
3350718|NCT03575975|4081102|FG000|STARTED|Overall Study||4
3350719|NCT03575975|4081103|FG001|STARTED|Overall Study||5
3350720|NCT03575975|4081104|FG002|STARTED|Overall Study||0
3350721|NCT03575975|4081102|FG000|COMPLETED|Overall Study||3
3350722|NCT03575975|4081103|FG001|COMPLETED|Overall Study||5
3350723|NCT03575975|4081104|FG002|COMPLETED|Overall Study||0
3350724|NCT03575975|4081102|FG000|NOT COMPLETED|Overall Study||1
3350725|NCT03575975|4081103|FG001|NOT COMPLETED|Overall Study||0
3350726|NCT03575975|4081104|FG002|NOT COMPLETED|Overall Study||0
3350727|NCT03576066|4081112|FG000|STARTED|Overall Study||45
3350728|NCT03576066|4081113|FG001|STARTED|Overall Study||28
3350729|NCT03576066|4081112|FG000|COMPLETED|Overall Study||45
3350730|NCT03576066|4081113|FG001|COMPLETED|Overall Study||27
3350731|NCT03576066|4081112|FG000|NOT COMPLETED|Overall Study||0
3350732|NCT03576066|4081113|FG001|NOT COMPLETED|Overall Study||1
3350733|NCT03576118|4081125|FG000|STARTED|Overall Study||37
3350734|NCT03576118|4081126|FG001|STARTED|Overall Study||37
3350735|NCT03576118|4081125|FG000|COMPLETED|Overall Study||34
3350736|NCT03576118|4081126|FG001|COMPLETED|Overall Study||33
3350737|NCT03576118|4081125|FG000|NOT COMPLETED|Overall Study||3
3350738|NCT03576118|4081126|FG001|NOT COMPLETED|Overall Study||4
3350739|NCT03576183|4081134|FG000|STARTED|Overall Study||17
3350740|NCT03576183|4081135|FG001|STARTED|Overall Study||17
3350741|NCT03576183|4081134|FG000|COMPLETED|Overall Study||15
3350742|NCT03576183|4081135|FG001|COMPLETED|Overall Study||16
3350743|NCT03576183|4081134|FG000|NOT COMPLETED|Overall Study||2
3350744|NCT03576183|4081135|FG001|NOT COMPLETED|Overall Study||1
3350745|NCT03576716|4081143|FG000|STARTED|Overall Study||10
3350746|NCT03576716|4081144|FG001|STARTED|Overall Study||9
3350747|NCT03576716|4081143|FG000|COMPLETED|Overall Study||10
3350748|NCT03576716|4081144|FG001|COMPLETED|Overall Study||8
3350749|NCT03576716|4081143|FG000|NOT COMPLETED|Overall Study||0
3350750|NCT03576716|4081144|FG001|NOT COMPLETED|Overall Study||1
3350751|NCT03576768|4081154|FG000|STARTED|Overall Study||13
3350752|NCT03576768|4081155|FG001|STARTED|Overall Study||12
3350753|NCT03576768|4081156|FG002|STARTED|Overall Study|The study was ended before recruitment into this arm started.|0
3350754|NCT03576768|4081157|FG003|STARTED|Overall Study|The study was ended before recruitment into this arm started.|0
3350755|NCT03576768|4081154|FG000|COMPLETED|Overall Study||10
3350756|NCT03576768|4081155|FG001|COMPLETED|Overall Study||9
3350757|NCT03576768|4081156|FG002|COMPLETED|Overall Study||0
3350758|NCT03576768|4081157|FG003|COMPLETED|Overall Study||0
3350759|NCT03576768|4081154|FG000|NOT COMPLETED|Overall Study||3
3350760|NCT03576768|4081155|FG001|NOT COMPLETED|Overall Study||3
3350761|NCT03576768|4081156|FG002|NOT COMPLETED|Overall Study||0
3350762|NCT03576768|4081157|FG003|NOT COMPLETED|Overall Study||0
3350763|NCT03577171|4081169|FG000|STARTED|Overall Study||13
3350764|NCT03577171|4081170|FG001|STARTED|Overall Study||12
3350765|NCT03577171|4081169|FG000|COMPLETED|Overall Study||13
3350766|NCT03577171|4081170|FG001|COMPLETED|Overall Study||12
3350767|NCT03577171|4081169|FG000|NOT COMPLETED|Overall Study||0
3350768|NCT03577171|4081170|FG001|NOT COMPLETED|Overall Study||0
3350769|NCT03577275|4081176|FG000|STARTED|Overall Study|All participants received all of the 4 interventions|32
3350770|NCT03577275|4081176|FG000|Placebo|Overall Study||32
3178106|NCT01975090|3905993|FG000|COMPLETED|Overall Study||117
3178107|NCT01975090|3905993|FG000|NOT COMPLETED|Overall Study||12
3178108|NCT01975220|3906006|FG000|STARTED|Test Period 1||12
3350771|NCT03577275|4081176|FG000|Moxifloxacin 400mg|Overall Study||32
3350772|NCT03577275|4081176|FG000|NST-4016 600mg|Overall Study||32
3350773|NCT03577275|4081176|FG000|NST-4016 2000mg|Overall Study||32
3350774|NCT03577275|4081176|FG000|COMPLETED|Overall Study||32
3350775|NCT03577275|4081176|FG000|NOT COMPLETED|Overall Study||0
3350776|NCT03577730|4081192|FG000|STARTED|Overall Study||34
3350777|NCT03577730|4081193|FG001|STARTED|Overall Study||31
3350778|NCT03577730|4081192|FG000|Received Treatment|Overall Study||33
3350779|NCT03577730|4081193|FG001|Received Treatment|Overall Study||31
3350780|NCT03577730|4081192|FG000|COMPLETED|Overall Study||30
3350781|NCT03577730|4081193|FG001|COMPLETED|Overall Study||30
3350782|NCT03577730|4081192|FG000|NOT COMPLETED|Overall Study||4
3350783|NCT03577730|4081193|FG001|NOT COMPLETED|Overall Study||1
3350784|NCT03578146|4081205|FG000|STARTED|Overall Study||16
3350785|NCT03578146|4081206|FG001|STARTED|Overall Study||6
3350786|NCT03578146|4081207|FG002|STARTED|Overall Study||6
3350787|NCT03578146|4081208|FG003|STARTED|Overall Study||6
3350788|NCT03578146|4081209|FG004|STARTED|Overall Study||6
3350789|NCT03578146|4081210|FG005|STARTED|Overall Study||8
3350790|NCT03578146|4081205|FG000|COMPLETED|Overall Study||15
3350791|NCT03578146|4081206|FG001|COMPLETED|Overall Study||5
3350792|NCT03578146|4081207|FG002|COMPLETED|Overall Study||5
3350793|NCT03578146|4081208|FG003|COMPLETED|Overall Study||6
3350794|NCT03578146|4081209|FG004|COMPLETED|Overall Study||6
3350795|NCT03578146|4081210|FG005|COMPLETED|Overall Study||5
3350796|NCT03578146|4081205|FG000|NOT COMPLETED|Overall Study||1
3350797|NCT03578146|4081206|FG001|NOT COMPLETED|Overall Study||1
3350798|NCT03578146|4081207|FG002|NOT COMPLETED|Overall Study||1
3350799|NCT03578146|4081208|FG003|NOT COMPLETED|Overall Study||0
3350800|NCT03578146|4081209|FG004|NOT COMPLETED|Overall Study||0
3350801|NCT03578146|4081210|FG005|NOT COMPLETED|Overall Study||3
3350802|NCT03578549|4081224|FG000|STARTED|Overall Study||30
3350803|NCT03578549|4081224|FG000|COMPLETED|Overall Study||29
3350804|NCT03578549|4081224|FG000|NOT COMPLETED|Overall Study||1
3350805|NCT03578926|4081228|FG000|STARTED|First Intervention||21
3350806|NCT03578926|4081229|FG001|STARTED|First Intervention||23
3350807|NCT03578926|4081228|FG000|COMPLETED|First Intervention||21
3350808|NCT03578926|4081229|FG001|COMPLETED|First Intervention||23
3350809|NCT03578926|4081228|FG000|NOT COMPLETED|First Intervention||0
3350810|NCT03578926|4081229|FG001|NOT COMPLETED|First Intervention||0
3350811|NCT03578926|4081228|FG000|STARTED|Second Intervention||23
3350812|NCT03578926|4081229|FG001|STARTED|Second Intervention||21
3350813|NCT03578926|4081228|FG000|COMPLETED|Second Intervention||23
3350814|NCT03578926|4081229|FG001|COMPLETED|Second Intervention||21
3350815|NCT03578926|4081228|FG000|NOT COMPLETED|Second Intervention||0
3350816|NCT03578926|4081229|FG001|NOT COMPLETED|Second Intervention||0
3350817|NCT03579290|4081237|FG000|STARTED|Overall Study||40
3350818|NCT03579290|4081237|FG000|COMPLETED|Overall Study||31
3350819|NCT03579290|4081237|FG000|NOT COMPLETED|Overall Study||9
3350820|NCT03579433|4081241|FG000|STARTED|Overall Study||104
3350821|NCT03579433|4081241|FG000|ORA With VerifEye+|Overall Study||96
3350822|NCT03579433|4081241|FG000|Barrett Calculator|Overall Study||102
3350823|NCT03579433|4081241|FG000|COMPLETED|Overall Study||98
3350824|NCT03579433|4081241|FG000|NOT COMPLETED|Overall Study||6
3350825|NCT03579719|4081249|FG000|STARTED|Overall Study||15
3350826|NCT03579719|4081249|FG000|COMPLETED|Overall Study||14
3350827|NCT03579719|4081249|FG000|NOT COMPLETED|Overall Study||1
3350828|NCT03579940|4081264|FG000|STARTED|Period 1||3
3350829|NCT03579940|4081265|FG001|STARTED|Period 1||2
3350830|NCT03579940|4081266|FG002|STARTED|Period 1||2
3350831|NCT03579940|4081267|FG003|STARTED|Period 1||2
3350832|NCT03579940|4081268|FG004|STARTED|Period 1||2
3350833|NCT03579940|4081269|FG005|STARTED|Period 1||2
3350834|NCT03579940|4081270|FG006|STARTED|Period 1||3
3350835|NCT03579940|4081271|FG007|STARTED|Period 1||3
3350836|NCT03579940|4081272|FG008|STARTED|Period 1||3
3350837|NCT03579940|4081273|FG009|STARTED|Period 1||2
3350838|NCT03579940|4081274|FG010|STARTED|Period 1||3
3350839|NCT03579940|4081264|FG000|Received at Least 1 Dose of Study Drug|Period 1||3
3350840|NCT03579940|4081265|FG001|Received at Least 1 Dose of Study Drug|Period 1||2
3350841|NCT03579940|4081266|FG002|Received at Least 1 Dose of Study Drug|Period 1||2
3350842|NCT03579940|4081267|FG003|Received at Least 1 Dose of Study Drug|Period 1||2
3350843|NCT03579940|4081268|FG004|Received at Least 1 Dose of Study Drug|Period 1||2
3350844|NCT03579940|4081269|FG005|Received at Least 1 Dose of Study Drug|Period 1||2
3350845|NCT03579940|4081270|FG006|Received at Least 1 Dose of Study Drug|Period 1||3
3350846|NCT03579940|4081271|FG007|Received at Least 1 Dose of Study Drug|Period 1||3
3350847|NCT03579940|4081272|FG008|Received at Least 1 Dose of Study Drug|Period 1||3
3350848|NCT03579940|4081273|FG009|Received at Least 1 Dose of Study Drug|Period 1||2
3350849|NCT03579940|4081274|FG010|Received at Least 1 Dose of Study Drug|Period 1||3
3350850|NCT03579940|4081264|FG000|COMPLETED|Period 1||3
3350851|NCT03579940|4081265|FG001|COMPLETED|Period 1||2
3350852|NCT03579940|4081266|FG002|COMPLETED|Period 1||2
3350853|NCT03579940|4081267|FG003|COMPLETED|Period 1||2
3350854|NCT03579940|4081268|FG004|COMPLETED|Period 1||2
3350855|NCT03579940|4081269|FG005|COMPLETED|Period 1||2
3350856|NCT03579940|4081270|FG006|COMPLETED|Period 1||3
3350857|NCT03579940|4081271|FG007|COMPLETED|Period 1||3
3350858|NCT03579940|4081272|FG008|COMPLETED|Period 1||3
3350859|NCT03579940|4081273|FG009|COMPLETED|Period 1||2
3350860|NCT03579940|4081274|FG010|COMPLETED|Period 1||3
3350861|NCT03579940|4081264|FG000|NOT COMPLETED|Period 1||0
3350862|NCT03579940|4081265|FG001|NOT COMPLETED|Period 1||0
3350863|NCT03579940|4081266|FG002|NOT COMPLETED|Period 1||0
3350864|NCT03579940|4081267|FG003|NOT COMPLETED|Period 1||0
3350865|NCT03579940|4081268|FG004|NOT COMPLETED|Period 1||0
3350866|NCT03579940|4081269|FG005|NOT COMPLETED|Period 1||0
3350867|NCT03579940|4081270|FG006|NOT COMPLETED|Period 1||0
3350868|NCT03579940|4081271|FG007|NOT COMPLETED|Period 1||0
3350869|NCT03579940|4081272|FG008|NOT COMPLETED|Period 1||0
3350870|NCT03579940|4081273|FG009|NOT COMPLETED|Period 1||0
3350871|NCT03579940|4081274|FG010|NOT COMPLETED|Period 1||0
3350872|NCT03579940|4081264|FG000|STARTED|Period 2||3
3350873|NCT03579940|4081265|FG001|STARTED|Period 2||2
3350874|NCT03579940|4081266|FG002|STARTED|Period 2||2
3350875|NCT03579940|4081267|FG003|STARTED|Period 2||2
3350876|NCT03579940|4081268|FG004|STARTED|Period 2||2
3178109|NCT01975220|3906007|FG001|STARTED|Test Period 1||12
3178110|NCT01975220|3906008|FG002|STARTED|Test Period 1||12
3178111|NCT01975220|3906009|FG003|STARTED|Test Period 1||12
3178112|NCT01975220|3906010|FG004|STARTED|Test Period 1||12
3178113|NCT01975220|3906011|FG005|STARTED|Test Period 1||12
3178114|NCT01975220|3906006|FG000|COMPLETED|Test Period 1||12
3178115|NCT01975220|3906007|FG001|COMPLETED|Test Period 1||11
3178116|NCT01975220|3906008|FG002|COMPLETED|Test Period 1||12
3178117|NCT01975220|3906009|FG003|COMPLETED|Test Period 1||12
3350877|NCT03579940|4081269|FG005|STARTED|Period 2||2
3350878|NCT03579940|4081270|FG006|STARTED|Period 2||3
3350879|NCT03579940|4081271|FG007|STARTED|Period 2||3
3350880|NCT03579940|4081272|FG008|STARTED|Period 2||3
3350881|NCT03579940|4081273|FG009|STARTED|Period 2||2
3350882|NCT03579940|4081274|FG010|STARTED|Period 2||3
3350883|NCT03579940|4081264|FG000|COMPLETED|Period 2||3
3350884|NCT03579940|4081265|FG001|COMPLETED|Period 2||2
3350885|NCT03579940|4081266|FG002|COMPLETED|Period 2||1
3350886|NCT03579940|4081267|FG003|COMPLETED|Period 2||2
3350887|NCT03579940|4081268|FG004|COMPLETED|Period 2||2
3350888|NCT03579940|4081269|FG005|COMPLETED|Period 2||2
3350889|NCT03579940|4081270|FG006|COMPLETED|Period 2||3
3350890|NCT03579940|4081271|FG007|COMPLETED|Period 2||3
3350891|NCT03579940|4081272|FG008|COMPLETED|Period 2||3
3350892|NCT03579940|4081273|FG009|COMPLETED|Period 2||2
3350893|NCT03579940|4081274|FG010|COMPLETED|Period 2||3
3350894|NCT03579940|4081264|FG000|NOT COMPLETED|Period 2||0
3350895|NCT03579940|4081265|FG001|NOT COMPLETED|Period 2||0
3350896|NCT03579940|4081266|FG002|NOT COMPLETED|Period 2||1
3350897|NCT03579940|4081267|FG003|NOT COMPLETED|Period 2||0
3350898|NCT03579940|4081268|FG004|NOT COMPLETED|Period 2||0
3350899|NCT03579940|4081269|FG005|NOT COMPLETED|Period 2||0
3350900|NCT03579940|4081270|FG006|NOT COMPLETED|Period 2||0
3350901|NCT03579940|4081271|FG007|NOT COMPLETED|Period 2||0
3350902|NCT03579940|4081272|FG008|NOT COMPLETED|Period 2||0
3350903|NCT03579940|4081273|FG009|NOT COMPLETED|Period 2||0
3350904|NCT03579940|4081274|FG010|NOT COMPLETED|Period 2||0
3350905|NCT03579940|4081264|FG000|STARTED|Period 3||3
3350906|NCT03579940|4081265|FG001|STARTED|Period 3||2
3350907|NCT03579940|4081266|FG002|STARTED|Period 3||1
3350908|NCT03579940|4081267|FG003|STARTED|Period 3||2
3350909|NCT03579940|4081268|FG004|STARTED|Period 3||2
3350910|NCT03579940|4081269|FG005|STARTED|Period 3||2
3350911|NCT03579940|4081270|FG006|STARTED|Period 3||3
3350912|NCT03579940|4081271|FG007|STARTED|Period 3||3
3350913|NCT03579940|4081272|FG008|STARTED|Period 3||3
3350914|NCT03579940|4081273|FG009|STARTED|Period 3||2
3350915|NCT03579940|4081274|FG010|STARTED|Period 3||3
3350916|NCT03579940|4081264|FG000|COMPLETED|Period 3||3
3350917|NCT03579940|4081265|FG001|COMPLETED|Period 3||2
3350918|NCT03579940|4081266|FG002|COMPLETED|Period 3||1
3350919|NCT03579940|4081267|FG003|COMPLETED|Period 3||2
3350920|NCT03579940|4081268|FG004|COMPLETED|Period 3||2
3350921|NCT03579940|4081269|FG005|COMPLETED|Period 3||2
3350922|NCT03579940|4081270|FG006|COMPLETED|Period 3||3
3350923|NCT03579940|4081271|FG007|COMPLETED|Period 3||3
3350924|NCT03579940|4081272|FG008|COMPLETED|Period 3||3
3350925|NCT03579940|4081273|FG009|COMPLETED|Period 3||2
3350926|NCT03579940|4081274|FG010|COMPLETED|Period 3||3
3350927|NCT03579940|4081264|FG000|NOT COMPLETED|Period 3||0
3350928|NCT03579940|4081265|FG001|NOT COMPLETED|Period 3||0
3350929|NCT03579940|4081266|FG002|NOT COMPLETED|Period 3||0
3178118|NCT01975220|3906010|FG004|COMPLETED|Test Period 1||12
3178119|NCT01975220|3906011|FG005|COMPLETED|Test Period 1||12
3350930|NCT03579940|4081267|FG003|NOT COMPLETED|Period 3||0
3350931|NCT03579940|4081268|FG004|NOT COMPLETED|Period 3||0
3350932|NCT03579940|4081269|FG005|NOT COMPLETED|Period 3||0
3350933|NCT03579940|4081270|FG006|NOT COMPLETED|Period 3||0
3350934|NCT03579940|4081271|FG007|NOT COMPLETED|Period 3||0
3350935|NCT03579940|4081272|FG008|NOT COMPLETED|Period 3||0
3350936|NCT03579940|4081273|FG009|NOT COMPLETED|Period 3||0
3350937|NCT03579940|4081274|FG010|NOT COMPLETED|Period 3||0
3350938|NCT03580343|4081306|FG000|STARTED|Overall Study||5
3350939|NCT03580343|4081306|FG000|COMPLETED|Overall Study||4
3350940|NCT03580343|4081306|FG000|NOT COMPLETED|Overall Study||1
3350941|NCT03581084|4081310|FG000|STARTED|Overall Study||1
3350942|NCT03581084|4081310|FG000|COMPLETED|Overall Study||1
3350943|NCT03581084|4081310|FG000|NOT COMPLETED|Overall Study||0
3350944|NCT03581097|4081316|FG000|STARTED|Overall Study||46
3350945|NCT03581097|4081317|FG001|STARTED|Overall Study||47
3350946|NCT03581097|4081316|FG000|COMPLETED|Overall Study||46
3350947|NCT03581097|4081317|FG001|COMPLETED|Overall Study||47
3350948|NCT03581097|4081316|FG000|NOT COMPLETED|Overall Study||0
3350949|NCT03581097|4081317|FG001|NOT COMPLETED|Overall Study||0
3350950|NCT03581474|4081325|FG000|STARTED|Overall Study||12
3350951|NCT03581474|4081325|FG000|COMPLETED|Overall Study||12
3350952|NCT03581474|4081325|FG000|NOT COMPLETED|Overall Study||0
3178120|NCT01975220|3906006|FG000|NOT COMPLETED|Test Period 1||0
3178121|NCT01975220|3906007|FG001|NOT COMPLETED|Test Period 1||1
3350953|NCT03581825|4081329|FG000|STARTED|Period 1||31
3350954|NCT03581825|4081330|FG001|STARTED|Period 1||31
3350955|NCT03581825|4081329|FG000|COMPLETED|Period 1||30
3350956|NCT03581825|4081330|FG001|COMPLETED|Period 1||31
3350957|NCT03581825|4081329|FG000|NOT COMPLETED|Period 1||1
3350958|NCT03581825|4081330|FG001|NOT COMPLETED|Period 1||0
3350959|NCT03581825|4081329|FG000|STARTED|Period 2||30
3350960|NCT03581825|4081330|FG001|STARTED|Period 2||31
3350961|NCT03581825|4081329|FG000|COMPLETED|Period 2||30
3350962|NCT03581825|4081330|FG001|COMPLETED|Period 2||30
3350963|NCT03581825|4081329|FG000|NOT COMPLETED|Period 2||0
3350964|NCT03581825|4081330|FG001|NOT COMPLETED|Period 2||1
3350965|NCT03582215|4081344|FG000|STARTED|Overall Study||6
3350966|NCT03582215|4081345|FG001|STARTED|Overall Study||6
3350967|NCT03582215|4081346|FG002|STARTED|Overall Study||6
3350968|NCT03582215|4081347|FG003|STARTED|Overall Study||6
3350969|NCT03582215|4081348|FG004|STARTED|Overall Study||12
3350970|NCT03582215|4081349|FG005|STARTED|Overall Study||12
3350971|NCT03582215|4081350|FG006|STARTED|Overall Study||12
3350972|NCT03582215|4081351|FG007|STARTED|Overall Study||12
3350973|NCT03582215|4081344|FG000|COMPLETED|Overall Study||5
3350974|NCT03582215|4081345|FG001|COMPLETED|Overall Study||6
3350975|NCT03582215|4081346|FG002|COMPLETED|Overall Study||6
3350976|NCT03582215|4081347|FG003|COMPLETED|Overall Study||6
3350977|NCT03582215|4081348|FG004|COMPLETED|Overall Study||12
3350978|NCT03582215|4081349|FG005|COMPLETED|Overall Study||12
3350979|NCT03582215|4081350|FG006|COMPLETED|Overall Study||10
3350980|NCT03582215|4081351|FG007|COMPLETED|Overall Study||10
3350981|NCT03582215|4081344|FG000|NOT COMPLETED|Overall Study||1
3350982|NCT03582215|4081345|FG001|NOT COMPLETED|Overall Study||0
3350983|NCT03582215|4081346|FG002|NOT COMPLETED|Overall Study||0
3350984|NCT03582215|4081347|FG003|NOT COMPLETED|Overall Study||0
3350985|NCT03582215|4081348|FG004|NOT COMPLETED|Overall Study||0
3350986|NCT03582215|4081349|FG005|NOT COMPLETED|Overall Study||0
3350987|NCT03582215|4081350|FG006|NOT COMPLETED|Overall Study||2
3350988|NCT03582215|4081351|FG007|NOT COMPLETED|Overall Study||2
3350989|NCT03582553|4081386|FG000|STARTED|Intervention 1/Visit 1||3
3350990|NCT03582553|4081387|FG001|STARTED|Intervention 1/Visit 1||3
3350991|NCT03582553|4081388|FG002|STARTED|Intervention 1/Visit 1||3
3350992|NCT03582553|4081389|FG003|STARTED|Intervention 1/Visit 1||3
3350993|NCT03582553|4081390|FG004|STARTED|Intervention 1/Visit 1||3
3350994|NCT03582553|4081391|FG005|STARTED|Intervention 1/Visit 1||3
3350995|NCT03582553|4081386|FG000|COMPLETED|Intervention 1/Visit 1||3
3350996|NCT03582553|4081387|FG001|COMPLETED|Intervention 1/Visit 1||3
3350997|NCT03582553|4081388|FG002|COMPLETED|Intervention 1/Visit 1||3
3350998|NCT03582553|4081389|FG003|COMPLETED|Intervention 1/Visit 1||3
3350999|NCT03582553|4081390|FG004|COMPLETED|Intervention 1/Visit 1||3
3178122|NCT01975220|3906008|FG002|NOT COMPLETED|Test Period 1||0
3178123|NCT01975220|3906009|FG003|NOT COMPLETED|Test Period 1||0
3178124|NCT01975220|3906010|FG004|NOT COMPLETED|Test Period 1||0
3178125|NCT01975220|3906011|FG005|NOT COMPLETED|Test Period 1||0
3178126|NCT01975220|3906006|FG000|STARTED|Test Period 2||12
3351000|NCT03582553|4081391|FG005|COMPLETED|Intervention 1/Visit 1||3
3351001|NCT03582553|4081386|FG000|NOT COMPLETED|Intervention 1/Visit 1||0
3351002|NCT03582553|4081387|FG001|NOT COMPLETED|Intervention 1/Visit 1||0
3351003|NCT03582553|4081388|FG002|NOT COMPLETED|Intervention 1/Visit 1||0
3351004|NCT03582553|4081389|FG003|NOT COMPLETED|Intervention 1/Visit 1||0
3351005|NCT03582553|4081390|FG004|NOT COMPLETED|Intervention 1/Visit 1||0
3351006|NCT03582553|4081391|FG005|NOT COMPLETED|Intervention 1/Visit 1||0
3351007|NCT03582553|4081386|FG000|STARTED|Washout Period ( At Least 1 Week)||3
3351008|NCT03582553|4081387|FG001|STARTED|Washout Period ( At Least 1 Week)||3
3351009|NCT03582553|4081388|FG002|STARTED|Washout Period ( At Least 1 Week)||3
3351010|NCT03582553|4081389|FG003|STARTED|Washout Period ( At Least 1 Week)||3
3351011|NCT03582553|4081390|FG004|STARTED|Washout Period ( At Least 1 Week)||3
3351012|NCT03582553|4081391|FG005|STARTED|Washout Period ( At Least 1 Week)||3
3351013|NCT03582553|4081386|FG000|COMPLETED|Washout Period ( At Least 1 Week)||3
3351014|NCT03582553|4081387|FG001|COMPLETED|Washout Period ( At Least 1 Week)||3
3351015|NCT03582553|4081388|FG002|COMPLETED|Washout Period ( At Least 1 Week)||3
3351016|NCT03582553|4081389|FG003|COMPLETED|Washout Period ( At Least 1 Week)||3
3351017|NCT03582553|4081390|FG004|COMPLETED|Washout Period ( At Least 1 Week)||3
3351018|NCT03582553|4081391|FG005|COMPLETED|Washout Period ( At Least 1 Week)||3
3351019|NCT03582553|4081386|FG000|NOT COMPLETED|Washout Period ( At Least 1 Week)||0
3351020|NCT03582553|4081387|FG001|NOT COMPLETED|Washout Period ( At Least 1 Week)||0
3351021|NCT03582553|4081388|FG002|NOT COMPLETED|Washout Period ( At Least 1 Week)||0
3351022|NCT03582553|4081389|FG003|NOT COMPLETED|Washout Period ( At Least 1 Week)||0
3351023|NCT03582553|4081390|FG004|NOT COMPLETED|Washout Period ( At Least 1 Week)||0
3351024|NCT03582553|4081391|FG005|NOT COMPLETED|Washout Period ( At Least 1 Week)||0
3351025|NCT03582553|4081386|FG000|STARTED|Intervention 2/Visit 2||3
3351026|NCT03582553|4081387|FG001|STARTED|Intervention 2/Visit 2||3
3351027|NCT03582553|4081388|FG002|STARTED|Intervention 2/Visit 2||3
3351028|NCT03582553|4081389|FG003|STARTED|Intervention 2/Visit 2||3
3351029|NCT03582553|4081390|FG004|STARTED|Intervention 2/Visit 2||3
3351030|NCT03582553|4081391|FG005|STARTED|Intervention 2/Visit 2||3
3351031|NCT03582553|4081386|FG000|COMPLETED|Intervention 2/Visit 2||3
3351032|NCT03582553|4081387|FG001|COMPLETED|Intervention 2/Visit 2||3
3351033|NCT03582553|4081388|FG002|COMPLETED|Intervention 2/Visit 2||3
3351034|NCT03582553|4081389|FG003|COMPLETED|Intervention 2/Visit 2||3
3351035|NCT03582553|4081390|FG004|COMPLETED|Intervention 2/Visit 2||3
3351036|NCT03582553|4081391|FG005|COMPLETED|Intervention 2/Visit 2||3
3351037|NCT03582553|4081386|FG000|NOT COMPLETED|Intervention 2/Visit 2||0
3351038|NCT03582553|4081387|FG001|NOT COMPLETED|Intervention 2/Visit 2||0
3351039|NCT03582553|4081388|FG002|NOT COMPLETED|Intervention 2/Visit 2||0
3178127|NCT01975220|3906007|FG001|STARTED|Test Period 2||11
3351040|NCT03582553|4081389|FG003|NOT COMPLETED|Intervention 2/Visit 2||0
3351041|NCT03582553|4081390|FG004|NOT COMPLETED|Intervention 2/Visit 2||0
3351042|NCT03582553|4081391|FG005|NOT COMPLETED|Intervention 2/Visit 2||0
3351043|NCT03582553|4081386|FG000|STARTED|Washout Period (At Least 1 Week)||3
3351044|NCT03582553|4081387|FG001|STARTED|Washout Period (At Least 1 Week)||3
3351045|NCT03582553|4081388|FG002|STARTED|Washout Period (At Least 1 Week)||3
3351046|NCT03582553|4081389|FG003|STARTED|Washout Period (At Least 1 Week)||3
3351047|NCT03582553|4081390|FG004|STARTED|Washout Period (At Least 1 Week)||3
3351048|NCT03582553|4081391|FG005|STARTED|Washout Period (At Least 1 Week)||3
3351049|NCT03582553|4081386|FG000|COMPLETED|Washout Period (At Least 1 Week)||3
3351050|NCT03582553|4081387|FG001|COMPLETED|Washout Period (At Least 1 Week)||3
3351051|NCT03582553|4081388|FG002|COMPLETED|Washout Period (At Least 1 Week)||3
3351052|NCT03582553|4081389|FG003|COMPLETED|Washout Period (At Least 1 Week)||3
3351053|NCT03582553|4081390|FG004|COMPLETED|Washout Period (At Least 1 Week)||3
3351054|NCT03582553|4081391|FG005|COMPLETED|Washout Period (At Least 1 Week)||3
3351055|NCT03582553|4081386|FG000|NOT COMPLETED|Washout Period (At Least 1 Week)||0
3351056|NCT03582553|4081387|FG001|NOT COMPLETED|Washout Period (At Least 1 Week)||0
3351057|NCT03582553|4081388|FG002|NOT COMPLETED|Washout Period (At Least 1 Week)||0
3351058|NCT03582553|4081389|FG003|NOT COMPLETED|Washout Period (At Least 1 Week)||0
3351059|NCT03582553|4081390|FG004|NOT COMPLETED|Washout Period (At Least 1 Week)||0
3351060|NCT03582553|4081391|FG005|NOT COMPLETED|Washout Period (At Least 1 Week)||0
3351061|NCT03582553|4081386|FG000|STARTED|Intervention 3/Visit 3||3
3178128|NCT01975220|3906008|FG002|STARTED|Test Period 2||12
3178129|NCT01975220|3906009|FG003|STARTED|Test Period 2||12
3351062|NCT03582553|4081387|FG001|STARTED|Intervention 3/Visit 3||3
3351063|NCT03582553|4081388|FG002|STARTED|Intervention 3/Visit 3||3
3351064|NCT03582553|4081389|FG003|STARTED|Intervention 3/Visit 3||3
3351065|NCT03582553|4081390|FG004|STARTED|Intervention 3/Visit 3||3
3351066|NCT03582553|4081391|FG005|STARTED|Intervention 3/Visit 3||3
3351067|NCT03582553|4081386|FG000|COMPLETED|Intervention 3/Visit 3||3
3351068|NCT03582553|4081387|FG001|COMPLETED|Intervention 3/Visit 3||3
3351069|NCT03582553|4081388|FG002|COMPLETED|Intervention 3/Visit 3||3
3351070|NCT03582553|4081389|FG003|COMPLETED|Intervention 3/Visit 3||3
3351071|NCT03582553|4081390|FG004|COMPLETED|Intervention 3/Visit 3||3
3351072|NCT03582553|4081391|FG005|COMPLETED|Intervention 3/Visit 3||3
3351073|NCT03582553|4081386|FG000|NOT COMPLETED|Intervention 3/Visit 3||0
3351074|NCT03582553|4081387|FG001|NOT COMPLETED|Intervention 3/Visit 3||0
3351075|NCT03582553|4081388|FG002|NOT COMPLETED|Intervention 3/Visit 3||0
3351076|NCT03582553|4081389|FG003|NOT COMPLETED|Intervention 3/Visit 3||0
3351077|NCT03582553|4081390|FG004|NOT COMPLETED|Intervention 3/Visit 3||0
3351078|NCT03582553|4081391|FG005|NOT COMPLETED|Intervention 3/Visit 3||0
3351079|NCT03582813|4081411|FG000|STARTED|Overall Study||114
3351080|NCT03582813|4081412|FG001|STARTED|Overall Study||102
3351081|NCT03582813|4081411|FG000|COMPLETED|Overall Study||95
3351082|NCT03582813|4081412|FG001|COMPLETED|Overall Study||81
3351083|NCT03582813|4081411|FG000|NOT COMPLETED|Overall Study||19
3351084|NCT03582813|4081412|FG001|NOT COMPLETED|Overall Study||21
3351085|NCT03582826|4081420|FG000|STARTED|Overall Study||119
3351086|NCT03582826|4081421|FG001|STARTED|Overall Study||6
3351087|NCT03582826|4081420|FG000|COMPLETED|Overall Study||78
3351088|NCT03582826|4081421|FG001|COMPLETED|Overall Study||6
3351089|NCT03582826|4081420|FG000|NOT COMPLETED|Overall Study||41
3351090|NCT03582826|4081421|FG001|NOT COMPLETED|Overall Study||0
3351091|NCT03582943|4081438|FG000|STARTED|Allocated to Groups||42
3351092|NCT03582943|4081439|FG001|STARTED|Allocated to Groups||40
3351093|NCT03582943|4081438|FG000|COMPLETED|Allocated to Groups||41
3351094|NCT03582943|4081439|FG001|COMPLETED|Allocated to Groups||39
3351095|NCT03582943|4081438|FG000|NOT COMPLETED|Allocated to Groups||1
3351096|NCT03582943|4081439|FG001|NOT COMPLETED|Allocated to Groups||1
3351097|NCT03582943|4081438|FG000|STARTED|Intervention and Follow up||41
3351098|NCT03582943|4081439|FG001|STARTED|Intervention and Follow up||39
3351099|NCT03582943|4081438|FG000|COMPLETED|Intervention and Follow up||37
3351100|NCT03582943|4081439|FG001|COMPLETED|Intervention and Follow up||37
3351101|NCT03582943|4081438|FG000|NOT COMPLETED|Intervention and Follow up||4
3351102|NCT03582943|4081439|FG001|NOT COMPLETED|Intervention and Follow up||2
3351103|NCT03582943|4081438|FG000|STARTED|Analyzed||37
3351104|NCT03582943|4081439|FG001|STARTED|Analyzed||37
3351105|NCT03582943|4081438|FG000|COMPLETED|Analyzed||33
3351106|NCT03582943|4081439|FG001|COMPLETED|Analyzed||36
3351107|NCT03582943|4081438|FG000|NOT COMPLETED|Analyzed||4
3351108|NCT03582943|4081439|FG001|NOT COMPLETED|Analyzed||1
3351109|NCT03583372|4081449|FG000|STARTED|Overall Study||92
3351110|NCT03583372|4081450|FG001|STARTED|Overall Study||182
3351111|NCT03583372|4081451|FG002|STARTED|Overall Study||91
3351112|NCT03583372|4081452|FG003|STARTED|Overall Study||141
2928012|NCT00575588|3638972|FG000|NOT COMPLETED|Overall Study||263
3178130|NCT01975220|3906010|FG004|STARTED|Test Period 2||12
3351113|NCT03583372|4081449|FG000|COMPLETED|Overall Study||79
3351114|NCT03583372|4081450|FG001|COMPLETED|Overall Study||156
3351115|NCT03583372|4081451|FG002|COMPLETED|Overall Study||72
3351116|NCT03583372|4081452|FG003|COMPLETED|Overall Study||123
3351117|NCT03583372|4081449|FG000|NOT COMPLETED|Overall Study||13
3351118|NCT03583372|4081450|FG001|NOT COMPLETED|Overall Study||26
3351119|NCT03583372|4081451|FG002|NOT COMPLETED|Overall Study||19
3351120|NCT03583372|4081452|FG003|NOT COMPLETED|Overall Study||18
3351121|NCT03583385|4081462|FG000|STARTED|Treatment Period 1||24
3351122|NCT03583385|4081463|FG001|STARTED|Treatment Period 1||24
3351123|NCT03583385|4081462|FG000|COMPLETED|Treatment Period 1||23
3351124|NCT03583385|4081463|FG001|COMPLETED|Treatment Period 1||23
3351125|NCT03583385|4081462|FG000|NOT COMPLETED|Treatment Period 1||1
3351126|NCT03583385|4081463|FG001|NOT COMPLETED|Treatment Period 1||1
3351127|NCT03583385|4081462|FG000|STARTED|Treatment Period 2|Of 46 participants who completed period 1, 45 entered period2 & 1 participant didn't attend period2.|22
3351128|NCT03583385|4081463|FG001|STARTED|Treatment Period 2||23
3351129|NCT03583385|4081462|FG000|COMPLETED|Treatment Period 2||21
3351130|NCT03583385|4081463|FG001|COMPLETED|Treatment Period 2||23
3351131|NCT03583385|4081462|FG000|NOT COMPLETED|Treatment Period 2||1
3351132|NCT03583385|4081463|FG001|NOT COMPLETED|Treatment Period 2||0
3351133|NCT03583450|4081471|FG000|STARTED|Overall Study||34
3351134|NCT03583450|4081472|FG001|STARTED|Overall Study||37
3351135|NCT03583450|4081471|FG000|COMPLETED|Overall Study||33
3351136|NCT03583450|4081472|FG001|COMPLETED|Overall Study||37
3351137|NCT03583450|4081471|FG000|NOT COMPLETED|Overall Study||1
3351138|NCT03583450|4081472|FG001|NOT COMPLETED|Overall Study||0
3351139|NCT03583606|4081483|FG000|STARTED|Overall Study||22
3351140|NCT03583606|4081484|FG001|STARTED|Overall Study||20
3351141|NCT03583606|4081485|FG002|STARTED|Overall Study||19
3351142|NCT03583606|4081483|FG000|COMPLETED|Overall Study||21
3351143|NCT03583606|4081484|FG001|COMPLETED|Overall Study||19
3351144|NCT03583606|4081485|FG002|COMPLETED|Overall Study||19
3351145|NCT03583606|4081483|FG000|NOT COMPLETED|Overall Study||1
3351146|NCT03583606|4081484|FG001|NOT COMPLETED|Overall Study||1
3351147|NCT03583606|4081485|FG002|NOT COMPLETED|Overall Study||0
3351148|NCT03584009|4081496|FG000|STARTED|Overall Study||51
3351149|NCT03584009|4081497|FG001|STARTED|Overall Study||52
3351150|NCT03584009|4081496|FG000|COMPLETED|Overall Study||0
3351151|NCT03584009|4081497|FG001|COMPLETED|Overall Study||0
3351152|NCT03584009|4081496|FG000|NOT COMPLETED|Overall Study||51
3351153|NCT03584009|4081497|FG001|NOT COMPLETED|Overall Study||52
3351154|NCT03584100|4081503|FG000|STARTED|Overall Study||12
3351155|NCT03584100|4081503|FG000|COMPLETED|Overall Study||12
3351156|NCT03584100|4081503|FG000|NOT COMPLETED|Overall Study||0
3351157|NCT03585244|4081510|FG000|STARTED|Overall Study||180
3351158|NCT03585244|4081510|FG000|COMPLETED|Overall Study||165
3351159|NCT03585244|4081510|FG000|NOT COMPLETED|Overall Study||15
3351160|NCT03585296|4081514|FG000|STARTED|Overall Study||22
3351161|NCT03585296|4081514|FG000|COMPLETED|Overall Study||17
3351162|NCT03585296|4081514|FG000|NOT COMPLETED|Overall Study||5
3351163|NCT03585504|4081520|FG000|STARTED|Overall Study||41
3351164|NCT03585504|4081521|FG001|STARTED|Overall Study||40
3351165|NCT03585504|4081520|FG000|COMPLETED|Overall Study||15
3351166|NCT03585504|4081521|FG001|COMPLETED|Overall Study||11
3351167|NCT03585504|4081520|FG000|NOT COMPLETED|Overall Study||26
3351168|NCT03585504|4081521|FG001|NOT COMPLETED|Overall Study||29
3351169|NCT03585543|4081527|FG000|STARTED|Overall Study||30
3351170|NCT03585543|4081527|FG000|Mid-intervention Assessment (6-weeks)|Overall Study||25
3351171|NCT03585543|4081527|FG000|End-of-intervention Assessment (12 Weeks|Overall Study||22
3351172|NCT03585543|4081527|FG000|3-month Post-intervention Follow-up (6 m|Overall Study||15
2928013|NCT00575588|3638973|FG001|NOT COMPLETED|Overall Study||283
3351173|NCT03585543|4081527|FG000|COMPLETED|Overall Study||15
3351174|NCT03585543|4081527|FG000|NOT COMPLETED|Overall Study||15
3351175|NCT03585712|4081532|FG000|STARTED|Treatment Period 1||52
3351176|NCT03585712|4081533|FG001|STARTED|Treatment Period 1|Randomization in Treatment Period 2|0
3351177|NCT03585712|4081534|FG002|STARTED|Treatment Period 1|Randomization in Treatment Period 2|0
3351178|NCT03585712|4081532|FG000|COMPLETED|Treatment Period 1||51
3351179|NCT03585712|4081533|FG001|COMPLETED|Treatment Period 1||0
3351180|NCT03585712|4081534|FG002|COMPLETED|Treatment Period 1||0
3351181|NCT03585712|4081532|FG000|NOT COMPLETED|Treatment Period 1||1
3351182|NCT03585712|4081533|FG001|NOT COMPLETED|Treatment Period 1||0
3351183|NCT03585712|4081534|FG002|NOT COMPLETED|Treatment Period 1||0
3351184|NCT03585712|4081532|FG000|STARTED|Treatment Periods 2 and 3|Subjects having completed Treatment Period 1 randomized in Arm A or Arm B|0
3351185|NCT03585712|4081533|FG001|STARTED|Treatment Periods 2 and 3||26
3351186|NCT03585712|4081534|FG002|STARTED|Treatment Periods 2 and 3||25
3351187|NCT03585712|4081532|FG000|COMPLETED|Treatment Periods 2 and 3||0
3351188|NCT03585712|4081533|FG001|COMPLETED|Treatment Periods 2 and 3||23
3351189|NCT03585712|4081534|FG002|COMPLETED|Treatment Periods 2 and 3||22
3351190|NCT03585712|4081532|FG000|NOT COMPLETED|Treatment Periods 2 and 3||0
3351191|NCT03585712|4081533|FG001|NOT COMPLETED|Treatment Periods 2 and 3||3
3351192|NCT03585712|4081534|FG002|NOT COMPLETED|Treatment Periods 2 and 3||3
3351193|NCT03585790|4081553|FG000|STARTED|First Intervention (1 Week)||23
3351194|NCT03585790|4081554|FG001|STARTED|First Intervention (1 Week)||22
3351195|NCT03585790|4081553|FG000|COMPLETED|First Intervention (1 Week)||23
3351196|NCT03585790|4081554|FG001|COMPLETED|First Intervention (1 Week)||22
3351197|NCT03585790|4081553|FG000|NOT COMPLETED|First Intervention (1 Week)||0
3351198|NCT03585790|4081554|FG001|NOT COMPLETED|First Intervention (1 Week)||0
3351199|NCT03585790|4081553|FG000|STARTED|Second Intervention (1 Week)||23
3351200|NCT03585790|4081554|FG001|STARTED|Second Intervention (1 Week)||22
3351201|NCT03585790|4081553|FG000|COMPLETED|Second Intervention (1 Week)||23
3351202|NCT03585790|4081554|FG001|COMPLETED|Second Intervention (1 Week)||22
3351203|NCT03585790|4081553|FG000|NOT COMPLETED|Second Intervention (1 Week)||0
3351204|NCT03585790|4081554|FG001|NOT COMPLETED|Second Intervention (1 Week)||0
3351205|NCT03585959|4081561|FG000|STARTED|Overall Study||50
3351206|NCT03585959|4081561|FG000|COMPLETED|Overall Study||47
3351207|NCT03585959|4081561|FG000|NOT COMPLETED|Overall Study||3
3351208|NCT03586167|4081569|FG000|STARTED|Overall Study||58
3351209|NCT03586167|4081570|FG001|STARTED|Overall Study||28
3351210|NCT03586167|4081569|FG000|COMPLETED|Overall Study||57
3351211|NCT03586167|4081570|FG001|COMPLETED|Overall Study||28
3351212|NCT03586167|4081569|FG000|NOT COMPLETED|Overall Study||1
3351213|NCT03586167|4081570|FG001|NOT COMPLETED|Overall Study||0
3351214|NCT03586544|4081578|FG000|STARTED|First Intervention||6
3351215|NCT03586544|4081579|FG001|STARTED|First Intervention||12
3351216|NCT03586544|4081578|FG000|COMPLETED|First Intervention||6
3351217|NCT03586544|4081579|FG001|COMPLETED|First Intervention||11
3351218|NCT03586544|4081578|FG000|NOT COMPLETED|First Intervention||0
3351219|NCT03586544|4081579|FG001|NOT COMPLETED|First Intervention||1
3351220|NCT03586544|4081578|FG000|STARTED|Second Intervention||6
3351221|NCT03586544|4081579|FG001|STARTED|Second Intervention||11
3351222|NCT03586544|4081578|FG000|COMPLETED|Second Intervention||6
3351223|NCT03586544|4081579|FG001|COMPLETED|Second Intervention||10
3351224|NCT03586544|4081578|FG000|NOT COMPLETED|Second Intervention||0
3351225|NCT03586544|4081579|FG001|NOT COMPLETED|Second Intervention||1
3351226|NCT03586583|4081585|FG000|STARTED|Overall Study||600
3351227|NCT03586583|4081585|FG000|COMPLETED|Overall Study||600
3351228|NCT03586583|4081585|FG000|NOT COMPLETED|Overall Study||0
3351229|NCT03586648|4081590|FG000|STARTED|Period 1||36
3351230|NCT03586648|4081591|FG001|STARTED|Period 1||34
3351231|NCT03586648|4081590|FG000|COMPLETED|Period 1||32
3351232|NCT03586648|4081591|FG001|COMPLETED|Period 1||30
3351233|NCT03586648|4081590|FG000|NOT COMPLETED|Period 1||4
3351234|NCT03586648|4081591|FG001|NOT COMPLETED|Period 1||4
3351235|NCT03586648|4081590|FG000|STARTED|Period 2||32
3351236|NCT03586648|4081591|FG001|STARTED|Period 2||30
3351237|NCT03586648|4081590|FG000|COMPLETED|Period 2||31
3351238|NCT03586648|4081591|FG001|COMPLETED|Period 2||30
3351239|NCT03586648|4081590|FG000|NOT COMPLETED|Period 2||1
3351240|NCT03586648|4081591|FG001|NOT COMPLETED|Period 2||0
3351241|NCT03586726|4081597|FG000|STARTED|Overall Study||16
3351242|NCT03586726|4081597|FG000|COMPLETED|Overall Study||15
3351243|NCT03586726|4081597|FG000|NOT COMPLETED|Overall Study||1
3351244|NCT03586830|4081605|FG000|STARTED|Overall Study||50
3351245|NCT03586830|4081606|FG001|STARTED|Overall Study||48
3351246|NCT03586830|4081607|FG002|STARTED|Overall Study||49
3351247|NCT03586830|4081608|FG003|STARTED|Overall Study||49
3351248|NCT03586830|4081605|FG000|Treated|Overall Study||49
3351249|NCT03586830|4081606|FG001|Treated|Overall Study||48
3351250|NCT03586830|4081607|FG002|Treated|Overall Study||49
3351251|NCT03586830|4081608|FG003|Treated|Overall Study||49
3351252|NCT03586830|4081605|FG000|COMPLETED|Overall Study||48
3351253|NCT03586830|4081606|FG001|COMPLETED|Overall Study||42
3351254|NCT03586830|4081607|FG002|COMPLETED|Overall Study||41
3351255|NCT03586830|4081608|FG003|COMPLETED|Overall Study||44
3351256|NCT03586830|4081605|FG000|NOT COMPLETED|Overall Study||2
3351257|NCT03586830|4081606|FG001|NOT COMPLETED|Overall Study||6
3351258|NCT03586830|4081607|FG002|NOT COMPLETED|Overall Study||8
3351259|NCT03586830|4081608|FG003|NOT COMPLETED|Overall Study||5
3351260|NCT03587207|4081623|FG000|STARTED|Overall Study||100
3351261|NCT03587207|4081624|FG001|STARTED|Overall Study||104
3351262|NCT03587207|4081625|FG002|STARTED|Overall Study||100
3351263|NCT03587207|4081626|FG003|STARTED|Overall Study||94
3351264|NCT03587207|4081627|FG004|STARTED|Overall Study||102
3351265|NCT03587207|4081623|FG000|COMPLETED|Overall Study||100
3351266|NCT03587207|4081624|FG001|COMPLETED|Overall Study||104
3351267|NCT03587207|4081625|FG002|COMPLETED|Overall Study||100
3351268|NCT03587207|4081626|FG003|COMPLETED|Overall Study||94
3351269|NCT03587207|4081627|FG004|COMPLETED|Overall Study||102
3351270|NCT03587207|4081623|FG000|NOT COMPLETED|Overall Study||0
3351271|NCT03587207|4081624|FG001|NOT COMPLETED|Overall Study||0
3351272|NCT03587207|4081625|FG002|NOT COMPLETED|Overall Study||0
3351273|NCT03587207|4081626|FG003|NOT COMPLETED|Overall Study||0
3351274|NCT03587207|4081627|FG004|NOT COMPLETED|Overall Study||0
3351275|NCT03587428|4081639|FG000|STARTED|Period 1||3
3351276|NCT03587428|4081640|FG001|STARTED|Period 1||2
3351277|NCT03587428|4081641|FG002|STARTED|Period 1||3
3351278|NCT03587428|4081642|FG003|STARTED|Period 1||3
3351279|NCT03587428|4081643|FG004|STARTED|Period 1||2
3351280|NCT03587428|4081644|FG005|STARTED|Period 1||2
3351281|NCT03587428|4081639|FG000|COMPLETED|Period 1||3
3351282|NCT03587428|4081640|FG001|COMPLETED|Period 1||2
3351283|NCT03587428|4081641|FG002|COMPLETED|Period 1||3
3351284|NCT03587428|4081642|FG003|COMPLETED|Period 1||3
3351285|NCT03587428|4081643|FG004|COMPLETED|Period 1||2
3351286|NCT03587428|4081644|FG005|COMPLETED|Period 1||2
3351287|NCT03587428|4081639|FG000|NOT COMPLETED|Period 1||0
3351288|NCT03587428|4081640|FG001|NOT COMPLETED|Period 1||0
3351289|NCT03587428|4081641|FG002|NOT COMPLETED|Period 1||0
3351290|NCT03587428|4081642|FG003|NOT COMPLETED|Period 1||0
3351291|NCT03587428|4081643|FG004|NOT COMPLETED|Period 1||0
3351292|NCT03587428|4081644|FG005|NOT COMPLETED|Period 1||0
3351293|NCT03587428|4081639|FG000|STARTED|Period 2||3
3351294|NCT03587428|4081640|FG001|STARTED|Period 2||2
3351295|NCT03587428|4081641|FG002|STARTED|Period 2||3
3351296|NCT03587428|4081642|FG003|STARTED|Period 2||3
3351297|NCT03587428|4081643|FG004|STARTED|Period 2||2
3351298|NCT03587428|4081644|FG005|STARTED|Period 2||2
3351299|NCT03587428|4081639|FG000|COMPLETED|Period 2||3
3351300|NCT03587428|4081640|FG001|COMPLETED|Period 2||2
3351301|NCT03587428|4081641|FG002|COMPLETED|Period 2||3
3351302|NCT03587428|4081642|FG003|COMPLETED|Period 2||3
3351303|NCT03587428|4081643|FG004|COMPLETED|Period 2||2
3351304|NCT03587428|4081644|FG005|COMPLETED|Period 2||2
3351305|NCT03587428|4081639|FG000|NOT COMPLETED|Period 2||0
3351306|NCT03587428|4081640|FG001|NOT COMPLETED|Period 2||0
3351307|NCT03587428|4081641|FG002|NOT COMPLETED|Period 2||0
3351308|NCT03587428|4081642|FG003|NOT COMPLETED|Period 2||0
3351309|NCT03587428|4081643|FG004|NOT COMPLETED|Period 2||0
3351310|NCT03587428|4081644|FG005|NOT COMPLETED|Period 2||0
3351311|NCT03587428|4081639|FG000|STARTED|Period 3||3
3351312|NCT03587428|4081640|FG001|STARTED|Period 3||2
3351313|NCT03587428|4081641|FG002|STARTED|Period 3||3
3351314|NCT03587428|4081642|FG003|STARTED|Period 3||3
3351315|NCT03587428|4081643|FG004|STARTED|Period 3||2
3351316|NCT03587428|4081644|FG005|STARTED|Period 3||2
3351317|NCT03587428|4081639|FG000|COMPLETED|Period 3||3
3351318|NCT03587428|4081640|FG001|COMPLETED|Period 3||2
3351319|NCT03587428|4081641|FG002|COMPLETED|Period 3||3
3351320|NCT03587428|4081642|FG003|COMPLETED|Period 3||3
3351321|NCT03587428|4081643|FG004|COMPLETED|Period 3||2
3351322|NCT03587428|4081644|FG005|COMPLETED|Period 3||2
3351323|NCT03587428|4081639|FG000|NOT COMPLETED|Period 3||0
3351324|NCT03587428|4081640|FG001|NOT COMPLETED|Period 3||0
3351325|NCT03587428|4081641|FG002|NOT COMPLETED|Period 3||0
3351326|NCT03587428|4081642|FG003|NOT COMPLETED|Period 3||0
3351327|NCT03587428|4081643|FG004|NOT COMPLETED|Period 3||0
3351328|NCT03587428|4081644|FG005|NOT COMPLETED|Period 3||0
3351329|NCT03587974|4081654|FG000|STARTED|Overall Study||30
3351330|NCT03587974|4081655|FG001|STARTED|Overall Study||30
3351331|NCT03587974|4081654|FG000|COMPLETED|Overall Study||25
3351332|NCT03587974|4081655|FG001|COMPLETED|Overall Study||26
3351333|NCT03587974|4081654|FG000|NOT COMPLETED|Overall Study||5
3351334|NCT03587974|4081655|FG001|NOT COMPLETED|Overall Study||4
3351335|NCT03588572|4081663|FG000|STARTED|Visitation 1||22
3351336|NCT03588572|4081664|FG001|STARTED|Visitation 1||21
3351337|NCT03588572|4081663|FG000|COMPLETED|Visitation 1||21
3351338|NCT03588572|4081664|FG001|COMPLETED|Visitation 1||20
3351339|NCT03588572|4081663|FG000|NOT COMPLETED|Visitation 1||1
3351340|NCT03588572|4081664|FG001|NOT COMPLETED|Visitation 1||1
3351341|NCT03588572|4081663|FG000|STARTED|Visitation 2||21
3351342|NCT03588572|4081664|FG001|STARTED|Visitation 2||20
3351343|NCT03588572|4081663|FG000|COMPLETED|Visitation 2||19
3351344|NCT03588572|4081664|FG001|COMPLETED|Visitation 2||18
3351345|NCT03588572|4081663|FG000|NOT COMPLETED|Visitation 2||2
3351346|NCT03588572|4081664|FG001|NOT COMPLETED|Visitation 2||2
3351347|NCT03588572|4081663|FG000|STARTED|Visitation 3||19
3351348|NCT03588572|4081664|FG001|STARTED|Visitation 3||18
3351349|NCT03588572|4081663|FG000|COMPLETED|Visitation 3||16
3351350|NCT03588572|4081664|FG001|COMPLETED|Visitation 3||16
3351351|NCT03588572|4081663|FG000|NOT COMPLETED|Visitation 3||3
3351352|NCT03588572|4081664|FG001|NOT COMPLETED|Visitation 3||2
3351353|NCT03588741|4081670|FG000|STARTED|Overall Study||1
3178131|NCT01975220|3906011|FG005|STARTED|Test Period 2||12
3351354|NCT03588741|4081670|FG000|COMPLETED|Overall Study||0
3351355|NCT03588741|4081670|FG000|NOT COMPLETED|Overall Study||1
3351356|NCT03588806|4081674|FG000|STARTED|Overall Study||11
3351357|NCT03588806|4081674|FG000|COMPLETED|Overall Study||11
3351358|NCT03588806|4081674|FG000|NOT COMPLETED|Overall Study||0
3351359|NCT03588910|4081680|FG000|STARTED|Overall Study||60
3351360|NCT03588910|4081681|FG001|STARTED|Overall Study||60
3351361|NCT03588910|4081680|FG000|Post Op Day 1 Survey|Overall Study||52
3351362|NCT03588910|4081681|FG001|Post Op Day 1 Survey|Overall Study||47
3351363|NCT03588910|4081680|FG000|COMPLETED|Overall Study||47
3351364|NCT03588910|4081681|FG001|COMPLETED|Overall Study||45
3351365|NCT03588910|4081680|FG000|NOT COMPLETED|Overall Study||13
3351366|NCT03588910|4081681|FG001|NOT COMPLETED|Overall Study||15
3351367|NCT03589469|4081687|FG000|STARTED|Overall Study||145
3351368|NCT03589469|4081687|FG000|Received Treatment|Overall Study||145
3351369|NCT03589469|4081687|FG000|COMPLETED|Overall Study||0
3351370|NCT03589469|4081687|FG000|NOT COMPLETED|Overall Study||145
3351371|NCT03589807|4081697|FG000|STARTED|Overall Study||27
3351372|NCT03589807|4081698|FG001|STARTED|Overall Study||30
3351373|NCT03589807|4081699|FG002|STARTED|Overall Study||33
3351374|NCT03589807|4081700|FG003|STARTED|Overall Study||32
3351375|NCT03589807|4081701|FG004|STARTED|Overall Study||28
3351376|NCT03589807|4081702|FG005|STARTED|Overall Study||30
3351377|NCT03589807|4081697|FG000|COMPLETED|Overall Study||27
3351378|NCT03589807|4081698|FG001|COMPLETED|Overall Study||23
3351379|NCT03589807|4081699|FG002|COMPLETED|Overall Study||31
3351380|NCT03589807|4081700|FG003|COMPLETED|Overall Study||28
3351381|NCT03589807|4081701|FG004|COMPLETED|Overall Study||26
3351382|NCT03589807|4081702|FG005|COMPLETED|Overall Study||29
3351383|NCT03589807|4081697|FG000|NOT COMPLETED|Overall Study||0
3178132|NCT01975220|3906006|FG000|COMPLETED|Test Period 2||12
3178133|NCT01975220|3906007|FG001|COMPLETED|Test Period 2||11
3178134|NCT01975220|3906008|FG002|COMPLETED|Test Period 2||12
3178135|NCT01975220|3906009|FG003|COMPLETED|Test Period 2||12
3351384|NCT03589807|4081698|FG001|NOT COMPLETED|Overall Study||7
3351385|NCT03589807|4081699|FG002|NOT COMPLETED|Overall Study||2
3351386|NCT03589807|4081700|FG003|NOT COMPLETED|Overall Study||4
3351387|NCT03589807|4081701|FG004|NOT COMPLETED|Overall Study||2
3351388|NCT03589807|4081702|FG005|NOT COMPLETED|Overall Study||1
3351389|NCT03589885|4081722|FG000|STARTED|Treatment Period 1-Randomized Set||41
3351390|NCT03589885|4081723|FG001|STARTED|Treatment Period 1-Randomized Set||41
3351391|NCT03589885|4081724|FG002|STARTED|Treatment Period 1-Randomized Set||40
3351392|NCT03589885|4081725|FG003|STARTED|Treatment Period 1-Randomized Set||0
3351393|NCT03589885|4081726|FG004|STARTED|Treatment Period 1-Randomized Set||0
3351394|NCT03589885|4081722|FG000|COMPLETED|Treatment Period 1-Randomized Set||41
3351395|NCT03589885|4081723|FG001|COMPLETED|Treatment Period 1-Randomized Set||39
3351396|NCT03589885|4081724|FG002|COMPLETED|Treatment Period 1-Randomized Set||37
3351397|NCT03589885|4081725|FG003|COMPLETED|Treatment Period 1-Randomized Set||0
3351398|NCT03589885|4081726|FG004|COMPLETED|Treatment Period 1-Randomized Set||0
3351399|NCT03589885|4081722|FG000|NOT COMPLETED|Treatment Period 1-Randomized Set||0
3351400|NCT03589885|4081723|FG001|NOT COMPLETED|Treatment Period 1-Randomized Set||2
3351401|NCT03589885|4081724|FG002|NOT COMPLETED|Treatment Period 1-Randomized Set||3
3351402|NCT03589885|4081725|FG003|NOT COMPLETED|Treatment Period 1-Randomized Set||0
3351403|NCT03589885|4081726|FG004|NOT COMPLETED|Treatment Period 1-Randomized Set||0
3351404|NCT03589885|4081722|FG000|STARTED|Treatment Period 2-Randomized Set||41
3351405|NCT03589885|4081723|FG001|STARTED|Treatment Period 2-Randomized Set||39
3351406|NCT03589885|4081724|FG002|STARTED|Treatment Period 2-Randomized Set||4
3351407|NCT03589885|4081725|FG003|STARTED|Treatment Period 2-Randomized Set||16
3351408|NCT03589885|4081726|FG004|STARTED|Treatment Period 2-Randomized Set||17
3351409|NCT03589885|4081722|FG000|COMPLETED|Treatment Period 2-Randomized Set||40
3351410|NCT03589885|4081723|FG001|COMPLETED|Treatment Period 2-Randomized Set||34
3351411|NCT03589885|4081724|FG002|COMPLETED|Treatment Period 2-Randomized Set||3
3351412|NCT03589885|4081725|FG003|COMPLETED|Treatment Period 2-Randomized Set||16
3351413|NCT03589885|4081726|FG004|COMPLETED|Treatment Period 2-Randomized Set||16
3351414|NCT03589885|4081722|FG000|NOT COMPLETED|Treatment Period 2-Randomized Set||1
3351415|NCT03589885|4081723|FG001|NOT COMPLETED|Treatment Period 2-Randomized Set||5
3351416|NCT03589885|4081724|FG002|NOT COMPLETED|Treatment Period 2-Randomized Set||1
3351417|NCT03589885|4081725|FG003|NOT COMPLETED|Treatment Period 2-Randomized Set||0
3351418|NCT03589885|4081726|FG004|NOT COMPLETED|Treatment Period 2-Randomized Set||1
3351419|NCT03590613|4081744|FG000|STARTED|Period 1, 4 Days||3
3351420|NCT03590613|4081745|FG001|STARTED|Period 1, 4 Days||3
3178136|NCT01975220|3906010|FG004|COMPLETED|Test Period 2||12
3351421|NCT03590613|4081746|FG002|STARTED|Period 1, 4 Days||3
3351422|NCT03590613|4081747|FG003|STARTED|Period 1, 4 Days||3
3351423|NCT03590613|4081744|FG000|COMPLETED|Period 1, 4 Days||3
3351424|NCT03590613|4081745|FG001|COMPLETED|Period 1, 4 Days||3
3351425|NCT03590613|4081746|FG002|COMPLETED|Period 1, 4 Days||3
3351426|NCT03590613|4081747|FG003|COMPLETED|Period 1, 4 Days||3
3351427|NCT03590613|4081744|FG000|NOT COMPLETED|Period 1, 4 Days||0
3351428|NCT03590613|4081745|FG001|NOT COMPLETED|Period 1, 4 Days||0
3351429|NCT03590613|4081746|FG002|NOT COMPLETED|Period 1, 4 Days||0
3351430|NCT03590613|4081747|FG003|NOT COMPLETED|Period 1, 4 Days||0
3351431|NCT03590613|4081744|FG000|STARTED|Period 1, Wash-out, at Least 3 Days||3
3351432|NCT03590613|4081745|FG001|STARTED|Period 1, Wash-out, at Least 3 Days||3
3351433|NCT03590613|4081746|FG002|STARTED|Period 1, Wash-out, at Least 3 Days||3
3351434|NCT03590613|4081747|FG003|STARTED|Period 1, Wash-out, at Least 3 Days||3
3351435|NCT03590613|4081744|FG000|COMPLETED|Period 1, Wash-out, at Least 3 Days||3
3351436|NCT03590613|4081745|FG001|COMPLETED|Period 1, Wash-out, at Least 3 Days||3
3351437|NCT03590613|4081746|FG002|COMPLETED|Period 1, Wash-out, at Least 3 Days||3
3351438|NCT03590613|4081747|FG003|COMPLETED|Period 1, Wash-out, at Least 3 Days||3
3351439|NCT03590613|4081744|FG000|NOT COMPLETED|Period 1, Wash-out, at Least 3 Days||0
3351440|NCT03590613|4081745|FG001|NOT COMPLETED|Period 1, Wash-out, at Least 3 Days||0
3351441|NCT03590613|4081746|FG002|NOT COMPLETED|Period 1, Wash-out, at Least 3 Days||0
3351442|NCT03590613|4081747|FG003|NOT COMPLETED|Period 1, Wash-out, at Least 3 Days||0
3351443|NCT03590613|4081744|FG000|STARTED|Period 2, 4 Days||3
3351444|NCT03590613|4081745|FG001|STARTED|Period 2, 4 Days||3
3351445|NCT03590613|4081746|FG002|STARTED|Period 2, 4 Days||3
3351446|NCT03590613|4081747|FG003|STARTED|Period 2, 4 Days|One additional participant was enrolled in Period 2.|4
3351447|NCT03590613|4081744|FG000|COMPLETED|Period 2, 4 Days||3
3351448|NCT03590613|4081745|FG001|COMPLETED|Period 2, 4 Days||3
3351449|NCT03590613|4081746|FG002|COMPLETED|Period 2, 4 Days||3
3351450|NCT03590613|4081747|FG003|COMPLETED|Period 2, 4 Days||3
3351451|NCT03590613|4081744|FG000|NOT COMPLETED|Period 2, 4 Days||0
3351452|NCT03590613|4081745|FG001|NOT COMPLETED|Period 2, 4 Days||0
3351453|NCT03590613|4081746|FG002|NOT COMPLETED|Period 2, 4 Days||0
3351454|NCT03590613|4081747|FG003|NOT COMPLETED|Period 2, 4 Days||1
3351455|NCT03590613|4081744|FG000|STARTED|Period 2, Wash-out, at Least 3 Days||3
3351456|NCT03590613|4081745|FG001|STARTED|Period 2, Wash-out, at Least 3 Days||3
3351457|NCT03590613|4081746|FG002|STARTED|Period 2, Wash-out, at Least 3 Days||3
3351458|NCT03590613|4081747|FG003|STARTED|Period 2, Wash-out, at Least 3 Days||3
3351459|NCT03590613|4081744|FG000|COMPLETED|Period 2, Wash-out, at Least 3 Days||3
3351460|NCT03590613|4081745|FG001|COMPLETED|Period 2, Wash-out, at Least 3 Days||3
3351461|NCT03590613|4081746|FG002|COMPLETED|Period 2, Wash-out, at Least 3 Days||3
3351462|NCT03590613|4081747|FG003|COMPLETED|Period 2, Wash-out, at Least 3 Days||3
3351463|NCT03590613|4081744|FG000|NOT COMPLETED|Period 2, Wash-out, at Least 3 Days||0
3351464|NCT03590613|4081745|FG001|NOT COMPLETED|Period 2, Wash-out, at Least 3 Days||0
3351465|NCT03590613|4081746|FG002|NOT COMPLETED|Period 2, Wash-out, at Least 3 Days||0
3351466|NCT03590613|4081747|FG003|NOT COMPLETED|Period 2, Wash-out, at Least 3 Days||0
3351467|NCT03590613|4081744|FG000|STARTED|Period 3, 4 Days||3
3351468|NCT03590613|4081745|FG001|STARTED|Period 3, 4 Days||3
3351469|NCT03590613|4081746|FG002|STARTED|Period 3, 4 Days||3
3351470|NCT03590613|4081747|FG003|STARTED|Period 3, 4 Days||3
3351471|NCT03590613|4081744|FG000|COMPLETED|Period 3, 4 Days||3
3351472|NCT03590613|4081745|FG001|COMPLETED|Period 3, 4 Days||3
3351473|NCT03590613|4081746|FG002|COMPLETED|Period 3, 4 Days||3
3351474|NCT03590613|4081747|FG003|COMPLETED|Period 3, 4 Days||3
3351475|NCT03590613|4081744|FG000|NOT COMPLETED|Period 3, 4 Days||0
3351476|NCT03590613|4081745|FG001|NOT COMPLETED|Period 3, 4 Days||0
3351477|NCT03590613|4081746|FG002|NOT COMPLETED|Period 3, 4 Days||0
3351478|NCT03590613|4081747|FG003|NOT COMPLETED|Period 3, 4 Days||0
3351479|NCT03590613|4081744|FG000|STARTED|Period 3,Wash-out, at Least 3 Days||3
3351480|NCT03590613|4081745|FG001|STARTED|Period 3,Wash-out, at Least 3 Days||3
3351481|NCT03590613|4081746|FG002|STARTED|Period 3,Wash-out, at Least 3 Days||3
3351482|NCT03590613|4081747|FG003|STARTED|Period 3,Wash-out, at Least 3 Days||3
3351483|NCT03590613|4081744|FG000|COMPLETED|Period 3,Wash-out, at Least 3 Days||3
3351484|NCT03590613|4081745|FG001|COMPLETED|Period 3,Wash-out, at Least 3 Days||3
3351485|NCT03590613|4081746|FG002|COMPLETED|Period 3,Wash-out, at Least 3 Days||3
3351486|NCT03590613|4081747|FG003|COMPLETED|Period 3,Wash-out, at Least 3 Days||3
3351487|NCT03590613|4081744|FG000|NOT COMPLETED|Period 3,Wash-out, at Least 3 Days||0
3351488|NCT03590613|4081745|FG001|NOT COMPLETED|Period 3,Wash-out, at Least 3 Days||0
3351489|NCT03590613|4081746|FG002|NOT COMPLETED|Period 3,Wash-out, at Least 3 Days||0
3351490|NCT03590613|4081747|FG003|NOT COMPLETED|Period 3,Wash-out, at Least 3 Days||0
3351491|NCT03590613|4081744|FG000|STARTED|Period 4, 4 Days||3
3351492|NCT03590613|4081745|FG001|STARTED|Period 4, 4 Days||3
3351493|NCT03590613|4081746|FG002|STARTED|Period 4, 4 Days||3
3351494|NCT03590613|4081747|FG003|STARTED|Period 4, 4 Days||3
3351495|NCT03590613|4081744|FG000|COMPLETED|Period 4, 4 Days||3
3351496|NCT03590613|4081745|FG001|COMPLETED|Period 4, 4 Days||3
3351497|NCT03590613|4081746|FG002|COMPLETED|Period 4, 4 Days||3
3351498|NCT03590613|4081747|FG003|COMPLETED|Period 4, 4 Days||3
3351499|NCT03590613|4081744|FG000|NOT COMPLETED|Period 4, 4 Days||0
3351500|NCT03590613|4081745|FG001|NOT COMPLETED|Period 4, 4 Days||0
3351501|NCT03590613|4081746|FG002|NOT COMPLETED|Period 4, 4 Days||0
3351502|NCT03590613|4081747|FG003|NOT COMPLETED|Period 4, 4 Days||0
3351503|NCT03591068|4081760|FG000|STARTED|Overall Study||11
3351504|NCT03591068|4081760|FG000|COMPLETED|Overall Study||9
3351505|NCT03591068|4081760|FG000|NOT COMPLETED|Overall Study||2
3351506|NCT03591146|4081771|FG000|STARTED|TLC590 190mg and Naropin 150mg||12
3351507|NCT03591146|4081772|FG001|STARTED|TLC590 190mg and Naropin 150mg||0
3351508|NCT03591146|4081773|FG002|STARTED|TLC590 190mg and Naropin 150mg||0
3351509|NCT03591146|4081774|FG003|STARTED|TLC590 190mg and Naropin 150mg||0
3351510|NCT03591146|4081775|FG004|STARTED|TLC590 190mg and Naropin 150mg||4
3351511|NCT03591146|4081771|FG000|COMPLETED|TLC590 190mg and Naropin 150mg||12
3351512|NCT03591146|4081772|FG001|COMPLETED|TLC590 190mg and Naropin 150mg||0
3351513|NCT03591146|4081773|FG002|COMPLETED|TLC590 190mg and Naropin 150mg||0
3351514|NCT03591146|4081774|FG003|COMPLETED|TLC590 190mg and Naropin 150mg||0
3351515|NCT03591146|4081775|FG004|COMPLETED|TLC590 190mg and Naropin 150mg||3
3351516|NCT03591146|4081771|FG000|NOT COMPLETED|TLC590 190mg and Naropin 150mg||0
3351517|NCT03591146|4081772|FG001|NOT COMPLETED|TLC590 190mg and Naropin 150mg||0
3351518|NCT03591146|4081773|FG002|NOT COMPLETED|TLC590 190mg and Naropin 150mg||0
3351519|NCT03591146|4081774|FG003|NOT COMPLETED|TLC590 190mg and Naropin 150mg||0
3351520|NCT03591146|4081775|FG004|NOT COMPLETED|TLC590 190mg and Naropin 150mg||1
3351521|NCT03591146|4081771|FG000|STARTED|TLC590 380mg and Naropin 150mg||0
3351522|NCT03591146|4081772|FG001|STARTED|TLC590 380mg and Naropin 150mg||12
3351523|NCT03591146|4081773|FG002|STARTED|TLC590 380mg and Naropin 150mg||0
3351524|NCT03591146|4081774|FG003|STARTED|TLC590 380mg and Naropin 150mg||0
3351525|NCT03591146|4081775|FG004|STARTED|TLC590 380mg and Naropin 150mg||5
3351526|NCT03591146|4081771|FG000|COMPLETED|TLC590 380mg and Naropin 150mg||0
3351527|NCT03591146|4081772|FG001|COMPLETED|TLC590 380mg and Naropin 150mg||11
3351528|NCT03591146|4081773|FG002|COMPLETED|TLC590 380mg and Naropin 150mg||0
3351529|NCT03591146|4081774|FG003|COMPLETED|TLC590 380mg and Naropin 150mg||0
3351530|NCT03591146|4081775|FG004|COMPLETED|TLC590 380mg and Naropin 150mg||4
3351531|NCT03591146|4081771|FG000|NOT COMPLETED|TLC590 380mg and Naropin 150mg||0
3351532|NCT03591146|4081772|FG001|NOT COMPLETED|TLC590 380mg and Naropin 150mg||1
3351533|NCT03591146|4081773|FG002|NOT COMPLETED|TLC590 380mg and Naropin 150mg||0
3351534|NCT03591146|4081774|FG003|NOT COMPLETED|TLC590 380mg and Naropin 150mg||0
3351535|NCT03591146|4081775|FG004|NOT COMPLETED|TLC590 380mg and Naropin 150mg||1
3351536|NCT03591146|4081771|FG000|STARTED|TLC590 570mg and Naropin 150mg||0
3351537|NCT03591146|4081772|FG001|STARTED|TLC590 570mg and Naropin 150mg||0
3351538|NCT03591146|4081773|FG002|STARTED|TLC590 570mg and Naropin 150mg||12
3351539|NCT03591146|4081774|FG003|STARTED|TLC590 570mg and Naropin 150mg||0
3351540|NCT03591146|4081775|FG004|STARTED|TLC590 570mg and Naropin 150mg||4
3351541|NCT03591146|4081771|FG000|COMPLETED|TLC590 570mg and Naropin 150mg||0
3351542|NCT03591146|4081772|FG001|COMPLETED|TLC590 570mg and Naropin 150mg||0
3351543|NCT03591146|4081773|FG002|COMPLETED|TLC590 570mg and Naropin 150mg||11
3351544|NCT03591146|4081774|FG003|COMPLETED|TLC590 570mg and Naropin 150mg||0
3351545|NCT03591146|4081775|FG004|COMPLETED|TLC590 570mg and Naropin 150mg||3
3351546|NCT03591146|4081771|FG000|NOT COMPLETED|TLC590 570mg and Naropin 150mg||0
3351547|NCT03591146|4081772|FG001|NOT COMPLETED|TLC590 570mg and Naropin 150mg||0
3351548|NCT03591146|4081773|FG002|NOT COMPLETED|TLC590 570mg and Naropin 150mg||1
3351549|NCT03591146|4081774|FG003|NOT COMPLETED|TLC590 570mg and Naropin 150mg||0
3351550|NCT03591146|4081775|FG004|NOT COMPLETED|TLC590 570mg and Naropin 150mg||1
3351551|NCT03591146|4081771|FG000|STARTED|TLC590 475mg and Naropin 150mg||0
3351552|NCT03591146|4081772|FG001|STARTED|TLC590 475mg and Naropin 150mg||0
3351553|NCT03591146|4081773|FG002|STARTED|TLC590 475mg and Naropin 150mg||0
3351554|NCT03591146|4081774|FG003|STARTED|TLC590 475mg and Naropin 150mg||12
3351555|NCT03591146|4081775|FG004|STARTED|TLC590 475mg and Naropin 150mg||4
3351556|NCT03591146|4081771|FG000|COMPLETED|TLC590 475mg and Naropin 150mg||0
3351557|NCT03591146|4081772|FG001|COMPLETED|TLC590 475mg and Naropin 150mg||0
3351558|NCT03591146|4081773|FG002|COMPLETED|TLC590 475mg and Naropin 150mg||0
3178137|NCT01975220|3906011|FG005|COMPLETED|Test Period 2||12
3178138|NCT01975220|3906006|FG000|NOT COMPLETED|Test Period 2||0
3178139|NCT01975220|3906007|FG001|NOT COMPLETED|Test Period 2||0
3351559|NCT03591146|4081774|FG003|COMPLETED|TLC590 475mg and Naropin 150mg||12
3351560|NCT03591146|4081775|FG004|COMPLETED|TLC590 475mg and Naropin 150mg||4
3351561|NCT03591146|4081771|FG000|NOT COMPLETED|TLC590 475mg and Naropin 150mg||0
3351562|NCT03591146|4081772|FG001|NOT COMPLETED|TLC590 475mg and Naropin 150mg||0
3351563|NCT03591146|4081773|FG002|NOT COMPLETED|TLC590 475mg and Naropin 150mg||0
3351564|NCT03591146|4081774|FG003|NOT COMPLETED|TLC590 475mg and Naropin 150mg||0
3351565|NCT03591146|4081775|FG004|NOT COMPLETED|TLC590 475mg and Naropin 150mg||0
3351566|NCT03591406|4081789|FG000|STARTED|Overall Study||188
3351567|NCT03591406|4081790|FG001|STARTED|Overall Study||183
3351568|NCT03591406|4081789|FG000|COMPLETED|Overall Study||181
3351569|NCT03591406|4081790|FG001|COMPLETED|Overall Study||174
3178140|NCT01975220|3906008|FG002|NOT COMPLETED|Test Period 2||0
3351570|NCT03591406|4081789|FG000|NOT COMPLETED|Overall Study||7
3351571|NCT03591406|4081790|FG001|NOT COMPLETED|Overall Study||9
3351572|NCT03592121|4081798|FG000|STARTED|Overall Study||3
3351573|NCT03592121|4081799|FG001|STARTED|Overall Study||0
3351574|NCT03592121|4081798|FG000|COMPLETED|Overall Study||3
3351575|NCT03592121|4081799|FG001|COMPLETED|Overall Study||0
3351576|NCT03592121|4081798|FG000|NOT COMPLETED|Overall Study||0
3351577|NCT03592121|4081799|FG001|NOT COMPLETED|Overall Study||0
3351578|NCT03592745|4081807|FG000|STARTED|Overall Study||18
3351579|NCT03592745|4081808|FG001|STARTED|Overall Study||18
3351580|NCT03592745|4081807|FG000|COMPLETED|Overall Study||15
3351581|NCT03592745|4081808|FG001|COMPLETED|Overall Study||15
3351582|NCT03592745|4081807|FG000|NOT COMPLETED|Overall Study||3
3351583|NCT03592745|4081808|FG001|NOT COMPLETED|Overall Study||3
3351584|NCT03593200|4081814|FG000|STARTED|Overall Study||4
3351585|NCT03593200|4081814|FG000|COMPLETED|Overall Study||4
3351586|NCT03593200|4081814|FG000|NOT COMPLETED|Overall Study||0
3351587|NCT03593538|4081821|FG000|STARTED|Overall Study||26
3351588|NCT03593538|4081822|FG001|STARTED|Overall Study||21
3351589|NCT03593538|4081823|FG002|STARTED|Overall Study||22
3351590|NCT03593538|4081821|FG000|COMPLETED|Overall Study||15
3351591|NCT03593538|4081822|FG001|COMPLETED|Overall Study||15
3351592|NCT03593538|4081823|FG002|COMPLETED|Overall Study||11
3351593|NCT03593538|4081821|FG000|NOT COMPLETED|Overall Study||11
3351594|NCT03593538|4081822|FG001|NOT COMPLETED|Overall Study||6
3178141|NCT01975220|3906009|FG003|NOT COMPLETED|Test Period 2||0
3178142|NCT01975220|3906010|FG004|NOT COMPLETED|Test Period 2||0
3178143|NCT01975220|3906011|FG005|NOT COMPLETED|Test Period 2||0
3178144|NCT01975246|3906028|FG000|STARTED|Overall Study||149
3178145|NCT01975246|3906029|FG001|STARTED|Overall Study||160
3178146|NCT01975246|3906028|FG000|COMPLETED|Overall Study||145
3178147|NCT01975246|3906029|FG001|COMPLETED|Overall Study||158
3178148|NCT01975246|3906028|FG000|NOT COMPLETED|Overall Study||4
3178149|NCT01975246|3906029|FG001|NOT COMPLETED|Overall Study||2
3178150|NCT01975285|3906037|FG000|STARTED|Overall Study||30
3178151|NCT01975285|3906038|FG001|STARTED|Overall Study||30
3178152|NCT01975285|3906037|FG000|COMPLETED|Overall Study||28
3178153|NCT01975285|3906038|FG001|COMPLETED|Overall Study||28
3178154|NCT01975285|3906037|FG000|NOT COMPLETED|Overall Study||2
3178155|NCT01975285|3906038|FG001|NOT COMPLETED|Overall Study||2
3178156|NCT01975376|3906046|FG000|STARTED|Overall Study||8390
3178157|NCT01975376|3906047|FG001|STARTED|Overall Study||8394
3178158|NCT01975376|3906046|FG000|Treated|Overall Study||8374
3178159|NCT01975376|3906047|FG001|Treated|Overall Study||8386
3178160|NCT01975376|3906046|FG000|COMPLETED|Overall Study||8164
3178161|NCT01975376|3906047|FG001|COMPLETED|Overall Study||8177
3178162|NCT01975376|3906046|FG000|NOT COMPLETED|Overall Study||226
3178163|NCT01975376|3906047|FG001|NOT COMPLETED|Overall Study||217
3178164|NCT01975389|3906055|FG000|STARTED|Overall Study||5283
3178165|NCT01975389|3906056|FG001|STARTED|Overall Study||5281
3178166|NCT01975389|3906055|FG000|Treated|Overall Study||5279
3178167|NCT01975389|3906056|FG001|Treated|Overall Study||5276
3178168|NCT01975389|3906055|FG000|COMPLETED|Overall Study||5031
3178169|NCT01975389|3906056|FG001|COMPLETED|Overall Study||5045
3178170|NCT01975389|3906055|FG000|NOT COMPLETED|Overall Study||252
3178171|NCT01975389|3906056|FG001|NOT COMPLETED|Overall Study||236
3178172|NCT01975428|3906064|FG000|STARTED|Overall Study||85
3178173|NCT01975428|3906065|FG001|STARTED|Overall Study||97
3178174|NCT01975428|3906064|FG000|COMPLETED|Overall Study||65
3178175|NCT01975428|3906065|FG001|COMPLETED|Overall Study||83
3178176|NCT01975428|3906064|FG000|NOT COMPLETED|Overall Study||20
3178177|NCT01975428|3906065|FG001|NOT COMPLETED|Overall Study||14
3178178|NCT01975519|3906073|FG000|STARTED|Overall Study||3
3178179|NCT01975519|3906074|FG001|STARTED|Overall Study||108
3178180|NCT01975519|3906073|FG000|Phase 1b|Overall Study||3
3178181|NCT01975519|3906074|FG001|Phase 1b|Overall Study||23
3178182|NCT01975519|3906073|FG000|Phase 2a Soft Tissue Sarcoma|Overall Study||0
3178183|NCT01975519|3906074|FG001|Phase 2a Soft Tissue Sarcoma|Overall Study||63
3178184|NCT01975519|3906073|FG000|Phase 2a Angiosarcoma Cohort|Overall Study||0
3178185|NCT01975519|3906074|FG001|Phase 2a Angiosarcoma Cohort|Overall Study||22
3178186|NCT01975519|3906073|FG000|COMPLETED|Overall Study||3
3178187|NCT01975519|3906074|FG001|COMPLETED|Overall Study||108
3178188|NCT01975519|3906073|FG000|NOT COMPLETED|Overall Study||0
3178189|NCT01975519|3906074|FG001|NOT COMPLETED|Overall Study||0
3178190|NCT01975675|3906092|FG000|STARTED|Overall Study||83
3178191|NCT01975675|3906093|FG001|STARTED|Overall Study||83
3178192|NCT01975675|3906094|FG002|STARTED|Overall Study||88
3178193|NCT01975675|3906095|FG003|STARTED|Overall Study||87
3178194|NCT01975675|3906092|FG000|COMPLETED|Overall Study||83
3178195|NCT01975675|3906093|FG001|COMPLETED|Overall Study||82
3178196|NCT01975675|3906094|FG002|COMPLETED|Overall Study||88
3178197|NCT01975675|3906095|FG003|COMPLETED|Overall Study||87
3178198|NCT01975675|3906092|FG000|NOT COMPLETED|Overall Study||0
3178199|NCT01975675|3906093|FG001|NOT COMPLETED|Overall Study||1
3178200|NCT01975675|3906094|FG002|NOT COMPLETED|Overall Study||0
3178201|NCT01975675|3906095|FG003|NOT COMPLETED|Overall Study||0
3351595|NCT03593538|4081823|FG002|NOT COMPLETED|Overall Study||11
3351596|NCT03593681|4081831|FG000|STARTED|Overall Study||150
3351597|NCT03593681|4081831|FG000|COMPLETED|Overall Study||115
3351598|NCT03593681|4081831|FG000|NOT COMPLETED|Overall Study||35
3351599|NCT03593876|4081852|FG000|STARTED|Overall Study||16
3351600|NCT03593876|4081852|FG000|COMPLETED|Overall Study||13
3178202|NCT01975701|3906105|FG000|STARTED|Overall Study||26
3178203|NCT01975701|3906105|FG000|COMPLETED|Overall Study||1
3178204|NCT01975701|3906105|FG000|NOT COMPLETED|Overall Study||25
3178205|NCT01975831|3906118|FG000|STARTED|Overall Study||3
3178206|NCT01975831|3906119|FG001|STARTED|Overall Study||11
3178207|NCT01975831|3906120|FG002|STARTED|Overall Study||4
3178208|NCT01975831|3906121|FG003|STARTED|Overall Study||4
3178209|NCT01975831|3906122|FG004|STARTED|Overall Study||19
3178210|NCT01975831|3906123|FG005|STARTED|Overall Study||16
3178211|NCT01975831|3906124|FG006|STARTED|Overall Study||16
3178212|NCT01975831|3906125|FG007|STARTED|Overall Study||16
3178213|NCT01975831|3906126|FG008|STARTED|Overall Study||15
3178214|NCT01975831|3906118|FG000|COMPLETED|Overall Study||0
3178215|NCT01975831|3906119|FG001|COMPLETED|Overall Study||2
3178216|NCT01975831|3906120|FG002|COMPLETED|Overall Study||0
3178217|NCT01975831|3906121|FG003|COMPLETED|Overall Study||0
3178218|NCT01975831|3906122|FG004|COMPLETED|Overall Study||1
3178219|NCT01975831|3906123|FG005|COMPLETED|Overall Study||2
3178220|NCT01975831|3906124|FG006|COMPLETED|Overall Study||0
3178221|NCT01975831|3906125|FG007|COMPLETED|Overall Study||1
3178222|NCT01975831|3906126|FG008|COMPLETED|Overall Study||3
3178223|NCT01975831|3906118|FG000|NOT COMPLETED|Overall Study||3
3178224|NCT01975831|3906119|FG001|NOT COMPLETED|Overall Study||9
3178225|NCT01975831|3906120|FG002|NOT COMPLETED|Overall Study||4
3178226|NCT01975831|3906121|FG003|NOT COMPLETED|Overall Study||4
3178227|NCT01975831|3906122|FG004|NOT COMPLETED|Overall Study||18
3178228|NCT01975831|3906123|FG005|NOT COMPLETED|Overall Study||14
3178229|NCT01975831|3906124|FG006|NOT COMPLETED|Overall Study||16
3178230|NCT01975831|3906125|FG007|NOT COMPLETED|Overall Study||15
3178231|NCT01975831|3906126|FG008|NOT COMPLETED|Overall Study||12
3178232|NCT01975909|3906148|FG000|STARTED|Overall Study||10
3178233|NCT01975909|3906149|FG001|STARTED|Overall Study||10
3178234|NCT01975909|3906148|FG000|COMPLETED|Overall Study||10
3178235|NCT01975909|3906149|FG001|COMPLETED|Overall Study||10
3178236|NCT01975909|3906148|FG000|NOT COMPLETED|Overall Study||0
3178237|NCT01975909|3906149|FG001|NOT COMPLETED|Overall Study||0
3178238|NCT01975922|3906157|FG000|STARTED|Overall Study||45
3178239|NCT01975922|3906158|FG001|STARTED|Overall Study||52
3178240|NCT01975922|3906157|FG000|COMPLETED|Overall Study||45
3178241|NCT01975922|3906158|FG001|COMPLETED|Overall Study||43
3178242|NCT01975922|3906157|FG000|NOT COMPLETED|Overall Study||0
3178243|NCT01975922|3906158|FG001|NOT COMPLETED|Overall Study||9
3178244|NCT01975935|3906166|FG000|STARTED|Overall Study||21
3178245|NCT01975935|3906167|FG001|STARTED|Overall Study||21
3178246|NCT01975935|3906166|FG000|COMPLETED|Overall Study||18
3178247|NCT01975935|3906167|FG001|COMPLETED|Overall Study||20
3178248|NCT01975935|3906166|FG000|NOT COMPLETED|Overall Study||3
3178249|NCT01975935|3906167|FG001|NOT COMPLETED|Overall Study||1
3178250|NCT01975948|3906177|FG000|STARTED|Overall Study||56
3178251|NCT01975948|3906178|FG001|STARTED|Overall Study||55
3178252|NCT01975948|3906179|FG002|STARTED|Overall Study||72
3178253|NCT01975948|3906180|FG003|STARTED|Overall Study||57
3178254|NCT01975948|3906177|FG000|COMPLETED|Overall Study||39
3178255|NCT01975948|3906178|FG001|COMPLETED|Overall Study||34
3178256|NCT01975948|3906179|FG002|COMPLETED|Overall Study||65
3178257|NCT01975948|3906180|FG003|COMPLETED|Overall Study||51
3178258|NCT01975948|3906177|FG000|NOT COMPLETED|Overall Study||17
3178259|NCT01975948|3906178|FG001|NOT COMPLETED|Overall Study||21
3178260|NCT01975948|3906179|FG002|NOT COMPLETED|Overall Study||7
3178261|NCT01975948|3906180|FG003|NOT COMPLETED|Overall Study||6
3178262|NCT01975974|3906190|FG000|STARTED|Overall Study||100
3178263|NCT01975974|3906190|FG000|COMPLETED|Overall Study||100
3178264|NCT01975974|3906190|FG000|NOT COMPLETED|Overall Study||0
3178265|NCT01976104|3906198|FG000|STARTED|Overall Study||43
3178266|NCT01976104|3906199|FG001|STARTED|Overall Study||70
3178267|NCT01976104|3906200|FG002|STARTED|Overall Study||33
3178268|NCT01976104|3906201|FG003|STARTED|Overall Study||58
3178269|NCT01976104|3906198|FG000|COMPLETED|Overall Study||37
3178270|NCT01976104|3906199|FG001|COMPLETED|Overall Study||68
3178271|NCT01976104|3906200|FG002|COMPLETED|Overall Study||31
3178272|NCT01976104|3906201|FG003|COMPLETED|Overall Study||55
3178273|NCT01976104|3906198|FG000|NOT COMPLETED|Overall Study||6
3178274|NCT01976104|3906199|FG001|NOT COMPLETED|Overall Study||2
3178275|NCT01976104|3906200|FG002|NOT COMPLETED|Overall Study||2
3178276|NCT01976104|3906201|FG003|NOT COMPLETED|Overall Study||3
3178277|NCT01976299|3906214|FG000|STARTED|Overall Study||292
3178278|NCT01976299|3906215|FG001|STARTED|Overall Study||286
3178279|NCT01976299|3906214|FG000|Completed Procedure|Overall Study||283
3178280|NCT01976299|3906215|FG001|Completed Procedure|Overall Study||284
3178281|NCT01976299|3906214|FG000|COMPLETED|Overall Study|9 subjects did not proceed onto procedure in this arm.|269
3178282|NCT01976299|3906215|FG001|COMPLETED|Overall Study|2 subjects did not proceed onto procedure in this arm.|280
3178283|NCT01976299|3906214|FG000|NOT COMPLETED|Overall Study||23
3178284|NCT01976299|3906215|FG001|NOT COMPLETED|Overall Study||6
3178285|NCT01976312|3906223|FG000|STARTED|Overall Study||190
3178286|NCT01976312|3906224|FG001|STARTED|Overall Study||62
3178287|NCT01976312|3906223|FG000|Completed 3 Months|Overall Study||186
3178288|NCT01976312|3906224|FG001|Completed 3 Months|Overall Study||60
3178289|NCT01976312|3906223|FG000|Discontinued Study Prior to 3 Months|Overall Study||4
3178290|NCT01976312|3906224|FG001|Discontinued Study Prior to 3 Months|Overall Study||2
3178291|NCT01976312|3906223|FG000|COMPLETED|Overall Study|Completed study at 12 months|173
3178292|NCT01976312|3906224|FG001|COMPLETED|Overall Study|Completed study at 12 months|53
3178293|NCT01976312|3906223|FG000|NOT COMPLETED|Overall Study||17
3178294|NCT01976312|3906224|FG001|NOT COMPLETED|Overall Study||9
3178295|NCT01976338|3906233|FG000|STARTED|Overall Study||190
3178296|NCT01976338|3906234|FG001|STARTED|Overall Study||93
3178297|NCT01976338|3906233|FG000|Completed 6 Months|Overall Study||185
3178298|NCT01976338|3906234|FG001|Completed 6 Months|Overall Study||91
3178299|NCT01976338|3906233|FG000|Discontinued Study Prior to 6 Months|Overall Study||5
3178300|NCT01976338|3906234|FG001|Discontinued Study Prior to 6 Months|Overall Study||2
3178301|NCT01976338|3906233|FG000|COMPLETED|Overall Study|12 months|177
3178302|NCT01976338|3906234|FG001|COMPLETED|Overall Study|12 months|89
3178303|NCT01976338|3906233|FG000|NOT COMPLETED|Overall Study||13
3178304|NCT01976338|3906234|FG001|NOT COMPLETED|Overall Study||4
3178305|NCT01976364|3906241|FG000|STARTED|Main Study (36 Months)||686
3178306|NCT01976364|3906242|FG001|STARTED|Main Study (36 Months)||0
3178307|NCT01976364|3906243|FG002|STARTED|Main Study (36 Months)||0
3178308|NCT01976364|3906241|FG000|COMPLETED|Main Study (36 Months)||465
3178309|NCT01976364|3906242|FG001|COMPLETED|Main Study (36 Months)||0
3178310|NCT01976364|3906243|FG002|COMPLETED|Main Study (36 Months)||0
3178311|NCT01976364|3906241|FG000|NOT COMPLETED|Main Study (36 Months)||221
3178312|NCT01976364|3906242|FG001|NOT COMPLETED|Main Study (36 Months)||0
3178313|NCT01976364|3906243|FG002|NOT COMPLETED|Main Study (36 Months)||0
3178314|NCT01976364|3906241|FG000|STARTED|Sub-study (12 Months)||0
3178315|NCT01976364|3906242|FG001|STARTED|Sub-study (12 Months)|Participants from main study who consented to take part in sub-study, continued into sub-study.|89
3178316|NCT01976364|3906243|FG002|STARTED|Sub-study (12 Months)|Participants from main study who consented to take part in sub-study, continued into sub-study.|90
3178317|NCT01976364|3906241|FG000|COMPLETED|Sub-study (12 Months)||0
3178318|NCT01976364|3906242|FG001|COMPLETED|Sub-study (12 Months)||83
3178319|NCT01976364|3906243|FG002|COMPLETED|Sub-study (12 Months)||85
3178320|NCT01976364|3906241|FG000|NOT COMPLETED|Sub-study (12 Months)||0
3178321|NCT01976364|3906242|FG001|NOT COMPLETED|Sub-study (12 Months)||6
3178322|NCT01976364|3906243|FG002|NOT COMPLETED|Sub-study (12 Months)||5
3178323|NCT01976390|3906254|FG000|STARTED|Overall Study||41
3178324|NCT01976390|3906255|FG001|STARTED|Overall Study||19
3178325|NCT01976390|3906254|FG000|COMPLETED|Overall Study||41
3178326|NCT01976390|3906255|FG001|COMPLETED|Overall Study||19
3178327|NCT01976390|3906254|FG000|NOT COMPLETED|Overall Study||0
3178328|NCT01976390|3906255|FG001|NOT COMPLETED|Overall Study||0
3178329|NCT01976416|3906263|FG000|STARTED|Overall Study||104
3178330|NCT01976416|3906264|FG001|STARTED|Overall Study||104
3178331|NCT01976416|3906263|FG000|COMPLETED|Overall Study||102
3178332|NCT01976416|3906264|FG001|COMPLETED|Overall Study||102
3178333|NCT01976416|3906263|FG000|NOT COMPLETED|Overall Study||2
3178334|NCT01976416|3906264|FG001|NOT COMPLETED|Overall Study||2
3178335|NCT01976442|3906272|FG000|STARTED|Overall Study||69
3178336|NCT01976442|3906273|FG001|STARTED|Overall Study||31
3178337|NCT01976442|3906272|FG000|COMPLETED|Overall Study||69
3178338|NCT01976442|3906273|FG001|COMPLETED|Overall Study||31
3178339|NCT01976442|3906272|FG000|NOT COMPLETED|Overall Study||0
3178340|NCT01976442|3906273|FG001|NOT COMPLETED|Overall Study||0
3178341|NCT01976507|3906279|FG000|STARTED|Overall Study||101
3178342|NCT01976507|3906279|FG000|Received Initial Dose of Dabigatran|Overall Study||100
3178343|NCT01976507|3906279|FG000|COMPLETED|Overall Study||94
3178344|NCT01976507|3906279|FG000|NOT COMPLETED|Overall Study||7
3178345|NCT01976572|3906283|FG000|STARTED|Overall Study||6
3178346|NCT01976572|3906284|FG001|STARTED|Overall Study||6
3178347|NCT01976572|3906285|FG002|STARTED|Overall Study||6
3178348|NCT01976572|3906283|FG000|COMPLETED|Overall Study||6
3178349|NCT01976572|3906284|FG001|COMPLETED|Overall Study||6
3178350|NCT01976572|3906285|FG002|COMPLETED|Overall Study||6
3178351|NCT01976572|3906283|FG000|NOT COMPLETED|Overall Study||0
3178352|NCT01976572|3906284|FG001|NOT COMPLETED|Overall Study||0
3178353|NCT01976572|3906285|FG002|NOT COMPLETED|Overall Study||0
3178354|NCT01976624|3906294|FG000|STARTED|Overall Study||756
3178355|NCT01976624|3906294|FG000|COMPLETED|Overall Study||742
3178356|NCT01976624|3906294|FG000|NOT COMPLETED|Overall Study||14
3178357|NCT01976650|3906298|FG000|STARTED|Overall Study||724
3178358|NCT01976650|3906298|FG000|COMPLETED|Overall Study||718
3178359|NCT01976650|3906298|FG000|NOT COMPLETED|Overall Study||6
3178360|NCT01976663|3906302|FG000|STARTED|Overall Study||126
3178361|NCT01976663|3906302|FG000|Received Touch-up Treatment|Overall Study||63
3178362|NCT01976663|3906302|FG000|Received Asymmetry Correction|Overall Study||45
3178363|NCT01976663|3906302|FG000|Received Repeat Treatment|Overall Study||85
3178364|NCT01976663|3906302|FG000|COMPLETED|Overall Study||84
3178365|NCT01976663|3906302|FG000|NOT COMPLETED|Overall Study||42
3178366|NCT01976728|3906314|FG000|STARTED|Overall Study||10
3178367|NCT01976728|3906315|FG001|STARTED|Overall Study||9
3178368|NCT01976728|3906316|FG002|STARTED|Overall Study||10
3178369|NCT01976728|3906317|FG003|STARTED|Overall Study||10
3178370|NCT01976728|3906314|FG000|Dosed|Overall Study||10
3178371|NCT01976728|3906315|FG001|Dosed|Overall Study||9
3178372|NCT01976728|3906316|FG002|Dosed|Overall Study||10
3178373|NCT01976728|3906317|FG003|Dosed|Overall Study||10
3178374|NCT01976728|3906314|FG000|COMPLETED|Overall Study||9
3178375|NCT01976728|3906315|FG001|COMPLETED|Overall Study||9
3178376|NCT01976728|3906316|FG002|COMPLETED|Overall Study||10
3178377|NCT01976728|3906317|FG003|COMPLETED|Overall Study||10
3178378|NCT01976728|3906314|FG000|NOT COMPLETED|Overall Study||1
3178379|NCT01976728|3906315|FG001|NOT COMPLETED|Overall Study||0
3178380|NCT01976728|3906316|FG002|NOT COMPLETED|Overall Study||0
3178381|NCT01976728|3906317|FG003|NOT COMPLETED|Overall Study||0
3178382|NCT01976741|3906353|FG000|STARTED|Overall Study||4
3178383|NCT01976741|3906354|FG001|STARTED|Overall Study||4
3178384|NCT01976741|3906355|FG002|STARTED|Overall Study||4
3178385|NCT01976741|3906356|FG003|STARTED|Overall Study||3
3178386|NCT01976741|3906357|FG004|STARTED|Overall Study||4
3178387|NCT01976741|3906358|FG005|STARTED|Overall Study||4
3178388|NCT01976741|3906359|FG006|STARTED|Overall Study||23
3178389|NCT01976741|3906360|FG007|STARTED|Overall Study||74
3178390|NCT01976741|3906361|FG008|STARTED|Overall Study||8
3178391|NCT01976741|3906362|FG009|STARTED|Overall Study||40
3178392|NCT01976741|3906353|FG000|COMPLETED|Overall Study||3
3178393|NCT01976741|3906354|FG001|COMPLETED|Overall Study||4
3178394|NCT01976741|3906355|FG002|COMPLETED|Overall Study||1
3178395|NCT01976741|3906356|FG003|COMPLETED|Overall Study||2
3178396|NCT01976741|3906357|FG004|COMPLETED|Overall Study||4
3178397|NCT01976741|3906358|FG005|COMPLETED|Overall Study||4
3178398|NCT01976741|3906359|FG006|COMPLETED|Overall Study||19
3178399|NCT01976741|3906360|FG007|COMPLETED|Overall Study||62
3178400|NCT01976741|3906361|FG008|COMPLETED|Overall Study||7
3178401|NCT01976741|3906362|FG009|COMPLETED|Overall Study||36
3178402|NCT01976741|3906353|FG000|NOT COMPLETED|Overall Study||1
3178403|NCT01976741|3906354|FG001|NOT COMPLETED|Overall Study||0
3178404|NCT01976741|3906355|FG002|NOT COMPLETED|Overall Study||3
3178405|NCT01976741|3906356|FG003|NOT COMPLETED|Overall Study||1
3178406|NCT01976741|3906357|FG004|NOT COMPLETED|Overall Study||0
3178407|NCT01976741|3906358|FG005|NOT COMPLETED|Overall Study||0
3178408|NCT01976741|3906359|FG006|NOT COMPLETED|Overall Study||4
3178409|NCT01976741|3906360|FG007|NOT COMPLETED|Overall Study||12
3178410|NCT01976741|3906361|FG008|NOT COMPLETED|Overall Study||1
3178411|NCT01976741|3906362|FG009|NOT COMPLETED|Overall Study||4
3178412|NCT01976806|3906398|FG000|STARTED|Overall Study||27
3178413|NCT01976806|3906399|FG001|STARTED|Overall Study||28
3178414|NCT01976806|3906398|FG000|COMPLETED|Overall Study||24
3178415|NCT01976806|3906399|FG001|COMPLETED|Overall Study||22
3178416|NCT01976806|3906398|FG000|NOT COMPLETED|Overall Study||3
3178417|NCT01976806|3906399|FG001|NOT COMPLETED|Overall Study||6
3178418|NCT01976819|3906405|FG000|STARTED|Overall Study||16
3178419|NCT01976819|3906405|FG000|COMPLETED|Overall Study||11
3178420|NCT01976819|3906405|FG000|NOT COMPLETED|Overall Study||5
3178421|NCT01976845|3906417|FG000|STARTED|Overall Study||48
3178422|NCT01976845|3906418|FG001|STARTED|Overall Study||48
3178423|NCT01976845|3906419|FG002|STARTED|Overall Study||43
3178424|NCT01976845|3906417|FG000|COMPLETED|Overall Study||40
3178425|NCT01976845|3906418|FG001|COMPLETED|Overall Study||40
3178426|NCT01976845|3906419|FG002|COMPLETED|Overall Study||40
3178427|NCT01976845|3906417|FG000|NOT COMPLETED|Overall Study||8
3178428|NCT01976845|3906418|FG001|NOT COMPLETED|Overall Study||8
3178429|NCT01976845|3906419|FG002|NOT COMPLETED|Overall Study||3
3178430|NCT01976871|3906427|FG000|STARTED|Overall Study||21
3178431|NCT01976871|3906427|FG000|COMPLETED|Overall Study||20
3178432|NCT01976871|3906427|FG000|NOT COMPLETED|Overall Study||1
3178433|NCT01976975|3906433|FG000|STARTED|Overall Study||226
3178434|NCT01976975|3906434|FG001|STARTED|Overall Study||44
3178435|NCT01976975|3906433|FG000|COMPLETED|Overall Study||79
3178436|NCT01976975|3906434|FG001|COMPLETED|Overall Study||32
3178437|NCT01976975|3906433|FG000|NOT COMPLETED|Overall Study||147
3178438|NCT01976975|3906434|FG001|NOT COMPLETED|Overall Study||12
3178439|NCT01976988|3906442|FG000|STARTED|Overall Study||208
3178440|NCT01976988|3906443|FG001|STARTED|Overall Study||202
3178441|NCT01976988|3906442|FG000|COMPLETED|Overall Study||192
3178442|NCT01976988|3906443|FG001|COMPLETED|Overall Study||184
3178443|NCT01976988|3906442|FG000|NOT COMPLETED|Overall Study||16
3178444|NCT01976988|3906443|FG001|NOT COMPLETED|Overall Study||18
3178445|NCT01977040|3906451|FG000|STARTED|Overall Study||68
3178446|NCT01977040|3906451|FG000|COMPLETED|Overall Study||66
3178447|NCT01977040|3906451|FG000|NOT COMPLETED|Overall Study||2
3178448|NCT01977092|3906461|FG000|STARTED|Overall Study||149
3178449|NCT01977092|3906462|FG001|STARTED|Overall Study||181
3178450|NCT01977092|3906461|FG000|COMPLETED|Overall Study||118
3178451|NCT01977092|3906462|FG001|COMPLETED|Overall Study||151
3178452|NCT01977092|3906461|FG000|NOT COMPLETED|Overall Study||31
3178453|NCT01977092|3906462|FG001|NOT COMPLETED|Overall Study||30
3178454|NCT01977222|3906468|FG000|STARTED|Overall Study||12
3178455|NCT01977222|3906468|FG000|COMPLETED|Overall Study||11
3178456|NCT01977222|3906468|FG000|NOT COMPLETED|Overall Study||1
3178457|NCT01977352|3906474|FG000|STARTED|Overall Study||21
3178458|NCT01977352|3906475|FG001|STARTED|Overall Study||21
3178459|NCT01977352|3906474|FG000|COMPLETED|Overall Study||20
3178460|NCT01977352|3906475|FG001|COMPLETED|Overall Study||19
3178461|NCT01977352|3906474|FG000|NOT COMPLETED|Overall Study||1
3178462|NCT01977352|3906475|FG001|NOT COMPLETED|Overall Study||2
3178463|NCT01977456|3906481|FG000|STARTED|Overall Study||27
3178464|NCT01977456|3906481|FG000|COMPLETED|Overall Study||22
3178465|NCT01977456|3906481|FG000|NOT COMPLETED|Overall Study||5
3178466|NCT01977482|3906491|FG000|STARTED|Overall Study||39
3178467|NCT01977482|3906492|FG001|STARTED|Overall Study||39
3178468|NCT01977482|3906493|FG002|STARTED|Overall Study||40
3178469|NCT01977482|3906494|FG003|STARTED|Overall Study||39
3178470|NCT01977482|3906495|FG004|STARTED|Overall Study||40
3178471|NCT01977482|3906496|FG005|STARTED|Overall Study||19
3178472|NCT01977482|3906491|FG000|COMPLETED|Overall Study||36
3178473|NCT01977482|3906492|FG001|COMPLETED|Overall Study||30
3178474|NCT01977482|3906493|FG002|COMPLETED|Overall Study||35
3178475|NCT01977482|3906494|FG003|COMPLETED|Overall Study||35
3178476|NCT01977482|3906495|FG004|COMPLETED|Overall Study||37
3178477|NCT01977482|3906496|FG005|COMPLETED|Overall Study||14
3178478|NCT01977482|3906491|FG000|NOT COMPLETED|Overall Study||3
3178479|NCT01977482|3906492|FG001|NOT COMPLETED|Overall Study||9
3178480|NCT01977482|3906493|FG002|NOT COMPLETED|Overall Study||5
3178481|NCT01977482|3906494|FG003|NOT COMPLETED|Overall Study||4
3178482|NCT01977482|3906495|FG004|NOT COMPLETED|Overall Study||3
3178483|NCT01977482|3906496|FG005|NOT COMPLETED|Overall Study||5
3178484|NCT01977547|3906517|FG000|STARTED|Overall Study||768
3178485|NCT01977547|3906518|FG001|STARTED|Overall Study||770
3178486|NCT01977547|3906517|FG000|COMPLETED|Overall Study||728
3178487|NCT01977547|3906518|FG001|COMPLETED|Overall Study||733
3178488|NCT01977547|3906517|FG000|NOT COMPLETED|Overall Study||40
3178489|NCT01977547|3906518|FG001|NOT COMPLETED|Overall Study||37
3178490|NCT01977573|3906528|FG000|STARTED|Overall Study||136
3178491|NCT01977573|3906529|FG001|STARTED|Overall Study||44
3178492|NCT01977573|3906530|FG002|STARTED|Overall Study||36
3178493|NCT01977573|3906531|FG003|STARTED|Overall Study||36
3178494|NCT01977573|3906528|FG000|COMPLETED|Overall Study||116
3178495|NCT01977573|3906529|FG001|COMPLETED|Overall Study||41
3178496|NCT01977573|3906530|FG002|COMPLETED|Overall Study||32
3178497|NCT01977573|3906531|FG003|COMPLETED|Overall Study||33
3178498|NCT01977573|3906528|FG000|NOT COMPLETED|Overall Study||20
3178499|NCT01977573|3906529|FG001|NOT COMPLETED|Overall Study||3
3178500|NCT01977573|3906530|FG002|NOT COMPLETED|Overall Study||4
3178501|NCT01977573|3906531|FG003|NOT COMPLETED|Overall Study||3
3178502|NCT01977599|3906544|FG000|STARTED|Overall Study||1118
3178503|NCT01977599|3906545|FG001|STARTED|Overall Study||1122
3178504|NCT01977599|3906544|FG000|COMPLETED|Overall Study||1118
3178505|NCT01977599|3906545|FG001|COMPLETED|Overall Study||1122
3178506|NCT01977599|3906544|FG000|NOT COMPLETED|Overall Study||0
3178507|NCT01977599|3906545|FG001|NOT COMPLETED|Overall Study||0
3178508|NCT01977612|3906553|FG000|STARTED|Overall Study||85
3178509|NCT01977612|3906554|FG001|STARTED|Overall Study||80
3178510|NCT01977612|3906553|FG000|COMPLETED|Overall Study||84
3178511|NCT01977612|3906554|FG001|COMPLETED|Overall Study||79
3178512|NCT01977612|3906553|FG000|NOT COMPLETED|Overall Study||1
3178513|NCT01977612|3906554|FG001|NOT COMPLETED|Overall Study||1
3178514|NCT01977625|3906560|FG000|STARTED|First Intervention (4 Weeks)||11
3178515|NCT01977625|3906561|FG001|STARTED|First Intervention (4 Weeks)||7
3178516|NCT01977625|3906560|FG000|COMPLETED|First Intervention (4 Weeks)||8
3178517|NCT01977625|3906561|FG001|COMPLETED|First Intervention (4 Weeks)||7
3178518|NCT01977625|3906560|FG000|NOT COMPLETED|First Intervention (4 Weeks)||3
3178519|NCT01977625|3906561|FG001|NOT COMPLETED|First Intervention (4 Weeks)||0
3178520|NCT01977625|3906560|FG000|STARTED|Washout (2 Weeks)||8
3178521|NCT01977625|3906561|FG001|STARTED|Washout (2 Weeks)||7
3178522|NCT01977625|3906560|FG000|COMPLETED|Washout (2 Weeks)||8
3178523|NCT01977625|3906561|FG001|COMPLETED|Washout (2 Weeks)||7
3178524|NCT01977625|3906560|FG000|NOT COMPLETED|Washout (2 Weeks)||0
3178525|NCT01977625|3906561|FG001|NOT COMPLETED|Washout (2 Weeks)||0
3178526|NCT01977625|3906560|FG000|STARTED|Second Intervention (4 Weeks)||8
3178527|NCT01977625|3906561|FG001|STARTED|Second Intervention (4 Weeks)||7
3178528|NCT01977625|3906560|FG000|COMPLETED|Second Intervention (4 Weeks)||7
3178529|NCT01977625|3906561|FG001|COMPLETED|Second Intervention (4 Weeks)||7
3178530|NCT01977625|3906560|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||1
3178531|NCT01977625|3906561|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||0
3178532|NCT01977651|3906569|FG000|STARTED|4 Month Treatment Period||423
3178533|NCT01977651|3906569|FG000|COMPLETED|4 Month Treatment Period||322
3178534|NCT01977651|3906569|FG000|NOT COMPLETED|4 Month Treatment Period||101
3178535|NCT01977651|3906569|FG000|STARTED|1 Year Extension Period|Participants who benefited from enzalutamide treatment continued in the 1 year extension period|287
3178536|NCT01977651|3906569|FG000|COMPLETED|1 Year Extension Period||157
3351601|NCT03593876|4081852|FG000|NOT COMPLETED|Overall Study||3
3351602|NCT03593902|4081856|FG000|STARTED|Overall Study||9
3351603|NCT03593902|4081856|FG000|COMPLETED|Overall Study||9
3351604|NCT03593902|4081856|FG000|NOT COMPLETED|Overall Study||0
3351605|NCT03594045|4081862|FG000|STARTED|Overall Study||0
3351606|NCT03594045|4081863|FG001|STARTED|Overall Study||5
3351607|NCT03594045|4081862|FG000|COMPLETED|Overall Study||0
3351608|NCT03594045|4081863|FG001|COMPLETED|Overall Study||5
3351609|NCT03594045|4081862|FG000|NOT COMPLETED|Overall Study||0
3351610|NCT03594045|4081863|FG001|NOT COMPLETED|Overall Study||0
3351611|NCT03594071|4081869|FG000|STARTED|Overall Study||294
3351612|NCT03594071|4081869|FG000|COMPLETED|Overall Study||289
3351613|NCT03594071|4081869|FG000|NOT COMPLETED|Overall Study||5
3351614|NCT03594227|4081877|FG000|STARTED|Overall Study||23
3351615|NCT03594227|4081878|FG001|STARTED|Overall Study||23
3351616|NCT03594227|4081879|FG002|STARTED|Overall Study||22
3351617|NCT03594227|4081880|FG003|STARTED|Overall Study||19
3351618|NCT03594227|4081877|FG000|COMPLETED|Overall Study||18
3351619|NCT03594227|4081878|FG001|COMPLETED|Overall Study||19
3351620|NCT03594227|4081879|FG002|COMPLETED|Overall Study||19
3351621|NCT03594227|4081880|FG003|COMPLETED|Overall Study||14
3351622|NCT03594227|4081877|FG000|NOT COMPLETED|Overall Study||5
3351623|NCT03594227|4081878|FG001|NOT COMPLETED|Overall Study||4
3351624|NCT03594227|4081879|FG002|NOT COMPLETED|Overall Study||3
3351625|NCT03594227|4081880|FG003|NOT COMPLETED|Overall Study||5
3351626|NCT03594500|4081903|FG000|STARTED|Overall Study||66
3351627|NCT03594500|4081904|FG001|STARTED|Overall Study||67
3178537|NCT01977651|3906569|FG000|NOT COMPLETED|1 Year Extension Period||130
3178538|NCT01977651|3906569|FG000|STARTED|Post 1 Year Extension Period|Participants who benefited from enzalutamide treatment continued in the post 1 year extension period|145
3178539|NCT01977651|3906569|FG000|COMPLETED|Post 1 Year Extension Period||1
3178540|NCT01977651|3906569|FG000|NOT COMPLETED|Post 1 Year Extension Period||144
3178541|NCT01977677|3906576|FG000|STARTED|Overall Study||3
3178542|NCT01977677|3906577|FG001|STARTED|Overall Study||6
3178543|NCT01977677|3906578|FG002|STARTED|Overall Study||21
3178544|NCT01977677|3906576|FG000|COMPLETED|Overall Study||3
3178545|NCT01977677|3906577|FG001|COMPLETED|Overall Study||6
3178546|NCT01977677|3906578|FG002|COMPLETED|Overall Study||20
3178547|NCT01977677|3906576|FG000|NOT COMPLETED|Overall Study||0
3178548|NCT01977677|3906577|FG001|NOT COMPLETED|Overall Study||0
3178549|NCT01977677|3906578|FG002|NOT COMPLETED|Overall Study||1
3178550|NCT01977690|3906588|FG000|STARTED|Overall Study||15
3178551|NCT01977690|3906589|FG001|STARTED|Overall Study||15
3178552|NCT01977690|3906588|FG000|COMPLETED|Overall Study||15
3178553|NCT01977690|3906589|FG001|COMPLETED|Overall Study||11
3178554|NCT01977690|3906588|FG000|NOT COMPLETED|Overall Study||0
3178555|NCT01977690|3906589|FG001|NOT COMPLETED|Overall Study||4
3178556|NCT01977781|3906597|FG000|STARTED|Overall Study||24
3178557|NCT01977781|3906598|FG001|STARTED|Overall Study||16
3178558|NCT01977781|3906597|FG000|COMPLETED|Overall Study||18
3178559|NCT01977781|3906598|FG001|COMPLETED|Overall Study||15
3178560|NCT01977781|3906597|FG000|NOT COMPLETED|Overall Study||6
3178561|NCT01977781|3906598|FG001|NOT COMPLETED|Overall Study||1
3178562|NCT01977794|3906606|FG000|STARTED|Overall Study||100
3178563|NCT01977794|3906607|FG001|STARTED|Overall Study||100
3178564|NCT01977794|3906606|FG000|COMPLETED|Overall Study||92
3178565|NCT01977794|3906607|FG001|COMPLETED|Overall Study||94
3178566|NCT01977794|3906606|FG000|NOT COMPLETED|Overall Study||8
3178567|NCT01977794|3906607|FG001|NOT COMPLETED|Overall Study||6
3178568|NCT01977820|3906615|FG000|STARTED|Overall Study||1
3178569|NCT01977820|3906616|FG001|STARTED|Overall Study||1
3178570|NCT01977820|3906615|FG000|COMPLETED|Overall Study||0
3178571|NCT01977820|3906616|FG001|COMPLETED|Overall Study||0
3178572|NCT01977820|3906615|FG000|NOT COMPLETED|Overall Study||1
3178573|NCT01977820|3906616|FG001|NOT COMPLETED|Overall Study||1
3178574|NCT01977846|3906624|FG000|STARTED|Total Study - Retrospective||251
3178575|NCT01977846|3906625|FG001|STARTED|Total Study - Retrospective||0
3178576|NCT01977846|3906624|FG000|COMPLETED|Total Study - Retrospective||251
3178577|NCT01977846|3906625|FG001|COMPLETED|Total Study - Retrospective||0
3178578|NCT01977846|3906624|FG000|NOT COMPLETED|Total Study - Retrospective||0
3178579|NCT01977846|3906625|FG001|NOT COMPLETED|Total Study - Retrospective||0
3178580|NCT01977846|3906624|FG000|STARTED|Total Study - Prospective||0
3178581|NCT01977846|3906625|FG001|STARTED|Total Study - Prospective||259
3178582|NCT01977846|3906624|FG000|COMPLETED|Total Study - Prospective||0
3178583|NCT01977846|3906625|FG001|COMPLETED|Total Study - Prospective||230
3178584|NCT01977846|3906624|FG000|NOT COMPLETED|Total Study - Prospective||0
3178585|NCT01977846|3906625|FG001|NOT COMPLETED|Total Study - Prospective||29
3178586|NCT01977898|3906634|FG000|STARTED|Overall Study||28
3178587|NCT01977898|3906635|FG001|STARTED|Overall Study||35
3178588|NCT01977898|3906634|FG000|COMPLETED|Overall Study||27
3178589|NCT01977898|3906635|FG001|COMPLETED|Overall Study||34
3178590|NCT01977898|3906634|FG000|NOT COMPLETED|Overall Study||1
3178591|NCT01977898|3906635|FG001|NOT COMPLETED|Overall Study||1
3178592|NCT01977937|3906643|FG000|STARTED|Overall Study||27
3178593|NCT01977937|3906644|FG001|STARTED|Overall Study||28
3178594|NCT01977937|3906643|FG000|COMPLETED|Overall Study||24
3178595|NCT01977937|3906644|FG001|COMPLETED|Overall Study||26
3178596|NCT01977937|3906643|FG000|NOT COMPLETED|Overall Study||3
3178597|NCT01977937|3906644|FG001|NOT COMPLETED|Overall Study||2
3178598|NCT01978093|3906652|FG000|STARTED|Overall Study||297
3178599|NCT01978093|3906653|FG001|STARTED|Overall Study||303
3178600|NCT01978093|3906652|FG000|COMPLETED|Overall Study||232
3178601|NCT01978093|3906653|FG001|COMPLETED|Overall Study||230
3178602|NCT01978093|3906652|FG000|NOT COMPLETED|Overall Study||65
3178603|NCT01978093|3906653|FG001|NOT COMPLETED|Overall Study||73
3178604|NCT01978119|3906662|FG000|STARTED|Treatment Period 1 (12 Weeks)||40
3178605|NCT01978119|3906663|FG001|STARTED|Treatment Period 1 (12 Weeks)||42
3178606|NCT01978119|3906662|FG000|COMPLETED|Treatment Period 1 (12 Weeks)||38
3178607|NCT01978119|3906663|FG001|COMPLETED|Treatment Period 1 (12 Weeks)||42
3178608|NCT01978119|3906662|FG000|NOT COMPLETED|Treatment Period 1 (12 Weeks)||2
3178609|NCT01978119|3906663|FG001|NOT COMPLETED|Treatment Period 1 (12 Weeks)||0
3178610|NCT01978119|3906662|FG000|STARTED|Washout Period 1 (3 Weeks)||38
3178611|NCT01978119|3906663|FG001|STARTED|Washout Period 1 (3 Weeks)||42
3178612|NCT01978119|3906662|FG000|COMPLETED|Washout Period 1 (3 Weeks)||38
3178613|NCT01978119|3906663|FG001|COMPLETED|Washout Period 1 (3 Weeks)||42
3178614|NCT01978119|3906662|FG000|NOT COMPLETED|Washout Period 1 (3 Weeks)||0
3178615|NCT01978119|3906663|FG001|NOT COMPLETED|Washout Period 1 (3 Weeks)||0
3178616|NCT01978119|3906662|FG000|STARTED|Treatment Period 2 (12 Weeks)||38
3178617|NCT01978119|3906663|FG001|STARTED|Treatment Period 2 (12 Weeks)||42
3178618|NCT01978119|3906662|FG000|COMPLETED|Treatment Period 2 (12 Weeks)||38
3178619|NCT01978119|3906663|FG001|COMPLETED|Treatment Period 2 (12 Weeks)||40
3178620|NCT01978119|3906662|FG000|NOT COMPLETED|Treatment Period 2 (12 Weeks)||0
3178621|NCT01978119|3906663|FG001|NOT COMPLETED|Treatment Period 2 (12 Weeks)||2
3178622|NCT01978145|3906669|FG000|STARTED|Treatment Period 1||214
3178623|NCT01978145|3906670|FG001|STARTED|Treatment Period 1||212
3178624|NCT01978145|3906669|FG000|COMPLETED|Treatment Period 1||205
3178625|NCT01978145|3906670|FG001|COMPLETED|Treatment Period 1||196
3178626|NCT01978145|3906669|FG000|NOT COMPLETED|Treatment Period 1||9
3178627|NCT01978145|3906670|FG001|NOT COMPLETED|Treatment Period 1||16
3178628|NCT01978145|3906669|FG000|STARTED|Washout Period 1||205
3178629|NCT01978145|3906670|FG001|STARTED|Washout Period 1||196
3178630|NCT01978145|3906669|FG000|COMPLETED|Washout Period 1||204
3178631|NCT01978145|3906670|FG001|COMPLETED|Washout Period 1||193
3178632|NCT01978145|3906669|FG000|NOT COMPLETED|Washout Period 1||1
3178633|NCT01978145|3906670|FG001|NOT COMPLETED|Washout Period 1||3
3178634|NCT01978145|3906669|FG000|STARTED|Treatment Period 2||204
3178635|NCT01978145|3906670|FG001|STARTED|Treatment Period 2||193
3178636|NCT01978145|3906669|FG000|COMPLETED|Treatment Period 2||185
3178637|NCT01978145|3906670|FG001|COMPLETED|Treatment Period 2||179
3178638|NCT01978145|3906669|FG000|NOT COMPLETED|Treatment Period 2||19
3178639|NCT01978145|3906670|FG001|NOT COMPLETED|Treatment Period 2||14
3178640|NCT01978184|3906678|FG000|STARTED|Overall Study||43
3178641|NCT01978184|3906679|FG001|STARTED|Overall Study||61
3178642|NCT01978184|3906678|FG000|COMPLETED|Overall Study||30
3178643|NCT01978184|3906679|FG001|COMPLETED|Overall Study||41
3178644|NCT01978184|3906678|FG000|NOT COMPLETED|Overall Study||13
3178645|NCT01978184|3906679|FG001|NOT COMPLETED|Overall Study||20
3178646|NCT01978236|3906685|FG000|STARTED|Overall Study||6
3351628|NCT03594500|4081903|FG000|COMPLETED|Overall Study||60
3351629|NCT03594500|4081904|FG001|COMPLETED|Overall Study||63
3351630|NCT03594500|4081903|FG000|NOT COMPLETED|Overall Study||6
3351631|NCT03594500|4081904|FG001|NOT COMPLETED|Overall Study||4
3351632|NCT03595176|4081915|FG000|STARTED|Overall Study||47
3351633|NCT03595176|4081916|FG001|STARTED|Overall Study||384
3351634|NCT03595176|4081915|FG000|COMPLETED|Overall Study||47
3351635|NCT03595176|4081916|FG001|COMPLETED|Overall Study||381
3351636|NCT03595176|4081915|FG000|NOT COMPLETED|Overall Study||0
3351637|NCT03595176|4081916|FG001|NOT COMPLETED|Overall Study||3
3351638|NCT03595215|4081921|FG000|STARTED|Overall Study||18
3351639|NCT03595215|4081921|FG000|COMPLETED|Overall Study||10
3351640|NCT03595215|4081921|FG000|NOT COMPLETED|Overall Study||8
3351641|NCT03595280|4081928|FG000|STARTED|Overall Study||119
3351642|NCT03595280|4081929|FG001|STARTED|Overall Study||117
3351643|NCT03595280|4081930|FG002|STARTED|Overall Study||113
3351644|NCT03595280|4081928|FG000|COMPLETED|Overall Study||113
3351645|NCT03595280|4081929|FG001|COMPLETED|Overall Study||108
3351646|NCT03595280|4081930|FG002|COMPLETED|Overall Study||98
3351647|NCT03595280|4081928|FG000|NOT COMPLETED|Overall Study||6
3351648|NCT03595280|4081929|FG001|NOT COMPLETED|Overall Study||9
3351649|NCT03595280|4081930|FG002|NOT COMPLETED|Overall Study||15
3351650|NCT03595449|4081940|FG000|STARTED|Overall Study||118
3351651|NCT03595449|4081941|FG001|STARTED|Overall Study||115
3351652|NCT03595449|4081940|FG000|COMPLETED|Overall Study||118
3351653|NCT03595449|4081941|FG001|COMPLETED|Overall Study||115
3351654|NCT03595449|4081940|FG000|NOT COMPLETED|Overall Study||0
3351655|NCT03595449|4081941|FG001|NOT COMPLETED|Overall Study||0
3351656|NCT03595579|4081949|FG000|STARTED|Overall Study||48
3351657|NCT03595579|4081950|FG001|STARTED|Overall Study||49
3351658|NCT03595579|4081949|FG000|mITT Population|Overall Study||43
3351659|NCT03595579|4081950|FG001|mITT Population|Overall Study||37
3351660|NCT03595579|4081949|FG000|Safety Population|Overall Study||48
3351661|NCT03595579|4081950|FG001|Safety Population|Overall Study||48
3351662|NCT03595579|4081949|FG000|COMPLETED|Overall Study||38
3351663|NCT03595579|4081950|FG001|COMPLETED|Overall Study||35
3351664|NCT03595579|4081949|FG000|NOT COMPLETED|Overall Study||10
3351665|NCT03595579|4081950|FG001|NOT COMPLETED|Overall Study||14
3351666|NCT03595618|4081960|FG000|STARTED|Overall Study||234
3351667|NCT03595618|4081961|FG001|STARTED|Overall Study||231
3351668|NCT03595618|4081962|FG002|STARTED|Overall Study||233
3351669|NCT03595618|4081963|FG003|STARTED|Overall Study||234
3351670|NCT03595618|4081960|FG000|Treated|Overall Study||234
3351671|NCT03595618|4081961|FG001|Treated|Overall Study||231
3351672|NCT03595618|4081962|FG002|Treated|Overall Study||232
3351673|NCT03595618|4081963|FG003|Treated|Overall Study||234
3351674|NCT03595618|4081960|FG000|COMPLETED|Overall Study||191
3351675|NCT03595618|4081961|FG001|COMPLETED|Overall Study||191
3351676|NCT03595618|4081962|FG002|COMPLETED|Overall Study||177
3351677|NCT03595618|4081963|FG003|COMPLETED|Overall Study||200
3351678|NCT03595618|4081960|FG000|NOT COMPLETED|Overall Study||43
3351679|NCT03595618|4081961|FG001|NOT COMPLETED|Overall Study||40
3351680|NCT03595618|4081962|FG002|NOT COMPLETED|Overall Study||56
3351681|NCT03595618|4081963|FG003|NOT COMPLETED|Overall Study||34
3351682|NCT03595904|4081975|FG000|STARTED|Overall Study||39
3351683|NCT03595904|4081976|FG001|STARTED|Overall Study||39
3351684|NCT03595904|4081975|FG000|COMPLETED|Overall Study||29
3351685|NCT03595904|4081976|FG001|COMPLETED|Overall Study||34
2928014|NCT00575666|3638981|FG000|STARTED|Overall Study||21
3178647|NCT01978236|3906685|FG000|COMPLETED|Overall Study||4
3178648|NCT01978236|3906685|FG000|NOT COMPLETED|Overall Study||2
3178649|NCT01978262|3906689|FG000|STARTED|Overall Study||103
3178650|NCT01978262|3906689|FG000|COMPLETED|Overall Study||92
3178651|NCT01978262|3906689|FG000|NOT COMPLETED|Overall Study||11
3178652|NCT01978314|3906699|FG000|STARTED|Overall Study||8
3178653|NCT01978314|3906700|FG001|STARTED|Overall Study||8
3178654|NCT01978314|3906701|FG002|STARTED|Overall Study||8
3178655|NCT01978314|3906702|FG003|STARTED|Overall Study||1
3178656|NCT01978314|3906703|FG004|STARTED|Overall Study||8
3178657|NCT01978314|3906699|FG000|COMPLETED|Overall Study||8
3178658|NCT01978314|3906700|FG001|COMPLETED|Overall Study||8
3178659|NCT01978314|3906701|FG002|COMPLETED|Overall Study||8
3178660|NCT01978314|3906702|FG003|COMPLETED|Overall Study||1
3178661|NCT01978314|3906703|FG004|COMPLETED|Overall Study||8
3178662|NCT01978314|3906699|FG000|NOT COMPLETED|Overall Study||0
3178663|NCT01978314|3906700|FG001|NOT COMPLETED|Overall Study||0
3178664|NCT01978314|3906701|FG002|NOT COMPLETED|Overall Study||0
3178665|NCT01978314|3906702|FG003|NOT COMPLETED|Overall Study||0
3178666|NCT01978314|3906703|FG004|NOT COMPLETED|Overall Study||0
3178667|NCT01978509|3906729|FG000|STARTED|Overall Study||10
3178668|NCT01978509|3906730|FG001|STARTED|Overall Study||13
3178669|NCT01978509|3906731|FG002|STARTED|Overall Study||9
3178670|NCT01978509|3906729|FG000|COMPLETED|Overall Study||8
3178671|NCT01978509|3906730|FG001|COMPLETED|Overall Study||8
3178672|NCT01978509|3906731|FG002|COMPLETED|Overall Study||9
3178673|NCT01978509|3906729|FG000|NOT COMPLETED|Overall Study||2
3178674|NCT01978509|3906730|FG001|NOT COMPLETED|Overall Study||5
3178675|NCT01978509|3906731|FG002|NOT COMPLETED|Overall Study||0
3178676|NCT01978600|3906741|FG000|STARTED|Overall Study||44
3178677|NCT01978600|3906742|FG001|STARTED|Overall Study||42
3178678|NCT01978600|3906741|FG000|COMPLETED|Overall Study||44
3178679|NCT01978600|3906742|FG001|COMPLETED|Overall Study||42
3178680|NCT01978600|3906741|FG000|NOT COMPLETED|Overall Study||0
3178681|NCT01978600|3906742|FG001|NOT COMPLETED|Overall Study||0
3178682|NCT01978743|3906748|FG000|STARTED|Overall Study||10
3178683|NCT01978743|3906748|FG000|COMPLETED|Overall Study||10
3178684|NCT01978743|3906748|FG000|NOT COMPLETED|Overall Study||0
3178685|NCT01978912|3906757|FG000|STARTED|Overall Study||6
3178686|NCT01978912|3906758|FG001|STARTED|Overall Study||6
3178687|NCT01978912|3906759|FG002|STARTED|Overall Study||6
3178688|NCT01978912|3906760|FG003|STARTED|Overall Study||6
3178689|NCT01978912|3906757|FG000|COMPLETED|Overall Study||3
3178690|NCT01978912|3906758|FG001|COMPLETED|Overall Study||3
3178691|NCT01978912|3906759|FG002|COMPLETED|Overall Study||3
3178692|NCT01978912|3906760|FG003|COMPLETED|Overall Study||3
3178693|NCT01978912|3906757|FG000|NOT COMPLETED|Overall Study||3
3178694|NCT01978912|3906758|FG001|NOT COMPLETED|Overall Study||3
3178695|NCT01978912|3906759|FG002|NOT COMPLETED|Overall Study||3
3178696|NCT01978912|3906760|FG003|NOT COMPLETED|Overall Study||3
3178697|NCT01979016|3906772|FG000|STARTED|Overall Study||27
3178698|NCT01979016|3906773|FG001|STARTED|Overall Study||27
3178699|NCT01979016|3906772|FG000|COMPLETED|Overall Study||25
3178700|NCT01979016|3906773|FG001|COMPLETED|Overall Study||26
3178701|NCT01979016|3906772|FG000|NOT COMPLETED|Overall Study||2
3178702|NCT01979016|3906773|FG001|NOT COMPLETED|Overall Study||1
3178703|NCT01979029|3906781|FG000|STARTED|Overall Study||29
3178704|NCT01979029|3906782|FG001|STARTED|Overall Study||28
3178705|NCT01979029|3906781|FG000|COMPLETED|Overall Study||29
3178706|NCT01979029|3906782|FG001|COMPLETED|Overall Study||28
3178707|NCT01979029|3906781|FG000|NOT COMPLETED|Overall Study||0
3178708|NCT01979029|3906782|FG001|NOT COMPLETED|Overall Study||0
3178709|NCT01979133|3906788|FG000|STARTED|Overall Study||10
3178710|NCT01979133|3906788|FG000|COMPLETED|Overall Study||7
3178711|NCT01979133|3906788|FG000|NOT COMPLETED|Overall Study||3
3178712|NCT01979159|3906805|FG000|STARTED|Overall Study||4
3178713|NCT01979159|3906805|FG000|COMPLETED|Overall Study||4
3178714|NCT01979159|3906805|FG000|NOT COMPLETED|Overall Study||0
3178715|NCT01979185|3906813|FG000|STARTED|Period 1||15
3178716|NCT01979185|3906814|FG001|STARTED|Period 1||15
3178717|NCT01979185|3906813|FG000|COMPLETED|Period 1||15
3178718|NCT01979185|3906814|FG001|COMPLETED|Period 1||15
3178719|NCT01979185|3906813|FG000|NOT COMPLETED|Period 1||0
3178720|NCT01979185|3906814|FG001|NOT COMPLETED|Period 1||0
3178721|NCT01979185|3906813|FG000|STARTED|Period 2||15
3178722|NCT01979185|3906814|FG001|STARTED|Period 2||15
3178723|NCT01979185|3906813|FG000|COMPLETED|Period 2||15
3178724|NCT01979185|3906814|FG001|COMPLETED|Period 2|1 subject discontinued due to a positive drug test prior to receiving Simvastatin alone in Period 2.|14
3178725|NCT01979185|3906813|FG000|NOT COMPLETED|Period 2||0
3178726|NCT01979185|3906814|FG001|NOT COMPLETED|Period 2||1
3178727|NCT01979276|3906820|FG000|STARTED|Overall Study||2
3178728|NCT01979276|3906820|FG000|COMPLETED|Overall Study||2
3178729|NCT01979276|3906820|FG000|NOT COMPLETED|Overall Study||0
3178730|NCT01979445|3906826|FG000|STARTED|Overall Study||3
3178731|NCT01979445|3906827|FG001|STARTED|Overall Study||3
3178732|NCT01979445|3906828|FG002|STARTED|Overall Study||6
3178733|NCT01979445|3906829|FG003|STARTED|Overall Study||3
3178734|NCT01979445|3906826|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
3178735|NCT01979445|3906827|FG001|Received at Least 1 Dose of Study Drug|Overall Study||3
3178736|NCT01979445|3906828|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
3178737|NCT01979445|3906829|FG003|Received at Least 1 Dose of Study Drug|Overall Study||3
3178738|NCT01979445|3906826|FG000|ITT Population|Overall Study||3
3351686|NCT03595904|4081975|FG000|NOT COMPLETED|Overall Study||10
3351687|NCT03595904|4081976|FG001|NOT COMPLETED|Overall Study||5
3351688|NCT03596151|4081982|FG000|STARTED|Overall Study||295
3351689|NCT03596151|4081982|FG000|COMPLETED|Overall Study||294
3351690|NCT03596151|4081982|FG000|NOT COMPLETED|Overall Study||1
3351691|NCT03596177|4081988|FG000|STARTED|Single Blind Period||9
3351692|NCT03596177|4081989|FG001|STARTED|Single Blind Period||19
3351693|NCT03596177|4081988|FG000|COMPLETED|Single Blind Period||7
3351694|NCT03596177|4081989|FG001|COMPLETED|Single Blind Period||18
3351695|NCT03596177|4081988|FG000|NOT COMPLETED|Single Blind Period||2
3351696|NCT03596177|4081989|FG001|NOT COMPLETED|Single Blind Period||1
3351697|NCT03596177|4081988|FG000|STARTED|Double Blind Period||7
3351698|NCT03596177|4081989|FG001|STARTED|Double Blind Period||18
3351699|NCT03596177|4081988|FG000|COMPLETED|Double Blind Period||7
3351700|NCT03596177|4081989|FG001|COMPLETED|Double Blind Period||12
3351701|NCT03596177|4081988|FG000|NOT COMPLETED|Double Blind Period||0
3351702|NCT03596177|4081989|FG001|NOT COMPLETED|Double Blind Period||6
3351703|NCT03596723|4081997|FG000|STARTED|Overall Study||1
3351704|NCT03596723|4081998|FG001|STARTED|Overall Study||1
3351705|NCT03596723|4081997|FG000|COMPLETED|Overall Study||1
3351706|NCT03596723|4081998|FG001|COMPLETED|Overall Study||1
3351707|NCT03596723|4081997|FG000|NOT COMPLETED|Overall Study||0
3351708|NCT03596723|4081998|FG001|NOT COMPLETED|Overall Study||0
3351709|NCT03597009|4082004|FG000|STARTED|Overall Study||1
3351710|NCT03597009|4082004|FG000|COMPLETED|Overall Study||1
3351711|NCT03597009|4082004|FG000|NOT COMPLETED|Overall Study||0
3351712|NCT03597022|4082011|FG000|STARTED|Overall Study||8
3351713|NCT03597022|4082012|FG001|STARTED|Overall Study||8
3351714|NCT03597022|4082013|FG002|STARTED|Overall Study||8
3351715|NCT03597022|4082011|FG000|COMPLETED|Overall Study||0
3351716|NCT03597022|4082012|FG001|COMPLETED|Overall Study||0
3351717|NCT03597022|4082013|FG002|COMPLETED|Overall Study||0
3351718|NCT03597022|4082011|FG000|NOT COMPLETED|Overall Study||8
3351719|NCT03597022|4082012|FG001|NOT COMPLETED|Overall Study||8
3351720|NCT03597022|4082013|FG002|NOT COMPLETED|Overall Study||8
3351721|NCT03597061|4082023|FG000|STARTED|Overall Study||17
3351722|NCT03597061|4082024|FG001|STARTED|Overall Study||17
3351723|NCT03597061|4082023|FG000|COMPLETED|Overall Study||16
3351724|NCT03597061|4082024|FG001|COMPLETED|Overall Study||16
3351725|NCT03597061|4082023|FG000|NOT COMPLETED|Overall Study||1
3351726|NCT03597061|4082024|FG001|NOT COMPLETED|Overall Study||1
3351727|NCT03597139|4082032|FG000|STARTED|Overall Study||51
3351728|NCT03597139|4082033|FG001|STARTED|Overall Study||49
3351729|NCT03597139|4082032|FG000|COMPLETED|Overall Study||47
3351730|NCT03597139|4082033|FG001|COMPLETED|Overall Study||49
3351731|NCT03597139|4082032|FG000|NOT COMPLETED|Overall Study||4
3351732|NCT03597139|4082033|FG001|NOT COMPLETED|Overall Study||0
3351733|NCT03597178|4082039|FG000|STARTED|Overall Study||14
3351734|NCT03597178|4082039|FG000|COMPLETED|Overall Study||14
3351735|NCT03597178|4082039|FG000|NOT COMPLETED|Overall Study||0
3351736|NCT03597347|4082046|FG000|STARTED|Overall Study||7
3351737|NCT03597347|4082047|FG001|STARTED|Overall Study||3
3351738|NCT03597347|4082048|FG002|STARTED|Overall Study||4
3351739|NCT03597347|4082046|FG000|COMPLETED|Overall Study||0
3351740|NCT03597347|4082047|FG001|COMPLETED|Overall Study||0
3351741|NCT03597347|4082048|FG002|COMPLETED|Overall Study||0
3351742|NCT03597347|4082046|FG000|NOT COMPLETED|Overall Study||7
3351743|NCT03597347|4082047|FG001|NOT COMPLETED|Overall Study||3
3351744|NCT03597347|4082048|FG002|NOT COMPLETED|Overall Study||4
3351745|NCT03597529|4082058|FG000|STARTED|Overall Study||42
3351746|NCT03597529|4082059|FG001|STARTED|Overall Study||42
3351747|NCT03597529|4082058|FG000|Follow-up|Overall Study||22
3351748|NCT03597529|4082059|FG001|Follow-up|Overall Study||24
3351749|NCT03597529|4082058|FG000|COMPLETED|Overall Study||22
3351750|NCT03597529|4082059|FG001|COMPLETED|Overall Study||24
3351751|NCT03597529|4082058|FG000|NOT COMPLETED|Overall Study||20
3351752|NCT03597529|4082059|FG001|NOT COMPLETED|Overall Study||18
3351753|NCT03597789|4082065|FG000|STARTED|Overall Study||45
3351754|NCT03597789|4082065|FG000|COMPLETED|Overall Study||10
3351755|NCT03597789|4082065|FG000|NOT COMPLETED|Overall Study||35
3351756|NCT03598647|4082071|FG000|STARTED|Exercisers vs. Non-exercisers||30
3351757|NCT03598647|4082072|FG001|STARTED|Exercisers vs. Non-exercisers||30
3351758|NCT03598647|4082073|FG002|STARTED|Exercisers vs. Non-exercisers||0
3351759|NCT03598647|4082074|FG003|STARTED|Exercisers vs. Non-exercisers||0
3351760|NCT03598647|4082071|FG000|COMPLETED|Exercisers vs. Non-exercisers||29
3351761|NCT03598647|4082072|FG001|COMPLETED|Exercisers vs. Non-exercisers||30
3351762|NCT03598647|4082073|FG002|COMPLETED|Exercisers vs. Non-exercisers||0
3351763|NCT03598647|4082074|FG003|COMPLETED|Exercisers vs. Non-exercisers||0
3351764|NCT03598647|4082071|FG000|NOT COMPLETED|Exercisers vs. Non-exercisers||1
3351765|NCT03598647|4082072|FG001|NOT COMPLETED|Exercisers vs. Non-exercisers||0
3351766|NCT03598647|4082073|FG002|NOT COMPLETED|Exercisers vs. Non-exercisers||0
3351767|NCT03598647|4082074|FG003|NOT COMPLETED|Exercisers vs. Non-exercisers||0
3351768|NCT03598647|4082071|FG000|STARTED|Interventions for Non-exercisers||0
3351769|NCT03598647|4082072|FG001|STARTED|Interventions for Non-exercisers||0
3351770|NCT03598647|4082073|FG002|STARTED|Interventions for Non-exercisers||14
3351771|NCT03598647|4082074|FG003|STARTED|Interventions for Non-exercisers||16
3351772|NCT03598647|4082071|FG000|COMPLETED|Interventions for Non-exercisers||0
3351773|NCT03598647|4082072|FG001|COMPLETED|Interventions for Non-exercisers||0
3351774|NCT03598647|4082073|FG002|COMPLETED|Interventions for Non-exercisers||14
3351775|NCT03598647|4082074|FG003|COMPLETED|Interventions for Non-exercisers||16
3351776|NCT03598647|4082071|FG000|NOT COMPLETED|Interventions for Non-exercisers||0
3351777|NCT03598647|4082072|FG001|NOT COMPLETED|Interventions for Non-exercisers||0
3351778|NCT03598647|4082073|FG002|NOT COMPLETED|Interventions for Non-exercisers||0
3351779|NCT03598647|4082074|FG003|NOT COMPLETED|Interventions for Non-exercisers||0
3351780|NCT03599089|4082088|FG000|STARTED|Overall Study||36
3351781|NCT03599089|4082089|FG001|STARTED|Overall Study||36
3351782|NCT03599089|4082090|FG002|STARTED|Overall Study||38
3351783|NCT03599089|4082091|FG003|STARTED|Overall Study||37
3351784|NCT03599089|4082088|FG000|COMPLETED|Overall Study||33
3351785|NCT03599089|4082089|FG001|COMPLETED|Overall Study||35
3351786|NCT03599089|4082090|FG002|COMPLETED|Overall Study||37
3351787|NCT03599089|4082091|FG003|COMPLETED|Overall Study||35
3351788|NCT03599089|4082088|FG000|NOT COMPLETED|Overall Study||3
3351789|NCT03599089|4082089|FG001|NOT COMPLETED|Overall Study||1
3351790|NCT03599089|4082090|FG002|NOT COMPLETED|Overall Study||1
3351791|NCT03599089|4082091|FG003|NOT COMPLETED|Overall Study||2
3351792|NCT03599193|4082103|FG000|STARTED|Overall Study||34
3351793|NCT03599193|4082104|FG001|STARTED|Overall Study||24
3351794|NCT03599193|4082103|FG000|COMPLETED|Overall Study||32
3351795|NCT03599193|4082104|FG001|COMPLETED|Overall Study||21
3351796|NCT03599193|4082103|FG000|NOT COMPLETED|Overall Study||2
3351797|NCT03599193|4082104|FG001|NOT COMPLETED|Overall Study||3
3351798|NCT03599271|4082113|FG000|STARTED|Overall Study||70
3351799|NCT03599271|4082114|FG001|STARTED|Overall Study||5
3351800|NCT03599271|4082113|FG000|Drug-Coated Device|Overall Study||70
3351801|NCT03599271|4082114|FG001|Drug-Coated Device|Overall Study||5
3351802|NCT03599271|4082113|FG000|Control Device|Overall Study||70
3351803|NCT03599271|4082114|FG001|Control Device|Overall Study||0
3351804|NCT03599271|4082113|FG000|COMPLETED|Overall Study||70
3351805|NCT03599271|4082114|FG001|COMPLETED|Overall Study||5
3351806|NCT03599271|4082113|FG000|NOT COMPLETED|Overall Study||0
3351807|NCT03599271|4082114|FG001|NOT COMPLETED|Overall Study||0
3351808|NCT03599349|4082122|FG000|STARTED|Overall Study||20
3351809|NCT03599349|4082122|FG000|Treated|Overall Study||20
3351810|NCT03599349|4082122|FG000|COMPLETED|Overall Study||19
3351811|NCT03599349|4082122|FG000|NOT COMPLETED|Overall Study||1
3351812|NCT03599362|4082126|FG000|STARTED|Overall Study||7
3351813|NCT03599362|4082126|FG000|COMPLETED|Overall Study||4
3351814|NCT03599362|4082126|FG000|NOT COMPLETED|Overall Study||3
3351815|NCT03599687|4082132|FG000|STARTED|Overall Study||82
3351816|NCT03599687|4082133|FG001|STARTED|Overall Study||82
3351817|NCT03599687|4082132|FG000|COMPLETED|Overall Study||82
3351818|NCT03599687|4082133|FG001|COMPLETED|Overall Study||82
3351819|NCT03599687|4082132|FG000|NOT COMPLETED|Overall Study||0
3351820|NCT03599687|4082133|FG001|NOT COMPLETED|Overall Study||0
3351821|NCT03599986|4082139|FG000|STARTED|Overall Study||398
3351822|NCT03599986|4082139|FG000|COMPLETED|Overall Study||366
3351823|NCT03599986|4082139|FG000|NOT COMPLETED|Overall Study||32
3351824|NCT03600142|4082146|FG000|STARTED|Overall Study||777
3351825|NCT03600142|4082147|FG001|STARTED|Overall Study||762
3351826|NCT03600142|4082146|FG000|COMPLETED|Overall Study||773
3351827|NCT03600142|4082147|FG001|COMPLETED|Overall Study||758
3351828|NCT03600142|4082146|FG000|NOT COMPLETED|Overall Study||4
3351829|NCT03600142|4082147|FG001|NOT COMPLETED|Overall Study||4
3351830|NCT03600194|4082155|FG000|STARTED|Screening||38
3351831|NCT03600194|4082156|FG001|STARTED|Screening||0
3351832|NCT03600194|4082157|FG002|STARTED|Screening||0
3351833|NCT03600194|4082155|FG000|COMPLETED|Screening||11
3351834|NCT03600194|4082156|FG001|COMPLETED|Screening||0
3351835|NCT03600194|4082157|FG002|COMPLETED|Screening||0
3351836|NCT03600194|4082155|FG000|NOT COMPLETED|Screening||27
3351837|NCT03600194|4082156|FG001|NOT COMPLETED|Screening||0
3351838|NCT03600194|4082157|FG002|NOT COMPLETED|Screening||0
3351839|NCT03600194|4082155|FG000|STARTED|In Lab Phase||0
3351840|NCT03600194|4082156|FG001|STARTED|In Lab Phase||5
3351841|NCT03600194|4082157|FG002|STARTED|In Lab Phase||6
3351842|NCT03600194|4082155|FG000|COMPLETED|In Lab Phase||0
3351843|NCT03600194|4082156|FG001|COMPLETED|In Lab Phase||5
3351844|NCT03600194|4082157|FG002|COMPLETED|In Lab Phase||6
3351845|NCT03600194|4082155|FG000|NOT COMPLETED|In Lab Phase||0
3351846|NCT03600194|4082156|FG001|NOT COMPLETED|In Lab Phase||0
3351847|NCT03600194|4082157|FG002|NOT COMPLETED|In Lab Phase||0
3351848|NCT03600376|4082170|FG000|STARTED|Overall Study||9
3351849|NCT03600376|4082171|FG001|STARTED|Overall Study||8
3351850|NCT03600376|4082170|FG000|COMPLETED|Overall Study||7
3351851|NCT03600376|4082171|FG001|COMPLETED|Overall Study||2
3351852|NCT03600376|4082170|FG000|NOT COMPLETED|Overall Study||2
3351853|NCT03600376|4082171|FG001|NOT COMPLETED|Overall Study||6
3351854|NCT03600428|4082179|FG000|STARTED|Overall Study||79
3351855|NCT03600428|4082180|FG001|STARTED|Overall Study||73
3351856|NCT03600428|4082179|FG000|15-day Follow-up|Overall Study||76
3351857|NCT03600428|4082180|FG001|15-day Follow-up|Overall Study||70
3351858|NCT03600428|4082179|FG000|43-day Follow-up|Overall Study||74
3351859|NCT03600428|4082180|FG001|43-day Follow-up|Overall Study||68
3351860|NCT03600428|4082179|FG000|COMPLETED|Overall Study||74
3351861|NCT03600428|4082180|FG001|COMPLETED|Overall Study||68
3351862|NCT03600428|4082179|FG000|NOT COMPLETED|Overall Study||5
3351863|NCT03600428|4082180|FG001|NOT COMPLETED|Overall Study||5
3351864|NCT03601052|4082186|FG000|STARTED|Overall Study||14
3351865|NCT03601052|4082186|FG000|COMPLETED|Overall Study||12
3351866|NCT03601052|4082186|FG000|NOT COMPLETED|Overall Study||2
3351867|NCT03601117|4082197|FG000|STARTED|Overall Study||20
3351868|NCT03601117|4082198|FG001|STARTED|Overall Study||2
3351869|NCT03601117|4082197|FG000|COMPLETED|Overall Study||17
3351870|NCT03601117|4082198|FG001|COMPLETED|Overall Study||1
3351871|NCT03601117|4082197|FG000|NOT COMPLETED|Overall Study||3
3351872|NCT03601117|4082198|FG001|NOT COMPLETED|Overall Study||1
3351873|NCT03601715|4082209|FG000|STARTED|First Intervention||7
3351874|NCT03601715|4082210|FG001|STARTED|First Intervention||7
3351875|NCT03601715|4082211|FG002|STARTED|First Intervention||6
3351876|NCT03601715|4082209|FG000|COMPLETED|First Intervention||7
3351877|NCT03601715|4082210|FG001|COMPLETED|First Intervention||7
3351878|NCT03601715|4082211|FG002|COMPLETED|First Intervention||6
3351879|NCT03601715|4082209|FG000|NOT COMPLETED|First Intervention||0
3351880|NCT03601715|4082210|FG001|NOT COMPLETED|First Intervention||0
3351881|NCT03601715|4082211|FG002|NOT COMPLETED|First Intervention||0
3351882|NCT03601715|4082209|FG000|STARTED|Washout 1 (at Least 24 Hours)||7
3351883|NCT03601715|4082210|FG001|STARTED|Washout 1 (at Least 24 Hours)||7
3351884|NCT03601715|4082211|FG002|STARTED|Washout 1 (at Least 24 Hours)||6
3351885|NCT03601715|4082209|FG000|COMPLETED|Washout 1 (at Least 24 Hours)||7
3351886|NCT03601715|4082210|FG001|COMPLETED|Washout 1 (at Least 24 Hours)||7
3351887|NCT03601715|4082211|FG002|COMPLETED|Washout 1 (at Least 24 Hours)||6
3351888|NCT03601715|4082209|FG000|NOT COMPLETED|Washout 1 (at Least 24 Hours)||0
3039932|NCT01161472|3759430|FG001|COMPLETED|Second Intervention Period||5
3039933|NCT01161472|3759431|FG002|COMPLETED|Second Intervention Period||5
3039934|NCT01161472|3759432|FG003|COMPLETED|Second Intervention Period||5
3039935|NCT01161472|3759429|FG000|NOT COMPLETED|Second Intervention Period||0
3039936|NCT01161472|3759430|FG001|NOT COMPLETED|Second Intervention Period||0
3039937|NCT01161472|3759431|FG002|NOT COMPLETED|Second Intervention Period||0
3039938|NCT01161472|3759432|FG003|NOT COMPLETED|Second Intervention Period||0
3351889|NCT03601715|4082210|FG001|NOT COMPLETED|Washout 1 (at Least 24 Hours)||0
3351890|NCT03601715|4082211|FG002|NOT COMPLETED|Washout 1 (at Least 24 Hours)||0
3351891|NCT03601715|4082209|FG000|STARTED|Second Intervention||7
3351892|NCT03601715|4082210|FG001|STARTED|Second Intervention||7
3351893|NCT03601715|4082211|FG002|STARTED|Second Intervention||6
3351894|NCT03601715|4082209|FG000|COMPLETED|Second Intervention||6
3351895|NCT03601715|4082210|FG001|COMPLETED|Second Intervention||6
3351896|NCT03601715|4082211|FG002|COMPLETED|Second Intervention||6
3351897|NCT03601715|4082209|FG000|NOT COMPLETED|Second Intervention||1
3351898|NCT03601715|4082210|FG001|NOT COMPLETED|Second Intervention||1
3351899|NCT03601715|4082211|FG002|NOT COMPLETED|Second Intervention||0
3351900|NCT03601715|4082209|FG000|STARTED|Wash Out 2 (at Least 24 Hours)||6
3351901|NCT03601715|4082210|FG001|STARTED|Wash Out 2 (at Least 24 Hours)||6
3351902|NCT03601715|4082211|FG002|STARTED|Wash Out 2 (at Least 24 Hours)||6
3351903|NCT03601715|4082209|FG000|COMPLETED|Wash Out 2 (at Least 24 Hours)||6
3351904|NCT03601715|4082210|FG001|COMPLETED|Wash Out 2 (at Least 24 Hours)||6
3351905|NCT03601715|4082211|FG002|COMPLETED|Wash Out 2 (at Least 24 Hours)||6
3351906|NCT03601715|4082209|FG000|NOT COMPLETED|Wash Out 2 (at Least 24 Hours)||0
3351907|NCT03601715|4082210|FG001|NOT COMPLETED|Wash Out 2 (at Least 24 Hours)||0
3351908|NCT03601715|4082211|FG002|NOT COMPLETED|Wash Out 2 (at Least 24 Hours)||0
3351909|NCT03601715|4082209|FG000|STARTED|Third Intervention||6
3351910|NCT03601715|4082210|FG001|STARTED|Third Intervention||6
3351911|NCT03601715|4082211|FG002|STARTED|Third Intervention||6
3351912|NCT03601715|4082209|FG000|COMPLETED|Third Intervention||6
3351913|NCT03601715|4082210|FG001|COMPLETED|Third Intervention||6
3351914|NCT03601715|4082211|FG002|COMPLETED|Third Intervention||6
3351915|NCT03601715|4082209|FG000|NOT COMPLETED|Third Intervention||0
3351916|NCT03601715|4082210|FG001|NOT COMPLETED|Third Intervention||0
3351917|NCT03601715|4082211|FG002|NOT COMPLETED|Third Intervention||0
3351918|NCT03602053|4082222|FG000|STARTED|Overall Study||150
3351919|NCT03602053|4082223|FG001|STARTED|Overall Study||150
3351920|NCT03602053|4082224|FG002|STARTED|Overall Study||150
3351921|NCT03602053|4082222|FG000|COMPLETED|Overall Study||131
3351922|NCT03602053|4082223|FG001|COMPLETED|Overall Study||132
3351923|NCT03602053|4082224|FG002|COMPLETED|Overall Study||139
3351924|NCT03602053|4082222|FG000|NOT COMPLETED|Overall Study||19
3351925|NCT03602053|4082223|FG001|NOT COMPLETED|Overall Study||18
3351926|NCT03602053|4082224|FG002|NOT COMPLETED|Overall Study||11
3351927|NCT03602339|4082236|FG000|STARTED|Overall Study||157
3351928|NCT03602339|4082236|FG000|Completed Period 1 (Gadoterate)|Overall Study||155
3351929|NCT03602339|4082236|FG000|Started Period 2 (Gadobutrol)|Overall Study||142
3351930|NCT03602339|4082236|FG000|COMPLETED|Overall Study||142
3351931|NCT03602339|4082236|FG000|NOT COMPLETED|Overall Study||15
3351932|NCT03602482|4082245|FG000|STARTED|Overall Study||50
3351933|NCT03602482|4082246|FG001|STARTED|Overall Study||50
3351934|NCT03602482|4082247|FG002|STARTED|Overall Study||20
3351935|NCT03602482|4082248|FG003|STARTED|Overall Study||19
3351936|NCT03602482|4082245|FG000|COMPLETED|Overall Study||44
3351937|NCT03602482|4082246|FG001|COMPLETED|Overall Study||43
3351938|NCT03602482|4082247|FG002|COMPLETED|Overall Study||20
3351939|NCT03602482|4082248|FG003|COMPLETED|Overall Study||19
3351940|NCT03602482|4082245|FG000|NOT COMPLETED|Overall Study||6
3351941|NCT03602482|4082246|FG001|NOT COMPLETED|Overall Study||7
3351942|NCT03602482|4082247|FG002|NOT COMPLETED|Overall Study||0
3351943|NCT03602482|4082248|FG003|NOT COMPLETED|Overall Study||0
3351944|NCT03603028|4082261|FG000|STARTED|Overall Study||13
3351945|NCT03603028|4082261|FG000|COMPLETED|Overall Study||12
3351946|NCT03603028|4082261|FG000|NOT COMPLETED|Overall Study||1
3351947|NCT03603106|4082276|FG000|STARTED|Overall Study||6
3351948|NCT03603106|4082277|FG001|STARTED|Overall Study||6
3351949|NCT03603106|4082278|FG002|STARTED|Overall Study||6
3351950|NCT03603106|4082279|FG003|STARTED|Overall Study||6
3351951|NCT03603106|4082280|FG004|STARTED|Overall Study||6
3351952|NCT03603106|4082281|FG005|STARTED|Overall Study||6
3351953|NCT03603106|4082282|FG006|STARTED|Overall Study||18
3351954|NCT03603106|4082283|FG007|STARTED|Overall Study||3
3351955|NCT03603106|4082284|FG008|STARTED|Overall Study||3
3351956|NCT03603106|4082285|FG009|STARTED|Overall Study||3
3351957|NCT03603106|4082286|FG010|STARTED|Overall Study||3
3351958|NCT03603106|4082276|FG000|COMPLETED|Overall Study||6
3351959|NCT03603106|4082277|FG001|COMPLETED|Overall Study||6
3351960|NCT03603106|4082278|FG002|COMPLETED|Overall Study||6
3351961|NCT03603106|4082279|FG003|COMPLETED|Overall Study||6
3351962|NCT03603106|4082280|FG004|COMPLETED|Overall Study||6
3351963|NCT03603106|4082281|FG005|COMPLETED|Overall Study||6
3351964|NCT03603106|4082282|FG006|COMPLETED|Overall Study||18
3351965|NCT03603106|4082283|FG007|COMPLETED|Overall Study||3
3351966|NCT03603106|4082284|FG008|COMPLETED|Overall Study||3
3351967|NCT03603106|4082285|FG009|COMPLETED|Overall Study||3
3351968|NCT03603106|4082286|FG010|COMPLETED|Overall Study||3
3351969|NCT03603106|4082276|FG000|NOT COMPLETED|Overall Study||0
3351970|NCT03603106|4082277|FG001|NOT COMPLETED|Overall Study||0
3351971|NCT03603106|4082278|FG002|NOT COMPLETED|Overall Study||0
3351972|NCT03603106|4082279|FG003|NOT COMPLETED|Overall Study||0
3351973|NCT03603106|4082280|FG004|NOT COMPLETED|Overall Study||0
3351974|NCT03603106|4082281|FG005|NOT COMPLETED|Overall Study||0
3178739|NCT01979445|3906827|FG001|ITT Population|Overall Study||3
3178740|NCT01979445|3906828|FG002|ITT Population|Overall Study||6
2928015|NCT00575666|3638982|FG001|STARTED|Overall Study||24
2928016|NCT00575666|3638981|FG000|COMPLETED|Overall Study||17
2928017|NCT00575666|3638982|FG001|COMPLETED|Overall Study||21
2928018|NCT00575666|3638981|FG000|NOT COMPLETED|Overall Study||4
2928019|NCT00575666|3638982|FG001|NOT COMPLETED|Overall Study||3
2928020|NCT00575887|3638988|FG000|STARTED|Overall Study||25
2928021|NCT00575887|3638988|FG000|COMPLETED|Overall Study||25
2928022|NCT00575887|3638988|FG000|NOT COMPLETED|Overall Study||0
2928023|NCT00575965|3638992|FG000|STARTED|Overall Study||18
2928024|NCT00575965|3638992|FG000|COMPLETED|Overall Study||18
2928025|NCT00575965|3638992|FG000|NOT COMPLETED|Overall Study||0
2928026|NCT00576056|3638996|FG000|STARTED|Overall Study||19
2928027|NCT00576056|3638996|FG000|COMPLETED|Overall Study||5
2928028|NCT00576056|3638996|FG000|NOT COMPLETED|Overall Study||14
2928029|NCT00576147|3639000|FG000|STARTED|Overall Study||431
2928030|NCT00576147|3639000|FG000|COMPLETED|Overall Study||431
2928031|NCT00576147|3639000|FG000|NOT COMPLETED|Overall Study||0
2928032|NCT00576199|3639004|FG000|STARTED|Overall Study||30
2928033|NCT00576199|3639004|FG000|COMPLETED|Overall Study||0
3178741|NCT01979445|3906829|FG003|ITT Population|Overall Study||3
3351975|NCT03603106|4082282|FG006|NOT COMPLETED|Overall Study||0
3351976|NCT03603106|4082283|FG007|NOT COMPLETED|Overall Study||0
3351977|NCT03603106|4082284|FG008|NOT COMPLETED|Overall Study||0
3351978|NCT03603106|4082285|FG009|NOT COMPLETED|Overall Study||0
3351979|NCT03603106|4082286|FG010|NOT COMPLETED|Overall Study||0
3351980|NCT03603652|4082319|FG000|STARTED|Overall Study||10
3351981|NCT03603652|4082319|FG000|COMPLETED|Overall Study||8
3351982|NCT03603652|4082319|FG000|NOT COMPLETED|Overall Study||2
3351983|NCT03604263|4082323|FG000|STARTED|Overall Study||17
3351984|NCT03604263|4082323|FG000|COMPLETED|Overall Study||15
3351985|NCT03604263|4082323|FG000|NOT COMPLETED|Overall Study||2
3351986|NCT03604341|4082329|FG000|STARTED|Overall Study||35
3351987|NCT03604341|4082330|FG001|STARTED|Overall Study||35
3351988|NCT03604341|4082329|FG000|COMPLETED|Overall Study||33
3351989|NCT03604341|4082330|FG001|COMPLETED|Overall Study||33
3351990|NCT03604341|4082329|FG000|NOT COMPLETED|Overall Study||2
3351991|NCT03604341|4082330|FG001|NOT COMPLETED|Overall Study||2
3351992|NCT03604497|4082336|FG000|STARTED|Overall Study||437
3351993|NCT03604497|4082336|FG000|COMPLETED|Overall Study||385
3351994|NCT03604497|4082336|FG000|NOT COMPLETED|Overall Study||52
3351995|NCT03604523|4082346|FG000|STARTED|Overall Study||5
3351996|NCT03604523|4082347|FG001|STARTED|Overall Study||5
3351997|NCT03604523|4082346|FG000|COMPLETED|Overall Study||4
3351998|NCT03604523|4082347|FG001|COMPLETED|Overall Study||5
3351999|NCT03604523|4082346|FG000|NOT COMPLETED|Overall Study||1
3352000|NCT03604523|4082347|FG001|NOT COMPLETED|Overall Study||0
3352001|NCT03604705|4082353|FG000|STARTED|Overall Study||21
3352002|NCT03604705|4082353|FG000|COMPLETED|Overall Study||20
3352003|NCT03604705|4082353|FG000|NOT COMPLETED|Overall Study||1
3352004|NCT03605212|4082370|FG000|STARTED|Baseline Period||3
3352005|NCT03605212|4082371|FG001|STARTED|Baseline Period||0
3352006|NCT03605212|4082372|FG002|STARTED|Baseline Period||3
3352007|NCT03605212|4082373|FG003|STARTED|Baseline Period||0
3352008|NCT03605212|4082374|FG004|STARTED|Baseline Period||24
3352009|NCT03605212|4082370|FG000|COMPLETED|Baseline Period||3
3352010|NCT03605212|4082371|FG001|COMPLETED|Baseline Period||0
3352011|NCT03605212|4082372|FG002|COMPLETED|Baseline Period||3
3352012|NCT03605212|4082373|FG003|COMPLETED|Baseline Period||0
3352013|NCT03605212|4082374|FG004|COMPLETED|Baseline Period||24
3352014|NCT03605212|4082370|FG000|NOT COMPLETED|Baseline Period||0
3352015|NCT03605212|4082371|FG001|NOT COMPLETED|Baseline Period||0
3352016|NCT03605212|4082372|FG002|NOT COMPLETED|Baseline Period||0
3352017|NCT03605212|4082373|FG003|NOT COMPLETED|Baseline Period||0
3352018|NCT03605212|4082374|FG004|NOT COMPLETED|Baseline Period||0
3352019|NCT03605212|4082370|FG000|STARTED|Treatment Period||3
3352020|NCT03605212|4082371|FG001|STARTED|Treatment Period||0
3352021|NCT03605212|4082372|FG002|STARTED|Treatment Period||3
3352022|NCT03605212|4082373|FG003|STARTED|Treatment Period||0
3352023|NCT03605212|4082374|FG004|STARTED|Treatment Period||24
3352024|NCT03605212|4082370|FG000|COMPLETED|Treatment Period||2
3352025|NCT03605212|4082371|FG001|COMPLETED|Treatment Period||0
3352026|NCT03605212|4082372|FG002|COMPLETED|Treatment Period||3
3352027|NCT03605212|4082373|FG003|COMPLETED|Treatment Period||0
3352028|NCT03605212|4082374|FG004|COMPLETED|Treatment Period||23
3352029|NCT03605212|4082370|FG000|NOT COMPLETED|Treatment Period||1
3352030|NCT03605212|4082371|FG001|NOT COMPLETED|Treatment Period||0
3352031|NCT03605212|4082372|FG002|NOT COMPLETED|Treatment Period||0
3352032|NCT03605212|4082373|FG003|NOT COMPLETED|Treatment Period||0
3352033|NCT03605212|4082374|FG004|NOT COMPLETED|Treatment Period||1
3178742|NCT01979445|3906826|FG000|COMPLETED|Overall Study||3
3178743|NCT01979445|3906827|FG001|COMPLETED|Overall Study||3
3178744|NCT01979445|3906828|FG002|COMPLETED|Overall Study||6
3352034|NCT03605680|4082391|FG000|STARTED|SB Placebo Run-in Period (1 Week)||604
3352035|NCT03605680|4082392|FG001|STARTED|SB Placebo Run-in Period (1 Week)||0
3352036|NCT03605680|4082393|FG002|STARTED|SB Placebo Run-in Period (1 Week)||0
3352037|NCT03605680|4082394|FG003|STARTED|SB Placebo Run-in Period (1 Week)||0
3352038|NCT03605680|4082391|FG000|Treated|SB Placebo Run-in Period (1 Week)||584
3352039|NCT03605680|4082392|FG001|Treated|SB Placebo Run-in Period (1 Week)||0
3352040|NCT03605680|4082393|FG002|Treated|SB Placebo Run-in Period (1 Week)||0
3352041|NCT03605680|4082394|FG003|Treated|SB Placebo Run-in Period (1 Week)||0
3352042|NCT03605680|4082391|FG000|COMPLETED|SB Placebo Run-in Period (1 Week)||466
3352043|NCT03605680|4082392|FG001|COMPLETED|SB Placebo Run-in Period (1 Week)||0
3352044|NCT03605680|4082393|FG002|COMPLETED|SB Placebo Run-in Period (1 Week)||0
3352045|NCT03605680|4082394|FG003|COMPLETED|SB Placebo Run-in Period (1 Week)||0
3352046|NCT03605680|4082391|FG000|NOT COMPLETED|SB Placebo Run-in Period (1 Week)||138
3352047|NCT03605680|4082392|FG001|NOT COMPLETED|SB Placebo Run-in Period (1 Week)||0
3352048|NCT03605680|4082393|FG002|NOT COMPLETED|SB Placebo Run-in Period (1 Week)||0
3352049|NCT03605680|4082394|FG003|NOT COMPLETED|SB Placebo Run-in Period (1 Week)||0
3352050|NCT03605680|4082391|FG000|STARTED|Double-blind Treatment Period (6 Weeks)||0
3352051|NCT03605680|4082392|FG001|STARTED|Double-blind Treatment Period (6 Weeks)||154
3352052|NCT03605680|4082393|FG002|STARTED|Double-blind Treatment Period (6 Weeks)||156
3352053|NCT03605680|4082394|FG003|STARTED|Double-blind Treatment Period (6 Weeks)||156
3352054|NCT03605680|4082391|FG000|COMPLETED|Double-blind Treatment Period (6 Weeks)||0
3352055|NCT03605680|4082392|FG001|COMPLETED|Double-blind Treatment Period (6 Weeks)||110
3352056|NCT03605680|4082393|FG002|COMPLETED|Double-blind Treatment Period (6 Weeks)||117
3352057|NCT03605680|4082394|FG003|COMPLETED|Double-blind Treatment Period (6 Weeks)||121
3352058|NCT03605680|4082391|FG000|NOT COMPLETED|Double-blind Treatment Period (6 Weeks)||0
3352059|NCT03605680|4082392|FG001|NOT COMPLETED|Double-blind Treatment Period (6 Weeks)||44
3352060|NCT03605680|4082393|FG002|NOT COMPLETED|Double-blind Treatment Period (6 Weeks)||39
3352061|NCT03605680|4082394|FG003|NOT COMPLETED|Double-blind Treatment Period (6 Weeks)||35
3352062|NCT03605693|4082405|FG000|STARTED|Overall Study||5
3352063|NCT03605693|4082406|FG001|STARTED|Overall Study||5
3352064|NCT03605693|4082405|FG000|COMPLETED|Overall Study||0
3352065|NCT03605693|4082406|FG001|COMPLETED|Overall Study||5
3352066|NCT03605693|4082405|FG000|NOT COMPLETED|Overall Study||5
3352067|NCT03605693|4082406|FG001|NOT COMPLETED|Overall Study||0
3352068|NCT03605745|4082412|FG000|STARTED|Overall Study||47
3352069|NCT03605745|4082412|FG000|2 Weeks|Overall Study||47
3352070|NCT03605745|4082412|FG000|6 Weeks|Overall Study||47
3352071|NCT03605745|4082412|FG000|3 Months|Overall Study||47
3352072|NCT03605745|4082412|FG000|6 Months|Overall Study||47
3352073|NCT03605745|4082412|FG000|12 Months|Overall Study||40
3352074|NCT03605745|4082412|FG000|24 Months|Overall Study||1
3352075|NCT03605745|4082412|FG000|COMPLETED|Overall Study||0
3352076|NCT03605745|4082412|FG000|NOT COMPLETED|Overall Study||47
3352077|NCT03605836|4082420|FG000|STARTED|OL Placebo Run-in Period [1 Week]||590
3352078|NCT03605836|4082421|FG001|STARTED|OL Placebo Run-in Period [1 Week]||0
3352079|NCT03605836|4082422|FG002|STARTED|OL Placebo Run-in Period [1 Week]||0
3352080|NCT03605836|4082423|FG003|STARTED|OL Placebo Run-in Period [1 Week]||0
3352081|NCT03605836|4082420|FG000|Treated|OL Placebo Run-in Period [1 Week]||579
3352082|NCT03605836|4082421|FG001|Treated|OL Placebo Run-in Period [1 Week]||0
3352083|NCT03605836|4082422|FG002|Treated|OL Placebo Run-in Period [1 Week]||0
3352084|NCT03605836|4082423|FG003|Treated|OL Placebo Run-in Period [1 Week]||0
3352085|NCT03605836|4082420|FG000|COMPLETED|OL Placebo Run-in Period [1 Week]||440
3352086|NCT03605836|4082421|FG001|COMPLETED|OL Placebo Run-in Period [1 Week]||0
3352087|NCT03605836|4082422|FG002|COMPLETED|OL Placebo Run-in Period [1 Week]||0
3352088|NCT03605836|4082423|FG003|COMPLETED|OL Placebo Run-in Period [1 Week]||0
3352089|NCT03605836|4082420|FG000|NOT COMPLETED|OL Placebo Run-in Period [1 Week]||150
3352090|NCT03605836|4082421|FG001|NOT COMPLETED|OL Placebo Run-in Period [1 Week]||0
3352091|NCT03605836|4082422|FG002|NOT COMPLETED|OL Placebo Run-in Period [1 Week]||0
3352092|NCT03605836|4082423|FG003|NOT COMPLETED|OL Placebo Run-in Period [1 Week]||0
3352093|NCT03605836|4082420|FG000|STARTED|Double-blind Treatment Period [6 Weeks]||0
3352094|NCT03605836|4082421|FG001|STARTED|Double-blind Treatment Period [6 Weeks]||147
3352095|NCT03605836|4082422|FG002|STARTED|Double-blind Treatment Period [6 Weeks]||147
3352096|NCT03605836|4082423|FG003|STARTED|Double-blind Treatment Period [6 Weeks]||146
3352097|NCT03605836|4082420|FG000|Treated|Double-blind Treatment Period [6 Weeks]||0
3352098|NCT03605836|4082421|FG001|Treated|Double-blind Treatment Period [6 Weeks]||145
3352099|NCT03605836|4082422|FG002|Treated|Double-blind Treatment Period [6 Weeks]||143
3352100|NCT03605836|4082423|FG003|Treated|Double-blind Treatment Period [6 Weeks]||142
3352101|NCT03605836|4082420|FG000|COMPLETED|Double-blind Treatment Period [6 Weeks]||0
3352102|NCT03605836|4082421|FG001|COMPLETED|Double-blind Treatment Period [6 Weeks]||111
3352103|NCT03605836|4082422|FG002|COMPLETED|Double-blind Treatment Period [6 Weeks]||102
3352104|NCT03605836|4082423|FG003|COMPLETED|Double-blind Treatment Period [6 Weeks]||123
3352105|NCT03605836|4082420|FG000|NOT COMPLETED|Double-blind Treatment Period [6 Weeks]||0
3352106|NCT03605836|4082421|FG001|NOT COMPLETED|Double-blind Treatment Period [6 Weeks]||36
3352107|NCT03605836|4082422|FG002|NOT COMPLETED|Double-blind Treatment Period [6 Weeks]||45
3352108|NCT03605836|4082423|FG003|NOT COMPLETED|Double-blind Treatment Period [6 Weeks]||23
3352109|NCT03605914|4082434|FG000|STARTED|Overall Study||57
3352110|NCT03605914|4082435|FG001|STARTED|Overall Study||43
3352111|NCT03605914|4082434|FG000|Completed Day 1 Assessment|Overall Study||31
3352112|NCT03605914|4082435|FG001|Completed Day 1 Assessment|Overall Study||26
3352113|NCT03605914|4082434|FG000|Completed Day 2 Assessment|Overall Study||32
3352114|NCT03605914|4082435|FG001|Completed Day 2 Assessment|Overall Study||27
3352115|NCT03605914|4082434|FG000|Completed Day 3 Assessment|Overall Study||31
3352116|NCT03605914|4082435|FG001|Completed Day 3 Assessment|Overall Study||28
3352117|NCT03605914|4082434|FG000|Completed Day 5 Assessment|Overall Study||30
3352118|NCT03605914|4082435|FG001|Completed Day 5 Assessment|Overall Study||24
3352119|NCT03605914|4082434|FG000|COMPLETED|Overall Study||30
3352120|NCT03605914|4082435|FG001|COMPLETED|Overall Study||24
3352121|NCT03605914|4082434|FG000|NOT COMPLETED|Overall Study||27
3352122|NCT03605914|4082435|FG001|NOT COMPLETED|Overall Study||19
3352123|NCT03606187|4082443|FG000|STARTED|Overall Study||67
3352124|NCT03606187|4082444|FG001|STARTED|Overall Study||61
3352125|NCT03606187|4082443|FG000|COMPLETED|Overall Study||67
3352126|NCT03606187|4082444|FG001|COMPLETED|Overall Study||61
3352127|NCT03606187|4082443|FG000|NOT COMPLETED|Overall Study||0
3352128|NCT03606187|4082444|FG001|NOT COMPLETED|Overall Study||0
3352129|NCT03606343|4082450|FG000|STARTED|Overall Study||21
3352130|NCT03606343|4082450|FG000|COMPLETED|Overall Study||21
3352131|NCT03606343|4082450|FG000|NOT COMPLETED|Overall Study||0
3352132|NCT03606460|4082456|FG000|STARTED|Overall Study||95
3352133|NCT03606460|4082457|FG001|STARTED|Overall Study||46
3352134|NCT03606460|4082456|FG000|COMPLETED|Overall Study||94
3352135|NCT03606460|4082457|FG001|COMPLETED|Overall Study||38
3352136|NCT03606460|4082456|FG000|NOT COMPLETED|Overall Study||1
3352137|NCT03606460|4082457|FG001|NOT COMPLETED|Overall Study||8
3352138|NCT03607487|4082468|FG000|STARTED|Overall Study||9
3352139|NCT03607487|4082469|FG001|STARTED|Overall Study||9
3352140|NCT03607487|4082470|FG002|STARTED|Overall Study||9
3352141|NCT03607487|4082471|FG003|STARTED|Overall Study||8
3352142|NCT03607487|4082468|FG000|COMPLETED|Overall Study||7
3352143|NCT03607487|4082469|FG001|COMPLETED|Overall Study||9
3352144|NCT03607487|4082470|FG002|COMPLETED|Overall Study||9
3352145|NCT03607487|4082471|FG003|COMPLETED|Overall Study||7
3352146|NCT03607487|4082468|FG000|NOT COMPLETED|Overall Study||2
3352147|NCT03607487|4082469|FG001|NOT COMPLETED|Overall Study||0
3352148|NCT03607487|4082470|FG002|NOT COMPLETED|Overall Study||0
3352149|NCT03607487|4082471|FG003|NOT COMPLETED|Overall Study||1
3352150|NCT03607539|4082485|FG000|STARTED|Overall Study||266
3352151|NCT03607539|4082486|FG001|STARTED|Overall Study||131
3352152|NCT03607539|4082485|FG000|COMPLETED|Overall Study||0
3352153|NCT03607539|4082486|FG001|COMPLETED|Overall Study||0
3352154|NCT03607539|4082485|FG000|NOT COMPLETED|Overall Study||266
3352155|NCT03607539|4082486|FG001|NOT COMPLETED|Overall Study||131
3352156|NCT03607682|4082492|FG000|STARTED|Overall Study||2
3352157|NCT03607682|4082492|FG000|COMPLETED|Overall Study||0
3352158|NCT03607682|4082492|FG000|NOT COMPLETED|Overall Study||2
3352159|NCT03607695|4082496|FG000|STARTED|2 Week||19
3352160|NCT03607695|4082496|FG000|COMPLETED|2 Week||19
3352161|NCT03607695|4082496|FG000|NOT COMPLETED|2 Week||0
3352162|NCT03607695|4082496|FG000|STARTED|10 Week||19
3352163|NCT03607695|4082496|FG000|COMPLETED|10 Week||18
3352164|NCT03607695|4082496|FG000|NOT COMPLETED|10 Week||1
3352165|NCT03607695|4082496|FG000|STARTED|16 Week||18
3352166|NCT03607695|4082496|FG000|COMPLETED|16 Week||16
3352167|NCT03607695|4082496|FG000|NOT COMPLETED|16 Week||2
3352168|NCT03607994|4082502|FG000|STARTED|Overall Study||10
3178745|NCT01979445|3906829|FG003|COMPLETED|Overall Study||3
3178746|NCT01979445|3906826|FG000|NOT COMPLETED|Overall Study||0
3178747|NCT01979445|3906827|FG001|NOT COMPLETED|Overall Study||0
3178748|NCT01979445|3906828|FG002|NOT COMPLETED|Overall Study||0
3178749|NCT01979445|3906829|FG003|NOT COMPLETED|Overall Study||0
3178750|NCT01979523|3906849|FG000|STARTED|Overall Study||21
3352169|NCT03607994|4082503|FG001|STARTED|Overall Study||12
3352170|NCT03607994|4082502|FG000|COMPLETED|Overall Study||9
3352171|NCT03607994|4082503|FG001|COMPLETED|Overall Study||11
3352172|NCT03607994|4082502|FG000|NOT COMPLETED|Overall Study||1
3352173|NCT03607994|4082503|FG001|NOT COMPLETED|Overall Study||1
3352174|NCT03608488|4082513|FG000|STARTED|Overall Study||22
3352175|NCT03608488|4082514|FG001|STARTED|Overall Study||21
3352176|NCT03608488|4082515|FG002|STARTED|Overall Study||22
3352177|NCT03608488|4082516|FG003|STARTED|Overall Study||45
3352178|NCT03608488|4082513|FG000|COMPLETED|Overall Study||21
3352179|NCT03608488|4082514|FG001|COMPLETED|Overall Study||18
3352180|NCT03608488|4082515|FG002|COMPLETED|Overall Study||20
3352181|NCT03608488|4082516|FG003|COMPLETED|Overall Study||40
3352182|NCT03608488|4082513|FG000|NOT COMPLETED|Overall Study||1
3352183|NCT03608488|4082514|FG001|NOT COMPLETED|Overall Study||3
3352184|NCT03608488|4082515|FG002|NOT COMPLETED|Overall Study||2
3352185|NCT03608488|4082516|FG003|NOT COMPLETED|Overall Study||5
3352186|NCT03608774|4082528|FG000|STARTED|Overall Study||89
3352187|NCT03608774|4082529|FG001|STARTED|Overall Study||88
3352188|NCT03608774|4082528|FG000|COMPLETED|Overall Study||82
3352189|NCT03608774|4082529|FG001|COMPLETED|Overall Study||81
3352190|NCT03608774|4082528|FG000|NOT COMPLETED|Overall Study||7
3352191|NCT03608774|4082529|FG001|NOT COMPLETED|Overall Study||7
3352192|NCT03608839|4082538|FG000|STARTED|Overall Study||9
3352193|NCT03608839|4082539|FG001|STARTED|Overall Study||9
3352194|NCT03608839|4082540|FG002|STARTED|Overall Study||9
3352195|NCT03608839|4082538|FG000|COMPLETED|Overall Study||9
3352196|NCT03608839|4082539|FG001|COMPLETED|Overall Study||9
3352197|NCT03608839|4082540|FG002|COMPLETED|Overall Study||9
3352198|NCT03608839|4082538|FG000|NOT COMPLETED|Overall Study||0
3352199|NCT03608839|4082539|FG001|NOT COMPLETED|Overall Study||0
3352200|NCT03608839|4082540|FG002|NOT COMPLETED|Overall Study||0
3352201|NCT03609619|4082550|FG000|STARTED|Overall Study||54
3352202|NCT03609619|4082551|FG001|STARTED|Overall Study||55
3352203|NCT03609619|4082550|FG000|COMPLETED|Overall Study||44
3352204|NCT03609619|4082551|FG001|COMPLETED|Overall Study||49
3352205|NCT03609619|4082550|FG000|NOT COMPLETED|Overall Study||10
3352206|NCT03609619|4082551|FG001|NOT COMPLETED|Overall Study||6
3352207|NCT03609658|4082559|FG000|STARTED|Overall Study||379
3352208|NCT03609658|4082560|FG001|STARTED|Overall Study||380
3352209|NCT03609658|4082559|FG000|COMPLETED|Overall Study||379
3352210|NCT03609658|4082560|FG001|COMPLETED|Overall Study||380
3178751|NCT01979523|3906850|FG001|STARTED|Overall Study||21
3178752|NCT01979523|3906849|FG000|COMPLETED|Overall Study||20
3178753|NCT01979523|3906850|FG001|COMPLETED|Overall Study||21
3178754|NCT01979523|3906849|FG000|NOT COMPLETED|Overall Study||1
3178755|NCT01979523|3906850|FG001|NOT COMPLETED|Overall Study||0
3352211|NCT03609658|4082559|FG000|NOT COMPLETED|Overall Study||0
3352212|NCT03609658|4082560|FG001|NOT COMPLETED|Overall Study||0
3352213|NCT03610048|4082566|FG000|STARTED|Overall Study||175
3352214|NCT03610048|4082566|FG000|Completed Treatment|Overall Study||15
3352215|NCT03610048|4082566|FG000|COMPLETED|Overall Study||14
3352216|NCT03610048|4082566|FG000|NOT COMPLETED|Overall Study||161
3352217|NCT03610165|4082572|FG000|STARTED|Overall Study||108
3352218|NCT03610165|4082573|FG001|STARTED|Overall Study||106
3352219|NCT03610165|4082572|FG000|COMPLETED|Overall Study||108
3352220|NCT03610165|4082573|FG001|COMPLETED|Overall Study||105
3352221|NCT03610165|4082572|FG000|NOT COMPLETED|Overall Study||0
3352222|NCT03610165|4082573|FG001|NOT COMPLETED|Overall Study||1
3352223|NCT03610269|4082579|FG000|STARTED|Overall Study||143
3352224|NCT03610269|4082579|FG000|COMPLETED|Overall Study||127
3352225|NCT03610269|4082579|FG000|NOT COMPLETED|Overall Study||16
3178756|NCT01979614|3906859|FG000|STARTED|Overall Study||30
3178757|NCT01979614|3906860|FG001|STARTED|Overall Study||28
3178758|NCT01979614|3906859|FG000|Safety Analysis Set|Overall Study||30
3178759|NCT01979614|3906860|FG001|Safety Analysis Set|Overall Study||28
3178760|NCT01979614|3906859|FG000|PK Analysis Set|Overall Study||30
3178761|NCT01979614|3906860|FG001|PK Analysis Set|Overall Study||0
3178762|NCT01979614|3906859|FG000|PD Analysis Set|Overall Study||25
3352226|NCT03610399|4082586|FG000|STARTED|Overall Study||63
3352227|NCT03610399|4082587|FG001|STARTED|Overall Study||96
3352228|NCT03610399|4082588|FG002|STARTED|Overall Study||95
3352229|NCT03610399|4082586|FG000|COMPLETED|Overall Study||53
3352230|NCT03610399|4082587|FG001|COMPLETED|Overall Study||78
3352231|NCT03610399|4082588|FG002|COMPLETED|Overall Study||79
3352232|NCT03610399|4082586|FG000|NOT COMPLETED|Overall Study||10
3352233|NCT03610399|4082587|FG001|NOT COMPLETED|Overall Study||18
3352234|NCT03610399|4082588|FG002|NOT COMPLETED|Overall Study||16
3352235|NCT03610464|4082596|FG000|STARTED|Overall Study||5
3352236|NCT03610464|4082596|FG000|COMPLETED|Overall Study||5
3352237|NCT03610464|4082596|FG000|NOT COMPLETED|Overall Study||0
3352238|NCT03610581|4082603|FG000|STARTED|Overall Study||5
3352239|NCT03610581|4082604|FG001|STARTED|Overall Study||4
3352240|NCT03610581|4082603|FG000|Vaccinated|Overall Study||4
3352241|NCT03610581|4082604|FG001|Vaccinated|Overall Study||4
3352242|NCT03610581|4082603|FG000|COMPLETED|Overall Study||2
3352243|NCT03610581|4082604|FG001|COMPLETED|Overall Study||3
3352244|NCT03610581|4082603|FG000|NOT COMPLETED|Overall Study||3
3352245|NCT03610581|4082604|FG001|NOT COMPLETED|Overall Study||1
3352246|NCT03610633|4082612|FG000|STARTED|Overall Study||5
3352247|NCT03610633|4082613|FG001|STARTED|Overall Study||6
3352248|NCT03610633|4082612|FG000|COMPLETED|Overall Study||5
3352249|NCT03610633|4082613|FG001|COMPLETED|Overall Study||5
3352250|NCT03610633|4082612|FG000|NOT COMPLETED|Overall Study||0
3352251|NCT03610633|4082613|FG001|NOT COMPLETED|Overall Study||1
3352252|NCT03611062|4082621|FG000|STARTED|Overall Study||14
3352253|NCT03611062|4082622|FG001|STARTED|Overall Study||13
3352254|NCT03611062|4082621|FG000|COMPLETED|Overall Study||13
3352255|NCT03611062|4082622|FG001|COMPLETED|Overall Study||12
3352256|NCT03611062|4082621|FG000|NOT COMPLETED|Overall Study||1
3352257|NCT03611062|4082622|FG001|NOT COMPLETED|Overall Study||1
3352258|NCT03611075|4082637|FG000|STARTED|Overall Study||16
3352259|NCT03611075|4082638|FG001|STARTED|Overall Study||15
3352260|NCT03611075|4082639|FG002|STARTED|Overall Study||16
3352261|NCT03611075|4082640|FG003|STARTED|Overall Study||17
3352262|NCT03611075|4082641|FG004|STARTED|Overall Study||13
3352263|NCT03611075|4082642|FG005|STARTED|Overall Study||18
3352264|NCT03611075|4082643|FG006|STARTED|Overall Study||15
3352265|NCT03611075|4082644|FG007|STARTED|Overall Study||17
3352266|NCT03611075|4082645|FG008|STARTED|Overall Study||17
3352267|NCT03611075|4082637|FG000|COMPLETED|Overall Study||15
3352268|NCT03611075|4082638|FG001|COMPLETED|Overall Study||13
3352269|NCT03611075|4082639|FG002|COMPLETED|Overall Study||14
3352270|NCT03611075|4082640|FG003|COMPLETED|Overall Study||13
3352271|NCT03611075|4082641|FG004|COMPLETED|Overall Study||13
3352272|NCT03611075|4082642|FG005|COMPLETED|Overall Study||18
3352273|NCT03611075|4082643|FG006|COMPLETED|Overall Study||13
3352274|NCT03611075|4082644|FG007|COMPLETED|Overall Study||17
3352275|NCT03611075|4082645|FG008|COMPLETED|Overall Study||17
3352276|NCT03611075|4082637|FG000|NOT COMPLETED|Overall Study||1
3352277|NCT03611075|4082638|FG001|NOT COMPLETED|Overall Study||2
3352278|NCT03611075|4082639|FG002|NOT COMPLETED|Overall Study||2
3352279|NCT03611075|4082640|FG003|NOT COMPLETED|Overall Study||4
3352280|NCT03611075|4082641|FG004|NOT COMPLETED|Overall Study||0
3352281|NCT03611075|4082642|FG005|NOT COMPLETED|Overall Study||0
3352282|NCT03611075|4082643|FG006|NOT COMPLETED|Overall Study||2
3352283|NCT03611075|4082644|FG007|NOT COMPLETED|Overall Study||0
3352284|NCT03611075|4082645|FG008|NOT COMPLETED|Overall Study||0
3352285|NCT03611582|4082690|FG000|STARTED|Overall Study||407
3352286|NCT03611582|4082691|FG001|STARTED|Overall Study||204
3352287|NCT03611582|4082690|FG000|Full Analysis Set (FAS)|Overall Study||407
3352288|NCT03611582|4082691|FG001|Full Analysis Set (FAS)|Overall Study||204
3352289|NCT03611582|4082690|FG000|Safety Analysis Set (SAS)|Overall Study||407
3352290|NCT03611582|4082691|FG001|Safety Analysis Set (SAS)|Overall Study||204
3352291|NCT03611582|4082690|FG000|COMPLETED|Overall Study||339
3352292|NCT03611582|4082691|FG001|COMPLETED|Overall Study||166
3352293|NCT03611582|4082690|FG000|NOT COMPLETED|Overall Study||68
3352294|NCT03611582|4082691|FG001|NOT COMPLETED|Overall Study||38
3352295|NCT03611777|4082699|FG000|STARTED|Overall Study||432
3352296|NCT03611777|4082700|FG001|STARTED|Overall Study||469
3352297|NCT03611777|4082699|FG000|COMPLETED|Overall Study||432
3352298|NCT03611777|4082700|FG001|COMPLETED|Overall Study||469
3352299|NCT03611777|4082699|FG000|NOT COMPLETED|Overall Study||0
3352300|NCT03611777|4082700|FG001|NOT COMPLETED|Overall Study||0
3352301|NCT03611829|4082711|FG000|STARTED|Overall Study||43
3352302|NCT03611829|4082712|FG001|STARTED|Overall Study||44
3352303|NCT03611829|4082711|FG000|COMPLETED|Overall Study||21
3352304|NCT03611829|4082712|FG001|COMPLETED|Overall Study||19
3352305|NCT03611829|4082711|FG000|NOT COMPLETED|Overall Study||22
3352306|NCT03611829|4082712|FG001|NOT COMPLETED|Overall Study||25
3352307|NCT03612856|4082722|FG000|STARTED|Pre-dose Period||8
3352308|NCT03612856|4082723|FG001|STARTED|Pre-dose Period||10
3352309|NCT03612856|4082724|FG002|STARTED|Pre-dose Period||9
3352310|NCT03612856|4082722|FG000|COMPLETED|Pre-dose Period||8
3352311|NCT03612856|4082723|FG001|COMPLETED|Pre-dose Period||8
3352312|NCT03612856|4082724|FG002|COMPLETED|Pre-dose Period||8
3352313|NCT03612856|4082722|FG000|NOT COMPLETED|Pre-dose Period||0
3352314|NCT03612856|4082723|FG001|NOT COMPLETED|Pre-dose Period||2
3352315|NCT03612856|4082724|FG002|NOT COMPLETED|Pre-dose Period||1
3352316|NCT03612856|4082722|FG000|STARTED|Post-dose Period||8
3178763|NCT01979614|3906860|FG001|PD Analysis Set|Overall Study||26
3178764|NCT01979614|3906859|FG000|COMPLETED|Overall Study||29
3178765|NCT01979614|3906860|FG001|COMPLETED|Overall Study||27
3178766|NCT01979614|3906859|FG000|NOT COMPLETED|Overall Study||1
3352317|NCT03612856|4082723|FG001|STARTED|Post-dose Period||8
3352318|NCT03612856|4082724|FG002|STARTED|Post-dose Period||8
3352319|NCT03612856|4082722|FG000|COMPLETED|Post-dose Period||8
3352320|NCT03612856|4082723|FG001|COMPLETED|Post-dose Period||8
3352321|NCT03612856|4082724|FG002|COMPLETED|Post-dose Period||8
3352322|NCT03612856|4082722|FG000|NOT COMPLETED|Post-dose Period||0
3352323|NCT03612856|4082723|FG001|NOT COMPLETED|Post-dose Period||0
3352324|NCT03612856|4082724|FG002|NOT COMPLETED|Post-dose Period||0
3352325|NCT03613129|4082736|FG000|STARTED|Pre-treatment Assessment||3
3352326|NCT03613129|4082737|FG001|STARTED|Pre-treatment Assessment||3
3352327|NCT03613129|4082738|FG002|STARTED|Pre-treatment Assessment||7
3352328|NCT03613129|4082739|FG003|STARTED|Pre-treatment Assessment||2
3352329|NCT03613129|4082740|FG004|STARTED|Pre-treatment Assessment||2
3352330|NCT03613129|4082736|FG000|COMPLETED|Pre-treatment Assessment||0
3352331|NCT03613129|4082737|FG001|COMPLETED|Pre-treatment Assessment||3
3352332|NCT03613129|4082738|FG002|COMPLETED|Pre-treatment Assessment||7
3352333|NCT03613129|4082739|FG003|COMPLETED|Pre-treatment Assessment||2
3352334|NCT03613129|4082740|FG004|COMPLETED|Pre-treatment Assessment||2
3352335|NCT03613129|4082736|FG000|NOT COMPLETED|Pre-treatment Assessment||3
3352336|NCT03613129|4082737|FG001|NOT COMPLETED|Pre-treatment Assessment||0
3352337|NCT03613129|4082738|FG002|NOT COMPLETED|Pre-treatment Assessment||0
3352338|NCT03613129|4082739|FG003|NOT COMPLETED|Pre-treatment Assessment||0
3352339|NCT03613129|4082740|FG004|NOT COMPLETED|Pre-treatment Assessment||0
3352340|NCT03613129|4082736|FG000|STARTED|Treatment||0
3352341|NCT03613129|4082737|FG001|STARTED|Treatment||3
3352342|NCT03613129|4082738|FG002|STARTED|Treatment||7
3352343|NCT03613129|4082739|FG003|STARTED|Treatment||2
3352344|NCT03613129|4082740|FG004|STARTED|Treatment||2
3352345|NCT03613129|4082736|FG000|COMPLETED|Treatment||0
3352346|NCT03613129|4082737|FG001|COMPLETED|Treatment|ID35 received only 1 infusion (due to symptom worsening)|3
3352347|NCT03613129|4082738|FG002|COMPLETED|Treatment||7
3352348|NCT03613129|4082739|FG003|COMPLETED|Treatment|ID34 did not receive 3rd infusion (for lack of venous access)|2
3352349|NCT03613129|4082740|FG004|COMPLETED|Treatment||2
3352350|NCT03613129|4082736|FG000|NOT COMPLETED|Treatment||0
3352351|NCT03613129|4082737|FG001|NOT COMPLETED|Treatment||0
3352352|NCT03613129|4082738|FG002|NOT COMPLETED|Treatment||0
3352353|NCT03613129|4082739|FG003|NOT COMPLETED|Treatment||0
3352354|NCT03613129|4082740|FG004|NOT COMPLETED|Treatment||0
3352355|NCT03613129|4082736|FG000|STARTED|Post-treatment Assessment||0
3352356|NCT03613129|4082737|FG001|STARTED|Post-treatment Assessment||3
3352357|NCT03613129|4082738|FG002|STARTED|Post-treatment Assessment||7
3352358|NCT03613129|4082739|FG003|STARTED|Post-treatment Assessment||2
3352359|NCT03613129|4082740|FG004|STARTED|Post-treatment Assessment||2
3352360|NCT03613129|4082736|FG000|COMPLETED|Post-treatment Assessment||0
3352361|NCT03613129|4082737|FG001|COMPLETED|Post-treatment Assessment||3
3178767|NCT01979614|3906860|FG001|NOT COMPLETED|Overall Study||1
3352362|NCT03613129|4082738|FG002|COMPLETED|Post-treatment Assessment||7
3352363|NCT03613129|4082739|FG003|COMPLETED|Post-treatment Assessment||2
3352364|NCT03613129|4082740|FG004|COMPLETED|Post-treatment Assessment||2
3352365|NCT03613129|4082736|FG000|NOT COMPLETED|Post-treatment Assessment||0
3352366|NCT03613129|4082737|FG001|NOT COMPLETED|Post-treatment Assessment||0
3352367|NCT03613129|4082738|FG002|NOT COMPLETED|Post-treatment Assessment||0
3352368|NCT03613129|4082739|FG003|NOT COMPLETED|Post-treatment Assessment||0
3352369|NCT03613129|4082740|FG004|NOT COMPLETED|Post-treatment Assessment||0
3352370|NCT03613454|4082754|FG000|STARTED|Overall Study||24
3352371|NCT03613454|4082755|FG001|STARTED|Overall Study||24
3352372|NCT03613454|4082754|FG000|COMPLETED|Overall Study||23
3352373|NCT03613454|4082755|FG001|COMPLETED|Overall Study||23
3352374|NCT03613454|4082754|FG000|NOT COMPLETED|Overall Study||1
3352375|NCT03613454|4082755|FG001|NOT COMPLETED|Overall Study||1
3352376|NCT03613493|4082765|FG000|STARTED|Overall Study||10
3352377|NCT03613493|4082766|FG001|STARTED|Overall Study||75
3352378|NCT03613493|4082767|FG002|STARTED|Overall Study||0
3352379|NCT03613493|4082768|FG003|STARTED|Overall Study||90
3352380|NCT03613493|4082765|FG000|Enrollment Criteria Met|Overall Study||10
3352381|NCT03613493|4082766|FG001|Enrollment Criteria Met|Overall Study||74
3352382|NCT03613493|4082767|FG002|Enrollment Criteria Met|Overall Study||0
3352383|NCT03613493|4082768|FG003|Enrollment Criteria Met|Overall Study||89
3352384|NCT03613493|4082765|FG000|COMPLETED|Overall Study||10
3352385|NCT03613493|4082766|FG001|COMPLETED|Overall Study||73
3352386|NCT03613493|4082767|FG002|COMPLETED|Overall Study||0
3352387|NCT03613493|4082768|FG003|COMPLETED|Overall Study||83
3352388|NCT03613493|4082765|FG000|NOT COMPLETED|Overall Study||0
3178768|NCT01979835|3906866|FG000|STARTED|Primary Outcome SA Measurment||1030
3178769|NCT01979835|3906866|FG000|COMPLETED|Primary Outcome SA Measurment||1012
3352389|NCT03613493|4082766|FG001|NOT COMPLETED|Overall Study||2
3352390|NCT03613493|4082767|FG002|NOT COMPLETED|Overall Study||0
3352391|NCT03613493|4082768|FG003|NOT COMPLETED|Overall Study||7
3352392|NCT03613649|4082789|FG000|STARTED|First Treatment||6
3352393|NCT03613649|4082790|FG001|STARTED|First Treatment||6
3352394|NCT03613649|4082791|FG002|STARTED|First Treatment||6
3352395|NCT03613649|4082792|FG003|STARTED|First Treatment||6
3352396|NCT03613649|4082793|FG004|STARTED|First Treatment||6
3352397|NCT03613649|4082794|FG005|STARTED|First Treatment||6
3352398|NCT03613649|4082795|FG006|STARTED|First Treatment||6
3352399|NCT03613649|4082796|FG007|STARTED|First Treatment||6
3352400|NCT03613649|4082797|FG008|STARTED|First Treatment||6
3352401|NCT03613649|4082798|FG009|STARTED|First Treatment||6
3352402|NCT03613649|4082799|FG010|STARTED|First Treatment||6
3352403|NCT03613649|4082800|FG011|STARTED|First Treatment||6
3352404|NCT03613649|4082789|FG000|Received Treatment|First Treatment||6
3352405|NCT03613649|4082790|FG001|Received Treatment|First Treatment||6
3352406|NCT03613649|4082791|FG002|Received Treatment|First Treatment||6
3352407|NCT03613649|4082792|FG003|Received Treatment|First Treatment||6
3352408|NCT03613649|4082793|FG004|Received Treatment|First Treatment||6
3352409|NCT03613649|4082794|FG005|Received Treatment|First Treatment||6
3352410|NCT03613649|4082795|FG006|Received Treatment|First Treatment||6
3352411|NCT03613649|4082796|FG007|Received Treatment|First Treatment||6
3352412|NCT03613649|4082797|FG008|Received Treatment|First Treatment||6
3352413|NCT03613649|4082798|FG009|Received Treatment|First Treatment||6
3178770|NCT01979835|3906866|FG000|NOT COMPLETED|Primary Outcome SA Measurment||18
3178771|NCT01979835|3906866|FG000|STARTED|Follow-up||1012
3178772|NCT01979835|3906866|FG000|COMPLETED|Follow-up||980
3178773|NCT01979835|3906866|FG000|NOT COMPLETED|Follow-up||32
3178774|NCT01979952|3906872|FG000|STARTED|Overall Study||56
3352414|NCT03613649|4082799|FG010|Received Treatment|First Treatment||6
3352415|NCT03613649|4082800|FG011|Received Treatment|First Treatment||6
3352416|NCT03613649|4082789|FG000|COMPLETED|First Treatment||6
3352417|NCT03613649|4082790|FG001|COMPLETED|First Treatment||6
3352418|NCT03613649|4082791|FG002|COMPLETED|First Treatment||6
3352419|NCT03613649|4082792|FG003|COMPLETED|First Treatment||6
3352420|NCT03613649|4082793|FG004|COMPLETED|First Treatment||6
3352421|NCT03613649|4082794|FG005|COMPLETED|First Treatment||6
3352422|NCT03613649|4082795|FG006|COMPLETED|First Treatment||6
3352423|NCT03613649|4082796|FG007|COMPLETED|First Treatment||6
3352424|NCT03613649|4082797|FG008|COMPLETED|First Treatment||6
3352425|NCT03613649|4082798|FG009|COMPLETED|First Treatment||6
3352426|NCT03613649|4082799|FG010|COMPLETED|First Treatment||6
3352427|NCT03613649|4082800|FG011|COMPLETED|First Treatment||6
3352428|NCT03613649|4082789|FG000|NOT COMPLETED|First Treatment||0
3352429|NCT03613649|4082790|FG001|NOT COMPLETED|First Treatment||0
3352430|NCT03613649|4082791|FG002|NOT COMPLETED|First Treatment||0
3352431|NCT03613649|4082792|FG003|NOT COMPLETED|First Treatment||0
3352432|NCT03613649|4082793|FG004|NOT COMPLETED|First Treatment||0
3352433|NCT03613649|4082794|FG005|NOT COMPLETED|First Treatment||0
3352434|NCT03613649|4082795|FG006|NOT COMPLETED|First Treatment||0
3352435|NCT03613649|4082796|FG007|NOT COMPLETED|First Treatment||0
3352436|NCT03613649|4082797|FG008|NOT COMPLETED|First Treatment||0
3352437|NCT03613649|4082798|FG009|NOT COMPLETED|First Treatment||0
3352438|NCT03613649|4082799|FG010|NOT COMPLETED|First Treatment||0
3352439|NCT03613649|4082800|FG011|NOT COMPLETED|First Treatment||0
3352440|NCT03613649|4082789|FG000|STARTED|Second Treatment||6
3352441|NCT03613649|4082790|FG001|STARTED|Second Treatment||6
3352442|NCT03613649|4082791|FG002|STARTED|Second Treatment||6
3352443|NCT03613649|4082792|FG003|STARTED|Second Treatment||6
3352444|NCT03613649|4082793|FG004|STARTED|Second Treatment||6
3352445|NCT03613649|4082794|FG005|STARTED|Second Treatment||6
3352446|NCT03613649|4082795|FG006|STARTED|Second Treatment||6
3352447|NCT03613649|4082796|FG007|STARTED|Second Treatment||6
3352448|NCT03613649|4082797|FG008|STARTED|Second Treatment||6
3352449|NCT03613649|4082798|FG009|STARTED|Second Treatment||6
3352450|NCT03613649|4082799|FG010|STARTED|Second Treatment||6
3352451|NCT03613649|4082800|FG011|STARTED|Second Treatment||6
3352452|NCT03613649|4082789|FG000|Received Treatment|Second Treatment||6
3352453|NCT03613649|4082790|FG001|Received Treatment|Second Treatment||6
3352454|NCT03613649|4082791|FG002|Received Treatment|Second Treatment||6
3352455|NCT03613649|4082792|FG003|Received Treatment|Second Treatment||6
3352456|NCT03613649|4082793|FG004|Received Treatment|Second Treatment||6
3352457|NCT03613649|4082794|FG005|Received Treatment|Second Treatment||6
3352458|NCT03613649|4082795|FG006|Received Treatment|Second Treatment||6
3352459|NCT03613649|4082796|FG007|Received Treatment|Second Treatment||6
3352460|NCT03613649|4082797|FG008|Received Treatment|Second Treatment||6
3352461|NCT03613649|4082798|FG009|Received Treatment|Second Treatment||6
3352462|NCT03613649|4082799|FG010|Received Treatment|Second Treatment||6
3352463|NCT03613649|4082800|FG011|Received Treatment|Second Treatment||6
3352464|NCT03613649|4082789|FG000|COMPLETED|Second Treatment||6
3352465|NCT03613649|4082790|FG001|COMPLETED|Second Treatment||6
3352466|NCT03613649|4082791|FG002|COMPLETED|Second Treatment||5
3352467|NCT03613649|4082792|FG003|COMPLETED|Second Treatment||6
3352468|NCT03613649|4082793|FG004|COMPLETED|Second Treatment||5
3352469|NCT03613649|4082794|FG005|COMPLETED|Second Treatment||6
3178775|NCT01979952|3906873|FG001|STARTED|Overall Study||57
3352470|NCT03613649|4082795|FG006|COMPLETED|Second Treatment||6
3352471|NCT03613649|4082796|FG007|COMPLETED|Second Treatment||6
3352472|NCT03613649|4082797|FG008|COMPLETED|Second Treatment||6
3352473|NCT03613649|4082798|FG009|COMPLETED|Second Treatment||6
3178776|NCT01979952|3906872|FG000|COMPLETED|Overall Study||48
3352474|NCT03613649|4082799|FG010|COMPLETED|Second Treatment||6
3352475|NCT03613649|4082800|FG011|COMPLETED|Second Treatment||6
3352476|NCT03613649|4082789|FG000|NOT COMPLETED|Second Treatment||0
3352477|NCT03613649|4082790|FG001|NOT COMPLETED|Second Treatment||0
3352478|NCT03613649|4082791|FG002|NOT COMPLETED|Second Treatment||1
3352479|NCT03613649|4082792|FG003|NOT COMPLETED|Second Treatment||0
3352480|NCT03613649|4082793|FG004|NOT COMPLETED|Second Treatment||1
3352481|NCT03613649|4082794|FG005|NOT COMPLETED|Second Treatment||0
3352482|NCT03613649|4082795|FG006|NOT COMPLETED|Second Treatment||0
3352483|NCT03613649|4082796|FG007|NOT COMPLETED|Second Treatment||0
3352484|NCT03613649|4082797|FG008|NOT COMPLETED|Second Treatment||0
3352485|NCT03613649|4082798|FG009|NOT COMPLETED|Second Treatment||0
3352486|NCT03613649|4082799|FG010|NOT COMPLETED|Second Treatment||0
3352487|NCT03613649|4082800|FG011|NOT COMPLETED|Second Treatment||0
3352488|NCT03613649|4082789|FG000|STARTED|Third Treatment||6
3352489|NCT03613649|4082790|FG001|STARTED|Third Treatment||6
3352490|NCT03613649|4082791|FG002|STARTED|Third Treatment||5
3352491|NCT03613649|4082792|FG003|STARTED|Third Treatment||6
3352492|NCT03613649|4082793|FG004|STARTED|Third Treatment||5
3352493|NCT03613649|4082794|FG005|STARTED|Third Treatment||6
3352494|NCT03613649|4082795|FG006|STARTED|Third Treatment||6
3352495|NCT03613649|4082796|FG007|STARTED|Third Treatment||6
3352496|NCT03613649|4082797|FG008|STARTED|Third Treatment||6
3352497|NCT03613649|4082798|FG009|STARTED|Third Treatment||6
3352498|NCT03613649|4082799|FG010|STARTED|Third Treatment||6
3352499|NCT03613649|4082800|FG011|STARTED|Third Treatment||6
3352500|NCT03613649|4082789|FG000|Received Treatment|Third Treatment||6
3352501|NCT03613649|4082790|FG001|Received Treatment|Third Treatment||6
3352502|NCT03613649|4082791|FG002|Received Treatment|Third Treatment||5
3352503|NCT03613649|4082792|FG003|Received Treatment|Third Treatment||6
3352504|NCT03613649|4082793|FG004|Received Treatment|Third Treatment||5
3352505|NCT03613649|4082794|FG005|Received Treatment|Third Treatment||6
3352506|NCT03613649|4082795|FG006|Received Treatment|Third Treatment||5
3352507|NCT03613649|4082796|FG007|Received Treatment|Third Treatment||6
3352508|NCT03613649|4082797|FG008|Received Treatment|Third Treatment||6
3352509|NCT03613649|4082798|FG009|Received Treatment|Third Treatment||6
3352510|NCT03613649|4082799|FG010|Received Treatment|Third Treatment||6
3352511|NCT03613649|4082800|FG011|Received Treatment|Third Treatment||6
3352512|NCT03613649|4082789|FG000|COMPLETED|Third Treatment||6
3352513|NCT03613649|4082790|FG001|COMPLETED|Third Treatment||6
3352514|NCT03613649|4082791|FG002|COMPLETED|Third Treatment||5
3352515|NCT03613649|4082792|FG003|COMPLETED|Third Treatment||6
3352516|NCT03613649|4082793|FG004|COMPLETED|Third Treatment||4
3352517|NCT03613649|4082794|FG005|COMPLETED|Third Treatment||6
3352518|NCT03613649|4082795|FG006|COMPLETED|Third Treatment||5
3352519|NCT03613649|4082796|FG007|COMPLETED|Third Treatment||6
3352520|NCT03613649|4082797|FG008|COMPLETED|Third Treatment||6
3352521|NCT03613649|4082798|FG009|COMPLETED|Third Treatment||6
3352522|NCT03613649|4082799|FG010|COMPLETED|Third Treatment||6
3352523|NCT03613649|4082800|FG011|COMPLETED|Third Treatment||4
3352524|NCT03613649|4082789|FG000|NOT COMPLETED|Third Treatment||0
3352525|NCT03613649|4082790|FG001|NOT COMPLETED|Third Treatment||0
3352526|NCT03613649|4082791|FG002|NOT COMPLETED|Third Treatment||0
3352527|NCT03613649|4082792|FG003|NOT COMPLETED|Third Treatment||0
3352528|NCT03613649|4082793|FG004|NOT COMPLETED|Third Treatment||1
3352529|NCT03613649|4082794|FG005|NOT COMPLETED|Third Treatment||0
3352530|NCT03613649|4082795|FG006|NOT COMPLETED|Third Treatment||1
3352531|NCT03613649|4082796|FG007|NOT COMPLETED|Third Treatment||0
3352532|NCT03613649|4082797|FG008|NOT COMPLETED|Third Treatment||0
3352533|NCT03613649|4082798|FG009|NOT COMPLETED|Third Treatment||0
3352534|NCT03613649|4082799|FG010|NOT COMPLETED|Third Treatment||0
3352535|NCT03613649|4082800|FG011|NOT COMPLETED|Third Treatment||2
3178777|NCT01979952|3906873|FG001|COMPLETED|Overall Study||51
3178778|NCT01979952|3906872|FG000|NOT COMPLETED|Overall Study||8
3178779|NCT01979952|3906873|FG001|NOT COMPLETED|Overall Study||6
3178780|NCT01980056|3906882|FG000|STARTED|Overall Study||4
3352536|NCT03613649|4082789|FG000|STARTED|Fourth Treatment||6
3352537|NCT03613649|4082790|FG001|STARTED|Fourth Treatment||6
3352538|NCT03613649|4082791|FG002|STARTED|Fourth Treatment||5
3352539|NCT03613649|4082792|FG003|STARTED|Fourth Treatment||6
3352540|NCT03613649|4082793|FG004|STARTED|Fourth Treatment||4
3352541|NCT03613649|4082794|FG005|STARTED|Fourth Treatment||6
3352542|NCT03613649|4082795|FG006|STARTED|Fourth Treatment||5
3352543|NCT03613649|4082796|FG007|STARTED|Fourth Treatment||6
3352544|NCT03613649|4082797|FG008|STARTED|Fourth Treatment||6
3352545|NCT03613649|4082798|FG009|STARTED|Fourth Treatment||6
3352546|NCT03613649|4082799|FG010|STARTED|Fourth Treatment||6
3352547|NCT03613649|4082800|FG011|STARTED|Fourth Treatment||4
3352548|NCT03613649|4082789|FG000|Received Treatment|Fourth Treatment||5
3352549|NCT03613649|4082790|FG001|Received Treatment|Fourth Treatment||6
3352550|NCT03613649|4082791|FG002|Received Treatment|Fourth Treatment||5
3352551|NCT03613649|4082792|FG003|Received Treatment|Fourth Treatment||6
3352552|NCT03613649|4082793|FG004|Received Treatment|Fourth Treatment||4
3352553|NCT03613649|4082794|FG005|Received Treatment|Fourth Treatment||6
3352554|NCT03613649|4082795|FG006|Received Treatment|Fourth Treatment||4
3352555|NCT03613649|4082796|FG007|Received Treatment|Fourth Treatment||6
3352556|NCT03613649|4082797|FG008|Received Treatment|Fourth Treatment||6
3352557|NCT03613649|4082798|FG009|Received Treatment|Fourth Treatment||6
3352558|NCT03613649|4082799|FG010|Received Treatment|Fourth Treatment||6
3352559|NCT03613649|4082800|FG011|Received Treatment|Fourth Treatment||4
3352560|NCT03613649|4082789|FG000|COMPLETED|Fourth Treatment||5
3352561|NCT03613649|4082790|FG001|COMPLETED|Fourth Treatment||6
3352562|NCT03613649|4082791|FG002|COMPLETED|Fourth Treatment||5
3352563|NCT03613649|4082792|FG003|COMPLETED|Fourth Treatment||6
3352564|NCT03613649|4082793|FG004|COMPLETED|Fourth Treatment||3
3352565|NCT03613649|4082794|FG005|COMPLETED|Fourth Treatment||6
3352566|NCT03613649|4082795|FG006|COMPLETED|Fourth Treatment||4
3352567|NCT03613649|4082796|FG007|COMPLETED|Fourth Treatment||6
3352568|NCT03613649|4082797|FG008|COMPLETED|Fourth Treatment||6
3352569|NCT03613649|4082798|FG009|COMPLETED|Fourth Treatment||6
3352570|NCT03613649|4082799|FG010|COMPLETED|Fourth Treatment||6
3352571|NCT03613649|4082800|FG011|COMPLETED|Fourth Treatment||4
3352572|NCT03613649|4082789|FG000|NOT COMPLETED|Fourth Treatment||1
3352573|NCT03613649|4082790|FG001|NOT COMPLETED|Fourth Treatment||0
3352574|NCT03613649|4082791|FG002|NOT COMPLETED|Fourth Treatment||0
3352575|NCT03613649|4082792|FG003|NOT COMPLETED|Fourth Treatment||0
3352576|NCT03613649|4082793|FG004|NOT COMPLETED|Fourth Treatment||1
3352577|NCT03613649|4082794|FG005|NOT COMPLETED|Fourth Treatment||0
3352578|NCT03613649|4082795|FG006|NOT COMPLETED|Fourth Treatment||1
3352579|NCT03613649|4082796|FG007|NOT COMPLETED|Fourth Treatment||0
3352580|NCT03613649|4082797|FG008|NOT COMPLETED|Fourth Treatment||0
3352581|NCT03613649|4082798|FG009|NOT COMPLETED|Fourth Treatment||0
3352582|NCT03613649|4082799|FG010|NOT COMPLETED|Fourth Treatment||0
3352583|NCT03613649|4082800|FG011|NOT COMPLETED|Fourth Treatment||0
3352584|NCT03613818|4082820|FG000|STARTED|Overall Study||174
3352585|NCT03613818|4082821|FG001|STARTED|Overall Study||137
3352586|NCT03613818|4082820|FG000|COMPLETED|Overall Study||137
3352587|NCT03613818|4082821|FG001|COMPLETED|Overall Study||110
3352588|NCT03613818|4082820|FG000|NOT COMPLETED|Overall Study||37
3352589|NCT03613818|4082821|FG001|NOT COMPLETED|Overall Study||27
3352590|NCT03614078|4082830|FG000|STARTED|Overall Study||31
3352591|NCT03614078|4082831|FG001|STARTED|Overall Study||30
3352592|NCT03614078|4082832|FG002|STARTED|Overall Study||31
3352593|NCT03614078|4082830|FG000|COMPLETED|Overall Study||28
3352594|NCT03614078|4082831|FG001|COMPLETED|Overall Study||23
3352595|NCT03614078|4082832|FG002|COMPLETED|Overall Study||26
3352596|NCT03614078|4082830|FG000|NOT COMPLETED|Overall Study||3
3352597|NCT03614078|4082831|FG001|NOT COMPLETED|Overall Study||7
3352598|NCT03614078|4082832|FG002|NOT COMPLETED|Overall Study||5
3352599|NCT03614130|4082842|FG000|STARTED|Overall Study||10
3352600|NCT03614130|4082843|FG001|STARTED|Overall Study||12
3352601|NCT03614130|4082842|FG000|COMPLETED|Overall Study||10
3352602|NCT03614130|4082843|FG001|COMPLETED|Overall Study||12
3352603|NCT03614130|4082842|FG000|NOT COMPLETED|Overall Study||0
3352604|NCT03614130|4082843|FG001|NOT COMPLETED|Overall Study||0
3352605|NCT03614156|4082854|FG000|STARTED|Open-Label Treatment Period||363
3352606|NCT03614156|4082855|FG001|STARTED|Open-Label Treatment Period||0
3352607|NCT03614156|4082856|FG002|STARTED|Open-Label Treatment Period||0
3352608|NCT03614156|4082857|FG003|STARTED|Open-Label Treatment Period||0
3352609|NCT03614156|4082854|FG000|COMPLETED|Open-Label Treatment Period||209
3352610|NCT03614156|4082855|FG001|COMPLETED|Open-Label Treatment Period||0
3352611|NCT03614156|4082856|FG002|COMPLETED|Open-Label Treatment Period||0
3352612|NCT03614156|4082857|FG003|COMPLETED|Open-Label Treatment Period||0
3352613|NCT03614156|4082854|FG000|NOT COMPLETED|Open-Label Treatment Period||154
3352614|NCT03614156|4082855|FG001|NOT COMPLETED|Open-Label Treatment Period||0
3352615|NCT03614156|4082856|FG002|NOT COMPLETED|Open-Label Treatment Period||0
3352616|NCT03614156|4082857|FG003|NOT COMPLETED|Open-Label Treatment Period||0
3352617|NCT03614156|4082854|FG000|STARTED|Double-Blind Treatment Period (DBTP)||0
3352618|NCT03614156|4082855|FG001|STARTED|Double-Blind Treatment Period (DBTP)||40
3352619|NCT03614156|4082856|FG002|STARTED|Double-Blind Treatment Period (DBTP)||42
3352620|NCT03614156|4082857|FG003|STARTED|Double-Blind Treatment Period (DBTP)||55
3352621|NCT03614156|4082854|FG000|COMPLETED|Double-Blind Treatment Period (DBTP)||0
3352622|NCT03614156|4082855|FG001|COMPLETED|Double-Blind Treatment Period (DBTP)||10
3352623|NCT03614156|4082856|FG002|COMPLETED|Double-Blind Treatment Period (DBTP)||11
3352624|NCT03614156|4082857|FG003|COMPLETED|Double-Blind Treatment Period (DBTP)||10
3352625|NCT03614156|4082854|FG000|NOT COMPLETED|Double-Blind Treatment Period (DBTP)||0
3352626|NCT03614156|4082855|FG001|NOT COMPLETED|Double-Blind Treatment Period (DBTP)||30
3352627|NCT03614156|4082856|FG002|NOT COMPLETED|Double-Blind Treatment Period (DBTP)||31
3352628|NCT03614156|4082857|FG003|NOT COMPLETED|Double-Blind Treatment Period (DBTP)||45
3352629|NCT03614156|4082854|FG000|STARTED|Safety Follow-Up Period||165
3352630|NCT03614156|4082855|FG001|STARTED|Safety Follow-Up Period||26
3352631|NCT03614156|4082856|FG002|STARTED|Safety Follow-Up Period||30
3352632|NCT03614156|4082857|FG003|STARTED|Safety Follow-Up Period||35
3352633|NCT03614156|4082854|FG000|COMPLETED|Safety Follow-Up Period||162
3352634|NCT03614156|4082855|FG001|COMPLETED|Safety Follow-Up Period||26
3352635|NCT03614156|4082856|FG002|COMPLETED|Safety Follow-Up Period||29
3352636|NCT03614156|4082857|FG003|COMPLETED|Safety Follow-Up Period||34
3352637|NCT03614156|4082854|FG000|NOT COMPLETED|Safety Follow-Up Period||3
3352638|NCT03614156|4082855|FG001|NOT COMPLETED|Safety Follow-Up Period||0
3352639|NCT03614156|4082856|FG002|NOT COMPLETED|Safety Follow-Up Period||1
3352640|NCT03614156|4082857|FG003|NOT COMPLETED|Safety Follow-Up Period||1
3352641|NCT03614416|4082866|FG000|STARTED|Overall Study||13
3352642|NCT03614416|4082866|FG000|COMPLETED|Overall Study||13
3352643|NCT03614416|4082866|FG000|NOT COMPLETED|Overall Study||0
3352644|NCT03614975|4082874|FG000|STARTED|Overall Study||85
3352645|NCT03614975|4082875|FG001|STARTED|Overall Study||81
3352646|NCT03614975|4082874|FG000|COMPLETED|Overall Study||75
3352647|NCT03614975|4082875|FG001|COMPLETED|Overall Study||73
3352648|NCT03614975|4082874|FG000|NOT COMPLETED|Overall Study||10
3352649|NCT03614975|4082875|FG001|NOT COMPLETED|Overall Study||8
3352650|NCT03615001|4082881|FG000|STARTED|Overall Study||20
3352651|NCT03615001|4082881|FG000|COMPLETED|Overall Study||20
3352652|NCT03615001|4082881|FG000|NOT COMPLETED|Overall Study||0
3352653|NCT03615066|4082888|FG000|STARTED|Overall Study||26
3352654|NCT03615066|4082889|FG001|STARTED|Overall Study||28
3352655|NCT03615066|4082890|FG002|STARTED|Overall Study||13
3352656|NCT03615066|4082888|FG000|COMPLETED|Overall Study||17
3352657|NCT03615066|4082889|FG001|COMPLETED|Overall Study||20
3352658|NCT03615066|4082890|FG002|COMPLETED|Overall Study||9
3352659|NCT03615066|4082888|FG000|NOT COMPLETED|Overall Study||9
3352660|NCT03615066|4082889|FG001|NOT COMPLETED|Overall Study||8
3352661|NCT03615066|4082890|FG002|NOT COMPLETED|Overall Study||4
3352662|NCT03615079|4082902|FG000|STARTED|Overall Study||28
3352663|NCT03615079|4082902|FG000|COMPLETED|Overall Study||11
3352664|NCT03615079|4082902|FG000|NOT COMPLETED|Overall Study||17
3352665|NCT03615183|4082911|FG000|STARTED|Overall Study||6
3352666|NCT03615183|4082912|FG001|STARTED|Overall Study||6
3352667|NCT03615183|4082913|FG002|STARTED|Overall Study||5
3352668|NCT03615183|4082914|FG003|STARTED|Overall Study|Panel D was not conducted as the scientific study objectives were met in the conducted panels.|0
3178781|NCT01980056|3906883|FG001|STARTED|Overall Study||4
3178782|NCT01980056|3906884|FG002|STARTED|Overall Study||2
3178783|NCT01980056|3906882|FG000|COMPLETED|Overall Study||3
3178784|NCT01980056|3906883|FG001|COMPLETED|Overall Study||3
3178785|NCT01980056|3906884|FG002|COMPLETED|Overall Study||2
3178786|NCT01980056|3906882|FG000|NOT COMPLETED|Overall Study||1
3178787|NCT01980056|3906883|FG001|NOT COMPLETED|Overall Study||1
3178788|NCT01980056|3906884|FG002|NOT COMPLETED|Overall Study||0
3352669|NCT03615183|4082915|FG004|STARTED|Overall Study|Panel E was not conducted as the scientific study objectives were met in the conducted panels.|0
3352670|NCT03615183|4082911|FG000|COMPLETED|Overall Study||6
3352671|NCT03615183|4082912|FG001|COMPLETED|Overall Study||6
3352672|NCT03615183|4082913|FG002|COMPLETED|Overall Study||5
3352673|NCT03615183|4082914|FG003|COMPLETED|Overall Study||0
3352674|NCT03615183|4082915|FG004|COMPLETED|Overall Study||0
3352675|NCT03615183|4082911|FG000|NOT COMPLETED|Overall Study||0
3352676|NCT03615183|4082912|FG001|NOT COMPLETED|Overall Study||0
3352677|NCT03615183|4082913|FG002|NOT COMPLETED|Overall Study||0
3352678|NCT03615183|4082914|FG003|NOT COMPLETED|Overall Study||0
3352679|NCT03615183|4082915|FG004|NOT COMPLETED|Overall Study||0
3352680|NCT03615404|4082923|FG000|STARTED|Overall Study||11
3352681|NCT03615404|4082923|FG000|COMPLETED|Overall Study||9
3352682|NCT03615404|4082923|FG000|NOT COMPLETED|Overall Study||2
3352683|NCT03615482|4082929|FG000|STARTED|Overall Study||600
3178789|NCT01980095|3906898|FG000|STARTED|Overall Study|Protocol planned for 90 patients, protocol amendment increase up to 120 patients.|78
3178790|NCT01980095|3906899|FG001|STARTED|Overall Study|Protocol planned for 90 patients, protocol amendment increase up to 120 patients.|41
3178791|NCT01980095|3906898|FG000|Treated|Overall Study|Of 78 patients randomized, 1 patient erroneously randomized and not treated|77
3178792|NCT01980095|3906899|FG001|Treated|Overall Study||41
3178793|NCT01980095|3906898|FG000|COMPLETED|Overall Study||63
3178794|NCT01980095|3906899|FG001|COMPLETED|Overall Study||30
3178795|NCT01980095|3906898|FG000|NOT COMPLETED|Overall Study||15
3178796|NCT01980095|3906899|FG001|NOT COMPLETED|Overall Study||11
3352684|NCT03615482|4082930|FG001|STARTED|Overall Study||600
3352685|NCT03615482|4082929|FG000|Vaccinated|Overall Study||599
3352686|NCT03615482|4082930|FG001|Vaccinated|Overall Study||598
3352687|NCT03615482|4082929|FG000|COMPLETED|Overall Study||583
3352688|NCT03615482|4082930|FG001|COMPLETED|Overall Study||583
3352689|NCT03615482|4082929|FG000|NOT COMPLETED|Overall Study||17
3352690|NCT03615482|4082930|FG001|NOT COMPLETED|Overall Study||17
3352691|NCT03615534|4082940|FG000|STARTED|Overall Study||14
3352692|NCT03615534|4082941|FG001|STARTED|Overall Study||15
3352693|NCT03615534|4082942|FG002|STARTED|Overall Study||14
3352694|NCT03615534|4082943|FG003|STARTED|Overall Study||14
3352695|NCT03615534|4082940|FG000|COMPLETED|Overall Study||12
3352696|NCT03615534|4082941|FG001|COMPLETED|Overall Study||15
3352697|NCT03615534|4082942|FG002|COMPLETED|Overall Study||14
3352698|NCT03615534|4082943|FG003|COMPLETED|Overall Study||13
3352699|NCT03615534|4082940|FG000|NOT COMPLETED|Overall Study||2
3352700|NCT03615534|4082941|FG001|NOT COMPLETED|Overall Study||0
3352701|NCT03615534|4082942|FG002|NOT COMPLETED|Overall Study||0
3352702|NCT03615534|4082943|FG003|NOT COMPLETED|Overall Study||1
3352703|NCT03615807|4082955|FG000|STARTED|Overall Study||91
3352704|NCT03615807|4082956|FG001|STARTED|Overall Study||91
3352705|NCT03615807|4082955|FG000|COMPLETED|Overall Study||79
3352706|NCT03615807|4082956|FG001|COMPLETED|Overall Study||80
3352707|NCT03615807|4082955|FG000|NOT COMPLETED|Overall Study||12
3352708|NCT03615807|4082956|FG001|NOT COMPLETED|Overall Study||11
3352709|NCT03615911|4082964|FG000|STARTED|Overall Study||14
3352710|NCT03615911|4082965|FG001|STARTED|Overall Study||12
3352711|NCT03615911|4082964|FG000|Received Late Booster Immunization|Overall Study||3
3352712|NCT03615911|4082965|FG001|Received Late Booster Immunization|Overall Study||7
3352713|NCT03615911|4082964|FG000|COMPLETED|Overall Study|A subgroup received an additional booster of 1x10^8 PFU MVA-MERS-S 12 (+/-4) months after prime.|12
3352714|NCT03615911|4082965|FG001|COMPLETED|Overall Study|A subgroup received an additional booster of 1x10^8 PFU MVA-MERS-S 12 (+/-4) months after prime.|11
3352715|NCT03615911|4082964|FG000|NOT COMPLETED|Overall Study||2
3352716|NCT03615911|4082965|FG001|NOT COMPLETED|Overall Study||1
3352717|NCT03615924|4082975|FG000|STARTED|Overall Study||101
3352718|NCT03615924|4082976|FG001|STARTED|Overall Study||92
3352719|NCT03615924|4082975|FG000|Received Treatment|Overall Study||101
3352720|NCT03615924|4082976|FG001|Received Treatment|Overall Study||92
3352721|NCT03615924|4082975|FG000|COMPLETED|Overall Study||0
3352722|NCT03615924|4082976|FG001|COMPLETED|Overall Study||0
3352723|NCT03615924|4082975|FG000|NOT COMPLETED|Overall Study||101
3352724|NCT03615924|4082976|FG001|NOT COMPLETED|Overall Study||92
3352725|NCT03616106|4082984|FG000|STARTED|Overall Study||56
3352726|NCT03616106|4082985|FG001|STARTED|Overall Study||3
3352727|NCT03616106|4082984|FG000|COMPLETED|Overall Study||42
3352728|NCT03616106|4082985|FG001|COMPLETED|Overall Study||2
3352729|NCT03616106|4082984|FG000|NOT COMPLETED|Overall Study||14
3352730|NCT03616106|4082985|FG001|NOT COMPLETED|Overall Study||1
3352731|NCT03616171|4082992|FG000|STARTED|Overall Study||4
3352732|NCT03616171|4082993|FG001|STARTED|Overall Study||2
3178797|NCT01980485|3906909|FG000|STARTED|Overall Study||120
3178798|NCT01980485|3906910|FG001|STARTED|Overall Study||105
3178799|NCT01980485|3906909|FG000|COMPLETED|Overall Study||84
3178800|NCT01980485|3906910|FG001|COMPLETED|Overall Study||80
3178801|NCT01980485|3906909|FG000|NOT COMPLETED|Overall Study||36
3178802|NCT01980485|3906910|FG001|NOT COMPLETED|Overall Study||25
3178803|NCT01980524|3906918|FG000|STARTED|Study Day 1||4
3178804|NCT01980524|3906919|FG001|STARTED|Study Day 1||4
3352733|NCT03616171|4082992|FG000|COMPLETED|Overall Study||4
3352734|NCT03616171|4082993|FG001|COMPLETED|Overall Study||2
3352735|NCT03616171|4082992|FG000|NOT COMPLETED|Overall Study||0
3352736|NCT03616171|4082993|FG001|NOT COMPLETED|Overall Study||0
3352737|NCT03616600|4083002|FG000|STARTED|Overall Study||16
3352738|NCT03616600|4083003|FG001|STARTED|Overall Study||15
3352739|NCT03616600|4083002|FG000|COMPLETED|Overall Study||15
3352740|NCT03616600|4083003|FG001|COMPLETED|Overall Study||15
3352741|NCT03616600|4083002|FG000|NOT COMPLETED|Overall Study||1
3352742|NCT03616600|4083003|FG001|NOT COMPLETED|Overall Study||0
3352743|NCT03616899|4083012|FG000|STARTED|Overall Study||447
3352744|NCT03616899|4083013|FG001|STARTED|Overall Study||454
3352745|NCT03616899|4083012|FG000|COMPLETED|Overall Study||437
3352746|NCT03616899|4083013|FG001|COMPLETED|Overall Study||453
3352747|NCT03616899|4083012|FG000|NOT COMPLETED|Overall Study||10
3352748|NCT03616899|4083013|FG001|NOT COMPLETED|Overall Study||1
3352749|NCT03616977|4083019|FG000|STARTED|Period 1||34
3352750|NCT03616977|4083020|FG001|STARTED|Period 1||35
3352751|NCT03616977|4083019|FG000|Received at Least One Dose of Study Drug|Period 1||34
3352752|NCT03616977|4083020|FG001|Received at Least One Dose of Study Drug|Period 1||34
3352753|NCT03616977|4083019|FG000|COMPLETED|Period 1||34
3352754|NCT03616977|4083020|FG001|COMPLETED|Period 1||34
3352755|NCT03616977|4083019|FG000|NOT COMPLETED|Period 1||0
3352756|NCT03616977|4083020|FG001|NOT COMPLETED|Period 1||1
3352757|NCT03616977|4083019|FG000|STARTED|Period 2||34
3352758|NCT03616977|4083020|FG001|STARTED|Period 2||34
3352759|NCT03616977|4083019|FG000|COMPLETED|Period 2||34
3352760|NCT03616977|4083020|FG001|COMPLETED|Period 2||34
3352761|NCT03616977|4083019|FG000|NOT COMPLETED|Period 2||0
3352762|NCT03616977|4083020|FG001|NOT COMPLETED|Period 2||0
3352763|NCT03616977|4083019|FG000|STARTED|Period 3||34
3352764|NCT03616977|4083020|FG001|STARTED|Period 3|Participant completed Period 2 and withdrew from the study.|33
3352765|NCT03616977|4083019|FG000|Received Study Drug|Period 3|Participant not dosed due to adverse event.|33
3352766|NCT03616977|4083020|FG001|Received Study Drug|Period 3|Participant not dosed due to adverse event.|32
3352767|NCT03616977|4083019|FG000|COMPLETED|Period 3||33
3352768|NCT03616977|4083020|FG001|COMPLETED|Period 3||32
3178805|NCT01980524|3906918|FG000|COMPLETED|Study Day 1||4
3178806|NCT01980524|3906919|FG001|COMPLETED|Study Day 1||4
3178807|NCT01980524|3906918|FG000|NOT COMPLETED|Study Day 1||0
3352769|NCT03616977|4083019|FG000|NOT COMPLETED|Period 3||1
3352770|NCT03616977|4083020|FG001|NOT COMPLETED|Period 3||1
3352771|NCT03616977|4083019|FG000|STARTED|Period 4||33
3352772|NCT03616977|4083020|FG001|STARTED|Period 4||32
3352773|NCT03616977|4083019|FG000|COMPLETED|Period 4||33
3352774|NCT03616977|4083020|FG001|COMPLETED|Period 4||32
3352775|NCT03616977|4083019|FG000|NOT COMPLETED|Period 4||0
3352776|NCT03616977|4083020|FG001|NOT COMPLETED|Period 4||0
3352777|NCT03617419|4083027|FG000|STARTED|Part 1||2
3352778|NCT03617419|4083027|FG000|COMPLETED|Part 1||2
3352779|NCT03617419|4083027|FG000|NOT COMPLETED|Part 1||0
3352780|NCT03617419|4083027|FG000|STARTED|Part 2||14
3178808|NCT01980524|3906919|FG001|NOT COMPLETED|Study Day 1||0
3178809|NCT01980524|3906918|FG000|STARTED|Washout (at Least 2 Weeks)||4
3178810|NCT01980524|3906919|FG001|STARTED|Washout (at Least 2 Weeks)||4
3178811|NCT01980524|3906918|FG000|COMPLETED|Washout (at Least 2 Weeks)||4
3178812|NCT01980524|3906919|FG001|COMPLETED|Washout (at Least 2 Weeks)||4
3178813|NCT01980524|3906918|FG000|NOT COMPLETED|Washout (at Least 2 Weeks)||0
3178814|NCT01980524|3906919|FG001|NOT COMPLETED|Washout (at Least 2 Weeks)||0
3178815|NCT01980524|3906918|FG000|STARTED|Study Day 2||4
3178816|NCT01980524|3906919|FG001|STARTED|Study Day 2||4
3178817|NCT01980524|3906918|FG000|COMPLETED|Study Day 2||4
3178818|NCT01980524|3906919|FG001|COMPLETED|Study Day 2||4
3178819|NCT01980524|3906918|FG000|NOT COMPLETED|Study Day 2||0
3178820|NCT01980524|3906919|FG001|NOT COMPLETED|Study Day 2||0
3178821|NCT01980589|3906928|FG000|STARTED|Overall Study||3
3178822|NCT01980589|3906929|FG001|STARTED|Overall Study||3
3178823|NCT01980589|3906930|FG002|STARTED|Overall Study||16
3178824|NCT01980589|3906928|FG000|COMPLETED|Overall Study||3
3352781|NCT03617419|4083027|FG000|COMPLETED|Part 2||14
3352782|NCT03617419|4083027|FG000|NOT COMPLETED|Part 2||0
3352783|NCT03617523|4083036|FG000|STARTED|Overall Study||30
3352784|NCT03617523|4083037|FG001|STARTED|Overall Study||30
3352785|NCT03617523|4083038|FG002|STARTED|Overall Study||61
3352786|NCT03617523|4083039|FG003|STARTED|Overall Study||59
3352787|NCT03617523|4083040|FG004|STARTED|Overall Study||60
3352788|NCT03617523|4083036|FG000|COMPLETED|Overall Study||30
3352789|NCT03617523|4083037|FG001|COMPLETED|Overall Study||30
3352790|NCT03617523|4083038|FG002|COMPLETED|Overall Study||61
3352791|NCT03617523|4083039|FG003|COMPLETED|Overall Study||59
3352792|NCT03617523|4083040|FG004|COMPLETED|Overall Study||60
3352793|NCT03617523|4083036|FG000|NOT COMPLETED|Overall Study||0
3178825|NCT01980589|3906929|FG001|COMPLETED|Overall Study||3
3178826|NCT01980589|3906930|FG002|COMPLETED|Overall Study||16
3352794|NCT03617523|4083037|FG001|NOT COMPLETED|Overall Study||0
3352795|NCT03617523|4083038|FG002|NOT COMPLETED|Overall Study||0
3352796|NCT03617523|4083039|FG003|NOT COMPLETED|Overall Study||0
3352797|NCT03617523|4083040|FG004|NOT COMPLETED|Overall Study||0
3352798|NCT03617588|4083059|FG000|STARTED|Overall Study||20
3352799|NCT03617588|4083060|FG001|STARTED|Overall Study||29
3352800|NCT03617588|4083059|FG000|COMPLETED|Overall Study||19
3352801|NCT03617588|4083060|FG001|COMPLETED|Overall Study||29
3352802|NCT03617588|4083059|FG000|NOT COMPLETED|Overall Study||1
3352803|NCT03617588|4083060|FG001|NOT COMPLETED|Overall Study||0
3352804|NCT03617770|4083072|FG000|STARTED|Overall Study|9|9
3352805|NCT03617770|4083073|FG001|STARTED|Overall Study|5|5
3352806|NCT03617770|4083072|FG000|COMPLETED|Overall Study|8|8
3352807|NCT03617770|4083073|FG001|COMPLETED|Overall Study||5
3352808|NCT03617770|4083072|FG000|NOT COMPLETED|Overall Study||1
3352809|NCT03617770|4083073|FG001|NOT COMPLETED|Overall Study||0
3352810|NCT03617861|4083081|FG000|STARTED|First Intervention (1 Day)||5
3352811|NCT03617861|4083082|FG001|STARTED|First Intervention (1 Day)||5
3352812|NCT03617861|4083083|FG002|STARTED|First Intervention (1 Day)||5
3352813|NCT03617861|4083084|FG003|STARTED|First Intervention (1 Day)||5
3352814|NCT03617861|4083081|FG000|COMPLETED|First Intervention (1 Day)||5
3352815|NCT03617861|4083082|FG001|COMPLETED|First Intervention (1 Day)||5
3352816|NCT03617861|4083083|FG002|COMPLETED|First Intervention (1 Day)||5
3352817|NCT03617861|4083084|FG003|COMPLETED|First Intervention (1 Day)||5
3352818|NCT03617861|4083081|FG000|NOT COMPLETED|First Intervention (1 Day)||0
3352819|NCT03617861|4083082|FG001|NOT COMPLETED|First Intervention (1 Day)||0
3352820|NCT03617861|4083083|FG002|NOT COMPLETED|First Intervention (1 Day)||0
3352821|NCT03617861|4083084|FG003|NOT COMPLETED|First Intervention (1 Day)||0
3352822|NCT03617861|4083081|FG000|STARTED|Washout (1 to 4 Weeks)||5
3352823|NCT03617861|4083082|FG001|STARTED|Washout (1 to 4 Weeks)||5
3352824|NCT03617861|4083083|FG002|STARTED|Washout (1 to 4 Weeks)||5
3352825|NCT03617861|4083084|FG003|STARTED|Washout (1 to 4 Weeks)||5
3352826|NCT03617861|4083081|FG000|COMPLETED|Washout (1 to 4 Weeks)||5
3352827|NCT03617861|4083082|FG001|COMPLETED|Washout (1 to 4 Weeks)||5
3352828|NCT03617861|4083083|FG002|COMPLETED|Washout (1 to 4 Weeks)||5
3352829|NCT03617861|4083084|FG003|COMPLETED|Washout (1 to 4 Weeks)||5
3352830|NCT03617861|4083081|FG000|NOT COMPLETED|Washout (1 to 4 Weeks)||0
3352831|NCT03617861|4083082|FG001|NOT COMPLETED|Washout (1 to 4 Weeks)||0
3352832|NCT03617861|4083083|FG002|NOT COMPLETED|Washout (1 to 4 Weeks)||0
3352833|NCT03617861|4083084|FG003|NOT COMPLETED|Washout (1 to 4 Weeks)||0
3352834|NCT03617861|4083081|FG000|STARTED|Second Intervention (1 Day)||5
3352835|NCT03617861|4083082|FG001|STARTED|Second Intervention (1 Day)||5
3352836|NCT03617861|4083083|FG002|STARTED|Second Intervention (1 Day)||5
3352837|NCT03617861|4083084|FG003|STARTED|Second Intervention (1 Day)||5
3352838|NCT03617861|4083081|FG000|COMPLETED|Second Intervention (1 Day)||5
3352839|NCT03617861|4083082|FG001|COMPLETED|Second Intervention (1 Day)||5
3352840|NCT03617861|4083083|FG002|COMPLETED|Second Intervention (1 Day)||4
3352841|NCT03617861|4083084|FG003|COMPLETED|Second Intervention (1 Day)||5
3352842|NCT03617861|4083081|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
3352843|NCT03617861|4083082|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
3352844|NCT03617861|4083083|FG002|NOT COMPLETED|Second Intervention (1 Day)||1
3352845|NCT03617861|4083084|FG003|NOT COMPLETED|Second Intervention (1 Day)||0
3352846|NCT03617913|4083094|FG000|STARTED|Overall Study||2
3352847|NCT03617913|4083094|FG000|COMPLETED|Overall Study||2
3352848|NCT03617913|4083094|FG000|NOT COMPLETED|Overall Study||0
3352849|NCT03618017|4083100|FG000|STARTED|Overall Study||33
3352850|NCT03618017|4083101|FG001|STARTED|Overall Study||33
3352851|NCT03618017|4083100|FG000|COMPLETED|Overall Study||26
3352852|NCT03618017|4083101|FG001|COMPLETED|Overall Study||28
3352853|NCT03618017|4083100|FG000|NOT COMPLETED|Overall Study||7
3352854|NCT03618017|4083101|FG001|NOT COMPLETED|Overall Study||5
3352855|NCT03618030|4083111|FG000|STARTED|Overall Study||15
3352856|NCT03618030|4083112|FG001|STARTED|Overall Study||14
3352857|NCT03618030|4083113|FG002|STARTED|Overall Study||21
3352858|NCT03618030|4083114|FG003|STARTED|Overall Study||39
3352859|NCT03618030|4083115|FG004|STARTED|Overall Study||36
3352860|NCT03618030|4083116|FG005|STARTED|Overall Study||27
3352861|NCT03618030|4083117|FG006|STARTED|Overall Study||18
3352862|NCT03618030|4083118|FG007|STARTED|Overall Study||118
3352863|NCT03618030|4083111|FG000|COMPLETED|Overall Study||3
3352864|NCT03618030|4083112|FG001|COMPLETED|Overall Study||3
3352865|NCT03618030|4083113|FG002|COMPLETED|Overall Study||13
3352866|NCT03618030|4083114|FG003|COMPLETED|Overall Study||30
3352867|NCT03618030|4083115|FG004|COMPLETED|Overall Study||29
3352868|NCT03618030|4083116|FG005|COMPLETED|Overall Study||21
3352869|NCT03618030|4083117|FG006|COMPLETED|Overall Study||14
3352870|NCT03618030|4083118|FG007|COMPLETED|Overall Study||108
3352871|NCT03618030|4083111|FG000|NOT COMPLETED|Overall Study||12
3352872|NCT03618030|4083112|FG001|NOT COMPLETED|Overall Study||11
3352873|NCT03618030|4083113|FG002|NOT COMPLETED|Overall Study||8
3352874|NCT03618030|4083114|FG003|NOT COMPLETED|Overall Study||9
3352875|NCT03618030|4083115|FG004|NOT COMPLETED|Overall Study||7
3352876|NCT03618030|4083116|FG005|NOT COMPLETED|Overall Study||6
3352877|NCT03618030|4083117|FG006|NOT COMPLETED|Overall Study||4
3352878|NCT03618030|4083118|FG007|NOT COMPLETED|Overall Study||10
3352879|NCT03618147|4083131|FG000|STARTED|Overall Study||314
3352880|NCT03618147|4083131|FG000|COMPLETED|Overall Study||314
3352881|NCT03618147|4083131|FG000|NOT COMPLETED|Overall Study||0
3352882|NCT03618420|4083136|FG000|STARTED|Overall Study||50
3352883|NCT03618420|4083136|FG000|COMPLETED|Overall Study||50
3352884|NCT03618420|4083136|FG000|NOT COMPLETED|Overall Study||0
3352885|NCT03618628|4083140|FG000|STARTED|Overall Study||3
3352886|NCT03618628|4083140|FG000|COMPLETED|Overall Study||1
3352887|NCT03618628|4083140|FG000|NOT COMPLETED|Overall Study||2
3352888|NCT03618641|4083144|FG000|STARTED|Overall Study||34
3352889|NCT03618641|4083144|FG000|COMPLETED|Overall Study||34
3352890|NCT03618641|4083144|FG000|NOT COMPLETED|Overall Study||0
3352891|NCT03618823|4083150|FG000|STARTED|Overall Study||132
3352892|NCT03618823|4083151|FG001|STARTED|Overall Study||136
3352893|NCT03618823|4083150|FG000|COMPLETED|Overall Study||69
3352894|NCT03618823|4083151|FG001|COMPLETED|Overall Study||75
3352895|NCT03618823|4083150|FG000|NOT COMPLETED|Overall Study||63
3352896|NCT03618823|4083151|FG001|NOT COMPLETED|Overall Study||61
3352897|NCT03619135|4083162|FG000|STARTED|Overall Study||50
3352898|NCT03619135|4083163|FG001|STARTED|Overall Study||50
3352899|NCT03619135|4083162|FG000|COMPLETED|Overall Study||50
3352900|NCT03619135|4083163|FG001|COMPLETED|Overall Study||50
3352901|NCT03619135|4083162|FG000|NOT COMPLETED|Overall Study||0
3352902|NCT03619135|4083163|FG001|NOT COMPLETED|Overall Study||0
3352903|NCT03619590|4083169|FG000|STARTED|Overall Study||103
3352904|NCT03619590|4083169|FG000|COMPLETED|Overall Study||103
3352905|NCT03619590|4083169|FG000|NOT COMPLETED|Overall Study||0
3352906|NCT03619811|4083173|FG000|STARTED|Overall Study||43
3352907|NCT03619811|4083173|FG000|COMPLETED|Overall Study||31
3352908|NCT03619811|4083173|FG000|NOT COMPLETED|Overall Study||12
3352909|NCT03619837|4083177|FG000|STARTED|Screening||122
3178827|NCT01980589|3906928|FG000|NOT COMPLETED|Overall Study||0
3178828|NCT01980589|3906929|FG001|NOT COMPLETED|Overall Study||0
3178829|NCT01980589|3906930|FG002|NOT COMPLETED|Overall Study||0
3178830|NCT01980628|3906938|FG000|STARTED|Overall Study|Total number of patients enrolled to the study and received study treatment|63
3178831|NCT01980628|3906938|FG000|COMPLETED|Overall Study|Participants who remain on treatment at Final Analysis.|0
3178832|NCT01980628|3906938|FG000|NOT COMPLETED|Overall Study||63
3178833|NCT01980654|3906945|FG000|STARTED|Overall Study||60
3178834|NCT01980654|3906946|FG001|STARTED|Overall Study||20
3178835|NCT01980654|3906945|FG000|COMPLETED|Overall Study||60
3352910|NCT03619837|4083177|FG000|COMPLETED|Screening||24
3352911|NCT03619837|4083177|FG000|NOT COMPLETED|Screening||98
3352912|NCT03619837|4083177|FG000|STARTED|Main Study||24
3352913|NCT03619837|4083177|FG000|COMPLETED|Main Study||24
3352914|NCT03619837|4083177|FG000|NOT COMPLETED|Main Study||0
3352915|NCT03619889|4083183|FG000|STARTED|Overall Study||37
3178836|NCT01980654|3906946|FG001|COMPLETED|Overall Study||20
3178837|NCT01980654|3906945|FG000|NOT COMPLETED|Overall Study||0
3178838|NCT01980654|3906946|FG001|NOT COMPLETED|Overall Study||0
3178839|NCT01980706|3906955|FG000|STARTED|Overall Study||40
3178840|NCT01980706|3906956|FG001|STARTED|Overall Study||43
3178841|NCT01980706|3906957|FG002|STARTED|Overall Study||37
3178842|NCT01980706|3906955|FG000|COMPLETED|Overall Study||23
3178843|NCT01980706|3906956|FG001|COMPLETED|Overall Study||26
3178844|NCT01980706|3906957|FG002|COMPLETED|Overall Study||24
3178845|NCT01980706|3906955|FG000|NOT COMPLETED|Overall Study||17
3178846|NCT01980706|3906956|FG001|NOT COMPLETED|Overall Study||17
3178847|NCT01980706|3906957|FG002|NOT COMPLETED|Overall Study||13
3178848|NCT01980771|3906967|FG000|STARTED|Overall Study||436
3178849|NCT01980771|3906968|FG001|STARTED|Overall Study||424
3178850|NCT01980771|3906967|FG000|COMPLETED|Overall Study||352
3178851|NCT01980771|3906968|FG001|COMPLETED|Overall Study||305
3178852|NCT01980771|3906967|FG000|NOT COMPLETED|Overall Study||84
3178853|NCT01980771|3906968|FG001|NOT COMPLETED|Overall Study||119
3178854|NCT01980888|3906976|FG000|STARTED|Overall Study||157
3178855|NCT01980888|3906977|FG001|STARTED|Overall Study||154
3178856|NCT01980888|3906976|FG000|COMPLETED|Overall Study|Completed = reached primary efficacy endpoint of progressive disease or death.|13
3178857|NCT01980888|3906977|FG001|COMPLETED|Overall Study|Completed = reached primary efficacy endpoint of progressive disease or death.|21
3178858|NCT01980888|3906976|FG000|NOT COMPLETED|Overall Study||144
3178859|NCT01980888|3906977|FG001|NOT COMPLETED|Overall Study||133
3352916|NCT03619889|4083184|FG001|STARTED|Overall Study||37
3352917|NCT03619889|4083183|FG000|COMPLETED|Overall Study||35
3352918|NCT03619889|4083184|FG001|COMPLETED|Overall Study||37
3352919|NCT03619889|4083183|FG000|NOT COMPLETED|Overall Study||2
3352920|NCT03619889|4083184|FG001|NOT COMPLETED|Overall Study||0
3352921|NCT03620162|4083195|FG000|STARTED|Overall Study||179
3352922|NCT03620162|4083196|FG001|STARTED|Overall Study||181
3352923|NCT03620162|4083197|FG002|STARTED|Overall Study||180
3352924|NCT03620162|4083198|FG003|STARTED|Overall Study||180
3352925|NCT03620162|4083199|FG004|STARTED|Overall Study||180
3352926|NCT03620162|4083195|FG000|Vaccination 1 (V114 or Prevnar 13™)|Overall Study||179
3352927|NCT03620162|4083196|FG001|Vaccination 1 (V114 or Prevnar 13™)|Overall Study||181
3352928|NCT03620162|4083197|FG002|Vaccination 1 (V114 or Prevnar 13™)|Overall Study||178
3352929|NCT03620162|4083198|FG003|Vaccination 1 (V114 or Prevnar 13™)|Overall Study||179
3352930|NCT03620162|4083199|FG004|Vaccination 1 (V114 or Prevnar 13™)|Overall Study||179
3352931|NCT03620162|4083195|FG000|Vaccination 2 (V114 or Prevnar 13™)|Overall Study||176
3352932|NCT03620162|4083196|FG001|Vaccination 2 (V114 or Prevnar 13™)|Overall Study||175
3352933|NCT03620162|4083197|FG002|Vaccination 2 (V114 or Prevnar 13™)|Overall Study||166
3352934|NCT03620162|4083198|FG003|Vaccination 2 (V114 or Prevnar 13™)|Overall Study||169
3352935|NCT03620162|4083199|FG004|Vaccination 2 (V114 or Prevnar 13™)|Overall Study||173
3352936|NCT03620162|4083195|FG000|Vaccination 3 (V114 or Prevnar 13™)|Overall Study||175
3352937|NCT03620162|4083196|FG001|Vaccination 3 (V114 or Prevnar 13™)|Overall Study||174
3352938|NCT03620162|4083197|FG002|Vaccination 3 (V114 or Prevnar 13™)|Overall Study||161
3352939|NCT03620162|4083198|FG003|Vaccination 3 (V114 or Prevnar 13™)|Overall Study||167
3352940|NCT03620162|4083199|FG004|Vaccination 3 (V114 or Prevnar 13™)|Overall Study||173
3352941|NCT03620162|4083195|FG000|Vaccination 4 (V114 or Prevnar 13™)|Overall Study||165
3352942|NCT03620162|4083196|FG001|Vaccination 4 (V114 or Prevnar 13™)|Overall Study||168
3352943|NCT03620162|4083197|FG002|Vaccination 4 (V114 or Prevnar 13™)|Overall Study||150
3352944|NCT03620162|4083198|FG003|Vaccination 4 (V114 or Prevnar 13™)|Overall Study||162
3352945|NCT03620162|4083199|FG004|Vaccination 4 (V114 or Prevnar 13™)|Overall Study||168
3352946|NCT03620162|4083195|FG000|COMPLETED|Overall Study||164
3352947|NCT03620162|4083196|FG001|COMPLETED|Overall Study||167
3352948|NCT03620162|4083197|FG002|COMPLETED|Overall Study||147
3352949|NCT03620162|4083198|FG003|COMPLETED|Overall Study||160
3352950|NCT03620162|4083199|FG004|COMPLETED|Overall Study||167
3352951|NCT03620162|4083195|FG000|NOT COMPLETED|Overall Study||15
3352952|NCT03620162|4083196|FG001|NOT COMPLETED|Overall Study||14
3352953|NCT03620162|4083197|FG002|NOT COMPLETED|Overall Study||33
3178860|NCT01980914|3906983|FG000|STARTED|Overall Study||11
3178861|NCT01980914|3906983|FG000|COMPLETED|Overall Study||11
3178862|NCT01980914|3906983|FG000|NOT COMPLETED|Overall Study||0
3178863|NCT01980992|3906990|FG000|STARTED|52 Weeks Blinded Study Treatment||23
3178864|NCT01980992|3906991|FG001|STARTED|52 Weeks Blinded Study Treatment||23
3178865|NCT01980992|3906990|FG000|COMPLETED|52 Weeks Blinded Study Treatment||21
3352954|NCT03620162|4083198|FG003|NOT COMPLETED|Overall Study||20
3352955|NCT03620162|4083199|FG004|NOT COMPLETED|Overall Study||13
3352956|NCT03620383|4083215|FG000|STARTED|Overall Study||30
3352957|NCT03620383|4083216|FG001|STARTED|Overall Study||15
3352958|NCT03620383|4083215|FG000|COMPLETED|Overall Study||30
3352959|NCT03620383|4083216|FG001|COMPLETED|Overall Study||15
3352960|NCT03620383|4083215|FG000|NOT COMPLETED|Overall Study||0
3352961|NCT03620383|4083216|FG001|NOT COMPLETED|Overall Study||0
3352962|NCT03620708|4083225|FG000|STARTED|Overall Study||19
3352963|NCT03620708|4083226|FG001|STARTED|Overall Study||19
3352964|NCT03620708|4083227|FG002|STARTED|Overall Study||20
3352965|NCT03620708|4083225|FG000|COMPLETED|Overall Study||18
3352966|NCT03620708|4083226|FG001|COMPLETED|Overall Study||18
3352967|NCT03620708|4083227|FG002|COMPLETED|Overall Study||17
3352968|NCT03620708|4083225|FG000|NOT COMPLETED|Overall Study||1
3352969|NCT03620708|4083226|FG001|NOT COMPLETED|Overall Study||1
3352970|NCT03620708|4083227|FG002|NOT COMPLETED|Overall Study||3
3352971|NCT03620890|4083237|FG000|STARTED|Overall Study||57
3352972|NCT03620890|4083238|FG001|STARTED|Overall Study||51
3352973|NCT03620890|4083237|FG000|First Trimester Miscarriage|Overall Study||2
3352974|NCT03620890|4083238|FG001|First Trimester Miscarriage|Overall Study||1
3352975|NCT03620890|4083237|FG000|Major Fetal Anomalies (Hypoplastic Left Heart and Sacral Agenesis) With 2nd Trimester Stillbirth|Overall Study||1
3352976|NCT03620890|4083238|FG001|Major Fetal Anomalies (Hypoplastic Left Heart and Sacral Agenesis) With 2nd Trimester Stillbirth|Overall Study||0
3352977|NCT03620890|4083237|FG000|Major Fetal Anomaly (Holoprosencephaly) With 2nd Trimester Pregnancy Termination|Overall Study||1
3352978|NCT03620890|4083238|FG001|Major Fetal Anomaly (Holoprosencephaly) With 2nd Trimester Pregnancy Termination|Overall Study||0
3352979|NCT03620890|4083237|FG000|COMPLETED|Overall Study||53
3352980|NCT03620890|4083238|FG001|COMPLETED|Overall Study||50
3352981|NCT03620890|4083237|FG000|NOT COMPLETED|Overall Study||4
3352982|NCT03620890|4083238|FG001|NOT COMPLETED|Overall Study||1
3352983|NCT03621085|4083244|FG000|STARTED|Enrollment||22
3352984|NCT03621085|4083245|FG001|STARTED|Enrollment||21
3352985|NCT03621085|4083244|FG000|COMPLETED|Enrollment||16
3352986|NCT03621085|4083245|FG001|COMPLETED|Enrollment||14
3352987|NCT03621085|4083244|FG000|NOT COMPLETED|Enrollment||6
3352988|NCT03621085|4083245|FG001|NOT COMPLETED|Enrollment||7
3352989|NCT03621085|4083244|FG000|STARTED|First Visit||16
3352990|NCT03621085|4083245|FG001|STARTED|First Visit||14
3352991|NCT03621085|4083244|FG000|COMPLETED|First Visit||16
3352992|NCT03621085|4083245|FG001|COMPLETED|First Visit||14
3352993|NCT03621085|4083244|FG000|NOT COMPLETED|First Visit||0
3352994|NCT03621085|4083245|FG001|NOT COMPLETED|First Visit||0
3352995|NCT03621085|4083244|FG000|STARTED|Washout (at Least 48 Hours)||16
3352996|NCT03621085|4083245|FG001|STARTED|Washout (at Least 48 Hours)||14
3352997|NCT03621085|4083244|FG000|COMPLETED|Washout (at Least 48 Hours)||16
3352998|NCT03621085|4083245|FG001|COMPLETED|Washout (at Least 48 Hours)||14
3352999|NCT03621085|4083244|FG000|NOT COMPLETED|Washout (at Least 48 Hours)||0
3353000|NCT03621085|4083245|FG001|NOT COMPLETED|Washout (at Least 48 Hours)||0
3353001|NCT03621085|4083244|FG000|STARTED|Second Visit||16
3353002|NCT03621085|4083245|FG001|STARTED|Second Visit||14
3353003|NCT03621085|4083244|FG000|COMPLETED|Second Visit||16
3353004|NCT03621085|4083245|FG001|COMPLETED|Second Visit||14
3353005|NCT03621085|4083244|FG000|NOT COMPLETED|Second Visit||0
3353006|NCT03621085|4083245|FG001|NOT COMPLETED|Second Visit||0
3353007|NCT03621189|4083253|FG000|STARTED|Overall Study||40
3353008|NCT03621189|4083254|FG001|STARTED|Overall Study||40
3353009|NCT03621189|4083253|FG000|COMPLETED|Overall Study||40
3353010|NCT03621189|4083254|FG001|COMPLETED|Overall Study||35
3353011|NCT03621189|4083253|FG000|NOT COMPLETED|Overall Study||0
3353012|NCT03621189|4083254|FG001|NOT COMPLETED|Overall Study||5
3353013|NCT03621202|4083261|FG000|STARTED|Overall Study||66
3353014|NCT03621202|4083261|FG000|COMPLETED|Overall Study||60
3353015|NCT03621202|4083261|FG000|NOT COMPLETED|Overall Study||6
3353016|NCT03621787|4083265|FG000|STARTED|Overall Study||9
3353017|NCT03621787|4083265|FG000|COMPLETED|Overall Study||9
3353018|NCT03621787|4083265|FG000|NOT COMPLETED|Overall Study||0
3353019|NCT03621878|4083272|FG000|STARTED|Overall Study||17
3353020|NCT03621878|4083273|FG001|STARTED|Overall Study||17
3353021|NCT03621878|4083274|FG002|STARTED|Overall Study||17
3353022|NCT03621878|4083272|FG000|COMPLETED|Overall Study||17
3353023|NCT03621878|4083273|FG001|COMPLETED|Overall Study||17
3353024|NCT03621878|4083274|FG002|COMPLETED|Overall Study||17
3353025|NCT03621878|4083272|FG000|NOT COMPLETED|Overall Study||0
3353026|NCT03621878|4083273|FG001|NOT COMPLETED|Overall Study||0
3353027|NCT03621878|4083274|FG002|NOT COMPLETED|Overall Study||0
3353028|NCT03622112|4083289|FG000|STARTED|Overall Study||110
3353029|NCT03622112|4083290|FG001|STARTED|Overall Study||112
3353030|NCT03622112|4083291|FG002|STARTED|Overall Study||111
3353031|NCT03622112|4083292|FG003|STARTED|Overall Study||113
3353032|NCT03622112|4083293|FG004|STARTED|Overall Study||134
3353033|NCT03622112|4083294|FG005|STARTED|Overall Study||113
3353034|NCT03622112|4083295|FG006|STARTED|Overall Study||112
3353035|NCT03622112|4083289|FG000|COMPLETED|Overall Study||85
3353036|NCT03622112|4083290|FG001|COMPLETED|Overall Study||92
3353037|NCT03622112|4083291|FG002|COMPLETED|Overall Study||95
3353038|NCT03622112|4083292|FG003|COMPLETED|Overall Study||91
3353039|NCT03622112|4083293|FG004|COMPLETED|Overall Study||124
3353040|NCT03622112|4083294|FG005|COMPLETED|Overall Study||71
3353041|NCT03622112|4083295|FG006|COMPLETED|Overall Study||103
3353042|NCT03622112|4083289|FG000|NOT COMPLETED|Overall Study||25
3353043|NCT03622112|4083290|FG001|NOT COMPLETED|Overall Study||20
3353044|NCT03622112|4083291|FG002|NOT COMPLETED|Overall Study||16
3353045|NCT03622112|4083292|FG003|NOT COMPLETED|Overall Study||22
3353046|NCT03622112|4083293|FG004|NOT COMPLETED|Overall Study||10
3353047|NCT03622112|4083294|FG005|NOT COMPLETED|Overall Study||42
3353048|NCT03622112|4083295|FG006|NOT COMPLETED|Overall Study||9
3353049|NCT03622619|4083313|FG000|STARTED|Overall Study||23
3353050|NCT03622619|4083314|FG001|STARTED|Overall Study||23
3353051|NCT03622619|4083313|FG000|COMPLETED|Overall Study||21
3353052|NCT03622619|4083314|FG001|COMPLETED|Overall Study||21
3353053|NCT03622619|4083313|FG000|NOT COMPLETED|Overall Study||2
3353054|NCT03622619|4083314|FG001|NOT COMPLETED|Overall Study||2
3353055|NCT03623035|4083320|FG000|STARTED|Overall Study||10
3353056|NCT03623035|4083320|FG000|COMPLETED|Overall Study||10
3353057|NCT03623035|4083320|FG000|NOT COMPLETED|Overall Study||0
3353058|NCT03623334|4083327|FG000|STARTED|Overall Study||15
3353059|NCT03623334|4083328|FG001|STARTED|Overall Study||21
3353060|NCT03623334|4083329|FG002|STARTED|Overall Study||19
3353061|NCT03623334|4083327|FG000|COMPLETED|Overall Study||15
3353062|NCT03623334|4083328|FG001|COMPLETED|Overall Study||21
3353063|NCT03623334|4083329|FG002|COMPLETED|Overall Study||19
3353064|NCT03623334|4083327|FG000|NOT COMPLETED|Overall Study||0
3353065|NCT03623334|4083328|FG001|NOT COMPLETED|Overall Study||0
3353066|NCT03623334|4083329|FG002|NOT COMPLETED|Overall Study||0
3353067|NCT03623698|4083337|FG000|STARTED|Overall Study||24
3353068|NCT03623698|4083337|FG000|COMPLETED|Overall Study||24
3353069|NCT03623698|4083337|FG000|NOT COMPLETED|Overall Study||0
3353070|NCT03624192|4083348|FG000|STARTED|Overall Study||3
3353071|NCT03624192|4083349|FG001|STARTED|Overall Study||3
3353072|NCT03624192|4083348|FG000|COMPLETED|Overall Study||2
3353073|NCT03624192|4083349|FG001|COMPLETED|Overall Study||2
3353074|NCT03624192|4083348|FG000|NOT COMPLETED|Overall Study||1
3353075|NCT03624192|4083349|FG001|NOT COMPLETED|Overall Study||1
3353076|NCT03624504|4083357|FG000|STARTED|Overall Study||82
3353077|NCT03624504|4083357|FG000|COMPLETED|Overall Study||81
3353078|NCT03624504|4083357|FG000|NOT COMPLETED|Overall Study||1
3353079|NCT03624920|4083367|FG000|STARTED|Overall Study||14
3353080|NCT03624920|4083368|FG001|STARTED|Overall Study||14
3353081|NCT03624920|4083369|FG002|STARTED|Overall Study||13
3353082|NCT03624920|4083370|FG003|STARTED|Overall Study||13
3353083|NCT03624920|4083371|FG004|STARTED|Overall Study||11
3353084|NCT03624920|4083372|FG005|STARTED|Overall Study||12
3353085|NCT03624920|4083367|FG000|COMPLETED|Overall Study||13
3353086|NCT03624920|4083368|FG001|COMPLETED|Overall Study||12
3353087|NCT03624920|4083369|FG002|COMPLETED|Overall Study||12
3353088|NCT03624920|4083370|FG003|COMPLETED|Overall Study||12
3353089|NCT03624920|4083371|FG004|COMPLETED|Overall Study||7
3353090|NCT03624920|4083372|FG005|COMPLETED|Overall Study||11
3353091|NCT03624920|4083367|FG000|NOT COMPLETED|Overall Study||1
3353092|NCT03624920|4083368|FG001|NOT COMPLETED|Overall Study||2
3353093|NCT03624920|4083369|FG002|NOT COMPLETED|Overall Study||1
3353094|NCT03624920|4083370|FG003|NOT COMPLETED|Overall Study||1
3353095|NCT03624920|4083371|FG004|NOT COMPLETED|Overall Study||4
3353096|NCT03624920|4083372|FG005|NOT COMPLETED|Overall Study||1
3353097|NCT03624946|4083382|FG000|STARTED|Overall Study||19
3353098|NCT03624946|4083383|FG001|STARTED|Overall Study||11
3353099|NCT03624946|4083382|FG000|COMPLETED|Overall Study||19
3353100|NCT03624946|4083383|FG001|COMPLETED|Overall Study||10
3353101|NCT03624946|4083382|FG000|NOT COMPLETED|Overall Study||0
3353102|NCT03624946|4083383|FG001|NOT COMPLETED|Overall Study||1
3353103|NCT03624972|4083396|FG000|STARTED|Overall Study||71
3353104|NCT03624972|4083397|FG001|STARTED|Overall Study||73
3353105|NCT03624972|4083398|FG002|STARTED|Overall Study||9
3353106|NCT03624972|4083396|FG000|COMPLETED|Overall Study||69
3353107|NCT03624972|4083397|FG001|COMPLETED|Overall Study||71
3353108|NCT03624972|4083398|FG002|COMPLETED|Overall Study||9
3353109|NCT03624972|4083396|FG000|NOT COMPLETED|Overall Study||2
3353110|NCT03624972|4083397|FG001|NOT COMPLETED|Overall Study||2
3353111|NCT03624972|4083398|FG002|NOT COMPLETED|Overall Study||0
3353112|NCT03626415|4083410|FG000|STARTED|Overall Study||8
3353113|NCT03626415|4083411|FG001|STARTED|Overall Study||8
3353114|NCT03626415|4083412|FG002|STARTED|Overall Study||8
3353115|NCT03626415|4083410|FG000|COMPLETED|Overall Study||8
3353116|NCT03626415|4083411|FG001|COMPLETED|Overall Study||8
3353117|NCT03626415|4083412|FG002|COMPLETED|Overall Study||8
3353118|NCT03626415|4083410|FG000|NOT COMPLETED|Overall Study||0
3353119|NCT03626415|4083411|FG001|NOT COMPLETED|Overall Study||0
3353120|NCT03626415|4083412|FG002|NOT COMPLETED|Overall Study||0
3353121|NCT03626623|4083422|FG000|STARTED|Overall Study||5
3353122|NCT03626623|4083423|FG001|STARTED|Overall Study||10
3353123|NCT03626623|4083422|FG000|COMPLETED|Overall Study||0
3353124|NCT03626623|4083423|FG001|COMPLETED|Overall Study||0
3353125|NCT03626623|4083422|FG000|NOT COMPLETED|Overall Study||5
3353126|NCT03626623|4083423|FG001|NOT COMPLETED|Overall Study||10
3353127|NCT03626714|4083429|FG000|STARTED|Overall Study||8
3353128|NCT03626714|4083429|FG000|COMPLETED|Overall Study||8
3353129|NCT03626714|4083429|FG000|NOT COMPLETED|Overall Study||0
3353130|NCT03627065|4083433|FG000|STARTED|Overall Study||10
3353131|NCT03627065|4083433|FG000|COMPLETED|Overall Study||7
3353132|NCT03627065|4083433|FG000|NOT COMPLETED|Overall Study||3
3353133|NCT03627195|4083443|FG000|STARTED|Overall Study||6
3353134|NCT03627195|4083444|FG001|STARTED|Overall Study||6
3353135|NCT03627195|4083445|FG002|STARTED|Overall Study||6
3353136|NCT03627195|4083446|FG003|STARTED|Overall Study||6
3353137|NCT03627195|4083447|FG004|STARTED|Overall Study||6
3353138|NCT03627195|4083448|FG005|STARTED|Overall Study||10
3353139|NCT03627195|4083443|FG000|COMPLETED|Overall Study||5
3353140|NCT03627195|4083444|FG001|COMPLETED|Overall Study||6
3353141|NCT03627195|4083445|FG002|COMPLETED|Overall Study||6
3353142|NCT03627195|4083446|FG003|COMPLETED|Overall Study||6
3353143|NCT03627195|4083447|FG004|COMPLETED|Overall Study||6
3353144|NCT03627195|4083448|FG005|COMPLETED|Overall Study||10
3353145|NCT03627195|4083443|FG000|NOT COMPLETED|Overall Study||1
3353146|NCT03627195|4083444|FG001|NOT COMPLETED|Overall Study||0
3353147|NCT03627195|4083445|FG002|NOT COMPLETED|Overall Study||0
3353148|NCT03627195|4083446|FG003|NOT COMPLETED|Overall Study||0
3353149|NCT03627195|4083447|FG004|NOT COMPLETED|Overall Study||0
3353150|NCT03627195|4083448|FG005|NOT COMPLETED|Overall Study||0
3353151|NCT03627299|4083462|FG000|STARTED|Overall Study||10
3353152|NCT03627299|4083462|FG000|COMPLETED|Overall Study||10
3353153|NCT03627299|4083462|FG000|NOT COMPLETED|Overall Study||0
3353154|NCT03627416|4083468|FG000|STARTED|Overall Study||8
3353155|NCT03627416|4083469|FG001|STARTED|Overall Study||7
3353156|NCT03627416|4083468|FG000|COMPLETED|Overall Study||8
3353157|NCT03627416|4083469|FG001|COMPLETED|Overall Study||6
3353158|NCT03627416|4083468|FG000|NOT COMPLETED|Overall Study||0
3353159|NCT03627416|4083469|FG001|NOT COMPLETED|Overall Study||1
3353160|NCT03627494|4083487|FG000|STARTED|Part A Period 1 (4 Days)||3
3353161|NCT03627494|4083488|FG001|STARTED|Part A Period 1 (4 Days)||3
3353162|NCT03627494|4083489|FG002|STARTED|Part A Period 1 (4 Days)||3
3353163|NCT03627494|4083490|FG003|STARTED|Part A Period 1 (4 Days)||3
3353164|NCT03627494|4083491|FG004|STARTED|Part A Period 1 (4 Days)||3
3353165|NCT03627494|4083492|FG005|STARTED|Part A Period 1 (4 Days)||3
3353166|NCT03627494|4083493|FG006|STARTED|Part A Period 1 (4 Days)||0
3353167|NCT03627494|4083494|FG007|STARTED|Part A Period 1 (4 Days)||0
3353168|NCT03627494|4083495|FG008|STARTED|Part A Period 1 (4 Days)||0
3353169|NCT03627494|4083496|FG009|STARTED|Part A Period 1 (4 Days)||0
3353170|NCT03627494|4083497|FG010|STARTED|Part A Period 1 (4 Days)||0
3353171|NCT03627494|4083498|FG011|STARTED|Part A Period 1 (4 Days)||0
3353172|NCT03627494|4083487|FG000|COMPLETED|Part A Period 1 (4 Days)||3
3353173|NCT03627494|4083488|FG001|COMPLETED|Part A Period 1 (4 Days)||3
3353174|NCT03627494|4083489|FG002|COMPLETED|Part A Period 1 (4 Days)||3
3353175|NCT03627494|4083490|FG003|COMPLETED|Part A Period 1 (4 Days)||3
3353176|NCT03627494|4083491|FG004|COMPLETED|Part A Period 1 (4 Days)||3
3353177|NCT03627494|4083492|FG005|COMPLETED|Part A Period 1 (4 Days)||3
3353178|NCT03627494|4083493|FG006|COMPLETED|Part A Period 1 (4 Days)||0
3353179|NCT03627494|4083494|FG007|COMPLETED|Part A Period 1 (4 Days)||0
3353180|NCT03627494|4083495|FG008|COMPLETED|Part A Period 1 (4 Days)||0
3353181|NCT03627494|4083496|FG009|COMPLETED|Part A Period 1 (4 Days)||0
3353182|NCT03627494|4083497|FG010|COMPLETED|Part A Period 1 (4 Days)||0
3353183|NCT03627494|4083498|FG011|COMPLETED|Part A Period 1 (4 Days)||0
3353184|NCT03627494|4083487|FG000|NOT COMPLETED|Part A Period 1 (4 Days)||0
3353185|NCT03627494|4083488|FG001|NOT COMPLETED|Part A Period 1 (4 Days)||0
3353186|NCT03627494|4083489|FG002|NOT COMPLETED|Part A Period 1 (4 Days)||0
3353187|NCT03627494|4083490|FG003|NOT COMPLETED|Part A Period 1 (4 Days)||0
3353188|NCT03627494|4083491|FG004|NOT COMPLETED|Part A Period 1 (4 Days)||0
3353189|NCT03627494|4083492|FG005|NOT COMPLETED|Part A Period 1 (4 Days)||0
3353190|NCT03627494|4083493|FG006|NOT COMPLETED|Part A Period 1 (4 Days)||0
3353191|NCT03627494|4083494|FG007|NOT COMPLETED|Part A Period 1 (4 Days)||0
3353192|NCT03627494|4083495|FG008|NOT COMPLETED|Part A Period 1 (4 Days)||0
3353193|NCT03627494|4083496|FG009|NOT COMPLETED|Part A Period 1 (4 Days)||0
3353194|NCT03627494|4083497|FG010|NOT COMPLETED|Part A Period 1 (4 Days)||0
3353195|NCT03627494|4083498|FG011|NOT COMPLETED|Part A Period 1 (4 Days)||0
3353196|NCT03627494|4083487|FG000|STARTED|Part A Washout 1 (7 Days)||3
3353197|NCT03627494|4083488|FG001|STARTED|Part A Washout 1 (7 Days)||3
3353198|NCT03627494|4083489|FG002|STARTED|Part A Washout 1 (7 Days)||3
3353199|NCT03627494|4083490|FG003|STARTED|Part A Washout 1 (7 Days)||3
3353200|NCT03627494|4083491|FG004|STARTED|Part A Washout 1 (7 Days)||3
3353201|NCT03627494|4083492|FG005|STARTED|Part A Washout 1 (7 Days)||3
3353202|NCT03627494|4083493|FG006|STARTED|Part A Washout 1 (7 Days)||0
3353203|NCT03627494|4083494|FG007|STARTED|Part A Washout 1 (7 Days)||0
3353204|NCT03627494|4083495|FG008|STARTED|Part A Washout 1 (7 Days)||0
3353205|NCT03627494|4083496|FG009|STARTED|Part A Washout 1 (7 Days)||0
3353206|NCT03627494|4083497|FG010|STARTED|Part A Washout 1 (7 Days)||0
3353207|NCT03627494|4083498|FG011|STARTED|Part A Washout 1 (7 Days)||0
3353208|NCT03627494|4083487|FG000|COMPLETED|Part A Washout 1 (7 Days)||3
3353209|NCT03627494|4083488|FG001|COMPLETED|Part A Washout 1 (7 Days)||3
3353210|NCT03627494|4083489|FG002|COMPLETED|Part A Washout 1 (7 Days)||3
3353211|NCT03627494|4083490|FG003|COMPLETED|Part A Washout 1 (7 Days)||3
3178866|NCT01980992|3906991|FG001|COMPLETED|52 Weeks Blinded Study Treatment||19
3178867|NCT01980992|3906990|FG000|NOT COMPLETED|52 Weeks Blinded Study Treatment||2
3178868|NCT01980992|3906991|FG001|NOT COMPLETED|52 Weeks Blinded Study Treatment||4
3178869|NCT01980992|3906990|FG000|STARTED|52 Weeks Open Label Active Wheat OIT||21
3178870|NCT01980992|3906991|FG001|STARTED|52 Weeks Open Label Active Wheat OIT||19
3353212|NCT03627494|4083491|FG004|COMPLETED|Part A Washout 1 (7 Days)||3
3353213|NCT03627494|4083492|FG005|COMPLETED|Part A Washout 1 (7 Days)||3
3353214|NCT03627494|4083493|FG006|COMPLETED|Part A Washout 1 (7 Days)||0
3353215|NCT03627494|4083494|FG007|COMPLETED|Part A Washout 1 (7 Days)||0
3353216|NCT03627494|4083495|FG008|COMPLETED|Part A Washout 1 (7 Days)||0
3353217|NCT03627494|4083496|FG009|COMPLETED|Part A Washout 1 (7 Days)||0
3353218|NCT03627494|4083497|FG010|COMPLETED|Part A Washout 1 (7 Days)||0
3353219|NCT03627494|4083498|FG011|COMPLETED|Part A Washout 1 (7 Days)||0
3353220|NCT03627494|4083487|FG000|NOT COMPLETED|Part A Washout 1 (7 Days)||0
3353221|NCT03627494|4083488|FG001|NOT COMPLETED|Part A Washout 1 (7 Days)||0
3353222|NCT03627494|4083489|FG002|NOT COMPLETED|Part A Washout 1 (7 Days)||0
3353223|NCT03627494|4083490|FG003|NOT COMPLETED|Part A Washout 1 (7 Days)||0
3353224|NCT03627494|4083491|FG004|NOT COMPLETED|Part A Washout 1 (7 Days)||0
3353225|NCT03627494|4083492|FG005|NOT COMPLETED|Part A Washout 1 (7 Days)||0
3353226|NCT03627494|4083493|FG006|NOT COMPLETED|Part A Washout 1 (7 Days)||0
3353227|NCT03627494|4083494|FG007|NOT COMPLETED|Part A Washout 1 (7 Days)||0
3353228|NCT03627494|4083495|FG008|NOT COMPLETED|Part A Washout 1 (7 Days)||0
3353229|NCT03627494|4083496|FG009|NOT COMPLETED|Part A Washout 1 (7 Days)||0
3353230|NCT03627494|4083497|FG010|NOT COMPLETED|Part A Washout 1 (7 Days)||0
3353231|NCT03627494|4083498|FG011|NOT COMPLETED|Part A Washout 1 (7 Days)||0
3353232|NCT03627494|4083487|FG000|STARTED|Part A Period 2 (4 Days)||3
3353233|NCT03627494|4083488|FG001|STARTED|Part A Period 2 (4 Days)||3
3353234|NCT03627494|4083489|FG002|STARTED|Part A Period 2 (4 Days)||3
3353235|NCT03627494|4083490|FG003|STARTED|Part A Period 2 (4 Days)||3
3353236|NCT03627494|4083491|FG004|STARTED|Part A Period 2 (4 Days)||3
3353237|NCT03627494|4083492|FG005|STARTED|Part A Period 2 (4 Days)||3
3353238|NCT03627494|4083493|FG006|STARTED|Part A Period 2 (4 Days)||0
3353239|NCT03627494|4083494|FG007|STARTED|Part A Period 2 (4 Days)||0
3353240|NCT03627494|4083495|FG008|STARTED|Part A Period 2 (4 Days)||0
3353241|NCT03627494|4083496|FG009|STARTED|Part A Period 2 (4 Days)||0
3353242|NCT03627494|4083497|FG010|STARTED|Part A Period 2 (4 Days)||0
3353243|NCT03627494|4083498|FG011|STARTED|Part A Period 2 (4 Days)||0
3353244|NCT03627494|4083487|FG000|COMPLETED|Part A Period 2 (4 Days)||3
3353245|NCT03627494|4083488|FG001|COMPLETED|Part A Period 2 (4 Days)||3
3353246|NCT03627494|4083489|FG002|COMPLETED|Part A Period 2 (4 Days)||3
3353247|NCT03627494|4083490|FG003|COMPLETED|Part A Period 2 (4 Days)||3
3353248|NCT03627494|4083491|FG004|COMPLETED|Part A Period 2 (4 Days)||3
3353249|NCT03627494|4083492|FG005|COMPLETED|Part A Period 2 (4 Days)||3
3353250|NCT03627494|4083493|FG006|COMPLETED|Part A Period 2 (4 Days)||0
3353251|NCT03627494|4083494|FG007|COMPLETED|Part A Period 2 (4 Days)||0
3353252|NCT03627494|4083495|FG008|COMPLETED|Part A Period 2 (4 Days)||0
3353253|NCT03627494|4083496|FG009|COMPLETED|Part A Period 2 (4 Days)||0
3353254|NCT03627494|4083497|FG010|COMPLETED|Part A Period 2 (4 Days)||0
3353255|NCT03627494|4083498|FG011|COMPLETED|Part A Period 2 (4 Days)||0
3353256|NCT03627494|4083487|FG000|NOT COMPLETED|Part A Period 2 (4 Days)||0
3353257|NCT03627494|4083488|FG001|NOT COMPLETED|Part A Period 2 (4 Days)||0
3353258|NCT03627494|4083489|FG002|NOT COMPLETED|Part A Period 2 (4 Days)||0
3353259|NCT03627494|4083490|FG003|NOT COMPLETED|Part A Period 2 (4 Days)||0
3353260|NCT03627494|4083491|FG004|NOT COMPLETED|Part A Period 2 (4 Days)||0
3353261|NCT03627494|4083492|FG005|NOT COMPLETED|Part A Period 2 (4 Days)||0
3353262|NCT03627494|4083493|FG006|NOT COMPLETED|Part A Period 2 (4 Days)||0
3353263|NCT03627494|4083494|FG007|NOT COMPLETED|Part A Period 2 (4 Days)||0
3353264|NCT03627494|4083495|FG008|NOT COMPLETED|Part A Period 2 (4 Days)||0
3353265|NCT03627494|4083496|FG009|NOT COMPLETED|Part A Period 2 (4 Days)||0
3353266|NCT03627494|4083497|FG010|NOT COMPLETED|Part A Period 2 (4 Days)||0
3353267|NCT03627494|4083498|FG011|NOT COMPLETED|Part A Period 2 (4 Days)||0
3353268|NCT03627494|4083487|FG000|STARTED|Part A Washout 2 (7 Days)||3
3353269|NCT03627494|4083488|FG001|STARTED|Part A Washout 2 (7 Days)||3
3353270|NCT03627494|4083489|FG002|STARTED|Part A Washout 2 (7 Days)||3
3353271|NCT03627494|4083490|FG003|STARTED|Part A Washout 2 (7 Days)||3
3353272|NCT03627494|4083491|FG004|STARTED|Part A Washout 2 (7 Days)||3
3353273|NCT03627494|4083492|FG005|STARTED|Part A Washout 2 (7 Days)||3
3353274|NCT03627494|4083493|FG006|STARTED|Part A Washout 2 (7 Days)||0
3353275|NCT03627494|4083494|FG007|STARTED|Part A Washout 2 (7 Days)||0
3353276|NCT03627494|4083495|FG008|STARTED|Part A Washout 2 (7 Days)||0
3353277|NCT03627494|4083496|FG009|STARTED|Part A Washout 2 (7 Days)||0
3353278|NCT03627494|4083497|FG010|STARTED|Part A Washout 2 (7 Days)||0
3353279|NCT03627494|4083498|FG011|STARTED|Part A Washout 2 (7 Days)||0
3353280|NCT03627494|4083487|FG000|COMPLETED|Part A Washout 2 (7 Days)||2
3353281|NCT03627494|4083488|FG001|COMPLETED|Part A Washout 2 (7 Days)||3
3353282|NCT03627494|4083489|FG002|COMPLETED|Part A Washout 2 (7 Days)||2
3353283|NCT03627494|4083490|FG003|COMPLETED|Part A Washout 2 (7 Days)||3
3353284|NCT03627494|4083491|FG004|COMPLETED|Part A Washout 2 (7 Days)||3
3353285|NCT03627494|4083492|FG005|COMPLETED|Part A Washout 2 (7 Days)||3
3353286|NCT03627494|4083493|FG006|COMPLETED|Part A Washout 2 (7 Days)||0
3353287|NCT03627494|4083494|FG007|COMPLETED|Part A Washout 2 (7 Days)||0
3353288|NCT03627494|4083495|FG008|COMPLETED|Part A Washout 2 (7 Days)||0
3353289|NCT03627494|4083496|FG009|COMPLETED|Part A Washout 2 (7 Days)||0
3353290|NCT03627494|4083497|FG010|COMPLETED|Part A Washout 2 (7 Days)||0
3353291|NCT03627494|4083498|FG011|COMPLETED|Part A Washout 2 (7 Days)||0
3353292|NCT03627494|4083487|FG000|NOT COMPLETED|Part A Washout 2 (7 Days)||1
3353293|NCT03627494|4083488|FG001|NOT COMPLETED|Part A Washout 2 (7 Days)||0
3353294|NCT03627494|4083489|FG002|NOT COMPLETED|Part A Washout 2 (7 Days)||1
3353295|NCT03627494|4083490|FG003|NOT COMPLETED|Part A Washout 2 (7 Days)||0
3353296|NCT03627494|4083491|FG004|NOT COMPLETED|Part A Washout 2 (7 Days)||0
3353297|NCT03627494|4083492|FG005|NOT COMPLETED|Part A Washout 2 (7 Days)||0
3353298|NCT03627494|4083493|FG006|NOT COMPLETED|Part A Washout 2 (7 Days)||0
3353299|NCT03627494|4083494|FG007|NOT COMPLETED|Part A Washout 2 (7 Days)||0
3353300|NCT03627494|4083495|FG008|NOT COMPLETED|Part A Washout 2 (7 Days)||0
3353301|NCT03627494|4083496|FG009|NOT COMPLETED|Part A Washout 2 (7 Days)||0
3353302|NCT03627494|4083497|FG010|NOT COMPLETED|Part A Washout 2 (7 Days)||0
3353303|NCT03627494|4083498|FG011|NOT COMPLETED|Part A Washout 2 (7 Days)||0
3353304|NCT03627494|4083487|FG000|STARTED|Part A Period3(4days)+Follow-up(14days)||2
3353305|NCT03627494|4083488|FG001|STARTED|Part A Period3(4days)+Follow-up(14days)||3
3353306|NCT03627494|4083489|FG002|STARTED|Part A Period3(4days)+Follow-up(14days)||2
3353307|NCT03627494|4083490|FG003|STARTED|Part A Period3(4days)+Follow-up(14days)||3
3353308|NCT03627494|4083491|FG004|STARTED|Part A Period3(4days)+Follow-up(14days)||3
3353309|NCT03627494|4083492|FG005|STARTED|Part A Period3(4days)+Follow-up(14days)||3
3353310|NCT03627494|4083493|FG006|STARTED|Part A Period3(4days)+Follow-up(14days)||0
3353311|NCT03627494|4083494|FG007|STARTED|Part A Period3(4days)+Follow-up(14days)||0
3353312|NCT03627494|4083495|FG008|STARTED|Part A Period3(4days)+Follow-up(14days)||0
3353313|NCT03627494|4083496|FG009|STARTED|Part A Period3(4days)+Follow-up(14days)||0
3353314|NCT03627494|4083497|FG010|STARTED|Part A Period3(4days)+Follow-up(14days)||0
3353315|NCT03627494|4083498|FG011|STARTED|Part A Period3(4days)+Follow-up(14days)||0
3353316|NCT03627494|4083487|FG000|COMPLETED|Part A Period3(4days)+Follow-up(14days)||2
3178871|NCT01980992|3906990|FG000|COMPLETED|52 Weeks Open Label Active Wheat OIT||18
3178872|NCT01980992|3906991|FG001|COMPLETED|52 Weeks Open Label Active Wheat OIT||18
3178873|NCT01980992|3906990|FG000|NOT COMPLETED|52 Weeks Open Label Active Wheat OIT||3
3353317|NCT03627494|4083488|FG001|COMPLETED|Part A Period3(4days)+Follow-up(14days)||3
3353318|NCT03627494|4083489|FG002|COMPLETED|Part A Period3(4days)+Follow-up(14days)||2
3353319|NCT03627494|4083490|FG003|COMPLETED|Part A Period3(4days)+Follow-up(14days)||3
3353320|NCT03627494|4083491|FG004|COMPLETED|Part A Period3(4days)+Follow-up(14days)||3
3353321|NCT03627494|4083492|FG005|COMPLETED|Part A Period3(4days)+Follow-up(14days)||3
3353322|NCT03627494|4083493|FG006|COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
3178874|NCT01980992|3906991|FG001|NOT COMPLETED|52 Weeks Open Label Active Wheat OIT||1
3178875|NCT01981057|3907006|FG000|STARTED|Overall Study||50
3178876|NCT01981057|3907007|FG001|STARTED|Overall Study||50
3353323|NCT03627494|4083494|FG007|COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
3353324|NCT03627494|4083495|FG008|COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
3353325|NCT03627494|4083496|FG009|COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
3353326|NCT03627494|4083497|FG010|COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
3353327|NCT03627494|4083498|FG011|COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
3353328|NCT03627494|4083487|FG000|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
3353329|NCT03627494|4083488|FG001|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
3353330|NCT03627494|4083489|FG002|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
3353331|NCT03627494|4083490|FG003|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
3353332|NCT03627494|4083491|FG004|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
3353333|NCT03627494|4083492|FG005|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
3353334|NCT03627494|4083493|FG006|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
3353335|NCT03627494|4083494|FG007|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
3353336|NCT03627494|4083495|FG008|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
3353337|NCT03627494|4083496|FG009|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
3353338|NCT03627494|4083497|FG010|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
3353339|NCT03627494|4083498|FG011|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
3353340|NCT03627494|4083487|FG000|STARTED|Part B (Maximum of 34 Days)||0
3353341|NCT03627494|4083488|FG001|STARTED|Part B (Maximum of 34 Days)||0
3353342|NCT03627494|4083489|FG002|STARTED|Part B (Maximum of 34 Days)||0
3353343|NCT03627494|4083490|FG003|STARTED|Part B (Maximum of 34 Days)||0
3353344|NCT03627494|4083491|FG004|STARTED|Part B (Maximum of 34 Days)||0
3353345|NCT03627494|4083492|FG005|STARTED|Part B (Maximum of 34 Days)||0
3353346|NCT03627494|4083493|FG006|STARTED|Part B (Maximum of 34 Days)||9
3353347|NCT03627494|4083494|FG007|STARTED|Part B (Maximum of 34 Days)||9
3353348|NCT03627494|4083495|FG008|STARTED|Part B (Maximum of 34 Days)||9
3353349|NCT03627494|4083496|FG009|STARTED|Part B (Maximum of 34 Days)||9
3353350|NCT03627494|4083497|FG010|STARTED|Part B (Maximum of 34 Days)||0
3353351|NCT03627494|4083498|FG011|STARTED|Part B (Maximum of 34 Days)||0
3353352|NCT03627494|4083487|FG000|COMPLETED|Part B (Maximum of 34 Days)||0
3353353|NCT03627494|4083488|FG001|COMPLETED|Part B (Maximum of 34 Days)||0
3353354|NCT03627494|4083489|FG002|COMPLETED|Part B (Maximum of 34 Days)||0
3353355|NCT03627494|4083490|FG003|COMPLETED|Part B (Maximum of 34 Days)||0
3353356|NCT03627494|4083491|FG004|COMPLETED|Part B (Maximum of 34 Days)||0
3353357|NCT03627494|4083492|FG005|COMPLETED|Part B (Maximum of 34 Days)||0
3353358|NCT03627494|4083493|FG006|COMPLETED|Part B (Maximum of 34 Days)||9
3353359|NCT03627494|4083494|FG007|COMPLETED|Part B (Maximum of 34 Days)||9
3353360|NCT03627494|4083495|FG008|COMPLETED|Part B (Maximum of 34 Days)||7
3353361|NCT03627494|4083496|FG009|COMPLETED|Part B (Maximum of 34 Days)||9
3353362|NCT03627494|4083497|FG010|COMPLETED|Part B (Maximum of 34 Days)||0
3353363|NCT03627494|4083498|FG011|COMPLETED|Part B (Maximum of 34 Days)||0
3353364|NCT03627494|4083487|FG000|NOT COMPLETED|Part B (Maximum of 34 Days)||0
3353365|NCT03627494|4083488|FG001|NOT COMPLETED|Part B (Maximum of 34 Days)||0
3353366|NCT03627494|4083489|FG002|NOT COMPLETED|Part B (Maximum of 34 Days)||0
3353367|NCT03627494|4083490|FG003|NOT COMPLETED|Part B (Maximum of 34 Days)||0
3353368|NCT03627494|4083491|FG004|NOT COMPLETED|Part B (Maximum of 34 Days)||0
3353369|NCT03627494|4083492|FG005|NOT COMPLETED|Part B (Maximum of 34 Days)||0
3353370|NCT03627494|4083493|FG006|NOT COMPLETED|Part B (Maximum of 34 Days)||0
3353371|NCT03627494|4083494|FG007|NOT COMPLETED|Part B (Maximum of 34 Days)||0
3353372|NCT03627494|4083495|FG008|NOT COMPLETED|Part B (Maximum of 34 Days)||2
3353373|NCT03627494|4083496|FG009|NOT COMPLETED|Part B (Maximum of 34 Days)||0
3353374|NCT03627494|4083497|FG010|NOT COMPLETED|Part B (Maximum of 34 Days)||0
3353375|NCT03627494|4083498|FG011|NOT COMPLETED|Part B (Maximum of 34 Days)||0
3353376|NCT03627494|4083487|FG000|STARTED|Part C Period 1 (4 Days)||0
3353377|NCT03627494|4083488|FG001|STARTED|Part C Period 1 (4 Days)||0
3353378|NCT03627494|4083489|FG002|STARTED|Part C Period 1 (4 Days)||0
3353379|NCT03627494|4083490|FG003|STARTED|Part C Period 1 (4 Days)||0
3353380|NCT03627494|4083491|FG004|STARTED|Part C Period 1 (4 Days)||0
3353381|NCT03627494|4083492|FG005|STARTED|Part C Period 1 (4 Days)||0
3353382|NCT03627494|4083493|FG006|STARTED|Part C Period 1 (4 Days)||0
3353383|NCT03627494|4083494|FG007|STARTED|Part C Period 1 (4 Days)||0
3353384|NCT03627494|4083495|FG008|STARTED|Part C Period 1 (4 Days)||0
3353385|NCT03627494|4083496|FG009|STARTED|Part C Period 1 (4 Days)||0
3353386|NCT03627494|4083497|FG010|STARTED|Part C Period 1 (4 Days)||6
3353387|NCT03627494|4083498|FG011|STARTED|Part C Period 1 (4 Days)||6
3353388|NCT03627494|4083487|FG000|COMPLETED|Part C Period 1 (4 Days)||0
3353389|NCT03627494|4083488|FG001|COMPLETED|Part C Period 1 (4 Days)||0
3353390|NCT03627494|4083489|FG002|COMPLETED|Part C Period 1 (4 Days)||0
3353391|NCT03627494|4083490|FG003|COMPLETED|Part C Period 1 (4 Days)||0
3353392|NCT03627494|4083491|FG004|COMPLETED|Part C Period 1 (4 Days)||0
3353393|NCT03627494|4083492|FG005|COMPLETED|Part C Period 1 (4 Days)||0
3353394|NCT03627494|4083493|FG006|COMPLETED|Part C Period 1 (4 Days)||0
3353395|NCT03627494|4083494|FG007|COMPLETED|Part C Period 1 (4 Days)||0
3353396|NCT03627494|4083495|FG008|COMPLETED|Part C Period 1 (4 Days)||0
3353397|NCT03627494|4083496|FG009|COMPLETED|Part C Period 1 (4 Days)||0
3353398|NCT03627494|4083497|FG010|COMPLETED|Part C Period 1 (4 Days)||6
3353399|NCT03627494|4083498|FG011|COMPLETED|Part C Period 1 (4 Days)||6
3353400|NCT03627494|4083487|FG000|NOT COMPLETED|Part C Period 1 (4 Days)||0
3353401|NCT03627494|4083488|FG001|NOT COMPLETED|Part C Period 1 (4 Days)||0
3353402|NCT03627494|4083489|FG002|NOT COMPLETED|Part C Period 1 (4 Days)||0
3353403|NCT03627494|4083490|FG003|NOT COMPLETED|Part C Period 1 (4 Days)||0
3353404|NCT03627494|4083491|FG004|NOT COMPLETED|Part C Period 1 (4 Days)||0
3353405|NCT03627494|4083492|FG005|NOT COMPLETED|Part C Period 1 (4 Days)||0
3353406|NCT03627494|4083493|FG006|NOT COMPLETED|Part C Period 1 (4 Days)||0
3353407|NCT03627494|4083494|FG007|NOT COMPLETED|Part C Period 1 (4 Days)||0
3353408|NCT03627494|4083495|FG008|NOT COMPLETED|Part C Period 1 (4 Days)||0
3353409|NCT03627494|4083496|FG009|NOT COMPLETED|Part C Period 1 (4 Days)||0
3353410|NCT03627494|4083497|FG010|NOT COMPLETED|Part C Period 1 (4 Days)||0
3353411|NCT03627494|4083498|FG011|NOT COMPLETED|Part C Period 1 (4 Days)||0
3353412|NCT03627494|4083487|FG000|STARTED|Part C Washout 1 (7 Days)||0
3353413|NCT03627494|4083488|FG001|STARTED|Part C Washout 1 (7 Days)||0
3353414|NCT03627494|4083489|FG002|STARTED|Part C Washout 1 (7 Days)||0
3353415|NCT03627494|4083490|FG003|STARTED|Part C Washout 1 (7 Days)||0
3353416|NCT03627494|4083491|FG004|STARTED|Part C Washout 1 (7 Days)||0
3353417|NCT03627494|4083492|FG005|STARTED|Part C Washout 1 (7 Days)||0
3353418|NCT03627494|4083493|FG006|STARTED|Part C Washout 1 (7 Days)||0
3353419|NCT03627494|4083494|FG007|STARTED|Part C Washout 1 (7 Days)||0
3353420|NCT03627494|4083495|FG008|STARTED|Part C Washout 1 (7 Days)||0
3353421|NCT03627494|4083496|FG009|STARTED|Part C Washout 1 (7 Days)||0
3353422|NCT03627494|4083497|FG010|STARTED|Part C Washout 1 (7 Days)||6
3353423|NCT03627494|4083498|FG011|STARTED|Part C Washout 1 (7 Days)||6
3353424|NCT03627494|4083487|FG000|COMPLETED|Part C Washout 1 (7 Days)||0
3353425|NCT03627494|4083488|FG001|COMPLETED|Part C Washout 1 (7 Days)||0
3353426|NCT03627494|4083489|FG002|COMPLETED|Part C Washout 1 (7 Days)||0
3353427|NCT03627494|4083490|FG003|COMPLETED|Part C Washout 1 (7 Days)||0
3353428|NCT03627494|4083491|FG004|COMPLETED|Part C Washout 1 (7 Days)||0
3353429|NCT03627494|4083492|FG005|COMPLETED|Part C Washout 1 (7 Days)||0
3353430|NCT03627494|4083493|FG006|COMPLETED|Part C Washout 1 (7 Days)||0
3353431|NCT03627494|4083494|FG007|COMPLETED|Part C Washout 1 (7 Days)||0
3353432|NCT03627494|4083495|FG008|COMPLETED|Part C Washout 1 (7 Days)||0
3353433|NCT03627494|4083496|FG009|COMPLETED|Part C Washout 1 (7 Days)||0
3353434|NCT03627494|4083497|FG010|COMPLETED|Part C Washout 1 (7 Days)||5
3353435|NCT03627494|4083498|FG011|COMPLETED|Part C Washout 1 (7 Days)||5
3353436|NCT03627494|4083487|FG000|NOT COMPLETED|Part C Washout 1 (7 Days)||0
3353437|NCT03627494|4083488|FG001|NOT COMPLETED|Part C Washout 1 (7 Days)||0
3353438|NCT03627494|4083489|FG002|NOT COMPLETED|Part C Washout 1 (7 Days)||0
3353439|NCT03627494|4083490|FG003|NOT COMPLETED|Part C Washout 1 (7 Days)||0
3353440|NCT03627494|4083491|FG004|NOT COMPLETED|Part C Washout 1 (7 Days)||0
3353441|NCT03627494|4083492|FG005|NOT COMPLETED|Part C Washout 1 (7 Days)||0
3353442|NCT03627494|4083493|FG006|NOT COMPLETED|Part C Washout 1 (7 Days)||0
3353443|NCT03627494|4083494|FG007|NOT COMPLETED|Part C Washout 1 (7 Days)||0
3353444|NCT03627494|4083495|FG008|NOT COMPLETED|Part C Washout 1 (7 Days)||0
3353445|NCT03627494|4083496|FG009|NOT COMPLETED|Part C Washout 1 (7 Days)||0
3353446|NCT03627494|4083497|FG010|NOT COMPLETED|Part C Washout 1 (7 Days)||1
3353447|NCT03627494|4083498|FG011|NOT COMPLETED|Part C Washout 1 (7 Days)||1
3353448|NCT03627494|4083487|FG000|STARTED|Part C Period2(4days)+Follow-up(14days)||0
3353449|NCT03627494|4083488|FG001|STARTED|Part C Period2(4days)+Follow-up(14days)||0
3353450|NCT03627494|4083489|FG002|STARTED|Part C Period2(4days)+Follow-up(14days)||0
3353451|NCT03627494|4083490|FG003|STARTED|Part C Period2(4days)+Follow-up(14days)||0
3353452|NCT03627494|4083491|FG004|STARTED|Part C Period2(4days)+Follow-up(14days)||0
3353453|NCT03627494|4083492|FG005|STARTED|Part C Period2(4days)+Follow-up(14days)||0
3353454|NCT03627494|4083493|FG006|STARTED|Part C Period2(4days)+Follow-up(14days)||0
3353455|NCT03627494|4083494|FG007|STARTED|Part C Period2(4days)+Follow-up(14days)||0
3353456|NCT03627494|4083495|FG008|STARTED|Part C Period2(4days)+Follow-up(14days)||0
3353457|NCT03627494|4083496|FG009|STARTED|Part C Period2(4days)+Follow-up(14days)||0
3353458|NCT03627494|4083497|FG010|STARTED|Part C Period2(4days)+Follow-up(14days)||5
3353459|NCT03627494|4083498|FG011|STARTED|Part C Period2(4days)+Follow-up(14days)||5
3353460|NCT03627494|4083487|FG000|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
3353461|NCT03627494|4083488|FG001|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
3353462|NCT03627494|4083489|FG002|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
3353463|NCT03627494|4083490|FG003|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
3353464|NCT03627494|4083491|FG004|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
3353465|NCT03627494|4083492|FG005|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
3353466|NCT03627494|4083493|FG006|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
3353467|NCT03627494|4083494|FG007|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
3353468|NCT03627494|4083495|FG008|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
3353469|NCT03627494|4083496|FG009|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
3353470|NCT03627494|4083497|FG010|COMPLETED|Part C Period2(4days)+Follow-up(14days)||5
3353471|NCT03627494|4083498|FG011|COMPLETED|Part C Period2(4days)+Follow-up(14days)||5
3353472|NCT03627494|4083487|FG000|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
3353473|NCT03627494|4083488|FG001|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
3353474|NCT03627494|4083489|FG002|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
3353475|NCT03627494|4083490|FG003|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
3353476|NCT03627494|4083491|FG004|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
3353477|NCT03627494|4083492|FG005|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
3353478|NCT03627494|4083493|FG006|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
3353479|NCT03627494|4083494|FG007|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
3353480|NCT03627494|4083495|FG008|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
3353481|NCT03627494|4083496|FG009|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
3353482|NCT03627494|4083497|FG010|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
3353483|NCT03627494|4083498|FG011|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
3353484|NCT03627767|4083540|FG000|STARTED|Open-label (OL) Run-in Period (12 Weeks)||1235
3353485|NCT03627767|4083541|FG001|STARTED|Open-label (OL) Run-in Period (12 Weeks)||0
3353486|NCT03627767|4083542|FG002|STARTED|Open-label (OL) Run-in Period (12 Weeks)||0
3353487|NCT03627767|4083543|FG003|STARTED|Open-label (OL) Run-in Period (12 Weeks)||0
3353488|NCT03627767|4083544|FG004|STARTED|Open-label (OL) Run-in Period (12 Weeks)||0
3353489|NCT03627767|4083540|FG000|Treated|Open-label (OL) Run-in Period (12 Weeks)||1233
3353490|NCT03627767|4083541|FG001|Treated|Open-label (OL) Run-in Period (12 Weeks)||0
3353491|NCT03627767|4083542|FG002|Treated|Open-label (OL) Run-in Period (12 Weeks)||0
3353492|NCT03627767|4083543|FG003|Treated|Open-label (OL) Run-in Period (12 Weeks)||0
3353493|NCT03627767|4083544|FG004|Treated|Open-label (OL) Run-in Period (12 Weeks)||0
3353494|NCT03627767|4083540|FG000|COMPLETED|Open-label (OL) Run-in Period (12 Weeks)||798
3353495|NCT03627767|4083541|FG001|COMPLETED|Open-label (OL) Run-in Period (12 Weeks)||0
3353496|NCT03627767|4083542|FG002|COMPLETED|Open-label (OL) Run-in Period (12 Weeks)||0
3353497|NCT03627767|4083543|FG003|COMPLETED|Open-label (OL) Run-in Period (12 Weeks)||0
3353498|NCT03627767|4083544|FG004|COMPLETED|Open-label (OL) Run-in Period (12 Weeks)||0
3353499|NCT03627767|4083540|FG000|NOT COMPLETED|Open-label (OL) Run-in Period (12 Weeks)||437
3353500|NCT03627767|4083541|FG001|NOT COMPLETED|Open-label (OL) Run-in Period (12 Weeks)||0
3353501|NCT03627767|4083542|FG002|NOT COMPLETED|Open-label (OL) Run-in Period (12 Weeks)||0
3353502|NCT03627767|4083543|FG003|NOT COMPLETED|Open-label (OL) Run-in Period (12 Weeks)||0
3353503|NCT03627767|4083544|FG004|NOT COMPLETED|Open-label (OL) Run-in Period (12 Weeks)||0
3353504|NCT03627767|4083540|FG000|STARTED|Double-blind Treatment Period (40 Weeks)|Participants did not enter into the DB period.|0
3353505|NCT03627767|4083541|FG001|STARTED|Double-blind Treatment Period (40 Weeks)|Participants who met the pre-defined criteria for DB.|267
3353506|NCT03627767|4083542|FG002|STARTED|Double-blind Treatment Period (40 Weeks)|Participants who met the pre-defined criteria for DB.|265
3353507|NCT03627767|4083543|FG003|STARTED|Double-blind Treatment Period (40 Weeks)|Participants who met the pre-defined criteria for DB.|266
3353508|NCT03627767|4083544|FG004|STARTED|Double-blind Treatment Period (40 Weeks)||0
3353509|NCT03627767|4083540|FG000|Participants Entered Rescue Period|Double-blind Treatment Period (40 Weeks)||0
3353510|NCT03627767|4083541|FG001|Participants Entered Rescue Period|Double-blind Treatment Period (40 Weeks)||208
3353511|NCT03627767|4083542|FG002|Participants Entered Rescue Period|Double-blind Treatment Period (40 Weeks)||109
3353512|NCT03627767|4083543|FG003|Participants Entered Rescue Period|Double-blind Treatment Period (40 Weeks)||44
3353513|NCT03627767|4083544|FG004|Participants Entered Rescue Period|Double-blind Treatment Period (40 Weeks)||0
3353514|NCT03627767|4083540|FG000|Completed After Entering Rescue Period|Double-blind Treatment Period (40 Weeks)||0
3353515|NCT03627767|4083541|FG001|Completed After Entering Rescue Period|Double-blind Treatment Period (40 Weeks)||201
3353516|NCT03627767|4083542|FG002|Completed After Entering Rescue Period|Double-blind Treatment Period (40 Weeks)||99
3353517|NCT03627767|4083543|FG003|Completed After Entering Rescue Period|Double-blind Treatment Period (40 Weeks)||41
3353518|NCT03627767|4083544|FG004|Completed After Entering Rescue Period|Double-blind Treatment Period (40 Weeks)||0
3353519|NCT03627767|4083540|FG000|Completed Without Entering Rescue Period|Double-blind Treatment Period (40 Weeks)||0
3353520|NCT03627767|4083541|FG001|Completed Without Entering Rescue Period|Double-blind Treatment Period (40 Weeks)||43
3353521|NCT03627767|4083542|FG002|Completed Without Entering Rescue Period|Double-blind Treatment Period (40 Weeks)||134
3353522|NCT03627767|4083543|FG003|Completed Without Entering Rescue Period|Double-blind Treatment Period (40 Weeks)||187
3353523|NCT03627767|4083544|FG004|Completed Without Entering Rescue Period|Double-blind Treatment Period (40 Weeks)||0
3353524|NCT03627767|4083540|FG000|COMPLETED|Double-blind Treatment Period (40 Weeks)||0
3353525|NCT03627767|4083541|FG001|COMPLETED|Double-blind Treatment Period (40 Weeks)|208 entered RP+43 completed study in DB period|251
3353526|NCT03627767|4083542|FG002|COMPLETED|Double-blind Treatment Period (40 Weeks)|109 entered RP+134 completed study in DB period|243
3353527|NCT03627767|4083543|FG003|COMPLETED|Double-blind Treatment Period (40 Weeks)|44 entered RP+187 completed study in DB period|231
3353528|NCT03627767|4083544|FG004|COMPLETED|Double-blind Treatment Period (40 Weeks)||0
3353529|NCT03627767|4083540|FG000|NOT COMPLETED|Double-blind Treatment Period (40 Weeks)||0
3353530|NCT03627767|4083541|FG001|NOT COMPLETED|Double-blind Treatment Period (40 Weeks)||16
3353531|NCT03627767|4083542|FG002|NOT COMPLETED|Double-blind Treatment Period (40 Weeks)||22
3353532|NCT03627767|4083543|FG003|NOT COMPLETED|Double-blind Treatment Period (40 Weeks)||35
3353533|NCT03627767|4083544|FG004|NOT COMPLETED|Double-blind Treatment Period (40 Weeks)||0
3353534|NCT03627767|4083540|FG000|STARTED|Open-label Rescue Period (12 Weeks)||0
3353535|NCT03627767|4083541|FG001|STARTED|Open-label Rescue Period (12 Weeks)|Participants did not enter into the OL- Rescue Period.|0
3353536|NCT03627767|4083542|FG002|STARTED|Open-label Rescue Period (12 Weeks)|Participants did not enter into the OL- Rescue Period.|0
3353537|NCT03627767|4083543|FG003|STARTED|Open-label Rescue Period (12 Weeks)|Participants did not enter into the OL- Rescue Period.|0
3353538|NCT03627767|4083544|FG004|STARTED|Open-label Rescue Period (12 Weeks)|Participants who met the pre-defined criteria for OL- Rescue Period.|361
3353539|NCT03627767|4083540|FG000|Met Protocol-defined Flare Criteria|Open-label Rescue Period (12 Weeks)||0
3353540|NCT03627767|4083541|FG001|Met Protocol-defined Flare Criteria|Open-label Rescue Period (12 Weeks)||0
3353541|NCT03627767|4083542|FG002|Met Protocol-defined Flare Criteria|Open-label Rescue Period (12 Weeks)||0
3353542|NCT03627767|4083543|FG003|Met Protocol-defined Flare Criteria|Open-label Rescue Period (12 Weeks)||0
3353543|NCT03627767|4083544|FG004|Met Protocol-defined Flare Criteria|Open-label Rescue Period (12 Weeks)||351
3353544|NCT03627767|4083540|FG000|COMPLETED|Open-label Rescue Period (12 Weeks)||0
3353545|NCT03627767|4083541|FG001|COMPLETED|Open-label Rescue Period (12 Weeks)||0
3353546|NCT03627767|4083542|FG002|COMPLETED|Open-label Rescue Period (12 Weeks)||0
3353547|NCT03627767|4083543|FG003|COMPLETED|Open-label Rescue Period (12 Weeks)||0
3353548|NCT03627767|4083544|FG004|COMPLETED|Open-label Rescue Period (12 Weeks)||341
3353549|NCT03627767|4083540|FG000|NOT COMPLETED|Open-label Rescue Period (12 Weeks)||0
3353550|NCT03627767|4083541|FG001|NOT COMPLETED|Open-label Rescue Period (12 Weeks)||0
3353551|NCT03627767|4083542|FG002|NOT COMPLETED|Open-label Rescue Period (12 Weeks)||0
3353552|NCT03627767|4083543|FG003|NOT COMPLETED|Open-label Rescue Period (12 Weeks)||0
3353553|NCT03627767|4083544|FG004|NOT COMPLETED|Open-label Rescue Period (12 Weeks)||20
3353554|NCT03627832|4083557|FG000|STARTED|Overall Study||28
3353555|NCT03627832|4083558|FG001|STARTED|Overall Study||28
3353556|NCT03627832|4083557|FG000|COMPLETED|Overall Study||18
3353557|NCT03627832|4083558|FG001|COMPLETED|Overall Study||27
3353558|NCT03627832|4083557|FG000|NOT COMPLETED|Overall Study||10
3353559|NCT03627832|4083558|FG001|NOT COMPLETED|Overall Study||1
3353560|NCT03628417|4083564|FG000|STARTED|Overall Study||7
3353561|NCT03628417|4083565|FG001|STARTED|Overall Study||7
3353562|NCT03628417|4083564|FG000|Day 0|Overall Study||7
3353563|NCT03628417|4083565|FG001|Day 0|Overall Study||7
3353564|NCT03628417|4083564|FG000|Day 7|Overall Study||7
3353565|NCT03628417|4083565|FG001|Day 7|Overall Study||7
3353566|NCT03628417|4083564|FG000|Day 15|Overall Study||7
3353567|NCT03628417|4083565|FG001|Day 15|Overall Study||7
3353568|NCT03628417|4083564|FG000|Day 30|Overall Study||7
3353569|NCT03628417|4083565|FG001|Day 30|Overall Study||7
3353570|NCT03628417|4083564|FG000|Day 60|Overall Study||7
3353571|NCT03628417|4083565|FG001|Day 60|Overall Study||7
3353572|NCT03628417|4083564|FG000|Day 90|Overall Study||7
3353573|NCT03628417|4083565|FG001|Day 90|Overall Study||7
3353574|NCT03628417|4083564|FG000|Day 180|Overall Study||7
3353575|NCT03628417|4083565|FG001|Day 180|Overall Study||7
3353576|NCT03628417|4083564|FG000|COMPLETED|Overall Study|One patient died and 3 more Ca electroporated lesions were removed before the one-year closing visit|6
3353577|NCT03628417|4083565|FG001|COMPLETED|Overall Study|One patient died before the one-year closing visit,this is why decreased the number of metastases|6
3353578|NCT03628417|4083564|FG000|NOT COMPLETED|Overall Study||1
3353579|NCT03628417|4083565|FG001|NOT COMPLETED|Overall Study||1
3353580|NCT03628456|4083575|FG000|STARTED|Overall Study||10
3353581|NCT03628456|4083575|FG000|COMPLETED|Overall Study||10
3353582|NCT03628456|4083575|FG000|NOT COMPLETED|Overall Study||0
3353583|NCT03628508|4083583|FG000|STARTED|Overall Study||40
3353584|NCT03628508|4083583|FG000|COMPLETED|Overall Study||39
3353585|NCT03628508|4083583|FG000|NOT COMPLETED|Overall Study||1
3353586|NCT03628599|4083589|FG000|STARTED|Overall Study||18
3353587|NCT03628599|4083590|FG001|STARTED|Overall Study||19
3353588|NCT03628599|4083589|FG000|COMPLETED|Overall Study||18
3353589|NCT03628599|4083590|FG001|COMPLETED|Overall Study||18
3353590|NCT03628599|4083589|FG000|NOT COMPLETED|Overall Study||0
3353591|NCT03628599|4083590|FG001|NOT COMPLETED|Overall Study||1
3353592|NCT03628885|4083603|FG000|STARTED|Overall Study||306
3353593|NCT03628885|4083604|FG001|STARTED|Overall Study||299
3353594|NCT03628885|4083605|FG002|STARTED|Overall Study||303
3353595|NCT03628885|4083603|FG000|COMPLETED|Overall Study||267
3353596|NCT03628885|4083604|FG001|COMPLETED|Overall Study||252
3353597|NCT03628885|4083605|FG002|COMPLETED|Overall Study||243
3353598|NCT03628885|4083603|FG000|NOT COMPLETED|Overall Study||39
3353599|NCT03628885|4083604|FG001|NOT COMPLETED|Overall Study||47
3353600|NCT03628885|4083605|FG002|NOT COMPLETED|Overall Study||60
3353601|NCT03628898|4083613|FG000|STARTED|Overall Study||27
3353602|NCT03628898|4083613|FG000|COMPLETED|Overall Study||26
3353603|NCT03628898|4083613|FG000|NOT COMPLETED|Overall Study||1
3353604|NCT03628924|4083620|FG000|STARTED|Placebo Controlled Period (Week 0 - 16)||62
3353605|NCT03628924|4083621|FG001|STARTED|Placebo Controlled Period (Week 0 - 16)||59
3353606|NCT03628924|4083622|FG002|STARTED|Placebo Controlled Period (Week 0 - 16)||60
3353607|NCT03628924|4083623|FG003|STARTED|Placebo Controlled Period (Week 0 - 16)||0
3353608|NCT03628924|4083624|FG004|STARTED|Placebo Controlled Period (Week 0 - 16)||0
3353609|NCT03628924|4083625|FG005|STARTED|Placebo Controlled Period (Week 0 - 16)||0
3353610|NCT03628924|4083626|FG006|STARTED|Placebo Controlled Period (Week 0 - 16)||0
3353611|NCT03628924|4083620|FG000|COMPLETED|Placebo Controlled Period (Week 0 - 16)||56
3353612|NCT03628924|4083621|FG001|COMPLETED|Placebo Controlled Period (Week 0 - 16)||56
3353613|NCT03628924|4083622|FG002|COMPLETED|Placebo Controlled Period (Week 0 - 16)||57
3353614|NCT03628924|4083623|FG003|COMPLETED|Placebo Controlled Period (Week 0 - 16)||0
3353615|NCT03628924|4083624|FG004|COMPLETED|Placebo Controlled Period (Week 0 - 16)||0
3353616|NCT03628924|4083625|FG005|COMPLETED|Placebo Controlled Period (Week 0 - 16)||0
3353617|NCT03628924|4083626|FG006|COMPLETED|Placebo Controlled Period (Week 0 - 16)||0
3353618|NCT03628924|4083620|FG000|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||6
3353619|NCT03628924|4083621|FG001|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||3
3353620|NCT03628924|4083622|FG002|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||3
3353621|NCT03628924|4083623|FG003|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||0
3353622|NCT03628924|4083624|FG004|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||0
3353623|NCT03628924|4083625|FG005|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||0
3353624|NCT03628924|4083626|FG006|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||0
3353625|NCT03628924|4083620|FG000|STARTED|Active Treatment Period (Week 16-48)||0
3353626|NCT03628924|4083621|FG001|STARTED|Active Treatment Period (Week 16-48)||0
3353627|NCT03628924|4083622|FG002|STARTED|Active Treatment Period (Week 16-48)||0
3353628|NCT03628924|4083623|FG003|STARTED|Active Treatment Period (Week 16-48)||28
3353629|NCT03628924|4083624|FG004|STARTED|Active Treatment Period (Week 16-48)||28
3353630|NCT03628924|4083625|FG005|STARTED|Active Treatment Period (Week 16-48)||56
3353631|NCT03628924|4083626|FG006|STARTED|Active Treatment Period (Week 16-48)||57
3353632|NCT03628924|4083620|FG000|COMPLETED|Active Treatment Period (Week 16-48)||0
3353633|NCT03628924|4083621|FG001|COMPLETED|Active Treatment Period (Week 16-48)||0
3353634|NCT03628924|4083622|FG002|COMPLETED|Active Treatment Period (Week 16-48)||0
3353635|NCT03628924|4083623|FG003|COMPLETED|Active Treatment Period (Week 16-48)||20
3353636|NCT03628924|4083624|FG004|COMPLETED|Active Treatment Period (Week 16-48)||24
3353637|NCT03628924|4083625|FG005|COMPLETED|Active Treatment Period (Week 16-48)||43
3353638|NCT03628924|4083626|FG006|COMPLETED|Active Treatment Period (Week 16-48)||46
3353639|NCT03628924|4083620|FG000|NOT COMPLETED|Active Treatment Period (Week 16-48)||0
3353640|NCT03628924|4083621|FG001|NOT COMPLETED|Active Treatment Period (Week 16-48)||0
3353641|NCT03628924|4083622|FG002|NOT COMPLETED|Active Treatment Period (Week 16-48)||0
3353642|NCT03628924|4083623|FG003|NOT COMPLETED|Active Treatment Period (Week 16-48)||8
3353643|NCT03628924|4083624|FG004|NOT COMPLETED|Active Treatment Period (Week 16-48)||4
3353644|NCT03628924|4083625|FG005|NOT COMPLETED|Active Treatment Period (Week 16-48)||13
3353645|NCT03628924|4083626|FG006|NOT COMPLETED|Active Treatment Period (Week 16-48)||11
3353646|NCT03629028|4083640|FG000|STARTED|Overall Study||141
3353647|NCT03629028|4083641|FG001|STARTED|Overall Study||141
3353648|NCT03629028|4083640|FG000|COMPLETED|Overall Study||109
3353649|NCT03629028|4083641|FG001|COMPLETED|Overall Study||116
3353650|NCT03629028|4083640|FG000|NOT COMPLETED|Overall Study||32
3353651|NCT03629028|4083641|FG001|NOT COMPLETED|Overall Study||25
3353652|NCT03629041|4083657|FG000|STARTED|Visit 1||4
3353653|NCT03629041|4083658|FG001|STARTED|Visit 1||4
3353654|NCT03629041|4083659|FG002|STARTED|Visit 1||4
3353655|NCT03629041|4083660|FG003|STARTED|Visit 1||4
3353656|NCT03629041|4083657|FG000|COMPLETED|Visit 1||4
3353657|NCT03629041|4083658|FG001|COMPLETED|Visit 1||4
3353658|NCT03629041|4083659|FG002|COMPLETED|Visit 1||4
3353659|NCT03629041|4083660|FG003|COMPLETED|Visit 1||4
3353660|NCT03629041|4083657|FG000|NOT COMPLETED|Visit 1||0
3353661|NCT03629041|4083658|FG001|NOT COMPLETED|Visit 1||0
3353662|NCT03629041|4083659|FG002|NOT COMPLETED|Visit 1||0
3353663|NCT03629041|4083660|FG003|NOT COMPLETED|Visit 1||0
3353664|NCT03629041|4083657|FG000|STARTED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||4
3353665|NCT03629041|4083658|FG001|STARTED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||4
3353666|NCT03629041|4083659|FG002|STARTED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||4
3353667|NCT03629041|4083660|FG003|STARTED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||4
3353668|NCT03629041|4083657|FG000|COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||4
3353669|NCT03629041|4083658|FG001|COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||3
3353670|NCT03629041|4083659|FG002|COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||4
3353671|NCT03629041|4083660|FG003|COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||4
3353672|NCT03629041|4083657|FG000|NOT COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||0
3353673|NCT03629041|4083658|FG001|NOT COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||1
3353674|NCT03629041|4083659|FG002|NOT COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||0
3353675|NCT03629041|4083660|FG003|NOT COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||0
3353676|NCT03629054|4083680|FG000|STARTED|Period 1 (4 Days)|Started this period|15
3353677|NCT03629054|4083681|FG001|STARTED|Period 1 (4 Days)|Started this period|15
3353678|NCT03629054|4083680|FG000|COMPLETED|Period 1 (4 Days)||15
3353679|NCT03629054|4083681|FG001|COMPLETED|Period 1 (4 Days)||15
3353680|NCT03629054|4083680|FG000|NOT COMPLETED|Period 1 (4 Days)||0
3353681|NCT03629054|4083681|FG001|NOT COMPLETED|Period 1 (4 Days)||0
3353682|NCT03629054|4083680|FG000|STARTED|Wasout Period (35 Days)|Started this period|15
3353683|NCT03629054|4083681|FG001|STARTED|Wasout Period (35 Days)|Started this period|15
3353684|NCT03629054|4083680|FG000|COMPLETED|Wasout Period (35 Days)||15
3353685|NCT03629054|4083681|FG001|COMPLETED|Wasout Period (35 Days)||15
3353686|NCT03629054|4083680|FG000|NOT COMPLETED|Wasout Period (35 Days)||0
3353687|NCT03629054|4083681|FG001|NOT COMPLETED|Wasout Period (35 Days)||0
3353688|NCT03629054|4083680|FG000|STARTED|Period 2 (4 Days)|Started this period|15
3353689|NCT03629054|4083681|FG001|STARTED|Period 2 (4 Days)|Started this period|15
3353690|NCT03629054|4083680|FG000|Treated|Period 2 (4 Days)||15
3353691|NCT03629054|4083681|FG001|Treated|Period 2 (4 Days)||14
3353692|NCT03629054|4083680|FG000|COMPLETED|Period 2 (4 Days)||15
3353693|NCT03629054|4083681|FG001|COMPLETED|Period 2 (4 Days)||14
3353694|NCT03629054|4083680|FG000|NOT COMPLETED|Period 2 (4 Days)||0
3353695|NCT03629054|4083681|FG001|NOT COMPLETED|Period 2 (4 Days)||1
3353696|NCT03629184|4083689|FG000|STARTED|Overall Study||115
3353697|NCT03629184|4083690|FG001|STARTED|Overall Study||58
3353698|NCT03629184|4083689|FG000|COMPLETED|Overall Study||112
3353699|NCT03629184|4083690|FG001|COMPLETED|Overall Study||57
3353700|NCT03629184|4083689|FG000|NOT COMPLETED|Overall Study||3
3353701|NCT03629184|4083690|FG001|NOT COMPLETED|Overall Study||1
3353702|NCT03629249|4083699|FG000|STARTED|Overall Study||201
3353703|NCT03629249|4083700|FG001|STARTED|Overall Study||201
3353704|NCT03629249|4083701|FG002|STARTED|Overall Study||202
3353705|NCT03629249|4083699|FG000|Full Analysis Set (FAS)|Overall Study||201
3353706|NCT03629249|4083700|FG001|Full Analysis Set (FAS)|Overall Study||200
3353707|NCT03629249|4083701|FG002|Full Analysis Set (FAS)|Overall Study||201
3353708|NCT03629249|4083699|FG000|Safety Set (SAF)|Overall Study||201
3353709|NCT03629249|4083700|FG001|Safety Set (SAF)|Overall Study||200
3353710|NCT03629249|4083701|FG002|Safety Set (SAF)|Overall Study||201
3353711|NCT03629249|4083699|FG000|COMPLETED|Overall Study||0
3353712|NCT03629249|4083700|FG001|COMPLETED|Overall Study||0
3353713|NCT03629249|4083701|FG002|COMPLETED|Overall Study||0
3353714|NCT03629249|4083699|FG000|NOT COMPLETED|Overall Study||201
3353715|NCT03629249|4083700|FG001|NOT COMPLETED|Overall Study||201
3353716|NCT03629249|4083701|FG002|NOT COMPLETED|Overall Study||202
3353717|NCT03629535|4083709|FG000|STARTED|Overall Study||8
3353718|NCT03629535|4083709|FG000|COMPLETED|Overall Study||8
3353719|NCT03629535|4083709|FG000|NOT COMPLETED|Overall Study||0
3353720|NCT03629886|4083715|FG000|STARTED|Overall Study||1671
3353721|NCT03629886|4083716|FG001|STARTED|Overall Study||1866
3353722|NCT03629886|4083715|FG000|COMPLETED|Overall Study||1671
3353723|NCT03629886|4083716|FG001|COMPLETED|Overall Study||1686
3353724|NCT03629886|4083715|FG000|NOT COMPLETED|Overall Study||0
3178877|NCT01981057|3907006|FG000|COMPLETED|Overall Study||50
3353725|NCT03629886|4083716|FG001|NOT COMPLETED|Overall Study||180
3353726|NCT03629925|4083725|FG000|STARTED|Overall Study||179
3353727|NCT03629925|4083726|FG001|STARTED|Overall Study||178
3353728|NCT03629925|4083725|FG000|COMPLETED|Overall Study||0
3353729|NCT03629925|4083726|FG001|COMPLETED|Overall Study||0
3353730|NCT03629925|4083725|FG000|NOT COMPLETED|Overall Study||179
3353731|NCT03629925|4083726|FG001|NOT COMPLETED|Overall Study||178
3353732|NCT03630016|4083732|FG000|STARTED|Overall Study||11
3353733|NCT03630016|4083732|FG000|COMPLETED|Overall Study||10
3353734|NCT03630016|4083732|FG000|NOT COMPLETED|Overall Study||1
3353735|NCT03630185|4083738|FG000|STARTED|Overall Study||4
3353736|NCT03630185|4083739|FG001|STARTED|Overall Study||4
3353737|NCT03630185|4083738|FG000|30 Day Follow up|Overall Study||1
3353738|NCT03630185|4083739|FG001|30 Day Follow up|Overall Study||1
3353739|NCT03630185|4083738|FG000|90 Day Follow up|Overall Study||0
3353740|NCT03630185|4083739|FG001|90 Day Follow up|Overall Study||1
3353741|NCT03630185|4083738|FG000|6 Month Follow up|Overall Study||0
3353742|NCT03630185|4083739|FG001|6 Month Follow up|Overall Study||0
3353743|NCT03630185|4083738|FG000|COMPLETED|Overall Study||0
3353744|NCT03630185|4083739|FG001|COMPLETED|Overall Study||0
3353745|NCT03630185|4083738|FG000|NOT COMPLETED|Overall Study||4
3353746|NCT03630185|4083739|FG001|NOT COMPLETED|Overall Study||4
3353747|NCT03630198|4083747|FG000|STARTED|Overall Study||13
3353748|NCT03630198|4083748|FG001|STARTED|Overall Study||18
3353749|NCT03630198|4083747|FG000|COMPLETED|Overall Study||13
3353750|NCT03630198|4083748|FG001|COMPLETED|Overall Study||18
3353751|NCT03630198|4083747|FG000|NOT COMPLETED|Overall Study||0
3353752|NCT03630198|4083748|FG001|NOT COMPLETED|Overall Study||0
3353753|NCT03630302|4083754|FG000|STARTED|Surgery||10
3353754|NCT03630302|4083754|FG000|COMPLETED|Surgery||9
3353755|NCT03630302|4083754|FG000|NOT COMPLETED|Surgery||1
3353756|NCT03630302|4083754|FG000|STARTED|3 Month Visit||9
3353757|NCT03630302|4083754|FG000|COMPLETED|3 Month Visit||7
3353758|NCT03630302|4083754|FG000|NOT COMPLETED|3 Month Visit||2
3353759|NCT03630302|4083754|FG000|STARTED|Data Post Analyses||7
3353760|NCT03630302|4083754|FG000|COMPLETED|Data Post Analyses||5
3353761|NCT03630302|4083754|FG000|NOT COMPLETED|Data Post Analyses||2
3353762|NCT03630679|4083760|FG000|STARTED|Overall Study||20
3353763|NCT03630679|4083761|FG001|STARTED|Overall Study||25
3353764|NCT03630679|4083760|FG000|COMPLETED|Overall Study||13
3353765|NCT03630679|4083761|FG001|COMPLETED|Overall Study||13
3353766|NCT03630679|4083760|FG000|NOT COMPLETED|Overall Study||7
3353767|NCT03630679|4083761|FG001|NOT COMPLETED|Overall Study||12
3353768|NCT03631355|4083769|FG000|STARTED|Overall Study||55
3353769|NCT03631355|4083770|FG001|STARTED|Overall Study||55
3353770|NCT03631355|4083769|FG000|COMPLETED|Overall Study||54
3353771|NCT03631355|4083770|FG001|COMPLETED|Overall Study||53
3353772|NCT03631355|4083769|FG000|NOT COMPLETED|Overall Study||1
3353773|NCT03631355|4083770|FG001|NOT COMPLETED|Overall Study||2
3353774|NCT03631433|4083778|FG000|STARTED|Overall Study||49
3353775|NCT03631433|4083779|FG001|STARTED|Overall Study||53
3353776|NCT03631433|4083778|FG000|COMPLETED|Overall Study||49
3353777|NCT03631433|4083779|FG001|COMPLETED|Overall Study||53
3353778|NCT03631433|4083778|FG000|NOT COMPLETED|Overall Study||0
3353779|NCT03631433|4083779|FG001|NOT COMPLETED|Overall Study||0
3353780|NCT03631732|4083787|FG000|STARTED|Randomized Phase Up to Week 24||331
3353781|NCT03631732|4083788|FG001|STARTED|Randomized Phase Up to Week 24||165
3353782|NCT03631732|4083787|FG000|COMPLETED|Randomized Phase Up to Week 24||324
3353783|NCT03631732|4083788|FG001|COMPLETED|Randomized Phase Up to Week 24||163
3353784|NCT03631732|4083787|FG000|NOT COMPLETED|Randomized Phase Up to Week 24||7
3353785|NCT03631732|4083788|FG001|NOT COMPLETED|Randomized Phase Up to Week 24||2
3353786|NCT03631732|4083787|FG000|STARTED|B/F/TAF Treatment Phase (After Week 24)|5 participants completed 24 weeks of the study, but did not receive study treatment after Week 24.|319
3353787|NCT03631732|4083788|FG001|STARTED|B/F/TAF Treatment Phase (After Week 24)||163
3353788|NCT03631732|4083787|FG000|COMPLETED|B/F/TAF Treatment Phase (After Week 24)||303
3353789|NCT03631732|4083788|FG001|COMPLETED|B/F/TAF Treatment Phase (After Week 24)||158
3353790|NCT03631732|4083787|FG000|NOT COMPLETED|B/F/TAF Treatment Phase (After Week 24)||16
3353791|NCT03631732|4083788|FG001|NOT COMPLETED|B/F/TAF Treatment Phase (After Week 24)||5
3353792|NCT03631927|4083798|FG000|STARTED|Overall Study||5094
3353793|NCT03631927|4083798|FG000|COMPLETED|Overall Study||4669
3353794|NCT03631927|4083798|FG000|NOT COMPLETED|Overall Study||425
3353795|NCT03632083|4083802|FG000|STARTED|First Intervention||5
3353796|NCT03632083|4083803|FG001|STARTED|First Intervention||5
3353797|NCT03632083|4083804|FG002|STARTED|First Intervention||7
3353798|NCT03632083|4083805|FG003|STARTED|First Intervention||7
3353799|NCT03632083|4083806|FG004|STARTED|First Intervention||9
3353800|NCT03632083|4083807|FG005|STARTED|First Intervention||9
3353801|NCT03632083|4083808|FG006|STARTED|First Intervention||7
3353802|NCT03632083|4083809|FG007|STARTED|First Intervention||7
3353803|NCT03632083|4083802|FG000|COMPLETED|First Intervention||5
3353804|NCT03632083|4083803|FG001|COMPLETED|First Intervention||5
3353805|NCT03632083|4083804|FG002|COMPLETED|First Intervention||7
3353806|NCT03632083|4083805|FG003|COMPLETED|First Intervention||7
3353807|NCT03632083|4083806|FG004|COMPLETED|First Intervention||9
3353808|NCT03632083|4083807|FG005|COMPLETED|First Intervention||9
3353809|NCT03632083|4083808|FG006|COMPLETED|First Intervention||7
3353810|NCT03632083|4083809|FG007|COMPLETED|First Intervention||7
3353811|NCT03632083|4083802|FG000|NOT COMPLETED|First Intervention||0
3353812|NCT03632083|4083803|FG001|NOT COMPLETED|First Intervention||0
3353813|NCT03632083|4083804|FG002|NOT COMPLETED|First Intervention||0
3353814|NCT03632083|4083805|FG003|NOT COMPLETED|First Intervention||0
3353815|NCT03632083|4083806|FG004|NOT COMPLETED|First Intervention||0
3353816|NCT03632083|4083807|FG005|NOT COMPLETED|First Intervention||0
3353817|NCT03632083|4083808|FG006|NOT COMPLETED|First Intervention||0
3353818|NCT03632083|4083809|FG007|NOT COMPLETED|First Intervention||0
3353819|NCT03632083|4083802|FG000|STARTED|Second Intervention||5
3353820|NCT03632083|4083803|FG001|STARTED|Second Intervention||5
3353821|NCT03632083|4083804|FG002|STARTED|Second Intervention||7
3353822|NCT03632083|4083805|FG003|STARTED|Second Intervention||7
3353823|NCT03632083|4083806|FG004|STARTED|Second Intervention||9
3353824|NCT03632083|4083807|FG005|STARTED|Second Intervention||9
3353825|NCT03632083|4083808|FG006|STARTED|Second Intervention||7
3353826|NCT03632083|4083809|FG007|STARTED|Second Intervention||7
3353827|NCT03632083|4083802|FG000|COMPLETED|Second Intervention||5
3353828|NCT03632083|4083803|FG001|COMPLETED|Second Intervention||5
3353829|NCT03632083|4083804|FG002|COMPLETED|Second Intervention||7
3353830|NCT03632083|4083805|FG003|COMPLETED|Second Intervention||7
3353831|NCT03632083|4083806|FG004|COMPLETED|Second Intervention||9
3353832|NCT03632083|4083807|FG005|COMPLETED|Second Intervention||9
3353833|NCT03632083|4083808|FG006|COMPLETED|Second Intervention||7
3353834|NCT03632083|4083809|FG007|COMPLETED|Second Intervention||5
3353835|NCT03632083|4083802|FG000|NOT COMPLETED|Second Intervention||0
3353836|NCT03632083|4083803|FG001|NOT COMPLETED|Second Intervention||0
3353837|NCT03632083|4083804|FG002|NOT COMPLETED|Second Intervention||0
3353838|NCT03632083|4083805|FG003|NOT COMPLETED|Second Intervention||0
3353839|NCT03632083|4083806|FG004|NOT COMPLETED|Second Intervention||0
3353840|NCT03632083|4083807|FG005|NOT COMPLETED|Second Intervention||0
3353841|NCT03632083|4083808|FG006|NOT COMPLETED|Second Intervention||0
3353842|NCT03632083|4083809|FG007|NOT COMPLETED|Second Intervention||2
3353843|NCT03632109|4083821|FG000|STARTED|Overall Study||13
3353844|NCT03632109|4083821|FG000|COMPLETED|Overall Study||13
3353845|NCT03632109|4083821|FG000|NOT COMPLETED|Overall Study||0
3353846|NCT03632954|4083827|FG000|STARTED|Overall Study||37
3353847|NCT03632954|4083827|FG000|COMPLETED|Overall Study||3
3353848|NCT03632954|4083827|FG000|NOT COMPLETED|Overall Study||34
3353849|NCT03633084|4083834|FG000|STARTED|Overall Study||3
3353850|NCT03633084|4083835|FG001|STARTED|Overall Study||3
3353851|NCT03633084|4083836|FG002|STARTED|Overall Study||3
3353852|NCT03633084|4083834|FG000|COMPLETED|Overall Study||3
3353853|NCT03633084|4083835|FG001|COMPLETED|Overall Study||3
3353854|NCT03633084|4083836|FG002|COMPLETED|Overall Study||3
3353855|NCT03633084|4083834|FG000|NOT COMPLETED|Overall Study||0
3353856|NCT03633084|4083835|FG001|NOT COMPLETED|Overall Study||0
3353857|NCT03633084|4083836|FG002|NOT COMPLETED|Overall Study||0
3353858|NCT03633331|4083845|FG000|STARTED|Overall Study||93
3353859|NCT03633331|4083845|FG000|COMPLETED|Overall Study||92
3353860|NCT03633331|4083845|FG000|NOT COMPLETED|Overall Study||1
3353861|NCT03633344|4083851|FG000|STARTED|Overall Study||120
3353862|NCT03633344|4083852|FG001|STARTED|Overall Study||24
3353863|NCT03633344|4083851|FG000|COMPLETED|Overall Study||120
3353864|NCT03633344|4083852|FG001|COMPLETED|Overall Study||24
3353865|NCT03633344|4083851|FG000|NOT COMPLETED|Overall Study||0
3353866|NCT03633344|4083852|FG001|NOT COMPLETED|Overall Study||0
3353867|NCT03633448|4083862|FG000|STARTED|Period 1 (1 Day)||12
3353868|NCT03633448|4083863|FG001|STARTED|Period 1 (1 Day)||12
3353869|NCT03633448|4083862|FG000|COMPLETED|Period 1 (1 Day)||12
3353870|NCT03633448|4083863|FG001|COMPLETED|Period 1 (1 Day)||12
3353871|NCT03633448|4083862|FG000|NOT COMPLETED|Period 1 (1 Day)||0
3353872|NCT03633448|4083863|FG001|NOT COMPLETED|Period 1 (1 Day)||0
3353873|NCT03633448|4083862|FG000|STARTED|Washout (7 Days)||12
3353874|NCT03633448|4083863|FG001|STARTED|Washout (7 Days)||12
3353875|NCT03633448|4083862|FG000|COMPLETED|Washout (7 Days)||12
3353876|NCT03633448|4083863|FG001|COMPLETED|Washout (7 Days)||12
3353877|NCT03633448|4083862|FG000|NOT COMPLETED|Washout (7 Days)||0
3353878|NCT03633448|4083863|FG001|NOT COMPLETED|Washout (7 Days)||0
3353879|NCT03633448|4083862|FG000|STARTED|Period 2 (1 Day)||12
3353880|NCT03633448|4083863|FG001|STARTED|Period 2 (1 Day)||12
3353881|NCT03633448|4083862|FG000|COMPLETED|Period 2 (1 Day)||12
3353882|NCT03633448|4083863|FG001|COMPLETED|Period 2 (1 Day)||12
3353883|NCT03633448|4083862|FG000|NOT COMPLETED|Period 2 (1 Day)||0
3353884|NCT03633448|4083863|FG001|NOT COMPLETED|Period 2 (1 Day)||0
3353885|NCT03633487|4083873|FG000|STARTED|Overall Study||24
3353886|NCT03633487|4083873|FG000|COMPLETED|Overall Study||24
3353887|NCT03633487|4083873|FG000|NOT COMPLETED|Overall Study||0
3353888|NCT03633526|4083877|FG000|STARTED|Overall Study||16
3353889|NCT03633526|4083877|FG000|COMPLETED|Overall Study||16
3353890|NCT03633526|4083877|FG000|NOT COMPLETED|Overall Study||0
3353891|NCT03633825|4083883|FG000|STARTED|Enrollment||19838
3353892|NCT03633825|4083884|FG001|STARTED|Enrollment||19612
3353893|NCT03633825|4083883|FG000|COMPLETED|Enrollment||805
3353894|NCT03633825|4083884|FG001|COMPLETED|Enrollment||775
3353895|NCT03633825|4083883|FG000|NOT COMPLETED|Enrollment||19033
3353896|NCT03633825|4083884|FG001|NOT COMPLETED|Enrollment||18837
3353897|NCT03633825|4083883|FG000|STARTED|Allocation||805
3353898|NCT03633825|4083884|FG001|STARTED|Allocation||775
3353899|NCT03633825|4083883|FG000|COMPLETED|Allocation||805
3353900|NCT03633825|4083884|FG001|COMPLETED|Allocation||775
3353901|NCT03633825|4083883|FG000|NOT COMPLETED|Allocation||0
3353902|NCT03633825|4083884|FG001|NOT COMPLETED|Allocation||0
3353903|NCT03633825|4083883|FG000|STARTED|Follow up||805
3353904|NCT03633825|4083884|FG001|STARTED|Follow up||775
3353905|NCT03633825|4083883|FG000|COMPLETED|Follow up||327
3353906|NCT03633825|4083884|FG001|COMPLETED|Follow up||325
3353907|NCT03633825|4083883|FG000|NOT COMPLETED|Follow up||478
3353908|NCT03633825|4083884|FG001|NOT COMPLETED|Follow up||450
3353909|NCT03633825|4083883|FG000|STARTED|Analysis||327
3353910|NCT03633825|4083884|FG001|STARTED|Analysis||325
3353911|NCT03633825|4083883|FG000|COMPLETED|Analysis||327
3353912|NCT03633825|4083884|FG001|COMPLETED|Analysis||325
3353913|NCT03633825|4083883|FG000|NOT COMPLETED|Analysis||0
3353914|NCT03633825|4083884|FG001|NOT COMPLETED|Analysis||0
3353915|NCT03633903|4083892|FG000|STARTED|Overall Study||22
3353916|NCT03633903|4083893|FG001|STARTED|Overall Study||18
3353917|NCT03633903|4083892|FG000|Intent to Treat|Overall Study||0
3353918|NCT03633903|4083893|FG001|Intent to Treat|Overall Study||18
3353919|NCT03633903|4083892|FG000|COMPLETED|Overall Study||16
3353920|NCT03633903|4083893|FG001|COMPLETED|Overall Study||11
3353921|NCT03633903|4083892|FG000|NOT COMPLETED|Overall Study||6
3353922|NCT03633903|4083893|FG001|NOT COMPLETED|Overall Study||7
3353923|NCT03633929|4083899|FG000|STARTED|Overall Study||19
3353924|NCT03633929|4083899|FG000|COMPLETED|Overall Study||15
3353925|NCT03633929|4083899|FG000|NOT COMPLETED|Overall Study||4
3353926|NCT03634085|4083905|FG000|STARTED|Overall Study||8
3353927|NCT03634085|4083906|FG001|STARTED|Overall Study||8
3353928|NCT03634085|4083905|FG000|Period 1|Overall Study|8 subjects started BDM2-50 mg and 8 subjects completed BDM2-50 mg including matching placebo.|8
3353929|NCT03634085|4083906|FG001|Period 1|Overall Study|8 subjects started BDM2 - 150mg and 8 subjects completed BDM2 - 150 mg including matching placebo|8
3353930|NCT03634085|4083905|FG000|Period 2|Overall Study|8 subjects started BDM2 - 450 mg and 7 subjects completed BDM2 - 450 mg (drop out; 1 active)|8
3353931|NCT03634085|4083906|FG001|Period 2|Overall Study|8 subjects started BDM2 - 900 mg fasted and 8 subjects completed BDM2 - 900 mg fasted|8
3353932|NCT03634085|4083905|FG000|Period 3|Overall Study|8 subjects started BDM2 - 1800 mg and 7 subjects completed BDM2 - 1800 mg (drop out; 1 active)|8
3353933|NCT03634085|4083906|FG001|Period 3|Overall Study|8 subjects started and 6 subjects completed BDM2 - 900 mg fed (dropout; 1 active 1 placebo)|8
3353934|NCT03634085|4083905|FG000|Period 4|Overall Study|8 subjects started BDM2 - 3100 mg and 7 subjects completed BDM2 - 3100 mg (drop out; 1 active)|8
3353935|NCT03634085|4083906|FG001|Period 4|Overall Study|this period is not applicable for Cohort B|0
3353936|NCT03634085|4083905|FG000|COMPLETED|Overall Study|1 subject dropped out due to car accident|7
3353937|NCT03634085|4083906|FG001|COMPLETED|Overall Study|"1 subject dropped out due to personal emergency~1 subject dropped out due to personal circumstances"|6
3353938|NCT03634085|4083905|FG000|NOT COMPLETED|Overall Study||1
3353939|NCT03634085|4083906|FG001|NOT COMPLETED|Overall Study||2
3353940|NCT03634306|4083922|FG000|STARTED|Overall Study||15
3353941|NCT03634306|4083923|FG001|STARTED|Overall Study||15
3353942|NCT03634306|4083924|FG002|STARTED|Overall Study||5
3353943|NCT03634306|4083922|FG000|COMPLETED|Overall Study||15
3353944|NCT03634306|4083923|FG001|COMPLETED|Overall Study||15
3353945|NCT03634306|4083924|FG002|COMPLETED|Overall Study||5
3353946|NCT03634306|4083922|FG000|NOT COMPLETED|Overall Study||0
3353947|NCT03634306|4083923|FG001|NOT COMPLETED|Overall Study||0
3353948|NCT03634306|4083924|FG002|NOT COMPLETED|Overall Study||0
3353949|NCT03634579|4083932|FG000|STARTED|Overall Study||9
3353950|NCT03634579|4083932|FG000|COMPLETED|Overall Study||0
3353951|NCT03634579|4083932|FG000|NOT COMPLETED|Overall Study||9
3353952|NCT03634800|4083936|FG000|STARTED|Overall Study||6
3353953|NCT03634800|4083936|FG000|COMPLETED|Overall Study||0
3353954|NCT03634800|4083936|FG000|NOT COMPLETED|Overall Study||6
3353955|NCT03634813|4083942|FG000|STARTED|Overall Study||49
3353956|NCT03634813|4083943|FG001|STARTED|Overall Study||51
3353957|NCT03634813|4083942|FG000|COMPLETED|Overall Study||49
3353958|NCT03634813|4083943|FG001|COMPLETED|Overall Study||51
3353959|NCT03634813|4083942|FG000|NOT COMPLETED|Overall Study||0
3353960|NCT03634813|4083943|FG001|NOT COMPLETED|Overall Study||0
3353961|NCT03635086|4083955|FG000|STARTED|Overall Study||12
3353962|NCT03635086|4083956|FG001|STARTED|Overall Study||12
3353963|NCT03635086|4083957|FG002|STARTED|Overall Study||12
3353964|NCT03635086|4083958|FG003|STARTED|Overall Study||12
3353965|NCT03635086|4083959|FG004|STARTED|Overall Study||12
3353966|NCT03635086|4083955|FG000|COMPLETED|Overall Study||11
3353967|NCT03635086|4083956|FG001|COMPLETED|Overall Study||11
3353968|NCT03635086|4083957|FG002|COMPLETED|Overall Study||11
3353969|NCT03635086|4083958|FG003|COMPLETED|Overall Study||12
3353970|NCT03635086|4083959|FG004|COMPLETED|Overall Study||12
3353971|NCT03635086|4083955|FG000|NOT COMPLETED|Overall Study||1
3353972|NCT03635086|4083956|FG001|NOT COMPLETED|Overall Study||1
3353973|NCT03635086|4083957|FG002|NOT COMPLETED|Overall Study||1
3353974|NCT03635086|4083958|FG003|NOT COMPLETED|Overall Study||0
3353975|NCT03635086|4083959|FG004|NOT COMPLETED|Overall Study||0
3353976|NCT03635320|4083974|FG000|STARTED|Overall Study||94
3353977|NCT03635320|4083975|FG001|STARTED|Overall Study||94
3353978|NCT03635320|4083974|FG000|FAS|Overall Study|1 subject was not implanted the device|93
3353979|NCT03635320|4083975|FG001|FAS|Overall Study|2 subjects were not implant the device|92
3353980|NCT03635320|4083974|FG000|PPS|Overall Study|11 subjects early discontinued and didn't complete the trial which were excluded from PPS, 1 subject had a risk of unblinding, which was excluded from the PPS.|81
3353981|NCT03635320|4083975|FG001|PPS|Overall Study|6 subjects early discontinued and didn't complete the trial which were excluded from PPS, 1 subject didn't undergo the evaluation or laboratory examination required by the clinical trial, 1 subject violated the inclusion/exclusion criteria and 1 subject used the device beyond the scope of the specifications, which were excluded from the PPS.|83
3353982|NCT03635320|4083974|FG000|COMPLETED|Overall Study||82
3353983|NCT03635320|4083975|FG001|COMPLETED|Overall Study||86
3353984|NCT03635320|4083974|FG000|NOT COMPLETED|Overall Study||12
3353985|NCT03635320|4083975|FG001|NOT COMPLETED|Overall Study||8
3353986|NCT03635424|4083981|FG000|STARTED|Overall Study||150
3353987|NCT03635424|4083981|FG000|COMPLETED|Overall Study||147
3353988|NCT03635424|4083981|FG000|NOT COMPLETED|Overall Study||3
3353989|NCT03635775|4083989|FG000|STARTED|Overall Study||5
3353990|NCT03635775|4083990|FG001|STARTED|Overall Study||0
3353991|NCT03635775|4083991|FG002|STARTED|Overall Study||5
3353992|NCT03635775|4083992|FG003|STARTED|Overall Study||10
3353993|NCT03635775|4083989|FG000|COMPLETED|Overall Study||5
3353994|NCT03635775|4083990|FG001|COMPLETED|Overall Study||0
3353995|NCT03635775|4083991|FG002|COMPLETED|Overall Study||5
3353996|NCT03635775|4083992|FG003|COMPLETED|Overall Study||9
3353997|NCT03635775|4083989|FG000|NOT COMPLETED|Overall Study||0
3353998|NCT03635775|4083990|FG001|NOT COMPLETED|Overall Study||0
3353999|NCT03635775|4083991|FG002|NOT COMPLETED|Overall Study||0
3354000|NCT03635775|4083992|FG003|NOT COMPLETED|Overall Study||1
3354001|NCT03635957|4084002|FG000|STARTED|Run-In Period||15
3354002|NCT03635957|4084002|FG000|COMPLETED|Run-In Period||14
3354003|NCT03635957|4084002|FG000|NOT COMPLETED|Run-In Period||1
3354004|NCT03635957|4084002|FG000|STARTED|Pegloticase + IMM Period||14
3354005|NCT03635957|4084002|FG000|Completed Study at 24 Weeks-Amendment 1|Pegloticase + IMM Period||1
3354006|NCT03635957|4084002|FG000|Completed Study at 52 Weeks-Amendment 2|Pegloticase + IMM Period||10
3354007|NCT03635957|4084002|FG000|Discontinued Study Treatment Early|Pegloticase + IMM Period||5
3354008|NCT03635957|4084002|FG000|Had 3-Month Follow-up|Pegloticase + IMM Period||7
3354009|NCT03635957|4084002|FG000|Had 6-Month Follow-up|Pegloticase + IMM Period||6
3354010|NCT03635957|4084002|FG000|COMPLETED|Pegloticase + IMM Period||11
3354011|NCT03635957|4084002|FG000|NOT COMPLETED|Pegloticase + IMM Period||3
3354012|NCT03636061|4084011|FG000|STARTED|Overall Study||47
3354013|NCT03636061|4084012|FG001|STARTED|Overall Study||48
3354014|NCT03636061|4084013|FG002|STARTED|Overall Study||44
3354015|NCT03636061|4084014|FG003|STARTED|Overall Study||43
3354016|NCT03636061|4084011|FG000|COMPLETED|Overall Study||47
3354017|NCT03636061|4084012|FG001|COMPLETED|Overall Study||46
3354018|NCT03636061|4084013|FG002|COMPLETED|Overall Study||40
3354019|NCT03636061|4084014|FG003|COMPLETED|Overall Study||43
3354020|NCT03636061|4084011|FG000|NOT COMPLETED|Overall Study||0
3354021|NCT03636061|4084012|FG001|NOT COMPLETED|Overall Study||2
3354022|NCT03636061|4084013|FG002|NOT COMPLETED|Overall Study||4
3354023|NCT03636061|4084014|FG003|NOT COMPLETED|Overall Study||0
3354024|NCT03636386|4084029|FG000|STARTED|Overall Study||24
3354025|NCT03636386|4084030|FG001|STARTED|Overall Study||24
3354026|NCT03636386|4084029|FG000|COMPLETED|Overall Study||24
3354027|NCT03636386|4084030|FG001|COMPLETED|Overall Study||24
3354028|NCT03636386|4084029|FG000|NOT COMPLETED|Overall Study||0
3354029|NCT03636386|4084030|FG001|NOT COMPLETED|Overall Study||0
3354030|NCT03636893|4084038|FG000|STARTED|Overall Study||40
3354031|NCT03636893|4084039|FG001|STARTED|Overall Study||34
3354032|NCT03636893|4084038|FG000|COMPLETED|Overall Study||31
3354033|NCT03636893|4084039|FG001|COMPLETED|Overall Study||24
3354034|NCT03636893|4084038|FG000|NOT COMPLETED|Overall Study||9
3354035|NCT03636893|4084039|FG001|NOT COMPLETED|Overall Study||10
3354036|NCT03637296|4084047|FG000|STARTED|Overall Study||10
3354037|NCT03637296|4084048|FG001|STARTED|Overall Study||5
3354038|NCT03637296|4084047|FG000|COMPLETED|Overall Study||10
3354039|NCT03637296|4084048|FG001|COMPLETED|Overall Study||5
3354040|NCT03637296|4084047|FG000|NOT COMPLETED|Overall Study||0
3354041|NCT03637296|4084048|FG001|NOT COMPLETED|Overall Study||0
3354042|NCT03637348|4084054|FG000|STARTED|Overall Study||45
3354043|NCT03637348|4084054|FG000|COMPLETED|Overall Study||45
3354044|NCT03637348|4084054|FG000|NOT COMPLETED|Overall Study||0
3354045|NCT03637517|4084062|FG000|STARTED|Overall Study||14
3354046|NCT03637517|4084063|FG001|STARTED|Overall Study||14
3354047|NCT03637517|4084064|FG002|STARTED|Overall Study||14
3354048|NCT03637517|4084062|FG000|COMPLETED|Overall Study||14
3354049|NCT03637517|4084063|FG001|COMPLETED|Overall Study||14
3354050|NCT03637517|4084064|FG002|COMPLETED|Overall Study||14
3354051|NCT03637517|4084062|FG000|NOT COMPLETED|Overall Study||0
3354052|NCT03637517|4084063|FG001|NOT COMPLETED|Overall Study||0
3354053|NCT03637517|4084064|FG002|NOT COMPLETED|Overall Study||0
3354054|NCT03637699|4084074|FG000|STARTED|Overall Study||15
3354055|NCT03637699|4084075|FG001|STARTED|Overall Study||15
3354056|NCT03637699|4084074|FG000|COMPLETED|Overall Study||14
3354057|NCT03637699|4084075|FG001|COMPLETED|Overall Study||14
3354058|NCT03637699|4084074|FG000|NOT COMPLETED|Overall Study||1
3354059|NCT03637699|4084075|FG001|NOT COMPLETED|Overall Study||1
3354060|NCT03637842|4084084|FG000|STARTED|Overall Study||2
3354061|NCT03637842|4084085|FG001|STARTED|Overall Study||2
3354062|NCT03637842|4084084|FG000|COMPLETED|Overall Study||2
3354063|NCT03637842|4084085|FG001|COMPLETED|Overall Study||2
3354064|NCT03637842|4084084|FG000|NOT COMPLETED|Overall Study||0
3354065|NCT03637842|4084085|FG001|NOT COMPLETED|Overall Study||0
3354066|NCT03638011|4084093|FG000|STARTED|Overall Study||38
3354067|NCT03638011|4084094|FG001|STARTED|Overall Study||33
3354068|NCT03638011|4084093|FG000|COMPLETED|Overall Study||38
3354069|NCT03638011|4084094|FG001|COMPLETED|Overall Study||33
3354070|NCT03638011|4084093|FG000|NOT COMPLETED|Overall Study||0
3354071|NCT03638011|4084094|FG001|NOT COMPLETED|Overall Study||0
3354072|NCT03638323|4084102|FG000|STARTED|Overall Study||38
3354073|NCT03638323|4084102|FG000|COMPLETED|Overall Study||37
3354074|NCT03638323|4084102|FG000|NOT COMPLETED|Overall Study||1
3354075|NCT03638622|4084109|FG000|STARTED|Overall Study||30
3354076|NCT03638622|4084109|FG000|COMPLETED|Overall Study||29
3354077|NCT03638622|4084109|FG000|NOT COMPLETED|Overall Study||1
3354078|NCT03638635|4084115|FG000|STARTED|Initial Hospitalization||39
3354079|NCT03638635|4084116|FG001|STARTED|Initial Hospitalization||24
3354080|NCT03638635|4084115|FG000|COMPLETED|Initial Hospitalization||39
3354081|NCT03638635|4084116|FG001|COMPLETED|Initial Hospitalization||22
3354082|NCT03638635|4084115|FG000|NOT COMPLETED|Initial Hospitalization||0
3354083|NCT03638635|4084116|FG001|NOT COMPLETED|Initial Hospitalization||2
3354084|NCT03638635|4084115|FG000|STARTED|Follow-Up (30 Days After Discharge)||39
3354085|NCT03638635|4084116|FG001|STARTED|Follow-Up (30 Days After Discharge)||22
3354086|NCT03638635|4084115|FG000|COMPLETED|Follow-Up (30 Days After Discharge)||0
3354087|NCT03638635|4084116|FG001|COMPLETED|Follow-Up (30 Days After Discharge)||0
3354088|NCT03638635|4084115|FG000|NOT COMPLETED|Follow-Up (30 Days After Discharge)||39
3354089|NCT03638635|4084116|FG001|NOT COMPLETED|Follow-Up (30 Days After Discharge)||22
3354090|NCT03638908|4084122|FG000|STARTED|Overall Study||8
3354091|NCT03638908|4084122|FG000|COMPLETED|Overall Study||7
3354092|NCT03638908|4084122|FG000|NOT COMPLETED|Overall Study||1
3354093|NCT03639311|4084132|FG000|STARTED|Overall Study||90
3354094|NCT03639311|4084133|FG001|STARTED|Overall Study||7
3354095|NCT03639311|4084132|FG000|COMPLETED|Overall Study||0
3354096|NCT03639311|4084133|FG001|COMPLETED|Overall Study||7
3354097|NCT03639311|4084132|FG000|NOT COMPLETED|Overall Study||90
3354098|NCT03639311|4084133|FG001|NOT COMPLETED|Overall Study||0
3354099|NCT03639675|4084142|FG000|STARTED|Overall Study||16
3354100|NCT03639675|4084142|FG000|Received Treatment|Overall Study||16
3354101|NCT03639675|4084142|FG000|COMPLETED|Overall Study||15
3354102|NCT03639675|4084142|FG000|NOT COMPLETED|Overall Study||1
3354103|NCT03639766|4084146|FG000|STARTED|Overall Study||3
3354104|NCT03639766|4084146|FG000|COMPLETED|Overall Study||3
3354105|NCT03639766|4084146|FG000|NOT COMPLETED|Overall Study||0
3354106|NCT03639779|4084152|FG000|STARTED|Overall Study||5
3354107|NCT03639779|4084152|FG000|Baseline|Overall Study||5
3354108|NCT03639779|4084152|FG000|Month 1|Overall Study||5
3354109|NCT03639779|4084152|FG000|Month 2|Overall Study||4
3354110|NCT03639779|4084152|FG000|Month 3|Overall Study||4
3354111|NCT03639779|4084152|FG000|COMPLETED|Overall Study||4
3354112|NCT03639779|4084152|FG000|NOT COMPLETED|Overall Study||1
3354113|NCT03639857|4084158|FG000|STARTED|Overall Study||1
3354114|NCT03639857|4084159|FG001|STARTED|Overall Study||3
3354115|NCT03639857|4084160|FG002|STARTED|Overall Study||3
3354116|NCT03639857|4084158|FG000|COMPLETED|Overall Study||1
3354117|NCT03639857|4084159|FG001|COMPLETED|Overall Study||3
3354118|NCT03639857|4084160|FG002|COMPLETED|Overall Study||3
3354119|NCT03639857|4084158|FG000|NOT COMPLETED|Overall Study||0
3354120|NCT03639857|4084159|FG001|NOT COMPLETED|Overall Study||0
3354121|NCT03639857|4084160|FG002|NOT COMPLETED|Overall Study||0
3354122|NCT03639987|4084170|FG000|STARTED|Overall Study||26
3354123|NCT03639987|4084171|FG001|STARTED|Overall Study||26
3354124|NCT03639987|4084170|FG000|COMPLETED|Overall Study||0
3354125|NCT03639987|4084171|FG001|COMPLETED|Overall Study||0
3354126|NCT03639987|4084170|FG000|NOT COMPLETED|Overall Study||26
3354127|NCT03639987|4084171|FG001|NOT COMPLETED|Overall Study||26
3354128|NCT03640052|4084177|FG000|STARTED|Overall Study||2
3354129|NCT03640052|4084178|FG001|STARTED|Overall Study||1
3354130|NCT03640052|4084179|FG002|STARTED|Overall Study||1
3354131|NCT03640052|4084180|FG003|STARTED|Overall Study||1
3354132|NCT03640052|4084181|FG004|STARTED|Overall Study||1
3354133|NCT03640052|4084177|FG000|COMPLETED|Overall Study||2
3354134|NCT03640052|4084178|FG001|COMPLETED|Overall Study|the patient performed 4 out of 5 nights|0
3354135|NCT03640052|4084179|FG002|COMPLETED|Overall Study||1
3354136|NCT03640052|4084180|FG003|COMPLETED|Overall Study||1
3354137|NCT03640052|4084181|FG004|COMPLETED|Overall Study||1
3354138|NCT03640052|4084177|FG000|NOT COMPLETED|Overall Study||0
3354139|NCT03640052|4084178|FG001|NOT COMPLETED|Overall Study||1
3354140|NCT03640052|4084179|FG002|NOT COMPLETED|Overall Study||0
3354141|NCT03640052|4084180|FG003|NOT COMPLETED|Overall Study||0
3354142|NCT03640052|4084181|FG004|NOT COMPLETED|Overall Study||0
3354143|NCT03640507|4084196|FG000|STARTED|Overall Study||10
3354144|NCT03640507|4084197|FG001|STARTED|Overall Study||9
3354145|NCT03640507|4084198|FG002|STARTED|Overall Study||11
3354146|NCT03640507|4084196|FG000|COMPLETED|Overall Study||10
3354147|NCT03640507|4084197|FG001|COMPLETED|Overall Study||9
3354148|NCT03640507|4084198|FG002|COMPLETED|Overall Study||10
3354149|NCT03640507|4084196|FG000|NOT COMPLETED|Overall Study||0
3354150|NCT03640507|4084197|FG001|NOT COMPLETED|Overall Study||0
3354151|NCT03640507|4084198|FG002|NOT COMPLETED|Overall Study||1
3354152|NCT03640559|4084208|FG000|STARTED|Overall Study||25
3354153|NCT03640559|4084209|FG001|STARTED|Overall Study||25
3354154|NCT03640559|4084208|FG000|COMPLETED|Overall Study||23
3354155|NCT03640559|4084209|FG001|COMPLETED|Overall Study||24
3354156|NCT03640559|4084208|FG000|NOT COMPLETED|Overall Study||2
3354157|NCT03640559|4084209|FG001|NOT COMPLETED|Overall Study||1
3354158|NCT03640832|4084217|FG000|STARTED|Overall Study||44
3354159|NCT03640832|4084218|FG001|STARTED|Overall Study||46
3354160|NCT03640832|4084217|FG000|COMPLETED|Overall Study||44
3354161|NCT03640832|4084218|FG001|COMPLETED|Overall Study||46
3354162|NCT03640832|4084217|FG000|NOT COMPLETED|Overall Study||0
3354163|NCT03640832|4084218|FG001|NOT COMPLETED|Overall Study||0
3178878|NCT01981057|3907007|FG001|COMPLETED|Overall Study||50
3178879|NCT01981057|3907006|FG000|NOT COMPLETED|Overall Study||0
3178880|NCT01981057|3907007|FG001|NOT COMPLETED|Overall Study||0
3178881|NCT01981109|3907013|FG000|STARTED|Overall Study||225
3178882|NCT01981109|3907013|FG000|COMPLETED|Overall Study||1
3178883|NCT01981109|3907013|FG000|NOT COMPLETED|Overall Study||224
3178884|NCT01981122|3907020|FG000|STARTED|Overall Study||25
3178885|NCT01981122|3907021|FG001|STARTED|Overall Study||27
3178886|NCT01981122|3907020|FG000|COMPLETED|Overall Study||11
3178887|NCT01981122|3907021|FG001|COMPLETED|Overall Study||7
3178888|NCT01981122|3907020|FG000|NOT COMPLETED|Overall Study||14
3178889|NCT01981122|3907021|FG001|NOT COMPLETED|Overall Study||20
3178890|NCT01981187|3907027|FG000|STARTED|Overall Study||12
3178891|NCT01981187|3907027|FG000|COMPLETED|Overall Study||0
3178892|NCT01981187|3907027|FG000|NOT COMPLETED|Overall Study||12
3178893|NCT01981356|3907033|FG000|STARTED|Overall Study||12
3178894|NCT01981356|3907034|FG001|STARTED|Overall Study||6
3178895|NCT01981356|3907033|FG000|COMPLETED|Overall Study||5
3178896|NCT01981356|3907034|FG001|COMPLETED|Overall Study||4
3178897|NCT01981356|3907033|FG000|NOT COMPLETED|Overall Study||7
3178898|NCT01981356|3907034|FG001|NOT COMPLETED|Overall Study||2
3354164|NCT03641508|4084226|FG000|STARTED|First Injection||37
3354165|NCT03641508|4084227|FG001|STARTED|First Injection||32
3354166|NCT03641508|4084226|FG000|COMPLETED|First Injection||35
3354167|NCT03641508|4084227|FG001|COMPLETED|First Injection||32
3354168|NCT03641508|4084226|FG000|NOT COMPLETED|First Injection||2
3354169|NCT03641508|4084227|FG001|NOT COMPLETED|First Injection||0
3354170|NCT03641508|4084226|FG000|STARTED|Follow-up/Second Injection||2
3354171|NCT03641508|4084227|FG001|STARTED|Follow-up/Second Injection|Only those who had symptoms at the six-week follow-up received the second injection|10
3354172|NCT03641508|4084226|FG000|COMPLETED|Follow-up/Second Injection|Only those who had symptoms at the six-week follow-up received the second injection|2
3354173|NCT03641508|4084227|FG001|COMPLETED|Follow-up/Second Injection|Only those who had symptoms at the six-week follow-up received the second injection|10
3354174|NCT03641508|4084226|FG000|NOT COMPLETED|Follow-up/Second Injection||0
3354175|NCT03641508|4084227|FG001|NOT COMPLETED|Follow-up/Second Injection||0
3354176|NCT03641716|4084233|FG000|STARTED|Overall Study||20
3354177|NCT03641716|4084233|FG000|COMPLETED|Overall Study||15
3354178|NCT03641716|4084233|FG000|NOT COMPLETED|Overall Study||5
3354179|NCT03642262|4084237|FG000|STARTED|Period 1||12
3354180|NCT03642262|4084238|FG001|STARTED|Period 1||18
3354181|NCT03642262|4084237|FG000|COMPLETED|Period 1||11
3354182|NCT03642262|4084238|FG001|COMPLETED|Period 1||16
3354183|NCT03642262|4084237|FG000|NOT COMPLETED|Period 1||1
3354184|NCT03642262|4084238|FG001|NOT COMPLETED|Period 1||2
3354185|NCT03642262|4084237|FG000|STARTED|Washout: 7 Days||11
3354186|NCT03642262|4084238|FG001|STARTED|Washout: 7 Days||16
3354187|NCT03642262|4084237|FG000|COMPLETED|Washout: 7 Days||11
3354188|NCT03642262|4084238|FG001|COMPLETED|Washout: 7 Days||16
3354189|NCT03642262|4084237|FG000|NOT COMPLETED|Washout: 7 Days||0
3354190|NCT03642262|4084238|FG001|NOT COMPLETED|Washout: 7 Days||0
3354191|NCT03642262|4084237|FG000|STARTED|Period 2||11
3354192|NCT03642262|4084238|FG001|STARTED|Period 2||16
3354193|NCT03642262|4084237|FG000|COMPLETED|Period 2||11
3354194|NCT03642262|4084238|FG001|COMPLETED|Period 2||16
3354195|NCT03642262|4084237|FG000|NOT COMPLETED|Period 2||0
3354196|NCT03642262|4084238|FG001|NOT COMPLETED|Period 2||0
3354197|NCT03642457|4084247|FG000|STARTED|Overall Study||35
3354198|NCT03642457|4084248|FG001|STARTED|Overall Study||30
3354199|NCT03642457|4084247|FG000|COMPLETED|Overall Study||35
3354200|NCT03642457|4084248|FG001|COMPLETED|Overall Study||30
3354201|NCT03642457|4084247|FG000|NOT COMPLETED|Overall Study||0
3354202|NCT03642457|4084248|FG001|NOT COMPLETED|Overall Study||0
3354203|NCT03642717|4084254|FG000|STARTED|Overall Study||658
3354204|NCT03642717|4084254|FG000|COMPLETED|Overall Study||620
3354205|NCT03642717|4084254|FG000|NOT COMPLETED|Overall Study||38
3354206|NCT03642873|4084259|FG000|STARTED|First Intervention (1 Day)||4
3354207|NCT03642873|4084260|FG001|STARTED|First Intervention (1 Day)||4
3354208|NCT03642873|4084261|FG002|STARTED|First Intervention (1 Day)||4
3354209|NCT03642873|4084262|FG003|STARTED|First Intervention (1 Day)||4
3354210|NCT03642873|4084263|FG004|STARTED|First Intervention (1 Day)||4
3354211|NCT03642873|4084264|FG005|STARTED|First Intervention (1 Day)||4
3354212|NCT03642873|4084259|FG000|COMPLETED|First Intervention (1 Day)||4
3354213|NCT03642873|4084260|FG001|COMPLETED|First Intervention (1 Day)||4
3354214|NCT03642873|4084261|FG002|COMPLETED|First Intervention (1 Day)||4
3354215|NCT03642873|4084262|FG003|COMPLETED|First Intervention (1 Day)||4
3354216|NCT03642873|4084263|FG004|COMPLETED|First Intervention (1 Day)||4
3354217|NCT03642873|4084264|FG005|COMPLETED|First Intervention (1 Day)||4
3354218|NCT03642873|4084259|FG000|NOT COMPLETED|First Intervention (1 Day)||0
3354219|NCT03642873|4084260|FG001|NOT COMPLETED|First Intervention (1 Day)||0
3354220|NCT03642873|4084261|FG002|NOT COMPLETED|First Intervention (1 Day)||0
3354221|NCT03642873|4084262|FG003|NOT COMPLETED|First Intervention (1 Day)||0
3354222|NCT03642873|4084263|FG004|NOT COMPLETED|First Intervention (1 Day)||0
3354223|NCT03642873|4084264|FG005|NOT COMPLETED|First Intervention (1 Day)||0
3354224|NCT03642873|4084259|FG000|STARTED|Washout (7 Days)||4
3354225|NCT03642873|4084260|FG001|STARTED|Washout (7 Days)||4
3354226|NCT03642873|4084261|FG002|STARTED|Washout (7 Days)||4
3354227|NCT03642873|4084262|FG003|STARTED|Washout (7 Days)||4
3354228|NCT03642873|4084263|FG004|STARTED|Washout (7 Days)||4
3354229|NCT03642873|4084264|FG005|STARTED|Washout (7 Days)||4
3354230|NCT03642873|4084259|FG000|COMPLETED|Washout (7 Days)||4
3354231|NCT03642873|4084260|FG001|COMPLETED|Washout (7 Days)||4
3354232|NCT03642873|4084261|FG002|COMPLETED|Washout (7 Days)||4
3354233|NCT03642873|4084262|FG003|COMPLETED|Washout (7 Days)||4
3354234|NCT03642873|4084263|FG004|COMPLETED|Washout (7 Days)||4
3354235|NCT03642873|4084264|FG005|COMPLETED|Washout (7 Days)||4
3354236|NCT03642873|4084259|FG000|NOT COMPLETED|Washout (7 Days)||0
3354237|NCT03642873|4084260|FG001|NOT COMPLETED|Washout (7 Days)||0
3354238|NCT03642873|4084261|FG002|NOT COMPLETED|Washout (7 Days)||0
3354239|NCT03642873|4084262|FG003|NOT COMPLETED|Washout (7 Days)||0
3354240|NCT03642873|4084263|FG004|NOT COMPLETED|Washout (7 Days)||0
3354241|NCT03642873|4084264|FG005|NOT COMPLETED|Washout (7 Days)||0
3354242|NCT03642873|4084259|FG000|STARTED|Second Intervention (1 Day)||4
3354243|NCT03642873|4084260|FG001|STARTED|Second Intervention (1 Day)||4
3354244|NCT03642873|4084261|FG002|STARTED|Second Intervention (1 Day)||4
3354245|NCT03642873|4084262|FG003|STARTED|Second Intervention (1 Day)||4
3354246|NCT03642873|4084263|FG004|STARTED|Second Intervention (1 Day)||4
3354247|NCT03642873|4084264|FG005|STARTED|Second Intervention (1 Day)||4
3354248|NCT03642873|4084259|FG000|COMPLETED|Second Intervention (1 Day)||4
3354249|NCT03642873|4084260|FG001|COMPLETED|Second Intervention (1 Day)||4
3354250|NCT03642873|4084261|FG002|COMPLETED|Second Intervention (1 Day)||4
3354251|NCT03642873|4084262|FG003|COMPLETED|Second Intervention (1 Day)||4
3354252|NCT03642873|4084263|FG004|COMPLETED|Second Intervention (1 Day)||4
3354253|NCT03642873|4084264|FG005|COMPLETED|Second Intervention (1 Day)||4
3354254|NCT03642873|4084259|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
3354255|NCT03642873|4084260|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
3354256|NCT03642873|4084261|FG002|NOT COMPLETED|Second Intervention (1 Day)||0
3354257|NCT03642873|4084262|FG003|NOT COMPLETED|Second Intervention (1 Day)||0
3354258|NCT03642873|4084263|FG004|NOT COMPLETED|Second Intervention (1 Day)||0
3354259|NCT03642873|4084264|FG005|NOT COMPLETED|Second Intervention (1 Day)||0
3354260|NCT03642873|4084259|FG000|STARTED|Washout (7 Days)||4
3354261|NCT03642873|4084260|FG001|STARTED|Washout (7 Days)||4
3354262|NCT03642873|4084261|FG002|STARTED|Washout (7 Days)||4
3354263|NCT03642873|4084262|FG003|STARTED|Washout (7 Days)||4
3354264|NCT03642873|4084263|FG004|STARTED|Washout (7 Days)||4
3354265|NCT03642873|4084264|FG005|STARTED|Washout (7 Days)||4
3354266|NCT03642873|4084259|FG000|COMPLETED|Washout (7 Days)||4
3354267|NCT03642873|4084260|FG001|COMPLETED|Washout (7 Days)||4
3354268|NCT03642873|4084261|FG002|COMPLETED|Washout (7 Days)||4
3354269|NCT03642873|4084262|FG003|COMPLETED|Washout (7 Days)||4
3354270|NCT03642873|4084263|FG004|COMPLETED|Washout (7 Days)||4
3354271|NCT03642873|4084264|FG005|COMPLETED|Washout (7 Days)||4
3354272|NCT03642873|4084259|FG000|NOT COMPLETED|Washout (7 Days)||0
3354273|NCT03642873|4084260|FG001|NOT COMPLETED|Washout (7 Days)||0
3354274|NCT03642873|4084261|FG002|NOT COMPLETED|Washout (7 Days)||0
3354275|NCT03642873|4084262|FG003|NOT COMPLETED|Washout (7 Days)||0
3354276|NCT03642873|4084263|FG004|NOT COMPLETED|Washout (7 Days)||0
3354277|NCT03642873|4084264|FG005|NOT COMPLETED|Washout (7 Days)||0
3354278|NCT03642873|4084259|FG000|STARTED|Third Intervention (1 Day)||4
3354279|NCT03642873|4084260|FG001|STARTED|Third Intervention (1 Day)||4
3354280|NCT03642873|4084261|FG002|STARTED|Third Intervention (1 Day)||4
3354281|NCT03642873|4084262|FG003|STARTED|Third Intervention (1 Day)||4
3354282|NCT03642873|4084263|FG004|STARTED|Third Intervention (1 Day)||4
3354283|NCT03642873|4084264|FG005|STARTED|Third Intervention (1 Day)||4
3354284|NCT03642873|4084259|FG000|COMPLETED|Third Intervention (1 Day)||4
3354285|NCT03642873|4084260|FG001|COMPLETED|Third Intervention (1 Day)||4
3354286|NCT03642873|4084261|FG002|COMPLETED|Third Intervention (1 Day)||4
3354287|NCT03642873|4084262|FG003|COMPLETED|Third Intervention (1 Day)||4
3354288|NCT03642873|4084263|FG004|COMPLETED|Third Intervention (1 Day)||3
3354289|NCT03642873|4084264|FG005|COMPLETED|Third Intervention (1 Day)||4
3354290|NCT03642873|4084259|FG000|NOT COMPLETED|Third Intervention (1 Day)||0
3354291|NCT03642873|4084260|FG001|NOT COMPLETED|Third Intervention (1 Day)||0
3354292|NCT03642873|4084261|FG002|NOT COMPLETED|Third Intervention (1 Day)||0
3354293|NCT03642873|4084262|FG003|NOT COMPLETED|Third Intervention (1 Day)||0
3354294|NCT03642873|4084263|FG004|NOT COMPLETED|Third Intervention (1 Day)||1
3354295|NCT03642873|4084264|FG005|NOT COMPLETED|Third Intervention (1 Day)||0
3354296|NCT03643432|4084278|FG000|STARTED|Overall Study||27
3354297|NCT03643432|4084279|FG001|STARTED|Overall Study||21
3354298|NCT03643432|4084278|FG000|COMPLETED|Overall Study||26
3354299|NCT03643432|4084279|FG001|COMPLETED|Overall Study||21
3354300|NCT03643432|4084278|FG000|NOT COMPLETED|Overall Study||1
3354301|NCT03643432|4084279|FG001|NOT COMPLETED|Overall Study||0
3354302|NCT03643575|4084285|FG000|STARTED|Period 1||5
3354303|NCT03643575|4084286|FG001|STARTED|Period 1||5
3354304|NCT03643575|4084287|FG002|STARTED|Period 1||5
3354305|NCT03643575|4084288|FG003|STARTED|Period 1||5
3354306|NCT03643575|4084289|FG004|STARTED|Period 1||5
3354307|NCT03643575|4084290|FG005|STARTED|Period 1||5
3354308|NCT03643575|4084285|FG000|COMPLETED|Period 1||5
3354309|NCT03643575|4084286|FG001|COMPLETED|Period 1||5
3354310|NCT03643575|4084287|FG002|COMPLETED|Period 1||5
3354311|NCT03643575|4084288|FG003|COMPLETED|Period 1||5
3354312|NCT03643575|4084289|FG004|COMPLETED|Period 1||5
3354313|NCT03643575|4084290|FG005|COMPLETED|Period 1||5
3354314|NCT03643575|4084285|FG000|NOT COMPLETED|Period 1||0
2928034|NCT00576199|3639004|FG000|NOT COMPLETED|Overall Study||30
2928035|NCT00576251|3639010|FG000|STARTED|Overall Study||109
2928036|NCT00576251|3639011|FG001|STARTED|Overall Study||112
2928037|NCT00576251|3639010|FG000|COMPLETED|Overall Study||108
2928038|NCT00576251|3639011|FG001|COMPLETED|Overall Study||111
2928039|NCT00576251|3639010|FG000|NOT COMPLETED|Overall Study||1
2928040|NCT00576251|3639011|FG001|NOT COMPLETED|Overall Study||1
2928041|NCT00576303|3639017|FG000|STARTED|Dose Titration Period||200
2928042|NCT00576303|3639017|FG000|COMPLETED|Dose Titration Period||183
2928043|NCT00576303|3639017|FG000|NOT COMPLETED|Dose Titration Period||17
3354315|NCT03643575|4084286|FG001|NOT COMPLETED|Period 1||0
3354316|NCT03643575|4084287|FG002|NOT COMPLETED|Period 1||0
3354317|NCT03643575|4084288|FG003|NOT COMPLETED|Period 1||0
3354318|NCT03643575|4084289|FG004|NOT COMPLETED|Period 1||0
3354319|NCT03643575|4084290|FG005|NOT COMPLETED|Period 1||0
3354320|NCT03643575|4084285|FG000|STARTED|Washout: 7 Days||5
3354321|NCT03643575|4084286|FG001|STARTED|Washout: 7 Days||5
3354322|NCT03643575|4084287|FG002|STARTED|Washout: 7 Days||5
3354323|NCT03643575|4084288|FG003|STARTED|Washout: 7 Days||5
3354324|NCT03643575|4084289|FG004|STARTED|Washout: 7 Days||5
3354325|NCT03643575|4084290|FG005|STARTED|Washout: 7 Days||5
3354326|NCT03643575|4084285|FG000|COMPLETED|Washout: 7 Days||4
3354327|NCT03643575|4084286|FG001|COMPLETED|Washout: 7 Days||5
3354328|NCT03643575|4084287|FG002|COMPLETED|Washout: 7 Days||5
3354329|NCT03643575|4084288|FG003|COMPLETED|Washout: 7 Days||4
3354330|NCT03643575|4084289|FG004|COMPLETED|Washout: 7 Days||5
3354331|NCT03643575|4084290|FG005|COMPLETED|Washout: 7 Days||5
3354332|NCT03643575|4084285|FG000|NOT COMPLETED|Washout: 7 Days||1
3354333|NCT03643575|4084286|FG001|NOT COMPLETED|Washout: 7 Days||0
3354334|NCT03643575|4084287|FG002|NOT COMPLETED|Washout: 7 Days||0
3354335|NCT03643575|4084288|FG003|NOT COMPLETED|Washout: 7 Days||1
3354336|NCT03643575|4084289|FG004|NOT COMPLETED|Washout: 7 Days||0
3354337|NCT03643575|4084290|FG005|NOT COMPLETED|Washout: 7 Days||0
3354338|NCT03643575|4084285|FG000|STARTED|Period 2||4
3354339|NCT03643575|4084286|FG001|STARTED|Period 2||5
3354340|NCT03643575|4084287|FG002|STARTED|Period 2||5
3354341|NCT03643575|4084288|FG003|STARTED|Period 2||4
3354342|NCT03643575|4084289|FG004|STARTED|Period 2||5
3354343|NCT03643575|4084290|FG005|STARTED|Period 2||5
3354344|NCT03643575|4084285|FG000|COMPLETED|Period 2||4
3354345|NCT03643575|4084286|FG001|COMPLETED|Period 2||5
3354346|NCT03643575|4084287|FG002|COMPLETED|Period 2||5
3354347|NCT03643575|4084288|FG003|COMPLETED|Period 2||4
3354348|NCT03643575|4084289|FG004|COMPLETED|Period 2||5
3354349|NCT03643575|4084290|FG005|COMPLETED|Period 2||5
3354350|NCT03643575|4084285|FG000|NOT COMPLETED|Period 2||0
3354351|NCT03643575|4084286|FG001|NOT COMPLETED|Period 2||0
3354352|NCT03643575|4084287|FG002|NOT COMPLETED|Period 2||0
3354353|NCT03643575|4084288|FG003|NOT COMPLETED|Period 2||0
3354354|NCT03643575|4084289|FG004|NOT COMPLETED|Period 2||0
3354355|NCT03643575|4084290|FG005|NOT COMPLETED|Period 2||0
3354356|NCT03643575|4084285|FG000|STARTED|Washout: 7 Days||4
3354357|NCT03643575|4084286|FG001|STARTED|Washout: 7 Days||5
3354358|NCT03643575|4084287|FG002|STARTED|Washout: 7 Days||5
3354359|NCT03643575|4084288|FG003|STARTED|Washout: 7 Days||4
3354360|NCT03643575|4084289|FG004|STARTED|Washout: 7 Days||5
3354361|NCT03643575|4084290|FG005|STARTED|Washout: 7 Days||5
3354362|NCT03643575|4084285|FG000|COMPLETED|Washout: 7 Days||4
3354363|NCT03643575|4084286|FG001|COMPLETED|Washout: 7 Days||4
3354364|NCT03643575|4084287|FG002|COMPLETED|Washout: 7 Days||5
3354365|NCT03643575|4084288|FG003|COMPLETED|Washout: 7 Days||4
3354366|NCT03643575|4084289|FG004|COMPLETED|Washout: 7 Days||5
3354367|NCT03643575|4084290|FG005|COMPLETED|Washout: 7 Days||5
3354368|NCT03643575|4084285|FG000|NOT COMPLETED|Washout: 7 Days||0
3354369|NCT03643575|4084286|FG001|NOT COMPLETED|Washout: 7 Days||1
3354370|NCT03643575|4084287|FG002|NOT COMPLETED|Washout: 7 Days||0
3354371|NCT03643575|4084288|FG003|NOT COMPLETED|Washout: 7 Days||0
3354372|NCT03643575|4084289|FG004|NOT COMPLETED|Washout: 7 Days||0
3354373|NCT03643575|4084290|FG005|NOT COMPLETED|Washout: 7 Days||0
3354374|NCT03643575|4084285|FG000|STARTED|Period 3||4
3354375|NCT03643575|4084286|FG001|STARTED|Period 3||4
3354376|NCT03643575|4084287|FG002|STARTED|Period 3||5
3354377|NCT03643575|4084288|FG003|STARTED|Period 3||4
3354378|NCT03643575|4084289|FG004|STARTED|Period 3||5
3354379|NCT03643575|4084290|FG005|STARTED|Period 3||5
3354380|NCT03643575|4084285|FG000|COMPLETED|Period 3||4
3354381|NCT03643575|4084286|FG001|COMPLETED|Period 3||4
3354382|NCT03643575|4084287|FG002|COMPLETED|Period 3||5
3354383|NCT03643575|4084288|FG003|COMPLETED|Period 3||4
3354384|NCT03643575|4084289|FG004|COMPLETED|Period 3||5
3354385|NCT03643575|4084290|FG005|COMPLETED|Period 3||5
3354386|NCT03643575|4084285|FG000|NOT COMPLETED|Period 3||0
3354387|NCT03643575|4084286|FG001|NOT COMPLETED|Period 3||0
3354388|NCT03643575|4084287|FG002|NOT COMPLETED|Period 3||0
3354389|NCT03643575|4084288|FG003|NOT COMPLETED|Period 3||0
3354390|NCT03643575|4084289|FG004|NOT COMPLETED|Period 3||0
3354391|NCT03643575|4084290|FG005|NOT COMPLETED|Period 3||0
3354392|NCT03643692|4084298|FG000|STARTED|Overall Study||12
3354393|NCT03643692|4084298|FG000|COMPLETED|Overall Study||12
3354394|NCT03643692|4084298|FG000|NOT COMPLETED|Overall Study||0
3354395|NCT03643952|4084302|FG000|STARTED|Overall Study||18
3354396|NCT03643952|4084302|FG000|COMPLETED|Overall Study||17
3354397|NCT03643952|4084302|FG000|NOT COMPLETED|Overall Study||1
3354398|NCT03644095|4084314|FG000|STARTED|Period 1||15
3354399|NCT03644095|4084315|FG001|STARTED|Period 1||15
3354400|NCT03644095|4084314|FG000|COMPLETED|Period 1||15
3354401|NCT03644095|4084315|FG001|COMPLETED|Period 1||15
3354402|NCT03644095|4084314|FG000|NOT COMPLETED|Period 1||0
3354403|NCT03644095|4084315|FG001|NOT COMPLETED|Period 1||0
3354404|NCT03644095|4084314|FG000|STARTED|Washout (7 Days)||15
3354405|NCT03644095|4084315|FG001|STARTED|Washout (7 Days)||15
3354406|NCT03644095|4084314|FG000|COMPLETED|Washout (7 Days)||15
3354407|NCT03644095|4084315|FG001|COMPLETED|Washout (7 Days)||15
3354408|NCT03644095|4084314|FG000|NOT COMPLETED|Washout (7 Days)||0
3354409|NCT03644095|4084315|FG001|NOT COMPLETED|Washout (7 Days)||0
3354410|NCT03644095|4084314|FG000|STARTED|Period 2||15
3354411|NCT03644095|4084315|FG001|STARTED|Period 2||15
3354412|NCT03644095|4084314|FG000|COMPLETED|Period 2||15
3354413|NCT03644095|4084315|FG001|COMPLETED|Period 2||15
3354414|NCT03644095|4084314|FG000|NOT COMPLETED|Period 2||0
3354415|NCT03644095|4084315|FG001|NOT COMPLETED|Period 2||0
3354416|NCT03644108|4084321|FG000|STARTED|Overall Study||30
3354417|NCT03644108|4084321|FG000|COMPLETED|Overall Study||30
3354418|NCT03644108|4084321|FG000|NOT COMPLETED|Overall Study||0
3354419|NCT03644173|4084325|FG000|STARTED|Participants at Last Visit (Pre-surveys)||37
3354420|NCT03644173|4084325|FG000|COMPLETED|Participants at Last Visit (Pre-surveys)||16
3354421|NCT03644173|4084325|FG000|NOT COMPLETED|Participants at Last Visit (Pre-surveys)||21
3354422|NCT03644173|4084325|FG000|STARTED|Participants at the 1-month Follow up||16
3354423|NCT03644173|4084325|FG000|COMPLETED|Participants at the 1-month Follow up||12
3354424|NCT03644173|4084325|FG000|NOT COMPLETED|Participants at the 1-month Follow up||4
3354425|NCT03644173|4084325|FG000|STARTED|Participants at the 3-month Follow up||12
3354426|NCT03644173|4084325|FG000|COMPLETED|Participants at the 3-month Follow up||10
3354427|NCT03644173|4084325|FG000|NOT COMPLETED|Participants at the 3-month Follow up||2
3354428|NCT03644212|4084332|FG000|STARTED|Overall Study||63
3354429|NCT03644212|4084333|FG001|STARTED|Overall Study||16
3354430|NCT03644212|4084332|FG000|COMPLETED|Overall Study||63
3354431|NCT03644212|4084333|FG001|COMPLETED|Overall Study||16
3354432|NCT03644212|4084332|FG000|NOT COMPLETED|Overall Study||0
3354433|NCT03644212|4084333|FG001|NOT COMPLETED|Overall Study||0
3354434|NCT03645421|4084343|FG000|STARTED|Overall Study||16
3354435|NCT03645421|4084344|FG001|STARTED|Overall Study||15
3354436|NCT03645421|4084345|FG002|STARTED|Overall Study||15
3354437|NCT03645421|4084346|FG003|STARTED|Overall Study||15
3354438|NCT03645421|4084343|FG000|Received Investigational Product (IP)|Overall Study||16
3354439|NCT03645421|4084344|FG001|Received Investigational Product (IP)|Overall Study||15
3354440|NCT03645421|4084345|FG002|Received Investigational Product (IP)|Overall Study||15
3354441|NCT03645421|4084346|FG003|Received Investigational Product (IP)|Overall Study||15
3354442|NCT03645421|4084343|FG000|COMPLETED|Overall Study||16
3354443|NCT03645421|4084344|FG001|COMPLETED|Overall Study||15
3354444|NCT03645421|4084345|FG002|COMPLETED|Overall Study||10
3354445|NCT03645421|4084346|FG003|COMPLETED|Overall Study||11
3354446|NCT03645421|4084343|FG000|NOT COMPLETED|Overall Study||0
3354447|NCT03645421|4084344|FG001|NOT COMPLETED|Overall Study||0
3354448|NCT03645421|4084345|FG002|NOT COMPLETED|Overall Study||5
3354449|NCT03645421|4084346|FG003|NOT COMPLETED|Overall Study||4
3354450|NCT03645434|4084359|FG000|STARTED|Period 1||12
3354451|NCT03645434|4084360|FG001|STARTED|Period 1||13
3354452|NCT03645434|4084361|FG002|STARTED|Period 1||13
3354453|NCT03645434|4084362|FG003|STARTED|Period 1||11
3354454|NCT03645434|4084363|FG004|STARTED|Period 1||12
3354455|NCT03645434|4084364|FG005|STARTED|Period 1||12
3354456|NCT03645434|4084359|FG000|COMPLETED|Period 1||12
3354457|NCT03645434|4084360|FG001|COMPLETED|Period 1||13
3354458|NCT03645434|4084361|FG002|COMPLETED|Period 1||13
3354459|NCT03645434|4084362|FG003|COMPLETED|Period 1||10
3354460|NCT03645434|4084363|FG004|COMPLETED|Period 1||11
3354461|NCT03645434|4084364|FG005|COMPLETED|Period 1||12
3354462|NCT03645434|4084359|FG000|NOT COMPLETED|Period 1||0
3354463|NCT03645434|4084360|FG001|NOT COMPLETED|Period 1||0
3354464|NCT03645434|4084361|FG002|NOT COMPLETED|Period 1||0
3354465|NCT03645434|4084362|FG003|NOT COMPLETED|Period 1||1
3354466|NCT03645434|4084363|FG004|NOT COMPLETED|Period 1||1
3354467|NCT03645434|4084364|FG005|NOT COMPLETED|Period 1||0
3354468|NCT03645434|4084359|FG000|STARTED|Period 2|2 subject discontinued as they did not meet stability or FEV1 variability.|10
3354469|NCT03645434|4084360|FG001|STARTED|Period 2||13
3354470|NCT03645434|4084361|FG002|STARTED|Period 2||13
3354471|NCT03645434|4084362|FG003|STARTED|Period 2||10
3354472|NCT03645434|4084363|FG004|STARTED|Period 2||11
3354473|NCT03645434|4084364|FG005|STARTED|Period 2|1 subject completed Period 1 but not allowed to enter Period 2 due to physician decision.|11
3354474|NCT03645434|4084359|FG000|COMPLETED|Period 2||10
3354475|NCT03645434|4084360|FG001|COMPLETED|Period 2||13
3354476|NCT03645434|4084361|FG002|COMPLETED|Period 2||13
3354477|NCT03645434|4084362|FG003|COMPLETED|Period 2||10
3354478|NCT03645434|4084363|FG004|COMPLETED|Period 2||11
3354479|NCT03645434|4084364|FG005|COMPLETED|Period 2||11
3354480|NCT03645434|4084359|FG000|NOT COMPLETED|Period 2||0
3354481|NCT03645434|4084360|FG001|NOT COMPLETED|Period 2||0
3354482|NCT03645434|4084361|FG002|NOT COMPLETED|Period 2||0
3354483|NCT03645434|4084362|FG003|NOT COMPLETED|Period 2||0
3354484|NCT03645434|4084363|FG004|NOT COMPLETED|Period 2||0
3354485|NCT03645434|4084364|FG005|NOT COMPLETED|Period 2||0
3354486|NCT03645434|4084359|FG000|STARTED|Period 3||10
3354487|NCT03645434|4084360|FG001|STARTED|Period 3||13
3354488|NCT03645434|4084361|FG002|STARTED|Period 3|2 subjects discontinued as they did not meet FEV1 stability criteria or pfts variability criteria.|11
3354489|NCT03645434|4084362|FG003|STARTED|Period 3||10
3354490|NCT03645434|4084363|FG004|STARTED|Period 3||11
3354491|NCT03645434|4084364|FG005|STARTED|Period 3||11
3354492|NCT03645434|4084359|FG000|COMPLETED|Period 3||10
3354493|NCT03645434|4084360|FG001|COMPLETED|Period 3||13
3354494|NCT03645434|4084361|FG002|COMPLETED|Period 3||11
3178899|NCT01981473|3907044|FG000|STARTED|Overall Study||202
3178900|NCT01981473|3907045|FG001|STARTED|Overall Study||199
3178901|NCT01981473|3907046|FG002|STARTED|Overall Study||204
3178902|NCT01981473|3907044|FG000|COMPLETED|Overall Study||200
3354495|NCT03645434|4084362|FG003|COMPLETED|Period 3||10
3354496|NCT03645434|4084363|FG004|COMPLETED|Period 3||11
3354497|NCT03645434|4084364|FG005|COMPLETED|Period 3||11
3354498|NCT03645434|4084359|FG000|NOT COMPLETED|Period 3||0
3354499|NCT03645434|4084360|FG001|NOT COMPLETED|Period 3||0
3354500|NCT03645434|4084361|FG002|NOT COMPLETED|Period 3||0
3354501|NCT03645434|4084362|FG003|NOT COMPLETED|Period 3||0
3354502|NCT03645434|4084363|FG004|NOT COMPLETED|Period 3||0
3354503|NCT03645434|4084364|FG005|NOT COMPLETED|Period 3||0
3354504|NCT03645785|4084372|FG000|STARTED|Day 1 (Normal Fluid Intake and Diet)||23
3354505|NCT03645785|4084372|FG000|COMPLETED|Day 1 (Normal Fluid Intake and Diet)||23
3354506|NCT03645785|4084372|FG000|NOT COMPLETED|Day 1 (Normal Fluid Intake and Diet)||0
3354507|NCT03645785|4084372|FG000|STARTED|Day 2-4 (Double Fluid and Add Citrate)||23
3354508|NCT03645785|4084372|FG000|COMPLETED|Day 2-4 (Double Fluid and Add Citrate)||23
3354509|NCT03645785|4084372|FG000|NOT COMPLETED|Day 2-4 (Double Fluid and Add Citrate)||0
3354510|NCT03645811|4084391|FG000|STARTED|Overall Study||32
3354511|NCT03645811|4084392|FG001|STARTED|Overall Study||32
3354512|NCT03645811|4084393|FG002|STARTED|Overall Study||32
3354513|NCT03645811|4084391|FG000|COMPLETED|Overall Study||30
3354514|NCT03645811|4084392|FG001|COMPLETED|Overall Study||30
3354515|NCT03645811|4084393|FG002|COMPLETED|Overall Study||30
3354516|NCT03645811|4084391|FG000|NOT COMPLETED|Overall Study||2
3354517|NCT03645811|4084392|FG001|NOT COMPLETED|Overall Study||2
3354518|NCT03645811|4084393|FG002|NOT COMPLETED|Overall Study||2
3354519|NCT03645954|4084403|FG000|STARTED|Overall Study||40
3354520|NCT03645954|4084404|FG001|STARTED|Overall Study||40
3354521|NCT03645954|4084403|FG000|COMPLETED|Overall Study||37
3354522|NCT03645954|4084404|FG001|COMPLETED|Overall Study||40
3354523|NCT03645954|4084403|FG000|NOT COMPLETED|Overall Study||3
3354524|NCT03645954|4084404|FG001|NOT COMPLETED|Overall Study||0
3354525|NCT03646305|4084414|FG000|STARTED|Overall Study||32
3354526|NCT03646305|4084415|FG001|STARTED|Overall Study||35
3354527|NCT03646305|4084416|FG002|STARTED|Overall Study||33
3354528|NCT03646305|4084417|FG003|STARTED|Overall Study||33
3354529|NCT03646305|4084414|FG000|Received Treatment|Overall Study||31
3354530|NCT03646305|4084415|FG001|Received Treatment|Overall Study||35
3354531|NCT03646305|4084416|FG002|Received Treatment|Overall Study||32
3354532|NCT03646305|4084417|FG003|Received Treatment|Overall Study||32
3354533|NCT03646305|4084414|FG000|No Treatment Recieved|Overall Study||1
3354534|NCT03646305|4084415|FG001|No Treatment Recieved|Overall Study||0
3354535|NCT03646305|4084416|FG002|No Treatment Recieved|Overall Study||1
3354536|NCT03646305|4084417|FG003|No Treatment Recieved|Overall Study||1
3354537|NCT03646305|4084414|FG000|COMPLETED|Overall Study||27
3354538|NCT03646305|4084415|FG001|COMPLETED|Overall Study||33
3354539|NCT03646305|4084416|FG002|COMPLETED|Overall Study||31
3354540|NCT03646305|4084417|FG003|COMPLETED|Overall Study||31
3354541|NCT03646305|4084414|FG000|NOT COMPLETED|Overall Study||5
3354542|NCT03646305|4084415|FG001|NOT COMPLETED|Overall Study||2
3354543|NCT03646305|4084416|FG002|NOT COMPLETED|Overall Study||2
3354544|NCT03646305|4084417|FG003|NOT COMPLETED|Overall Study||2
3354545|NCT03646656|4084433|FG000|STARTED|Overall Study||12
3354546|NCT03646656|4084434|FG001|STARTED|Overall Study||3
3354547|NCT03646656|4084433|FG000|Attended 1st Group Session|Overall Study||10
3354548|NCT03646656|4084434|FG001|Attended 1st Group Session|Overall Study||3
3354549|NCT03646656|4084433|FG000|COMPLETED|Overall Study||9
3354550|NCT03646656|4084434|FG001|COMPLETED|Overall Study||3
3354551|NCT03646656|4084433|FG000|NOT COMPLETED|Overall Study||3
3354552|NCT03646656|4084434|FG001|NOT COMPLETED|Overall Study||0
3354553|NCT03647033|4084446|FG000|STARTED|Overall Study||16
3354554|NCT03647033|4084447|FG001|STARTED|Overall Study||16
3354555|NCT03647033|4084446|FG000|COMPLETED|Overall Study||16
3354556|NCT03647033|4084447|FG001|COMPLETED|Overall Study||16
3354557|NCT03647033|4084446|FG000|NOT COMPLETED|Overall Study||0
3354558|NCT03647033|4084447|FG001|NOT COMPLETED|Overall Study||0
3354559|NCT03647046|4084453|FG000|STARTED|Overall Study||12
3354560|NCT03647046|4084453|FG000|COMPLETED|Overall Study||8
3354561|NCT03647046|4084453|FG000|NOT COMPLETED|Overall Study||4
3354562|NCT03647267|4084459|FG000|STARTED|Overall Study||24
3354563|NCT03647267|4084460|FG001|STARTED|Overall Study||22
3354564|NCT03647267|4084459|FG000|COMPLETED|Overall Study||23
3354565|NCT03647267|4084460|FG001|COMPLETED|Overall Study||22
3354566|NCT03647267|4084459|FG000|NOT COMPLETED|Overall Study||1
3354567|NCT03647267|4084460|FG001|NOT COMPLETED|Overall Study||0
3354568|NCT03647475|4084468|FG000|STARTED|Overall Study||752
3354569|NCT03647475|4084468|FG000|NCT03647475 - Included in One Month Clear Analysis Population|Overall Study||601
3354570|NCT03647475|4084468|FG000|NCT03344653- Included in One Month Clear Analysis Population|Overall Study||905
3354571|NCT03647475|4084468|FG000|COMPLETED|Overall Study||75
3354572|NCT03647475|4084468|FG000|NOT COMPLETED|Overall Study||677
3354573|NCT03647709|4084472|FG000|STARTED|Overall Study||400
3354574|NCT03647709|4084472|FG000|COMPLETED|Overall Study||386
3354575|NCT03647709|4084472|FG000|NOT COMPLETED|Overall Study||14
3354576|NCT03648853|4084478|FG000|STARTED|Overall Study||12
3354577|NCT03648853|4084478|FG000|COMPLETED|Overall Study||12
3354578|NCT03648853|4084478|FG000|NOT COMPLETED|Overall Study||0
3354579|NCT03648879|4084482|FG000|STARTED|Overall Study||37
3354580|NCT03648879|4084482|FG000|COMPLETED|Overall Study||36
3354581|NCT03648879|4084482|FG000|NOT COMPLETED|Overall Study||1
3354582|NCT03649412|4084488|FG000|STARTED|Part A, Period 1 (4 Days)||16
3354583|NCT03649412|4084489|FG001|STARTED|Part A, Period 1 (4 Days)||0
3354584|NCT03649412|4084488|FG000|COMPLETED|Part A, Period 1 (4 Days)||16
3354585|NCT03649412|4084489|FG001|COMPLETED|Part A, Period 1 (4 Days)||0
3354586|NCT03649412|4084488|FG000|NOT COMPLETED|Part A, Period 1 (4 Days)||0
3354587|NCT03649412|4084489|FG001|NOT COMPLETED|Part A, Period 1 (4 Days)||0
3354588|NCT03649412|4084488|FG000|STARTED|Part A, Washout Period 1 (7 Days)||16
3354589|NCT03649412|4084489|FG001|STARTED|Part A, Washout Period 1 (7 Days)||0
3354590|NCT03649412|4084488|FG000|COMPLETED|Part A, Washout Period 1 (7 Days)||15
3354591|NCT03649412|4084489|FG001|COMPLETED|Part A, Washout Period 1 (7 Days)||0
3354592|NCT03649412|4084488|FG000|NOT COMPLETED|Part A, Washout Period 1 (7 Days)||1
3354593|NCT03649412|4084489|FG001|NOT COMPLETED|Part A, Washout Period 1 (7 Days)||0
3354594|NCT03649412|4084488|FG000|STARTED|Part A, Period 2 (3 Days)|1 Replacement par. was enrolled & dosed|16
3354595|NCT03649412|4084489|FG001|STARTED|Part A, Period 2 (3 Days)||0
3178903|NCT01981473|3907045|FG001|COMPLETED|Overall Study||199
3178904|NCT01981473|3907046|FG002|COMPLETED|Overall Study||196
3178905|NCT01981473|3907044|FG000|NOT COMPLETED|Overall Study||2
3178906|NCT01981473|3907045|FG001|NOT COMPLETED|Overall Study||0
3178907|NCT01981473|3907046|FG002|NOT COMPLETED|Overall Study||8
3178908|NCT01981564|3907059|FG000|STARTED|Overall Study||107
3178909|NCT01981564|3907060|FG001|STARTED|Overall Study||115
3178910|NCT01981564|3907059|FG000|COMPLETED|Overall Study||98
3178911|NCT01981564|3907060|FG001|COMPLETED|Overall Study||106
3178912|NCT01981564|3907059|FG000|NOT COMPLETED|Overall Study||9
3178913|NCT01981564|3907060|FG001|NOT COMPLETED|Overall Study||9
3178914|NCT01981590|3907067|FG000|STARTED|Overall Study||15
3178915|NCT01981590|3907067|FG000|COMPLETED|Overall Study||15
3178916|NCT01981590|3907067|FG000|NOT COMPLETED|Overall Study||0
3178917|NCT01981616|3907074|FG000|STARTED|Overall Study||64
3178918|NCT01981616|3907075|FG001|STARTED|Overall Study||63
3178919|NCT01981616|3907074|FG000|COMPLETED|Overall Study||63
3178920|NCT01981616|3907075|FG001|COMPLETED|Overall Study||62
3178921|NCT01981616|3907074|FG000|NOT COMPLETED|Overall Study||1
3354596|NCT03649412|4084488|FG000|COMPLETED|Part A, Period 2 (3 Days)||16
3354597|NCT03649412|4084489|FG001|COMPLETED|Part A, Period 2 (3 Days)||0
3354598|NCT03649412|4084488|FG000|NOT COMPLETED|Part A, Period 2 (3 Days)||0
3354599|NCT03649412|4084489|FG001|NOT COMPLETED|Part A, Period 2 (3 Days)||0
3354600|NCT03649412|4084488|FG000|STARTED|Part A, Washout Period 2 (7 Days)||16
3354601|NCT03649412|4084489|FG001|STARTED|Part A, Washout Period 2 (7 Days)||0
3354602|NCT03649412|4084488|FG000|COMPLETED|Part A, Washout Period 2 (7 Days)||16
3354603|NCT03649412|4084489|FG001|COMPLETED|Part A, Washout Period 2 (7 Days)||0
3354604|NCT03649412|4084488|FG000|NOT COMPLETED|Part A, Washout Period 2 (7 Days)||0
3354605|NCT03649412|4084489|FG001|NOT COMPLETED|Part A, Washout Period 2 (7 Days)||0
3354606|NCT03649412|4084488|FG000|STARTED|Part A, Period 3 (4 Days)||16
3354607|NCT03649412|4084489|FG001|STARTED|Part A, Period 3 (4 Days)||0
3354608|NCT03649412|4084488|FG000|COMPLETED|Part A, Period 3 (4 Days)||16
3354609|NCT03649412|4084489|FG001|COMPLETED|Part A, Period 3 (4 Days)||0
3354610|NCT03649412|4084488|FG000|NOT COMPLETED|Part A, Period 3 (4 Days)||0
3354611|NCT03649412|4084489|FG001|NOT COMPLETED|Part A, Period 3 (4 Days)||0
3354612|NCT03649412|4084488|FG000|STARTED|Part A, Washout Period 3 (7 Days)||16
3354613|NCT03649412|4084489|FG001|STARTED|Part A, Washout Period 3 (7 Days)||0
3354614|NCT03649412|4084488|FG000|COMPLETED|Part A, Washout Period 3 (7 Days)||16
3354615|NCT03649412|4084489|FG001|COMPLETED|Part A, Washout Period 3 (7 Days)||0
3354616|NCT03649412|4084488|FG000|NOT COMPLETED|Part A, Washout Period 3 (7 Days)||0
3354617|NCT03649412|4084489|FG001|NOT COMPLETED|Part A, Washout Period 3 (7 Days)||0
3354618|NCT03649412|4084488|FG000|STARTED|Part A, Period 4 (4 Days)||16
3354619|NCT03649412|4084489|FG001|STARTED|Part A, Period 4 (4 Days)||0
3354620|NCT03649412|4084488|FG000|COMPLETED|Part A, Period 4 (4 Days)||16
3354621|NCT03649412|4084489|FG001|COMPLETED|Part A, Period 4 (4 Days)||0
3354622|NCT03649412|4084488|FG000|NOT COMPLETED|Part A, Period 4 (4 Days)||0
3354623|NCT03649412|4084489|FG001|NOT COMPLETED|Part A, Period 4 (4 Days)||0
3354624|NCT03649412|4084488|FG000|STARTED|Part A, Washout Period 4 (7 Days)||16
3354625|NCT03649412|4084489|FG001|STARTED|Part A, Washout Period 4 (7 Days)||0
3354626|NCT03649412|4084488|FG000|COMPLETED|Part A, Washout Period 4 (7 Days)||14
3354627|NCT03649412|4084489|FG001|COMPLETED|Part A, Washout Period 4 (7 Days)||0
3354628|NCT03649412|4084488|FG000|NOT COMPLETED|Part A, Washout Period 4 (7 Days)||2
3354629|NCT03649412|4084489|FG001|NOT COMPLETED|Part A, Washout Period 4 (7 Days)||0
3354630|NCT03649412|4084488|FG000|STARTED|Part A, Period 5 (4 Days)|Two participant did not start in Period 5|12
3354631|NCT03649412|4084489|FG001|STARTED|Part A, Period 5 (4 Days)||0
3354632|NCT03649412|4084488|FG000|COMPLETED|Part A, Period 5 (4 Days)||12
3354633|NCT03649412|4084489|FG001|COMPLETED|Part A, Period 5 (4 Days)||0
3354634|NCT03649412|4084488|FG000|NOT COMPLETED|Part A, Period 5 (4 Days)||0
3354635|NCT03649412|4084489|FG001|NOT COMPLETED|Part A, Period 5 (4 Days)||0
3354636|NCT03649412|4084488|FG000|STARTED|Part A, Washout Period 5 (7 Days)||12
3354637|NCT03649412|4084489|FG001|STARTED|Part A, Washout Period 5 (7 Days)||0
3354638|NCT03649412|4084488|FG000|COMPLETED|Part A, Washout Period 5 (7 Days)||11
3354639|NCT03649412|4084489|FG001|COMPLETED|Part A, Washout Period 5 (7 Days)||0
3354640|NCT03649412|4084488|FG000|NOT COMPLETED|Part A, Washout Period 5 (7 Days)||1
3354641|NCT03649412|4084489|FG001|NOT COMPLETED|Part A, Washout Period 5 (7 Days)||0
3354642|NCT03649412|4084488|FG000|STARTED|Part A, Period 6 (4 Days)|1 of the participant who did not start Period 5 directly joined into Period 6|12
3354643|NCT03649412|4084489|FG001|STARTED|Part A, Period 6 (4 Days)||0
3354644|NCT03649412|4084488|FG000|COMPLETED|Part A, Period 6 (4 Days)||12
3354645|NCT03649412|4084489|FG001|COMPLETED|Part A, Period 6 (4 Days)||0
3354646|NCT03649412|4084488|FG000|NOT COMPLETED|Part A, Period 6 (4 Days)||0
3354647|NCT03649412|4084489|FG001|NOT COMPLETED|Part A, Period 6 (4 Days)||0
3354648|NCT03649412|4084488|FG000|STARTED|Part B, Period 1 (4 Days)|Participants in Part A did not enter Part B|0
3354649|NCT03649412|4084489|FG001|STARTED|Part B, Period 1 (4 Days)|16 new participants enrolled in Part B|16
3354650|NCT03649412|4084488|FG000|COMPLETED|Part B, Period 1 (4 Days)||0
3354651|NCT03649412|4084489|FG001|COMPLETED|Part B, Period 1 (4 Days)||16
3354652|NCT03649412|4084488|FG000|NOT COMPLETED|Part B, Period 1 (4 Days)||0
3354653|NCT03649412|4084489|FG001|NOT COMPLETED|Part B, Period 1 (4 Days)||0
3354654|NCT03649412|4084488|FG000|STARTED|Part B, Washout Period 1 (7 Days)||0
3354655|NCT03649412|4084489|FG001|STARTED|Part B, Washout Period 1 (7 Days)||16
3354656|NCT03649412|4084488|FG000|COMPLETED|Part B, Washout Period 1 (7 Days)||0
3354657|NCT03649412|4084489|FG001|COMPLETED|Part B, Washout Period 1 (7 Days)||15
3354658|NCT03649412|4084488|FG000|NOT COMPLETED|Part B, Washout Period 1 (7 Days)||0
3354659|NCT03649412|4084489|FG001|NOT COMPLETED|Part B, Washout Period 1 (7 Days)||1
3354660|NCT03649412|4084488|FG000|STARTED|Part B, Period 2 (4 Days)||0
3354661|NCT03649412|4084489|FG001|STARTED|Part B, Period 2 (4 Days)||15
3354662|NCT03649412|4084488|FG000|COMPLETED|Part B, Period 2 (4 Days)||0
3354663|NCT03649412|4084489|FG001|COMPLETED|Part B, Period 2 (4 Days)||15
3354664|NCT03649412|4084488|FG000|NOT COMPLETED|Part B, Period 2 (4 Days)||0
3354665|NCT03649412|4084489|FG001|NOT COMPLETED|Part B, Period 2 (4 Days)||0
3354666|NCT03649412|4084488|FG000|STARTED|Part B, Washout Period 2 (7 Days)||0
3354667|NCT03649412|4084489|FG001|STARTED|Part B, Washout Period 2 (7 Days)||15
3354668|NCT03649412|4084488|FG000|COMPLETED|Part B, Washout Period 2 (7 Days)||0
3354669|NCT03649412|4084489|FG001|COMPLETED|Part B, Washout Period 2 (7 Days)||15
3354670|NCT03649412|4084488|FG000|NOT COMPLETED|Part B, Washout Period 2 (7 Days)||0
3354671|NCT03649412|4084489|FG001|NOT COMPLETED|Part B, Washout Period 2 (7 Days)||0
3354672|NCT03649412|4084488|FG000|STARTED|Part B, Period 3 (4 Days)||0
3354673|NCT03649412|4084489|FG001|STARTED|Part B, Period 3 (4 Days)||15
3354674|NCT03649412|4084488|FG000|COMPLETED|Part B, Period 3 (4 Days)||0
3354675|NCT03649412|4084489|FG001|COMPLETED|Part B, Period 3 (4 Days)||15
3354676|NCT03649412|4084488|FG000|NOT COMPLETED|Part B, Period 3 (4 Days)||0
3354677|NCT03649412|4084489|FG001|NOT COMPLETED|Part B, Period 3 (4 Days)||0
3354678|NCT03649412|4084488|FG000|STARTED|Part B, Washout Period 3 (7 Days)||0
3354679|NCT03649412|4084489|FG001|STARTED|Part B, Washout Period 3 (7 Days)||15
3354680|NCT03649412|4084488|FG000|COMPLETED|Part B, Washout Period 3 (7 Days)||0
3354681|NCT03649412|4084489|FG001|COMPLETED|Part B, Washout Period 3 (7 Days)||15
3354682|NCT03649412|4084488|FG000|NOT COMPLETED|Part B, Washout Period 3 (7 Days)||0
3354683|NCT03649412|4084489|FG001|NOT COMPLETED|Part B, Washout Period 3 (7 Days)||0
3354684|NCT03649412|4084488|FG000|STARTED|Part B, Period 4 (4 Days)||0
3354685|NCT03649412|4084489|FG001|STARTED|Part B, Period 4 (4 Days)||15
3354686|NCT03649412|4084488|FG000|COMPLETED|Part B, Period 4 (4 Days)||0
3354687|NCT03649412|4084489|FG001|COMPLETED|Part B, Period 4 (4 Days)||15
3354688|NCT03649412|4084488|FG000|NOT COMPLETED|Part B, Period 4 (4 Days)||0
3354689|NCT03649412|4084489|FG001|NOT COMPLETED|Part B, Period 4 (4 Days)||0
3354690|NCT03649412|4084488|FG000|STARTED|Part B, Washout Period 4 (7 Days)||0
3354691|NCT03649412|4084489|FG001|STARTED|Part B, Washout Period 4 (7 Days)||15
3354692|NCT03649412|4084488|FG000|COMPLETED|Part B, Washout Period 4 (7 Days)||0
3354693|NCT03649412|4084489|FG001|COMPLETED|Part B, Washout Period 4 (7 Days)||15
3354694|NCT03649412|4084488|FG000|NOT COMPLETED|Part B, Washout Period 4 (7 Days)||0
3354695|NCT03649412|4084489|FG001|NOT COMPLETED|Part B, Washout Period 4 (7 Days)||0
3354696|NCT03649412|4084488|FG000|STARTED|Part B, Period 5 (4 Days)||0
3354697|NCT03649412|4084489|FG001|STARTED|Part B, Period 5 (4 Days)|One participant did not start in Period 5|14
3354698|NCT03649412|4084488|FG000|COMPLETED|Part B, Period 5 (4 Days)||0
3354699|NCT03649412|4084489|FG001|COMPLETED|Part B, Period 5 (4 Days)||14
3354700|NCT03649412|4084488|FG000|NOT COMPLETED|Part B, Period 5 (4 Days)||0
3354701|NCT03649412|4084489|FG001|NOT COMPLETED|Part B, Period 5 (4 Days)||0
3354702|NCT03649412|4084488|FG000|STARTED|Part B, Washout Period 5 (7 Days)||0
3354703|NCT03649412|4084489|FG001|STARTED|Part B, Washout Period 5 (7 Days)||14
3354704|NCT03649412|4084488|FG000|COMPLETED|Part B, Washout Period 5 (7 Days)||0
3354705|NCT03649412|4084489|FG001|COMPLETED|Part B, Washout Period 5 (7 Days)||13
3354706|NCT03649412|4084488|FG000|NOT COMPLETED|Part B, Washout Period 5 (7 Days)||0
3354707|NCT03649412|4084489|FG001|NOT COMPLETED|Part B, Washout Period 5 (7 Days)||1
3354708|NCT03649412|4084488|FG000|STARTED|Part B, Period 6 (4days)||0
3354709|NCT03649412|4084489|FG001|STARTED|Part B, Period 6 (4days)|Participant who did not start Period 5 directly joined into Period 6|14
3354710|NCT03649412|4084488|FG000|COMPLETED|Part B, Period 6 (4days)||0
3354711|NCT03649412|4084489|FG001|COMPLETED|Part B, Period 6 (4days)||14
3354712|NCT03649412|4084488|FG000|NOT COMPLETED|Part B, Period 6 (4days)||0
3354713|NCT03649412|4084489|FG001|NOT COMPLETED|Part B, Period 6 (4days)||0
3354714|NCT03649477|4084535|FG000|STARTED|Overall Study||44
3354715|NCT03649477|4084536|FG001|STARTED|Overall Study||43
3354716|NCT03649477|4084537|FG002|STARTED|Overall Study||43
3354717|NCT03649477|4084535|FG000|COMPLETED|Overall Study||42
3354718|NCT03649477|4084536|FG001|COMPLETED|Overall Study||43
3354719|NCT03649477|4084537|FG002|COMPLETED|Overall Study||43
3354720|NCT03649477|4084535|FG000|NOT COMPLETED|Overall Study||2
3354721|NCT03649477|4084536|FG001|NOT COMPLETED|Overall Study||0
3354722|NCT03649477|4084537|FG002|NOT COMPLETED|Overall Study||0
3354723|NCT03649646|4084545|FG000|STARTED|Overall Study||4542
3354724|NCT03649646|4084545|FG000|COMPLETED|Overall Study||4075
3354725|NCT03649646|4084545|FG000|NOT COMPLETED|Overall Study||467
3354726|NCT03649750|4084549|FG000|STARTED|Period 1||12
3354727|NCT03649750|4084550|FG001|STARTED|Period 1||24
3354728|NCT03649750|4084549|FG000|COMPLETED|Period 1||12
3354729|NCT03649750|4084550|FG001|COMPLETED|Period 1||24
3354730|NCT03649750|4084549|FG000|NOT COMPLETED|Period 1||0
3354731|NCT03649750|4084550|FG001|NOT COMPLETED|Period 1||0
3354732|NCT03649750|4084549|FG000|STARTED|Washout: 7 Days||12
3354733|NCT03649750|4084550|FG001|STARTED|Washout: 7 Days||24
3354734|NCT03649750|4084549|FG000|COMPLETED|Washout: 7 Days||12
3354735|NCT03649750|4084550|FG001|COMPLETED|Washout: 7 Days||24
3354736|NCT03649750|4084549|FG000|NOT COMPLETED|Washout: 7 Days||0
3354737|NCT03649750|4084550|FG001|NOT COMPLETED|Washout: 7 Days||0
3354738|NCT03649750|4084549|FG000|STARTED|Period 2||12
3354739|NCT03649750|4084550|FG001|STARTED|Period 2||24
3354740|NCT03649750|4084549|FG000|COMPLETED|Period 2||12
3354741|NCT03649750|4084550|FG001|COMPLETED|Period 2||24
3354742|NCT03649750|4084549|FG000|NOT COMPLETED|Period 2||0
3354743|NCT03649750|4084550|FG001|NOT COMPLETED|Period 2||0
3354744|NCT03649815|4084557|FG000|STARTED|Overall Study||38
3354745|NCT03649815|4084557|FG000|COMPLETED|Overall Study||38
3354746|NCT03649815|4084557|FG000|NOT COMPLETED|Overall Study||0
3354747|NCT03649867|4084561|FG000|STARTED|Overall Study||13
3354748|NCT03649867|4084561|FG000|COMPLETED|Overall Study||13
3354749|NCT03649867|4084561|FG000|NOT COMPLETED|Overall Study||0
3354750|NCT03649932|4084568|FG000|STARTED|Overall Study||14
3354751|NCT03649932|4084569|FG001|STARTED|Overall Study||14
3354752|NCT03649932|4084570|FG002|STARTED|Overall Study||14
3354753|NCT03649932|4084568|FG000|COMPLETED|Overall Study||14
3354754|NCT03649932|4084569|FG001|COMPLETED|Overall Study||13
3354755|NCT03649932|4084570|FG002|COMPLETED|Overall Study||13
3354756|NCT03649932|4084568|FG000|NOT COMPLETED|Overall Study||0
3354757|NCT03649932|4084569|FG001|NOT COMPLETED|Overall Study||1
3354758|NCT03649932|4084570|FG002|NOT COMPLETED|Overall Study||1
3354759|NCT03650192|4084578|FG000|STARTED|Overall Study||40
3354760|NCT03650192|4084578|FG000|COMPLETED|Overall Study||40
3354761|NCT03650192|4084578|FG000|NOT COMPLETED|Overall Study||0
3354762|NCT03650387|4084582|FG000|STARTED|Overall Study||207
3354763|NCT03650387|4084582|FG000|COMPLETED|Overall Study||173
3354764|NCT03650387|4084582|FG000|NOT COMPLETED|Overall Study||34
3354765|NCT03650400|4084597|FG000|STARTED|Overall Study||6
3354766|NCT03650400|4084598|FG001|STARTED|Overall Study||5
3354767|NCT03650400|4084597|FG000|COMPLETED|Overall Study||6
3354768|NCT03650400|4084598|FG001|COMPLETED|Overall Study||0
3354769|NCT03650400|4084597|FG000|NOT COMPLETED|Overall Study||0
3354770|NCT03650400|4084598|FG001|NOT COMPLETED|Overall Study||5
3354771|NCT03650452|4084606|FG000|STARTED|Overall Study||70
3354772|NCT03650452|4084607|FG001|STARTED|Overall Study||71
3354773|NCT03650452|4084606|FG000|COMPLETED|Overall Study||60
3354774|NCT03650452|4084607|FG001|COMPLETED|Overall Study||66
3354775|NCT03650452|4084606|FG000|NOT COMPLETED|Overall Study||10
3354776|NCT03650452|4084607|FG001|NOT COMPLETED|Overall Study||5
3354777|NCT03650842|4084613|FG000|STARTED|Overall Study||25
3354778|NCT03650842|4084613|FG000|COMPLETED|Overall Study||25
3354779|NCT03650842|4084613|FG000|NOT COMPLETED|Overall Study||0
3354780|NCT03651479|4084619|FG000|STARTED|Overall Study||20
3354781|NCT03651479|4084620|FG001|STARTED|Overall Study||20
3354782|NCT03651479|4084619|FG000|COMPLETED|Overall Study||20
3354783|NCT03651479|4084620|FG001|COMPLETED|Overall Study||20
3354784|NCT03651479|4084619|FG000|NOT COMPLETED|Overall Study||0
3354785|NCT03651479|4084620|FG001|NOT COMPLETED|Overall Study||0
3354786|NCT03651856|4084626|FG000|STARTED|Overall Study||10
3354787|NCT03651856|4084626|FG000|COMPLETED|Overall Study||10
3354788|NCT03651856|4084626|FG000|NOT COMPLETED|Overall Study||0
3354789|NCT03652610|4084632|FG000|STARTED|Overall Study||490
3354790|NCT03652610|4084633|FG001|STARTED|Overall Study||489
3354791|NCT03652610|4084632|FG000|COMPLETED|Overall Study||486
3354792|NCT03652610|4084633|FG001|COMPLETED|Overall Study||484
3354793|NCT03652610|4084632|FG000|NOT COMPLETED|Overall Study||4
3354794|NCT03652610|4084633|FG001|NOT COMPLETED|Overall Study||5
3354795|NCT03652662|4084641|FG000|STARTED|Overall Study||18
3354796|NCT03652662|4084642|FG001|STARTED|Overall Study||16
3354797|NCT03652662|4084641|FG000|COMPLETED|Overall Study||15
3354798|NCT03652662|4084642|FG001|COMPLETED|Overall Study||15
3354799|NCT03652662|4084641|FG000|NOT COMPLETED|Overall Study||3
3354800|NCT03652662|4084642|FG001|NOT COMPLETED|Overall Study||1
3354801|NCT03652675|4084650|FG000|STARTED|Overall Study||16
3354802|NCT03652675|4084651|FG001|STARTED|Overall Study||15
3354803|NCT03652675|4084650|FG000|COMPLETED|Overall Study||12
3354804|NCT03652675|4084651|FG001|COMPLETED|Overall Study||11
3354805|NCT03652675|4084650|FG000|NOT COMPLETED|Overall Study||4
3354806|NCT03652675|4084651|FG001|NOT COMPLETED|Overall Study||4
3354807|NCT03652818|4084662|FG000|STARTED|Overall Study||24
3354808|NCT03652818|4084663|FG001|STARTED|Overall Study||23
3354809|NCT03652818|4084664|FG002|STARTED|Overall Study||22
3354810|NCT03652818|4084665|FG003|STARTED|Overall Study||23
3354811|NCT03652818|4084666|FG004|STARTED|Overall Study||23
3354812|NCT03652818|4084662|FG000|COMPLETED|Overall Study||22
3354813|NCT03652818|4084663|FG001|COMPLETED|Overall Study||22
3354814|NCT03652818|4084664|FG002|COMPLETED|Overall Study||20
3354815|NCT03652818|4084665|FG003|COMPLETED|Overall Study||22
3354816|NCT03652818|4084666|FG004|COMPLETED|Overall Study||22
3354817|NCT03652818|4084662|FG000|NOT COMPLETED|Overall Study||2
3354818|NCT03652818|4084663|FG001|NOT COMPLETED|Overall Study||1
3354819|NCT03652818|4084664|FG002|NOT COMPLETED|Overall Study||2
3354820|NCT03652818|4084665|FG003|NOT COMPLETED|Overall Study||1
3354821|NCT03652818|4084666|FG004|NOT COMPLETED|Overall Study||1
3354822|NCT03653026|4084680|FG000|STARTED|Part 1: Placebo-controlled Period||345
3354823|NCT03653026|4084681|FG001|STARTED|Part 1: Placebo-controlled Period||177
3354824|NCT03653026|4084682|FG002|STARTED|Part 1: Placebo-controlled Period||0
3354825|NCT03653026|4084683|FG003|STARTED|Part 1: Placebo-controlled Period||0
3354826|NCT03653026|4084680|FG000|Received Treatment|Part 1: Placebo-controlled Period||344
3354827|NCT03653026|4084681|FG001|Received Treatment|Part 1: Placebo-controlled Period||177
3354828|NCT03653026|4084682|FG002|Received Treatment|Part 1: Placebo-controlled Period||0
3354829|NCT03653026|4084683|FG003|Received Treatment|Part 1: Placebo-controlled Period||0
3354830|NCT03653026|4084680|FG000|COMPLETED|Part 1: Placebo-controlled Period||334
3354831|NCT03653026|4084681|FG001|COMPLETED|Part 1: Placebo-controlled Period||164
3354832|NCT03653026|4084682|FG002|COMPLETED|Part 1: Placebo-controlled Period||0
3354833|NCT03653026|4084683|FG003|COMPLETED|Part 1: Placebo-controlled Period||0
3354834|NCT03653026|4084680|FG000|NOT COMPLETED|Part 1: Placebo-controlled Period||11
3354835|NCT03653026|4084681|FG001|NOT COMPLETED|Part 1: Placebo-controlled Period||13
3354836|NCT03653026|4084682|FG002|NOT COMPLETED|Part 1: Placebo-controlled Period||0
3354837|NCT03653026|4084683|FG003|NOT COMPLETED|Part 1: Placebo-controlled Period||0
3354838|NCT03653026|4084680|FG000|STARTED|Part 2: Open-label Extension||0
3354839|NCT03653026|4084681|FG001|STARTED|Part 2: Open-label Extension||0
3354840|NCT03653026|4084682|FG002|STARTED|Part 2: Open-label Extension||68
3354841|NCT03653026|4084683|FG003|STARTED|Part 2: Open-label Extension||116
3354842|NCT03653026|4084680|FG000|COMPLETED|Part 2: Open-label Extension||0
3354843|NCT03653026|4084681|FG001|COMPLETED|Part 2: Open-label Extension||0
3354844|NCT03653026|4084682|FG002|COMPLETED|Part 2: Open-label Extension||65
3354845|NCT03653026|4084683|FG003|COMPLETED|Part 2: Open-label Extension||111
3354846|NCT03653026|4084680|FG000|NOT COMPLETED|Part 2: Open-label Extension||0
3354847|NCT03653026|4084681|FG001|NOT COMPLETED|Part 2: Open-label Extension||0
3354848|NCT03653026|4084682|FG002|NOT COMPLETED|Part 2: Open-label Extension||3
3354849|NCT03653026|4084683|FG003|NOT COMPLETED|Part 2: Open-label Extension||5
3354850|NCT03653208|4084700|FG000|STARTED|Overall Study||3
3354851|NCT03653208|4084701|FG001|STARTED|Overall Study||3
3354852|NCT03653208|4084702|FG002|STARTED|Overall Study||6
3354853|NCT03653208|4084703|FG003|STARTED|Overall Study||6
3354854|NCT03653208|4084704|FG004|STARTED|Overall Study||6
3354855|NCT03653208|4084705|FG005|STARTED|Overall Study||6
3354856|NCT03653208|4084706|FG006|STARTED|Overall Study||6
3354857|NCT03653208|4084707|FG007|STARTED|Overall Study||6
3354858|NCT03653208|4084708|FG008|STARTED|Overall Study||14
3354859|NCT03653208|4084700|FG000|COMPLETED|Overall Study||3
3354860|NCT03653208|4084701|FG001|COMPLETED|Overall Study||3
3354861|NCT03653208|4084702|FG002|COMPLETED|Overall Study||6
3354862|NCT03653208|4084703|FG003|COMPLETED|Overall Study||6
3354863|NCT03653208|4084704|FG004|COMPLETED|Overall Study||5
3354864|NCT03653208|4084705|FG005|COMPLETED|Overall Study||6
3354865|NCT03653208|4084706|FG006|COMPLETED|Overall Study||6
3354866|NCT03653208|4084707|FG007|COMPLETED|Overall Study||5
3354867|NCT03653208|4084708|FG008|COMPLETED|Overall Study||13
3354868|NCT03653208|4084700|FG000|NOT COMPLETED|Overall Study||0
3354869|NCT03653208|4084701|FG001|NOT COMPLETED|Overall Study||0
3354870|NCT03653208|4084702|FG002|NOT COMPLETED|Overall Study||0
3354871|NCT03653208|4084703|FG003|NOT COMPLETED|Overall Study||0
3354872|NCT03653208|4084704|FG004|NOT COMPLETED|Overall Study||1
3354873|NCT03653208|4084705|FG005|NOT COMPLETED|Overall Study||0
3354874|NCT03653208|4084706|FG006|NOT COMPLETED|Overall Study||0
3178922|NCT01981616|3907075|FG001|NOT COMPLETED|Overall Study||1
3178923|NCT01981759|3907083|FG000|STARTED|Overall Study||28
3178924|NCT01981759|3907084|FG001|STARTED|Overall Study||30
3178925|NCT01981759|3907083|FG000|Baseline (Week 1)|Overall Study||28
3178926|NCT01981759|3907084|FG001|Baseline (Week 1)|Overall Study||30
3178927|NCT01981759|3907083|FG000|Randomization (Week 3)|Overall Study||28
3178928|NCT01981759|3907084|FG001|Randomization (Week 3)|Overall Study||30
3178929|NCT01981759|3907083|FG000|Completed Week 12|Overall Study||22
3178930|NCT01981759|3907084|FG001|Completed Week 12|Overall Study||22
3178931|NCT01981759|3907083|FG000|COMPLETED|Overall Study||21
3178932|NCT01981759|3907084|FG001|COMPLETED|Overall Study||19
3178933|NCT01981759|3907083|FG000|NOT COMPLETED|Overall Study||7
3178934|NCT01981759|3907084|FG001|NOT COMPLETED|Overall Study||11
3178935|NCT01981772|3907092|FG000|STARTED|Overall Study||45
3178936|NCT01981772|3907093|FG001|STARTED|Overall Study||43
3354875|NCT03653208|4084707|FG007|NOT COMPLETED|Overall Study||1
3354876|NCT03653208|4084708|FG008|NOT COMPLETED|Overall Study||1
3354877|NCT03653351|4084730|FG000|STARTED|Overall Study||14
3354878|NCT03653351|4084731|FG001|STARTED|Overall Study||12
3354879|NCT03653351|4084730|FG000|COMPLETED|Overall Study||13
3354880|NCT03653351|4084731|FG001|COMPLETED|Overall Study||10
3354881|NCT03653351|4084730|FG000|NOT COMPLETED|Overall Study||1
3354882|NCT03653351|4084731|FG001|NOT COMPLETED|Overall Study||2
3354883|NCT03653416|4084739|FG000|STARTED|Overall Study||52
3354884|NCT03653416|4084740|FG001|STARTED|Overall Study||47
3354885|NCT03653416|4084739|FG000|COMPLETED|Overall Study||46
3354886|NCT03653416|4084740|FG001|COMPLETED|Overall Study||46
3354887|NCT03653416|4084739|FG000|NOT COMPLETED|Overall Study||6
3354888|NCT03653416|4084740|FG001|NOT COMPLETED|Overall Study||1
3354889|NCT03653429|4084748|FG000|STARTED|Overall Study||49
3354890|NCT03653429|4084749|FG001|STARTED|Overall Study||51
3354891|NCT03653429|4084748|FG000|COMPLETED|Overall Study||45
3354892|NCT03653429|4084749|FG001|COMPLETED|Overall Study||41
3354893|NCT03653429|4084748|FG000|NOT COMPLETED|Overall Study||4
3178937|NCT01981772|3907092|FG000|COMPLETED|Overall Study||45
3178938|NCT01981772|3907093|FG001|COMPLETED|Overall Study||43
3178939|NCT01981772|3907092|FG000|NOT COMPLETED|Overall Study||0
3178940|NCT01981772|3907093|FG001|NOT COMPLETED|Overall Study||0
3178941|NCT01981863|3907101|FG000|STARTED|Overall Study||20
3178942|NCT01981863|3907102|FG001|STARTED|Overall Study||20
3354894|NCT03653429|4084749|FG001|NOT COMPLETED|Overall Study||10
3354895|NCT03654326|4084757|FG000|STARTED|Overall Study||94
3354896|NCT03654326|4084758|FG001|STARTED|Overall Study||93
3354897|NCT03654326|4084757|FG000|COMPLETED|Overall Study||88
3354898|NCT03654326|4084758|FG001|COMPLETED|Overall Study||87
3354899|NCT03654326|4084757|FG000|NOT COMPLETED|Overall Study||6
3354900|NCT03654326|4084758|FG001|NOT COMPLETED|Overall Study||6
3354901|NCT03654417|4084766|FG000|STARTED|Overall Study||19
3354902|NCT03654417|4084767|FG001|STARTED|Overall Study||18
3354903|NCT03654417|4084766|FG000|COMPLETED|Overall Study||19
3354904|NCT03654417|4084767|FG001|COMPLETED|Overall Study||18
3354905|NCT03654417|4084766|FG000|NOT COMPLETED|Overall Study||0
3354906|NCT03654417|4084767|FG001|NOT COMPLETED|Overall Study||0
3354907|NCT03654560|4084775|FG000|STARTED|Overall Study||118
3354908|NCT03654560|4084776|FG001|STARTED|Overall Study||118
3354909|NCT03654560|4084775|FG000|COMPLETED|Overall Study||114
3354910|NCT03654560|4084776|FG001|COMPLETED|Overall Study||117
3354911|NCT03654560|4084775|FG000|NOT COMPLETED|Overall Study||4
3354912|NCT03654560|4084776|FG001|NOT COMPLETED|Overall Study||1
3354913|NCT03655054|4084782|FG000|STARTED|Overall Study||23
3354914|NCT03655054|4084782|FG000|COMPLETED|Overall Study||22
3354915|NCT03655054|4084782|FG000|NOT COMPLETED|Overall Study||1
3178943|NCT01981863|3907101|FG000|COMPLETED|Overall Study||20
3178944|NCT01981863|3907102|FG001|COMPLETED|Overall Study||20
3178945|NCT01981863|3907101|FG000|NOT COMPLETED|Overall Study||0
3354916|NCT03655080|4084786|FG000|STARTED|Overall Study||2
3354917|NCT03655080|4084786|FG000|COMPLETED|Overall Study||2
3354918|NCT03655080|4084786|FG000|NOT COMPLETED|Overall Study||0
3354919|NCT03655106|4084792|FG000|STARTED|Overall Study||135
3354920|NCT03655106|4084793|FG001|STARTED|Overall Study||135
3354921|NCT03655106|4084792|FG000|COMPLETED|Overall Study||126
3354922|NCT03655106|4084793|FG001|COMPLETED|Overall Study||131
3354923|NCT03655106|4084792|FG000|NOT COMPLETED|Overall Study||9
3354924|NCT03655106|4084793|FG001|NOT COMPLETED|Overall Study||4
3354925|NCT03655301|4084799|FG000|STARTED|Overall Study||13
3354926|NCT03655301|4084799|FG000|COMPLETED|Overall Study||13
3354927|NCT03655301|4084799|FG000|NOT COMPLETED|Overall Study||0
3354928|NCT03655405|4084805|FG000|STARTED|Overall Study||32
3354929|NCT03655405|4084806|FG001|STARTED|Overall Study||30
3354930|NCT03655405|4084805|FG000|COMPLETED|Overall Study||27
3354931|NCT03655405|4084806|FG001|COMPLETED|Overall Study||25
3354932|NCT03655405|4084805|FG000|NOT COMPLETED|Overall Study||5
3354933|NCT03655405|4084806|FG001|NOT COMPLETED|Overall Study||5
3354934|NCT03655444|4084814|FG000|STARTED|Overall Study||3
3354935|NCT03655444|4084815|FG001|STARTED|Overall Study||3
3354936|NCT03655444|4084814|FG000|COMPLETED|Overall Study||3
3178946|NCT01981863|3907102|FG001|NOT COMPLETED|Overall Study||0
3178947|NCT01981954|3907108|FG000|STARTED|Titration Period||23
3178948|NCT01981954|3907108|FG000|Treated|Titration Period||23
3178949|NCT01981954|3907108|FG000|COMPLETED|Titration Period||22
3178950|NCT01981954|3907108|FG000|NOT COMPLETED|Titration Period||1
3178951|NCT01981954|3907108|FG000|STARTED|Fixed-Dose Assessment Period||22
3354937|NCT03655444|4084815|FG001|COMPLETED|Overall Study||3
3354938|NCT03655444|4084814|FG000|NOT COMPLETED|Overall Study||0
3354939|NCT03655444|4084815|FG001|NOT COMPLETED|Overall Study||0
3354940|NCT03655951|4084823|FG000|STARTED|Overall Study||358
3354941|NCT03655951|4084824|FG001|STARTED|Overall Study||372
3354942|NCT03655951|4084823|FG000|Completed Pretest|Overall Study||344
3354943|NCT03655951|4084824|FG001|Completed Pretest|Overall Study||366
3354944|NCT03655951|4084823|FG000|COMPLETED|Overall Study||319
3354945|NCT03655951|4084824|FG001|COMPLETED|Overall Study||351
3354946|NCT03655951|4084823|FG000|NOT COMPLETED|Overall Study||39
3354947|NCT03655951|4084824|FG001|NOT COMPLETED|Overall Study||21
3354948|NCT03656939|4084830|FG000|STARTED|Overall Study||21240
3354949|NCT03656939|4084830|FG000|Main Study Cohort|Overall Study||21240
3354950|NCT03656939|4084830|FG000|Main Study Cohort: Participants Who Received Dose 1|Overall Study||20318
3354951|NCT03656939|4084830|FG000|Main Study Cohort: Participants Who Received Dose 2|Overall Study||19387
3354952|NCT03656939|4084830|FG000|Main Study Cohort: Participants Who Received Dose 3|Overall Study||18415
3354953|NCT03656939|4084830|FG000|Main Study Cohort: Participants Who Received Dose 4|Overall Study||12944
3354954|NCT03656939|4084830|FG000|Prospective Study Cohort|Overall Study||2300
3354955|NCT03656939|4084830|FG000|Prospective Study Cohort: Participants Who Received Dose 1|Overall Study||2300
3354956|NCT03656939|4084830|FG000|Prospective Study Cohort: Participants Who Received Dose 2|Overall Study||2203
3354957|NCT03656939|4084830|FG000|Prospective Study Cohort: Participants Who Received Dose 3|Overall Study||2047
3354958|NCT03656939|4084830|FG000|Prospective Study Cohort: Participants Who Received Dose 4|Overall Study||1291
3354959|NCT03656939|4084830|FG000|COMPLETED|Overall Study||21240
3354960|NCT03656939|4084830|FG000|NOT COMPLETED|Overall Study||0
3354961|NCT03657095|4084838|FG000|STARTED|Overall Study||59
3354962|NCT03657095|4084839|FG001|STARTED|Overall Study||53
3354963|NCT03657095|4084838|FG000|Received at Least 1 Dose of Study Drug|Overall Study||59
3354964|NCT03657095|4084839|FG001|Received at Least 1 Dose of Study Drug|Overall Study||53
3354965|NCT03657095|4084838|FG000|COMPLETED|Overall Study||0
3354966|NCT03657095|4084839|FG001|COMPLETED|Overall Study||0
3178952|NCT01981954|3907108|FG000|Treated|Fixed-Dose Assessment Period||22
3178953|NCT01981954|3907108|FG000|COMPLETED|Fixed-Dose Assessment Period||21
3178954|NCT01981954|3907108|FG000|NOT COMPLETED|Fixed-Dose Assessment Period||1
3178955|NCT01981967|3907114|FG000|STARTED|Overall Study||6851
3354967|NCT03657095|4084838|FG000|NOT COMPLETED|Overall Study||59
3354968|NCT03657095|4084839|FG001|NOT COMPLETED|Overall Study||53
3354969|NCT03657134|4084845|FG000|STARTED|Overall Study||20
3354970|NCT03657134|4084845|FG000|COMPLETED|Overall Study||20
3354971|NCT03657134|4084845|FG000|NOT COMPLETED|Overall Study||0
3354972|NCT03657264|4084854|FG000|STARTED|Overall Study||12
3354973|NCT03657264|4084855|FG001|STARTED|Overall Study||12
3354974|NCT03657264|4084856|FG002|STARTED|Overall Study||12
3354975|NCT03657264|4084857|FG003|STARTED|Overall Study||12
3354976|NCT03657264|4084854|FG000|COMPLETED|Overall Study||12
3354977|NCT03657264|4084855|FG001|COMPLETED|Overall Study||12
3354978|NCT03657264|4084856|FG002|COMPLETED|Overall Study||12
3354979|NCT03657264|4084857|FG003|COMPLETED|Overall Study||12
3354980|NCT03657264|4084854|FG000|NOT COMPLETED|Overall Study||0
3354981|NCT03657264|4084855|FG001|NOT COMPLETED|Overall Study||0
3354982|NCT03657264|4084856|FG002|NOT COMPLETED|Overall Study||0
3354983|NCT03657264|4084857|FG003|NOT COMPLETED|Overall Study||0
3354984|NCT03657277|4084868|FG000|STARTED|Overall Study||46
3354985|NCT03657277|4084868|FG000|COMPLETED|Overall Study||35
3354986|NCT03657277|4084868|FG000|NOT COMPLETED|Overall Study||11
3354987|NCT03657407|4084874|FG000|STARTED|Overall Study||29
3354988|NCT03657407|4084875|FG001|STARTED|Overall Study||27
3354989|NCT03657407|4084874|FG000|COMPLETED|Overall Study||29
3354990|NCT03657407|4084875|FG001|COMPLETED|Overall Study||27
3354991|NCT03657407|4084874|FG000|NOT COMPLETED|Overall Study||0
3354992|NCT03657407|4084875|FG001|NOT COMPLETED|Overall Study||0
3354993|NCT03658811|4084881|FG000|STARTED|Overall Study||19
3354994|NCT03658811|4084881|FG000|COMPLETED|Overall Study||16
3354995|NCT03658811|4084881|FG000|NOT COMPLETED|Overall Study||3
3354996|NCT03658876|4084887|FG000|STARTED|Overall Study||88
3354997|NCT03658876|4084888|FG001|STARTED|Overall Study||96
3354998|NCT03658876|4084887|FG000|COMPLETED|Overall Study||76
3354999|NCT03658876|4084888|FG001|COMPLETED|Overall Study||84
3355000|NCT03658876|4084887|FG000|NOT COMPLETED|Overall Study||12
3355001|NCT03658876|4084888|FG001|NOT COMPLETED|Overall Study||12
3355002|NCT03658889|4084896|FG000|STARTED|Overall Study|Enrolled population|308
3355003|NCT03658889|4084897|FG001|STARTED|Overall Study||69
3355004|NCT03658889|4084896|FG000|COMPLETED|Overall Study|Analysis population|306
3355005|NCT03658889|4084897|FG001|COMPLETED|Overall Study||69
3355006|NCT03658889|4084896|FG000|NOT COMPLETED|Overall Study||2
3355007|NCT03658889|4084897|FG001|NOT COMPLETED|Overall Study||0
3355008|NCT03660241|4084905|FG000|STARTED|Overall Study||8
3355009|NCT03660241|4084906|FG001|STARTED|Overall Study||7
3355010|NCT03660241|4084907|FG002|STARTED|Overall Study||8
3355011|NCT03660241|4084905|FG000|COMPLETED|Overall Study||8
3355012|NCT03660241|4084906|FG001|COMPLETED|Overall Study||7
3355013|NCT03660241|4084907|FG002|COMPLETED|Overall Study||8
3355014|NCT03660241|4084905|FG000|NOT COMPLETED|Overall Study||0
3355015|NCT03660241|4084906|FG001|NOT COMPLETED|Overall Study||0
3355016|NCT03660241|4084907|FG002|NOT COMPLETED|Overall Study||0
3355017|NCT03660787|4084919|FG000|STARTED|Overall Study||26
3355018|NCT03660787|4084920|FG001|STARTED|Overall Study||26
3355019|NCT03660787|4084921|FG002|STARTED|Overall Study||26
3355020|NCT03660787|4084922|FG003|STARTED|Overall Study||26
3355021|NCT03660787|4084919|FG000|COMPLETED|Overall Study||25
3355022|NCT03660787|4084920|FG001|COMPLETED|Overall Study||25
3355023|NCT03660787|4084921|FG002|COMPLETED|Overall Study||25
3355024|NCT03660787|4084922|FG003|COMPLETED|Overall Study||26
3355025|NCT03660787|4084919|FG000|NOT COMPLETED|Overall Study||1
3355026|NCT03660787|4084920|FG001|NOT COMPLETED|Overall Study||1
3355027|NCT03660787|4084921|FG002|NOT COMPLETED|Overall Study||1
3355028|NCT03660787|4084922|FG003|NOT COMPLETED|Overall Study||0
3355029|NCT03660839|4084936|FG000|STARTED|Overall Study||35
3355030|NCT03660839|4084937|FG001|STARTED|Overall Study||36
3355031|NCT03660839|4084938|FG002|STARTED|Overall Study||36
3355032|NCT03660839|4084939|FG003|STARTED|Overall Study||33
3355033|NCT03660839|4084936|FG000|COMPLETED|Overall Study||35
3355034|NCT03660839|4084937|FG001|COMPLETED|Overall Study||36
3355035|NCT03660839|4084938|FG002|COMPLETED|Overall Study||36
3355036|NCT03660839|4084939|FG003|COMPLETED|Overall Study||33
3355037|NCT03660839|4084936|FG000|NOT COMPLETED|Overall Study||0
3355038|NCT03660839|4084937|FG001|NOT COMPLETED|Overall Study||0
3355039|NCT03660839|4084938|FG002|NOT COMPLETED|Overall Study||0
3355040|NCT03660839|4084939|FG003|NOT COMPLETED|Overall Study||0
3355041|NCT03661346|4084954|FG000|STARTED|Overall Study|Esmolol administration|13
3355042|NCT03661346|4084955|FG001|STARTED|Overall Study||15
3355043|NCT03661346|4084954|FG000|COMPLETED|Overall Study||13
3355044|NCT03661346|4084955|FG001|COMPLETED|Overall Study||15
3355045|NCT03661346|4084954|FG000|NOT COMPLETED|Overall Study||0
3355046|NCT03661346|4084955|FG001|NOT COMPLETED|Overall Study||0
3355047|NCT03661541|4084964|FG000|STARTED|Overall Study||12
3355048|NCT03661541|4084965|FG001|STARTED|Overall Study||12
3355049|NCT03661541|4084966|FG002|STARTED|Overall Study||12
3355050|NCT03661541|4084964|FG000|COMPLETED|Overall Study||10
3355051|NCT03661541|4084965|FG001|COMPLETED|Overall Study||10
3355052|NCT03661541|4084966|FG002|COMPLETED|Overall Study||10
3355053|NCT03661541|4084964|FG000|NOT COMPLETED|Overall Study||2
3355054|NCT03661541|4084965|FG001|NOT COMPLETED|Overall Study||2
3355055|NCT03661541|4084966|FG002|NOT COMPLETED|Overall Study||2
3355056|NCT03661697|4084980|FG000|STARTED|Overall Study||7
3355057|NCT03661697|4084981|FG001|STARTED|Overall Study||7
3355058|NCT03661697|4084980|FG000|COMPLETED|Overall Study||7
3355059|NCT03661697|4084981|FG001|COMPLETED|Overall Study||7
3355060|NCT03661697|4084980|FG000|NOT COMPLETED|Overall Study||0
3355061|NCT03661697|4084981|FG001|NOT COMPLETED|Overall Study||0
3355062|NCT03661762|4084987|FG000|STARTED|Overall Study||18
3355063|NCT03661762|4084987|FG000|COMPLETED|Overall Study||10
3355064|NCT03661762|4084987|FG000|NOT COMPLETED|Overall Study||8
3355065|NCT03661814|4084994|FG000|STARTED|Overall Study||2
3355066|NCT03661814|4084995|FG001|STARTED|Overall Study||5
3355067|NCT03661814|4084994|FG000|COMPLETED|Overall Study||2
3355068|NCT03661814|4084995|FG001|COMPLETED|Overall Study||5
3137063|NCT01716585|3862319|FG001|Randomized But Not Treated|Double-blind Treatment||1
3137064|NCT01716585|3862318|FG000|COMPLETED|Double-blind Treatment|The number of participants who completed double-blind study drug.|464
3137065|NCT01716585|3862319|FG001|COMPLETED|Double-blind Treatment|The number of participants who completed double-blind study drug.|157
3137066|NCT01716585|3862318|FG000|NOT COMPLETED|Double-blind Treatment||13
3137067|NCT01716585|3862319|FG001|NOT COMPLETED|Double-blind Treatment||2
3137068|NCT01716585|3862318|FG000|STARTED|Open-label Treatment|not applicable to this arm|0
3137069|NCT01716585|3862319|FG001|STARTED|Open-label Treatment||157
3178956|NCT01981967|3907115|FG001|STARTED|Overall Study||3149
3355069|NCT03661814|4084994|FG000|NOT COMPLETED|Overall Study||0
3355070|NCT03661814|4084995|FG001|NOT COMPLETED|Overall Study||0
3355071|NCT03661983|4085001|FG000|STARTED|Open Label Stabilization Phase||36
3355072|NCT03661983|4085002|FG001|STARTED|Open Label Stabilization Phase||0
3355073|NCT03661983|4085003|FG002|STARTED|Open Label Stabilization Phase||0
3355074|NCT03661983|4085004|FG003|STARTED|Open Label Stabilization Phase||0
3355075|NCT03661983|4085001|FG000|COMPLETED|Open Label Stabilization Phase||25
3355076|NCT03661983|4085002|FG001|COMPLETED|Open Label Stabilization Phase||0
3355077|NCT03661983|4085003|FG002|COMPLETED|Open Label Stabilization Phase||0
3355078|NCT03661983|4085004|FG003|COMPLETED|Open Label Stabilization Phase||0
3355079|NCT03661983|4085001|FG000|NOT COMPLETED|Open Label Stabilization Phase||11
3355080|NCT03661983|4085002|FG001|NOT COMPLETED|Open Label Stabilization Phase||0
3355081|NCT03661983|4085003|FG002|NOT COMPLETED|Open Label Stabilization Phase||0
3355082|NCT03661983|4085004|FG003|NOT COMPLETED|Open Label Stabilization Phase||0
3355083|NCT03661983|4085001|FG000|STARTED|Double-blind Randomized Phase||0
3355084|NCT03661983|4085002|FG001|STARTED|Double-blind Randomized Phase||9
3355085|NCT03661983|4085003|FG002|STARTED|Double-blind Randomized Phase||8
3355086|NCT03661983|4085004|FG003|STARTED|Double-blind Randomized Phase||8
3355087|NCT03661983|4085001|FG000|COMPLETED|Double-blind Randomized Phase||0
3355088|NCT03661983|4085002|FG001|COMPLETED|Double-blind Randomized Phase||7
3355089|NCT03661983|4085003|FG002|COMPLETED|Double-blind Randomized Phase||7
3355090|NCT03661983|4085004|FG003|COMPLETED|Double-blind Randomized Phase||0
3355091|NCT03661983|4085001|FG000|NOT COMPLETED|Double-blind Randomized Phase||0
3355092|NCT03661983|4085002|FG001|NOT COMPLETED|Double-blind Randomized Phase||2
3355093|NCT03661983|4085003|FG002|NOT COMPLETED|Double-blind Randomized Phase||1
3355094|NCT03661983|4085004|FG003|NOT COMPLETED|Double-blind Randomized Phase||8
3355095|NCT03662074|4085013|FG000|STARTED|Overall Study||14
3355096|NCT03662074|4085013|FG000|COMPLETED|Overall Study||14
3355097|NCT03662074|4085013|FG000|NOT COMPLETED|Overall Study||0
3355098|NCT03662139|4085019|FG000|STARTED|Overall Study||16
3355099|NCT03662139|4085020|FG001|STARTED|Overall Study||16
3355100|NCT03662139|4085019|FG000|COMPLETED|Overall Study||16
3355101|NCT03662139|4085020|FG001|COMPLETED|Overall Study||16
3355102|NCT03662139|4085019|FG000|NOT COMPLETED|Overall Study||0
3355103|NCT03662139|4085020|FG001|NOT COMPLETED|Overall Study||0
3355104|NCT03662282|4085028|FG000|STARTED|Overall Study||2
3355105|NCT03662282|4085028|FG000|COMPLETED|Overall Study||2
3355106|NCT03662282|4085028|FG000|NOT COMPLETED|Overall Study||0
3355107|NCT03662334|4085034|FG000|STARTED|Part 1: Treatment Period 1||0
3355108|NCT03662334|4085035|FG001|STARTED|Part 1: Treatment Period 1||0
3355109|NCT03662334|4085034|FG000|COMPLETED|Part 1: Treatment Period 1||0
3355110|NCT03662334|4085035|FG001|COMPLETED|Part 1: Treatment Period 1||0
3355111|NCT03662334|4085034|FG000|NOT COMPLETED|Part 1: Treatment Period 1||0
3355112|NCT03662334|4085035|FG001|NOT COMPLETED|Part 1: Treatment Period 1||0
3355113|NCT03662334|4085034|FG000|STARTED|Part 1: Treatment Period 2||0
3355114|NCT03662334|4085035|FG001|STARTED|Part 1: Treatment Period 2||0
3355115|NCT03662334|4085034|FG000|COMPLETED|Part 1: Treatment Period 2||0
3355116|NCT03662334|4085035|FG001|COMPLETED|Part 1: Treatment Period 2||0
3355117|NCT03662334|4085034|FG000|NOT COMPLETED|Part 1: Treatment Period 2||0
3355118|NCT03662334|4085035|FG001|NOT COMPLETED|Part 1: Treatment Period 2||0
3355119|NCT03662334|4085034|FG000|STARTED|Part 2: Treatment Period 1 (2 Days)|Part 1 of the study was not conducted. Participants were enrolled starting with Part 2.|7
3355120|NCT03662334|4085035|FG001|STARTED|Part 2: Treatment Period 1 (2 Days)|Part 1 of the study was not conducted. Participants were enrolled starting with Part 2.|7
3355121|NCT03662334|4085034|FG000|COMPLETED|Part 2: Treatment Period 1 (2 Days)||7
3355122|NCT03662334|4085035|FG001|COMPLETED|Part 2: Treatment Period 1 (2 Days)||7
3355123|NCT03662334|4085034|FG000|NOT COMPLETED|Part 2: Treatment Period 1 (2 Days)||0
3355124|NCT03662334|4085035|FG001|NOT COMPLETED|Part 2: Treatment Period 1 (2 Days)||0
3355125|NCT03662334|4085034|FG000|STARTED|Part 2: Treatment Period 2 (2 Days)||7
3355126|NCT03662334|4085035|FG001|STARTED|Part 2: Treatment Period 2 (2 Days)||7
3355127|NCT03662334|4085034|FG000|COMPLETED|Part 2: Treatment Period 2 (2 Days)||6
3355128|NCT03662334|4085035|FG001|COMPLETED|Part 2: Treatment Period 2 (2 Days)||7
3355129|NCT03662334|4085034|FG000|NOT COMPLETED|Part 2: Treatment Period 2 (2 Days)||1
3355130|NCT03662334|4085035|FG001|NOT COMPLETED|Part 2: Treatment Period 2 (2 Days)||0
3355131|NCT03662334|4085034|FG000|STARTED|Part 3: Treatment Period 1|Part 3 of the study was not conducted. No participants were enrolled in this part of the study.|0
3355132|NCT03662334|4085035|FG001|STARTED|Part 3: Treatment Period 1|Part 3 of the study was not conducted. No participants were enrolled in this part of the study.|0
3355133|NCT03662334|4085034|FG000|COMPLETED|Part 3: Treatment Period 1||0
3355134|NCT03662334|4085035|FG001|COMPLETED|Part 3: Treatment Period 1||0
3355135|NCT03662334|4085034|FG000|NOT COMPLETED|Part 3: Treatment Period 1||0
3355136|NCT03662334|4085035|FG001|NOT COMPLETED|Part 3: Treatment Period 1||0
3355137|NCT03662334|4085034|FG000|STARTED|Part 3: Treatment Period 2||0
3355138|NCT03662334|4085035|FG001|STARTED|Part 3: Treatment Period 2||0
3355139|NCT03662334|4085034|FG000|COMPLETED|Part 3: Treatment Period 2||0
3355140|NCT03662334|4085035|FG001|COMPLETED|Part 3: Treatment Period 2||0
3355141|NCT03662334|4085034|FG000|NOT COMPLETED|Part 3: Treatment Period 2||0
3355142|NCT03662334|4085035|FG001|NOT COMPLETED|Part 3: Treatment Period 2||0
3355143|NCT03662360|4085043|FG000|STARTED|Overall Study||16
3355144|NCT03662360|4085044|FG001|STARTED|Overall Study||16
3355145|NCT03662360|4085043|FG000|COMPLETED|Overall Study||16
3355146|NCT03662360|4085044|FG001|COMPLETED|Overall Study||14
3355147|NCT03662360|4085043|FG000|NOT COMPLETED|Overall Study||0
3355148|NCT03662360|4085044|FG001|NOT COMPLETED|Overall Study||2
3355149|NCT03662750|4085051|FG000|STARTED|Overall Study||3
3355150|NCT03662750|4085051|FG000|COMPLETED|Overall Study||2
3355151|NCT03662750|4085051|FG000|NOT COMPLETED|Overall Study||1
3355152|NCT03662789|4085057|FG000|STARTED|Overall Study|Baseline|52
3355153|NCT03662789|4085058|FG001|STARTED|Overall Study|Baseline|50
3355154|NCT03662789|4085057|FG000|COMPLETED|Overall Study|Follow-up at 6 months|47
3355155|NCT03662789|4085058|FG001|COMPLETED|Overall Study|Follow-up at 6 months|43
3355156|NCT03662789|4085057|FG000|NOT COMPLETED|Overall Study||5
3355157|NCT03662789|4085058|FG001|NOT COMPLETED|Overall Study||7
3355158|NCT03662997|4085068|FG000|STARTED|Overall Study||11
3355159|NCT03662997|4085069|FG001|STARTED|Overall Study||10
3355160|NCT03662997|4085070|FG002|STARTED|Overall Study||11
3355161|NCT03662997|4085071|FG003|STARTED|Overall Study||8
3355162|NCT03662997|4085068|FG000|COMPLETED|Overall Study||11
3355163|NCT03662997|4085069|FG001|COMPLETED|Overall Study||8
3355164|NCT03662997|4085070|FG002|COMPLETED|Overall Study||11
3355165|NCT03662997|4085071|FG003|COMPLETED|Overall Study||8
3355166|NCT03662997|4085068|FG000|NOT COMPLETED|Overall Study||0
3355167|NCT03662997|4085069|FG001|NOT COMPLETED|Overall Study||2
3355168|NCT03662997|4085070|FG002|NOT COMPLETED|Overall Study||0
3355169|NCT03662997|4085071|FG003|NOT COMPLETED|Overall Study||0
3355170|NCT03663101|4085087|FG000|STARTED|Overall Study||4
3355171|NCT03663101|4085088|FG001|STARTED|Overall Study||3
3355172|NCT03663101|4085089|FG002|STARTED|Overall Study||5
3355173|NCT03663101|4085090|FG003|STARTED|Overall Study||4
3355174|NCT03663101|4085087|FG000|COMPLETED|Overall Study||4
3355175|NCT03663101|4085088|FG001|COMPLETED|Overall Study||3
3355176|NCT03663101|4085089|FG002|COMPLETED|Overall Study||5
3355177|NCT03663101|4085090|FG003|COMPLETED|Overall Study||4
3355178|NCT03663101|4085087|FG000|NOT COMPLETED|Overall Study||0
3355179|NCT03663101|4085088|FG001|NOT COMPLETED|Overall Study||0
3355180|NCT03663101|4085089|FG002|NOT COMPLETED|Overall Study||0
3355181|NCT03663101|4085090|FG003|NOT COMPLETED|Overall Study||0
3355182|NCT03663179|4085102|FG000|STARTED|Overall Study||18
3355183|NCT03663179|4085103|FG001|STARTED|Overall Study||14
3355184|NCT03663179|4085102|FG000|COMPLETED|Overall Study||14
3355185|NCT03663179|4085103|FG001|COMPLETED|Overall Study||13
3355186|NCT03663179|4085102|FG000|NOT COMPLETED|Overall Study||4
3355187|NCT03663179|4085103|FG001|NOT COMPLETED|Overall Study||1
3355188|NCT03663231|4085111|FG000|STARTED|First Intervention||16
3355189|NCT03663231|4085112|FG001|STARTED|First Intervention||13
3355190|NCT03663231|4085111|FG000|COMPLETED|First Intervention||14
3355191|NCT03663231|4085112|FG001|COMPLETED|First Intervention||12
3355192|NCT03663231|4085111|FG000|NOT COMPLETED|First Intervention||2
3355193|NCT03663231|4085112|FG001|NOT COMPLETED|First Intervention||1
3355194|NCT03663231|4085111|FG000|STARTED|Washout||14
3355195|NCT03663231|4085112|FG001|STARTED|Washout||12
3178957|NCT01981967|3907114|FG000|COMPLETED|Overall Study||6851
3178958|NCT01981967|3907115|FG001|COMPLETED|Overall Study||3149
3178959|NCT01981967|3907114|FG000|NOT COMPLETED|Overall Study||0
3178960|NCT01981967|3907115|FG001|NOT COMPLETED|Overall Study||0
3178961|NCT01982123|3907121|FG000|STARTED|Overall Study||12
3178962|NCT01982123|3907121|FG000|COMPLETED|Overall Study||12
3178963|NCT01982123|3907121|FG000|NOT COMPLETED|Overall Study||0
3178964|NCT01982240|3907128|FG000|STARTED|Overall Study||452
3178965|NCT01982240|3907129|FG001|STARTED|Overall Study||453
3355196|NCT03663231|4085111|FG000|COMPLETED|Washout||14
3355197|NCT03663231|4085112|FG001|COMPLETED|Washout||12
3355198|NCT03663231|4085111|FG000|NOT COMPLETED|Washout||0
3355199|NCT03663231|4085112|FG001|NOT COMPLETED|Washout||0
3355200|NCT03663231|4085111|FG000|STARTED|Second Intervention||14
3355201|NCT03663231|4085112|FG001|STARTED|Second Intervention||12
3355202|NCT03663231|4085111|FG000|COMPLETED|Second Intervention||14
3355203|NCT03663231|4085112|FG001|COMPLETED|Second Intervention||12
3355204|NCT03663231|4085111|FG000|NOT COMPLETED|Second Intervention||0
3355205|NCT03663231|4085112|FG001|NOT COMPLETED|Second Intervention||0
3355206|NCT03663283|4085120|FG000|STARTED|Overall Study||52
3355207|NCT03663283|4085121|FG001|STARTED|Overall Study||52
3355208|NCT03663283|4085120|FG000|COMPLETED|Overall Study||52
3355209|NCT03663283|4085121|FG001|COMPLETED|Overall Study||52
3355210|NCT03663283|4085120|FG000|NOT COMPLETED|Overall Study||0
3355211|NCT03663283|4085121|FG001|NOT COMPLETED|Overall Study||0
3355212|NCT03663569|4085127|FG000|STARTED|Overall Study||4819
3355213|NCT03663569|4085127|FG000|COMPLETED|Overall Study||4756
3355214|NCT03663569|4085127|FG000|NOT COMPLETED|Overall Study||63
3355215|NCT03663582|4085131|FG000|STARTED|Overall Study||7
3355216|NCT03663582|4085131|FG000|COMPLETED|Overall Study||6
3355217|NCT03663582|4085131|FG000|NOT COMPLETED|Overall Study||1
3355218|NCT03663816|4085135|FG000|STARTED|Overall Study||15
3355219|NCT03663816|4085135|FG000|COMPLETED|Overall Study||15
3355220|NCT03663816|4085135|FG000|NOT COMPLETED|Overall Study||0
3355221|NCT03664193|4085139|FG000|STARTED|Overall Study||30
3355222|NCT03664193|4085139|FG000|COMPLETED|Overall Study||30
3355223|NCT03664193|4085139|FG000|NOT COMPLETED|Overall Study||0
3355224|NCT03664544|4085145|FG000|STARTED|Overall Study||6
3355225|NCT03664544|4085146|FG001|STARTED|Overall Study||6
3355226|NCT03664544|4085145|FG000|COMPLETED|Overall Study||6
3355227|NCT03664544|4085146|FG001|COMPLETED|Overall Study||6
3355228|NCT03664544|4085145|FG000|NOT COMPLETED|Overall Study||0
3355229|NCT03664544|4085146|FG001|NOT COMPLETED|Overall Study||0
3355230|NCT03665155|4085155|FG000|STARTED|Overall Study||3
3355231|NCT03665155|4085156|FG001|STARTED|Overall Study||7
3355232|NCT03665155|4085157|FG002|STARTED|Overall Study||1
3355233|NCT03665155|4085155|FG000|COMPLETED|Overall Study||3
3355234|NCT03665155|4085156|FG001|COMPLETED|Overall Study||7
3355235|NCT03665155|4085157|FG002|COMPLETED|Overall Study||1
3355236|NCT03665155|4085155|FG000|NOT COMPLETED|Overall Study||0
3355237|NCT03665155|4085156|FG001|NOT COMPLETED|Overall Study||0
3355238|NCT03665155|4085157|FG002|NOT COMPLETED|Overall Study||0
3355239|NCT03666026|4085167|FG000|STARTED|Overall Study||41070
3355240|NCT03666026|4085168|FG001|STARTED|Overall Study||41055
3355241|NCT03666026|4085169|FG002|STARTED|Overall Study||41046
3355242|NCT03666026|4085170|FG003|STARTED|Overall Study||41034
3355243|NCT03666026|4085167|FG000|COMPLETED|Overall Study||41070
3355244|NCT03666026|4085168|FG001|COMPLETED|Overall Study||41055
3355245|NCT03666026|4085169|FG002|COMPLETED|Overall Study||41046
3355246|NCT03666026|4085170|FG003|COMPLETED|Overall Study||41034
3355247|NCT03666026|4085167|FG000|NOT COMPLETED|Overall Study||0
3355248|NCT03666026|4085168|FG001|NOT COMPLETED|Overall Study||0
3355249|NCT03666026|4085169|FG002|NOT COMPLETED|Overall Study||0
3355250|NCT03666026|4085170|FG003|NOT COMPLETED|Overall Study||0
3355251|NCT03666663|4085184|FG000|STARTED|Overall Study||3
3355252|NCT03666663|4085185|FG001|STARTED|Overall Study||1
3355253|NCT03666663|4085186|FG002|STARTED|Overall Study||3
3355254|NCT03666663|4085187|FG003|STARTED|Overall Study||3
3355255|NCT03666663|4085184|FG000|COMPLETED|Overall Study||3
3355256|NCT03666663|4085185|FG001|COMPLETED|Overall Study||1
3355257|NCT03666663|4085186|FG002|COMPLETED|Overall Study||1
3355258|NCT03666663|4085187|FG003|COMPLETED|Overall Study||1
3355259|NCT03666663|4085184|FG000|NOT COMPLETED|Overall Study||0
3355260|NCT03666663|4085185|FG001|NOT COMPLETED|Overall Study||0
3355261|NCT03666663|4085186|FG002|NOT COMPLETED|Overall Study||2
3355262|NCT03666663|4085187|FG003|NOT COMPLETED|Overall Study||2
3355263|NCT03666858|4085197|FG000|STARTED|Cohort 1|All participants with TTH who had reported at least one headache and Neosaldina intake.|216
3355264|NCT03666858|4085198|FG001|STARTED|Cohort 1||0
3355265|NCT03666858|4085197|FG000|COMPLETED|Cohort 1||215
3355266|NCT03666858|4085198|FG001|COMPLETED|Cohort 1||0
3355267|NCT03666858|4085197|FG000|NOT COMPLETED|Cohort 1||1
3355268|NCT03666858|4085198|FG001|NOT COMPLETED|Cohort 1||0
3355269|NCT03666858|4085197|FG000|STARTED|Cohort 2||0
3355270|NCT03666858|4085198|FG001|STARTED|Cohort 2|Cohort 1 participants with pain intensity at 0,120minutes after Neosaldina/0 pain before 120minutes.|138
3355271|NCT03666858|4085197|FG000|COMPLETED|Cohort 2||0
3355272|NCT03666858|4085198|FG001|COMPLETED|Cohort 2||137
3355273|NCT03666858|4085197|FG000|NOT COMPLETED|Cohort 2||0
3355274|NCT03666858|4085198|FG001|NOT COMPLETED|Cohort 2||1
3355275|NCT03667053|4085207|FG000|STARTED|Overall Study||21
3355276|NCT03667053|4085208|FG001|STARTED|Overall Study||11
3355277|NCT03667053|4085209|FG002|STARTED|Overall Study||10
3355278|NCT03667053|4085207|FG000|Randomized and Treated|Overall Study||20
3355279|NCT03667053|4085208|FG001|Randomized and Treated|Overall Study||11
3355280|NCT03667053|4085209|FG002|Randomized and Treated|Overall Study||10
3355281|NCT03667053|4085207|FG000|COMPLETED|Overall Study||20
3355282|NCT03667053|4085208|FG001|COMPLETED|Overall Study||11
3355283|NCT03667053|4085209|FG002|COMPLETED|Overall Study||10
3355284|NCT03667053|4085207|FG000|NOT COMPLETED|Overall Study||1
3355285|NCT03667053|4085208|FG001|NOT COMPLETED|Overall Study||0
3355286|NCT03667053|4085209|FG002|NOT COMPLETED|Overall Study||0
3355287|NCT03667547|4085224|FG000|STARTED|Overall Study||12
3355288|NCT03667547|4085224|FG000|COMPLETED|Overall Study||12
3355289|NCT03667547|4085224|FG000|NOT COMPLETED|Overall Study||0
3355290|NCT03668600|4085228|FG000|STARTED|Overall Study||230
3355291|NCT03668600|4085228|FG000|COMPLETED|Overall Study||0
3355292|NCT03668600|4085228|FG000|NOT COMPLETED|Overall Study||230
3355293|NCT03668613|4085234|FG000|STARTED|Overall Study||42
3355294|NCT03668613|4085235|FG001|STARTED|Overall Study||42
3355295|NCT03668613|4085234|FG000|COMPLETED|Overall Study||42
3355296|NCT03668613|4085235|FG001|COMPLETED|Overall Study||39
3355297|NCT03668613|4085234|FG000|NOT COMPLETED|Overall Study||0
3355298|NCT03668613|4085235|FG001|NOT COMPLETED|Overall Study||3
3355299|NCT03669081|4085244|FG000|STARTED|Overall Study||34
3355300|NCT03669081|4085245|FG001|STARTED|Overall Study||30
3355301|NCT03669081|4085244|FG000|COMPLETED|Overall Study||33
3355302|NCT03669081|4085245|FG001|COMPLETED|Overall Study||29
3355303|NCT03669081|4085244|FG000|NOT COMPLETED|Overall Study||1
3178966|NCT01982240|3907130|FG002|STARTED|Overall Study||441
3178967|NCT01982240|3907128|FG000|COMPLETED|Overall Study||385
3178968|NCT01982240|3907129|FG001|COMPLETED|Overall Study||384
3178969|NCT01982240|3907130|FG002|COMPLETED|Overall Study||371
3178970|NCT01982240|3907128|FG000|NOT COMPLETED|Overall Study||67
3178971|NCT01982240|3907129|FG001|NOT COMPLETED|Overall Study||69
3178972|NCT01982240|3907130|FG002|NOT COMPLETED|Overall Study||70
3178973|NCT01982292|3907144|FG000|STARTED|Overall Study|"Started indicates Randomized set"|215
3178974|NCT01982292|3907145|FG001|STARTED|Overall Study||108
3178975|NCT01982292|3907144|FG000|Full Analaysis Set (FAS)|Overall Study|FAS excludes mis-randomized patients|213
3178976|NCT01982292|3907145|FG001|Full Analaysis Set (FAS)|Overall Study||108
3178977|NCT01982292|3907144|FG000|Safety Set|Overall Study||212
3178978|NCT01982292|3907145|FG001|Safety Set|Overall Study||108
3178979|NCT01982292|3907144|FG000|COMPLETED|Overall Study||203
3178980|NCT01982292|3907145|FG001|COMPLETED|Overall Study||107
3178981|NCT01982292|3907144|FG000|NOT COMPLETED|Overall Study||12
3178982|NCT01982292|3907145|FG001|NOT COMPLETED|Overall Study||1
3178983|NCT01982331|3907153|FG000|STARTED|Received Vaccination 1||28
3178984|NCT01982331|3907154|FG001|STARTED|Received Vaccination 1||10
3178985|NCT01982331|3907153|FG000|COMPLETED|Received Vaccination 1||28
3178986|NCT01982331|3907154|FG001|COMPLETED|Received Vaccination 1||10
3178987|NCT01982331|3907153|FG000|NOT COMPLETED|Received Vaccination 1||0
3178988|NCT01982331|3907154|FG001|NOT COMPLETED|Received Vaccination 1||0
2928044|NCT00576303|3639017|FG000|STARTED|Efficacy Evaluation Period||183
3355304|NCT03669081|4085245|FG001|NOT COMPLETED|Overall Study||1
3355305|NCT03669354|4085255|FG000|STARTED|Overall Study||73
3178989|NCT01982331|3907153|FG000|STARTED|Received Vaccination 2||28
3178990|NCT01982331|3907154|FG001|STARTED|Received Vaccination 2||10
3178991|NCT01982331|3907153|FG000|COMPLETED|Received Vaccination 2||27
3355306|NCT03669354|4085256|FG001|STARTED|Overall Study||22
3355307|NCT03669354|4085257|FG002|STARTED|Overall Study||47
3355308|NCT03669354|4085258|FG003|STARTED|Overall Study||53
3355309|NCT03669354|4085255|FG000|COMPLETED|Overall Study||73
3355310|NCT03669354|4085256|FG001|COMPLETED|Overall Study||22
3355311|NCT03669354|4085257|FG002|COMPLETED|Overall Study||47
3355312|NCT03669354|4085258|FG003|COMPLETED|Overall Study||53
3355313|NCT03669354|4085255|FG000|NOT COMPLETED|Overall Study||0
3355314|NCT03669354|4085256|FG001|NOT COMPLETED|Overall Study||0
3355315|NCT03669354|4085257|FG002|NOT COMPLETED|Overall Study||0
3355316|NCT03669354|4085258|FG003|NOT COMPLETED|Overall Study||0
3355317|NCT03669549|4085269|FG000|STARTED|Overall Study||15
3355318|NCT03669549|4085269|FG000|COMPLETED|Overall Study||9
3355319|NCT03669549|4085269|FG000|NOT COMPLETED|Overall Study||6
3355320|NCT03669861|4085277|FG000|STARTED|Overall Study||10
3355321|NCT03669861|4085277|FG000|COMPLETED|Overall Study||3
3355322|NCT03669861|4085277|FG000|NOT COMPLETED|Overall Study||7
3355323|NCT03670017|4085281|FG000|STARTED|Overall Study||68
3355324|NCT03670017|4085281|FG000|COMPLETED|Overall Study||50
3355325|NCT03670017|4085281|FG000|NOT COMPLETED|Overall Study||18
3355326|NCT03670030|4085285|FG000|STARTED|Overall Study||5
3355327|NCT03670030|4085285|FG000|COMPLETED|Overall Study||5
3355328|NCT03670030|4085285|FG000|NOT COMPLETED|Overall Study||0
3355329|NCT03670160|4085291|FG000|STARTED|Overall Study||11
3355330|NCT03670160|4085292|FG001|STARTED|Overall Study||14
3355331|NCT03670160|4085291|FG000|COMPLETED|Overall Study||11
3355332|NCT03670160|4085292|FG001|COMPLETED|Overall Study||14
3178992|NCT01982331|3907154|FG001|COMPLETED|Received Vaccination 2||7
3178993|NCT01982331|3907153|FG000|NOT COMPLETED|Received Vaccination 2||1
3178994|NCT01982331|3907154|FG001|NOT COMPLETED|Received Vaccination 2||3
3355333|NCT03670160|4085291|FG000|NOT COMPLETED|Overall Study||0
3355334|NCT03670160|4085292|FG001|NOT COMPLETED|Overall Study||0
3355335|NCT03670264|4085301|FG000|STARTED|Overall Study||5
3355336|NCT03670264|4085302|FG001|STARTED|Overall Study||5
3355337|NCT03670264|4085303|FG002|STARTED|Overall Study||5
3355338|NCT03670264|4085301|FG000|COMPLETED|Overall Study||5
3355339|NCT03670264|4085302|FG001|COMPLETED|Overall Study||5
3355340|NCT03670264|4085303|FG002|COMPLETED|Overall Study||5
3355341|NCT03670264|4085301|FG000|NOT COMPLETED|Overall Study||0
3355342|NCT03670264|4085302|FG001|NOT COMPLETED|Overall Study||0
3355343|NCT03670264|4085303|FG002|NOT COMPLETED|Overall Study||0
3355344|NCT03670537|4085311|FG000|STARTED|Overall Study||102
3355345|NCT03670537|4085311|FG000|COMPLETED|Overall Study||101
3355346|NCT03670537|4085311|FG000|NOT COMPLETED|Overall Study||1
3355347|NCT03670641|4085315|FG000|STARTED|Overall Study||10
3355348|NCT03670641|4085315|FG000|COMPLETED|Overall Study|3 participants were lost to follow up by 12 months|7
3355349|NCT03670641|4085315|FG000|NOT COMPLETED|Overall Study||3
3355350|NCT03670810|4085325|FG000|STARTED|Overall Study||485
3355351|NCT03670810|4085326|FG001|STARTED|Overall Study||486
3355352|NCT03670810|4085327|FG002|STARTED|Overall Study||249
3355353|NCT03670810|4085328|FG003|STARTED|Overall Study||251
3355354|NCT03670810|4085325|FG000|Treated at Least One Migraine Attack|Overall Study||485
3355355|NCT03670810|4085326|FG001|Treated at Least One Migraine Attack|Overall Study||486
3355356|NCT03670810|4085327|FG002|Treated at Least One Migraine Attack|Overall Study||249
3355357|NCT03670810|4085328|FG003|Treated at Least One Migraine Attack|Overall Study||251
3355358|NCT03670810|4085325|FG000|COMPLETED|Overall Study||381
3355359|NCT03670810|4085326|FG001|COMPLETED|Overall Study||369
3355360|NCT03670810|4085327|FG002|COMPLETED|Overall Study||208
3355361|NCT03670810|4085328|FG003|COMPLETED|Overall Study||213
3355362|NCT03670810|4085325|FG000|NOT COMPLETED|Overall Study||104
3355363|NCT03670810|4085326|FG001|NOT COMPLETED|Overall Study||117
3355364|NCT03670810|4085327|FG002|NOT COMPLETED|Overall Study||41
3355365|NCT03670810|4085328|FG003|NOT COMPLETED|Overall Study||38
3355366|NCT03672006|4085340|FG000|STARTED|Overall Study||10
3355367|NCT03672006|4085341|FG001|STARTED|Overall Study||10
3355368|NCT03672006|4085340|FG000|COMPLETED|Overall Study||10
3355369|NCT03672006|4085341|FG001|COMPLETED|Overall Study||9
3355370|NCT03672006|4085340|FG000|NOT COMPLETED|Overall Study||0
3355371|NCT03672006|4085341|FG001|NOT COMPLETED|Overall Study||1
3355372|NCT03672032|4085351|FG000|STARTED|Overall Study||67
3355373|NCT03672032|4085352|FG001|STARTED|Overall Study||67
3355374|NCT03672032|4085351|FG000|COMPLETED|Overall Study||67
3355375|NCT03672032|4085352|FG001|COMPLETED|Overall Study||67
3355376|NCT03672032|4085351|FG000|NOT COMPLETED|Overall Study||0
3355377|NCT03672032|4085352|FG001|NOT COMPLETED|Overall Study||0
3355378|NCT03672097|4085358|FG000|STARTED|Period 1||204
3355379|NCT03672097|4085358|FG000|COMPLETED|Period 1||200
3355380|NCT03672097|4085358|FG000|NOT COMPLETED|Period 1||4
3178995|NCT01982331|3907153|FG000|STARTED|Completed Study (Day 112)||27
3178996|NCT01982331|3907154|FG001|STARTED|Completed Study (Day 112)||7
3355381|NCT03672097|4085358|FG000|STARTED|Period 2||200
3355382|NCT03672097|4085358|FG000|COMPLETED|Period 2||196
3355383|NCT03672097|4085358|FG000|NOT COMPLETED|Period 2||4
3355384|NCT03672370|4085362|FG000|STARTED|Overall Study|11 hips did not receive the study devices acc. to the protocol and therefore had to be excluded.|89
3355385|NCT03672370|4085362|FG000|COMPLETED|Overall Study||42
3355386|NCT03672370|4085362|FG000|NOT COMPLETED|Overall Study||47
3355387|NCT03672396|4085366|FG000|STARTED|Overall Study||22
3355388|NCT03672396|4085366|FG000|COMPLETED|Overall Study||16
3355389|NCT03672396|4085366|FG000|NOT COMPLETED|Overall Study||6
3355390|NCT03673670|4085376|FG000|STARTED|Treatment Period 1 (3 Days)||14
3178997|NCT01982331|3907153|FG000|COMPLETED|Completed Study (Day 112)||25
3178998|NCT01982331|3907154|FG001|COMPLETED|Completed Study (Day 112)||7
3178999|NCT01982331|3907153|FG000|NOT COMPLETED|Completed Study (Day 112)||2
3179000|NCT01982331|3907154|FG001|NOT COMPLETED|Completed Study (Day 112)||0
3179001|NCT01982435|3907162|FG000|STARTED|Overall Study||15
3179002|NCT01982435|3907163|FG001|STARTED|Overall Study||12
3355391|NCT03673670|4085377|FG001|STARTED|Treatment Period 1 (3 Days)||14
3355392|NCT03673670|4085378|FG002|STARTED|Treatment Period 1 (3 Days)||13
3355393|NCT03673670|4085379|FG003|STARTED|Treatment Period 1 (3 Days)||12
3355394|NCT03673670|4085380|FG004|STARTED|Treatment Period 1 (3 Days)||13
3355395|NCT03673670|4085381|FG005|STARTED|Treatment Period 1 (3 Days)||13
3355396|NCT03673670|4085376|FG000|COMPLETED|Treatment Period 1 (3 Days)||13
3355397|NCT03673670|4085377|FG001|COMPLETED|Treatment Period 1 (3 Days)||14
3355398|NCT03673670|4085378|FG002|COMPLETED|Treatment Period 1 (3 Days)||12
3355399|NCT03673670|4085379|FG003|COMPLETED|Treatment Period 1 (3 Days)||12
3355400|NCT03673670|4085380|FG004|COMPLETED|Treatment Period 1 (3 Days)||13
3355401|NCT03673670|4085381|FG005|COMPLETED|Treatment Period 1 (3 Days)||11
3355402|NCT03673670|4085376|FG000|NOT COMPLETED|Treatment Period 1 (3 Days)||1
3355403|NCT03673670|4085377|FG001|NOT COMPLETED|Treatment Period 1 (3 Days)||0
3355404|NCT03673670|4085378|FG002|NOT COMPLETED|Treatment Period 1 (3 Days)||1
3355405|NCT03673670|4085379|FG003|NOT COMPLETED|Treatment Period 1 (3 Days)||0
3355406|NCT03673670|4085380|FG004|NOT COMPLETED|Treatment Period 1 (3 Days)||0
3355407|NCT03673670|4085381|FG005|NOT COMPLETED|Treatment Period 1 (3 Days)||2
3355408|NCT03673670|4085376|FG000|STARTED|Washout Period 1 (7-14 Days)||13
3355409|NCT03673670|4085377|FG001|STARTED|Washout Period 1 (7-14 Days)||14
3355410|NCT03673670|4085378|FG002|STARTED|Washout Period 1 (7-14 Days)||12
3355411|NCT03673670|4085379|FG003|STARTED|Washout Period 1 (7-14 Days)||12
3355412|NCT03673670|4085380|FG004|STARTED|Washout Period 1 (7-14 Days)||13
3355413|NCT03673670|4085381|FG005|STARTED|Washout Period 1 (7-14 Days)||11
3355414|NCT03673670|4085376|FG000|COMPLETED|Washout Period 1 (7-14 Days)||13
3355415|NCT03673670|4085377|FG001|COMPLETED|Washout Period 1 (7-14 Days)||14
3355416|NCT03673670|4085378|FG002|COMPLETED|Washout Period 1 (7-14 Days)||12
3355417|NCT03673670|4085379|FG003|COMPLETED|Washout Period 1 (7-14 Days)||12
3355418|NCT03673670|4085380|FG004|COMPLETED|Washout Period 1 (7-14 Days)||13
3355419|NCT03673670|4085381|FG005|COMPLETED|Washout Period 1 (7-14 Days)||11
3355420|NCT03673670|4085376|FG000|NOT COMPLETED|Washout Period 1 (7-14 Days)||0
3355421|NCT03673670|4085377|FG001|NOT COMPLETED|Washout Period 1 (7-14 Days)||0
3355422|NCT03673670|4085378|FG002|NOT COMPLETED|Washout Period 1 (7-14 Days)||0
3355423|NCT03673670|4085379|FG003|NOT COMPLETED|Washout Period 1 (7-14 Days)||0
3355424|NCT03673670|4085380|FG004|NOT COMPLETED|Washout Period 1 (7-14 Days)||0
3355425|NCT03673670|4085381|FG005|NOT COMPLETED|Washout Period 1 (7-14 Days)||0
3355426|NCT03673670|4085376|FG000|STARTED|Treatment Period 2 (3 Days)||13
3355427|NCT03673670|4085377|FG001|STARTED|Treatment Period 2 (3 Days)||14
3355428|NCT03673670|4085378|FG002|STARTED|Treatment Period 2 (3 Days)||12
3355429|NCT03673670|4085379|FG003|STARTED|Treatment Period 2 (3 Days)||12
3355430|NCT03673670|4085380|FG004|STARTED|Treatment Period 2 (3 Days)||13
3355431|NCT03673670|4085381|FG005|STARTED|Treatment Period 2 (3 Days)||11
3355432|NCT03673670|4085376|FG000|COMPLETED|Treatment Period 2 (3 Days)||13
3355433|NCT03673670|4085377|FG001|COMPLETED|Treatment Period 2 (3 Days)||14
3355434|NCT03673670|4085378|FG002|COMPLETED|Treatment Period 2 (3 Days)||11
3355435|NCT03673670|4085379|FG003|COMPLETED|Treatment Period 2 (3 Days)||12
3355436|NCT03673670|4085380|FG004|COMPLETED|Treatment Period 2 (3 Days)||12
3355437|NCT03673670|4085381|FG005|COMPLETED|Treatment Period 2 (3 Days)||11
3355438|NCT03673670|4085376|FG000|NOT COMPLETED|Treatment Period 2 (3 Days)||0
3355439|NCT03673670|4085377|FG001|NOT COMPLETED|Treatment Period 2 (3 Days)||0
3355440|NCT03673670|4085378|FG002|NOT COMPLETED|Treatment Period 2 (3 Days)||1
3355441|NCT03673670|4085379|FG003|NOT COMPLETED|Treatment Period 2 (3 Days)||0
3355442|NCT03673670|4085380|FG004|NOT COMPLETED|Treatment Period 2 (3 Days)||1
3355443|NCT03673670|4085381|FG005|NOT COMPLETED|Treatment Period 2 (3 Days)||0
3355444|NCT03673670|4085376|FG000|STARTED|Washout Period 2 (7-14 Days)||13
3355445|NCT03673670|4085377|FG001|STARTED|Washout Period 2 (7-14 Days)||14
3355446|NCT03673670|4085378|FG002|STARTED|Washout Period 2 (7-14 Days)||11
3355447|NCT03673670|4085379|FG003|STARTED|Washout Period 2 (7-14 Days)||12
3355448|NCT03673670|4085380|FG004|STARTED|Washout Period 2 (7-14 Days)||12
3355449|NCT03673670|4085381|FG005|STARTED|Washout Period 2 (7-14 Days)||11
3355450|NCT03673670|4085376|FG000|COMPLETED|Washout Period 2 (7-14 Days)||13
3355451|NCT03673670|4085377|FG001|COMPLETED|Washout Period 2 (7-14 Days)||14
3355452|NCT03673670|4085378|FG002|COMPLETED|Washout Period 2 (7-14 Days)||11
3355453|NCT03673670|4085379|FG003|COMPLETED|Washout Period 2 (7-14 Days)||12
3355454|NCT03673670|4085380|FG004|COMPLETED|Washout Period 2 (7-14 Days)||11
3355455|NCT03673670|4085381|FG005|COMPLETED|Washout Period 2 (7-14 Days)||11
3355456|NCT03673670|4085376|FG000|NOT COMPLETED|Washout Period 2 (7-14 Days)||0
3355457|NCT03673670|4085377|FG001|NOT COMPLETED|Washout Period 2 (7-14 Days)||0
3355458|NCT03673670|4085378|FG002|NOT COMPLETED|Washout Period 2 (7-14 Days)||0
3355459|NCT03673670|4085379|FG003|NOT COMPLETED|Washout Period 2 (7-14 Days)||0
3355460|NCT03673670|4085380|FG004|NOT COMPLETED|Washout Period 2 (7-14 Days)||1
3355461|NCT03673670|4085381|FG005|NOT COMPLETED|Washout Period 2 (7-14 Days)||0
3355462|NCT03673670|4085376|FG000|STARTED|Treatment Period 3 (3 Days)||13
3355463|NCT03673670|4085377|FG001|STARTED|Treatment Period 3 (3 Days)||14
3355464|NCT03673670|4085378|FG002|STARTED|Treatment Period 3 (3 Days)||11
3355465|NCT03673670|4085379|FG003|STARTED|Treatment Period 3 (3 Days)||12
3355466|NCT03673670|4085380|FG004|STARTED|Treatment Period 3 (3 Days)||11
3355467|NCT03673670|4085381|FG005|STARTED|Treatment Period 3 (3 Days)||11
3355468|NCT03673670|4085376|FG000|COMPLETED|Treatment Period 3 (3 Days)||13
3355469|NCT03673670|4085377|FG001|COMPLETED|Treatment Period 3 (3 Days)||14
3355470|NCT03673670|4085378|FG002|COMPLETED|Treatment Period 3 (3 Days)||11
3355471|NCT03673670|4085379|FG003|COMPLETED|Treatment Period 3 (3 Days)||12
3355472|NCT03673670|4085380|FG004|COMPLETED|Treatment Period 3 (3 Days)||10
3355473|NCT03673670|4085381|FG005|COMPLETED|Treatment Period 3 (3 Days)||11
3355474|NCT03673670|4085376|FG000|NOT COMPLETED|Treatment Period 3 (3 Days)||0
3355475|NCT03673670|4085377|FG001|NOT COMPLETED|Treatment Period 3 (3 Days)||0
3355476|NCT03673670|4085378|FG002|NOT COMPLETED|Treatment Period 3 (3 Days)||0
3355477|NCT03673670|4085379|FG003|NOT COMPLETED|Treatment Period 3 (3 Days)||0
3355478|NCT03673670|4085380|FG004|NOT COMPLETED|Treatment Period 3 (3 Days)||1
3355479|NCT03673670|4085381|FG005|NOT COMPLETED|Treatment Period 3 (3 Days)||0
3355480|NCT03674177|4085402|FG000|STARTED|Overall Study||124
3355481|NCT03674177|4085403|FG001|STARTED|Overall Study||126
3355482|NCT03674177|4085404|FG002|STARTED|Overall Study||126
3355483|NCT03674177|4085405|FG003|STARTED|Overall Study||126
3355484|NCT03674177|4085402|FG000|COMPLETED|Overall Study||122
3355485|NCT03674177|4085403|FG001|COMPLETED|Overall Study||125
3355486|NCT03674177|4085404|FG002|COMPLETED|Overall Study||126
3355487|NCT03674177|4085405|FG003|COMPLETED|Overall Study||124
3355488|NCT03674177|4085402|FG000|NOT COMPLETED|Overall Study||2
3355489|NCT03674177|4085403|FG001|NOT COMPLETED|Overall Study||1
3355490|NCT03674177|4085404|FG002|NOT COMPLETED|Overall Study||0
3355491|NCT03674177|4085405|FG003|NOT COMPLETED|Overall Study||2
3355492|NCT03674281|4085418|FG000|STARTED|Overall Study||18
3355493|NCT03674281|4085419|FG001|STARTED|Overall Study||16
3355494|NCT03674281|4085420|FG002|STARTED|Overall Study||16
3355495|NCT03674281|4085418|FG000|COMPLETED|Overall Study||15
3355496|NCT03674281|4085419|FG001|COMPLETED|Overall Study||13
3355497|NCT03674281|4085420|FG002|COMPLETED|Overall Study||13
3355498|NCT03674281|4085418|FG000|NOT COMPLETED|Overall Study||3
3355499|NCT03674281|4085419|FG001|NOT COMPLETED|Overall Study||3
3355500|NCT03674281|4085420|FG002|NOT COMPLETED|Overall Study||3
3355501|NCT03674970|4085439|FG000|STARTED|Overall Study||15
3355502|NCT03674970|4085440|FG001|STARTED|Overall Study||15
3355503|NCT03674970|4085441|FG002|STARTED|Overall Study||15
3355504|NCT03674970|4085439|FG000|COMPLETED|Overall Study||12
3355505|NCT03674970|4085440|FG001|COMPLETED|Overall Study||8
3355506|NCT03674970|4085441|FG002|COMPLETED|Overall Study||12
3355507|NCT03674970|4085439|FG000|NOT COMPLETED|Overall Study||3
3355508|NCT03674970|4085440|FG001|NOT COMPLETED|Overall Study||7
3179003|NCT01982435|3907162|FG000|COMPLETED|Overall Study||14
3179004|NCT01982435|3907163|FG001|COMPLETED|Overall Study||12
3179005|NCT01982435|3907162|FG000|NOT COMPLETED|Overall Study||1
3179006|NCT01982435|3907163|FG001|NOT COMPLETED|Overall Study||0
3179007|NCT01982448|3907171|FG000|STARTED|Preoperative Chemotherapy||75
3179008|NCT01982448|3907172|FG001|STARTED|Preoperative Chemotherapy||72
3179009|NCT01982448|3907171|FG000|Eligible & Treated|Preoperative Chemotherapy||72
3179010|NCT01982448|3907172|FG001|Eligible & Treated|Preoperative Chemotherapy||70
3355509|NCT03674970|4085441|FG002|NOT COMPLETED|Overall Study||3
3355510|NCT03675451|4085449|FG000|STARTED|Overall Study||20
3355511|NCT03675451|4085449|FG000|COMPLETED|Overall Study||20
3355512|NCT03675451|4085449|FG000|NOT COMPLETED|Overall Study||0
3355513|NCT03675581|4085460|FG000|STARTED|Period 1: Microgynon Alone||17
3355514|NCT03675581|4085460|FG000|COMPLETED|Period 1: Microgynon Alone||17
3355515|NCT03675581|4085460|FG000|NOT COMPLETED|Period 1: Microgynon Alone||0
2928045|NCT00576303|3639017|FG000|COMPLETED|Efficacy Evaluation Period||178
2928046|NCT00576303|3639017|FG000|NOT COMPLETED|Efficacy Evaluation Period||5
2928047|NCT00576303|3639017|FG000|STARTED|Long Term Safety Period||178
2928048|NCT00576303|3639017|FG000|COMPLETED|Long Term Safety Period||162
2928049|NCT00576303|3639017|FG000|NOT COMPLETED|Long Term Safety Period||16
2928050|NCT00576316|3639021|FG000|STARTED|Overall Study|Number of patients recruited|201
2928051|NCT00576316|3639021|FG000|COMPLETED|Overall Study|Number of patients who completed study|181
2928052|NCT00576316|3639021|FG000|NOT COMPLETED|Overall Study||20
2928053|NCT00576381|3639025|FG000|STARTED|Overall Study||30
3039939|NCT01161472|3759429|FG000|STARTED|Washout Period (At Least 3 to 6 Days)||5
3039940|NCT01161472|3759430|FG001|STARTED|Washout Period (At Least 3 to 6 Days)||5
3039941|NCT01161472|3759431|FG002|STARTED|Washout Period (At Least 3 to 6 Days)||5
3039942|NCT01161472|3759432|FG003|STARTED|Washout Period (At Least 3 to 6 Days)||5
3039943|NCT01161472|3759429|FG000|COMPLETED|Washout Period (At Least 3 to 6 Days)||4
3039944|NCT01161472|3759430|FG001|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
3039945|NCT01161472|3759431|FG002|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
3039946|NCT01161472|3759432|FG003|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
3039947|NCT01161472|3759429|FG000|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||1
3039948|NCT01161472|3759430|FG001|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
3039949|NCT01161472|3759431|FG002|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
3039950|NCT01161472|3759432|FG003|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
3039951|NCT01161472|3759429|FG000|STARTED|Third Intervention Period||4
3039952|NCT01161472|3759430|FG001|STARTED|Third Intervention Period||5
3039953|NCT01161472|3759431|FG002|STARTED|Third Intervention Period||5
3039954|NCT01161472|3759432|FG003|STARTED|Third Intervention Period||5
3039955|NCT01161472|3759429|FG000|COMPLETED|Third Intervention Period||4
3039956|NCT01161472|3759430|FG001|COMPLETED|Third Intervention Period||5
3039957|NCT01161472|3759431|FG002|COMPLETED|Third Intervention Period||5
3039958|NCT01161472|3759432|FG003|COMPLETED|Third Intervention Period||5
3039959|NCT01161472|3759429|FG000|NOT COMPLETED|Third Intervention Period||0
3039960|NCT01161472|3759430|FG001|NOT COMPLETED|Third Intervention Period||0
3039961|NCT01161472|3759431|FG002|NOT COMPLETED|Third Intervention Period||0
3039962|NCT01161472|3759432|FG003|NOT COMPLETED|Third Intervention Period||0
3039963|NCT01161472|3759429|FG000|STARTED|Washout Period (At Least 3 to 6 Days)||4
3039964|NCT01161472|3759430|FG001|STARTED|Washout Period (At Least 3 to 6 Days)||5
3039965|NCT01161472|3759431|FG002|STARTED|Washout Period (At Least 3 to 6 Days)||5
3355516|NCT03675581|4085460|FG000|STARTED|Period 2: Microgynon + Nintedanib||17
3355517|NCT03675581|4085460|FG000|COMPLETED|Period 2: Microgynon + Nintedanib||17
3355518|NCT03675581|4085460|FG000|NOT COMPLETED|Period 2: Microgynon + Nintedanib||0
3355519|NCT03675685|4085468|FG000|STARTED|Overall Study||12
3355520|NCT03675685|4085468|FG000|COMPLETED|Overall Study||12
3355521|NCT03675685|4085468|FG000|NOT COMPLETED|Overall Study||0
3355522|NCT03675776|4085479|FG000|STARTED|Double Blind Treatment Period||15
3355523|NCT03675776|4085480|FG001|STARTED|Double Blind Treatment Period||17
3355524|NCT03675776|4085481|FG002|STARTED|Double Blind Treatment Period||18
3355525|NCT03675776|4085479|FG000|COMPLETED|Double Blind Treatment Period||9
3355526|NCT03675776|4085480|FG001|COMPLETED|Double Blind Treatment Period||11
3355527|NCT03675776|4085481|FG002|COMPLETED|Double Blind Treatment Period||10
3355528|NCT03675776|4085479|FG000|NOT COMPLETED|Double Blind Treatment Period||6
3355529|NCT03675776|4085480|FG001|NOT COMPLETED|Double Blind Treatment Period||6
3355530|NCT03675776|4085481|FG002|NOT COMPLETED|Double Blind Treatment Period||8
3355531|NCT03675776|4085479|FG000|STARTED|Safety Follow-up Period||6
3355532|NCT03675776|4085480|FG001|STARTED|Safety Follow-up Period||8
3355533|NCT03675776|4085481|FG002|STARTED|Safety Follow-up Period||7
3355534|NCT03675776|4085479|FG000|COMPLETED|Safety Follow-up Period||6
3355535|NCT03675776|4085480|FG001|COMPLETED|Safety Follow-up Period||8
3355536|NCT03675776|4085481|FG002|COMPLETED|Safety Follow-up Period||7
3355537|NCT03675776|4085479|FG000|NOT COMPLETED|Safety Follow-up Period||0
3355538|NCT03675776|4085480|FG001|NOT COMPLETED|Safety Follow-up Period||0
3355539|NCT03675776|4085481|FG002|NOT COMPLETED|Safety Follow-up Period||0
3355540|NCT03676270|4085489|FG000|STARTED|Overall Study||6915
3355541|NCT03676270|4085489|FG000|COMPLETED|Overall Study||6915
3355542|NCT03676270|4085489|FG000|NOT COMPLETED|Overall Study||0
3355543|NCT03676634|4085493|FG000|STARTED|Overall Study||32
3355544|NCT03676634|4085493|FG000|Screening|Overall Study||32
3355545|NCT03676634|4085493|FG000|Participants Received rBV A/B Injection|Overall Study||32
3355546|NCT03676634|4085493|FG000|Participants Included in the Plasma-donating Population|Overall Study||32
3355547|NCT03676634|4085493|FG000|Participants Completed Follow up|Overall Study||32
3355548|NCT03676634|4085493|FG000|COMPLETED|Overall Study||29
3355549|NCT03676634|4085493|FG000|NOT COMPLETED|Overall Study||3
3355550|NCT03676725|4085503|FG000|STARTED|Overall Study||23
3355551|NCT03676725|4085504|FG001|STARTED|Overall Study||14
3355552|NCT03676725|4085505|FG002|STARTED|Overall Study||22
3355553|NCT03676725|4085506|FG003|STARTED|Overall Study||5
3355554|NCT03676725|4085507|FG004|STARTED|Overall Study||15
3355555|NCT03676725|4085508|FG005|STARTED|Overall Study||11
3355556|NCT03676725|4085503|FG000|COMPLETED|Overall Study||23
3355557|NCT03676725|4085504|FG001|COMPLETED|Overall Study||14
3355558|NCT03676725|4085505|FG002|COMPLETED|Overall Study||22
3355559|NCT03676725|4085506|FG003|COMPLETED|Overall Study||5
3355560|NCT03676725|4085507|FG004|COMPLETED|Overall Study||15
3355561|NCT03676725|4085508|FG005|COMPLETED|Overall Study||11
3355562|NCT03676725|4085503|FG000|NOT COMPLETED|Overall Study||0
3355563|NCT03676725|4085504|FG001|NOT COMPLETED|Overall Study||0
3355564|NCT03676725|4085505|FG002|NOT COMPLETED|Overall Study||0
3355565|NCT03676725|4085506|FG003|NOT COMPLETED|Overall Study||0
3355566|NCT03676725|4085507|FG004|NOT COMPLETED|Overall Study||0
3355567|NCT03676725|4085508|FG005|NOT COMPLETED|Overall Study||0
3355568|NCT03676803|4085519|FG000|STARTED|Overall Study||15
3355569|NCT03676803|4085520|FG001|STARTED|Overall Study||16
3355570|NCT03676803|4085519|FG000|COMPLETED|Overall Study||15
3355571|NCT03676803|4085520|FG001|COMPLETED|Overall Study||16
3355572|NCT03676803|4085519|FG000|NOT COMPLETED|Overall Study||0
3355573|NCT03676803|4085520|FG001|NOT COMPLETED|Overall Study||0
3355574|NCT03676972|4085528|FG000|STARTED|Overall Study||60
3355575|NCT03676972|4085528|FG000|COMPLETED|Overall Study||58
3355576|NCT03676972|4085528|FG000|NOT COMPLETED|Overall Study||2
3355577|NCT03677089|4085532|FG000|STARTED|Overall Study||148
3355578|NCT03677089|4085532|FG000|Baseline/Pre-Intervention|Overall Study||137
3355579|NCT03677089|4085532|FG000|Mid-Intervention|Overall Study||120
3355580|NCT03677089|4085532|FG000|Post-Intervention|Overall Study||117
3355581|NCT03677089|4085532|FG000|Follow-Up|Overall Study||114
3355582|NCT03677089|4085532|FG000|COMPLETED|Overall Study||114
3039966|NCT01161472|3759432|FG003|STARTED|Washout Period (At Least 3 to 6 Days)||5
3039967|NCT01161472|3759429|FG000|COMPLETED|Washout Period (At Least 3 to 6 Days)||4
3039968|NCT01161472|3759430|FG001|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
3039969|NCT01161472|3759431|FG002|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
3039970|NCT01161472|3759432|FG003|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
3355583|NCT03677089|4085532|FG000|NOT COMPLETED|Overall Study||34
3355584|NCT03677245|4085540|FG000|STARTED|Overall Study||8
3355585|NCT03677245|4085540|FG000|COMPLETED|Overall Study||8
3355586|NCT03677245|4085540|FG000|NOT COMPLETED|Overall Study||0
3355587|NCT03677375|4085545|FG000|STARTED|Overall Study||93
3355588|NCT03677375|4085545|FG000|COMPLETED|Overall Study||81
3355589|NCT03677375|4085545|FG000|NOT COMPLETED|Overall Study||12
3355590|NCT03677401|4085551|FG000|STARTED|Overall Study||148
3355591|NCT03677401|4085552|FG001|STARTED|Overall Study||147
3355592|NCT03677401|4085551|FG000|COMPLETED|Overall Study||138
3355593|NCT03677401|4085552|FG001|COMPLETED|Overall Study||129
3355594|NCT03677401|4085551|FG000|NOT COMPLETED|Overall Study||10
3355595|NCT03677401|4085552|FG001|NOT COMPLETED|Overall Study||18
3355596|NCT03677869|4085558|FG000|STARTED|Overall Study||35
3355597|NCT03677869|4085558|FG000|COMPLETED|Overall Study||34
3355598|NCT03677869|4085558|FG000|NOT COMPLETED|Overall Study||1
3355599|NCT03678103|4085562|FG000|STARTED|Overall Study||30
3355600|NCT03678103|4085562|FG000|COMPLETED|Overall Study||26
3355601|NCT03678103|4085562|FG000|NOT COMPLETED|Overall Study||4
3355602|NCT03678285|4085566|FG000|STARTED|Overall Study||42
3355603|NCT03678285|4085566|FG000|Started Workout|Overall Study||40
3355604|NCT03678285|4085566|FG000|COMPLETED|Overall Study||38
3355605|NCT03678285|4085566|FG000|NOT COMPLETED|Overall Study||4
3355606|NCT03678311|4085570|FG000|STARTED|Overall Study||9
3355607|NCT03678311|4085570|FG000|COMPLETED|Overall Study||9
3355608|NCT03678311|4085570|FG000|NOT COMPLETED|Overall Study||0
3355609|NCT03678870|4085576|FG000|STARTED|Overall Study||97
3355610|NCT03678870|4085577|FG001|STARTED|Overall Study||99
3355611|NCT03678870|4085576|FG000|COMPLETED|Overall Study||84
3355612|NCT03678870|4085577|FG001|COMPLETED|Overall Study||91
3355613|NCT03678870|4085576|FG000|NOT COMPLETED|Overall Study||13
3355614|NCT03678870|4085577|FG001|NOT COMPLETED|Overall Study||8
3355615|NCT03679494|4085585|FG000|STARTED|Overall Study||67
3355616|NCT03679494|4085586|FG001|STARTED|Overall Study||63
3355617|NCT03679494|4085585|FG000|COMPLETED|Overall Study||67
3355618|NCT03679494|4085586|FG001|COMPLETED|Overall Study||63
3355619|NCT03679494|4085585|FG000|NOT COMPLETED|Overall Study||0
3355620|NCT03679494|4085586|FG001|NOT COMPLETED|Overall Study||0
3355621|NCT03679741|4085592|FG000|STARTED|Period 1||59
3355622|NCT03679741|4085593|FG001|STARTED|Period 1||61
3355623|NCT03679741|4085592|FG000|COMPLETED|Period 1||57
3355624|NCT03679741|4085593|FG001|COMPLETED|Period 1||58
3355625|NCT03679741|4085592|FG000|NOT COMPLETED|Period 1||2
3355626|NCT03679741|4085593|FG001|NOT COMPLETED|Period 1||3
3355627|NCT03679741|4085592|FG000|STARTED|Period 2||57
3355628|NCT03679741|4085593|FG001|STARTED|Period 2||58
3355629|NCT03679741|4085592|FG000|COMPLETED|Period 2||54
3355630|NCT03679741|4085593|FG001|COMPLETED|Period 2||56
3355631|NCT03679741|4085592|FG000|NOT COMPLETED|Period 2||3
3355632|NCT03679741|4085593|FG001|NOT COMPLETED|Period 2||2
3355633|NCT03679741|4085592|FG000|STARTED|Period 3||54
3355634|NCT03679741|4085593|FG001|STARTED|Period 3||56
3355635|NCT03679741|4085592|FG000|COMPLETED|Period 3||54
3355636|NCT03679741|4085593|FG001|COMPLETED|Period 3||56
3355637|NCT03679741|4085592|FG000|NOT COMPLETED|Period 3||0
3355638|NCT03679741|4085593|FG001|NOT COMPLETED|Period 3||0
3355639|NCT03679975|4085599|FG000|STARTED|Overall Study||9
3355640|NCT03679975|4085599|FG000|COMPLETED|Overall Study||9
3355641|NCT03679975|4085599|FG000|NOT COMPLETED|Overall Study||0
3355642|NCT03680105|4085612|FG000|STARTED|Overall Study||8
3355643|NCT03680105|4085613|FG001|STARTED|Overall Study||8
3355644|NCT03680105|4085614|FG002|STARTED|Overall Study||8
3355645|NCT03680105|4085615|FG003|STARTED|Overall Study||8
3355646|NCT03680105|4085616|FG004|STARTED|Overall Study||8
3355647|NCT03680105|4085617|FG005|STARTED|Overall Study||12
3355648|NCT03680105|4085618|FG006|STARTED|Overall Study||8
3355649|NCT03680105|4085619|FG007|STARTED|Overall Study||8
3355650|NCT03680105|4085620|FG008|STARTED|Overall Study||8
3355651|NCT03680105|4085612|FG000|COMPLETED|Overall Study||8
3355652|NCT03680105|4085613|FG001|COMPLETED|Overall Study||8
3355653|NCT03680105|4085614|FG002|COMPLETED|Overall Study||8
3355654|NCT03680105|4085615|FG003|COMPLETED|Overall Study||8
3355655|NCT03680105|4085616|FG004|COMPLETED|Overall Study||8
3355656|NCT03680105|4085617|FG005|COMPLETED|Overall Study||12
3355657|NCT03680105|4085618|FG006|COMPLETED|Overall Study||8
3355658|NCT03680105|4085619|FG007|COMPLETED|Overall Study||8
3355659|NCT03680105|4085620|FG008|COMPLETED|Overall Study||8
3355660|NCT03680105|4085612|FG000|NOT COMPLETED|Overall Study||0
3355661|NCT03680105|4085613|FG001|NOT COMPLETED|Overall Study||0
3355662|NCT03680105|4085614|FG002|NOT COMPLETED|Overall Study||0
3355663|NCT03680105|4085615|FG003|NOT COMPLETED|Overall Study||0
3355664|NCT03680105|4085616|FG004|NOT COMPLETED|Overall Study||0
3355665|NCT03680105|4085617|FG005|NOT COMPLETED|Overall Study||0
3355666|NCT03680105|4085618|FG006|NOT COMPLETED|Overall Study||0
3355667|NCT03680105|4085619|FG007|NOT COMPLETED|Overall Study||0
3355668|NCT03680105|4085620|FG008|NOT COMPLETED|Overall Study||0
3355669|NCT03680521|4085646|FG000|STARTED|Overall Study||7
3355670|NCT03680521|4085647|FG001|STARTED|Overall Study||13
3355671|NCT03680521|4085646|FG000|COMPLETED|Overall Study||0
3355672|NCT03680521|4085647|FG001|COMPLETED|Overall Study||2
3355673|NCT03680521|4085646|FG000|NOT COMPLETED|Overall Study||7
3355674|NCT03680521|4085647|FG001|NOT COMPLETED|Overall Study||11
3355675|NCT03680742|4085656|FG000|STARTED|Overall Study||34
3355676|NCT03680742|4085656|FG000|COMPLETED|Overall Study||32
3355677|NCT03680742|4085656|FG000|NOT COMPLETED|Overall Study||2
3355678|NCT03681093|4085663|FG000|STARTED|Overall Study||32
3355679|NCT03681093|4085664|FG001|STARTED|Overall Study||34
3355680|NCT03681093|4085665|FG002|STARTED|Overall Study||32
3355681|NCT03681093|4085663|FG000|Full Analysis Set (FAS)|Overall Study||31
3355682|NCT03681093|4085664|FG001|Full Analysis Set (FAS)|Overall Study||32
3355683|NCT03681093|4085665|FG002|Full Analysis Set (FAS)|Overall Study||28
3355684|NCT03681093|4085663|FG000|Safety Analysis Set (SAF)|Overall Study||32
3355685|NCT03681093|4085664|FG001|Safety Analysis Set (SAF)|Overall Study||34
3355686|NCT03681093|4085665|FG002|Safety Analysis Set (SAF)|Overall Study||32
3355687|NCT03681093|4085663|FG000|COMPLETED|Overall Study||32
3355688|NCT03681093|4085664|FG001|COMPLETED|Overall Study||32
3355689|NCT03681093|4085665|FG002|COMPLETED|Overall Study||31
3355690|NCT03681093|4085663|FG000|NOT COMPLETED|Overall Study||0
3355691|NCT03681093|4085664|FG001|NOT COMPLETED|Overall Study||2
3355692|NCT03681093|4085665|FG002|NOT COMPLETED|Overall Study||1
3355693|NCT03681119|4085675|FG000|STARTED|Overall Study||72
3355694|NCT03681119|4085676|FG001|STARTED|Overall Study||11
3355695|NCT03681119|4085675|FG000|COMPLETED|Overall Study||66
3355696|NCT03681119|4085676|FG001|COMPLETED|Overall Study||11
3355697|NCT03681119|4085675|FG000|NOT COMPLETED|Overall Study||6
3355698|NCT03681119|4085676|FG001|NOT COMPLETED|Overall Study||0
3355699|NCT03681353|4085680|FG000|STARTED|Overall Study||25
3355700|NCT03681353|4085680|FG000|COMPLETED|Overall Study||18
3355701|NCT03681353|4085680|FG000|NOT COMPLETED|Overall Study||7
3355702|NCT03681405|4085686|FG000|STARTED|Overall Study||14
3355703|NCT03681405|4085687|FG001|STARTED|Overall Study||17
3355704|NCT03681405|4085686|FG000|COMPLETED|Overall Study||13
3355705|NCT03681405|4085687|FG001|COMPLETED|Overall Study||17
3355706|NCT03681405|4085686|FG000|NOT COMPLETED|Overall Study||1
3355707|NCT03681405|4085687|FG001|NOT COMPLETED|Overall Study||0
3355708|NCT03681808|4085697|FG000|STARTED|Overall Study||123
3355709|NCT03681808|4085698|FG001|STARTED|Overall Study||119
3355710|NCT03681808|4085697|FG000|COMPLETED|Overall Study||109
3355711|NCT03681808|4085698|FG001|COMPLETED|Overall Study||102
3355712|NCT03681808|4085697|FG000|NOT COMPLETED|Overall Study||14
3355713|NCT03681808|4085698|FG001|NOT COMPLETED|Overall Study||17
3355714|NCT03681886|4085704|FG000|STARTED|Overall Study||78
3355715|NCT03681886|4085704|FG000|Successful Implantation|Overall Study||76
3179011|NCT01982448|3907171|FG000|Evaluable for Safety|Preoperative Chemotherapy||72
3179012|NCT01982448|3907172|FG001|Evaluable for Safety|Preoperative Chemotherapy||68
3179013|NCT01982448|3907171|FG000|COMPLETED|Preoperative Chemotherapy||72
3179014|NCT01982448|3907172|FG001|COMPLETED|Preoperative Chemotherapy||67
3179015|NCT01982448|3907171|FG000|NOT COMPLETED|Preoperative Chemotherapy||3
3179016|NCT01982448|3907172|FG001|NOT COMPLETED|Preoperative Chemotherapy||5
3179017|NCT01982448|3907171|FG000|STARTED|Definitive Breast Surgery||72
3179018|NCT01982448|3907172|FG001|STARTED|Definitive Breast Surgery||67
3179019|NCT01982448|3907171|FG000|Evaluable for Response by Homologous Recombination Deficiency (HRD)|Definitive Breast Surgery||56
3179020|NCT01982448|3907172|FG001|Evaluable for Response by Homologous Recombination Deficiency (HRD)|Definitive Breast Surgery||48
3179021|NCT01982448|3907171|FG000|COMPLETED|Definitive Breast Surgery||72
3355716|NCT03681886|4085704|FG000|Failed Implantation|Overall Study||2
3355717|NCT03681886|4085704|FG000|Underwent Optic Exchange|Overall Study||4
3355718|NCT03681886|4085704|FG000|COMPLETED|Overall Study||76
3355719|NCT03681886|4085704|FG000|NOT COMPLETED|Overall Study||2
3355720|NCT03681951|4085733|FG000|STARTED|Part1: Monotherapy DE (Up to Day 95)||8
3355721|NCT03681951|4085734|FG001|STARTED|Part1: Monotherapy DE (Up to Day 95)|"No participant was enrolled in this arm as study was terminated during cohort GSK3145095 50mg BID"|0
3355722|NCT03681951|4085735|FG002|STARTED|Part1: Monotherapy DE (Up to Day 95)|"No participant was enrolled in this arm as study was terminated during cohort GSK3145095 50mg BID."|0
3355723|NCT03681951|4085736|FG003|STARTED|Part1: Monotherapy DE (Up to Day 95)|"No participant was enrolled in this arm as study was terminated during cohort GSK3145095 50mg BID"|0
3355724|NCT03681951|4085737|FG004|STARTED|Part1: Monotherapy DE (Up to Day 95)|"No participant was enrolled in this arm as study was terminated during cohort GSK3145095 50mg BID"|0
3355725|NCT03681951|4085738|FG005|STARTED|Part1: Monotherapy DE (Up to Day 95)|Part 2 was not initiated as this study was terminated during Part 1|0
3355726|NCT03681951|4085739|FG006|STARTED|Part1: Monotherapy DE (Up to Day 95)|Part 3 was not initiated as this study was terminated during Part 1|0
3355727|NCT03681951|4085740|FG007|STARTED|Part1: Monotherapy DE (Up to Day 95)|Part 4 was not initiated as this study was terminated during Part 1|0
3355728|NCT03681951|4085733|FG000|COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
3355729|NCT03681951|4085734|FG001|COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
3355730|NCT03681951|4085735|FG002|COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
3355731|NCT03681951|4085736|FG003|COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
3355732|NCT03681951|4085737|FG004|COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
3355733|NCT03681951|4085738|FG005|COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
3355734|NCT03681951|4085739|FG006|COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
3355735|NCT03681951|4085740|FG007|COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
3355736|NCT03681951|4085733|FG000|NOT COMPLETED|Part1: Monotherapy DE (Up to Day 95)||8
3355737|NCT03681951|4085734|FG001|NOT COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
3355738|NCT03681951|4085735|FG002|NOT COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
3355739|NCT03681951|4085736|FG003|NOT COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
3355740|NCT03681951|4085737|FG004|NOT COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
3355741|NCT03681951|4085738|FG005|NOT COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
3355742|NCT03681951|4085739|FG006|NOT COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
3355743|NCT03681951|4085740|FG007|NOT COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
3355744|NCT03681951|4085733|FG000|STARTED|Part2:Combination Therapy(Upto 2yr90day)||0
3355745|NCT03681951|4085734|FG001|STARTED|Part2:Combination Therapy(Upto 2yr90day)||0
3355746|NCT03681951|4085735|FG002|STARTED|Part2:Combination Therapy(Upto 2yr90day)||0
3355747|NCT03681951|4085736|FG003|STARTED|Part2:Combination Therapy(Upto 2yr90day)||0
3355748|NCT03681951|4085737|FG004|STARTED|Part2:Combination Therapy(Upto 2yr90day)||0
3355749|NCT03681951|4085738|FG005|STARTED|Part2:Combination Therapy(Upto 2yr90day)||0
3355750|NCT03681951|4085739|FG006|STARTED|Part2:Combination Therapy(Upto 2yr90day)||0
3355751|NCT03681951|4085740|FG007|STARTED|Part2:Combination Therapy(Upto 2yr90day)||0
3355752|NCT03681951|4085733|FG000|COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
3355753|NCT03681951|4085734|FG001|COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
3355754|NCT03681951|4085735|FG002|COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
3355755|NCT03681951|4085736|FG003|COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
3355756|NCT03681951|4085737|FG004|COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
3355757|NCT03681951|4085738|FG005|COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
3355758|NCT03681951|4085739|FG006|COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
3355759|NCT03681951|4085740|FG007|COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
3355760|NCT03681951|4085733|FG000|NOT COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
3355761|NCT03681951|4085734|FG001|NOT COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
3355762|NCT03681951|4085735|FG002|NOT COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
3355763|NCT03681951|4085736|FG003|NOT COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
3355764|NCT03681951|4085737|FG004|NOT COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
3355765|NCT03681951|4085738|FG005|NOT COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
3355766|NCT03681951|4085739|FG006|NOT COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
3355767|NCT03681951|4085740|FG007|NOT COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
3355768|NCT03681951|4085733|FG000|STARTED|Part 3:Dose Expansion (Up to 2yr90day)||0
3355769|NCT03681951|4085734|FG001|STARTED|Part 3:Dose Expansion (Up to 2yr90day)||0
3355770|NCT03681951|4085735|FG002|STARTED|Part 3:Dose Expansion (Up to 2yr90day)||0
3355771|NCT03681951|4085736|FG003|STARTED|Part 3:Dose Expansion (Up to 2yr90day)||0
3355772|NCT03681951|4085737|FG004|STARTED|Part 3:Dose Expansion (Up to 2yr90day)||0
3355773|NCT03681951|4085738|FG005|STARTED|Part 3:Dose Expansion (Up to 2yr90day)||0
3355774|NCT03681951|4085739|FG006|STARTED|Part 3:Dose Expansion (Up to 2yr90day)||0
3355775|NCT03681951|4085740|FG007|STARTED|Part 3:Dose Expansion (Up to 2yr90day)||0
3355776|NCT03681951|4085733|FG000|COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
3179022|NCT01982448|3907172|FG001|COMPLETED|Definitive Breast Surgery||67
3179023|NCT01982448|3907171|FG000|NOT COMPLETED|Definitive Breast Surgery||0
3179024|NCT01982448|3907172|FG001|NOT COMPLETED|Definitive Breast Surgery||0
3355777|NCT03681951|4085734|FG001|COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
3179025|NCT01982539|3907182|FG000|STARTED|Overall Study||25
3179026|NCT01982539|3907182|FG000|COMPLETED|Overall Study||25
3355778|NCT03681951|4085735|FG002|COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
3355779|NCT03681951|4085736|FG003|COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
3355780|NCT03681951|4085737|FG004|COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
3355781|NCT03681951|4085738|FG005|COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
3355782|NCT03681951|4085739|FG006|COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
3355783|NCT03681951|4085740|FG007|COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
3355784|NCT03681951|4085733|FG000|NOT COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
3355785|NCT03681951|4085734|FG001|NOT COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
3355786|NCT03681951|4085735|FG002|NOT COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
3355787|NCT03681951|4085736|FG003|NOT COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
3355788|NCT03681951|4085737|FG004|NOT COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
3355789|NCT03681951|4085738|FG005|NOT COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
3355790|NCT03681951|4085739|FG006|NOT COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
3355791|NCT03681951|4085740|FG007|NOT COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
3355792|NCT03681951|4085733|FG000|STARTED|Part 4: Dose Expansion(Up to 2 yr90day)||0
3355793|NCT03681951|4085734|FG001|STARTED|Part 4: Dose Expansion(Up to 2 yr90day)||0
3355794|NCT03681951|4085735|FG002|STARTED|Part 4: Dose Expansion(Up to 2 yr90day)||0
3355795|NCT03681951|4085736|FG003|STARTED|Part 4: Dose Expansion(Up to 2 yr90day)||0
3355796|NCT03681951|4085737|FG004|STARTED|Part 4: Dose Expansion(Up to 2 yr90day)||0
3355797|NCT03681951|4085738|FG005|STARTED|Part 4: Dose Expansion(Up to 2 yr90day)||0
3355798|NCT03681951|4085739|FG006|STARTED|Part 4: Dose Expansion(Up to 2 yr90day)||0
3355799|NCT03681951|4085740|FG007|STARTED|Part 4: Dose Expansion(Up to 2 yr90day)||0
3355800|NCT03681951|4085733|FG000|COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
3355801|NCT03681951|4085734|FG001|COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
3355802|NCT03681951|4085735|FG002|COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
3355803|NCT03681951|4085736|FG003|COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
3355804|NCT03681951|4085737|FG004|COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
3355805|NCT03681951|4085738|FG005|COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
3355806|NCT03681951|4085739|FG006|COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
3355807|NCT03681951|4085740|FG007|COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
3355808|NCT03681951|4085733|FG000|NOT COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
3355809|NCT03681951|4085734|FG001|NOT COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
3355810|NCT03681951|4085735|FG002|NOT COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
3355811|NCT03681951|4085736|FG003|NOT COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
3355812|NCT03681951|4085737|FG004|NOT COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
3355813|NCT03681951|4085738|FG005|NOT COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
3355814|NCT03681951|4085739|FG006|NOT COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
3355815|NCT03681951|4085740|FG007|NOT COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
3355816|NCT03682107|4085768|FG000|STARTED|Overall Study||10
3355817|NCT03682107|4085769|FG001|STARTED|Overall Study||10
3355818|NCT03682107|4085770|FG002|STARTED|Overall Study||10
3355819|NCT03682107|4085771|FG003|STARTED|Overall Study||10
3355820|NCT03682107|4085772|FG004|STARTED|Overall Study||8
3355821|NCT03682107|4085768|FG000|COMPLETED|Overall Study||10
3355822|NCT03682107|4085769|FG001|COMPLETED|Overall Study||9
3355823|NCT03682107|4085770|FG002|COMPLETED|Overall Study||10
3355824|NCT03682107|4085771|FG003|COMPLETED|Overall Study||10
3355825|NCT03682107|4085772|FG004|COMPLETED|Overall Study||8
3355826|NCT03682107|4085768|FG000|NOT COMPLETED|Overall Study||0
3355827|NCT03682107|4085769|FG001|NOT COMPLETED|Overall Study||1
3355828|NCT03682107|4085770|FG002|NOT COMPLETED|Overall Study||0
3355829|NCT03682107|4085771|FG003|NOT COMPLETED|Overall Study||0
3355830|NCT03682107|4085772|FG004|NOT COMPLETED|Overall Study||0
3355831|NCT03682120|4085788|FG000|STARTED|Overall Study||105
3355832|NCT03682120|4085789|FG001|STARTED|Overall Study||105
3355833|NCT03682120|4085790|FG002|STARTED|Overall Study||105
3355834|NCT03682120|4085791|FG003|STARTED|Overall Study||57
3355835|NCT03682120|4085788|FG000|COMPLETED|Overall Study||92
3355836|NCT03682120|4085789|FG001|COMPLETED|Overall Study||97
3355837|NCT03682120|4085790|FG002|COMPLETED|Overall Study||97
3355838|NCT03682120|4085791|FG003|COMPLETED|Overall Study||55
3355839|NCT03682120|4085788|FG000|NOT COMPLETED|Overall Study||13
3355840|NCT03682120|4085789|FG001|NOT COMPLETED|Overall Study||8
3355841|NCT03682120|4085790|FG002|NOT COMPLETED|Overall Study||8
3355842|NCT03682120|4085791|FG003|NOT COMPLETED|Overall Study||2
3355843|NCT03682302|4085807|FG000|STARTED|Overall Study||31
3355844|NCT03682302|4085808|FG001|STARTED|Overall Study||30
3355845|NCT03682302|4085809|FG002|STARTED|Overall Study|1 subject enrolled in Group 2, not treated, and surgery type unknown. Subject is not counted here.|6
3355846|NCT03682302|4085810|FG003|STARTED|Overall Study|1 subject enrolled in Group 2, not treated, and surgery type unknown. Subject is not counted here.|30
3179027|NCT01982539|3907182|FG000|NOT COMPLETED|Overall Study||0
3179028|NCT01982643|3907186|FG000|STARTED|Overall Study||49
3355847|NCT03682302|4085807|FG000|COMPLETED|Overall Study||30
3355848|NCT03682302|4085808|FG001|COMPLETED|Overall Study||28
3355849|NCT03682302|4085809|FG002|COMPLETED|Overall Study||5
3355850|NCT03682302|4085810|FG003|COMPLETED|Overall Study||28
3355851|NCT03682302|4085807|FG000|NOT COMPLETED|Overall Study||1
3355852|NCT03682302|4085808|FG001|NOT COMPLETED|Overall Study||2
3355853|NCT03682302|4085809|FG002|NOT COMPLETED|Overall Study||1
3355854|NCT03682302|4085810|FG003|NOT COMPLETED|Overall Study||2
3355855|NCT03682705|4085826|FG000|STARTED|Overall Study||19
3355856|NCT03682705|4085827|FG001|STARTED|Overall Study||62
3355857|NCT03682705|4085828|FG002|STARTED|Overall Study||41
3355858|NCT03682705|4085829|FG003|STARTED|Overall Study||39
3355859|NCT03682705|4085830|FG004|STARTED|Overall Study||41
3355860|NCT03682705|4085831|FG005|STARTED|Overall Study||40
3355861|NCT03682705|4085826|FG000|COMPLETED|Overall Study||17
3355862|NCT03682705|4085827|FG001|COMPLETED|Overall Study||58
3355863|NCT03682705|4085828|FG002|COMPLETED|Overall Study||38
3355864|NCT03682705|4085829|FG003|COMPLETED|Overall Study||34
3355865|NCT03682705|4085830|FG004|COMPLETED|Overall Study||35
3355866|NCT03682705|4085831|FG005|COMPLETED|Overall Study||38
3355867|NCT03682705|4085826|FG000|NOT COMPLETED|Overall Study||2
3355868|NCT03682705|4085827|FG001|NOT COMPLETED|Overall Study||4
3355869|NCT03682705|4085828|FG002|NOT COMPLETED|Overall Study||3
3355870|NCT03682705|4085829|FG003|NOT COMPLETED|Overall Study||5
3355871|NCT03682705|4085830|FG004|NOT COMPLETED|Overall Study||6
3355872|NCT03682705|4085831|FG005|NOT COMPLETED|Overall Study||2
3355873|NCT03682809|4085847|FG000|STARTED|Overall Study||22
3355874|NCT03682809|4085848|FG001|STARTED|Overall Study||24
3355875|NCT03682809|4085847|FG000|COMPLETED|Overall Study||22
3355876|NCT03682809|4085848|FG001|COMPLETED|Overall Study||24
3355877|NCT03682809|4085847|FG000|NOT COMPLETED|Overall Study||0
3355878|NCT03682809|4085848|FG001|NOT COMPLETED|Overall Study||0
3355879|NCT03682965|4085856|FG000|STARTED|Overall Study||11
3355880|NCT03682965|4085857|FG001|STARTED|Overall Study||10
3355881|NCT03682965|4085856|FG000|COMPLETED|Overall Study||11
3355882|NCT03682965|4085857|FG001|COMPLETED|Overall Study||10
3355883|NCT03682965|4085856|FG000|NOT COMPLETED|Overall Study||0
3355884|NCT03682965|4085857|FG001|NOT COMPLETED|Overall Study||0
3355885|NCT03683576|4085867|FG000|STARTED|Overall Study||120
3355886|NCT03683576|4085868|FG001|STARTED|Overall Study||120
3355887|NCT03683576|4085869|FG002|STARTED|Overall Study||118
3355888|NCT03683576|4085870|FG003|STARTED|Overall Study||122
3355889|NCT03683576|4085867|FG000|COMPLETED|Overall Study||114
3355890|NCT03683576|4085868|FG001|COMPLETED|Overall Study||116
3355891|NCT03683576|4085869|FG002|COMPLETED|Overall Study||106
3355892|NCT03683576|4085870|FG003|COMPLETED|Overall Study||114
3355893|NCT03683576|4085867|FG000|NOT COMPLETED|Overall Study||6
3355894|NCT03683576|4085868|FG001|NOT COMPLETED|Overall Study||4
3355895|NCT03683576|4085869|FG002|NOT COMPLETED|Overall Study||12
3355896|NCT03683576|4085870|FG003|NOT COMPLETED|Overall Study||8
3355897|NCT03683719|4085885|FG000|STARTED|Overall Study||52
3355898|NCT03683719|4085886|FG001|STARTED|Overall Study||51
3355899|NCT03683719|4085887|FG002|STARTED|Overall Study||52
3179029|NCT01982643|3907186|FG000|COMPLETED|Overall Study||37
3179030|NCT01982643|3907186|FG000|NOT COMPLETED|Overall Study||12
3179031|NCT01982682|3907190|FG000|STARTED|Overall Study||41
3179032|NCT01982682|3907190|FG000|COMPLETED|Overall Study||40
3179033|NCT01982682|3907190|FG000|NOT COMPLETED|Overall Study||1
3179034|NCT01982695|3907197|FG000|STARTED|Overall Study||12
3179035|NCT01982695|3907198|FG001|STARTED|Overall Study||11
3179036|NCT01982695|3907197|FG000|COMPLETED|Overall Study||12
3179037|NCT01982695|3907198|FG001|COMPLETED|Overall Study||10
3179038|NCT01982695|3907197|FG000|NOT COMPLETED|Overall Study||0
3179039|NCT01982695|3907198|FG001|NOT COMPLETED|Overall Study||1
3179040|NCT01982773|3907206|FG000|STARTED|Overall Study||58
3179041|NCT01982773|3907207|FG001|STARTED|Overall Study||60
3179042|NCT01982773|3907206|FG000|COMPLETED|Overall Study||50
3179043|NCT01982773|3907207|FG001|COMPLETED|Overall Study||56
3179044|NCT01982773|3907206|FG000|NOT COMPLETED|Overall Study||8
3179045|NCT01982773|3907207|FG001|NOT COMPLETED|Overall Study||4
3179046|NCT01982786|3907215|FG000|STARTED|Overall Study||29
3179047|NCT01982786|3907216|FG001|STARTED|Overall Study||28
3179048|NCT01982786|3907215|FG000|COMPLETED|Overall Study||29
3179049|NCT01982786|3907216|FG001|COMPLETED|Overall Study||28
3179050|NCT01982786|3907215|FG000|NOT COMPLETED|Overall Study||0
3179051|NCT01982786|3907216|FG001|NOT COMPLETED|Overall Study||0
3179052|NCT01982812|3907224|FG000|STARTED|Overall Study||23
3179053|NCT01982812|3907225|FG001|STARTED|Overall Study||21
3179054|NCT01982812|3907224|FG000|COMPLETED|Overall Study||22
3179055|NCT01982812|3907225|FG001|COMPLETED|Overall Study||11
3179056|NCT01982812|3907224|FG000|NOT COMPLETED|Overall Study||1
3179057|NCT01982812|3907225|FG001|NOT COMPLETED|Overall Study||10
3179058|NCT01982942|3907233|FG000|STARTED|Overall Study||129
3179059|NCT01982942|3907234|FG001|STARTED|Overall Study||126
3179060|NCT01982942|3907233|FG000|COMPLETED|Overall Study||108
3179061|NCT01982942|3907234|FG001|COMPLETED|Overall Study||112
3179062|NCT01982942|3907233|FG000|NOT COMPLETED|Overall Study||21
3179063|NCT01982942|3907234|FG001|NOT COMPLETED|Overall Study||14
3355900|NCT03683719|4085888|FG003|STARTED|Overall Study||53
3355901|NCT03683719|4085889|FG004|STARTED|Overall Study||50
3355902|NCT03683719|4085885|FG000|COMPLETED|Overall Study||40
3179064|NCT01982955|3907245|FG000|STARTED|Overall Study||6
3179065|NCT01982955|3907246|FG001|STARTED|Overall Study||12
3179066|NCT01982955|3907247|FG002|STARTED|Overall Study||31
3179067|NCT01982955|3907248|FG003|STARTED|Overall Study||24
3179068|NCT01982955|3907249|FG004|STARTED|Overall Study||15
3179069|NCT01982955|3907245|FG000|Treated|Overall Study||6
3179070|NCT01982955|3907246|FG001|Treated|Overall Study||12
3179071|NCT01982955|3907247|FG002|Treated|Overall Study||31
3179072|NCT01982955|3907248|FG003|Treated|Overall Study||23
3179073|NCT01982955|3907249|FG004|Treated|Overall Study||15
3179074|NCT01982955|3907245|FG000|COMPLETED|Overall Study||6
3179075|NCT01982955|3907246|FG001|COMPLETED|Overall Study||12
3179076|NCT01982955|3907247|FG002|COMPLETED|Overall Study||27
3179077|NCT01982955|3907248|FG003|COMPLETED|Overall Study||23
3179078|NCT01982955|3907249|FG004|COMPLETED|Overall Study||15
3179079|NCT01982955|3907245|FG000|NOT COMPLETED|Overall Study||0
3179080|NCT01982955|3907246|FG001|NOT COMPLETED|Overall Study||0
3179081|NCT01982955|3907247|FG002|NOT COMPLETED|Overall Study||4
3179082|NCT01982955|3907248|FG003|NOT COMPLETED|Overall Study||1
3179083|NCT01982955|3907249|FG004|NOT COMPLETED|Overall Study||0
3179084|NCT01982968|3907264|FG000|STARTED|Overall Study||29
3179085|NCT01982968|3907265|FG001|STARTED|Overall Study||29
3355903|NCT03683719|4085886|FG001|COMPLETED|Overall Study||38
3355904|NCT03683719|4085887|FG002|COMPLETED|Overall Study||44
3355905|NCT03683719|4085888|FG003|COMPLETED|Overall Study||46
3355906|NCT03683719|4085889|FG004|COMPLETED|Overall Study||36
3355907|NCT03683719|4085885|FG000|NOT COMPLETED|Overall Study||12
3355908|NCT03683719|4085886|FG001|NOT COMPLETED|Overall Study||13
3355909|NCT03683719|4085887|FG002|NOT COMPLETED|Overall Study||8
3355910|NCT03683719|4085888|FG003|NOT COMPLETED|Overall Study||7
3355911|NCT03683719|4085889|FG004|NOT COMPLETED|Overall Study||14
3355912|NCT03683758|4085903|FG000|STARTED|Overall Study||11
3355913|NCT03683758|4085904|FG001|STARTED|Overall Study||10
3355914|NCT03683758|4085903|FG000|COMPLETED|Overall Study||8
3355915|NCT03683758|4085904|FG001|COMPLETED|Overall Study||7
3355916|NCT03683758|4085903|FG000|NOT COMPLETED|Overall Study||3
3355917|NCT03683758|4085904|FG001|NOT COMPLETED|Overall Study||3
3355918|NCT03683901|4085910|FG000|STARTED|Overall Study||10
3355919|NCT03683901|4085910|FG000|COMPLETED|Overall Study||10
3355920|NCT03683901|4085910|FG000|NOT COMPLETED|Overall Study||0
3355921|NCT03684044|4085918|FG000|STARTED|Overall Study||239
3355922|NCT03684044|4085919|FG001|STARTED|Overall Study||124
3355923|NCT03684044|4085918|FG000|COMPLETED|Overall Study||217
3355924|NCT03684044|4085919|FG001|COMPLETED|Overall Study||104
3355925|NCT03684044|4085918|FG000|NOT COMPLETED|Overall Study||22
3355926|NCT03684044|4085919|FG001|NOT COMPLETED|Overall Study||20
3355927|NCT03684265|4085927|FG000|STARTED|Treatment Period 1||13
3355928|NCT03684265|4085928|FG001|STARTED|Treatment Period 1||13
3355929|NCT03684265|4085927|FG000|COMPLETED|Treatment Period 1||13
3355930|NCT03684265|4085928|FG001|COMPLETED|Treatment Period 1||13
3355931|NCT03684265|4085927|FG000|NOT COMPLETED|Treatment Period 1||0
3355932|NCT03684265|4085928|FG001|NOT COMPLETED|Treatment Period 1||0
3355933|NCT03684265|4085927|FG000|STARTED|Washout Period of 1 Week||13
3355934|NCT03684265|4085928|FG001|STARTED|Washout Period of 1 Week||13
3355935|NCT03684265|4085927|FG000|COMPLETED|Washout Period of 1 Week||13
3355936|NCT03684265|4085928|FG001|COMPLETED|Washout Period of 1 Week||13
3355937|NCT03684265|4085927|FG000|NOT COMPLETED|Washout Period of 1 Week||0
3355938|NCT03684265|4085928|FG001|NOT COMPLETED|Washout Period of 1 Week||0
3355939|NCT03684265|4085927|FG000|STARTED|Treatment Period 2||13
3355940|NCT03684265|4085928|FG001|STARTED|Treatment Period 2||13
3355941|NCT03684265|4085927|FG000|COMPLETED|Treatment Period 2||13
3355942|NCT03684265|4085928|FG001|COMPLETED|Treatment Period 2||13
3355943|NCT03684265|4085927|FG000|NOT COMPLETED|Treatment Period 2||0
3355944|NCT03684265|4085928|FG001|NOT COMPLETED|Treatment Period 2||0
3355945|NCT03684642|4085937|FG000|STARTED|Overall Study||303
3355946|NCT03684642|4085938|FG001|STARTED|Overall Study||302
3355947|NCT03684642|4085939|FG002|STARTED|Overall Study||303
3355948|NCT03684642|4085937|FG000|Treated|Overall Study||303
3355949|NCT03684642|4085938|FG001|Treated|Overall Study||302
3355950|NCT03684642|4085939|FG002|Treated|Overall Study||302
3355951|NCT03684642|4085937|FG000|Safety Population|Overall Study|For safety analysis participants are included in the treatment group that they are exposed for longer duration. 10 participants randomized to Efpeglenatide 6 mg received 4 mg dose for longer duration, and considered in the Efpeglenatide 4 mg group for safety analysis.|313
3355952|NCT03684642|4085938|FG001|Safety Population|Overall Study||292
3355953|NCT03684642|4085939|FG002|Safety Population|Overall Study||302
3355954|NCT03684642|4085937|FG000|COMPLETED|Overall Study||200
3355955|NCT03684642|4085938|FG001|COMPLETED|Overall Study||169
3355956|NCT03684642|4085939|FG002|COMPLETED|Overall Study||197
3355957|NCT03684642|4085937|FG000|NOT COMPLETED|Overall Study||103
3355958|NCT03684642|4085938|FG001|NOT COMPLETED|Overall Study||133
3355959|NCT03684642|4085939|FG002|NOT COMPLETED|Overall Study||106
3355960|NCT03684928|4085947|FG000|STARTED|First Intervention||23
3355961|NCT03684928|4085948|FG001|STARTED|First Intervention||22
3179086|NCT01982968|3907264|FG000|COMPLETED|Overall Study||21
3179087|NCT01982968|3907265|FG001|COMPLETED|Overall Study||27
3179088|NCT01982968|3907264|FG000|NOT COMPLETED|Overall Study||8
3179089|NCT01982968|3907265|FG001|NOT COMPLETED|Overall Study||2
3179090|NCT01983020|3907275|FG000|STARTED|Overall Study||12
3179091|NCT01983020|3907276|FG001|STARTED|Overall Study||11
3179092|NCT01983020|3907277|FG002|STARTED|Overall Study||12
3355962|NCT03684928|4085947|FG000|COMPLETED|First Intervention||23
3355963|NCT03684928|4085948|FG001|COMPLETED|First Intervention||19
3355964|NCT03684928|4085947|FG000|NOT COMPLETED|First Intervention||0
3355965|NCT03684928|4085948|FG001|NOT COMPLETED|First Intervention||3
3355966|NCT03684928|4085947|FG000|STARTED|Second Intervention|Two participants discontinued between the first intervention and second intervention.|21
3355967|NCT03684928|4085948|FG001|STARTED|Second Intervention||19
3355968|NCT03684928|4085947|FG000|COMPLETED|Second Intervention||20
3355969|NCT03684928|4085948|FG001|COMPLETED|Second Intervention||19
3355970|NCT03684928|4085947|FG000|NOT COMPLETED|Second Intervention||1
3355971|NCT03684928|4085948|FG001|NOT COMPLETED|Second Intervention||0
3355972|NCT03685344|4085958|FG000|STARTED|Overall Study||3
3355973|NCT03685344|4085959|FG001|STARTED|Overall Study||3
3355974|NCT03685344|4085960|FG002|STARTED|Overall Study||7
3355975|NCT03685344|4085961|FG003|STARTED|Overall Study||0
3355976|NCT03685344|4085958|FG000|Received Treatment|Overall Study||3
3355977|NCT03685344|4085959|FG001|Received Treatment|Overall Study||3
3355978|NCT03685344|4085960|FG002|Received Treatment|Overall Study||7
3355979|NCT03685344|4085961|FG003|Received Treatment|Overall Study||0
3355980|NCT03685344|4085958|FG000|COMPLETED|Overall Study||0
3355981|NCT03685344|4085959|FG001|COMPLETED|Overall Study||0
3355982|NCT03685344|4085960|FG002|COMPLETED|Overall Study||0
3355983|NCT03685344|4085961|FG003|COMPLETED|Overall Study||0
3355984|NCT03685344|4085958|FG000|NOT COMPLETED|Overall Study||3
3355985|NCT03685344|4085959|FG001|NOT COMPLETED|Overall Study||3
3355986|NCT03685344|4085960|FG002|NOT COMPLETED|Overall Study||7
3355987|NCT03685344|4085961|FG003|NOT COMPLETED|Overall Study||0
3355988|NCT03685396|4085973|FG000|STARTED|Overall Study||21
3355989|NCT03685396|4085974|FG001|STARTED|Overall Study||21
3355990|NCT03685396|4085973|FG000|COMPLETED|Overall Study||21
3355991|NCT03685396|4085974|FG001|COMPLETED|Overall Study||21
3355992|NCT03685396|4085973|FG000|NOT COMPLETED|Overall Study||0
3355993|NCT03685396|4085974|FG001|NOT COMPLETED|Overall Study||0
3355994|NCT03685643|4085982|FG000|STARTED|Overall Study||290
3355995|NCT03685643|4085983|FG001|STARTED|Overall Study||288
3355996|NCT03685643|4085982|FG000|COMPLETED|Overall Study||276
3355997|NCT03685643|4085983|FG001|COMPLETED|Overall Study||266
3355998|NCT03685643|4085982|FG000|NOT COMPLETED|Overall Study||14
3355999|NCT03685643|4085983|FG001|NOT COMPLETED|Overall Study||22
3356000|NCT03685968|4085992|FG000|STARTED|Overall Study||75
3356001|NCT03685968|4085993|FG001|STARTED|Overall Study||75
3356002|NCT03685968|4085994|FG002|STARTED|Overall Study||75
3356003|NCT03685968|4085992|FG000|COMPLETED|Overall Study||75
3356004|NCT03685968|4085993|FG001|COMPLETED|Overall Study||75
3356005|NCT03685968|4085994|FG002|COMPLETED|Overall Study||75
3356006|NCT03685968|4085992|FG000|NOT COMPLETED|Overall Study||0
3356007|NCT03685968|4085993|FG001|NOT COMPLETED|Overall Study||0
3356008|NCT03685968|4085994|FG002|NOT COMPLETED|Overall Study||0
3356009|NCT03686033|4086002|FG000|STARTED|Treatment Period 1 (1 Day)||1
3356010|NCT03686033|4086003|FG001|STARTED|Treatment Period 1 (1 Day)||1
3356011|NCT03686033|4086004|FG002|STARTED|Treatment Period 1 (1 Day)||1
3356012|NCT03686033|4086005|FG003|STARTED|Treatment Period 1 (1 Day)||1
3356013|NCT03686033|4086006|FG004|STARTED|Treatment Period 1 (1 Day)||1
3356014|NCT03686033|4086007|FG005|STARTED|Treatment Period 1 (1 Day)||0
3356015|NCT03686033|4086002|FG000|COMPLETED|Treatment Period 1 (1 Day)||1
3356016|NCT03686033|4086003|FG001|COMPLETED|Treatment Period 1 (1 Day)||1
3356017|NCT03686033|4086004|FG002|COMPLETED|Treatment Period 1 (1 Day)||1
3356018|NCT03686033|4086005|FG003|COMPLETED|Treatment Period 1 (1 Day)||1
3356019|NCT03686033|4086006|FG004|COMPLETED|Treatment Period 1 (1 Day)||1
3356020|NCT03686033|4086007|FG005|COMPLETED|Treatment Period 1 (1 Day)||0
3356021|NCT03686033|4086002|FG000|NOT COMPLETED|Treatment Period 1 (1 Day)||0
3356022|NCT03686033|4086003|FG001|NOT COMPLETED|Treatment Period 1 (1 Day)||0
3356023|NCT03686033|4086004|FG002|NOT COMPLETED|Treatment Period 1 (1 Day)||0
3356024|NCT03686033|4086005|FG003|NOT COMPLETED|Treatment Period 1 (1 Day)||0
3356025|NCT03686033|4086006|FG004|NOT COMPLETED|Treatment Period 1 (1 Day)||0
3356026|NCT03686033|4086007|FG005|NOT COMPLETED|Treatment Period 1 (1 Day)||0
3356027|NCT03686033|4086002|FG000|STARTED|Washout Phase (at Least 2 Weeks)||1
3356028|NCT03686033|4086003|FG001|STARTED|Washout Phase (at Least 2 Weeks)||1
3356029|NCT03686033|4086004|FG002|STARTED|Washout Phase (at Least 2 Weeks)||1
3356030|NCT03686033|4086005|FG003|STARTED|Washout Phase (at Least 2 Weeks)||1
3356031|NCT03686033|4086006|FG004|STARTED|Washout Phase (at Least 2 Weeks)||1
3356032|NCT03686033|4086007|FG005|STARTED|Washout Phase (at Least 2 Weeks)||0
3356033|NCT03686033|4086002|FG000|COMPLETED|Washout Phase (at Least 2 Weeks)||1
3356034|NCT03686033|4086003|FG001|COMPLETED|Washout Phase (at Least 2 Weeks)||1
3356035|NCT03686033|4086004|FG002|COMPLETED|Washout Phase (at Least 2 Weeks)||1
3356036|NCT03686033|4086005|FG003|COMPLETED|Washout Phase (at Least 2 Weeks)||1
3356037|NCT03686033|4086006|FG004|COMPLETED|Washout Phase (at Least 2 Weeks)||1
3356038|NCT03686033|4086007|FG005|COMPLETED|Washout Phase (at Least 2 Weeks)||0
3356039|NCT03686033|4086002|FG000|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
3356040|NCT03686033|4086003|FG001|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
3356041|NCT03686033|4086004|FG002|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
3356042|NCT03686033|4086005|FG003|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
3356043|NCT03686033|4086006|FG004|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
3356044|NCT03686033|4086007|FG005|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
3356045|NCT03686033|4086002|FG000|STARTED|Treatment Period 2 (1 Day)||1
3356046|NCT03686033|4086003|FG001|STARTED|Treatment Period 2 (1 Day)||1
3356047|NCT03686033|4086004|FG002|STARTED|Treatment Period 2 (1 Day)||1
3356048|NCT03686033|4086005|FG003|STARTED|Treatment Period 2 (1 Day)||1
3356049|NCT03686033|4086006|FG004|STARTED|Treatment Period 2 (1 Day)||1
3356050|NCT03686033|4086007|FG005|STARTED|Treatment Period 2 (1 Day)||0
3356051|NCT03686033|4086002|FG000|COMPLETED|Treatment Period 2 (1 Day)||1
3356052|NCT03686033|4086003|FG001|COMPLETED|Treatment Period 2 (1 Day)||1
3356053|NCT03686033|4086004|FG002|COMPLETED|Treatment Period 2 (1 Day)||1
3356054|NCT03686033|4086005|FG003|COMPLETED|Treatment Period 2 (1 Day)||1
3356055|NCT03686033|4086006|FG004|COMPLETED|Treatment Period 2 (1 Day)||0
3356056|NCT03686033|4086007|FG005|COMPLETED|Treatment Period 2 (1 Day)||0
3356057|NCT03686033|4086002|FG000|NOT COMPLETED|Treatment Period 2 (1 Day)||0
3356058|NCT03686033|4086003|FG001|NOT COMPLETED|Treatment Period 2 (1 Day)||0
3356059|NCT03686033|4086004|FG002|NOT COMPLETED|Treatment Period 2 (1 Day)||0
3356060|NCT03686033|4086005|FG003|NOT COMPLETED|Treatment Period 2 (1 Day)||0
3356061|NCT03686033|4086006|FG004|NOT COMPLETED|Treatment Period 2 (1 Day)||1
3356062|NCT03686033|4086007|FG005|NOT COMPLETED|Treatment Period 2 (1 Day)||0
3356063|NCT03686033|4086002|FG000|STARTED|Washout Phase (at Least 2 Weeks)||1
3356064|NCT03686033|4086003|FG001|STARTED|Washout Phase (at Least 2 Weeks)||1
3356065|NCT03686033|4086004|FG002|STARTED|Washout Phase (at Least 2 Weeks)||1
3356066|NCT03686033|4086005|FG003|STARTED|Washout Phase (at Least 2 Weeks)||1
3356067|NCT03686033|4086006|FG004|STARTED|Washout Phase (at Least 2 Weeks)||0
3356068|NCT03686033|4086007|FG005|STARTED|Washout Phase (at Least 2 Weeks)||0
3356069|NCT03686033|4086002|FG000|COMPLETED|Washout Phase (at Least 2 Weeks)||1
3356070|NCT03686033|4086003|FG001|COMPLETED|Washout Phase (at Least 2 Weeks)||1
3356071|NCT03686033|4086004|FG002|COMPLETED|Washout Phase (at Least 2 Weeks)||1
3356072|NCT03686033|4086005|FG003|COMPLETED|Washout Phase (at Least 2 Weeks)||1
3356073|NCT03686033|4086006|FG004|COMPLETED|Washout Phase (at Least 2 Weeks)||0
3356074|NCT03686033|4086007|FG005|COMPLETED|Washout Phase (at Least 2 Weeks)||0
3356075|NCT03686033|4086002|FG000|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
3356076|NCT03686033|4086003|FG001|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
3356077|NCT03686033|4086004|FG002|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
3356078|NCT03686033|4086005|FG003|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
3356079|NCT03686033|4086006|FG004|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
3356080|NCT03686033|4086007|FG005|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
3356081|NCT03686033|4086002|FG000|STARTED|Treatment Period 3 (1 Day)||1
3356082|NCT03686033|4086003|FG001|STARTED|Treatment Period 3 (1 Day)||1
3356083|NCT03686033|4086004|FG002|STARTED|Treatment Period 3 (1 Day)||1
3356084|NCT03686033|4086005|FG003|STARTED|Treatment Period 3 (1 Day)||1
3356085|NCT03686033|4086006|FG004|STARTED|Treatment Period 3 (1 Day)||0
3356086|NCT03686033|4086007|FG005|STARTED|Treatment Period 3 (1 Day)||0
3356087|NCT03686033|4086002|FG000|COMPLETED|Treatment Period 3 (1 Day)||1
3356088|NCT03686033|4086003|FG001|COMPLETED|Treatment Period 3 (1 Day)||1
3356089|NCT03686033|4086004|FG002|COMPLETED|Treatment Period 3 (1 Day)||1
3356090|NCT03686033|4086005|FG003|COMPLETED|Treatment Period 3 (1 Day)||1
3356091|NCT03686033|4086006|FG004|COMPLETED|Treatment Period 3 (1 Day)||0
3356092|NCT03686033|4086007|FG005|COMPLETED|Treatment Period 3 (1 Day)||0
3356093|NCT03686033|4086002|FG000|NOT COMPLETED|Treatment Period 3 (1 Day)||0
3356094|NCT03686033|4086003|FG001|NOT COMPLETED|Treatment Period 3 (1 Day)||0
3356095|NCT03686033|4086004|FG002|NOT COMPLETED|Treatment Period 3 (1 Day)||0
3356096|NCT03686033|4086005|FG003|NOT COMPLETED|Treatment Period 3 (1 Day)||0
3356097|NCT03686033|4086006|FG004|NOT COMPLETED|Treatment Period 3 (1 Day)||0
3356098|NCT03686033|4086007|FG005|NOT COMPLETED|Treatment Period 3 (1 Day)||0
3356099|NCT03686033|4086002|FG000|STARTED|Washout Phase (at Least 2 Weeks)||1
3356100|NCT03686033|4086003|FG001|STARTED|Washout Phase (at Least 2 Weeks)||1
3356101|NCT03686033|4086004|FG002|STARTED|Washout Phase (at Least 2 Weeks)||1
3356102|NCT03686033|4086005|FG003|STARTED|Washout Phase (at Least 2 Weeks)||1
3356103|NCT03686033|4086006|FG004|STARTED|Washout Phase (at Least 2 Weeks)||0
3356104|NCT03686033|4086007|FG005|STARTED|Washout Phase (at Least 2 Weeks)||0
3356105|NCT03686033|4086002|FG000|COMPLETED|Washout Phase (at Least 2 Weeks)||1
3356106|NCT03686033|4086003|FG001|COMPLETED|Washout Phase (at Least 2 Weeks)||1
3356107|NCT03686033|4086004|FG002|COMPLETED|Washout Phase (at Least 2 Weeks)||1
3356108|NCT03686033|4086005|FG003|COMPLETED|Washout Phase (at Least 2 Weeks)||1
3356109|NCT03686033|4086006|FG004|COMPLETED|Washout Phase (at Least 2 Weeks)||0
3356110|NCT03686033|4086007|FG005|COMPLETED|Washout Phase (at Least 2 Weeks)||0
3356111|NCT03686033|4086002|FG000|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
3356112|NCT03686033|4086003|FG001|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
3356113|NCT03686033|4086004|FG002|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
3356114|NCT03686033|4086005|FG003|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
3356115|NCT03686033|4086006|FG004|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
3356116|NCT03686033|4086007|FG005|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
3356117|NCT03686033|4086002|FG000|STARTED|Treatment Period 4 (1 Day)||1
3356118|NCT03686033|4086003|FG001|STARTED|Treatment Period 4 (1 Day)||1
3356119|NCT03686033|4086004|FG002|STARTED|Treatment Period 4 (1 Day)||1
3356120|NCT03686033|4086005|FG003|STARTED|Treatment Period 4 (1 Day)||1
3356121|NCT03686033|4086006|FG004|STARTED|Treatment Period 4 (1 Day)||0
3356122|NCT03686033|4086007|FG005|STARTED|Treatment Period 4 (1 Day)||0
3356123|NCT03686033|4086002|FG000|COMPLETED|Treatment Period 4 (1 Day)||1
3356124|NCT03686033|4086003|FG001|COMPLETED|Treatment Period 4 (1 Day)||1
3356125|NCT03686033|4086004|FG002|COMPLETED|Treatment Period 4 (1 Day)||1
3356126|NCT03686033|4086005|FG003|COMPLETED|Treatment Period 4 (1 Day)||1
3356127|NCT03686033|4086006|FG004|COMPLETED|Treatment Period 4 (1 Day)||0
3356128|NCT03686033|4086007|FG005|COMPLETED|Treatment Period 4 (1 Day)||0
3356129|NCT03686033|4086002|FG000|NOT COMPLETED|Treatment Period 4 (1 Day)||0
3356130|NCT03686033|4086003|FG001|NOT COMPLETED|Treatment Period 4 (1 Day)||0
3356131|NCT03686033|4086004|FG002|NOT COMPLETED|Treatment Period 4 (1 Day)||0
3356132|NCT03686033|4086005|FG003|NOT COMPLETED|Treatment Period 4 (1 Day)||0
3356133|NCT03686033|4086006|FG004|NOT COMPLETED|Treatment Period 4 (1 Day)||0
3356134|NCT03686033|4086007|FG005|NOT COMPLETED|Treatment Period 4 (1 Day)||0
3356135|NCT03686176|4086024|FG000|STARTED|Overall Study||19
3356136|NCT03686176|4086025|FG001|STARTED|Overall Study||25
3356137|NCT03686176|4086026|FG002|STARTED|Overall Study||20
3356138|NCT03686176|4086024|FG000|COMPLETED|Overall Study||17
3356139|NCT03686176|4086025|FG001|COMPLETED|Overall Study||25
3356140|NCT03686176|4086026|FG002|COMPLETED|Overall Study||20
3356141|NCT03686176|4086024|FG000|NOT COMPLETED|Overall Study||2
3356142|NCT03686176|4086025|FG001|NOT COMPLETED|Overall Study||0
3356143|NCT03686176|4086026|FG002|NOT COMPLETED|Overall Study||0
3356144|NCT03687125|4086036|FG000|STARTED|Overall Study||3
3356145|NCT03687125|4086037|FG001|STARTED|Overall Study||3
3356146|NCT03687125|4086036|FG000|COMPLETED|Overall Study||0
3179093|NCT01983020|3907278|FG003|STARTED|Overall Study||11
3179094|NCT01983020|3907275|FG000|COMPLETED|Overall Study||12
3179095|NCT01983020|3907276|FG001|COMPLETED|Overall Study||11
3356147|NCT03687125|4086037|FG001|COMPLETED|Overall Study||2
3356148|NCT03687125|4086036|FG000|NOT COMPLETED|Overall Study||3
3356149|NCT03687125|4086037|FG001|NOT COMPLETED|Overall Study||1
3356150|NCT03687372|4086047|FG000|STARTED|Overall Study||254
3356151|NCT03687372|4086048|FG001|STARTED|Overall Study||249
3356152|NCT03687372|4086047|FG000|COMPLETED|Overall Study||237
3356153|NCT03687372|4086048|FG001|COMPLETED|Overall Study||210
3356154|NCT03687372|4086047|FG000|NOT COMPLETED|Overall Study||17
3356155|NCT03687372|4086048|FG001|NOT COMPLETED|Overall Study||39
3356156|NCT03687450|4086058|FG000|STARTED|Overall Study||38
3356157|NCT03687450|4086059|FG001|STARTED|Overall Study||18
3356158|NCT03687450|4086058|FG000|Post-Program Follow-Up|Overall Study|1 withdrew, 9 lost to follow-up|28
3356159|NCT03687450|4086059|FG001|Post-Program Follow-Up|Overall Study|3 lost to follow-up|15
3356160|NCT03687450|4086058|FG000|Two-month Follow-up|Overall Study|2 lost to follow-up|26
3356161|NCT03687450|4086059|FG001|Two-month Follow-up|Overall Study|2 lost to follow-up (N.B. 1 participant completed 2-month follow-up but not post-program follow-up)|16
3356162|NCT03687450|4086058|FG000|COMPLETED|Overall Study||26
3356163|NCT03687450|4086059|FG001|COMPLETED|Overall Study||16
3356164|NCT03687450|4086058|FG000|NOT COMPLETED|Overall Study||12
3356165|NCT03687450|4086059|FG001|NOT COMPLETED|Overall Study||2
3356166|NCT03687684|4086074|FG000|STARTED|Overall Study||4
3356167|NCT03687684|4086075|FG001|STARTED|Overall Study||2
3356168|NCT03687684|4086076|FG002|STARTED|Overall Study||2
3179096|NCT01983020|3907277|FG002|COMPLETED|Overall Study||12
3179097|NCT01983020|3907278|FG003|COMPLETED|Overall Study||11
3179098|NCT01983020|3907275|FG000|NOT COMPLETED|Overall Study||0
3179099|NCT01983020|3907276|FG001|NOT COMPLETED|Overall Study||0
3179100|NCT01983020|3907277|FG002|NOT COMPLETED|Overall Study||0
3179101|NCT01983020|3907278|FG003|NOT COMPLETED|Overall Study||0
3179102|NCT01983111|3907290|FG000|STARTED|Overall Study||70
3179103|NCT01983111|3907291|FG001|STARTED|Overall Study||66
3179104|NCT01983111|3907290|FG000|COMPLETED|Overall Study||58
3356169|NCT03687684|4086077|FG003|STARTED|Overall Study||6
3356170|NCT03687684|4086078|FG004|STARTED|Overall Study||6
3356171|NCT03687684|4086079|FG005|STARTED|Overall Study||6
3356172|NCT03687684|4086080|FG006|STARTED|Overall Study||6
3356173|NCT03687684|4086081|FG007|STARTED|Overall Study||2
3356174|NCT03687684|4086082|FG008|STARTED|Overall Study||6
3356175|NCT03687684|4086074|FG000|COMPLETED|Overall Study||4
3356176|NCT03687684|4086075|FG001|COMPLETED|Overall Study||2
3356177|NCT03687684|4086076|FG002|COMPLETED|Overall Study||2
3356178|NCT03687684|4086077|FG003|COMPLETED|Overall Study||6
3356179|NCT03687684|4086078|FG004|COMPLETED|Overall Study||6
3356180|NCT03687684|4086079|FG005|COMPLETED|Overall Study||6
3356181|NCT03687684|4086080|FG006|COMPLETED|Overall Study||6
3356182|NCT03687684|4086081|FG007|COMPLETED|Overall Study||2
3356183|NCT03687684|4086082|FG008|COMPLETED|Overall Study||6
3356184|NCT03687684|4086074|FG000|NOT COMPLETED|Overall Study||0
3356185|NCT03687684|4086075|FG001|NOT COMPLETED|Overall Study||0
3356186|NCT03687684|4086076|FG002|NOT COMPLETED|Overall Study||0
3356187|NCT03687684|4086077|FG003|NOT COMPLETED|Overall Study||0
3356188|NCT03687684|4086078|FG004|NOT COMPLETED|Overall Study||0
3356189|NCT03687684|4086079|FG005|NOT COMPLETED|Overall Study||0
3356190|NCT03687684|4086080|FG006|NOT COMPLETED|Overall Study||0
3356191|NCT03687684|4086081|FG007|NOT COMPLETED|Overall Study||0
3356192|NCT03687684|4086082|FG008|NOT COMPLETED|Overall Study||0
3356193|NCT03687736|4086112|FG000|STARTED|Overall Study||120
3356194|NCT03687736|4086112|FG000|COMPLETED|Overall Study||110
3179105|NCT01983111|3907291|FG001|COMPLETED|Overall Study||59
3356195|NCT03687736|4086112|FG000|NOT COMPLETED|Overall Study||10
3356196|NCT03687827|4086118|FG000|STARTED|Treatment Period 1||249
3356197|NCT03687827|4086119|FG001|STARTED|Treatment Period 1||249
3356198|NCT03687827|4086118|FG000|Full Analysis Set (FAS)|Treatment Period 1||249
3356199|NCT03687827|4086119|FG001|Full Analysis Set (FAS)|Treatment Period 1||249
3356200|NCT03687827|4086118|FG000|Safety Analysis Set (SAS)|Treatment Period 1||249
3356201|NCT03687827|4086119|FG001|Safety Analysis Set (SAS)|Treatment Period 1||249
3356202|NCT03687827|4086118|FG000|Per Protocol Set|Treatment Period 1||219
3356203|NCT03687827|4086119|FG001|Per Protocol Set|Treatment Period 1||229
3356204|NCT03687827|4086118|FG000|COMPLETED|Treatment Period 1||235
3356205|NCT03687827|4086119|FG001|COMPLETED|Treatment Period 1||241
3356206|NCT03687827|4086118|FG000|NOT COMPLETED|Treatment Period 1||14
3356207|NCT03687827|4086119|FG001|NOT COMPLETED|Treatment Period 1||8
3356208|NCT03687827|4086118|FG000|STARTED|Treatment Period 2||235
3356209|NCT03687827|4086119|FG001|STARTED|Treatment Period 2||241
3356210|NCT03687827|4086118|FG000|COMPLETED|Treatment Period 2||230
3356211|NCT03687827|4086119|FG001|COMPLETED|Treatment Period 2||238
3356212|NCT03687827|4086118|FG000|NOT COMPLETED|Treatment Period 2||5
3356213|NCT03687827|4086119|FG001|NOT COMPLETED|Treatment Period 2||3
3356214|NCT03687970|4086127|FG000|STARTED|Overall Study||22
3356215|NCT03687970|4086128|FG001|STARTED|Overall Study||20
3179106|NCT01983111|3907290|FG000|NOT COMPLETED|Overall Study||12
3179107|NCT01983111|3907291|FG001|NOT COMPLETED|Overall Study||7
3179108|NCT01983228|3907299|FG000|STARTED|Overall Study||249
3179109|NCT01983228|3907300|FG001|STARTED|Overall Study||251
3179110|NCT01983228|3907299|FG000|COMPLETED|Overall Study||211
3179111|NCT01983228|3907300|FG001|COMPLETED|Overall Study||189
3179112|NCT01983228|3907299|FG000|NOT COMPLETED|Overall Study||38
3179113|NCT01983228|3907300|FG001|NOT COMPLETED|Overall Study||62
3356216|NCT03687970|4086127|FG000|COMPLETED|Overall Study||20
3356217|NCT03687970|4086128|FG001|COMPLETED|Overall Study||20
3356218|NCT03687970|4086127|FG000|NOT COMPLETED|Overall Study||2
3356219|NCT03687970|4086128|FG001|NOT COMPLETED|Overall Study||0
3356220|NCT03688282|4086136|FG000|STARTED|Sham Treatment for 30 Minutes||18
3356221|NCT03688282|4086136|FG000|COMPLETED|Sham Treatment for 30 Minutes||17
3356222|NCT03688282|4086136|FG000|NOT COMPLETED|Sham Treatment for 30 Minutes||1
3356223|NCT03688282|4086136|FG000|STARTED|Washout (7 Days)||17
3356224|NCT03688282|4086136|FG000|COMPLETED|Washout (7 Days)||17
3356225|NCT03688282|4086136|FG000|NOT COMPLETED|Washout (7 Days)||0
3356226|NCT03688282|4086136|FG000|STARTED|Active Treatment for 30 Minutes||17
3356227|NCT03688282|4086136|FG000|COMPLETED|Active Treatment for 30 Minutes||17
3356228|NCT03688282|4086136|FG000|NOT COMPLETED|Active Treatment for 30 Minutes||0
3356229|NCT03688542|4086144|FG000|STARTED|Overall Study|No individual participants were recruited, only nursing homes.|
3356230|NCT03688542|4086145|FG001|STARTED|Overall Study|No individual participants were recruited, only nursing homes.|
3356231|NCT03688542|4086144|FG000|COMPLETED|Overall Study|No individual participants were recruited, only nursing homes.|
3356232|NCT03688542|4086145|FG001|COMPLETED|Overall Study|"1 nursing home withdrew from the study.~No individual participants were recruited, only nursing homes."|
3356233|NCT03688542|4086144|FG000|NOT COMPLETED|Overall Study||
3356234|NCT03688542|4086145|FG001|NOT COMPLETED|Overall Study||
3356235|NCT03688620|4086154|FG000|STARTED|Overall Study||329
3356236|NCT03688620|4086155|FG001|STARTED|Overall Study||278
3356237|NCT03688620|4086156|FG002|STARTED|Overall Study||453
3356238|NCT03688620|4086154|FG000|COMPLETED|Overall Study||313
3356239|NCT03688620|4086155|FG001|COMPLETED|Overall Study||277
3356240|NCT03688620|4086156|FG002|COMPLETED|Overall Study||445
3356241|NCT03688620|4086154|FG000|NOT COMPLETED|Overall Study||16
3356242|NCT03688620|4086155|FG001|NOT COMPLETED|Overall Study||1
3356243|NCT03688620|4086156|FG002|NOT COMPLETED|Overall Study||8
3356244|NCT03688685|4086166|FG000|STARTED|Overall Study||25
3356245|NCT03688685|4086166|FG000|COMPLETED|Overall Study||21
3356246|NCT03688685|4086166|FG000|NOT COMPLETED|Overall Study||4
3356247|NCT03688711|4086172|FG000|STARTED|Overall Study||34
3356248|NCT03688711|4086173|FG001|STARTED|Overall Study||11
3356249|NCT03688711|4086172|FG000|COMPLETED|Overall Study||34
3356250|NCT03688711|4086173|FG001|COMPLETED|Overall Study||10
3356251|NCT03688711|4086172|FG000|NOT COMPLETED|Overall Study||0
3356252|NCT03688711|4086173|FG001|NOT COMPLETED|Overall Study||1
3356253|NCT03688880|4086181|FG000|STARTED|Overall Study||29
3356254|NCT03688880|4086182|FG001|STARTED|Overall Study||60
3356255|NCT03688880|4086181|FG000|COMPLETED|Overall Study||15
3356256|NCT03688880|4086182|FG001|COMPLETED|Overall Study||29
3356257|NCT03688880|4086181|FG000|NOT COMPLETED|Overall Study||14
3356258|NCT03688880|4086182|FG001|NOT COMPLETED|Overall Study||31
3356259|NCT03689452|4086190|FG000|STARTED|Overall Study||15
3356260|NCT03689452|4086191|FG001|STARTED|Overall Study||15
3356261|NCT03689452|4086190|FG000|COMPLETED|Overall Study||14
3356262|NCT03689452|4086191|FG001|COMPLETED|Overall Study||14
3356263|NCT03689452|4086190|FG000|NOT COMPLETED|Overall Study||1
3356264|NCT03689452|4086191|FG001|NOT COMPLETED|Overall Study||1
3356265|NCT03689504|4086199|FG000|STARTED|Overall Study||70
3356266|NCT03689504|4086200|FG001|STARTED|Overall Study||70
3356267|NCT03689504|4086199|FG000|COMPLETED|Overall Study||65
3356268|NCT03689504|4086200|FG001|COMPLETED|Overall Study||70
3356269|NCT03689504|4086199|FG000|NOT COMPLETED|Overall Study||5
3356270|NCT03689504|4086200|FG001|NOT COMPLETED|Overall Study||0
3356271|NCT03690375|4086208|FG000|STARTED|Overall Study||10
3356272|NCT03690375|4086209|FG001|STARTED|Overall Study||10
3356273|NCT03690375|4086208|FG000|COMPLETED|Overall Study||10
3356274|NCT03690375|4086209|FG001|COMPLETED|Overall Study||10
3356275|NCT03690375|4086208|FG000|NOT COMPLETED|Overall Study||0
3356276|NCT03690375|4086209|FG001|NOT COMPLETED|Overall Study||0
3356277|NCT03691779|4086218|FG000|STARTED|Part A (15 Days)||16
3356278|NCT03691779|4086219|FG001|STARTED|Part A (15 Days)||0
3356279|NCT03691779|4086218|FG000|COMPLETED|Part A (15 Days)||16
3356280|NCT03691779|4086219|FG001|COMPLETED|Part A (15 Days)||0
3356281|NCT03691779|4086218|FG000|NOT COMPLETED|Part A (15 Days)||0
3356282|NCT03691779|4086219|FG001|NOT COMPLETED|Part A (15 Days)||0
3356283|NCT03691779|4086218|FG000|STARTED|Part B (24 Weeks)||0
3356284|NCT03691779|4086219|FG001|STARTED|Part B (24 Weeks)|Out of the 16 participants from Part A, 11 participants also participated in Part B of the study.|66
3356285|NCT03691779|4086218|FG000|COMPLETED|Part B (24 Weeks)||0
3356286|NCT03691779|4086219|FG001|COMPLETED|Part B (24 Weeks)||64
3356287|NCT03691779|4086218|FG000|NOT COMPLETED|Part B (24 Weeks)||0
3356288|NCT03691779|4086219|FG001|NOT COMPLETED|Part B (24 Weeks)||2
3356289|NCT03691831|4086228|FG000|STARTED|Overall Study||251
3356290|NCT03691831|4086229|FG001|STARTED|Overall Study||251
3356291|NCT03691831|4086228|FG000|COMPLETED|Overall Study||224
3356292|NCT03691831|4086229|FG001|COMPLETED|Overall Study||220
3356293|NCT03691831|4086228|FG000|NOT COMPLETED|Overall Study||27
3356294|NCT03691831|4086229|FG001|NOT COMPLETED|Overall Study||31
3356295|NCT03691844|4086239|FG000|STARTED|Overall Study||121
3356296|NCT03691844|4086240|FG001|STARTED|Overall Study||121
3356297|NCT03691844|4086241|FG002|STARTED|Overall Study||121
3356298|NCT03691844|4086242|FG003|STARTED|Overall Study||81
3356299|NCT03691844|4086239|FG000|COMPLETED|Overall Study||114
3356300|NCT03691844|4086240|FG001|COMPLETED|Overall Study||109
3356301|NCT03691844|4086241|FG002|COMPLETED|Overall Study||108
3356302|NCT03691844|4086242|FG003|COMPLETED|Overall Study||70
3356303|NCT03691844|4086239|FG000|NOT COMPLETED|Overall Study||7
3356304|NCT03691844|4086240|FG001|NOT COMPLETED|Overall Study||12
3356305|NCT03691844|4086241|FG002|NOT COMPLETED|Overall Study||13
3356306|NCT03691844|4086242|FG003|NOT COMPLETED|Overall Study||11
3356307|NCT03691948|4086256|FG000|STARTED|Overall Study||27
3356308|NCT03691948|4086257|FG001|STARTED|Overall Study||33
3356309|NCT03691948|4086256|FG000|COMPLETED|Overall Study||26
3356310|NCT03691948|4086257|FG001|COMPLETED|Overall Study||30
3356311|NCT03691948|4086256|FG000|NOT COMPLETED|Overall Study||1
3356312|NCT03691948|4086257|FG001|NOT COMPLETED|Overall Study||3
3356313|NCT03692676|4086268|FG000|STARTED|Overall Study||10365
3356314|NCT03692676|4086269|FG001|STARTED|Overall Study||51142
3356315|NCT03692676|4086270|FG002|STARTED|Overall Study||49479
3356316|NCT03692676|4086271|FG003|STARTED|Overall Study||5147
3356317|NCT03692676|4086268|FG000|COMPLETED|Overall Study||940
3356318|NCT03692676|4086269|FG001|COMPLETED|Overall Study||3704
3356319|NCT03692676|4086270|FG002|COMPLETED|Overall Study||11135
3356320|NCT03692676|4086271|FG003|COMPLETED|Overall Study||1561
3356321|NCT03692676|4086268|FG000|NOT COMPLETED|Overall Study||9425
3356322|NCT03692676|4086269|FG001|NOT COMPLETED|Overall Study||47438
3356323|NCT03692676|4086270|FG002|NOT COMPLETED|Overall Study||38344
3356324|NCT03692676|4086271|FG003|NOT COMPLETED|Overall Study||3586
3356325|NCT03693625|4086283|FG000|STARTED|Overall Study||23
3356326|NCT03693625|4086284|FG001|STARTED|Overall Study||8
3356327|NCT03693625|4086283|FG000|COMPLETED|Overall Study||0
3356328|NCT03693625|4086284|FG001|COMPLETED|Overall Study||0
3356329|NCT03693625|4086283|FG000|NOT COMPLETED|Overall Study||23
3356330|NCT03693625|4086284|FG001|NOT COMPLETED|Overall Study||8
3356331|NCT03693742|4086292|FG000|STARTED|Overall Study||7
3356332|NCT03693742|4086293|FG001|STARTED|Overall Study||3
3356333|NCT03693742|4086292|FG000|COMPLETED|Overall Study||7
3356334|NCT03693742|4086293|FG001|COMPLETED|Overall Study||3
3356335|NCT03693742|4086292|FG000|NOT COMPLETED|Overall Study||0
3356336|NCT03693742|4086293|FG001|NOT COMPLETED|Overall Study||0
3356337|NCT03693937|4086301|FG000|STARTED|Overall Study||776
3356338|NCT03693937|4086301|FG000|COMPLETED|Overall Study||776
3356339|NCT03693937|4086301|FG000|NOT COMPLETED|Overall Study||0
3356340|NCT03693950|4086307|FG000|STARTED|Overall Study||29
3356341|NCT03693950|4086308|FG001|STARTED|Overall Study||28
3356342|NCT03693950|4086307|FG000|COMPLETED|Overall Study||28
3356343|NCT03693950|4086308|FG001|COMPLETED|Overall Study||28
3356344|NCT03693950|4086307|FG000|NOT COMPLETED|Overall Study||1
3356345|NCT03693950|4086308|FG001|NOT COMPLETED|Overall Study||0
3356346|NCT03693989|4086316|FG000|STARTED|Overall Study||88
3356347|NCT03693989|4086317|FG001|STARTED|Overall Study||90
3356348|NCT03693989|4086316|FG000|COMPLETED|Overall Study||85
3356349|NCT03693989|4086317|FG001|COMPLETED|Overall Study||86
3356350|NCT03693989|4086316|FG000|NOT COMPLETED|Overall Study||3
3356351|NCT03693989|4086317|FG001|NOT COMPLETED|Overall Study||4
3356352|NCT03694197|4086323|FG000|STARTED|Overall Study||1385
3356353|NCT03694197|4086323|FG000|COMPLETED|Overall Study||0
3356354|NCT03694197|4086323|FG000|NOT COMPLETED|Overall Study||1385
3356355|NCT03694210|4086327|FG000|STARTED|Overall Study||37
3356356|NCT03694210|4086327|FG000|COMPLETED|Overall Study||29
3356357|NCT03694210|4086327|FG000|NOT COMPLETED|Overall Study||8
3356358|NCT03694275|4086335|FG000|STARTED|Overall Study||8
3356359|NCT03694275|4086336|FG001|STARTED|Overall Study||12
3356360|NCT03694275|4086335|FG000|COMPLETED|Overall Study||8
3356361|NCT03694275|4086336|FG001|COMPLETED|Overall Study||10
3356362|NCT03694275|4086335|FG000|NOT COMPLETED|Overall Study||0
3356363|NCT03694275|4086336|FG001|NOT COMPLETED|Overall Study||2
3356364|NCT03694548|4086345|FG000|STARTED|Part A Survey||18
3356365|NCT03694548|4086346|FG001|STARTED|Part A Survey||17
3356366|NCT03694548|4086347|FG002|STARTED|Part A Survey||0
3356367|NCT03694548|4086345|FG000|COMPLETED|Part A Survey||15
3356368|NCT03694548|4086346|FG001|COMPLETED|Part A Survey||14
3356369|NCT03694548|4086347|FG002|COMPLETED|Part A Survey||0
3356370|NCT03694548|4086345|FG000|NOT COMPLETED|Part A Survey||3
3356371|NCT03694548|4086346|FG001|NOT COMPLETED|Part A Survey||3
3356372|NCT03694548|4086347|FG002|NOT COMPLETED|Part A Survey||0
3356373|NCT03694548|4086345|FG000|STARTED|Part B Yoga Program||0
3356374|NCT03694548|4086346|FG001|STARTED|Part B Yoga Program||0
3356375|NCT03694548|4086347|FG002|STARTED|Part B Yoga Program||12
3356376|NCT03694548|4086345|FG000|COMPLETED|Part B Yoga Program||0
3356377|NCT03694548|4086346|FG001|COMPLETED|Part B Yoga Program||0
3356378|NCT03694548|4086347|FG002|COMPLETED|Part B Yoga Program||1
3356379|NCT03694548|4086345|FG000|NOT COMPLETED|Part B Yoga Program||0
3356380|NCT03694548|4086346|FG001|NOT COMPLETED|Part B Yoga Program||0
3356381|NCT03694548|4086347|FG002|NOT COMPLETED|Part B Yoga Program||11
3356382|NCT03694613|4086357|FG000|STARTED|Overall Study||65
3356383|NCT03694613|4086357|FG000|COMPLETED|Overall Study|65 samples were collected and analyzed. at least 3 ml were collected.|65
3356384|NCT03694613|4086357|FG000|NOT COMPLETED|Overall Study||0
3356385|NCT03694925|4086373|FG000|STARTED|Overall Study||30
3356386|NCT03694925|4086374|FG001|STARTED|Overall Study||73
3356387|NCT03694925|4086375|FG002|STARTED|Overall Study||53
3179114|NCT01983254|3907310|FG000|STARTED|Overall Study|86 patients, 39 caregivers|125
3179115|NCT01983254|3907311|FG001|STARTED|Overall Study|89 patients, 47 caregivers|136
3356388|NCT03694925|4086373|FG000|COMPLETED|Overall Study||30
3356389|NCT03694925|4086374|FG001|COMPLETED|Overall Study||70
3356390|NCT03694925|4086375|FG002|COMPLETED|Overall Study||53
3356391|NCT03694925|4086373|FG000|NOT COMPLETED|Overall Study||0
3356392|NCT03694925|4086374|FG001|NOT COMPLETED|Overall Study||3
3356393|NCT03694925|4086375|FG002|NOT COMPLETED|Overall Study||0
3356394|NCT03695094|4086387|FG000|STARTED|Overall Study||16
3356395|NCT03695094|4086388|FG001|STARTED|Overall Study||15
3356396|NCT03695094|4086387|FG000|COMPLETED|Overall Study||14
3356397|NCT03695094|4086388|FG001|COMPLETED|Overall Study||14
3356398|NCT03695094|4086387|FG000|NOT COMPLETED|Overall Study||2
3356399|NCT03695094|4086388|FG001|NOT COMPLETED|Overall Study||1
3356400|NCT03695367|4086398|FG000|STARTED|Overall Study||33
3356401|NCT03695367|4086399|FG001|STARTED|Overall Study||30
3356402|NCT03695367|4086398|FG000|COMPLETED|Overall Study||32
3356403|NCT03695367|4086399|FG001|COMPLETED|Overall Study||26
3356404|NCT03695367|4086398|FG000|NOT COMPLETED|Overall Study||1
3356405|NCT03695367|4086399|FG001|NOT COMPLETED|Overall Study||4
3356406|NCT03695393|4086407|FG000|STARTED|Overall Study||67
3356407|NCT03695393|4086408|FG001|STARTED|Overall Study||33
3356408|NCT03695393|4086407|FG000|1-month|Overall Study||66
3356409|NCT03695393|4086408|FG001|1-month|Overall Study||32
3356410|NCT03695393|4086407|FG000|6-month|Overall Study||64
3356411|NCT03695393|4086408|FG001|6-month|Overall Study||31
3356412|NCT03695393|4086407|FG000|COMPLETED|Overall Study||64
3356413|NCT03695393|4086408|FG001|COMPLETED|Overall Study||31
3356414|NCT03695393|4086407|FG000|NOT COMPLETED|Overall Study||3
3356415|NCT03695393|4086408|FG001|NOT COMPLETED|Overall Study||2
3356416|NCT03695913|4086414|FG000|STARTED|Overall Study||15
3356417|NCT03695913|4086414|FG000|COMPLETED|Overall Study||15
3356418|NCT03695913|4086414|FG000|NOT COMPLETED|Overall Study||0
3356419|NCT03696108|4086420|FG000|STARTED|Overall Study||84
3356420|NCT03696108|4086421|FG001|STARTED|Overall Study||85
3356421|NCT03696108|4086420|FG000|COMPLETED|Overall Study||80
3356422|NCT03696108|4086421|FG001|COMPLETED|Overall Study||79
3356423|NCT03696108|4086420|FG000|NOT COMPLETED|Overall Study||4
3356424|NCT03696108|4086421|FG001|NOT COMPLETED|Overall Study||6
3356425|NCT03696342|4086429|FG000|STARTED|Overall Study||23
3356426|NCT03696342|4086430|FG001|STARTED|Overall Study||23
3356427|NCT03696342|4086429|FG000|COMPLETED|Overall Study||22
3356428|NCT03696342|4086430|FG001|COMPLETED|Overall Study||23
3356429|NCT03696342|4086429|FG000|NOT COMPLETED|Overall Study||1
3356430|NCT03696342|4086430|FG001|NOT COMPLETED|Overall Study||0
3356431|NCT03696576|4086438|FG000|STARTED|Overall Study||13
3356432|NCT03696576|4086439|FG001|STARTED|Overall Study||11
3356433|NCT03696576|4086438|FG000|COMPLETED|Overall Study||10
3356434|NCT03696576|4086439|FG001|COMPLETED|Overall Study||6
3356435|NCT03696576|4086438|FG000|NOT COMPLETED|Overall Study||3
3356436|NCT03696576|4086439|FG001|NOT COMPLETED|Overall Study||5
3179116|NCT01983254|3907310|FG000|Interview 1|Overall Study|86 patients, 39 caregivers|125
3179117|NCT01983254|3907311|FG001|Interview 1|Overall Study|89 patients, 47 caregivers|136
3356437|NCT03696589|4086445|FG000|STARTED|Overall Study||13
3356438|NCT03696589|4086445|FG000|COMPLETED|Overall Study||12
3356439|NCT03696589|4086445|FG000|NOT COMPLETED|Overall Study||1
3356440|NCT03696758|4086458|FG000|STARTED|First Intervention||3
3356441|NCT03696758|4086459|FG001|STARTED|First Intervention||6
3356442|NCT03696758|4086458|FG000|COMPLETED|First Intervention||3
3356443|NCT03696758|4086459|FG001|COMPLETED|First Intervention||6
3356444|NCT03696758|4086458|FG000|NOT COMPLETED|First Intervention||0
3356445|NCT03696758|4086459|FG001|NOT COMPLETED|First Intervention||0
3356446|NCT03696758|4086458|FG000|STARTED|Wash Out>12 Hours||3
3356447|NCT03696758|4086459|FG001|STARTED|Wash Out>12 Hours||6
3356448|NCT03696758|4086458|FG000|COMPLETED|Wash Out>12 Hours||3
3356449|NCT03696758|4086459|FG001|COMPLETED|Wash Out>12 Hours||6
3356450|NCT03696758|4086458|FG000|NOT COMPLETED|Wash Out>12 Hours||0
3356451|NCT03696758|4086459|FG001|NOT COMPLETED|Wash Out>12 Hours||0
3356452|NCT03696758|4086458|FG000|STARTED|Second Intervention||3
3356453|NCT03696758|4086459|FG001|STARTED|Second Intervention||6
3356454|NCT03696758|4086458|FG000|COMPLETED|Second Intervention||3
3356455|NCT03696758|4086459|FG001|COMPLETED|Second Intervention||6
3356456|NCT03696758|4086458|FG000|NOT COMPLETED|Second Intervention||0
3356457|NCT03696758|4086459|FG001|NOT COMPLETED|Second Intervention||0
3356458|NCT03697083|4086468|FG000|STARTED|Overall Study||262
3356459|NCT03697083|4086469|FG001|STARTED|Overall Study||260
3356460|NCT03697083|4086470|FG002|STARTED|Overall Study||255
3356461|NCT03697083|4086468|FG000|COMPLETED|Overall Study||262
3356462|NCT03697083|4086469|FG001|COMPLETED|Overall Study||250
3356463|NCT03697083|4086470|FG002|COMPLETED|Overall Study||255
3356464|NCT03697083|4086468|FG000|NOT COMPLETED|Overall Study||0
3356465|NCT03697083|4086469|FG001|NOT COMPLETED|Overall Study||10
3356466|NCT03697083|4086470|FG002|NOT COMPLETED|Overall Study||0
3356467|NCT03697122|4086478|FG000|STARTED|Overall Study||14
3356468|NCT03697122|4086478|FG000|COMPLETED|Overall Study||14
3356469|NCT03697122|4086478|FG000|NOT COMPLETED|Overall Study||0
3356470|NCT03697252|4086484|FG000|STARTED|Overall Study||90
3356471|NCT03697252|4086485|FG001|STARTED|Overall Study||92
3356472|NCT03697252|4086484|FG000|COMPLETED|Overall Study||72
3356473|NCT03697252|4086485|FG001|COMPLETED|Overall Study||73
3356474|NCT03697252|4086484|FG000|NOT COMPLETED|Overall Study||18
3356475|NCT03697252|4086485|FG001|NOT COMPLETED|Overall Study||19
3356476|NCT03697460|4086491|FG000|STARTED|Overall Study||12
3356477|NCT03697460|4086491|FG000|COMPLETED|Overall Study||9
3356478|NCT03697460|4086491|FG000|NOT COMPLETED|Overall Study||3
3356479|NCT03697993|4086497|FG000|STARTED|Overall Study||32
3356480|NCT03697993|4086498|FG001|STARTED|Overall Study||30
3356481|NCT03697993|4086497|FG000|Initiated Treatment|Overall Study||30
3356482|NCT03697993|4086498|FG001|Initiated Treatment|Overall Study||28
3356483|NCT03697993|4086497|FG000|Switched Treatment|Overall Study||0
3356484|NCT03697993|4086498|FG001|Switched Treatment|Overall Study|Five (5) participants switched to Fosfomycin; 1 participant switched to Cefixime.|6
3356485|NCT03697993|4086497|FG000|Treated With at Least Two Dose of Fosfomycin|Overall Study||27
3356486|NCT03697993|4086498|FG001|Treated With at Least Two Dose of Fosfomycin|Overall Study||4
3356487|NCT03697993|4086497|FG000|COMPLETED|Overall Study||22
3356488|NCT03697993|4086498|FG001|COMPLETED|Overall Study||25
3356489|NCT03697993|4086497|FG000|NOT COMPLETED|Overall Study||10
3356490|NCT03697993|4086498|FG001|NOT COMPLETED|Overall Study||5
3356491|NCT03698279|4086511|FG000|STARTED|Overall Study||124
3356492|NCT03698279|4086512|FG001|STARTED|Overall Study||122
3356493|NCT03698279|4086513|FG002|STARTED|Overall Study||159
3356494|NCT03698279|4086514|FG003|STARTED|Overall Study||234
3356495|NCT03698279|4086515|FG004|STARTED|Overall Study||13
3356496|NCT03698279|4086516|FG005|STARTED|Overall Study||13
3356497|NCT03698279|4086511|FG000|Safety Analysis Set Population (SafAS)|Overall Study||122
3356498|NCT03698279|4086512|FG001|Safety Analysis Set Population (SafAS)|Overall Study||121
3356499|NCT03698279|4086513|FG002|Safety Analysis Set Population (SafAS)|Overall Study||158
3356500|NCT03698279|4086514|FG003|Safety Analysis Set Population (SafAS)|Overall Study||234
3356501|NCT03698279|4086515|FG004|Safety Analysis Set Population (SafAS)|Overall Study||13
3356502|NCT03698279|4086516|FG005|Safety Analysis Set Population (SafAS)|Overall Study||13
3356503|NCT03698279|4086511|FG000|COMPLETED|Overall Study||119
3356504|NCT03698279|4086512|FG001|COMPLETED|Overall Study||120
3356505|NCT03698279|4086513|FG002|COMPLETED|Overall Study||152
3356506|NCT03698279|4086514|FG003|COMPLETED|Overall Study||228
3356507|NCT03698279|4086515|FG004|COMPLETED|Overall Study||13
3356508|NCT03698279|4086516|FG005|COMPLETED|Overall Study||13
3356509|NCT03698279|4086511|FG000|NOT COMPLETED|Overall Study||5
3356510|NCT03698279|4086512|FG001|NOT COMPLETED|Overall Study||2
3356511|NCT03698279|4086513|FG002|NOT COMPLETED|Overall Study||7
3356512|NCT03698279|4086514|FG003|NOT COMPLETED|Overall Study||6
3356513|NCT03698279|4086515|FG004|NOT COMPLETED|Overall Study||0
3356514|NCT03698279|4086516|FG005|NOT COMPLETED|Overall Study||0
3356515|NCT03698331|4086537|FG000|STARTED|Overall Study||44
3356516|NCT03698331|4086538|FG001|STARTED|Overall Study||45
3356517|NCT03698331|4086537|FG000|Entered Withdrawal Period|Overall Study||42
3356518|NCT03698331|4086538|FG001|Entered Withdrawal Period|Overall Study||39
3356519|NCT03698331|4086537|FG000|COMPLETED|Overall Study||40
3356520|NCT03698331|4086538|FG001|COMPLETED|Overall Study||39
3179118|NCT01983254|3907310|FG000|Interview 2|Overall Study|65 patients, 30 caregivers|95
3179119|NCT01983254|3907311|FG001|Interview 2|Overall Study|71 patients, 39 caregivers|110
3179120|NCT01983254|3907310|FG000|Interview 3|Overall Study|62 patients, 29 caregivers|91
3356521|NCT03698331|4086537|FG000|NOT COMPLETED|Overall Study||4
3356522|NCT03698331|4086538|FG001|NOT COMPLETED|Overall Study||6
3356523|NCT03698591|4086546|FG000|STARTED|Overall Study||20
3356524|NCT03698591|4086547|FG001|STARTED|Overall Study||20
3356525|NCT03698591|4086546|FG000|COMPLETED|Overall Study||15
3356526|NCT03698591|4086547|FG001|COMPLETED|Overall Study||15
3356527|NCT03698591|4086546|FG000|NOT COMPLETED|Overall Study||5
3356528|NCT03698591|4086547|FG001|NOT COMPLETED|Overall Study||5
3356529|NCT03699124|4086556|FG000|STARTED|Overall Study||377
3356530|NCT03699124|4086557|FG001|STARTED|Overall Study||375
3356531|NCT03699124|4086558|FG002|STARTED|Overall Study||377
3356532|NCT03699124|4086556|FG000|COMPLETED|Overall Study||332
3356533|NCT03699124|4086557|FG001|COMPLETED|Overall Study||335
3356534|NCT03699124|4086558|FG002|COMPLETED|Overall Study||337
3356535|NCT03699124|4086556|FG000|NOT COMPLETED|Overall Study||45
3356536|NCT03699124|4086557|FG001|NOT COMPLETED|Overall Study||40
3356537|NCT03699124|4086558|FG002|NOT COMPLETED|Overall Study||40
3356538|NCT03700320|4086568|FG000|STARTED|Overall Study||198
3356539|NCT03700320|4086569|FG001|STARTED|Overall Study||546
3356540|NCT03700320|4086568|FG000|Safety Population; Received Treatment|Overall Study||196
3356541|NCT03700320|4086569|FG001|Safety Population; Received Treatment|Overall Study||543
3356542|NCT03700320|4086568|FG000|Entered Safety Follow-up|Overall Study||159
3356543|NCT03700320|4086569|FG001|Entered Safety Follow-up|Overall Study||472
3356544|NCT03700320|4086568|FG000|COMPLETED|Overall Study||136
3356545|NCT03700320|4086569|FG001|COMPLETED|Overall Study||373
3356546|NCT03700320|4086568|FG000|NOT COMPLETED|Overall Study||62
3356547|NCT03700320|4086569|FG001|NOT COMPLETED|Overall Study||173
3356548|NCT03700372|4086575|FG000|STARTED|Overall Study||7
3356549|NCT03700372|4086575|FG000|COMPLETED|Overall Study||7
3356550|NCT03700372|4086575|FG000|NOT COMPLETED|Overall Study||0
3356551|NCT03700385|4086579|FG000|STARTED|Overall Study||40
3356552|NCT03700385|4086579|FG000|COMPLETED|Overall Study||39
3356553|NCT03700385|4086579|FG000|NOT COMPLETED|Overall Study||1
3356554|NCT03700671|4086585|FG000|STARTED|Overall Study||21
3356555|NCT03700671|4086586|FG001|STARTED|Overall Study||21
3356556|NCT03700671|4086585|FG000|COMPLETED|Overall Study||20
3356557|NCT03700671|4086586|FG001|COMPLETED|Overall Study||19
3356558|NCT03700671|4086585|FG000|NOT COMPLETED|Overall Study||1
3356559|NCT03700671|4086586|FG001|NOT COMPLETED|Overall Study||2
3356560|NCT03700736|4086596|FG000|STARTED|Overall Study||30
3356561|NCT03700736|4086597|FG001|STARTED|Overall Study||32
3356562|NCT03700736|4086596|FG000|COMPLETED|Overall Study||27
3356563|NCT03700736|4086597|FG001|COMPLETED|Overall Study||25
3356564|NCT03700736|4086596|FG000|NOT COMPLETED|Overall Study||3
3356565|NCT03700736|4086597|FG001|NOT COMPLETED|Overall Study||7
3356566|NCT03700892|4086608|FG000|STARTED|Baseline||15
3356567|NCT03700892|4086609|FG001|STARTED|Baseline||0
3356568|NCT03700892|4086610|FG002|STARTED|Baseline||4
3356569|NCT03700892|4086608|FG000|COMPLETED|Baseline||15
3356570|NCT03700892|4086609|FG001|COMPLETED|Baseline||0
3356571|NCT03700892|4086610|FG002|COMPLETED|Baseline||4
3356572|NCT03700892|4086608|FG000|NOT COMPLETED|Baseline||0
3356573|NCT03700892|4086609|FG001|NOT COMPLETED|Baseline||0
3356574|NCT03700892|4086610|FG002|NOT COMPLETED|Baseline||0
3356575|NCT03700892|4086608|FG000|STARTED|First Intervention (Single 1-Day Visit)||1
3356576|NCT03700892|4086609|FG001|STARTED|First Intervention (Single 1-Day Visit)||4
3356577|NCT03700892|4086610|FG002|STARTED|First Intervention (Single 1-Day Visit)||0
3356578|NCT03700892|4086608|FG000|COMPLETED|First Intervention (Single 1-Day Visit)||1
3356579|NCT03700892|4086609|FG001|COMPLETED|First Intervention (Single 1-Day Visit)||4
3356580|NCT03700892|4086610|FG002|COMPLETED|First Intervention (Single 1-Day Visit)||0
3356581|NCT03700892|4086608|FG000|NOT COMPLETED|First Intervention (Single 1-Day Visit)||0
3356582|NCT03700892|4086609|FG001|NOT COMPLETED|First Intervention (Single 1-Day Visit)||0
3356583|NCT03700892|4086610|FG002|NOT COMPLETED|First Intervention (Single 1-Day Visit)||0
3356584|NCT03700892|4086608|FG000|STARTED|Washout (2-3 Weeks)||1
3356585|NCT03700892|4086609|FG001|STARTED|Washout (2-3 Weeks)||4
3356586|NCT03700892|4086610|FG002|STARTED|Washout (2-3 Weeks)||0
3356587|NCT03700892|4086608|FG000|COMPLETED|Washout (2-3 Weeks)||1
3356588|NCT03700892|4086609|FG001|COMPLETED|Washout (2-3 Weeks)||4
3356589|NCT03700892|4086610|FG002|COMPLETED|Washout (2-3 Weeks)||0
3356590|NCT03700892|4086608|FG000|NOT COMPLETED|Washout (2-3 Weeks)||0
3356591|NCT03700892|4086609|FG001|NOT COMPLETED|Washout (2-3 Weeks)||0
3356592|NCT03700892|4086610|FG002|NOT COMPLETED|Washout (2-3 Weeks)||0
3356593|NCT03700892|4086608|FG000|STARTED|Second Intervention (Single 1-Day Visit)||1
3356594|NCT03700892|4086609|FG001|STARTED|Second Intervention (Single 1-Day Visit)||4
3356595|NCT03700892|4086610|FG002|STARTED|Second Intervention (Single 1-Day Visit)||0
3356596|NCT03700892|4086608|FG000|Received Intervention|Second Intervention (Single 1-Day Visit)||1
3356597|NCT03700892|4086609|FG001|Received Intervention|Second Intervention (Single 1-Day Visit)||3
3356598|NCT03700892|4086610|FG002|Received Intervention|Second Intervention (Single 1-Day Visit)||0
3356599|NCT03700892|4086608|FG000|COMPLETED|Second Intervention (Single 1-Day Visit)||1
3356600|NCT03700892|4086609|FG001|COMPLETED|Second Intervention (Single 1-Day Visit)||3
3356601|NCT03700892|4086610|FG002|COMPLETED|Second Intervention (Single 1-Day Visit)||0
3356602|NCT03700892|4086608|FG000|NOT COMPLETED|Second Intervention (Single 1-Day Visit)||0
3356603|NCT03700892|4086609|FG001|NOT COMPLETED|Second Intervention (Single 1-Day Visit)||1
3356604|NCT03700892|4086610|FG002|NOT COMPLETED|Second Intervention (Single 1-Day Visit)||0
3356605|NCT03701061|4086621|FG000|STARTED|Overall Study||9
3356606|NCT03701061|4086622|FG001|STARTED|Overall Study||3
3356607|NCT03701061|4086621|FG000|COMPLETED|Overall Study||9
3356608|NCT03701061|4086622|FG001|COMPLETED|Overall Study||3
3356609|NCT03701061|4086621|FG000|NOT COMPLETED|Overall Study||0
3356610|NCT03701061|4086622|FG001|NOT COMPLETED|Overall Study||0
3356611|NCT03701074|4086630|FG000|STARTED|Overall Study||1
3356612|NCT03701074|4086631|FG001|STARTED|Overall Study||0
3356613|NCT03701074|4086630|FG000|COMPLETED|Overall Study|Treatment was withdrawn after the 10th dose of oral medication (acetaminophen), on day 3 of treatment, as the infant developed mild abdominal distension which was as per the study protocol|0
3356614|NCT03701074|4086631|FG001|COMPLETED|Overall Study||0
3356615|NCT03701074|4086630|FG000|NOT COMPLETED|Overall Study||1
3356616|NCT03701074|4086631|FG001|NOT COMPLETED|Overall Study||0
3356617|NCT03702010|4086639|FG000|STARTED|First Stimulation (5 Days)||13
3356618|NCT03702010|4086640|FG001|STARTED|First Stimulation (5 Days)||14
3356619|NCT03702010|4086639|FG000|COMPLETED|First Stimulation (5 Days)||13
3356620|NCT03702010|4086640|FG001|COMPLETED|First Stimulation (5 Days)||14
3356621|NCT03702010|4086639|FG000|NOT COMPLETED|First Stimulation (5 Days)||0
3356622|NCT03702010|4086640|FG001|NOT COMPLETED|First Stimulation (5 Days)||0
3356623|NCT03702010|4086639|FG000|STARTED|Washout + Second Stimulation (2+5days)||13
3356624|NCT03702010|4086640|FG001|STARTED|Washout + Second Stimulation (2+5days)||14
3356625|NCT03702010|4086639|FG000|COMPLETED|Washout + Second Stimulation (2+5days)||13
3356626|NCT03702010|4086640|FG001|COMPLETED|Washout + Second Stimulation (2+5days)||14
3356627|NCT03702010|4086639|FG000|NOT COMPLETED|Washout + Second Stimulation (2+5days)||0
3356628|NCT03702010|4086640|FG001|NOT COMPLETED|Washout + Second Stimulation (2+5days)||0
3356629|NCT03702010|4086639|FG000|STARTED|Follow-up (30days)||13
3356630|NCT03702010|4086640|FG001|STARTED|Follow-up (30days)||14
3356631|NCT03702010|4086639|FG000|COMPLETED|Follow-up (30days)||11
3356632|NCT03702010|4086640|FG001|COMPLETED|Follow-up (30days)||12
3356633|NCT03702010|4086639|FG000|NOT COMPLETED|Follow-up (30days)||2
3356634|NCT03702010|4086640|FG001|NOT COMPLETED|Follow-up (30days)||2
3356635|NCT03702166|4086652|FG000|STARTED|Overall Study||10
3356636|NCT03702166|4086652|FG000|COMPLETED|Overall Study||8
3356637|NCT03702166|4086652|FG000|NOT COMPLETED|Overall Study||2
3356638|NCT03702608|4086657|FG000|STARTED|Overall Study||50
3356639|NCT03702608|4086657|FG000|COMPLETED|Overall Study||50
3356640|NCT03702608|4086657|FG000|NOT COMPLETED|Overall Study||0
3356641|NCT03703336|4086663|FG000|STARTED|Overall Study||552
3356642|NCT03703336|4086664|FG001|STARTED|Overall Study||273
3356643|NCT03703336|4086663|FG000|Received Dose 1|Overall Study||552
3356644|NCT03703336|4086664|FG001|Received Dose 1|Overall Study||273
3356645|NCT03703336|4086663|FG000|Received Dose 2|Overall Study||518
3356646|NCT03703336|4086664|FG001|Received Dose 2|Overall Study||263
3356647|NCT03703336|4086663|FG000|Safety Population|Overall Study||551
3356648|NCT03703336|4086664|FG001|Safety Population|Overall Study||274
3356649|NCT03703336|4086663|FG000|COMPLETED|Overall Study||514
3356650|NCT03703336|4086664|FG001|COMPLETED|Overall Study||259
3356651|NCT03703336|4086663|FG000|NOT COMPLETED|Overall Study||38
3356652|NCT03703336|4086664|FG001|NOT COMPLETED|Overall Study||14
3356653|NCT03703466|4086673|FG000|STARTED|Overall Study||24
3356654|NCT03703466|4086674|FG001|STARTED|Overall Study||24
3356655|NCT03703466|4086675|FG002|STARTED|Overall Study||24
3356656|NCT03703466|4086673|FG000|Received at Least One Dose of Study Drug|Overall Study||24
3356657|NCT03703466|4086674|FG001|Received at Least One Dose of Study Drug|Overall Study||23
3356658|NCT03703466|4086675|FG002|Received at Least One Dose of Study Drug|Overall Study||24
3356659|NCT03703466|4086673|FG000|COMPLETED|Overall Study||20
3356660|NCT03703466|4086674|FG001|COMPLETED|Overall Study||18
3356661|NCT03703466|4086675|FG002|COMPLETED|Overall Study||22
3356662|NCT03703466|4086673|FG000|NOT COMPLETED|Overall Study||4
3356663|NCT03703466|4086674|FG001|NOT COMPLETED|Overall Study||6
3356664|NCT03703466|4086675|FG002|NOT COMPLETED|Overall Study||2
3356665|NCT03703817|4086686|FG000|STARTED|Overall Study||288
3356666|NCT03703817|4086687|FG001|STARTED|Overall Study||133
3356667|NCT03703817|4086686|FG000|COMPLETED|Overall Study||281
3356668|NCT03703817|4086687|FG001|COMPLETED|Overall Study||129
3356669|NCT03703817|4086686|FG000|NOT COMPLETED|Overall Study||7
3356670|NCT03703817|4086687|FG001|NOT COMPLETED|Overall Study||4
3356671|NCT03704194|4086695|FG000|STARTED|Overall Study||8
3356672|NCT03704194|4086696|FG001|STARTED|Overall Study||9
3356673|NCT03704194|4086695|FG000|COMPLETED|Overall Study||8
3356674|NCT03704194|4086696|FG001|COMPLETED|Overall Study||8
3356675|NCT03704194|4086695|FG000|NOT COMPLETED|Overall Study||0
3356676|NCT03704194|4086696|FG001|NOT COMPLETED|Overall Study||1
3356677|NCT03704376|4086706|FG000|STARTED|Overall Study||42
3356678|NCT03704376|4086707|FG001|STARTED|Overall Study||44
3356679|NCT03704376|4086706|FG000|COMPLETED|Overall Study||38
3356680|NCT03704376|4086707|FG001|COMPLETED|Overall Study||40
3356681|NCT03704376|4086706|FG000|NOT COMPLETED|Overall Study||4
3356682|NCT03704376|4086707|FG001|NOT COMPLETED|Overall Study||4
3356683|NCT03704467|4086713|FG000|STARTED|Overall Study||3
3356684|NCT03704467|4086713|FG000|COMPLETED|Overall Study||3
3356685|NCT03704467|4086713|FG000|NOT COMPLETED|Overall Study||0
3356686|NCT03705273|4086719|FG000|STARTED|Overall Study|Planned enrollment of 110 participants in the arm was not achieved due to lack of study personnel.|20
3356687|NCT03705273|4086720|FG001|STARTED|Overall Study|Planned enrollment of 110 participants in the arm was not achieved due to lack of study personnel.|20
3356688|NCT03705273|4086719|FG000|COMPLETED|Overall Study||20
3356689|NCT03705273|4086720|FG001|COMPLETED|Overall Study||20
3356690|NCT03705273|4086719|FG000|NOT COMPLETED|Overall Study||0
3356691|NCT03705273|4086720|FG001|NOT COMPLETED|Overall Study||0
3356692|NCT03705481|4086726|FG000|STARTED|Overall Study||5
3356693|NCT03705481|4086726|FG000|COMPLETED|Overall Study||5
3356694|NCT03705481|4086726|FG000|NOT COMPLETED|Overall Study||0
3356695|NCT03705494|4086735|FG000|STARTED|Overall Study||10
3356696|NCT03705494|4086736|FG001|STARTED|Overall Study||10
3356697|NCT03705494|4086735|FG000|COMPLETED|Overall Study||3
3356698|NCT03705494|4086736|FG001|COMPLETED|Overall Study||7
3356699|NCT03705494|4086735|FG000|NOT COMPLETED|Overall Study||7
3356700|NCT03705494|4086736|FG001|NOT COMPLETED|Overall Study||3
3356701|NCT03705793|4086744|FG000|STARTED|Overall Study||27
3356702|NCT03705793|4086745|FG001|STARTED|Overall Study||26
3356703|NCT03705793|4086744|FG000|COMPLETED|Overall Study||22
3356704|NCT03705793|4086745|FG001|COMPLETED|Overall Study||21
3356705|NCT03705793|4086744|FG000|NOT COMPLETED|Overall Study||5
3356706|NCT03705793|4086745|FG001|NOT COMPLETED|Overall Study||5
3356707|NCT03706040|4086754|FG000|STARTED|Period A (Week 0 to Week 16)||34
3356708|NCT03706040|4086755|FG001|STARTED|Period A (Week 0 to Week 16)||69
3356709|NCT03706040|4086756|FG002|STARTED|Period A (Week 0 to Week 16)||69
3356710|NCT03706040|4086757|FG003|STARTED|Period A (Week 0 to Week 16)||0
3356711|NCT03706040|4086758|FG004|STARTED|Period A (Week 0 to Week 16)||0
3356712|NCT03706040|4086759|FG005|STARTED|Period A (Week 0 to Week 16)||0
3356713|NCT03706040|4086760|FG006|STARTED|Period A (Week 0 to Week 16)||0
3356714|NCT03706040|4086754|FG000|Received Study Drug|Period A (Week 0 to Week 16)||34
3356715|NCT03706040|4086755|FG001|Received Study Drug|Period A (Week 0 to Week 16)||69
3356716|NCT03706040|4086756|FG002|Received Study Drug|Period A (Week 0 to Week 16)||69
3356717|NCT03706040|4086757|FG003|Received Study Drug|Period A (Week 0 to Week 16)||0
3356718|NCT03706040|4086758|FG004|Received Study Drug|Period A (Week 0 to Week 16)||0
3356719|NCT03706040|4086759|FG005|Received Study Drug|Period A (Week 0 to Week 16)||0
3356720|NCT03706040|4086760|FG006|Received Study Drug|Period A (Week 0 to Week 16)||0
3356721|NCT03706040|4086754|FG000|COMPLETED|Period A (Week 0 to Week 16)||25
3356722|NCT03706040|4086755|FG001|COMPLETED|Period A (Week 0 to Week 16)||61
3356723|NCT03706040|4086756|FG002|COMPLETED|Period A (Week 0 to Week 16)||58
3356724|NCT03706040|4086757|FG003|COMPLETED|Period A (Week 0 to Week 16)||0
3356725|NCT03706040|4086758|FG004|COMPLETED|Period A (Week 0 to Week 16)||0
3356726|NCT03706040|4086759|FG005|COMPLETED|Period A (Week 0 to Week 16)||0
3356727|NCT03706040|4086760|FG006|COMPLETED|Period A (Week 0 to Week 16)||0
3356728|NCT03706040|4086754|FG000|NOT COMPLETED|Period A (Week 0 to Week 16)||9
3356729|NCT03706040|4086755|FG001|NOT COMPLETED|Period A (Week 0 to Week 16)||8
3356730|NCT03706040|4086756|FG002|NOT COMPLETED|Period A (Week 0 to Week 16)||11
3356731|NCT03706040|4086757|FG003|NOT COMPLETED|Period A (Week 0 to Week 16)||0
3356732|NCT03706040|4086758|FG004|NOT COMPLETED|Period A (Week 0 to Week 16)||0
3356733|NCT03706040|4086759|FG005|NOT COMPLETED|Period A (Week 0 to Week 16)||0
3356734|NCT03706040|4086760|FG006|NOT COMPLETED|Period A (Week 0 to Week 16)||0
3356735|NCT03706040|4086754|FG000|STARTED|Period B (Week 16 to Week 52)||0
3356736|NCT03706040|4086755|FG001|STARTED|Period B (Week 16 to Week 52)||0
3356737|NCT03706040|4086756|FG002|STARTED|Period B (Week 16 to Week 52)||0
3356738|NCT03706040|4086757|FG003|STARTED|Period B (Week 16 to Week 52)||13
3356739|NCT03706040|4086758|FG004|STARTED|Period B (Week 16 to Week 52)||12
3356740|NCT03706040|4086759|FG005|STARTED|Period B (Week 16 to Week 52)||61
3356741|NCT03706040|4086760|FG006|STARTED|Period B (Week 16 to Week 52)||58
3356742|NCT03706040|4086754|FG000|Received Study Drug|Period B (Week 16 to Week 52)||0
3356743|NCT03706040|4086755|FG001|Received Study Drug|Period B (Week 16 to Week 52)||0
2928054|NCT00576381|3639025|FG000|COMPLETED|Overall Study||23
2928055|NCT00576381|3639025|FG000|NOT COMPLETED|Overall Study||7
2928056|NCT00576407|3639029|FG000|STARTED|Overall Study||26
2928057|NCT00576407|3639029|FG000|COMPLETED|Overall Study||18
2928058|NCT00576407|3639029|FG000|NOT COMPLETED|Overall Study||8
2928059|NCT00576420|3639037|FG000|STARTED|Overall Study||26
2928060|NCT00576420|3639038|FG001|STARTED|Overall Study||24
2928061|NCT00576420|3639039|FG002|STARTED|Overall Study||23
2928062|NCT00576420|3639037|FG000|COMPLETED|Overall Study||26
2928063|NCT00576420|3639038|FG001|COMPLETED|Overall Study||24
2928064|NCT00576420|3639039|FG002|COMPLETED|Overall Study||22
2928065|NCT00576420|3639037|FG000|NOT COMPLETED|Overall Study||0
2928066|NCT00576420|3639038|FG001|NOT COMPLETED|Overall Study||0
2928067|NCT00576420|3639039|FG002|NOT COMPLETED|Overall Study||1
2928068|NCT00576472|3639103|FG000|STARTED|Initial Screening||230
2928069|NCT00576472|3639104|FG001|STARTED|Initial Screening||40
2928070|NCT00576472|3639105|FG002|STARTED|Initial Screening||199
2928071|NCT00576472|3639106|FG003|STARTED|Initial Screening||0
2928072|NCT00576472|3639107|FG004|STARTED|Initial Screening||0
2928073|NCT00576472|3639108|FG005|STARTED|Initial Screening||0
2928074|NCT00576472|3639109|FG006|STARTED|Initial Screening||0
2928075|NCT00576472|3639110|FG007|STARTED|Initial Screening||0
2928076|NCT00576472|3639111|FG008|STARTED|Initial Screening||0
2928077|NCT00576472|3639112|FG009|STARTED|Initial Screening||0
2928078|NCT00576472|3639113|FG010|STARTED|Initial Screening||0
2928079|NCT00576472|3639114|FG011|STARTED|Initial Screening||0
2928080|NCT00576472|3639115|FG012|STARTED|Initial Screening||0
2928081|NCT00576472|3639116|FG013|STARTED|Initial Screening||0
2928082|NCT00576472|3639117|FG014|STARTED|Initial Screening||0
2928083|NCT00576472|3639103|FG000|COMPLETED|Initial Screening||230
2928084|NCT00576472|3639104|FG001|COMPLETED|Initial Screening||40
2928085|NCT00576472|3639105|FG002|COMPLETED|Initial Screening||199
2928086|NCT00576472|3639106|FG003|COMPLETED|Initial Screening||0
2928087|NCT00576472|3639107|FG004|COMPLETED|Initial Screening||0
2928088|NCT00576472|3639108|FG005|COMPLETED|Initial Screening||0
2928089|NCT00576472|3639109|FG006|COMPLETED|Initial Screening||0
2928090|NCT00576472|3639110|FG007|COMPLETED|Initial Screening||0
3356744|NCT03706040|4086756|FG002|Received Study Drug|Period B (Week 16 to Week 52)||0
3356745|NCT03706040|4086757|FG003|Received Study Drug|Period B (Week 16 to Week 52)||13
3356746|NCT03706040|4086758|FG004|Received Study Drug|Period B (Week 16 to Week 52)||11
3356747|NCT03706040|4086759|FG005|Received Study Drug|Period B (Week 16 to Week 52)||61
3356748|NCT03706040|4086760|FG006|Received Study Drug|Period B (Week 16 to Week 52)||57
3356749|NCT03706040|4086754|FG000|COMPLETED|Period B (Week 16 to Week 52)||0
3356750|NCT03706040|4086755|FG001|COMPLETED|Period B (Week 16 to Week 52)||0
3356751|NCT03706040|4086756|FG002|COMPLETED|Period B (Week 16 to Week 52)||0
3356752|NCT03706040|4086757|FG003|COMPLETED|Period B (Week 16 to Week 52)||5
3356753|NCT03706040|4086758|FG004|COMPLETED|Period B (Week 16 to Week 52)||3
3356754|NCT03706040|4086759|FG005|COMPLETED|Period B (Week 16 to Week 52)||33
3356755|NCT03706040|4086760|FG006|COMPLETED|Period B (Week 16 to Week 52)||30
3356756|NCT03706040|4086754|FG000|NOT COMPLETED|Period B (Week 16 to Week 52)||0
3356757|NCT03706040|4086755|FG001|NOT COMPLETED|Period B (Week 16 to Week 52)||0
3356758|NCT03706040|4086756|FG002|NOT COMPLETED|Period B (Week 16 to Week 52)||0
3356759|NCT03706040|4086757|FG003|NOT COMPLETED|Period B (Week 16 to Week 52)||8
3356760|NCT03706040|4086758|FG004|NOT COMPLETED|Period B (Week 16 to Week 52)||9
3356761|NCT03706040|4086759|FG005|NOT COMPLETED|Period B (Week 16 to Week 52)||28
3356762|NCT03706040|4086760|FG006|NOT COMPLETED|Period B (Week 16 to Week 52)||28
3356763|NCT03706313|4086778|FG000|STARTED|Overall Study||20
3356764|NCT03706313|4086779|FG001|STARTED|Overall Study||20
3356765|NCT03706313|4086778|FG000|COMPLETED|Overall Study||20
3356766|NCT03706313|4086779|FG001|COMPLETED|Overall Study||20
3356767|NCT03706313|4086778|FG000|NOT COMPLETED|Overall Study||0
3356768|NCT03706313|4086779|FG001|NOT COMPLETED|Overall Study||0
3356769|NCT03706456|4086785|FG000|STARTED|Overall Study||22
3356770|NCT03706456|4086785|FG000|Started|Overall Study||22
3356771|NCT03706456|4086785|FG000|Completed|Overall Study||0
3356772|NCT03706456|4086785|FG000|COMPLETED|Overall Study||0
3356773|NCT03706456|4086785|FG000|NOT COMPLETED|Overall Study||22
3356774|NCT03706469|4086793|FG000|STARTED|Overall Study||4
3356775|NCT03706469|4086794|FG001|STARTED|Overall Study||4
3356776|NCT03706469|4086795|FG002|STARTED|Overall Study||4
3356777|NCT03706469|4086796|FG003|STARTED|Overall Study||4
3356778|NCT03706469|4086793|FG000|COMPLETED|Overall Study||4
3356779|NCT03706469|4086794|FG001|COMPLETED|Overall Study||4
3356780|NCT03706469|4086795|FG002|COMPLETED|Overall Study||4
3356781|NCT03706469|4086796|FG003|COMPLETED|Overall Study||4
3356782|NCT03706469|4086793|FG000|NOT COMPLETED|Overall Study||0
3356783|NCT03706469|4086794|FG001|NOT COMPLETED|Overall Study||0
3356784|NCT03706469|4086795|FG002|NOT COMPLETED|Overall Study||0
3356785|NCT03706469|4086796|FG003|NOT COMPLETED|Overall Study||0
3356786|NCT03707041|4086813|FG000|STARTED|Overall Study||6
3356787|NCT03707041|4086814|FG001|STARTED|Overall Study||2
3356788|NCT03707041|4086815|FG002|STARTED|Overall Study||9
3356789|NCT03707041|4086816|FG003|STARTED|Overall Study||3
3356790|NCT03707041|4086817|FG004|STARTED|Overall Study||9
3356791|NCT03707041|4086818|FG005|STARTED|Overall Study||3
3356792|NCT03707041|4086813|FG000|COMPLETED|Overall Study||6
3356793|NCT03707041|4086814|FG001|COMPLETED|Overall Study||2
3356794|NCT03707041|4086815|FG002|COMPLETED|Overall Study||9
3356795|NCT03707041|4086816|FG003|COMPLETED|Overall Study||3
3356796|NCT03707041|4086817|FG004|COMPLETED|Overall Study||9
3356797|NCT03707041|4086818|FG005|COMPLETED|Overall Study||3
3356798|NCT03707041|4086813|FG000|NOT COMPLETED|Overall Study||0
3356799|NCT03707041|4086814|FG001|NOT COMPLETED|Overall Study||0
3356800|NCT03707041|4086815|FG002|NOT COMPLETED|Overall Study||0
3356801|NCT03707041|4086816|FG003|NOT COMPLETED|Overall Study||0
3356802|NCT03707041|4086817|FG004|NOT COMPLETED|Overall Study||0
3356803|NCT03707041|4086818|FG005|NOT COMPLETED|Overall Study||0
3356804|NCT03707522|4086837|FG000|STARTED|Overall Study||31
3356805|NCT03707522|4086838|FG001|STARTED|Overall Study||36
3356806|NCT03707522|4086839|FG002|STARTED|Overall Study||52
3356807|NCT03707522|4086840|FG003|STARTED|Overall Study||43
3356808|NCT03707522|4086837|FG000|COMPLETED|Overall Study||7
3356809|NCT03707522|4086838|FG001|COMPLETED|Overall Study||9
3356810|NCT03707522|4086839|FG002|COMPLETED|Overall Study||11
3356811|NCT03707522|4086840|FG003|COMPLETED|Overall Study||7
3356812|NCT03707522|4086837|FG000|NOT COMPLETED|Overall Study||24
3356813|NCT03707522|4086838|FG001|NOT COMPLETED|Overall Study||27
3356814|NCT03707522|4086839|FG002|NOT COMPLETED|Overall Study||41
3356815|NCT03707522|4086840|FG003|NOT COMPLETED|Overall Study||36
3356816|NCT03707587|4086852|FG000|STARTED|Overall Study||7
3356817|NCT03707587|4086853|FG001|STARTED|Overall Study||2
3356818|NCT03707587|4086852|FG000|COMPLETED|Overall Study||7
3356819|NCT03707587|4086853|FG001|COMPLETED|Overall Study||1
3356820|NCT03707587|4086852|FG000|NOT COMPLETED|Overall Study||0
3356821|NCT03707587|4086853|FG001|NOT COMPLETED|Overall Study||1
3356822|NCT03707821|4086861|FG000|STARTED|Overall Study||125
3356823|NCT03707821|4086862|FG001|STARTED|Overall Study||126
3356824|NCT03707821|4086861|FG000|COMPLETED|Overall Study||123
3356825|NCT03707821|4086862|FG001|COMPLETED|Overall Study||125
3356826|NCT03707821|4086861|FG000|NOT COMPLETED|Overall Study||2
3356827|NCT03707821|4086862|FG001|NOT COMPLETED|Overall Study||1
3356828|NCT03707912|4086870|FG000|STARTED|Overall Study||104
3356829|NCT03707912|4086871|FG001|STARTED|Overall Study||100
3356830|NCT03707912|4086870|FG000|COMPLETED|Overall Study||103
3356831|NCT03707912|4086871|FG001|COMPLETED|Overall Study||100
3356832|NCT03707912|4086870|FG000|NOT COMPLETED|Overall Study||1
3356833|NCT03707912|4086871|FG001|NOT COMPLETED|Overall Study||0
3356834|NCT03708211|4086879|FG000|STARTED|Overall Study||12
3356835|NCT03708211|4086880|FG001|STARTED|Overall Study||8
3356836|NCT03708211|4086879|FG000|COMPLETED|Overall Study||0
3356837|NCT03708211|4086880|FG001|COMPLETED|Overall Study||0
3356838|NCT03708211|4086879|FG000|NOT COMPLETED|Overall Study||12
3356839|NCT03708211|4086880|FG001|NOT COMPLETED|Overall Study||8
3179121|NCT01983254|3907311|FG001|Interview 3|Overall Study|69 patients, 37 caregivers|106
3179122|NCT01983254|3907310|FG000|COMPLETED|Overall Study|62 patients, 29 caregivers|91
3179123|NCT01983254|3907311|FG001|COMPLETED|Overall Study|69 patients, 37 caregivers|106
3179124|NCT01983254|3907310|FG000|NOT COMPLETED|Overall Study||34
3179125|NCT01983254|3907311|FG001|NOT COMPLETED|Overall Study||30
3179126|NCT01983293|3907319|FG000|STARTED|Overall Study||161
3179127|NCT01983293|3907320|FG001|STARTED|Overall Study||81
3179128|NCT01983293|3907319|FG000|COMPLETED|Overall Study||128
3179129|NCT01983293|3907320|FG001|COMPLETED|Overall Study||62
3179130|NCT01983293|3907319|FG000|NOT COMPLETED|Overall Study||33
3179131|NCT01983293|3907320|FG001|NOT COMPLETED|Overall Study||19
3179132|NCT01983553|3907328|FG000|STARTED|Overall Study||2131
3179133|NCT01983553|3907329|FG001|STARTED|Overall Study||1072
3179134|NCT01983553|3907328|FG000|COMPLETED|Overall Study||2131
3179135|NCT01983553|3907329|FG001|COMPLETED|Overall Study||1072
3179136|NCT01983553|3907328|FG000|NOT COMPLETED|Overall Study||0
3179137|NCT01983553|3907329|FG001|NOT COMPLETED|Overall Study||0
3179138|NCT01983566|3907339|FG000|STARTED|Test Period 1||4
3179139|NCT01983566|3907340|FG001|STARTED|Test Period 1||4
3179140|NCT01983566|3907341|FG002|STARTED|Test Period 1||4
3179141|NCT01983566|3907342|FG003|STARTED|Test Period 1||4
3179142|NCT01983566|3907339|FG000|COMPLETED|Test Period 1||4
3179143|NCT01983566|3907340|FG001|COMPLETED|Test Period 1||4
3179144|NCT01983566|3907341|FG002|COMPLETED|Test Period 1||4
3179145|NCT01983566|3907342|FG003|COMPLETED|Test Period 1||4
3179146|NCT01983566|3907339|FG000|NOT COMPLETED|Test Period 1||0
3179147|NCT01983566|3907340|FG001|NOT COMPLETED|Test Period 1||0
3179148|NCT01983566|3907341|FG002|NOT COMPLETED|Test Period 1||0
3179149|NCT01983566|3907342|FG003|NOT COMPLETED|Test Period 1||0
3179150|NCT01983566|3907339|FG000|STARTED|Wash-Out 1||4
3356840|NCT03708367|4086890|FG000|STARTED|Overall Study||59
3179151|NCT01983566|3907340|FG001|STARTED|Wash-Out 1||4
3179152|NCT01983566|3907341|FG002|STARTED|Wash-Out 1||4
3179153|NCT01983566|3907342|FG003|STARTED|Wash-Out 1||4
3179154|NCT01983566|3907339|FG000|COMPLETED|Wash-Out 1||4
3179155|NCT01983566|3907340|FG001|COMPLETED|Wash-Out 1||4
3179156|NCT01983566|3907341|FG002|COMPLETED|Wash-Out 1||4
3179157|NCT01983566|3907342|FG003|COMPLETED|Wash-Out 1||4
3179158|NCT01983566|3907339|FG000|NOT COMPLETED|Wash-Out 1||0
3179159|NCT01983566|3907340|FG001|NOT COMPLETED|Wash-Out 1||0
3179160|NCT01983566|3907341|FG002|NOT COMPLETED|Wash-Out 1||0
3179161|NCT01983566|3907342|FG003|NOT COMPLETED|Wash-Out 1||0
3179162|NCT01983566|3907339|FG000|STARTED|Test Period 2||4
3179163|NCT01983566|3907340|FG001|STARTED|Test Period 2||4
3179164|NCT01983566|3907341|FG002|STARTED|Test Period 2||4
3179165|NCT01983566|3907342|FG003|STARTED|Test Period 2||4
3179166|NCT01983566|3907339|FG000|COMPLETED|Test Period 2||4
3179167|NCT01983566|3907340|FG001|COMPLETED|Test Period 2||4
3179168|NCT01983566|3907341|FG002|COMPLETED|Test Period 2||4
3179169|NCT01983566|3907342|FG003|COMPLETED|Test Period 2||4
3179170|NCT01983566|3907339|FG000|NOT COMPLETED|Test Period 2||0
3179171|NCT01983566|3907340|FG001|NOT COMPLETED|Test Period 2||0
3356841|NCT03708367|4086891|FG001|STARTED|Overall Study||58
3356842|NCT03708367|4086890|FG000|COMPLETED|Overall Study||58
3356843|NCT03708367|4086891|FG001|COMPLETED|Overall Study||57
3356844|NCT03708367|4086890|FG000|NOT COMPLETED|Overall Study||1
3356845|NCT03708367|4086891|FG001|NOT COMPLETED|Overall Study||1
3356846|NCT03708393|4086898|FG000|STARTED|Overall Study||155
3356847|NCT03708393|4086898|FG000|COMPLETED|Overall Study||155
3356848|NCT03708393|4086898|FG000|NOT COMPLETED|Overall Study||0
3356849|NCT03708562|4086907|FG000|STARTED|Overall Study||24
3356850|NCT03708562|4086907|FG000|COMPLETED|Overall Study||12
3356851|NCT03708562|4086907|FG000|NOT COMPLETED|Overall Study||12
3356852|NCT03708744|4086911|FG000|STARTED|Overall Study||7
3356853|NCT03708744|4086912|FG001|STARTED|Overall Study||6
3356854|NCT03708744|4086913|FG002|STARTED|Overall Study||5
3356855|NCT03708744|4086914|FG003|STARTED|Overall Study||6
3356856|NCT03708744|4086911|FG000|COMPLETED|Overall Study||7
3356857|NCT03708744|4086912|FG001|COMPLETED|Overall Study||6
3356858|NCT03708744|4086913|FG002|COMPLETED|Overall Study||4
3356859|NCT03708744|4086914|FG003|COMPLETED|Overall Study||6
3356860|NCT03708744|4086911|FG000|NOT COMPLETED|Overall Study||0
3356861|NCT03708744|4086912|FG001|NOT COMPLETED|Overall Study||0
3356862|NCT03708744|4086913|FG002|NOT COMPLETED|Overall Study||1
3356863|NCT03708744|4086914|FG003|NOT COMPLETED|Overall Study||0
3356864|NCT03708770|4086924|FG000|STARTED|Overall Study||32
3356865|NCT03708770|4086924|FG000|COMPLETED|Overall Study||22
3356866|NCT03708770|4086924|FG000|NOT COMPLETED|Overall Study||10
3356867|NCT03709602|4086931|FG000|STARTED|Overall Study|Adolescents recruited for qualitative interviews.|16
3356868|NCT03709602|4086932|FG001|STARTED|Overall Study|Parents recruited for qualitative interviews.|16
3356869|NCT03709602|4086933|FG002|STARTED|Overall Study|Cohort of adolescents created from the EHR data for the quantitative portion of the study.|3044
3356870|NCT03709602|4086931|FG000|COMPLETED|Overall Study|Adolescents recruited for qualitative interviews.|16
3356871|NCT03709602|4086932|FG001|COMPLETED|Overall Study|Parents recruited for qualitative interviews.|16
3356872|NCT03709602|4086933|FG002|COMPLETED|Overall Study|Cohort of adolescents created from the EHR data for the quantitative portion of the study.|3044
3356873|NCT03709602|4086931|FG000|NOT COMPLETED|Overall Study||0
3356874|NCT03709602|4086932|FG001|NOT COMPLETED|Overall Study||0
3356875|NCT03709602|4086933|FG002|NOT COMPLETED|Overall Study||0
3356876|NCT03709654|4086941|FG000|STARTED|Overall Study||23
3356877|NCT03709654|4086942|FG001|STARTED|Overall Study||13
3356878|NCT03709654|4086941|FG000|COMPLETED|Overall Study||20
3356879|NCT03709654|4086942|FG001|COMPLETED|Overall Study||11
3356880|NCT03709654|4086941|FG000|NOT COMPLETED|Overall Study||3
3356881|NCT03709654|4086942|FG001|NOT COMPLETED|Overall Study||2
3356882|NCT03709810|4086948|FG000|STARTED|Treatment Period 1 (Visit 2)||24
3356883|NCT03709810|4086949|FG001|STARTED|Treatment Period 1 (Visit 2)||24
3356884|NCT03709810|4086948|FG000|COMPLETED|Treatment Period 1 (Visit 2)||24
3356885|NCT03709810|4086949|FG001|COMPLETED|Treatment Period 1 (Visit 2)||24
3356886|NCT03709810|4086948|FG000|NOT COMPLETED|Treatment Period 1 (Visit 2)||0
3356887|NCT03709810|4086949|FG001|NOT COMPLETED|Treatment Period 1 (Visit 2)||0
3356888|NCT03709810|4086948|FG000|STARTED|Treatment Period 2 (Visit 3)||24
3356889|NCT03709810|4086949|FG001|STARTED|Treatment Period 2 (Visit 3)||24
3356890|NCT03709810|4086948|FG000|COMPLETED|Treatment Period 2 (Visit 3)||24
3356891|NCT03709810|4086949|FG001|COMPLETED|Treatment Period 2 (Visit 3)||24
3356892|NCT03709810|4086948|FG000|NOT COMPLETED|Treatment Period 2 (Visit 3)||0
3356893|NCT03709810|4086949|FG001|NOT COMPLETED|Treatment Period 2 (Visit 3)||0
3356894|NCT03709823|4086961|FG000|STARTED|Overall Study||51
3356895|NCT03709823|4086962|FG001|STARTED|Overall Study||50
3356896|NCT03709823|4086963|FG002|STARTED|Overall Study||25
3356897|NCT03709823|4086964|FG003|STARTED|Overall Study||52
3356898|NCT03709823|4086965|FG004|STARTED|Overall Study||50
3179172|NCT01983566|3907341|FG002|NOT COMPLETED|Test Period 2||0
3179173|NCT01983566|3907342|FG003|NOT COMPLETED|Test Period 2||0
3179174|NCT01983566|3907339|FG000|STARTED|Wash-Out 2|Subjects starting may not equal number completing the previous period due to early study termination|2
3179175|NCT01983566|3907340|FG001|STARTED|Wash-Out 2|Subjects starting may not equal number completing the previous period due to early study termination|3
3356899|NCT03709823|4086966|FG005|STARTED|Overall Study||26
3356900|NCT03709823|4086961|FG000|COMPLETED|Overall Study||48
3356901|NCT03709823|4086962|FG001|COMPLETED|Overall Study||45
3356902|NCT03709823|4086963|FG002|COMPLETED|Overall Study||22
3356903|NCT03709823|4086964|FG003|COMPLETED|Overall Study||50
3356904|NCT03709823|4086965|FG004|COMPLETED|Overall Study||49
3356905|NCT03709823|4086966|FG005|COMPLETED|Overall Study||26
3356906|NCT03709823|4086961|FG000|NOT COMPLETED|Overall Study||3
3356907|NCT03709823|4086962|FG001|NOT COMPLETED|Overall Study||5
3356908|NCT03709823|4086963|FG002|NOT COMPLETED|Overall Study||3
3356909|NCT03709823|4086964|FG003|NOT COMPLETED|Overall Study||2
3356910|NCT03709823|4086965|FG004|NOT COMPLETED|Overall Study||1
3356911|NCT03709823|4086966|FG005|NOT COMPLETED|Overall Study||0
3356912|NCT03710083|4086983|FG000|STARTED|Overall Study||66
3356913|NCT03710083|4086983|FG000|COMPLETED|Overall Study||63
3356914|NCT03710083|4086983|FG000|NOT COMPLETED|Overall Study||3
3356915|NCT03710161|4086989|FG000|STARTED|Overall Study||3
3356916|NCT03710161|4086990|FG001|STARTED|Overall Study||2
3356917|NCT03710161|4086989|FG000|COMPLETED|Overall Study|Study halted due to COVID pandemic|0
3356918|NCT03710161|4086990|FG001|COMPLETED|Overall Study|Study halted due to COVID pandemic|0
3356919|NCT03710161|4086989|FG000|NOT COMPLETED|Overall Study||3
3356920|NCT03710161|4086990|FG001|NOT COMPLETED|Overall Study||2
3356921|NCT03710187|4086998|FG000|STARTED|Overall Study||41
3356922|NCT03710187|4086999|FG001|STARTED|Overall Study||43
3356923|NCT03710187|4086998|FG000|COMPLETED|Overall Study||41
3356924|NCT03710187|4086999|FG001|COMPLETED|Overall Study||43
3356925|NCT03710187|4086998|FG000|NOT COMPLETED|Overall Study||0
3356926|NCT03710187|4086999|FG001|NOT COMPLETED|Overall Study||0
3356927|NCT03710577|4087007|FG000|STARTED|First Intervention||8
3356928|NCT03710577|4087008|FG001|STARTED|First Intervention||4
3356929|NCT03710577|4087007|FG000|COMPLETED|First Intervention||8
3356930|NCT03710577|4087008|FG001|COMPLETED|First Intervention||4
3356931|NCT03710577|4087007|FG000|NOT COMPLETED|First Intervention||0
3356932|NCT03710577|4087008|FG001|NOT COMPLETED|First Intervention||0
3356933|NCT03710577|4087007|FG000|STARTED|Time Between Sessions (2-5 Days)||8
3356934|NCT03710577|4087008|FG001|STARTED|Time Between Sessions (2-5 Days)||4
3356935|NCT03710577|4087007|FG000|COMPLETED|Time Between Sessions (2-5 Days)||8
3356936|NCT03710577|4087008|FG001|COMPLETED|Time Between Sessions (2-5 Days)||4
3356937|NCT03710577|4087007|FG000|NOT COMPLETED|Time Between Sessions (2-5 Days)||0
3356938|NCT03710577|4087008|FG001|NOT COMPLETED|Time Between Sessions (2-5 Days)||0
3356939|NCT03710577|4087007|FG000|STARTED|Second Intervention||8
3039971|NCT01161472|3759429|FG000|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
3039972|NCT01161472|3759430|FG001|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
3039973|NCT01161472|3759431|FG002|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
3039974|NCT01161472|3759432|FG003|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
3039975|NCT01161472|3759429|FG000|STARTED|Fourth Intervention Period||4
3039976|NCT01161472|3759430|FG001|STARTED|Fourth Intervention Period||5
3039977|NCT01161472|3759431|FG002|STARTED|Fourth Intervention Period||5
3356940|NCT03710577|4087008|FG001|STARTED|Second Intervention||4
3356941|NCT03710577|4087007|FG000|COMPLETED|Second Intervention||8
3356942|NCT03710577|4087008|FG001|COMPLETED|Second Intervention||4
3356943|NCT03710577|4087007|FG000|NOT COMPLETED|Second Intervention||0
3356944|NCT03710577|4087008|FG001|NOT COMPLETED|Second Intervention||0
3356945|NCT03710590|4087016|FG000|STARTED|Overall Study||22
3356946|NCT03710590|4087017|FG001|STARTED|Overall Study||23
3356947|NCT03710590|4087016|FG000|Session 1: ECIG Lab Session 15 Watts, 10 mg Nicotine|Overall Study||12
3356948|NCT03710590|4087017|FG001|Session 1: ECIG Lab Session 15 Watts, 10 mg Nicotine|Overall Study||15
3356949|NCT03710590|4087016|FG000|Session 2: ECIG Lab Session 15 Watts, 15 mg Nicotine|Overall Study||12
3356950|NCT03710590|4087017|FG001|Session 2: ECIG Lab Session 15 Watts, 15 mg Nicotine|Overall Study||15
3356951|NCT03710590|4087016|FG000|Session 3: ECIG Lab Session 15 Watts, 30 mg Nicotine|Overall Study||12
3356952|NCT03710590|4087017|FG001|Session 3: ECIG Lab Session 15 Watts, 30 mg Nicotine|Overall Study||15
3356953|NCT03710590|4087016|FG000|Session 4: ECIG Lab Session 30 Watts, 10 mg Nicotine|Overall Study||12
3356954|NCT03710590|4087017|FG001|Session 4: ECIG Lab Session 30 Watts, 10 mg Nicotine|Overall Study||15
3356955|NCT03710590|4087016|FG000|Session 5: ECIG Lab Session 30 Watts, 15 mg Nicotine|Overall Study||12
3356956|NCT03710590|4087017|FG001|Session 5: ECIG Lab Session 30 Watts, 15 mg Nicotine|Overall Study||15
3356957|NCT03710590|4087016|FG000|Session 6: ECIG Lab Session 30 Watts, 30 mg Nicotine|Overall Study||12
3356958|NCT03710590|4087017|FG001|Session 6: ECIG Lab Session 30 Watts, 30 mg Nicotine|Overall Study||15
3356959|NCT03710590|4087016|FG000|COMPLETED|Overall Study||12
3356960|NCT03710590|4087017|FG001|COMPLETED|Overall Study||15
3356961|NCT03710590|4087016|FG000|NOT COMPLETED|Overall Study||10
3356962|NCT03710590|4087017|FG001|NOT COMPLETED|Overall Study||8
3356963|NCT03710889|4087023|FG000|STARTED|Overall Study||23
3356964|NCT03710889|4087023|FG000|Received at Least 1 Dose of Study Drug|Overall Study||23
3356965|NCT03710889|4087023|FG000|Bone-Biopsy Population|Overall Study||19
3356966|NCT03710889|4087023|FG000|COMPLETED|Overall Study||20
3356967|NCT03710889|4087023|FG000|NOT COMPLETED|Overall Study||3
3356968|NCT03711396|4087027|FG000|STARTED|Overall Study||13
3356969|NCT03711396|4087028|FG001|STARTED|Overall Study||13
3356970|NCT03711396|4087027|FG000|COMPLETED|Overall Study||13
3356971|NCT03711396|4087028|FG001|COMPLETED|Overall Study||13
3356972|NCT03711396|4087027|FG000|NOT COMPLETED|Overall Study||0
3356973|NCT03711396|4087028|FG001|NOT COMPLETED|Overall Study||0
3356974|NCT03711578|4087035|FG000|STARTED|Overall Study||20
3356975|NCT03711578|4087035|FG000|COMPLETED|Overall Study||20
3356976|NCT03711578|4087035|FG000|NOT COMPLETED|Overall Study||0
3356977|NCT03712189|4087041|FG000|STARTED|Overall Study||15
3356978|NCT03712189|4087042|FG001|STARTED|Overall Study||15
3356979|NCT03712189|4087041|FG000|COMPLETED|Overall Study||15
3356980|NCT03712189|4087042|FG001|COMPLETED|Overall Study||15
3356981|NCT03712189|4087041|FG000|NOT COMPLETED|Overall Study||0
3356982|NCT03712189|4087042|FG001|NOT COMPLETED|Overall Study||0
3356983|NCT03712280|4087052|FG000|STARTED|Overall Study||12
3356984|NCT03712280|4087053|FG001|STARTED|Overall Study||12
3356985|NCT03712280|4087054|FG002|STARTED|Overall Study||13
3356986|NCT03712280|4087055|FG003|STARTED|Overall Study||13
3356987|NCT03712280|4087052|FG000|Safety Population|Overall Study||12
3356988|NCT03712280|4087053|FG001|Safety Population|Overall Study||11
3356989|NCT03712280|4087054|FG002|Safety Population|Overall Study||13
3356990|NCT03712280|4087055|FG003|Safety Population|Overall Study||12
3356991|NCT03712280|4087052|FG000|Modified Intent to Treat Population|Overall Study||12
3356992|NCT03712280|4087053|FG001|Modified Intent to Treat Population|Overall Study||11
3356993|NCT03712280|4087054|FG002|Modified Intent to Treat Population|Overall Study||13
3356994|NCT03712280|4087055|FG003|Modified Intent to Treat Population|Overall Study||12
3356995|NCT03712280|4087052|FG000|Completed 5 Day Treatment|Overall Study||11
3356996|NCT03712280|4087053|FG001|Completed 5 Day Treatment|Overall Study||11
3356997|NCT03712280|4087054|FG002|Completed 5 Day Treatment|Overall Study||12
3356998|NCT03712280|4087055|FG003|Completed 5 Day Treatment|Overall Study||12
3356999|NCT03712280|4087052|FG000|COMPLETED|Overall Study||11
3357000|NCT03712280|4087053|FG001|COMPLETED|Overall Study||11
3357001|NCT03712280|4087054|FG002|COMPLETED|Overall Study||12
3357002|NCT03712280|4087055|FG003|COMPLETED|Overall Study||12
3357003|NCT03712280|4087052|FG000|NOT COMPLETED|Overall Study||1
3357004|NCT03712280|4087053|FG001|NOT COMPLETED|Overall Study||1
3357005|NCT03712280|4087054|FG002|NOT COMPLETED|Overall Study||1
3357006|NCT03712280|4087055|FG003|NOT COMPLETED|Overall Study||1
3357007|NCT03712449|4087067|FG000|STARTED|Overall Study||13
3357008|NCT03712449|4087068|FG001|STARTED|Overall Study||46
2928091|NCT00576472|3639111|FG008|COMPLETED|Initial Screening||0
2928092|NCT00576472|3639112|FG009|COMPLETED|Initial Screening||0
2928093|NCT00576472|3639113|FG010|COMPLETED|Initial Screening||0
2928094|NCT00576472|3639114|FG011|COMPLETED|Initial Screening||0
2928095|NCT00576472|3639115|FG012|COMPLETED|Initial Screening||0
3357009|NCT03712449|4087067|FG000|Full Analysis Population|Overall Study||13
3357010|NCT03712449|4087068|FG001|Full Analysis Population|Overall Study||45
3357011|NCT03712449|4087067|FG000|COMPLETED|Overall Study||13
3357012|NCT03712449|4087068|FG001|COMPLETED|Overall Study||45
3357013|NCT03712449|4087067|FG000|NOT COMPLETED|Overall Study||0
3357014|NCT03712449|4087068|FG001|NOT COMPLETED|Overall Study||1
3357015|NCT03712852|4087077|FG000|STARTED|Overall Study||20
3357016|NCT03712852|4087078|FG001|STARTED|Overall Study||20
3357017|NCT03712852|4087079|FG002|STARTED|Overall Study||20
3357018|NCT03712852|4087077|FG000|COMPLETED|Overall Study||20
3357019|NCT03712852|4087078|FG001|COMPLETED|Overall Study||20
3357020|NCT03712852|4087079|FG002|COMPLETED|Overall Study||20
3357021|NCT03712852|4087077|FG000|NOT COMPLETED|Overall Study||0
3357022|NCT03712852|4087078|FG001|NOT COMPLETED|Overall Study||0
3357023|NCT03712852|4087079|FG002|NOT COMPLETED|Overall Study||0
3357024|NCT03712917|4087090|FG000|STARTED|Overall Study||40
3357025|NCT03712917|4087091|FG001|STARTED|Overall Study||40
3357026|NCT03712917|4087092|FG002|STARTED|Overall Study||40
3357027|NCT03712917|4087090|FG000|COMPLETED|Overall Study||31
3357028|NCT03712917|4087091|FG001|COMPLETED|Overall Study||32
3357029|NCT03712917|4087092|FG002|COMPLETED|Overall Study||31
3357030|NCT03712917|4087090|FG000|NOT COMPLETED|Overall Study||9
3357031|NCT03712917|4087091|FG001|NOT COMPLETED|Overall Study||8
3357032|NCT03712917|4087092|FG002|NOT COMPLETED|Overall Study||9
3357033|NCT03712930|4087100|FG000|STARTED|Overall Study||13
3357034|NCT03712930|4087100|FG000|COMPLETED|Overall Study||0
3357035|NCT03712930|4087100|FG000|NOT COMPLETED|Overall Study||13
3357036|NCT03713398|4087106|FG000|STARTED|Overall Study||50
3357037|NCT03713398|4087107|FG001|STARTED|Overall Study||50
3357038|NCT03713398|4087106|FG000|COMPLETED|Overall Study||24
3357039|NCT03713398|4087107|FG001|COMPLETED|Overall Study||23
3357040|NCT03713398|4087106|FG000|NOT COMPLETED|Overall Study||26
3357041|NCT03713398|4087107|FG001|NOT COMPLETED|Overall Study||27
3357042|NCT03714022|4087115|FG000|STARTED|Overall Study||70
3357043|NCT03714022|4087116|FG001|STARTED|Overall Study||70
3357044|NCT03714022|4087115|FG000|COMPLETED|Overall Study||66
3357045|NCT03714022|4087116|FG001|COMPLETED|Overall Study||67
3357046|NCT03714022|4087115|FG000|NOT COMPLETED|Overall Study||4
3357047|NCT03714022|4087116|FG001|NOT COMPLETED|Overall Study||3
3357048|NCT03714256|4087124|FG000|STARTED|Overall Study||14
3357049|NCT03714256|4087125|FG001|STARTED|Overall Study||19
3357050|NCT03714256|4087124|FG000|COMPLETED|Overall Study||14
3357051|NCT03714256|4087125|FG001|COMPLETED|Overall Study||19
3357052|NCT03714256|4087124|FG000|NOT COMPLETED|Overall Study||0
3357053|NCT03714256|4087125|FG001|NOT COMPLETED|Overall Study||0
3357054|NCT03714659|4087131|FG000|STARTED|Overall Study||20
3357055|NCT03714659|4087131|FG000|COMPLETED|Overall Study||19
3357056|NCT03714659|4087131|FG000|NOT COMPLETED|Overall Study||1
3357057|NCT03714672|4087139|FG000|STARTED|Overall Study||209
3357058|NCT03714672|4087140|FG001|STARTED|Overall Study||206
3357059|NCT03714672|4087141|FG002|STARTED|Overall Study||206
3357060|NCT03714672|4087142|FG003|STARTED|Overall Study||208
3357061|NCT03714672|4087139|FG000|Safety Set|Overall Study||208
3357062|NCT03714672|4087140|FG001|Safety Set|Overall Study||205
3357063|NCT03714672|4087141|FG002|Safety Set|Overall Study||206
3357064|NCT03714672|4087142|FG003|Safety Set|Overall Study||207
3357065|NCT03714672|4087139|FG000|COMPLETED|Overall Study||207
3357066|NCT03714672|4087140|FG001|COMPLETED|Overall Study||202
3357067|NCT03714672|4087141|FG002|COMPLETED|Overall Study||202
3357068|NCT03714672|4087142|FG003|COMPLETED|Overall Study||207
3357069|NCT03714672|4087139|FG000|NOT COMPLETED|Overall Study||2
3357070|NCT03714672|4087140|FG001|NOT COMPLETED|Overall Study||4
3357071|NCT03714672|4087141|FG002|NOT COMPLETED|Overall Study||4
3357072|NCT03714672|4087142|FG003|NOT COMPLETED|Overall Study||1
3357073|NCT03714919|4087153|FG000|STARTED|Overall Study||10
3357074|NCT03714919|4087153|FG000|COMPLETED|Overall Study||10
3357075|NCT03714919|4087153|FG000|NOT COMPLETED|Overall Study||0
3357076|NCT03715426|4087159|FG000|STARTED|Overall Study||133
3357077|NCT03715426|4087160|FG001|STARTED|Overall Study||117
3357078|NCT03715426|4087159|FG000|1-Month Follow-Up Survey|Overall Study||113
3357079|NCT03715426|4087160|FG001|1-Month Follow-Up Survey|Overall Study||97
3357080|NCT03715426|4087159|FG000|4-Month Follow-Up Survey|Overall Study||112
3357081|NCT03715426|4087160|FG001|4-Month Follow-Up Survey|Overall Study||92
3357082|NCT03715426|4087159|FG000|COMPLETED|Overall Study||112
3357083|NCT03715426|4087160|FG001|COMPLETED|Overall Study||92
3357084|NCT03715426|4087159|FG000|NOT COMPLETED|Overall Study||21
3357085|NCT03715426|4087160|FG001|NOT COMPLETED|Overall Study||25
3357086|NCT03715452|4087166|FG000|STARTED|Overall Study||114
3357087|NCT03715452|4087166|FG000|COMPLETED|Overall Study||114
3357088|NCT03715452|4087166|FG000|NOT COMPLETED|Overall Study||0
3357089|NCT03715530|4087173|FG000|STARTED|Overall Study||33
3357090|NCT03715530|4087174|FG001|STARTED|Overall Study||42
3357091|NCT03715530|4087175|FG002|STARTED|Overall Study||87
3357092|NCT03715530|4087173|FG000|COMPLETED|Overall Study||30
3357093|NCT03715530|4087174|FG001|COMPLETED|Overall Study||41
3357094|NCT03715530|4087175|FG002|COMPLETED|Overall Study||85
3357095|NCT03715530|4087173|FG000|NOT COMPLETED|Overall Study||3
3357096|NCT03715530|4087174|FG001|NOT COMPLETED|Overall Study||1
3357097|NCT03715530|4087175|FG002|NOT COMPLETED|Overall Study||2
3357098|NCT03715803|4087185|FG000|STARTED|Overall Study||91
3357099|NCT03715803|4087186|FG001|STARTED|Overall Study||126
3357100|NCT03715803|4087185|FG000|COMPLETED|Overall Study||91
3357101|NCT03715803|4087186|FG001|COMPLETED|Overall Study||126
3357102|NCT03715803|4087185|FG000|NOT COMPLETED|Overall Study||0
3357103|NCT03715803|4087186|FG001|NOT COMPLETED|Overall Study||0
3357104|NCT03716024|4087194|FG000|STARTED|Overall Study||118
3357105|NCT03716024|4087195|FG001|STARTED|Overall Study||116
3357106|NCT03716024|4087194|FG000|COMPLETED|Overall Study||107
3357107|NCT03716024|4087195|FG001|COMPLETED|Overall Study||98
3357108|NCT03716024|4087194|FG000|NOT COMPLETED|Overall Study||11
3357109|NCT03716024|4087195|FG001|NOT COMPLETED|Overall Study||18
3357110|NCT03716050|4087209|FG000|STARTED|Overall Study||2
3357111|NCT03716050|4087210|FG001|STARTED|Overall Study||4
3357112|NCT03716050|4087211|FG002|STARTED|Overall Study||1
3357113|NCT03716050|4087212|FG003|STARTED|Overall Study||3
3357114|NCT03716050|4087213|FG004|STARTED|Overall Study||1
3357115|NCT03716050|4087214|FG005|STARTED|Overall Study||0
3357116|NCT03716050|4087215|FG006|STARTED|Overall Study||4
3357117|NCT03716050|4087216|FG007|STARTED|Overall Study||2
3357118|NCT03716050|4087209|FG000|COMPLETED|Overall Study||2
3357119|NCT03716050|4087210|FG001|COMPLETED|Overall Study||4
3357120|NCT03716050|4087211|FG002|COMPLETED|Overall Study||0
3357121|NCT03716050|4087212|FG003|COMPLETED|Overall Study||1
3357122|NCT03716050|4087213|FG004|COMPLETED|Overall Study||1
3357123|NCT03716050|4087214|FG005|COMPLETED|Overall Study||0
3357124|NCT03716050|4087215|FG006|COMPLETED|Overall Study||4
3357125|NCT03716050|4087216|FG007|COMPLETED|Overall Study||0
3357126|NCT03716050|4087209|FG000|NOT COMPLETED|Overall Study||0
3357127|NCT03716050|4087210|FG001|NOT COMPLETED|Overall Study||0
3357128|NCT03716050|4087211|FG002|NOT COMPLETED|Overall Study||1
3357129|NCT03716050|4087212|FG003|NOT COMPLETED|Overall Study||2
3357130|NCT03716050|4087213|FG004|NOT COMPLETED|Overall Study||0
3357131|NCT03716050|4087214|FG005|NOT COMPLETED|Overall Study||0
3357132|NCT03716050|4087215|FG006|NOT COMPLETED|Overall Study||0
3357133|NCT03716050|4087216|FG007|NOT COMPLETED|Overall Study||2
3357134|NCT03716076|4087235|FG000|STARTED|Overall Study||25
3357135|NCT03716076|4087236|FG001|STARTED|Overall Study||25
3357136|NCT03716076|4087235|FG000|COMPLETED|Overall Study||22
3357137|NCT03716076|4087236|FG001|COMPLETED|Overall Study||19
3357138|NCT03716076|4087235|FG000|NOT COMPLETED|Overall Study||3
3357139|NCT03716076|4087236|FG001|NOT COMPLETED|Overall Study||6
3357140|NCT03717012|4087244|FG000|STARTED|Overall Study||9
3357141|NCT03717012|4087245|FG001|STARTED|Overall Study||10
3357142|NCT03717012|4087244|FG000|COMPLETED|Overall Study||8
3357143|NCT03717012|4087245|FG001|COMPLETED|Overall Study||4
3357144|NCT03717012|4087244|FG000|NOT COMPLETED|Overall Study||1
3357145|NCT03717012|4087245|FG001|NOT COMPLETED|Overall Study||6
3357146|NCT03717051|4087253|FG000|STARTED|Overall Study||352
3357147|NCT03717051|4087254|FG001|STARTED|Overall Study||482
3357148|NCT03717051|4087253|FG000|COMPLETED|Overall Study||352
3357149|NCT03717051|4087254|FG001|COMPLETED|Overall Study||482
3357150|NCT03717051|4087253|FG000|NOT COMPLETED|Overall Study||0
3357151|NCT03717051|4087254|FG001|NOT COMPLETED|Overall Study||0
3357152|NCT03717064|4087260|FG000|STARTED|Period 1||18
3357153|NCT03717064|4087260|FG000|COMPLETED|Period 1||18
3357154|NCT03717064|4087260|FG000|NOT COMPLETED|Period 1||0
3357155|NCT03717064|4087260|FG000|STARTED|Period 2||18
3357156|NCT03717064|4087260|FG000|COMPLETED|Period 2||17
3357157|NCT03717064|4087260|FG000|NOT COMPLETED|Period 2||1
3357158|NCT03717155|4087264|FG000|STARTED|Overall Study||43
3357159|NCT03717155|4087264|FG000|COMPLETED|Overall Study||43
3357160|NCT03717155|4087264|FG000|NOT COMPLETED|Overall Study||0
3357161|NCT03717506|4087271|FG000|STARTED|Overall Study||496
3357162|NCT03717506|4087272|FG001|STARTED|Overall Study||491
3357163|NCT03717506|4087273|FG002|STARTED|Overall Study||249
3357164|NCT03717506|4087271|FG000|COMPLETED|Overall Study||447
3357165|NCT03717506|4087272|FG001|COMPLETED|Overall Study||441
3357166|NCT03717506|4087273|FG002|COMPLETED|Overall Study||222
3357167|NCT03717506|4087271|FG000|NOT COMPLETED|Overall Study||49
3357168|NCT03717506|4087272|FG001|NOT COMPLETED|Overall Study||50
3357169|NCT03717506|4087273|FG002|NOT COMPLETED|Overall Study||27
3357170|NCT03718000|4087283|FG000|STARTED|Overall Study||55
3357171|NCT03718000|4087284|FG001|STARTED|Overall Study||56
3357172|NCT03718000|4087283|FG000|COMPLETED|Overall Study||53
3357173|NCT03718000|4087284|FG001|COMPLETED|Overall Study||51
3357174|NCT03718000|4087283|FG000|NOT COMPLETED|Overall Study||2
3357175|NCT03718000|4087284|FG001|NOT COMPLETED|Overall Study||5
3357176|NCT03718871|4087293|FG000|STARTED|Overall Study||250
3357177|NCT03718871|4087294|FG001|STARTED|Overall Study||250
3357178|NCT03718871|4087293|FG000|COMPLETED|Overall Study||250
3357179|NCT03718871|4087294|FG001|COMPLETED|Overall Study||250
3357180|NCT03718871|4087293|FG000|NOT COMPLETED|Overall Study||0
3357181|NCT03718871|4087294|FG001|NOT COMPLETED|Overall Study||0
3357182|NCT03719300|4087301|FG000|STARTED|Overall Study||32
3357183|NCT03719300|4087301|FG000|COMPLETED|Overall Study||32
3357184|NCT03719300|4087301|FG000|NOT COMPLETED|Overall Study||0
3357185|NCT03719378|4087307|FG000|STARTED|Overall Study||75
3357186|NCT03719378|4087308|FG001|STARTED|Overall Study||75
3357187|NCT03719378|4087307|FG000|COMPLETED|Overall Study||65
3357188|NCT03719378|4087308|FG001|COMPLETED|Overall Study||65
3357189|NCT03719378|4087307|FG000|NOT COMPLETED|Overall Study||10
3179176|NCT01983566|3907341|FG002|STARTED|Wash-Out 2|Subjects starting may not equal number completing the previous period due to early study termination|2
3179177|NCT01983566|3907342|FG003|STARTED|Wash-Out 2||4
3179178|NCT01983566|3907339|FG000|COMPLETED|Wash-Out 2||2
3179179|NCT01983566|3907340|FG001|COMPLETED|Wash-Out 2||3
3179180|NCT01983566|3907341|FG002|COMPLETED|Wash-Out 2||2
3179181|NCT01983566|3907342|FG003|COMPLETED|Wash-Out 2||4
3179182|NCT01983566|3907339|FG000|NOT COMPLETED|Wash-Out 2||0
3179183|NCT01983566|3907340|FG001|NOT COMPLETED|Wash-Out 2||0
3179184|NCT01983566|3907341|FG002|NOT COMPLETED|Wash-Out 2||0
3179185|NCT01983566|3907342|FG003|NOT COMPLETED|Wash-Out 2||0
3179186|NCT01983566|3907339|FG000|STARTED|Test Period 3||2
3179187|NCT01983566|3907340|FG001|STARTED|Test Period 3||3
3357190|NCT03719378|4087308|FG001|NOT COMPLETED|Overall Study||10
3357191|NCT03719586|4087318|FG000|STARTED|Overall Study||177
3357192|NCT03719586|4087319|FG001|STARTED|Overall Study||176
3357193|NCT03719586|4087320|FG002|STARTED|Overall Study|The REGN-EB3 arm was added in 1/2019 after the trial had initially begun in November 2018.|158
3357194|NCT03719586|4087321|FG003|STARTED|Overall Study||169
3357195|NCT03719586|4087318|FG000|COMPLETED|Overall Study|in 8/2019 the DSMB recommended further randomization only occur to the MAb114 and REGN-EB3 arms.|169
3357196|NCT03719586|4087319|FG001|COMPLETED|Overall Study|in 8/2019 the DSMB recommended further randomization only occur to the MAb114 and REGN-EB3 arms.|169
3357197|NCT03719586|4087320|FG002|COMPLETED|Overall Study|in 8/2019 the DSMB recommended further randomization only occur to the MAb114 and REGN-EB3 arms.|154
3357198|NCT03719586|4087321|FG003|COMPLETED|Overall Study|in 8/2019 the DSMB recommended further randomization only occur to the MAb114 and REGN-EB3 arms.|169
3357199|NCT03719586|4087318|FG000|NOT COMPLETED|Overall Study||8
3357200|NCT03719586|4087319|FG001|NOT COMPLETED|Overall Study||7
3357201|NCT03719586|4087320|FG002|NOT COMPLETED|Overall Study||4
3357202|NCT03719586|4087321|FG003|NOT COMPLETED|Overall Study||0
3357203|NCT03719612|4087331|FG000|STARTED|Overall Study||160
3357204|NCT03719612|4087331|FG000|COMPLETED|Overall Study||148
3357205|NCT03719612|4087331|FG000|NOT COMPLETED|Overall Study||12
3357206|NCT03719677|4087337|FG000|STARTED|Overall Study||7
3357207|NCT03719677|4087337|FG000|COMPLETED|Overall Study||7
3357208|NCT03719677|4087337|FG000|NOT COMPLETED|Overall Study||0
3357209|NCT03719885|4087341|FG000|STARTED|Overall Study||55
3357210|NCT03719885|4087341|FG000|COMPLETED|Overall Study||35
3357211|NCT03719885|4087341|FG000|NOT COMPLETED|Overall Study||20
3357212|NCT03720119|4087347|FG000|STARTED|Overall Study||78
3357213|NCT03720119|4087347|FG000|COMPLETED|Overall Study||69
3357214|NCT03720119|4087347|FG000|NOT COMPLETED|Overall Study||9
3357215|NCT03720470|4087355|FG000|STARTED|Treatment Period: First Part 16 Weeks||131
3357216|NCT03720470|4087356|FG001|STARTED|Treatment Period: First Part 16 Weeks||0
3357217|NCT03720470|4087357|FG002|STARTED|Treatment Period: First Part 16 Weeks||0
3357218|NCT03720470|4087358|FG003|STARTED|Treatment Period: First Part 16 Weeks||238
3357219|NCT03720470|4087359|FG004|STARTED|Treatment Period: First Part 16 Weeks||226
3357220|NCT03720470|4087360|FG005|STARTED|Treatment Period: First Part 16 Weeks||243
3357221|NCT03720470|4087355|FG000|Treated/ Safety Analysis Set|Treatment Period: First Part 16 Weeks||131
3357222|NCT03720470|4087356|FG001|Treated/ Safety Analysis Set|Treatment Period: First Part 16 Weeks||0
3357223|NCT03720470|4087357|FG002|Treated/ Safety Analysis Set|Treatment Period: First Part 16 Weeks||0
3357224|NCT03720470|4087358|FG003|Treated/ Safety Analysis Set|Treatment Period: First Part 16 Weeks||238
3357225|NCT03720470|4087359|FG004|Treated/ Safety Analysis Set|Treatment Period: First Part 16 Weeks||226
3357226|NCT03720470|4087360|FG005|Treated/ Safety Analysis Set|Treatment Period: First Part 16 Weeks||242
3357227|NCT03720470|4087355|FG000|Full Analysis Set|Treatment Period: First Part 16 Weeks||131
3357228|NCT03720470|4087356|FG001|Full Analysis Set|Treatment Period: First Part 16 Weeks||0
3179188|NCT01983566|3907341|FG002|STARTED|Test Period 3||2
3179189|NCT01983566|3907342|FG003|STARTED|Test Period 3||4
3357229|NCT03720470|4087357|FG002|Full Analysis Set|Treatment Period: First Part 16 Weeks||0
3357230|NCT03720470|4087358|FG003|Full Analysis Set|Treatment Period: First Part 16 Weeks||238
3357231|NCT03720470|4087359|FG004|Full Analysis Set|Treatment Period: First Part 16 Weeks||226
3357232|NCT03720470|4087360|FG005|Full Analysis Set|Treatment Period: First Part 16 Weeks||242
3357233|NCT03720470|4087355|FG000|COMPLETED|Treatment Period: First Part 16 Weeks||117
3357234|NCT03720470|4087356|FG001|COMPLETED|Treatment Period: First Part 16 Weeks||0
3357235|NCT03720470|4087357|FG002|COMPLETED|Treatment Period: First Part 16 Weeks||0
3357236|NCT03720470|4087358|FG003|COMPLETED|Treatment Period: First Part 16 Weeks||217
3357237|NCT03720470|4087359|FG004|COMPLETED|Treatment Period: First Part 16 Weeks||208
3357238|NCT03720470|4087360|FG005|COMPLETED|Treatment Period: First Part 16 Weeks||223
3357239|NCT03720470|4087355|FG000|NOT COMPLETED|Treatment Period: First Part 16 Weeks||14
3357240|NCT03720470|4087356|FG001|NOT COMPLETED|Treatment Period: First Part 16 Weeks||0
3357241|NCT03720470|4087357|FG002|NOT COMPLETED|Treatment Period: First Part 16 Weeks||0
3357242|NCT03720470|4087358|FG003|NOT COMPLETED|Treatment Period: First Part 16 Weeks||21
3357243|NCT03720470|4087359|FG004|NOT COMPLETED|Treatment Period: First Part 16 Weeks||18
3357244|NCT03720470|4087360|FG005|NOT COMPLETED|Treatment Period: First Part 16 Weeks||20
2928096|NCT00576472|3639116|FG013|COMPLETED|Initial Screening||0
2928097|NCT00576472|3639117|FG014|COMPLETED|Initial Screening||0
3039978|NCT01161472|3759432|FG003|STARTED|Fourth Intervention Period||5
3039979|NCT01161472|3759429|FG000|COMPLETED|Fourth Intervention Period||4
3039980|NCT01161472|3759430|FG001|COMPLETED|Fourth Intervention Period||5
3039981|NCT01161472|3759431|FG002|COMPLETED|Fourth Intervention Period||5
3039982|NCT01161472|3759432|FG003|COMPLETED|Fourth Intervention Period||5
3039983|NCT01161472|3759429|FG000|NOT COMPLETED|Fourth Intervention Period||0
3039984|NCT01161472|3759430|FG001|NOT COMPLETED|Fourth Intervention Period||0
3039985|NCT01161472|3759431|FG002|NOT COMPLETED|Fourth Intervention Period||0
3039986|NCT01161472|3759432|FG003|NOT COMPLETED|Fourth Intervention Period||0
3039987|NCT01161498|3759444|FG000|STARTED|Overall Study||3
3039988|NCT01161498|3759445|FG001|STARTED|Overall Study||2
3039989|NCT01161498|3759444|FG000|COMPLETED|Overall Study||3
3357245|NCT03720470|4087355|FG000|STARTED|Treatment Period: Final 4 Weeks|Participants received placebo till Week 16 then allocated to receive PF-04965842 post Week 16.|0
3357246|NCT03720470|4087356|FG001|STARTED|Treatment Period: Final 4 Weeks|Participants received placebo till Week 16 then allocated to receive PF-04965842 post Week 16.|60
3357247|NCT03720470|4087357|FG002|STARTED|Treatment Period: Final 4 Weeks|Participants received placebo till Week 16 then allocated to receive PF-04965842 post Week 16.|57
3357248|NCT03720470|4087358|FG003|STARTED|Treatment Period: Final 4 Weeks||217
3357249|NCT03720470|4087359|FG004|STARTED|Treatment Period: Final 4 Weeks||208
3357250|NCT03720470|4087360|FG005|STARTED|Treatment Period: Final 4 Weeks||223
3357251|NCT03720470|4087355|FG000|Treated/ Safety Analysis Set|Treatment Period: Final 4 Weeks||0
3357252|NCT03720470|4087356|FG001|Treated/ Safety Analysis Set|Treatment Period: Final 4 Weeks||60
3357253|NCT03720470|4087357|FG002|Treated/ Safety Analysis Set|Treatment Period: Final 4 Weeks||57
3357254|NCT03720470|4087358|FG003|Treated/ Safety Analysis Set|Treatment Period: Final 4 Weeks||217
3357255|NCT03720470|4087359|FG004|Treated/ Safety Analysis Set|Treatment Period: Final 4 Weeks||208
3357256|NCT03720470|4087360|FG005|Treated/ Safety Analysis Set|Treatment Period: Final 4 Weeks||223
3357257|NCT03720470|4087355|FG000|Full Analysis Set|Treatment Period: Final 4 Weeks||0
3357258|NCT03720470|4087356|FG001|Full Analysis Set|Treatment Period: Final 4 Weeks||60
3357259|NCT03720470|4087357|FG002|Full Analysis Set|Treatment Period: Final 4 Weeks||57
3357260|NCT03720470|4087358|FG003|Full Analysis Set|Treatment Period: Final 4 Weeks||217
3357261|NCT03720470|4087359|FG004|Full Analysis Set|Treatment Period: Final 4 Weeks||208
3357262|NCT03720470|4087360|FG005|Full Analysis Set|Treatment Period: Final 4 Weeks||223
3357263|NCT03720470|4087355|FG000|COMPLETED|Treatment Period: Final 4 Weeks||0
3357264|NCT03720470|4087356|FG001|COMPLETED|Treatment Period: Final 4 Weeks||58
3357265|NCT03720470|4087357|FG002|COMPLETED|Treatment Period: Final 4 Weeks||55
3357266|NCT03720470|4087358|FG003|COMPLETED|Treatment Period: Final 4 Weeks||210
3357267|NCT03720470|4087359|FG004|COMPLETED|Treatment Period: Final 4 Weeks||204
3357268|NCT03720470|4087360|FG005|COMPLETED|Treatment Period: Final 4 Weeks||218
3357269|NCT03720470|4087355|FG000|NOT COMPLETED|Treatment Period: Final 4 Weeks||0
3357270|NCT03720470|4087356|FG001|NOT COMPLETED|Treatment Period: Final 4 Weeks||2
3357271|NCT03720470|4087357|FG002|NOT COMPLETED|Treatment Period: Final 4 Weeks||2
3357272|NCT03720470|4087358|FG003|NOT COMPLETED|Treatment Period: Final 4 Weeks||7
3357273|NCT03720470|4087359|FG004|NOT COMPLETED|Treatment Period: Final 4 Weeks||4
3357274|NCT03720470|4087360|FG005|NOT COMPLETED|Treatment Period: Final 4 Weeks||5
3357275|NCT03720652|4087382|FG000|STARTED|Overall Study||12
3357276|NCT03720652|4087383|FG001|STARTED|Overall Study||27
3357277|NCT03720652|4087382|FG000|Baseline Interview|Overall Study||12
3357278|NCT03720652|4087383|FG001|Baseline Interview|Overall Study||22
3357279|NCT03720652|4087382|FG000|Start Intervention|Overall Study||11
3357280|NCT03720652|4087383|FG001|Start Intervention|Overall Study||21
3357281|NCT03720652|4087382|FG000|Complete Intervention|Overall Study||10
3357282|NCT03720652|4087383|FG001|Complete Intervention|Overall Study||20
3357283|NCT03720652|4087382|FG000|3-Month Follow Up Interview|Overall Study||10
3357284|NCT03720652|4087383|FG001|3-Month Follow Up Interview|Overall Study||19
3357285|NCT03720652|4087382|FG000|6-Month Follow Up Interview|Overall Study||10
3357286|NCT03720652|4087383|FG001|6-Month Follow Up Interview|Overall Study||16
3357287|NCT03720652|4087382|FG000|COMPLETED|Overall Study||10
3357288|NCT03720652|4087383|FG001|COMPLETED|Overall Study||16
3357289|NCT03720652|4087382|FG000|NOT COMPLETED|Overall Study||2
3357290|NCT03720652|4087383|FG001|NOT COMPLETED|Overall Study||11
3357291|NCT03720847|4087391|FG000|STARTED|Condition 1||15
3357292|NCT03720847|4087392|FG001|STARTED|Condition 1||15
3357293|NCT03720847|4087391|FG000|COMPLETED|Condition 1||15
3357294|NCT03720847|4087392|FG001|COMPLETED|Condition 1||15
3357295|NCT03720847|4087391|FG000|NOT COMPLETED|Condition 1||0
3357296|NCT03720847|4087392|FG001|NOT COMPLETED|Condition 1||0
3357297|NCT03720847|4087391|FG000|STARTED|Washout||15
3357298|NCT03720847|4087392|FG001|STARTED|Washout||15
3357299|NCT03720847|4087391|FG000|COMPLETED|Washout||14
3357300|NCT03720847|4087392|FG001|COMPLETED|Washout||13
3357301|NCT03720847|4087391|FG000|NOT COMPLETED|Washout||1
3357302|NCT03720847|4087392|FG001|NOT COMPLETED|Washout||2
3357303|NCT03720847|4087391|FG000|STARTED|Condition 2||14
3357304|NCT03720847|4087392|FG001|STARTED|Condition 2||13
3357305|NCT03720847|4087391|FG000|COMPLETED|Condition 2||14
3357306|NCT03720847|4087392|FG001|COMPLETED|Condition 2||13
3357307|NCT03720847|4087391|FG000|NOT COMPLETED|Condition 2||0
3357308|NCT03720847|4087392|FG001|NOT COMPLETED|Condition 2||0
3357309|NCT03720938|4087401|FG000|STARTED|Overall Study||242
3357310|NCT03720938|4087402|FG001|STARTED|Overall Study||676
3357311|NCT03720938|4087401|FG000|COMPLETED|Overall Study||53
3357312|NCT03720938|4087402|FG001|COMPLETED|Overall Study||53
3357313|NCT03720938|4087401|FG000|NOT COMPLETED|Overall Study||189
3357314|NCT03720938|4087402|FG001|NOT COMPLETED|Overall Study||623
3357315|NCT03721172|4087421|FG000|STARTED|Placebo-controlled Phase||298
3357316|NCT03721172|4087422|FG001|STARTED|Placebo-controlled Phase||297
3357317|NCT03721172|4087423|FG002|STARTED|Placebo-controlled Phase|This arm was not included in the placebo-controlled phase.|0
3357318|NCT03721172|4087421|FG000|Received at Least 1 Dose of Treatment|Placebo-controlled Phase||297
3357319|NCT03721172|4087422|FG001|Received at Least 1 Dose of Treatment|Placebo-controlled Phase||297
3357320|NCT03721172|4087423|FG002|Received at Least 1 Dose of Treatment|Placebo-controlled Phase|This arm was not included in the placebo-controlled phase.|0
3357321|NCT03721172|4087421|FG000|COMPLETED|Placebo-controlled Phase||246
3357322|NCT03721172|4087422|FG001|COMPLETED|Placebo-controlled Phase||258
2928098|NCT00576472|3639103|FG000|NOT COMPLETED|Initial Screening||0
3357323|NCT03721172|4087423|FG002|COMPLETED|Placebo-controlled Phase|This arm was not included in the placebo-controlled phase.|0
3357324|NCT03721172|4087421|FG000|NOT COMPLETED|Placebo-controlled Phase||52
3357325|NCT03721172|4087422|FG001|NOT COMPLETED|Placebo-controlled Phase||39
3357326|NCT03721172|4087423|FG002|NOT COMPLETED|Placebo-controlled Phase||0
3357327|NCT03721172|4087421|FG000|STARTED|Apremilast Extension Phase|This arm was not included in the extension phase.|0
3357328|NCT03721172|4087422|FG001|STARTED|Apremilast Extension Phase|This arm was not included in the extension phase.|0
3357329|NCT03721172|4087423|FG002|STARTED|Apremilast Extension Phase|1 participant did not enter the extension phase due to physician decision.|503
3357330|NCT03721172|4087421|FG000|Received at Least 1 Dose|Apremilast Extension Phase|This arm was not included in the extension phase.|0
3357331|NCT03721172|4087422|FG001|Received at Least 1 Dose|Apremilast Extension Phase|This arm was not included in the extension phase.|0
3357332|NCT03721172|4087423|FG002|Received at Least 1 Dose|Apremilast Extension Phase||503
3357333|NCT03721172|4087421|FG000|COMPLETED|Apremilast Extension Phase|This arm was not included in the extension phase.|0
3357334|NCT03721172|4087422|FG001|COMPLETED|Apremilast Extension Phase|This arm was not included in the extension phase.|0
3357335|NCT03721172|4087423|FG002|COMPLETED|Apremilast Extension Phase||437
3357336|NCT03721172|4087421|FG000|NOT COMPLETED|Apremilast Extension Phase||0
3357337|NCT03721172|4087422|FG001|NOT COMPLETED|Apremilast Extension Phase||0
3357338|NCT03721172|4087423|FG002|NOT COMPLETED|Apremilast Extension Phase||66
3357339|NCT03721549|4087433|FG000|STARTED|Overall Study||8
3357340|NCT03721549|4087434|FG001|STARTED|Overall Study||8
3357341|NCT03721549|4087433|FG000|COMPLETED|Overall Study||7
3357342|NCT03721549|4087434|FG001|COMPLETED|Overall Study||8
3357343|NCT03721549|4087433|FG000|NOT COMPLETED|Overall Study||1
3357344|NCT03721549|4087434|FG001|NOT COMPLETED|Overall Study||0
3357345|NCT03722030|4087442|FG000|STARTED|Overall Study||20
3357346|NCT03722030|4087443|FG001|STARTED|Overall Study||20
3357347|NCT03722030|4087442|FG000|COMPLETED|Overall Study||19
3357348|NCT03722030|4087443|FG001|COMPLETED|Overall Study||20
3357349|NCT03722030|4087442|FG000|NOT COMPLETED|Overall Study||1
3357350|NCT03722030|4087443|FG001|NOT COMPLETED|Overall Study||0
3357351|NCT03722238|4087452|FG000|STARTED|Overall Study||608
3357352|NCT03722238|4087453|FG001|STARTED|Overall Study||5
3357353|NCT03722238|4087452|FG000|Safety Set|Overall Study||198
3357354|NCT03722238|4087453|FG001|Safety Set|Overall Study||5
3357355|NCT03722238|4087452|FG000|Actual Drug Users|Overall Study||179
3357356|NCT03722238|4087453|FG001|Actual Drug Users|Overall Study||5
3357357|NCT03722238|4087452|FG000|COMPLETED|Overall Study||143
3357358|NCT03722238|4087453|FG001|COMPLETED|Overall Study||4
3357359|NCT03722238|4087452|FG000|NOT COMPLETED|Overall Study||465
3357360|NCT03722238|4087453|FG001|NOT COMPLETED|Overall Study||1
3357361|NCT03722264|4087459|FG000|STARTED|Overall Study||12
3357362|NCT03722264|4087459|FG000|COMPLETED|Overall Study||9
3357363|NCT03722264|4087459|FG000|NOT COMPLETED|Overall Study||3
3357364|NCT03722446|4087467|FG000|STARTED|Overall Study||135
3357365|NCT03722446|4087468|FG001|STARTED|Overall Study||122
3357366|NCT03722446|4087467|FG000|COMPLETED|Overall Study||120
3357367|NCT03722446|4087468|FG001|COMPLETED|Overall Study||120
3357368|NCT03722446|4087467|FG000|NOT COMPLETED|Overall Study||15
3357369|NCT03722446|4087468|FG001|NOT COMPLETED|Overall Study||2
3357370|NCT03722524|4087474|FG000|STARTED|Overall Study||1247
3357371|NCT03722524|4087474|FG000|COMPLETED|Overall Study||1148
3357372|NCT03722524|4087474|FG000|NOT COMPLETED|Overall Study||99
3357373|NCT03722576|4087478|FG000|STARTED|Overall Study||18
3357374|NCT03722576|4087478|FG000|COMPLETED|Overall Study||11
3357375|NCT03722576|4087478|FG000|NOT COMPLETED|Overall Study||7
3357376|NCT03722784|4087484|FG000|STARTED|Overall Study||58
3357377|NCT03722784|4087485|FG001|STARTED|Overall Study||30
3357378|NCT03722784|4087484|FG000|COMPLETED|Overall Study||56
3357379|NCT03722784|4087485|FG001|COMPLETED|Overall Study||28
3357380|NCT03722784|4087484|FG000|NOT COMPLETED|Overall Study||2
3357381|NCT03722784|4087485|FG001|NOT COMPLETED|Overall Study||2
3357382|NCT03723915|4087492|FG000|STARTED|Screening||17
3357383|NCT03723915|4087492|FG000|COMPLETED|Screening||15
3357384|NCT03723915|4087492|FG000|NOT COMPLETED|Screening||2
3357385|NCT03723915|4087492|FG000|STARTED|On Treatment||15
3357386|NCT03723915|4087492|FG000|Registered on Study|On Treatment||15
3357387|NCT03723915|4087492|FG000|Received First Dose of Study Drugs|On Treatment||13
3357388|NCT03723915|4087492|FG000|COMPLETED|On Treatment||13
3357389|NCT03723915|4087492|FG000|NOT COMPLETED|On Treatment||2
3357390|NCT03723915|4087492|FG000|STARTED|Survival Follow-up||13
3357391|NCT03723915|4087492|FG000|COMPLETED|Survival Follow-up||13
3357392|NCT03723915|4087492|FG000|NOT COMPLETED|Survival Follow-up||0
3357393|NCT03724812|4087496|FG000|STARTED|Overall Study||46
3357394|NCT03724812|4087496|FG000|Discharge|Overall Study||46
3357395|NCT03724812|4087496|FG000|30 Day Follow-Up|Overall Study||45
3357396|NCT03724812|4087496|FG000|6 Month Follow-Up|Overall Study||42
3357397|NCT03724812|4087496|FG000|12-Month Follow-Up|Overall Study||42
3357398|NCT03724812|4087496|FG000|COMPLETED|Overall Study||42
3357399|NCT03724812|4087496|FG000|NOT COMPLETED|Overall Study||4
3357400|NCT03725982|4087503|FG000|STARTED|First Intervention||20
3357401|NCT03725982|4087504|FG001|STARTED|First Intervention||19
3357402|NCT03725982|4087503|FG000|COMPLETED|First Intervention||19
3357403|NCT03725982|4087504|FG001|COMPLETED|First Intervention||17
3357404|NCT03725982|4087503|FG000|NOT COMPLETED|First Intervention||1
3357405|NCT03725982|4087504|FG001|NOT COMPLETED|First Intervention||2
3357406|NCT03725982|4087503|FG000|STARTED|Second Intervention||19
3357407|NCT03725982|4087504|FG001|STARTED|Second Intervention||17
3357408|NCT03725982|4087503|FG000|COMPLETED|Second Intervention||19
3357409|NCT03725982|4087504|FG001|COMPLETED|Second Intervention||17
3357410|NCT03725982|4087503|FG000|NOT COMPLETED|Second Intervention||0
3357411|NCT03725982|4087504|FG001|NOT COMPLETED|Second Intervention||0
3179190|NCT01983566|3907339|FG000|COMPLETED|Test Period 3||2
3179191|NCT01983566|3907340|FG001|COMPLETED|Test Period 3||3
3179192|NCT01983566|3907341|FG002|COMPLETED|Test Period 3||2
3179193|NCT01983566|3907342|FG003|COMPLETED|Test Period 3||4
3179194|NCT01983566|3907339|FG000|NOT COMPLETED|Test Period 3||0
3179195|NCT01983566|3907340|FG001|NOT COMPLETED|Test Period 3||0
3179196|NCT01983566|3907341|FG002|NOT COMPLETED|Test Period 3||0
3179197|NCT01983566|3907342|FG003|NOT COMPLETED|Test Period 3||0
3179198|NCT01983566|3907339|FG000|STARTED|Wash-Out 3|Subjects starting may not equal number completing the previous period due to early study termination|0
3179199|NCT01983566|3907340|FG001|STARTED|Wash-Out 3|Subjects starting may not equal number completing the previous period due to early study termination|0
3179200|NCT01983566|3907341|FG002|STARTED|Wash-Out 3|Subjects starting may not equal number completing the previous period due to early study termination|0
3179201|NCT01983566|3907342|FG003|STARTED|Wash-Out 3|Subjects starting may not equal number completing the previous period due to early study termination|0
3179202|NCT01983566|3907339|FG000|COMPLETED|Wash-Out 3||0
3357412|NCT03727841|4087518|FG000|STARTED|Overall Study||3
3357413|NCT03727841|4087519|FG001|STARTED|Overall Study||1
2928099|NCT00576472|3639104|FG001|NOT COMPLETED|Initial Screening||0
2928100|NCT00576472|3639105|FG002|NOT COMPLETED|Initial Screening||0
2928101|NCT00576472|3639106|FG003|NOT COMPLETED|Initial Screening||0
2928102|NCT00576472|3639107|FG004|NOT COMPLETED|Initial Screening||0
2928103|NCT00576472|3639108|FG005|NOT COMPLETED|Initial Screening||0
2928104|NCT00576472|3639109|FG006|NOT COMPLETED|Initial Screening||0
2928105|NCT00576472|3639110|FG007|NOT COMPLETED|Initial Screening||0
2928106|NCT00576472|3639111|FG008|NOT COMPLETED|Initial Screening||0
2928107|NCT00576472|3639112|FG009|NOT COMPLETED|Initial Screening||0
3357414|NCT03727841|4087518|FG000|COMPLETED|Overall Study||1
3357415|NCT03727841|4087519|FG001|COMPLETED|Overall Study||0
3357416|NCT03727841|4087518|FG000|NOT COMPLETED|Overall Study||2
3357417|NCT03727841|4087519|FG001|NOT COMPLETED|Overall Study||1
3357418|NCT03736967|4087529|FG000|STARTED|Overall Study||51
3357419|NCT03736967|4087530|FG001|STARTED|Overall Study||52
3357420|NCT03736967|4087531|FG002|STARTED|Overall Study||51
3357421|NCT03736967|4087532|FG003|STARTED|Overall Study||52
3357422|NCT03736967|4087529|FG000|Treated|Overall Study||50
3357423|NCT03736967|4087530|FG001|Treated|Overall Study||52
3357424|NCT03736967|4087531|FG002|Treated|Overall Study||51
3357425|NCT03736967|4087532|FG003|Treated|Overall Study||52
3357426|NCT03736967|4087529|FG000|COMPLETED|Overall Study||20
3357427|NCT03736967|4087530|FG001|COMPLETED|Overall Study||24
3357428|NCT03736967|4087531|FG002|COMPLETED|Overall Study||27
3357429|NCT03736967|4087532|FG003|COMPLETED|Overall Study||22
3357430|NCT03736967|4087529|FG000|NOT COMPLETED|Overall Study||31
3357431|NCT03736967|4087530|FG001|NOT COMPLETED|Overall Study||28
3357432|NCT03736967|4087531|FG002|NOT COMPLETED|Overall Study||24
3357433|NCT03736967|4087532|FG003|NOT COMPLETED|Overall Study||30
3357434|NCT03739840|4087549|FG000|STARTED|Treatment Period: Wk0-16||56
3357435|NCT03739840|4087550|FG001|STARTED|Treatment Period: Wk0-16||60
3357436|NCT03739840|4087551|FG002|STARTED|Treatment Period: Wk0-16||57
3357437|NCT03739840|4087552|FG003|STARTED|Treatment Period: Wk0-16||59
3357438|NCT03739840|4087549|FG000|Completed Titration and Stabilization|Treatment Period: Wk0-16||54
3357439|NCT03739840|4087550|FG001|Completed Titration and Stabilization|Treatment Period: Wk0-16||58
3179203|NCT01983566|3907340|FG001|COMPLETED|Wash-Out 3||0
3179204|NCT01983566|3907341|FG002|COMPLETED|Wash-Out 3||0
3357440|NCT03739840|4087551|FG002|Completed Titration and Stabilization|Treatment Period: Wk0-16||51
3357441|NCT03739840|4087552|FG003|Completed Titration and Stabilization|Treatment Period: Wk0-16||54
3357442|NCT03739840|4087549|FG000|Completed Maintenance Period|Treatment Period: Wk0-16||46
3357443|NCT03739840|4087550|FG001|Completed Maintenance Period|Treatment Period: Wk0-16||44
3357444|NCT03739840|4087551|FG002|Completed Maintenance Period|Treatment Period: Wk0-16||44
3357445|NCT03739840|4087552|FG003|Completed Maintenance Period|Treatment Period: Wk0-16||36
3357446|NCT03739840|4087549|FG000|COMPLETED|Treatment Period: Wk0-16||46
3357447|NCT03739840|4087550|FG001|COMPLETED|Treatment Period: Wk0-16||44
3357448|NCT03739840|4087551|FG002|COMPLETED|Treatment Period: Wk0-16||44
3357449|NCT03739840|4087552|FG003|COMPLETED|Treatment Period: Wk0-16||36
3357450|NCT03739840|4087549|FG000|NOT COMPLETED|Treatment Period: Wk0-16||10
3357451|NCT03739840|4087550|FG001|NOT COMPLETED|Treatment Period: Wk0-16||16
3357452|NCT03739840|4087551|FG002|NOT COMPLETED|Treatment Period: Wk0-16||13
3357453|NCT03739840|4087552|FG003|NOT COMPLETED|Treatment Period: Wk0-16||23
3357454|NCT03739840|4087549|FG000|STARTED|Post-Treatment Period: Wk16-23||46
3357455|NCT03739840|4087550|FG001|STARTED|Post-Treatment Period: Wk16-23||44
3357456|NCT03739840|4087551|FG002|STARTED|Post-Treatment Period: Wk16-23||44
3357457|NCT03739840|4087552|FG003|STARTED|Post-Treatment Period: Wk16-23||36
3357458|NCT03739840|4087549|FG000|Started Conversion Period|Post-Treatment Period: Wk16-23||33
3357459|NCT03739840|4087550|FG001|Started Conversion Period|Post-Treatment Period: Wk16-23||31
3357460|NCT03739840|4087551|FG002|Started Conversion Period|Post-Treatment Period: Wk16-23||29
3357461|NCT03739840|4087552|FG003|Started Conversion Period|Post-Treatment Period: Wk16-23||28
3357462|NCT03739840|4087549|FG000|Completed Conversion Period|Post-Treatment Period: Wk16-23||33
3357463|NCT03739840|4087550|FG001|Completed Conversion Period|Post-Treatment Period: Wk16-23||31
3357464|NCT03739840|4087551|FG002|Completed Conversion Period|Post-Treatment Period: Wk16-23||29
3357465|NCT03739840|4087552|FG003|Completed Conversion Period|Post-Treatment Period: Wk16-23||28
3357466|NCT03739840|4087549|FG000|Started Taper and Safety Follow-up|Post-Treatment Period: Wk16-23||19
3357467|NCT03739840|4087550|FG001|Started Taper and Safety Follow-up|Post-Treatment Period: Wk16-23||18
3357468|NCT03739840|4087551|FG002|Started Taper and Safety Follow-up|Post-Treatment Period: Wk16-23||21
3357469|NCT03739840|4087552|FG003|Started Taper and Safety Follow-up|Post-Treatment Period: Wk16-23||13
3357470|NCT03739840|4087549|FG000|Completed Taper and Safety Follow-up|Post-Treatment Period: Wk16-23||15
3357471|NCT03739840|4087550|FG001|Completed Taper and Safety Follow-up|Post-Treatment Period: Wk16-23||16
3357472|NCT03739840|4087551|FG002|Completed Taper and Safety Follow-up|Post-Treatment Period: Wk16-23||18
3357473|NCT03739840|4087552|FG003|Completed Taper and Safety Follow-up|Post-Treatment Period: Wk16-23||12
3357474|NCT03739840|4087549|FG000|Enrolled in EP0093|Post-Treatment Period: Wk16-23||27
3357475|NCT03739840|4087550|FG001|Enrolled in EP0093|Post-Treatment Period: Wk16-23||26
3357476|NCT03739840|4087551|FG002|Enrolled in EP0093|Post-Treatment Period: Wk16-23||23
3357477|NCT03739840|4087552|FG003|Enrolled in EP0093|Post-Treatment Period: Wk16-23||23
3357478|NCT03739840|4087549|FG000|COMPLETED|Post-Treatment Period: Wk16-23||42
3357479|NCT03739840|4087550|FG001|COMPLETED|Post-Treatment Period: Wk16-23||42
3357480|NCT03739840|4087551|FG002|COMPLETED|Post-Treatment Period: Wk16-23||41
3357481|NCT03739840|4087552|FG003|COMPLETED|Post-Treatment Period: Wk16-23||35
3357482|NCT03739840|4087549|FG000|NOT COMPLETED|Post-Treatment Period: Wk16-23||4
3357483|NCT03739840|4087550|FG001|NOT COMPLETED|Post-Treatment Period: Wk16-23||2
3357484|NCT03739840|4087551|FG002|NOT COMPLETED|Post-Treatment Period: Wk16-23||3
3357485|NCT03739840|4087552|FG003|NOT COMPLETED|Post-Treatment Period: Wk16-23||1
3357486|NCT03739983|4087574|FG000|STARTED|Overall Study||2
3357487|NCT03739983|4087574|FG000|COMPLETED|Overall Study||2
3357488|NCT03739983|4087574|FG000|NOT COMPLETED|Overall Study||0
3357489|NCT03746002|4087580|FG000|STARTED|Overall Study||1
3357490|NCT03746002|4087581|FG001|STARTED|Overall Study||2
3357491|NCT03746002|4087580|FG000|COMPLETED|Overall Study||1
3357492|NCT03746002|4087581|FG001|COMPLETED|Overall Study||2
3357493|NCT03746002|4087580|FG000|NOT COMPLETED|Overall Study||0
3357494|NCT03746002|4087581|FG001|NOT COMPLETED|Overall Study||0
3357495|NCT03748771|4087587|FG000|STARTED|Overall Study||20
3357496|NCT03748771|4087587|FG000|COMPLETED|Overall Study||20
3357497|NCT03748771|4087587|FG000|NOT COMPLETED|Overall Study||0
3357498|NCT03752177|4087595|FG000|STARTED|Overall Study||3
3357499|NCT03752177|4087596|FG001|STARTED|Overall Study||3
3357500|NCT03752177|4087597|FG002|STARTED|Overall Study||3
3357501|NCT03752177|4087598|FG003|STARTED|Overall Study||3
3357502|NCT03752177|4087595|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
3179205|NCT01983566|3907342|FG003|COMPLETED|Wash-Out 3||0
3357503|NCT03752177|4087596|FG001|Received at Least 1 Dose of Study Drug|Overall Study||3
3357504|NCT03752177|4087597|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3
3179206|NCT01983566|3907339|FG000|NOT COMPLETED|Wash-Out 3||0
3179207|NCT01983566|3907340|FG001|NOT COMPLETED|Wash-Out 3||0
3179208|NCT01983566|3907341|FG002|NOT COMPLETED|Wash-Out 3||0
3357505|NCT03752177|4087598|FG003|Received at Least 1 Dose of Study Drug|Overall Study||3
3357506|NCT03752177|4087595|FG000|COMPLETED|Overall Study||3
3357507|NCT03752177|4087596|FG001|COMPLETED|Overall Study||3
3357508|NCT03752177|4087597|FG002|COMPLETED|Overall Study||3
3357509|NCT03752177|4087598|FG003|COMPLETED|Overall Study||3
3357510|NCT03752177|4087595|FG000|NOT COMPLETED|Overall Study||0
3357511|NCT03752177|4087596|FG001|NOT COMPLETED|Overall Study||0
3357512|NCT03752177|4087597|FG002|NOT COMPLETED|Overall Study||0
3357513|NCT03752177|4087598|FG003|NOT COMPLETED|Overall Study||0
3357514|NCT03753763|4087611|FG000|STARTED|Overall Study||32
3357515|NCT03753763|4087612|FG001|STARTED|Overall Study||17
3357516|NCT03753763|4087611|FG000|COMPLETED|Overall Study||26
3357517|NCT03753763|4087612|FG001|COMPLETED|Overall Study||16
3357518|NCT03753763|4087611|FG000|NOT COMPLETED|Overall Study||6
3357519|NCT03753763|4087612|FG001|NOT COMPLETED|Overall Study||1
3357520|NCT03756571|4087620|FG000|STARTED|Overall Study||10
3357521|NCT03756571|4087621|FG001|STARTED|Overall Study||11
3357522|NCT03756571|4087620|FG000|COMPLETED|Overall Study||9
3357523|NCT03756571|4087621|FG001|COMPLETED|Overall Study||10
3357524|NCT03756571|4087620|FG000|NOT COMPLETED|Overall Study||1
3357525|NCT03756571|4087621|FG001|NOT COMPLETED|Overall Study||1
3357526|NCT03761537|4087629|FG000|STARTED|Overall Study||140
3357527|NCT03761537|4087630|FG001|STARTED|Overall Study||137
3357528|NCT03761537|4087629|FG000|COMPLETED|Overall Study||125
3357529|NCT03761537|4087630|FG001|COMPLETED|Overall Study||120
3357530|NCT03761537|4087629|FG000|NOT COMPLETED|Overall Study||15
3357531|NCT03761537|4087630|FG001|NOT COMPLETED|Overall Study||17
3357532|NCT03763877|4087648|FG000|STARTED|Overall Study||31
3357533|NCT03763877|4087649|FG001|STARTED|Overall Study||30
3357534|NCT03763877|4087650|FG002|STARTED|Overall Study||31
3357535|NCT03763877|4087651|FG003|STARTED|Overall Study||29
3357536|NCT03763877|4087648|FG000|Received at Least 1 Dose of Double-blind Study Treatment|Overall Study||31
3357537|NCT03763877|4087649|FG001|Received at Least 1 Dose of Double-blind Study Treatment|Overall Study||30
3357538|NCT03763877|4087650|FG002|Received at Least 1 Dose of Double-blind Study Treatment|Overall Study||30
3357539|NCT03763877|4087651|FG003|Received at Least 1 Dose of Double-blind Study Treatment|Overall Study||29
3357540|NCT03763877|4087648|FG000|Completed the Double-blind Period|Overall Study||27
3357541|NCT03763877|4087649|FG001|Completed the Double-blind Period|Overall Study||26
3357542|NCT03763877|4087650|FG002|Completed the Double-blind Period|Overall Study||25
3357543|NCT03763877|4087651|FG003|Completed the Double-blind Period|Overall Study||24
3357544|NCT03763877|4087648|FG000|COMPLETED|Overall Study||26
3357545|NCT03763877|4087649|FG001|COMPLETED|Overall Study||26
3357546|NCT03763877|4087650|FG002|COMPLETED|Overall Study||24
3357547|NCT03763877|4087651|FG003|COMPLETED|Overall Study||24
3357548|NCT03763877|4087648|FG000|NOT COMPLETED|Overall Study||5
3357549|NCT03763877|4087649|FG001|NOT COMPLETED|Overall Study||4
3357550|NCT03763877|4087650|FG002|NOT COMPLETED|Overall Study||7
3357551|NCT03763877|4087651|FG003|NOT COMPLETED|Overall Study||5
3357552|NCT03764007|4087665|FG000|STARTED|Overall Study||98
3357553|NCT03764007|4087665|FG000|Imaging Completed|Overall Study||98
3357554|NCT03764007|4087665|FG000|Underwent Parathyroidectomy Surgery|Overall Study||77
3357555|NCT03764007|4087665|FG000|COMPLETED|Overall Study||77
3357556|NCT03764007|4087665|FG000|NOT COMPLETED|Overall Study||21
3357557|NCT03772587|4087674|FG000|STARTED|Overall Study||14
3357558|NCT03772587|4087675|FG001|STARTED|Overall Study||14
3357559|NCT03772587|4087676|FG002|STARTED|Overall Study||13
3357560|NCT03772587|4087677|FG003|STARTED|Overall Study||13
3357561|NCT03772587|4087678|FG004|STARTED|Overall Study||14
3357562|NCT03772587|4087674|FG000|COMPLETED|Overall Study||13
3357563|NCT03772587|4087675|FG001|COMPLETED|Overall Study||14
3357564|NCT03772587|4087676|FG002|COMPLETED|Overall Study||12
3357565|NCT03772587|4087677|FG003|COMPLETED|Overall Study||12
3357566|NCT03772587|4087678|FG004|COMPLETED|Overall Study||14
3357567|NCT03772587|4087674|FG000|NOT COMPLETED|Overall Study||1
3357568|NCT03772587|4087675|FG001|NOT COMPLETED|Overall Study||0
3357569|NCT03772587|4087676|FG002|NOT COMPLETED|Overall Study||1
3357570|NCT03772587|4087677|FG003|NOT COMPLETED|Overall Study||1
3357571|NCT03772587|4087678|FG004|NOT COMPLETED|Overall Study||0
3357572|NCT03789292|4087702|FG000|STARTED|Treatment Period I (Week 0 to Week 26)||324
3357573|NCT03789292|4087703|FG001|STARTED|Treatment Period I (Week 0 to Week 26)||324
3357574|NCT03789292|4087704|FG002|STARTED|Treatment Period I (Week 0 to Week 26)||0
3357575|NCT03789292|4087702|FG000|COMPLETED|Treatment Period I (Week 0 to Week 26)||303
3357576|NCT03789292|4087703|FG001|COMPLETED|Treatment Period I (Week 0 to Week 26)||305
3357577|NCT03789292|4087704|FG002|COMPLETED|Treatment Period I (Week 0 to Week 26)||0
3357578|NCT03789292|4087702|FG000|NOT COMPLETED|Treatment Period I (Week 0 to Week 26)||21
3357579|NCT03789292|4087703|FG001|NOT COMPLETED|Treatment Period I (Week 0 to Week 26)||19
3357580|NCT03789292|4087704|FG002|NOT COMPLETED|Treatment Period I (Week 0 to Week 26)||0
3357581|NCT03789292|4087702|FG000|STARTED|Treatment Period II (Week 26 to Week 52)||303
3357582|NCT03789292|4087703|FG001|STARTED|Treatment Period II (Week 26 to Week 52)|Patients who had administrated Humira SC during Treatment Period 1 has been devided into 2 groups - maintaining Humira SC and switched to CT-P17.|153
3357583|NCT03789292|4087704|FG002|STARTED|Treatment Period II (Week 26 to Week 52)|Patients who had administrated Humira SC during Treatment Period 1 has been devided into 2 groups - maintaining Humira SC and switched to CT-P17.|152
3357584|NCT03789292|4087702|FG000|COMPLETED|Treatment Period II (Week 26 to Week 52)||287
3357585|NCT03789292|4087703|FG001|COMPLETED|Treatment Period II (Week 26 to Week 52)||147
3357586|NCT03789292|4087704|FG002|COMPLETED|Treatment Period II (Week 26 to Week 52)||143
3357587|NCT03789292|4087702|FG000|NOT COMPLETED|Treatment Period II (Week 26 to Week 52)||16
3357588|NCT03789292|4087703|FG001|NOT COMPLETED|Treatment Period II (Week 26 to Week 52)||6
3357589|NCT03789292|4087704|FG002|NOT COMPLETED|Treatment Period II (Week 26 to Week 52)||9
3357590|NCT03799289|4087720|FG000|STARTED|Initial Weight Loss Program (Weeks 1-12)||30
3357591|NCT03799289|4087721|FG001|STARTED|Initial Weight Loss Program (Weeks 1-12)||30
3357592|NCT03799289|4087720|FG000|COMPLETED|Initial Weight Loss Program (Weeks 1-12)||24
3357593|NCT03799289|4087721|FG001|COMPLETED|Initial Weight Loss Program (Weeks 1-12)||27
3357594|NCT03799289|4087720|FG000|NOT COMPLETED|Initial Weight Loss Program (Weeks 1-12)||6
3357595|NCT03799289|4087721|FG001|NOT COMPLETED|Initial Weight Loss Program (Weeks 1-12)||3
3357596|NCT03799289|4087720|FG000|STARTED|Maintenance Intervention (Weeks 13-24)||24
3357597|NCT03799289|4087721|FG001|STARTED|Maintenance Intervention (Weeks 13-24)||27
3357598|NCT03799289|4087720|FG000|COMPLETED|Maintenance Intervention (Weeks 13-24)||24
3357599|NCT03799289|4087721|FG001|COMPLETED|Maintenance Intervention (Weeks 13-24)||27
3357600|NCT03799289|4087720|FG000|NOT COMPLETED|Maintenance Intervention (Weeks 13-24)||0
3357601|NCT03799289|4087721|FG001|NOT COMPLETED|Maintenance Intervention (Weeks 13-24)||0
3357602|NCT03801408|4087727|FG000|STARTED|Overall Study||145
3357603|NCT03801408|4087727|FG000|COMPLETED|Overall Study||145
3357604|NCT03801408|4087727|FG000|NOT COMPLETED|Overall Study||0
3357605|NCT03805438|4087731|FG000|STARTED|Overall Study||47
3357606|NCT03805438|4087731|FG000|COMPLETED|Overall Study||45
3357607|NCT03805438|4087731|FG000|NOT COMPLETED|Overall Study||2
3357608|NCT03808948|4087735|FG000|STARTED|Overall Study||50
3357609|NCT03808948|4087735|FG000|COMPLETED|Overall Study||50
3357610|NCT03808948|4087735|FG000|NOT COMPLETED|Overall Study||0
3357611|NCT03810053|4087739|FG000|STARTED|Overall Study||290
3357612|NCT03810053|4087739|FG000|COMPLETED|Overall Study||290
3357613|NCT03810053|4087739|FG000|NOT COMPLETED|Overall Study||0
3357614|NCT03812224|4087745|FG000|STARTED|Double-blind Treatment Period||131
3357615|NCT03812224|4087746|FG001|STARTED|Double-blind Treatment Period||130
3357616|NCT03812224|4087745|FG000|COMPLETED|Double-blind Treatment Period||127
3357617|NCT03812224|4087746|FG001|COMPLETED|Double-blind Treatment Period||127
3357618|NCT03812224|4087745|FG000|NOT COMPLETED|Double-blind Treatment Period||4
3357619|NCT03812224|4087746|FG001|NOT COMPLETED|Double-blind Treatment Period||3
3357620|NCT03812224|4087745|FG000|STARTED|Open-label Treatment Period||127
3357621|NCT03812224|4087746|FG001|STARTED|Open-label Treatment Period||127
3357622|NCT03812224|4087745|FG000|COMPLETED|Open-label Treatment Period||125
3357623|NCT03812224|4087746|FG001|COMPLETED|Open-label Treatment Period||124
3357624|NCT03812224|4087745|FG000|NOT COMPLETED|Open-label Treatment Period||2
3357625|NCT03812224|4087746|FG001|NOT COMPLETED|Open-label Treatment Period||3
3357626|NCT03817528|4087753|FG000|STARTED|Overall Study||4
3357627|NCT03817528|4087753|FG000|COMPLETED|Overall Study||1
3357628|NCT03817528|4087753|FG000|NOT COMPLETED|Overall Study||3
3357629|NCT03817580|4087760|FG000|STARTED|Overall Study||57
3357630|NCT03817580|4087761|FG001|STARTED|Overall Study||56
3357631|NCT03817580|4087762|FG002|STARTED|Overall Study||57
3357632|NCT03817580|4087760|FG000|COMPLETED|Overall Study||57
3357633|NCT03817580|4087761|FG001|COMPLETED|Overall Study||56
3357634|NCT03817580|4087762|FG002|COMPLETED|Overall Study||57
3357635|NCT03817580|4087760|FG000|NOT COMPLETED|Overall Study||0
3357636|NCT03817580|4087761|FG001|NOT COMPLETED|Overall Study||0
3357637|NCT03817580|4087762|FG002|NOT COMPLETED|Overall Study||0
3357638|NCT03828422|4087772|FG000|STARTED|Overall Study||40
3357639|NCT03828422|4087773|FG001|STARTED|Overall Study||42
3357640|NCT03828422|4087772|FG000|COMPLETED|Overall Study||36
3357641|NCT03828422|4087773|FG001|COMPLETED|Overall Study||38
3357642|NCT03828422|4087772|FG000|NOT COMPLETED|Overall Study||4
3357643|NCT03828422|4087773|FG001|NOT COMPLETED|Overall Study||4
3357644|NCT03829228|4087780|FG000|STARTED|Overall Study||30
3357645|NCT03829228|4087780|FG000|COMPLETED|Overall Study||29
3357646|NCT03829228|4087780|FG000|NOT COMPLETED|Overall Study||1
3357647|NCT03829618|4087787|FG000|STARTED|Overall Study||15
3357648|NCT03829618|4087788|FG001|STARTED|Overall Study||7
3357649|NCT03829618|4087789|FG002|STARTED|Overall Study||7
3357650|NCT03829618|4087787|FG000|COMPLETED|Overall Study||15
3357651|NCT03829618|4087788|FG001|COMPLETED|Overall Study||7
3357652|NCT03829618|4087789|FG002|COMPLETED|Overall Study||7
3357653|NCT03829618|4087787|FG000|NOT COMPLETED|Overall Study||0
3357654|NCT03829618|4087788|FG001|NOT COMPLETED|Overall Study||0
3357655|NCT03829618|4087789|FG002|NOT COMPLETED|Overall Study||0
3357656|NCT03830333|4087799|FG000|STARTED|Overall Study||134
3357657|NCT03830333|4087800|FG001|STARTED|Overall Study||134
3357658|NCT03830333|4087799|FG000|Clinically Evaluable Population|Overall Study||105
3357659|NCT03830333|4087800|FG001|Clinically Evaluable Population|Overall Study||116
3357660|NCT03830333|4087799|FG000|COMPLETED|Overall Study||126
3357661|NCT03830333|4087800|FG001|COMPLETED|Overall Study||130
3357662|NCT03830333|4087799|FG000|NOT COMPLETED|Overall Study||8
3357663|NCT03830333|4087800|FG001|NOT COMPLETED|Overall Study||4
3357664|NCT03831880|4087808|FG000|STARTED|Period 1 (12 Weeks)||43
3357665|NCT03831880|4087809|FG001|STARTED|Period 1 (12 Weeks)||44
3357666|NCT03831880|4087808|FG000|COMPLETED|Period 1 (12 Weeks)||43
3357667|NCT03831880|4087809|FG001|COMPLETED|Period 1 (12 Weeks)||43
3357668|NCT03831880|4087808|FG000|NOT COMPLETED|Period 1 (12 Weeks)||0
3357669|NCT03831880|4087809|FG001|NOT COMPLETED|Period 1 (12 Weeks)||1
3357670|NCT03831880|4087808|FG000|STARTED|Period 2 (12 Weeks)||43
3357671|NCT03831880|4087809|FG001|STARTED|Period 2 (12 Weeks)||43
3357672|NCT03831880|4087808|FG000|COMPLETED|Period 2 (12 Weeks)||43
3357673|NCT03831880|4087809|FG001|COMPLETED|Period 2 (12 Weeks)||42
3357674|NCT03831880|4087808|FG000|NOT COMPLETED|Period 2 (12 Weeks)||0
3357675|NCT03831880|4087809|FG001|NOT COMPLETED|Period 2 (12 Weeks)||1
3357676|NCT03831880|4087808|FG000|STARTED|Follow-up (5 Weeks)||43
3357677|NCT03831880|4087809|FG001|STARTED|Follow-up (5 Weeks)|1 participant who discontinued from Period 1 completed follow-up visit.|43
3357678|NCT03831880|4087808|FG000|COMPLETED|Follow-up (5 Weeks)||43
3357679|NCT03831880|4087809|FG001|COMPLETED|Follow-up (5 Weeks)||43
3357680|NCT03831880|4087808|FG000|NOT COMPLETED|Follow-up (5 Weeks)||0
3357681|NCT03831880|4087809|FG001|NOT COMPLETED|Follow-up (5 Weeks)||0
2928108|NCT00576472|3639113|FG010|NOT COMPLETED|Initial Screening||0
2928109|NCT00576472|3639114|FG011|NOT COMPLETED|Initial Screening||0
2928110|NCT00576472|3639115|FG012|NOT COMPLETED|Initial Screening||0
2928111|NCT00576472|3639116|FG013|NOT COMPLETED|Initial Screening||0
2928112|NCT00576472|3639117|FG014|NOT COMPLETED|Initial Screening||0
2928113|NCT00576472|3639103|FG000|STARTED|MPH In-Lab Phase|Group only associated with Screening phase.|0
2928114|NCT00576472|3639104|FG001|STARTED|MPH In-Lab Phase|Group only associated with Screening phase.|0
3357682|NCT03831945|4087819|FG000|STARTED|Overall Study||10
3357683|NCT03831945|4087820|FG001|STARTED|Overall Study||10
3357684|NCT03831945|4087819|FG000|COMPLETED|Overall Study||3
3357685|NCT03831945|4087820|FG001|COMPLETED|Overall Study||4
3357686|NCT03831945|4087819|FG000|NOT COMPLETED|Overall Study||7
3357687|NCT03831945|4087820|FG001|NOT COMPLETED|Overall Study||6
3357688|NCT03835728|4087828|FG000|STARTED|Overall Study||2
3357689|NCT03835728|4087829|FG001|STARTED|Overall Study||1
3357690|NCT03835728|4087828|FG000|COMPLETED|Overall Study||2
3357691|NCT03835728|4087829|FG001|COMPLETED|Overall Study||1
3357692|NCT03835728|4087828|FG000|NOT COMPLETED|Overall Study||0
3357693|NCT03835728|4087829|FG001|NOT COMPLETED|Overall Study||0
3357694|NCT03840174|4087839|FG000|STARTED|Overall Study||6
3357695|NCT03840174|4087840|FG001|STARTED|Overall Study||6
3357696|NCT03840174|4087841|FG002|STARTED|Overall Study||3
3357697|NCT03840174|4087842|FG003|STARTED|Overall Study||3
3357698|NCT03840174|4087839|FG000|Vaccination 1|Overall Study||6
3357699|NCT03840174|4087840|FG001|Vaccination 1|Overall Study||6
3357700|NCT03840174|4087841|FG002|Vaccination 1|Overall Study||3
3357701|NCT03840174|4087842|FG003|Vaccination 1|Overall Study||3
3357702|NCT03840174|4087839|FG000|Vaccination 2|Overall Study||5
3357703|NCT03840174|4087840|FG001|Vaccination 2|Overall Study||6
3357704|NCT03840174|4087841|FG002|Vaccination 2|Overall Study||3
3357705|NCT03840174|4087842|FG003|Vaccination 2|Overall Study||3
3357706|NCT03840174|4087839|FG000|Vaccination 3|Overall Study||5
3357707|NCT03840174|4087840|FG001|Vaccination 3|Overall Study||6
3357708|NCT03840174|4087841|FG002|Vaccination 3|Overall Study||3
3357709|NCT03840174|4087842|FG003|Vaccination 3|Overall Study||3
3357710|NCT03840174|4087839|FG000|COMPLETED|Overall Study||5
3357711|NCT03840174|4087840|FG001|COMPLETED|Overall Study||6
3357712|NCT03840174|4087841|FG002|COMPLETED|Overall Study||3
3357713|NCT03840174|4087842|FG003|COMPLETED|Overall Study||3
3357714|NCT03840174|4087839|FG000|NOT COMPLETED|Overall Study||1
3357715|NCT03840174|4087840|FG001|NOT COMPLETED|Overall Study||0
3357716|NCT03840174|4087841|FG002|NOT COMPLETED|Overall Study||0
3357717|NCT03840174|4087842|FG003|NOT COMPLETED|Overall Study||0
3357718|NCT03848910|4087853|FG000|STARTED|Overall Study||11
3357719|NCT03848910|4087853|FG000|COMPLETED|Overall Study||11
3357720|NCT03848910|4087853|FG000|NOT COMPLETED|Overall Study||0
3357721|NCT03852524|4087860|FG000|STARTED|Overall Study||41
3357722|NCT03852524|4087861|FG001|STARTED|Overall Study||41
3357723|NCT03852524|4087860|FG000|COMPLETED|Overall Study||41
3357724|NCT03852524|4087861|FG001|COMPLETED|Overall Study||41
3357725|NCT03852524|4087860|FG000|NOT COMPLETED|Overall Study||0
3357726|NCT03852524|4087861|FG001|NOT COMPLETED|Overall Study||0
3357727|NCT03857841|4087871|FG000|STARTED|Overall Study||2
3357728|NCT03857841|4087872|FG001|STARTED|Overall Study||0
3357729|NCT03857841|4087873|FG002|STARTED|Overall Study||0
3357730|NCT03857841|4087874|FG003|STARTED|Overall Study||1
3357731|NCT03857841|4087871|FG000|COMPLETED|Overall Study||0
3357732|NCT03857841|4087872|FG001|COMPLETED|Overall Study||0
3357733|NCT03857841|4087873|FG002|COMPLETED|Overall Study||0
3357734|NCT03857841|4087874|FG003|COMPLETED|Overall Study||1
3357735|NCT03857841|4087871|FG000|NOT COMPLETED|Overall Study||2
3357736|NCT03857841|4087872|FG001|NOT COMPLETED|Overall Study||0
3357737|NCT03857841|4087873|FG002|NOT COMPLETED|Overall Study||0
3357738|NCT03857841|4087874|FG003|NOT COMPLETED|Overall Study||0
3357739|NCT03861780|4087887|FG000|STARTED|Overall Study||51
3357740|NCT03861780|4087888|FG001|STARTED|Overall Study||50
3357741|NCT03861780|4087889|FG002|STARTED|Overall Study||51
3357742|NCT03861780|4087887|FG000|COMPLETED|Overall Study||51
3357743|NCT03861780|4087888|FG001|COMPLETED|Overall Study||50
3357744|NCT03861780|4087889|FG002|COMPLETED|Overall Study||51
3357745|NCT03861780|4087887|FG000|NOT COMPLETED|Overall Study||0
3357746|NCT03861780|4087888|FG001|NOT COMPLETED|Overall Study||0
3357747|NCT03861780|4087889|FG002|NOT COMPLETED|Overall Study||0
3357748|NCT03862625|4087899|FG000|STARTED|Overall Study||15
3357749|NCT03862625|4087900|FG001|STARTED|Overall Study||15
3357750|NCT03862625|4087899|FG000|COMPLETED|Overall Study||15
3357751|NCT03862625|4087900|FG001|COMPLETED|Overall Study||14
3357752|NCT03862625|4087899|FG000|NOT COMPLETED|Overall Study||0
3357753|NCT03862625|4087900|FG001|NOT COMPLETED|Overall Study||1
3357754|NCT03862755|4087906|FG000|STARTED|Overall Study||581
3357755|NCT03862755|4087906|FG000|COMPLETED|Overall Study||581
3357756|NCT03862755|4087906|FG000|NOT COMPLETED|Overall Study||0
3357757|NCT03869541|4087913|FG000|STARTED|Overall Study||40
3357758|NCT03869541|4087914|FG001|STARTED|Overall Study||50
3357759|NCT03869541|4087915|FG002|STARTED|Overall Study||10
3357760|NCT03869541|4087913|FG000|COMPLETED|Overall Study||40
3357761|NCT03869541|4087914|FG001|COMPLETED|Overall Study||50
3357762|NCT03869541|4087915|FG002|COMPLETED|Overall Study||10
3357763|NCT03869541|4087913|FG000|NOT COMPLETED|Overall Study||0
3357764|NCT03869541|4087914|FG001|NOT COMPLETED|Overall Study||0
3357765|NCT03869541|4087915|FG002|NOT COMPLETED|Overall Study||0
3357766|NCT03877224|4087928|FG000|STARTED|Overall Study||253
3357767|NCT03877224|4087929|FG001|STARTED|Overall Study||251
3357768|NCT03877224|4087928|FG000|Treated|Overall Study||252
3357769|NCT03877224|4087929|FG001|Treated|Overall Study||249
3357770|NCT03877224|4087928|FG000|COMPLETED|Overall Study||248
3357771|NCT03877224|4087929|FG001|COMPLETED|Overall Study||243
3357772|NCT03877224|4087928|FG000|NOT COMPLETED|Overall Study||5
3357773|NCT03877224|4087929|FG001|NOT COMPLETED|Overall Study||8
3357774|NCT03880565|4087937|FG000|STARTED|Overall Study||15
3357775|NCT03880565|4087938|FG001|STARTED|Overall Study||15
3357776|NCT03880565|4087937|FG000|COMPLETED|Overall Study||14
3357777|NCT03880565|4087938|FG001|COMPLETED|Overall Study||15
3357778|NCT03880565|4087937|FG000|NOT COMPLETED|Overall Study||1
3357779|NCT03880565|4087938|FG001|NOT COMPLETED|Overall Study||0
3357780|NCT03883607|4087946|FG000|STARTED|Overall Study||5
3357781|NCT03883607|4087947|FG001|STARTED|Overall Study||5
3357782|NCT03883607|4087946|FG000|COMPLETED|Overall Study||5
3357783|NCT03883607|4087947|FG001|COMPLETED|Overall Study||5
3357784|NCT03883607|4087946|FG000|NOT COMPLETED|Overall Study||0
3357785|NCT03883607|4087947|FG001|NOT COMPLETED|Overall Study||0
3357786|NCT03885596|4087957|FG000|STARTED|Overall Study||9
3357787|NCT03885596|4087958|FG001|STARTED|Overall Study||9
3357788|NCT03885596|4087959|FG002|STARTED|Overall Study||9
3357789|NCT03885596|4087960|FG003|STARTED|Overall Study||9
3357790|NCT03885596|4087957|FG000|COMPLETED|Overall Study||7
3357791|NCT03885596|4087958|FG001|COMPLETED|Overall Study||8
3357792|NCT03885596|4087959|FG002|COMPLETED|Overall Study||9
3357793|NCT03885596|4087960|FG003|COMPLETED|Overall Study||9
3357794|NCT03885596|4087957|FG000|NOT COMPLETED|Overall Study||2
3357795|NCT03885596|4087958|FG001|NOT COMPLETED|Overall Study||1
3357796|NCT03885596|4087959|FG002|NOT COMPLETED|Overall Study||0
3357797|NCT03885596|4087960|FG003|NOT COMPLETED|Overall Study||0
3357798|NCT03885661|4087975|FG000|STARTED|Overall Study||12
3357799|NCT03885661|4087976|FG001|STARTED|Overall Study||8
3357800|NCT03885661|4087975|FG000|Baseline|Overall Study||12
3357801|NCT03885661|4087976|FG001|Baseline|Overall Study||8
3357802|NCT03885661|4087975|FG000|Treatment Visit (12 Week)|Overall Study||11
3357803|NCT03885661|4087976|FG001|Treatment Visit (12 Week)|Overall Study||7
3357804|NCT03885661|4087975|FG000|COMPLETED|Overall Study||11
3357805|NCT03885661|4087976|FG001|COMPLETED|Overall Study||7
3357806|NCT03885661|4087975|FG000|NOT COMPLETED|Overall Study||1
3357807|NCT03885661|4087976|FG001|NOT COMPLETED|Overall Study||1
3357808|NCT03886493|4087982|FG000|STARTED|Overall Study||7
3357809|NCT03886493|4087982|FG000|COMPLETED|Overall Study||6
3357810|NCT03886493|4087982|FG000|NOT COMPLETED|Overall Study||1
3357811|NCT03888235|4087989|FG000|STARTED|Overall Study|1 Participant dropped out after the first visit and was replaced.|21
3357812|NCT03888235|4087990|FG001|STARTED|Overall Study|1 participants dropped out after the first visit and was replaced|21
3357813|NCT03888235|4087991|FG002|STARTED|Overall Study||20
3357814|NCT03888235|4087989|FG000|COMPLETED|Overall Study||20
3357815|NCT03888235|4087990|FG001|COMPLETED|Overall Study||20
3357816|NCT03888235|4087991|FG002|COMPLETED|Overall Study||20
3357817|NCT03888235|4087989|FG000|NOT COMPLETED|Overall Study||1
3357818|NCT03888235|4087990|FG001|NOT COMPLETED|Overall Study||1
3357819|NCT03888235|4087991|FG002|NOT COMPLETED|Overall Study||0
3357820|NCT03889158|4088024|FG000|STARTED|Overall Study||20
3357821|NCT03889158|4088025|FG001|STARTED|Overall Study||15
3357822|NCT03889158|4088024|FG000|COMPLETED|Overall Study||16
3357823|NCT03889158|4088025|FG001|COMPLETED|Overall Study||9
3357824|NCT03889158|4088024|FG000|NOT COMPLETED|Overall Study||4
3357825|NCT03889158|4088025|FG001|NOT COMPLETED|Overall Study||6
3357826|NCT03890419|4088035|FG000|STARTED|Overall Study||34
3357827|NCT03890419|4088036|FG001|STARTED|Overall Study||30
3357828|NCT03890419|4088037|FG002|STARTED|Overall Study||30
3357829|NCT03890419|4088035|FG000|COMPLETED|Overall Study||27
3357830|NCT03890419|4088036|FG001|COMPLETED|Overall Study||27
3357831|NCT03890419|4088037|FG002|COMPLETED|Overall Study||25
3357832|NCT03890419|4088035|FG000|NOT COMPLETED|Overall Study||7
3357833|NCT03890419|4088036|FG001|NOT COMPLETED|Overall Study||3
3357834|NCT03890419|4088037|FG002|NOT COMPLETED|Overall Study||5
3357835|NCT03897348|4088049|FG000|STARTED|ADP Session 1||1
3357836|NCT03897348|4088050|FG001|STARTED|ADP Session 1||1
3357837|NCT03897348|4088051|FG002|STARTED|ADP Session 1||1
3357838|NCT03897348|4088052|FG003|STARTED|ADP Session 1||1
3357839|NCT03897348|4088049|FG000|COMPLETED|ADP Session 1||1
3357840|NCT03897348|4088050|FG001|COMPLETED|ADP Session 1||1
3357841|NCT03897348|4088051|FG002|COMPLETED|ADP Session 1||1
3357842|NCT03897348|4088052|FG003|COMPLETED|ADP Session 1||1
3357843|NCT03897348|4088049|FG000|NOT COMPLETED|ADP Session 1||0
3357844|NCT03897348|4088050|FG001|NOT COMPLETED|ADP Session 1||0
3357845|NCT03897348|4088051|FG002|NOT COMPLETED|ADP Session 1||0
3357846|NCT03897348|4088052|FG003|NOT COMPLETED|ADP Session 1||0
3357847|NCT03897348|4088049|FG000|STARTED|ADP Session 2||1
3357848|NCT03897348|4088050|FG001|STARTED|ADP Session 2||1
3357849|NCT03897348|4088051|FG002|STARTED|ADP Session 2||1
3357850|NCT03897348|4088052|FG003|STARTED|ADP Session 2||1
3357851|NCT03897348|4088049|FG000|COMPLETED|ADP Session 2||1
3357852|NCT03897348|4088050|FG001|COMPLETED|ADP Session 2||1
3357853|NCT03897348|4088051|FG002|COMPLETED|ADP Session 2||1
3357854|NCT03897348|4088052|FG003|COMPLETED|ADP Session 2||1
3357855|NCT03897348|4088049|FG000|NOT COMPLETED|ADP Session 2||0
3357856|NCT03897348|4088050|FG001|NOT COMPLETED|ADP Session 2||0
3357857|NCT03897348|4088051|FG002|NOT COMPLETED|ADP Session 2||0
3357858|NCT03897348|4088052|FG003|NOT COMPLETED|ADP Session 2||0
3357859|NCT03897348|4088049|FG000|STARTED|ADP Session 3||1
3357860|NCT03897348|4088050|FG001|STARTED|ADP Session 3||1
3357861|NCT03897348|4088051|FG002|STARTED|ADP Session 3||0
3357862|NCT03897348|4088052|FG003|STARTED|ADP Session 3||1
3357863|NCT03897348|4088049|FG000|COMPLETED|ADP Session 3||1
3357864|NCT03897348|4088050|FG001|COMPLETED|ADP Session 3||1
3357865|NCT03897348|4088051|FG002|COMPLETED|ADP Session 3||0
3357866|NCT03897348|4088052|FG003|COMPLETED|ADP Session 3||1
3357867|NCT03897348|4088049|FG000|NOT COMPLETED|ADP Session 3||0
3357868|NCT03897348|4088050|FG001|NOT COMPLETED|ADP Session 3||0
3357869|NCT03897348|4088051|FG002|NOT COMPLETED|ADP Session 3||0
3357870|NCT03897348|4088052|FG003|NOT COMPLETED|ADP Session 3||0
3357871|NCT03900416|4088063|FG000|STARTED|Baseline||72
3357872|NCT03900416|4088064|FG001|STARTED|Baseline||80
3357873|NCT03900416|4088063|FG000|COMPLETED|Baseline||72
3357874|NCT03900416|4088064|FG001|COMPLETED|Baseline||80
3357875|NCT03900416|4088063|FG000|NOT COMPLETED|Baseline||0
3357876|NCT03900416|4088064|FG001|NOT COMPLETED|Baseline||0
3357877|NCT03900416|4088063|FG000|STARTED|Post||72
3357878|NCT03900416|4088064|FG001|STARTED|Post||80
3357879|NCT03900416|4088063|FG000|COMPLETED|Post||72
3357880|NCT03900416|4088064|FG001|COMPLETED|Post||80
3357881|NCT03900416|4088063|FG000|NOT COMPLETED|Post||0
3357882|NCT03900416|4088064|FG001|NOT COMPLETED|Post||0
3357883|NCT03900416|4088063|FG000|STARTED|Six Week Follow-up||72
3357884|NCT03900416|4088064|FG001|STARTED|Six Week Follow-up||80
3357885|NCT03900416|4088063|FG000|COMPLETED|Six Week Follow-up||70
3357886|NCT03900416|4088064|FG001|COMPLETED|Six Week Follow-up||80
3357887|NCT03900416|4088063|FG000|NOT COMPLETED|Six Week Follow-up||2
3357888|NCT03900416|4088064|FG001|NOT COMPLETED|Six Week Follow-up||0
3357889|NCT03900416|4088063|FG000|STARTED|Twelve Week Follow-up||70
3357890|NCT03900416|4088064|FG001|STARTED|Twelve Week Follow-up||80
3357891|NCT03900416|4088063|FG000|COMPLETED|Twelve Week Follow-up||69
3357892|NCT03900416|4088064|FG001|COMPLETED|Twelve Week Follow-up||76
3357893|NCT03900416|4088063|FG000|NOT COMPLETED|Twelve Week Follow-up||1
3357894|NCT03900416|4088064|FG001|NOT COMPLETED|Twelve Week Follow-up||4
3357895|NCT03900416|4088063|FG000|STARTED|Six Month Follow-up||69
3357896|NCT03900416|4088064|FG001|STARTED|Six Month Follow-up||76
3357897|NCT03900416|4088063|FG000|COMPLETED|Six Month Follow-up||64
3357898|NCT03900416|4088064|FG001|COMPLETED|Six Month Follow-up||72
3357899|NCT03900416|4088063|FG000|NOT COMPLETED|Six Month Follow-up||5
3357900|NCT03900416|4088064|FG001|NOT COMPLETED|Six Month Follow-up||4
3357901|NCT03905863|4088072|FG000|STARTED|Overall Study||64
3357902|NCT03905863|4088073|FG001|STARTED|Overall Study||81
3357903|NCT03905863|4088072|FG000|COMPLETED|Overall Study||59
3357904|NCT03905863|4088073|FG001|COMPLETED|Overall Study||69
3357905|NCT03905863|4088072|FG000|NOT COMPLETED|Overall Study||5
3357906|NCT03905863|4088073|FG001|NOT COMPLETED|Overall Study||12
3357907|NCT03907033|4088081|FG000|STARTED|Overall Study||14
3357908|NCT03907033|4088082|FG001|STARTED|Overall Study||14
3357909|NCT03907033|4088081|FG000|COMPLETED|Overall Study||14
3357910|NCT03907033|4088082|FG001|COMPLETED|Overall Study||14
3357911|NCT03907033|4088081|FG000|NOT COMPLETED|Overall Study||0
3357912|NCT03907033|4088082|FG001|NOT COMPLETED|Overall Study||0
3357913|NCT03909178|4088090|FG000|STARTED|Overall Study||46
3357914|NCT03909178|4088091|FG001|STARTED|Overall Study||44
3357915|NCT03909178|4088090|FG000|COMPLETED|Overall Study||42
3357916|NCT03909178|4088091|FG001|COMPLETED|Overall Study||39
3357917|NCT03909178|4088090|FG000|NOT COMPLETED|Overall Study||4
3357918|NCT03909178|4088091|FG001|NOT COMPLETED|Overall Study||5
3357919|NCT03909971|4088101|FG000|STARTED|Overall Study||67
3357920|NCT03909971|4088102|FG001|STARTED|Overall Study||42
3357921|NCT03909971|4088101|FG000|COMPLETED|Overall Study||57
3357922|NCT03909971|4088102|FG001|COMPLETED|Overall Study||20
3357923|NCT03909971|4088101|FG000|NOT COMPLETED|Overall Study||10
3357924|NCT03909971|4088102|FG001|NOT COMPLETED|Overall Study||22
3357925|NCT03920215|4088113|FG000|STARTED|Overall Study||26
3357926|NCT03920215|4088114|FG001|STARTED|Overall Study||29
3357927|NCT03920215|4088115|FG002|STARTED|Overall Study||23
3357928|NCT03920215|4088116|FG003|STARTED|Overall Study||23
3357929|NCT03920215|4088113|FG000|COMPLETED|Overall Study||25
3357930|NCT03920215|4088114|FG001|COMPLETED|Overall Study||27
3357931|NCT03920215|4088115|FG002|COMPLETED|Overall Study||23
3357932|NCT03920215|4088116|FG003|COMPLETED|Overall Study||22
3357933|NCT03920215|4088113|FG000|NOT COMPLETED|Overall Study||1
3357934|NCT03920215|4088114|FG001|NOT COMPLETED|Overall Study||2
3357935|NCT03920215|4088115|FG002|NOT COMPLETED|Overall Study||0
3357936|NCT03920215|4088116|FG003|NOT COMPLETED|Overall Study||1
3357937|NCT03921151|4088128|FG000|STARTED|Overall Study||46
3357938|NCT03921151|4088129|FG001|STARTED|Overall Study||44
3357939|NCT03921151|4088128|FG000|COMPLETED|Overall Study||35
3357940|NCT03921151|4088129|FG001|COMPLETED|Overall Study||28
3357941|NCT03921151|4088128|FG000|NOT COMPLETED|Overall Study||11
3357942|NCT03921151|4088129|FG001|NOT COMPLETED|Overall Study||16
3357943|NCT03926039|4088137|FG000|STARTED|Overall Study||35
3357944|NCT03926039|4088138|FG001|STARTED|Overall Study||35
3357945|NCT03926039|4088137|FG000|COMPLETED|Overall Study||35
3357946|NCT03926039|4088138|FG001|COMPLETED|Overall Study||34
3357947|NCT03926039|4088137|FG000|NOT COMPLETED|Overall Study||0
3357948|NCT03926039|4088138|FG001|NOT COMPLETED|Overall Study||1
3357949|NCT03927911|4088150|FG000|STARTED|Overall Study||0
3357950|NCT03927911|4088151|FG001|STARTED|Overall Study||17
3357951|NCT03927911|4088152|FG002|STARTED|Overall Study||0
3357952|NCT03927911|4088153|FG003|STARTED|Overall Study||3
3357953|NCT03927911|4088154|FG004|STARTED|Overall Study||13
3357954|NCT03927911|4088155|FG005|STARTED|Overall Study||32
3357955|NCT03927911|4088150|FG000|COMPLETED|Overall Study||0
3357956|NCT03927911|4088151|FG001|COMPLETED|Overall Study||15
3357957|NCT03927911|4088152|FG002|COMPLETED|Overall Study||0
3357958|NCT03927911|4088153|FG003|COMPLETED|Overall Study||1
3357959|NCT03927911|4088154|FG004|COMPLETED|Overall Study||13
3357960|NCT03927911|4088155|FG005|COMPLETED|Overall Study||25
3357961|NCT03927911|4088150|FG000|NOT COMPLETED|Overall Study||0
3179209|NCT01983566|3907342|FG003|NOT COMPLETED|Wash-Out 3||0
3179210|NCT01983566|3907339|FG000|STARTED|Test Period 4||0
3179211|NCT01983566|3907340|FG001|STARTED|Test Period 4||0
3179212|NCT01983566|3907341|FG002|STARTED|Test Period 4||0
3357962|NCT03927911|4088151|FG001|NOT COMPLETED|Overall Study||2
3357963|NCT03927911|4088152|FG002|NOT COMPLETED|Overall Study||0
3357964|NCT03927911|4088153|FG003|NOT COMPLETED|Overall Study||2
3357965|NCT03927911|4088154|FG004|NOT COMPLETED|Overall Study||0
3357966|NCT03927911|4088155|FG005|NOT COMPLETED|Overall Study||7
3357967|NCT03937570|4088171|FG000|STARTED|Overall Study||13
3357968|NCT03937570|4088172|FG001|STARTED|Overall Study||14
3357969|NCT03937570|4088171|FG000|COMPLETED|Overall Study||13
3357970|NCT03937570|4088172|FG001|COMPLETED|Overall Study||14
3357971|NCT03937570|4088171|FG000|NOT COMPLETED|Overall Study||0
3357972|NCT03937570|4088172|FG001|NOT COMPLETED|Overall Study||0
3357973|NCT03938857|4088182|FG000|STARTED|Overall Study||6
3357974|NCT03938857|4088183|FG001|STARTED|Overall Study||12
3357975|NCT03938857|4088184|FG002|STARTED|Overall Study||12
3357976|NCT03938857|4088185|FG003|STARTED|Overall Study||0
3357977|NCT03938857|4088182|FG000|COMPLETED|Overall Study||5
3357978|NCT03938857|4088183|FG001|COMPLETED|Overall Study||12
3357979|NCT03938857|4088184|FG002|COMPLETED|Overall Study||12
3357980|NCT03938857|4088185|FG003|COMPLETED|Overall Study||0
3357981|NCT03938857|4088182|FG000|NOT COMPLETED|Overall Study||1
3357982|NCT03938857|4088183|FG001|NOT COMPLETED|Overall Study||0
3357983|NCT03938857|4088184|FG002|NOT COMPLETED|Overall Study||0
3357984|NCT03938857|4088185|FG003|NOT COMPLETED|Overall Study||0
3357985|NCT03941912|4088195|FG000|STARTED|Overall Study||44
3357986|NCT03941912|4088195|FG000|COMPLETED|Overall Study||44
3357987|NCT03941912|4088195|FG000|NOT COMPLETED|Overall Study||0
3357988|NCT03945981|4088199|FG000|STARTED|Overall Study||131
3357989|NCT03945981|4088199|FG000|COMPLETED|Overall Study||108
3357990|NCT03945981|4088199|FG000|NOT COMPLETED|Overall Study||23
3357991|NCT03950167|4088205|FG000|STARTED|Overall Study||25
3357992|NCT03950167|4088206|FG001|STARTED|Overall Study||25
3357993|NCT03950167|4088205|FG000|COMPLETED|Overall Study||24
3357994|NCT03950167|4088206|FG001|COMPLETED|Overall Study||22
3357995|NCT03950167|4088205|FG000|NOT COMPLETED|Overall Study||1
3357996|NCT03950167|4088206|FG001|NOT COMPLETED|Overall Study||3
3357997|NCT03950674|4088214|FG000|STARTED|Overall Study||25
3357998|NCT03950674|4088215|FG001|STARTED|Overall Study||15
3357999|NCT03950674|4088214|FG000|Treated|Overall Study||25
3358000|NCT03950674|4088215|FG001|Treated|Overall Study||15
3358001|NCT03950674|4088214|FG000|Switched to Pembrolizumab|Overall Study||0
3358002|NCT03950674|4088215|FG001|Switched to Pembrolizumab|Overall Study||4
3358003|NCT03950674|4088214|FG000|COMPLETED|Overall Study||0
3358004|NCT03950674|4088215|FG001|COMPLETED|Overall Study||0
3358005|NCT03950674|4088214|FG000|NOT COMPLETED|Overall Study||25
3358006|NCT03950674|4088215|FG001|NOT COMPLETED|Overall Study||15
3358007|NCT03954834|4088226|FG000|STARTED|Overall Study||121
3358008|NCT03954834|4088227|FG001|STARTED|Overall Study||121
3358009|NCT03954834|4088228|FG002|STARTED|Overall Study||121
3358010|NCT03954834|4088229|FG003|STARTED|Overall Study||115
3358011|NCT03954834|4088226|FG000|Received at Least One Dose of Study Drug|Overall Study||121
3358012|NCT03954834|4088227|FG001|Received at Least One Dose of Study Drug|Overall Study||121
3358013|NCT03954834|4088228|FG002|Received at Least One Dose of Study Drug|Overall Study||121
3358014|NCT03954834|4088229|FG003|Received at Least One Dose of Study Drug|Overall Study||115
3358015|NCT03954834|4088226|FG000|COMPLETED|Overall Study||114
3358016|NCT03954834|4088227|FG001|COMPLETED|Overall Study||112
3358017|NCT03954834|4088228|FG002|COMPLETED|Overall Study||103
3358018|NCT03954834|4088229|FG003|COMPLETED|Overall Study||99
3358019|NCT03954834|4088226|FG000|NOT COMPLETED|Overall Study||7
3358020|NCT03954834|4088227|FG001|NOT COMPLETED|Overall Study||9
3358021|NCT03954834|4088228|FG002|NOT COMPLETED|Overall Study||18
3358022|NCT03954834|4088229|FG003|NOT COMPLETED|Overall Study||16
3358023|NCT03958071|4088242|FG000|STARTED|Overall Study||347
3358024|NCT03958071|4088243|FG001|STARTED|Overall Study||423
3358025|NCT03958071|4088244|FG002|STARTED|Overall Study||12494
3358026|NCT03958071|4088242|FG000|COMPLETED|Overall Study||347
3358027|NCT03958071|4088243|FG001|COMPLETED|Overall Study||423
3358028|NCT03958071|4088244|FG002|COMPLETED|Overall Study||12494
3358029|NCT03958071|4088242|FG000|NOT COMPLETED|Overall Study||0
3358030|NCT03958071|4088243|FG001|NOT COMPLETED|Overall Study||0
3358031|NCT03958071|4088244|FG002|NOT COMPLETED|Overall Study||0
3358032|NCT03961529|4088256|FG000|STARTED|Overall Study||166
3358033|NCT03961529|4088257|FG001|STARTED|Overall Study||144
3358034|NCT03961529|4088258|FG002|STARTED|Overall Study||56
3358035|NCT03961529|4088256|FG000|COMPLETED|Overall Study||124
3358036|NCT03961529|4088257|FG001|COMPLETED|Overall Study||127
3358037|NCT03961529|4088258|FG002|COMPLETED|Overall Study||51
3358038|NCT03961529|4088256|FG000|NOT COMPLETED|Overall Study||42
3358039|NCT03961529|4088257|FG001|NOT COMPLETED|Overall Study||17
3358040|NCT03961529|4088258|FG002|NOT COMPLETED|Overall Study||5
3358041|NCT03968159|4088268|FG000|STARTED|Overall Study||148
3358042|NCT03968159|4088269|FG001|STARTED|Overall Study||150
3358043|NCT03968159|4088268|FG000|COMPLETED|Overall Study||135
3358044|NCT03968159|4088269|FG001|COMPLETED|Overall Study||135
3358045|NCT03968159|4088268|FG000|NOT COMPLETED|Overall Study||13
3358046|NCT03968159|4088269|FG001|NOT COMPLETED|Overall Study||15
3358047|NCT03968965|4088277|FG000|STARTED|Overall Study||32
3358048|NCT03968965|4088278|FG001|STARTED|Overall Study||32
3358049|NCT03968965|4088277|FG000|COMPLETED|Overall Study||32
3358050|NCT03968965|4088278|FG001|COMPLETED|Overall Study||30
3358051|NCT03968965|4088277|FG000|NOT COMPLETED|Overall Study||0
3358052|NCT03968965|4088278|FG001|NOT COMPLETED|Overall Study||2
3358053|NCT03970824|4088287|FG000|STARTED|Overall Study||103
3358054|NCT03970824|4088288|FG001|STARTED|Overall Study||103
3358055|NCT03970824|4088289|FG002|STARTED|Overall Study||106
3358056|NCT03970824|4088287|FG000|COMPLETED|Overall Study||101
3358057|NCT03970824|4088288|FG001|COMPLETED|Overall Study||100
3358058|NCT03970824|4088289|FG002|COMPLETED|Overall Study||102
3358059|NCT03970824|4088287|FG000|NOT COMPLETED|Overall Study||2
3358060|NCT03970824|4088288|FG001|NOT COMPLETED|Overall Study||3
3358061|NCT03970824|4088289|FG002|NOT COMPLETED|Overall Study||4
3358062|NCT03978403|4088301|FG000|STARTED|Overall Study||6
3358063|NCT03978403|4088302|FG001|STARTED|Overall Study||6
3358064|NCT03978403|4088303|FG002|STARTED|Overall Study||6
3358065|NCT03978403|4088304|FG003|STARTED|Overall Study||6
3358066|NCT03978403|4088301|FG000|COMPLETED|Overall Study||6
3358067|NCT03978403|4088302|FG001|COMPLETED|Overall Study||6
3358068|NCT03978403|4088303|FG002|COMPLETED|Overall Study||6
3358069|NCT03978403|4088304|FG003|COMPLETED|Overall Study||6
3358070|NCT03978403|4088301|FG000|NOT COMPLETED|Overall Study||0
3358071|NCT03978403|4088302|FG001|NOT COMPLETED|Overall Study||0
3358072|NCT03978403|4088303|FG002|NOT COMPLETED|Overall Study||0
3358073|NCT03978403|4088304|FG003|NOT COMPLETED|Overall Study||0
3358074|NCT03979807|4088317|FG000|STARTED|Overall Study||3876
3358075|NCT03979807|4088318|FG001|STARTED|Overall Study||7420
3358076|NCT03979807|4088317|FG000|COMPLETED|Overall Study||3876
3358077|NCT03979807|4088318|FG001|COMPLETED|Overall Study||7420
3358078|NCT03979807|4088317|FG000|NOT COMPLETED|Overall Study||0
3358079|NCT03979807|4088318|FG001|NOT COMPLETED|Overall Study||0
3358080|NCT03980470|4088324|FG000|STARTED|Overall Study||50
3358081|NCT03980470|4088324|FG000|COMPLETED|Overall Study||50
3358082|NCT03980470|4088324|FG000|NOT COMPLETED|Overall Study||0
3358083|NCT03982069|4088335|FG000|STARTED|Overall Study||108
3358084|NCT03982069|4088336|FG001|STARTED|Overall Study||110
3358085|NCT03982069|4088337|FG002|STARTED|Overall Study||127
3358086|NCT03982069|4088338|FG003|STARTED|Overall Study||120
3358087|NCT03982069|4088335|FG000|COMPLETED|Overall Study||98
3358088|NCT03982069|4088336|FG001|COMPLETED|Overall Study||100
3358089|NCT03982069|4088337|FG002|COMPLETED|Overall Study||118
3358090|NCT03982069|4088338|FG003|COMPLETED|Overall Study||112
3358091|NCT03982069|4088335|FG000|NOT COMPLETED|Overall Study||10
3358092|NCT03982069|4088336|FG001|NOT COMPLETED|Overall Study||10
3358093|NCT03982069|4088337|FG002|NOT COMPLETED|Overall Study||9
3358094|NCT03982069|4088338|FG003|NOT COMPLETED|Overall Study||8
3358095|NCT03984812|4088357|FG000|STARTED|Part 1 (Up to Day 28)||6
3358096|NCT03984812|4088358|FG001|STARTED|Part 1 (Up to Day 28)||6
3358097|NCT03984812|4088359|FG002|STARTED|Part 1 (Up to Day 28)||6
3358098|NCT03984812|4088360|FG003|STARTED|Part 1 (Up to Day 28)||6
3358099|NCT03984812|4088361|FG004|STARTED|Part 1 (Up to Day 28)|No participants were enrolled in this arm as the study was terminated due to non-safety reasons.|0
3358100|NCT03984812|4088362|FG005|STARTED|Part 1 (Up to Day 28)|No participants were enrolled in this arm as the study was terminated due to non-safety reasons.|0
3358101|NCT03984812|4088363|FG006|STARTED|Part 1 (Up to Day 28)|No participants were enrolled in this arm as the study was terminated due to non-safety reasons.|0
3358102|NCT03984812|4088364|FG007|STARTED|Part 1 (Up to Day 28)||0
3358103|NCT03984812|4088365|FG008|STARTED|Part 1 (Up to Day 28)||0
3358104|NCT03984812|4088366|FG009|STARTED|Part 1 (Up to Day 28)||0
3358105|NCT03984812|4088367|FG010|STARTED|Part 1 (Up to Day 28)||0
3358106|NCT03984812|4088357|FG000|COMPLETED|Part 1 (Up to Day 28)||6
3358107|NCT03984812|4088358|FG001|COMPLETED|Part 1 (Up to Day 28)||6
3358108|NCT03984812|4088359|FG002|COMPLETED|Part 1 (Up to Day 28)||5
3358109|NCT03984812|4088360|FG003|COMPLETED|Part 1 (Up to Day 28)||6
3358110|NCT03984812|4088361|FG004|COMPLETED|Part 1 (Up to Day 28)||0
3358111|NCT03984812|4088362|FG005|COMPLETED|Part 1 (Up to Day 28)||0
3358112|NCT03984812|4088363|FG006|COMPLETED|Part 1 (Up to Day 28)||0
3358113|NCT03984812|4088364|FG007|COMPLETED|Part 1 (Up to Day 28)||0
3358114|NCT03984812|4088365|FG008|COMPLETED|Part 1 (Up to Day 28)||0
3358115|NCT03984812|4088366|FG009|COMPLETED|Part 1 (Up to Day 28)||0
3358116|NCT03984812|4088367|FG010|COMPLETED|Part 1 (Up to Day 28)||0
3358117|NCT03984812|4088357|FG000|NOT COMPLETED|Part 1 (Up to Day 28)||0
3358118|NCT03984812|4088358|FG001|NOT COMPLETED|Part 1 (Up to Day 28)||0
3358119|NCT03984812|4088359|FG002|NOT COMPLETED|Part 1 (Up to Day 28)||1
3358120|NCT03984812|4088360|FG003|NOT COMPLETED|Part 1 (Up to Day 28)||0
3358121|NCT03984812|4088361|FG004|NOT COMPLETED|Part 1 (Up to Day 28)||0
3358122|NCT03984812|4088362|FG005|NOT COMPLETED|Part 1 (Up to Day 28)||0
3358123|NCT03984812|4088363|FG006|NOT COMPLETED|Part 1 (Up to Day 28)||0
3358124|NCT03984812|4088364|FG007|NOT COMPLETED|Part 1 (Up to Day 28)||0
3358125|NCT03984812|4088365|FG008|NOT COMPLETED|Part 1 (Up to Day 28)||0
3358126|NCT03984812|4088366|FG009|NOT COMPLETED|Part 1 (Up to Day 28)||0
3358127|NCT03984812|4088367|FG010|NOT COMPLETED|Part 1 (Up to Day 28)||0
3358128|NCT03984812|4088357|FG000|STARTED|Part 2 (Up to Day 49)||0
3358129|NCT03984812|4088358|FG001|STARTED|Part 2 (Up to Day 49)||0
3358130|NCT03984812|4088359|FG002|STARTED|Part 2 (Up to Day 49)||0
3358131|NCT03984812|4088360|FG003|STARTED|Part 2 (Up to Day 49)||0
3358132|NCT03984812|4088361|FG004|STARTED|Part 2 (Up to Day 49)||0
3358133|NCT03984812|4088362|FG005|STARTED|Part 2 (Up to Day 49)||0
3358134|NCT03984812|4088363|FG006|STARTED|Part 2 (Up to Day 49)||0
3179213|NCT01983566|3907342|FG003|STARTED|Test Period 4||0
3179214|NCT01983566|3907339|FG000|COMPLETED|Test Period 4||0
3179215|NCT01983566|3907340|FG001|COMPLETED|Test Period 4||0
3358135|NCT03984812|4088364|FG007|STARTED|Part 2 (Up to Day 49)|No participants were enrolled in Part 2 as the study was terminated due to non-safety reasons.|0
3358136|NCT03984812|4088365|FG008|STARTED|Part 2 (Up to Day 49)|No participants were enrolled in Part 2 as the study was terminated due to non-safety reasons.|0
3358137|NCT03984812|4088366|FG009|STARTED|Part 2 (Up to Day 49)|No participants were enrolled in Part 2 as the study was terminated due to non-safety reasons.|0
3358138|NCT03984812|4088367|FG010|STARTED|Part 2 (Up to Day 49)|No participants were enrolled in Part 2 as the study was terminated due to non-safety reasons.|0
3358139|NCT03984812|4088357|FG000|COMPLETED|Part 2 (Up to Day 49)||0
3358140|NCT03984812|4088358|FG001|COMPLETED|Part 2 (Up to Day 49)||0
3358141|NCT03984812|4088359|FG002|COMPLETED|Part 2 (Up to Day 49)||0
3358142|NCT03984812|4088360|FG003|COMPLETED|Part 2 (Up to Day 49)||0
3358143|NCT03984812|4088361|FG004|COMPLETED|Part 2 (Up to Day 49)||0
3358144|NCT03984812|4088362|FG005|COMPLETED|Part 2 (Up to Day 49)||0
3358145|NCT03984812|4088363|FG006|COMPLETED|Part 2 (Up to Day 49)||0
3358146|NCT03984812|4088364|FG007|COMPLETED|Part 2 (Up to Day 49)||0
3358147|NCT03984812|4088365|FG008|COMPLETED|Part 2 (Up to Day 49)||0
3358148|NCT03984812|4088366|FG009|COMPLETED|Part 2 (Up to Day 49)||0
3358149|NCT03984812|4088367|FG010|COMPLETED|Part 2 (Up to Day 49)||0
3358150|NCT03984812|4088357|FG000|NOT COMPLETED|Part 2 (Up to Day 49)||0
3358151|NCT03984812|4088358|FG001|NOT COMPLETED|Part 2 (Up to Day 49)||0
3358152|NCT03984812|4088359|FG002|NOT COMPLETED|Part 2 (Up to Day 49)||0
3358153|NCT03984812|4088360|FG003|NOT COMPLETED|Part 2 (Up to Day 49)||0
3358154|NCT03984812|4088361|FG004|NOT COMPLETED|Part 2 (Up to Day 49)||0
3358155|NCT03984812|4088362|FG005|NOT COMPLETED|Part 2 (Up to Day 49)||0
3358156|NCT03984812|4088363|FG006|NOT COMPLETED|Part 2 (Up to Day 49)||0
3358157|NCT03984812|4088364|FG007|NOT COMPLETED|Part 2 (Up to Day 49)||0
3358158|NCT03984812|4088365|FG008|NOT COMPLETED|Part 2 (Up to Day 49)||0
3358159|NCT03984812|4088366|FG009|NOT COMPLETED|Part 2 (Up to Day 49)||0
3358160|NCT03984812|4088367|FG010|NOT COMPLETED|Part 2 (Up to Day 49)||0
3179216|NCT01983566|3907341|FG002|COMPLETED|Test Period 4||0
3179217|NCT01983566|3907342|FG003|COMPLETED|Test Period 4||0
3179218|NCT01983566|3907339|FG000|NOT COMPLETED|Test Period 4||0
3179219|NCT01983566|3907340|FG001|NOT COMPLETED|Test Period 4||0
3179220|NCT01983566|3907341|FG002|NOT COMPLETED|Test Period 4||0
3179221|NCT01983566|3907342|FG003|NOT COMPLETED|Test Period 4||0
3358161|NCT03985813|4088396|FG000|STARTED|Overall Study||27
3358162|NCT03985813|4088397|FG001|STARTED|Overall Study||26
3358163|NCT03985813|4088396|FG000|COMPLETED|Overall Study||27
3358164|NCT03985813|4088397|FG001|COMPLETED|Overall Study||26
3358165|NCT03985813|4088396|FG000|NOT COMPLETED|Overall Study||0
3358166|NCT03985813|4088397|FG001|NOT COMPLETED|Overall Study||0
3358167|NCT03998163|4088403|FG000|STARTED|Overall Study||222
3358168|NCT03998163|4088403|FG000|COMPLETED|Overall Study||197
3358169|NCT03998163|4088403|FG000|NOT COMPLETED|Overall Study||25
3358170|NCT04000373|4088407|FG000|STARTED|Overall Study||5
3358171|NCT04000373|4088407|FG000|COMPLETED|Overall Study||5
3358172|NCT04000373|4088407|FG000|NOT COMPLETED|Overall Study||0
3358173|NCT04001517|4088414|FG000|STARTED|Overall Study||20
3358174|NCT04001517|4088415|FG001|STARTED|Overall Study||26
3358175|NCT04001517|4088416|FG002|STARTED|Overall Study||27
3358176|NCT04001517|4088417|FG003|STARTED|Overall Study||18
3358177|NCT04001517|4088414|FG000|COMPLETED|Overall Study||20
3358178|NCT04001517|4088415|FG001|COMPLETED|Overall Study||20
3358179|NCT04001517|4088416|FG002|COMPLETED|Overall Study||26
3358180|NCT04001517|4088417|FG003|COMPLETED|Overall Study||15
3358181|NCT04001517|4088414|FG000|NOT COMPLETED|Overall Study||0
3358182|NCT04001517|4088415|FG001|NOT COMPLETED|Overall Study||6
3358183|NCT04001517|4088416|FG002|NOT COMPLETED|Overall Study||1
3358184|NCT04001517|4088417|FG003|NOT COMPLETED|Overall Study||3
3358185|NCT04005859|4088430|FG000|STARTED|Overall Study||32
3358186|NCT04005859|4088431|FG001|STARTED|Overall Study||29
3358187|NCT04005859|4088430|FG000|COMPLETED|Overall Study||28
3358188|NCT04005859|4088431|FG001|COMPLETED|Overall Study||25
3358189|NCT04005859|4088430|FG000|NOT COMPLETED|Overall Study||4
3358190|NCT04005859|4088431|FG001|NOT COMPLETED|Overall Study||4
3358191|NCT04006171|4088439|FG000|STARTED|Overall Study||48
3358192|NCT04006171|4088440|FG001|STARTED|Overall Study||42
3358193|NCT04006171|4088439|FG000|COMPLETED|Overall Study||36
3358194|NCT04006171|4088440|FG001|COMPLETED|Overall Study||30
3358195|NCT04006171|4088439|FG000|NOT COMPLETED|Overall Study||12
3358196|NCT04006171|4088440|FG001|NOT COMPLETED|Overall Study||12
3358197|NCT04011436|4088449|FG000|STARTED|Overall Study||20
3358198|NCT04011436|4088450|FG001|STARTED|Overall Study||20
3358199|NCT04011436|4088449|FG000|COMPLETED|Overall Study||19
3358200|NCT04011436|4088450|FG001|COMPLETED|Overall Study||19
3358201|NCT04011436|4088449|FG000|NOT COMPLETED|Overall Study||1
3358202|NCT04011436|4088450|FG001|NOT COMPLETED|Overall Study||1
3358203|NCT04011592|4088458|FG000|STARTED|Overall Study||1
3358204|NCT04011592|4088459|FG001|STARTED|Overall Study||0
3358205|NCT04011592|4088458|FG000|COMPLETED|Overall Study||1
3358206|NCT04011592|4088459|FG001|COMPLETED|Overall Study||0
3358207|NCT04011592|4088458|FG000|NOT COMPLETED|Overall Study||0
3358208|NCT04011592|4088459|FG001|NOT COMPLETED|Overall Study||0
3358209|NCT04013529|4088467|FG000|STARTED|Overall Study||20
3358210|NCT04013529|4088468|FG001|STARTED|Overall Study||20
3358211|NCT04013529|4088467|FG000|COMPLETED|Overall Study||19
3358212|NCT04013529|4088468|FG001|COMPLETED|Overall Study||19
3358213|NCT04013529|4088467|FG000|NOT COMPLETED|Overall Study||1
3358214|NCT04013529|4088468|FG001|NOT COMPLETED|Overall Study||1
3358215|NCT04016324|4088474|FG000|STARTED|Overall Study||110
3358216|NCT04016324|4088474|FG000|COMPLETED|Overall Study||107
3358217|NCT04016324|4088474|FG000|NOT COMPLETED|Overall Study||3
3358218|NCT04017910|4088479|FG000|STARTED|Overall Study||17
3358219|NCT04017910|4088479|FG000|COMPLETED|Overall Study||17
3358220|NCT04017910|4088479|FG000|NOT COMPLETED|Overall Study||0
3358221|NCT04018066|4088483|FG000|STARTED|Overall Study|34 participants were enrolled in the study|34
3358222|NCT04018066|4088483|FG000|COMPLETED|Overall Study|30 participants completed the study protocol.|30
3358223|NCT04018066|4088483|FG000|NOT COMPLETED|Overall Study||4
3358224|NCT04018794|4088488|FG000|STARTED|Overall Study|N=15 students participants completed the open trial of usability/feasibility of the intervention and completed quantitative ratings of usability before and after using the program.|15
3179222|NCT01983683|3907355|FG000|STARTED|Overall Study||298
3179223|NCT01983683|3907356|FG001|STARTED|Overall Study||311
3179224|NCT01983683|3907355|FG000|COMPLETED|Overall Study||260
3179225|NCT01983683|3907356|FG001|COMPLETED|Overall Study||260
3179226|NCT01983683|3907355|FG000|NOT COMPLETED|Overall Study||38
3179227|NCT01983683|3907356|FG001|NOT COMPLETED|Overall Study||51
3358225|NCT04018794|4088488|FG000|COMPLETED|Overall Study|N=15 students participants completed the open trial of usability/feasibility of the intervention and completed quantitative ratings of usability before and after using the program.|15
3358226|NCT04018794|4088488|FG000|NOT COMPLETED|Overall Study||0
3358227|NCT04032327|4088494|FG000|STARTED|Overall Study||60
3358228|NCT04032327|4088495|FG001|STARTED|Overall Study||60
3358229|NCT04032327|4088494|FG000|COMPLETED|Overall Study||60
3358230|NCT04032327|4088495|FG001|COMPLETED|Overall Study||60
3358231|NCT04032327|4088494|FG000|NOT COMPLETED|Overall Study||0
3358232|NCT04032327|4088495|FG001|NOT COMPLETED|Overall Study||0
3358233|NCT04033640|4088503|FG000|STARTED|Overall Study||1736
3358234|NCT04033640|4088504|FG001|STARTED|Overall Study||18
3358235|NCT04033640|4088503|FG000|COMPLETED|Overall Study||1736
3358236|NCT04033640|4088504|FG001|COMPLETED|Overall Study||18
3358237|NCT04033640|4088503|FG000|NOT COMPLETED|Overall Study||0
3358238|NCT04033640|4088504|FG001|NOT COMPLETED|Overall Study||0
3358239|NCT04036292|4088513|FG000|STARTED|Overall Study||260
3358240|NCT04036292|4088514|FG001|STARTED|Overall Study||246
3358241|NCT04036292|4088515|FG002|STARTED|Overall Study||252
3358242|NCT04036292|4088513|FG000|COMPLETED|Overall Study||239
3358243|NCT04036292|4088514|FG001|COMPLETED|Overall Study||212
3358244|NCT04036292|4088515|FG002|COMPLETED|Overall Study||228
3358245|NCT04036292|4088513|FG000|NOT COMPLETED|Overall Study||21
3358246|NCT04036292|4088514|FG001|NOT COMPLETED|Overall Study||34
3179228|NCT01983787|3907362|FG000|STARTED|Overall Study||10
3179229|NCT01983787|3907362|FG000|COMPLETED|Overall Study||10
3179230|NCT01983787|3907362|FG000|NOT COMPLETED|Overall Study||0
3179231|NCT01983826|3907387|FG000|STARTED|Overall Study||13
3179232|NCT01983826|3907388|FG001|STARTED|Overall Study||8
3179233|NCT01983826|3907387|FG000|COMPLETED|Overall Study||13
3179234|NCT01983826|3907388|FG001|COMPLETED|Overall Study||8
3179235|NCT01983826|3907387|FG000|NOT COMPLETED|Overall Study||0
3179236|NCT01983826|3907388|FG001|NOT COMPLETED|Overall Study||0
3179237|NCT01983839|3907398|FG000|STARTED|Overall Study||18
3358247|NCT04036292|4088515|FG002|NOT COMPLETED|Overall Study||24
3358248|NCT04041440|4088528|FG000|STARTED|Overall Study||12
3358249|NCT04041440|4088529|FG001|STARTED|Overall Study||22
3358250|NCT04041440|4088528|FG000|COMPLETED|Overall Study||12
3358251|NCT04041440|4088529|FG001|COMPLETED|Overall Study||20
3358252|NCT04041440|4088528|FG000|NOT COMPLETED|Overall Study||0
3179238|NCT01983839|3907398|FG000|COMPLETED|Overall Study||18
3358253|NCT04041440|4088529|FG001|NOT COMPLETED|Overall Study||2
3358254|NCT04041570|4088538|FG000|STARTED|Overall Study||20
3358255|NCT04041570|4088539|FG001|STARTED|Overall Study||20
3358256|NCT04041570|4088538|FG000|COMPLETED|Overall Study||20
3358257|NCT04041570|4088539|FG001|COMPLETED|Overall Study||18
3358258|NCT04041570|4088538|FG000|NOT COMPLETED|Overall Study||0
3358259|NCT04041570|4088539|FG001|NOT COMPLETED|Overall Study||2
3358260|NCT04043143|4088548|FG000|STARTED|Overall Study||29
3358261|NCT04043143|4088549|FG001|STARTED|Overall Study||27
3358262|NCT04043143|4088548|FG000|COMPLETED|Overall Study||23
3358263|NCT04043143|4088549|FG001|COMPLETED|Overall Study||22
3358264|NCT04043143|4088548|FG000|NOT COMPLETED|Overall Study||6
3358265|NCT04043143|4088549|FG001|NOT COMPLETED|Overall Study||5
3358266|NCT04049123|4088555|FG000|STARTED|Period 1||5
3358267|NCT04049123|4088556|FG001|STARTED|Period 1||5
3358268|NCT04049123|4088557|FG002|STARTED|Period 1||5
3358269|NCT04049123|4088555|FG000|Received at Least One Dose of Study Drug|Period 1||5
3358270|NCT04049123|4088556|FG001|Received at Least One Dose of Study Drug|Period 1||5
3358271|NCT04049123|4088557|FG002|Received at Least One Dose of Study Drug|Period 1||5
3358272|NCT04049123|4088555|FG000|COMPLETED|Period 1||5
3358273|NCT04049123|4088556|FG001|COMPLETED|Period 1||5
3358274|NCT04049123|4088557|FG002|COMPLETED|Period 1||5
3358275|NCT04049123|4088555|FG000|NOT COMPLETED|Period 1||0
3358276|NCT04049123|4088556|FG001|NOT COMPLETED|Period 1||0
3358277|NCT04049123|4088557|FG002|NOT COMPLETED|Period 1||0
3358278|NCT04049123|4088555|FG000|STARTED|Period 2||5
3358279|NCT04049123|4088556|FG001|STARTED|Period 2||5
3358280|NCT04049123|4088557|FG002|STARTED|Period 2||5
3358281|NCT04049123|4088555|FG000|COMPLETED|Period 2||5
3358282|NCT04049123|4088556|FG001|COMPLETED|Period 2||5
3358283|NCT04049123|4088557|FG002|COMPLETED|Period 2||5
3358284|NCT04049123|4088555|FG000|NOT COMPLETED|Period 2||0
3358285|NCT04049123|4088556|FG001|NOT COMPLETED|Period 2||0
3358286|NCT04049123|4088557|FG002|NOT COMPLETED|Period 2||0
3358287|NCT04049123|4088555|FG000|STARTED|Period 3||5
3358288|NCT04049123|4088556|FG001|STARTED|Period 3||5
3358289|NCT04049123|4088557|FG002|STARTED|Period 3||5
3358290|NCT04049123|4088555|FG000|COMPLETED|Period 3||5
3358291|NCT04049123|4088556|FG001|COMPLETED|Period 3||5
3358292|NCT04049123|4088557|FG002|COMPLETED|Period 3||5
3358293|NCT04049123|4088555|FG000|NOT COMPLETED|Period 3||0
3358294|NCT04049123|4088556|FG001|NOT COMPLETED|Period 3||0
3358295|NCT04049123|4088557|FG002|NOT COMPLETED|Period 3||0
3358296|NCT04051463|4088567|FG000|STARTED|Overall Study||15
3358297|NCT04051463|4088568|FG001|STARTED|Overall Study||14
3358298|NCT04051463|4088567|FG000|COMPLETED|Overall Study||13
3358299|NCT04051463|4088568|FG001|COMPLETED|Overall Study||13
3358300|NCT04051463|4088567|FG000|NOT COMPLETED|Overall Study||2
3358301|NCT04051463|4088568|FG001|NOT COMPLETED|Overall Study||1
3358302|NCT04052204|4088574|FG000|STARTED|Overall Study||3
3358303|NCT04052204|4088575|FG001|STARTED|Overall Study|Arm was not tested due to study termination.|0
3358304|NCT04052204|4088576|FG002|STARTED|Overall Study|Arm was not tested due to study termination.|0
3358305|NCT04052204|4088574|FG000|COMPLETED|Overall Study||0
3358306|NCT04052204|4088575|FG001|COMPLETED|Overall Study||0
3358307|NCT04052204|4088576|FG002|COMPLETED|Overall Study||0
3358308|NCT04052204|4088574|FG000|NOT COMPLETED|Overall Study||3
3358309|NCT04052204|4088575|FG001|NOT COMPLETED|Overall Study||0
3358310|NCT04052204|4088576|FG002|NOT COMPLETED|Overall Study||0
3358311|NCT04054661|4088580|FG000|STARTED|Overall Study||229
3358312|NCT04054661|4088580|FG000|Enrolled in Repeatability Sub-study|Overall Study||15
3358313|NCT04054661|4088580|FG000|Enrolled in Sample Stability Sub-study|Overall Study||3
3358314|NCT04054661|4088580|FG000|COMPLETED|Overall Study||229
3358315|NCT04054661|4088580|FG000|NOT COMPLETED|Overall Study||0
3358316|NCT04067011|4088596|FG000|STARTED|Overall Study||70
3358317|NCT04067011|4088597|FG001|STARTED|Overall Study||71
3358318|NCT04067011|4088598|FG002|STARTED|Overall Study||69
3358319|NCT04067011|4088596|FG000|COMPLETED|Overall Study||51
3358320|NCT04067011|4088597|FG001|COMPLETED|Overall Study||58
3358321|NCT04067011|4088598|FG002|COMPLETED|Overall Study||61
3358322|NCT04067011|4088596|FG000|NOT COMPLETED|Overall Study||19
3358323|NCT04067011|4088597|FG001|NOT COMPLETED|Overall Study||13
3358324|NCT04067011|4088598|FG002|NOT COMPLETED|Overall Study||8
3358325|NCT04072159|4088610|FG000|STARTED|Overall Study||16
3358326|NCT04072159|4088611|FG001|STARTED|Overall Study||17
3358327|NCT04072159|4088610|FG000|COMPLETED|Overall Study||8
3358328|NCT04072159|4088611|FG001|COMPLETED|Overall Study||11
3358329|NCT04072159|4088610|FG000|NOT COMPLETED|Overall Study||8
3358330|NCT04072159|4088611|FG001|NOT COMPLETED|Overall Study||6
3358331|NCT04085341|4088621|FG000|STARTED|Overall Study||10
3358332|NCT04085341|4088622|FG001|STARTED|Overall Study||11
3358333|NCT04085341|4088621|FG000|COMPLETED|Overall Study||10
3358334|NCT04085341|4088622|FG001|COMPLETED|Overall Study||11
3358335|NCT04085341|4088621|FG000|NOT COMPLETED|Overall Study||0
3358336|NCT04085341|4088622|FG001|NOT COMPLETED|Overall Study||0
3358337|NCT04094870|4088630|FG000|STARTED|Overall Study||40
3358338|NCT04094870|4088631|FG001|STARTED|Overall Study||40
3358339|NCT04094870|4088630|FG000|COMPLETED|Overall Study||39
3358340|NCT04094870|4088631|FG001|COMPLETED|Overall Study||39
3358341|NCT04094870|4088630|FG000|NOT COMPLETED|Overall Study||1
3358342|NCT04094870|4088631|FG001|NOT COMPLETED|Overall Study||1
2928115|NCT00576472|3639105|FG002|STARTED|MPH In-Lab Phase|Group only associated with Screening phase.|0
2928116|NCT00576472|3639106|FG003|STARTED|MPH In-Lab Phase||335
2928117|NCT00576472|3639107|FG004|STARTED|MPH In-Lab Phase||67
3358343|NCT04096482|4088644|FG000|STARTED|Overall Study||6
3358344|NCT04096482|4088644|FG000|COMPLETED|Overall Study||6
3358345|NCT04096482|4088644|FG000|NOT COMPLETED|Overall Study||0
3358346|NCT04098172|4088650|FG000|STARTED|Overall Study||39
3358347|NCT04098172|4088650|FG000|COMPLETED|Overall Study||39
3358348|NCT04098172|4088650|FG000|NOT COMPLETED|Overall Study||0
3358349|NCT04103515|4088657|FG000|STARTED|Overall Study||25
3358350|NCT04103515|4088658|FG001|STARTED|Overall Study||25
3358351|NCT04103515|4088657|FG000|COMPLETED|Overall Study||25
3358352|NCT04103515|4088658|FG001|COMPLETED|Overall Study||25
3358353|NCT04103515|4088657|FG000|NOT COMPLETED|Overall Study||0
3358354|NCT04103515|4088658|FG001|NOT COMPLETED|Overall Study||0
3358355|NCT04111276|4088664|FG000|STARTED|Overall Study||23
3358356|NCT04111276|4088664|FG000|COMPLETED|Overall Study||20
3358357|NCT04111276|4088664|FG000|NOT COMPLETED|Overall Study||3
3358358|NCT04123405|4088672|FG000|STARTED|Overall Study||235
3358359|NCT04123405|4088673|FG001|STARTED|Overall Study||238
3358360|NCT04123405|4088674|FG002|STARTED|Overall Study||238
3358361|NCT04123405|4088675|FG003|STARTED|Overall Study||233
3358362|NCT04123405|4088672|FG000|Full Analysis Set|Overall Study||235
3358363|NCT04123405|4088673|FG001|Full Analysis Set|Overall Study||236
3358364|NCT04123405|4088674|FG002|Full Analysis Set|Overall Study||238
3358365|NCT04123405|4088675|FG003|Full Analysis Set|Overall Study||230
3358366|NCT04123405|4088672|FG000|Per-protocol Set|Overall Study||213
3358367|NCT04123405|4088673|FG001|Per-protocol Set|Overall Study||215
3358368|NCT04123405|4088674|FG002|Per-protocol Set|Overall Study||212
3358369|NCT04123405|4088675|FG003|Per-protocol Set|Overall Study||207
3358370|NCT04123405|4088672|FG000|Safety Set|Overall Study||235
3358371|NCT04123405|4088673|FG001|Safety Set|Overall Study||238
3358372|NCT04123405|4088674|FG002|Safety Set|Overall Study||238
3358373|NCT04123405|4088675|FG003|Safety Set|Overall Study||233
3358374|NCT04123405|4088672|FG000|COMPLETED|Overall Study||231
3358375|NCT04123405|4088673|FG001|COMPLETED|Overall Study||231
3358376|NCT04123405|4088674|FG002|COMPLETED|Overall Study||235
3358377|NCT04123405|4088675|FG003|COMPLETED|Overall Study||225
3358378|NCT04123405|4088672|FG000|NOT COMPLETED|Overall Study||4
3358379|NCT04123405|4088673|FG001|NOT COMPLETED|Overall Study||7
3358380|NCT04123405|4088674|FG002|NOT COMPLETED|Overall Study||3
3358381|NCT04123405|4088675|FG003|NOT COMPLETED|Overall Study||8
3358382|NCT04128527|4088685|FG000|STARTED|Overall Study||16
3358383|NCT04128527|4088685|FG000|COMPLETED|Overall Study||16
3358384|NCT04128527|4088685|FG000|NOT COMPLETED|Overall Study||0
3358385|NCT04132973|4088689|FG000|STARTED|Overall Study||34
3358386|NCT04132973|4088689|FG000|Completed Intervention|Overall Study||11
3358387|NCT04132973|4088689|FG000|COMPLETED|Overall Study||8
3358388|NCT04132973|4088689|FG000|NOT COMPLETED|Overall Study||26
3358389|NCT04133415|4088693|FG000|STARTED|Overall Study||20
3358390|NCT04133415|4088693|FG000|COMPLETED|Overall Study||20
3358391|NCT04133415|4088693|FG000|NOT COMPLETED|Overall Study||0
3358392|NCT04138758|4088699|FG000|STARTED|Overall Study||2600
3358393|NCT04138758|4088700|FG001|STARTED|Overall Study||40353
3358394|NCT04138758|4088699|FG000|COMPLETED|Overall Study||2600
3358395|NCT04138758|4088700|FG001|COMPLETED|Overall Study||40353
3358396|NCT04138758|4088699|FG000|NOT COMPLETED|Overall Study||0
3358397|NCT04138758|4088700|FG001|NOT COMPLETED|Overall Study||0
3358398|NCT04147715|4088718|FG000|STARTED|Overall Study||12
3358399|NCT04147715|4088719|FG001|STARTED|Overall Study||6
3358400|NCT04147715|4088720|FG002|STARTED|Overall Study||6
3358401|NCT04147715|4088721|FG003|STARTED|Overall Study||8
3358402|NCT04147715|4088722|FG004|STARTED|Overall Study||6
3358403|NCT04147715|4088723|FG005|STARTED|Overall Study||6
3358404|NCT04147715|4088724|FG006|STARTED|Overall Study||6
3358405|NCT04147715|4088725|FG007|STARTED|Overall Study||4
3358406|NCT04147715|4088726|FG008|STARTED|Overall Study||8
3358407|NCT04147715|4088727|FG009|STARTED|Overall Study||8
3358408|NCT04147715|4088728|FG010|STARTED|Overall Study||14
3358409|NCT04147715|4088729|FG011|STARTED|Overall Study||14
3358410|NCT04147715|4088718|FG000|COMPLETED|Overall Study||12
3358411|NCT04147715|4088719|FG001|COMPLETED|Overall Study||6
3358412|NCT04147715|4088720|FG002|COMPLETED|Overall Study||6
3358413|NCT04147715|4088721|FG003|COMPLETED|Overall Study||8
3358414|NCT04147715|4088722|FG004|COMPLETED|Overall Study||6
3358415|NCT04147715|4088723|FG005|COMPLETED|Overall Study||6
3358416|NCT04147715|4088724|FG006|COMPLETED|Overall Study||6
3358417|NCT04147715|4088725|FG007|COMPLETED|Overall Study||2
3358418|NCT04147715|4088726|FG008|COMPLETED|Overall Study||7
3358419|NCT04147715|4088727|FG009|COMPLETED|Overall Study||8
3358420|NCT04147715|4088728|FG010|COMPLETED|Overall Study||14
3358421|NCT04147715|4088729|FG011|COMPLETED|Overall Study||14
3358422|NCT04147715|4088718|FG000|NOT COMPLETED|Overall Study||0
3358423|NCT04147715|4088719|FG001|NOT COMPLETED|Overall Study||0
3358424|NCT04147715|4088720|FG002|NOT COMPLETED|Overall Study||0
3358425|NCT04147715|4088721|FG003|NOT COMPLETED|Overall Study||0
3358426|NCT04147715|4088722|FG004|NOT COMPLETED|Overall Study||0
3358427|NCT04147715|4088723|FG005|NOT COMPLETED|Overall Study||0
3358428|NCT04147715|4088724|FG006|NOT COMPLETED|Overall Study||0
3358429|NCT04147715|4088725|FG007|NOT COMPLETED|Overall Study||2
3358430|NCT04147715|4088726|FG008|NOT COMPLETED|Overall Study||1
3358431|NCT04147715|4088727|FG009|NOT COMPLETED|Overall Study||0
3358432|NCT04147715|4088728|FG010|NOT COMPLETED|Overall Study||0
3358433|NCT04147715|4088729|FG011|NOT COMPLETED|Overall Study||0
3358434|NCT04150068|4088804|FG000|STARTED|Overall Study||24
3358435|NCT04150068|4088805|FG001|STARTED|Overall Study||12
3358436|NCT04150068|4088806|FG002|STARTED|Overall Study||16
3358437|NCT04150068|4088804|FG000|Completed Functional Monotherapy/Oral Lead-in (14 Days) Period|Overall Study||24
3358438|NCT04150068|4088805|FG001|Completed Functional Monotherapy/Oral Lead-in (14 Days) Period|Overall Study||12
3358439|NCT04150068|4088806|FG002|Completed Functional Monotherapy/Oral Lead-in (14 Days) Period|Overall Study||16
3358440|NCT04150068|4088804|FG000|COMPLETED|Overall Study||0
3358441|NCT04150068|4088805|FG001|COMPLETED|Overall Study||0
3358442|NCT04150068|4088806|FG002|COMPLETED|Overall Study||0
3358443|NCT04150068|4088804|FG000|NOT COMPLETED|Overall Study||24
3358444|NCT04150068|4088805|FG001|NOT COMPLETED|Overall Study||12
3358445|NCT04150068|4088806|FG002|NOT COMPLETED|Overall Study||16
3358446|NCT04154605|4088815|FG000|STARTED|Overall Study||68
3358447|NCT04154605|4088816|FG001|STARTED|Overall Study||65
3358448|NCT04154605|4088815|FG000|COMPLETED|Overall Study||65
3358449|NCT04154605|4088816|FG001|COMPLETED|Overall Study||63
3358450|NCT04154605|4088815|FG000|NOT COMPLETED|Overall Study||3
3358451|NCT04154605|4088816|FG001|NOT COMPLETED|Overall Study||2
3358452|NCT04160091|4088826|FG000|STARTED|Overall Study||7
3358453|NCT04160091|4088827|FG001|STARTED|Overall Study||3
3358454|NCT04160091|4088828|FG002|STARTED|Overall Study||5
3358455|NCT04160091|4088829|FG003|STARTED|Overall Study||4
3358456|NCT04160091|4088826|FG000|COMPLETED|Overall Study||0
3358457|NCT04160091|4088827|FG001|COMPLETED|Overall Study||0
3358458|NCT04160091|4088828|FG002|COMPLETED|Overall Study||0
3358459|NCT04160091|4088829|FG003|COMPLETED|Overall Study||0
3358460|NCT04160091|4088826|FG000|NOT COMPLETED|Overall Study||7
3358461|NCT04160091|4088827|FG001|NOT COMPLETED|Overall Study||3
3358462|NCT04160091|4088828|FG002|NOT COMPLETED|Overall Study||5
3358463|NCT04160091|4088829|FG003|NOT COMPLETED|Overall Study||4
3358464|NCT04160260|4088839|FG000|STARTED|Overall Study||18
3358465|NCT04160260|4088839|FG000|COMPLETED|Overall Study||18
3358466|NCT04160260|4088839|FG000|NOT COMPLETED|Overall Study||0
3358467|NCT04164758|4088846|FG000|STARTED|Overall Study||4
3358468|NCT04164758|4088847|FG001|STARTED|Overall Study||4
3358469|NCT04164758|4088848|FG002|STARTED|Overall Study||3
3358470|NCT04164758|4088846|FG000|COMPLETED|Overall Study||3
3358471|NCT04164758|4088847|FG001|COMPLETED|Overall Study||3
3358472|NCT04164758|4088848|FG002|COMPLETED|Overall Study||3
3358473|NCT04164758|4088846|FG000|NOT COMPLETED|Overall Study||1
3358474|NCT04164758|4088847|FG001|NOT COMPLETED|Overall Study||1
3358475|NCT04164758|4088848|FG002|NOT COMPLETED|Overall Study||0
3358476|NCT04165031|4088862|FG000|STARTED|Overall Study||2
3358477|NCT04165031|4088863|FG001|STARTED|Overall Study||1
3358478|NCT04165031|4088864|FG002|STARTED|Overall Study||2
3358479|NCT04165031|4088865|FG003|STARTED|Overall Study||0
3358480|NCT04165031|4088866|FG004|STARTED|Overall Study||0
3358481|NCT04165031|4088867|FG005|STARTED|Overall Study||0
3358482|NCT04165031|4088862|FG000|Received at Least One Dose of Study Drug|Overall Study||2
3358483|NCT04165031|4088863|FG001|Received at Least One Dose of Study Drug|Overall Study||1
3358484|NCT04165031|4088864|FG002|Received at Least One Dose of Study Drug|Overall Study||2
3358485|NCT04165031|4088865|FG003|Received at Least One Dose of Study Drug|Overall Study||0
3358486|NCT04165031|4088866|FG004|Received at Least One Dose of Study Drug|Overall Study||0
3358487|NCT04165031|4088867|FG005|Received at Least One Dose of Study Drug|Overall Study||0
3358488|NCT04165031|4088862|FG000|COMPLETED|Overall Study||1
3358489|NCT04165031|4088863|FG001|COMPLETED|Overall Study||0
3358490|NCT04165031|4088864|FG002|COMPLETED|Overall Study||1
3358491|NCT04165031|4088865|FG003|COMPLETED|Overall Study||0
3358492|NCT04165031|4088866|FG004|COMPLETED|Overall Study||0
3358493|NCT04165031|4088867|FG005|COMPLETED|Overall Study||0
3358494|NCT04165031|4088862|FG000|NOT COMPLETED|Overall Study||1
3358495|NCT04165031|4088863|FG001|NOT COMPLETED|Overall Study||1
3358496|NCT04165031|4088864|FG002|NOT COMPLETED|Overall Study||1
3358497|NCT04165031|4088865|FG003|NOT COMPLETED|Overall Study||0
3358498|NCT04165031|4088866|FG004|NOT COMPLETED|Overall Study||0
3358499|NCT04165031|4088867|FG005|NOT COMPLETED|Overall Study||0
3358500|NCT04166032|4088882|FG000|STARTED|Overall Study||15
3358501|NCT04166032|4088882|FG000|COMPLETED|Overall Study||14
3358502|NCT04166032|4088882|FG000|NOT COMPLETED|Overall Study||1
3358503|NCT04171414|4088886|FG000|STARTED|Overall Study||62
3358504|NCT04171414|4088886|FG000|COMPLETED|Overall Study||60
3358505|NCT04171414|4088886|FG000|NOT COMPLETED|Overall Study||2
3358506|NCT04175808|4088890|FG000|STARTED|Part A||70
3358507|NCT04175808|4088891|FG001|STARTED|Part A||0
3358508|NCT04175808|4088892|FG002|STARTED|Part A||0
3358509|NCT04175808|4088893|FG003|STARTED|Part A||0
3358510|NCT04175808|4088894|FG004|STARTED|Part A||0
3358511|NCT04175808|4088895|FG005|STARTED|Part A||0
3358512|NCT04175808|4088896|FG006|STARTED|Part A||0
3358513|NCT04175808|4088890|FG000|COMPLETED|Part A||68
3358514|NCT04175808|4088891|FG001|COMPLETED|Part A||0
3358515|NCT04175808|4088892|FG002|COMPLETED|Part A||0
3358516|NCT04175808|4088893|FG003|COMPLETED|Part A||0
3358517|NCT04175808|4088894|FG004|COMPLETED|Part A||0
3358518|NCT04175808|4088895|FG005|COMPLETED|Part A||0
3358519|NCT04175808|4088896|FG006|COMPLETED|Part A||0
3358520|NCT04175808|4088890|FG000|NOT COMPLETED|Part A||2
3358521|NCT04175808|4088891|FG001|NOT COMPLETED|Part A||0
3358522|NCT04175808|4088892|FG002|NOT COMPLETED|Part A||0
3358523|NCT04175808|4088893|FG003|NOT COMPLETED|Part A||0
3358524|NCT04175808|4088894|FG004|NOT COMPLETED|Part A||0
3358525|NCT04175808|4088895|FG005|NOT COMPLETED|Part A||0
3358526|NCT04175808|4088896|FG006|NOT COMPLETED|Part A||0
3358527|NCT04175808|4088890|FG000|STARTED|Part B||0
3358528|NCT04175808|4088891|FG001|STARTED|Part B||10
3358529|NCT04175808|4088892|FG002|STARTED|Part B||10
3358530|NCT04175808|4088893|FG003|STARTED|Part B||10
3358531|NCT04175808|4088894|FG004|STARTED|Part B||10
3358532|NCT04175808|4088895|FG005|STARTED|Part B||10
3358533|NCT04175808|4088896|FG006|STARTED|Part B||10
3358534|NCT04175808|4088890|FG000|COMPLETED|Part B||0
3358535|NCT04175808|4088891|FG001|COMPLETED|Part B||10
3358536|NCT04175808|4088892|FG002|COMPLETED|Part B||10
3358537|NCT04175808|4088893|FG003|COMPLETED|Part B||10
3358538|NCT04175808|4088894|FG004|COMPLETED|Part B||10
3358539|NCT04175808|4088895|FG005|COMPLETED|Part B||10
3358540|NCT04175808|4088896|FG006|COMPLETED|Part B||10
3358541|NCT04175808|4088890|FG000|NOT COMPLETED|Part B||0
3358542|NCT04175808|4088891|FG001|NOT COMPLETED|Part B||0
3358543|NCT04175808|4088892|FG002|NOT COMPLETED|Part B||0
3358544|NCT04175808|4088893|FG003|NOT COMPLETED|Part B||0
3358545|NCT04175808|4088894|FG004|NOT COMPLETED|Part B||0
3358546|NCT04175808|4088895|FG005|NOT COMPLETED|Part B||0
3358547|NCT04175808|4088896|FG006|NOT COMPLETED|Part B||0
3358548|NCT04178720|4088914|FG000|STARTED|Overall Study||40
3358549|NCT04178720|4088915|FG001|STARTED|Overall Study||78
3358550|NCT04178720|4088914|FG000|COMPLETED|Overall Study||38
3358551|NCT04178720|4088915|FG001|COMPLETED|Overall Study||77
3358552|NCT04178720|4088914|FG000|NOT COMPLETED|Overall Study||2
3358553|NCT04178720|4088915|FG001|NOT COMPLETED|Overall Study||1
3358554|NCT04184297|4088926|FG000|STARTED|Overall Study||2864
3358555|NCT04184297|4088927|FG001|STARTED|Overall Study||24326
3358556|NCT04184297|4088926|FG000|COMPLETED|Overall Study||2864
3358557|NCT04184297|4088927|FG001|COMPLETED|Overall Study||24326
3358558|NCT04184297|4088926|FG000|NOT COMPLETED|Overall Study||0
3358559|NCT04184297|4088927|FG001|NOT COMPLETED|Overall Study||0
3358560|NCT04189848|4088933|FG000|STARTED|Treatment Period 1 (Day 1)||26
3358561|NCT04189848|4088934|FG001|STARTED|Treatment Period 1 (Day 1)||26
3358562|NCT04189848|4088935|FG002|STARTED|Treatment Period 1 (Day 1)||25
3358563|NCT04189848|4088936|FG003|STARTED|Treatment Period 1 (Day 1)||27
3358564|NCT04189848|4088933|FG000|COMPLETED|Treatment Period 1 (Day 1)||26
3358565|NCT04189848|4088934|FG001|COMPLETED|Treatment Period 1 (Day 1)||26
3358566|NCT04189848|4088935|FG002|COMPLETED|Treatment Period 1 (Day 1)||25
3358567|NCT04189848|4088936|FG003|COMPLETED|Treatment Period 1 (Day 1)||27
3358568|NCT04189848|4088933|FG000|NOT COMPLETED|Treatment Period 1 (Day 1)||0
3358569|NCT04189848|4088934|FG001|NOT COMPLETED|Treatment Period 1 (Day 1)||0
3358570|NCT04189848|4088935|FG002|NOT COMPLETED|Treatment Period 1 (Day 1)||0
3358571|NCT04189848|4088936|FG003|NOT COMPLETED|Treatment Period 1 (Day 1)||0
3358572|NCT04189848|4088933|FG000|STARTED|Treatment Period 2 (Day 1)||26
3358573|NCT04189848|4088934|FG001|STARTED|Treatment Period 2 (Day 1)||26
3358574|NCT04189848|4088935|FG002|STARTED|Treatment Period 2 (Day 1)||25
3358575|NCT04189848|4088936|FG003|STARTED|Treatment Period 2 (Day 1)||27
3358576|NCT04189848|4088933|FG000|COMPLETED|Treatment Period 2 (Day 1)||26
3358577|NCT04189848|4088934|FG001|COMPLETED|Treatment Period 2 (Day 1)||26
3358578|NCT04189848|4088935|FG002|COMPLETED|Treatment Period 2 (Day 1)||25
3358579|NCT04189848|4088936|FG003|COMPLETED|Treatment Period 2 (Day 1)||27
3358580|NCT04189848|4088933|FG000|NOT COMPLETED|Treatment Period 2 (Day 1)||0
3358581|NCT04189848|4088934|FG001|NOT COMPLETED|Treatment Period 2 (Day 1)||0
3358582|NCT04189848|4088935|FG002|NOT COMPLETED|Treatment Period 2 (Day 1)||0
3358583|NCT04189848|4088936|FG003|NOT COMPLETED|Treatment Period 2 (Day 1)||0
3358584|NCT04210232|4088941|FG000|STARTED|Overall Study||54
3358585|NCT04210232|4088941|FG000|COMPLETED|Overall Study||54
3358586|NCT04210232|4088941|FG000|NOT COMPLETED|Overall Study||0
3358587|NCT04211909|4088947|FG000|STARTED|Overall Study||54
3358588|NCT04211909|4088948|FG001|STARTED|Overall Study||33
3358589|NCT04211909|4088947|FG000|COMPLETED|Overall Study||54
3358590|NCT04211909|4088948|FG001|COMPLETED|Overall Study||33
3358591|NCT04211909|4088947|FG000|NOT COMPLETED|Overall Study||0
3358592|NCT04211909|4088948|FG001|NOT COMPLETED|Overall Study||0
3358593|NCT04218110|4088958|FG000|STARTED|Overall Study||82
3358594|NCT04218110|4088959|FG001|STARTED|Overall Study||81
3358595|NCT04218110|4088960|FG002|STARTED|Overall Study||83
3358596|NCT04218110|4088961|FG003|STARTED|Overall Study||83
3358597|NCT04218110|4088958|FG000|Received Treatment|Overall Study||82
3358598|NCT04218110|4088959|FG001|Received Treatment|Overall Study||81
3358599|NCT04218110|4088960|FG002|Received Treatment|Overall Study||83
3358600|NCT04218110|4088961|FG003|Received Treatment|Overall Study||82
3358601|NCT04218110|4088958|FG000|COMPLETED|Overall Study||82
3358602|NCT04218110|4088959|FG001|COMPLETED|Overall Study||81
3358603|NCT04218110|4088960|FG002|COMPLETED|Overall Study||83
3358604|NCT04218110|4088961|FG003|COMPLETED|Overall Study||82
3358605|NCT04218110|4088958|FG000|NOT COMPLETED|Overall Study||0
3358606|NCT04218110|4088959|FG001|NOT COMPLETED|Overall Study||0
3358607|NCT04218110|4088960|FG002|NOT COMPLETED|Overall Study||0
3179239|NCT01983839|3907398|FG000|NOT COMPLETED|Overall Study||0
3179240|NCT01983878|3907402|FG000|STARTED|Overall Study||36
3358608|NCT04218110|4088961|FG003|NOT COMPLETED|Overall Study||1
3358609|NCT04222725|4088975|FG000|STARTED|Overall Study||8
3358610|NCT04222725|4088976|FG001|STARTED|Overall Study||10
3358611|NCT04222725|4088977|FG002|STARTED|Overall Study||9
3358612|NCT04222725|4088978|FG003|STARTED|Overall Study||10
3358613|NCT04222725|4088975|FG000|COMPLETED|Overall Study||8
3358614|NCT04222725|4088976|FG001|COMPLETED|Overall Study||9
3358615|NCT04222725|4088977|FG002|COMPLETED|Overall Study||9
3358616|NCT04222725|4088978|FG003|COMPLETED|Overall Study||10
3358617|NCT04222725|4088975|FG000|NOT COMPLETED|Overall Study||0
3358618|NCT04222725|4088976|FG001|NOT COMPLETED|Overall Study||1
3358619|NCT04222725|4088977|FG002|NOT COMPLETED|Overall Study||0
3358620|NCT04222725|4088978|FG003|NOT COMPLETED|Overall Study||0
3358621|NCT04223843|4088992|FG000|STARTED|Overall Study||55
3358622|NCT04223843|4088993|FG001|STARTED|Overall Study||55
3358623|NCT04223843|4088994|FG002|STARTED|Overall Study||51
3358624|NCT04223843|4088995|FG003|STARTED|Overall Study||52
3358625|NCT04223843|4088992|FG000|COMPLETED|Overall Study||55
3358626|NCT04223843|4088993|FG001|COMPLETED|Overall Study||55
3358627|NCT04223843|4088994|FG002|COMPLETED|Overall Study||51
3358628|NCT04223843|4088995|FG003|COMPLETED|Overall Study||52
3358629|NCT04223843|4088992|FG000|NOT COMPLETED|Overall Study||0
3358630|NCT04223843|4088993|FG001|NOT COMPLETED|Overall Study||0
3358631|NCT04223843|4088994|FG002|NOT COMPLETED|Overall Study||0
3358632|NCT04223843|4088995|FG003|NOT COMPLETED|Overall Study||0
3358633|NCT04229303|4089012|FG000|STARTED|Overall Study||6
3358634|NCT04229303|4089013|FG001|STARTED|Overall Study||6
3358635|NCT04229303|4089014|FG002|STARTED|Overall Study||6
3358636|NCT04229303|4089015|FG003|STARTED|Overall Study||6
3358637|NCT04229303|4089016|FG004|STARTED|Overall Study||6
3358638|NCT04229303|4089017|FG005|STARTED|Overall Study||6
3358639|NCT04229303|4089018|FG006|STARTED|Overall Study||6
3358640|NCT04229303|4089019|FG007|STARTED|Overall Study||8
3358641|NCT04229303|4089020|FG008|STARTED|Overall Study||8
3358642|NCT04229303|4089012|FG000|COMPLETED|Overall Study||6
3358643|NCT04229303|4089013|FG001|COMPLETED|Overall Study||6
3358644|NCT04229303|4089014|FG002|COMPLETED|Overall Study||6
3358645|NCT04229303|4089015|FG003|COMPLETED|Overall Study||6
3358646|NCT04229303|4089016|FG004|COMPLETED|Overall Study||6
3358647|NCT04229303|4089017|FG005|COMPLETED|Overall Study||6
3358648|NCT04229303|4089018|FG006|COMPLETED|Overall Study||6
3358649|NCT04229303|4089019|FG007|COMPLETED|Overall Study||8
3358650|NCT04229303|4089020|FG008|COMPLETED|Overall Study||8
3358651|NCT04229303|4089012|FG000|NOT COMPLETED|Overall Study||0
3358652|NCT04229303|4089013|FG001|NOT COMPLETED|Overall Study||0
3358653|NCT04229303|4089014|FG002|NOT COMPLETED|Overall Study||0
3358654|NCT04229303|4089015|FG003|NOT COMPLETED|Overall Study||0
3358655|NCT04229303|4089016|FG004|NOT COMPLETED|Overall Study||0
3358656|NCT04229303|4089017|FG005|NOT COMPLETED|Overall Study||0
3358657|NCT04229303|4089018|FG006|NOT COMPLETED|Overall Study||0
3358658|NCT04229303|4089019|FG007|NOT COMPLETED|Overall Study||0
3358659|NCT04229303|4089020|FG008|NOT COMPLETED|Overall Study||0
3358660|NCT04231825|4089050|FG000|STARTED|Overall Study||23
3358661|NCT04231825|4089051|FG001|STARTED|Overall Study||24
3358662|NCT04231825|4089050|FG000|COMPLETED|Overall Study||20
3358663|NCT04231825|4089051|FG001|COMPLETED|Overall Study||20
3358664|NCT04231825|4089050|FG000|NOT COMPLETED|Overall Study||3
3358665|NCT04231825|4089051|FG001|NOT COMPLETED|Overall Study||4
3358666|NCT04243421|4089057|FG000|STARTED|Overall Study||30
3358667|NCT04243421|4089057|FG000|COMPLETED|Overall Study||30
3358668|NCT04243421|4089057|FG000|NOT COMPLETED|Overall Study||0
3358669|NCT04244084|4089064|FG000|STARTED|Overall Study||118
3358670|NCT04244084|4089065|FG001|STARTED|Overall Study||122
3358671|NCT04244084|4089064|FG000|COMPLETED|Overall Study||118
3358672|NCT04244084|4089065|FG001|COMPLETED|Overall Study||122
3358673|NCT04244084|4089064|FG000|NOT COMPLETED|Overall Study||0
3358674|NCT04244084|4089065|FG001|NOT COMPLETED|Overall Study||0
3358675|NCT04256603|4089073|FG000|STARTED|Overall Study||21
3358676|NCT04256603|4089074|FG001|STARTED|Overall Study||6
3358677|NCT04256603|4089073|FG000|COMPLETED|Overall Study||21
3358678|NCT04256603|4089074|FG001|COMPLETED|Overall Study||6
3358679|NCT04256603|4089073|FG000|NOT COMPLETED|Overall Study||0
3358680|NCT04256603|4089074|FG001|NOT COMPLETED|Overall Study||0
3358681|NCT04258995|4089082|FG000|STARTED|Overall Study||76
3358682|NCT04258995|4089083|FG001|STARTED|Overall Study||75
3358683|NCT04258995|4089082|FG000|Vaccinated|Overall Study||76
3358684|NCT04258995|4089083|FG001|Vaccinated|Overall Study||75
3358685|NCT04258995|4089082|FG000|COMPLETED|Overall Study||75
3358686|NCT04258995|4089083|FG001|COMPLETED|Overall Study||74
3358687|NCT04258995|4089082|FG000|NOT COMPLETED|Overall Study||1
3358688|NCT04258995|4089083|FG001|NOT COMPLETED|Overall Study||1
3358689|NCT04280445|4089089|FG000|STARTED|Overall Study||3
3358690|NCT04280445|4089089|FG000|COMPLETED|Overall Study||3
3358691|NCT04280445|4089089|FG000|NOT COMPLETED|Overall Study||0
3358692|NCT04285489|4089093|FG000|STARTED|Overall Study||130
3358693|NCT04285489|4089093|FG000|COMPLETED|Overall Study|all subjects finished the study before Jul 1, 2020.|130
3358694|NCT04285489|4089093|FG000|NOT COMPLETED|Overall Study||0
3358695|NCT04290494|4089100|FG000|STARTED|Overall Study||10968
3358696|NCT04290494|4089101|FG001|STARTED|Overall Study||17823
3358697|NCT04290494|4089102|FG002|STARTED|Overall Study||13397
3358698|NCT04290494|4089100|FG000|COMPLETED|Overall Study||10968
3358699|NCT04290494|4089101|FG001|COMPLETED|Overall Study||17823
3358700|NCT04290494|4089102|FG002|COMPLETED|Overall Study||13397
3358701|NCT04290494|4089100|FG000|NOT COMPLETED|Overall Study||0
3358702|NCT04290494|4089101|FG001|NOT COMPLETED|Overall Study||0
3179241|NCT01983878|3907402|FG000|Received At Least One Dose of Study Drug|Overall Study||36
3358703|NCT04290494|4089102|FG002|NOT COMPLETED|Overall Study||0
3358704|NCT04303156|4089112|FG000|STARTED|Overall Study||6
3358705|NCT04303156|4089113|FG001|STARTED|Overall Study||6
3358706|NCT04303156|4089112|FG000|COMPLETED|Overall Study||6
3358707|NCT04303156|4089113|FG001|COMPLETED|Overall Study||6
3358708|NCT04303156|4089112|FG000|NOT COMPLETED|Overall Study||0
3358709|NCT04303156|4089113|FG001|NOT COMPLETED|Overall Study||0
3358710|NCT04317040|4089122|FG000|STARTED|Overall Study||116
3358711|NCT04317040|4089123|FG001|STARTED|Overall Study||118
3358712|NCT04317040|4089122|FG000|Treated|Overall Study||114
3358713|NCT04317040|4089123|FG001|Treated|Overall Study||115
3358714|NCT04317040|4089122|FG000|COMPLETED|Overall Study||98
3358715|NCT04317040|4089123|FG001|COMPLETED|Overall Study||98
3358716|NCT04317040|4089122|FG000|NOT COMPLETED|Overall Study||18
3358717|NCT04317040|4089123|FG001|NOT COMPLETED|Overall Study||20
3358718|NCT04317313|4089131|FG000|STARTED|Overall Study||100
3358719|NCT04317313|4089132|FG001|STARTED|Overall Study||52
3358720|NCT04317313|4089131|FG000|COMPLETED|Overall Study||100
3358721|NCT04317313|4089132|FG001|COMPLETED|Overall Study||52
3358722|NCT04317313|4089131|FG000|NOT COMPLETED|Overall Study||0
3358723|NCT04317313|4089132|FG001|NOT COMPLETED|Overall Study||0
3358724|NCT04319159|4089140|FG000|STARTED|Overall Study||48
3358725|NCT04319159|4089140|FG000|COMPLETED|Overall Study||32
3358726|NCT04319159|4089140|FG000|NOT COMPLETED|Overall Study||16
3358727|NCT04321239|4089148|FG000|STARTED|Overall Study||25
3358728|NCT04321239|4089149|FG001|STARTED|Overall Study||26
3358729|NCT04321239|4089148|FG000|COMPLETED|Overall Study||22
3358730|NCT04321239|4089149|FG001|COMPLETED|Overall Study||24
3358731|NCT04321239|4089148|FG000|NOT COMPLETED|Overall Study||3
3358732|NCT04321239|4089149|FG001|NOT COMPLETED|Overall Study||2
3358733|NCT04323852|4089157|FG000|STARTED|Overall Study||35
3358734|NCT04323852|4089158|FG001|STARTED|Overall Study||35
3358735|NCT04323852|4089157|FG000|COMPLETED|Overall Study||35
3358736|NCT04323852|4089158|FG001|COMPLETED|Overall Study||35
3358737|NCT04323852|4089157|FG000|NOT COMPLETED|Overall Study||0
3358738|NCT04323852|4089158|FG001|NOT COMPLETED|Overall Study||0
3358739|NCT04327843|4089164|FG000|STARTED|Baseline Assessment||19
3358740|NCT04327843|4089164|FG000|COMPLETED|Baseline Assessment||19
3358741|NCT04327843|4089164|FG000|NOT COMPLETED|Baseline Assessment||0
3358742|NCT04327843|4089164|FG000|STARTED|Week 13 Assessment||19
3358743|NCT04327843|4089164|FG000|COMPLETED|Week 13 Assessment||19
3358744|NCT04327843|4089164|FG000|NOT COMPLETED|Week 13 Assessment||0
3358745|NCT04327843|4089164|FG000|STARTED|Week 25 Assessment||19
3358746|NCT04327843|4089164|FG000|COMPLETED|Week 25 Assessment||18
3358747|NCT04327843|4089164|FG000|NOT COMPLETED|Week 25 Assessment||1
3358748|NCT04331899|4089170|FG000|STARTED|Trial Period (28 Days)||60
3358749|NCT04331899|4089171|FG001|STARTED|Trial Period (28 Days)||60
3358750|NCT04331899|4089170|FG000|COMPLETED|Trial Period (28 Days)||58
3358751|NCT04331899|4089171|FG001|COMPLETED|Trial Period (28 Days)||58
3358752|NCT04331899|4089170|FG000|NOT COMPLETED|Trial Period (28 Days)||2
3358753|NCT04331899|4089171|FG001|NOT COMPLETED|Trial Period (28 Days)||2
3358754|NCT04331899|4089170|FG000|STARTED|Follow-up Period (10 Months)|16 participants who completed the trial period did not continue in the follow-up period.|42
3358755|NCT04331899|4089171|FG001|STARTED|Follow-up Period (10 Months)|15 participants who completed the trial period did not continue in the follow-up period.|43
3358756|NCT04331899|4089170|FG000|COMPLETED|Follow-up Period (10 Months)||42
3358757|NCT04331899|4089171|FG001|COMPLETED|Follow-up Period (10 Months)||43
3358758|NCT04331899|4089170|FG000|NOT COMPLETED|Follow-up Period (10 Months)||0
3358759|NCT04331899|4089171|FG001|NOT COMPLETED|Follow-up Period (10 Months)||0
3358760|NCT04334148|4089179|FG000|STARTED|Overall Study||683
3358761|NCT04334148|4089180|FG001|STARTED|Overall Study||677
3358762|NCT04334148|4089179|FG000|COMPLETED|Overall Study||683
3358763|NCT04334148|4089180|FG001|COMPLETED|Overall Study||676
3358764|NCT04334148|4089179|FG000|NOT COMPLETED|Overall Study||0
3358765|NCT04334148|4089180|FG001|NOT COMPLETED|Overall Study||1
3358766|NCT04343287|4089188|FG000|STARTED|Overall Study||108
2928118|NCT00576472|3639108|FG005|STARTED|MPH In-Lab Phase||67
2928119|NCT00576472|3639109|FG006|STARTED|MPH In-Lab Phase||0
2928120|NCT00576472|3639110|FG007|STARTED|MPH In-Lab Phase||0
2928121|NCT00576472|3639111|FG008|STARTED|MPH In-Lab Phase||0
2928122|NCT00576472|3639112|FG009|STARTED|MPH In-Lab Phase||0
2928123|NCT00576472|3639113|FG010|STARTED|MPH In-Lab Phase||0
2928124|NCT00576472|3639114|FG011|STARTED|MPH In-Lab Phase||0
2928125|NCT00576472|3639115|FG012|STARTED|MPH In-Lab Phase||0
2928126|NCT00576472|3639116|FG013|STARTED|MPH In-Lab Phase||0
2928127|NCT00576472|3639117|FG014|STARTED|MPH In-Lab Phase||0
2928128|NCT00576472|3639103|FG000|COMPLETED|MPH In-Lab Phase||0
2928129|NCT00576472|3639104|FG001|COMPLETED|MPH In-Lab Phase||0
2928130|NCT00576472|3639105|FG002|COMPLETED|MPH In-Lab Phase||0
2928131|NCT00576472|3639106|FG003|COMPLETED|MPH In-Lab Phase||0
2928132|NCT00576472|3639107|FG004|COMPLETED|MPH In-Lab Phase||67
2928133|NCT00576472|3639108|FG005|COMPLETED|MPH In-Lab Phase||67
2928134|NCT00576472|3639109|FG006|COMPLETED|MPH In-Lab Phase||0
2928135|NCT00576472|3639110|FG007|COMPLETED|MPH In-Lab Phase||0
2928136|NCT00576472|3639111|FG008|COMPLETED|MPH In-Lab Phase||0
2928137|NCT00576472|3639112|FG009|COMPLETED|MPH In-Lab Phase||0
2928138|NCT00576472|3639113|FG010|COMPLETED|MPH In-Lab Phase||0
2928139|NCT00576472|3639114|FG011|COMPLETED|MPH In-Lab Phase||0
2928140|NCT00576472|3639115|FG012|COMPLETED|MPH In-Lab Phase||0
2928141|NCT00576472|3639116|FG013|COMPLETED|MPH In-Lab Phase||0
2928142|NCT00576472|3639117|FG014|COMPLETED|MPH In-Lab Phase||0
2928143|NCT00576472|3639103|FG000|NOT COMPLETED|MPH In-Lab Phase||0
2928144|NCT00576472|3639104|FG001|NOT COMPLETED|MPH In-Lab Phase||0
2928145|NCT00576472|3639105|FG002|NOT COMPLETED|MPH In-Lab Phase||0
2928146|NCT00576472|3639106|FG003|NOT COMPLETED|MPH In-Lab Phase||335
2928147|NCT00576472|3639107|FG004|NOT COMPLETED|MPH In-Lab Phase||0
2928148|NCT00576472|3639108|FG005|NOT COMPLETED|MPH In-Lab Phase||0
2928149|NCT00576472|3639109|FG006|NOT COMPLETED|MPH In-Lab Phase||0
2928150|NCT00576472|3639110|FG007|NOT COMPLETED|MPH In-Lab Phase||0
2928151|NCT00576472|3639111|FG008|NOT COMPLETED|MPH In-Lab Phase||0
2928152|NCT00576472|3639112|FG009|NOT COMPLETED|MPH In-Lab Phase||0
2928153|NCT00576472|3639113|FG010|NOT COMPLETED|MPH In-Lab Phase||0
3358767|NCT04343287|4089189|FG001|STARTED|Overall Study||112
3358768|NCT04343287|4089188|FG000|COMPLETED|Overall Study||108
3358769|NCT04343287|4089189|FG001|COMPLETED|Overall Study||111
3358770|NCT04343287|4089188|FG000|NOT COMPLETED|Overall Study||0
3358771|NCT04343287|4089189|FG001|NOT COMPLETED|Overall Study||1
3358772|NCT04347954|4089200|FG000|STARTED|Overall Study||15
3358773|NCT04347954|4089201|FG001|STARTED|Overall Study||15
3358774|NCT04347954|4089202|FG002|STARTED|Overall Study||17
3358775|NCT04347954|4089200|FG000|Received Allocated Intervention|Overall Study||12
3358776|NCT04347954|4089201|FG001|Received Allocated Intervention|Overall Study||15
3358777|NCT04347954|4089202|FG002|Received Allocated Intervention|Overall Study||14
3358778|NCT04347954|4089200|FG000|Negative PCR Swab at Baseline|Overall Study||1
3358779|NCT04347954|4089201|FG001|Negative PCR Swab at Baseline|Overall Study||3
3358780|NCT04347954|4089202|FG002|Negative PCR Swab at Baseline|Overall Study||1
3358781|NCT04347954|4089200|FG000|COMPLETED|Overall Study||12
3358782|NCT04347954|4089201|FG001|COMPLETED|Overall Study||14
3358783|NCT04347954|4089202|FG002|COMPLETED|Overall Study||14
3358784|NCT04347954|4089200|FG000|NOT COMPLETED|Overall Study||3
3358785|NCT04347954|4089201|FG001|NOT COMPLETED|Overall Study||1
3358786|NCT04347954|4089202|FG002|NOT COMPLETED|Overall Study||3
3358787|NCT04349098|4089212|FG000|STARTED|Overall Study||103
3358788|NCT04349098|4089213|FG001|STARTED|Overall Study||87
3358789|NCT04349098|4089212|FG000|Treated|Overall Study||102
3358790|NCT04349098|4089213|FG001|Treated|Overall Study||86
3358791|NCT04349098|4089212|FG000|COMPLETED|Overall Study||65
3358792|NCT04349098|4089213|FG001|COMPLETED|Overall Study||61
3358793|NCT04349098|4089212|FG000|NOT COMPLETED|Overall Study||38
3358794|NCT04349098|4089213|FG001|NOT COMPLETED|Overall Study||26
3358795|NCT04353037|4089223|FG000|STARTED|Overall Study||6
3358796|NCT04353037|4089224|FG001|STARTED|Overall Study||3
3358797|NCT04353037|4089225|FG002|STARTED|Overall Study||13
3358798|NCT04353037|4089226|FG003|STARTED|Overall Study||17
3358799|NCT04353037|4089223|FG000|COMPLETED|Overall Study||6
3358800|NCT04353037|4089224|FG001|COMPLETED|Overall Study||0
3358801|NCT04353037|4089225|FG002|COMPLETED|Overall Study||6
3358802|NCT04353037|4089226|FG003|COMPLETED|Overall Study||7
3358803|NCT04353037|4089223|FG000|NOT COMPLETED|Overall Study||0
3358804|NCT04353037|4089224|FG001|NOT COMPLETED|Overall Study||3
3358805|NCT04353037|4089225|FG002|NOT COMPLETED|Overall Study||7
3358806|NCT04353037|4089226|FG003|NOT COMPLETED|Overall Study||10
3358807|NCT04355117|4089238|FG000|STARTED|Overall Study||71
3358808|NCT04355117|4089238|FG000|COMPLETED|Overall Study||71
3358809|NCT04355117|4089238|FG000|NOT COMPLETED|Overall Study||0
3358810|NCT04355767|4089246|FG000|STARTED|Overall Study||257
3358811|NCT04355767|4089247|FG001|STARTED|Overall Study||254
3358812|NCT04355767|4089246|FG000|Intention-to-treat Population|Overall Study||257
3358813|NCT04355767|4089247|FG001|Intention-to-treat Population|Overall Study||254
3358814|NCT04355767|4089246|FG000|Had Data for 15-day Outcome|Overall Study||257
3358815|NCT04355767|4089247|FG001|Had Data for 15-day Outcome|Overall Study||254
3358816|NCT04355767|4089246|FG000|COMPLETED|Overall Study||250
3358817|NCT04355767|4089247|FG001|COMPLETED|Overall Study||251
3358818|NCT04355767|4089246|FG000|NOT COMPLETED|Overall Study||7
3358819|NCT04355767|4089247|FG001|NOT COMPLETED|Overall Study||3
3358820|NCT04356573|4089255|FG000|STARTED|Overall Study||7
3358821|NCT04356573|4089256|FG001|STARTED|Overall Study||6
3358822|NCT04356573|4089255|FG000|COMPLETED|Overall Study||6
3358823|NCT04356573|4089256|FG001|COMPLETED|Overall Study||6
3358824|NCT04356573|4089255|FG000|NOT COMPLETED|Overall Study||1
3358825|NCT04356573|4089256|FG001|NOT COMPLETED|Overall Study||0
3358826|NCT04357379|4089262|FG000|STARTED|Overall Study||10
3358827|NCT04357379|4089262|FG000|COMPLETED|Overall Study||10
3358828|NCT04357379|4089262|FG000|NOT COMPLETED|Overall Study||0
3358829|NCT04358068|4089268|FG000|STARTED|Overall Study||9
3358830|NCT04358068|4089269|FG001|STARTED|Overall Study||11
3358831|NCT04358068|4089268|FG000|COMPLETED|Overall Study||7
3358832|NCT04358068|4089269|FG001|COMPLETED|Overall Study||9
3358833|NCT04358068|4089268|FG000|NOT COMPLETED|Overall Study||2
3179242|NCT01983878|3907402|FG000|COMPLETED|Overall Study||36
3179243|NCT01983878|3907402|FG000|NOT COMPLETED|Overall Study||0
3179244|NCT01983930|3907409|FG000|STARTED|Overall Study||41
3179245|NCT01983930|3907410|FG001|STARTED|Overall Study||38
3179246|NCT01983930|3907409|FG000|COMPLETED|Overall Study||32
3358834|NCT04358068|4089269|FG001|NOT COMPLETED|Overall Study||2
3358835|NCT04366349|4089281|FG000|STARTED|Overall Study||13
3358836|NCT04366349|4089282|FG001|STARTED|Overall Study||18
3358837|NCT04366349|4089283|FG002|STARTED|Overall Study||18
3358838|NCT04366349|4089284|FG003|STARTED|Overall Study||4
3358839|NCT04366349|4089285|FG004|STARTED|Overall Study||6
3358840|NCT04366349|4089286|FG005|STARTED|Overall Study||6
3358841|NCT04366349|4089281|FG000|COMPLETED|Overall Study||12
3358842|NCT04366349|4089282|FG001|COMPLETED|Overall Study||18
3358843|NCT04366349|4089283|FG002|COMPLETED|Overall Study||18
3358844|NCT04366349|4089284|FG003|COMPLETED|Overall Study||4
3358845|NCT04366349|4089285|FG004|COMPLETED|Overall Study||6
3358846|NCT04366349|4089286|FG005|COMPLETED|Overall Study||6
3358847|NCT04366349|4089281|FG000|NOT COMPLETED|Overall Study||1
3358848|NCT04366349|4089282|FG001|NOT COMPLETED|Overall Study||0
3358849|NCT04366349|4089283|FG002|NOT COMPLETED|Overall Study||0
3358850|NCT04366349|4089284|FG003|NOT COMPLETED|Overall Study||0
3358851|NCT04366349|4089285|FG004|NOT COMPLETED|Overall Study||0
3358852|NCT04366349|4089286|FG005|NOT COMPLETED|Overall Study||0
3358853|NCT04369885|4089304|FG000|STARTED|Overall Study||12
3358854|NCT04369885|4089304|FG000|COMPLETED|Overall Study||10
3358855|NCT04369885|4089304|FG000|NOT COMPLETED|Overall Study||2
3179247|NCT01983930|3907410|FG001|COMPLETED|Overall Study||29
3179248|NCT01983930|3907409|FG000|NOT COMPLETED|Overall Study||9
3358856|NCT04373421|4089311|FG000|STARTED|Overall Study||30
3358857|NCT04373421|4089312|FG001|STARTED|Overall Study||30
3358858|NCT04373421|4089313|FG002|STARTED|Overall Study||30
3358859|NCT04373421|4089311|FG000|COMPLETED|Overall Study||26
3358860|NCT04373421|4089312|FG001|COMPLETED|Overall Study||26
3358861|NCT04373421|4089313|FG002|COMPLETED|Overall Study||29
3358862|NCT04373421|4089311|FG000|NOT COMPLETED|Overall Study||4
3358863|NCT04373421|4089312|FG001|NOT COMPLETED|Overall Study||4
3358864|NCT04373421|4089313|FG002|NOT COMPLETED|Overall Study||1
3358865|NCT04381728|4089324|FG000|STARTED|Overall Study||23
3358866|NCT04381728|4089324|FG000|COMPLETED|Overall Study||23
3358867|NCT04381728|4089324|FG000|NOT COMPLETED|Overall Study||0
3358868|NCT04382053|4089330|FG000|STARTED|Overall Study||71
3358869|NCT04382053|4089331|FG001|STARTED|Overall Study||72
3358870|NCT04382053|4089330|FG000|Safety Analysis Set|Overall Study|One participant that was randomized to the DFV890 + SoC arm did not attend any post-baseline visit|70
3358871|NCT04382053|4089331|FG001|Safety Analysis Set|Overall Study||72
3358872|NCT04382053|4089330|FG000|PD Analysis Set|Overall Study||62
3358873|NCT04382053|4089331|FG001|PD Analysis Set|Overall Study||68
3358874|NCT04382053|4089330|FG000|COMPLETED|Overall Study||62
3358875|NCT04382053|4089331|FG001|COMPLETED|Overall Study||59
3358876|NCT04382053|4089330|FG000|NOT COMPLETED|Overall Study||9
3358877|NCT04382053|4089331|FG001|NOT COMPLETED|Overall Study||13
3358878|NCT04388826|4089340|FG000|STARTED|Overall Study||19
3358879|NCT04388826|4089341|FG001|STARTED|Overall Study||20
3358880|NCT04388826|4089340|FG000|COMPLETED|Overall Study||15
3358881|NCT04388826|4089341|FG001|COMPLETED|Overall Study||18
3358882|NCT04388826|4089340|FG000|NOT COMPLETED|Overall Study||4
3358883|NCT04388826|4089341|FG001|NOT COMPLETED|Overall Study||2
3358884|NCT04394845|4089347|FG000|STARTED|Overall Study||6
3358885|NCT04394845|4089347|FG000|COMPLETED|Overall Study||6
3358886|NCT04394845|4089347|FG000|NOT COMPLETED|Overall Study||0
3358887|NCT04398732|4089353|FG000|STARTED|Overall Study||486
3358888|NCT04398732|4089353|FG000|COMPLETED|Overall Study||436
3358889|NCT04398732|4089353|FG000|NOT COMPLETED|Overall Study||50
3358890|NCT04401293|4089361|FG000|STARTED|Overall Study||130
3358891|NCT04401293|4089362|FG001|STARTED|Overall Study||127
3358892|NCT04401293|4089361|FG000|COMPLETED|Overall Study||129
3358893|NCT04401293|4089362|FG001|COMPLETED|Overall Study||124
3358894|NCT04401293|4089361|FG000|NOT COMPLETED|Overall Study||1
3358895|NCT04401293|4089362|FG001|NOT COMPLETED|Overall Study||3
3358896|NCT04411628|4089372|FG000|STARTED|Overall Study||7
3358897|NCT04411628|4089373|FG001|STARTED|Overall Study||6
3358898|NCT04411628|4089374|FG002|STARTED|Overall Study||7
3358899|NCT04411628|4089375|FG003|STARTED|Overall Study||6
3358900|NCT04411628|4089372|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6
3358901|NCT04411628|4089373|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6
3358902|NCT04411628|4089374|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
3358903|NCT04411628|4089375|FG003|Received at Least 1 Dose of Study Drug|Overall Study||6
3358904|NCT04411628|4089372|FG000|COMPLETED|Overall Study||6
3358905|NCT04411628|4089373|FG001|COMPLETED|Overall Study||4
3358906|NCT04411628|4089374|FG002|COMPLETED|Overall Study||5
3358907|NCT04411628|4089375|FG003|COMPLETED|Overall Study||6
3358908|NCT04411628|4089372|FG000|NOT COMPLETED|Overall Study||1
3358909|NCT04411628|4089373|FG001|NOT COMPLETED|Overall Study||2
3358910|NCT04411628|4089374|FG002|NOT COMPLETED|Overall Study||2
3358911|NCT04411628|4089375|FG003|NOT COMPLETED|Overall Study||0
3358912|NCT04418947|4089393|FG000|STARTED|Overall Study||1108
3358913|NCT04418947|4089394|FG001|STARTED|Overall Study||1351
3358914|NCT04418947|4089395|FG002|STARTED|Overall Study||1351
3358915|NCT04418947|4089396|FG003|STARTED|Overall Study||3655
3358916|NCT04418947|4089397|FG004|STARTED|Overall Study||3655
3358917|NCT04418947|4089393|FG000|COMPLETED|Overall Study||1108
3358918|NCT04418947|4089394|FG001|COMPLETED|Overall Study||1351
3358919|NCT04418947|4089395|FG002|COMPLETED|Overall Study||1351
3358920|NCT04418947|4089396|FG003|COMPLETED|Overall Study||3655
3358921|NCT04418947|4089397|FG004|COMPLETED|Overall Study||3655
3358922|NCT04418947|4089393|FG000|NOT COMPLETED|Overall Study||0
3358923|NCT04418947|4089394|FG001|NOT COMPLETED|Overall Study||0
3358924|NCT04418947|4089395|FG002|NOT COMPLETED|Overall Study||0
3358925|NCT04418947|4089396|FG003|NOT COMPLETED|Overall Study||0
3358926|NCT04418947|4089397|FG004|NOT COMPLETED|Overall Study||0
3358927|NCT04420273|4089411|FG000|STARTED|Overall Study||501
3358928|NCT04420273|4089412|FG001|STARTED|Overall Study||499
3358929|NCT04420273|4089411|FG000|COMPLETED|Overall Study||390
3358930|NCT04420273|4089412|FG001|COMPLETED|Overall Study||414
3358931|NCT04420273|4089411|FG000|NOT COMPLETED|Overall Study||111
3358932|NCT04420273|4089412|FG001|NOT COMPLETED|Overall Study||85
3358933|NCT04420572|4089420|FG000|STARTED|Overall Study||33
3358934|NCT04420572|4089421|FG001|STARTED|Overall Study||30
3358935|NCT04420572|4089420|FG000|COMPLETED|Overall Study||33
3358936|NCT04420572|4089421|FG001|COMPLETED|Overall Study||30
3358937|NCT04420572|4089420|FG000|NOT COMPLETED|Overall Study||0
3358938|NCT04420572|4089421|FG001|NOT COMPLETED|Overall Study||0
3358939|NCT04428411|4089427|FG000|STARTED|Overall Study||486
3358940|NCT04428411|4089427|FG000|Participants With Difficult to Treat Sites|Overall Study||397
3358941|NCT04428411|4089427|FG000|Participants Without Difficulty to Treat Sites|Overall Study||89
3358942|NCT04428411|4089427|FG000|Participants Adherent to Treatment|Overall Study||417
3358943|NCT04428411|4089427|FG000|Participants Not Adherent to Treatment|Overall Study||69
3358944|NCT04428411|4089427|FG000|COMPLETED|Overall Study||372
3358945|NCT04428411|4089427|FG000|NOT COMPLETED|Overall Study||114
3358946|NCT04435184|4089436|FG000|STARTED|Overall Study||25
3358947|NCT04435184|4089437|FG001|STARTED|Overall Study||25
3358948|NCT04435184|4089436|FG000|COMPLETED|Overall Study||22
3358949|NCT04435184|4089437|FG001|COMPLETED|Overall Study||20
3358950|NCT04435184|4089436|FG000|NOT COMPLETED|Overall Study||3
3358951|NCT04435184|4089437|FG001|NOT COMPLETED|Overall Study||5
3358952|NCT04476784|4089445|FG000|STARTED|First Wear Period (30 Days ± 2 Days)||31
3358953|NCT04476784|4089446|FG001|STARTED|First Wear Period (30 Days ± 2 Days)||35
3358954|NCT04476784|4089445|FG000|COMPLETED|First Wear Period (30 Days ± 2 Days)||30
3358955|NCT04476784|4089446|FG001|COMPLETED|First Wear Period (30 Days ± 2 Days)||35
3358956|NCT04476784|4089445|FG000|NOT COMPLETED|First Wear Period (30 Days ± 2 Days)||1
3358957|NCT04476784|4089446|FG001|NOT COMPLETED|First Wear Period (30 Days ± 2 Days)||0
3358958|NCT04476784|4089445|FG000|STARTED|Second Wear Period (30 Days ± 2 Days)||30
3358959|NCT04476784|4089446|FG001|STARTED|Second Wear Period (30 Days ± 2 Days)||35
3358960|NCT04476784|4089445|FG000|COMPLETED|Second Wear Period (30 Days ± 2 Days)||30
3358961|NCT04476784|4089446|FG001|COMPLETED|Second Wear Period (30 Days ± 2 Days)||35
3358962|NCT04476784|4089445|FG000|NOT COMPLETED|Second Wear Period (30 Days ± 2 Days)||0
3358963|NCT04476784|4089446|FG001|NOT COMPLETED|Second Wear Period (30 Days ± 2 Days)||0
3358964|NCT04484207|4089458|FG000|STARTED|Overall Study||86
3358965|NCT04484207|4089459|FG001|STARTED|Overall Study||44
3358966|NCT04484207|4089460|FG002|STARTED|Overall Study||42
3358967|NCT04484207|4089458|FG000|14-Day Follow-Up|Overall Study||69
3358968|NCT04484207|4089459|FG001|14-Day Follow-Up|Overall Study||40
3358969|NCT04484207|4089460|FG002|14-Day Follow-Up|Overall Study||33
3358970|NCT04484207|4089458|FG000|30-Day Follow-Up|Overall Study||65
3358971|NCT04484207|4089459|FG001|30-Day Follow-Up|Overall Study||34
3358972|NCT04484207|4089460|FG002|30-Day Follow-Up|Overall Study||31
3358973|NCT04484207|4089458|FG000|COMPLETED|Overall Study||65
3358974|NCT04484207|4089459|FG001|COMPLETED|Overall Study||34
3358975|NCT04484207|4089460|FG002|COMPLETED|Overall Study||31
3358976|NCT04484207|4089458|FG000|NOT COMPLETED|Overall Study||21
3358977|NCT04484207|4089459|FG001|NOT COMPLETED|Overall Study||10
3358978|NCT04484207|4089460|FG002|NOT COMPLETED|Overall Study||11
3358979|NCT04485455|4089471|FG000|STARTED|Overall Study||5
3358980|NCT04485455|4089471|FG000|COMPLETED|Overall Study||5
3358981|NCT04485455|4089471|FG000|NOT COMPLETED|Overall Study||0
3358982|NCT04492475|4089477|FG000|STARTED|Overall Study||487
3358983|NCT04492475|4089478|FG001|STARTED|Overall Study||482
3358984|NCT04492475|4089477|FG000|ITT and Modified ITT Population|Overall Study||487
3358985|NCT04492475|4089478|FG001|ITT and Modified ITT Population|Overall Study||482
3358986|NCT04492475|4089477|FG000|As Treated Population|Overall Study||477
3358987|NCT04492475|4089478|FG001|As Treated Population|Overall Study||468
3358988|NCT04492475|4089477|FG000|COMPLETED|Overall Study||473
3358989|NCT04492475|4089478|FG001|COMPLETED|Overall Study||474
3358990|NCT04492475|4089477|FG000|NOT COMPLETED|Overall Study||14
3358991|NCT04492475|4089478|FG001|NOT COMPLETED|Overall Study||8
3358992|NCT04495283|4089494|FG000|STARTED|Overall Study||35
3358993|NCT04495283|4089495|FG001|STARTED|Overall Study||35
3358994|NCT04495283|4089496|FG002|STARTED|Overall Study||17
3358995|NCT04495283|4089494|FG000|COMPLETED|Overall Study||34
3358996|NCT04495283|4089495|FG001|COMPLETED|Overall Study||34
3358997|NCT04495283|4089496|FG002|COMPLETED|Overall Study||14
3358998|NCT04495283|4089494|FG000|NOT COMPLETED|Overall Study||1
3358999|NCT04495283|4089495|FG001|NOT COMPLETED|Overall Study||1
3179249|NCT01983930|3907410|FG001|NOT COMPLETED|Overall Study||9
3179250|NCT01983969|3907420|FG000|STARTED|Overall Study||37
3179251|NCT01983969|3907421|FG001|STARTED|Overall Study||19
3179252|NCT01983969|3907422|FG002|STARTED|Overall Study||5
3179253|NCT01983969|3907420|FG000|COMPLETED|Overall Study||37
3179254|NCT01983969|3907421|FG001|COMPLETED|Overall Study||18
3179255|NCT01983969|3907422|FG002|COMPLETED|Overall Study||5
3179256|NCT01983969|3907420|FG000|NOT COMPLETED|Overall Study||0
3179257|NCT01983969|3907421|FG001|NOT COMPLETED|Overall Study||1
3179258|NCT01983969|3907422|FG002|NOT COMPLETED|Overall Study||0
3359000|NCT04495283|4089496|FG002|NOT COMPLETED|Overall Study||3
3359001|NCT04497948|4089507|FG000|STARTED|Overall Study||9
3359002|NCT04497948|4089507|FG000|COMPLETED|Overall Study||7
3359003|NCT04497948|4089507|FG000|NOT COMPLETED|Overall Study||2
3359004|NCT04501640|4089519|FG000|STARTED|Period 1 (5 Days)||6
3359005|NCT04501640|4089520|FG001|STARTED|Period 1 (5 Days)||6
3359006|NCT04501640|4089521|FG002|STARTED|Period 1 (5 Days)||6
3359007|NCT04501640|4089522|FG003|STARTED|Period 1 (5 Days)||6
3359008|NCT04501640|4089519|FG000|COMPLETED|Period 1 (5 Days)||6
3359009|NCT04501640|4089520|FG001|COMPLETED|Period 1 (5 Days)||6
3359010|NCT04501640|4089521|FG002|COMPLETED|Period 1 (5 Days)||6
3359011|NCT04501640|4089522|FG003|COMPLETED|Period 1 (5 Days)||6
3359012|NCT04501640|4089519|FG000|NOT COMPLETED|Period 1 (5 Days)||0
3359013|NCT04501640|4089520|FG001|NOT COMPLETED|Period 1 (5 Days)||0
3359014|NCT04501640|4089521|FG002|NOT COMPLETED|Period 1 (5 Days)||0
3359015|NCT04501640|4089522|FG003|NOT COMPLETED|Period 1 (5 Days)||0
3359016|NCT04501640|4089519|FG000|STARTED|Washout Period (10 Days)||6
3359017|NCT04501640|4089520|FG001|STARTED|Washout Period (10 Days)||6
3359018|NCT04501640|4089521|FG002|STARTED|Washout Period (10 Days)||6
3359019|NCT04501640|4089522|FG003|STARTED|Washout Period (10 Days)||6
3359020|NCT04501640|4089519|FG000|COMPLETED|Washout Period (10 Days)||6
3359021|NCT04501640|4089520|FG001|COMPLETED|Washout Period (10 Days)||6
3359022|NCT04501640|4089521|FG002|COMPLETED|Washout Period (10 Days)||6
3359023|NCT04501640|4089522|FG003|COMPLETED|Washout Period (10 Days)||6
3359024|NCT04501640|4089519|FG000|NOT COMPLETED|Washout Period (10 Days)||0
3359025|NCT04501640|4089520|FG001|NOT COMPLETED|Washout Period (10 Days)||0
3359026|NCT04501640|4089521|FG002|NOT COMPLETED|Washout Period (10 Days)||0
3359027|NCT04501640|4089522|FG003|NOT COMPLETED|Washout Period (10 Days)||0
3359028|NCT04501640|4089519|FG000|STARTED|Period 2 (5 Days)||6
3359029|NCT04501640|4089520|FG001|STARTED|Period 2 (5 Days)||6
3359030|NCT04501640|4089521|FG002|STARTED|Period 2 (5 Days)||6
3359031|NCT04501640|4089522|FG003|STARTED|Period 2 (5 Days)||6
3359032|NCT04501640|4089519|FG000|COMPLETED|Period 2 (5 Days)||6
3359033|NCT04501640|4089520|FG001|COMPLETED|Period 2 (5 Days)||6
3359034|NCT04501640|4089521|FG002|COMPLETED|Period 2 (5 Days)||6
3359035|NCT04501640|4089522|FG003|COMPLETED|Period 2 (5 Days)||6
3359036|NCT04501640|4089519|FG000|NOT COMPLETED|Period 2 (5 Days)||0
3359037|NCT04501640|4089520|FG001|NOT COMPLETED|Period 2 (5 Days)||0
3359038|NCT04501640|4089521|FG002|NOT COMPLETED|Period 2 (5 Days)||0
3359039|NCT04501640|4089522|FG003|NOT COMPLETED|Period 2 (5 Days)||0
3359040|NCT04501952|4089534|FG000|STARTED|Overall Study||292
3359041|NCT04501952|4089535|FG001|STARTED|Overall Study||292
3359042|NCT04501952|4089534|FG000|COMPLETED|Overall Study||266
3359043|NCT04501952|4089535|FG001|COMPLETED|Overall Study||272
3359044|NCT04501952|4089534|FG000|NOT COMPLETED|Overall Study||26
3359045|NCT04501952|4089535|FG001|NOT COMPLETED|Overall Study||20
3359046|NCT04504032|4089544|FG000|STARTED|Overall Study||246
3359047|NCT04504032|4089545|FG001|STARTED|Overall Study||251
3359048|NCT04504032|4089544|FG000|COMPLETED|Overall Study||210
3359049|NCT04504032|4089545|FG001|COMPLETED|Overall Study||223
3359050|NCT04504032|4089544|FG000|NOT COMPLETED|Overall Study||36
3359051|NCT04504032|4089545|FG001|NOT COMPLETED|Overall Study||28
3359052|NCT04507763|4089551|FG000|STARTED|Overall Study||763
3359053|NCT04507763|4089551|FG000|COMPLETED|Overall Study||562
3359054|NCT04507763|4089551|FG000|NOT COMPLETED|Overall Study||201
3359055|NCT04507867|4089560|FG000|STARTED|Overall Study||40
3359056|NCT04507867|4089561|FG001|STARTED|Overall Study||40
3359057|NCT04507867|4089560|FG000|COMPLETED|Overall Study||33
3359058|NCT04507867|4089561|FG001|COMPLETED|Overall Study||39
3359059|NCT04507867|4089560|FG000|NOT COMPLETED|Overall Study||7
3359060|NCT04507867|4089561|FG001|NOT COMPLETED|Overall Study||1
3359061|NCT04525079|4089588|FG000|STARTED|Overall Study||6
3359062|NCT04525079|4089589|FG001|STARTED|Overall Study||6
3359063|NCT04525079|4089590|FG002|STARTED|Overall Study||6
3359064|NCT04525079|4089591|FG003|STARTED|Overall Study||6
3359065|NCT04525079|4089592|FG004|STARTED|Overall Study||8
3359066|NCT04525079|4089588|FG000|COMPLETED|Overall Study||6
3359067|NCT04525079|4089589|FG001|COMPLETED|Overall Study||6
3359068|NCT04525079|4089590|FG002|COMPLETED|Overall Study||6
3359069|NCT04525079|4089591|FG003|COMPLETED|Overall Study||6
3359070|NCT04525079|4089592|FG004|COMPLETED|Overall Study||8
3359071|NCT04525079|4089588|FG000|NOT COMPLETED|Overall Study||0
3359072|NCT04525079|4089589|FG001|NOT COMPLETED|Overall Study||0
3359073|NCT04525079|4089590|FG002|NOT COMPLETED|Overall Study||0
3359074|NCT04525079|4089591|FG003|NOT COMPLETED|Overall Study||0
3359075|NCT04525079|4089592|FG004|NOT COMPLETED|Overall Study||0
3359076|NCT04527978|4089606|FG000|STARTED|First Wear Period (8 -0/+3 Days)||27
3359077|NCT04527978|4089607|FG001|STARTED|First Wear Period (8 -0/+3 Days)||28
3359078|NCT04527978|4089606|FG000|COMPLETED|First Wear Period (8 -0/+3 Days)||26
3359079|NCT04527978|4089607|FG001|COMPLETED|First Wear Period (8 -0/+3 Days)||28
3359080|NCT04527978|4089606|FG000|NOT COMPLETED|First Wear Period (8 -0/+3 Days)||1
3359081|NCT04527978|4089607|FG001|NOT COMPLETED|First Wear Period (8 -0/+3 Days)||0
3359082|NCT04527978|4089606|FG000|STARTED|Second Wear Period (8 -0/+3 Days)||26
3359083|NCT04527978|4089607|FG001|STARTED|Second Wear Period (8 -0/+3 Days)||28
3359084|NCT04527978|4089606|FG000|COMPLETED|Second Wear Period (8 -0/+3 Days)||26
3359085|NCT04527978|4089607|FG001|COMPLETED|Second Wear Period (8 -0/+3 Days)||28
3359086|NCT04527978|4089606|FG000|NOT COMPLETED|Second Wear Period (8 -0/+3 Days)||0
3359087|NCT04527978|4089607|FG001|NOT COMPLETED|Second Wear Period (8 -0/+3 Days)||0
3359088|NCT04528017|4089618|FG000|STARTED|First Wear Period (8 -0/+3 Days)||27
3359089|NCT04528017|4089619|FG001|STARTED|First Wear Period (8 -0/+3 Days)||28
3359090|NCT04528017|4089618|FG000|COMPLETED|First Wear Period (8 -0/+3 Days)||27
3359091|NCT04528017|4089619|FG001|COMPLETED|First Wear Period (8 -0/+3 Days)||28
3359092|NCT04528017|4089618|FG000|NOT COMPLETED|First Wear Period (8 -0/+3 Days)||0
3359093|NCT04528017|4089619|FG001|NOT COMPLETED|First Wear Period (8 -0/+3 Days)||0
3359094|NCT04528017|4089618|FG000|STARTED|Second Wear Period (8 -0/+3 Days)||27
3359095|NCT04528017|4089619|FG001|STARTED|Second Wear Period (8 -0/+3 Days)||28
3359096|NCT04528017|4089618|FG000|COMPLETED|Second Wear Period (8 -0/+3 Days)||27
3359097|NCT04528017|4089619|FG001|COMPLETED|Second Wear Period (8 -0/+3 Days)||28
3359098|NCT04528017|4089618|FG000|NOT COMPLETED|Second Wear Period (8 -0/+3 Days)||0
3359099|NCT04528017|4089619|FG001|NOT COMPLETED|Second Wear Period (8 -0/+3 Days)||0
3359100|NCT04529109|4089628|FG000|STARTED|Period 1||27
3359101|NCT04529109|4089629|FG001|STARTED|Period 1||29
3359102|NCT04529109|4089628|FG000|COMPLETED|Period 1||27
3359103|NCT04529109|4089629|FG001|COMPLETED|Period 1||28
3359104|NCT04529109|4089628|FG000|NOT COMPLETED|Period 1||0
3359105|NCT04529109|4089629|FG001|NOT COMPLETED|Period 1||1
3359106|NCT04529109|4089628|FG000|STARTED|Period 2||27
3359107|NCT04529109|4089629|FG001|STARTED|Period 2||28
3359108|NCT04529109|4089628|FG000|COMPLETED|Period 2||27
3359109|NCT04529109|4089629|FG001|COMPLETED|Period 2||28
3359110|NCT04529109|4089628|FG000|NOT COMPLETED|Period 2||0
3359111|NCT04529109|4089629|FG001|NOT COMPLETED|Period 2||0
3359112|NCT04536571|4089635|FG000|STARTED|First Intervention||11
3359113|NCT04536571|4089636|FG001|STARTED|First Intervention||16
3359114|NCT04536571|4089635|FG000|COMPLETED|First Intervention||11
3359115|NCT04536571|4089636|FG001|COMPLETED|First Intervention||16
3359116|NCT04536571|4089635|FG000|NOT COMPLETED|First Intervention||0
3359117|NCT04536571|4089636|FG001|NOT COMPLETED|First Intervention||0
3359118|NCT04536571|4089635|FG000|STARTED|Second Intervention||11
3359119|NCT04536571|4089636|FG001|STARTED|Second Intervention||16
3359120|NCT04536571|4089635|FG000|COMPLETED|Second Intervention||11
3359121|NCT04536571|4089636|FG001|COMPLETED|Second Intervention||16
3359122|NCT04536571|4089635|FG000|NOT COMPLETED|Second Intervention||0
3359123|NCT04536571|4089636|FG001|NOT COMPLETED|Second Intervention||0
3359124|NCT04537234|4089648|FG000|STARTED|Overall Study||82
3359125|NCT04537234|4089649|FG001|STARTED|Overall Study||83
3359126|NCT04537234|4089648|FG000|COMPLETED|Overall Study||80
3359127|NCT04537234|4089649|FG001|COMPLETED|Overall Study||83
3359128|NCT04537234|4089648|FG000|NOT COMPLETED|Overall Study||2
3359129|NCT04537234|4089649|FG001|NOT COMPLETED|Overall Study||0
3359130|NCT04544787|4089662|FG000|STARTED|Overall Study||50
3359131|NCT04544787|4089663|FG001|STARTED|Overall Study||50
3359132|NCT04544787|4089664|FG002|STARTED|Overall Study||50
3359133|NCT04544787|4089665|FG003|STARTED|Overall Study||50
3359134|NCT04544787|4089666|FG004|STARTED|Overall Study||17
3359135|NCT04544787|4089667|FG005|STARTED|Overall Study||16
3359136|NCT04544787|4089668|FG006|STARTED|Overall Study||17
3359137|NCT04544787|4089662|FG000|Received First Dose of Vaccine|Overall Study||50
3359138|NCT04544787|4089663|FG001|Received First Dose of Vaccine|Overall Study||50
3359139|NCT04544787|4089664|FG002|Received First Dose of Vaccine|Overall Study||50
3359140|NCT04544787|4089665|FG003|Received First Dose of Vaccine|Overall Study||50
3359141|NCT04544787|4089666|FG004|Received First Dose of Vaccine|Overall Study||17
3359142|NCT04544787|4089667|FG005|Received First Dose of Vaccine|Overall Study||16
2928154|NCT00576472|3639114|FG011|NOT COMPLETED|MPH In-Lab Phase||0
2928155|NCT00576472|3639115|FG012|NOT COMPLETED|MPH In-Lab Phase||0
2928156|NCT00576472|3639116|FG013|NOT COMPLETED|MPH In-Lab Phase||0
2928157|NCT00576472|3639117|FG014|NOT COMPLETED|MPH In-Lab Phase||0
2928158|NCT00576472|3639103|FG000|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
2928159|NCT00576472|3639104|FG001|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
2928160|NCT00576472|3639105|FG002|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
3179259|NCT01984164|3907436|FG000|STARTED|Overall Study||87
3179260|NCT01984164|3907437|FG001|STARTED|Overall Study||89
3179261|NCT01984164|3907436|FG000|COMPLETED|Overall Study||77
2928161|NCT00576472|3639106|FG003|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
2928162|NCT00576472|3639107|FG004|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
3359143|NCT04544787|4089668|FG006|Received First Dose of Vaccine|Overall Study||17
3359144|NCT04544787|4089662|FG000|Received Second Dose of Vaccine|Overall Study||0
3359145|NCT04544787|4089663|FG001|Received Second Dose of Vaccine|Overall Study||49
3359146|NCT04544787|4089664|FG002|Received Second Dose of Vaccine|Overall Study||0
3359147|NCT04544787|4089665|FG003|Received Second Dose of Vaccine|Overall Study||49
3359148|NCT04544787|4089666|FG004|Received Second Dose of Vaccine|Overall Study||17
3359149|NCT04544787|4089667|FG005|Received Second Dose of Vaccine|Overall Study||15
3359150|NCT04544787|4089668|FG006|Received Second Dose of Vaccine|Overall Study||16
3359151|NCT04544787|4089662|FG000|COMPLETED|Overall Study||50
3359152|NCT04544787|4089663|FG001|COMPLETED|Overall Study||50
3359153|NCT04544787|4089664|FG002|COMPLETED|Overall Study||50
3359154|NCT04544787|4089665|FG003|COMPLETED|Overall Study||50
3359155|NCT04544787|4089666|FG004|COMPLETED|Overall Study||17
3359156|NCT04544787|4089667|FG005|COMPLETED|Overall Study||16
3359157|NCT04544787|4089668|FG006|COMPLETED|Overall Study||17
3359158|NCT04544787|4089662|FG000|NOT COMPLETED|Overall Study||0
3359159|NCT04544787|4089663|FG001|NOT COMPLETED|Overall Study||0
3359160|NCT04544787|4089664|FG002|NOT COMPLETED|Overall Study||0
3359161|NCT04544787|4089665|FG003|NOT COMPLETED|Overall Study||0
3359162|NCT04544787|4089666|FG004|NOT COMPLETED|Overall Study||0
3359163|NCT04544787|4089667|FG005|NOT COMPLETED|Overall Study||0
3359164|NCT04544787|4089668|FG006|NOT COMPLETED|Overall Study||0
3359165|NCT04555031|4089707|FG000|STARTED|Overall Study||10
3359166|NCT04555031|4089707|FG000|COMPLETED|Overall Study||10
3359167|NCT04555031|4089707|FG000|NOT COMPLETED|Overall Study||0
3359168|NCT04559282|4089714|FG000|STARTED|Intervention 1 (Day 0)||8
3359169|NCT04559282|4089715|FG001|STARTED|Intervention 1 (Day 0)||8
3359170|NCT04559282|4089714|FG000|COMPLETED|Intervention 1 (Day 0)||8
3359171|NCT04559282|4089715|FG001|COMPLETED|Intervention 1 (Day 0)||8
3359172|NCT04559282|4089714|FG000|NOT COMPLETED|Intervention 1 (Day 0)||0
3359173|NCT04559282|4089715|FG001|NOT COMPLETED|Intervention 1 (Day 0)||0
3359174|NCT04559282|4089714|FG000|STARTED|Intervention 2 (Day 7)||8
3359175|NCT04559282|4089715|FG001|STARTED|Intervention 2 (Day 7)||8
3359176|NCT04559282|4089714|FG000|COMPLETED|Intervention 2 (Day 7)||8
3359177|NCT04559282|4089715|FG001|COMPLETED|Intervention 2 (Day 7)||8
3359178|NCT04559282|4089714|FG000|NOT COMPLETED|Intervention 2 (Day 7)||0
3359179|NCT04559282|4089715|FG001|NOT COMPLETED|Intervention 2 (Day 7)||0
3359180|NCT04559282|4089714|FG000|STARTED|Intervention 3 (Day 14)||8
3359181|NCT04559282|4089715|FG001|STARTED|Intervention 3 (Day 14)||8
3359182|NCT04559282|4089714|FG000|COMPLETED|Intervention 3 (Day 14)||8
3359183|NCT04559282|4089715|FG001|COMPLETED|Intervention 3 (Day 14)||8
3359184|NCT04559282|4089714|FG000|NOT COMPLETED|Intervention 3 (Day 14)||0
3359185|NCT04559282|4089715|FG001|NOT COMPLETED|Intervention 3 (Day 14)||0
3359186|NCT04573972|4089726|FG000|STARTED|Overall Study||88
3359187|NCT04573972|4089727|FG001|STARTED|Overall Study||84
3359188|NCT04573972|4089726|FG000|COMPLETED|Overall Study||56
3359189|NCT04573972|4089727|FG001|COMPLETED|Overall Study||70
3359190|NCT04573972|4089726|FG000|NOT COMPLETED|Overall Study||32
3359191|NCT04573972|4089727|FG001|NOT COMPLETED|Overall Study||14
3359192|NCT04574297|4089737|FG000|STARTED|Overall Study||180
3359193|NCT04574297|4089738|FG001|STARTED|Overall Study||263
3359194|NCT04574297|4089739|FG002|STARTED|Overall Study||230
3359195|NCT04574297|4089740|FG003|STARTED|Overall Study||125
3359196|NCT04574297|4089737|FG000|COMPLETED|Overall Study||180
3359197|NCT04574297|4089738|FG001|COMPLETED|Overall Study||263
3359198|NCT04574297|4089739|FG002|COMPLETED|Overall Study||230
3359199|NCT04574297|4089740|FG003|COMPLETED|Overall Study||125
3359200|NCT04574297|4089737|FG000|NOT COMPLETED|Overall Study||0
3359201|NCT04574297|4089738|FG001|NOT COMPLETED|Overall Study||0
3359202|NCT04574297|4089739|FG002|NOT COMPLETED|Overall Study||0
3359203|NCT04574297|4089740|FG003|NOT COMPLETED|Overall Study||0
3359204|NCT04580290|4089752|FG000|STARTED|Overall Study||88
3359205|NCT04580290|4089753|FG001|STARTED|Overall Study||32
3359206|NCT04580290|4089752|FG000|COMPLETED|Overall Study||88
3359207|NCT04580290|4089753|FG001|COMPLETED|Overall Study||32
3359208|NCT04580290|4089752|FG000|NOT COMPLETED|Overall Study||0
3359209|NCT04580290|4089753|FG001|NOT COMPLETED|Overall Study||0
3359210|NCT04601103|4089762|FG000|STARTED|Overall Study||18
3359211|NCT04601103|4089763|FG001|STARTED|Overall Study||18
3359212|NCT04601103|4089764|FG002|STARTED|Overall Study||17
3359213|NCT04601103|4089762|FG000|COMPLETED|Overall Study||0
3359214|NCT04601103|4089763|FG001|COMPLETED|Overall Study||0
3359215|NCT04601103|4089764|FG002|COMPLETED|Overall Study||0
3359216|NCT04601103|4089762|FG000|NOT COMPLETED|Overall Study||18
3359217|NCT04601103|4089763|FG001|NOT COMPLETED|Overall Study||18
3359218|NCT04601103|4089764|FG002|NOT COMPLETED|Overall Study||17
3359219|NCT04617574|4089774|FG000|STARTED|Overall Study||30
3359220|NCT04617574|4089775|FG001|STARTED|Overall Study||30
3359221|NCT04617574|4089774|FG000|COMPLETED|Overall Study||30
3359222|NCT04617574|4089775|FG001|COMPLETED|Overall Study||30
3359223|NCT04617574|4089774|FG000|NOT COMPLETED|Overall Study||0
3359224|NCT04617574|4089775|FG001|NOT COMPLETED|Overall Study||0
3359225|NCT04658797|4089783|FG000|STARTED|Overall Study||15
3359226|NCT04658797|4089784|FG001|STARTED|Overall Study||15
3359227|NCT04658797|4089783|FG000|COMPLETED|Overall Study||15
3359228|NCT04658797|4089784|FG001|COMPLETED|Overall Study||15
3359229|NCT04658797|4089783|FG000|NOT COMPLETED|Overall Study||0
3359230|NCT04658797|4089784|FG001|NOT COMPLETED|Overall Study||0
3359231|NCT04664855|4089792|FG000|STARTED|Overall Study||23
3359232|NCT04664855|4089793|FG001|STARTED|Overall Study||24
3359233|NCT04664855|4089792|FG000|COMPLETED|Overall Study||23
3359234|NCT04664855|4089793|FG001|COMPLETED|Overall Study||22
3359235|NCT04664855|4089792|FG000|NOT COMPLETED|Overall Study||0
3359236|NCT04664855|4089793|FG001|NOT COMPLETED|Overall Study||2
3359237|NCT04701658|4089799|FG000|STARTED|Overall Study||109
3359238|NCT04701658|4089799|FG000|Received Single Dose of Bamlanivimab|Overall Study||109
3359239|NCT04701658|4089799|FG000|COMPLETED|Overall Study||103
3359240|NCT04701658|4089799|FG000|NOT COMPLETED|Overall Study||6
3359241|NCT04706416|4089805|FG000|STARTED|Overall Study||50
3359242|NCT04706416|4089806|FG001|STARTED|Overall Study||100
3359243|NCT04706416|4089805|FG000|COMPLETED|Overall Study||48
3359244|NCT04706416|4089806|FG001|COMPLETED|Overall Study||100
3359245|NCT04706416|4089805|FG000|NOT COMPLETED|Overall Study||2
3359246|NCT04706416|4089806|FG001|NOT COMPLETED|Overall Study||0
3359247|NCT04709484|4089817|FG000|STARTED|Overall Study||34
3359248|NCT04709484|4089818|FG001|STARTED|Overall Study||32
3359249|NCT04709484|4089817|FG000|COMPLETED|Overall Study||34
3359250|NCT04709484|4089818|FG001|COMPLETED|Overall Study||32
3359251|NCT04709484|4089817|FG000|NOT COMPLETED|Overall Study||0
3359252|NCT04709484|4089818|FG001|NOT COMPLETED|Overall Study||0
3359253|NCT04717323|4089826|FG000|STARTED|Overall Study||0
3359254|NCT04717323|4089827|FG001|STARTED|Overall Study||10
3359255|NCT04717323|4089826|FG000|COMPLETED|Overall Study||0
3359256|NCT04717323|4089827|FG001|COMPLETED|Overall Study||10
3359257|NCT04717323|4089826|FG000|NOT COMPLETED|Overall Study||0
3359258|NCT04717323|4089827|FG001|NOT COMPLETED|Overall Study||0
3039990|NCT01161498|3759445|FG001|COMPLETED|Overall Study||1
3359259|NCT04727749|4089835|FG000|STARTED|Overall Study||107
3359260|NCT04727749|4089836|FG001|STARTED|Overall Study||104
3359261|NCT04727749|4089835|FG000|COMPLETED|Overall Study||97
3359262|NCT04727749|4089836|FG001|COMPLETED|Overall Study||101
3359263|NCT04727749|4089835|FG000|NOT COMPLETED|Overall Study||10
3359264|NCT04727749|4089836|FG001|NOT COMPLETED|Overall Study||3
3179262|NCT01984164|3907437|FG001|COMPLETED|Overall Study||64
3179263|NCT01984164|3907436|FG000|NOT COMPLETED|Overall Study||10
3179264|NCT01984164|3907437|FG001|NOT COMPLETED|Overall Study||25
3179265|NCT01984229|3907445|FG000|STARTED|Period 1||6
3179266|NCT01984229|3907446|FG001|STARTED|Period 1||17
3179267|NCT01984229|3907445|FG000|COMPLETED|Period 1||6
3179268|NCT01984229|3907446|FG001|COMPLETED|Period 1||17
3179269|NCT01984229|3907445|FG000|NOT COMPLETED|Period 1||0
3359265|NCT04777214|4089846|FG000|STARTED|Initial Randomization||5
3359266|NCT04777214|4089847|FG001|STARTED|Initial Randomization||5
3359267|NCT04777214|4089846|FG000|COMPLETED|Initial Randomization||5
3359268|NCT04777214|4089847|FG001|COMPLETED|Initial Randomization||5
3359269|NCT04777214|4089846|FG000|NOT COMPLETED|Initial Randomization||0
3359270|NCT04777214|4089847|FG001|NOT COMPLETED|Initial Randomization||0
3359271|NCT04777214|4089846|FG000|STARTED|Sham Crossover to Active TMS Arm||0
3359272|NCT04777214|4089847|FG001|STARTED|Sham Crossover to Active TMS Arm||5
3359273|NCT04777214|4089846|FG000|COMPLETED|Sham Crossover to Active TMS Arm||0
3359274|NCT04777214|4089847|FG001|COMPLETED|Sham Crossover to Active TMS Arm||5
3359275|NCT04777214|4089846|FG000|NOT COMPLETED|Sham Crossover to Active TMS Arm||0
3359276|NCT04777214|4089847|FG001|NOT COMPLETED|Sham Crossover to Active TMS Arm||0
3359277|NCT04854707|4089858|FG000|STARTED|Overall Study||2625
3359278|NCT04854707|4089859|FG001|STARTED|Overall Study||2183
3359279|NCT04854707|4089860|FG002|STARTED|Overall Study||676
3359280|NCT04854707|4089858|FG000|COMPLETED|Overall Study||2547
3359281|NCT04854707|4089859|FG001|COMPLETED|Overall Study||2124
3359282|NCT04854707|4089860|FG002|COMPLETED|Overall Study||646
3359283|NCT04854707|4089858|FG000|NOT COMPLETED|Overall Study||78
3359284|NCT04854707|4089859|FG001|NOT COMPLETED|Overall Study||59
3359285|NCT04854707|4089860|FG002|NOT COMPLETED|Overall Study||30
3359286|NCT04898166|4089874|FG000|STARTED|Overall Study||220
3359287|NCT04898166|4089875|FG001|STARTED|Overall Study||80
3359288|NCT04898166|4089874|FG000|COMPLETED|Overall Study||220
3359289|NCT04898166|4089875|FG001|COMPLETED|Overall Study||80
3359290|NCT04898166|4089874|FG000|NOT COMPLETED|Overall Study||0
3359291|NCT04898166|4089875|FG001|NOT COMPLETED|Overall Study||0
3359292|NCT04926233|4089895|FG000|STARTED|Overall Study||1280486
3359293|NCT04926233|4089896|FG001|STARTED|Overall Study||90660
3359294|NCT04926233|4089895|FG000|COMPLETED|Overall Study||1280486
3359295|NCT04926233|4089896|FG001|COMPLETED|Overall Study||90660
3359296|NCT04926233|4089895|FG000|NOT COMPLETED|Overall Study||0
3359297|NCT04926233|4089896|FG001|NOT COMPLETED|Overall Study||0
3359298|NCT04943159|4089948|FG000|STARTED|Overall Study||3
3359299|NCT04943159|4089948|FG000|COMPLETED|Overall Study||3
3359300|NCT04943159|4089948|FG000|NOT COMPLETED|Overall Study||0
3359301|NCT04947436|4089955|FG000|STARTED|Overall Study||7
3359302|NCT04947436|4089956|FG001|STARTED|Overall Study||10
3359303|NCT04947436|4089957|FG002|STARTED|Overall Study||11
3039991|NCT01161498|3759444|FG000|NOT COMPLETED|Overall Study||0
3039992|NCT01161498|3759445|FG001|NOT COMPLETED|Overall Study||1
3039993|NCT01161524|3759453|FG000|STARTED|Core Study (23 Weeks)||85
3039994|NCT01161524|3759454|FG001|STARTED|Core Study (23 Weeks)||48
3039995|NCT01161524|3759455|FG002|STARTED|Core Study (23 Weeks)||0
3039996|NCT01161524|3759453|FG000|COMPLETED|Core Study (23 Weeks)||76
3359304|NCT04947436|4089955|FG000|COMPLETED|Overall Study||3
3359305|NCT04947436|4089956|FG001|COMPLETED|Overall Study||2
3359306|NCT04947436|4089957|FG002|COMPLETED|Overall Study||5
3359307|NCT04947436|4089955|FG000|NOT COMPLETED|Overall Study||4
3359308|NCT04947436|4089956|FG001|NOT COMPLETED|Overall Study||8
3359309|NCT04947436|4089957|FG002|NOT COMPLETED|Overall Study||6
3359310|NCT05002972|4089965|FG000|STARTED|Overall Study||63
3359311|NCT05002972|4089965|FG000|COMPLETED|Overall Study||61
3359312|NCT05002972|4089965|FG000|NOT COMPLETED|Overall Study||2
3359313|NCT05002985|4089969|FG000|STARTED|Overall Study||49
3179270|NCT01984229|3907446|FG001|NOT COMPLETED|Period 1||0
3359314|NCT05002985|4089969|FG000|COMPLETED|Overall Study||48
3359315|NCT05002985|4089969|FG000|NOT COMPLETED|Overall Study||1
3359316|NCT04512482|4089975|FG000|STARTED|First Intervention (1 Day)||24
3359317|NCT04512482|4089976|FG001|STARTED|First Intervention (1 Day)||21
3359318|NCT04512482|4089975|FG000|Baseline Plaque Assessment|First Intervention (1 Day)||24
3359319|NCT04512482|4089976|FG001|Baseline Plaque Assessment|First Intervention (1 Day)||21
3359320|NCT04512482|4089975|FG000|Baseline Photographs|First Intervention (1 Day)||24
3359321|NCT04512482|4089976|FG001|Baseline Photographs|First Intervention (1 Day)||21
3359322|NCT04512482|4089975|FG000|Received Rinse Intervention|First Intervention (1 Day)||24
3359323|NCT04512482|4089976|FG001|Received Rinse Intervention|First Intervention (1 Day)||21
3359324|NCT04512482|4089975|FG000|Post-rinse Photographs|First Intervention (1 Day)||24
3359325|NCT04512482|4089976|FG001|Post-rinse Photographs|First Intervention (1 Day)||21
3359326|NCT04512482|4089975|FG000|Toothbrush Utilization|First Intervention (1 Day)||24
3359327|NCT04512482|4089976|FG001|Toothbrush Utilization|First Intervention (1 Day)||21
3359328|NCT04512482|4089975|FG000|Post-toothbrush Photographs|First Intervention (1 Day)||24
3359329|NCT04512482|4089976|FG001|Post-toothbrush Photographs|First Intervention (1 Day)||21
3359330|NCT04512482|4089975|FG000|Waterpik Utilization|First Intervention (1 Day)||24
3359331|NCT04512482|4089976|FG001|Waterpik Utilization|First Intervention (1 Day)||21
3359332|NCT04512482|4089975|FG000|Post-Waterpik Photographs|First Intervention (1 Day)||24
3359333|NCT04512482|4089976|FG001|Post-Waterpik Photographs|First Intervention (1 Day)||21
3359334|NCT04512482|4089975|FG000|COMPLETED|First Intervention (1 Day)||24
3359335|NCT04512482|4089976|FG001|COMPLETED|First Intervention (1 Day)||21
3359336|NCT04512482|4089975|FG000|NOT COMPLETED|First Intervention (1 Day)||0
3359337|NCT04512482|4089976|FG001|NOT COMPLETED|First Intervention (1 Day)||0
3359338|NCT04512482|4089975|FG000|STARTED|Washout (1 Week)||24
3359339|NCT04512482|4089976|FG001|STARTED|Washout (1 Week)||21
3359340|NCT04512482|4089975|FG000|COMPLETED|Washout (1 Week)||24
3359341|NCT04512482|4089976|FG001|COMPLETED|Washout (1 Week)||21
3359342|NCT04512482|4089975|FG000|NOT COMPLETED|Washout (1 Week)||0
3359343|NCT04512482|4089976|FG001|NOT COMPLETED|Washout (1 Week)||0
3359344|NCT04512482|4089975|FG000|STARTED|Second Intervention (1 Day)||24
3359345|NCT04512482|4089976|FG001|STARTED|Second Intervention (1 Day)||21
3359346|NCT04512482|4089975|FG000|Baseline Plaque Assessment|Second Intervention (1 Day)||22
3359347|NCT04512482|4089976|FG001|Baseline Plaque Assessment|Second Intervention (1 Day)||20
3359348|NCT04512482|4089975|FG000|Baseline Photographs|Second Intervention (1 Day)||22
3359349|NCT04512482|4089976|FG001|Baseline Photographs|Second Intervention (1 Day)||20
3359350|NCT04512482|4089975|FG000|Received Intervention|Second Intervention (1 Day)||22
3359351|NCT04512482|4089976|FG001|Received Intervention|Second Intervention (1 Day)||20
3359352|NCT04512482|4089975|FG000|Post-rinse Photographs|Second Intervention (1 Day)||22
3359353|NCT04512482|4089976|FG001|Post-rinse Photographs|Second Intervention (1 Day)||20
3359354|NCT04512482|4089975|FG000|Toothbrush Utilization|Second Intervention (1 Day)||22
3359355|NCT04512482|4089976|FG001|Toothbrush Utilization|Second Intervention (1 Day)||20
3359356|NCT04512482|4089975|FG000|Post-toothbrush Photographs|Second Intervention (1 Day)||22
3359357|NCT04512482|4089976|FG001|Post-toothbrush Photographs|Second Intervention (1 Day)||20
3359358|NCT04512482|4089975|FG000|Waterpik Utilization|Second Intervention (1 Day)||22
3359359|NCT04512482|4089976|FG001|Waterpik Utilization|Second Intervention (1 Day)||20
3359360|NCT04512482|4089975|FG000|Post-Waterpik Photographs|Second Intervention (1 Day)||22
3359361|NCT04512482|4089976|FG001|Post-Waterpik Photographs|Second Intervention (1 Day)||20
3359362|NCT04512482|4089975|FG000|COMPLETED|Second Intervention (1 Day)||22
3359363|NCT04512482|4089976|FG001|COMPLETED|Second Intervention (1 Day)||20
3359364|NCT04512482|4089975|FG000|NOT COMPLETED|Second Intervention (1 Day)||2
3359365|NCT04512482|4089976|FG001|NOT COMPLETED|Second Intervention (1 Day)||1
3359366|NCT04499599|4089985|FG000|STARTED|Overall Study||35
3179271|NCT01984229|3907445|FG000|STARTED|Period 2||6
3179272|NCT01984229|3907446|FG001|STARTED|Period 2||17
3179273|NCT01984229|3907445|FG000|COMPLETED|Period 2||6
3179274|NCT01984229|3907446|FG001|COMPLETED|Period 2||17
3179275|NCT01984229|3907445|FG000|NOT COMPLETED|Period 2||0
3179276|NCT01984229|3907446|FG001|NOT COMPLETED|Period 2||0
3359367|NCT04499599|4089986|FG001|STARTED|Overall Study||35
3359368|NCT04499599|4089987|FG002|STARTED|Overall Study||35
3359369|NCT04499599|4089985|FG000|COMPLETED|Overall Study||35
3359370|NCT04499599|4089986|FG001|COMPLETED|Overall Study||35
3359371|NCT04499599|4089987|FG002|COMPLETED|Overall Study||35
3359372|NCT04499599|4089985|FG000|NOT COMPLETED|Overall Study||0
3359373|NCT04499599|4089986|FG001|NOT COMPLETED|Overall Study||0
3359374|NCT04499599|4089987|FG002|NOT COMPLETED|Overall Study||0
3359375|NCT04525157|4089995|FG000|STARTED|Overall Study||18
3359376|NCT04525157|4089995|FG000|COMPLETED|Overall Study||15
3359377|NCT04525157|4089995|FG000|NOT COMPLETED|Overall Study||3
3359378|NCT04523831|4090001|FG000|STARTED|Overall Study||200
3359379|NCT04523831|4090002|FG001|STARTED|Overall Study||200
3359380|NCT04523831|4090001|FG000|COMPLETED|Overall Study||183
3359381|NCT04523831|4090002|FG001|COMPLETED|Overall Study||180
3359382|NCT04523831|4090001|FG000|NOT COMPLETED|Overall Study||17
3359383|NCT04523831|4090002|FG001|NOT COMPLETED|Overall Study||20
3359384|NCT04521777|4090011|FG000|STARTED|Overall Study||24
3359385|NCT04521777|4090011|FG000|COMPLETED|Overall Study||20
3359386|NCT04521777|4090011|FG000|NOT COMPLETED|Overall Study||4
3359387|NCT04512703|4090017|FG000|STARTED|Within 7 Days From Start of Device Wear||6
3359388|NCT04512703|4090018|FG001|STARTED|Within 7 Days From Start of Device Wear||45
3359389|NCT04512703|4090017|FG000|Wore Front Position|Within 7 Days From Start of Device Wear||6
3359390|NCT04512703|4090018|FG001|Wore Front Position|Within 7 Days From Start of Device Wear||45
3359391|NCT04512703|4090017|FG000|Wore Side Position|Within 7 Days From Start of Device Wear||6
3359392|NCT04512703|4090018|FG001|Wore Side Position|Within 7 Days From Start of Device Wear||45
3359393|NCT04512703|4090017|FG000|COMPLETED|Within 7 Days From Start of Device Wear||6
3359394|NCT04512703|4090018|FG001|COMPLETED|Within 7 Days From Start of Device Wear||45
3359395|NCT04512703|4090017|FG000|NOT COMPLETED|Within 7 Days From Start of Device Wear||0
3359396|NCT04512703|4090018|FG001|NOT COMPLETED|Within 7 Days From Start of Device Wear||0
3359397|NCT04512703|4090017|FG000|STARTED|Between 7th and 90th Day of Device Wear||6
3359398|NCT04512703|4090018|FG001|STARTED|Between 7th and 90th Day of Device Wear||45
2928163|NCT00576472|3639108|FG005|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
2928164|NCT00576472|3639109|FG006|STARTED|MPH Cross Over Phase||12
2928165|NCT00576472|3639110|FG007|STARTED|MPH Cross Over Phase||20
3039997|NCT01161524|3759454|FG001|COMPLETED|Core Study (23 Weeks)||43
3039998|NCT01161524|3759455|FG002|COMPLETED|Core Study (23 Weeks)||0
3039999|NCT01161524|3759453|FG000|NOT COMPLETED|Core Study (23 Weeks)||9
3040000|NCT01161524|3759454|FG001|NOT COMPLETED|Core Study (23 Weeks)||5
3040001|NCT01161524|3759455|FG002|NOT COMPLETED|Core Study (23 Weeks)||0
3040002|NCT01161524|3759453|FG000|STARTED|Extension Phase (Approximately 83 Weeks)||0
3040003|NCT01161524|3759454|FG001|STARTED|Extension Phase (Approximately 83 Weeks)||0
3040004|NCT01161524|3759455|FG002|STARTED|Extension Phase (Approximately 83 Weeks)||114
3040005|NCT01161524|3759453|FG000|COMPLETED|Extension Phase (Approximately 83 Weeks)||0
3040006|NCT01161524|3759454|FG001|COMPLETED|Extension Phase (Approximately 83 Weeks)||0
3040007|NCT01161524|3759455|FG002|COMPLETED|Extension Phase (Approximately 83 Weeks)||90
3040008|NCT01161524|3759453|FG000|NOT COMPLETED|Extension Phase (Approximately 83 Weeks)||0
3040009|NCT01161524|3759454|FG001|NOT COMPLETED|Extension Phase (Approximately 83 Weeks)||0
3040010|NCT01161524|3759455|FG002|NOT COMPLETED|Extension Phase (Approximately 83 Weeks)||24
3040011|NCT01161537|3759464|FG000|STARTED|Part A||8
3040012|NCT01161537|3759464|FG000|COMPLETED|Part A||8
3040013|NCT01161537|3759464|FG000|NOT COMPLETED|Part A||0
3040014|NCT01161537|3759464|FG000|STARTED|Part B|4 subjects from Part A continued in Part B of the study.|9
3040015|NCT01161537|3759464|FG000|COMPLETED|Part B||7
3040016|NCT01161537|3759464|FG000|NOT COMPLETED|Part B||2
3040017|NCT01161563|3759475|FG000|STARTED|Overall Study||63
3040018|NCT01161563|3759476|FG001|STARTED|Overall Study||55
3040019|NCT01161563|3759475|FG000|COMPLETED|Overall Study||58
3040020|NCT01161563|3759476|FG001|COMPLETED|Overall Study||49
3040021|NCT01161563|3759475|FG000|NOT COMPLETED|Overall Study||5
3040022|NCT01161563|3759476|FG001|NOT COMPLETED|Overall Study||6
3040023|NCT01161628|3759482|FG000|STARTED|Overall Study||25
3040024|NCT01161628|3759482|FG000|COMPLETED|Overall Study||17
3040025|NCT01161628|3759482|FG000|NOT COMPLETED|Overall Study||8
3040026|NCT01161771|3759486|FG000|STARTED|Overall Study||32
3040027|NCT01161771|3759486|FG000|COMPLETED|Overall Study||32
3040028|NCT01161771|3759486|FG000|NOT COMPLETED|Overall Study||0
3040029|NCT01161862|3759492|FG000|STARTED|Overall Study||12
3040030|NCT01161862|3759493|FG001|STARTED|Overall Study||12
3040031|NCT01161862|3759492|FG000|COMPLETED|Overall Study||12
3040032|NCT01161862|3759493|FG001|COMPLETED|Overall Study||12
3040033|NCT01161862|3759492|FG000|NOT COMPLETED|Overall Study||0
3359399|NCT04512703|4090017|FG000|Wore Side Position Device|Between 7th and 90th Day of Device Wear||3
3359400|NCT04512703|4090018|FG001|Wore Side Position Device|Between 7th and 90th Day of Device Wear||23
3359401|NCT04512703|4090017|FG000|Wore Front Position Device|Between 7th and 90th Day of Device Wear||3
3359402|NCT04512703|4090018|FG001|Wore Front Position Device|Between 7th and 90th Day of Device Wear||22
3359403|NCT04512703|4090017|FG000|COMPLETED|Between 7th and 90th Day of Device Wear||6
3359404|NCT04512703|4090018|FG001|COMPLETED|Between 7th and 90th Day of Device Wear||45
3359405|NCT04512703|4090017|FG000|NOT COMPLETED|Between 7th and 90th Day of Device Wear||0
3359406|NCT04512703|4090018|FG001|NOT COMPLETED|Between 7th and 90th Day of Device Wear||0
3359407|NCT04511520|4090030|FG000|STARTED|Overall Study||24
3359408|NCT04511520|4090031|FG001|STARTED|Overall Study||24
3359409|NCT04511520|4090032|FG002|STARTED|Overall Study||24
3359410|NCT04511520|4090030|FG000|COMPLETED|Overall Study||24
3359411|NCT04511520|4090031|FG001|COMPLETED|Overall Study||24
3359412|NCT04511520|4090032|FG002|COMPLETED|Overall Study||24
3359413|NCT04511520|4090030|FG000|NOT COMPLETED|Overall Study||0
3359414|NCT04511520|4090031|FG001|NOT COMPLETED|Overall Study||0
3359415|NCT04511520|4090032|FG002|NOT COMPLETED|Overall Study||0
3359416|NCT04507776|4090041|FG000|STARTED|Overall Study||763
3359417|NCT04507776|4090041|FG000|COMPLETED|Overall Study||562
3359418|NCT04507776|4090041|FG000|NOT COMPLETED|Overall Study||201
3359419|NCT04502979|4090052|FG000|STARTED|Overall Study||37
3359420|NCT04502979|4090053|FG001|STARTED|Overall Study||34
3359421|NCT04502979|4090052|FG000|COMPLETED|Overall Study||34
3359422|NCT04502979|4090053|FG001|COMPLETED|Overall Study||30
3359423|NCT04502979|4090052|FG000|NOT COMPLETED|Overall Study||3
3359424|NCT04502979|4090053|FG001|NOT COMPLETED|Overall Study||4
3359425|NCT04502056|4090061|FG000|STARTED|Overall Study||2046
3359426|NCT04502056|4090062|FG001|STARTED|Overall Study||2044
3359427|NCT04502056|4090063|FG002|STARTED|Overall Study||2045
3359428|NCT04502056|4090064|FG003|STARTED|Overall Study||2046
3359429|NCT04502056|4090065|FG004|STARTED|Overall Study||2044
3359430|NCT04502056|4090066|FG005|STARTED|Overall Study||2052
3359431|NCT04502056|4090067|FG006|STARTED|Overall Study||2046
3359432|NCT04502056|4090068|FG007|STARTED|Overall Study||2043
3359433|NCT04502056|4090069|FG008|STARTED|Overall Study||1026
3359434|NCT04502056|4090070|FG009|STARTED|Overall Study||1025
3359435|NCT04502056|4090071|FG010|STARTED|Overall Study||1023
3359436|NCT04502056|4090072|FG011|STARTED|Overall Study||1020
3359437|NCT04502056|4090061|FG000|Completed the Knowledge Questions, Included for the Knowledge Gaps Analysis|Overall Study||1859
3359438|NCT04502056|4090062|FG001|Completed the Knowledge Questions, Included for the Knowledge Gaps Analysis|Overall Study||1881
3359439|NCT04502056|4090063|FG002|Completed the Knowledge Questions, Included for the Knowledge Gaps Analysis|Overall Study||1879
3359440|NCT04502056|4090064|FG003|Completed the Knowledge Questions, Included for the Knowledge Gaps Analysis|Overall Study||1886
3359441|NCT04502056|4090065|FG004|Completed the Knowledge Questions, Included for the Knowledge Gaps Analysis|Overall Study||1846
3359442|NCT04502056|4090066|FG005|Completed the Knowledge Questions, Included for the Knowledge Gaps Analysis|Overall Study||1877
3359443|NCT04502056|4090067|FG006|Completed the Knowledge Questions, Included for the Knowledge Gaps Analysis|Overall Study||1888
3359444|NCT04502056|4090068|FG007|Completed the Knowledge Questions, Included for the Knowledge Gaps Analysis|Overall Study||1883
3359445|NCT04502056|4090069|FG008|Completed the Knowledge Questions, Included for the Knowledge Gaps Analysis|Overall Study||947
3359446|NCT04502056|4090070|FG009|Completed the Knowledge Questions, Included for the Knowledge Gaps Analysis|Overall Study||942
3359447|NCT04502056|4090071|FG010|Completed the Knowledge Questions, Included for the Knowledge Gaps Analysis|Overall Study||946
3359448|NCT04502056|4090072|FG011|Completed the Knowledge Questions, Included for the Knowledge Gaps Analysis|Overall Study||928
3359449|NCT04502056|4090061|FG000|Completed the Entire Survey, Included for All Analysis Besides Knowledge Gaps, Except Follow-up|Overall Study||1799
3359450|NCT04502056|4090062|FG001|Completed the Entire Survey, Included for All Analysis Besides Knowledge Gaps, Except Follow-up|Overall Study||1828
3359451|NCT04502056|4090063|FG002|Completed the Entire Survey, Included for All Analysis Besides Knowledge Gaps, Except Follow-up|Overall Study||1830
3359452|NCT04502056|4090064|FG003|Completed the Entire Survey, Included for All Analysis Besides Knowledge Gaps, Except Follow-up|Overall Study||1835
3359453|NCT04502056|4090065|FG004|Completed the Entire Survey, Included for All Analysis Besides Knowledge Gaps, Except Follow-up|Overall Study||1792
3359454|NCT04502056|4090066|FG005|Completed the Entire Survey, Included for All Analysis Besides Knowledge Gaps, Except Follow-up|Overall Study||1820
3359455|NCT04502056|4090067|FG006|Completed the Entire Survey, Included for All Analysis Besides Knowledge Gaps, Except Follow-up|Overall Study||1821
3359456|NCT04502056|4090068|FG007|Completed the Entire Survey, Included for All Analysis Besides Knowledge Gaps, Except Follow-up|Overall Study||1844
3359457|NCT04502056|4090069|FG008|Completed the Entire Survey, Included for All Analysis Besides Knowledge Gaps, Except Follow-up|Overall Study||914
3359458|NCT04502056|4090070|FG009|Completed the Entire Survey, Included for All Analysis Besides Knowledge Gaps, Except Follow-up|Overall Study||912
3359459|NCT04502056|4090071|FG010|Completed the Entire Survey, Included for All Analysis Besides Knowledge Gaps, Except Follow-up|Overall Study||928
3359460|NCT04502056|4090072|FG011|Completed the Entire Survey, Included for All Analysis Besides Knowledge Gaps, Except Follow-up|Overall Study||900
3359461|NCT04502056|4090061|FG000|Completed the Follow-up Survey|Overall Study||608
3359462|NCT04502056|4090062|FG001|Completed the Follow-up Survey|Overall Study||607
3359463|NCT04502056|4090063|FG002|Completed the Follow-up Survey|Overall Study||591
3359464|NCT04502056|4090064|FG003|Completed the Follow-up Survey|Overall Study||601
3359465|NCT04502056|4090065|FG004|Completed the Follow-up Survey|Overall Study||631
3359466|NCT04502056|4090066|FG005|Completed the Follow-up Survey|Overall Study||598
3359467|NCT04502056|4090067|FG006|Completed the Follow-up Survey|Overall Study||607
3359468|NCT04502056|4090068|FG007|Completed the Follow-up Survey|Overall Study||607
3359469|NCT04502056|4090069|FG008|Completed the Follow-up Survey|Overall Study||301
3359470|NCT04502056|4090070|FG009|Completed the Follow-up Survey|Overall Study||313
3359471|NCT04502056|4090071|FG010|Completed the Follow-up Survey|Overall Study||291
3179277|NCT01984229|3907445|FG000|STARTED|Period 3||6
3179278|NCT01984229|3907446|FG001|STARTED|Period 3||17
3179279|NCT01984229|3907445|FG000|COMPLETED|Period 3||6
3179280|NCT01984229|3907446|FG001|COMPLETED|Period 3||17
3179281|NCT01984229|3907445|FG000|NOT COMPLETED|Period 3||0
3359472|NCT04502056|4090072|FG011|Completed the Follow-up Survey|Overall Study||316
3359473|NCT04502056|4090061|FG000|COMPLETED|Overall Study||604
3359474|NCT04502056|4090062|FG001|COMPLETED|Overall Study||602
3359475|NCT04502056|4090063|FG002|COMPLETED|Overall Study||586
3359476|NCT04502056|4090064|FG003|COMPLETED|Overall Study||597
3359477|NCT04502056|4090065|FG004|COMPLETED|Overall Study||626
3359478|NCT04502056|4090066|FG005|COMPLETED|Overall Study||596
3359479|NCT04502056|4090067|FG006|COMPLETED|Overall Study||605
3359480|NCT04502056|4090068|FG007|COMPLETED|Overall Study||603
3359481|NCT04502056|4090069|FG008|COMPLETED|Overall Study||298
3359482|NCT04502056|4090070|FG009|COMPLETED|Overall Study||311
3359483|NCT04502056|4090071|FG010|COMPLETED|Overall Study||288
3359484|NCT04502056|4090072|FG011|COMPLETED|Overall Study||614
3359485|NCT04502056|4090061|FG000|NOT COMPLETED|Overall Study||1442
3179282|NCT01984229|3907446|FG001|NOT COMPLETED|Period 3||0
3179283|NCT01984229|3907445|FG000|STARTED|Safety Follow-up Period||6
3359486|NCT04502056|4090062|FG001|NOT COMPLETED|Overall Study||1442
3359487|NCT04502056|4090063|FG002|NOT COMPLETED|Overall Study||1459
3359488|NCT04502056|4090064|FG003|NOT COMPLETED|Overall Study||1449
3359489|NCT04502056|4090065|FG004|NOT COMPLETED|Overall Study||1418
3359490|NCT04502056|4090066|FG005|NOT COMPLETED|Overall Study||1456
3359491|NCT04502056|4090067|FG006|NOT COMPLETED|Overall Study||1441
3359492|NCT04502056|4090068|FG007|NOT COMPLETED|Overall Study||1440
3359493|NCT04502056|4090069|FG008|NOT COMPLETED|Overall Study||728
3359494|NCT04502056|4090070|FG009|NOT COMPLETED|Overall Study||714
3359495|NCT04502056|4090071|FG010|NOT COMPLETED|Overall Study||735
3359496|NCT04502056|4090072|FG011|NOT COMPLETED|Overall Study||406
3359497|NCT04498403|4090096|FG000|STARTED|Overall Study||30
3359498|NCT04498403|4090097|FG001|STARTED|Overall Study||10
3359499|NCT04498403|4090096|FG000|Completed Follow up|Overall Study||30
3359500|NCT04498403|4090097|FG001|Completed Follow up|Overall Study||10
3359501|NCT04498403|4090096|FG000|COMPLETED|Overall Study||0
3359502|NCT04498403|4090097|FG001|COMPLETED|Overall Study||0
3359503|NCT04498403|4090096|FG000|NOT COMPLETED|Overall Study||30
3359504|NCT04498403|4090097|FG001|NOT COMPLETED|Overall Study||10
3359505|NCT04495374|4090105|FG000|STARTED|Overall Study||30
3359506|NCT04495374|4090106|FG001|STARTED|Overall Study||28
3359507|NCT04495374|4090105|FG000|COMPLETED|Overall Study||28
3359508|NCT04495374|4090106|FG001|COMPLETED|Overall Study||27
3359509|NCT04495374|4090105|FG000|NOT COMPLETED|Overall Study||2
3359510|NCT04495374|4090106|FG001|NOT COMPLETED|Overall Study||1
3359511|NCT04495712|4090114|FG000|STARTED|Overall Study||44
3359512|NCT04495712|4090115|FG001|STARTED|Overall Study||46
3359513|NCT04495712|4090114|FG000|COMPLETED|Overall Study||44
3359514|NCT04495712|4090115|FG001|COMPLETED|Overall Study||46
3359515|NCT04495712|4090114|FG000|NOT COMPLETED|Overall Study||0
3359516|NCT04495712|4090115|FG001|NOT COMPLETED|Overall Study||0
3359517|NCT04492397|4090121|FG000|STARTED|First Intervention||17
3359518|NCT04492397|4090122|FG001|STARTED|First Intervention||18
3359519|NCT04492397|4090121|FG000|COMPLETED|First Intervention||17
3359520|NCT04492397|4090122|FG001|COMPLETED|First Intervention||18
3359521|NCT04492397|4090121|FG000|NOT COMPLETED|First Intervention||0
3359522|NCT04492397|4090122|FG001|NOT COMPLETED|First Intervention||0
3359523|NCT04492397|4090121|FG000|STARTED|Second Intervention||17
3359524|NCT04492397|4090122|FG001|STARTED|Second Intervention||18
3359525|NCT04492397|4090121|FG000|COMPLETED|Second Intervention||17
3359526|NCT04492397|4090122|FG001|COMPLETED|Second Intervention||18
3359527|NCT04492397|4090121|FG000|NOT COMPLETED|Second Intervention||0
3359528|NCT04492397|4090122|FG001|NOT COMPLETED|Second Intervention||0
3359529|NCT04491994|4090130|FG000|STARTED|Overall Study||180
3359530|NCT04491994|4090131|FG001|STARTED|Overall Study||360
3359531|NCT04491994|4090130|FG000|COMPLETED|Overall Study||151
3359532|NCT04491994|4090131|FG001|COMPLETED|Overall Study||349
3359533|NCT04491994|4090130|FG000|NOT COMPLETED|Overall Study||29
3359534|NCT04491994|4090131|FG001|NOT COMPLETED|Overall Study||11
3359535|NCT04491240|4090140|FG000|STARTED|Overall Study||10
3359536|NCT04491240|4090141|FG001|STARTED|Overall Study||10
3359537|NCT04491240|4090142|FG002|STARTED|Overall Study||10
3359538|NCT04491240|4090140|FG000|COMPLETED|Overall Study||10
3359539|NCT04491240|4090141|FG001|COMPLETED|Overall Study||10
3359540|NCT04491240|4090142|FG002|COMPLETED|Overall Study||10
3359541|NCT04491240|4090140|FG000|NOT COMPLETED|Overall Study||0
3359542|NCT04491240|4090141|FG001|NOT COMPLETED|Overall Study||0
3359543|NCT04491240|4090142|FG002|NOT COMPLETED|Overall Study||0
3359544|NCT04490863|4090150|FG000|STARTED|Overall Study||26
3359545|NCT04490863|4090150|FG000|COMPLETED|Overall Study||26
3359546|NCT04490863|4090150|FG000|NOT COMPLETED|Overall Study||0
3359547|NCT04490499|4090154|FG000|STARTED|Overall Study||207
3359548|NCT04490499|4090154|FG000|Vaccinated|Overall Study||205
3359549|NCT04490499|4090154|FG000|COMPLETED|Overall Study||205
3359550|NCT04490499|4090154|FG000|NOT COMPLETED|Overall Study||2
3359551|NCT04490239|4090158|FG000|STARTED|1000 U Acute (One Dose, Day 1)||6
3359552|NCT04490239|4090158|FG000|COMPLETED|1000 U Acute (One Dose, Day 1)||6
3359553|NCT04490239|4090158|FG000|NOT COMPLETED|1000 U Acute (One Dose, Day 1)||0
3359554|NCT04490239|4090158|FG000|STARTED|2000 U Acute (One Dose, Day 3)||6
3359555|NCT04490239|4090158|FG000|COMPLETED|2000 U Acute (One Dose, Day 3)||6
3359556|NCT04490239|4090158|FG000|NOT COMPLETED|2000 U Acute (One Dose, Day 3)||0
3359557|NCT04490239|4090158|FG000|STARTED|2000 U Chronic (Daily, 14 Days)||6
3359558|NCT04490239|4090158|FG000|COMPLETED|2000 U Chronic (Daily, 14 Days)||6
3359559|NCT04490239|4090158|FG000|NOT COMPLETED|2000 U Chronic (Daily, 14 Days)||0
3359560|NCT04486235|4090164|FG000|STARTED|Overall Study||32
3359561|NCT04486235|4090165|FG001|STARTED|Overall Study||30
3359562|NCT04486235|4090164|FG000|Analysis|Overall Study||30
3359563|NCT04486235|4090165|FG001|Analysis|Overall Study||30
3359564|NCT04486235|4090164|FG000|COMPLETED|Overall Study||30
3359565|NCT04486235|4090165|FG001|COMPLETED|Overall Study||30
3359566|NCT04486235|4090164|FG000|NOT COMPLETED|Overall Study||2
3359567|NCT04486235|4090165|FG001|NOT COMPLETED|Overall Study||0
3359568|NCT04483011|4090174|FG000|STARTED|Intervention Period 1 (8 Days)||9
3359569|NCT04483011|4090175|FG001|STARTED|Intervention Period 1 (8 Days)||9
3359570|NCT04483011|4090174|FG000|COMPLETED|Intervention Period 1 (8 Days)||9
3359571|NCT04483011|4090175|FG001|COMPLETED|Intervention Period 1 (8 Days)||9
3359572|NCT04483011|4090174|FG000|NOT COMPLETED|Intervention Period 1 (8 Days)||0
3359573|NCT04483011|4090175|FG001|NOT COMPLETED|Intervention Period 1 (8 Days)||0
3359574|NCT04483011|4090174|FG000|STARTED|Washout (7 Days)||9
3359575|NCT04483011|4090175|FG001|STARTED|Washout (7 Days)||9
3359576|NCT04483011|4090174|FG000|COMPLETED|Washout (7 Days)||9
3359577|NCT04483011|4090175|FG001|COMPLETED|Washout (7 Days)||8
3359578|NCT04483011|4090174|FG000|NOT COMPLETED|Washout (7 Days)||0
3359579|NCT04483011|4090175|FG001|NOT COMPLETED|Washout (7 Days)||1
3359580|NCT04483011|4090174|FG000|STARTED|Intervention Period 2 (8 Days)||9
3359581|NCT04483011|4090175|FG001|STARTED|Intervention Period 2 (8 Days)||8
3359582|NCT04483011|4090174|FG000|COMPLETED|Intervention Period 2 (8 Days)||9
3359583|NCT04483011|4090175|FG001|COMPLETED|Intervention Period 2 (8 Days)||8
3359584|NCT04483011|4090174|FG000|NOT COMPLETED|Intervention Period 2 (8 Days)||0
3359585|NCT04483011|4090175|FG001|NOT COMPLETED|Intervention Period 2 (8 Days)||0
2928166|NCT00576472|3639111|FG008|STARTED|MPH Cross Over Phase||18
2928167|NCT00576472|3639112|FG009|STARTED|MPH Cross Over Phase||22
2928168|NCT00576472|3639113|FG010|STARTED|MPH Cross Over Phase||23
2928169|NCT00576472|3639114|FG011|STARTED|MPH Cross Over Phase||18
2928170|NCT00576472|3639115|FG012|STARTED|MPH Cross Over Phase||21
2928171|NCT00576472|3639116|FG013|STARTED|MPH Cross Over Phase||0
2928172|NCT00576472|3639117|FG014|STARTED|MPH Cross Over Phase||0
2928173|NCT00576472|3639103|FG000|COMPLETED|MPH Cross Over Phase||0
2928174|NCT00576472|3639104|FG001|COMPLETED|MPH Cross Over Phase||0
2928175|NCT00576472|3639105|FG002|COMPLETED|MPH Cross Over Phase||0
2928176|NCT00576472|3639106|FG003|COMPLETED|MPH Cross Over Phase||0
2928177|NCT00576472|3639107|FG004|COMPLETED|MPH Cross Over Phase||0
2928178|NCT00576472|3639108|FG005|COMPLETED|MPH Cross Over Phase||0
2928179|NCT00576472|3639109|FG006|COMPLETED|MPH Cross Over Phase||0
2928180|NCT00576472|3639110|FG007|COMPLETED|MPH Cross Over Phase||20
2928181|NCT00576472|3639111|FG008|COMPLETED|MPH Cross Over Phase||16
2928182|NCT00576472|3639112|FG009|COMPLETED|MPH Cross Over Phase||22
2928183|NCT00576472|3639113|FG010|COMPLETED|MPH Cross Over Phase||22
2928184|NCT00576472|3639114|FG011|COMPLETED|MPH Cross Over Phase||17
2928185|NCT00576472|3639115|FG012|COMPLETED|MPH Cross Over Phase||21
2928186|NCT00576472|3639116|FG013|COMPLETED|MPH Cross Over Phase||0
2928187|NCT00576472|3639117|FG014|COMPLETED|MPH Cross Over Phase||0
2928188|NCT00576472|3639103|FG000|NOT COMPLETED|MPH Cross Over Phase||0
2928189|NCT00576472|3639104|FG001|NOT COMPLETED|MPH Cross Over Phase||0
2928190|NCT00576472|3639105|FG002|NOT COMPLETED|MPH Cross Over Phase||0
2928191|NCT00576472|3639106|FG003|NOT COMPLETED|MPH Cross Over Phase||0
2928192|NCT00576472|3639107|FG004|NOT COMPLETED|MPH Cross Over Phase||0
2928193|NCT00576472|3639108|FG005|NOT COMPLETED|MPH Cross Over Phase||0
2928194|NCT00576472|3639109|FG006|NOT COMPLETED|MPH Cross Over Phase||12
2928195|NCT00576472|3639110|FG007|NOT COMPLETED|MPH Cross Over Phase||0
2928196|NCT00576472|3639111|FG008|NOT COMPLETED|MPH Cross Over Phase||2
2928197|NCT00576472|3639112|FG009|NOT COMPLETED|MPH Cross Over Phase||0
2928198|NCT00576472|3639113|FG010|NOT COMPLETED|MPH Cross Over Phase||1
2928199|NCT00576472|3639114|FG011|NOT COMPLETED|MPH Cross Over Phase||1
2928200|NCT00576472|3639115|FG012|NOT COMPLETED|MPH Cross Over Phase||0
2928201|NCT00576472|3639116|FG013|NOT COMPLETED|MPH Cross Over Phase||0
2928202|NCT00576472|3639117|FG014|NOT COMPLETED|MPH Cross Over Phase||0
2928203|NCT00576472|3639103|FG000|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
2928204|NCT00576472|3639104|FG001|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
2928205|NCT00576472|3639105|FG002|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
2928206|NCT00576472|3639106|FG003|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
2928207|NCT00576472|3639107|FG004|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
2928208|NCT00576472|3639108|FG005|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
2928209|NCT00576472|3639109|FG006|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
2928210|NCT00576472|3639110|FG007|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
3359586|NCT04475588|4090185|FG000|STARTED|Overall Study|Stated in protocol apriori, patient not completing 1st infusion were not evaluable & were replaced.|22
3359587|NCT04475588|4090186|FG001|STARTED|Overall Study||10
3359588|NCT04475588|4090185|FG000|COMPLETED|Overall Study||20
3359589|NCT04475588|4090186|FG001|COMPLETED|Overall Study||10
3359590|NCT04475588|4090185|FG000|NOT COMPLETED|Overall Study||2
3359591|NCT04475588|4090186|FG001|NOT COMPLETED|Overall Study||0
3359592|NCT04474496|4090193|FG000|STARTED|Overall Study||120
3359593|NCT04474496|4090193|FG000|COMPLETED|Overall Study|120 individuals were deemed eligible based on inclusion criteria, completed at least 10 survey items, and were included in the final analytical sample|120
3359594|NCT04474496|4090193|FG000|NOT COMPLETED|Overall Study||0
3359595|NCT04448210|4090199|FG000|STARTED|Overall Study||22
3359596|NCT04448210|4090200|FG001|STARTED|Overall Study||20
3359597|NCT04448210|4090199|FG000|COMPLETED|Overall Study||22
3359598|NCT04448210|4090200|FG001|COMPLETED|Overall Study||20
3359599|NCT04448210|4090199|FG000|NOT COMPLETED|Overall Study||0
3359600|NCT04448210|4090200|FG001|NOT COMPLETED|Overall Study||0
3359601|NCT04474405|4090212|FG000|STARTED|Overall Study||4
3359602|NCT04474405|4090213|FG001|STARTED|Overall Study||3
3359603|NCT04474405|4090214|FG002|STARTED|Overall Study||5
3359604|NCT04474405|4090215|FG003|STARTED|Overall Study||4
3359605|NCT04474405|4090216|FG004|STARTED|Overall Study||13
3359606|NCT04474405|4090217|FG005|STARTED|Overall Study||7
3359607|NCT04474405|4090212|FG000|Flortaucipir PET Scan|Overall Study||4
3359608|NCT04474405|4090213|FG001|Flortaucipir PET Scan|Overall Study||3
3359609|NCT04474405|4090214|FG002|Flortaucipir PET Scan|Overall Study||4
3359610|NCT04474405|4090215|FG003|Flortaucipir PET Scan|Overall Study||4
3359611|NCT04474405|4090216|FG004|Flortaucipir PET Scan|Overall Study||9
3359612|NCT04474405|4090217|FG005|Flortaucipir PET Scan|Overall Study||0
3359613|NCT04474405|4090212|FG000|Florbetapir PET Scan|Overall Study||4
3359614|NCT04474405|4090213|FG001|Florbetapir PET Scan|Overall Study||3
3359615|NCT04474405|4090214|FG002|Florbetapir PET Scan|Overall Study||0
3359616|NCT04474405|4090215|FG003|Florbetapir PET Scan|Overall Study||4
3359617|NCT04474405|4090216|FG004|Florbetapir PET Scan|Overall Study||0
3359618|NCT04474405|4090217|FG005|Florbetapir PET Scan|Overall Study||4
3359619|NCT04474405|4090212|FG000|COMPLETED|Overall Study||4
3359620|NCT04474405|4090213|FG001|COMPLETED|Overall Study||3
3359621|NCT04474405|4090214|FG002|COMPLETED|Overall Study||4
3359622|NCT04474405|4090215|FG003|COMPLETED|Overall Study||4
3359623|NCT04474405|4090216|FG004|COMPLETED|Overall Study||9
3359624|NCT04474405|4090217|FG005|COMPLETED|Overall Study||7
3359625|NCT04474405|4090212|FG000|NOT COMPLETED|Overall Study||0
3359626|NCT04474405|4090213|FG001|NOT COMPLETED|Overall Study||0
3359627|NCT04474405|4090214|FG002|NOT COMPLETED|Overall Study||1
3359628|NCT04474405|4090215|FG003|NOT COMPLETED|Overall Study||0
3359629|NCT04474405|4090216|FG004|NOT COMPLETED|Overall Study||4
3359630|NCT04474405|4090217|FG005|NOT COMPLETED|Overall Study||0
3359631|NCT04470375|4090231|FG000|STARTED|Overall Study||20
3359632|NCT04470375|4090231|FG000|COMPLETED|Overall Study||20
3359633|NCT04470375|4090231|FG000|NOT COMPLETED|Overall Study||0
3359634|NCT04468347|4090239|FG000|STARTED|Overall Study||6
3359635|NCT04468347|4090240|FG001|STARTED|Overall Study||11
3359636|NCT04468347|4090241|FG002|STARTED|Overall Study||47
3359637|NCT04468347|4090242|FG003|STARTED|Overall Study||25
3359638|NCT04468347|4090239|FG000|Baseline Flortacuipir PET Scan|Overall Study||5
3359639|NCT04468347|4090240|FG001|Baseline Flortacuipir PET Scan|Overall Study||11
3359640|NCT04468347|4090241|FG002|Baseline Flortacuipir PET Scan|Overall Study||45
3359641|NCT04468347|4090242|FG003|Baseline Flortacuipir PET Scan|Overall Study||25
3359642|NCT04468347|4090239|FG000|COMPLETED|Overall Study||4
3359643|NCT04468347|4090240|FG001|COMPLETED|Overall Study||10
3359644|NCT04468347|4090241|FG002|COMPLETED|Overall Study||41
3359645|NCT04468347|4090242|FG003|COMPLETED|Overall Study||21
3359646|NCT04468347|4090239|FG000|NOT COMPLETED|Overall Study||2
3359647|NCT04468347|4090240|FG001|NOT COMPLETED|Overall Study||1
3359648|NCT04468347|4090241|FG002|NOT COMPLETED|Overall Study||6
3359649|NCT04468347|4090242|FG003|NOT COMPLETED|Overall Study||4
3359650|NCT04467424|4090258|FG000|STARTED|Overall Study||100
3359651|NCT04467424|4090259|FG001|STARTED|Overall Study||100
3359652|NCT04467424|4090258|FG000|COMPLETED|Overall Study||100
3359653|NCT04467424|4090259|FG001|COMPLETED|Overall Study||100
3359654|NCT04467424|4090258|FG000|NOT COMPLETED|Overall Study||0
3359655|NCT04467424|4090259|FG001|NOT COMPLETED|Overall Study||0
3359656|NCT04465422|4090267|FG000|STARTED|Overall Study||17
3359657|NCT04465422|4090268|FG001|STARTED|Overall Study||16
3359658|NCT04465422|4090267|FG000|COMPLETED|Overall Study||17
3359659|NCT04465422|4090268|FG001|COMPLETED|Overall Study||14
3359660|NCT04465422|4090267|FG000|NOT COMPLETED|Overall Study||0
3359661|NCT04465422|4090268|FG001|NOT COMPLETED|Overall Study||2
3359662|NCT04463004|4090278|FG000|STARTED|Overall Study||1
3359663|NCT04463004|4090279|FG001|STARTED|Overall Study||1
3359664|NCT04463004|4090278|FG000|COMPLETED|Overall Study||1
3359665|NCT04463004|4090279|FG001|COMPLETED|Overall Study||1
3359666|NCT04463004|4090278|FG000|NOT COMPLETED|Overall Study||0
3359667|NCT04463004|4090279|FG001|NOT COMPLETED|Overall Study||0
3359668|NCT04463069|4090287|FG000|STARTED|Overall Study||41
3359669|NCT04463069|4090288|FG001|STARTED|Overall Study||45
3359670|NCT04463069|4090287|FG000|COMPLETED|Overall Study||39
3359671|NCT04463069|4090288|FG001|COMPLETED|Overall Study||22
3359672|NCT04463069|4090287|FG000|NOT COMPLETED|Overall Study||2
3359673|NCT04463069|4090288|FG001|NOT COMPLETED|Overall Study||23
3359674|NCT04448561|4090296|FG000|STARTED|Overall Study||16
3359675|NCT04448561|4090297|FG001|STARTED|Overall Study||8
3359676|NCT04448561|4090296|FG000|COMPLETED|Overall Study||15
3359677|NCT04448561|4090297|FG001|COMPLETED|Overall Study||8
3359678|NCT04448561|4090296|FG000|NOT COMPLETED|Overall Study||1
3359679|NCT04448561|4090297|FG001|NOT COMPLETED|Overall Study||0
3359680|NCT04462731|4090313|FG000|STARTED|Overall Study||97
3359681|NCT04462731|4090314|FG001|STARTED|Overall Study||97
3359682|NCT04462731|4090313|FG000|COMPLETED|Overall Study||41
3359683|NCT04462731|4090314|FG001|COMPLETED|Overall Study||51
3359684|NCT04462731|4090313|FG000|NOT COMPLETED|Overall Study||56
3359685|NCT04462731|4090314|FG001|NOT COMPLETED|Overall Study||46
3359686|NCT04459585|4090320|FG000|STARTED|Period 1 (Day 1 to Day 5)||20
3359687|NCT04459585|4090320|FG000|COMPLETED|Period 1 (Day 1 to Day 5)||20
3359688|NCT04459585|4090320|FG000|NOT COMPLETED|Period 1 (Day 1 to Day 5)||0
3359689|NCT04459585|4090320|FG000|STARTED|Period 2 (Day 5 to Day 12)||20
3359690|NCT04459585|4090320|FG000|COMPLETED|Period 2 (Day 5 to Day 12)||20
3359691|NCT04459585|4090320|FG000|NOT COMPLETED|Period 2 (Day 5 to Day 12)||0
3359692|NCT04458818|4090327|FG000|STARTED|Overall Study|May 01 2020|39
3359693|NCT04458818|4090327|FG000|COMPLETED|Overall Study|Jan 30 2021|39
3359694|NCT04458818|4090327|FG000|NOT COMPLETED|Overall Study||0
3359695|NCT04456634|4090333|FG000|STARTED|Overall Study||6
3359696|NCT04456634|4090334|FG001|STARTED|Overall Study||2
3359697|NCT04456634|4090333|FG000|COMPLETED|Overall Study||5
3359698|NCT04456634|4090334|FG001|COMPLETED|Overall Study||2
3359699|NCT04456634|4090333|FG000|NOT COMPLETED|Overall Study||1
3359700|NCT04456634|4090334|FG001|NOT COMPLETED|Overall Study||0
3359701|NCT04454138|4090342|FG000|STARTED|Overall Study||65
3359702|NCT04454138|4090343|FG001|STARTED|Overall Study||77
3359703|NCT04454138|4090342|FG000|COMPLETED|Overall Study||65
3359704|NCT04454138|4090343|FG001|COMPLETED|Overall Study||77
3359705|NCT04454138|4090342|FG000|NOT COMPLETED|Overall Study||0
3359706|NCT04454138|4090343|FG001|NOT COMPLETED|Overall Study||0
3359707|NCT04452435|4090351|FG000|STARTED|Screening||51
3359708|NCT04452435|4090352|FG001|STARTED|Screening||55
3359709|NCT04452435|4090351|FG000|COMPLETED|Screening||51
3359710|NCT04452435|4090352|FG001|COMPLETED|Screening||55
3359711|NCT04452435|4090351|FG000|NOT COMPLETED|Screening||0
3359712|NCT04452435|4090352|FG001|NOT COMPLETED|Screening||0
3359713|NCT04452435|4090351|FG000|STARTED|Treatment Period||51
3359714|NCT04452435|4090352|FG001|STARTED|Treatment Period||55
3359715|NCT04452435|4090351|FG000|COMPLETED|Treatment Period||45
3359716|NCT04452435|4090352|FG001|COMPLETED|Treatment Period||43
3359717|NCT04452435|4090351|FG000|NOT COMPLETED|Treatment Period||6
3359718|NCT04452435|4090352|FG001|NOT COMPLETED|Treatment Period||12
3359719|NCT04452435|4090351|FG000|STARTED|Follow-up||45
3359720|NCT04452435|4090352|FG001|STARTED|Follow-up||43
3359721|NCT04452435|4090351|FG000|COMPLETED|Follow-up||45
3359722|NCT04452435|4090352|FG001|COMPLETED|Follow-up||42
3359723|NCT04452435|4090351|FG000|NOT COMPLETED|Follow-up||0
3359724|NCT04452435|4090352|FG001|NOT COMPLETED|Follow-up||1
3359725|NCT04451707|4090359|FG000|STARTED|Overall Study||67
3359726|NCT04451707|4090359|FG000|COMPLETED|Overall Study||67
2928211|NCT00576472|3639111|FG008|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
2928212|NCT00576472|3639112|FG009|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
2928213|NCT00576472|3639113|FG010|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
2928214|NCT00576472|3639114|FG011|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
2928215|NCT00576472|3639115|FG012|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
2928216|NCT00576472|3639116|FG013|STARTED|MPH Home Maintenance Phase||27
2928217|NCT00576472|3639117|FG014|STARTED|MPH Home Maintenance Phase||91
2928218|NCT00576472|3639103|FG000|COMPLETED|MPH Home Maintenance Phase||0
2928219|NCT00576472|3639104|FG001|COMPLETED|MPH Home Maintenance Phase||0
2928220|NCT00576472|3639105|FG002|COMPLETED|MPH Home Maintenance Phase||0
2928221|NCT00576472|3639106|FG003|COMPLETED|MPH Home Maintenance Phase||0
3359727|NCT04451707|4090359|FG000|NOT COMPLETED|Overall Study||0
3359728|NCT04449263|4090363|FG000|STARTED|First Intervention||29
3359729|NCT04449263|4090364|FG001|STARTED|First Intervention||30
3359730|NCT04449263|4090363|FG000|COMPLETED|First Intervention||29
3359731|NCT04449263|4090364|FG001|COMPLETED|First Intervention||30
3359732|NCT04449263|4090363|FG000|NOT COMPLETED|First Intervention||0
3359733|NCT04449263|4090364|FG001|NOT COMPLETED|First Intervention||0
3359734|NCT04449263|4090363|FG000|STARTED|Second Intervention||29
3359735|NCT04449263|4090364|FG001|STARTED|Second Intervention||30
3359736|NCT04449263|4090363|FG000|COMPLETED|Second Intervention||29
3359737|NCT04449263|4090364|FG001|COMPLETED|Second Intervention||30
3359738|NCT04449263|4090363|FG000|NOT COMPLETED|Second Intervention||0
3359739|NCT04449263|4090364|FG001|NOT COMPLETED|Second Intervention||0
3359740|NCT04449263|4090363|FG000|STARTED|Third Intervention||29
3359741|NCT04449263|4090364|FG001|STARTED|Third Intervention||30
3359742|NCT04449263|4090363|FG000|COMPLETED|Third Intervention||29
3359743|NCT04449263|4090364|FG001|COMPLETED|Third Intervention||30
3359744|NCT04449263|4090363|FG000|NOT COMPLETED|Third Intervention||0
3359745|NCT04449263|4090364|FG001|NOT COMPLETED|Third Intervention||0
3359746|NCT04450381|4090372|FG000|STARTED|Overall Study||131
3359747|NCT04450381|4090372|FG000|COMPLETED|Overall Study||125
3359748|NCT04450381|4090372|FG000|NOT COMPLETED|Overall Study||6
3359749|NCT04449341|4090378|FG000|STARTED|Overall Study||31
3359750|NCT04449341|4090379|FG001|STARTED|Overall Study||28
3359751|NCT04449341|4090378|FG000|COMPLETED|Overall Study||30
3359752|NCT04449341|4090379|FG001|COMPLETED|Overall Study||28
3359753|NCT04449341|4090378|FG000|NOT COMPLETED|Overall Study||1
3359754|NCT04449341|4090379|FG001|NOT COMPLETED|Overall Study||0
3359755|NCT04441255|4090387|FG000|STARTED|Period 1 (1 Day)||7
3359756|NCT04441255|4090388|FG001|STARTED|Period 1 (1 Day)||7
3359757|NCT04441255|4090387|FG000|COMPLETED|Period 1 (1 Day)||7
3359758|NCT04441255|4090388|FG001|COMPLETED|Period 1 (1 Day)||7
3359759|NCT04441255|4090387|FG000|NOT COMPLETED|Period 1 (1 Day)||0
3359760|NCT04441255|4090388|FG001|NOT COMPLETED|Period 1 (1 Day)||0
3359761|NCT04441255|4090387|FG000|STARTED|Washout Period (10 Days)||7
3359762|NCT04441255|4090388|FG001|STARTED|Washout Period (10 Days)||7
3359763|NCT04441255|4090387|FG000|COMPLETED|Washout Period (10 Days)||7
3359764|NCT04441255|4090388|FG001|COMPLETED|Washout Period (10 Days)||7
3359765|NCT04441255|4090387|FG000|NOT COMPLETED|Washout Period (10 Days)||0
3359766|NCT04441255|4090388|FG001|NOT COMPLETED|Washout Period (10 Days)||0
3359767|NCT04441255|4090387|FG000|STARTED|Period 2 (1 Day)||7
3359768|NCT04441255|4090388|FG001|STARTED|Period 2 (1 Day)||7
3359769|NCT04441255|4090387|FG000|COMPLETED|Period 2 (1 Day)||7
3359770|NCT04441255|4090388|FG001|COMPLETED|Period 2 (1 Day)||7
3359771|NCT04441255|4090387|FG000|NOT COMPLETED|Period 2 (1 Day)||0
3359772|NCT04441255|4090388|FG001|NOT COMPLETED|Period 2 (1 Day)||0
3359773|NCT04440449|4090396|FG000|STARTED|Overall Study||20
3359774|NCT04440449|4090397|FG001|STARTED|Overall Study||0
3359775|NCT04440449|4090396|FG000|COMPLETED|Overall Study||18
3359776|NCT04440449|4090397|FG001|COMPLETED|Overall Study||0
3359777|NCT04440449|4090396|FG000|NOT COMPLETED|Overall Study||2
3359778|NCT04440449|4090397|FG001|NOT COMPLETED|Overall Study||0
3359779|NCT04439214|4090404|FG000|STARTED|Overall Study||47
3359780|NCT04439214|4090404|FG000|Eligible|Overall Study||42
3359781|NCT04439214|4090404|FG000|Treated|Overall Study||47
3359782|NCT04439214|4090404|FG000|Treated and Reported Adverse Event Data|Overall Study|One patient experienced disease progression in cycle 1 and an AE form was not submitted.|46
3359783|NCT04439214|4090404|FG000|Eligible and Treated|Overall Study||42
3359784|NCT04439214|4090404|FG000|COMPLETED|Overall Study||0
3359785|NCT04439214|4090404|FG000|NOT COMPLETED|Overall Study||47
3359786|NCT04439240|4090408|FG000|STARTED|Overall Study||52
3359787|NCT04439240|4090408|FG000|Started Protocol Therapy|Overall Study||50
3359788|NCT04439240|4090408|FG000|Eligible|Overall Study||49
3359789|NCT04439240|4090408|FG000|Eligible and Started Protocol Therapy|Overall Study||48
3359790|NCT04439240|4090408|FG000|Reported Adverse Events Data|Overall Study||49
3359791|NCT04439240|4090408|FG000|COMPLETED|Overall Study||0
3359792|NCT04439240|4090408|FG000|NOT COMPLETED|Overall Study||52
3359793|NCT04438785|4090414|FG000|STARTED|Overall Study||20
3359794|NCT04438785|4090415|FG001|STARTED|Overall Study||20
3359795|NCT04438785|4090414|FG000|COMPLETED|Overall Study||18
3359796|NCT04438785|4090415|FG001|COMPLETED|Overall Study||10
3359797|NCT04438785|4090414|FG000|NOT COMPLETED|Overall Study||2
3359798|NCT04438785|4090415|FG001|NOT COMPLETED|Overall Study||10
3359799|NCT04431908|4090423|FG000|STARTED|Overall Study||1042
3359800|NCT04431908|4090424|FG001|STARTED|Overall Study||278
3359801|NCT04431908|4090423|FG000|COMPLETED|Overall Study||1042
3359802|NCT04431908|4090424|FG001|COMPLETED|Overall Study||278
3359803|NCT04431908|4090423|FG000|NOT COMPLETED|Overall Study||0
3359804|NCT04431908|4090424|FG001|NOT COMPLETED|Overall Study||0
3359805|NCT04413929|4090431|FG000|STARTED|Overall Study||8411
3359806|NCT04413929|4090431|FG000|COMPLETED|Overall Study||8411
3359807|NCT04413929|4090431|FG000|NOT COMPLETED|Overall Study||0
3359808|NCT04430634|4090444|FG000|STARTED|Overall Study||5
3359809|NCT04430634|4090445|FG001|STARTED|Overall Study||5
3359810|NCT04430634|4090446|FG002|STARTED|Overall Study||5
3359811|NCT04430634|4090447|FG003|STARTED|Overall Study||5
3359812|NCT04430634|4090448|FG004|STARTED|Overall Study||5
3359813|NCT04430634|4090449|FG005|STARTED|Overall Study||5
3359814|NCT04430634|4090450|FG006|STARTED|Overall Study||5
3359815|NCT04430634|4090451|FG007|STARTED|Overall Study||5
3359816|NCT04430634|4090444|FG000|COMPLETED|Overall Study||5
3359817|NCT04430634|4090445|FG001|COMPLETED|Overall Study||5
3359818|NCT04430634|4090446|FG002|COMPLETED|Overall Study||5
3359819|NCT04430634|4090447|FG003|COMPLETED|Overall Study||4
3359820|NCT04430634|4090448|FG004|COMPLETED|Overall Study||5
3359821|NCT04430634|4090449|FG005|COMPLETED|Overall Study||5
3359822|NCT04430634|4090450|FG006|COMPLETED|Overall Study||4
3359823|NCT04430634|4090451|FG007|COMPLETED|Overall Study||5
3359824|NCT04430634|4090444|FG000|NOT COMPLETED|Overall Study||0
3359825|NCT04430634|4090445|FG001|NOT COMPLETED|Overall Study||0
3359826|NCT04430634|4090446|FG002|NOT COMPLETED|Overall Study||0
3359827|NCT04430634|4090447|FG003|NOT COMPLETED|Overall Study||1
3359828|NCT04430634|4090448|FG004|NOT COMPLETED|Overall Study||0
3359829|NCT04430634|4090449|FG005|NOT COMPLETED|Overall Study||0
3359830|NCT04430634|4090450|FG006|NOT COMPLETED|Overall Study||1
3359831|NCT04430634|4090451|FG007|NOT COMPLETED|Overall Study||0
3359832|NCT04429932|4090478|FG000|STARTED|Overall Study||4
3359833|NCT04429932|4090479|FG001|STARTED|Overall Study||5
3359834|NCT04429932|4090480|FG002|STARTED|Overall Study||5
3359835|NCT04429932|4090481|FG003|STARTED|Overall Study||5
3359836|NCT04429932|4090482|FG004|STARTED|Overall Study||5
3359837|NCT04429932|4090483|FG005|STARTED|Overall Study||5
3359838|NCT04429932|4090484|FG006|STARTED|Overall Study||5
3359839|NCT04429932|4090485|FG007|STARTED|Overall Study||5
3179284|NCT01984229|3907446|FG001|STARTED|Safety Follow-up Period||17
3179285|NCT01984229|3907445|FG000|COMPLETED|Safety Follow-up Period||4
3179286|NCT01984229|3907446|FG001|COMPLETED|Safety Follow-up Period||16
2928222|NCT00576472|3639107|FG004|COMPLETED|MPH Home Maintenance Phase||0
2928223|NCT00576472|3639108|FG005|COMPLETED|MPH Home Maintenance Phase||0
2928224|NCT00576472|3639109|FG006|COMPLETED|MPH Home Maintenance Phase||0
2928225|NCT00576472|3639110|FG007|COMPLETED|MPH Home Maintenance Phase||0
2928226|NCT00576472|3639111|FG008|COMPLETED|MPH Home Maintenance Phase||0
2928227|NCT00576472|3639112|FG009|COMPLETED|MPH Home Maintenance Phase||0
2928228|NCT00576472|3639113|FG010|COMPLETED|MPH Home Maintenance Phase||0
2928229|NCT00576472|3639114|FG011|COMPLETED|MPH Home Maintenance Phase||0
2928230|NCT00576472|3639115|FG012|COMPLETED|MPH Home Maintenance Phase||0
2928231|NCT00576472|3639116|FG013|COMPLETED|MPH Home Maintenance Phase||0
2928232|NCT00576472|3639117|FG014|COMPLETED|MPH Home Maintenance Phase||68
2928233|NCT00576472|3639103|FG000|NOT COMPLETED|MPH Home Maintenance Phase||0
3040034|NCT01161862|3759493|FG001|NOT COMPLETED|Overall Study||0
3040035|NCT01162005|3759504|FG000|STARTED|Overall Study||44
3359840|NCT04429932|4090478|FG000|COMPLETED|Overall Study||3
3359841|NCT04429932|4090479|FG001|COMPLETED|Overall Study||5
3359842|NCT04429932|4090480|FG002|COMPLETED|Overall Study||5
3359843|NCT04429932|4090481|FG003|COMPLETED|Overall Study||2
3359844|NCT04429932|4090482|FG004|COMPLETED|Overall Study||5
3359845|NCT04429932|4090483|FG005|COMPLETED|Overall Study||5
3359846|NCT04429932|4090484|FG006|COMPLETED|Overall Study||5
3359847|NCT04429932|4090485|FG007|COMPLETED|Overall Study||5
3359848|NCT04429932|4090478|FG000|NOT COMPLETED|Overall Study||1
3359849|NCT04429932|4090479|FG001|NOT COMPLETED|Overall Study||0
3359850|NCT04429932|4090480|FG002|NOT COMPLETED|Overall Study||0
3359851|NCT04429932|4090481|FG003|NOT COMPLETED|Overall Study||3
3359852|NCT04429932|4090482|FG004|NOT COMPLETED|Overall Study||0
3359853|NCT04429932|4090483|FG005|NOT COMPLETED|Overall Study||0
3359854|NCT04429932|4090484|FG006|NOT COMPLETED|Overall Study||0
3359855|NCT04429932|4090485|FG007|NOT COMPLETED|Overall Study||0
3359856|NCT04428502|4090504|FG000|STARTED|Overall Study||127
3359857|NCT04428502|4090504|FG000|COMPLETED|Overall Study||113
3359858|NCT04428502|4090504|FG000|NOT COMPLETED|Overall Study||14
3359859|NCT04428424|4090509|FG000|STARTED|Overall Study||1493
3359860|NCT04428424|4090509|FG000|COMPLETED|Overall Study||1246
3359861|NCT04428424|4090509|FG000|NOT COMPLETED|Overall Study||247
3359862|NCT04428359|4090515|FG000|STARTED|Overall Study||33
3359863|NCT04428359|4090516|FG001|STARTED|Overall Study||33
3359864|NCT04428359|4090515|FG000|COMPLETED|Overall Study||31
3359865|NCT04428359|4090516|FG001|COMPLETED|Overall Study||30
3359866|NCT04428359|4090515|FG000|NOT COMPLETED|Overall Study||2
3359867|NCT04428359|4090516|FG001|NOT COMPLETED|Overall Study||3
3359868|NCT04410159|4090526|FG000|STARTED|Overall Study||5
3359869|NCT04410159|4090527|FG001|STARTED|Overall Study||5
3359870|NCT04410159|4090528|FG002|STARTED|Overall Study||5
3359871|NCT04410159|4090529|FG003|STARTED|Overall Study||5
3359872|NCT04410159|4090526|FG000|COMPLETED|Overall Study||5
3359873|NCT04410159|4090527|FG001|COMPLETED|Overall Study||5
3359874|NCT04410159|4090528|FG002|COMPLETED|Overall Study||5
3359875|NCT04410159|4090529|FG003|COMPLETED|Overall Study||5
3359876|NCT04410159|4090526|FG000|NOT COMPLETED|Overall Study||0
3359877|NCT04410159|4090527|FG001|NOT COMPLETED|Overall Study||0
3359878|NCT04410159|4090528|FG002|NOT COMPLETED|Overall Study||0
3359879|NCT04410159|4090529|FG003|NOT COMPLETED|Overall Study||0
3359880|NCT04425850|4090541|FG000|STARTED|Overall Study|Standard prophylactic measures and PPE + iota carrageenan (nasal and buccal) and ivermectin (buccal)|131
3359881|NCT04425850|4090542|FG001|STARTED|Overall Study|Standard prophylactic measures and PPE only|98
3359882|NCT04425850|4090541|FG000|COMPLETED|Overall Study||131
3359883|NCT04425850|4090542|FG001|COMPLETED|Overall Study||98
3359884|NCT04425850|4090541|FG000|NOT COMPLETED|Overall Study||0
3359885|NCT04425850|4090542|FG001|NOT COMPLETED|Overall Study||0
3359886|NCT04425863|4090553|FG000|STARTED|Overall Study||135
3359887|NCT04425863|4090554|FG001|STARTED|Overall Study||12
3359888|NCT04425863|4090555|FG002|STARTED|Overall Study||20
3359889|NCT04425863|4090553|FG000|COMPLETED|Overall Study||135
3359890|NCT04425863|4090554|FG001|COMPLETED|Overall Study||12
3359891|NCT04425863|4090555|FG002|COMPLETED|Overall Study||19
3359892|NCT04425863|4090553|FG000|NOT COMPLETED|Overall Study||0
3359893|NCT04425863|4090554|FG001|NOT COMPLETED|Overall Study||0
3359894|NCT04425863|4090555|FG002|NOT COMPLETED|Overall Study||1
3359895|NCT04425746|4090577|FG000|STARTED|Overall Study||9
3359896|NCT04425746|4090578|FG001|STARTED|Overall Study||7
3359897|NCT04425746|4090577|FG000|COMPLETED|Overall Study||9
3359898|NCT04425746|4090578|FG001|COMPLETED|Overall Study||6
3359899|NCT04425746|4090577|FG000|NOT COMPLETED|Overall Study||0
3359900|NCT04425746|4090578|FG001|NOT COMPLETED|Overall Study||1
3359901|NCT04422561|4090588|FG000|STARTED|Overall Study||228
3359902|NCT04422561|4090589|FG001|STARTED|Overall Study||112
3359903|NCT04422561|4090588|FG000|COMPLETED|Overall Study||203
3359904|NCT04422561|4090589|FG001|COMPLETED|Overall Study||101
3359905|NCT04422561|4090588|FG000|NOT COMPLETED|Overall Study||25
3359906|NCT04422561|4090589|FG001|NOT COMPLETED|Overall Study||11
3359907|NCT04421404|4090597|FG000|STARTED|Overall Study||16
3359908|NCT04421404|4090598|FG001|STARTED|Overall Study||18
3359909|NCT04421404|4090597|FG000|COMPLETED|Overall Study||16
3359910|NCT04421404|4090598|FG001|COMPLETED|Overall Study||18
3359911|NCT04421404|4090597|FG000|NOT COMPLETED|Overall Study||0
3359912|NCT04421404|4090598|FG001|NOT COMPLETED|Overall Study||0
3359913|NCT04419311|4090606|FG000|STARTED|Overall Study||33
3359914|NCT04419311|4090607|FG001|STARTED|Overall Study||33
3359915|NCT04419311|4090606|FG000|COMPLETED|Overall Study||32
3359916|NCT04419311|4090607|FG001|COMPLETED|Overall Study||33
3359917|NCT04419311|4090606|FG000|NOT COMPLETED|Overall Study||1
3359918|NCT04419311|4090607|FG001|NOT COMPLETED|Overall Study||0
3359919|NCT04415489|4090617|FG000|STARTED|Overall Study||50
3359920|NCT04415489|4090618|FG001|STARTED|Overall Study||50
3359921|NCT04415489|4090617|FG000|COMPLETED|Overall Study||50
3359922|NCT04415489|4090618|FG001|COMPLETED|Overall Study||50
3359923|NCT04415489|4090617|FG000|NOT COMPLETED|Overall Study||0
3359924|NCT04415489|4090618|FG001|NOT COMPLETED|Overall Study||0
3359925|NCT04411667|4090627|FG000|STARTED|Overall Study||17
3359926|NCT04411667|4090628|FG001|STARTED|Overall Study||17
3359927|NCT04411667|4090627|FG000|COMPLETED|Overall Study||16
3359928|NCT04411667|4090628|FG001|COMPLETED|Overall Study||17
3359929|NCT04411667|4090627|FG000|NOT COMPLETED|Overall Study||1
3359930|NCT04411667|4090628|FG001|NOT COMPLETED|Overall Study||0
3359931|NCT04409886|4090634|FG000|STARTED|Overall Study||1
3359932|NCT04409886|4090634|FG000|COMPLETED|Overall Study||1
3359933|NCT04409886|4090634|FG000|NOT COMPLETED|Overall Study||0
3359934|NCT04407507|4090640|FG000|STARTED|Overall Study||33
3359935|NCT04407507|4090641|FG001|STARTED|Overall Study||33
3359936|NCT04407507|4090640|FG000|COMPLETED|Overall Study||33
3359937|NCT04407507|4090641|FG001|COMPLETED|Overall Study||32
3359938|NCT04407507|4090640|FG000|NOT COMPLETED|Overall Study||0
3359939|NCT04407507|4090641|FG001|NOT COMPLETED|Overall Study||1
3359940|NCT04406194|4090649|FG000|STARTED|Period 1||15
3359941|NCT04406194|4090650|FG001|STARTED|Period 1||15
3359942|NCT04406194|4090649|FG000|COMPLETED|Period 1||15
3359943|NCT04406194|4090650|FG001|COMPLETED|Period 1||14
3359944|NCT04406194|4090649|FG000|NOT COMPLETED|Period 1||0
3359945|NCT04406194|4090650|FG001|NOT COMPLETED|Period 1||1
3179287|NCT01984229|3907445|FG000|NOT COMPLETED|Safety Follow-up Period||2
3179288|NCT01984229|3907446|FG001|NOT COMPLETED|Safety Follow-up Period||1
3179289|NCT01984242|3907461|FG000|STARTED|Overall Study||101
3179290|NCT01984242|3907462|FG001|STARTED|Overall Study||103
3359946|NCT04406194|4090649|FG000|STARTED|Period 2||15
3359947|NCT04406194|4090650|FG001|STARTED|Period 2||14
3359948|NCT04406194|4090649|FG000|COMPLETED|Period 2||15
3359949|NCT04406194|4090650|FG001|COMPLETED|Period 2||14
3359950|NCT04406194|4090649|FG000|NOT COMPLETED|Period 2||0
3359951|NCT04406194|4090650|FG001|NOT COMPLETED|Period 2||0
3359952|NCT04404907|4090661|FG000|STARTED|Overall Study||442
3359953|NCT04404907|4090662|FG001|STARTED|Overall Study||95
3359954|NCT04404907|4090661|FG000|Occasional Tan|Overall Study||0
3359955|NCT04404907|4090662|FG001|Occasional Tan|Overall Study||88
3359956|NCT04404907|4090661|FG000|Frequent Tan|Overall Study||0
3359957|NCT04404907|4090662|FG001|Frequent Tan|Overall Study||7
3359958|NCT04404907|4090661|FG000|COMPLETED|Overall Study||442
3359959|NCT04404907|4090662|FG001|COMPLETED|Overall Study||95
3359960|NCT04404907|4090661|FG000|NOT COMPLETED|Overall Study||0
3359961|NCT04404907|4090662|FG001|NOT COMPLETED|Overall Study||0
3359962|NCT04404010|4090670|FG000|STARTED|Overall Study|1 participant was mistakenly consented, enrolled and randomized as part of study. After randomization, but prior to study testing we realized the participant was not eligible (they were not a PGY4 or 5), therefore they were excluded prior to any further study procedures commenced. Therefore, only 9 participants completed all study procedures/were followed for purposes of study.|10
3359963|NCT04404010|4090671|FG001|STARTED|Overall Study||9
3359964|NCT04404010|4090670|FG000|COMPLETED|Overall Study||9
3359965|NCT04404010|4090671|FG001|COMPLETED|Overall Study||9
3359966|NCT04404010|4090670|FG000|NOT COMPLETED|Overall Study||1
3359967|NCT04404010|4090671|FG001|NOT COMPLETED|Overall Study||0
3359968|NCT04403399|4090681|FG000|STARTED|Period 1||18
3359969|NCT04403399|4090682|FG001|STARTED|Period 1||16
3359970|NCT04403399|4090681|FG000|COMPLETED|Period 1||18
3359971|NCT04403399|4090682|FG001|COMPLETED|Period 1||16
3179291|NCT01984242|3907463|FG002|STARTED|Overall Study||101
3179292|NCT01984242|3907461|FG000|Treated|Overall Study||101
3359972|NCT04403399|4090681|FG000|NOT COMPLETED|Period 1||0
3359973|NCT04403399|4090682|FG001|NOT COMPLETED|Period 1||0
3359974|NCT04403399|4090681|FG000|STARTED|Period 2||18
3359975|NCT04403399|4090682|FG001|STARTED|Period 2||16
3359976|NCT04403399|4090681|FG000|COMPLETED|Period 2||18
3359977|NCT04403399|4090682|FG001|COMPLETED|Period 2||15
3359978|NCT04403399|4090681|FG000|NOT COMPLETED|Period 2||0
3359979|NCT04403399|4090682|FG001|NOT COMPLETED|Period 2||1
2928234|NCT00576472|3639104|FG001|NOT COMPLETED|MPH Home Maintenance Phase||0
2928235|NCT00576472|3639105|FG002|NOT COMPLETED|MPH Home Maintenance Phase||0
2928236|NCT00576472|3639106|FG003|NOT COMPLETED|MPH Home Maintenance Phase||0
2928237|NCT00576472|3639107|FG004|NOT COMPLETED|MPH Home Maintenance Phase||0
2928238|NCT00576472|3639108|FG005|NOT COMPLETED|MPH Home Maintenance Phase||0
2928239|NCT00576472|3639109|FG006|NOT COMPLETED|MPH Home Maintenance Phase||0
2928240|NCT00576472|3639110|FG007|NOT COMPLETED|MPH Home Maintenance Phase||0
2928241|NCT00576472|3639111|FG008|NOT COMPLETED|MPH Home Maintenance Phase||0
2928242|NCT00576472|3639112|FG009|NOT COMPLETED|MPH Home Maintenance Phase||0
2928243|NCT00576472|3639113|FG010|NOT COMPLETED|MPH Home Maintenance Phase||0
2928244|NCT00576472|3639114|FG011|NOT COMPLETED|MPH Home Maintenance Phase||0
2928245|NCT00576472|3639115|FG012|NOT COMPLETED|MPH Home Maintenance Phase||0
2928246|NCT00576472|3639116|FG013|NOT COMPLETED|MPH Home Maintenance Phase||27
2928247|NCT00576472|3639117|FG014|NOT COMPLETED|MPH Home Maintenance Phase||23
2928248|NCT00576576|3639148|FG000|STARTED|Overall Study||27
2928249|NCT00576576|3639148|FG000|COMPLETED|Overall Study||20
2928250|NCT00576576|3639148|FG000|NOT COMPLETED|Overall Study||7
2928251|NCT00576628|3639152|FG000|STARTED|Overall Study||125
2928252|NCT00576628|3639152|FG000|COMPLETED|Overall Study||82
2928253|NCT00576628|3639152|FG000|NOT COMPLETED|Overall Study||43
2928254|NCT00576680|3639157|FG000|STARTED|Overall Study||43
2928255|NCT00576680|3639157|FG000|COMPLETED|Overall Study||43
2928256|NCT00576680|3639157|FG000|NOT COMPLETED|Overall Study||0
2928257|NCT00576693|3639163|FG000|STARTED|Overall Study||224
2928258|NCT00576693|3639164|FG001|STARTED|Overall Study||227
3359980|NCT04402970|4090690|FG000|STARTED|Overall Study||10
3359981|NCT04402970|4090691|FG001|STARTED|Overall Study||20
3359982|NCT04402970|4090690|FG000|COMPLETED|Overall Study||10
3359983|NCT04402970|4090691|FG001|COMPLETED|Overall Study||20
3359984|NCT04402970|4090690|FG000|NOT COMPLETED|Overall Study||0
3359985|NCT04402970|4090691|FG001|NOT COMPLETED|Overall Study||0
3359986|NCT04403113|4090699|FG000|STARTED|Overall Study||20
3359987|NCT04403113|4090700|FG001|STARTED|Overall Study||20
3359988|NCT04403113|4090699|FG000|COMPLETED|Overall Study||20
3359989|NCT04403113|4090700|FG001|COMPLETED|Overall Study||20
3359990|NCT04403113|4090699|FG000|NOT COMPLETED|Overall Study||0
3359991|NCT04403113|4090700|FG001|NOT COMPLETED|Overall Study||0
3359992|NCT04401202|4090712|FG000|STARTED|Overall Study||92
3359993|NCT04401202|4090713|FG001|STARTED|Overall Study||91
3359994|NCT04401202|4090712|FG000|COMPLETED|Overall Study||86
3359995|NCT04401202|4090713|FG001|COMPLETED|Overall Study||87
3359996|NCT04401202|4090712|FG000|NOT COMPLETED|Overall Study||6
3359997|NCT04401202|4090713|FG001|NOT COMPLETED|Overall Study||4
3359998|NCT04401579|4090722|FG000|STARTED|Overall Study||515
3359999|NCT04401579|4090723|FG001|STARTED|Overall Study||518
3360000|NCT04401579|4090722|FG000|Treated|Overall Study||507
3360001|NCT04401579|4090723|FG001|Treated|Overall Study||509
3360002|NCT04401579|4090722|FG000|COMPLETED|Overall Study||431
3360003|NCT04401579|4090723|FG001|COMPLETED|Overall Study||408
3360004|NCT04401579|4090722|FG000|NOT COMPLETED|Overall Study||84
3360005|NCT04401579|4090723|FG001|NOT COMPLETED|Overall Study||110
3360006|NCT04400682|4090731|FG000|STARTED|Period 1||15
3360007|NCT04400682|4090732|FG001|STARTED|Period 1||15
3360008|NCT04400682|4090731|FG000|COMPLETED|Period 1||14
3360009|NCT04400682|4090732|FG001|COMPLETED|Period 1||11
3360010|NCT04400682|4090731|FG000|NOT COMPLETED|Period 1||1
3360011|NCT04400682|4090732|FG001|NOT COMPLETED|Period 1||4
3360012|NCT04400682|4090731|FG000|STARTED|Period 2||14
3360013|NCT04400682|4090732|FG001|STARTED|Period 2||11
3360014|NCT04400682|4090731|FG000|COMPLETED|Period 2||14
3360015|NCT04400682|4090732|FG001|COMPLETED|Period 2||11
3360016|NCT04400682|4090731|FG000|NOT COMPLETED|Period 2||0
3360017|NCT04400682|4090732|FG001|NOT COMPLETED|Period 2||0
3360018|NCT04399161|4090741|FG000|STARTED|Overall Study||20
3360019|NCT04399161|4090742|FG001|STARTED|Overall Study||20
3360020|NCT04399161|4090743|FG002|STARTED|Overall Study||20
3360021|NCT04399161|4090741|FG000|COMPLETED|Overall Study||18
3360022|NCT04399161|4090742|FG001|COMPLETED|Overall Study||18
3360023|NCT04399161|4090743|FG002|COMPLETED|Overall Study||18
3360024|NCT04399161|4090741|FG000|NOT COMPLETED|Overall Study||2
3360025|NCT04399161|4090742|FG001|NOT COMPLETED|Overall Study||2
3360026|NCT04399161|4090743|FG002|NOT COMPLETED|Overall Study||2
3360027|NCT04399980|4090753|FG000|STARTED|Overall Study||21
3360028|NCT04399980|4090754|FG001|STARTED|Overall Study||19
3360029|NCT04399980|4090753|FG000|COMPLETED|Overall Study||21
3360030|NCT04399980|4090754|FG001|COMPLETED|Overall Study||19
3360031|NCT04399980|4090753|FG000|NOT COMPLETED|Overall Study||0
3360032|NCT04399980|4090754|FG001|NOT COMPLETED|Overall Study||0
3360033|NCT04399122|4090762|FG000|STARTED|Overall Study||100
3360034|NCT04399122|4090763|FG001|STARTED|Overall Study||100
3360035|NCT04399122|4090762|FG000|COMPLETED|Overall Study||97
3360036|NCT04399122|4090763|FG001|COMPLETED|Overall Study||100
3360037|NCT04399122|4090762|FG000|NOT COMPLETED|Overall Study||3
3360038|NCT04399122|4090763|FG001|NOT COMPLETED|Overall Study||0
3360039|NCT04397445|4090769|FG000|STARTED|Overall Study||5
3360040|NCT04397445|4090770|FG001|STARTED|Overall Study||5
3360041|NCT04397445|4090771|FG002|STARTED|Overall Study||4
3360042|NCT04397445|4090772|FG003|STARTED|Overall Study||4
3360043|NCT04397445|4090769|FG000|COMPLETED|Overall Study||4
3360044|NCT04397445|4090770|FG001|COMPLETED|Overall Study||5
3360045|NCT04397445|4090771|FG002|COMPLETED|Overall Study||4
3360046|NCT04397445|4090772|FG003|COMPLETED|Overall Study||4
3360047|NCT04397445|4090769|FG000|NOT COMPLETED|Overall Study||1
3360048|NCT04397445|4090770|FG001|NOT COMPLETED|Overall Study||0
3360049|NCT04397445|4090771|FG002|NOT COMPLETED|Overall Study||0
3360050|NCT04397445|4090772|FG003|NOT COMPLETED|Overall Study||0
3360051|NCT04397094|4090789|FG000|STARTED|Overall Study||30
3360052|NCT04397094|4090790|FG001|STARTED|Overall Study||30
3360053|NCT04397094|4090789|FG000|COMPLETED|Overall Study||30
3360054|NCT04397094|4090790|FG001|COMPLETED|Overall Study||30
3360055|NCT04397094|4090789|FG000|NOT COMPLETED|Overall Study||0
3360056|NCT04397094|4090790|FG001|NOT COMPLETED|Overall Study||0
3360057|NCT04396639|4090798|FG000|STARTED|Overall Study||50
3360058|NCT04396639|4090798|FG000|Completed Follow up|Overall Study||48
3360059|NCT04396639|4090798|FG000|COMPLETED|Overall Study||48
3360060|NCT04396639|4090798|FG000|NOT COMPLETED|Overall Study||2
3360061|NCT04396665|4090804|FG000|STARTED|Overall Study||134
3360062|NCT04396665|4090805|FG001|STARTED|Overall Study||90
3360063|NCT04396665|4090804|FG000|COMPLETED|Overall Study||99
3360064|NCT04396665|4090805|FG001|COMPLETED|Overall Study||83
3360065|NCT04396665|4090804|FG000|NOT COMPLETED|Overall Study||35
3360066|NCT04396665|4090805|FG001|NOT COMPLETED|Overall Study||7
3360067|NCT04393493|4090817|FG000|STARTED|Follow up||40
3360068|NCT04393493|4090818|FG001|STARTED|Follow up||40
3360069|NCT04393493|4090817|FG000|COMPLETED|Follow up||40
3360070|NCT04393493|4090818|FG001|COMPLETED|Follow up||40
3360071|NCT04393493|4090817|FG000|NOT COMPLETED|Follow up||0
3360072|NCT04393493|4090818|FG001|NOT COMPLETED|Follow up||0
3360073|NCT04393493|4090817|FG000|STARTED|First 4 Days of Intervention||40
3360074|NCT04393493|4090818|FG001|STARTED|First 4 Days of Intervention||40
3360075|NCT04393493|4090817|FG000|COMPLETED|First 4 Days of Intervention||35
3360076|NCT04393493|4090818|FG001|COMPLETED|First 4 Days of Intervention||33
3360077|NCT04393493|4090817|FG000|NOT COMPLETED|First 4 Days of Intervention||5
3360078|NCT04393493|4090818|FG001|NOT COMPLETED|First 4 Days of Intervention||7
3360079|NCT04392362|4090828|FG000|STARTED|Overall Study||23
3360080|NCT04392362|4090829|FG001|STARTED|Overall Study||7
3360081|NCT04392362|4090828|FG000|COMPLETED|Overall Study||23
3360082|NCT04392362|4090829|FG001|COMPLETED|Overall Study||7
3360083|NCT04392362|4090828|FG000|NOT COMPLETED|Overall Study||0
3360084|NCT04392362|4090829|FG001|NOT COMPLETED|Overall Study||0
3360085|NCT04392141|4090837|FG000|STARTED|Overall Study||60
3360086|NCT04392141|4090838|FG001|STARTED|Overall Study||60
3360087|NCT04392141|4090837|FG000|COMPLETED|Overall Study||60
3360088|NCT04392141|4090838|FG001|COMPLETED|Overall Study||60
3360089|NCT04392141|4090837|FG000|NOT COMPLETED|Overall Study||0
3360090|NCT04392141|4090838|FG001|NOT COMPLETED|Overall Study||0
3360091|NCT04392219|4090862|FG000|STARTED|Overall Study||16
3360092|NCT04392219|4090863|FG001|STARTED|Overall Study||6
3360093|NCT04392219|4090864|FG002|STARTED|Overall Study||6
3360094|NCT04392219|4090865|FG003|STARTED|Overall Study||6
3360095|NCT04392219|4090866|FG004|STARTED|Overall Study||6
3360096|NCT04392219|4090867|FG005|STARTED|Overall Study||6
3360097|NCT04392219|4090868|FG006|STARTED|Overall Study||6
3360098|NCT04392219|4090869|FG007|STARTED|Overall Study||6
3360099|NCT04392219|4090870|FG008|STARTED|Overall Study||6
3360100|NCT04392219|4090871|FG009|STARTED|Overall Study||10
3360101|NCT04392219|4090872|FG010|STARTED|Overall Study||14
3360102|NCT04392219|4090873|FG011|STARTED|Overall Study||6
3360103|NCT04392219|4090874|FG012|STARTED|Overall Study||6
3360104|NCT04392219|4090875|FG013|STARTED|Overall Study||6
3179293|NCT01984242|3907462|FG001|Treated|Overall Study||103
3179294|NCT01984242|3907463|FG002|Treated|Overall Study||100
3179295|NCT01984242|3907461|FG000|COMPLETED|Overall Study||0
3360105|NCT04392219|4090876|FG014|STARTED|Overall Study||6
3360106|NCT04392219|4090877|FG015|STARTED|Overall Study||6
3360107|NCT04392219|4090878|FG016|STARTED|Overall Study||6
3360108|NCT04392219|4090879|FG017|STARTED|Overall Study||6
3360109|NCT04392219|4090862|FG000|COMPLETED|Overall Study||16
3360110|NCT04392219|4090863|FG001|COMPLETED|Overall Study||6
3360111|NCT04392219|4090864|FG002|COMPLETED|Overall Study||6
3360112|NCT04392219|4090865|FG003|COMPLETED|Overall Study||6
3360113|NCT04392219|4090866|FG004|COMPLETED|Overall Study||6
3360114|NCT04392219|4090867|FG005|COMPLETED|Overall Study||6
3360115|NCT04392219|4090868|FG006|COMPLETED|Overall Study||6
3360116|NCT04392219|4090869|FG007|COMPLETED|Overall Study||6
3360117|NCT04392219|4090870|FG008|COMPLETED|Overall Study||6
3360118|NCT04392219|4090871|FG009|COMPLETED|Overall Study||10
3360119|NCT04392219|4090872|FG010|COMPLETED|Overall Study||14
3360120|NCT04392219|4090873|FG011|COMPLETED|Overall Study||6
3360121|NCT04392219|4090874|FG012|COMPLETED|Overall Study||6
3360122|NCT04392219|4090875|FG013|COMPLETED|Overall Study||6
3360123|NCT04392219|4090876|FG014|COMPLETED|Overall Study||6
3360124|NCT04392219|4090877|FG015|COMPLETED|Overall Study||6
3360125|NCT04392219|4090878|FG016|COMPLETED|Overall Study||6
3360126|NCT04392219|4090879|FG017|COMPLETED|Overall Study||6
3360127|NCT04392219|4090862|FG000|NOT COMPLETED|Overall Study||0
3360128|NCT04392219|4090863|FG001|NOT COMPLETED|Overall Study||0
3360129|NCT04392219|4090864|FG002|NOT COMPLETED|Overall Study||0
3360130|NCT04392219|4090865|FG003|NOT COMPLETED|Overall Study||0
3360131|NCT04392219|4090866|FG004|NOT COMPLETED|Overall Study||0
3360132|NCT04392219|4090867|FG005|NOT COMPLETED|Overall Study||0
3360133|NCT04392219|4090868|FG006|NOT COMPLETED|Overall Study||0
3360134|NCT04392219|4090869|FG007|NOT COMPLETED|Overall Study||0
3360135|NCT04392219|4090870|FG008|NOT COMPLETED|Overall Study||0
3360136|NCT04392219|4090871|FG009|NOT COMPLETED|Overall Study||0
3360137|NCT04392219|4090872|FG010|NOT COMPLETED|Overall Study||0
3360138|NCT04392219|4090873|FG011|NOT COMPLETED|Overall Study||0
3360139|NCT04392219|4090874|FG012|NOT COMPLETED|Overall Study||0
3360140|NCT04392219|4090875|FG013|NOT COMPLETED|Overall Study||0
3360141|NCT04392219|4090876|FG014|NOT COMPLETED|Overall Study||0
3360142|NCT04392219|4090877|FG015|NOT COMPLETED|Overall Study||0
3360143|NCT04392219|4090878|FG016|NOT COMPLETED|Overall Study||0
3360144|NCT04392219|4090879|FG017|NOT COMPLETED|Overall Study||0
3360145|NCT04391842|4090917|FG000|STARTED|Overall Study||34
3360146|NCT04391842|4090917|FG000|COMPLETED|Overall Study||32
3360147|NCT04391842|4090917|FG000|NOT COMPLETED|Overall Study||2
3360148|NCT04390022|4090923|FG000|STARTED|Overall Study||12
3360149|NCT04390022|4090924|FG001|STARTED|Overall Study||12
3360150|NCT04390022|4090923|FG000|COMPLETED|Overall Study||12
3360151|NCT04390022|4090924|FG001|COMPLETED|Overall Study||12
3360152|NCT04390022|4090923|FG000|NOT COMPLETED|Overall Study||0
3360153|NCT04390022|4090924|FG001|NOT COMPLETED|Overall Study||0
3360154|NCT04386902|4090930|FG000|STARTED|Overall Study||60
3360155|NCT04386902|4090930|FG000|COMPLETED|Overall Study||50
3360156|NCT04386902|4090930|FG000|NOT COMPLETED|Overall Study||10
3360157|NCT04385238|4090936|FG000|STARTED|Overall Study||5712
3360158|NCT04385238|4090937|FG001|STARTED|Overall Study||1182
3360159|NCT04385238|4090936|FG000|COMPLETED|Overall Study||5712
3360160|NCT04385238|4090937|FG001|COMPLETED|Overall Study||1182
3360161|NCT04385238|4090936|FG000|NOT COMPLETED|Overall Study||0
3360162|NCT04385238|4090937|FG001|NOT COMPLETED|Overall Study||0
3360163|NCT04384523|4090949|FG000|STARTED|Overall Study||10
3360164|NCT04384523|4090950|FG001|STARTED|Overall Study||6
3360165|NCT04384523|4090951|FG002|STARTED|Overall Study||6
3360166|NCT04384523|4090952|FG003|STARTED|Overall Study||6
3360167|NCT04384523|4090953|FG004|STARTED|Overall Study||7
3360168|NCT04384523|4090954|FG005|STARTED|Overall Study||6
3360169|NCT04384523|4090949|FG000|COMPLETED|Overall Study||9
3360170|NCT04384523|4090950|FG001|COMPLETED|Overall Study||5
3360171|NCT04384523|4090951|FG002|COMPLETED|Overall Study||6
3360172|NCT04384523|4090952|FG003|COMPLETED|Overall Study||6
3360173|NCT04384523|4090953|FG004|COMPLETED|Overall Study||7
3360174|NCT04384523|4090954|FG005|COMPLETED|Overall Study||5
3360175|NCT04384523|4090949|FG000|NOT COMPLETED|Overall Study||1
3360176|NCT04384523|4090950|FG001|NOT COMPLETED|Overall Study||1
3360177|NCT04384523|4090951|FG002|NOT COMPLETED|Overall Study||0
3360178|NCT04384523|4090952|FG003|NOT COMPLETED|Overall Study||0
3360179|NCT04384523|4090953|FG004|NOT COMPLETED|Overall Study||0
3360180|NCT04384523|4090954|FG005|NOT COMPLETED|Overall Study||1
3360181|NCT04383665|4090974|FG000|STARTED|Overall Study||2
3360182|NCT04383665|4090975|FG001|STARTED|Overall Study||2
3360183|NCT04383665|4090976|FG002|STARTED|Overall Study||2
3360184|NCT04383665|4090977|FG003|STARTED|Overall Study||2
3360185|NCT04383665|4090978|FG004|STARTED|Overall Study||2
3360186|NCT04383665|4090979|FG005|STARTED|Overall Study||2
3360187|NCT04383665|4090974|FG000|COMPLETED|Overall Study||2
3360188|NCT04383665|4090975|FG001|COMPLETED|Overall Study||2
3360189|NCT04383665|4090976|FG002|COMPLETED|Overall Study||2
3360190|NCT04383665|4090977|FG003|COMPLETED|Overall Study||2
3360191|NCT04383665|4090978|FG004|COMPLETED|Overall Study||2
3360192|NCT04383665|4090979|FG005|COMPLETED|Overall Study||2
3360193|NCT04383665|4090974|FG000|NOT COMPLETED|Overall Study||0
3360194|NCT04383665|4090975|FG001|NOT COMPLETED|Overall Study||0
3360195|NCT04383665|4090976|FG002|NOT COMPLETED|Overall Study||0
3360196|NCT04383665|4090977|FG003|NOT COMPLETED|Overall Study||0
3360197|NCT04383665|4090978|FG004|NOT COMPLETED|Overall Study||0
3360198|NCT04383665|4090979|FG005|NOT COMPLETED|Overall Study||0
3360199|NCT04383132|4090989|FG000|STARTED|Overall Study||173
3360200|NCT04383132|4090990|FG001|STARTED|Overall Study||173
3360201|NCT04383132|4090989|FG000|COMPLETED|Overall Study||173
3360202|NCT04383132|4090990|FG001|COMPLETED|Overall Study||173
2928259|NCT00576693|3639163|FG000|COMPLETED|Overall Study||214
2928260|NCT00576693|3639164|FG001|COMPLETED|Overall Study||203
2928261|NCT00576693|3639163|FG000|NOT COMPLETED|Overall Study||10
2928262|NCT00576693|3639164|FG001|NOT COMPLETED|Overall Study||24
2928263|NCT00576732|3639173|FG000|STARTED|DOUBLE BLIND||35
2928264|NCT00576732|3639174|FG001|STARTED|DOUBLE BLIND||30
2928265|NCT00576732|3639175|FG002|STARTED|DOUBLE BLIND||31
2928266|NCT00576732|3639176|FG003|STARTED|DOUBLE BLIND||0
2928267|NCT00576732|3639177|FG004|STARTED|DOUBLE BLIND||0
2928268|NCT00576732|3639178|FG005|STARTED|DOUBLE BLIND||0
2928269|NCT00576732|3639173|FG000|COMPLETED|DOUBLE BLIND||27
2928270|NCT00576732|3639174|FG001|COMPLETED|DOUBLE BLIND||25
2928271|NCT00576732|3639175|FG002|COMPLETED|DOUBLE BLIND||25
2928272|NCT00576732|3639176|FG003|COMPLETED|DOUBLE BLIND||0
3360203|NCT04383132|4090989|FG000|NOT COMPLETED|Overall Study||0
3360204|NCT04383132|4090990|FG001|NOT COMPLETED|Overall Study||0
3360205|NCT04382066|4090999|FG000|STARTED|Overall Study||15
3360206|NCT04382066|4091000|FG001|STARTED|Overall Study||15
3360207|NCT04382066|4091001|FG002|STARTED|Overall Study||15
3360208|NCT04382066|4090999|FG000|Completed 3-day Treatment|Overall Study||14
3360209|NCT04382066|4091000|FG001|Completed 3-day Treatment|Overall Study||15
3360210|NCT04382066|4091001|FG002|Completed 3-day Treatment|Overall Study||15
3360211|NCT04382066|4090999|FG000|COMPLETED|Overall Study||13
3360212|NCT04382066|4091000|FG001|COMPLETED|Overall Study||15
3360213|NCT04382066|4091001|FG002|COMPLETED|Overall Study||14
3360214|NCT04382066|4090999|FG000|NOT COMPLETED|Overall Study||2
3360215|NCT04382066|4091000|FG001|NOT COMPLETED|Overall Study||0
3360216|NCT04382066|4091001|FG002|NOT COMPLETED|Overall Study||1
3360217|NCT04381481|4091023|FG000|STARTED|Overall Study||200
3360218|NCT04381481|4091024|FG001|STARTED|Overall Study||205
3360219|NCT04381481|4091025|FG002|STARTED|Overall Study||199
3360220|NCT04381481|4091026|FG003|STARTED|Overall Study||197
3360221|NCT04381481|4091027|FG004|STARTED|Overall Study||199
3360222|NCT04381481|4091028|FG005|STARTED|Overall Study||195
3360223|NCT04381481|4091029|FG006|STARTED|Overall Study||194
3360224|NCT04381481|4091030|FG007|STARTED|Overall Study||193
3360225|NCT04381481|4091031|FG008|STARTED|Overall Study||214
3360226|NCT04381481|4091032|FG009|STARTED|Overall Study||198
3360227|NCT04381481|4091033|FG010|STARTED|Overall Study||192
3360228|NCT04381481|4091034|FG011|STARTED|Overall Study||188
3360229|NCT04381481|4091023|FG000|COMPLETED|Overall Study||185
3360230|NCT04381481|4091024|FG001|COMPLETED|Overall Study||190
3360231|NCT04381481|4091025|FG002|COMPLETED|Overall Study||190
3360232|NCT04381481|4091026|FG003|COMPLETED|Overall Study||183
3360233|NCT04381481|4091027|FG004|COMPLETED|Overall Study||191
3360234|NCT04381481|4091028|FG005|COMPLETED|Overall Study||180
3360235|NCT04381481|4091029|FG006|COMPLETED|Overall Study||184
3360236|NCT04381481|4091030|FG007|COMPLETED|Overall Study||177
3360237|NCT04381481|4091031|FG008|COMPLETED|Overall Study||195
3360238|NCT04381481|4091032|FG009|COMPLETED|Overall Study||188
3360239|NCT04381481|4091033|FG010|COMPLETED|Overall Study||183
3360240|NCT04381481|4091034|FG011|COMPLETED|Overall Study||173
3360241|NCT04381481|4091023|FG000|NOT COMPLETED|Overall Study||15
3360242|NCT04381481|4091024|FG001|NOT COMPLETED|Overall Study||15
3360243|NCT04381481|4091025|FG002|NOT COMPLETED|Overall Study||9
3360244|NCT04381481|4091026|FG003|NOT COMPLETED|Overall Study||14
3360245|NCT04381481|4091027|FG004|NOT COMPLETED|Overall Study||8
3360246|NCT04381481|4091028|FG005|NOT COMPLETED|Overall Study||15
3360247|NCT04381481|4091029|FG006|NOT COMPLETED|Overall Study||10
3360248|NCT04381481|4091030|FG007|NOT COMPLETED|Overall Study||16
3360249|NCT04381481|4091031|FG008|NOT COMPLETED|Overall Study||19
3360250|NCT04381481|4091032|FG009|NOT COMPLETED|Overall Study||10
3360251|NCT04381481|4091033|FG010|NOT COMPLETED|Overall Study||9
3360252|NCT04381481|4091034|FG011|NOT COMPLETED|Overall Study||15
3360253|NCT04380688|4091062|FG000|STARTED|Overall Study||31
3360254|NCT04380688|4091063|FG001|STARTED|Overall Study||31
3360255|NCT04380688|4091062|FG000|COMPLETED|Overall Study||24
3360256|NCT04380688|4091063|FG001|COMPLETED|Overall Study||22
3360257|NCT04380688|4091062|FG000|NOT COMPLETED|Overall Study||7
3360258|NCT04380688|4091063|FG001|NOT COMPLETED|Overall Study||9
3360259|NCT04376060|4091069|FG000|STARTED|Overall Study||15
3360260|NCT04376060|4091069|FG000|COMPLETED|Overall Study||14
3360261|NCT04376060|4091069|FG000|NOT COMPLETED|Overall Study||1
3360262|NCT04374500|4091073|FG000|STARTED|Overall Study||10
3360263|NCT04374500|4091074|FG001|STARTED|Overall Study||10
3360264|NCT04374500|4091075|FG002|STARTED|Overall Study||83
3360265|NCT04374500|4091073|FG000|COMPLETED|Overall Study||10
3360266|NCT04374500|4091074|FG001|COMPLETED|Overall Study||10
3360267|NCT04374500|4091075|FG002|COMPLETED|Overall Study||83
3360268|NCT04374500|4091073|FG000|NOT COMPLETED|Overall Study||0
3360269|NCT04374500|4091074|FG001|NOT COMPLETED|Overall Study||0
3360270|NCT04374500|4091075|FG002|NOT COMPLETED|Overall Study||0
3360271|NCT04372186|4091088|FG000|STARTED|Overall Study||249
3360272|NCT04372186|4091089|FG001|STARTED|Overall Study||128
3360273|NCT04372186|4091088|FG000|COMPLETED|Overall Study||225
3360274|NCT04372186|4091089|FG001|COMPLETED|Overall Study||115
3360275|NCT04372186|4091088|FG000|NOT COMPLETED|Overall Study||24
3360276|NCT04372186|4091089|FG001|NOT COMPLETED|Overall Study||13
3360277|NCT04371419|4091097|FG000|STARTED|Overall Study||784
3360278|NCT04371419|4091098|FG001|STARTED|Overall Study||791
3360279|NCT04371419|4091099|FG002|STARTED|Overall Study||780
3360280|NCT04371419|4091100|FG003|STARTED|Overall Study||778
3360281|NCT04371419|4091101|FG004|STARTED|Overall Study||777
3360282|NCT04371419|4091102|FG005|STARTED|Overall Study||788
3360283|NCT04371419|4091103|FG006|STARTED|Overall Study||783
3360284|NCT04371419|4091104|FG007|STARTED|Overall Study||788
3360285|NCT04371419|4091105|FG008|STARTED|Overall Study||779
3360286|NCT04371419|4091106|FG009|STARTED|Overall Study||780
3360287|NCT04371419|4091107|FG010|STARTED|Overall Study||782
3360288|NCT04371419|4091108|FG011|STARTED|Overall Study||790
3360289|NCT04371419|4091109|FG012|STARTED|Overall Study||779
3360290|NCT04371419|4091110|FG013|STARTED|Overall Study||786
3360291|NCT04371419|4091111|FG014|STARTED|Overall Study||781
3360292|NCT04371419|4091112|FG015|STARTED|Overall Study||781
3360293|NCT04371419|4091113|FG016|STARTED|Overall Study||1617
3360294|NCT04371419|4091097|FG000|Completed the Knowledge Questions|Overall Study||663
3360295|NCT04371419|4091098|FG001|Completed the Knowledge Questions|Overall Study||669
3360296|NCT04371419|4091099|FG002|Completed the Knowledge Questions|Overall Study||673
3360297|NCT04371419|4091100|FG003|Completed the Knowledge Questions|Overall Study||664
3360298|NCT04371419|4091101|FG004|Completed the Knowledge Questions|Overall Study||666
3360299|NCT04371419|4091102|FG005|Completed the Knowledge Questions|Overall Study||683
3360300|NCT04371419|4091103|FG006|Completed the Knowledge Questions|Overall Study||664
3360301|NCT04371419|4091104|FG007|Completed the Knowledge Questions|Overall Study||679
3360302|NCT04371419|4091105|FG008|Completed the Knowledge Questions|Overall Study||670
3360303|NCT04371419|4091106|FG009|Completed the Knowledge Questions|Overall Study||655
3360304|NCT04371419|4091107|FG010|Completed the Knowledge Questions|Overall Study||656
3360305|NCT04371419|4091108|FG011|Completed the Knowledge Questions|Overall Study||692
3360306|NCT04371419|4091109|FG012|Completed the Knowledge Questions|Overall Study||664
3360307|NCT04371419|4091110|FG013|Completed the Knowledge Questions|Overall Study||687
2928273|NCT00576732|3639177|FG004|COMPLETED|DOUBLE BLIND||0
2928274|NCT00576732|3639178|FG005|COMPLETED|DOUBLE BLIND||0
2928275|NCT00576732|3639173|FG000|NOT COMPLETED|DOUBLE BLIND||8
2928276|NCT00576732|3639174|FG001|NOT COMPLETED|DOUBLE BLIND||5
2928277|NCT00576732|3639175|FG002|NOT COMPLETED|DOUBLE BLIND||6
2928278|NCT00576732|3639176|FG003|NOT COMPLETED|DOUBLE BLIND||0
2928279|NCT00576732|3639177|FG004|NOT COMPLETED|DOUBLE BLIND||0
2928280|NCT00576732|3639178|FG005|NOT COMPLETED|DOUBLE BLIND||0
2928281|NCT00576732|3639173|FG000|STARTED|OPEN LABEL||0
2928282|NCT00576732|3639174|FG001|STARTED|OPEN LABEL||0
2928283|NCT00576732|3639175|FG002|STARTED|OPEN LABEL||0
2928284|NCT00576732|3639176|FG003|STARTED|OPEN LABEL|26 of 27 double-blind placebo completers and 4 of 8 placebo non-completers entered open-label.|30
2928285|NCT00576732|3639177|FG004|STARTED|OPEN LABEL|24 of 25 double-blind RIS low dose completers and 0 RIS low dose non-completers entered open-label.|24
2928286|NCT00576732|3639178|FG005|STARTED|OPEN LABEL|All 25 double-blind RIS high dose completers and 0 RIS high dose non-completers entered open-label.|25
2928287|NCT00576732|3639173|FG000|COMPLETED|OPEN LABEL||0
2928288|NCT00576732|3639174|FG001|COMPLETED|OPEN LABEL||0
2928289|NCT00576732|3639175|FG002|COMPLETED|OPEN LABEL||0
2928290|NCT00576732|3639176|FG003|COMPLETED|OPEN LABEL||19
2928291|NCT00576732|3639177|FG004|COMPLETED|OPEN LABEL||20
2928292|NCT00576732|3639178|FG005|COMPLETED|OPEN LABEL||17
2928293|NCT00576732|3639173|FG000|NOT COMPLETED|OPEN LABEL||0
2928294|NCT00576732|3639174|FG001|NOT COMPLETED|OPEN LABEL||0
2928295|NCT00576732|3639175|FG002|NOT COMPLETED|OPEN LABEL||0
2928296|NCT00576732|3639176|FG003|NOT COMPLETED|OPEN LABEL||11
2928297|NCT00576732|3639177|FG004|NOT COMPLETED|OPEN LABEL||4
3040036|NCT01162005|3759505|FG001|STARTED|Overall Study||33
3040037|NCT01162005|3759504|FG000|COMPLETED|Overall Study||44
3040038|NCT01162005|3759505|FG001|COMPLETED|Overall Study||33
3040039|NCT01162005|3759504|FG000|NOT COMPLETED|Overall Study||0
3040040|NCT01162005|3759505|FG001|NOT COMPLETED|Overall Study||0
3040041|NCT01162096|3759513|FG000|STARTED|Overall Study||34
3040042|NCT01162096|3759513|FG000|COMPLETED|Overall Study||34
3040043|NCT01162096|3759513|FG000|NOT COMPLETED|Overall Study||0
3040044|NCT01162122|3759520|FG000|STARTED|Overall Study||3552
3040045|NCT01162122|3759521|FG001|STARTED|Overall Study||3552
3040046|NCT01162122|3759520|FG000|Vaccinated|Overall Study||3541
3040047|NCT01162122|3759521|FG001|Vaccinated|Overall Study||3541
3040048|NCT01162122|3759520|FG000|COMPLETED|Overall Study||3361
3040049|NCT01162122|3759521|FG001|COMPLETED|Overall Study||3356
3040050|NCT01162122|3759520|FG000|NOT COMPLETED|Overall Study||191
3040051|NCT01162122|3759521|FG001|NOT COMPLETED|Overall Study||196
3040052|NCT01162135|3759530|FG000|STARTED|Overall Study||16
3040053|NCT01162135|3759530|FG000|COMPLETED|Overall Study||13
3040054|NCT01162135|3759530|FG000|NOT COMPLETED|Overall Study||3
3040055|NCT01162239|3759538|FG000|STARTED|Treatment Phase||55
3040056|NCT01162239|3759539|FG001|STARTED|Treatment Phase||54
3040057|NCT01162239|3759540|FG002|STARTED|Treatment Phase||52
3040058|NCT01162239|3759541|FG003|STARTED|Treatment Phase||55
3040059|NCT01162239|3759538|FG000|Week 12|Treatment Phase||50
3040060|NCT01162239|3759539|FG001|Week 12|Treatment Phase||51
3040061|NCT01162239|3759540|FG002|Week 12|Treatment Phase||49
3040062|NCT01162239|3759541|FG003|Week 12|Treatment Phase||53
3040063|NCT01162239|3759538|FG000|Week 24|Treatment Phase||51
3040064|NCT01162239|3759539|FG001|Week 24|Treatment Phase||48
3040065|NCT01162239|3759540|FG002|Week 24|Treatment Phase||48
3040066|NCT01162239|3759541|FG003|Week 24|Treatment Phase||50
3040067|NCT01162239|3759538|FG000|Week 52|Treatment Phase||49
3040068|NCT01162239|3759539|FG001|Week 52|Treatment Phase||47
3040069|NCT01162239|3759540|FG002|Week 52|Treatment Phase||48
3040070|NCT01162239|3759541|FG003|Week 52|Treatment Phase||50
3040071|NCT01162239|3759538|FG000|COMPLETED|Treatment Phase||49
3040072|NCT01162239|3759539|FG001|COMPLETED|Treatment Phase||47
3040073|NCT01162239|3759540|FG002|COMPLETED|Treatment Phase||48
3040074|NCT01162239|3759541|FG003|COMPLETED|Treatment Phase||50
3040075|NCT01162239|3759538|FG000|NOT COMPLETED|Treatment Phase||6
3040076|NCT01162239|3759539|FG001|NOT COMPLETED|Treatment Phase||7
3040077|NCT01162239|3759540|FG002|NOT COMPLETED|Treatment Phase||4
3040078|NCT01162239|3759541|FG003|NOT COMPLETED|Treatment Phase||5
3360308|NCT04371419|4091111|FG014|Completed the Knowledge Questions|Overall Study||652
3360309|NCT04371419|4091112|FG015|Completed the Knowledge Questions|Overall Study||652
3360310|NCT04371419|4091113|FG016|Completed the Knowledge Questions|Overall Study||1526
3040079|NCT01162239|3759538|FG000|STARTED|Extended Follow-up||47
3040080|NCT01162239|3759539|FG001|STARTED|Extended Follow-up||45
3360311|NCT04371419|4091097|FG000|COMPLETED|Overall Study||641
3360312|NCT04371419|4091098|FG001|COMPLETED|Overall Study||636
3360313|NCT04371419|4091099|FG002|COMPLETED|Overall Study||639
3360314|NCT04371419|4091100|FG003|COMPLETED|Overall Study||631
3360315|NCT04371419|4091101|FG004|COMPLETED|Overall Study||644
3360316|NCT04371419|4091102|FG005|COMPLETED|Overall Study||654
3360317|NCT04371419|4091103|FG006|COMPLETED|Overall Study||639
3360318|NCT04371419|4091104|FG007|COMPLETED|Overall Study||658
3360319|NCT04371419|4091105|FG008|COMPLETED|Overall Study||649
3360320|NCT04371419|4091106|FG009|COMPLETED|Overall Study||621
3360321|NCT04371419|4091107|FG010|COMPLETED|Overall Study||626
3360322|NCT04371419|4091108|FG011|COMPLETED|Overall Study||662
3360323|NCT04371419|4091109|FG012|COMPLETED|Overall Study||633
3360324|NCT04371419|4091110|FG013|COMPLETED|Overall Study||660
3360325|NCT04371419|4091111|FG014|COMPLETED|Overall Study||626
3360326|NCT04371419|4091112|FG015|COMPLETED|Overall Study||625
3360327|NCT04371419|4091113|FG016|COMPLETED|Overall Study||1450
3360328|NCT04371419|4091097|FG000|NOT COMPLETED|Overall Study||143
3360329|NCT04371419|4091098|FG001|NOT COMPLETED|Overall Study||155
3360330|NCT04371419|4091099|FG002|NOT COMPLETED|Overall Study||141
3360331|NCT04371419|4091100|FG003|NOT COMPLETED|Overall Study||147
3360332|NCT04371419|4091101|FG004|NOT COMPLETED|Overall Study||133
3360333|NCT04371419|4091102|FG005|NOT COMPLETED|Overall Study||134
3360334|NCT04371419|4091103|FG006|NOT COMPLETED|Overall Study||144
3360335|NCT04371419|4091104|FG007|NOT COMPLETED|Overall Study||130
3360336|NCT04371419|4091105|FG008|NOT COMPLETED|Overall Study||130
3360337|NCT04371419|4091106|FG009|NOT COMPLETED|Overall Study||159
3360338|NCT04371419|4091107|FG010|NOT COMPLETED|Overall Study||156
3360339|NCT04371419|4091108|FG011|NOT COMPLETED|Overall Study||128
3360340|NCT04371419|4091109|FG012|NOT COMPLETED|Overall Study||146
3360341|NCT04371419|4091110|FG013|NOT COMPLETED|Overall Study||126
3360342|NCT04371419|4091111|FG014|NOT COMPLETED|Overall Study||155
3360343|NCT04371419|4091112|FG015|NOT COMPLETED|Overall Study||156
3360344|NCT04371419|4091113|FG016|NOT COMPLETED|Overall Study||167
3360345|NCT04370834|4091144|FG000|STARTED|Overall Study||1
3360346|NCT04370834|4091144|FG000|COMPLETED|Overall Study||1
3360347|NCT04370834|4091144|FG000|NOT COMPLETED|Overall Study||0
3360348|NCT04370548|4091156|FG000|STARTED|Overall Study||204
3360349|NCT04370548|4091157|FG001|STARTED|Overall Study||103
3360350|NCT04370548|4091156|FG000|COMPLETED|Overall Study||190
3360351|NCT04370548|4091157|FG001|COMPLETED|Overall Study||100
3360352|NCT04370548|4091156|FG000|NOT COMPLETED|Overall Study||14
3360353|NCT04370548|4091157|FG001|NOT COMPLETED|Overall Study||3
3360354|NCT04370028|4091163|FG000|STARTED|Overall Study||2583
3360355|NCT04370028|4091163|FG000|COMPLETED|Overall Study||1876
3360356|NCT04370028|4091163|FG000|NOT COMPLETED|Overall Study||707
3360357|NCT04368429|4091176|FG000|STARTED|Overall Study||180
3360358|NCT04368429|4091177|FG001|STARTED|Overall Study||180
3360359|NCT04368429|4091176|FG000|Safety Analysis Set|Overall Study||179
3360360|NCT04368429|4091177|FG001|Safety Analysis Set|Overall Study||180
3360361|NCT04368429|4091176|FG000|COMPLETED|Overall Study||179
3360362|NCT04368429|4091177|FG001|COMPLETED|Overall Study||180
3360363|NCT04368429|4091176|FG000|NOT COMPLETED|Overall Study||1
3360364|NCT04368429|4091177|FG001|NOT COMPLETED|Overall Study||0
3360365|NCT04363736|4091185|FG000|STARTED|Overall Study||49
3360366|NCT04363736|4091186|FG001|STARTED|Overall Study||48
3360367|NCT04363736|4091185|FG000|COMPLETED|Overall Study||30
3360368|NCT04363736|4091186|FG001|COMPLETED|Overall Study||35
3360369|NCT04363736|4091185|FG000|NOT COMPLETED|Overall Study||19
3360370|NCT04363736|4091186|FG001|NOT COMPLETED|Overall Study||13
3360371|NCT04366583|4091194|FG000|STARTED|Overall Study||82
3360372|NCT04366583|4091195|FG001|STARTED|Overall Study||84
3360373|NCT04366583|4091194|FG000|COMPLETED|Overall Study||82
3360374|NCT04366583|4091195|FG001|COMPLETED|Overall Study||84
3360375|NCT04366583|4091194|FG000|NOT COMPLETED|Overall Study||0
3360376|NCT04366583|4091195|FG001|NOT COMPLETED|Overall Study||0
3360377|NCT04365699|4091204|FG000|STARTED|Overall Study||10
3360378|NCT04365699|4091205|FG001|STARTED|Overall Study||16
3360379|NCT04365699|4091206|FG002|STARTED|Overall Study||55
3360380|NCT04365699|4091204|FG000|COMPLETED|Overall Study||8
3360381|NCT04365699|4091205|FG001|COMPLETED|Overall Study||11
3360382|NCT04365699|4091206|FG002|COMPLETED|Overall Study||40
3360383|NCT04365699|4091204|FG000|NOT COMPLETED|Overall Study||2
3360384|NCT04365699|4091205|FG001|NOT COMPLETED|Overall Study||5
3360385|NCT04365699|4091206|FG002|NOT COMPLETED|Overall Study||15
3360386|NCT04365153|4091217|FG000|STARTED|Overall Study||15
3360387|NCT04365153|4091218|FG001|STARTED|Overall Study||14
3360388|NCT04365153|4091219|FG002|STARTED|Overall Study||16
3360389|NCT04365153|4091217|FG000|COMPLETED|Overall Study||15
3360390|NCT04365153|4091218|FG001|COMPLETED|Overall Study||14
3360391|NCT04365153|4091219|FG002|COMPLETED|Overall Study||16
3360392|NCT04365153|4091217|FG000|NOT COMPLETED|Overall Study||0
3360393|NCT04365153|4091218|FG001|NOT COMPLETED|Overall Study||0
3360394|NCT04365153|4091219|FG002|NOT COMPLETED|Overall Study||0
3360395|NCT04363879|4091230|FG000|STARTED|Overall Study||78
3360396|NCT04363879|4091231|FG001|STARTED|Overall Study||92
3360397|NCT04363879|4091230|FG000|COMPLETED|Overall Study||78
3360398|NCT04363879|4091231|FG001|COMPLETED|Overall Study||92
3360399|NCT04363879|4091230|FG000|NOT COMPLETED|Overall Study||0
3360400|NCT04363879|4091231|FG001|NOT COMPLETED|Overall Study||0
3360401|NCT04362137|4091239|FG000|STARTED|Overall Study||287
3360402|NCT04362137|4091240|FG001|STARTED|Overall Study||145
3360403|NCT04362137|4091239|FG000|Safety Set|Overall Study||281
3360404|NCT04362137|4091240|FG001|Safety Set|Overall Study||143
3360405|NCT04362137|4091239|FG000|COMPLETED|Overall Study||269
3360406|NCT04362137|4091240|FG001|COMPLETED|Overall Study||139
3360407|NCT04362137|4091239|FG000|NOT COMPLETED|Overall Study||18
3360408|NCT04362137|4091240|FG001|NOT COMPLETED|Overall Study||6
3360409|NCT04359771|4091248|FG000|STARTED|Overall Study|Right eye of every participant was assigned to the diode MPL group|15
3360410|NCT04359771|4091249|FG001|STARTED|Overall Study|Left eye of every participant was assigned to the diode MPL group|15
3360411|NCT04359771|4091248|FG000|COMPLETED|Overall Study|The right eye of each participant was assigned to the diode MPL group|13
3360412|NCT04359771|4091249|FG001|COMPLETED|Overall Study|The left eye of every participant was assigned to the diode MPL group|13
3360413|NCT04359771|4091248|FG000|NOT COMPLETED|Overall Study||2
3360414|NCT04359771|4091249|FG001|NOT COMPLETED|Overall Study||2
3360415|NCT04358991|4091255|FG000|STARTED|Overall Study||20
3360416|NCT04358991|4091255|FG000|COMPLETED|Overall Study||20
3360417|NCT04358991|4091255|FG000|NOT COMPLETED|Overall Study||0
3360418|NCT04358081|4091262|FG000|STARTED|Treatment Phase of Study||7
3360419|NCT04358081|4091263|FG001|STARTED|Treatment Phase of Study||7
3360420|NCT04358081|4091264|FG002|STARTED|Treatment Phase of Study||5
3360421|NCT04358081|4091262|FG000|COMPLETED|Treatment Phase of Study||3
3360422|NCT04358081|4091263|FG001|COMPLETED|Treatment Phase of Study||6
3360423|NCT04358081|4091264|FG002|COMPLETED|Treatment Phase of Study||2
3360424|NCT04358081|4091262|FG000|NOT COMPLETED|Treatment Phase of Study||4
3360425|NCT04358081|4091263|FG001|NOT COMPLETED|Treatment Phase of Study||1
3360426|NCT04358081|4091264|FG002|NOT COMPLETED|Treatment Phase of Study||3
3360427|NCT04358081|4091262|FG000|STARTED|Study Completion Phase||7
3360428|NCT04358081|4091263|FG001|STARTED|Study Completion Phase||7
3360429|NCT04358081|4091264|FG002|STARTED|Study Completion Phase||5
3360430|NCT04358081|4091262|FG000|COMPLETED|Study Completion Phase||6
3360431|NCT04358081|4091263|FG001|COMPLETED|Study Completion Phase||7
3360432|NCT04358081|4091264|FG002|COMPLETED|Study Completion Phase||3
3360433|NCT04358081|4091262|FG000|NOT COMPLETED|Study Completion Phase||1
3360434|NCT04358081|4091263|FG001|NOT COMPLETED|Study Completion Phase||0
3360435|NCT04358081|4091264|FG002|NOT COMPLETED|Study Completion Phase||2
3360436|NCT04356937|4091276|FG000|STARTED|Randomization (Safety Population)||161
3360437|NCT04356937|4091277|FG001|STARTED|Randomization (Safety Population)||82
3360438|NCT04356937|4091276|FG000|COMPLETED|Randomization (Safety Population)||161
3360439|NCT04356937|4091277|FG001|COMPLETED|Randomization (Safety Population)||82
3360440|NCT04356937|4091276|FG000|NOT COMPLETED|Randomization (Safety Population)||0
3360441|NCT04356937|4091277|FG001|NOT COMPLETED|Randomization (Safety Population)||0
3360442|NCT04356937|4091276|FG000|STARTED|Treatment (mITT Population)||161
3360443|NCT04356937|4091277|FG001|STARTED|Treatment (mITT Population)||82
3360444|NCT04356937|4091276|FG000|COMPLETED|Treatment (mITT Population)||161
3360445|NCT04356937|4091277|FG001|COMPLETED|Treatment (mITT Population)||81
3360446|NCT04356937|4091276|FG000|NOT COMPLETED|Treatment (mITT Population)||0
3360447|NCT04356937|4091277|FG001|NOT COMPLETED|Treatment (mITT Population)||1
3360448|NCT04355663|4091286|FG000|STARTED|Overall Study||42
3360449|NCT04355663|4091287|FG001|STARTED|Overall Study||29
3360450|NCT04355663|4091288|FG002|STARTED|Overall Study||21
3360451|NCT04355663|4091286|FG000|COMPLETED|Overall Study||40
3360452|NCT04355663|4091287|FG001|COMPLETED|Overall Study||14
3360453|NCT04355663|4091288|FG002|COMPLETED|Overall Study||17
3360454|NCT04355663|4091286|FG000|NOT COMPLETED|Overall Study||2
3179296|NCT01984242|3907462|FG001|COMPLETED|Overall Study||0
3179297|NCT01984242|3907463|FG002|COMPLETED|Overall Study||0
3360455|NCT04355663|4091287|FG001|NOT COMPLETED|Overall Study||15
3360456|NCT04355663|4091288|FG002|NOT COMPLETED|Overall Study||4
3360457|NCT04354870|4091298|FG000|STARTED|Overall Study||83
3360458|NCT04354870|4091299|FG001|STARTED|Overall Study||47
3360459|NCT04354870|4091298|FG000|COMPLETED|Overall Study||35
3360460|NCT04354870|4091299|FG001|COMPLETED|Overall Study||14
3360461|NCT04354870|4091298|FG000|NOT COMPLETED|Overall Study||48
3360462|NCT04354870|4091299|FG001|NOT COMPLETED|Overall Study||33
3360463|NCT04350307|4091307|FG000|STARTED|Overall Study||84
3360464|NCT04350307|4091308|FG001|STARTED|Overall Study||78
3360465|NCT04350307|4091307|FG000|COMPLETED|Overall Study||84
3360466|NCT04350307|4091308|FG001|COMPLETED|Overall Study||78
3360467|NCT04350307|4091307|FG000|NOT COMPLETED|Overall Study||0
3360468|NCT04350307|4091308|FG001|NOT COMPLETED|Overall Study||0
3360469|NCT04352660|4091316|FG000|STARTED|Overall Study||50
3360470|NCT04352660|4091317|FG001|STARTED|Overall Study||50
3360471|NCT04352660|4091316|FG000|COMPLETED|Overall Study||36
3360472|NCT04352660|4091317|FG001|COMPLETED|Overall Study||40
3360473|NCT04352660|4091316|FG000|NOT COMPLETED|Overall Study||14
3360474|NCT04352660|4091317|FG001|NOT COMPLETED|Overall Study||10
3360475|NCT04350788|4091325|FG000|STARTED|Overall Study||62
3360476|NCT04350788|4091326|FG001|STARTED|Overall Study||62
3360477|NCT04350788|4091325|FG000|COMPLETED|Overall Study||50
3360478|NCT04350788|4091326|FG001|COMPLETED|Overall Study||56
3360479|NCT04350788|4091325|FG000|NOT COMPLETED|Overall Study||12
3360480|NCT04350788|4091326|FG001|NOT COMPLETED|Overall Study||6
3360481|NCT04349917|4091339|FG000|STARTED|First Intervention (2-4 Hours)||19
3360482|NCT04349917|4091340|FG001|STARTED|First Intervention (2-4 Hours)||18
3360483|NCT04349917|4091339|FG000|Received Intervention|First Intervention (2-4 Hours)||19
3360484|NCT04349917|4091340|FG001|Received Intervention|First Intervention (2-4 Hours)||17
3360485|NCT04349917|4091339|FG000|COMPLETED|First Intervention (2-4 Hours)||19
3360486|NCT04349917|4091340|FG001|COMPLETED|First Intervention (2-4 Hours)||16
3360487|NCT04349917|4091339|FG000|NOT COMPLETED|First Intervention (2-4 Hours)||0
3360488|NCT04349917|4091340|FG001|NOT COMPLETED|First Intervention (2-4 Hours)||2
3360489|NCT04349917|4091339|FG000|STARTED|Washout Period (4-20 Days)||19
3360490|NCT04349917|4091340|FG001|STARTED|Washout Period (4-20 Days)||16
3360491|NCT04349917|4091339|FG000|COMPLETED|Washout Period (4-20 Days)||19
3360492|NCT04349917|4091340|FG001|COMPLETED|Washout Period (4-20 Days)||16
3360493|NCT04349917|4091339|FG000|NOT COMPLETED|Washout Period (4-20 Days)||0
3360494|NCT04349917|4091340|FG001|NOT COMPLETED|Washout Period (4-20 Days)||0
3360495|NCT04349917|4091339|FG000|STARTED|Second Intervention (2-4 Hours)||19
3360496|NCT04349917|4091340|FG001|STARTED|Second Intervention (2-4 Hours)||16
3360497|NCT04349917|4091339|FG000|Received Intervention|Second Intervention (2-4 Hours)||19
3360498|NCT04349917|4091340|FG001|Received Intervention|Second Intervention (2-4 Hours)||16
3360499|NCT04349917|4091339|FG000|COMPLETED|Second Intervention (2-4 Hours)||19
3360500|NCT04349917|4091340|FG001|COMPLETED|Second Intervention (2-4 Hours)||16
3360501|NCT04349917|4091339|FG000|NOT COMPLETED|Second Intervention (2-4 Hours)||0
3360502|NCT04349917|4091340|FG001|NOT COMPLETED|Second Intervention (2-4 Hours)||0
3360503|NCT04348851|4091351|FG000|STARTED|Post-Test 1||13
3360504|NCT04348851|4091352|FG001|STARTED|Post-Test 1||13
3360505|NCT04348851|4091353|FG002|STARTED|Post-Test 1||13
3360506|NCT04348851|4091354|FG003|STARTED|Post-Test 1||14
3360507|NCT04348851|4091351|FG000|COMPLETED|Post-Test 1||13
3360508|NCT04348851|4091352|FG001|COMPLETED|Post-Test 1||11
3360509|NCT04348851|4091353|FG002|COMPLETED|Post-Test 1||13
3360510|NCT04348851|4091354|FG003|COMPLETED|Post-Test 1||14
3360511|NCT04348851|4091351|FG000|NOT COMPLETED|Post-Test 1||0
3360512|NCT04348851|4091352|FG001|NOT COMPLETED|Post-Test 1||2
3360513|NCT04348851|4091353|FG002|NOT COMPLETED|Post-Test 1||0
3360514|NCT04348851|4091354|FG003|NOT COMPLETED|Post-Test 1||0
3360515|NCT04348851|4091351|FG000|STARTED|Post-Test 2||13
3360516|NCT04348851|4091352|FG001|STARTED|Post-Test 2||11
3360517|NCT04348851|4091353|FG002|STARTED|Post-Test 2||13
3360518|NCT04348851|4091354|FG003|STARTED|Post-Test 2||14
3360519|NCT04348851|4091351|FG000|COMPLETED|Post-Test 2||13
3360520|NCT04348851|4091352|FG001|COMPLETED|Post-Test 2||10
3360521|NCT04348851|4091353|FG002|COMPLETED|Post-Test 2||13
3360522|NCT04348851|4091354|FG003|COMPLETED|Post-Test 2||13
3360523|NCT04348851|4091351|FG000|NOT COMPLETED|Post-Test 2||0
3360524|NCT04348851|4091352|FG001|NOT COMPLETED|Post-Test 2||1
3360525|NCT04348851|4091353|FG002|NOT COMPLETED|Post-Test 2||0
3360526|NCT04348851|4091354|FG003|NOT COMPLETED|Post-Test 2||1
3360527|NCT04348357|4091366|FG000|STARTED|Overall Study||25
3360528|NCT04348357|4091367|FG001|STARTED|Overall Study||28
3360529|NCT04348357|4091366|FG000|COMPLETED|Overall Study||25
3360530|NCT04348357|4091367|FG001|COMPLETED|Overall Study||16
3360531|NCT04348357|4091366|FG000|NOT COMPLETED|Overall Study||0
3360532|NCT04348357|4091367|FG001|NOT COMPLETED|Overall Study||12
3360533|NCT04346199|4091375|FG000|STARTED|Overall Study||89
3360534|NCT04346199|4091376|FG001|STARTED|Overall Study||88
3360535|NCT04346199|4091375|FG000|COMPLETED|Overall Study||74
3360536|NCT04346199|4091376|FG001|COMPLETED|Overall Study||77
3360537|NCT04346199|4091375|FG000|NOT COMPLETED|Overall Study||15
3360538|NCT04346199|4091376|FG001|NOT COMPLETED|Overall Study||11
3360539|NCT04345653|4091382|FG000|STARTED|Overall Study||48
3360540|NCT04345653|4091382|FG000|COMPLETED|Overall Study||46
3360541|NCT04345653|4091382|FG000|NOT COMPLETED|Overall Study||2
3360542|NCT04343261|4091387|FG000|STARTED|Overall Study||48
3360543|NCT04343261|4091387|FG000|COMPLETED|Overall Study||40
3360544|NCT04343261|4091387|FG000|NOT COMPLETED|Overall Study||8
3360545|NCT04343222|4091394|FG000|STARTED|Overall Study||16
3360546|NCT04343222|4091395|FG001|STARTED|Overall Study||15
3360547|NCT04343222|4091396|FG002|STARTED|Overall Study||15
3360548|NCT04343222|4091394|FG000|COMPLETED|Overall Study||16
3360549|NCT04343222|4091395|FG001|COMPLETED|Overall Study||15
3360550|NCT04343222|4091396|FG002|COMPLETED|Overall Study||15
3360551|NCT04343222|4091394|FG000|NOT COMPLETED|Overall Study||0
3360552|NCT04343222|4091395|FG001|NOT COMPLETED|Overall Study||0
3360553|NCT04343222|4091396|FG002|NOT COMPLETED|Overall Study||0
3360554|NCT04343092|4091404|FG000|STARTED|Overall Study||16
3360555|NCT04343092|4091404|FG000|COMPLETED|Overall Study||16
3360556|NCT04343092|4091404|FG000|NOT COMPLETED|Overall Study||0
3360557|NCT04342663|4091410|FG000|STARTED|Overall Study||80
3360558|NCT04342663|4091411|FG001|STARTED|Overall Study||72
3360559|NCT04342663|4091410|FG000|COMPLETED|Overall Study||62
3360560|NCT04342663|4091411|FG001|COMPLETED|Overall Study||53
3360561|NCT04342663|4091410|FG000|NOT COMPLETED|Overall Study||18
3360562|NCT04342663|4091411|FG001|NOT COMPLETED|Overall Study||19
3360563|NCT04342897|4091419|FG000|STARTED|Overall Study||47
3360564|NCT04342897|4091420|FG001|STARTED|Overall Study||48
3360565|NCT04342897|4091419|FG000|Received at Least One Dose of Study Drug|Overall Study||47
3360566|NCT04342897|4091420|FG001|Received at Least One Dose of Study Drug|Overall Study||48
3360567|NCT04342897|4091419|FG000|COMPLETED|Overall Study||33
3360568|NCT04342897|4091420|FG001|COMPLETED|Overall Study||36
3360569|NCT04342897|4091419|FG000|NOT COMPLETED|Overall Study||14
3360570|NCT04342897|4091420|FG001|NOT COMPLETED|Overall Study||12
3360571|NCT04342130|4091426|FG000|STARTED|Overall Study||10
3360572|NCT04342130|4091426|FG000|COMPLETED|Overall Study||10
3360573|NCT04342130|4091426|FG000|NOT COMPLETED|Overall Study||0
3360574|NCT04340557|4091432|FG000|STARTED|Overall Study||16
3179298|NCT01984242|3907461|FG000|NOT COMPLETED|Overall Study||101
3179299|NCT01984242|3907462|FG001|NOT COMPLETED|Overall Study||103
3179300|NCT01984242|3907463|FG002|NOT COMPLETED|Overall Study||101
3179301|NCT01984294|3907482|FG000|STARTED|Overall Study||35
3179302|NCT01984294|3907483|FG001|STARTED|Overall Study||32
3179303|NCT01984294|3907484|FG002|STARTED|Overall Study||34
3179304|NCT01984294|3907482|FG000|COMPLETED|Overall Study||31
3360575|NCT04340557|4091433|FG001|STARTED|Overall Study||15
3360576|NCT04340557|4091432|FG000|COMPLETED|Overall Study||15
3360577|NCT04340557|4091433|FG001|COMPLETED|Overall Study||13
3360578|NCT04340557|4091432|FG000|NOT COMPLETED|Overall Study||1
3360579|NCT04340557|4091433|FG001|NOT COMPLETED|Overall Study||2
3360580|NCT04339972|4091441|FG000|STARTED|Overall Study||15
3360581|NCT04339972|4091442|FG001|STARTED|Overall Study||14
3360582|NCT04339972|4091441|FG000|COMPLETED|Overall Study||10
3360583|NCT04339972|4091442|FG001|COMPLETED|Overall Study||9
3360584|NCT04339972|4091441|FG000|NOT COMPLETED|Overall Study||5
3360585|NCT04339972|4091442|FG001|NOT COMPLETED|Overall Study||5
3360586|NCT04339296|4091450|FG000|STARTED|Overall Study||24
3360587|NCT04339296|4091451|FG001|STARTED|Overall Study||26
3360588|NCT04339296|4091450|FG000|Completed Baseline|Overall Study||23
3360589|NCT04339296|4091451|FG001|Completed Baseline|Overall Study||25
3360590|NCT04339296|4091450|FG000|Received Allocated Intervention|Overall Study||21
3360591|NCT04339296|4091451|FG001|Received Allocated Intervention|Overall Study||24
3360592|NCT04339296|4091450|FG000|COMPLETED|Overall Study||16
3360593|NCT04339296|4091451|FG001|COMPLETED|Overall Study||17
3360594|NCT04339296|4091450|FG000|NOT COMPLETED|Overall Study||8
3360595|NCT04339296|4091451|FG001|NOT COMPLETED|Overall Study||9
3360596|NCT04338009|4091459|FG000|STARTED|Overall Study||77
3360597|NCT04338009|4091460|FG001|STARTED|Overall Study||75
3360598|NCT04338009|4091459|FG000|COMPLETED|Overall Study||77
3360599|NCT04338009|4091460|FG001|COMPLETED|Overall Study||75
3360600|NCT04338009|4091459|FG000|NOT COMPLETED|Overall Study||0
3360601|NCT04338009|4091460|FG001|NOT COMPLETED|Overall Study||0
3360602|NCT04338074|4091468|FG000|STARTED|Overall Study||3
3360603|NCT04338074|4091469|FG001|STARTED|Overall Study||2
3360604|NCT04338074|4091468|FG000|COMPLETED|Overall Study||3
3360605|NCT04338074|4091469|FG001|COMPLETED|Overall Study||2
3360606|NCT04338074|4091468|FG000|NOT COMPLETED|Overall Study||0
3360607|NCT04338074|4091469|FG001|NOT COMPLETED|Overall Study||0
3360608|NCT04337138|4091475|FG000|STARTED|Overall Study||32
3360609|NCT04337138|4091475|FG000|COMPLETED|Overall Study||32
3360610|NCT04337138|4091475|FG000|NOT COMPLETED|Overall Study||0
3360611|NCT04336475|4091481|FG000|STARTED|Overall Study||30
3360612|NCT04336475|4091482|FG001|STARTED|Overall Study||30
3360613|NCT04336475|4091481|FG000|COMPLETED|Overall Study||28
3360614|NCT04336475|4091482|FG001|COMPLETED|Overall Study||28
3360615|NCT04336475|4091481|FG000|NOT COMPLETED|Overall Study||2
3360616|NCT04336475|4091482|FG001|NOT COMPLETED|Overall Study||2
3360617|NCT04335929|4091488|FG000|STARTED|Overall Study||32
3360618|NCT04335929|4091488|FG000|COMPLETED|Overall Study||22
3360619|NCT04335929|4091488|FG000|NOT COMPLETED|Overall Study||10
3360620|NCT04335812|4091494|FG000|STARTED|Overall Study||63
3360621|NCT04335812|4091495|FG001|STARTED|Overall Study||63
3360622|NCT04335812|4091494|FG000|COMPLETED|Overall Study||28
3360623|NCT04335812|4091495|FG001|COMPLETED|Overall Study||30
3360624|NCT04335812|4091494|FG000|NOT COMPLETED|Overall Study||35
3360625|NCT04335812|4091495|FG001|NOT COMPLETED|Overall Study||33
3360626|NCT04335136|4091503|FG000|STARTED|Overall Study||91
3360627|NCT04335136|4091504|FG001|STARTED|Overall Study||90
3360628|NCT04335136|4091503|FG000|Treated|Overall Study||88
3360629|NCT04335136|4091504|FG001|Treated|Overall Study||90
3179305|NCT01984294|3907483|FG001|COMPLETED|Overall Study||29
3360630|NCT04335136|4091503|FG000|COMPLETED|Overall Study||77
3360631|NCT04335136|4091504|FG001|COMPLETED|Overall Study||83
3360632|NCT04335136|4091503|FG000|NOT COMPLETED|Overall Study||14
3360633|NCT04335136|4091504|FG001|NOT COMPLETED|Overall Study||7
3360634|NCT04335552|4091514|FG000|STARTED|Overall Study||2
3360635|NCT04335552|4091515|FG001|STARTED|Overall Study||4
3360636|NCT04335552|4091516|FG002|STARTED|Overall Study||3
3360637|NCT04335552|4091517|FG003|STARTED|Overall Study||2
3360638|NCT04335552|4091514|FG000|COMPLETED|Overall Study||1
3360639|NCT04335552|4091515|FG001|COMPLETED|Overall Study||4
3360640|NCT04335552|4091516|FG002|COMPLETED|Overall Study||3
3360641|NCT04335552|4091517|FG003|COMPLETED|Overall Study||2
3360642|NCT04335552|4091514|FG000|NOT COMPLETED|Overall Study||1
3360643|NCT04335552|4091515|FG001|NOT COMPLETED|Overall Study||0
3360644|NCT04335552|4091516|FG002|NOT COMPLETED|Overall Study||0
3360645|NCT04335552|4091517|FG003|NOT COMPLETED|Overall Study||0
3360646|NCT04334876|4091527|FG000|STARTED|Overall Study||571
3360647|NCT04334876|4091527|FG000|COMPLETED|Overall Study||500
3360648|NCT04334876|4091527|FG000|NOT COMPLETED|Overall Study||71
3360649|NCT04334681|4091533|FG000|STARTED|Overall Study||135
3360650|NCT04334681|4091534|FG001|STARTED|Overall Study||143
3360651|NCT04334681|4091533|FG000|COMPLETED|Overall Study||135
3360652|NCT04334681|4091534|FG001|COMPLETED|Overall Study||143
3360653|NCT04334681|4091533|FG000|NOT COMPLETED|Overall Study||0
3360654|NCT04334681|4091534|FG001|NOT COMPLETED|Overall Study||0
3360655|NCT04333225|4091544|FG000|STARTED|Overall Study||101
3360656|NCT04333225|4091545|FG001|STARTED|Overall Study||120
3360657|NCT04333225|4091544|FG000|COMPLETED|Overall Study||98
3360658|NCT04333225|4091545|FG001|COMPLETED|Overall Study||115
3360659|NCT04333225|4091544|FG000|NOT COMPLETED|Overall Study||3
3360660|NCT04333225|4091545|FG001|NOT COMPLETED|Overall Study||5
3360661|NCT04333199|4091554|FG000|STARTED|Evaluated Patients||1669
3360662|NCT04333199|4091555|FG001|STARTED|Evaluated Patients||1672
3360663|NCT04333199|4091556|FG002|STARTED|Evaluated Patients||1671
3360664|NCT04333199|4091554|FG000|COMPLETED|Evaluated Patients||1669
3360665|NCT04333199|4091555|FG001|COMPLETED|Evaluated Patients||1671
3360666|NCT04333199|4091556|FG002|COMPLETED|Evaluated Patients||1669
3360667|NCT04333199|4091554|FG000|NOT COMPLETED|Evaluated Patients||0
3360668|NCT04333199|4091555|FG001|NOT COMPLETED|Evaluated Patients||1
3360669|NCT04333199|4091556|FG002|NOT COMPLETED|Evaluated Patients||2
3360670|NCT04333199|4091554|FG000|STARTED|Emailed Patients|Patients in this group were not emailed|0
3360671|NCT04333199|4091555|FG001|STARTED|Emailed Patients||1671
3360672|NCT04333199|4091556|FG002|STARTED|Emailed Patients||1669
3360673|NCT04333199|4091554|FG000|Valid Email Address|Emailed Patients|Patients in this group were not emailed|0
3360674|NCT04333199|4091555|FG001|Valid Email Address|Emailed Patients||1495
3360675|NCT04333199|4091556|FG002|Valid Email Address|Emailed Patients||1441
3360676|NCT04333199|4091554|FG000|COMPLETED|Emailed Patients|Patients in this group were not emailed|0
3360677|NCT04333199|4091555|FG001|COMPLETED|Emailed Patients||1399
3360678|NCT04333199|4091556|FG002|COMPLETED|Emailed Patients||1351
3360679|NCT04333199|4091554|FG000|NOT COMPLETED|Emailed Patients||0
3360680|NCT04333199|4091555|FG001|NOT COMPLETED|Emailed Patients||272
3360681|NCT04333199|4091556|FG002|NOT COMPLETED|Emailed Patients||318
3360682|NCT04332991|4091567|FG000|STARTED|Overall Study||242
3360683|NCT04332991|4091568|FG001|STARTED|Overall Study||237
3360684|NCT04332991|4091567|FG000|COMPLETED|Overall Study||242
3360685|NCT04332991|4091568|FG001|COMPLETED|Overall Study||237
3360686|NCT04332991|4091567|FG000|NOT COMPLETED|Overall Study||0
3360687|NCT04332991|4091568|FG001|NOT COMPLETED|Overall Study||0
3360688|NCT04332614|4091580|FG000|STARTED|~1 Week After Study Launch||2350
3360689|NCT04332614|4091581|FG001|STARTED|~1 Week After Study Launch||2350
3360690|NCT04332614|4091582|FG002|STARTED|~1 Week After Study Launch||2350
3360691|NCT04332614|4091583|FG003|STARTED|~1 Week After Study Launch||2350
3360692|NCT04332614|4091584|FG004|STARTED|~1 Week After Study Launch||2350
3360693|NCT04332614|4091585|FG005|STARTED|~1 Week After Study Launch||2349
3360694|NCT04332614|4091580|FG000|Data in EHR|~1 Week After Study Launch||2245
3360695|NCT04332614|4091581|FG001|Data in EHR|~1 Week After Study Launch||2273
3360696|NCT04332614|4091582|FG002|Data in EHR|~1 Week After Study Launch||2251
3360697|NCT04332614|4091583|FG003|Data in EHR|~1 Week After Study Launch||2254
3360698|NCT04332614|4091584|FG004|Data in EHR|~1 Week After Study Launch||2251
3360699|NCT04332614|4091585|FG005|Data in EHR|~1 Week After Study Launch||2249
3360700|NCT04332614|4091580|FG000|COMPLETED|~1 Week After Study Launch||2117
3360701|NCT04332614|4091581|FG001|COMPLETED|~1 Week After Study Launch||2129
3360702|NCT04332614|4091582|FG002|COMPLETED|~1 Week After Study Launch||2124
3360703|NCT04332614|4091583|FG003|COMPLETED|~1 Week After Study Launch||2131
3360704|NCT04332614|4091584|FG004|COMPLETED|~1 Week After Study Launch||2127
3360705|NCT04332614|4091585|FG005|COMPLETED|~1 Week After Study Launch||2115
3360706|NCT04332614|4091580|FG000|NOT COMPLETED|~1 Week After Study Launch||233
3360707|NCT04332614|4091581|FG001|NOT COMPLETED|~1 Week After Study Launch||221
3360708|NCT04332614|4091582|FG002|NOT COMPLETED|~1 Week After Study Launch||226
3360709|NCT04332614|4091583|FG003|NOT COMPLETED|~1 Week After Study Launch||219
3360710|NCT04332614|4091584|FG004|NOT COMPLETED|~1 Week After Study Launch||223
3360711|NCT04332614|4091585|FG005|NOT COMPLETED|~1 Week After Study Launch||234
3360712|NCT04332614|4091580|FG000|STARTED|~1 Month After Study Launch||2117
3360713|NCT04332614|4091581|FG001|STARTED|~1 Month After Study Launch||2129
3360714|NCT04332614|4091582|FG002|STARTED|~1 Month After Study Launch||2124
3360715|NCT04332614|4091583|FG003|STARTED|~1 Month After Study Launch||2131
3360716|NCT04332614|4091584|FG004|STARTED|~1 Month After Study Launch||2127
3360717|NCT04332614|4091585|FG005|STARTED|~1 Month After Study Launch||2115
3360718|NCT04332614|4091580|FG000|COMPLETED|~1 Month After Study Launch||2095
3360719|NCT04332614|4091581|FG001|COMPLETED|~1 Month After Study Launch||2107
3360720|NCT04332614|4091582|FG002|COMPLETED|~1 Month After Study Launch||2094
3360721|NCT04332614|4091583|FG003|COMPLETED|~1 Month After Study Launch||2107
3360722|NCT04332614|4091584|FG004|COMPLETED|~1 Month After Study Launch||2107
3360723|NCT04332614|4091585|FG005|COMPLETED|~1 Month After Study Launch||2096
3360724|NCT04332614|4091580|FG000|NOT COMPLETED|~1 Month After Study Launch||22
3360725|NCT04332614|4091581|FG001|NOT COMPLETED|~1 Month After Study Launch||22
3360726|NCT04332614|4091582|FG002|NOT COMPLETED|~1 Month After Study Launch||30
3360727|NCT04332614|4091583|FG003|NOT COMPLETED|~1 Month After Study Launch||24
3360728|NCT04332614|4091584|FG004|NOT COMPLETED|~1 Month After Study Launch||20
3360729|NCT04332614|4091585|FG005|NOT COMPLETED|~1 Month After Study Launch||19
3360730|NCT04322968|4091604|FG000|STARTED|Overall Study||11
3360731|NCT04322968|4091605|FG001|STARTED|Overall Study||10
3360732|NCT04322968|4091606|FG002|STARTED|Overall Study||10
3360733|NCT04322968|4091607|FG003|STARTED|Overall Study||10
3360734|NCT04322968|4091604|FG000|COMPLETED|Overall Study||10
3360735|NCT04322968|4091605|FG001|COMPLETED|Overall Study||9
3360736|NCT04322968|4091606|FG002|COMPLETED|Overall Study||10
3360737|NCT04322968|4091607|FG003|COMPLETED|Overall Study||10
3360738|NCT04322968|4091604|FG000|NOT COMPLETED|Overall Study||1
3360739|NCT04322968|4091605|FG001|NOT COMPLETED|Overall Study||1
3360740|NCT04322968|4091606|FG002|NOT COMPLETED|Overall Study||0
3360741|NCT04322968|4091607|FG003|NOT COMPLETED|Overall Study||0
3360742|NCT04332419|4091617|FG000|STARTED|Overall Study||11
3360743|NCT04332419|4091617|FG000|COMPLETED|Overall Study||10
3360744|NCT04332419|4091617|FG000|NOT COMPLETED|Overall Study||1
3360745|NCT04332081|4091623|FG000|STARTED|Overall Study||20
3360746|NCT04332081|4091624|FG001|STARTED|Overall Study||60
3360747|NCT04332081|4091623|FG000|COMPLETED|Overall Study||20
3360748|NCT04332081|4091624|FG001|COMPLETED|Overall Study||60
3360749|NCT04332081|4091623|FG000|NOT COMPLETED|Overall Study||0
3360750|NCT04332081|4091624|FG001|NOT COMPLETED|Overall Study||0
3360751|NCT04332107|4091632|FG000|STARTED|Day 3||171
3360752|NCT04332107|4091633|FG001|STARTED|Day 3||92
3360753|NCT04332107|4091632|FG000|COMPLETED|Day 3||145
3360754|NCT04332107|4091633|FG001|COMPLETED|Day 3||72
3360755|NCT04332107|4091632|FG000|NOT COMPLETED|Day 3||26
3360756|NCT04332107|4091633|FG001|NOT COMPLETED|Day 3||20
3360757|NCT04332107|4091632|FG000|STARTED|Day 14|Those who had missing measurements at Day 3 but were not completely lost-to-followup were allowed to continue with the trial.|148
3360758|NCT04332107|4091633|FG001|STARTED|Day 14|Those who had missing measurements at Day 3 but were not completely lost-to-followup were allowed to continue with the trial.|78
3360759|NCT04332107|4091632|FG000|COMPLETED|Day 14||131
3360760|NCT04332107|4091633|FG001|COMPLETED|Day 14||70
3360761|NCT04332107|4091632|FG000|NOT COMPLETED|Day 14||17
3360762|NCT04332107|4091633|FG001|NOT COMPLETED|Day 14||8
3360763|NCT04332107|4091632|FG000|STARTED|Day 21|Those who had missing measurements at Day 14 but were not completely lost-to-followup were allowed to continue with the trial.|135
3360764|NCT04332107|4091633|FG001|STARTED|Day 21|Those who had missing measurements at Day 14 but were not completely lost-to-followup were allowed to continue with the trial.|74
3360765|NCT04332107|4091632|FG000|COMPLETED|Day 21||125
3360766|NCT04332107|4091633|FG001|COMPLETED|Day 21||72
3360767|NCT04332107|4091632|FG000|NOT COMPLETED|Day 21||10
3360768|NCT04332107|4091633|FG001|NOT COMPLETED|Day 21||2
3360769|NCT04323592|4091641|FG000|STARTED|Overall Study||83
3360770|NCT04323592|4091642|FG001|STARTED|Overall Study||90
3360771|NCT04323592|4091641|FG000|COMPLETED|Overall Study||83
3360772|NCT04323592|4091642|FG001|COMPLETED|Overall Study||90
3360773|NCT04323592|4091641|FG000|NOT COMPLETED|Overall Study||0
3360774|NCT04323592|4091642|FG001|NOT COMPLETED|Overall Study||0
3360775|NCT04326842|4091650|FG000|STARTED|Overall Study||40
3360776|NCT04326842|4091651|FG001|STARTED|Overall Study||89
3360777|NCT04326842|4091650|FG000|COMPLETED|Overall Study||31
3360778|NCT04326842|4091651|FG001|COMPLETED|Overall Study||31
3360779|NCT04326842|4091650|FG000|NOT COMPLETED|Overall Study||9
3360780|NCT04326842|4091651|FG001|NOT COMPLETED|Overall Study||58
3360781|NCT04325542|4091657|FG000|STARTED|Overall Study|one participant withdraw consent during the study|743
3360782|NCT04325542|4091657|FG000|COMPLETED|Overall Study||742
3360783|NCT04325542|4091657|FG000|NOT COMPLETED|Overall Study||1
3360784|NCT04329923|4091667|FG000|STARTED|Overall Study||17
3360785|NCT04329923|4091668|FG001|STARTED|Overall Study||17
3360786|NCT04329923|4091669|FG002|STARTED|Overall Study||4
3360787|NCT04329923|4091670|FG003|STARTED|Overall Study||3
3360788|NCT04329923|4091671|FG004|STARTED|Overall Study||66
3360789|NCT04329923|4091672|FG005|STARTED|Overall Study||66
3360790|NCT04329923|4091667|FG000|COMPLETED|Overall Study||16
3360791|NCT04329923|4091668|FG001|COMPLETED|Overall Study||13
3360792|NCT04329923|4091669|FG002|COMPLETED|Overall Study||3
3360793|NCT04329923|4091670|FG003|COMPLETED|Overall Study||2
3360794|NCT04329923|4091671|FG004|COMPLETED|Overall Study||64
3360795|NCT04329923|4091672|FG005|COMPLETED|Overall Study||61
3360796|NCT04329923|4091667|FG000|NOT COMPLETED|Overall Study||1
3360797|NCT04329923|4091668|FG001|NOT COMPLETED|Overall Study||4
3360798|NCT04329923|4091669|FG002|NOT COMPLETED|Overall Study||1
3360799|NCT04329923|4091670|FG003|NOT COMPLETED|Overall Study||1
3360800|NCT04329923|4091671|FG004|NOT COMPLETED|Overall Study||2
3360801|NCT04329923|4091672|FG005|NOT COMPLETED|Overall Study||5
3360802|NCT04328467|4091689|FG000|STARTED|Overall Study||494
3360803|NCT04328467|4091690|FG001|STARTED|Overall Study||495
3360804|NCT04328467|4091691|FG002|STARTED|Overall Study||494
3360805|NCT04328467|4091689|FG000|COMPLETED|Overall Study||490
3360806|NCT04328467|4091690|FG001|COMPLETED|Overall Study||493
3360807|NCT04328467|4091691|FG002|COMPLETED|Overall Study||493
3360808|NCT04328467|4091689|FG000|NOT COMPLETED|Overall Study||4
3179306|NCT01984294|3907484|FG002|COMPLETED|Overall Study||27
3179307|NCT01984294|3907482|FG000|NOT COMPLETED|Overall Study||4
3360809|NCT04328467|4091690|FG001|NOT COMPLETED|Overall Study||2
3360810|NCT04328467|4091691|FG002|NOT COMPLETED|Overall Study||1
3360811|NCT04327388|4091702|FG000|STARTED|Overall Study||161
3360812|NCT04327388|4091703|FG001|STARTED|Overall Study||173
3360813|NCT04327388|4091704|FG002|STARTED|Overall Study||86
3360814|NCT04327388|4091702|FG000|Treated|Overall Study||159
3360815|NCT04327388|4091703|FG001|Treated|Overall Study||173
3360816|NCT04327388|4091704|FG002|Treated|Overall Study||84
3360817|NCT04327388|4091702|FG000|Participants Who Received Second Dose|Overall Study||13
3360818|NCT04327388|4091703|FG001|Participants Who Received Second Dose|Overall Study||11
3360819|NCT04327388|4091704|FG002|Participants Who Received Second Dose|Overall Study||5
3360820|NCT04327388|4091702|FG000|COMPLETED|Overall Study||141
3360821|NCT04327388|4091703|FG001|COMPLETED|Overall Study||153
3360822|NCT04327388|4091704|FG002|COMPLETED|Overall Study||75
3360823|NCT04327388|4091702|FG000|NOT COMPLETED|Overall Study||20
3360824|NCT04327388|4091703|FG001|NOT COMPLETED|Overall Study||20
3360825|NCT04327388|4091704|FG002|NOT COMPLETED|Overall Study||11
3360826|NCT04322526|4091714|FG000|STARTED|First Intervention (1 Day)||13
3360827|NCT04322526|4091715|FG001|STARTED|First Intervention (1 Day)||12
3360828|NCT04322526|4091714|FG000|COMPLETED|First Intervention (1 Day)||12
3360829|NCT04322526|4091715|FG001|COMPLETED|First Intervention (1 Day)||11
3360830|NCT04322526|4091714|FG000|NOT COMPLETED|First Intervention (1 Day)||1
3360831|NCT04322526|4091715|FG001|NOT COMPLETED|First Intervention (1 Day)||1
3360832|NCT04322526|4091714|FG000|STARTED|Washout (1 Week)||12
3360833|NCT04322526|4091715|FG001|STARTED|Washout (1 Week)||11
3360834|NCT04322526|4091714|FG000|COMPLETED|Washout (1 Week)||11
3360835|NCT04322526|4091715|FG001|COMPLETED|Washout (1 Week)||9
3360836|NCT04322526|4091714|FG000|NOT COMPLETED|Washout (1 Week)||1
3360837|NCT04322526|4091715|FG001|NOT COMPLETED|Washout (1 Week)||2
3360838|NCT04322526|4091714|FG000|STARTED|Second Intervention (1day)||11
3360839|NCT04322526|4091715|FG001|STARTED|Second Intervention (1day)||9
3360840|NCT04322526|4091714|FG000|COMPLETED|Second Intervention (1day)||11
3360841|NCT04322526|4091715|FG001|COMPLETED|Second Intervention (1day)||9
3360842|NCT04322526|4091714|FG000|NOT COMPLETED|Second Intervention (1day)||0
3360843|NCT04322526|4091715|FG001|NOT COMPLETED|Second Intervention (1day)||0
3360844|NCT04322500|4091723|FG000|STARTED|Overall Study||13
3360845|NCT04322500|4091724|FG001|STARTED|Overall Study||13
3360846|NCT04322500|4091723|FG000|COMPLETED|Overall Study||13
3360847|NCT04322500|4091724|FG001|COMPLETED|Overall Study||13
3360848|NCT04322500|4091723|FG000|NOT COMPLETED|Overall Study||0
3360849|NCT04322500|4091724|FG001|NOT COMPLETED|Overall Study||0
3360850|NCT04322682|4091732|FG000|STARTED|Overall Study||2235
3360851|NCT04322682|4091733|FG001|STARTED|Overall Study||2253
3360852|NCT04322682|4091732|FG000|COMPLETED|Overall Study||2192
3360853|NCT04322682|4091733|FG001|COMPLETED|Overall Study||2189
3360854|NCT04322682|4091732|FG000|NOT COMPLETED|Overall Study||43
3360855|NCT04322682|4091733|FG001|NOT COMPLETED|Overall Study||64
3360856|NCT04321980|4091741|FG000|STARTED|Overall Study||4
3360857|NCT04321980|4091742|FG001|STARTED|Overall Study||4
3360858|NCT04321980|4091741|FG000|COMPLETED|Overall Study||4
3360859|NCT04321980|4091742|FG001|COMPLETED|Overall Study||4
3360860|NCT04321980|4091741|FG000|NOT COMPLETED|Overall Study||0
3360861|NCT04321980|4091742|FG001|NOT COMPLETED|Overall Study||0
3360862|NCT04322396|4091750|FG000|STARTED|Overall Study||56
3360863|NCT04322396|4091751|FG001|STARTED|Overall Study||61
3360864|NCT04322396|4091750|FG000|COMPLETED|Overall Study||56
3360865|NCT04322396|4091751|FG001|COMPLETED|Overall Study||61
3179308|NCT01984294|3907483|FG001|NOT COMPLETED|Overall Study||3
3360866|NCT04322396|4091750|FG000|NOT COMPLETED|Overall Study||0
3360867|NCT04322396|4091751|FG001|NOT COMPLETED|Overall Study||0
3360868|NCT04320823|4091759|FG000|STARTED|Overall Study||1717
3360869|NCT04320823|4091760|FG001|STARTED|Overall Study||1726
3360870|NCT04320823|4091759|FG000|COMPLETED|Overall Study|Includes 47 donors who withdrew from the study after one or more donations.|1717
3360871|NCT04320823|4091760|FG001|COMPLETED|Overall Study|Includes 38 donors who withdrew from the study after one or more donations.|1726
3360872|NCT04320823|4091759|FG000|NOT COMPLETED|Overall Study||0
3360873|NCT04320823|4091760|FG001|NOT COMPLETED|Overall Study||0
3360874|NCT04320615|4091784|FG000|STARTED|Overall Study||144
3360875|NCT04320615|4091785|FG001|STARTED|Overall Study||294
3360876|NCT04320615|4091784|FG000|COMPLETED|Overall Study||96
3360877|NCT04320615|4091785|FG001|COMPLETED|Overall Study||190
3360878|NCT04320615|4091784|FG000|NOT COMPLETED|Overall Study||48
3360879|NCT04320615|4091785|FG001|NOT COMPLETED|Overall Study||104
3360880|NCT04318535|4091795|FG000|STARTED|Treatment Period 1 (Day -1 to Day 5)||12
3360881|NCT04318535|4091796|FG001|STARTED|Treatment Period 1 (Day -1 to Day 5)||12
3360882|NCT04318535|4091797|FG002|STARTED|Treatment Period 1 (Day -1 to Day 5)||12
3360883|NCT04318535|4091795|FG000|COMPLETED|Treatment Period 1 (Day -1 to Day 5)||12
3360884|NCT04318535|4091796|FG001|COMPLETED|Treatment Period 1 (Day -1 to Day 5)||12
3360885|NCT04318535|4091797|FG002|COMPLETED|Treatment Period 1 (Day -1 to Day 5)||12
3360886|NCT04318535|4091795|FG000|NOT COMPLETED|Treatment Period 1 (Day -1 to Day 5)||0
3360887|NCT04318535|4091796|FG001|NOT COMPLETED|Treatment Period 1 (Day -1 to Day 5)||0
3360888|NCT04318535|4091797|FG002|NOT COMPLETED|Treatment Period 1 (Day -1 to Day 5)||0
3360889|NCT04318535|4091795|FG000|STARTED|Period1washout(Atleast 7 Days Post-dose)||12
3360890|NCT04318535|4091796|FG001|STARTED|Period1washout(Atleast 7 Days Post-dose)||12
3360891|NCT04318535|4091797|FG002|STARTED|Period1washout(Atleast 7 Days Post-dose)||12
3360892|NCT04318535|4091795|FG000|COMPLETED|Period1washout(Atleast 7 Days Post-dose)||12
3360893|NCT04318535|4091796|FG001|COMPLETED|Period1washout(Atleast 7 Days Post-dose)||12
3360894|NCT04318535|4091797|FG002|COMPLETED|Period1washout(Atleast 7 Days Post-dose)||12
3360895|NCT04318535|4091795|FG000|NOT COMPLETED|Period1washout(Atleast 7 Days Post-dose)||0
3360896|NCT04318535|4091796|FG001|NOT COMPLETED|Period1washout(Atleast 7 Days Post-dose)||0
3360897|NCT04318535|4091797|FG002|NOT COMPLETED|Period1washout(Atleast 7 Days Post-dose)||0
3360898|NCT04318535|4091795|FG000|STARTED|Treatment Period 2 (Day 7 to Day 12)||12
3360899|NCT04318535|4091796|FG001|STARTED|Treatment Period 2 (Day 7 to Day 12)||12
3360900|NCT04318535|4091797|FG002|STARTED|Treatment Period 2 (Day 7 to Day 12)||12
3360901|NCT04318535|4091795|FG000|COMPLETED|Treatment Period 2 (Day 7 to Day 12)||12
3360902|NCT04318535|4091796|FG001|COMPLETED|Treatment Period 2 (Day 7 to Day 12)||12
3360903|NCT04318535|4091797|FG002|COMPLETED|Treatment Period 2 (Day 7 to Day 12)||12
3360904|NCT04318535|4091795|FG000|NOT COMPLETED|Treatment Period 2 (Day 7 to Day 12)||0
3360905|NCT04318535|4091796|FG001|NOT COMPLETED|Treatment Period 2 (Day 7 to Day 12)||0
3360906|NCT04318535|4091797|FG002|NOT COMPLETED|Treatment Period 2 (Day 7 to Day 12)||0
3360907|NCT04318535|4091795|FG000|STARTED|Period2washout(Atleast 7 Days Post-dose)||12
3360908|NCT04318535|4091796|FG001|STARTED|Period2washout(Atleast 7 Days Post-dose)||12
3360909|NCT04318535|4091797|FG002|STARTED|Period2washout(Atleast 7 Days Post-dose)||12
3179309|NCT01984294|3907484|FG002|NOT COMPLETED|Overall Study||7
3179310|NCT01984398|3907494|FG000|STARTED|Treatment Period 1||4
3179311|NCT01984398|3907495|FG001|STARTED|Treatment Period 1||4
3179312|NCT01984398|3907496|FG002|STARTED|Treatment Period 1||4
3179313|NCT01984398|3907497|FG003|STARTED|Treatment Period 1||4
2928298|NCT00576732|3639178|FG005|NOT COMPLETED|OPEN LABEL||8
2928299|NCT00576758|3639192|FG000|STARTED|Induction Treatment Period||87
2928300|NCT00576758|3639193|FG001|STARTED|Induction Treatment Period||88
2928301|NCT00576758|3639192|FG000|Received Treatment|Induction Treatment Period||86
2928302|NCT00576758|3639193|FG001|Received Treatment|Induction Treatment Period||87
2928303|NCT00576758|3639192|FG000|COMPLETED|Induction Treatment Period||79
2928304|NCT00576758|3639193|FG001|COMPLETED|Induction Treatment Period||83
2928305|NCT00576758|3639192|FG000|NOT COMPLETED|Induction Treatment Period||8
2928306|NCT00576758|3639193|FG001|NOT COMPLETED|Induction Treatment Period||5
2928307|NCT00576758|3639192|FG000|STARTED|Extension Treatment Period|6 patients did not enter extended treatment phase/follow-up + 1 patient entered follow-up.|72
2928308|NCT00576758|3639193|FG001|STARTED|Extension Treatment Period|8 patients did not enter extended treatment phase/follow-up phase + 2 patients entered follow-up.|73
2928309|NCT00576758|3639192|FG000|COMPLETED|Extension Treatment Period|+ 2 patients (pts) who withdrew prior to receiving study drug.|30
2928310|NCT00576758|3639193|FG001|COMPLETED|Extension Treatment Period||30
2928311|NCT00576758|3639192|FG000|NOT COMPLETED|Extension Treatment Period||42
2928312|NCT00576758|3639193|FG001|NOT COMPLETED|Extension Treatment Period||43
3040081|NCT01162239|3759540|FG002|STARTED|Extended Follow-up||45
3360910|NCT04318535|4091795|FG000|COMPLETED|Period2washout(Atleast 7 Days Post-dose)||12
3360911|NCT04318535|4091796|FG001|COMPLETED|Period2washout(Atleast 7 Days Post-dose)||11
3360912|NCT04318535|4091797|FG002|COMPLETED|Period2washout(Atleast 7 Days Post-dose)||12
3360913|NCT04318535|4091795|FG000|NOT COMPLETED|Period2washout(Atleast 7 Days Post-dose)||0
3360914|NCT04318535|4091796|FG001|NOT COMPLETED|Period2washout(Atleast 7 Days Post-dose)||1
3360915|NCT04318535|4091797|FG002|NOT COMPLETED|Period2washout(Atleast 7 Days Post-dose)||0
3360916|NCT04318535|4091795|FG000|STARTED|Treatment Period 3 (Day 17 to Day 22)||12
3360917|NCT04318535|4091796|FG001|STARTED|Treatment Period 3 (Day 17 to Day 22)||11
3360918|NCT04318535|4091797|FG002|STARTED|Treatment Period 3 (Day 17 to Day 22)||12
3360919|NCT04318535|4091795|FG000|COMPLETED|Treatment Period 3 (Day 17 to Day 22)||12
3360920|NCT04318535|4091796|FG001|COMPLETED|Treatment Period 3 (Day 17 to Day 22)||11
3360921|NCT04318535|4091797|FG002|COMPLETED|Treatment Period 3 (Day 17 to Day 22)||12
3360922|NCT04318535|4091795|FG000|NOT COMPLETED|Treatment Period 3 (Day 17 to Day 22)||0
3360923|NCT04318535|4091796|FG001|NOT COMPLETED|Treatment Period 3 (Day 17 to Day 22)||0
3360924|NCT04318535|4091797|FG002|NOT COMPLETED|Treatment Period 3 (Day 17 to Day 22)||0
3360925|NCT04316260|4091808|FG000|STARTED|Overall Study||34
3360926|NCT04316260|4091809|FG001|STARTED|Overall Study||17
3360927|NCT04316260|4091808|FG000|COMPLETED|Overall Study||34
3360928|NCT04316260|4091809|FG001|COMPLETED|Overall Study||17
3360929|NCT04316260|4091808|FG000|NOT COMPLETED|Overall Study||0
3360930|NCT04316260|4091809|FG001|NOT COMPLETED|Overall Study||0
3360931|NCT04314037|4091818|FG000|STARTED|Treatment Period 1||18
3360932|NCT04314037|4091819|FG001|STARTED|Treatment Period 1||18
3360933|NCT04314037|4091818|FG000|COMPLETED|Treatment Period 1||18
3360934|NCT04314037|4091819|FG001|COMPLETED|Treatment Period 1||18
3360935|NCT04314037|4091818|FG000|NOT COMPLETED|Treatment Period 1||0
3360936|NCT04314037|4091819|FG001|NOT COMPLETED|Treatment Period 1||0
3360937|NCT04314037|4091818|FG000|STARTED|Treatment Period 2||18
3360938|NCT04314037|4091819|FG001|STARTED|Treatment Period 2||18
3179314|NCT01984398|3907494|FG000|COMPLETED|Treatment Period 1||4
3179315|NCT01984398|3907495|FG001|COMPLETED|Treatment Period 1||4
3179316|NCT01984398|3907496|FG002|COMPLETED|Treatment Period 1||4
3360939|NCT04314037|4091818|FG000|COMPLETED|Treatment Period 2||17
3360940|NCT04314037|4091819|FG001|COMPLETED|Treatment Period 2||18
3360941|NCT04314037|4091818|FG000|NOT COMPLETED|Treatment Period 2||1
3360942|NCT04314037|4091819|FG001|NOT COMPLETED|Treatment Period 2||0
3360943|NCT04314037|4091818|FG000|STARTED|Treatment Period 3||17
3360944|NCT04314037|4091819|FG001|STARTED|Treatment Period 3||18
3360945|NCT04314037|4091818|FG000|COMPLETED|Treatment Period 3||16
3360946|NCT04314037|4091819|FG001|COMPLETED|Treatment Period 3||17
3360947|NCT04314037|4091818|FG000|NOT COMPLETED|Treatment Period 3||1
3360948|NCT04314037|4091819|FG001|NOT COMPLETED|Treatment Period 3||1
3360949|NCT04314037|4091818|FG000|STARTED|Treatment Period 4||16
3360950|NCT04314037|4091819|FG001|STARTED|Treatment Period 4||17
3360951|NCT04314037|4091818|FG000|COMPLETED|Treatment Period 4||16
3360952|NCT04314037|4091819|FG001|COMPLETED|Treatment Period 4||17
3360953|NCT04314037|4091818|FG000|NOT COMPLETED|Treatment Period 4||0
3360954|NCT04314037|4091819|FG001|NOT COMPLETED|Treatment Period 4||0
3360955|NCT04315298|4091850|FG000|STARTED|Overall Study||90
3360956|NCT04315298|4091851|FG001|STARTED|Overall Study||187
3360957|NCT04315298|4091852|FG002|STARTED|Overall Study||180
3360958|NCT04315298|4091853|FG003|STARTED|Overall Study||170
3360959|NCT04315298|4091854|FG004|STARTED|Overall Study||242
3360960|NCT04315298|4091855|FG005|STARTED|Overall Study||338
3360961|NCT04315298|4091856|FG006|STARTED|Overall Study||70
3360962|NCT04315298|4091857|FG007|STARTED|Overall Study||140
3360963|NCT04315298|4091858|FG008|STARTED|Overall Study||137
3360964|NCT04315298|4091859|FG009|STARTED|Overall Study||46
3360965|NCT04315298|4091860|FG010|STARTED|Overall Study||95
3360966|NCT04315298|4091861|FG011|STARTED|Overall Study||92
3360967|NCT04315298|4091862|FG012|STARTED|Overall Study||8
3360968|NCT04315298|4091863|FG013|STARTED|Overall Study||12
3360969|NCT04315298|4091864|FG014|STARTED|Overall Study||15
3360970|NCT04315298|4091865|FG015|STARTED|Overall Study||15
3360971|NCT04315298|4091866|FG016|STARTED|Overall Study||16
3360972|NCT04315298|4091867|FG017|STARTED|Overall Study||6
3360973|NCT04315298|4091868|FG018|STARTED|Overall Study||2
3360974|NCT04315298|4091850|FG000|COMPLETED|Overall Study||61
3360975|NCT04315298|4091851|FG001|COMPLETED|Overall Study||117
3360976|NCT04315298|4091852|FG002|COMPLETED|Overall Study||125
3360977|NCT04315298|4091853|FG003|COMPLETED|Overall Study||101
3360978|NCT04315298|4091854|FG004|COMPLETED|Overall Study||157
3360979|NCT04315298|4091855|FG005|COMPLETED|Overall Study||209
3360980|NCT04315298|4091856|FG006|COMPLETED|Overall Study||52
3360981|NCT04315298|4091857|FG007|COMPLETED|Overall Study||111
3360982|NCT04315298|4091858|FG008|COMPLETED|Overall Study||101
3360983|NCT04315298|4091859|FG009|COMPLETED|Overall Study||29
3360984|NCT04315298|4091860|FG010|COMPLETED|Overall Study||53
3360985|NCT04315298|4091861|FG011|COMPLETED|Overall Study||51
3360986|NCT04315298|4091862|FG012|COMPLETED|Overall Study||5
3360987|NCT04315298|4091863|FG013|COMPLETED|Overall Study||8
3360988|NCT04315298|4091864|FG014|COMPLETED|Overall Study||9
3360989|NCT04315298|4091865|FG015|COMPLETED|Overall Study||9
3360990|NCT04315298|4091866|FG016|COMPLETED|Overall Study||13
3360991|NCT04315298|4091867|FG017|COMPLETED|Overall Study||5
3360992|NCT04315298|4091868|FG018|COMPLETED|Overall Study||2
3360993|NCT04315298|4091850|FG000|NOT COMPLETED|Overall Study||29
3360994|NCT04315298|4091851|FG001|NOT COMPLETED|Overall Study||70
3360995|NCT04315298|4091852|FG002|NOT COMPLETED|Overall Study||55
3360996|NCT04315298|4091853|FG003|NOT COMPLETED|Overall Study||69
3360997|NCT04315298|4091854|FG004|NOT COMPLETED|Overall Study||85
3360998|NCT04315298|4091855|FG005|NOT COMPLETED|Overall Study||129
3360999|NCT04315298|4091856|FG006|NOT COMPLETED|Overall Study||18
3361000|NCT04315298|4091857|FG007|NOT COMPLETED|Overall Study||29
3361001|NCT04315298|4091858|FG008|NOT COMPLETED|Overall Study||36
3361002|NCT04315298|4091859|FG009|NOT COMPLETED|Overall Study||17
3361003|NCT04315298|4091860|FG010|NOT COMPLETED|Overall Study||42
3361004|NCT04315298|4091861|FG011|NOT COMPLETED|Overall Study||41
3361005|NCT04315298|4091862|FG012|NOT COMPLETED|Overall Study||3
3361006|NCT04315298|4091863|FG013|NOT COMPLETED|Overall Study||4
3361007|NCT04315298|4091864|FG014|NOT COMPLETED|Overall Study||6
3361008|NCT04315298|4091865|FG015|NOT COMPLETED|Overall Study||6
3361009|NCT04315298|4091866|FG016|NOT COMPLETED|Overall Study||3
3361010|NCT04315298|4091867|FG017|NOT COMPLETED|Overall Study||1
3361011|NCT04315298|4091868|FG018|NOT COMPLETED|Overall Study||0
3361012|NCT04313647|4091940|FG000|STARTED|Overall Study||3
3361013|NCT04313647|4091941|FG001|STARTED|Overall Study||3
3361014|NCT04313647|4091942|FG002|STARTED|Overall Study||6
3361015|NCT04313647|4091943|FG003|STARTED|Overall Study||6
3361016|NCT04313647|4091944|FG004|STARTED|Overall Study||6
3361017|NCT04313647|4091940|FG000|COMPLETED|Overall Study||3
3361018|NCT04313647|4091941|FG001|COMPLETED|Overall Study||3
3179317|NCT01984398|3907497|FG003|COMPLETED|Treatment Period 1||4
3179318|NCT01984398|3907494|FG000|NOT COMPLETED|Treatment Period 1||0
3179319|NCT01984398|3907495|FG001|NOT COMPLETED|Treatment Period 1||0
3179320|NCT01984398|3907496|FG002|NOT COMPLETED|Treatment Period 1||0
3179321|NCT01984398|3907497|FG003|NOT COMPLETED|Treatment Period 1||0
3179322|NCT01984398|3907494|FG000|STARTED|Washout Period of 5 to 7 Days||4
3179323|NCT01984398|3907495|FG001|STARTED|Washout Period of 5 to 7 Days||4
3179324|NCT01984398|3907496|FG002|STARTED|Washout Period of 5 to 7 Days||4
3179325|NCT01984398|3907497|FG003|STARTED|Washout Period of 5 to 7 Days||4
3361019|NCT04313647|4091942|FG002|COMPLETED|Overall Study||6
3361020|NCT04313647|4091943|FG003|COMPLETED|Overall Study||6
3361021|NCT04313647|4091944|FG004|COMPLETED|Overall Study||6
3361022|NCT04313647|4091940|FG000|NOT COMPLETED|Overall Study||0
3361023|NCT04313647|4091941|FG001|NOT COMPLETED|Overall Study||0
3361024|NCT04313647|4091942|FG002|NOT COMPLETED|Overall Study||0
3361025|NCT04313647|4091943|FG003|NOT COMPLETED|Overall Study||0
3361026|NCT04313647|4091944|FG004|NOT COMPLETED|Overall Study||0
3361027|NCT04310085|4091963|FG000|STARTED|Overall Study||8
3361028|NCT04310085|4091964|FG001|STARTED|Overall Study||8
3361029|NCT04310085|4091963|FG000|COMPLETED|Overall Study||8
3361030|NCT04310085|4091964|FG001|COMPLETED|Overall Study||8
3361031|NCT04310085|4091963|FG000|NOT COMPLETED|Overall Study||0
3361032|NCT04310085|4091964|FG001|NOT COMPLETED|Overall Study||0
3361033|NCT04309617|4091970|FG000|STARTED|Overall Study||618
3361034|NCT04309617|4091970|FG000|Modified High Risk of Recurrence|Overall Study||136
3361035|NCT04309617|4091970|FG000|COMPLETED|Overall Study||618
3361036|NCT04309617|4091970|FG000|NOT COMPLETED|Overall Study||0
3361037|NCT04308239|4091978|FG000|STARTED|Pre-intervention Evaluation (1 Week)||20
3361038|NCT04308239|4091979|FG001|STARTED|Pre-intervention Evaluation (1 Week)||14
3361039|NCT04308239|4091978|FG000|COMPLETED|Pre-intervention Evaluation (1 Week)|No withdrawals. These participants just missed this evaluation but stayed in study.|17
3361040|NCT04308239|4091979|FG001|COMPLETED|Pre-intervention Evaluation (1 Week)|No withdrawals. These participants just missed this evaluation but stayed in study.|11
3361041|NCT04308239|4091978|FG000|NOT COMPLETED|Pre-intervention Evaluation (1 Week)||3
3361042|NCT04308239|4091979|FG001|NOT COMPLETED|Pre-intervention Evaluation (1 Week)||3
3361043|NCT04308239|4091978|FG000|STARTED|Intervention (2 Weeks)||20
3179326|NCT01984398|3907494|FG000|COMPLETED|Washout Period of 5 to 7 Days||4
3361044|NCT04308239|4091979|FG001|STARTED|Intervention (2 Weeks)||14
3361045|NCT04308239|4091978|FG000|COMPLETED|Intervention (2 Weeks)||20
3361046|NCT04308239|4091979|FG001|COMPLETED|Intervention (2 Weeks)||14
3361047|NCT04308239|4091978|FG000|NOT COMPLETED|Intervention (2 Weeks)||0
3361048|NCT04308239|4091979|FG001|NOT COMPLETED|Intervention (2 Weeks)||0
3361049|NCT04308239|4091978|FG000|STARTED|Post-intervention Evaluation (1 Week)||20
3361050|NCT04308239|4091979|FG001|STARTED|Post-intervention Evaluation (1 Week)||14
3361051|NCT04308239|4091978|FG000|COMPLETED|Post-intervention Evaluation (1 Week)||19
3361052|NCT04308239|4091979|FG001|COMPLETED|Post-intervention Evaluation (1 Week)||10
3361053|NCT04308239|4091978|FG000|NOT COMPLETED|Post-intervention Evaluation (1 Week)||1
3361054|NCT04308239|4091979|FG001|NOT COMPLETED|Post-intervention Evaluation (1 Week)||4
3361055|NCT04308668|4091991|FG000|STARTED|Overall Study||658
3361056|NCT04308668|4091992|FG001|STARTED|Overall Study||654
3361057|NCT04308668|4091991|FG000|COMPLETED|Overall Study||622
3361058|NCT04308668|4091992|FG001|COMPLETED|Overall Study||612
3361059|NCT04308668|4091991|FG000|NOT COMPLETED|Overall Study||36
3361060|NCT04308668|4091992|FG001|NOT COMPLETED|Overall Study||42
3361061|NCT04307940|4092001|FG000|STARTED|Overall Study||90
3361062|NCT04307940|4092002|FG001|STARTED|Overall Study||87
3361063|NCT04307940|4092003|FG002|STARTED|Overall Study||44
3361064|NCT04307940|4092001|FG000|COMPLETED|Overall Study||85
3361065|NCT04307940|4092002|FG001|COMPLETED|Overall Study||84
3361066|NCT04307940|4092003|FG002|COMPLETED|Overall Study||42
3361067|NCT04307940|4092001|FG000|NOT COMPLETED|Overall Study||5
3361068|NCT04307940|4092002|FG001|NOT COMPLETED|Overall Study||3
3361069|NCT04307940|4092003|FG002|NOT COMPLETED|Overall Study||2
3361070|NCT04302545|4092013|FG000|STARTED|Overall Study||107
3361071|NCT04302545|4092014|FG001|STARTED|Overall Study||107
3361072|NCT04302545|4092013|FG000|COMPLETED|Overall Study||104
3361073|NCT04302545|4092014|FG001|COMPLETED|Overall Study||103
3361074|NCT04302545|4092013|FG000|NOT COMPLETED|Overall Study||3
3361075|NCT04302545|4092014|FG001|NOT COMPLETED|Overall Study||4
3361076|NCT04297631|4092031|FG000|STARTED|Overall Study||20
3361077|NCT04297631|4092031|FG000|COMPLETED|Overall Study||20
3361078|NCT04297631|4092031|FG000|NOT COMPLETED|Overall Study||0
3361079|NCT04297241|4092036|FG000|STARTED|Overall Study||20
3361080|NCT04297241|4092036|FG000|COMPLETED|Overall Study||15
3361081|NCT04297241|4092036|FG000|NOT COMPLETED|Overall Study||5
3361082|NCT04296448|4092052|FG000|STARTED|Overall Study||98
3361083|NCT04296448|4092053|FG001|STARTED|Overall Study||99
3179327|NCT01984398|3907495|FG001|COMPLETED|Washout Period of 5 to 7 Days||4
3179328|NCT01984398|3907496|FG002|COMPLETED|Washout Period of 5 to 7 Days||4
3179329|NCT01984398|3907497|FG003|COMPLETED|Washout Period of 5 to 7 Days||4
3361084|NCT04296448|4092052|FG000|COMPLETED|Overall Study||98
3361085|NCT04296448|4092053|FG001|COMPLETED|Overall Study||99
3361086|NCT04296448|4092052|FG000|NOT COMPLETED|Overall Study||0
3361087|NCT04296448|4092053|FG001|NOT COMPLETED|Overall Study||0
3361088|NCT04296227|4092059|FG000|STARTED|Overall Study||85
3361089|NCT04296227|4092059|FG000|COMPLETED|Overall Study||85
3361090|NCT04296227|4092059|FG000|NOT COMPLETED|Overall Study||0
3361091|NCT04295356|4092065|FG000|STARTED|Overall Study||93
3361092|NCT04295356|4092066|FG001|STARTED|Overall Study||87
3361093|NCT04295356|4092065|FG000|COMPLETED|Overall Study||92
3361094|NCT04295356|4092066|FG001|COMPLETED|Overall Study||83
3361095|NCT04295356|4092065|FG000|NOT COMPLETED|Overall Study||1
3361096|NCT04295356|4092066|FG001|NOT COMPLETED|Overall Study||4
3361097|NCT04292639|4092072|FG000|STARTED|Overall Study||20
3361098|NCT04292639|4092072|FG000|COMPLETED|Overall Study||20
3361099|NCT04292639|4092072|FG000|NOT COMPLETED|Overall Study||0
3361100|NCT04292535|4092090|FG000|STARTED|Overall Study||8
3361101|NCT04292535|4092091|FG001|STARTED|Overall Study||8
2928313|NCT00576758|3639192|FG000|STARTED|Follow-up Period|Includes 23 pts who entered follow-up after induction and didn't enter the extended treatment phase.|55
2928314|NCT00576758|3639193|FG001|STARTED|Follow-up Period|Includes 21 pts who entered follow-up after induction and didn't enter the extended treatment phase.|51
2928315|NCT00576758|3639192|FG000|COMPLETED|Follow-up Period||28
2928316|NCT00576758|3639193|FG001|COMPLETED|Follow-up Period||34
2928317|NCT00576758|3639192|FG000|NOT COMPLETED|Follow-up Period||27
2928318|NCT00576758|3639193|FG001|NOT COMPLETED|Follow-up Period||17
2928319|NCT00576823|3639203|FG000|STARTED|12-week Efficacy Phase||12
2928320|NCT00576823|3639204|FG001|STARTED|12-week Efficacy Phase||6
2928321|NCT00576823|3639205|FG002|STARTED|12-week Efficacy Phase||7
2928322|NCT00576823|3639203|FG000|COMPLETED|12-week Efficacy Phase||11
2928323|NCT00576823|3639204|FG001|COMPLETED|12-week Efficacy Phase||6
2928324|NCT00576823|3639205|FG002|COMPLETED|12-week Efficacy Phase||7
2928325|NCT00576823|3639203|FG000|NOT COMPLETED|12-week Efficacy Phase||1
2928326|NCT00576823|3639204|FG001|NOT COMPLETED|12-week Efficacy Phase||0
2928327|NCT00576823|3639205|FG002|NOT COMPLETED|12-week Efficacy Phase||0
2928328|NCT00576823|3639203|FG000|STARTED|40-week Safety Extension Phase||11
2928329|NCT00576823|3639204|FG001|STARTED|40-week Safety Extension Phase||6
2928330|NCT00576823|3639205|FG002|STARTED|40-week Safety Extension Phase|One patient refused to continue in the extension phase.|6
2928331|NCT00576823|3639203|FG000|COMPLETED|40-week Safety Extension Phase||10
2928332|NCT00576823|3639204|FG001|COMPLETED|40-week Safety Extension Phase||6
2928333|NCT00576823|3639205|FG002|COMPLETED|40-week Safety Extension Phase||6
3361102|NCT04292535|4092092|FG002|STARTED|Overall Study||9
3361103|NCT04292535|4092093|FG003|STARTED|Overall Study||8
3361104|NCT04292535|4092094|FG004|STARTED|Overall Study||8
3361105|NCT04292535|4092095|FG005|STARTED|Overall Study||9
3361106|NCT04292535|4092096|FG006|STARTED|Overall Study||8
3361107|NCT04292535|4092097|FG007|STARTED|Overall Study||10
3361108|NCT04292535|4092098|FG008|STARTED|Overall Study||8
3361109|NCT04292535|4092099|FG009|STARTED|Overall Study||8
3361110|NCT04292535|4092100|FG010|STARTED|Overall Study||7
3361111|NCT04292535|4092101|FG011|STARTED|Overall Study||7
3361112|NCT04292535|4092102|FG012|STARTED|Overall Study||9
3361113|NCT04292535|4092103|FG013|STARTED|Overall Study||9
3361114|NCT04292535|4092090|FG000|COMPLETED|Overall Study||8
3361115|NCT04292535|4092091|FG001|COMPLETED|Overall Study||8
3361116|NCT04292535|4092092|FG002|COMPLETED|Overall Study||9
3361117|NCT04292535|4092093|FG003|COMPLETED|Overall Study||8
3361118|NCT04292535|4092094|FG004|COMPLETED|Overall Study||8
3361119|NCT04292535|4092095|FG005|COMPLETED|Overall Study||9
3361120|NCT04292535|4092096|FG006|COMPLETED|Overall Study||8
3361121|NCT04292535|4092097|FG007|COMPLETED|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL (n = 1)|8
3361122|NCT04292535|4092098|FG008|COMPLETED|Overall Study||8
3361123|NCT04292535|4092099|FG009|COMPLETED|Overall Study||8
3361124|NCT04292535|4092100|FG010|COMPLETED|Overall Study||7
3361125|NCT04292535|4092101|FG011|COMPLETED|Overall Study||6
3361126|NCT04292535|4092102|FG012|COMPLETED|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL (n = 1)|8
3361127|NCT04292535|4092103|FG013|COMPLETED|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL (n = 1) Condition stopped due to Report of Dizziness (n = 1)|7
3361128|NCT04292535|4092090|FG000|NOT COMPLETED|Overall Study||0
3361129|NCT04292535|4092091|FG001|NOT COMPLETED|Overall Study||0
3361130|NCT04292535|4092092|FG002|NOT COMPLETED|Overall Study||0
3361131|NCT04292535|4092093|FG003|NOT COMPLETED|Overall Study||0
3361132|NCT04292535|4092094|FG004|NOT COMPLETED|Overall Study||0
3361133|NCT04292535|4092095|FG005|NOT COMPLETED|Overall Study||0
3361134|NCT04292535|4092096|FG006|NOT COMPLETED|Overall Study||0
3361135|NCT04292535|4092097|FG007|NOT COMPLETED|Overall Study||2
3361136|NCT04292535|4092098|FG008|NOT COMPLETED|Overall Study||0
3361137|NCT04292535|4092099|FG009|NOT COMPLETED|Overall Study||0
3361138|NCT04292535|4092100|FG010|NOT COMPLETED|Overall Study||0
3361139|NCT04292535|4092101|FG011|NOT COMPLETED|Overall Study||1
3361140|NCT04292535|4092102|FG012|NOT COMPLETED|Overall Study||1
3361141|NCT04292535|4092103|FG013|NOT COMPLETED|Overall Study||2
3361142|NCT04292171|4092135|FG000|STARTED|Overall Study||109
3361143|NCT04292171|4092136|FG001|STARTED|Overall Study||110
3361144|NCT04292171|4092135|FG000|COMPLETED|Overall Study||107
3361145|NCT04292171|4092136|FG001|COMPLETED|Overall Study||109
3361146|NCT04292171|4092135|FG000|NOT COMPLETED|Overall Study||2
3361147|NCT04292171|4092136|FG001|NOT COMPLETED|Overall Study||1
3361148|NCT04292899|4092146|FG000|STARTED|Overall Study||200
3361149|NCT04292899|4092147|FG001|STARTED|Overall Study||197
3361150|NCT04292899|4092148|FG002|STARTED|Overall Study||844
3361151|NCT04292899|4092149|FG003|STARTED|Overall Study||3597
3361152|NCT04292899|4092146|FG000|COMPLETED|Overall Study||168
3361153|NCT04292899|4092147|FG001|COMPLETED|Overall Study||164
3361154|NCT04292899|4092148|FG002|COMPLETED|Overall Study||621
3361155|NCT04292899|4092149|FG003|COMPLETED|Overall Study||2952
3361156|NCT04292899|4092146|FG000|NOT COMPLETED|Overall Study||32
3361157|NCT04292899|4092147|FG001|NOT COMPLETED|Overall Study||33
3361158|NCT04292899|4092148|FG002|NOT COMPLETED|Overall Study||223
3361159|NCT04292899|4092149|FG003|NOT COMPLETED|Overall Study||645
3361160|NCT04292730|4092161|FG000|STARTED|Overall Study||199
3361161|NCT04292730|4092162|FG001|STARTED|Overall Study||197
3361162|NCT04292730|4092163|FG002|STARTED|Overall Study||200
3361163|NCT04292730|4092164|FG003|STARTED|Overall Study||517
3361164|NCT04292730|4092161|FG000|COMPLETED|Overall Study||179
3361165|NCT04292730|4092162|FG001|COMPLETED|Overall Study||176
3361166|NCT04292730|4092163|FG002|COMPLETED|Overall Study||178
3361167|NCT04292730|4092164|FG003|COMPLETED|Overall Study||437
3361168|NCT04292730|4092161|FG000|NOT COMPLETED|Overall Study||20
3361169|NCT04292730|4092162|FG001|NOT COMPLETED|Overall Study||21
3361170|NCT04292730|4092163|FG002|NOT COMPLETED|Overall Study||22
3361171|NCT04292730|4092164|FG003|NOT COMPLETED|Overall Study||80
3361172|NCT04290676|4092173|FG000|STARTED|Overall Study||527
3361173|NCT04290676|4092173|FG000|COMPLETED|Overall Study||527
3361174|NCT04290676|4092173|FG000|NOT COMPLETED|Overall Study||0
3361175|NCT04290039|4092180|FG000|STARTED|Period 1 (Visit 1; Day 1)||5
3361176|NCT04290039|4092181|FG001|STARTED|Period 1 (Visit 1; Day 1)||5
3361177|NCT04290039|4092182|FG002|STARTED|Period 1 (Visit 1; Day 1)||5
3361178|NCT04290039|4092180|FG000|COMPLETED|Period 1 (Visit 1; Day 1)||5
3361179|NCT04290039|4092181|FG001|COMPLETED|Period 1 (Visit 1; Day 1)||5
3361180|NCT04290039|4092182|FG002|COMPLETED|Period 1 (Visit 1; Day 1)||5
3361181|NCT04290039|4092180|FG000|NOT COMPLETED|Period 1 (Visit 1; Day 1)||0
3361182|NCT04290039|4092181|FG001|NOT COMPLETED|Period 1 (Visit 1; Day 1)||0
3361183|NCT04290039|4092182|FG002|NOT COMPLETED|Period 1 (Visit 1; Day 1)||0
3361184|NCT04290039|4092180|FG000|STARTED|Period 2 (Visit 2; Day 8)||5
3361185|NCT04290039|4092181|FG001|STARTED|Period 2 (Visit 2; Day 8)||5
3361186|NCT04290039|4092182|FG002|STARTED|Period 2 (Visit 2; Day 8)||5
3361187|NCT04290039|4092180|FG000|COMPLETED|Period 2 (Visit 2; Day 8)||5
3361188|NCT04290039|4092181|FG001|COMPLETED|Period 2 (Visit 2; Day 8)||5
3361189|NCT04290039|4092182|FG002|COMPLETED|Period 2 (Visit 2; Day 8)||5
3361190|NCT04290039|4092180|FG000|NOT COMPLETED|Period 2 (Visit 2; Day 8)||0
3361191|NCT04290039|4092181|FG001|NOT COMPLETED|Period 2 (Visit 2; Day 8)||0
3361192|NCT04290039|4092182|FG002|NOT COMPLETED|Period 2 (Visit 2; Day 8)||0
3361193|NCT04290039|4092180|FG000|STARTED|Period 3 (Visit 3; Day 15)||5
3361194|NCT04290039|4092181|FG001|STARTED|Period 3 (Visit 3; Day 15)||4
3361195|NCT04290039|4092182|FG002|STARTED|Period 3 (Visit 3; Day 15)||5
3361196|NCT04290039|4092180|FG000|COMPLETED|Period 3 (Visit 3; Day 15)||5
3361197|NCT04290039|4092181|FG001|COMPLETED|Period 3 (Visit 3; Day 15)||4
3361198|NCT04290039|4092182|FG002|COMPLETED|Period 3 (Visit 3; Day 15)||5
3361199|NCT04290039|4092180|FG000|NOT COMPLETED|Period 3 (Visit 3; Day 15)||0
3361200|NCT04290039|4092181|FG001|NOT COMPLETED|Period 3 (Visit 3; Day 15)||0
3361201|NCT04290039|4092182|FG002|NOT COMPLETED|Period 3 (Visit 3; Day 15)||0
3361202|NCT04289623|4092197|FG000|STARTED|Wave 1 Emails||6782
3361203|NCT04289623|4092198|FG001|STARTED|Wave 1 Emails||6764
3361204|NCT04289623|4092199|FG002|STARTED|Wave 1 Emails|Participants who did not respond to the intervention in Wave 1 were randomly assigned to this intervention or the testimonial (rank-and-file) email in Wave 2.|0
3361205|NCT04289623|4092200|FG003|STARTED|Wave 1 Emails|Participants who did not respond to the intervention in Wave 1 were randomly assigned to this intervention or the testimonial (medical expert) email in Wave 2.|0
3361206|NCT04289623|4092201|FG004|STARTED|Wave 1 Emails|A planned Wave 3 of the study was not conducted due to COVID-19-related changes in the program being offered as part of the intervention.|0
3361207|NCT04289623|4092202|FG005|STARTED|Wave 1 Emails|A planned Wave 3 of the study was not conducted due to COVID-19-related changes in the program being offered as part of the intervention.|0
3361208|NCT04289623|4092197|FG000|COMPLETED|Wave 1 Emails||6514
3361209|NCT04289623|4092198|FG001|COMPLETED|Wave 1 Emails||6507
3361210|NCT04289623|4092199|FG002|COMPLETED|Wave 1 Emails||0
3361211|NCT04289623|4092200|FG003|COMPLETED|Wave 1 Emails||0
3361212|NCT04289623|4092201|FG004|COMPLETED|Wave 1 Emails||0
3361213|NCT04289623|4092202|FG005|COMPLETED|Wave 1 Emails||0
3361214|NCT04289623|4092197|FG000|NOT COMPLETED|Wave 1 Emails||268
3361215|NCT04289623|4092198|FG001|NOT COMPLETED|Wave 1 Emails||257
3361216|NCT04289623|4092199|FG002|NOT COMPLETED|Wave 1 Emails||0
3361217|NCT04289623|4092200|FG003|NOT COMPLETED|Wave 1 Emails||0
3361218|NCT04289623|4092201|FG004|NOT COMPLETED|Wave 1 Emails||0
3361219|NCT04289623|4092202|FG005|NOT COMPLETED|Wave 1 Emails||0
3361220|NCT04289623|4092197|FG000|STARTED|Wave 2 Emails|Participants were already sent this intervention or the loss frame email in Wave 1.|0
3361221|NCT04289623|4092198|FG001|STARTED|Wave 2 Emails|Participants were already sent this intervention or the standard email in Wave 1.|0
3361222|NCT04289623|4092199|FG002|STARTED|Wave 2 Emails|Participants who did not respond to the intervention in Wave 1 were randomly assigned to these groups in Wave 2.|6099
3361223|NCT04289623|4092200|FG003|STARTED|Wave 2 Emails|Participants who did not respond to the intervention in Wave 1 were randomly assigned to these groups in Wave 2.|6117
3361224|NCT04289623|4092201|FG004|STARTED|Wave 2 Emails|A planned Wave 3 of the study was not conducted due to COVID-19-related changes in the program being offered as part of the intervention.|0
3361225|NCT04289623|4092202|FG005|STARTED|Wave 2 Emails|A planned Wave 3 of the study was not conducted due to COVID-19-related changes in the program being offered as part of the intervention.|0
3361226|NCT04289623|4092197|FG000|COMPLETED|Wave 2 Emails||0
3361227|NCT04289623|4092198|FG001|COMPLETED|Wave 2 Emails||0
3361228|NCT04289623|4092199|FG002|COMPLETED|Wave 2 Emails||6099
3361229|NCT04289623|4092200|FG003|COMPLETED|Wave 2 Emails||6117
3361230|NCT04289623|4092201|FG004|COMPLETED|Wave 2 Emails||0
3361231|NCT04289623|4092202|FG005|COMPLETED|Wave 2 Emails||0
3361232|NCT04289623|4092197|FG000|NOT COMPLETED|Wave 2 Emails||0
3361233|NCT04289623|4092198|FG001|NOT COMPLETED|Wave 2 Emails||0
3361234|NCT04289623|4092199|FG002|NOT COMPLETED|Wave 2 Emails||0
3361235|NCT04289623|4092200|FG003|NOT COMPLETED|Wave 2 Emails||0
3361236|NCT04289623|4092201|FG004|NOT COMPLETED|Wave 2 Emails||0
3361237|NCT04289623|4092202|FG005|NOT COMPLETED|Wave 2 Emails||0
3361238|NCT04276207|4092216|FG000|STARTED|Period 1||15
3361239|NCT04276207|4092217|FG001|STARTED|Period 1||17
3361240|NCT04276207|4092216|FG000|Received at Least One Dose of Study Drug|Period 1||15
3361241|NCT04276207|4092217|FG001|Received at Least One Dose of Study Drug|Period 1||17
3361242|NCT04276207|4092216|FG000|COMPLETED|Period 1||15
3361243|NCT04276207|4092217|FG001|COMPLETED|Period 1||16
3361244|NCT04276207|4092216|FG000|NOT COMPLETED|Period 1||0
3361245|NCT04276207|4092217|FG001|NOT COMPLETED|Period 1||1
3361246|NCT04276207|4092216|FG000|STARTED|Washout (3- 14 Days)||15
3361247|NCT04276207|4092217|FG001|STARTED|Washout (3- 14 Days)||16
3361248|NCT04276207|4092216|FG000|COMPLETED|Washout (3- 14 Days)||15
3361249|NCT04276207|4092217|FG001|COMPLETED|Washout (3- 14 Days)||16
3361250|NCT04276207|4092216|FG000|NOT COMPLETED|Washout (3- 14 Days)||0
3361251|NCT04276207|4092217|FG001|NOT COMPLETED|Washout (3- 14 Days)||0
3361252|NCT04276207|4092216|FG000|STARTED|Period 2||15
3361253|NCT04276207|4092217|FG001|STARTED|Period 2||16
3361254|NCT04276207|4092216|FG000|COMPLETED|Period 2||15
3361255|NCT04276207|4092217|FG001|COMPLETED|Period 2||16
3361256|NCT04276207|4092216|FG000|NOT COMPLETED|Period 2||0
3361257|NCT04276207|4092217|FG001|NOT COMPLETED|Period 2||0
3361258|NCT04289714|4092226|FG000|STARTED|Overall Study||14
3361259|NCT04289714|4092227|FG001|STARTED|Overall Study||11
3361260|NCT04289714|4092228|FG002|STARTED|Overall Study||10
3361261|NCT04289714|4092226|FG000|COMPLETED|Overall Study||8
3361262|NCT04289714|4092227|FG001|COMPLETED|Overall Study||6
3361263|NCT04289714|4092228|FG002|COMPLETED|Overall Study||4
3361264|NCT04289714|4092226|FG000|NOT COMPLETED|Overall Study||6
3361265|NCT04289714|4092227|FG001|NOT COMPLETED|Overall Study||5
3361266|NCT04289714|4092228|FG002|NOT COMPLETED|Overall Study||6
3179330|NCT01984398|3907494|FG000|NOT COMPLETED|Washout Period of 5 to 7 Days||0
3179331|NCT01984398|3907495|FG001|NOT COMPLETED|Washout Period of 5 to 7 Days||0
3179332|NCT01984398|3907496|FG002|NOT COMPLETED|Washout Period of 5 to 7 Days||0
3179333|NCT01984398|3907497|FG003|NOT COMPLETED|Washout Period of 5 to 7 Days||0
3179334|NCT01984398|3907494|FG000|STARTED|Treatment Period 2||4
3179335|NCT01984398|3907495|FG001|STARTED|Treatment Period 2||4
3179336|NCT01984398|3907496|FG002|STARTED|Treatment Period 2||4
3179337|NCT01984398|3907497|FG003|STARTED|Treatment Period 2||4
3179338|NCT01984398|3907494|FG000|COMPLETED|Treatment Period 2||4
3179339|NCT01984398|3907495|FG001|COMPLETED|Treatment Period 2||4
3179340|NCT01984398|3907496|FG002|COMPLETED|Treatment Period 2||4
3179341|NCT01984398|3907497|FG003|COMPLETED|Treatment Period 2||4
3361267|NCT04288752|4092238|FG000|STARTED|Overall Study|88 Participants were randomized to the VR101 group. However, one randomized participant (AR33) was unable to place the device and was immediately terminated from the study, prior to any post-randomization data collection. Therefore, 87 participants assigned to the VR101 group entered the treatment phase.|87
3361268|NCT04288752|4092239|FG001|STARTED|Overall Study||88
3361269|NCT04288752|4092238|FG000|COMPLETED|Overall Study||81
3361270|NCT04288752|4092239|FG001|COMPLETED|Overall Study||85
3361271|NCT04288752|4092238|FG000|NOT COMPLETED|Overall Study||6
3361272|NCT04288752|4092239|FG001|NOT COMPLETED|Overall Study||3
3361273|NCT04280705|4092247|FG000|STARTED|Overall Study||521
3361274|NCT04280705|4092248|FG001|STARTED|Overall Study||541
3361275|NCT04280705|4092247|FG000|Received Treatment|Overall Study||517
3361276|NCT04280705|4092248|FG001|Received Treatment|Overall Study||531
3361277|NCT04280705|4092247|FG000|COMPLETED|Overall Study||508
3361278|NCT04280705|4092248|FG001|COMPLETED|Overall Study||517
3361279|NCT04280705|4092247|FG000|NOT COMPLETED|Overall Study||13
3361280|NCT04280705|4092248|FG001|NOT COMPLETED|Overall Study||24
3179342|NCT01984398|3907494|FG000|NOT COMPLETED|Treatment Period 2||0
3179343|NCT01984398|3907495|FG001|NOT COMPLETED|Treatment Period 2||0
3179344|NCT01984398|3907496|FG002|NOT COMPLETED|Treatment Period 2||0
3179345|NCT01984398|3907497|FG003|NOT COMPLETED|Treatment Period 2||0
3179346|NCT01984424|3907509|FG000|STARTED|Overall Study||73
3179347|NCT01984424|3907510|FG001|STARTED|Overall Study||145
3179348|NCT01984424|3907509|FG000|COMPLETED|Overall Study||70
3179349|NCT01984424|3907510|FG001|COMPLETED|Overall Study||138
3179350|NCT01984424|3907509|FG000|NOT COMPLETED|Overall Study||3
3179351|NCT01984424|3907510|FG001|NOT COMPLETED|Overall Study||7
3179352|NCT01984515|3907516|FG000|STARTED|Overall Study||59
3179353|NCT01984515|3907516|FG000|Received CBT Session|Overall Study||40
3179354|NCT01984515|3907516|FG000|COMPLETED|Overall Study||40
3179355|NCT01984515|3907516|FG000|NOT COMPLETED|Overall Study||19
3179356|NCT01984684|3907522|FG000|STARTED|Overall Study||423
3179357|NCT01984684|3907523|FG001|STARTED|Overall Study||427
3179358|NCT01984684|3907522|FG000|COMPLETED|Overall Study||366
3361281|NCT04287517|4092256|FG000|STARTED|Overall Study||19
3361282|NCT04287517|4092257|FG001|STARTED|Overall Study||19
3361283|NCT04287517|4092256|FG000|COMPLETED|Overall Study||18
3361284|NCT04287517|4092257|FG001|COMPLETED|Overall Study||18
3361285|NCT04287517|4092256|FG000|NOT COMPLETED|Overall Study||1
3361286|NCT04287517|4092257|FG001|NOT COMPLETED|Overall Study||1
3361287|NCT04287036|4092263|FG000|STARTED|Period 1||13
3361288|NCT04287036|4092264|FG001|STARTED|Period 1||12
3361289|NCT04287036|4092263|FG000|COMPLETED|Period 1||13
3361290|NCT04287036|4092264|FG001|COMPLETED|Period 1||12
3361291|NCT04287036|4092263|FG000|NOT COMPLETED|Period 1||0
3361292|NCT04287036|4092264|FG001|NOT COMPLETED|Period 1||0
3361293|NCT04287036|4092263|FG000|STARTED|Period 2||13
3361294|NCT04287036|4092264|FG001|STARTED|Period 2||12
3361295|NCT04287036|4092263|FG000|COMPLETED|Period 2||13
3361296|NCT04287036|4092264|FG001|COMPLETED|Period 2||12
3361297|NCT04287036|4092263|FG000|NOT COMPLETED|Period 2||0
3361298|NCT04287036|4092264|FG001|NOT COMPLETED|Period 2||0
3361299|NCT04286412|4092270|FG000|STARTED|Overall Study||25
3361300|NCT04286412|4092270|FG000|COMPLETED|Overall Study||25
3361301|NCT04286412|4092270|FG000|NOT COMPLETED|Overall Study||0
3361302|NCT04285411|4092274|FG000|STARTED|Overall Study||10
3361303|NCT04285411|4092274|FG000|COMPLETED|Overall Study||10
3361304|NCT04285411|4092274|FG000|NOT COMPLETED|Overall Study||0
3361305|NCT04284930|4092282|FG000|STARTED|Overall Study||8
3361306|NCT04284930|4092283|FG001|STARTED|Overall Study||5
3361307|NCT04284930|4092284|FG002|STARTED|Overall Study||8
3361308|NCT04284930|4092282|FG000|COMPLETED|Overall Study||8
3361309|NCT04284930|4092283|FG001|COMPLETED|Overall Study||5
3361310|NCT04284930|4092284|FG002|COMPLETED|Overall Study||8
3361311|NCT04284930|4092282|FG000|NOT COMPLETED|Overall Study||0
3361312|NCT04284930|4092283|FG001|NOT COMPLETED|Overall Study||0
3361313|NCT04284930|4092284|FG002|NOT COMPLETED|Overall Study||0
3361314|NCT04283773|4092295|FG000|STARTED|Overall Study||22
3361315|NCT04283773|4092296|FG001|STARTED|Overall Study||20
3361316|NCT04283773|4092297|FG002|STARTED|Overall Study||20
3361317|NCT04283773|4092295|FG000|COMPLETED|Overall Study||22
3361318|NCT04283773|4092296|FG001|COMPLETED|Overall Study||20
3361319|NCT04283773|4092297|FG002|COMPLETED|Overall Study||20
3361320|NCT04283773|4092295|FG000|NOT COMPLETED|Overall Study||0
3361321|NCT04283773|4092296|FG001|NOT COMPLETED|Overall Study||0
3361322|NCT04283773|4092297|FG002|NOT COMPLETED|Overall Study||0
3361323|NCT04281901|4092309|FG000|STARTED|Overall Study||12
3361324|NCT04281901|4092310|FG001|STARTED|Overall Study||12
3361325|NCT04281901|4092309|FG000|2. Check-up|Overall Study||11
3361326|NCT04281901|4092310|FG001|2. Check-up|Overall Study||11
3361327|NCT04281901|4092309|FG000|3. Check-up|Overall Study||11
3361328|NCT04281901|4092310|FG001|3. Check-up|Overall Study||11
3361329|NCT04281901|4092309|FG000|COMPLETED|Overall Study||11
3361330|NCT04281901|4092310|FG001|COMPLETED|Overall Study||11
3361331|NCT04281901|4092309|FG000|NOT COMPLETED|Overall Study||1
3361332|NCT04281901|4092310|FG001|NOT COMPLETED|Overall Study||1
3361333|NCT04280653|4092316|FG000|STARTED|Overall Study||15
3361334|NCT04280653|4092316|FG000|COMPLETED|Overall Study||15
3361335|NCT04280653|4092316|FG000|NOT COMPLETED|Overall Study||0
3361336|NCT04277936|4092320|FG000|STARTED|Overall Study||1
3361337|NCT04277936|4092320|FG000|COMPLETED|Overall Study||1
3361338|NCT04277936|4092320|FG000|NOT COMPLETED|Overall Study||0
3361339|NCT04275336|4092327|FG000|STARTED|Overall Study||120
3361340|NCT04275336|4092328|FG001|STARTED|Overall Study||118
3361341|NCT04275336|4092329|FG002|STARTED|Overall Study||116
3361342|NCT04275336|4092327|FG000|COMPLETED|Overall Study||103
3361343|NCT04275336|4092328|FG001|COMPLETED|Overall Study||96
3361344|NCT04275336|4092329|FG002|COMPLETED|Overall Study||100
3361345|NCT04275336|4092327|FG000|NOT COMPLETED|Overall Study||17
3361346|NCT04275336|4092328|FG001|NOT COMPLETED|Overall Study||22
3361347|NCT04275336|4092329|FG002|NOT COMPLETED|Overall Study||16
3361348|NCT04272775|4092342|FG000|STARTED|Overall Study||7
3361349|NCT04272775|4092343|FG001|STARTED|Overall Study||7
3361350|NCT04272775|4092342|FG000|COMPLETED|Overall Study||0
3361351|NCT04272775|4092343|FG001|COMPLETED|Overall Study||0
3361352|NCT04272775|4092342|FG000|NOT COMPLETED|Overall Study||7
3361353|NCT04272775|4092343|FG001|NOT COMPLETED|Overall Study||7
3361354|NCT04271020|4092349|FG000|STARTED|Overall Study||12
3361355|NCT04271020|4092349|FG000|COMPLETED|Overall Study||12
3361356|NCT04271020|4092349|FG000|NOT COMPLETED|Overall Study||0
3361357|NCT04274075|4092359|FG000|STARTED|Overall Study||3
3361358|NCT04274075|4092360|FG001|STARTED|Overall Study||3
3361359|NCT04274075|4092361|FG002|STARTED|Overall Study||3
3361360|NCT04274075|4092362|FG003|STARTED|Overall Study||3
3361361|NCT04274075|4092363|FG004|STARTED|Overall Study||3
3361362|NCT04274075|4092364|FG005|STARTED|Overall Study||3
3361363|NCT04274075|4092359|FG000|Completed Treatment Period 1 (9 Days)|Overall Study||3
3361364|NCT04274075|4092360|FG001|Completed Treatment Period 1 (9 Days)|Overall Study||3
3361365|NCT04274075|4092361|FG002|Completed Treatment Period 1 (9 Days)|Overall Study||3
3361366|NCT04274075|4092362|FG003|Completed Treatment Period 1 (9 Days)|Overall Study||3
3361367|NCT04274075|4092363|FG004|Completed Treatment Period 1 (9 Days)|Overall Study||3
3361368|NCT04274075|4092364|FG005|Completed Treatment Period 1 (9 Days)|Overall Study||3
3040082|NCT01162239|3759541|FG003|STARTED|Extended Follow-up||47
3361369|NCT04274075|4092359|FG000|Completed Treatment Period 2 (9 Days)|Overall Study||3
3361370|NCT04274075|4092360|FG001|Completed Treatment Period 2 (9 Days)|Overall Study||3
3361371|NCT04274075|4092361|FG002|Completed Treatment Period 2 (9 Days)|Overall Study||3
3361372|NCT04274075|4092362|FG003|Completed Treatment Period 2 (9 Days)|Overall Study||3
3361373|NCT04274075|4092363|FG004|Completed Treatment Period 2 (9 Days)|Overall Study||3
3361374|NCT04274075|4092364|FG005|Completed Treatment Period 2 (9 Days)|Overall Study||3
3361375|NCT04274075|4092359|FG000|Completed Treatment Period 3 (9 Days)|Overall Study||3
3361376|NCT04274075|4092360|FG001|Completed Treatment Period 3 (9 Days)|Overall Study||3
3361377|NCT04274075|4092361|FG002|Completed Treatment Period 3 (9 Days)|Overall Study||3
3361378|NCT04274075|4092362|FG003|Completed Treatment Period 3 (9 Days)|Overall Study||3
3361379|NCT04274075|4092363|FG004|Completed Treatment Period 3 (9 Days)|Overall Study||3
3361380|NCT04274075|4092364|FG005|Completed Treatment Period 3 (9 Days)|Overall Study||3
3361381|NCT04274075|4092359|FG000|Completed Follow-up Visit|Overall Study||3
3361382|NCT04274075|4092360|FG001|Completed Follow-up Visit|Overall Study||3
3361383|NCT04274075|4092361|FG002|Completed Follow-up Visit|Overall Study||3
3361384|NCT04274075|4092362|FG003|Completed Follow-up Visit|Overall Study||3
3361385|NCT04274075|4092363|FG004|Completed Follow-up Visit|Overall Study||3
3361386|NCT04274075|4092364|FG005|Completed Follow-up Visit|Overall Study||3
3361387|NCT04274075|4092359|FG000|COMPLETED|Overall Study||3
3361388|NCT04274075|4092360|FG001|COMPLETED|Overall Study||3
3361389|NCT04274075|4092361|FG002|COMPLETED|Overall Study||3
3361390|NCT04274075|4092362|FG003|COMPLETED|Overall Study||3
3361391|NCT04274075|4092363|FG004|COMPLETED|Overall Study||3
3361392|NCT04274075|4092364|FG005|COMPLETED|Overall Study||3
3361393|NCT04274075|4092359|FG000|NOT COMPLETED|Overall Study||0
3361394|NCT04274075|4092360|FG001|NOT COMPLETED|Overall Study||0
3361395|NCT04274075|4092361|FG002|NOT COMPLETED|Overall Study||0
3361396|NCT04274075|4092362|FG003|NOT COMPLETED|Overall Study||0
3361397|NCT04274075|4092363|FG004|NOT COMPLETED|Overall Study||0
3361398|NCT04274075|4092364|FG005|NOT COMPLETED|Overall Study||0
3361399|NCT04271605|4092375|FG000|STARTED|Overall Study|Baseline questionnaire and examination were done after enrollment.|5
3361400|NCT04271605|4092375|FG000|COMPLETED|Overall Study||0
3361401|NCT04271605|4092375|FG000|NOT COMPLETED|Overall Study||5
3361402|NCT04271761|4092379|FG000|STARTED|Overall Study||14
3361403|NCT04271761|4092379|FG000|COMPLETED|Overall Study||14
3361404|NCT04271761|4092379|FG000|NOT COMPLETED|Overall Study||0
3361405|NCT04268316|4092386|FG000|STARTED|Overall Study||5
3179359|NCT01984684|3907523|FG001|COMPLETED|Overall Study||368
3179360|NCT01984684|3907522|FG000|NOT COMPLETED|Overall Study||57
3361406|NCT04268316|4092387|FG001|STARTED|Overall Study||4
3361407|NCT04268316|4092388|FG002|STARTED|Overall Study||4
3361408|NCT04268316|4092386|FG000|COMPLETED|Overall Study||3
3361409|NCT04268316|4092387|FG001|COMPLETED|Overall Study||3
3361410|NCT04268316|4092388|FG002|COMPLETED|Overall Study||4
3361411|NCT04268316|4092386|FG000|NOT COMPLETED|Overall Study||2
3361412|NCT04268316|4092387|FG001|NOT COMPLETED|Overall Study||1
3361413|NCT04268316|4092388|FG002|NOT COMPLETED|Overall Study||0
3361414|NCT04269629|4092396|FG000|STARTED|Overall Study|1425 patients were included in the study (=Visit 1)|1425
3361415|NCT04269629|4092396|FG000|Number of Patients Who Performed VIT|Overall Study|Visit 2 was performed with 1342 patients|1342
3361416|NCT04269629|4092396|FG000|COMPLETED|Overall Study|Visit 3 was performed with 1186 patients|1186
3361417|NCT04269629|4092396|FG000|NOT COMPLETED|Overall Study||239
3361418|NCT04267575|4092404|FG000|STARTED|Overall Study||20
3361419|NCT04267575|4092404|FG000|COMPLETED|Overall Study||20
3361420|NCT04267575|4092404|FG000|NOT COMPLETED|Overall Study||0
3361421|NCT04267770|4092410|FG000|STARTED|Overall Study||9
3361422|NCT04267770|4092411|FG001|STARTED|Overall Study||8
3361423|NCT04267770|4092410|FG000|COMPLETED|Overall Study||9
3361424|NCT04267770|4092411|FG001|COMPLETED|Overall Study||8
3361425|NCT04267770|4092410|FG000|NOT COMPLETED|Overall Study||0
3361426|NCT04267770|4092411|FG001|NOT COMPLETED|Overall Study||0
3361427|NCT04266925|4092419|FG000|STARTED|1 Referee Game (~1 Hour)||23
3361428|NCT04266925|4092420|FG001|STARTED|1 Referee Game (~1 Hour)||26
3361429|NCT04266925|4092419|FG000|COMPLETED|1 Referee Game (~1 Hour)||23
3361430|NCT04266925|4092420|FG001|COMPLETED|1 Referee Game (~1 Hour)||26
3361431|NCT04266925|4092419|FG000|NOT COMPLETED|1 Referee Game (~1 Hour)||0
3361432|NCT04266925|4092420|FG001|NOT COMPLETED|1 Referee Game (~1 Hour)||0
3361433|NCT04266925|4092419|FG000|STARTED|3 Referee Game (~1 Hour)||23
3361434|NCT04266925|4092420|FG001|STARTED|3 Referee Game (~1 Hour)||26
3361435|NCT04266925|4092419|FG000|COMPLETED|3 Referee Game (~1 Hour)||23
3361436|NCT04266925|4092420|FG001|COMPLETED|3 Referee Game (~1 Hour)||26
3361437|NCT04266925|4092419|FG000|NOT COMPLETED|3 Referee Game (~1 Hour)||0
3361438|NCT04266925|4092420|FG001|NOT COMPLETED|3 Referee Game (~1 Hour)||0
3361439|NCT04263142|4092431|FG000|STARTED|Part 1 Period 1 (Day 1)||9
3361440|NCT04263142|4092432|FG001|STARTED|Part 1 Period 1 (Day 1)||9
3361441|NCT04263142|4092433|FG002|STARTED|Part 1 Period 1 (Day 1)||0
3361442|NCT04263142|4092434|FG003|STARTED|Part 1 Period 1 (Day 1)||0
3361443|NCT04263142|4092435|FG004|STARTED|Part 1 Period 1 (Day 1)||0
3361444|NCT04263142|4092431|FG000|COMPLETED|Part 1 Period 1 (Day 1)||9
3361445|NCT04263142|4092432|FG001|COMPLETED|Part 1 Period 1 (Day 1)||9
3361446|NCT04263142|4092433|FG002|COMPLETED|Part 1 Period 1 (Day 1)||0
3361447|NCT04263142|4092434|FG003|COMPLETED|Part 1 Period 1 (Day 1)||0
3361448|NCT04263142|4092435|FG004|COMPLETED|Part 1 Period 1 (Day 1)||0
3361449|NCT04263142|4092431|FG000|NOT COMPLETED|Part 1 Period 1 (Day 1)||0
3361450|NCT04263142|4092432|FG001|NOT COMPLETED|Part 1 Period 1 (Day 1)||0
3361451|NCT04263142|4092433|FG002|NOT COMPLETED|Part 1 Period 1 (Day 1)||0
3361452|NCT04263142|4092434|FG003|NOT COMPLETED|Part 1 Period 1 (Day 1)||0
3361453|NCT04263142|4092435|FG004|NOT COMPLETED|Part 1 Period 1 (Day 1)||0
3361454|NCT04263142|4092431|FG000|STARTED|Part 1 Period 2 (Up to Day 5)||9
3361455|NCT04263142|4092432|FG001|STARTED|Part 1 Period 2 (Up to Day 5)||9
3361456|NCT04263142|4092433|FG002|STARTED|Part 1 Period 2 (Up to Day 5)||0
3361457|NCT04263142|4092434|FG003|STARTED|Part 1 Period 2 (Up to Day 5)||0
3361458|NCT04263142|4092435|FG004|STARTED|Part 1 Period 2 (Up to Day 5)||0
3361459|NCT04263142|4092431|FG000|COMPLETED|Part 1 Period 2 (Up to Day 5)||9
3361460|NCT04263142|4092432|FG001|COMPLETED|Part 1 Period 2 (Up to Day 5)||9
3361461|NCT04263142|4092433|FG002|COMPLETED|Part 1 Period 2 (Up to Day 5)||0
3361462|NCT04263142|4092434|FG003|COMPLETED|Part 1 Period 2 (Up to Day 5)||0
3361463|NCT04263142|4092435|FG004|COMPLETED|Part 1 Period 2 (Up to Day 5)||0
3361464|NCT04263142|4092431|FG000|NOT COMPLETED|Part 1 Period 2 (Up to Day 5)||0
3361465|NCT04263142|4092432|FG001|NOT COMPLETED|Part 1 Period 2 (Up to Day 5)||0
3361466|NCT04263142|4092433|FG002|NOT COMPLETED|Part 1 Period 2 (Up to Day 5)||0
3361467|NCT04263142|4092434|FG003|NOT COMPLETED|Part 1 Period 2 (Up to Day 5)||0
3361468|NCT04263142|4092435|FG004|NOT COMPLETED|Part 1 Period 2 (Up to Day 5)||0
3361469|NCT04263142|4092431|FG000|STARTED|Part 2 Period 1 (Day 1)||0
3361470|NCT04263142|4092432|FG001|STARTED|Part 2 Period 1 (Day 1)||0
3361471|NCT04263142|4092433|FG002|STARTED|Part 2 Period 1 (Day 1)||7
3361472|NCT04263142|4092434|FG003|STARTED|Part 2 Period 1 (Day 1)||7
3361473|NCT04263142|4092435|FG004|STARTED|Part 2 Period 1 (Day 1)||7
3361474|NCT04263142|4092431|FG000|COMPLETED|Part 2 Period 1 (Day 1)||0
3361475|NCT04263142|4092432|FG001|COMPLETED|Part 2 Period 1 (Day 1)||0
3361476|NCT04263142|4092433|FG002|COMPLETED|Part 2 Period 1 (Day 1)||7
3361477|NCT04263142|4092434|FG003|COMPLETED|Part 2 Period 1 (Day 1)||7
3361478|NCT04263142|4092435|FG004|COMPLETED|Part 2 Period 1 (Day 1)||6
3179361|NCT01984684|3907523|FG001|NOT COMPLETED|Overall Study||59
3179362|NCT01984697|3907534|FG000|STARTED|Overall Study||301
3179363|NCT01984697|3907535|FG001|STARTED|Overall Study||301
3179364|NCT01984697|3907536|FG002|STARTED|Overall Study||301
3179365|NCT01984697|3907537|FG003|STARTED|Overall Study||301
3361479|NCT04263142|4092431|FG000|NOT COMPLETED|Part 2 Period 1 (Day 1)||0
3361480|NCT04263142|4092432|FG001|NOT COMPLETED|Part 2 Period 1 (Day 1)||0
3361481|NCT04263142|4092433|FG002|NOT COMPLETED|Part 2 Period 1 (Day 1)||0
3361482|NCT04263142|4092434|FG003|NOT COMPLETED|Part 2 Period 1 (Day 1)||0
3361483|NCT04263142|4092435|FG004|NOT COMPLETED|Part 2 Period 1 (Day 1)||1
3361484|NCT04263142|4092431|FG000|STARTED|Part 2 Period 2 (Day 1)||0
3361485|NCT04263142|4092432|FG001|STARTED|Part 2 Period 2 (Day 1)||0
3361486|NCT04263142|4092433|FG002|STARTED|Part 2 Period 2 (Day 1)||7
3361487|NCT04263142|4092434|FG003|STARTED|Part 2 Period 2 (Day 1)||7
3361488|NCT04263142|4092435|FG004|STARTED|Part 2 Period 2 (Day 1)||6
3361489|NCT04263142|4092431|FG000|COMPLETED|Part 2 Period 2 (Day 1)||0
3361490|NCT04263142|4092432|FG001|COMPLETED|Part 2 Period 2 (Day 1)||0
3361491|NCT04263142|4092433|FG002|COMPLETED|Part 2 Period 2 (Day 1)||7
3361492|NCT04263142|4092434|FG003|COMPLETED|Part 2 Period 2 (Day 1)||7
3361493|NCT04263142|4092435|FG004|COMPLETED|Part 2 Period 2 (Day 1)||5
3361494|NCT04263142|4092431|FG000|NOT COMPLETED|Part 2 Period 2 (Day 1)||0
3361495|NCT04263142|4092432|FG001|NOT COMPLETED|Part 2 Period 2 (Day 1)||0
3361496|NCT04263142|4092433|FG002|NOT COMPLETED|Part 2 Period 2 (Day 1)||0
3361497|NCT04263142|4092434|FG003|NOT COMPLETED|Part 2 Period 2 (Day 1)||0
3361498|NCT04263142|4092435|FG004|NOT COMPLETED|Part 2 Period 2 (Day 1)||1
3361499|NCT04263142|4092431|FG000|STARTED|Part 2 Period 3 (Up to Day 5)||0
3361500|NCT04263142|4092432|FG001|STARTED|Part 2 Period 3 (Up to Day 5)||0
3361501|NCT04263142|4092433|FG002|STARTED|Part 2 Period 3 (Up to Day 5)||7
3361502|NCT04263142|4092434|FG003|STARTED|Part 2 Period 3 (Up to Day 5)||7
3361503|NCT04263142|4092435|FG004|STARTED|Part 2 Period 3 (Up to Day 5)||5
3361504|NCT04263142|4092431|FG000|COMPLETED|Part 2 Period 3 (Up to Day 5)||0
3361505|NCT04263142|4092432|FG001|COMPLETED|Part 2 Period 3 (Up to Day 5)||0
2928334|NCT00576823|3639203|FG000|NOT COMPLETED|40-week Safety Extension Phase||1
3179366|NCT01984697|3907538|FG004|STARTED|Overall Study||314
3361506|NCT04263142|4092433|FG002|COMPLETED|Part 2 Period 3 (Up to Day 5)||7
3361507|NCT04263142|4092434|FG003|COMPLETED|Part 2 Period 3 (Up to Day 5)||7
3361508|NCT04263142|4092435|FG004|COMPLETED|Part 2 Period 3 (Up to Day 5)||5
3361509|NCT04263142|4092431|FG000|NOT COMPLETED|Part 2 Period 3 (Up to Day 5)||0
3361510|NCT04263142|4092432|FG001|NOT COMPLETED|Part 2 Period 3 (Up to Day 5)||0
3361511|NCT04263142|4092433|FG002|NOT COMPLETED|Part 2 Period 3 (Up to Day 5)||0
3361512|NCT04263142|4092434|FG003|NOT COMPLETED|Part 2 Period 3 (Up to Day 5)||0
3361513|NCT04263142|4092435|FG004|NOT COMPLETED|Part 2 Period 3 (Up to Day 5)||0
3361514|NCT04256785|4092450|FG000|STARTED|Overall Study||54
3361515|NCT04256785|4092451|FG001|STARTED|Overall Study||56
3361516|NCT04256785|4092450|FG000|COMPLETED|Overall Study||26
3361517|NCT04256785|4092451|FG001|COMPLETED|Overall Study||31
3361518|NCT04256785|4092450|FG000|NOT COMPLETED|Overall Study||28
3361519|NCT04256785|4092451|FG001|NOT COMPLETED|Overall Study||25
3361520|NCT04252092|4092461|FG000|STARTED|Overall Study||15
3361521|NCT04252092|4092462|FG001|STARTED|Overall Study||15
3361522|NCT04252092|4092461|FG000|COMPLETED|Overall Study||15
3361523|NCT04252092|4092462|FG001|COMPLETED|Overall Study||15
3361524|NCT04252092|4092461|FG000|NOT COMPLETED|Overall Study||0
3361525|NCT04252092|4092462|FG001|NOT COMPLETED|Overall Study||0
3361526|NCT04251884|4092470|FG000|STARTED|Overall Study||23
3361527|NCT04251884|4092471|FG001|STARTED|Overall Study||26
3361528|NCT04251884|4092470|FG000|COMPLETED|Overall Study||23
3361529|NCT04251884|4092471|FG001|COMPLETED|Overall Study||26
3361530|NCT04251884|4092470|FG000|NOT COMPLETED|Overall Study||0
3361531|NCT04251884|4092471|FG001|NOT COMPLETED|Overall Study||0
3361532|NCT04250987|4092478|FG000|STARTED|Overall Study||12
3361533|NCT04250987|4092478|FG000|COMPLETED|Overall Study||12
3361534|NCT04250987|4092478|FG000|NOT COMPLETED|Overall Study||0
3361535|NCT04249336|4092486|FG000|STARTED|Overall Study||35
3361536|NCT04249336|4092487|FG001|STARTED|Overall Study||35
3361537|NCT04249336|4092488|FG002|STARTED|Overall Study||35
3361538|NCT04249336|4092489|FG003|STARTED|Overall Study||35
3361539|NCT04249336|4092486|FG000|Per Protocol Population Day 3|Overall Study||32
3361540|NCT04249336|4092487|FG001|Per Protocol Population Day 3|Overall Study||32
3361541|NCT04249336|4092488|FG002|Per Protocol Population Day 3|Overall Study||32
3361542|NCT04249336|4092489|FG003|Per Protocol Population Day 3|Overall Study||32
3361543|NCT04249336|4092486|FG000|Per Protocol Population Week 4|Overall Study||33
3361544|NCT04249336|4092487|FG001|Per Protocol Population Week 4|Overall Study||35
3361545|NCT04249336|4092488|FG002|Per Protocol Population Week 4|Overall Study||33
3361546|NCT04249336|4092489|FG003|Per Protocol Population Week 4|Overall Study||34
3361547|NCT04249336|4092486|FG000|COMPLETED|Overall Study||32
3361548|NCT04249336|4092487|FG001|COMPLETED|Overall Study||32
3361549|NCT04249336|4092488|FG002|COMPLETED|Overall Study||32
3361550|NCT04249336|4092489|FG003|COMPLETED|Overall Study||32
3361551|NCT04249336|4092486|FG000|NOT COMPLETED|Overall Study||3
3361552|NCT04249336|4092487|FG001|NOT COMPLETED|Overall Study||3
3361553|NCT04249336|4092488|FG002|NOT COMPLETED|Overall Study||3
3361554|NCT04249336|4092489|FG003|NOT COMPLETED|Overall Study||3
3361555|NCT04249310|4092501|FG000|STARTED|Overall Study||1436
3361556|NCT04249310|4092502|FG001|STARTED|Overall Study||5352
3361557|NCT04249310|4092501|FG000|PS-matched Cohort|Overall Study||1412
3361558|NCT04249310|4092502|FG001|PS-matched Cohort|Overall Study||1412
3361559|NCT04249310|4092501|FG000|hdPS-matched Cohort|Overall Study||1302
3361560|NCT04249310|4092502|FG001|hdPS-matched Cohort|Overall Study||1302
3361561|NCT04249310|4092501|FG000|COMPLETED|Overall Study||1436
3361562|NCT04249310|4092502|FG001|COMPLETED|Overall Study||5352
3361563|NCT04249310|4092501|FG000|NOT COMPLETED|Overall Study||0
3361564|NCT04249310|4092502|FG001|NOT COMPLETED|Overall Study||0
3361565|NCT04247581|4092510|FG000|STARTED|Overall Study||241
3361566|NCT04247581|4092511|FG001|STARTED|Overall Study||305
3361567|NCT04247581|4092510|FG000|COMPLETED|Overall Study||241
3361568|NCT04247581|4092511|FG001|COMPLETED|Overall Study||293
3361569|NCT04247581|4092510|FG000|NOT COMPLETED|Overall Study||0
3361570|NCT04247581|4092511|FG001|NOT COMPLETED|Overall Study||12
3361571|NCT04247061|4092517|FG000|STARTED|Overall Study|13 Subjects completed the required pre-dental appointment study activities and were scheduled to attend the dental clinic|13
3361572|NCT04247061|4092517|FG000|COMPLETED|Overall Study||4
3361573|NCT04247061|4092517|FG000|NOT COMPLETED|Overall Study||9
3361574|NCT04245202|4092523|FG000|STARTED|Overall Study|After getting consent.|48
3361575|NCT04245202|4092524|FG001|STARTED|Overall Study|After getting consent|39
3361576|NCT04245202|4092523|FG000|COMPLETED|Overall Study||38
3361577|NCT04245202|4092524|FG001|COMPLETED|Overall Study||38
3361578|NCT04245202|4092523|FG000|NOT COMPLETED|Overall Study||10
3361579|NCT04245202|4092524|FG001|NOT COMPLETED|Overall Study||1
3361580|NCT04243369|4092531|FG000|STARTED|Overall Study||30
3361581|NCT04243369|4092531|FG000|COMPLETED|Overall Study||30
3361582|NCT04243369|4092531|FG000|NOT COMPLETED|Overall Study||0
3361583|NCT04241146|4092537|FG000|STARTED|Overall Study||24
3361584|NCT04241146|4092538|FG001|STARTED|Overall Study||28
3361585|NCT04241146|4092537|FG000|COMPLETED|Overall Study||24
3361586|NCT04241146|4092538|FG001|COMPLETED|Overall Study||28
3361587|NCT04241146|4092537|FG000|NOT COMPLETED|Overall Study||0
3361588|NCT04241146|4092538|FG001|NOT COMPLETED|Overall Study||0
3361589|NCT04240678|4092546|FG000|STARTED|Overall Study||4141
3361590|NCT04240678|4092547|FG001|STARTED|Overall Study||4158
3361591|NCT04240678|4092546|FG000|COMPLETED|Overall Study||4141
3361592|NCT04240678|4092547|FG001|COMPLETED|Overall Study||4158
3361593|NCT04240678|4092546|FG000|NOT COMPLETED|Overall Study||0
3361594|NCT04240678|4092547|FG001|NOT COMPLETED|Overall Study||0
3361595|NCT04238650|4092555|FG000|STARTED|Overall Study||24
3361596|NCT04238650|4092556|FG001|STARTED|Overall Study|One subject was enrolled and randomized to EU Avastin® but the subject was not dosed (subject withdrawal before study drug administration)|25
3361597|NCT04238650|4092555|FG000|COMPLETED|Overall Study||24
3361598|NCT04238650|4092556|FG001|COMPLETED|Overall Study||24
3361599|NCT04238650|4092555|FG000|NOT COMPLETED|Overall Study||0
3361600|NCT04238650|4092556|FG001|NOT COMPLETED|Overall Study||1
3361601|NCT04238663|4092565|FG000|STARTED|Overall Study||38
3361602|NCT04238663|4092566|FG001|STARTED|Overall Study||38
3361603|NCT04238663|4092567|FG002|STARTED|Overall Study||38
3361604|NCT04238663|4092565|FG000|COMPLETED|Overall Study||38
3361605|NCT04238663|4092566|FG001|COMPLETED|Overall Study||37
3361606|NCT04238663|4092567|FG002|COMPLETED|Overall Study||38
3361607|NCT04238663|4092565|FG000|NOT COMPLETED|Overall Study||0
3361608|NCT04238663|4092566|FG001|NOT COMPLETED|Overall Study||1
3361609|NCT04238663|4092567|FG002|NOT COMPLETED|Overall Study||0
3361610|NCT04235582|4092578|FG000|STARTED|Overall Study||12
3361611|NCT04235582|4092579|FG001|STARTED|Overall Study||13
3361612|NCT04235582|4092580|FG002|STARTED|Overall Study||11
3361613|NCT04235582|4092578|FG000|COMPLETED|Overall Study||12
3361614|NCT04235582|4092579|FG001|COMPLETED|Overall Study||12
3361615|NCT04235582|4092580|FG002|COMPLETED|Overall Study||8
3361616|NCT04235582|4092578|FG000|NOT COMPLETED|Overall Study||0
3361617|NCT04235582|4092579|FG001|NOT COMPLETED|Overall Study||1
3361618|NCT04235582|4092580|FG002|NOT COMPLETED|Overall Study||3
3361619|NCT04203225|4092590|FG000|STARTED|Overall Study||21
3361620|NCT04203225|4092591|FG001|STARTED|Overall Study||27
3361621|NCT04203225|4092590|FG000|COMPLETED|Overall Study||21
3361622|NCT04203225|4092591|FG001|COMPLETED|Overall Study||27
3361623|NCT04203225|4092590|FG000|NOT COMPLETED|Overall Study||0
3361624|NCT04203225|4092591|FG001|NOT COMPLETED|Overall Study||0
3361625|NCT04234672|4092597|FG000|STARTED|Treatment Period 1 (Day 1)||6
3361626|NCT04234672|4092597|FG000|COMPLETED|Treatment Period 1 (Day 1)||6
3361627|NCT04234672|4092597|FG000|NOT COMPLETED|Treatment Period 1 (Day 1)||0
3361628|NCT04234672|4092597|FG000|STARTED|Washout Period (Day 2 to 8)||6
3361629|NCT04234672|4092597|FG000|COMPLETED|Washout Period (Day 2 to 8)||6
3361630|NCT04234672|4092597|FG000|NOT COMPLETED|Washout Period (Day 2 to 8)||0
3361631|NCT04234672|4092597|FG000|STARTED|Treatment Period 2(Day9[Day1of Period2])||6
3361632|NCT04234672|4092597|FG000|COMPLETED|Treatment Period 2(Day9[Day1of Period2])||6
3361633|NCT04234672|4092597|FG000|NOT COMPLETED|Treatment Period 2(Day9[Day1of Period2])||0
3361634|NCT04223635|4092610|FG000|STARTED|Overall Study||8
3361635|NCT04223635|4092611|FG001|STARTED|Overall Study||8
3361636|NCT04223635|4092610|FG000|COMPLETED|Overall Study||8
3361637|NCT04223635|4092611|FG001|COMPLETED|Overall Study||8
3361638|NCT04223635|4092610|FG000|NOT COMPLETED|Overall Study||0
3361639|NCT04223635|4092611|FG001|NOT COMPLETED|Overall Study||0
3361640|NCT04214951|4092619|FG000|STARTED|Overall Study||50
3361641|NCT04214951|4092620|FG001|STARTED|Overall Study||50
3361642|NCT04214951|4092619|FG000|COMPLETED|Overall Study||10
3361643|NCT04214951|4092620|FG001|COMPLETED|Overall Study||10
3361644|NCT04214951|4092619|FG000|NOT COMPLETED|Overall Study||40
3361645|NCT04214951|4092620|FG001|NOT COMPLETED|Overall Study||40
3361646|NCT04234425|4092626|FG000|STARTED|Overall Study||18
3361647|NCT04234425|4092626|FG000|Midpoint-Week 4|Overall Study||18
3361648|NCT04234425|4092626|FG000|COMPLETED|Overall Study||18
3361649|NCT04234425|4092626|FG000|NOT COMPLETED|Overall Study||0
3361650|NCT04232137|4092634|FG000|STARTED|Overall Study||254
3361651|NCT04232137|4092635|FG001|STARTED|Overall Study||185
3361652|NCT04232137|4092634|FG000|COMPLETED|Overall Study||254
3361653|NCT04232137|4092635|FG001|COMPLETED|Overall Study||185
3361654|NCT04232137|4092634|FG000|NOT COMPLETED|Overall Study||0
3361655|NCT04232137|4092635|FG001|NOT COMPLETED|Overall Study||0
3361656|NCT04222699|4092641|FG000|STARTED|Overall Study||28
3361657|NCT04222699|4092641|FG000|COMPLETED|Overall Study||26
3361658|NCT04222699|4092641|FG000|NOT COMPLETED|Overall Study||2
3361659|NCT04208698|4092650|FG000|STARTED|Overall Study||2
3361660|NCT04208698|4092651|FG001|STARTED|Overall Study||0
3361661|NCT04208698|4092652|FG002|STARTED|Overall Study||0
3361662|NCT04208698|4092653|FG003|STARTED|Overall Study||0
3361663|NCT04208698|4092654|FG004|STARTED|Overall Study||0
3361664|NCT04208698|4092650|FG000|COMPLETED|Overall Study||0
3361665|NCT04208698|4092651|FG001|COMPLETED|Overall Study||0
3361666|NCT04208698|4092652|FG002|COMPLETED|Overall Study||0
3361667|NCT04208698|4092653|FG003|COMPLETED|Overall Study||0
3361668|NCT04208698|4092654|FG004|COMPLETED|Overall Study||0
3361669|NCT04208698|4092650|FG000|NOT COMPLETED|Overall Study||2
3361670|NCT04208698|4092651|FG001|NOT COMPLETED|Overall Study||0
3361671|NCT04208698|4092652|FG002|NOT COMPLETED|Overall Study||0
3361672|NCT04208698|4092653|FG003|NOT COMPLETED|Overall Study||0
3361673|NCT04208698|4092654|FG004|NOT COMPLETED|Overall Study||0
3361674|NCT04206293|4092664|FG000|STARTED|Overall Study||11
3361675|NCT04206293|4092664|FG000|COMPLETED|Overall Study||10
3361676|NCT04206293|4092664|FG000|NOT COMPLETED|Overall Study||1
3361677|NCT04228302|4092675|FG000|STARTED|Overall Study||6
3361678|NCT04228302|4092676|FG001|STARTED|Overall Study||6
3361679|NCT04228302|4092677|FG002|STARTED|Overall Study||6
3361680|NCT04228302|4092678|FG003|STARTED|Overall Study||6
3361681|NCT04228302|4092679|FG004|STARTED|Overall Study||6
3361682|NCT04228302|4092680|FG005|STARTED|Overall Study||10
3361683|NCT04228302|4092675|FG000|COMPLETED|Overall Study||6
3361684|NCT04228302|4092676|FG001|COMPLETED|Overall Study||6
3361685|NCT04228302|4092677|FG002|COMPLETED|Overall Study||6
3361686|NCT04228302|4092678|FG003|COMPLETED|Overall Study||6
3361687|NCT04228302|4092679|FG004|COMPLETED|Overall Study||5
3361688|NCT04228302|4092680|FG005|COMPLETED|Overall Study||10
3361689|NCT04228302|4092675|FG000|NOT COMPLETED|Overall Study||0
3361690|NCT04228302|4092676|FG001|NOT COMPLETED|Overall Study||0
3361691|NCT04228302|4092677|FG002|NOT COMPLETED|Overall Study||0
3361692|NCT04228302|4092678|FG003|NOT COMPLETED|Overall Study||0
3361693|NCT04228302|4092679|FG004|NOT COMPLETED|Overall Study||1
3361694|NCT04228302|4092680|FG005|NOT COMPLETED|Overall Study||0
3361695|NCT04227119|4092694|FG000|STARTED|Overall Study||11
3361696|NCT04227119|4092694|FG000|COMPLETED|Overall Study||11
3361697|NCT04227119|4092694|FG000|NOT COMPLETED|Overall Study||0
3361698|NCT04224753|4092700|FG000|STARTED|Overall Study||51
3361699|NCT04224753|4092700|FG000|COMPLETED|Overall Study||51
3361700|NCT04224753|4092700|FG000|NOT COMPLETED|Overall Study||0
3361701|NCT04218799|4092704|FG000|STARTED|Overall Study||7
3361702|NCT04218799|4092704|FG000|COMPLETED|Overall Study||7
3361703|NCT04218799|4092704|FG000|NOT COMPLETED|Overall Study||0
3361704|NCT04204057|4092708|FG000|STARTED|Overall Study||21
3361705|NCT04204057|4092708|FG000|COMPLETED|Overall Study||21
3361706|NCT04204057|4092708|FG000|NOT COMPLETED|Overall Study||0
3361707|NCT04195594|4092712|FG000|STARTED|Overall Study||14
3361708|NCT04195594|4092712|FG000|COMPLETED|Overall Study||11
3361709|NCT04195594|4092712|FG000|NOT COMPLETED|Overall Study||3
3361710|NCT04223687|4092718|FG000|STARTED|Overall Study||163
3361711|NCT04223687|4092719|FG001|STARTED|Overall Study||163
3361712|NCT04223687|4092718|FG000|COMPLETED|Overall Study||162
3361713|NCT04223687|4092719|FG001|COMPLETED|Overall Study||163
3361714|NCT04223687|4092718|FG000|NOT COMPLETED|Overall Study||1
3361715|NCT04223687|4092719|FG001|NOT COMPLETED|Overall Study||0
3361716|NCT04223232|4092725|FG000|STARTED|Overall Study||6
3361717|NCT04223232|4092725|FG000|COMPLETED|Overall Study||5
3361718|NCT04223232|4092725|FG000|NOT COMPLETED|Overall Study||1
3361719|NCT04189224|4092729|FG000|STARTED|Period 1||23
3361720|NCT04189224|4092730|FG001|STARTED|Period 1||21
3361721|NCT04189224|4092729|FG000|COMPLETED|Period 1||23
3361722|NCT04189224|4092730|FG001|COMPLETED|Period 1||21
3361723|NCT04189224|4092729|FG000|NOT COMPLETED|Period 1||0
3361724|NCT04189224|4092730|FG001|NOT COMPLETED|Period 1||0
3361725|NCT04189224|4092729|FG000|STARTED|Period 2||23
3361726|NCT04189224|4092730|FG001|STARTED|Period 2||21
3361727|NCT04189224|4092729|FG000|COMPLETED|Period 2||23
3361728|NCT04189224|4092730|FG001|COMPLETED|Period 2||20
3361729|NCT04189224|4092729|FG000|NOT COMPLETED|Period 2||0
3361730|NCT04189224|4092730|FG001|NOT COMPLETED|Period 2||1
3361731|NCT04214600|4092738|FG000|STARTED|Overall Study||50
3361732|NCT04214600|4092739|FG001|STARTED|Overall Study||50
3361733|NCT04214600|4092738|FG000|COMPLETED|Overall Study||41
3361734|NCT04214600|4092739|FG001|COMPLETED|Overall Study||36
3361735|NCT04214600|4092738|FG000|NOT COMPLETED|Overall Study||9
3361736|NCT04214600|4092739|FG001|NOT COMPLETED|Overall Study||14
3361737|NCT04202497|4092746|FG000|STARTED|Baseline Scan (Day-1)||7
3179367|NCT01984697|3907534|FG000|Vaccination 1|Overall Study||301
3179368|NCT01984697|3907535|FG001|Vaccination 1|Overall Study||301
3361738|NCT04202497|4092747|FG001|STARTED|Baseline Scan (Day-1)||0
3361739|NCT04202497|4092748|FG002|STARTED|Baseline Scan (Day-1)||0
3361740|NCT04202497|4092749|FG003|STARTED|Baseline Scan (Day-1)||0
3361741|NCT04202497|4092746|FG000|COMPLETED|Baseline Scan (Day-1)||6
3361742|NCT04202497|4092747|FG001|COMPLETED|Baseline Scan (Day-1)||0
3361743|NCT04202497|4092748|FG002|COMPLETED|Baseline Scan (Day-1)||0
3361744|NCT04202497|4092749|FG003|COMPLETED|Baseline Scan (Day-1)||0
3361745|NCT04202497|4092746|FG000|NOT COMPLETED|Baseline Scan (Day-1)||1
3361746|NCT04202497|4092747|FG001|NOT COMPLETED|Baseline Scan (Day-1)||0
3361747|NCT04202497|4092748|FG002|NOT COMPLETED|Baseline Scan (Day-1)||0
3361748|NCT04202497|4092749|FG003|NOT COMPLETED|Baseline Scan (Day-1)||0
3361749|NCT04202497|4092746|FG000|STARTED|Treatment Period (Day 1 Through Day 2-3)||0
3361750|NCT04202497|4092747|FG001|STARTED|Treatment Period (Day 1 Through Day 2-3)|Eligible participants from Baseline Period who received 10 mCi of [18F]MNI-1054 on Day -1.|2
3361751|NCT04202497|4092748|FG002|STARTED|Treatment Period (Day 1 Through Day 2-3)|Eligible participants from Baseline Period who received 10 mCi of [18F]MNI-1054 on Day -1.|2
3361752|NCT04202497|4092749|FG003|STARTED|Treatment Period (Day 1 Through Day 2-3)|Eligible participants from Baseline Period who received 10 mCi of [18F]MNI-1054 on Day -1.|2
3361753|NCT04202497|4092746|FG000|COMPLETED|Treatment Period (Day 1 Through Day 2-3)||0
3361754|NCT04202497|4092747|FG001|COMPLETED|Treatment Period (Day 1 Through Day 2-3)||2
3361755|NCT04202497|4092748|FG002|COMPLETED|Treatment Period (Day 1 Through Day 2-3)||2
3361756|NCT04202497|4092749|FG003|COMPLETED|Treatment Period (Day 1 Through Day 2-3)||2
3361757|NCT04202497|4092746|FG000|NOT COMPLETED|Treatment Period (Day 1 Through Day 2-3)||0
3361758|NCT04202497|4092747|FG001|NOT COMPLETED|Treatment Period (Day 1 Through Day 2-3)||0
3361759|NCT04202497|4092748|FG002|NOT COMPLETED|Treatment Period (Day 1 Through Day 2-3)||0
3361760|NCT04202497|4092749|FG003|NOT COMPLETED|Treatment Period (Day 1 Through Day 2-3)||0
3361761|NCT04214080|4092765|FG000|STARTED|Overall Study||20
3361762|NCT04214080|4092766|FG001|STARTED|Overall Study||20
3361763|NCT04214080|4092765|FG000|COMPLETED|Overall Study||20
3361764|NCT04214080|4092766|FG001|COMPLETED|Overall Study||20
3361765|NCT04214080|4092765|FG000|NOT COMPLETED|Overall Study||0
3361766|NCT04214080|4092766|FG001|NOT COMPLETED|Overall Study||0
3361767|NCT04209530|4092776|FG000|STARTED|Overall Study||4
3361768|NCT04209530|4092777|FG001|STARTED|Overall Study||3
3361769|NCT04209530|4092776|FG000|COMPLETED|Overall Study||0
3361770|NCT04209530|4092777|FG001|COMPLETED|Overall Study||0
3361771|NCT04209530|4092776|FG000|NOT COMPLETED|Overall Study||4
3361772|NCT04209530|4092777|FG001|NOT COMPLETED|Overall Study||3
3361773|NCT04209335|4092783|FG000|STARTED|Overall Study||48
3361774|NCT04209335|4092783|FG000|COMPLETED|Overall Study||48
3361775|NCT04209335|4092783|FG000|NOT COMPLETED|Overall Study||0
3361776|NCT04207333|4092790|FG000|STARTED|First Intervention (Single 1-Day Visit)||3
3361777|NCT04207333|4092791|FG001|STARTED|First Intervention (Single 1-Day Visit)||3
3361778|NCT04207333|4092790|FG000|COMPLETED|First Intervention (Single 1-Day Visit)||3
3361779|NCT04207333|4092791|FG001|COMPLETED|First Intervention (Single 1-Day Visit)||3
3361780|NCT04207333|4092790|FG000|NOT COMPLETED|First Intervention (Single 1-Day Visit)||0
3361781|NCT04207333|4092791|FG001|NOT COMPLETED|First Intervention (Single 1-Day Visit)||0
3361782|NCT04207333|4092790|FG000|STARTED|Washout (2-7 Days)||3
3361783|NCT04207333|4092791|FG001|STARTED|Washout (2-7 Days)||3
3361784|NCT04207333|4092790|FG000|COMPLETED|Washout (2-7 Days)||3
3361785|NCT04207333|4092791|FG001|COMPLETED|Washout (2-7 Days)||3
3361786|NCT04207333|4092790|FG000|NOT COMPLETED|Washout (2-7 Days)||0
3361787|NCT04207333|4092791|FG001|NOT COMPLETED|Washout (2-7 Days)||0
3361788|NCT04207333|4092790|FG000|STARTED|Second Intervention (Single 1-Day Visit)||3
3361789|NCT04207333|4092791|FG001|STARTED|Second Intervention (Single 1-Day Visit)||3
3361790|NCT04207333|4092790|FG000|COMPLETED|Second Intervention (Single 1-Day Visit)||3
3361791|NCT04207333|4092791|FG001|COMPLETED|Second Intervention (Single 1-Day Visit)||3
3361792|NCT04207333|4092790|FG000|NOT COMPLETED|Second Intervention (Single 1-Day Visit)||0
3361793|NCT04207333|4092791|FG001|NOT COMPLETED|Second Intervention (Single 1-Day Visit)||0
3361794|NCT04207840|4092797|FG000|STARTED|Treatment Period 1||9
3361795|NCT04207840|4092798|FG001|STARTED|Treatment Period 1||10
3361796|NCT04207840|4092799|FG002|STARTED|Treatment Period 1||9
3361797|NCT04207840|4092797|FG000|COMPLETED|Treatment Period 1||9
3361798|NCT04207840|4092798|FG001|COMPLETED|Treatment Period 1||10
3361799|NCT04207840|4092799|FG002|COMPLETED|Treatment Period 1||9
3361800|NCT04207840|4092797|FG000|NOT COMPLETED|Treatment Period 1||0
3361801|NCT04207840|4092798|FG001|NOT COMPLETED|Treatment Period 1||0
3179369|NCT01984697|3907536|FG002|Vaccination 1|Overall Study||300
3361802|NCT04207840|4092799|FG002|NOT COMPLETED|Treatment Period 1||0
3361803|NCT04207840|4092797|FG000|STARTED|Washout Period 1 (2-7 Days)||9
3361804|NCT04207840|4092798|FG001|STARTED|Washout Period 1 (2-7 Days)||10
3361805|NCT04207840|4092799|FG002|STARTED|Washout Period 1 (2-7 Days)||9
3361806|NCT04207840|4092797|FG000|COMPLETED|Washout Period 1 (2-7 Days)||9
3361807|NCT04207840|4092798|FG001|COMPLETED|Washout Period 1 (2-7 Days)||10
3361808|NCT04207840|4092799|FG002|COMPLETED|Washout Period 1 (2-7 Days)||8
3361809|NCT04207840|4092797|FG000|NOT COMPLETED|Washout Period 1 (2-7 Days)||0
3361810|NCT04207840|4092798|FG001|NOT COMPLETED|Washout Period 1 (2-7 Days)||0
3361811|NCT04207840|4092799|FG002|NOT COMPLETED|Washout Period 1 (2-7 Days)||1
3361812|NCT04207840|4092797|FG000|STARTED|Treatment Period 2||9
3361813|NCT04207840|4092798|FG001|STARTED|Treatment Period 2||10
3361814|NCT04207840|4092799|FG002|STARTED|Treatment Period 2||8
3361815|NCT04207840|4092797|FG000|COMPLETED|Treatment Period 2||9
3361816|NCT04207840|4092798|FG001|COMPLETED|Treatment Period 2||10
3361817|NCT04207840|4092799|FG002|COMPLETED|Treatment Period 2||8
3361818|NCT04207840|4092797|FG000|NOT COMPLETED|Treatment Period 2||0
3361819|NCT04207840|4092798|FG001|NOT COMPLETED|Treatment Period 2||0
3361820|NCT04207840|4092799|FG002|NOT COMPLETED|Treatment Period 2||0
3361821|NCT04207840|4092797|FG000|STARTED|Washout Period 2 (2-7 Days)||9
3361822|NCT04207840|4092798|FG001|STARTED|Washout Period 2 (2-7 Days)||10
3361823|NCT04207840|4092799|FG002|STARTED|Washout Period 2 (2-7 Days)||8
3361824|NCT04207840|4092797|FG000|COMPLETED|Washout Period 2 (2-7 Days)||9
3361825|NCT04207840|4092798|FG001|COMPLETED|Washout Period 2 (2-7 Days)||10
3361826|NCT04207840|4092799|FG002|COMPLETED|Washout Period 2 (2-7 Days)||7
3361827|NCT04207840|4092797|FG000|NOT COMPLETED|Washout Period 2 (2-7 Days)||0
3361828|NCT04207840|4092798|FG001|NOT COMPLETED|Washout Period 2 (2-7 Days)||0
3361829|NCT04207840|4092799|FG002|NOT COMPLETED|Washout Period 2 (2-7 Days)||1
3361830|NCT04207840|4092797|FG000|STARTED|Treatment Period 3||9
3361831|NCT04207840|4092798|FG001|STARTED|Treatment Period 3||10
3361832|NCT04207840|4092799|FG002|STARTED|Treatment Period 3||7
3361833|NCT04207840|4092797|FG000|COMPLETED|Treatment Period 3||9
3361834|NCT04207840|4092798|FG001|COMPLETED|Treatment Period 3||10
3361835|NCT04207840|4092799|FG002|COMPLETED|Treatment Period 3||7
3361836|NCT04207840|4092797|FG000|NOT COMPLETED|Treatment Period 3||0
3361837|NCT04207840|4092798|FG001|NOT COMPLETED|Treatment Period 3||0
3361838|NCT04207840|4092799|FG002|NOT COMPLETED|Treatment Period 3||0
3361839|NCT04206800|4092809|FG000|STARTED|Overall Study||4
3361840|NCT04206800|4092810|FG001|STARTED|Overall Study||1
3361841|NCT04206800|4092809|FG000|COMPLETED|Overall Study||4
3361842|NCT04206800|4092810|FG001|COMPLETED|Overall Study||1
3361843|NCT04206800|4092809|FG000|NOT COMPLETED|Overall Study||0
3361844|NCT04206800|4092810|FG001|NOT COMPLETED|Overall Study||0
3361845|NCT04205669|4092818|FG000|STARTED|Overall Study||47
3361846|NCT04205669|4092819|FG001|STARTED|Overall Study||57
3361847|NCT04205669|4092818|FG000|COMPLETED|Overall Study||34
3361848|NCT04205669|4092819|FG001|COMPLETED|Overall Study||45
3361849|NCT04205669|4092818|FG000|NOT COMPLETED|Overall Study||13
3361850|NCT04205669|4092819|FG001|NOT COMPLETED|Overall Study||12
3361851|NCT04198948|4092827|FG000|STARTED|First Period||7
3361852|NCT04198948|4092828|FG001|STARTED|First Period||8
3361853|NCT04198948|4092827|FG000|COMPLETED|First Period||7
3361854|NCT04198948|4092828|FG001|COMPLETED|First Period||8
3361855|NCT04198948|4092827|FG000|NOT COMPLETED|First Period||0
3361856|NCT04198948|4092828|FG001|NOT COMPLETED|First Period||0
3361857|NCT04198948|4092827|FG000|STARTED|Wash-out (10 Days)||7
3361858|NCT04198948|4092828|FG001|STARTED|Wash-out (10 Days)||8
3361859|NCT04198948|4092827|FG000|COMPLETED|Wash-out (10 Days)||7
3361860|NCT04198948|4092828|FG001|COMPLETED|Wash-out (10 Days)||8
3361861|NCT04198948|4092827|FG000|NOT COMPLETED|Wash-out (10 Days)||0
3361862|NCT04198948|4092828|FG001|NOT COMPLETED|Wash-out (10 Days)||0
3361863|NCT04198948|4092827|FG000|STARTED|Second Period||7
3361864|NCT04198948|4092828|FG001|STARTED|Second Period||8
3361865|NCT04198948|4092827|FG000|COMPLETED|Second Period||7
3361866|NCT04198948|4092828|FG001|COMPLETED|Second Period||7
3361867|NCT04198948|4092827|FG000|NOT COMPLETED|Second Period||0
3361868|NCT04198948|4092828|FG001|NOT COMPLETED|Second Period||1
3361869|NCT04206384|4092834|FG000|STARTED|Overall Study||52
3361870|NCT04206384|4092834|FG000|COMPLETED|Overall Study||42
3361871|NCT04206384|4092834|FG000|NOT COMPLETED|Overall Study||10
3361872|NCT04204200|4092841|FG000|STARTED|Overall Study||22
3361873|NCT04204200|4092842|FG001|STARTED|Overall Study||22
3361874|NCT04204200|4092843|FG002|STARTED|Overall Study||22
3361875|NCT04204200|4092841|FG000|COMPLETED|Overall Study||22
3361876|NCT04204200|4092842|FG001|COMPLETED|Overall Study||22
3361877|NCT04204200|4092843|FG002|COMPLETED|Overall Study||22
3361878|NCT04204200|4092841|FG000|NOT COMPLETED|Overall Study||0
3361879|NCT04204200|4092842|FG001|NOT COMPLETED|Overall Study||0
3361880|NCT04204200|4092843|FG002|NOT COMPLETED|Overall Study||0
3361881|NCT04196907|4092851|FG000|STARTED|Overall Study||20
3361882|NCT04196907|4092851|FG000|COMPLETED|Overall Study||20
3361883|NCT04196907|4092851|FG000|NOT COMPLETED|Overall Study||0
3361884|NCT04195893|4092855|FG000|STARTED|First Intervention||27
3361885|NCT04195893|4092856|FG001|STARTED|First Intervention||29
3361886|NCT04195893|4092855|FG000|COMPLETED|First Intervention||27
3361887|NCT04195893|4092856|FG001|COMPLETED|First Intervention||29
3361888|NCT04195893|4092855|FG000|NOT COMPLETED|First Intervention||0
3361889|NCT04195893|4092856|FG001|NOT COMPLETED|First Intervention||0
3361890|NCT04195893|4092855|FG000|STARTED|Second Intervention||27
3361891|NCT04195893|4092856|FG001|STARTED|Second Intervention||29
3361892|NCT04195893|4092855|FG000|COMPLETED|Second Intervention||26
3361893|NCT04195893|4092856|FG001|COMPLETED|Second Intervention||29
3361894|NCT04195893|4092855|FG000|NOT COMPLETED|Second Intervention||1
3361895|NCT04195893|4092856|FG001|NOT COMPLETED|Second Intervention||0
3361896|NCT04195880|4092864|FG000|STARTED|Overall Study||3205
3361897|NCT04195880|4092865|FG001|STARTED|Overall Study||3338
3361898|NCT04195880|4092864|FG000|COMPLETED|Overall Study||3205
3361899|NCT04195880|4092865|FG001|COMPLETED|Overall Study||3338
3361900|NCT04195880|4092864|FG000|NOT COMPLETED|Overall Study||0
3361901|NCT04195880|4092865|FG001|NOT COMPLETED|Overall Study||0
3361902|NCT04195581|4092871|FG000|STARTED|Comfilcon A With All in One Light||28
3361903|NCT04195581|4092871|FG000|COMPLETED|Comfilcon A With All in One Light||24
3361904|NCT04195581|4092871|FG000|NOT COMPLETED|Comfilcon A With All in One Light||4
3361905|NCT04195581|4092871|FG000|STARTED|Comfilcon A With Hy-Care||30
3361906|NCT04195581|4092871|FG000|COMPLETED|Comfilcon A With Hy-Care||25
3361907|NCT04195581|4092871|FG000|NOT COMPLETED|Comfilcon A With Hy-Care||5
3361908|NCT04195581|4092871|FG000|STARTED|Comfilcon A With Refine One Step||25
3361909|NCT04195581|4092871|FG000|COMPLETED|Comfilcon A With Refine One Step||24
3361910|NCT04195581|4092871|FG000|NOT COMPLETED|Comfilcon A With Refine One Step||1
3361911|NCT04195581|4092871|FG000|STARTED|Fanfilcon A With All in One Light||28
3361912|NCT04195581|4092871|FG000|COMPLETED|Fanfilcon A With All in One Light||27
3361913|NCT04195581|4092871|FG000|NOT COMPLETED|Fanfilcon A With All in One Light||1
3361914|NCT04195581|4092871|FG000|STARTED|Fanfilcon A With Hy-Care||28
3361915|NCT04195581|4092871|FG000|COMPLETED|Fanfilcon A With Hy-Care||25
3361916|NCT04195581|4092871|FG000|NOT COMPLETED|Fanfilcon A With Hy-Care||3
3361917|NCT04195581|4092871|FG000|STARTED|Fanfilcon A With Refine One Step||29
3361918|NCT04195581|4092871|FG000|COMPLETED|Fanfilcon A With Refine One Step||27
3361919|NCT04195581|4092871|FG000|NOT COMPLETED|Fanfilcon A With Refine One Step||2
3361920|NCT04194151|4092895|FG000|STARTED|Overall Study||32
3361921|NCT04194151|4092896|FG001|STARTED|Overall Study||32
3361922|NCT04194151|4092897|FG002|STARTED|Overall Study||32
3361923|NCT04194151|4092898|FG003|STARTED|Overall Study||32
3361924|NCT04194151|4092899|FG004|STARTED|Overall Study||32
3361925|NCT04194151|4092900|FG005|STARTED|Overall Study||32
3361926|NCT04194151|4092895|FG000|COMPLETED|Overall Study||31
3361927|NCT04194151|4092896|FG001|COMPLETED|Overall Study||30
3361928|NCT04194151|4092897|FG002|COMPLETED|Overall Study||31
3361929|NCT04194151|4092898|FG003|COMPLETED|Overall Study||31
3361930|NCT04194151|4092899|FG004|COMPLETED|Overall Study||32
3361931|NCT04194151|4092900|FG005|COMPLETED|Overall Study||31
3361932|NCT04194151|4092895|FG000|NOT COMPLETED|Overall Study||1
3361933|NCT04194151|4092896|FG001|NOT COMPLETED|Overall Study||2
3361934|NCT04194151|4092897|FG002|NOT COMPLETED|Overall Study||1
3361935|NCT04194151|4092898|FG003|NOT COMPLETED|Overall Study||1
3361936|NCT04194151|4092899|FG004|NOT COMPLETED|Overall Study||0
3361937|NCT04194151|4092900|FG005|NOT COMPLETED|Overall Study||1
3361938|NCT04194008|4092914|FG000|STARTED|Baseline (Run-in) Phase||126
3361939|NCT04194008|4092914|FG000|COMPLETED|Baseline (Run-in) Phase||99
3361940|NCT04194008|4092914|FG000|NOT COMPLETED|Baseline (Run-in) Phase||27
3361941|NCT04194008|4092914|FG000|STARTED|Treatment Phase With Nerivio||99
3361942|NCT04194008|4092914|FG000|COMPLETED|Treatment Phase With Nerivio||91
3361943|NCT04194008|4092914|FG000|NOT COMPLETED|Treatment Phase With Nerivio||8
3361944|NCT04191668|4092918|FG000|STARTED|Overall Study||106
3361945|NCT04191668|4092918|FG000|COMPLETED|Overall Study||106
3361946|NCT04191668|4092918|FG000|NOT COMPLETED|Overall Study||0
3361947|NCT04189081|4092925|FG000|STARTED|Overall Study||46
3361948|NCT04189081|4092926|FG001|STARTED|Overall Study||45
3361949|NCT04189081|4092927|FG002|STARTED|Overall Study||46
3361950|NCT04189081|4092925|FG000|COMPLETED|Overall Study||45
3361951|NCT04189081|4092926|FG001|COMPLETED|Overall Study||45
3361952|NCT04189081|4092927|FG002|COMPLETED|Overall Study||45
3361953|NCT04189081|4092925|FG000|NOT COMPLETED|Overall Study||1
3361954|NCT04189081|4092926|FG001|NOT COMPLETED|Overall Study||0
3361955|NCT04189081|4092927|FG002|NOT COMPLETED|Overall Study||1
3361956|NCT04186780|4092937|FG000|STARTED|Overall Study||36
3361957|NCT04186780|4092938|FG001|STARTED|Overall Study||32
3361958|NCT04186780|4092937|FG000|COMPLETED|Overall Study||22
3361959|NCT04186780|4092938|FG001|COMPLETED|Overall Study||25
3361960|NCT04186780|4092937|FG000|NOT COMPLETED|Overall Study||14
3361961|NCT04186780|4092938|FG001|NOT COMPLETED|Overall Study||7
3361962|NCT04186806|4092948|FG000|STARTED|Period 1: 7 Days||20
3137070|NCT01716585|3862318|FG000|COMPLETED|Open-label Treatment|not applicable to this arm|0
3137071|NCT01716585|3862319|FG001|COMPLETED|Open-label Treatment|The number of participants who completed open-label study drug.|150
3137072|NCT01716585|3862318|FG000|NOT COMPLETED|Open-label Treatment||0
3137073|NCT01716585|3862319|FG001|NOT COMPLETED|Open-label Treatment||7
3137074|NCT01716663|3862326|FG000|STARTED|Overall Study|Enrolled = signed informed consent and met eligibility requirements|234
3137075|NCT01716663|3862326|FG000|Safety|Overall Study|Enrolled patients who had a study device inserted.|230
3361963|NCT04186806|4092949|FG001|STARTED|Period 1: 7 Days||20
3361964|NCT04186806|4092948|FG000|COMPLETED|Period 1: 7 Days||19
3361965|NCT04186806|4092949|FG001|COMPLETED|Period 1: 7 Days||20
3361966|NCT04186806|4092948|FG000|NOT COMPLETED|Period 1: 7 Days||1
3361967|NCT04186806|4092949|FG001|NOT COMPLETED|Period 1: 7 Days||0
3361968|NCT04186806|4092948|FG000|STARTED|Washout Period: at Least 2 Days||19
3361969|NCT04186806|4092949|FG001|STARTED|Washout Period: at Least 2 Days||20
3361970|NCT04186806|4092948|FG000|COMPLETED|Washout Period: at Least 2 Days||19
3361971|NCT04186806|4092949|FG001|COMPLETED|Washout Period: at Least 2 Days||20
3361972|NCT04186806|4092948|FG000|NOT COMPLETED|Washout Period: at Least 2 Days||0
3361973|NCT04186806|4092949|FG001|NOT COMPLETED|Washout Period: at Least 2 Days||0
3361974|NCT04186806|4092948|FG000|STARTED|Period 2: 7 Days||19
3361975|NCT04186806|4092949|FG001|STARTED|Period 2: 7 Days||20
3361976|NCT04186806|4092948|FG000|COMPLETED|Period 2: 7 Days||19
3361977|NCT04186806|4092949|FG001|COMPLETED|Period 2: 7 Days||20
3361978|NCT04186806|4092948|FG000|NOT COMPLETED|Period 2: 7 Days||0
3361979|NCT04186806|4092949|FG001|NOT COMPLETED|Period 2: 7 Days||0
3361980|NCT04186481|4092956|FG000|STARTED|Overall Study||32
3361981|NCT04186481|4092956|FG000|Completed 6 Month Visit|Overall Study||31
3361982|NCT04186481|4092956|FG000|Completed 12 Month Visit|Overall Study||4
3361983|NCT04186481|4092956|FG000|COMPLETED|Overall Study||32
3361984|NCT04186481|4092956|FG000|NOT COMPLETED|Overall Study||0
3361985|NCT04184999|4092962|FG000|STARTED|Overall Study||40
3361986|NCT04184999|4092963|FG001|STARTED|Overall Study||40
3361987|NCT04184999|4092962|FG000|3 Week Tear Film Osmolarity Testing|Overall Study||40
3361988|NCT04184999|4092963|FG001|3 Week Tear Film Osmolarity Testing|Overall Study||40
3361989|NCT04184999|4092962|FG000|COMPLETED|Overall Study||40
3361990|NCT04184999|4092963|FG001|COMPLETED|Overall Study||40
3361991|NCT04184999|4092962|FG000|NOT COMPLETED|Overall Study||0
3361992|NCT04184999|4092963|FG001|NOT COMPLETED|Overall Study||0
3361993|NCT04184271|4092969|FG000|STARTED|Overall Study||16
3361994|NCT04184271|4092969|FG000|COMPLETED|Overall Study||16
3361995|NCT04184271|4092969|FG000|NOT COMPLETED|Overall Study||0
3361996|NCT04183231|4092973|FG000|STARTED|Overall Study||16
3361997|NCT04183231|4092973|FG000|COMPLETED|Overall Study||16
3361998|NCT04183231|4092973|FG000|NOT COMPLETED|Overall Study||0
3361999|NCT04182958|4092977|FG000|STARTED|Overall Study||8
3362000|NCT04182958|4092977|FG000|COMPLETED|Overall Study||8
3362001|NCT04182958|4092977|FG000|NOT COMPLETED|Overall Study||0
3362002|NCT04179838|4092983|FG000|STARTED|First Intervention (1 Day)||13
3362003|NCT04179838|4092984|FG001|STARTED|First Intervention (1 Day)||16
3362004|NCT04179838|4092983|FG000|COMPLETED|First Intervention (1 Day)||13
3362005|NCT04179838|4092984|FG001|COMPLETED|First Intervention (1 Day)||13
3362006|NCT04179838|4092983|FG000|NOT COMPLETED|First Intervention (1 Day)||0
3362007|NCT04179838|4092984|FG001|NOT COMPLETED|First Intervention (1 Day)||3
3362008|NCT04179838|4092983|FG000|STARTED|Washout (4 Weeks)||13
3362009|NCT04179838|4092984|FG001|STARTED|Washout (4 Weeks)||13
3362010|NCT04179838|4092983|FG000|COMPLETED|Washout (4 Weeks)||13
3362011|NCT04179838|4092984|FG001|COMPLETED|Washout (4 Weeks)||13
3362012|NCT04179838|4092983|FG000|NOT COMPLETED|Washout (4 Weeks)||0
3362013|NCT04179838|4092984|FG001|NOT COMPLETED|Washout (4 Weeks)||0
3362014|NCT04179838|4092983|FG000|STARTED|Second Intervention (1 Day)||13
3362015|NCT04179838|4092984|FG001|STARTED|Second Intervention (1 Day)||13
3362016|NCT04179838|4092983|FG000|COMPLETED|Second Intervention (1 Day)||13
3362017|NCT04179838|4092984|FG001|COMPLETED|Second Intervention (1 Day)||12
3362018|NCT04179838|4092983|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
3362019|NCT04179838|4092984|FG001|NOT COMPLETED|Second Intervention (1 Day)||1
3362020|NCT04179461|4092990|FG000|STARTED|Overall Study||21
3362021|NCT04179461|4092990|FG000|COMPLETED|Overall Study||17
3362022|NCT04179461|4092990|FG000|NOT COMPLETED|Overall Study||4
3362023|NCT04179474|4092996|FG000|STARTED|Treatment Period 1 (First Intervention)||20
3362024|NCT04179474|4092997|FG001|STARTED|Treatment Period 1 (First Intervention)||20
3362025|NCT04179474|4092996|FG000|COMPLETED|Treatment Period 1 (First Intervention)||20
3362026|NCT04179474|4092997|FG001|COMPLETED|Treatment Period 1 (First Intervention)||20
3362027|NCT04179474|4092996|FG000|NOT COMPLETED|Treatment Period 1 (First Intervention)||0
3362028|NCT04179474|4092997|FG001|NOT COMPLETED|Treatment Period 1 (First Intervention)||0
3362029|NCT04179474|4092996|FG000|STARTED|Treatment Period 2 (Second Intervention)|1 participant did not receive Intervention B.|19
3362030|NCT04179474|4092997|FG001|STARTED|Treatment Period 2 (Second Intervention)||20
3137076|NCT01716663|3862326|FG000|COMPLETED|Overall Study|Effectiveness population = enrolled and treated (study device inserted and RF energy applied)|228
3137077|NCT01716663|3862326|FG000|NOT COMPLETED|Overall Study||6
3137078|NCT01716715|3862332|FG000|STARTED|Overall Study||57
3137079|NCT01716715|3862333|FG001|STARTED|Overall Study||54
3362031|NCT04179474|4092996|FG000|COMPLETED|Treatment Period 2 (Second Intervention)||19
3362032|NCT04179474|4092997|FG001|COMPLETED|Treatment Period 2 (Second Intervention)||20
3362033|NCT04179474|4092996|FG000|NOT COMPLETED|Treatment Period 2 (Second Intervention)||0
3362034|NCT04179474|4092997|FG001|NOT COMPLETED|Treatment Period 2 (Second Intervention)||0
3362035|NCT04179474|4092996|FG000|STARTED|Treatment Period 3 (Third Intervention)||19
3362036|NCT04179474|4092997|FG001|STARTED|Treatment Period 3 (Third Intervention)|1 participant did not receive Intervention D.|19
3362037|NCT04179474|4092996|FG000|COMPLETED|Treatment Period 3 (Third Intervention)||19
3362038|NCT04179474|4092997|FG001|COMPLETED|Treatment Period 3 (Third Intervention)||19
3362039|NCT04179474|4092996|FG000|NOT COMPLETED|Treatment Period 3 (Third Intervention)||0
3362040|NCT04179474|4092997|FG001|NOT COMPLETED|Treatment Period 3 (Third Intervention)||0
3362041|NCT04178590|4093018|FG000|STARTED|Overall Study||32
3362042|NCT04178590|4093018|FG000|COMPLETED|Overall Study||30
3362043|NCT04178590|4093018|FG000|NOT COMPLETED|Overall Study||2
3362044|NCT04177862|4093046|FG000|STARTED|Overall Study||35
3362045|NCT04177862|4093047|FG001|STARTED|Overall Study||40
3362046|NCT04177862|4093046|FG000|COMPLETED|Overall Study||33
3362047|NCT04177862|4093047|FG001|COMPLETED|Overall Study||33
3362048|NCT04177862|4093046|FG000|NOT COMPLETED|Overall Study||2
3362049|NCT04177862|4093047|FG001|NOT COMPLETED|Overall Study||7
3362050|NCT04176406|4093054|FG000|STARTED|Overall Study||0
3362051|NCT04176406|4093055|FG001|STARTED|Overall Study||0
3362052|NCT04176406|4093056|FG002|STARTED|Overall Study||0
3362053|NCT04176406|4093057|FG003|STARTED|Overall Study||0
3362054|NCT04176406|4093054|FG000|COMPLETED|Overall Study||0
3362055|NCT04176406|4093055|FG001|COMPLETED|Overall Study||0
3362056|NCT04176406|4093056|FG002|COMPLETED|Overall Study||0
3362057|NCT04176406|4093057|FG003|COMPLETED|Overall Study||0
3362058|NCT04176406|4093054|FG000|NOT COMPLETED|Overall Study||0
3362059|NCT04176406|4093055|FG001|NOT COMPLETED|Overall Study||0
3362060|NCT04176406|4093056|FG002|NOT COMPLETED|Overall Study||0
3362061|NCT04176406|4093057|FG003|NOT COMPLETED|Overall Study||0
3362062|NCT04175262|4093068|FG000|STARTED|Overall Study||102
3362063|NCT04175262|4093068|FG000|COMPLETED|Overall Study||102
3362064|NCT04175262|4093068|FG000|NOT COMPLETED|Overall Study||0
3362065|NCT04171102|4093075|FG000|STARTED|Overall Study||4
3362066|NCT04171102|4093076|FG001|STARTED|Overall Study||5
3362067|NCT04171102|4093077|FG002|STARTED|Overall Study||6
3362068|NCT04171102|4093075|FG000|COMPLETED|Overall Study||4
3362069|NCT04171102|4093076|FG001|COMPLETED|Overall Study||5
3179370|NCT01984697|3907537|FG003|Vaccination 1|Overall Study||300
3179371|NCT01984697|3907538|FG004|Vaccination 1|Overall Study||314
3179372|NCT01984697|3907534|FG000|Vaccination 2|Overall Study||293
3179373|NCT01984697|3907535|FG001|Vaccination 2|Overall Study||296
3179374|NCT01984697|3907536|FG002|Vaccination 2|Overall Study||291
3179375|NCT01984697|3907537|FG003|Vaccination 2|Overall Study||298
3179376|NCT01984697|3907538|FG004|Vaccination 2|Overall Study||313
3179377|NCT01984697|3907534|FG000|Vaccination 3|Overall Study||0
3179378|NCT01984697|3907535|FG001|Vaccination 3|Overall Study||0
3179379|NCT01984697|3907536|FG002|Vaccination 3|Overall Study||0
3179380|NCT01984697|3907537|FG003|Vaccination 3|Overall Study||293
3179381|NCT01984697|3907538|FG004|Vaccination 3|Overall Study||311
3179382|NCT01984697|3907534|FG000|Month 36 Vaccination|Overall Study||270
3179383|NCT01984697|3907535|FG001|Month 36 Vaccination|Overall Study||281
3179384|NCT01984697|3907536|FG002|Month 36 Vaccination|Overall Study||280
3179385|NCT01984697|3907537|FG003|Month 36 Vaccination|Overall Study||9
3179386|NCT01984697|3907538|FG004|Month 36 Vaccination|Overall Study||31
3179387|NCT01984697|3907534|FG000|COMPLETED|Overall Study||258
3179388|NCT01984697|3907535|FG001|COMPLETED|Overall Study||270
3179389|NCT01984697|3907536|FG002|COMPLETED|Overall Study||272
3179390|NCT01984697|3907537|FG003|COMPLETED|Overall Study||280
3179391|NCT01984697|3907538|FG004|COMPLETED|Overall Study||279
3179392|NCT01984697|3907534|FG000|NOT COMPLETED|Overall Study||43
3179393|NCT01984697|3907535|FG001|NOT COMPLETED|Overall Study||31
3179394|NCT01984697|3907536|FG002|NOT COMPLETED|Overall Study||29
3362070|NCT04171102|4093077|FG002|COMPLETED|Overall Study||6
3362071|NCT04171102|4093075|FG000|NOT COMPLETED|Overall Study||0
3362072|NCT04171102|4093076|FG001|NOT COMPLETED|Overall Study||0
3362073|NCT04171102|4093077|FG002|NOT COMPLETED|Overall Study||0
3362074|NCT04174638|4093087|FG000|STARTED|Overall Study||32
3362075|NCT04174638|4093088|FG001|STARTED|Overall Study||28
3362076|NCT04174638|4093087|FG000|COMPLETED|Overall Study||32
3362077|NCT04174638|4093088|FG001|COMPLETED|Overall Study||28
3362078|NCT04174638|4093087|FG000|NOT COMPLETED|Overall Study||0
3362079|NCT04174638|4093088|FG001|NOT COMPLETED|Overall Study||0
3179395|NCT01984697|3907537|FG003|NOT COMPLETED|Overall Study||21
3362080|NCT04174313|4093099|FG000|STARTED|Overall Study||15
3362081|NCT04174313|4093100|FG001|STARTED|Overall Study||50
3362082|NCT04174313|4093099|FG000|COMPLETED|Overall Study||15
3362083|NCT04174313|4093100|FG001|COMPLETED|Overall Study||50
3362084|NCT04174313|4093099|FG000|NOT COMPLETED|Overall Study||0
3362085|NCT04174313|4093100|FG001|NOT COMPLETED|Overall Study||0
3362086|NCT04173429|4093112|FG000|STARTED|Overall Study||32
3362087|NCT04173429|4093113|FG001|STARTED|Overall Study||32
3179396|NCT01984697|3907538|FG004|NOT COMPLETED|Overall Study||35
3179397|NCT01984892|3907550|FG000|STARTED|Overall Study||8
3362088|NCT04173429|4093112|FG000|Completed the Nadroparin Calcium Therapy and Received Warfarin|Overall Study||32
3362089|NCT04173429|4093113|FG001|Completed the Nadroparin Calcium Therapy and Received Warfarin|Overall Study||0
3179398|NCT01984892|3907550|FG000|COMPLETED|Overall Study|1 completed all study visits up until the termination of the study, last study visit not done.|1
3179399|NCT01984892|3907550|FG000|NOT COMPLETED|Overall Study||7
3179400|NCT01985126|3907556|FG000|STARTED|Overall Study||18
3179401|NCT01985126|3907557|FG001|STARTED|Overall Study||106
3179402|NCT01985126|3907556|FG000|COMPLETED|Overall Study||0
3179403|NCT01985126|3907557|FG001|COMPLETED|Overall Study||0
3179404|NCT01985126|3907556|FG000|NOT COMPLETED|Overall Study||18
3179405|NCT01985126|3907557|FG001|NOT COMPLETED|Overall Study||106
3179406|NCT01985321|3907565|FG000|STARTED|Overall Study|This is Treatment Eligible Subjects only|90
3179407|NCT01985321|3907566|FG001|STARTED|Overall Study|This is treatment eligible subjects only|83
3179408|NCT01985321|3907565|FG000|COMPLETED|Overall Study||79
3179409|NCT01985321|3907566|FG001|COMPLETED|Overall Study||78
3179410|NCT01985321|3907565|FG000|NOT COMPLETED|Overall Study||11
3179411|NCT01985321|3907566|FG001|NOT COMPLETED|Overall Study||5
3179412|NCT01985334|3907580|FG000|STARTED|Overall Study||130
3179413|NCT01985334|3907581|FG001|STARTED|Overall Study||387
3179414|NCT01985334|3907582|FG002|STARTED|Overall Study||420
3179415|NCT01985334|3907583|FG003|STARTED|Overall Study||1262
3179416|NCT01985334|3907584|FG004|STARTED|Overall Study||274
3179417|NCT01985334|3907585|FG005|STARTED|Overall Study||822
3179418|NCT01985334|3907586|FG006|STARTED|Overall Study||274
3179419|NCT01985334|3907587|FG007|STARTED|Overall Study||820
3179420|NCT01985334|3907580|FG000|The Intention-to-treat (ITT) Population|Overall Study||122
3179421|NCT01985334|3907581|FG001|The Intention-to-treat (ITT) Population|Overall Study||369
3179422|NCT01985334|3907582|FG002|The Intention-to-treat (ITT) Population|Overall Study||420
3179423|NCT01985334|3907583|FG003|The Intention-to-treat (ITT) Population|Overall Study||1254
3179424|NCT01985334|3907584|FG004|The Intention-to-treat (ITT) Population|Overall Study||269
3179425|NCT01985334|3907585|FG005|The Intention-to-treat (ITT) Population|Overall Study||811
3179426|NCT01985334|3907586|FG006|The Intention-to-treat (ITT) Population|Overall Study||268
3179427|NCT01985334|3907587|FG007|The Intention-to-treat (ITT) Population|Overall Study||811
3362090|NCT04173429|4093112|FG000|COMPLETED|Overall Study||30
3362091|NCT04173429|4093113|FG001|COMPLETED|Overall Study||30
3362092|NCT04173429|4093112|FG000|NOT COMPLETED|Overall Study||2
3362093|NCT04173429|4093113|FG001|NOT COMPLETED|Overall Study||2
3362094|NCT04173741|4093122|FG000|STARTED|Overall Study||23
3362095|NCT04173741|4093123|FG001|STARTED|Overall Study||23
3362096|NCT04173741|4093122|FG000|COMPLETED|Overall Study||22
3362097|NCT04173741|4093123|FG001|COMPLETED|Overall Study||22
3362098|NCT04173741|4093122|FG000|NOT COMPLETED|Overall Study||1
3362099|NCT04173741|4093123|FG001|NOT COMPLETED|Overall Study||1
3362100|NCT04169061|4093129|FG000|STARTED|Overall Study||36
3362101|NCT04169061|4093129|FG000|Safety Population|Overall Study||36
3362102|NCT04169061|4093129|FG000|Modified Intent to Treat (mITT) Population|Overall Study||34
3362103|NCT04169061|4093129|FG000|COMPLETED|Overall Study||31
3362104|NCT04169061|4093129|FG000|NOT COMPLETED|Overall Study||5
3362105|NCT04157738|4093135|FG000|STARTED|Overall Study||12
3362106|NCT04157738|4093136|FG001|STARTED|Overall Study||12
3362107|NCT04157738|4093135|FG000|COMPLETED|Overall Study||11
3362108|NCT04157738|4093136|FG001|COMPLETED|Overall Study||10
3362109|NCT04157738|4093135|FG000|NOT COMPLETED|Overall Study||1
3362110|NCT04157738|4093136|FG001|NOT COMPLETED|Overall Study||2
3362111|NCT04156646|4093144|FG000|STARTED|Treatment Period 1 (6 Days)||8
3362112|NCT04156646|4093145|FG001|STARTED|Treatment Period 1 (6 Days)||8
3362113|NCT04156646|4093144|FG000|COMPLETED|Treatment Period 1 (6 Days)||8
3362114|NCT04156646|4093145|FG001|COMPLETED|Treatment Period 1 (6 Days)||8
3362115|NCT04156646|4093144|FG000|NOT COMPLETED|Treatment Period 1 (6 Days)||0
3362116|NCT04156646|4093145|FG001|NOT COMPLETED|Treatment Period 1 (6 Days)||0
3362117|NCT04156646|4093144|FG000|STARTED|Wash-out Period (12- to 21-days)||8
3362118|NCT04156646|4093145|FG001|STARTED|Wash-out Period (12- to 21-days)||8
3362119|NCT04156646|4093144|FG000|COMPLETED|Wash-out Period (12- to 21-days)||8
3362120|NCT04156646|4093145|FG001|COMPLETED|Wash-out Period (12- to 21-days)||8
3362121|NCT04156646|4093144|FG000|NOT COMPLETED|Wash-out Period (12- to 21-days)||0
3362122|NCT04156646|4093145|FG001|NOT COMPLETED|Wash-out Period (12- to 21-days)||0
3362123|NCT04156646|4093144|FG000|STARTED|Treatment Period 2 (6 Days)||8
3362124|NCT04156646|4093145|FG001|STARTED|Treatment Period 2 (6 Days)||8
3362125|NCT04156646|4093144|FG000|COMPLETED|Treatment Period 2 (6 Days)||8
3362126|NCT04156646|4093145|FG001|COMPLETED|Treatment Period 2 (6 Days)||8
3362127|NCT04156646|4093144|FG000|NOT COMPLETED|Treatment Period 2 (6 Days)||0
3362128|NCT04156646|4093145|FG001|NOT COMPLETED|Treatment Period 2 (6 Days)||0
3362129|NCT04156646|4093144|FG000|STARTED|Wash-out Period (12- to 21-days)||8
3362130|NCT04156646|4093145|FG001|STARTED|Wash-out Period (12- to 21-days)||8
3362131|NCT04156646|4093144|FG000|COMPLETED|Wash-out Period (12- to 21-days)||8
3362132|NCT04156646|4093145|FG001|COMPLETED|Wash-out Period (12- to 21-days)||8
3362133|NCT04156646|4093144|FG000|NOT COMPLETED|Wash-out Period (12- to 21-days)||0
3362134|NCT04156646|4093145|FG001|NOT COMPLETED|Wash-out Period (12- to 21-days)||0
3362135|NCT04156646|4093144|FG000|STARTED|Treatment Period 3 (6 Days)||8
3362136|NCT04156646|4093145|FG001|STARTED|Treatment Period 3 (6 Days)||8
3362137|NCT04156646|4093144|FG000|COMPLETED|Treatment Period 3 (6 Days)||8
3362138|NCT04156646|4093145|FG001|COMPLETED|Treatment Period 3 (6 Days)||7
3362139|NCT04156646|4093144|FG000|NOT COMPLETED|Treatment Period 3 (6 Days)||0
3362140|NCT04156646|4093145|FG001|NOT COMPLETED|Treatment Period 3 (6 Days)||1
3362141|NCT04170686|4093156|FG000|STARTED|Screening||74
3362142|NCT04170686|4093157|FG001|STARTED|Screening||72
3362143|NCT04170686|4093156|FG000|COMPLETED|Screening||62
3362144|NCT04170686|4093157|FG001|COMPLETED|Screening||59
3362145|NCT04170686|4093156|FG000|NOT COMPLETED|Screening||12
3362146|NCT04170686|4093157|FG001|NOT COMPLETED|Screening||13
3362147|NCT04170686|4093156|FG000|STARTED|Randomization and Treatment||62
3362148|NCT04170686|4093157|FG001|STARTED|Randomization and Treatment||59
3362149|NCT04170686|4093156|FG000|COMPLETED|Randomization and Treatment||36
3362150|NCT04170686|4093157|FG001|COMPLETED|Randomization and Treatment||44
3362151|NCT04170686|4093156|FG000|NOT COMPLETED|Randomization and Treatment||26
3362152|NCT04170686|4093157|FG001|NOT COMPLETED|Randomization and Treatment||15
3362153|NCT04169113|4093165|FG000|STARTED|Overall Study||52
3362154|NCT04169113|4093166|FG001|STARTED|Overall Study||59
3362155|NCT04169113|4093165|FG000|COMPLETED|Overall Study||47
3362156|NCT04169113|4093166|FG001|COMPLETED|Overall Study||53
3362157|NCT04169113|4093165|FG000|NOT COMPLETED|Overall Study||5
3362158|NCT04169113|4093166|FG001|NOT COMPLETED|Overall Study||6
3362159|NCT04160975|4093178|FG000|STARTED|Overall Study||479
3362160|NCT04160975|4093179|FG001|STARTED|Overall Study||496
3362161|NCT04160975|4093180|FG002|STARTED|Overall Study||478
3362162|NCT04160975|4093181|FG003|STARTED|Overall Study||485
3362163|NCT04160975|4093182|FG004|STARTED|Overall Study||649
3362164|NCT04160975|4093183|FG005|STARTED|Overall Study||658
3362165|NCT04160975|4093178|FG000|COMPLETED|Overall Study||415
3362166|NCT04160975|4093179|FG001|COMPLETED|Overall Study||430
3362167|NCT04160975|4093180|FG002|COMPLETED|Overall Study||417
3362168|NCT04160975|4093181|FG003|COMPLETED|Overall Study||410
3362169|NCT04160975|4093182|FG004|COMPLETED|Overall Study||614
3362170|NCT04160975|4093183|FG005|COMPLETED|Overall Study||607
3362171|NCT04160975|4093178|FG000|NOT COMPLETED|Overall Study||64
3362172|NCT04160975|4093179|FG001|NOT COMPLETED|Overall Study||66
3362173|NCT04160975|4093180|FG002|NOT COMPLETED|Overall Study||61
3362174|NCT04160975|4093181|FG003|NOT COMPLETED|Overall Study||75
3362175|NCT04160975|4093182|FG004|NOT COMPLETED|Overall Study||35
3362176|NCT04160975|4093183|FG005|NOT COMPLETED|Overall Study||51
3362177|NCT04153409|4093198|FG000|STARTED|Overall Study||10
3362178|NCT04153409|4093199|FG001|STARTED|Overall Study||11
3362179|NCT04153409|4093198|FG000|COMPLETED|Overall Study||8
3362180|NCT04153409|4093199|FG001|COMPLETED|Overall Study||9
3362181|NCT04153409|4093198|FG000|NOT COMPLETED|Overall Study||2
3362182|NCT04153409|4093199|FG001|NOT COMPLETED|Overall Study||2
3362183|NCT04151628|4093207|FG000|STARTED|Overall Study||8
3362184|NCT04151628|4093208|FG001|STARTED|Overall Study||64
3362185|NCT04151628|4093207|FG000|COMPLETED|Overall Study||8
3362186|NCT04151628|4093208|FG001|COMPLETED|Overall Study||64
3362187|NCT04151628|4093207|FG000|NOT COMPLETED|Overall Study||0
3362188|NCT04151628|4093208|FG001|NOT COMPLETED|Overall Study||0
3362189|NCT04167189|4093213|FG000|STARTED|Overall Study||28
3362190|NCT04167189|4093213|FG000|COMPLETED|Overall Study||28
3362191|NCT04167189|4093213|FG000|NOT COMPLETED|Overall Study||0
3362192|NCT04162795|4093217|FG000|STARTED|Overall Study||468
3362193|NCT04162795|4093217|FG000|COMPLETED|Overall Study||442
3179428|NCT01985334|3907580|FG000|COMPLETED|Overall Study||107
3179429|NCT01985334|3907581|FG001|COMPLETED|Overall Study||303
3179430|NCT01985334|3907582|FG002|COMPLETED|Overall Study||367
3179431|NCT01985334|3907583|FG003|COMPLETED|Overall Study||1033
3362194|NCT04162795|4093217|FG000|NOT COMPLETED|Overall Study||26
3362195|NCT04161807|4093221|FG000|STARTED|Overall Study||42
3362196|NCT04161807|4093221|FG000|COMPLETED|Overall Study||38
3362197|NCT04161807|4093221|FG000|NOT COMPLETED|Overall Study||4
3362198|NCT04161144|4093227|FG000|STARTED|Overall Study||12
3362199|NCT04161144|4093228|FG001|STARTED|Overall Study||10
3362200|NCT04161144|4093227|FG000|COMPLETED|Overall Study||11
3362201|NCT04161144|4093228|FG001|COMPLETED|Overall Study||9
3362202|NCT04161144|4093227|FG000|NOT COMPLETED|Overall Study||1
3362203|NCT04161144|4093228|FG001|NOT COMPLETED|Overall Study||1
3362204|NCT04161131|4093234|FG000|STARTED|Overall Study||28
3362205|NCT04161131|4093234|FG000|Completed Baseline Surveys|Overall Study||27
3362206|NCT04161131|4093234|FG000|Received Intervention|Overall Study||22
3362207|NCT04161131|4093234|FG000|COMPLETED|Overall Study||22
3362208|NCT04161131|4093234|FG000|NOT COMPLETED|Overall Study||6
3362209|NCT04161079|4093238|FG000|STARTED|Clinical Investigation 2010-040||12
3362210|NCT04161079|4093238|FG000|COMPLETED|Clinical Investigation 2010-040||11
3362211|NCT04161079|4093238|FG000|NOT COMPLETED|Clinical Investigation 2010-040||1
3362212|NCT04161079|4093238|FG000|STARTED|2010-040FU5 >5 Years Follow-up|Of 11 subjects 3 refused to participate and 1 died.|7
3362213|NCT04161079|4093238|FG000|COMPLETED|2010-040FU5 >5 Years Follow-up|Timepoint distribution for individual patients ranged approximately 6-8 yrs after MAR implantation.|7
3362214|NCT04161079|4093238|FG000|NOT COMPLETED|2010-040FU5 >5 Years Follow-up||0
3362215|NCT04158466|4093248|FG000|STARTED|Overall Study||124
3362216|NCT04158466|4093249|FG001|STARTED|Overall Study||127
3362217|NCT04158466|4093248|FG000|COMPLETED|Overall Study||121
3362218|NCT04158466|4093249|FG001|COMPLETED|Overall Study||126
3362219|NCT04158466|4093248|FG000|NOT COMPLETED|Overall Study||3
3362220|NCT04158466|4093249|FG001|NOT COMPLETED|Overall Study||1
3362221|NCT04152083|4093257|FG000|STARTED|Overall Study||241
3362222|NCT04152083|4093258|FG001|STARTED|Overall Study||244
3362223|NCT04152083|4093257|FG000|Received at Least 1 Dose of Study Drug|Overall Study||238
3362224|NCT04152083|4093258|FG001|Received at Least 1 Dose of Study Drug|Overall Study||242
3362225|NCT04152083|4093257|FG000|COMPLETED|Overall Study||235
3362226|NCT04152083|4093258|FG001|COMPLETED|Overall Study||241
3362227|NCT04152083|4093257|FG000|NOT COMPLETED|Overall Study||6
3362228|NCT04152083|4093258|FG001|NOT COMPLETED|Overall Study||3
3362229|NCT04155567|4093264|FG000|STARTED|Overall Study||10
3362230|NCT04155567|4093264|FG000|COMPLETED|Overall Study||10
3362231|NCT04155567|4093264|FG000|NOT COMPLETED|Overall Study||0
3362232|NCT04155047|4093270|FG000|STARTED|Overall Study||11
3362233|NCT04155047|4093271|FG001|STARTED|Overall Study||11
3362234|NCT04155047|4093270|FG000|COMPLETED|Overall Study||9
3362235|NCT04155047|4093271|FG001|COMPLETED|Overall Study||11
3362236|NCT04155047|4093270|FG000|NOT COMPLETED|Overall Study||2
3362237|NCT04155047|4093271|FG001|NOT COMPLETED|Overall Study||0
3362238|NCT04152642|4093277|FG000|STARTED|Overall Study||22
3362239|NCT04152642|4093277|FG000|C (Water/Negative) Control|Overall Study||20
3362240|NCT04152642|4093277|FG000|A (Marketed Rinse)|Overall Study||19
3362241|NCT04152642|4093277|FG000|B (Experimental Rinse)|Overall Study||19
3362242|NCT04152642|4093277|FG000|COMPLETED|Overall Study||15
3362243|NCT04152642|4093277|FG000|NOT COMPLETED|Overall Study||7
3362244|NCT04150861|4093288|FG000|STARTED|Overall Study||8
3362245|NCT04150861|4093289|FG001|STARTED|Overall Study||8
3362246|NCT04150861|4093290|FG002|STARTED|Overall Study||8
3362247|NCT04150861|4093288|FG000|COMPLETED|Overall Study||8
3362248|NCT04150861|4093289|FG001|COMPLETED|Overall Study||8
3362249|NCT04150861|4093290|FG002|COMPLETED|Overall Study||8
3362250|NCT04150861|4093288|FG000|NOT COMPLETED|Overall Study||0
3362251|NCT04150861|4093289|FG001|NOT COMPLETED|Overall Study||0
3362252|NCT04150861|4093290|FG002|NOT COMPLETED|Overall Study||0
3362253|NCT04150250|4093300|FG000|STARTED|Overall Study||23
3362254|NCT04150250|4093301|FG001|STARTED|Overall Study||24
3362255|NCT04150250|4093300|FG000|COMPLETED|Overall Study||23
3362256|NCT04150250|4093301|FG001|COMPLETED|Overall Study||22
3362257|NCT04150250|4093300|FG000|NOT COMPLETED|Overall Study||0
3362258|NCT04150250|4093301|FG001|NOT COMPLETED|Overall Study||2
3362259|NCT04149925|4093309|FG000|STARTED|Overall Study||30
3362260|NCT04149925|4093310|FG001|STARTED|Overall Study||30
3362261|NCT04149925|4093309|FG000|COMPLETED|Overall Study||30
3362262|NCT04149925|4093310|FG001|COMPLETED|Overall Study||30
3362263|NCT04149925|4093309|FG000|NOT COMPLETED|Overall Study||0
3362264|NCT04149925|4093310|FG001|NOT COMPLETED|Overall Study||0
3362265|NCT04150224|4093322|FG000|STARTED|Overall Study|10 healthy volunteers receiving PBTZ169 + 1 backup volunteer|10
3362266|NCT04150224|4093323|FG001|STARTED|Overall Study|10 healthy volunteers receiving PBTZ169 + 1 backup volunteer|10
3362267|NCT04150224|4093324|FG002|STARTED|Overall Study|10 healthy volunteers receiving PBTZ169 + 1 backup volunteer|10
3362268|NCT04150224|4093325|FG003|STARTED|Overall Study|10 healthy volunteers receiving PBTZ169 + 1 backup volunteer|10
3362269|NCT04150224|4093326|FG004|STARTED|Overall Study|10 healthy volunteers receiving PBTZ169 + 1 backup volunteer|10
3362270|NCT04150224|4093327|FG005|STARTED|Overall Study|Period 2: Multple Dosing|10
3362271|NCT04150224|4093322|FG000|COMPLETED|Overall Study||10
3362272|NCT04150224|4093323|FG001|COMPLETED|Overall Study||10
3362273|NCT04150224|4093324|FG002|COMPLETED|Overall Study||10
3362274|NCT04150224|4093325|FG003|COMPLETED|Overall Study||10
3362275|NCT04150224|4093326|FG004|COMPLETED|Overall Study||10
3362276|NCT04150224|4093327|FG005|COMPLETED|Overall Study|Period 2: Multple Dosing|10
3362277|NCT04150224|4093322|FG000|NOT COMPLETED|Overall Study||0
3362278|NCT04150224|4093323|FG001|NOT COMPLETED|Overall Study||0
3362279|NCT04150224|4093324|FG002|NOT COMPLETED|Overall Study||0
3362280|NCT04150224|4093325|FG003|NOT COMPLETED|Overall Study||0
3362281|NCT04150224|4093326|FG004|NOT COMPLETED|Overall Study||0
3362282|NCT04150224|4093327|FG005|NOT COMPLETED|Overall Study||0
3362283|NCT04149405|4093354|FG000|STARTED|Overall Study||12
3362284|NCT04149405|4093355|FG001|STARTED|Overall Study||10
3362285|NCT04149405|4093356|FG002|STARTED|Overall Study||11
3362286|NCT04149405|4093357|FG003|STARTED|Overall Study||10
3362287|NCT04149405|4093354|FG000|COMPLETED|Overall Study||12
3362288|NCT04149405|4093355|FG001|COMPLETED|Overall Study||10
3362289|NCT04149405|4093356|FG002|COMPLETED|Overall Study||11
3362290|NCT04149405|4093357|FG003|COMPLETED|Overall Study||10
3362291|NCT04149405|4093354|FG000|NOT COMPLETED|Overall Study||0
3362292|NCT04149405|4093355|FG001|NOT COMPLETED|Overall Study||0
3362293|NCT04149405|4093356|FG002|NOT COMPLETED|Overall Study||0
3362294|NCT04149405|4093357|FG003|NOT COMPLETED|Overall Study||0
3362295|NCT04144088|4093376|FG000|STARTED|Overall Study||20
3362296|NCT04144088|4093377|FG001|STARTED|Overall Study||20
3362297|NCT04144088|4093378|FG002|STARTED|Overall Study||20
3362298|NCT04144088|4093376|FG000|COMPLETED|Overall Study||14
3362299|NCT04144088|4093377|FG001|COMPLETED|Overall Study||15
3362300|NCT04144088|4093378|FG002|COMPLETED|Overall Study||13
3362301|NCT04144088|4093376|FG000|NOT COMPLETED|Overall Study||6
3362302|NCT04144088|4093377|FG001|NOT COMPLETED|Overall Study||5
3362303|NCT04144088|4093378|FG002|NOT COMPLETED|Overall Study||7
3362304|NCT04149353|4093386|FG000|STARTED|Overall Study|The study was terminated for low recruitment before this subject's second imaging scan was due.|1
3362305|NCT04149353|4093386|FG000|COMPLETED|Overall Study||0
3362306|NCT04149353|4093386|FG000|NOT COMPLETED|Overall Study||1
3362307|NCT04148651|4093391|FG000|STARTED|Overall Study||12
3362308|NCT04148651|4093391|FG000|COMPLETED|Overall Study|2 subjects didn't complete final follow-up due to COVID-19 pandemic|10
3362309|NCT04148651|4093391|FG000|NOT COMPLETED|Overall Study||2
3362310|NCT04137783|4093399|FG000|STARTED|Overall Study||7
3362311|NCT04137783|4093400|FG001|STARTED|Overall Study||10
3362312|NCT04137783|4093401|FG002|STARTED|Overall Study||22
3362313|NCT04137783|4093399|FG000|COMPLETED|Overall Study||7
3362314|NCT04137783|4093400|FG001|COMPLETED|Overall Study||10
3362315|NCT04137783|4093401|FG002|COMPLETED|Overall Study||22
3362316|NCT04137783|4093399|FG000|NOT COMPLETED|Overall Study||0
3362317|NCT04137783|4093400|FG001|NOT COMPLETED|Overall Study||0
3362318|NCT04137783|4093401|FG002|NOT COMPLETED|Overall Study||0
3362319|NCT04136444|4093411|FG000|STARTED|Overall Study||3
3362320|NCT04136444|4093412|FG001|STARTED|Overall Study||9
3362321|NCT04136444|4093411|FG000|COMPLETED|Overall Study|The cohort was not completely recruited, as the study was stopped/terminated due to COVID-19.|3
3362322|NCT04136444|4093412|FG001|COMPLETED|Overall Study||8
3362323|NCT04136444|4093411|FG000|NOT COMPLETED|Overall Study||0
3362324|NCT04136444|4093412|FG001|NOT COMPLETED|Overall Study||1
3362325|NCT04124536|4093429|FG000|STARTED|Overall Study||58
3362326|NCT04124536|4093430|FG001|STARTED|Overall Study||58
3362327|NCT04124536|4093431|FG002|STARTED|Overall Study||105
3362328|NCT04124536|4093432|FG003|STARTED|Overall Study||105
3362329|NCT04124536|4093433|FG004|STARTED|Overall Study||15
3362330|NCT04124536|4093429|FG000|COMPLETED|Overall Study||47
3362331|NCT04124536|4093430|FG001|COMPLETED|Overall Study||53
3362332|NCT04124536|4093431|FG002|COMPLETED|Overall Study||102
3362333|NCT04124536|4093432|FG003|COMPLETED|Overall Study||98
3362334|NCT04124536|4093433|FG004|COMPLETED|Overall Study||15
3362335|NCT04124536|4093429|FG000|NOT COMPLETED|Overall Study||11
3362336|NCT04124536|4093430|FG001|NOT COMPLETED|Overall Study||5
3362337|NCT04124536|4093431|FG002|NOT COMPLETED|Overall Study||3
3362338|NCT04124536|4093432|FG003|NOT COMPLETED|Overall Study||7
3179432|NCT01985334|3907584|FG004|COMPLETED|Overall Study||234
3179433|NCT01985334|3907585|FG005|COMPLETED|Overall Study||666
3179434|NCT01985334|3907586|FG006|COMPLETED|Overall Study||237
3179435|NCT01985334|3907587|FG007|COMPLETED|Overall Study||699
3179436|NCT01985334|3907580|FG000|NOT COMPLETED|Overall Study||23
3179437|NCT01985334|3907581|FG001|NOT COMPLETED|Overall Study||84
3362339|NCT04124536|4093433|FG004|NOT COMPLETED|Overall Study||0
3362340|NCT04147611|4093446|FG000|STARTED|Overall Study||9
3362341|NCT04147611|4093447|FG001|STARTED|Overall Study||13
3362342|NCT04147611|4093446|FG000|COMPLETED|Overall Study||9
3362343|NCT04147611|4093447|FG001|COMPLETED|Overall Study||12
3362344|NCT04147611|4093446|FG000|NOT COMPLETED|Overall Study||0
3362345|NCT04147611|4093447|FG001|NOT COMPLETED|Overall Study||1
2928335|NCT00576823|3639204|FG001|NOT COMPLETED|40-week Safety Extension Phase||0
2928336|NCT00576823|3639205|FG002|NOT COMPLETED|40-week Safety Extension Phase||0
2928337|NCT00576836|3639216|FG000|STARTED|Overall Study||0
2928338|NCT00576836|3639217|FG001|STARTED|Overall Study||7
2928339|NCT00576836|3639216|FG000|COMPLETED|Overall Study||0
2928340|NCT00576836|3639217|FG001|COMPLETED|Overall Study||5
2928341|NCT00576836|3639216|FG000|NOT COMPLETED|Overall Study||0
2928342|NCT00576836|3639217|FG001|NOT COMPLETED|Overall Study||2
3040083|NCT01162239|3759538|FG000|COMPLETED|Extended Follow-up||39
3040084|NCT01162239|3759539|FG001|COMPLETED|Extended Follow-up||32
3040085|NCT01162239|3759540|FG002|COMPLETED|Extended Follow-up||37
3040086|NCT01162239|3759541|FG003|COMPLETED|Extended Follow-up||41
3040087|NCT01162239|3759538|FG000|NOT COMPLETED|Extended Follow-up||8
3040088|NCT01162239|3759539|FG001|NOT COMPLETED|Extended Follow-up||13
3040089|NCT01162239|3759540|FG002|NOT COMPLETED|Extended Follow-up||8
3362346|NCT04147442|4093453|FG000|STARTED|Overall Study||20
3362347|NCT04147442|4093453|FG000|COMPLETED|Overall Study||20
3362348|NCT04147442|4093453|FG000|NOT COMPLETED|Overall Study||0
3362349|NCT04147455|4093467|FG000|STARTED|Overall Study||397
3362350|NCT04147455|4093468|FG001|STARTED|Overall Study||396
3362351|NCT04147455|4093467|FG000|COMPLETED|Overall Study||375
3362352|NCT04147455|4093468|FG001|COMPLETED|Overall Study||364
3362353|NCT04147455|4093467|FG000|NOT COMPLETED|Overall Study||22
3362354|NCT04147455|4093468|FG001|NOT COMPLETED|Overall Study||32
3362355|NCT04146272|4093478|FG000|STARTED|First Intervention||11
3362356|NCT04146272|4093479|FG001|STARTED|First Intervention||11
3362357|NCT04146272|4093480|FG002|STARTED|First Intervention||6
3362358|NCT04146272|4093481|FG003|STARTED|First Intervention||5
3362359|NCT04146272|4093478|FG000|COMPLETED|First Intervention||11
3362360|NCT04146272|4093479|FG001|COMPLETED|First Intervention||11
3362361|NCT04146272|4093480|FG002|COMPLETED|First Intervention||6
3362362|NCT04146272|4093481|FG003|COMPLETED|First Intervention||5
3362363|NCT04146272|4093478|FG000|NOT COMPLETED|First Intervention||0
3362364|NCT04146272|4093479|FG001|NOT COMPLETED|First Intervention||0
3362365|NCT04146272|4093480|FG002|NOT COMPLETED|First Intervention||0
3362366|NCT04146272|4093481|FG003|NOT COMPLETED|First Intervention||0
3362367|NCT04146272|4093478|FG000|STARTED|Second Intervention||11
3362368|NCT04146272|4093479|FG001|STARTED|Second Intervention||11
3362369|NCT04146272|4093480|FG002|STARTED|Second Intervention||6
3362370|NCT04146272|4093481|FG003|STARTED|Second Intervention||5
3362371|NCT04146272|4093478|FG000|COMPLETED|Second Intervention||11
3362372|NCT04146272|4093479|FG001|COMPLETED|Second Intervention||11
3362373|NCT04146272|4093480|FG002|COMPLETED|Second Intervention||6
3362374|NCT04146272|4093481|FG003|COMPLETED|Second Intervention||5
3362375|NCT04146272|4093478|FG000|NOT COMPLETED|Second Intervention||0
3362376|NCT04146272|4093479|FG001|NOT COMPLETED|Second Intervention||0
3362377|NCT04146272|4093480|FG002|NOT COMPLETED|Second Intervention||0
3362378|NCT04146272|4093481|FG003|NOT COMPLETED|Second Intervention||0
3362379|NCT04143945|4093500|FG000|STARTED|Treatment Period 1 (Day 1)||26
3362380|NCT04143945|4093501|FG001|STARTED|Treatment Period 1 (Day 1)||26
3362381|NCT04143945|4093502|FG002|STARTED|Treatment Period 1 (Day 1)||26
3362382|NCT04143945|4093503|FG003|STARTED|Treatment Period 1 (Day 1)||26
3362383|NCT04143945|4093500|FG000|Full Analysis Set (FAS)|Treatment Period 1 (Day 1)||26
3362384|NCT04143945|4093501|FG001|Full Analysis Set (FAS)|Treatment Period 1 (Day 1)||26
3362385|NCT04143945|4093502|FG002|Full Analysis Set (FAS)|Treatment Period 1 (Day 1)||26
3362386|NCT04143945|4093503|FG003|Full Analysis Set (FAS)|Treatment Period 1 (Day 1)||26
3362387|NCT04143945|4093500|FG000|Safety Analysis Set (SAS)|Treatment Period 1 (Day 1)||26
3362388|NCT04143945|4093501|FG001|Safety Analysis Set (SAS)|Treatment Period 1 (Day 1)||26
3362389|NCT04143945|4093502|FG002|Safety Analysis Set (SAS)|Treatment Period 1 (Day 1)||26
3362390|NCT04143945|4093503|FG003|Safety Analysis Set (SAS)|Treatment Period 1 (Day 1)||26
3362391|NCT04143945|4093500|FG000|Per Protocol Set|Treatment Period 1 (Day 1)||26
3362392|NCT04143945|4093501|FG001|Per Protocol Set|Treatment Period 1 (Day 1)||26
3362393|NCT04143945|4093502|FG002|Per Protocol Set|Treatment Period 1 (Day 1)||26
3362394|NCT04143945|4093503|FG003|Per Protocol Set|Treatment Period 1 (Day 1)||26
3362395|NCT04143945|4093500|FG000|COMPLETED|Treatment Period 1 (Day 1)||26
3362396|NCT04143945|4093501|FG001|COMPLETED|Treatment Period 1 (Day 1)||26
3362397|NCT04143945|4093502|FG002|COMPLETED|Treatment Period 1 (Day 1)||26
3362398|NCT04143945|4093503|FG003|COMPLETED|Treatment Period 1 (Day 1)||26
3362399|NCT04143945|4093500|FG000|NOT COMPLETED|Treatment Period 1 (Day 1)||0
3362400|NCT04143945|4093501|FG001|NOT COMPLETED|Treatment Period 1 (Day 1)||0
3362401|NCT04143945|4093502|FG002|NOT COMPLETED|Treatment Period 1 (Day 1)||0
3362402|NCT04143945|4093503|FG003|NOT COMPLETED|Treatment Period 1 (Day 1)||0
3362403|NCT04143945|4093500|FG000|STARTED|Treatment Period 2 (Day 1)||26
3362404|NCT04143945|4093501|FG001|STARTED|Treatment Period 2 (Day 1)||26
3362405|NCT04143945|4093502|FG002|STARTED|Treatment Period 2 (Day 1)||26
3362406|NCT04143945|4093503|FG003|STARTED|Treatment Period 2 (Day 1)||26
3362407|NCT04143945|4093500|FG000|COMPLETED|Treatment Period 2 (Day 1)||26
3362408|NCT04143945|4093501|FG001|COMPLETED|Treatment Period 2 (Day 1)||26
3362409|NCT04143945|4093502|FG002|COMPLETED|Treatment Period 2 (Day 1)||26
3362410|NCT04143945|4093503|FG003|COMPLETED|Treatment Period 2 (Day 1)||26
3362411|NCT04143945|4093500|FG000|NOT COMPLETED|Treatment Period 2 (Day 1)||0
3362412|NCT04143945|4093501|FG001|NOT COMPLETED|Treatment Period 2 (Day 1)||0
3362413|NCT04143945|4093502|FG002|NOT COMPLETED|Treatment Period 2 (Day 1)||0
3362414|NCT04143945|4093503|FG003|NOT COMPLETED|Treatment Period 2 (Day 1)||0
3362415|NCT04143373|4093508|FG000|STARTED|Overall Study||20
3362416|NCT04143373|4093509|FG001|STARTED|Overall Study||20
3362417|NCT04143373|4093508|FG000|COMPLETED|Overall Study||20
3362418|NCT04143373|4093509|FG001|COMPLETED|Overall Study||20
3362419|NCT04143373|4093508|FG000|NOT COMPLETED|Overall Study||0
3362420|NCT04143373|4093509|FG001|NOT COMPLETED|Overall Study||0
3362421|NCT04142216|4093516|FG000|STARTED|Overall Study||28
3362422|NCT04142216|4093517|FG001|STARTED|Overall Study||28
3362423|NCT04142216|4093516|FG000|COMPLETED|Overall Study||22
3362424|NCT04142216|4093517|FG001|COMPLETED|Overall Study||22
3362425|NCT04142216|4093516|FG000|NOT COMPLETED|Overall Study||6
3362426|NCT04142216|4093517|FG001|NOT COMPLETED|Overall Study||6
3362427|NCT04141930|4093523|FG000|STARTED|Overall Study||302
3362428|NCT04141930|4093524|FG001|STARTED|Overall Study|The 179 individuals that were not eligible to receive the study drug, participated in an observation portion of the study where all study procedures were the same excluding telehealth visit and an antiviral delivery.|179
3362429|NCT04141930|4093523|FG000|COMPLETED|Overall Study||302
3362430|NCT04141930|4093524|FG001|COMPLETED|Overall Study||179
3362431|NCT04141930|4093523|FG000|NOT COMPLETED|Overall Study||0
3362432|NCT04141930|4093524|FG001|NOT COMPLETED|Overall Study||0
3362433|NCT04142450|4093528|FG000|STARTED|Overall Study||50
3362434|NCT04142450|4093528|FG000|Safety Population|Overall Study||49
3362435|NCT04142450|4093528|FG000|COMPLETED|Overall Study||48
3362436|NCT04142450|4093528|FG000|NOT COMPLETED|Overall Study||2
3362437|NCT04142242|4093538|FG000|STARTED|Overall Study||139
3362438|NCT04142242|4093539|FG001|STARTED|Overall Study||176
3362439|NCT04142242|4093540|FG002|STARTED|Overall Study||31
3362440|NCT04142242|4093541|FG003|STARTED|Overall Study||39
3362441|NCT04142242|4093542|FG004|STARTED|Overall Study||26
3362442|NCT04142242|4093543|FG005|STARTED|Overall Study||60
3362443|NCT04142242|4093538|FG000|Vaccinated|Overall Study||138
3362444|NCT04142242|4093539|FG001|Vaccinated|Overall Study||175
3362445|NCT04142242|4093540|FG002|Vaccinated|Overall Study||0
3362446|NCT04142242|4093541|FG003|Vaccinated|Overall Study||0
3362447|NCT04142242|4093542|FG004|Vaccinated|Overall Study||0
3362448|NCT04142242|4093543|FG005|Vaccinated|Overall Study||0
3362449|NCT04142242|4093538|FG000|Full Analysis Set (FAS)|Overall Study||138
3362450|NCT04142242|4093539|FG001|Full Analysis Set (FAS)|Overall Study||175
3362451|NCT04142242|4093540|FG002|Full Analysis Set (FAS)|Overall Study||31
3362452|NCT04142242|4093541|FG003|Full Analysis Set (FAS)|Overall Study||39
3362453|NCT04142242|4093542|FG004|Full Analysis Set (FAS)|Overall Study||26
3362454|NCT04142242|4093543|FG005|Full Analysis Set (FAS)|Overall Study||59
3362455|NCT04142242|4093538|FG000|Safety Analysis Set (SAfAS)|Overall Study|1 MenACYW Conjugate vaccine-primed participant was erroneously assigned by Investigator to Group 1 but per planned analysis was counted in Group 2 for safety analysis.|151
3362456|NCT04142242|4093539|FG001|Safety Analysis Set (SAfAS)|Overall Study|14 Menomune-primed participants were erroneously assigned by Investigator to Group 2 but per planned analysis they were counted in Group 1 for safety analysis.|162
3362457|NCT04142242|4093540|FG002|Safety Analysis Set (SAfAS)|Overall Study||0
3362458|NCT04142242|4093541|FG003|Safety Analysis Set (SAfAS)|Overall Study||0
3362459|NCT04142242|4093542|FG004|Safety Analysis Set (SAfAS)|Overall Study||0
3362460|NCT04142242|4093543|FG005|Safety Analysis Set (SAfAS)|Overall Study||0
3362461|NCT04142242|4093538|FG000|COMPLETED|Overall Study||138
3362462|NCT04142242|4093539|FG001|COMPLETED|Overall Study||175
3362463|NCT04142242|4093540|FG002|COMPLETED|Overall Study||0
3362464|NCT04142242|4093541|FG003|COMPLETED|Overall Study||0
3362465|NCT04142242|4093542|FG004|COMPLETED|Overall Study||26
3362466|NCT04142242|4093543|FG005|COMPLETED|Overall Study||59
3362467|NCT04142242|4093538|FG000|NOT COMPLETED|Overall Study||1
3362468|NCT04142242|4093539|FG001|NOT COMPLETED|Overall Study||1
3362469|NCT04142242|4093540|FG002|NOT COMPLETED|Overall Study||31
3362470|NCT04142242|4093541|FG003|NOT COMPLETED|Overall Study||39
3362471|NCT04142242|4093542|FG004|NOT COMPLETED|Overall Study||0
3362472|NCT04142242|4093543|FG005|NOT COMPLETED|Overall Study||1
3362473|NCT04140890|4093558|FG000|STARTED|Overall Study||9
3362474|NCT04140890|4093559|FG001|STARTED|Overall Study||12
3362475|NCT04140890|4093558|FG000|COMPLETED|Overall Study||9
3362476|NCT04140890|4093559|FG001|COMPLETED|Overall Study||11
3362477|NCT04140890|4093558|FG000|NOT COMPLETED|Overall Study||0
3362478|NCT04140890|4093559|FG001|NOT COMPLETED|Overall Study||1
3362479|NCT04139018|4093570|FG000|STARTED|Overall Study||14
3362480|NCT04139018|4093571|FG001|STARTED|Overall Study||13
3362481|NCT04139018|4093570|FG000|COMPLETED|Overall Study||11
3362482|NCT04139018|4093571|FG001|COMPLETED|Overall Study||12
3362483|NCT04139018|4093570|FG000|NOT COMPLETED|Overall Study||3
3362484|NCT04139018|4093571|FG001|NOT COMPLETED|Overall Study||1
3362485|NCT04138810|4093579|FG000|STARTED|Overall Study||27
3362486|NCT04138810|4093580|FG001|STARTED|Overall Study||27
3362487|NCT04138810|4093579|FG000|COMPLETED|Overall Study||26
3362488|NCT04138810|4093580|FG001|COMPLETED|Overall Study||26
3362489|NCT04138810|4093579|FG000|NOT COMPLETED|Overall Study||1
3362490|NCT04138810|4093580|FG001|NOT COMPLETED|Overall Study||1
3362491|NCT04131556|4093586|FG000|STARTED|Overall Study||20
3362492|NCT04131556|4093586|FG000|COMPLETED|Overall Study||18
3362493|NCT04131556|4093586|FG000|NOT COMPLETED|Overall Study||2
3362494|NCT04126174|4093593|FG000|STARTED|Overall Study||41
3362495|NCT04126174|4093594|FG001|STARTED|Overall Study||41
3362496|NCT04126174|4093593|FG000|COMPLETED|Overall Study||38
3362497|NCT04126174|4093594|FG001|COMPLETED|Overall Study||38
3362498|NCT04126174|4093593|FG000|NOT COMPLETED|Overall Study||3
3362499|NCT04126174|4093594|FG001|NOT COMPLETED|Overall Study||3
3362500|NCT04134429|4093600|FG000|STARTED|Overall Study||20
3362501|NCT04134429|4093600|FG000|COMPLETED|Overall Study||19
3362502|NCT04134429|4093600|FG000|NOT COMPLETED|Overall Study||1
3362503|NCT04130425|4093604|FG000|STARTED|Overall Study||30
3362504|NCT04130425|4093604|FG000|COMPLETED|Overall Study||30
3362505|NCT04130425|4093604|FG000|NOT COMPLETED|Overall Study||0
3362506|NCT04138498|4093619|FG000|STARTED|Overall Study||11
3362507|NCT04138498|4093620|FG001|STARTED|Overall Study||10
3362508|NCT04138498|4093621|FG002|STARTED|Overall Study||12
3362509|NCT04138498|4093622|FG003|STARTED|Overall Study||12
3362510|NCT04138498|4093619|FG000|COMPLETED|Overall Study||10
3362511|NCT04138498|4093620|FG001|COMPLETED|Overall Study||10
3362512|NCT04138498|4093621|FG002|COMPLETED|Overall Study||10
3362513|NCT04138498|4093622|FG003|COMPLETED|Overall Study||9
3362514|NCT04138498|4093619|FG000|NOT COMPLETED|Overall Study||1
3362515|NCT04138498|4093620|FG001|NOT COMPLETED|Overall Study||0
3362516|NCT04138498|4093621|FG002|NOT COMPLETED|Overall Study||2
3362517|NCT04138498|4093622|FG003|NOT COMPLETED|Overall Study||3
3362518|NCT04138043|4093638|FG000|STARTED|Overall Study||2
3362519|NCT04138043|4093639|FG001|STARTED|Overall Study||7
3362520|NCT04138043|4093638|FG000|COMPLETED|Overall Study||2
3362521|NCT04138043|4093639|FG001|COMPLETED|Overall Study||6
3362522|NCT04138043|4093638|FG000|NOT COMPLETED|Overall Study||0
3362523|NCT04138043|4093639|FG001|NOT COMPLETED|Overall Study||1
3362524|NCT04137627|4093648|FG000|STARTED|Overall Study||25
3362525|NCT04137627|4093649|FG001|STARTED|Overall Study||25
3362526|NCT04137627|4093648|FG000|COMPLETED|Overall Study||13
3362527|NCT04137627|4093649|FG001|COMPLETED|Overall Study||12
3362528|NCT04137627|4093648|FG000|NOT COMPLETED|Overall Study||12
3362529|NCT04137627|4093649|FG001|NOT COMPLETED|Overall Study||13
3362530|NCT04136145|4093657|FG000|STARTED|Overall Study||12
3362531|NCT04136145|4093658|FG001|STARTED|Overall Study||24
3362532|NCT04136145|4093657|FG000|COMPLETED|Overall Study||12
3362533|NCT04136145|4093658|FG001|COMPLETED|Overall Study||24
3362534|NCT04136145|4093657|FG000|NOT COMPLETED|Overall Study||0
3362535|NCT04136145|4093658|FG001|NOT COMPLETED|Overall Study||0
3362536|NCT04132336|4093672|FG000|STARTED|Overall Study||32
3362537|NCT04132336|4093673|FG001|STARTED|Overall Study||32
3362538|NCT04132336|4093674|FG002|STARTED|Overall Study||32
3362539|NCT04132336|4093675|FG003|STARTED|Overall Study||32
3362540|NCT04132336|4093676|FG004|STARTED|Overall Study||32
3362541|NCT04132336|4093677|FG005|STARTED|Overall Study||16
3362542|NCT04132336|4093678|FG006|STARTED|Overall Study||17
3362543|NCT04132336|4093672|FG000|COMPLETED|Overall Study||32
3362544|NCT04132336|4093673|FG001|COMPLETED|Overall Study||31
3362545|NCT04132336|4093674|FG002|COMPLETED|Overall Study||32
3362546|NCT04132336|4093675|FG003|COMPLETED|Overall Study||32
3362547|NCT04132336|4093676|FG004|COMPLETED|Overall Study||32
3362548|NCT04132336|4093677|FG005|COMPLETED|Overall Study||16
3362549|NCT04132336|4093678|FG006|COMPLETED|Overall Study||17
3362550|NCT04132336|4093672|FG000|NOT COMPLETED|Overall Study||0
3362551|NCT04132336|4093673|FG001|NOT COMPLETED|Overall Study||1
3362552|NCT04132336|4093674|FG002|NOT COMPLETED|Overall Study||0
3362553|NCT04132336|4093675|FG003|NOT COMPLETED|Overall Study||0
3362554|NCT04132336|4093676|FG004|NOT COMPLETED|Overall Study||0
3362555|NCT04132336|4093677|FG005|NOT COMPLETED|Overall Study||0
3362556|NCT04132336|4093678|FG006|NOT COMPLETED|Overall Study||0
3362557|NCT04131517|4093696|FG000|STARTED|Overall Study||7
3362558|NCT04131517|4093697|FG001|STARTED|Overall Study||7
3362559|NCT04131517|4093696|FG000|COMPLETED|Overall Study||7
3362560|NCT04131517|4093697|FG001|COMPLETED|Overall Study||7
3362561|NCT04131517|4093696|FG000|NOT COMPLETED|Overall Study||0
3362562|NCT04131517|4093697|FG001|NOT COMPLETED|Overall Study||0
3362563|NCT04128293|4093718|FG000|STARTED|Treatment Period 1 (1 Day)||4
3362564|NCT04128293|4093719|FG001|STARTED|Treatment Period 1 (1 Day)||4
3362565|NCT04128293|4093720|FG002|STARTED|Treatment Period 1 (1 Day)||4
3362566|NCT04128293|4093721|FG003|STARTED|Treatment Period 1 (1 Day)||4
3362567|NCT04128293|4093718|FG000|COMPLETED|Treatment Period 1 (1 Day)||4
3362568|NCT04128293|4093719|FG001|COMPLETED|Treatment Period 1 (1 Day)||4
3362569|NCT04128293|4093720|FG002|COMPLETED|Treatment Period 1 (1 Day)||4
3362570|NCT04128293|4093721|FG003|COMPLETED|Treatment Period 1 (1 Day)||4
3362571|NCT04128293|4093718|FG000|NOT COMPLETED|Treatment Period 1 (1 Day)||0
3362572|NCT04128293|4093719|FG001|NOT COMPLETED|Treatment Period 1 (1 Day)||0
3362573|NCT04128293|4093720|FG002|NOT COMPLETED|Treatment Period 1 (1 Day)||0
3362574|NCT04128293|4093721|FG003|NOT COMPLETED|Treatment Period 1 (1 Day)||0
3362575|NCT04128293|4093718|FG000|STARTED|Washout Period 1 (Up to 7 Days)||4
3362576|NCT04128293|4093719|FG001|STARTED|Washout Period 1 (Up to 7 Days)||4
3362577|NCT04128293|4093720|FG002|STARTED|Washout Period 1 (Up to 7 Days)||4
3362578|NCT04128293|4093721|FG003|STARTED|Washout Period 1 (Up to 7 Days)||4
3362579|NCT04128293|4093718|FG000|COMPLETED|Washout Period 1 (Up to 7 Days)||4
3362580|NCT04128293|4093719|FG001|COMPLETED|Washout Period 1 (Up to 7 Days)||4
3362581|NCT04128293|4093720|FG002|COMPLETED|Washout Period 1 (Up to 7 Days)||4
3362582|NCT04128293|4093721|FG003|COMPLETED|Washout Period 1 (Up to 7 Days)||4
3362583|NCT04128293|4093718|FG000|NOT COMPLETED|Washout Period 1 (Up to 7 Days)||0
3362584|NCT04128293|4093719|FG001|NOT COMPLETED|Washout Period 1 (Up to 7 Days)||0
3362585|NCT04128293|4093720|FG002|NOT COMPLETED|Washout Period 1 (Up to 7 Days)||0
3362586|NCT04128293|4093721|FG003|NOT COMPLETED|Washout Period 1 (Up to 7 Days)||0
3362587|NCT04128293|4093718|FG000|STARTED|Treatment Period 2 (1 Day)||4
3362588|NCT04128293|4093719|FG001|STARTED|Treatment Period 2 (1 Day)||4
3362589|NCT04128293|4093720|FG002|STARTED|Treatment Period 2 (1 Day)||4
3362590|NCT04128293|4093721|FG003|STARTED|Treatment Period 2 (1 Day)||4
3362591|NCT04128293|4093718|FG000|COMPLETED|Treatment Period 2 (1 Day)||4
3362592|NCT04128293|4093719|FG001|COMPLETED|Treatment Period 2 (1 Day)||4
3362593|NCT04128293|4093720|FG002|COMPLETED|Treatment Period 2 (1 Day)||4
3362594|NCT04128293|4093721|FG003|COMPLETED|Treatment Period 2 (1 Day)||4
3362595|NCT04128293|4093718|FG000|NOT COMPLETED|Treatment Period 2 (1 Day)||0
3362596|NCT04128293|4093719|FG001|NOT COMPLETED|Treatment Period 2 (1 Day)||0
3362597|NCT04128293|4093720|FG002|NOT COMPLETED|Treatment Period 2 (1 Day)||0
3362598|NCT04128293|4093721|FG003|NOT COMPLETED|Treatment Period 2 (1 Day)||0
3362599|NCT04128293|4093718|FG000|STARTED|Washout Period 2 (Up to 7 Days)||4
3362600|NCT04128293|4093719|FG001|STARTED|Washout Period 2 (Up to 7 Days)||4
3362601|NCT04128293|4093720|FG002|STARTED|Washout Period 2 (Up to 7 Days)||4
3362602|NCT04128293|4093721|FG003|STARTED|Washout Period 2 (Up to 7 Days)||4
3362603|NCT04128293|4093718|FG000|COMPLETED|Washout Period 2 (Up to 7 Days)||0
3362604|NCT04128293|4093719|FG001|COMPLETED|Washout Period 2 (Up to 7 Days)||0
3362605|NCT04128293|4093720|FG002|COMPLETED|Washout Period 2 (Up to 7 Days)||0
3362606|NCT04128293|4093721|FG003|COMPLETED|Washout Period 2 (Up to 7 Days)||0
3362607|NCT04128293|4093718|FG000|NOT COMPLETED|Washout Period 2 (Up to 7 Days)||4
3362608|NCT04128293|4093719|FG001|NOT COMPLETED|Washout Period 2 (Up to 7 Days)||4
3362609|NCT04128293|4093720|FG002|NOT COMPLETED|Washout Period 2 (Up to 7 Days)||4
3362610|NCT04128293|4093721|FG003|NOT COMPLETED|Washout Period 2 (Up to 7 Days)||4
3362611|NCT04128293|4093718|FG000|STARTED|Treatment Period 3 (1 Day)||0
3362612|NCT04128293|4093719|FG001|STARTED|Treatment Period 3 (1 Day)||0
3362613|NCT04128293|4093720|FG002|STARTED|Treatment Period 3 (1 Day)||0
3362614|NCT04128293|4093721|FG003|STARTED|Treatment Period 3 (1 Day)||0
3179438|NCT01985334|3907582|FG002|NOT COMPLETED|Overall Study||53
3179439|NCT01985334|3907583|FG003|NOT COMPLETED|Overall Study||229
3179440|NCT01985334|3907584|FG004|NOT COMPLETED|Overall Study||40
3179441|NCT01985334|3907585|FG005|NOT COMPLETED|Overall Study||156
3179442|NCT01985334|3907586|FG006|NOT COMPLETED|Overall Study||37
3179443|NCT01985334|3907587|FG007|NOT COMPLETED|Overall Study||121
3179444|NCT01985360|3907621|FG000|STARTED|Overall Study||388
3179445|NCT01985360|3907622|FG001|STARTED|Overall Study||389
3179446|NCT01985360|3907621|FG000|COMPLETED|Overall Study||379
3179447|NCT01985360|3907622|FG001|COMPLETED|Overall Study||386
3179448|NCT01985360|3907621|FG000|NOT COMPLETED|Overall Study||9
3179449|NCT01985360|3907622|FG001|NOT COMPLETED|Overall Study||3
3179450|NCT01985425|3907630|FG000|STARTED|Overall Study||49
3362615|NCT04128293|4093718|FG000|COMPLETED|Treatment Period 3 (1 Day)||0
3362616|NCT04128293|4093719|FG001|COMPLETED|Treatment Period 3 (1 Day)||0
3362617|NCT04128293|4093720|FG002|COMPLETED|Treatment Period 3 (1 Day)||0
3362618|NCT04128293|4093721|FG003|COMPLETED|Treatment Period 3 (1 Day)||0
3362619|NCT04128293|4093718|FG000|NOT COMPLETED|Treatment Period 3 (1 Day)||0
3362620|NCT04128293|4093719|FG001|NOT COMPLETED|Treatment Period 3 (1 Day)||0
3362621|NCT04128293|4093720|FG002|NOT COMPLETED|Treatment Period 3 (1 Day)||0
3362622|NCT04128293|4093721|FG003|NOT COMPLETED|Treatment Period 3 (1 Day)||0
3362623|NCT04128293|4093718|FG000|STARTED|Washout Period 3 (Up to 7 Days)||0
3362624|NCT04128293|4093719|FG001|STARTED|Washout Period 3 (Up to 7 Days)||0
3362625|NCT04128293|4093720|FG002|STARTED|Washout Period 3 (Up to 7 Days)||0
3362626|NCT04128293|4093721|FG003|STARTED|Washout Period 3 (Up to 7 Days)||0
3362627|NCT04128293|4093718|FG000|COMPLETED|Washout Period 3 (Up to 7 Days)||0
3362628|NCT04128293|4093719|FG001|COMPLETED|Washout Period 3 (Up to 7 Days)||0
3362629|NCT04128293|4093720|FG002|COMPLETED|Washout Period 3 (Up to 7 Days)||0
3362630|NCT04128293|4093721|FG003|COMPLETED|Washout Period 3 (Up to 7 Days)||0
3362631|NCT04128293|4093718|FG000|NOT COMPLETED|Washout Period 3 (Up to 7 Days)||0
3362632|NCT04128293|4093719|FG001|NOT COMPLETED|Washout Period 3 (Up to 7 Days)||0
3362633|NCT04128293|4093720|FG002|NOT COMPLETED|Washout Period 3 (Up to 7 Days)||0
3362634|NCT04128293|4093721|FG003|NOT COMPLETED|Washout Period 3 (Up to 7 Days)||0
3362635|NCT04128293|4093718|FG000|STARTED|Treatment Period 4 (1 Day)||0
3362636|NCT04128293|4093719|FG001|STARTED|Treatment Period 4 (1 Day)||0
3362637|NCT04128293|4093720|FG002|STARTED|Treatment Period 4 (1 Day)||0
3362638|NCT04128293|4093721|FG003|STARTED|Treatment Period 4 (1 Day)||0
3362639|NCT04128293|4093718|FG000|COMPLETED|Treatment Period 4 (1 Day)||0
3362640|NCT04128293|4093719|FG001|COMPLETED|Treatment Period 4 (1 Day)||0
3362641|NCT04128293|4093720|FG002|COMPLETED|Treatment Period 4 (1 Day)||0
3362642|NCT04128293|4093721|FG003|COMPLETED|Treatment Period 4 (1 Day)||0
3362643|NCT04128293|4093718|FG000|NOT COMPLETED|Treatment Period 4 (1 Day)||0
3362644|NCT04128293|4093719|FG001|NOT COMPLETED|Treatment Period 4 (1 Day)||0
3362645|NCT04128293|4093720|FG002|NOT COMPLETED|Treatment Period 4 (1 Day)||0
3362646|NCT04128293|4093721|FG003|NOT COMPLETED|Treatment Period 4 (1 Day)||0
3362647|NCT04126343|4093742|FG000|STARTED|Overall Study||9
3362648|NCT04126343|4093743|FG001|STARTED|Overall Study||9
3362649|NCT04126343|4093744|FG002|STARTED|Overall Study||9
3362650|NCT04126343|4093745|FG003|STARTED|Overall Study||9
3362651|NCT04126343|4093746|FG004|STARTED|Overall Study||9
3362652|NCT04126343|4093747|FG005|STARTED|Overall Study||9
3362653|NCT04126343|4093742|FG000|Completed Padsevonil Period|Overall Study||9
3362654|NCT04126343|4093743|FG001|Completed Padsevonil Period|Overall Study||9
3362655|NCT04126343|4093744|FG002|Completed Padsevonil Period|Overall Study||9
3179451|NCT01985425|3907631|FG001|STARTED|Overall Study||51
3179452|NCT01985425|3907630|FG000|COMPLETED|Overall Study||49
3179453|NCT01985425|3907631|FG001|COMPLETED|Overall Study||51
3362656|NCT04126343|4093745|FG003|Completed Padsevonil Period|Overall Study||7
3362657|NCT04126343|4093746|FG004|Completed Padsevonil Period|Overall Study||9
3362658|NCT04126343|4093747|FG005|Completed Padsevonil Period|Overall Study||8
3362659|NCT04126343|4093742|FG000|Completed Placebo Period|Overall Study||9
3362660|NCT04126343|4093743|FG001|Completed Placebo Period|Overall Study||7
3362661|NCT04126343|4093744|FG002|Completed Placebo Period|Overall Study||9
3362662|NCT04126343|4093745|FG003|Completed Placebo Period|Overall Study||9
3362663|NCT04126343|4093746|FG004|Completed Placebo Period|Overall Study||7
3362664|NCT04126343|4093747|FG005|Completed Placebo Period|Overall Study||9
3362665|NCT04126343|4093742|FG000|Completed Moxifloxacin Period|Overall Study||8
3362666|NCT04126343|4093743|FG001|Completed Moxifloxacin Period|Overall Study||9
3362667|NCT04126343|4093744|FG002|Completed Moxifloxacin Period|Overall Study||7
3362668|NCT04126343|4093745|FG003|Completed Moxifloxacin Period|Overall Study||9
3362669|NCT04126343|4093746|FG004|Completed Moxifloxacin Period|Overall Study||9
3362670|NCT04126343|4093747|FG005|Completed Moxifloxacin Period|Overall Study||9
3362671|NCT04126343|4093742|FG000|COMPLETED|Overall Study||6
3362672|NCT04126343|4093743|FG001|COMPLETED|Overall Study||5
3362673|NCT04126343|4093744|FG002|COMPLETED|Overall Study||6
3362674|NCT04126343|4093745|FG003|COMPLETED|Overall Study||5
3362675|NCT04126343|4093746|FG004|COMPLETED|Overall Study||6
3362676|NCT04126343|4093747|FG005|COMPLETED|Overall Study||5
3362677|NCT04126343|4093742|FG000|NOT COMPLETED|Overall Study||3
3362678|NCT04126343|4093743|FG001|NOT COMPLETED|Overall Study||4
3362679|NCT04126343|4093744|FG002|NOT COMPLETED|Overall Study||3
3362680|NCT04126343|4093745|FG003|NOT COMPLETED|Overall Study||4
3362681|NCT04126343|4093746|FG004|NOT COMPLETED|Overall Study||3
3362682|NCT04126343|4093747|FG005|NOT COMPLETED|Overall Study||4
3362683|NCT04126187|4093762|FG000|STARTED|Overall Study||30
3362684|NCT04126187|4093762|FG000|COMPLETED|Overall Study||30
3362685|NCT04126187|4093762|FG000|NOT COMPLETED|Overall Study||0
3362686|NCT04124952|4093766|FG000|STARTED|Overall Study||30
3362687|NCT04124952|4093766|FG000|COMPLETED|Overall Study||29
3362688|NCT04124952|4093766|FG000|NOT COMPLETED|Overall Study||1
3362689|NCT04123665|4093772|FG000|STARTED|Overall Study||50
3362690|NCT04123665|4093773|FG001|STARTED|Overall Study||48
3362691|NCT04123665|4093772|FG000|COMPLETED|Overall Study||42
3362692|NCT04123665|4093773|FG001|COMPLETED|Overall Study||48
3362693|NCT04123665|4093772|FG000|NOT COMPLETED|Overall Study||8
3362694|NCT04123665|4093773|FG001|NOT COMPLETED|Overall Study||0
3362695|NCT04122534|4093779|FG000|STARTED|Overall Study||48
3362696|NCT04122534|4093779|FG000|COMPLETED|Overall Study||44
3362697|NCT04122534|4093779|FG000|NOT COMPLETED|Overall Study||4
3362698|NCT04121078|4093785|FG000|STARTED|Study Period 1 (1 Day)||6
3362699|NCT04121078|4093786|FG001|STARTED|Study Period 1 (1 Day)||6
3362700|NCT04121078|4093785|FG000|COMPLETED|Study Period 1 (1 Day)||6
3362701|NCT04121078|4093786|FG001|COMPLETED|Study Period 1 (1 Day)||6
3362702|NCT04121078|4093785|FG000|NOT COMPLETED|Study Period 1 (1 Day)||0
3362703|NCT04121078|4093786|FG001|NOT COMPLETED|Study Period 1 (1 Day)||0
3362704|NCT04121078|4093785|FG000|STARTED|Washout Period (at Least 7 Days)||6
3362705|NCT04121078|4093786|FG001|STARTED|Washout Period (at Least 7 Days)||6
3362706|NCT04121078|4093785|FG000|COMPLETED|Washout Period (at Least 7 Days)||6
3362707|NCT04121078|4093786|FG001|COMPLETED|Washout Period (at Least 7 Days)||6
3362708|NCT04121078|4093785|FG000|NOT COMPLETED|Washout Period (at Least 7 Days)||0
3362709|NCT04121078|4093786|FG001|NOT COMPLETED|Washout Period (at Least 7 Days)||0
3362710|NCT04121078|4093785|FG000|STARTED|Study Period 2 (1 Day)||6
3362711|NCT04121078|4093786|FG001|STARTED|Study Period 2 (1 Day)||6
3362712|NCT04121078|4093785|FG000|COMPLETED|Study Period 2 (1 Day)||6
3362713|NCT04121078|4093786|FG001|COMPLETED|Study Period 2 (1 Day)||6
3362714|NCT04121078|4093785|FG000|NOT COMPLETED|Study Period 2 (1 Day)||0
3362715|NCT04121078|4093786|FG001|NOT COMPLETED|Study Period 2 (1 Day)||0
3362716|NCT04117607|4093795|FG000|STARTED|Overall Study||3
3362717|NCT04117607|4093796|FG001|STARTED|Overall Study||7
3362718|NCT04117607|4093797|FG002|STARTED|Overall Study|The study was terminated on 27APR2020 due to safety concerns. No subjects were enrolled into this group.|0
3362719|NCT04117607|4093798|FG003|STARTED|Overall Study|The study was terminated on 27APR2020 due to safety concerns. No subjects were enrolled into this group.|0
3362720|NCT04117607|4093799|FG004|STARTED|Overall Study|The study was terminated on 27APR2020 due to safety concerns. No subjects were enrolled into this group.|0
3362721|NCT04117607|4093800|FG005|STARTED|Overall Study|The study was terminated on 27APR2020 due to safety concerns. No subjects were enrolled into this group.|0
3362722|NCT04117607|4093801|FG006|STARTED|Overall Study||4
3362723|NCT04117607|4093802|FG007|STARTED|Overall Study|The study was terminated on 27APR2020 due to safety concerns. No subjects were enrolled into this group.|0
3362724|NCT04117607|4093803|FG008|STARTED|Overall Study|The study was terminated on 27APR2020 due to safety concerns. No subjects were enrolled into this group.|0
3362725|NCT04117607|4093804|FG009|STARTED|Overall Study|The study was terminated on 27APR2020 due to safety concerns. No subjects were enrolled into this group.|0
3362726|NCT04117607|4093805|FG010|STARTED|Overall Study|The study was terminated on 27APR2020 due to safety concerns. No subjects were enrolled into this group.|0
3362727|NCT04117607|4093806|FG011|STARTED|Overall Study|The study was terminated on 27APR2020 due to safety concerns. No subjects were enrolled into this group.|0
3362728|NCT04117607|4093807|FG012|STARTED|Overall Study|The study was terminated on 27APR2020 due to safety concerns. No subjects were enrolled into this group.|0
3362729|NCT04117607|4093808|FG013|STARTED|Overall Study|The study was terminated on 27APR2020 due to safety concerns. No subjects were enrolled into this group.|0
3362730|NCT04117607|4093795|FG000|Received Study Product|Overall Study||3
3362731|NCT04117607|4093796|FG001|Received Study Product|Overall Study||6
3362732|NCT04117607|4093797|FG002|Received Study Product|Overall Study||0
3362733|NCT04117607|4093798|FG003|Received Study Product|Overall Study||0
3362734|NCT04117607|4093799|FG004|Received Study Product|Overall Study||0
3362735|NCT04117607|4093800|FG005|Received Study Product|Overall Study||0
3362736|NCT04117607|4093801|FG006|Received Study Product|Overall Study||3
3362737|NCT04117607|4093802|FG007|Received Study Product|Overall Study||0
3362738|NCT04117607|4093803|FG008|Received Study Product|Overall Study||0
3362739|NCT04117607|4093804|FG009|Received Study Product|Overall Study||0
3362740|NCT04117607|4093805|FG010|Received Study Product|Overall Study||0
3362741|NCT04117607|4093806|FG011|Received Study Product|Overall Study||0
3362742|NCT04117607|4093807|FG012|Received Study Product|Overall Study||0
3362743|NCT04117607|4093808|FG013|Received Study Product|Overall Study||0
3362744|NCT04117607|4093795|FG000|Completed All PK Blood Draws|Overall Study||0
3362745|NCT04117607|4093796|FG001|Completed All PK Blood Draws|Overall Study||6
3362746|NCT04117607|4093797|FG002|Completed All PK Blood Draws|Overall Study||0
3362747|NCT04117607|4093798|FG003|Completed All PK Blood Draws|Overall Study||0
3362748|NCT04117607|4093799|FG004|Completed All PK Blood Draws|Overall Study||0
3362749|NCT04117607|4093800|FG005|Completed All PK Blood Draws|Overall Study||0
3362750|NCT04117607|4093801|FG006|Completed All PK Blood Draws|Overall Study||1
3362751|NCT04117607|4093802|FG007|Completed All PK Blood Draws|Overall Study||0
3362752|NCT04117607|4093803|FG008|Completed All PK Blood Draws|Overall Study||0
3362753|NCT04117607|4093804|FG009|Completed All PK Blood Draws|Overall Study||0
3362754|NCT04117607|4093805|FG010|Completed All PK Blood Draws|Overall Study||0
3362755|NCT04117607|4093806|FG011|Completed All PK Blood Draws|Overall Study||0
3362756|NCT04117607|4093807|FG012|Completed All PK Blood Draws|Overall Study||0
3362757|NCT04117607|4093808|FG013|Completed All PK Blood Draws|Overall Study||0
3362758|NCT04117607|4093795|FG000|COMPLETED|Overall Study||3
3362759|NCT04117607|4093796|FG001|COMPLETED|Overall Study||6
3362760|NCT04117607|4093797|FG002|COMPLETED|Overall Study||0
3362761|NCT04117607|4093798|FG003|COMPLETED|Overall Study||0
3362762|NCT04117607|4093799|FG004|COMPLETED|Overall Study||0
3362763|NCT04117607|4093800|FG005|COMPLETED|Overall Study||0
3362764|NCT04117607|4093801|FG006|COMPLETED|Overall Study||3
3362765|NCT04117607|4093802|FG007|COMPLETED|Overall Study||0
3362766|NCT04117607|4093803|FG008|COMPLETED|Overall Study||0
3362767|NCT04117607|4093804|FG009|COMPLETED|Overall Study||0
3362768|NCT04117607|4093805|FG010|COMPLETED|Overall Study||0
3362769|NCT04117607|4093806|FG011|COMPLETED|Overall Study||0
3362770|NCT04117607|4093807|FG012|COMPLETED|Overall Study||0
3362771|NCT04117607|4093808|FG013|COMPLETED|Overall Study||0
3362772|NCT04117607|4093795|FG000|NOT COMPLETED|Overall Study||0
3362773|NCT04117607|4093796|FG001|NOT COMPLETED|Overall Study||1
3362774|NCT04117607|4093797|FG002|NOT COMPLETED|Overall Study||0
3362775|NCT04117607|4093798|FG003|NOT COMPLETED|Overall Study||0
3362776|NCT04117607|4093799|FG004|NOT COMPLETED|Overall Study||0
3362777|NCT04117607|4093800|FG005|NOT COMPLETED|Overall Study||0
3362778|NCT04117607|4093801|FG006|NOT COMPLETED|Overall Study||1
3362779|NCT04117607|4093802|FG007|NOT COMPLETED|Overall Study||0
3362780|NCT04117607|4093803|FG008|NOT COMPLETED|Overall Study||0
3362781|NCT04117607|4093804|FG009|NOT COMPLETED|Overall Study||0
3362782|NCT04117607|4093805|FG010|NOT COMPLETED|Overall Study||0
3362783|NCT04117607|4093806|FG011|NOT COMPLETED|Overall Study||0
3362784|NCT04117607|4093807|FG012|NOT COMPLETED|Overall Study||0
3362785|NCT04117607|4093808|FG013|NOT COMPLETED|Overall Study||0
3362786|NCT04116684|4093826|FG000|STARTED|Overall Study||3
3362787|NCT04116684|4093827|FG001|STARTED|Overall Study||1
3362788|NCT04116684|4093826|FG000|COMPLETED|Overall Study||1
3362789|NCT04116684|4093827|FG001|COMPLETED|Overall Study||1
3362790|NCT04116684|4093826|FG000|NOT COMPLETED|Overall Study||2
3362791|NCT04116684|4093827|FG001|NOT COMPLETED|Overall Study||0
3362792|NCT04096365|4093833|FG000|STARTED|Overall Study||12
3362793|NCT04096365|4093833|FG000|COMPLETED|Overall Study||11
3362794|NCT04096365|4093833|FG000|NOT COMPLETED|Overall Study||1
3362795|NCT04080297|4093839|FG000|STARTED|Overall Study||10
3362796|NCT04080297|4093840|FG001|STARTED|Overall Study||11
3362797|NCT04080297|4093839|FG000|COMPLETED|Overall Study||8
3362798|NCT04080297|4093840|FG001|COMPLETED|Overall Study||8
3362799|NCT04080297|4093839|FG000|NOT COMPLETED|Overall Study||2
3362800|NCT04080297|4093840|FG001|NOT COMPLETED|Overall Study||3
3362801|NCT04115358|4093849|FG000|STARTED|Overall Study||34
3362802|NCT04115358|4093850|FG001|STARTED|Overall Study||33
3362803|NCT04115358|4093851|FG002|STARTED|Overall Study||34
3362804|NCT04115358|4093849|FG000|COMPLETED|Overall Study|34 participants 48 teeth for clinical assessment, 28 participants 35 teeth for radiographic assessment.|34
3362805|NCT04115358|4093850|FG001|COMPLETED|Overall Study|33 participants 40 teeth for clinical assessment, 26 participants 32 teeth for radiographic assessment.|33
3362806|NCT04115358|4093851|FG002|COMPLETED|Overall Study|34 participants 38 teeth for clinical assessment, 26 participants 31 teeth for radiographic assessment.|33
3362807|NCT04115358|4093849|FG000|NOT COMPLETED|Overall Study||0
3362808|NCT04115358|4093850|FG001|NOT COMPLETED|Overall Study||0
3362809|NCT04115358|4093851|FG002|NOT COMPLETED|Overall Study||1
3362810|NCT04114058|4093862|FG000|STARTED|Overall Study||20
3362811|NCT04114058|4093863|FG001|STARTED|Overall Study||17
3362812|NCT04114058|4093862|FG000|COMPLETED|Overall Study||20
3362813|NCT04114058|4093863|FG001|COMPLETED|Overall Study||17
3362814|NCT04114058|4093862|FG000|NOT COMPLETED|Overall Study||0
3362815|NCT04114058|4093863|FG001|NOT COMPLETED|Overall Study||0
3362816|NCT04113785|4093869|FG000|STARTED|Overall Study||21
3362817|NCT04113785|4093869|FG000|COMPLETED|Overall Study||21
3362818|NCT04113785|4093869|FG000|NOT COMPLETED|Overall Study||0
3362819|NCT04113694|4093875|FG000|STARTED|Overall Study||259
3362820|NCT04113694|4093875|FG000|COMPLETED|Overall Study||248
3362821|NCT04113694|4093875|FG000|NOT COMPLETED|Overall Study||11
3362822|NCT04112160|4093884|FG000|STARTED|Overall Study||63
3362823|NCT04112160|4093885|FG001|STARTED|Overall Study||62
3362824|NCT04112160|4093884|FG000|COMPLETED|Overall Study||62
3362825|NCT04112160|4093885|FG001|COMPLETED|Overall Study||62
3362826|NCT04112160|4093884|FG000|NOT COMPLETED|Overall Study||1
3362827|NCT04112160|4093885|FG001|NOT COMPLETED|Overall Study||0
3362828|NCT04112069|4093891|FG000|STARTED|Overall Study||10
3362829|NCT04112069|4093892|FG001|STARTED|Overall Study||10
3362830|NCT04112069|4093891|FG000|COMPLETED|Overall Study||10
3362831|NCT04112069|4093892|FG001|COMPLETED|Overall Study||10
3362832|NCT04112069|4093891|FG000|NOT COMPLETED|Overall Study||0
3362833|NCT04112069|4093892|FG001|NOT COMPLETED|Overall Study||0
3362834|NCT04109703|4093900|FG000|STARTED|Overall Study||49
3362835|NCT04109703|4093901|FG001|STARTED|Overall Study||51
3362836|NCT04109703|4093900|FG000|COMPLETED|Overall Study||49
3362837|NCT04109703|4093901|FG001|COMPLETED|Overall Study||51
3362838|NCT04109703|4093900|FG000|NOT COMPLETED|Overall Study||0
3362839|NCT04109703|4093901|FG001|NOT COMPLETED|Overall Study||0
3362840|NCT04109443|4093911|FG000|STARTED|Overall Study||77
3362841|NCT04109443|4093912|FG001|STARTED|Overall Study||77
3362842|NCT04109443|4093911|FG000|COMPLETED|Overall Study||67
3362843|NCT04109443|4093912|FG001|COMPLETED|Overall Study||65
3362844|NCT04109443|4093911|FG000|NOT COMPLETED|Overall Study||10
3362845|NCT04109443|4093912|FG001|NOT COMPLETED|Overall Study||12
3362846|NCT04109222|4093924|FG000|STARTED|Overall Study||30
3362847|NCT04109222|4093925|FG001|STARTED|Overall Study||30
3362848|NCT04109222|4093926|FG002|STARTED|Overall Study||30
3362849|NCT04109222|4093924|FG000|COMPLETED|Overall Study||29
3362850|NCT04109222|4093925|FG001|COMPLETED|Overall Study||30
3362851|NCT04109222|4093926|FG002|COMPLETED|Overall Study||30
3362852|NCT04109222|4093924|FG000|NOT COMPLETED|Overall Study||1
3362853|NCT04109222|4093925|FG001|NOT COMPLETED|Overall Study||0
3362854|NCT04109222|4093926|FG002|NOT COMPLETED|Overall Study||0
3362855|NCT04107493|4093934|FG000|STARTED|First Intervention (1 Hour)||16
3362856|NCT04107493|4093935|FG001|STARTED|First Intervention (1 Hour)||17
3362857|NCT04107493|4093934|FG000|COMPLETED|First Intervention (1 Hour)||16
3362858|NCT04107493|4093935|FG001|COMPLETED|First Intervention (1 Hour)||17
3362859|NCT04107493|4093934|FG000|NOT COMPLETED|First Intervention (1 Hour)||0
3362860|NCT04107493|4093935|FG001|NOT COMPLETED|First Intervention (1 Hour)||0
3362861|NCT04107493|4093934|FG000|STARTED|Washout (One Hour)||16
3362862|NCT04107493|4093935|FG001|STARTED|Washout (One Hour)||17
3362863|NCT04107493|4093934|FG000|COMPLETED|Washout (One Hour)||16
3362864|NCT04107493|4093935|FG001|COMPLETED|Washout (One Hour)||17
3362865|NCT04107493|4093934|FG000|NOT COMPLETED|Washout (One Hour)||0
3362866|NCT04107493|4093935|FG001|NOT COMPLETED|Washout (One Hour)||0
3362867|NCT04107493|4093934|FG000|STARTED|Second Intervention||16
3362868|NCT04107493|4093935|FG001|STARTED|Second Intervention||17
3362869|NCT04107493|4093934|FG000|COMPLETED|Second Intervention||16
3362870|NCT04107493|4093935|FG001|COMPLETED|Second Intervention||17
3362871|NCT04107493|4093934|FG000|NOT COMPLETED|Second Intervention||0
3362872|NCT04107493|4093935|FG001|NOT COMPLETED|Second Intervention||0
3362873|NCT04106817|4093944|FG000|STARTED|Overall Study||12
3362874|NCT04106817|4093945|FG001|STARTED|Overall Study||11
3362875|NCT04106817|4093946|FG002|STARTED|Overall Study||12
3362876|NCT04106817|4093944|FG000|COMPLETED|Overall Study||11
3362877|NCT04106817|4093945|FG001|COMPLETED|Overall Study||11
3362878|NCT04106817|4093946|FG002|COMPLETED|Overall Study||12
3362879|NCT04106817|4093944|FG000|NOT COMPLETED|Overall Study||1
3362880|NCT04106817|4093945|FG001|NOT COMPLETED|Overall Study||0
3362881|NCT04106817|4093946|FG002|NOT COMPLETED|Overall Study||0
3362882|NCT04105972|4093956|FG000|STARTED|Overall Study||88
3362883|NCT04105972|4093957|FG001|STARTED|Overall Study||87
3362884|NCT04105972|4093956|FG000|COMPLETED|Overall Study||86
3362885|NCT04105972|4093957|FG001|COMPLETED|Overall Study||86
3362886|NCT04105972|4093956|FG000|NOT COMPLETED|Overall Study||2
3362887|NCT04105972|4093957|FG001|NOT COMPLETED|Overall Study||1
3362888|NCT04105218|4093965|FG000|STARTED|Overall Study||6
3362889|NCT04105218|4093966|FG001|STARTED|Overall Study||6
3362890|NCT04105218|4093965|FG000|Completed First Condition|Overall Study||0
3362891|NCT04105218|4093966|FG001|Completed First Condition|Overall Study||1
3362892|NCT04105218|4093965|FG000|Completed Second Condition|Overall Study||0
3362893|NCT04105218|4093966|FG001|Completed Second Condition|Overall Study||0
3362894|NCT04105218|4093965|FG000|COMPLETED|Overall Study||0
3362895|NCT04105218|4093966|FG001|COMPLETED|Overall Study||0
3362896|NCT04105218|4093965|FG000|NOT COMPLETED|Overall Study||6
3362897|NCT04105218|4093966|FG001|NOT COMPLETED|Overall Study||6
3362898|NCT04102956|4093974|FG000|STARTED|Overall Study||42
3362899|NCT04102956|4093975|FG001|STARTED|Overall Study||38
3362900|NCT04102956|4093974|FG000|COMPLETED|Overall Study||42
3362901|NCT04102956|4093975|FG001|COMPLETED|Overall Study||38
3362902|NCT04102956|4093974|FG000|NOT COMPLETED|Overall Study||0
3362903|NCT04102956|4093975|FG001|NOT COMPLETED|Overall Study||0
3362904|NCT04102540|4093981|FG000|STARTED|Overall Study||32
3362905|NCT04102540|4093981|FG000|COMPLETED|Overall Study||24
3362906|NCT04102540|4093981|FG000|NOT COMPLETED|Overall Study||8
3362907|NCT04102345|4093987|FG000|STARTED|Overall Study||26
3362908|NCT04102345|4093988|FG001|STARTED|Overall Study||32
3362909|NCT04102345|4093987|FG000|COMPLETED|Overall Study||25
3362910|NCT04102345|4093988|FG001|COMPLETED|Overall Study||32
3362911|NCT04102345|4093987|FG000|NOT COMPLETED|Overall Study||1
3362912|NCT04102345|4093988|FG001|NOT COMPLETED|Overall Study||0
3362913|NCT04092907|4093996|FG000|STARTED|Overall Study||50
3362914|NCT04092907|4093997|FG001|STARTED|Overall Study||50
3362915|NCT04092907|4093996|FG000|COMPLETED|Overall Study||48
3362916|NCT04092907|4093997|FG001|COMPLETED|Overall Study||50
3362917|NCT04092907|4093996|FG000|NOT COMPLETED|Overall Study||2
3362918|NCT04092907|4093997|FG001|NOT COMPLETED|Overall Study||0
3362919|NCT04089982|4094005|FG000|STARTED|Overall Study||6
3362920|NCT04089982|4094006|FG001|STARTED|Overall Study||5
3362921|NCT04089982|4094005|FG000|COMPLETED|Overall Study||6
3362922|NCT04089982|4094006|FG001|COMPLETED|Overall Study||5
3362923|NCT04089982|4094005|FG000|NOT COMPLETED|Overall Study||0
3362924|NCT04089982|4094006|FG001|NOT COMPLETED|Overall Study||0
3362925|NCT04086433|4094014|FG000|STARTED|Overall Study||17
3362926|NCT04086433|4094015|FG001|STARTED|Overall Study||18
3362927|NCT04086433|4094014|FG000|COMPLETED|Overall Study||17
3362928|NCT04086433|4094015|FG001|COMPLETED|Overall Study||18
3362929|NCT04086433|4094014|FG000|NOT COMPLETED|Overall Study||0
3362930|NCT04086433|4094015|FG001|NOT COMPLETED|Overall Study||0
3362931|NCT04086407|4094021|FG000|STARTED|Overall Study||8
3362932|NCT04086407|4094021|FG000|COMPLETED|Overall Study||8
3362933|NCT04086407|4094021|FG000|NOT COMPLETED|Overall Study||0
3362934|NCT04099277|4094028|FG000|STARTED|Overall Study||2
3362935|NCT04099277|4094028|FG000|Received at Least 1 Dose of Study Drug|Overall Study||2
3362936|NCT04099277|4094028|FG000|COMPLETED|Overall Study||0
3362937|NCT04099277|4094028|FG000|NOT COMPLETED|Overall Study||2
3362938|NCT04098809|4094034|FG000|STARTED|Overall Study||27
3362939|NCT04098809|4094035|FG001|STARTED|Overall Study||25
3362940|NCT04098809|4094034|FG000|COMPLETED|Overall Study||24
3362941|NCT04098809|4094035|FG001|COMPLETED|Overall Study||21
3362942|NCT04098809|4094034|FG000|NOT COMPLETED|Overall Study||3
3362943|NCT04098809|4094035|FG001|NOT COMPLETED|Overall Study||4
3362944|NCT04098575|4094044|FG000|STARTED|Overall Study||505
3362945|NCT04098575|4094045|FG001|STARTED|Overall Study||2961
3362946|NCT04098575|4094046|FG002|STARTED|Overall Study||6105
3362947|NCT04098575|4094044|FG000|COMPLETED|Overall Study||505
3362948|NCT04098575|4094045|FG001|COMPLETED|Overall Study||2961
3362949|NCT04098575|4094046|FG002|COMPLETED|Overall Study||6105
3362950|NCT04098575|4094044|FG000|NOT COMPLETED|Overall Study||0
3362951|NCT04098575|4094045|FG001|NOT COMPLETED|Overall Study||0
3362952|NCT04098575|4094046|FG002|NOT COMPLETED|Overall Study||0
3362953|NCT04098458|4094054|FG000|STARTED|Overall Study||18
3362954|NCT04098458|4094054|FG000|COMPLETED|Overall Study||14
3362955|NCT04098458|4094054|FG000|NOT COMPLETED|Overall Study||4
3362956|NCT04095286|4094059|FG000|STARTED|Period 1 (4 Days) + Washout (7days)||4
3362957|NCT04095286|4094060|FG001|STARTED|Period 1 (4 Days) + Washout (7days)||5
3362958|NCT04095286|4094061|FG002|STARTED|Period 1 (4 Days) + Washout (7days)||5
3362959|NCT04095286|4094062|FG003|STARTED|Period 1 (4 Days) + Washout (7days)||5
3362960|NCT04095286|4094063|FG004|STARTED|Period 1 (4 Days) + Washout (7days)||5
3362961|NCT04095286|4094064|FG005|STARTED|Period 1 (4 Days) + Washout (7days)||5
3362962|NCT04095286|4094059|FG000|COMPLETED|Period 1 (4 Days) + Washout (7days)||3
3362963|NCT04095286|4094060|FG001|COMPLETED|Period 1 (4 Days) + Washout (7days)||4
3362964|NCT04095286|4094061|FG002|COMPLETED|Period 1 (4 Days) + Washout (7days)||4
3362965|NCT04095286|4094062|FG003|COMPLETED|Period 1 (4 Days) + Washout (7days)||5
3362966|NCT04095286|4094063|FG004|COMPLETED|Period 1 (4 Days) + Washout (7days)||5
3362967|NCT04095286|4094064|FG005|COMPLETED|Period 1 (4 Days) + Washout (7days)||5
3362968|NCT04095286|4094059|FG000|NOT COMPLETED|Period 1 (4 Days) + Washout (7days)||1
3362969|NCT04095286|4094060|FG001|NOT COMPLETED|Period 1 (4 Days) + Washout (7days)||1
3362970|NCT04095286|4094061|FG002|NOT COMPLETED|Period 1 (4 Days) + Washout (7days)||1
3362971|NCT04095286|4094062|FG003|NOT COMPLETED|Period 1 (4 Days) + Washout (7days)||0
3362972|NCT04095286|4094063|FG004|NOT COMPLETED|Period 1 (4 Days) + Washout (7days)||0
3362973|NCT04095286|4094064|FG005|NOT COMPLETED|Period 1 (4 Days) + Washout (7days)||0
3362974|NCT04095286|4094059|FG000|STARTED|Period 2 (4 Days) + Washout (7days)||3
3362975|NCT04095286|4094060|FG001|STARTED|Period 2 (4 Days) + Washout (7days)||4
3362976|NCT04095286|4094061|FG002|STARTED|Period 2 (4 Days) + Washout (7days)||4
3362977|NCT04095286|4094062|FG003|STARTED|Period 2 (4 Days) + Washout (7days)||5
3362978|NCT04095286|4094063|FG004|STARTED|Period 2 (4 Days) + Washout (7days)||5
3362979|NCT04095286|4094064|FG005|STARTED|Period 2 (4 Days) + Washout (7days)||5
3362980|NCT04095286|4094059|FG000|COMPLETED|Period 2 (4 Days) + Washout (7days)||3
3362981|NCT04095286|4094060|FG001|COMPLETED|Period 2 (4 Days) + Washout (7days)||4
3362982|NCT04095286|4094061|FG002|COMPLETED|Period 2 (4 Days) + Washout (7days)||2
3362983|NCT04095286|4094062|FG003|COMPLETED|Period 2 (4 Days) + Washout (7days)||5
3362984|NCT04095286|4094063|FG004|COMPLETED|Period 2 (4 Days) + Washout (7days)||4
3362985|NCT04095286|4094064|FG005|COMPLETED|Period 2 (4 Days) + Washout (7days)||5
3362986|NCT04095286|4094059|FG000|NOT COMPLETED|Period 2 (4 Days) + Washout (7days)||0
3362987|NCT04095286|4094060|FG001|NOT COMPLETED|Period 2 (4 Days) + Washout (7days)||0
3362988|NCT04095286|4094061|FG002|NOT COMPLETED|Period 2 (4 Days) + Washout (7days)||2
3362989|NCT04095286|4094062|FG003|NOT COMPLETED|Period 2 (4 Days) + Washout (7days)||0
3362990|NCT04095286|4094063|FG004|NOT COMPLETED|Period 2 (4 Days) + Washout (7days)||1
3362991|NCT04095286|4094064|FG005|NOT COMPLETED|Period 2 (4 Days) + Washout (7days)||0
3362992|NCT04095286|4094059|FG000|STARTED|Period 3 (4 Days) + Follow up (14 Days)||3
3362993|NCT04095286|4094060|FG001|STARTED|Period 3 (4 Days) + Follow up (14 Days)||4
3362994|NCT04095286|4094061|FG002|STARTED|Period 3 (4 Days) + Follow up (14 Days)||2
3362995|NCT04095286|4094062|FG003|STARTED|Period 3 (4 Days) + Follow up (14 Days)||5
3362996|NCT04095286|4094063|FG004|STARTED|Period 3 (4 Days) + Follow up (14 Days)||4
3362997|NCT04095286|4094064|FG005|STARTED|Period 3 (4 Days) + Follow up (14 Days)||5
3362998|NCT04095286|4094059|FG000|COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||3
3362999|NCT04095286|4094060|FG001|COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||4
3363000|NCT04095286|4094061|FG002|COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||2
3363001|NCT04095286|4094062|FG003|COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||5
3363002|NCT04095286|4094063|FG004|COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||4
3363003|NCT04095286|4094064|FG005|COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||5
3363004|NCT04095286|4094059|FG000|NOT COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||0
3363005|NCT04095286|4094060|FG001|NOT COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||0
3363006|NCT04095286|4094061|FG002|NOT COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||0
3363007|NCT04095286|4094062|FG003|NOT COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||0
3363008|NCT04095286|4094063|FG004|NOT COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||0
3363009|NCT04095286|4094064|FG005|NOT COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||0
3363010|NCT04094883|4094072|FG000|STARTED|Overall Study||11
3363011|NCT04094883|4094072|FG000|COMPLETED|Overall Study||10
3363012|NCT04094883|4094072|FG000|NOT COMPLETED|Overall Study||1
3363013|NCT04091659|4094078|FG000|STARTED|Overall Study||40
3363014|NCT04091659|4094079|FG001|STARTED|Overall Study||58
3363015|NCT04091659|4094078|FG000|COMPLETED|Overall Study||37
3363016|NCT04091659|4094079|FG001|COMPLETED|Overall Study||57
3363017|NCT04091659|4094078|FG000|NOT COMPLETED|Overall Study||3
3363018|NCT04091659|4094079|FG001|NOT COMPLETED|Overall Study||1
3363019|NCT04091061|4094089|FG000|STARTED|Overall Study||6
3363020|NCT04091061|4094090|FG001|STARTED|Overall Study||6
3363021|NCT04091061|4094091|FG002|STARTED|Overall Study||6
3363022|NCT04091061|4094092|FG003|STARTED|Overall Study||6
3363023|NCT04091061|4094089|FG000|COMPLETED|Overall Study||6
3363024|NCT04091061|4094090|FG001|COMPLETED|Overall Study||6
3363025|NCT04091061|4094091|FG002|COMPLETED|Overall Study||6
3363026|NCT04091061|4094092|FG003|COMPLETED|Overall Study||6
3363027|NCT04091061|4094089|FG000|NOT COMPLETED|Overall Study||0
3363028|NCT04091061|4094090|FG001|NOT COMPLETED|Overall Study||0
3363029|NCT04091061|4094091|FG002|NOT COMPLETED|Overall Study||0
3363030|NCT04091061|4094092|FG003|NOT COMPLETED|Overall Study||0
3363031|NCT04090242|4094104|FG000|STARTED|Overall Study||28
3363032|NCT04090242|4094105|FG001|STARTED|Overall Study||30
3363033|NCT04090242|4094104|FG000|COMPLETED|Overall Study||27
3363034|NCT04090242|4094105|FG001|COMPLETED|Overall Study||30
3363035|NCT04090242|4094104|FG000|NOT COMPLETED|Overall Study||1
3363036|NCT04090242|4094105|FG001|NOT COMPLETED|Overall Study||0
3363037|NCT04089761|4094112|FG000|STARTED|"Run In Phase"||60
3179454|NCT01985425|3907630|FG000|NOT COMPLETED|Overall Study||0
3179455|NCT01985425|3907631|FG001|NOT COMPLETED|Overall Study||0
3179456|NCT01985542|3907639|FG000|STARTED|Overall Study||7
3363038|NCT04089761|4094112|FG000|COMPLETED|"Run In Phase"||45
3363039|NCT04089761|4094112|FG000|NOT COMPLETED|"Run In Phase"||15
3363040|NCT04089761|4094112|FG000|STARTED|"Treatment Phase"||45
3363041|NCT04089761|4094112|FG000|COMPLETED|"Treatment Phase"||39
3363042|NCT04089761|4094112|FG000|NOT COMPLETED|"Treatment Phase"||6
3363043|NCT04089761|4094112|FG000|STARTED|"Follow Up Phase (Optional)"|"Due to the COVID-19 pandemic, Only 27 participants were able to continue to the folllow Up phase"|27
3363044|NCT04089761|4094112|FG000|COMPLETED|"Follow Up Phase (Optional)"||27
3363045|NCT04089761|4094112|FG000|NOT COMPLETED|"Follow Up Phase (Optional)"||0
3363046|NCT04079803|4094119|FG000|STARTED|Overall Study||22
3363047|NCT04079803|4094120|FG001|STARTED|Overall Study||21
3363048|NCT04079803|4094121|FG002|STARTED|Overall Study||21
3363049|NCT04079803|4094119|FG000|COMPLETED|Overall Study||22
3363050|NCT04079803|4094120|FG001|COMPLETED|Overall Study||21
3363051|NCT04079803|4094121|FG002|COMPLETED|Overall Study||20
3363052|NCT04079803|4094119|FG000|NOT COMPLETED|Overall Study||0
3363053|NCT04079803|4094120|FG001|NOT COMPLETED|Overall Study||0
3363054|NCT04079803|4094121|FG002|NOT COMPLETED|Overall Study||1
3363055|NCT04087343|4094145|FG000|STARTED|Overall Study||4
3363056|NCT04087343|4094146|FG001|STARTED|Overall Study||5
3363057|NCT04087343|4094145|FG000|COMPLETED|Overall Study||4
3363058|NCT04087343|4094146|FG001|COMPLETED|Overall Study||5
3363059|NCT04087343|4094145|FG000|NOT COMPLETED|Overall Study||0
3363060|NCT04087343|4094146|FG001|NOT COMPLETED|Overall Study||0
3363061|NCT04087122|4094152|FG000|STARTED|Overall Study||20
3363062|NCT04087122|4094152|FG000|COMPLETED|Overall Study||20
3363063|NCT04087122|4094152|FG000|NOT COMPLETED|Overall Study||0
3363064|NCT04084769|4094160|FG000|STARTED|Overall Study||191
2928343|NCT00576901|3639221|FG000|STARTED|Overall Study||23
2928344|NCT00576901|3639221|FG000|COMPLETED|Overall Study||20
2928345|NCT00576901|3639221|FG000|NOT COMPLETED|Overall Study||3
2928346|NCT00576927|3639227|FG000|STARTED|Clinical Assessment||79
2928347|NCT00576927|3639227|FG000|COMPLETED|Clinical Assessment||43
2928348|NCT00576927|3639227|FG000|NOT COMPLETED|Clinical Assessment||36
2928349|NCT00576927|3639227|FG000|STARTED|Baseline||43
2928350|NCT00576927|3639227|FG000|COMPLETED|Baseline||30
2928351|NCT00576927|3639227|FG000|NOT COMPLETED|Baseline||13
2928352|NCT00576927|3639227|FG000|STARTED|Sleep Hygiene Behavioral Intervention||30
2928353|NCT00576927|3639227|FG000|COMPLETED|Sleep Hygiene Behavioral Intervention||23
3363065|NCT04084769|4094161|FG001|STARTED|Overall Study||190
3363066|NCT04084769|4094162|FG002|STARTED|Overall Study||95
3363067|NCT04084769|4094163|FG003|STARTED|Overall Study||94
3363068|NCT04084769|4094160|FG000|Safety Analysis Set (SAfAS)|Overall Study||186
3363069|NCT04084769|4094161|FG001|Safety Analysis Set (SAfAS)|Overall Study||184
3363070|NCT04084769|4094162|FG002|Safety Analysis Set (SAfAS)|Overall Study||93
3363071|NCT04084769|4094163|FG003|Safety Analysis Set (SAfAS)|Overall Study||92
3363072|NCT04084769|4094160|FG000|Full Analysis Set|Overall Study||191
3363073|NCT04084769|4094161|FG001|Full Analysis Set|Overall Study||190
3363074|NCT04084769|4094162|FG002|Full Analysis Set|Overall Study||95
3363075|NCT04084769|4094163|FG003|Full Analysis Set|Overall Study||94
3363076|NCT04084769|4094160|FG000|Per-Protocol Analysis Set 1 (PPAS1)|Overall Study||46
3363077|NCT04084769|4094161|FG001|Per-Protocol Analysis Set 1 (PPAS1)|Overall Study||45
3363078|NCT04084769|4094162|FG002|Per-Protocol Analysis Set 1 (PPAS1)|Overall Study||0
3363079|NCT04084769|4094163|FG003|Per-Protocol Analysis Set 1 (PPAS1)|Overall Study||0
3363080|NCT04084769|4094160|FG000|Per-Protocol Analysis Set 2 (PPAS2)|Overall Study||174
3363081|NCT04084769|4094161|FG001|Per-Protocol Analysis Set 2 (PPAS2)|Overall Study||176
3363082|NCT04084769|4094162|FG002|Per-Protocol Analysis Set 2 (PPAS2)|Overall Study||90
3363083|NCT04084769|4094163|FG003|Per-Protocol Analysis Set 2 (PPAS2)|Overall Study||89
3363084|NCT04084769|4094160|FG000|COMPLETED|Overall Study||187
3363085|NCT04084769|4094161|FG001|COMPLETED|Overall Study||186
3363086|NCT04084769|4094162|FG002|COMPLETED|Overall Study||95
3363087|NCT04084769|4094163|FG003|COMPLETED|Overall Study||92
3363088|NCT04084769|4094160|FG000|NOT COMPLETED|Overall Study||4
3363089|NCT04084769|4094161|FG001|NOT COMPLETED|Overall Study||4
3363090|NCT04084769|4094162|FG002|NOT COMPLETED|Overall Study||0
3363091|NCT04084769|4094163|FG003|NOT COMPLETED|Overall Study||2
3363092|NCT04086576|4094180|FG000|STARTED|Overall Study||10
3363093|NCT04086576|4094181|FG001|STARTED|Overall Study||10
3363094|NCT04086576|4094180|FG000|COMPLETED|Overall Study||10
3363095|NCT04086576|4094181|FG001|COMPLETED|Overall Study||10
3363096|NCT04086576|4094180|FG000|NOT COMPLETED|Overall Study||0
3363097|NCT04086576|4094181|FG001|NOT COMPLETED|Overall Study||0
3363098|NCT04086641|4094199|FG000|STARTED|Foot 1 (Two Week Utilization)||2
3363099|NCT04086641|4094200|FG001|STARTED|Foot 1 (Two Week Utilization)||3
3363100|NCT04086641|4094199|FG000|COMPLETED|Foot 1 (Two Week Utilization)||1
3363101|NCT04086641|4094200|FG001|COMPLETED|Foot 1 (Two Week Utilization)||1
3363102|NCT04086641|4094199|FG000|NOT COMPLETED|Foot 1 (Two Week Utilization)||1
3363103|NCT04086641|4094200|FG001|NOT COMPLETED|Foot 1 (Two Week Utilization)||2
3363104|NCT04086641|4094199|FG000|STARTED|Foot 2 (Two Week Utilization)||1
3363105|NCT04086641|4094200|FG001|STARTED|Foot 2 (Two Week Utilization)||1
3363106|NCT04086641|4094199|FG000|COMPLETED|Foot 2 (Two Week Utilization)||1
3363107|NCT04086641|4094200|FG001|COMPLETED|Foot 2 (Two Week Utilization)||1
3363108|NCT04086641|4094199|FG000|NOT COMPLETED|Foot 2 (Two Week Utilization)||0
3363109|NCT04086641|4094200|FG001|NOT COMPLETED|Foot 2 (Two Week Utilization)||0
3363110|NCT04080882|4094208|FG000|STARTED|Overall Study||20
3363111|NCT04080882|4094209|FG001|STARTED|Overall Study||60
3363112|NCT04080882|4094208|FG000|COMPLETED|Overall Study||18
3363113|NCT04080882|4094209|FG001|COMPLETED|Overall Study||58
3363114|NCT04080882|4094208|FG000|NOT COMPLETED|Overall Study||2
3363115|NCT04080882|4094209|FG001|NOT COMPLETED|Overall Study||2
3363116|NCT04086472|4094220|FG000|STARTED|Overall Study||16
3363117|NCT04086472|4094221|FG001|STARTED|Overall Study||16
3363118|NCT04086472|4094222|FG002|STARTED|Overall Study||16
3363119|NCT04086472|4094223|FG003|STARTED|Overall Study||16
3363120|NCT04086472|4094224|FG004|STARTED|Overall Study||16
3363121|NCT04086472|4094220|FG000|Received MK-1654 or Placebo|Overall Study||16
3363122|NCT04086472|4094221|FG001|Received MK-1654 or Placebo|Overall Study||16
3363123|NCT04086472|4094222|FG002|Received MK-1654 or Placebo|Overall Study||16
3363124|NCT04086472|4094223|FG003|Received MK-1654 or Placebo|Overall Study||16
3363125|NCT04086472|4094224|FG004|Received MK-1654 or Placebo|Overall Study||16
3363126|NCT04086472|4094220|FG000|Inoculated With Respiratory Syncytial Virus (RSV) A Memphis 37b|Overall Study||14
3363127|NCT04086472|4094221|FG001|Inoculated With Respiratory Syncytial Virus (RSV) A Memphis 37b|Overall Study||14
3363128|NCT04086472|4094222|FG002|Inoculated With Respiratory Syncytial Virus (RSV) A Memphis 37b|Overall Study||14
3363129|NCT04086472|4094223|FG003|Inoculated With Respiratory Syncytial Virus (RSV) A Memphis 37b|Overall Study||13
3363130|NCT04086472|4094224|FG004|Inoculated With Respiratory Syncytial Virus (RSV) A Memphis 37b|Overall Study||15
3363131|NCT04086472|4094220|FG000|Not Inoculated|Overall Study||2
3363132|NCT04086472|4094221|FG001|Not Inoculated|Overall Study||2
3363133|NCT04086472|4094222|FG002|Not Inoculated|Overall Study||2
3363134|NCT04086472|4094223|FG003|Not Inoculated|Overall Study||3
3363135|NCT04086472|4094224|FG004|Not Inoculated|Overall Study||1
3363136|NCT04086472|4094220|FG000|COMPLETED|Overall Study||12
3363137|NCT04086472|4094221|FG001|COMPLETED|Overall Study||14
3363138|NCT04086472|4094222|FG002|COMPLETED|Overall Study||14
3363139|NCT04086472|4094223|FG003|COMPLETED|Overall Study||13
3363140|NCT04086472|4094224|FG004|COMPLETED|Overall Study||14
3363141|NCT04086472|4094220|FG000|NOT COMPLETED|Overall Study||4
3363142|NCT04086472|4094221|FG001|NOT COMPLETED|Overall Study||2
3363143|NCT04086472|4094222|FG002|NOT COMPLETED|Overall Study||2
3363144|NCT04086472|4094223|FG003|NOT COMPLETED|Overall Study||3
3363145|NCT04086472|4094224|FG004|NOT COMPLETED|Overall Study||2
3363146|NCT04085289|4094239|FG000|STARTED|Overall Study||6
3363147|NCT04085289|4094240|FG001|STARTED|Overall Study||12
3363148|NCT04085289|4094241|FG002|STARTED|Overall Study||12
3363149|NCT04085289|4094239|FG000|Received at Least One Dose of Study Drug|Overall Study||6
3363150|NCT04085289|4094240|FG001|Received at Least One Dose of Study Drug|Overall Study||12
3363151|NCT04085289|4094241|FG002|Received at Least One Dose of Study Drug|Overall Study||12
3363152|NCT04085289|4094239|FG000|COMPLETED|Overall Study||6
3363153|NCT04085289|4094240|FG001|COMPLETED|Overall Study||12
3363154|NCT04085289|4094241|FG002|COMPLETED|Overall Study||11
3363155|NCT04085289|4094239|FG000|NOT COMPLETED|Overall Study||0
3363156|NCT04085289|4094240|FG001|NOT COMPLETED|Overall Study||0
3363157|NCT04085289|4094241|FG002|NOT COMPLETED|Overall Study||1
3363158|NCT04084015|4094248|FG000|STARTED|Overall Study||2
3363159|NCT04084015|4094248|FG000|COMPLETED|Overall Study||2
3363160|NCT04084015|4094248|FG000|NOT COMPLETED|Overall Study||0
3363161|NCT04082663|4094252|FG000|STARTED|Overall Study||20
3363162|NCT04082663|4094252|FG000|COMPLETED|Overall Study||13
3363163|NCT04082663|4094252|FG000|NOT COMPLETED|Overall Study||7
3363164|NCT04084028|4094260|FG000|STARTED|Overall Study||18
3363165|NCT04084028|4094261|FG001|STARTED|Overall Study||16
3363166|NCT04084028|4094262|FG002|STARTED|Overall Study||9
3363167|NCT04084028|4094263|FG003|STARTED|Overall Study||10
3363168|NCT04084028|4094260|FG000|COMPLETED|Overall Study||18
3363169|NCT04084028|4094261|FG001|COMPLETED|Overall Study||16
3363170|NCT04084028|4094262|FG002|COMPLETED|Overall Study||9
3363171|NCT04084028|4094263|FG003|COMPLETED|Overall Study||10
3363172|NCT04084028|4094260|FG000|NOT COMPLETED|Overall Study||0
3363173|NCT04084028|4094261|FG001|NOT COMPLETED|Overall Study||0
3363174|NCT04084028|4094262|FG002|NOT COMPLETED|Overall Study||0
3363175|NCT04084028|4094263|FG003|NOT COMPLETED|Overall Study||0
3363176|NCT04082819|4094278|FG000|STARTED|Overall Study||37
3363177|NCT04082819|4094279|FG001|STARTED|Overall Study||54
3363178|NCT04082819|4094280|FG002|STARTED|Overall Study||3
3363179|NCT04082819|4094278|FG000|COMPLETED|Overall Study||37
3363180|NCT04082819|4094279|FG001|COMPLETED|Overall Study||54
3363181|NCT04082819|4094280|FG002|COMPLETED|Overall Study||3
3363182|NCT04082819|4094278|FG000|NOT COMPLETED|Overall Study||0
3363183|NCT04082819|4094279|FG001|NOT COMPLETED|Overall Study||0
3363184|NCT04082819|4094280|FG002|NOT COMPLETED|Overall Study||0
3363185|NCT04081961|4094294|FG000|STARTED|Overall Study||9
3363186|NCT04081961|4094295|FG001|STARTED|Overall Study||9
3363187|NCT04081961|4094296|FG002|STARTED|Overall Study||9
3363188|NCT04081961|4094294|FG000|COMPLETED|Overall Study||9
3363189|NCT04081961|4094295|FG001|COMPLETED|Overall Study||9
3363190|NCT04081961|4094296|FG002|COMPLETED|Overall Study||9
3363191|NCT04081961|4094294|FG000|NOT COMPLETED|Overall Study||0
3040090|NCT01162239|3759541|FG003|NOT COMPLETED|Extended Follow-up||6
3040091|NCT01162317|3759554|FG000|STARTED|Overall Study||30
3040092|NCT01162317|3759555|FG001|STARTED|Overall Study||30
3040093|NCT01162317|3759554|FG000|COMPLETED|Overall Study||27
3040094|NCT01162317|3759555|FG001|COMPLETED|Overall Study||28
3040095|NCT01162317|3759554|FG000|NOT COMPLETED|Overall Study||3
3040096|NCT01162317|3759555|FG001|NOT COMPLETED|Overall Study||2
3040097|NCT01162343|3759561|FG000|STARTED|Overall Study||498
3040098|NCT01162343|3759561|FG000|COMPLETED|Overall Study||406
3363192|NCT04081961|4094295|FG001|NOT COMPLETED|Overall Study||0
3363193|NCT04081961|4094296|FG002|NOT COMPLETED|Overall Study||0
3363194|NCT04081610|4094306|FG000|STARTED|Overall Study||16
3363195|NCT04081610|4094307|FG001|STARTED|Overall Study||18
3363196|NCT04081610|4094306|FG000|COMPLETED|Overall Study||16
3363197|NCT04081610|4094307|FG001|COMPLETED|Overall Study||18
3363198|NCT04081610|4094306|FG000|NOT COMPLETED|Overall Study||0
3363199|NCT04081610|4094307|FG001|NOT COMPLETED|Overall Study||0
3363200|NCT04081324|4094317|FG000|STARTED|Overall Study||6
3363201|NCT04081324|4094318|FG001|STARTED|Overall Study||10
3363202|NCT04081324|4094319|FG002|STARTED|Overall Study||10
3363203|NCT04081324|4094320|FG003|STARTED|Overall Study||10
3363204|NCT04081324|4094317|FG000|Received At Least One Dose of Study Drug|Overall Study||6
3363205|NCT04081324|4094318|FG001|Received At Least One Dose of Study Drug|Overall Study||10
3363206|NCT04081324|4094319|FG002|Received At Least One Dose of Study Drug|Overall Study||10
3363207|NCT04081324|4094320|FG003|Received At Least One Dose of Study Drug|Overall Study||10
3363208|NCT04081324|4094317|FG000|COMPLETED|Overall Study||6
3363209|NCT04081324|4094318|FG001|COMPLETED|Overall Study||10
3363210|NCT04081324|4094319|FG002|COMPLETED|Overall Study||10
3363211|NCT04081324|4094320|FG003|COMPLETED|Overall Study||10
3363212|NCT04081324|4094317|FG000|NOT COMPLETED|Overall Study||0
3363213|NCT04081324|4094318|FG001|NOT COMPLETED|Overall Study||0
3363214|NCT04081324|4094319|FG002|NOT COMPLETED|Overall Study||0
3363215|NCT04081324|4094320|FG003|NOT COMPLETED|Overall Study||0
3363216|NCT04079790|4094333|FG000|STARTED|Part 1, Period 1(Day 1 to Day 4)||14
3363217|NCT04079790|4094334|FG001|STARTED|Part 1, Period 1(Day 1 to Day 4)||2
3363218|NCT04079790|4094335|FG002|STARTED|Part 1, Period 1(Day 1 to Day 4)||0
3363219|NCT04079790|4094336|FG003|STARTED|Part 1, Period 1(Day 1 to Day 4)||0
3363220|NCT04079790|4094333|FG000|COMPLETED|Part 1, Period 1(Day 1 to Day 4)||13
3363221|NCT04079790|4094334|FG001|COMPLETED|Part 1, Period 1(Day 1 to Day 4)||2
3363222|NCT04079790|4094335|FG002|COMPLETED|Part 1, Period 1(Day 1 to Day 4)||0
3363223|NCT04079790|4094336|FG003|COMPLETED|Part 1, Period 1(Day 1 to Day 4)||0
3363224|NCT04079790|4094333|FG000|NOT COMPLETED|Part 1, Period 1(Day 1 to Day 4)||1
3363225|NCT04079790|4094334|FG001|NOT COMPLETED|Part 1, Period 1(Day 1 to Day 4)||0
3363226|NCT04079790|4094335|FG002|NOT COMPLETED|Part 1, Period 1(Day 1 to Day 4)||0
3363227|NCT04079790|4094336|FG003|NOT COMPLETED|Part 1, Period 1(Day 1 to Day 4)||0
3363228|NCT04079790|4094333|FG000|STARTED|Part 1, Period 2 (Day 5 to Day 8)||13
3363229|NCT04079790|4094334|FG001|STARTED|Part 1, Period 2 (Day 5 to Day 8)||2
3363230|NCT04079790|4094335|FG002|STARTED|Part 1, Period 2 (Day 5 to Day 8)||0
3363231|NCT04079790|4094336|FG003|STARTED|Part 1, Period 2 (Day 5 to Day 8)||0
3363232|NCT04079790|4094333|FG000|COMPLETED|Part 1, Period 2 (Day 5 to Day 8)||13
3363233|NCT04079790|4094334|FG001|COMPLETED|Part 1, Period 2 (Day 5 to Day 8)||2
3363234|NCT04079790|4094335|FG002|COMPLETED|Part 1, Period 2 (Day 5 to Day 8)||0
3363235|NCT04079790|4094336|FG003|COMPLETED|Part 1, Period 2 (Day 5 to Day 8)||0
3363236|NCT04079790|4094333|FG000|NOT COMPLETED|Part 1, Period 2 (Day 5 to Day 8)||0
3363237|NCT04079790|4094334|FG001|NOT COMPLETED|Part 1, Period 2 (Day 5 to Day 8)||0
3363238|NCT04079790|4094335|FG002|NOT COMPLETED|Part 1, Period 2 (Day 5 to Day 8)||0
3363239|NCT04079790|4094336|FG003|NOT COMPLETED|Part 1, Period 2 (Day 5 to Day 8)||0
3363240|NCT04079790|4094333|FG000|STARTED|Part 1, Period 3 (Day 9 to Day 11)||13
3363241|NCT04079790|4094334|FG001|STARTED|Part 1, Period 3 (Day 9 to Day 11)||2
3363242|NCT04079790|4094335|FG002|STARTED|Part 1, Period 3 (Day 9 to Day 11)||0
3363243|NCT04079790|4094336|FG003|STARTED|Part 1, Period 3 (Day 9 to Day 11)||0
3363244|NCT04079790|4094333|FG000|COMPLETED|Part 1, Period 3 (Day 9 to Day 11)||13
3363245|NCT04079790|4094334|FG001|COMPLETED|Part 1, Period 3 (Day 9 to Day 11)||2
3363246|NCT04079790|4094335|FG002|COMPLETED|Part 1, Period 3 (Day 9 to Day 11)||0
3363247|NCT04079790|4094336|FG003|COMPLETED|Part 1, Period 3 (Day 9 to Day 11)||0
3363248|NCT04079790|4094333|FG000|NOT COMPLETED|Part 1, Period 3 (Day 9 to Day 11)||0
3363249|NCT04079790|4094334|FG001|NOT COMPLETED|Part 1, Period 3 (Day 9 to Day 11)||0
3363250|NCT04079790|4094335|FG002|NOT COMPLETED|Part 1, Period 3 (Day 9 to Day 11)||0
3363251|NCT04079790|4094336|FG003|NOT COMPLETED|Part 1, Period 3 (Day 9 to Day 11)||0
3363252|NCT04079790|4094333|FG000|STARTED|Part 2, Period 1 (Day 1 to Day 3)||0
3363253|NCT04079790|4094334|FG001|STARTED|Part 2, Period 1 (Day 1 to Day 3)||0
3363254|NCT04079790|4094335|FG002|STARTED|Part 2, Period 1 (Day 1 to Day 3)||15
3363255|NCT04079790|4094336|FG003|STARTED|Part 2, Period 1 (Day 1 to Day 3)||3
3363256|NCT04079790|4094333|FG000|COMPLETED|Part 2, Period 1 (Day 1 to Day 3)||0
3363257|NCT04079790|4094334|FG001|COMPLETED|Part 2, Period 1 (Day 1 to Day 3)||0
3363258|NCT04079790|4094335|FG002|COMPLETED|Part 2, Period 1 (Day 1 to Day 3)||12
3363259|NCT04079790|4094336|FG003|COMPLETED|Part 2, Period 1 (Day 1 to Day 3)||3
3363260|NCT04079790|4094333|FG000|NOT COMPLETED|Part 2, Period 1 (Day 1 to Day 3)||0
3363261|NCT04079790|4094334|FG001|NOT COMPLETED|Part 2, Period 1 (Day 1 to Day 3)||0
3363262|NCT04079790|4094335|FG002|NOT COMPLETED|Part 2, Period 1 (Day 1 to Day 3)||3
3363263|NCT04079790|4094336|FG003|NOT COMPLETED|Part 2, Period 1 (Day 1 to Day 3)||0
3363264|NCT04079790|4094333|FG000|STARTED|Part 2, Period 2 (Day 1 to Day 3)||0
3363265|NCT04079790|4094334|FG001|STARTED|Part 2, Period 2 (Day 1 to Day 3)||0
3363266|NCT04079790|4094335|FG002|STARTED|Part 2, Period 2 (Day 1 to Day 3)||12
3363267|NCT04079790|4094336|FG003|STARTED|Part 2, Period 2 (Day 1 to Day 3)||3
3363268|NCT04079790|4094333|FG000|COMPLETED|Part 2, Period 2 (Day 1 to Day 3)||0
3363269|NCT04079790|4094334|FG001|COMPLETED|Part 2, Period 2 (Day 1 to Day 3)||0
3363270|NCT04079790|4094335|FG002|COMPLETED|Part 2, Period 2 (Day 1 to Day 3)||12
3363271|NCT04079790|4094336|FG003|COMPLETED|Part 2, Period 2 (Day 1 to Day 3)||3
3363272|NCT04079790|4094333|FG000|NOT COMPLETED|Part 2, Period 2 (Day 1 to Day 3)||0
3363273|NCT04079790|4094334|FG001|NOT COMPLETED|Part 2, Period 2 (Day 1 to Day 3)||0
3363274|NCT04079790|4094335|FG002|NOT COMPLETED|Part 2, Period 2 (Day 1 to Day 3)||0
3363275|NCT04079790|4094336|FG003|NOT COMPLETED|Part 2, Period 2 (Day 1 to Day 3)||0
3363276|NCT04079127|4094362|FG000|STARTED|Overall Study|hips (in 141 patients)|150
2928354|NCT00576927|3639227|FG000|NOT COMPLETED|Sleep Hygiene Behavioral Intervention||7
2928355|NCT00576927|3639227|FG000|STARTED|Sleep Hygiene With the Placebo||23
2928356|NCT00576927|3639227|FG000|COMPLETED|Sleep Hygiene With the Placebo||22
2928357|NCT00576927|3639227|FG000|NOT COMPLETED|Sleep Hygiene With the Placebo||1
2928358|NCT00576927|3639227|FG000|STARTED|Sleep Hygiene With Study Drug||22
2928359|NCT00576927|3639227|FG000|COMPLETED|Sleep Hygiene With Study Drug||22
2928360|NCT00576927|3639227|FG000|NOT COMPLETED|Sleep Hygiene With Study Drug||0
2928361|NCT00576927|3639227|FG000|STARTED|Randomization 1:1 Placebo or Active Drug||22
2928362|NCT00576927|3639227|FG000|COMPLETED|Randomization 1:1 Placebo or Active Drug||22
2928363|NCT00576927|3639227|FG000|NOT COMPLETED|Randomization 1:1 Placebo or Active Drug||0
2928364|NCT00577005|3639235|FG000|STARTED|Overall Study||16
2928365|NCT00577005|3639236|FG001|STARTED|Overall Study||12
2928366|NCT00577005|3639235|FG000|COMPLETED|Overall Study||11
2928367|NCT00577005|3639236|FG001|COMPLETED|Overall Study||9
2928368|NCT00577005|3639235|FG000|NOT COMPLETED|Overall Study||5
2928369|NCT00577005|3639236|FG001|NOT COMPLETED|Overall Study||3
2928370|NCT00577031|3639245|FG000|STARTED|Overall Study||205
2928371|NCT00577031|3639245|FG000|COMPLETED|Overall Study||0
2928372|NCT00577031|3639245|FG000|NOT COMPLETED|Overall Study||205
2928373|NCT00577083|3639254|FG000|STARTED|First Intervention (14 Days)||48
2928374|NCT00577083|3639255|FG001|STARTED|First Intervention (14 Days)||52
2928375|NCT00577083|3639254|FG000|COMPLETED|First Intervention (14 Days)||48
2928376|NCT00577083|3639255|FG001|COMPLETED|First Intervention (14 Days)||52
2928377|NCT00577083|3639254|FG000|NOT COMPLETED|First Intervention (14 Days)||0
2928378|NCT00577083|3639255|FG001|NOT COMPLETED|First Intervention (14 Days)||0
2928379|NCT00577083|3639254|FG000|STARTED|Washout (14 Days)||48
2928380|NCT00577083|3639255|FG001|STARTED|Washout (14 Days)||52
2928381|NCT00577083|3639254|FG000|COMPLETED|Washout (14 Days)||48
2928382|NCT00577083|3639255|FG001|COMPLETED|Washout (14 Days)||52
2928383|NCT00577083|3639254|FG000|NOT COMPLETED|Washout (14 Days)||0
2928384|NCT00577083|3639255|FG001|NOT COMPLETED|Washout (14 Days)||0
2928385|NCT00577083|3639254|FG000|STARTED|Second Intervention (14days)||48
2928386|NCT00577083|3639255|FG001|STARTED|Second Intervention (14days)||52
2928387|NCT00577083|3639254|FG000|COMPLETED|Second Intervention (14days)||48
2928388|NCT00577083|3639255|FG001|COMPLETED|Second Intervention (14days)||52
2928389|NCT00577083|3639254|FG000|NOT COMPLETED|Second Intervention (14days)||0
2928390|NCT00577083|3639255|FG001|NOT COMPLETED|Second Intervention (14days)||0
2928391|NCT00577096|3639269|FG000|STARTED|Short Term Participation||69
2928392|NCT00577096|3639270|FG001|STARTED|Short Term Participation||66
2928393|NCT00577096|3639269|FG000|COMPLETED|Short Term Participation||62
2928394|NCT00577096|3639270|FG001|COMPLETED|Short Term Participation||58
2928395|NCT00577096|3639269|FG000|NOT COMPLETED|Short Term Participation||7
2928396|NCT00577096|3639270|FG001|NOT COMPLETED|Short Term Participation||8
2928397|NCT00577096|3639269|FG000|STARTED|Long Term Participation|Only the first 34 patients who met long-term eligibility (response to EPO) were enrolled.|34
2928398|NCT00577096|3639270|FG001|STARTED|Long Term Participation|Only 35 patients who met long-term eligibility (response to EPO) were enrolled.|35
2928399|NCT00577096|3639269|FG000|COMPLETED|Long Term Participation||34
2928400|NCT00577096|3639270|FG001|COMPLETED|Long Term Participation|Sub-set of patients (n=69) who completed short term (n=120) continued in long term participation.|35
2928401|NCT00577096|3639269|FG000|NOT COMPLETED|Long Term Participation||0
2928402|NCT00577096|3639270|FG001|NOT COMPLETED|Long Term Participation||0
2928403|NCT00577122|3639278|FG000|STARTED|Overall Study||14
2928404|NCT00577122|3639279|FG001|STARTED|Overall Study||16
2928405|NCT00577122|3639278|FG000|COMPLETED|Overall Study||0
3363277|NCT04079127|4094362|FG000|COMPLETED|Overall Study|89 hips have completed the study, and all 10 year data of 81 were available for analysis.|89
3363278|NCT04079127|4094362|FG000|NOT COMPLETED|Overall Study||61
3363279|NCT04076787|4094369|FG000|STARTED|Overall Study||318
3363280|NCT04076787|4094370|FG001|STARTED|Overall Study||1031
3363281|NCT04076787|4094371|FG002|STARTED|Overall Study||420
3363282|NCT04076787|4094369|FG000|COMPLETED|Overall Study||318
3363283|NCT04076787|4094370|FG001|COMPLETED|Overall Study||1031
3363284|NCT04076787|4094371|FG002|COMPLETED|Overall Study||420
3363285|NCT04076787|4094369|FG000|NOT COMPLETED|Overall Study||0
3363286|NCT04076787|4094370|FG001|NOT COMPLETED|Overall Study||0
3363287|NCT04076787|4094371|FG002|NOT COMPLETED|Overall Study||0
3363288|NCT04075812|4094379|FG000|STARTED|Overall Study||2
3363289|NCT04075812|4094379|FG000|COMPLETED|Overall Study||2
3363290|NCT04075812|4094379|FG000|NOT COMPLETED|Overall Study||0
3363291|NCT04075409|4094386|FG000|STARTED|Overall Study||13
3363292|NCT04075409|4094387|FG001|STARTED|Overall Study||13
3363293|NCT04075409|4094388|FG002|STARTED|Overall Study||13
3363294|NCT04075409|4094386|FG000|COMPLETED|Overall Study||13
3363295|NCT04075409|4094387|FG001|COMPLETED|Overall Study||13
3363296|NCT04075409|4094388|FG002|COMPLETED|Overall Study||13
3363297|NCT04075409|4094386|FG000|NOT COMPLETED|Overall Study||0
3363298|NCT04075409|4094387|FG001|NOT COMPLETED|Overall Study||0
3363299|NCT04075409|4094388|FG002|NOT COMPLETED|Overall Study||0
3363300|NCT04074941|4094409|FG000|STARTED|Overall Study||11
3363301|NCT04074941|4094410|FG001|STARTED|Overall Study||9
3363302|NCT04074941|4094409|FG000|COMPLETED|Overall Study||11
3363303|NCT04074941|4094410|FG001|COMPLETED|Overall Study||9
3363304|NCT04074941|4094409|FG000|NOT COMPLETED|Overall Study||0
3363305|NCT04074941|4094410|FG001|NOT COMPLETED|Overall Study||0
3363306|NCT04073823|4094418|FG000|STARTED|Overall Study||1
3363307|NCT04073823|4094419|FG001|STARTED|Overall Study||1
3363308|NCT04073823|4094418|FG000|COMPLETED|Overall Study||1
3363309|NCT04073823|4094419|FG001|COMPLETED|Overall Study||1
3363310|NCT04073823|4094418|FG000|NOT COMPLETED|Overall Study||0
3363311|NCT04073823|4094419|FG001|NOT COMPLETED|Overall Study||0
3363312|NCT04073407|4094427|FG000|STARTED|Part 1||6
3363313|NCT04073407|4094428|FG001|STARTED|Part 1||3
3363314|NCT04073407|4094427|FG000|COMPLETED|Part 1||1
3363315|NCT04073407|4094428|FG001|COMPLETED|Part 1||2
3363316|NCT04073407|4094427|FG000|NOT COMPLETED|Part 1||5
3363317|NCT04073407|4094428|FG001|NOT COMPLETED|Part 1||1
3363318|NCT04073407|4094427|FG000|STARTED|Part 2|Following Part 1, all subjects (including those randomly assigned to the placebo arm in Part 1) were given the option to continue in Part 2 to receive the study food product twice daily for an additional 12 weeks. If the subject chose to not take part in Part 2, the subject underwent a safety follow-up visit approximately 2 weeks after Week13 (Visit 6).|0
3363319|NCT04073407|4094428|FG001|STARTED|Part 2|Following Part 1, all subjects (including those randomly assigned to the placebo arm in Part 1) were given the option to continue in Part 2 to receive the study food product twice daily for an additional 12 weeks. If the subject chose to not take part in Part 2, the subject underwent a safety follow-up visit approximately 2 weeks after Week13 (Visit 6).|1
3363320|NCT04073407|4094427|FG000|COMPLETED|Part 2||0
3363321|NCT04073407|4094428|FG001|COMPLETED|Part 2||0
3363322|NCT04073407|4094427|FG000|NOT COMPLETED|Part 2||0
3363323|NCT04073407|4094428|FG001|NOT COMPLETED|Part 2||1
3363324|NCT04073368|4094438|FG000|STARTED|Overall Study||32
3363325|NCT04073368|4094439|FG001|STARTED|Overall Study||26
3363326|NCT04073368|4094440|FG002|STARTED|Overall Study||29
3363327|NCT04073368|4094441|FG003|STARTED|Overall Study||15
3363328|NCT04073368|4094438|FG000|COMPLETED|Overall Study||20
3363329|NCT04073368|4094439|FG001|COMPLETED|Overall Study||18
3363330|NCT04073368|4094440|FG002|COMPLETED|Overall Study||26
3363331|NCT04073368|4094441|FG003|COMPLETED|Overall Study||13
3363332|NCT04073368|4094438|FG000|NOT COMPLETED|Overall Study||12
3363333|NCT04073368|4094439|FG001|NOT COMPLETED|Overall Study||8
3363334|NCT04073368|4094440|FG002|NOT COMPLETED|Overall Study||3
3363335|NCT04073368|4094441|FG003|NOT COMPLETED|Overall Study||2
3363336|NCT04073186|4094451|FG000|STARTED|First Wearing Cycle||86
3363337|NCT04073186|4094451|FG000|COMPLETED|First Wearing Cycle||80
3179457|NCT01985542|3907640|FG001|STARTED|Overall Study||9
3179458|NCT01985542|3907639|FG000|COMPLETED|Overall Study||3
3179459|NCT01985542|3907640|FG001|COMPLETED|Overall Study||3
3179460|NCT01985542|3907639|FG000|NOT COMPLETED|Overall Study||4
3179461|NCT01985542|3907640|FG001|NOT COMPLETED|Overall Study||6
3179462|NCT01985581|3907649|FG000|STARTED|First Intervention||25
3179463|NCT01985581|3907650|FG001|STARTED|First Intervention||25
3179464|NCT01985581|3907649|FG000|COMPLETED|First Intervention||22
3179465|NCT01985581|3907650|FG001|COMPLETED|First Intervention||23
3179466|NCT01985581|3907649|FG000|NOT COMPLETED|First Intervention||3
3179467|NCT01985581|3907650|FG001|NOT COMPLETED|First Intervention||2
3179468|NCT01985581|3907649|FG000|STARTED|Second Intervention||22
3179469|NCT01985581|3907650|FG001|STARTED|Second Intervention||23
3179470|NCT01985581|3907649|FG000|COMPLETED|Second Intervention||20
3179471|NCT01985581|3907650|FG001|COMPLETED|Second Intervention||19
3363338|NCT04073186|4094451|FG000|NOT COMPLETED|First Wearing Cycle||6
3363339|NCT04073186|4094451|FG000|STARTED|Second Wearing Cycle||80
3363340|NCT04073186|4094451|FG000|COMPLETED|Second Wearing Cycle||79
3363341|NCT04073186|4094451|FG000|NOT COMPLETED|Second Wearing Cycle||1
3363342|NCT04072237|4094456|FG000|STARTED|Stage I: MarzAA 18 µg/kg IV||11
3363343|NCT04072237|4094456|FG000|COMPLETED|Stage I: MarzAA 18 µg/kg IV||10
3363344|NCT04072237|4094456|FG000|NOT COMPLETED|Stage I: MarzAA 18 µg/kg IV||1
3363345|NCT04072237|4094456|FG000|STARTED|Stage 2: MarzAA 30 µg/kg SC||8
3363346|NCT04072237|4094456|FG000|COMPLETED|Stage 2: MarzAA 30 µg/kg SC||8
3363347|NCT04072237|4094456|FG000|NOT COMPLETED|Stage 2: MarzAA 30 µg/kg SC||0
3363348|NCT04072237|4094456|FG000|STARTED|Stage 3: MarzAA 45 µg/kg SC||8
3363349|NCT04072237|4094456|FG000|COMPLETED|Stage 3: MarzAA 45 µg/kg SC||8
3363350|NCT04072237|4094456|FG000|NOT COMPLETED|Stage 3: MarzAA 45 µg/kg SC||0
3363351|NCT04072237|4094456|FG000|STARTED|Stage 4: MarzAA 60 µg/kg SC||8
3363352|NCT04072237|4094456|FG000|COMPLETED|Stage 4: MarzAA 60 µg/kg SC||8
3363353|NCT04072237|4094456|FG000|NOT COMPLETED|Stage 4: MarzAA 60 µg/kg SC||0
3363354|NCT04072237|4094456|FG000|STARTED|Stage 5: MarzAA 2 x 30 ug/kg SC||8
3363355|NCT04072237|4094456|FG000|COMPLETED|Stage 5: MarzAA 2 x 30 ug/kg SC||8
3363356|NCT04072237|4094456|FG000|NOT COMPLETED|Stage 5: MarzAA 2 x 30 ug/kg SC||0
3363357|NCT04072237|4094456|FG000|STARTED|Stage 6: MarzAA 90 µg/kg SC||8
3363358|NCT04072237|4094456|FG000|COMPLETED|Stage 6: MarzAA 90 µg/kg SC||8
3363359|NCT04072237|4094456|FG000|NOT COMPLETED|Stage 6: MarzAA 90 µg/kg SC||0
3363360|NCT04072237|4094456|FG000|STARTED|Stage 7: MarzAA 120 µg/kg SC||8
3363361|NCT04072237|4094456|FG000|COMPLETED|Stage 7: MarzAA 120 µg/kg SC||8
3363362|NCT04072237|4094456|FG000|NOT COMPLETED|Stage 7: MarzAA 120 µg/kg SC||0
3363363|NCT04072237|4094456|FG000|STARTED|Stage 8: MarzAA 2 x 60 µg/kg Q3H SC||8
3363364|NCT04072237|4094456|FG000|COMPLETED|Stage 8: MarzAA 2 x 60 µg/kg Q3H SC||8
3363365|NCT04072237|4094456|FG000|NOT COMPLETED|Stage 8: MarzAA 2 x 60 µg/kg Q3H SC||0
3363366|NCT04072237|4094456|FG000|STARTED|Stage 9: MarzAA 3 x 60 µg/kg Q3H SC||8
3363367|NCT04072237|4094456|FG000|COMPLETED|Stage 9: MarzAA 3 x 60 µg/kg Q3H SC||8
3363368|NCT04072237|4094456|FG000|NOT COMPLETED|Stage 9: MarzAA 3 x 60 µg/kg Q3H SC||0
3363369|NCT04063371|4094486|FG000|STARTED|Overall Study||100
3363370|NCT04063371|4094487|FG001|STARTED|Overall Study||100
3363371|NCT04063371|4094488|FG002|STARTED|Overall Study||100
3363372|NCT04063371|4094486|FG000|COMPLETED|Overall Study||100
3363373|NCT04063371|4094487|FG001|COMPLETED|Overall Study||100
3363374|NCT04063371|4094488|FG002|COMPLETED|Overall Study||100
3363375|NCT04063371|4094486|FG000|NOT COMPLETED|Overall Study||0
3363376|NCT04063371|4094487|FG001|NOT COMPLETED|Overall Study||0
3363377|NCT04063371|4094488|FG002|NOT COMPLETED|Overall Study||0
3363378|NCT04042324|4094498|FG000|STARTED|UFH and Triferic Admixture (Day 1)||12
3363379|NCT04042324|4094499|FG001|STARTED|UFH and Triferic Admixture (Day 1)||0
3363380|NCT04042324|4094500|FG002|STARTED|UFH and Triferic Admixture (Day 1)||0
3363381|NCT04042324|4094498|FG000|COMPLETED|UFH and Triferic Admixture (Day 1)||12
3363382|NCT04042324|4094499|FG001|COMPLETED|UFH and Triferic Admixture (Day 1)||0
3363383|NCT04042324|4094500|FG002|COMPLETED|UFH and Triferic Admixture (Day 1)||0
3363384|NCT04042324|4094498|FG000|NOT COMPLETED|UFH and Triferic Admixture (Day 1)||0
3363385|NCT04042324|4094499|FG001|NOT COMPLETED|UFH and Triferic Admixture (Day 1)||0
3363386|NCT04042324|4094500|FG002|NOT COMPLETED|UFH and Triferic Admixture (Day 1)||0
3363387|NCT04042324|4094498|FG000|STARTED|Triferic Post-dialyzer (Day 3)||0
3363388|NCT04042324|4094499|FG001|STARTED|Triferic Post-dialyzer (Day 3)||12
3363389|NCT04042324|4094500|FG002|STARTED|Triferic Post-dialyzer (Day 3)||0
3363390|NCT04042324|4094498|FG000|COMPLETED|Triferic Post-dialyzer (Day 3)||0
3363391|NCT04042324|4094499|FG001|COMPLETED|Triferic Post-dialyzer (Day 3)||12
3363392|NCT04042324|4094500|FG002|COMPLETED|Triferic Post-dialyzer (Day 3)||0
3363393|NCT04042324|4094498|FG000|NOT COMPLETED|Triferic Post-dialyzer (Day 3)||0
3363394|NCT04042324|4094499|FG001|NOT COMPLETED|Triferic Post-dialyzer (Day 3)||0
3363395|NCT04042324|4094500|FG002|NOT COMPLETED|Triferic Post-dialyzer (Day 3)||0
3363396|NCT04042324|4094498|FG000|STARTED|Triferic Pre-dialyzer (Day 5)||0
3363397|NCT04042324|4094499|FG001|STARTED|Triferic Pre-dialyzer (Day 5)||0
3363398|NCT04042324|4094500|FG002|STARTED|Triferic Pre-dialyzer (Day 5)||12
3363399|NCT04042324|4094498|FG000|COMPLETED|Triferic Pre-dialyzer (Day 5)||0
3363400|NCT04042324|4094499|FG001|COMPLETED|Triferic Pre-dialyzer (Day 5)||0
3363401|NCT04042324|4094500|FG002|COMPLETED|Triferic Pre-dialyzer (Day 5)||12
3363402|NCT04042324|4094498|FG000|NOT COMPLETED|Triferic Pre-dialyzer (Day 5)||0
3363403|NCT04042324|4094499|FG001|NOT COMPLETED|Triferic Pre-dialyzer (Day 5)||0
3363404|NCT04042324|4094500|FG002|NOT COMPLETED|Triferic Pre-dialyzer (Day 5)||0
3363405|NCT04071392|4094512|FG000|STARTED|Overall Study||12
3363406|NCT04071392|4094513|FG001|STARTED|Overall Study||12
3363407|NCT04071392|4094512|FG000|COMPLETED|Overall Study||10
3363408|NCT04071392|4094513|FG001|COMPLETED|Overall Study||10
3363409|NCT04071392|4094512|FG000|NOT COMPLETED|Overall Study||2
3363410|NCT04071392|4094513|FG001|NOT COMPLETED|Overall Study||2
3363411|NCT04071301|4094519|FG000|STARTED|Overall Study||15
3363412|NCT04071301|4094519|FG000|COMPLETED|Overall Study||8
3363413|NCT04071301|4094519|FG000|NOT COMPLETED|Overall Study||7
3363414|NCT04071158|4094528|FG000|STARTED|Overall Study||143
3363415|NCT04071158|4094529|FG001|STARTED|Overall Study||143
3363416|NCT04071158|4094530|FG002|STARTED|Overall Study||143
3363417|NCT04071158|4094531|FG003|STARTED|Overall Study||143
3363418|NCT04071158|4094532|FG004|STARTED|Overall Study||141
3363419|NCT04071158|4094528|FG000|Treated|Overall Study||141
3363420|NCT04071158|4094529|FG001|Treated|Overall Study||141
3363421|NCT04071158|4094530|FG002|Treated|Overall Study||143
3363422|NCT04071158|4094531|FG003|Treated|Overall Study||143
3363423|NCT04071158|4094532|FG004|Treated|Overall Study||141
3363424|NCT04071158|4094528|FG000|Safety Population|Overall Study||141
3363425|NCT04071158|4094529|FG001|Safety Population|Overall Study||141
3363426|NCT04071158|4094530|FG002|Safety Population|Overall Study|1 participant randomized to this arm received RSV vaccine 240 mcg with aluminum hydroxide withTdap|142
3363427|NCT04071158|4094531|FG003|Safety Population|Overall Study|1 participant of this arm actually received RSV vaccine 240 mcg with aluminum hydroxide with Tdap|144
3363428|NCT04071158|4094532|FG004|Safety Population|Overall Study||141
3363429|NCT04071158|4094528|FG000|COMPLETED|Overall Study||140
3363430|NCT04071158|4094529|FG001|COMPLETED|Overall Study||139
3363431|NCT04071158|4094530|FG002|COMPLETED|Overall Study||140
3363432|NCT04071158|4094531|FG003|COMPLETED|Overall Study||140
3363433|NCT04071158|4094532|FG004|COMPLETED|Overall Study||136
3363434|NCT04071158|4094528|FG000|NOT COMPLETED|Overall Study||3
3363435|NCT04071158|4094529|FG001|NOT COMPLETED|Overall Study||4
3363436|NCT04071158|4094530|FG002|NOT COMPLETED|Overall Study||3
3363437|NCT04071158|4094531|FG003|NOT COMPLETED|Overall Study||3
3363438|NCT04071158|4094532|FG004|NOT COMPLETED|Overall Study||5
3363439|NCT04070287|4094555|FG000|STARTED|Overall Study||114
3363440|NCT04070287|4094556|FG001|STARTED|Overall Study||86
3363441|NCT04070287|4094557|FG002|STARTED|Overall Study||81
3363442|NCT04070287|4094558|FG003|STARTED|Overall Study||11
3363443|NCT04070287|4094559|FG004|STARTED|Overall Study||96
3363444|NCT04070287|4094555|FG000|COMPLETED|Overall Study||103
3363445|NCT04070287|4094556|FG001|COMPLETED|Overall Study||44
3363446|NCT04070287|4094557|FG002|COMPLETED|Overall Study||75
2928406|NCT00577122|3639279|FG001|COMPLETED|Overall Study||0
2928407|NCT00577122|3639278|FG000|NOT COMPLETED|Overall Study||14
2928408|NCT00577122|3639279|FG001|NOT COMPLETED|Overall Study||16
2928409|NCT00577135|3639290|FG000|STARTED|Overall Study||74
2928410|NCT00577135|3639291|FG001|STARTED|Overall Study||82
3040099|NCT01162343|3759561|FG000|NOT COMPLETED|Overall Study||92
3040100|NCT01162421|3759567|FG000|STARTED|Overall Study||37
3040101|NCT01162421|3759568|FG001|STARTED|Overall Study||40
3040102|NCT01162421|3759567|FG000|COMPLETED|Overall Study||29
3040103|NCT01162421|3759568|FG001|COMPLETED|Overall Study||27
3040104|NCT01162421|3759567|FG000|NOT COMPLETED|Overall Study||8
3040105|NCT01162421|3759568|FG001|NOT COMPLETED|Overall Study||13
3040106|NCT01162473|3759576|FG000|STARTED|Overall Study||8
3040107|NCT01162473|3759577|FG001|STARTED|Overall Study||17
3040108|NCT01162473|3759576|FG000|COMPLETED|Overall Study||6
3040109|NCT01162473|3759577|FG001|COMPLETED|Overall Study||12
3040110|NCT01162473|3759576|FG000|NOT COMPLETED|Overall Study||2
3040111|NCT01162473|3759577|FG001|NOT COMPLETED|Overall Study||5
3040112|NCT01162486|3759588|FG000|STARTED|Overall Study||8
3040113|NCT01162486|3759589|FG001|STARTED|Overall Study||6
3040114|NCT01162486|3759590|FG002|STARTED|Overall Study||6
3040115|NCT01162486|3759591|FG003|STARTED|Overall Study||7
3040116|NCT01162486|3759592|FG004|STARTED|Overall Study||6
3040117|NCT01162486|3759588|FG000|Took at Least One Dose Study Drug|Overall Study||8
3040118|NCT01162486|3759589|FG001|Took at Least One Dose Study Drug|Overall Study||6
3363447|NCT04070287|4094558|FG003|COMPLETED|Overall Study||7
3363448|NCT04070287|4094559|FG004|COMPLETED|Overall Study||95
3363449|NCT04070287|4094555|FG000|NOT COMPLETED|Overall Study||11
3363450|NCT04070287|4094556|FG001|NOT COMPLETED|Overall Study||42
3363451|NCT04070287|4094557|FG002|NOT COMPLETED|Overall Study||6
3363452|NCT04070287|4094558|FG003|NOT COMPLETED|Overall Study||4
3363453|NCT04070287|4094559|FG004|NOT COMPLETED|Overall Study||1
3363454|NCT04069715|4094573|FG000|STARTED|Overall Study||47
3363455|NCT04069715|4094574|FG001|STARTED|Overall Study||48
3363456|NCT04069715|4094573|FG000|COMPLETED|Overall Study||42
3363457|NCT04069715|4094574|FG001|COMPLETED|Overall Study||43
3363458|NCT04069715|4094573|FG000|NOT COMPLETED|Overall Study||5
3363459|NCT04069715|4094574|FG001|NOT COMPLETED|Overall Study||5
3363460|NCT04050722|4094582|FG000|STARTED|Overall Study||65
3363461|NCT04050722|4094583|FG001|STARTED|Overall Study||65
3363462|NCT04050722|4094582|FG000|COMPLETED|Overall Study||64
2928411|NCT00577135|3639292|FG002|STARTED|Overall Study||77
2928412|NCT00577135|3639293|FG003|STARTED|Overall Study||75
2928413|NCT00577135|3639290|FG000|COMPLETED|Overall Study||74
2928414|NCT00577135|3639291|FG001|COMPLETED|Overall Study||82
2928415|NCT00577135|3639292|FG002|COMPLETED|Overall Study||77
2928416|NCT00577135|3639293|FG003|COMPLETED|Overall Study||75
2928417|NCT00577135|3639290|FG000|NOT COMPLETED|Overall Study||0
2928418|NCT00577135|3639291|FG001|NOT COMPLETED|Overall Study||0
2928419|NCT00577135|3639292|FG002|NOT COMPLETED|Overall Study||0
2928420|NCT00577135|3639293|FG003|NOT COMPLETED|Overall Study||0
2928421|NCT00577382|3639305|FG000|STARTED|Overall Study||21
2928422|NCT00577382|3639306|FG001|STARTED|Overall Study||31
2928423|NCT00577382|3639305|FG000|COMPLETED|Overall Study|Since treatment duration was not fixed, patients were not considered to have completed treatment.|0
2928424|NCT00577382|3639306|FG001|COMPLETED|Overall Study|Since treatment duration was not fixed, patients were not considered to have completed treatment.|0
2928425|NCT00577382|3639305|FG000|NOT COMPLETED|Overall Study||21
2928426|NCT00577382|3639306|FG001|NOT COMPLETED|Overall Study||31
2928427|NCT00577408|3639314|FG000|STARTED|Overall Study||28
2928428|NCT00577408|3639315|FG001|STARTED|Overall Study||32
2928429|NCT00577408|3639314|FG000|COMPLETED|Overall Study||16
2928430|NCT00577408|3639315|FG001|COMPLETED|Overall Study||9
2928431|NCT00577408|3639314|FG000|NOT COMPLETED|Overall Study||12
2928432|NCT00577408|3639315|FG001|NOT COMPLETED|Overall Study||23
2928433|NCT00577460|3639324|FG000|STARTED|Overall Study||129
2928434|NCT00577460|3639325|FG001|STARTED|Overall Study||123
2928435|NCT00577460|3639326|FG002|STARTED|Overall Study||139
2928436|NCT00577460|3639324|FG000|COMPLETED|Overall Study||113
2928437|NCT00577460|3639325|FG001|COMPLETED|Overall Study||104
2928438|NCT00577460|3639326|FG002|COMPLETED|Overall Study||112
2928439|NCT00577460|3639324|FG000|NOT COMPLETED|Overall Study||16
2928440|NCT00577460|3639325|FG001|NOT COMPLETED|Overall Study||19
2928441|NCT00577460|3639326|FG002|NOT COMPLETED|Overall Study||27
2928442|NCT00577473|3639343|FG000|STARTED|Overall Study||154
2928443|NCT00577473|3639344|FG001|STARTED|Overall Study||147
2928444|NCT00577473|3639343|FG000|ITT Population|Overall Study||150
2928445|NCT00577473|3639344|FG001|ITT Population|Overall Study||136
2928446|NCT00577473|3639343|FG000|COMPLETED|Overall Study||133
2928447|NCT00577473|3639344|FG001|COMPLETED|Overall Study||123
2928448|NCT00577473|3639343|FG000|NOT COMPLETED|Overall Study||21
2928449|NCT00577473|3639344|FG001|NOT COMPLETED|Overall Study||24
2928450|NCT00577512|3639350|FG000|STARTED|Overall Study||4
2928451|NCT00577512|3639350|FG000|COMPLETED|Overall Study||0
2928452|NCT00577512|3639350|FG000|NOT COMPLETED|Overall Study||4
2928453|NCT00577590|3639357|FG000|STARTED|Overall Study||28
2928454|NCT00577590|3639358|FG001|STARTED|Overall Study||27
2928455|NCT00577590|3639359|FG002|STARTED|Overall Study||23
2928456|NCT00577590|3639357|FG000|COMPLETED|Overall Study||28
2928457|NCT00577590|3639358|FG001|COMPLETED|Overall Study||27
2928458|NCT00577590|3639359|FG002|COMPLETED|Overall Study||23
2928459|NCT00577590|3639357|FG000|NOT COMPLETED|Overall Study||0
2928460|NCT00577590|3639358|FG001|NOT COMPLETED|Overall Study||0
2928461|NCT00577590|3639359|FG002|NOT COMPLETED|Overall Study||0
2928462|NCT00577629|3639367|FG000|STARTED|Treatment Period||39
2928463|NCT00577629|3639367|FG000|COMPLETED|Treatment Period||38
3040119|NCT01162486|3759590|FG002|Took at Least One Dose Study Drug|Overall Study||6
3040120|NCT01162486|3759591|FG003|Took at Least One Dose Study Drug|Overall Study||7
3040121|NCT01162486|3759592|FG004|Took at Least One Dose Study Drug|Overall Study||6
3040122|NCT01162486|3759588|FG000|COMPLETED|Overall Study||6
3040123|NCT01162486|3759589|FG001|COMPLETED|Overall Study||6
3040124|NCT01162486|3759590|FG002|COMPLETED|Overall Study||5
3040125|NCT01162486|3759591|FG003|COMPLETED|Overall Study||6
3040126|NCT01162486|3759592|FG004|COMPLETED|Overall Study||6
3040127|NCT01162486|3759588|FG000|NOT COMPLETED|Overall Study||2
3040128|NCT01162486|3759589|FG001|NOT COMPLETED|Overall Study||0
3040129|NCT01162486|3759590|FG002|NOT COMPLETED|Overall Study||1
3363463|NCT04050722|4094583|FG001|COMPLETED|Overall Study||65
3040130|NCT01162486|3759591|FG003|NOT COMPLETED|Overall Study||1
3040131|NCT01162486|3759592|FG004|NOT COMPLETED|Overall Study||0
3363464|NCT04050722|4094582|FG000|NOT COMPLETED|Overall Study||1
3363465|NCT04050722|4094583|FG001|NOT COMPLETED|Overall Study||0
3363466|NCT04069221|4094591|FG000|STARTED|Overall Study||8
2928464|NCT00577629|3639367|FG000|NOT COMPLETED|Treatment Period||1
2928465|NCT00577629|3639367|FG000|STARTED|Long Term Follow-Up||38
2928466|NCT00577629|3639367|FG000|COMPLETED|Long Term Follow-Up||13
2928467|NCT00577629|3639367|FG000|NOT COMPLETED|Long Term Follow-Up||25
2928468|NCT00577642|3639373|FG000|STARTED|Overall Study||29
2928469|NCT00577642|3639373|FG000|COMPLETED|Overall Study||28
2928470|NCT00577642|3639373|FG000|NOT COMPLETED|Overall Study||1
2928471|NCT00577655|3639379|FG000|STARTED|Overall Study|This number represents the number of participants randomized.|52
2928472|NCT00577655|3639380|FG001|STARTED|Overall Study|This number represents the number of participants randomized.|51
2928473|NCT00577655|3639379|FG000|COMPLETED|Overall Study||51
2928474|NCT00577655|3639380|FG001|COMPLETED|Overall Study||47
2928475|NCT00577655|3639379|FG000|NOT COMPLETED|Overall Study||1
2928476|NCT00577655|3639380|FG001|NOT COMPLETED|Overall Study||4
2928477|NCT00577707|3639387|FG000|STARTED|Overall Study||9
2928478|NCT00577707|3639387|FG000|COMPLETED|Overall Study||6
2928479|NCT00577707|3639387|FG000|NOT COMPLETED|Overall Study||3
2928480|NCT00577720|3639395|FG000|STARTED|Overall Study||37
2928481|NCT00577720|3639396|FG001|STARTED|Overall Study||36
2928482|NCT00577720|3639397|FG002|STARTED|Overall Study||36
2928483|NCT00577720|3639398|FG003|STARTED|Overall Study||72
2928484|NCT00577720|3639395|FG000|ITT (Intent to Treat) Population|Overall Study||34
2928485|NCT00577720|3639396|FG001|ITT (Intent to Treat) Population|Overall Study||35
2928486|NCT00577720|3639397|FG002|ITT (Intent to Treat) Population|Overall Study||35
2928487|NCT00577720|3639398|FG003|ITT (Intent to Treat) Population|Overall Study||65
2928488|NCT00577720|3639395|FG000|COMPLETED|Overall Study||33
2928489|NCT00577720|3639396|FG001|COMPLETED|Overall Study||35
2928490|NCT00577720|3639397|FG002|COMPLETED|Overall Study||35
2928491|NCT00577720|3639398|FG003|COMPLETED|Overall Study||65
2928492|NCT00577720|3639395|FG000|NOT COMPLETED|Overall Study||4
2928493|NCT00577720|3639396|FG001|NOT COMPLETED|Overall Study||1
2928494|NCT00577720|3639397|FG002|NOT COMPLETED|Overall Study||1
2928495|NCT00577720|3639398|FG003|NOT COMPLETED|Overall Study||7
2928496|NCT00577824|3639411|FG000|STARTED|Overall Study|Started=Randomized|72
2928497|NCT00577824|3639412|FG001|STARTED|Overall Study||73
2928498|NCT00577824|3639413|FG002|STARTED|Overall Study||36
2928499|NCT00577824|3639411|FG000|Full Analysis Set|Overall Study|Full Analysis Set=subject received at least one dose of study medication (active or placebo)|72
2928500|NCT00577824|3639412|FG001|Full Analysis Set|Overall Study||72
2928501|NCT00577824|3639413|FG002|Full Analysis Set|Overall Study||35
2928502|NCT00577824|3639411|FG000|COMPLETED|Overall Study||65
2928503|NCT00577824|3639412|FG001|COMPLETED|Overall Study||53
2928504|NCT00577824|3639413|FG002|COMPLETED|Overall Study||34
2928505|NCT00577824|3639411|FG000|NOT COMPLETED|Overall Study||7
2928506|NCT00577824|3639412|FG001|NOT COMPLETED|Overall Study||20
2928507|NCT00577824|3639413|FG002|NOT COMPLETED|Overall Study||2
2928508|NCT00577863|3639423|FG000|STARTED|Overall Study||92
2928509|NCT00577863|3639424|FG001|STARTED|Overall Study||108
2928510|NCT00577863|3639423|FG000|Received at Least One Injection|Overall Study||92
2928511|NCT00577863|3639424|FG001|Received at Least One Injection|Overall Study||107
2928512|NCT00577863|3639423|FG000|COMPLETED|Overall Study||82
2928513|NCT00577863|3639424|FG001|COMPLETED|Overall Study||94
2928514|NCT00577863|3639423|FG000|NOT COMPLETED|Overall Study||10
2928515|NCT00577863|3639424|FG001|NOT COMPLETED|Overall Study||14
2928516|NCT00577889|3639433|FG000|STARTED|Overall Study||9
2928517|NCT00577889|3639434|FG001|STARTED|Overall Study||6
2928518|NCT00577889|3639435|FG002|STARTED|Overall Study||6
2928519|NCT00577889|3639433|FG000|COMPLETED|Overall Study||8
2928520|NCT00577889|3639434|FG001|COMPLETED|Overall Study||6
2928521|NCT00577889|3639435|FG002|COMPLETED|Overall Study||6
2928522|NCT00577889|3639433|FG000|NOT COMPLETED|Overall Study||1
2928523|NCT00577889|3639434|FG001|NOT COMPLETED|Overall Study||0
2928524|NCT00577889|3639435|FG002|NOT COMPLETED|Overall Study||0
2928525|NCT00577993|3639446|FG000|STARTED|Overall Study||85
2928526|NCT00577993|3639447|FG001|STARTED|Overall Study||90
2928527|NCT00577993|3639448|FG002|STARTED|Overall Study||35
2928528|NCT00577993|3639446|FG000|COMPLETED|Overall Study||78
2928529|NCT00577993|3639447|FG001|COMPLETED|Overall Study||80
2928530|NCT00577993|3639448|FG002|COMPLETED|Overall Study||32
2928531|NCT00577993|3639446|FG000|NOT COMPLETED|Overall Study||7
3040132|NCT01162499|3759608|FG000|STARTED|Intervention 1 (4 Hours)||3
3040133|NCT01162499|3759609|FG001|STARTED|Intervention 1 (4 Hours)||4
3040134|NCT01162499|3759608|FG000|Received Intervention|Intervention 1 (4 Hours)||3
3040135|NCT01162499|3759609|FG001|Received Intervention|Intervention 1 (4 Hours)||3
3040136|NCT01162499|3759608|FG000|COMPLETED|Intervention 1 (4 Hours)||3
3040137|NCT01162499|3759609|FG001|COMPLETED|Intervention 1 (4 Hours)||3
3040138|NCT01162499|3759608|FG000|NOT COMPLETED|Intervention 1 (4 Hours)||0
3040139|NCT01162499|3759609|FG001|NOT COMPLETED|Intervention 1 (4 Hours)||1
3040140|NCT01162499|3759608|FG000|STARTED|Intervention 2 (4 Hours)||3
3040141|NCT01162499|3759609|FG001|STARTED|Intervention 2 (4 Hours)||3
3040142|NCT01162499|3759608|FG000|COMPLETED|Intervention 2 (4 Hours)||3
3040143|NCT01162499|3759609|FG001|COMPLETED|Intervention 2 (4 Hours)||3
3040144|NCT01162499|3759608|FG000|NOT COMPLETED|Intervention 2 (4 Hours)||0
3040145|NCT01162499|3759609|FG001|NOT COMPLETED|Intervention 2 (4 Hours)||0
3040146|NCT01162551|3759617|FG000|STARTED|Overall Study|2 subjects were enrolled but withdrew before receiving any study treatment|3
3040147|NCT01162551|3759617|FG000|COMPLETED|Overall Study||3
3040148|NCT01162551|3759617|FG000|NOT COMPLETED|Overall Study||0
3040149|NCT01162733|3759623|FG000|STARTED|Overall Study||49
3040150|NCT01162733|3759624|FG001|STARTED|Overall Study||50
3040151|NCT01162733|3759623|FG000|COMPLETED|Overall Study||22
3040152|NCT01162733|3759624|FG001|COMPLETED|Overall Study||25
3040153|NCT01162733|3759623|FG000|NOT COMPLETED|Overall Study||27
3040154|NCT01162733|3759624|FG001|NOT COMPLETED|Overall Study||25
3137080|NCT01716715|3862332|FG000|COMPLETED|Overall Study||55
3137081|NCT01716715|3862333|FG001|COMPLETED|Overall Study||50
3137082|NCT01716715|3862332|FG000|NOT COMPLETED|Overall Study||2
3137083|NCT01716715|3862333|FG001|NOT COMPLETED|Overall Study||4
3137084|NCT01716754|3862345|FG000|STARTED|Overall Study||199
3137085|NCT01716754|3862346|FG001|STARTED|Overall Study||40
3137086|NCT01716754|3862347|FG002|STARTED|Overall Study||135
3137087|NCT01716754|3862348|FG003|STARTED|Overall Study||97
3137088|NCT01716754|3862345|FG000|FAS|Overall Study||199
3137089|NCT01716754|3862346|FG001|FAS|Overall Study||40
3137090|NCT01716754|3862347|FG002|FAS|Overall Study||131
3137091|NCT01716754|3862348|FG003|FAS|Overall Study||96
3137092|NCT01716754|3862345|FG000|Safety Set|Overall Study||199
3137093|NCT01716754|3862346|FG001|Safety Set|Overall Study||40
3137094|NCT01716754|3862347|FG002|Safety Set|Overall Study||131
3137095|NCT01716754|3862348|FG003|Safety Set|Overall Study||96
3137096|NCT01716754|3862345|FG000|COMPLETED|Overall Study||188
3137097|NCT01716754|3862346|FG001|COMPLETED|Overall Study||36
3137098|NCT01716754|3862347|FG002|COMPLETED|Overall Study||121
3137099|NCT01716754|3862348|FG003|COMPLETED|Overall Study||89
3137100|NCT01716754|3862345|FG000|NOT COMPLETED|Overall Study||11
3137101|NCT01716754|3862346|FG001|NOT COMPLETED|Overall Study||4
3137102|NCT01716754|3862347|FG002|NOT COMPLETED|Overall Study||14
3179472|NCT01985581|3907649|FG000|NOT COMPLETED|Second Intervention||2
3179473|NCT01985581|3907650|FG001|NOT COMPLETED|Second Intervention||4
3179474|NCT01985685|3907669|FG000|STARTED|Overall Study||27
3179475|NCT01985685|3907670|FG001|STARTED|Overall Study||29
3179476|NCT01985685|3907669|FG000|COMPLETED|Overall Study||27
3179477|NCT01985685|3907670|FG001|COMPLETED|Overall Study||29
3179478|NCT01985685|3907669|FG000|NOT COMPLETED|Overall Study||0
3179479|NCT01985685|3907670|FG001|NOT COMPLETED|Overall Study||0
3179480|NCT01985763|3907676|FG000|STARTED|Overall Study||13
3179481|NCT01985763|3907676|FG000|COMPLETED|Overall Study||13
3179482|NCT01985763|3907676|FG000|NOT COMPLETED|Overall Study||0
3179483|NCT01985932|3907681|FG000|STARTED|Overall Study||15
3179484|NCT01985932|3907681|FG000|COMPLETED|Overall Study||15
3179485|NCT01985932|3907681|FG000|NOT COMPLETED|Overall Study||0
3179486|NCT01985958|3907685|FG000|STARTED|Overall Study||4
3179487|NCT01985958|3907685|FG000|COMPLETED|Overall Study||3
3179488|NCT01985958|3907685|FG000|NOT COMPLETED|Overall Study||1
2928532|NCT00577993|3639447|FG001|NOT COMPLETED|Overall Study||10
2928533|NCT00577993|3639448|FG002|NOT COMPLETED|Overall Study||3
2928534|NCT00578071|3639454|FG000|STARTED|Overall Study||29
2928535|NCT00578071|3639454|FG000|COMPLETED|Overall Study||29
2928536|NCT00578071|3639454|FG000|NOT COMPLETED|Overall Study||0
2928537|NCT00578136|3639461|FG000|STARTED|Overall Study||27
2928538|NCT00578136|3639462|FG001|STARTED|Overall Study||27
2928539|NCT00578136|3639461|FG000|COMPLETED|Overall Study||26
2928540|NCT00578136|3639462|FG001|COMPLETED|Overall Study||26
2928541|NCT00578136|3639461|FG000|NOT COMPLETED|Overall Study||1
2928542|NCT00578136|3639462|FG001|NOT COMPLETED|Overall Study||1
2928543|NCT00578175|3639471|FG000|STARTED|Overall Study||705
2928544|NCT00578175|3639472|FG001|STARTED|Overall Study||689
2928545|NCT00578175|3639473|FG002|STARTED|Overall Study||389
2928546|NCT00578175|3639471|FG000|COMPLETED|Overall Study||635
2928547|NCT00578175|3639472|FG001|COMPLETED|Overall Study||646
2928548|NCT00578175|3639473|FG002|COMPLETED|Overall Study||365
2928549|NCT00578175|3639471|FG000|NOT COMPLETED|Overall Study||70
2928550|NCT00578175|3639472|FG001|NOT COMPLETED|Overall Study||43
2928551|NCT00578175|3639473|FG002|NOT COMPLETED|Overall Study||24
2928552|NCT00578214|3639486|FG000|STARTED|Overall Study||22
2928553|NCT00578214|3639487|FG001|STARTED|Overall Study||22
2928554|NCT00578214|3639488|FG002|STARTED|Overall Study||31
2928555|NCT00578214|3639486|FG000|COMPLETED|Overall Study||22
2928556|NCT00578214|3639487|FG001|COMPLETED|Overall Study||22
2928557|NCT00578214|3639488|FG002|COMPLETED|Overall Study||31
2928558|NCT00578214|3639486|FG000|NOT COMPLETED|Overall Study||0
2928559|NCT00578214|3639487|FG001|NOT COMPLETED|Overall Study||0
2928560|NCT00578214|3639488|FG002|NOT COMPLETED|Overall Study||0
2928561|NCT00578227|3639499|FG000|STARTED|Overall Study||272
2928562|NCT00578227|3639500|FG001|STARTED|Overall Study||270
2928563|NCT00578227|3639501|FG002|STARTED|Overall Study||271
2928564|NCT00578227|3639499|FG000|COMPLETED|Overall Study||267
2928565|NCT00578227|3639500|FG001|COMPLETED|Overall Study||268
2928566|NCT00578227|3639501|FG002|COMPLETED|Overall Study||267
2928567|NCT00578227|3639499|FG000|NOT COMPLETED|Overall Study||5
2928568|NCT00578227|3639500|FG001|NOT COMPLETED|Overall Study||2
2928569|NCT00578227|3639501|FG002|NOT COMPLETED|Overall Study||4
2928570|NCT00578279|3639513|FG000|STARTED|Overall Study||10
2928571|NCT00578279|3639514|FG001|STARTED|Overall Study||10
2928572|NCT00578279|3639513|FG000|COMPLETED|Overall Study||10
2928573|NCT00578279|3639514|FG001|COMPLETED|Overall Study||10
2928574|NCT00578279|3639513|FG000|NOT COMPLETED|Overall Study||0
2928575|NCT00578279|3639514|FG001|NOT COMPLETED|Overall Study||0
2928576|NCT00578292|3639520|FG000|STARTED|Overall Study||10
2928577|NCT00578292|3639520|FG000|COMPLETED|Overall Study||7
2928578|NCT00578292|3639520|FG000|NOT COMPLETED|Overall Study||3
2928579|NCT00578305|3639527|FG000|STARTED|Double-blind Treatment Phase||62
2928580|NCT00578305|3639528|FG001|STARTED|Double-blind Treatment Phase||60
2928581|NCT00578305|3639529|FG002|STARTED|Double-blind Treatment Phase||63
2928582|NCT00578305|3639527|FG000|Treated|Double-blind Treatment Phase||62
2928583|NCT00578305|3639528|FG001|Treated|Double-blind Treatment Phase||60
2928584|NCT00578305|3639529|FG002|Treated|Double-blind Treatment Phase||63
2928585|NCT00578305|3639527|FG000|COMPLETED|Double-blind Treatment Phase||59
2928586|NCT00578305|3639528|FG001|COMPLETED|Double-blind Treatment Phase||56
2928587|NCT00578305|3639529|FG002|COMPLETED|Double-blind Treatment Phase||49
2928588|NCT00578305|3639527|FG000|NOT COMPLETED|Double-blind Treatment Phase||3
2928589|NCT00578305|3639528|FG001|NOT COMPLETED|Double-blind Treatment Phase||4
3040155|NCT01162863|3759633|FG000|STARTED|Overall Study||18
3040156|NCT01162863|3759634|FG001|STARTED|Overall Study||17
3040157|NCT01162863|3759635|FG002|STARTED|Overall Study||17
3040158|NCT01162863|3759633|FG000|COMPLETED|Overall Study||17
3040159|NCT01162863|3759634|FG001|COMPLETED|Overall Study||16
3040160|NCT01162863|3759635|FG002|COMPLETED|Overall Study||17
3040161|NCT01162863|3759633|FG000|NOT COMPLETED|Overall Study||1
3040162|NCT01162863|3759634|FG001|NOT COMPLETED|Overall Study||1
3040163|NCT01162863|3759635|FG002|NOT COMPLETED|Overall Study||0
3040164|NCT01163032|3759646|FG000|STARTED|Randomization Phase||42
2928590|NCT00578305|3639529|FG002|NOT COMPLETED|Double-blind Treatment Phase||14
2928591|NCT00578305|3639527|FG000|STARTED|Extension Phase||53
2928592|NCT00578305|3639528|FG001|STARTED|Extension Phase||50
3040165|NCT01163032|3759647|FG001|STARTED|Randomization Phase||42
3040166|NCT01163032|3759648|FG002|STARTED|Randomization Phase|Not applicable for Randomized Phase|0
2928593|NCT00578305|3639529|FG002|STARTED|Extension Phase||43
2928594|NCT00578305|3639527|FG000|COMPLETED|Extension Phase|Some participants completed the study in this period and did not enter the safety follow-up period.|49
2928595|NCT00578305|3639528|FG001|COMPLETED|Extension Phase|Some participants completed the study in this period and did not enter the safety follow-up period.|49
2928596|NCT00578305|3639529|FG002|COMPLETED|Extension Phase|Some participants completed the study in this period and did not enter the safety follow-up period.|40
2928597|NCT00578305|3639527|FG000|NOT COMPLETED|Extension Phase||4
2928598|NCT00578305|3639528|FG001|NOT COMPLETED|Extension Phase||1
2928599|NCT00578305|3639529|FG002|NOT COMPLETED|Extension Phase||3
2928600|NCT00578305|3639527|FG000|STARTED|Safety Follow-up Phase|Some participants entered safety follow-up directly from the double-blind treatment period.|57
2928601|NCT00578305|3639528|FG001|STARTED|Safety Follow-up Phase|Some participants entered safety follow-up directly from the double-blind treatment period.|54
2928602|NCT00578305|3639529|FG002|STARTED|Safety Follow-up Phase|Some participants entered safety follow-up directly from the double-blind treatment period.|54
2928603|NCT00578305|3639527|FG000|COMPLETED|Safety Follow-up Phase||11
2928604|NCT00578305|3639528|FG001|COMPLETED|Safety Follow-up Phase||9
2928605|NCT00578305|3639529|FG002|COMPLETED|Safety Follow-up Phase||8
2928606|NCT00578305|3639527|FG000|NOT COMPLETED|Safety Follow-up Phase||46
2928607|NCT00578305|3639528|FG001|NOT COMPLETED|Safety Follow-up Phase||45
2928608|NCT00578305|3639529|FG002|NOT COMPLETED|Safety Follow-up Phase||46
2928609|NCT00578318|3639545|FG000|STARTED|Overall Study||8
2928610|NCT00578318|3639546|FG001|STARTED|Overall Study||8
2928611|NCT00578318|3639545|FG000|COMPLETED|Overall Study||5
2928612|NCT00578318|3639546|FG001|COMPLETED|Overall Study||8
2928613|NCT00578318|3639545|FG000|NOT COMPLETED|Overall Study||3
2928614|NCT00578318|3639546|FG001|NOT COMPLETED|Overall Study||0
2928615|NCT00578331|3639554|FG000|STARTED|Overall Study||445
2928616|NCT00578331|3639555|FG001|STARTED|Overall Study||445
2928617|NCT00578331|3639554|FG000|COMPLETED|Overall Study||329
2928618|NCT00578331|3639555|FG001|COMPLETED|Overall Study||320
2928619|NCT00578331|3639554|FG000|NOT COMPLETED|Overall Study||116
2928620|NCT00578331|3639555|FG001|NOT COMPLETED|Overall Study||125
2928621|NCT00578344|3639561|FG000|STARTED|Overall Study||8
2928622|NCT00578344|3639561|FG000|COMPLETED|Overall Study||6
2928623|NCT00578344|3639561|FG000|NOT COMPLETED|Overall Study||2
2928624|NCT00578383|3639569|FG000|STARTED|Overall Study||37
2928625|NCT00578383|3639570|FG001|STARTED|Overall Study||36
2928626|NCT00578383|3639571|FG002|STARTED|Overall Study||19
2928627|NCT00578383|3639572|FG003|STARTED|Overall Study||15
3179489|NCT01985971|3907689|FG000|STARTED|Overall Study||2
3179490|NCT01985971|3907689|FG000|COMPLETED|Overall Study||1
3179491|NCT01985971|3907689|FG000|NOT COMPLETED|Overall Study||1
2928628|NCT00578383|3639569|FG000|COMPLETED|Overall Study||21
2928629|NCT00578383|3639570|FG001|COMPLETED|Overall Study||20
2928630|NCT00578383|3639571|FG002|COMPLETED|Overall Study||13
2928631|NCT00578383|3639572|FG003|COMPLETED|Overall Study||9
2928632|NCT00578383|3639569|FG000|NOT COMPLETED|Overall Study||16
3179492|NCT01986010|3907710|FG000|STARTED|Overall Study||13
2928633|NCT00578383|3639570|FG001|NOT COMPLETED|Overall Study||16
2928634|NCT00578383|3639571|FG002|NOT COMPLETED|Overall Study||6
2928635|NCT00578383|3639572|FG003|NOT COMPLETED|Overall Study||6
3040167|NCT01163032|3759646|FG000|COMPLETED|Randomization Phase||32
3040168|NCT01163032|3759647|FG001|COMPLETED|Randomization Phase||30
3040169|NCT01163032|3759648|FG002|COMPLETED|Randomization Phase|Not applicable for Randomized Phase|0
3040170|NCT01163032|3759646|FG000|NOT COMPLETED|Randomization Phase||10
3040171|NCT01163032|3759647|FG001|NOT COMPLETED|Randomization Phase||12
3040172|NCT01163032|3759648|FG002|NOT COMPLETED|Randomization Phase||0
3040173|NCT01163032|3759646|FG000|STARTED|Open Label Extension Phase|Not applicable for Open Label Extension Phase|0
3040174|NCT01163032|3759647|FG001|STARTED|Open Label Extension Phase|Not applicable for Open Label Extension Phase|0
3040175|NCT01163032|3759648|FG002|STARTED|Open Label Extension Phase|3 randomized patients rolled into extension (2 randomized to tasimelteon and one to placebo)|55
3040176|NCT01163032|3759646|FG000|COMPLETED|Open Label Extension Phase|Not applicable for Open Label Extension Phase|0
3040177|NCT01163032|3759647|FG001|COMPLETED|Open Label Extension Phase|Not applicable for Open Label Extension Phase|0
3040178|NCT01163032|3759648|FG002|COMPLETED|Open Label Extension Phase||39
3040179|NCT01163032|3759646|FG000|NOT COMPLETED|Open Label Extension Phase||0
3040180|NCT01163032|3759647|FG001|NOT COMPLETED|Open Label Extension Phase||0
3040181|NCT01163032|3759648|FG002|NOT COMPLETED|Open Label Extension Phase||16
3040182|NCT01163097|3759659|FG000|STARTED|Overall Study|15 subjects were successfully titrated and entered the palifermin treatment|20
3040183|NCT01163097|3759660|FG001|STARTED|Overall Study||16
3040184|NCT01163097|3759661|FG002|STARTED|Overall Study||8
3040185|NCT01163097|3759659|FG000|COMPLETED|Overall Study||14
3040186|NCT01163097|3759660|FG001|COMPLETED|Overall Study||16
3040187|NCT01163097|3759661|FG002|COMPLETED|Overall Study||8
3040188|NCT01163097|3759659|FG000|NOT COMPLETED|Overall Study||6
3040189|NCT01163097|3759660|FG001|NOT COMPLETED|Overall Study||0
3040190|NCT01163097|3759661|FG002|NOT COMPLETED|Overall Study||0
3040191|NCT01163149|3759674|FG000|STARTED|Primary Treatment Period||7
3040192|NCT01163149|3759675|FG001|STARTED|Primary Treatment Period||6
3040193|NCT01163149|3759676|FG002|STARTED|Primary Treatment Period||6
3040194|NCT01163149|3759674|FG000|COMPLETED|Primary Treatment Period||7
3179493|NCT01986010|3907711|FG001|STARTED|Overall Study||14
3179494|NCT01986010|3907712|FG002|STARTED|Overall Study||14
3179495|NCT01986010|3907713|FG003|STARTED|Overall Study||10
3179496|NCT01986010|3907714|FG004|STARTED|Overall Study||11
3179497|NCT01986010|3907715|FG005|STARTED|Overall Study||19
3179498|NCT01986010|3907716|FG006|STARTED|Overall Study||10
3179499|NCT01986010|3907717|FG007|STARTED|Overall Study||4
3179500|NCT01986010|3907718|FG008|STARTED|Overall Study||12
3179501|NCT01986010|3907719|FG009|STARTED|Overall Study||10
3179502|NCT01986010|3907720|FG010|STARTED|Overall Study||10
3179503|NCT01986010|3907721|FG011|STARTED|Overall Study||11
3179504|NCT01986010|3907722|FG012|STARTED|Overall Study||10
3179505|NCT01986010|3907723|FG013|STARTED|Overall Study||11
3179506|NCT01986010|3907724|FG014|STARTED|Overall Study||16
3179507|NCT01986010|3907725|FG015|STARTED|Overall Study||11
3179508|NCT01986010|3907726|FG016|STARTED|Overall Study||4
3179509|NCT01986010|3907710|FG000|Vaccination 1|Overall Study||13
3179510|NCT01986010|3907711|FG001|Vaccination 1|Overall Study||14
3179511|NCT01986010|3907712|FG002|Vaccination 1|Overall Study||14
3179512|NCT01986010|3907713|FG003|Vaccination 1|Overall Study||10
3179513|NCT01986010|3907714|FG004|Vaccination 1|Overall Study||11
3179514|NCT01986010|3907715|FG005|Vaccination 1|Overall Study||19
3179515|NCT01986010|3907716|FG006|Vaccination 1|Overall Study||10
3179516|NCT01986010|3907717|FG007|Vaccination 1|Overall Study||4
3179517|NCT01986010|3907718|FG008|Vaccination 1|Overall Study||12
3179518|NCT01986010|3907719|FG009|Vaccination 1|Overall Study||10
3179519|NCT01986010|3907720|FG010|Vaccination 1|Overall Study||10
3179520|NCT01986010|3907721|FG011|Vaccination 1|Overall Study||11
3179521|NCT01986010|3907722|FG012|Vaccination 1|Overall Study||10
3179522|NCT01986010|3907723|FG013|Vaccination 1|Overall Study||11
3179523|NCT01986010|3907724|FG014|Vaccination 1|Overall Study||16
3179524|NCT01986010|3907725|FG015|Vaccination 1|Overall Study||11
3179525|NCT01986010|3907726|FG016|Vaccination 1|Overall Study||4
3179526|NCT01986010|3907710|FG000|Vaccination 2|Overall Study||12
3179527|NCT01986010|3907711|FG001|Vaccination 2|Overall Study||13
3179528|NCT01986010|3907712|FG002|Vaccination 2|Overall Study||12
3179529|NCT01986010|3907713|FG003|Vaccination 2|Overall Study||10
3179530|NCT01986010|3907714|FG004|Vaccination 2|Overall Study||9
3179531|NCT01986010|3907715|FG005|Vaccination 2|Overall Study||19
3179532|NCT01986010|3907716|FG006|Vaccination 2|Overall Study||10
3179533|NCT01986010|3907717|FG007|Vaccination 2|Overall Study||4
3179534|NCT01986010|3907718|FG008|Vaccination 2|Overall Study||11
3179535|NCT01986010|3907719|FG009|Vaccination 2|Overall Study||10
3179536|NCT01986010|3907720|FG010|Vaccination 2|Overall Study||10
3179537|NCT01986010|3907721|FG011|Vaccination 2|Overall Study||10
3179538|NCT01986010|3907722|FG012|Vaccination 2|Overall Study||10
3179539|NCT01986010|3907723|FG013|Vaccination 2|Overall Study||9
3179540|NCT01986010|3907724|FG014|Vaccination 2|Overall Study||16
3179541|NCT01986010|3907725|FG015|Vaccination 2|Overall Study||10
3179542|NCT01986010|3907726|FG016|Vaccination 2|Overall Study||4
3179543|NCT01986010|3907710|FG000|Vaccination 3|Overall Study||10
3179544|NCT01986010|3907711|FG001|Vaccination 3|Overall Study||10
3179545|NCT01986010|3907712|FG002|Vaccination 3|Overall Study||9
3179546|NCT01986010|3907713|FG003|Vaccination 3|Overall Study||10
3179547|NCT01986010|3907714|FG004|Vaccination 3|Overall Study||9
3179548|NCT01986010|3907715|FG005|Vaccination 3|Overall Study||15
3179549|NCT01986010|3907716|FG006|Vaccination 3|Overall Study||10
3179550|NCT01986010|3907717|FG007|Vaccination 3|Overall Study||4
3179551|NCT01986010|3907718|FG008|Vaccination 3|Overall Study||10
3179552|NCT01986010|3907719|FG009|Vaccination 3|Overall Study||10
3179553|NCT01986010|3907720|FG010|Vaccination 3|Overall Study||10
3179554|NCT01986010|3907721|FG011|Vaccination 3|Overall Study||8
3179555|NCT01986010|3907722|FG012|Vaccination 3|Overall Study||10
3179556|NCT01986010|3907723|FG013|Vaccination 3|Overall Study||9
3179557|NCT01986010|3907724|FG014|Vaccination 3|Overall Study||13
3179558|NCT01986010|3907725|FG015|Vaccination 3|Overall Study||10
3040195|NCT01163149|3759675|FG001|COMPLETED|Primary Treatment Period||6
3040196|NCT01163149|3759676|FG002|COMPLETED|Primary Treatment Period||6
3040197|NCT01163149|3759674|FG000|NOT COMPLETED|Primary Treatment Period||0
3040198|NCT01163149|3759675|FG001|NOT COMPLETED|Primary Treatment Period||0
3040199|NCT01163149|3759676|FG002|NOT COMPLETED|Primary Treatment Period||0
3040200|NCT01163149|3759674|FG000|STARTED|Extension Treatment Period||7
3040201|NCT01163149|3759675|FG001|STARTED|Extension Treatment Period||6
3040202|NCT01163149|3759676|FG002|STARTED|Extension Treatment Period||6
3040203|NCT01163149|3759674|FG000|COMPLETED|Extension Treatment Period||5
3040204|NCT01163149|3759675|FG001|COMPLETED|Extension Treatment Period||5
3040205|NCT01163149|3759676|FG002|COMPLETED|Extension Treatment Period||4
3040206|NCT01163149|3759674|FG000|NOT COMPLETED|Extension Treatment Period||2
2928636|NCT00578448|3639586|FG000|STARTED|Day 1 up to 3 Years of Planned Study||12
2928637|NCT00578448|3639586|FG000|COMPLETED|Day 1 up to 3 Years of Planned Study||9
2928638|NCT00578448|3639586|FG000|NOT COMPLETED|Day 1 up to 3 Years of Planned Study||3
2928639|NCT00578448|3639586|FG000|STARTED|1 Year Long Term Extension (LTE)||9
2928640|NCT00578448|3639586|FG000|COMPLETED|1 Year Long Term Extension (LTE)||8
2928641|NCT00578448|3639586|FG000|NOT COMPLETED|1 Year Long Term Extension (LTE)||1
2928642|NCT00578461|3639592|FG000|STARTED|Overall Study||26
2928643|NCT00578461|3639592|FG000|COMPLETED|Overall Study||26
2928644|NCT00578461|3639592|FG000|NOT COMPLETED|Overall Study||0
2928645|NCT00578539|3639596|FG000|STARTED|Overall Study||24
2928646|NCT00578539|3639596|FG000|COMPLETED|Overall Study||24
2928647|NCT00578539|3639596|FG000|NOT COMPLETED|Overall Study||0
2928648|NCT00578552|3639603|FG000|STARTED|Overall Study||27
2928649|NCT00578552|3639604|FG001|STARTED|Overall Study||27
2928650|NCT00578552|3639605|FG002|STARTED|Overall Study||26
2928651|NCT00578552|3639603|FG000|COMPLETED|Overall Study||12
2928652|NCT00578552|3639604|FG001|COMPLETED|Overall Study||13
2928653|NCT00578552|3639605|FG002|COMPLETED|Overall Study||11
2928654|NCT00578552|3639603|FG000|NOT COMPLETED|Overall Study||15
2928655|NCT00578552|3639604|FG001|NOT COMPLETED|Overall Study||14
2928656|NCT00578552|3639605|FG002|NOT COMPLETED|Overall Study||15
2928657|NCT00578565|3639613|FG000|STARTED|Overall Study||10
2928658|NCT00578565|3639613|FG000|COMPLETED|Overall Study||7
2928659|NCT00578565|3639613|FG000|NOT COMPLETED|Overall Study||3
2928660|NCT00578617|3639620|FG000|STARTED|Overall Study||31
2928661|NCT00578617|3639621|FG001|STARTED|Overall Study||29
2928662|NCT00578617|3639620|FG000|COMPLETED|Overall Study||31
2928663|NCT00578617|3639621|FG001|COMPLETED|Overall Study||29
2928664|NCT00578617|3639620|FG000|NOT COMPLETED|Overall Study||0
2928665|NCT00578617|3639621|FG001|NOT COMPLETED|Overall Study||0
2928666|NCT00578643|3639627|FG000|STARTED|Overall Study||15
2928667|NCT00578643|3639627|FG000|COMPLETED|Overall Study||13
2928668|NCT00578643|3639627|FG000|NOT COMPLETED|Overall Study||2
2928669|NCT00578669|3639633|FG000|STARTED|Overall Study||107
2928670|NCT00578669|3639634|FG001|STARTED|Overall Study||99
2928671|NCT00578669|3639633|FG000|COMPLETED|Overall Study||107
2928672|NCT00578669|3639634|FG001|COMPLETED|Overall Study||99
2928673|NCT00578669|3639633|FG000|NOT COMPLETED|Overall Study||0
2928674|NCT00578669|3639634|FG001|NOT COMPLETED|Overall Study||0
2928675|NCT00578734|3639642|FG000|STARTED|Overall Study||84
2928676|NCT00578734|3639643|FG001|STARTED|Overall Study||81
2928677|NCT00578734|3639642|FG000|COMPLETED|Overall Study||84
2928678|NCT00578734|3639643|FG001|COMPLETED|Overall Study||81
2928679|NCT00578734|3639642|FG000|NOT COMPLETED|Overall Study||0
2928680|NCT00578734|3639643|FG001|NOT COMPLETED|Overall Study||0
2928681|NCT00578786|3639652|FG000|STARTED|Overall Study||96
2928682|NCT00578786|3639653|FG001|STARTED|Overall Study||190
2928683|NCT00578786|3639654|FG002|STARTED|Overall Study||97
2928684|NCT00578786|3639652|FG000|COMPLETED|Overall Study||57
2928685|NCT00578786|3639653|FG001|COMPLETED|Overall Study||124
2928686|NCT00578786|3639654|FG002|COMPLETED|Overall Study||67
3040207|NCT01163149|3759675|FG001|NOT COMPLETED|Extension Treatment Period||1
3040208|NCT01163149|3759676|FG002|NOT COMPLETED|Extension Treatment Period||2
3040209|NCT01163162|3759698|FG000|STARTED|Overall Study||16
3040210|NCT01163162|3759698|FG000|COMPLETED|Overall Study||16
3040211|NCT01163162|3759698|FG000|NOT COMPLETED|Overall Study||0
3040212|NCT01163214|3759704|FG000|STARTED|Overall Study||79
3040213|NCT01163214|3759705|FG001|STARTED|Overall Study||81
3040214|NCT01163214|3759704|FG000|COMPLETED|Overall Study||79
3040215|NCT01163214|3759705|FG001|COMPLETED|Overall Study||81
3040216|NCT01163214|3759704|FG000|NOT COMPLETED|Overall Study||0
3040217|NCT01163214|3759705|FG001|NOT COMPLETED|Overall Study||0
3179559|NCT01986010|3907726|FG016|Vaccination 3|Overall Study||4
3179560|NCT01986010|3907710|FG000|COMPLETED|Overall Study||7
3179561|NCT01986010|3907711|FG001|COMPLETED|Overall Study||6
3179562|NCT01986010|3907712|FG002|COMPLETED|Overall Study||7
3179563|NCT01986010|3907713|FG003|COMPLETED|Overall Study||8
3179564|NCT01986010|3907714|FG004|COMPLETED|Overall Study||6
3179565|NCT01986010|3907715|FG005|COMPLETED|Overall Study||11
3179566|NCT01986010|3907716|FG006|COMPLETED|Overall Study||10
3040218|NCT01163253|3759713|FG000|STARTED|Overall Study||2281
3040219|NCT01163253|3759714|FG001|STARTED|Overall Study||586
3040220|NCT01163253|3759713|FG000|COMPLETED|Overall Study||0
3040221|NCT01163253|3759714|FG001|COMPLETED|Overall Study||0
3040222|NCT01163253|3759713|FG000|NOT COMPLETED|Overall Study||2281
3040223|NCT01163253|3759714|FG001|NOT COMPLETED|Overall Study||586
3040224|NCT01163266|3759723|FG000|STARTED|Overall Study||157
3040225|NCT01163266|3759724|FG001|STARTED|Overall Study||155
3040226|NCT01163266|3759725|FG002|STARTED|Overall Study||150
3040227|NCT01163266|3759723|FG000|Treated|Overall Study||157
3040228|NCT01163266|3759724|FG001|Treated|Overall Study||155
3040229|NCT01163266|3759725|FG002|Treated|Overall Study||150
3179567|NCT01986010|3907717|FG007|COMPLETED|Overall Study||4
3040230|NCT01163266|3759723|FG000|COMPLETED|Overall Study||139
3040231|NCT01163266|3759724|FG001|COMPLETED|Overall Study||124
3040232|NCT01163266|3759725|FG002|COMPLETED|Overall Study||122
3040233|NCT01163266|3759723|FG000|NOT COMPLETED|Overall Study||18
3040234|NCT01163266|3759724|FG001|NOT COMPLETED|Overall Study||31
3179568|NCT01986010|3907718|FG008|COMPLETED|Overall Study||6
3179569|NCT01986010|3907719|FG009|COMPLETED|Overall Study||7
3179570|NCT01986010|3907720|FG010|COMPLETED|Overall Study||3
3179571|NCT01986010|3907721|FG011|COMPLETED|Overall Study||1
2928687|NCT00578786|3639652|FG000|NOT COMPLETED|Overall Study||39
2928688|NCT00578786|3639653|FG001|NOT COMPLETED|Overall Study||66
2928689|NCT00578786|3639654|FG002|NOT COMPLETED|Overall Study||30
2928690|NCT00578812|3639674|FG000|STARTED|Overall Study|Does not include investigational training patients (78 STARTED, 76 COMPLETED, 2 Not Treated).|224
2928691|NCT00578812|3639675|FG001|STARTED|Overall Study||192
2928692|NCT00578812|3639674|FG000|COMPLETED|Overall Study|Modified Intent-to-Treat (treated patients; analyzed as randomized).|218
2928693|NCT00578812|3639675|FG001|COMPLETED|Overall Study||185
2928694|NCT00578812|3639674|FG000|NOT COMPLETED|Overall Study||6
2928695|NCT00578812|3639675|FG001|NOT COMPLETED|Overall Study||7
2928696|NCT00578864|3639684|FG000|STARTED|Overall Study||7
2928697|NCT00578864|3639685|FG001|STARTED|Overall Study||6
2928698|NCT00578864|3639684|FG000|COMPLETED|Overall Study|died of complications of surgery after 2 cycles|6
2928699|NCT00578864|3639685|FG001|COMPLETED|Overall Study||6
2928700|NCT00578864|3639684|FG000|NOT COMPLETED|Overall Study||1
2928701|NCT00578864|3639685|FG001|NOT COMPLETED|Overall Study||0
2928702|NCT00578877|3639693|FG000|STARTED|Overall Study||150
2928703|NCT00578877|3639694|FG001|STARTED|Overall Study||300
2928704|NCT00578877|3639693|FG000|COMPLETED|Overall Study||69
2928705|NCT00578877|3639694|FG001|COMPLETED|Overall Study||172
2928706|NCT00578877|3639693|FG000|NOT COMPLETED|Overall Study||81
2928707|NCT00578877|3639694|FG001|NOT COMPLETED|Overall Study||128
2928708|NCT00578903|3639700|FG000|STARTED|Overall Study||22
2928709|NCT00578903|3639700|FG000|COMPLETED|Overall Study||22
2928710|NCT00578903|3639700|FG000|NOT COMPLETED|Overall Study||0
2928711|NCT00578929|3639708|FG000|STARTED|Vehicle Run-In Period||0
2928712|NCT00578929|3639709|FG001|STARTED|Vehicle Run-In Period||2388
2928713|NCT00578929|3639710|FG002|STARTED|Vehicle Run-In Period||0
2928714|NCT00578929|3639711|FG003|STARTED|Vehicle Run-In Period||0
2928715|NCT00578929|3639708|FG000|COMPLETED|Vehicle Run-In Period||0
2928716|NCT00578929|3639709|FG001|COMPLETED|Vehicle Run-In Period||2388
2928717|NCT00578929|3639710|FG002|COMPLETED|Vehicle Run-In Period||0
2928718|NCT00578929|3639711|FG003|COMPLETED|Vehicle Run-In Period||0
2928719|NCT00578929|3639708|FG000|NOT COMPLETED|Vehicle Run-In Period||0
2928720|NCT00578929|3639709|FG001|NOT COMPLETED|Vehicle Run-In Period||0
2928721|NCT00578929|3639710|FG002|NOT COMPLETED|Vehicle Run-In Period||0
2928722|NCT00578929|3639711|FG003|NOT COMPLETED|Vehicle Run-In Period||0
2928723|NCT00578929|3639708|FG000|STARTED|Randomized Period||298
2928724|NCT00578929|3639709|FG001|STARTED|Randomized Period||297
2928725|NCT00578929|3639710|FG002|STARTED|Randomized Period||296
2928726|NCT00578929|3639711|FG003|STARTED|Randomized Period||297
2928727|NCT00578929|3639708|FG000|COMPLETED|Randomized Period||281
2928728|NCT00578929|3639709|FG001|COMPLETED|Randomized Period||283
2928729|NCT00578929|3639710|FG002|COMPLETED|Randomized Period||288
2928730|NCT00578929|3639711|FG003|COMPLETED|Randomized Period||283
2928731|NCT00578929|3639708|FG000|NOT COMPLETED|Randomized Period||17
2928732|NCT00578929|3639709|FG001|NOT COMPLETED|Randomized Period||14
2928733|NCT00578929|3639710|FG002|NOT COMPLETED|Randomized Period||8
2928734|NCT00578929|3639711|FG003|NOT COMPLETED|Randomized Period||14
2928735|NCT00578942|3639722|FG000|STARTED|Overall Study||48
2928736|NCT00578942|3639722|FG000|COMPLETED|Overall Study||47
2928737|NCT00578942|3639722|FG000|NOT COMPLETED|Overall Study||1
2928738|NCT00578968|3639729|FG000|STARTED|Baseline (Prior to Intervention)||12
2928739|NCT00578968|3639730|FG001|STARTED|Baseline (Prior to Intervention)||12
2928740|NCT00578968|3639731|FG002|STARTED|Baseline (Prior to Intervention)||12
2928741|NCT00578968|3639729|FG000|COMPLETED|Baseline (Prior to Intervention)||12
2928742|NCT00578968|3639730|FG001|COMPLETED|Baseline (Prior to Intervention)||12
2928743|NCT00578968|3639731|FG002|COMPLETED|Baseline (Prior to Intervention)||12
2928744|NCT00578968|3639729|FG000|NOT COMPLETED|Baseline (Prior to Intervention)||0
2928745|NCT00578968|3639730|FG001|NOT COMPLETED|Baseline (Prior to Intervention)||0
2928746|NCT00578968|3639731|FG002|NOT COMPLETED|Baseline (Prior to Intervention)||0
2928747|NCT00578968|3639729|FG000|STARTED|Intervention||12
2928748|NCT00578968|3639730|FG001|STARTED|Intervention||12
2928749|NCT00578968|3639731|FG002|STARTED|Intervention||0
2928750|NCT00578968|3639729|FG000|COMPLETED|Intervention||12
2928751|NCT00578968|3639730|FG001|COMPLETED|Intervention||12
2928752|NCT00578968|3639731|FG002|COMPLETED|Intervention||0
2928753|NCT00578968|3639729|FG000|NOT COMPLETED|Intervention||0
2928754|NCT00578968|3639730|FG001|NOT COMPLETED|Intervention||0
2928755|NCT00578968|3639731|FG002|NOT COMPLETED|Intervention||0
2928756|NCT00579059|3639742|FG000|STARTED|Overall Study|Enrollment was incomplete due to study cancellation.|21
2928757|NCT00579059|3639743|FG001|STARTED|Overall Study|Enrollment was incomplete due to study cancellation.|10
2928758|NCT00579059|3639742|FG000|Immediate Post-Op|Overall Study|1 Patient didn't return for follow-up.|20
2928759|NCT00579059|3639743|FG001|Immediate Post-Op|Overall Study|1 Patient didn't return for follow-up.|9
2928760|NCT00579059|3639742|FG000|6 Months|Overall Study|10 Patients didn't return for follow-up.|11
2928761|NCT00579059|3639743|FG001|6 Months|Overall Study|6 patients didn't return for follow-up.|4
2928762|NCT00579059|3639742|FG000|1 Year|Overall Study|13 patients didn't return for follow-up.|8
2928763|NCT00579059|3639743|FG001|1 Year|Overall Study|7 patients didn't return for follow-up.|3
3179572|NCT01986010|3907722|FG012|COMPLETED|Overall Study||0
3179573|NCT01986010|3907723|FG013|COMPLETED|Overall Study||0
3179574|NCT01986010|3907724|FG014|COMPLETED|Overall Study||6
3179575|NCT01986010|3907725|FG015|COMPLETED|Overall Study||0
3179576|NCT01986010|3907726|FG016|COMPLETED|Overall Study||0
3179577|NCT01986010|3907710|FG000|NOT COMPLETED|Overall Study||6
3179578|NCT01986010|3907711|FG001|NOT COMPLETED|Overall Study||8
3179579|NCT01986010|3907712|FG002|NOT COMPLETED|Overall Study||7
3179580|NCT01986010|3907713|FG003|NOT COMPLETED|Overall Study||2
3040235|NCT01163266|3759725|FG002|NOT COMPLETED|Overall Study||28
3040236|NCT01163279|3759735|FG000|STARTED|Overall Study||10
3040237|NCT01163279|3759736|FG001|STARTED|Overall Study||9
3040238|NCT01163279|3759735|FG000|COMPLETED|Overall Study||8
3040239|NCT01163279|3759736|FG001|COMPLETED|Overall Study||9
3040240|NCT01163279|3759735|FG000|NOT COMPLETED|Overall Study||2
3040241|NCT01163279|3759736|FG001|NOT COMPLETED|Overall Study||0
3040242|NCT01163292|3759745|FG000|STARTED|Overall Study||106
3040243|NCT01163292|3759746|FG001|STARTED|Overall Study||114
3040244|NCT01163292|3759745|FG000|COMPLETED|Overall Study||65
3040245|NCT01163292|3759746|FG001|COMPLETED|Overall Study||92
3040246|NCT01163292|3759745|FG000|NOT COMPLETED|Overall Study||41
3179581|NCT01986010|3907714|FG004|NOT COMPLETED|Overall Study||5
2928764|NCT00579059|3639742|FG000|3 Years|Overall Study|Incomplete due to study closure at 1-year of follow-up.|0
2928765|NCT00579059|3639743|FG001|3 Years|Overall Study|Incomplete due to study closure at 1-year of follow-up.|0
2928766|NCT00579059|3639742|FG000|5 Years|Overall Study|Incomplete due to study closure at 1-year of follow-up.|0
2928767|NCT00579059|3639743|FG001|5 Years|Overall Study|Incomplete due to study closure at 1-year of follow-up.|0
2928768|NCT00579059|3639742|FG000|COMPLETED|Overall Study|No Patients completed through 5 years due to study closure at 1-year of follow-up.|0
2928769|NCT00579059|3639743|FG001|COMPLETED|Overall Study|No Patients completed through 5 years due to study closure at 1-year of follow-up.|0
2928770|NCT00579059|3639742|FG000|NOT COMPLETED|Overall Study||21
2928771|NCT00579059|3639743|FG001|NOT COMPLETED|Overall Study||10
2928772|NCT00579098|3639751|FG000|STARTED|Overall Study||62
2928773|NCT00579098|3639752|FG001|STARTED|Overall Study||63
2928774|NCT00579098|3639751|FG000|COMPLETED|Overall Study||53
2928775|NCT00579098|3639752|FG001|COMPLETED|Overall Study||55
3040247|NCT01163292|3759746|FG001|NOT COMPLETED|Overall Study||22
3040248|NCT01163318|3759752|FG000|STARTED|Overall Study||552
3040249|NCT01163318|3759752|FG000|COMPLETED|Overall Study||284
3040250|NCT01163318|3759752|FG000|NOT COMPLETED|Overall Study||268
3040251|NCT01163461|3759756|FG000|STARTED|Overall Study||14
3040252|NCT01163461|3759757|FG001|STARTED|Overall Study||14
3040253|NCT01163461|3759756|FG000|COMPLETED|Overall Study||14
3040254|NCT01163461|3759757|FG001|COMPLETED|Overall Study||14
3040255|NCT01163461|3759756|FG000|NOT COMPLETED|Overall Study||0
3040256|NCT01163461|3759757|FG001|NOT COMPLETED|Overall Study||0
3040257|NCT01163474|3759761|FG000|STARTED|Overall Study||40
3040258|NCT01163474|3759761|FG000|COMPLETED|Overall Study||24
3040259|NCT01163474|3759761|FG000|NOT COMPLETED|Overall Study||16
3040260|NCT01163604|3759770|FG000|STARTED|Overall Study|August 2010|58
3040261|NCT01163604|3759771|FG001|STARTED|Overall Study|August 2010|56
3040262|NCT01163604|3759770|FG000|COMPLETED|Overall Study|August 2011|58
3040263|NCT01163604|3759771|FG001|COMPLETED|Overall Study|August 2011|56
3040264|NCT01163604|3759770|FG000|NOT COMPLETED|Overall Study||0
3040265|NCT01163604|3759771|FG001|NOT COMPLETED|Overall Study||0
3040266|NCT01163617|3759777|FG000|STARTED|Phase A (User Experience), Weeks 0 and 2||19
3040267|NCT01163617|3759778|FG001|STARTED|Phase A (User Experience), Weeks 0 and 2||23
3040268|NCT01163617|3759779|FG002|STARTED|Phase A (User Experience), Weeks 0 and 2||21
3040269|NCT01163617|3759780|FG003|STARTED|Phase A (User Experience), Weeks 0 and 2||21
3040270|NCT01163617|3759781|FG004|STARTED|Phase A (User Experience), Weeks 0 and 2||0
3040271|NCT01163617|3759782|FG005|STARTED|Phase A (User Experience), Weeks 0 and 2||0
3040272|NCT01163617|3759783|FG006|STARTED|Phase A (User Experience), Weeks 0 and 2||0
3040273|NCT01163617|3759784|FG007|STARTED|Phase A (User Experience), Weeks 0 and 2||0
3040274|NCT01163617|3759777|FG000|COMPLETED|Phase A (User Experience), Weeks 0 and 2||19
3040275|NCT01163617|3759778|FG001|COMPLETED|Phase A (User Experience), Weeks 0 and 2||21
3040276|NCT01163617|3759779|FG002|COMPLETED|Phase A (User Experience), Weeks 0 and 2||20
3040277|NCT01163617|3759780|FG003|COMPLETED|Phase A (User Experience), Weeks 0 and 2||21
3040278|NCT01163617|3759781|FG004|COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
3040279|NCT01163617|3759782|FG005|COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
3040280|NCT01163617|3759783|FG006|COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
3040281|NCT01163617|3759784|FG007|COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
3040282|NCT01163617|3759777|FG000|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
3040283|NCT01163617|3759778|FG001|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||2
2928776|NCT00579098|3639751|FG000|NOT COMPLETED|Overall Study||9
2928777|NCT00579098|3639752|FG001|NOT COMPLETED|Overall Study||8
2928778|NCT00579111|3639760|FG000|STARTED|Overall Study||3
2928779|NCT00579111|3639761|FG001|STARTED|Overall Study||1
2928780|NCT00579111|3639760|FG000|COMPLETED|Overall Study||1
2928781|NCT00579111|3639761|FG001|COMPLETED|Overall Study||0
2928782|NCT00579111|3639760|FG000|NOT COMPLETED|Overall Study||2
2928783|NCT00579111|3639761|FG001|NOT COMPLETED|Overall Study||1
2928784|NCT00579137|3639767|FG000|STARTED|Overall Study||3
2928785|NCT00579137|3639767|FG000|COMPLETED|Overall Study||3
2928786|NCT00579137|3639767|FG000|NOT COMPLETED|Overall Study||0
2928787|NCT00579280|3639774|FG000|STARTED|Overall Study||49
2928788|NCT00579280|3639775|FG001|STARTED|Overall Study||49
2928789|NCT00579280|3639776|FG002|STARTED|Overall Study||51
2928790|NCT00579280|3639774|FG000|COMPLETED|Overall Study|LOCF evaluable sample|47
2928791|NCT00579280|3639775|FG001|COMPLETED|Overall Study|LOCF evaluable sample|46
2928792|NCT00579280|3639776|FG002|COMPLETED|Overall Study|LOCF evaluable sample|51
2928793|NCT00579280|3639774|FG000|NOT COMPLETED|Overall Study||2
2928794|NCT00579280|3639775|FG001|NOT COMPLETED|Overall Study||3
2928795|NCT00579280|3639776|FG002|NOT COMPLETED|Overall Study||0
2928796|NCT00579345|3639792|FG000|STARTED|Overall Study||549
2928797|NCT00579345|3639793|FG001|STARTED|Overall Study||169
2928798|NCT00579345|3639794|FG002|STARTED|Overall Study||391
2928799|NCT00579345|3639795|FG003|STARTED|Overall Study||144
2928800|NCT00579345|3639796|FG004|STARTED|Overall Study||90
2928801|NCT00579345|3639797|FG005|STARTED|Overall Study||78
2928802|NCT00579345|3639798|FG006|STARTED|Overall Study||57
2928803|NCT00579345|3639799|FG007|STARTED|Overall Study||44
2928804|NCT00579345|3639792|FG000|COMPLETED|Overall Study||544
2928805|NCT00579345|3639793|FG001|COMPLETED|Overall Study||168
2928806|NCT00579345|3639794|FG002|COMPLETED|Overall Study||389
2928807|NCT00579345|3639795|FG003|COMPLETED|Overall Study||143
2928808|NCT00579345|3639796|FG004|COMPLETED|Overall Study||90
2928809|NCT00579345|3639797|FG005|COMPLETED|Overall Study||78
2928810|NCT00579345|3639798|FG006|COMPLETED|Overall Study||57
2928811|NCT00579345|3639799|FG007|COMPLETED|Overall Study||42
2928812|NCT00579345|3639792|FG000|NOT COMPLETED|Overall Study||5
2928813|NCT00579345|3639793|FG001|NOT COMPLETED|Overall Study||1
2928814|NCT00579345|3639794|FG002|NOT COMPLETED|Overall Study||2
2928815|NCT00579345|3639795|FG003|NOT COMPLETED|Overall Study||1
2928816|NCT00579345|3639796|FG004|NOT COMPLETED|Overall Study||0
2928817|NCT00579345|3639797|FG005|NOT COMPLETED|Overall Study||0
2928818|NCT00579345|3639798|FG006|NOT COMPLETED|Overall Study||0
2928819|NCT00579345|3639799|FG007|NOT COMPLETED|Overall Study||2
2928820|NCT00579436|3639829|FG000|STARTED|Overall Study||19
2928821|NCT00579436|3639830|FG001|STARTED|Overall Study||14
2928822|NCT00579436|3639829|FG000|COMPLETED|Overall Study||19
2928823|NCT00579436|3639830|FG001|COMPLETED|Overall Study||14
2928824|NCT00579436|3639829|FG000|NOT COMPLETED|Overall Study||0
2928825|NCT00579436|3639830|FG001|NOT COMPLETED|Overall Study||0
2928826|NCT00579501|3639836|FG000|STARTED|Overall Study||29
2928827|NCT00579501|3639836|FG000|COMPLETED|Overall Study||0
2928828|NCT00579501|3639836|FG000|NOT COMPLETED|Overall Study||29
2928829|NCT00579527|3639840|FG000|STARTED|Overall Study||14
2928830|NCT00579527|3639840|FG000|COMPLETED|Overall Study||10
2928831|NCT00579527|3639840|FG000|NOT COMPLETED|Overall Study||4
3040284|NCT01163617|3759779|FG002|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||1
3040285|NCT01163617|3759780|FG003|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
3040286|NCT01163617|3759781|FG004|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
3040287|NCT01163617|3759782|FG005|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
3040288|NCT01163617|3759783|FG006|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
3040289|NCT01163617|3759784|FG007|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
3040290|NCT01163617|3759777|FG000|STARTED|Phase B (Injection Time), Week 4||0
3040291|NCT01163617|3759778|FG001|STARTED|Phase B (Injection Time), Week 4||0
3040292|NCT01163617|3759779|FG002|STARTED|Phase B (Injection Time), Week 4||0
3040293|NCT01163617|3759780|FG003|STARTED|Phase B (Injection Time), Week 4||0
3040294|NCT01163617|3759781|FG004|STARTED|Phase B (Injection Time), Week 4||18
3040295|NCT01163617|3759782|FG005|STARTED|Phase B (Injection Time), Week 4||27
3040296|NCT01163617|3759783|FG006|STARTED|Phase B (Injection Time), Week 4||16
3040297|NCT01163617|3759784|FG007|STARTED|Phase B (Injection Time), Week 4||20
3040298|NCT01163617|3759777|FG000|COMPLETED|Phase B (Injection Time), Week 4||0
3040299|NCT01163617|3759778|FG001|COMPLETED|Phase B (Injection Time), Week 4||0
3040300|NCT01163617|3759779|FG002|COMPLETED|Phase B (Injection Time), Week 4||0
3040301|NCT01163617|3759780|FG003|COMPLETED|Phase B (Injection Time), Week 4||0
3040302|NCT01163617|3759781|FG004|COMPLETED|Phase B (Injection Time), Week 4||18
3040303|NCT01163617|3759782|FG005|COMPLETED|Phase B (Injection Time), Week 4||27
3040304|NCT01163617|3759783|FG006|COMPLETED|Phase B (Injection Time), Week 4||16
3040305|NCT01163617|3759784|FG007|COMPLETED|Phase B (Injection Time), Week 4||20
3040306|NCT01163617|3759777|FG000|NOT COMPLETED|Phase B (Injection Time), Week 4||0
3040307|NCT01163617|3759778|FG001|NOT COMPLETED|Phase B (Injection Time), Week 4||0
3040308|NCT01163617|3759779|FG002|NOT COMPLETED|Phase B (Injection Time), Week 4||0
3040309|NCT01163617|3759780|FG003|NOT COMPLETED|Phase B (Injection Time), Week 4||0
3040310|NCT01163617|3759781|FG004|NOT COMPLETED|Phase B (Injection Time), Week 4||0
3040311|NCT01163617|3759782|FG005|NOT COMPLETED|Phase B (Injection Time), Week 4||0
3040312|NCT01163617|3759783|FG006|NOT COMPLETED|Phase B (Injection Time), Week 4||0
3040313|NCT01163617|3759784|FG007|NOT COMPLETED|Phase B (Injection Time), Week 4||0
3040314|NCT01163643|3759810|FG000|STARTED|Overall Study||68
3040315|NCT01163643|3759811|FG001|STARTED|Overall Study||37
2928832|NCT00579553|3639847|FG000|STARTED|Overall Study||82
2928833|NCT00579553|3639848|FG001|STARTED|Overall Study||92
2928834|NCT00579553|3639847|FG000|COMPLETED|Overall Study||66
2928835|NCT00579553|3639848|FG001|COMPLETED|Overall Study||79
2928836|NCT00579553|3639847|FG000|NOT COMPLETED|Overall Study||16
2928837|NCT00579553|3639848|FG001|NOT COMPLETED|Overall Study||13
2928838|NCT00579670|3639859|FG000|STARTED|Overall Study|Full Analysis Set (FAS): at least 1 dose study medication and at least 1 efficacy measurement|15
2928839|NCT00579670|3639860|FG001|STARTED|Overall Study||57
2928840|NCT00579670|3639861|FG002|STARTED|Overall Study||88
2928841|NCT00579670|3639862|FG003|STARTED|Overall Study||285
2928842|NCT00579670|3639863|FG004|STARTED|Overall Study||5
2928843|NCT00579670|3639859|FG000|Population: Within SmPC (Started)|Overall Study|"Within summary of product characteristics (SmPC): FAS subjects who received all doses Within SmPC"|15
2928844|NCT00579670|3639860|FG001|Population: Within SmPC (Started)|Overall Study||56
2928845|NCT00579670|3639861|FG002|Population: Within SmPC (Started)|Overall Study||83
2928846|NCT00579670|3639862|FG003|Population: Within SmPC (Started)|Overall Study||159
2928847|NCT00579670|3639863|FG004|Population: Within SmPC (Started)|Overall Study|"Ziprasidone Unknown reporting group is not applicable to the Within SmPC population"|0
2928848|NCT00579670|3639859|FG000|Population: Within SmPC (Completed)|Overall Study|Not Completed (DC): Subject died N=1; Adverse Event (AE) N=1|13
2928849|NCT00579670|3639860|FG001|Population: Within SmPC (Completed)|Overall Study|DC: Lost to follow-up (LTFU) N=1|55
2928850|NCT00579670|3639861|FG002|Population: Within SmPC (Completed)|Overall Study|DC: AE N=1; Lack of efficacy N=1; Other unspecified N=1; Withdrawal by subject N=1|79
2928851|NCT00579670|3639862|FG003|Population: Within SmPC (Completed)|Overall Study|DC: AE N=2; Lack of efficacy N=5; LTFU N=3; Other unspecified N=2|147
2928852|NCT00579670|3639863|FG004|Population: Within SmPC (Completed)|Overall Study||0
2928853|NCT00579670|3639859|FG000|COMPLETED|Overall Study||13
2928854|NCT00579670|3639860|FG001|COMPLETED|Overall Study||56
2928855|NCT00579670|3639861|FG002|COMPLETED|Overall Study||84
2928856|NCT00579670|3639862|FG003|COMPLETED|Overall Study||263
2928857|NCT00579670|3639863|FG004|COMPLETED|Overall Study||5
2928858|NCT00579670|3639859|FG000|NOT COMPLETED|Overall Study||2
2928859|NCT00579670|3639860|FG001|NOT COMPLETED|Overall Study||1
2928860|NCT00579670|3639861|FG002|NOT COMPLETED|Overall Study||4
2928861|NCT00579670|3639862|FG003|NOT COMPLETED|Overall Study||22
2928862|NCT00579670|3639863|FG004|NOT COMPLETED|Overall Study||0
2928863|NCT00579813|3639889|FG000|STARTED|Overall Study||60
2928864|NCT00579813|3639890|FG001|STARTED|Overall Study||10
2928865|NCT00579813|3639889|FG000|COMPLETED|Overall Study||60
2928866|NCT00579813|3639890|FG001|COMPLETED|Overall Study||10
2928867|NCT00579813|3639889|FG000|NOT COMPLETED|Overall Study||0
2928868|NCT00579813|3639890|FG001|NOT COMPLETED|Overall Study||0
2928869|NCT00579878|3639900|FG000|STARTED|Overall Study||22
2928870|NCT00579878|3639901|FG001|STARTED|Overall Study||23
2928871|NCT00579878|3639902|FG002|STARTED|Overall Study||24
2928872|NCT00579878|3639900|FG000|COMPLETED|Overall Study||15
2928873|NCT00579878|3639901|FG001|COMPLETED|Overall Study||20
2928874|NCT00579878|3639902|FG002|COMPLETED|Overall Study||14
2928875|NCT00579878|3639900|FG000|NOT COMPLETED|Overall Study||7
2928876|NCT00579878|3639901|FG001|NOT COMPLETED|Overall Study||3
2928877|NCT00579878|3639902|FG002|NOT COMPLETED|Overall Study||10
2928878|NCT00579982|3639910|FG000|STARTED|Overall Study||97
2928879|NCT00579982|3639910|FG000|COMPLETED|Overall Study||89
2928880|NCT00579982|3639910|FG000|NOT COMPLETED|Overall Study||8
2928881|NCT00580034|3639914|FG000|STARTED|Overall Study||88
2928882|NCT00580034|3639915|FG001|STARTED|Overall Study||88
2928883|NCT00580034|3639914|FG000|COMPLETED|Overall Study||78
2928884|NCT00580034|3639915|FG001|COMPLETED|Overall Study||88
2928885|NCT00580034|3639914|FG000|NOT COMPLETED|Overall Study||10
2928886|NCT00580034|3639915|FG001|NOT COMPLETED|Overall Study||0
2928887|NCT00580047|3639922|FG000|STARTED|Overall Study||24
2928888|NCT00580047|3639923|FG001|STARTED|Overall Study||23
2928889|NCT00580047|3639924|FG002|STARTED|Overall Study||12
2928890|NCT00580047|3639922|FG000|COMPLETED|Overall Study||21
2928891|NCT00580047|3639923|FG001|COMPLETED|Overall Study||21
3040316|NCT01163643|3759812|FG002|STARTED|Overall Study||35
3040317|NCT01163643|3759813|FG003|STARTED|Overall Study||74
3040318|NCT01163643|3759814|FG004|STARTED|Overall Study||69
3040319|NCT01163643|3759815|FG005|STARTED|Overall Study||73
3040320|NCT01163643|3759810|FG000|COMPLETED|Overall Study||62
3040321|NCT01163643|3759811|FG001|COMPLETED|Overall Study||35
3040322|NCT01163643|3759812|FG002|COMPLETED|Overall Study||33
3179582|NCT01986010|3907715|FG005|NOT COMPLETED|Overall Study||8
3179583|NCT01986010|3907716|FG006|NOT COMPLETED|Overall Study||0
3179584|NCT01986010|3907717|FG007|NOT COMPLETED|Overall Study||0
2928892|NCT00580047|3639924|FG002|COMPLETED|Overall Study||10
2928893|NCT00580047|3639922|FG000|NOT COMPLETED|Overall Study||3
2928894|NCT00580047|3639923|FG001|NOT COMPLETED|Overall Study||2
2928895|NCT00580047|3639924|FG002|NOT COMPLETED|Overall Study||2
2928896|NCT00580073|3639935|FG000|STARTED|Overall Study||6
2928897|NCT00580073|3639935|FG000|COMPLETED|Overall Study||6
2928898|NCT00580073|3639935|FG000|NOT COMPLETED|Overall Study||0
2928899|NCT00580138|3639939|FG000|STARTED|Overall Study||30
2928900|NCT00580138|3639939|FG000|COMPLETED|Overall Study||30
2928901|NCT00580138|3639939|FG000|NOT COMPLETED|Overall Study||0
2928902|NCT00580151|3639945|FG000|STARTED|Overall Study||9
2928903|NCT00580151|3639946|FG001|STARTED|Overall Study||0
2928904|NCT00580151|3639945|FG000|COMPLETED|Overall Study||9
2928905|NCT00580151|3639946|FG001|COMPLETED|Overall Study||0
2928906|NCT00580151|3639945|FG000|NOT COMPLETED|Overall Study||0
2928907|NCT00580151|3639946|FG001|NOT COMPLETED|Overall Study||0
2928908|NCT00580229|3639952|FG000|STARTED|Overall Study||50
2928909|NCT00580229|3639952|FG000|COMPLETED|Overall Study||50
2928910|NCT00580229|3639952|FG000|NOT COMPLETED|Overall Study||0
2928911|NCT00580294|3639956|FG000|STARTED|Overall Study||12
2928912|NCT00580294|3639956|FG000|COMPLETED|Overall Study||12
2928913|NCT00580294|3639956|FG000|NOT COMPLETED|Overall Study||0
2928914|NCT00580333|3639960|FG000|STARTED|Overall Study||51
2928915|NCT00580333|3639960|FG000|COMPLETED|Overall Study||51
2928916|NCT00580333|3639960|FG000|NOT COMPLETED|Overall Study||0
2928917|NCT00580372|3639965|FG000|STARTED|Overall Study||231
2928918|NCT00580372|3639965|FG000|COMPLETED|Overall Study||231
2928919|NCT00580372|3639965|FG000|NOT COMPLETED|Overall Study||0
2928920|NCT00580398|3639971|FG000|STARTED|Overall Study||17
2928921|NCT00580398|3639972|FG001|STARTED|Overall Study||32
2928922|NCT00580398|3639971|FG000|COMPLETED|Overall Study||17
2928923|NCT00580398|3639972|FG001|COMPLETED|Overall Study||32
2928924|NCT00580398|3639971|FG000|NOT COMPLETED|Overall Study||0
2928925|NCT00580398|3639972|FG001|NOT COMPLETED|Overall Study||0
2928926|NCT00580502|3639978|FG000|STARTED|Overall Study||50
2928927|NCT00580502|3639978|FG000|COMPLETED|Overall Study||50
2928928|NCT00580502|3639978|FG000|NOT COMPLETED|Overall Study||0
2928929|NCT00580606|3639984|FG000|STARTED|Double Blind (DB)||20
2928930|NCT00580606|3639985|FG001|STARTED|Double Blind (DB)||20
2928931|NCT00580606|3639984|FG000|Had Week 44 Oral Food Challenge|Double Blind (DB)||18
2928932|NCT00580606|3639985|FG001|Had Week 44 Oral Food Challenge|Double Blind (DB)||19
2928933|NCT00580606|3639984|FG000|COMPLETED|Double Blind (DB)|Completed: Participants who were assessed for the primary outcome measure.|20
2928934|NCT00580606|3639985|FG001|COMPLETED|Double Blind (DB)|Completed: Participants who were assessed for the primary outcome measure.|20
2928935|NCT00580606|3639984|FG000|NOT COMPLETED|Double Blind (DB)||0
2928936|NCT00580606|3639985|FG001|NOT COMPLETED|Double Blind (DB)||0
2928937|NCT00580606|3639984|FG000|STARTED|Open Label (OL)|2 participants discontinued dosing before Open Label (OL) period.|18
2928938|NCT00580606|3639985|FG001|STARTED|Open Label (OL)|1 participant discontinued dosing before OL period; 2 passed Week 44 OFC & ineligible to crossover.|17
2928939|NCT00580606|3639984|FG000|Had Week 44 Oral Food Challenge|Open Label (OL)|The Week 44 OFC for Low Dose Peanut SLIT was done at the end of the DB Period, not the OL period.|0
3040323|NCT01163643|3759813|FG003|COMPLETED|Overall Study||69
3040324|NCT01163643|3759814|FG004|COMPLETED|Overall Study||61
3040325|NCT01163643|3759815|FG005|COMPLETED|Overall Study||66
3040326|NCT01163643|3759810|FG000|NOT COMPLETED|Overall Study||6
3040327|NCT01163643|3759811|FG001|NOT COMPLETED|Overall Study||2
3040328|NCT01163643|3759812|FG002|NOT COMPLETED|Overall Study||2
3040329|NCT01163643|3759813|FG003|NOT COMPLETED|Overall Study||5
3040330|NCT01163643|3759814|FG004|NOT COMPLETED|Overall Study||8
3040331|NCT01163643|3759815|FG005|NOT COMPLETED|Overall Study||7
3040332|NCT01163656|3759831|FG000|STARTED|Overall Study||33
3040333|NCT01163656|3759832|FG001|STARTED|Overall Study||33
3040334|NCT01163656|3759831|FG000|COMPLETED|Overall Study||30
3040335|NCT01163656|3759832|FG001|COMPLETED|Overall Study||30
3040336|NCT01163656|3759831|FG000|NOT COMPLETED|Overall Study||3
3040337|NCT01163656|3759832|FG001|NOT COMPLETED|Overall Study||3
3040338|NCT01163721|3759840|FG000|STARTED|Overall Study||39
3040339|NCT01163721|3759841|FG001|STARTED|Overall Study||41
3040340|NCT01163721|3759840|FG000|COMPLETED|Overall Study||31
3040341|NCT01163721|3759841|FG001|COMPLETED|Overall Study||29
3040342|NCT01163721|3759840|FG000|NOT COMPLETED|Overall Study||8
3040343|NCT01163721|3759841|FG001|NOT COMPLETED|Overall Study||12
3040344|NCT01163747|3759849|FG000|STARTED|Overall Study||31
3040345|NCT01163747|3759850|FG001|STARTED|Overall Study||60
3040346|NCT01163747|3759849|FG000|Per Protocol Population|Overall Study|Participants who received at least 1 dose of study treatment excluding major protocol violators.|27
3040347|NCT01163747|3759850|FG001|Per Protocol Population|Overall Study|Participants who received at least 1 dose of study treatment excluding major protocol violators.|54
3040348|NCT01163747|3759849|FG000|COMPLETED|Overall Study||25
3040349|NCT01163747|3759850|FG001|COMPLETED|Overall Study||49
3040350|NCT01163747|3759849|FG000|NOT COMPLETED|Overall Study||6
3040351|NCT01163747|3759850|FG001|NOT COMPLETED|Overall Study||11
3040352|NCT01163760|3759856|FG000|STARTED|Period 1 (Fit)||12
3040353|NCT01163760|3759857|FG001|STARTED|Period 1 (Fit)||13
3040354|NCT01163760|3759858|FG002|STARTED|Period 1 (Fit)||13
3040355|NCT01163760|3759859|FG003|STARTED|Period 1 (Fit)||12
3040356|NCT01163760|3759856|FG000|COMPLETED|Period 1 (Fit)||12
3040357|NCT01163760|3759857|FG001|COMPLETED|Period 1 (Fit)||13
3040358|NCT01163760|3759858|FG002|COMPLETED|Period 1 (Fit)||13
3040359|NCT01163760|3759859|FG003|COMPLETED|Period 1 (Fit)||12
3040360|NCT01163760|3759856|FG000|NOT COMPLETED|Period 1 (Fit)||0
3040361|NCT01163760|3759857|FG001|NOT COMPLETED|Period 1 (Fit)||0
3179585|NCT01986010|3907718|FG008|NOT COMPLETED|Overall Study||6
3179586|NCT01986010|3907719|FG009|NOT COMPLETED|Overall Study||3
3179587|NCT01986010|3907720|FG010|NOT COMPLETED|Overall Study||7
3179588|NCT01986010|3907721|FG011|NOT COMPLETED|Overall Study||10
3179589|NCT01986010|3907722|FG012|NOT COMPLETED|Overall Study||10
3179590|NCT01986010|3907723|FG013|NOT COMPLETED|Overall Study||11
3179591|NCT01986010|3907724|FG014|NOT COMPLETED|Overall Study||10
2928940|NCT00580606|3639985|FG001|Had Week 44 Oral Food Challenge|Open Label (OL)|After 44 weeks of OL high dose SLIT; 1 additional participant declined Week 44 OFC in OL period.|12
2928941|NCT00580606|3639984|FG000|Had Week 68 Oral Food Challenge|Open Label (OL)||15
2928942|NCT00580606|3639985|FG001|Had Week 68 Oral Food Challenge|Open Label (OL)||12
2928943|NCT00580606|3639984|FG000|Had Week 116 Oral Food Challenge|Open Label (OL)||13
2928944|NCT00580606|3639985|FG001|Had Week 116 Oral Food Challenge|Open Label (OL)||6
2928945|NCT00580606|3639984|FG000|Had Week 164 Oral Food Challenge|Open Label (OL)||9
2928946|NCT00580606|3639985|FG001|Had Week 164 Oral Food Challenge|Open Label (OL)||5
2928947|NCT00580606|3639984|FG000|Had Week 172 Oral Food Challenge|Open Label (OL)||2
2928948|NCT00580606|3639985|FG001|Had Week 172 Oral Food Challenge|Open Label (OL)||2
2928949|NCT00580606|3639984|FG000|COMPLETED|Open Label (OL)|Completed dosing & final Wk 164 desensitization OFC & Wk 172 tolerance OFC (if passed Wk 164 OFC).|9
2928950|NCT00580606|3639985|FG001|COMPLETED|Open Label (OL)|Completed dosing & final Wk 164 desensitization OFC & Wk 172 tolerance OFC (if passed Wk 164 OFC).|5
2928951|NCT00580606|3639984|FG000|NOT COMPLETED|Open Label (OL)||9
2928952|NCT00580606|3639985|FG001|NOT COMPLETED|Open Label (OL)||12
3040362|NCT01163760|3759858|FG002|NOT COMPLETED|Period 1 (Fit)||0
3040363|NCT01163760|3759859|FG003|NOT COMPLETED|Period 1 (Fit)||0
3040364|NCT01163760|3759856|FG000|STARTED|Period 2 (Follow-up)||12
3040365|NCT01163760|3759857|FG001|STARTED|Period 2 (Follow-up)||13
3040366|NCT01163760|3759858|FG002|STARTED|Period 2 (Follow-up)||13
3040367|NCT01163760|3759859|FG003|STARTED|Period 2 (Follow-up)||12
3040368|NCT01163760|3759856|FG000|COMPLETED|Period 2 (Follow-up)||12
3040369|NCT01163760|3759857|FG001|COMPLETED|Period 2 (Follow-up)||13
3040370|NCT01163760|3759858|FG002|COMPLETED|Period 2 (Follow-up)||13
3040371|NCT01163760|3759859|FG003|COMPLETED|Period 2 (Follow-up)||12
3040372|NCT01163760|3759856|FG000|NOT COMPLETED|Period 2 (Follow-up)||0
3040373|NCT01163760|3759857|FG001|NOT COMPLETED|Period 2 (Follow-up)||0
3040374|NCT01163760|3759858|FG002|NOT COMPLETED|Period 2 (Follow-up)||0
3040375|NCT01163760|3759859|FG003|NOT COMPLETED|Period 2 (Follow-up)||0
3040376|NCT01163760|3759856|FG000|STARTED|Period 3 (Fit)||12
3040377|NCT01163760|3759857|FG001|STARTED|Period 3 (Fit)||13
3040378|NCT01163760|3759858|FG002|STARTED|Period 3 (Fit)||13
3040379|NCT01163760|3759859|FG003|STARTED|Period 3 (Fit)||12
3040380|NCT01163760|3759856|FG000|COMPLETED|Period 3 (Fit)||12
3040381|NCT01163760|3759857|FG001|COMPLETED|Period 3 (Fit)||13
3040382|NCT01163760|3759858|FG002|COMPLETED|Period 3 (Fit)||13
3040383|NCT01163760|3759859|FG003|COMPLETED|Period 3 (Fit)||12
3040384|NCT01163760|3759856|FG000|NOT COMPLETED|Period 3 (Fit)||0
3040385|NCT01163760|3759857|FG001|NOT COMPLETED|Period 3 (Fit)||0
3040386|NCT01163760|3759858|FG002|NOT COMPLETED|Period 3 (Fit)||0
3040387|NCT01163760|3759859|FG003|NOT COMPLETED|Period 3 (Fit)||0
2928953|NCT00580645|3640002|FG000|STARTED|Overall Study||20
2928954|NCT00580645|3640003|FG001|STARTED|Overall Study||20
2928955|NCT00580645|3640004|FG002|STARTED|Overall Study||20
2928956|NCT00580645|3640002|FG000|COMPLETED|Overall Study||20
2928957|NCT00580645|3640003|FG001|COMPLETED|Overall Study||20
3179592|NCT01986010|3907725|FG015|NOT COMPLETED|Overall Study||11
3179593|NCT01986010|3907726|FG016|NOT COMPLETED|Overall Study||4
3179594|NCT01986062|3907774|FG000|STARTED|Overall Study||47
3179595|NCT01986062|3907775|FG001|STARTED|Overall Study||50
3179596|NCT01986062|3907774|FG000|COMPLETED|Overall Study||46
3179597|NCT01986062|3907775|FG001|COMPLETED|Overall Study||49
3179598|NCT01986062|3907774|FG000|NOT COMPLETED|Overall Study||1
3179599|NCT01986062|3907775|FG001|NOT COMPLETED|Overall Study||1
3179600|NCT01986101|3907784|FG000|STARTED|Overall Study||172
3179601|NCT01986101|3907785|FG001|STARTED|Overall Study||184
3179602|NCT01986101|3907786|FG002|STARTED|Overall Study||169
3179603|NCT01986101|3907784|FG000|Intent-to-Treat Population|Overall Study||171
3179604|NCT01986101|3907785|FG001|Intent-to-Treat Population|Overall Study||182
3179605|NCT01986101|3907786|FG002|Intent-to-Treat Population|Overall Study||169
3179606|NCT01986101|3907784|FG000|Safety Population|Overall Study||172
3179607|NCT01986101|3907785|FG001|Safety Population|Overall Study||184
2928958|NCT00580645|3640004|FG002|COMPLETED|Overall Study||20
2928959|NCT00580645|3640002|FG000|NOT COMPLETED|Overall Study||0
3040388|NCT01163760|3759856|FG000|STARTED|Period 4 (Follow-up)||12
3040389|NCT01163760|3759857|FG001|STARTED|Period 4 (Follow-up)||13
3040390|NCT01163760|3759858|FG002|STARTED|Period 4 (Follow-up)||13
3040391|NCT01163760|3759859|FG003|STARTED|Period 4 (Follow-up)||12
3040392|NCT01163760|3759856|FG000|COMPLETED|Period 4 (Follow-up)||12
3040393|NCT01163760|3759857|FG001|COMPLETED|Period 4 (Follow-up)||13
3040394|NCT01163760|3759858|FG002|COMPLETED|Period 4 (Follow-up)||13
3040395|NCT01163760|3759859|FG003|COMPLETED|Period 4 (Follow-up)||12
3040396|NCT01163760|3759856|FG000|NOT COMPLETED|Period 4 (Follow-up)||0
3040397|NCT01163760|3759857|FG001|NOT COMPLETED|Period 4 (Follow-up)||0
3040398|NCT01163760|3759858|FG002|NOT COMPLETED|Period 4 (Follow-up)||0
3040399|NCT01163760|3759859|FG003|NOT COMPLETED|Period 4 (Follow-up)||0
3040400|NCT01163786|3759867|FG000|STARTED|Treatment With Bortezomib||17
3040401|NCT01163786|3759867|FG000|Completed 1st Cycle|Treatment With Bortezomib||17
3040402|NCT01163786|3759867|FG000|Completed 2nd Cycle|Treatment With Bortezomib|One patient completed cycle 2 but missed one dose of Bortezomib.|14
3040403|NCT01163786|3759867|FG000|COMPLETED|Treatment With Bortezomib||14
3040404|NCT01163786|3759867|FG000|NOT COMPLETED|Treatment With Bortezomib||3
3040405|NCT01163786|3759867|FG000|STARTED|Completed Follow up (Visit 9 and 10)||14
3040406|NCT01163786|3759867|FG000|Completed Week 12 Follow up (Visit 9)|Completed Follow up (Visit 9 and 10)||14
3040407|NCT01163786|3759867|FG000|Completed Week 18 Follow up (Visit 10)|Completed Follow up (Visit 9 and 10)||13
3040408|NCT01163786|3759867|FG000|COMPLETED|Completed Follow up (Visit 9 and 10)||13
3040409|NCT01163786|3759867|FG000|NOT COMPLETED|Completed Follow up (Visit 9 and 10)||1
3040410|NCT01163851|3759873|FG000|STARTED|Overall Study||13
3040411|NCT01163851|3759874|FG001|STARTED|Overall Study||12
3040412|NCT01163851|3759873|FG000|Treated|Overall Study||12
3040413|NCT01163851|3759874|FG001|Treated|Overall Study||12
3040414|NCT01163851|3759873|FG000|COMPLETED|Overall Study||12
3040415|NCT01163851|3759874|FG001|COMPLETED|Overall Study||11
3040416|NCT01163851|3759873|FG000|NOT COMPLETED|Overall Study||1
3040417|NCT01163851|3759874|FG001|NOT COMPLETED|Overall Study||1
3040418|NCT01163916|3759883|FG000|STARTED|Overall Study||126
3040419|NCT01163916|3759884|FG001|STARTED|Overall Study||35
3040420|NCT01163916|3759885|FG002|STARTED|Overall Study||91
3040421|NCT01163916|3759883|FG000|Safety Population|Overall Study|One patient discontinued prior to receiving treatment with adalimumab due to absence of medication.|125
3040422|NCT01163916|3759884|FG001|Safety Population|Overall Study||35
3040423|NCT01163916|3759885|FG002|Safety Population|Overall Study||91
3040424|NCT01163916|3759883|FG000|COMPLETED|Overall Study|Completed 12-months treatment with adalimumab|96
3040425|NCT01163916|3759884|FG001|COMPLETED|Overall Study|Completed 12-months treatment with adalimumab|31
3040426|NCT01163916|3759885|FG002|COMPLETED|Overall Study|Completed 12-months treatment with adalimumab|71
3040427|NCT01163916|3759883|FG000|NOT COMPLETED|Overall Study||30
3040428|NCT01163916|3759884|FG001|NOT COMPLETED|Overall Study||4
3040429|NCT01163916|3759885|FG002|NOT COMPLETED|Overall Study||20
3040430|NCT01163955|3759900|FG000|STARTED|Overall Study||26
3040431|NCT01163955|3759901|FG001|STARTED|Overall Study||30
3040432|NCT01163955|3759900|FG000|COMPLETED|Overall Study||26
3040433|NCT01163955|3759901|FG001|COMPLETED|Overall Study||26
3040434|NCT01163955|3759900|FG000|NOT COMPLETED|Overall Study||0
3040435|NCT01163955|3759901|FG001|NOT COMPLETED|Overall Study||4
3040436|NCT01164007|3759907|FG000|STARTED|Overall Study||40
3040437|NCT01164007|3759907|FG000|Treated|Overall Study||37
3040438|NCT01164007|3759907|FG000|COMPLETED|Overall Study||0
3040439|NCT01164007|3759907|FG000|NOT COMPLETED|Overall Study||40
3040440|NCT01164098|3759913|FG000|STARTED|Overall Study||15
3040441|NCT01164098|3759914|FG001|STARTED|Overall Study||15
3040442|NCT01164098|3759913|FG000|COMPLETED|Overall Study||15
3040443|NCT01164098|3759914|FG001|COMPLETED|Overall Study||15
3040444|NCT01164098|3759913|FG000|NOT COMPLETED|Overall Study||0
3040445|NCT01164098|3759914|FG001|NOT COMPLETED|Overall Study||0
3040446|NCT01164137|3759922|FG000|STARTED|Overall Study||80
3040447|NCT01164137|3759923|FG001|STARTED|Overall Study||76
3040448|NCT01164137|3759922|FG000|COMPLETED|Overall Study||77
3040449|NCT01164137|3759923|FG001|COMPLETED|Overall Study||76
3040450|NCT01164137|3759922|FG000|NOT COMPLETED|Overall Study||3
3040451|NCT01164137|3759923|FG001|NOT COMPLETED|Overall Study||0
3040452|NCT01164475|3759931|FG000|STARTED|Overall Study||30
2928960|NCT00580645|3640003|FG001|NOT COMPLETED|Overall Study||0
2928961|NCT00580645|3640004|FG002|NOT COMPLETED|Overall Study||0
2928962|NCT00580671|3640015|FG000|STARTED|Overall Study||51
2928963|NCT00580671|3640016|FG001|STARTED|Overall Study||51
2928964|NCT00580671|3640017|FG002|STARTED|Overall Study||51
2928965|NCT00580671|3640015|FG000|COMPLETED|Overall Study||35
2928966|NCT00580671|3640016|FG001|COMPLETED|Overall Study||35
2928967|NCT00580671|3640017|FG002|COMPLETED|Overall Study||34
2928968|NCT00580671|3640015|FG000|NOT COMPLETED|Overall Study||16
2928969|NCT00580671|3640016|FG001|NOT COMPLETED|Overall Study||16
2928970|NCT00580671|3640017|FG002|NOT COMPLETED|Overall Study||17
2928971|NCT00580723|3640025|FG000|STARTED|Overall Study||24
2928972|NCT00580723|3640025|FG000|COMPLETED|Overall Study||16
2928973|NCT00580723|3640025|FG000|NOT COMPLETED|Overall Study||8
2928974|NCT00580788|3640033|FG000|STARTED|Overall Study||3
2928975|NCT00580788|3640034|FG001|STARTED|Overall Study||6
2928976|NCT00580788|3640035|FG002|STARTED|Overall Study||3
2928977|NCT00580788|3640036|FG003|STARTED|Overall Study||2
2928978|NCT00580788|3640033|FG000|COMPLETED|Overall Study||3
2928979|NCT00580788|3640034|FG001|COMPLETED|Overall Study||6
2928980|NCT00580788|3640035|FG002|COMPLETED|Overall Study||3
2928981|NCT00580788|3640036|FG003|COMPLETED|Overall Study|One subject was stopped early for hypertension. One subject completed but was not analyzed.|1
2928982|NCT00580788|3640033|FG000|NOT COMPLETED|Overall Study||0
2928983|NCT00580788|3640034|FG001|NOT COMPLETED|Overall Study||0
2928984|NCT00580788|3640035|FG002|NOT COMPLETED|Overall Study||0
2928985|NCT00580788|3640036|FG003|NOT COMPLETED|Overall Study||1
2928986|NCT00580801|3640056|FG000|STARTED|Overall Study||8
2928987|NCT00580801|3640057|FG001|STARTED|Overall Study||8
2928988|NCT00580801|3640058|FG002|STARTED|Overall Study||8
2928989|NCT00580801|3640056|FG000|COMPLETED|Overall Study||2
2928990|NCT00580801|3640057|FG001|COMPLETED|Overall Study||7
2928991|NCT00580801|3640058|FG002|COMPLETED|Overall Study||5
2928992|NCT00580801|3640056|FG000|NOT COMPLETED|Overall Study||6
2928993|NCT00580801|3640057|FG001|NOT COMPLETED|Overall Study||1
2928994|NCT00580801|3640058|FG002|NOT COMPLETED|Overall Study||3
2928995|NCT00580840|3640066|FG000|STARTED|Run-in|620 subjects were screened for the study with 333 being enrolled.|333
2928996|NCT00580840|3640067|FG001|STARTED|Run-in||0
2928997|NCT00580840|3640068|FG002|STARTED|Run-in||0
2928998|NCT00580840|3640069|FG003|STARTED|Run-in||0
2928999|NCT00580840|3640066|FG000|COMPLETED|Run-in|Of the 209 randomized participants, 208 are in the Full Analysis Set (FAS).|209
2929000|NCT00580840|3640067|FG001|COMPLETED|Run-in||0
2929001|NCT00580840|3640068|FG002|COMPLETED|Run-in||0
2929002|NCT00580840|3640069|FG003|COMPLETED|Run-in||0
2929003|NCT00580840|3640066|FG000|NOT COMPLETED|Run-in||124
2929004|NCT00580840|3640067|FG001|NOT COMPLETED|Run-in||0
2929005|NCT00580840|3640068|FG002|NOT COMPLETED|Run-in||0
2929006|NCT00580840|3640069|FG003|NOT COMPLETED|Run-in||0
2929007|NCT00580840|3640066|FG000|STARTED|Double-Blind||0
2929008|NCT00580840|3640067|FG001|STARTED|Double-Blind||70
2929009|NCT00580840|3640068|FG002|STARTED|Double-Blind||70
2929010|NCT00580840|3640069|FG003|STARTED|Double-Blind||69
2929011|NCT00580840|3640066|FG000|COMPLETED|Double-Blind||0
2929012|NCT00580840|3640067|FG001|COMPLETED|Double-Blind||63
2929013|NCT00580840|3640068|FG002|COMPLETED|Double-Blind||61
2929014|NCT00580840|3640069|FG003|COMPLETED|Double-Blind||54
2929015|NCT00580840|3640066|FG000|NOT COMPLETED|Double-Blind||0
2929016|NCT00580840|3640067|FG001|NOT COMPLETED|Double-Blind||7
2929017|NCT00580840|3640068|FG002|NOT COMPLETED|Double-Blind||9
2929018|NCT00580840|3640069|FG003|NOT COMPLETED|Double-Blind||15
2929019|NCT00580853|3640082|FG000|STARTED|Overall Study||20
2929020|NCT00580853|3640083|FG001|STARTED|Overall Study||21
2929021|NCT00580853|3640084|FG002|STARTED|Overall Study||21
2929022|NCT00580853|3640082|FG000|COMPLETED|Overall Study||20
2929023|NCT00580853|3640083|FG001|COMPLETED|Overall Study||21
2929024|NCT00580853|3640084|FG002|COMPLETED|Overall Study||21
2929025|NCT00580853|3640082|FG000|NOT COMPLETED|Overall Study||0
2929026|NCT00580853|3640083|FG001|NOT COMPLETED|Overall Study||0
2929027|NCT00580853|3640084|FG002|NOT COMPLETED|Overall Study||0
2929028|NCT00580866|3640094|FG000|STARTED|Overall Study||10
2929029|NCT00580866|3640095|FG001|STARTED|Overall Study||7
2929030|NCT00580866|3640094|FG000|COMPLETED|Overall Study||8
2929031|NCT00580866|3640095|FG001|COMPLETED|Overall Study||5
2929032|NCT00580866|3640094|FG000|NOT COMPLETED|Overall Study||2
2929033|NCT00580866|3640095|FG001|NOT COMPLETED|Overall Study||2
2929034|NCT00580957|3640103|FG000|STARTED|Overall Study||28
2929035|NCT00580957|3640104|FG001|STARTED|Overall Study||28
2929036|NCT00580957|3640103|FG000|COMPLETED|Overall Study||21
2929037|NCT00580957|3640104|FG001|COMPLETED|Overall Study||21
2929038|NCT00580957|3640103|FG000|NOT COMPLETED|Overall Study||7
2929039|NCT00580957|3640104|FG001|NOT COMPLETED|Overall Study||7
2929040|NCT00580970|3640112|FG000|STARTED|Pre-treatment||73
2929041|NCT00580970|3640112|FG000|COMPLETED|Pre-treatment||72
2929042|NCT00580970|3640112|FG000|NOT COMPLETED|Pre-treatment||1
2929043|NCT00580970|3640112|FG000|STARTED|Treatment (Lovastatin)||72
2929044|NCT00580970|3640112|FG000|6 Months of Treatment|Treatment (Lovastatin)|Subjects evaluable for analysis|53
2929045|NCT00580970|3640112|FG000|COMPLETED|Treatment (Lovastatin)||53
2929046|NCT00580970|3640112|FG000|NOT COMPLETED|Treatment (Lovastatin)||19
2929047|NCT00580983|3640116|FG000|STARTED|Overall Study||80
2929048|NCT00580983|3640116|FG000|COMPLETED|Overall Study||73
2929049|NCT00580983|3640116|FG000|NOT COMPLETED|Overall Study||7
2929050|NCT00581048|3640120|FG000|STARTED|Overall Study||33
2929051|NCT00581048|3640120|FG000|COMPLETED|Overall Study||33
2929052|NCT00581048|3640120|FG000|NOT COMPLETED|Overall Study||0
2929053|NCT00581061|3640125|FG000|STARTED|Overall Study||13
2929054|NCT00581061|3640125|FG000|COMPLETED|Overall Study||13
2929055|NCT00581061|3640125|FG000|NOT COMPLETED|Overall Study||0
2929056|NCT00581100|3640133|FG000|STARTED|Overall Study||38
2929057|NCT00581100|3640134|FG001|STARTED|Overall Study||34
2929058|NCT00581100|3640133|FG000|Modified Intent-To-Treat Population|Overall Study|At least one dose of study medication, and had baseline and post-baseline data.|36
2929059|NCT00581100|3640134|FG001|Modified Intent-To-Treat Population|Overall Study|At least one dose of study medication, and had baseline and post-baseline data.|33
2929060|NCT00581100|3640133|FG000|COMPLETED|Overall Study||31
2929061|NCT00581100|3640134|FG001|COMPLETED|Overall Study||29
2929062|NCT00581100|3640133|FG000|NOT COMPLETED|Overall Study||7
2929063|NCT00581100|3640134|FG001|NOT COMPLETED|Overall Study||5
2929064|NCT00581230|3640140|FG000|STARTED|Overall Study||51
2929065|NCT00581230|3640140|FG000|Laryngoscopy Without RAMP|Overall Study||51
2929066|NCT00581230|3640140|FG000|Laryngoscopy With RAMP|Overall Study||51
2929067|NCT00581230|3640140|FG000|COMPLETED|Overall Study||51
2929068|NCT00581230|3640140|FG000|NOT COMPLETED|Overall Study||0
2929069|NCT00581256|3640149|FG000|STARTED|Overall Study||28
2929070|NCT00581256|3640150|FG001|STARTED|Overall Study||26
3040453|NCT01164475|3759932|FG001|STARTED|Overall Study||31
3040454|NCT01164475|3759931|FG000|COMPLETED|Overall Study||28
3040455|NCT01164475|3759932|FG001|COMPLETED|Overall Study||29
3040456|NCT01164475|3759931|FG000|NOT COMPLETED|Overall Study||2
3040457|NCT01164475|3759932|FG001|NOT COMPLETED|Overall Study||2
3040458|NCT01164501|3759941|FG000|STARTED|Overall Study||321
3040459|NCT01164501|3759942|FG001|STARTED|Overall Study||98
3040460|NCT01164501|3759943|FG002|STARTED|Overall Study||322
3040461|NCT01164501|3759941|FG000|COMPLETED|Overall Study||278
3040462|NCT01164501|3759942|FG001|COMPLETED|Overall Study||88
3040463|NCT01164501|3759943|FG002|COMPLETED|Overall Study||280
3040464|NCT01164501|3759941|FG000|NOT COMPLETED|Overall Study||43
3040465|NCT01164501|3759942|FG001|NOT COMPLETED|Overall Study||10
3040466|NCT01164501|3759943|FG002|NOT COMPLETED|Overall Study||42
3040467|NCT01164579|3759956|FG000|STARTED|Overall Study||36
3040468|NCT01164579|3759957|FG001|STARTED|Overall Study||36
3040469|NCT01164579|3759958|FG002|STARTED|Overall Study||37
3040470|NCT01164579|3759956|FG000|COMPLETED|Overall Study||28
3040471|NCT01164579|3759957|FG001|COMPLETED|Overall Study||27
3040472|NCT01164579|3759958|FG002|COMPLETED|Overall Study||21
3179608|NCT01986101|3907786|FG002|Safety Population|Overall Study||169
3179609|NCT01986101|3907784|FG000|COMPLETED|Overall Study||139
3179610|NCT01986101|3907785|FG001|COMPLETED|Overall Study||157
3179611|NCT01986101|3907786|FG002|COMPLETED|Overall Study||137
3179612|NCT01986101|3907784|FG000|NOT COMPLETED|Overall Study||33
3179613|NCT01986101|3907785|FG001|NOT COMPLETED|Overall Study||27
3179614|NCT01986101|3907786|FG002|NOT COMPLETED|Overall Study||32
3179615|NCT01986114|3907797|FG000|STARTED|Overall Study||495
3179616|NCT01986114|3907797|FG000|COMPLETED|Overall Study||339
3179617|NCT01986114|3907797|FG000|NOT COMPLETED|Overall Study||156
3179618|NCT01986140|3907805|FG000|STARTED|Overall Study||157
3179619|NCT01986140|3907806|FG001|STARTED|Overall Study||79
3179620|NCT01986140|3907805|FG000|COMPLETED|Overall Study||122
3179621|NCT01986140|3907806|FG001|COMPLETED|Overall Study||51
3179622|NCT01986140|3907805|FG000|NOT COMPLETED|Overall Study||35
3179623|NCT01986140|3907806|FG001|NOT COMPLETED|Overall Study||28
3179624|NCT01986231|3907812|FG000|STARTED|Overall Study||12
3179625|NCT01986231|3907812|FG000|COMPLETED|Overall Study||11
3179626|NCT01986231|3907812|FG000|NOT COMPLETED|Overall Study||1
3179627|NCT01986348|3907820|FG000|STARTED|Overall Study||8
3179628|NCT01986348|3907821|FG001|STARTED|Overall Study||24
3179629|NCT01986348|3907822|FG002|STARTED|Overall Study||14
3179630|NCT01986348|3907823|FG003|STARTED|Overall Study||30
3179631|NCT01986348|3907820|FG000|COMPLETED|Overall Study||0
3179632|NCT01986348|3907821|FG001|COMPLETED|Overall Study||0
3179633|NCT01986348|3907822|FG002|COMPLETED|Overall Study||0
3179634|NCT01986348|3907823|FG003|COMPLETED|Overall Study||0
3179635|NCT01986348|3907820|FG000|NOT COMPLETED|Overall Study||8
3179636|NCT01986348|3907821|FG001|NOT COMPLETED|Overall Study||24
3179637|NCT01986348|3907822|FG002|NOT COMPLETED|Overall Study||14
3179638|NCT01986348|3907823|FG003|NOT COMPLETED|Overall Study||30
3179639|NCT01986361|3907838|FG000|STARTED|Overall Study||101
3179640|NCT01986361|3907839|FG001|STARTED|Overall Study||21
3179641|NCT01986361|3907838|FG000|COMPLETED|Overall Study||101
3179642|NCT01986361|3907839|FG001|COMPLETED|Overall Study||21
3179643|NCT01986361|3907838|FG000|NOT COMPLETED|Overall Study||0
3179644|NCT01986361|3907839|FG001|NOT COMPLETED|Overall Study||0
3179645|NCT01986647|3907849|FG000|STARTED|Overall Study||152
3179646|NCT01986647|3907850|FG001|STARTED|Overall Study||146
3179647|NCT01986647|3907851|FG002|STARTED|Overall Study||49
3179648|NCT01986647|3907852|FG003|STARTED|Overall Study||77
2929071|NCT00581256|3640149|FG000|COMPLETED|Overall Study||28
2929072|NCT00581256|3640150|FG001|COMPLETED|Overall Study||26
2929073|NCT00581256|3640149|FG000|NOT COMPLETED|Overall Study||0
2929074|NCT00581256|3640150|FG001|NOT COMPLETED|Overall Study||0
2929075|NCT00581308|3640156|FG000|STARTED|Pre Discharge||215
2929076|NCT00581308|3640156|FG000|COMPLETED|Pre Discharge||213
2929077|NCT00581308|3640156|FG000|NOT COMPLETED|Pre Discharge||2
2929078|NCT00581308|3640156|FG000|STARTED|Month 1||213
2929079|NCT00581308|3640156|FG000|COMPLETED|Month 1||205
2929080|NCT00581308|3640156|FG000|NOT COMPLETED|Month 1||8
2929081|NCT00581308|3640156|FG000|STARTED|Month 6||205
2929082|NCT00581308|3640156|FG000|COMPLETED|Month 6||202
2929083|NCT00581308|3640156|FG000|NOT COMPLETED|Month 6||3
2929084|NCT00581308|3640156|FG000|STARTED|Month 12||202
2929085|NCT00581308|3640156|FG000|COMPLETED|Month 12||182
2929086|NCT00581308|3640156|FG000|NOT COMPLETED|Month 12||20
2929087|NCT00581308|3640156|FG000|STARTED|24 Months||182
2929088|NCT00581308|3640156|FG000|COMPLETED|24 Months||176
2929089|NCT00581308|3640156|FG000|NOT COMPLETED|24 Months||6
2929090|NCT00581308|3640156|FG000|STARTED|36 Months||176
2929091|NCT00581308|3640156|FG000|COMPLETED|36 Months||170
2929092|NCT00581308|3640156|FG000|NOT COMPLETED|36 Months||6
2929093|NCT00581308|3640156|FG000|STARTED|48 Months||170
2929094|NCT00581308|3640156|FG000|COMPLETED|48 Months||161
2929095|NCT00581308|3640156|FG000|NOT COMPLETED|48 Months||9
2929096|NCT00581308|3640156|FG000|STARTED|60 Months||161
2929097|NCT00581308|3640156|FG000|COMPLETED|60 Months||158
2929098|NCT00581308|3640156|FG000|NOT COMPLETED|60 Months||3
2929099|NCT00581347|3640165|FG000|STARTED|Overall Study||3839
2929100|NCT00581347|3640166|FG001|STARTED|Overall Study||3707
2929101|NCT00581347|3640165|FG000|COMPLETED|Overall Study||3839
2929102|NCT00581347|3640166|FG001|COMPLETED|Overall Study||3707
2929103|NCT00581347|3640165|FG000|NOT COMPLETED|Overall Study||0
2929104|NCT00581347|3640166|FG001|NOT COMPLETED|Overall Study||0
2929105|NCT00581360|3640172|FG000|STARTED|Overall Study||10
2929106|NCT00581360|3640172|FG000|COMPLETED|Overall Study||9
2929107|NCT00581360|3640172|FG000|NOT COMPLETED|Overall Study||1
2929108|NCT00581386|3640179|FG000|STARTED|Overall Study|05/30/2007|73
2929109|NCT00581386|3640180|FG001|STARTED|Overall Study|05/30/2007|73
2929110|NCT00581386|3640181|FG002|STARTED|Overall Study|05/30/2007|72
2929111|NCT00581386|3640179|FG000|COMPLETED|Overall Study|04/15/2009|73
2929112|NCT00581386|3640180|FG001|COMPLETED|Overall Study|04/15/2009|73
3040473|NCT01164579|3759956|FG000|NOT COMPLETED|Overall Study||8
3040474|NCT01164579|3759957|FG001|NOT COMPLETED|Overall Study||9
3040475|NCT01164579|3759958|FG002|NOT COMPLETED|Overall Study||16
3040476|NCT01164644|3759969|FG000|STARTED|Overall Study||12
3040477|NCT01164644|3759970|FG001|STARTED|Overall Study||14
3040478|NCT01164644|3759969|FG000|COMPLETED|Overall Study||9
3040479|NCT01164644|3759970|FG001|COMPLETED|Overall Study||13
3040480|NCT01164644|3759969|FG000|NOT COMPLETED|Overall Study||3
3040481|NCT01164644|3759970|FG001|NOT COMPLETED|Overall Study||1
3040482|NCT01164722|3759978|FG000|STARTED|Overall Study||60
3040483|NCT01164722|3759979|FG001|STARTED|Overall Study||60
3040484|NCT01164722|3759978|FG000|COMPLETED|Overall Study||42
3040485|NCT01164722|3759979|FG001|COMPLETED|Overall Study||45
3040486|NCT01164722|3759978|FG000|NOT COMPLETED|Overall Study||18
3040487|NCT01164722|3759979|FG001|NOT COMPLETED|Overall Study||15
3040488|NCT01164865|3759987|FG000|STARTED|Overall Study||39
3040489|NCT01164865|3759988|FG001|STARTED|Overall Study||39
3040490|NCT01164865|3759987|FG000|COMPLETED|Overall Study||37
3040491|NCT01164865|3759988|FG001|COMPLETED|Overall Study||38
3040492|NCT01164865|3759987|FG000|NOT COMPLETED|Overall Study||2
3040493|NCT01164865|3759988|FG001|NOT COMPLETED|Overall Study||1
3040494|NCT01164891|3759994|FG000|STARTED|Overall Study||7
3040495|NCT01164891|3759994|FG000|COMPLETED|Overall Study||1
3040496|NCT01164891|3759994|FG000|NOT COMPLETED|Overall Study||6
3040497|NCT01164956|3759999|FG000|STARTED|Overall Study||1
3040498|NCT01164956|3760000|FG001|STARTED|Overall Study||1
3040499|NCT01164956|3760001|FG002|STARTED|Overall Study||1
3040500|NCT01164956|3759999|FG000|Evaluable for pedsFACIT-F Score Change|Overall Study||0
3040501|NCT01164956|3760000|FG001|Evaluable for pedsFACIT-F Score Change|Overall Study||1
3040502|NCT01164956|3760001|FG002|Evaluable for pedsFACIT-F Score Change|Overall Study||0
3040503|NCT01164956|3759999|FG000|COMPLETED|Overall Study||0
3040504|NCT01164956|3760000|FG001|COMPLETED|Overall Study||1
3040505|NCT01164956|3760001|FG002|COMPLETED|Overall Study||0
3040506|NCT01164956|3759999|FG000|NOT COMPLETED|Overall Study||1
3040507|NCT01164956|3760000|FG001|NOT COMPLETED|Overall Study||0
3040508|NCT01164956|3760001|FG002|NOT COMPLETED|Overall Study||1
3040509|NCT01165021|3760009|FG000|STARTED|Overall Study||19
3040510|NCT01165021|3760009|FG000|≥1 Dose Chemo|Overall Study||19
3040511|NCT01165021|3760009|FG000|≥1 Dose Chemo, Baseline, Cy 3 Assessment|Overall Study||17
3040512|NCT01165021|3760009|FG000|3 Cycles of Chemo, Then Surgery|Overall Study||15
3040513|NCT01165021|3760009|FG000|COMPLETED|Overall Study||18
3040514|NCT01165021|3760009|FG000|NOT COMPLETED|Overall Study||1
3040515|NCT01165047|3760013|FG000|STARTED|Overall Study||10
3040516|NCT01165047|3760013|FG000|COMPLETED|Overall Study||10
3179649|NCT01986647|3907849|FG000|COMPLETED|Overall Study||142
3179650|NCT01986647|3907850|FG001|COMPLETED|Overall Study||139
3179651|NCT01986647|3907851|FG002|COMPLETED|Overall Study||37
3179652|NCT01986647|3907852|FG003|COMPLETED|Overall Study||66
2929113|NCT00581386|3640181|FG002|COMPLETED|Overall Study|04/15/2009|72
2929114|NCT00581386|3640179|FG000|NOT COMPLETED|Overall Study||0
2929115|NCT00581386|3640180|FG001|NOT COMPLETED|Overall Study||0
2929116|NCT00581386|3640181|FG002|NOT COMPLETED|Overall Study||0
2929117|NCT00581399|3640191|FG000|STARTED|Overall Study||46
2929118|NCT00581399|3640192|FG001|STARTED|Overall Study||48
2929119|NCT00581399|3640191|FG000|COMPLETED|Overall Study||46
2929120|NCT00581399|3640192|FG001|COMPLETED|Overall Study||48
2929121|NCT00581399|3640191|FG000|NOT COMPLETED|Overall Study||0
2929122|NCT00581399|3640192|FG001|NOT COMPLETED|Overall Study||0
2929123|NCT00581529|3640198|FG000|STARTED|Overall Study||34
2929124|NCT00581529|3640198|FG000|COMPLETED|Overall Study||34
2929125|NCT00581529|3640198|FG000|NOT COMPLETED|Overall Study||0
2929126|NCT00581542|3640204|FG000|STARTED|Overall Study||62
2929127|NCT00581542|3640205|FG001|STARTED|Overall Study||62
2929128|NCT00581542|3640204|FG000|COMPLETED|Overall Study||51
2929129|NCT00581542|3640205|FG001|COMPLETED|Overall Study||39
2929130|NCT00581542|3640204|FG000|NOT COMPLETED|Overall Study||11
2929131|NCT00581542|3640205|FG001|NOT COMPLETED|Overall Study||23
2929132|NCT00581555|3640215|FG000|STARTED|Overall Study||62
2929133|NCT00581555|3640216|FG001|STARTED|Overall Study||58
2929134|NCT00581555|3640215|FG000|COMPLETED|Overall Study||19
2929135|NCT00581555|3640216|FG001|COMPLETED|Overall Study||38
2929136|NCT00581555|3640215|FG000|NOT COMPLETED|Overall Study||43
2929137|NCT00581555|3640216|FG001|NOT COMPLETED|Overall Study||20
2929138|NCT00581581|3640224|FG000|STARTED|Overall Study||32
2929139|NCT00581581|3640225|FG001|STARTED|Overall Study||30
2929140|NCT00581581|3640224|FG000|COMPLETED|Overall Study||32
3179653|NCT01986647|3907849|FG000|NOT COMPLETED|Overall Study||10
3179654|NCT01986647|3907850|FG001|NOT COMPLETED|Overall Study||7
3179655|NCT01986647|3907851|FG002|NOT COMPLETED|Overall Study||12
2929141|NCT00581581|3640225|FG001|COMPLETED|Overall Study||30
2929142|NCT00581581|3640224|FG000|NOT COMPLETED|Overall Study||0
2929143|NCT00581581|3640225|FG001|NOT COMPLETED|Overall Study||0
2929144|NCT00581776|3640231|FG000|STARTED|Overall Study||30
2929145|NCT00581776|3640231|FG000|COMPLETED|Overall Study|3 subjects did not complete the planned induction chemotherapy.|27
2929146|NCT00581776|3640231|FG000|NOT COMPLETED|Overall Study||3
2929147|NCT00581828|3640235|FG000|STARTED|Overall Study||19
2929148|NCT00581828|3640235|FG000|COMPLETED|Overall Study||18
2929149|NCT00581828|3640235|FG000|NOT COMPLETED|Overall Study||1
3040517|NCT01165047|3760013|FG000|NOT COMPLETED|Overall Study||0
3040518|NCT01165112|3760017|FG000|STARTED|Overall Study||48
3040519|NCT01165112|3760017|FG000|COMPLETED|Overall Study||48
3040520|NCT01165112|3760017|FG000|NOT COMPLETED|Overall Study||0
3040521|NCT01165138|3760024|FG000|STARTED|Overall Study||0
3040522|NCT01165138|3760025|FG001|STARTED|Overall Study||203
3040523|NCT01165138|3760026|FG002|STARTED|Overall Study||205
3040524|NCT01165138|3760027|FG003|STARTED|Overall Study||201
3040525|NCT01165138|3760024|FG000|COMPLETED|Overall Study||0
3040526|NCT01165138|3760025|FG001|COMPLETED|Overall Study||151
3040527|NCT01165138|3760026|FG002|COMPLETED|Overall Study||185
3040528|NCT01165138|3760027|FG003|COMPLETED|Overall Study||179
3040529|NCT01165138|3760024|FG000|NOT COMPLETED|Overall Study||0
3040530|NCT01165138|3760025|FG001|NOT COMPLETED|Overall Study||52
3040531|NCT01165138|3760026|FG002|NOT COMPLETED|Overall Study||20
3040532|NCT01165138|3760027|FG003|NOT COMPLETED|Overall Study||22
3040533|NCT01165177|3760037|FG000|STARTED|Overall Study||7695
3040534|NCT01165177|3760038|FG001|STARTED|Overall Study||7710
3040535|NCT01165177|3760037|FG000|COMPLETED|Overall Study||6773
3040536|NCT01165177|3760038|FG001|COMPLETED|Overall Study||6808
3040537|NCT01165177|3760037|FG000|NOT COMPLETED|Overall Study||922
3040538|NCT01165177|3760038|FG001|NOT COMPLETED|Overall Study||902
3040539|NCT01165203|3760054|FG000|STARTED|Active Phase||74
3040540|NCT01165203|3760055|FG001|STARTED|Active Phase||49
3040541|NCT01165203|3760054|FG000|COMPLETED|Active Phase||69
3040542|NCT01165203|3760055|FG001|COMPLETED|Active Phase||47
3040543|NCT01165203|3760054|FG000|NOT COMPLETED|Active Phase||5
3040544|NCT01165203|3760055|FG001|NOT COMPLETED|Active Phase||2
3040545|NCT01165203|3760054|FG000|STARTED|Extended Safety Follow-up Phase||74
3040546|NCT01165203|3760055|FG001|STARTED|Extended Safety Follow-up Phase||49
3040547|NCT01165203|3760054|FG000|COMPLETED|Extended Safety Follow-up Phase||67
3040548|NCT01165203|3760055|FG001|COMPLETED|Extended Safety Follow-up Phase||45
3040549|NCT01165203|3760054|FG000|NOT COMPLETED|Extended Safety Follow-up Phase||7
3040550|NCT01165203|3760055|FG001|NOT COMPLETED|Extended Safety Follow-up Phase||4
3040551|NCT01165216|3760070|FG000|STARTED|Overall Study|Participants who received any study drug|8
3179656|NCT01986647|3907852|FG003|NOT COMPLETED|Overall Study||11
3179657|NCT01986686|3907868|FG000|STARTED|Overall Study||81
3040552|NCT01165216|3760071|FG001|STARTED|Overall Study|Participants who received any study drug|7
3040553|NCT01165216|3760070|FG000|Received at Least 1 Dose of Ipilimumab|Overall Study||6
3040554|NCT01165216|3760071|FG001|Received at Least 1 Dose of Ipilimumab|Overall Study||6
3040555|NCT01165216|3760070|FG000|COMPLETED|Overall Study|Completed=still on study drug|0
2929150|NCT00581854|3640239|FG000|STARTED|Overall Study||22
2929151|NCT00581854|3640239|FG000|COMPLETED|Overall Study||22
2929152|NCT00581854|3640239|FG000|NOT COMPLETED|Overall Study||0
2929153|NCT00581867|3640243|FG000|STARTED|First Intervention||16
2929154|NCT00581867|3640244|FG001|STARTED|First Intervention||15
2929155|NCT00581867|3640243|FG000|COMPLETED|First Intervention||16
2929156|NCT00581867|3640244|FG001|COMPLETED|First Intervention||15
2929157|NCT00581867|3640243|FG000|NOT COMPLETED|First Intervention||0
2929158|NCT00581867|3640244|FG001|NOT COMPLETED|First Intervention||0
2929159|NCT00581867|3640243|FG000|STARTED|Second Intervention|n=1 completed period 1 (placebo) but not period 2 (insulin). This individuals died between periods.|15
2929160|NCT00581867|3640244|FG001|STARTED|Second Intervention|1 individual completed period 1 (Intranasal Insulin) but did not complete period 2 (Placebo).|14
2929161|NCT00581867|3640243|FG000|COMPLETED|Second Intervention||15
2929162|NCT00581867|3640244|FG001|COMPLETED|Second Intervention||14
2929163|NCT00581867|3640243|FG000|NOT COMPLETED|Second Intervention||0
2929164|NCT00581867|3640244|FG001|NOT COMPLETED|Second Intervention||0
2929165|NCT00581893|3640250|FG000|STARTED|First Intervention (1 Month)||10
2929166|NCT00581893|3640251|FG001|STARTED|First Intervention (1 Month)||10
2929167|NCT00581893|3640250|FG000|COMPLETED|First Intervention (1 Month)||10
2929168|NCT00581893|3640251|FG001|COMPLETED|First Intervention (1 Month)||10
2929169|NCT00581893|3640250|FG000|NOT COMPLETED|First Intervention (1 Month)||0
2929170|NCT00581893|3640251|FG001|NOT COMPLETED|First Intervention (1 Month)||0
2929171|NCT00581893|3640250|FG000|STARTED|Washout (14 Days)||10
2929172|NCT00581893|3640251|FG001|STARTED|Washout (14 Days)||10
2929173|NCT00581893|3640250|FG000|COMPLETED|Washout (14 Days)||10
2929174|NCT00581893|3640251|FG001|COMPLETED|Washout (14 Days)||10
2929175|NCT00581893|3640250|FG000|NOT COMPLETED|Washout (14 Days)||0
2929176|NCT00581893|3640251|FG001|NOT COMPLETED|Washout (14 Days)||0
2929177|NCT00581893|3640250|FG000|STARTED|Second Intervention (1 Month)||10
2929178|NCT00581893|3640251|FG001|STARTED|Second Intervention (1 Month)||10
2929179|NCT00581893|3640250|FG000|COMPLETED|Second Intervention (1 Month)||7
2929180|NCT00581893|3640251|FG001|COMPLETED|Second Intervention (1 Month)||8
2929181|NCT00581893|3640250|FG000|NOT COMPLETED|Second Intervention (1 Month)||3
2929182|NCT00581893|3640251|FG001|NOT COMPLETED|Second Intervention (1 Month)||2
2929183|NCT00581919|3640257|FG000|STARTED|Overall Study||32
2929184|NCT00581919|3640257|FG000|COMPLETED|Overall Study||8
2929185|NCT00581919|3640257|FG000|NOT COMPLETED|Overall Study||24
2929186|NCT00581945|3640264|FG000|STARTED|Overall Study||74
2929187|NCT00581945|3640265|FG001|STARTED|Overall Study||73
2929188|NCT00581945|3640264|FG000|COMPLETED|Overall Study||65
2929189|NCT00581945|3640265|FG001|COMPLETED|Overall Study||63
2929190|NCT00581945|3640264|FG000|NOT COMPLETED|Overall Study||9
2929191|NCT00581945|3640265|FG001|NOT COMPLETED|Overall Study||10
2929192|NCT00581971|3640271|FG000|STARTED|Overall Study||30
2929193|NCT00581971|3640271|FG000|COMPLETED|Overall Study||30
2929194|NCT00581971|3640271|FG000|NOT COMPLETED|Overall Study||0
3040556|NCT01165216|3760071|FG001|COMPLETED|Overall Study|Completed=still on study drug|0
3040557|NCT01165216|3760070|FG000|NOT COMPLETED|Overall Study||8
3040558|NCT01165216|3760071|FG001|NOT COMPLETED|Overall Study||7
3040559|NCT01165229|3760081|FG000|STARTED|Overall Study||6950
3040560|NCT01165229|3760082|FG001|STARTED|Overall Study||6950
3040561|NCT01165229|3760081|FG000|COMPLETED|Overall Study||5770
3040562|NCT01165229|3760082|FG001|COMPLETED|Overall Study||5760
3040563|NCT01165229|3760081|FG000|NOT COMPLETED|Overall Study||1180
3040564|NCT01165229|3760082|FG001|NOT COMPLETED|Overall Study||1190
3040565|NCT01165242|3760121|FG000|STARTED|Overall Study||337
3040566|NCT01165242|3760122|FG001|STARTED|Overall Study||336
3040567|NCT01165242|3760123|FG002|STARTED|Overall Study||338
3040568|NCT01165242|3760121|FG000|COMPLETED|Overall Study||327
3040569|NCT01165242|3760122|FG001|COMPLETED|Overall Study||326
3040570|NCT01165242|3760123|FG002|COMPLETED|Overall Study||324
3040571|NCT01165242|3760121|FG000|NOT COMPLETED|Overall Study||10
2929195|NCT00582010|3640278|FG000|STARTED|Overall Study||40
2929196|NCT00582010|3640279|FG001|STARTED|Overall Study||40
2929197|NCT00582010|3640278|FG000|COMPLETED|Overall Study||40
2929198|NCT00582010|3640279|FG001|COMPLETED|Overall Study||39
2929199|NCT00582010|3640278|FG000|NOT COMPLETED|Overall Study||0
2929200|NCT00582010|3640279|FG001|NOT COMPLETED|Overall Study||1
2929201|NCT00582075|3640285|FG000|STARTED|Overall Study||25
2929202|NCT00582075|3640285|FG000|COMPLETED|Overall Study||25
2929203|NCT00582075|3640285|FG000|NOT COMPLETED|Overall Study||0
2929204|NCT00582114|3640291|FG000|STARTED|Overall Study||100
2929205|NCT00582114|3640292|FG001|STARTED|Overall Study||100
2929206|NCT00582114|3640291|FG000|COMPLETED|Overall Study||58
2929207|NCT00582114|3640292|FG001|COMPLETED|Overall Study||46
2929208|NCT00582114|3640291|FG000|NOT COMPLETED|Overall Study||42
2929209|NCT00582114|3640292|FG001|NOT COMPLETED|Overall Study||54
2929210|NCT00582166|3640298|FG000|STARTED|Overall Study||18
2929211|NCT00582166|3640298|FG000|COMPLETED|Overall Study||16
2929212|NCT00582166|3640298|FG000|NOT COMPLETED|Overall Study||2
2929213|NCT00582205|3640302|FG000|STARTED|Overall Study||21
2929214|NCT00582205|3640302|FG000|COMPLETED|Overall Study||11
2929215|NCT00582205|3640302|FG000|NOT COMPLETED|Overall Study||10
2929216|NCT00582309|3640309|FG000|STARTED|Overall Study||56
2929217|NCT00582309|3640310|FG001|STARTED|Overall Study||49
2929218|NCT00582309|3640311|FG002|STARTED|Overall Study||46
2929219|NCT00582309|3640309|FG000|COMPLETED|Overall Study||56
2929220|NCT00582309|3640310|FG001|COMPLETED|Overall Study||49
2929221|NCT00582309|3640311|FG002|COMPLETED|Overall Study|2 did not have enough data collected to be used|44
2929222|NCT00582309|3640309|FG000|NOT COMPLETED|Overall Study||0
2929223|NCT00582309|3640310|FG001|NOT COMPLETED|Overall Study||0
2929224|NCT00582309|3640311|FG002|NOT COMPLETED|Overall Study||2
2929225|NCT00582361|3640321|FG000|STARTED|Overall Study||25
2929226|NCT00582361|3640322|FG001|STARTED|Overall Study||38
2929227|NCT00582361|3640321|FG000|COMPLETED|Overall Study||25
2929228|NCT00582361|3640322|FG001|COMPLETED|Overall Study||38
2929229|NCT00582361|3640321|FG000|NOT COMPLETED|Overall Study||0
2929230|NCT00582361|3640322|FG001|NOT COMPLETED|Overall Study||0
2929231|NCT00582400|3640328|FG000|STARTED|Overall Study||9
2929232|NCT00582400|3640328|FG000|COMPLETED|Overall Study||6
2929233|NCT00582400|3640328|FG000|NOT COMPLETED|Overall Study||3
2929234|NCT00582426|3640334|FG000|STARTED|Overall Study|"Patient in both arms belongs to started indicates safety and intent to treat (ITT) populations."|68
2929235|NCT00582426|3640335|FG001|STARTED|Overall Study||71
2929236|NCT00582426|3640334|FG000|COMPLETED|Overall Study||48
2929237|NCT00582426|3640335|FG001|COMPLETED|Overall Study||58
2929238|NCT00582426|3640334|FG000|NOT COMPLETED|Overall Study||20
2929239|NCT00582426|3640335|FG001|NOT COMPLETED|Overall Study||13
2929240|NCT00582491|3640343|FG000|STARTED|Overall Study||11
2929241|NCT00582491|3640344|FG001|STARTED|Overall Study||10
2929242|NCT00582491|3640343|FG000|COMPLETED|Overall Study||10
2929243|NCT00582491|3640344|FG001|COMPLETED|Overall Study||10
2929244|NCT00582491|3640343|FG000|NOT COMPLETED|Overall Study||1
2929245|NCT00582491|3640344|FG001|NOT COMPLETED|Overall Study||0
2929246|NCT00582517|3640352|FG000|STARTED|Overall Study||45
2929247|NCT00582517|3640353|FG001|STARTED|Overall Study||55
2929248|NCT00582517|3640352|FG000|COMPLETED|Overall Study||45
2929249|NCT00582517|3640353|FG001|COMPLETED|Overall Study||55
2929250|NCT00582517|3640352|FG000|NOT COMPLETED|Overall Study||0
2929251|NCT00582517|3640353|FG001|NOT COMPLETED|Overall Study||0
2929252|NCT00582556|3640362|FG000|STARTED|Overall Study||14
2929253|NCT00582556|3640363|FG001|STARTED|Overall Study||15
2929254|NCT00582556|3640364|FG002|STARTED|Overall Study||14
2929255|NCT00582556|3640362|FG000|COMPLETED|Overall Study||14
2929256|NCT00582556|3640363|FG001|COMPLETED|Overall Study||14
2929257|NCT00582556|3640364|FG002|COMPLETED|Overall Study||12
2929258|NCT00582556|3640362|FG000|NOT COMPLETED|Overall Study||0
3040572|NCT01165242|3760122|FG001|NOT COMPLETED|Overall Study||10
3040573|NCT01165242|3760123|FG002|NOT COMPLETED|Overall Study||14
3040574|NCT01165281|3760135|FG000|STARTED|Overall Study||168
3040575|NCT01165281|3760136|FG001|STARTED|Overall Study||172
3040576|NCT01165281|3760135|FG000|COMPLETED|Overall Study||110
3040577|NCT01165281|3760136|FG001|COMPLETED|Overall Study||121
3040578|NCT01165281|3760135|FG000|NOT COMPLETED|Overall Study||58
3040579|NCT01165281|3760136|FG001|NOT COMPLETED|Overall Study||51
3040580|NCT01165307|3760144|FG000|STARTED|Overall Study||33
3040581|NCT01165307|3760145|FG001|STARTED|Overall Study||34
3040582|NCT01165307|3760144|FG000|COMPLETED|Overall Study||19
3040583|NCT01165307|3760145|FG001|COMPLETED|Overall Study||31
3040584|NCT01165307|3760144|FG000|NOT COMPLETED|Overall Study||14
3040585|NCT01165307|3760145|FG001|NOT COMPLETED|Overall Study||3
3040586|NCT01165320|3760153|FG000|STARTED|Overall Study||12
3040587|NCT01165320|3760154|FG001|STARTED|Overall Study||8
3040588|NCT01165320|3760155|FG002|STARTED|Overall Study|No participants with esophageal candidiasis were identified for inclusion in the study|0
3040589|NCT01165320|3760153|FG000|COMPLETED|Overall Study||9
3040590|NCT01165320|3760154|FG001|COMPLETED|Overall Study||4
3040591|NCT01165320|3760155|FG002|COMPLETED|Overall Study||0
3040592|NCT01165320|3760153|FG000|NOT COMPLETED|Overall Study||3
3040593|NCT01165320|3760154|FG001|NOT COMPLETED|Overall Study||4
3040594|NCT01165320|3760155|FG002|NOT COMPLETED|Overall Study||0
3040595|NCT01165541|3760161|FG000|STARTED|Quetiapine XR Monotherapy||20
3040596|NCT01165541|3760161|FG000|COMPLETED|Quetiapine XR Monotherapy||16
3040597|NCT01165541|3760161|FG000|NOT COMPLETED|Quetiapine XR Monotherapy||4
3040598|NCT01165541|3760161|FG000|STARTED|Quetiapine XR and Mirtazepine||16
3040599|NCT01165541|3760161|FG000|COMPLETED|Quetiapine XR and Mirtazepine||11
3040600|NCT01165541|3760161|FG000|NOT COMPLETED|Quetiapine XR and Mirtazepine||5
3040601|NCT01165554|3760167|FG000|STARTED|Overall Study|This was the number of subjects that started the study.|203
2929259|NCT00582556|3640363|FG001|NOT COMPLETED|Overall Study||1
2929260|NCT00582556|3640364|FG002|NOT COMPLETED|Overall Study||2
2929261|NCT00582608|3640373|FG000|STARTED|Overall Study||12
2929262|NCT00582608|3640373|FG000|COMPLETED|Overall Study||0
2929263|NCT00582608|3640373|FG000|NOT COMPLETED|Overall Study||12
2929264|NCT00582660|3640379|FG000|STARTED|Overall Study||20
2929265|NCT00582660|3640380|FG001|STARTED|Overall Study||20
2929266|NCT00582660|3640379|FG000|COMPLETED|Overall Study||20
2929267|NCT00582660|3640380|FG001|COMPLETED|Overall Study||20
2929268|NCT00582660|3640379|FG000|NOT COMPLETED|Overall Study||0
2929269|NCT00582660|3640380|FG001|NOT COMPLETED|Overall Study||0
2929270|NCT00582738|3640388|FG000|STARTED|Overall Study||21
2929271|NCT00582738|3640389|FG001|STARTED|Overall Study||22
2929272|NCT00582738|3640388|FG000|COMPLETED|Overall Study||12
2929273|NCT00582738|3640389|FG001|COMPLETED|Overall Study||4
2929274|NCT00582738|3640388|FG000|NOT COMPLETED|Overall Study||9
2929275|NCT00582738|3640389|FG001|NOT COMPLETED|Overall Study||18
2929276|NCT00582790|3640401|FG000|STARTED|Overall Study|only 11 of the 12 patients received study treatment.|12
2929277|NCT00582790|3640401|FG000|COMPLETED|Overall Study||11
2929278|NCT00582790|3640401|FG000|NOT COMPLETED|Overall Study||1
2929279|NCT00582816|3640406|FG000|STARTED|Overall Study||9
2929280|NCT00582816|3640406|FG000|COMPLETED|Overall Study|"Completed here means patients stably engrafted with donor cells."|6
2929281|NCT00582816|3640406|FG000|NOT COMPLETED|Overall Study||3
2929282|NCT00582894|3640410|FG000|STARTED|Overall Study||17
2929283|NCT00582894|3640410|FG000|Day 100 Post Transplant|Overall Study||17
2929284|NCT00582894|3640410|FG000|COMPLETED|Overall Study||17
2929285|NCT00582894|3640410|FG000|NOT COMPLETED|Overall Study||0
2929286|NCT00582907|3640414|FG000|STARTED|1st Course||4
2929287|NCT00582907|3640415|FG001|STARTED|1st Course||3
2929288|NCT00582907|3640416|FG002|STARTED|1st Course||3
2929289|NCT00582907|3640417|FG003|STARTED|1st Course||4
2929290|NCT00582907|3640414|FG000|COMPLETED|1st Course|1 left after 1st course (transportation issues)|3
2929291|NCT00582907|3640415|FG001|COMPLETED|1st Course||3
2929292|NCT00582907|3640416|FG002|COMPLETED|1st Course||3
2929293|NCT00582907|3640417|FG003|COMPLETED|1st Course|Patient lost to follow-up towards end of 1st course|3
2929294|NCT00582907|3640414|FG000|NOT COMPLETED|1st Course||1
2929295|NCT00582907|3640415|FG001|NOT COMPLETED|1st Course||0
2929296|NCT00582907|3640416|FG002|NOT COMPLETED|1st Course||0
2929297|NCT00582907|3640417|FG003|NOT COMPLETED|1st Course||1
2929298|NCT00582907|3640414|FG000|STARTED|2nd Course||3
2929299|NCT00582907|3640415|FG001|STARTED|2nd Course||3
2929300|NCT00582907|3640416|FG002|STARTED|2nd Course||3
2929301|NCT00582907|3640417|FG003|STARTED|2nd Course||3
2929302|NCT00582907|3640414|FG000|COMPLETED|2nd Course||2
2929303|NCT00582907|3640415|FG001|COMPLETED|2nd Course||3
2929304|NCT00582907|3640416|FG002|COMPLETED|2nd Course||3
3040602|NCT01165554|3760167|FG000|COMPLETED|Overall Study||180
3179658|NCT01986686|3907869|FG001|STARTED|Overall Study||26
3179659|NCT01986686|3907868|FG000|COMPLETED|Overall Study||81
3179660|NCT01986686|3907869|FG001|COMPLETED|Overall Study||26
3179661|NCT01986686|3907868|FG000|NOT COMPLETED|Overall Study||0
3179662|NCT01986686|3907869|FG001|NOT COMPLETED|Overall Study||0
3179663|NCT01986790|3907878|FG000|STARTED|Overall Study||91
3179664|NCT01986790|3907879|FG001|STARTED|Overall Study||154
3179665|NCT01986790|3907880|FG002|STARTED|Overall Study||98
3179666|NCT01986790|3907878|FG000|COMPLETED|Overall Study||91
3179667|NCT01986790|3907879|FG001|COMPLETED|Overall Study||154
3179668|NCT01986790|3907880|FG002|COMPLETED|Overall Study||98
3179669|NCT01986790|3907878|FG000|NOT COMPLETED|Overall Study||0
3179670|NCT01986790|3907879|FG001|NOT COMPLETED|Overall Study||0
2929305|NCT00582907|3640417|FG003|COMPLETED|2nd Course||3
2929306|NCT00582907|3640414|FG000|NOT COMPLETED|2nd Course||1
2929307|NCT00582907|3640415|FG001|NOT COMPLETED|2nd Course||0
2929308|NCT00582907|3640416|FG002|NOT COMPLETED|2nd Course||0
2929309|NCT00582907|3640417|FG003|NOT COMPLETED|2nd Course||0
2929310|NCT00582907|3640414|FG000|STARTED|3rd Course||2
3040603|NCT01165554|3760167|FG000|NOT COMPLETED|Overall Study||23
3040604|NCT01165684|3760176|FG000|STARTED|Overall Study||201
3040605|NCT01165684|3760177|FG001|STARTED|Overall Study||200
3040606|NCT01165684|3760176|FG000|Exposed|Overall Study|3 subjects withdrew prior to exposure to trial drug|198
3040607|NCT01165684|3760177|FG001|Exposed|Overall Study|1 subject withdrew prior to exposure to trial drug|199
3040608|NCT01165684|3760176|FG000|COMPLETED|Overall Study||173
3040609|NCT01165684|3760177|FG001|COMPLETED|Overall Study||148
3040610|NCT01165684|3760176|FG000|NOT COMPLETED|Overall Study||28
3040611|NCT01165684|3760177|FG001|NOT COMPLETED|Overall Study||52
3040612|NCT01165775|3760183|FG000|STARTED|Overall Study||17
2929311|NCT00582907|3640415|FG001|STARTED|3rd Course||3
2929312|NCT00582907|3640416|FG002|STARTED|3rd Course||3
3040613|NCT01165775|3760183|FG000|COMPLETED|Overall Study||15
2929313|NCT00582907|3640417|FG003|STARTED|3rd Course||3
2929314|NCT00582907|3640414|FG000|COMPLETED|3rd Course||2
2929315|NCT00582907|3640415|FG001|COMPLETED|3rd Course||3
2929316|NCT00582907|3640416|FG002|COMPLETED|3rd Course||3
2929317|NCT00582907|3640417|FG003|COMPLETED|3rd Course||3
2929318|NCT00582907|3640414|FG000|NOT COMPLETED|3rd Course||0
2929319|NCT00582907|3640415|FG001|NOT COMPLETED|3rd Course||0
2929320|NCT00582907|3640416|FG002|NOT COMPLETED|3rd Course||0
2929321|NCT00582907|3640417|FG003|NOT COMPLETED|3rd Course||0
2929322|NCT00582907|3640414|FG000|STARTED|4th Course||2
2929323|NCT00582907|3640415|FG001|STARTED|4th Course||3
2929324|NCT00582907|3640416|FG002|STARTED|4th Course||3
2929325|NCT00582907|3640417|FG003|STARTED|4th Course||3
2929326|NCT00582907|3640414|FG000|COMPLETED|4th Course||2
2929327|NCT00582907|3640415|FG001|COMPLETED|4th Course||3
2929328|NCT00582907|3640416|FG002|COMPLETED|4th Course||3
2929329|NCT00582907|3640417|FG003|COMPLETED|4th Course||3
2929330|NCT00582907|3640414|FG000|NOT COMPLETED|4th Course||0
2929331|NCT00582907|3640415|FG001|NOT COMPLETED|4th Course||0
2929332|NCT00582907|3640416|FG002|NOT COMPLETED|4th Course||0
2929333|NCT00582907|3640417|FG003|NOT COMPLETED|4th Course||0
2929334|NCT00582933|3640423|FG000|STARTED|Overall Study||95
2929335|NCT00582933|3640423|FG000|COMPLETED|Overall Study||92
2929336|NCT00582933|3640423|FG000|NOT COMPLETED|Overall Study||3
2929337|NCT00582946|3640427|FG000|STARTED|Overall Study||16
2929338|NCT00582946|3640427|FG000|COMPLETED|Overall Study||16
2929339|NCT00582946|3640427|FG000|NOT COMPLETED|Overall Study||0
2929340|NCT00582972|3640431|FG000|STARTED|Overall Study||23
2929341|NCT00582972|3640431|FG000|COMPLETED|Overall Study||21
2929342|NCT00582972|3640431|FG000|NOT COMPLETED|Overall Study||2
2929343|NCT00582998|3640438|FG000|STARTED|Overall Study||119
2929344|NCT00582998|3640439|FG001|STARTED|Overall Study||130
2929345|NCT00582998|3640438|FG000|COMPLETED|Overall Study||119
2929346|NCT00582998|3640439|FG001|COMPLETED|Overall Study||130
2929347|NCT00582998|3640438|FG000|NOT COMPLETED|Overall Study||0
2929348|NCT00582998|3640439|FG001|NOT COMPLETED|Overall Study||0
2929349|NCT00583011|3640447|FG000|STARTED|Overall Study||36
2929350|NCT00583011|3640448|FG001|STARTED|Overall Study||40
2929351|NCT00583011|3640447|FG000|COMPLETED|Overall Study||36
2929352|NCT00583011|3640448|FG001|COMPLETED|Overall Study||40
2929353|NCT00583011|3640447|FG000|NOT COMPLETED|Overall Study||0
2929354|NCT00583011|3640448|FG001|NOT COMPLETED|Overall Study||0
2929355|NCT00583050|3640455|FG000|STARTED|Overall Study||1366
2929356|NCT00583050|3640455|FG000|COMPLETED|Overall Study||1366
2929357|NCT00583050|3640455|FG000|NOT COMPLETED|Overall Study||0
2929358|NCT00583102|3640459|FG000|STARTED|Overall Study||23
2929359|NCT00583102|3640459|FG000|COMPLETED|Overall Study||20
2929360|NCT00583102|3640459|FG000|NOT COMPLETED|Overall Study||3
2929361|NCT00583219|3640463|FG000|STARTED|Phase 1|First 3 subjects in Phase 1 received 200 units Botox. The remaining subjects got 300 units Botox.|9
2929362|NCT00583219|3640463|FG000|COMPLETED|Phase 1||9
2929363|NCT00583219|3640463|FG000|NOT COMPLETED|Phase 1||0
2929364|NCT00583219|3640463|FG000|STARTED|Phase 2|6 subjects from P1 continued in P2; plus 16 new subjects. All subjects in P2 got 300 units Botox.|22
2929365|NCT00583219|3640463|FG000|COMPLETED|Phase 2||21
2929366|NCT00583219|3640463|FG000|NOT COMPLETED|Phase 2||1
2929367|NCT00583362|3640467|FG000|STARTED|Overall Study||298
2929368|NCT00583362|3640467|FG000|COMPLETED|Overall Study||96
2929369|NCT00583362|3640467|FG000|NOT COMPLETED|Overall Study||202
2929370|NCT00583375|3640473|FG000|STARTED|Overall Study||142
2929371|NCT00583375|3640474|FG001|STARTED|Overall Study||272
3040614|NCT01165775|3760183|FG000|NOT COMPLETED|Overall Study||2
3040615|NCT01165840|3760191|FG000|STARTED|Overall Study||36
3040616|NCT01165840|3760191|FG000|COMPLETED|Overall Study||36
3040617|NCT01165840|3760191|FG000|NOT COMPLETED|Overall Study||0
3040618|NCT01165983|3760197|FG000|STARTED|Overall Study||51
3040619|NCT01165983|3760198|FG001|STARTED|Overall Study||49
3040620|NCT01165983|3760197|FG000|COMPLETED|Overall Study||46
3040621|NCT01165983|3760198|FG001|COMPLETED|Overall Study||42
3179671|NCT01986790|3907880|FG002|NOT COMPLETED|Overall Study||0
3179672|NCT01986829|3907888|FG000|STARTED|Overall Study||9
3179673|NCT01986829|3907888|FG000|COMPLETED|Overall Study||8
3179674|NCT01986829|3907888|FG000|NOT COMPLETED|Overall Study||1
3179675|NCT01986855|3907898|FG000|STARTED|Overall Study||158
2929372|NCT00583375|3640473|FG000|COMPLETED|Overall Study||142
3040622|NCT01165983|3760197|FG000|NOT COMPLETED|Overall Study||5
3040623|NCT01165983|3760198|FG001|NOT COMPLETED|Overall Study||7
3040624|NCT01165996|3760206|FG000|STARTED|Overall Study||25
3040625|NCT01165996|3760206|FG000|Induction Phase|Overall Study||25
3040626|NCT01165996|3760206|FG000|Maintenance Phase|Overall Study||23
3040627|NCT01165996|3760206|FG000|COMPLETED|Overall Study||23
3040628|NCT01165996|3760206|FG000|NOT COMPLETED|Overall Study||2
3040629|NCT01166126|3760211|FG000|STARTED|Overall Study||4
3040630|NCT01166126|3760211|FG000|COMPLETED|Overall Study||4
3040631|NCT01166126|3760211|FG000|NOT COMPLETED|Overall Study||0
3040632|NCT01166139|3760215|FG000|STARTED|Overall Study||10
3040633|NCT01166139|3760215|FG000|COMPLETED|Overall Study||7
3040634|NCT01166139|3760215|FG000|NOT COMPLETED|Overall Study||3
3040635|NCT01166230|3760221|FG000|STARTED|Overall Study||280
3040636|NCT01166230|3760222|FG001|STARTED|Overall Study||271
3040637|NCT01166230|3760221|FG000|COMPLETED|Overall Study||261
3040638|NCT01166230|3760222|FG001|COMPLETED|Overall Study||255
3040639|NCT01166230|3760221|FG000|NOT COMPLETED|Overall Study||19
3040640|NCT01166230|3760222|FG001|NOT COMPLETED|Overall Study||16
3040641|NCT01166282|3760230|FG000|STARTED|Double-blind Period||15
3040642|NCT01166282|3760231|FG001|STARTED|Double-blind Period||31
3040643|NCT01166282|3760232|FG002|STARTED|Double-blind Period||0
3040644|NCT01166282|3760230|FG000|COMPLETED|Double-blind Period||15
3040645|NCT01166282|3760231|FG001|COMPLETED|Double-blind Period||31
3040646|NCT01166282|3760232|FG002|COMPLETED|Double-blind Period||0
3040647|NCT01166282|3760230|FG000|NOT COMPLETED|Double-blind Period||0
3040648|NCT01166282|3760231|FG001|NOT COMPLETED|Double-blind Period||0
3040649|NCT01166282|3760232|FG002|NOT COMPLETED|Double-blind Period||0
3040650|NCT01166282|3760230|FG000|STARTED|Open-label Period||0
3040651|NCT01166282|3760231|FG001|STARTED|Open-label Period||0
3179676|NCT01986855|3907899|FG001|STARTED|Overall Study||156
2929373|NCT00583375|3640474|FG001|COMPLETED|Overall Study||272
2929374|NCT00583375|3640473|FG000|NOT COMPLETED|Overall Study||0
2929375|NCT00583375|3640474|FG001|NOT COMPLETED|Overall Study||0
2929376|NCT00583414|3640480|FG000|STARTED|Overall Study||401
2929377|NCT00583414|3640480|FG000|COMPLETED|Overall Study||401
2929378|NCT00583414|3640480|FG000|NOT COMPLETED|Overall Study||0
2929379|NCT00583453|3640486|FG000|STARTED|Overall Study||9
2929380|NCT00583453|3640487|FG001|STARTED|Overall Study||8
2929381|NCT00583453|3640486|FG000|COMPLETED|Overall Study||9
2929382|NCT00583453|3640487|FG001|COMPLETED|Overall Study||6
2929383|NCT00583453|3640486|FG000|NOT COMPLETED|Overall Study||0
2929384|NCT00583453|3640487|FG001|NOT COMPLETED|Overall Study||2
2929385|NCT00583492|3640497|FG000|STARTED|Overall Study||21
2929386|NCT00583492|3640498|FG001|STARTED|Overall Study||23
2929387|NCT00583492|3640497|FG000|COMPLETED|Overall Study||21
2929388|NCT00583492|3640498|FG001|COMPLETED|Overall Study||23
2929389|NCT00583492|3640497|FG000|NOT COMPLETED|Overall Study||0
2929390|NCT00583492|3640498|FG001|NOT COMPLETED|Overall Study||0
2929391|NCT00583557|3640504|FG000|STARTED|Overall Study||155
2929392|NCT00583557|3640504|FG000|Received at Least 1 Dose Belimumab|Overall Study||153
2929393|NCT00583557|3640504|FG000|COMPLETED|Overall Study|Completer defined as subjects whose reason for discontinuation was sponsor discontinuation of study|85
2929394|NCT00583557|3640504|FG000|NOT COMPLETED|Overall Study||70
2929395|NCT00583596|3640508|FG000|STARTED|Overall Study|Subjects in Phase 2 clinical trial who received the AMPLATZER Duct Occluder.|436
2929396|NCT00583596|3640508|FG000|COMPLETED|Overall Study||152
2929397|NCT00583596|3640508|FG000|NOT COMPLETED|Overall Study||284
2929398|NCT00583622|3640513|FG000|STARTED|Overall Study||12
2929399|NCT00583622|3640513|FG000|COMPLETED|Overall Study||12
2929400|NCT00583622|3640513|FG000|NOT COMPLETED|Overall Study||0
2929401|NCT00583661|3640517|FG000|STARTED|Overall Study||48
2929402|NCT00583661|3640517|FG000|COMPLETED|Overall Study||48
2929403|NCT00583661|3640517|FG000|NOT COMPLETED|Overall Study||0
2929404|NCT00583700|3640524|FG000|STARTED|Overall Study||27
2929405|NCT00583700|3640525|FG001|STARTED|Overall Study||27
2929406|NCT00583700|3640524|FG000|COMPLETED|Overall Study||24
2929407|NCT00583700|3640525|FG001|COMPLETED|Overall Study||23
2929408|NCT00583700|3640524|FG000|NOT COMPLETED|Overall Study||3
2929409|NCT00583700|3640525|FG001|NOT COMPLETED|Overall Study||4
2929410|NCT00583713|3640534|FG000|STARTED|Overall Study||6
2929411|NCT00583713|3640535|FG001|STARTED|Overall Study||6
2929412|NCT00583713|3640536|FG002|STARTED|Overall Study||6
2929413|NCT00583713|3640534|FG000|COMPLETED|Overall Study||6
2929414|NCT00583713|3640535|FG001|COMPLETED|Overall Study||6
2929415|NCT00583713|3640536|FG002|COMPLETED|Overall Study||6
2929416|NCT00583713|3640534|FG000|NOT COMPLETED|Overall Study||0
2929417|NCT00583713|3640535|FG001|NOT COMPLETED|Overall Study||0
2929418|NCT00583713|3640536|FG002|NOT COMPLETED|Overall Study||0
2929419|NCT00583791|3640544|FG000|STARTED|Overall Study||91
2929420|NCT00583791|3640544|FG000|COMPLETED|Overall Study||18
2929421|NCT00583791|3640544|FG000|NOT COMPLETED|Overall Study||73
2929422|NCT00583804|3640548|FG000|STARTED|Overall Study||10
2929423|NCT00583804|3640548|FG000|COMPLETED|Overall Study|Subjects were considered enrolled when they underwent implantation of the device. All completed.|10
2929424|NCT00583804|3640548|FG000|NOT COMPLETED|Overall Study||0
2929425|NCT00583908|3640554|FG000|STARTED|Period 1 - First Intervention||1
2929426|NCT00583908|3640555|FG001|STARTED|Period 1 - First Intervention||2
2929427|NCT00583908|3640556|FG002|STARTED|Period 1 - First Intervention||1
2929428|NCT00583908|3640557|FG003|STARTED|Period 1 - First Intervention||1
2929429|NCT00583908|3640558|FG004|STARTED|Period 1 - First Intervention||2
2929430|NCT00583908|3640559|FG005|STARTED|Period 1 - First Intervention||1
2929431|NCT00583908|3640560|FG006|STARTED|Period 1 - First Intervention||1
2929432|NCT00583908|3640561|FG007|STARTED|Period 1 - First Intervention||1
2929433|NCT00583908|3640562|FG008|STARTED|Period 1 - First Intervention||1
2929434|NCT00583908|3640563|FG009|STARTED|Period 1 - First Intervention||1
2929435|NCT00583908|3640564|FG010|STARTED|Period 1 - First Intervention||1
2929436|NCT00583908|3640565|FG011|STARTED|Period 1 - First Intervention||1
2929437|NCT00583908|3640554|FG000|COMPLETED|Period 1 - First Intervention||1
2929438|NCT00583908|3640555|FG001|COMPLETED|Period 1 - First Intervention||2
2929439|NCT00583908|3640556|FG002|COMPLETED|Period 1 - First Intervention||1
2929440|NCT00583908|3640557|FG003|COMPLETED|Period 1 - First Intervention||1
2929441|NCT00583908|3640558|FG004|COMPLETED|Period 1 - First Intervention||2
2929442|NCT00583908|3640559|FG005|COMPLETED|Period 1 - First Intervention||1
2929443|NCT00583908|3640560|FG006|COMPLETED|Period 1 - First Intervention||1
2929444|NCT00583908|3640561|FG007|COMPLETED|Period 1 - First Intervention||1
2929445|NCT00583908|3640562|FG008|COMPLETED|Period 1 - First Intervention||1
2929446|NCT00583908|3640563|FG009|COMPLETED|Period 1 - First Intervention||1
2929447|NCT00583908|3640564|FG010|COMPLETED|Period 1 - First Intervention||1
2929448|NCT00583908|3640565|FG011|COMPLETED|Period 1 - First Intervention||1
2929449|NCT00583908|3640554|FG000|NOT COMPLETED|Period 1 - First Intervention||0
2929450|NCT00583908|3640555|FG001|NOT COMPLETED|Period 1 - First Intervention||0
2929451|NCT00583908|3640556|FG002|NOT COMPLETED|Period 1 - First Intervention||0
2929452|NCT00583908|3640557|FG003|NOT COMPLETED|Period 1 - First Intervention||0
2929453|NCT00583908|3640558|FG004|NOT COMPLETED|Period 1 - First Intervention||0
2929454|NCT00583908|3640559|FG005|NOT COMPLETED|Period 1 - First Intervention||0
2929455|NCT00583908|3640560|FG006|NOT COMPLETED|Period 1 - First Intervention||0
2929456|NCT00583908|3640561|FG007|NOT COMPLETED|Period 1 - First Intervention||0
2929457|NCT00583908|3640562|FG008|NOT COMPLETED|Period 1 - First Intervention||0
2929458|NCT00583908|3640563|FG009|NOT COMPLETED|Period 1 - First Intervention||0
2929459|NCT00583908|3640564|FG010|NOT COMPLETED|Period 1 - First Intervention||0
2929460|NCT00583908|3640565|FG011|NOT COMPLETED|Period 1 - First Intervention||0
2929461|NCT00583908|3640554|FG000|STARTED|Period 2 - Second Intervention||1
2929462|NCT00583908|3640555|FG001|STARTED|Period 2 - Second Intervention||2
2929463|NCT00583908|3640556|FG002|STARTED|Period 2 - Second Intervention||1
2929464|NCT00583908|3640557|FG003|STARTED|Period 2 - Second Intervention||1
2929465|NCT00583908|3640558|FG004|STARTED|Period 2 - Second Intervention||2
2929466|NCT00583908|3640559|FG005|STARTED|Period 2 - Second Intervention||1
2929467|NCT00583908|3640560|FG006|STARTED|Period 2 - Second Intervention||1
2929468|NCT00583908|3640561|FG007|STARTED|Period 2 - Second Intervention||1
2929469|NCT00583908|3640562|FG008|STARTED|Period 2 - Second Intervention||1
2929470|NCT00583908|3640563|FG009|STARTED|Period 2 - Second Intervention||1
2929471|NCT00583908|3640564|FG010|STARTED|Period 2 - Second Intervention||1
2929472|NCT00583908|3640565|FG011|STARTED|Period 2 - Second Intervention||1
2929473|NCT00583908|3640554|FG000|COMPLETED|Period 2 - Second Intervention||1
2929474|NCT00583908|3640555|FG001|COMPLETED|Period 2 - Second Intervention||2
2929475|NCT00583908|3640556|FG002|COMPLETED|Period 2 - Second Intervention||1
2929476|NCT00583908|3640557|FG003|COMPLETED|Period 2 - Second Intervention||1
2929477|NCT00583908|3640558|FG004|COMPLETED|Period 2 - Second Intervention||2
2929478|NCT00583908|3640559|FG005|COMPLETED|Period 2 - Second Intervention||1
2929479|NCT00583908|3640560|FG006|COMPLETED|Period 2 - Second Intervention||1
2929480|NCT00583908|3640561|FG007|COMPLETED|Period 2 - Second Intervention||1
2929481|NCT00583908|3640562|FG008|COMPLETED|Period 2 - Second Intervention||1
2929482|NCT00583908|3640563|FG009|COMPLETED|Period 2 - Second Intervention||1
2929483|NCT00583908|3640564|FG010|COMPLETED|Period 2 - Second Intervention||1
2929484|NCT00583908|3640565|FG011|COMPLETED|Period 2 - Second Intervention||1
2929485|NCT00583908|3640554|FG000|NOT COMPLETED|Period 2 - Second Intervention||0
2929486|NCT00583908|3640555|FG001|NOT COMPLETED|Period 2 - Second Intervention||0
2929487|NCT00583908|3640556|FG002|NOT COMPLETED|Period 2 - Second Intervention||0
2929488|NCT00583908|3640557|FG003|NOT COMPLETED|Period 2 - Second Intervention||0
2929489|NCT00583908|3640558|FG004|NOT COMPLETED|Period 2 - Second Intervention||0
2929490|NCT00583908|3640559|FG005|NOT COMPLETED|Period 2 - Second Intervention||0
2929491|NCT00583908|3640560|FG006|NOT COMPLETED|Period 2 - Second Intervention||0
2929492|NCT00583908|3640561|FG007|NOT COMPLETED|Period 2 - Second Intervention||0
2929493|NCT00583908|3640562|FG008|NOT COMPLETED|Period 2 - Second Intervention||0
2929494|NCT00583908|3640563|FG009|NOT COMPLETED|Period 2 - Second Intervention||0
2929495|NCT00583908|3640564|FG010|NOT COMPLETED|Period 2 - Second Intervention||0
3040652|NCT01166282|3760232|FG002|STARTED|Open-label Period||46
3040653|NCT01166282|3760230|FG000|COMPLETED|Open-label Period||0
3040654|NCT01166282|3760231|FG001|COMPLETED|Open-label Period||0
3040655|NCT01166282|3760232|FG002|COMPLETED|Open-label Period||29
3040656|NCT01166282|3760230|FG000|NOT COMPLETED|Open-label Period||0
3040657|NCT01166282|3760231|FG001|NOT COMPLETED|Open-label Period||0
3040658|NCT01166282|3760232|FG002|NOT COMPLETED|Open-label Period||17
3040659|NCT01166347|3760242|FG000|STARTED|Overall Study||297
3040660|NCT01166347|3760243|FG001|STARTED|Overall Study||149
3040661|NCT01166347|3760242|FG000|COMPLETED|Overall Study||295
3040662|NCT01166347|3760243|FG001|COMPLETED|Overall Study||148
3040663|NCT01166347|3760242|FG000|NOT COMPLETED|Overall Study||2
3040664|NCT01166347|3760243|FG001|NOT COMPLETED|Overall Study||1
3040665|NCT01166373|3760253|FG000|STARTED|Overall Study||95
3040666|NCT01166373|3760254|FG001|STARTED|Overall Study||91
3040667|NCT01166373|3760255|FG002|STARTED|Overall Study||91
3040668|NCT01166373|3760256|FG003|STARTED|Overall Study||97
3040669|NCT01166373|3760253|FG000|Completed OPTIMAL Year 2 Visit|Overall Study||81
3040670|NCT01166373|3760254|FG001|Completed OPTIMAL Year 2 Visit|Overall Study||80
3040671|NCT01166373|3760255|FG002|Completed OPTIMAL Year 2 Visit|Overall Study||79
3040672|NCT01166373|3760256|FG003|Completed OPTIMAL Year 2 Visit|Overall Study||87
3040673|NCT01166373|3760253|FG000|Randomized to Video|Overall Study||32
3040674|NCT01166373|3760254|FG001|Randomized to Video|Overall Study||43
3040675|NCT01166373|3760255|FG002|Randomized to Video|Overall Study||38
3040676|NCT01166373|3760256|FG003|Randomized to Video|Overall Study||40
3040677|NCT01166373|3760253|FG000|Randomized to No Video|Overall Study||45
3040678|NCT01166373|3760254|FG001|Randomized to No Video|Overall Study||30
3040679|NCT01166373|3760255|FG002|Randomized to No Video|Overall Study||34
3040680|NCT01166373|3760256|FG003|Randomized to No Video|Overall Study||42
3040681|NCT01166373|3760253|FG000|Consented to Participate E-OPTIMAL|Overall Study||72
3040682|NCT01166373|3760254|FG001|Consented to Participate E-OPTIMAL|Overall Study||66
3179677|NCT01986855|3907900|FG002|STARTED|Overall Study||154
3179678|NCT01986855|3907898|FG000|Treated|Overall Study||158
3179679|NCT01986855|3907899|FG001|Treated|Overall Study||155
3179680|NCT01986855|3907900|FG002|Treated|Overall Study||154
3179681|NCT01986855|3907898|FG000|COMPLETED|Overall Study||145
3179682|NCT01986855|3907899|FG001|COMPLETED|Overall Study||142
3179683|NCT01986855|3907900|FG002|COMPLETED|Overall Study||143
3179684|NCT01986855|3907898|FG000|NOT COMPLETED|Overall Study||13
3179685|NCT01986855|3907899|FG001|NOT COMPLETED|Overall Study||14
3179686|NCT01986855|3907900|FG002|NOT COMPLETED|Overall Study||11
3179687|NCT01986881|3907911|FG000|STARTED|Overall Study||2752
3040683|NCT01166373|3760255|FG002|Consented to Participate E-OPTIMAL|Overall Study||69
3040684|NCT01166373|3760256|FG003|Consented to Participate E-OPTIMAL|Overall Study||78
3040685|NCT01166373|3760253|FG000|Completed E-OPTIMAL Year 3 Visit|Overall Study||70
3040686|NCT01166373|3760254|FG001|Completed E-OPTIMAL Year 3 Visit|Overall Study||66
3040687|NCT01166373|3760255|FG002|Completed E-OPTIMAL Year 3 Visit|Overall Study||66
2929496|NCT00583908|3640565|FG011|NOT COMPLETED|Period 2 - Second Intervention||0
2929497|NCT00583908|3640554|FG000|STARTED|Period 3 - Third Intervention||1
2929498|NCT00583908|3640555|FG001|STARTED|Period 3 - Third Intervention||2
2929499|NCT00583908|3640556|FG002|STARTED|Period 3 - Third Intervention||1
2929500|NCT00583908|3640557|FG003|STARTED|Period 3 - Third Intervention||1
2929501|NCT00583908|3640558|FG004|STARTED|Period 3 - Third Intervention||2
2929502|NCT00583908|3640559|FG005|STARTED|Period 3 - Third Intervention||1
2929503|NCT00583908|3640560|FG006|STARTED|Period 3 - Third Intervention||1
2929504|NCT00583908|3640561|FG007|STARTED|Period 3 - Third Intervention||1
2929505|NCT00583908|3640562|FG008|STARTED|Period 3 - Third Intervention||1
2929506|NCT00583908|3640563|FG009|STARTED|Period 3 - Third Intervention||1
2929507|NCT00583908|3640564|FG010|STARTED|Period 3 - Third Intervention||1
2929508|NCT00583908|3640565|FG011|STARTED|Period 3 - Third Intervention||1
3179688|NCT01986881|3907912|FG001|STARTED|Overall Study||2747
3179689|NCT01986881|3907913|FG002|STARTED|Overall Study||2747
3179690|NCT01986881|3907911|FG000|Treated|Overall Study||2746
2929509|NCT00583908|3640554|FG000|COMPLETED|Period 3 - Third Intervention||1
2929510|NCT00583908|3640555|FG001|COMPLETED|Period 3 - Third Intervention||2
2929511|NCT00583908|3640556|FG002|COMPLETED|Period 3 - Third Intervention||1
2929512|NCT00583908|3640557|FG003|COMPLETED|Period 3 - Third Intervention||1
2929513|NCT00583908|3640558|FG004|COMPLETED|Period 3 - Third Intervention||2
2929514|NCT00583908|3640559|FG005|COMPLETED|Period 3 - Third Intervention||1
2929515|NCT00583908|3640560|FG006|COMPLETED|Period 3 - Third Intervention||1
2929516|NCT00583908|3640561|FG007|COMPLETED|Period 3 - Third Intervention||1
2929517|NCT00583908|3640562|FG008|COMPLETED|Period 3 - Third Intervention||1
2929518|NCT00583908|3640563|FG009|COMPLETED|Period 3 - Third Intervention||1
2929519|NCT00583908|3640564|FG010|COMPLETED|Period 3 - Third Intervention||1
2929520|NCT00583908|3640565|FG011|COMPLETED|Period 3 - Third Intervention||1
2929521|NCT00583908|3640554|FG000|NOT COMPLETED|Period 3 - Third Intervention||0
2929522|NCT00583908|3640555|FG001|NOT COMPLETED|Period 3 - Third Intervention||0
2929523|NCT00583908|3640556|FG002|NOT COMPLETED|Period 3 - Third Intervention||0
2929524|NCT00583908|3640557|FG003|NOT COMPLETED|Period 3 - Third Intervention||0
2929525|NCT00583908|3640558|FG004|NOT COMPLETED|Period 3 - Third Intervention||0
2929526|NCT00583908|3640559|FG005|NOT COMPLETED|Period 3 - Third Intervention||0
2929527|NCT00583908|3640560|FG006|NOT COMPLETED|Period 3 - Third Intervention||0
2929528|NCT00583908|3640561|FG007|NOT COMPLETED|Period 3 - Third Intervention||0
2929529|NCT00583908|3640562|FG008|NOT COMPLETED|Period 3 - Third Intervention||0
2929530|NCT00583908|3640563|FG009|NOT COMPLETED|Period 3 - Third Intervention||0
2929531|NCT00583908|3640564|FG010|NOT COMPLETED|Period 3 - Third Intervention||0
2929532|NCT00583908|3640565|FG011|NOT COMPLETED|Period 3 - Third Intervention||0
2929533|NCT00583908|3640554|FG000|STARTED|Period 4 - Fourth Intervention||1
2929534|NCT00583908|3640555|FG001|STARTED|Period 4 - Fourth Intervention||2
2929535|NCT00583908|3640556|FG002|STARTED|Period 4 - Fourth Intervention||1
2929536|NCT00583908|3640557|FG003|STARTED|Period 4 - Fourth Intervention||1
2929537|NCT00583908|3640558|FG004|STARTED|Period 4 - Fourth Intervention||2
2929538|NCT00583908|3640559|FG005|STARTED|Period 4 - Fourth Intervention||1
2929539|NCT00583908|3640560|FG006|STARTED|Period 4 - Fourth Intervention||1
2929540|NCT00583908|3640561|FG007|STARTED|Period 4 - Fourth Intervention||1
2929541|NCT00583908|3640562|FG008|STARTED|Period 4 - Fourth Intervention||1
2929542|NCT00583908|3640563|FG009|STARTED|Period 4 - Fourth Intervention||1
2929543|NCT00583908|3640564|FG010|STARTED|Period 4 - Fourth Intervention||1
3040688|NCT01166373|3760256|FG003|Completed E-OPTIMAL Year 3 Visit|Overall Study||77
3040689|NCT01166373|3760253|FG000|Completed E-OPTIMAL Year 4 Visit|Overall Study||67
3040690|NCT01166373|3760254|FG001|Completed E-OPTIMAL Year 4 Visit|Overall Study||61
3040691|NCT01166373|3760255|FG002|Completed E-OPTIMAL Year 4 Visit|Overall Study||63
3040692|NCT01166373|3760256|FG003|Completed E-OPTIMAL Year 4 Visit|Overall Study||68
3040693|NCT01166373|3760253|FG000|Completed E-OPTIMAL Year 5 Visit|Overall Study||62
3040694|NCT01166373|3760254|FG001|Completed E-OPTIMAL Year 5 Visit|Overall Study||56
3040695|NCT01166373|3760255|FG002|Completed E-OPTIMAL Year 5 Visit|Overall Study||62
3040696|NCT01166373|3760256|FG003|Completed E-OPTIMAL Year 5 Visit|Overall Study||64
3040697|NCT01166373|3760253|FG000|COMPLETED|Overall Study||90
3040698|NCT01166373|3760254|FG001|COMPLETED|Overall Study||87
3040699|NCT01166373|3760255|FG002|COMPLETED|Overall Study||87
3040700|NCT01166373|3760256|FG003|COMPLETED|Overall Study||92
3040701|NCT01166373|3760253|FG000|NOT COMPLETED|Overall Study||5
3040702|NCT01166373|3760254|FG001|NOT COMPLETED|Overall Study||4
3040703|NCT01166373|3760255|FG002|NOT COMPLETED|Overall Study||4
3040704|NCT01166373|3760256|FG003|NOT COMPLETED|Overall Study||5
3040705|NCT01166386|3760270|FG000|STARTED|Overall Study||82
3040706|NCT01166386|3760271|FG001|STARTED|Overall Study||83
3179691|NCT01986881|3907912|FG001|Treated|Overall Study||2747
3179692|NCT01986881|3907913|FG002|Treated|Overall Study||2745
3179693|NCT01986881|3907911|FG000|Participants Enrolled in the Insulin +/- Metformin Glycemic Sub-Study|Overall Study||348
2929544|NCT00583908|3640565|FG011|STARTED|Period 4 - Fourth Intervention||1
2929545|NCT00583908|3640554|FG000|COMPLETED|Period 4 - Fourth Intervention||1
2929546|NCT00583908|3640555|FG001|COMPLETED|Period 4 - Fourth Intervention||2
3040707|NCT01166386|3760270|FG000|COMPLETED|Overall Study||79
3040708|NCT01166386|3760271|FG001|COMPLETED|Overall Study||78
3040709|NCT01166386|3760270|FG000|NOT COMPLETED|Overall Study||3
3040710|NCT01166386|3760271|FG001|NOT COMPLETED|Overall Study||5
3040711|NCT01166438|3760279|FG000|STARTED|Double-blind Phase: 1st 6 Months||122
3040712|NCT01166438|3760280|FG001|STARTED|Double-blind Phase: 1st 6 Months||127
3040713|NCT01166438|3760279|FG000|Treated|Double-blind Phase: 1st 6 Months||121
3040714|NCT01166438|3760280|FG001|Treated|Double-blind Phase: 1st 6 Months||126
3040715|NCT01166438|3760279|FG000|COMPLETED|Double-blind Phase: 1st 6 Months|Completion of 12 month follow-up visit|113
3040716|NCT01166438|3760280|FG001|COMPLETED|Double-blind Phase: 1st 6 Months|Completion of 12 month follow-up visit|118
3040717|NCT01166438|3760279|FG000|NOT COMPLETED|Double-blind Phase: 1st 6 Months||9
2929547|NCT00583908|3640556|FG002|COMPLETED|Period 4 - Fourth Intervention||1
2929548|NCT00583908|3640557|FG003|COMPLETED|Period 4 - Fourth Intervention||1
2929549|NCT00583908|3640558|FG004|COMPLETED|Period 4 - Fourth Intervention||2
2929550|NCT00583908|3640559|FG005|COMPLETED|Period 4 - Fourth Intervention||1
2929551|NCT00583908|3640560|FG006|COMPLETED|Period 4 - Fourth Intervention||1
2929552|NCT00583908|3640561|FG007|COMPLETED|Period 4 - Fourth Intervention||1
2929553|NCT00583908|3640562|FG008|COMPLETED|Period 4 - Fourth Intervention||1
2929554|NCT00583908|3640563|FG009|COMPLETED|Period 4 - Fourth Intervention||1
2929555|NCT00583908|3640564|FG010|COMPLETED|Period 4 - Fourth Intervention||1
2929556|NCT00583908|3640565|FG011|COMPLETED|Period 4 - Fourth Intervention||1
2929557|NCT00583908|3640554|FG000|NOT COMPLETED|Period 4 - Fourth Intervention||0
2929558|NCT00583908|3640555|FG001|NOT COMPLETED|Period 4 - Fourth Intervention||0
2929559|NCT00583908|3640556|FG002|NOT COMPLETED|Period 4 - Fourth Intervention||0
2929560|NCT00583908|3640557|FG003|NOT COMPLETED|Period 4 - Fourth Intervention||0
2929561|NCT00583908|3640558|FG004|NOT COMPLETED|Period 4 - Fourth Intervention||0
2929562|NCT00583908|3640559|FG005|NOT COMPLETED|Period 4 - Fourth Intervention||0
2929563|NCT00583908|3640560|FG006|NOT COMPLETED|Period 4 - Fourth Intervention||0
2929564|NCT00583908|3640561|FG007|NOT COMPLETED|Period 4 - Fourth Intervention||0
2929565|NCT00583908|3640562|FG008|NOT COMPLETED|Period 4 - Fourth Intervention||0
2929566|NCT00583908|3640563|FG009|NOT COMPLETED|Period 4 - Fourth Intervention||0
2929567|NCT00583908|3640564|FG010|NOT COMPLETED|Period 4 - Fourth Intervention||0
2929568|NCT00583908|3640565|FG011|NOT COMPLETED|Period 4 - Fourth Intervention||0
2929569|NCT00583947|3640585|FG000|STARTED|Cross-over Period|Participants were stratified by age group at randomization: ages 2-5 yrs and 6-11 years|27
2929570|NCT00583947|3640586|FG001|STARTED|Cross-over Period|Participants were stratified by age group at randomization: ages 2-5 yrs and 6-11 years|26
2929571|NCT00583947|3640585|FG000|COMPLETED|Cross-over Period||22
2929572|NCT00583947|3640586|FG001|COMPLETED|Cross-over Period||24
2929573|NCT00583947|3640585|FG000|NOT COMPLETED|Cross-over Period||5
2929574|NCT00583947|3640586|FG001|NOT COMPLETED|Cross-over Period||2
2929575|NCT00583947|3640585|FG000|STARTED|Washout||22
2929576|NCT00583947|3640586|FG001|STARTED|Washout||24
2929577|NCT00583947|3640585|FG000|COMPLETED|Washout||22
2929578|NCT00583947|3640586|FG001|COMPLETED|Washout||24
2929579|NCT00583947|3640585|FG000|NOT COMPLETED|Washout||0
3179694|NCT01986881|3907912|FG001|Participants Enrolled in the Insulin +/- Metformin Glycemic Sub-Study|Overall Study||370
3179695|NCT01986881|3907913|FG002|Participants Enrolled in the Insulin +/- Metformin Glycemic Sub-Study|Overall Study||347
3179696|NCT01986881|3907911|FG000|Participants Enrolled in the Sulfonylurea Monotherapy Glycemic Sub-Study|Overall Study||55
3363467|NCT04069221|4094592|FG001|STARTED|Overall Study||6
3179697|NCT01986881|3907912|FG001|Participants Enrolled in the Sulfonylurea Monotherapy Glycemic Sub-Study|Overall Study||54
3179698|NCT01986881|3907913|FG002|Participants Enrolled in the Sulfonylurea Monotherapy Glycemic Sub-Study|Overall Study||48
3179699|NCT01986881|3907911|FG000|Participants Enrolled in the Metformin With Sulfonylurea Glycemic Sub-Study|Overall Study||100
2929580|NCT00583947|3640586|FG001|NOT COMPLETED|Washout||0
2929581|NCT00583947|3640585|FG000|STARTED|Open Label Period|3 subjects were dosed with arformoterol 7.5 microgram in error|22
2929582|NCT00583947|3640586|FG001|STARTED|Open Label Period|3 subjects were dosed with arformoterol 7.5 microgram in error|24
2929583|NCT00583947|3640585|FG000|COMPLETED|Open Label Period||22
2929584|NCT00583947|3640586|FG001|COMPLETED|Open Label Period||24
2929585|NCT00583947|3640585|FG000|NOT COMPLETED|Open Label Period||0
3040718|NCT01166438|3760280|FG001|NOT COMPLETED|Double-blind Phase: 1st 6 Months||9
3040719|NCT01166438|3760279|FG000|STARTED|Off Treatment Follow-up Phase||85
3040720|NCT01166438|3760280|FG001|STARTED|Off Treatment Follow-up Phase||89
3040721|NCT01166438|3760279|FG000|COMPLETED|Off Treatment Follow-up Phase||51
3040722|NCT01166438|3760280|FG001|COMPLETED|Off Treatment Follow-up Phase||33
3040723|NCT01166438|3760279|FG000|NOT COMPLETED|Off Treatment Follow-up Phase||34
3040724|NCT01166438|3760280|FG001|NOT COMPLETED|Off Treatment Follow-up Phase||56
3040725|NCT01166568|3760290|FG000|STARTED|Deferred Implantation- Randomized||0
3040726|NCT01166568|3760291|FG001|STARTED|Deferred Implantation- Randomized||0
3040727|NCT01166568|3760292|FG002|STARTED|Deferred Implantation- Randomized||16
3040728|NCT01166568|3760290|FG000|COMPLETED|Deferred Implantation- Randomized||0
3040729|NCT01166568|3760291|FG001|COMPLETED|Deferred Implantation- Randomized||0
3040730|NCT01166568|3760292|FG002|COMPLETED|Deferred Implantation- Randomized|From the randomized sub-study control group (n=16), 1 subject withdrew during the observation phase|15
3040731|NCT01166568|3760290|FG000|NOT COMPLETED|Deferred Implantation- Randomized||0
3040732|NCT01166568|3760291|FG001|NOT COMPLETED|Deferred Implantation- Randomized||0
3040733|NCT01166568|3760292|FG002|NOT COMPLETED|Deferred Implantation- Randomized||1
3040734|NCT01166568|3760290|FG000|STARTED|Implantation- Nonrandomized & Randomized||288
3040735|NCT01166568|3760291|FG001|STARTED|Implantation- Nonrandomized & Randomized||33
3040736|NCT01166568|3760292|FG002|STARTED|Implantation- Nonrandomized & Randomized|15 subjects completed the observation phase and 9 subjects (17 eyes) proceeded with implantation.|9
3040737|NCT01166568|3760290|FG000|COMPLETED|Implantation- Nonrandomized & Randomized||274
3040738|NCT01166568|3760291|FG001|COMPLETED|Implantation- Nonrandomized & Randomized||32
3040739|NCT01166568|3760292|FG002|COMPLETED|Implantation- Nonrandomized & Randomized|(1) Primary eye implanted only subject withdrew consent after implantation of the device.|8
3040740|NCT01166568|3760290|FG000|NOT COMPLETED|Implantation- Nonrandomized & Randomized||14
3040741|NCT01166568|3760291|FG001|NOT COMPLETED|Implantation- Nonrandomized & Randomized||1
3040742|NCT01166568|3760292|FG002|NOT COMPLETED|Implantation- Nonrandomized & Randomized||1
3040743|NCT01166646|3760300|FG000|STARTED|Overall Study||21
3040744|NCT01166646|3760301|FG001|STARTED|Overall Study||22
3040745|NCT01166646|3760300|FG000|COMPLETED|Overall Study||20
3040746|NCT01166646|3760301|FG001|COMPLETED|Overall Study||21
3040747|NCT01166646|3760300|FG000|NOT COMPLETED|Overall Study||1
3040748|NCT01166646|3760301|FG001|NOT COMPLETED|Overall Study||1
3040749|NCT01166659|3760307|FG000|STARTED|Overall Study||48
3040750|NCT01166659|3760307|FG000|COMPLETED|Overall Study||35
3040751|NCT01166659|3760307|FG000|NOT COMPLETED|Overall Study||13
3040752|NCT01166750|3760314|FG000|STARTED|Overall Study||10
3040753|NCT01166750|3760315|FG001|STARTED|Overall Study||13
2929586|NCT00583947|3640586|FG001|NOT COMPLETED|Open Label Period||0
2929587|NCT00584077|3640594|FG000|STARTED|Overall Study||15
2929588|NCT00584077|3640594|FG000|COMPLETED|Overall Study||15
2929589|NCT00584077|3640594|FG000|NOT COMPLETED|Overall Study||0
2929590|NCT00584194|3640599|FG000|STARTED|Overall Study||278
2929591|NCT00584194|3640599|FG000|COMPLETED|Overall Study||143
2929592|NCT00584194|3640599|FG000|NOT COMPLETED|Overall Study||135
2929593|NCT00584220|3640603|FG000|STARTED|First Period||48
2929594|NCT00584220|3640604|FG001|STARTED|First Period||39
2929595|NCT00584220|3640603|FG000|COMPLETED|First Period||48
2929596|NCT00584220|3640604|FG001|COMPLETED|First Period||39
2929597|NCT00584220|3640603|FG000|NOT COMPLETED|First Period||0
2929598|NCT00584220|3640604|FG001|NOT COMPLETED|First Period||0
2929599|NCT00584220|3640603|FG000|STARTED|Second Period||48
2929600|NCT00584220|3640604|FG001|STARTED|Second Period||39
2929601|NCT00584220|3640603|FG000|COMPLETED|Second Period||48
2929602|NCT00584220|3640604|FG001|COMPLETED|Second Period||39
2929603|NCT00584220|3640603|FG000|NOT COMPLETED|Second Period||0
2929604|NCT00584220|3640604|FG001|NOT COMPLETED|Second Period||0
2929605|NCT00584285|3640610|FG000|STARTED|Overall Study||18
2929606|NCT00584285|3640610|FG000|COMPLETED|Overall Study||18
2929607|NCT00584285|3640610|FG000|NOT COMPLETED|Overall Study||0
2929608|NCT00584402|3640614|FG000|STARTED|Overall Study||8
2929609|NCT00584402|3640614|FG000|COMPLETED|Overall Study||8
2929610|NCT00584402|3640614|FG000|NOT COMPLETED|Overall Study||0
2929611|NCT00584415|3640618|FG000|STARTED|Overall Study|A total of 119 enrolled and 112 underwent the ablation procedure;|119
2929612|NCT00584415|3640618|FG000|COMPLETED|Overall Study||112
2929613|NCT00584415|3640618|FG000|NOT COMPLETED|Overall Study||7
2929614|NCT00584454|3640623|FG000|STARTED|Overall Study||10
2929615|NCT00584454|3640623|FG000|COMPLETED|Overall Study||6
2929616|NCT00584454|3640623|FG000|NOT COMPLETED|Overall Study||4
2929617|NCT00584480|3640627|FG000|STARTED|First 8 Weeks (40 Treatments)||10
2929618|NCT00584480|3640627|FG000|COMPLETED|First 8 Weeks (40 Treatments)||10
2929619|NCT00584480|3640627|FG000|NOT COMPLETED|First 8 Weeks (40 Treatments)||0
2929620|NCT00584480|3640627|FG000|STARTED|4-Week Break From Treatment||10
2929621|NCT00584480|3640627|FG000|COMPLETED|4-Week Break From Treatment||10
2929622|NCT00584480|3640627|FG000|NOT COMPLETED|4-Week Break From Treatment||0
2929623|NCT00584480|3640627|FG000|STARTED|Second 8 Weeks (40 Treatments)||10
2929624|NCT00584480|3640627|FG000|COMPLETED|Second 8 Weeks (40 Treatments)||10
2929625|NCT00584480|3640627|FG000|NOT COMPLETED|Second 8 Weeks (40 Treatments)||0
2929626|NCT00584558|3640631|FG000|STARTED|Overall Study||2420
2929627|NCT00584558|3640631|FG000|COMPLETED|Overall Study||2420
2929628|NCT00584558|3640631|FG000|NOT COMPLETED|Overall Study||0
2929629|NCT00584701|3640636|FG000|STARTED|Active Risperidone||49
2929630|NCT00584701|3640636|FG000|COMPLETED|Active Risperidone||46
2929631|NCT00584701|3640636|FG000|NOT COMPLETED|Active Risperidone||3
2929632|NCT00584701|3640636|FG000|STARTED|Follow-up||46
2929633|NCT00584701|3640636|FG000|COMPLETED|Follow-up||34
2929634|NCT00584701|3640636|FG000|NOT COMPLETED|Follow-up||12
2929635|NCT00584727|3640641|FG000|STARTED|First Intervention||17
2929636|NCT00584727|3640642|FG001|STARTED|First Intervention||17
2929637|NCT00584727|3640643|FG002|STARTED|First Intervention||16
2929638|NCT00584727|3640644|FG003|STARTED|First Intervention||14
2929639|NCT00584727|3640645|FG004|STARTED|First Intervention||16
2929640|NCT00584727|3640646|FG005|STARTED|First Intervention||16
2929641|NCT00584727|3640641|FG000|COMPLETED|First Intervention||17
2929642|NCT00584727|3640642|FG001|COMPLETED|First Intervention||17
2929643|NCT00584727|3640643|FG002|COMPLETED|First Intervention||15
2929644|NCT00584727|3640644|FG003|COMPLETED|First Intervention||14
2929645|NCT00584727|3640645|FG004|COMPLETED|First Intervention||16
2929646|NCT00584727|3640646|FG005|COMPLETED|First Intervention||16
2929647|NCT00584727|3640641|FG000|NOT COMPLETED|First Intervention||0
2929648|NCT00584727|3640642|FG001|NOT COMPLETED|First Intervention||0
2929649|NCT00584727|3640643|FG002|NOT COMPLETED|First Intervention||1
2929650|NCT00584727|3640644|FG003|NOT COMPLETED|First Intervention||0
2929651|NCT00584727|3640645|FG004|NOT COMPLETED|First Intervention||0
2929652|NCT00584727|3640646|FG005|NOT COMPLETED|First Intervention||0
2929653|NCT00584727|3640641|FG000|STARTED|Second Intervention||17
2929654|NCT00584727|3640642|FG001|STARTED|Second Intervention||17
2929655|NCT00584727|3640643|FG002|STARTED|Second Intervention||15
2929656|NCT00584727|3640644|FG003|STARTED|Second Intervention||14
3040754|NCT01166750|3760314|FG000|COMPLETED|Overall Study||9
3040755|NCT01166750|3760315|FG001|COMPLETED|Overall Study||13
3040756|NCT01166750|3760314|FG000|NOT COMPLETED|Overall Study||1
3040757|NCT01166750|3760315|FG001|NOT COMPLETED|Overall Study||0
3040758|NCT01166763|3760321|FG000|STARTED|Overall Study||30
3040759|NCT01166763|3760321|FG000|COMPLETED|Overall Study||27
3040760|NCT01166763|3760321|FG000|NOT COMPLETED|Overall Study||3
3040761|NCT01166945|3760327|FG000|STARTED|Randomized||51
3040762|NCT01166945|3760328|FG001|STARTED|Randomized||47
3040763|NCT01166945|3760327|FG000|COMPLETED|Randomized||47
3040764|NCT01166945|3760328|FG001|COMPLETED|Randomized||43
3040765|NCT01166945|3760327|FG000|NOT COMPLETED|Randomized||4
3040766|NCT01166945|3760328|FG001|NOT COMPLETED|Randomized||4
3040767|NCT01166945|3760327|FG000|STARTED|Day 5||47
3040768|NCT01166945|3760328|FG001|STARTED|Day 5||43
3040769|NCT01166945|3760327|FG000|COMPLETED|Day 5||47
3040770|NCT01166945|3760328|FG001|COMPLETED|Day 5||43
3040771|NCT01166945|3760327|FG000|NOT COMPLETED|Day 5||0
3040772|NCT01166945|3760328|FG001|NOT COMPLETED|Day 5||0
3040773|NCT01166945|3760327|FG000|STARTED|Day 10||47
3040774|NCT01166945|3760328|FG001|STARTED|Day 10||43
3040775|NCT01166945|3760327|FG000|COMPLETED|Day 10||44
3040776|NCT01166945|3760328|FG001|COMPLETED|Day 10||41
3040777|NCT01166945|3760327|FG000|NOT COMPLETED|Day 10||3
3040778|NCT01166945|3760328|FG001|NOT COMPLETED|Day 10||2
3040779|NCT01166945|3760327|FG000|STARTED|Day 15||44
3040780|NCT01166945|3760328|FG001|STARTED|Day 15||41
3040781|NCT01166945|3760327|FG000|COMPLETED|Day 15||42
3040782|NCT01166945|3760328|FG001|COMPLETED|Day 15||40
3040783|NCT01166945|3760327|FG000|NOT COMPLETED|Day 15||2
3040784|NCT01166945|3760328|FG001|NOT COMPLETED|Day 15||1
3040785|NCT01166945|3760327|FG000|STARTED|Day 20||42
3040786|NCT01166945|3760328|FG001|STARTED|Day 20||40
3040787|NCT01166945|3760327|FG000|COMPLETED|Day 20||42
3040788|NCT01166945|3760328|FG001|COMPLETED|Day 20||40
3040789|NCT01166945|3760327|FG000|NOT COMPLETED|Day 20||0
3040790|NCT01166945|3760328|FG001|NOT COMPLETED|Day 20||0
3040791|NCT01166945|3760327|FG000|STARTED|Day 30||42
3040792|NCT01166945|3760328|FG001|STARTED|Day 30||40
3040793|NCT01166945|3760327|FG000|COMPLETED|Day 30||38
3040794|NCT01166945|3760328|FG001|COMPLETED|Day 30||37
3040795|NCT01166945|3760327|FG000|NOT COMPLETED|Day 30||4
3040796|NCT01166945|3760328|FG001|NOT COMPLETED|Day 30||3
3040797|NCT01166958|3760338|FG000|STARTED|Overall Study||13
3040798|NCT01166958|3760339|FG001|STARTED|Overall Study||13
3040799|NCT01166958|3760338|FG000|COMPLETED|Overall Study||12
3040800|NCT01166958|3760339|FG001|COMPLETED|Overall Study||13
3040801|NCT01166958|3760338|FG000|NOT COMPLETED|Overall Study||1
3040802|NCT01166958|3760339|FG001|NOT COMPLETED|Overall Study||0
3040803|NCT01166971|3760347|FG000|STARTED|Overall Study||33
3040804|NCT01166971|3760348|FG001|STARTED|Overall Study||31
3040805|NCT01166971|3760347|FG000|COMPLETED|Overall Study||32
3040806|NCT01166971|3760348|FG001|COMPLETED|Overall Study||30
3040807|NCT01166971|3760347|FG000|NOT COMPLETED|Overall Study||1
3040808|NCT01166971|3760348|FG001|NOT COMPLETED|Overall Study||1
3040809|NCT01166984|3760359|FG000|STARTED|Overall Study||5
3040810|NCT01166984|3760360|FG001|STARTED|Overall Study||5
3040811|NCT01166984|3760361|FG002|STARTED|Overall Study||5
3040812|NCT01166984|3760362|FG003|STARTED|Overall Study||5
3040813|NCT01166984|3760363|FG004|STARTED|Overall Study||5
3040814|NCT01166984|3760359|FG000|COMPLETED|Overall Study||5
2929657|NCT00584727|3640645|FG004|STARTED|Second Intervention||16
2929658|NCT00584727|3640646|FG005|STARTED|Second Intervention||16
2929659|NCT00584727|3640641|FG000|COMPLETED|Second Intervention||17
2929660|NCT00584727|3640642|FG001|COMPLETED|Second Intervention||17
2929661|NCT00584727|3640643|FG002|COMPLETED|Second Intervention||15
2929662|NCT00584727|3640644|FG003|COMPLETED|Second Intervention||14
2929663|NCT00584727|3640645|FG004|COMPLETED|Second Intervention||16
2929664|NCT00584727|3640646|FG005|COMPLETED|Second Intervention||16
2929665|NCT00584727|3640641|FG000|NOT COMPLETED|Second Intervention||0
2929666|NCT00584727|3640642|FG001|NOT COMPLETED|Second Intervention||0
2929667|NCT00584727|3640643|FG002|NOT COMPLETED|Second Intervention||0
2929668|NCT00584727|3640644|FG003|NOT COMPLETED|Second Intervention||0
2929669|NCT00584727|3640645|FG004|NOT COMPLETED|Second Intervention||0
2929670|NCT00584727|3640646|FG005|NOT COMPLETED|Second Intervention||0
2929671|NCT00584727|3640641|FG000|STARTED|Third Intervention||17
2929672|NCT00584727|3640642|FG001|STARTED|Third Intervention||17
2929673|NCT00584727|3640643|FG002|STARTED|Third Intervention||15
2929674|NCT00584727|3640644|FG003|STARTED|Third Intervention||14
2929675|NCT00584727|3640645|FG004|STARTED|Third Intervention||16
2929676|NCT00584727|3640646|FG005|STARTED|Third Intervention||16
2929677|NCT00584727|3640641|FG000|COMPLETED|Third Intervention||17
2929678|NCT00584727|3640642|FG001|COMPLETED|Third Intervention||17
2929679|NCT00584727|3640643|FG002|COMPLETED|Third Intervention||14
2929680|NCT00584727|3640644|FG003|COMPLETED|Third Intervention||14
2929681|NCT00584727|3640645|FG004|COMPLETED|Third Intervention||12
2929682|NCT00584727|3640646|FG005|COMPLETED|Third Intervention||14
2929683|NCT00584727|3640641|FG000|NOT COMPLETED|Third Intervention||0
2929684|NCT00584727|3640642|FG001|NOT COMPLETED|Third Intervention||0
2929685|NCT00584727|3640643|FG002|NOT COMPLETED|Third Intervention||1
2929686|NCT00584727|3640644|FG003|NOT COMPLETED|Third Intervention||0
2929687|NCT00584727|3640645|FG004|NOT COMPLETED|Third Intervention||4
2929688|NCT00584727|3640646|FG005|NOT COMPLETED|Third Intervention||2
2929689|NCT00584740|3640659|FG000|STARTED|Overall Study||39
2929690|NCT00584740|3640660|FG001|STARTED|Overall Study||20
2929691|NCT00584740|3640659|FG000|COMPLETED|Overall Study||27
2929692|NCT00584740|3640660|FG001|COMPLETED|Overall Study||14
2929693|NCT00584740|3640659|FG000|NOT COMPLETED|Overall Study||12
2929694|NCT00584740|3640660|FG001|NOT COMPLETED|Overall Study||6
2929695|NCT00584805|3640666|FG000|STARTED|Overall Study||138
2929696|NCT00584805|3640666|FG000|COMPLETED|Overall Study||39
2929697|NCT00584805|3640666|FG000|NOT COMPLETED|Overall Study||99
2929698|NCT00584831|3640672|FG000|STARTED|Intervention 1||1
2929699|NCT00584831|3640673|FG001|STARTED|Intervention 1||3
2929700|NCT00584831|3640674|FG002|STARTED|Intervention 1||2
2929701|NCT00584831|3640675|FG003|STARTED|Intervention 1||1
2929702|NCT00584831|3640676|FG004|STARTED|Intervention 1||2
2929703|NCT00584831|3640677|FG005|STARTED|Intervention 1||1
2929704|NCT00584831|3640678|FG006|STARTED|Intervention 1||6
2929705|NCT00584831|3640679|FG007|STARTED|Intervention 1||2
2929706|NCT00584831|3640680|FG008|STARTED|Intervention 1||4
2929707|NCT00584831|3640681|FG009|STARTED|Intervention 1||2
2929708|NCT00584831|3640682|FG010|STARTED|Intervention 1||2
2929709|NCT00584831|3640683|FG011|STARTED|Intervention 1||1
2929710|NCT00584831|3640684|FG012|STARTED|Intervention 1||2
2929711|NCT00584831|3640685|FG013|STARTED|Intervention 1||1
2929712|NCT00584831|3640686|FG014|STARTED|Intervention 1||3
2929713|NCT00584831|3640687|FG015|STARTED|Intervention 1||1
2929714|NCT00584831|3640688|FG016|STARTED|Intervention 1||4
2929715|NCT00584831|3640689|FG017|STARTED|Intervention 1||1
2929716|NCT00584831|3640690|FG018|STARTED|Intervention 1||1
2929717|NCT00584831|3640672|FG000|COMPLETED|Intervention 1||1
2929718|NCT00584831|3640673|FG001|COMPLETED|Intervention 1||3
2929719|NCT00584831|3640674|FG002|COMPLETED|Intervention 1||2
2929720|NCT00584831|3640675|FG003|COMPLETED|Intervention 1||1
2929721|NCT00584831|3640676|FG004|COMPLETED|Intervention 1||2
2929722|NCT00584831|3640677|FG005|COMPLETED|Intervention 1||1
2929723|NCT00584831|3640678|FG006|COMPLETED|Intervention 1||6
2929724|NCT00584831|3640679|FG007|COMPLETED|Intervention 1||2
2929725|NCT00584831|3640680|FG008|COMPLETED|Intervention 1||4
2929726|NCT00584831|3640681|FG009|COMPLETED|Intervention 1||2
2929727|NCT00584831|3640682|FG010|COMPLETED|Intervention 1||2
2929728|NCT00584831|3640683|FG011|COMPLETED|Intervention 1||1
2929729|NCT00584831|3640684|FG012|COMPLETED|Intervention 1||2
2929730|NCT00584831|3640685|FG013|COMPLETED|Intervention 1||1
2929731|NCT00584831|3640686|FG014|COMPLETED|Intervention 1||3
2929732|NCT00584831|3640687|FG015|COMPLETED|Intervention 1||1
2929733|NCT00584831|3640688|FG016|COMPLETED|Intervention 1||4
2929734|NCT00584831|3640689|FG017|COMPLETED|Intervention 1||1
2929735|NCT00584831|3640690|FG018|COMPLETED|Intervention 1||1
2929736|NCT00584831|3640672|FG000|NOT COMPLETED|Intervention 1||0
2929737|NCT00584831|3640673|FG001|NOT COMPLETED|Intervention 1||0
2929738|NCT00584831|3640674|FG002|NOT COMPLETED|Intervention 1||0
2929739|NCT00584831|3640675|FG003|NOT COMPLETED|Intervention 1||0
2929740|NCT00584831|3640676|FG004|NOT COMPLETED|Intervention 1||0
2929741|NCT00584831|3640677|FG005|NOT COMPLETED|Intervention 1||0
2929742|NCT00584831|3640678|FG006|NOT COMPLETED|Intervention 1||0
2929743|NCT00584831|3640679|FG007|NOT COMPLETED|Intervention 1||0
2929744|NCT00584831|3640680|FG008|NOT COMPLETED|Intervention 1||0
2929745|NCT00584831|3640681|FG009|NOT COMPLETED|Intervention 1||0
2929746|NCT00584831|3640682|FG010|NOT COMPLETED|Intervention 1||0
2929747|NCT00584831|3640683|FG011|NOT COMPLETED|Intervention 1||0
2929748|NCT00584831|3640684|FG012|NOT COMPLETED|Intervention 1||0
2929749|NCT00584831|3640685|FG013|NOT COMPLETED|Intervention 1||0
2929750|NCT00584831|3640686|FG014|NOT COMPLETED|Intervention 1||0
2929751|NCT00584831|3640687|FG015|NOT COMPLETED|Intervention 1||0
2929752|NCT00584831|3640688|FG016|NOT COMPLETED|Intervention 1||0
2929753|NCT00584831|3640689|FG017|NOT COMPLETED|Intervention 1||0
2929754|NCT00584831|3640690|FG018|NOT COMPLETED|Intervention 1||0
2929755|NCT00584831|3640672|FG000|STARTED|Intervention 2||1
2929756|NCT00584831|3640673|FG001|STARTED|Intervention 2||3
2929757|NCT00584831|3640674|FG002|STARTED|Intervention 2||2
2929758|NCT00584831|3640675|FG003|STARTED|Intervention 2||1
2929759|NCT00584831|3640676|FG004|STARTED|Intervention 2||2
2929760|NCT00584831|3640677|FG005|STARTED|Intervention 2||1
2929761|NCT00584831|3640678|FG006|STARTED|Intervention 2||6
2929762|NCT00584831|3640679|FG007|STARTED|Intervention 2||2
2929763|NCT00584831|3640680|FG008|STARTED|Intervention 2||4
2929764|NCT00584831|3640681|FG009|STARTED|Intervention 2||2
2929765|NCT00584831|3640682|FG010|STARTED|Intervention 2||2
2929766|NCT00584831|3640683|FG011|STARTED|Intervention 2||1
2929767|NCT00584831|3640684|FG012|STARTED|Intervention 2||2
2929768|NCT00584831|3640685|FG013|STARTED|Intervention 2||1
2929769|NCT00584831|3640686|FG014|STARTED|Intervention 2||3
2929770|NCT00584831|3640687|FG015|STARTED|Intervention 2||1
2929771|NCT00584831|3640688|FG016|STARTED|Intervention 2||4
2929772|NCT00584831|3640689|FG017|STARTED|Intervention 2||1
2929773|NCT00584831|3640690|FG018|STARTED|Intervention 2||1
2929774|NCT00584831|3640672|FG000|COMPLETED|Intervention 2||1
2929775|NCT00584831|3640673|FG001|COMPLETED|Intervention 2||3
2929776|NCT00584831|3640674|FG002|COMPLETED|Intervention 2||2
2929777|NCT00584831|3640675|FG003|COMPLETED|Intervention 2||1
2929778|NCT00584831|3640676|FG004|COMPLETED|Intervention 2||2
2929779|NCT00584831|3640677|FG005|COMPLETED|Intervention 2||1
2929780|NCT00584831|3640678|FG006|COMPLETED|Intervention 2||6
2929781|NCT00584831|3640679|FG007|COMPLETED|Intervention 2||2
2929782|NCT00584831|3640680|FG008|COMPLETED|Intervention 2||4
2929783|NCT00584831|3640681|FG009|COMPLETED|Intervention 2||2
2929784|NCT00584831|3640682|FG010|COMPLETED|Intervention 2||2
2929785|NCT00584831|3640683|FG011|COMPLETED|Intervention 2||1
2929786|NCT00584831|3640684|FG012|COMPLETED|Intervention 2||2
2929787|NCT00584831|3640685|FG013|COMPLETED|Intervention 2||1
2929788|NCT00584831|3640686|FG014|COMPLETED|Intervention 2||3
2929789|NCT00584831|3640687|FG015|COMPLETED|Intervention 2||1
2929790|NCT00584831|3640688|FG016|COMPLETED|Intervention 2||4
2929791|NCT00584831|3640689|FG017|COMPLETED|Intervention 2||1
2929792|NCT00584831|3640690|FG018|COMPLETED|Intervention 2||1
2929793|NCT00584831|3640672|FG000|NOT COMPLETED|Intervention 2||0
2929794|NCT00584831|3640673|FG001|NOT COMPLETED|Intervention 2||0
2929795|NCT00584831|3640674|FG002|NOT COMPLETED|Intervention 2||0
2929796|NCT00584831|3640675|FG003|NOT COMPLETED|Intervention 2||0
2929797|NCT00584831|3640676|FG004|NOT COMPLETED|Intervention 2||0
2929798|NCT00584831|3640677|FG005|NOT COMPLETED|Intervention 2||0
2929799|NCT00584831|3640678|FG006|NOT COMPLETED|Intervention 2||0
2929800|NCT00584831|3640679|FG007|NOT COMPLETED|Intervention 2||0
2929801|NCT00584831|3640680|FG008|NOT COMPLETED|Intervention 2||0
2929802|NCT00584831|3640681|FG009|NOT COMPLETED|Intervention 2||0
2929803|NCT00584831|3640682|FG010|NOT COMPLETED|Intervention 2||0
2929804|NCT00584831|3640683|FG011|NOT COMPLETED|Intervention 2||0
2929805|NCT00584831|3640684|FG012|NOT COMPLETED|Intervention 2||0
2929806|NCT00584831|3640685|FG013|NOT COMPLETED|Intervention 2||0
2929807|NCT00584831|3640686|FG014|NOT COMPLETED|Intervention 2||0
2929808|NCT00584831|3640687|FG015|NOT COMPLETED|Intervention 2||0
2929809|NCT00584831|3640688|FG016|NOT COMPLETED|Intervention 2||0
2929810|NCT00584831|3640689|FG017|NOT COMPLETED|Intervention 2||0
3040815|NCT01166984|3760360|FG001|COMPLETED|Overall Study||5
3040816|NCT01166984|3760361|FG002|COMPLETED|Overall Study||5
3040817|NCT01166984|3760362|FG003|COMPLETED|Overall Study||5
3040818|NCT01166984|3760363|FG004|COMPLETED|Overall Study||5
3040819|NCT01166984|3760359|FG000|NOT COMPLETED|Overall Study||0
3040820|NCT01166984|3760360|FG001|NOT COMPLETED|Overall Study||0
3040821|NCT01166984|3760361|FG002|NOT COMPLETED|Overall Study||0
3040822|NCT01166984|3760362|FG003|NOT COMPLETED|Overall Study||0
3040823|NCT01166984|3760363|FG004|NOT COMPLETED|Overall Study||0
3040824|NCT01166997|3760387|FG000|STARTED|Overall Study||29
3040825|NCT01166997|3760388|FG001|STARTED|Overall Study||30
3040826|NCT01166997|3760387|FG000|COMPLETED|Overall Study||27
3040827|NCT01166997|3760388|FG001|COMPLETED|Overall Study||30
3040828|NCT01166997|3760387|FG000|NOT COMPLETED|Overall Study||2
3040829|NCT01166997|3760388|FG001|NOT COMPLETED|Overall Study||0
3040830|NCT01167023|3760398|FG000|STARTED|Overall Study||0
3040831|NCT01167023|3760399|FG001|STARTED|Overall Study||21
3040832|NCT01167023|3760400|FG002|STARTED|Overall Study||41
3040833|NCT01167023|3760398|FG000|Received at Least 1 Dose of Study Drug|Overall Study||0
3040834|NCT01167023|3760399|FG001|Received at Least 1 Dose of Study Drug|Overall Study||19
3040835|NCT01167023|3760400|FG002|Received at Least 1 Dose of Study Drug|Overall Study||41
3040836|NCT01167023|3760398|FG000|COMPLETED|Overall Study||0
3040837|NCT01167023|3760399|FG001|COMPLETED|Overall Study||18
3040838|NCT01167023|3760400|FG002|COMPLETED|Overall Study||39
3040839|NCT01167023|3760398|FG000|NOT COMPLETED|Overall Study||0
3040840|NCT01167023|3760399|FG001|NOT COMPLETED|Overall Study||3
3040841|NCT01167023|3760400|FG002|NOT COMPLETED|Overall Study||2
3040842|NCT01167140|3760406|FG000|STARTED|Overall Study||42
3040843|NCT01167140|3760406|FG000|COMPLETED|Overall Study||41
3040844|NCT01167140|3760406|FG000|NOT COMPLETED|Overall Study||1
3040845|NCT01167153|3760412|FG000|STARTED|Overall Study||282
3040846|NCT01167153|3760413|FG001|STARTED|Overall Study||282
3040847|NCT01167153|3760412|FG000|Intention to Treat (ITT)|Overall Study||272
3040848|NCT01167153|3760413|FG001|Intention to Treat (ITT)|Overall Study||268
3040849|NCT01167153|3760412|FG000|COMPLETED|Overall Study||264
3040850|NCT01167153|3760413|FG001|COMPLETED|Overall Study||249
3040851|NCT01167153|3760412|FG000|NOT COMPLETED|Overall Study||18
3040852|NCT01167153|3760413|FG001|NOT COMPLETED|Overall Study||33
3040853|NCT01167179|3760421|FG000|STARTED|Overall Study||80
3040854|NCT01167179|3760422|FG001|STARTED|Overall Study||80
3040855|NCT01167179|3760421|FG000|COMPLETED|Overall Study||65
3040856|NCT01167179|3760422|FG001|COMPLETED|Overall Study||59
3040857|NCT01167179|3760421|FG000|NOT COMPLETED|Overall Study||15
3040858|NCT01167179|3760422|FG001|NOT COMPLETED|Overall Study||21
3040859|NCT01167192|3760428|FG000|STARTED|Overall Study||10
3179700|NCT01986881|3907912|FG001|Participants Enrolled in the Metformin With Sulfonylurea Glycemic Sub-Study|Overall Study||113
3179701|NCT01986881|3907913|FG002|Participants Enrolled in the Metformin With Sulfonylurea Glycemic Sub-Study|Overall Study||117
2929811|NCT00584831|3640690|FG018|NOT COMPLETED|Intervention 2||0
2929812|NCT00584831|3640672|FG000|STARTED|Intervention 3||1
2929813|NCT00584831|3640673|FG001|STARTED|Intervention 3||3
2929814|NCT00584831|3640674|FG002|STARTED|Intervention 3||2
2929815|NCT00584831|3640675|FG003|STARTED|Intervention 3||1
2929816|NCT00584831|3640676|FG004|STARTED|Intervention 3||2
2929817|NCT00584831|3640677|FG005|STARTED|Intervention 3||1
2929818|NCT00584831|3640678|FG006|STARTED|Intervention 3||6
2929819|NCT00584831|3640679|FG007|STARTED|Intervention 3||2
2929820|NCT00584831|3640680|FG008|STARTED|Intervention 3||4
2929821|NCT00584831|3640681|FG009|STARTED|Intervention 3||2
2929822|NCT00584831|3640682|FG010|STARTED|Intervention 3||2
2929823|NCT00584831|3640683|FG011|STARTED|Intervention 3||1
2929824|NCT00584831|3640684|FG012|STARTED|Intervention 3||2
2929825|NCT00584831|3640685|FG013|STARTED|Intervention 3||1
2929826|NCT00584831|3640686|FG014|STARTED|Intervention 3||3
2929827|NCT00584831|3640687|FG015|STARTED|Intervention 3||1
2929828|NCT00584831|3640688|FG016|STARTED|Intervention 3||4
2929829|NCT00584831|3640689|FG017|STARTED|Intervention 3||1
2929830|NCT00584831|3640690|FG018|STARTED|Intervention 3||1
2929831|NCT00584831|3640672|FG000|COMPLETED|Intervention 3||1
2929832|NCT00584831|3640673|FG001|COMPLETED|Intervention 3||3
2929833|NCT00584831|3640674|FG002|COMPLETED|Intervention 3||2
2929834|NCT00584831|3640675|FG003|COMPLETED|Intervention 3||1
2929835|NCT00584831|3640676|FG004|COMPLETED|Intervention 3||2
2929836|NCT00584831|3640677|FG005|COMPLETED|Intervention 3||1
2929837|NCT00584831|3640678|FG006|COMPLETED|Intervention 3||6
2929838|NCT00584831|3640679|FG007|COMPLETED|Intervention 3||2
2929839|NCT00584831|3640680|FG008|COMPLETED|Intervention 3||4
2929840|NCT00584831|3640681|FG009|COMPLETED|Intervention 3||2
2929841|NCT00584831|3640682|FG010|COMPLETED|Intervention 3||2
2929842|NCT00584831|3640683|FG011|COMPLETED|Intervention 3||1
2929843|NCT00584831|3640684|FG012|COMPLETED|Intervention 3||2
2929844|NCT00584831|3640685|FG013|COMPLETED|Intervention 3||1
2929845|NCT00584831|3640686|FG014|COMPLETED|Intervention 3||3
2929846|NCT00584831|3640687|FG015|COMPLETED|Intervention 3||1
2929847|NCT00584831|3640688|FG016|COMPLETED|Intervention 3||4
2929848|NCT00584831|3640689|FG017|COMPLETED|Intervention 3||1
2929849|NCT00584831|3640690|FG018|COMPLETED|Intervention 3||1
2929850|NCT00584831|3640672|FG000|NOT COMPLETED|Intervention 3||0
2929851|NCT00584831|3640673|FG001|NOT COMPLETED|Intervention 3||0
2929852|NCT00584831|3640674|FG002|NOT COMPLETED|Intervention 3||0
2929853|NCT00584831|3640675|FG003|NOT COMPLETED|Intervention 3||0
2929854|NCT00584831|3640676|FG004|NOT COMPLETED|Intervention 3||0
2929855|NCT00584831|3640677|FG005|NOT COMPLETED|Intervention 3||0
2929856|NCT00584831|3640678|FG006|NOT COMPLETED|Intervention 3||0
2929857|NCT00584831|3640679|FG007|NOT COMPLETED|Intervention 3||0
2929858|NCT00584831|3640680|FG008|NOT COMPLETED|Intervention 3||0
2929859|NCT00584831|3640681|FG009|NOT COMPLETED|Intervention 3||0
2929860|NCT00584831|3640682|FG010|NOT COMPLETED|Intervention 3||0
2929861|NCT00584831|3640683|FG011|NOT COMPLETED|Intervention 3||0
2929862|NCT00584831|3640684|FG012|NOT COMPLETED|Intervention 3||0
2929863|NCT00584831|3640685|FG013|NOT COMPLETED|Intervention 3||0
2929864|NCT00584831|3640686|FG014|NOT COMPLETED|Intervention 3||0
2929865|NCT00584831|3640687|FG015|NOT COMPLETED|Intervention 3||0
2929866|NCT00584831|3640688|FG016|NOT COMPLETED|Intervention 3||0
2929867|NCT00584831|3640689|FG017|NOT COMPLETED|Intervention 3||0
2929868|NCT00584831|3640690|FG018|NOT COMPLETED|Intervention 3||0
2929869|NCT00584831|3640672|FG000|STARTED|Intervention 4||1
2929870|NCT00584831|3640673|FG001|STARTED|Intervention 4||3
2929871|NCT00584831|3640674|FG002|STARTED|Intervention 4||2
2929872|NCT00584831|3640675|FG003|STARTED|Intervention 4||1
3040860|NCT01167192|3760428|FG000|COMPLETED|Overall Study||6
3040861|NCT01167192|3760428|FG000|NOT COMPLETED|Overall Study||4
3040862|NCT01167257|3760434|FG000|STARTED|Overall Study||31
3040863|NCT01167257|3760435|FG001|STARTED|Overall Study||31
3040864|NCT01167257|3760434|FG000|COMPLETED|Overall Study||28
3040865|NCT01167257|3760435|FG001|COMPLETED|Overall Study||28
3040866|NCT01167257|3760434|FG000|NOT COMPLETED|Overall Study||3
3040867|NCT01167257|3760435|FG001|NOT COMPLETED|Overall Study||3
3040868|NCT01167426|3760445|FG000|STARTED|Overall Study||148
3040869|NCT01167426|3760445|FG000|COMPLETED|Overall Study||138
3040870|NCT01167426|3760445|FG000|NOT COMPLETED|Overall Study||10
3040871|NCT01167452|3760450|FG000|STARTED|Overall Study||36
3040872|NCT01167452|3760450|FG000|COMPLETED|Overall Study||36
3040873|NCT01167452|3760450|FG000|NOT COMPLETED|Overall Study||0
3040874|NCT01167504|3760455|FG000|STARTED|Overall Study||15
3040875|NCT01167504|3760455|FG000|COMPLETED|Overall Study||12
3040876|NCT01167504|3760455|FG000|NOT COMPLETED|Overall Study||3
3040877|NCT01167569|3760461|FG000|STARTED|Overall Study||28
3040878|NCT01167569|3760462|FG001|STARTED|Overall Study||29
3040879|NCT01167569|3760461|FG000|COMPLETED|Overall Study||27
3040880|NCT01167569|3760462|FG001|COMPLETED|Overall Study||27
3040881|NCT01167569|3760461|FG000|NOT COMPLETED|Overall Study||1
3040882|NCT01167569|3760462|FG001|NOT COMPLETED|Overall Study||2
3040883|NCT01167582|3760472|FG000|STARTED|Overall Study||55
3040884|NCT01167582|3760473|FG001|STARTED|Overall Study||55
3040885|NCT01167582|3760472|FG000|COMPLETED|Overall Study||55
3040886|NCT01167582|3760473|FG001|COMPLETED|Overall Study||54
3040887|NCT01167582|3760472|FG000|NOT COMPLETED|Overall Study||0
3040888|NCT01167582|3760473|FG001|NOT COMPLETED|Overall Study||1
3040889|NCT01167595|3760481|FG000|STARTED|Overall Study||522
3040890|NCT01167595|3760482|FG001|STARTED|Overall Study||537
3040891|NCT01167595|3760481|FG000|COMPLETED|Overall Study||522
3040892|NCT01167595|3760482|FG001|COMPLETED|Overall Study||537
3040893|NCT01167595|3760481|FG000|NOT COMPLETED|Overall Study||0
3040894|NCT01167595|3760482|FG001|NOT COMPLETED|Overall Study||0
3040895|NCT01167608|3760488|FG000|STARTED|Overall Study||883
3040896|NCT01167608|3760488|FG000|COMPLETED|Overall Study||769
3040897|NCT01167608|3760488|FG000|NOT COMPLETED|Overall Study||114
3040898|NCT01167634|3760497|FG000|STARTED|Overall Study||33
3040899|NCT01167634|3760498|FG001|STARTED|Overall Study||33
3040900|NCT01167634|3760499|FG002|STARTED|Overall Study||33
3040901|NCT01167634|3760500|FG003|STARTED|Overall Study||33
3040902|NCT01167634|3760497|FG000|COMPLETED|Overall Study||31
3040903|NCT01167634|3760498|FG001|COMPLETED|Overall Study||29
3040904|NCT01167634|3760499|FG002|COMPLETED|Overall Study||30
3040905|NCT01167634|3760500|FG003|COMPLETED|Overall Study||29
3040906|NCT01167634|3760497|FG000|NOT COMPLETED|Overall Study||2
3040907|NCT01167634|3760498|FG001|NOT COMPLETED|Overall Study||4
3040908|NCT01167634|3760499|FG002|NOT COMPLETED|Overall Study||3
3040909|NCT01167634|3760500|FG003|NOT COMPLETED|Overall Study||4
3040910|NCT01167712|3760512|FG000|STARTED|Overall Study||346
3040911|NCT01167712|3760513|FG001|STARTED|Overall Study||346
3040912|NCT01167712|3760512|FG000|COMPLETED|Overall Study||346
3040913|NCT01167712|3760513|FG001|COMPLETED|Overall Study||346
3040914|NCT01167712|3760512|FG000|NOT COMPLETED|Overall Study||0
3040915|NCT01167712|3760513|FG001|NOT COMPLETED|Overall Study||0
2929873|NCT00584831|3640676|FG004|STARTED|Intervention 4||2
2929874|NCT00584831|3640677|FG005|STARTED|Intervention 4||1
2929875|NCT00584831|3640678|FG006|STARTED|Intervention 4||6
2929876|NCT00584831|3640679|FG007|STARTED|Intervention 4||2
2929877|NCT00584831|3640680|FG008|STARTED|Intervention 4||3
2929878|NCT00584831|3640681|FG009|STARTED|Intervention 4||2
2929879|NCT00584831|3640682|FG010|STARTED|Intervention 4||2
2929880|NCT00584831|3640683|FG011|STARTED|Intervention 4||1
2929881|NCT00584831|3640684|FG012|STARTED|Intervention 4||2
2929882|NCT00584831|3640685|FG013|STARTED|Intervention 4||1
2929883|NCT00584831|3640686|FG014|STARTED|Intervention 4||2
2929884|NCT00584831|3640687|FG015|STARTED|Intervention 4||1
2929885|NCT00584831|3640688|FG016|STARTED|Intervention 4||4
2929886|NCT00584831|3640689|FG017|STARTED|Intervention 4||1
2929887|NCT00584831|3640690|FG018|STARTED|Intervention 4||1
2929888|NCT00584831|3640672|FG000|COMPLETED|Intervention 4||1
2929889|NCT00584831|3640673|FG001|COMPLETED|Intervention 4||3
2929890|NCT00584831|3640674|FG002|COMPLETED|Intervention 4||2
2929891|NCT00584831|3640675|FG003|COMPLETED|Intervention 4||1
2929892|NCT00584831|3640676|FG004|COMPLETED|Intervention 4||2
2929893|NCT00584831|3640677|FG005|COMPLETED|Intervention 4||1
2929894|NCT00584831|3640678|FG006|COMPLETED|Intervention 4||6
2929895|NCT00584831|3640679|FG007|COMPLETED|Intervention 4||2
2929896|NCT00584831|3640680|FG008|COMPLETED|Intervention 4||3
2929897|NCT00584831|3640681|FG009|COMPLETED|Intervention 4||2
2929898|NCT00584831|3640682|FG010|COMPLETED|Intervention 4||2
2929899|NCT00584831|3640683|FG011|COMPLETED|Intervention 4||1
2929900|NCT00584831|3640684|FG012|COMPLETED|Intervention 4||2
2929901|NCT00584831|3640685|FG013|COMPLETED|Intervention 4||1
2929902|NCT00584831|3640686|FG014|COMPLETED|Intervention 4||2
2929903|NCT00584831|3640687|FG015|COMPLETED|Intervention 4||1
2929904|NCT00584831|3640688|FG016|COMPLETED|Intervention 4||4
2929905|NCT00584831|3640689|FG017|COMPLETED|Intervention 4||1
2929906|NCT00584831|3640690|FG018|COMPLETED|Intervention 4||1
2929907|NCT00584831|3640672|FG000|NOT COMPLETED|Intervention 4||0
2929908|NCT00584831|3640673|FG001|NOT COMPLETED|Intervention 4||0
2929909|NCT00584831|3640674|FG002|NOT COMPLETED|Intervention 4||0
2929910|NCT00584831|3640675|FG003|NOT COMPLETED|Intervention 4||0
2929911|NCT00584831|3640676|FG004|NOT COMPLETED|Intervention 4||0
2929912|NCT00584831|3640677|FG005|NOT COMPLETED|Intervention 4||0
2929913|NCT00584831|3640678|FG006|NOT COMPLETED|Intervention 4||0
2929914|NCT00584831|3640679|FG007|NOT COMPLETED|Intervention 4||0
2929915|NCT00584831|3640680|FG008|NOT COMPLETED|Intervention 4||0
2929916|NCT00584831|3640681|FG009|NOT COMPLETED|Intervention 4||0
2929917|NCT00584831|3640682|FG010|NOT COMPLETED|Intervention 4||0
2929918|NCT00584831|3640683|FG011|NOT COMPLETED|Intervention 4||0
2929919|NCT00584831|3640684|FG012|NOT COMPLETED|Intervention 4||0
2929920|NCT00584831|3640685|FG013|NOT COMPLETED|Intervention 4||0
2929921|NCT00584831|3640686|FG014|NOT COMPLETED|Intervention 4||0
2929922|NCT00584831|3640687|FG015|NOT COMPLETED|Intervention 4||0
2929923|NCT00584831|3640688|FG016|NOT COMPLETED|Intervention 4||0
2929924|NCT00584831|3640689|FG017|NOT COMPLETED|Intervention 4||0
2929925|NCT00584831|3640690|FG018|NOT COMPLETED|Intervention 4||0
2929926|NCT00584844|3640700|FG000|STARTED|Overall Study||484
2929927|NCT00584844|3640700|FG000|COMPLETED|Overall Study||405
2929928|NCT00584844|3640700|FG000|NOT COMPLETED|Overall Study||79
2929929|NCT00584857|3640708|FG000|STARTED|Overall Study||30
2929930|NCT00584857|3640708|FG000|COMPLETED|Overall Study||30
2929931|NCT00584857|3640708|FG000|NOT COMPLETED|Overall Study||0
3040916|NCT01167829|3760519|FG000|STARTED|Overall Study||12
3040917|NCT01167829|3760519|FG000|COMPLETED|Overall Study||12
3040918|NCT01167829|3760519|FG000|NOT COMPLETED|Overall Study||0
3040919|NCT01167881|3760527|FG000|STARTED|Overall Study||769
3040920|NCT01167881|3760528|FG001|STARTED|Overall Study||780
3040921|NCT01167881|3760527|FG000|Completed After 2 Years Treatment|Overall Study||95
3040922|NCT01167881|3760528|FG001|Completed After 2 Years Treatment|Overall Study||127
3040923|NCT01167881|3760527|FG000|Completed After 4 Years Treatment|Overall Study||515
3040924|NCT01167881|3760528|FG001|Completed After 4 Years Treatment|Overall Study||462
3040925|NCT01167881|3760527|FG000|COMPLETED|Overall Study||610
3179702|NCT01986881|3907911|FG000|COMPLETED|Overall Study||2422
3179703|NCT01986881|3907912|FG001|COMPLETED|Overall Study||2401
3179704|NCT01986881|3907913|FG002|COMPLETED|Overall Study||2389
2929932|NCT00584870|3640715|FG000|STARTED|Overall Study||88
3040926|NCT01167881|3760528|FG001|COMPLETED|Overall Study||589
3040927|NCT01167881|3760527|FG000|NOT COMPLETED|Overall Study||159
3179705|NCT01986881|3907911|FG000|NOT COMPLETED|Overall Study||330
3179706|NCT01986881|3907912|FG001|NOT COMPLETED|Overall Study||346
3179707|NCT01986881|3907913|FG002|NOT COMPLETED|Overall Study||358
3179708|NCT01986907|3907944|FG000|STARTED|Overall Study||936
3179709|NCT01986907|3907944|FG000|COMPLETED|Overall Study||774
3179710|NCT01986907|3907944|FG000|NOT COMPLETED|Overall Study||162
3179711|NCT01986920|3907951|FG000|STARTED|A- 101 25%||35
3179712|NCT01986920|3907952|FG001|STARTED|A- 101 25%||0
3179713|NCT01986920|3907953|FG002|STARTED|A- 101 25%||0
3179714|NCT01986920|3907954|FG003|STARTED|A- 101 25%||0
3179715|NCT01986920|3907951|FG000|COMPLETED|A- 101 25%||34
3179716|NCT01986920|3907952|FG001|COMPLETED|A- 101 25%||0
3179717|NCT01986920|3907953|FG002|COMPLETED|A- 101 25%||0
3179718|NCT01986920|3907954|FG003|COMPLETED|A- 101 25%||0
3179719|NCT01986920|3907951|FG000|NOT COMPLETED|A- 101 25%||1
3179720|NCT01986920|3907952|FG001|NOT COMPLETED|A- 101 25%||0
3179721|NCT01986920|3907953|FG002|NOT COMPLETED|A- 101 25%||0
3179722|NCT01986920|3907954|FG003|NOT COMPLETED|A- 101 25%||0
3179723|NCT01986920|3907951|FG000|STARTED|A-101 32.5%||0
3179724|NCT01986920|3907952|FG001|STARTED|A-101 32.5%||35
3040928|NCT01167881|3760528|FG001|NOT COMPLETED|Overall Study||191
3040929|NCT01167907|3760536|FG000|STARTED|Overall Study||17
3040930|NCT01167907|3760537|FG001|STARTED|Overall Study||15
3040931|NCT01167907|3760536|FG000|COMPLETED|Overall Study||15
3040932|NCT01167907|3760537|FG001|COMPLETED|Overall Study||14
3040933|NCT01167907|3760536|FG000|NOT COMPLETED|Overall Study||2
3040934|NCT01167907|3760537|FG001|NOT COMPLETED|Overall Study||1
3040935|NCT01168024|3760545|FG000|STARTED|Overall Study|13 tx/3 controls. Roll-ins occurred for product training, several more treatment cases than control.|13
3040936|NCT01168024|3760546|FG001|STARTED|Overall Study||3
3040937|NCT01168024|3760545|FG000|COMPLETED|Overall Study||13
3040938|NCT01168024|3760546|FG001|COMPLETED|Overall Study||3
3179725|NCT01986920|3907953|FG002|STARTED|A-101 32.5%||0
2929933|NCT00584870|3640716|FG001|STARTED|Overall Study||89
2929934|NCT00584870|3640717|FG002|STARTED|Overall Study||43
2929935|NCT00584870|3640715|FG000|Treated|Overall Study||88
2929936|NCT00584870|3640716|FG001|Treated|Overall Study||88
2929937|NCT00584870|3640717|FG002|Treated|Overall Study||41
2929938|NCT00584870|3640715|FG000|COMPLETED|Overall Study||59
2929939|NCT00584870|3640716|FG001|COMPLETED|Overall Study||64
2929940|NCT00584870|3640717|FG002|COMPLETED|Overall Study||25
2929941|NCT00584870|3640715|FG000|NOT COMPLETED|Overall Study||29
2929942|NCT00584870|3640716|FG001|NOT COMPLETED|Overall Study||25
2929943|NCT00584870|3640717|FG002|NOT COMPLETED|Overall Study||18
2929944|NCT00584909|3640725|FG000|STARTED|Overall Study||13
2929945|NCT00584909|3640725|FG000|COMPLETED|Overall Study||9
2929946|NCT00584909|3640725|FG000|NOT COMPLETED|Overall Study||4
2929947|NCT00584922|3640729|FG000|STARTED|Overall Study||175
2929948|NCT00584922|3640729|FG000|COMPLETED|Overall Study||175
2929949|NCT00584922|3640729|FG000|NOT COMPLETED|Overall Study||0
2929950|NCT00584948|3640735|FG000|STARTED|Overall Study||47
2929951|NCT00584948|3640736|FG001|STARTED|Overall Study||47
2929952|NCT00584948|3640735|FG000|COMPLETED|Overall Study||34
2929953|NCT00584948|3640736|FG001|COMPLETED|Overall Study||36
2929954|NCT00584948|3640735|FG000|NOT COMPLETED|Overall Study||13
2929955|NCT00584948|3640736|FG001|NOT COMPLETED|Overall Study||11
2929956|NCT00584987|3640746|FG000|STARTED|Overall Study||15
2929957|NCT00584987|3640747|FG001|STARTED|Overall Study||16
2929958|NCT00584987|3640748|FG002|STARTED|Overall Study||17
2929959|NCT00584987|3640749|FG003|STARTED|Overall Study||16
2929960|NCT00584987|3640746|FG000|COMPLETED|Overall Study||14
2929961|NCT00584987|3640747|FG001|COMPLETED|Overall Study||15
2929962|NCT00584987|3640748|FG002|COMPLETED|Overall Study||16
2929963|NCT00584987|3640749|FG003|COMPLETED|Overall Study||15
2929964|NCT00584987|3640746|FG000|NOT COMPLETED|Overall Study||1
2929965|NCT00584987|3640747|FG001|NOT COMPLETED|Overall Study||1
2929966|NCT00584987|3640748|FG002|NOT COMPLETED|Overall Study||1
2929967|NCT00584987|3640749|FG003|NOT COMPLETED|Overall Study||1
2929968|NCT00585013|3640761|FG000|STARTED|Overall Study||8
2929969|NCT00585013|3640762|FG001|STARTED|Overall Study||8
2929970|NCT00585013|3640761|FG000|COMPLETED|Overall Study||8
2929971|NCT00585013|3640762|FG001|COMPLETED|Overall Study||8
2929972|NCT00585013|3640761|FG000|NOT COMPLETED|Overall Study||0
2929973|NCT00585013|3640762|FG001|NOT COMPLETED|Overall Study||0
2929974|NCT00585039|3640772|FG000|STARTED|Overall Study||57
2929975|NCT00585039|3640773|FG001|STARTED|Overall Study||44
2929976|NCT00585039|3640772|FG000|COMPLETED|Overall Study||55
2929977|NCT00585039|3640773|FG001|COMPLETED|Overall Study||44
2929978|NCT00585039|3640772|FG000|NOT COMPLETED|Overall Study||2
2929979|NCT00585039|3640773|FG001|NOT COMPLETED|Overall Study||0
2929980|NCT00585052|3640781|FG000|STARTED|Overall Study||11
2929981|NCT00585052|3640781|FG000|COMPLETED|Overall Study||10
2929982|NCT00585052|3640781|FG000|NOT COMPLETED|Overall Study||1
2929983|NCT00585078|3640785|FG000|STARTED|Overall Study||40
2929984|NCT00585078|3640785|FG000|Treated|Overall Study||37
2929985|NCT00585078|3640785|FG000|Toxicity Evaluable|Overall Study||36
2929986|NCT00585078|3640785|FG000|Response Evaluable|Overall Study||24
2929987|NCT00585078|3640785|FG000|COMPLETED|Overall Study||0
2929988|NCT00585078|3640785|FG000|NOT COMPLETED|Overall Study||40
3040939|NCT01168024|3760545|FG000|NOT COMPLETED|Overall Study||0
3040940|NCT01168024|3760546|FG001|NOT COMPLETED|Overall Study||0
3040941|NCT01168232|3760552|FG000|STARTED|Overall Study||42
3040942|NCT01168232|3760552|FG000|COMPLETED|Overall Study|Eligible and treated patients|34
3040943|NCT01168232|3760552|FG000|NOT COMPLETED|Overall Study||8
3040944|NCT01168349|3760556|FG000|STARTED|Overall Study||1055
3040945|NCT01168349|3760556|FG000|COMPLETED|Overall Study||754
3040946|NCT01168349|3760556|FG000|NOT COMPLETED|Overall Study||301
3040947|NCT01168401|3760587|FG000|STARTED|Overall Study||10
3040948|NCT01168401|3760588|FG001|STARTED|Overall Study||10
3040949|NCT01168401|3760589|FG002|STARTED|Overall Study||10
3040950|NCT01168401|3760590|FG003|STARTED|Overall Study||9
3040951|NCT01168401|3760591|FG004|STARTED|Overall Study||9
3040952|NCT01168401|3760592|FG005|STARTED|Overall Study||9
3040953|NCT01168401|3760593|FG006|STARTED|Overall Study||10
3040954|NCT01168401|3760594|FG007|STARTED|Overall Study||10
3040955|NCT01168401|3760595|FG008|STARTED|Overall Study||9
3040956|NCT01168401|3760596|FG009|STARTED|Overall Study||8
3040957|NCT01168401|3760597|FG010|STARTED|Overall Study||8
3040958|NCT01168401|3760587|FG000|COMPLETED|Overall Study||9
3040959|NCT01168401|3760588|FG001|COMPLETED|Overall Study||9
3040960|NCT01168401|3760589|FG002|COMPLETED|Overall Study||8
3040961|NCT01168401|3760590|FG003|COMPLETED|Overall Study||7
3040962|NCT01168401|3760591|FG004|COMPLETED|Overall Study||9
3040963|NCT01168401|3760592|FG005|COMPLETED|Overall Study||9
3040964|NCT01168401|3760593|FG006|COMPLETED|Overall Study||10
3040965|NCT01168401|3760594|FG007|COMPLETED|Overall Study||10
3040966|NCT01168401|3760595|FG008|COMPLETED|Overall Study||9
3040967|NCT01168401|3760596|FG009|COMPLETED|Overall Study||8
3040968|NCT01168401|3760597|FG010|COMPLETED|Overall Study||8
3040969|NCT01168401|3760587|FG000|NOT COMPLETED|Overall Study||1
3040970|NCT01168401|3760588|FG001|NOT COMPLETED|Overall Study||1
3040971|NCT01168401|3760589|FG002|NOT COMPLETED|Overall Study||2
3040972|NCT01168401|3760590|FG003|NOT COMPLETED|Overall Study||2
3040973|NCT01168401|3760591|FG004|NOT COMPLETED|Overall Study||0
3040974|NCT01168401|3760592|FG005|NOT COMPLETED|Overall Study||0
3040975|NCT01168401|3760593|FG006|NOT COMPLETED|Overall Study||0
3040976|NCT01168401|3760594|FG007|NOT COMPLETED|Overall Study||0
3040977|NCT01168401|3760595|FG008|NOT COMPLETED|Overall Study||0
3040978|NCT01168401|3760596|FG009|NOT COMPLETED|Overall Study||0
3040979|NCT01168401|3760597|FG010|NOT COMPLETED|Overall Study||0
3040980|NCT01168427|3760621|FG000|STARTED|Overall Study||66
3040981|NCT01168427|3760621|FG000|COMPLETED|Overall Study||65
3040982|NCT01168427|3760621|FG000|NOT COMPLETED|Overall Study||1
3040983|NCT01168596|3760627|FG000|STARTED|Overall Study||16
3040984|NCT01168596|3760628|FG001|STARTED|Overall Study||14
3040985|NCT01168596|3760627|FG000|COMPLETED|Overall Study||13
3040986|NCT01168596|3760628|FG001|COMPLETED|Overall Study||13
3040987|NCT01168596|3760627|FG000|NOT COMPLETED|Overall Study||3
3040988|NCT01168596|3760628|FG001|NOT COMPLETED|Overall Study||1
3040989|NCT01168674|3760634|FG000|STARTED|Overall Study||25
3040990|NCT01168674|3760635|FG001|STARTED|Overall Study||24
3040991|NCT01168674|3760634|FG000|COMPLETED|Overall Study||25
3040992|NCT01168674|3760635|FG001|COMPLETED|Overall Study||24
3040993|NCT01168674|3760634|FG000|NOT COMPLETED|Overall Study||0
3040994|NCT01168674|3760635|FG001|NOT COMPLETED|Overall Study||0
3040995|NCT01168687|3760644|FG000|STARTED|Overall Study||23
3040996|NCT01168687|3760645|FG001|STARTED|Overall Study||23
3040997|NCT01168687|3760644|FG000|COMPLETED|Overall Study||23
3040998|NCT01168687|3760645|FG001|COMPLETED|Overall Study||23
3040999|NCT01168687|3760644|FG000|NOT COMPLETED|Overall Study||0
3041000|NCT01168687|3760645|FG001|NOT COMPLETED|Overall Study||0
3041001|NCT01168726|3760654|FG000|STARTED|Overall Study||111
3041002|NCT01168726|3760655|FG001|STARTED|Overall Study||121
3041003|NCT01168726|3760656|FG002|STARTED|Overall Study||133
3041004|NCT01168726|3760654|FG000|COMPLETED|Overall Study||103
3041005|NCT01168726|3760655|FG001|COMPLETED|Overall Study||112
3041006|NCT01168726|3760656|FG002|COMPLETED|Overall Study||128
3041007|NCT01168726|3760654|FG000|NOT COMPLETED|Overall Study||8
3041008|NCT01168726|3760655|FG001|NOT COMPLETED|Overall Study||9
3041009|NCT01168726|3760656|FG002|NOT COMPLETED|Overall Study||5
3041010|NCT01168856|3760666|FG000|STARTED|Overall Study||176
2929989|NCT00585104|3640789|FG000|STARTED|Overall Study||10
2929990|NCT00585104|3640789|FG000|COMPLETED|Overall Study||6
2929991|NCT00585104|3640789|FG000|NOT COMPLETED|Overall Study||4
2929992|NCT00585169|3640793|FG000|STARTED|Overall Study||29
2929993|NCT00585169|3640793|FG000|COMPLETED|Overall Study||28
2929994|NCT00585169|3640793|FG000|NOT COMPLETED|Overall Study||1
2929995|NCT00585182|3640799|FG000|STARTED|Overall Study||28
2929996|NCT00585182|3640799|FG000|COMPLETED|Overall Study||28
2929997|NCT00585182|3640799|FG000|NOT COMPLETED|Overall Study||0
3179726|NCT01986920|3907954|FG003|STARTED|A-101 32.5%||0
3179727|NCT01986920|3907951|FG000|COMPLETED|A-101 32.5%||0
3179728|NCT01986920|3907952|FG001|COMPLETED|A-101 32.5%||34
3179729|NCT01986920|3907953|FG002|COMPLETED|A-101 32.5%||0
3179730|NCT01986920|3907954|FG003|COMPLETED|A-101 32.5%||0
3179731|NCT01986920|3907951|FG000|NOT COMPLETED|A-101 32.5%||0
3179732|NCT01986920|3907952|FG001|NOT COMPLETED|A-101 32.5%||1
3179733|NCT01986920|3907953|FG002|NOT COMPLETED|A-101 32.5%||0
3179734|NCT01986920|3907954|FG003|NOT COMPLETED|A-101 32.5%||0
3041011|NCT01168856|3760667|FG001|STARTED|Overall Study||558
3041012|NCT01168856|3760666|FG000|COMPLETED|Overall Study||158
3041013|NCT01168856|3760667|FG001|COMPLETED|Overall Study||215
3041014|NCT01168856|3760666|FG000|NOT COMPLETED|Overall Study||18
3041015|NCT01168856|3760667|FG001|NOT COMPLETED|Overall Study||343
3137103|NCT01716754|3862348|FG003|NOT COMPLETED|Overall Study||8
3137104|NCT01717001|3862359|FG000|STARTED|Overall Study||38
3137105|NCT01717001|3862360|FG001|STARTED|Overall Study||28
3137106|NCT01717001|3862359|FG000|COMPLETED|Overall Study||32
3137107|NCT01717001|3862360|FG001|COMPLETED|Overall Study||24
3137108|NCT01717001|3862359|FG000|NOT COMPLETED|Overall Study||6
3137109|NCT01717001|3862360|FG001|NOT COMPLETED|Overall Study||4
3137110|NCT01717014|3862366|FG000|STARTED|Overall Study||8
3137111|NCT01717014|3862366|FG000|COMPLETED|Overall Study||8
3137112|NCT01717014|3862366|FG000|NOT COMPLETED|Overall Study||0
3137113|NCT01717040|3862372|FG000|STARTED|Overall Study||17
3137114|NCT01717040|3862373|FG001|STARTED|Overall Study||20
3137115|NCT01717040|3862372|FG000|COMPLETED|Overall Study||12
3137116|NCT01717040|3862373|FG001|COMPLETED|Overall Study||15
3137117|NCT01717040|3862372|FG000|NOT COMPLETED|Overall Study||5
3137118|NCT01717040|3862373|FG001|NOT COMPLETED|Overall Study||5
3137119|NCT01717053|3862379|FG000|STARTED|Overall Study||37
3137120|NCT01717053|3862379|FG000|COMPLETED|Overall Study||33
3137121|NCT01717053|3862379|FG000|NOT COMPLETED|Overall Study||4
3137122|NCT01717209|3862383|FG000|STARTED|Overall Study||14
3137123|NCT01717209|3862383|FG000|COMPLETED|Overall Study||14
3137124|NCT01717209|3862383|FG000|NOT COMPLETED|Overall Study||0
3137125|NCT01717287|3862389|FG000|STARTED|Overall Study||4
3137126|NCT01717287|3862390|FG001|STARTED|Overall Study||28
3137127|NCT01717287|3862389|FG000|COMPLETED|Overall Study||4
3137128|NCT01717287|3862390|FG001|COMPLETED|Overall Study||25
3137129|NCT01717287|3862389|FG000|NOT COMPLETED|Overall Study||0
3137130|NCT01717287|3862390|FG001|NOT COMPLETED|Overall Study||3
3137131|NCT01717313|3862398|FG000|STARTED|Phase A (Weeks 0 to 24)||165
3137132|NCT01717313|3862399|FG001|STARTED|Phase A (Weeks 0 to 24)||164
3137133|NCT01717313|3862398|FG000|COMPLETED|Phase A (Weeks 0 to 24)||147
3137134|NCT01717313|3862399|FG001|COMPLETED|Phase A (Weeks 0 to 24)||151
3137135|NCT01717313|3862398|FG000|NOT COMPLETED|Phase A (Weeks 0 to 24)||18
3137136|NCT01717313|3862399|FG001|NOT COMPLETED|Phase A (Weeks 0 to 24)||13
3137137|NCT01717313|3862398|FG000|STARTED|Interphase||147
3137138|NCT01717313|3862399|FG001|STARTED|Interphase||151
3179735|NCT01986920|3907951|FG000|STARTED|A-101 40%||0
3179736|NCT01986920|3907952|FG001|STARTED|A-101 40%||0
3179737|NCT01986920|3907953|FG002|STARTED|A-101 40%||35
3179738|NCT01986920|3907954|FG003|STARTED|A-101 40%||0
3179739|NCT01986920|3907951|FG000|COMPLETED|A-101 40%||0
3179740|NCT01986920|3907952|FG001|COMPLETED|A-101 40%||0
3179741|NCT01986920|3907953|FG002|COMPLETED|A-101 40%||34
3179742|NCT01986920|3907954|FG003|COMPLETED|A-101 40%||0
3179743|NCT01986920|3907951|FG000|NOT COMPLETED|A-101 40%||0
3179744|NCT01986920|3907952|FG001|NOT COMPLETED|A-101 40%||0
3179745|NCT01986920|3907953|FG002|NOT COMPLETED|A-101 40%||1
3179746|NCT01986920|3907954|FG003|NOT COMPLETED|A-101 40%||0
3179747|NCT01986920|3907951|FG000|STARTED|Placebo||0
3179748|NCT01986920|3907952|FG001|STARTED|Placebo||0
3179749|NCT01986920|3907953|FG002|STARTED|Placebo||0
3179750|NCT01986920|3907954|FG003|STARTED|Placebo||35
3179751|NCT01986920|3907951|FG000|COMPLETED|Placebo||0
3179752|NCT01986920|3907952|FG001|COMPLETED|Placebo||0
3179753|NCT01986920|3907953|FG002|COMPLETED|Placebo||0
3179754|NCT01986920|3907954|FG003|COMPLETED|Placebo||34
3179755|NCT01986920|3907951|FG000|NOT COMPLETED|Placebo||0
3179756|NCT01986920|3907952|FG001|NOT COMPLETED|Placebo||0
3179757|NCT01986920|3907953|FG002|NOT COMPLETED|Placebo||0
3179758|NCT01986920|3907954|FG003|NOT COMPLETED|Placebo||1
3179759|NCT01986946|3907966|FG000|STARTED|Overall Study||5
3179760|NCT01986946|3907967|FG001|STARTED|Overall Study||9
3179761|NCT01986946|3907966|FG000|COMPLETED|Overall Study||5
3179762|NCT01986946|3907967|FG001|COMPLETED|Overall Study||9
3179763|NCT01986946|3907966|FG000|NOT COMPLETED|Overall Study||0
3179764|NCT01986946|3907967|FG001|NOT COMPLETED|Overall Study||0
3179765|NCT01986985|3907973|FG000|STARTED|Overall Study||58
3179766|NCT01986985|3907973|FG000|COMPLETED|Overall Study||51
3179767|NCT01986985|3907973|FG000|NOT COMPLETED|Overall Study||7
2930082|NCT00585247|3640929|FG000|STARTED|Overall Study||14
2930083|NCT00585247|3640930|FG001|STARTED|Overall Study||13
2930084|NCT00585247|3640929|FG000|COMPLETED|Overall Study||14
2930085|NCT00585247|3640930|FG001|COMPLETED|Overall Study||13
2930086|NCT00585247|3640929|FG000|NOT COMPLETED|Overall Study||0
2930087|NCT00585247|3640930|FG001|NOT COMPLETED|Overall Study||0
2930088|NCT00585286|3640936|FG000|STARTED|Overall Study||15
2930089|NCT00585286|3640936|FG000|COMPLETED|Overall Study||14
2930090|NCT00585286|3640936|FG000|NOT COMPLETED|Overall Study||1
2930091|NCT00585312|3640942|FG000|STARTED|Overall Study|STARTED=Randomized|55
2930092|NCT00585312|3640943|FG001|STARTED|Overall Study|STARTED=Randomized|51
2930093|NCT00585312|3640942|FG000|Treated|Overall Study||53
2930094|NCT00585312|3640943|FG001|Treated|Overall Study||48
2930095|NCT00585312|3640942|FG000|COMPLETED|Overall Study||4
2930096|NCT00585312|3640943|FG001|COMPLETED|Overall Study||7
2930097|NCT00585312|3640942|FG000|NOT COMPLETED|Overall Study||51
2930098|NCT00585312|3640943|FG001|NOT COMPLETED|Overall Study||44
2930099|NCT00585325|3640951|FG000|STARTED|Overall Study||10
2930100|NCT00585325|3640952|FG001|STARTED|Overall Study||13
2930101|NCT00585325|3640951|FG000|COMPLETED|Overall Study||9
2930102|NCT00585325|3640952|FG001|COMPLETED|Overall Study||12
2930103|NCT00585325|3640951|FG000|NOT COMPLETED|Overall Study||1
2930104|NCT00585325|3640952|FG001|NOT COMPLETED|Overall Study||1
2930105|NCT00585351|3640964|FG000|STARTED|Notification Period (Informed Consent)||50
2930106|NCT00585351|3640965|FG001|STARTED|Notification Period (Informed Consent)||50
2930107|NCT00585351|3640966|FG002|STARTED|Notification Period (Informed Consent)||0
2930108|NCT00585351|3640967|FG003|STARTED|Notification Period (Informed Consent)||0
2930109|NCT00585351|3640968|FG004|STARTED|Notification Period (Informed Consent)||0
2930110|NCT00585351|3640969|FG005|STARTED|Notification Period (Informed Consent)||0
2930111|NCT00585351|3640970|FG006|STARTED|Notification Period (Informed Consent)||0
2930112|NCT00585351|3640971|FG007|STARTED|Notification Period (Informed Consent)||0
2930113|NCT00585351|3640964|FG000|COMPLETED|Notification Period (Informed Consent)||27
2930114|NCT00585351|3640965|FG001|COMPLETED|Notification Period (Informed Consent)||25
3041016|NCT01168908|3760680|FG000|STARTED|Double Blind, Placebo Controlled||10
3041017|NCT01168908|3760681|FG001|STARTED|Double Blind, Placebo Controlled||10
3041018|NCT01168908|3760680|FG000|COMPLETED|Double Blind, Placebo Controlled||7
3041019|NCT01168908|3760681|FG001|COMPLETED|Double Blind, Placebo Controlled||8
3041020|NCT01168908|3760680|FG000|NOT COMPLETED|Double Blind, Placebo Controlled||3
3041021|NCT01168908|3760681|FG001|NOT COMPLETED|Double Blind, Placebo Controlled||2
3041022|NCT01168908|3760680|FG000|STARTED|Open Label||7
3041023|NCT01168908|3760681|FG001|STARTED|Open Label||8
3041024|NCT01168908|3760680|FG000|COMPLETED|Open Label||6
3041025|NCT01168908|3760681|FG001|COMPLETED|Open Label||7
3041026|NCT01168908|3760680|FG000|NOT COMPLETED|Open Label||1
3041027|NCT01168908|3760681|FG001|NOT COMPLETED|Open Label||1
3041028|NCT01168934|3760687|FG000|STARTED|First Intervention Period||7
3041029|NCT01168934|3760688|FG001|STARTED|First Intervention Period||7
3041030|NCT01168934|3760687|FG000|COMPLETED|First Intervention Period||7
3041031|NCT01168934|3760688|FG001|COMPLETED|First Intervention Period||7
3041032|NCT01168934|3760687|FG000|NOT COMPLETED|First Intervention Period||0
3041033|NCT01168934|3760688|FG001|NOT COMPLETED|First Intervention Period||0
3041034|NCT01168934|3760687|FG000|STARTED|Washout Period (at Least 14 Days)||7
3041035|NCT01168934|3760688|FG001|STARTED|Washout Period (at Least 14 Days)||7
3041036|NCT01168934|3760687|FG000|COMPLETED|Washout Period (at Least 14 Days)||7
3041037|NCT01168934|3760688|FG001|COMPLETED|Washout Period (at Least 14 Days)||7
3041038|NCT01168934|3760687|FG000|NOT COMPLETED|Washout Period (at Least 14 Days)||0
3041039|NCT01168934|3760688|FG001|NOT COMPLETED|Washout Period (at Least 14 Days)||0
3041040|NCT01168934|3760687|FG000|STARTED|Second Intervention Period||7
3041041|NCT01168934|3760688|FG001|STARTED|Second Intervention Period||7
3041042|NCT01168934|3760687|FG000|COMPLETED|Second Intervention Period||7
3041043|NCT01168934|3760688|FG001|COMPLETED|Second Intervention Period||7
3041044|NCT01168934|3760687|FG000|NOT COMPLETED|Second Intervention Period||0
3041045|NCT01168934|3760688|FG001|NOT COMPLETED|Second Intervention Period||0
3041046|NCT01168973|3760697|FG000|STARTED|Overall Study||628
3041047|NCT01168973|3760698|FG001|STARTED|Overall Study||625
3041048|NCT01168973|3760697|FG000|Received Any Quantity of Any Study Drug|Overall Study||624
3041049|NCT01168973|3760698|FG001|Received Any Quantity of Any Study Drug|Overall Study|Three participants randomized to placebo and docetaxel received 1 dose of ramucirumab in error.|621
3041050|NCT01168973|3760697|FG000|COMPLETED|Overall Study||15
3041051|NCT01168973|3760698|FG001|COMPLETED|Overall Study||14
3041052|NCT01168973|3760697|FG000|NOT COMPLETED|Overall Study||613
3041053|NCT01168973|3760698|FG001|NOT COMPLETED|Overall Study||611
3041054|NCT01168986|3760707|FG000|STARTED|Overall Study||20
3041055|NCT01168986|3760708|FG001|STARTED|Overall Study||21
3041056|NCT01168986|3760709|FG002|STARTED|Overall Study||21
3041057|NCT01168986|3760707|FG000|COMPLETED|Overall Study||18
3041058|NCT01168986|3760708|FG001|COMPLETED|Overall Study||20
3041059|NCT01168986|3760709|FG002|COMPLETED|Overall Study||21
3041060|NCT01168986|3760707|FG000|NOT COMPLETED|Overall Study||2
3041061|NCT01168986|3760708|FG001|NOT COMPLETED|Overall Study||1
3041062|NCT01168986|3760709|FG002|NOT COMPLETED|Overall Study||0
3041063|NCT01168999|3760721|FG000|STARTED|Overall Study||28
3041064|NCT01168999|3760722|FG001|STARTED|Overall Study||27
3041065|NCT01168999|3760723|FG002|STARTED|Overall Study||27
2930115|NCT00585351|3640966|FG002|COMPLETED|Notification Period (Informed Consent)||0
2930116|NCT00585351|3640967|FG003|COMPLETED|Notification Period (Informed Consent)||0
2930117|NCT00585351|3640968|FG004|COMPLETED|Notification Period (Informed Consent)||0
2930118|NCT00585351|3640969|FG005|COMPLETED|Notification Period (Informed Consent)||0
2930119|NCT00585351|3640970|FG006|COMPLETED|Notification Period (Informed Consent)||0
2930120|NCT00585351|3640971|FG007|COMPLETED|Notification Period (Informed Consent)||0
2930121|NCT00585351|3640964|FG000|NOT COMPLETED|Notification Period (Informed Consent)||23
2930122|NCT00585351|3640965|FG001|NOT COMPLETED|Notification Period (Informed Consent)||25
2930123|NCT00585351|3640966|FG002|NOT COMPLETED|Notification Period (Informed Consent)||0
2930124|NCT00585351|3640967|FG003|NOT COMPLETED|Notification Period (Informed Consent)||0
2930125|NCT00585351|3640968|FG004|NOT COMPLETED|Notification Period (Informed Consent)||0
2930126|NCT00585351|3640969|FG005|NOT COMPLETED|Notification Period (Informed Consent)||0
2930127|NCT00585351|3640970|FG006|NOT COMPLETED|Notification Period (Informed Consent)||0
2930128|NCT00585351|3640971|FG007|NOT COMPLETED|Notification Period (Informed Consent)||0
2930129|NCT00585351|3640964|FG000|STARTED|Enrollment Period (Intervention)|"Please refer to additional columns for subjects in Advanced Notification group for this period."|0
2930130|NCT00585351|3640965|FG001|STARTED|Enrollment Period (Intervention)|"Please refer to additional columns for subjects in No Advanced Notification group for this period."|0
2930131|NCT00585351|3640966|FG002|STARTED|Enrollment Period (Intervention)||15
2930132|NCT00585351|3640967|FG003|STARTED|Enrollment Period (Intervention)||15
2930133|NCT00585351|3640968|FG004|STARTED|Enrollment Period (Intervention)||5
2930134|NCT00585351|3640969|FG005|STARTED|Enrollment Period (Intervention)||7
2930135|NCT00585351|3640970|FG006|STARTED|Enrollment Period (Intervention)||7
2930136|NCT00585351|3640971|FG007|STARTED|Enrollment Period (Intervention)||3
2930137|NCT00585351|3640964|FG000|COMPLETED|Enrollment Period (Intervention)||0
2930138|NCT00585351|3640965|FG001|COMPLETED|Enrollment Period (Intervention)||0
2930139|NCT00585351|3640966|FG002|COMPLETED|Enrollment Period (Intervention)||15
2930140|NCT00585351|3640967|FG003|COMPLETED|Enrollment Period (Intervention)||15
2930141|NCT00585351|3640968|FG004|COMPLETED|Enrollment Period (Intervention)||3
2930142|NCT00585351|3640969|FG005|COMPLETED|Enrollment Period (Intervention)||5
2930143|NCT00585351|3640970|FG006|COMPLETED|Enrollment Period (Intervention)||5
2930144|NCT00585351|3640971|FG007|COMPLETED|Enrollment Period (Intervention)||2
2930145|NCT00585351|3640964|FG000|NOT COMPLETED|Enrollment Period (Intervention)||0
2930146|NCT00585351|3640965|FG001|NOT COMPLETED|Enrollment Period (Intervention)||0
2930147|NCT00585351|3640966|FG002|NOT COMPLETED|Enrollment Period (Intervention)||0
2930148|NCT00585351|3640967|FG003|NOT COMPLETED|Enrollment Period (Intervention)||0
2930149|NCT00585351|3640968|FG004|NOT COMPLETED|Enrollment Period (Intervention)||2
2930150|NCT00585351|3640969|FG005|NOT COMPLETED|Enrollment Period (Intervention)||2
2930151|NCT00585351|3640970|FG006|NOT COMPLETED|Enrollment Period (Intervention)||2
2930152|NCT00585351|3640971|FG007|NOT COMPLETED|Enrollment Period (Intervention)||1
2930153|NCT00585377|3640985|FG000|STARTED|Overall Study||50
2930154|NCT00585377|3640985|FG000|COMPLETED|Overall Study||50
2930155|NCT00585377|3640985|FG000|NOT COMPLETED|Overall Study||0
2930156|NCT00585468|3640989|FG000|STARTED|First Intervention||10
2930157|NCT00585468|3640990|FG001|STARTED|First Intervention||11
2930158|NCT00585468|3640989|FG000|COMPLETED|First Intervention||9
2930159|NCT00585468|3640990|FG001|COMPLETED|First Intervention||10
2930160|NCT00585468|3640989|FG000|NOT COMPLETED|First Intervention||1
2930161|NCT00585468|3640990|FG001|NOT COMPLETED|First Intervention||1
2930162|NCT00585468|3640989|FG000|STARTED|Second Intervention||9
2930163|NCT00585468|3640990|FG001|STARTED|Second Intervention||10
2930164|NCT00585468|3640989|FG000|COMPLETED|Second Intervention||9
2930165|NCT00585468|3640990|FG001|COMPLETED|Second Intervention||10
2930166|NCT00585468|3640989|FG000|NOT COMPLETED|Second Intervention||0
2930167|NCT00585468|3640990|FG001|NOT COMPLETED|Second Intervention||0
2930168|NCT00585494|3640998|FG000|STARTED|Overall Study||300
2930169|NCT00585494|3640998|FG000|COMPLETED|Overall Study||244
2930170|NCT00585494|3640998|FG000|NOT COMPLETED|Overall Study||56
2930171|NCT00585533|3641002|FG000|STARTED|Overall Study||40
2930172|NCT00585533|3641002|FG000|COMPLETED|Overall Study||31
2930173|NCT00585533|3641002|FG000|NOT COMPLETED|Overall Study||9
2930174|NCT00585546|3641006|FG000|STARTED|LVAD Implantation Required for 4 Months||18
2930175|NCT00585546|3641006|FG000|COMPLETED|LVAD Implantation Required for 4 Months||13
2930176|NCT00585546|3641006|FG000|NOT COMPLETED|LVAD Implantation Required for 4 Months||5
2930177|NCT00585546|3641006|FG000|STARTED|Clenbuterol Treatment - up to 12 Months||13
2930178|NCT00585546|3641006|FG000|COMPLETED|Clenbuterol Treatment - up to 12 Months||9
2930179|NCT00585546|3641006|FG000|NOT COMPLETED|Clenbuterol Treatment - up to 12 Months||4
2930180|NCT00585637|3641014|FG000|STARTED|Baseline||81
2930181|NCT00585637|3641015|FG001|STARTED|Baseline||81
2930182|NCT00585637|3641016|FG002|STARTED|Baseline||83
2930183|NCT00585637|3641017|FG003|STARTED|Baseline||83
2930184|NCT00585637|3641014|FG000|COMPLETED|Baseline||81
2930185|NCT00585637|3641015|FG001|COMPLETED|Baseline||81
2930186|NCT00585637|3641016|FG002|COMPLETED|Baseline||83
2930187|NCT00585637|3641017|FG003|COMPLETED|Baseline||83
2930188|NCT00585637|3641014|FG000|NOT COMPLETED|Baseline||0
2930189|NCT00585637|3641015|FG001|NOT COMPLETED|Baseline||0
2930190|NCT00585637|3641016|FG002|NOT COMPLETED|Baseline||0
2930191|NCT00585637|3641017|FG003|NOT COMPLETED|Baseline||0
2930192|NCT00585637|3641014|FG000|STARTED|3-month Time Point||81
2930193|NCT00585637|3641015|FG001|STARTED|3-month Time Point||81
2930194|NCT00585637|3641016|FG002|STARTED|3-month Time Point||83
2930195|NCT00585637|3641017|FG003|STARTED|3-month Time Point||83
2930196|NCT00585637|3641014|FG000|COMPLETED|3-month Time Point||71
2930197|NCT00585637|3641015|FG001|COMPLETED|3-month Time Point||67
2930198|NCT00585637|3641016|FG002|COMPLETED|3-month Time Point||76
2930199|NCT00585637|3641017|FG003|COMPLETED|3-month Time Point||78
2930200|NCT00585637|3641014|FG000|NOT COMPLETED|3-month Time Point||10
2930201|NCT00585637|3641015|FG001|NOT COMPLETED|3-month Time Point||14
2930202|NCT00585637|3641016|FG002|NOT COMPLETED|3-month Time Point||7
2930203|NCT00585637|3641017|FG003|NOT COMPLETED|3-month Time Point||5
2930204|NCT00585637|3641014|FG000|STARTED|6-month Time Point||81
2930205|NCT00585637|3641015|FG001|STARTED|6-month Time Point||81
2930206|NCT00585637|3641016|FG002|STARTED|6-month Time Point||83
2930207|NCT00585637|3641017|FG003|STARTED|6-month Time Point||83
2930208|NCT00585637|3641014|FG000|COMPLETED|6-month Time Point||75
2930209|NCT00585637|3641015|FG001|COMPLETED|6-month Time Point||68
2930210|NCT00585637|3641016|FG002|COMPLETED|6-month Time Point||72
2930211|NCT00585637|3641017|FG003|COMPLETED|6-month Time Point||77
2930212|NCT00585637|3641014|FG000|NOT COMPLETED|6-month Time Point||6
2930213|NCT00585637|3641015|FG001|NOT COMPLETED|6-month Time Point||13
2930214|NCT00585637|3641016|FG002|NOT COMPLETED|6-month Time Point||11
2930215|NCT00585637|3641017|FG003|NOT COMPLETED|6-month Time Point||6
2930216|NCT00585650|3641029|FG000|STARTED|Overall Study||8
2930217|NCT00585650|3641030|FG001|STARTED|Overall Study||12
2930218|NCT00585650|3641029|FG000|COMPLETED|Overall Study||8
2930219|NCT00585650|3641030|FG001|COMPLETED|Overall Study||12
2930220|NCT00585650|3641029|FG000|NOT COMPLETED|Overall Study||0
2930221|NCT00585650|3641030|FG001|NOT COMPLETED|Overall Study||0
2930222|NCT00585689|3641036|FG000|STARTED|Overall Study||29
2930223|NCT00585689|3641036|FG000|COMPLETED|Overall Study||22
2930224|NCT00585689|3641036|FG000|NOT COMPLETED|Overall Study||7
2930225|NCT00585715|3641042|FG000|STARTED|Overall Study||11
2930226|NCT00585715|3641043|FG001|STARTED|Overall Study||11
2930227|NCT00585715|3641042|FG000|COMPLETED|Overall Study||8
2930228|NCT00585715|3641043|FG001|COMPLETED|Overall Study||11
2930229|NCT00585715|3641042|FG000|NOT COMPLETED|Overall Study||3
2930230|NCT00585715|3641043|FG001|NOT COMPLETED|Overall Study||0
2930231|NCT00585780|3641053|FG000|STARTED|Overall Study||21
2930232|NCT00585780|3641054|FG001|STARTED|Overall Study||23
2930233|NCT00585780|3641055|FG002|STARTED|Overall Study||34
2930234|NCT00585780|3641056|FG003|STARTED|Overall Study||22
2930235|NCT00585780|3641053|FG000|COMPLETED|Overall Study||13
2930236|NCT00585780|3641054|FG001|COMPLETED|Overall Study||14
2930237|NCT00585780|3641055|FG002|COMPLETED|Overall Study||21
2930238|NCT00585780|3641056|FG003|COMPLETED|Overall Study||14
2930239|NCT00585780|3641053|FG000|NOT COMPLETED|Overall Study||8
2930240|NCT00585780|3641054|FG001|NOT COMPLETED|Overall Study||9
2930241|NCT00585780|3641055|FG002|NOT COMPLETED|Overall Study||13
2930242|NCT00585780|3641056|FG003|NOT COMPLETED|Overall Study||8
2930243|NCT00585910|3641070|FG000|STARTED|Atomoxetine (ATMX) Alone|This is the number of subjects who were exposed to ATMX in Phase I of the study.|72
2930244|NCT00585910|3641070|FG000|COMPLETED|Atomoxetine (ATMX) Alone|Number of subjects who completed Phase I. 15 completed only Phase I. 40 proceeded onto Phase II.|55
2930245|NCT00585910|3641070|FG000|NOT COMPLETED|Atomoxetine (ATMX) Alone||17
2930246|NCT00585910|3641070|FG000|STARTED|ATMX + Osmotic-Release Methylphenidate|Number of participants to add OROS MPH to their ATMX regimen|50
2930247|NCT00585910|3641070|FG000|COMPLETED|ATMX + Osmotic-Release Methylphenidate||41
2930248|NCT00585910|3641070|FG000|NOT COMPLETED|ATMX + Osmotic-Release Methylphenidate||9
2930249|NCT00585923|3641077|FG000|STARTED|Overall Study||56
2930250|NCT00585923|3641078|FG001|STARTED|Overall Study||59
2930251|NCT00585923|3641077|FG000|COMPLETED|Overall Study||25
2930252|NCT00585923|3641078|FG001|COMPLETED|Overall Study||26
2930253|NCT00585923|3641077|FG000|NOT COMPLETED|Overall Study||31
2930254|NCT00585923|3641078|FG001|NOT COMPLETED|Overall Study||33
3041066|NCT01168999|3760724|FG003|STARTED|Overall Study||28
3041067|NCT01168999|3760721|FG000|COMPLETED|Overall Study||26
3041068|NCT01168999|3760722|FG001|COMPLETED|Overall Study||26
3041069|NCT01168999|3760723|FG002|COMPLETED|Overall Study||27
3041070|NCT01168999|3760724|FG003|COMPLETED|Overall Study||28
3041071|NCT01168999|3760721|FG000|NOT COMPLETED|Overall Study||2
3041072|NCT01168999|3760722|FG001|NOT COMPLETED|Overall Study||1
3041073|NCT01168999|3760723|FG002|NOT COMPLETED|Overall Study||0
3041074|NCT01168999|3760724|FG003|NOT COMPLETED|Overall Study||0
3041075|NCT01169038|3760734|FG000|STARTED|Overall Study||15
3041076|NCT01169038|3760734|FG000|COMPLETED|Overall Study||8
3041077|NCT01169038|3760734|FG000|NOT COMPLETED|Overall Study||7
3041078|NCT01169064|3760740|FG000|STARTED|Overall Study||239
3041079|NCT01169064|3760741|FG001|STARTED|Overall Study||236
3041080|NCT01169064|3760740|FG000|COMPLETED|Overall Study||239
3041081|NCT01169064|3760741|FG001|COMPLETED|Overall Study||236
3041082|NCT01169064|3760740|FG000|NOT COMPLETED|Overall Study||0
3041083|NCT01169064|3760741|FG001|NOT COMPLETED|Overall Study||0
2930255|NCT00585975|3641086|FG000|STARTED|Overall Study||277
2930256|NCT00585975|3641087|FG001|STARTED|Overall Study||291
2930257|NCT00585975|3641086|FG000|COMPLETED|Overall Study||262
2930258|NCT00585975|3641087|FG001|COMPLETED|Overall Study||278
2930259|NCT00585975|3641086|FG000|NOT COMPLETED|Overall Study||15
2930260|NCT00585975|3641087|FG001|NOT COMPLETED|Overall Study||13
2930261|NCT00586001|3641095|FG000|STARTED|Overall Study||26
2930262|NCT00586001|3641096|FG001|STARTED|Overall Study||11
2930263|NCT00586001|3641095|FG000|COMPLETED|Overall Study||22
2930264|NCT00586001|3641096|FG001|COMPLETED|Overall Study||10
2930265|NCT00586001|3641095|FG000|NOT COMPLETED|Overall Study||4
2930266|NCT00586001|3641096|FG001|NOT COMPLETED|Overall Study||1
2930267|NCT00586066|3641105|FG000|STARTED|Overall Study||48
2930268|NCT00586066|3641106|FG001|STARTED|Overall Study||24
2930269|NCT00586066|3641105|FG000|COMPLETED|Overall Study||30
2930270|NCT00586066|3641106|FG001|COMPLETED|Overall Study||14
2930271|NCT00586066|3641105|FG000|NOT COMPLETED|Overall Study||18
2930272|NCT00586066|3641106|FG001|NOT COMPLETED|Overall Study||10
2930273|NCT00586105|3641112|FG000|STARTED|Overall Study||39
2930274|NCT00586105|3641112|FG000|COMPLETED|Overall Study||0
2930275|NCT00586105|3641112|FG000|NOT COMPLETED|Overall Study||39
2930276|NCT00586157|3641116|FG000|STARTED|First Intervention||15
2930277|NCT00586157|3641117|FG001|STARTED|First Intervention||15
2930278|NCT00586157|3641116|FG000|COMPLETED|First Intervention||14
2930279|NCT00586157|3641117|FG001|COMPLETED|First Intervention||15
2930280|NCT00586157|3641116|FG000|NOT COMPLETED|First Intervention||1
2930281|NCT00586157|3641117|FG001|NOT COMPLETED|First Intervention||0
2930282|NCT00586157|3641116|FG000|STARTED|Second Intervention||14
2930283|NCT00586157|3641117|FG001|STARTED|Second Intervention||15
2930284|NCT00586157|3641116|FG000|COMPLETED|Second Intervention||12
2930285|NCT00586157|3641117|FG001|COMPLETED|Second Intervention||14
2930286|NCT00586157|3641116|FG000|NOT COMPLETED|Second Intervention||2
2930287|NCT00586157|3641117|FG001|NOT COMPLETED|Second Intervention||1
2930288|NCT00586170|3641125|FG000|STARTED|Overall Study||5
2930289|NCT00586170|3641126|FG001|STARTED|Overall Study|Initially enrollment was listed as 9. 1 placebo patient withdrew prior to surgery, so enrollment=8.|3
2930290|NCT00586170|3641125|FG000|COMPLETED|Overall Study||5
2930291|NCT00586170|3641126|FG001|COMPLETED|Overall Study||3
2930292|NCT00586170|3641125|FG000|NOT COMPLETED|Overall Study||0
2930293|NCT00586170|3641126|FG001|NOT COMPLETED|Overall Study||0
2930294|NCT00586196|3641134|FG000|STARTED|Overall Study||7
2930295|NCT00586196|3641135|FG001|STARTED|Overall Study||9
2930296|NCT00586196|3641134|FG000|COMPLETED|Overall Study||7
2930297|NCT00586196|3641135|FG001|COMPLETED|Overall Study||9
3041084|NCT01169103|3760751|FG000|STARTED|Overall Study||11
3041085|NCT01169103|3760752|FG001|STARTED|Overall Study||11
3041086|NCT01169103|3760751|FG000|COMPLETED|Overall Study||5
3041087|NCT01169103|3760752|FG001|COMPLETED|Overall Study||7
3041088|NCT01169103|3760751|FG000|NOT COMPLETED|Overall Study||6
3041089|NCT01169103|3760752|FG001|NOT COMPLETED|Overall Study||4
3041090|NCT01169259|3760762|FG000|STARTED|Overall Study||6463
3041091|NCT01169259|3760763|FG001|STARTED|Overall Study||6464
3041092|NCT01169259|3760764|FG002|STARTED|Overall Study||6470
3041093|NCT01169259|3760765|FG003|STARTED|Overall Study||6474
3041094|NCT01169259|3760762|FG000|COMPLETED|Overall Study||6463
3041095|NCT01169259|3760763|FG001|COMPLETED|Overall Study||6464
3041096|NCT01169259|3760764|FG002|COMPLETED|Overall Study||6470
3041097|NCT01169259|3760765|FG003|COMPLETED|Overall Study||6474
3041098|NCT01169259|3760762|FG000|NOT COMPLETED|Overall Study||0
3041099|NCT01169259|3760763|FG001|NOT COMPLETED|Overall Study||0
3041100|NCT01169259|3760764|FG002|NOT COMPLETED|Overall Study||0
3041101|NCT01169259|3760765|FG003|NOT COMPLETED|Overall Study||0
3041102|NCT01169311|3760777|FG000|STARTED|Overall Study||27
3041103|NCT01169311|3760777|FG000|COMPLETED|Overall Study||27
3041104|NCT01169311|3760777|FG000|NOT COMPLETED|Overall Study||0
3041105|NCT01169337|3760785|FG000|STARTED|Overall Study||44
3041106|NCT01169337|3760786|FG001|STARTED|Overall Study||90
3041107|NCT01169337|3760787|FG002|STARTED|Overall Study||92
3041108|NCT01169337|3760785|FG000|Received Treatment/Observation|Overall Study||44
3041109|NCT01169337|3760786|FG001|Received Treatment/Observation|Overall Study||88
3041110|NCT01169337|3760787|FG002|Received Treatment/Observation|Overall Study||86
3041111|NCT01169337|3760785|FG000|COMPLETED|Overall Study||0
3041112|NCT01169337|3760786|FG001|COMPLETED|Overall Study||0
3041113|NCT01169337|3760787|FG002|COMPLETED|Overall Study||86
3041114|NCT01169337|3760785|FG000|NOT COMPLETED|Overall Study||44
3041115|NCT01169337|3760786|FG001|NOT COMPLETED|Overall Study||90
3041116|NCT01169337|3760787|FG002|NOT COMPLETED|Overall Study||6
3041117|NCT01169350|3760795|FG000|STARTED|Overall Study||8
3041118|NCT01169350|3760795|FG000|COMPLETED|Overall Study||3
3041119|NCT01169350|3760795|FG000|NOT COMPLETED|Overall Study||5
3041120|NCT01169467|3760801|FG000|STARTED|Overall Study||44
3041121|NCT01169467|3760802|FG001|STARTED|Overall Study||40
3041122|NCT01169467|3760801|FG000|COMPLETED|Overall Study||37
3041123|NCT01169467|3760802|FG001|COMPLETED|Overall Study||36
3041124|NCT01169467|3760801|FG000|NOT COMPLETED|Overall Study||7
3041125|NCT01169467|3760802|FG001|NOT COMPLETED|Overall Study||4
3041126|NCT01169493|3760814|FG000|STARTED|Period 1 (6 Months)||2
3041127|NCT01169493|3760815|FG001|STARTED|Period 1 (6 Months)||4
3179768|NCT01987089|3907979|FG000|STARTED|Overall Study||31
3179769|NCT01987089|3907980|FG001|STARTED|Overall Study||32
3179770|NCT01987089|3907979|FG000|COMPLETED|Overall Study||30
3179771|NCT01987089|3907980|FG001|COMPLETED|Overall Study||28
3179772|NCT01987089|3907979|FG000|NOT COMPLETED|Overall Study||1
3179773|NCT01987089|3907980|FG001|NOT COMPLETED|Overall Study||4
3179774|NCT01987102|3907988|FG000|STARTED|2 Courses of HDMTX With SOC Rescue||8
3179775|NCT01987102|3907989|FG001|STARTED|2 Courses of HDMTX With SOC Rescue||10
3179776|NCT01987102|3907988|FG000|COMPLETED|2 Courses of HDMTX With SOC Rescue||4
3179777|NCT01987102|3907989|FG001|COMPLETED|2 Courses of HDMTX With SOC Rescue||4
3179778|NCT01987102|3907988|FG000|NOT COMPLETED|2 Courses of HDMTX With SOC Rescue||4
3179779|NCT01987102|3907989|FG001|NOT COMPLETED|2 Courses of HDMTX With SOC Rescue||6
3179780|NCT01987102|3907988|FG000|STARTED|2 Courses of HDMTX With MOD Rescue||4
3179781|NCT01987102|3907989|FG001|STARTED|2 Courses of HDMTX With MOD Rescue||4
3179782|NCT01987102|3907988|FG000|COMPLETED|2 Courses of HDMTX With MOD Rescue||4
3179783|NCT01987102|3907989|FG001|COMPLETED|2 Courses of HDMTX With MOD Rescue||3
3179784|NCT01987102|3907988|FG000|NOT COMPLETED|2 Courses of HDMTX With MOD Rescue||0
3179785|NCT01987102|3907989|FG001|NOT COMPLETED|2 Courses of HDMTX With MOD Rescue||1
3179786|NCT01987219|3908002|FG000|STARTED|Overall Study||2
3179787|NCT01987219|3908003|FG001|STARTED|Overall Study||2
3179788|NCT01987219|3908004|FG002|STARTED|Overall Study||7
3179789|NCT01987219|3908005|FG003|STARTED|Overall Study||2
3179790|NCT01987219|3908006|FG004|STARTED|Overall Study||1
3179791|NCT01987219|3908007|FG005|STARTED|Overall Study||1
3179792|NCT01987219|3908002|FG000|COMPLETED|Overall Study||2
3179793|NCT01987219|3908003|FG001|COMPLETED|Overall Study||2
3179794|NCT01987219|3908004|FG002|COMPLETED|Overall Study||6
3179795|NCT01987219|3908005|FG003|COMPLETED|Overall Study||2
3179796|NCT01987219|3908006|FG004|COMPLETED|Overall Study||1
3179797|NCT01987219|3908007|FG005|COMPLETED|Overall Study||1
3179798|NCT01987219|3908002|FG000|NOT COMPLETED|Overall Study||0
3179799|NCT01987219|3908003|FG001|NOT COMPLETED|Overall Study||0
3179800|NCT01987219|3908004|FG002|NOT COMPLETED|Overall Study||1
2930298|NCT00586196|3641134|FG000|NOT COMPLETED|Overall Study||0
2930299|NCT00586196|3641135|FG001|NOT COMPLETED|Overall Study||0
2930300|NCT00586261|3641143|FG000|STARTED|Overall Study||17
2930301|NCT00586261|3641144|FG001|STARTED|Overall Study||19
2930302|NCT00586261|3641143|FG000|COMPLETED|Overall Study||17
2930303|NCT00586261|3641144|FG001|COMPLETED|Overall Study||19
2930304|NCT00586261|3641143|FG000|NOT COMPLETED|Overall Study||0
2930305|NCT00586261|3641144|FG001|NOT COMPLETED|Overall Study||0
2930306|NCT00586313|3641150|FG000|STARTED|Overall Study||21
2930307|NCT00586313|3641150|FG000|COMPLETED|Overall Study||19
2930308|NCT00586313|3641150|FG000|NOT COMPLETED|Overall Study||2
2930309|NCT00586326|3641154|FG000|STARTED|Enrollment to Device Placement-Enrolled||133
2930310|NCT00586326|3641154|FG000|COMPLETED|Enrollment to Device Placement-Enrolled||118
2930311|NCT00586326|3641154|FG000|NOT COMPLETED|Enrollment to Device Placement-Enrolled||15
2930312|NCT00586326|3641154|FG000|STARTED|Device Placed toTreatment-ITT||118
2930313|NCT00586326|3641154|FG000|COMPLETED|Device Placed toTreatment-ITT||100
2930314|NCT00586326|3641154|FG000|NOT COMPLETED|Device Placed toTreatment-ITT||18
2930315|NCT00586326|3641154|FG000|STARTED|Treated Through 5-yr Follow Up-Treated||100
2930316|NCT00586326|3641154|FG000|COMPLETED|Treated Through 5-yr Follow Up-Treated||74
2930317|NCT00586326|3641154|FG000|NOT COMPLETED|Treated Through 5-yr Follow Up-Treated||26
2930318|NCT00586339|3641165|FG000|STARTED|Overall Study||61
2930319|NCT00586339|3641166|FG001|STARTED|Overall Study||59
3179801|NCT01987219|3908005|FG003|NOT COMPLETED|Overall Study||0
3179802|NCT01987219|3908006|FG004|NOT COMPLETED|Overall Study||0
3179803|NCT01987219|3908007|FG005|NOT COMPLETED|Overall Study||0
3179804|NCT01987232|3908020|FG000|STARTED|Overall Study||5
2930320|NCT00586339|3641167|FG002|STARTED|Overall Study||30
2930321|NCT00586339|3641165|FG000|COMPLETED|Overall Study||54
2930322|NCT00586339|3641166|FG001|COMPLETED|Overall Study||52
2930323|NCT00586339|3641167|FG002|COMPLETED|Overall Study||24
2930324|NCT00586339|3641165|FG000|NOT COMPLETED|Overall Study||7
2930325|NCT00586339|3641166|FG001|NOT COMPLETED|Overall Study||7
2930326|NCT00586339|3641167|FG002|NOT COMPLETED|Overall Study||6
2930327|NCT00586469|3641177|FG000|STARTED|Overall Study||500
2930328|NCT00586469|3641178|FG001|STARTED|Overall Study||500
2930329|NCT00586469|3641177|FG000|COMPLETED|Overall Study||500
2930330|NCT00586469|3641178|FG001|COMPLETED|Overall Study||499
2930331|NCT00586469|3641177|FG000|NOT COMPLETED|Overall Study||0
2930332|NCT00586469|3641178|FG001|NOT COMPLETED|Overall Study||1
2930333|NCT00586482|3641186|FG000|STARTED|Overall Study||22
2930334|NCT00586482|3641187|FG001|STARTED|Overall Study||24
2930335|NCT00586482|3641186|FG000|COMPLETED|Overall Study||22
2930336|NCT00586482|3641187|FG001|COMPLETED|Overall Study||24
2930337|NCT00586482|3641186|FG000|NOT COMPLETED|Overall Study||0
2930338|NCT00586482|3641187|FG001|NOT COMPLETED|Overall Study||0
2930339|NCT00586495|3641193|FG000|STARTED|Treatment Period||95
2930340|NCT00586495|3641193|FG000|COMPLETED|Treatment Period||0
2930341|NCT00586495|3641193|FG000|NOT COMPLETED|Treatment Period||95
2930342|NCT00586495|3641193|FG000|STARTED|Follow-up||92
2930343|NCT00586495|3641193|FG000|COMPLETED|Follow-up||0
2930344|NCT00586495|3641193|FG000|NOT COMPLETED|Follow-up||92
3041128|NCT01169493|3760816|FG002|STARTED|Period 1 (6 Months)||5
3041129|NCT01169493|3760817|FG003|STARTED|Period 1 (6 Months)||0
3041130|NCT01169493|3760818|FG004|STARTED|Period 1 (6 Months)||0
3041131|NCT01169493|3760819|FG005|STARTED|Period 1 (6 Months)||5
3041132|NCT01169493|3760814|FG000|COMPLETED|Period 1 (6 Months)||2
3041133|NCT01169493|3760815|FG001|COMPLETED|Period 1 (6 Months)||3
3041134|NCT01169493|3760816|FG002|COMPLETED|Period 1 (6 Months)||3
3041135|NCT01169493|3760817|FG003|COMPLETED|Period 1 (6 Months)||0
3041136|NCT01169493|3760818|FG004|COMPLETED|Period 1 (6 Months)||0
3041137|NCT01169493|3760819|FG005|COMPLETED|Period 1 (6 Months)||2
3041138|NCT01169493|3760814|FG000|NOT COMPLETED|Period 1 (6 Months)||0
3041139|NCT01169493|3760815|FG001|NOT COMPLETED|Period 1 (6 Months)||1
3041140|NCT01169493|3760816|FG002|NOT COMPLETED|Period 1 (6 Months)||2
3041141|NCT01169493|3760817|FG003|NOT COMPLETED|Period 1 (6 Months)||0
3041142|NCT01169493|3760818|FG004|NOT COMPLETED|Period 1 (6 Months)||0
3041143|NCT01169493|3760819|FG005|NOT COMPLETED|Period 1 (6 Months)||3
3041144|NCT01169493|3760814|FG000|STARTED|Period 2 (6 Months)||2
3041145|NCT01169493|3760815|FG001|STARTED|Period 2 (6 Months)||3
3041146|NCT01169493|3760816|FG002|STARTED|Period 2 (6 Months)||3
3041147|NCT01169493|3760817|FG003|STARTED|Period 2 (6 Months)||0
3041148|NCT01169493|3760818|FG004|STARTED|Period 2 (6 Months)||0
3041149|NCT01169493|3760819|FG005|STARTED|Period 2 (6 Months)||2
3041150|NCT01169493|3760814|FG000|COMPLETED|Period 2 (6 Months)||2
3041151|NCT01169493|3760815|FG001|COMPLETED|Period 2 (6 Months)||3
3041152|NCT01169493|3760816|FG002|COMPLETED|Period 2 (6 Months)||3
3041153|NCT01169493|3760817|FG003|COMPLETED|Period 2 (6 Months)||0
3041154|NCT01169493|3760818|FG004|COMPLETED|Period 2 (6 Months)||0
3041155|NCT01169493|3760819|FG005|COMPLETED|Period 2 (6 Months)||2
3041156|NCT01169493|3760814|FG000|NOT COMPLETED|Period 2 (6 Months)||0
3041157|NCT01169493|3760815|FG001|NOT COMPLETED|Period 2 (6 Months)||0
3041158|NCT01169493|3760816|FG002|NOT COMPLETED|Period 2 (6 Months)||0
3041159|NCT01169493|3760817|FG003|NOT COMPLETED|Period 2 (6 Months)||0
3041160|NCT01169493|3760818|FG004|NOT COMPLETED|Period 2 (6 Months)||0
3041161|NCT01169493|3760819|FG005|NOT COMPLETED|Period 2 (6 Months)||0
3179805|NCT01987232|3908021|FG001|STARTED|Overall Study||3
3041162|NCT01169493|3760814|FG000|STARTED|Period 3 (6 Months)||2
2930345|NCT00586508|3641199|FG000|STARTED|Overall Study||68
2930346|NCT00586508|3641200|FG001|STARTED|Overall Study||13
2930347|NCT00586508|3641199|FG000|Received at Least 1 Dose of Study Drug|Overall Study||68
2930348|NCT00586508|3641200|FG001|Received at Least 1 Dose of Study Drug|Overall Study||13
2930349|NCT00586508|3641199|FG000|COMPLETED|Overall Study||0
2930350|NCT00586508|3641200|FG001|COMPLETED|Overall Study||0
2930351|NCT00586508|3641199|FG000|NOT COMPLETED|Overall Study||68
2930352|NCT00586508|3641200|FG001|NOT COMPLETED|Overall Study||13
2930353|NCT00586521|3641206|FG000|STARTED|On Demand Treatment (Months 1-6)||20
2930354|NCT00586521|3641206|FG000|COMPLETED|On Demand Treatment (Months 1-6)||19
2930355|NCT00586521|3641206|FG000|NOT COMPLETED|On Demand Treatment (Months 1-6)||1
2930356|NCT00586521|3641206|FG000|STARTED|Prophylactic Treatment (Months 8-13)||19
2930357|NCT00586521|3641206|FG000|COMPLETED|Prophylactic Treatment (Months 8-13)||19
2930358|NCT00586521|3641206|FG000|NOT COMPLETED|Prophylactic Treatment (Months 8-13)||0
2930359|NCT00586573|3641210|FG000|STARTED|Overall Study||34
2930360|NCT00586573|3641210|FG000|COMPLETED|Overall Study||28
2930361|NCT00586573|3641210|FG000|NOT COMPLETED|Overall Study||6
2930362|NCT00586612|3641216|FG000|STARTED|Primary Phase||163
2930363|NCT00586612|3641217|FG001|STARTED|Primary Phase||150
2930364|NCT00586612|3641216|FG000|COMPLETED|Primary Phase||162
2930365|NCT00586612|3641217|FG001|COMPLETED|Primary Phase||147
3179806|NCT01987232|3908022|FG002|STARTED|Overall Study||3
3179807|NCT01987232|3908023|FG003|STARTED|Overall Study||15
2930366|NCT00586612|3641216|FG000|NOT COMPLETED|Primary Phase||1
2930367|NCT00586612|3641217|FG001|NOT COMPLETED|Primary Phase||3
2930368|NCT00586612|3641216|FG000|STARTED|Booster Phase||154
2930369|NCT00586612|3641217|FG001|STARTED|Booster Phase||144
2930370|NCT00586612|3641216|FG000|COMPLETED|Booster Phase||151
2930371|NCT00586612|3641217|FG001|COMPLETED|Booster Phase||143
2930372|NCT00586612|3641216|FG000|NOT COMPLETED|Booster Phase||3
2930373|NCT00586612|3641217|FG001|NOT COMPLETED|Booster Phase||1
2930374|NCT00586625|3641225|FG000|STARTED|Overall Study||575
2930375|NCT00586625|3641226|FG001|STARTED|Overall Study||286
2930376|NCT00586625|3641225|FG000|COMPLETED|Overall Study||532
2930377|NCT00586625|3641226|FG001|COMPLETED|Overall Study||269
2930378|NCT00586625|3641225|FG000|NOT COMPLETED|Overall Study||43
2930379|NCT00586625|3641226|FG001|NOT COMPLETED|Overall Study||17
2930380|NCT00586664|3641235|FG000|STARTED|Overall Study||43
2930381|NCT00586664|3641236|FG001|STARTED|Overall Study||43
2930382|NCT00586664|3641237|FG002|STARTED|Overall Study||44
2930383|NCT00586664|3641235|FG000|COMPLETED|Overall Study||38
2930384|NCT00586664|3641236|FG001|COMPLETED|Overall Study||36
2930385|NCT00586664|3641237|FG002|COMPLETED|Overall Study||43
2930386|NCT00586664|3641235|FG000|NOT COMPLETED|Overall Study||5
2930387|NCT00586664|3641236|FG001|NOT COMPLETED|Overall Study||7
2930388|NCT00586664|3641237|FG002|NOT COMPLETED|Overall Study||1
2930389|NCT00586690|3641247|FG000|STARTED|Overall Study|Four consented subjects were screen failures.|21
2930390|NCT00586690|3641248|FG001|STARTED|Overall Study||22
2930391|NCT00586690|3641247|FG000|COMPLETED|Overall Study||5
2930392|NCT00586690|3641248|FG001|COMPLETED|Overall Study||22
2930393|NCT00586690|3641247|FG000|NOT COMPLETED|Overall Study||16
2930394|NCT00586690|3641248|FG001|NOT COMPLETED|Overall Study||0
2930395|NCT00586703|3641253|FG000|STARTED|Overall Study||16
2930396|NCT00586703|3641253|FG000|COMPLETED|Overall Study||4
2930397|NCT00586703|3641253|FG000|NOT COMPLETED|Overall Study||12
2930398|NCT00586729|3641259|FG000|STARTED|Overall Study||14
2930399|NCT00586729|3641260|FG001|STARTED|Overall Study||9
2930400|NCT00586729|3641259|FG000|COMPLETED|Overall Study||11
2930401|NCT00586729|3641260|FG001|COMPLETED|Overall Study||8
2930402|NCT00586729|3641259|FG000|NOT COMPLETED|Overall Study||3
2930403|NCT00586729|3641260|FG001|NOT COMPLETED|Overall Study||1
2930404|NCT00586820|3641268|FG000|STARTED|Overall Study||12
2930405|NCT00586820|3641269|FG001|STARTED|Overall Study||11
2930406|NCT00586820|3641268|FG000|COMPLETED|Overall Study||11
2930407|NCT00586820|3641269|FG001|COMPLETED|Overall Study||11
2930408|NCT00586820|3641268|FG000|NOT COMPLETED|Overall Study||1
3041163|NCT01169493|3760815|FG001|STARTED|Period 3 (6 Months)||3
3041164|NCT01169493|3760816|FG002|STARTED|Period 3 (6 Months)||3
3041165|NCT01169493|3760817|FG003|STARTED|Period 3 (6 Months)||0
3041166|NCT01169493|3760818|FG004|STARTED|Period 3 (6 Months)||0
3041167|NCT01169493|3760819|FG005|STARTED|Period 3 (6 Months)||2
3041168|NCT01169493|3760814|FG000|COMPLETED|Period 3 (6 Months)||2
3041169|NCT01169493|3760815|FG001|COMPLETED|Period 3 (6 Months)||1
3041170|NCT01169493|3760816|FG002|COMPLETED|Period 3 (6 Months)||2
3041171|NCT01169493|3760817|FG003|COMPLETED|Period 3 (6 Months)||0
3041172|NCT01169493|3760818|FG004|COMPLETED|Period 3 (6 Months)||0
3041173|NCT01169493|3760819|FG005|COMPLETED|Period 3 (6 Months)||2
3041174|NCT01169493|3760814|FG000|NOT COMPLETED|Period 3 (6 Months)||0
3041175|NCT01169493|3760815|FG001|NOT COMPLETED|Period 3 (6 Months)||2
3041176|NCT01169493|3760816|FG002|NOT COMPLETED|Period 3 (6 Months)||1
3179808|NCT01987232|3908024|FG004|STARTED|Overall Study||6
2930409|NCT00586820|3641269|FG001|NOT COMPLETED|Overall Study||0
2930410|NCT00586846|3641275|FG000|STARTED|Overall Study||40
2930411|NCT00586846|3641275|FG000|COMPLETED|Overall Study||34
2930412|NCT00586846|3641275|FG000|NOT COMPLETED|Overall Study||6
2930413|NCT00586898|3641279|FG000|STARTED|Overall Study||36
2930414|NCT00586898|3641279|FG000|COMPLETED|Overall Study||29
2930415|NCT00586898|3641279|FG000|NOT COMPLETED|Overall Study||7
2930416|NCT00587041|3641286|FG000|STARTED|Overall Study||12
2930417|NCT00587041|3641287|FG001|STARTED|Overall Study||14
2930418|NCT00587041|3641288|FG002|STARTED|Overall Study||14
2930419|NCT00587041|3641286|FG000|COMPLETED|Overall Study||12
2930420|NCT00587041|3641287|FG001|COMPLETED|Overall Study||14
2930421|NCT00587041|3641288|FG002|COMPLETED|Overall Study||14
2930422|NCT00587041|3641286|FG000|NOT COMPLETED|Overall Study||0
2930423|NCT00587041|3641287|FG001|NOT COMPLETED|Overall Study||0
2930424|NCT00587041|3641288|FG002|NOT COMPLETED|Overall Study||0
2930425|NCT00587054|3641296|FG000|STARTED|Overall Study||129
2930426|NCT00587054|3641296|FG000|COMPLETED|Overall Study||120
2930427|NCT00587054|3641296|FG000|NOT COMPLETED|Overall Study||9
2930428|NCT00587067|3641300|FG000|STARTED|Overall Study||34
2930429|NCT00587067|3641300|FG000|COMPLETED|Overall Study||34
2930430|NCT00587067|3641300|FG000|NOT COMPLETED|Overall Study||0
2930431|NCT00587132|3641308|FG000|STARTED|Overall Study||4
2930432|NCT00587132|3641309|FG001|STARTED|Overall Study||0
2930433|NCT00587132|3641310|FG002|STARTED|Overall Study||0
2930434|NCT00587132|3641311|FG003|STARTED|Overall Study||0
2930435|NCT00587132|3641308|FG000|COMPLETED|Overall Study||4
2930436|NCT00587132|3641309|FG001|COMPLETED|Overall Study||0
2930437|NCT00587132|3641310|FG002|COMPLETED|Overall Study||0
2930438|NCT00587132|3641311|FG003|COMPLETED|Overall Study||0
2930439|NCT00587132|3641308|FG000|NOT COMPLETED|Overall Study||0
2930440|NCT00587132|3641309|FG001|NOT COMPLETED|Overall Study||0
2930441|NCT00587132|3641310|FG002|NOT COMPLETED|Overall Study||0
2930442|NCT00587132|3641311|FG003|NOT COMPLETED|Overall Study||0
2930443|NCT00587158|3641323|FG000|STARTED|Overall Study||49
2930444|NCT00587158|3641324|FG001|STARTED|Overall Study||51
2930445|NCT00587158|3641323|FG000|Continued in Study|Overall Study||45
2930446|NCT00587158|3641324|FG001|Continued in Study|Overall Study||46
2930447|NCT00587158|3641323|FG000|COMPLETED|Overall Study||44
2930448|NCT00587158|3641324|FG001|COMPLETED|Overall Study||43
2930449|NCT00587158|3641323|FG000|NOT COMPLETED|Overall Study||5
2930450|NCT00587158|3641324|FG001|NOT COMPLETED|Overall Study||8
2930451|NCT00587171|3641332|FG000|STARTED|Overall Study||9
2930452|NCT00587171|3641333|FG001|STARTED|Overall Study||10
2930453|NCT00587171|3641332|FG000|COMPLETED|Overall Study||8
2930454|NCT00587171|3641333|FG001|COMPLETED|Overall Study||9
2930455|NCT00587171|3641332|FG000|NOT COMPLETED|Overall Study||1
2930456|NCT00587171|3641333|FG001|NOT COMPLETED|Overall Study||1
2930457|NCT00587288|3641341|FG000|STARTED|Overall Study||53
2930458|NCT00587288|3641342|FG001|STARTED|Overall Study||53
2930459|NCT00587288|3641341|FG000|COMPLETED|Overall Study||50
2930460|NCT00587288|3641342|FG001|COMPLETED|Overall Study||44
2930461|NCT00587288|3641341|FG000|NOT COMPLETED|Overall Study||3
2930462|NCT00587288|3641342|FG001|NOT COMPLETED|Overall Study||9
2930463|NCT00587431|3641352|FG000|STARTED|Overall Study||63
2930464|NCT00587431|3641353|FG001|STARTED|Overall Study||39
2930465|NCT00587431|3641352|FG000|COMPLETED|Overall Study||62
2930466|NCT00587431|3641353|FG001|COMPLETED|Overall Study||38
2930467|NCT00587431|3641352|FG000|NOT COMPLETED|Overall Study||1
2930468|NCT00587431|3641353|FG001|NOT COMPLETED|Overall Study||1
2930469|NCT00587457|3641365|FG000|STARTED|Overall Study||3
2930470|NCT00587457|3641366|FG001|STARTED|Overall Study||3
2930471|NCT00587457|3641367|FG002|STARTED|Overall Study||5
2930472|NCT00587457|3641365|FG000|COMPLETED|Overall Study||0
2930473|NCT00587457|3641366|FG001|COMPLETED|Overall Study||0
2930474|NCT00587457|3641367|FG002|COMPLETED|Overall Study||0
2930475|NCT00587457|3641365|FG000|NOT COMPLETED|Overall Study||3
2930476|NCT00587457|3641366|FG001|NOT COMPLETED|Overall Study||3
2930477|NCT00587457|3641367|FG002|NOT COMPLETED|Overall Study||5
2930478|NCT00587483|3641378|FG000|STARTED|Overall Study||115
2930479|NCT00587483|3641379|FG001|STARTED|Overall Study||115
2930480|NCT00587483|3641380|FG002|STARTED|Overall Study||112
2930481|NCT00587483|3641378|FG000|COMPLETED|Overall Study||115
2930482|NCT00587483|3641379|FG001|COMPLETED|Overall Study||115
2930483|NCT00587483|3641380|FG002|COMPLETED|Overall Study||112
2930484|NCT00587483|3641378|FG000|NOT COMPLETED|Overall Study||0
2930485|NCT00587483|3641379|FG001|NOT COMPLETED|Overall Study||0
2930486|NCT00587483|3641380|FG002|NOT COMPLETED|Overall Study||0
2930487|NCT00587587|3641390|FG000|STARTED|Overall Study||17
3179809|NCT01987232|3908020|FG000|COMPLETED|Overall Study||5
3179810|NCT01987232|3908021|FG001|COMPLETED|Overall Study||3
2930488|NCT00587587|3641391|FG001|STARTED|Overall Study||13
2930489|NCT00587587|3641390|FG000|COMPLETED|Overall Study||11
2930490|NCT00587587|3641391|FG001|COMPLETED|Overall Study||12
2930491|NCT00587587|3641390|FG000|NOT COMPLETED|Overall Study||6
2930492|NCT00587587|3641391|FG001|NOT COMPLETED|Overall Study||1
2930493|NCT00587639|3641399|FG000|STARTED|Overall Study||8
2930494|NCT00587639|3641399|FG000|COMPLETED|Overall Study||7
2930495|NCT00587639|3641399|FG000|NOT COMPLETED|Overall Study||1
2930496|NCT00587678|3641406|FG000|STARTED|Overall Study||22
2930497|NCT00587678|3641407|FG001|STARTED|Overall Study||22
2930498|NCT00587678|3641408|FG002|STARTED|Overall Study||41
2930499|NCT00587678|3641406|FG000|COMPLETED|Overall Study||16
2930500|NCT00587678|3641407|FG001|COMPLETED|Overall Study||18
2930501|NCT00587678|3641408|FG002|COMPLETED|Overall Study||33
2930502|NCT00587678|3641406|FG000|NOT COMPLETED|Overall Study||6
2930503|NCT00587678|3641407|FG001|NOT COMPLETED|Overall Study||4
2930504|NCT00587678|3641408|FG002|NOT COMPLETED|Overall Study||8
2930505|NCT00587769|3641416|FG000|STARTED|Overall Study||38
2930506|NCT00587769|3641416|FG000|COMPLETED|Overall Study||38
2930507|NCT00587769|3641416|FG000|NOT COMPLETED|Overall Study||0
2930508|NCT00587834|3641420|FG000|STARTED|Overall Study||96
2930509|NCT00587834|3641420|FG000|COMPLETED|Overall Study||96
2930510|NCT00587834|3641420|FG000|NOT COMPLETED|Overall Study||0
2930511|NCT00587847|3641435|FG000|STARTED|Overall Study||12
2930512|NCT00587847|3641435|FG000|COMPLETED|Overall Study||5
2930513|NCT00587847|3641435|FG000|NOT COMPLETED|Overall Study||7
3041177|NCT01169493|3760817|FG003|NOT COMPLETED|Period 3 (6 Months)||0
3041178|NCT01169493|3760818|FG004|NOT COMPLETED|Period 3 (6 Months)||0
3041179|NCT01169493|3760819|FG005|NOT COMPLETED|Period 3 (6 Months)||0
3137139|NCT01717313|3862398|FG000|COMPLETED|Interphase||146
3137140|NCT01717313|3862399|FG001|COMPLETED|Interphase||151
3137141|NCT01717313|3862398|FG000|NOT COMPLETED|Interphase||1
3137142|NCT01717313|3862399|FG001|NOT COMPLETED|Interphase||0
3137143|NCT01717313|3862398|FG000|STARTED|Phase B (Weeks 24 to 54)||146
3137144|NCT01717313|3862399|FG001|STARTED|Phase B (Weeks 24 to 54)||151
3137145|NCT01717313|3862398|FG000|COMPLETED|Phase B (Weeks 24 to 54)||134
3137146|NCT01717313|3862399|FG001|COMPLETED|Phase B (Weeks 24 to 54)||135
3137147|NCT01717313|3862398|FG000|NOT COMPLETED|Phase B (Weeks 24 to 54)||12
3137148|NCT01717313|3862399|FG001|NOT COMPLETED|Phase B (Weeks 24 to 54)||16
3137149|NCT01717326|3862425|FG000|STARTED|Overall Study||25
3137150|NCT01717326|3862426|FG001|STARTED|Overall Study||27
3137151|NCT01717326|3862427|FG002|STARTED|Overall Study||13
3137152|NCT01717326|3862428|FG003|STARTED|Overall Study||30
3137153|NCT01717326|3862429|FG004|STARTED|Overall Study||33
3137154|NCT01717326|3862430|FG005|STARTED|Overall Study||31
3137155|NCT01717326|3862431|FG006|STARTED|Overall Study||31
2930514|NCT04545008|3641440|FG000|STARTED|Overall Study||2
2930515|NCT04545008|3641440|FG000|COMPLETED|Overall Study||2
2930516|NCT04545008|3641440|FG000|NOT COMPLETED|Overall Study||0
3041180|NCT01169519|3760827|FG000|STARTED|Overall Study|This was a pre-post study, All patients receiving a baseline assessment, also received sildenafil.|21
3041181|NCT01169519|3760827|FG000|COMPLETED|Overall Study||21
3041182|NCT01169519|3760827|FG000|NOT COMPLETED|Overall Study||0
3041183|NCT01169532|3760839|FG000|STARTED|Overall Study||16
3041184|NCT01169532|3760839|FG000|COMPLETED|Overall Study||15
3041185|NCT01169532|3760839|FG000|NOT COMPLETED|Overall Study||1
3041186|NCT01169558|3760843|FG000|STARTED|Overall Study||162
3041187|NCT01169558|3760843|FG000|COMPLETED|Overall Study||6
3041188|NCT01169558|3760843|FG000|NOT COMPLETED|Overall Study||156
3041189|NCT01169636|3760852|FG000|STARTED|Overall Study||3
3041190|NCT01169636|3760853|FG001|STARTED|Overall Study||6
3041191|NCT01169636|3760854|FG002|STARTED|Overall Study||20
3041192|NCT01169636|3760855|FG003|STARTED|Overall Study||13
3041193|NCT01169636|3760856|FG004|STARTED|Overall Study||14
3041194|NCT01169636|3760852|FG000|COMPLETED|Overall Study||3
3041195|NCT01169636|3760853|FG001|COMPLETED|Overall Study||6
3041196|NCT01169636|3760854|FG002|COMPLETED|Overall Study||17
3041197|NCT01169636|3760855|FG003|COMPLETED|Overall Study||12
3041198|NCT01169636|3760856|FG004|COMPLETED|Overall Study||11
3041199|NCT01169636|3760852|FG000|NOT COMPLETED|Overall Study||0
3041200|NCT01169636|3760853|FG001|NOT COMPLETED|Overall Study||0
3041201|NCT01169636|3760854|FG002|NOT COMPLETED|Overall Study||3
3041202|NCT01169636|3760855|FG003|NOT COMPLETED|Overall Study||1
3041203|NCT01169636|3760856|FG004|NOT COMPLETED|Overall Study||3
3041204|NCT01169649|3760866|FG000|STARTED|Overall Study||11
3041205|NCT01169649|3760866|FG000|COMPLETED|Overall Study||8
3041206|NCT01169649|3760866|FG000|NOT COMPLETED|Overall Study||3
3041207|NCT01169675|3760875|FG000|STARTED|Overall Study||20
3041208|NCT01169675|3760876|FG001|STARTED|Overall Study||3
3041209|NCT01169675|3760877|FG002|STARTED|Overall Study||7
3041210|NCT01169675|3760878|FG003|STARTED|Overall Study||17
3041211|NCT01169675|3760879|FG004|STARTED|Overall Study||6
3041212|NCT01169675|3760875|FG000|COMPLETED|Overall Study||0
3041213|NCT01169675|3760876|FG001|COMPLETED|Overall Study||0
3041214|NCT01169675|3760877|FG002|COMPLETED|Overall Study||0
3041215|NCT01169675|3760878|FG003|COMPLETED|Overall Study||0
3041216|NCT01169675|3760879|FG004|COMPLETED|Overall Study||0
3041217|NCT01169675|3760875|FG000|NOT COMPLETED|Overall Study||20
3041218|NCT01169675|3760876|FG001|NOT COMPLETED|Overall Study||3
3041219|NCT01169675|3760877|FG002|NOT COMPLETED|Overall Study||7
3041220|NCT01169675|3760878|FG003|NOT COMPLETED|Overall Study||17
3041221|NCT01169675|3760879|FG004|NOT COMPLETED|Overall Study||6
3041222|NCT01169701|3760893|FG000|STARTED|Overall Study||36
3041223|NCT01169701|3760894|FG001|STARTED|Overall Study||35
3041224|NCT01169701|3760893|FG000|Safety Set|Overall Study||36
3041225|NCT01169701|3760894|FG001|Safety Set|Overall Study||35
3041226|NCT01169701|3760893|FG000|Intent to Treat (ITT) Set|Overall Study||32
3041227|NCT01169701|3760894|FG001|Intent to Treat (ITT) Set|Overall Study||28
3041228|NCT01169701|3760893|FG000|COMPLETED|Overall Study||31
3041229|NCT01169701|3760894|FG001|COMPLETED|Overall Study||25
3041230|NCT01169701|3760893|FG000|NOT COMPLETED|Overall Study||5
3041231|NCT01169701|3760894|FG001|NOT COMPLETED|Overall Study||10
3041232|NCT01169779|3760902|FG000|STARTED|Overall Study|Randomized.|195
3041233|NCT01169779|3760903|FG001|STARTED|Overall Study||196
3041234|NCT01169779|3760902|FG000|Treated/Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|194
3137156|NCT01717326|3862432|FG007|STARTED|Overall Study||29
3137157|NCT01717326|3862433|FG008|STARTED|Overall Study||32
3179811|NCT01987232|3908022|FG002|COMPLETED|Overall Study||3
3041235|NCT01169779|3760903|FG001|Treated/Safety Population|Overall Study||196
3041236|NCT01169779|3760902|FG000|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|193
3137158|NCT01717326|3862434|FG009|STARTED|Overall Study||31
3137159|NCT01717326|3862435|FG010|STARTED|Overall Study||32
3137160|NCT01717326|3862436|FG011|STARTED|Overall Study||33
3137161|NCT01717326|3862437|FG012|STARTED|Overall Study||33
3137162|NCT01717326|3862438|FG013|STARTED|Overall Study||32
2930517|NCT04496414|3641444|FG000|STARTED|Overall Study||50
2930518|NCT04496414|3641444|FG000|COMPLETED|Overall Study||50
2930519|NCT04496414|3641444|FG000|NOT COMPLETED|Overall Study||0
2930520|NCT04411680|3641450|FG000|STARTED|Treatment Period||78
2930521|NCT04411680|3641451|FG001|STARTED|Treatment Period||44
2930522|NCT04411680|3641450|FG000|COMPLETED|Treatment Period||49
2930523|NCT04411680|3641451|FG001|COMPLETED|Treatment Period||36
2930524|NCT04411680|3641450|FG000|NOT COMPLETED|Treatment Period||29
2930525|NCT04411680|3641451|FG001|NOT COMPLETED|Treatment Period||8
2930526|NCT04411680|3641450|FG000|STARTED|Follow up Period||78
2930527|NCT04411680|3641451|FG001|STARTED|Follow up Period||44
2930528|NCT04411680|3641450|FG000|COMPLETED|Follow up Period||60
3179812|NCT01987232|3908023|FG003|COMPLETED|Overall Study||14
3179813|NCT01987232|3908024|FG004|COMPLETED|Overall Study||6
3179814|NCT01987232|3908020|FG000|NOT COMPLETED|Overall Study||0
3179815|NCT01987232|3908021|FG001|NOT COMPLETED|Overall Study||0
3179816|NCT01987232|3908022|FG002|NOT COMPLETED|Overall Study||0
3179817|NCT01987232|3908023|FG003|NOT COMPLETED|Overall Study||1
2930529|NCT04411680|3641451|FG001|COMPLETED|Follow up Period||30
2930530|NCT04411680|3641450|FG000|NOT COMPLETED|Follow up Period||18
2930531|NCT04411680|3641451|FG001|NOT COMPLETED|Follow up Period||14
2930532|NCT04364984|3641460|FG000|STARTED|Overall Study||37
2930533|NCT04364984|3641461|FG001|STARTED|Overall Study||44
2930534|NCT04364984|3641462|FG002|STARTED|Overall Study||31
2930535|NCT04364984|3641460|FG000|COMPLETED|Overall Study||35
2930536|NCT04364984|3641461|FG001|COMPLETED|Overall Study||42
2930537|NCT04364984|3641462|FG002|COMPLETED|Overall Study||31
2930538|NCT04364984|3641460|FG000|NOT COMPLETED|Overall Study||2
2930539|NCT04364984|3641461|FG001|NOT COMPLETED|Overall Study||2
2930540|NCT04364984|3641462|FG002|NOT COMPLETED|Overall Study||0
2930541|NCT04363437|3641472|FG000|STARTED|Overall Study||10
2930542|NCT04363437|3641473|FG001|STARTED|Overall Study||11
2930543|NCT04363437|3641472|FG000|COMPLETED|Overall Study||10
2930544|NCT04363437|3641473|FG001|COMPLETED|Overall Study||11
2930545|NCT04363437|3641472|FG000|NOT COMPLETED|Overall Study||0
2930546|NCT04363437|3641473|FG001|NOT COMPLETED|Overall Study||0
3041237|NCT01169779|3760903|FG001|Modified Intent-to-Treat(mITT)Population|Overall Study||195
3041238|NCT01169779|3760902|FG000|Subgroup for Standardized Meal Test|Overall Study|Patients at selected sites where standardized meal test was performed.|130
3041239|NCT01169779|3760903|FG001|Subgroup for Standardized Meal Test|Overall Study||121
3041240|NCT01169779|3760902|FG000|COMPLETED|Overall Study||184
3041241|NCT01169779|3760903|FG001|COMPLETED|Overall Study||179
3041242|NCT01169779|3760902|FG000|NOT COMPLETED|Overall Study||11
3041243|NCT01169779|3760903|FG001|NOT COMPLETED|Overall Study||17
3041244|NCT01169844|3760911|FG000|STARTED|Overall Study||19
3041245|NCT01169844|3760912|FG001|STARTED|Overall Study||9
3041246|NCT01169844|3760911|FG000|COMPLETED|Overall Study||14
3041247|NCT01169844|3760912|FG001|COMPLETED|Overall Study||8
3041248|NCT01169844|3760911|FG000|NOT COMPLETED|Overall Study||5
3041249|NCT01169844|3760912|FG001|NOT COMPLETED|Overall Study||1
3041250|NCT01169987|3760918|FG000|STARTED|Overall Study||191
3041251|NCT01169987|3760918|FG000|COMPLETED|Overall Study||160
3041252|NCT01169987|3760918|FG000|NOT COMPLETED|Overall Study||31
3041253|NCT01170039|3760930|FG000|STARTED|Overall Study||37
3041254|NCT01170039|3760931|FG001|STARTED|Overall Study||39
3041255|NCT01170039|3760930|FG000|COMPLETED|Overall Study||29
3041256|NCT01170039|3760931|FG001|COMPLETED|Overall Study||33
3041257|NCT01170039|3760930|FG000|NOT COMPLETED|Overall Study||8
3041258|NCT01170039|3760931|FG001|NOT COMPLETED|Overall Study||6
3041259|NCT01170065|3760940|FG000|STARTED|Overall Study||37
3041260|NCT01170065|3760941|FG001|STARTED|Overall Study||126
3041261|NCT01170065|3760942|FG002|STARTED|Overall Study||35
3041262|NCT01170065|3760940|FG000|COMPLETED|Overall Study|Planned observation time is from first trial drug intake to follow-up visit|9
3041263|NCT01170065|3760941|FG001|COMPLETED|Overall Study|Planned observation time is from first trial drug intake to follow-up visit|34
3041264|NCT01170065|3760942|FG002|COMPLETED|Overall Study|Planned observation time is from first trial drug intake to follow-up visit|9
3041265|NCT01170065|3760940|FG000|NOT COMPLETED|Overall Study||28
3041266|NCT01170065|3760941|FG001|NOT COMPLETED|Overall Study||92
3041267|NCT01170065|3760942|FG002|NOT COMPLETED|Overall Study||26
3041268|NCT01170091|3760950|FG000|STARTED|Overall Study||651
3041269|NCT01170091|3760950|FG000|COMPLETED|Overall Study||627
3041270|NCT01170091|3760950|FG000|NOT COMPLETED|Overall Study||24
3041271|NCT01170117|3760956|FG000|STARTED|Overall Study||77
3041272|NCT01170117|3760957|FG001|STARTED|Overall Study||75
3041273|NCT01170117|3760956|FG000|COMPLETED|Overall Study||47
3041274|NCT01170117|3760957|FG001|COMPLETED|Overall Study||55
3041275|NCT01170117|3760956|FG000|NOT COMPLETED|Overall Study||30
3041276|NCT01170117|3760957|FG001|NOT COMPLETED|Overall Study||20
3041277|NCT01170208|3760966|FG000|STARTED|Overall Study||20
3041278|NCT01170208|3760967|FG001|STARTED|Overall Study||20
3041279|NCT01170208|3760968|FG002|STARTED|Overall Study||6
3041280|NCT01170208|3760966|FG000|COMPLETED|Overall Study||14
3041281|NCT01170208|3760967|FG001|COMPLETED|Overall Study||20
3041282|NCT01170208|3760968|FG002|COMPLETED|Overall Study||4
3041283|NCT01170208|3760966|FG000|NOT COMPLETED|Overall Study||6
3041284|NCT01170208|3760967|FG001|NOT COMPLETED|Overall Study||0
3041285|NCT01170208|3760968|FG002|NOT COMPLETED|Overall Study||2
3041286|NCT01170221|3760981|FG000|STARTED|Overall Study||332
3041287|NCT01170221|3760982|FG001|STARTED|Overall Study||335
3041288|NCT01170221|3760981|FG000|COMPLETED|Overall Study||299
3041289|NCT01170221|3760982|FG001|COMPLETED|Overall Study||307
3041290|NCT01170221|3760981|FG000|NOT COMPLETED|Overall Study||33
3137163|NCT01717326|3862439|FG014|STARTED|Overall Study||29
3137164|NCT01717326|3862440|FG015|STARTED|Overall Study||30
3137165|NCT01717326|3862441|FG016|STARTED|Overall Study||30
3137166|NCT01717326|3862442|FG017|STARTED|Overall Study||31
3137167|NCT01717326|3862443|FG018|STARTED|Overall Study||20
3179818|NCT01987232|3908024|FG004|NOT COMPLETED|Overall Study||0
2930547|NCT04033991|3641479|FG000|STARTED|Overall Study||684
2930548|NCT04033991|3641479|FG000|Participants Who Took First-line Sunitinib Therapy|Overall Study||622
2930549|NCT04033991|3641479|FG000|Participants Who Took Second-line Axitinib Therapy|Overall Study||121
2930550|NCT04033991|3641479|FG000|Participants Who Took First-line Sunitinib Therapy and Then Second-line Axitinib Therapy|Overall Study||59
2930551|NCT04033991|3641479|FG000|Participants Who Took Drugs Other Than Sunitinib as First-line and Then Second-line Axitinib Therapy|Overall Study||62
2930552|NCT04033991|3641479|FG000|COMPLETED|Overall Study||684
2930553|NCT04033991|3641479|FG000|NOT COMPLETED|Overall Study||0
2930554|NCT03930849|3641488|FG000|STARTED|Overall Study||17
2930555|NCT03930849|3641489|FG001|STARTED|Overall Study||18
2930556|NCT03930849|3641490|FG002|STARTED|Overall Study||18
2930557|NCT03930849|3641488|FG000|COMPLETED|Overall Study||13
2930558|NCT03930849|3641489|FG001|COMPLETED|Overall Study||18
2930559|NCT03930849|3641490|FG002|COMPLETED|Overall Study||14
2930560|NCT03930849|3641488|FG000|NOT COMPLETED|Overall Study||4
2930561|NCT03930849|3641489|FG001|NOT COMPLETED|Overall Study||0
3179819|NCT01987349|3908046|FG000|STARTED|Overall Study||6
3179820|NCT01987349|3908047|FG001|STARTED|Overall Study||6
2930562|NCT03930849|3641490|FG002|NOT COMPLETED|Overall Study||4
2930563|NCT03793439|3641498|FG000|STARTED|Overall Study||5
2930564|NCT03793439|3641498|FG000|COMPLETED|Overall Study||3
2930565|NCT03793439|3641498|FG000|NOT COMPLETED|Overall Study||2
2930566|NCT03711266|3641502|FG000|STARTED|Overall Study||30
2930567|NCT03711266|3641502|FG000|COMPLETED|Overall Study||20
2930568|NCT03711266|3641502|FG000|NOT COMPLETED|Overall Study||10
2930569|NCT03655691|3641509|FG000|STARTED|Overall Study||26
2930570|NCT03655691|3641510|FG001|STARTED|Overall Study||26
2930571|NCT03655691|3641511|FG002|STARTED|Overall Study||27
2930572|NCT03655691|3641509|FG000|COMPLETED|Overall Study||24
2930573|NCT03655691|3641510|FG001|COMPLETED|Overall Study||23
2930574|NCT03655691|3641511|FG002|COMPLETED|Overall Study||24
2930575|NCT03655691|3641509|FG000|NOT COMPLETED|Overall Study||2
2930576|NCT03655691|3641510|FG001|NOT COMPLETED|Overall Study||3
2930577|NCT03655691|3641511|FG002|NOT COMPLETED|Overall Study||3
2930578|NCT03630393|3641521|FG000|STARTED|Overall Study||68
2930579|NCT03630393|3641522|FG001|STARTED|Overall Study||71
2930580|NCT03630393|3641521|FG000|COMPLETED|Overall Study||67
2930581|NCT03630393|3641522|FG001|COMPLETED|Overall Study||71
2930582|NCT03630393|3641521|FG000|NOT COMPLETED|Overall Study||1
2930583|NCT03630393|3641522|FG001|NOT COMPLETED|Overall Study||0
2930584|NCT03531788|3641530|FG000|STARTED|Overall Study||12
2930585|NCT03531788|3641531|FG001|STARTED|Overall Study||6
2930586|NCT03531788|3641530|FG000|COMPLETED|Overall Study||11
2930587|NCT03531788|3641531|FG001|COMPLETED|Overall Study||6
2930588|NCT03531788|3641530|FG000|NOT COMPLETED|Overall Study||1
2930589|NCT03531788|3641531|FG001|NOT COMPLETED|Overall Study||0
2930590|NCT03402230|3641537|FG000|STARTED|Overall Study||25
2930591|NCT03402230|3641538|FG001|STARTED|Overall Study||24
2930592|NCT03402230|3641537|FG000|COMPLETED|Overall Study||25
2930593|NCT03402230|3641538|FG001|COMPLETED|Overall Study||23
2930594|NCT03402230|3641537|FG000|NOT COMPLETED|Overall Study||0
2930595|NCT03402230|3641538|FG001|NOT COMPLETED|Overall Study||1
2930596|NCT03359811|3641545|FG000|STARTED|Overall Study||35
2930597|NCT03359811|3641546|FG001|STARTED|Overall Study||35
2930598|NCT03359811|3641545|FG000|COMPLETED|Overall Study||33
2930599|NCT03359811|3641546|FG001|COMPLETED|Overall Study||35
2930600|NCT03359811|3641545|FG000|NOT COMPLETED|Overall Study||2
2930601|NCT03359811|3641546|FG001|NOT COMPLETED|Overall Study||0
2930602|NCT03249714|3641555|FG000|STARTED|Double-blind Treatment (Core Part)||43
2930603|NCT03249714|3641556|FG001|STARTED|Double-blind Treatment (Core Part)||21
2930604|NCT03249714|3641555|FG000|COMPLETED|Double-blind Treatment (Core Part)||40
2930605|NCT03249714|3641556|FG001|COMPLETED|Double-blind Treatment (Core Part)||19
3179821|NCT01987349|3908048|FG002|STARTED|Overall Study||8
3179822|NCT01987349|3908049|FG003|STARTED|Overall Study||6
3179823|NCT01987349|3908050|FG004|STARTED|Overall Study||6
3179824|NCT01987349|3908051|FG005|STARTED|Overall Study||6
3179825|NCT01987349|3908052|FG006|STARTED|Overall Study||10
3179826|NCT01987349|3908053|FG007|STARTED|Overall Study||25
2930606|NCT03249714|3641555|FG000|NOT COMPLETED|Double-blind Treatment (Core Part)||3
2930607|NCT03249714|3641556|FG001|NOT COMPLETED|Double-blind Treatment (Core Part)||2
2930608|NCT03249714|3641555|FG000|STARTED|Open-label Treatment (Extension Part)||40
3179827|NCT01987349|3908046|FG000|COMPLETED|Overall Study||6
2930609|NCT03249714|3641556|FG001|STARTED|Open-label Treatment (Extension Part)||19
2930610|NCT03249714|3641555|FG000|COMPLETED|Open-label Treatment (Extension Part)||38
2930611|NCT03249714|3641556|FG001|COMPLETED|Open-label Treatment (Extension Part)||19
3179828|NCT01987349|3908047|FG001|COMPLETED|Overall Study||6
2930612|NCT03249714|3641555|FG000|NOT COMPLETED|Open-label Treatment (Extension Part)||2
2930613|NCT03249714|3641556|FG001|NOT COMPLETED|Open-label Treatment (Extension Part)||0
2930614|NCT03241589|3641580|FG000|STARTED|Overall Study||109
2930615|NCT03241589|3641581|FG001|STARTED|Overall Study||357
2930616|NCT03241589|3641580|FG000|COMPLETED|Overall Study||109
2930617|NCT03241589|3641581|FG001|COMPLETED|Overall Study||357
2930618|NCT03241589|3641580|FG000|NOT COMPLETED|Overall Study||0
2930619|NCT03241589|3641581|FG001|NOT COMPLETED|Overall Study||0
2930620|NCT03096834|3641591|FG000|STARTED|Double-Blind Treatment Epoch||121
2930621|NCT03096834|3641592|FG001|STARTED|Double-Blind Treatment Epoch||125
2930622|NCT03096834|3641593|FG002|STARTED|Double-Blind Treatment Epoch||0
2930623|NCT03096834|3641594|FG003|STARTED|Double-Blind Treatment Epoch||0
2930624|NCT03096834|3641591|FG000|COMPLETED|Double-Blind Treatment Epoch||118
2930625|NCT03096834|3641592|FG001|COMPLETED|Double-Blind Treatment Epoch||122
2930626|NCT03096834|3641593|FG002|COMPLETED|Double-Blind Treatment Epoch||0
2930627|NCT03096834|3641594|FG003|COMPLETED|Double-Blind Treatment Epoch||0
2930628|NCT03096834|3641591|FG000|NOT COMPLETED|Double-Blind Treatment Epoch||3
2930629|NCT03096834|3641592|FG001|NOT COMPLETED|Double-Blind Treatment Epoch||3
2930630|NCT03096834|3641593|FG002|NOT COMPLETED|Double-Blind Treatment Epoch||0
2930631|NCT03096834|3641594|FG003|NOT COMPLETED|Double-Blind Treatment Epoch||0
2930632|NCT03096834|3641591|FG000|STARTED|Open-Label Treatment Epoch||0
2930633|NCT03096834|3641592|FG001|STARTED|Open-Label Treatment Epoch||0
2930634|NCT03096834|3641593|FG002|STARTED|Open-Label Treatment Epoch||118
2930635|NCT03096834|3641594|FG003|STARTED|Open-Label Treatment Epoch||122
2930636|NCT03096834|3641591|FG000|COMPLETED|Open-Label Treatment Epoch||0
2930637|NCT03096834|3641592|FG001|COMPLETED|Open-Label Treatment Epoch||0
2930638|NCT03096834|3641593|FG002|COMPLETED|Open-Label Treatment Epoch||86
2930639|NCT03096834|3641594|FG003|COMPLETED|Open-Label Treatment Epoch||83
2930640|NCT03096834|3641591|FG000|NOT COMPLETED|Open-Label Treatment Epoch||0
2930641|NCT03096834|3641592|FG001|NOT COMPLETED|Open-Label Treatment Epoch||0
2930642|NCT03096834|3641593|FG002|NOT COMPLETED|Open-Label Treatment Epoch||32
2930643|NCT03096834|3641594|FG003|NOT COMPLETED|Open-Label Treatment Epoch||39
2930644|NCT03096834|3641591|FG000|STARTED|Safety Follow-Up Epoch||0
2930645|NCT03096834|3641592|FG001|STARTED|Safety Follow-Up Epoch||0
2930646|NCT03096834|3641593|FG002|STARTED|Safety Follow-Up Epoch||66
2930647|NCT03096834|3641594|FG003|STARTED|Safety Follow-Up Epoch||61
2930648|NCT03096834|3641591|FG000|COMPLETED|Safety Follow-Up Epoch||0
2930649|NCT03096834|3641592|FG001|COMPLETED|Safety Follow-Up Epoch||0
2930650|NCT03096834|3641593|FG002|COMPLETED|Safety Follow-Up Epoch||65
2930651|NCT03096834|3641594|FG003|COMPLETED|Safety Follow-Up Epoch||59
2930652|NCT03096834|3641591|FG000|NOT COMPLETED|Safety Follow-Up Epoch||0
2930653|NCT03096834|3641592|FG001|NOT COMPLETED|Safety Follow-Up Epoch||0
2930654|NCT03096834|3641593|FG002|NOT COMPLETED|Safety Follow-Up Epoch||1
2930655|NCT03096834|3641594|FG003|NOT COMPLETED|Safety Follow-Up Epoch||2
3041291|NCT01170221|3760982|FG001|NOT COMPLETED|Overall Study||28
3041292|NCT01170247|3760990|FG000|STARTED|Overall Study||2
3041293|NCT01170247|3760991|FG001|STARTED|Overall Study||1
3041294|NCT01170247|3760990|FG000|COMPLETED|Overall Study||2
3041295|NCT01170247|3760991|FG001|COMPLETED|Overall Study||1
3041296|NCT01170247|3760990|FG000|NOT COMPLETED|Overall Study||0
3041297|NCT01170247|3760991|FG001|NOT COMPLETED|Overall Study||0
3041298|NCT01170273|3760999|FG000|STARTED|Overall Study||64
3041299|NCT01170273|3761000|FG001|STARTED|Overall Study||66
3041300|NCT01170273|3760999|FG000|COMPLETED|Overall Study||56
3041301|NCT01170273|3761000|FG001|COMPLETED|Overall Study||57
3041302|NCT01170273|3760999|FG000|NOT COMPLETED|Overall Study||8
3041303|NCT01170273|3761000|FG001|NOT COMPLETED|Overall Study||9
3041304|NCT01170364|3761008|FG000|STARTED|Overall Study||8
3041305|NCT01170364|3761009|FG001|STARTED|Overall Study||6
3041306|NCT01170364|3761008|FG000|COMPLETED|Overall Study||4
3041307|NCT01170364|3761009|FG001|COMPLETED|Overall Study|One participant was unable to begin the second testing period due to scheduling conflicts.|5
3041308|NCT01170364|3761008|FG000|NOT COMPLETED|Overall Study||4
3179829|NCT01987349|3908048|FG002|COMPLETED|Overall Study||8
3179830|NCT01987349|3908049|FG003|COMPLETED|Overall Study||6
3179831|NCT01987349|3908050|FG004|COMPLETED|Overall Study||6
3179832|NCT01987349|3908051|FG005|COMPLETED|Overall Study||6
3179833|NCT01987349|3908052|FG006|COMPLETED|Overall Study||10
3179834|NCT01987349|3908053|FG007|COMPLETED|Overall Study||24
3179835|NCT01987349|3908046|FG000|NOT COMPLETED|Overall Study||0
3179836|NCT01987349|3908047|FG001|NOT COMPLETED|Overall Study||0
3041309|NCT01170364|3761009|FG001|NOT COMPLETED|Overall Study||1
3041310|NCT01170390|3761017|FG000|STARTED|Oral Contraceptives||32
3041311|NCT01170390|3761018|FG001|STARTED|Oral Contraceptives||0
3041312|NCT01170390|3761019|FG002|STARTED|Oral Contraceptives||0
3041313|NCT01170390|3761017|FG000|COMPLETED|Oral Contraceptives||31
3041314|NCT01170390|3761018|FG001|COMPLETED|Oral Contraceptives||0
3041315|NCT01170390|3761019|FG002|COMPLETED|Oral Contraceptives||0
3041316|NCT01170390|3761017|FG000|NOT COMPLETED|Oral Contraceptives||1
3041317|NCT01170390|3761018|FG001|NOT COMPLETED|Oral Contraceptives||0
3041318|NCT01170390|3761019|FG002|NOT COMPLETED|Oral Contraceptives||0
3041319|NCT01170390|3761017|FG000|STARTED|Randomized Treatment||0
3179837|NCT01987349|3908048|FG002|NOT COMPLETED|Overall Study||0
3179838|NCT01987349|3908049|FG003|NOT COMPLETED|Overall Study||0
3179839|NCT01987349|3908050|FG004|NOT COMPLETED|Overall Study||0
3179840|NCT01987349|3908051|FG005|NOT COMPLETED|Overall Study||0
3179841|NCT01987349|3908052|FG006|NOT COMPLETED|Overall Study||0
3179842|NCT01987349|3908053|FG007|NOT COMPLETED|Overall Study||1
3179843|NCT01987401|3908078|FG000|STARTED|Overall Study||591
3179844|NCT01987401|3908079|FG001|STARTED|Overall Study||591
2930656|NCT03096834|3641591|FG000|STARTED|Post-Trial Access Epoch||0
2930657|NCT03096834|3641592|FG001|STARTED|Post-Trial Access Epoch||0
2930658|NCT03096834|3641593|FG002|STARTED|Post-Trial Access Epoch||21
2930659|NCT03096834|3641594|FG003|STARTED|Post-Trial Access Epoch||15
2930660|NCT03096834|3641591|FG000|COMPLETED|Post-Trial Access Epoch||0
2930661|NCT03096834|3641592|FG001|COMPLETED|Post-Trial Access Epoch||0
2930662|NCT03096834|3641593|FG002|COMPLETED|Post-Trial Access Epoch||21
2930663|NCT03096834|3641594|FG003|COMPLETED|Post-Trial Access Epoch||15
2930664|NCT03096834|3641591|FG000|NOT COMPLETED|Post-Trial Access Epoch||0
2930665|NCT03096834|3641592|FG001|NOT COMPLETED|Post-Trial Access Epoch||0
2930666|NCT03096834|3641593|FG002|NOT COMPLETED|Post-Trial Access Epoch||0
2930667|NCT03096834|3641594|FG003|NOT COMPLETED|Post-Trial Access Epoch||0
2930668|NCT02959775|3641606|FG000|STARTED|Overall Study||160
2930669|NCT02959775|3641607|FG001|STARTED|Overall Study||160
2930670|NCT02959775|3641608|FG002|STARTED|Overall Study||160
2930671|NCT02959775|3641606|FG000|COMPLETED|Overall Study||133
2930672|NCT02959775|3641607|FG001|COMPLETED|Overall Study||133
2930673|NCT02959775|3641608|FG002|COMPLETED|Overall Study||124
2930674|NCT02959775|3641606|FG000|NOT COMPLETED|Overall Study||27
2930675|NCT02959775|3641607|FG001|NOT COMPLETED|Overall Study||27
2930676|NCT02959775|3641608|FG002|NOT COMPLETED|Overall Study||36
2930677|NCT02954406|3641627|FG000|STARTED|Overall Study||3
2930678|NCT02954406|3641628|FG001|STARTED|Overall Study||6
2930679|NCT02954406|3641629|FG002|STARTED|Overall Study||6
2930680|NCT02954406|3641630|FG003|STARTED|Overall Study||6
2930681|NCT02954406|3641631|FG004|STARTED|Overall Study||7
2930682|NCT02954406|3641632|FG005|STARTED|Overall Study||3
2930683|NCT02954406|3641633|FG006|STARTED|Overall Study||3
2930684|NCT02954406|3641634|FG007|STARTED|Overall Study||2
2930685|NCT02954406|3641635|FG008|STARTED|Overall Study||4
2930686|NCT02954406|3641636|FG009|STARTED|Overall Study||3
2930687|NCT02954406|3641637|FG010|STARTED|Overall Study||0
2930688|NCT02954406|3641627|FG000|COMPLETED|Overall Study||0
2930689|NCT02954406|3641628|FG001|COMPLETED|Overall Study||0
2930690|NCT02954406|3641629|FG002|COMPLETED|Overall Study||0
2930691|NCT02954406|3641630|FG003|COMPLETED|Overall Study||0
2930692|NCT02954406|3641631|FG004|COMPLETED|Overall Study||0
2930693|NCT02954406|3641632|FG005|COMPLETED|Overall Study||0
2930694|NCT02954406|3641633|FG006|COMPLETED|Overall Study||0
2930695|NCT02954406|3641634|FG007|COMPLETED|Overall Study||0
2930696|NCT02954406|3641635|FG008|COMPLETED|Overall Study||0
2930697|NCT02954406|3641636|FG009|COMPLETED|Overall Study||0
2930698|NCT02954406|3641637|FG010|COMPLETED|Overall Study||0
2930699|NCT02954406|3641627|FG000|NOT COMPLETED|Overall Study||3
2930700|NCT02954406|3641628|FG001|NOT COMPLETED|Overall Study||6
2930701|NCT02954406|3641629|FG002|NOT COMPLETED|Overall Study||6
2930702|NCT02954406|3641630|FG003|NOT COMPLETED|Overall Study||6
2930703|NCT02954406|3641631|FG004|NOT COMPLETED|Overall Study||7
2930704|NCT02954406|3641632|FG005|NOT COMPLETED|Overall Study||3
2930705|NCT02954406|3641633|FG006|NOT COMPLETED|Overall Study||3
2930706|NCT02954406|3641634|FG007|NOT COMPLETED|Overall Study||2
2930707|NCT02954406|3641635|FG008|NOT COMPLETED|Overall Study||4
2930708|NCT02954406|3641636|FG009|NOT COMPLETED|Overall Study||3
2930709|NCT02954406|3641637|FG010|NOT COMPLETED|Overall Study||0
2930710|NCT02927145|3641672|FG000|STARTED|Initial Recruitment||12
2930711|NCT02927145|3641673|FG001|STARTED|Initial Recruitment||12
2930712|NCT02927145|3641674|FG002|STARTED|Initial Recruitment||12
2930713|NCT02927145|3641675|FG003|STARTED|Initial Recruitment||14
2930714|NCT02927145|3641676|FG004|STARTED|Initial Recruitment||17
2930715|NCT02927145|3641677|FG005|STARTED|Initial Recruitment||15
3041320|NCT01170390|3761018|FG001|STARTED|Randomized Treatment||17
3041321|NCT01170390|3761019|FG002|STARTED|Randomized Treatment||15
3041322|NCT01170390|3761017|FG000|COMPLETED|Randomized Treatment||0
3041323|NCT01170390|3761018|FG001|COMPLETED|Randomized Treatment||16
3041324|NCT01170390|3761019|FG002|COMPLETED|Randomized Treatment||15
3041325|NCT01170390|3761017|FG000|NOT COMPLETED|Randomized Treatment||0
3041326|NCT01170390|3761018|FG001|NOT COMPLETED|Randomized Treatment||1
3041327|NCT01170390|3761019|FG002|NOT COMPLETED|Randomized Treatment||0
3041328|NCT01170533|3761027|FG000|STARTED|Omeprazole Cross-over||20
3041329|NCT01170533|3761028|FG001|STARTED|Omeprazole Cross-over||0
3041330|NCT01170533|3761027|FG000|COMPLETED|Omeprazole Cross-over||20
3041331|NCT01170533|3761028|FG001|COMPLETED|Omeprazole Cross-over||0
3041332|NCT01170533|3761027|FG000|NOT COMPLETED|Omeprazole Cross-over||0
3041333|NCT01170533|3761028|FG001|NOT COMPLETED|Omeprazole Cross-over||0
3041334|NCT01170533|3761027|FG000|STARTED|Pantoprazole Cross-over||0
3041335|NCT01170533|3761028|FG001|STARTED|Pantoprazole Cross-over|15 participants continued from omeprazole cross-over; the remaining 5 were new participants|20
2930716|NCT02927145|3641678|FG006|STARTED|Initial Recruitment||0
2930717|NCT02927145|3641679|FG007|STARTED|Initial Recruitment||0
2930718|NCT02927145|3641680|FG008|STARTED|Initial Recruitment||6
2930719|NCT02927145|3641672|FG000|COMPLETED|Initial Recruitment||12
2930720|NCT02927145|3641673|FG001|COMPLETED|Initial Recruitment||11
2930721|NCT02927145|3641674|FG002|COMPLETED|Initial Recruitment||11
2930722|NCT02927145|3641675|FG003|COMPLETED|Initial Recruitment||10
2930723|NCT02927145|3641676|FG004|COMPLETED|Initial Recruitment||14
2930724|NCT02927145|3641677|FG005|COMPLETED|Initial Recruitment||14
2930725|NCT02927145|3641678|FG006|COMPLETED|Initial Recruitment||0
2930726|NCT02927145|3641679|FG007|COMPLETED|Initial Recruitment||0
2930727|NCT02927145|3641680|FG008|COMPLETED|Initial Recruitment||4
2930728|NCT02927145|3641672|FG000|NOT COMPLETED|Initial Recruitment||0
2930729|NCT02927145|3641673|FG001|NOT COMPLETED|Initial Recruitment||1
2930730|NCT02927145|3641674|FG002|NOT COMPLETED|Initial Recruitment||1
2930731|NCT02927145|3641675|FG003|NOT COMPLETED|Initial Recruitment||4
2930732|NCT02927145|3641676|FG004|NOT COMPLETED|Initial Recruitment||3
2930733|NCT02927145|3641677|FG005|NOT COMPLETED|Initial Recruitment||1
2930734|NCT02927145|3641678|FG006|NOT COMPLETED|Initial Recruitment||0
2930735|NCT02927145|3641679|FG007|NOT COMPLETED|Initial Recruitment||0
2930736|NCT02927145|3641680|FG008|NOT COMPLETED|Initial Recruitment||2
2930737|NCT02927145|3641672|FG000|STARTED|Invitation for Additional Challenge||0
2930738|NCT02927145|3641673|FG001|STARTED|Invitation for Additional Challenge||0
2930739|NCT02927145|3641674|FG002|STARTED|Invitation for Additional Challenge||0
2930740|NCT02927145|3641675|FG003|STARTED|Invitation for Additional Challenge||0
2930741|NCT02927145|3641676|FG004|STARTED|Invitation for Additional Challenge||0
2930742|NCT02927145|3641677|FG005|STARTED|Invitation for Additional Challenge||0
2930743|NCT02927145|3641678|FG006|STARTED|Invitation for Additional Challenge||9
2930744|NCT02927145|3641679|FG007|STARTED|Invitation for Additional Challenge||8
2930745|NCT02927145|3641680|FG008|STARTED|Invitation for Additional Challenge||0
2930746|NCT02927145|3641672|FG000|COMPLETED|Invitation for Additional Challenge||0
2930747|NCT02927145|3641673|FG001|COMPLETED|Invitation for Additional Challenge||0
2930748|NCT02927145|3641674|FG002|COMPLETED|Invitation for Additional Challenge||0
2930749|NCT02927145|3641675|FG003|COMPLETED|Invitation for Additional Challenge||0
2930750|NCT02927145|3641676|FG004|COMPLETED|Invitation for Additional Challenge||0
2930751|NCT02927145|3641677|FG005|COMPLETED|Invitation for Additional Challenge||0
2930752|NCT02927145|3641678|FG006|COMPLETED|Invitation for Additional Challenge||8
2930753|NCT02927145|3641679|FG007|COMPLETED|Invitation for Additional Challenge||8
2930754|NCT02927145|3641680|FG008|COMPLETED|Invitation for Additional Challenge||0
2930755|NCT02927145|3641672|FG000|NOT COMPLETED|Invitation for Additional Challenge||0
2930756|NCT02927145|3641673|FG001|NOT COMPLETED|Invitation for Additional Challenge||0
2930757|NCT02927145|3641674|FG002|NOT COMPLETED|Invitation for Additional Challenge||0
2930758|NCT02927145|3641675|FG003|NOT COMPLETED|Invitation for Additional Challenge||0
2930759|NCT02927145|3641676|FG004|NOT COMPLETED|Invitation for Additional Challenge||0
3179845|NCT01987401|3908080|FG002|STARTED|Overall Study||60
3179846|NCT01987401|3908078|FG000|COMPLETED|Overall Study||137
3179847|NCT01987401|3908079|FG001|COMPLETED|Overall Study||121
2930760|NCT02927145|3641677|FG005|NOT COMPLETED|Invitation for Additional Challenge||0
2930761|NCT02927145|3641678|FG006|NOT COMPLETED|Invitation for Additional Challenge||1
2930762|NCT02927145|3641679|FG007|NOT COMPLETED|Invitation for Additional Challenge||0
2930763|NCT02927145|3641680|FG008|NOT COMPLETED|Invitation for Additional Challenge||0
3041336|NCT01170533|3761027|FG000|COMPLETED|Pantoprazole Cross-over||0
3041337|NCT01170533|3761028|FG001|COMPLETED|Pantoprazole Cross-over||20
3041338|NCT01170533|3761027|FG000|NOT COMPLETED|Pantoprazole Cross-over||0
3041339|NCT01170533|3761028|FG001|NOT COMPLETED|Pantoprazole Cross-over||0
3179848|NCT01987401|3908080|FG002|COMPLETED|Overall Study||16
2930764|NCT02910583|3641703|FG000|STARTED|Overall Study||159
2930765|NCT02910583|3641704|FG001|STARTED|Overall Study||164
2930766|NCT02910583|3641703|FG000|MRD Cohort/ Not Randomized|Overall Study|Not applicable to this cohort.|0
2930767|NCT02910583|3641704|FG001|MRD Cohort/ Not Randomized|Overall Study||15
2930768|NCT02910583|3641703|FG000|MRD Cohort/ Confirmed uMRD: Randomized to Ibrutinib (Blinded)|Overall Study|Not applicable to this cohort.|0
2930769|NCT02910583|3641704|FG001|MRD Cohort/ Confirmed uMRD: Randomized to Ibrutinib (Blinded)|Overall Study||43
2930770|NCT02910583|3641703|FG000|MRD Cohort/ Confirmed uMRD: Randomized Placebo (Blinded)|Overall Study|Not applicable to this cohort.|0
2930771|NCT02910583|3641704|FG001|MRD Cohort/ Confirmed uMRD: Randomized Placebo (Blinded)|Overall Study||43
2930772|NCT02910583|3641703|FG000|MRD Cohort/uMRD Not Confirmed: Randomized to Ibrutinib (Open-Label)|Overall Study|Not applicable to this cohort.|0
2930773|NCT02910583|3641704|FG001|MRD Cohort/uMRD Not Confirmed: Randomized to Ibrutinib (Open-Label)|Overall Study||31
2930774|NCT02910583|3641703|FG000|MRD Cohort/uMRD Not Confirmed: Randomized Ibrutinib + Venetoclax (Open-Label)|Overall Study|Not applicable to this cohort.|0
2930775|NCT02910583|3641704|FG001|MRD Cohort/uMRD Not Confirmed: Randomized Ibrutinib + Venetoclax (Open-Label)|Overall Study||32
2930776|NCT02910583|3641703|FG000|COMPLETED|Overall Study||152
2930777|NCT02910583|3641704|FG001|COMPLETED|Overall Study||157
2930778|NCT02910583|3641703|FG000|NOT COMPLETED|Overall Study||7
2930779|NCT02910583|3641704|FG001|NOT COMPLETED|Overall Study||7
2930780|NCT02699060|3641741|FG000|STARTED|Overall Study||68
2930781|NCT02699060|3641741|FG000|COMPLETED|Overall Study||68
2930782|NCT02699060|3641741|FG000|NOT COMPLETED|Overall Study||0
2930783|NCT02598388|3641761|FG000|STARTED|Overall Study||40
2930784|NCT02598388|3641762|FG001|STARTED|Overall Study||10
2930785|NCT02598388|3641763|FG002|STARTED|Overall Study||20
2930786|NCT02598388|3641764|FG003|STARTED|Overall Study||5
2930787|NCT02598388|3641765|FG004|STARTED|Overall Study||161
2930788|NCT02598388|3641766|FG005|STARTED|Overall Study||39
2930789|NCT02598388|3641767|FG006|STARTED|Overall Study||161
2930790|NCT02598388|3641768|FG007|STARTED|Overall Study||39
2930791|NCT02598388|3641769|FG008|STARTED|Overall Study||39
2930792|NCT02598388|3641770|FG009|STARTED|Overall Study||10
2930793|NCT02598388|3641771|FG010|STARTED|Overall Study||40
2930794|NCT02598388|3641772|FG011|STARTED|Overall Study||10
2930795|NCT02598388|3641761|FG000|COMPLETED|Overall Study||39
2930796|NCT02598388|3641762|FG001|COMPLETED|Overall Study||10
2930797|NCT02598388|3641763|FG002|COMPLETED|Overall Study||18
2930798|NCT02598388|3641764|FG003|COMPLETED|Overall Study||5
2930799|NCT02598388|3641765|FG004|COMPLETED|Overall Study||151
2930800|NCT02598388|3641766|FG005|COMPLETED|Overall Study||38
2930801|NCT02598388|3641767|FG006|COMPLETED|Overall Study||156
2930802|NCT02598388|3641768|FG007|COMPLETED|Overall Study||38
2930803|NCT02598388|3641769|FG008|COMPLETED|Overall Study||39
2930804|NCT02598388|3641770|FG009|COMPLETED|Overall Study||9
2930805|NCT02598388|3641771|FG010|COMPLETED|Overall Study||39
2930806|NCT02598388|3641772|FG011|COMPLETED|Overall Study||10
2930807|NCT02598388|3641761|FG000|NOT COMPLETED|Overall Study||1
2930808|NCT02598388|3641762|FG001|NOT COMPLETED|Overall Study||0
2930809|NCT02598388|3641763|FG002|NOT COMPLETED|Overall Study||2
2930810|NCT02598388|3641764|FG003|NOT COMPLETED|Overall Study||0
2930811|NCT02598388|3641765|FG004|NOT COMPLETED|Overall Study||10
2930812|NCT02598388|3641766|FG005|NOT COMPLETED|Overall Study||1
2930813|NCT02598388|3641767|FG006|NOT COMPLETED|Overall Study||5
2930814|NCT02598388|3641768|FG007|NOT COMPLETED|Overall Study||1
2930815|NCT02598388|3641769|FG008|NOT COMPLETED|Overall Study||0
2930816|NCT02598388|3641770|FG009|NOT COMPLETED|Overall Study||1
2930817|NCT02598388|3641771|FG010|NOT COMPLETED|Overall Study||1
2930818|NCT02598388|3641772|FG011|NOT COMPLETED|Overall Study||0
2930819|NCT02493751|3641805|FG000|STARTED|Overall Study||16
2930820|NCT02493751|3641806|FG001|STARTED|Overall Study||39
2930821|NCT02493751|3641805|FG000|COMPLETED|Overall Study||0
2930822|NCT02493751|3641806|FG001|COMPLETED|Overall Study||0
2930823|NCT02493751|3641805|FG000|NOT COMPLETED|Overall Study||16
2930824|NCT02493751|3641806|FG001|NOT COMPLETED|Overall Study||39
2930825|NCT02285166|3641813|FG000|STARTED|Overall Study||15330
2930826|NCT02285166|3641813|FG000|COMPLETED|Overall Study||14364
2930827|NCT02285166|3641813|FG000|NOT COMPLETED|Overall Study||966
2930828|NCT02278120|3641821|FG000|STARTED|Overall Study||335
2930829|NCT02278120|3641822|FG001|STARTED|Overall Study||337
2930830|NCT02278120|3641821|FG000|COMPLETED|Overall Study||174
2930831|NCT02278120|3641822|FG001|COMPLETED|Overall Study||121
2930832|NCT02278120|3641821|FG000|NOT COMPLETED|Overall Study||161
2930833|NCT02278120|3641822|FG001|NOT COMPLETED|Overall Study||216
3041340|NCT01170546|3761042|FG000|STARTED|Overall Study||7
3041341|NCT01170546|3761043|FG001|STARTED|Overall Study||7
3041342|NCT01170546|3761044|FG002|STARTED|Overall Study||6
3041343|NCT01170546|3761045|FG003|STARTED|Overall Study||8
3041344|NCT01170546|3761042|FG000|COMPLETED|Overall Study||7
3041345|NCT01170546|3761043|FG001|COMPLETED|Overall Study||7
3041346|NCT01170546|3761044|FG002|COMPLETED|Overall Study||6
3041347|NCT01170546|3761045|FG003|COMPLETED|Overall Study||8
3041348|NCT01170546|3761042|FG000|NOT COMPLETED|Overall Study||0
3041349|NCT01170546|3761043|FG001|NOT COMPLETED|Overall Study||0
3041350|NCT01170546|3761044|FG002|NOT COMPLETED|Overall Study||0
3041351|NCT01170546|3761045|FG003|NOT COMPLETED|Overall Study||0
3041352|NCT01170598|3761055|FG000|STARTED|Overall Study||35
3041353|NCT01170598|3761055|FG000|COMPLETED|Overall Study||29
3041354|NCT01170598|3761055|FG000|NOT COMPLETED|Overall Study||6
3041355|NCT01170663|3761061|FG000|STARTED|Overall Study|Participant was included in ramucirumab (IMC-1121B)/paclitaxel treatment arm (safety population).|330
3041356|NCT01170663|3761062|FG001|STARTED|Overall Study|Participant was included in the placebo/paclitaxel treatment arm (intent-to-treat (ITT) population).|335
3041357|NCT01170663|3761061|FG000|Received Any Treatment (Safety Pop)|Overall Study||327
3041358|NCT01170663|3761062|FG001|Received Any Treatment (Safety Pop)|Overall Study||329
3041359|NCT01170663|3761061|FG000|COMPLETED|Overall Study||316
3041360|NCT01170663|3761062|FG001|COMPLETED|Overall Study||315
3041361|NCT01170663|3761061|FG000|NOT COMPLETED|Overall Study||14
3041362|NCT01170663|3761062|FG001|NOT COMPLETED|Overall Study||20
3041363|NCT01170715|3761068|FG000|STARTED|Overall Study||21
3041364|NCT01170715|3761068|FG000|COMPLETED|Overall Study||14
3041365|NCT01170715|3761068|FG000|NOT COMPLETED|Overall Study||7
3041366|NCT01170754|3761074|FG000|STARTED|Overall Study||66
3041367|NCT01170754|3761075|FG001|STARTED|Overall Study||70
3041368|NCT01170754|3761074|FG000|COMPLETED|Overall Study||66
3041369|NCT01170754|3761075|FG001|COMPLETED|Overall Study||70
3041370|NCT01170754|3761074|FG000|NOT COMPLETED|Overall Study||0
3041371|NCT01170754|3761075|FG001|NOT COMPLETED|Overall Study||0
3041372|NCT01170884|3761085|FG000|STARTED|Overall Study||59
3041373|NCT01170884|3761086|FG001|STARTED|Overall Study||62
3041374|NCT01170884|3761085|FG000|COMPLETED|Overall Study||54
3041375|NCT01170884|3761086|FG001|COMPLETED|Overall Study||60
3041376|NCT01170884|3761085|FG000|NOT COMPLETED|Overall Study||5
3041377|NCT01170884|3761086|FG001|NOT COMPLETED|Overall Study||2
3041378|NCT01170949|3761094|FG000|STARTED|Overall Study||50
3041379|NCT01170949|3761095|FG001|STARTED|Overall Study||26
3363468|NCT04069221|4094593|FG002|STARTED|Overall Study||6
3363469|NCT04069221|4094594|FG003|STARTED|Overall Study||6
3363470|NCT04069221|4094591|FG000|COMPLETED|Overall Study||8
3363471|NCT04069221|4094592|FG001|COMPLETED|Overall Study||6
3363472|NCT04069221|4094593|FG002|COMPLETED|Overall Study||6
3363473|NCT04069221|4094594|FG003|COMPLETED|Overall Study||6
3363474|NCT04069221|4094591|FG000|NOT COMPLETED|Overall Study||0
3363475|NCT04069221|4094592|FG001|NOT COMPLETED|Overall Study||0
3363476|NCT04069221|4094593|FG002|NOT COMPLETED|Overall Study||0
3363477|NCT04069221|4094594|FG003|NOT COMPLETED|Overall Study||0
3363478|NCT04067141|4094604|FG000|STARTED|First Intervention||35
3363479|NCT04067141|4094605|FG001|STARTED|First Intervention||35
3363480|NCT04067141|4094604|FG000|COMPLETED|First Intervention||35
3363481|NCT04067141|4094605|FG001|COMPLETED|First Intervention||34
3363482|NCT04067141|4094604|FG000|NOT COMPLETED|First Intervention||0
3363483|NCT04067141|4094605|FG001|NOT COMPLETED|First Intervention||1
3363484|NCT04067141|4094604|FG000|STARTED|Second Intervention|Unacceptable lens fit at dispense. One withdrawal by subject.|34
3363485|NCT04067141|4094605|FG001|STARTED|Second Intervention|Unacceptable lens fit at dispense. One withdrawal by subject|33
3363486|NCT04067141|4094604|FG000|COMPLETED|Second Intervention||34
3363487|NCT04067141|4094605|FG001|COMPLETED|Second Intervention||31
3363488|NCT04067141|4094604|FG000|NOT COMPLETED|Second Intervention||0
3363489|NCT04067141|4094605|FG001|NOT COMPLETED|Second Intervention||2
3363490|NCT04049578|4094611|FG000|STARTED|Overall Study||2
3179849|NCT01987401|3908078|FG000|NOT COMPLETED|Overall Study||454
3179850|NCT01987401|3908079|FG001|NOT COMPLETED|Overall Study||470
3179851|NCT01987401|3908080|FG002|NOT COMPLETED|Overall Study||44
3179852|NCT01987414|3908090|FG000|STARTED|Overall Study||10
3179853|NCT01987414|3908091|FG001|STARTED|Overall Study||8
2930834|NCT02075593|3641828|FG000|STARTED|Overall Study||4
2930835|NCT02075593|3641828|FG000|Infants Born to Pregnant Women Who Received at Least One Dose of Study Treatment|Overall Study||4
2930836|NCT02075593|3641828|FG000|COMPLETED|Overall Study||1
2930837|NCT02075593|3641828|FG000|NOT COMPLETED|Overall Study||3
2930838|NCT01856140|3641836|FG000|STARTED|Overall Study||6
2930839|NCT01856140|3641837|FG001|STARTED|Overall Study||6
2930840|NCT01856140|3641836|FG000|COMPLETED|Overall Study||6
2930841|NCT01856140|3641837|FG001|COMPLETED|Overall Study||6
2930842|NCT01856140|3641836|FG000|NOT COMPLETED|Overall Study||0
2930843|NCT01856140|3641837|FG001|NOT COMPLETED|Overall Study||0
2930844|NCT00587860|3641845|FG000|STARTED|Overall Study||35
2930845|NCT00587860|3641846|FG001|STARTED|Overall Study||35
2930846|NCT00587860|3641845|FG000|COMPLETED|Overall Study||30
2930847|NCT00587860|3641846|FG001|COMPLETED|Overall Study||30
2930848|NCT00587860|3641845|FG000|NOT COMPLETED|Overall Study||5
2930849|NCT00587860|3641846|FG001|NOT COMPLETED|Overall Study||5
2930850|NCT00587964|3641852|FG000|STARTED|Overall Study||51
3041380|NCT01170949|3761094|FG000|COMPLETED|Overall Study||43
3041381|NCT01170949|3761095|FG001|COMPLETED|Overall Study||22
3041382|NCT01170949|3761094|FG000|NOT COMPLETED|Overall Study||7
3041383|NCT01170949|3761095|FG001|NOT COMPLETED|Overall Study||4
3041384|NCT01170962|3761104|FG000|STARTED|Treatment Period||203
3041385|NCT01170962|3761105|FG001|STARTED|Treatment Period||199
3041386|NCT01170962|3761106|FG002|STARTED|Treatment Period||17
3041387|NCT01170962|3761104|FG000|No PDR|Treatment Period||145
3041388|NCT01170962|3761105|FG001|No PDR|Treatment Period||127
3041389|NCT01170962|3761106|FG002|No PDR|Treatment Period||17
3363491|NCT04049578|4094611|FG000|COMPLETED|Overall Study||1
3363492|NCT04049578|4094611|FG000|NOT COMPLETED|Overall Study||1
3363493|NCT04067401|4094617|FG000|STARTED|Overall Study||748
3363494|NCT04067401|4094618|FG001|STARTED|Overall Study||737
3363495|NCT04067401|4094617|FG000|Baseline Survey Completion|Overall Study||746
3363496|NCT04067401|4094618|FG001|Baseline Survey Completion|Overall Study||735
3363497|NCT04067401|4094617|FG000|1 Month Survey Completion|Overall Study||697
3363498|NCT04067401|4094618|FG001|1 Month Survey Completion|Overall Study||694
3363499|NCT04067401|4094617|FG000|6 Month Survey Completion|Overall Study||629
3363500|NCT04067401|4094618|FG001|6 Month Survey Completion|Overall Study||618
2930851|NCT00587964|3641852|FG000|COMPLETED|Overall Study||39
2930852|NCT00587964|3641852|FG000|NOT COMPLETED|Overall Study||12
2930853|NCT00587990|3641859|FG000|STARTED|Overall Study||2
2930854|NCT00587990|3641860|FG001|STARTED|Overall Study||4
2930855|NCT00587990|3641861|FG002|STARTED|Overall Study||3
2930856|NCT00587990|3641859|FG000|COMPLETED|Overall Study||2
2930857|NCT00587990|3641860|FG001|COMPLETED|Overall Study||4
2930858|NCT00587990|3641861|FG002|COMPLETED|Overall Study||2
2930859|NCT00587990|3641859|FG000|NOT COMPLETED|Overall Study||0
2930860|NCT00587990|3641860|FG001|NOT COMPLETED|Overall Study||0
2930861|NCT00587990|3641861|FG002|NOT COMPLETED|Overall Study||1
2930862|NCT00588094|3641869|FG000|STARTED|Overall Study||20
2930863|NCT00588094|3641869|FG000|COMPLETED|Overall Study||15
2930864|NCT00588094|3641869|FG000|NOT COMPLETED|Overall Study||5
2930865|NCT00588159|3641875|FG000|STARTED|Overall Study||72
2930866|NCT00588159|3641876|FG001|STARTED|Overall Study||74
2930867|NCT00588159|3641875|FG000|COMPLETED|Overall Study||57
2930868|NCT00588159|3641876|FG001|COMPLETED|Overall Study||63
2930869|NCT00588159|3641875|FG000|NOT COMPLETED|Overall Study||15
2930870|NCT00588159|3641876|FG001|NOT COMPLETED|Overall Study||11
2930871|NCT00588237|3641882|FG000|STARTED|Overall Study||42
2930872|NCT00588237|3641882|FG000|COMPLETED|Overall Study||38
2930873|NCT00588237|3641882|FG000|NOT COMPLETED|Overall Study||4
2930874|NCT00588341|3641886|FG000|STARTED|Overall Study||24
2930875|NCT00588341|3641886|FG000|COMPLETED|Overall Study||19
2930876|NCT00588341|3641886|FG000|NOT COMPLETED|Overall Study||5
2930877|NCT00588354|3641892|FG000|STARTED|Baseline to 2 Weeks||11
2930878|NCT00588354|3641893|FG001|STARTED|Baseline to 2 Weeks||15
2930879|NCT00588354|3641892|FG000|COMPLETED|Baseline to 2 Weeks||9
2930880|NCT00588354|3641893|FG001|COMPLETED|Baseline to 2 Weeks||15
2930881|NCT00588354|3641892|FG000|NOT COMPLETED|Baseline to 2 Weeks||2
2930882|NCT00588354|3641893|FG001|NOT COMPLETED|Baseline to 2 Weeks||0
2930883|NCT00588354|3641892|FG000|STARTED|Baseline to 4 Weeks||9
2930884|NCT00588354|3641893|FG001|STARTED|Baseline to 4 Weeks||15
2930885|NCT00588354|3641892|FG000|COMPLETED|Baseline to 4 Weeks||9
2930886|NCT00588354|3641893|FG001|COMPLETED|Baseline to 4 Weeks||14
2930887|NCT00588354|3641892|FG000|NOT COMPLETED|Baseline to 4 Weeks||0
2930888|NCT00588354|3641893|FG001|NOT COMPLETED|Baseline to 4 Weeks||1
2930889|NCT00588380|3641900|FG000|STARTED|Overall Study||88
2930890|NCT00588380|3641900|FG000|COMPLETED|Overall Study||88
2930891|NCT00588380|3641900|FG000|NOT COMPLETED|Overall Study||0
2930892|NCT00588406|3641907|FG000|STARTED|Overall Study||46
2930893|NCT00588406|3641908|FG001|STARTED|Overall Study||49
3041390|NCT01170962|3761104|FG000|PDR -Randomized to 24 Weeks pegIFNα--2a|Treatment Period||30
3041391|NCT01170962|3761105|FG001|PDR -Randomized to 24 Weeks pegIFNα--2a|Treatment Period||36
3041392|NCT01170962|3761106|FG002|PDR -Randomized to 24 Weeks pegIFNα--2a|Treatment Period||0
3041393|NCT01170962|3761104|FG000|PDR -Randomized to 48 Weeks Follow--up|Treatment Period||28
3041394|NCT01170962|3761105|FG001|PDR -Randomized to 48 Weeks Follow--up|Treatment Period||36
3041395|NCT01170962|3761106|FG002|PDR -Randomized to 48 Weeks Follow--up|Treatment Period||0
3041396|NCT01170962|3761104|FG000|COMPLETED|Treatment Period||76
3041397|NCT01170962|3761105|FG001|COMPLETED|Treatment Period||88
3041398|NCT01170962|3761106|FG002|COMPLETED|Treatment Period||5
3041399|NCT01170962|3761104|FG000|NOT COMPLETED|Treatment Period||127
3041400|NCT01170962|3761105|FG001|NOT COMPLETED|Treatment Period||111
3041401|NCT01170962|3761106|FG002|NOT COMPLETED|Treatment Period||12
3041402|NCT01170962|3761104|FG000|STARTED|Follow up Period|Out of 203 participants who entered the treatment period, 198 continued in the follow-up period.|198
3041403|NCT01170962|3761105|FG001|STARTED|Follow up Period|Out of 199 participants who entered the treatment period, 192 continued in the follow-up period.|192
3041404|NCT01170962|3761106|FG002|STARTED|Follow up Period|Out of 17 participants who entered the treatment period, 15 continued in the follow-up period.|15
3041405|NCT01170962|3761104|FG000|COMPLETED|Follow up Period||159
3041406|NCT01170962|3761105|FG001|COMPLETED|Follow up Period||165
3041407|NCT01170962|3761106|FG002|COMPLETED|Follow up Period||9
3041408|NCT01170962|3761104|FG000|NOT COMPLETED|Follow up Period||39
3041409|NCT01170962|3761105|FG001|NOT COMPLETED|Follow up Period||27
3041410|NCT01170962|3761106|FG002|NOT COMPLETED|Follow up Period||6
3041411|NCT01171118|3761123|FG000|STARTED|Overall Study||10
3041412|NCT01171118|3761123|FG000|COMPLETED|Overall Study||10
3041413|NCT01171118|3761123|FG000|NOT COMPLETED|Overall Study||0
3041414|NCT01171183|3761135|FG000|STARTED|Residential Facility (Weeks 1-2)|Those who were admitted to the residential facility and received at least one dose of study med.|15
3041415|NCT01171183|3761136|FG001|STARTED|Residential Facility (Weeks 1-2)|Subjects receiving at least one dose of study med. One did not due to BP outside study parameters.|16
3041416|NCT01171183|3761135|FG000|COMPLETED|Residential Facility (Weeks 1-2)||13
3041417|NCT01171183|3761136|FG001|COMPLETED|Residential Facility (Weeks 1-2)||10
3041418|NCT01171183|3761135|FG000|NOT COMPLETED|Residential Facility (Weeks 1-2)||2
3041419|NCT01171183|3761136|FG001|NOT COMPLETED|Residential Facility (Weeks 1-2)||6
3041420|NCT01171183|3761135|FG000|STARTED|Outpatient Participation (Weeks 3-10)|One subject completed the residential stay but withdrew prior to starting the outpatient phase.|12
3041421|NCT01171183|3761136|FG001|STARTED|Outpatient Participation (Weeks 3-10)|One subject completed the residential stay but was discharged due to protocol noncompliance.|9
3041422|NCT01171183|3761135|FG000|COMPLETED|Outpatient Participation (Weeks 3-10)||2
3041423|NCT01171183|3761136|FG001|COMPLETED|Outpatient Participation (Weeks 3-10)||4
3041424|NCT01171183|3761135|FG000|NOT COMPLETED|Outpatient Participation (Weeks 3-10)||10
3041425|NCT01171183|3761136|FG001|NOT COMPLETED|Outpatient Participation (Weeks 3-10)||5
3041426|NCT01171521|3761142|FG000|STARTED|Overall Study||6
3041427|NCT01171521|3761142|FG000|COMPLETED|Overall Study||0
3041428|NCT01171521|3761142|FG000|NOT COMPLETED|Overall Study||6
3041429|NCT01171612|3761146|FG000|STARTED|Overall Study||483
3041430|NCT01171612|3761146|FG000|COMPLETED|Overall Study||432
3041431|NCT01171612|3761146|FG000|NOT COMPLETED|Overall Study||51
3041432|NCT01171625|3761153|FG000|STARTED|Overall Study||283
3041433|NCT01171625|3761153|FG000|Subjects Implanted With Device|Overall Study||258
3041434|NCT01171625|3761153|FG000|COMPLETED|Overall Study||103
3041435|NCT01171625|3761153|FG000|NOT COMPLETED|Overall Study||180
3041436|NCT01171677|3761167|FG000|STARTED|Overall Study||17
3041437|NCT01171677|3761168|FG001|STARTED|Overall Study||15
3041438|NCT01171677|3761167|FG000|COMPLETED|Overall Study||11
3041439|NCT01171677|3761168|FG001|COMPLETED|Overall Study||12
3041440|NCT01171677|3761167|FG000|NOT COMPLETED|Overall Study||6
3041441|NCT01171677|3761168|FG001|NOT COMPLETED|Overall Study||3
3041442|NCT01171690|3761176|FG000|STARTED|Overall Study||5
3179854|NCT01987414|3908090|FG000|COMPLETED|Overall Study||8
3179855|NCT01987414|3908091|FG001|COMPLETED|Overall Study||6
3179856|NCT01987414|3908090|FG000|NOT COMPLETED|Overall Study||2
3179857|NCT01987414|3908091|FG001|NOT COMPLETED|Overall Study||2
3179858|NCT01987427|3908100|FG000|STARTED|Overall Study||78
3179859|NCT01987427|3908101|FG001|STARTED|Overall Study||78
3179860|NCT01987427|3908102|FG002|STARTED|Overall Study||79
3179861|NCT01987427|3908100|FG000|COMPLETED|Overall Study||64
2930894|NCT00588406|3641907|FG000|COMPLETED|Overall Study||46
2930895|NCT00588406|3641908|FG001|COMPLETED|Overall Study||49
2930896|NCT00588406|3641907|FG000|NOT COMPLETED|Overall Study||0
2930897|NCT00588406|3641908|FG001|NOT COMPLETED|Overall Study||0
2930898|NCT00588445|3641914|FG000|STARTED|Overall Study||65
2930899|NCT00588445|3641914|FG000|COMPLETED|Overall Study||50
2930900|NCT00588445|3641914|FG000|NOT COMPLETED|Overall Study||15
2930901|NCT00588536|3641920|FG000|STARTED|Overall Study||5
2930902|NCT00588536|3641920|FG000|COMPLETED|Overall Study||5
2930903|NCT00588536|3641920|FG000|NOT COMPLETED|Overall Study||0
2930904|NCT00588640|3641924|FG000|STARTED|Overall Study||10
2930905|NCT00588640|3641924|FG000|COMPLETED|Overall Study||8
2930906|NCT00588640|3641924|FG000|NOT COMPLETED|Overall Study||2
2930907|NCT00588666|3641928|FG000|STARTED|Overall Study||51
2930908|NCT00588666|3641928|FG000|COMPLETED|Overall Study||47
2930909|NCT00588666|3641928|FG000|NOT COMPLETED|Overall Study||4
2930910|NCT00588692|3641934|FG000|STARTED|Overall Study||30
2930911|NCT00588692|3641935|FG001|STARTED|Overall Study||30
2930912|NCT00588692|3641934|FG000|COMPLETED|Overall Study||23
2930913|NCT00588692|3641935|FG001|COMPLETED|Overall Study||27
2930914|NCT00588692|3641934|FG000|NOT COMPLETED|Overall Study||7
2930915|NCT00588692|3641935|FG001|NOT COMPLETED|Overall Study||3
2930916|NCT00588731|3641945|FG000|STARTED|Overall Study||21
2930917|NCT00588731|3641946|FG001|STARTED|Overall Study||20
2930918|NCT00588731|3641945|FG000|COMPLETED|Overall Study||18
2930919|NCT00588731|3641946|FG001|COMPLETED|Overall Study||18
2930920|NCT00588731|3641945|FG000|NOT COMPLETED|Overall Study||3
2930921|NCT00588731|3641946|FG001|NOT COMPLETED|Overall Study||2
2930922|NCT00588809|3641952|FG000|STARTED|Overall Study||47
2930923|NCT00588809|3641952|FG000|COMPLETED|Overall Study||47
2930924|NCT00588809|3641952|FG000|NOT COMPLETED|Overall Study||0
2930925|NCT00588822|3641956|FG000|STARTED|Overall Study||21
2930926|NCT00588822|3641956|FG000|COMPLETED|Overall Study||13
2930927|NCT00588822|3641956|FG000|NOT COMPLETED|Overall Study||8
2930928|NCT00588848|3641962|FG000|STARTED|Overall Study||3
2930929|NCT00588848|3641963|FG001|STARTED|Overall Study||8
2930930|NCT00588848|3641962|FG000|COMPLETED|Overall Study||3
2930931|NCT00588848|3641963|FG001|COMPLETED|Overall Study||5
2930932|NCT00588848|3641962|FG000|NOT COMPLETED|Overall Study||0
2930933|NCT00588848|3641963|FG001|NOT COMPLETED|Overall Study||3
2930934|NCT00588900|3641971|FG000|STARTED|Overall Study||5
2930935|NCT00588900|3641971|FG000|COMPLETED|Overall Study||5
2930936|NCT00588900|3641971|FG000|NOT COMPLETED|Overall Study||0
2930937|NCT00588952|3641977|FG000|STARTED|Overall Study||29
2930938|NCT00588952|3641978|FG001|STARTED|Overall Study||70
2930939|NCT00588952|3641977|FG000|COMPLETED|Overall Study||26
2930940|NCT00588952|3641978|FG001|COMPLETED|Overall Study||63
2930941|NCT00588952|3641977|FG000|NOT COMPLETED|Overall Study||3
2930942|NCT00588952|3641978|FG001|NOT COMPLETED|Overall Study||7
2930943|NCT00588965|3641984|FG000|STARTED|Overall Study||35
2930944|NCT00588965|3641984|FG000|COMPLETED|Overall Study||35
2930945|NCT00588965|3641984|FG000|NOT COMPLETED|Overall Study||0
2930946|NCT00589056|3641990|FG000|STARTED|Overall Study||55
2930947|NCT00589056|3641990|FG000|COMPLETED|Overall Study||52
2930948|NCT00589056|3641990|FG000|NOT COMPLETED|Overall Study||3
2930949|NCT00589108|3641997|FG000|STARTED|Overall Study||80
2930950|NCT00589108|3641998|FG001|STARTED|Overall Study||80
2930951|NCT00589108|3641999|FG002|STARTED|Overall Study||80
2930952|NCT00589108|3641997|FG000|COMPLETED|Overall Study||76
2930953|NCT00589108|3641998|FG001|COMPLETED|Overall Study||76
2930954|NCT00589108|3641999|FG002|COMPLETED|Overall Study||75
2930955|NCT00589108|3641997|FG000|NOT COMPLETED|Overall Study||4
2930956|NCT00589108|3641998|FG001|NOT COMPLETED|Overall Study||4
2930957|NCT00589108|3641999|FG002|NOT COMPLETED|Overall Study||5
2930958|NCT00589121|3642009|FG000|STARTED|Overall Study||12
2930959|NCT00589121|3642010|FG001|STARTED|Overall Study||86
2930960|NCT00589121|3642009|FG000|COMPLETED|Overall Study|Subjects with data available for the analysis are considered to have completed the study.|10
2930961|NCT00589121|3642010|FG001|COMPLETED|Overall Study|Subjects with data available for the analysis are considered to have completed the study.|79
2930962|NCT00589121|3642009|FG000|NOT COMPLETED|Overall Study||2
2930963|NCT00589121|3642010|FG001|NOT COMPLETED|Overall Study||7
2930964|NCT00589277|3642021|FG000|STARTED|Overall Study||1222
2930965|NCT00589277|3642022|FG001|STARTED|Overall Study||810
2930966|NCT00589277|3642021|FG000|Completed 2 Week Follow Up|Overall Study||603
2930967|NCT00589277|3642022|FG001|Completed 2 Week Follow Up|Overall Study||424
2930968|NCT00589277|3642021|FG000|Completed 3 Month Follow Up|Overall Study||762
2930969|NCT00589277|3642022|FG001|Completed 3 Month Follow Up|Overall Study||524
2930970|NCT00589277|3642021|FG000|COMPLETED|Overall Study||762
2930971|NCT00589277|3642022|FG001|COMPLETED|Overall Study||524
2930972|NCT00589277|3642021|FG000|NOT COMPLETED|Overall Study||460
2930973|NCT00589277|3642022|FG001|NOT COMPLETED|Overall Study||286
2930974|NCT00589290|3642028|FG000|STARTED|Overall Study||41
2930975|NCT00589290|3642028|FG000|COMPLETED|Overall Study||40
2930976|NCT00589290|3642028|FG000|NOT COMPLETED|Overall Study||1
2930977|NCT00589303|3642036|FG000|STARTED|Overall Study||14
2930978|NCT00589303|3642037|FG001|STARTED|Overall Study||13
2930979|NCT00589303|3642036|FG000|COMPLETED|Overall Study||12
2930980|NCT00589303|3642037|FG001|COMPLETED|Overall Study||12
2930981|NCT00589303|3642036|FG000|NOT COMPLETED|Overall Study||2
2930982|NCT00589303|3642037|FG001|NOT COMPLETED|Overall Study||1
3041443|NCT01171690|3761177|FG001|STARTED|Overall Study||5
3041444|NCT01171690|3761176|FG000|COMPLETED|Overall Study||5
3041445|NCT01171690|3761177|FG001|COMPLETED|Overall Study||5
3041446|NCT01171690|3761176|FG000|NOT COMPLETED|Overall Study||0
3041447|NCT01171690|3761177|FG001|NOT COMPLETED|Overall Study||0
3041448|NCT01171794|3761185|FG000|STARTED|Overall Study||47
3041449|NCT01171794|3761186|FG001|STARTED|Overall Study||42
3041450|NCT01171794|3761185|FG000|COMPLETED|Overall Study||44
3041451|NCT01171794|3761186|FG001|COMPLETED|Overall Study||42
3041452|NCT01171794|3761185|FG000|NOT COMPLETED|Overall Study||3
3041453|NCT01171794|3761186|FG001|NOT COMPLETED|Overall Study||0
2930983|NCT00589329|3642045|FG000|STARTED|Overall Study||10
2930984|NCT00589329|3642046|FG001|STARTED|Overall Study||10
2930985|NCT00589329|3642045|FG000|COMPLETED|Overall Study||10
2930986|NCT00589329|3642046|FG001|COMPLETED|Overall Study||10
2930987|NCT00589329|3642045|FG000|NOT COMPLETED|Overall Study||0
2930988|NCT00589329|3642046|FG001|NOT COMPLETED|Overall Study||0
2930989|NCT00589472|3642053|FG000|STARTED|Overall Study||19
2930990|NCT00589472|3642053|FG000|COMPLETED|Overall Study||18
2930991|NCT00589472|3642053|FG000|NOT COMPLETED|Overall Study||1
2930992|NCT00589563|3642057|FG000|STARTED|Overall Study||32
2930993|NCT00589563|3642057|FG000|COMPLETED|Overall Study||32
2930994|NCT00589563|3642057|FG000|NOT COMPLETED|Overall Study||0
2930995|NCT00589602|3642061|FG000|STARTED|Overall Study||13
2930996|NCT00589602|3642061|FG000|COMPLETED|Overall Study||12
2930997|NCT00589602|3642061|FG000|NOT COMPLETED|Overall Study||1
2930998|NCT00589628|3642069|FG000|STARTED|Overall Study||7
2930999|NCT00589628|3642070|FG001|STARTED|Overall Study||6
2931000|NCT00589628|3642069|FG000|COMPLETED|Overall Study||7
2931001|NCT00589628|3642070|FG001|COMPLETED|Overall Study||5
2931002|NCT00589628|3642069|FG000|NOT COMPLETED|Overall Study||0
2931003|NCT00589628|3642070|FG001|NOT COMPLETED|Overall Study||1
2931004|NCT00589667|3642076|FG000|STARTED|Overall Study||26
2931005|NCT00589667|3642076|FG000|COMPLETED|Overall Study||23
2931006|NCT00589667|3642076|FG000|NOT COMPLETED|Overall Study||3
2931007|NCT00589693|3642082|FG000|STARTED|Overall Study||115
2931008|NCT00589693|3642083|FG001|STARTED|Overall Study||112
2931009|NCT00589693|3642082|FG000|COMPLETED|Overall Study||71
2931010|NCT00589693|3642083|FG001|COMPLETED|Overall Study||83
2931011|NCT00589693|3642082|FG000|NOT COMPLETED|Overall Study||44
2931012|NCT00589693|3642083|FG001|NOT COMPLETED|Overall Study||29
2931013|NCT00589784|3642091|FG000|STARTED|Overall Study||36
2931014|NCT00589784|3642092|FG001|STARTED|Overall Study||14
2931015|NCT00589784|3642091|FG000|COMPLETED|Overall Study||35
2931016|NCT00589784|3642092|FG001|COMPLETED|Overall Study||4
2931017|NCT00589784|3642091|FG000|NOT COMPLETED|Overall Study||1
2931018|NCT00589784|3642092|FG001|NOT COMPLETED|Overall Study||10
2931019|NCT00589797|3642099|FG000|STARTED|Overall Study||264
2931020|NCT00589797|3642100|FG001|STARTED|Overall Study||112
2931021|NCT00589797|3642099|FG000|Baseline|Overall Study||218
2931022|NCT00589797|3642100|FG001|Baseline|Overall Study||106
2931023|NCT00589797|3642099|FG000|24 Months|Overall Study||191
2931024|NCT00589797|3642100|FG001|24 Months|Overall Study||89
2931025|NCT00589797|3642099|FG000|COMPLETED|Overall Study||191
3041454|NCT01171820|3761194|FG000|STARTED|Overall Study||106
3041455|NCT01171820|3761195|FG001|STARTED|Overall Study||218
3041456|NCT01171820|3761194|FG000|COMPLETED|Overall Study||100
3041457|NCT01171820|3761195|FG001|COMPLETED|Overall Study||212
3041458|NCT01171820|3761194|FG000|NOT COMPLETED|Overall Study||6
3041459|NCT01171820|3761195|FG001|NOT COMPLETED|Overall Study||6
3041460|NCT01171924|3761203|FG000|STARTED|Overall Study||23
3041461|NCT01171924|3761204|FG001|STARTED|Overall Study||23
2931026|NCT00589797|3642100|FG001|COMPLETED|Overall Study||89
2931027|NCT00589797|3642099|FG000|NOT COMPLETED|Overall Study||73
2931028|NCT00589797|3642100|FG001|NOT COMPLETED|Overall Study||23
2931029|NCT00589836|3642106|FG000|STARTED|Overall Study||20
2931030|NCT00589836|3642106|FG000|COMPLETED|Overall Study||20
2931031|NCT00589836|3642106|FG000|NOT COMPLETED|Overall Study||0
2931032|NCT00589849|3642110|FG000|STARTED|Overall Study||32
2931033|NCT00589849|3642110|FG000|COMPLETED|Overall Study||32
2931034|NCT00589849|3642110|FG000|NOT COMPLETED|Overall Study||0
2931035|NCT00589888|3642114|FG000|STARTED|Normal Saline @ 40cc/Hour|the same 13 patients did each of the 5 arms at 5 different visits|13
2931036|NCT00589888|3642115|FG001|STARTED|Normal Saline @ 40cc/Hour||0
2931037|NCT00589888|3642116|FG002|STARTED|Normal Saline @ 40cc/Hour||0
2931038|NCT00589888|3642117|FG003|STARTED|Normal Saline @ 40cc/Hour||0
2931039|NCT00589888|3642118|FG004|STARTED|Normal Saline @ 40cc/Hour||0
2931040|NCT00589888|3642114|FG000|COMPLETED|Normal Saline @ 40cc/Hour||13
2931041|NCT00589888|3642115|FG001|COMPLETED|Normal Saline @ 40cc/Hour||0
2931042|NCT00589888|3642116|FG002|COMPLETED|Normal Saline @ 40cc/Hour||0
2931043|NCT00589888|3642117|FG003|COMPLETED|Normal Saline @ 40cc/Hour||0
2931044|NCT00589888|3642118|FG004|COMPLETED|Normal Saline @ 40cc/Hour||0
2931045|NCT00589888|3642114|FG000|NOT COMPLETED|Normal Saline @ 40cc/Hour||0
2931046|NCT00589888|3642115|FG001|NOT COMPLETED|Normal Saline @ 40cc/Hour||0
2931047|NCT00589888|3642116|FG002|NOT COMPLETED|Normal Saline @ 40cc/Hour||0
2931048|NCT00589888|3642117|FG003|NOT COMPLETED|Normal Saline @ 40cc/Hour||0
2931049|NCT00589888|3642118|FG004|NOT COMPLETED|Normal Saline @ 40cc/Hour||0
2931050|NCT00589888|3642114|FG000|STARTED|Intralipid 20% @ 20cc/hr|the same 13 patients did each of the 5 arms at 5 different visits|0
2931051|NCT00589888|3642115|FG001|STARTED|Intralipid 20% @ 20cc/hr||13
2931052|NCT00589888|3642116|FG002|STARTED|Intralipid 20% @ 20cc/hr||0
2931053|NCT00589888|3642117|FG003|STARTED|Intralipid 20% @ 20cc/hr||0
2931054|NCT00589888|3642118|FG004|STARTED|Intralipid 20% @ 20cc/hr||0
2931055|NCT00589888|3642114|FG000|COMPLETED|Intralipid 20% @ 20cc/hr||0
2931056|NCT00589888|3642115|FG001|COMPLETED|Intralipid 20% @ 20cc/hr||13
2931057|NCT00589888|3642116|FG002|COMPLETED|Intralipid 20% @ 20cc/hr||0
2931058|NCT00589888|3642117|FG003|COMPLETED|Intralipid 20% @ 20cc/hr||0
2931059|NCT00589888|3642118|FG004|COMPLETED|Intralipid 20% @ 20cc/hr||0
2931060|NCT00589888|3642114|FG000|NOT COMPLETED|Intralipid 20% @ 20cc/hr||0
2931061|NCT00589888|3642115|FG001|NOT COMPLETED|Intralipid 20% @ 20cc/hr||0
2931062|NCT00589888|3642116|FG002|NOT COMPLETED|Intralipid 20% @ 20cc/hr||0
2931063|NCT00589888|3642117|FG003|NOT COMPLETED|Intralipid 20% @ 20cc/hr||0
2931064|NCT00589888|3642118|FG004|NOT COMPLETED|Intralipid 20% @ 20cc/hr||0
2931065|NCT00589888|3642114|FG000|STARTED|Intralipid 20% @ 40cc/Hour||0
2931066|NCT00589888|3642115|FG001|STARTED|Intralipid 20% @ 40cc/Hour|the same 13 patients did each of the 5 arms at 5 different visits|0
2931067|NCT00589888|3642116|FG002|STARTED|Intralipid 20% @ 40cc/Hour|the same 13 patients did each of the 5 arms at 5 different visits|13
2931068|NCT00589888|3642117|FG003|STARTED|Intralipid 20% @ 40cc/Hour||0
2931069|NCT00589888|3642118|FG004|STARTED|Intralipid 20% @ 40cc/Hour||0
2931070|NCT00589888|3642114|FG000|COMPLETED|Intralipid 20% @ 40cc/Hour||0
2931071|NCT00589888|3642115|FG001|COMPLETED|Intralipid 20% @ 40cc/Hour||0
2931072|NCT00589888|3642116|FG002|COMPLETED|Intralipid 20% @ 40cc/Hour||13
2931073|NCT00589888|3642117|FG003|COMPLETED|Intralipid 20% @ 40cc/Hour||0
2931074|NCT00589888|3642118|FG004|COMPLETED|Intralipid 20% @ 40cc/Hour||0
2931075|NCT00589888|3642114|FG000|NOT COMPLETED|Intralipid 20% @ 40cc/Hour||0
2931076|NCT00589888|3642115|FG001|NOT COMPLETED|Intralipid 20% @ 40cc/Hour||0
2931077|NCT00589888|3642116|FG002|NOT COMPLETED|Intralipid 20% @ 40cc/Hour||0
2931078|NCT00589888|3642117|FG003|NOT COMPLETED|Intralipid 20% @ 40cc/Hour||0
2931079|NCT00589888|3642118|FG004|NOT COMPLETED|Intralipid 20% @ 40cc/Hour||0
2931080|NCT00589888|3642114|FG000|STARTED|32-gram Oral Fat Load||0
2931081|NCT00589888|3642115|FG001|STARTED|32-gram Oral Fat Load||0
2931082|NCT00589888|3642116|FG002|STARTED|32-gram Oral Fat Load|the same 13 patients did each of the 5 arms at 5 different visits|0
2931083|NCT00589888|3642117|FG003|STARTED|32-gram Oral Fat Load|the same 13 patients did each of the 5 arms at 5 different visits|13
2931084|NCT00589888|3642118|FG004|STARTED|32-gram Oral Fat Load||0
2931085|NCT00589888|3642114|FG000|COMPLETED|32-gram Oral Fat Load||0
2931086|NCT00589888|3642115|FG001|COMPLETED|32-gram Oral Fat Load||0
2931087|NCT00589888|3642116|FG002|COMPLETED|32-gram Oral Fat Load||0
2931088|NCT00589888|3642117|FG003|COMPLETED|32-gram Oral Fat Load||13
2931089|NCT00589888|3642118|FG004|COMPLETED|32-gram Oral Fat Load||0
2931090|NCT00589888|3642114|FG000|NOT COMPLETED|32-gram Oral Fat Load||0
2931091|NCT00589888|3642115|FG001|NOT COMPLETED|32-gram Oral Fat Load||0
2931092|NCT00589888|3642116|FG002|NOT COMPLETED|32-gram Oral Fat Load||0
2931093|NCT00589888|3642117|FG003|NOT COMPLETED|32-gram Oral Fat Load||0
2931094|NCT00589888|3642118|FG004|NOT COMPLETED|32-gram Oral Fat Load||0
2931095|NCT00589888|3642114|FG000|STARTED|64-gram Oral Fat Load||0
2931096|NCT00589888|3642115|FG001|STARTED|64-gram Oral Fat Load||0
2931097|NCT00589888|3642116|FG002|STARTED|64-gram Oral Fat Load||0
2931098|NCT00589888|3642117|FG003|STARTED|64-gram Oral Fat Load|the same 13 patients did each of the 5 arms at 5 different visits|0
2931099|NCT00589888|3642118|FG004|STARTED|64-gram Oral Fat Load|the same 13 patients did each of the 5 arms at 5 different visits|13
2931100|NCT00589888|3642114|FG000|COMPLETED|64-gram Oral Fat Load||0
2931101|NCT00589888|3642115|FG001|COMPLETED|64-gram Oral Fat Load||0
2931102|NCT00589888|3642116|FG002|COMPLETED|64-gram Oral Fat Load||0
2931103|NCT00589888|3642117|FG003|COMPLETED|64-gram Oral Fat Load||0
2931104|NCT00589888|3642118|FG004|COMPLETED|64-gram Oral Fat Load||13
2931105|NCT00589888|3642114|FG000|NOT COMPLETED|64-gram Oral Fat Load||0
2931106|NCT00589888|3642115|FG001|NOT COMPLETED|64-gram Oral Fat Load||0
2931107|NCT00589888|3642116|FG002|NOT COMPLETED|64-gram Oral Fat Load||0
2931108|NCT00589888|3642117|FG003|NOT COMPLETED|64-gram Oral Fat Load||0
2931109|NCT00589888|3642118|FG004|NOT COMPLETED|64-gram Oral Fat Load||0
2931110|NCT00589914|3642137|FG000|STARTED|Overall Study||606
2931111|NCT00589914|3642138|FG001|STARTED|Overall Study||608
2931112|NCT00589914|3642137|FG000|COMPLETED|Overall Study||456
2931113|NCT00589914|3642138|FG001|COMPLETED|Overall Study||471
2931114|NCT00589914|3642137|FG000|NOT COMPLETED|Overall Study||150
2931115|NCT00589914|3642138|FG001|NOT COMPLETED|Overall Study||137
2931116|NCT00589979|3642146|FG000|STARTED|Run-In Period||169
2931117|NCT00589979|3642147|FG001|STARTED|Run-In Period||0
2931118|NCT00589979|3642148|FG002|STARTED|Run-In Period||0
2931119|NCT00589979|3642146|FG000|COMPLETED|Run-In Period||93
2931120|NCT00589979|3642147|FG001|COMPLETED|Run-In Period||0
2931121|NCT00589979|3642148|FG002|COMPLETED|Run-In Period||0
2931122|NCT00589979|3642146|FG000|NOT COMPLETED|Run-In Period||76
2931123|NCT00589979|3642147|FG001|NOT COMPLETED|Run-In Period||0
2931124|NCT00589979|3642148|FG002|NOT COMPLETED|Run-In Period||0
2931125|NCT00589979|3642146|FG000|STARTED|Double-Blind Treatment Period 1|Participants completing the Run-in Period were then randomized to two different treatment sequences.|0
2931126|NCT00589979|3642147|FG001|STARTED|Double-Blind Treatment Period 1|N=21 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|50
2931127|NCT00589979|3642148|FG002|STARTED|Double-Blind Treatment Period 1|N=21 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|43
2931128|NCT00589979|3642146|FG000|COMPLETED|Double-Blind Treatment Period 1||0
2931129|NCT00589979|3642147|FG001|COMPLETED|Double-Blind Treatment Period 1||48
3179862|NCT01987427|3908101|FG001|COMPLETED|Overall Study||68
3179863|NCT01987427|3908102|FG002|COMPLETED|Overall Study||59
3179864|NCT01987427|3908100|FG000|NOT COMPLETED|Overall Study||14
2931130|NCT00589979|3642148|FG002|COMPLETED|Double-Blind Treatment Period 1||41
2931131|NCT00589979|3642146|FG000|NOT COMPLETED|Double-Blind Treatment Period 1||0
2931132|NCT00589979|3642147|FG001|NOT COMPLETED|Double-Blind Treatment Period 1||2
2931133|NCT00589979|3642148|FG002|NOT COMPLETED|Double-Blind Treatment Period 1||2
2931134|NCT00589979|3642146|FG000|STARTED|Double-Blind Treatment Period 2||0
2931135|NCT00589979|3642147|FG001|STARTED|Double-Blind Treatment Period 2|N=19 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|48
3041462|NCT01171924|3761203|FG000|COMPLETED|Overall Study||0
3041463|NCT01171924|3761204|FG001|COMPLETED|Overall Study||0
3179865|NCT01987427|3908101|FG001|NOT COMPLETED|Overall Study||10
3179866|NCT01987427|3908102|FG002|NOT COMPLETED|Overall Study||20
3179867|NCT01987453|3908113|FG000|STARTED|Overall Study||51
3179868|NCT01987453|3908114|FG001|STARTED|Overall Study||41
3179869|NCT01987453|3908115|FG002|STARTED|Overall Study||8
3179870|NCT01987453|3908113|FG000|COMPLETED|Overall Study||50
3179871|NCT01987453|3908114|FG001|COMPLETED|Overall Study||29
3179872|NCT01987453|3908115|FG002|COMPLETED|Overall Study||7
3179873|NCT01987453|3908113|FG000|NOT COMPLETED|Overall Study||1
3179874|NCT01987453|3908114|FG001|NOT COMPLETED|Overall Study||12
3179875|NCT01987453|3908115|FG002|NOT COMPLETED|Overall Study||1
3179876|NCT01987479|3908127|FG000|STARTED|Overall Study||150
3179877|NCT01987479|3908127|FG000|COMPLETED|Overall Study||133
3179878|NCT01987479|3908127|FG000|NOT COMPLETED|Overall Study||17
3179879|NCT01987505|3908133|FG000|STARTED|Overall Study||140
2931136|NCT00589979|3642148|FG002|STARTED|Double-Blind Treatment Period 2|N=20 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|41
2931137|NCT00589979|3642146|FG000|COMPLETED|Double-Blind Treatment Period 2||0
2931138|NCT00589979|3642147|FG001|COMPLETED|Double-Blind Treatment Period 2||47
2931139|NCT00589979|3642148|FG002|COMPLETED|Double-Blind Treatment Period 2||39
2931140|NCT00589979|3642146|FG000|NOT COMPLETED|Double-Blind Treatment Period 2||0
2931141|NCT00589979|3642147|FG001|NOT COMPLETED|Double-Blind Treatment Period 2||1
3041464|NCT01171924|3761203|FG000|NOT COMPLETED|Overall Study||23
3041465|NCT01171924|3761204|FG001|NOT COMPLETED|Overall Study||23
3041466|NCT01171963|3761212|FG000|STARTED|Overall Study||1666
3041467|NCT01171963|3761213|FG001|STARTED|Overall Study||1667
3041468|NCT01171963|3761212|FG000|COMPLETED|Overall Study||1518
3041469|NCT01171963|3761213|FG001|COMPLETED|Overall Study||1499
3041470|NCT01171963|3761212|FG000|NOT COMPLETED|Overall Study||148
3041471|NCT01171963|3761213|FG001|NOT COMPLETED|Overall Study||168
3041472|NCT01171976|3761225|FG000|STARTED|Overall Study||121
3041473|NCT01171976|3761226|FG001|STARTED|Overall Study||128
3041474|NCT01171976|3761227|FG002|STARTED|Overall Study||123
3041475|NCT01171976|3761225|FG000|Safety Set|Overall Study|Include 4 from PRN and 3 from TE alone who got laser treatment, exclude 2 with no laser treatment.|126
3041476|NCT01171976|3761226|FG001|Safety Set|Overall Study|Exclude 1 who did not get drug and 3 got laser treatment, include 2 from 1st arm with no laser|126
3041477|NCT01171976|3761227|FG002|Safety Set|Overall Study|Exclude 1 who did not get drug and 4 got laser treatment|118
3041478|NCT01171976|3761225|FG000|COMPLETED|Overall Study||107
3041479|NCT01171976|3761226|FG001|COMPLETED|Overall Study||117
3041480|NCT01171976|3761227|FG002|COMPLETED|Overall Study||108
3041481|NCT01171976|3761225|FG000|NOT COMPLETED|Overall Study||14
3041482|NCT01171976|3761226|FG001|NOT COMPLETED|Overall Study||11
3041483|NCT01171976|3761227|FG002|NOT COMPLETED|Overall Study||15
3041484|NCT01171989|3761238|FG000|STARTED|Overall Study||137
3041485|NCT01171989|3761239|FG001|STARTED|Overall Study||133
3041486|NCT01171989|3761240|FG002|STARTED|Overall Study||121
3041487|NCT01171989|3761238|FG000|COMPLETED|Overall Study||137
3041488|NCT01171989|3761239|FG001|COMPLETED|Overall Study||133
3041489|NCT01171989|3761240|FG002|COMPLETED|Overall Study||120
3041490|NCT01171989|3761238|FG000|NOT COMPLETED|Overall Study||0
3041491|NCT01171989|3761239|FG001|NOT COMPLETED|Overall Study||0
3041492|NCT01171989|3761240|FG002|NOT COMPLETED|Overall Study||1
3041493|NCT01172067|3761250|FG000|STARTED|Overall Study||200
3041494|NCT01172067|3761251|FG001|STARTED|Overall Study||200
3041495|NCT01172067|3761250|FG000|COMPLETED|Overall Study||153
3179880|NCT01987505|3908133|FG000|COMPLETED|Overall Study||106
3179881|NCT01987505|3908133|FG000|NOT COMPLETED|Overall Study||34
3179882|NCT01987557|3908142|FG000|STARTED|Overall Study||16
3179883|NCT01987557|3908143|FG001|STARTED|Overall Study||16
3179884|NCT01987557|3908144|FG002|STARTED|Overall Study||16
3179885|NCT01987557|3908142|FG000|COMPLETED|Overall Study||13
3179886|NCT01987557|3908143|FG001|COMPLETED|Overall Study||13
3179887|NCT01987557|3908144|FG002|COMPLETED|Overall Study||13
3179888|NCT01987557|3908142|FG000|NOT COMPLETED|Overall Study||3
3179889|NCT01987557|3908143|FG001|NOT COMPLETED|Overall Study||3
3179890|NCT01987557|3908144|FG002|NOT COMPLETED|Overall Study||3
3041496|NCT01172067|3761251|FG001|COMPLETED|Overall Study||163
3041497|NCT01172067|3761250|FG000|NOT COMPLETED|Overall Study||47
3041498|NCT01172067|3761251|FG001|NOT COMPLETED|Overall Study||37
3041499|NCT01172145|3761259|FG000|STARTED|Overall Study||11
3041500|NCT01172145|3761260|FG001|STARTED|Overall Study||11
3041501|NCT01172145|3761259|FG000|COMPLETED|Overall Study||11
3041502|NCT01172145|3761260|FG001|COMPLETED|Overall Study||11
3041503|NCT01172145|3761259|FG000|NOT COMPLETED|Overall Study||0
3041504|NCT01172145|3761260|FG001|NOT COMPLETED|Overall Study||0
3041505|NCT01172184|3761266|FG000|STARTED|Overall Study||111
3041506|NCT01172184|3761266|FG000|COMPLETED|Overall Study||111
3041507|NCT01172184|3761266|FG000|NOT COMPLETED|Overall Study||0
3041508|NCT01172197|3761272|FG000|STARTED|Overall Study||7
3041509|NCT01172197|3761273|FG001|STARTED|Overall Study||7
3041510|NCT01172197|3761272|FG000|COMPLETED|Overall Study||7
3041511|NCT01172197|3761273|FG001|COMPLETED|Overall Study||7
3041512|NCT01172197|3761272|FG000|NOT COMPLETED|Overall Study||0
3041513|NCT01172197|3761273|FG001|NOT COMPLETED|Overall Study||0
3041514|NCT01172275|3761281|FG000|STARTED|Overall Study||5
3041515|NCT01172275|3761282|FG001|STARTED|Overall Study||6
3041516|NCT01172275|3761281|FG000|COMPLETED|Overall Study||3
3041517|NCT01172275|3761282|FG001|COMPLETED|Overall Study||6
3041518|NCT01172275|3761281|FG000|NOT COMPLETED|Overall Study||2
3041519|NCT01172275|3761282|FG001|NOT COMPLETED|Overall Study||0
3041520|NCT01172288|3761290|FG000|STARTED|Overall Study||17
3041521|NCT01172288|3761291|FG001|STARTED|Overall Study||14
3041522|NCT01172288|3761290|FG000|COMPLETED|Overall Study||16
3041523|NCT01172288|3761291|FG001|COMPLETED|Overall Study||13
3041524|NCT01172288|3761290|FG000|NOT COMPLETED|Overall Study||1
3041525|NCT01172288|3761291|FG001|NOT COMPLETED|Overall Study||1
3041526|NCT01172353|3761299|FG000|STARTED|Overall Study||150
3041527|NCT01172353|3761300|FG001|STARTED|Overall Study||151
3041528|NCT01172353|3761299|FG000|COMPLETED|Overall Study||150
3041529|NCT01172353|3761300|FG001|COMPLETED|Overall Study||151
3041530|NCT01172353|3761299|FG000|NOT COMPLETED|Overall Study||0
3041531|NCT01172353|3761300|FG001|NOT COMPLETED|Overall Study||0
2931142|NCT00589979|3642148|FG002|NOT COMPLETED|Double-Blind Treatment Period 2||2
2931143|NCT00589979|3642146|FG000|STARTED|Double-Blind Treatment Period 3||0
3179891|NCT01987583|3908154|FG000|STARTED|Overall Study||40
2931144|NCT00589979|3642147|FG001|STARTED|Double-Blind Treatment Period 3|N=19 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|47
2931145|NCT00589979|3642148|FG002|STARTED|Double-Blind Treatment Period 3|N=19 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|39
2931146|NCT00589979|3642146|FG000|COMPLETED|Double-Blind Treatment Period 3||0
2931147|NCT00589979|3642147|FG001|COMPLETED|Double-Blind Treatment Period 3||46
2931148|NCT00589979|3642148|FG002|COMPLETED|Double-Blind Treatment Period 3||38
2931149|NCT00589979|3642146|FG000|NOT COMPLETED|Double-Blind Treatment Period 3||0
2931150|NCT00589979|3642147|FG001|NOT COMPLETED|Double-Blind Treatment Period 3||1
2931151|NCT00589979|3642148|FG002|NOT COMPLETED|Double-Blind Treatment Period 3||1
2931152|NCT00590005|3642160|FG000|STARTED|Overall Study||106
2931153|NCT00590005|3642161|FG001|STARTED|Overall Study||119
2931154|NCT00590005|3642160|FG000|COMPLETED|Overall Study||106
2931155|NCT00590005|3642161|FG001|COMPLETED|Overall Study||119
2931156|NCT00590005|3642160|FG000|NOT COMPLETED|Overall Study||0
2931157|NCT00590005|3642161|FG001|NOT COMPLETED|Overall Study||0
2931158|NCT00590018|3642169|FG000|STARTED|Overall Study||9
2931159|NCT00590018|3642170|FG001|STARTED|Overall Study||9
2931160|NCT00590018|3642169|FG000|COMPLETED|Overall Study||9
2931161|NCT00590018|3642170|FG001|COMPLETED|Overall Study||9
2931162|NCT00590018|3642169|FG000|NOT COMPLETED|Overall Study||0
2931163|NCT00590018|3642170|FG001|NOT COMPLETED|Overall Study||0
2931164|NCT00590031|3642176|FG000|STARTED|Overall Study||61
2931165|NCT00590031|3642176|FG000|COMPLETED|Overall Study||55
2931166|NCT00590031|3642176|FG000|NOT COMPLETED|Overall Study||6
2931167|NCT00590044|3642182|FG000|STARTED|Overall Study||38
2931168|NCT00590044|3642183|FG001|STARTED|Overall Study||36
2931169|NCT00590044|3642182|FG000|COMPLETED|Overall Study||34
2931170|NCT00590044|3642183|FG001|COMPLETED|Overall Study||34
2931171|NCT00590044|3642182|FG000|NOT COMPLETED|Overall Study||4
2931172|NCT00590044|3642183|FG001|NOT COMPLETED|Overall Study||2
2931173|NCT00590161|3642194|FG000|STARTED|Overall Study||26
2931174|NCT00590161|3642195|FG001|STARTED|Overall Study||29
2931175|NCT00590161|3642194|FG000|COMPLETED|Overall Study||23
2931176|NCT00590161|3642195|FG001|COMPLETED|Overall Study||26
2931177|NCT00590161|3642194|FG000|NOT COMPLETED|Overall Study||3
2931178|NCT00590161|3642195|FG001|NOT COMPLETED|Overall Study||3
2931179|NCT00590226|3642203|FG000|STARTED|Overall Study||67
2931180|NCT00590226|3642204|FG001|STARTED|Overall Study||63
2931181|NCT00590226|3642203|FG000|COMPLETED|Overall Study||67
3041532|NCT01172418|3761308|FG000|STARTED|Overall Study||100
3041533|NCT01172418|3761309|FG001|STARTED|Overall Study||100
3041534|NCT01172418|3761308|FG000|COMPLETED|Overall Study||100
3041535|NCT01172418|3761309|FG001|COMPLETED|Overall Study||100
3041536|NCT01172418|3761308|FG000|NOT COMPLETED|Overall Study||0
3041537|NCT01172418|3761309|FG001|NOT COMPLETED|Overall Study||0
3041538|NCT01172522|3761319|FG000|STARTED|Overall Study||15
3041539|NCT01172522|3761320|FG001|STARTED|Overall Study||15
3041540|NCT01172522|3761319|FG000|COMPLETED|Overall Study||15
3041541|NCT01172522|3761320|FG001|COMPLETED|Overall Study||15
3041542|NCT01172522|3761319|FG000|NOT COMPLETED|Overall Study||0
3041543|NCT01172522|3761320|FG001|NOT COMPLETED|Overall Study||0
3041544|NCT01172535|3761325|FG000|STARTED|Overall Study||97
3041545|NCT01172535|3761325|FG000|COMPLETED|Overall Study||89
3041546|NCT01172535|3761325|FG000|NOT COMPLETED|Overall Study||8
3041547|NCT01172600|3761334|FG000|STARTED|Overall Study||39
3041548|NCT01172600|3761335|FG001|STARTED|Overall Study||39
3041549|NCT01172600|3761334|FG000|COMPLETED|Overall Study||39
3041550|NCT01172600|3761335|FG001|COMPLETED|Overall Study||39
3041551|NCT01172600|3761334|FG000|NOT COMPLETED|Overall Study||0
3041552|NCT01172600|3761335|FG001|NOT COMPLETED|Overall Study||0
3041553|NCT01172639|3761346|FG000|STARTED|Overall Study||98
3041554|NCT01172639|3761347|FG001|STARTED|Overall Study||98
3041555|NCT01172639|3761348|FG002|STARTED|Overall Study||93
3041556|NCT01172639|3761349|FG003|STARTED|Overall Study||43
3041557|NCT01172639|3761350|FG004|STARTED|Overall Study||47
3041558|NCT01172639|3761346|FG000|Week 16|Overall Study||94
3041559|NCT01172639|3761347|FG001|Week 16|Overall Study||96
3041560|NCT01172639|3761348|FG002|Week 16|Overall Study||91
3041561|NCT01172639|3761349|FG003|Week 16|Overall Study||39
3041562|NCT01172639|3761350|FG004|Week 16|Overall Study||47
3041563|NCT01172639|3761346|FG000|Week 52|Overall Study||89
3041564|NCT01172639|3761347|FG001|Week 52|Overall Study||89
3041565|NCT01172639|3761348|FG002|Week 52|Overall Study||88
3041566|NCT01172639|3761349|FG003|Week 52|Overall Study||38
3041567|NCT01172639|3761350|FG004|Week 52|Overall Study||45
3041568|NCT01172639|3761346|FG000|COMPLETED|Overall Study||85
3041569|NCT01172639|3761347|FG001|COMPLETED|Overall Study||87
3041570|NCT01172639|3761348|FG002|COMPLETED|Overall Study||77
3041571|NCT01172639|3761349|FG003|COMPLETED|Overall Study||32
3041572|NCT01172639|3761350|FG004|COMPLETED|Overall Study||41
3041573|NCT01172639|3761346|FG000|NOT COMPLETED|Overall Study||13
3041574|NCT01172639|3761347|FG001|NOT COMPLETED|Overall Study||11
3041575|NCT01172639|3761348|FG002|NOT COMPLETED|Overall Study||16
3179892|NCT01987583|3908155|FG001|STARTED|Overall Study||40
3179893|NCT01987583|3908154|FG000|COMPLETED|Overall Study||37
3179894|NCT01987583|3908155|FG001|COMPLETED|Overall Study||38
3179895|NCT01987583|3908154|FG000|NOT COMPLETED|Overall Study||3
3179896|NCT01987583|3908155|FG001|NOT COMPLETED|Overall Study||2
3179897|NCT01987596|3908163|FG000|STARTED|Overall Study||12
3179898|NCT01987596|3908164|FG001|STARTED|Overall Study||11
3179899|NCT01987596|3908163|FG000|COMPLETED|Overall Study||11
3179900|NCT01987596|3908164|FG001|COMPLETED|Overall Study||10
3179901|NCT01987596|3908163|FG000|NOT COMPLETED|Overall Study||1
3179902|NCT01987596|3908164|FG001|NOT COMPLETED|Overall Study||1
3179903|NCT01987609|3908176|FG000|STARTED|Overall Study|one arm on one patient|7
3179904|NCT01987609|3908176|FG000|Hylenex Injected in Arm|Overall Study||6
3179905|NCT01987609|3908176|FG000|Normal Saline Injected in Arm|Overall Study||6
3179906|NCT01987609|3908176|FG000|COMPLETED|Overall Study||6
3179907|NCT01987609|3908176|FG000|NOT COMPLETED|Overall Study||1
3179908|NCT01987752|3908190|FG000|STARTED|Overall Study||732
2931182|NCT00590226|3642204|FG001|COMPLETED|Overall Study||63
2931183|NCT00590226|3642203|FG000|NOT COMPLETED|Overall Study||0
2931184|NCT00590226|3642204|FG001|NOT COMPLETED|Overall Study||0
2931185|NCT00590317|3642212|FG000|STARTED|Overall Study||32
2931186|NCT00590317|3642213|FG001|STARTED|Overall Study||32
2931187|NCT00590317|3642212|FG000|COMPLETED|Overall Study||31
2931188|NCT00590317|3642213|FG001|COMPLETED|Overall Study||27
2931189|NCT00590317|3642212|FG000|NOT COMPLETED|Overall Study||1
2931190|NCT00590317|3642213|FG001|NOT COMPLETED|Overall Study||5
2931191|NCT00590369|3642222|FG000|STARTED|Overall Study||6
2931192|NCT00590369|3642223|FG001|STARTED|Overall Study||5
2931193|NCT00590369|3642222|FG000|COMPLETED|Overall Study|Study stopped early due to difficulty recruiting subjects|6
2931194|NCT00590369|3642223|FG001|COMPLETED|Overall Study||5
2931195|NCT00590369|3642222|FG000|NOT COMPLETED|Overall Study||0
2931196|NCT00590369|3642223|FG001|NOT COMPLETED|Overall Study||0
2931197|NCT00590395|3642229|FG000|STARTED|Overall Study||19
2931198|NCT00590395|3642229|FG000|COMPLETED|Overall Study||19
2931199|NCT00590395|3642229|FG000|NOT COMPLETED|Overall Study||0
2931200|NCT00590460|3642233|FG000|STARTED|Overall Study||5
2931201|NCT00590460|3642233|FG000|COMPLETED|Overall Study||5
2931202|NCT00590460|3642233|FG000|NOT COMPLETED|Overall Study||0
2931203|NCT00590564|3642241|FG000|STARTED|Overall Study||42
2931204|NCT00590564|3642241|FG000|COMPLETED|Overall Study||24
3179909|NCT01987752|3908190|FG000|COMPLETED|Overall Study||732
3179910|NCT01987752|3908190|FG000|NOT COMPLETED|Overall Study||0
3179911|NCT01987765|3908194|FG000|STARTED|Overall Study||847
2931205|NCT00590564|3642241|FG000|NOT COMPLETED|Overall Study||18
2931206|NCT00590577|3642249|FG000|STARTED|Overall Study||160
2931207|NCT00590577|3642250|FG001|STARTED|Overall Study||165
2931208|NCT00590577|3642251|FG002|STARTED|Overall Study||163
2931209|NCT00590577|3642252|FG003|STARTED|Overall Study||164
2931210|NCT00590577|3642249|FG000|COMPLETED|Overall Study||83
2931211|NCT00590577|3642250|FG001|COMPLETED|Overall Study||89
2931212|NCT00590577|3642251|FG002|COMPLETED|Overall Study||90
2931213|NCT00590577|3642252|FG003|COMPLETED|Overall Study||71
2931214|NCT00590577|3642249|FG000|NOT COMPLETED|Overall Study||77
2931215|NCT00590577|3642250|FG001|NOT COMPLETED|Overall Study||76
2931216|NCT00590577|3642251|FG002|NOT COMPLETED|Overall Study||73
2931217|NCT00590577|3642252|FG003|NOT COMPLETED|Overall Study||93
2931218|NCT00590590|3642265|FG000|STARTED|Overall Study||39
2931219|NCT00590590|3642266|FG001|STARTED|Overall Study||39
2931220|NCT00590590|3642267|FG002|STARTED|Overall Study||27
2931221|NCT00590590|3642265|FG000|COMPLETED|Overall Study||32
2931222|NCT00590590|3642266|FG001|COMPLETED|Overall Study||33
2931223|NCT00590590|3642267|FG002|COMPLETED|Overall Study||21
2931224|NCT00590590|3642265|FG000|NOT COMPLETED|Overall Study||7
2931225|NCT00590590|3642266|FG001|NOT COMPLETED|Overall Study||6
2931226|NCT00590590|3642267|FG002|NOT COMPLETED|Overall Study||6
2931227|NCT00590681|3642275|FG000|STARTED|Overall Study||62
2931228|NCT00590681|3642275|FG000|COMPLETED|Overall Study|The forty-two participants who did proceed to the post-RT phase|42
2931229|NCT00590681|3642275|FG000|NOT COMPLETED|Overall Study||20
2931230|NCT00590707|3642281|FG000|STARTED|Overall Study||100
2931231|NCT00590707|3642282|FG001|STARTED|Overall Study||100
2931232|NCT00590707|3642281|FG000|COMPLETED|Overall Study||100
2931233|NCT00590707|3642282|FG001|COMPLETED|Overall Study||100
2931234|NCT00590707|3642281|FG000|NOT COMPLETED|Overall Study||0
2931235|NCT00590707|3642282|FG001|NOT COMPLETED|Overall Study||0
2931236|NCT00590720|3642290|FG000|STARTED|Overall Study||4
2931237|NCT00590720|3642291|FG001|STARTED|Overall Study||7
2931238|NCT00590720|3642290|FG000|COMPLETED|Overall Study||3
2931239|NCT00590720|3642291|FG001|COMPLETED|Overall Study||6
2931240|NCT00590720|3642290|FG000|NOT COMPLETED|Overall Study||1
2931241|NCT00590720|3642291|FG001|NOT COMPLETED|Overall Study||1
2931242|NCT00590759|3642297|FG000|STARTED|Overall Study||150
2931243|NCT00590759|3642297|FG000|COMPLETED|Overall Study||70
2931244|NCT00590759|3642297|FG000|NOT COMPLETED|Overall Study||80
2931245|NCT00590772|3642301|FG000|STARTED|Overall Study||31
2931246|NCT00590772|3642301|FG000|COMPLETED|Overall Study||31
2931247|NCT00590772|3642301|FG000|NOT COMPLETED|Overall Study||0
2931248|NCT00590824|3642311|FG000|STARTED|Overall Study||11
2931249|NCT00590824|3642312|FG001|STARTED|Overall Study||9
2931250|NCT00590824|3642313|FG002|STARTED|Overall Study||2
2931251|NCT00590824|3642314|FG003|STARTED|Overall Study||1
2931252|NCT00590824|3642311|FG000|COMPLETED|Overall Study||11
2931253|NCT00590824|3642312|FG001|COMPLETED|Overall Study||7
2931254|NCT00590824|3642313|FG002|COMPLETED|Overall Study||1
2931255|NCT00590824|3642314|FG003|COMPLETED|Overall Study||0
2931256|NCT00590824|3642311|FG000|NOT COMPLETED|Overall Study||0
2931257|NCT00590824|3642312|FG001|NOT COMPLETED|Overall Study||2
2931258|NCT00590824|3642313|FG002|NOT COMPLETED|Overall Study||1
2931259|NCT00590824|3642314|FG003|NOT COMPLETED|Overall Study||1
2931260|NCT00590863|3642327|FG000|STARTED|Overall Study||221
3179912|NCT01987765|3908194|FG000|COMPLETED|Overall Study||745
2931261|NCT00590863|3642328|FG001|STARTED|Overall Study||220
2931262|NCT00590863|3642329|FG002|STARTED|Overall Study||224
2931263|NCT00590863|3642327|FG000|COMPLETED|Overall Study||137
2931264|NCT00590863|3642328|FG001|COMPLETED|Overall Study||138
2931265|NCT00590863|3642329|FG002|COMPLETED|Overall Study||146
2931266|NCT00590863|3642327|FG000|NOT COMPLETED|Overall Study||84
2931267|NCT00590863|3642328|FG001|NOT COMPLETED|Overall Study||82
2931268|NCT00590863|3642329|FG002|NOT COMPLETED|Overall Study||78
2931269|NCT00590889|3642340|FG000|STARTED|Overall Study||404
2931270|NCT00590889|3642341|FG001|STARTED|Overall Study||403
2931271|NCT00590889|3642340|FG000|COMPLETED|Overall Study||118
2931272|NCT00590889|3642341|FG001|COMPLETED|Overall Study||104
2931273|NCT00590889|3642340|FG000|NOT COMPLETED|Overall Study||286
3041576|NCT01172639|3761349|FG003|NOT COMPLETED|Overall Study||11
3041577|NCT01172639|3761350|FG004|NOT COMPLETED|Overall Study||6
3041578|NCT01172808|3761366|FG000|STARTED|Overall Study|Entered and Treated|269
3041579|NCT01172808|3761367|FG001|STARTED|Overall Study|Entered and Treated|262
3041580|NCT01172808|3761368|FG002|STARTED|Overall Study|Entered and Treated|264
3179913|NCT01987765|3908194|FG000|NOT COMPLETED|Overall Study||102
3179914|NCT01987817|3908200|FG000|STARTED|Overall Study||29
3179915|NCT01987817|3908201|FG001|STARTED|Overall Study||27
3179916|NCT01987817|3908200|FG000|COMPLETED|Overall Study||23
3179917|NCT01987817|3908201|FG001|COMPLETED|Overall Study||26
3179918|NCT01987817|3908200|FG000|NOT COMPLETED|Overall Study||6
3179919|NCT01987817|3908201|FG001|NOT COMPLETED|Overall Study||1
3179920|NCT01987830|3908208|FG000|STARTED|Overall Study||13
3041581|NCT01172808|3761369|FG003|STARTED|Overall Study|Entered and Treated|275
3041582|NCT01172808|3761366|FG000|COMPLETED|Overall Study||248
3041583|NCT01172808|3761367|FG001|COMPLETED|Overall Study||249
3041584|NCT01172808|3761368|FG002|COMPLETED|Overall Study||241
3041585|NCT01172808|3761369|FG003|COMPLETED|Overall Study||260
3041586|NCT01172808|3761366|FG000|NOT COMPLETED|Overall Study||21
3179921|NCT01987830|3908208|FG000|COMPLETED|Overall Study||12
3179922|NCT01987830|3908208|FG000|NOT COMPLETED|Overall Study||1
3179923|NCT01987895|3908214|FG000|STARTED|Overall Study||306
3179924|NCT01987895|3908215|FG001|STARTED|Overall Study||326
3179925|NCT01987895|3908214|FG000|COMPLETED|Overall Study||276
3179926|NCT01987895|3908215|FG001|COMPLETED|Overall Study||296
3041587|NCT01172808|3761367|FG001|NOT COMPLETED|Overall Study||13
3041588|NCT01172808|3761368|FG002|NOT COMPLETED|Overall Study||23
3041589|NCT01172808|3761369|FG003|NOT COMPLETED|Overall Study||15
3041590|NCT01172821|3761383|FG000|STARTED|Overall Study|Entered and Treated|254
3041591|NCT01172821|3761384|FG001|STARTED|Overall Study|Entered and Treated|257
3041592|NCT01172821|3761385|FG002|STARTED|Overall Study|Entered and Treated|253
3041593|NCT01172821|3761386|FG003|STARTED|Overall Study|Entered and Treated|266
3041594|NCT01172821|3761383|FG000|COMPLETED|Overall Study||240
3041595|NCT01172821|3761384|FG001|COMPLETED|Overall Study||245
3041596|NCT01172821|3761385|FG002|COMPLETED|Overall Study||240
3041597|NCT01172821|3761386|FG003|COMPLETED|Overall Study||249
3041598|NCT01172821|3761383|FG000|NOT COMPLETED|Overall Study||14
3041599|NCT01172821|3761384|FG001|NOT COMPLETED|Overall Study||12
3041600|NCT01172821|3761385|FG002|NOT COMPLETED|Overall Study||13
3041601|NCT01172821|3761386|FG003|NOT COMPLETED|Overall Study||17
3041602|NCT01172847|3761396|FG000|STARTED|Overall Study||24
3041603|NCT01172847|3761396|FG000|Oseltamivir|Overall Study||24
3041604|NCT01172847|3761396|FG000|Rimantadine|Overall Study||22
3041605|NCT01172847|3761396|FG000|Oseltamivir + Rimantadine|Overall Study||21
3041606|NCT01172847|3761396|FG000|COMPLETED|Overall Study||21
3041607|NCT01172847|3761396|FG000|NOT COMPLETED|Overall Study||3
3041608|NCT01172873|3761408|FG000|STARTED|Overall Study||11
3041609|NCT01172873|3761409|FG001|STARTED|Overall Study||5
3041610|NCT01172873|3761408|FG000|COMPLETED|Overall Study||8
3041611|NCT01172873|3761409|FG001|COMPLETED|Overall Study||3
3041612|NCT01172873|3761408|FG000|NOT COMPLETED|Overall Study||3
3041613|NCT01172873|3761409|FG001|NOT COMPLETED|Overall Study||2
3041614|NCT01172938|3761418|FG000|STARTED|Placebo-controlled Phase (Week 0-24)||168
3041615|NCT01172938|3761419|FG001|STARTED|Placebo-controlled Phase (Week 0-24)||168
3041616|NCT01172938|3761420|FG002|STARTED|Placebo-controlled Phase (Week 0-24)||168
3041617|NCT01172938|3761421|FG003|STARTED|Placebo-controlled Phase (Week 0-24)||0
3041618|NCT01172938|3761422|FG004|STARTED|Placebo-controlled Phase (Week 0-24)||0
3041619|NCT01172938|3761423|FG005|STARTED|Placebo-controlled Phase (Week 0-24)||0
3041620|NCT01172938|3761424|FG006|STARTED|Placebo-controlled Phase (Week 0-24)||0
3041621|NCT01172938|3761425|FG007|STARTED|Placebo-controlled Phase (Week 0-24)||0
3041622|NCT01172938|3761426|FG008|STARTED|Placebo-controlled Phase (Week 0-24)||0
3041623|NCT01172938|3761418|FG000|Received Treatment|Placebo-controlled Phase (Week 0-24)||168
3041624|NCT01172938|3761419|FG001|Received Treatment|Placebo-controlled Phase (Week 0-24)||168
3041625|NCT01172938|3761420|FG002|Received Treatment|Placebo-controlled Phase (Week 0-24)||168
3041626|NCT01172938|3761421|FG003|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
3041627|NCT01172938|3761422|FG004|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
3041628|NCT01172938|3761423|FG005|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
3041629|NCT01172938|3761424|FG006|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
3041630|NCT01172938|3761425|FG007|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
3041631|NCT01172938|3761426|FG008|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
3041632|NCT01172938|3761418|FG000|Completed Week 16|Placebo-controlled Phase (Week 0-24)||158
3041633|NCT01172938|3761419|FG001|Completed Week 16|Placebo-controlled Phase (Week 0-24)||158
3179927|NCT01987895|3908214|FG000|NOT COMPLETED|Overall Study||30
2931274|NCT00590889|3642341|FG001|NOT COMPLETED|Overall Study||299
2931275|NCT00590902|3642347|FG000|STARTED|Overall Study||81
2931276|NCT00590902|3642347|FG000|COMPLETED|Overall Study||80
2931277|NCT00590902|3642347|FG000|NOT COMPLETED|Overall Study||1
2931278|NCT00590954|3642351|FG000|STARTED|Overall Study||32
2931279|NCT00590954|3642351|FG000|COMPLETED|Overall Study||30
2931280|NCT00590954|3642351|FG000|NOT COMPLETED|Overall Study||2
2931281|NCT00590967|3642359|FG000|STARTED|Overall Study||44
2931282|NCT00590967|3642360|FG001|STARTED|Overall Study||25
2931283|NCT00590967|3642359|FG000|COMPLETED|Overall Study||41
2931284|NCT00590967|3642360|FG001|COMPLETED|Overall Study||20
2931285|NCT00590967|3642359|FG000|NOT COMPLETED|Overall Study||3
2931286|NCT00590967|3642360|FG001|NOT COMPLETED|Overall Study||5
2931287|NCT00590980|3642366|FG000|STARTED|Overall Study||82
2931288|NCT00590980|3642366|FG000|COMPLETED|Overall Study||72
2931289|NCT00590980|3642366|FG000|NOT COMPLETED|Overall Study||10
2931290|NCT00591006|3642370|FG000|STARTED|Overall Study||1
2931291|NCT00591006|3642371|FG001|STARTED|Overall Study||0
2931292|NCT00591006|3642372|FG002|STARTED|Overall Study||1
2931293|NCT00591006|3642373|FG003|STARTED|Overall Study||1
2931294|NCT00591006|3642374|FG004|STARTED|Overall Study||1
2931295|NCT00591006|3642375|FG005|STARTED|Overall Study||0
2931296|NCT00591006|3642376|FG006|STARTED|Overall Study||1
2931297|NCT00591006|3642377|FG007|STARTED|Overall Study||0
2931298|NCT00591006|3642378|FG008|STARTED|Overall Study||1
2931299|NCT00591006|3642379|FG009|STARTED|Overall Study||1
2931300|NCT00591006|3642380|FG010|STARTED|Overall Study||0
2931301|NCT00591006|3642381|FG011|STARTED|Overall Study||1
2931302|NCT00591006|3642382|FG012|STARTED|Overall Study||1
2931303|NCT00591006|3642383|FG013|STARTED|Overall Study||2
2931304|NCT00591006|3642384|FG014|STARTED|Overall Study||0
2931305|NCT00591006|3642385|FG015|STARTED|Overall Study||1
2931306|NCT00591006|3642386|FG016|STARTED|Overall Study||0
2931307|NCT00591006|3642387|FG017|STARTED|Overall Study||1
2931308|NCT00591006|3642388|FG018|STARTED|Overall Study||0
2931309|NCT00591006|3642389|FG019|STARTED|Overall Study||1
2931310|NCT00591006|3642390|FG020|STARTED|Overall Study||0
2931311|NCT00591006|3642391|FG021|STARTED|Overall Study||1
2931312|NCT00591006|3642392|FG022|STARTED|Overall Study||1
2931313|NCT00591006|3642393|FG023|STARTED|Overall Study||1
2931314|NCT00591006|3642370|FG000|Treatment #2|Overall Study||1
2931315|NCT00591006|3642371|FG001|Treatment #2|Overall Study||0
2931316|NCT00591006|3642372|FG002|Treatment #2|Overall Study||1
2931317|NCT00591006|3642373|FG003|Treatment #2|Overall Study||1
2931318|NCT00591006|3642374|FG004|Treatment #2|Overall Study||1
2931319|NCT00591006|3642375|FG005|Treatment #2|Overall Study||0
2931320|NCT00591006|3642376|FG006|Treatment #2|Overall Study||1
2931321|NCT00591006|3642377|FG007|Treatment #2|Overall Study||0
2931322|NCT00591006|3642378|FG008|Treatment #2|Overall Study||1
2931323|NCT00591006|3642379|FG009|Treatment #2|Overall Study||1
2931324|NCT00591006|3642380|FG010|Treatment #2|Overall Study||0
2931325|NCT00591006|3642381|FG011|Treatment #2|Overall Study||1
2931326|NCT00591006|3642382|FG012|Treatment #2|Overall Study||1
2931327|NCT00591006|3642383|FG013|Treatment #2|Overall Study||2
2931328|NCT00591006|3642384|FG014|Treatment #2|Overall Study||0
2931329|NCT00591006|3642385|FG015|Treatment #2|Overall Study||0
2931330|NCT00591006|3642386|FG016|Treatment #2|Overall Study||0
2931331|NCT00591006|3642387|FG017|Treatment #2|Overall Study||1
2931332|NCT00591006|3642388|FG018|Treatment #2|Overall Study||0
2931333|NCT00591006|3642389|FG019|Treatment #2|Overall Study||1
3041634|NCT01172938|3761420|FG002|Completed Week 16|Placebo-controlled Phase (Week 0-24)||154
3041635|NCT01172938|3761421|FG003|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
3041636|NCT01172938|3761422|FG004|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
3041637|NCT01172938|3761423|FG005|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
3041638|NCT01172938|3761424|FG006|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
3041639|NCT01172938|3761425|FG007|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
3041640|NCT01172938|3761426|FG008|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
3041641|NCT01172938|3761418|FG000|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)|Five participants who escaped early did not complete Week 24|107
3041642|NCT01172938|3761419|FG001|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)|Six participants who escaped early did not complete Week 24|78
3041643|NCT01172938|3761420|FG002|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||58
3041644|NCT01172938|3761421|FG003|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
3041645|NCT01172938|3761422|FG004|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
3041646|NCT01172938|3761423|FG005|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
3041647|NCT01172938|3761424|FG006|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
3041648|NCT01172938|3761425|FG007|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
3041649|NCT01172938|3761426|FG008|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
3041650|NCT01172938|3761418|FG000|COMPLETED|Placebo-controlled Phase (Week 0-24)|One participant who completed Week 24 did not enter the active treatment phase|150
3041651|NCT01172938|3761419|FG001|COMPLETED|Placebo-controlled Phase (Week 0-24)||146
3041652|NCT01172938|3761420|FG002|COMPLETED|Placebo-controlled Phase (Week 0-24)||148
3041653|NCT01172938|3761421|FG003|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
3041654|NCT01172938|3761422|FG004|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
3041655|NCT01172938|3761423|FG005|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
3041656|NCT01172938|3761424|FG006|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
2931334|NCT00591006|3642390|FG020|Treatment #2|Overall Study||0
2931335|NCT00591006|3642391|FG021|Treatment #2|Overall Study||1
2931336|NCT00591006|3642392|FG022|Treatment #2|Overall Study||1
2931337|NCT00591006|3642393|FG023|Treatment #2|Overall Study||1
2931338|NCT00591006|3642370|FG000|Treatment #3|Overall Study||1
2931339|NCT00591006|3642371|FG001|Treatment #3|Overall Study||0
2931340|NCT00591006|3642372|FG002|Treatment #3|Overall Study||1
2931341|NCT00591006|3642373|FG003|Treatment #3|Overall Study||1
2931342|NCT00591006|3642374|FG004|Treatment #3|Overall Study||1
2931343|NCT00591006|3642375|FG005|Treatment #3|Overall Study||0
2931344|NCT00591006|3642376|FG006|Treatment #3|Overall Study||1
2931345|NCT00591006|3642377|FG007|Treatment #3|Overall Study||0
2931346|NCT00591006|3642378|FG008|Treatment #3|Overall Study||1
2931347|NCT00591006|3642379|FG009|Treatment #3|Overall Study||1
2931348|NCT00591006|3642380|FG010|Treatment #3|Overall Study||0
2931349|NCT00591006|3642381|FG011|Treatment #3|Overall Study||1
3179928|NCT01987895|3908215|FG001|NOT COMPLETED|Overall Study||30
3179929|NCT01987908|3908221|FG000|STARTED|Placebo Lead-in Period||23
3179930|NCT01987908|3908222|FG001|STARTED|Placebo Lead-in Period||0
3179931|NCT01987908|3908223|FG002|STARTED|Placebo Lead-in Period||0
3179932|NCT01987908|3908221|FG000|COMPLETED|Placebo Lead-in Period||14
3179933|NCT01987908|3908222|FG001|COMPLETED|Placebo Lead-in Period||0
3179934|NCT01987908|3908223|FG002|COMPLETED|Placebo Lead-in Period||0
3179935|NCT01987908|3908221|FG000|NOT COMPLETED|Placebo Lead-in Period||9
3179936|NCT01987908|3908222|FG001|NOT COMPLETED|Placebo Lead-in Period||0
3179937|NCT01987908|3908223|FG002|NOT COMPLETED|Placebo Lead-in Period||0
3179938|NCT01987908|3908221|FG000|STARTED|Treatment Period||0
2931350|NCT00591006|3642382|FG012|Treatment #3|Overall Study||1
2931351|NCT00591006|3642383|FG013|Treatment #3|Overall Study||2
2931352|NCT00591006|3642384|FG014|Treatment #3|Overall Study||0
2931353|NCT00591006|3642385|FG015|Treatment #3|Overall Study||0
2931354|NCT00591006|3642386|FG016|Treatment #3|Overall Study||0
2931355|NCT00591006|3642387|FG017|Treatment #3|Overall Study||1
2931356|NCT00591006|3642388|FG018|Treatment #3|Overall Study||0
2931357|NCT00591006|3642389|FG019|Treatment #3|Overall Study||1
2931358|NCT00591006|3642390|FG020|Treatment #3|Overall Study||0
2931359|NCT00591006|3642391|FG021|Treatment #3|Overall Study||1
2931360|NCT00591006|3642392|FG022|Treatment #3|Overall Study||1
2931361|NCT00591006|3642393|FG023|Treatment #3|Overall Study||1
2931362|NCT00591006|3642370|FG000|Treatment #4|Overall Study||1
2931363|NCT00591006|3642371|FG001|Treatment #4|Overall Study||0
2931364|NCT00591006|3642372|FG002|Treatment #4|Overall Study||1
2931365|NCT00591006|3642373|FG003|Treatment #4|Overall Study||1
2931366|NCT00591006|3642374|FG004|Treatment #4|Overall Study||1
2931367|NCT00591006|3642375|FG005|Treatment #4|Overall Study||0
2931368|NCT00591006|3642376|FG006|Treatment #4|Overall Study||1
2931369|NCT00591006|3642377|FG007|Treatment #4|Overall Study||0
2931370|NCT00591006|3642378|FG008|Treatment #4|Overall Study||1
2931371|NCT00591006|3642379|FG009|Treatment #4|Overall Study||1
2931372|NCT00591006|3642380|FG010|Treatment #4|Overall Study||0
2931373|NCT00591006|3642381|FG011|Treatment #4|Overall Study||1
2931374|NCT00591006|3642382|FG012|Treatment #4|Overall Study||1
2931375|NCT00591006|3642383|FG013|Treatment #4|Overall Study||2
2931376|NCT00591006|3642384|FG014|Treatment #4|Overall Study||0
2931377|NCT00591006|3642385|FG015|Treatment #4|Overall Study||0
2931378|NCT00591006|3642386|FG016|Treatment #4|Overall Study||0
2931379|NCT00591006|3642387|FG017|Treatment #4|Overall Study||1
2931380|NCT00591006|3642388|FG018|Treatment #4|Overall Study||0
2931381|NCT00591006|3642389|FG019|Treatment #4|Overall Study||1
2931382|NCT00591006|3642390|FG020|Treatment #4|Overall Study||0
2931383|NCT00591006|3642391|FG021|Treatment #4|Overall Study||1
2931384|NCT00591006|3642392|FG022|Treatment #4|Overall Study||0
3041657|NCT01172938|3761425|FG007|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
3041658|NCT01172938|3761426|FG008|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
3041659|NCT01172938|3761418|FG000|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||18
3041660|NCT01172938|3761419|FG001|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||22
3041661|NCT01172938|3761420|FG002|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||20
3041662|NCT01172938|3761421|FG003|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
3041663|NCT01172938|3761422|FG004|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
3041664|NCT01172938|3761423|FG005|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
3041665|NCT01172938|3761424|FG006|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
3041666|NCT01172938|3761425|FG007|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
3041667|NCT01172938|3761426|FG008|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
3041668|NCT01172938|3761418|FG000|STARTED|Active Treatment Phase (Weeks 25-52)||0
3041669|NCT01172938|3761419|FG001|STARTED|Active Treatment Phase (Weeks 25-52)|Ten participants who completed Week 24 did not enter the active treatment phase|136
3041670|NCT01172938|3761420|FG002|STARTED|Active Treatment Phase (Weeks 25-52)|Three participants who completed Week 24 did not enter the active treatment phase|145
3041671|NCT01172938|3761421|FG003|STARTED|Active Treatment Phase (Weeks 25-52)|One participant who escaped early and completed Week 24 did not enter the active treatment phase|51
3041672|NCT01172938|3761422|FG004|STARTED|Active Treatment Phase (Weeks 25-52)||23
3041673|NCT01172938|3761423|FG005|STARTED|Active Treatment Phase (Weeks 25-52)|One participant who escaped early and completed Week 24 did not enter the active treatment phase|49
3041674|NCT01172938|3761424|FG006|STARTED|Active Treatment Phase (Weeks 25-52)||24
2931385|NCT00591006|3642393|FG023|Treatment #4|Overall Study||0
2931386|NCT00591006|3642370|FG000|COMPLETED|Overall Study||1
2931387|NCT00591006|3642371|FG001|COMPLETED|Overall Study||0
2931388|NCT00591006|3642372|FG002|COMPLETED|Overall Study||1
2931389|NCT00591006|3642373|FG003|COMPLETED|Overall Study||1
2931390|NCT00591006|3642374|FG004|COMPLETED|Overall Study||1
2931391|NCT00591006|3642375|FG005|COMPLETED|Overall Study||0
2931392|NCT00591006|3642376|FG006|COMPLETED|Overall Study||1
2931393|NCT00591006|3642377|FG007|COMPLETED|Overall Study||0
2931394|NCT00591006|3642378|FG008|COMPLETED|Overall Study||1
2931395|NCT00591006|3642379|FG009|COMPLETED|Overall Study||1
2931396|NCT00591006|3642380|FG010|COMPLETED|Overall Study||0
2931397|NCT00591006|3642381|FG011|COMPLETED|Overall Study||1
2931398|NCT00591006|3642382|FG012|COMPLETED|Overall Study||1
2931399|NCT00591006|3642383|FG013|COMPLETED|Overall Study||2
2931400|NCT00591006|3642384|FG014|COMPLETED|Overall Study||0
2931401|NCT00591006|3642385|FG015|COMPLETED|Overall Study||0
2931402|NCT00591006|3642386|FG016|COMPLETED|Overall Study||0
2931403|NCT00591006|3642387|FG017|COMPLETED|Overall Study||1
2931404|NCT00591006|3642388|FG018|COMPLETED|Overall Study||0
2931405|NCT00591006|3642389|FG019|COMPLETED|Overall Study||1
2931406|NCT00591006|3642390|FG020|COMPLETED|Overall Study||0
2931407|NCT00591006|3642391|FG021|COMPLETED|Overall Study||1
2931408|NCT00591006|3642392|FG022|COMPLETED|Overall Study||0
2931409|NCT00591006|3642393|FG023|COMPLETED|Overall Study||0
2931410|NCT00591006|3642370|FG000|NOT COMPLETED|Overall Study||0
2931411|NCT00591006|3642371|FG001|NOT COMPLETED|Overall Study||0
2931412|NCT00591006|3642372|FG002|NOT COMPLETED|Overall Study||0
2931413|NCT00591006|3642373|FG003|NOT COMPLETED|Overall Study||0
2931414|NCT00591006|3642374|FG004|NOT COMPLETED|Overall Study||0
2931415|NCT00591006|3642375|FG005|NOT COMPLETED|Overall Study||0
2931416|NCT00591006|3642376|FG006|NOT COMPLETED|Overall Study||0
2931417|NCT00591006|3642377|FG007|NOT COMPLETED|Overall Study||0
2931418|NCT00591006|3642378|FG008|NOT COMPLETED|Overall Study||0
2931419|NCT00591006|3642379|FG009|NOT COMPLETED|Overall Study||0
2931420|NCT00591006|3642380|FG010|NOT COMPLETED|Overall Study||0
2931421|NCT00591006|3642381|FG011|NOT COMPLETED|Overall Study||0
2931422|NCT00591006|3642382|FG012|NOT COMPLETED|Overall Study||0
2931423|NCT00591006|3642383|FG013|NOT COMPLETED|Overall Study||0
2931424|NCT00591006|3642384|FG014|NOT COMPLETED|Overall Study||0
2931425|NCT00591006|3642385|FG015|NOT COMPLETED|Overall Study||1
2931426|NCT00591006|3642386|FG016|NOT COMPLETED|Overall Study||0
2931427|NCT00591006|3642387|FG017|NOT COMPLETED|Overall Study||0
2931428|NCT00591006|3642388|FG018|NOT COMPLETED|Overall Study||0
2931429|NCT00591006|3642389|FG019|NOT COMPLETED|Overall Study||0
3041675|NCT01172938|3761425|FG007|STARTED|Active Treatment Phase (Weeks 25-52)||0
3041676|NCT01172938|3761426|FG008|STARTED|Active Treatment Phase (Weeks 25-52)||0
3041677|NCT01172938|3761418|FG000|COMPLETED|Active Treatment Phase (Weeks 25-52)||0
3041678|NCT01172938|3761419|FG001|COMPLETED|Active Treatment Phase (Weeks 25-52)||124
3041679|NCT01172938|3761420|FG002|COMPLETED|Active Treatment Phase (Weeks 25-52)||130
3041680|NCT01172938|3761421|FG003|COMPLETED|Active Treatment Phase (Weeks 25-52)||44
3041681|NCT01172938|3761422|FG004|COMPLETED|Active Treatment Phase (Weeks 25-52)||19
3041682|NCT01172938|3761423|FG005|COMPLETED|Active Treatment Phase (Weeks 25-52)||34
3041683|NCT01172938|3761424|FG006|COMPLETED|Active Treatment Phase (Weeks 25-52)||22
3041684|NCT01172938|3761425|FG007|COMPLETED|Active Treatment Phase (Weeks 25-52)||0
3041685|NCT01172938|3761426|FG008|COMPLETED|Active Treatment Phase (Weeks 25-52)||0
3041686|NCT01172938|3761418|FG000|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||0
3041687|NCT01172938|3761419|FG001|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||12
3041688|NCT01172938|3761420|FG002|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||15
3041689|NCT01172938|3761421|FG003|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||7
3041690|NCT01172938|3761422|FG004|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||4
3041691|NCT01172938|3761423|FG005|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||15
3041692|NCT01172938|3761424|FG006|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||2
3041693|NCT01172938|3761425|FG007|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||0
3041694|NCT01172938|3761426|FG008|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||0
3041695|NCT01172938|3761418|FG000|STARTED|Active-Treatment Phase (Weeks 52-104)||0
3041696|NCT01172938|3761419|FG001|STARTED|Active-Treatment Phase (Weeks 52-104)|Six participants who completed Week 52 did not enter the next year of active treatment phase|118
3041697|NCT01172938|3761420|FG002|STARTED|Active-Treatment Phase (Weeks 52-104)|Nine participants who completed Week 52 did not enter the next year of active treatment phase|121
3041698|NCT01172938|3761421|FG003|STARTED|Active-Treatment Phase (Weeks 52-104)||0
3041699|NCT01172938|3761422|FG004|STARTED|Active-Treatment Phase (Weeks 52-104)||0
3041700|NCT01172938|3761423|FG005|STARTED|Active-Treatment Phase (Weeks 52-104)||0
3041701|NCT01172938|3761424|FG006|STARTED|Active-Treatment Phase (Weeks 52-104)||0
3041702|NCT01172938|3761425|FG007|STARTED|Active-Treatment Phase (Weeks 52-104)||61
3041703|NCT01172938|3761426|FG008|STARTED|Active-Treatment Phase (Weeks 52-104)||49
3041704|NCT01172938|3761418|FG000|COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
3041705|NCT01172938|3761419|FG001|COMPLETED|Active-Treatment Phase (Weeks 52-104)||95
3041706|NCT01172938|3761420|FG002|COMPLETED|Active-Treatment Phase (Weeks 52-104)||100
3041707|NCT01172938|3761421|FG003|COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
3041708|NCT01172938|3761422|FG004|COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
3041709|NCT01172938|3761423|FG005|COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
2931430|NCT00591006|3642390|FG020|NOT COMPLETED|Overall Study||0
2931431|NCT00591006|3642391|FG021|NOT COMPLETED|Overall Study||0
2931432|NCT00591006|3642392|FG022|NOT COMPLETED|Overall Study||1
2931433|NCT00591006|3642393|FG023|NOT COMPLETED|Overall Study||1
2931434|NCT00591019|3642410|FG000|STARTED|Baseline (1 Day)||3
2931435|NCT00591019|3642411|FG001|STARTED|Baseline (1 Day)||4
2931436|NCT00591019|3642410|FG000|COMPLETED|Baseline (1 Day)||3
2931437|NCT00591019|3642411|FG001|COMPLETED|Baseline (1 Day)||4
2931438|NCT00591019|3642410|FG000|NOT COMPLETED|Baseline (1 Day)||0
2931439|NCT00591019|3642411|FG001|NOT COMPLETED|Baseline (1 Day)||0
2931440|NCT00591019|3642410|FG000|STARTED|Intervention 1 (14 Days)|One subject dropped out after baseline|2
2931441|NCT00591019|3642411|FG001|STARTED|Intervention 1 (14 Days)|One subject dropped out after baseline|3
2931442|NCT00591019|3642410|FG000|COMPLETED|Intervention 1 (14 Days)||2
2931443|NCT00591019|3642411|FG001|COMPLETED|Intervention 1 (14 Days)||3
2931444|NCT00591019|3642410|FG000|NOT COMPLETED|Intervention 1 (14 Days)||0
2931445|NCT00591019|3642411|FG001|NOT COMPLETED|Intervention 1 (14 Days)||0
2931446|NCT00591019|3642410|FG000|STARTED|Intevention 2 (14 Days)||2
2931447|NCT00591019|3642411|FG001|STARTED|Intevention 2 (14 Days)||3
2931448|NCT00591019|3642410|FG000|COMPLETED|Intevention 2 (14 Days)||2
2931449|NCT00591019|3642411|FG001|COMPLETED|Intevention 2 (14 Days)||3
2931450|NCT00591019|3642410|FG000|NOT COMPLETED|Intevention 2 (14 Days)||0
2931451|NCT00591019|3642411|FG001|NOT COMPLETED|Intevention 2 (14 Days)||0
2931452|NCT00591123|3642419|FG000|STARTED|Overall Study||38
2931453|NCT00591123|3642419|FG000|COMPLETED|Overall Study|38 were analyzed for safety, 33 were included for efficacy.|38
2931454|NCT00591123|3642419|FG000|NOT COMPLETED|Overall Study||0
2931455|NCT00591149|3642423|FG000|STARTED|Overall Study||16
2931456|NCT00591149|3642423|FG000|COMPLETED|Overall Study||11
2931457|NCT00591149|3642423|FG000|NOT COMPLETED|Overall Study||5
2931458|NCT00591214|3642427|FG000|STARTED|Overall Study||10
2931459|NCT00591214|3642427|FG000|COMPLETED|Overall Study||2
2931460|NCT00591214|3642427|FG000|NOT COMPLETED|Overall Study||8
2931461|NCT00591240|3642433|FG000|STARTED|Overall Study||116
2931462|NCT00591240|3642434|FG001|STARTED|Overall Study||222
2931463|NCT00591240|3642433|FG000|COMPLETED|Overall Study||116
2931464|NCT00591240|3642434|FG001|COMPLETED|Overall Study||222
2931465|NCT00591240|3642433|FG000|NOT COMPLETED|Overall Study||0
2931466|NCT00591240|3642434|FG001|NOT COMPLETED|Overall Study||0
2931467|NCT00591253|3642443|FG000|STARTED|Overall Study|Randomized or Treated|140
2931468|NCT00591253|3642444|FG001|STARTED|Overall Study|Randomized or Treated|137
2931469|NCT00591253|3642445|FG002|STARTED|Overall Study|Randomized or Treated|138
2931470|NCT00591253|3642443|FG000|COMPLETED|Overall Study||126
2931471|NCT00591253|3642444|FG001|COMPLETED|Overall Study||116
3179939|NCT01987908|3908222|FG001|STARTED|Treatment Period||11
3179940|NCT01987908|3908223|FG002|STARTED|Treatment Period||3
3179941|NCT01987908|3908221|FG000|COMPLETED|Treatment Period||0
3179942|NCT01987908|3908222|FG001|COMPLETED|Treatment Period||10
3179943|NCT01987908|3908223|FG002|COMPLETED|Treatment Period||2
3179944|NCT01987908|3908221|FG000|NOT COMPLETED|Treatment Period||0
3179945|NCT01987908|3908222|FG001|NOT COMPLETED|Treatment Period||1
3179946|NCT01987908|3908223|FG002|NOT COMPLETED|Treatment Period||1
3179947|NCT01987908|3908221|FG000|STARTED|Post-Treatment Observation Period||0
3179948|NCT01987908|3908222|FG001|STARTED|Post-Treatment Observation Period||10
2931472|NCT00591253|3642445|FG002|COMPLETED|Overall Study||123
2931473|NCT00591253|3642443|FG000|NOT COMPLETED|Overall Study||14
2931474|NCT00591253|3642444|FG001|NOT COMPLETED|Overall Study||21
2931475|NCT00591253|3642445|FG002|NOT COMPLETED|Overall Study||15
2931476|NCT00591266|3642456|FG000|STARTED|Overall Study|Randomized only|189
2931477|NCT00591266|3642457|FG001|STARTED|Overall Study|Randomized only|188
2931478|NCT00591266|3642458|FG002|STARTED|Overall Study|Randomized only|189
2931479|NCT00591266|3642456|FG000|COMPLETED|Overall Study||180
2931480|NCT00591266|3642457|FG001|COMPLETED|Overall Study||177
2931481|NCT00591266|3642458|FG002|COMPLETED|Overall Study||175
2931482|NCT00591266|3642456|FG000|NOT COMPLETED|Overall Study||9
2931483|NCT00591266|3642457|FG001|NOT COMPLETED|Overall Study||11
2931484|NCT00591266|3642458|FG002|NOT COMPLETED|Overall Study||14
2931485|NCT00591305|3642468|FG000|STARTED|Overall Study||1
2931486|NCT00591305|3642469|FG001|STARTED|Overall Study||0
2931487|NCT00591305|3642468|FG000|1st Follow-up in 2 Wks After Surgery|Overall Study||1
2931488|NCT00591305|3642469|FG001|1st Follow-up in 2 Wks After Surgery|Overall Study||0
2931489|NCT00591305|3642468|FG000|COMPLETED|Overall Study||1
2931490|NCT00591305|3642469|FG001|COMPLETED|Overall Study||0
2931491|NCT00591305|3642468|FG000|NOT COMPLETED|Overall Study||0
2931492|NCT00591305|3642469|FG001|NOT COMPLETED|Overall Study||0
2931493|NCT00591344|3642478|FG000|STARTED|Overall Study|25 randomized, 1 withdrew before the 6 month test and was replaced; 24 completed the 6 month test|25
2931494|NCT00591344|3642479|FG001|STARTED|Overall Study|26 randomized, 2 withdrew before the 6 month test and were replaced, 24 completed 6 month test|26
2931495|NCT00591344|3642478|FG000|Completed the 6 Month Test|Overall Study|Number of subjects who completed the 6 month test|24
2931496|NCT00591344|3642479|FG001|Completed the 6 Month Test|Overall Study|Number of subjects who completed the 6 month test|24
2931497|NCT00591344|3642478|FG000|COMPLETED|Overall Study|Number of subjects who completed the final 24 month test|20
2931498|NCT00591344|3642479|FG001|COMPLETED|Overall Study|Number of subjects who completed the final 24 month test|18
2931499|NCT00591344|3642478|FG000|NOT COMPLETED|Overall Study||5
2931500|NCT00591344|3642479|FG001|NOT COMPLETED|Overall Study||8
2931501|NCT00591370|3642489|FG000|STARTED|Overall Study||51
3179949|NCT01987908|3908223|FG002|STARTED|Post-Treatment Observation Period||2
2931502|NCT00591370|3642489|FG000|COMPLETED|Overall Study||49
2931503|NCT00591370|3642489|FG000|NOT COMPLETED|Overall Study||2
2931504|NCT00591409|3642503|FG000|STARTED|Overall Study||10
2931505|NCT00591409|3642504|FG001|STARTED|Overall Study||10
2931506|NCT00591409|3642505|FG002|STARTED|Overall Study||10
2931507|NCT00591409|3642506|FG003|STARTED|Overall Study||10
3041710|NCT01172938|3761424|FG006|COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
3041711|NCT01172938|3761425|FG007|COMPLETED|Active-Treatment Phase (Weeks 52-104)||46
3041712|NCT01172938|3761426|FG008|COMPLETED|Active-Treatment Phase (Weeks 52-104)||45
3041713|NCT01172938|3761418|FG000|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
3041714|NCT01172938|3761419|FG001|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||23
3041715|NCT01172938|3761420|FG002|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||21
3041716|NCT01172938|3761421|FG003|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
3041717|NCT01172938|3761422|FG004|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
3041718|NCT01172938|3761423|FG005|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
3041719|NCT01172938|3761424|FG006|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
3041720|NCT01172938|3761425|FG007|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||15
3041721|NCT01172938|3761426|FG008|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||4
3041722|NCT01172938|3761418|FG000|STARTED|Active-Treatment Phase Weeks (104-156)||0
3041723|NCT01172938|3761419|FG001|STARTED|Active-Treatment Phase Weeks (104-156)||95
3041724|NCT01172938|3761420|FG002|STARTED|Active-Treatment Phase Weeks (104-156)||100
3041725|NCT01172938|3761421|FG003|STARTED|Active-Treatment Phase Weeks (104-156)||0
3041726|NCT01172938|3761422|FG004|STARTED|Active-Treatment Phase Weeks (104-156)||0
3041727|NCT01172938|3761423|FG005|STARTED|Active-Treatment Phase Weeks (104-156)||0
3041728|NCT01172938|3761424|FG006|STARTED|Active-Treatment Phase Weeks (104-156)||0
3041729|NCT01172938|3761425|FG007|STARTED|Active-Treatment Phase Weeks (104-156)||46
3041730|NCT01172938|3761426|FG008|STARTED|Active-Treatment Phase Weeks (104-156)||45
3041731|NCT01172938|3761418|FG000|COMPLETED|Active-Treatment Phase Weeks (104-156)||0
3041732|NCT01172938|3761419|FG001|COMPLETED|Active-Treatment Phase Weeks (104-156)||84
3041733|NCT01172938|3761420|FG002|COMPLETED|Active-Treatment Phase Weeks (104-156)||93
3041734|NCT01172938|3761421|FG003|COMPLETED|Active-Treatment Phase Weeks (104-156)||0
3041735|NCT01172938|3761422|FG004|COMPLETED|Active-Treatment Phase Weeks (104-156)||0
3041736|NCT01172938|3761423|FG005|COMPLETED|Active-Treatment Phase Weeks (104-156)||0
3041737|NCT01172938|3761424|FG006|COMPLETED|Active-Treatment Phase Weeks (104-156)||0
3041738|NCT01172938|3761425|FG007|COMPLETED|Active-Treatment Phase Weeks (104-156)||41
3041739|NCT01172938|3761426|FG008|COMPLETED|Active-Treatment Phase Weeks (104-156)||41
3041740|NCT01172938|3761418|FG000|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||0
3041741|NCT01172938|3761419|FG001|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||11
3041742|NCT01172938|3761420|FG002|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||7
3041743|NCT01172938|3761421|FG003|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||0
3041744|NCT01172938|3761422|FG004|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||0
3041745|NCT01172938|3761423|FG005|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||0
3041746|NCT01172938|3761424|FG006|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||0
3041747|NCT01172938|3761425|FG007|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||5
3041748|NCT01172938|3761426|FG008|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||4
3041749|NCT01172938|3761418|FG000|STARTED|Active-Treatment Phase (Weeks 156-208)||0
3041750|NCT01172938|3761419|FG001|STARTED|Active-Treatment Phase (Weeks 156-208)||84
3041751|NCT01172938|3761420|FG002|STARTED|Active-Treatment Phase (Weeks 156-208)||93
3041752|NCT01172938|3761421|FG003|STARTED|Active-Treatment Phase (Weeks 156-208)||0
3041753|NCT01172938|3761422|FG004|STARTED|Active-Treatment Phase (Weeks 156-208)||0
3041754|NCT01172938|3761423|FG005|STARTED|Active-Treatment Phase (Weeks 156-208)||0
3041755|NCT01172938|3761424|FG006|STARTED|Active-Treatment Phase (Weeks 156-208)||0
3041756|NCT01172938|3761425|FG007|STARTED|Active-Treatment Phase (Weeks 156-208)||41
3041757|NCT01172938|3761426|FG008|STARTED|Active-Treatment Phase (Weeks 156-208)||41
3041758|NCT01172938|3761418|FG000|COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
3041759|NCT01172938|3761419|FG001|COMPLETED|Active-Treatment Phase (Weeks 156-208)||75
3041760|NCT01172938|3761420|FG002|COMPLETED|Active-Treatment Phase (Weeks 156-208)||88
3041761|NCT01172938|3761421|FG003|COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
3041762|NCT01172938|3761422|FG004|COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
3041763|NCT01172938|3761423|FG005|COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
3041764|NCT01172938|3761424|FG006|COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
3041765|NCT01172938|3761425|FG007|COMPLETED|Active-Treatment Phase (Weeks 156-208)||32
3041766|NCT01172938|3761426|FG008|COMPLETED|Active-Treatment Phase (Weeks 156-208)||34
3041767|NCT01172938|3761418|FG000|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
3041768|NCT01172938|3761419|FG001|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||9
3041769|NCT01172938|3761420|FG002|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||5
3041770|NCT01172938|3761421|FG003|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
3041771|NCT01172938|3761422|FG004|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
3041772|NCT01172938|3761423|FG005|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
3041773|NCT01172938|3761424|FG006|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
3041774|NCT01172938|3761425|FG007|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||9
2931508|NCT00591409|3642507|FG004|STARTED|Overall Study||10
2931509|NCT00591409|3642508|FG005|STARTED|Overall Study||10
2931510|NCT00591409|3642509|FG006|STARTED|Overall Study||10
2931511|NCT00591409|3642510|FG007|STARTED|Overall Study||10
2931512|NCT00591409|3642511|FG008|STARTED|Overall Study||9
2931513|NCT00591409|3642512|FG009|STARTED|Overall Study||11
2931514|NCT00591409|3642503|FG000|Treated|Overall Study||10
2931515|NCT00591409|3642504|FG001|Treated|Overall Study||10
2931516|NCT00591409|3642505|FG002|Treated|Overall Study||10
2931517|NCT00591409|3642506|FG003|Treated|Overall Study||10
2931518|NCT00591409|3642507|FG004|Treated|Overall Study||9
2931519|NCT00591409|3642508|FG005|Treated|Overall Study||10
2931520|NCT00591409|3642509|FG006|Treated|Overall Study||10
2931521|NCT00591409|3642510|FG007|Treated|Overall Study||10
2931522|NCT00591409|3642511|FG008|Treated|Overall Study||9
2931523|NCT00591409|3642512|FG009|Treated|Overall Study||10
2931524|NCT00591409|3642503|FG000|COMPLETED|Overall Study||10
2931525|NCT00591409|3642504|FG001|COMPLETED|Overall Study||10
2931526|NCT00591409|3642505|FG002|COMPLETED|Overall Study||10
2931527|NCT00591409|3642506|FG003|COMPLETED|Overall Study||10
2931528|NCT00591409|3642507|FG004|COMPLETED|Overall Study||9
2931529|NCT00591409|3642508|FG005|COMPLETED|Overall Study||10
2931530|NCT00591409|3642509|FG006|COMPLETED|Overall Study||10
2931531|NCT00591409|3642510|FG007|COMPLETED|Overall Study||10
2931532|NCT00591409|3642511|FG008|COMPLETED|Overall Study||9
2931533|NCT00591409|3642512|FG009|COMPLETED|Overall Study||10
2931534|NCT00591409|3642503|FG000|NOT COMPLETED|Overall Study||0
2931535|NCT00591409|3642504|FG001|NOT COMPLETED|Overall Study||0
2931536|NCT00591409|3642505|FG002|NOT COMPLETED|Overall Study||0
2931537|NCT00591409|3642506|FG003|NOT COMPLETED|Overall Study||0
2931538|NCT00591409|3642507|FG004|NOT COMPLETED|Overall Study||1
2931539|NCT00591409|3642508|FG005|NOT COMPLETED|Overall Study||0
2931540|NCT00591409|3642509|FG006|NOT COMPLETED|Overall Study||0
2931541|NCT00591409|3642510|FG007|NOT COMPLETED|Overall Study||0
2931542|NCT00591409|3642511|FG008|NOT COMPLETED|Overall Study||0
2931543|NCT00591409|3642512|FG009|NOT COMPLETED|Overall Study||1
2931544|NCT00591565|3642534|FG000|STARTED|Overall Study||13
2931545|NCT00591565|3642534|FG000|COMPLETED|Overall Study||8
2931546|NCT00591565|3642534|FG000|NOT COMPLETED|Overall Study||5
2931547|NCT00591578|3642541|FG000|STARTED|Double-Blind Treatment Phase||327
2931548|NCT00591578|3642542|FG001|STARTED|Double-Blind Treatment Phase||329
2931549|NCT00591578|3642543|FG002|STARTED|Double-Blind Treatment Phase|Two participants randomized but not treated.|328
2931550|NCT00591578|3642541|FG000|COMPLETED|Double-Blind Treatment Phase||249
2931551|NCT00591578|3642542|FG001|COMPLETED|Double-Blind Treatment Phase||249
2931552|NCT00591578|3642543|FG002|COMPLETED|Double-Blind Treatment Phase||244
2931553|NCT00591578|3642541|FG000|NOT COMPLETED|Double-Blind Treatment Phase||78
2931554|NCT00591578|3642542|FG001|NOT COMPLETED|Double-Blind Treatment Phase||80
2931555|NCT00591578|3642543|FG002|NOT COMPLETED|Double-Blind Treatment Phase||84
2931556|NCT00591578|3642541|FG000|STARTED|Open-Label Extension Phase||55
2931557|NCT00591578|3642542|FG001|STARTED|Open-Label Extension Phase||115
2931558|NCT00591578|3642543|FG002|STARTED|Open-Label Extension Phase||0
2931559|NCT00591578|3642541|FG000|COMPLETED|Open-Label Extension Phase||49
3041775|NCT01172938|3761426|FG008|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||7
3041776|NCT01172938|3761418|FG000|STARTED|Active-Treatment Phase (Weeks 208-260)||0
3041777|NCT01172938|3761419|FG001|STARTED|Active-Treatment Phase (Weeks 208-260)||75
3041778|NCT01172938|3761420|FG002|STARTED|Active-Treatment Phase (Weeks 208-260)||88
3041779|NCT01172938|3761421|FG003|STARTED|Active-Treatment Phase (Weeks 208-260)||0
3041780|NCT01172938|3761422|FG004|STARTED|Active-Treatment Phase (Weeks 208-260)||0
3041781|NCT01172938|3761423|FG005|STARTED|Active-Treatment Phase (Weeks 208-260)||0
3041782|NCT01172938|3761424|FG006|STARTED|Active-Treatment Phase (Weeks 208-260)||0
3041783|NCT01172938|3761425|FG007|STARTED|Active-Treatment Phase (Weeks 208-260)||32
3041784|NCT01172938|3761426|FG008|STARTED|Active-Treatment Phase (Weeks 208-260)||34
3179950|NCT01987908|3908221|FG000|COMPLETED|Post-Treatment Observation Period||0
3179951|NCT01987908|3908222|FG001|COMPLETED|Post-Treatment Observation Period||7
3179952|NCT01987908|3908223|FG002|COMPLETED|Post-Treatment Observation Period||2
3179953|NCT01987908|3908221|FG000|NOT COMPLETED|Post-Treatment Observation Period||0
3179954|NCT01987908|3908222|FG001|NOT COMPLETED|Post-Treatment Observation Period||3
3179955|NCT01987908|3908223|FG002|NOT COMPLETED|Post-Treatment Observation Period||0
3363501|NCT04067401|4094617|FG000|COMPLETED|Overall Study||740
3363502|NCT04067401|4094618|FG001|COMPLETED|Overall Study||737
3363503|NCT04067401|4094617|FG000|NOT COMPLETED|Overall Study||8
3363504|NCT04067401|4094618|FG001|NOT COMPLETED|Overall Study||0
3363505|NCT04067050|4094626|FG000|STARTED|One Month||32
3363506|NCT04067050|4094627|FG001|STARTED|One Month||29
3363507|NCT04067050|4094626|FG000|COMPLETED|One Month||28
3363508|NCT04067050|4094627|FG001|COMPLETED|One Month||29
3363509|NCT04067050|4094626|FG000|NOT COMPLETED|One Month||4
3041785|NCT01172938|3761418|FG000|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
3041786|NCT01172938|3761419|FG001|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
3041787|NCT01172938|3761420|FG002|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
3041788|NCT01172938|3761421|FG003|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
3041789|NCT01172938|3761422|FG004|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
3041790|NCT01172938|3761423|FG005|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
3041791|NCT01172938|3761424|FG006|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
3041792|NCT01172938|3761425|FG007|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||25
3363510|NCT04067050|4094627|FG001|NOT COMPLETED|One Month||0
2931560|NCT00591578|3642542|FG001|COMPLETED|Open-Label Extension Phase||105
2931561|NCT00591578|3642543|FG002|COMPLETED|Open-Label Extension Phase||0
2931562|NCT00591578|3642541|FG000|NOT COMPLETED|Open-Label Extension Phase||6
2931563|NCT00591578|3642542|FG001|NOT COMPLETED|Open-Label Extension Phase||10
2931564|NCT00591578|3642543|FG002|NOT COMPLETED|Open-Label Extension Phase||0
2931565|NCT00591591|3642554|FG000|STARTED|Overall Study||176
2931566|NCT00591591|3642555|FG001|STARTED|Overall Study||133
2931567|NCT00591591|3642554|FG000|COMPLETED|Overall Study||165
2931568|NCT00591591|3642555|FG001|COMPLETED|Overall Study||94
2931569|NCT00591591|3642554|FG000|NOT COMPLETED|Overall Study||11
2931570|NCT00591591|3642555|FG001|NOT COMPLETED|Overall Study||39
2931571|NCT00591630|3642565|FG000|STARTED|Overall Study||6
2931572|NCT00591630|3642566|FG001|STARTED|Overall Study||8
2931573|NCT00591630|3642567|FG002|STARTED|Overall Study||10
2931574|NCT00591630|3642568|FG003|STARTED|Overall Study||6
2931575|NCT00591630|3642565|FG000|COMPLETED|Overall Study||6
2931576|NCT00591630|3642566|FG001|COMPLETED|Overall Study||8
2931577|NCT00591630|3642567|FG002|COMPLETED|Overall Study||9
2931578|NCT00591630|3642568|FG003|COMPLETED|Overall Study||6
2931579|NCT00591630|3642565|FG000|NOT COMPLETED|Overall Study||0
2931580|NCT00591630|3642566|FG001|NOT COMPLETED|Overall Study||0
2931581|NCT00591630|3642567|FG002|NOT COMPLETED|Overall Study||1
2931582|NCT00591630|3642568|FG003|NOT COMPLETED|Overall Study||0
2931583|NCT00591721|3642580|FG000|STARTED|Overall Study||89
2931584|NCT00591721|3642581|FG001|STARTED|Overall Study||92
2931585|NCT00591721|3642580|FG000|COMPLETED|Overall Study||68
2931586|NCT00591721|3642581|FG001|COMPLETED|Overall Study||70
2931587|NCT00591721|3642580|FG000|NOT COMPLETED|Overall Study||21
2931588|NCT00591721|3642581|FG001|NOT COMPLETED|Overall Study||22
2931589|NCT00591734|3642587|FG000|STARTED|Overall Study||57
2931590|NCT00591734|3642587|FG000|COMPLETED|Overall Study||4
2931591|NCT00591734|3642587|FG000|NOT COMPLETED|Overall Study||53
2931592|NCT00591760|3642593|FG000|STARTED|Overall Study||28
2931593|NCT00591760|3642594|FG001|STARTED|Overall Study||28
2931594|NCT00591760|3642593|FG000|COMPLETED|Overall Study||28
2931595|NCT00591760|3642594|FG001|COMPLETED|Overall Study||28
2931596|NCT00591760|3642593|FG000|NOT COMPLETED|Overall Study||0
2931597|NCT00591760|3642594|FG001|NOT COMPLETED|Overall Study||0
2931598|NCT00591773|3642603|FG000|STARTED|Overall Study||185
2931599|NCT00591773|3642604|FG001|STARTED|Overall Study||182
2931600|NCT00591773|3642605|FG002|STARTED|Overall Study||184
2931601|NCT00591773|3642603|FG000|COMPLETED|Overall Study||169
2931602|NCT00591773|3642604|FG001|COMPLETED|Overall Study||158
2931603|NCT00591773|3642605|FG002|COMPLETED|Overall Study||168
2931604|NCT00591773|3642603|FG000|NOT COMPLETED|Overall Study||16
2931605|NCT00591773|3642604|FG001|NOT COMPLETED|Overall Study||24
2931606|NCT00591773|3642605|FG002|NOT COMPLETED|Overall Study||16
2931607|NCT00591786|3642623|FG000|STARTED|Overall Study||9
2931608|NCT00591786|3642624|FG001|STARTED|Overall Study||9
2931609|NCT00591786|3642625|FG002|STARTED|Overall Study||11
2931610|NCT00591786|3642626|FG003|STARTED|Overall Study||11
2931611|NCT00591786|3642627|FG004|STARTED|Overall Study||10
2931612|NCT00591786|3642628|FG005|STARTED|Overall Study||10
2931613|NCT00591786|3642629|FG006|STARTED|Overall Study||10
2931614|NCT00591786|3642630|FG007|STARTED|Overall Study||10
2931615|NCT00591786|3642631|FG008|STARTED|Overall Study||10
3041793|NCT01172938|3761426|FG008|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
3041794|NCT01172938|3761418|FG000|COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
3041795|NCT01172938|3761419|FG001|COMPLETED|Active-Treatment Phase (Weeks 208-260)||72
3041796|NCT01172938|3761420|FG002|COMPLETED|Active-Treatment Phase (Weeks 208-260)||80
3041797|NCT01172938|3761421|FG003|COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
3041798|NCT01172938|3761422|FG004|COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
3041799|NCT01172938|3761423|FG005|COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
3041800|NCT01172938|3761424|FG006|COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
3041801|NCT01172938|3761425|FG007|COMPLETED|Active-Treatment Phase (Weeks 208-260)||29
3041802|NCT01172938|3761426|FG008|COMPLETED|Active-Treatment Phase (Weeks 208-260)||32
3041803|NCT01172938|3761418|FG000|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
3041804|NCT01172938|3761419|FG001|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||3
3041805|NCT01172938|3761420|FG002|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||8
3041806|NCT01172938|3761421|FG003|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
3041807|NCT01172938|3761422|FG004|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
3041808|NCT01172938|3761423|FG005|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
3041809|NCT01172938|3761424|FG006|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
3041810|NCT01172938|3761425|FG007|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||3
3041811|NCT01172938|3761426|FG008|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||2
3041812|NCT01173016|3761444|FG000|STARTED|Overall Study||11
3041813|NCT01173016|3761444|FG000|COMPLETED|Overall Study||10
3041814|NCT01173016|3761444|FG000|NOT COMPLETED|Overall Study||1
3041815|NCT01173029|3761450|FG000|STARTED|Overall Study||61
3041816|NCT01173029|3761451|FG001|STARTED|Overall Study||31
3041817|NCT01173029|3761450|FG000|COMPLETED|Overall Study||61
3041818|NCT01173029|3761451|FG001|COMPLETED|Overall Study||31
3041819|NCT01173029|3761450|FG000|NOT COMPLETED|Overall Study||0
3041820|NCT01173029|3761451|FG001|NOT COMPLETED|Overall Study||0
3041821|NCT01173055|3761468|FG000|STARTED|Period 1 - Day 1 to 49||10
3041822|NCT01173055|3761469|FG001|STARTED|Period 1 - Day 1 to 49||12
3041823|NCT01173055|3761468|FG000|COMPLETED|Period 1 - Day 1 to 49||8
2931616|NCT00591786|3642632|FG009|STARTED|Overall Study||10
2931617|NCT00591786|3642623|FG000|Treated Participants|Overall Study||9
2931618|NCT00591786|3642624|FG001|Treated Participants|Overall Study||9
2931619|NCT00591786|3642625|FG002|Treated Participants|Overall Study||10
2931620|NCT00591786|3642626|FG003|Treated Participants|Overall Study||11
2931621|NCT00591786|3642627|FG004|Treated Participants|Overall Study||10
2931622|NCT00591786|3642628|FG005|Treated Participants|Overall Study||10
2931623|NCT00591786|3642629|FG006|Treated Participants|Overall Study||10
2931624|NCT00591786|3642630|FG007|Treated Participants|Overall Study||10
2931625|NCT00591786|3642631|FG008|Treated Participants|Overall Study||10
2931626|NCT00591786|3642632|FG009|Treated Participants|Overall Study||10
2931627|NCT00591786|3642623|FG000|COMPLETED|Overall Study||9
2931628|NCT00591786|3642624|FG001|COMPLETED|Overall Study||9
2931629|NCT00591786|3642625|FG002|COMPLETED|Overall Study||10
2931630|NCT00591786|3642626|FG003|COMPLETED|Overall Study||11
2931631|NCT00591786|3642627|FG004|COMPLETED|Overall Study||10
2931632|NCT00591786|3642628|FG005|COMPLETED|Overall Study||10
2931633|NCT00591786|3642629|FG006|COMPLETED|Overall Study||10
2931634|NCT00591786|3642630|FG007|COMPLETED|Overall Study||10
2931635|NCT00591786|3642631|FG008|COMPLETED|Overall Study||10
2931636|NCT00591786|3642632|FG009|COMPLETED|Overall Study||10
2931637|NCT00591786|3642623|FG000|NOT COMPLETED|Overall Study||0
2931638|NCT00591786|3642624|FG001|NOT COMPLETED|Overall Study||0
2931639|NCT00591786|3642625|FG002|NOT COMPLETED|Overall Study||1
2931640|NCT00591786|3642626|FG003|NOT COMPLETED|Overall Study||0
2931641|NCT00591786|3642627|FG004|NOT COMPLETED|Overall Study||0
2931642|NCT00591786|3642628|FG005|NOT COMPLETED|Overall Study||0
2931643|NCT00591786|3642629|FG006|NOT COMPLETED|Overall Study||0
2931644|NCT00591786|3642630|FG007|NOT COMPLETED|Overall Study||0
2931645|NCT00591786|3642631|FG008|NOT COMPLETED|Overall Study||0
2931646|NCT00591786|3642632|FG009|NOT COMPLETED|Overall Study||0
2931647|NCT00591825|3642658|FG000|STARTED|Overall Study||14
2931648|NCT00591825|3642659|FG001|STARTED|Overall Study||13
2931649|NCT00591825|3642660|FG002|STARTED|Overall Study||13
2931650|NCT00591825|3642661|FG003|STARTED|Overall Study||14
2931651|NCT00591825|3642658|FG000|COMPLETED|Overall Study||14
2931652|NCT00591825|3642659|FG001|COMPLETED|Overall Study||13
2931653|NCT00591825|3642660|FG002|COMPLETED|Overall Study||13
2931654|NCT00591825|3642661|FG003|COMPLETED|Overall Study||14
2931655|NCT00591825|3642658|FG000|NOT COMPLETED|Overall Study||0
2931656|NCT00591825|3642659|FG001|NOT COMPLETED|Overall Study||0
2931657|NCT00591825|3642660|FG002|NOT COMPLETED|Overall Study||0
2931658|NCT00591825|3642661|FG003|NOT COMPLETED|Overall Study||0
2931659|NCT00591838|3642686|FG000|STARTED|Overall Study||5
2931660|NCT00591838|3642687|FG001|STARTED|Overall Study||6
2931661|NCT00591838|3642688|FG002|STARTED|Overall Study||6
2931662|NCT00591838|3642689|FG003|STARTED|Overall Study||6
2931663|NCT00591838|3642690|FG004|STARTED|Overall Study||51
2931664|NCT00591838|3642686|FG000|COMPLETED|Overall Study||5
2931665|NCT00591838|3642687|FG001|COMPLETED|Overall Study||6
2931666|NCT00591838|3642688|FG002|COMPLETED|Overall Study||6
2931667|NCT00591838|3642689|FG003|COMPLETED|Overall Study||5
2931668|NCT00591838|3642690|FG004|COMPLETED|Overall Study||51
2931669|NCT00591838|3642686|FG000|NOT COMPLETED|Overall Study||0
2931670|NCT00591838|3642687|FG001|NOT COMPLETED|Overall Study||0
2931671|NCT00591838|3642688|FG002|NOT COMPLETED|Overall Study||0
2931672|NCT00591838|3642689|FG003|NOT COMPLETED|Overall Study||1
2931673|NCT00591838|3642690|FG004|NOT COMPLETED|Overall Study||0
2931674|NCT00591851|3642703|FG000|STARTED|Overall Study||70
2931675|NCT00591851|3642703|FG000|COMPLETED|Overall Study||64
2931676|NCT00591851|3642703|FG000|NOT COMPLETED|Overall Study||6
2931677|NCT00591864|3642707|FG000|STARTED|Overall Study||89
2931678|NCT00591864|3642707|FG000|COMPLETED|Overall Study||84
2931679|NCT00591864|3642707|FG000|NOT COMPLETED|Overall Study||5
2931680|NCT00591942|3642712|FG000|STARTED|Overall Study||36
2931681|NCT00591942|3642713|FG001|STARTED|Overall Study||36
2931682|NCT00591942|3642712|FG000|COMPLETED|Overall Study||36
2931683|NCT00591942|3642713|FG001|COMPLETED|Overall Study||36
2931684|NCT00591942|3642712|FG000|NOT COMPLETED|Overall Study||0
2931685|NCT00591942|3642713|FG001|NOT COMPLETED|Overall Study||0
2931686|NCT00592072|3642719|FG000|STARTED|First Sequence||6
2931687|NCT00592072|3642720|FG001|STARTED|First Sequence||6
2931688|NCT00592072|3642719|FG000|COMPLETED|First Sequence||6
2931689|NCT00592072|3642720|FG001|COMPLETED|First Sequence||6
2931690|NCT00592072|3642719|FG000|NOT COMPLETED|First Sequence||0
2931691|NCT00592072|3642720|FG001|NOT COMPLETED|First Sequence||0
2931692|NCT00592072|3642719|FG000|STARTED|Wash Out Period||6
2931693|NCT00592072|3642720|FG001|STARTED|Wash Out Period||6
2931694|NCT00592072|3642719|FG000|COMPLETED|Wash Out Period||5
2931695|NCT00592072|3642720|FG001|COMPLETED|Wash Out Period||5
2931696|NCT00592072|3642719|FG000|NOT COMPLETED|Wash Out Period||1
2931697|NCT00592072|3642720|FG001|NOT COMPLETED|Wash Out Period||1
2931698|NCT00592072|3642719|FG000|STARTED|Second Sequence||5
2931699|NCT00592072|3642720|FG001|STARTED|Second Sequence||5
2931700|NCT00592072|3642719|FG000|COMPLETED|Second Sequence||5
2931701|NCT00592072|3642720|FG001|COMPLETED|Second Sequence||5
2931702|NCT00592072|3642719|FG000|NOT COMPLETED|Second Sequence||0
2931703|NCT00592072|3642720|FG001|NOT COMPLETED|Second Sequence||0
2931704|NCT00592124|3642732|FG000|STARTED|Overall Study||28
2931705|NCT00592124|3642733|FG001|STARTED|Overall Study||29
2931706|NCT00592124|3642734|FG002|STARTED|Overall Study||30
2931707|NCT00592124|3642735|FG003|STARTED|Overall Study||27
2931708|NCT00592124|3642736|FG004|STARTED|Overall Study||27
2931709|NCT00592124|3642737|FG005|STARTED|Overall Study||27
2931710|NCT00592124|3642732|FG000|COMPLETED|Overall Study||24
2931711|NCT00592124|3642733|FG001|COMPLETED|Overall Study||24
2931712|NCT00592124|3642734|FG002|COMPLETED|Overall Study||24
2931713|NCT00592124|3642735|FG003|COMPLETED|Overall Study||24
2931714|NCT00592124|3642736|FG004|COMPLETED|Overall Study||24
2931715|NCT00592124|3642737|FG005|COMPLETED|Overall Study||24
2931716|NCT00592124|3642732|FG000|NOT COMPLETED|Overall Study||4
2931717|NCT00592124|3642733|FG001|NOT COMPLETED|Overall Study||5
2931718|NCT00592124|3642734|FG002|NOT COMPLETED|Overall Study||6
2931719|NCT00592124|3642735|FG003|NOT COMPLETED|Overall Study||3
2931720|NCT00592124|3642736|FG004|NOT COMPLETED|Overall Study||3
2931721|NCT00592124|3642737|FG005|NOT COMPLETED|Overall Study||3
2931722|NCT00592176|3642747|FG000|STARTED|Overall Study||5
2931723|NCT00592176|3642747|FG000|COMPLETED|Overall Study||5
2931724|NCT00592176|3642747|FG000|NOT COMPLETED|Overall Study||0
2931725|NCT00592319|3642753|FG000|STARTED|Overall Study||2
2931726|NCT00592319|3642754|FG001|STARTED|Overall Study||8
2931727|NCT00592319|3642753|FG000|COMPLETED|Overall Study||2
2931728|NCT00592319|3642754|FG001|COMPLETED|Overall Study||5
2931729|NCT00592319|3642753|FG000|NOT COMPLETED|Overall Study||0
2931730|NCT00592319|3642754|FG001|NOT COMPLETED|Overall Study||3
2931731|NCT00592358|3642762|FG000|STARTED|Overall Study||17
2931732|NCT00592358|3642762|FG000|COMPLETED|Overall Study||11
2931733|NCT00592358|3642762|FG000|NOT COMPLETED|Overall Study||6
2931734|NCT00592384|3642768|FG000|STARTED|Overall Study||64
2931735|NCT00592384|3642769|FG001|STARTED|Overall Study||69
2931736|NCT00592384|3642768|FG000|COMPLETED|Overall Study||59
2931737|NCT00592384|3642769|FG001|COMPLETED|Overall Study||63
2931738|NCT00592384|3642768|FG000|NOT COMPLETED|Overall Study||5
2931739|NCT00592384|3642769|FG001|NOT COMPLETED|Overall Study||6
2931740|NCT00592475|3642778|FG000|STARTED|Overall Study||6
2931741|NCT00592475|3642779|FG001|STARTED|Overall Study||9
2931742|NCT00592475|3642780|FG002|STARTED|Overall Study||5
2931743|NCT00592475|3642778|FG000|COMPLETED|Overall Study||6
2931744|NCT00592475|3642779|FG001|COMPLETED|Overall Study||9
2931745|NCT00592475|3642780|FG002|COMPLETED|Overall Study||5
2931746|NCT00592475|3642778|FG000|NOT COMPLETED|Overall Study||0
2931747|NCT00592475|3642779|FG001|NOT COMPLETED|Overall Study||0
2931748|NCT00592475|3642780|FG002|NOT COMPLETED|Overall Study||0
2931749|NCT00592488|3642790|FG000|STARTED|Overall Study||6
2931750|NCT00592488|3642791|FG001|STARTED|Overall Study||7
2931751|NCT00592488|3642790|FG000|COMPLETED|Overall Study||6
2931752|NCT00592488|3642791|FG001|COMPLETED|Overall Study||7
2931753|NCT00592488|3642790|FG000|NOT COMPLETED|Overall Study||0
2931754|NCT00592488|3642791|FG001|NOT COMPLETED|Overall Study||0
2931755|NCT00592501|3642799|FG000|STARTED|Overall Study||25
2931756|NCT00592501|3642799|FG000|COMPLETED|Overall Study||23
2931757|NCT00592501|3642799|FG000|NOT COMPLETED|Overall Study||2
2931758|NCT00592553|3642806|FG000|STARTED|Overall Study||60
2931759|NCT00592553|3642807|FG001|STARTED|Overall Study||57
2931760|NCT00592553|3642808|FG002|STARTED|Overall Study||57
2931761|NCT00592553|3642806|FG000|As-treated Population|Overall Study||60
2931762|NCT00592553|3642807|FG001|As-treated Population|Overall Study||57
3179956|NCT01987960|3908249|FG000|STARTED|Period 1||417
2931763|NCT00592553|3642808|FG002|As-treated Population|Overall Study||57
2931764|NCT00592553|3642806|FG000|ITT Population|Overall Study||60
2931765|NCT00592553|3642807|FG001|ITT Population|Overall Study||57
2931766|NCT00592553|3642808|FG002|ITT Population|Overall Study||57
2931767|NCT00592553|3642806|FG000|COMPLETED|Overall Study||59
2931768|NCT00592553|3642807|FG001|COMPLETED|Overall Study||57
2931769|NCT00592553|3642808|FG002|COMPLETED|Overall Study||57
2931770|NCT00592553|3642806|FG000|NOT COMPLETED|Overall Study||1
2931771|NCT00592553|3642807|FG001|NOT COMPLETED|Overall Study||0
2931772|NCT00592553|3642808|FG002|NOT COMPLETED|Overall Study||0
2931773|NCT00592631|3642818|FG000|STARTED|Overall Study||16
2931774|NCT00592631|3642819|FG001|STARTED|Overall Study||11
2931775|NCT00592631|3642818|FG000|COMPLETED|Overall Study||16
2931776|NCT00592631|3642819|FG001|COMPLETED|Overall Study||9
2931777|NCT00592631|3642818|FG000|NOT COMPLETED|Overall Study||0
2931778|NCT00592631|3642819|FG001|NOT COMPLETED|Overall Study||2
2931779|NCT00592683|3642827|FG000|STARTED|Overall Study||10
2931780|NCT00592683|3642828|FG001|STARTED|Overall Study||10
2931781|NCT00592683|3642827|FG000|COMPLETED|Overall Study||6
2931782|NCT00592683|3642828|FG001|COMPLETED|Overall Study||6
2931783|NCT00592683|3642827|FG000|NOT COMPLETED|Overall Study||4
2931784|NCT00592683|3642828|FG001|NOT COMPLETED|Overall Study||4
2931785|NCT00592761|3642834|FG000|STARTED|First Intervention (2 Weeks)||9
2931786|NCT00592761|3642835|FG001|STARTED|First Intervention (2 Weeks)||9
2931787|NCT00592761|3642834|FG000|COMPLETED|First Intervention (2 Weeks)||9
2931788|NCT00592761|3642835|FG001|COMPLETED|First Intervention (2 Weeks)||9
2931789|NCT00592761|3642834|FG000|NOT COMPLETED|First Intervention (2 Weeks)||0
2931790|NCT00592761|3642835|FG001|NOT COMPLETED|First Intervention (2 Weeks)||0
2931791|NCT00592761|3642834|FG000|STARTED|Second Intervention (2 Weeks)||9
2931792|NCT00592761|3642835|FG001|STARTED|Second Intervention (2 Weeks)||9
2931793|NCT00592761|3642834|FG000|COMPLETED|Second Intervention (2 Weeks)||9
2931794|NCT00592761|3642835|FG001|COMPLETED|Second Intervention (2 Weeks)||9
3179957|NCT01987960|3908250|FG001|STARTED|Period 1||0
2931795|NCT00592761|3642834|FG000|NOT COMPLETED|Second Intervention (2 Weeks)||0
3041824|NCT01173055|3761469|FG001|COMPLETED|Period 1 - Day 1 to 49||10
2931796|NCT00592761|3642835|FG001|NOT COMPLETED|Second Intervention (2 Weeks)||0
2931797|NCT00592774|3642846|FG000|STARTED|Overall Study||26
2931798|NCT00592774|3642847|FG001|STARTED|Overall Study||53
2931799|NCT00592774|3642848|FG002|STARTED|Overall Study||22
2931800|NCT00592774|3642849|FG003|STARTED|Overall Study||22
2931801|NCT00592774|3642850|FG004|STARTED|Overall Study||23
2931802|NCT00592774|3642846|FG000|COMPLETED|Overall Study||15
2931803|NCT00592774|3642847|FG001|COMPLETED|Overall Study||21
2931804|NCT00592774|3642848|FG002|COMPLETED|Overall Study||18
2931805|NCT00592774|3642849|FG003|COMPLETED|Overall Study||8
2931806|NCT00592774|3642850|FG004|COMPLETED|Overall Study||9
2931807|NCT00592774|3642846|FG000|NOT COMPLETED|Overall Study||11
2931808|NCT00592774|3642847|FG001|NOT COMPLETED|Overall Study||32
2931809|NCT00592774|3642848|FG002|NOT COMPLETED|Overall Study||4
2931810|NCT00592774|3642849|FG003|NOT COMPLETED|Overall Study||14
2931811|NCT00592774|3642850|FG004|NOT COMPLETED|Overall Study||14
2931812|NCT00592839|3642865|FG000|STARTED|Overall Study||53
2931813|NCT00592839|3642866|FG001|STARTED|Overall Study||52
2931814|NCT00592839|3642867|FG002|STARTED|Overall Study||52
2931815|NCT00592839|3642865|FG000|COMPLETED|Overall Study||51
2931816|NCT00592839|3642866|FG001|COMPLETED|Overall Study||48
2931817|NCT00592839|3642867|FG002|COMPLETED|Overall Study||46
2931818|NCT00592839|3642865|FG000|NOT COMPLETED|Overall Study||2
2931819|NCT00592839|3642866|FG001|NOT COMPLETED|Overall Study||4
2931820|NCT00592839|3642867|FG002|NOT COMPLETED|Overall Study||6
2931821|NCT00592852|3642875|FG000|STARTED|Overall Study||13
2931822|NCT00592852|3642875|FG000|COMPLETED|Overall Study||7
2931823|NCT00592852|3642875|FG000|NOT COMPLETED|Overall Study||6
2931824|NCT00592904|3642883|FG000|STARTED|Overall Study||57
2931825|NCT00592904|3642884|FG001|STARTED|Overall Study||148
2931826|NCT00592904|3642885|FG002|STARTED|Overall Study||27
2931827|NCT00592904|3642886|FG003|STARTED|Overall Study||30
2931828|NCT00592904|3642883|FG000|COMPLETED|Overall Study||32
2931829|NCT00592904|3642884|FG001|COMPLETED|Overall Study||93
2931830|NCT00592904|3642885|FG002|COMPLETED|Overall Study||10
2931831|NCT00592904|3642886|FG003|COMPLETED|Overall Study||19
2931832|NCT00592904|3642883|FG000|NOT COMPLETED|Overall Study||25
2931833|NCT00592904|3642884|FG001|NOT COMPLETED|Overall Study||55
2931834|NCT00592904|3642885|FG002|NOT COMPLETED|Overall Study||17
2931835|NCT00592904|3642886|FG003|NOT COMPLETED|Overall Study||11
2931836|NCT00592943|3642898|FG000|STARTED|Overall Study||6
2931837|NCT00592943|3642899|FG001|STARTED|Overall Study||6
2931838|NCT00592943|3642898|FG000|COMPLETED|Overall Study||6
2931839|NCT00592943|3642899|FG001|COMPLETED|Overall Study||6
2931840|NCT00592943|3642898|FG000|NOT COMPLETED|Overall Study||0
2931841|NCT00592943|3642899|FG001|NOT COMPLETED|Overall Study||0
2931842|NCT00593112|3642907|FG000|STARTED|Overall Study||27
2931843|NCT00593112|3642908|FG001|STARTED|Overall Study||12
2931844|NCT00593112|3642907|FG000|COMPLETED|Overall Study||17
2931845|NCT00593112|3642908|FG001|COMPLETED|Overall Study||12
2931846|NCT00593112|3642907|FG000|NOT COMPLETED|Overall Study||10
2931847|NCT00593112|3642908|FG001|NOT COMPLETED|Overall Study||0
2931848|NCT00593333|3642916|FG000|STARTED|Overall Study||54
2931849|NCT00593333|3642917|FG001|STARTED|Overall Study||56
2931850|NCT00593333|3642916|FG000|COMPLETED|Overall Study||44
2931851|NCT00593333|3642917|FG001|COMPLETED|Overall Study||45
2931852|NCT00593333|3642916|FG000|NOT COMPLETED|Overall Study||10
2931853|NCT00593333|3642917|FG001|NOT COMPLETED|Overall Study||11
2931854|NCT00593346|3642923|FG000|STARTED|Overall Study||151
2931855|NCT00593346|3642923|FG000|COMPLETED|Overall Study||151
2931856|NCT00593346|3642923|FG000|NOT COMPLETED|Overall Study||0
2931857|NCT00593372|3642930|FG000|STARTED|Overall Study|Eight enrolled in behavioral treatment.|8
2931858|NCT00593372|3642931|FG001|STARTED|Overall Study|Three evaluated but only maintained medical treatment.|3
2931859|NCT00593372|3642930|FG000|COMPLETED|Overall Study|Eight completed behavioral treatment.|8
2931860|NCT00593372|3642931|FG001|COMPLETED|Overall Study|Three evaluated and completed protocol.|3
3179958|NCT01987960|3908251|FG002|STARTED|Period 1||0
3179959|NCT01987960|3908252|FG003|STARTED|Period 1||0
2931861|NCT00593372|3642930|FG000|NOT COMPLETED|Overall Study||0
3041825|NCT01173055|3761468|FG000|NOT COMPLETED|Period 1 - Day 1 to 49||2
3041826|NCT01173055|3761469|FG001|NOT COMPLETED|Period 1 - Day 1 to 49||2
3041827|NCT01173055|3761468|FG000|STARTED|Placebo Washout Period - Day 50 to 63||8
3041828|NCT01173055|3761469|FG001|STARTED|Placebo Washout Period - Day 50 to 63||10
3041829|NCT01173055|3761468|FG000|COMPLETED|Placebo Washout Period - Day 50 to 63||8
3041830|NCT01173055|3761469|FG001|COMPLETED|Placebo Washout Period - Day 50 to 63||10
3041831|NCT01173055|3761468|FG000|NOT COMPLETED|Placebo Washout Period - Day 50 to 63||0
3041832|NCT01173055|3761469|FG001|NOT COMPLETED|Placebo Washout Period - Day 50 to 63||0
3041833|NCT01173055|3761468|FG000|STARTED|Period 2 - Day 64 to 112||8
3041834|NCT01173055|3761469|FG001|STARTED|Period 2 - Day 64 to 112||10
3041835|NCT01173055|3761468|FG000|COMPLETED|Period 2 - Day 64 to 112||8
3041836|NCT01173055|3761469|FG001|COMPLETED|Period 2 - Day 64 to 112||9
3137168|NCT01717326|3862444|FG019|STARTED|Overall Study||21
3137169|NCT01717326|3862425|FG000|Treated|Overall Study||25
3137170|NCT01717326|3862426|FG001|Treated|Overall Study|Number includes 1 additional participant randomized to A3 but treated on A2|28
3137171|NCT01717326|3862427|FG002|Treated|Overall Study|Number excludes 1 participant randomized to A3 but treated on Arm A2|12
3137172|NCT01717326|3862428|FG003|Treated|Overall Study||30
3137173|NCT01717326|3862429|FG004|Treated|Overall Study||33
3137174|NCT01717326|3862430|FG005|Treated|Overall Study||31
3179960|NCT01987960|3908249|FG000|COMPLETED|Period 1||231
2931862|NCT00593372|3642931|FG001|NOT COMPLETED|Overall Study||0
2931863|NCT00593385|3642937|FG000|STARTED|Overall Study||165
3179961|NCT01987960|3908250|FG001|COMPLETED|Period 1||0
3179962|NCT01987960|3908251|FG002|COMPLETED|Period 1||0
3179963|NCT01987960|3908252|FG003|COMPLETED|Period 1||0
2931864|NCT00593385|3642937|FG000|Intention to Treat (ITT) Population|Overall Study|Excludes 13 subjects who did not meet inclusion/exclusion criteria.|152
2931865|NCT00593385|3642937|FG000|COMPLETED|Overall Study|125 of 165 enrolled patients completed the study.|125
2931866|NCT00593385|3642937|FG000|NOT COMPLETED|Overall Study||40
2931867|NCT00593450|3642947|FG000|STARTED|Overall Study||301
2931868|NCT00593450|3642948|FG001|STARTED|Overall Study||286
2931869|NCT00593450|3642949|FG002|STARTED|Overall Study||298
2931870|NCT00593450|3642950|FG003|STARTED|Overall Study||300
2931871|NCT00593450|3642947|FG000|COMPLETED|Overall Study||284
2931872|NCT00593450|3642948|FG001|COMPLETED|Overall Study||265
2931873|NCT00593450|3642949|FG002|COMPLETED|Overall Study||285
2931874|NCT00593450|3642950|FG003|COMPLETED|Overall Study||271
2931875|NCT00593450|3642947|FG000|NOT COMPLETED|Overall Study||17
2931876|NCT00593450|3642948|FG001|NOT COMPLETED|Overall Study||21
2931877|NCT00593450|3642949|FG002|NOT COMPLETED|Overall Study||13
2931878|NCT00593450|3642950|FG003|NOT COMPLETED|Overall Study||29
2931879|NCT00593489|3642962|FG000|STARTED|Allocation|allocated to intervention group to receive the intervention|75
2931880|NCT00593489|3642963|FG001|STARTED|Allocation|allocated to usual care group|79
2931881|NCT00593489|3642962|FG000|COMPLETED|Allocation||73
2931882|NCT00593489|3642963|FG001|COMPLETED|Allocation||78
2931883|NCT00593489|3642962|FG000|NOT COMPLETED|Allocation||2
2931884|NCT00593489|3642963|FG001|NOT COMPLETED|Allocation||1
2931885|NCT00593489|3642962|FG000|STARTED|Analysis|physician withdrawal (N=3) primary outcome set to 0|73
2931886|NCT00593489|3642963|FG001|STARTED|Analysis|physician withdrawal (N=3) primary outcome set to 0|78
2931887|NCT00593489|3642962|FG000|COMPLETED|Analysis||73
2931888|NCT00593489|3642963|FG001|COMPLETED|Analysis||78
2931889|NCT00593489|3642962|FG000|NOT COMPLETED|Analysis||0
2931890|NCT00593489|3642963|FG001|NOT COMPLETED|Analysis||0
3179964|NCT01987960|3908249|FG000|NOT COMPLETED|Period 1||186
3179965|NCT01987960|3908250|FG001|NOT COMPLETED|Period 1||0
3179966|NCT01987960|3908251|FG002|NOT COMPLETED|Period 1||0
3179967|NCT01987960|3908252|FG003|NOT COMPLETED|Period 1||0
3179968|NCT01987960|3908249|FG000|STARTED|Period 2||0
3179969|NCT01987960|3908250|FG001|STARTED|Period 2||17
3179970|NCT01987960|3908251|FG002|STARTED|Period 2||23
3179971|NCT01987960|3908252|FG003|STARTED|Period 2||0
2931891|NCT00593554|3642973|FG000|STARTED|Overall Study||3
2931892|NCT00593554|3642974|FG001|STARTED|Overall Study||5
2931893|NCT00593554|3642973|FG000|COMPLETED|Overall Study||0
2931894|NCT00593554|3642974|FG001|COMPLETED|Overall Study||0
2931895|NCT00593554|3642973|FG000|NOT COMPLETED|Overall Study||3
2931896|NCT00593554|3642974|FG001|NOT COMPLETED|Overall Study||5
2931897|NCT00593606|3642980|FG000|STARTED|Overall Study||124
2931898|NCT00593606|3642980|FG000|Start of Treatment - Safety Set|Overall Study||116
2931899|NCT00593606|3642980|FG000|Full Analysis Set|Overall Study||114
2931900|NCT00593606|3642980|FG000|Treatment Period Completed|Overall Study||99
2931901|NCT00593606|3642980|FG000|COMPLETED|Overall Study||97
2931902|NCT00593606|3642980|FG000|NOT COMPLETED|Overall Study||27
2931903|NCT00593645|3642984|FG000|STARTED|Overall Study||7
2931904|NCT00593645|3642984|FG000|COMPLETED|Overall Study||7
2931905|NCT00593645|3642984|FG000|NOT COMPLETED|Overall Study||0
2931906|NCT00593684|3642990|FG000|STARTED|Overall Study||25
2931907|NCT00593684|3642991|FG001|STARTED|Overall Study||25
2931908|NCT00593684|3642990|FG000|COMPLETED|Overall Study||23
2931909|NCT00593684|3642991|FG001|COMPLETED|Overall Study||24
2931910|NCT00593684|3642990|FG000|NOT COMPLETED|Overall Study||2
2931911|NCT00593684|3642991|FG001|NOT COMPLETED|Overall Study||1
2931912|NCT00593736|3643001|FG000|STARTED|Screening Period and Placebo Run-in||0
2931913|NCT00593736|3643002|FG001|STARTED|Screening Period and Placebo Run-in||0
2931914|NCT00593736|3643003|FG002|STARTED|Screening Period and Placebo Run-in||0
2931915|NCT00593736|3643004|FG003|STARTED|Screening Period and Placebo Run-in||549
2931916|NCT00593736|3643001|FG000|COMPLETED|Screening Period and Placebo Run-in||0
2931917|NCT00593736|3643002|FG001|COMPLETED|Screening Period and Placebo Run-in||0
2931918|NCT00593736|3643003|FG002|COMPLETED|Screening Period and Placebo Run-in||0
2931919|NCT00593736|3643004|FG003|COMPLETED|Screening Period and Placebo Run-in||132
2931920|NCT00593736|3643001|FG000|NOT COMPLETED|Screening Period and Placebo Run-in||0
2931921|NCT00593736|3643002|FG001|NOT COMPLETED|Screening Period and Placebo Run-in||0
2931922|NCT00593736|3643003|FG002|NOT COMPLETED|Screening Period and Placebo Run-in||0
2931923|NCT00593736|3643004|FG003|NOT COMPLETED|Screening Period and Placebo Run-in||417
2931924|NCT00593736|3643001|FG000|STARTED|Treatment Period and Placebo Run-out||32
2931925|NCT00593736|3643002|FG001|STARTED|Treatment Period and Placebo Run-out||33
2931926|NCT00593736|3643003|FG002|STARTED|Treatment Period and Placebo Run-out||35
2931927|NCT00593736|3643004|FG003|STARTED|Treatment Period and Placebo Run-out||32
2931928|NCT00593736|3643001|FG000|COMPLETED|Treatment Period and Placebo Run-out||29
2931929|NCT00593736|3643002|FG001|COMPLETED|Treatment Period and Placebo Run-out||31
2931930|NCT00593736|3643003|FG002|COMPLETED|Treatment Period and Placebo Run-out||30
2931931|NCT00593736|3643004|FG003|COMPLETED|Treatment Period and Placebo Run-out||28
2931932|NCT00593736|3643001|FG000|NOT COMPLETED|Treatment Period and Placebo Run-out||3
2931933|NCT00593736|3643002|FG001|NOT COMPLETED|Treatment Period and Placebo Run-out||2
3041837|NCT01173055|3761468|FG000|NOT COMPLETED|Period 2 - Day 64 to 112||0
2931934|NCT00593736|3643003|FG002|NOT COMPLETED|Treatment Period and Placebo Run-out||5
2931935|NCT00593736|3643004|FG003|NOT COMPLETED|Treatment Period and Placebo Run-out||4
2931936|NCT00593814|3643016|FG000|STARTED|Overall Study||139
2931937|NCT00593814|3643017|FG001|STARTED|Overall Study||120
2931938|NCT00593814|3643016|FG000|COMPLETED|Overall Study||115
2931939|NCT00593814|3643017|FG001|COMPLETED|Overall Study||120
2931940|NCT00593814|3643016|FG000|NOT COMPLETED|Overall Study||24
2931941|NCT00593814|3643017|FG001|NOT COMPLETED|Overall Study||0
2931942|NCT00593827|3643025|FG000|STARTED|Overall Study|Intent-to-Treat (ITT) Population: Participants who were randomized (eligible and ineligible).|85
2931943|NCT00593827|3643026|FG001|STARTED|Overall Study|ITT Population: Participants who were randomized (eligible and ineligible).|91
2931944|NCT00593827|3643025|FG000|Safety Population|Overall Study|Participants (eligible and ineligible) who received at least 1 dose of study drug.|82
2931945|NCT00593827|3643026|FG001|Safety Population|Overall Study|Participants (eligible and ineligible) who received at least 1 dose of study drug.|89
2931946|NCT00593827|3643025|FG000|Evaluable Population|Overall Study|Treated participants with CR, PR, SD, PD, or NE response. Refer outcome measure 3 and 4 for details.|79
2931947|NCT00593827|3643026|FG001|Evaluable Population|Overall Study|Treated participants with CR, PR, SD, PD, or NE response. Refer outcome measure 3 and 4 for details.|89
2931948|NCT00593827|3643025|FG000|COMPLETED|Overall Study|Completed=off-study (Major reasons: Adverse events (AE)=15; disease progression=76; not treated=3).|85
2931949|NCT00593827|3643026|FG001|COMPLETED|Overall Study|Completed=off-study (Major reasons: AEs=30; disease progression=55; not treated=2).|89
2931950|NCT00593827|3643025|FG000|NOT COMPLETED|Overall Study||0
2931951|NCT00593827|3643026|FG001|NOT COMPLETED|Overall Study||2
2931952|NCT00593840|3643032|FG000|STARTED|Overall Study||73
2931953|NCT00593840|3643032|FG000|COMPLETED|Overall Study||72
2931954|NCT00593840|3643032|FG000|NOT COMPLETED|Overall Study||1
2931955|NCT00593866|3643036|FG000|STARTED|Overall Study||50
2931956|NCT00593866|3643036|FG000|COMPLETED|Overall Study||50
2931957|NCT00593866|3643036|FG000|NOT COMPLETED|Overall Study||0
2931958|NCT00593918|3643042|FG000|STARTED|Overall Study|Number of children with Toll-like Receptor 4 (TLR4) -2026/GG Genotype|17
2931959|NCT00593918|3643043|FG001|STARTED|Overall Study|Number of children with Toll-like Receptor 4 (TLR4) -2026/AG and AA genotypes|74
2931960|NCT00593918|3643042|FG000|COMPLETED|Overall Study|Some children did not come in for the blood draw at visit 2|12
2931961|NCT00593918|3643043|FG001|COMPLETED|Overall Study|Some children did not come in for the blood draw at visit 2|50
2931962|NCT00593918|3643042|FG000|NOT COMPLETED|Overall Study||5
2931963|NCT00593918|3643043|FG001|NOT COMPLETED|Overall Study||24
3041838|NCT01173055|3761469|FG001|NOT COMPLETED|Period 2 - Day 64 to 112||1
3041839|NCT01173120|3761475|FG000|STARTED|Overall Study||62
3041840|NCT01173120|3761475|FG000|Switched Back to Main Study|Overall Study||57
3041841|NCT01173120|3761475|FG000|Discontinued ACP Substudy and Main Study|Overall Study||5
3041842|NCT01173120|3761475|FG000|COMPLETED|Overall Study||0
3041843|NCT01173120|3761475|FG000|NOT COMPLETED|Overall Study||62
3041844|NCT01173159|3761481|FG000|STARTED|Overall Study||10
3041845|NCT01173159|3761481|FG000|COMPLETED|Overall Study||10
3041846|NCT01173159|3761481|FG000|NOT COMPLETED|Overall Study||0
3041847|NCT01173211|3761491|FG000|STARTED|Overall Study||48
3041848|NCT01173211|3761492|FG001|STARTED|Overall Study||45
3041849|NCT01173211|3761493|FG002|STARTED|Overall Study||46
3041850|NCT01173211|3761494|FG003|STARTED|Overall Study||15
3041851|NCT01173211|3761495|FG004|STARTED|Overall Study||16
3041852|NCT01173211|3761496|FG005|STARTED|Overall Study||13
3041853|NCT01173211|3761491|FG000|COMPLETED|Overall Study||46
3041854|NCT01173211|3761492|FG001|COMPLETED|Overall Study||44
3041855|NCT01173211|3761493|FG002|COMPLETED|Overall Study||44
3041856|NCT01173211|3761494|FG003|COMPLETED|Overall Study||15
3041857|NCT01173211|3761495|FG004|COMPLETED|Overall Study||16
3041858|NCT01173211|3761496|FG005|COMPLETED|Overall Study||13
3041859|NCT01173211|3761491|FG000|NOT COMPLETED|Overall Study||2
3041860|NCT01173211|3761492|FG001|NOT COMPLETED|Overall Study||1
3041861|NCT01173211|3761493|FG002|NOT COMPLETED|Overall Study||2
3041862|NCT01173211|3761494|FG003|NOT COMPLETED|Overall Study||0
3041863|NCT01173211|3761495|FG004|NOT COMPLETED|Overall Study||0
3041864|NCT01173211|3761496|FG005|NOT COMPLETED|Overall Study||0
3041865|NCT01173471|3761514|FG000|STARTED|Overall Study|Randomized|6
3041866|NCT01173471|3761515|FG001|STARTED|Overall Study|Randomized|7
3041867|NCT01173471|3761516|FG002|STARTED|Overall Study|Randomized|18
3041868|NCT01173471|3761517|FG003|STARTED|Overall Study|Randomized|19
3041869|NCT01173471|3761514|FG000|Received Treatment|Overall Study||6
3041870|NCT01173471|3761515|FG001|Received Treatment|Overall Study||7
3041871|NCT01173471|3761516|FG002|Received Treatment|Overall Study||18
3041872|NCT01173471|3761517|FG003|Received Treatment|Overall Study||19
3041873|NCT01173471|3761514|FG000|Completed Treatment|Overall Study||4
3041874|NCT01173471|3761515|FG001|Completed Treatment|Overall Study||7
3041875|NCT01173471|3761516|FG002|Completed Treatment|Overall Study||15
3041876|NCT01173471|3761517|FG003|Completed Treatment|Overall Study||18
3041877|NCT01173471|3761514|FG000|COMPLETED|Overall Study|Completed study|4
3041878|NCT01173471|3761515|FG001|COMPLETED|Overall Study|Completed study|7
3041879|NCT01173471|3761516|FG002|COMPLETED|Overall Study|Completed study|15
3041880|NCT01173471|3761517|FG003|COMPLETED|Overall Study|Completed study|18
3041881|NCT01173471|3761514|FG000|NOT COMPLETED|Overall Study||2
3041882|NCT01173471|3761515|FG001|NOT COMPLETED|Overall Study||0
3041883|NCT01173471|3761516|FG002|NOT COMPLETED|Overall Study||3
3041884|NCT01173471|3761517|FG003|NOT COMPLETED|Overall Study||1
3179972|NCT01987960|3908249|FG000|COMPLETED|Period 2||0
2931964|NCT00593957|3643052|FG000|STARTED|Overall Study||13
2931965|NCT00593957|3643053|FG001|STARTED|Overall Study||13
2931966|NCT00593957|3643054|FG002|STARTED|Overall Study||12
2931967|NCT00593957|3643052|FG000|COMPLETED|Overall Study||13
2931968|NCT00593957|3643053|FG001|COMPLETED|Overall Study||12
2931969|NCT00593957|3643054|FG002|COMPLETED|Overall Study||10
2931970|NCT00593957|3643052|FG000|NOT COMPLETED|Overall Study||0
2931971|NCT00593957|3643053|FG001|NOT COMPLETED|Overall Study||1
2931972|NCT00593957|3643054|FG002|NOT COMPLETED|Overall Study||2
2931973|NCT00594009|3643076|FG000|STARTED|Overall Study||1
2931974|NCT00594009|3643076|FG000|COMPLETED|Overall Study||1
2931975|NCT00594009|3643076|FG000|NOT COMPLETED|Overall Study||0
2931976|NCT00594022|3643082|FG000|STARTED|Overall Study||176
2931977|NCT00594022|3643083|FG001|STARTED|Overall Study||173
2931978|NCT00594022|3643082|FG000|COMPLETED|Overall Study||176
2931979|NCT00594022|3643083|FG001|COMPLETED|Overall Study||173
2931980|NCT00594022|3643082|FG000|NOT COMPLETED|Overall Study||0
2931981|NCT00594022|3643083|FG001|NOT COMPLETED|Overall Study||0
2931982|NCT00594035|3643091|FG000|STARTED|Overall Study|102 subjects were randomized to Spinal Sealant|102
2931983|NCT00594035|3643092|FG001|STARTED|Overall Study|56 subjects were randomized to the control group (standard of care)|56
2931984|NCT00594035|3643091|FG000|COMPLETED|Overall Study|100 Spinal Sealant subjects were evaluable at the 90-day visit|100
2931985|NCT00594035|3643092|FG001|COMPLETED|Overall Study|53 control group subjects were evaluable at the 90-day visit|53
2931986|NCT00594035|3643091|FG000|NOT COMPLETED|Overall Study||2
2931987|NCT00594035|3643092|FG001|NOT COMPLETED|Overall Study||3
2931988|NCT00594061|3643098|FG000|STARTED|Overall Study||9
2931989|NCT00594061|3643098|FG000|COMPLETED|Overall Study||9
2931990|NCT00594061|3643098|FG000|NOT COMPLETED|Overall Study||0
2931991|NCT00594100|3643102|FG000|STARTED|Procedure||245
2931992|NCT00594100|3643102|FG000|COMPLETED|Procedure||236
2931993|NCT00594100|3643102|FG000|NOT COMPLETED|Procedure||9
2931994|NCT00594100|3643102|FG000|STARTED|Follow-up Through 30 Days Post Procedure||236
2931995|NCT00594100|3643102|FG000|COMPLETED|Follow-up Through 30 Days Post Procedure||224
2931996|NCT00594100|3643102|FG000|NOT COMPLETED|Follow-up Through 30 Days Post Procedure||12
2931997|NCT00594165|3643106|FG000|STARTED|Overall Study||217
2931998|NCT00594165|3643106|FG000|COMPLETED|Overall Study|Study fully recruited. Completed upon market authorization and commercial availability of Neupro.|0
2931999|NCT00594165|3643106|FG000|NOT COMPLETED|Overall Study||217
2932000|NCT00594178|3643110|FG000|STARTED|Overall Study||17
2932001|NCT00594178|3643110|FG000|COMPLETED|Overall Study||12
2932002|NCT00594178|3643110|FG000|NOT COMPLETED|Overall Study||5
2932003|NCT00594204|3643116|FG000|STARTED|Overall Study||394
2932004|NCT00594204|3643117|FG001|STARTED|Overall Study||199
2932005|NCT00594204|3643116|FG000|Received Treatment|Overall Study||390
2932006|NCT00594204|3643117|FG001|Received Treatment|Overall Study||198
2932007|NCT00594204|3643116|FG000|COMPLETED|Overall Study||336
2932008|NCT00594204|3643117|FG001|COMPLETED|Overall Study||154
2932009|NCT00594204|3643116|FG000|NOT COMPLETED|Overall Study||58
2932010|NCT00594204|3643117|FG001|NOT COMPLETED|Overall Study||45
2932011|NCT00594230|3643125|FG000|STARTED|Overall Study||16
2932012|NCT00594230|3643126|FG001|STARTED|Overall Study||10
2932013|NCT00594230|3643125|FG000|COMPLETED|Overall Study||1
2932014|NCT00594230|3643126|FG001|COMPLETED|Overall Study||1
2932015|NCT00594230|3643125|FG000|NOT COMPLETED|Overall Study||15
2932016|NCT00594230|3643126|FG001|NOT COMPLETED|Overall Study||9
2932017|NCT00594256|3643132|FG000|STARTED|Overall Study||8
2932018|NCT00594256|3643132|FG000|COMPLETED|Overall Study||8
2932019|NCT00594256|3643132|FG000|NOT COMPLETED|Overall Study||0
2932020|NCT00594308|3643137|FG000|STARTED|Overall Study||10
2932021|NCT00594308|3643137|FG000|COMPLETED|Overall Study||10
2932022|NCT00594308|3643137|FG000|NOT COMPLETED|Overall Study||0
2932023|NCT00594386|3643141|FG000|STARTED|Overall Study||258
3179973|NCT01987960|3908250|FG001|COMPLETED|Period 2||12
3179974|NCT01987960|3908251|FG002|COMPLETED|Period 2||14
3179975|NCT01987960|3908252|FG003|COMPLETED|Period 2||0
2932024|NCT00594386|3643141|FG000|COMPLETED|Overall Study|Study fully recruited. Completed upon market authorization and commercial availability of Neupro.|0
2932025|NCT00594386|3643141|FG000|NOT COMPLETED|Overall Study||258
2932026|NCT00594399|3643147|FG000|STARTED|Initial 3 Month Counseling||180
2932027|NCT00594399|3643148|FG001|STARTED|Initial 3 Month Counseling||122
2932028|NCT00594399|3643149|FG002|STARTED|Initial 3 Month Counseling||0
2932029|NCT00594399|3643147|FG000|COMPLETED|Initial 3 Month Counseling||163
2932030|NCT00594399|3643148|FG001|COMPLETED|Initial 3 Month Counseling||118
2932031|NCT00594399|3643149|FG002|COMPLETED|Initial 3 Month Counseling||0
2932032|NCT00594399|3643147|FG000|NOT COMPLETED|Initial 3 Month Counseling||17
2932033|NCT00594399|3643148|FG001|NOT COMPLETED|Initial 3 Month Counseling||4
2932034|NCT00594399|3643149|FG002|NOT COMPLETED|Initial 3 Month Counseling||0
2932035|NCT00594399|3643147|FG000|STARTED|Rerandomization Arm 1 Only|Total sample in Arm 1 was rerandomized and allocated to remain in Arm 1 or assigned to Arm 3|81
2932036|NCT00594399|3643148|FG001|STARTED|Rerandomization Arm 1 Only||118
2932037|NCT00594399|3643149|FG002|STARTED|Rerandomization Arm 1 Only|This sample reflects newly randomized study Arm|82
2932038|NCT00594399|3643147|FG000|Rerandomization|Rerandomization Arm 1 Only|Rerandomized to continue to receive telephone calls every 2 weeks or at a reduced dose of 1/ month|81
2932039|NCT00594399|3643148|FG001|Rerandomization|Rerandomization Arm 1 Only||114
2932040|NCT00594399|3643149|FG002|Rerandomization|Rerandomization Arm 1 Only||82
2932041|NCT00594399|3643147|FG000|COMPLETED|Rerandomization Arm 1 Only||79
2932042|NCT00594399|3643148|FG001|COMPLETED|Rerandomization Arm 1 Only||114
2932043|NCT00594399|3643149|FG002|COMPLETED|Rerandomization Arm 1 Only||82
2932044|NCT00594399|3643147|FG000|NOT COMPLETED|Rerandomization Arm 1 Only||2
2932045|NCT00594399|3643148|FG001|NOT COMPLETED|Rerandomization Arm 1 Only||4
2932046|NCT00594399|3643149|FG002|NOT COMPLETED|Rerandomization Arm 1 Only||0
2932047|NCT00594425|3643158|FG000|STARTED|Overall Study||50
2932048|NCT00594425|3643159|FG001|STARTED|Overall Study||48
2932049|NCT00594425|3643160|FG002|STARTED|Overall Study||52
2932050|NCT00594425|3643158|FG000|COMPLETED|Overall Study||43
2932051|NCT00594425|3643159|FG001|COMPLETED|Overall Study||34
2932052|NCT00594425|3643160|FG002|COMPLETED|Overall Study||42
2932053|NCT00594425|3643158|FG000|NOT COMPLETED|Overall Study||7
2932054|NCT00594425|3643159|FG001|NOT COMPLETED|Overall Study||14
2932055|NCT00594425|3643160|FG002|NOT COMPLETED|Overall Study||10
2932056|NCT00594464|3643168|FG000|STARTED|Overall Study||14
2932057|NCT00594464|3643168|FG000|COMPLETED|Overall Study||11
2932058|NCT00594464|3643168|FG000|NOT COMPLETED|Overall Study||3
2932059|NCT00594516|3643178|FG000|STARTED|Open Label (OL): Tapentadol IR|one patient was enrolled but lost to follow up at the start of open label therefore was not included|116
2932060|NCT00594516|3643179|FG001|STARTED|Open Label (OL): Tapentadol IR||0
2932061|NCT00594516|3643180|FG002|STARTED|Open Label (OL): Tapentadol IR||0
2932062|NCT00594516|3643178|FG000|COMPLETED|Open Label (OL): Tapentadol IR||87
2932063|NCT00594516|3643179|FG001|COMPLETED|Open Label (OL): Tapentadol IR||0
2932064|NCT00594516|3643180|FG002|COMPLETED|Open Label (OL): Tapentadol IR||0
2932065|NCT00594516|3643178|FG000|NOT COMPLETED|Open Label (OL): Tapentadol IR||29
2932066|NCT00594516|3643179|FG001|NOT COMPLETED|Open Label (OL): Tapentadol IR||0
2932067|NCT00594516|3643180|FG002|NOT COMPLETED|Open Label (OL): Tapentadol IR||0
2932068|NCT00594516|3643178|FG000|STARTED|DB: Tapentadol IR to ER & ER to IR||0
2932069|NCT00594516|3643179|FG001|STARTED|DB: Tapentadol IR to ER & ER to IR||44
2932070|NCT00594516|3643180|FG002|STARTED|DB: Tapentadol IR to ER & ER to IR||43
2932071|NCT00594516|3643178|FG000|COMPLETED|DB: Tapentadol IR to ER & ER to IR||0
2932072|NCT00594516|3643179|FG001|COMPLETED|DB: Tapentadol IR to ER & ER to IR||37
2932073|NCT00594516|3643180|FG002|COMPLETED|DB: Tapentadol IR to ER & ER to IR||35
2932074|NCT00594516|3643178|FG000|NOT COMPLETED|DB: Tapentadol IR to ER & ER to IR||0
2932075|NCT00594516|3643179|FG001|NOT COMPLETED|DB: Tapentadol IR to ER & ER to IR||7
2932076|NCT00594516|3643180|FG002|NOT COMPLETED|DB: Tapentadol IR to ER & ER to IR||8
2932077|NCT00594568|3643187|FG000|STARTED|Initial Treatment||501
2932078|NCT00594568|3643188|FG001|STARTED|Initial Treatment||507
2932079|NCT00594568|3643189|FG002|STARTED|Initial Treatment||529
2932080|NCT00594568|3643187|FG000|Intent-to-treat (ITT)|Initial Treatment|ITT population included all randomized participants (pts) who had at least 1 dose of study drug.|501
2932081|NCT00594568|3643188|FG001|Intent-to-treat (ITT)|Initial Treatment|ITT population included all randomized participants who had at least 1 dose of study drug.|506
2932082|NCT00594568|3643189|FG002|Intent-to-treat (ITT)|Initial Treatment|ITT population included all randomized participants who had at least 1 dose of study drug.|527
2932083|NCT00594568|3643187|FG000|COMPLETED|Initial Treatment||189
2932084|NCT00594568|3643188|FG001|COMPLETED|Initial Treatment||153
2932085|NCT00594568|3643189|FG002|COMPLETED|Initial Treatment||121
2932086|NCT00594568|3643187|FG000|NOT COMPLETED|Initial Treatment||312
2932087|NCT00594568|3643188|FG001|NOT COMPLETED|Initial Treatment||354
2932088|NCT00594568|3643189|FG002|NOT COMPLETED|Initial Treatment||408
2932089|NCT00594568|3643187|FG000|STARTED|Delayed Start||189
2932090|NCT00594568|3643188|FG001|STARTED|Delayed Start||153
2932091|NCT00594568|3643189|FG002|STARTED|Delayed Start||121
2932092|NCT00594568|3643187|FG000|COMPLETED|Delayed Start||91
2932093|NCT00594568|3643188|FG001|COMPLETED|Delayed Start||76
2932094|NCT00594568|3643189|FG002|COMPLETED|Delayed Start||55
2932095|NCT00594568|3643187|FG000|NOT COMPLETED|Delayed Start||98
2932096|NCT00594568|3643188|FG001|NOT COMPLETED|Delayed Start||77
2932097|NCT00594568|3643189|FG002|NOT COMPLETED|Delayed Start||66
2932098|NCT00594568|3643187|FG000|STARTED|Safety Follow Up (SFU)-Optional|SFU was optional; pts entered from initial treatment and delayed start or did not enter SFU.|290
2932099|NCT00594568|3643188|FG001|STARTED|Safety Follow Up (SFU)-Optional|SFU was optional; pts entered from initial treatment and delayed start or did not enter SFU.|223
2932100|NCT00594568|3643189|FG002|STARTED|Safety Follow Up (SFU)-Optional|SFU was optional, pts entered from initial treatment and delayed start or did not enter SFU.|214
2932101|NCT00594568|3643187|FG000|COMPLETED|Safety Follow Up (SFU)-Optional||229
2932102|NCT00594568|3643188|FG001|COMPLETED|Safety Follow Up (SFU)-Optional||168
2932103|NCT00594568|3643189|FG002|COMPLETED|Safety Follow Up (SFU)-Optional||172
2932104|NCT00594568|3643187|FG000|NOT COMPLETED|Safety Follow Up (SFU)-Optional||61
2932105|NCT00594568|3643188|FG001|NOT COMPLETED|Safety Follow Up (SFU)-Optional||55
2932106|NCT00594568|3643189|FG002|NOT COMPLETED|Safety Follow Up (SFU)-Optional||42
2932107|NCT00594646|3643205|FG000|STARTED|Overall Study||100
3041885|NCT01173523|3761529|FG000|STARTED|Overall Study||13
3041886|NCT01173523|3761530|FG001|STARTED|Overall Study||12
3041887|NCT01173523|3761529|FG000|COMPLETED|Overall Study|Since treatment was not of fixed duration, all participants were considered as 'Not Completed'.|0
3041888|NCT01173523|3761530|FG001|COMPLETED|Overall Study|Since treatment was not of fixed duration, all participants were considered as 'Not Completed'.|0
3041889|NCT01173523|3761529|FG000|NOT COMPLETED|Overall Study||13
3041890|NCT01173523|3761530|FG001|NOT COMPLETED|Overall Study||12
3041891|NCT01173601|3761540|FG000|STARTED|Confirmation (CF) Phase, 3 Weeks||1416
3041892|NCT01173601|3761541|FG001|STARTED|Confirmation (CF) Phase, 3 Weeks||0
3041893|NCT01173601|3761542|FG002|STARTED|Confirmation (CF) Phase, 3 Weeks||0
3041894|NCT01173601|3761543|FG003|STARTED|Confirmation (CF) Phase, 3 Weeks||0
3041895|NCT01173601|3761544|FG004|STARTED|Confirmation (CF) Phase, 3 Weeks||0
2932108|NCT00594646|3643205|FG000|COMPLETED|Overall Study||84
2932109|NCT00594646|3643205|FG000|NOT COMPLETED|Overall Study||16
2932110|NCT00594659|3643213|FG000|STARTED|Overall Study||29
2932111|NCT00594659|3643214|FG001|STARTED|Overall Study||30
2932112|NCT00594659|3643215|FG002|STARTED|Overall Study||16
2932113|NCT00594659|3643213|FG000|COMPLETED|Overall Study||16
2932114|NCT00594659|3643214|FG001|COMPLETED|Overall Study||21
2932115|NCT00594659|3643215|FG002|COMPLETED|Overall Study||9
2932116|NCT00594659|3643213|FG000|NOT COMPLETED|Overall Study||13
2932117|NCT00594659|3643214|FG001|NOT COMPLETED|Overall Study||9
2932118|NCT00594659|3643215|FG002|NOT COMPLETED|Overall Study||7
2932119|NCT00594685|3643223|FG000|STARTED|Overall Study||10
2932120|NCT00594685|3643223|FG000|COMPLETED|Overall Study||10
2932121|NCT00594685|3643223|FG000|NOT COMPLETED|Overall Study||0
2932122|NCT00594815|3643227|FG000|STARTED|Overall Study||52
2932123|NCT00594815|3643227|FG000|COMPLETED|Overall Study||43
2932124|NCT00594815|3643227|FG000|NOT COMPLETED|Overall Study||9
2932125|NCT00594854|3643233|FG000|STARTED|Overall Study||9
2932126|NCT00594854|3643234|FG001|STARTED|Overall Study||11
2932127|NCT00594854|3643233|FG000|COMPLETED|Overall Study|POZEN reached an agreement with the FDA to terminate the study due to low and inadequate enrollment.|2
2932128|NCT00594854|3643234|FG001|COMPLETED|Overall Study|POZEN reached an agreement with the FDA to terminate the study due to low and inadequate enrollment.|1
2932129|NCT00594854|3643233|FG000|NOT COMPLETED|Overall Study||7
2932130|NCT00594854|3643234|FG001|NOT COMPLETED|Overall Study||10
2932131|NCT00594880|3643242|FG000|STARTED|Overall Study||12
2932132|NCT00594880|3643243|FG001|STARTED|Overall Study||11
2932133|NCT00594880|3643242|FG000|COMPLETED|Overall Study||10
2932134|NCT00594880|3643243|FG001|COMPLETED|Overall Study||10
2932135|NCT00594880|3643242|FG000|NOT COMPLETED|Overall Study||2
2932136|NCT00594880|3643243|FG001|NOT COMPLETED|Overall Study||1
2932137|NCT00594906|3643255|FG000|STARTED|Overall Study||7
2932138|NCT00594906|3643256|FG001|STARTED|Overall Study||3
2932139|NCT00594906|3643255|FG000|COMPLETED|Overall Study||6
2932140|NCT00594906|3643256|FG001|COMPLETED|Overall Study||1
2932141|NCT00594906|3643255|FG000|NOT COMPLETED|Overall Study||1
2932142|NCT00594906|3643256|FG001|NOT COMPLETED|Overall Study||2
2932143|NCT00594932|3643264|FG000|STARTED|First 3 Months||13
2932144|NCT00594932|3643265|FG001|STARTED|First 3 Months||14
2932145|NCT00594932|3643264|FG000|COMPLETED|First 3 Months||12
2932146|NCT00594932|3643265|FG001|COMPLETED|First 3 Months||11
2932147|NCT00594932|3643264|FG000|NOT COMPLETED|First 3 Months||1
2932148|NCT00594932|3643265|FG001|NOT COMPLETED|First 3 Months||3
2932149|NCT00594932|3643264|FG000|STARTED|Final 3 Months||12
2932150|NCT00594932|3643265|FG001|STARTED|Final 3 Months||11
2932151|NCT00594932|3643264|FG000|COMPLETED|Final 3 Months||8
2932152|NCT00594932|3643265|FG001|COMPLETED|Final 3 Months||8
2932153|NCT00594932|3643264|FG000|NOT COMPLETED|Final 3 Months||4
2932154|NCT00594932|3643265|FG001|NOT COMPLETED|Final 3 Months||3
2932155|NCT00594945|3643274|FG000|STARTED|Cohort 1 / Treatment Period 1||4
2932156|NCT00594945|3643275|FG001|STARTED|Cohort 1 / Treatment Period 1||0
2932157|NCT00594945|3643276|FG002|STARTED|Cohort 1 / Treatment Period 1||2
2932158|NCT00594945|3643274|FG000|COMPLETED|Cohort 1 / Treatment Period 1||4
2932159|NCT00594945|3643275|FG001|COMPLETED|Cohort 1 / Treatment Period 1||0
2932160|NCT00594945|3643276|FG002|COMPLETED|Cohort 1 / Treatment Period 1||2
2932161|NCT00594945|3643274|FG000|NOT COMPLETED|Cohort 1 / Treatment Period 1||0
2932162|NCT00594945|3643275|FG001|NOT COMPLETED|Cohort 1 / Treatment Period 1||0
2932163|NCT00594945|3643276|FG002|NOT COMPLETED|Cohort 1 / Treatment Period 1||0
2932164|NCT00594945|3643274|FG000|STARTED|Cohort 2 / Treatment Period 2||0
2932165|NCT00594945|3643275|FG001|STARTED|Cohort 2 / Treatment Period 2||3
2932166|NCT00594945|3643276|FG002|STARTED|Cohort 2 / Treatment Period 2||2
2932167|NCT00594945|3643274|FG000|COMPLETED|Cohort 2 / Treatment Period 2||0
2932168|NCT00594945|3643275|FG001|COMPLETED|Cohort 2 / Treatment Period 2||3
2932169|NCT00594945|3643276|FG002|COMPLETED|Cohort 2 / Treatment Period 2||2
2932170|NCT00594945|3643274|FG000|NOT COMPLETED|Cohort 2 / Treatment Period 2||0
2932171|NCT00594945|3643275|FG001|NOT COMPLETED|Cohort 2 / Treatment Period 2||0
2932172|NCT00594945|3643276|FG002|NOT COMPLETED|Cohort 2 / Treatment Period 2||0
2932173|NCT00594958|3643285|FG000|STARTED|Overall Study||214
2932174|NCT00594958|3643286|FG001|STARTED|Overall Study||213
2932175|NCT00594958|3643287|FG002|STARTED|Overall Study||212
2932176|NCT00594958|3643285|FG000|Randomized and at Least 1 Vaccination|Overall Study||212
2932177|NCT00594958|3643286|FG001|Randomized and at Least 1 Vaccination|Overall Study||213
2932178|NCT00594958|3643287|FG002|Randomized and at Least 1 Vaccination|Overall Study||211
2932179|NCT00594958|3643285|FG000|COMPLETED|Overall Study||200
2932180|NCT00594958|3643286|FG001|COMPLETED|Overall Study||210
2932181|NCT00594958|3643287|FG002|COMPLETED|Overall Study||202
2932182|NCT00594958|3643285|FG000|NOT COMPLETED|Overall Study||14
2932183|NCT00594958|3643286|FG001|NOT COMPLETED|Overall Study||3
2932184|NCT00594958|3643287|FG002|NOT COMPLETED|Overall Study||10
2932185|NCT00594997|3643297|FG000|STARTED|Overall Study||1562
2932186|NCT00594997|3643298|FG001|STARTED|Overall Study||2008
2932187|NCT00594997|3643297|FG000|COMPLETED|Overall Study||1562
2932188|NCT00594997|3643298|FG001|COMPLETED|Overall Study||2008
2932189|NCT00594997|3643297|FG000|NOT COMPLETED|Overall Study||0
2932190|NCT00594997|3643298|FG001|NOT COMPLETED|Overall Study||0
2932191|NCT00595075|3643308|FG000|STARTED|Overall Study||6
2932192|NCT00595075|3643309|FG001|STARTED|Overall Study||5
2932193|NCT00595075|3643308|FG000|COMPLETED|Overall Study||5
2932194|NCT00595075|3643309|FG001|COMPLETED|Overall Study||5
2932195|NCT00595075|3643308|FG000|NOT COMPLETED|Overall Study||1
2932196|NCT00595075|3643309|FG001|NOT COMPLETED|Overall Study||0
2932197|NCT00595088|3643315|FG000|STARTED|Overall Study||47
2932198|NCT00595088|3643315|FG000|COMPLETED|Overall Study|5 patients ongoing, 7 completed the study (week 46)and 35 withdrew prematurely|7
2932199|NCT00595088|3643315|FG000|NOT COMPLETED|Overall Study||40
2932200|NCT00595101|3643323|FG000|STARTED|Overall Study||29
2932201|NCT00595101|3643324|FG001|STARTED|Overall Study||29
2932202|NCT00595101|3643325|FG002|STARTED|Overall Study||29
2932203|NCT00595101|3643326|FG003|STARTED|Overall Study||30
2932204|NCT00595101|3643323|FG000|COMPLETED|Overall Study||29
2932205|NCT00595101|3643324|FG001|COMPLETED|Overall Study||28
2932206|NCT00595101|3643325|FG002|COMPLETED|Overall Study||29
2932207|NCT00595101|3643326|FG003|COMPLETED|Overall Study||30
2932208|NCT00595101|3643323|FG000|NOT COMPLETED|Overall Study||0
2932209|NCT00595101|3643324|FG001|NOT COMPLETED|Overall Study||1
2932210|NCT00595101|3643325|FG002|NOT COMPLETED|Overall Study||0
2932211|NCT00595101|3643326|FG003|NOT COMPLETED|Overall Study||0
2932212|NCT00595114|3643338|FG000|STARTED|Overall Study||24
2932213|NCT00595114|3643339|FG001|STARTED|Overall Study||19
2932214|NCT00595114|3643338|FG000|COMPLETED|Overall Study||24
2932215|NCT00595114|3643339|FG001|COMPLETED|Overall Study||19
2932216|NCT00595114|3643338|FG000|NOT COMPLETED|Overall Study||0
2932217|NCT00595114|3643339|FG001|NOT COMPLETED|Overall Study||0
2932218|NCT00595127|3643345|FG000|STARTED|Overall Study||21
2932219|NCT00595127|3643345|FG000|COMPLETED|Overall Study||11
2932220|NCT00595127|3643345|FG000|NOT COMPLETED|Overall Study||10
2932221|NCT00595153|3643352|FG000|STARTED|Overall Study||24
2932222|NCT00595153|3643353|FG001|STARTED|Overall Study||42
2932223|NCT00595153|3643354|FG002|STARTED|Overall Study||61
2932224|NCT00595153|3643352|FG000|COMPLETED|Overall Study||20
2932225|NCT00595153|3643353|FG001|COMPLETED|Overall Study||26
2932226|NCT00595153|3643354|FG002|COMPLETED|Overall Study||36
2932227|NCT00595153|3643352|FG000|NOT COMPLETED|Overall Study||4
2932228|NCT00595153|3643353|FG001|NOT COMPLETED|Overall Study||16
2932229|NCT00595153|3643354|FG002|NOT COMPLETED|Overall Study||25
2932230|NCT00595231|3643364|FG000|STARTED|Overall Study||120
2932231|NCT00595231|3643365|FG001|STARTED|Overall Study||119
2932232|NCT00595231|3643364|FG000|COMPLETED|Overall Study||115
2932233|NCT00595231|3643365|FG001|COMPLETED|Overall Study||114
2932234|NCT00595231|3643364|FG000|NOT COMPLETED|Overall Study||5
2932235|NCT00595231|3643365|FG001|NOT COMPLETED|Overall Study||5
2932236|NCT00595270|3643374|FG000|STARTED|Overall Study||116
2932237|NCT00595270|3643375|FG001|STARTED|Overall Study||117
2932238|NCT00595270|3643376|FG002|STARTED|Overall Study||116
2932239|NCT00595270|3643374|FG000|COMPLETED|Overall Study||110
2932240|NCT00595270|3643375|FG001|COMPLETED|Overall Study||107
2932241|NCT00595270|3643376|FG002|COMPLETED|Overall Study||108
2932242|NCT00595270|3643374|FG000|NOT COMPLETED|Overall Study||6
2932243|NCT00595270|3643375|FG001|NOT COMPLETED|Overall Study||10
2932244|NCT00595270|3643376|FG002|NOT COMPLETED|Overall Study||8
2932245|NCT00595309|3643384|FG000|STARTED|Overall Study||198
2932246|NCT00595309|3643384|FG000|COMPLETED|Overall Study||194
2932247|NCT00595309|3643384|FG000|NOT COMPLETED|Overall Study||4
2932248|NCT00595335|3643390|FG000|STARTED|Baseline to Six Months||13
2932249|NCT00595335|3643391|FG001|STARTED|Baseline to Six Months||12
2932250|NCT00595335|3643390|FG000|COMPLETED|Baseline to Six Months||11
2932251|NCT00595335|3643391|FG001|COMPLETED|Baseline to Six Months||10
2932252|NCT00595335|3643390|FG000|NOT COMPLETED|Baseline to Six Months||2
2932253|NCT00595335|3643391|FG001|NOT COMPLETED|Baseline to Six Months||2
2932254|NCT00595335|3643390|FG000|STARTED|Six Months to Twelve Months||11
2932255|NCT00595335|3643391|FG001|STARTED|Six Months to Twelve Months||10
2932256|NCT00595335|3643390|FG000|COMPLETED|Six Months to Twelve Months||10
2932257|NCT00595335|3643391|FG001|COMPLETED|Six Months to Twelve Months||9
2932258|NCT00595335|3643390|FG000|NOT COMPLETED|Six Months to Twelve Months||1
2932259|NCT00595335|3643391|FG001|NOT COMPLETED|Six Months to Twelve Months||1
2932260|NCT00595361|3643403|FG000|STARTED|Overall Study||12
2932261|NCT00595361|3643404|FG001|STARTED|Overall Study||18
2932262|NCT00595361|3643403|FG000|COMPLETED|Overall Study||12
2932263|NCT00595361|3643404|FG001|COMPLETED|Overall Study||18
3179976|NCT01987960|3908249|FG000|NOT COMPLETED|Period 2||0
3179977|NCT01987960|3908250|FG001|NOT COMPLETED|Period 2||5
3179978|NCT01987960|3908251|FG002|NOT COMPLETED|Period 2||9
3179979|NCT01987960|3908252|FG003|NOT COMPLETED|Period 2||0
3179980|NCT01987960|3908249|FG000|STARTED|Period 3||0
3179981|NCT01987960|3908250|FG001|STARTED|Period 3||0
3179982|NCT01987960|3908251|FG002|STARTED|Period 3||0
3179983|NCT01987960|3908252|FG003|STARTED|Period 3||190
2932264|NCT00595361|3643403|FG000|NOT COMPLETED|Overall Study||0
2932265|NCT00595361|3643404|FG001|NOT COMPLETED|Overall Study||0
2932266|NCT00595413|3643414|FG000|STARTED|Overall Study||76
2932267|NCT00595413|3643415|FG001|STARTED|Overall Study||78
2932268|NCT00595413|3643416|FG002|STARTED|Overall Study||78
2932269|NCT00595413|3643417|FG003|STARTED|Overall Study||79
2932270|NCT00595413|3643414|FG000|COMPLETED|Overall Study||69
2932271|NCT00595413|3643415|FG001|COMPLETED|Overall Study||73
2932272|NCT00595413|3643416|FG002|COMPLETED|Overall Study||70
2932273|NCT00595413|3643417|FG003|COMPLETED|Overall Study||75
2932274|NCT00595413|3643414|FG000|NOT COMPLETED|Overall Study||7
2932275|NCT00595413|3643415|FG001|NOT COMPLETED|Overall Study||5
2932276|NCT00595413|3643416|FG002|NOT COMPLETED|Overall Study||8
2932277|NCT00595413|3643417|FG003|NOT COMPLETED|Overall Study||4
3179984|NCT01987960|3908249|FG000|COMPLETED|Period 3||0
2932278|NCT00595465|3643430|FG000|STARTED|Overall Study||130
2932279|NCT00595465|3643431|FG001|STARTED|Overall Study||129
2932280|NCT00595465|3643432|FG002|STARTED|Overall Study||128
2932281|NCT00595465|3643430|FG000|COMPLETED|Overall Study||124
2932282|NCT00595465|3643431|FG001|COMPLETED|Overall Study||125
2932283|NCT00595465|3643432|FG002|COMPLETED|Overall Study||121
2932284|NCT00595465|3643430|FG000|NOT COMPLETED|Overall Study||6
2932285|NCT00595465|3643431|FG001|NOT COMPLETED|Overall Study||4
2932286|NCT00595465|3643432|FG002|NOT COMPLETED|Overall Study||7
2932287|NCT00595478|3643442|FG000|STARTED|Treatment||37
2932288|NCT00595478|3643443|FG001|STARTED|Treatment||38
2932289|NCT00595478|3643442|FG000|COMPLETED|Treatment||37
2932290|NCT00595478|3643443|FG001|COMPLETED|Treatment||38
2932291|NCT00595478|3643442|FG000|NOT COMPLETED|Treatment||0
2932292|NCT00595478|3643443|FG001|NOT COMPLETED|Treatment||0
2932293|NCT00595478|3643442|FG000|STARTED|36-week Follow-up Period||37
2932294|NCT00595478|3643443|FG001|STARTED|36-week Follow-up Period||38
2932295|NCT00595478|3643442|FG000|COMPLETED|36-week Follow-up Period||28
2932296|NCT00595478|3643443|FG001|COMPLETED|36-week Follow-up Period||30
2932297|NCT00595478|3643442|FG000|NOT COMPLETED|36-week Follow-up Period||9
2932298|NCT00595478|3643443|FG001|NOT COMPLETED|36-week Follow-up Period||8
2932299|NCT00595504|3643451|FG000|STARTED|Overall Study||16
2932300|NCT00595504|3643452|FG001|STARTED|Overall Study||9
2932301|NCT00595504|3643451|FG000|COMPLETED|Overall Study||14
2932302|NCT00595504|3643452|FG001|COMPLETED|Overall Study||6
2932303|NCT00595504|3643451|FG000|NOT COMPLETED|Overall Study||2
2932304|NCT00595504|3643452|FG001|NOT COMPLETED|Overall Study||3
2932305|NCT00595517|3643458|FG000|STARTED|Overall Study||130
2932306|NCT00595517|3643458|FG000|COMPLETED|Overall Study||111
2932307|NCT00595517|3643458|FG000|NOT COMPLETED|Overall Study||19
2932308|NCT00595530|3643462|FG000|STARTED|Overall Study||3
2932309|NCT00595530|3643462|FG000|COMPLETED|Overall Study||3
2932310|NCT00595530|3643462|FG000|NOT COMPLETED|Overall Study||0
2932311|NCT00595556|3643469|FG000|STARTED|Overall Study||20
2932312|NCT00595556|3643470|FG001|STARTED|Overall Study||20
2932313|NCT00595556|3643469|FG000|COMPLETED|Overall Study||17
2932314|NCT00595556|3643470|FG001|COMPLETED|Overall Study||19
2932315|NCT00595556|3643469|FG000|NOT COMPLETED|Overall Study||3
2932316|NCT00595556|3643470|FG001|NOT COMPLETED|Overall Study||1
2932317|NCT00595621|3643478|FG000|STARTED|Open Label Run in||22
2932318|NCT00595621|3643479|FG001|STARTED|Open Label Run in||0
2932319|NCT00595621|3643478|FG000|COMPLETED|Open Label Run in||19
2932320|NCT00595621|3643479|FG001|COMPLETED|Open Label Run in||0
2932321|NCT00595621|3643478|FG000|NOT COMPLETED|Open Label Run in||3
2932322|NCT00595621|3643479|FG001|NOT COMPLETED|Open Label Run in||0
2932323|NCT00595621|3643478|FG000|STARTED|Randomization and Study||10
2932324|NCT00595621|3643479|FG001|STARTED|Randomization and Study||9
2932325|NCT00595621|3643478|FG000|COMPLETED|Randomization and Study||8
2932326|NCT00595621|3643479|FG001|COMPLETED|Randomization and Study||8
2932327|NCT00595621|3643478|FG000|NOT COMPLETED|Randomization and Study||2
2932328|NCT00595621|3643479|FG001|NOT COMPLETED|Randomization and Study||1
2932329|NCT00595764|3643488|FG000|STARTED|Overall Study||71
2932330|NCT00595764|3643489|FG001|STARTED|Overall Study||70
2932331|NCT00595764|3643488|FG000|COMPLETED|Overall Study||32
2932332|NCT00595764|3643489|FG001|COMPLETED|Overall Study||27
2932333|NCT00595764|3643488|FG000|NOT COMPLETED|Overall Study||39
2932334|NCT00595764|3643489|FG001|NOT COMPLETED|Overall Study||43
2932335|NCT00595790|3643498|FG000|STARTED|Overall Study||125
2932336|NCT00595790|3643499|FG001|STARTED|Overall Study|124 subjects randomized to this group, 125 subjects received 1x12 mcg.(Safety Population: N=125)|124
2932337|NCT00595790|3643500|FG002|STARTED|Overall Study|125 subjects randomized to this group, 124 subjects received 1x6 mcg.(Safety Population: N=124)|125
2932338|NCT00595790|3643498|FG000|COMPLETED|Overall Study|The Participant Flow shows all study participants randomized.Prim. Outcome is based on PP Population|123
2932339|NCT00595790|3643499|FG001|COMPLETED|Overall Study|The Participant Flow shows all study participants randomized.Prim. Outcome is based on PP Population|123
2932340|NCT00595790|3643500|FG002|COMPLETED|Overall Study|The Participant Flow shows all study participants randomized.Prim. Outcome is based on PP Population|122
2932341|NCT00595790|3643498|FG000|NOT COMPLETED|Overall Study||2
2932342|NCT00595790|3643499|FG001|NOT COMPLETED|Overall Study||1
2932343|NCT00595790|3643500|FG002|NOT COMPLETED|Overall Study||3
2932344|NCT00595868|3643510|FG000|STARTED|Overall Study||107
2932345|NCT00595868|3643511|FG001|STARTED|Overall Study||111
3041896|NCT01173601|3761540|FG000|Entered Discontinuation Phase|Confirmation (CF) Phase, 3 Weeks|Participants who discontinued the CF Phase had the option to enter the DC phase.|21
3041897|NCT01173601|3761541|FG001|Entered Discontinuation Phase|Confirmation (CF) Phase, 3 Weeks||0
3041898|NCT01173601|3761542|FG002|Entered Discontinuation Phase|Confirmation (CF) Phase, 3 Weeks||0
3041899|NCT01173601|3761543|FG003|Entered Discontinuation Phase|Confirmation (CF) Phase, 3 Weeks||0
3041900|NCT01173601|3761544|FG004|Entered Discontinuation Phase|Confirmation (CF) Phase, 3 Weeks||0
3041901|NCT01173601|3761540|FG000|COMPLETED|Confirmation (CF) Phase, 3 Weeks|Participants who completed the CF Phase entered the AT Phase.|1328
3041902|NCT01173601|3761541|FG001|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
3041903|NCT01173601|3761542|FG002|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
3041904|NCT01173601|3761543|FG003|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
3041905|NCT01173601|3761544|FG004|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
3041906|NCT01173601|3761540|FG000|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||88
3041907|NCT01173601|3761541|FG001|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
3041908|NCT01173601|3761542|FG002|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
2932346|NCT00595868|3643510|FG000|COMPLETED|Overall Study||62
2932347|NCT00595868|3643511|FG001|COMPLETED|Overall Study||61
2932348|NCT00595868|3643510|FG000|NOT COMPLETED|Overall Study||45
2932349|NCT00595868|3643511|FG001|NOT COMPLETED|Overall Study||50
2932350|NCT00595881|3643517|FG000|STARTED|Overall Study||420
2932351|NCT00595881|3643517|FG000|COMPLETED|Overall Study||420
2932352|NCT00595881|3643517|FG000|NOT COMPLETED|Overall Study||0
2932353|NCT00595946|3643524|FG000|STARTED|Overall Study||218
2932354|NCT00595946|3643525|FG001|STARTED|Overall Study||221
2932355|NCT00595946|3643524|FG000|COMPLETED|Overall Study||154
2932356|NCT00595946|3643525|FG001|COMPLETED|Overall Study||152
2932357|NCT00595946|3643524|FG000|NOT COMPLETED|Overall Study||64
2932358|NCT00595946|3643525|FG001|NOT COMPLETED|Overall Study||69
2932359|NCT00595959|3643531|FG000|STARTED|Overall Study||65
2932360|NCT00595959|3643531|FG000|COMPLETED|Overall Study||63
2932361|NCT00595959|3643531|FG000|NOT COMPLETED|Overall Study||2
2932362|NCT00596011|3643537|FG000|STARTED|Overall Study||49
2932363|NCT00596011|3643538|FG001|STARTED|Overall Study||48
2932364|NCT00596011|3643537|FG000|COMPLETED|Overall Study||36
2932365|NCT00596011|3643538|FG001|COMPLETED|Overall Study||38
2932366|NCT00596011|3643537|FG000|NOT COMPLETED|Overall Study||13
2932367|NCT00596011|3643538|FG001|NOT COMPLETED|Overall Study||10
2932368|NCT00596102|3643547|FG000|STARTED|Up to Month 6||2283
2932369|NCT00596102|3643548|FG001|STARTED|Up to Month 6||338
2932370|NCT00596102|3643549|FG002|STARTED|Up to Month 6||637
2932371|NCT00596102|3643547|FG000|COMPLETED|Up to Month 6||2283
2932372|NCT00596102|3643548|FG001|COMPLETED|Up to Month 6||338
2932373|NCT00596102|3643549|FG002|COMPLETED|Up to Month 6||637
2932374|NCT00596102|3643547|FG000|NOT COMPLETED|Up to Month 6||0
2932375|NCT00596102|3643548|FG001|NOT COMPLETED|Up to Month 6||0
2932376|NCT00596102|3643549|FG002|NOT COMPLETED|Up to Month 6||0
2932377|NCT00596102|3643547|FG000|STARTED|Up to Month 60||2283
2932378|NCT00596102|3643548|FG001|STARTED|Up to Month 60||338
2932379|NCT00596102|3643549|FG002|STARTED|Up to Month 60||637
2932380|NCT00596102|3643547|FG000|COMPLETED|Up to Month 60|"long-term safety follow-up beyond Month 6 for a sub-set of subjects in IC51 group only"|102
2932381|NCT00596102|3643548|FG001|COMPLETED|Up to Month 60||0
2932382|NCT00596102|3643549|FG002|COMPLETED|Up to Month 60||0
2932383|NCT00596102|3643547|FG000|NOT COMPLETED|Up to Month 60||2181
2932384|NCT00596102|3643548|FG001|NOT COMPLETED|Up to Month 60||338
2932385|NCT00596102|3643549|FG002|NOT COMPLETED|Up to Month 60||637
2932386|NCT00596167|3643556|FG000|STARTED|Overall Study|All recruited subjects completed the study.|6
2932387|NCT00596167|3643556|FG000|COMPLETED|Overall Study||6
2932388|NCT00596167|3643556|FG000|NOT COMPLETED|Overall Study||0
2932389|NCT00596271|3643563|FG000|STARTED|Overall Study||65
2932390|NCT00596271|3643564|FG001|STARTED|Overall Study||65
2932391|NCT00596271|3643565|FG002|STARTED|Overall Study||62
2932392|NCT00596271|3643563|FG000|COMPLETED|Overall Study||60
2932393|NCT00596271|3643564|FG001|COMPLETED|Overall Study||59
2932394|NCT00596271|3643565|FG002|COMPLETED|Overall Study||61
2932395|NCT00596271|3643563|FG000|NOT COMPLETED|Overall Study||5
2932396|NCT00596271|3643564|FG001|NOT COMPLETED|Overall Study||6
2932397|NCT00596271|3643565|FG002|NOT COMPLETED|Overall Study||1
2932398|NCT00596362|3643574|FG000|STARTED|Overall Study||1
2932399|NCT00596362|3643574|FG000|COMPLETED|Overall Study||0
2932400|NCT00596362|3643574|FG000|NOT COMPLETED|Overall Study||1
2932401|NCT00596427|3643580|FG000|STARTED|Overall Study||30
2932402|NCT00596427|3643581|FG001|STARTED|Overall Study||30
2932403|NCT00596427|3643580|FG000|COMPLETED|Overall Study||26
2932404|NCT00596427|3643581|FG001|COMPLETED|Overall Study||28
2932405|NCT00596427|3643580|FG000|NOT COMPLETED|Overall Study||4
2932406|NCT00596427|3643581|FG001|NOT COMPLETED|Overall Study||2
2932407|NCT00596440|3643590|FG000|STARTED|Overall Study||113
2932408|NCT00596440|3643591|FG001|STARTED|Overall Study||121
2932409|NCT00596440|3643590|FG000|Showed to Eligibility Visit|Overall Study||85
2932410|NCT00596440|3643591|FG001|Showed to Eligibility Visit|Overall Study||72
2932411|NCT00596440|3643590|FG000|Showed to First Treatment Session|Overall Study||61
2932412|NCT00596440|3643591|FG001|Showed to First Treatment Session|Overall Study||52
2932413|NCT00596440|3643590|FG000|COMPLETED|Overall Study||48
2932414|NCT00596440|3643591|FG001|COMPLETED|Overall Study||41
2932415|NCT00596440|3643590|FG000|NOT COMPLETED|Overall Study||65
2932416|NCT00596440|3643591|FG001|NOT COMPLETED|Overall Study||80
2932417|NCT00596453|3643599|FG000|STARTED|Overall Study||13
2932418|NCT00596453|3643600|FG001|STARTED|Overall Study||15
2932419|NCT00596453|3643599|FG000|COMPLETED|Overall Study||12
2932420|NCT00596453|3643600|FG001|COMPLETED|Overall Study||12
2932421|NCT00596453|3643599|FG000|NOT COMPLETED|Overall Study||1
2932422|NCT00596453|3643600|FG001|NOT COMPLETED|Overall Study||3
2932423|NCT00596466|3643606|FG000|STARTED|Overall Study||75
2932424|NCT00596466|3643606|FG000|Enrolled, Treated|Overall Study||73
2932425|NCT00596466|3643606|FG000|COMPLETED|Overall Study||58
2932426|NCT00596466|3643606|FG000|NOT COMPLETED|Overall Study||17
2932427|NCT00596622|3643613|FG000|STARTED|Overall Study||46
2932428|NCT00596622|3643613|FG000|COMPLETED|Overall Study||33
2932429|NCT00596622|3643613|FG000|NOT COMPLETED|Overall Study||13
2932430|NCT00596635|3643625|FG000|STARTED|Overall Study||17
2932431|NCT00596635|3643626|FG001|STARTED|Overall Study||20
2932432|NCT00596635|3643627|FG002|STARTED|Overall Study||19
2932433|NCT00596635|3643625|FG000|COMPLETED|Overall Study||10
2932434|NCT00596635|3643626|FG001|COMPLETED|Overall Study||7
2932435|NCT00596635|3643627|FG002|COMPLETED|Overall Study||11
2932436|NCT00596635|3643625|FG000|NOT COMPLETED|Overall Study||7
2932437|NCT00596635|3643626|FG001|NOT COMPLETED|Overall Study||13
2932438|NCT00596635|3643627|FG002|NOT COMPLETED|Overall Study||8
2932439|NCT00596687|3643637|FG000|STARTED|Overall Study||118
2932440|NCT00596687|3643638|FG001|STARTED|Overall Study||116
2932441|NCT00596687|3643637|FG000|COMPLETED|Overall Study||104
2932442|NCT00596687|3643638|FG001|COMPLETED|Overall Study||107
2932443|NCT00596687|3643637|FG000|NOT COMPLETED|Overall Study||14
2932444|NCT00596687|3643638|FG001|NOT COMPLETED|Overall Study||9
2932445|NCT00596752|3643646|FG000|STARTED|Overall Study||415
2932446|NCT00596752|3643647|FG001|STARTED|Overall Study||425
2932447|NCT00596752|3643646|FG000|Randomized and Treated|Overall Study||415
2932448|NCT00596752|3643647|FG001|Randomized and Treated|Overall Study||424
2932449|NCT00596752|3643646|FG000|COMPLETED|Overall Study||289
2932450|NCT00596752|3643647|FG001|COMPLETED|Overall Study||282
2932451|NCT00596752|3643646|FG000|NOT COMPLETED|Overall Study||126
2932452|NCT00596752|3643647|FG001|NOT COMPLETED|Overall Study||143
2932453|NCT00596817|3643656|FG000|STARTED|Open-label Period||0
2932454|NCT00596817|3643657|FG001|STARTED|Open-label Period||639
2932455|NCT00596817|3643656|FG000|COMPLETED|Open-label Period||0
2932456|NCT00596817|3643657|FG001|COMPLETED|Open-label Period||492
2932457|NCT00596817|3643656|FG000|NOT COMPLETED|Open-label Period||0
2932458|NCT00596817|3643657|FG001|NOT COMPLETED|Open-label Period||147
2932459|NCT00596817|3643656|FG000|STARTED|Open-label Period to Double-blind Period||0
2932460|NCT00596817|3643657|FG001|STARTED|Open-label Period to Double-blind Period||492
2932461|NCT00596817|3643656|FG000|COMPLETED|Open-label Period to Double-blind Period||0
2932462|NCT00596817|3643657|FG001|COMPLETED|Open-label Period to Double-blind Period||400
2932463|NCT00596817|3643656|FG000|NOT COMPLETED|Open-label Period to Double-blind Period||0
2932464|NCT00596817|3643657|FG001|NOT COMPLETED|Open-label Period to Double-blind Period||92
2932465|NCT00596817|3643656|FG000|STARTED|Double-blind Period|194 patients were randomised. 2 did not receive study medication. 192 is full-analysis set (FAS).|192
2932466|NCT00596817|3643657|FG001|STARTED|Double-blind Period|206 patients were randomised. 2 did not receive study medication. 204 is FAS.|204
2932467|NCT00596817|3643656|FG000|COMPLETED|Double-blind Period||104
2932468|NCT00596817|3643657|FG001|COMPLETED|Double-blind Period||125
2932469|NCT00596817|3643656|FG000|NOT COMPLETED|Double-blind Period||88
2932470|NCT00596817|3643657|FG001|NOT COMPLETED|Double-blind Period||79
2932471|NCT00596830|3643666|FG000|STARTED|Overall Study|1 participant in this group only received paclitaxel and carboplatin (chemo).|342
2932472|NCT00596830|3643667|FG001|STARTED|Overall Study||339
2932473|NCT00596830|3643666|FG000|Treated|Overall Study|1 participant in this group only received chemo and did not complete due to death.|339
2932474|NCT00596830|3643667|FG001|Treated|Overall Study||332
2932475|NCT00596830|3643666|FG000|COMPLETED|Overall Study||0
2932476|NCT00596830|3643667|FG001|COMPLETED|Overall Study||0
2932477|NCT00596830|3643666|FG000|NOT COMPLETED|Overall Study||342
2932478|NCT00596830|3643667|FG001|NOT COMPLETED|Overall Study||339
2932479|NCT00596934|3643673|FG000|STARTED|Overall Study||9
2932480|NCT00596934|3643673|FG000|COMPLETED|Overall Study||7
2932481|NCT00596934|3643673|FG000|NOT COMPLETED|Overall Study||2
2932482|NCT00596960|3643681|FG000|STARTED|Overall Study||70
2932483|NCT00596960|3643682|FG001|STARTED|Overall Study|One subject did not have any alcohol use data and thus was excluded from the statistical analysis|69
2932484|NCT00596960|3643681|FG000|COMPLETED|Overall Study||59
2932485|NCT00596960|3643682|FG001|COMPLETED|Overall Study||60
2932486|NCT00596960|3643681|FG000|NOT COMPLETED|Overall Study||11
2932487|NCT00596960|3643682|FG001|NOT COMPLETED|Overall Study||9
2932488|NCT00597012|3643690|FG000|STARTED|Overall Study||174
2932489|NCT00597012|3643691|FG001|STARTED|Overall Study||177
2932490|NCT00597012|3643690|FG000|COMPLETED|Overall Study||161
2932491|NCT00597012|3643691|FG001|COMPLETED|Overall Study||169
2932492|NCT00597012|3643690|FG000|NOT COMPLETED|Overall Study||13
2932493|NCT00597012|3643691|FG001|NOT COMPLETED|Overall Study||8
2932494|NCT00597038|3643701|FG000|STARTED|Overall Study||16
2932495|NCT00597038|3643702|FG001|STARTED|Overall Study||34
2932496|NCT00597038|3643701|FG000|COMPLETED|Overall Study|One did not complete due to PI decision, one did not complete due to progressive disease.|14
3179985|NCT01987960|3908250|FG001|COMPLETED|Period 3||0
3179986|NCT01987960|3908251|FG002|COMPLETED|Period 3||0
3179987|NCT01987960|3908252|FG003|COMPLETED|Period 3||119
2932497|NCT00597038|3643702|FG001|COMPLETED|Overall Study|Two patients withdrew, one did not complete due to progressive disease, one patient died.|30
2932498|NCT00597038|3643701|FG000|NOT COMPLETED|Overall Study||2
2932499|NCT00597038|3643702|FG001|NOT COMPLETED|Overall Study||4
2932500|NCT00597116|3643712|FG000|STARTED|Overall Study||14
2932501|NCT00597116|3643713|FG001|STARTED|Overall Study||11
2932502|NCT00597116|3643712|FG000|COMPLETED|Overall Study|Randomised patients ongoing study treatment at data cut-off|0
2932503|NCT00597116|3643713|FG001|COMPLETED|Overall Study|Randomised patients ongoing study treatment at data cut-off|0
2932504|NCT00597116|3643712|FG000|NOT COMPLETED|Overall Study||14
2932505|NCT00597116|3643713|FG001|NOT COMPLETED|Overall Study||11
2932506|NCT00597207|3643721|FG000|STARTED|Overall Study||2099
2932507|NCT00597207|3643722|FG001|STARTED|Overall Study||2132
2932508|NCT00597207|3643721|FG000|COMPLETED|Overall Study||2094
3041909|NCT01173601|3761543|FG003|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
3041910|NCT01173601|3761544|FG004|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
3041911|NCT01173601|3761540|FG000|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
3041912|NCT01173601|3761541|FG001|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||231
3041913|NCT01173601|3761542|FG002|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||230
3041914|NCT01173601|3761543|FG003|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||240
2932509|NCT00597207|3643722|FG001|COMPLETED|Overall Study||2125
2932510|NCT00597207|3643721|FG000|NOT COMPLETED|Overall Study||5
2932511|NCT00597207|3643722|FG001|NOT COMPLETED|Overall Study||7
2932512|NCT00597246|3643728|FG000|STARTED|Overall Study||30
2932513|NCT00597246|3643728|FG000|COMPLETED|Overall Study||30
2932514|NCT00597246|3643728|FG000|NOT COMPLETED|Overall Study||0
2932515|NCT00597272|3643739|FG000|STARTED|Overall Study||1
2932516|NCT00597272|3643740|FG001|STARTED|Overall Study||1
2932517|NCT00597272|3643741|FG002|STARTED|Overall Study||10
2932518|NCT00597272|3643742|FG003|STARTED|Overall Study||1
2932519|NCT00597272|3643743|FG004|STARTED|Overall Study||1
2932520|NCT00597272|3643744|FG005|STARTED|Overall Study||10
2932521|NCT00597272|3643745|FG006|STARTED|Overall Study||10
2932522|NCT00597272|3643739|FG000|COMPLETED|Overall Study||1
2932523|NCT00597272|3643740|FG001|COMPLETED|Overall Study||1
2932524|NCT00597272|3643741|FG002|COMPLETED|Overall Study||10
2932525|NCT00597272|3643742|FG003|COMPLETED|Overall Study||1
2932526|NCT00597272|3643743|FG004|COMPLETED|Overall Study||1
2932527|NCT00597272|3643744|FG005|COMPLETED|Overall Study||10
2932528|NCT00597272|3643745|FG006|COMPLETED|Overall Study||10
2932529|NCT00597272|3643739|FG000|NOT COMPLETED|Overall Study||0
2932530|NCT00597272|3643740|FG001|NOT COMPLETED|Overall Study||0
2932531|NCT00597272|3643741|FG002|NOT COMPLETED|Overall Study||0
2932532|NCT00597272|3643742|FG003|NOT COMPLETED|Overall Study||0
2932533|NCT00597272|3643743|FG004|NOT COMPLETED|Overall Study||0
2932534|NCT00597272|3643744|FG005|NOT COMPLETED|Overall Study||0
2932535|NCT00597272|3643745|FG006|NOT COMPLETED|Overall Study||0
2932536|NCT00597376|3643763|FG000|STARTED|Overall Study||51
2932537|NCT00597376|3643764|FG001|STARTED|Overall Study||53
2932538|NCT00597376|3643763|FG000|COMPLETED|Overall Study|All participants started (51) were included in primary analyses.|43
2932539|NCT00597376|3643764|FG001|COMPLETED|Overall Study|All participants started (53) were included in primary analyses.|49
2932540|NCT00597376|3643763|FG000|NOT COMPLETED|Overall Study||8
2932541|NCT00597376|3643764|FG001|NOT COMPLETED|Overall Study||4
2932542|NCT00597402|3643770|FG000|STARTED|Overall Study||125
2932543|NCT00597402|3643770|FG000|COMPLETED|Overall Study||125
2932544|NCT00597402|3643770|FG000|NOT COMPLETED|Overall Study||0
2932545|NCT00597428|3643776|FG000|STARTED|Overall Study||214
2932546|NCT00597428|3643777|FG001|STARTED|Overall Study||223
2932547|NCT00597428|3643776|FG000|COMPLETED|Overall Study||153
2932548|NCT00597428|3643777|FG001|COMPLETED|Overall Study||152
2932549|NCT00597428|3643776|FG000|NOT COMPLETED|Overall Study||61
2932550|NCT00597428|3643777|FG001|NOT COMPLETED|Overall Study||71
2932551|NCT00597493|3643783|FG000|STARTED|Overall Study||32
2932552|NCT00597493|3643783|FG000|COMPLETED|Overall Study||32
2932553|NCT00597493|3643783|FG000|NOT COMPLETED|Overall Study||0
2932554|NCT00597506|3643791|FG000|STARTED|Overall Study||50
2932555|NCT00597506|3643791|FG000|COMPLETED|Overall Study||49
2932556|NCT00597506|3643791|FG000|NOT COMPLETED|Overall Study||1
2932557|NCT00597519|3643795|FG000|STARTED|Overall Study||28
2932558|NCT00597519|3643795|FG000|COMPLETED|Overall Study||27
2932559|NCT00597519|3643795|FG000|NOT COMPLETED|Overall Study||1
2932560|NCT00597545|3643801|FG000|STARTED|Overall Study||4
2932561|NCT00597545|3643802|FG001|STARTED|Overall Study||6
2932562|NCT00597545|3643801|FG000|COMPLETED|Overall Study||4
2932563|NCT00597545|3643802|FG001|COMPLETED|Overall Study||6
2932564|NCT00597545|3643801|FG000|NOT COMPLETED|Overall Study||0
2932565|NCT00597545|3643802|FG001|NOT COMPLETED|Overall Study||0
2932566|NCT00597558|3643808|FG000|STARTED|Overall Study||13
2932567|NCT00597558|3643808|FG000|COMPLETED|Overall Study||9
2932568|NCT00597558|3643808|FG000|NOT COMPLETED|Overall Study||4
2932569|NCT00597584|3643814|FG000|STARTED|Overall Study|Randomization was 2:1 peginesatide to epoetin|549
2932570|NCT00597584|3643815|FG001|STARTED|Overall Study||274
2932571|NCT00597584|3643814|FG000|COMPLETED|Overall Study||421
2932572|NCT00597584|3643815|FG001|COMPLETED|Overall Study||211
2932573|NCT00597584|3643814|FG000|NOT COMPLETED|Overall Study||128
2932574|NCT00597584|3643815|FG001|NOT COMPLETED|Overall Study||63
2932575|NCT00597675|3643823|FG000|STARTED|Blinded Phase||4
2932576|NCT00597675|3643824|FG001|STARTED|Blinded Phase||6
2932577|NCT00597675|3643823|FG000|COMPLETED|Blinded Phase||2
2932578|NCT00597675|3643824|FG001|COMPLETED|Blinded Phase||5
2932579|NCT00597675|3643823|FG000|NOT COMPLETED|Blinded Phase||2
2932580|NCT00597675|3643824|FG001|NOT COMPLETED|Blinded Phase||1
2932581|NCT00597675|3643823|FG000|STARTED|Open Label Phase|Patients previously on placebo were crossed over onto open label peanut OIT|2
2932582|NCT00597675|3643824|FG001|STARTED|Open Label Phase||5
2932583|NCT00597675|3643823|FG000|COMPLETED|Open Label Phase||2
2932584|NCT00597675|3643824|FG001|COMPLETED|Open Label Phase||5
2932585|NCT00597675|3643823|FG000|NOT COMPLETED|Open Label Phase||0
2932586|NCT00597675|3643824|FG001|NOT COMPLETED|Open Label Phase||0
2932587|NCT00597701|3643834|FG000|STARTED|Overall Study||25
2932588|NCT00597701|3643835|FG001|STARTED|Overall Study||21
2932589|NCT00597701|3643834|FG000|COMPLETED|Overall Study||18
2932590|NCT00597701|3643835|FG001|COMPLETED|Overall Study||13
2932591|NCT00597701|3643834|FG000|NOT COMPLETED|Overall Study||7
2932592|NCT00597701|3643835|FG001|NOT COMPLETED|Overall Study||8
2932593|NCT00597714|3643843|FG000|STARTED|Overall Study||80
2932594|NCT00597714|3643844|FG001|STARTED|Overall Study||57
2932595|NCT00597714|3643845|FG002|STARTED|Overall Study||94
2932596|NCT00597714|3643843|FG000|COMPLETED|Overall Study||24
2932597|NCT00597714|3643844|FG001|COMPLETED|Overall Study||11
2932598|NCT00597714|3643845|FG002|COMPLETED|Overall Study||84
2932599|NCT00597714|3643843|FG000|NOT COMPLETED|Overall Study||56
2932600|NCT00597714|3643844|FG001|NOT COMPLETED|Overall Study||46
2932601|NCT00597714|3643845|FG002|NOT COMPLETED|Overall Study||10
2932602|NCT00597727|3643858|FG000|STARTED|12 Month Blinded Phase||14
2932603|NCT00597727|3643859|FG001|STARTED|12 Month Blinded Phase||15
2932604|NCT00597727|3643860|FG002|STARTED|12 Month Blinded Phase||0
2932605|NCT00597727|3643861|FG003|STARTED|12 Month Blinded Phase||27
2932606|NCT00597727|3643862|FG004|STARTED|12 Month Blinded Phase||4
2932607|NCT00597727|3643858|FG000|COMPLETED|12 Month Blinded Phase||14
2932608|NCT00597727|3643859|FG001|COMPLETED|12 Month Blinded Phase||15
2932609|NCT00597727|3643860|FG002|COMPLETED|12 Month Blinded Phase||0
2932610|NCT00597727|3643861|FG003|COMPLETED|12 Month Blinded Phase||17
2932611|NCT00597727|3643862|FG004|COMPLETED|12 Month Blinded Phase||3
2932612|NCT00597727|3643858|FG000|NOT COMPLETED|12 Month Blinded Phase||0
2932613|NCT00597727|3643859|FG001|NOT COMPLETED|12 Month Blinded Phase||0
2932614|NCT00597727|3643860|FG002|NOT COMPLETED|12 Month Blinded Phase||0
2932615|NCT00597727|3643861|FG003|NOT COMPLETED|12 Month Blinded Phase||10
2932616|NCT00597727|3643862|FG004|NOT COMPLETED|12 Month Blinded Phase||1
2932617|NCT00597727|3643858|FG000|STARTED|Open-label Extended Maintenance Phase|Blinded peanut SLIT + blinded placebo SLIT continued in Ext Open Label Peanut SLIT after unblinding|0
2932618|NCT00597727|3643859|FG001|STARTED|Open-label Extended Maintenance Phase|Blinded peanut SLIT + blinded placebo SLIT continued in Ext Open Label Peanut SLIT after unblinding|0
2932619|NCT00597727|3643860|FG002|STARTED|Open-label Extended Maintenance Phase|Blinded peanut SLIT + blinded placebo SLIT continued in Ext Open Label Peanut SLIT after unblinding.|29
2932620|NCT00597727|3643861|FG003|STARTED|Open-label Extended Maintenance Phase||17
2932621|NCT00597727|3643862|FG004|STARTED|Open-label Extended Maintenance Phase||3
2932622|NCT00597727|3643858|FG000|COMPLETED|Open-label Extended Maintenance Phase||0
2932623|NCT00597727|3643859|FG001|COMPLETED|Open-label Extended Maintenance Phase||0
2932624|NCT00597727|3643860|FG002|COMPLETED|Open-label Extended Maintenance Phase||23
2932625|NCT00597727|3643861|FG003|COMPLETED|Open-label Extended Maintenance Phase||14
2932626|NCT00597727|3643862|FG004|COMPLETED|Open-label Extended Maintenance Phase||1
2932627|NCT00597727|3643858|FG000|NOT COMPLETED|Open-label Extended Maintenance Phase||0
2932628|NCT00597727|3643859|FG001|NOT COMPLETED|Open-label Extended Maintenance Phase||0
2932629|NCT00597727|3643860|FG002|NOT COMPLETED|Open-label Extended Maintenance Phase||6
2932630|NCT00597727|3643861|FG003|NOT COMPLETED|Open-label Extended Maintenance Phase||3
2932631|NCT00597727|3643862|FG004|NOT COMPLETED|Open-label Extended Maintenance Phase||2
2932632|NCT00597753|3643878|FG000|STARTED|Overall Study|Randomization was 2:1 peginesatide to epoetin alfa|532
2932633|NCT00597753|3643879|FG001|STARTED|Overall Study||271
2932634|NCT00597753|3643878|FG000|COMPLETED|Overall Study||366
2932635|NCT00597753|3643879|FG001|COMPLETED|Overall Study||202
2932636|NCT00597753|3643878|FG000|NOT COMPLETED|Overall Study||166
2932637|NCT00597753|3643879|FG001|NOT COMPLETED|Overall Study||69
2932638|NCT00597766|3643888|FG000|STARTED|Enrolled||9
2932639|NCT00597766|3643889|FG001|STARTED|Enrolled||9
2932640|NCT00597766|3643890|FG002|STARTED|Enrolled||10
2932641|NCT00597766|3643888|FG000|COMPLETED|Enrolled||9
2932642|NCT00597766|3643889|FG001|COMPLETED|Enrolled||9
2932643|NCT00597766|3643890|FG002|COMPLETED|Enrolled||10
2932644|NCT00597766|3643888|FG000|NOT COMPLETED|Enrolled||0
2932645|NCT00597766|3643889|FG001|NOT COMPLETED|Enrolled||0
2932646|NCT00597766|3643890|FG002|NOT COMPLETED|Enrolled||0
2932647|NCT00597766|3643888|FG000|STARTED|Follow-up 1, Week 4||9
2932648|NCT00597766|3643889|FG001|STARTED|Follow-up 1, Week 4||9
2932649|NCT00597766|3643890|FG002|STARTED|Follow-up 1, Week 4||10
2932650|NCT00597766|3643888|FG000|COMPLETED|Follow-up 1, Week 4||8
2932651|NCT00597766|3643889|FG001|COMPLETED|Follow-up 1, Week 4||9
2932652|NCT00597766|3643890|FG002|COMPLETED|Follow-up 1, Week 4||10
2932653|NCT00597766|3643888|FG000|NOT COMPLETED|Follow-up 1, Week 4||1
2932654|NCT00597766|3643889|FG001|NOT COMPLETED|Follow-up 1, Week 4||0
2932655|NCT00597766|3643890|FG002|NOT COMPLETED|Follow-up 1, Week 4||0
3041915|NCT01173601|3761544|FG004|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||627
3041916|NCT01173601|3761540|FG000|Entered Taper Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||0
3041917|NCT01173601|3761541|FG001|Entered Taper Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early entered the taper DC Phase.|100
3041918|NCT01173601|3761542|FG002|Entered Taper Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early entered the taper DC Phase.|107
3041919|NCT01173601|3761543|FG003|Entered Taper Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||0
3041920|NCT01173601|3761544|FG004|Entered Taper Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||0
3041921|NCT01173601|3761540|FG000|Entered Abrupt Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||0
3041922|NCT01173601|3761541|FG001|Entered Abrupt Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early entered the abrupt DC Phase.|100
3041923|NCT01173601|3761542|FG002|Entered Abrupt Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early entered the abrupt DC Phase.|108
3041924|NCT01173601|3761543|FG003|Entered Abrupt Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early entered the abrupt DC Phase.|221
3041925|NCT01173601|3761544|FG004|Entered Abrupt Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early entered the abrupt DC Phase.|586
3041926|NCT01173601|3761540|FG000|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
3041927|NCT01173601|3761541|FG001|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||196
3137175|NCT01717326|3862431|FG006|Treated|Overall Study||31
2932656|NCT00597766|3643888|FG000|STARTED|Follow-up 2, Week 8||8
2932657|NCT00597766|3643889|FG001|STARTED|Follow-up 2, Week 8||9
2932658|NCT00597766|3643890|FG002|STARTED|Follow-up 2, Week 8||10
2932659|NCT00597766|3643888|FG000|COMPLETED|Follow-up 2, Week 8||8
2932660|NCT00597766|3643889|FG001|COMPLETED|Follow-up 2, Week 8||9
2932661|NCT00597766|3643890|FG002|COMPLETED|Follow-up 2, Week 8||9
2932662|NCT00597766|3643888|FG000|NOT COMPLETED|Follow-up 2, Week 8||0
2932663|NCT00597766|3643889|FG001|NOT COMPLETED|Follow-up 2, Week 8||0
2932664|NCT00597766|3643890|FG002|NOT COMPLETED|Follow-up 2, Week 8||1
2932665|NCT00597766|3643888|FG000|STARTED|Follow-up 3, Week 12||8
2932666|NCT00597766|3643889|FG001|STARTED|Follow-up 3, Week 12||9
2932667|NCT00597766|3643890|FG002|STARTED|Follow-up 3, Week 12||9
2932668|NCT00597766|3643888|FG000|COMPLETED|Follow-up 3, Week 12||8
2932669|NCT00597766|3643889|FG001|COMPLETED|Follow-up 3, Week 12||9
2932670|NCT00597766|3643890|FG002|COMPLETED|Follow-up 3, Week 12||9
2932671|NCT00597766|3643888|FG000|NOT COMPLETED|Follow-up 3, Week 12||0
2932672|NCT00597766|3643889|FG001|NOT COMPLETED|Follow-up 3, Week 12||0
2932673|NCT00597766|3643890|FG002|NOT COMPLETED|Follow-up 3, Week 12||0
2932674|NCT00597818|3643902|FG000|STARTED|Overall Study||30
2932675|NCT00597818|3643903|FG001|STARTED|Overall Study||30
2932676|NCT00597818|3643904|FG002|STARTED|Overall Study||31
2932677|NCT00597818|3643905|FG003|STARTED|Overall Study||30
2932678|NCT00597818|3643902|FG000|COMPLETED|Overall Study||12
2932679|NCT00597818|3643903|FG001|COMPLETED|Overall Study||14
2932680|NCT00597818|3643904|FG002|COMPLETED|Overall Study||12
2932681|NCT00597818|3643905|FG003|COMPLETED|Overall Study||20
2932682|NCT00597818|3643902|FG000|NOT COMPLETED|Overall Study||18
2932683|NCT00597818|3643903|FG001|NOT COMPLETED|Overall Study||16
2932684|NCT00597818|3643904|FG002|NOT COMPLETED|Overall Study||19
2932685|NCT00597818|3643905|FG003|NOT COMPLETED|Overall Study||10
2932686|NCT00597896|3643917|FG000|STARTED|Overall Study||24
2932687|NCT00597896|3643918|FG001|STARTED|Overall Study||26
2932688|NCT00597896|3643917|FG000|COMPLETED|Overall Study||21
2932689|NCT00597896|3643918|FG001|COMPLETED|Overall Study||24
2932690|NCT00597896|3643917|FG000|NOT COMPLETED|Overall Study||3
2932691|NCT00597896|3643918|FG001|NOT COMPLETED|Overall Study||2
2932692|NCT00597935|3643929|FG000|STARTED|Randomized to Surgical and BPMT Arms||95
2932693|NCT00597935|3643930|FG001|STARTED|Randomized to Surgical and BPMT Arms||91
2932694|NCT00597935|3643931|FG002|STARTED|Randomized to Surgical and BPMT Arms||91
2932695|NCT00597935|3643932|FG003|STARTED|Randomized to Surgical and BPMT Arms||97
2932696|NCT00597935|3643929|FG000|COMPLETED|Randomized to Surgical and BPMT Arms||95
2932697|NCT00597935|3643930|FG001|COMPLETED|Randomized to Surgical and BPMT Arms||91
2932698|NCT00597935|3643931|FG002|COMPLETED|Randomized to Surgical and BPMT Arms||91
2932699|NCT00597935|3643932|FG003|COMPLETED|Randomized to Surgical and BPMT Arms||97
2932700|NCT00597935|3643929|FG000|NOT COMPLETED|Randomized to Surgical and BPMT Arms||0
2932701|NCT00597935|3643930|FG001|NOT COMPLETED|Randomized to Surgical and BPMT Arms||0
2932702|NCT00597935|3643931|FG002|NOT COMPLETED|Randomized to Surgical and BPMT Arms||0
2932703|NCT00597935|3643932|FG003|NOT COMPLETED|Randomized to Surgical and BPMT Arms||0
2932704|NCT00597935|3643929|FG000|STARTED|Baseline to 6-Months||95
2932705|NCT00597935|3643930|FG001|STARTED|Baseline to 6-Months||91
2932706|NCT00597935|3643931|FG002|STARTED|Baseline to 6-Months||91
2932707|NCT00597935|3643932|FG003|STARTED|Baseline to 6-Months||97
2932708|NCT00597935|3643929|FG000|COMPLETED|Baseline to 6-Months||93
2932709|NCT00597935|3643930|FG001|COMPLETED|Baseline to 6-Months||87
2932710|NCT00597935|3643931|FG002|COMPLETED|Baseline to 6-Months||87
2932711|NCT00597935|3643932|FG003|COMPLETED|Baseline to 6-Months||93
2932712|NCT00597935|3643929|FG000|NOT COMPLETED|Baseline to 6-Months||2
2932713|NCT00597935|3643930|FG001|NOT COMPLETED|Baseline to 6-Months||4
2932714|NCT00597935|3643931|FG002|NOT COMPLETED|Baseline to 6-Months||4
2932715|NCT00597935|3643932|FG003|NOT COMPLETED|Baseline to 6-Months||4
2932716|NCT00597935|3643929|FG000|STARTED|6-Months to 24-Months||93
2932717|NCT00597935|3643930|FG001|STARTED|6-Months to 24-Months||87
2932718|NCT00597935|3643931|FG002|STARTED|6-Months to 24-Months||87
2932719|NCT00597935|3643932|FG003|STARTED|6-Months to 24-Months||93
2932720|NCT00597935|3643929|FG000|COMPLETED|6-Months to 24-Months||76
2932721|NCT00597935|3643930|FG001|COMPLETED|6-Months to 24-Months||79
2932722|NCT00597935|3643931|FG002|COMPLETED|6-Months to 24-Months||77
2932723|NCT00597935|3643932|FG003|COMPLETED|6-Months to 24-Months||85
2932724|NCT00597935|3643929|FG000|NOT COMPLETED|6-Months to 24-Months||17
2932725|NCT00597935|3643930|FG001|NOT COMPLETED|6-Months to 24-Months||8
2932726|NCT00597935|3643931|FG002|NOT COMPLETED|6-Months to 24-Months||10
2932727|NCT00597935|3643932|FG003|NOT COMPLETED|6-Months to 24-Months||8
2932728|NCT00598078|3643942|FG000|STARTED|Period 1 (Day 1)||10
2932729|NCT00598078|3643943|FG001|STARTED|Period 1 (Day 1)||10
2932730|NCT00598078|3643942|FG000|COMPLETED|Period 1 (Day 1)||10
2932731|NCT00598078|3643943|FG001|COMPLETED|Period 1 (Day 1)||10
2932732|NCT00598078|3643942|FG000|NOT COMPLETED|Period 1 (Day 1)||0
2932733|NCT00598078|3643943|FG001|NOT COMPLETED|Period 1 (Day 1)||0
2932734|NCT00598078|3643942|FG000|STARTED|Period 2 (Day 2)||10
2932735|NCT00598078|3643943|FG001|STARTED|Period 2 (Day 2)||10
2932736|NCT00598078|3643942|FG000|COMPLETED|Period 2 (Day 2)||9
2932737|NCT00598078|3643943|FG001|COMPLETED|Period 2 (Day 2)||10
2932738|NCT00598078|3643942|FG000|NOT COMPLETED|Period 2 (Day 2)||1
2932739|NCT00598078|3643943|FG001|NOT COMPLETED|Period 2 (Day 2)||0
2932740|NCT00598078|3643942|FG000|STARTED|Period 3 (Day 3)||9
2932741|NCT00598078|3643943|FG001|STARTED|Period 3 (Day 3)||10
2932742|NCT00598078|3643942|FG000|COMPLETED|Period 3 (Day 3)||9
2932743|NCT00598078|3643943|FG001|COMPLETED|Period 3 (Day 3)||10
2932744|NCT00598078|3643942|FG000|NOT COMPLETED|Period 3 (Day 3)||0
2932745|NCT00598078|3643943|FG001|NOT COMPLETED|Period 3 (Day 3)||0
2932746|NCT00598273|3643954|FG000|STARTED|Overall Study||161
2932747|NCT00598273|3643955|FG001|STARTED|Overall Study||165
2932748|NCT00598273|3643956|FG002|STARTED|Overall Study||164
2932749|NCT00598273|3643954|FG000|COMPLETED|Overall Study||120
2932750|NCT00598273|3643955|FG001|COMPLETED|Overall Study||127
2932751|NCT00598273|3643956|FG002|COMPLETED|Overall Study||125
2932752|NCT00598273|3643954|FG000|NOT COMPLETED|Overall Study||41
2932753|NCT00598273|3643955|FG001|NOT COMPLETED|Overall Study||38
2932754|NCT00598273|3643956|FG002|NOT COMPLETED|Overall Study||39
2932755|NCT00598442|3643967|FG000|STARTED|Overall Study||167
2932756|NCT00598442|3643968|FG001|STARTED|Overall Study||163
2932757|NCT00598442|3643969|FG002|STARTED|Overall Study||163
2932758|NCT00598442|3643967|FG000|COMPLETED|Overall Study||124
2932759|NCT00598442|3643968|FG001|COMPLETED|Overall Study||124
2932760|NCT00598442|3643969|FG002|COMPLETED|Overall Study||139
2932761|NCT00598442|3643967|FG000|NOT COMPLETED|Overall Study||43
2932762|NCT00598442|3643968|FG001|NOT COMPLETED|Overall Study||39
2932763|NCT00598442|3643969|FG002|NOT COMPLETED|Overall Study||24
2932764|NCT00598481|3643977|FG000|STARTED|Baseline||12
2932765|NCT00598481|3643977|FG000|COMPLETED|Baseline||12
2932766|NCT00598481|3643977|FG000|NOT COMPLETED|Baseline||0
2932767|NCT00598481|3643977|FG000|STARTED|Treatment||12
2932768|NCT00598481|3643977|FG000|COMPLETED|Treatment||11
2932769|NCT00598481|3643977|FG000|NOT COMPLETED|Treatment||1
2932770|NCT00598507|3643984|FG000|STARTED|Overall Study||35
2932771|NCT00598507|3643984|FG000|COMPLETED|Overall Study||35
2932772|NCT00598507|3643984|FG000|NOT COMPLETED|Overall Study||0
3041928|NCT01173601|3761542|FG002|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||197
3041929|NCT01173601|3761543|FG003|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||210
3041930|NCT01173601|3761544|FG004|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||559
3041931|NCT01173601|3761540|FG000|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
3041932|NCT01173601|3761541|FG001|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||35
3041933|NCT01173601|3761542|FG002|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||33
3041934|NCT01173601|3761543|FG003|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||30
3041935|NCT01173601|3761544|FG004|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||68
3041936|NCT01173653|3761564|FG000|STARTED|Overall Study||109
3041937|NCT01173653|3761565|FG001|STARTED|Overall Study||90
3041938|NCT01173653|3761564|FG000|COMPLETED|Overall Study||56
3041939|NCT01173653|3761565|FG001|COMPLETED|Overall Study||49
3041940|NCT01173653|3761564|FG000|NOT COMPLETED|Overall Study||53
3041941|NCT01173653|3761565|FG001|NOT COMPLETED|Overall Study||41
3041942|NCT01173679|3761571|FG000|STARTED|Overall Study||10
3041943|NCT01173679|3761571|FG000|COMPLETED|Overall Study||9
3041944|NCT01173679|3761571|FG000|NOT COMPLETED|Overall Study||1
3041945|NCT01173692|3761578|FG000|STARTED|Overall Study||22
3041946|NCT01173692|3761579|FG001|STARTED|Overall Study||25
3179988|NCT01987960|3908249|FG000|NOT COMPLETED|Period 3||0
3179989|NCT01987960|3908250|FG001|NOT COMPLETED|Period 3||0
3179990|NCT01987960|3908251|FG002|NOT COMPLETED|Period 3||0
3179991|NCT01987960|3908252|FG003|NOT COMPLETED|Period 3||71
3179992|NCT01987986|3908266|FG000|STARTED|Overall Study||43
3179993|NCT01987986|3908267|FG001|STARTED|Overall Study||43
3041947|NCT01173692|3761578|FG000|COMPLETED|Overall Study||20
3041948|NCT01173692|3761579|FG001|COMPLETED|Overall Study||20
3041949|NCT01173692|3761578|FG000|NOT COMPLETED|Overall Study||2
3041950|NCT01173692|3761579|FG001|NOT COMPLETED|Overall Study||5
3041951|NCT01173718|3761585|FG000|STARTED|Overall Study||138
3041952|NCT01173718|3761585|FG000|COMPLETED|Overall Study||94
3041953|NCT01173718|3761585|FG000|NOT COMPLETED|Overall Study||44
3041954|NCT01173848|3761591|FG000|STARTED|Overall Study||8
3041955|NCT01173848|3761592|FG001|STARTED|Overall Study||11
3041956|NCT01173848|3761591|FG000|COMPLETED|Overall Study||4
3041957|NCT01173848|3761592|FG001|COMPLETED|Overall Study||3
3041958|NCT01173848|3761591|FG000|NOT COMPLETED|Overall Study||4
3041959|NCT01173848|3761592|FG001|NOT COMPLETED|Overall Study||8
3041960|NCT01173874|3761599|FG000|STARTED|Overall Study||56
3041961|NCT01173874|3761600|FG001|STARTED|Overall Study||64
3041962|NCT01173874|3761599|FG000|COMPLETED|Overall Study||33
3041963|NCT01173874|3761600|FG001|COMPLETED|Overall Study||41
3041964|NCT01173874|3761599|FG000|NOT COMPLETED|Overall Study||23
3041965|NCT01173874|3761600|FG001|NOT COMPLETED|Overall Study||23
3041966|NCT01174004|3761608|FG000|STARTED|Overall Study||94
3041967|NCT01174004|3761609|FG001|STARTED|Overall Study||105
3041968|NCT01174004|3761608|FG000|COMPLETED|Overall Study||87
3041969|NCT01174004|3761609|FG001|COMPLETED|Overall Study||89
3041970|NCT01174004|3761608|FG000|NOT COMPLETED|Overall Study||7
3041971|NCT01174004|3761609|FG001|NOT COMPLETED|Overall Study||16
3041972|NCT01174030|3761620|FG000|STARTED|Overall Study||53
3041973|NCT01174030|3761621|FG001|STARTED|Overall Study||54
3179994|NCT01987986|3908268|FG002|STARTED|Overall Study||40
3041974|NCT01174030|3761622|FG002|STARTED|Overall Study||54
3041975|NCT01174030|3761623|FG003|STARTED|Overall Study||55
3041976|NCT01174030|3761624|FG004|STARTED|Overall Study||53
3041977|NCT01174030|3761620|FG000|COMPLETED|Overall Study||51
3041978|NCT01174030|3761621|FG001|COMPLETED|Overall Study||52
3041979|NCT01174030|3761622|FG002|COMPLETED|Overall Study||52
3041980|NCT01174030|3761623|FG003|COMPLETED|Overall Study||53
3041981|NCT01174030|3761624|FG004|COMPLETED|Overall Study||52
2932773|NCT00598559|3643991|FG000|STARTED|Overall Study||92
2932774|NCT00598559|3643992|FG001|STARTED|Overall Study||91
2932775|NCT00598559|3643993|FG002|STARTED|Overall Study||30
2932776|NCT00598559|3643991|FG000|COMPLETED|Overall Study|Subjects completed 5 days of treatment|65
2932777|NCT00598559|3643992|FG001|COMPLETED|Overall Study|Subjects completed 5 days of treatment|63
2932778|NCT00598559|3643993|FG002|COMPLETED|Overall Study|Subjects completed 5 days of treatment|27
2932779|NCT00598559|3643991|FG000|NOT COMPLETED|Overall Study||27
2932780|NCT00598559|3643992|FG001|NOT COMPLETED|Overall Study||28
2932781|NCT00598559|3643993|FG002|NOT COMPLETED|Overall Study||3
2932782|NCT00598585|3644003|FG000|STARTED|Overall Study||6
2932783|NCT00598585|3644004|FG001|STARTED|Overall Study||6
2932784|NCT00598585|3644003|FG000|COMPLETED|Overall Study||5
2932785|NCT00598585|3644004|FG001|COMPLETED|Overall Study||6
2932786|NCT00598585|3644003|FG000|NOT COMPLETED|Overall Study||1
2932787|NCT00598585|3644004|FG001|NOT COMPLETED|Overall Study||0
2932788|NCT00598650|3644010|FG000|STARTED|Overall Study||108
2932789|NCT00598650|3644010|FG000|COMPLETED|Overall Study|5 subjects withdrew for multiple reasons|81
2932790|NCT00598650|3644010|FG000|NOT COMPLETED|Overall Study||27
2932791|NCT00598663|3644017|FG000|STARTED|First Intervention (6 Months)||76
2932792|NCT00598663|3644018|FG001|STARTED|First Intervention (6 Months)||77
2932793|NCT00598663|3644017|FG000|COMPLETED|First Intervention (6 Months)||73
2932794|NCT00598663|3644018|FG001|COMPLETED|First Intervention (6 Months)||71
2932795|NCT00598663|3644017|FG000|NOT COMPLETED|First Intervention (6 Months)||3
2932796|NCT00598663|3644018|FG001|NOT COMPLETED|First Intervention (6 Months)||6
2932797|NCT00598663|3644017|FG000|STARTED|Washout (4 Months)||73
2932798|NCT00598663|3644018|FG001|STARTED|Washout (4 Months)||71
2932799|NCT00598663|3644017|FG000|COMPLETED|Washout (4 Months)||73
2932800|NCT00598663|3644018|FG001|COMPLETED|Washout (4 Months)||70
2932801|NCT00598663|3644017|FG000|NOT COMPLETED|Washout (4 Months)||0
2932802|NCT00598663|3644018|FG001|NOT COMPLETED|Washout (4 Months)||1
2932803|NCT00598663|3644017|FG000|STARTED|Second Intervention (6 Months)||73
2932804|NCT00598663|3644018|FG001|STARTED|Second Intervention (6 Months)||70
2932805|NCT00598663|3644017|FG000|COMPLETED|Second Intervention (6 Months)||69
2932806|NCT00598663|3644018|FG001|COMPLETED|Second Intervention (6 Months)||69
2932807|NCT00598663|3644017|FG000|NOT COMPLETED|Second Intervention (6 Months)||4
2932808|NCT00598663|3644018|FG001|NOT COMPLETED|Second Intervention (6 Months)||1
2932809|NCT00598689|3644029|FG000|STARTED|Overall Study||40
2932810|NCT00598689|3644030|FG001|STARTED|Overall Study||40
2932811|NCT00598689|3644029|FG000|COMPLETED|Overall Study||40
2932812|NCT00598689|3644030|FG001|COMPLETED|Overall Study||40
2932813|NCT00598689|3644029|FG000|NOT COMPLETED|Overall Study||0
2932814|NCT00598689|3644030|FG001|NOT COMPLETED|Overall Study||0
2932815|NCT00598702|3644044|FG000|STARTED|Overall Study||1
2932816|NCT00598702|3644045|FG001|STARTED|Overall Study||3
2932817|NCT00598702|3644046|FG002|STARTED|Overall Study||7
2932818|NCT00598702|3644047|FG003|STARTED|Overall Study||33
2932819|NCT00598702|3644048|FG004|STARTED|Overall Study||9
2932820|NCT00598702|3644049|FG005|STARTED|Overall Study||42
2932821|NCT00598702|3644050|FG006|STARTED|Overall Study||1
2932822|NCT00598702|3644051|FG007|STARTED|Overall Study||4
2932823|NCT00598702|3644044|FG000|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|1
2932824|NCT00598702|3644045|FG001|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|1
2932825|NCT00598702|3644046|FG002|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|5
2932826|NCT00598702|3644047|FG003|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|25
2932827|NCT00598702|3644048|FG004|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|6
2932828|NCT00598702|3644049|FG005|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|30
2932829|NCT00598702|3644050|FG006|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|0
2932830|NCT00598702|3644051|FG007|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|4
2932831|NCT00598702|3644044|FG000|NOT COMPLETED|Overall Study||0
2932832|NCT00598702|3644045|FG001|NOT COMPLETED|Overall Study||2
2932833|NCT00598702|3644046|FG002|NOT COMPLETED|Overall Study||2
2932834|NCT00598702|3644047|FG003|NOT COMPLETED|Overall Study||8
2932835|NCT00598702|3644048|FG004|NOT COMPLETED|Overall Study||3
2932836|NCT00598702|3644049|FG005|NOT COMPLETED|Overall Study||12
2932837|NCT00598702|3644050|FG006|NOT COMPLETED|Overall Study||1
2932838|NCT00598702|3644051|FG007|NOT COMPLETED|Overall Study||0
2932839|NCT00598806|3644071|FG000|STARTED|Overall Study||402
2932840|NCT00598806|3644072|FG001|STARTED|Overall Study||410
2932841|NCT00598806|3644071|FG000|COMPLETED|Overall Study||329
2932842|NCT00598806|3644072|FG001|COMPLETED|Overall Study||346
2932843|NCT00598806|3644071|FG000|NOT COMPLETED|Overall Study||73
2932844|NCT00598806|3644072|FG001|NOT COMPLETED|Overall Study||64
2932845|NCT00598819|3644078|FG000|STARTED|Overall Study||14
2932846|NCT00598819|3644078|FG000|COMPLETED|Overall Study||14
2932847|NCT00598819|3644078|FG000|NOT COMPLETED|Overall Study||0
2932848|NCT00598832|3644084|FG000|STARTED|Overall Study||533
2932849|NCT00598832|3644085|FG001|STARTED|Overall Study||542
2932850|NCT00598832|3644084|FG000|COMPLETED|Overall Study||471
2932851|NCT00598832|3644085|FG001|COMPLETED|Overall Study||460
2932852|NCT00598832|3644084|FG000|NOT COMPLETED|Overall Study||62
2932853|NCT00598832|3644085|FG001|NOT COMPLETED|Overall Study||82
2932854|NCT00598871|3644093|FG000|STARTED|Overall Study||3
2932855|NCT00598871|3644094|FG001|STARTED|Overall Study||9
2932856|NCT00598871|3644093|FG000|COMPLETED|Overall Study||3
2932857|NCT00598871|3644094|FG001|COMPLETED|Overall Study||8
3179995|NCT01987986|3908269|FG003|STARTED|Overall Study||24
3179996|NCT01987986|3908266|FG000|COMPLETED|Overall Study||41
3179997|NCT01987986|3908267|FG001|COMPLETED|Overall Study||43
3179998|NCT01987986|3908268|FG002|COMPLETED|Overall Study||38
3179999|NCT01987986|3908269|FG003|COMPLETED|Overall Study||24
3180000|NCT01987986|3908266|FG000|NOT COMPLETED|Overall Study||2
3180001|NCT01987986|3908267|FG001|NOT COMPLETED|Overall Study||0
3180002|NCT01987986|3908268|FG002|NOT COMPLETED|Overall Study||2
3180003|NCT01987986|3908269|FG003|NOT COMPLETED|Overall Study||0
3180004|NCT01988012|3908279|FG000|STARTED|Overall Study||100
2932858|NCT00598871|3644093|FG000|NOT COMPLETED|Overall Study||0
3041982|NCT01174030|3761620|FG000|NOT COMPLETED|Overall Study||2
3041983|NCT01174030|3761621|FG001|NOT COMPLETED|Overall Study||2
3041984|NCT01174030|3761622|FG002|NOT COMPLETED|Overall Study||2
3041985|NCT01174030|3761623|FG003|NOT COMPLETED|Overall Study||2
3041986|NCT01174030|3761624|FG004|NOT COMPLETED|Overall Study||1
3041987|NCT01174043|3761636|FG000|STARTED|Overall Study||11
3041988|NCT01174043|3761636|FG000|COMPLETED|Overall Study||0
3041989|NCT01174043|3761636|FG000|NOT COMPLETED|Overall Study||11
3041990|NCT01174082|3761642|FG000|STARTED|Overall Study||1
3041991|NCT01174082|3761643|FG001|STARTED|Overall Study||1
3041992|NCT01174082|3761642|FG000|COMPLETED|Overall Study||1
3041993|NCT01174082|3761643|FG001|COMPLETED|Overall Study||1
3041994|NCT01174082|3761642|FG000|NOT COMPLETED|Overall Study||0
3041995|NCT01174082|3761643|FG001|NOT COMPLETED|Overall Study||0
3041996|NCT01174160|3761651|FG000|STARTED|Overall Study||61
3041997|NCT01174160|3761652|FG001|STARTED|Overall Study||62
3041998|NCT01174160|3761651|FG000|Discontinued Pre Dose|Overall Study||6
3041999|NCT01174160|3761652|FG001|Discontinued Pre Dose|Overall Study||6
3042000|NCT01174160|3761651|FG000|Dosed|Overall Study||55
3042001|NCT01174160|3761652|FG001|Dosed|Overall Study||56
3042002|NCT01174160|3761651|FG000|Discontinued Post Dose|Overall Study||2
3042003|NCT01174160|3761652|FG001|Discontinued Post Dose|Overall Study||0
3042004|NCT01174160|3761651|FG000|COMPLETED|Overall Study||53
3042005|NCT01174160|3761652|FG001|COMPLETED|Overall Study||56
3042006|NCT01174160|3761651|FG000|NOT COMPLETED|Overall Study||8
3042007|NCT01174160|3761652|FG001|NOT COMPLETED|Overall Study||6
3042008|NCT01174173|3761658|FG000|STARTED|Overall Study||11
3042009|NCT01174173|3761658|FG000|COMPLETED|Overall Study||10
3042010|NCT01174173|3761658|FG000|NOT COMPLETED|Overall Study||1
3042011|NCT01174186|3761665|FG000|STARTED|Overall Study|Patients were included over three years|15
3042012|NCT01174186|3761666|FG001|STARTED|Overall Study||15
3042013|NCT01174186|3761665|FG000|COMPLETED|Overall Study||15
3042014|NCT01174186|3761666|FG001|COMPLETED|Overall Study||12
3042015|NCT01174186|3761665|FG000|NOT COMPLETED|Overall Study||0
3042016|NCT01174186|3761666|FG001|NOT COMPLETED|Overall Study||3
3042017|NCT01174238|3761672|FG000|STARTED|Overall Study||38
3042018|NCT01174238|3761672|FG000|Participants That Underwent FLT-PET Scan|Overall Study||6
3042019|NCT01174238|3761672|FG000|COMPLETED|Overall Study||36
3042020|NCT01174238|3761672|FG000|NOT COMPLETED|Overall Study||2
3042021|NCT01174264|3761682|FG000|STARTED|Single Dose Pharmacokinetics||23
3042022|NCT01174264|3761683|FG001|STARTED|Single Dose Pharmacokinetics||20
3042023|NCT01174264|3761684|FG002|STARTED|Single Dose Pharmacokinetics||20
3042024|NCT01174264|3761682|FG000|COMPLETED|Single Dose Pharmacokinetics||22
3042025|NCT01174264|3761683|FG001|COMPLETED|Single Dose Pharmacokinetics||20
3042026|NCT01174264|3761684|FG002|COMPLETED|Single Dose Pharmacokinetics||18
3042027|NCT01174264|3761682|FG000|NOT COMPLETED|Single Dose Pharmacokinetics||1
3042028|NCT01174264|3761683|FG001|NOT COMPLETED|Single Dose Pharmacokinetics||0
3042029|NCT01174264|3761684|FG002|NOT COMPLETED|Single Dose Pharmacokinetics||2
3042030|NCT01174264|3761682|FG000|STARTED|Steady-state Pharmacokinetics|Includes 22 patients from period 1 fasting arm and 9 patients from period 1 high-fat arm|31
3042031|NCT01174264|3761683|FG001|STARTED|Steady-state Pharmacokinetics|Patients in period 2 were randomized to fasting vs. fed state only.|0
3042032|NCT01174264|3761684|FG002|STARTED|Steady-state Pharmacokinetics|Includes 11 patients from period 1 high-fat arm and 18 patients from period 1 low-fat arm|29
3042033|NCT01174264|3761682|FG000|COMPLETED|Steady-state Pharmacokinetics||25
3042034|NCT01174264|3761683|FG001|COMPLETED|Steady-state Pharmacokinetics||0
3042035|NCT01174264|3761684|FG002|COMPLETED|Steady-state Pharmacokinetics||27
3180005|NCT01988012|3908279|FG000|COMPLETED|Overall Study||85
3180006|NCT01988012|3908279|FG000|NOT COMPLETED|Overall Study||15
2932859|NCT00598871|3644094|FG001|NOT COMPLETED|Overall Study||1
2932860|NCT00598975|3644102|FG000|STARTED|Overall Study||12
2932861|NCT00598975|3644103|FG001|STARTED|Overall Study||6
2932862|NCT00598975|3644102|FG000|Completed Cycle 1|Overall Study||12
2932863|NCT00598975|3644103|FG001|Completed Cycle 1|Overall Study||6
2932864|NCT00598975|3644102|FG000|COMPLETED|Overall Study||0
2932865|NCT00598975|3644103|FG001|COMPLETED|Overall Study||0
2932866|NCT00598975|3644102|FG000|NOT COMPLETED|Overall Study||12
2932867|NCT00598975|3644103|FG001|NOT COMPLETED|Overall Study||6
2932868|NCT00599014|3644111|FG000|STARTED|Overall Study||335
2932869|NCT00599014|3644111|FG000|COMPLETED|Overall Study||335
2932870|NCT00599014|3644111|FG000|NOT COMPLETED|Overall Study||0
2932871|NCT00599053|3644117|FG000|STARTED|Overall Study||5
2932872|NCT00599053|3644118|FG001|STARTED|Overall Study||2
2932873|NCT00599053|3644117|FG000|COMPLETED|Overall Study||5
2932874|NCT00599053|3644118|FG001|COMPLETED|Overall Study||2
2932875|NCT00599053|3644117|FG000|NOT COMPLETED|Overall Study||0
2932876|NCT00599053|3644118|FG001|NOT COMPLETED|Overall Study||0
2932877|NCT00599196|3644124|FG000|STARTED|Overall Study||381
2932878|NCT00599196|3644124|FG000|COMPLETED|Overall Study|Study fully recruited. Completed upon market authorization and commercial availability of Neupro.|0
2932879|NCT00599196|3644124|FG000|NOT COMPLETED|Overall Study||381
2932880|NCT00599248|3644130|FG000|STARTED|Overall Study||3
2932881|NCT00599248|3644131|FG001|STARTED|Overall Study||3
2932882|NCT00599248|3644132|FG002|STARTED|Overall Study||3
2932883|NCT00599248|3644133|FG003|STARTED|Overall Study||3
2932884|NCT00599248|3644130|FG000|COMPLETED|Overall Study||3
2932885|NCT00599248|3644131|FG001|COMPLETED|Overall Study||3
2932886|NCT00599248|3644132|FG002|COMPLETED|Overall Study||3
2932887|NCT00599248|3644133|FG003|COMPLETED|Overall Study||3
2932888|NCT00599248|3644130|FG000|NOT COMPLETED|Overall Study||0
2932889|NCT00599248|3644131|FG001|NOT COMPLETED|Overall Study||0
2932890|NCT00599248|3644132|FG002|NOT COMPLETED|Overall Study||0
2932891|NCT00599248|3644133|FG003|NOT COMPLETED|Overall Study||0
2932892|NCT00599313|3644142|FG000|STARTED|Overall Study||36
2932893|NCT00599313|3644142|FG000|COMPLETED|Overall Study||0
2932894|NCT00599313|3644142|FG000|NOT COMPLETED|Overall Study||36
2932895|NCT00599326|3644146|FG000|STARTED|Overall Study||10
2932896|NCT00599326|3644146|FG000|COMPLETED|Overall Study||8
2932897|NCT00599326|3644146|FG000|NOT COMPLETED|Overall Study||2
2932898|NCT00599339|3644150|FG000|STARTED|Overall Study||2195
2932899|NCT00599339|3644150|FG000|Safety Set|Overall Study||2179
2932900|NCT00599339|3644150|FG000|COMPLETED|Overall Study||1531
2932901|NCT00599339|3644150|FG000|NOT COMPLETED|Overall Study||664
2932902|NCT00599521|3644174|FG000|STARTED|Overall Study||535
2932903|NCT00599521|3644175|FG001|STARTED|Overall Study||531
2932904|NCT00599521|3644174|FG000|COMPLETED|Overall Study||475
2932905|NCT00599521|3644175|FG001|COMPLETED|Overall Study||462
2932906|NCT00599521|3644174|FG000|NOT COMPLETED|Overall Study||60
2932907|NCT00599521|3644175|FG001|NOT COMPLETED|Overall Study||69
2932908|NCT00599638|3644185|FG000|STARTED|First Intervention Period (2 Weeks)||16
2932909|NCT00599638|3644186|FG001|STARTED|First Intervention Period (2 Weeks)||14
2932910|NCT00599638|3644187|FG002|STARTED|First Intervention Period (2 Weeks)||20
2932911|NCT00599638|3644188|FG003|STARTED|First Intervention Period (2 Weeks)||22
2932912|NCT00599638|3644185|FG000|Treated|First Intervention Period (2 Weeks)||16
2932913|NCT00599638|3644186|FG001|Treated|First Intervention Period (2 Weeks)||13
2932914|NCT00599638|3644187|FG002|Treated|First Intervention Period (2 Weeks)||20
2932915|NCT00599638|3644188|FG003|Treated|First Intervention Period (2 Weeks)||21
2932916|NCT00599638|3644185|FG000|COMPLETED|First Intervention Period (2 Weeks)||14
2932917|NCT00599638|3644186|FG001|COMPLETED|First Intervention Period (2 Weeks)||12
2932918|NCT00599638|3644187|FG002|COMPLETED|First Intervention Period (2 Weeks)||17
2932919|NCT00599638|3644188|FG003|COMPLETED|First Intervention Period (2 Weeks)||17
2932920|NCT00599638|3644185|FG000|NOT COMPLETED|First Intervention Period (2 Weeks)||2
2932921|NCT00599638|3644186|FG001|NOT COMPLETED|First Intervention Period (2 Weeks)||2
2932922|NCT00599638|3644187|FG002|NOT COMPLETED|First Intervention Period (2 Weeks)||3
2932923|NCT00599638|3644188|FG003|NOT COMPLETED|First Intervention Period (2 Weeks)||5
2932924|NCT00599638|3644185|FG000|STARTED|Washout Period (2 Weeks)||14
2932925|NCT00599638|3644186|FG001|STARTED|Washout Period (2 Weeks)||12
2932926|NCT00599638|3644187|FG002|STARTED|Washout Period (2 Weeks)||17
2932927|NCT00599638|3644188|FG003|STARTED|Washout Period (2 Weeks)||17
2932928|NCT00599638|3644185|FG000|COMPLETED|Washout Period (2 Weeks)||13
2932929|NCT00599638|3644186|FG001|COMPLETED|Washout Period (2 Weeks)||11
3042036|NCT01174264|3761682|FG000|NOT COMPLETED|Steady-state Pharmacokinetics||6
3042037|NCT01174264|3761683|FG001|NOT COMPLETED|Steady-state Pharmacokinetics||0
3042038|NCT01174264|3761684|FG002|NOT COMPLETED|Steady-state Pharmacokinetics||2
3042039|NCT01174342|3761692|FG000|STARTED|Overall Study||30
3042040|NCT01174342|3761692|FG000|COMPLETED|Overall Study||26
3042041|NCT01174342|3761692|FG000|NOT COMPLETED|Overall Study||4
3042042|NCT01174446|3761696|FG000|STARTED|Part 1 -Pharmacokinetic Crossover||14
3042043|NCT01174446|3761697|FG001|STARTED|Part 1 -Pharmacokinetic Crossover||14
3042044|NCT01174446|3761698|FG002|STARTED|Part 1 -Pharmacokinetic Crossover||0
3042045|NCT01174446|3761699|FG003|STARTED|Part 1 -Pharmacokinetic Crossover||0
3042046|NCT01174446|3761696|FG000|COMPLETED|Part 1 -Pharmacokinetic Crossover|BAX326 was mistakenly infused for second PK infusion (ie should have been BeneFIX) for 1 participant|14
3042047|NCT01174446|3761697|FG001|COMPLETED|Part 1 -Pharmacokinetic Crossover||14
3042048|NCT01174446|3761698|FG002|COMPLETED|Part 1 -Pharmacokinetic Crossover||0
3042049|NCT01174446|3761699|FG003|COMPLETED|Part 1 -Pharmacokinetic Crossover||0
3042050|NCT01174446|3761696|FG000|NOT COMPLETED|Part 1 -Pharmacokinetic Crossover||0
3042051|NCT01174446|3761697|FG001|NOT COMPLETED|Part 1 -Pharmacokinetic Crossover||0
3042052|NCT01174446|3761698|FG002|NOT COMPLETED|Part 1 -Pharmacokinetic Crossover||0
3042053|NCT01174446|3761699|FG003|NOT COMPLETED|Part 1 -Pharmacokinetic Crossover||0
3042054|NCT01174446|3761696|FG000|STARTED|Part 2 -BAX326 Prophylaxis and On-demand|In Study Part 2 all 14 participants received Prophylaxis|14
3042055|NCT01174446|3761697|FG001|STARTED|Part 2 -BAX326 Prophylaxis and On-demand|In Study Part 2 all 14 participants received Prophylaxis|14
3042056|NCT01174446|3761698|FG002|STARTED|Part 2 -BAX326 Prophylaxis and On-demand|This group only participated in Study Part 2|31
3042057|NCT01174446|3761699|FG003|STARTED|Part 2 -BAX326 Prophylaxis and On-demand|This group only participated in Study Part 2|14
3042058|NCT01174446|3761696|FG000|COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||14
2932930|NCT00599638|3644187|FG002|COMPLETED|Washout Period (2 Weeks)||17
2932931|NCT00599638|3644188|FG003|COMPLETED|Washout Period (2 Weeks)||14
2932932|NCT00599638|3644185|FG000|NOT COMPLETED|Washout Period (2 Weeks)||1
2932933|NCT00599638|3644186|FG001|NOT COMPLETED|Washout Period (2 Weeks)||1
2932934|NCT00599638|3644187|FG002|NOT COMPLETED|Washout Period (2 Weeks)||0
2932935|NCT00599638|3644188|FG003|NOT COMPLETED|Washout Period (2 Weeks)||3
2932936|NCT00599638|3644185|FG000|STARTED|Second Intervention Period (2 Weeks)||13
2932937|NCT00599638|3644186|FG001|STARTED|Second Intervention Period (2 Weeks)||11
2932938|NCT00599638|3644187|FG002|STARTED|Second Intervention Period (2 Weeks)||17
2932939|NCT00599638|3644188|FG003|STARTED|Second Intervention Period (2 Weeks)||14
2932940|NCT00599638|3644185|FG000|COMPLETED|Second Intervention Period (2 Weeks)||12
2932941|NCT00599638|3644186|FG001|COMPLETED|Second Intervention Period (2 Weeks)||11
2932942|NCT00599638|3644187|FG002|COMPLETED|Second Intervention Period (2 Weeks)||17
2932943|NCT00599638|3644188|FG003|COMPLETED|Second Intervention Period (2 Weeks)||14
2932944|NCT00599638|3644185|FG000|NOT COMPLETED|Second Intervention Period (2 Weeks)||1
2932945|NCT00599638|3644186|FG001|NOT COMPLETED|Second Intervention Period (2 Weeks)||0
2932946|NCT00599638|3644187|FG002|NOT COMPLETED|Second Intervention Period (2 Weeks)||0
2932947|NCT00599638|3644188|FG003|NOT COMPLETED|Second Intervention Period (2 Weeks)||0
2932948|NCT00599755|3644196|FG000|STARTED|Overall Study||68
2932949|NCT00599755|3644196|FG000|COMPLETED|Overall Study||49
2932950|NCT00599755|3644196|FG000|NOT COMPLETED|Overall Study||19
2932951|NCT00599872|3644202|FG000|STARTED|Overall Study||216
2932952|NCT00599872|3644203|FG001|STARTED|Overall Study||214
2932953|NCT00599872|3644202|FG000|COMPLETED|Overall Study||167
2932954|NCT00599872|3644203|FG001|COMPLETED|Overall Study||181
2932955|NCT00599872|3644202|FG000|NOT COMPLETED|Overall Study||49
2932956|NCT00599872|3644203|FG001|NOT COMPLETED|Overall Study||33
2932957|NCT00599924|3644220|FG000|STARTED|Overall Study||4
2932958|NCT00599924|3644221|FG001|STARTED|Overall Study||9
2932959|NCT00599924|3644222|FG002|STARTED|Overall Study||5
2932960|NCT00599924|3644223|FG003|STARTED|Overall Study||12
2932961|NCT00599924|3644224|FG004|STARTED|Overall Study||9
2932962|NCT00599924|3644225|FG005|STARTED|Overall Study||6
2932963|NCT00599924|3644226|FG006|STARTED|Overall Study||8
3042059|NCT01174446|3761697|FG001|COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||14
3042060|NCT01174446|3761698|FG002|COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||29
3042061|NCT01174446|3761699|FG003|COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||14
3042062|NCT01174446|3761696|FG000|NOT COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||0
3042063|NCT01174446|3761697|FG001|NOT COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||0
3042064|NCT01174446|3761698|FG002|NOT COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||2
3042065|NCT01174446|3761699|FG003|NOT COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||0
3042066|NCT01174446|3761696|FG000|STARTED|Part 3 -Pharmacokinetic BAX326 Only|Includes all participants who completed Part 1|14
3042067|NCT01174446|3761697|FG001|STARTED|Part 3 -Pharmacokinetic BAX326 Only|Includes all participants who completed Part 1|14
3042068|NCT01174446|3761698|FG002|STARTED|Part 3 -Pharmacokinetic BAX326 Only||0
3042069|NCT01174446|3761699|FG003|STARTED|Part 3 -Pharmacokinetic BAX326 Only||0
3042070|NCT01174446|3761696|FG000|COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||13
3042071|NCT01174446|3761697|FG001|COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||13
3042072|NCT01174446|3761698|FG002|COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||0
3042073|NCT01174446|3761699|FG003|COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||0
3042074|NCT01174446|3761696|FG000|NOT COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||1
3042075|NCT01174446|3761697|FG001|NOT COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||1
3042076|NCT01174446|3761698|FG002|NOT COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||0
3042077|NCT01174446|3761699|FG003|NOT COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||0
3042078|NCT01174459|3761746|FG000|STARTED|Overall Study|Registered patients|571
3042079|NCT01174459|3761746|FG000|COMPLETED|Overall Study|Case report form (CRF) collected|566
3042080|NCT01174459|3761746|FG000|NOT COMPLETED|Overall Study||5
3137176|NCT01717326|3862432|FG007|Treated|Overall Study||29
3137177|NCT01717326|3862433|FG008|Treated|Overall Study||32
3137178|NCT01717326|3862434|FG009|Treated|Overall Study||31
3137179|NCT01717326|3862435|FG010|Treated|Overall Study||32
3137180|NCT01717326|3862436|FG011|Treated|Overall Study||33
3137181|NCT01717326|3862437|FG012|Treated|Overall Study||33
3137182|NCT01717326|3862438|FG013|Treated|Overall Study||32
3137183|NCT01717326|3862439|FG014|Treated|Overall Study||29
3137184|NCT01717326|3862440|FG015|Treated|Overall Study||30
3137185|NCT01717326|3862441|FG016|Treated|Overall Study||30
3137186|NCT01717326|3862442|FG017|Treated|Overall Study||31
3137187|NCT01717326|3862443|FG018|Treated|Overall Study||20
3137188|NCT01717326|3862444|FG019|Treated|Overall Study||21
3137189|NCT01717326|3862425|FG000|COMPLETED|Overall Study||22
3137190|NCT01717326|3862426|FG001|COMPLETED|Overall Study||26
3137191|NCT01717326|3862427|FG002|COMPLETED|Overall Study||13
3137192|NCT01717326|3862428|FG003|COMPLETED|Overall Study||28
3137193|NCT01717326|3862429|FG004|COMPLETED|Overall Study||31
3137194|NCT01717326|3862430|FG005|COMPLETED|Overall Study||31
3137195|NCT01717326|3862431|FG006|COMPLETED|Overall Study||30
3137196|NCT01717326|3862432|FG007|COMPLETED|Overall Study||29
3137197|NCT01717326|3862433|FG008|COMPLETED|Overall Study||32
3137198|NCT01717326|3862434|FG009|COMPLETED|Overall Study||29
3137199|NCT01717326|3862435|FG010|COMPLETED|Overall Study||30
3137200|NCT01717326|3862436|FG011|COMPLETED|Overall Study||33
3137201|NCT01717326|3862437|FG012|COMPLETED|Overall Study||32
3137202|NCT01717326|3862438|FG013|COMPLETED|Overall Study||32
2932964|NCT00599924|3644220|FG000|COMPLETED|Overall Study||1
2932965|NCT00599924|3644221|FG001|COMPLETED|Overall Study||4
2932966|NCT00599924|3644222|FG002|COMPLETED|Overall Study||3
2932967|NCT00599924|3644223|FG003|COMPLETED|Overall Study||4
2932968|NCT00599924|3644224|FG004|COMPLETED|Overall Study||3
2932969|NCT00599924|3644225|FG005|COMPLETED|Overall Study||2
2932970|NCT00599924|3644226|FG006|COMPLETED|Overall Study||3
2932971|NCT00599924|3644220|FG000|NOT COMPLETED|Overall Study||3
2932972|NCT00599924|3644221|FG001|NOT COMPLETED|Overall Study||5
2932973|NCT00599924|3644222|FG002|NOT COMPLETED|Overall Study||2
2932974|NCT00599924|3644223|FG003|NOT COMPLETED|Overall Study||8
2932975|NCT00599924|3644224|FG004|NOT COMPLETED|Overall Study||6
2932976|NCT00599924|3644225|FG005|NOT COMPLETED|Overall Study||4
2932977|NCT00599924|3644226|FG006|NOT COMPLETED|Overall Study||5
2932978|NCT00600015|3644249|FG000|STARTED|Overall Study||111
2932979|NCT00600015|3644250|FG001|STARTED|Overall Study||55
2932980|NCT00600015|3644249|FG000|COMPLETED|Overall Study|Completed >=2 cycles|51
2932981|NCT00600015|3644250|FG001|COMPLETED|Overall Study|Completed >=2 cycles|20
2932982|NCT00600015|3644249|FG000|NOT COMPLETED|Overall Study||60
2932983|NCT00600015|3644250|FG001|NOT COMPLETED|Overall Study||35
2932984|NCT00600028|3644257|FG000|STARTED|First Intervention (12 Weeks)|Number of participants starting the first intervention (prior to washout)|13
2932985|NCT00600028|3644258|FG001|STARTED|First Intervention (12 Weeks)|Number of participants starting the first intervention (prior to washout)|11
2932986|NCT00600028|3644257|FG000|COMPLETED|First Intervention (12 Weeks)||12
2932987|NCT00600028|3644258|FG001|COMPLETED|First Intervention (12 Weeks)||10
2932988|NCT00600028|3644257|FG000|NOT COMPLETED|First Intervention (12 Weeks)||1
2932989|NCT00600028|3644258|FG001|NOT COMPLETED|First Intervention (12 Weeks)||1
2932990|NCT00600028|3644257|FG000|STARTED|Second Intervention (12 Weeks)|Number of participants starting the second intervention (after a 2-week washout)|12
2932991|NCT00600028|3644258|FG001|STARTED|Second Intervention (12 Weeks)|Number of participants starting the second intervention (after a 2-week washout)|10
2932992|NCT00600028|3644257|FG000|COMPLETED|Second Intervention (12 Weeks)||12
2932993|NCT00600028|3644258|FG001|COMPLETED|Second Intervention (12 Weeks)||8
2932994|NCT00600028|3644257|FG000|NOT COMPLETED|Second Intervention (12 Weeks)||0
2932995|NCT00600028|3644258|FG001|NOT COMPLETED|Second Intervention (12 Weeks)||2
2932996|NCT00600067|3644269|FG000|STARTED|Overall Study||55
2932997|NCT00600067|3644270|FG001|STARTED|Overall Study||75
2932998|NCT00600067|3644269|FG000|COMPLETED|Overall Study||52
2932999|NCT00600067|3644270|FG001|COMPLETED|Overall Study||68
2933000|NCT00600067|3644269|FG000|NOT COMPLETED|Overall Study||3
2933001|NCT00600067|3644270|FG001|NOT COMPLETED|Overall Study||7
2933002|NCT00600080|3644277|FG000|STARTED|Period 1: Baseline to One-week||28
2933003|NCT00600080|3644278|FG001|STARTED|Period 1: Baseline to One-week||32
2933004|NCT00600080|3644277|FG000|COMPLETED|Period 1: Baseline to One-week||28
2933005|NCT00600080|3644278|FG001|COMPLETED|Period 1: Baseline to One-week||32
2933006|NCT00600080|3644277|FG000|NOT COMPLETED|Period 1: Baseline to One-week||0
2933007|NCT00600080|3644278|FG001|NOT COMPLETED|Period 1: Baseline to One-week||0
2933008|NCT00600080|3644277|FG000|STARTED|Period 2: One-week to Two-weeks|This is a crossover study, arms are switched at period change.|28
3042081|NCT01174550|3761752|FG000|STARTED|Overall Study||5007
3042082|NCT01174550|3761753|FG001|STARTED|Overall Study||4996
3042083|NCT01174550|3761752|FG000|COMPLETED|Overall Study||3737
3042084|NCT01174550|3761753|FG001|COMPLETED|Overall Study||4123
3042085|NCT01174550|3761752|FG000|NOT COMPLETED|Overall Study||1270
3042086|NCT01174550|3761753|FG001|NOT COMPLETED|Overall Study||873
3042087|NCT01174576|3761759|FG000|STARTED|Overall Study|All participants received all interventions without exception.|16
3042088|NCT01174576|3761759|FG000|COMPLETED|Overall Study||16
3042089|NCT01174576|3761759|FG000|NOT COMPLETED|Overall Study||0
3042090|NCT01174784|3761772|FG000|STARTED|Overall Study||88
3042091|NCT01174784|3761772|FG000|COMPLETED|Overall Study|While 88 subjects did complete the procedure, 4 were considered screen failures post-procedure.|84
3042092|NCT01174784|3761772|FG000|NOT COMPLETED|Overall Study||4
3042093|NCT01174823|3761779|FG000|STARTED|Overall Study||122
3042094|NCT01174823|3761780|FG001|STARTED|Overall Study||123
3042095|NCT01174823|3761779|FG000|COMPLETED|Overall Study||115
3042096|NCT01174823|3761780|FG001|COMPLETED|Overall Study||119
3042097|NCT01174823|3761779|FG000|NOT COMPLETED|Overall Study||7
3042098|NCT01174823|3761780|FG001|NOT COMPLETED|Overall Study||4
3042099|NCT01175005|3761786|FG000|STARTED|Overall Study||62
3042100|NCT01175005|3761786|FG000|COMPLETED|Overall Study||62
3042101|NCT01175005|3761786|FG000|NOT COMPLETED|Overall Study||0
3042102|NCT01175018|3761793|FG000|STARTED|Overall Study||15
3042103|NCT01175018|3761794|FG001|STARTED|Overall Study||15
3042104|NCT01175018|3761793|FG000|COMPLETED|Overall Study||12
3042105|NCT01175018|3761794|FG001|COMPLETED|Overall Study||14
3042106|NCT01175018|3761793|FG000|NOT COMPLETED|Overall Study||3
3042107|NCT01175018|3761794|FG001|NOT COMPLETED|Overall Study||1
3042108|NCT01175031|3761802|FG000|STARTED|Overall Study||45
3042109|NCT01175031|3761802|FG000|COMPLETED|Overall Study||45
3042110|NCT01175031|3761802|FG000|NOT COMPLETED|Overall Study||0
3137203|NCT01717326|3862439|FG014|COMPLETED|Overall Study||29
3137204|NCT01717326|3862440|FG015|COMPLETED|Overall Study||27
3137205|NCT01717326|3862441|FG016|COMPLETED|Overall Study||29
3137206|NCT01717326|3862442|FG017|COMPLETED|Overall Study||31
3137207|NCT01717326|3862443|FG018|COMPLETED|Overall Study||16
3137208|NCT01717326|3862444|FG019|COMPLETED|Overall Study||15
3137209|NCT01717326|3862425|FG000|NOT COMPLETED|Overall Study||3
3137210|NCT01717326|3862426|FG001|NOT COMPLETED|Overall Study||1
2933009|NCT00600080|3644278|FG001|STARTED|Period 2: One-week to Two-weeks|This is a crossover study, arms are switched at period change.|32
2933010|NCT00600080|3644277|FG000|COMPLETED|Period 2: One-week to Two-weeks||28
2933011|NCT00600080|3644278|FG001|COMPLETED|Period 2: One-week to Two-weeks||32
2933012|NCT00600080|3644277|FG000|NOT COMPLETED|Period 2: One-week to Two-weeks||0
2933013|NCT00600080|3644278|FG001|NOT COMPLETED|Period 2: One-week to Two-weeks||0
2933014|NCT00600106|3644286|FG000|STARTED|Overall Study||18
2933015|NCT00600106|3644287|FG001|STARTED|Overall Study||19
2933016|NCT00600106|3644286|FG000|COMPLETED|Overall Study||17
2933017|NCT00600106|3644287|FG001|COMPLETED|Overall Study||18
2933018|NCT00600106|3644286|FG000|NOT COMPLETED|Overall Study||1
2933019|NCT00600106|3644287|FG001|NOT COMPLETED|Overall Study||1
2933020|NCT00600119|3644299|FG000|STARTED|Single-blind Placebo run-in Period||36
2933021|NCT00600119|3644300|FG001|STARTED|Single-blind Placebo run-in Period||35
2933022|NCT00600119|3644301|FG002|STARTED|Single-blind Placebo run-in Period||29
2933023|NCT00600119|3644302|FG003|STARTED|Single-blind Placebo run-in Period||31
2933024|NCT00600119|3644303|FG004|STARTED|Single-blind Placebo run-in Period||39
2933025|NCT00600119|3644304|FG005|STARTED|Single-blind Placebo run-in Period||37
2933026|NCT00600119|3644299|FG000|COMPLETED|Single-blind Placebo run-in Period||32
2933027|NCT00600119|3644300|FG001|COMPLETED|Single-blind Placebo run-in Period||33
2933028|NCT00600119|3644301|FG002|COMPLETED|Single-blind Placebo run-in Period||27
2933029|NCT00600119|3644302|FG003|COMPLETED|Single-blind Placebo run-in Period||30
2933030|NCT00600119|3644303|FG004|COMPLETED|Single-blind Placebo run-in Period||37
2933031|NCT00600119|3644304|FG005|COMPLETED|Single-blind Placebo run-in Period||35
2933032|NCT00600119|3644299|FG000|NOT COMPLETED|Single-blind Placebo run-in Period||4
2933033|NCT00600119|3644300|FG001|NOT COMPLETED|Single-blind Placebo run-in Period||2
2933034|NCT00600119|3644301|FG002|NOT COMPLETED|Single-blind Placebo run-in Period||2
2933035|NCT00600119|3644302|FG003|NOT COMPLETED|Single-blind Placebo run-in Period||1
2933036|NCT00600119|3644303|FG004|NOT COMPLETED|Single-blind Placebo run-in Period||2
2933037|NCT00600119|3644304|FG005|NOT COMPLETED|Single-blind Placebo run-in Period||2
2933038|NCT00600119|3644299|FG000|STARTED|Double-blind Treatment Period||32
2933039|NCT00600119|3644300|FG001|STARTED|Double-blind Treatment Period||33
2933040|NCT00600119|3644301|FG002|STARTED|Double-blind Treatment Period||27
2933041|NCT00600119|3644302|FG003|STARTED|Double-blind Treatment Period||30
2933042|NCT00600119|3644303|FG004|STARTED|Double-blind Treatment Period||37
2933043|NCT00600119|3644304|FG005|STARTED|Double-blind Treatment Period||35
2933044|NCT00600119|3644299|FG000|COMPLETED|Double-blind Treatment Period||27
2933045|NCT00600119|3644300|FG001|COMPLETED|Double-blind Treatment Period||28
2933046|NCT00600119|3644301|FG002|COMPLETED|Double-blind Treatment Period||27
2933047|NCT00600119|3644302|FG003|COMPLETED|Double-blind Treatment Period||28
2933048|NCT00600119|3644303|FG004|COMPLETED|Double-blind Treatment Period||31
2933049|NCT00600119|3644304|FG005|COMPLETED|Double-blind Treatment Period||21
2933050|NCT00600119|3644299|FG000|NOT COMPLETED|Double-blind Treatment Period||5
2933051|NCT00600119|3644300|FG001|NOT COMPLETED|Double-blind Treatment Period||5
2933052|NCT00600119|3644301|FG002|NOT COMPLETED|Double-blind Treatment Period||0
2933053|NCT00600119|3644302|FG003|NOT COMPLETED|Double-blind Treatment Period||2
2933054|NCT00600119|3644303|FG004|NOT COMPLETED|Double-blind Treatment Period||6
2933055|NCT00600119|3644304|FG005|NOT COMPLETED|Double-blind Treatment Period||14
2933056|NCT00600119|3644299|FG000|STARTED|Follow-up Period||27
2933057|NCT00600119|3644300|FG001|STARTED|Follow-up Period||28
2933058|NCT00600119|3644301|FG002|STARTED|Follow-up Period||27
2933059|NCT00600119|3644302|FG003|STARTED|Follow-up Period||28
2933060|NCT00600119|3644303|FG004|STARTED|Follow-up Period||31
2933061|NCT00600119|3644304|FG005|STARTED|Follow-up Period||21
2933062|NCT00600119|3644299|FG000|COMPLETED|Follow-up Period||26
2933063|NCT00600119|3644300|FG001|COMPLETED|Follow-up Period||28
2933064|NCT00600119|3644301|FG002|COMPLETED|Follow-up Period||27
2933065|NCT00600119|3644302|FG003|COMPLETED|Follow-up Period||28
2933066|NCT00600119|3644303|FG004|COMPLETED|Follow-up Period||31
2933067|NCT00600119|3644304|FG005|COMPLETED|Follow-up Period||20
2933068|NCT00600119|3644299|FG000|NOT COMPLETED|Follow-up Period||1
2933069|NCT00600119|3644300|FG001|NOT COMPLETED|Follow-up Period||0
2933070|NCT00600119|3644301|FG002|NOT COMPLETED|Follow-up Period||0
3042111|NCT01175083|3761816|FG000|STARTED|Primary Epoch||50
3042112|NCT01175083|3761817|FG001|STARTED|Primary Epoch||50
3042113|NCT01175083|3761818|FG002|STARTED|Primary Epoch||50
3042114|NCT01175083|3761819|FG003|STARTED|Primary Epoch||50
3042115|NCT01175083|3761820|FG004|STARTED|Primary Epoch||50
3042116|NCT01175083|3761821|FG005|STARTED|Primary Epoch||50
3042117|NCT01175083|3761816|FG000|COMPLETED|Primary Epoch||50
3042118|NCT01175083|3761817|FG001|COMPLETED|Primary Epoch||50
3042119|NCT01175083|3761818|FG002|COMPLETED|Primary Epoch||50
3042120|NCT01175083|3761819|FG003|COMPLETED|Primary Epoch||50
3042121|NCT01175083|3761820|FG004|COMPLETED|Primary Epoch||50
3042122|NCT01175083|3761821|FG005|COMPLETED|Primary Epoch||47
3042123|NCT01175083|3761816|FG000|NOT COMPLETED|Primary Epoch||0
3042124|NCT01175083|3761817|FG001|NOT COMPLETED|Primary Epoch||0
3042125|NCT01175083|3761818|FG002|NOT COMPLETED|Primary Epoch||0
3042126|NCT01175083|3761819|FG003|NOT COMPLETED|Primary Epoch||0
3042127|NCT01175083|3761820|FG004|NOT COMPLETED|Primary Epoch||0
3042128|NCT01175083|3761821|FG005|NOT COMPLETED|Primary Epoch||3
3042129|NCT01175083|3761816|FG000|STARTED|Booster Epoch|One subject died between both Epochs and hence did not participate in the Booster Epoch.|49
3137211|NCT01717326|3862427|FG002|NOT COMPLETED|Overall Study||0
2933071|NCT00600119|3644302|FG003|NOT COMPLETED|Follow-up Period||0
2933072|NCT00600119|3644303|FG004|NOT COMPLETED|Follow-up Period||0
2933073|NCT00600119|3644304|FG005|NOT COMPLETED|Follow-up Period||1
2933074|NCT00600171|3644324|FG000|STARTED|Overall Study||102
2933075|NCT00600171|3644325|FG001|STARTED|Overall Study||101
2933076|NCT00600171|3644326|FG002|STARTED|Overall Study||101
2933077|NCT00600171|3644327|FG003|STARTED|Overall Study||100
2933078|NCT00600171|3644328|FG004|STARTED|Overall Study||101
2933079|NCT00600171|3644329|FG005|STARTED|Overall Study||102
2933080|NCT00600171|3644324|FG000|COMPLETED|Overall Study||86
2933081|NCT00600171|3644325|FG001|COMPLETED|Overall Study||84
2933082|NCT00600171|3644326|FG002|COMPLETED|Overall Study||91
2933083|NCT00600171|3644327|FG003|COMPLETED|Overall Study||88
2933084|NCT00600171|3644328|FG004|COMPLETED|Overall Study||93
2933085|NCT00600171|3644329|FG005|COMPLETED|Overall Study||97
2933086|NCT00600171|3644324|FG000|NOT COMPLETED|Overall Study||16
2933087|NCT00600171|3644325|FG001|NOT COMPLETED|Overall Study||17
2933088|NCT00600171|3644326|FG002|NOT COMPLETED|Overall Study||10
2933089|NCT00600171|3644327|FG003|NOT COMPLETED|Overall Study||12
2933090|NCT00600171|3644328|FG004|NOT COMPLETED|Overall Study||8
2933091|NCT00600171|3644329|FG005|NOT COMPLETED|Overall Study||5
2933092|NCT00600340|3644347|FG000|STARTED|Overall Study||285
2933093|NCT00600340|3644348|FG001|STARTED|Overall Study||279
2933094|NCT00600340|3644347|FG000|COMPLETED|Overall Study||285
2933095|NCT00600340|3644348|FG001|COMPLETED|Overall Study||279
2933096|NCT00600340|3644347|FG000|NOT COMPLETED|Overall Study||0
2933097|NCT00600340|3644348|FG001|NOT COMPLETED|Overall Study||0
2933098|NCT00600353|3644356|FG000|STARTED|Overall Study||10
2933099|NCT00600353|3644357|FG001|STARTED|Overall Study||10
2933100|NCT00600353|3644356|FG000|COMPLETED|Overall Study||9
2933101|NCT00600353|3644357|FG001|COMPLETED|Overall Study||9
2933102|NCT00600353|3644356|FG000|NOT COMPLETED|Overall Study||1
2933103|NCT00600353|3644357|FG001|NOT COMPLETED|Overall Study||1
2933104|NCT00600613|3644363|FG000|STARTED|Overall Study||6
2933105|NCT00600613|3644363|FG000|COMPLETED|Overall Study||5
2933106|NCT00600613|3644363|FG000|NOT COMPLETED|Overall Study||1
2933107|NCT00600704|3644369|FG000|STARTED|Overall Study||100
2933108|NCT00600704|3644370|FG001|STARTED|Overall Study||92
2933109|NCT00600704|3644369|FG000|COMPLETED|Overall Study||100
2933110|NCT00600704|3644370|FG001|COMPLETED|Overall Study||92
2933111|NCT00600704|3644369|FG000|NOT COMPLETED|Overall Study||0
2933112|NCT00600704|3644370|FG001|NOT COMPLETED|Overall Study||0
2933113|NCT00600743|3644380|FG000|STARTED|Overall Study||4
2933114|NCT00600743|3644381|FG001|STARTED|Overall Study||4
2933115|NCT00600743|3644382|FG002|STARTED|Overall Study||8
2933116|NCT00600743|3644383|FG003|STARTED|Overall Study||7
2933117|NCT00600743|3644380|FG000|COMPLETED|Overall Study||4
2933118|NCT00600743|3644381|FG001|COMPLETED|Overall Study||4
2933119|NCT00600743|3644382|FG002|COMPLETED|Overall Study||8
2933120|NCT00600743|3644383|FG003|COMPLETED|Overall Study||7
2933121|NCT00600743|3644380|FG000|NOT COMPLETED|Overall Study||0
2933122|NCT00600743|3644381|FG001|NOT COMPLETED|Overall Study||0
2933123|NCT00600743|3644382|FG002|NOT COMPLETED|Overall Study||0
2933124|NCT00600743|3644383|FG003|NOT COMPLETED|Overall Study||0
2933125|NCT00600756|3644404|FG000|STARTED|Analysis After 6 Months||395
2933126|NCT00600756|3644405|FG001|STARTED|Analysis After 6 Months||403
3042130|NCT01175083|3761817|FG001|STARTED|Booster Epoch|One subject died between both Epochs and hence did not participate in the Booster Epoch.|49
3042131|NCT01175083|3761818|FG002|STARTED|Booster Epoch||50
3042132|NCT01175083|3761819|FG003|STARTED|Booster Epoch||50
3042133|NCT01175083|3761820|FG004|STARTED|Booster Epoch|No subjects participated in the Booster Epoch, as no booster dose was planned per protocol.|0
3042134|NCT01175083|3761821|FG005|STARTED|Booster Epoch|No subjects participated in the Booster Epoch, as no booster dose was planned per protocol.|0
3042135|NCT01175083|3761816|FG000|COMPLETED|Booster Epoch||49
3042136|NCT01175083|3761817|FG001|COMPLETED|Booster Epoch||49
3042137|NCT01175083|3761818|FG002|COMPLETED|Booster Epoch||49
3042138|NCT01175083|3761819|FG003|COMPLETED|Booster Epoch||49
3042139|NCT01175083|3761820|FG004|COMPLETED|Booster Epoch||0
3042140|NCT01175083|3761821|FG005|COMPLETED|Booster Epoch||0
3042141|NCT01175083|3761816|FG000|NOT COMPLETED|Booster Epoch||0
3042142|NCT01175083|3761817|FG001|NOT COMPLETED|Booster Epoch||0
3042143|NCT01175083|3761818|FG002|NOT COMPLETED|Booster Epoch||1
3042144|NCT01175083|3761819|FG003|NOT COMPLETED|Booster Epoch||1
3042145|NCT01175083|3761820|FG004|NOT COMPLETED|Booster Epoch||0
3042146|NCT01175083|3761821|FG005|NOT COMPLETED|Booster Epoch||0
3042147|NCT01175135|3761843|FG000|STARTED|Overall Study||74
3042148|NCT01175135|3761844|FG001|STARTED|Overall Study||74
3042149|NCT01175135|3761845|FG002|STARTED|Overall Study||37
3042150|NCT01175135|3761846|FG003|STARTED|Overall Study||74
3042151|NCT01175135|3761843|FG000|Treated|Overall Study||74
3042152|NCT01175135|3761844|FG001|Treated|Overall Study||74
3042153|NCT01175135|3761845|FG002|Treated|Overall Study||36
3042154|NCT01175135|3761846|FG003|Treated|Overall Study||74
3042155|NCT01175135|3761843|FG000|Analyzed for Efficacy|Overall Study||74
3042156|NCT01175135|3761844|FG001|Analyzed for Efficacy|Overall Study||73
3042157|NCT01175135|3761845|FG002|Analyzed for Efficacy|Overall Study||34
3042158|NCT01175135|3761846|FG003|Analyzed for Efficacy|Overall Study||73
3042159|NCT01175135|3761843|FG000|COMPLETED|Overall Study||58
3042160|NCT01175135|3761844|FG001|COMPLETED|Overall Study||52
3042161|NCT01175135|3761845|FG002|COMPLETED|Overall Study||25
3042162|NCT01175135|3761846|FG003|COMPLETED|Overall Study||60
3042163|NCT01175135|3761843|FG000|NOT COMPLETED|Overall Study||16
2933127|NCT00600756|3644404|FG000|COMPLETED|Analysis After 6 Months|Completers are all patients who completed the study up to Visit 5 (including premature withdraw)|264
2933128|NCT00600756|3644405|FG001|COMPLETED|Analysis After 6 Months|Completers are all patients who completed the study up to Visit 5 (including premature withdraw)|283
2933129|NCT00600756|3644404|FG000|NOT COMPLETED|Analysis After 6 Months||131
2933130|NCT00600756|3644405|FG001|NOT COMPLETED|Analysis After 6 Months||120
2933131|NCT00600756|3644404|FG000|STARTED|Overall Study Analysis After 12 Months||395
2933132|NCT00600756|3644405|FG001|STARTED|Overall Study Analysis After 12 Months||403
2933133|NCT00600756|3644404|FG000|Randomized Analysis|Overall Study Analysis After 12 Months||395
2933134|NCT00600756|3644405|FG001|Randomized Analysis|Overall Study Analysis After 12 Months||403
2933135|NCT00600756|3644404|FG000|Safety Analysis|Overall Study Analysis After 12 Months||391
2933136|NCT00600756|3644405|FG001|Safety Analysis|Overall Study Analysis After 12 Months||402
2933137|NCT00600756|3644404|FG000|ITT Analysis|Overall Study Analysis After 12 Months||379
2933138|NCT00600756|3644405|FG001|ITT Analysis|Overall Study Analysis After 12 Months||392
2933139|NCT00600756|3644404|FG000|COMPLETED|Overall Study Analysis After 12 Months|Completed study to Visit 7 (includes premature withdrawals with final visit in the Visit 7 window)|212
2933140|NCT00600756|3644405|FG001|COMPLETED|Overall Study Analysis After 12 Months|Completed study to Visit 7 (includes premature withdrawals with final visit in the Visit 7 window)|227
2933141|NCT00600756|3644404|FG000|NOT COMPLETED|Overall Study Analysis After 12 Months||183
2933142|NCT00600756|3644405|FG001|NOT COMPLETED|Overall Study Analysis After 12 Months||176
2933143|NCT00600821|3644413|FG000|STARTED|Overall Study||58
2933144|NCT00600821|3644414|FG001|STARTED|Overall Study||60
2933145|NCT00600821|3644413|FG000|Treated|Overall Study||58
2933146|NCT00600821|3644414|FG001|Treated|Overall Study||59
2933147|NCT00600821|3644413|FG000|COMPLETED|Overall Study||0
2933148|NCT00600821|3644414|FG001|COMPLETED|Overall Study||0
2933149|NCT00600821|3644413|FG000|NOT COMPLETED|Overall Study||58
2933150|NCT00600821|3644414|FG001|NOT COMPLETED|Overall Study||60
2933151|NCT00600886|3644424|FG000|STARTED|Core Phase - Full Analysis Set (FAS)||176
2933152|NCT00600886|3644425|FG001|STARTED|Core Phase - Full Analysis Set (FAS)||182
2933153|NCT00600886|3644424|FG000|Did Not Enter Extension|Core Phase - Full Analysis Set (FAS)||29
2933154|NCT00600886|3644425|FG001|Did Not Enter Extension|Core Phase - Full Analysis Set (FAS)||29
2933155|NCT00600886|3644424|FG000|Entered Extension, Crossed Over|Core Phase - Full Analysis Set (FAS)||38
2933156|NCT00600886|3644425|FG001|Entered Extension, Crossed Over|Core Phase - Full Analysis Set (FAS)||81
2933157|NCT00600886|3644424|FG000|Entered Ext Continued Same Treatment|Core Phase - Full Analysis Set (FAS)||74
2933158|NCT00600886|3644425|FG001|Entered Ext Continued Same Treatment|Core Phase - Full Analysis Set (FAS)||46
2933159|NCT00600886|3644424|FG000|COMPLETED|Core Phase - Full Analysis Set (FAS)|Completed = anyone who did not discontinue prior to month 12.|141
2933160|NCT00600886|3644425|FG001|COMPLETED|Core Phase - Full Analysis Set (FAS)|Completed = anyone who did not discontinue prior to month 12.|156
2933161|NCT00600886|3644424|FG000|NOT COMPLETED|Core Phase - Full Analysis Set (FAS)||35
2933162|NCT00600886|3644425|FG001|NOT COMPLETED|Core Phase - Full Analysis Set (FAS)||26
2933163|NCT00600886|3644424|FG000|STARTED|Extension - Same Treatment (FAS)|Started = anyone who entered the extension and continued the same treatment of Pasireotide LAR|74
2933164|NCT00600886|3644425|FG001|STARTED|Extension - Same Treatment (FAS)|Started = anyone who entered the extension and continued the same treatment of Octreotide LAR|46
2933165|NCT00600886|3644424|FG000|Completed Study at Month 26|Extension - Same Treatment (FAS)|Pas. LAR pts in Ext. were not considered completers at M26 as treatment could continue after M26.|0
2933166|NCT00600886|3644425|FG001|Completed Study at Month 26|Extension - Same Treatment (FAS)|Per protocol, pts who received Octreotide LAR in ext. phase were not followed in the study after M26|31
2933167|NCT00600886|3644424|FG000|Completed Study After Month 26|Extension - Same Treatment (FAS)|Completed = Pts who transferred to a roll-over protocol or commercial supply of Pasireotide LAR|28
2933168|NCT00600886|3644425|FG001|Completed Study After Month 26|Extension - Same Treatment (FAS)|Received treatment and completed after M26: Recorded as protocol deviation|4
2933169|NCT00600886|3644424|FG000|Discontinued After Month 26|Extension - Same Treatment (FAS)||23
2933170|NCT00600886|3644425|FG001|Discontinued After Month 26|Extension - Same Treatment (FAS)|Received treatment and discontinued after M26: Recorded as protocol deviation|1
2933171|NCT00600886|3644424|FG000|Discontinued Between M12 and M26|Extension - Same Treatment (FAS)||23
3042164|NCT01175135|3761844|FG001|NOT COMPLETED|Overall Study||22
3042165|NCT01175135|3761845|FG002|NOT COMPLETED|Overall Study||12
3042166|NCT01175135|3761846|FG003|NOT COMPLETED|Overall Study||14
3042167|NCT01175148|3761858|FG000|STARTED|Overall Study||30
3042168|NCT01175148|3761859|FG001|STARTED|Overall Study||30
3042169|NCT01175148|3761858|FG000|COMPLETED|Overall Study||30
3042170|NCT01175148|3761859|FG001|COMPLETED|Overall Study||30
3042171|NCT01175148|3761858|FG000|NOT COMPLETED|Overall Study||0
3042172|NCT01175148|3761859|FG001|NOT COMPLETED|Overall Study||0
3042173|NCT01175213|3761868|FG000|STARTED|IGSC, 10%/rHuPH20||63
3042174|NCT01175213|3761869|FG001|STARTED|IGSC, 10%/rHuPH20|3 participants treated IV with IGIV,10% without rHuPH20 throughout the study.|3
3042175|NCT01175213|3761868|FG000|COMPLETED|IGSC, 10%/rHuPH20||48
3042176|NCT01175213|3761869|FG001|COMPLETED|IGSC, 10%/rHuPH20||3
3042177|NCT01175213|3761868|FG000|NOT COMPLETED|IGSC, 10%/rHuPH20||15
3042178|NCT01175213|3761869|FG001|NOT COMPLETED|IGSC, 10%/rHuPH20||0
3042179|NCT01175213|3761868|FG000|STARTED|Safety Follow-up||48
3042180|NCT01175213|3761869|FG001|STARTED|Safety Follow-up||3
3042181|NCT01175213|3761868|FG000|COMPLETED|Safety Follow-up||47
3042182|NCT01175213|3761869|FG001|COMPLETED|Safety Follow-up||3
3042183|NCT01175213|3761868|FG000|NOT COMPLETED|Safety Follow-up||1
2933172|NCT00600886|3644425|FG001|Discontinued Between M12 and M26|Extension - Same Treatment (FAS)||10
2933173|NCT00600886|3644424|FG000|COMPLETED|Extension - Same Treatment (FAS)|Completed= completed after M26, switched to commercial pasireotide LAR or entered roll-over protocol|28
2933174|NCT00600886|3644425|FG001|COMPLETED|Extension - Same Treatment (FAS)|Completed = completed the study|35
2933175|NCT00600886|3644424|FG000|NOT COMPLETED|Extension - Same Treatment (FAS)||46
2933176|NCT00600886|3644425|FG001|NOT COMPLETED|Extension - Same Treatment (FAS)||11
2933177|NCT00600886|3644424|FG000|STARTED|Extension - After Crossover (CAS)|Started = anyone who entered the extension and crossed over to Pasireotide LAR|81
2933178|NCT00600886|3644425|FG001|STARTED|Extension - After Crossover (CAS)|Started = anyone who entered the extension and crossed over to Octreotide LAR|38
2933179|NCT00600886|3644424|FG000|Completed Study at Month 26|Extension - After Crossover (CAS)|Pas. LAR pts in Ext. were not considered completers at M26 as treatment could continue after M26.|0
2933180|NCT00600886|3644425|FG001|Completed Study at Month 26|Extension - After Crossover (CAS)|Per protocol, Pts who received Octreotide LAR in Ext. phase were not followed in study after M26|25
2933181|NCT00600886|3644424|FG000|Completed After Month 26|Extension - After Crossover (CAS)|Completed = Pts who transferred to a roll-over protocol or commercial supply of Pasireotide LAR|19
2933182|NCT00600886|3644425|FG001|Completed After Month 26|Extension - After Crossover (CAS)|Per protocol, pts who received Octreotide LAR in ext. phase were not followed in study after M26|0
2933183|NCT00600886|3644424|FG000|Discontinued Between M12 and M26|Extension - After Crossover (CAS)||31
2933184|NCT00600886|3644425|FG001|Discontinued Between M12 and M26|Extension - After Crossover (CAS)||13
2933185|NCT00600886|3644424|FG000|Discontinued After M26|Extension - After Crossover (CAS)||31
2933186|NCT00600886|3644425|FG001|Discontinued After M26|Extension - After Crossover (CAS)|Per protocol, Pts who received Octreotide LAR in Ext. phase were not followed in study after M26|0
2933187|NCT00600886|3644424|FG000|COMPLETED|Extension - After Crossover (CAS)|Completed after month 26: transferred to a roll-over protocol or commercial supply of Pas.LAR|19
2933188|NCT00600886|3644425|FG001|COMPLETED|Extension - After Crossover (CAS)|Completed the study|25
2933189|NCT00600886|3644424|FG000|NOT COMPLETED|Extension - After Crossover (CAS)||62
2933190|NCT00600886|3644425|FG001|NOT COMPLETED|Extension - After Crossover (CAS)||13
2933191|NCT00600925|3644447|FG000|STARTED|Overall Study||300
2933192|NCT00600925|3644448|FG001|STARTED|Overall Study||302
2933193|NCT00600925|3644447|FG000|COMPLETED|Overall Study||300
2933194|NCT00600925|3644448|FG001|COMPLETED|Overall Study||302
2933195|NCT00600925|3644447|FG000|NOT COMPLETED|Overall Study||0
2933196|NCT00600925|3644448|FG001|NOT COMPLETED|Overall Study||0
2933197|NCT00600938|3644456|FG000|STARTED|Core Study||98
2933198|NCT00600938|3644457|FG001|STARTED|Core Study||99
2933199|NCT00600938|3644458|FG002|STARTED|Core Study||0
2933200|NCT00600938|3644459|FG003|STARTED|Core Study||0
2933201|NCT00600938|3644456|FG000|Core Safety Set|Core Study||96
2933202|NCT00600938|3644457|FG001|Core Safety Set|Core Study||91
2933203|NCT00600938|3644458|FG002|Core Safety Set|Core Study||0
2933204|NCT00600938|3644459|FG003|Core Safety Set|Core Study||0
2933205|NCT00600938|3644456|FG000|Per Protocol Set (PPS)|Core Study||91
2933206|NCT00600938|3644457|FG001|Per Protocol Set (PPS)|Core Study||81
2933207|NCT00600938|3644458|FG002|Per Protocol Set (PPS)|Core Study||0
2933208|NCT00600938|3644459|FG003|Per Protocol Set (PPS)|Core Study||0
2933209|NCT00600938|3644456|FG000|COMPLETED|Core Study||82
3042184|NCT01175213|3761869|FG001|NOT COMPLETED|Safety Follow-up||0
3042185|NCT01175226|3761880|FG000|STARTED|Overall Study||155
3042186|NCT01175226|3761881|FG001|STARTED|Overall Study||145
3042187|NCT01175226|3761880|FG000|COMPLETED|Overall Study||144
3042188|NCT01175226|3761881|FG001|COMPLETED|Overall Study||140
3042189|NCT01175226|3761880|FG000|NOT COMPLETED|Overall Study||11
3042190|NCT01175226|3761881|FG001|NOT COMPLETED|Overall Study||5
3042191|NCT01175317|3761889|FG000|STARTED|Overall Study||27
3042192|NCT01175317|3761890|FG001|STARTED|Overall Study||31
3042193|NCT01175317|3761889|FG000|COMPLETED|Overall Study||27
3042194|NCT01175317|3761890|FG001|COMPLETED|Overall Study||31
3042195|NCT01175317|3761889|FG000|NOT COMPLETED|Overall Study||0
3042196|NCT01175317|3761890|FG001|NOT COMPLETED|Overall Study||0
3042197|NCT01175343|3761896|FG000|STARTED|Overall Study||44
3042198|NCT01175343|3761896|FG000|COMPLETED|Overall Study||44
3042199|NCT01175343|3761896|FG000|NOT COMPLETED|Overall Study||0
3042200|NCT01175356|3761900|FG000|STARTED|Overall Study||99
3042201|NCT01175356|3761900|FG000|COMPLETED|Overall Study||18
3042202|NCT01175356|3761900|FG000|NOT COMPLETED|Overall Study||81
3042203|NCT01175369|3761906|FG000|STARTED|Overall Study||265
3042204|NCT01175369|3761907|FG001|STARTED|Overall Study||265
3042205|NCT01175369|3761906|FG000|COMPLETED|Overall Study||263
3042206|NCT01175369|3761907|FG001|COMPLETED|Overall Study||260
3042207|NCT01175369|3761906|FG000|NOT COMPLETED|Overall Study||2
3042208|NCT01175369|3761907|FG001|NOT COMPLETED|Overall Study||5
3042209|NCT01175382|3761916|FG000|STARTED|Overall Study||71
3042210|NCT01175382|3761917|FG001|STARTED|Overall Study||68
3042211|NCT01175382|3761918|FG002|STARTED|Overall Study||65
3042212|NCT01175382|3761916|FG000|COMPLETED|Overall Study||63
3042213|NCT01175382|3761917|FG001|COMPLETED|Overall Study||61
3042214|NCT01175382|3761918|FG002|COMPLETED|Overall Study||59
3042215|NCT01175382|3761916|FG000|NOT COMPLETED|Overall Study||8
3042216|NCT01175382|3761917|FG001|NOT COMPLETED|Overall Study||7
3042217|NCT01175382|3761918|FG002|NOT COMPLETED|Overall Study||6
3042218|NCT01175395|3761926|FG000|STARTED|Overall Study||10
3042219|NCT01175395|3761926|FG000|COMPLETED|Overall Study||10
3042220|NCT01175395|3761926|FG000|NOT COMPLETED|Overall Study||0
3042221|NCT01175434|3761932|FG000|STARTED|Overall Study||48
2933210|NCT00600938|3644457|FG001|COMPLETED|Core Study||78
2933211|NCT00600938|3644458|FG002|COMPLETED|Core Study||0
2933212|NCT00600938|3644459|FG003|COMPLETED|Core Study||0
2933213|NCT00600938|3644456|FG000|NOT COMPLETED|Core Study||16
2933214|NCT00600938|3644457|FG001|NOT COMPLETED|Core Study||21
2933215|NCT00600938|3644458|FG002|NOT COMPLETED|Core Study||0
2933216|NCT00600938|3644459|FG003|NOT COMPLETED|Core Study||0
2933217|NCT00600938|3644456|FG000|STARTED|Extension Study|Of the 82 patients who completed the ICL core, 74 continued on the ICL ext. phase; 1 went to ICL-DFO|74
2933218|NCT00600938|3644457|FG001|STARTED|Extension Study|Of the 78 patients who completed the DFO core, 29 went on DFO ext. phase; 42 went to the DFO-ICL|29
2933219|NCT00600938|3644458|FG002|STARTED|Extension Study|Of the 78 patients who completed the DFO core, 29 went on DFO ext. phase; 42 went to the DFO-ICL|42
2933220|NCT00600938|3644459|FG003|STARTED|Extension Study|Of the 82 patients who completed the ICL core, 74 continued on the ICL ext. phase; 1 went to ICL-DFO|1
2933221|NCT00600938|3644456|FG000|Extension Safety Set|Extension Study|1 patient did not receive drug in the ext. phase but received drug in the core phase|73
2933222|NCT00600938|3644457|FG001|Extension Safety Set|Extension Study||29
2933223|NCT00600938|3644458|FG002|Extension Safety Set|Extension Study||42
2933224|NCT00600938|3644459|FG003|Extension Safety Set|Extension Study||1
2933225|NCT00600938|3644456|FG000|COMPLETED|Extension Study||65
2933226|NCT00600938|3644457|FG001|COMPLETED|Extension Study||24
2933227|NCT00600938|3644458|FG002|COMPLETED|Extension Study||33
2933228|NCT00600938|3644459|FG003|COMPLETED|Extension Study||0
2933229|NCT00600938|3644456|FG000|NOT COMPLETED|Extension Study||9
2933230|NCT00600938|3644457|FG001|NOT COMPLETED|Extension Study||5
2933231|NCT00600938|3644458|FG002|NOT COMPLETED|Extension Study||9
2933232|NCT00600938|3644459|FG003|NOT COMPLETED|Extension Study||1
2933233|NCT00601107|3644488|FG000|STARTED|Overall Study|Randomized.|27
2933234|NCT00601107|3644489|FG001|STARTED|Overall Study||31
2933235|NCT00601107|3644490|FG002|STARTED|Overall Study||28
2933236|NCT00601107|3644491|FG003|STARTED|Overall Study||25
2933237|NCT00601107|3644488|FG000|Treated|Overall Study||27
2933238|NCT00601107|3644489|FG001|Treated|Overall Study||31
2933239|NCT00601107|3644490|FG002|Treated|Overall Study||28
2933240|NCT00601107|3644491|FG003|Treated|Overall Study||25
2933241|NCT00601107|3644488|FG000|COMPLETED|Overall Study||14
2933242|NCT00601107|3644489|FG001|COMPLETED|Overall Study||22
2933243|NCT00601107|3644490|FG002|COMPLETED|Overall Study||16
2933244|NCT00601107|3644491|FG003|COMPLETED|Overall Study||13
2933245|NCT00601107|3644488|FG000|NOT COMPLETED|Overall Study||13
2933246|NCT00601107|3644489|FG001|NOT COMPLETED|Overall Study||9
2933247|NCT00601107|3644490|FG002|NOT COMPLETED|Overall Study||12
2933248|NCT00601107|3644491|FG003|NOT COMPLETED|Overall Study||12
2933249|NCT00601146|3644501|FG000|STARTED|Overall Study||39
2933250|NCT00601146|3644501|FG000|COMPLETED|Overall Study||39
2933251|NCT00601146|3644501|FG000|NOT COMPLETED|Overall Study||0
2933252|NCT00601172|3644507|FG000|STARTED|Overall Study||355
2933253|NCT00601172|3644508|FG001|STARTED|Overall Study||355
3042222|NCT01175434|3761933|FG001|STARTED|Overall Study||51
3042223|NCT01175434|3761932|FG000|COMPLETED|Overall Study||48
3042224|NCT01175434|3761933|FG001|COMPLETED|Overall Study||51
3042225|NCT01175434|3761932|FG000|NOT COMPLETED|Overall Study||0
3042226|NCT01175434|3761933|FG001|NOT COMPLETED|Overall Study||0
3042227|NCT01175473|3761941|FG000|STARTED|Overall Study|Randomized and treated.|77
3042228|NCT01175473|3761942|FG001|STARTED|Overall Study||71
3042229|NCT01175473|3761941|FG000|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|77
3042230|NCT01175473|3761942|FG001|Safety Population|Overall Study||71
3042231|NCT01175473|3761941|FG000|Pharmacodynamic (PD) Population|Overall Study|All patients who received at least 1 dose; had baseline and at least 1 post-baseline PD assessment.|75
3042232|NCT01175473|3761942|FG001|Pharmacodynamic (PD) Population|Overall Study||68
3042233|NCT01175473|3761941|FG000|COMPLETED|Overall Study||75
3042234|NCT01175473|3761942|FG001|COMPLETED|Overall Study||69
3042235|NCT01175473|3761941|FG000|NOT COMPLETED|Overall Study||2
3042236|NCT01175473|3761942|FG001|NOT COMPLETED|Overall Study||2
3042237|NCT01175590|3761950|FG000|STARTED|Overall Study||347
3042238|NCT01175590|3761951|FG001|STARTED|Overall Study||171
3042239|NCT01175590|3761950|FG000|Modified Intent to Treat Population|Overall Study||212
3042240|NCT01175590|3761951|FG001|Modified Intent to Treat Population|Overall Study||87
3042241|NCT01175590|3761950|FG000|Safety Population|Overall Study||344
3042242|NCT01175590|3761951|FG001|Safety Population|Overall Study||170
3042243|NCT01175590|3761950|FG000|COMPLETED|Overall Study||335
3042244|NCT01175590|3761951|FG001|COMPLETED|Overall Study||161
3042245|NCT01175590|3761950|FG000|NOT COMPLETED|Overall Study||12
3042246|NCT01175590|3761951|FG001|NOT COMPLETED|Overall Study||10
3042247|NCT01175668|3761960|FG000|STARTED|Overall Study||34
3042248|NCT01175668|3761961|FG001|STARTED|Overall Study||34
3042249|NCT01175668|3761960|FG000|COMPLETED|Overall Study||32
3042250|NCT01175668|3761961|FG001|COMPLETED|Overall Study||34
3042251|NCT01175668|3761960|FG000|NOT COMPLETED|Overall Study||2
3042252|NCT01175668|3761961|FG001|NOT COMPLETED|Overall Study||0
3042253|NCT01175707|3761969|FG000|STARTED|Overall Study||40
3042254|NCT01175707|3761970|FG001|STARTED|Overall Study||40
3042255|NCT01175707|3761969|FG000|COMPLETED|Overall Study||36
3042256|NCT01175707|3761970|FG001|COMPLETED|Overall Study||34
3042257|NCT01175707|3761969|FG000|NOT COMPLETED|Overall Study||4
3042258|NCT01175707|3761970|FG001|NOT COMPLETED|Overall Study||6
3042259|NCT01175798|3761979|FG000|STARTED|Overall Study||34
3042260|NCT01175798|3761980|FG001|STARTED|Overall Study||62
2933254|NCT00601172|3644507|FG000|COMPLETED|Overall Study||214
2933255|NCT00601172|3644508|FG001|COMPLETED|Overall Study||228
2933256|NCT00601172|3644507|FG000|NOT COMPLETED|Overall Study||141
2933257|NCT00601172|3644508|FG001|NOT COMPLETED|Overall Study||127
2933258|NCT00601250|3644517|FG000|STARTED|Overall Study|number who started treatment|177
2933259|NCT00601250|3644518|FG001|STARTED|Overall Study|number who started treatment. One additional patient was randomised but not treated.|523
2933260|NCT00601250|3644517|FG000|COMPLETED|Overall Study|number who completed treatment|163
2933261|NCT00601250|3644518|FG001|COMPLETED|Overall Study|number who completed treatment|484
2933262|NCT00601250|3644517|FG000|NOT COMPLETED|Overall Study||14
2933263|NCT00601250|3644518|FG001|NOT COMPLETED|Overall Study||39
2933264|NCT00601354|3644526|FG000|STARTED|Overall Study||8
2933265|NCT00601354|3644527|FG001|STARTED|Overall Study||9
2933266|NCT00601354|3644526|FG000|COMPLETED|Overall Study||4
2933267|NCT00601354|3644527|FG001|COMPLETED|Overall Study||4
2933268|NCT00601354|3644526|FG000|NOT COMPLETED|Overall Study||4
2933269|NCT00601354|3644527|FG001|NOT COMPLETED|Overall Study||5
2933270|NCT00601367|3644533|FG000|STARTED|Overall Study||480
2933271|NCT00601367|3644533|FG000|COMPLETED|Overall Study||293
2933272|NCT00601367|3644533|FG000|NOT COMPLETED|Overall Study||187
2933273|NCT00601419|3644537|FG000|STARTED|Overall Study||230
2933274|NCT00601419|3644537|FG000|COMPLETED|Overall Study||226
2933275|NCT00601419|3644537|FG000|NOT COMPLETED|Overall Study||4
2933276|NCT00601458|3644560|FG000|STARTED|Overall Study||36
2933277|NCT00601458|3644561|FG001|STARTED|Overall Study||34
2933278|NCT00601458|3644562|FG002|STARTED|Overall Study||30
2933279|NCT00601458|3644560|FG000|COMPLETED|Overall Study||32
2933280|NCT00601458|3644561|FG001|COMPLETED|Overall Study||29
2933281|NCT00601458|3644562|FG002|COMPLETED|Overall Study||28
2933282|NCT00601458|3644560|FG000|NOT COMPLETED|Overall Study||4
2933283|NCT00601458|3644561|FG001|NOT COMPLETED|Overall Study||5
2933284|NCT00601458|3644562|FG002|NOT COMPLETED|Overall Study||2
2933285|NCT00601484|3644572|FG000|STARTED|Overall Study||34
2933286|NCT00601484|3644573|FG001|STARTED|Overall Study||31
2933287|NCT00601484|3644572|FG000|Treated|Overall Study||34
2933288|NCT00601484|3644573|FG001|Treated|Overall Study||30
2933289|NCT00601484|3644572|FG000|COMPLETED|Overall Study||29
2933290|NCT00601484|3644573|FG001|COMPLETED|Overall Study||23
2933291|NCT00601484|3644572|FG000|NOT COMPLETED|Overall Study||5
2933292|NCT00601484|3644573|FG001|NOT COMPLETED|Overall Study||8
2933293|NCT00601523|3644581|FG000|STARTED|Overall Study||368
2933294|NCT00601523|3644582|FG001|STARTED|Overall Study||143
2933295|NCT00601523|3644581|FG000|COMPLETED|Overall Study||291
2933296|NCT00601523|3644582|FG001|COMPLETED|Overall Study||117
2933297|NCT00601523|3644581|FG000|NOT COMPLETED|Overall Study||77
2933298|NCT00601523|3644582|FG001|NOT COMPLETED|Overall Study||26
2933299|NCT00601627|3644588|FG000|STARTED|Overall Study||51
2933300|NCT00601627|3644588|FG000|COMPLETED|Overall Study||51
2933301|NCT00601627|3644588|FG000|NOT COMPLETED|Overall Study||0
2933302|NCT00601640|3644595|FG000|STARTED|Overall Study||52
2933303|NCT00601640|3644596|FG001|STARTED|Overall Study||52
2933304|NCT00601640|3644597|FG002|STARTED|Overall Study||52
3042261|NCT01175798|3761979|FG000|COMPLETED|Overall Study||27
3042262|NCT01175798|3761980|FG001|COMPLETED|Overall Study||41
3042263|NCT01175798|3761979|FG000|NOT COMPLETED|Overall Study||7
3042264|NCT01175798|3761980|FG001|NOT COMPLETED|Overall Study||21
3042265|NCT01175811|3761988|FG000|STARTED|Overall Study||199
3042266|NCT01175811|3761989|FG001|STARTED|Overall Study||203
3042267|NCT01175811|3761988|FG000|Received at Least 1 Dose of Study Drug|Overall Study||197
3042268|NCT01175811|3761989|FG001|Received at Least 1 Dose of Study Drug|Overall Study||202
3042269|NCT01175811|3761988|FG000|COMPLETED|Overall Study||183
3042270|NCT01175811|3761989|FG001|COMPLETED|Overall Study||189
3042271|NCT01175811|3761988|FG000|NOT COMPLETED|Overall Study||16
3042272|NCT01175811|3761989|FG001|NOT COMPLETED|Overall Study||14
3042273|NCT01175824|3761997|FG000|STARTED|Overall Study||236
3042274|NCT01175824|3761998|FG001|STARTED|Overall Study||242
3042275|NCT01175824|3761997|FG000|Received at Least 1 Dose of Study Drug|Overall Study||236
3042276|NCT01175824|3761998|FG001|Received at Least 1 Dose of Study Drug|Overall Study||240
3042277|NCT01175824|3761997|FG000|COMPLETED|Overall Study||220
3042278|NCT01175824|3761998|FG001|COMPLETED|Overall Study||220
3042279|NCT01175824|3761997|FG000|NOT COMPLETED|Overall Study||16
3042280|NCT01175824|3761998|FG001|NOT COMPLETED|Overall Study||22
3042281|NCT01175850|3762006|FG000|STARTED|IN.PACT SFA I Phase||99
3042282|NCT01175850|3762007|FG001|STARTED|IN.PACT SFA I Phase||51
3042283|NCT01175850|3762006|FG000|COMPLETED|IN.PACT SFA I Phase||88
3042284|NCT01175850|3762007|FG001|COMPLETED|IN.PACT SFA I Phase||49
3042285|NCT01175850|3762006|FG000|NOT COMPLETED|IN.PACT SFA I Phase||11
3042286|NCT01175850|3762007|FG001|NOT COMPLETED|IN.PACT SFA I Phase||2
3042287|NCT01175850|3762006|FG000|STARTED|IN.PACT SFA II Phase||121
3042288|NCT01175850|3762007|FG001|STARTED|IN.PACT SFA II Phase||60
3042289|NCT01175850|3762006|FG000|COMPLETED|IN.PACT SFA II Phase||109
3042290|NCT01175850|3762007|FG001|COMPLETED|IN.PACT SFA II Phase||55
3042291|NCT01175850|3762006|FG000|NOT COMPLETED|IN.PACT SFA II Phase||12
3042292|NCT01175850|3762007|FG001|NOT COMPLETED|IN.PACT SFA II Phase||5
3042293|NCT01175902|3762016|FG000|STARTED|Overall Study||22
3042294|NCT01175902|3762017|FG001|STARTED|Overall Study||22
3042295|NCT01175902|3762016|FG000|COMPLETED|Overall Study||22
3042296|NCT01175902|3762017|FG001|COMPLETED|Overall Study||22
2933305|NCT00601640|3644595|FG000|COMPLETED|Overall Study||47
2933306|NCT00601640|3644596|FG001|COMPLETED|Overall Study||47
2933307|NCT00601640|3644597|FG002|COMPLETED|Overall Study||42
2933308|NCT00601640|3644595|FG000|NOT COMPLETED|Overall Study||5
2933309|NCT00601640|3644596|FG001|NOT COMPLETED|Overall Study||5
2933310|NCT00601640|3644597|FG002|NOT COMPLETED|Overall Study||10
2933311|NCT00601705|3644607|FG000|STARTED|Overall Study||61
2933312|NCT00601705|3644607|FG000|COMPLETED|Overall Study||60
2933313|NCT00601705|3644607|FG000|NOT COMPLETED|Overall Study||1
2933314|NCT00601718|3644612|FG000|STARTED|Overall Study||29
2933315|NCT00601718|3644612|FG000|COMPLETED|Overall Study||29
2933316|NCT00601718|3644612|FG000|NOT COMPLETED|Overall Study||0
2933317|NCT00601731|3644628|FG000|STARTED|Overall Study||143
2933318|NCT00601731|3644629|FG001|STARTED|Overall Study||43
2933319|NCT00601731|3644630|FG002|STARTED|Overall Study||166
2933320|NCT00601731|3644631|FG003|STARTED|Overall Study||30
2933321|NCT00601731|3644628|FG000|COMPLETED|Overall Study||120
2933322|NCT00601731|3644629|FG001|COMPLETED|Overall Study||43
2933323|NCT00601731|3644630|FG002|COMPLETED|Overall Study||151
2933324|NCT00601731|3644631|FG003|COMPLETED|Overall Study||29
2933325|NCT00601731|3644628|FG000|NOT COMPLETED|Overall Study||23
2933326|NCT00601731|3644629|FG001|NOT COMPLETED|Overall Study||0
2933327|NCT00601731|3644630|FG002|NOT COMPLETED|Overall Study||15
2933328|NCT00601731|3644631|FG003|NOT COMPLETED|Overall Study||1
2933329|NCT00601796|3644657|FG000|STARTED|Overall Study||24
2933330|NCT00601796|3644657|FG000|COMPLETED|Overall Study||24
2933331|NCT00601796|3644657|FG000|NOT COMPLETED|Overall Study||0
2933332|NCT00601835|3644663|FG000|STARTED|Overall Study||2950
2933333|NCT00601835|3644664|FG001|STARTED|Overall Study||700
2933334|NCT00601835|3644663|FG000|COMPLETED|Overall Study||2890
2933335|NCT00601835|3644664|FG001|COMPLETED|Overall Study||686
2933336|NCT00601835|3644663|FG000|NOT COMPLETED|Overall Study||60
2933337|NCT00601835|3644664|FG001|NOT COMPLETED|Overall Study||14
2933338|NCT00601926|3644670|FG000|STARTED|Overall Study||5
2933339|NCT00601926|3644670|FG000|COMPLETED|Overall Study||5
2933340|NCT00601926|3644670|FG000|NOT COMPLETED|Overall Study||0
2933341|NCT00601952|3644676|FG000|STARTED|Overall Study||14
2933342|NCT00601952|3644677|FG001|STARTED|Overall Study||17
2933343|NCT00601952|3644676|FG000|COMPLETED|Overall Study||12
2933344|NCT00601952|3644677|FG001|COMPLETED|Overall Study||17
2933345|NCT00601952|3644676|FG000|NOT COMPLETED|Overall Study||2
2933346|NCT00601952|3644677|FG001|NOT COMPLETED|Overall Study||0
2933347|NCT00601965|3644687|FG000|STARTED|Overall Study||18
2933348|NCT00601965|3644688|FG001|STARTED|Overall Study||18
2933349|NCT00601965|3644689|FG002|STARTED|Overall Study||19
2933350|NCT00601965|3644690|FG003|STARTED|Overall Study||18
2933351|NCT00601965|3644687|FG000|COMPLETED|Overall Study||18
2933352|NCT00601965|3644688|FG001|COMPLETED|Overall Study||16
2933353|NCT00601965|3644689|FG002|COMPLETED|Overall Study||19
2933354|NCT00601965|3644690|FG003|COMPLETED|Overall Study||17
2933355|NCT00601965|3644687|FG000|NOT COMPLETED|Overall Study||0
2933356|NCT00601965|3644688|FG001|NOT COMPLETED|Overall Study||2
2933357|NCT00601965|3644689|FG002|NOT COMPLETED|Overall Study||0
2933358|NCT00601965|3644690|FG003|NOT COMPLETED|Overall Study||1
2933359|NCT00602043|3644700|FG000|STARTED|Overall Study||20
2933360|NCT00602043|3644700|FG000|COMPLETED|Overall Study||15
2933361|NCT00602043|3644700|FG000|NOT COMPLETED|Overall Study||5
2933362|NCT00602225|3644707|FG000|STARTED|Overall Study||50
2933363|NCT00602225|3644707|FG000|COMPLETED|Overall Study||50
2933364|NCT00602225|3644707|FG000|NOT COMPLETED|Overall Study||0
2933365|NCT00602290|3644715|FG000|STARTED|Overall Study||48
2933366|NCT00602290|3644716|FG001|STARTED|Overall Study||48
2933367|NCT00602290|3644717|FG002|STARTED|Overall Study||47
2933368|NCT00602290|3644715|FG000|COMPLETED|Overall Study||46
2933369|NCT00602290|3644716|FG001|COMPLETED|Overall Study||46
2933370|NCT00602290|3644717|FG002|COMPLETED|Overall Study||46
2933371|NCT00602290|3644715|FG000|NOT COMPLETED|Overall Study||2
2933372|NCT00602290|3644716|FG001|NOT COMPLETED|Overall Study||2
2933373|NCT00602290|3644717|FG002|NOT COMPLETED|Overall Study||1
2933374|NCT00602355|3644728|FG000|STARTED|Overall Study||53
2933375|NCT00602355|3644729|FG001|STARTED|Overall Study||56
2933376|NCT00602355|3644730|FG002|STARTED|Overall Study||53
2933377|NCT00602355|3644728|FG000|COMPLETED|Overall Study||44
2933378|NCT00602355|3644729|FG001|COMPLETED|Overall Study||38
2933379|NCT00602355|3644730|FG002|COMPLETED|Overall Study||43
2933380|NCT00602355|3644728|FG000|NOT COMPLETED|Overall Study||9
2933381|NCT00602355|3644729|FG001|NOT COMPLETED|Overall Study||18
2933382|NCT00602355|3644730|FG002|NOT COMPLETED|Overall Study||10
2933383|NCT00602420|3644740|FG000|STARTED|Overall Study||257
2933384|NCT00602420|3644741|FG001|STARTED|Overall Study||253
2933385|NCT00602420|3644740|FG000|COMPLETED|Overall Study||232
2933386|NCT00602420|3644741|FG001|COMPLETED|Overall Study||229
2933387|NCT00602420|3644740|FG000|NOT COMPLETED|Overall Study||25
2933388|NCT00602420|3644741|FG001|NOT COMPLETED|Overall Study||24
2933389|NCT00602446|3644747|FG000|STARTED|Overall Study||3
2933390|NCT00602446|3644747|FG000|COMPLETED|Overall Study||3
2933391|NCT00602446|3644747|FG000|NOT COMPLETED|Overall Study||0
2933392|NCT00602459|3644755|FG000|STARTED|Initial Registration/Randomization||138
2933393|NCT00602459|3644756|FG001|STARTED|Initial Registration/Randomization||140
2933394|NCT00602459|3644757|FG002|STARTED|Initial Registration/Randomization||140
2933395|NCT00602459|3644758|FG003|STARTED|Initial Registration/Randomization||0
2933396|NCT00602459|3644755|FG000|COMPLETED|Initial Registration/Randomization||133
2933397|NCT00602459|3644756|FG001|COMPLETED|Initial Registration/Randomization||130
2933398|NCT00602459|3644757|FG002|COMPLETED|Initial Registration/Randomization||137
2933399|NCT00602459|3644758|FG003|COMPLETED|Initial Registration/Randomization||0
2933400|NCT00602459|3644755|FG000|NOT COMPLETED|Initial Registration/Randomization||5
2933401|NCT00602459|3644756|FG001|NOT COMPLETED|Initial Registration/Randomization||10
2933402|NCT00602459|3644757|FG002|NOT COMPLETED|Initial Registration/Randomization||3
3042297|NCT01175902|3762016|FG000|NOT COMPLETED|Overall Study||0
3042298|NCT01175902|3762017|FG001|NOT COMPLETED|Overall Study||0
3042299|NCT01175980|3762025|FG000|STARTED|Overall Study||30
3042300|NCT01175980|3762025|FG000|COMPLETED|Overall Study||30
3042301|NCT01175980|3762025|FG000|NOT COMPLETED|Overall Study||0
3042302|NCT01176032|3762031|FG000|STARTED|Overall Study|"Started indicates randomized and safety population"|37
3042303|NCT01176032|3762032|FG001|STARTED|Overall Study||37
3042304|NCT01176032|3762031|FG000|Intention-to-treat (ITT) Population|Overall Study||32
3042305|NCT01176032|3762032|FG001|Intention-to-treat (ITT) Population|Overall Study||37
3042306|NCT01176032|3762031|FG000|COMPLETED|Overall Study||31
3042307|NCT01176032|3762032|FG001|COMPLETED|Overall Study||36
3042308|NCT01176032|3762031|FG000|NOT COMPLETED|Overall Study||6
3042309|NCT01176032|3762032|FG001|NOT COMPLETED|Overall Study||1
3042310|NCT01176058|3762045|FG000|STARTED|Overall Study||9
3042311|NCT01176058|3762046|FG001|STARTED|Overall Study||8
3042312|NCT01176058|3762045|FG000|COMPLETED|Overall Study||5
3042313|NCT01176058|3762046|FG001|COMPLETED|Overall Study||5
3042314|NCT01176058|3762045|FG000|NOT COMPLETED|Overall Study||4
3042315|NCT01176058|3762046|FG001|NOT COMPLETED|Overall Study||3
3042316|NCT01176240|3762056|FG000|STARTED|Study 306A||24
3042317|NCT01176240|3762057|FG001|STARTED|Study 306A||27
3042318|NCT01176240|3762056|FG000|COMPLETED|Study 306A||21
3042319|NCT01176240|3762057|FG001|COMPLETED|Study 306A||24
3042320|NCT01176240|3762056|FG000|NOT COMPLETED|Study 306A||3
3042321|NCT01176240|3762057|FG001|NOT COMPLETED|Study 306A||3
3042322|NCT01176240|3762056|FG000|STARTED|Study 306B||89
3042323|NCT01176240|3762057|FG001|STARTED|Study 306B||85
3042324|NCT01176240|3762056|FG000|Took at Least 1 Dose of Study Drug|Study 306B|Two randomized patients discontinued before receiving study drug.|87
3042325|NCT01176240|3762057|FG001|Took at Least 1 Dose of Study Drug|Study 306B|One randomized patient discontinued before receiving study drug.|84
3042326|NCT01176240|3762056|FG000|1 wk of Stable Dosing and Visit 4|Study 306B||69
3042327|NCT01176240|3762057|FG001|1 wk of Stable Dosing and Visit 4|Study 306B||78
3042328|NCT01176240|3762056|FG000|2 wk of Stable Dosing and Visit 5|Study 306B||68
3042329|NCT01176240|3762057|FG001|2 wk of Stable Dosing and Visit 5|Study 306B||75
3042330|NCT01176240|3762056|FG000|4 wk of Stable Dosing and Visit 6|Study 306B||67
3042331|NCT01176240|3762057|FG001|4 wk of Stable Dosing and Visit 6|Study 306B||73
3042332|NCT01176240|3762056|FG000|COMPLETED|Study 306B||63
3042333|NCT01176240|3762057|FG001|COMPLETED|Study 306B||68
3042334|NCT01176240|3762056|FG000|NOT COMPLETED|Study 306B||26
3042335|NCT01176240|3762057|FG001|NOT COMPLETED|Study 306B||17
3042336|NCT01176266|3762063|FG000|STARTED|Overall Study||69
3042337|NCT01176266|3762063|FG000|COMPLETED|Overall Study||60
3042338|NCT01176266|3762063|FG000|NOT COMPLETED|Overall Study||9
3042339|NCT01176292|3762073|FG000|STARTED|Overall Study||71
3042340|NCT01176292|3762074|FG001|STARTED|Overall Study||71
3042341|NCT01176292|3762073|FG000|COMPLETED|Overall Study||66
3042342|NCT01176292|3762074|FG001|COMPLETED|Overall Study||62
3042343|NCT01176292|3762073|FG000|NOT COMPLETED|Overall Study||5
3042344|NCT01176292|3762074|FG001|NOT COMPLETED|Overall Study||9
3042345|NCT01176435|3762083|FG000|STARTED|Overall Study||15
3042346|NCT01176435|3762084|FG001|STARTED|Overall Study||15
3042347|NCT01176435|3762085|FG002|STARTED|Overall Study||15
3042348|NCT01176435|3762083|FG000|COMPLETED|Overall Study||15
3042349|NCT01176435|3762084|FG001|COMPLETED|Overall Study||15
3042350|NCT01176435|3762085|FG002|COMPLETED|Overall Study||15
3042351|NCT01176435|3762083|FG000|NOT COMPLETED|Overall Study||0
3042352|NCT01176435|3762084|FG001|NOT COMPLETED|Overall Study||0
3042353|NCT01176435|3762085|FG002|NOT COMPLETED|Overall Study||0
3042354|NCT01176448|3762093|FG000|STARTED|Overall Study||6
3042355|NCT01176448|3762093|FG000|COMPLETED|Overall Study||6
3042356|NCT01176448|3762093|FG000|NOT COMPLETED|Overall Study||0
3042357|NCT01176565|3762103|FG000|STARTED|Overall Study||500
3042358|NCT01176565|3762104|FG001|STARTED|Overall Study||500
3042359|NCT01176565|3762103|FG000|COMPLETED|Overall Study||480
3042360|NCT01176565|3762104|FG001|COMPLETED|Overall Study||481
3042361|NCT01176565|3762103|FG000|NOT COMPLETED|Overall Study||20
3042362|NCT01176565|3762104|FG001|NOT COMPLETED|Overall Study||19
3042363|NCT01176591|3762112|FG000|STARTED|Session 1||10
3042364|NCT01176591|3762113|FG001|STARTED|Session 1||3
3042365|NCT01176591|3762112|FG000|COMPLETED|Session 1||10
3042366|NCT01176591|3762113|FG001|COMPLETED|Session 1||3
3042367|NCT01176591|3762112|FG000|NOT COMPLETED|Session 1||0
3042368|NCT01176591|3762113|FG001|NOT COMPLETED|Session 1||0
3042369|NCT01176591|3762112|FG000|STARTED|Session 2||10
3042370|NCT01176591|3762113|FG001|STARTED|Session 2||3
3042371|NCT01176591|3762112|FG000|COMPLETED|Session 2||10
3042372|NCT01176591|3762113|FG001|COMPLETED|Session 2||3
3042373|NCT01176591|3762112|FG000|NOT COMPLETED|Session 2||0
3042374|NCT01176591|3762113|FG001|NOT COMPLETED|Session 2||0
3042375|NCT01176617|3762123|FG000|STARTED|1 - 6 Months (Ron-randomized)||0
3042376|NCT01176617|3762124|FG001|STARTED|1 - 6 Months (Ron-randomized)||0
3042377|NCT01176617|3762125|FG002|STARTED|1 - 6 Months (Ron-randomized)||38
3042378|NCT01176617|3762123|FG000|COMPLETED|1 - 6 Months (Ron-randomized)||0
3042379|NCT01176617|3762124|FG001|COMPLETED|1 - 6 Months (Ron-randomized)||0
3042380|NCT01176617|3762125|FG002|COMPLETED|1 - 6 Months (Ron-randomized)||38
2933403|NCT00602459|3644758|FG003|NOT COMPLETED|Initial Registration/Randomization||0
2933404|NCT00602459|3644755|FG000|STARTED|Re-assignment After Del(11q22.3) Testing||123
2933405|NCT00602459|3644756|FG001|STARTED|Re-assignment After Del(11q22.3) Testing||109
2933406|NCT00602459|3644757|FG002|STARTED|Re-assignment After Del(11q22.3) Testing||137
2933407|NCT00602459|3644758|FG003|STARTED|Re-assignment After Del(11q22.3) Testing||31
2933408|NCT00602459|3644755|FG000|COMPLETED|Re-assignment After Del(11q22.3) Testing||123
2933409|NCT00602459|3644756|FG001|COMPLETED|Re-assignment After Del(11q22.3) Testing||109
2933410|NCT00602459|3644757|FG002|COMPLETED|Re-assignment After Del(11q22.3) Testing||137
2933411|NCT00602459|3644758|FG003|COMPLETED|Re-assignment After Del(11q22.3) Testing||31
2933412|NCT00602459|3644755|FG000|NOT COMPLETED|Re-assignment After Del(11q22.3) Testing||0
2933413|NCT00602459|3644756|FG001|NOT COMPLETED|Re-assignment After Del(11q22.3) Testing||0
2933414|NCT00602459|3644757|FG002|NOT COMPLETED|Re-assignment After Del(11q22.3) Testing||0
2933415|NCT00602459|3644758|FG003|NOT COMPLETED|Re-assignment After Del(11q22.3) Testing||0
2933416|NCT00602472|3644776|FG000|STARTED|Overall Study|3 randomised patients never took medication.|263
2933417|NCT00602472|3644777|FG001|STARTED|Overall Study|3 randomised patients never took medication.|792
2933418|NCT00602472|3644776|FG000|COMPLETED|Overall Study|number who completed treatment|242
2933419|NCT00602472|3644777|FG001|COMPLETED|Overall Study|number who completed treatment|734
2933420|NCT00602472|3644776|FG000|NOT COMPLETED|Overall Study||21
2933421|NCT00602472|3644777|FG001|NOT COMPLETED|Overall Study||58
2933422|NCT00602537|3644785|FG000|STARTED|12 Week Double Blind Comparison||65
2933423|NCT00602537|3644786|FG001|STARTED|12 Week Double Blind Comparison||64
2933424|NCT00602537|3644785|FG000|Responded|12 Week Double Blind Comparison||44
2933425|NCT00602537|3644786|FG001|Responded|12 Week Double Blind Comparison||22
2933426|NCT00602537|3644785|FG000|COMPLETED|12 Week Double Blind Comparison||42
2933427|NCT00602537|3644786|FG001|COMPLETED|12 Week Double Blind Comparison||17
2933428|NCT00602537|3644785|FG000|NOT COMPLETED|12 Week Double Blind Comparison||23
2933429|NCT00602537|3644786|FG001|NOT COMPLETED|12 Week Double Blind Comparison||47
2933430|NCT00602537|3644785|FG000|STARTED|Follow Up Study Comparison||42
2933431|NCT00602537|3644786|FG001|STARTED|Follow Up Study Comparison||17
2933432|NCT00602537|3644785|FG000|COMPLETED|Follow Up Study Comparison||31
2933433|NCT00602537|3644786|FG001|COMPLETED|Follow Up Study Comparison||14
2933434|NCT00602537|3644785|FG000|NOT COMPLETED|Follow Up Study Comparison||11
2933435|NCT00602537|3644786|FG001|NOT COMPLETED|Follow Up Study Comparison||3
2933436|NCT00602771|3644794|FG000|STARTED|Overall Study||63
2933437|NCT00602771|3644795|FG001|STARTED|Overall Study||21
2933438|NCT00602771|3644794|FG000|COMPLETED|Overall Study||62
2933439|NCT00602771|3644795|FG001|COMPLETED|Overall Study||21
2933440|NCT00602771|3644794|FG000|NOT COMPLETED|Overall Study||1
2933441|NCT00602771|3644795|FG001|NOT COMPLETED|Overall Study||0
2933442|NCT00602797|3644801|FG000|STARTED|Overall Study||20
2933443|NCT00602797|3644801|FG000|COMPLETED|Overall Study||19
2933444|NCT00602797|3644801|FG000|NOT COMPLETED|Overall Study||1
2933445|NCT00602836|3644806|FG000|STARTED|Overall Study||44
2933446|NCT00602836|3644806|FG000|COMPLETED|Overall Study||39
2933447|NCT00602836|3644806|FG000|NOT COMPLETED|Overall Study||5
2933448|NCT00602927|3644812|FG000|STARTED|Period 1: 13 Days||19
2933449|NCT00602927|3644813|FG001|STARTED|Period 1: 13 Days||19
2933450|NCT00602927|3644812|FG000|COMPLETED|Period 1: 13 Days||15
2933451|NCT00602927|3644813|FG001|COMPLETED|Period 1: 13 Days||14
2933452|NCT00602927|3644812|FG000|NOT COMPLETED|Period 1: 13 Days||4
2933453|NCT00602927|3644813|FG001|NOT COMPLETED|Period 1: 13 Days||5
2933454|NCT00602927|3644812|FG000|STARTED|Period 2: 14 Days||15
2933455|NCT00602927|3644813|FG001|STARTED|Period 2: 14 Days||14
2933456|NCT00602927|3644812|FG000|COMPLETED|Period 2: 14 Days||15
2933457|NCT00602927|3644813|FG001|COMPLETED|Period 2: 14 Days||12
2933458|NCT00602927|3644812|FG000|NOT COMPLETED|Period 2: 14 Days||0
2933459|NCT00602927|3644813|FG001|NOT COMPLETED|Period 2: 14 Days||2
2933460|NCT00602927|3644812|FG000|STARTED|Period 3: 13 Days||15
3042381|NCT01176617|3762123|FG000|NOT COMPLETED|1 - 6 Months (Ron-randomized)||0
3042382|NCT01176617|3762124|FG001|NOT COMPLETED|1 - 6 Months (Ron-randomized)||0
3042383|NCT01176617|3762125|FG002|NOT COMPLETED|1 - 6 Months (Ron-randomized)||0
3042384|NCT01176617|3762123|FG000|STARTED|6 - 12 Months (Randomized)||18
3042385|NCT01176617|3762124|FG001|STARTED|6 - 12 Months (Randomized)||20
3042386|NCT01176617|3762125|FG002|STARTED|6 - 12 Months (Randomized)||0
3042387|NCT01176617|3762123|FG000|COMPLETED|6 - 12 Months (Randomized)||13
3042388|NCT01176617|3762124|FG001|COMPLETED|6 - 12 Months (Randomized)||20
3042389|NCT01176617|3762125|FG002|COMPLETED|6 - 12 Months (Randomized)||0
3042390|NCT01176617|3762123|FG000|NOT COMPLETED|6 - 12 Months (Randomized)||5
3042391|NCT01176617|3762124|FG001|NOT COMPLETED|6 - 12 Months (Randomized)||0
3042392|NCT01176617|3762125|FG002|NOT COMPLETED|6 - 12 Months (Randomized)||0
3042393|NCT01176773|3762133|FG000|STARTED|Overall Study||62
3042394|NCT01176773|3762133|FG000|COMPLETED|Overall Study||59
3042395|NCT01176773|3762133|FG000|NOT COMPLETED|Overall Study||3
3042396|NCT01176877|3762138|FG000|STARTED|Overall Study||40
3042397|NCT01176877|3762138|FG000|COMPLETED|Overall Study||31
3042398|NCT01176877|3762138|FG000|NOT COMPLETED|Overall Study||9
3042399|NCT01176916|3762143|FG000|STARTED|Overall Study||564
3042400|NCT01176916|3762143|FG000|Treated|Overall Study||558
3042401|NCT01176916|3762143|FG000|Assigne But Not Treated|Overall Study||6
3042402|NCT01176916|3762143|FG000|COMPLETED|Overall Study||397
3042403|NCT01176916|3762143|FG000|NOT COMPLETED|Overall Study||167
3042404|NCT01176955|3762149|FG000|STARTED|Overall Study||10
3042405|NCT01176955|3762150|FG001|STARTED|Overall Study||10
2933461|NCT00602927|3644813|FG001|STARTED|Period 3: 13 Days||12
2933462|NCT00602927|3644812|FG000|COMPLETED|Period 3: 13 Days||13
2933463|NCT00602927|3644813|FG001|COMPLETED|Period 3: 13 Days||9
2933464|NCT00602927|3644812|FG000|NOT COMPLETED|Period 3: 13 Days||2
2933465|NCT00602927|3644813|FG001|NOT COMPLETED|Period 3: 13 Days||3
2933466|NCT00602953|3644824|FG000|STARTED|Overall Study||15
2933467|NCT00602953|3644825|FG001|STARTED|Overall Study||26
2933468|NCT00602953|3644826|FG002|STARTED|Overall Study||47
2933469|NCT00602953|3644827|FG003|STARTED|Overall Study||13
2933470|NCT00602953|3644828|FG004|STARTED|Overall Study||0
2933471|NCT00602953|3644824|FG000|COMPLETED|Overall Study||15
2933472|NCT00602953|3644825|FG001|COMPLETED|Overall Study||26
2933473|NCT00602953|3644826|FG002|COMPLETED|Overall Study||47
2933474|NCT00602953|3644827|FG003|COMPLETED|Overall Study||13
2933475|NCT00602953|3644828|FG004|COMPLETED|Overall Study||0
2933476|NCT00602953|3644824|FG000|NOT COMPLETED|Overall Study||0
2933477|NCT00602953|3644825|FG001|NOT COMPLETED|Overall Study||0
2933478|NCT00602953|3644826|FG002|NOT COMPLETED|Overall Study||0
2933479|NCT00602953|3644827|FG003|NOT COMPLETED|Overall Study||0
2933480|NCT00602953|3644828|FG004|NOT COMPLETED|Overall Study||0
2933481|NCT00602979|3644845|FG000|STARTED|Overall Study||48
2933482|NCT00602979|3644846|FG001|STARTED|Overall Study||48
2933483|NCT00602979|3644847|FG002|STARTED|Overall Study||48
2933484|NCT00602979|3644848|FG003|STARTED|Overall Study||48
2933485|NCT00602979|3644849|FG004|STARTED|Overall Study||48
2933486|NCT00602979|3644845|FG000|COMPLETED|Overall Study||45
2933487|NCT00602979|3644846|FG001|COMPLETED|Overall Study||45
2933488|NCT00602979|3644847|FG002|COMPLETED|Overall Study||45
2933489|NCT00602979|3644848|FG003|COMPLETED|Overall Study||45
2933490|NCT00602979|3644849|FG004|COMPLETED|Overall Study||45
2933491|NCT00602979|3644845|FG000|NOT COMPLETED|Overall Study||3
2933492|NCT00602979|3644846|FG001|NOT COMPLETED|Overall Study||3
2933493|NCT00602979|3644847|FG002|NOT COMPLETED|Overall Study||3
2933494|NCT00602979|3644848|FG003|NOT COMPLETED|Overall Study||3
2933495|NCT00602979|3644849|FG004|NOT COMPLETED|Overall Study||3
2933496|NCT00603018|3644861|FG000|STARTED|Overall Study||23
2933497|NCT00603018|3644861|FG000|COMPLETED|Overall Study||23
2933498|NCT00603018|3644861|FG000|NOT COMPLETED|Overall Study||0
2933499|NCT00603044|3644868|FG000|STARTED|Overall Study||11
2933500|NCT00603044|3644869|FG001|STARTED|Overall Study||13
2933501|NCT00603044|3644868|FG000|COMPLETED|Overall Study||11
2933502|NCT00603044|3644869|FG001|COMPLETED|Overall Study||13
2933503|NCT00603044|3644868|FG000|NOT COMPLETED|Overall Study||0
2933504|NCT00603044|3644869|FG001|NOT COMPLETED|Overall Study||0
2933505|NCT00603187|3644875|FG000|STARTED|Overall Study||4
2933506|NCT00603187|3644875|FG000|COMPLETED|Overall Study||4
2933507|NCT00603187|3644875|FG000|NOT COMPLETED|Overall Study||0
2933508|NCT00603239|3644881|FG000|STARTED|Overall Study||111
2933509|NCT00603239|3644882|FG001|STARTED|Overall Study||54
2933510|NCT00603239|3644881|FG000|COMPLETED|Overall Study||96
2933511|NCT00603239|3644882|FG001|COMPLETED|Overall Study||50
2933512|NCT00603239|3644881|FG000|NOT COMPLETED|Overall Study||15
2933513|NCT00603239|3644882|FG001|NOT COMPLETED|Overall Study||4
2933514|NCT00603265|3644891|FG000|STARTED|Overall Study|1 participant was randomized in error and did not receive study medication|76
2933515|NCT00603265|3644892|FG001|STARTED|Overall Study||78
2933516|NCT00603265|3644893|FG002|STARTED|Overall Study||72
2933517|NCT00603265|3644891|FG000|Received at Least 1 Dose of Study Drug|Overall Study||75
3042406|NCT01176955|3762149|FG000|COMPLETED|Overall Study||7
3042407|NCT01176955|3762150|FG001|COMPLETED|Overall Study||8
3042408|NCT01176955|3762149|FG000|NOT COMPLETED|Overall Study||3
3042409|NCT01176955|3762150|FG001|NOT COMPLETED|Overall Study||2
3042410|NCT01176968|3762161|FG000|STARTED|Overall Study||506
3042411|NCT01176968|3762162|FG001|STARTED|Overall Study||506
3042412|NCT01176968|3762161|FG000|Treated|Overall Study||505
3042413|NCT01176968|3762162|FG001|Treated|Overall Study||505
3042414|NCT01176968|3762161|FG000|COMPLETED|Overall Study||422
3042415|NCT01176968|3762162|FG001|COMPLETED|Overall Study||424
3042416|NCT01176968|3762161|FG000|NOT COMPLETED|Overall Study||84
3042417|NCT01176968|3762162|FG001|NOT COMPLETED|Overall Study||82
3042418|NCT01176981|3762168|FG000|STARTED|Overall Study||6
3042419|NCT01176981|3762168|FG000|COMPLETED|Overall Study||6
3042420|NCT01176981|3762168|FG000|NOT COMPLETED|Overall Study||0
3042421|NCT01177007|3762172|FG000|STARTED|Overall Study||50
3042422|NCT01177007|3762172|FG000|Completed First Y90 Treatment|Overall Study||50
3042423|NCT01177007|3762172|FG000|Completed First Clinical and Imaging|Overall Study||43
3042424|NCT01177007|3762172|FG000|COMPLETED|Overall Study||12
3042425|NCT01177007|3762172|FG000|NOT COMPLETED|Overall Study||38
3042426|NCT01177059|3762178|FG000|STARTED|Overall Study||68
3042427|NCT01177059|3762178|FG000|COMPLETED|Overall Study||18
3042428|NCT01177059|3762178|FG000|NOT COMPLETED|Overall Study||50
3042429|NCT01177098|3762184|FG000|STARTED|Overall Study||278
3042430|NCT01177098|3762185|FG001|STARTED|Overall Study||283
3042431|NCT01177098|3762184|FG000|COMPLETED|Overall Study||269
3042432|NCT01177098|3762185|FG001|COMPLETED|Overall Study||271
3042433|NCT01177098|3762184|FG000|NOT COMPLETED|Overall Study||9
3042434|NCT01177098|3762185|FG001|NOT COMPLETED|Overall Study||12
3042435|NCT01177137|3762194|FG000|STARTED|Overall Study||51
2933518|NCT00603265|3644892|FG001|Received at Least 1 Dose of Study Drug|Overall Study||78
2933519|NCT00603265|3644893|FG002|Received at Least 1 Dose of Study Drug|Overall Study||72
2933520|NCT00603265|3644891|FG000|COMPLETED|Overall Study||69
2933521|NCT00603265|3644892|FG001|COMPLETED|Overall Study||62
2933522|NCT00603265|3644893|FG002|COMPLETED|Overall Study||67
2933523|NCT00603265|3644891|FG000|NOT COMPLETED|Overall Study||7
2933524|NCT00603265|3644892|FG001|NOT COMPLETED|Overall Study||16
2933525|NCT00603265|3644893|FG002|NOT COMPLETED|Overall Study||5
2933526|NCT00603278|3644907|FG000|STARTED|Overall Study||107
2933527|NCT00603278|3644908|FG001|STARTED|Overall Study||105
2933528|NCT00603278|3644909|FG002|STARTED|Overall Study||101
2933529|NCT00603278|3644910|FG003|STARTED|Overall Study||103
3180007|NCT01988090|3908285|FG000|STARTED|Start Treament After Randomization||46
3180008|NCT01988090|3908286|FG001|STARTED|Start Treament After Randomization||47
3180009|NCT01988090|3908285|FG000|COMPLETED|Start Treament After Randomization||44
3180010|NCT01988090|3908286|FG001|COMPLETED|Start Treament After Randomization||43
3180011|NCT01988090|3908285|FG000|NOT COMPLETED|Start Treament After Randomization||2
3180012|NCT01988090|3908286|FG001|NOT COMPLETED|Start Treament After Randomization||4
3180013|NCT01988090|3908285|FG000|STARTED|Complete Study After Start||44
3180014|NCT01988090|3908286|FG001|STARTED|Complete Study After Start||43
3180015|NCT01988090|3908285|FG000|COMPLETED|Complete Study After Start||41
3180016|NCT01988090|3908286|FG001|COMPLETED|Complete Study After Start||42
3180017|NCT01988090|3908285|FG000|NOT COMPLETED|Complete Study After Start||3
3180018|NCT01988090|3908286|FG001|NOT COMPLETED|Complete Study After Start||1
3180019|NCT01988103|3908295|FG000|STARTED|Placebo-Controlled Phase Week 0-16||84
3180020|NCT01988103|3908296|FG001|STARTED|Placebo-Controlled Phase Week 0-16||85
3180021|NCT01988103|3908297|FG002|STARTED|Placebo-Controlled Phase Week 0-16||85
3180022|NCT01988103|3908298|FG003|STARTED|Placebo-Controlled Phase Week 0-16||0
3180023|NCT01988103|3908299|FG004|STARTED|Placebo-Controlled Phase Week 0-16||0
3180024|NCT01988103|3908295|FG000|COMPLETED|Placebo-Controlled Phase Week 0-16||72
3180025|NCT01988103|3908296|FG001|COMPLETED|Placebo-Controlled Phase Week 0-16||69
3180026|NCT01988103|3908297|FG002|COMPLETED|Placebo-Controlled Phase Week 0-16||76
3180027|NCT01988103|3908298|FG003|COMPLETED|Placebo-Controlled Phase Week 0-16||0
3180028|NCT01988103|3908299|FG004|COMPLETED|Placebo-Controlled Phase Week 0-16||0
3180029|NCT01988103|3908295|FG000|NOT COMPLETED|Placebo-Controlled Phase Week 0-16||12
3180030|NCT01988103|3908296|FG001|NOT COMPLETED|Placebo-Controlled Phase Week 0-16||16
3180031|NCT01988103|3908297|FG002|NOT COMPLETED|Placebo-Controlled Phase Week 0-16||9
3180032|NCT01988103|3908298|FG003|NOT COMPLETED|Placebo-Controlled Phase Week 0-16||0
3180033|NCT01988103|3908299|FG004|NOT COMPLETED|Placebo-Controlled Phase Week 0-16||0
3180034|NCT01988103|3908295|FG000|STARTED|Active Treatment Phase (Weeks 16-68)||0
3180035|NCT01988103|3908296|FG001|STARTED|Active Treatment Phase (Weeks 16-68)||69
3180036|NCT01988103|3908297|FG002|STARTED|Active Treatment Phase (Weeks 16-68)||76
3180037|NCT01988103|3908298|FG003|STARTED|Active Treatment Phase (Weeks 16-68)||36
3180038|NCT01988103|3908299|FG004|STARTED|Active Treatment Phase (Weeks 16-68)||35
3180039|NCT01988103|3908295|FG000|COMPLETED|Active Treatment Phase (Weeks 16-68)||0
3180040|NCT01988103|3908296|FG001|COMPLETED|Active Treatment Phase (Weeks 16-68)||56
3180041|NCT01988103|3908297|FG002|COMPLETED|Active Treatment Phase (Weeks 16-68)||65
3180042|NCT01988103|3908298|FG003|COMPLETED|Active Treatment Phase (Weeks 16-68)||33
3180043|NCT01988103|3908299|FG004|COMPLETED|Active Treatment Phase (Weeks 16-68)||30
3180044|NCT01988103|3908295|FG000|NOT COMPLETED|Active Treatment Phase (Weeks 16-68)||0
3180045|NCT01988103|3908296|FG001|NOT COMPLETED|Active Treatment Phase (Weeks 16-68)||13
3180046|NCT01988103|3908297|FG002|NOT COMPLETED|Active Treatment Phase (Weeks 16-68)||11
2933530|NCT00603278|3644911|FG004|STARTED|Overall Study||99
2933531|NCT00603278|3644912|FG005|STARTED|Overall Study||100
2933532|NCT00603278|3644907|FG000|COMPLETED|Overall Study||66
2933533|NCT00603278|3644908|FG001|COMPLETED|Overall Study||88
2933534|NCT00603278|3644909|FG002|COMPLETED|Overall Study||87
2933535|NCT00603278|3644910|FG003|COMPLETED|Overall Study||92
3180047|NCT01988103|3908298|FG003|NOT COMPLETED|Active Treatment Phase (Weeks 16-68)||3
3180048|NCT01988103|3908299|FG004|NOT COMPLETED|Active Treatment Phase (Weeks 16-68)||5
3180049|NCT01988103|3908295|FG000|STARTED|Observational Follow-up Phase||12
3180050|NCT01988103|3908296|FG001|STARTED|Observational Follow-up Phase||82
3180051|NCT01988103|3908297|FG002|STARTED|Observational Follow-up Phase||83
2933536|NCT00603278|3644911|FG004|COMPLETED|Overall Study||86
2933537|NCT00603278|3644912|FG005|COMPLETED|Overall Study||81
2933538|NCT00603278|3644907|FG000|NOT COMPLETED|Overall Study||41
2933539|NCT00603278|3644908|FG001|NOT COMPLETED|Overall Study||17
2933540|NCT00603278|3644909|FG002|NOT COMPLETED|Overall Study||14
2933541|NCT00603278|3644910|FG003|NOT COMPLETED|Overall Study||11
2933542|NCT00603278|3644911|FG004|NOT COMPLETED|Overall Study||13
2933543|NCT00603278|3644912|FG005|NOT COMPLETED|Overall Study||19
2933544|NCT00603291|3644929|FG000|STARTED|Overall Study||95
2933545|NCT00603291|3644930|FG001|STARTED|Overall Study||256
2933546|NCT00603291|3644931|FG002|STARTED|Overall Study||253
2933547|NCT00603291|3644929|FG000|COMPLETED|Overall Study||75
2933548|NCT00603291|3644930|FG001|COMPLETED|Overall Study||169
2933549|NCT00603291|3644931|FG002|COMPLETED|Overall Study||157
2933550|NCT00603291|3644929|FG000|NOT COMPLETED|Overall Study||20
2933551|NCT00603291|3644930|FG001|NOT COMPLETED|Overall Study||87
2933552|NCT00603291|3644931|FG002|NOT COMPLETED|Overall Study||96
2933553|NCT00603304|3644941|FG000|STARTED|Overall Study||183
2933554|NCT00603304|3644942|FG001|STARTED|Overall Study||186
2933555|NCT00603304|3644941|FG000|COMPLETED|Overall Study||151
2933556|NCT00603304|3644942|FG001|COMPLETED|Overall Study||155
2933557|NCT00603304|3644941|FG000|NOT COMPLETED|Overall Study||32
2933558|NCT00603304|3644942|FG001|NOT COMPLETED|Overall Study||31
2933559|NCT00603382|3644956|FG000|STARTED|Overall Study||94
2933560|NCT00603382|3644957|FG001|STARTED|Overall Study||97
2933561|NCT00603382|3644958|FG002|STARTED|Overall Study||100
2933562|NCT00603382|3644959|FG003|STARTED|Overall Study||110
2933563|NCT00603382|3644960|FG004|STARTED|Overall Study||95
2933564|NCT00603382|3644961|FG005|STARTED|Overall Study||102
2933565|NCT00603382|3644956|FG000|COMPLETED|Overall Study||76
2933566|NCT00603382|3644957|FG001|COMPLETED|Overall Study||83
2933567|NCT00603382|3644958|FG002|COMPLETED|Overall Study||91
2933568|NCT00603382|3644959|FG003|COMPLETED|Overall Study||98
2933569|NCT00603382|3644960|FG004|COMPLETED|Overall Study||86
2933570|NCT00603382|3644961|FG005|COMPLETED|Overall Study||84
2933571|NCT00603382|3644956|FG000|NOT COMPLETED|Overall Study||18
2933572|NCT00603382|3644957|FG001|NOT COMPLETED|Overall Study||14
2933573|NCT00603382|3644958|FG002|NOT COMPLETED|Overall Study||9
2933574|NCT00603382|3644959|FG003|NOT COMPLETED|Overall Study||12
2933575|NCT00603382|3644960|FG004|NOT COMPLETED|Overall Study||9
2933576|NCT00603382|3644961|FG005|NOT COMPLETED|Overall Study||18
2933577|NCT00603408|3644975|FG000|STARTED|Overall Study||5
2933578|NCT00603408|3644975|FG000|COMPLETED|Overall Study||5
2933579|NCT00603408|3644975|FG000|NOT COMPLETED|Overall Study||0
2933580|NCT00603447|3644987|FG000|STARTED|Overall Study||6
2933581|NCT00603447|3644988|FG001|STARTED|Overall Study||6
2933582|NCT00603447|3644989|FG002|STARTED|Overall Study||8
2933583|NCT00603447|3644990|FG003|STARTED|Overall Study||6
2933584|NCT00603447|3644991|FG004|STARTED|Overall Study||6
2933585|NCT00603447|3644992|FG005|STARTED|Overall Study||8
2933586|NCT00603447|3644993|FG006|STARTED|Overall Study||44
2933587|NCT00603447|3644987|FG000|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|6
2933588|NCT00603447|3644988|FG001|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|3
2933589|NCT00603447|3644989|FG002|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|6
3042436|NCT01177137|3762195|FG001|STARTED|Overall Study||51
3042437|NCT01177137|3762196|FG002|STARTED|Overall Study||49
3042438|NCT01177137|3762194|FG000|COMPLETED|Overall Study||41
3042439|NCT01177137|3762195|FG001|COMPLETED|Overall Study||41
3042440|NCT01177137|3762196|FG002|COMPLETED|Overall Study||47
3042441|NCT01177137|3762194|FG000|NOT COMPLETED|Overall Study||10
3042442|NCT01177137|3762195|FG001|NOT COMPLETED|Overall Study||10
3042443|NCT01177137|3762196|FG002|NOT COMPLETED|Overall Study||2
3042444|NCT01177189|3762209|FG000|STARTED|Overall Study||42
3042445|NCT01177189|3762210|FG001|STARTED|Overall Study||45
3042446|NCT01177189|3762209|FG000|COMPLETED|Overall Study||42
3042447|NCT01177189|3762210|FG001|COMPLETED|Overall Study||45
3042448|NCT01177189|3762209|FG000|NOT COMPLETED|Overall Study||0
3042449|NCT01177189|3762210|FG001|NOT COMPLETED|Overall Study||0
3042450|NCT01177228|3762220|FG000|STARTED|Overall Study||9
3042451|NCT01177228|3762221|FG001|STARTED|Overall Study||13
3042452|NCT01177228|3762222|FG002|STARTED|Overall Study||14
3042453|NCT01177228|3762223|FG003|STARTED|Overall Study||11
3042454|NCT01177228|3762220|FG000|Received Treatment|Overall Study||9
3042455|NCT01177228|3762221|FG001|Received Treatment|Overall Study||12
3042456|NCT01177228|3762222|FG002|Received Treatment|Overall Study||14
3042457|NCT01177228|3762223|FG003|Received Treatment|Overall Study||11
3042458|NCT01177228|3762220|FG000|COMPLETED|Overall Study||8
3042459|NCT01177228|3762221|FG001|COMPLETED|Overall Study||11
3042460|NCT01177228|3762222|FG002|COMPLETED|Overall Study||14
3042461|NCT01177228|3762223|FG003|COMPLETED|Overall Study||11
3042462|NCT01177228|3762220|FG000|NOT COMPLETED|Overall Study||1
3042463|NCT01177228|3762221|FG001|NOT COMPLETED|Overall Study||2
3042464|NCT01177228|3762222|FG002|NOT COMPLETED|Overall Study||0
3042465|NCT01177228|3762223|FG003|NOT COMPLETED|Overall Study||0
3042466|NCT01177293|3762238|FG000|STARTED|First Intervention Period||7
3042467|NCT01177293|3762239|FG001|STARTED|First Intervention Period||7
3042468|NCT01177293|3762238|FG000|COMPLETED|First Intervention Period||7
3042469|NCT01177293|3762239|FG001|COMPLETED|First Intervention Period||7
3042470|NCT01177293|3762238|FG000|NOT COMPLETED|First Intervention Period||0
3042471|NCT01177293|3762239|FG001|NOT COMPLETED|First Intervention Period||0
3042472|NCT01177293|3762238|FG000|STARTED|Washout Period (of 14 Days)||7
3042473|NCT01177293|3762239|FG001|STARTED|Washout Period (of 14 Days)||7
3042474|NCT01177293|3762238|FG000|COMPLETED|Washout Period (of 14 Days)||7
3042475|NCT01177293|3762239|FG001|COMPLETED|Washout Period (of 14 Days)||6
3042476|NCT01177293|3762238|FG000|NOT COMPLETED|Washout Period (of 14 Days)||0
3042477|NCT01177293|3762239|FG001|NOT COMPLETED|Washout Period (of 14 Days)||1
3042478|NCT01177293|3762238|FG000|STARTED|Second Intervention Period||7
3042479|NCT01177293|3762239|FG001|STARTED|Second Intervention Period||6
3042480|NCT01177293|3762238|FG000|COMPLETED|Second Intervention Period||7
3042481|NCT01177293|3762239|FG001|COMPLETED|Second Intervention Period||6
3042482|NCT01177293|3762238|FG000|NOT COMPLETED|Second Intervention Period||0
3042483|NCT01177293|3762239|FG001|NOT COMPLETED|Second Intervention Period||0
3042484|NCT01177384|3762247|FG000|STARTED|Overall Study||191
3042485|NCT01177384|3762248|FG001|STARTED|Overall Study|Includes the second randomization of a participant|190
3180052|NCT01988103|3908298|FG003|STARTED|Observational Follow-up Phase||36
3180053|NCT01988103|3908299|FG004|STARTED|Observational Follow-up Phase||33
3180054|NCT01988103|3908295|FG000|COMPLETED|Observational Follow-up Phase||12
3042486|NCT01177384|3762247|FG000|COMPLETED|Overall Study||177
3042487|NCT01177384|3762248|FG001|COMPLETED|Overall Study||164
3180055|NCT01988103|3908296|FG001|COMPLETED|Observational Follow-up Phase||79
3180056|NCT01988103|3908297|FG002|COMPLETED|Observational Follow-up Phase||82
3180057|NCT01988103|3908298|FG003|COMPLETED|Observational Follow-up Phase||36
2933590|NCT00603447|3644990|FG003|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|4
2933591|NCT00603447|3644991|FG004|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|1
2933592|NCT00603447|3644992|FG005|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|6
2933593|NCT00603447|3644993|FG006|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|20
2933594|NCT00603447|3644987|FG000|NOT COMPLETED|Overall Study||0
2933595|NCT00603447|3644988|FG001|NOT COMPLETED|Overall Study||3
2933596|NCT00603447|3644989|FG002|NOT COMPLETED|Overall Study||2
2933597|NCT00603447|3644990|FG003|NOT COMPLETED|Overall Study||2
2933598|NCT00603447|3644991|FG004|NOT COMPLETED|Overall Study||5
2933599|NCT00603447|3644992|FG005|NOT COMPLETED|Overall Study||2
2933600|NCT00603447|3644993|FG006|NOT COMPLETED|Overall Study||24
2933601|NCT00603473|3645009|FG000|STARTED|Overall Study||89
2933602|NCT00603473|3645009|FG000|COMPLETED|Overall Study||80
2933603|NCT00603473|3645009|FG000|NOT COMPLETED|Overall Study||9
2933604|NCT00603512|3645018|FG000|STARTED|Overall Study||28
2933605|NCT00603512|3645019|FG001|STARTED|Overall Study||28
2933606|NCT00603512|3645020|FG002|STARTED|Overall Study||28
2933607|NCT00603512|3645021|FG003|STARTED|Overall Study||28
2933608|NCT00603512|3645022|FG004|STARTED|Overall Study||28
2933609|NCT00603512|3645018|FG000|Treated|Overall Study||28
2933610|NCT00603512|3645019|FG001|Treated|Overall Study||27
2933611|NCT00603512|3645020|FG002|Treated|Overall Study||27
2933612|NCT00603512|3645021|FG003|Treated|Overall Study||26
2933613|NCT00603512|3645022|FG004|Treated|Overall Study||28
2933614|NCT00603512|3645018|FG000|COMPLETED|Overall Study||26
2933615|NCT00603512|3645019|FG001|COMPLETED|Overall Study||23
2933616|NCT00603512|3645020|FG002|COMPLETED|Overall Study||23
2933617|NCT00603512|3645021|FG003|COMPLETED|Overall Study||21
2933618|NCT00603512|3645022|FG004|COMPLETED|Overall Study||23
2933619|NCT00603512|3645018|FG000|NOT COMPLETED|Overall Study||2
2933620|NCT00603512|3645019|FG001|NOT COMPLETED|Overall Study||5
2933621|NCT00603512|3645020|FG002|NOT COMPLETED|Overall Study||5
3042488|NCT01177384|3762247|FG000|NOT COMPLETED|Overall Study||14
3042489|NCT01177384|3762248|FG001|NOT COMPLETED|Overall Study||26
3042490|NCT01177410|3762257|FG000|STARTED|Overall Study||51
3042491|NCT01177410|3762258|FG001|STARTED|Overall Study||47
3042492|NCT01177410|3762259|FG002|STARTED|Overall Study||50
3042493|NCT01177410|3762257|FG000|COMPLETED|Overall Study||50
3042494|NCT01177410|3762258|FG001|COMPLETED|Overall Study||40
3042495|NCT01177410|3762259|FG002|COMPLETED|Overall Study||45
3042496|NCT01177410|3762257|FG000|NOT COMPLETED|Overall Study||1
3042497|NCT01177410|3762258|FG001|NOT COMPLETED|Overall Study||7
3042498|NCT01177410|3762259|FG002|NOT COMPLETED|Overall Study||5
3042499|NCT01177553|3762269|FG000|STARTED|Overall Study||3
3042500|NCT01177553|3762270|FG001|STARTED|Overall Study||2
3042501|NCT01177553|3762269|FG000|COMPLETED|Overall Study|data as of March 2009|2
3042502|NCT01177553|3762270|FG001|COMPLETED|Overall Study|data as of March 2009|2
3042503|NCT01177553|3762269|FG000|NOT COMPLETED|Overall Study||1
3042504|NCT01177553|3762270|FG001|NOT COMPLETED|Overall Study||0
3042505|NCT01177670|3762276|FG000|STARTED|Overall Study||169
3042506|NCT01177670|3762276|FG000|COMPLETED|Overall Study||0
3042507|NCT01177670|3762276|FG000|NOT COMPLETED|Overall Study||169
3042508|NCT01177709|3762280|FG000|STARTED|Overall Study||12
3042509|NCT01177709|3762280|FG000|COMPLETED|Overall Study||12
3042510|NCT01177709|3762280|FG000|NOT COMPLETED|Overall Study||0
3042511|NCT01177722|3762288|FG000|STARTED|Overall Study|A Batch B participant got Batch A vaccine data analyses was according to actual vaccine administered|344
3042512|NCT01177722|3762289|FG001|STARTED|Overall Study|A randomized participant got Batch A vaccine, analyses was according to actual vaccine administered.|344
3042513|NCT01177722|3762290|FG002|STARTED|Overall Study||342
3042514|NCT01177722|3762291|FG003|STARTED|Overall Study||345
3042515|NCT01177722|3762288|FG000|COMPLETED|Overall Study||331
3042516|NCT01177722|3762289|FG001|COMPLETED|Overall Study||334
3042517|NCT01177722|3762290|FG002|COMPLETED|Overall Study||333
3042518|NCT01177722|3762291|FG003|COMPLETED|Overall Study||338
3042519|NCT01177722|3762288|FG000|NOT COMPLETED|Overall Study||13
3042520|NCT01177722|3762289|FG001|NOT COMPLETED|Overall Study||10
3042521|NCT01177722|3762290|FG002|NOT COMPLETED|Overall Study||9
3042522|NCT01177722|3762291|FG003|NOT COMPLETED|Overall Study||7
3042523|NCT01177735|3762302|FG000|STARTED|Overall Study||71
3042524|NCT01177735|3762302|FG000|COMPLETED|Overall Study||0
3042525|NCT01177735|3762302|FG000|NOT COMPLETED|Overall Study||71
3042526|NCT01177787|3762306|FG000|STARTED|Clinical Efficacy of Cryolipolysis||28
3042527|NCT01177787|3762306|FG000|COMPLETED|Clinical Efficacy of Cryolipolysis||28
3042528|NCT01177787|3762306|FG000|NOT COMPLETED|Clinical Efficacy of Cryolipolysis||0
3042529|NCT01177787|3762306|FG000|STARTED|Cryolipolysis on Thigh||28
3042530|NCT01177787|3762306|FG000|COMPLETED|Cryolipolysis on Thigh||14
3042531|NCT01177787|3762306|FG000|NOT COMPLETED|Cryolipolysis on Thigh||14
3042532|NCT01177800|3762320|FG000|STARTED|Overall Study||84
3042533|NCT01177800|3762321|FG001|STARTED|Overall Study||45
3042534|NCT01177800|3762320|FG000|COMPLETED|Overall Study||74
3042535|NCT01177800|3762321|FG001|COMPLETED|Overall Study||40
3042536|NCT01177800|3762320|FG000|NOT COMPLETED|Overall Study||10
2933622|NCT00603512|3645021|FG003|NOT COMPLETED|Overall Study||7
2933623|NCT00603512|3645022|FG004|NOT COMPLETED|Overall Study||5
2933624|NCT00603525|3645036|FG000|STARTED|DB Treatment Period (24 Weeks)||84
2933625|NCT00603525|3645037|FG001|STARTED|DB Treatment Period (24 Weeks)||85
2933626|NCT00603525|3645038|FG002|STARTED|DB Treatment Period (24 Weeks)||0
2933627|NCT00603525|3645036|FG000|COMPLETED|DB Treatment Period (24 Weeks)||67
2933628|NCT00603525|3645037|FG001|COMPLETED|DB Treatment Period (24 Weeks)||63
2933629|NCT00603525|3645038|FG002|COMPLETED|DB Treatment Period (24 Weeks)||0
2933630|NCT00603525|3645036|FG000|NOT COMPLETED|DB Treatment Period (24 Weeks)||17
2933631|NCT00603525|3645037|FG001|NOT COMPLETED|DB Treatment Period (24 Weeks)||22
2933632|NCT00603525|3645038|FG002|NOT COMPLETED|DB Treatment Period (24 Weeks)||0
2933633|NCT00603525|3645036|FG000|STARTED|OL Treatment Period (120 Weeks)||0
2933634|NCT00603525|3645037|FG001|STARTED|OL Treatment Period (120 Weeks)|61 participants received OFA during the DB Period; 64 received placebo during the DB Period.|125
2933635|NCT00603525|3645038|FG002|STARTED|OL Treatment Period (120 Weeks)||0
2933636|NCT00603525|3645036|FG000|COMPLETED|OL Treatment Period (120 Weeks)||0
2933637|NCT00603525|3645037|FG001|COMPLETED|OL Treatment Period (120 Weeks)||13
2933638|NCT00603525|3645038|FG002|COMPLETED|OL Treatment Period (120 Weeks)||0
2933639|NCT00603525|3645036|FG000|NOT COMPLETED|OL Treatment Period (120 Weeks)||0
2933640|NCT00603525|3645037|FG001|NOT COMPLETED|OL Treatment Period (120 Weeks)||112
2933641|NCT00603525|3645038|FG002|NOT COMPLETED|OL Treatment Period (120 Weeks)||0
2933642|NCT00603525|3645036|FG000|STARTED|Follow-up Period (Approximately 2 Years)||0
2933643|NCT00603525|3645037|FG001|STARTED|Follow-up Period (Approximately 2 Years)||0
2933644|NCT00603525|3645038|FG002|STARTED|Follow-up Period (Approximately 2 Years)|124 participants (par) completing/withdrawing from the DB or OL Periods attended >=1 follow-up visit|124
2933645|NCT00603525|3645036|FG000|Unknown Reason for Withdrawal|Follow-up Period (Approximately 2 Years)||0
2933646|NCT00603525|3645037|FG001|Unknown Reason for Withdrawal|Follow-up Period (Approximately 2 Years)||0
2933647|NCT00603525|3645038|FG002|Unknown Reason for Withdrawal|Follow-up Period (Approximately 2 Years)|As par. were not on active drug during the Follow-up Period, withdrawal reasons were not collected.|111
2933648|NCT00603525|3645036|FG000|COMPLETED|Follow-up Period (Approximately 2 Years)||0
2933649|NCT00603525|3645037|FG001|COMPLETED|Follow-up Period (Approximately 2 Years)||0
2933650|NCT00603525|3645038|FG002|COMPLETED|Follow-up Period (Approximately 2 Years)||13
2933651|NCT00603525|3645036|FG000|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||0
2933652|NCT00603525|3645037|FG001|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||0
2933653|NCT00603525|3645038|FG002|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||111
2933654|NCT00603538|3645052|FG000|STARTED|Overall Study||6
2933655|NCT00603538|3645053|FG001|STARTED|Overall Study|Including one participant who discontinued from the study prior to CP-751,871 administration.|7
2933656|NCT00603538|3645054|FG002|STARTED|Overall Study||6
2933657|NCT00603538|3645052|FG000|COMPLETED|Overall Study||3
2933658|NCT00603538|3645053|FG001|COMPLETED|Overall Study||3
2933659|NCT00603538|3645054|FG002|COMPLETED|Overall Study||4
2933660|NCT00603538|3645052|FG000|NOT COMPLETED|Overall Study||3
2933661|NCT00603538|3645053|FG001|NOT COMPLETED|Overall Study||4
2933662|NCT00603538|3645054|FG002|NOT COMPLETED|Overall Study||2
2933663|NCT00603564|3645067|FG000|STARTED|Overall Study|January 2006|20
2933664|NCT00603564|3645068|FG001|STARTED|Overall Study|January 2006|27
2933665|NCT00603564|3645067|FG000|COMPLETED|Overall Study|February 2008|20
2933666|NCT00603564|3645068|FG001|COMPLETED|Overall Study|February 2008|27
2933667|NCT00603564|3645067|FG000|NOT COMPLETED|Overall Study||0
2933668|NCT00603564|3645068|FG001|NOT COMPLETED|Overall Study||0
2933669|NCT00603590|3645076|FG000|STARTED|Overall Study||241
2933670|NCT00603590|3645077|FG001|STARTED|Overall Study||234
2933671|NCT00603590|3645076|FG000|One Month|Overall Study||204
2933672|NCT00603590|3645077|FG001|One Month|Overall Study||212
2933673|NCT00603590|3645076|FG000|Four Months|Overall Study||187
3042537|NCT01177800|3762321|FG001|NOT COMPLETED|Overall Study||5
3042538|NCT01177813|3762332|FG000|STARTED|Overall Study||228
3042539|NCT01177813|3762333|FG001|STARTED|Overall Study||224
3042540|NCT01177813|3762334|FG002|STARTED|Overall Study||224
3042541|NCT01177813|3762335|FG003|STARTED|Overall Study||223
3042542|NCT01177813|3762336|FG004|STARTED|Overall Study||87
3042543|NCT01177813|3762332|FG000|COMPLETED|Overall Study||187
3042544|NCT01177813|3762333|FG001|COMPLETED|Overall Study||206
3042545|NCT01177813|3762334|FG002|COMPLETED|Overall Study||204
3042546|NCT01177813|3762335|FG003|COMPLETED|Overall Study||206
3042547|NCT01177813|3762336|FG004|COMPLETED|Overall Study||78
3042548|NCT01177813|3762332|FG000|NOT COMPLETED|Overall Study||41
3042549|NCT01177813|3762333|FG001|NOT COMPLETED|Overall Study||18
3042550|NCT01177813|3762334|FG002|NOT COMPLETED|Overall Study||20
3042551|NCT01177813|3762335|FG003|NOT COMPLETED|Overall Study||17
3042552|NCT01177813|3762336|FG004|NOT COMPLETED|Overall Study||9
3042553|NCT01177943|3762350|FG000|STARTED|First Intervention||21
3042554|NCT01177943|3762351|FG001|STARTED|First Intervention||21
3042555|NCT01177943|3762350|FG000|COMPLETED|First Intervention||19
3042556|NCT01177943|3762351|FG001|COMPLETED|First Intervention||21
3042557|NCT01177943|3762350|FG000|NOT COMPLETED|First Intervention||2
3042558|NCT01177943|3762351|FG001|NOT COMPLETED|First Intervention||0
3042559|NCT01177943|3762350|FG000|STARTED|Second Intervention||19
3042560|NCT01177943|3762351|FG001|STARTED|Second Intervention||21
3042561|NCT01177943|3762350|FG000|COMPLETED|Second Intervention||19
3042562|NCT01177943|3762351|FG001|COMPLETED|Second Intervention||21
3042563|NCT01177943|3762350|FG000|NOT COMPLETED|Second Intervention||0
2933674|NCT00603590|3645077|FG001|Four Months|Overall Study||200
2933675|NCT00603590|3645076|FG000|Eight Months|Overall Study||178
2933676|NCT00603590|3645077|FG001|Eight Months|Overall Study||194
2933677|NCT00603590|3645076|FG000|COMPLETED|Overall Study||165
2933678|NCT00603590|3645077|FG001|COMPLETED|Overall Study||183
2933679|NCT00603590|3645076|FG000|NOT COMPLETED|Overall Study||76
2933680|NCT00603590|3645077|FG001|NOT COMPLETED|Overall Study||51
2933681|NCT00603642|3645085|FG000|STARTED|Overall Study||12
2933682|NCT00603642|3645086|FG001|STARTED|Overall Study||22
2933683|NCT00603642|3645085|FG000|COMPLETED|Overall Study||12
2933684|NCT00603642|3645086|FG001|COMPLETED|Overall Study||22
2933685|NCT00603642|3645085|FG000|NOT COMPLETED|Overall Study||0
2933686|NCT00603642|3645086|FG001|NOT COMPLETED|Overall Study||0
2933687|NCT00603720|3645097|FG000|STARTED|Overall Study||10
2933688|NCT00603720|3645098|FG001|STARTED|Overall Study||10
2933689|NCT00603720|3645099|FG002|STARTED|Overall Study||12
2933690|NCT00603720|3645100|FG003|STARTED|Overall Study||10
2933691|NCT00603720|3645101|FG004|STARTED|Overall Study||12
2933692|NCT00603720|3645097|FG000|COMPLETED|Overall Study||10
2933693|NCT00603720|3645098|FG001|COMPLETED|Overall Study||10
2933694|NCT00603720|3645099|FG002|COMPLETED|Overall Study||12
2933695|NCT00603720|3645100|FG003|COMPLETED|Overall Study||10
2933696|NCT00603720|3645101|FG004|COMPLETED|Overall Study||12
2933697|NCT00603720|3645097|FG000|NOT COMPLETED|Overall Study||0
2933698|NCT00603720|3645098|FG001|NOT COMPLETED|Overall Study||0
2933699|NCT00603720|3645099|FG002|NOT COMPLETED|Overall Study||0
2933700|NCT00603720|3645100|FG003|NOT COMPLETED|Overall Study||0
2933701|NCT00603720|3645101|FG004|NOT COMPLETED|Overall Study||0
2933702|NCT00603733|3645115|FG000|STARTED|Active Phase ITT|Note: a total of 190 new participants were enrolled and randomized in the Active Phase|95
2933703|NCT00603733|3645116|FG001|STARTED|Active Phase ITT||95
2933704|NCT00603733|3645115|FG000|COMPLETED|Active Phase ITT||84
2933705|NCT00603733|3645116|FG001|COMPLETED|Active Phase ITT||78
2933706|NCT00603733|3645115|FG000|NOT COMPLETED|Active Phase ITT||11
2933707|NCT00603733|3645116|FG001|NOT COMPLETED|Active Phase ITT||17
2933708|NCT00603733|3645115|FG000|STARTED|Run-In Phase - 4 Weeks|Note: Of the 98 subjects randomized at Run-In, 71 progressed into the maintenance phase.|49
2933709|NCT00603733|3645116|FG001|STARTED|Run-In Phase - 4 Weeks||49
2933710|NCT00603733|3645115|FG000|COMPLETED|Run-In Phase - 4 Weeks||35
2933711|NCT00603733|3645116|FG001|COMPLETED|Run-In Phase - 4 Weeks||36
2933712|NCT00603733|3645115|FG000|NOT COMPLETED|Run-In Phase - 4 Weeks||14
2933713|NCT00603733|3645116|FG001|NOT COMPLETED|Run-In Phase - 4 Weeks||13
2933714|NCT00603733|3645115|FG000|STARTED|Maintenance Phase ITT|Note:82 subjects randomized at Active phase & 71 at Run-In phase progressed to the maintenance phase|71
2933715|NCT00603733|3645116|FG001|STARTED|Maintenance Phase ITT||82
2933716|NCT00603733|3645115|FG000|COMPLETED|Maintenance Phase ITT||61
2933717|NCT00603733|3645116|FG001|COMPLETED|Maintenance Phase ITT||66
2933718|NCT00603733|3645115|FG000|NOT COMPLETED|Maintenance Phase ITT||10
2933719|NCT00603733|3645116|FG001|NOT COMPLETED|Maintenance Phase ITT||16
2933720|NCT00603746|3645128|FG000|STARTED|Overall Study||103
2933721|NCT00603746|3645129|FG001|STARTED|Overall Study||99
2933722|NCT00603746|3645130|FG002|STARTED|Overall Study||101
2933723|NCT00603746|3645131|FG003|STARTED|Overall Study||107
2933724|NCT00603746|3645132|FG004|STARTED|Overall Study||102
2933725|NCT00603746|3645133|FG005|STARTED|Overall Study||110
2933726|NCT00603746|3645128|FG000|COMPLETED|Overall Study||65
2933727|NCT00603746|3645129|FG001|COMPLETED|Overall Study||81
2933728|NCT00603746|3645130|FG002|COMPLETED|Overall Study||93
2933729|NCT00603746|3645131|FG003|COMPLETED|Overall Study||94
2933730|NCT00603746|3645132|FG004|COMPLETED|Overall Study||85
2933731|NCT00603746|3645133|FG005|COMPLETED|Overall Study||97
2933732|NCT00603746|3645128|FG000|NOT COMPLETED|Overall Study||38
2933733|NCT00603746|3645129|FG001|NOT COMPLETED|Overall Study||18
2933734|NCT00603746|3645130|FG002|NOT COMPLETED|Overall Study||8
2933735|NCT00603746|3645131|FG003|NOT COMPLETED|Overall Study||13
2933736|NCT00603746|3645132|FG004|NOT COMPLETED|Overall Study||17
2933737|NCT00603746|3645133|FG005|NOT COMPLETED|Overall Study||13
2933738|NCT00603798|3645150|FG000|STARTED|Overall Study||162
2933739|NCT00603798|3645151|FG001|STARTED|Overall Study||164
2933740|NCT00603798|3645152|FG002|STARTED|Overall Study||164
2933741|NCT00603798|3645150|FG000|COMPLETED|Overall Study||152
2933742|NCT00603798|3645151|FG001|COMPLETED|Overall Study||157
2933743|NCT00603798|3645152|FG002|COMPLETED|Overall Study||154
2933744|NCT00603798|3645150|FG000|NOT COMPLETED|Overall Study||10
3042564|NCT01177943|3762351|FG001|NOT COMPLETED|Second Intervention||0
3042565|NCT01177956|3762357|FG000|STARTED|Overall Study||68
3042566|NCT01177956|3762357|FG000|COMPLETED|Overall Study||68
3042567|NCT01177956|3762357|FG000|NOT COMPLETED|Overall Study||0
3042568|NCT01177969|3762364|FG000|STARTED|Overall Study||19
3042569|NCT01177969|3762365|FG001|STARTED|Overall Study||14
3042570|NCT01177969|3762364|FG000|COMPLETED|Overall Study||16
3042571|NCT01177969|3762365|FG001|COMPLETED|Overall Study||11
3042572|NCT01177969|3762364|FG000|NOT COMPLETED|Overall Study||3
3042573|NCT01177969|3762365|FG001|NOT COMPLETED|Overall Study||3
3042574|NCT01178073|3762374|FG000|STARTED|Overall Study||302
3042575|NCT01178073|3762375|FG001|STARTED|Overall Study||152
3042576|NCT01178073|3762376|FG002|STARTED|Overall Study||151
3042577|NCT01178073|3762374|FG000|COMPLETED|Overall Study||240
3180058|NCT01988103|3908299|FG004|COMPLETED|Observational Follow-up Phase||33
3180059|NCT01988103|3908295|FG000|NOT COMPLETED|Observational Follow-up Phase||0
3042578|NCT01178073|3762375|FG001|COMPLETED|Overall Study||108
3042579|NCT01178073|3762376|FG002|COMPLETED|Overall Study||105
2933745|NCT00603798|3645151|FG001|NOT COMPLETED|Overall Study||7
2933746|NCT00603798|3645152|FG002|NOT COMPLETED|Overall Study||10
2933747|NCT00603837|3645162|FG000|STARTED|Overall Study||20
2933748|NCT00603837|3645163|FG001|STARTED|Overall Study||19
2933749|NCT00603837|3645162|FG000|COMPLETED|Overall Study||17
2933750|NCT00603837|3645163|FG001|COMPLETED|Overall Study||19
2933751|NCT00603837|3645162|FG000|NOT COMPLETED|Overall Study||3
2933752|NCT00603837|3645163|FG001|NOT COMPLETED|Overall Study||0
2933753|NCT00603889|3645169|FG000|STARTED|Overall Study||12
2933754|NCT00603889|3645169|FG000|COMPLETED|Overall Study||12
2933755|NCT00603889|3645169|FG000|NOT COMPLETED|Overall Study||0
2933756|NCT00603902|3645176|FG000|STARTED|Overall Study||802
2933757|NCT00603902|3645177|FG001|STARTED|Overall Study||1603
2933758|NCT00603902|3645178|FG002|STARTED|Overall Study||1603
2933759|NCT00603902|3645176|FG000|COMPLETED|Overall Study||473
3180060|NCT01988103|3908296|FG001|NOT COMPLETED|Observational Follow-up Phase||3
3180061|NCT01988103|3908297|FG002|NOT COMPLETED|Observational Follow-up Phase||1
3180062|NCT01988103|3908298|FG003|NOT COMPLETED|Observational Follow-up Phase||0
2933760|NCT00603902|3645177|FG001|COMPLETED|Overall Study||917
2933761|NCT00603902|3645178|FG002|COMPLETED|Overall Study||834
2933762|NCT00603902|3645176|FG000|NOT COMPLETED|Overall Study||329
2933763|NCT00603902|3645177|FG001|NOT COMPLETED|Overall Study||686
2933764|NCT00603902|3645178|FG002|NOT COMPLETED|Overall Study||769
3042580|NCT01178073|3762374|FG000|NOT COMPLETED|Overall Study||62
3042581|NCT01178073|3762375|FG001|NOT COMPLETED|Overall Study||44
3042582|NCT01178073|3762376|FG002|NOT COMPLETED|Overall Study||46
3042583|NCT01178086|3762387|FG000|STARTED|Overall Study|Safety analysis set: participants who received at least one dose of rituximab.|681
3042584|NCT01178086|3762387|FG000|Effectiveness Analysis Set (EAS)|Overall Study|who received at least 1 dose of rituximab and had data from baseline and at least 1 follow-up visit.|661
3042585|NCT01178086|3762387|FG000|COMPLETED|Overall Study||349
3042586|NCT01178086|3762387|FG000|NOT COMPLETED|Overall Study||332
3042587|NCT01178099|3762397|FG000|STARTED|Overall Study||13
3042588|NCT01178099|3762398|FG001|STARTED|Overall Study||13
3042589|NCT01178099|3762397|FG000|COMPLETED|Overall Study||13
3042590|NCT01178099|3762398|FG001|COMPLETED|Overall Study||12
3042591|NCT01178099|3762397|FG000|NOT COMPLETED|Overall Study||0
3042592|NCT01178099|3762398|FG001|NOT COMPLETED|Overall Study||1
3042593|NCT01178125|3762408|FG000|STARTED|Overall Study|Number enrolled.|2858
3042594|NCT01178125|3762408|FG000|Safety Population|Overall Study|Received at least 1 dose of DR-102.|2765
3042595|NCT01178125|3762408|FG000|Intent to Treat (ITT) Population|Overall Study|Completed at least one 28-day cycle of investigational product.|2607
3042596|NCT01178125|3762408|FG000|Pregnancy ITT (PITT) Population|Overall Study|Participants in the ITT population between the ages of 18 and 35, inclusive.|2401
3042597|NCT01178125|3762408|FG000|COMPLETED|Overall Study||1680
3042598|NCT01178125|3762408|FG000|NOT COMPLETED|Overall Study||1178
3042599|NCT01178138|3762417|FG000|STARTED|Overall Study||24
3042600|NCT01178138|3762417|FG000|Completed 6 Sessions|Overall Study||1
3042601|NCT01178138|3762417|FG000|Completed 5 Sessions|Overall Study||1
3042602|NCT01178138|3762417|FG000|Completed 3 Sessions|Overall Study||1
3042603|NCT01178138|3762417|FG000|COMPLETED|Overall Study||1
3042604|NCT01178138|3762417|FG000|NOT COMPLETED|Overall Study||23
3042605|NCT01178216|3762426|FG000|STARTED|Overall Study||41
3042606|NCT01178216|3762426|FG000|COMPLETED|Overall Study||39
3042607|NCT01178216|3762426|FG000|NOT COMPLETED|Overall Study||2
3042608|NCT01178268|3762432|FG000|STARTED|Overall Study||367
3042609|NCT01178268|3762433|FG001|STARTED|Overall Study||121
3042610|NCT01178268|3762432|FG000|COMPLETED|Overall Study||360
3042611|NCT01178268|3762433|FG001|COMPLETED|Overall Study||120
3042612|NCT01178268|3762432|FG000|NOT COMPLETED|Overall Study||7
3042613|NCT01178268|3762433|FG001|NOT COMPLETED|Overall Study||1
3042614|NCT01178281|3762442|FG000|STARTED|Overall Study||168
3042615|NCT01178281|3762443|FG001|STARTED|Overall Study||84
3042616|NCT01178281|3762444|FG002|STARTED|Overall Study||15
3042617|NCT01178281|3762442|FG000|Received Study Drug|Overall Study||167
3042618|NCT01178281|3762443|FG001|Received Study Drug|Overall Study||83
3042619|NCT01178281|3762444|FG002|Received Study Drug|Overall Study||15
3042620|NCT01178281|3762442|FG000|COMPLETED|Overall Study||168
3042621|NCT01178281|3762443|FG001|COMPLETED|Overall Study||84
3042622|NCT01178281|3762444|FG002|COMPLETED|Overall Study||15
3042623|NCT01178281|3762442|FG000|NOT COMPLETED|Overall Study||0
3042624|NCT01178281|3762443|FG001|NOT COMPLETED|Overall Study||0
3042625|NCT01178281|3762444|FG002|NOT COMPLETED|Overall Study||0
3042626|NCT01178294|3762454|FG000|STARTED|Overall Study|25 subjects enrolled under OBI-1-301 + 4 subjects enrolled under expanded access OBI-1-301a.|29
3042627|NCT01178294|3762454|FG000|COMPLETED|Overall Study||18
3042628|NCT01178294|3762454|FG000|NOT COMPLETED|Overall Study||11
3042629|NCT01178333|3762461|FG000|STARTED|Overall Study||71
3042630|NCT01178333|3762462|FG001|STARTED|Overall Study||284
3042631|NCT01178333|3762463|FG002|STARTED|Overall Study||87
3042632|NCT01178333|3762461|FG000|COMPLETED|Overall Study||71
3042633|NCT01178333|3762462|FG001|COMPLETED|Overall Study||284
3042634|NCT01178333|3762463|FG002|COMPLETED|Overall Study||87
3042635|NCT01178333|3762461|FG000|NOT COMPLETED|Overall Study||0
3042636|NCT01178333|3762462|FG001|NOT COMPLETED|Overall Study||0
3042637|NCT01178333|3762463|FG002|NOT COMPLETED|Overall Study||0
3042638|NCT01178385|3762475|FG000|STARTED|Overall Study||24
3042639|NCT01178385|3762476|FG001|STARTED|Overall Study||21
3042640|NCT01178385|3762475|FG000|COMPLETED|Overall Study||22
3042641|NCT01178385|3762476|FG001|COMPLETED|Overall Study||21
3042642|NCT01178385|3762475|FG000|NOT COMPLETED|Overall Study||2
2933765|NCT00603915|3645186|FG000|STARTED|Overall Study||20
2933766|NCT00603915|3645186|FG000|COMPLETED|Overall Study||19
2933767|NCT00603915|3645186|FG000|NOT COMPLETED|Overall Study||1
2933768|NCT00603941|3645193|FG000|STARTED|Overall Study||7
2933769|NCT00603941|3645194|FG001|STARTED|Overall Study||10
2933770|NCT00603941|3645195|FG002|STARTED|Overall Study||2
2933771|NCT00603941|3645193|FG000|COMPLETED|Overall Study||0
2933772|NCT00603941|3645194|FG001|COMPLETED|Overall Study||0
2933773|NCT00603941|3645195|FG002|COMPLETED|Overall Study||0
2933774|NCT00603941|3645193|FG000|NOT COMPLETED|Overall Study||7
2933775|NCT00603941|3645194|FG001|NOT COMPLETED|Overall Study||10
2933776|NCT00603941|3645195|FG002|NOT COMPLETED|Overall Study||2
2933777|NCT00603980|3645204|FG000|STARTED|Study Qualification||31
2933778|NCT00603980|3645204|FG000|COMPLETED|Study Qualification||15
2933779|NCT00603980|3645204|FG000|NOT COMPLETED|Study Qualification||16
2933780|NCT00603980|3645204|FG000|STARTED|Main Study||15
2933781|NCT00603980|3645204|FG000|COMPLETED|Main Study||14
2933782|NCT00603980|3645204|FG000|NOT COMPLETED|Main Study||1
2933783|NCT00603993|3645224|FG000|STARTED|Overall Study||88
2933784|NCT00603993|3645224|FG000|COMPLETED|Overall Study||68
2933785|NCT00603993|3645224|FG000|NOT COMPLETED|Overall Study||20
2933786|NCT00604019|3645230|FG000|STARTED|Overall Study||134
2933787|NCT00604019|3645231|FG001|STARTED|Overall Study||118
2933788|NCT00604019|3645230|FG000|COMPLETED|Overall Study||134
2933789|NCT00604019|3645231|FG001|COMPLETED|Overall Study||118
2933790|NCT00604019|3645230|FG000|NOT COMPLETED|Overall Study||0
2933791|NCT00604019|3645231|FG001|NOT COMPLETED|Overall Study||0
2933792|NCT00604045|3645239|FG000|STARTED|Overall Study||15
2933793|NCT00604045|3645240|FG001|STARTED|Overall Study||10
2933794|NCT00604045|3645239|FG000|COMPLETED|Overall Study||14
2933795|NCT00604045|3645240|FG001|COMPLETED|Overall Study||9
2933796|NCT00604045|3645239|FG000|NOT COMPLETED|Overall Study||1
2933797|NCT00604045|3645240|FG001|NOT COMPLETED|Overall Study||1
2933798|NCT00604162|3645246|FG000|STARTED|Overall Study||332
2933799|NCT00604162|3645246|FG000|COMPLETED|Overall Study||328
2933800|NCT00604162|3645246|FG000|NOT COMPLETED|Overall Study||4
2933801|NCT00604175|3645256|FG000|STARTED|Entry Through Week 28||130
2933802|NCT00604175|3645257|FG001|STARTED|Entry Through Week 28||95
2933803|NCT00604175|3645258|FG002|STARTED|Entry Through Week 28||94
2933804|NCT00604175|3645256|FG000|COMPLETED|Entry Through Week 28|Completed 28 weeks of the study (the primary endpoint time point).|120
2933805|NCT00604175|3645257|FG001|COMPLETED|Entry Through Week 28|Completed 28 weeks of the study (the primary endpoint time point).|92
2933806|NCT00604175|3645258|FG002|COMPLETED|Entry Through Week 28|Completed 28 weeks of the study (the primary endpoint time point).|93
2933807|NCT00604175|3645256|FG000|NOT COMPLETED|Entry Through Week 28||10
2933808|NCT00604175|3645257|FG001|NOT COMPLETED|Entry Through Week 28||3
2933809|NCT00604175|3645258|FG002|NOT COMPLETED|Entry Through Week 28||1
2933810|NCT00604175|3645256|FG000|STARTED|Week 29 Through Week 72||120
2933811|NCT00604175|3645257|FG001|STARTED|Week 29 Through Week 72||92
2933812|NCT00604175|3645258|FG002|STARTED|Week 29 Through Week 72||93
2933813|NCT00604175|3645256|FG000|COMPLETED|Week 29 Through Week 72||108
2933814|NCT00604175|3645257|FG001|COMPLETED|Week 29 Through Week 72||85
2933815|NCT00604175|3645258|FG002|COMPLETED|Week 29 Through Week 72||89
2933816|NCT00604175|3645256|FG000|NOT COMPLETED|Week 29 Through Week 72||12
2933817|NCT00604175|3645257|FG001|NOT COMPLETED|Week 29 Through Week 72||7
2933818|NCT00604175|3645258|FG002|NOT COMPLETED|Week 29 Through Week 72||4
2933819|NCT00604188|3645292|FG000|STARTED|Overall Study||93
2933820|NCT00604188|3645293|FG001|STARTED|Overall Study|The ITT population for Subutex-to-Suboxone Induction is 94 participants|95
2933821|NCT00604188|3645292|FG000|COMPLETED|Overall Study||66
3042643|NCT01178385|3762476|FG001|NOT COMPLETED|Overall Study||0
3042644|NCT01178411|3762482|FG000|STARTED|Overall Study||60
3042645|NCT01178411|3762482|FG000|COMPLETED|Overall Study||0
3042646|NCT01178411|3762482|FG000|NOT COMPLETED|Overall Study||60
3042647|NCT01178528|3762489|FG000|STARTED|Overall Study||41
3042648|NCT01178528|3762490|FG001|STARTED|Overall Study||38
3042649|NCT01178528|3762491|FG002|STARTED|Overall Study||42
3042650|NCT01178528|3762489|FG000|COMPLETED|Overall Study||41
3042651|NCT01178528|3762490|FG001|COMPLETED|Overall Study||38
3042652|NCT01178528|3762491|FG002|COMPLETED|Overall Study||42
3042653|NCT01178528|3762489|FG000|NOT COMPLETED|Overall Study||0
3042654|NCT01178528|3762490|FG001|NOT COMPLETED|Overall Study||0
3042655|NCT01178528|3762491|FG002|NOT COMPLETED|Overall Study||0
3042656|NCT01178671|3762502|FG000|STARTED|Overall Study||18
3042657|NCT01178671|3762503|FG001|STARTED|Overall Study||18
3042658|NCT01178671|3762502|FG000|COMPLETED|Overall Study||6
3042659|NCT01178671|3762503|FG001|COMPLETED|Overall Study||3
3042660|NCT01178671|3762502|FG000|NOT COMPLETED|Overall Study||12
3180063|NCT01988103|3908299|FG004|NOT COMPLETED|Observational Follow-up Phase||0
3180064|NCT01988129|3908316|FG000|STARTED|Overall Study|Intervention participant data obtained from department. Individuals not enrolled for primary aim.|601
3180065|NCT01988129|3908317|FG001|STARTED|Overall Study|Control participant data obtained from department. Individuals were not enrolled.|588
3180066|NCT01988129|3908316|FG000|Attended Education Session|Overall Study||542
3180067|NCT01988129|3908317|FG001|Attended Education Session|Overall Study||18
3042661|NCT01178671|3762503|FG001|NOT COMPLETED|Overall Study||15
3042662|NCT01178762|3762509|FG000|STARTED|Overall Study||42
3042663|NCT01178762|3762509|FG000|COMPLETED|Overall Study||27
3042664|NCT01178762|3762509|FG000|NOT COMPLETED|Overall Study||15
3042665|NCT01178827|3762516|FG000|STARTED|Overall Study||6
3042666|NCT01178827|3762517|FG001|STARTED|Overall Study||10
2933822|NCT00604188|3645293|FG001|COMPLETED|Overall Study||70
2933823|NCT00604188|3645292|FG000|NOT COMPLETED|Overall Study||27
2933824|NCT00604188|3645293|FG001|NOT COMPLETED|Overall Study||25
2933825|NCT00604214|3645301|FG000|STARTED|Baseline to Day 28||851
2933826|NCT00604214|3645302|FG001|STARTED|Baseline to Day 28||845
2933827|NCT00604214|3645301|FG000|Received Study Drug|Baseline to Day 28||833
2933828|NCT00604214|3645302|FG001|Received Study Drug|Baseline to Day 28||833
2933829|NCT00604214|3645301|FG000|COMPLETED|Baseline to Day 28||623
2933830|NCT00604214|3645302|FG001|COMPLETED|Baseline to Day 28||632
2933831|NCT00604214|3645301|FG000|NOT COMPLETED|Baseline to Day 28||228
2933832|NCT00604214|3645302|FG001|NOT COMPLETED|Baseline to Day 28||213
2933833|NCT00604214|3645301|FG000|STARTED|Day 29 to Day 90||623
2933834|NCT00604214|3645302|FG001|STARTED|Day 29 to Day 90||632
2933835|NCT00604214|3645301|FG000|COMPLETED|Day 29 to Day 90||555
2933836|NCT00604214|3645302|FG001|COMPLETED|Day 29 to Day 90||553
2933837|NCT00604214|3645301|FG000|NOT COMPLETED|Day 29 to Day 90||68
2933838|NCT00604214|3645302|FG001|NOT COMPLETED|Day 29 to Day 90||79
2933839|NCT00604214|3645301|FG000|STARTED|Day 91 to Day 180||555
2933840|NCT00604214|3645302|FG001|STARTED|Day 91 to Day 180||553
2933841|NCT00604214|3645301|FG000|COMPLETED|Day 91 to Day 180||529
2933842|NCT00604214|3645302|FG001|COMPLETED|Day 91 to Day 180||521
2933843|NCT00604214|3645301|FG000|NOT COMPLETED|Day 91 to Day 180||26
2933844|NCT00604214|3645302|FG001|NOT COMPLETED|Day 91 to Day 180||32
2933845|NCT00604279|3645310|FG000|STARTED|Overall Study||229
2933846|NCT00604279|3645311|FG001|STARTED|Overall Study||223
2933847|NCT00604279|3645310|FG000|COMPLETED|Overall Study||165
2933848|NCT00604279|3645311|FG001|COMPLETED|Overall Study||185
2933849|NCT00604279|3645310|FG000|NOT COMPLETED|Overall Study||64
2933850|NCT00604279|3645311|FG001|NOT COMPLETED|Overall Study||38
2933851|NCT00604383|3645319|FG000|STARTED|Overall Study||345
2933852|NCT00604383|3645320|FG001|STARTED|Overall Study||340
2933853|NCT00604383|3645319|FG000|Received at Least 1 Dose of Study Drug|Overall Study||345
2933854|NCT00604383|3645320|FG001|Received at Least 1 Dose of Study Drug|Overall Study||340
2933855|NCT00604383|3645319|FG000|Received Extended Treatment|Overall Study||136
2933856|NCT00604383|3645320|FG001|Received Extended Treatment|Overall Study||141
2933857|NCT00604383|3645319|FG000|COMPLETED|Overall Study||258
2933858|NCT00604383|3645320|FG001|COMPLETED|Overall Study||256
2933859|NCT00604383|3645319|FG000|NOT COMPLETED|Overall Study||87
2933860|NCT00604383|3645320|FG001|NOT COMPLETED|Overall Study||84
2933861|NCT00604461|3645326|FG000|STARTED|Overall Study||13
2933862|NCT00604461|3645326|FG000|COMPLETED|Overall Study|Death within 30 days of treatment occurred in 1 patient.|12
2933863|NCT00604461|3645326|FG000|NOT COMPLETED|Overall Study||1
2933864|NCT00604552|3645332|FG000|STARTED|Overall Study||189
2933865|NCT00604552|3645333|FG001|STARTED|Overall Study||160
2933866|NCT00604552|3645332|FG000|COMPLETED|Overall Study||189
2933867|NCT00604552|3645333|FG001|COMPLETED|Overall Study||160
2933868|NCT00604552|3645332|FG000|NOT COMPLETED|Overall Study||0
2933869|NCT00604552|3645333|FG001|NOT COMPLETED|Overall Study||0
2933870|NCT00604565|3645343|FG000|STARTED|Overall Study||4
3042667|NCT01178827|3762518|FG002|STARTED|Overall Study||4
3042668|NCT01178827|3762516|FG000|COMPLETED|Overall Study||6
3042669|NCT01178827|3762517|FG001|COMPLETED|Overall Study||10
3042670|NCT01178827|3762518|FG002|COMPLETED|Overall Study||4
3042671|NCT01178827|3762516|FG000|NOT COMPLETED|Overall Study||0
3042672|NCT01178827|3762517|FG001|NOT COMPLETED|Overall Study||0
3042673|NCT01178827|3762518|FG002|NOT COMPLETED|Overall Study||0
3042674|NCT01178853|3762528|FG000|STARTED|Period 1 (Warfarin Titration)||24
3042675|NCT01178853|3762529|FG001|STARTED|Period 1 (Warfarin Titration)||24
3042676|NCT01178853|3762528|FG000|COMPLETED|Period 1 (Warfarin Titration)||23
3042677|NCT01178853|3762529|FG001|COMPLETED|Period 1 (Warfarin Titration)||22
3042678|NCT01178853|3762528|FG000|NOT COMPLETED|Period 1 (Warfarin Titration)||1
3042679|NCT01178853|3762529|FG001|NOT COMPLETED|Period 1 (Warfarin Titration)||2
3042680|NCT01178853|3762528|FG000|STARTED|Period 2 (Warfarin + Study Drug)||23
3042681|NCT01178853|3762529|FG001|STARTED|Period 2 (Warfarin + Study Drug)||22
3042682|NCT01178853|3762528|FG000|COMPLETED|Period 2 (Warfarin + Study Drug)||22
3042683|NCT01178853|3762529|FG001|COMPLETED|Period 2 (Warfarin + Study Drug)||22
3042684|NCT01178853|3762528|FG000|NOT COMPLETED|Period 2 (Warfarin + Study Drug)||1
3042685|NCT01178853|3762529|FG001|NOT COMPLETED|Period 2 (Warfarin + Study Drug)||0
3042686|NCT01178853|3762528|FG000|STARTED|Period 3 (Warfarin Titration)||22
3042687|NCT01178853|3762529|FG001|STARTED|Period 3 (Warfarin Titration)||22
3042688|NCT01178853|3762528|FG000|COMPLETED|Period 3 (Warfarin Titration)||21
3042689|NCT01178853|3762529|FG001|COMPLETED|Period 3 (Warfarin Titration)||22
3042690|NCT01178853|3762528|FG000|NOT COMPLETED|Period 3 (Warfarin Titration)||1
3042691|NCT01178853|3762529|FG001|NOT COMPLETED|Period 3 (Warfarin Titration)||0
3042692|NCT01178853|3762528|FG000|STARTED|Period 4 (Warfarin + Study Drug)||21
3042693|NCT01178853|3762529|FG001|STARTED|Period 4 (Warfarin + Study Drug)||22
3042694|NCT01178853|3762528|FG000|COMPLETED|Period 4 (Warfarin + Study Drug)||21
3042695|NCT01178853|3762529|FG001|COMPLETED|Period 4 (Warfarin + Study Drug)||19
3042696|NCT01178853|3762528|FG000|NOT COMPLETED|Period 4 (Warfarin + Study Drug)||0
3042697|NCT01178853|3762529|FG001|NOT COMPLETED|Period 4 (Warfarin + Study Drug)||3
3042698|NCT01178944|3762535|FG000|STARTED|Overall Study||35
3042699|NCT01178944|3762535|FG000|COMPLETED|Overall Study||35
3042700|NCT01178944|3762535|FG000|NOT COMPLETED|Overall Study||0
3042701|NCT01179048|3762541|FG000|STARTED|Overall Study||4668
3042702|NCT01179048|3762542|FG001|STARTED|Overall Study||4672
3042703|NCT01179048|3762541|FG000|COMPLETED|Overall Study||4529
2933871|NCT00604565|3645344|FG001|STARTED|Overall Study||7
2933872|NCT00604565|3645343|FG000|COMPLETED|Overall Study||4
2933873|NCT00604565|3645344|FG001|COMPLETED|Overall Study||4
2933874|NCT00604565|3645343|FG000|NOT COMPLETED|Overall Study||0
2933875|NCT00604565|3645344|FG001|NOT COMPLETED|Overall Study||3
2933876|NCT00604669|3645350|FG000|STARTED|Overall Study||170
2933877|NCT00604669|3645350|FG000|COMPLETED|Overall Study||163
2933878|NCT00604669|3645350|FG000|NOT COMPLETED|Overall Study||7
2933879|NCT00604695|3645356|FG000|STARTED|Overall Study||20
2933880|NCT00604695|3645357|FG001|STARTED|Overall Study||20
2933881|NCT00604695|3645356|FG000|COMPLETED|Overall Study||20
2933882|NCT00604695|3645357|FG001|COMPLETED|Overall Study||16
2933883|NCT00604695|3645356|FG000|NOT COMPLETED|Overall Study||0
2933884|NCT00604695|3645357|FG001|NOT COMPLETED|Overall Study||4
2933885|NCT00604708|3645365|FG000|STARTED|Overall Study||430
2933886|NCT00604708|3645366|FG001|STARTED|Overall Study||437
2933887|NCT00604708|3645365|FG000|COMPLETED|Overall Study||399
2933888|NCT00604708|3645366|FG001|COMPLETED|Overall Study||397
2933889|NCT00604708|3645365|FG000|NOT COMPLETED|Overall Study||31
2933890|NCT00604708|3645366|FG001|NOT COMPLETED|Overall Study||40
2933891|NCT00604721|3645372|FG000|STARTED|Overall Study||19
2933892|NCT00604721|3645372|FG000|COMPLETED|Overall Study|2 patients failed to complete a full cycle of therapy.|17
2933893|NCT00604721|3645372|FG000|NOT COMPLETED|Overall Study||2
2933894|NCT00604786|3645379|FG000|STARTED|Overall Study||14
2933895|NCT00604786|3645380|FG001|STARTED|Overall Study||4
2933896|NCT00604786|3645379|FG000|COMPLETED|Overall Study||12
2933897|NCT00604786|3645380|FG001|COMPLETED|Overall Study||4
2933898|NCT00604786|3645379|FG000|NOT COMPLETED|Overall Study||2
2933899|NCT00604786|3645380|FG001|NOT COMPLETED|Overall Study||0
2933900|NCT00604825|3645390|FG000|STARTED|Overall Study||90
2933901|NCT00604825|3645391|FG001|STARTED|Overall Study||87
2933902|NCT00604825|3645392|FG002|STARTED|Overall Study||89
2933903|NCT00604825|3645393|FG003|STARTED|Overall Study||90
2933904|NCT00604825|3645390|FG000|COMPLETED|Overall Study||81
2933905|NCT00604825|3645391|FG001|COMPLETED|Overall Study||72
2933906|NCT00604825|3645392|FG002|COMPLETED|Overall Study||73
2933907|NCT00604825|3645393|FG003|COMPLETED|Overall Study||79
2933908|NCT00604825|3645390|FG000|NOT COMPLETED|Overall Study||9
2933909|NCT00604825|3645391|FG001|NOT COMPLETED|Overall Study||15
2933910|NCT00604825|3645392|FG002|NOT COMPLETED|Overall Study||16
2933911|NCT00604825|3645393|FG003|NOT COMPLETED|Overall Study||11
2933912|NCT00604890|3645407|FG000|STARTED|Overall Study||47
2933913|NCT00604890|3645408|FG001|STARTED|Overall Study||45
2933914|NCT00604890|3645409|FG002|STARTED|Overall Study||48
2933915|NCT00604890|3645410|FG003|STARTED|Overall Study||46
2933916|NCT00604890|3645407|FG000|COMPLETED|Overall Study||44
2933917|NCT00604890|3645408|FG001|COMPLETED|Overall Study||45
2933918|NCT00604890|3645409|FG002|COMPLETED|Overall Study||47
2933919|NCT00604890|3645410|FG003|COMPLETED|Overall Study||42
2933920|NCT00604890|3645407|FG000|NOT COMPLETED|Overall Study||3
2933921|NCT00604890|3645408|FG001|NOT COMPLETED|Overall Study||0
2933922|NCT00604890|3645409|FG002|NOT COMPLETED|Overall Study||1
2933923|NCT00604890|3645410|FG003|NOT COMPLETED|Overall Study||4
2933924|NCT00604968|3645421|FG000|STARTED|Overall Study||25
2933925|NCT00604968|3645421|FG000|COMPLETED|Overall Study|Due to the nature of study, all subjects receiving drug were considered to have completed.|25
2933926|NCT00604968|3645421|FG000|NOT COMPLETED|Overall Study||0
2933927|NCT00605033|3645427|FG000|STARTED|Overall Study||143
2933928|NCT00605033|3645428|FG001|STARTED|Overall Study|One participant was randomized but withdrew before taking any study medication (treated n=97).|98
2933929|NCT00605033|3645427|FG000|COMPLETED|Overall Study||136
2933930|NCT00605033|3645428|FG001|COMPLETED|Overall Study||90
2933931|NCT00605033|3645427|FG000|NOT COMPLETED|Overall Study||7
2933932|NCT00605033|3645428|FG001|NOT COMPLETED|Overall Study||8
2933933|NCT00605072|3645437|FG000|STARTED|Overall Study||18
2933934|NCT00605072|3645438|FG001|STARTED|Overall Study||20
3042704|NCT01179048|3762542|FG001|COMPLETED|Overall Study||4513
3042705|NCT01179048|3762541|FG000|NOT COMPLETED|Overall Study||139
3042706|NCT01179048|3762542|FG001|NOT COMPLETED|Overall Study||159
3042707|NCT01179113|3762550|FG000|STARTED|Overall Study||17
3042708|NCT01179113|3762551|FG001|STARTED|Overall Study||16
3042709|NCT01179113|3762550|FG000|COMPLETED|Overall Study||17
3042710|NCT01179113|3762551|FG001|COMPLETED|Overall Study||16
3042711|NCT01179113|3762550|FG000|NOT COMPLETED|Overall Study||0
3042712|NCT01179113|3762551|FG001|NOT COMPLETED|Overall Study||0
3042713|NCT01179191|3762557|FG000|STARTED|Titration Phase (up to 6 Weeks)||684
3042714|NCT01179191|3762557|FG000|COMPLETED|Titration Phase (up to 6 Weeks)||351
3042715|NCT01179191|3762557|FG000|NOT COMPLETED|Titration Phase (up to 6 Weeks)||333
3042716|NCT01179191|3762557|FG000|STARTED|Maintenance Phase (8 Weeks)||351
3042717|NCT01179191|3762557|FG000|COMPLETED|Maintenance Phase (8 Weeks)||234
3042718|NCT01179191|3762557|FG000|NOT COMPLETED|Maintenance Phase (8 Weeks)||117
3042719|NCT01179217|3762563|FG000|STARTED|Overall Study||152
3042720|NCT01179217|3762564|FG001|STARTED|Overall Study||78
3042721|NCT01179217|3762563|FG000|COMPLETED|Overall Study||97
3042722|NCT01179217|3762564|FG001|COMPLETED|Overall Study||59
3042723|NCT01179217|3762563|FG000|NOT COMPLETED|Overall Study||55
3042724|NCT01179217|3762564|FG001|NOT COMPLETED|Overall Study||19
3042725|NCT01179334|3762574|FG000|STARTED|Treatment Period||12
3042726|NCT01179334|3762575|FG001|STARTED|Treatment Period||6
3042727|NCT01179334|3762574|FG000|Participants Received Treatment|Treatment Period||12
3042728|NCT01179334|3762575|FG001|Participants Received Treatment|Treatment Period||6
2933935|NCT00605072|3645439|FG002|STARTED|Overall Study||15
2933936|NCT00605072|3645437|FG000|COMPLETED|Overall Study||11
2933937|NCT00605072|3645438|FG001|COMPLETED|Overall Study||9
2933938|NCT00605072|3645439|FG002|COMPLETED|Overall Study||11
2933939|NCT00605072|3645437|FG000|NOT COMPLETED|Overall Study||7
2933940|NCT00605072|3645438|FG001|NOT COMPLETED|Overall Study||11
2933941|NCT00605072|3645439|FG002|NOT COMPLETED|Overall Study||4
2933942|NCT00605085|3645449|FG000|STARTED|Overall Study||2012
2933943|NCT00605085|3645450|FG001|STARTED|Overall Study||663
2933944|NCT00605085|3645449|FG000|COMPLETED|Overall Study||1962
2933945|NCT00605085|3645450|FG001|COMPLETED|Overall Study||638
2933946|NCT00605085|3645449|FG000|NOT COMPLETED|Overall Study||50
2933947|NCT00605085|3645450|FG001|NOT COMPLETED|Overall Study||25
2933948|NCT00605150|3645456|FG000|STARTED|Overall Study|11 started|11
2933949|NCT00605150|3645456|FG000|COMPLETED|Overall Study||10
2933950|NCT00605150|3645456|FG000|NOT COMPLETED|Overall Study||1
2933951|NCT00605176|3645463|FG000|STARTED|Overall Study||160
2933952|NCT00605176|3645464|FG001|STARTED|Overall Study||160
2933953|NCT00605176|3645465|FG002|STARTED|Overall Study||159
2933954|NCT00605176|3645463|FG000|COMPLETED|Overall Study||149
2933955|NCT00605176|3645464|FG001|COMPLETED|Overall Study||154
2933956|NCT00605176|3645465|FG002|COMPLETED|Overall Study||150
2933957|NCT00605176|3645463|FG000|NOT COMPLETED|Overall Study||11
2933958|NCT00605176|3645464|FG001|NOT COMPLETED|Overall Study||6
2933959|NCT00605176|3645465|FG002|NOT COMPLETED|Overall Study||9
2933960|NCT00605189|3645476|FG000|STARTED|Overall Study||20
2933961|NCT00605189|3645477|FG001|STARTED|Overall Study||21
2933962|NCT00605189|3645478|FG002|STARTED|Overall Study||9
2933963|NCT00605189|3645476|FG000|COMPLETED|Overall Study||17
2933964|NCT00605189|3645477|FG001|COMPLETED|Overall Study||19
2933965|NCT00605189|3645478|FG002|COMPLETED|Overall Study||9
2933966|NCT00605189|3645476|FG000|NOT COMPLETED|Overall Study||3
2933967|NCT00605189|3645477|FG001|NOT COMPLETED|Overall Study||2
2933968|NCT00605189|3645478|FG002|NOT COMPLETED|Overall Study||0
2933969|NCT00605202|3645486|FG000|STARTED|First Intervention||5
2933970|NCT00605202|3645487|FG001|STARTED|First Intervention||5
2933971|NCT00605202|3645486|FG000|COMPLETED|First Intervention||5
2933972|NCT00605202|3645487|FG001|COMPLETED|First Intervention||5
2933973|NCT00605202|3645486|FG000|NOT COMPLETED|First Intervention||0
2933974|NCT00605202|3645487|FG001|NOT COMPLETED|First Intervention||0
2933975|NCT00605202|3645486|FG000|STARTED|Washout Period of 3 Weeks||5
2933976|NCT00605202|3645487|FG001|STARTED|Washout Period of 3 Weeks||5
2933977|NCT00605202|3645486|FG000|COMPLETED|Washout Period of 3 Weeks||5
2933978|NCT00605202|3645487|FG001|COMPLETED|Washout Period of 3 Weeks||5
2933979|NCT00605202|3645486|FG000|NOT COMPLETED|Washout Period of 3 Weeks||0
2933980|NCT00605202|3645487|FG001|NOT COMPLETED|Washout Period of 3 Weeks||0
2933981|NCT00605202|3645486|FG000|STARTED|Second Intervention||5
2933982|NCT00605202|3645487|FG001|STARTED|Second Intervention||5
2933983|NCT00605202|3645486|FG000|COMPLETED|Second Intervention||5
2933984|NCT00605202|3645487|FG001|COMPLETED|Second Intervention||5
2933985|NCT00605202|3645486|FG000|NOT COMPLETED|Second Intervention||0
3042729|NCT01179334|3762574|FG000|COMPLETED|Treatment Period||11
3042730|NCT01179334|3762575|FG001|COMPLETED|Treatment Period||6
3042731|NCT01179334|3762574|FG000|NOT COMPLETED|Treatment Period||1
3042732|NCT01179334|3762575|FG001|NOT COMPLETED|Treatment Period||0
3042733|NCT01179334|3762574|FG000|STARTED|Long-term Extension (LTE) Period||11
3042734|NCT01179334|3762575|FG001|STARTED|Long-term Extension (LTE) Period||6
3042735|NCT01179334|3762574|FG000|COMPLETED|Long-term Extension (LTE) Period|LTE phase was terminated by sponsor|0
3042736|NCT01179334|3762575|FG001|COMPLETED|Long-term Extension (LTE) Period|LTE phase was terminated by sponsor|0
3042737|NCT01179334|3762574|FG000|NOT COMPLETED|Long-term Extension (LTE) Period||11
3042738|NCT01179334|3762575|FG001|NOT COMPLETED|Long-term Extension (LTE) Period||6
3042739|NCT01179347|3762583|FG000|STARTED|Double-blind Period (12 Weeks)|Entered and treated in double-blind period.|155
3042740|NCT01179347|3762584|FG001|STARTED|Double-blind Period (12 Weeks)|Entered and treated in double-blind period.|308
3042741|NCT01179347|3762583|FG000|COMPLETED|Double-blind Period (12 Weeks)|Completed double-blind period.|147
3042742|NCT01179347|3762584|FG001|COMPLETED|Double-blind Period (12 Weeks)|Completed double-blind period.|294
3042743|NCT01179347|3762583|FG000|NOT COMPLETED|Double-blind Period (12 Weeks)||8
3042744|NCT01179347|3762584|FG001|NOT COMPLETED|Double-blind Period (12 Weeks)||14
3042745|NCT01179347|3762583|FG000|STARTED|Open-label Period (12 Weeks)|Treated in open-label period.|147
3042746|NCT01179347|3762584|FG001|STARTED|Open-label Period (12 Weeks)|Treated in open-label period.|294
3042747|NCT01179347|3762583|FG000|COMPLETED|Open-label Period (12 Weeks)|Completed open-label period.|132
3042748|NCT01179347|3762584|FG001|COMPLETED|Open-label Period (12 Weeks)|Completed open-label period.|278
3042749|NCT01179347|3762583|FG000|NOT COMPLETED|Open-label Period (12 Weeks)||15
3042750|NCT01179347|3762584|FG001|NOT COMPLETED|Open-label Period (12 Weeks)||16
3042751|NCT01179477|3762592|FG000|STARTED|Overall Study||1930
3042752|NCT01179477|3762592|FG000|COMPLETED|Overall Study||843
3042753|NCT01179477|3762592|FG000|NOT COMPLETED|Overall Study||1087
3042754|NCT01179490|3762596|FG000|STARTED|Overall Study||5
3042755|NCT01179490|3762596|FG000|COMPLETED|Overall Study||5
3042756|NCT01179490|3762596|FG000|NOT COMPLETED|Overall Study||0
3042757|NCT01179516|3762603|FG000|STARTED|Overall Study||160
3042758|NCT01179516|3762604|FG001|STARTED|Overall Study||157
2933986|NCT00605202|3645487|FG001|NOT COMPLETED|Second Intervention||0
2933987|NCT00605267|3645495|FG000|STARTED|Overall Study||98
2933988|NCT00605267|3645496|FG001|STARTED|Overall Study||99
2933989|NCT00605267|3645495|FG000|COMPLETED|Overall Study|Breast surgery performed|95
2933990|NCT00605267|3645496|FG001|COMPLETED|Overall Study|Breast surgery performed|90
2933991|NCT00605267|3645495|FG000|NOT COMPLETED|Overall Study||3
2933992|NCT00605267|3645496|FG001|NOT COMPLETED|Overall Study||9
2933993|NCT00605280|3645506|FG000|STARTED|Year 1||145
2933994|NCT00605280|3645507|FG001|STARTED|Year 1||22
2933995|NCT00605280|3645508|FG002|STARTED|Year 1||7
2933996|NCT00605280|3645509|FG003|STARTED|Year 1||143
2933997|NCT00605280|3645506|FG000|Received 0.3 mg Treatment|Year 1||144
2933998|NCT00605280|3645507|FG001|Received 0.3 mg Treatment|Year 1||13
2933999|NCT00605280|3645508|FG002|Received 0.3 mg Treatment|Year 1||3
2934000|NCT00605280|3645509|FG003|Received 0.3 mg Treatment|Year 1||0
2934001|NCT00605280|3645506|FG000|COMPLETED|Year 1||126
2934002|NCT00605280|3645507|FG001|COMPLETED|Year 1||11
2934003|NCT00605280|3645508|FG002|COMPLETED|Year 1||6
2934004|NCT00605280|3645509|FG003|COMPLETED|Year 1||124
2934005|NCT00605280|3645506|FG000|NOT COMPLETED|Year 1||19
2934006|NCT00605280|3645507|FG001|NOT COMPLETED|Year 1||11
2934007|NCT00605280|3645508|FG002|NOT COMPLETED|Year 1||1
2934008|NCT00605280|3645509|FG003|NOT COMPLETED|Year 1||19
2934009|NCT00605280|3645506|FG000|STARTED|Year 2||126
2934010|NCT00605280|3645507|FG001|STARTED|Year 2||11
2934011|NCT00605280|3645508|FG002|STARTED|Year 2||6
2934012|NCT00605280|3645509|FG003|STARTED|Year 2||124
2934013|NCT00605280|3645506|FG000|Received 0.3 mg Treatment|Year 2||126
2934014|NCT00605280|3645507|FG001|Received 0.3 mg Treatment|Year 2||3
2934015|NCT00605280|3645508|FG002|Received 0.3 mg Treatment|Year 2||2
2934016|NCT00605280|3645509|FG003|Received 0.3 mg Treatment|Year 2||0
2934017|NCT00605280|3645506|FG000|COMPLETED|Year 2||102
2934018|NCT00605280|3645507|FG001|COMPLETED|Year 2||5
2934019|NCT00605280|3645508|FG002|COMPLETED|Year 2||0
2934020|NCT00605280|3645509|FG003|COMPLETED|Year 2||102
2934021|NCT00605280|3645506|FG000|NOT COMPLETED|Year 2||24
2934022|NCT00605280|3645507|FG001|NOT COMPLETED|Year 2||6
2934023|NCT00605280|3645508|FG002|NOT COMPLETED|Year 2||6
2934024|NCT00605280|3645509|FG003|NOT COMPLETED|Year 2||22
2934025|NCT00605280|3645506|FG000|STARTED|Year 3 Extension||46
2934026|NCT00605280|3645507|FG001|STARTED|Year 3 Extension||0
2934027|NCT00605280|3645508|FG002|STARTED|Year 3 Extension||0
2934028|NCT00605280|3645509|FG003|STARTED|Year 3 Extension||54
2934029|NCT00605280|3645506|FG000|Received 0.3 mg Treatment|Year 3 Extension||46
2934030|NCT00605280|3645507|FG001|Received 0.3 mg Treatment|Year 3 Extension||0
2934031|NCT00605280|3645508|FG002|Received 0.3 mg Treatment|Year 3 Extension||0
2934032|NCT00605280|3645509|FG003|Received 0.3 mg Treatment|Year 3 Extension||54
2934033|NCT00605280|3645506|FG000|COMPLETED|Year 3 Extension||38
2934034|NCT00605280|3645507|FG001|COMPLETED|Year 3 Extension||0
2934035|NCT00605280|3645508|FG002|COMPLETED|Year 3 Extension||0
2934036|NCT00605280|3645509|FG003|COMPLETED|Year 3 Extension||45
2934037|NCT00605280|3645506|FG000|NOT COMPLETED|Year 3 Extension||8
2934038|NCT00605280|3645507|FG001|NOT COMPLETED|Year 3 Extension||0
2934039|NCT00605280|3645508|FG002|NOT COMPLETED|Year 3 Extension||0
2934040|NCT00605280|3645509|FG003|NOT COMPLETED|Year 3 Extension||9
2934041|NCT00605293|3645521|FG000|STARTED|Overall Study||65
2934042|NCT00605293|3645522|FG001|STARTED|Overall Study||36
2934043|NCT00605293|3645521|FG000|COMPLETED|Overall Study||48
2934044|NCT00605293|3645522|FG001|COMPLETED|Overall Study||31
2934045|NCT00605293|3645521|FG000|NOT COMPLETED|Overall Study||17
2934046|NCT00605293|3645522|FG001|NOT COMPLETED|Overall Study||5
2934047|NCT00605306|3645530|FG000|STARTED|Overall Study||14
2934048|NCT00605306|3645531|FG001|STARTED|Overall Study||14
2934049|NCT00605306|3645530|FG000|COMPLETED|Overall Study||14
2934050|NCT00605306|3645531|FG001|COMPLETED|Overall Study||13
2934051|NCT00605306|3645530|FG000|NOT COMPLETED|Overall Study||0
2934052|NCT00605306|3645531|FG001|NOT COMPLETED|Overall Study||1
2934053|NCT00605319|3645537|FG000|STARTED|Overall Study||17
2934054|NCT00605319|3645537|FG000|COMPLETED|Overall Study||11
2934055|NCT00605319|3645537|FG000|NOT COMPLETED|Overall Study||6
2934056|NCT00605345|3645549|FG000|STARTED|Overall Study||46
2934057|NCT00605345|3645550|FG001|STARTED|Overall Study||25
2934058|NCT00605345|3645549|FG000|COMPLETED|Overall Study||45
2934059|NCT00605345|3645550|FG001|COMPLETED|Overall Study||22
2934060|NCT00605345|3645549|FG000|NOT COMPLETED|Overall Study||1
2934061|NCT00605345|3645550|FG001|NOT COMPLETED|Overall Study||3
2934062|NCT00605358|3645558|FG000|STARTED|Overall Study||81
2934063|NCT00605358|3645559|FG001|STARTED|Overall Study||80
2934064|NCT00605358|3645558|FG000|COMPLETED|Overall Study||81
2934065|NCT00605358|3645559|FG001|COMPLETED|Overall Study||80
2934066|NCT00605358|3645558|FG000|NOT COMPLETED|Overall Study||0
2934067|NCT00605358|3645559|FG001|NOT COMPLETED|Overall Study||0
2934068|NCT00605384|3645567|FG000|STARTED|Overall Study||1
2934069|NCT00605384|3645568|FG001|STARTED|Overall Study||1
2934070|NCT00605384|3645567|FG000|COMPLETED|Overall Study|study terminated early|0
2934071|NCT00605384|3645568|FG001|COMPLETED|Overall Study|study terminated early|0
2934072|NCT00605384|3645567|FG000|NOT COMPLETED|Overall Study||1
2934073|NCT00605384|3645568|FG001|NOT COMPLETED|Overall Study||1
2934074|NCT00605423|3645576|FG000|STARTED|Overall Study||4
2934075|NCT00605423|3645577|FG001|STARTED|Overall Study||2
2934076|NCT00605423|3645576|FG000|COMPLETED|Overall Study||4
2934077|NCT00605423|3645577|FG001|COMPLETED|Overall Study||2
2934078|NCT00605423|3645576|FG000|NOT COMPLETED|Overall Study||0
2934079|NCT00605423|3645577|FG001|NOT COMPLETED|Overall Study||0
2934080|NCT00605475|3645593|FG000|STARTED|Overall Study||10
2934081|NCT00605475|3645594|FG001|STARTED|Overall Study||5
2934082|NCT00605475|3645595|FG002|STARTED|Overall Study||45
2934083|NCT00605475|3645596|FG003|STARTED|Overall Study||45
2934084|NCT00605475|3645597|FG004|STARTED|Overall Study||25
2934085|NCT00605475|3645598|FG005|STARTED|Overall Study||24
2934086|NCT00605475|3645599|FG006|STARTED|Overall Study||23
2934087|NCT00605475|3645600|FG007|STARTED|Overall Study||24
2934088|NCT00605475|3645601|FG008|STARTED|Overall Study||20
2934089|NCT00605475|3645602|FG009|STARTED|Overall Study||10
2934090|NCT00605475|3645593|FG000|COMPLETED|Overall Study||10
2934091|NCT00605475|3645594|FG001|COMPLETED|Overall Study||5
2934092|NCT00605475|3645595|FG002|COMPLETED|Overall Study||45
2934093|NCT00605475|3645596|FG003|COMPLETED|Overall Study||45
2934094|NCT00605475|3645597|FG004|COMPLETED|Overall Study||24
3180068|NCT01988129|3908316|FG000|Screened for Sleep Disorders|Overall Study||416
3180069|NCT01988129|3908317|FG001|Screened for Sleep Disorders|Overall Study||15
2934095|NCT00605475|3645598|FG005|COMPLETED|Overall Study||22
2934096|NCT00605475|3645599|FG006|COMPLETED|Overall Study||22
2934097|NCT00605475|3645600|FG007|COMPLETED|Overall Study||24
2934098|NCT00605475|3645601|FG008|COMPLETED|Overall Study||18
2934099|NCT00605475|3645602|FG009|COMPLETED|Overall Study||8
2934100|NCT00605475|3645593|FG000|NOT COMPLETED|Overall Study||0
2934101|NCT00605475|3645594|FG001|NOT COMPLETED|Overall Study||0
2934102|NCT00605475|3645595|FG002|NOT COMPLETED|Overall Study||0
2934103|NCT00605475|3645596|FG003|NOT COMPLETED|Overall Study||0
2934104|NCT00605475|3645597|FG004|NOT COMPLETED|Overall Study||1
2934105|NCT00605475|3645598|FG005|NOT COMPLETED|Overall Study||2
2934106|NCT00605475|3645599|FG006|NOT COMPLETED|Overall Study||1
2934107|NCT00605475|3645600|FG007|NOT COMPLETED|Overall Study||0
2934108|NCT00605475|3645601|FG008|NOT COMPLETED|Overall Study||2
2934109|NCT00605475|3645602|FG009|NOT COMPLETED|Overall Study||2
2934110|NCT00605540|3645645|FG000|STARTED|Overall Study||133
2934111|NCT00605540|3645645|FG000|COMPLETED|Overall Study||95
2934112|NCT00605540|3645645|FG000|NOT COMPLETED|Overall Study||38
2934113|NCT00605566|3645649|FG000|STARTED|Overall Study||22
2934114|NCT00605566|3645649|FG000|COMPLETED|Overall Study||19
2934115|NCT00605566|3645649|FG000|NOT COMPLETED|Overall Study||3
2934116|NCT00605644|3645658|FG000|STARTED|Overall Study||29
2934117|NCT00605644|3645659|FG001|STARTED|Overall Study||19
2934118|NCT00605644|3645660|FG002|STARTED|Overall Study||20
2934119|NCT00605644|3645661|FG003|STARTED|Overall Study||30
2934120|NCT00605644|3645662|FG004|STARTED|Overall Study||30
2934121|NCT00605644|3645658|FG000|COMPLETED|Overall Study||28
2934122|NCT00605644|3645659|FG001|COMPLETED|Overall Study||18
2934123|NCT00605644|3645660|FG002|COMPLETED|Overall Study||18
2934124|NCT00605644|3645661|FG003|COMPLETED|Overall Study||25
2934125|NCT00605644|3645662|FG004|COMPLETED|Overall Study||22
2934126|NCT00605644|3645658|FG000|NOT COMPLETED|Overall Study||1
2934127|NCT00605644|3645659|FG001|NOT COMPLETED|Overall Study||1
2934128|NCT00605644|3645660|FG002|NOT COMPLETED|Overall Study||2
2934129|NCT00605644|3645661|FG003|NOT COMPLETED|Overall Study||5
2934130|NCT00605644|3645662|FG004|NOT COMPLETED|Overall Study||8
2934131|NCT00605657|3645674|FG000|STARTED|Overall Study||5
2934132|NCT00605657|3645674|FG000|COMPLETED|Overall Study||3
2934133|NCT00605657|3645674|FG000|NOT COMPLETED|Overall Study||2
2934134|NCT00605696|3645680|FG000|STARTED|Overall Study||7
2934135|NCT00605696|3645681|FG001|STARTED|Overall Study||11
3042759|NCT01179516|3762605|FG002|STARTED|Overall Study||152
3042760|NCT01179516|3762603|FG000|Treated|Overall Study||160
3042761|NCT01179516|3762604|FG001|Treated|Overall Study||154
3042762|NCT01179516|3762605|FG002|Treated|Overall Study||151
3042763|NCT01179516|3762603|FG000|COMPLETED|Overall Study||133
3042764|NCT01179516|3762604|FG001|COMPLETED|Overall Study||131
3042765|NCT01179516|3762605|FG002|COMPLETED|Overall Study||121
3042766|NCT01179516|3762603|FG000|NOT COMPLETED|Overall Study||27
3042767|NCT01179516|3762604|FG001|NOT COMPLETED|Overall Study||26
3042768|NCT01179516|3762605|FG002|NOT COMPLETED|Overall Study||31
3042769|NCT01179568|3762617|FG000|STARTED|Overall Study||101
3042770|NCT01179568|3762618|FG001|STARTED|Overall Study||99
3042771|NCT01179568|3762619|FG002|STARTED|Overall Study||99
3042772|NCT01179568|3762620|FG003|STARTED|Overall Study||96
3042773|NCT01179568|3762617|FG000|Completed Week 12 Assessment|Overall Study||69
3042774|NCT01179568|3762618|FG001|Completed Week 12 Assessment|Overall Study||69
3042775|NCT01179568|3762619|FG002|Completed Week 12 Assessment|Overall Study||76
3042776|NCT01179568|3762620|FG003|Completed Week 12 Assessment|Overall Study||75
3042777|NCT01179568|3762617|FG000|COMPLETED|Overall Study||73
3042778|NCT01179568|3762618|FG001|COMPLETED|Overall Study||61
3042779|NCT01179568|3762619|FG002|COMPLETED|Overall Study||76
3042780|NCT01179568|3762620|FG003|COMPLETED|Overall Study||76
3042781|NCT01179568|3762617|FG000|NOT COMPLETED|Overall Study||28
3042782|NCT01179568|3762618|FG001|NOT COMPLETED|Overall Study||38
3042783|NCT01179568|3762619|FG002|NOT COMPLETED|Overall Study||23
3042784|NCT01179568|3762620|FG003|NOT COMPLETED|Overall Study||20
3042785|NCT01179672|3762635|FG000|STARTED|Overall Study||203
3042786|NCT01179672|3762636|FG001|STARTED|Overall Study||202
3042787|NCT01179672|3762635|FG000|Received at Least 1 Dose of Study Drug|Overall Study||202
3042788|NCT01179672|3762636|FG001|Received at Least 1 Dose of Study Drug|Overall Study||202
2934136|NCT00605696|3645680|FG000|COMPLETED|Overall Study||7
2934137|NCT00605696|3645681|FG001|COMPLETED|Overall Study||11
2934138|NCT00605696|3645680|FG000|NOT COMPLETED|Overall Study||0
2934139|NCT00605696|3645681|FG001|NOT COMPLETED|Overall Study||0
2934140|NCT00605722|3645687|FG000|STARTED|Overall Study||51
2934141|NCT00605722|3645687|FG000|COMPLETED|Overall Study|Completed=Completed Treatment.|0
2934142|NCT00605722|3645687|FG000|NOT COMPLETED|Overall Study||51
2934143|NCT00605813|3645691|FG000|STARTED|Overall Study||542
2934144|NCT00605813|3645691|FG000|COMPLETED|Overall Study||517
2934145|NCT00605813|3645691|FG000|NOT COMPLETED|Overall Study||25
2934146|NCT00605826|3645706|FG000|STARTED|Overall Study||136
2934147|NCT00605826|3645707|FG001|STARTED|Overall Study||70
2934148|NCT00605826|3645706|FG000|COMPLETED|Overall Study||129
2934149|NCT00605826|3645707|FG001|COMPLETED|Overall Study||60
3180070|NCT01988129|3908316|FG000|Completed 1-year Follow-up Survey|Overall Study||100
3180071|NCT01988129|3908317|FG001|Completed 1-year Follow-up Survey|Overall Study||4
3180072|NCT01988129|3908316|FG000|COMPLETED|Overall Study||601
2934150|NCT00605826|3645706|FG000|NOT COMPLETED|Overall Study||7
2934151|NCT00605826|3645707|FG001|NOT COMPLETED|Overall Study||10
2934152|NCT00605839|3645716|FG000|STARTED|Overall Study||40
2934153|NCT00605839|3645717|FG001|STARTED|Overall Study||37
2934154|NCT00605839|3645718|FG002|STARTED|Overall Study||28
2934155|NCT00605839|3645716|FG000|COMPLETED|Overall Study|One patient would not keep to the text messaging constraints and had to be removed.|39
2934156|NCT00605839|3645717|FG001|COMPLETED|Overall Study||37
2934157|NCT00605839|3645718|FG002|COMPLETED|Overall Study||28
2934158|NCT00605839|3645716|FG000|NOT COMPLETED|Overall Study||1
2934159|NCT00605839|3645717|FG001|NOT COMPLETED|Overall Study||0
2934160|NCT00605839|3645718|FG002|NOT COMPLETED|Overall Study||0
2934161|NCT00605865|3645726|FG000|STARTED|Overall Study||2272
2934162|NCT00605865|3645726|FG000|COMPLETED|Overall Study||2157
2934163|NCT00605865|3645726|FG000|NOT COMPLETED|Overall Study||115
2934164|NCT00605904|3645760|FG000|STARTED|Baseline Data Collection and Dosing|While 37 subjects were enrolled in the protocol, only 34 were randomized to a study arm|13
2934165|NCT00605904|3645761|FG001|STARTED|Baseline Data Collection and Dosing|While 37 subjects were enrolled in the protocol, only 34 were randomized to a study arm|21
2934166|NCT00605904|3645760|FG000|COMPLETED|Baseline Data Collection and Dosing||13
2934167|NCT00605904|3645761|FG001|COMPLETED|Baseline Data Collection and Dosing||16
2934168|NCT00605904|3645760|FG000|NOT COMPLETED|Baseline Data Collection and Dosing||0
2934169|NCT00605904|3645761|FG001|NOT COMPLETED|Baseline Data Collection and Dosing||5
2934170|NCT00605904|3645760|FG000|STARTED|Infusion Sessions||13
2934171|NCT00605904|3645761|FG001|STARTED|Infusion Sessions||16
2934172|NCT00605904|3645760|FG000|Saline Infusion|Infusion Sessions||13
2934173|NCT00605904|3645761|FG001|Saline Infusion|Infusion Sessions||14
2934174|NCT00605904|3645760|FG000|mCPP Infusion|Infusion Sessions||12
2934175|NCT00605904|3645761|FG001|mCPP Infusion|Infusion Sessions||13
2934176|NCT00605904|3645760|FG000|Yohimbine Infusion|Infusion Sessions||12
2934177|NCT00605904|3645761|FG001|Yohimbine Infusion|Infusion Sessions|Milestones (infusions) were not received in the same order for each subjects so are not consecutive.|15
2934178|NCT00605904|3645760|FG000|COMPLETED|Infusion Sessions|Subjects who completed all three types of infusion (given in a different order for each subject)|12
2934179|NCT00605904|3645761|FG001|COMPLETED|Infusion Sessions|Subjects who completed all three types of infusion (given in a different order for each subject)|13
2934180|NCT00605904|3645760|FG000|NOT COMPLETED|Infusion Sessions||1
2934181|NCT00605904|3645761|FG001|NOT COMPLETED|Infusion Sessions||3
2934182|NCT00605917|3645767|FG000|STARTED|Overall Study||987
2934183|NCT00605917|3645767|FG000|COMPLETED|Overall Study||908
2934184|NCT00605917|3645767|FG000|NOT COMPLETED|Overall Study||79
2934185|NCT00606008|3645802|FG000|STARTED|Overall Study||30
2934186|NCT00606008|3645802|FG000|COMPLETED|Overall Study||25
2934187|NCT00606008|3645802|FG000|NOT COMPLETED|Overall Study||5
2934188|NCT00606021|3645812|FG000|STARTED|Induction Phase||106
2934189|NCT00606021|3645813|FG001|STARTED|Induction Phase||0
2934190|NCT00606021|3645814|FG002|STARTED|Induction Phase||0
2934191|NCT00606021|3645812|FG000|COMPLETED|Induction Phase||19
2934192|NCT00606021|3645813|FG001|COMPLETED|Induction Phase||0
2934193|NCT00606021|3645814|FG002|COMPLETED|Induction Phase||0
2934194|NCT00606021|3645812|FG000|NOT COMPLETED|Induction Phase||87
2934195|NCT00606021|3645813|FG001|NOT COMPLETED|Induction Phase||0
2934196|NCT00606021|3645814|FG002|NOT COMPLETED|Induction Phase||0
2934197|NCT00606021|3645812|FG000|STARTED|Maintenance Phase||0
2934198|NCT00606021|3645813|FG001|STARTED|Maintenance Phase||28
2934199|NCT00606021|3645814|FG002|STARTED|Maintenance Phase||27
2934200|NCT00606021|3645812|FG000|COMPLETED|Maintenance Phase||0
2934201|NCT00606021|3645813|FG001|COMPLETED|Maintenance Phase||5
2934202|NCT00606021|3645814|FG002|COMPLETED|Maintenance Phase||10
2934203|NCT00606021|3645812|FG000|NOT COMPLETED|Maintenance Phase||0
2934204|NCT00606021|3645813|FG001|NOT COMPLETED|Maintenance Phase||23
2934205|NCT00606021|3645814|FG002|NOT COMPLETED|Maintenance Phase||17
2934206|NCT00606034|3645822|FG000|STARTED|Overall Study||21
2934207|NCT00606034|3645822|FG000|COMPLETED|Overall Study||20
2934208|NCT00606034|3645822|FG000|NOT COMPLETED|Overall Study||1
2934209|NCT00606047|3645828|FG000|STARTED|Overall Study||200
2934210|NCT00606047|3645828|FG000|COMPLETED|Overall Study||200
2934211|NCT00606047|3645828|FG000|NOT COMPLETED|Overall Study||0
2934212|NCT00606086|3645834|FG000|STARTED|Overall Study||72
3180073|NCT01988129|3908317|FG001|COMPLETED|Overall Study||588
3180074|NCT01988129|3908316|FG000|NOT COMPLETED|Overall Study||0
3180075|NCT01988129|3908317|FG001|NOT COMPLETED|Overall Study||0
3180076|NCT01988246|3908328|FG000|STARTED|Overall Study||15
3180077|NCT01988246|3908329|FG001|STARTED|Overall Study||15
3180078|NCT01988246|3908328|FG000|COMPLETED|Overall Study||14
3180079|NCT01988246|3908329|FG001|COMPLETED|Overall Study||15
3180080|NCT01988246|3908328|FG000|NOT COMPLETED|Overall Study||1
3180081|NCT01988246|3908329|FG001|NOT COMPLETED|Overall Study||0
2934213|NCT00606086|3645835|FG001|STARTED|Overall Study||68
2934214|NCT00606086|3645834|FG000|COMPLETED|Overall Study||60
2934215|NCT00606086|3645835|FG001|COMPLETED|Overall Study||53
2934216|NCT00606086|3645834|FG000|NOT COMPLETED|Overall Study||12
2934217|NCT00606086|3645835|FG001|NOT COMPLETED|Overall Study||15
2934218|NCT00606138|3645843|FG000|STARTED|Overall Study||6
2934219|NCT00606138|3645844|FG001|STARTED|Overall Study||2
2934220|NCT00606138|3645843|FG000|COMPLETED|Overall Study||6
2934221|NCT00606138|3645844|FG001|COMPLETED|Overall Study||2
2934222|NCT00606138|3645843|FG000|NOT COMPLETED|Overall Study||0
2934223|NCT00606138|3645844|FG001|NOT COMPLETED|Overall Study||0
2934224|NCT00606177|3645852|FG000|STARTED|Overall Study||55
2934225|NCT00606177|3645853|FG001|STARTED|Overall Study||44
2934226|NCT00606177|3645852|FG000|COMPLETED|Overall Study||28
2934227|NCT00606177|3645853|FG001|COMPLETED|Overall Study||19
2934228|NCT00606177|3645852|FG000|NOT COMPLETED|Overall Study||27
3180082|NCT01988376|3908337|FG000|STARTED|Overall Study||129
3180083|NCT01988376|3908338|FG001|STARTED|Overall Study||129
3180084|NCT01988376|3908337|FG000|COMPLETED|Overall Study||129
3180085|NCT01988376|3908338|FG001|COMPLETED|Overall Study||129
3180086|NCT01988376|3908337|FG000|NOT COMPLETED|Overall Study||0
3180087|NCT01988376|3908338|FG001|NOT COMPLETED|Overall Study||0
3180088|NCT01988402|3908346|FG000|STARTED|Overall Study||16
3180089|NCT01988402|3908347|FG001|STARTED|Overall Study||19
2934229|NCT00606177|3645853|FG001|NOT COMPLETED|Overall Study||25
2934230|NCT00606229|3645859|FG000|STARTED|Overall Study||41
2934231|NCT00606229|3645859|FG000|COMPLETED|Overall Study||19
2934232|NCT00606229|3645859|FG000|NOT COMPLETED|Overall Study||22
2934233|NCT00606281|3645865|FG000|STARTED|Overall Study||128
2934234|NCT00606281|3645866|FG001|STARTED|Overall Study||130
2934235|NCT00606281|3645865|FG000|COMPLETED|Overall Study||72
2934236|NCT00606281|3645866|FG001|COMPLETED|Overall Study||64
3042789|NCT01179672|3762635|FG000|Entered Taper|Overall Study||181
3042790|NCT01179672|3762636|FG001|Entered Taper|Overall Study||177
3042791|NCT01179672|3762635|FG000|COMPLETED|Overall Study||173
3042792|NCT01179672|3762636|FG001|COMPLETED|Overall Study||176
3042793|NCT01179672|3762635|FG000|NOT COMPLETED|Overall Study||30
3042794|NCT01179672|3762636|FG001|NOT COMPLETED|Overall Study||26
3042795|NCT01179919|3762646|FG000|STARTED|Overall Study||21
3042796|NCT01179919|3762646|FG000|COMPLETED|Overall Study||19
3042797|NCT01179919|3762646|FG000|NOT COMPLETED|Overall Study||2
3042798|NCT01179984|3762650|FG000|STARTED|Overall Study||76
3042799|NCT01179984|3762650|FG000|COMPLETED|Overall Study||58
3042800|NCT01179984|3762650|FG000|NOT COMPLETED|Overall Study||18
3042801|NCT01180036|3762657|FG000|STARTED|Overall Study||65
3042802|NCT01180036|3762658|FG001|STARTED|Overall Study||65
3042803|NCT01180036|3762657|FG000|COMPLETED|Overall Study||65
3042804|NCT01180036|3762658|FG001|COMPLETED|Overall Study||65
3042805|NCT01180036|3762657|FG000|NOT COMPLETED|Overall Study||0
3042806|NCT01180036|3762658|FG001|NOT COMPLETED|Overall Study||0
3042807|NCT01180049|3762668|FG000|STARTED|Overall Study||53
3042808|NCT01180049|3762669|FG001|STARTED|Overall Study||48
3042809|NCT01180049|3762668|FG000|COMPLETED|Overall Study||0
3042810|NCT01180049|3762669|FG001|COMPLETED|Overall Study||0
3042811|NCT01180049|3762668|FG000|NOT COMPLETED|Overall Study||53
3042812|NCT01180049|3762669|FG001|NOT COMPLETED|Overall Study||48
3042813|NCT01180127|3762679|FG000|STARTED|Overall Study||10
3042814|NCT01180127|3762680|FG001|STARTED|Overall Study||11
3042815|NCT01180127|3762681|FG002|STARTED|Overall Study||10
3042816|NCT01180127|3762682|FG003|STARTED|Overall Study||10
3042817|NCT01180127|3762679|FG000|COMPLETED|Overall Study||8
3042818|NCT01180127|3762680|FG001|COMPLETED|Overall Study||11
3042819|NCT01180127|3762681|FG002|COMPLETED|Overall Study||9
3042820|NCT01180127|3762682|FG003|COMPLETED|Overall Study||9
3042821|NCT01180127|3762679|FG000|NOT COMPLETED|Overall Study||2
3042822|NCT01180127|3762680|FG001|NOT COMPLETED|Overall Study||0
3042823|NCT01180127|3762681|FG002|NOT COMPLETED|Overall Study||1
3042824|NCT01180127|3762682|FG003|NOT COMPLETED|Overall Study||1
3042825|NCT01180244|3762698|FG000|STARTED|Overall Study|Number of enrolled patients initially randomized to active treatment group|45
3042826|NCT01180244|3762699|FG001|STARTED|Overall Study|Number of enrolled patients initially randomized to placebo group|46
3042827|NCT01180244|3762698|FG000|Received Treatment|Overall Study|Number of patients in the active treatment group that received at least one study treatment|40
3042828|NCT01180244|3762699|FG001|Received Treatment|Overall Study|Number of patients in the placebo group that received at least one sham treatment|45
3042829|NCT01180244|3762698|FG000|COMPLETED|Overall Study|Number of active treatment patients who completed all study visits and are evaluable|39
3042830|NCT01180244|3762699|FG001|COMPLETED|Overall Study|Number of placebo group patients who completed all study visits and are evaluable|38
3042831|NCT01180244|3762698|FG000|NOT COMPLETED|Overall Study||6
3042832|NCT01180244|3762699|FG001|NOT COMPLETED|Overall Study||8
3137212|NCT01717326|3862428|FG003|NOT COMPLETED|Overall Study||2
3137213|NCT01717326|3862429|FG004|NOT COMPLETED|Overall Study||2
3137214|NCT01717326|3862430|FG005|NOT COMPLETED|Overall Study||0
3137215|NCT01717326|3862431|FG006|NOT COMPLETED|Overall Study||1
2934237|NCT00606281|3645865|FG000|NOT COMPLETED|Overall Study||56
3137216|NCT01717326|3862432|FG007|NOT COMPLETED|Overall Study||0
3137217|NCT01717326|3862433|FG008|NOT COMPLETED|Overall Study||0
3137218|NCT01717326|3862434|FG009|NOT COMPLETED|Overall Study||2
3137219|NCT01717326|3862435|FG010|NOT COMPLETED|Overall Study||2
3137220|NCT01717326|3862436|FG011|NOT COMPLETED|Overall Study||0
3137221|NCT01717326|3862437|FG012|NOT COMPLETED|Overall Study||1
2934238|NCT00606281|3645866|FG001|NOT COMPLETED|Overall Study||66
2934239|NCT00606294|3645874|FG000|STARTED|Overall Study||197
2934240|NCT00606294|3645875|FG001|STARTED|Overall Study||19
2934241|NCT00606294|3645874|FG000|COMPLETED|Overall Study||161
2934242|NCT00606294|3645875|FG001|COMPLETED|Overall Study||19
2934243|NCT00606294|3645874|FG000|NOT COMPLETED|Overall Study||36
2934244|NCT00606294|3645875|FG001|NOT COMPLETED|Overall Study||0
2934245|NCT00606307|3645881|FG000|STARTED|Overall Study||29
2934246|NCT00606307|3645881|FG000|COMPLETED|Overall Study||18
2934247|NCT00606307|3645881|FG000|NOT COMPLETED|Overall Study||11
2934248|NCT00606320|3645885|FG000|STARTED|Overall Study||59
2934249|NCT00606320|3645885|FG000|COMPLETED|Overall Study||22
2934250|NCT00606320|3645885|FG000|NOT COMPLETED|Overall Study||37
2934251|NCT00606489|3645891|FG000|STARTED|Overall Study||21
2934252|NCT00606489|3645892|FG001|STARTED|Overall Study||40
2934253|NCT00606489|3645891|FG000|COMPLETED|Overall Study||21
2934254|NCT00606489|3645892|FG001|COMPLETED|Overall Study||40
2934255|NCT00606489|3645891|FG000|NOT COMPLETED|Overall Study||0
2934256|NCT00606489|3645892|FG001|NOT COMPLETED|Overall Study||0
2934257|NCT00606502|3645900|FG000|STARTED|Randomization||100
2934258|NCT00606502|3645901|FG001|STARTED|Randomization||101
2934259|NCT00606502|3645900|FG000|COMPLETED|Randomization||97
2934260|NCT00606502|3645901|FG001|COMPLETED|Randomization||101
2934261|NCT00606502|3645900|FG000|NOT COMPLETED|Randomization||3
2934262|NCT00606502|3645901|FG001|NOT COMPLETED|Randomization||0
2934263|NCT00606502|3645900|FG000|STARTED|Treatment||97
2934264|NCT00606502|3645901|FG001|STARTED|Treatment||101
2934265|NCT00606502|3645900|FG000|COMPLETED|Treatment||97
2934266|NCT00606502|3645901|FG001|COMPLETED|Treatment||98
2934267|NCT00606502|3645900|FG000|NOT COMPLETED|Treatment||0
2934268|NCT00606502|3645901|FG001|NOT COMPLETED|Treatment||3
2934269|NCT00606554|3645909|FG000|STARTED|Overall Study||15
2934270|NCT00606554|3645910|FG001|STARTED|Overall Study||18
2934271|NCT00606554|3645909|FG000|COMPLETED|Overall Study||15
2934272|NCT00606554|3645910|FG001|COMPLETED|Overall Study||18
2934273|NCT00606554|3645909|FG000|NOT COMPLETED|Overall Study||0
2934274|NCT00606554|3645910|FG001|NOT COMPLETED|Overall Study||0
2934275|NCT00606580|3645923|FG000|STARTED|Overall Study||125
2934276|NCT00606580|3645924|FG001|STARTED|Overall Study||125
2934277|NCT00606580|3645925|FG002|STARTED|Overall Study||125
2934278|NCT00606580|3645923|FG000|COMPLETED|Overall Study||123
2934279|NCT00606580|3645924|FG001|COMPLETED|Overall Study||122
2934280|NCT00606580|3645925|FG002|COMPLETED|Overall Study||103
2934281|NCT00606580|3645923|FG000|NOT COMPLETED|Overall Study||2
2934282|NCT00606580|3645924|FG001|NOT COMPLETED|Overall Study||3
2934283|NCT00606580|3645925|FG002|NOT COMPLETED|Overall Study||22
2934284|NCT00606593|3645933|FG000|STARTED|Overall Study|Randomized participants|11
2934285|NCT00606593|3645934|FG001|STARTED|Overall Study|Randomized participants|11
2934286|NCT00606593|3645935|FG002|STARTED|Overall Study|Randomized participants|11
2934287|NCT00606593|3645936|FG003|STARTED|Overall Study|Randomized participants|11
2934288|NCT00606593|3645937|FG004|STARTED|Overall Study|Randomized participants|12
2934289|NCT00606593|3645938|FG005|STARTED|Overall Study|Randomized participants|11
2934290|NCT00606593|3645939|FG006|STARTED|Overall Study|Randomized participants|11
2934291|NCT00606593|3645940|FG007|STARTED|Overall Study|Randomized participants. One participant actually received the treatment sequence 200/P/100/ 50/25|11
2934292|NCT00606593|3645941|FG008|STARTED|Overall Study|Randomized participants|12
2934293|NCT00606593|3645942|FG009|STARTED|Overall Study|Randomized participants|11
2934294|NCT00606593|3645933|FG000|1st Double-blind Treatment|Overall Study||11
2934295|NCT00606593|3645934|FG001|1st Double-blind Treatment|Overall Study||11
2934296|NCT00606593|3645935|FG002|1st Double-blind Treatment|Overall Study||11
2934297|NCT00606593|3645936|FG003|1st Double-blind Treatment|Overall Study||11
2934298|NCT00606593|3645937|FG004|1st Double-blind Treatment|Overall Study||12
2934299|NCT00606593|3645938|FG005|1st Double-blind Treatment|Overall Study||11
2934300|NCT00606593|3645939|FG006|1st Double-blind Treatment|Overall Study||11
2934301|NCT00606593|3645940|FG007|1st Double-blind Treatment|Overall Study||11
2934302|NCT00606593|3645941|FG008|1st Double-blind Treatment|Overall Study||12
2934303|NCT00606593|3645942|FG009|1st Double-blind Treatment|Overall Study||11
3042833|NCT01180296|3762707|FG000|STARTED|Overall Study||20
3042834|NCT01180296|3762708|FG001|STARTED|Overall Study||16
3042835|NCT01180296|3762707|FG000|COMPLETED|Overall Study||19
3042836|NCT01180296|3762708|FG001|COMPLETED|Overall Study||14
3042837|NCT01180296|3762707|FG000|NOT COMPLETED|Overall Study||1
3042838|NCT01180296|3762708|FG001|NOT COMPLETED|Overall Study||2
3042839|NCT01180400|3762718|FG000|STARTED|Overall Study||147
3042840|NCT01180400|3762719|FG001|STARTED|Overall Study||148
3042841|NCT01180400|3762718|FG000|Received Treatment|Overall Study||147
3042842|NCT01180400|3762719|FG001|Received Treatment|Overall Study||146
3042843|NCT01180400|3762718|FG000|COMPLETED|Overall Study||122
3042844|NCT01180400|3762719|FG001|COMPLETED|Overall Study||121
3042845|NCT01180400|3762718|FG000|NOT COMPLETED|Overall Study||25
3042846|NCT01180400|3762719|FG001|NOT COMPLETED|Overall Study||27
3042847|NCT01180478|3762727|FG000|STARTED|Overall Study||484
3042848|NCT01180478|3762728|FG001|STARTED|Overall Study||481
3042849|NCT01180478|3762727|FG000|COMPLETED|Overall Study||303
3042850|NCT01180478|3762728|FG001|COMPLETED|Overall Study||293
3042851|NCT01180478|3762727|FG000|NOT COMPLETED|Overall Study||181
3042852|NCT01180478|3762728|FG001|NOT COMPLETED|Overall Study||188
3042853|NCT01180647|3762738|FG000|STARTED|Overall Study||17
3042854|NCT01180647|3762739|FG001|STARTED|Overall Study||17
3042855|NCT01180647|3762738|FG000|COMPLETED|Overall Study||12
2934304|NCT00606593|3645933|FG000|2nd Double-blind Treatment|Overall Study||11
2934305|NCT00606593|3645934|FG001|2nd Double-blind Treatment|Overall Study||11
2934306|NCT00606593|3645935|FG002|2nd Double-blind Treatment|Overall Study||11
2934307|NCT00606593|3645936|FG003|2nd Double-blind Treatment|Overall Study||10
2934308|NCT00606593|3645937|FG004|2nd Double-blind Treatment|Overall Study||12
2934309|NCT00606593|3645938|FG005|2nd Double-blind Treatment|Overall Study||11
2934310|NCT00606593|3645939|FG006|2nd Double-blind Treatment|Overall Study||10
2934311|NCT00606593|3645940|FG007|2nd Double-blind Treatment|Overall Study||9
2934312|NCT00606593|3645941|FG008|2nd Double-blind Treatment|Overall Study||12
2934313|NCT00606593|3645942|FG009|2nd Double-blind Treatment|Overall Study||11
2934314|NCT00606593|3645933|FG000|3rd Double-blind Treatment|Overall Study||11
2934315|NCT00606593|3645934|FG001|3rd Double-blind Treatment|Overall Study||11
2934316|NCT00606593|3645935|FG002|3rd Double-blind Treatment|Overall Study||10
2934317|NCT00606593|3645936|FG003|3rd Double-blind Treatment|Overall Study||10
2934318|NCT00606593|3645937|FG004|3rd Double-blind Treatment|Overall Study||11
2934319|NCT00606593|3645938|FG005|3rd Double-blind Treatment|Overall Study||11
2934320|NCT00606593|3645939|FG006|3rd Double-blind Treatment|Overall Study||10
2934321|NCT00606593|3645940|FG007|3rd Double-blind Treatment|Overall Study||9
2934322|NCT00606593|3645941|FG008|3rd Double-blind Treatment|Overall Study||12
2934323|NCT00606593|3645942|FG009|3rd Double-blind Treatment|Overall Study||11
2934324|NCT00606593|3645933|FG000|4th Double-blind Treatment|Overall Study||10
2934325|NCT00606593|3645934|FG001|4th Double-blind Treatment|Overall Study||11
2934326|NCT00606593|3645935|FG002|4th Double-blind Treatment|Overall Study||10
2934327|NCT00606593|3645936|FG003|4th Double-blind Treatment|Overall Study||10
2934328|NCT00606593|3645937|FG004|4th Double-blind Treatment|Overall Study||11
2934329|NCT00606593|3645938|FG005|4th Double-blind Treatment|Overall Study||11
2934330|NCT00606593|3645939|FG006|4th Double-blind Treatment|Overall Study||10
2934331|NCT00606593|3645940|FG007|4th Double-blind Treatment|Overall Study||9
2934332|NCT00606593|3645941|FG008|4th Double-blind Treatment|Overall Study||11
2934333|NCT00606593|3645942|FG009|4th Double-blind Treatment|Overall Study||11
2934334|NCT00606593|3645933|FG000|5th Double-blind Treatment|Overall Study||10
2934335|NCT00606593|3645934|FG001|5th Double-blind Treatment|Overall Study||11
2934336|NCT00606593|3645935|FG002|5th Double-blind Treatment|Overall Study||9
2934337|NCT00606593|3645936|FG003|5th Double-blind Treatment|Overall Study||10
2934338|NCT00606593|3645937|FG004|5th Double-blind Treatment|Overall Study||11
2934339|NCT00606593|3645938|FG005|5th Double-blind Treatment|Overall Study||11
2934340|NCT00606593|3645939|FG006|5th Double-blind Treatment|Overall Study||10
2934341|NCT00606593|3645940|FG007|5th Double-blind Treatment|Overall Study||9
2934342|NCT00606593|3645941|FG008|5th Double-blind Treatment|Overall Study||11
2934343|NCT00606593|3645942|FG009|5th Double-blind Treatment|Overall Study||11
2934344|NCT00606593|3645933|FG000|COMPLETED|Overall Study||10
2934345|NCT00606593|3645934|FG001|COMPLETED|Overall Study||11
2934346|NCT00606593|3645935|FG002|COMPLETED|Overall Study||9
2934347|NCT00606593|3645936|FG003|COMPLETED|Overall Study||10
2934348|NCT00606593|3645937|FG004|COMPLETED|Overall Study||11
2934349|NCT00606593|3645938|FG005|COMPLETED|Overall Study||11
2934350|NCT00606593|3645939|FG006|COMPLETED|Overall Study||10
2934351|NCT00606593|3645940|FG007|COMPLETED|Overall Study||9
2934352|NCT00606593|3645941|FG008|COMPLETED|Overall Study||11
3042856|NCT01180647|3762739|FG001|COMPLETED|Overall Study||11
3042857|NCT01180647|3762738|FG000|NOT COMPLETED|Overall Study||5
3042858|NCT01180647|3762739|FG001|NOT COMPLETED|Overall Study||6
3042859|NCT01180660|3762747|FG000|STARTED|Overall Study||25
3042860|NCT01180660|3762748|FG001|STARTED|Overall Study||26
3042861|NCT01180660|3762747|FG000|COMPLETED|Overall Study||24
3042862|NCT01180660|3762748|FG001|COMPLETED|Overall Study||26
3042863|NCT01180660|3762747|FG000|NOT COMPLETED|Overall Study||1
3042864|NCT01180660|3762748|FG001|NOT COMPLETED|Overall Study||0
3042865|NCT01180777|3762754|FG000|STARTED|Overall Study||92
3042866|NCT01180777|3762754|FG000|COMPLETED|Overall Study||80
3042867|NCT01180777|3762754|FG000|NOT COMPLETED|Overall Study||12
3042868|NCT01180790|3762767|FG000|STARTED|Overall Study||16
3042869|NCT01180790|3762768|FG001|STARTED|Overall Study||16
3042870|NCT01180790|3762769|FG002|STARTED|Overall Study||17
3042871|NCT01180790|3762770|FG003|STARTED|Overall Study||15
3042872|NCT01180790|3762771|FG004|STARTED|Overall Study||19
3042873|NCT01180790|3762772|FG005|STARTED|Overall Study||20
3042874|NCT01180790|3762773|FG006|STARTED|Overall Study||19
3042875|NCT01180790|3762767|FG000|COMPLETED|Overall Study||7
3042876|NCT01180790|3762768|FG001|COMPLETED|Overall Study||11
3042877|NCT01180790|3762769|FG002|COMPLETED|Overall Study||4
3042878|NCT01180790|3762770|FG003|COMPLETED|Overall Study||6
3042879|NCT01180790|3762771|FG004|COMPLETED|Overall Study||14
3042880|NCT01180790|3762772|FG005|COMPLETED|Overall Study||13
3042881|NCT01180790|3762773|FG006|COMPLETED|Overall Study||18
3042882|NCT01180790|3762767|FG000|NOT COMPLETED|Overall Study||9
3042883|NCT01180790|3762768|FG001|NOT COMPLETED|Overall Study||5
3042884|NCT01180790|3762769|FG002|NOT COMPLETED|Overall Study||13
3042885|NCT01180790|3762770|FG003|NOT COMPLETED|Overall Study||9
3042886|NCT01180790|3762771|FG004|NOT COMPLETED|Overall Study||5
3042887|NCT01180790|3762772|FG005|NOT COMPLETED|Overall Study||7
3042888|NCT01180790|3762773|FG006|NOT COMPLETED|Overall Study||1
3042889|NCT01180894|3762819|FG000|STARTED|Overall Study||75
3042890|NCT01180894|3762820|FG001|STARTED|Overall Study||75
3042891|NCT01180894|3762819|FG000|COMPLETED|Overall Study||75
3042892|NCT01180894|3762820|FG001|COMPLETED|Overall Study||75
3042893|NCT01180894|3762819|FG000|NOT COMPLETED|Overall Study||0
3042894|NCT01180894|3762820|FG001|NOT COMPLETED|Overall Study||0
2934353|NCT00606593|3645942|FG009|COMPLETED|Overall Study||11
2934354|NCT00606593|3645933|FG000|NOT COMPLETED|Overall Study||1
2934355|NCT00606593|3645934|FG001|NOT COMPLETED|Overall Study||0
2934356|NCT00606593|3645935|FG002|NOT COMPLETED|Overall Study||2
2934357|NCT00606593|3645936|FG003|NOT COMPLETED|Overall Study||1
2934358|NCT00606593|3645937|FG004|NOT COMPLETED|Overall Study||1
2934359|NCT00606593|3645938|FG005|NOT COMPLETED|Overall Study||0
2934360|NCT00606593|3645939|FG006|NOT COMPLETED|Overall Study||1
2934361|NCT00606593|3645940|FG007|NOT COMPLETED|Overall Study||2
2934362|NCT00606593|3645941|FG008|NOT COMPLETED|Overall Study||1
2934363|NCT00606593|3645942|FG009|NOT COMPLETED|Overall Study||0
2934364|NCT00606632|3645955|FG000|STARTED|Overall Study||226
2934365|NCT00606632|3645955|FG000|COMPLETED|Overall Study||204
2934366|NCT00606632|3645955|FG000|NOT COMPLETED|Overall Study||22
2934367|NCT00606684|3645970|FG000|STARTED|2-week Single-Blind Run-in Period||851
2934368|NCT00606684|3645971|FG001|STARTED|2-week Single-Blind Run-in Period||0
2934369|NCT00606684|3645972|FG002|STARTED|2-week Single-Blind Run-in Period||0
2934370|NCT00606684|3645973|FG003|STARTED|2-week Single-Blind Run-in Period||0
2934371|NCT00606684|3645974|FG004|STARTED|2-week Single-Blind Run-in Period||0
2934372|NCT00606684|3645975|FG005|STARTED|2-week Single-Blind Run-in Period||0
2934373|NCT00606684|3645976|FG006|STARTED|2-week Single-Blind Run-in Period||0
2934374|NCT00606684|3645970|FG000|COMPLETED|2-week Single-Blind Run-in Period||605
2934375|NCT00606684|3645971|FG001|COMPLETED|2-week Single-Blind Run-in Period||0
2934376|NCT00606684|3645972|FG002|COMPLETED|2-week Single-Blind Run-in Period||0
2934377|NCT00606684|3645973|FG003|COMPLETED|2-week Single-Blind Run-in Period||0
2934378|NCT00606684|3645974|FG004|COMPLETED|2-week Single-Blind Run-in Period||0
2934379|NCT00606684|3645975|FG005|COMPLETED|2-week Single-Blind Run-in Period||0
2934380|NCT00606684|3645976|FG006|COMPLETED|2-week Single-Blind Run-in Period||0
2934381|NCT00606684|3645970|FG000|NOT COMPLETED|2-week Single-Blind Run-in Period||246
2934382|NCT00606684|3645971|FG001|NOT COMPLETED|2-week Single-Blind Run-in Period||0
2934383|NCT00606684|3645972|FG002|NOT COMPLETED|2-week Single-Blind Run-in Period||0
2934384|NCT00606684|3645973|FG003|NOT COMPLETED|2-week Single-Blind Run-in Period||0
2934385|NCT00606684|3645974|FG004|NOT COMPLETED|2-week Single-Blind Run-in Period||0
2934386|NCT00606684|3645975|FG005|NOT COMPLETED|2-week Single-Blind Run-in Period||0
2934387|NCT00606684|3645976|FG006|NOT COMPLETED|2-week Single-Blind Run-in Period||0
2934388|NCT00606684|3645970|FG000|STARTED|Double-Blind Treatment Period||0
2934389|NCT00606684|3645971|FG001|STARTED|Double-Blind Treatment Period||101
2934390|NCT00606684|3645972|FG002|STARTED|Double-Blind Treatment Period||99
2934391|NCT00606684|3645973|FG003|STARTED|Double-Blind Treatment Period||101
2934392|NCT00606684|3645974|FG004|STARTED|Double-Blind Treatment Period||101
2934393|NCT00606684|3645975|FG005|STARTED|Double-Blind Treatment Period||101
2934394|NCT00606684|3645976|FG006|STARTED|Double-Blind Treatment Period||99
2934395|NCT00606684|3645970|FG000|COMPLETED|Double-Blind Treatment Period||0
2934396|NCT00606684|3645971|FG001|COMPLETED|Double-Blind Treatment Period||85
2934397|NCT00606684|3645972|FG002|COMPLETED|Double-Blind Treatment Period||88
2934398|NCT00606684|3645973|FG003|COMPLETED|Double-Blind Treatment Period||91
2934399|NCT00606684|3645974|FG004|COMPLETED|Double-Blind Treatment Period||92
2934400|NCT00606684|3645975|FG005|COMPLETED|Double-Blind Treatment Period||92
2934401|NCT00606684|3645976|FG006|COMPLETED|Double-Blind Treatment Period||91
2934402|NCT00606684|3645970|FG000|NOT COMPLETED|Double-Blind Treatment Period||0
2934403|NCT00606684|3645971|FG001|NOT COMPLETED|Double-Blind Treatment Period||16
2934404|NCT00606684|3645972|FG002|NOT COMPLETED|Double-Blind Treatment Period||11
2934405|NCT00606684|3645973|FG003|NOT COMPLETED|Double-Blind Treatment Period||10
2934406|NCT00606684|3645974|FG004|NOT COMPLETED|Double-Blind Treatment Period||9
2934407|NCT00606684|3645975|FG005|NOT COMPLETED|Double-Blind Treatment Period||9
2934408|NCT00606684|3645976|FG006|NOT COMPLETED|Double-Blind Treatment Period||8
2934409|NCT00606801|3645992|FG000|STARTED|Adaptation||17
2934410|NCT00606801|3645993|FG001|STARTED|Adaptation||17
2934411|NCT00606801|3645992|FG000|COMPLETED|Adaptation||17
2934412|NCT00606801|3645993|FG001|COMPLETED|Adaptation||17
2934413|NCT00606801|3645992|FG000|NOT COMPLETED|Adaptation||0
2934414|NCT00606801|3645993|FG001|NOT COMPLETED|Adaptation||0
2934415|NCT00606801|3645992|FG000|STARTED|Intervention||17
2934416|NCT00606801|3645993|FG001|STARTED|Intervention||17
2934417|NCT00606801|3645992|FG000|COMPLETED|Intervention||14
2934418|NCT00606801|3645993|FG001|COMPLETED|Intervention||14
2934419|NCT00606801|3645992|FG000|NOT COMPLETED|Intervention||3
2934420|NCT00606801|3645993|FG001|NOT COMPLETED|Intervention||3
2934421|NCT00606892|3646003|FG000|STARTED|Adaptation||9
2934422|NCT00606892|3646004|FG001|STARTED|Adaptation||8
2934423|NCT00606892|3646003|FG000|COMPLETED|Adaptation||9
3042895|NCT01180985|3762828|FG000|STARTED|Period 1 (7 +/- Days)||27
3042896|NCT01180985|3762829|FG001|STARTED|Period 1 (7 +/- Days)||26
3042897|NCT01180985|3762828|FG000|COMPLETED|Period 1 (7 +/- Days)||27
3042898|NCT01180985|3762829|FG001|COMPLETED|Period 1 (7 +/- Days)||26
3042899|NCT01180985|3762828|FG000|NOT COMPLETED|Period 1 (7 +/- Days)||0
3042900|NCT01180985|3762829|FG001|NOT COMPLETED|Period 1 (7 +/- Days)||0
3042901|NCT01180985|3762828|FG000|STARTED|Period 2 (7 +/- 1 Days)||27
3042902|NCT01180985|3762829|FG001|STARTED|Period 2 (7 +/- 1 Days)||26
3042903|NCT01180985|3762828|FG000|COMPLETED|Period 2 (7 +/- 1 Days)||26
3042904|NCT01180985|3762829|FG001|COMPLETED|Period 2 (7 +/- 1 Days)||26
3042905|NCT01180985|3762828|FG000|NOT COMPLETED|Period 2 (7 +/- 1 Days)||1
3042906|NCT01180985|3762829|FG001|NOT COMPLETED|Period 2 (7 +/- 1 Days)||0
3042907|NCT01180998|3762839|FG000|STARTED|Overall Study||67
2934424|NCT00606892|3646004|FG001|COMPLETED|Adaptation||8
2934425|NCT00606892|3646003|FG000|NOT COMPLETED|Adaptation||0
2934426|NCT00606892|3646004|FG001|NOT COMPLETED|Adaptation||0
2934427|NCT00606892|3646003|FG000|STARTED|First Intervention||9
2934428|NCT00606892|3646004|FG001|STARTED|First Intervention||8
2934429|NCT00606892|3646003|FG000|COMPLETED|First Intervention||8
2934430|NCT00606892|3646004|FG001|COMPLETED|First Intervention||4
2934431|NCT00606892|3646003|FG000|NOT COMPLETED|First Intervention||1
2934432|NCT00606892|3646004|FG001|NOT COMPLETED|First Intervention||4
2934433|NCT00606892|3646003|FG000|STARTED|Washout Period||8
2934434|NCT00606892|3646004|FG001|STARTED|Washout Period||4
2934435|NCT00606892|3646003|FG000|COMPLETED|Washout Period||8
2934436|NCT00606892|3646004|FG001|COMPLETED|Washout Period||4
2934437|NCT00606892|3646003|FG000|NOT COMPLETED|Washout Period||0
2934438|NCT00606892|3646004|FG001|NOT COMPLETED|Washout Period||0
2934439|NCT00606892|3646003|FG000|STARTED|Second Intervention||8
2934440|NCT00606892|3646004|FG001|STARTED|Second Intervention||4
2934441|NCT00606892|3646003|FG000|COMPLETED|Second Intervention||8
2934442|NCT00606892|3646004|FG001|COMPLETED|Second Intervention||4
2934443|NCT00606892|3646003|FG000|NOT COMPLETED|Second Intervention||0
2934444|NCT00606892|3646004|FG001|NOT COMPLETED|Second Intervention||0
2934445|NCT00606905|3646038|FG000|STARTED|Overall Study||38
2934446|NCT00606905|3646039|FG001|STARTED|Overall Study||39
2934447|NCT00606905|3646038|FG000|Pregnancy|Overall Study||29
2934448|NCT00606905|3646039|FG001|Pregnancy|Overall Study||33
2934449|NCT00606905|3646038|FG000|COMPLETED|Overall Study||23
2934450|NCT00606905|3646039|FG001|COMPLETED|Overall Study||24
2934451|NCT00606905|3646038|FG000|NOT COMPLETED|Overall Study||15
2934452|NCT00606905|3646039|FG001|NOT COMPLETED|Overall Study||15
2934453|NCT00606931|3646045|FG000|STARTED|Overall Study||22
3180090|NCT01988402|3908346|FG000|COMPLETED|Overall Study||14
3180091|NCT01988402|3908347|FG001|COMPLETED|Overall Study||17
3180092|NCT01988402|3908346|FG000|NOT COMPLETED|Overall Study||2
3180093|NCT01988402|3908347|FG001|NOT COMPLETED|Overall Study||2
3180094|NCT01988415|3908353|FG000|STARTED|Overall Study|52 eyes of 26 subjects (paired-eyes: commercial and investigational software)|26
2934454|NCT00606931|3646045|FG000|COMPLETED|Overall Study||19
2934455|NCT00606931|3646045|FG000|NOT COMPLETED|Overall Study||3
2934456|NCT00606944|3646051|FG000|STARTED|Overall Study||98
2934457|NCT00606944|3646052|FG001|STARTED|Overall Study||100
2934458|NCT00606944|3646051|FG000|COMPLETED|Overall Study||98
2934459|NCT00606944|3646052|FG001|COMPLETED|Overall Study||100
2934460|NCT00606944|3646051|FG000|NOT COMPLETED|Overall Study||0
2934461|NCT00606944|3646052|FG001|NOT COMPLETED|Overall Study||0
2934462|NCT00607022|3646061|FG000|STARTED|Overall Study||7
2934463|NCT00607022|3646062|FG001|STARTED|Overall Study||15
2934464|NCT00607022|3646063|FG002|STARTED|Overall Study||19
2934465|NCT00607022|3646061|FG000|COMPLETED|Overall Study||6
2934466|NCT00607022|3646062|FG001|COMPLETED|Overall Study||15
2934467|NCT00607022|3646063|FG002|COMPLETED|Overall Study||19
2934468|NCT00607022|3646061|FG000|NOT COMPLETED|Overall Study||1
2934469|NCT00607022|3646062|FG001|NOT COMPLETED|Overall Study||0
2934470|NCT00607022|3646063|FG002|NOT COMPLETED|Overall Study||0
2934471|NCT00607048|3646073|FG000|STARTED|Overall Study||3
2934472|NCT00607048|3646074|FG001|STARTED|Overall Study||6
2934473|NCT00607048|3646075|FG002|STARTED|Overall Study||7
2934474|NCT00607048|3646076|FG003|STARTED|Overall Study||3
2934475|NCT00607048|3646077|FG004|STARTED|Overall Study||6
2934476|NCT00607048|3646078|FG005|STARTED|Overall Study||7
2934477|NCT00607048|3646073|FG000|COMPLETED|Overall Study||0
2934478|NCT00607048|3646074|FG001|COMPLETED|Overall Study||2
2934479|NCT00607048|3646075|FG002|COMPLETED|Overall Study||3
2934480|NCT00607048|3646076|FG003|COMPLETED|Overall Study||0
2934481|NCT00607048|3646077|FG004|COMPLETED|Overall Study||0
2934482|NCT00607048|3646078|FG005|COMPLETED|Overall Study||2
2934483|NCT00607048|3646073|FG000|NOT COMPLETED|Overall Study||3
2934484|NCT00607048|3646074|FG001|NOT COMPLETED|Overall Study||4
2934485|NCT00607048|3646075|FG002|NOT COMPLETED|Overall Study||4
2934486|NCT00607048|3646076|FG003|NOT COMPLETED|Overall Study||3
2934487|NCT00607048|3646077|FG004|NOT COMPLETED|Overall Study||6
3042908|NCT01180998|3762840|FG001|STARTED|Overall Study||72
3042909|NCT01180998|3762841|FG002|STARTED|Overall Study||61
3042910|NCT01180998|3762839|FG000|COMPLETED|Overall Study||63
3042911|NCT01180998|3762840|FG001|COMPLETED|Overall Study||68
3042912|NCT01180998|3762841|FG002|COMPLETED|Overall Study||51
3042913|NCT01180998|3762839|FG000|NOT COMPLETED|Overall Study||4
3042914|NCT01180998|3762840|FG001|NOT COMPLETED|Overall Study||4
3042915|NCT01180998|3762841|FG002|NOT COMPLETED|Overall Study||10
3042916|NCT01181011|3762850|FG000|STARTED|Overall Study||28
3042917|NCT01181011|3762850|FG000|Received Telmisartan 80mg|Overall Study||27
3042918|NCT01181011|3762850|FG000|Received Telmisartan 80mg,Amlodipine 5mg|Overall Study||27
3042919|NCT01181011|3762850|FG000|Received Amlodipine 5mg|Overall Study||26
3042920|NCT01181011|3762850|FG000|COMPLETED|Overall Study||25
3042921|NCT01181011|3762850|FG000|NOT COMPLETED|Overall Study||3
3042922|NCT01181050|3762861|FG000|STARTED|Overall Study||41
3042923|NCT01181050|3762862|FG001|STARTED|Overall Study||22
3042924|NCT01181050|3762861|FG000|COMPLETED|Overall Study||41
3042925|NCT01181050|3762862|FG001|COMPLETED|Overall Study||22
3042926|NCT01181050|3762861|FG000|NOT COMPLETED|Overall Study||0
3042927|NCT01181050|3762862|FG001|NOT COMPLETED|Overall Study||0
3042928|NCT01181076|3762870|FG000|STARTED|Overall Study||59
2934488|NCT00607048|3646078|FG005|NOT COMPLETED|Overall Study||5
3042929|NCT01181076|3762871|FG001|STARTED|Overall Study||60
2934489|NCT00607087|3646097|FG000|STARTED|Overall Study||99
2934490|NCT00607087|3646098|FG001|STARTED|Overall Study||95
2934491|NCT00607087|3646099|FG002|STARTED|Overall Study||94
2934492|NCT00607087|3646097|FG000|COMPLETED|Overall Study||84
2934493|NCT00607087|3646098|FG001|COMPLETED|Overall Study||84
2934494|NCT00607087|3646099|FG002|COMPLETED|Overall Study||84
2934495|NCT00607087|3646097|FG000|NOT COMPLETED|Overall Study||15
2934496|NCT00607087|3646098|FG001|NOT COMPLETED|Overall Study||11
2934497|NCT00607087|3646099|FG002|NOT COMPLETED|Overall Study||10
2934498|NCT00607087|3646097|FG000|STARTED|Period 1||99
2934499|NCT00607087|3646098|FG001|STARTED|Period 1||95
2934500|NCT00607087|3646099|FG002|STARTED|Period 1||94
2934501|NCT00607087|3646097|FG000|COMPLETED|Period 1||87
2934502|NCT00607087|3646098|FG001|COMPLETED|Period 1||89
2934503|NCT00607087|3646099|FG002|COMPLETED|Period 1||89
2934504|NCT00607087|3646097|FG000|NOT COMPLETED|Period 1||12
2934505|NCT00607087|3646098|FG001|NOT COMPLETED|Period 1||6
2934506|NCT00607087|3646099|FG002|NOT COMPLETED|Period 1||5
2934507|NCT00607087|3646097|FG000|STARTED|Period 2||87
2934508|NCT00607087|3646098|FG001|STARTED|Period 2||89
2934509|NCT00607087|3646099|FG002|STARTED|Period 2||89
2934510|NCT00607087|3646097|FG000|COMPLETED|Period 2||86
2934511|NCT00607087|3646098|FG001|COMPLETED|Period 2||86
2934512|NCT00607087|3646099|FG002|COMPLETED|Period 2||84
2934513|NCT00607087|3646097|FG000|NOT COMPLETED|Period 2||1
2934514|NCT00607087|3646098|FG001|NOT COMPLETED|Period 2||3
2934515|NCT00607087|3646099|FG002|NOT COMPLETED|Period 2||5
2934516|NCT00607087|3646097|FG000|STARTED|Period 3||86
2934517|NCT00607087|3646098|FG001|STARTED|Period 3||86
2934518|NCT00607087|3646099|FG002|STARTED|Period 3||84
2934519|NCT00607087|3646097|FG000|COMPLETED|Period 3||84
2934520|NCT00607087|3646098|FG001|COMPLETED|Period 3||84
2934521|NCT00607087|3646099|FG002|COMPLETED|Period 3||84
2934522|NCT00607087|3646097|FG000|NOT COMPLETED|Period 3||2
2934523|NCT00607087|3646098|FG001|NOT COMPLETED|Period 3||2
2934524|NCT00607087|3646099|FG002|NOT COMPLETED|Period 3||0
2934525|NCT00607113|3646109|FG000|STARTED|Overall Study||19
2934526|NCT00607113|3646110|FG001|STARTED|Overall Study||20
2934527|NCT00607113|3646109|FG000|COMPLETED|Overall Study||19
2934528|NCT00607113|3646110|FG001|COMPLETED|Overall Study||20
2934529|NCT00607113|3646109|FG000|NOT COMPLETED|Overall Study||0
2934530|NCT00607113|3646110|FG001|NOT COMPLETED|Overall Study||0
2934531|NCT00607126|3646117|FG000|STARTED|Overall Study||17
2934532|NCT00607126|3646118|FG001|STARTED|Overall Study||19
2934533|NCT00607126|3646117|FG000|COMPLETED|Overall Study||17
2934534|NCT00607126|3646118|FG001|COMPLETED|Overall Study||19
2934535|NCT00607126|3646117|FG000|NOT COMPLETED|Overall Study||0
2934536|NCT00607126|3646118|FG001|NOT COMPLETED|Overall Study||0
2934537|NCT00607243|3646126|FG000|STARTED|Initial Post-vaccination Period||82
2934538|NCT00607243|3646127|FG001|STARTED|Initial Post-vaccination Period||41
2934539|NCT00607243|3646126|FG000|COMPLETED|Initial Post-vaccination Period||82
3042930|NCT01181076|3762870|FG000|COMPLETED|Overall Study||40
3180095|NCT01988415|3908353|FG000|COMPLETED|Overall Study||26
3180096|NCT01988415|3908353|FG000|NOT COMPLETED|Overall Study||0
3180097|NCT01988493|3908364|FG000|STARTED|Overall Study||7
3180098|NCT01988493|3908365|FG001|STARTED|Overall Study||14
3180099|NCT01988493|3908366|FG002|STARTED|Overall Study||6
3180100|NCT01988493|3908367|FG003|STARTED|Overall Study||45
3180101|NCT01988493|3908368|FG004|STARTED|Overall Study||45
3180102|NCT01988493|3908364|FG000|Treated|Overall Study||7
3180103|NCT01988493|3908365|FG001|Treated|Overall Study||14
3180104|NCT01988493|3908366|FG002|Treated|Overall Study||6
3180105|NCT01988493|3908367|FG003|Treated|Overall Study||45
3180106|NCT01988493|3908368|FG004|Treated|Overall Study||44
3180107|NCT01988493|3908364|FG000|Safety Population|Overall Study||7
3180108|NCT01988493|3908365|FG001|Safety Population|Overall Study||14
3180109|NCT01988493|3908366|FG002|Safety Population|Overall Study||6
3180110|NCT01988493|3908367|FG003|Safety Population|Overall Study||45
3180111|NCT01988493|3908368|FG004|Safety Population|Overall Study||44
3180112|NCT01988493|3908364|FG000|COMPLETED|Overall Study||7
3180113|NCT01988493|3908365|FG001|COMPLETED|Overall Study||14
3180114|NCT01988493|3908366|FG002|COMPLETED|Overall Study||6
3180115|NCT01988493|3908367|FG003|COMPLETED|Overall Study||43
3180116|NCT01988493|3908368|FG004|COMPLETED|Overall Study||44
3180117|NCT01988493|3908364|FG000|NOT COMPLETED|Overall Study||0
3180118|NCT01988493|3908365|FG001|NOT COMPLETED|Overall Study||0
3180119|NCT01988493|3908366|FG002|NOT COMPLETED|Overall Study||0
3180120|NCT01988493|3908367|FG003|NOT COMPLETED|Overall Study||2
3180121|NCT01988493|3908368|FG004|NOT COMPLETED|Overall Study||1
3180122|NCT01988662|3908382|FG000|STARTED|Overall Study||104
3042931|NCT01181076|3762871|FG001|COMPLETED|Overall Study|As determined|48
3042932|NCT01181076|3762870|FG000|NOT COMPLETED|Overall Study||19
3180123|NCT01988662|3908383|FG001|STARTED|Overall Study||101
3180124|NCT01988662|3908382|FG000|COMPLETED|Overall Study||100
3042933|NCT01181076|3762871|FG001|NOT COMPLETED|Overall Study||12
3042934|NCT01181102|3762879|FG000|STARTED|Overall Study||360
3042935|NCT01181102|3762880|FG001|STARTED|Overall Study||356
3042936|NCT01181102|3762879|FG000|Safety Analysis Set|Overall Study||354
3042937|NCT01181102|3762880|FG001|Safety Analysis Set|Overall Study||349
3042938|NCT01181102|3762879|FG000|Efficacy Analysis Population|Overall Study||299
3180125|NCT01988662|3908383|FG001|COMPLETED|Overall Study||99
3180126|NCT01988662|3908382|FG000|NOT COMPLETED|Overall Study||4
3180127|NCT01988662|3908383|FG001|NOT COMPLETED|Overall Study||2
2934540|NCT00607243|3646127|FG001|COMPLETED|Initial Post-vaccination Period||41
2934541|NCT00607243|3646126|FG000|NOT COMPLETED|Initial Post-vaccination Period||0
2934542|NCT00607243|3646127|FG001|NOT COMPLETED|Initial Post-vaccination Period||0
2934543|NCT00607243|3646126|FG000|STARTED|Telephone Safety Assessment Period||82
2934544|NCT00607243|3646127|FG001|STARTED|Telephone Safety Assessment Period||41
2934545|NCT00607243|3646126|FG000|COMPLETED|Telephone Safety Assessment Period|80 Available for 3 months 77 Available for 6 months|77
2934546|NCT00607243|3646127|FG001|COMPLETED|Telephone Safety Assessment Period|40 Available for 3 months 39 Available for 6 months|39
2934547|NCT00607243|3646126|FG000|NOT COMPLETED|Telephone Safety Assessment Period||5
2934548|NCT00607243|3646127|FG001|NOT COMPLETED|Telephone Safety Assessment Period||2
2934549|NCT00607269|3646135|FG000|STARTED|Overall Study||67
2934550|NCT00607269|3646136|FG001|STARTED|Overall Study||64
2934551|NCT00607269|3646135|FG000|COMPLETED|Overall Study||67
2934552|NCT00607269|3646136|FG001|COMPLETED|Overall Study||64
2934553|NCT00607269|3646135|FG000|NOT COMPLETED|Overall Study||0
2934554|NCT00607269|3646136|FG001|NOT COMPLETED|Overall Study||0
2934555|NCT00607321|3646142|FG000|STARTED|Overall Study||60
2934556|NCT00607321|3646142|FG000|COMPLETED|Overall Study||60
2934557|NCT00607321|3646142|FG000|NOT COMPLETED|Overall Study||0
2934558|NCT00607373|3646150|FG000|STARTED|Treatment Period||17
2934559|NCT00607373|3646151|FG001|STARTED|Treatment Period||34
2934560|NCT00607373|3646150|FG000|COMPLETED|Treatment Period|16 enrolled in open-label extension study NCT00694109|17
2934561|NCT00607373|3646151|FG001|COMPLETED|Treatment Period|23 enrolled in open-label extension study NCT00694109|28
2934562|NCT00607373|3646150|FG000|NOT COMPLETED|Treatment Period||0
2934563|NCT00607373|3646151|FG001|NOT COMPLETED|Treatment Period||6
2934564|NCT00607373|3646150|FG000|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|1
2934565|NCT00607373|3646151|FG001|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|11
2934566|NCT00607373|3646150|FG000|COMPLETED|Follow-up Period||0
2934567|NCT00607373|3646151|FG001|COMPLETED|Follow-up Period||6
2934568|NCT00607373|3646150|FG000|NOT COMPLETED|Follow-up Period||1
2934569|NCT00607373|3646151|FG001|NOT COMPLETED|Follow-up Period||5
2934570|NCT00607386|3646157|FG000|STARTED|Overall Study||28
2934571|NCT00607386|3646157|FG000|COMPLETED|Overall Study||27
2934572|NCT00607386|3646157|FG000|NOT COMPLETED|Overall Study||1
2934573|NCT00607594|3646161|FG000|STARTED|Overall Study||21
2934574|NCT00607594|3646161|FG000|COMPLETED|Overall Study||21
2934575|NCT00607594|3646161|FG000|NOT COMPLETED|Overall Study||0
2934576|NCT00607620|3646169|FG000|STARTED|Overall Study||409
2934577|NCT00607620|3646170|FG001|STARTED|Overall Study||469
2934578|NCT00607620|3646169|FG000|COMPLETED|Overall Study||409
3042939|NCT01181102|3762880|FG001|Efficacy Analysis Population|Overall Study||295
3042940|NCT01181102|3762879|FG000|COMPLETED|Overall Study||309
3042941|NCT01181102|3762880|FG001|COMPLETED|Overall Study||310
3042942|NCT01181102|3762879|FG000|NOT COMPLETED|Overall Study||51
3042943|NCT01181102|3762880|FG001|NOT COMPLETED|Overall Study||46
3042944|NCT01181128|3762889|FG000|STARTED|Overall Study||118
3042945|NCT01181128|3762890|FG001|STARTED|Overall Study||24
3042946|NCT01181128|3762891|FG002|STARTED|Overall Study||23
3042947|NCT01181128|3762889|FG000|Pharmacokinetic (PK) Subgroup|Overall Study||30
3042948|NCT01181128|3762890|FG001|Pharmacokinetic (PK) Subgroup|Overall Study||0
3042949|NCT01181128|3762891|FG002|Pharmacokinetic (PK) Subgroup|Overall Study||0
3042950|NCT01181128|3762889|FG000|Perioperative Management Subgroup|Overall Study|Participants who underwent major surgery.|8
3042951|NCT01181128|3762890|FG001|Perioperative Management Subgroup|Overall Study|Participants who underwent major surgery.|1
3042952|NCT01181128|3762891|FG002|Perioperative Management Subgroup|Overall Study|Participants who underwent major surgery.|0
3042953|NCT01181128|3762889|FG000|COMPLETED|Overall Study||112
3042954|NCT01181128|3762890|FG001|COMPLETED|Overall Study||19
3042955|NCT01181128|3762891|FG002|COMPLETED|Overall Study||22
3042956|NCT01181128|3762889|FG000|NOT COMPLETED|Overall Study||6
3042957|NCT01181128|3762890|FG001|NOT COMPLETED|Overall Study||5
3180128|NCT01988779|3908392|FG000|STARTED|Overall Study||12
3180129|NCT01988779|3908393|FG001|STARTED|Overall Study||13
3180130|NCT01988779|3908392|FG000|COMPLETED|Overall Study||9
3042958|NCT01181128|3762891|FG002|NOT COMPLETED|Overall Study||1
3042959|NCT01181141|3762913|FG000|STARTED|Overall Study||62
3042960|NCT01181141|3762914|FG001|STARTED|Overall Study||30
3042961|NCT01181141|3762913|FG000|Safety Analysis Population|Overall Study||59
3042962|NCT01181141|3762914|FG001|Safety Analysis Population|Overall Study||29
3042963|NCT01181141|3762913|FG000|COMPLETED|Overall Study||50
3042964|NCT01181141|3762914|FG001|COMPLETED|Overall Study||26
3042965|NCT01181141|3762913|FG000|NOT COMPLETED|Overall Study||12
3042966|NCT01181141|3762914|FG001|NOT COMPLETED|Overall Study||4
3042967|NCT01181167|3762922|FG000|STARTED|Overall Study||307
3042968|NCT01181167|3762923|FG001|STARTED|Overall Study||303
3180131|NCT01988779|3908393|FG001|COMPLETED|Overall Study||11
3180132|NCT01988779|3908392|FG000|NOT COMPLETED|Overall Study||3
3180133|NCT01988779|3908393|FG001|NOT COMPLETED|Overall Study||2
3180134|NCT01988857|3908399|FG000|STARTED|Overall Study||300
3180135|NCT01988857|3908399|FG000|COMPLETED|Overall Study||300
3180136|NCT01988857|3908399|FG000|NOT COMPLETED|Overall Study||0
3180137|NCT01988922|3908406|FG000|STARTED|Overall Study||10
3180138|NCT01988922|3908407|FG001|STARTED|Overall Study||10
3180139|NCT01988922|3908408|FG002|STARTED|Overall Study||10
3180140|NCT01988922|3908406|FG000|COMPLETED|Overall Study||10
3180141|NCT01988922|3908407|FG001|COMPLETED|Overall Study||10
3180142|NCT01988922|3908408|FG002|COMPLETED|Overall Study||10
2934579|NCT00607620|3646170|FG001|COMPLETED|Overall Study||469
2934580|NCT00607620|3646169|FG000|NOT COMPLETED|Overall Study||0
2934581|NCT00607620|3646170|FG001|NOT COMPLETED|Overall Study||0
2934582|NCT00607672|3646179|FG000|STARTED|Overall Study||32
2934583|NCT00607672|3646180|FG001|STARTED|Overall Study||27
2934584|NCT00607672|3646181|FG002|STARTED|Overall Study||27
2934585|NCT00607672|3646179|FG000|COMPLETED|Overall Study||28
2934586|NCT00607672|3646180|FG001|COMPLETED|Overall Study||24
2934587|NCT00607672|3646181|FG002|COMPLETED|Overall Study||22
2934588|NCT00607672|3646179|FG000|NOT COMPLETED|Overall Study||4
2934589|NCT00607672|3646180|FG001|NOT COMPLETED|Overall Study||3
2934590|NCT00607672|3646181|FG002|NOT COMPLETED|Overall Study||5
2934591|NCT00607724|3646199|FG000|STARTED|Stage 1: Dose Escalation||7
2934592|NCT00607724|3646200|FG001|STARTED|Stage 1: Dose Escalation||9
2934593|NCT00607724|3646201|FG002|STARTED|Stage 1: Dose Escalation||4
2934594|NCT00607724|3646202|FG003|STARTED|Stage 1: Dose Escalation||0
2934595|NCT00607724|3646203|FG004|STARTED|Stage 1: Dose Escalation||0
2934596|NCT00607724|3646204|FG005|STARTED|Stage 1: Dose Escalation||0
2934597|NCT00607724|3646205|FG006|STARTED|Stage 1: Dose Escalation||0
2934598|NCT00607724|3646199|FG000|COMPLETED|Stage 1: Dose Escalation||0
2934599|NCT00607724|3646200|FG001|COMPLETED|Stage 1: Dose Escalation|Participants still on treatment at time of study closure were considered 'completers'.|1
2934600|NCT00607724|3646201|FG002|COMPLETED|Stage 1: Dose Escalation||0
2934601|NCT00607724|3646202|FG003|COMPLETED|Stage 1: Dose Escalation||0
2934602|NCT00607724|3646203|FG004|COMPLETED|Stage 1: Dose Escalation||0
2934603|NCT00607724|3646204|FG005|COMPLETED|Stage 1: Dose Escalation||0
2934604|NCT00607724|3646205|FG006|COMPLETED|Stage 1: Dose Escalation||0
2934605|NCT00607724|3646199|FG000|NOT COMPLETED|Stage 1: Dose Escalation||7
2934606|NCT00607724|3646200|FG001|NOT COMPLETED|Stage 1: Dose Escalation||8
2934607|NCT00607724|3646201|FG002|NOT COMPLETED|Stage 1: Dose Escalation||4
2934608|NCT00607724|3646202|FG003|NOT COMPLETED|Stage 1: Dose Escalation||0
2934609|NCT00607724|3646203|FG004|NOT COMPLETED|Stage 1: Dose Escalation||0
2934610|NCT00607724|3646204|FG005|NOT COMPLETED|Stage 1: Dose Escalation||0
2934611|NCT00607724|3646205|FG006|NOT COMPLETED|Stage 1: Dose Escalation||0
2934612|NCT00607724|3646199|FG000|STARTED|Stage 2: Expanded Cohort||0
2934613|NCT00607724|3646200|FG001|STARTED|Stage 2: Expanded Cohort||0
2934614|NCT00607724|3646201|FG002|STARTED|Stage 2: Expanded Cohort||0
2934615|NCT00607724|3646202|FG003|STARTED|Stage 2: Expanded Cohort||6
2934616|NCT00607724|3646203|FG004|STARTED|Stage 2: Expanded Cohort||14
2934617|NCT00607724|3646204|FG005|STARTED|Stage 2: Expanded Cohort||12
2934618|NCT00607724|3646205|FG006|STARTED|Stage 2: Expanded Cohort||16
2934619|NCT00607724|3646199|FG000|COMPLETED|Stage 2: Expanded Cohort||0
2934620|NCT00607724|3646200|FG001|COMPLETED|Stage 2: Expanded Cohort||0
2934621|NCT00607724|3646201|FG002|COMPLETED|Stage 2: Expanded Cohort||0
2934622|NCT00607724|3646202|FG003|COMPLETED|Stage 2: Expanded Cohort|Participants still on treatment at time of study closure were considered 'completers'.|1
3042969|NCT01181167|3762922|FG000|Efficacy Analysis Population|Overall Study||255
3042970|NCT01181167|3762923|FG001|Efficacy Analysis Population|Overall Study||248
3042971|NCT01181167|3762922|FG000|COMPLETED|Overall Study||284
3042972|NCT01181167|3762923|FG001|COMPLETED|Overall Study||271
3042973|NCT01181167|3762922|FG000|NOT COMPLETED|Overall Study||23
3042974|NCT01181167|3762923|FG001|NOT COMPLETED|Overall Study||32
3042975|NCT01181258|3762929|FG000|STARTED|Overall Study||16
3042976|NCT01181258|3762929|FG000|COMPLETED|Overall Study||16
3042977|NCT01181258|3762929|FG000|NOT COMPLETED|Overall Study||0
3042978|NCT01181271|3762933|FG000|STARTED|Autologous Transplant||42
3042979|NCT01181271|3762933|FG000|COMPLETED|Autologous Transplant||42
3042980|NCT01181271|3762933|FG000|NOT COMPLETED|Autologous Transplant||0
3042981|NCT01181271|3762933|FG000|STARTED|Evaluation for Allogeneic Transplant||42
3042982|NCT01181271|3762933|FG000|COMPLETED|Evaluation for Allogeneic Transplant||29
3042983|NCT01181271|3762933|FG000|NOT COMPLETED|Evaluation for Allogeneic Transplant||13
3042984|NCT01181271|3762933|FG000|STARTED|Allogeneic Transplant||29
3042985|NCT01181271|3762933|FG000|COMPLETED|Allogeneic Transplant||29
3042986|NCT01181271|3762933|FG000|NOT COMPLETED|Allogeneic Transplant||0
3042987|NCT01181323|3762941|FG000|STARTED|Overall Study||124
3042988|NCT01181323|3762942|FG001|STARTED|Overall Study||124
3042989|NCT01181323|3762943|FG002|STARTED|Overall Study||124
3042990|NCT01181323|3762944|FG003|STARTED|Overall Study||125
3042991|NCT01181323|3762941|FG000|COMPLETED|Overall Study||123
3042992|NCT01181323|3762942|FG001|COMPLETED|Overall Study||121
3042993|NCT01181323|3762943|FG002|COMPLETED|Overall Study||123
3042994|NCT01181323|3762944|FG003|COMPLETED|Overall Study||122
3042995|NCT01181323|3762941|FG000|NOT COMPLETED|Overall Study||1
3137222|NCT01717326|3862438|FG013|NOT COMPLETED|Overall Study||0
3137223|NCT01717326|3862439|FG014|NOT COMPLETED|Overall Study||0
3137224|NCT01717326|3862440|FG015|NOT COMPLETED|Overall Study||3
3137225|NCT01717326|3862441|FG016|NOT COMPLETED|Overall Study||1
3137226|NCT01717326|3862442|FG017|NOT COMPLETED|Overall Study||0
3137227|NCT01717326|3862443|FG018|NOT COMPLETED|Overall Study||4
3137228|NCT01717326|3862444|FG019|NOT COMPLETED|Overall Study||6
3137229|NCT01717391|3862486|FG000|STARTED|Overall Study||36
3137230|NCT01717391|3862486|FG000|COMPLETED|Overall Study||27
3137231|NCT01717391|3862486|FG000|NOT COMPLETED|Overall Study||9
3137232|NCT01717456|3862494|FG000|STARTED|End of Treatment||11
3137233|NCT01717456|3862495|FG001|STARTED|End of Treatment||8
3137234|NCT01717456|3862494|FG000|COMPLETED|End of Treatment||11
3137235|NCT01717456|3862495|FG001|COMPLETED|End of Treatment||6
2934623|NCT00607724|3646203|FG004|COMPLETED|Stage 2: Expanded Cohort|Participants still on treatment at time of study closure were considered 'completers'.|5
2934624|NCT00607724|3646204|FG005|COMPLETED|Stage 2: Expanded Cohort||0
2934625|NCT00607724|3646205|FG006|COMPLETED|Stage 2: Expanded Cohort|Participants still on treatment at time of study closure were considered 'completers'.|5
2934626|NCT00607724|3646199|FG000|NOT COMPLETED|Stage 2: Expanded Cohort||0
2934627|NCT00607724|3646200|FG001|NOT COMPLETED|Stage 2: Expanded Cohort||0
2934628|NCT00607724|3646201|FG002|NOT COMPLETED|Stage 2: Expanded Cohort||0
2934629|NCT00607724|3646202|FG003|NOT COMPLETED|Stage 2: Expanded Cohort||5
2934630|NCT00607724|3646203|FG004|NOT COMPLETED|Stage 2: Expanded Cohort||9
2934631|NCT00607724|3646204|FG005|NOT COMPLETED|Stage 2: Expanded Cohort||12
2934632|NCT00607724|3646205|FG006|NOT COMPLETED|Stage 2: Expanded Cohort||11
2934633|NCT00607789|3646231|FG000|STARTED|Overall Study|20 participants were randomized in each group|20
2934634|NCT00607789|3646232|FG001|STARTED|Overall Study||20
2934635|NCT00607789|3646231|FG000|COMPLETED|Overall Study||13
2934636|NCT00607789|3646232|FG001|COMPLETED|Overall Study||14
2934637|NCT00607789|3646231|FG000|NOT COMPLETED|Overall Study||7
2934638|NCT00607789|3646232|FG001|NOT COMPLETED|Overall Study||6
2934639|NCT00607815|3646240|FG000|STARTED|Overall Study||43
2934640|NCT00607815|3646241|FG001|STARTED|Overall Study||36
2934641|NCT00607815|3646240|FG000|COMPLETED|Overall Study||20
2934642|NCT00607815|3646241|FG001|COMPLETED|Overall Study||25
2934643|NCT00607815|3646240|FG000|NOT COMPLETED|Overall Study||23
2934644|NCT00607815|3646241|FG001|NOT COMPLETED|Overall Study||11
2934645|NCT00607867|3646251|FG000|STARTED|Overall Study||7
2934646|NCT00607867|3646252|FG001|STARTED|Overall Study||7
2934647|NCT00607867|3646251|FG000|COMPLETED|Overall Study||7
2934648|NCT00607867|3646252|FG001|COMPLETED|Overall Study||7
2934649|NCT00607867|3646251|FG000|NOT COMPLETED|Overall Study||0
2934650|NCT00607867|3646252|FG001|NOT COMPLETED|Overall Study||0
2934651|NCT00607880|3646260|FG000|STARTED|Overall Study||50
2934652|NCT00607880|3646261|FG001|STARTED|Overall Study||50
2934653|NCT00607880|3646260|FG000|COMPLETED|Overall Study||49
2934654|NCT00607880|3646261|FG001|COMPLETED|Overall Study||50
2934655|NCT00607880|3646260|FG000|NOT COMPLETED|Overall Study||1
2934656|NCT00607880|3646261|FG001|NOT COMPLETED|Overall Study||0
2934657|NCT00607893|3646269|FG000|STARTED|Overall Study||77
2934658|NCT00607893|3646270|FG001|STARTED|Overall Study||76
2934659|NCT00607893|3646269|FG000|Completed Baseline Visit|Overall Study||74
2934660|NCT00607893|3646270|FG001|Completed Baseline Visit|Overall Study||75
2934661|NCT00607893|3646269|FG000|Completed 8 Week Visit|Overall Study||71
2934662|NCT00607893|3646270|FG001|Completed 8 Week Visit|Overall Study||72
2934663|NCT00607893|3646269|FG000|Completed 12 Week Visit|Overall Study|12 Week Visit only offered to participants on actual CPAP Treatment|0
2934664|NCT00607893|3646270|FG001|Completed 12 Week Visit|Overall Study|12 Week Visit only offered to participants on actual CPAP Treatment|29
2934665|NCT00607893|3646269|FG000|COMPLETED|Overall Study||71
2934666|NCT00607893|3646270|FG001|COMPLETED|Overall Study||72
3042996|NCT01181323|3762942|FG001|NOT COMPLETED|Overall Study||3
3042997|NCT01181323|3762943|FG002|NOT COMPLETED|Overall Study||1
3042998|NCT01181323|3762944|FG003|NOT COMPLETED|Overall Study||3
3042999|NCT01181349|3762966|FG000|STARTED|Overall Study||350
3043000|NCT01181349|3762966|FG000|COMPLETED|Overall Study||350
3043001|NCT01181349|3762966|FG000|NOT COMPLETED|Overall Study||0
3043002|NCT01181479|3762974|FG000|STARTED|Subjects Receive AG200-15 or Lessina||1129
3043003|NCT01181479|3762975|FG001|STARTED|Subjects Receive AG200-15 or Lessina||375
3043004|NCT01181479|3762976|FG002|STARTED|Subjects Receive AG200-15 or Lessina|"This column is a subset of the Lessina completers in the Lessina (Cycles 1-6) column."|0
3043005|NCT01181479|3762974|FG000|COMPLETED|Subjects Receive AG200-15 or Lessina||485
3043006|NCT01181479|3762975|FG001|COMPLETED|Subjects Receive AG200-15 or Lessina||249
3043007|NCT01181479|3762976|FG002|COMPLETED|Subjects Receive AG200-15 or Lessina||0
3043008|NCT01181479|3762974|FG000|NOT COMPLETED|Subjects Receive AG200-15 or Lessina||644
3043009|NCT01181479|3762975|FG001|NOT COMPLETED|Subjects Receive AG200-15 or Lessina||126
3043010|NCT01181479|3762976|FG002|NOT COMPLETED|Subjects Receive AG200-15 or Lessina||0
3043011|NCT01181479|3762974|FG000|STARTED|Crossover Subjects Recieve AG200-15||0
3043012|NCT01181479|3762975|FG001|STARTED|Crossover Subjects Recieve AG200-15||0
3043013|NCT01181479|3762976|FG002|STARTED|Crossover Subjects Recieve AG200-15|"This column is a subset of the Lessina completers in the Lessina (Cycles 1-6) column."|249
3043014|NCT01181479|3762974|FG000|COMPLETED|Crossover Subjects Recieve AG200-15||0
3043015|NCT01181479|3762975|FG001|COMPLETED|Crossover Subjects Recieve AG200-15||0
3043016|NCT01181479|3762976|FG002|COMPLETED|Crossover Subjects Recieve AG200-15||150
3043017|NCT01181479|3762974|FG000|NOT COMPLETED|Crossover Subjects Recieve AG200-15||0
3043018|NCT01181479|3762975|FG001|NOT COMPLETED|Crossover Subjects Recieve AG200-15||0
3043019|NCT01181479|3762976|FG002|NOT COMPLETED|Crossover Subjects Recieve AG200-15||99
3043020|NCT01181492|3762991|FG000|STARTED|Overall Study||103
3043021|NCT01181492|3762992|FG001|STARTED|Overall Study||66
3043022|NCT01181492|3762993|FG002|STARTED|Overall Study||7
3043023|NCT01181492|3762991|FG000|COMPLETED|Overall Study||103
3043024|NCT01181492|3762992|FG001|COMPLETED|Overall Study||66
3043025|NCT01181492|3762993|FG002|COMPLETED|Overall Study||7
3043026|NCT01181492|3762991|FG000|NOT COMPLETED|Overall Study||0
3043027|NCT01181492|3762992|FG001|NOT COMPLETED|Overall Study||0
3043028|NCT01181492|3762993|FG002|NOT COMPLETED|Overall Study||0
3043029|NCT01181531|3763003|FG000|STARTED|Overall Study|Subjects are randomized after washout.|157
3043030|NCT01181531|3763004|FG001|STARTED|Overall Study|Subjects are randomized after washout.|155
2934667|NCT00607893|3646269|FG000|NOT COMPLETED|Overall Study||6
2934668|NCT00607893|3646270|FG001|NOT COMPLETED|Overall Study||4
2934669|NCT00607919|3646280|FG000|STARTED|Acute Phase||120
2934670|NCT00607919|3646281|FG001|STARTED|Acute Phase||89
2934671|NCT00607919|3646280|FG000|COMPLETED|Acute Phase|2 participants completed acute phase but did not continue into open-label.|86
2934672|NCT00607919|3646281|FG001|COMPLETED|Acute Phase|2 participants completed acute phase but did not continue into open-label.|73
2934673|NCT00607919|3646280|FG000|NOT COMPLETED|Acute Phase||34
2934674|NCT00607919|3646281|FG001|NOT COMPLETED|Acute Phase||16
2934675|NCT00607919|3646280|FG000|STARTED|Open-Label Phase||84
2934676|NCT00607919|3646281|FG001|STARTED|Open-Label Phase||71
2934677|NCT00607919|3646280|FG000|COMPLETED|Open-Label Phase||74
2934678|NCT00607919|3646281|FG001|COMPLETED|Open-Label Phase||59
2934679|NCT00607919|3646280|FG000|NOT COMPLETED|Open-Label Phase||10
2934680|NCT00607919|3646281|FG001|NOT COMPLETED|Open-Label Phase||12
2934681|NCT00607997|3646293|FG000|STARTED|Overall Study||29
2934682|NCT00607997|3646294|FG001|STARTED|Overall Study||35
2934683|NCT00607997|3646295|FG002|STARTED|Overall Study||29
2934684|NCT00607997|3646296|FG003|STARTED|Overall Study||20
2934685|NCT00607997|3646293|FG000|COMPLETED|Overall Study||2
2934686|NCT00607997|3646294|FG001|COMPLETED|Overall Study||8
2934687|NCT00607997|3646295|FG002|COMPLETED|Overall Study||5
2934688|NCT00607997|3646296|FG003|COMPLETED|Overall Study||4
2934689|NCT00607997|3646293|FG000|NOT COMPLETED|Overall Study||27
2934690|NCT00607997|3646294|FG001|NOT COMPLETED|Overall Study||27
2934691|NCT00607997|3646295|FG002|NOT COMPLETED|Overall Study||24
2934692|NCT00607997|3646296|FG003|NOT COMPLETED|Overall Study||16
2934693|NCT00608023|3646314|FG000|STARTED|Overall Study||92
2934694|NCT00608023|3646315|FG001|STARTED|Overall Study||85
2934695|NCT00608023|3646316|FG002|STARTED|Overall Study||86
2934696|NCT00608023|3646314|FG000|COMPLETED|Overall Study||80
2934697|NCT00608023|3646315|FG001|COMPLETED|Overall Study||63
2934698|NCT00608023|3646316|FG002|COMPLETED|Overall Study||72
2934699|NCT00608023|3646314|FG000|NOT COMPLETED|Overall Study||12
2934700|NCT00608023|3646315|FG001|NOT COMPLETED|Overall Study||22
2934701|NCT00608023|3646316|FG002|NOT COMPLETED|Overall Study||14
2934702|NCT00608062|3646333|FG000|STARTED|Overall Study|25 women completed baseline testing, 4 women withdrew prior to randomization|12
2934703|NCT00608062|3646334|FG001|STARTED|Overall Study||12
2934704|NCT00608062|3646335|FG002|STARTED|Overall Study|43 women completed baseline testing, 3 women withdrew prior to randomization|19
2934705|NCT00608062|3646336|FG003|STARTED|Overall Study||21
2934706|NCT00608062|3646337|FG004|STARTED|Overall Study||13
2934707|NCT00608062|3646338|FG005|STARTED|Overall Study||15
2934708|NCT00608062|3646333|FG000|COMPLETED|Overall Study||12
2934709|NCT00608062|3646334|FG001|COMPLETED|Overall Study||12
2934710|NCT00608062|3646335|FG002|COMPLETED|Overall Study||19
2934711|NCT00608062|3646336|FG003|COMPLETED|Overall Study||21
2934712|NCT00608062|3646337|FG004|COMPLETED|Overall Study||13
2934713|NCT00608062|3646338|FG005|COMPLETED|Overall Study||15
2934714|NCT00608062|3646333|FG000|NOT COMPLETED|Overall Study||0
2934715|NCT00608062|3646334|FG001|NOT COMPLETED|Overall Study||0
2934716|NCT00608062|3646335|FG002|NOT COMPLETED|Overall Study||0
2934717|NCT00608062|3646336|FG003|NOT COMPLETED|Overall Study||0
2934718|NCT00608062|3646337|FG004|NOT COMPLETED|Overall Study||0
2934719|NCT00608062|3646338|FG005|NOT COMPLETED|Overall Study||0
2934720|NCT00608140|3646356|FG000|STARTED|Overall Study||1
2934721|NCT00608140|3646357|FG001|STARTED|Overall Study||1
2934722|NCT00608140|3646356|FG000|COMPLETED|Overall Study|Study ended early due to low enrollment|0
2934723|NCT00608140|3646357|FG001|COMPLETED|Overall Study|Study ended early due to low enrollment|0
2934724|NCT00608140|3646356|FG000|NOT COMPLETED|Overall Study||1
2934725|NCT00608140|3646357|FG001|NOT COMPLETED|Overall Study||1
3043031|NCT01181531|3763003|FG000|Received Investigational Product|Overall Study||155
3043032|NCT01181531|3763004|FG001|Received Investigational Product|Overall Study||153
3043033|NCT01181531|3763003|FG000|COMPLETED|Overall Study||96
3043034|NCT01181531|3763004|FG001|COMPLETED|Overall Study||102
3043035|NCT01181531|3763003|FG000|NOT COMPLETED|Overall Study||61
3043036|NCT01181531|3763004|FG001|NOT COMPLETED|Overall Study||53
3043037|NCT01181596|3763010|FG000|STARTED|Overall Study||31
3043038|NCT01181596|3763010|FG000|COMPLETED|Overall Study||31
3043039|NCT01181596|3763010|FG000|NOT COMPLETED|Overall Study||0
3043040|NCT01181609|3763015|FG000|STARTED|Overall Study||54
3043041|NCT01181609|3763015|FG000|COMPLETED|Overall Study||1
3043042|NCT01181609|3763015|FG000|NOT COMPLETED|Overall Study||53
3043043|NCT01181674|3763022|FG000|STARTED|Overall Study||28
3043044|NCT01181674|3763023|FG001|STARTED|Overall Study||27
3043045|NCT01181674|3763024|FG002|STARTED|Overall Study||28
3043046|NCT01181674|3763022|FG000|COMPLETED|Overall Study||28
3043047|NCT01181674|3763023|FG001|COMPLETED|Overall Study||27
3043048|NCT01181674|3763024|FG002|COMPLETED|Overall Study|28 included in analyses|26
3043049|NCT01181674|3763022|FG000|NOT COMPLETED|Overall Study||0
3043050|NCT01181674|3763023|FG001|NOT COMPLETED|Overall Study||0
3043051|NCT01181674|3763024|FG002|NOT COMPLETED|Overall Study||2
3043052|NCT01181726|3763034|FG000|STARTED|First Intervention||20
3043053|NCT01181726|3763035|FG001|STARTED|First Intervention||20
3043054|NCT01181726|3763034|FG000|COMPLETED|First Intervention||19
3043055|NCT01181726|3763035|FG001|COMPLETED|First Intervention||20
3043056|NCT01181726|3763034|FG000|NOT COMPLETED|First Intervention||1
3043057|NCT01181726|3763035|FG001|NOT COMPLETED|First Intervention||0
3043058|NCT01181726|3763034|FG000|STARTED|Washout of 28 Days||19
3043059|NCT01181726|3763035|FG001|STARTED|Washout of 28 Days||20
2934726|NCT00608205|3646374|FG000|STARTED|Overall Study||35
2934727|NCT00608205|3646375|FG001|STARTED|Overall Study||34
2934728|NCT00608205|3646374|FG000|COMPLETED|Overall Study||32
2934729|NCT00608205|3646375|FG001|COMPLETED|Overall Study||31
3043060|NCT01181726|3763034|FG000|COMPLETED|Washout of 28 Days||19
3043061|NCT01181726|3763035|FG001|COMPLETED|Washout of 28 Days||20
3043062|NCT01181726|3763034|FG000|NOT COMPLETED|Washout of 28 Days||0
3043063|NCT01181726|3763035|FG001|NOT COMPLETED|Washout of 28 Days||0
3043064|NCT01181726|3763034|FG000|STARTED|Second Intervention||19
3043065|NCT01181726|3763035|FG001|STARTED|Second Intervention||20
3043066|NCT01181726|3763034|FG000|COMPLETED|Second Intervention||19
3043067|NCT01181726|3763035|FG001|COMPLETED|Second Intervention||20
3043068|NCT01181726|3763034|FG000|NOT COMPLETED|Second Intervention||0
3043069|NCT01181726|3763035|FG001|NOT COMPLETED|Second Intervention||0
3043070|NCT01181804|3763045|FG000|STARTED|Period 1, Fed (Part 1)||30
3043071|NCT01181804|3763046|FG001|STARTED|Period 1, Fed (Part 1)||30
3043072|NCT01181804|3763047|FG002|STARTED|Period 1, Fed (Part 1)||0
3043073|NCT01181804|3763048|FG003|STARTED|Period 1, Fed (Part 1)||0
3043074|NCT01181804|3763045|FG000|COMPLETED|Period 1, Fed (Part 1)||30
3043075|NCT01181804|3763046|FG001|COMPLETED|Period 1, Fed (Part 1)||30
3043076|NCT01181804|3763047|FG002|COMPLETED|Period 1, Fed (Part 1)||0
3043077|NCT01181804|3763048|FG003|COMPLETED|Period 1, Fed (Part 1)||0
3043078|NCT01181804|3763045|FG000|NOT COMPLETED|Period 1, Fed (Part 1)||0
3043079|NCT01181804|3763046|FG001|NOT COMPLETED|Period 1, Fed (Part 1)||0
3043080|NCT01181804|3763047|FG002|NOT COMPLETED|Period 1, Fed (Part 1)||0
3043081|NCT01181804|3763048|FG003|NOT COMPLETED|Period 1, Fed (Part 1)||0
3043082|NCT01181804|3763045|FG000|STARTED|Period 2, Fed (Part 1)||30
3043083|NCT01181804|3763046|FG001|STARTED|Period 2, Fed (Part 1)||30
3043084|NCT01181804|3763047|FG002|STARTED|Period 2, Fed (Part 1)||0
3043085|NCT01181804|3763048|FG003|STARTED|Period 2, Fed (Part 1)||0
3043086|NCT01181804|3763045|FG000|COMPLETED|Period 2, Fed (Part 1)||30
3043087|NCT01181804|3763046|FG001|COMPLETED|Period 2, Fed (Part 1)||30
3043088|NCT01181804|3763047|FG002|COMPLETED|Period 2, Fed (Part 1)||0
3043089|NCT01181804|3763048|FG003|COMPLETED|Period 2, Fed (Part 1)||0
3043090|NCT01181804|3763045|FG000|NOT COMPLETED|Period 2, Fed (Part 1)||0
3043091|NCT01181804|3763046|FG001|NOT COMPLETED|Period 2, Fed (Part 1)||0
3043092|NCT01181804|3763047|FG002|NOT COMPLETED|Period 2, Fed (Part 1)||0
3043093|NCT01181804|3763048|FG003|NOT COMPLETED|Period 2, Fed (Part 1)||0
3043094|NCT01181804|3763045|FG000|STARTED|Period 3, Fasted (Part 2)||0
3043095|NCT01181804|3763046|FG001|STARTED|Period 3, Fasted (Part 2)||0
3043096|NCT01181804|3763047|FG002|STARTED|Period 3, Fasted (Part 2)||59
3043097|NCT01181804|3763048|FG003|STARTED|Period 3, Fasted (Part 2)||58
3043098|NCT01181804|3763045|FG000|COMPLETED|Period 3, Fasted (Part 2)||0
3043099|NCT01181804|3763046|FG001|COMPLETED|Period 3, Fasted (Part 2)||0
3043100|NCT01181804|3763047|FG002|COMPLETED|Period 3, Fasted (Part 2)||59
3043101|NCT01181804|3763048|FG003|COMPLETED|Period 3, Fasted (Part 2)||58
3043102|NCT01181804|3763045|FG000|NOT COMPLETED|Period 3, Fasted (Part 2)||0
3043103|NCT01181804|3763046|FG001|NOT COMPLETED|Period 3, Fasted (Part 2)||0
3043104|NCT01181804|3763047|FG002|NOT COMPLETED|Period 3, Fasted (Part 2)||0
3043105|NCT01181804|3763048|FG003|NOT COMPLETED|Period 3, Fasted (Part 2)||0
3043106|NCT01181804|3763045|FG000|STARTED|Period 4, Fasted (Part 2)||0
3043107|NCT01181804|3763046|FG001|STARTED|Period 4, Fasted (Part 2)||0
3043108|NCT01181804|3763047|FG002|STARTED|Period 4, Fasted (Part 2)||59
3043109|NCT01181804|3763048|FG003|STARTED|Period 4, Fasted (Part 2)||58
3043110|NCT01181804|3763045|FG000|COMPLETED|Period 4, Fasted (Part 2)||0
3043111|NCT01181804|3763046|FG001|COMPLETED|Period 4, Fasted (Part 2)||0
3043112|NCT01181804|3763047|FG002|COMPLETED|Period 4, Fasted (Part 2)||58
3043113|NCT01181804|3763048|FG003|COMPLETED|Period 4, Fasted (Part 2)||58
3043114|NCT01181804|3763045|FG000|NOT COMPLETED|Period 4, Fasted (Part 2)||0
3043115|NCT01181804|3763046|FG001|NOT COMPLETED|Period 4, Fasted (Part 2)||0
3043116|NCT01181804|3763047|FG002|NOT COMPLETED|Period 4, Fasted (Part 2)||1
3043117|NCT01181804|3763048|FG003|NOT COMPLETED|Period 4, Fasted (Part 2)||0
3043118|NCT01181895|3763061|FG000|STARTED|Overall Study||116
3043119|NCT01181895|3763062|FG001|STARTED|Overall Study||115
3043120|NCT01181895|3763063|FG002|STARTED|Overall Study||116
3043121|NCT01181895|3763061|FG000|COMPLETED|Overall Study||99
3043122|NCT01181895|3763062|FG001|COMPLETED|Overall Study||101
3043123|NCT01181895|3763063|FG002|COMPLETED|Overall Study||98
3043124|NCT01181895|3763061|FG000|NOT COMPLETED|Overall Study||17
3043125|NCT01181895|3763062|FG001|NOT COMPLETED|Overall Study||14
3043126|NCT01181895|3763063|FG002|NOT COMPLETED|Overall Study||18
3043127|NCT01181947|3763071|FG000|STARTED|Overall Study||100
3043128|NCT01181947|3763071|FG000|COMPLETED|Overall Study||100
3043129|NCT01181947|3763071|FG000|NOT COMPLETED|Overall Study||0
3043130|NCT01181986|3763078|FG000|STARTED|Phase 1||19
3043131|NCT01181986|3763079|FG001|STARTED|Phase 1||23
3043132|NCT01181986|3763080|FG002|STARTED|Phase 1||34
3043133|NCT01181986|3763078|FG000|Saline+Exenatide|Phase 1|N/A for this arm|0
3043134|NCT01181986|3763079|FG001|Saline+Exenatide|Phase 1|N/A for this arm|0
3043135|NCT01181986|3763080|FG002|Saline+Exenatide|Phase 1||32
2934730|NCT00608205|3646374|FG000|NOT COMPLETED|Overall Study||3
2934731|NCT00608205|3646375|FG001|NOT COMPLETED|Overall Study||3
2934732|NCT00608244|3646383|FG000|STARTED|Overall Study||59
2934733|NCT00608244|3646383|FG000|COMPLETED|Overall Study||57
2934734|NCT00608244|3646383|FG000|NOT COMPLETED|Overall Study||2
2934735|NCT00608322|3646391|FG000|STARTED|Overall Study||26
2934736|NCT00608322|3646392|FG001|STARTED|Overall Study||23
2934737|NCT00608322|3646391|FG000|COMPLETED|Overall Study||24
2934738|NCT00608322|3646392|FG001|COMPLETED|Overall Study||22
2934739|NCT00608322|3646391|FG000|NOT COMPLETED|Overall Study||2
2934740|NCT00608322|3646392|FG001|NOT COMPLETED|Overall Study||1
2934741|NCT00608426|3646400|FG000|STARTED|Overall Study||2604
2934742|NCT00608426|3646401|FG001|STARTED|Overall Study||2519
2934743|NCT00608426|3646400|FG000|COMPLETED|Overall Study|This is total # of completed surveys. Not completed primary outcome.|1768
2934744|NCT00608426|3646401|FG001|COMPLETED|Overall Study|This is total # of completed surveys. Not completed primary outcome.|1614
2934745|NCT00608426|3646400|FG000|NOT COMPLETED|Overall Study||836
2934746|NCT00608426|3646401|FG001|NOT COMPLETED|Overall Study||905
2934747|NCT00608491|3646409|FG000|STARTED|Overall Study||94
2934748|NCT00608491|3646410|FG001|STARTED|Overall Study||94
2934749|NCT00608491|3646409|FG000|COMPLETED|Overall Study||73
2934750|NCT00608491|3646410|FG001|COMPLETED|Overall Study||72
2934751|NCT00608491|3646409|FG000|NOT COMPLETED|Overall Study||21
2934752|NCT00608491|3646410|FG001|NOT COMPLETED|Overall Study||22
2934753|NCT00608517|3646419|FG000|STARTED|Overall Study||2
2934754|NCT00608517|3646420|FG001|STARTED|Overall Study||3
2934755|NCT00608517|3646421|FG002|STARTED|Overall Study||1
2934756|NCT00608517|3646419|FG000|COMPLETED|Overall Study||1
2934757|NCT00608517|3646420|FG001|COMPLETED|Overall Study||3
2934758|NCT00608517|3646421|FG002|COMPLETED|Overall Study||1
2934759|NCT00608517|3646419|FG000|NOT COMPLETED|Overall Study||1
2934760|NCT00608517|3646420|FG001|NOT COMPLETED|Overall Study||0
2934761|NCT00608517|3646421|FG002|NOT COMPLETED|Overall Study||0
2934762|NCT00608530|3646434|FG000|STARTED|Study 1 Psychologist-delivered Treatment|Randomized|33
2934763|NCT00608530|3646435|FG001|STARTED|Study 1 Psychologist-delivered Treatment|Randomized|33
2934764|NCT00608530|3646436|FG002|STARTED|Study 1 Psychologist-delivered Treatment||0
2934765|NCT00608530|3646437|FG003|STARTED|Study 1 Psychologist-delivered Treatment||0
2934766|NCT00608530|3646434|FG000|Attended > 0 Treatment Sessions|Study 1 Psychologist-delivered Treatment||28
2934767|NCT00608530|3646435|FG001|Attended > 0 Treatment Sessions|Study 1 Psychologist-delivered Treatment||31
2934768|NCT00608530|3646436|FG002|Attended > 0 Treatment Sessions|Study 1 Psychologist-delivered Treatment||0
2934769|NCT00608530|3646437|FG003|Attended > 0 Treatment Sessions|Study 1 Psychologist-delivered Treatment||0
2934770|NCT00608530|3646434|FG000|COMPLETED|Study 1 Psychologist-delivered Treatment||22
2934771|NCT00608530|3646435|FG001|COMPLETED|Study 1 Psychologist-delivered Treatment||28
2934772|NCT00608530|3646436|FG002|COMPLETED|Study 1 Psychologist-delivered Treatment||0
2934773|NCT00608530|3646437|FG003|COMPLETED|Study 1 Psychologist-delivered Treatment||0
2934774|NCT00608530|3646434|FG000|NOT COMPLETED|Study 1 Psychologist-delivered Treatment||11
2934775|NCT00608530|3646435|FG001|NOT COMPLETED|Study 1 Psychologist-delivered Treatment||5
2934776|NCT00608530|3646436|FG002|NOT COMPLETED|Study 1 Psychologist-delivered Treatment||0
2934777|NCT00608530|3646437|FG003|NOT COMPLETED|Study 1 Psychologist-delivered Treatment||0
2934778|NCT00608530|3646434|FG000|STARTED|Study 2 Nurse-delivered Treatments||0
3043136|NCT01181986|3763078|FG000|Saline+Placebo|Phase 1|N/A for this arm|0
3043137|NCT01181986|3763079|FG001|Saline+Placebo|Phase 1|N/A for this arm|0
3043138|NCT01181986|3763080|FG002|Saline+Placebo|Phase 1||33
3043139|NCT01181986|3763078|FG000|Exendin-9+Exenatide|Phase 1|N/A for this arm|0
3043140|NCT01181986|3763079|FG001|Exendin-9+Exenatide|Phase 1|N/A for this arm|0
3043141|NCT01181986|3763080|FG002|Exendin-9+Exenatide|Phase 1||33
3043142|NCT01181986|3763078|FG000|COMPLETED|Phase 1||18
3043143|NCT01181986|3763079|FG001|COMPLETED|Phase 1||22
3043144|NCT01181986|3763080|FG002|COMPLETED|Phase 1||32
3043145|NCT01181986|3763078|FG000|NOT COMPLETED|Phase 1||1
3043146|NCT01181986|3763079|FG001|NOT COMPLETED|Phase 1||1
3043147|NCT01181986|3763080|FG002|NOT COMPLETED|Phase 1||2
3043148|NCT01181986|3763078|FG000|STARTED|Phase 2||18
3043149|NCT01181986|3763079|FG001|STARTED|Phase 2||22
3043150|NCT01181986|3763080|FG002|STARTED|Phase 2|N/A for Sub-study 2|0
3043151|NCT01181986|3763078|FG000|COMPLETED|Phase 2||18
3043152|NCT01181986|3763079|FG001|COMPLETED|Phase 2||18
3043153|NCT01181986|3763080|FG002|COMPLETED|Phase 2||0
3043154|NCT01181986|3763078|FG000|NOT COMPLETED|Phase 2||0
3043155|NCT01181986|3763079|FG001|NOT COMPLETED|Phase 2||4
3043156|NCT01181986|3763080|FG002|NOT COMPLETED|Phase 2||0
3043157|NCT01182103|3763096|FG000|STARTED|Overall Study||48
3043158|NCT01182103|3763097|FG001|STARTED|Overall Study||62
3043159|NCT01182103|3763096|FG000|COMPLETED|Overall Study||48
3043160|NCT01182103|3763097|FG001|COMPLETED|Overall Study||62
3043161|NCT01182103|3763096|FG000|NOT COMPLETED|Overall Study||0
3043162|NCT01182103|3763097|FG001|NOT COMPLETED|Overall Study||0
3043163|NCT01182181|3763108|FG000|STARTED|First Intervention||11
3043164|NCT01182181|3763109|FG001|STARTED|First Intervention||11
3043165|NCT01182181|3763108|FG000|COMPLETED|First Intervention||10
3043166|NCT01182181|3763109|FG001|COMPLETED|First Intervention||11
3043167|NCT01182181|3763108|FG000|NOT COMPLETED|First Intervention||1
3043168|NCT01182181|3763109|FG001|NOT COMPLETED|First Intervention||0
3043169|NCT01182181|3763108|FG000|STARTED|Washout of 21 Days||10
3043170|NCT01182181|3763109|FG001|STARTED|Washout of 21 Days||11
3043171|NCT01182181|3763108|FG000|COMPLETED|Washout of 21 Days||10
3043172|NCT01182181|3763109|FG001|COMPLETED|Washout of 21 Days||10
3043173|NCT01182181|3763108|FG000|NOT COMPLETED|Washout of 21 Days||0
3043174|NCT01182181|3763109|FG001|NOT COMPLETED|Washout of 21 Days||1
3043175|NCT01182181|3763108|FG000|STARTED|Second Intervention||10
3043176|NCT01182181|3763109|FG001|STARTED|Second Intervention||10
3043177|NCT01182181|3763108|FG000|COMPLETED|Second Intervention||10
3043178|NCT01182181|3763109|FG001|COMPLETED|Second Intervention||10
2934779|NCT00608530|3646435|FG001|STARTED|Study 2 Nurse-delivered Treatments||0
2934780|NCT00608530|3646436|FG002|STARTED|Study 2 Nurse-delivered Treatments||33
2934781|NCT00608530|3646437|FG003|STARTED|Study 2 Nurse-delivered Treatments||34
2934782|NCT00608530|3646434|FG000|Attended > 0 Treatments|Study 2 Nurse-delivered Treatments||0
2934783|NCT00608530|3646435|FG001|Attended > 0 Treatments|Study 2 Nurse-delivered Treatments||0
2934784|NCT00608530|3646436|FG002|Attended > 0 Treatments|Study 2 Nurse-delivered Treatments||30
2934785|NCT00608530|3646437|FG003|Attended > 0 Treatments|Study 2 Nurse-delivered Treatments||31
2934786|NCT00608530|3646434|FG000|COMPLETED|Study 2 Nurse-delivered Treatments||0
2934787|NCT00608530|3646435|FG001|COMPLETED|Study 2 Nurse-delivered Treatments||0
2934788|NCT00608530|3646436|FG002|COMPLETED|Study 2 Nurse-delivered Treatments||21
2934789|NCT00608530|3646437|FG003|COMPLETED|Study 2 Nurse-delivered Treatments||27
2934790|NCT00608530|3646434|FG000|NOT COMPLETED|Study 2 Nurse-delivered Treatments||0
2934791|NCT00608530|3646435|FG001|NOT COMPLETED|Study 2 Nurse-delivered Treatments||0
2934792|NCT00608530|3646436|FG002|NOT COMPLETED|Study 2 Nurse-delivered Treatments||12
2934793|NCT00608530|3646437|FG003|NOT COMPLETED|Study 2 Nurse-delivered Treatments||7
2934794|NCT00608543|3646452|FG000|STARTED|Overall Study||17
2934795|NCT00608543|3646452|FG000|COMPLETED|Overall Study||13
2934796|NCT00608543|3646452|FG000|NOT COMPLETED|Overall Study||4
2934797|NCT00608569|3646459|FG000|STARTED|Overall Study||129
2934798|NCT00608569|3646460|FG001|STARTED|Overall Study||128
2934799|NCT00608569|3646459|FG000|COMPLETED|Overall Study||119
2934800|NCT00608569|3646460|FG001|COMPLETED|Overall Study||119
2934801|NCT00608569|3646459|FG000|NOT COMPLETED|Overall Study||10
2934802|NCT00608569|3646460|FG001|NOT COMPLETED|Overall Study||9
2934803|NCT00608582|3646468|FG000|STARTED|Overall Study||14
2934804|NCT00608582|3646469|FG001|STARTED|Overall Study||11
2934805|NCT00608582|3646468|FG000|COMPLETED|Overall Study||10
2934806|NCT00608582|3646469|FG001|COMPLETED|Overall Study||7
2934807|NCT00608582|3646468|FG000|NOT COMPLETED|Overall Study||4
2934808|NCT00608582|3646469|FG001|NOT COMPLETED|Overall Study||4
2934809|NCT00608634|3646480|FG000|STARTED|Overall Study||28
2934810|NCT00608634|3646481|FG001|STARTED|Overall Study||27
2934811|NCT00608634|3646482|FG002|STARTED|Overall Study||28
2934812|NCT00608634|3646480|FG000|COMPLETED|Overall Study||26
2934813|NCT00608634|3646481|FG001|COMPLETED|Overall Study||26
2934814|NCT00608634|3646482|FG002|COMPLETED|Overall Study||27
2934815|NCT00608634|3646480|FG000|NOT COMPLETED|Overall Study||2
2934816|NCT00608634|3646481|FG001|NOT COMPLETED|Overall Study||1
2934817|NCT00608634|3646482|FG002|NOT COMPLETED|Overall Study||1
2934818|NCT00608829|3646492|FG000|STARTED|Overall Study||23
2934819|NCT00608829|3646492|FG000|COMPLETED|Overall Study||8
2934820|NCT00608829|3646492|FG000|NOT COMPLETED|Overall Study||15
2934821|NCT00608842|3646500|FG000|STARTED|Overall Study||15
2934822|NCT00608842|3646501|FG001|STARTED|Overall Study||15
2934823|NCT00608842|3646502|FG002|STARTED|Overall Study||15
2934824|NCT00608842|3646503|FG003|STARTED|Overall Study||17
2934825|NCT00608842|3646500|FG000|COMPLETED|Overall Study||14
2934826|NCT00608842|3646501|FG001|COMPLETED|Overall Study||14
2934827|NCT00608842|3646502|FG002|COMPLETED|Overall Study||13
2934828|NCT00608842|3646503|FG003|COMPLETED|Overall Study||16
3043179|NCT01182181|3763108|FG000|NOT COMPLETED|Second Intervention||0
3043180|NCT01182181|3763109|FG001|NOT COMPLETED|Second Intervention||0
3043181|NCT01182194|3763117|FG000|STARTED|First Intervention||16
3043182|NCT01182194|3763118|FG001|STARTED|First Intervention||16
3043183|NCT01182194|3763117|FG000|COMPLETED|First Intervention||16
3043184|NCT01182194|3763118|FG001|COMPLETED|First Intervention||16
3043185|NCT01182194|3763117|FG000|NOT COMPLETED|First Intervention||0
3043186|NCT01182194|3763118|FG001|NOT COMPLETED|First Intervention||0
3043187|NCT01182194|3763117|FG000|STARTED|Washout of 28 Days||16
3043188|NCT01182194|3763118|FG001|STARTED|Washout of 28 Days||16
3043189|NCT01182194|3763117|FG000|COMPLETED|Washout of 28 Days||15
3043190|NCT01182194|3763118|FG001|COMPLETED|Washout of 28 Days||16
3043191|NCT01182194|3763117|FG000|NOT COMPLETED|Washout of 28 Days||1
3043192|NCT01182194|3763118|FG001|NOT COMPLETED|Washout of 28 Days||0
3043193|NCT01182194|3763117|FG000|STARTED|Second Intervention||15
3043194|NCT01182194|3763118|FG001|STARTED|Second Intervention||16
3043195|NCT01182194|3763117|FG000|COMPLETED|Second Intervention||15
3043196|NCT01182194|3763118|FG001|COMPLETED|Second Intervention||16
3043197|NCT01182194|3763117|FG000|NOT COMPLETED|Second Intervention||0
3043198|NCT01182194|3763118|FG001|NOT COMPLETED|Second Intervention||0
3043199|NCT01182207|3763126|FG000|STARTED|First Intervention||18
3043200|NCT01182207|3763127|FG001|STARTED|First Intervention||15
3043201|NCT01182207|3763126|FG000|COMPLETED|First Intervention||18
3043202|NCT01182207|3763127|FG001|COMPLETED|First Intervention||14
3043203|NCT01182207|3763126|FG000|NOT COMPLETED|First Intervention||0
3043204|NCT01182207|3763127|FG001|NOT COMPLETED|First Intervention||1
3043205|NCT01182207|3763126|FG000|STARTED|Washout of 28 Days||18
3043206|NCT01182207|3763127|FG001|STARTED|Washout of 28 Days||14
3043207|NCT01182207|3763126|FG000|COMPLETED|Washout of 28 Days||18
3043208|NCT01182207|3763127|FG001|COMPLETED|Washout of 28 Days||14
3043209|NCT01182207|3763126|FG000|NOT COMPLETED|Washout of 28 Days||0
3043210|NCT01182207|3763127|FG001|NOT COMPLETED|Washout of 28 Days||0
3043211|NCT01182207|3763126|FG000|STARTED|Second Intervention||18
3043212|NCT01182207|3763127|FG001|STARTED|Second Intervention||14
3043213|NCT01182207|3763126|FG000|COMPLETED|Second Intervention||17
3043214|NCT01182207|3763127|FG001|COMPLETED|Second Intervention||14
3043215|NCT01182207|3763126|FG000|NOT COMPLETED|Second Intervention||1
2934829|NCT00608842|3646500|FG000|NOT COMPLETED|Overall Study||1
2934830|NCT00608842|3646501|FG001|NOT COMPLETED|Overall Study||1
2934831|NCT00608842|3646502|FG002|NOT COMPLETED|Overall Study||2
2934832|NCT00608842|3646503|FG003|NOT COMPLETED|Overall Study||1
2934833|NCT00608868|3646513|FG000|STARTED|Overall Study||156
2934834|NCT00608868|3646513|FG000|Enrolled|Overall Study||156
2934835|NCT00608868|3646513|FG000|Safety Population|Overall Study|2 patients who received no study treatment were excluded|154
2934836|NCT00608868|3646513|FG000|Treatment Completed|Overall Study||141
2934837|NCT00608868|3646513|FG000|Intention to Treat (ITT) Population|Overall Study|8 patients who had no target lesion and 8 who had no tumor assessment after baseline were excluded|138
2934838|NCT00608868|3646513|FG000|Per Protocol (PP) Population|Overall Study||121
2934839|NCT00608868|3646513|FG000|COMPLETED|Overall Study||141
2934840|NCT00608868|3646513|FG000|NOT COMPLETED|Overall Study||15
2934841|NCT00608881|3646519|FG000|STARTED|Overall Study||303
2934842|NCT00608881|3646520|FG001|STARTED|Overall Study||306
2934843|NCT00608881|3646519|FG000|COMPLETED|Overall Study||224
2934844|NCT00608881|3646520|FG001|COMPLETED|Overall Study||240
2934845|NCT00608881|3646519|FG000|NOT COMPLETED|Overall Study||79
2934846|NCT00608881|3646520|FG001|NOT COMPLETED|Overall Study||66
2934847|NCT00608894|3646528|FG000|STARTED|Overall Study||7
2934848|NCT00608894|3646529|FG001|STARTED|Overall Study||6
2934849|NCT00608894|3646528|FG000|COMPLETED|Overall Study||7
2934850|NCT00608894|3646529|FG001|COMPLETED|Overall Study|One patient was granted permission to crossover to LCP-Tacro due to treatment intolerance|4
2934851|NCT00608894|3646528|FG000|NOT COMPLETED|Overall Study||0
2934852|NCT00608894|3646529|FG001|NOT COMPLETED|Overall Study||2
2934853|NCT00608907|3646540|FG000|STARTED|Overall Study||30
2934854|NCT00608907|3646541|FG001|STARTED|Overall Study||13
2934855|NCT00608907|3646542|FG002|STARTED|Overall Study||18
2934856|NCT00608907|3646540|FG000|COMPLETED|Overall Study||18
2934857|NCT00608907|3646541|FG001|COMPLETED|Overall Study||13
2934858|NCT00608907|3646542|FG002|COMPLETED|Overall Study||17
2934859|NCT00608907|3646540|FG000|NOT COMPLETED|Overall Study||12
2934860|NCT00608907|3646541|FG001|NOT COMPLETED|Overall Study||0
2934861|NCT00608907|3646542|FG002|NOT COMPLETED|Overall Study||1
2934862|NCT00608959|3646552|FG000|STARTED|Part 1|25 subjects each participated in Parts 1 and 2 .A total of 20 subjects participated in both parts.|25
2934863|NCT00608959|3646552|FG000|COMPLETED|Part 1||24
2934864|NCT00608959|3646552|FG000|NOT COMPLETED|Part 1||1
2934865|NCT00608959|3646552|FG000|STARTED|Part 2|20 Part 1 subjects also participated in Part 2.Five more subjects were enrolled for a total of 25.|25
2934866|NCT00608959|3646552|FG000|COMPLETED|Part 2||25
2934867|NCT00608959|3646552|FG000|NOT COMPLETED|Part 2||0
2934868|NCT00608985|3646566|FG000|STARTED|Overall Study|Randomized and started double-blind treatment|177
2934869|NCT00608985|3646567|FG001|STARTED|Overall Study|Randomized and started double-blind treatment|186
2934870|NCT00608985|3646568|FG002|STARTED|Overall Study|Randomized and started double-blind treatment|176
2934871|NCT00608985|3646569|FG003|STARTED|Overall Study|Randomized and started double-blind treatment|168
2934872|NCT00608985|3646566|FG000|Completed Double-blind Treatment|Overall Study||163
2934873|NCT00608985|3646567|FG001|Completed Double-blind Treatment|Overall Study||174
3043216|NCT01182207|3763127|FG001|NOT COMPLETED|Second Intervention||0
3043217|NCT01182285|3763133|FG000|STARTED|First Intervention Week 1-10||13
3043218|NCT01182285|3763134|FG001|STARTED|First Intervention Week 1-10||0
3043219|NCT01182285|3763135|FG002|STARTED|First Intervention Week 1-10||0
3043220|NCT01182285|3763133|FG000|COMPLETED|First Intervention Week 1-10||10
3043221|NCT01182285|3763134|FG001|COMPLETED|First Intervention Week 1-10||0
3043222|NCT01182285|3763135|FG002|COMPLETED|First Intervention Week 1-10||0
3043223|NCT01182285|3763133|FG000|NOT COMPLETED|First Intervention Week 1-10||3
3043224|NCT01182285|3763134|FG001|NOT COMPLETED|First Intervention Week 1-10||0
3043225|NCT01182285|3763135|FG002|NOT COMPLETED|First Intervention Week 1-10||0
3043226|NCT01182285|3763133|FG000|STARTED|Second Intervention Week 11-17||0
3043227|NCT01182285|3763134|FG001|STARTED|Second Intervention Week 11-17||0
3043228|NCT01182285|3763135|FG002|STARTED|Second Intervention Week 11-17||0
3043229|NCT01182285|3763133|FG000|COMPLETED|Second Intervention Week 11-17||0
3043230|NCT01182285|3763134|FG001|COMPLETED|Second Intervention Week 11-17||0
3043231|NCT01182285|3763135|FG002|COMPLETED|Second Intervention Week 11-17||0
3043232|NCT01182285|3763133|FG000|NOT COMPLETED|Second Intervention Week 11-17||0
3043233|NCT01182285|3763134|FG001|NOT COMPLETED|Second Intervention Week 11-17||0
3043234|NCT01182285|3763135|FG002|NOT COMPLETED|Second Intervention Week 11-17||0
3043235|NCT01182285|3763133|FG000|STARTED|Third Intervention Week 11-52||0
3043236|NCT01182285|3763134|FG001|STARTED|Third Intervention Week 11-52||0
3043237|NCT01182285|3763135|FG002|STARTED|Third Intervention Week 11-52|2 subj. taken off study after completing ph 1: 1 due to a negative uptake scan & one off due to PD.|8
3043238|NCT01182285|3763133|FG000|COMPLETED|Third Intervention Week 11-52||0
3043239|NCT01182285|3763134|FG001|COMPLETED|Third Intervention Week 11-52||0
3043240|NCT01182285|3763135|FG002|COMPLETED|Third Intervention Week 11-52||0
3043241|NCT01182285|3763133|FG000|NOT COMPLETED|Third Intervention Week 11-52||0
3043242|NCT01182285|3763134|FG001|NOT COMPLETED|Third Intervention Week 11-52||0
3043243|NCT01182285|3763135|FG002|NOT COMPLETED|Third Intervention Week 11-52||8
3043244|NCT01182298|3763142|FG000|STARTED|Overall Study||10
3043245|NCT01182298|3763142|FG000|COMPLETED|Overall Study||4
3043246|NCT01182298|3763142|FG000|NOT COMPLETED|Overall Study||6
3043247|NCT01182337|3763148|FG000|STARTED|Overall Study||22
3043248|NCT01182337|3763149|FG001|STARTED|Overall Study||9
3043249|NCT01182337|3763148|FG000|COMPLETED|Overall Study||19
3043250|NCT01182337|3763149|FG001|COMPLETED|Overall Study||7
3180143|NCT01988922|3908406|FG000|NOT COMPLETED|Overall Study||0
3180144|NCT01988922|3908407|FG001|NOT COMPLETED|Overall Study||0
3180145|NCT01988922|3908408|FG002|NOT COMPLETED|Overall Study||0
3180146|NCT01989130|3908421|FG000|STARTED|Overall Study||43
3180147|NCT01989130|3908422|FG001|STARTED|Overall Study||27
3180148|NCT01989130|3908421|FG000|COMPLETED|Overall Study||43
3180149|NCT01989130|3908422|FG001|COMPLETED|Overall Study||27
2934874|NCT00608985|3646568|FG002|Completed Double-blind Treatment|Overall Study||171
2934875|NCT00608985|3646569|FG003|Completed Double-blind Treatment|Overall Study||161
2934876|NCT00608985|3646566|FG000|COMPLETED|Overall Study|Completed follow-up|161
2934877|NCT00608985|3646567|FG001|COMPLETED|Overall Study|Completed follow-up|173
2934878|NCT00608985|3646568|FG002|COMPLETED|Overall Study|Completed follow-up|170
2934879|NCT00608985|3646569|FG003|COMPLETED|Overall Study|Completed follow-up|159
2934880|NCT00608985|3646566|FG000|NOT COMPLETED|Overall Study||16
2934881|NCT00608985|3646567|FG001|NOT COMPLETED|Overall Study||13
2934882|NCT00608985|3646568|FG002|NOT COMPLETED|Overall Study||6
2934883|NCT00608985|3646569|FG003|NOT COMPLETED|Overall Study||9
2934884|NCT00609128|3646579|FG000|STARTED|Overall Study||21
2934885|NCT00609128|3646579|FG000|COMPLETED|Overall Study||21
2934886|NCT00609128|3646579|FG000|NOT COMPLETED|Overall Study||0
2934887|NCT00609167|3646586|FG000|STARTED|Overall Study||33
2934888|NCT00609167|3646587|FG001|STARTED|Overall Study||30
2934889|NCT00609167|3646586|FG000|COMPLETED|Overall Study||25
2934890|NCT00609167|3646587|FG001|COMPLETED|Overall Study||23
2934891|NCT00609167|3646586|FG000|NOT COMPLETED|Overall Study||8
2934892|NCT00609167|3646587|FG001|NOT COMPLETED|Overall Study||7
2934893|NCT00609245|3646593|FG000|STARTED|Overall Study||13
2934894|NCT00609245|3646593|FG000|COMPLETED|Overall Study||12
2934895|NCT00609245|3646593|FG000|NOT COMPLETED|Overall Study||1
2934896|NCT00609271|3646601|FG000|STARTED|Overall Study||75
2934897|NCT00609271|3646602|FG001|STARTED|Overall Study||73
2934898|NCT00609271|3646601|FG000|COMPLETED|Overall Study||59
2934899|NCT00609271|3646602|FG001|COMPLETED|Overall Study||60
2934900|NCT00609271|3646601|FG000|NOT COMPLETED|Overall Study||16
2934901|NCT00609271|3646602|FG001|NOT COMPLETED|Overall Study||13
2934902|NCT00609336|3646608|FG000|STARTED|Overall Study||35
2934903|NCT00609336|3646608|FG000|Surgery|Overall Study||22
2934904|NCT00609336|3646608|FG000|COMPLETED|Overall Study||22
2934905|NCT00609336|3646608|FG000|NOT COMPLETED|Overall Study||13
2934906|NCT00609362|3646615|FG000|STARTED|Overall Study||29
2934907|NCT00609362|3646616|FG001|STARTED|Overall Study||28
2934908|NCT00609362|3646615|FG000|COMPLETED|Overall Study||26
2934909|NCT00609362|3646616|FG001|COMPLETED|Overall Study||27
2934910|NCT00609362|3646615|FG000|NOT COMPLETED|Overall Study||3
2934911|NCT00609362|3646616|FG001|NOT COMPLETED|Overall Study||1
2934912|NCT00609466|3646625|FG000|STARTED|Overall Study||96
2934913|NCT00609466|3646626|FG001|STARTED|Overall Study||96
2934914|NCT00609466|3646627|FG002|STARTED|Overall Study||99
2934915|NCT00609466|3646625|FG000|COMPLETED|Overall Study||94
2934916|NCT00609466|3646626|FG001|COMPLETED|Overall Study||90
2934917|NCT00609466|3646627|FG002|COMPLETED|Overall Study||95
2934918|NCT00609466|3646625|FG000|NOT COMPLETED|Overall Study||2
2934919|NCT00609466|3646626|FG001|NOT COMPLETED|Overall Study||6
2934920|NCT00609466|3646627|FG002|NOT COMPLETED|Overall Study||4
2934921|NCT00609492|3646638|FG000|STARTED|Overall Study||44
2934922|NCT00609492|3646639|FG001|STARTED|Overall Study||72
2934923|NCT00609492|3646640|FG002|STARTED|Overall Study||129
2934924|NCT00609492|3646638|FG000|COMPLETED|Overall Study||43
2934925|NCT00609492|3646639|FG001|COMPLETED|Overall Study||69
2934926|NCT00609492|3646640|FG002|COMPLETED|Overall Study||122
2934927|NCT00609492|3646638|FG000|NOT COMPLETED|Overall Study||1
2934928|NCT00609492|3646639|FG001|NOT COMPLETED|Overall Study||3
2934929|NCT00609492|3646640|FG002|NOT COMPLETED|Overall Study||7
2934930|NCT00609518|3646652|FG000|STARTED|Overall Study||54
2934931|NCT00609518|3646653|FG001|STARTED|Overall Study||57
2934932|NCT00609518|3646652|FG000|Completed 6 Treatment Cycles|Overall Study||19
2934933|NCT00609518|3646653|FG001|Completed 6 Treatment Cycles|Overall Study||22
2934934|NCT00609518|3646652|FG000|COMPLETED|Overall Study||11
2934935|NCT00609518|3646653|FG001|COMPLETED|Overall Study||17
2934936|NCT00609518|3646652|FG000|NOT COMPLETED|Overall Study||43
3180150|NCT01989130|3908421|FG000|NOT COMPLETED|Overall Study||0
3180151|NCT01989130|3908422|FG001|NOT COMPLETED|Overall Study||0
3180152|NCT01989156|3908431|FG000|STARTED|Confinement Period (Population at Day 5)||80
2934937|NCT00609518|3646653|FG001|NOT COMPLETED|Overall Study||40
2934938|NCT00609609|3646661|FG000|STARTED|Overall Study||30
2934939|NCT00609609|3646662|FG001|STARTED|Overall Study||51
2934940|NCT00609609|3646661|FG000|COMPLETED|Overall Study||24
2934941|NCT00609609|3646662|FG001|COMPLETED|Overall Study||49
2934942|NCT00609609|3646661|FG000|NOT COMPLETED|Overall Study||6
2934943|NCT00609609|3646662|FG001|NOT COMPLETED|Overall Study||2
2934944|NCT00609622|3646670|FG000|STARTED|Overall Study||96
2934945|NCT00609622|3646671|FG001|STARTED|Overall Study||95
2934946|NCT00609622|3646670|FG000|COMPLETED|Overall Study||0
2934947|NCT00609622|3646671|FG001|COMPLETED|Overall Study||0
2934948|NCT00609622|3646670|FG000|NOT COMPLETED|Overall Study||96
2934949|NCT00609622|3646671|FG001|NOT COMPLETED|Overall Study||95
2934950|NCT00609674|3646679|FG000|STARTED|Overall Study||155
2934951|NCT00609674|3646680|FG001|STARTED|Overall Study||160
2934952|NCT00609674|3646679|FG000|COMPLETED|Overall Study||148
2934953|NCT00609674|3646680|FG001|COMPLETED|Overall Study||153
2934954|NCT00609674|3646679|FG000|NOT COMPLETED|Overall Study||7
2934955|NCT00609674|3646680|FG001|NOT COMPLETED|Overall Study||7
2934956|NCT00609739|3646686|FG000|STARTED|Overall Study||1
2934957|NCT00609739|3646686|FG000|COMPLETED|Overall Study||1
2934958|NCT00609739|3646686|FG000|NOT COMPLETED|Overall Study||0
2934959|NCT00609804|3646692|FG000|STARTED|Overall Study||25
2934960|NCT00609804|3646693|FG001|STARTED|Overall Study||28
2934961|NCT00609804|3646692|FG000|COMPLETED|Overall Study|Pts remained on study until required to end treatment due to progression/toxicity/MD decision/etc|0
2934962|NCT00609804|3646693|FG001|COMPLETED|Overall Study|Pts remained on study until required to end treatment due to progression/toxicity/MD decision/etc|0
2934963|NCT00609804|3646692|FG000|NOT COMPLETED|Overall Study||25
2934964|NCT00609804|3646693|FG001|NOT COMPLETED|Overall Study||28
2934965|NCT00609869|3646702|FG000|STARTED|Overall Study||29
2934966|NCT00609869|3646702|FG000|COMPLETED|Overall Study||18
2934967|NCT00609869|3646702|FG000|NOT COMPLETED|Overall Study||11
2934968|NCT00609947|3646706|FG000|STARTED|Overall Study||241
2934969|NCT00609947|3646706|FG000|COMPLETED|Overall Study|One death due to automobile accident.|240
2934970|NCT00609947|3646706|FG000|NOT COMPLETED|Overall Study||1
2934971|NCT00609973|3646713|FG000|STARTED|Overall Study||17
2934972|NCT00609973|3646714|FG001|STARTED|Overall Study||16
2934973|NCT00609973|3646713|FG000|COMPLETED|Overall Study||9
2934974|NCT00609973|3646714|FG001|COMPLETED|Overall Study||10
2934975|NCT00609973|3646713|FG000|NOT COMPLETED|Overall Study||8
2934976|NCT00609973|3646714|FG001|NOT COMPLETED|Overall Study||6
2934977|NCT00609986|3646722|FG000|STARTED|Overall Study||52
2934978|NCT00609986|3646723|FG001|STARTED|Overall Study||52
2934979|NCT00609986|3646722|FG000|Received Transplant|Overall Study||44
2934980|NCT00609986|3646723|FG001|Received Transplant|Overall Study||49
2934981|NCT00609986|3646722|FG000|COMPLETED|Overall Study||44
2934982|NCT00609986|3646723|FG001|COMPLETED|Overall Study||49
2934983|NCT00609986|3646722|FG000|NOT COMPLETED|Overall Study||8
2934984|NCT00609986|3646723|FG001|NOT COMPLETED|Overall Study||3
2934985|NCT00610116|3646729|FG000|STARTED|Overall Study||305
2934986|NCT00610116|3646729|FG000|COMPLETED|Overall Study|Number of analyzable patients|292
2934987|NCT00610116|3646729|FG000|NOT COMPLETED|Overall Study||13
2934988|NCT00610129|3646733|FG000|STARTED|Overall Study||28
2934989|NCT00610129|3646733|FG000|COMPLETED|Overall Study||25
2934990|NCT00610129|3646733|FG000|NOT COMPLETED|Overall Study||3
2934991|NCT00610155|3646737|FG000|STARTED|Period 1||4
2934992|NCT00610155|3646738|FG001|STARTED|Period 1||3
2934993|NCT00610155|3646739|FG002|STARTED|Period 1||4
2934994|NCT00610155|3646740|FG003|STARTED|Period 1||3
2934995|NCT00610155|3646741|FG004|STARTED|Period 1||3
2934996|NCT00610155|3646742|FG005|STARTED|Period 1||1
2934997|NCT00610155|3646737|FG000|COMPLETED|Period 1||4
2934998|NCT00610155|3646738|FG001|COMPLETED|Period 1||3
2934999|NCT00610155|3646739|FG002|COMPLETED|Period 1||3
2935000|NCT00610155|3646740|FG003|COMPLETED|Period 1||3
2935001|NCT00610155|3646741|FG004|COMPLETED|Period 1||3
2935002|NCT00610155|3646742|FG005|COMPLETED|Period 1||1
2935003|NCT00610155|3646737|FG000|NOT COMPLETED|Period 1||0
2935004|NCT00610155|3646738|FG001|NOT COMPLETED|Period 1||0
2935005|NCT00610155|3646739|FG002|NOT COMPLETED|Period 1||1
2935006|NCT00610155|3646740|FG003|NOT COMPLETED|Period 1||0
2935007|NCT00610155|3646741|FG004|NOT COMPLETED|Period 1||0
2935008|NCT00610155|3646742|FG005|NOT COMPLETED|Period 1||0
2935009|NCT00610155|3646737|FG000|STARTED|Washout Period 1 (7 Days)||4
2935010|NCT00610155|3646738|FG001|STARTED|Washout Period 1 (7 Days)||3
2935011|NCT00610155|3646739|FG002|STARTED|Washout Period 1 (7 Days)||3
2935012|NCT00610155|3646740|FG003|STARTED|Washout Period 1 (7 Days)||3
2935013|NCT00610155|3646741|FG004|STARTED|Washout Period 1 (7 Days)||3
2935014|NCT00610155|3646742|FG005|STARTED|Washout Period 1 (7 Days)||1
2935015|NCT00610155|3646737|FG000|COMPLETED|Washout Period 1 (7 Days)||4
2935016|NCT00610155|3646738|FG001|COMPLETED|Washout Period 1 (7 Days)||3
2935017|NCT00610155|3646739|FG002|COMPLETED|Washout Period 1 (7 Days)||3
2935018|NCT00610155|3646740|FG003|COMPLETED|Washout Period 1 (7 Days)||3
2935019|NCT00610155|3646741|FG004|COMPLETED|Washout Period 1 (7 Days)||3
2935020|NCT00610155|3646742|FG005|COMPLETED|Washout Period 1 (7 Days)||1
2935021|NCT00610155|3646737|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0
2935022|NCT00610155|3646738|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0
2935023|NCT00610155|3646739|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||0
2935024|NCT00610155|3646740|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||0
2935025|NCT00610155|3646741|FG004|NOT COMPLETED|Washout Period 1 (7 Days)||0
2935026|NCT00610155|3646742|FG005|NOT COMPLETED|Washout Period 1 (7 Days)||0
2935027|NCT00610155|3646737|FG000|STARTED|Period 2||4
2935028|NCT00610155|3646738|FG001|STARTED|Period 2||3
2935029|NCT00610155|3646739|FG002|STARTED|Period 2||3
2935030|NCT00610155|3646740|FG003|STARTED|Period 2||3
2935031|NCT00610155|3646741|FG004|STARTED|Period 2||3
2935032|NCT00610155|3646742|FG005|STARTED|Period 2||1
2935033|NCT00610155|3646737|FG000|COMPLETED|Period 2||4
2935034|NCT00610155|3646738|FG001|COMPLETED|Period 2||3
2935035|NCT00610155|3646739|FG002|COMPLETED|Period 2||3
2935036|NCT00610155|3646740|FG003|COMPLETED|Period 2||3
2935037|NCT00610155|3646741|FG004|COMPLETED|Period 2||3
2935038|NCT00610155|3646742|FG005|COMPLETED|Period 2||1
2935039|NCT00610155|3646737|FG000|NOT COMPLETED|Period 2||0
2935040|NCT00610155|3646738|FG001|NOT COMPLETED|Period 2||0
2935041|NCT00610155|3646739|FG002|NOT COMPLETED|Period 2||0
2935042|NCT00610155|3646740|FG003|NOT COMPLETED|Period 2||0
2935043|NCT00610155|3646741|FG004|NOT COMPLETED|Period 2||0
2935044|NCT00610155|3646742|FG005|NOT COMPLETED|Period 2||0
2935045|NCT00610155|3646737|FG000|STARTED|Washout Period 2 (7 Days)||4
2935046|NCT00610155|3646738|FG001|STARTED|Washout Period 2 (7 Days)||3
2935047|NCT00610155|3646739|FG002|STARTED|Washout Period 2 (7 Days)||3
2935048|NCT00610155|3646740|FG003|STARTED|Washout Period 2 (7 Days)||3
2935049|NCT00610155|3646741|FG004|STARTED|Washout Period 2 (7 Days)||3
2935050|NCT00610155|3646742|FG005|STARTED|Washout Period 2 (7 Days)||1
2935051|NCT00610155|3646737|FG000|COMPLETED|Washout Period 2 (7 Days)||4
2935052|NCT00610155|3646738|FG001|COMPLETED|Washout Period 2 (7 Days)||3
2935053|NCT00610155|3646739|FG002|COMPLETED|Washout Period 2 (7 Days)||3
2935054|NCT00610155|3646740|FG003|COMPLETED|Washout Period 2 (7 Days)||3
2935055|NCT00610155|3646741|FG004|COMPLETED|Washout Period 2 (7 Days)||3
2935056|NCT00610155|3646742|FG005|COMPLETED|Washout Period 2 (7 Days)||1
2935057|NCT00610155|3646737|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||0
2935058|NCT00610155|3646738|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0
2935059|NCT00610155|3646739|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0
2935060|NCT00610155|3646740|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||0
2935061|NCT00610155|3646741|FG004|NOT COMPLETED|Washout Period 2 (7 Days)||0
2935062|NCT00610155|3646742|FG005|NOT COMPLETED|Washout Period 2 (7 Days)||0
2935063|NCT00610155|3646737|FG000|STARTED|Period 3||4
2935064|NCT00610155|3646738|FG001|STARTED|Period 3||3
2935065|NCT00610155|3646739|FG002|STARTED|Period 3||3
2935066|NCT00610155|3646740|FG003|STARTED|Period 3||3
2935067|NCT00610155|3646741|FG004|STARTED|Period 3||3
2935068|NCT00610155|3646742|FG005|STARTED|Period 3||1
2935069|NCT00610155|3646737|FG000|COMPLETED|Period 3||3
2935070|NCT00610155|3646738|FG001|COMPLETED|Period 3||3
2935071|NCT00610155|3646739|FG002|COMPLETED|Period 3||3
2935072|NCT00610155|3646740|FG003|COMPLETED|Period 3||3
2935073|NCT00610155|3646741|FG004|COMPLETED|Period 3||3
2935074|NCT00610155|3646742|FG005|COMPLETED|Period 3||1
2935075|NCT00610155|3646737|FG000|NOT COMPLETED|Period 3||1
2935076|NCT00610155|3646738|FG001|NOT COMPLETED|Period 3||0
2935077|NCT00610155|3646739|FG002|NOT COMPLETED|Period 3||0
2935078|NCT00610155|3646740|FG003|NOT COMPLETED|Period 3||0
2935079|NCT00610155|3646741|FG004|NOT COMPLETED|Period 3||0
2935080|NCT00610155|3646742|FG005|NOT COMPLETED|Period 3||0
2935081|NCT00610168|3646752|FG000|STARTED|Overall Study||75
2935082|NCT00610168|3646753|FG001|STARTED|Overall Study||7
2935083|NCT00610168|3646752|FG000|COMPLETED|Overall Study||73
2935084|NCT00610168|3646753|FG001|COMPLETED|Overall Study||7
2935085|NCT00610168|3646752|FG000|NOT COMPLETED|Overall Study||2
2935086|NCT00610168|3646753|FG001|NOT COMPLETED|Overall Study||0
2935087|NCT00610207|3646759|FG000|STARTED|Overall Study||21
2935088|NCT00610207|3646759|FG000|COMPLETED|Overall Study||18
2935089|NCT00610207|3646759|FG000|NOT COMPLETED|Overall Study||3
2935090|NCT00610311|3646763|FG000|STARTED|Overall Study||3
2935091|NCT00610311|3646763|FG000|COMPLETED|Overall Study||3
2935092|NCT00610311|3646763|FG000|NOT COMPLETED|Overall Study||0
2935093|NCT00610363|3646769|FG000|STARTED|Overall Study||42
2935094|NCT00610363|3646770|FG001|STARTED|Overall Study||41
2935095|NCT00610363|3646769|FG000|COMPLETED|Overall Study||31
2935096|NCT00610363|3646770|FG001|COMPLETED|Overall Study||38
2935097|NCT00610363|3646769|FG000|NOT COMPLETED|Overall Study||11
2935098|NCT00610363|3646770|FG001|NOT COMPLETED|Overall Study||3
2935099|NCT00610428|3646780|FG000|STARTED|Overall Study||24
2935100|NCT00610428|3646781|FG001|STARTED|Overall Study||24
2935101|NCT00610428|3646782|FG002|STARTED|Overall Study||27
2935102|NCT00610428|3646780|FG000|COMPLETED|Overall Study||24
2935103|NCT00610428|3646781|FG001|COMPLETED|Overall Study||23
2935104|NCT00610428|3646782|FG002|COMPLETED|Overall Study||25
2935105|NCT00610428|3646780|FG000|NOT COMPLETED|Overall Study||0
2935106|NCT00610428|3646781|FG001|NOT COMPLETED|Overall Study||1
2935107|NCT00610428|3646782|FG002|NOT COMPLETED|Overall Study||2
2935108|NCT00610441|3646794|FG000|STARTED|Treatment Period 1 - 3 Weeks||15
2935109|NCT00610441|3646795|FG001|STARTED|Treatment Period 1 - 3 Weeks||16
2935110|NCT00610441|3646796|FG002|STARTED|Treatment Period 1 - 3 Weeks||18
2935111|NCT00610441|3646797|FG003|STARTED|Treatment Period 1 - 3 Weeks||18
2935112|NCT00610441|3646794|FG000|COMPLETED|Treatment Period 1 - 3 Weeks||12
2935113|NCT00610441|3646795|FG001|COMPLETED|Treatment Period 1 - 3 Weeks||14
2935114|NCT00610441|3646796|FG002|COMPLETED|Treatment Period 1 - 3 Weeks||11
2935115|NCT00610441|3646797|FG003|COMPLETED|Treatment Period 1 - 3 Weeks||16
2935116|NCT00610441|3646794|FG000|NOT COMPLETED|Treatment Period 1 - 3 Weeks||3
2935117|NCT00610441|3646795|FG001|NOT COMPLETED|Treatment Period 1 - 3 Weeks||2
2935118|NCT00610441|3646796|FG002|NOT COMPLETED|Treatment Period 1 - 3 Weeks||7
2935119|NCT00610441|3646797|FG003|NOT COMPLETED|Treatment Period 1 - 3 Weeks||2
2935120|NCT00610441|3646794|FG000|STARTED|Placebo Washout Period - 2 Weeks||12
2935121|NCT00610441|3646795|FG001|STARTED|Placebo Washout Period - 2 Weeks||14
2935122|NCT00610441|3646796|FG002|STARTED|Placebo Washout Period - 2 Weeks||11
2935123|NCT00610441|3646797|FG003|STARTED|Placebo Washout Period - 2 Weeks||16
2935124|NCT00610441|3646794|FG000|COMPLETED|Placebo Washout Period - 2 Weeks||12
2935125|NCT00610441|3646795|FG001|COMPLETED|Placebo Washout Period - 2 Weeks||13
2935126|NCT00610441|3646796|FG002|COMPLETED|Placebo Washout Period - 2 Weeks||9
2935127|NCT00610441|3646797|FG003|COMPLETED|Placebo Washout Period - 2 Weeks||16
2935128|NCT00610441|3646794|FG000|NOT COMPLETED|Placebo Washout Period - 2 Weeks||0
2935129|NCT00610441|3646795|FG001|NOT COMPLETED|Placebo Washout Period - 2 Weeks||1
2935130|NCT00610441|3646796|FG002|NOT COMPLETED|Placebo Washout Period - 2 Weeks||2
3043251|NCT01182337|3763148|FG000|NOT COMPLETED|Overall Study||3
2935131|NCT00610441|3646797|FG003|NOT COMPLETED|Placebo Washout Period - 2 Weeks||0
2935132|NCT00610441|3646794|FG000|STARTED|Treatment Period 2 - 3 Weeks||12
2935133|NCT00610441|3646795|FG001|STARTED|Treatment Period 2 - 3 Weeks||13
2935134|NCT00610441|3646796|FG002|STARTED|Treatment Period 2 - 3 Weeks||9
2935135|NCT00610441|3646797|FG003|STARTED|Treatment Period 2 - 3 Weeks||16
2935136|NCT00610441|3646794|FG000|COMPLETED|Treatment Period 2 - 3 Weeks||10
2935137|NCT00610441|3646795|FG001|COMPLETED|Treatment Period 2 - 3 Weeks||12
2935138|NCT00610441|3646796|FG002|COMPLETED|Treatment Period 2 - 3 Weeks||9
2935139|NCT00610441|3646797|FG003|COMPLETED|Treatment Period 2 - 3 Weeks||14
3180153|NCT01989156|3908432|FG001|STARTED|Confinement Period (Population at Day 5)||41
3180154|NCT01989156|3908433|FG002|STARTED|Confinement Period (Population at Day 5)||39
3180155|NCT01989156|3908431|FG000|COMPLETED|Confinement Period (Population at Day 5)||80
2935140|NCT00610441|3646794|FG000|NOT COMPLETED|Treatment Period 2 - 3 Weeks||2
2935141|NCT00610441|3646795|FG001|NOT COMPLETED|Treatment Period 2 - 3 Weeks||1
2935142|NCT00610441|3646796|FG002|NOT COMPLETED|Treatment Period 2 - 3 Weeks||0
2935143|NCT00610441|3646797|FG003|NOT COMPLETED|Treatment Period 2 - 3 Weeks||2
2935144|NCT00610480|3646811|FG000|STARTED|Overall Study|10 assigned patients x 2 interventions.|10
2935145|NCT00610480|3646812|FG001|STARTED|Overall Study|10 assigned patients x 2 interventions.|10
2935146|NCT00610480|3646811|FG000|COMPLETED|Overall Study|10 assigned patients x 2 interventions.|10
2935147|NCT00610480|3646812|FG001|COMPLETED|Overall Study|10 assigned patients x 2 interventions.|10
2935148|NCT00610480|3646811|FG000|NOT COMPLETED|Overall Study||0
2935149|NCT00610480|3646812|FG001|NOT COMPLETED|Overall Study||0
2935150|NCT00610649|3646829|FG000|STARTED|Overall Study||4
2935151|NCT00610649|3646830|FG001|STARTED|Overall Study||2
2935152|NCT00610649|3646831|FG002|STARTED|Overall Study||4
2935153|NCT00610649|3646832|FG003|STARTED|Overall Study||2
2935154|NCT00610649|3646833|FG004|STARTED|Overall Study||4
2935155|NCT00610649|3646834|FG005|STARTED|Overall Study||2
2935156|NCT00610649|3646835|FG006|STARTED|Overall Study||4
2935157|NCT00610649|3646836|FG007|STARTED|Overall Study||2
2935158|NCT00610649|3646837|FG008|STARTED|Overall Study||10
2935159|NCT00610649|3646838|FG009|STARTED|Overall Study||10
2935160|NCT00610649|3646839|FG010|STARTED|Overall Study||10
2935161|NCT00610649|3646829|FG000|COMPLETED|Overall Study||3
2935162|NCT00610649|3646830|FG001|COMPLETED|Overall Study||1
2935163|NCT00610649|3646831|FG002|COMPLETED|Overall Study||4
2935164|NCT00610649|3646832|FG003|COMPLETED|Overall Study||2
2935165|NCT00610649|3646833|FG004|COMPLETED|Overall Study||4
2935166|NCT00610649|3646834|FG005|COMPLETED|Overall Study||2
2935167|NCT00610649|3646835|FG006|COMPLETED|Overall Study||4
2935168|NCT00610649|3646836|FG007|COMPLETED|Overall Study||2
2935169|NCT00610649|3646837|FG008|COMPLETED|Overall Study||10
2935170|NCT00610649|3646838|FG009|COMPLETED|Overall Study||9
2935171|NCT00610649|3646839|FG010|COMPLETED|Overall Study||9
2935172|NCT00610649|3646829|FG000|NOT COMPLETED|Overall Study||1
2935173|NCT00610649|3646830|FG001|NOT COMPLETED|Overall Study||1
2935174|NCT00610649|3646831|FG002|NOT COMPLETED|Overall Study||0
2935175|NCT00610649|3646832|FG003|NOT COMPLETED|Overall Study||0
2935176|NCT00610649|3646833|FG004|NOT COMPLETED|Overall Study||0
2935177|NCT00610649|3646834|FG005|NOT COMPLETED|Overall Study||0
2935178|NCT00610649|3646835|FG006|NOT COMPLETED|Overall Study||0
2935179|NCT00610649|3646836|FG007|NOT COMPLETED|Overall Study||0
2935180|NCT00610649|3646837|FG008|NOT COMPLETED|Overall Study||0
2935181|NCT00610649|3646838|FG009|NOT COMPLETED|Overall Study||1
2935182|NCT00610649|3646839|FG010|NOT COMPLETED|Overall Study||1
2935183|NCT00610675|3646863|FG000|STARTED|Overall Study||346
2935184|NCT00610675|3646863|FG000|Treated|Overall Study||342
2935185|NCT00610675|3646863|FG000|COMPLETED|Overall Study||126
2935186|NCT00610675|3646863|FG000|NOT COMPLETED|Overall Study||220
2935187|NCT00610688|3646870|FG000|STARTED|Overall Study||64
2935188|NCT00610688|3646871|FG001|STARTED|Overall Study||65
2935189|NCT00610688|3646872|FG002|STARTED|Overall Study||63
2935190|NCT00610688|3646870|FG000|COMPLETED|Overall Study||55
2935191|NCT00610688|3646871|FG001|COMPLETED|Overall Study||52
2935192|NCT00610688|3646872|FG002|COMPLETED|Overall Study||55
2935193|NCT00610688|3646870|FG000|NOT COMPLETED|Overall Study||9
2935194|NCT00610688|3646871|FG001|NOT COMPLETED|Overall Study||13
2935195|NCT00610688|3646872|FG002|NOT COMPLETED|Overall Study||8
2935196|NCT00610701|3646882|FG000|STARTED|Overall Study||15
2935197|NCT00610701|3646883|FG001|STARTED|Overall Study||20
2935198|NCT00610701|3646882|FG000|COMPLETED|Overall Study||5
2935199|NCT00610701|3646883|FG001|COMPLETED|Overall Study||9
2935200|NCT00610701|3646882|FG000|NOT COMPLETED|Overall Study||10
2935201|NCT00610701|3646883|FG001|NOT COMPLETED|Overall Study||11
2935202|NCT00610714|3646891|FG000|STARTED|Overall Study||105
2935203|NCT00610714|3646892|FG001|STARTED|Overall Study||106
2935204|NCT00610714|3646891|FG000|COMPLETED|Overall Study||79
2935205|NCT00610714|3646892|FG001|COMPLETED|Overall Study||82
2935206|NCT00610714|3646891|FG000|NOT COMPLETED|Overall Study||26
2935207|NCT00610714|3646892|FG001|NOT COMPLETED|Overall Study||24
2935208|NCT00610727|3646904|FG000|STARTED|Overall Study||14
2935209|NCT00610727|3646905|FG001|STARTED|Overall Study||8
2935210|NCT00610727|3646906|FG002|STARTED|Overall Study||8
2935211|NCT00610727|3646907|FG003|STARTED|Overall Study||8
2935212|NCT00610727|3646908|FG004|STARTED|Overall Study||8
2935213|NCT00610727|3646909|FG005|STARTED|Overall Study||8
2935214|NCT00610727|3646904|FG000|COMPLETED|Overall Study||14
2935215|NCT00610727|3646905|FG001|COMPLETED|Overall Study||8
2935216|NCT00610727|3646906|FG002|COMPLETED|Overall Study||8
2935217|NCT00610727|3646907|FG003|COMPLETED|Overall Study||8
2935218|NCT00610727|3646908|FG004|COMPLETED|Overall Study||8
2935219|NCT00610727|3646909|FG005|COMPLETED|Overall Study||8
2935220|NCT00610727|3646904|FG000|NOT COMPLETED|Overall Study||0
2935221|NCT00610727|3646905|FG001|NOT COMPLETED|Overall Study||0
2935222|NCT00610727|3646906|FG002|NOT COMPLETED|Overall Study||0
2935223|NCT00610727|3646907|FG003|NOT COMPLETED|Overall Study||0
2935224|NCT00610727|3646908|FG004|NOT COMPLETED|Overall Study||0
2935225|NCT00610727|3646909|FG005|NOT COMPLETED|Overall Study||0
2935226|NCT00610740|3646927|FG000|STARTED|Overall Study||18
2935227|NCT00610740|3646927|FG000|COMPLETED|Overall Study||18
2935228|NCT00610740|3646927|FG000|NOT COMPLETED|Overall Study||0
2935229|NCT00610857|3646931|FG000|STARTED|Overall Study||37
2935230|NCT00610857|3646931|FG000|COMPLETED|Overall Study||35
2935231|NCT00610857|3646931|FG000|NOT COMPLETED|Overall Study||2
2935232|NCT00610883|3646935|FG000|STARTED|Overall Study||17
2935233|NCT00610883|3646935|FG000|COMPLETED|Overall Study||17
2935234|NCT00610883|3646935|FG000|NOT COMPLETED|Overall Study||0
2935235|NCT00610935|3646941|FG000|STARTED|Overall Study||25
2935236|NCT00610935|3646942|FG001|STARTED|Overall Study||57
2935237|NCT00610935|3646941|FG000|ITTI Population|Overall Study||25
2935238|NCT00610935|3646942|FG001|ITTI Population|Overall Study||55
2935239|NCT00610935|3646941|FG000|ITT Population|Overall Study||25
2935240|NCT00610935|3646942|FG001|ITT Population|Overall Study||57
2935241|NCT00610935|3646941|FG000|COMPLETED|Overall Study||24
2935242|NCT00610935|3646942|FG001|COMPLETED|Overall Study||54
2935243|NCT00610935|3646941|FG000|NOT COMPLETED|Overall Study||1
2935244|NCT00610935|3646942|FG001|NOT COMPLETED|Overall Study||3
2935245|NCT00610987|3646950|FG000|STARTED|Overall Study||75
2935246|NCT00610987|3646951|FG001|STARTED|Overall Study||71
2935247|NCT00610987|3646950|FG000|COMPLETED|Overall Study||75
2935248|NCT00610987|3646951|FG001|COMPLETED|Overall Study||71
2935249|NCT00610987|3646950|FG000|NOT COMPLETED|Overall Study||0
2935250|NCT00610987|3646951|FG001|NOT COMPLETED|Overall Study||0
3043252|NCT01182337|3763149|FG001|NOT COMPLETED|Overall Study||2
3043253|NCT01182350|3763156|FG000|STARTED|Overall Study||30
3043254|NCT01182350|3763157|FG001|STARTED|Overall Study||14
3043255|NCT01182350|3763158|FG002|STARTED|Overall Study||3
3043256|NCT01182350|3763159|FG003|STARTED|Overall Study||3
3043257|NCT01182350|3763160|FG004|STARTED|Overall Study||3
3043258|NCT01182350|3763156|FG000|Underwent Stereotactic Biopsy|Overall Study||30
3043259|NCT01182350|3763157|FG001|Underwent Stereotactic Biopsy|Overall Study||14
3043260|NCT01182350|3763158|FG002|Underwent Stereotactic Biopsy|Overall Study||3
3043261|NCT01182350|3763159|FG003|Underwent Stereotactic Biopsy|Overall Study||3
3043262|NCT01182350|3763160|FG004|Underwent Stereotactic Biopsy|Overall Study||0
3043263|NCT01182350|3763156|FG000|Started Assigned Chemoradiation|Overall Study||27
3043264|NCT01182350|3763157|FG001|Started Assigned Chemoradiation|Overall Study||14
3043265|NCT01182350|3763158|FG002|Started Assigned Chemoradiation|Overall Study||2
3043266|NCT01182350|3763159|FG003|Started Assigned Chemoradiation|Overall Study||2
3043267|NCT01182350|3763160|FG004|Started Assigned Chemoradiation|Overall Study||0
3043268|NCT01182350|3763156|FG000|COMPLETED|Overall Study||3
3043269|NCT01182350|3763157|FG001|COMPLETED|Overall Study||0
3043270|NCT01182350|3763158|FG002|COMPLETED|Overall Study||0
3043271|NCT01182350|3763159|FG003|COMPLETED|Overall Study||0
3043272|NCT01182350|3763160|FG004|COMPLETED|Overall Study||0
3043273|NCT01182350|3763156|FG000|NOT COMPLETED|Overall Study||27
3043274|NCT01182350|3763157|FG001|NOT COMPLETED|Overall Study||14
3043275|NCT01182350|3763158|FG002|NOT COMPLETED|Overall Study||3
3043276|NCT01182350|3763159|FG003|NOT COMPLETED|Overall Study||3
3043277|NCT01182350|3763160|FG004|NOT COMPLETED|Overall Study||3
3043278|NCT01182376|3763178|FG000|STARTED|Overall Study||15
3043279|NCT01182376|3763179|FG001|STARTED|Overall Study||18
3043280|NCT01182376|3763178|FG000|COMPLETED|Overall Study||4
3043281|NCT01182376|3763179|FG001|COMPLETED|Overall Study||13
3043282|NCT01182376|3763178|FG000|NOT COMPLETED|Overall Study||11
3043283|NCT01182376|3763179|FG001|NOT COMPLETED|Overall Study||5
3043284|NCT01182415|3763185|FG000|STARTED|Overall Study||30
3043285|NCT01182415|3763185|FG000|COMPLETED|Overall Study||29
3043286|NCT01182415|3763185|FG000|NOT COMPLETED|Overall Study||1
3043287|NCT01182428|3763191|FG000|STARTED|Overall Study||304
3043288|NCT01182428|3763192|FG001|STARTED|Overall Study||151
3043289|NCT01182428|3763191|FG000|COMPLETED|Overall Study||293
3043290|NCT01182428|3763192|FG001|COMPLETED|Overall Study||150
3043291|NCT01182428|3763191|FG000|NOT COMPLETED|Overall Study||11
3043292|NCT01182428|3763192|FG001|NOT COMPLETED|Overall Study||1
3043293|NCT01182441|3763200|FG000|STARTED|Overall Study||269
3043294|NCT01182441|3763201|FG001|STARTED|Overall Study||138
3043295|NCT01182441|3763200|FG000|COMPLETED|Overall Study||49
3043296|NCT01182441|3763201|FG001|COMPLETED|Overall Study||19
3043297|NCT01182441|3763200|FG000|NOT COMPLETED|Overall Study||220
3043298|NCT01182441|3763201|FG001|NOT COMPLETED|Overall Study||119
3043299|NCT01182480|3763207|FG000|STARTED|Overall Study||47
3043300|NCT01182480|3763207|FG000|COMPLETED|Overall Study||47
3043301|NCT01182480|3763207|FG000|NOT COMPLETED|Overall Study||0
3043302|NCT01182493|3763213|FG000|STARTED|Overall Study||168
3043303|NCT01182493|3763214|FG001|STARTED|Overall Study||163
3043304|NCT01182493|3763213|FG000|COMPLETED|Overall Study||152
3043305|NCT01182493|3763214|FG001|COMPLETED|Overall Study||156
3043306|NCT01182493|3763213|FG000|NOT COMPLETED|Overall Study||16
3043307|NCT01182493|3763214|FG001|NOT COMPLETED|Overall Study||7
3043308|NCT01182675|3763222|FG000|STARTED|Overall Study||7
3043309|NCT01182675|3763223|FG001|STARTED|Overall Study||0
3043310|NCT01182675|3763222|FG000|COMPLETED|Overall Study||7
3043311|NCT01182675|3763223|FG001|COMPLETED|Overall Study||0
3043312|NCT01182675|3763222|FG000|NOT COMPLETED|Overall Study||0
3043313|NCT01182675|3763223|FG001|NOT COMPLETED|Overall Study||0
3043314|NCT01182727|3763231|FG000|STARTED|Overall Study||10
3043315|NCT01182727|3763231|FG000|COMPLETED|Overall Study||10
3043316|NCT01182727|3763231|FG000|NOT COMPLETED|Overall Study||0
3043317|NCT01182805|3763235|FG000|STARTED|Overall Study||50
3043318|NCT01182805|3763235|FG000|COMPLETED|Overall Study||50
3043319|NCT01182805|3763235|FG000|NOT COMPLETED|Overall Study||0
3043320|NCT01182844|3763243|FG000|STARTED|Overall Study||15
3043321|NCT01182844|3763244|FG001|STARTED|Overall Study||15
3043322|NCT01182844|3763243|FG000|COMPLETED|Overall Study||15
3043323|NCT01182844|3763244|FG001|COMPLETED|Overall Study||13
3180156|NCT01989156|3908432|FG001|COMPLETED|Confinement Period (Population at Day 5)||40
3180157|NCT01989156|3908433|FG002|COMPLETED|Confinement Period (Population at Day 5)||34
3043324|NCT01182844|3763243|FG000|NOT COMPLETED|Overall Study||0
3043325|NCT01182844|3763244|FG001|NOT COMPLETED|Overall Study||2
3043326|NCT01183013|3763257|FG000|STARTED|Overall Study||131
3043327|NCT01183013|3763258|FG001|STARTED|Overall Study||140
3043328|NCT01183013|3763259|FG002|STARTED|Overall Study||138
3043329|NCT01183013|3763260|FG003|STARTED|Overall Study||135
3043330|NCT01183013|3763261|FG004|STARTED|Overall Study||126
3043331|NCT01183013|3763262|FG005|STARTED|Overall Study||133
3043332|NCT01183013|3763263|FG006|STARTED|Overall Study||133
3043333|NCT01183013|3763257|FG000|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|86
3043334|NCT01183013|3763258|FG001|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|101
3043335|NCT01183013|3763259|FG002|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|97
3043336|NCT01183013|3763260|FG003|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|105
3043337|NCT01183013|3763261|FG004|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|90
3043338|NCT01183013|3763262|FG005|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|88
3043339|NCT01183013|3763263|FG006|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|96
3043340|NCT01183013|3763257|FG000|NOT COMPLETED|Overall Study||45
3043341|NCT01183013|3763258|FG001|NOT COMPLETED|Overall Study||39
3043342|NCT01183013|3763259|FG002|NOT COMPLETED|Overall Study||41
3043343|NCT01183013|3763260|FG003|NOT COMPLETED|Overall Study||30
3043344|NCT01183013|3763261|FG004|NOT COMPLETED|Overall Study||36
3043345|NCT01183013|3763262|FG005|NOT COMPLETED|Overall Study||45
3043346|NCT01183013|3763263|FG006|NOT COMPLETED|Overall Study||37
3043347|NCT01183065|3763280|FG000|STARTED|Overall Study||13
3043348|NCT01183065|3763280|FG000|COMPLETED|Overall Study||12
3043349|NCT01183065|3763280|FG000|NOT COMPLETED|Overall Study||1
3043350|NCT01183104|3763286|FG000|STARTED|Overall Study||153
3043351|NCT01183104|3763287|FG001|STARTED|Overall Study||152
3043352|NCT01183104|3763286|FG000|Received Study Drug|Overall Study||148
3043353|NCT01183104|3763287|FG001|Received Study Drug|Overall Study||143
3043354|NCT01183104|3763286|FG000|Continued Treatment for 12 Weeks|Overall Study||143
3043355|NCT01183104|3763287|FG001|Continued Treatment for 12 Weeks|Overall Study||129
3043356|NCT01183104|3763286|FG000|Completed 52-week Treatment|Overall Study||119
3043357|NCT01183104|3763287|FG001|Completed 52-week Treatment|Overall Study||111
3043358|NCT01183104|3763286|FG000|Enrolled in Extension Study|Overall Study||80
3043359|NCT01183104|3763287|FG001|Enrolled in Extension Study|Overall Study||61
3043360|NCT01183104|3763286|FG000|COMPLETED|Overall Study||76
3043361|NCT01183104|3763287|FG001|COMPLETED|Overall Study||60
3043362|NCT01183104|3763286|FG000|NOT COMPLETED|Overall Study||77
3043363|NCT01183104|3763287|FG001|NOT COMPLETED|Overall Study||92
3043364|NCT01183143|3763293|FG000|STARTED|Overall Study||215
3043365|NCT01183143|3763293|FG000|Intention to Treat (ITT) Population|Overall Study|ITT=Subjects who received at least 1 dose of the investigational medicinal product (IMP).|204
3043366|NCT01183143|3763293|FG000|COMPLETED|Overall Study||65
3043367|NCT01183143|3763293|FG000|NOT COMPLETED|Overall Study||150
3043368|NCT01183169|3763301|FG000|STARTED|Main Phase||121
3043369|NCT01183169|3763302|FG001|STARTED|Main Phase||115
3043370|NCT01183169|3763303|FG002|STARTED|Main Phase||59
3043371|NCT01183169|3763304|FG003|STARTED|Main Phase||55
3043372|NCT01183169|3763305|FG004|STARTED|Main Phase||109
3043373|NCT01183169|3763306|FG005|STARTED|Main Phase||0
3043374|NCT01183169|3763307|FG006|STARTED|Main Phase||0
3043375|NCT01183169|3763301|FG000|Completed Treatment|Main Phase||72
3043376|NCT01183169|3763302|FG001|Completed Treatment|Main Phase||78
3043377|NCT01183169|3763303|FG002|Completed Treatment|Main Phase||17
3043378|NCT01183169|3763304|FG003|Completed Treatment|Main Phase||17
3043379|NCT01183169|3763305|FG004|Completed Treatment|Main Phase||77
3043380|NCT01183169|3763306|FG005|Completed Treatment|Main Phase||0
3043381|NCT01183169|3763307|FG006|Completed Treatment|Main Phase||0
3043382|NCT01183169|3763301|FG000|Switched to ALV|Main Phase||0
3043383|NCT01183169|3763302|FG001|Switched to ALV|Main Phase||0
3043384|NCT01183169|3763303|FG002|Switched to ALV|Main Phase||35
3043385|NCT01183169|3763304|FG003|Switched to ALV|Main Phase||30
3043386|NCT01183169|3763305|FG004|Switched to ALV|Main Phase||0
3043387|NCT01183169|3763306|FG005|Switched to ALV|Main Phase||0
3043388|NCT01183169|3763307|FG006|Switched to ALV|Main Phase||0
3043389|NCT01183169|3763301|FG000|COMPLETED|Main Phase||94
3043390|NCT01183169|3763302|FG001|COMPLETED|Main Phase||93
3043391|NCT01183169|3763303|FG002|COMPLETED|Main Phase||18
3043392|NCT01183169|3763304|FG003|COMPLETED|Main Phase||18
3043393|NCT01183169|3763305|FG004|COMPLETED|Main Phase||83
3043394|NCT01183169|3763306|FG005|COMPLETED|Main Phase||0
3043395|NCT01183169|3763307|FG006|COMPLETED|Main Phase||0
3043396|NCT01183169|3763301|FG000|NOT COMPLETED|Main Phase||27
3043397|NCT01183169|3763302|FG001|NOT COMPLETED|Main Phase||22
3043398|NCT01183169|3763303|FG002|NOT COMPLETED|Main Phase||41
3043399|NCT01183169|3763304|FG003|NOT COMPLETED|Main Phase||37
3043400|NCT01183169|3763305|FG004|NOT COMPLETED|Main Phase||26
3043401|NCT01183169|3763306|FG005|NOT COMPLETED|Main Phase||0
3043402|NCT01183169|3763307|FG006|NOT COMPLETED|Main Phase||0
3043403|NCT01183169|3763301|FG000|STARTED|Post-switch Phase|Not a post-switch group|0
3043404|NCT01183169|3763302|FG001|STARTED|Post-switch Phase|Not a post-switch group|0
3043405|NCT01183169|3763303|FG002|STARTED|Post-switch Phase|Not a post-switch group|0
3043406|NCT01183169|3763304|FG003|STARTED|Post-switch Phase|Not a post-switch group|0
3043407|NCT01183169|3763305|FG004|STARTED|Post-switch Phase|Not a post-switch group|0
3043408|NCT01183169|3763306|FG005|STARTED|Post-switch Phase|Participants in Treatment C1 who switched to active ALV|35
3043409|NCT01183169|3763307|FG006|STARTED|Post-switch Phase|Participants in Treatment C2 who switched to active ALV|30
3043410|NCT01183169|3763301|FG000|Completed Treatment|Post-switch Phase||0
3043411|NCT01183169|3763302|FG001|Completed Treatment|Post-switch Phase||0
3043412|NCT01183169|3763303|FG002|Completed Treatment|Post-switch Phase||0
3043413|NCT01183169|3763304|FG003|Completed Treatment|Post-switch Phase||0
3043414|NCT01183169|3763305|FG004|Completed Treatment|Post-switch Phase||0
3043415|NCT01183169|3763306|FG005|Completed Treatment|Post-switch Phase||12
3043416|NCT01183169|3763307|FG006|Completed Treatment|Post-switch Phase||13
3043417|NCT01183169|3763301|FG000|COMPLETED|Post-switch Phase||0
3043418|NCT01183169|3763302|FG001|COMPLETED|Post-switch Phase||0
3043419|NCT01183169|3763303|FG002|COMPLETED|Post-switch Phase||0
3043420|NCT01183169|3763304|FG003|COMPLETED|Post-switch Phase||0
3043421|NCT01183169|3763305|FG004|COMPLETED|Post-switch Phase||0
3043422|NCT01183169|3763306|FG005|COMPLETED|Post-switch Phase||21
3043423|NCT01183169|3763307|FG006|COMPLETED|Post-switch Phase||21
3043424|NCT01183169|3763301|FG000|NOT COMPLETED|Post-switch Phase||0
3043425|NCT01183169|3763302|FG001|NOT COMPLETED|Post-switch Phase||0
3043426|NCT01183169|3763303|FG002|NOT COMPLETED|Post-switch Phase||0
3043427|NCT01183169|3763304|FG003|NOT COMPLETED|Post-switch Phase||0
3043428|NCT01183169|3763305|FG004|NOT COMPLETED|Post-switch Phase||0
3043429|NCT01183169|3763306|FG005|NOT COMPLETED|Post-switch Phase||14
3043430|NCT01183169|3763307|FG006|NOT COMPLETED|Post-switch Phase||9
3043431|NCT01183234|3763327|FG000|STARTED|First Intervention||14
3043432|NCT01183234|3763328|FG001|STARTED|First Intervention||14
3043433|NCT01183234|3763327|FG000|COMPLETED|First Intervention||13
3043434|NCT01183234|3763328|FG001|COMPLETED|First Intervention||14
3043435|NCT01183234|3763327|FG000|NOT COMPLETED|First Intervention||1
3043436|NCT01183234|3763328|FG001|NOT COMPLETED|First Intervention||0
3043437|NCT01183234|3763327|FG000|STARTED|Washout||13
3043438|NCT01183234|3763328|FG001|STARTED|Washout||14
3043439|NCT01183234|3763327|FG000|COMPLETED|Washout||13
3043440|NCT01183234|3763328|FG001|COMPLETED|Washout||14
3043441|NCT01183234|3763327|FG000|NOT COMPLETED|Washout||0
3043442|NCT01183234|3763328|FG001|NOT COMPLETED|Washout||0
3043443|NCT01183234|3763327|FG000|STARTED|Second Intervention||13
3043444|NCT01183234|3763328|FG001|STARTED|Second Intervention||14
3043445|NCT01183234|3763327|FG000|COMPLETED|Second Intervention||13
3043446|NCT01183234|3763328|FG001|COMPLETED|Second Intervention||14
3043447|NCT01183234|3763327|FG000|NOT COMPLETED|Second Intervention||0
3043448|NCT01183234|3763328|FG001|NOT COMPLETED|Second Intervention||0
3043449|NCT01183260|3763336|FG000|STARTED|Overall Study||14
3043450|NCT01183260|3763337|FG001|STARTED|Overall Study||11
3043451|NCT01183260|3763336|FG000|COMPLETED|Overall Study||10
3043452|NCT01183260|3763337|FG001|COMPLETED|Overall Study||9
3043453|NCT01183260|3763336|FG000|NOT COMPLETED|Overall Study||4
3043454|NCT01183260|3763337|FG001|NOT COMPLETED|Overall Study||2
3043455|NCT01183312|3763345|FG000|STARTED|First Intervention Day||5
3043456|NCT01183312|3763346|FG001|STARTED|First Intervention Day||5
3043457|NCT01183312|3763345|FG000|COMPLETED|First Intervention Day||5
3043458|NCT01183312|3763346|FG001|COMPLETED|First Intervention Day||5
3043459|NCT01183312|3763345|FG000|NOT COMPLETED|First Intervention Day||0
3043460|NCT01183312|3763346|FG001|NOT COMPLETED|First Intervention Day||0
3043461|NCT01183312|3763345|FG000|STARTED|Washout Period of at Least 1 Week||5
3043462|NCT01183312|3763346|FG001|STARTED|Washout Period of at Least 1 Week||5
3043463|NCT01183312|3763345|FG000|COMPLETED|Washout Period of at Least 1 Week||5
3043464|NCT01183312|3763346|FG001|COMPLETED|Washout Period of at Least 1 Week||5
3043465|NCT01183312|3763345|FG000|NOT COMPLETED|Washout Period of at Least 1 Week||0
3043466|NCT01183312|3763346|FG001|NOT COMPLETED|Washout Period of at Least 1 Week||0
3043467|NCT01183312|3763345|FG000|STARTED|Second Intervention Day||5
3043468|NCT01183312|3763346|FG001|STARTED|Second Intervention Day||5
3043469|NCT01183312|3763345|FG000|COMPLETED|Second Intervention Day||5
3043470|NCT01183312|3763346|FG001|COMPLETED|Second Intervention Day||5
3043471|NCT01183312|3763345|FG000|NOT COMPLETED|Second Intervention Day||0
3043472|NCT01183312|3763346|FG001|NOT COMPLETED|Second Intervention Day||0
3043473|NCT01183390|3763354|FG000|STARTED|First Intervention||11
3043474|NCT01183390|3763355|FG001|STARTED|First Intervention||11
3043475|NCT01183390|3763354|FG000|COMPLETED|First Intervention||11
3043476|NCT01183390|3763355|FG001|COMPLETED|First Intervention||10
3043477|NCT01183390|3763354|FG000|NOT COMPLETED|First Intervention||0
3043478|NCT01183390|3763355|FG001|NOT COMPLETED|First Intervention||1
3043479|NCT01183390|3763354|FG000|STARTED|Washout of 21 Days||11
3043480|NCT01183390|3763355|FG001|STARTED|Washout of 21 Days||10
3043481|NCT01183390|3763354|FG000|COMPLETED|Washout of 21 Days||11
3043482|NCT01183390|3763355|FG001|COMPLETED|Washout of 21 Days||10
3043483|NCT01183390|3763354|FG000|NOT COMPLETED|Washout of 21 Days||0
3043484|NCT01183390|3763355|FG001|NOT COMPLETED|Washout of 21 Days||0
3043485|NCT01183390|3763354|FG000|STARTED|Second Intervention||11
3043486|NCT01183390|3763355|FG001|STARTED|Second Intervention||10
3043487|NCT01183390|3763354|FG000|COMPLETED|Second Intervention||11
3043488|NCT01183390|3763355|FG001|COMPLETED|Second Intervention||10
3043489|NCT01183390|3763354|FG000|NOT COMPLETED|Second Intervention||0
3043490|NCT01183390|3763355|FG001|NOT COMPLETED|Second Intervention||0
3043491|NCT01183481|3763361|FG000|STARTED|Overall Study||19
3043492|NCT01183481|3763361|FG000|COMPLETED|Overall Study||19
3043493|NCT01183481|3763361|FG000|NOT COMPLETED|Overall Study||0
3043494|NCT01183533|3763366|FG000|STARTED|Overall Study|Between Oct 2010 and Oct 2013.|40
3043495|NCT01183533|3763366|FG000|COMPLETED|Overall Study|- all pre-planned 40 patients received the study medication.|40
3043496|NCT01183533|3763366|FG000|NOT COMPLETED|Overall Study||0
3043497|NCT01183546|3763370|FG000|STARTED|Overall Study||53
3043498|NCT01183546|3763370|FG000|COMPLETED|Overall Study||53
3043499|NCT01183546|3763370|FG000|NOT COMPLETED|Overall Study||0
3043500|NCT01183559|3763375|FG000|STARTED|Overall Study||9
3043501|NCT01183559|3763375|FG000|COMPLETED|Overall Study||9
3043502|NCT01183559|3763375|FG000|NOT COMPLETED|Overall Study||0
3043503|NCT01183650|3763382|FG000|STARTED|Overall Study||12
3043504|NCT01183650|3763383|FG001|STARTED|Overall Study||12
3180158|NCT01989156|3908431|FG000|NOT COMPLETED|Confinement Period (Population at Day 5)||0
3180159|NCT01989156|3908432|FG001|NOT COMPLETED|Confinement Period (Population at Day 5)||1
3043505|NCT01183650|3763382|FG000|COMPLETED|Overall Study||12
3043506|NCT01183650|3763383|FG001|COMPLETED|Overall Study||12
3043507|NCT01183650|3763382|FG000|NOT COMPLETED|Overall Study||0
3043508|NCT01183650|3763383|FG001|NOT COMPLETED|Overall Study||0
3043509|NCT01183689|3763392|FG000|STARTED|Overall Study||202
3043510|NCT01183689|3763393|FG001|STARTED|Overall Study||200
3043511|NCT01183689|3763394|FG002|STARTED|Overall Study||197
3043512|NCT01183689|3763392|FG000|Month 4 Visit|Overall Study||197
3043513|NCT01183689|3763393|FG001|Month 4 Visit|Overall Study||192
3043514|NCT01183689|3763394|FG002|Month 4 Visit|Overall Study||187
3043515|NCT01183689|3763392|FG000|Year 1 Visit|Overall Study||187
3043516|NCT01183689|3763393|FG001|Year 1 Visit|Overall Study||172
3043517|NCT01183689|3763394|FG002|Year 1 Visit|Overall Study||183
3043518|NCT01183689|3763392|FG000|Year 2 Visit|Overall Study||178
3043519|NCT01183689|3763393|FG001|Year 2 Visit|Overall Study||172
3043520|NCT01183689|3763394|FG002|Year 2 Visit|Overall Study||174
3043521|NCT01183689|3763392|FG000|Year 3 Visit|Overall Study||139
3043522|NCT01183689|3763393|FG001|Year 3 Visit|Overall Study||125
3043523|NCT01183689|3763394|FG002|Year 3 Visit|Overall Study||126
3043524|NCT01183689|3763392|FG000|Year 4 Visit|Overall Study||38
3043525|NCT01183689|3763393|FG001|Year 4 Visit|Overall Study||33
3043526|NCT01183689|3763394|FG002|Year 4 Visit|Overall Study||30
3043527|NCT01183689|3763392|FG000|COMPLETED|Overall Study||202
3043528|NCT01183689|3763393|FG001|COMPLETED|Overall Study||200
3043529|NCT01183689|3763394|FG002|COMPLETED|Overall Study||197
3043530|NCT01183689|3763392|FG000|NOT COMPLETED|Overall Study||0
3043531|NCT01183689|3763393|FG001|NOT COMPLETED|Overall Study||0
3043532|NCT01183689|3763394|FG002|NOT COMPLETED|Overall Study||0
3043533|NCT01183728|3763404|FG000|STARTED|Overall Study||12
3043534|NCT01183728|3763404|FG000|COMPLETED|Overall Study||12
3043535|NCT01183728|3763404|FG000|NOT COMPLETED|Overall Study||0
3043536|NCT01183780|3763410|FG000|STARTED|Overall Study||536
3043537|NCT01183780|3763411|FG001|STARTED|Overall Study||536
3043538|NCT01183780|3763410|FG000|Received at Least 1 Dose of Study Drug|Overall Study||528
3043539|NCT01183780|3763411|FG001|Received at Least 1 Dose of Study Drug|Overall Study||529
3043540|NCT01183780|3763410|FG000|COMPLETED|Overall Study||505
3043541|NCT01183780|3763411|FG001|COMPLETED|Overall Study||511
3043542|NCT01183780|3763410|FG000|NOT COMPLETED|Overall Study||31
3043543|NCT01183780|3763411|FG001|NOT COMPLETED|Overall Study||25
3043544|NCT01183858|3763419|FG000|STARTED|Overall Study||154
3043545|NCT01183858|3763420|FG001|STARTED|Overall Study||159
3043546|NCT01183858|3763419|FG000|Safety Population|Overall Study||154
3043547|NCT01183858|3763420|FG001|Safety Population|Overall Study||158
3043548|NCT01183858|3763419|FG000|COMPLETED|Overall Study||1
3043549|NCT01183858|3763420|FG001|COMPLETED|Overall Study||3
3043550|NCT01183858|3763419|FG000|NOT COMPLETED|Overall Study||153
3043551|NCT01183858|3763420|FG001|NOT COMPLETED|Overall Study||156
3043552|NCT01183923|3763426|FG000|STARTED|Intervention 1 (7 Days)||1
3043553|NCT01183923|3763427|FG001|STARTED|Intervention 1 (7 Days)||0
3043554|NCT01183923|3763426|FG000|COMPLETED|Intervention 1 (7 Days)||1
3043555|NCT01183923|3763427|FG001|COMPLETED|Intervention 1 (7 Days)||0
3043556|NCT01183923|3763426|FG000|NOT COMPLETED|Intervention 1 (7 Days)||0
3043557|NCT01183923|3763427|FG001|NOT COMPLETED|Intervention 1 (7 Days)||0
3043558|NCT01183923|3763426|FG000|STARTED|Washout (14 Days)||1
3043559|NCT01183923|3763427|FG001|STARTED|Washout (14 Days)||0
3043560|NCT01183923|3763426|FG000|COMPLETED|Washout (14 Days)||1
3043561|NCT01183923|3763427|FG001|COMPLETED|Washout (14 Days)||0
3043562|NCT01183923|3763426|FG000|NOT COMPLETED|Washout (14 Days)||0
3043563|NCT01183923|3763427|FG001|NOT COMPLETED|Washout (14 Days)||0
3043564|NCT01183923|3763426|FG000|STARTED|Intervention 2 (7 Days)||1
3043565|NCT01183923|3763427|FG001|STARTED|Intervention 2 (7 Days)||0
3043566|NCT01183923|3763426|FG000|COMPLETED|Intervention 2 (7 Days)||1
3043567|NCT01183923|3763427|FG001|COMPLETED|Intervention 2 (7 Days)||0
3043568|NCT01183923|3763426|FG000|NOT COMPLETED|Intervention 2 (7 Days)||0
3043569|NCT01183923|3763427|FG001|NOT COMPLETED|Intervention 2 (7 Days)||0
3043570|NCT01183975|3763432|FG000|STARTED|Overall Study||517
3043571|NCT01183975|3763432|FG000|COMPLETED|Overall Study||444
3043572|NCT01183975|3763432|FG000|NOT COMPLETED|Overall Study||73
3043573|NCT01184014|3763438|FG000|STARTED|Overall Study||35
3043574|NCT01184014|3763439|FG001|STARTED|Overall Study||37
3043575|NCT01184014|3763438|FG000|COMPLETED|Overall Study||30
3043576|NCT01184014|3763439|FG001|COMPLETED|Overall Study||31
3043577|NCT01184014|3763438|FG000|NOT COMPLETED|Overall Study||5
3043578|NCT01184014|3763439|FG001|NOT COMPLETED|Overall Study||6
3043579|NCT01184053|3763445|FG000|STARTED|Overall Study||3
3043580|NCT01184053|3763445|FG000|COMPLETED|Overall Study||0
3043581|NCT01184053|3763445|FG000|NOT COMPLETED|Overall Study||3
3043582|NCT01184079|3763452|FG000|STARTED|Overall Study||111
3043583|NCT01184079|3763453|FG001|STARTED|Overall Study||109
3043584|NCT01184079|3763452|FG000|Dose 2|Overall Study||110
3043585|NCT01184079|3763453|FG001|Dose 2|Overall Study||108
3043586|NCT01184079|3763452|FG000|Dose 3|Overall Study||101
3043587|NCT01184079|3763453|FG001|Dose 3|Overall Study||107
3043588|NCT01184079|3763452|FG000|Final Blood Draw|Overall Study||97
3043589|NCT01184079|3763453|FG001|Final Blood Draw|Overall Study||107
3043590|NCT01184079|3763452|FG000|COMPLETED|Overall Study||97
3043591|NCT01184079|3763453|FG001|COMPLETED|Overall Study||107
3043592|NCT01184079|3763452|FG000|NOT COMPLETED|Overall Study||14
3043593|NCT01184079|3763453|FG001|NOT COMPLETED|Overall Study||2
3043594|NCT01184118|3763461|FG000|STARTED|Overall Study||36
3043595|NCT01184118|3763461|FG000|FP MDI 1,760 mcg/Day (16 Weeks)|Overall Study||18
3043596|NCT01184118|3763461|FG000|FP MDI 880 mcg/Day (2 Weeks)|Overall Study||18
3043597|NCT01184118|3763461|FG000|FP MDI as Indicated (2 Weeks)|Overall Study||18
3043598|NCT01184118|3763461|FG000|COMPLETED|Overall Study||18
3043599|NCT01184118|3763461|FG000|NOT COMPLETED|Overall Study||18
3043600|NCT01184326|3763468|FG000|STARTED|Overall Study||3
3043601|NCT01184326|3763469|FG001|STARTED|Overall Study||6
3043602|NCT01184326|3763470|FG002|STARTED|Overall Study||14
3043603|NCT01184326|3763468|FG000|COMPLETED|Overall Study||0
3043604|NCT01184326|3763469|FG001|COMPLETED|Overall Study||0
3043605|NCT01184326|3763470|FG002|COMPLETED|Overall Study||0
3043606|NCT01184326|3763468|FG000|NOT COMPLETED|Overall Study||3
3043607|NCT01184326|3763469|FG001|NOT COMPLETED|Overall Study||6
3043608|NCT01184326|3763470|FG002|NOT COMPLETED|Overall Study||14
3043609|NCT01184417|3763483|FG000|STARTED|Overall Study||51
3043610|NCT01184417|3763484|FG001|STARTED|Overall Study||51
3043611|NCT01184417|3763483|FG000|COMPLETED|Overall Study||51
3043612|NCT01184417|3763484|FG001|COMPLETED|Overall Study||51
3043613|NCT01184417|3763483|FG000|NOT COMPLETED|Overall Study||0
3043614|NCT01184417|3763484|FG001|NOT COMPLETED|Overall Study||0
3043615|NCT01184508|3763492|FG000|STARTED|Overall Study||45
3043616|NCT01184508|3763493|FG001|STARTED|Overall Study||42
3043617|NCT01184508|3763492|FG000|Received at Least 1 Dose of Study Drug|Overall Study||45
3043618|NCT01184508|3763493|FG001|Received at Least 1 Dose of Study Drug|Overall Study||41
3043619|NCT01184508|3763492|FG000|COMPLETED|Overall Study||29
3043620|NCT01184508|3763493|FG001|COMPLETED|Overall Study||27
3043621|NCT01184508|3763492|FG000|NOT COMPLETED|Overall Study||16
3043622|NCT01184508|3763493|FG001|NOT COMPLETED|Overall Study||15
3043623|NCT01184755|3763503|FG000|STARTED|Overall Study||126
3043624|NCT01184755|3763504|FG001|STARTED|Overall Study||65
3043625|NCT01184755|3763505|FG002|STARTED|Overall Study||62
3043626|NCT01184755|3763503|FG000|COMPLETED|Overall Study||101
3043627|NCT01184755|3763504|FG001|COMPLETED|Overall Study||54
3043628|NCT01184755|3763505|FG002|COMPLETED|Overall Study||56
3043629|NCT01184755|3763503|FG000|NOT COMPLETED|Overall Study||25
3043630|NCT01184755|3763504|FG001|NOT COMPLETED|Overall Study||11
3043631|NCT01184755|3763505|FG002|NOT COMPLETED|Overall Study||6
3043632|NCT01184846|3763513|FG000|STARTED|Overall Study||28
3043633|NCT01184846|3763513|FG000|COMPLETED|Overall Study||25
3043634|NCT01184846|3763513|FG000|NOT COMPLETED|Overall Study||3
3043635|NCT01184859|3763524|FG000|STARTED|Period 1: Single Dose||23
3043636|NCT01184859|3763525|FG001|STARTED|Period 1: Single Dose||25
3043637|NCT01184859|3763526|FG002|STARTED|Period 1: Single Dose||22
3043638|NCT01184859|3763527|FG003|STARTED|Period 1: Single Dose||22
3043639|NCT01184859|3763528|FG004|STARTED|Period 1: Single Dose||24
3043640|NCT01184859|3763524|FG000|Full Analysis Set (FAS)|Period 1: Single Dose||23
3043641|NCT01184859|3763525|FG001|Full Analysis Set (FAS)|Period 1: Single Dose|2 participants disqualified due to no post-baseline primary efficacy data, and/or 'other'.|23
3043642|NCT01184859|3763526|FG002|Full Analysis Set (FAS)|Period 1: Single Dose||22
3043643|NCT01184859|3763527|FG003|Full Analysis Set (FAS)|Period 1: Single Dose|1 participant disqualified due to major entry criteria violation|21
3043644|NCT01184859|3763528|FG004|Full Analysis Set (FAS)|Period 1: Single Dose||24
3043645|NCT01184859|3763524|FG000|Per Protocol (PP)|Period 1: Single Dose||23
3043646|NCT01184859|3763525|FG001|Per Protocol (PP)|Period 1: Single Dose||23
3043647|NCT01184859|3763526|FG002|Per Protocol (PP)|Period 1: Single Dose||22
3043648|NCT01184859|3763527|FG003|Per Protocol (PP)|Period 1: Single Dose||21
3043649|NCT01184859|3763528|FG004|Per Protocol (PP)|Period 1: Single Dose|1 additional participant disqualified due to 'other'.|23
3043650|NCT01184859|3763524|FG000|COMPLETED|Period 1: Single Dose||23
3043651|NCT01184859|3763525|FG001|COMPLETED|Period 1: Single Dose||23
3043652|NCT01184859|3763526|FG002|COMPLETED|Period 1: Single Dose||22
3043653|NCT01184859|3763527|FG003|COMPLETED|Period 1: Single Dose||22
3043654|NCT01184859|3763528|FG004|COMPLETED|Period 1: Single Dose||23
3043655|NCT01184859|3763524|FG000|NOT COMPLETED|Period 1: Single Dose||0
3043656|NCT01184859|3763525|FG001|NOT COMPLETED|Period 1: Single Dose||2
3043657|NCT01184859|3763526|FG002|NOT COMPLETED|Period 1: Single Dose||0
3043658|NCT01184859|3763527|FG003|NOT COMPLETED|Period 1: Single Dose||0
3043659|NCT01184859|3763528|FG004|NOT COMPLETED|Period 1: Single Dose||1
3043660|NCT01184859|3763524|FG000|STARTED|Washout Period||23
3043661|NCT01184859|3763525|FG001|STARTED|Washout Period||23
3043662|NCT01184859|3763526|FG002|STARTED|Washout Period||22
3043663|NCT01184859|3763527|FG003|STARTED|Washout Period||22
3043664|NCT01184859|3763528|FG004|STARTED|Washout Period||23
3043665|NCT01184859|3763524|FG000|COMPLETED|Washout Period||23
3043666|NCT01184859|3763525|FG001|COMPLETED|Washout Period||23
3043667|NCT01184859|3763526|FG002|COMPLETED|Washout Period||22
3043668|NCT01184859|3763527|FG003|COMPLETED|Washout Period||22
3043669|NCT01184859|3763528|FG004|COMPLETED|Washout Period||23
3043670|NCT01184859|3763524|FG000|NOT COMPLETED|Washout Period||0
3043671|NCT01184859|3763525|FG001|NOT COMPLETED|Washout Period||0
3043672|NCT01184859|3763526|FG002|NOT COMPLETED|Washout Period||0
3043673|NCT01184859|3763527|FG003|NOT COMPLETED|Washout Period||0
3043674|NCT01184859|3763528|FG004|NOT COMPLETED|Washout Period||0
3043675|NCT01184859|3763524|FG000|STARTED|Period 2: Daily Dose for 28 Days||23
3043676|NCT01184859|3763525|FG001|STARTED|Period 2: Daily Dose for 28 Days||23
3043677|NCT01184859|3763526|FG002|STARTED|Period 2: Daily Dose for 28 Days||22
3043678|NCT01184859|3763527|FG003|STARTED|Period 2: Daily Dose for 28 Days||22
3043679|NCT01184859|3763528|FG004|STARTED|Period 2: Daily Dose for 28 Days||23
3043680|NCT01184859|3763524|FG000|COMPLETED|Period 2: Daily Dose for 28 Days||22
3043681|NCT01184859|3763525|FG001|COMPLETED|Period 2: Daily Dose for 28 Days||23
3043682|NCT01184859|3763526|FG002|COMPLETED|Period 2: Daily Dose for 28 Days||22
3043683|NCT01184859|3763527|FG003|COMPLETED|Period 2: Daily Dose for 28 Days||22
3043684|NCT01184859|3763528|FG004|COMPLETED|Period 2: Daily Dose for 28 Days||22
3043685|NCT01184859|3763524|FG000|NOT COMPLETED|Period 2: Daily Dose for 28 Days||1
3043686|NCT01184859|3763525|FG001|NOT COMPLETED|Period 2: Daily Dose for 28 Days||0
3043687|NCT01184859|3763526|FG002|NOT COMPLETED|Period 2: Daily Dose for 28 Days||0
3043688|NCT01184859|3763527|FG003|NOT COMPLETED|Period 2: Daily Dose for 28 Days||0
3043689|NCT01184859|3763528|FG004|NOT COMPLETED|Period 2: Daily Dose for 28 Days||1
3043690|NCT01184872|3763547|FG000|STARTED|Overall Study|"Started indicates randomized and full analysis set."|81
3043691|NCT01184872|3763548|FG001|STARTED|Overall Study||39
3043692|NCT01184872|3763547|FG000|Safety Set|Overall Study|One patient randomized to Daptomycin received Vancomycin.|80
3043693|NCT01184872|3763548|FG001|Safety Set|Overall Study||40
3043694|NCT01184872|3763547|FG000|Clinical Evaluable Set (CES)|Overall Study||73
3043695|NCT01184872|3763548|FG001|Clinical Evaluable Set (CES)|Overall Study||30
3043696|NCT01184872|3763547|FG000|Microbiologically Evaluable Set (MES)|Overall Study||65
3043697|NCT01184872|3763548|FG001|Microbiologically Evaluable Set (MES)|Overall Study||27
3043698|NCT01184872|3763547|FG000|COMPLETED|Overall Study||71
3043699|NCT01184872|3763548|FG001|COMPLETED|Overall Study||31
3043700|NCT01184872|3763547|FG000|NOT COMPLETED|Overall Study||10
3043701|NCT01184872|3763548|FG001|NOT COMPLETED|Overall Study||8
3043702|NCT01184885|3763554|FG000|STARTED|Overall Study||7
3043703|NCT01184885|3763554|FG000|COMPLETED|Overall Study||7
3043704|NCT01184885|3763554|FG000|NOT COMPLETED|Overall Study||0
3043705|NCT01184898|3763559|FG000|STARTED|Overall Study||36
3043706|NCT01184898|3763559|FG000|COMPLETED|Overall Study||36
3043707|NCT01184898|3763559|FG000|NOT COMPLETED|Overall Study||0
3043708|NCT01184989|3763563|FG000|STARTED|Overall Study|Treated Patients|112
3043709|NCT01184989|3763563|FG000|COMPLETED|Overall Study||100
3043710|NCT01184989|3763563|FG000|NOT COMPLETED|Overall Study||12
3043711|NCT01185028|3763567|FG000|STARTED|Overall Study||8
3043712|NCT01185028|3763567|FG000|COMPLETED|Overall Study||4
3043713|NCT01185028|3763567|FG000|NOT COMPLETED|Overall Study||4
3043714|NCT01185080|3763574|FG000|STARTED|Overall Study||50
3043715|NCT01185080|3763575|FG001|STARTED|Overall Study||16
3043716|NCT01185080|3763576|FG002|STARTED|Overall Study||17
3043717|NCT01185080|3763574|FG000|COMPLETED|Overall Study||49
3043718|NCT01185080|3763575|FG001|COMPLETED|Overall Study||15
3043719|NCT01185080|3763576|FG002|COMPLETED|Overall Study||16
3043720|NCT01185080|3763574|FG000|NOT COMPLETED|Overall Study||1
3043721|NCT01185080|3763575|FG001|NOT COMPLETED|Overall Study||1
3043722|NCT01185080|3763576|FG002|NOT COMPLETED|Overall Study||1
3043723|NCT01185171|3763584|FG000|STARTED|Induction Chemotherapy||59
3043724|NCT01185171|3763584|FG000|COMPLETED|Induction Chemotherapy||57
3043725|NCT01185171|3763584|FG000|NOT COMPLETED|Induction Chemotherapy||2
3043726|NCT01185171|3763584|FG000|STARTED|Concurrent Chemo and Radiation Treatment||69
3043727|NCT01185171|3763584|FG000|COMPLETED|Concurrent Chemo and Radiation Treatment||66
3043728|NCT01185171|3763584|FG000|NOT COMPLETED|Concurrent Chemo and Radiation Treatment||3
3043729|NCT01185171|3763584|FG000|STARTED|Maintenance||60
3043730|NCT01185171|3763584|FG000|COMPLETED|Maintenance||48
3043731|NCT01185171|3763584|FG000|NOT COMPLETED|Maintenance||12
3043732|NCT01185249|3763588|FG000|STARTED|Overall Study|Total number of patients consented to participate.|66
3043733|NCT01185249|3763588|FG000|COMPLETED|Overall Study|Data was analyzed for patients with three consecutive days of data.|24
3043734|NCT01185249|3763588|FG000|NOT COMPLETED|Overall Study||42
3043735|NCT01185288|3763595|FG000|STARTED|Overall Study||154
3043736|NCT01185288|3763596|FG001|STARTED|Overall Study||155
3043737|NCT01185288|3763595|FG000|COMPLETED|Overall Study||135
3043738|NCT01185288|3763596|FG001|COMPLETED|Overall Study||139
3043739|NCT01185288|3763595|FG000|NOT COMPLETED|Overall Study||19
3043740|NCT01185288|3763596|FG001|NOT COMPLETED|Overall Study||16
3043741|NCT01185301|3763606|FG000|STARTED|Overall Study||98
3043742|NCT01185301|3763607|FG001|STARTED|Overall Study||100
3043743|NCT01185301|3763608|FG002|STARTED|Overall Study||99
3043744|NCT01185301|3763609|FG003|STARTED|Overall Study||98
3043745|NCT01185301|3763606|FG000|COMPLETED|Overall Study||83
3043746|NCT01185301|3763607|FG001|COMPLETED|Overall Study||93
3043747|NCT01185301|3763608|FG002|COMPLETED|Overall Study||93
3043748|NCT01185301|3763609|FG003|COMPLETED|Overall Study||89
3043749|NCT01185301|3763606|FG000|NOT COMPLETED|Overall Study||15
3043750|NCT01185301|3763607|FG001|NOT COMPLETED|Overall Study||7
3043751|NCT01185301|3763608|FG002|NOT COMPLETED|Overall Study||6
3043752|NCT01185301|3763609|FG003|NOT COMPLETED|Overall Study||9
3043753|NCT01185340|3763622|FG000|STARTED|Confirmation (CF) Phase, 3 Weeks||1056
3043754|NCT01185340|3763623|FG001|STARTED|Confirmation (CF) Phase, 3 Weeks||0
3043755|NCT01185340|3763624|FG002|STARTED|Confirmation (CF) Phase, 3 Weeks||0
3043756|NCT01185340|3763625|FG003|STARTED|Confirmation (CF) Phase, 3 Weeks||0
3043757|NCT01185340|3763622|FG000|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks|Participants who discontinued the CF Phase early had the option to enter the DC Phase.|18
3043758|NCT01185340|3763623|FG001|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0
3043759|NCT01185340|3763624|FG002|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0
3043760|NCT01185340|3763625|FG003|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0
3043761|NCT01185340|3763622|FG000|COMPLETED|Confirmation (CF) Phase, 3 Weeks|Participants who completed the CF Phase entered the Adjunctive Treatment (AT) Phase.|968
3043762|NCT01185340|3763623|FG001|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
3043763|NCT01185340|3763624|FG002|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
3043764|NCT01185340|3763625|FG003|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
3043765|NCT01185340|3763622|FG000|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||88
3043766|NCT01185340|3763623|FG001|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
3043767|NCT01185340|3763624|FG002|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
3043768|NCT01185340|3763625|FG003|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
3043769|NCT01185340|3763622|FG000|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
3043770|NCT01185340|3763623|FG001|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||230
3043771|NCT01185340|3763624|FG002|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||219
3043772|NCT01185340|3763625|FG003|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||519
3043773|NCT01185340|3763622|FG000|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||0
3043774|NCT01185340|3763623|FG001|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|206
3043775|NCT01185340|3763624|FG002|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|204
3043776|NCT01185340|3763625|FG003|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|483
3043777|NCT01185340|3763622|FG000|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
3043778|NCT01185340|3763623|FG001|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||195
3043779|NCT01185340|3763624|FG002|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||186
3043780|NCT01185340|3763625|FG003|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||458
3043781|NCT01185340|3763622|FG000|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
3043782|NCT01185340|3763623|FG001|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||35
3043783|NCT01185340|3763624|FG002|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||33
3043784|NCT01185340|3763625|FG003|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||61
3180160|NCT01989156|3908433|FG002|NOT COMPLETED|Confinement Period (Population at Day 5)||5
3180161|NCT01989156|3908431|FG000|STARTED|End of Study (Population at Day 90)||80
3363511|NCT04067050|4094626|FG000|STARTED|Two Month|6 subjects discontinued after 1 month visit. 22 Subjects continued the study.|22
3043785|NCT01185353|3763642|FG000|STARTED|Part A (Weeks 0 Through 12)||49
3043786|NCT01185353|3763643|FG001|STARTED|Part A (Weeks 0 Through 12)||52
3043787|NCT01185353|3763644|FG002|STARTED|Part A (Weeks 0 Through 12)||52
3043788|NCT01185353|3763645|FG003|STARTED|Part A (Weeks 0 Through 12)||50
3043789|NCT01185353|3763646|FG004|STARTED|Part A (Weeks 0 Through 12)||98
3043790|NCT01185353|3763647|FG005|STARTED|Part A (Weeks 0 Through 12)||0
3043791|NCT01185353|3763648|FG006|STARTED|Part A (Weeks 0 Through 12)||0
3043792|NCT01185353|3763649|FG007|STARTED|Part A (Weeks 0 Through 12)||0
3043793|NCT01185353|3763650|FG008|STARTED|Part A (Weeks 0 Through 12)||0
3043794|NCT01185353|3763651|FG009|STARTED|Part A (Weeks 0 Through 12)||0
3043795|NCT01185353|3763642|FG000|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||49
3043796|NCT01185353|3763643|FG001|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||52
3043797|NCT01185353|3763644|FG002|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||52
3043798|NCT01185353|3763645|FG003|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||50
3043799|NCT01185353|3763646|FG004|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||98
3043800|NCT01185353|3763647|FG005|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||0
3043801|NCT01185353|3763648|FG006|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||0
3043802|NCT01185353|3763649|FG007|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||0
3043803|NCT01185353|3763650|FG008|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||0
3043804|NCT01185353|3763651|FG009|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||0
3043805|NCT01185353|3763642|FG000|COMPLETED|Part A (Weeks 0 Through 12)||44
3043806|NCT01185353|3763643|FG001|COMPLETED|Part A (Weeks 0 Through 12)||51
3043807|NCT01185353|3763644|FG002|COMPLETED|Part A (Weeks 0 Through 12)||50
3043808|NCT01185353|3763645|FG003|COMPLETED|Part A (Weeks 0 Through 12)||49
3043809|NCT01185353|3763646|FG004|COMPLETED|Part A (Weeks 0 Through 12)||82
3043810|NCT01185353|3763647|FG005|COMPLETED|Part A (Weeks 0 Through 12)||0
3043811|NCT01185353|3763648|FG006|COMPLETED|Part A (Weeks 0 Through 12)||0
3043812|NCT01185353|3763649|FG007|COMPLETED|Part A (Weeks 0 Through 12)||0
3043813|NCT01185353|3763650|FG008|COMPLETED|Part A (Weeks 0 Through 12)||0
3043814|NCT01185353|3763651|FG009|COMPLETED|Part A (Weeks 0 Through 12)||0
3043815|NCT01185353|3763642|FG000|NOT COMPLETED|Part A (Weeks 0 Through 12)||5
3043816|NCT01185353|3763643|FG001|NOT COMPLETED|Part A (Weeks 0 Through 12)||1
3043817|NCT01185353|3763644|FG002|NOT COMPLETED|Part A (Weeks 0 Through 12)||2
3043818|NCT01185353|3763645|FG003|NOT COMPLETED|Part A (Weeks 0 Through 12)||1
3043819|NCT01185353|3763646|FG004|NOT COMPLETED|Part A (Weeks 0 Through 12)||16
3043820|NCT01185353|3763647|FG005|NOT COMPLETED|Part A (Weeks 0 Through 12)||0
3043821|NCT01185353|3763648|FG006|NOT COMPLETED|Part A (Weeks 0 Through 12)||0
3043822|NCT01185353|3763649|FG007|NOT COMPLETED|Part A (Weeks 0 Through 12)||0
3043823|NCT01185353|3763650|FG008|NOT COMPLETED|Part A (Weeks 0 Through 12)||0
3043824|NCT01185353|3763651|FG009|NOT COMPLETED|Part A (Weeks 0 Through 12)||0
3043825|NCT01185353|3763642|FG000|STARTED|Part B (Weeks 12 Through 24)||0
3043826|NCT01185353|3763643|FG001|STARTED|Part B (Weeks 12 Through 24)||51
3043827|NCT01185353|3763644|FG002|STARTED|Part B (Weeks 12 Through 24)||50
3043828|NCT01185353|3763645|FG003|STARTED|Part B (Weeks 12 Through 24)||49
3043829|NCT01185353|3763646|FG004|STARTED|Part B (Weeks 12 Through 24)||0
3043830|NCT01185353|3763647|FG005|STARTED|Part B (Weeks 12 Through 24)||63
3043831|NCT01185353|3763648|FG006|STARTED|Part B (Weeks 12 Through 24)||63
3043832|NCT01185353|3763649|FG007|STARTED|Part B (Weeks 12 Through 24)||0
3043833|NCT01185353|3763650|FG008|STARTED|Part B (Weeks 12 Through 24)||0
3180162|NCT01989156|3908432|FG001|STARTED|End of Study (Population at Day 90)||40
3180163|NCT01989156|3908433|FG002|STARTED|End of Study (Population at Day 90)||34
3180164|NCT01989156|3908431|FG000|COMPLETED|End of Study (Population at Day 90)||73
3180165|NCT01989156|3908432|FG001|COMPLETED|End of Study (Population at Day 90)||35
3180166|NCT01989156|3908433|FG002|COMPLETED|End of Study (Population at Day 90)||31
3180167|NCT01989156|3908431|FG000|NOT COMPLETED|End of Study (Population at Day 90)||7
3180168|NCT01989156|3908432|FG001|NOT COMPLETED|End of Study (Population at Day 90)||5
3180169|NCT01989156|3908433|FG002|NOT COMPLETED|End of Study (Population at Day 90)||3
3180170|NCT01989169|3908443|FG000|STARTED|Period 1||15
3180171|NCT01989169|3908444|FG001|STARTED|Period 1||15
3180172|NCT01989169|3908443|FG000|COMPLETED|Period 1||15
3180173|NCT01989169|3908444|FG001|COMPLETED|Period 1||15
3180174|NCT01989169|3908443|FG000|NOT COMPLETED|Period 1||0
3180175|NCT01989169|3908444|FG001|NOT COMPLETED|Period 1||0
3180176|NCT01989169|3908443|FG000|STARTED|Period 2||15
3180177|NCT01989169|3908444|FG001|STARTED|Period 2||15
3180178|NCT01989169|3908443|FG000|COMPLETED|Period 2||15
3180179|NCT01989169|3908444|FG001|COMPLETED|Period 2||14
3180180|NCT01989169|3908443|FG000|NOT COMPLETED|Period 2||0
3180181|NCT01989169|3908444|FG001|NOT COMPLETED|Period 2||1
3180182|NCT01989195|3908450|FG000|STARTED|Overall Study||6
3180183|NCT01989195|3908450|FG000|COMPLETED|Overall Study||6
3180184|NCT01989195|3908450|FG000|NOT COMPLETED|Overall Study||0
3180185|NCT01989208|3908459|FG000|STARTED|200 mg (7 Days)||4
3180186|NCT01989208|3908460|FG001|STARTED|200 mg (7 Days)||12
3180187|NCT01989208|3908459|FG000|COMPLETED|200 mg (7 Days)||4
3180188|NCT01989208|3908460|FG001|COMPLETED|200 mg (7 Days)||11
3180189|NCT01989208|3908459|FG000|NOT COMPLETED|200 mg (7 Days)||0
3180190|NCT01989208|3908460|FG001|NOT COMPLETED|200 mg (7 Days)||1
3180191|NCT01989208|3908459|FG000|STARTED|400 mg (7 Days)||4
3180192|NCT01989208|3908460|FG001|STARTED|400 mg (7 Days)||11
3180193|NCT01989208|3908459|FG000|COMPLETED|400 mg (7 Days)||4
3180194|NCT01989208|3908460|FG001|COMPLETED|400 mg (7 Days)||11
3180195|NCT01989208|3908459|FG000|NOT COMPLETED|400 mg (7 Days)||0
3180196|NCT01989208|3908460|FG001|NOT COMPLETED|400 mg (7 Days)||0
3180197|NCT01989208|3908459|FG000|STARTED|800 mg (7 Days)||4
3180198|NCT01989208|3908460|FG001|STARTED|800 mg (7 Days)||11
3180199|NCT01989208|3908459|FG000|COMPLETED|800 mg (7 Days)||4
3180200|NCT01989208|3908460|FG001|COMPLETED|800 mg (7 Days)||11
3180201|NCT01989208|3908459|FG000|NOT COMPLETED|800 mg (7 Days)||0
3180202|NCT01989208|3908460|FG001|NOT COMPLETED|800 mg (7 Days)||0
3180203|NCT01989221|3908478|FG000|STARTED|Overall Study||14
3180204|NCT01989221|3908478|FG000|COMPLETED|Overall Study||14
3180205|NCT01989221|3908478|FG000|NOT COMPLETED|Overall Study||0
3180206|NCT01989455|3908487|FG000|STARTED|Overall Study||14
3180207|NCT01989455|3908488|FG001|STARTED|Overall Study||14
3180208|NCT01989455|3908489|FG002|STARTED|Overall Study||14
3180209|NCT01989455|3908490|FG003|STARTED|Overall Study||14
3180210|NCT01989455|3908491|FG004|STARTED|Overall Study||8
3180211|NCT01989455|3908487|FG000|COMPLETED|Overall Study||14
3180212|NCT01989455|3908488|FG001|COMPLETED|Overall Study||12
3180213|NCT01989455|3908489|FG002|COMPLETED|Overall Study||13
3180214|NCT01989455|3908490|FG003|COMPLETED|Overall Study||14
3180215|NCT01989455|3908491|FG004|COMPLETED|Overall Study||7
3180216|NCT01989455|3908487|FG000|NOT COMPLETED|Overall Study||0
3180217|NCT01989455|3908488|FG001|NOT COMPLETED|Overall Study||2
3180218|NCT01989455|3908489|FG002|NOT COMPLETED|Overall Study||1
3180219|NCT01989455|3908490|FG003|NOT COMPLETED|Overall Study||0
3180220|NCT01989455|3908491|FG004|NOT COMPLETED|Overall Study||1
3180221|NCT01989468|3908510|FG000|STARTED|Overall Study||138
3180222|NCT01989468|3908511|FG001|STARTED|Overall Study||139
3180223|NCT01989468|3908512|FG002|STARTED|Overall Study||64
3180224|NCT01989468|3908513|FG003|STARTED|Overall Study||65
3180225|NCT01989468|3908514|FG004|STARTED|Overall Study||8
3180226|NCT01989468|3908510|FG000|COMPLETED|Overall Study||91
3180227|NCT01989468|3908511|FG001|COMPLETED|Overall Study||102
3180228|NCT01989468|3908512|FG002|COMPLETED|Overall Study||45
3043834|NCT01185353|3763651|FG009|STARTED|Part B (Weeks 12 Through 24)||0
3043835|NCT01185353|3763642|FG000|COMPLETED|Part B (Weeks 12 Through 24)||0
3043836|NCT01185353|3763643|FG001|COMPLETED|Part B (Weeks 12 Through 24)||50
3043837|NCT01185353|3763644|FG002|COMPLETED|Part B (Weeks 12 Through 24)||48
3043838|NCT01185353|3763645|FG003|COMPLETED|Part B (Weeks 12 Through 24)||45
3043839|NCT01185353|3763646|FG004|COMPLETED|Part B (Weeks 12 Through 24)||0
3043840|NCT01185353|3763647|FG005|COMPLETED|Part B (Weeks 12 Through 24)||59
3043841|NCT01185353|3763648|FG006|COMPLETED|Part B (Weeks 12 Through 24)||57
3043842|NCT01185353|3763649|FG007|COMPLETED|Part B (Weeks 12 Through 24)||0
3043843|NCT01185353|3763650|FG008|COMPLETED|Part B (Weeks 12 Through 24)||0
3043844|NCT01185353|3763651|FG009|COMPLETED|Part B (Weeks 12 Through 24)||0
3043845|NCT01185353|3763642|FG000|NOT COMPLETED|Part B (Weeks 12 Through 24)||0
3043846|NCT01185353|3763643|FG001|NOT COMPLETED|Part B (Weeks 12 Through 24)||1
3043847|NCT01185353|3763644|FG002|NOT COMPLETED|Part B (Weeks 12 Through 24)||2
3043848|NCT01185353|3763645|FG003|NOT COMPLETED|Part B (Weeks 12 Through 24)||4
3043849|NCT01185353|3763646|FG004|NOT COMPLETED|Part B (Weeks 12 Through 24)||0
3043850|NCT01185353|3763647|FG005|NOT COMPLETED|Part B (Weeks 12 Through 24)||4
3043851|NCT01185353|3763648|FG006|NOT COMPLETED|Part B (Weeks 12 Through 24)||6
3043852|NCT01185353|3763649|FG007|NOT COMPLETED|Part B (Weeks 12 Through 24)||0
3043853|NCT01185353|3763650|FG008|NOT COMPLETED|Part B (Weeks 12 Through 24)||0
3043854|NCT01185353|3763651|FG009|NOT COMPLETED|Part B (Weeks 12 Through 24)||0
3043855|NCT01185353|3763642|FG000|STARTED|Part C (Weeks 24 Through 76)||0
3043856|NCT01185353|3763643|FG001|STARTED|Part C (Weeks 24 Through 76)||0
3043857|NCT01185353|3763644|FG002|STARTED|Part C (Weeks 24 Through 76)||0
3043858|NCT01185353|3763645|FG003|STARTED|Part C (Weeks 24 Through 76)||0
3043859|NCT01185353|3763646|FG004|STARTED|Part C (Weeks 24 Through 76)||0
3043860|NCT01185353|3763647|FG005|STARTED|Part C (Weeks 24 Through 76)||0
3043861|NCT01185353|3763648|FG006|STARTED|Part C (Weeks 24 Through 76)||0
3043862|NCT01185353|3763649|FG007|STARTED|Part C (Weeks 24 Through 76)||108
3043863|NCT01185353|3763650|FG008|STARTED|Part C (Weeks 24 Through 76)||61
3043864|NCT01185353|3763651|FG009|STARTED|Part C (Weeks 24 Through 76)||32
3043865|NCT01185353|3763642|FG000|COMPLETED|Part C (Weeks 24 Through 76)||0
3043866|NCT01185353|3763643|FG001|COMPLETED|Part C (Weeks 24 Through 76)||0
3043867|NCT01185353|3763644|FG002|COMPLETED|Part C (Weeks 24 Through 76)||0
3043868|NCT01185353|3763645|FG003|COMPLETED|Part C (Weeks 24 Through 76)||0
3043869|NCT01185353|3763646|FG004|COMPLETED|Part C (Weeks 24 Through 76)||0
3043870|NCT01185353|3763647|FG005|COMPLETED|Part C (Weeks 24 Through 76)||0
3043871|NCT01185353|3763648|FG006|COMPLETED|Part C (Weeks 24 Through 76)||0
3043872|NCT01185353|3763649|FG007|COMPLETED|Part C (Weeks 24 Through 76)||92
3043873|NCT01185353|3763650|FG008|COMPLETED|Part C (Weeks 24 Through 76)||53
3043874|NCT01185353|3763651|FG009|COMPLETED|Part C (Weeks 24 Through 76)||24
3043875|NCT01185353|3763642|FG000|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
3043876|NCT01185353|3763643|FG001|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
3043877|NCT01185353|3763644|FG002|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
3043878|NCT01185353|3763645|FG003|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
3043879|NCT01185353|3763646|FG004|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
3043880|NCT01185353|3763647|FG005|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
3043881|NCT01185353|3763648|FG006|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
3043882|NCT01185353|3763649|FG007|NOT COMPLETED|Part C (Weeks 24 Through 76)||16
3043883|NCT01185353|3763650|FG008|NOT COMPLETED|Part C (Weeks 24 Through 76)||8
3043884|NCT01185353|3763651|FG009|NOT COMPLETED|Part C (Weeks 24 Through 76)||8
3043885|NCT01185353|3763642|FG000|STARTED|Part D (Weeks 76 Through 128)||0
3043886|NCT01185353|3763643|FG001|STARTED|Part D (Weeks 76 Through 128)||0
3180229|NCT01989468|3908513|FG003|COMPLETED|Overall Study||49
3180230|NCT01989468|3908514|FG004|COMPLETED|Overall Study||0
3180231|NCT01989468|3908510|FG000|NOT COMPLETED|Overall Study||47
3180232|NCT01989468|3908511|FG001|NOT COMPLETED|Overall Study||37
3043887|NCT01185353|3763644|FG002|STARTED|Part D (Weeks 76 Through 128)||0
3043888|NCT01185353|3763645|FG003|STARTED|Part D (Weeks 76 Through 128)||0
3043889|NCT01185353|3763646|FG004|STARTED|Part D (Weeks 76 Through 128)||0
3043890|NCT01185353|3763647|FG005|STARTED|Part D (Weeks 76 Through 128)||0
3180233|NCT01989468|3908512|FG002|NOT COMPLETED|Overall Study||19
3180234|NCT01989468|3908513|FG003|NOT COMPLETED|Overall Study||16
3180235|NCT01989468|3908514|FG004|NOT COMPLETED|Overall Study||8
3043891|NCT01185353|3763648|FG006|STARTED|Part D (Weeks 76 Through 128)||0
3043892|NCT01185353|3763649|FG007|STARTED|Part D (Weeks 76 Through 128)||79
3043893|NCT01185353|3763650|FG008|STARTED|Part D (Weeks 76 Through 128)||47
3043894|NCT01185353|3763651|FG009|STARTED|Part D (Weeks 76 Through 128)||18
3043895|NCT01185353|3763642|FG000|COMPLETED|Part D (Weeks 76 Through 128)||0
3043896|NCT01185353|3763643|FG001|COMPLETED|Part D (Weeks 76 Through 128)||0
3043897|NCT01185353|3763644|FG002|COMPLETED|Part D (Weeks 76 Through 128)||0
3043898|NCT01185353|3763645|FG003|COMPLETED|Part D (Weeks 76 Through 128)||0
3043899|NCT01185353|3763646|FG004|COMPLETED|Part D (Weeks 76 Through 128)||0
3043900|NCT01185353|3763647|FG005|COMPLETED|Part D (Weeks 76 Through 128)||0
3043901|NCT01185353|3763648|FG006|COMPLETED|Part D (Weeks 76 Through 128)||0
3043902|NCT01185353|3763649|FG007|COMPLETED|Part D (Weeks 76 Through 128)||76
3043903|NCT01185353|3763650|FG008|COMPLETED|Part D (Weeks 76 Through 128)||40
3043904|NCT01185353|3763651|FG009|COMPLETED|Part D (Weeks 76 Through 128)||17
3043905|NCT01185353|3763642|FG000|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
3043906|NCT01185353|3763643|FG001|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
3043907|NCT01185353|3763644|FG002|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
3043908|NCT01185353|3763645|FG003|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
3043909|NCT01185353|3763646|FG004|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
3043910|NCT01185353|3763647|FG005|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
3043911|NCT01185353|3763648|FG006|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
3043912|NCT01185353|3763649|FG007|NOT COMPLETED|Part D (Weeks 76 Through 128)||3
3043913|NCT01185353|3763650|FG008|NOT COMPLETED|Part D (Weeks 76 Through 128)||7
3043914|NCT01185353|3763651|FG009|NOT COMPLETED|Part D (Weeks 76 Through 128)||1
3043915|NCT01185366|3763692|FG000|STARTED|First Line Therapy||38
3043916|NCT01185366|3763693|FG001|STARTED|First Line Therapy||34
3043917|NCT01185366|3763692|FG000|Received 1st Drug|First Line Therapy||36
3043918|NCT01185366|3763693|FG001|Received 1st Drug|First Line Therapy||33
3043919|NCT01185366|3763692|FG000|COMPLETED|First Line Therapy||35
3043920|NCT01185366|3763693|FG001|COMPLETED|First Line Therapy||33
3043921|NCT01185366|3763692|FG000|NOT COMPLETED|First Line Therapy||3
3043922|NCT01185366|3763693|FG001|NOT COMPLETED|First Line Therapy||1
3043923|NCT01185366|3763692|FG000|STARTED|Crossover to Second Line Therapy||35
3043924|NCT01185366|3763693|FG001|STARTED|Crossover to Second Line Therapy||33
3043925|NCT01185366|3763692|FG000|Received Crossover Drug|Crossover to Second Line Therapy||21
3043926|NCT01185366|3763693|FG001|Received Crossover Drug|Crossover to Second Line Therapy||23
3043927|NCT01185366|3763692|FG000|COMPLETED|Crossover to Second Line Therapy||21
3043928|NCT01185366|3763693|FG001|COMPLETED|Crossover to Second Line Therapy||23
3043929|NCT01185366|3763692|FG000|NOT COMPLETED|Crossover to Second Line Therapy||14
3043930|NCT01185366|3763693|FG001|NOT COMPLETED|Crossover to Second Line Therapy||10
3043931|NCT01185509|3763703|FG000|STARTED|Overall Study||11
3043932|NCT01185509|3763704|FG001|STARTED|Overall Study||20
3043933|NCT01185509|3763703|FG000|COMPLETED|Overall Study|Since treatment was not of fixed duration, all participants were considered as 'Not Completed'.|0
3043934|NCT01185509|3763704|FG001|COMPLETED|Overall Study|Since treatment was not of fixed duration, all participants were considered as 'Not Completed'.|0
3043935|NCT01185509|3763703|FG000|NOT COMPLETED|Overall Study||11
3043936|NCT01185509|3763704|FG001|NOT COMPLETED|Overall Study||20
3043937|NCT01185522|3763711|FG000|STARTED|Overall Study||693
3043938|NCT01185522|3763711|FG000|COMPLETED|Overall Study||585
3043939|NCT01185522|3763711|FG000|NOT COMPLETED|Overall Study||108
3043940|NCT01185548|3763716|FG000|STARTED|Period 1 : Tolbutamide||4
3043941|NCT01185548|3763716|FG000|COMPLETED|Period 1 : Tolbutamide||4
3043942|NCT01185548|3763716|FG000|NOT COMPLETED|Period 1 : Tolbutamide||0
3043943|NCT01185548|3763716|FG000|STARTED|Period 2: Tasisulam and Tolbutamide||4
3043944|NCT01185548|3763716|FG000|COMPLETED|Period 2: Tasisulam and Tolbutamide||2
3043945|NCT01185548|3763716|FG000|NOT COMPLETED|Period 2: Tasisulam and Tolbutamide||2
3043946|NCT01185548|3763716|FG000|STARTED|Period 3: Tasisulam and Tolbutamide||2
3043947|NCT01185548|3763716|FG000|COMPLETED|Period 3: Tasisulam and Tolbutamide||2
3043948|NCT01185548|3763716|FG000|NOT COMPLETED|Period 3: Tasisulam and Tolbutamide||0
3043949|NCT01185561|3763731|FG000|STARTED|Overall Study||36
3043950|NCT01185561|3763732|FG001|STARTED|Overall Study||38
3043951|NCT01185561|3763731|FG000|COMPLETED|Overall Study||34
3043952|NCT01185561|3763732|FG001|COMPLETED|Overall Study||26
3043953|NCT01185561|3763731|FG000|NOT COMPLETED|Overall Study||2
3043954|NCT01185561|3763732|FG001|NOT COMPLETED|Overall Study||12
3043955|NCT01185600|3763740|FG000|STARTED|Overall Study||73
3043956|NCT01185600|3763741|FG001|STARTED|Overall Study||104
3043957|NCT01185600|3763740|FG000|COMPLETED|Overall Study||41
3043958|NCT01185600|3763741|FG001|COMPLETED|Overall Study||59
3043959|NCT01185600|3763740|FG000|NOT COMPLETED|Overall Study||32
3043960|NCT01185600|3763741|FG001|NOT COMPLETED|Overall Study||45
3043961|NCT01185639|3763750|FG000|STARTED|Overall Study||29
3043962|NCT01185639|3763750|FG000|COMPLETED|Overall Study||27
3043963|NCT01185639|3763750|FG000|NOT COMPLETED|Overall Study||2
3043964|NCT01185704|3763756|FG000|STARTED|Overall Study||68
3043965|NCT01185704|3763757|FG001|STARTED|Overall Study||68
3043966|NCT01185704|3763756|FG000|Treated|Overall Study||65
3043967|NCT01185704|3763757|FG001|Treated|Overall Study||65
3043968|NCT01185704|3763756|FG000|COMPLETED|Overall Study||55
3043969|NCT01185704|3763757|FG001|COMPLETED|Overall Study||60
3043970|NCT01185704|3763756|FG000|NOT COMPLETED|Overall Study||13
3043971|NCT01185704|3763757|FG001|NOT COMPLETED|Overall Study||8
3137236|NCT01717456|3862494|FG000|NOT COMPLETED|End of Treatment||0
3043972|NCT01185782|3763765|FG000|STARTED|Overall Study||129
3043973|NCT01185782|3763766|FG001|STARTED|Overall Study||136
3043974|NCT01185782|3763765|FG000|Treated|Overall Study||129
3043975|NCT01185782|3763766|FG001|Treated|Overall Study||132
3043976|NCT01185782|3763765|FG000|COMPLETED|Overall Study||123
3043977|NCT01185782|3763766|FG001|COMPLETED|Overall Study||125
3043978|NCT01185782|3763765|FG000|NOT COMPLETED|Overall Study||6
3043979|NCT01185782|3763766|FG001|NOT COMPLETED|Overall Study||11
3043980|NCT01185821|3763777|FG000|STARTED|Overall Study||33
3043981|NCT01185821|3763778|FG001|STARTED|Overall Study||29
3043982|NCT01185821|3763779|FG002|STARTED|Overall Study||43
3043983|NCT01185821|3763780|FG003|STARTED|Overall Study||29
3043984|NCT01185821|3763781|FG004|STARTED|Overall Study||50
3043985|NCT01185821|3763777|FG000|Patients With Washout|Overall Study||33
3043986|NCT01185821|3763778|FG001|Patients With Washout|Overall Study||29
3043987|NCT01185821|3763779|FG002|Patients With Washout|Overall Study||39
3043988|NCT01185821|3763780|FG003|Patients With Washout|Overall Study||29
3043989|NCT01185821|3763781|FG004|Patients With Washout|Overall Study||33
3043990|NCT01185821|3763777|FG000|Patients Without Washout|Overall Study||0
3043991|NCT01185821|3763778|FG001|Patients Without Washout|Overall Study||0
3043992|NCT01185821|3763779|FG002|Patients Without Washout|Overall Study||4
3043993|NCT01185821|3763780|FG003|Patients Without Washout|Overall Study||0
3043994|NCT01185821|3763781|FG004|Patients Without Washout|Overall Study||17
3043995|NCT01185821|3763777|FG000|Patients on Placebo in Core|Overall Study||8
3043996|NCT01185821|3763778|FG001|Patients on Placebo in Core|Overall Study||7
3043997|NCT01185821|3763779|FG002|Patients on Placebo in Core|Overall Study||9
3043998|NCT01185821|3763780|FG003|Patients on Placebo in Core|Overall Study||8
3043999|NCT01185821|3763781|FG004|Patients on Placebo in Core|Overall Study||2
3044000|NCT01185821|3763777|FG000|COMPLETED|Overall Study||26
3044001|NCT01185821|3763778|FG001|COMPLETED|Overall Study||20
3044002|NCT01185821|3763779|FG002|COMPLETED|Overall Study||33
3044003|NCT01185821|3763780|FG003|COMPLETED|Overall Study||23
3044004|NCT01185821|3763781|FG004|COMPLETED|Overall Study||26
3044005|NCT01185821|3763777|FG000|NOT COMPLETED|Overall Study||7
3044006|NCT01185821|3763778|FG001|NOT COMPLETED|Overall Study||9
3044007|NCT01185821|3763779|FG002|NOT COMPLETED|Overall Study||10
3044008|NCT01185821|3763780|FG003|NOT COMPLETED|Overall Study||6
3044009|NCT01185821|3763781|FG004|NOT COMPLETED|Overall Study||24
3044010|NCT01185834|3763795|FG000|STARTED|Overall Study||118
3044011|NCT01185834|3763795|FG000|COMPLETED|Overall Study||104
3044012|NCT01185834|3763795|FG000|NOT COMPLETED|Overall Study||14
3044013|NCT01185964|3763802|FG000|STARTED|Phase 1b and Phase 2||15
3044014|NCT01185964|3763803|FG001|STARTED|Phase 1b and Phase 2||66
3044015|NCT01185964|3763804|FG002|STARTED|Phase 1b and Phase 2||67
3044016|NCT01185964|3763805|FG003|STARTED|Phase 1b and Phase 2||0
3044017|NCT01185964|3763802|FG000|Received at Least 1 Dose of Study Drug|Phase 1b and Phase 2||15
3044018|NCT01185964|3763803|FG001|Received at Least 1 Dose of Study Drug|Phase 1b and Phase 2||64
3044019|NCT01185964|3763804|FG002|Received at Least 1 Dose of Study Drug|Phase 1b and Phase 2||65
3044020|NCT01185964|3763805|FG003|Received at Least 1 Dose of Study Drug|Phase 1b and Phase 2||0
3044021|NCT01185964|3763802|FG000|COMPLETED|Phase 1b and Phase 2||13
3044022|NCT01185964|3763803|FG001|COMPLETED|Phase 1b and Phase 2||56
3044023|NCT01185964|3763804|FG002|COMPLETED|Phase 1b and Phase 2||58
3044024|NCT01185964|3763805|FG003|COMPLETED|Phase 1b and Phase 2||0
3044025|NCT01185964|3763802|FG000|NOT COMPLETED|Phase 1b and Phase 2||2
3044026|NCT01185964|3763803|FG001|NOT COMPLETED|Phase 1b and Phase 2||10
3044027|NCT01185964|3763804|FG002|NOT COMPLETED|Phase 1b and Phase 2||9
3044028|NCT01185964|3763805|FG003|NOT COMPLETED|Phase 1b and Phase 2||0
3044029|NCT01185964|3763802|FG000|STARTED|Optional Olaratumab Monotherapy on Dox||0
3044030|NCT01185964|3763803|FG001|STARTED|Optional Olaratumab Monotherapy on Dox||0
3044031|NCT01185964|3763804|FG002|STARTED|Optional Olaratumab Monotherapy on Dox||0
3044032|NCT01185964|3763805|FG003|STARTED|Optional Olaratumab Monotherapy on Dox|Participants with disease progression after treatment received olaratumab.|30
3044033|NCT01185964|3763802|FG000|COMPLETED|Optional Olaratumab Monotherapy on Dox||0
3044034|NCT01185964|3763803|FG001|COMPLETED|Optional Olaratumab Monotherapy on Dox||0
3044035|NCT01185964|3763804|FG002|COMPLETED|Optional Olaratumab Monotherapy on Dox||0
3044036|NCT01185964|3763805|FG003|COMPLETED|Optional Olaratumab Monotherapy on Dox||25
3044037|NCT01185964|3763802|FG000|NOT COMPLETED|Optional Olaratumab Monotherapy on Dox||0
3044038|NCT01185964|3763803|FG001|NOT COMPLETED|Optional Olaratumab Monotherapy on Dox||0
3044039|NCT01185964|3763804|FG002|NOT COMPLETED|Optional Olaratumab Monotherapy on Dox||0
3044040|NCT01185964|3763805|FG003|NOT COMPLETED|Optional Olaratumab Monotherapy on Dox||5
3044041|NCT01186250|3763823|FG000|STARTED|Overall Study||9
3044042|NCT01186250|3763824|FG001|STARTED|Overall Study||9
3044043|NCT01186250|3763823|FG000|COMPLETED|Overall Study||8
3044044|NCT01186250|3763824|FG001|COMPLETED|Overall Study||9
3044045|NCT01186250|3763823|FG000|NOT COMPLETED|Overall Study||1
3044046|NCT01186250|3763824|FG001|NOT COMPLETED|Overall Study||0
3044047|NCT01186328|3763830|FG000|STARTED|Overall Study||6
3044048|NCT01186328|3763831|FG001|STARTED|Overall Study||0
3044049|NCT01186328|3763832|FG002|STARTED|Overall Study||0
3044050|NCT01186328|3763830|FG000|COMPLETED|Overall Study||5
3044051|NCT01186328|3763831|FG001|COMPLETED|Overall Study||0
3044052|NCT01186328|3763832|FG002|COMPLETED|Overall Study||0
3044053|NCT01186328|3763830|FG000|NOT COMPLETED|Overall Study||1
3044054|NCT01186328|3763831|FG001|NOT COMPLETED|Overall Study||0
3044055|NCT01186328|3763832|FG002|NOT COMPLETED|Overall Study||0
3044056|NCT01186406|3763837|FG000|STARTED|Overall Study||41
3044057|NCT01186406|3763837|FG000|COMPLETED|Overall Study||41
3044058|NCT01186406|3763837|FG000|NOT COMPLETED|Overall Study||0
3044059|NCT01186419|3763843|FG000|STARTED|Overall Study||24
3044060|NCT01186419|3763844|FG001|STARTED|Overall Study||27
3044061|NCT01186419|3763843|FG000|COMPLETED|Overall Study||17
3044062|NCT01186419|3763844|FG001|COMPLETED|Overall Study||18
3044063|NCT01186419|3763843|FG000|NOT COMPLETED|Overall Study||7
3044064|NCT01186419|3763844|FG001|NOT COMPLETED|Overall Study||9
3044065|NCT01186458|3763849|FG000|STARTED|Overall Study||4
3044066|NCT01186458|3763849|FG000|COMPLETED|Overall Study||3
3044067|NCT01186458|3763849|FG000|NOT COMPLETED|Overall Study||1
3044068|NCT01186562|3763855|FG000|STARTED|Overall Study||54
3044069|NCT01186562|3763856|FG001|STARTED|Overall Study||29
3044070|NCT01186562|3763855|FG000|COMPLETED|Overall Study||50
3044071|NCT01186562|3763856|FG001|COMPLETED|Overall Study||27
3044072|NCT01186562|3763855|FG000|NOT COMPLETED|Overall Study||4
3044073|NCT01186562|3763856|FG001|NOT COMPLETED|Overall Study||2
3044074|NCT01186692|3763862|FG000|STARTED|Overall Study||131
3044075|NCT01186692|3763862|FG000|COMPLETED|Overall Study||99
3044076|NCT01186692|3763862|FG000|NOT COMPLETED|Overall Study||32
3044077|NCT01186705|3763870|FG000|STARTED|Overall Study||1
3044078|NCT01186705|3763870|FG000|COMPLETED|Overall Study||1
3044079|NCT01186705|3763870|FG000|NOT COMPLETED|Overall Study||0
3044080|NCT01186744|3763880|FG000|STARTED|Overall Study||218
3044081|NCT01186744|3763881|FG001|STARTED|Overall Study||157
3044082|NCT01186744|3763882|FG002|STARTED|Overall Study||31
3044083|NCT01186744|3763883|FG003|STARTED|Overall Study||82
3044084|NCT01186744|3763884|FG004|STARTED|Overall Study||45
3044085|NCT01186744|3763885|FG005|STARTED|Overall Study||133
3044086|NCT01186744|3763880|FG000|COMPLETED|Overall Study||10
3044087|NCT01186744|3763881|FG001|COMPLETED|Overall Study||5
3044088|NCT01186744|3763882|FG002|COMPLETED|Overall Study||25
3044089|NCT01186744|3763883|FG003|COMPLETED|Overall Study||70
3044090|NCT01186744|3763884|FG004|COMPLETED|Overall Study||39
3044091|NCT01186744|3763885|FG005|COMPLETED|Overall Study||107
3044092|NCT01186744|3763880|FG000|NOT COMPLETED|Overall Study||208
3044093|NCT01186744|3763881|FG001|NOT COMPLETED|Overall Study||152
3044094|NCT01186744|3763882|FG002|NOT COMPLETED|Overall Study||6
3044095|NCT01186744|3763883|FG003|NOT COMPLETED|Overall Study||12
3044096|NCT01186744|3763884|FG004|NOT COMPLETED|Overall Study||6
3044097|NCT01186744|3763885|FG005|NOT COMPLETED|Overall Study||26
3044098|NCT01186770|3763924|FG000|STARTED|Overall Study||201
3044099|NCT01186770|3763925|FG001|STARTED|Overall Study||202
3180236|NCT01989546|3908527|FG000|STARTED|Overall Study||9
3180237|NCT01989546|3908527|FG000|COMPLETED|Overall Study||0
3180238|NCT01989546|3908527|FG000|NOT COMPLETED|Overall Study||9
3180239|NCT01989572|3908537|FG000|STARTED|Overall Study||109
3180240|NCT01989572|3908538|FG001|STARTED|Overall Study||111
3180241|NCT01989572|3908539|FG002|STARTED|Overall Study||109
3044100|NCT01186770|3763926|FG002|STARTED|Overall Study||200
3180242|NCT01989572|3908540|FG003|STARTED|Overall Study||107
3180243|NCT01989572|3908541|FG004|STARTED|Overall Study||190
3044101|NCT01186770|3763927|FG003|STARTED|Overall Study||201
3044102|NCT01186770|3763924|FG000|Intent-to-treat (ITT Population)|Overall Study||201
3044103|NCT01186770|3763925|FG001|Intent-to-treat (ITT Population)|Overall Study||201
3044104|NCT01186770|3763926|FG002|Intent-to-treat (ITT Population)|Overall Study||200
3044105|NCT01186770|3763927|FG003|Intent-to-treat (ITT Population)|Overall Study||201
3044106|NCT01186770|3763924|FG000|COMPLETED|Overall Study||160
3044107|NCT01186770|3763925|FG001|COMPLETED|Overall Study||156
3044108|NCT01186770|3763926|FG002|COMPLETED|Overall Study||148
3044109|NCT01186770|3763927|FG003|COMPLETED|Overall Study||143
3044110|NCT01186770|3763924|FG000|NOT COMPLETED|Overall Study||41
3044111|NCT01186770|3763925|FG001|NOT COMPLETED|Overall Study||46
3044112|NCT01186770|3763926|FG002|NOT COMPLETED|Overall Study||52
3044113|NCT01186770|3763927|FG003|NOT COMPLETED|Overall Study||58
3044114|NCT01186796|3763939|FG000|STARTED|Overall Study||14
3044115|NCT01186796|3763940|FG001|STARTED|Overall Study|1 subject was randomized but withdrew before study interventions.|16
3044116|NCT01186796|3763939|FG000|COMPLETED|Overall Study||10
3044117|NCT01186796|3763940|FG001|COMPLETED|Overall Study||14
3044118|NCT01186796|3763939|FG000|NOT COMPLETED|Overall Study||4
3044119|NCT01186796|3763940|FG001|NOT COMPLETED|Overall Study||2
3044120|NCT01186809|3763946|FG000|STARTED|Overall Study||73
3044121|NCT01186809|3763946|FG000|COMPLETED|Overall Study||43
3044122|NCT01186809|3763946|FG000|NOT COMPLETED|Overall Study||30
3044123|NCT01186939|3763950|FG000|STARTED|Overall Study||40
3044124|NCT01186939|3763950|FG000|COMPLETED|Overall Study||0
3044125|NCT01186939|3763950|FG000|NOT COMPLETED|Overall Study||40
3044126|NCT01186978|3763954|FG000|STARTED|Overall Study||63
3044127|NCT01186978|3763954|FG000|COMPLETED|Overall Study||62
3044128|NCT01186978|3763954|FG000|NOT COMPLETED|Overall Study||1
3044129|NCT01187004|3763960|FG000|STARTED|Overall Study||20
3044130|NCT01187004|3763961|FG001|STARTED|Overall Study||144
3044131|NCT01187004|3763960|FG000|COMPLETED|Overall Study||20
3044132|NCT01187004|3763961|FG001|COMPLETED|Overall Study||144
3044133|NCT01187004|3763960|FG000|NOT COMPLETED|Overall Study||0
3044134|NCT01187004|3763961|FG001|NOT COMPLETED|Overall Study||0
3044135|NCT01187017|3763968|FG000|STARTED|Overall Study||1
3044136|NCT01187017|3763968|FG000|COMPLETED|Overall Study||1
3044137|NCT01187017|3763968|FG000|NOT COMPLETED|Overall Study||0
3044138|NCT01187043|3763979|FG000|STARTED|Overall Study||12
3180244|NCT01989572|3908542|FG005|STARTED|Overall Study||189
3044139|NCT01187043|3763980|FG001|STARTED|Overall Study||10
3044140|NCT01187043|3763981|FG002|STARTED|Overall Study||12
3044141|NCT01187043|3763982|FG003|STARTED|Overall Study||12
3044142|NCT01187043|3763983|FG004|STARTED|Overall Study||12
3044143|NCT01187043|3763979|FG000|COMPLETED|Overall Study||11
3044144|NCT01187043|3763980|FG001|COMPLETED|Overall Study||10
3044145|NCT01187043|3763981|FG002|COMPLETED|Overall Study||8
3044146|NCT01187043|3763982|FG003|COMPLETED|Overall Study||12
3044147|NCT01187043|3763983|FG004|COMPLETED|Overall Study||10
3044148|NCT01187043|3763979|FG000|NOT COMPLETED|Overall Study||1
3044149|NCT01187043|3763980|FG001|NOT COMPLETED|Overall Study||0
3044150|NCT01187043|3763981|FG002|NOT COMPLETED|Overall Study||4
3044151|NCT01187043|3763982|FG003|NOT COMPLETED|Overall Study||0
3044152|NCT01187043|3763983|FG004|NOT COMPLETED|Overall Study||2
3044153|NCT01187095|3763997|FG000|STARTED|Overall Study||153
3044154|NCT01187095|3763998|FG001|STARTED|Overall Study||142
3044155|NCT01187095|3763997|FG000|COMPLETED|Overall Study||108
3044156|NCT01187095|3763998|FG001|COMPLETED|Overall Study||108
3044157|NCT01187095|3763997|FG000|NOT COMPLETED|Overall Study||45
3044158|NCT01187095|3763998|FG001|NOT COMPLETED|Overall Study||34
3044159|NCT01187329|3764006|FG000|STARTED|Overall Study||50
3044160|NCT01187329|3764007|FG001|STARTED|Overall Study||50
3044161|NCT01187329|3764006|FG000|COMPLETED|Overall Study||49
3044162|NCT01187329|3764007|FG001|COMPLETED|Overall Study||48
3044163|NCT01187329|3764006|FG000|NOT COMPLETED|Overall Study||1
3044164|NCT01187329|3764007|FG001|NOT COMPLETED|Overall Study||2
3044165|NCT01187355|3764015|FG000|STARTED|Overall Study||294
3044166|NCT01187355|3764016|FG001|STARTED|Overall Study||297
3044167|NCT01187355|3764015|FG000|COMPLETED|Overall Study||276
3044168|NCT01187355|3764016|FG001|COMPLETED|Overall Study||277
3044169|NCT01187355|3764015|FG000|NOT COMPLETED|Overall Study||18
3044170|NCT01187355|3764016|FG001|NOT COMPLETED|Overall Study||20
3044171|NCT01187381|3764022|FG000|STARTED|Overall Study||250
3044172|NCT01187381|3764022|FG000|COMPLETED|Overall Study|A participant completed study when the trastuzumab treatment was discontinued.|250
3044173|NCT01187381|3764022|FG000|NOT COMPLETED|Overall Study||0
3044174|NCT01187407|3764030|FG000|STARTED|Confirmation (CF) Phase, 3 Weeks||1480
3044175|NCT01187407|3764031|FG001|STARTED|Confirmation (CF) Phase, 3 Weeks||0
3044176|NCT01187407|3764032|FG002|STARTED|Confirmation (CF) Phase, 3 Weeks||0
3044177|NCT01187407|3764033|FG003|STARTED|Confirmation (CF) Phase, 3 Weeks||0
3044178|NCT01187407|3764034|FG004|STARTED|Confirmation (CF) Phase, 3 Weeks||0
3044179|NCT01187407|3764030|FG000|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks|Participants who discontinued the CF Phase early had the option to enter the DC Phase.|25
3044180|NCT01187407|3764031|FG001|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0
3044181|NCT01187407|3764032|FG002|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0
3044182|NCT01187407|3764033|FG003|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0
3044183|NCT01187407|3764034|FG004|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0
3044184|NCT01187407|3764030|FG000|COMPLETED|Confirmation (CF) Phase, 3 Weeks|Participants who completed the CF Phase entered the Adjunctive Treatment (AT) Phase.|1390
3044185|NCT01187407|3764031|FG001|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
3044186|NCT01187407|3764032|FG002|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
3044187|NCT01187407|3764033|FG003|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
3044188|NCT01187407|3764034|FG004|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
3044189|NCT01187407|3764030|FG000|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||90
3180245|NCT01989572|3908537|FG000|Treated|Overall Study||104
3180246|NCT01989572|3908538|FG001|Treated|Overall Study||110
3180247|NCT01989572|3908539|FG002|Treated|Overall Study||107
3044190|NCT01187407|3764031|FG001|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
3044191|NCT01187407|3764032|FG002|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
3044192|NCT01187407|3764033|FG003|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
3044193|NCT01187407|3764034|FG004|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
3044194|NCT01187407|3764030|FG000|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
3044195|NCT01187407|3764031|FG001|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||232
3044196|NCT01187407|3764032|FG002|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||226
3044197|NCT01187407|3764033|FG003|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||231
3044198|NCT01187407|3764034|FG004|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||701
3044199|NCT01187407|3764030|FG000|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||0
3044200|NCT01187407|3764031|FG001|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|212
3044201|NCT01187407|3764032|FG002|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|215
3044202|NCT01187407|3764033|FG003|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|220
3044203|NCT01187407|3764034|FG004|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|660
3044204|NCT01187407|3764030|FG000|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
3044205|NCT01187407|3764031|FG001|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||196
3044206|NCT01187407|3764032|FG002|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||191
3044207|NCT01187407|3764033|FG003|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||202
3044208|NCT01187407|3764034|FG004|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||626
3180248|NCT01989572|3908540|FG003|Treated|Overall Study||104
3044209|NCT01187407|3764030|FG000|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
3044210|NCT01187407|3764031|FG001|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||36
3044211|NCT01187407|3764032|FG002|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||35
3044212|NCT01187407|3764033|FG003|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||29
3044213|NCT01187407|3764034|FG004|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||75
3044214|NCT01187433|3764053|FG000|STARTED|Overall Study||100
3044215|NCT01187433|3764054|FG001|STARTED|Overall Study||50
3044216|NCT01187433|3764053|FG000|COMPLETED|Overall Study||89
3044217|NCT01187433|3764054|FG001|COMPLETED|Overall Study||46
3044218|NCT01187433|3764053|FG000|NOT COMPLETED|Overall Study||11
3044219|NCT01187433|3764054|FG001|NOT COMPLETED|Overall Study||4
3044220|NCT01187446|3764062|FG000|STARTED|Overall Study||14
3044221|NCT01187446|3764063|FG001|STARTED|Overall Study||14
3044222|NCT01187446|3764062|FG000|COMPLETED|Overall Study||14
3044223|NCT01187446|3764063|FG001|COMPLETED|Overall Study||13
3044224|NCT01187446|3764062|FG000|NOT COMPLETED|Overall Study||0
3044225|NCT01187446|3764063|FG001|NOT COMPLETED|Overall Study||1
3044226|NCT01187498|3764071|FG000|STARTED|Overall Study||73
3044227|NCT01187498|3764072|FG001|STARTED|Overall Study||70
3044228|NCT01187498|3764071|FG000|COMPLETED|Overall Study||64
3044229|NCT01187498|3764072|FG001|COMPLETED|Overall Study||60
3044230|NCT01187498|3764071|FG000|NOT COMPLETED|Overall Study||9
3044231|NCT01187498|3764072|FG001|NOT COMPLETED|Overall Study||10
3044232|NCT01187511|3764080|FG000|STARTED|Overall Study||22
3044233|NCT01187511|3764081|FG001|STARTED|Overall Study||22
3180249|NCT01989572|3908541|FG004|Treated|Overall Study||186
3180250|NCT01989572|3908542|FG005|Treated|Overall Study||171
3180251|NCT01989572|3908537|FG000|COMPLETED|Overall Study||54
3180252|NCT01989572|3908538|FG001|COMPLETED|Overall Study||53
3180253|NCT01989572|3908539|FG002|COMPLETED|Overall Study||47
3180254|NCT01989572|3908540|FG003|COMPLETED|Overall Study||56
3180255|NCT01989572|3908541|FG004|COMPLETED|Overall Study||92
3180256|NCT01989572|3908542|FG005|COMPLETED|Overall Study||79
3180257|NCT01989572|3908537|FG000|NOT COMPLETED|Overall Study||55
3180258|NCT01989572|3908538|FG001|NOT COMPLETED|Overall Study||58
3180259|NCT01989572|3908539|FG002|NOT COMPLETED|Overall Study||62
3180260|NCT01989572|3908540|FG003|NOT COMPLETED|Overall Study||51
3180261|NCT01989572|3908541|FG004|NOT COMPLETED|Overall Study||98
3180262|NCT01989572|3908542|FG005|NOT COMPLETED|Overall Study||110
3180263|NCT01989689|3908562|FG000|STARTED|Baseline||11
3180264|NCT01989689|3908563|FG001|STARTED|Baseline||13
3180265|NCT01989689|3908562|FG000|COMPLETED|Baseline||11
3180266|NCT01989689|3908563|FG001|COMPLETED|Baseline||13
3180267|NCT01989689|3908562|FG000|NOT COMPLETED|Baseline||0
3180268|NCT01989689|3908563|FG001|NOT COMPLETED|Baseline||0
3180269|NCT01989689|3908562|FG000|STARTED|Treatment Period 1 ( 3 Months)||11
3180270|NCT01989689|3908563|FG001|STARTED|Treatment Period 1 ( 3 Months)||13
3180271|NCT01989689|3908562|FG000|COMPLETED|Treatment Period 1 ( 3 Months)||11
3180272|NCT01989689|3908563|FG001|COMPLETED|Treatment Period 1 ( 3 Months)||10
3180273|NCT01989689|3908562|FG000|NOT COMPLETED|Treatment Period 1 ( 3 Months)||0
3180274|NCT01989689|3908563|FG001|NOT COMPLETED|Treatment Period 1 ( 3 Months)||3
3180275|NCT01989689|3908562|FG000|STARTED|Treatment Period ( 3 Months)||11
3180276|NCT01989689|3908563|FG001|STARTED|Treatment Period ( 3 Months)||10
3180277|NCT01989689|3908562|FG000|COMPLETED|Treatment Period ( 3 Months)||11
3180278|NCT01989689|3908563|FG001|COMPLETED|Treatment Period ( 3 Months)||10
3044234|NCT01187511|3764080|FG000|COMPLETED|Overall Study||14
3044235|NCT01187511|3764081|FG001|COMPLETED|Overall Study||21
3044236|NCT01187511|3764080|FG000|NOT COMPLETED|Overall Study||8
3044237|NCT01187511|3764081|FG001|NOT COMPLETED|Overall Study||1
3044238|NCT01187550|3764089|FG000|STARTED|Overall Study||183
3044239|NCT01187550|3764090|FG001|STARTED|Overall Study||30
3044240|NCT01187550|3764089|FG000|Treated|Overall Study||175
3044241|NCT01187550|3764090|FG001|Treated|Overall Study||30
3044242|NCT01187550|3764089|FG000|COMPLETED|Overall Study||169
3044243|NCT01187550|3764090|FG001|COMPLETED|Overall Study||29
3044244|NCT01187550|3764089|FG000|NOT COMPLETED|Overall Study||14
3044245|NCT01187550|3764090|FG001|NOT COMPLETED|Overall Study||1
3044246|NCT01187771|3764098|FG000|STARTED|Overall Study||28
3044247|NCT01187771|3764099|FG001|STARTED|Overall Study||21
3044248|NCT01187771|3764098|FG000|COMPLETED|Overall Study||25
3180279|NCT01989689|3908562|FG000|NOT COMPLETED|Treatment Period ( 3 Months)||0
3180280|NCT01989689|3908563|FG001|NOT COMPLETED|Treatment Period ( 3 Months)||0
3180281|NCT01989754|3908573|FG000|STARTED|Overall Study||2905
3180282|NCT01989754|3908574|FG001|STARTED|Overall Study||2907
3180283|NCT01989754|3908573|FG000|Treated|Overall Study||2903
3180284|NCT01989754|3908574|FG001|Treated|Overall Study||2904
3180285|NCT01989754|3908573|FG000|COMPLETED|Overall Study|Participants who died are included in this category.|2866
3044249|NCT01187771|3764099|FG001|COMPLETED|Overall Study||18
3044250|NCT01187771|3764098|FG000|NOT COMPLETED|Overall Study||3
3044251|NCT01187771|3764099|FG001|NOT COMPLETED|Overall Study||3
3044252|NCT01187901|3764109|FG000|STARTED|Overall Study||46
3044253|NCT01187901|3764110|FG001|STARTED|Overall Study||46
3044254|NCT01187901|3764109|FG000|COMPLETED|Overall Study||37
3044255|NCT01187901|3764110|FG001|COMPLETED|Overall Study||36
3044256|NCT01187901|3764109|FG000|NOT COMPLETED|Overall Study||9
3044257|NCT01187901|3764110|FG001|NOT COMPLETED|Overall Study||10
3044258|NCT01187914|3764116|FG000|STARTED|Overall Study||40
3044259|NCT01187914|3764116|FG000|COMPLETED|Overall Study||40
3044260|NCT01187914|3764116|FG000|NOT COMPLETED|Overall Study||0
3044261|NCT01187953|3764122|FG000|STARTED|Overall Study||268
3044262|NCT01187953|3764123|FG001|STARTED|Overall Study||275
3044263|NCT01187953|3764122|FG000|Dosed|Overall Study||266
3044264|NCT01187953|3764123|FG001|Dosed|Overall Study||271
3044265|NCT01187953|3764122|FG000|COMPLETED|Overall Study||253
3044266|NCT01187953|3764123|FG001|COMPLETED|Overall Study||254
3044267|NCT01187953|3764122|FG000|NOT COMPLETED|Overall Study||15
3044268|NCT01187953|3764123|FG001|NOT COMPLETED|Overall Study||21
3044269|NCT01188109|3764129|FG000|STARTED|Overall Study||22
3044270|NCT01188109|3764129|FG000|COMPLETED|Overall Study||22
3044271|NCT01188109|3764129|FG000|NOT COMPLETED|Overall Study||0
3044272|NCT01188226|3764133|FG000|STARTED|Overall Study||10
3044273|NCT01188226|3764133|FG000|COMPLETED|Overall Study||6
3044274|NCT01188226|3764133|FG000|NOT COMPLETED|Overall Study||4
3044275|NCT01188343|3764150|FG000|STARTED|Overall Study||102
3044276|NCT01188343|3764151|FG001|STARTED|Overall Study||219
3044277|NCT01188343|3764152|FG002|STARTED|Overall Study||221
3044278|NCT01188343|3764150|FG000|COMPLETED|Overall Study||101
3044279|NCT01188343|3764151|FG001|COMPLETED|Overall Study||193
3044280|NCT01188343|3764152|FG002|COMPLETED|Overall Study||220
3044281|NCT01188343|3764150|FG000|NOT COMPLETED|Overall Study||1
3044282|NCT01188343|3764151|FG001|NOT COMPLETED|Overall Study||26
3044283|NCT01188343|3764152|FG002|NOT COMPLETED|Overall Study||1
3044284|NCT01188369|3764165|FG000|STARTED|Overall Study||10
3044285|NCT01188369|3764166|FG001|STARTED|Overall Study||10
3044286|NCT01188369|3764165|FG000|COMPLETED|Overall Study||10
3044287|NCT01188369|3764166|FG001|COMPLETED|Overall Study||10
3044288|NCT01188369|3764165|FG000|NOT COMPLETED|Overall Study||0
3044289|NCT01188369|3764166|FG001|NOT COMPLETED|Overall Study||0
3044290|NCT01188421|3764175|FG000|STARTED|Overall Study||31
3044291|NCT01188421|3764176|FG001|STARTED|Overall Study||36
3044292|NCT01188421|3764177|FG002|STARTED|Overall Study||36
3044293|NCT01188421|3764175|FG000|COMPLETED|Overall Study||28
3044294|NCT01188421|3764176|FG001|COMPLETED|Overall Study||26
3044295|NCT01188421|3764177|FG002|COMPLETED|Overall Study||22
3044296|NCT01188421|3764175|FG000|NOT COMPLETED|Overall Study||3
3044297|NCT01188421|3764176|FG001|NOT COMPLETED|Overall Study||10
3044298|NCT01188421|3764177|FG002|NOT COMPLETED|Overall Study||14
3044299|NCT01188447|3764185|FG000|STARTED|Overall Study||4034
3044300|NCT01188447|3764185|FG000|COMPLETED|Overall Study||4034
3044301|NCT01188447|3764185|FG000|NOT COMPLETED|Overall Study||0
3044302|NCT01188460|3764192|FG000|STARTED|Overall Study||25
3044303|NCT01188460|3764193|FG001|STARTED|Overall Study||23
3044304|NCT01188460|3764192|FG000|COMPLETED|Overall Study||25
3044305|NCT01188460|3764193|FG001|COMPLETED|Overall Study||23
3044306|NCT01188460|3764192|FG000|NOT COMPLETED|Overall Study||0
3044307|NCT01188460|3764193|FG001|NOT COMPLETED|Overall Study||0
3044308|NCT01188499|3764204|FG000|STARTED|Overall Study||24
3044309|NCT01188499|3764205|FG001|STARTED|Overall Study||83
3044310|NCT01188499|3764206|FG002|STARTED|Overall Study||33
3044311|NCT01188499|3764207|FG003|STARTED|Overall Study||18
3044312|NCT01188499|3764208|FG004|STARTED|Overall Study||18
3044313|NCT01188499|3764204|FG000|COMPLETED|Overall Study||24
3044314|NCT01188499|3764205|FG001|COMPLETED|Overall Study||83
3044315|NCT01188499|3764206|FG002|COMPLETED|Overall Study||33
3044316|NCT01188499|3764207|FG003|COMPLETED|Overall Study||18
3044317|NCT01188499|3764208|FG004|COMPLETED|Overall Study||18
3044318|NCT01188499|3764204|FG000|NOT COMPLETED|Overall Study||0
3044319|NCT01188499|3764205|FG001|NOT COMPLETED|Overall Study||0
3044320|NCT01188499|3764206|FG002|NOT COMPLETED|Overall Study||0
3044321|NCT01188499|3764207|FG003|NOT COMPLETED|Overall Study||0
3044322|NCT01188499|3764208|FG004|NOT COMPLETED|Overall Study||0
3044323|NCT01188538|3764222|FG000|STARTED|Overall Study||20
3044324|NCT01188538|3764223|FG001|STARTED|Overall Study||20
3044325|NCT01188538|3764222|FG000|COMPLETED|Overall Study||20
3044326|NCT01188538|3764223|FG001|COMPLETED|Overall Study||19
3044327|NCT01188538|3764222|FG000|NOT COMPLETED|Overall Study||0
3044328|NCT01188538|3764223|FG001|NOT COMPLETED|Overall Study||1
3044329|NCT01188551|3764235|FG000|STARTED|Overall Study||25
3044330|NCT01188551|3764236|FG001|STARTED|Overall Study||25
3044331|NCT01188551|3764237|FG002|STARTED|Overall Study||25
3044332|NCT01188551|3764238|FG003|STARTED|Overall Study||25
3044333|NCT01188551|3764235|FG000|COMPLETED|Overall Study||24
3044334|NCT01188551|3764236|FG001|COMPLETED|Overall Study||25
3044335|NCT01188551|3764237|FG002|COMPLETED|Overall Study||25
3044336|NCT01188551|3764238|FG003|COMPLETED|Overall Study||25
3044337|NCT01188551|3764235|FG000|NOT COMPLETED|Overall Study||1
3044338|NCT01188551|3764236|FG001|NOT COMPLETED|Overall Study||0
3044339|NCT01188551|3764237|FG002|NOT COMPLETED|Overall Study||0
3044340|NCT01188551|3764238|FG003|NOT COMPLETED|Overall Study||0
3044341|NCT01188564|3764250|FG000|STARTED|Double-blind Phase||44
3044342|NCT01188564|3764251|FG001|STARTED|Double-blind Phase||31
3044343|NCT01188564|3764250|FG000|COMPLETED|Double-blind Phase||43
3044344|NCT01188564|3764251|FG001|COMPLETED|Double-blind Phase||31
3044345|NCT01188564|3764250|FG000|NOT COMPLETED|Double-blind Phase||1
3044346|NCT01188564|3764251|FG001|NOT COMPLETED|Double-blind Phase||0
3044347|NCT01188564|3764250|FG000|STARTED|Open Label Phase|Not all Double-Blind Phase participants went on to Open Label Phase|24
3044348|NCT01188564|3764251|FG001|STARTED|Open Label Phase|Not all Double Blind Phase participants went on to Open Label Phase|20
3044349|NCT01188564|3764250|FG000|COMPLETED|Open Label Phase||24
3044350|NCT01188564|3764251|FG001|COMPLETED|Open Label Phase||20
3044351|NCT01188564|3764250|FG000|NOT COMPLETED|Open Label Phase||0
3044352|NCT01188564|3764251|FG001|NOT COMPLETED|Open Label Phase||0
3044353|NCT01188577|3764259|FG000|STARTED|Visit 1||11
3044354|NCT01188577|3764260|FG001|STARTED|Visit 1||12
3044355|NCT01188577|3764259|FG000|COMPLETED|Visit 1||11
3044356|NCT01188577|3764260|FG001|COMPLETED|Visit 1||12
3044357|NCT01188577|3764259|FG000|NOT COMPLETED|Visit 1||0
3044358|NCT01188577|3764260|FG001|NOT COMPLETED|Visit 1||0
3044359|NCT01188577|3764259|FG000|STARTED|3-14 Day Washout||11
3044360|NCT01188577|3764260|FG001|STARTED|3-14 Day Washout||12
3044361|NCT01188577|3764259|FG000|COMPLETED|3-14 Day Washout||11
3044362|NCT01188577|3764260|FG001|COMPLETED|3-14 Day Washout||12
3044363|NCT01188577|3764259|FG000|NOT COMPLETED|3-14 Day Washout||0
3044364|NCT01188577|3764260|FG001|NOT COMPLETED|3-14 Day Washout||0
3044365|NCT01188577|3764259|FG000|STARTED|Visit 2||11
3044366|NCT01188577|3764260|FG001|STARTED|Visit 2||12
3044367|NCT01188577|3764259|FG000|COMPLETED|Visit 2||11
3044368|NCT01188577|3764260|FG001|COMPLETED|Visit 2||12
3044369|NCT01188577|3764259|FG000|NOT COMPLETED|Visit 2||0
3044370|NCT01188577|3764260|FG001|NOT COMPLETED|Visit 2||0
3044371|NCT01188603|3764266|FG000|STARTED|Overall Study||24
3044372|NCT01188603|3764266|FG000|COMPLETED|Overall Study||24
3044373|NCT01188603|3764266|FG000|NOT COMPLETED|Overall Study||0
3044374|NCT01188655|3764270|FG000|STARTED|Overall Study||89
3044375|NCT01188655|3764270|FG000|COMPLETED|Overall Study||76
3044376|NCT01188655|3764270|FG000|NOT COMPLETED|Overall Study||13
3044377|NCT01188668|3764274|FG000|STARTED|Period 1: ARIP Alone||38
3180286|NCT01989754|3908574|FG001|COMPLETED|Overall Study|Participants who died are included in this category.|2872
3180287|NCT01989754|3908573|FG000|NOT COMPLETED|Overall Study||39
3180288|NCT01989754|3908574|FG001|NOT COMPLETED|Overall Study||35
3180289|NCT01989793|3908582|FG000|STARTED|Overall Study||18
3180290|NCT01989793|3908583|FG001|STARTED|Overall Study||19
3180291|NCT01989793|3908582|FG000|COMPLETED|Overall Study||10
3180292|NCT01989793|3908583|FG001|COMPLETED|Overall Study||15
3180293|NCT01989793|3908582|FG000|NOT COMPLETED|Overall Study||8
3180294|NCT01989793|3908583|FG001|NOT COMPLETED|Overall Study||4
3180295|NCT01989910|3908591|FG000|STARTED|Overall Study||53
3180296|NCT01989910|3908592|FG001|STARTED|Overall Study||54
3180297|NCT01989910|3908591|FG000|COMPLETED|Overall Study||51
3180298|NCT01989910|3908592|FG001|COMPLETED|Overall Study||54
3180299|NCT01989910|3908591|FG000|NOT COMPLETED|Overall Study||2
3180300|NCT01989910|3908592|FG001|NOT COMPLETED|Overall Study||0
3180301|NCT01989975|3908598|FG000|STARTED|Overall Study||40
3180302|NCT01989975|3908598|FG000|COMPLETED|Overall Study||40
3180303|NCT01989975|3908598|FG000|NOT COMPLETED|Overall Study||0
3044378|NCT01188668|3764274|FG000|COMPLETED|Period 1: ARIP Alone||36
3044379|NCT01188668|3764274|FG000|NOT COMPLETED|Period 1: ARIP Alone||2
3044380|NCT01188668|3764274|FG000|STARTED|Period 2: Coadministration ARIP + DVS SR||36
3044381|NCT01188668|3764274|FG000|COMPLETED|Period 2: Coadministration ARIP + DVS SR||33
3044382|NCT01188668|3764274|FG000|NOT COMPLETED|Period 2: Coadministration ARIP + DVS SR||3
3044383|NCT01188681|3764285|FG000|STARTED|Overall Study||6
3044384|NCT01188681|3764286|FG001|STARTED|Overall Study||6
3044385|NCT01188681|3764287|FG002|STARTED|Overall Study|33 patients enrolled, 32 patients treated. One patient had bladder cancer and was not treated.|33
3044386|NCT01188681|3764288|FG003|STARTED|Overall Study|34 patients enrolled, 33 patients treated. One patient withdrew consent and was not treated.|34
3044387|NCT01188681|3764285|FG000|COMPLETED|Overall Study||6
3044388|NCT01188681|3764286|FG001|COMPLETED|Overall Study||6
3044389|NCT01188681|3764287|FG002|COMPLETED|Overall Study||32
3044390|NCT01188681|3764288|FG003|COMPLETED|Overall Study||33
3044391|NCT01188681|3764285|FG000|NOT COMPLETED|Overall Study||0
3044392|NCT01188681|3764286|FG001|NOT COMPLETED|Overall Study||0
3044393|NCT01188681|3764287|FG002|NOT COMPLETED|Overall Study||1
3044394|NCT01188681|3764288|FG003|NOT COMPLETED|Overall Study||1
3044395|NCT01188694|3764305|FG000|STARTED|Overall Study||15
3044396|NCT01188694|3764306|FG001|STARTED|Overall Study||16
3044397|NCT01188694|3764307|FG002|STARTED|Overall Study||11
3044398|NCT01188694|3764305|FG000|COMPLETED|Overall Study||10
3044399|NCT01188694|3764306|FG001|COMPLETED|Overall Study||15
3044400|NCT01188694|3764307|FG002|COMPLETED|Overall Study||10
3044401|NCT01188694|3764305|FG000|NOT COMPLETED|Overall Study||5
3044402|NCT01188694|3764306|FG001|NOT COMPLETED|Overall Study||1
3044403|NCT01188694|3764307|FG002|NOT COMPLETED|Overall Study||1
3044404|NCT01188772|3764319|FG000|STARTED|Overall Study||48
3044405|NCT01188772|3764320|FG001|STARTED|Overall Study||48
3044406|NCT01188772|3764321|FG002|STARTED|Overall Study||26
3044407|NCT01188772|3764322|FG003|STARTED|Overall Study||25
3044408|NCT01188772|3764319|FG000|Randomized and Treated|Overall Study||48
3044409|NCT01188772|3764320|FG001|Randomized and Treated|Overall Study||47
3044410|NCT01188772|3764321|FG002|Randomized and Treated|Overall Study||26
3044411|NCT01188772|3764322|FG003|Randomized and Treated|Overall Study||25
3044412|NCT01188772|3764319|FG000|COMPLETED|Overall Study||43
3044413|NCT01188772|3764320|FG001|COMPLETED|Overall Study||45
3044414|NCT01188772|3764321|FG002|COMPLETED|Overall Study||15
3044415|NCT01188772|3764322|FG003|COMPLETED|Overall Study||24
3044416|NCT01188772|3764319|FG000|NOT COMPLETED|Overall Study||5
3044417|NCT01188772|3764320|FG001|NOT COMPLETED|Overall Study||3
3044418|NCT01188772|3764321|FG002|NOT COMPLETED|Overall Study||11
3044419|NCT01188772|3764322|FG003|NOT COMPLETED|Overall Study||1
3044420|NCT01188811|3764337|FG000|STARTED|Overall Study||28
3044421|NCT01188811|3764338|FG001|STARTED|Overall Study||26
3044422|NCT01188811|3764337|FG000|COMPLETED|Overall Study||22
3180304|NCT01990261|3908602|FG000|STARTED|Overall Study||33
3180305|NCT01990261|3908602|FG000|Treated|Overall Study||29
3044423|NCT01188811|3764338|FG001|COMPLETED|Overall Study||24
3044424|NCT01188811|3764337|FG000|NOT COMPLETED|Overall Study||6
3044425|NCT01188811|3764338|FG001|NOT COMPLETED|Overall Study||2
3044426|NCT01188876|3764344|FG000|STARTED|Overall Study||50
3044427|NCT01188876|3764344|FG000|COMPLETED|Overall Study||50
3044428|NCT01188876|3764344|FG000|NOT COMPLETED|Overall Study||0
3044429|NCT01188928|3764352|FG000|STARTED|Overall Study||482
3044430|NCT01188928|3764353|FG001|STARTED|Overall Study||479
3044431|NCT01188928|3764354|FG002|STARTED|Overall Study||96
3044432|NCT01188928|3764355|FG003|STARTED|Overall Study||95
3044433|NCT01188928|3764352|FG000|COMPLETED|Overall Study||444
3044434|NCT01188928|3764353|FG001|COMPLETED|Overall Study||417
3044435|NCT01188928|3764354|FG002|COMPLETED|Overall Study||82
3044436|NCT01188928|3764355|FG003|COMPLETED|Overall Study||77
3044437|NCT01188928|3764352|FG000|NOT COMPLETED|Overall Study||38
3044438|NCT01188928|3764353|FG001|NOT COMPLETED|Overall Study||62
3044439|NCT01188928|3764354|FG002|NOT COMPLETED|Overall Study||14
3044440|NCT01188928|3764355|FG003|NOT COMPLETED|Overall Study||18
3044441|NCT01188967|3764367|FG000|STARTED|Overall Study||10
3044442|NCT01188967|3764368|FG001|STARTED|Overall Study||8
3044443|NCT01188967|3764367|FG000|COMPLETED|Overall Study||5
3044444|NCT01188967|3764368|FG001|COMPLETED|Overall Study||4
3044445|NCT01188967|3764367|FG000|NOT COMPLETED|Overall Study||5
3044446|NCT01188967|3764368|FG001|NOT COMPLETED|Overall Study||4
3180306|NCT01990261|3908602|FG000|COMPLETED|Overall Study||8
3180307|NCT01990261|3908602|FG000|NOT COMPLETED|Overall Study||25
3180308|NCT01990300|3908606|FG000|STARTED|Overall Study||3281
3180309|NCT01990300|3908606|FG000|COMPLETED|Overall Study||3139
3180310|NCT01990300|3908606|FG000|NOT COMPLETED|Overall Study||142
3180311|NCT01990313|3908610|FG000|STARTED|Overall Study||15
3180312|NCT01990313|3908610|FG000|COMPLETED|Overall Study||14
3180313|NCT01990313|3908610|FG000|NOT COMPLETED|Overall Study||1
3180314|NCT01990339|3908614|FG000|STARTED|Overall Study||14965
3180315|NCT01990339|3908614|FG000|COMPLETED|Overall Study||12653
3180316|NCT01990339|3908614|FG000|NOT COMPLETED|Overall Study||2312
3180317|NCT01990495|3908620|FG000|STARTED|Overall Study||18
3180318|NCT01990495|3908621|FG001|STARTED|Overall Study||19
3180319|NCT01990495|3908620|FG000|COMPLETED|Overall Study||13
3180320|NCT01990495|3908621|FG001|COMPLETED|Overall Study||15
3180321|NCT01990495|3908620|FG000|NOT COMPLETED|Overall Study||5
3180322|NCT01990495|3908621|FG001|NOT COMPLETED|Overall Study||4
3180323|NCT01990534|3908629|FG000|STARTED|Overall Study||60
3044447|NCT01189032|3764379|FG000|STARTED|Overall Study||94
3044448|NCT01189032|3764380|FG001|STARTED|Overall Study||96
3044449|NCT01189032|3764381|FG002|STARTED|Overall Study||96
3044450|NCT01189032|3764379|FG000|COMPLETED|Overall Study||89
3044451|NCT01189032|3764380|FG001|COMPLETED|Overall Study||89
3044452|NCT01189032|3764381|FG002|COMPLETED|Overall Study||90
3180324|NCT01990534|3908629|FG000|COMPLETED|Overall Study||25
3180325|NCT01990534|3908629|FG000|NOT COMPLETED|Overall Study||35
3180326|NCT01990560|3908633|FG000|STARTED|Overall Study||8
3180327|NCT01990560|3908633|FG000|COMPLETED|Overall Study||7
3180328|NCT01990560|3908633|FG000|NOT COMPLETED|Overall Study||1
3044453|NCT01189032|3764379|FG000|NOT COMPLETED|Overall Study||5
3044454|NCT01189032|3764380|FG001|NOT COMPLETED|Overall Study||7
3044455|NCT01189032|3764381|FG002|NOT COMPLETED|Overall Study||6
3044456|NCT01189110|3764391|FG000|STARTED|Overall Study|September, 2010|64
3044457|NCT01189110|3764392|FG001|STARTED|Overall Study||61
3044458|NCT01189110|3764391|FG000|COMPLETED|Overall Study|February, 2011|64
3044459|NCT01189110|3764392|FG001|COMPLETED|Overall Study||61
3044460|NCT01189110|3764391|FG000|NOT COMPLETED|Overall Study||0
3044461|NCT01189110|3764392|FG001|NOT COMPLETED|Overall Study||0
3044462|NCT01189123|3764400|FG000|STARTED|Overall Study||52
3044463|NCT01189123|3764401|FG001|STARTED|Overall Study||53
3044464|NCT01189123|3764400|FG000|COMPLETED|Overall Study||50
3044465|NCT01189123|3764401|FG001|COMPLETED|Overall Study||47
3044466|NCT01189123|3764400|FG000|NOT COMPLETED|Overall Study||2
3044467|NCT01189123|3764401|FG001|NOT COMPLETED|Overall Study||6
3044468|NCT01189136|3764409|FG000|STARTED|Overall Study||42
3044469|NCT01189136|3764410|FG001|STARTED|Overall Study||42
3044470|NCT01189136|3764409|FG000|COMPLETED|Overall Study||42
3044471|NCT01189136|3764410|FG001|COMPLETED|Overall Study||42
3044472|NCT01189136|3764409|FG000|NOT COMPLETED|Overall Study||0
3044473|NCT01189136|3764410|FG001|NOT COMPLETED|Overall Study||0
3044474|NCT01189201|3764416|FG000|STARTED|Overall Study||42
3044475|NCT01189201|3764416|FG000|Received Empa/Linagliptin FDC A1(Fasted)|Overall Study||42
3044476|NCT01189201|3764416|FG000|Rec. Empa/Linagliptin Ind.Tablet(Fasted)|Overall Study||41
3044477|NCT01189201|3764416|FG000|Received Empa/Linagliptin FDC A1 (Fed)|Overall Study||18
3044478|NCT01189201|3764416|FG000|Received Empa/Linagliptin FDC A3(Fasted)|Overall Study||24
3044479|NCT01189201|3764416|FG000|COMPLETED|Overall Study||41
3044480|NCT01189201|3764416|FG000|NOT COMPLETED|Overall Study||1
3044481|NCT01189240|3764431|FG000|STARTED|Overall Study||4
3044482|NCT01189240|3764432|FG001|STARTED|Overall Study||6
3044483|NCT01189240|3764433|FG002|STARTED|Overall Study||3
3044484|NCT01189240|3764431|FG000|COMPLETED|Overall Study||4
3044485|NCT01189240|3764432|FG001|COMPLETED|Overall Study||6
3044486|NCT01189240|3764433|FG002|COMPLETED|Overall Study||3
3044487|NCT01189240|3764431|FG000|NOT COMPLETED|Overall Study||0
3044488|NCT01189240|3764432|FG001|NOT COMPLETED|Overall Study||0
3180329|NCT01990573|3908640|FG000|STARTED|Overall Study||20
3044489|NCT01189240|3764433|FG002|NOT COMPLETED|Overall Study||0
3044490|NCT01189266|3764446|FG000|STARTED|Overall Study||6
3044491|NCT01189266|3764447|FG001|STARTED|Overall Study||6
3044492|NCT01189266|3764448|FG002|STARTED|Overall Study||67
3044493|NCT01189266|3764446|FG000|COMPLETED|Overall Study||0
3044494|NCT01189266|3764447|FG001|COMPLETED|Overall Study||0
3044495|NCT01189266|3764448|FG002|COMPLETED|Overall Study||2
3044496|NCT01189266|3764446|FG000|NOT COMPLETED|Overall Study||6
3044497|NCT01189266|3764447|FG001|NOT COMPLETED|Overall Study||6
3044498|NCT01189266|3764448|FG002|NOT COMPLETED|Overall Study||65
3044499|NCT01189279|3764460|FG000|STARTED|Overall Study||14
3044500|NCT01189279|3764461|FG001|STARTED|Overall Study||14
3044501|NCT01189279|3764462|FG002|STARTED|Overall Study||14
3044502|NCT01189279|3764460|FG000|COMPLETED|Overall Study||13
3044503|NCT01189279|3764461|FG001|COMPLETED|Overall Study||14
3044504|NCT01189279|3764462|FG002|COMPLETED|Overall Study||13
3044505|NCT01189279|3764460|FG000|NOT COMPLETED|Overall Study||1
3044506|NCT01189279|3764461|FG001|NOT COMPLETED|Overall Study||0
3044507|NCT01189279|3764462|FG002|NOT COMPLETED|Overall Study||1
3044508|NCT01189292|3764472|FG000|STARTED|Intention to Treat Analysis||76
3044509|NCT01189292|3764473|FG001|STARTED|Intention to Treat Analysis||76
3044510|NCT01189292|3764472|FG000|COMPLETED|Intention to Treat Analysis||76
3044511|NCT01189292|3764473|FG001|COMPLETED|Intention to Treat Analysis||76
3044512|NCT01189292|3764472|FG000|NOT COMPLETED|Intention to Treat Analysis||0
3044513|NCT01189292|3764473|FG001|NOT COMPLETED|Intention to Treat Analysis||0
3044514|NCT01189292|3764472|FG000|STARTED|Per Protocol Analysis||76
3044515|NCT01189292|3764473|FG001|STARTED|Per Protocol Analysis||76
3044516|NCT01189292|3764472|FG000|COMPLETED|Per Protocol Analysis||65
3044517|NCT01189292|3764473|FG001|COMPLETED|Per Protocol Analysis||60
3044518|NCT01189292|3764472|FG000|NOT COMPLETED|Per Protocol Analysis||11
3044519|NCT01189292|3764473|FG001|NOT COMPLETED|Per Protocol Analysis||16
3044520|NCT01189370|3764479|FG000|STARTED|Dose Level 1||25
3044521|NCT01189370|3764480|FG001|STARTED|Dose Level 1||0
3044522|NCT01189370|3764481|FG002|STARTED|Dose Level 1||0
3044523|NCT01189370|3764479|FG000|COMPLETED|Dose Level 1||16
3044524|NCT01189370|3764480|FG001|COMPLETED|Dose Level 1||0
3044525|NCT01189370|3764481|FG002|COMPLETED|Dose Level 1||0
3044526|NCT01189370|3764479|FG000|NOT COMPLETED|Dose Level 1||9
3044527|NCT01189370|3764480|FG001|NOT COMPLETED|Dose Level 1||0
3044528|NCT01189370|3764481|FG002|NOT COMPLETED|Dose Level 1||0
3044529|NCT01189370|3764479|FG000|STARTED|Dose Level 2||0
3044530|NCT01189370|3764480|FG001|STARTED|Dose Level 2||16
3044531|NCT01189370|3764481|FG002|STARTED|Dose Level 2||0
3044532|NCT01189370|3764479|FG000|COMPLETED|Dose Level 2||0
3044533|NCT01189370|3764480|FG001|COMPLETED|Dose Level 2||12
3044534|NCT01189370|3764481|FG002|COMPLETED|Dose Level 2||0
3044535|NCT01189370|3764479|FG000|NOT COMPLETED|Dose Level 2||0
3044536|NCT01189370|3764480|FG001|NOT COMPLETED|Dose Level 2||4
3044537|NCT01189370|3764481|FG002|NOT COMPLETED|Dose Level 2||0
3044538|NCT01189370|3764479|FG000|STARTED|Dose Level 3||0
3044539|NCT01189370|3764480|FG001|STARTED|Dose Level 3||0
3044540|NCT01189370|3764481|FG002|STARTED|Dose Level 3||12
3044541|NCT01189370|3764479|FG000|COMPLETED|Dose Level 3||0
3044542|NCT01189370|3764480|FG001|COMPLETED|Dose Level 3||0
3044543|NCT01189370|3764481|FG002|COMPLETED|Dose Level 3||6
3044544|NCT01189370|3764479|FG000|NOT COMPLETED|Dose Level 3||0
3044545|NCT01189370|3764480|FG001|NOT COMPLETED|Dose Level 3||0
3044546|NCT01189370|3764481|FG002|NOT COMPLETED|Dose Level 3||6
3044547|NCT01189409|3764490|FG000|STARTED|First 3 Weeks||37
3044548|NCT01189409|3764491|FG001|STARTED|First 3 Weeks||33
3044549|NCT01189409|3764490|FG000|COMPLETED|First 3 Weeks||19
3044550|NCT01189409|3764491|FG001|COMPLETED|First 3 Weeks||23
3044551|NCT01189409|3764490|FG000|NOT COMPLETED|First 3 Weeks||18
3044552|NCT01189409|3764491|FG001|NOT COMPLETED|First 3 Weeks||10
3044553|NCT01189409|3764490|FG000|STARTED|Second 3 Weeks (Switch to 2nd Treatment)||19
3044554|NCT01189409|3764491|FG001|STARTED|Second 3 Weeks (Switch to 2nd Treatment)||23
3044555|NCT01189409|3764490|FG000|COMPLETED|Second 3 Weeks (Switch to 2nd Treatment)||13
3044556|NCT01189409|3764491|FG001|COMPLETED|Second 3 Weeks (Switch to 2nd Treatment)||15
3044557|NCT01189409|3764490|FG000|NOT COMPLETED|Second 3 Weeks (Switch to 2nd Treatment)||6
3044558|NCT01189409|3764491|FG001|NOT COMPLETED|Second 3 Weeks (Switch to 2nd Treatment)||8
3044559|NCT01189461|3764504|FG000|STARTED|Overall Study||46
3044560|NCT01189461|3764504|FG000|COMPLETED|Overall Study||12
3044561|NCT01189461|3764504|FG000|NOT COMPLETED|Overall Study||34
3044562|NCT01189487|3764508|FG000|STARTED|Overall Study|Treated participants|47
3044563|NCT01189487|3764508|FG000|COMPLETED|Overall Study||44
3044564|NCT01189487|3764508|FG000|NOT COMPLETED|Overall Study||3
3044565|NCT01189500|3764512|FG000|STARTED|Period 1: TAMOX Alone||30
3180330|NCT01990573|3908641|FG001|STARTED|Overall Study||14
3180331|NCT01990573|3908642|FG002|STARTED|Overall Study||17
3180332|NCT01990573|3908640|FG000|COMPLETED|Overall Study||20
3044566|NCT01189500|3764512|FG000|COMPLETED|Period 1: TAMOX Alone||29
3044567|NCT01189500|3764512|FG000|NOT COMPLETED|Period 1: TAMOX Alone||1
3044568|NCT01189500|3764512|FG000|STARTED|Period 2: Coadministration TAMOX+DVS SR||29
3044569|NCT01189500|3764512|FG000|COMPLETED|Period 2: Coadministration TAMOX+DVS SR||28
3044570|NCT01189500|3764512|FG000|NOT COMPLETED|Period 2: Coadministration TAMOX+DVS SR||1
3044571|NCT01189604|3764526|FG000|STARTED|Overall Study||21
3044572|NCT01189604|3764527|FG001|STARTED|Overall Study||21
3044573|NCT01189604|3764528|FG002|STARTED|Overall Study||20
3044574|NCT01189604|3764529|FG003|STARTED|Overall Study||20
3044575|NCT01189604|3764530|FG004|STARTED|Overall Study||20
3044576|NCT01189604|3764531|FG005|STARTED|Overall Study||11
3044577|NCT01189604|3764532|FG006|STARTED|Overall Study||10
3044578|NCT01189604|3764526|FG000|Administered Study Drug|Overall Study||20
3044579|NCT01189604|3764527|FG001|Administered Study Drug|Overall Study||20
3044580|NCT01189604|3764528|FG002|Administered Study Drug|Overall Study||20
3044581|NCT01189604|3764529|FG003|Administered Study Drug|Overall Study||20
3044582|NCT01189604|3764530|FG004|Administered Study Drug|Overall Study||20
3044583|NCT01189604|3764531|FG005|Administered Study Drug|Overall Study||10
3044584|NCT01189604|3764532|FG006|Administered Study Drug|Overall Study||10
3044585|NCT01189604|3764526|FG000|COMPLETED|Overall Study||20
3044586|NCT01189604|3764527|FG001|COMPLETED|Overall Study||20
3044587|NCT01189604|3764528|FG002|COMPLETED|Overall Study||20
3044588|NCT01189604|3764529|FG003|COMPLETED|Overall Study||20
3044589|NCT01189604|3764530|FG004|COMPLETED|Overall Study||18
3044590|NCT01189604|3764531|FG005|COMPLETED|Overall Study||10
3044591|NCT01189604|3764532|FG006|COMPLETED|Overall Study||9
3044592|NCT01189604|3764526|FG000|NOT COMPLETED|Overall Study||1
3044593|NCT01189604|3764527|FG001|NOT COMPLETED|Overall Study||1
3044594|NCT01189604|3764528|FG002|NOT COMPLETED|Overall Study||0
3044595|NCT01189604|3764529|FG003|NOT COMPLETED|Overall Study||0
3044596|NCT01189604|3764530|FG004|NOT COMPLETED|Overall Study||2
3044597|NCT01189604|3764531|FG005|NOT COMPLETED|Overall Study||1
3044598|NCT01189604|3764532|FG006|NOT COMPLETED|Overall Study||1
3044599|NCT01189617|3764550|FG000|STARTED|Overall Study||35
3044600|NCT01189617|3764551|FG001|STARTED|Overall Study||35
3044601|NCT01189617|3764550|FG000|COMPLETED|Overall Study||35
3044602|NCT01189617|3764551|FG001|COMPLETED|Overall Study||35
3044603|NCT01189617|3764550|FG000|NOT COMPLETED|Overall Study||0
3044604|NCT01189617|3764551|FG001|NOT COMPLETED|Overall Study||0
3044605|NCT01189747|3764559|FG000|STARTED|Overall Study||222
3044606|NCT01189747|3764560|FG001|STARTED|Overall Study||224
3044607|NCT01189747|3764559|FG000|COMPLETED|Overall Study||210
3044608|NCT01189747|3764560|FG001|COMPLETED|Overall Study||206
3044609|NCT01189747|3764559|FG000|NOT COMPLETED|Overall Study||12
3044610|NCT01189747|3764560|FG001|NOT COMPLETED|Overall Study||18
3044611|NCT01189760|3764569|FG000|STARTED|Overall Study||305
3044612|NCT01189760|3764570|FG001|STARTED|Overall Study||306
3044613|NCT01189760|3764571|FG002|STARTED|Overall Study||306
3044614|NCT01189760|3764569|FG000|COMPLETED|Overall Study||291
3044615|NCT01189760|3764570|FG001|COMPLETED|Overall Study||283
3044616|NCT01189760|3764571|FG002|COMPLETED|Overall Study||255
3044617|NCT01189760|3764569|FG000|NOT COMPLETED|Overall Study||14
3044618|NCT01189760|3764570|FG001|NOT COMPLETED|Overall Study||23
3044619|NCT01189760|3764571|FG002|NOT COMPLETED|Overall Study||51
3044620|NCT01189812|3764581|FG000|STARTED|Overall Study||40
3044621|NCT01189812|3764582|FG001|STARTED|Overall Study||40
3044622|NCT01189812|3764581|FG000|COMPLETED|Overall Study||32
3044623|NCT01189812|3764582|FG001|COMPLETED|Overall Study||32
3044624|NCT01189812|3764581|FG000|NOT COMPLETED|Overall Study||8
3044625|NCT01189812|3764582|FG001|NOT COMPLETED|Overall Study||8
3044626|NCT01189890|3764590|FG000|STARTED|Overall Study||241
3044627|NCT01189890|3764591|FG001|STARTED|Overall Study|3 randomized glimepiride participants did not receive study drug.|239
3044628|NCT01189890|3764590|FG000|COMPLETED|Overall Study||204
3044629|NCT01189890|3764591|FG001|COMPLETED|Overall Study||200
3044630|NCT01189890|3764590|FG000|NOT COMPLETED|Overall Study||37
3044631|NCT01189890|3764591|FG001|NOT COMPLETED|Overall Study||39
3044632|NCT01190007|3764597|FG000|STARTED|Overall Study|Treated|159
3044633|NCT01190007|3764597|FG000|COMPLETED|Overall Study||145
3044634|NCT01190007|3764597|FG000|NOT COMPLETED|Overall Study||14
3044635|NCT01190020|3764603|FG000|STARTED|Overall Study||29
3044636|NCT01190020|3764604|FG001|STARTED|Overall Study||12
3044637|NCT01190020|3764603|FG000|COMPLETED|Overall Study||22
3044638|NCT01190020|3764604|FG001|COMPLETED|Overall Study||12
3044639|NCT01190020|3764603|FG000|NOT COMPLETED|Overall Study||7
3044640|NCT01190020|3764604|FG001|NOT COMPLETED|Overall Study||0
3044641|NCT01190085|3764613|FG000|STARTED|Overall Study||13
3044642|NCT01190085|3764614|FG001|STARTED|Overall Study||14
3044643|NCT01190085|3764615|FG002|STARTED|Overall Study||18
3044644|NCT01190085|3764613|FG000|COMPLETED|Overall Study||13
3044645|NCT01190085|3764614|FG001|COMPLETED|Overall Study||14
3044646|NCT01190085|3764615|FG002|COMPLETED|Overall Study||18
3044647|NCT01190085|3764613|FG000|NOT COMPLETED|Overall Study||0
3044648|NCT01190085|3764614|FG001|NOT COMPLETED|Overall Study||0
3044649|NCT01190085|3764615|FG002|NOT COMPLETED|Overall Study||0
3044650|NCT01190098|3764625|FG000|STARTED|Overall Study||42
3044651|NCT01190098|3764626|FG001|STARTED|Overall Study||10
3044652|NCT01190098|3764625|FG000|COMPLETED|Overall Study||39
3044653|NCT01190098|3764626|FG001|COMPLETED|Overall Study||8
3044654|NCT01190098|3764625|FG000|NOT COMPLETED|Overall Study||3
3044655|NCT01190098|3764626|FG001|NOT COMPLETED|Overall Study||2
3044656|NCT01190124|3764635|FG000|STARTED|Overall Study||107
3044657|NCT01190124|3764636|FG001|STARTED|Overall Study||24
3044658|NCT01190124|3764637|FG002|STARTED|Overall Study||20
3044659|NCT01190124|3764635|FG000|COMPLETED|Overall Study||90
3044660|NCT01190124|3764636|FG001|COMPLETED|Overall Study||24
3044661|NCT01190124|3764637|FG002|COMPLETED|Overall Study||19
3044662|NCT01190124|3764635|FG000|NOT COMPLETED|Overall Study||17
3044663|NCT01190124|3764636|FG001|NOT COMPLETED|Overall Study||0
3044664|NCT01190124|3764637|FG002|NOT COMPLETED|Overall Study||1
3044665|NCT01190150|3764650|FG000|STARTED|First Treatment|Randomized, as well as Safety and PK populations|11
3044666|NCT01190150|3764651|FG001|STARTED|First Treatment|Randomized, as well as Safety and PK populations|9
3044667|NCT01190150|3764650|FG000|COMPLETED|First Treatment||10
3044668|NCT01190150|3764651|FG001|COMPLETED|First Treatment||9
3044669|NCT01190150|3764650|FG000|NOT COMPLETED|First Treatment||1
3044670|NCT01190150|3764651|FG001|NOT COMPLETED|First Treatment||0
3044671|NCT01190150|3764650|FG000|STARTED|Washout||10
3044672|NCT01190150|3764651|FG001|STARTED|Washout||9
3044673|NCT01190150|3764650|FG000|COMPLETED|Washout||10
3044674|NCT01190150|3764651|FG001|COMPLETED|Washout||7
3044675|NCT01190150|3764650|FG000|NOT COMPLETED|Washout||0
3044676|NCT01190150|3764651|FG001|NOT COMPLETED|Washout||2
3044677|NCT01190150|3764650|FG000|STARTED|Second Treatment||10
3044678|NCT01190150|3764651|FG001|STARTED|Second Treatment||7
3044679|NCT01190150|3764650|FG000|COMPLETED|Second Treatment||10
3044680|NCT01190150|3764651|FG001|COMPLETED|Second Treatment||7
3044681|NCT01190150|3764650|FG000|NOT COMPLETED|Second Treatment||0
3044682|NCT01190150|3764651|FG001|NOT COMPLETED|Second Treatment||0
3044683|NCT01190176|3764657|FG000|STARTED|Overall Study||32
3044684|NCT01190176|3764657|FG000|COMPLETED|Overall Study||30
3044685|NCT01190176|3764657|FG000|NOT COMPLETED|Overall Study||2
3044686|NCT01190189|3764661|FG000|STARTED|Overall Study||137
3044687|NCT01190189|3764661|FG000|COMPLETED|Overall Study||131
3044688|NCT01190189|3764661|FG000|NOT COMPLETED|Overall Study||6
3044689|NCT01190215|3764667|FG000|STARTED|Up to Day 28||38
3044690|NCT01190215|3764668|FG001|STARTED|Up to Day 28||39
3044691|NCT01190215|3764667|FG000|COMPLETED|Up to Day 28||38
3044692|NCT01190215|3764668|FG001|COMPLETED|Up to Day 28||39
3044693|NCT01190215|3764667|FG000|NOT COMPLETED|Up to Day 28||0
3044694|NCT01190215|3764668|FG001|NOT COMPLETED|Up to Day 28||0
3044695|NCT01190215|3764667|FG000|STARTED|Up to Month 6||38
3044696|NCT01190215|3764668|FG001|STARTED|Up to Month 6||39
3044697|NCT01190215|3764667|FG000|COMPLETED|Up to Month 6||36
3044698|NCT01190215|3764668|FG001|COMPLETED|Up to Month 6||39
3044699|NCT01190215|3764667|FG000|NOT COMPLETED|Up to Month 6||2
3044700|NCT01190215|3764668|FG001|NOT COMPLETED|Up to Month 6||0
3044701|NCT01190228|3764677|FG000|STARTED|Overall Study||349
3044702|NCT01190228|3764678|FG001|STARTED|Overall Study||46
3044703|NCT01190228|3764679|FG002|STARTED|Overall Study||59
3044704|NCT01190228|3764677|FG000|COMPLETED|Overall Study||344
3044705|NCT01190228|3764678|FG001|COMPLETED|Overall Study||46
3044706|NCT01190228|3764679|FG002|COMPLETED|Overall Study||59
3044707|NCT01190228|3764677|FG000|NOT COMPLETED|Overall Study||5
3044708|NCT01190228|3764678|FG001|NOT COMPLETED|Overall Study||0
3044709|NCT01190228|3764679|FG002|NOT COMPLETED|Overall Study||0
3044710|NCT01190410|3764691|FG000|STARTED|Overall Study||4
3044711|NCT01190410|3764692|FG001|STARTED|Overall Study||12
3180333|NCT01990573|3908641|FG001|COMPLETED|Overall Study||14
3180334|NCT01990573|3908642|FG002|COMPLETED|Overall Study||16
3180335|NCT01990573|3908640|FG000|NOT COMPLETED|Overall Study||0
3180336|NCT01990573|3908641|FG001|NOT COMPLETED|Overall Study||0
3180337|NCT01990573|3908642|FG002|NOT COMPLETED|Overall Study||1
3180338|NCT01990612|3908652|FG000|STARTED|Overall Study||3044
3180339|NCT01990612|3908653|FG001|STARTED|Overall Study||3062
3180340|NCT01990612|3908652|FG000|COMPLETED|Overall Study||3037
3180341|NCT01990612|3908653|FG001|COMPLETED|Overall Study||3059
3180342|NCT01990612|3908652|FG000|NOT COMPLETED|Overall Study||7
3180343|NCT01990612|3908653|FG001|NOT COMPLETED|Overall Study||3
3180344|NCT01990664|3908661|FG000|STARTED|Overall Study||102
3180345|NCT01990664|3908662|FG001|STARTED|Overall Study||90
3180346|NCT01990664|3908661|FG000|COMPLETED|Overall Study||95
3180347|NCT01990664|3908662|FG001|COMPLETED|Overall Study||79
3180348|NCT01990664|3908661|FG000|NOT COMPLETED|Overall Study||7
3180349|NCT01990664|3908662|FG001|NOT COMPLETED|Overall Study||11
3180350|NCT01990677|3908670|FG000|STARTED|Overall Study||12
3180351|NCT01990677|3908671|FG001|STARTED|Overall Study||6
3180352|NCT01990677|3908670|FG000|COMPLETED|Overall Study||10
3180353|NCT01990677|3908671|FG001|COMPLETED|Overall Study||5
3044712|NCT01190410|3764691|FG000|Re-Induction|Overall Study||0
3044713|NCT01190410|3764692|FG001|Re-Induction|Overall Study||2
3044714|NCT01190410|3764691|FG000|COMPLETED|Overall Study||3
3044715|NCT01190410|3764692|FG001|COMPLETED|Overall Study||3
3044716|NCT01190410|3764691|FG000|NOT COMPLETED|Overall Study||1
3044717|NCT01190410|3764692|FG001|NOT COMPLETED|Overall Study||9
3044718|NCT01190436|3764704|FG000|STARTED|Overall Study||125
3044719|NCT01190436|3764704|FG000|COMPLETED|Overall Study||86
3044720|NCT01190436|3764704|FG000|NOT COMPLETED|Overall Study||39
3044721|NCT01190449|3764711|FG000|STARTED|Overall Study||15
3044722|NCT01190449|3764712|FG001|STARTED|Overall Study||36
3044723|NCT01190449|3764711|FG000|COMPLETED|Overall Study||15
3044724|NCT01190449|3764712|FG001|COMPLETED|Overall Study||32
3044725|NCT01190449|3764711|FG000|NOT COMPLETED|Overall Study||0
3044726|NCT01190449|3764712|FG001|NOT COMPLETED|Overall Study||4
3044727|NCT01190475|3764721|FG000|STARTED|Overall Study||2
3044728|NCT01190475|3764722|FG001|STARTED|Overall Study||2
3044729|NCT01190475|3764723|FG002|STARTED|Overall Study||2
3044730|NCT01190475|3764721|FG000|COMPLETED|Overall Study||2
3044731|NCT01190475|3764722|FG001|COMPLETED|Overall Study||2
3044732|NCT01190475|3764723|FG002|COMPLETED|Overall Study||1
3044733|NCT01190475|3764721|FG000|NOT COMPLETED|Overall Study||0
3044734|NCT01190475|3764722|FG001|NOT COMPLETED|Overall Study||0
3044735|NCT01190475|3764723|FG002|NOT COMPLETED|Overall Study||1
3044736|NCT01190514|3764733|FG000|STARTED|First Intervention (Period 1)||11
3044737|NCT01190514|3764734|FG001|STARTED|First Intervention (Period 1)||10
3180354|NCT01990677|3908670|FG000|NOT COMPLETED|Overall Study||2
3044738|NCT01190514|3764735|FG002|STARTED|First Intervention (Period 1)||10
3044739|NCT01190514|3764736|FG003|STARTED|First Intervention (Period 1)||10
3044740|NCT01190514|3764733|FG000|COMPLETED|First Intervention (Period 1)|Discontinued participant received treatment A of sequence ABCD.|10
3044741|NCT01190514|3764734|FG001|COMPLETED|First Intervention (Period 1)||10
3044742|NCT01190514|3764735|FG002|COMPLETED|First Intervention (Period 1)||10
3044743|NCT01190514|3764736|FG003|COMPLETED|First Intervention (Period 1)||10
3044744|NCT01190514|3764733|FG000|NOT COMPLETED|First Intervention (Period 1)||1
3044745|NCT01190514|3764734|FG001|NOT COMPLETED|First Intervention (Period 1)||0
3044746|NCT01190514|3764735|FG002|NOT COMPLETED|First Intervention (Period 1)||0
3044747|NCT01190514|3764736|FG003|NOT COMPLETED|First Intervention (Period 1)||0
3044748|NCT01190514|3764733|FG000|STARTED|Second Intervention (Period 2)|Period 2 received treatment B|10
3044749|NCT01190514|3764734|FG001|STARTED|Second Intervention (Period 2)|Period 2 received treatment A|10
3044750|NCT01190514|3764735|FG002|STARTED|Second Intervention (Period 2)|Period 2 received treatment D|10
3044751|NCT01190514|3764736|FG003|STARTED|Second Intervention (Period 2)|Period 2 received treatment C|10
3044752|NCT01190514|3764733|FG000|COMPLETED|Second Intervention (Period 2)||10
3044753|NCT01190514|3764734|FG001|COMPLETED|Second Intervention (Period 2)||10
3044754|NCT01190514|3764735|FG002|COMPLETED|Second Intervention (Period 2)||10
3044755|NCT01190514|3764736|FG003|COMPLETED|Second Intervention (Period 2)||10
3044756|NCT01190514|3764733|FG000|NOT COMPLETED|Second Intervention (Period 2)||0
3044757|NCT01190514|3764734|FG001|NOT COMPLETED|Second Intervention (Period 2)||0
3044758|NCT01190514|3764735|FG002|NOT COMPLETED|Second Intervention (Period 2)||0
3044759|NCT01190514|3764736|FG003|NOT COMPLETED|Second Intervention (Period 2)||0
3044760|NCT01190514|3764733|FG000|STARTED|Third Intervention (Period 3)|Period 3 received treatment C|10
3044761|NCT01190514|3764734|FG001|STARTED|Third Intervention (Period 3)|Period 3 received treatment D|10
3044762|NCT01190514|3764735|FG002|STARTED|Third Intervention (Period 3)|Period 3 received treatment A|10
3044763|NCT01190514|3764736|FG003|STARTED|Third Intervention (Period 3)|Period 3 received treatment B|10
3044764|NCT01190514|3764733|FG000|COMPLETED|Third Intervention (Period 3)|Discontinued participant received treatments ABC of sequence ABCD.|9
3044765|NCT01190514|3764734|FG001|COMPLETED|Third Intervention (Period 3)||10
3044766|NCT01190514|3764735|FG002|COMPLETED|Third Intervention (Period 3)||10
3044767|NCT01190514|3764736|FG003|COMPLETED|Third Intervention (Period 3)||10
3044768|NCT01190514|3764733|FG000|NOT COMPLETED|Third Intervention (Period 3)||1
3044769|NCT01190514|3764734|FG001|NOT COMPLETED|Third Intervention (Period 3)||0
3044770|NCT01190514|3764735|FG002|NOT COMPLETED|Third Intervention (Period 3)||0
3044771|NCT01190514|3764736|FG003|NOT COMPLETED|Third Intervention (Period 3)||0
3044772|NCT01190514|3764733|FG000|STARTED|Fourth Intervention (Period 4)|Period 4 received treatment D|9
3044773|NCT01190514|3764734|FG001|STARTED|Fourth Intervention (Period 4)|Period 4 received treatment C|10
3044774|NCT01190514|3764735|FG002|STARTED|Fourth Intervention (Period 4)|Period 4 received treatment B|10
3044775|NCT01190514|3764736|FG003|STARTED|Fourth Intervention (Period 4)|Period 4 received treatment A|10
3044776|NCT01190514|3764733|FG000|COMPLETED|Fourth Intervention (Period 4)||9
3180355|NCT01990677|3908671|FG001|NOT COMPLETED|Overall Study||1
3180356|NCT01990703|3908679|FG000|STARTED|Overall Study||147
3044777|NCT01190514|3764734|FG001|COMPLETED|Fourth Intervention (Period 4)||10
3044778|NCT01190514|3764735|FG002|COMPLETED|Fourth Intervention (Period 4)||10
3044779|NCT01190514|3764736|FG003|COMPLETED|Fourth Intervention (Period 4)||10
3044780|NCT01190514|3764733|FG000|NOT COMPLETED|Fourth Intervention (Period 4)||0
3044781|NCT01190514|3764734|FG001|NOT COMPLETED|Fourth Intervention (Period 4)||0
3044782|NCT01190514|3764735|FG002|NOT COMPLETED|Fourth Intervention (Period 4)||0
3044783|NCT01190514|3764736|FG003|NOT COMPLETED|Fourth Intervention (Period 4)||0
3044784|NCT01190527|3764746|FG000|STARTED|Overall Study||42
3044785|NCT01190527|3764746|FG000|COMPLETED|Overall Study||42
3044786|NCT01190527|3764746|FG000|NOT COMPLETED|Overall Study||0
3044787|NCT01190566|3764752|FG000|STARTED|Overall Study||6
3044788|NCT01190566|3764753|FG001|STARTED|Overall Study||42
3044789|NCT01190566|3764752|FG000|COMPLETED|Overall Study||6
3044790|NCT01190566|3764753|FG001|COMPLETED|Overall Study||42
3044791|NCT01190566|3764752|FG000|NOT COMPLETED|Overall Study||0
3044792|NCT01190566|3764753|FG001|NOT COMPLETED|Overall Study||0
3044793|NCT01190813|3764762|FG000|STARTED|Overall Study||90
3044794|NCT01190813|3764763|FG001|STARTED|Overall Study||49
3044795|NCT01190813|3764762|FG000|2-week Phone Call|Overall Study|2 missed, 1 dropped|87
3044796|NCT01190813|3764763|FG001|2-week Phone Call|Overall Study|1 missed, 0 dropped|48
3044797|NCT01190813|3764762|FG000|4-week Visit|Overall Study|0 missed, 1 dropped|88
3044798|NCT01190813|3764763|FG001|4-week Visit|Overall Study|1 missed, 1 dropped|47
3044799|NCT01190813|3764762|FG000|7-week Phone Call|Overall Study|3 missed, 0 dropped|85
3044800|NCT01190813|3764763|FG001|7-week Phone Call|Overall Study|2 missed, 0 dropped|46
3044801|NCT01190813|3764762|FG000|10-week Visit|Overall Study|0 missed, 0 dropped|88
3044802|NCT01190813|3764763|FG001|10-week Visit|Overall Study|0 dropped, 0 missed|48
3044803|NCT01190813|3764762|FG000|13-week Phone Call|Overall Study|6 missed, 0 dropped|82
3044804|NCT01190813|3764763|FG001|13-week Phone Call|Overall Study|0 dropped, 0 missed|48
3044805|NCT01190813|3764762|FG000|16-week Visit|Overall Study|1 dropped|87
3044806|NCT01190813|3764763|FG001|16-week Visit|Overall Study|2 dropped|46
3044807|NCT01190813|3764762|FG000|18-week Visit (Masked Primary)|Overall Study|0 dropped|87
3044808|NCT01190813|3764763|FG001|18-week Visit (Masked Primary)|Overall Study|1 dropped|45
3044809|NCT01190813|3764762|FG000|23-week Phone Call|Overall Study|4 missed, 1 dropped|82
3044810|NCT01190813|3764763|FG001|23-week Phone Call|Overall Study|4 missed, 0 dropped|41
3180357|NCT01990703|3908680|FG001|STARTED|Overall Study||138
3044811|NCT01190813|3764762|FG000|26-week Visit|Overall Study|0 missed, 0 dropped|86
3044812|NCT01190813|3764763|FG001|26-week Visit|Overall Study|0 missed, 0 dropped|45
3044813|NCT01190813|3764762|FG000|COMPLETED|Overall Study||86
3044814|NCT01190813|3764763|FG001|COMPLETED|Overall Study||45
3044815|NCT01190813|3764762|FG000|NOT COMPLETED|Overall Study||4
3044816|NCT01190813|3764763|FG001|NOT COMPLETED|Overall Study||4
3044817|NCT01190839|3764771|FG000|STARTED|Overall Study||150
3044818|NCT01190839|3764772|FG001|STARTED|Overall Study||147
3044819|NCT01190839|3764771|FG000|Treated|Overall Study||148
3044820|NCT01190839|3764772|FG001|Treated|Overall Study||143
3044821|NCT01190839|3764771|FG000|COMPLETED|Overall Study||0
3044822|NCT01190839|3764772|FG001|COMPLETED|Overall Study||0
3044823|NCT01190839|3764771|FG000|NOT COMPLETED|Overall Study||150
3044824|NCT01190839|3764772|FG001|NOT COMPLETED|Overall Study||147
3044825|NCT01190865|3764780|FG000|STARTED|Overall Study||28
3044826|NCT01190865|3764780|FG000|COMPLETED|Overall Study||25
3044827|NCT01190865|3764780|FG000|NOT COMPLETED|Overall Study||3
3044828|NCT01190878|3764788|FG000|STARTED|Overall Study||40
3044829|NCT01190878|3764789|FG001|STARTED|Overall Study||45
3044830|NCT01190878|3764790|FG002|STARTED|Overall Study||42
3044831|NCT01190878|3764791|FG003|STARTED|Overall Study||42
3044832|NCT01190878|3764788|FG000|COMPLETED|Overall Study||37
3044833|NCT01190878|3764789|FG001|COMPLETED|Overall Study||42
3044834|NCT01190878|3764790|FG002|COMPLETED|Overall Study||37
3044835|NCT01190878|3764791|FG003|COMPLETED|Overall Study||22
3044836|NCT01190878|3764788|FG000|NOT COMPLETED|Overall Study||3
3044837|NCT01190878|3764789|FG001|NOT COMPLETED|Overall Study||3
3044838|NCT01190878|3764790|FG002|NOT COMPLETED|Overall Study||5
3044839|NCT01190878|3764791|FG003|NOT COMPLETED|Overall Study||20
3044840|NCT01190891|3764803|FG000|STARTED|Overall Study||52
3044841|NCT01190891|3764804|FG001|STARTED|Overall Study||52
3044842|NCT01190891|3764803|FG000|COMPLETED|Overall Study||46
3044843|NCT01190891|3764804|FG001|COMPLETED|Overall Study||52
3044844|NCT01190891|3764803|FG000|NOT COMPLETED|Overall Study||6
3044845|NCT01190891|3764804|FG001|NOT COMPLETED|Overall Study||0
3044846|NCT01190930|3764812|FG000|STARTED|Induction||9298
3044847|NCT01190930|3764813|FG001|STARTED|Induction||52
3044848|NCT01190930|3764814|FG002|STARTED|Induction||0
3044849|NCT01190930|3764815|FG003|STARTED|Induction||0
3044850|NCT01190930|3764816|FG004|STARTED|Induction||0
3044851|NCT01190930|3764817|FG005|STARTED|Induction||0
3044852|NCT01190930|3764818|FG006|STARTED|Induction||0
3044853|NCT01190930|3764819|FG007|STARTED|Induction||0
3044854|NCT01190930|3764820|FG008|STARTED|Induction||0
3044855|NCT01190930|3764821|FG009|STARTED|Induction||0
3044856|NCT01190930|3764812|FG000|COMPLETED|Induction||3949
3044857|NCT01190930|3764813|FG001|COMPLETED|Induction||43
3044858|NCT01190930|3764814|FG002|COMPLETED|Induction||0
3044859|NCT01190930|3764815|FG003|COMPLETED|Induction||0
3044860|NCT01190930|3764816|FG004|COMPLETED|Induction||0
3044861|NCT01190930|3764817|FG005|COMPLETED|Induction||0
3044862|NCT01190930|3764818|FG006|COMPLETED|Induction||0
3044863|NCT01190930|3764819|FG007|COMPLETED|Induction||0
3044864|NCT01190930|3764820|FG008|COMPLETED|Induction||0
3044865|NCT01190930|3764821|FG009|COMPLETED|Induction||0
3044866|NCT01190930|3764812|FG000|NOT COMPLETED|Induction||5349
3044867|NCT01190930|3764813|FG001|NOT COMPLETED|Induction||9
3044868|NCT01190930|3764814|FG002|NOT COMPLETED|Induction||0
3044869|NCT01190930|3764815|FG003|NOT COMPLETED|Induction||0
3044870|NCT01190930|3764816|FG004|NOT COMPLETED|Induction||0
3044871|NCT01190930|3764817|FG005|NOT COMPLETED|Induction||0
3044872|NCT01190930|3764818|FG006|NOT COMPLETED|Induction||0
3044873|NCT01190930|3764819|FG007|NOT COMPLETED|Induction||0
3044874|NCT01190930|3764820|FG008|NOT COMPLETED|Induction||0
3044875|NCT01190930|3764821|FG009|NOT COMPLETED|Induction||0
3044876|NCT01190930|3764812|FG000|STARTED|Post Induction Pre-Maintenance||0
3044877|NCT01190930|3764813|FG001|STARTED|Post Induction Pre-Maintenance||43
3044878|NCT01190930|3764814|FG002|STARTED|Post Induction Pre-Maintenance||3122
3044879|NCT01190930|3764815|FG003|STARTED|Post Induction Pre-Maintenance||224
3044880|NCT01190930|3764816|FG004|STARTED|Post Induction Pre-Maintenance||301
3044881|NCT01190930|3764817|FG005|STARTED|Post Induction Pre-Maintenance||302
3044882|NCT01190930|3764818|FG006|STARTED|Post Induction Pre-Maintenance||0
3044883|NCT01190930|3764819|FG007|STARTED|Post Induction Pre-Maintenance||0
3044884|NCT01190930|3764820|FG008|STARTED|Post Induction Pre-Maintenance||0
3044885|NCT01190930|3764821|FG009|STARTED|Post Induction Pre-Maintenance||0
3044886|NCT01190930|3764812|FG000|COMPLETED|Post Induction Pre-Maintenance||0
3044887|NCT01190930|3764813|FG001|COMPLETED|Post Induction Pre-Maintenance||37
3044888|NCT01190930|3764814|FG002|COMPLETED|Post Induction Pre-Maintenance||2364
3044889|NCT01190930|3764815|FG003|COMPLETED|Post Induction Pre-Maintenance||207
3044890|NCT01190930|3764816|FG004|COMPLETED|Post Induction Pre-Maintenance||296
3044891|NCT01190930|3764817|FG005|COMPLETED|Post Induction Pre-Maintenance||296
3044892|NCT01190930|3764818|FG006|COMPLETED|Post Induction Pre-Maintenance||0
3044893|NCT01190930|3764819|FG007|COMPLETED|Post Induction Pre-Maintenance||0
3044894|NCT01190930|3764820|FG008|COMPLETED|Post Induction Pre-Maintenance||0
3044895|NCT01190930|3764821|FG009|COMPLETED|Post Induction Pre-Maintenance||0
3044896|NCT01190930|3764812|FG000|NOT COMPLETED|Post Induction Pre-Maintenance||0
3044897|NCT01190930|3764813|FG001|NOT COMPLETED|Post Induction Pre-Maintenance||6
3044898|NCT01190930|3764814|FG002|NOT COMPLETED|Post Induction Pre-Maintenance||758
3044899|NCT01190930|3764815|FG003|NOT COMPLETED|Post Induction Pre-Maintenance||17
3044900|NCT01190930|3764816|FG004|NOT COMPLETED|Post Induction Pre-Maintenance||5
3137237|NCT01717456|3862495|FG001|NOT COMPLETED|End of Treatment||2
3044901|NCT01190930|3764817|FG005|NOT COMPLETED|Post Induction Pre-Maintenance||6
3044902|NCT01190930|3764818|FG006|NOT COMPLETED|Post Induction Pre-Maintenance||0
3044903|NCT01190930|3764819|FG007|NOT COMPLETED|Post Induction Pre-Maintenance||0
3044904|NCT01190930|3764820|FG008|NOT COMPLETED|Post Induction Pre-Maintenance||0
3044905|NCT01190930|3764821|FG009|NOT COMPLETED|Post Induction Pre-Maintenance||0
3044906|NCT01190930|3764812|FG000|STARTED|Maintenance||0
3044907|NCT01190930|3764813|FG001|STARTED|Maintenance||37
3044908|NCT01190930|3764814|FG002|STARTED|Maintenance||0
3044909|NCT01190930|3764815|FG003|STARTED|Maintenance||207
3044910|NCT01190930|3764816|FG004|STARTED|Maintenance||296
3044911|NCT01190930|3764817|FG005|STARTED|Maintenance||296
3044912|NCT01190930|3764818|FG006|STARTED|Maintenance||600
3044913|NCT01190930|3764819|FG007|STARTED|Maintenance||586
3044914|NCT01190930|3764820|FG008|STARTED|Maintenance||586
3044915|NCT01190930|3764821|FG009|STARTED|Maintenance||592
3044916|NCT01190930|3764812|FG000|COMPLETED|Maintenance||0
3044917|NCT01190930|3764813|FG001|COMPLETED|Maintenance||27
3044918|NCT01190930|3764814|FG002|COMPLETED|Maintenance||0
3044919|NCT01190930|3764815|FG003|COMPLETED|Maintenance||167
3044920|NCT01190930|3764816|FG004|COMPLETED|Maintenance||287
3044921|NCT01190930|3764817|FG005|COMPLETED|Maintenance||284
3044922|NCT01190930|3764818|FG006|COMPLETED|Maintenance||574
3044923|NCT01190930|3764819|FG007|COMPLETED|Maintenance||540
3044924|NCT01190930|3764820|FG008|COMPLETED|Maintenance||540
3044925|NCT01190930|3764821|FG009|COMPLETED|Maintenance||555
3044926|NCT01190930|3764812|FG000|NOT COMPLETED|Maintenance||0
3044927|NCT01190930|3764813|FG001|NOT COMPLETED|Maintenance||10
3044928|NCT01190930|3764814|FG002|NOT COMPLETED|Maintenance||0
3044929|NCT01190930|3764815|FG003|NOT COMPLETED|Maintenance||40
3044930|NCT01190930|3764816|FG004|NOT COMPLETED|Maintenance||9
3044931|NCT01190930|3764817|FG005|NOT COMPLETED|Maintenance||12
3044932|NCT01190930|3764818|FG006|NOT COMPLETED|Maintenance||26
3044933|NCT01190930|3764819|FG007|NOT COMPLETED|Maintenance||46
3044934|NCT01190930|3764820|FG008|NOT COMPLETED|Maintenance||46
3044935|NCT01190930|3764821|FG009|NOT COMPLETED|Maintenance||37
3137238|NCT01717456|3862494|FG000|STARTED|Follow-Up 6 Months After End of Tx||11
3137239|NCT01717456|3862495|FG001|STARTED|Follow-Up 6 Months After End of Tx||6
3137240|NCT01717456|3862494|FG000|COMPLETED|Follow-Up 6 Months After End of Tx||7
3137241|NCT01717456|3862495|FG001|COMPLETED|Follow-Up 6 Months After End of Tx||2
3137242|NCT01717456|3862494|FG000|NOT COMPLETED|Follow-Up 6 Months After End of Tx||4
3137243|NCT01717456|3862495|FG001|NOT COMPLETED|Follow-Up 6 Months After End of Tx||4
3137244|NCT01717521|3862502|FG000|STARTED|Overall Study||20
3137245|NCT01717521|3862502|FG000|COMPLETED|Overall Study||20
3137246|NCT01717521|3862502|FG000|NOT COMPLETED|Overall Study||0
3137247|NCT01717638|3862519|FG000|STARTED|Overall Study||67
3137248|NCT01717638|3862520|FG001|STARTED|Overall Study||61
3137249|NCT01717638|3862521|FG002|STARTED|Overall Study||60
3137250|NCT01717638|3862522|FG003|STARTED|Overall Study||66
3137251|NCT01717638|3862523|FG004|STARTED|Overall Study||64
3137252|NCT01717638|3862524|FG005|STARTED|Overall Study||55
3137253|NCT01717638|3862525|FG006|STARTED|Overall Study||43
3137254|NCT01717638|3862526|FG007|STARTED|Overall Study||29
3137255|NCT01717638|3862527|FG008|STARTED|Overall Study||28
3137256|NCT01717638|3862528|FG009|STARTED|Overall Study||100
3137257|NCT01717638|3862529|FG010|STARTED|Overall Study||11
3137258|NCT01717638|3862530|FG011|STARTED|Overall Study||12
3137259|NCT01717638|3862531|FG012|STARTED|Overall Study||209
3137260|NCT01717638|3862519|FG000|COMPLETED|Overall Study||67
3137261|NCT01717638|3862520|FG001|COMPLETED|Overall Study||60
3137262|NCT01717638|3862521|FG002|COMPLETED|Overall Study||59
3137263|NCT01717638|3862522|FG003|COMPLETED|Overall Study||66
3137264|NCT01717638|3862523|FG004|COMPLETED|Overall Study||63
3137265|NCT01717638|3862524|FG005|COMPLETED|Overall Study||54
3137266|NCT01717638|3862525|FG006|COMPLETED|Overall Study||41
3137267|NCT01717638|3862526|FG007|COMPLETED|Overall Study||28
3137268|NCT01717638|3862527|FG008|COMPLETED|Overall Study||26
3137269|NCT01717638|3862528|FG009|COMPLETED|Overall Study||99
3137270|NCT01717638|3862529|FG010|COMPLETED|Overall Study||11
3137271|NCT01717638|3862530|FG011|COMPLETED|Overall Study||12
3137272|NCT01717638|3862531|FG012|COMPLETED|Overall Study||190
3137273|NCT01717638|3862519|FG000|NOT COMPLETED|Overall Study||0
3137274|NCT01717638|3862520|FG001|NOT COMPLETED|Overall Study||1
3137275|NCT01717638|3862521|FG002|NOT COMPLETED|Overall Study||1
3137276|NCT01717638|3862522|FG003|NOT COMPLETED|Overall Study||0
3137277|NCT01717638|3862523|FG004|NOT COMPLETED|Overall Study||1
3137278|NCT01717638|3862524|FG005|NOT COMPLETED|Overall Study||1
3137279|NCT01717638|3862525|FG006|NOT COMPLETED|Overall Study||2
3137280|NCT01717638|3862526|FG007|NOT COMPLETED|Overall Study||1
3137281|NCT01717638|3862527|FG008|NOT COMPLETED|Overall Study||2
3137282|NCT01717638|3862528|FG009|NOT COMPLETED|Overall Study||1
3137283|NCT01717638|3862529|FG010|NOT COMPLETED|Overall Study||0
3137284|NCT01717638|3862530|FG011|NOT COMPLETED|Overall Study||0
3137285|NCT01717638|3862531|FG012|NOT COMPLETED|Overall Study||19
3137286|NCT01717742|3862567|FG000|STARTED|Overall Study||48
3137287|NCT01717742|3862568|FG001|STARTED|Overall Study||49
3137288|NCT01717742|3862567|FG000|COMPLETED|Overall Study||43
3137289|NCT01717742|3862568|FG001|COMPLETED|Overall Study||47
3137290|NCT01717742|3862567|FG000|NOT COMPLETED|Overall Study||5
3137291|NCT01717742|3862568|FG001|NOT COMPLETED|Overall Study||2
3137292|NCT01717768|3862584|FG000|STARTED|Part 1 (Duration of 15 Days)||17
3137293|NCT01717768|3862585|FG001|STARTED|Part 1 (Duration of 15 Days)||17
3044936|NCT01191008|3764845|FG000|STARTED|Overall Study||633
3044937|NCT01191008|3764845|FG000|COMPLETED|Overall Study||618
3044938|NCT01191008|3764845|FG000|NOT COMPLETED|Overall Study||15
3044939|NCT01191086|3764849|FG000|STARTED|Overall Study||210
3044940|NCT01191086|3764849|FG000|COMPLETED|Overall Study||148
3044941|NCT01191086|3764849|FG000|NOT COMPLETED|Overall Study||62
3044942|NCT01191190|3764853|FG000|STARTED|Overall Study||21
3044943|NCT01191190|3764853|FG000|COMPLETED|Overall Study||20
3044944|NCT01191190|3764853|FG000|NOT COMPLETED|Overall Study||1
3044945|NCT01191242|3764857|FG000|STARTED|Overall Study||31
3044946|NCT01191242|3764857|FG000|COMPLETED|Overall Study||31
3044947|NCT01191242|3764857|FG000|NOT COMPLETED|Overall Study||0
3137294|NCT01717768|3862586|FG002|STARTED|Part 1 (Duration of 15 Days)||0
3137295|NCT01717768|3862587|FG003|STARTED|Part 1 (Duration of 15 Days)||0
3137296|NCT01717768|3862588|FG004|STARTED|Part 1 (Duration of 15 Days)||0
3137297|NCT01717768|3862589|FG005|STARTED|Part 1 (Duration of 15 Days)||0
3137298|NCT01717768|3862590|FG006|STARTED|Part 1 (Duration of 15 Days)||0
3137299|NCT01717768|3862591|FG007|STARTED|Part 1 (Duration of 15 Days)||0
3137300|NCT01717768|3862592|FG008|STARTED|Part 1 (Duration of 15 Days)||0
3137301|NCT01717768|3862593|FG009|STARTED|Part 1 (Duration of 15 Days)||0
3137302|NCT01717768|3862594|FG010|STARTED|Part 1 (Duration of 15 Days)||0
3137303|NCT01717768|3862595|FG011|STARTED|Part 1 (Duration of 15 Days)||0
3137304|NCT01717768|3862584|FG000|COMPLETED|Part 1 (Duration of 15 Days)||17
3137305|NCT01717768|3862585|FG001|COMPLETED|Part 1 (Duration of 15 Days)||16
3137306|NCT01717768|3862586|FG002|COMPLETED|Part 1 (Duration of 15 Days)||0
3137307|NCT01717768|3862587|FG003|COMPLETED|Part 1 (Duration of 15 Days)||0
3137308|NCT01717768|3862588|FG004|COMPLETED|Part 1 (Duration of 15 Days)||0
3137309|NCT01717768|3862589|FG005|COMPLETED|Part 1 (Duration of 15 Days)||0
3137310|NCT01717768|3862590|FG006|COMPLETED|Part 1 (Duration of 15 Days)||0
3137311|NCT01717768|3862591|FG007|COMPLETED|Part 1 (Duration of 15 Days)||0
3137312|NCT01717768|3862592|FG008|COMPLETED|Part 1 (Duration of 15 Days)||0
3137313|NCT01717768|3862593|FG009|COMPLETED|Part 1 (Duration of 15 Days)||0
3137314|NCT01717768|3862594|FG010|COMPLETED|Part 1 (Duration of 15 Days)||0
3137315|NCT01717768|3862595|FG011|COMPLETED|Part 1 (Duration of 15 Days)||0
3137316|NCT01717768|3862584|FG000|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
3137317|NCT01717768|3862585|FG001|NOT COMPLETED|Part 1 (Duration of 15 Days)||1
3137318|NCT01717768|3862586|FG002|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
3137319|NCT01717768|3862587|FG003|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
3137320|NCT01717768|3862588|FG004|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
3137321|NCT01717768|3862589|FG005|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
3137322|NCT01717768|3862590|FG006|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
3137323|NCT01717768|3862591|FG007|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
3137324|NCT01717768|3862592|FG008|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
3137325|NCT01717768|3862593|FG009|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
3137326|NCT01717768|3862594|FG010|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
3137327|NCT01717768|3862595|FG011|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
3137328|NCT01717768|3862584|FG000|STARTED|Part 2 (Duration of 15 Days)||0
3137329|NCT01717768|3862585|FG001|STARTED|Part 2 (Duration of 15 Days)||0
3137330|NCT01717768|3862586|FG002|STARTED|Part 2 (Duration of 15 Days)||17
3137331|NCT01717768|3862587|FG003|STARTED|Part 2 (Duration of 15 Days)||0
3137332|NCT01717768|3862588|FG004|STARTED|Part 2 (Duration of 15 Days)||0
3137333|NCT01717768|3862589|FG005|STARTED|Part 2 (Duration of 15 Days)||0
3137334|NCT01717768|3862590|FG006|STARTED|Part 2 (Duration of 15 Days)||0
3137335|NCT01717768|3862591|FG007|STARTED|Part 2 (Duration of 15 Days)||0
3137336|NCT01717768|3862592|FG008|STARTED|Part 2 (Duration of 15 Days)||0
3137337|NCT01717768|3862593|FG009|STARTED|Part 2 (Duration of 15 Days)||0
3137338|NCT01717768|3862594|FG010|STARTED|Part 2 (Duration of 15 Days)||0
3137339|NCT01717768|3862595|FG011|STARTED|Part 2 (Duration of 15 Days)||0
3137340|NCT01717768|3862584|FG000|COMPLETED|Part 2 (Duration of 15 Days)||0
3137341|NCT01717768|3862585|FG001|COMPLETED|Part 2 (Duration of 15 Days)||0
3137342|NCT01717768|3862586|FG002|COMPLETED|Part 2 (Duration of 15 Days)||17
3137343|NCT01717768|3862587|FG003|COMPLETED|Part 2 (Duration of 15 Days)||0
3137344|NCT01717768|3862588|FG004|COMPLETED|Part 2 (Duration of 15 Days)||0
3137345|NCT01717768|3862589|FG005|COMPLETED|Part 2 (Duration of 15 Days)||0
3137346|NCT01717768|3862590|FG006|COMPLETED|Part 2 (Duration of 15 Days)||0
3137347|NCT01717768|3862591|FG007|COMPLETED|Part 2 (Duration of 15 Days)||0
3137348|NCT01717768|3862592|FG008|COMPLETED|Part 2 (Duration of 15 Days)||0
3137349|NCT01717768|3862593|FG009|COMPLETED|Part 2 (Duration of 15 Days)||0
3137350|NCT01717768|3862594|FG010|COMPLETED|Part 2 (Duration of 15 Days)||0
3137351|NCT01717768|3862595|FG011|COMPLETED|Part 2 (Duration of 15 Days)||0
3137352|NCT01717768|3862584|FG000|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
3137353|NCT01717768|3862585|FG001|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
3137354|NCT01717768|3862586|FG002|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
3137355|NCT01717768|3862587|FG003|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
3137356|NCT01717768|3862588|FG004|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
3137357|NCT01717768|3862589|FG005|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
3137358|NCT01717768|3862590|FG006|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
3137359|NCT01717768|3862591|FG007|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
3137360|NCT01717768|3862592|FG008|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
3137361|NCT01717768|3862593|FG009|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
3044948|NCT01191255|3764865|FG000|STARTED|Safety Assessment Period|3 subjects were assigned to receive KRX-0502 but didn't receive a single dose|149
3044949|NCT01191255|3764866|FG001|STARTED|Safety Assessment Period||292
3044950|NCT01191255|3764867|FG002|STARTED|Safety Assessment Period||0
3044951|NCT01191255|3764868|FG003|STARTED|Safety Assessment Period||0
3044952|NCT01191255|3764865|FG000|Safety Population|Safety Assessment Period||149
3044953|NCT01191255|3764866|FG001|Safety Population|Safety Assessment Period||289
3044954|NCT01191255|3764867|FG002|Safety Population|Safety Assessment Period||0
3044955|NCT01191255|3764868|FG003|Safety Population|Safety Assessment Period||0
3044956|NCT01191255|3764865|FG000|COMPLETED|Safety Assessment Period||111
3044957|NCT01191255|3764866|FG001|COMPLETED|Safety Assessment Period||193
3044958|NCT01191255|3764867|FG002|COMPLETED|Safety Assessment Period||0
3044959|NCT01191255|3764868|FG003|COMPLETED|Safety Assessment Period||0
3044960|NCT01191255|3764865|FG000|NOT COMPLETED|Safety Assessment Period||38
3044961|NCT01191255|3764866|FG001|NOT COMPLETED|Safety Assessment Period||99
3044962|NCT01191255|3764867|FG002|NOT COMPLETED|Safety Assessment Period||0
3044963|NCT01191255|3764868|FG003|NOT COMPLETED|Safety Assessment Period||0
3044964|NCT01191255|3764865|FG000|STARTED|Efficacy Assessment Period||0
3044965|NCT01191255|3764866|FG001|STARTED|Efficacy Assessment Period||0
3044966|NCT01191255|3764867|FG002|STARTED|Efficacy Assessment Period||96
3044967|NCT01191255|3764868|FG003|STARTED|Efficacy Assessment Period||96
3044968|NCT01191255|3764865|FG000|COMPLETED|Efficacy Assessment Period||0
3044969|NCT01191255|3764866|FG001|COMPLETED|Efficacy Assessment Period||0
3137362|NCT01717768|3862594|FG010|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
3137363|NCT01717768|3862595|FG011|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
3137364|NCT01717768|3862584|FG000|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
3137365|NCT01717768|3862585|FG001|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
3137366|NCT01717768|3862586|FG002|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
3137367|NCT01717768|3862587|FG003|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||4
3137368|NCT01717768|3862588|FG004|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||5
3137369|NCT01717768|3862589|FG005|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||5
3137370|NCT01717768|3862590|FG006|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
3137371|NCT01717768|3862591|FG007|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
3137372|NCT01717768|3862592|FG008|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
3137373|NCT01717768|3862593|FG009|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
3137374|NCT01717768|3862594|FG010|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
3137375|NCT01717768|3862595|FG011|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
3137376|NCT01717768|3862584|FG000|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
3137377|NCT01717768|3862585|FG001|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
3137378|NCT01717768|3862586|FG002|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
3137379|NCT01717768|3862587|FG003|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||4
3137380|NCT01717768|3862588|FG004|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||5
3137381|NCT01717768|3862589|FG005|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||5
3137382|NCT01717768|3862590|FG006|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
3137383|NCT01717768|3862591|FG007|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
3137384|NCT01717768|3862592|FG008|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
3137385|NCT01717768|3862593|FG009|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
3137386|NCT01717768|3862594|FG010|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
3137387|NCT01717768|3862595|FG011|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
3137388|NCT01717768|3862584|FG000|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
3137389|NCT01717768|3862585|FG001|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
3137390|NCT01717768|3862586|FG002|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
3137391|NCT01717768|3862587|FG003|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
3137392|NCT01717768|3862588|FG004|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
3137393|NCT01717768|3862589|FG005|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
3137394|NCT01717768|3862590|FG006|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
3137395|NCT01717768|3862591|FG007|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
3137396|NCT01717768|3862592|FG008|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
3137397|NCT01717768|3862593|FG009|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
3137398|NCT01717768|3862594|FG010|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
3137399|NCT01717768|3862595|FG011|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
3137400|NCT01717768|3862584|FG000|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
3137401|NCT01717768|3862585|FG001|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
3137402|NCT01717768|3862586|FG002|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
3137403|NCT01717768|3862587|FG003|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||4
3137404|NCT01717768|3862588|FG004|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||5
3137405|NCT01717768|3862589|FG005|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||5
3137406|NCT01717768|3862590|FG006|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
3137407|NCT01717768|3862591|FG007|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
3137408|NCT01717768|3862592|FG008|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
3137409|NCT01717768|3862593|FG009|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
3137410|NCT01717768|3862594|FG010|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
3137411|NCT01717768|3862595|FG011|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
3137412|NCT01717768|3862584|FG000|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
3363512|NCT04067050|4094627|FG001|STARTED|Two Month||29
3044970|NCT01191255|3764867|FG002|COMPLETED|Efficacy Assessment Period||70
3044971|NCT01191255|3764868|FG003|COMPLETED|Efficacy Assessment Period||90
3044972|NCT01191255|3764865|FG000|NOT COMPLETED|Efficacy Assessment Period||0
3044973|NCT01191255|3764866|FG001|NOT COMPLETED|Efficacy Assessment Period||0
3044974|NCT01191255|3764867|FG002|NOT COMPLETED|Efficacy Assessment Period||26
3044975|NCT01191255|3764868|FG003|NOT COMPLETED|Efficacy Assessment Period||6
3044976|NCT01191268|3764881|FG000|STARTED|Overall Study||295
3044977|NCT01191268|3764882|FG001|STARTED|Overall Study||293
3044978|NCT01191268|3764883|FG002|STARTED|Overall Study||296
3044979|NCT01191268|3764881|FG000|Received at Least One Dose of Study Drug|Overall Study||295
3044980|NCT01191268|3764882|FG001|Received at Least One Dose of Study Drug|Overall Study||293
3044981|NCT01191268|3764883|FG002|Received at Least One Dose of Study Drug|Overall Study||296
3044982|NCT01191268|3764881|FG000|COMPLETED|Overall Study||237
3044983|NCT01191268|3764882|FG001|COMPLETED|Overall Study||238
3044984|NCT01191268|3764883|FG002|COMPLETED|Overall Study||244
3044985|NCT01191268|3764881|FG000|NOT COMPLETED|Overall Study||58
3044986|NCT01191268|3764882|FG001|NOT COMPLETED|Overall Study||55
3044987|NCT01191268|3764883|FG002|NOT COMPLETED|Overall Study||52
3044988|NCT01191320|3764895|FG000|STARTED|Overall Study||43
3044989|NCT01191320|3764896|FG001|STARTED|Overall Study||38
3044990|NCT01191320|3764897|FG002|STARTED|Overall Study||38
3044991|NCT01191320|3764895|FG000|COMPLETED|Overall Study||36
3044992|NCT01191320|3764896|FG001|COMPLETED|Overall Study||32
3044993|NCT01191320|3764897|FG002|COMPLETED|Overall Study||31
3044994|NCT01191320|3764895|FG000|NOT COMPLETED|Overall Study||7
3044995|NCT01191320|3764896|FG001|NOT COMPLETED|Overall Study||6
3044996|NCT01191320|3764897|FG002|NOT COMPLETED|Overall Study||7
3044997|NCT01191333|3764907|FG000|STARTED|Overall Study||81
3044998|NCT01191333|3764908|FG001|STARTED|Overall Study||83
3044999|NCT01191333|3764907|FG000|COMPLETED|Overall Study||60
3045000|NCT01191333|3764908|FG001|COMPLETED|Overall Study||65
3045001|NCT01191333|3764907|FG000|NOT COMPLETED|Overall Study||21
3045002|NCT01191333|3764908|FG001|NOT COMPLETED|Overall Study||18
3045003|NCT01191398|3764917|FG000|STARTED|Overall Study||17
3045004|NCT01191398|3764918|FG001|STARTED|Overall Study||17
3045005|NCT01191398|3764919|FG002|STARTED|Overall Study||18
3045006|NCT01191398|3764917|FG000|COMPLETED|Overall Study||17
3045007|NCT01191398|3764918|FG001|COMPLETED|Overall Study||17
3045008|NCT01191398|3764919|FG002|COMPLETED|Overall Study||18
3045009|NCT01191398|3764917|FG000|NOT COMPLETED|Overall Study||0
3045010|NCT01191398|3764918|FG001|NOT COMPLETED|Overall Study||0
3045011|NCT01191398|3764919|FG002|NOT COMPLETED|Overall Study||0
3045012|NCT01191411|3764930|FG000|STARTED|Overall Study||1593
3045013|NCT01191411|3764931|FG001|STARTED|Overall Study||479
3045014|NCT01191411|3764932|FG002|STARTED|Overall Study||3898
3045015|NCT01191411|3764930|FG000|COMPLETED|Overall Study||648
3045016|NCT01191411|3764931|FG001|COMPLETED|Overall Study||118
3045017|NCT01191411|3764932|FG002|COMPLETED|Overall Study||471
3045018|NCT01191411|3764930|FG000|NOT COMPLETED|Overall Study||945
3045019|NCT01191411|3764931|FG001|NOT COMPLETED|Overall Study||361
3045020|NCT01191411|3764932|FG002|NOT COMPLETED|Overall Study||3427
3045021|NCT01191476|3764943|FG000|STARTED|Overall Study||112
3045022|NCT01191476|3764944|FG001|STARTED|Overall Study|Data was not collected for 1 subject for baseline characteristics or the full analysis set.|111
3045023|NCT01191476|3764945|FG002|STARTED|Overall Study|Data was not collected for 1 subject for baseline characteristics or the full analysis set.|111
3045024|NCT01191476|3764943|FG000|COMPLETED|Overall Study||109
3045025|NCT01191476|3764944|FG001|COMPLETED|Overall Study||107
3045026|NCT01191476|3764945|FG002|COMPLETED|Overall Study||111
3045027|NCT01191476|3764943|FG000|NOT COMPLETED|Overall Study||3
3045028|NCT01191476|3764944|FG001|NOT COMPLETED|Overall Study||4
3045029|NCT01191476|3764945|FG002|NOT COMPLETED|Overall Study||0
3045030|NCT01191541|3764957|FG000|STARTED|All the Patients||30
3045031|NCT01191541|3764958|FG001|STARTED|All the Patients||35
3045032|NCT01191541|3764957|FG000|COMPLETED|All the Patients||30
3045033|NCT01191541|3764958|FG001|COMPLETED|All the Patients||35
3045034|NCT01191541|3764957|FG000|NOT COMPLETED|All the Patients||0
3045035|NCT01191541|3764958|FG001|NOT COMPLETED|All the Patients||0
3045036|NCT01191541|3764957|FG000|STARTED|the Randomized Patients||30
3045037|NCT01191541|3764958|FG001|STARTED|the Randomized Patients||35
3045038|NCT01191541|3764957|FG000|COMPLETED|the Randomized Patients||30
3045039|NCT01191541|3764958|FG001|COMPLETED|the Randomized Patients||35
3045040|NCT01191541|3764957|FG000|NOT COMPLETED|the Randomized Patients||0
3045041|NCT01191541|3764958|FG001|NOT COMPLETED|the Randomized Patients||0
3045042|NCT01191723|3764974|FG000|STARTED|Overall Study||9
3045043|NCT01191723|3764975|FG001|STARTED|Overall Study||9
3045044|NCT01191723|3764976|FG002|STARTED|Overall Study||9
3045045|NCT01191723|3764977|FG003|STARTED|Overall Study||9
3045046|NCT01191723|3764978|FG004|STARTED|Overall Study||9
3045047|NCT01191723|3764979|FG005|STARTED|Overall Study||9
3045048|NCT01191723|3764974|FG000|COMPLETED|Overall Study||9
3045049|NCT01191723|3764975|FG001|COMPLETED|Overall Study||9
3045050|NCT01191723|3764976|FG002|COMPLETED|Overall Study||9
3045051|NCT01191723|3764977|FG003|COMPLETED|Overall Study||9
3045052|NCT01191723|3764978|FG004|COMPLETED|Overall Study||9
3045053|NCT01191723|3764979|FG005|COMPLETED|Overall Study||9
3045054|NCT01191723|3764974|FG000|NOT COMPLETED|Overall Study||0
3045055|NCT01191723|3764975|FG001|NOT COMPLETED|Overall Study||0
3045056|NCT01191723|3764976|FG002|NOT COMPLETED|Overall Study||0
3045057|NCT01191723|3764977|FG003|NOT COMPLETED|Overall Study||0
3045058|NCT01191723|3764978|FG004|NOT COMPLETED|Overall Study||0
3045059|NCT01191723|3764979|FG005|NOT COMPLETED|Overall Study||0
3045060|NCT01191736|3764995|FG000|STARTED|Overall Study||51
3045061|NCT01191736|3764996|FG001|STARTED|Overall Study||47
3045062|NCT01191736|3764997|FG002|STARTED|Overall Study||49
3045063|NCT01191736|3764998|FG003|STARTED|Overall Study||46
3045064|NCT01191736|3764999|FG004|STARTED|Overall Study||48
3045065|NCT01191736|3765000|FG005|STARTED|Overall Study||50
3045066|NCT01191736|3765001|FG006|STARTED|Overall Study||45
3045067|NCT01191736|3764995|FG000|COMPLETED|Overall Study||51
3045068|NCT01191736|3764996|FG001|COMPLETED|Overall Study||47
3045069|NCT01191736|3764997|FG002|COMPLETED|Overall Study||49
3045070|NCT01191736|3764998|FG003|COMPLETED|Overall Study||46
3045071|NCT01191736|3764999|FG004|COMPLETED|Overall Study||48
3045072|NCT01191736|3765000|FG005|COMPLETED|Overall Study||50
3045073|NCT01191736|3765001|FG006|COMPLETED|Overall Study||45
3045074|NCT01191736|3764995|FG000|NOT COMPLETED|Overall Study||0
3045075|NCT01191736|3764996|FG001|NOT COMPLETED|Overall Study||0
3045076|NCT01191736|3764997|FG002|NOT COMPLETED|Overall Study||0
3045077|NCT01191736|3764998|FG003|NOT COMPLETED|Overall Study||0
3045078|NCT01191736|3764999|FG004|NOT COMPLETED|Overall Study||0
3045079|NCT01191736|3765000|FG005|NOT COMPLETED|Overall Study||0
3180358|NCT01990703|3908679|FG000|COMPLETED|Overall Study||108
3180359|NCT01990703|3908680|FG001|COMPLETED|Overall Study||93
3180360|NCT01990703|3908679|FG000|NOT COMPLETED|Overall Study||39
3180361|NCT01990703|3908680|FG001|NOT COMPLETED|Overall Study||45
3180362|NCT01990742|3908688|FG000|STARTED|Overall Study|This is a facility-level intervention, access to individual level records occurred via MDS data only|3259
3180363|NCT01990742|3908689|FG001|STARTED|Overall Study|This is a facility-level control , access to individual participants occurred only via MDS records.|4331
3180364|NCT01990742|3908688|FG000|COMPLETED|Overall Study|Fourteen facilities completed the intervention.|2852
3180365|NCT01990742|3908689|FG001|COMPLETED|Overall Study|Eleven nursing homes completed the control group /usual care allocation.|2978
3045080|NCT01191736|3765001|FG006|NOT COMPLETED|Overall Study||0
3045081|NCT01191749|3765017|FG000|STARTED|Overall Study||7
3045082|NCT01191749|3765017|FG000|COMPLETED|Overall Study||7
3045083|NCT01191749|3765017|FG000|NOT COMPLETED|Overall Study||0
3045084|NCT01191762|3765023|FG000|STARTED|Overall Study||15
3045085|NCT01191762|3765024|FG001|STARTED|Overall Study||15
3045086|NCT01191762|3765023|FG000|COMPLETED|Overall Study|One subject dropped out on the 3rd treatment day because of gastrointestinal complaints.|14
3045087|NCT01191762|3765024|FG001|COMPLETED|Overall Study||15
3045088|NCT01191762|3765023|FG000|NOT COMPLETED|Overall Study||1
3045089|NCT01191762|3765024|FG001|NOT COMPLETED|Overall Study||0
3045090|NCT01191788|3765032|FG000|STARTED|Overall Study||140
3045091|NCT01191788|3765033|FG001|STARTED|Overall Study||159
3045092|NCT01191788|3765032|FG000|COMPLETED|Overall Study|Completed 3-month followup|119
3045093|NCT01191788|3765033|FG001|COMPLETED|Overall Study|Completed 3-month followup|137
3045094|NCT01191788|3765032|FG000|NOT COMPLETED|Overall Study||21
3045095|NCT01191788|3765033|FG001|NOT COMPLETED|Overall Study||22
3045096|NCT01191801|3765042|FG000|STARTED|Overall Study||356
3045097|NCT01191801|3765043|FG001|STARTED|Overall Study||355
3045098|NCT01191801|3765042|FG000|COMPLETED|Overall Study||40
3045099|NCT01191801|3765043|FG001|COMPLETED|Overall Study||18
3045100|NCT01191801|3765042|FG000|NOT COMPLETED|Overall Study||316
3045101|NCT01191801|3765043|FG001|NOT COMPLETED|Overall Study||337
3045102|NCT01191827|3765051|FG000|STARTED|Overall Study||20
3045103|NCT01191827|3765052|FG001|STARTED|Overall Study||20
3045104|NCT01191827|3765051|FG000|COMPLETED|Overall Study||20
3045105|NCT01191827|3765052|FG001|COMPLETED|Overall Study||20
3045106|NCT01191827|3765051|FG000|NOT COMPLETED|Overall Study||0
3045107|NCT01191827|3765052|FG001|NOT COMPLETED|Overall Study||0
3045108|NCT01191840|3765060|FG000|STARTED|Overall Study||254
3045109|NCT01191840|3765061|FG001|STARTED|Overall Study||255
3045110|NCT01191840|3765060|FG000|COMPLETED|Overall Study||240
3045111|NCT01191840|3765061|FG001|COMPLETED|Overall Study||240
3045112|NCT01191840|3765060|FG000|NOT COMPLETED|Overall Study||14
3045113|NCT01191840|3765061|FG001|NOT COMPLETED|Overall Study||15
3045114|NCT01191944|3765069|FG000|STARTED|Overall Study|Treated titration/maintenance|234
3045115|NCT01191944|3765070|FG001|STARTED|Overall Study|Treated titration/maintenance|239
3045116|NCT01191944|3765069|FG000|COMPLETED|Overall Study|Completed titration/maintenance|217
3045117|NCT01191944|3765070|FG001|COMPLETED|Overall Study|Completed titration/maintenance|220
3045118|NCT01191944|3765069|FG000|NOT COMPLETED|Overall Study||17
3045119|NCT01191944|3765070|FG001|NOT COMPLETED|Overall Study||19
3045120|NCT01192022|3765080|FG000|STARTED|Overall Study||114
3045121|NCT01192022|3765081|FG001|STARTED|Overall Study||110
3045122|NCT01192022|3765082|FG002|STARTED|Overall Study||8
3045123|NCT01192022|3765083|FG003|STARTED|Overall Study||9
3045124|NCT01192022|3765084|FG004|STARTED|Overall Study||12
3045125|NCT01192022|3765080|FG000|Safety Population-Received Treatment|Overall Study||114
3045126|NCT01192022|3765081|FG001|Safety Population-Received Treatment|Overall Study||109
3045127|NCT01192022|3765082|FG002|Safety Population-Received Treatment|Overall Study||8
3045128|NCT01192022|3765083|FG003|Safety Population-Received Treatment|Overall Study||9
3045129|NCT01192022|3765084|FG004|Safety Population-Received Treatment|Overall Study||12
3045130|NCT01192022|3765080|FG000|COMPLETED|Overall Study||101
3045131|NCT01192022|3765081|FG001|COMPLETED|Overall Study||99
3045132|NCT01192022|3765082|FG002|COMPLETED|Overall Study||7
3045133|NCT01192022|3765083|FG003|COMPLETED|Overall Study||7
3045134|NCT01192022|3765084|FG004|COMPLETED|Overall Study||11
3045135|NCT01192022|3765080|FG000|NOT COMPLETED|Overall Study||13
3045136|NCT01192022|3765081|FG001|NOT COMPLETED|Overall Study||11
3045137|NCT01192022|3765082|FG002|NOT COMPLETED|Overall Study||1
3045138|NCT01192022|3765083|FG003|NOT COMPLETED|Overall Study||2
3045139|NCT01192022|3765084|FG004|NOT COMPLETED|Overall Study||1
3045140|NCT01192100|3765095|FG000|STARTED|Overall Study||6
3045141|NCT01192100|3765096|FG001|STARTED|Overall Study||4
3045142|NCT01192100|3765097|FG002|STARTED|Overall Study||3
3045143|NCT01192100|3765098|FG003|STARTED|Overall Study||4
3045144|NCT01192100|3765099|FG004|STARTED|Overall Study||3
3045145|NCT01192100|3765100|FG005|STARTED|Overall Study||2
3045146|NCT01192100|3765095|FG000|Began 1st Intervention Week|Overall Study||6
3045147|NCT01192100|3765096|FG001|Began 1st Intervention Week|Overall Study||4
3045148|NCT01192100|3765097|FG002|Began 1st Intervention Week|Overall Study||3
3045149|NCT01192100|3765098|FG003|Began 1st Intervention Week|Overall Study||4
3045150|NCT01192100|3765099|FG004|Began 1st Intervention Week|Overall Study||3
3045151|NCT01192100|3765100|FG005|Began 1st Intervention Week|Overall Study||2
3045152|NCT01192100|3765095|FG000|Began 2nd Intervention Week|Overall Study||6
3045153|NCT01192100|3765096|FG001|Began 2nd Intervention Week|Overall Study||4
3045154|NCT01192100|3765097|FG002|Began 2nd Intervention Week|Overall Study||3
3045155|NCT01192100|3765098|FG003|Began 2nd Intervention Week|Overall Study||3
3045156|NCT01192100|3765099|FG004|Began 2nd Intervention Week|Overall Study||2
3045157|NCT01192100|3765100|FG005|Began 2nd Intervention Week|Overall Study||2
3045158|NCT01192100|3765095|FG000|Began 3rd Intervention Week|Overall Study||6
3045159|NCT01192100|3765096|FG001|Began 3rd Intervention Week|Overall Study||4
3045160|NCT01192100|3765097|FG002|Began 3rd Intervention Week|Overall Study||3
3045161|NCT01192100|3765098|FG003|Began 3rd Intervention Week|Overall Study||3
3045162|NCT01192100|3765099|FG004|Began 3rd Intervention Week|Overall Study||2
3045163|NCT01192100|3765100|FG005|Began 3rd Intervention Week|Overall Study||2
3045164|NCT01192100|3765095|FG000|COMPLETED|Overall Study||6
3045165|NCT01192100|3765096|FG001|COMPLETED|Overall Study||4
3045166|NCT01192100|3765097|FG002|COMPLETED|Overall Study||3
3045167|NCT01192100|3765098|FG003|COMPLETED|Overall Study||3
3045168|NCT01192100|3765099|FG004|COMPLETED|Overall Study||2
3045169|NCT01192100|3765100|FG005|COMPLETED|Overall Study||2
3045170|NCT01192100|3765095|FG000|NOT COMPLETED|Overall Study||0
3045171|NCT01192100|3765096|FG001|NOT COMPLETED|Overall Study||0
3045172|NCT01192100|3765097|FG002|NOT COMPLETED|Overall Study||0
3045173|NCT01192100|3765098|FG003|NOT COMPLETED|Overall Study||1
3045174|NCT01192100|3765099|FG004|NOT COMPLETED|Overall Study||1
3045175|NCT01192100|3765100|FG005|NOT COMPLETED|Overall Study||0
3045176|NCT01192126|3765110|FG000|STARTED|First Intervention (1 Week)||51
3045177|NCT01192126|3765111|FG001|STARTED|First Intervention (1 Week)||51
3045178|NCT01192126|3765110|FG000|COMPLETED|First Intervention (1 Week)||49
3045179|NCT01192126|3765111|FG001|COMPLETED|First Intervention (1 Week)||50
3045180|NCT01192126|3765110|FG000|NOT COMPLETED|First Intervention (1 Week)||2
3045181|NCT01192126|3765111|FG001|NOT COMPLETED|First Intervention (1 Week)||1
3045182|NCT01192126|3765110|FG000|STARTED|Second Intervention (1 Week)||49
3045183|NCT01192126|3765111|FG001|STARTED|Second Intervention (1 Week)||50
3045184|NCT01192126|3765110|FG000|COMPLETED|Second Intervention (1 Week)||49
3045185|NCT01192126|3765111|FG001|COMPLETED|Second Intervention (1 Week)||50
3045186|NCT01192126|3765110|FG000|NOT COMPLETED|Second Intervention (1 Week)||0
3045187|NCT01192126|3765111|FG001|NOT COMPLETED|Second Intervention (1 Week)||0
3045188|NCT01192139|3765117|FG000|STARTED|Period 1||5
3045189|NCT01192139|3765118|FG001|STARTED|Period 1||5
3045190|NCT01192139|3765119|FG002|STARTED|Period 1||5
3045191|NCT01192139|3765120|FG003|STARTED|Period 1||5
3045192|NCT01192139|3765121|FG004|STARTED|Period 1||5
3045193|NCT01192139|3765122|FG005|STARTED|Period 1||5
3045194|NCT01192139|3765117|FG000|COMPLETED|Period 1||5
3045195|NCT01192139|3765118|FG001|COMPLETED|Period 1||5
3045196|NCT01192139|3765119|FG002|COMPLETED|Period 1||5
3045197|NCT01192139|3765120|FG003|COMPLETED|Period 1||5
3045198|NCT01192139|3765121|FG004|COMPLETED|Period 1||5
3045199|NCT01192139|3765122|FG005|COMPLETED|Period 1||5
3045200|NCT01192139|3765117|FG000|NOT COMPLETED|Period 1||0
3045201|NCT01192139|3765118|FG001|NOT COMPLETED|Period 1||0
3045202|NCT01192139|3765119|FG002|NOT COMPLETED|Period 1||0
3045203|NCT01192139|3765120|FG003|NOT COMPLETED|Period 1||0
3045204|NCT01192139|3765121|FG004|NOT COMPLETED|Period 1||0
3045205|NCT01192139|3765122|FG005|NOT COMPLETED|Period 1||0
3045206|NCT01192139|3765117|FG000|STARTED|Period 2||5
3045207|NCT01192139|3765118|FG001|STARTED|Period 2||5
3045208|NCT01192139|3765119|FG002|STARTED|Period 2||5
3045209|NCT01192139|3765120|FG003|STARTED|Period 2||5
3045210|NCT01192139|3765121|FG004|STARTED|Period 2||5
3045211|NCT01192139|3765122|FG005|STARTED|Period 2||5
3045212|NCT01192139|3765117|FG000|COMPLETED|Period 2||5
3045213|NCT01192139|3765118|FG001|COMPLETED|Period 2||5
3045214|NCT01192139|3765119|FG002|COMPLETED|Period 2||5
3045215|NCT01192139|3765120|FG003|COMPLETED|Period 2||5
3045216|NCT01192139|3765121|FG004|COMPLETED|Period 2||5
3045217|NCT01192139|3765122|FG005|COMPLETED|Period 2||5
3045218|NCT01192139|3765117|FG000|NOT COMPLETED|Period 2||0
3045219|NCT01192139|3765118|FG001|NOT COMPLETED|Period 2||0
3045220|NCT01192139|3765119|FG002|NOT COMPLETED|Period 2||0
3045221|NCT01192139|3765120|FG003|NOT COMPLETED|Period 2||0
3045222|NCT01192139|3765121|FG004|NOT COMPLETED|Period 2||0
3045223|NCT01192139|3765122|FG005|NOT COMPLETED|Period 2||0
3045224|NCT01192139|3765117|FG000|STARTED|Period 3||5
3045225|NCT01192139|3765118|FG001|STARTED|Period 3||5
3045226|NCT01192139|3765119|FG002|STARTED|Period 3||5
3045227|NCT01192139|3765120|FG003|STARTED|Period 3||5
3045228|NCT01192139|3765121|FG004|STARTED|Period 3||5
3045229|NCT01192139|3765122|FG005|STARTED|Period 3||5
3045230|NCT01192139|3765117|FG000|COMPLETED|Period 3||5
3045231|NCT01192139|3765118|FG001|COMPLETED|Period 3||5
3045232|NCT01192139|3765119|FG002|COMPLETED|Period 3||5
3045233|NCT01192139|3765120|FG003|COMPLETED|Period 3||5
3045234|NCT01192139|3765121|FG004|COMPLETED|Period 3||5
3045235|NCT01192139|3765122|FG005|COMPLETED|Period 3||5
3045236|NCT01192139|3765117|FG000|NOT COMPLETED|Period 3||0
3045237|NCT01192139|3765118|FG001|NOT COMPLETED|Period 3||0
3045238|NCT01192139|3765119|FG002|NOT COMPLETED|Period 3||0
3045239|NCT01192139|3765120|FG003|NOT COMPLETED|Period 3||0
3045240|NCT01192139|3765121|FG004|NOT COMPLETED|Period 3||0
3045241|NCT01192139|3765122|FG005|NOT COMPLETED|Period 3||0
3045242|NCT01192152|3765130|FG000|STARTED|Period 1||15
3045243|NCT01192152|3765131|FG001|STARTED|Period 1||15
3045244|NCT01192152|3765130|FG000|COMPLETED|Period 1||15
3045245|NCT01192152|3765131|FG001|COMPLETED|Period 1||14
3045246|NCT01192152|3765130|FG000|NOT COMPLETED|Period 1||0
3045247|NCT01192152|3765131|FG001|NOT COMPLETED|Period 1||1
3045248|NCT01192152|3765130|FG000|STARTED|Period 2||15
3045249|NCT01192152|3765131|FG001|STARTED|Period 2||14
3045250|NCT01192152|3765130|FG000|COMPLETED|Period 2||15
3045251|NCT01192152|3765131|FG001|COMPLETED|Period 2||14
3045252|NCT01192152|3765130|FG000|NOT COMPLETED|Period 2||0
3045253|NCT01192152|3765131|FG001|NOT COMPLETED|Period 2||0
3045254|NCT01192152|3765130|FG000|STARTED|Period 3||15
3180366|NCT01990742|3908688|FG000|NOT COMPLETED|Overall Study||407
3180367|NCT01990742|3908689|FG001|NOT COMPLETED|Overall Study||1353
3180368|NCT01990768|3908698|FG000|STARTED|Intervention Started||345
3180369|NCT01990768|3908699|FG001|STARTED|Intervention Started||345
3180370|NCT01990768|3908700|FG002|STARTED|Intervention Started||373
3180371|NCT01990768|3908698|FG000|COMPLETED|Intervention Started||309
3045255|NCT01192152|3765131|FG001|STARTED|Period 3||0
3045256|NCT01192152|3765130|FG000|COMPLETED|Period 3||14
3045257|NCT01192152|3765131|FG001|COMPLETED|Period 3||0
3045258|NCT01192152|3765130|FG000|NOT COMPLETED|Period 3||1
3045259|NCT01192152|3765131|FG001|NOT COMPLETED|Period 3||0
3045260|NCT01192178|3765141|FG000|STARTED|Overall Study||171
3180372|NCT01990768|3908699|FG001|COMPLETED|Intervention Started||312
3180373|NCT01990768|3908700|FG002|COMPLETED|Intervention Started||346
3180374|NCT01990768|3908698|FG000|NOT COMPLETED|Intervention Started||36
3180375|NCT01990768|3908699|FG001|NOT COMPLETED|Intervention Started||33
3180376|NCT01990768|3908700|FG002|NOT COMPLETED|Intervention Started||27
3180377|NCT01990768|3908698|FG000|STARTED|Prehospital Study Drug Infusion||309
3180378|NCT01990768|3908699|FG001|STARTED|Prehospital Study Drug Infusion||312
3180379|NCT01990768|3908700|FG002|STARTED|Prehospital Study Drug Infusion||346
3180380|NCT01990768|3908698|FG000|COMPLETED|Prehospital Study Drug Infusion||290
3180381|NCT01990768|3908699|FG001|COMPLETED|Prehospital Study Drug Infusion||285
3180382|NCT01990768|3908700|FG002|COMPLETED|Prehospital Study Drug Infusion||327
3180383|NCT01990768|3908698|FG000|NOT COMPLETED|Prehospital Study Drug Infusion||19
3045261|NCT01192178|3765142|FG001|STARTED|Overall Study||168
3045262|NCT01192178|3765141|FG000|COMPLETED|Overall Study||147
3045263|NCT01192178|3765142|FG001|COMPLETED|Overall Study||145
3045264|NCT01192178|3765141|FG000|NOT COMPLETED|Overall Study||24
3045265|NCT01192178|3765142|FG001|NOT COMPLETED|Overall Study||23
3045266|NCT01192191|3765152|FG000|STARTED|Overall Study||60
3045267|NCT01192191|3765153|FG001|STARTED|Overall Study||127
3045268|NCT01192191|3765152|FG000|COMPLETED|Overall Study||49
3045269|NCT01192191|3765153|FG001|COMPLETED|Overall Study||106
3045270|NCT01192191|3765152|FG000|NOT COMPLETED|Overall Study||11
3045271|NCT01192191|3765153|FG001|NOT COMPLETED|Overall Study||21
3045272|NCT01192204|3765161|FG000|STARTED|Overall Study||23
3045273|NCT01192204|3765162|FG001|STARTED|Overall Study||18
3045274|NCT01192204|3765161|FG000|COMPLETED|Overall Study||22
3045275|NCT01192204|3765162|FG001|COMPLETED|Overall Study||18
3045276|NCT01192204|3765161|FG000|NOT COMPLETED|Overall Study||1
3045277|NCT01192204|3765162|FG001|NOT COMPLETED|Overall Study||0
3045278|NCT01192282|3765172|FG000|STARTED|Overall Study||156
3045279|NCT01192282|3765172|FG000|COMPLETED|Overall Study||156
3045280|NCT01192282|3765172|FG000|NOT COMPLETED|Overall Study||0
3045281|NCT01192295|3765187|FG000|STARTED|Overall Study||27
3045282|NCT01192295|3765188|FG001|STARTED|Overall Study||128
3045283|NCT01192295|3765187|FG000|COMPLETED|Overall Study||17
3045284|NCT01192295|3765188|FG001|COMPLETED|Overall Study||105
3045285|NCT01192295|3765187|FG000|NOT COMPLETED|Overall Study||10
3045286|NCT01192295|3765188|FG001|NOT COMPLETED|Overall Study||23
3045287|NCT01192347|3765196|FG000|STARTED|Overall Study||175
3045288|NCT01192347|3765196|FG000|COMPLETED|Overall Study||163
3045289|NCT01192347|3765196|FG000|NOT COMPLETED|Overall Study||12
3045290|NCT01192399|3765200|FG000|STARTED|Overall Study||29
3045291|NCT01192399|3765200|FG000|COMPLETED|Overall Study||27
3045292|NCT01192399|3765200|FG000|NOT COMPLETED|Overall Study||2
3045293|NCT01192412|3765206|FG000|STARTED|Overall Study||497
3045294|NCT01192412|3765207|FG001|STARTED|Overall Study||490
3045295|NCT01192412|3765206|FG000|COMPLETED|Overall Study||493
3045296|NCT01192412|3765207|FG001|COMPLETED|Overall Study||488
3045297|NCT01192412|3765206|FG000|NOT COMPLETED|Overall Study||4
3045298|NCT01192412|3765207|FG001|NOT COMPLETED|Overall Study||2
3045299|NCT01192516|3765216|FG000|STARTED|Overall Study|Indicates number of people initially randomized to group|66
3045300|NCT01192516|3765217|FG001|STARTED|Overall Study|Indicates number of people initially randomized to group|66
3045301|NCT01192516|3765218|FG002|STARTED|Overall Study|Indicates number of people initially randomized to group|63
3045302|NCT01192516|3765216|FG000|COMPLETED|Overall Study||46
3045303|NCT01192516|3765217|FG001|COMPLETED|Overall Study||49
3045304|NCT01192516|3765218|FG002|COMPLETED|Overall Study||55
3045305|NCT01192516|3765216|FG000|NOT COMPLETED|Overall Study||20
3045306|NCT01192516|3765217|FG001|NOT COMPLETED|Overall Study||17
3045307|NCT01192516|3765218|FG002|NOT COMPLETED|Overall Study||8
3045308|NCT01192542|3765230|FG000|STARTED|Period 1||18
3045309|NCT01192542|3765231|FG001|STARTED|Period 1||20
3045310|NCT01192542|3765230|FG000|COMPLETED|Period 1||18
3045311|NCT01192542|3765231|FG001|COMPLETED|Period 1||20
3045312|NCT01192542|3765230|FG000|NOT COMPLETED|Period 1||0
3045313|NCT01192542|3765231|FG001|NOT COMPLETED|Period 1||0
3045314|NCT01192542|3765230|FG000|STARTED|Period 2||18
3045315|NCT01192542|3765231|FG001|STARTED|Period 2||20
3045316|NCT01192542|3765230|FG000|COMPLETED|Period 2||18
3045317|NCT01192542|3765231|FG001|COMPLETED|Period 2||20
3045318|NCT01192542|3765230|FG000|NOT COMPLETED|Period 2||0
3137413|NCT01717768|3862585|FG001|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
3137414|NCT01717768|3862586|FG002|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
3137415|NCT01717768|3862587|FG003|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||4
3137416|NCT01717768|3862588|FG004|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||5
3137417|NCT01717768|3862589|FG005|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||5
3137418|NCT01717768|3862590|FG006|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
3137419|NCT01717768|3862591|FG007|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
3137420|NCT01717768|3862592|FG008|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
3137421|NCT01717768|3862593|FG009|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
3137422|NCT01717768|3862594|FG010|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
3137423|NCT01717768|3862595|FG011|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
3137424|NCT01717768|3862584|FG000|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
3137425|NCT01717768|3862585|FG001|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
3137426|NCT01717768|3862586|FG002|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
3137427|NCT01717768|3862587|FG003|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
3137428|NCT01717768|3862588|FG004|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
3137429|NCT01717768|3862589|FG005|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
3137430|NCT01717768|3862590|FG006|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
3137431|NCT01717768|3862591|FG007|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
3137432|NCT01717768|3862592|FG008|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
3137433|NCT01717768|3862593|FG009|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
3137434|NCT01717768|3862594|FG010|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
3137435|NCT01717768|3862595|FG011|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
3137436|NCT01717768|3862584|FG000|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
3137437|NCT01717768|3862585|FG001|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
3137438|NCT01717768|3862586|FG002|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
3137439|NCT01717768|3862587|FG003|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||4
3137440|NCT01717768|3862588|FG004|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||5
3137441|NCT01717768|3862589|FG005|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||5
3137442|NCT01717768|3862590|FG006|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
3137443|NCT01717768|3862591|FG007|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
3137444|NCT01717768|3862592|FG008|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
3137445|NCT01717768|3862593|FG009|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
3137446|NCT01717768|3862594|FG010|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
3137447|NCT01717768|3862595|FG011|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
3137448|NCT01717768|3862584|FG000|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
3137449|NCT01717768|3862585|FG001|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
3137450|NCT01717768|3862586|FG002|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
3137451|NCT01717768|3862587|FG003|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||4
3137452|NCT01717768|3862588|FG004|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||5
3137453|NCT01717768|3862589|FG005|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||5
3137454|NCT01717768|3862590|FG006|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
3137455|NCT01717768|3862591|FG007|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
3137456|NCT01717768|3862592|FG008|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
3137457|NCT01717768|3862593|FG009|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
3137458|NCT01717768|3862594|FG010|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
3137459|NCT01717768|3862595|FG011|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
3137460|NCT01717768|3862584|FG000|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
3137461|NCT01717768|3862585|FG001|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
3180384|NCT01990768|3908699|FG001|NOT COMPLETED|Prehospital Study Drug Infusion||27
3180385|NCT01990768|3908700|FG002|NOT COMPLETED|Prehospital Study Drug Infusion||19
3180386|NCT01990768|3908698|FG000|STARTED|In-Hospital Study Drug Infusion||309
3180387|NCT01990768|3908699|FG001|STARTED|In-Hospital Study Drug Infusion||312
3180388|NCT01990768|3908700|FG002|STARTED|In-Hospital Study Drug Infusion||346
3180389|NCT01990768|3908698|FG000|COMPLETED|In-Hospital Study Drug Infusion||214
3137462|NCT01717768|3862586|FG002|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
3180390|NCT01990768|3908699|FG001|COMPLETED|In-Hospital Study Drug Infusion||229
3045319|NCT01192542|3765231|FG001|NOT COMPLETED|Period 2||0
3045320|NCT01192698|3765241|FG000|STARTED|Overall Study||10
3045321|NCT01192698|3765242|FG001|STARTED|Overall Study||5
3045322|NCT01192698|3765241|FG000|COMPLETED|Overall Study||10
3045323|NCT01192698|3765242|FG001|COMPLETED|Overall Study||5
3045324|NCT01192698|3765241|FG000|NOT COMPLETED|Overall Study||0
3045325|NCT01192698|3765242|FG001|NOT COMPLETED|Overall Study||0
3045326|NCT01192776|3765252|FG000|STARTED|Overall Study||95
3045327|NCT01192776|3765253|FG001|STARTED|Overall Study||90
3045328|NCT01192776|3765254|FG002|STARTED|Overall Study||96
3045329|NCT01192776|3765255|FG003|STARTED|Overall Study||83
3045330|NCT01192776|3765252|FG000|Died Prior to Discharge|Overall Study||7
3045331|NCT01192776|3765253|FG001|Died Prior to Discharge|Overall Study||13
3045332|NCT01192776|3765254|FG002|Died Prior to Discharge|Overall Study||15
3045333|NCT01192776|3765255|FG003|Died Prior to Discharge|Overall Study||14
3045334|NCT01192776|3765252|FG000|Died After Discharge|Overall Study||1
3045335|NCT01192776|3765253|FG001|Died After Discharge|Overall Study||2
3045336|NCT01192776|3765254|FG002|Died After Discharge|Overall Study||3
3045337|NCT01192776|3765255|FG003|Died After Discharge|Overall Study||1
3045338|NCT01192776|3765252|FG000|COMPLETED|Overall Study||84
3045339|NCT01192776|3765253|FG001|COMPLETED|Overall Study||69
3045340|NCT01192776|3765254|FG002|COMPLETED|Overall Study||75
3045341|NCT01192776|3765255|FG003|COMPLETED|Overall Study||63
3045342|NCT01192776|3765252|FG000|NOT COMPLETED|Overall Study||11
3045343|NCT01192776|3765253|FG001|NOT COMPLETED|Overall Study||21
3045344|NCT01192776|3765254|FG002|NOT COMPLETED|Overall Study||21
3045345|NCT01192776|3765255|FG003|NOT COMPLETED|Overall Study||20
3045346|NCT01192815|3765267|FG000|STARTED|Overall Study||2
3045347|NCT01192815|3765267|FG000|COMPLETED|Overall Study||0
3045348|NCT01192815|3765267|FG000|NOT COMPLETED|Overall Study||2
3045349|NCT01192828|3765271|FG000|STARTED|Overall Study||14
3045350|NCT01192828|3765271|FG000|COMPLETED|Overall Study||14
3045351|NCT01192828|3765271|FG000|NOT COMPLETED|Overall Study||0
3045352|NCT01193010|3765279|FG000|STARTED|Overall Study||20
3045353|NCT01193010|3765280|FG001|STARTED|Overall Study||20
3045354|NCT01193010|3765279|FG000|COMPLETED|Overall Study||17
3045355|NCT01193010|3765280|FG001|COMPLETED|Overall Study||20
3045356|NCT01193010|3765279|FG000|NOT COMPLETED|Overall Study||3
3045357|NCT01193010|3765280|FG001|NOT COMPLETED|Overall Study||0
3045358|NCT01193049|3765286|FG000|STARTED|Period 1: Placebo Run-In||5
3045359|NCT01193049|3765287|FG001|STARTED|Period 1: Placebo Run-In||6
3045360|NCT01193049|3765286|FG000|COMPLETED|Period 1: Placebo Run-In||5
3045361|NCT01193049|3765287|FG001|COMPLETED|Period 1: Placebo Run-In||6
3180391|NCT01990768|3908700|FG002|COMPLETED|In-Hospital Study Drug Infusion||266
3180392|NCT01990768|3908698|FG000|NOT COMPLETED|In-Hospital Study Drug Infusion||95
3180393|NCT01990768|3908699|FG001|NOT COMPLETED|In-Hospital Study Drug Infusion||83
3180394|NCT01990768|3908700|FG002|NOT COMPLETED|In-Hospital Study Drug Infusion||80
3180395|NCT01990768|3908698|FG000|STARTED|6-Month Follow-up||309
3045362|NCT01193049|3765286|FG000|NOT COMPLETED|Period 1: Placebo Run-In||0
3045363|NCT01193049|3765287|FG001|NOT COMPLETED|Period 1: Placebo Run-In||0
3045364|NCT01193049|3765286|FG000|STARTED|Washout 1 : 21 Day Washout||5
3045365|NCT01193049|3765287|FG001|STARTED|Washout 1 : 21 Day Washout||6
3045366|NCT01193049|3765286|FG000|COMPLETED|Washout 1 : 21 Day Washout||5
3045367|NCT01193049|3765287|FG001|COMPLETED|Washout 1 : 21 Day Washout||6
3045368|NCT01193049|3765286|FG000|NOT COMPLETED|Washout 1 : 21 Day Washout||0
3045369|NCT01193049|3765287|FG001|NOT COMPLETED|Washout 1 : 21 Day Washout||0
3045370|NCT01193049|3765286|FG000|STARTED|Period 2 : Double Blind Crossover||5
3045371|NCT01193049|3765287|FG001|STARTED|Period 2 : Double Blind Crossover||6
3045372|NCT01193049|3765286|FG000|COMPLETED|Period 2 : Double Blind Crossover||5
3045373|NCT01193049|3765287|FG001|COMPLETED|Period 2 : Double Blind Crossover||6
3045374|NCT01193049|3765286|FG000|NOT COMPLETED|Period 2 : Double Blind Crossover||0
3045375|NCT01193049|3765287|FG001|NOT COMPLETED|Period 2 : Double Blind Crossover||0
3045376|NCT01193049|3765286|FG000|STARTED|Washout 2 : 21 Day Washout||5
3045377|NCT01193049|3765287|FG001|STARTED|Washout 2 : 21 Day Washout||6
3045378|NCT01193049|3765286|FG000|COMPLETED|Washout 2 : 21 Day Washout||5
3045379|NCT01193049|3765287|FG001|COMPLETED|Washout 2 : 21 Day Washout||6
3045380|NCT01193049|3765286|FG000|NOT COMPLETED|Washout 2 : 21 Day Washout||0
3045381|NCT01193049|3765287|FG001|NOT COMPLETED|Washout 2 : 21 Day Washout||0
3045382|NCT01193049|3765286|FG000|STARTED|Period 3 : Double Blind Crossover||5
3045383|NCT01193049|3765287|FG001|STARTED|Period 3 : Double Blind Crossover||6
3045384|NCT01193049|3765286|FG000|COMPLETED|Period 3 : Double Blind Crossover||5
3045385|NCT01193049|3765287|FG001|COMPLETED|Period 3 : Double Blind Crossover||6
3045386|NCT01193049|3765286|FG000|NOT COMPLETED|Period 3 : Double Blind Crossover||0
3045387|NCT01193049|3765287|FG001|NOT COMPLETED|Period 3 : Double Blind Crossover||0
3045388|NCT01193101|3765297|FG000|STARTED|Overall Study||100
3045389|NCT01193101|3765298|FG001|STARTED|Overall Study||101
3045390|NCT01193101|3765299|FG002|STARTED|Overall Study||96
3045391|NCT01193101|3765300|FG003|STARTED|Overall Study||92
3045392|NCT01193101|3765297|FG000|Full Analysis Set|Overall Study||100
3045393|NCT01193101|3765298|FG001|Full Analysis Set|Overall Study||101
3045394|NCT01193101|3765299|FG002|Full Analysis Set|Overall Study||96
3045395|NCT01193101|3765300|FG003|Full Analysis Set|Overall Study||92
3045396|NCT01193101|3765297|FG000|Placebo Withdrawal Set|Overall Study||95
3045397|NCT01193101|3765298|FG001|Placebo Withdrawal Set|Overall Study||94
3045398|NCT01193101|3765299|FG002|Placebo Withdrawal Set|Overall Study||93
3045399|NCT01193101|3765300|FG003|Placebo Withdrawal Set|Overall Study||80
3045400|NCT01193101|3765297|FG000|COMPLETED|Overall Study||95
3045401|NCT01193101|3765298|FG001|COMPLETED|Overall Study||94
3045402|NCT01193101|3765299|FG002|COMPLETED|Overall Study||93
3045403|NCT01193101|3765300|FG003|COMPLETED|Overall Study||80
3045404|NCT01193101|3765297|FG000|NOT COMPLETED|Overall Study||5
3045405|NCT01193101|3765298|FG001|NOT COMPLETED|Overall Study||7
3045406|NCT01193101|3765299|FG002|NOT COMPLETED|Overall Study||3
3045407|NCT01193101|3765300|FG003|NOT COMPLETED|Overall Study||12
3045408|NCT01193114|3765312|FG000|STARTED|Overall Study||30
3045409|NCT01193114|3765313|FG001|STARTED|Overall Study||30
3045410|NCT01193114|3765312|FG000|COMPLETED|Overall Study||30
3045411|NCT01193114|3765313|FG001|COMPLETED|Overall Study||30
3045412|NCT01193114|3765312|FG000|NOT COMPLETED|Overall Study||0
3045413|NCT01193114|3765313|FG001|NOT COMPLETED|Overall Study||0
3045414|NCT01193127|3765323|FG000|STARTED|Randomized||57
3045415|NCT01193127|3765324|FG001|STARTED|Randomized||54
3045416|NCT01193127|3765325|FG002|STARTED|Randomized||55
3045417|NCT01193127|3765326|FG003|STARTED|Randomized||57
3045418|NCT01193127|3765323|FG000|COMPLETED|Randomized||57
3045419|NCT01193127|3765324|FG001|COMPLETED|Randomized||54
3045420|NCT01193127|3765325|FG002|COMPLETED|Randomized||55
3045421|NCT01193127|3765326|FG003|COMPLETED|Randomized||56
3045422|NCT01193127|3765323|FG000|NOT COMPLETED|Randomized||0
3045423|NCT01193127|3765324|FG001|NOT COMPLETED|Randomized||0
3045424|NCT01193127|3765325|FG002|NOT COMPLETED|Randomized||0
3045425|NCT01193127|3765326|FG003|NOT COMPLETED|Randomized||1
3045426|NCT01193127|3765323|FG000|STARTED|Treated||57
3045427|NCT01193127|3765324|FG001|STARTED|Treated||54
3045428|NCT01193127|3765325|FG002|STARTED|Treated||55
3045429|NCT01193127|3765326|FG003|STARTED|Treated||56
3045430|NCT01193127|3765323|FG000|COMPLETED|Treated||57
3045431|NCT01193127|3765324|FG001|COMPLETED|Treated||54
3045432|NCT01193127|3765325|FG002|COMPLETED|Treated||55
3045433|NCT01193127|3765326|FG003|COMPLETED|Treated||55
3045434|NCT01193127|3765323|FG000|NOT COMPLETED|Treated||0
3045435|NCT01193127|3765324|FG001|NOT COMPLETED|Treated||0
3045436|NCT01193127|3765325|FG002|NOT COMPLETED|Treated||0
3045437|NCT01193127|3765326|FG003|NOT COMPLETED|Treated||1
3045438|NCT01193153|3765338|FG000|STARTED|Open-label Lead in Period||667
3045439|NCT01193153|3765339|FG001|STARTED|Open-label Lead in Period||0
3045440|NCT01193153|3765338|FG000|COMPLETED|Open-label Lead in Period||432
3045441|NCT01193153|3765339|FG001|COMPLETED|Open-label Lead in Period||0
3045442|NCT01193153|3765338|FG000|NOT COMPLETED|Open-label Lead in Period||235
3045443|NCT01193153|3765339|FG001|NOT COMPLETED|Open-label Lead in Period||0
3045444|NCT01193153|3765338|FG000|STARTED|Open-label Stabilization Period||432
3045445|NCT01193153|3765339|FG001|STARTED|Open-label Stabilization Period||0
3045446|NCT01193153|3765338|FG000|COMPLETED|Open-label Stabilization Period||334
3045447|NCT01193153|3765339|FG001|COMPLETED|Open-label Stabilization Period||0
3045448|NCT01193153|3765338|FG000|NOT COMPLETED|Open-label Stabilization Period||98
3045449|NCT01193153|3765339|FG001|NOT COMPLETED|Open-label Stabilization Period||0
3045450|NCT01193153|3765338|FG000|STARTED|Double Blind Relapse Prevention Period||164
3045451|NCT01193153|3765339|FG001|STARTED|Double Blind Relapse Prevention Period||170
3045452|NCT01193153|3765338|FG000|COMPLETED|Double Blind Relapse Prevention Period||100
3045453|NCT01193153|3765339|FG001|COMPLETED|Double Blind Relapse Prevention Period||65
3045454|NCT01193153|3765338|FG000|NOT COMPLETED|Double Blind Relapse Prevention Period||64
3045455|NCT01193153|3765339|FG001|NOT COMPLETED|Double Blind Relapse Prevention Period||105
3045456|NCT01193218|3765353|FG000|STARTED|0-12 Weeks|It is actually placebo group|109
3045457|NCT01193218|3765354|FG001|STARTED|0-12 Weeks|It is actually N/A|0
3045458|NCT01193218|3765355|FG002|STARTED|0-12 Weeks|It is actually empa 5mg group|110
3045459|NCT01193218|3765356|FG003|STARTED|0-12 Weeks|It is actually N/A|0
3045460|NCT01193218|3765357|FG004|STARTED|0-12 Weeks||109
3045461|NCT01193218|3765358|FG005|STARTED|0-12 Weeks||109
3045462|NCT01193218|3765359|FG006|STARTED|0-12 Weeks|It is actually empa 50mg group|110
3045463|NCT01193218|3765360|FG007|STARTED|0-12 Weeks|It is actually N/A|0
3045464|NCT01193218|3765353|FG000|COMPLETED|0-12 Weeks||100
3045465|NCT01193218|3765354|FG001|COMPLETED|0-12 Weeks||0
3045466|NCT01193218|3765355|FG002|COMPLETED|0-12 Weeks||107
3045467|NCT01193218|3765356|FG003|COMPLETED|0-12 Weeks||0
3045468|NCT01193218|3765357|FG004|COMPLETED|0-12 Weeks||108
3045469|NCT01193218|3765358|FG005|COMPLETED|0-12 Weeks||106
3045470|NCT01193218|3765359|FG006|COMPLETED|0-12 Weeks||107
3045471|NCT01193218|3765360|FG007|COMPLETED|0-12 Weeks||0
3045472|NCT01193218|3765353|FG000|NOT COMPLETED|0-12 Weeks||9
3045473|NCT01193218|3765354|FG001|NOT COMPLETED|0-12 Weeks||0
3045474|NCT01193218|3765355|FG002|NOT COMPLETED|0-12 Weeks||3
3045475|NCT01193218|3765356|FG003|NOT COMPLETED|0-12 Weeks||0
3045476|NCT01193218|3765357|FG004|NOT COMPLETED|0-12 Weeks||1
3045477|NCT01193218|3765358|FG005|NOT COMPLETED|0-12 Weeks||3
3045478|NCT01193218|3765359|FG006|NOT COMPLETED|0-12 Weeks||3
3045479|NCT01193218|3765360|FG007|NOT COMPLETED|0-12 Weeks||0
3045480|NCT01193218|3765353|FG000|STARTED|12-52 Weeks||50
3045481|NCT01193218|3765354|FG001|STARTED|12-52 Weeks||50
3045482|NCT01193218|3765355|FG002|STARTED|12-52 Weeks||54
3045483|NCT01193218|3765356|FG003|STARTED|12-52 Weeks||53
3045484|NCT01193218|3765357|FG004|STARTED|12-52 Weeks||108
3045485|NCT01193218|3765358|FG005|STARTED|12-52 Weeks||106
3045486|NCT01193218|3765359|FG006|STARTED|12-52 Weeks||54
3045487|NCT01193218|3765360|FG007|STARTED|12-52 Weeks||53
3045488|NCT01193218|3765353|FG000|COMPLETED|12-52 Weeks||45
3045489|NCT01193218|3765354|FG001|COMPLETED|12-52 Weeks||50
3045490|NCT01193218|3765355|FG002|COMPLETED|12-52 Weeks||50
3045491|NCT01193218|3765356|FG003|COMPLETED|12-52 Weeks||50
3045492|NCT01193218|3765357|FG004|COMPLETED|12-52 Weeks||104
3045493|NCT01193218|3765358|FG005|COMPLETED|12-52 Weeks||101
3045494|NCT01193218|3765359|FG006|COMPLETED|12-52 Weeks||51
3045495|NCT01193218|3765360|FG007|COMPLETED|12-52 Weeks||49
3045496|NCT01193218|3765353|FG000|NOT COMPLETED|12-52 Weeks||5
3045497|NCT01193218|3765354|FG001|NOT COMPLETED|12-52 Weeks||0
3045498|NCT01193218|3765355|FG002|NOT COMPLETED|12-52 Weeks||4
3045499|NCT01193218|3765356|FG003|NOT COMPLETED|12-52 Weeks||3
3045500|NCT01193218|3765357|FG004|NOT COMPLETED|12-52 Weeks||4
3045501|NCT01193218|3765358|FG005|NOT COMPLETED|12-52 Weeks||5
3045502|NCT01193218|3765359|FG006|NOT COMPLETED|12-52 Weeks||3
3045503|NCT01193218|3765360|FG007|NOT COMPLETED|12-52 Weeks||4
3045504|NCT01193244|3765378|FG000|STARTED|Overall Study||779
3045505|NCT01193244|3765379|FG001|STARTED|Overall Study||781
3045506|NCT01193244|3765378|FG000|Treated|Overall Study|Participants who continued to receive Placebo after unblinding.|770
3045507|NCT01193244|3765379|FG001|Treated|Overall Study|Participants randomized to receive Placebo but crossed-over to receive Orteronel after unblinding.|784
3045508|NCT01193244|3765378|FG000|COMPLETED|Overall Study||391
3045509|NCT01193244|3765379|FG001|COMPLETED|Overall Study||391
3045510|NCT01193244|3765378|FG000|NOT COMPLETED|Overall Study||388
3045511|NCT01193244|3765379|FG001|NOT COMPLETED|Overall Study||390
3045512|NCT01193257|3765387|FG000|STARTED|Overall Study||365
3045513|NCT01193257|3765388|FG001|STARTED|Overall Study||734
3045514|NCT01193257|3765387|FG000|Treated|Overall Study||363
3045515|NCT01193257|3765388|FG001|Treated|Overall Study||732
3045516|NCT01193257|3765387|FG000|COMPLETED|Overall Study||0
3045517|NCT01193257|3765388|FG001|COMPLETED|Overall Study||0
3045518|NCT01193257|3765387|FG000|NOT COMPLETED|Overall Study||365
3045519|NCT01193257|3765388|FG001|NOT COMPLETED|Overall Study||734
3045520|NCT01193283|3765394|FG000|STARTED|Overall Study||22
3045521|NCT01193283|3765394|FG000|COMPLETED|Overall Study||21
3045522|NCT01193283|3765394|FG000|NOT COMPLETED|Overall Study||1
3045523|NCT01193335|3765400|FG000|STARTED|Infant Series||100
3045524|NCT01193335|3765401|FG001|STARTED|Infant Series||100
3045525|NCT01193335|3765400|FG000|COMPLETED|Infant Series||100
3045526|NCT01193335|3765401|FG001|COMPLETED|Infant Series||100
3045527|NCT01193335|3765400|FG000|NOT COMPLETED|Infant Series||0
3045528|NCT01193335|3765401|FG001|NOT COMPLETED|Infant Series||0
3045529|NCT01193335|3765400|FG000|STARTED|After Infant Series||100
3180396|NCT01990768|3908699|FG001|STARTED|6-Month Follow-up||312
3180397|NCT01990768|3908700|FG002|STARTED|6-Month Follow-up||346
3180398|NCT01990768|3908698|FG000|COMPLETED|6-Month Follow-up||270
3180399|NCT01990768|3908699|FG001|COMPLETED|6-Month Follow-up||261
3180400|NCT01990768|3908700|FG002|COMPLETED|6-Month Follow-up||288
3180401|NCT01990768|3908698|FG000|NOT COMPLETED|6-Month Follow-up||39
3045530|NCT01193335|3765401|FG001|STARTED|After Infant Series||100
3045531|NCT01193335|3765400|FG000|COMPLETED|After Infant Series||99
3045532|NCT01193335|3765401|FG001|COMPLETED|After Infant Series||97
3045533|NCT01193335|3765400|FG000|NOT COMPLETED|After Infant Series||1
3045534|NCT01193335|3765401|FG001|NOT COMPLETED|After Infant Series||3
3045535|NCT01193335|3765400|FG000|STARTED|Toddler Dose||99
3180402|NCT01990768|3908699|FG001|NOT COMPLETED|6-Month Follow-up||51
3180403|NCT01990768|3908700|FG002|NOT COMPLETED|6-Month Follow-up||58
3180404|NCT01990794|3908709|FG000|STARTED|Overall Study||13
3180405|NCT01990794|3908709|FG000|One Month Into Study|Overall Study||10
3180406|NCT01990794|3908709|FG000|COMPLETED|Overall Study||10
3180407|NCT01990794|3908709|FG000|NOT COMPLETED|Overall Study||3
3180408|NCT01990820|3908798|FG000|STARTED|Overall Study||13
3045536|NCT01193335|3765401|FG001|STARTED|Toddler Dose||97
3045537|NCT01193335|3765400|FG000|COMPLETED|Toddler Dose||99
3045538|NCT01193335|3765401|FG001|COMPLETED|Toddler Dose||97
3045539|NCT01193335|3765400|FG000|NOT COMPLETED|Toddler Dose||0
3045540|NCT01193335|3765401|FG001|NOT COMPLETED|Toddler Dose||0
3045541|NCT01193335|3765400|FG000|STARTED|1-Year Follow-up||99
3045542|NCT01193335|3765401|FG001|STARTED|1-Year Follow-up||97
3045543|NCT01193335|3765400|FG000|COMPLETED|1-Year Follow-up||88
3045544|NCT01193335|3765401|FG001|COMPLETED|1-Year Follow-up||88
3045545|NCT01193335|3765400|FG000|NOT COMPLETED|1-Year Follow-up||11
3045546|NCT01193335|3765401|FG001|NOT COMPLETED|1-Year Follow-up||9
3045547|NCT01193335|3765400|FG000|STARTED|2-Year Follow-up||88
3045548|NCT01193335|3765401|FG001|STARTED|2-Year Follow-up||88
3045549|NCT01193335|3765400|FG000|COMPLETED|2-Year Follow-up||81
3045550|NCT01193335|3765401|FG001|COMPLETED|2-Year Follow-up||80
3045551|NCT01193335|3765400|FG000|NOT COMPLETED|2-Year Follow-up||7
3045552|NCT01193335|3765401|FG001|NOT COMPLETED|2-Year Follow-up||8
3045553|NCT01193348|3765423|FG000|STARTED|Screening Period||27
3045554|NCT01193348|3765423|FG000|COMPLETED|Screening Period||22
3045555|NCT01193348|3765423|FG000|NOT COMPLETED|Screening Period||5
3045556|NCT01193348|3765423|FG000|STARTED|Treatment Period (26 Weeks)||22
3180409|NCT01990820|3908799|FG001|STARTED|Overall Study||12
3045557|NCT01193348|3765423|FG000|COMPLETED|Treatment Period (26 Weeks)||19
3045558|NCT01193348|3765423|FG000|NOT COMPLETED|Treatment Period (26 Weeks)||3
3045559|NCT01193348|3765423|FG000|STARTED|Extension Treatment Period||17
3045560|NCT01193348|3765423|FG000|COMPLETED|Extension Treatment Period||16
3045561|NCT01193348|3765423|FG000|NOT COMPLETED|Extension Treatment Period||1
3045562|NCT01193348|3765423|FG000|STARTED|Post Treatment Period (Patients Who Disc||10
3045563|NCT01193348|3765423|FG000|COMPLETED|Post Treatment Period (Patients Who Disc||8
3045564|NCT01193348|3765423|FG000|NOT COMPLETED|Post Treatment Period (Patients Who Disc||2
3045565|NCT01193517|3765435|FG000|STARTED|Overall Study||3
3045566|NCT01193517|3765436|FG001|STARTED|Overall Study||12
3045567|NCT01193517|3765437|FG002|STARTED|Overall Study||11
3045568|NCT01193517|3765435|FG000|COMPLETED|Overall Study||2
3045569|NCT01193517|3765436|FG001|COMPLETED|Overall Study||12
3045570|NCT01193517|3765437|FG002|COMPLETED|Overall Study||11
3045571|NCT01193517|3765435|FG000|NOT COMPLETED|Overall Study||1
3045572|NCT01193517|3765436|FG001|NOT COMPLETED|Overall Study||0
3180410|NCT01990820|3908798|FG000|COMPLETED|Overall Study||13
3180411|NCT01990820|3908799|FG001|COMPLETED|Overall Study||12
3180412|NCT01990820|3908798|FG000|NOT COMPLETED|Overall Study||0
3180413|NCT01990820|3908799|FG001|NOT COMPLETED|Overall Study||0
3180414|NCT01990859|3908805|FG000|STARTED|Treatment (4 Doses Over 12 Weeks)||20
3045573|NCT01193517|3765437|FG002|NOT COMPLETED|Overall Study||0
3045574|NCT01193582|3765450|FG000|STARTED|Vaccination Series||100
3045575|NCT01193582|3765451|FG001|STARTED|Vaccination Series||101
3045576|NCT01193582|3765452|FG002|STARTED|Vaccination Series||125
3045577|NCT01193582|3765453|FG003|STARTED|Vaccination Series||180
3045578|NCT01193582|3765450|FG000|Vaccinated Dose 1|Vaccination Series||100
3045579|NCT01193582|3765451|FG001|Vaccinated Dose 1|Vaccination Series||100
3045580|NCT01193582|3765452|FG002|Vaccinated Dose 1|Vaccination Series||125
3045581|NCT01193582|3765453|FG003|Vaccinated Dose 1|Vaccination Series||180
3045582|NCT01193582|3765450|FG000|Vaccinated Dose 2|Vaccination Series||92
3045583|NCT01193582|3765451|FG001|Vaccinated Dose 2|Vaccination Series||91
3045584|NCT01193582|3765452|FG002|Vaccinated Dose 2|Vaccination Series||118
3045585|NCT01193582|3765453|FG003|Vaccinated Dose 2|Vaccination Series||0
3045586|NCT01193582|3765450|FG000|Vaccinated Dose 3|Vaccination Series||90
3045587|NCT01193582|3765451|FG001|Vaccinated Dose 3|Vaccination Series||89
3045588|NCT01193582|3765452|FG002|Vaccinated Dose 3|Vaccination Series||0
3045589|NCT01193582|3765453|FG003|Vaccinated Dose 3|Vaccination Series||0
3045590|NCT01193582|3765450|FG000|Vaccinated Dose 4|Vaccination Series||90
3045591|NCT01193582|3765451|FG001|Vaccinated Dose 4|Vaccination Series||0
3045592|NCT01193582|3765452|FG002|Vaccinated Dose 4|Vaccination Series||0
3045593|NCT01193582|3765453|FG003|Vaccinated Dose 4|Vaccination Series||0
3045594|NCT01193582|3765450|FG000|COMPLETED|Vaccination Series||89
3045595|NCT01193582|3765451|FG001|COMPLETED|Vaccination Series||88
3045596|NCT01193582|3765452|FG002|COMPLETED|Vaccination Series||117
3045597|NCT01193582|3765453|FG003|COMPLETED|Vaccination Series||177
3045598|NCT01193582|3765450|FG000|NOT COMPLETED|Vaccination Series||11
3045599|NCT01193582|3765451|FG001|NOT COMPLETED|Vaccination Series||13
3045600|NCT01193582|3765452|FG002|NOT COMPLETED|Vaccination Series||8
3045601|NCT01193582|3765453|FG003|NOT COMPLETED|Vaccination Series||3
3045602|NCT01193582|3765450|FG000|STARTED|12 Month Follow-up||89
3045603|NCT01193582|3765451|FG001|STARTED|12 Month Follow-up||88
3045604|NCT01193582|3765452|FG002|STARTED|12 Month Follow-up||117
3045605|NCT01193582|3765453|FG003|STARTED|12 Month Follow-up||177
3045606|NCT01193582|3765450|FG000|COMPLETED|12 Month Follow-up||83
3045607|NCT01193582|3765451|FG001|COMPLETED|12 Month Follow-up||88
3045608|NCT01193582|3765452|FG002|COMPLETED|12 Month Follow-up||113
3045609|NCT01193582|3765453|FG003|COMPLETED|12 Month Follow-up||166
3045610|NCT01193582|3765450|FG000|NOT COMPLETED|12 Month Follow-up||6
3045611|NCT01193582|3765451|FG001|NOT COMPLETED|12 Month Follow-up||0
3045612|NCT01193582|3765452|FG002|NOT COMPLETED|12 Month Follow-up||4
3045613|NCT01193582|3765453|FG003|NOT COMPLETED|12 Month Follow-up||11
3045614|NCT01193608|3765471|FG000|STARTED|Overall Study||6
3045615|NCT01193608|3765472|FG001|STARTED|Overall Study||6
3045616|NCT01193608|3765473|FG002|STARTED|Overall Study||16
3045617|NCT01193608|3765474|FG003|STARTED|Overall Study||17
3045618|NCT01193608|3765475|FG004|STARTED|Overall Study||24
3045619|NCT01193608|3765476|FG005|STARTED|Overall Study||19
3045620|NCT01193608|3765471|FG000|COMPLETED|Overall Study||6
3045621|NCT01193608|3765472|FG001|COMPLETED|Overall Study||4
3045622|NCT01193608|3765473|FG002|COMPLETED|Overall Study||14
3045623|NCT01193608|3765474|FG003|COMPLETED|Overall Study||14
3045624|NCT01193608|3765475|FG004|COMPLETED|Overall Study||19
3045625|NCT01193608|3765476|FG005|COMPLETED|Overall Study||17
3045626|NCT01193608|3765471|FG000|NOT COMPLETED|Overall Study||0
3045627|NCT01193608|3765472|FG001|NOT COMPLETED|Overall Study||2
3045628|NCT01193608|3765473|FG002|NOT COMPLETED|Overall Study||2
3045629|NCT01193608|3765474|FG003|NOT COMPLETED|Overall Study||3
3045630|NCT01193608|3765475|FG004|NOT COMPLETED|Overall Study||5
3045631|NCT01193608|3765476|FG005|NOT COMPLETED|Overall Study||2
3045632|NCT01193660|3765498|FG000|STARTED|Overall Study||35
3045633|NCT01193660|3765499|FG001|STARTED|Overall Study||36
3045634|NCT01193660|3765500|FG002|STARTED|Overall Study||34
3045635|NCT01193660|3765498|FG000|COMPLETED|Overall Study||31
3045636|NCT01193660|3765499|FG001|COMPLETED|Overall Study||33
3045637|NCT01193660|3765500|FG002|COMPLETED|Overall Study||32
3045638|NCT01193660|3765498|FG000|NOT COMPLETED|Overall Study||4
3045639|NCT01193660|3765499|FG001|NOT COMPLETED|Overall Study||3
3045640|NCT01193660|3765500|FG002|NOT COMPLETED|Overall Study||2
3045641|NCT01193686|3765510|FG000|STARTED|Overall Study||15
3045642|NCT01193686|3765511|FG001|STARTED|Overall Study||9
3045643|NCT01193686|3765510|FG000|Completed Baseline Assessment|Overall Study||15
3045644|NCT01193686|3765511|FG001|Completed Baseline Assessment|Overall Study||9
3045645|NCT01193686|3765510|FG000|Completed Mentor Training|Overall Study||9
3045646|NCT01193686|3765511|FG001|Completed Mentor Training|Overall Study|Not applicable. Recipients were not required to complete training.|0
3045647|NCT01193686|3765510|FG000|Completed Visits and Final Assessment|Overall Study||8
3045648|NCT01193686|3765511|FG001|Completed Visits and Final Assessment|Overall Study||8
3045649|NCT01193686|3765510|FG000|COMPLETED|Overall Study||8
3045650|NCT01193686|3765511|FG001|COMPLETED|Overall Study||8
3045651|NCT01193686|3765510|FG000|NOT COMPLETED|Overall Study||7
3045652|NCT01193686|3765511|FG001|NOT COMPLETED|Overall Study||1
3045653|NCT01193868|3765518|FG000|STARTED|Overall Study||6
3045654|NCT01193868|3765518|FG000|COMPLETED|Overall Study||6
3045655|NCT01193868|3765518|FG000|NOT COMPLETED|Overall Study||0
3045656|NCT01193907|3765526|FG000|STARTED|Overall Study||22
3045657|NCT01193907|3765527|FG001|STARTED|Overall Study||22
3045658|NCT01193907|3765528|FG002|STARTED|Overall Study||22
3045659|NCT01193907|3765529|FG003|STARTED|Overall Study||22
3045660|NCT01193907|3765526|FG000|COMPLETED|Overall Study||21
3045661|NCT01193907|3765527|FG001|COMPLETED|Overall Study||22
3045662|NCT01193907|3765528|FG002|COMPLETED|Overall Study||22
3045663|NCT01193907|3765529|FG003|COMPLETED|Overall Study||21
3045664|NCT01193907|3765526|FG000|NOT COMPLETED|Overall Study||1
3045665|NCT01193907|3765527|FG001|NOT COMPLETED|Overall Study||0
3045666|NCT01193907|3765528|FG002|NOT COMPLETED|Overall Study||0
3045667|NCT01193907|3765529|FG003|NOT COMPLETED|Overall Study||1
3045668|NCT01193920|3765549|FG000|STARTED|Overall Study||40
3045669|NCT01193920|3765550|FG001|STARTED|Overall Study||20
3045670|NCT01193920|3765551|FG002|STARTED|Overall Study||80
3045671|NCT01193920|3765552|FG003|STARTED|Overall Study||80
3045672|NCT01193920|3765553|FG004|STARTED|Overall Study||80
3045673|NCT01193920|3765554|FG005|STARTED|Overall Study||80
3045674|NCT01193920|3765555|FG006|STARTED|Overall Study||80
3045675|NCT01193920|3765556|FG007|STARTED|Overall Study||80
3045676|NCT01193920|3765557|FG008|STARTED|Overall Study||76
3045677|NCT01193920|3765558|FG009|STARTED|Overall Study||81
3045678|NCT01193920|3765549|FG000|COMPLETED|Overall Study||37
3045679|NCT01193920|3765550|FG001|COMPLETED|Overall Study||20
3045680|NCT01193920|3765551|FG002|COMPLETED|Overall Study||74
3045681|NCT01193920|3765552|FG003|COMPLETED|Overall Study||76
3045682|NCT01193920|3765553|FG004|COMPLETED|Overall Study||74
3045683|NCT01193920|3765554|FG005|COMPLETED|Overall Study||76
3045684|NCT01193920|3765555|FG006|COMPLETED|Overall Study||74
3045685|NCT01193920|3765556|FG007|COMPLETED|Overall Study||76
3045686|NCT01193920|3765557|FG008|COMPLETED|Overall Study||71
3045687|NCT01193920|3765558|FG009|COMPLETED|Overall Study||74
3045688|NCT01193920|3765549|FG000|NOT COMPLETED|Overall Study||3
3045689|NCT01193920|3765550|FG001|NOT COMPLETED|Overall Study||0
3045690|NCT01193920|3765551|FG002|NOT COMPLETED|Overall Study||6
3045691|NCT01193920|3765552|FG003|NOT COMPLETED|Overall Study||4
3045692|NCT01193920|3765553|FG004|NOT COMPLETED|Overall Study||6
3045693|NCT01193920|3765554|FG005|NOT COMPLETED|Overall Study||4
3045694|NCT01193920|3765555|FG006|NOT COMPLETED|Overall Study||6
3045695|NCT01193920|3765556|FG007|NOT COMPLETED|Overall Study||4
3045696|NCT01193920|3765557|FG008|NOT COMPLETED|Overall Study||5
3045697|NCT01193920|3765558|FG009|NOT COMPLETED|Overall Study||7
3045698|NCT01194089|3765583|FG000|STARTED|Overall Study||42
3045699|NCT01194089|3765584|FG001|STARTED|Overall Study||47
3045700|NCT01194089|3765583|FG000|COMPLETED|Overall Study||42
3045701|NCT01194089|3765584|FG001|COMPLETED|Overall Study||47
3045702|NCT01194089|3765583|FG000|NOT COMPLETED|Overall Study||0
3045703|NCT01194089|3765584|FG001|NOT COMPLETED|Overall Study||0
3045704|NCT01194154|3765592|FG000|STARTED|Overall Study||117
3045705|NCT01194154|3765593|FG001|STARTED|Overall Study||124
3045706|NCT01194154|3765592|FG000|Full Analysis Set|Overall Study||115
3045707|NCT01194154|3765593|FG001|Full Analysis Set|Overall Study||120
3045708|NCT01194154|3765592|FG000|Safety Analysis Set|Overall Study|3 participants randomized to placebo but received MIRCERA and included in MIRCERA arm (as treated).|118
3045709|NCT01194154|3765593|FG001|Safety Analysis Set|Overall Study|3 participants randomized to placebo but received MIRCERA and included in MIRCERA arm (as treated).|117
3045710|NCT01194154|3765592|FG000|COMPLETED|Overall Study||68
3045711|NCT01194154|3765593|FG001|COMPLETED|Overall Study||91
3045712|NCT01194154|3765592|FG000|NOT COMPLETED|Overall Study||49
3045713|NCT01194154|3765593|FG001|NOT COMPLETED|Overall Study||33
3180415|NCT01990859|3908805|FG000|COMPLETED|Treatment (4 Doses Over 12 Weeks)||15
3180416|NCT01990859|3908805|FG000|NOT COMPLETED|Treatment (4 Doses Over 12 Weeks)||5
3180417|NCT01990859|3908805|FG000|STARTED|Week 12 to Week 24 Post Dosing Follow Up|All were entered into follow-up whether dosing was completed or not.|20
3180418|NCT01990859|3908805|FG000|COMPLETED|Week 12 to Week 24 Post Dosing Follow Up||3
3180419|NCT01990859|3908805|FG000|NOT COMPLETED|Week 12 to Week 24 Post Dosing Follow Up||17
3363513|NCT04067050|4094626|FG000|COMPLETED|Two Month||20
3045714|NCT01194219|3765603|FG000|STARTED|Placebo-Controlled Phase Weeks 0-16||562
3045715|NCT01194219|3765604|FG001|STARTED|Placebo-Controlled Phase Weeks 0-16||282
3045716|NCT01194219|3765605|FG002|STARTED|Placebo-Controlled Phase Weeks 0-16||0
3363514|NCT04067050|4094627|FG001|COMPLETED|Two Month||29
3363515|NCT04067050|4094626|FG000|NOT COMPLETED|Two Month||2
3045717|NCT01194219|3765606|FG003|STARTED|Placebo-Controlled Phase Weeks 0-16||0
3045718|NCT01194219|3765607|FG004|STARTED|Placebo-Controlled Phase Weeks 0-16||0
3045719|NCT01194219|3765608|FG005|STARTED|Placebo-Controlled Phase Weeks 0-16||0
3045720|NCT01194219|3765609|FG006|STARTED|Placebo-Controlled Phase Weeks 0-16||0
3045721|NCT01194219|3765610|FG007|STARTED|Placebo-Controlled Phase Weeks 0-16||0
3045722|NCT01194219|3765611|FG008|STARTED|Placebo-Controlled Phase Weeks 0-16||0
3045723|NCT01194219|3765612|FG009|STARTED|Placebo-Controlled Phase Weeks 0-16||0
3045724|NCT01194219|3765603|FG000|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||560
3045725|NCT01194219|3765604|FG001|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||282
3045726|NCT01194219|3765605|FG002|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
3045727|NCT01194219|3765606|FG003|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
3045728|NCT01194219|3765607|FG004|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
3045729|NCT01194219|3765608|FG005|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
3045730|NCT01194219|3765609|FG006|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
3045731|NCT01194219|3765610|FG007|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
3045732|NCT01194219|3765611|FG008|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
3045733|NCT01194219|3765612|FG009|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
3045734|NCT01194219|3765603|FG000|COMPLETED|Placebo-Controlled Phase Weeks 0-16||503
3045735|NCT01194219|3765604|FG001|COMPLETED|Placebo-Controlled Phase Weeks 0-16||249
3045736|NCT01194219|3765605|FG002|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
3045737|NCT01194219|3765606|FG003|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
3045738|NCT01194219|3765607|FG004|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
3045739|NCT01194219|3765608|FG005|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
3045740|NCT01194219|3765609|FG006|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
3045741|NCT01194219|3765610|FG007|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
3045742|NCT01194219|3765611|FG008|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
3045743|NCT01194219|3765612|FG009|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
3045744|NCT01194219|3765603|FG000|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||59
3045745|NCT01194219|3765604|FG001|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||33
3045746|NCT01194219|3765605|FG002|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
3045747|NCT01194219|3765606|FG003|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
3045748|NCT01194219|3765607|FG004|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
3045749|NCT01194219|3765608|FG005|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
3045750|NCT01194219|3765609|FG006|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
3045751|NCT01194219|3765610|FG007|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
3045752|NCT01194219|3765611|FG008|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
3045753|NCT01194219|3765612|FG009|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
3045754|NCT01194219|3765603|FG000|STARTED|Maintenance Phase Weeks16-32||0
3045755|NCT01194219|3765604|FG001|STARTED|Maintenance Phase Weeks16-32||0
3045756|NCT01194219|3765605|FG002|STARTED|Maintenance Phase Weeks16-32|9 participants discontinued after Week 16 but prior to entry into the Maintenance Phase|494
3045757|NCT01194219|3765606|FG003|STARTED|Maintenance Phase Weeks16-32|4 participants discontinued after Week 16 but prior to entry into the Maintenance Phase|245
3045758|NCT01194219|3765607|FG004|STARTED|Maintenance Phase Weeks16-32||0
3045759|NCT01194219|3765608|FG005|STARTED|Maintenance Phase Weeks16-32||0
3045760|NCT01194219|3765609|FG006|STARTED|Maintenance Phase Weeks16-32||0
3045761|NCT01194219|3765610|FG007|STARTED|Maintenance Phase Weeks16-32||0
3045762|NCT01194219|3765611|FG008|STARTED|Maintenance Phase Weeks16-32||0
3045763|NCT01194219|3765612|FG009|STARTED|Maintenance Phase Weeks16-32||0
3045764|NCT01194219|3765603|FG000|Received Apremilast|Maintenance Phase Weeks16-32||0
3045765|NCT01194219|3765604|FG001|Received Apremilast|Maintenance Phase Weeks16-32||0
3045766|NCT01194219|3765605|FG002|Received Apremilast|Maintenance Phase Weeks16-32|1 participant elected not to participate at the time the first dose was dispensed.|493
3045767|NCT01194219|3765606|FG003|Received Apremilast|Maintenance Phase Weeks16-32|1 participant elected not to participate at the time the first dose was dispensed.|244
3045768|NCT01194219|3765607|FG004|Received Apremilast|Maintenance Phase Weeks16-32||0
3045769|NCT01194219|3765608|FG005|Received Apremilast|Maintenance Phase Weeks16-32||0
3045770|NCT01194219|3765609|FG006|Received Apremilast|Maintenance Phase Weeks16-32||0
3045771|NCT01194219|3765610|FG007|Received Apremilast|Maintenance Phase Weeks16-32||0
3045772|NCT01194219|3765611|FG008|Received Apremilast|Maintenance Phase Weeks16-32||0
3045773|NCT01194219|3765612|FG009|Received Apremilast|Maintenance Phase Weeks16-32||0
3045774|NCT01194219|3765603|FG000|COMPLETED|Maintenance Phase Weeks16-32||0
3045775|NCT01194219|3765604|FG001|COMPLETED|Maintenance Phase Weeks16-32||0
3045776|NCT01194219|3765605|FG002|COMPLETED|Maintenance Phase Weeks16-32||424
3180420|NCT01990859|3908805|FG000|STARTED|90 Day Follow Up for All Participants|All entered into 90 day follow-up whether treatment and/or post dose follow up was completed or not.|20
3045777|NCT01194219|3765606|FG003|COMPLETED|Maintenance Phase Weeks16-32||215
3045778|NCT01194219|3765607|FG004|COMPLETED|Maintenance Phase Weeks16-32||0
3045779|NCT01194219|3765608|FG005|COMPLETED|Maintenance Phase Weeks16-32||0
3045780|NCT01194219|3765609|FG006|COMPLETED|Maintenance Phase Weeks16-32||0
3045781|NCT01194219|3765610|FG007|COMPLETED|Maintenance Phase Weeks16-32||0
3045782|NCT01194219|3765611|FG008|COMPLETED|Maintenance Phase Weeks16-32||0
3045783|NCT01194219|3765612|FG009|COMPLETED|Maintenance Phase Weeks16-32||0
3045784|NCT01194219|3765603|FG000|NOT COMPLETED|Maintenance Phase Weeks16-32||0
3045785|NCT01194219|3765604|FG001|NOT COMPLETED|Maintenance Phase Weeks16-32||0
3045786|NCT01194219|3765605|FG002|NOT COMPLETED|Maintenance Phase Weeks16-32||70
3045787|NCT01194219|3765606|FG003|NOT COMPLETED|Maintenance Phase Weeks16-32||30
3045788|NCT01194219|3765607|FG004|NOT COMPLETED|Maintenance Phase Weeks16-32||0
3045789|NCT01194219|3765608|FG005|NOT COMPLETED|Maintenance Phase Weeks16-32||0
3045790|NCT01194219|3765609|FG006|NOT COMPLETED|Maintenance Phase Weeks16-32||0
3045791|NCT01194219|3765610|FG007|NOT COMPLETED|Maintenance Phase Weeks16-32||0
3045792|NCT01194219|3765611|FG008|NOT COMPLETED|Maintenance Phase Weeks16-32||0
3045793|NCT01194219|3765612|FG009|NOT COMPLETED|Maintenance Phase Weeks16-32||0
3045794|NCT01194219|3765603|FG000|STARTED|Randomized Withdrawal Phase-Weeks 32-52||0
3045795|NCT01194219|3765604|FG001|STARTED|Randomized Withdrawal Phase-Weeks 32-52||0
3045796|NCT01194219|3765605|FG002|STARTED|Randomized Withdrawal Phase-Weeks 32-52||0
3045797|NCT01194219|3765606|FG003|STARTED|Randomized Withdrawal Phase-Weeks 32-52||0
3045798|NCT01194219|3765607|FG004|STARTED|Randomized Withdrawal Phase-Weeks 32-52|7 participants discontinued after week 32 but prior to entry into the Randomized withdrawal Phase|77
3045799|NCT01194219|3765608|FG005|STARTED|Randomized Withdrawal Phase-Weeks 32-52|25 participants discontinued after week 32 but prior to entry into the Randomized withdrawal Phase|77
3045800|NCT01194219|3765609|FG006|STARTED|Randomized Withdrawal Phase-Weeks 32-52||245
3045801|NCT01194219|3765610|FG007|STARTED|Randomized Withdrawal Phase-Weeks 32-52||208
3045802|NCT01194219|3765611|FG008|STARTED|Randomized Withdrawal Phase-Weeks 32-52||0
3045803|NCT01194219|3765612|FG009|STARTED|Randomized Withdrawal Phase-Weeks 32-52||0
3045804|NCT01194219|3765603|FG000|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
3045805|NCT01194219|3765604|FG001|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
3045806|NCT01194219|3765605|FG002|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
3045807|NCT01194219|3765606|FG003|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
3045808|NCT01194219|3765607|FG004|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
3045809|NCT01194219|3765608|FG005|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
3045810|NCT01194219|3765609|FG006|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||126
3045811|NCT01194219|3765610|FG007|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||91
3045812|NCT01194219|3765611|FG008|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
3045813|NCT01194219|3765612|FG009|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
3045814|NCT01194219|3765603|FG000|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
3045815|NCT01194219|3765604|FG001|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
3045816|NCT01194219|3765605|FG002|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
3045817|NCT01194219|3765606|FG003|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
3045818|NCT01194219|3765607|FG004|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52|1 participant discontinued after Week 52 but prior to entry into the long term extension study|73
3045819|NCT01194219|3765608|FG005|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52|5 participants discontinued after Week 52 but prior to entry into the long term extension study|73
3045820|NCT01194219|3765609|FG006|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52|18 participants discontinued after Week 52 but prior to entry into the long term extension study|184
3045821|NCT01194219|3765610|FG007|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52|10 participants discontinued after Week 52 but prior to entry into the long term extension study|163
3045822|NCT01194219|3765611|FG008|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
3045823|NCT01194219|3765612|FG009|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
3045824|NCT01194219|3765603|FG000|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
3045825|NCT01194219|3765604|FG001|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
3045826|NCT01194219|3765605|FG002|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
3045827|NCT01194219|3765606|FG003|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
3045828|NCT01194219|3765607|FG004|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||4
3045829|NCT01194219|3765608|FG005|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||4
3045830|NCT01194219|3765609|FG006|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||61
3045831|NCT01194219|3765610|FG007|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||45
3045832|NCT01194219|3765611|FG008|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
3045833|NCT01194219|3765612|FG009|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
3045834|NCT01194219|3765603|FG000|STARTED|Long-Term Extension Weeks 52 to 260||0
3045835|NCT01194219|3765604|FG001|STARTED|Long-Term Extension Weeks 52 to 260||0
3045836|NCT01194219|3765605|FG002|STARTED|Long-Term Extension Weeks 52 to 260||0
3045837|NCT01194219|3765606|FG003|STARTED|Long-Term Extension Weeks 52 to 260||0
3045838|NCT01194219|3765607|FG004|STARTED|Long-Term Extension Weeks 52 to 260||0
3045839|NCT01194219|3765608|FG005|STARTED|Long-Term Extension Weeks 52 to 260||0
3045840|NCT01194219|3765609|FG006|STARTED|Long-Term Extension Weeks 52 to 260||0
3045841|NCT01194219|3765610|FG007|STARTED|Long-Term Extension Weeks 52 to 260||0
3045842|NCT01194219|3765611|FG008|STARTED|Long-Term Extension Weeks 52 to 260||306
3045843|NCT01194219|3765612|FG009|STARTED|Long-Term Extension Weeks 52 to 260||153
3045844|NCT01194219|3765603|FG000|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
3045845|NCT01194219|3765604|FG001|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
3045846|NCT01194219|3765605|FG002|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
3045847|NCT01194219|3765606|FG003|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
3045848|NCT01194219|3765607|FG004|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
3045849|NCT01194219|3765608|FG005|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
3045850|NCT01194219|3765609|FG006|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
3045851|NCT01194219|3765610|FG007|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
3045852|NCT01194219|3765611|FG008|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||304
3045853|NCT01194219|3765612|FG009|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||153
3045854|NCT01194219|3765603|FG000|COMPLETED|Long-Term Extension Weeks 52 to 260||0
3045855|NCT01194219|3765604|FG001|COMPLETED|Long-Term Extension Weeks 52 to 260||0
3045856|NCT01194219|3765605|FG002|COMPLETED|Long-Term Extension Weeks 52 to 260||0
3045857|NCT01194219|3765606|FG003|COMPLETED|Long-Term Extension Weeks 52 to 260||0
3045858|NCT01194219|3765607|FG004|COMPLETED|Long-Term Extension Weeks 52 to 260||0
3045859|NCT01194219|3765608|FG005|COMPLETED|Long-Term Extension Weeks 52 to 260||0
3045860|NCT01194219|3765609|FG006|COMPLETED|Long-Term Extension Weeks 52 to 260||0
3045861|NCT01194219|3765610|FG007|COMPLETED|Long-Term Extension Weeks 52 to 260||0
3045862|NCT01194219|3765611|FG008|COMPLETED|Long-Term Extension Weeks 52 to 260||86
3045863|NCT01194219|3765612|FG009|COMPLETED|Long-Term Extension Weeks 52 to 260||41
3045864|NCT01194219|3765603|FG000|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
3045865|NCT01194219|3765604|FG001|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
3045866|NCT01194219|3765605|FG002|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
3045867|NCT01194219|3765606|FG003|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
3045868|NCT01194219|3765607|FG004|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
3045869|NCT01194219|3765608|FG005|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
3045870|NCT01194219|3765609|FG006|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
3045871|NCT01194219|3765610|FG007|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
3045872|NCT01194219|3765611|FG008|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||220
3045873|NCT01194219|3765612|FG009|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||112
3045874|NCT01194245|3765640|FG000|STARTED|Titration Period (4 to 6 Weeks)||135
3045875|NCT01194245|3765641|FG001|STARTED|Titration Period (4 to 6 Weeks)||0
3045876|NCT01194245|3765642|FG002|STARTED|Titration Period (4 to 6 Weeks)||0
3045877|NCT01194245|3765643|FG003|STARTED|Titration Period (4 to 6 Weeks)||0
3045878|NCT01194245|3765644|FG004|STARTED|Titration Period (4 to 6 Weeks)||0
3045879|NCT01194245|3765640|FG000|COMPLETED|Titration Period (4 to 6 Weeks)|Participants that completed the Titration Period were randomized to Treatment Period 1.|117
3045880|NCT01194245|3765641|FG001|COMPLETED|Titration Period (4 to 6 Weeks)||0
3045881|NCT01194245|3765642|FG002|COMPLETED|Titration Period (4 to 6 Weeks)||0
3045882|NCT01194245|3765643|FG003|COMPLETED|Titration Period (4 to 6 Weeks)||0
3045883|NCT01194245|3765644|FG004|COMPLETED|Titration Period (4 to 6 Weeks)||0
3045884|NCT01194245|3765640|FG000|NOT COMPLETED|Titration Period (4 to 6 Weeks)||18
3045885|NCT01194245|3765641|FG001|NOT COMPLETED|Titration Period (4 to 6 Weeks)||0
3045886|NCT01194245|3765642|FG002|NOT COMPLETED|Titration Period (4 to 6 Weeks)||0
3045887|NCT01194245|3765643|FG003|NOT COMPLETED|Titration Period (4 to 6 Weeks)||0
3045888|NCT01194245|3765644|FG004|NOT COMPLETED|Titration Period (4 to 6 Weeks)||0
3045889|NCT01194245|3765640|FG000|STARTED|Treatment Period 1 (Weeks 0 to 12)||0
3045890|NCT01194245|3765641|FG001|STARTED|Treatment Period 1 (Weeks 0 to 12)||29
3045891|NCT01194245|3765642|FG002|STARTED|Treatment Period 1 (Weeks 0 to 12)||28
3045892|NCT01194245|3765643|FG003|STARTED|Treatment Period 1 (Weeks 0 to 12)||30
3045893|NCT01194245|3765644|FG004|STARTED|Treatment Period 1 (Weeks 0 to 12)||30
3045894|NCT01194245|3765640|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0 to 12)||0
3045895|NCT01194245|3765641|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0 to 12)||29
3045896|NCT01194245|3765642|FG002|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0 to 12)||28
3045897|NCT01194245|3765643|FG003|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0 to 12)||30
3045898|NCT01194245|3765644|FG004|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0 to 12)||30
3045899|NCT01194245|3765640|FG000|COMPLETED|Treatment Period 1 (Weeks 0 to 12)||0
3045900|NCT01194245|3765641|FG001|COMPLETED|Treatment Period 1 (Weeks 0 to 12)||29
3045901|NCT01194245|3765642|FG002|COMPLETED|Treatment Period 1 (Weeks 0 to 12)||27
3045902|NCT01194245|3765643|FG003|COMPLETED|Treatment Period 1 (Weeks 0 to 12)||29
3045903|NCT01194245|3765644|FG004|COMPLETED|Treatment Period 1 (Weeks 0 to 12)||28
3045904|NCT01194245|3765640|FG000|NOT COMPLETED|Treatment Period 1 (Weeks 0 to 12)||0
3045905|NCT01194245|3765641|FG001|NOT COMPLETED|Treatment Period 1 (Weeks 0 to 12)||0
3045906|NCT01194245|3765642|FG002|NOT COMPLETED|Treatment Period 1 (Weeks 0 to 12)||1
3045907|NCT01194245|3765643|FG003|NOT COMPLETED|Treatment Period 1 (Weeks 0 to 12)||1
3045908|NCT01194245|3765644|FG004|NOT COMPLETED|Treatment Period 1 (Weeks 0 to 12)||2
3045909|NCT01194245|3765640|FG000|STARTED|Treatment Period 2 (Weeks 12 to 24)||0
3045910|NCT01194245|3765641|FG001|STARTED|Treatment Period 2 (Weeks 12 to 24)||29
3045911|NCT01194245|3765642|FG002|STARTED|Treatment Period 2 (Weeks 12 to 24)||27
3045912|NCT01194245|3765643|FG003|STARTED|Treatment Period 2 (Weeks 12 to 24)||29
3045913|NCT01194245|3765644|FG004|STARTED|Treatment Period 2 (Weeks 12 to 24)||28
3045914|NCT01194245|3765640|FG000|COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
3045915|NCT01194245|3765641|FG001|COMPLETED|Treatment Period 2 (Weeks 12 to 24)||29
3045916|NCT01194245|3765642|FG002|COMPLETED|Treatment Period 2 (Weeks 12 to 24)||27
3045917|NCT01194245|3765643|FG003|COMPLETED|Treatment Period 2 (Weeks 12 to 24)||29
3045918|NCT01194245|3765644|FG004|COMPLETED|Treatment Period 2 (Weeks 12 to 24)||28
3045919|NCT01194245|3765640|FG000|NOT COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
3045920|NCT01194245|3765641|FG001|NOT COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
3045921|NCT01194245|3765642|FG002|NOT COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
3045922|NCT01194245|3765643|FG003|NOT COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
3045923|NCT01194245|3765644|FG004|NOT COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
3045924|NCT01194258|3765653|FG000|STARTED|Titration Period||132
3045925|NCT01194258|3765654|FG001|STARTED|Titration Period||0
3045926|NCT01194258|3765655|FG002|STARTED|Titration Period||0
3045927|NCT01194258|3765656|FG003|STARTED|Titration Period||0
3045928|NCT01194258|3765657|FG004|STARTED|Titration Period||0
3045929|NCT01194258|3765653|FG000|COMPLETED|Titration Period||121
3045930|NCT01194258|3765654|FG001|COMPLETED|Titration Period||0
3045931|NCT01194258|3765655|FG002|COMPLETED|Titration Period||0
3045932|NCT01194258|3765656|FG003|COMPLETED|Titration Period||0
3045933|NCT01194258|3765657|FG004|COMPLETED|Titration Period||0
3045934|NCT01194258|3765653|FG000|NOT COMPLETED|Titration Period||11
3045935|NCT01194258|3765654|FG001|NOT COMPLETED|Titration Period||0
3045936|NCT01194258|3765655|FG002|NOT COMPLETED|Titration Period||0
3045937|NCT01194258|3765656|FG003|NOT COMPLETED|Titration Period||0
3045938|NCT01194258|3765657|FG004|NOT COMPLETED|Titration Period||0
3045939|NCT01194258|3765653|FG000|STARTED|Period 1 (12 Weeks)|Participants were randomized to the Insulin lispro or an Analog-PH20 group after titration.|0
3045940|NCT01194258|3765654|FG001|STARTED|Period 1 (12 Weeks)|After the titration phase, 29 participants were randomized to the Insulin lispro/Lispro-PH20 group.|29
3045941|NCT01194258|3765655|FG002|STARTED|Period 1 (12 Weeks)|After the titration phase, 30 participants were randomized to the Lispro-PH20/Insulin lispro group.|30
3045942|NCT01194258|3765656|FG003|STARTED|Period 1 (12 Weeks)|After the titration phase, 29 participants were randomized to the Insulin lispro/Aspart-PH20 group.|29
3045943|NCT01194258|3765657|FG004|STARTED|Period 1 (12 Weeks)|After the titration phase, 33 participants were randomized to the Aspart-PH20/Insulin lispro group.|33
3045944|NCT01194258|3765653|FG000|Received at Least 1 Dose of Study Drug|Period 1 (12 Weeks)||0
3045945|NCT01194258|3765654|FG001|Received at Least 1 Dose of Study Drug|Period 1 (12 Weeks)||29
3045946|NCT01194258|3765655|FG002|Received at Least 1 Dose of Study Drug|Period 1 (12 Weeks)||30
3045947|NCT01194258|3765656|FG003|Received at Least 1 Dose of Study Drug|Period 1 (12 Weeks)||29
3045948|NCT01194258|3765657|FG004|Received at Least 1 Dose of Study Drug|Period 1 (12 Weeks)||33
3045949|NCT01194258|3765653|FG000|COMPLETED|Period 1 (12 Weeks)||0
3045950|NCT01194258|3765654|FG001|COMPLETED|Period 1 (12 Weeks)||29
3045951|NCT01194258|3765655|FG002|COMPLETED|Period 1 (12 Weeks)||30
3045952|NCT01194258|3765656|FG003|COMPLETED|Period 1 (12 Weeks)||29
3045953|NCT01194258|3765657|FG004|COMPLETED|Period 1 (12 Weeks)||32
3045954|NCT01194258|3765653|FG000|NOT COMPLETED|Period 1 (12 Weeks)||0
3045955|NCT01194258|3765654|FG001|NOT COMPLETED|Period 1 (12 Weeks)||0
3045956|NCT01194258|3765655|FG002|NOT COMPLETED|Period 1 (12 Weeks)||0
3045957|NCT01194258|3765656|FG003|NOT COMPLETED|Period 1 (12 Weeks)||0
3045958|NCT01194258|3765657|FG004|NOT COMPLETED|Period 1 (12 Weeks)||1
3045959|NCT01194258|3765653|FG000|STARTED|Period 2 (12 Weeks)||0
3045960|NCT01194258|3765654|FG001|STARTED|Period 2 (12 Weeks)||29
3045961|NCT01194258|3765655|FG002|STARTED|Period 2 (12 Weeks)||30
3045962|NCT01194258|3765656|FG003|STARTED|Period 2 (12 Weeks)||29
3045963|NCT01194258|3765657|FG004|STARTED|Period 2 (12 Weeks)||32
3045964|NCT01194258|3765653|FG000|COMPLETED|Period 2 (12 Weeks)||0
3045965|NCT01194258|3765654|FG001|COMPLETED|Period 2 (12 Weeks)||27
3045966|NCT01194258|3765655|FG002|COMPLETED|Period 2 (12 Weeks)||29
3045967|NCT01194258|3765656|FG003|COMPLETED|Period 2 (12 Weeks)||29
3045968|NCT01194258|3765657|FG004|COMPLETED|Period 2 (12 Weeks)||30
3045969|NCT01194258|3765653|FG000|NOT COMPLETED|Period 2 (12 Weeks)||0
3045970|NCT01194258|3765654|FG001|NOT COMPLETED|Period 2 (12 Weeks)||2
3045971|NCT01194258|3765655|FG002|NOT COMPLETED|Period 2 (12 Weeks)||1
3045972|NCT01194258|3765656|FG003|NOT COMPLETED|Period 2 (12 Weeks)||0
3045973|NCT01194258|3765657|FG004|NOT COMPLETED|Period 2 (12 Weeks)||2
3045974|NCT01194271|3765668|FG000|STARTED|Overall Study||19
3045975|NCT01194271|3765668|FG000|COMPLETED|Overall Study||16
3045976|NCT01194271|3765668|FG000|NOT COMPLETED|Overall Study||3
3045977|NCT01194297|3765674|FG000|STARTED|Overall Study||2
3045978|NCT01194297|3765675|FG001|STARTED|Overall Study||1
3045979|NCT01194297|3765674|FG000|COMPLETED|Overall Study||2
3045980|NCT01194297|3765675|FG001|COMPLETED|Overall Study||1
3045981|NCT01194297|3765674|FG000|NOT COMPLETED|Overall Study||0
3045982|NCT01194297|3765675|FG001|NOT COMPLETED|Overall Study||0
3045983|NCT01194414|3765683|FG000|STARTED|24 Weeks Double Blind Period||631
3045984|NCT01194414|3765684|FG001|STARTED|24 Weeks Double Blind Period||631
3045985|NCT01194414|3765685|FG002|STARTED|24 Weeks Double Blind Period||0
3045986|NCT01194414|3765686|FG003|STARTED|24 Weeks Double Blind Period||0
3045987|NCT01194414|3765683|FG000|Per Protocol Population|24 Weeks Double Blind Period||558
3045988|NCT01194414|3765684|FG001|Per Protocol Population|24 Weeks Double Blind Period||537
3045989|NCT01194414|3765685|FG002|Per Protocol Population|24 Weeks Double Blind Period||0
3045990|NCT01194414|3765686|FG003|Per Protocol Population|24 Weeks Double Blind Period||0
3045991|NCT01194414|3765683|FG000|COMPLETED|24 Weeks Double Blind Period||572
3045992|NCT01194414|3765684|FG001|COMPLETED|24 Weeks Double Blind Period||564
3045993|NCT01194414|3765685|FG002|COMPLETED|24 Weeks Double Blind Period||0
3045994|NCT01194414|3765686|FG003|COMPLETED|24 Weeks Double Blind Period||0
3045995|NCT01194414|3765683|FG000|NOT COMPLETED|24 Weeks Double Blind Period||59
3045996|NCT01194414|3765684|FG001|NOT COMPLETED|24 Weeks Double Blind Period||67
3045997|NCT01194414|3765685|FG002|NOT COMPLETED|24 Weeks Double Blind Period||0
3045998|NCT01194414|3765686|FG003|NOT COMPLETED|24 Weeks Double Blind Period||0
3045999|NCT01194414|3765683|FG000|STARTED|72 Weeks Open Label Extension||524
3046000|NCT01194414|3765684|FG001|STARTED|72 Weeks Open Label Extension||377
3046001|NCT01194414|3765685|FG002|STARTED|72 Weeks Open Label Extension||48
3046002|NCT01194414|3765686|FG003|STARTED|72 Weeks Open Label Extension||186
3046003|NCT01194414|3765683|FG000|COMPLETED|72 Weeks Open Label Extension||445
3046004|NCT01194414|3765684|FG001|COMPLETED|72 Weeks Open Label Extension||311
3046005|NCT01194414|3765685|FG002|COMPLETED|72 Weeks Open Label Extension||40
3046006|NCT01194414|3765686|FG003|COMPLETED|72 Weeks Open Label Extension||160
3046007|NCT01194414|3765683|FG000|NOT COMPLETED|72 Weeks Open Label Extension||79
3046008|NCT01194414|3765684|FG001|NOT COMPLETED|72 Weeks Open Label Extension||66
3046009|NCT01194414|3765685|FG002|NOT COMPLETED|72 Weeks Open Label Extension||8
3046010|NCT01194414|3765686|FG003|NOT COMPLETED|72 Weeks Open Label Extension||26
3046011|NCT01194440|3765698|FG000|STARTED|Baseline (First Dose)||59
3046012|NCT01194440|3765698|FG000|COMPLETED|Baseline (First Dose)||52
3046013|NCT01194440|3765698|FG000|NOT COMPLETED|Baseline (First Dose)||7
3046014|NCT01194440|3765698|FG000|STARTED|6-months (2nd Dose)||52
3046015|NCT01194440|3765698|FG000|COMPLETED|6-months (2nd Dose)||48
3046016|NCT01194440|3765698|FG000|NOT COMPLETED|6-months (2nd Dose)||4
3046017|NCT01194453|3765705|FG000|STARTED|Overall Study||144
3046018|NCT01194453|3765706|FG001|STARTED|Overall Study||144
3046019|NCT01194453|3765705|FG000|COMPLETED|Overall Study||127
3046020|NCT01194453|3765706|FG001|COMPLETED|Overall Study||127
3046021|NCT01194453|3765705|FG000|NOT COMPLETED|Overall Study||17
3046022|NCT01194453|3765706|FG001|NOT COMPLETED|Overall Study||17
3046023|NCT01194466|3765712|FG000|STARTED|Overall Study||14
3046024|NCT01194466|3765713|FG001|STARTED|Overall Study||14
3046025|NCT01194466|3765714|FG002|STARTED|Overall Study||13
3046026|NCT01194466|3765712|FG000|COMPLETED|Overall Study||14
3046027|NCT01194466|3765713|FG001|COMPLETED|Overall Study||14
3046028|NCT01194466|3765714|FG002|COMPLETED|Overall Study||13
3046029|NCT01194466|3765712|FG000|NOT COMPLETED|Overall Study||0
3046030|NCT01194466|3765713|FG001|NOT COMPLETED|Overall Study||0
3046031|NCT01194466|3765714|FG002|NOT COMPLETED|Overall Study||0
3046032|NCT01194479|3765724|FG000|STARTED|Overall Study||3
3046033|NCT01194479|3765725|FG001|STARTED|Overall Study||4
3046034|NCT01194479|3765726|FG002|STARTED|Overall Study||2
3046035|NCT01194479|3765727|FG003|STARTED|Overall Study||5
3046036|NCT01194479|3765724|FG000|Cross-over at Second Visit|Overall Study||3
3046037|NCT01194479|3765725|FG001|Cross-over at Second Visit|Overall Study||4
3046038|NCT01194479|3765726|FG002|Cross-over at Second Visit|Overall Study||2
3046039|NCT01194479|3765727|FG003|Cross-over at Second Visit|Overall Study||5
3046040|NCT01194479|3765724|FG000|COMPLETED|Overall Study||3
3046041|NCT01194479|3765725|FG001|COMPLETED|Overall Study||4
3046042|NCT01194479|3765726|FG002|COMPLETED|Overall Study||2
3046043|NCT01194479|3765727|FG003|COMPLETED|Overall Study||5
3046044|NCT01194479|3765724|FG000|NOT COMPLETED|Overall Study||0
3046045|NCT01194479|3765725|FG001|NOT COMPLETED|Overall Study||0
3046046|NCT01194479|3765726|FG002|NOT COMPLETED|Overall Study||0
3046047|NCT01194479|3765727|FG003|NOT COMPLETED|Overall Study||0
3046048|NCT01194531|3765739|FG000|STARTED|Overall Study||29
3046049|NCT01194531|3765740|FG001|STARTED|Overall Study||30
3046050|NCT01194531|3765739|FG000|COMPLETED|Overall Study||24
3046051|NCT01194531|3765740|FG001|COMPLETED|Overall Study||27
3046052|NCT01194531|3765739|FG000|NOT COMPLETED|Overall Study||5
3046053|NCT01194531|3765740|FG001|NOT COMPLETED|Overall Study||3
3046054|NCT01194674|3765746|FG000|STARTED|Overall Study||2
3046055|NCT01194674|3765746|FG000|COMPLETED|Overall Study||2
3046056|NCT01194674|3765746|FG000|NOT COMPLETED|Overall Study||0
3046057|NCT01194804|3765751|FG000|STARTED|Overall Study||27
3046058|NCT01194804|3765751|FG000|COMPLETED|Overall Study||26
3046059|NCT01194804|3765751|FG000|NOT COMPLETED|Overall Study||1
3046060|NCT01194830|3765757|FG000|STARTED|Overall Study||124
3046061|NCT01194830|3765758|FG001|STARTED|Overall Study||110
3046062|NCT01194830|3765757|FG000|COMPLETED|Overall Study||88
3046063|NCT01194830|3765758|FG001|COMPLETED|Overall Study||83
3046064|NCT01194830|3765757|FG000|NOT COMPLETED|Overall Study||36
3046065|NCT01194830|3765758|FG001|NOT COMPLETED|Overall Study||27
3046066|NCT01194869|3765764|FG000|STARTED|Overall Study||25
3046067|NCT01194869|3765764|FG000|COMPLETED|Overall Study||21
3046068|NCT01194869|3765764|FG000|NOT COMPLETED|Overall Study||4
3046069|NCT01194973|3765768|FG000|STARTED|Screening Period||44
3046070|NCT01194973|3765768|FG000|COMPLETED|Screening Period||41
3046071|NCT01194973|3765768|FG000|NOT COMPLETED|Screening Period||3
3046072|NCT01194973|3765768|FG000|STARTED|26 Week Treatment Period||41
3046073|NCT01194973|3765768|FG000|COMPLETED|26 Week Treatment Period||38
3046074|NCT01194973|3765768|FG000|NOT COMPLETED|26 Week Treatment Period||3
3046075|NCT01194999|3765772|FG000|STARTED|Overall Study||132
3046076|NCT01194999|3765772|FG000|COMPLETED|Overall Study||115
3046077|NCT01194999|3765772|FG000|NOT COMPLETED|Overall Study||17
3046078|NCT01195025|3765776|FG000|STARTED|First Intervention A||2
3046079|NCT01195025|3765777|FG001|STARTED|First Intervention A||3
3046080|NCT01195025|3765778|FG002|STARTED|First Intervention A||2
3046081|NCT01195025|3765779|FG003|STARTED|First Intervention A||2
3046082|NCT01195025|3765780|FG004|STARTED|First Intervention A||1
3046083|NCT01195025|3765776|FG000|COMPLETED|First Intervention A||2
3046084|NCT01195025|3765777|FG001|COMPLETED|First Intervention A||3
3046085|NCT01195025|3765778|FG002|COMPLETED|First Intervention A||2
3046086|NCT01195025|3765779|FG003|COMPLETED|First Intervention A||2
3046087|NCT01195025|3765780|FG004|COMPLETED|First Intervention A||1
3046088|NCT01195025|3765776|FG000|NOT COMPLETED|First Intervention A||0
3046089|NCT01195025|3765777|FG001|NOT COMPLETED|First Intervention A||0
3046090|NCT01195025|3765778|FG002|NOT COMPLETED|First Intervention A||0
3046091|NCT01195025|3765779|FG003|NOT COMPLETED|First Intervention A||0
3046092|NCT01195025|3765780|FG004|NOT COMPLETED|First Intervention A||0
3046093|NCT01195025|3765776|FG000|STARTED|Second Intervention B||2
3046094|NCT01195025|3765777|FG001|STARTED|Second Intervention B||3
3046095|NCT01195025|3765778|FG002|STARTED|Second Intervention B||2
3046096|NCT01195025|3765779|FG003|STARTED|Second Intervention B||2
3046097|NCT01195025|3765780|FG004|STARTED|Second Intervention B||1
3046098|NCT01195025|3765776|FG000|COMPLETED|Second Intervention B||2
3046099|NCT01195025|3765777|FG001|COMPLETED|Second Intervention B||3
3046100|NCT01195025|3765778|FG002|COMPLETED|Second Intervention B||2
3046101|NCT01195025|3765779|FG003|COMPLETED|Second Intervention B||2
3046102|NCT01195025|3765780|FG004|COMPLETED|Second Intervention B||1
3046103|NCT01195025|3765776|FG000|NOT COMPLETED|Second Intervention B||0
3046104|NCT01195025|3765777|FG001|NOT COMPLETED|Second Intervention B||0
3046105|NCT01195025|3765778|FG002|NOT COMPLETED|Second Intervention B||0
3046106|NCT01195025|3765779|FG003|NOT COMPLETED|Second Intervention B||0
3046107|NCT01195025|3765780|FG004|NOT COMPLETED|Second Intervention B||0
3046108|NCT01195025|3765776|FG000|STARTED|Third Intervention C||2
3046109|NCT01195025|3765777|FG001|STARTED|Third Intervention C||3
3046110|NCT01195025|3765778|FG002|STARTED|Third Intervention C||2
3046111|NCT01195025|3765779|FG003|STARTED|Third Intervention C||2
3046112|NCT01195025|3765780|FG004|STARTED|Third Intervention C||1
3046113|NCT01195025|3765776|FG000|COMPLETED|Third Intervention C||2
3046114|NCT01195025|3765777|FG001|COMPLETED|Third Intervention C||3
3046115|NCT01195025|3765778|FG002|COMPLETED|Third Intervention C||2
3046116|NCT01195025|3765779|FG003|COMPLETED|Third Intervention C||2
3046117|NCT01195025|3765780|FG004|COMPLETED|Third Intervention C||1
3046118|NCT01195025|3765776|FG000|NOT COMPLETED|Third Intervention C||0
3046119|NCT01195025|3765777|FG001|NOT COMPLETED|Third Intervention C||0
3046120|NCT01195025|3765778|FG002|NOT COMPLETED|Third Intervention C||0
3046121|NCT01195025|3765779|FG003|NOT COMPLETED|Third Intervention C||0
3046122|NCT01195025|3765780|FG004|NOT COMPLETED|Third Intervention C||0
3046123|NCT01195090|3765788|FG000|STARTED|Overall Study||60
3046124|NCT01195090|3765789|FG001|STARTED|Overall Study||60
3046125|NCT01195090|3765788|FG000|COMPLETED|Overall Study||54
3046126|NCT01195090|3765789|FG001|COMPLETED|Overall Study||52
3046127|NCT01195090|3765788|FG000|NOT COMPLETED|Overall Study||6
3046128|NCT01195090|3765789|FG001|NOT COMPLETED|Overall Study||8
3046129|NCT01195103|3765798|FG000|STARTED|Overall Study||6
3046130|NCT01195103|3765799|FG001|STARTED|Overall Study||2
3046131|NCT01195103|3765800|FG002|STARTED|Overall Study||5
3046132|NCT01195103|3765798|FG000|COMPLETED|Overall Study|One patient withdrew after randomization but before received study drug.|5
3046133|NCT01195103|3765799|FG001|COMPLETED|Overall Study||2
3046134|NCT01195103|3765800|FG002|COMPLETED|Overall Study||5
3046135|NCT01195103|3765798|FG000|NOT COMPLETED|Overall Study||1
3046136|NCT01195103|3765799|FG001|NOT COMPLETED|Overall Study||0
3046137|NCT01195103|3765800|FG002|NOT COMPLETED|Overall Study||0
3046138|NCT01195116|3765810|FG000|STARTED|Overall Study||21
3046139|NCT01195116|3765811|FG001|STARTED|Overall Study||20
3046140|NCT01195116|3765810|FG000|COMPLETED|Overall Study||21
3046141|NCT01195116|3765811|FG001|COMPLETED|Overall Study||20
3046142|NCT01195116|3765810|FG000|NOT COMPLETED|Overall Study||0
3046143|NCT01195116|3765811|FG001|NOT COMPLETED|Overall Study||0
3046144|NCT01195272|3765817|FG000|STARTED|Overall Study||21
3046145|NCT01195272|3765817|FG000|COMPLETED|Overall Study||17
3046146|NCT01195272|3765817|FG000|NOT COMPLETED|Overall Study||4
3046147|NCT01195363|3765823|FG000|STARTED|Overall Study||15
3046148|NCT01195363|3765824|FG001|STARTED|Overall Study||13
3046149|NCT01195363|3765823|FG000|COMPLETED|Overall Study||4
3046150|NCT01195363|3765824|FG001|COMPLETED|Overall Study||4
3046151|NCT01195363|3765823|FG000|NOT COMPLETED|Overall Study||11
3046152|NCT01195363|3765824|FG001|NOT COMPLETED|Overall Study||9
3046153|NCT01195415|3765830|FG000|STARTED|Overall Study||25
3046154|NCT01195415|3765830|FG000|COMPLETED|Overall Study||23
3046155|NCT01195415|3765830|FG000|NOT COMPLETED|Overall Study||2
3046156|NCT01195467|3765834|FG000|STARTED|Overall Study||40
3046157|NCT01195467|3765834|FG000|COMPLETED|Overall Study||30
3046158|NCT01195467|3765834|FG000|NOT COMPLETED|Overall Study||10
3046159|NCT01195545|3765838|FG000|STARTED|Overall Study||20
3046160|NCT01195545|3765838|FG000|COMPLETED|Overall Study||16
3046161|NCT01195545|3765838|FG000|NOT COMPLETED|Overall Study||4
3137463|NCT01717768|3862587|FG003|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
3137464|NCT01717768|3862588|FG004|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
3137465|NCT01717768|3862589|FG005|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
3137466|NCT01717768|3862590|FG006|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
3137467|NCT01717768|3862591|FG007|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
3137468|NCT01717768|3862592|FG008|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
3137469|NCT01717768|3862593|FG009|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
3137470|NCT01717768|3862594|FG010|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
3137471|NCT01717768|3862595|FG011|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
3137472|NCT01717768|3862584|FG000|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
3137473|NCT01717768|3862585|FG001|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
3137474|NCT01717768|3862586|FG002|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
3137475|NCT01717768|3862587|FG003|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
3137476|NCT01717768|3862588|FG004|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
3137477|NCT01717768|3862589|FG005|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
3137478|NCT01717768|3862590|FG006|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||17
3137479|NCT01717768|3862591|FG007|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
3137480|NCT01717768|3862592|FG008|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||16
3137481|NCT01717768|3862593|FG009|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
3137482|NCT01717768|3862594|FG010|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||16
3137483|NCT01717768|3862595|FG011|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||16
3137484|NCT01717768|3862584|FG000|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
3137485|NCT01717768|3862585|FG001|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
3046162|NCT01195584|3765845|FG000|STARTED|Overall Study||20
3046163|NCT01195584|3765846|FG001|STARTED|Overall Study||25
3046164|NCT01195584|3765847|FG002|STARTED|Overall Study||27
3046165|NCT01195584|3765845|FG000|COMPLETED|Overall Study||20
3046166|NCT01195584|3765846|FG001|COMPLETED|Overall Study||25
3046167|NCT01195584|3765847|FG002|COMPLETED|Overall Study||27
3046168|NCT01195584|3765845|FG000|NOT COMPLETED|Overall Study||0
3046169|NCT01195584|3765846|FG001|NOT COMPLETED|Overall Study||0
3046170|NCT01195584|3765847|FG002|NOT COMPLETED|Overall Study||0
3046171|NCT01195597|3765857|FG000|STARTED|Overall Study||40
3046172|NCT01195597|3765857|FG000|COMPLETED|Overall Study||27
3046173|NCT01195597|3765857|FG000|NOT COMPLETED|Overall Study||13
3046174|NCT01195623|3765863|FG000|STARTED|Overall Study|166 legs total operated|148
3046175|NCT01195623|3765864|FG001|STARTED|Overall Study|177 legs total operated|145
3046176|NCT01195623|3765863|FG000|COMPLETED|Overall Study|127 legs|113
3046177|NCT01195623|3765864|FG001|COMPLETED|Overall Study|129 legs|108
3046178|NCT01195623|3765863|FG000|NOT COMPLETED|Overall Study||35
3046179|NCT01195623|3765864|FG001|NOT COMPLETED|Overall Study||37
3046180|NCT01195636|3765872|FG000|STARTED|First Intervention (3 Weeks)||35
3046181|NCT01195636|3765873|FG001|STARTED|First Intervention (3 Weeks)||35
3046182|NCT01195636|3765872|FG000|Received at Least 1 Dose of Drug|First Intervention (3 Weeks)||33
3046183|NCT01195636|3765873|FG001|Received at Least 1 Dose of Drug|First Intervention (3 Weeks)||35
3046184|NCT01195636|3765872|FG000|COMPLETED|First Intervention (3 Weeks)||30
3046185|NCT01195636|3765873|FG001|COMPLETED|First Intervention (3 Weeks)||32
3046186|NCT01195636|3765872|FG000|NOT COMPLETED|First Intervention (3 Weeks)||5
3046187|NCT01195636|3765873|FG001|NOT COMPLETED|First Intervention (3 Weeks)||3
3046188|NCT01195636|3765872|FG000|STARTED|Washout Period (2 Weeks)||30
3046189|NCT01195636|3765873|FG001|STARTED|Washout Period (2 Weeks)||32
3046190|NCT01195636|3765872|FG000|COMPLETED|Washout Period (2 Weeks)||28
3046191|NCT01195636|3765873|FG001|COMPLETED|Washout Period (2 Weeks)||29
3046192|NCT01195636|3765872|FG000|NOT COMPLETED|Washout Period (2 Weeks)||2
3046193|NCT01195636|3765873|FG001|NOT COMPLETED|Washout Period (2 Weeks)||3
3046194|NCT01195636|3765872|FG000|STARTED|Second Intervention (3 Weeks)||28
3046195|NCT01195636|3765873|FG001|STARTED|Second Intervention (3 Weeks)||29
3046196|NCT01195636|3765872|FG000|COMPLETED|Second Intervention (3 Weeks)||27
3046197|NCT01195636|3765873|FG001|COMPLETED|Second Intervention (3 Weeks)||27
3046198|NCT01195636|3765872|FG000|NOT COMPLETED|Second Intervention (3 Weeks)||1
3046199|NCT01195636|3765873|FG001|NOT COMPLETED|Second Intervention (3 Weeks)||2
3046200|NCT01195662|3765882|FG000|STARTED|Double Blind Treatment Period||224
3046201|NCT01195662|3765883|FG001|STARTED|Double Blind Treatment Period||225
3046202|NCT01195662|3765884|FG002|STARTED|Double Blind Treatment Period||133
3046203|NCT01195662|3765882|FG000|COMPLETED|Double Blind Treatment Period||202
3046204|NCT01195662|3765883|FG001|COMPLETED|Double Blind Treatment Period||211
3046205|NCT01195662|3765884|FG002|COMPLETED|Double Blind Treatment Period||119
3046206|NCT01195662|3765882|FG000|NOT COMPLETED|Double Blind Treatment Period||22
3046207|NCT01195662|3765883|FG001|NOT COMPLETED|Double Blind Treatment Period||14
3046208|NCT01195662|3765884|FG002|NOT COMPLETED|Double Blind Treatment Period||14
3046209|NCT01195662|3765882|FG000|STARTED|Follow-Up(Week 13/1 Week Post Last Dose)|1 participant discontinued drug but remained in study and entered Follow-Up.|203
3046210|NCT01195662|3765883|FG001|STARTED|Follow-Up(Week 13/1 Week Post Last Dose)|2 participants completed treatment period but chose not to enter follow up period.|209
3046211|NCT01195662|3765884|FG002|STARTED|Follow-Up(Week 13/1 Week Post Last Dose)|1 participant discontinued drug but remained in the study and entered the follow up period.|120
3046212|NCT01195662|3765882|FG000|COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||200
3046213|NCT01195662|3765883|FG001|COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||209
3046214|NCT01195662|3765884|FG002|COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||119
3046215|NCT01195662|3765882|FG000|NOT COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||3
3046216|NCT01195662|3765883|FG001|NOT COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||0
3046217|NCT01195662|3765884|FG002|NOT COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||1
3046218|NCT01195675|3765893|FG000|STARTED|Overall Study||30
3046219|NCT01195675|3765893|FG000|Received Empa 25mg|Overall Study||28
3046220|NCT01195675|3765893|FG000|Received Empa 200mg|Overall Study||30
3046221|NCT01195675|3765893|FG000|Received Moxifloxacin|Overall Study||29
3046222|NCT01195675|3765893|FG000|Received Placebo 1|Overall Study||29
3046223|NCT01195675|3765893|FG000|Received Placebo 2|Overall Study||28
3046224|NCT01195675|3765893|FG000|COMPLETED|Overall Study||27
3046225|NCT01195675|3765893|FG000|NOT COMPLETED|Overall Study||3
3046226|NCT01195701|3765910|FG000|STARTED|Overall Study||10
3046227|NCT01195701|3765911|FG001|STARTED|Overall Study||25
3046228|NCT01195701|3765910|FG000|COMPLETED|Overall Study||10
3046229|NCT01195701|3765911|FG001|COMPLETED|Overall Study||20
3046230|NCT01195701|3765910|FG000|NOT COMPLETED|Overall Study||0
3046231|NCT01195701|3765911|FG001|NOT COMPLETED|Overall Study||5
3046232|NCT01195779|3765931|FG000|STARTED|Overall Study||0
3046233|NCT01195779|3765932|FG001|STARTED|Overall Study||0
3046234|NCT01195779|3765933|FG002|STARTED|Overall Study||0
3046235|NCT01195779|3765934|FG003|STARTED|Overall Study||0
3180421|NCT01990859|3908805|FG000|COMPLETED|90 Day Follow Up for All Participants||20
3180422|NCT01990859|3908805|FG000|NOT COMPLETED|90 Day Follow Up for All Participants||0
3180423|NCT01990898|3908810|FG000|STARTED|Overall Study||26
3180424|NCT01990898|3908810|FG000|3 Months|Overall Study||22
3180425|NCT01990898|3908810|FG000|COMPLETED|Overall Study||22
3180426|NCT01990898|3908810|FG000|NOT COMPLETED|Overall Study||4
3046236|NCT01195779|3765935|FG004|STARTED|Overall Study||1
3046237|NCT01195779|3765936|FG005|STARTED|Overall Study||0
3046238|NCT01195779|3765937|FG006|STARTED|Overall Study||0
3046239|NCT01195779|3765938|FG007|STARTED|Overall Study||1
3046240|NCT01195779|3765939|FG008|STARTED|Overall Study||0
3046241|NCT01195779|3765940|FG009|STARTED|Overall Study||0
3046242|NCT01195779|3765941|FG010|STARTED|Overall Study||0
3046243|NCT01195779|3765942|FG011|STARTED|Overall Study||1
3046244|NCT01195779|3765943|FG012|STARTED|Overall Study||0
3046245|NCT01195779|3765944|FG013|STARTED|Overall Study||1
3046246|NCT01195779|3765931|FG000|COMPLETED|Overall Study||0
3046247|NCT01195779|3765932|FG001|COMPLETED|Overall Study||0
3046248|NCT01195779|3765933|FG002|COMPLETED|Overall Study||0
3046249|NCT01195779|3765934|FG003|COMPLETED|Overall Study||0
3046250|NCT01195779|3765935|FG004|COMPLETED|Overall Study||1
3046251|NCT01195779|3765936|FG005|COMPLETED|Overall Study||0
3046252|NCT01195779|3765937|FG006|COMPLETED|Overall Study||0
3046253|NCT01195779|3765938|FG007|COMPLETED|Overall Study||1
3046254|NCT01195779|3765939|FG008|COMPLETED|Overall Study||0
3046255|NCT01195779|3765940|FG009|COMPLETED|Overall Study||0
3046256|NCT01195779|3765941|FG010|COMPLETED|Overall Study||0
3046257|NCT01195779|3765942|FG011|COMPLETED|Overall Study||1
3046258|NCT01195779|3765943|FG012|COMPLETED|Overall Study||0
3046259|NCT01195779|3765944|FG013|COMPLETED|Overall Study||1
3046260|NCT01195779|3765931|FG000|NOT COMPLETED|Overall Study||0
3046261|NCT01195779|3765932|FG001|NOT COMPLETED|Overall Study||0
3046262|NCT01195779|3765933|FG002|NOT COMPLETED|Overall Study||0
3046263|NCT01195779|3765934|FG003|NOT COMPLETED|Overall Study||0
3046264|NCT01195779|3765935|FG004|NOT COMPLETED|Overall Study||0
3046265|NCT01195779|3765936|FG005|NOT COMPLETED|Overall Study||0
3046266|NCT01195779|3765937|FG006|NOT COMPLETED|Overall Study||0
3046267|NCT01195779|3765938|FG007|NOT COMPLETED|Overall Study||0
3046268|NCT01195779|3765939|FG008|NOT COMPLETED|Overall Study||0
3046269|NCT01195779|3765940|FG009|NOT COMPLETED|Overall Study||0
3046270|NCT01195779|3765941|FG010|NOT COMPLETED|Overall Study||0
3046271|NCT01195779|3765942|FG011|NOT COMPLETED|Overall Study||0
3046272|NCT01195779|3765943|FG012|NOT COMPLETED|Overall Study||0
3046273|NCT01195779|3765944|FG013|NOT COMPLETED|Overall Study||0
3046274|NCT01195831|3765976|FG000|STARTED|Overall Study||120
3046275|NCT01195831|3765977|FG001|STARTED|Overall Study||124
3046276|NCT01195831|3765976|FG000|COMPLETED|Overall Study||112
3046277|NCT01195831|3765977|FG001|COMPLETED|Overall Study||114
3046278|NCT01195831|3765976|FG000|NOT COMPLETED|Overall Study||8
3046279|NCT01195831|3765977|FG001|NOT COMPLETED|Overall Study||10
3046280|NCT01195844|3765983|FG000|STARTED|Overall Study||230
3046281|NCT01195844|3765983|FG000|COMPLETED|Overall Study||190
3046282|NCT01195844|3765983|FG000|NOT COMPLETED|Overall Study||40
3046283|NCT01195883|3765999|FG000|STARTED|Overall Study||553
3046284|NCT01195883|3766000|FG001|STARTED|Overall Study||549
3046285|NCT01195883|3765999|FG000|COMPLETED|Overall Study||534
3046286|NCT01195883|3766000|FG001|COMPLETED|Overall Study||523
3046287|NCT01195883|3765999|FG000|NOT COMPLETED|Overall Study||19
3046288|NCT01195883|3766000|FG001|NOT COMPLETED|Overall Study||26
3046289|NCT01195922|3766006|FG000|STARTED|Overall Study||16
3046290|NCT01195922|3766006|FG000|COMPLETED|Overall Study||16
3046291|NCT01195922|3766006|FG000|NOT COMPLETED|Overall Study||0
3137486|NCT01717768|3862586|FG002|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
3137487|NCT01717768|3862587|FG003|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
3137488|NCT01717768|3862588|FG004|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
3137489|NCT01717768|3862589|FG005|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
3137490|NCT01717768|3862590|FG006|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||17
3137491|NCT01717768|3862591|FG007|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
3137492|NCT01717768|3862592|FG008|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||16
3137493|NCT01717768|3862593|FG009|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
3137494|NCT01717768|3862594|FG010|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||16
3137495|NCT01717768|3862595|FG011|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||15
3137496|NCT01717768|3862584|FG000|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
3137497|NCT01717768|3862585|FG001|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
3137498|NCT01717768|3862586|FG002|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
3137499|NCT01717768|3862587|FG003|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
3137500|NCT01717768|3862588|FG004|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
3137501|NCT01717768|3862589|FG005|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
3137502|NCT01717768|3862590|FG006|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
3137503|NCT01717768|3862591|FG007|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
3137504|NCT01717768|3862592|FG008|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
3137505|NCT01717768|3862593|FG009|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
3137506|NCT01717768|3862594|FG010|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
3137507|NCT01717768|3862595|FG011|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||1
3137508|NCT01717768|3862584|FG000|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
3137509|NCT01717768|3862585|FG001|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
3137510|NCT01717768|3862586|FG002|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
3137511|NCT01717768|3862587|FG003|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
3137512|NCT01717768|3862588|FG004|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
3137513|NCT01717768|3862589|FG005|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
3180427|NCT01990950|3908814|FG000|STARTED|Overall Study||21
3046292|NCT01195948|3766013|FG000|STARTED|Overall Study||10
3046293|NCT01195948|3766014|FG001|STARTED|Overall Study||10
3046294|NCT01195948|3766015|FG002|STARTED|Overall Study||11
3046295|NCT01195948|3766013|FG000|Week 24|Overall Study||10
3046296|NCT01195948|3766014|FG001|Week 24|Overall Study||10
3046297|NCT01195948|3766015|FG002|Week 24|Overall Study||10
3046298|NCT01195948|3766013|FG000|COMPLETED|Overall Study||10
3046299|NCT01195948|3766014|FG001|COMPLETED|Overall Study||9
3046300|NCT01195948|3766015|FG002|COMPLETED|Overall Study||9
3046301|NCT01195948|3766013|FG000|NOT COMPLETED|Overall Study||0
3046302|NCT01195948|3766014|FG001|NOT COMPLETED|Overall Study||1
3046303|NCT01195948|3766015|FG002|NOT COMPLETED|Overall Study||2
3046304|NCT01196026|3766032|FG000|STARTED|Overall Study||10
3046305|NCT01196026|3766033|FG001|STARTED|Overall Study||44
3046306|NCT01196026|3766034|FG002|STARTED|Overall Study||23
3046307|NCT01196026|3766035|FG003|STARTED|Overall Study||10
3046308|NCT01196026|3766036|FG004|STARTED|Overall Study||43
3046309|NCT01196026|3766037|FG005|STARTED|Overall Study||24
3046310|NCT01196026|3766032|FG000|Completed at Day 28|Overall Study||9
3046311|NCT01196026|3766033|FG001|Completed at Day 28|Overall Study||41
3046312|NCT01196026|3766034|FG002|Completed at Day 28|Overall Study||23
3046313|NCT01196026|3766035|FG003|Completed at Day 28|Overall Study||10
3046314|NCT01196026|3766036|FG004|Completed at Day 28|Overall Study||42
3046315|NCT01196026|3766037|FG005|Completed at Day 28|Overall Study||24
3046316|NCT01196026|3766032|FG000|COMPLETED|Overall Study||9
3046317|NCT01196026|3766033|FG001|COMPLETED|Overall Study||36
3046318|NCT01196026|3766034|FG002|COMPLETED|Overall Study||23
3046319|NCT01196026|3766035|FG003|COMPLETED|Overall Study||10
3046320|NCT01196026|3766036|FG004|COMPLETED|Overall Study||42
3046321|NCT01196026|3766037|FG005|COMPLETED|Overall Study||24
3046322|NCT01196026|3766032|FG000|NOT COMPLETED|Overall Study||1
3046323|NCT01196026|3766033|FG001|NOT COMPLETED|Overall Study||8
3046324|NCT01196026|3766034|FG002|NOT COMPLETED|Overall Study||0
3046325|NCT01196026|3766035|FG003|NOT COMPLETED|Overall Study||0
3046326|NCT01196026|3766036|FG004|NOT COMPLETED|Overall Study||1
3046327|NCT01196026|3766037|FG005|NOT COMPLETED|Overall Study||0
3046328|NCT01196052|3766053|FG000|STARTED|Overall Study||153
3046329|NCT01196052|3766053|FG000|Received Trastuzumab Emtansine|Overall Study||148
3046330|NCT01196052|3766053|FG000|COMPLETED|Overall Study||130
3046331|NCT01196052|3766053|FG000|NOT COMPLETED|Overall Study||23
3046332|NCT01196078|3766059|FG000|STARTED|Overall Study||57
3046333|NCT01196078|3766060|FG001|STARTED|Overall Study||57
3046334|NCT01196078|3766059|FG000|COMPLETED|Overall Study||24
3046335|NCT01196078|3766060|FG001|COMPLETED|Overall Study||20
3046336|NCT01196078|3766059|FG000|NOT COMPLETED|Overall Study||33
3046337|NCT01196078|3766060|FG001|NOT COMPLETED|Overall Study||37
3046338|NCT01196091|3766069|FG000|STARTED|Overall Study||387
3046339|NCT01196091|3766070|FG001|STARTED|Overall Study||389
3046340|NCT01196091|3766071|FG002|STARTED|Overall Study||388
3046341|NCT01196091|3766069|FG000|Received at Least 1 Dose of Study Drug|Overall Study||386
3046342|NCT01196091|3766070|FG001|Received at Least 1 Dose of Study Drug|Overall Study||389
3046343|NCT01196091|3766071|FG002|Received at Least 1 Dose of Study Drug|Overall Study||387
3046344|NCT01196091|3766069|FG000|ITT-Received Drug and Excluded Sites|Overall Study||381
3046345|NCT01196091|3766070|FG001|ITT-Received Drug and Excluded Sites|Overall Study||378
3046346|NCT01196091|3766071|FG002|ITT-Received Drug and Excluded Sites|Overall Study||379
3046347|NCT01196091|3766069|FG000|Follow-Up|Overall Study||103
3046348|NCT01196091|3766070|FG001|Follow-Up|Overall Study||105
3046349|NCT01196091|3766071|FG002|Follow-Up|Overall Study||128
3046350|NCT01196091|3766069|FG000|COMPLETED|Overall Study||299
3046351|NCT01196091|3766070|FG001|COMPLETED|Overall Study||291
3046352|NCT01196091|3766071|FG002|COMPLETED|Overall Study||284
3046353|NCT01196091|3766069|FG000|NOT COMPLETED|Overall Study||88
3046354|NCT01196091|3766070|FG001|NOT COMPLETED|Overall Study||98
3046355|NCT01196091|3766071|FG002|NOT COMPLETED|Overall Study||104
3046356|NCT01196104|3766086|FG000|STARTED|Overall Study||19
3046357|NCT01196104|3766087|FG001|STARTED|Overall Study||20
3046358|NCT01196104|3766086|FG000|COMPLETED|Overall Study||15
3046359|NCT01196104|3766087|FG001|COMPLETED|Overall Study||15
3046360|NCT01196104|3766086|FG000|NOT COMPLETED|Overall Study||4
3046361|NCT01196104|3766087|FG001|NOT COMPLETED|Overall Study||5
3046362|NCT01196117|3766095|FG000|STARTED|Placebo, Then CPAP||18
3046363|NCT01196117|3766096|FG001|STARTED|Placebo, Then CPAP||0
3046364|NCT01196117|3766095|FG000|COMPLETED|Placebo, Then CPAP||18
3046365|NCT01196117|3766096|FG001|COMPLETED|Placebo, Then CPAP||0
3046366|NCT01196117|3766095|FG000|NOT COMPLETED|Placebo, Then CPAP||0
3046367|NCT01196117|3766096|FG001|NOT COMPLETED|Placebo, Then CPAP||0
3046368|NCT01196117|3766095|FG000|STARTED|CPAP||0
3046369|NCT01196117|3766096|FG001|STARTED|CPAP||18
3046370|NCT01196117|3766095|FG000|COMPLETED|CPAP||0
3046371|NCT01196117|3766096|FG001|COMPLETED|CPAP||18
3046372|NCT01196117|3766095|FG000|NOT COMPLETED|CPAP||0
3046373|NCT01196117|3766096|FG001|NOT COMPLETED|CPAP||0
3046374|NCT01196377|3766110|FG000|STARTED|Overall Study||4
3046375|NCT01196377|3766111|FG001|STARTED|Overall Study||4
3046376|NCT01196377|3766112|FG002|STARTED|Overall Study||4
3046377|NCT01196377|3766113|FG003|STARTED|Overall Study||4
3046378|NCT01196377|3766110|FG000|COMPLETED|Overall Study||4
3046379|NCT01196377|3766111|FG001|COMPLETED|Overall Study||4
3046380|NCT01196377|3766112|FG002|COMPLETED|Overall Study||4
3046381|NCT01196377|3766113|FG003|COMPLETED|Overall Study||4
3046382|NCT01196377|3766110|FG000|NOT COMPLETED|Overall Study||0
3046383|NCT01196377|3766111|FG001|NOT COMPLETED|Overall Study||0
3046384|NCT01196377|3766112|FG002|NOT COMPLETED|Overall Study||0
3046385|NCT01196377|3766113|FG003|NOT COMPLETED|Overall Study||0
3046386|NCT01196416|3766123|FG000|STARTED|Overall Study||14
3046387|NCT01196416|3766123|FG000|COMPLETED|Overall Study||12
3046388|NCT01196416|3766123|FG000|NOT COMPLETED|Overall Study||2
3046389|NCT01196429|3766129|FG000|STARTED|Overall Study||45
3046390|NCT01196429|3766130|FG001|STARTED|Overall Study||45
3046391|NCT01196429|3766129|FG000|COMPLETED|Overall Study||42
3046392|NCT01196429|3766130|FG001|COMPLETED|Overall Study||45
3046393|NCT01196429|3766129|FG000|NOT COMPLETED|Overall Study||3
3046394|NCT01196429|3766130|FG001|NOT COMPLETED|Overall Study||0
3046395|NCT01196442|3766138|FG000|STARTED|Overall Study||39
3046396|NCT01196442|3766138|FG000|COMPLETED|Overall Study||39
3046397|NCT01196442|3766138|FG000|NOT COMPLETED|Overall Study||0
3046398|NCT01196533|3766143|FG000|STARTED|Overall Study||94
3046399|NCT01196533|3766143|FG000|COMPLETED|Overall Study||94
3046400|NCT01196533|3766143|FG000|NOT COMPLETED|Overall Study||0
3046401|NCT01196741|3766149|FG000|STARTED|Overall Study||71
3046402|NCT01196741|3766150|FG001|STARTED|Overall Study||36
3046403|NCT01196741|3766149|FG000|COMPLETED|Overall Study||11
3046404|NCT01196741|3766150|FG001|COMPLETED|Overall Study||8
3046405|NCT01196741|3766149|FG000|NOT COMPLETED|Overall Study||60
3046406|NCT01196741|3766150|FG001|NOT COMPLETED|Overall Study||28
3046407|NCT01196793|3766156|FG000|STARTED|Overall Study||108
3046408|NCT01196793|3766156|FG000|COMPLETED|Overall Study||108
3046409|NCT01196793|3766156|FG000|NOT COMPLETED|Overall Study||0
3046410|NCT01196819|3766162|FG000|STARTED|Overall Study||231
3046411|NCT01196819|3766163|FG001|STARTED|Overall Study||227
3046412|NCT01196819|3766162|FG000|COMPLETED|Overall Study||225
3046413|NCT01196819|3766163|FG001|COMPLETED|Overall Study||227
3046414|NCT01196819|3766162|FG000|NOT COMPLETED|Overall Study||6
3046415|NCT01196819|3766163|FG001|NOT COMPLETED|Overall Study||0
3046416|NCT01196871|3766175|FG000|STARTED|Stage 1: Period 1||5
3046417|NCT01196871|3766176|FG001|STARTED|Stage 1: Period 1||3
3046418|NCT01196871|3766177|FG002|STARTED|Stage 1: Period 1||4
3046419|NCT01196871|3766178|FG003|STARTED|Stage 1: Period 1|Zero participants noted since these participants started in Stage 2|0
3046420|NCT01196871|3766179|FG004|STARTED|Stage 1: Period 1|Zero participants noted since these participants started in Stage 2|0
3046421|NCT01196871|3766180|FG005|STARTED|Stage 1: Period 1|Zero participants noted since these participants started in Stage 2|0
3046422|NCT01196871|3766175|FG000|PK Population|Stage 1: Period 1||5
3046423|NCT01196871|3766176|FG001|PK Population|Stage 1: Period 1||3
3046424|NCT01196871|3766177|FG002|PK Population|Stage 1: Period 1||4
3046425|NCT01196871|3766178|FG003|PK Population|Stage 1: Period 1||0
3046426|NCT01196871|3766179|FG004|PK Population|Stage 1: Period 1||0
3046427|NCT01196871|3766180|FG005|PK Population|Stage 1: Period 1||0
3046428|NCT01196871|3766175|FG000|Received at Least 1 Dose of Study Drug|Stage 1: Period 1||5
3046429|NCT01196871|3766176|FG001|Received at Least 1 Dose of Study Drug|Stage 1: Period 1||3
3046430|NCT01196871|3766177|FG002|Received at Least 1 Dose of Study Drug|Stage 1: Period 1||4
3046431|NCT01196871|3766178|FG003|Received at Least 1 Dose of Study Drug|Stage 1: Period 1||0
3046432|NCT01196871|3766179|FG004|Received at Least 1 Dose of Study Drug|Stage 1: Period 1||0
3046433|NCT01196871|3766180|FG005|Received at Least 1 Dose of Study Drug|Stage 1: Period 1||0
3046434|NCT01196871|3766175|FG000|COMPLETED|Stage 1: Period 1||5
3046435|NCT01196871|3766176|FG001|COMPLETED|Stage 1: Period 1||3
3046436|NCT01196871|3766177|FG002|COMPLETED|Stage 1: Period 1||4
3046437|NCT01196871|3766178|FG003|COMPLETED|Stage 1: Period 1||0
3046438|NCT01196871|3766179|FG004|COMPLETED|Stage 1: Period 1||0
3046439|NCT01196871|3766180|FG005|COMPLETED|Stage 1: Period 1||0
3046440|NCT01196871|3766175|FG000|NOT COMPLETED|Stage 1: Period 1||0
3046441|NCT01196871|3766176|FG001|NOT COMPLETED|Stage 1: Period 1||0
3046442|NCT01196871|3766177|FG002|NOT COMPLETED|Stage 1: Period 1||0
3046443|NCT01196871|3766178|FG003|NOT COMPLETED|Stage 1: Period 1||0
3046444|NCT01196871|3766179|FG004|NOT COMPLETED|Stage 1: Period 1||0
3046445|NCT01196871|3766180|FG005|NOT COMPLETED|Stage 1: Period 1||0
3046446|NCT01196871|3766175|FG000|STARTED|Stage 1: Period 2||5
3046447|NCT01196871|3766176|FG001|STARTED|Stage 1: Period 2||3
3046448|NCT01196871|3766177|FG002|STARTED|Stage 1: Period 2||4
3046449|NCT01196871|3766178|FG003|STARTED|Stage 1: Period 2|Zero participants noted since these participants started in Stage 2|0
3046450|NCT01196871|3766179|FG004|STARTED|Stage 1: Period 2|Zero participants noted since these participants started in Stage 2|0
3046451|NCT01196871|3766180|FG005|STARTED|Stage 1: Period 2|Zero participants noted since these participants started in Stage 2|0
3046452|NCT01196871|3766175|FG000|PK Population|Stage 1: Period 2||5
3046453|NCT01196871|3766176|FG001|PK Population|Stage 1: Period 2||3
3046454|NCT01196871|3766177|FG002|PK Population|Stage 1: Period 2||4
3046455|NCT01196871|3766178|FG003|PK Population|Stage 1: Period 2||0
3046456|NCT01196871|3766179|FG004|PK Population|Stage 1: Period 2||0
3046457|NCT01196871|3766180|FG005|PK Population|Stage 1: Period 2||0
3046458|NCT01196871|3766175|FG000|COMPLETED|Stage 1: Period 2||5
3046459|NCT01196871|3766176|FG001|COMPLETED|Stage 1: Period 2||3
3046460|NCT01196871|3766177|FG002|COMPLETED|Stage 1: Period 2||4
3046461|NCT01196871|3766178|FG003|COMPLETED|Stage 1: Period 2||0
3046462|NCT01196871|3766179|FG004|COMPLETED|Stage 1: Period 2||0
3046463|NCT01196871|3766180|FG005|COMPLETED|Stage 1: Period 2||0
3046464|NCT01196871|3766175|FG000|NOT COMPLETED|Stage 1: Period 2||0
3046465|NCT01196871|3766176|FG001|NOT COMPLETED|Stage 1: Period 2||0
3046466|NCT01196871|3766177|FG002|NOT COMPLETED|Stage 1: Period 2||0
3046467|NCT01196871|3766178|FG003|NOT COMPLETED|Stage 1: Period 2||0
3180428|NCT01990950|3908814|FG000|COMPLETED|Overall Study||10
3180429|NCT01990950|3908814|FG000|NOT COMPLETED|Overall Study||11
3180430|NCT01991197|3908820|FG000|STARTED|Overall Study||9
3180431|NCT01991197|3908821|FG001|STARTED|Overall Study||11
3180432|NCT01991197|3908820|FG000|COMPLETED|Overall Study||6
3180433|NCT01991197|3908821|FG001|COMPLETED|Overall Study||8
3180434|NCT01991197|3908820|FG000|NOT COMPLETED|Overall Study||3
3180435|NCT01991197|3908821|FG001|NOT COMPLETED|Overall Study||3
3180436|NCT01991314|3908834|FG000|STARTED|Overall Study||45
3180437|NCT01991314|3908835|FG001|STARTED|Overall Study||43
3180438|NCT01991314|3908834|FG000|COMPLETED|Overall Study||34
3180439|NCT01991314|3908835|FG001|COMPLETED|Overall Study||32
3180440|NCT01991314|3908834|FG000|NOT COMPLETED|Overall Study||11
3180441|NCT01991314|3908835|FG001|NOT COMPLETED|Overall Study||11
3180442|NCT01991470|3908841|FG000|STARTED|Enlite 1 Period||161
3180443|NCT01991470|3908841|FG000|COMPLETED|Enlite 1 Period||141
3180444|NCT01991470|3908841|FG000|NOT COMPLETED|Enlite 1 Period||20
3180445|NCT01991470|3908841|FG000|STARTED|Enlite 3 Period|Additional 25 subjects who participated only Enlite 3 phase|158
3180446|NCT01991470|3908841|FG000|COMPLETED|Enlite 3 Period||146
3180447|NCT01991470|3908841|FG000|NOT COMPLETED|Enlite 3 Period||12
3180448|NCT01991483|3908857|FG000|STARTED|Dose Level: Placebo||7
3180449|NCT01991483|3908858|FG001|STARTED|Dose Level: Placebo||0
3180450|NCT01991483|3908859|FG002|STARTED|Dose Level: Placebo||0
3180451|NCT01991483|3908860|FG003|STARTED|Dose Level: Placebo||0
3046468|NCT01196871|3766179|FG004|NOT COMPLETED|Stage 1: Period 2||0
3046469|NCT01196871|3766180|FG005|NOT COMPLETED|Stage 1: Period 2||0
3046470|NCT01196871|3766175|FG000|STARTED|Stage 1: Period 3||5
3046471|NCT01196871|3766176|FG001|STARTED|Stage 1: Period 3||3
3046472|NCT01196871|3766177|FG002|STARTED|Stage 1: Period 3||4
3046473|NCT01196871|3766178|FG003|STARTED|Stage 1: Period 3|Zero participants noted since these participants started in Stage 2|0
3046474|NCT01196871|3766179|FG004|STARTED|Stage 1: Period 3|Zero participants noted since these participants started in Stage 2|0
3046475|NCT01196871|3766180|FG005|STARTED|Stage 1: Period 3|Zero participants noted since these participants started in Stage 2|0
3046476|NCT01196871|3766175|FG000|COMPLETED|Stage 1: Period 3||5
3046477|NCT01196871|3766176|FG001|COMPLETED|Stage 1: Period 3||3
3046478|NCT01196871|3766177|FG002|COMPLETED|Stage 1: Period 3||4
3046479|NCT01196871|3766178|FG003|COMPLETED|Stage 1: Period 3||0
3046480|NCT01196871|3766179|FG004|COMPLETED|Stage 1: Period 3||0
3046481|NCT01196871|3766180|FG005|COMPLETED|Stage 1: Period 3||0
3046482|NCT01196871|3766175|FG000|NOT COMPLETED|Stage 1: Period 3||0
3046483|NCT01196871|3766176|FG001|NOT COMPLETED|Stage 1: Period 3||0
3046484|NCT01196871|3766177|FG002|NOT COMPLETED|Stage 1: Period 3||0
3046485|NCT01196871|3766178|FG003|NOT COMPLETED|Stage 1: Period 3||0
3046486|NCT01196871|3766179|FG004|NOT COMPLETED|Stage 1: Period 3||0
3046487|NCT01196871|3766180|FG005|NOT COMPLETED|Stage 1: Period 3||0
3046488|NCT01196871|3766175|FG000|STARTED|Stage 2: Period 1|Zero participants noted because participants had completed Stage 1|0
3046489|NCT01196871|3766176|FG001|STARTED|Stage 2: Period 1|Zero participants noted because participants had completed Stage 1|0
3046490|NCT01196871|3766177|FG002|STARTED|Stage 2: Period 1|Zero participants noted because participants had completed Stage 1|0
3046491|NCT01196871|3766178|FG003|STARTED|Stage 2: Period 1|Both participants re-enrolled into Stage 2 after completing Stage 1|2
3046492|NCT01196871|3766179|FG004|STARTED|Stage 2: Period 1|One participant re-enrolled into Stage 2 after completing Stage 1|5
3046493|NCT01196871|3766180|FG005|STARTED|Stage 2: Period 1||4
3046494|NCT01196871|3766175|FG000|Received at Least 1 Dose of Study Drug|Stage 2: Period 1||0
3046495|NCT01196871|3766176|FG001|Received at Least 1 Dose of Study Drug|Stage 2: Period 1||0
3046496|NCT01196871|3766177|FG002|Received at Least 1 Dose of Study Drug|Stage 2: Period 1||0
3046497|NCT01196871|3766178|FG003|Received at Least 1 Dose of Study Drug|Stage 2: Period 1||2
3046498|NCT01196871|3766179|FG004|Received at Least 1 Dose of Study Drug|Stage 2: Period 1||5
3046499|NCT01196871|3766180|FG005|Received at Least 1 Dose of Study Drug|Stage 2: Period 1||4
3046500|NCT01196871|3766175|FG000|PK Population|Stage 2: Period 1||0
3046501|NCT01196871|3766176|FG001|PK Population|Stage 2: Period 1||0
3046502|NCT01196871|3766177|FG002|PK Population|Stage 2: Period 1||0
3046503|NCT01196871|3766178|FG003|PK Population|Stage 2: Period 1||1
3046504|NCT01196871|3766179|FG004|PK Population|Stage 2: Period 1||5
3046505|NCT01196871|3766180|FG005|PK Population|Stage 2: Period 1||4
3046506|NCT01196871|3766175|FG000|COMPLETED|Stage 2: Period 1||0
3046507|NCT01196871|3766176|FG001|COMPLETED|Stage 2: Period 1||0
3046508|NCT01196871|3766177|FG002|COMPLETED|Stage 2: Period 1||0
3046509|NCT01196871|3766178|FG003|COMPLETED|Stage 2: Period 1||2
3046510|NCT01196871|3766179|FG004|COMPLETED|Stage 2: Period 1||5
3046511|NCT01196871|3766180|FG005|COMPLETED|Stage 2: Period 1||4
3046512|NCT01196871|3766175|FG000|NOT COMPLETED|Stage 2: Period 1||0
3046513|NCT01196871|3766176|FG001|NOT COMPLETED|Stage 2: Period 1||0
3046514|NCT01196871|3766177|FG002|NOT COMPLETED|Stage 2: Period 1||0
3046515|NCT01196871|3766178|FG003|NOT COMPLETED|Stage 2: Period 1||0
3046516|NCT01196871|3766179|FG004|NOT COMPLETED|Stage 2: Period 1||0
3046517|NCT01196871|3766180|FG005|NOT COMPLETED|Stage 2: Period 1||0
3046518|NCT01196871|3766175|FG000|STARTED|Stage 2: Period 2|Zero participants noted because participants had completed Stage 1|0
3046519|NCT01196871|3766176|FG001|STARTED|Stage 2: Period 2|Zero participants noted because participants had completed Stage 1|0
3180452|NCT01991483|3908857|FG000|Received at Least One Dose of Study Drug|Dose Level: Placebo||7
3180453|NCT01991483|3908858|FG001|Received at Least One Dose of Study Drug|Dose Level: Placebo||0
3180454|NCT01991483|3908859|FG002|Received at Least One Dose of Study Drug|Dose Level: Placebo||0
3046520|NCT01196871|3766177|FG002|STARTED|Stage 2: Period 2|Zero participants noted because participants had completed Stage 1|0
3046521|NCT01196871|3766178|FG003|STARTED|Stage 2: Period 2|One participant switched agalsidase dose from 0.5 mg/kg in Period 1 to 1.0 mg/kg in Period 2|1
3046522|NCT01196871|3766179|FG004|STARTED|Stage 2: Period 2|One participant switched agalsidase dose from 0.5 mg/kg in Period 1 to 1.0 mg/kg in Period 2|6
3046523|NCT01196871|3766180|FG005|STARTED|Stage 2: Period 2||4
3046524|NCT01196871|3766175|FG000|PK Population|Stage 2: Period 2||0
3046525|NCT01196871|3766176|FG001|PK Population|Stage 2: Period 2||0
3046526|NCT01196871|3766177|FG002|PK Population|Stage 2: Period 2||0
3046527|NCT01196871|3766178|FG003|PK Population|Stage 2: Period 2||1
3046528|NCT01196871|3766179|FG004|PK Population|Stage 2: Period 2||6
3046529|NCT01196871|3766180|FG005|PK Population|Stage 2: Period 2||4
3046530|NCT01196871|3766175|FG000|COMPLETED|Stage 2: Period 2||0
3046531|NCT01196871|3766176|FG001|COMPLETED|Stage 2: Period 2||0
3046532|NCT01196871|3766177|FG002|COMPLETED|Stage 2: Period 2||0
3046533|NCT01196871|3766178|FG003|COMPLETED|Stage 2: Period 2||1
3046534|NCT01196871|3766179|FG004|COMPLETED|Stage 2: Period 2||6
3046535|NCT01196871|3766180|FG005|COMPLETED|Stage 2: Period 2||4
3046536|NCT01196871|3766175|FG000|NOT COMPLETED|Stage 2: Period 2||0
3046537|NCT01196871|3766176|FG001|NOT COMPLETED|Stage 2: Period 2||0
3046538|NCT01196871|3766177|FG002|NOT COMPLETED|Stage 2: Period 2||0
3046539|NCT01196871|3766178|FG003|NOT COMPLETED|Stage 2: Period 2||0
3046540|NCT01196871|3766179|FG004|NOT COMPLETED|Stage 2: Period 2||0
3046541|NCT01196871|3766180|FG005|NOT COMPLETED|Stage 2: Period 2||0
3046542|NCT01196923|3766203|FG000|STARTED|Overall Study||20
3046543|NCT01196923|3766203|FG000|COMPLETED|Overall Study||20
3046544|NCT01196923|3766203|FG000|NOT COMPLETED|Overall Study||0
3046545|NCT01196936|3766209|FG000|STARTED|Overall Study||34
3046546|NCT01196936|3766210|FG001|STARTED|Overall Study||38
3046547|NCT01196936|3766209|FG000|Year One Post Treatment|Overall Study||27
3046548|NCT01196936|3766210|FG001|Year One Post Treatment|Overall Study||28
3046549|NCT01196936|3766209|FG000|COMPLETED|Overall Study||23
3046550|NCT01196936|3766210|FG001|COMPLETED|Overall Study||21
3046551|NCT01196936|3766209|FG000|NOT COMPLETED|Overall Study||11
3046552|NCT01196936|3766210|FG001|NOT COMPLETED|Overall Study||17
3046553|NCT01196975|3766221|FG000|STARTED|Overall Study||423
3046554|NCT01196975|3766222|FG001|STARTED|Overall Study||424
3046555|NCT01196975|3766223|FG002|STARTED|Overall Study||425
3046556|NCT01196975|3766224|FG003|STARTED|Overall Study||213
3046557|NCT01196975|3766225|FG004|STARTED|Overall Study||218
3046558|NCT01196975|3766221|FG000|COMPLETED|Overall Study||408
3046559|NCT01196975|3766222|FG001|COMPLETED|Overall Study||415
3046560|NCT01196975|3766223|FG002|COMPLETED|Overall Study||420
3046561|NCT01196975|3766224|FG003|COMPLETED|Overall Study||207
3046562|NCT01196975|3766225|FG004|COMPLETED|Overall Study||205
3046563|NCT01196975|3766221|FG000|NOT COMPLETED|Overall Study||15
3046564|NCT01196975|3766222|FG001|NOT COMPLETED|Overall Study||9
3046565|NCT01196975|3766223|FG002|NOT COMPLETED|Overall Study||5
3046566|NCT01196975|3766224|FG003|NOT COMPLETED|Overall Study||6
3046567|NCT01196975|3766225|FG004|NOT COMPLETED|Overall Study||13
3046568|NCT01196988|3766264|FG000|STARTED|Overall Study||915
3046569|NCT01196988|3766265|FG001|STARTED|Overall Study||912
3046570|NCT01196988|3766266|FG002|STARTED|Overall Study||911
3046571|NCT01196988|3766267|FG003|STARTED|Overall Study||277
3046572|NCT01196988|3766264|FG000|COMPLETED|Overall Study||891
3046573|NCT01196988|3766265|FG001|COMPLETED|Overall Study||880
3046574|NCT01196988|3766266|FG002|COMPLETED|Overall Study||886
3046575|NCT01196988|3766267|FG003|COMPLETED|Overall Study||276
3046576|NCT01196988|3766264|FG000|NOT COMPLETED|Overall Study||24
3046577|NCT01196988|3766265|FG001|NOT COMPLETED|Overall Study||32
3046578|NCT01196988|3766266|FG002|NOT COMPLETED|Overall Study||25
3046579|NCT01196988|3766267|FG003|NOT COMPLETED|Overall Study||1
3046580|NCT01197300|3766280|FG000|STARTED|Overall Study||10
3046581|NCT01197300|3766281|FG001|STARTED|Overall Study||15
3046582|NCT01197300|3766280|FG000|COMPLETED|Overall Study||10
3046583|NCT01197300|3766281|FG001|COMPLETED|Overall Study||13
3046584|NCT01197300|3766280|FG000|NOT COMPLETED|Overall Study||0
3046585|NCT01197300|3766281|FG001|NOT COMPLETED|Overall Study||2
3046586|NCT01197326|3766289|FG000|STARTED|Overall Study||205
3046587|NCT01197326|3766290|FG001|STARTED|Overall Study||209
3046588|NCT01197326|3766289|FG000|COMPLETED|Overall Study||205
3046589|NCT01197326|3766290|FG001|COMPLETED|Overall Study||209
3046590|NCT01197326|3766289|FG000|NOT COMPLETED|Overall Study||0
3046591|NCT01197326|3766290|FG001|NOT COMPLETED|Overall Study||0
3046592|NCT01197378|3766298|FG000|STARTED|Overall Study||60
3046593|NCT01197378|3766298|FG000|Received Treatment|Overall Study||59
3046594|NCT01197378|3766298|FG000|COMPLETED|Overall Study||53
3046595|NCT01197378|3766298|FG000|NOT COMPLETED|Overall Study||7
3046596|NCT01197417|3766304|FG000|STARTED|Overall Study||104
3046597|NCT01197417|3766305|FG001|STARTED|Overall Study||104
3046598|NCT01197417|3766304|FG000|Received Study Drug|Overall Study||101
3046599|NCT01197417|3766305|FG001|Received Study Drug|Overall Study||103
3046600|NCT01197417|3766304|FG000|COMPLETED|Overall Study||96
3046601|NCT01197417|3766305|FG001|COMPLETED|Overall Study||86
3046602|NCT01197417|3766304|FG000|NOT COMPLETED|Overall Study||8
3046603|NCT01197417|3766305|FG001|NOT COMPLETED|Overall Study||18
3046604|NCT01197456|3766313|FG000|STARTED|Overall Study||171
3046605|NCT01197456|3766314|FG001|STARTED|Overall Study||61
3046606|NCT01197456|3766313|FG000|COMPLETED|Overall Study||171
3046607|NCT01197456|3766314|FG001|COMPLETED|Overall Study||61
3046608|NCT01197456|3766313|FG000|NOT COMPLETED|Overall Study||0
3046609|NCT01197456|3766314|FG001|NOT COMPLETED|Overall Study||0
3046610|NCT01197495|3766322|FG000|STARTED|Overall Study||157
3046611|NCT01197495|3766323|FG001|STARTED|Overall Study||56
3046612|NCT01197495|3766322|FG000|COMPLETED|Overall Study||144
3046613|NCT01197495|3766323|FG001|COMPLETED|Overall Study||49
3046614|NCT01197495|3766322|FG000|NOT COMPLETED|Overall Study||13
3046615|NCT01197495|3766323|FG001|NOT COMPLETED|Overall Study||7
3046616|NCT01197508|3766333|FG000|STARTED|Overall Study||174
3046617|NCT01197508|3766334|FG001|STARTED|Overall Study||174
3046618|NCT01197508|3766335|FG002|STARTED|Overall Study||174
3046619|NCT01197508|3766336|FG003|STARTED|Overall Study||174
3046620|NCT01197508|3766333|FG000|Received Treatment|Overall Study||174
3046621|NCT01197508|3766334|FG001|Received Treatment|Overall Study||174
3046622|NCT01197508|3766335|FG002|Received Treatment|Overall Study||171
3046623|NCT01197508|3766336|FG003|Received Treatment|Overall Study||174
3046624|NCT01197508|3766333|FG000|COMPLETED|Overall Study||151
3046625|NCT01197508|3766334|FG001|COMPLETED|Overall Study||144
3046626|NCT01197508|3766335|FG002|COMPLETED|Overall Study||125
3046627|NCT01197508|3766336|FG003|COMPLETED|Overall Study||158
3046628|NCT01197508|3766333|FG000|NOT COMPLETED|Overall Study||23
3046629|NCT01197508|3766334|FG001|NOT COMPLETED|Overall Study||30
3046630|NCT01197508|3766335|FG002|NOT COMPLETED|Overall Study||49
3046631|NCT01197508|3766336|FG003|NOT COMPLETED|Overall Study||16
3046632|NCT01197521|3766349|FG000|STARTED|Overall Study|Patients who received treatment|310
3046633|NCT01197521|3766350|FG001|STARTED|Overall Study|Patients who received treatment|304
3046634|NCT01197521|3766351|FG002|STARTED|Overall Study|Patients who received treatment|304
3046635|NCT01197521|3766349|FG000|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled|1
3046636|NCT01197521|3766350|FG001|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/other|2
3046637|NCT01197521|3766351|FG002|Randomised But Did Not Receive Treatment|Overall Study|Adverse event/eligibility criteria not fulfilled|2
3046638|NCT01197521|3766349|FG000|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|207
3046639|NCT01197521|3766350|FG001|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|191
3046640|NCT01197521|3766351|FG002|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|161
3046641|NCT01197521|3766349|FG000|NOT COMPLETED|Overall Study||103
3046642|NCT01197521|3766350|FG001|NOT COMPLETED|Overall Study||113
3046643|NCT01197521|3766351|FG002|NOT COMPLETED|Overall Study||143
3046644|NCT01197534|3766365|FG000|STARTED|Overall Study|Patients who received treatment|308
3046645|NCT01197534|3766366|FG001|STARTED|Overall Study|Patients who received treatment|298
3046646|NCT01197534|3766367|FG002|STARTED|Overall Study|Patients who received treatment|302
3046647|NCT01197534|3766365|FG000|Randomised But Did Not Receive Treatment|Overall Study||0
3046648|NCT01197534|3766366|FG001|Randomised But Did Not Receive Treatment|Overall Study|Adverse event / Other|2
3046649|NCT01197534|3766367|FG002|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled / Severe non-compliance to protocol|3
3046650|NCT01197534|3766365|FG000|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|174
3046651|NCT01197534|3766366|FG001|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|168
3046652|NCT01197534|3766367|FG002|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|129
3046653|NCT01197534|3766365|FG000|NOT COMPLETED|Overall Study||134
3046654|NCT01197534|3766366|FG001|NOT COMPLETED|Overall Study||130
3046655|NCT01197534|3766367|FG002|NOT COMPLETED|Overall Study||173
3046656|NCT01197547|3766378|FG000|STARTED|Overall Study||1014
3046657|NCT01197547|3766378|FG000|COMPLETED|Overall Study|992 Intent-To-Treat (ITT) 931 evaluable subjects|992
3046658|NCT01197547|3766378|FG000|NOT COMPLETED|Overall Study||22
3046659|NCT01197560|3766384|FG000|STARTED|Overall Study|This is the intent to treat population|54
3046660|NCT01197560|3766385|FG001|STARTED|Overall Study|This is the intent to treat population|57
3046661|NCT01197560|3766384|FG000|Received ≥ One Dose Study Drug|Overall Study||54
3046662|NCT01197560|3766385|FG001|Received ≥ One Dose Study Drug|Overall Study||55
3046663|NCT01197560|3766384|FG000|Lenalidomide Crossover|Overall Study||0
3046664|NCT01197560|3766385|FG001|Lenalidomide Crossover|Overall Study||29
3046665|NCT01197560|3766384|FG000|Discontinued Treatment After ≥ 6 Cycles|Overall Study||14
3046666|NCT01197560|3766385|FG001|Discontinued Treatment After ≥ 6 Cycles|Overall Study||0
3046667|NCT01197560|3766384|FG000|COMPLETED|Overall Study||0
3046668|NCT01197560|3766385|FG001|COMPLETED|Overall Study||4
3046669|NCT01197560|3766384|FG000|NOT COMPLETED|Overall Study||54
3046670|NCT01197560|3766385|FG001|NOT COMPLETED|Overall Study||53
3046671|NCT01197573|3766396|FG000|STARTED|Overall Study||33
3046672|NCT01197573|3766397|FG001|STARTED|Overall Study||46
3046673|NCT01197573|3766398|FG002|STARTED|Overall Study||12
3046674|NCT01197573|3766399|FG003|STARTED|Overall Study||12
3046675|NCT01197573|3766396|FG000|COMPLETED|Overall Study||33
3046676|NCT01197573|3766397|FG001|COMPLETED|Overall Study||46
3046677|NCT01197573|3766398|FG002|COMPLETED|Overall Study||12
3046678|NCT01197573|3766399|FG003|COMPLETED|Overall Study||12
3046679|NCT01197573|3766396|FG000|NOT COMPLETED|Overall Study||0
3046680|NCT01197573|3766397|FG001|NOT COMPLETED|Overall Study||0
3046681|NCT01197573|3766398|FG002|NOT COMPLETED|Overall Study||0
3046682|NCT01197573|3766399|FG003|NOT COMPLETED|Overall Study||0
3046683|NCT01197612|3766409|FG000|STARTED|Overall Study||18
3046684|NCT01197612|3766409|FG000|Week 3|Overall Study||16
3046685|NCT01197612|3766409|FG000|Returned for Week 24|Overall Study||6
3046686|NCT01197612|3766409|FG000|COMPLETED|Overall Study||6
3046687|NCT01197612|3766409|FG000|NOT COMPLETED|Overall Study||12
3046688|NCT01197755|3766419|FG000|STARTED|Overall Study|Patients who received treatment|105
3046689|NCT01197755|3766420|FG001|STARTED|Overall Study|Patients who received treatment|108
3046690|NCT01197755|3766421|FG002|STARTED|Overall Study|Patients who received treatment|109
3046691|NCT01197755|3766419|FG000|Randomised But Did Not Receive Treatment|Overall Study||0
3046692|NCT01197755|3766420|FG001|Randomised But Did Not Receive Treatment|Overall Study||0
3046693|NCT01197755|3766421|FG002|Randomised But Did Not Receive Treatment|Overall Study|Severe non-compliance to the protocol|1
3046694|NCT01197755|3766419|FG000|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|67
3046695|NCT01197755|3766420|FG001|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|65
3046696|NCT01197755|3766421|FG002|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|55
3046697|NCT01197755|3766419|FG000|NOT COMPLETED|Overall Study||38
3046698|NCT01197755|3766420|FG001|NOT COMPLETED|Overall Study||43
3046699|NCT01197755|3766421|FG002|NOT COMPLETED|Overall Study||54
3046700|NCT01197794|3766438|FG000|STARTED|Overall Study||164
3046701|NCT01197794|3766439|FG001|STARTED|Overall Study|Two participants did not receive study treatment|161
3046702|NCT01197794|3766440|FG002|STARTED|Overall Study|Two participants did not receive study treatment|166
3046703|NCT01197794|3766441|FG003|STARTED|Overall Study||164
3046704|NCT01197794|3766442|FG004|STARTED|Overall Study|One participant excluded due to Good Clinical Practice (GCP) violation at centre 4323|163
3046705|NCT01197794|3766443|FG005|STARTED|Overall Study||163
3046706|NCT01197794|3766444|FG006|STARTED|Overall Study|Two participants excluded due to Good Clinical Practice (GCP) violation at centre 4323|163
3046707|NCT01197794|3766438|FG000|COMPLETED|Overall Study||148
3046708|NCT01197794|3766439|FG001|COMPLETED|Overall Study||146
3046709|NCT01197794|3766440|FG002|COMPLETED|Overall Study||153
3046710|NCT01197794|3766441|FG003|COMPLETED|Overall Study||152
3046711|NCT01197794|3766442|FG004|COMPLETED|Overall Study||149
3046712|NCT01197794|3766443|FG005|COMPLETED|Overall Study||144
3046713|NCT01197794|3766444|FG006|COMPLETED|Overall Study||142
3046714|NCT01197794|3766438|FG000|NOT COMPLETED|Overall Study||16
3046715|NCT01197794|3766439|FG001|NOT COMPLETED|Overall Study||15
3046716|NCT01197794|3766440|FG002|NOT COMPLETED|Overall Study||13
3046717|NCT01197794|3766441|FG003|NOT COMPLETED|Overall Study||12
3046718|NCT01197794|3766442|FG004|NOT COMPLETED|Overall Study||14
3046719|NCT01197794|3766443|FG005|NOT COMPLETED|Overall Study||19
3046720|NCT01197794|3766444|FG006|NOT COMPLETED|Overall Study||21
3046721|NCT01197833|3766464|FG000|STARTED|Overall Study||38
3046722|NCT01197833|3766465|FG001|STARTED|Overall Study||39
3046723|NCT01197833|3766466|FG002|STARTED|Overall Study||40
3046724|NCT01197833|3766464|FG000|COMPLETED|Overall Study||38
3046725|NCT01197833|3766465|FG001|COMPLETED|Overall Study||39
3046726|NCT01197833|3766466|FG002|COMPLETED|Overall Study||40
3180455|NCT01991483|3908860|FG003|Received at Least One Dose of Study Drug|Dose Level: Placebo||0
3180456|NCT01991483|3908857|FG000|COMPLETED|Dose Level: Placebo||7
3180457|NCT01991483|3908858|FG001|COMPLETED|Dose Level: Placebo||0
3180458|NCT01991483|3908859|FG002|COMPLETED|Dose Level: Placebo||0
3180459|NCT01991483|3908860|FG003|COMPLETED|Dose Level: Placebo||0
3180460|NCT01991483|3908857|FG000|NOT COMPLETED|Dose Level: Placebo||0
3180461|NCT01991483|3908858|FG001|NOT COMPLETED|Dose Level: Placebo||0
3180462|NCT01991483|3908859|FG002|NOT COMPLETED|Dose Level: Placebo||0
3180463|NCT01991483|3908860|FG003|NOT COMPLETED|Dose Level: Placebo||0
3180464|NCT01991483|3908857|FG000|STARTED|Dose Level 300 mg|Multiple periods were added for each dose level to represent dose escalation.|0
3046727|NCT01197833|3766464|FG000|NOT COMPLETED|Overall Study||0
3046728|NCT01197833|3766465|FG001|NOT COMPLETED|Overall Study||0
3046729|NCT01197833|3766466|FG002|NOT COMPLETED|Overall Study||0
3046730|NCT01197898|3766476|FG000|STARTED|Overall Study||5
3046731|NCT01197898|3766477|FG001|STARTED|Overall Study||5
3046732|NCT01197898|3766476|FG000|COMPLETED|Overall Study||5
3046733|NCT01197898|3766477|FG001|COMPLETED|Overall Study||5
3046734|NCT01197898|3766476|FG000|NOT COMPLETED|Overall Study||0
3046735|NCT01197898|3766477|FG001|NOT COMPLETED|Overall Study||0
3046736|NCT01197911|3766486|FG000|STARTED|Overall Study||18
3046737|NCT01197911|3766487|FG001|STARTED|Overall Study||10
3046738|NCT01197911|3766488|FG002|STARTED|Overall Study||10
3046739|NCT01197911|3766486|FG000|COMPLETED|Overall Study||18
3046740|NCT01197911|3766487|FG001|COMPLETED|Overall Study||10
3046741|NCT01197911|3766488|FG002|COMPLETED|Overall Study||9
3046742|NCT01197911|3766486|FG000|NOT COMPLETED|Overall Study||0
3046743|NCT01197911|3766487|FG001|NOT COMPLETED|Overall Study||0
3046744|NCT01197911|3766488|FG002|NOT COMPLETED|Overall Study||1
3046745|NCT01198002|3766500|FG000|STARTED|Treatment Period 1 (Weeks 0-52)||345
3046746|NCT01198002|3766501|FG001|STARTED|Treatment Period 1 (Weeks 0-52)||347
3046747|NCT01198002|3766502|FG002|STARTED|Treatment Period 1 (Weeks 0-52)||349
3046748|NCT01198002|3766500|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0-52)||345
3046749|NCT01198002|3766501|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0-52)||345
3046750|NCT01198002|3766502|FG002|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0-52)||348
3046751|NCT01198002|3766500|FG000|Week 16 NR|Treatment Period 1 (Weeks 0-52)||58
3046752|NCT01198002|3766501|FG001|Week 16 NR|Treatment Period 1 (Weeks 0-52)||62
3046753|NCT01198002|3766502|FG002|Week 16 NR|Treatment Period 1 (Weeks 0-52)||90
3046754|NCT01198002|3766500|FG000|Post-Treatment Follow-Up Population|Treatment Period 1 (Weeks 0-52)||293
3046755|NCT01198002|3766501|FG001|Post-Treatment Follow-Up Population|Treatment Period 1 (Weeks 0-52)||303
3046756|NCT01198002|3766502|FG002|Post-Treatment Follow-Up Population|Treatment Period 1 (Weeks 0-52)||307
3046757|NCT01198002|3766500|FG000|COMPLETED|Treatment Period 1 (Weeks 0-52)|Those who completed 52-week Treatment Period 1 including both Week 16 responders and NR.|70
3046758|NCT01198002|3766501|FG001|COMPLETED|Treatment Period 1 (Weeks 0-52)|Those who completed 52-week Treatment Period 1 including both Week 16 responders and NR.|73
3046759|NCT01198002|3766502|FG002|COMPLETED|Treatment Period 1 (Weeks 0-52)|Those who completed 52-week Treatment Period 1 including both Week 16 responders and NR.|80
3046760|NCT01198002|3766500|FG000|NOT COMPLETED|Treatment Period 1 (Weeks 0-52)||275
3046761|NCT01198002|3766501|FG001|NOT COMPLETED|Treatment Period 1 (Weeks 0-52)||274
3046762|NCT01198002|3766502|FG002|NOT COMPLETED|Treatment Period 1 (Weeks 0-52)||269
3046763|NCT01198002|3766500|FG000|STARTED|Treatment Period 2 (Weeks 52-100)||70
3046764|NCT01198002|3766501|FG001|STARTED|Treatment Period 2 (Weeks 52-100)||73
3046765|NCT01198002|3766502|FG002|STARTED|Treatment Period 2 (Weeks 52-100)||80
3046766|NCT01198002|3766500|FG000|COMPLETED|Treatment Period 2 (Weeks 52-100)||1
3046767|NCT01198002|3766501|FG001|COMPLETED|Treatment Period 2 (Weeks 52-100)||0
3046768|NCT01198002|3766502|FG002|COMPLETED|Treatment Period 2 (Weeks 52-100)||2
3046769|NCT01198002|3766500|FG000|NOT COMPLETED|Treatment Period 2 (Weeks 52-100)||69
3046770|NCT01198002|3766501|FG001|NOT COMPLETED|Treatment Period 2 (Weeks 52-100)||73
3046771|NCT01198002|3766502|FG002|NOT COMPLETED|Treatment Period 2 (Weeks 52-100)||78
3046772|NCT01198028|3766532|FG000|STARTED|Overall Study||39
3046773|NCT01198028|3766532|FG000|COMPLETED|Overall Study||29
3046774|NCT01198028|3766532|FG000|NOT COMPLETED|Overall Study||10
3046775|NCT01198132|3766538|FG000|STARTED|Overall Study||63
3046776|NCT01198132|3766539|FG001|STARTED|Overall Study||66
3046777|NCT01198132|3766538|FG000|COMPLETED|Overall Study||45
3046778|NCT01198132|3766539|FG001|COMPLETED|Overall Study||45
3046779|NCT01198132|3766538|FG000|NOT COMPLETED|Overall Study||18
3180465|NCT01991483|3908858|FG001|STARTED|Dose Level 300 mg|Multiple periods were added for each dose level to represent dose escalation.|6
3180466|NCT01991483|3908859|FG002|STARTED|Dose Level 300 mg||0
3180467|NCT01991483|3908860|FG003|STARTED|Dose Level 300 mg||0
3180468|NCT01991483|3908857|FG000|Received at Least One Dose of Study Drug|Dose Level 300 mg||0
3180469|NCT01991483|3908858|FG001|Received at Least One Dose of Study Drug|Dose Level 300 mg||6
3180470|NCT01991483|3908859|FG002|Received at Least One Dose of Study Drug|Dose Level 300 mg||0
3046780|NCT01198132|3766539|FG001|NOT COMPLETED|Overall Study||21
3046781|NCT01198145|3766549|FG000|STARTED|Overall Study||44
3046782|NCT01198145|3766550|FG001|STARTED|Overall Study||43
3046783|NCT01198145|3766549|FG000|COMPLETED|Overall Study||43
3046784|NCT01198145|3766550|FG001|COMPLETED|Overall Study||42
3046785|NCT01198145|3766549|FG000|NOT COMPLETED|Overall Study||1
3046786|NCT01198145|3766550|FG001|NOT COMPLETED|Overall Study||1
3046787|NCT01198158|3766559|FG000|STARTED|Overall Study||41
3046788|NCT01198158|3766560|FG001|STARTED|Overall Study||36
3046789|NCT01198158|3766559|FG000|COMPLETED|Overall Study||41
3046790|NCT01198158|3766560|FG001|COMPLETED|Overall Study||36
3046791|NCT01198158|3766559|FG000|NOT COMPLETED|Overall Study||0
3046792|NCT01198158|3766560|FG001|NOT COMPLETED|Overall Study||0
3046793|NCT01198275|3766568|FG000|STARTED|Overall Study||100
3046794|NCT01198275|3766569|FG001|STARTED|Overall Study||99
3046795|NCT01198275|3766568|FG000|COMPLETED|Overall Study||94
3046796|NCT01198275|3766569|FG001|COMPLETED|Overall Study||94
3046797|NCT01198275|3766568|FG000|NOT COMPLETED|Overall Study||6
3046798|NCT01198275|3766569|FG001|NOT COMPLETED|Overall Study||5
3046799|NCT01198327|3766575|FG000|STARTED|Overall Study||66
3046800|NCT01198327|3766575|FG000|COMPLETED|Overall Study||56
3046801|NCT01198327|3766575|FG000|NOT COMPLETED|Overall Study||10
3046802|NCT01198366|3766588|FG000|STARTED|Overall Study||52
3046803|NCT01198366|3766589|FG001|STARTED|Overall Study||51
3046804|NCT01198366|3766590|FG002|STARTED|Overall Study||51
3046805|NCT01198366|3766591|FG003|STARTED|Overall Study||52
3046806|NCT01198366|3766592|FG004|STARTED|Overall Study||140
3046807|NCT01198366|3766593|FG005|STARTED|Overall Study||141
3046808|NCT01198366|3766588|FG000|COMPLETED|Overall Study||40
3046809|NCT01198366|3766589|FG001|COMPLETED|Overall Study||44
3046810|NCT01198366|3766590|FG002|COMPLETED|Overall Study||43
3046811|NCT01198366|3766591|FG003|COMPLETED|Overall Study||47
3046812|NCT01198366|3766592|FG004|COMPLETED|Overall Study||125
3046813|NCT01198366|3766593|FG005|COMPLETED|Overall Study||128
3046814|NCT01198366|3766588|FG000|NOT COMPLETED|Overall Study||12
3046815|NCT01198366|3766589|FG001|NOT COMPLETED|Overall Study||7
3046816|NCT01198366|3766590|FG002|NOT COMPLETED|Overall Study||8
3046817|NCT01198366|3766591|FG003|NOT COMPLETED|Overall Study||5
3046818|NCT01198366|3766592|FG004|NOT COMPLETED|Overall Study||15
3046819|NCT01198366|3766593|FG005|NOT COMPLETED|Overall Study||13
3046820|NCT01198470|3766607|FG000|STARTED|Overall Study||20
3046821|NCT01198470|3766607|FG000|COMPLETED|Overall Study||18
3180471|NCT01991483|3908860|FG003|Received at Least One Dose of Study Drug|Dose Level 300 mg||0
3180472|NCT01991483|3908857|FG000|COMPLETED|Dose Level 300 mg||0
3180473|NCT01991483|3908858|FG001|COMPLETED|Dose Level 300 mg||6
3180474|NCT01991483|3908859|FG002|COMPLETED|Dose Level 300 mg||0
3180475|NCT01991483|3908860|FG003|COMPLETED|Dose Level 300 mg||0
3180476|NCT01991483|3908857|FG000|NOT COMPLETED|Dose Level 300 mg||0
3180477|NCT01991483|3908858|FG001|NOT COMPLETED|Dose Level 300 mg||0
3180478|NCT01991483|3908859|FG002|NOT COMPLETED|Dose Level 300 mg||0
3180479|NCT01991483|3908860|FG003|NOT COMPLETED|Dose Level 300 mg||0
3180480|NCT01991483|3908857|FG000|STARTED|Dose Level 600 mg||0
3046822|NCT01198470|3766607|FG000|NOT COMPLETED|Overall Study||2
3046823|NCT01198509|3766617|FG000|STARTED|Overall Study||5
3046824|NCT01198509|3766618|FG001|STARTED|Overall Study||10
3046825|NCT01198509|3766619|FG002|STARTED|Overall Study||19
3046826|NCT01198509|3766620|FG003|STARTED|Overall Study||66
3046827|NCT01198509|3766621|FG004|STARTED|Overall Study||20
3046828|NCT01198509|3766622|FG005|STARTED|Overall Study||58
3046829|NCT01198509|3766617|FG000|COMPLETED|Overall Study|Patient declined further participation after enrollment and allocation to treatment group|4
3046830|NCT01198509|3766618|FG001|COMPLETED|Overall Study||10
3046831|NCT01198509|3766619|FG002|COMPLETED|Overall Study||19
3046832|NCT01198509|3766620|FG003|COMPLETED|Overall Study||66
3046833|NCT01198509|3766621|FG004|COMPLETED|Overall Study||20
3046834|NCT01198509|3766622|FG005|COMPLETED|Overall Study||58
3046835|NCT01198509|3766617|FG000|NOT COMPLETED|Overall Study||1
3046836|NCT01198509|3766618|FG001|NOT COMPLETED|Overall Study||0
3046837|NCT01198509|3766619|FG002|NOT COMPLETED|Overall Study||0
3046838|NCT01198509|3766620|FG003|NOT COMPLETED|Overall Study||0
3046839|NCT01198509|3766621|FG004|NOT COMPLETED|Overall Study||0
3046840|NCT01198509|3766622|FG005|NOT COMPLETED|Overall Study||0
3046841|NCT01198574|3766638|FG000|STARTED|Overall Study||98
3046842|NCT01198574|3766639|FG001|STARTED|Overall Study||102
3046843|NCT01198574|3766640|FG002|STARTED|Overall Study||100
3046844|NCT01198574|3766641|FG003|STARTED|Overall Study||102
3046845|NCT01198574|3766638|FG000|COMPLETED|Overall Study||94
3046846|NCT01198574|3766639|FG001|COMPLETED|Overall Study||101
3046847|NCT01198574|3766640|FG002|COMPLETED|Overall Study||99
3046848|NCT01198574|3766641|FG003|COMPLETED|Overall Study||98
3046849|NCT01198574|3766638|FG000|NOT COMPLETED|Overall Study||4
3046850|NCT01198574|3766639|FG001|NOT COMPLETED|Overall Study||1
3046851|NCT01198574|3766640|FG002|NOT COMPLETED|Overall Study||1
3046852|NCT01198574|3766641|FG003|NOT COMPLETED|Overall Study||4
3046853|NCT01198587|3766655|FG000|STARTED|Overall Study||31
3046854|NCT01198587|3766656|FG001|STARTED|Overall Study||5
3046855|NCT01198587|3766657|FG002|STARTED|Overall Study||30
3046856|NCT01198587|3766658|FG003|STARTED|Overall Study||5
3046857|NCT01198587|3766655|FG000|COMPLETED|Overall Study||23
3046858|NCT01198587|3766656|FG001|COMPLETED|Overall Study||5
3046859|NCT01198587|3766657|FG002|COMPLETED|Overall Study||21
3046860|NCT01198587|3766658|FG003|COMPLETED|Overall Study||5
3046861|NCT01198587|3766655|FG000|NOT COMPLETED|Overall Study||8
3046862|NCT01198587|3766656|FG001|NOT COMPLETED|Overall Study||0
3137514|NCT01717768|3862590|FG006|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
3137515|NCT01717768|3862591|FG007|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||17
3137516|NCT01717768|3862592|FG008|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
3137517|NCT01717768|3862593|FG009|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||16
3137518|NCT01717768|3862594|FG010|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
3137519|NCT01717768|3862595|FG011|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
3137520|NCT01717768|3862584|FG000|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
3137521|NCT01717768|3862585|FG001|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
3137522|NCT01717768|3862586|FG002|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
3137523|NCT01717768|3862587|FG003|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
3137524|NCT01717768|3862588|FG004|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
3137525|NCT01717768|3862589|FG005|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
3137526|NCT01717768|3862590|FG006|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
3137527|NCT01717768|3862591|FG007|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||15
3137528|NCT01717768|3862592|FG008|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
3137529|NCT01717768|3862593|FG009|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||15
3137530|NCT01717768|3862594|FG010|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
3137531|NCT01717768|3862595|FG011|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
3137532|NCT01717768|3862584|FG000|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
3137533|NCT01717768|3862585|FG001|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
3137534|NCT01717768|3862586|FG002|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
3137535|NCT01717768|3862587|FG003|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
3137536|NCT01717768|3862588|FG004|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
3137537|NCT01717768|3862589|FG005|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
3137538|NCT01717768|3862590|FG006|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
3137539|NCT01717768|3862591|FG007|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||2
3137540|NCT01717768|3862592|FG008|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
3137541|NCT01717768|3862593|FG009|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||1
3137542|NCT01717768|3862594|FG010|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
3137543|NCT01717768|3862595|FG011|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
3137544|NCT01717859|3862621|FG000|STARTED|Overall Study||54
3137545|NCT01717859|3862621|FG000|3 Month|Overall Study||50
3137546|NCT01717859|3862621|FG000|COMPLETED|Overall Study||44
3046863|NCT01198587|3766657|FG002|NOT COMPLETED|Overall Study||9
3046864|NCT01198587|3766658|FG003|NOT COMPLETED|Overall Study||0
3046865|NCT01198600|3766673|FG000|STARTED|Phase 1: Period One, 30 Days of Wear||35
3046866|NCT01198600|3766674|FG001|STARTED|Phase 1: Period One, 30 Days of Wear||37
3046867|NCT01198600|3766675|FG002|STARTED|Phase 1: Period One, 30 Days of Wear||0
3046868|NCT01198600|3766676|FG003|STARTED|Phase 1: Period One, 30 Days of Wear||0
3046869|NCT01198600|3766673|FG000|COMPLETED|Phase 1: Period One, 30 Days of Wear||33
3046870|NCT01198600|3766674|FG001|COMPLETED|Phase 1: Period One, 30 Days of Wear||36
3046871|NCT01198600|3766675|FG002|COMPLETED|Phase 1: Period One, 30 Days of Wear||0
3046872|NCT01198600|3766676|FG003|COMPLETED|Phase 1: Period One, 30 Days of Wear||0
3046873|NCT01198600|3766673|FG000|NOT COMPLETED|Phase 1: Period One, 30 Days of Wear||2
3046874|NCT01198600|3766674|FG001|NOT COMPLETED|Phase 1: Period One, 30 Days of Wear||1
3046875|NCT01198600|3766675|FG002|NOT COMPLETED|Phase 1: Period One, 30 Days of Wear||0
3046876|NCT01198600|3766676|FG003|NOT COMPLETED|Phase 1: Period One, 30 Days of Wear||0
3046877|NCT01198600|3766673|FG000|STARTED|Phase 1: Period Two, 30 Days of Wear|One participant discontinued between Period One and Period Two due to unconvenience.|32
3046878|NCT01198600|3766674|FG001|STARTED|Phase 1: Period Two, 30 Days of Wear||36
3046879|NCT01198600|3766675|FG002|STARTED|Phase 1: Period Two, 30 Days of Wear||0
3046880|NCT01198600|3766676|FG003|STARTED|Phase 1: Period Two, 30 Days of Wear||0
3046881|NCT01198600|3766673|FG000|COMPLETED|Phase 1: Period Two, 30 Days of Wear||32
3046882|NCT01198600|3766674|FG001|COMPLETED|Phase 1: Period Two, 30 Days of Wear||35
3180481|NCT01991483|3908858|FG001|STARTED|Dose Level 600 mg|Multiple periods were added for each dose level to represent dose escalation.|0
3180482|NCT01991483|3908859|FG002|STARTED|Dose Level 600 mg|Multiple periods were added for each dose level to represent dose escalation.|11
3180483|NCT01991483|3908860|FG003|STARTED|Dose Level 600 mg||0
3046883|NCT01198600|3766675|FG002|COMPLETED|Phase 1: Period Two, 30 Days of Wear||0
3046884|NCT01198600|3766676|FG003|COMPLETED|Phase 1: Period Two, 30 Days of Wear||0
3046885|NCT01198600|3766673|FG000|NOT COMPLETED|Phase 1: Period Two, 30 Days of Wear||0
3046886|NCT01198600|3766674|FG001|NOT COMPLETED|Phase 1: Period Two, 30 Days of Wear||1
3046887|NCT01198600|3766675|FG002|NOT COMPLETED|Phase 1: Period Two, 30 Days of Wear||0
3046888|NCT01198600|3766676|FG003|NOT COMPLETED|Phase 1: Period Two, 30 Days of Wear||0
3046889|NCT01198600|3766673|FG000|STARTED|Phase 2: 56 Days of Wear||0
3046890|NCT01198600|3766674|FG001|STARTED|Phase 2: 56 Days of Wear||0
3046891|NCT01198600|3766675|FG002|STARTED|Phase 2: 56 Days of Wear||67
3046892|NCT01198600|3766676|FG003|STARTED|Phase 2: 56 Days of Wear||0
3046893|NCT01198600|3766673|FG000|COMPLETED|Phase 2: 56 Days of Wear||0
3046894|NCT01198600|3766674|FG001|COMPLETED|Phase 2: 56 Days of Wear||0
3046895|NCT01198600|3766675|FG002|COMPLETED|Phase 2: 56 Days of Wear||62
3046896|NCT01198600|3766676|FG003|COMPLETED|Phase 2: 56 Days of Wear||0
3046897|NCT01198600|3766673|FG000|NOT COMPLETED|Phase 2: 56 Days of Wear||0
3046898|NCT01198600|3766674|FG001|NOT COMPLETED|Phase 2: 56 Days of Wear||0
3046899|NCT01198600|3766675|FG002|NOT COMPLETED|Phase 2: 56 Days of Wear||5
3046900|NCT01198600|3766676|FG003|NOT COMPLETED|Phase 2: 56 Days of Wear||0
3046901|NCT01198600|3766673|FG000|STARTED|Phase 3: 43 Days of Wear||0
3046902|NCT01198600|3766674|FG001|STARTED|Phase 3: 43 Days of Wear||0
3046903|NCT01198600|3766675|FG002|STARTED|Phase 3: 43 Days of Wear||0
3046904|NCT01198600|3766676|FG003|STARTED|Phase 3: 43 Days of Wear||38
3046905|NCT01198600|3766673|FG000|COMPLETED|Phase 3: 43 Days of Wear||0
3046906|NCT01198600|3766674|FG001|COMPLETED|Phase 3: 43 Days of Wear||0
3046907|NCT01198600|3766675|FG002|COMPLETED|Phase 3: 43 Days of Wear||0
3046908|NCT01198600|3766676|FG003|COMPLETED|Phase 3: 43 Days of Wear||38
3046909|NCT01198600|3766673|FG000|NOT COMPLETED|Phase 3: 43 Days of Wear||0
3046910|NCT01198600|3766674|FG001|NOT COMPLETED|Phase 3: 43 Days of Wear||0
3046911|NCT01198600|3766675|FG002|NOT COMPLETED|Phase 3: 43 Days of Wear||0
3046912|NCT01198600|3766676|FG003|NOT COMPLETED|Phase 3: 43 Days of Wear||0
3046913|NCT01198691|3766686|FG000|STARTED|Completed Surgery -Received Intervention||50
3046914|NCT01198691|3766687|FG001|STARTED|Completed Surgery -Received Intervention||50
3046915|NCT01198691|3766686|FG000|COMPLETED|Completed Surgery -Received Intervention||50
3046916|NCT01198691|3766687|FG001|COMPLETED|Completed Surgery -Received Intervention||50
3046917|NCT01198691|3766686|FG000|NOT COMPLETED|Completed Surgery -Received Intervention||0
3046918|NCT01198691|3766687|FG001|NOT COMPLETED|Completed Surgery -Received Intervention||0
3046919|NCT01198691|3766686|FG000|STARTED|Completed VAS Score Postop Day 1||50
3046920|NCT01198691|3766687|FG001|STARTED|Completed VAS Score Postop Day 1||50
3046921|NCT01198691|3766686|FG000|COMPLETED|Completed VAS Score Postop Day 1||47
3046922|NCT01198691|3766687|FG001|COMPLETED|Completed VAS Score Postop Day 1||46
3046923|NCT01198691|3766686|FG000|NOT COMPLETED|Completed VAS Score Postop Day 1||3
3046924|NCT01198691|3766687|FG001|NOT COMPLETED|Completed VAS Score Postop Day 1||4
3046925|NCT01198691|3766686|FG000|STARTED|Completed VAS Score at Discharge|Missing a VAS score on postop day one did not exclude participants from having a score at discharge.|50
3046926|NCT01198691|3766687|FG001|STARTED|Completed VAS Score at Discharge|Missing a VAS score on postop day one did not exclude participants from having a score at discharge.|50
3046927|NCT01198691|3766686|FG000|COMPLETED|Completed VAS Score at Discharge||45
3046928|NCT01198691|3766687|FG001|COMPLETED|Completed VAS Score at Discharge||44
3046929|NCT01198691|3766686|FG000|NOT COMPLETED|Completed VAS Score at Discharge||5
3046930|NCT01198691|3766687|FG001|NOT COMPLETED|Completed VAS Score at Discharge||6
3046931|NCT01198691|3766686|FG000|STARTED|Survey Prior to Discharge|Survey was given to all participants even if they were missing data from previous periods.|50
3046932|NCT01198691|3766687|FG001|STARTED|Survey Prior to Discharge|Survey was given to all participants even if they were missing data from previous periods.|50
3046933|NCT01198691|3766686|FG000|COMPLETED|Survey Prior to Discharge||18
3046934|NCT01198691|3766687|FG001|COMPLETED|Survey Prior to Discharge||17
3046935|NCT01198691|3766686|FG000|NOT COMPLETED|Survey Prior to Discharge||32
3046936|NCT01198691|3766687|FG001|NOT COMPLETED|Survey Prior to Discharge||33
3046937|NCT01198691|3766686|FG000|STARTED|6 Week Post-partum Survey|Survey was sent to all participants even if they were missing data from the previous two periods.|50
3046938|NCT01198691|3766687|FG001|STARTED|6 Week Post-partum Survey|Survey was sent to all participants even if they were missing data from the previous two periods.|50
3046939|NCT01198691|3766686|FG000|COMPLETED|6 Week Post-partum Survey||21
3046940|NCT01198691|3766687|FG001|COMPLETED|6 Week Post-partum Survey||26
3046941|NCT01198691|3766686|FG000|NOT COMPLETED|6 Week Post-partum Survey||29
3046942|NCT01198691|3766687|FG001|NOT COMPLETED|6 Week Post-partum Survey||24
3046943|NCT01198756|3766697|FG000|STARTED|Overall Study||932
3046944|NCT01198756|3766698|FG001|STARTED|Overall Study||929
3046945|NCT01198756|3766699|FG002|STARTED|Overall Study||932
3046946|NCT01198756|3766700|FG003|STARTED|Overall Study||301
3046947|NCT01198756|3766697|FG000|COMPLETED|Overall Study||894
3046948|NCT01198756|3766698|FG001|COMPLETED|Overall Study||889
3046949|NCT01198756|3766699|FG002|COMPLETED|Overall Study||902
3046950|NCT01198756|3766700|FG003|COMPLETED|Overall Study||275
3046951|NCT01198756|3766697|FG000|NOT COMPLETED|Overall Study||38
3046952|NCT01198756|3766698|FG001|NOT COMPLETED|Overall Study||40
3046953|NCT01198756|3766699|FG002|NOT COMPLETED|Overall Study||30
3046954|NCT01198756|3766700|FG003|NOT COMPLETED|Overall Study||26
3046955|NCT01198769|3766717|FG000|STARTED|Overall Study||15
3046956|NCT01198769|3766717|FG000|COMPLETED|Overall Study||15
3046957|NCT01198769|3766717|FG000|NOT COMPLETED|Overall Study||0
3046958|NCT01198795|3766721|FG000|STARTED|Overall Study||162
3046959|NCT01198795|3766721|FG000|COMPLETED|Overall Study||80
3046960|NCT01198795|3766721|FG000|NOT COMPLETED|Overall Study||82
3046961|NCT01198873|3766727|FG000|STARTED|Overall Study||41
3046962|NCT01198873|3766728|FG001|STARTED|Overall Study||35
3046963|NCT01198873|3766727|FG000|Treated|Overall Study||41
3046964|NCT01198873|3766728|FG001|Treated|Overall Study||35
3046965|NCT01198873|3766727|FG000|Evaluable for Efficacy|Overall Study|8 participants discontinued before completing 3-month treatment and were not assessed post-baseline|33
3046966|NCT01198873|3766728|FG001|Evaluable for Efficacy|Overall Study|9 participants discontinued before completing 3-month treatment and were not assessed post-baseline|26
3046967|NCT01198873|3766727|FG000|COMPLETED|Overall Study||4
3046968|NCT01198873|3766728|FG001|COMPLETED|Overall Study||3
3046969|NCT01198873|3766727|FG000|NOT COMPLETED|Overall Study||37
3046970|NCT01198873|3766728|FG001|NOT COMPLETED|Overall Study||32
3046971|NCT01198977|3766736|FG000|STARTED|Overall Study||31
3046972|NCT01198977|3766737|FG001|STARTED|Overall Study||33
3046973|NCT01198977|3766736|FG000|COMPLETED|Overall Study||30
3046974|NCT01198977|3766737|FG001|COMPLETED|Overall Study||33
3046975|NCT01198977|3766736|FG000|NOT COMPLETED|Overall Study||1
3046976|NCT01198977|3766737|FG001|NOT COMPLETED|Overall Study||0
3046977|NCT01199016|3766745|FG000|STARTED|Overall Study||239
3046978|NCT01199016|3766745|FG000|Treated|Overall Study||236
3046979|NCT01199016|3766745|FG000|COMPLETED|Overall Study||162
3046980|NCT01199016|3766745|FG000|NOT COMPLETED|Overall Study||77
3046981|NCT01199042|3766749|FG000|STARTED|Sleep Laboratory (3 Nights)||29
3046982|NCT01199042|3766749|FG000|COMPLETED|Sleep Laboratory (3 Nights)||27
3046983|NCT01199042|3766749|FG000|NOT COMPLETED|Sleep Laboratory (3 Nights)||2
3046984|NCT01199042|3766749|FG000|STARTED|At Home (3 Months)||27
3046985|NCT01199042|3766749|FG000|COMPLETED|At Home (3 Months)||26
3046986|NCT01199042|3766749|FG000|NOT COMPLETED|At Home (3 Months)||1
3046987|NCT01199055|3766761|FG000|STARTED|Overall Study||3
3046988|NCT01199055|3766762|FG001|STARTED|Overall Study||4
3046989|NCT01199055|3766763|FG002|STARTED|Overall Study||9
3046990|NCT01199055|3766761|FG000|COMPLETED|Overall Study||1
3046991|NCT01199055|3766762|FG001|COMPLETED|Overall Study||1
3046992|NCT01199055|3766763|FG002|COMPLETED|Overall Study||5
3046993|NCT01199055|3766761|FG000|NOT COMPLETED|Overall Study||2
3046994|NCT01199055|3766762|FG001|NOT COMPLETED|Overall Study||3
3180484|NCT01991483|3908857|FG000|Receive at Least One Dose of Study Drug|Dose Level 600 mg||0
3046995|NCT01199055|3766763|FG002|NOT COMPLETED|Overall Study||4
3046996|NCT01199068|3766776|FG000|STARTED|Overall Study||3
3046997|NCT01199068|3766777|FG001|STARTED|Overall Study||3
3046998|NCT01199068|3766778|FG002|STARTED|Overall Study||9
3046999|NCT01199068|3766776|FG000|Received Treatment|Overall Study||3
3047000|NCT01199068|3766777|FG001|Received Treatment|Overall Study||3
3047001|NCT01199068|3766778|FG002|Received Treatment|Overall Study||8
3047002|NCT01199068|3766776|FG000|COMPLETED|Overall Study||0
3047003|NCT01199068|3766777|FG001|COMPLETED|Overall Study||0
3047004|NCT01199068|3766778|FG002|COMPLETED|Overall Study||0
3047005|NCT01199068|3766776|FG000|NOT COMPLETED|Overall Study||3
3047006|NCT01199068|3766777|FG001|NOT COMPLETED|Overall Study||3
3047007|NCT01199068|3766778|FG002|NOT COMPLETED|Overall Study||9
3047008|NCT01199146|3766793|FG000|STARTED|Overall Study||42
3047009|NCT01199146|3766793|FG000|COMPLETED|Overall Study||39
3047010|NCT01199146|3766793|FG000|NOT COMPLETED|Overall Study||3
3047011|NCT01199198|3766799|FG000|STARTED|Overall Study||24
3047012|NCT01199198|3766800|FG001|STARTED|Overall Study||24
3047013|NCT01199198|3766799|FG000|COMPLETED|Overall Study||17
3047014|NCT01199198|3766800|FG001|COMPLETED|Overall Study||13
3047015|NCT01199198|3766799|FG000|NOT COMPLETED|Overall Study||7
3047016|NCT01199198|3766800|FG001|NOT COMPLETED|Overall Study||11
3047017|NCT01199237|3766808|FG000|STARTED|Overall Study||41
3047018|NCT01199237|3766809|FG001|STARTED|Overall Study||40
3047019|NCT01199237|3766808|FG000|COMPLETED|Overall Study||41
3047020|NCT01199237|3766809|FG001|COMPLETED|Overall Study||40
3047021|NCT01199237|3766808|FG000|NOT COMPLETED|Overall Study||0
3047022|NCT01199237|3766809|FG001|NOT COMPLETED|Overall Study||0
3047023|NCT01199263|3766819|FG000|STARTED|Overall Study||54
3047024|NCT01199263|3766820|FG001|STARTED|Overall Study||54
3047025|NCT01199263|3766819|FG000|COMPLETED|Overall Study||48
3047026|NCT01199263|3766820|FG001|COMPLETED|Overall Study||52
3047027|NCT01199263|3766819|FG000|NOT COMPLETED|Overall Study||6
3047028|NCT01199263|3766820|FG001|NOT COMPLETED|Overall Study||2
3047029|NCT01199289|3766832|FG000|STARTED|Overall Study||77
3047030|NCT01199289|3766833|FG001|STARTED|Overall Study||75
3047031|NCT01199289|3766834|FG002|STARTED|Overall Study||76
3047032|NCT01199289|3766835|FG003|STARTED|Overall Study||77
3047033|NCT01199289|3766832|FG000|Participants Who Received Study Treatment|Overall Study||76
3047034|NCT01199289|3766833|FG001|Participants Who Received Study Treatment|Overall Study||74
3047035|NCT01199289|3766834|FG002|Participants Who Received Study Treatment|Overall Study||76
3047036|NCT01199289|3766835|FG003|Participants Who Received Study Treatment|Overall Study||76
3047037|NCT01199289|3766832|FG000|COMPLETED|Overall Study||68
3047038|NCT01199289|3766833|FG001|COMPLETED|Overall Study||68
3047039|NCT01199289|3766834|FG002|COMPLETED|Overall Study||71
3047040|NCT01199289|3766835|FG003|COMPLETED|Overall Study||65
3047041|NCT01199289|3766832|FG000|NOT COMPLETED|Overall Study||9
3047042|NCT01199289|3766833|FG001|NOT COMPLETED|Overall Study||7
3047043|NCT01199289|3766834|FG002|NOT COMPLETED|Overall Study||5
3047044|NCT01199289|3766835|FG003|NOT COMPLETED|Overall Study||12
3047045|NCT01199380|3766850|FG000|STARTED|Overall Study||88
3047046|NCT01199380|3766851|FG001|STARTED|Overall Study||96
3047047|NCT01199380|3766850|FG000|COMPLETED|Overall Study||78
3047048|NCT01199380|3766851|FG001|COMPLETED|Overall Study||81
3047049|NCT01199380|3766850|FG000|NOT COMPLETED|Overall Study||10
3047050|NCT01199380|3766851|FG001|NOT COMPLETED|Overall Study||15
3047051|NCT01199471|3766857|FG000|STARTED|Overall Study|3 patients who did not meet ASA Physical Status Class 1 - 3 were excluded from all analyses.|4000
3047052|NCT01199471|3766857|FG000|COMPLETED|Overall Study||3994
3047053|NCT01199471|3766857|FG000|NOT COMPLETED|Overall Study||6
3047054|NCT01199575|3766862|FG000|STARTED|Overall Study||30
3047055|NCT01199575|3766862|FG000|COMPLETED|Overall Study||25
3047056|NCT01199575|3766862|FG000|NOT COMPLETED|Overall Study||5
3047057|NCT01199601|3766869|FG000|STARTED|Overall Study|Control Group|422
3047058|NCT01199601|3766870|FG001|STARTED|Overall Study|Intervention Group|422
3047059|NCT01199601|3766869|FG000|COMPLETED|Overall Study||353
3047060|NCT01199601|3766870|FG001|COMPLETED|Overall Study||344
3047061|NCT01199601|3766869|FG000|NOT COMPLETED|Overall Study||69
3047062|NCT01199601|3766870|FG001|NOT COMPLETED|Overall Study||78
3047063|NCT01199705|3766876|FG000|STARTED|IVIG Treatment||25
3047064|NCT01199705|3766876|FG000|COMPLETED|IVIG Treatment||25
3047065|NCT01199705|3766876|FG000|NOT COMPLETED|IVIG Treatment||0
3047066|NCT01199705|3766876|FG000|STARTED|SCIG Treatment (Wash-in/Wash-out)||25
3047067|NCT01199705|3766876|FG000|COMPLETED|SCIG Treatment (Wash-in/Wash-out)||24
3047068|NCT01199705|3766876|FG000|NOT COMPLETED|SCIG Treatment (Wash-in/Wash-out)||1
3047069|NCT01199705|3766876|FG000|STARTED|SCIG Treatment (Efficacy)||24
3047070|NCT01199705|3766876|FG000|COMPLETED|SCIG Treatment (Efficacy)||24
3047071|NCT01199705|3766876|FG000|NOT COMPLETED|SCIG Treatment (Efficacy)||0
3047072|NCT01199731|3766894|FG000|STARTED|Overall Study||9
3047073|NCT01199731|3766895|FG001|STARTED|Overall Study||11
3047074|NCT01199731|3766896|FG002|STARTED|Overall Study||10
3047075|NCT01199731|3766894|FG000|COMPLETED|Overall Study||0
3047076|NCT01199731|3766895|FG001|COMPLETED|Overall Study||0
3047077|NCT01199731|3766896|FG002|COMPLETED|Overall Study||0
3047078|NCT01199731|3766894|FG000|NOT COMPLETED|Overall Study||9
3047079|NCT01199731|3766895|FG001|NOT COMPLETED|Overall Study||11
3047080|NCT01199731|3766896|FG002|NOT COMPLETED|Overall Study||10
3047081|NCT01199744|3766904|FG000|STARTED|Overall Study||1575
3047082|NCT01199744|3766904|FG000|COMPLETED|Overall Study||1575
3047083|NCT01199744|3766904|FG000|NOT COMPLETED|Overall Study||0
3047084|NCT01199822|3766911|FG000|STARTED|Overall Study||3
3047085|NCT01199822|3766912|FG001|STARTED|Overall Study||7
3047086|NCT01199822|3766913|FG002|STARTED|Overall Study||6
3047087|NCT01199822|3766911|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
3047088|NCT01199822|3766912|FG001|Received at Least 1 Dose of Study Drug|Overall Study||7
3047089|NCT01199822|3766913|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
3047090|NCT01199822|3766911|FG000|COMPLETED|Overall Study||3
3047091|NCT01199822|3766912|FG001|COMPLETED|Overall Study||6
3047092|NCT01199822|3766913|FG002|COMPLETED|Overall Study||6
3047093|NCT01199822|3766911|FG000|NOT COMPLETED|Overall Study||0
3047094|NCT01199822|3766912|FG001|NOT COMPLETED|Overall Study||1
3047095|NCT01199822|3766913|FG002|NOT COMPLETED|Overall Study||0
3047096|NCT01199848|3766928|FG000|STARTED|Placebo Arm||29
3047097|NCT01199848|3766928|FG000|COMPLETED|Placebo Arm||21
3047098|NCT01199848|3766928|FG000|NOT COMPLETED|Placebo Arm||8
3047099|NCT01199848|3766928|FG000|STARTED|10g STR Arm||21
3047100|NCT01199848|3766928|FG000|COMPLETED|10g STR Arm||21
3047101|NCT01199848|3766928|FG000|NOT COMPLETED|10g STR Arm||0
3047102|NCT01199848|3766928|FG000|STARTED|20G STRB Arm||21
3047103|NCT01199848|3766928|FG000|COMPLETED|20G STRB Arm||21
3047104|NCT01199848|3766928|FG000|NOT COMPLETED|20G STRB Arm||0
3047105|NCT01199848|3766928|FG000|STARTED|40G STRB Arm||21
3047106|NCT01199848|3766928|FG000|COMPLETED|40G STRB Arm||21
3047107|NCT01199848|3766928|FG000|NOT COMPLETED|40G STRB Arm||0
3047108|NCT01199861|3766940|FG000|STARTED|Overall Study||95
3047109|NCT01199861|3766941|FG001|STARTED|Overall Study||43
3047110|NCT01199861|3766940|FG000|COMPLETED|Overall Study||93
3047111|NCT01199861|3766941|FG001|COMPLETED|Overall Study||43
3047112|NCT01199861|3766940|FG000|NOT COMPLETED|Overall Study||2
3047113|NCT01199861|3766941|FG001|NOT COMPLETED|Overall Study||0
3047114|NCT01199926|3766949|FG000|STARTED|Overall Study||17
3047115|NCT01199926|3766950|FG001|STARTED|Overall Study||17
3047116|NCT01199926|3766949|FG000|COMPLETED|Overall Study||10
3047117|NCT01199926|3766950|FG001|COMPLETED|Overall Study||13
3047118|NCT01199926|3766949|FG000|NOT COMPLETED|Overall Study||7
3047119|NCT01199926|3766950|FG001|NOT COMPLETED|Overall Study||4
3047120|NCT01199939|3766956|FG000|STARTED|Overall Study|Number of enrolled participants|54
3047121|NCT01199939|3766956|FG000|COMPLETED|Overall Study||41
3047122|NCT01199939|3766956|FG000|NOT COMPLETED|Overall Study||13
3047123|NCT01199952|3766962|FG000|STARTED|Overall Study||103
3047124|NCT01199952|3766963|FG001|STARTED|Overall Study||104
3047125|NCT01199952|3766962|FG000|COMPLETED|Overall Study||51
3047126|NCT01199952|3766963|FG001|COMPLETED|Overall Study||59
3047127|NCT01199952|3766962|FG000|NOT COMPLETED|Overall Study||52
3047128|NCT01199952|3766963|FG001|NOT COMPLETED|Overall Study||45
3047129|NCT01199965|3766972|FG000|STARTED|Overall Study||23
3047130|NCT01199965|3766973|FG001|STARTED|Overall Study||24
3047131|NCT01199965|3766972|FG000|COMPLETED|Overall Study||22
3047132|NCT01199965|3766973|FG001|COMPLETED|Overall Study||24
3047133|NCT01199965|3766972|FG000|NOT COMPLETED|Overall Study||1
3047134|NCT01199965|3766973|FG001|NOT COMPLETED|Overall Study||0
3047135|NCT01200030|3766990|FG000|STARTED|Overall Study||12
3047136|NCT01200030|3766991|FG001|STARTED|Overall Study||13
3047137|NCT01200030|3766992|FG002|STARTED|Overall Study||12
3047138|NCT01200030|3766990|FG000|COMPLETED|Overall Study||12
3047139|NCT01200030|3766991|FG001|COMPLETED|Overall Study||13
3047140|NCT01200030|3766992|FG002|COMPLETED|Overall Study||12
3047141|NCT01200030|3766990|FG000|NOT COMPLETED|Overall Study||0
3047142|NCT01200030|3766991|FG001|NOT COMPLETED|Overall Study||0
3047143|NCT01200030|3766992|FG002|NOT COMPLETED|Overall Study||0
3047144|NCT01200069|3767002|FG000|STARTED|Overall Study||8
3047145|NCT01200069|3767003|FG001|STARTED|Overall Study||6
3047146|NCT01200069|3767002|FG000|COMPLETED|Overall Study||8
3047147|NCT01200069|3767003|FG001|COMPLETED|Overall Study||5
3047148|NCT01200069|3767002|FG000|NOT COMPLETED|Overall Study||0
3047149|NCT01200069|3767003|FG001|NOT COMPLETED|Overall Study||1
3047150|NCT01200160|3767052|FG000|STARTED|Overall Study||128
3047151|NCT01200160|3767052|FG000|COMPLETED|Overall Study||66
3047152|NCT01200160|3767052|FG000|NOT COMPLETED|Overall Study||62
3047153|NCT01200238|3767058|FG000|STARTED|Overall Study||7
3047154|NCT01200238|3767059|FG001|STARTED|Overall Study||10
3047155|NCT01200238|3767058|FG000|COMPLETED|Overall Study||0
3047156|NCT01200238|3767059|FG001|COMPLETED|Overall Study||0
3047157|NCT01200238|3767058|FG000|NOT COMPLETED|Overall Study||7
3047158|NCT01200238|3767059|FG001|NOT COMPLETED|Overall Study||10
3047159|NCT01200290|3767065|FG000|STARTED|Treatment Period||18
3047160|NCT01200290|3767065|FG000|Received at Least 1 Dose of Study Drug|Treatment Period||18
3047161|NCT01200290|3767065|FG000|COMPLETED|Treatment Period||17
3047162|NCT01200290|3767065|FG000|NOT COMPLETED|Treatment Period||1
3047163|NCT01200290|3767065|FG000|STARTED|Post-Treatment Follow-Up Period|Participant who discontinued treatment was included in the post-treatment follow-up period.|18
3047164|NCT01200290|3767065|FG000|COMPLETED|Post-Treatment Follow-Up Period||16
3047165|NCT01200290|3767065|FG000|NOT COMPLETED|Post-Treatment Follow-Up Period||2
3047166|NCT01200329|3767069|FG000|STARTED|Overall Study||81
3047167|NCT01200329|3767069|FG000|COMPLETED|Overall Study||78
3047168|NCT01200329|3767069|FG000|NOT COMPLETED|Overall Study||3
3047169|NCT01200342|3767073|FG000|STARTED|Overall Study||7
3047170|NCT01200342|3767073|FG000|COMPLETED|Overall Study||6
3047171|NCT01200342|3767073|FG000|NOT COMPLETED|Overall Study||1
3047172|NCT01200355|3767079|FG000|STARTED|Overall Study||58
3047173|NCT01200355|3767080|FG001|STARTED|Overall Study||55
3047174|NCT01200355|3767079|FG000|COMPLETED|Overall Study||51
3047175|NCT01200355|3767080|FG001|COMPLETED|Overall Study||53
3047176|NCT01200355|3767079|FG000|NOT COMPLETED|Overall Study||7
3047177|NCT01200355|3767080|FG001|NOT COMPLETED|Overall Study||2
3047178|NCT01200368|3767089|FG000|STARTED|Infant Series||183
3047179|NCT01200368|3767090|FG001|STARTED|Infant Series||184
3047180|NCT01200368|3767091|FG002|STARTED|Infant Series||184
3047181|NCT01200368|3767089|FG000|Vaccinated Dose 1|Infant Series||183
3047182|NCT01200368|3767090|FG001|Vaccinated Dose 1|Infant Series||183
3047183|NCT01200368|3767091|FG002|Vaccinated Dose 1|Infant Series||183
3047184|NCT01200368|3767089|FG000|Vaccinated Dose 2|Infant Series||183
3047185|NCT01200368|3767090|FG001|Vaccinated Dose 2|Infant Series||182
3047186|NCT01200368|3767091|FG002|Vaccinated Dose 2|Infant Series||183
3047187|NCT01200368|3767089|FG000|Vaccinated Dose 3|Infant Series||181
3047188|NCT01200368|3767090|FG001|Vaccinated Dose 3|Infant Series||178
3047189|NCT01200368|3767091|FG002|Vaccinated Dose 3|Infant Series||182
3047190|NCT01200368|3767089|FG000|COMPLETED|Infant Series||180
3047191|NCT01200368|3767090|FG001|COMPLETED|Infant Series||178
3047192|NCT01200368|3767091|FG002|COMPLETED|Infant Series||178
3047193|NCT01200368|3767089|FG000|NOT COMPLETED|Infant Series||3
3047194|NCT01200368|3767090|FG001|NOT COMPLETED|Infant Series||6
3047195|NCT01200368|3767091|FG002|NOT COMPLETED|Infant Series||6
3047196|NCT01200368|3767089|FG000|STARTED|After Infant Series||180
3047197|NCT01200368|3767090|FG001|STARTED|After Infant Series||178
3047198|NCT01200368|3767091|FG002|STARTED|After Infant Series||178
3047199|NCT01200368|3767089|FG000|COMPLETED|After Infant Series||162
3047200|NCT01200368|3767090|FG001|COMPLETED|After Infant Series||162
3047201|NCT01200368|3767091|FG002|COMPLETED|After Infant Series||169
3047202|NCT01200368|3767089|FG000|NOT COMPLETED|After Infant Series||18
3047203|NCT01200368|3767090|FG001|NOT COMPLETED|After Infant Series||16
3047204|NCT01200368|3767091|FG002|NOT COMPLETED|After Infant Series||9
3047205|NCT01200368|3767089|FG000|STARTED|Toddler Dose||162
3047206|NCT01200368|3767090|FG001|STARTED|Toddler Dose||162
3047207|NCT01200368|3767091|FG002|STARTED|Toddler Dose||169
3047208|NCT01200368|3767089|FG000|COMPLETED|Toddler Dose||162
3047209|NCT01200368|3767090|FG001|COMPLETED|Toddler Dose||159
3047210|NCT01200368|3767091|FG002|COMPLETED|Toddler Dose||168
3047211|NCT01200368|3767089|FG000|NOT COMPLETED|Toddler Dose||0
3047212|NCT01200368|3767090|FG001|NOT COMPLETED|Toddler Dose||3
3047213|NCT01200368|3767091|FG002|NOT COMPLETED|Toddler Dose||1
3047214|NCT01200394|3767108|FG000|STARTED|Overall Study||64
3047215|NCT01200394|3767109|FG001|STARTED|Overall Study||192
3047216|NCT01200394|3767108|FG000|COMPLETED|Overall Study||62
3047217|NCT01200394|3767109|FG001|COMPLETED|Overall Study||164
3047218|NCT01200394|3767108|FG000|NOT COMPLETED|Overall Study||2
3047219|NCT01200394|3767109|FG001|NOT COMPLETED|Overall Study||28
3047220|NCT01200407|3767116|FG000|STARTED|Overall Study||615
3047221|NCT01200407|3767116|FG000|COMPLETED|Overall Study||533
3047222|NCT01200407|3767116|FG000|NOT COMPLETED|Overall Study||82
3047223|NCT01200433|3767122|FG000|STARTED|Overall Study||21
3047224|NCT01200433|3767123|FG001|STARTED|Overall Study||23
3047225|NCT01200433|3767122|FG000|COMPLETED|Overall Study||21
3047226|NCT01200433|3767123|FG001|COMPLETED|Overall Study||23
3047227|NCT01200433|3767122|FG000|NOT COMPLETED|Overall Study||0
3047228|NCT01200433|3767123|FG001|NOT COMPLETED|Overall Study||0
3047229|NCT01200485|3767129|FG000|STARTED|Cycle 1: Rasburicase Alone Delivery|Of 55 participants screened, only 52 treated.|55
3047230|NCT01200485|3767130|FG001|STARTED|Cycle 1: Rasburicase Alone Delivery||0
3047231|NCT01200485|3767131|FG002|STARTED|Cycle 1: Rasburicase Alone Delivery||0
3047232|NCT01200485|3767129|FG000|COMPLETED|Cycle 1: Rasburicase Alone Delivery||52
3047233|NCT01200485|3767130|FG001|COMPLETED|Cycle 1: Rasburicase Alone Delivery||0
3047234|NCT01200485|3767131|FG002|COMPLETED|Cycle 1: Rasburicase Alone Delivery||0
3047235|NCT01200485|3767129|FG000|NOT COMPLETED|Cycle 1: Rasburicase Alone Delivery||3
3047236|NCT01200485|3767130|FG001|NOT COMPLETED|Cycle 1: Rasburicase Alone Delivery||0
3047237|NCT01200485|3767131|FG002|NOT COMPLETED|Cycle 1: Rasburicase Alone Delivery||0
3047238|NCT01200485|3767129|FG000|STARTED|Cycle 2: Randomization|Of 55 enrolled on study, 52 participants were treated in Cycle 1, only 46 randomized to Cycle 2|0
3047239|NCT01200485|3767130|FG001|STARTED|Cycle 2: Randomization|Six not randomized: Methemoglobinemia-1, Kidney failure-2, Chemotherapy changed-2, Not evaluable-1|21
3047240|NCT01200485|3767131|FG002|STARTED|Cycle 2: Randomization||25
3047241|NCT01200485|3767129|FG000|COMPLETED|Cycle 2: Randomization||0
3047242|NCT01200485|3767130|FG001|COMPLETED|Cycle 2: Randomization||21
3047243|NCT01200485|3767131|FG002|COMPLETED|Cycle 2: Randomization||25
3047244|NCT01200485|3767129|FG000|NOT COMPLETED|Cycle 2: Randomization||0
3047245|NCT01200485|3767130|FG001|NOT COMPLETED|Cycle 2: Randomization||0
3047246|NCT01200485|3767131|FG002|NOT COMPLETED|Cycle 2: Randomization||0
3047247|NCT01200498|3767138|FG000|STARTED|Overall Study||22
3047248|NCT01200498|3767138|FG000|COMPLETED|Overall Study||22
3047249|NCT01200498|3767138|FG000|NOT COMPLETED|Overall Study||0
3047250|NCT01200511|3767142|FG000|STARTED|Overall Study||49
3047251|NCT01200511|3767142|FG000|COMPLETED|Overall Study||44
3047252|NCT01200511|3767142|FG000|NOT COMPLETED|Overall Study||5
3047253|NCT01200524|3767151|FG000|STARTED|Overall Study||41
3047254|NCT01200524|3767152|FG001|STARTED|Overall Study||48
3047255|NCT01200524|3767153|FG002|STARTED|Overall Study||44
3047256|NCT01200524|3767151|FG000|COMPLETED|Overall Study||39
3047257|NCT01200524|3767152|FG001|COMPLETED|Overall Study||47
3047258|NCT01200524|3767153|FG002|COMPLETED|Overall Study||40
3047259|NCT01200524|3767151|FG000|NOT COMPLETED|Overall Study||2
3047260|NCT01200524|3767152|FG001|NOT COMPLETED|Overall Study||1
3047261|NCT01200524|3767153|FG002|NOT COMPLETED|Overall Study||4
3047262|NCT01200589|3767163|FG000|STARTED|Overall Study||219
3047263|NCT01200589|3767164|FG001|STARTED|Overall Study||219
3047264|NCT01200589|3767163|FG000|Intent-to-treat (ITT) Analysis Set|Overall Study||219
3047265|NCT01200589|3767164|FG001|Intent-to-treat (ITT) Analysis Set|Overall Study||219
3047266|NCT01200589|3767163|FG000|Safety Set|Overall Study||217
3047267|NCT01200589|3767164|FG001|Safety Set|Overall Study||218
3047268|NCT01200589|3767163|FG000|COMPLETED|Overall Study||29
3047269|NCT01200589|3767164|FG001|COMPLETED|Overall Study||30
3047270|NCT01200589|3767163|FG000|NOT COMPLETED|Overall Study||190
3047271|NCT01200589|3767164|FG001|NOT COMPLETED|Overall Study||189
3047272|NCT01200758|3767172|FG000|STARTED|Stage I||64
3047273|NCT01200758|3767173|FG001|STARTED|Stage I||63
3047274|NCT01200758|3767174|FG002|STARTED|Stage I|Different participants were randomized into different stages of the study.|0
3047275|NCT01200758|3767175|FG003|STARTED|Stage I|Different participants were randomized into different stages of the study.|0
3047276|NCT01200758|3767172|FG000|COMPLETED|Stage I|Participants completed treatment period.|46
3047277|NCT01200758|3767173|FG001|COMPLETED|Stage I|Participants completed treatment period.|46
3047278|NCT01200758|3767174|FG002|COMPLETED|Stage I||0
3047279|NCT01200758|3767175|FG003|COMPLETED|Stage I||0
3047280|NCT01200758|3767172|FG000|NOT COMPLETED|Stage I||18
3047281|NCT01200758|3767173|FG001|NOT COMPLETED|Stage I||17
3047282|NCT01200758|3767174|FG002|NOT COMPLETED|Stage I||0
3047283|NCT01200758|3767175|FG003|NOT COMPLETED|Stage I||0
3047284|NCT01200758|3767172|FG000|STARTED|Stage 2|Different participants were randomized into different stages of the study.|0
3047285|NCT01200758|3767173|FG001|STARTED|Stage 2|Different participants were randomized into different stages of the study.|0
3047286|NCT01200758|3767174|FG002|STARTED|Stage 2||141
3047287|NCT01200758|3767175|FG003|STARTED|Stage 2||142
3047288|NCT01200758|3767172|FG000|COMPLETED|Stage 2||0
3047289|NCT01200758|3767173|FG001|COMPLETED|Stage 2||0
3047290|NCT01200758|3767174|FG002|COMPLETED|Stage 2|Participants completed treatment period.|100
3047291|NCT01200758|3767175|FG003|COMPLETED|Stage 2|Participants completed treatment period.|92
3047292|NCT01200758|3767172|FG000|NOT COMPLETED|Stage 2||0
3047293|NCT01200758|3767173|FG001|NOT COMPLETED|Stage 2||0
3047294|NCT01200758|3767174|FG002|NOT COMPLETED|Stage 2||41
3047295|NCT01200758|3767175|FG003|NOT COMPLETED|Stage 2||50
3047296|NCT01200797|3767187|FG000|STARTED|Overall Study||19
3047297|NCT01200797|3767187|FG000|COMPLETED|Overall Study||0
3047298|NCT01200797|3767187|FG000|NOT COMPLETED|Overall Study||19
3047299|NCT01200810|3767194|FG000|STARTED|Overall Study||5
3047300|NCT01200810|3767195|FG001|STARTED|Overall Study||5
3047301|NCT01200810|3767194|FG000|COMPLETED|Overall Study||0
3047302|NCT01200810|3767195|FG001|COMPLETED|Overall Study||0
3047303|NCT01200810|3767194|FG000|NOT COMPLETED|Overall Study||5
3047304|NCT01200810|3767195|FG001|NOT COMPLETED|Overall Study||5
3137547|NCT01717859|3862621|FG000|NOT COMPLETED|Overall Study||10
3137548|NCT01717872|3862634|FG000|STARTED|Overall Study||25
3137549|NCT01717872|3862635|FG001|STARTED|Overall Study||25
3137550|NCT01717872|3862634|FG000|COMPLETED|Overall Study||25
3137551|NCT01717872|3862635|FG001|COMPLETED|Overall Study||25
3137552|NCT01717872|3862634|FG000|NOT COMPLETED|Overall Study||0
3137553|NCT01717872|3862635|FG001|NOT COMPLETED|Overall Study||0
3137554|NCT01717898|3862645|FG000|STARTED|Overall Study||6
3137555|NCT01717898|3862646|FG001|STARTED|Overall Study|Study was terminated during Phase I, Dose level 1 due to toxicity.|0
3137556|NCT01717898|3862647|FG002|STARTED|Overall Study|Study was terminated during Phase I, Dose level 1 due to toxicity.|0
3137557|NCT01717898|3862648|FG003|STARTED|Overall Study|Study was terminated during Phase I, Dose level 1 due to toxicity.|0
3137558|NCT01717898|3862645|FG000|COMPLETED|Overall Study|Study was terminated during Phase I, Dose level 1 due to toxicity.|0
3137559|NCT01717898|3862646|FG001|COMPLETED|Overall Study||0
3137560|NCT01717898|3862647|FG002|COMPLETED|Overall Study||0
3137561|NCT01717898|3862648|FG003|COMPLETED|Overall Study||0
3137562|NCT01717898|3862645|FG000|NOT COMPLETED|Overall Study||6
3137563|NCT01717898|3862646|FG001|NOT COMPLETED|Overall Study||0
3137564|NCT01717898|3862647|FG002|NOT COMPLETED|Overall Study||0
3137565|NCT01717898|3862648|FG003|NOT COMPLETED|Overall Study||0
3137566|NCT01717976|3862660|FG000|STARTED|Overall Study||257
3137567|NCT01717976|3862661|FG001|STARTED|Overall Study||257
3137568|NCT01717976|3862660|FG000|COMPLETED|Overall Study||257
3137569|NCT01717976|3862661|FG001|COMPLETED|Overall Study||256
3137570|NCT01717976|3862660|FG000|NOT COMPLETED|Overall Study||0
3137571|NCT01717976|3862661|FG001|NOT COMPLETED|Overall Study||1
3137572|NCT01717989|3862667|FG000|STARTED|Overall Study||2248
3137573|NCT01717989|3862667|FG000|COMPLETED|Overall Study||1182
3137574|NCT01717989|3862667|FG000|NOT COMPLETED|Overall Study||1066
3137575|NCT01718028|3862688|FG000|STARTED|Overall Study||25
3137576|NCT01718028|3862689|FG001|STARTED|Overall Study||24
3137577|NCT01718028|3862688|FG000|COMPLETED|Overall Study||25
3137578|NCT01718028|3862689|FG001|COMPLETED|Overall Study||24
3137579|NCT01718028|3862688|FG000|NOT COMPLETED|Overall Study||0
3137580|NCT01718028|3862689|FG001|NOT COMPLETED|Overall Study||0
3137581|NCT01718353|3862697|FG000|STARTED|Overall Study||41
3137582|NCT01718353|3862698|FG001|STARTED|Overall Study||22
3137583|NCT01718353|3862697|FG000|Treated|Overall Study||39
3137584|NCT01718353|3862698|FG001|Treated|Overall Study||22
3137585|NCT01718353|3862697|FG000|Treated up to End of Cycle 4|Overall Study|7 participants discontinued before Cycle 5|32
3137586|NCT01718353|3862698|FG001|Treated up to End of Cycle 4|Overall Study|6 participants discontinued before Cycle 5|16
3137587|NCT01718353|3862697|FG000|Treated From Cycle 5|Overall Study|12 participants switched from Treatment A to B & 3 participants switched from Treatment B to A.|23
3137588|NCT01718353|3862698|FG001|Treated From Cycle 5|Overall Study|3 participants switched from Treatment B to A & 12 participants switched from Treatment A to B.|25
3137589|NCT01718353|3862697|FG000|COMPLETED|Overall Study|Participants at study cut-off, Adverse Event (AE), DP & consent withdrawn were considered completed.|29
3137590|NCT01718353|3862698|FG001|COMPLETED|Overall Study|Participants at study cut-off, AE, DP and consent withdrawn were considered completed.|17
3137591|NCT01718353|3862697|FG000|NOT COMPLETED|Overall Study||12
3137592|NCT01718353|3862698|FG001|NOT COMPLETED|Overall Study||5
3137593|NCT01718483|3862708|FG000|STARTED|Overall Study||191
3137594|NCT01718483|3862709|FG001|STARTED|Overall Study||192
3137595|NCT01718483|3862708|FG000|Treated|Overall Study||187
3137596|NCT01718483|3862709|FG001|Treated|Overall Study||192
3137597|NCT01718483|3862708|FG000|COMPLETED|Overall Study||157
3137598|NCT01718483|3862709|FG001|COMPLETED|Overall Study||158
3137599|NCT01718483|3862708|FG000|NOT COMPLETED|Overall Study||34
3137600|NCT01718483|3862709|FG001|NOT COMPLETED|Overall Study||34
3137601|NCT01718509|3862717|FG000|STARTED|Overall Study||195
3137602|NCT01718509|3862718|FG001|STARTED|Overall Study||195
3137603|NCT01718509|3862717|FG000|COMPLETED|Overall Study||147
3137604|NCT01718509|3862718|FG001|COMPLETED|Overall Study||147
3137605|NCT01718509|3862717|FG000|NOT COMPLETED|Overall Study||48
3137606|NCT01718509|3862718|FG001|NOT COMPLETED|Overall Study||48
3137607|NCT01718522|3862724|FG000|STARTED|Overall Study||75
3137608|NCT01718522|3862724|FG000|COMPLETED|Overall Study||67
3137609|NCT01718522|3862724|FG000|NOT COMPLETED|Overall Study||8
3137610|NCT01718535|3862741|FG000|STARTED|Overall Study||131
3137611|NCT01718535|3862742|FG001|STARTED|Overall Study||95
3137612|NCT01718535|3862743|FG002|STARTED|Overall Study||19
3137613|NCT01718535|3862744|FG003|STARTED|Overall Study||8
3047305|NCT01200875|3767201|FG000|STARTED|Overall Study||25
3047306|NCT01200875|3767201|FG000|COMPLETED|Overall Study||25
3047307|NCT01200875|3767201|FG000|NOT COMPLETED|Overall Study||0
3047308|NCT01200992|3767207|FG000|STARTED|Overall Study||39
3047309|NCT01200992|3767208|FG001|STARTED|Overall Study||45
3047310|NCT01200992|3767207|FG000|COMPLETED|Overall Study||2
3047311|NCT01200992|3767208|FG001|COMPLETED|Overall Study||4
3047312|NCT01200992|3767207|FG000|NOT COMPLETED|Overall Study||37
3047313|NCT01200992|3767208|FG001|NOT COMPLETED|Overall Study||41
3047314|NCT01201057|3767220|FG000|STARTED|Overall Study||34
3047315|NCT01201057|3767221|FG001|STARTED|Overall Study||33
3047316|NCT01201057|3767222|FG002|STARTED|Overall Study||32
3047317|NCT01201057|3767223|FG003|STARTED|Overall Study||33
3047318|NCT01201057|3767220|FG000|COMPLETED|Overall Study||32
3047319|NCT01201057|3767221|FG001|COMPLETED|Overall Study||29
3047320|NCT01201057|3767222|FG002|COMPLETED|Overall Study||27
3047321|NCT01201057|3767223|FG003|COMPLETED|Overall Study||29
3047322|NCT01201057|3767220|FG000|NOT COMPLETED|Overall Study||2
3047323|NCT01201057|3767221|FG001|NOT COMPLETED|Overall Study||4
3047324|NCT01201057|3767222|FG002|NOT COMPLETED|Overall Study||5
3047325|NCT01201057|3767223|FG003|NOT COMPLETED|Overall Study||4
3047326|NCT01201265|3767233|FG000|STARTED|Overall Study||40
3047327|NCT01201265|3767233|FG000|COMPLETED|Overall Study||2
3047328|NCT01201265|3767233|FG000|NOT COMPLETED|Overall Study||38
3047329|NCT01201317|3767240|FG000|STARTED|Overall Study||48
3047330|NCT01201317|3767241|FG001|STARTED|Overall Study||45
3047331|NCT01201317|3767242|FG002|STARTED|Overall Study||41
3047332|NCT01201317|3767240|FG000|COMPLETED|Overall Study||39
3047333|NCT01201317|3767241|FG001|COMPLETED|Overall Study||38
3047334|NCT01201317|3767242|FG002|COMPLETED|Overall Study||33
3047335|NCT01201317|3767240|FG000|NOT COMPLETED|Overall Study||9
3047336|NCT01201317|3767241|FG001|NOT COMPLETED|Overall Study||7
3047337|NCT01201317|3767242|FG002|NOT COMPLETED|Overall Study||8
3047338|NCT01201343|3767250|FG000|STARTED|Overall Study||79
3047339|NCT01201343|3767250|FG000|Treated|Overall Study||76
3047340|NCT01201343|3767250|FG000|COMPLETED|Overall Study||60
3047341|NCT01201343|3767250|FG000|NOT COMPLETED|Overall Study||19
3047342|NCT01201356|3767254|FG000|STARTED|Overall Study||4125
3047343|NCT01201356|3767254|FG000|Safety Set|Overall Study||4083
3047344|NCT01201356|3767254|FG000|Fingolimod Full Analysis Set|Overall Study||4046
3047345|NCT01201356|3767254|FG000|COMPLETED|Overall Study||3481
3047346|NCT01201356|3767254|FG000|NOT COMPLETED|Overall Study||644
3047347|NCT01201486|3767258|FG000|STARTED|Overall Study||6781
3047348|NCT01201486|3767258|FG000|COMPLETED|Overall Study||6781
3047349|NCT01201486|3767258|FG000|NOT COMPLETED|Overall Study||0
3047350|NCT01201629|3767264|FG000|STARTED|Overall Study||8
3047351|NCT01201629|3767265|FG001|STARTED|Overall Study||8
3047352|NCT01201629|3767264|FG000|COMPLETED|Overall Study||8
3047353|NCT01201629|3767265|FG001|COMPLETED|Overall Study||8
3047354|NCT01201629|3767264|FG000|NOT COMPLETED|Overall Study||0
3047355|NCT01201629|3767265|FG001|NOT COMPLETED|Overall Study||0
3047356|NCT01201759|3767273|FG000|STARTED|Visit 1 Wash-in ( Untreated)||10
3047357|NCT01201759|3767274|FG001|STARTED|Visit 1 Wash-in ( Untreated)||8
3047358|NCT01201759|3767273|FG000|COMPLETED|Visit 1 Wash-in ( Untreated)||8
3047359|NCT01201759|3767274|FG001|COMPLETED|Visit 1 Wash-in ( Untreated)||7
3047360|NCT01201759|3767273|FG000|NOT COMPLETED|Visit 1 Wash-in ( Untreated)||2
3047361|NCT01201759|3767274|FG001|NOT COMPLETED|Visit 1 Wash-in ( Untreated)||1
3047362|NCT01201759|3767273|FG000|STARTED|Visit 2||8
3047363|NCT01201759|3767274|FG001|STARTED|Visit 2||7
3047364|NCT01201759|3767273|FG000|COMPLETED|Visit 2||8
3047365|NCT01201759|3767274|FG001|COMPLETED|Visit 2||7
3047366|NCT01201759|3767273|FG000|NOT COMPLETED|Visit 2||0
3047367|NCT01201759|3767274|FG001|NOT COMPLETED|Visit 2||0
3047368|NCT01201759|3767273|FG000|STARTED|Visit 3 - Washout||8
3047369|NCT01201759|3767274|FG001|STARTED|Visit 3 - Washout||7
3047370|NCT01201759|3767273|FG000|COMPLETED|Visit 3 - Washout||7
3047371|NCT01201759|3767274|FG001|COMPLETED|Visit 3 - Washout||4
3047372|NCT01201759|3767273|FG000|NOT COMPLETED|Visit 3 - Washout||1
3047373|NCT01201759|3767274|FG001|NOT COMPLETED|Visit 3 - Washout||3
3047374|NCT01201759|3767273|FG000|STARTED|Visit 4 Crossover||7
3047375|NCT01201759|3767274|FG001|STARTED|Visit 4 Crossover||4
3047376|NCT01201759|3767273|FG000|COMPLETED|Visit 4 Crossover||7
3047377|NCT01201759|3767274|FG001|COMPLETED|Visit 4 Crossover||3
3047378|NCT01201759|3767273|FG000|NOT COMPLETED|Visit 4 Crossover||0
3047379|NCT01201759|3767274|FG001|NOT COMPLETED|Visit 4 Crossover||1
3047380|NCT01201759|3767273|FG000|STARTED|Visit 5||7
3047381|NCT01201759|3767274|FG001|STARTED|Visit 5||3
3047382|NCT01201759|3767273|FG000|COMPLETED|Visit 5||7
3047383|NCT01201759|3767274|FG001|COMPLETED|Visit 5||3
3047384|NCT01201759|3767273|FG000|NOT COMPLETED|Visit 5||0
3047385|NCT01201759|3767274|FG001|NOT COMPLETED|Visit 5||0
3047386|NCT01201772|3767285|FG000|STARTED|Overall Study||23
3047387|NCT01201772|3767286|FG001|STARTED|Overall Study||21
3047388|NCT01201772|3767287|FG002|STARTED|Overall Study||21
3047389|NCT01201772|3767285|FG000|COMPLETED|Overall Study||22
3047390|NCT01201772|3767286|FG001|COMPLETED|Overall Study||21
3047391|NCT01201772|3767287|FG002|COMPLETED|Overall Study||21
3047392|NCT01201772|3767285|FG000|NOT COMPLETED|Overall Study||1
3047393|NCT01201772|3767286|FG001|NOT COMPLETED|Overall Study||0
3047394|NCT01201772|3767287|FG002|NOT COMPLETED|Overall Study||0
3047395|NCT01201785|3767293|FG000|STARTED|Overall Study||36
3047396|NCT01201785|3767293|FG000|COMPLETED|Overall Study||20
3047397|NCT01201785|3767293|FG000|NOT COMPLETED|Overall Study||16
3047398|NCT01201798|3767299|FG000|STARTED|Overall Study||56
3047399|NCT01201798|3767300|FG001|STARTED|Overall Study||54
3047400|NCT01201798|3767299|FG000|COMPLETED|Overall Study||47
3047401|NCT01201798|3767300|FG001|COMPLETED|Overall Study||39
3047402|NCT01201798|3767299|FG000|NOT COMPLETED|Overall Study||9
3047403|NCT01201798|3767300|FG001|NOT COMPLETED|Overall Study||15
3047404|NCT01201811|3767306|FG000|STARTED|Overall Study||44
3047405|NCT01201811|3767306|FG000|COMPLETED|Overall Study||25
3047406|NCT01201811|3767306|FG000|NOT COMPLETED|Overall Study||19
3047407|NCT01201850|3767310|FG000|STARTED|Overall Study||7
3047408|NCT01201850|3767310|FG000|COMPLETED|Overall Study||3
3047409|NCT01201850|3767310|FG000|NOT COMPLETED|Overall Study||4
3047410|NCT01201863|3767317|FG000|STARTED|Overall Study||12
3047411|NCT01201863|3767318|FG001|STARTED|Overall Study||10
3047412|NCT01201863|3767319|FG002|STARTED|Overall Study||24
3047413|NCT01201863|3767317|FG000|COMPLETED|Overall Study||11
3047414|NCT01201863|3767318|FG001|COMPLETED|Overall Study||6
3047415|NCT01201863|3767319|FG002|COMPLETED|Overall Study||18
3047416|NCT01201863|3767317|FG000|NOT COMPLETED|Overall Study||1
3047417|NCT01201863|3767318|FG001|NOT COMPLETED|Overall Study||4
3047418|NCT01201863|3767319|FG002|NOT COMPLETED|Overall Study||6
3047419|NCT01201915|3767330|FG000|STARTED|Overall Study||24
3047420|NCT01201915|3767331|FG001|STARTED|Overall Study||25
3047421|NCT01201915|3767332|FG002|STARTED|Overall Study||25
3047422|NCT01201915|3767330|FG000|COMPLETED|Overall Study||16
3047423|NCT01201915|3767331|FG001|COMPLETED|Overall Study||14
3047424|NCT01201915|3767332|FG002|COMPLETED|Overall Study||19
3047425|NCT01201915|3767330|FG000|NOT COMPLETED|Overall Study||8
3047426|NCT01201915|3767331|FG001|NOT COMPLETED|Overall Study||11
3047427|NCT01201915|3767332|FG002|NOT COMPLETED|Overall Study||6
3137614|NCT01718535|3862745|FG004|STARTED|Overall Study||1
3137615|NCT01718535|3862746|FG005|STARTED|Overall Study||40
3137616|NCT01718535|3862747|FG006|STARTED|Overall Study||11
3137617|NCT01718535|3862748|FG007|STARTED|Overall Study||6
3137618|NCT01718535|3862749|FG008|STARTED|Overall Study||15
3137619|NCT01718535|3862750|FG009|STARTED|Overall Study||1
3137620|NCT01718535|3862741|FG000|First Pass|Overall Study||128
3137621|NCT01718535|3862742|FG001|First Pass|Overall Study||94
3137622|NCT01718535|3862743|FG002|First Pass|Overall Study||19
3137623|NCT01718535|3862744|FG003|First Pass|Overall Study||7
3137624|NCT01718535|3862745|FG004|First Pass|Overall Study||1
3137625|NCT01718535|3862746|FG005|First Pass|Overall Study||39
3137626|NCT01718535|3862747|FG006|First Pass|Overall Study||11
3137627|NCT01718535|3862748|FG007|First Pass|Overall Study||6
3137628|NCT01718535|3862749|FG008|First Pass|Overall Study||15
3137629|NCT01718535|3862750|FG009|First Pass|Overall Study||1
3137630|NCT01718535|3862741|FG000|COMPLETED|Overall Study||130
3137631|NCT01718535|3862742|FG001|COMPLETED|Overall Study||95
3137632|NCT01718535|3862743|FG002|COMPLETED|Overall Study||19
3137633|NCT01718535|3862744|FG003|COMPLETED|Overall Study||7
3137634|NCT01718535|3862745|FG004|COMPLETED|Overall Study||1
3137635|NCT01718535|3862746|FG005|COMPLETED|Overall Study||40
3137636|NCT01718535|3862747|FG006|COMPLETED|Overall Study||11
3137637|NCT01718535|3862748|FG007|COMPLETED|Overall Study||6
3137638|NCT01718535|3862749|FG008|COMPLETED|Overall Study||15
3137639|NCT01718535|3862750|FG009|COMPLETED|Overall Study||1
3137640|NCT01718535|3862741|FG000|NOT COMPLETED|Overall Study||1
3137641|NCT01718535|3862742|FG001|NOT COMPLETED|Overall Study||0
3137642|NCT01718535|3862743|FG002|NOT COMPLETED|Overall Study||0
3137643|NCT01718535|3862744|FG003|NOT COMPLETED|Overall Study||1
3137644|NCT01718535|3862745|FG004|NOT COMPLETED|Overall Study||0
3137645|NCT01718535|3862746|FG005|NOT COMPLETED|Overall Study||0
3137646|NCT01718535|3862747|FG006|NOT COMPLETED|Overall Study||0
3137647|NCT01718535|3862748|FG007|NOT COMPLETED|Overall Study||0
3137648|NCT01718535|3862749|FG008|NOT COMPLETED|Overall Study||0
3137649|NCT01718535|3862750|FG009|NOT COMPLETED|Overall Study||0
3137650|NCT01718691|3862774|FG000|STARTED|Overall Study||60
3137651|NCT01718691|3862775|FG001|STARTED|Overall Study||10
3137652|NCT01718691|3862774|FG000|COMPLETED|Overall Study||42
3137653|NCT01718691|3862775|FG001|COMPLETED|Overall Study||9
3137654|NCT01718691|3862774|FG000|NOT COMPLETED|Overall Study||18
3137655|NCT01718691|3862775|FG001|NOT COMPLETED|Overall Study||1
3137656|NCT01719003|3862794|FG000|STARTED|Overall Study||170
3137657|NCT01719003|3862795|FG001|STARTED|Overall Study||170
3137658|NCT01719003|3862796|FG002|STARTED|Overall Study||171
3137659|NCT01719003|3862797|FG003|STARTED|Overall Study||169
3137660|NCT01719003|3862798|FG004|STARTED|Overall Study||167
3137661|NCT01719003|3862799|FG005|STARTED|Overall Study||172
3137662|NCT01719003|3862800|FG006|STARTED|Overall Study||170
3137663|NCT01719003|3862801|FG007|STARTED|Overall Study||171
3137664|NCT01719003|3862802|FG008|STARTED|Overall Study||53
3137665|NCT01719003|3862794|FG000|COMPLETED|Overall Study||161
3137666|NCT01719003|3862795|FG001|COMPLETED|Overall Study||153
3137667|NCT01719003|3862796|FG002|COMPLETED|Overall Study||154
3137668|NCT01719003|3862797|FG003|COMPLETED|Overall Study||156
3137669|NCT01719003|3862798|FG004|COMPLETED|Overall Study||150
3137670|NCT01719003|3862799|FG005|COMPLETED|Overall Study||160
3137671|NCT01719003|3862800|FG006|COMPLETED|Overall Study||150
3137672|NCT01719003|3862801|FG007|COMPLETED|Overall Study||151
3137673|NCT01719003|3862802|FG008|COMPLETED|Overall Study||49
3137674|NCT01719003|3862794|FG000|NOT COMPLETED|Overall Study||9
3137675|NCT01719003|3862795|FG001|NOT COMPLETED|Overall Study||17
3137676|NCT01719003|3862796|FG002|NOT COMPLETED|Overall Study||17
3137677|NCT01719003|3862797|FG003|NOT COMPLETED|Overall Study||13
3137678|NCT01719003|3862798|FG004|NOT COMPLETED|Overall Study||17
3137679|NCT01719003|3862799|FG005|NOT COMPLETED|Overall Study||12
3137680|NCT01719003|3862800|FG006|NOT COMPLETED|Overall Study||20
3137681|NCT01719003|3862801|FG007|NOT COMPLETED|Overall Study||20
3137682|NCT01719003|3862802|FG008|NOT COMPLETED|Overall Study||4
3137683|NCT01719172|3862821|FG000|STARTED|Overall Study||30
3137684|NCT01719172|3862821|FG000|COMPLETED|Overall Study||28
3137685|NCT01719172|3862821|FG000|NOT COMPLETED|Overall Study||2
3137686|NCT01719224|3862825|FG000|STARTED|Intervention 1: Sleeping Position 1||18
3137687|NCT01719224|3862826|FG001|STARTED|Intervention 1: Sleeping Position 1||18
3137688|NCT01719224|3862825|FG000|COMPLETED|Intervention 1: Sleeping Position 1||14
3137689|NCT01719224|3862826|FG001|COMPLETED|Intervention 1: Sleeping Position 1||16
3137690|NCT01719224|3862825|FG000|NOT COMPLETED|Intervention 1: Sleeping Position 1||4
3137691|NCT01719224|3862826|FG001|NOT COMPLETED|Intervention 1: Sleeping Position 1||2
3137692|NCT01719224|3862825|FG000|STARTED|Intervention 2: Position Change(At 3.5h)||14
3137693|NCT01719224|3862826|FG001|STARTED|Intervention 2: Position Change(At 3.5h)||16
3137694|NCT01719224|3862825|FG000|COMPLETED|Intervention 2: Position Change(At 3.5h)||14
3137695|NCT01719224|3862826|FG001|COMPLETED|Intervention 2: Position Change(At 3.5h)||16
3137696|NCT01719224|3862825|FG000|NOT COMPLETED|Intervention 2: Position Change(At 3.5h)||0
3137697|NCT01719224|3862826|FG001|NOT COMPLETED|Intervention 2: Position Change(At 3.5h)||0
3137698|NCT01719367|3862835|FG000|STARTED|Overall Study||19
3137699|NCT01719367|3862836|FG001|STARTED|Overall Study||19
3137700|NCT01719367|3862835|FG000|COMPLETED|Overall Study||19
3137701|NCT01719367|3862836|FG001|COMPLETED|Overall Study||19
3137702|NCT01719367|3862835|FG000|NOT COMPLETED|Overall Study||0
3137703|NCT01719367|3862836|FG001|NOT COMPLETED|Overall Study||0
3137704|NCT01719380|3862852|FG000|STARTED|Overall Study||2
3137705|NCT01719380|3862853|FG001|STARTED|Overall Study||7
3137706|NCT01719380|3862854|FG002|STARTED|Overall Study||9
3137707|NCT01719380|3862855|FG003|STARTED|Overall Study||8
3137708|NCT01719380|3862856|FG004|STARTED|Overall Study||3
3137709|NCT01719380|3862857|FG005|STARTED|Overall Study||8
3137710|NCT01719380|3862858|FG006|STARTED|Overall Study||10
3137711|NCT01719380|3862859|FG007|STARTED|Overall Study||7
3137712|NCT01719380|3862860|FG008|STARTED|Overall Study||50
3137713|NCT01719380|3862861|FG009|STARTED|Overall Study||52
3137714|NCT01719380|3862852|FG000|COMPLETED|Overall Study||0
3137715|NCT01719380|3862853|FG001|COMPLETED|Overall Study||0
3137716|NCT01719380|3862854|FG002|COMPLETED|Overall Study||0
3137717|NCT01719380|3862855|FG003|COMPLETED|Overall Study||0
3137718|NCT01719380|3862856|FG004|COMPLETED|Overall Study||0
3137719|NCT01719380|3862857|FG005|COMPLETED|Overall Study||0
3137720|NCT01719380|3862858|FG006|COMPLETED|Overall Study||0
3137721|NCT01719380|3862859|FG007|COMPLETED|Overall Study||0
3137722|NCT01719380|3862860|FG008|COMPLETED|Overall Study||0
3137723|NCT01719380|3862861|FG009|COMPLETED|Overall Study||1
3137724|NCT01719380|3862852|FG000|NOT COMPLETED|Overall Study||2
3137725|NCT01719380|3862853|FG001|NOT COMPLETED|Overall Study||7
3137726|NCT01719380|3862854|FG002|NOT COMPLETED|Overall Study||9
3137727|NCT01719380|3862855|FG003|NOT COMPLETED|Overall Study||8
3137728|NCT01719380|3862856|FG004|NOT COMPLETED|Overall Study||3
3137729|NCT01719380|3862857|FG005|NOT COMPLETED|Overall Study||8
3137730|NCT01719380|3862858|FG006|NOT COMPLETED|Overall Study||10
3137731|NCT01719380|3862859|FG007|NOT COMPLETED|Overall Study||7
3137732|NCT01719380|3862860|FG008|NOT COMPLETED|Overall Study||50
3137733|NCT01719380|3862861|FG009|NOT COMPLETED|Overall Study||51
3137734|NCT01719653|3862895|FG000|STARTED|Overall Study||209
3137735|NCT01719653|3862896|FG001|STARTED|Overall Study||213
3137736|NCT01719653|3862897|FG002|STARTED|Overall Study||218
3137737|NCT01719653|3862898|FG003|STARTED|Overall Study||218
3137738|NCT01719653|3862899|FG004|STARTED|Overall Study||221
3137739|NCT01719653|3862895|FG000|COMPLETED|Overall Study||200
3137740|NCT01719653|3862896|FG001|COMPLETED|Overall Study||200
3137741|NCT01719653|3862897|FG002|COMPLETED|Overall Study||200
3137742|NCT01719653|3862898|FG003|COMPLETED|Overall Study||200
3137743|NCT01719653|3862899|FG004|COMPLETED|Overall Study||200
3137744|NCT01719653|3862895|FG000|NOT COMPLETED|Overall Study||9
3137745|NCT01719653|3862896|FG001|NOT COMPLETED|Overall Study||13
3137746|NCT01719653|3862897|FG002|NOT COMPLETED|Overall Study||18
3137747|NCT01719653|3862898|FG003|NOT COMPLETED|Overall Study||18
3137748|NCT01719653|3862899|FG004|NOT COMPLETED|Overall Study||21
3137749|NCT01719744|3862911|FG000|STARTED|Overall Study||25
3137750|NCT01719744|3862911|FG000|COMPLETED|Overall Study||25
3137751|NCT01719744|3862911|FG000|NOT COMPLETED|Overall Study||0
3137752|NCT01719757|3862915|FG000|STARTED|Overall Study||359
3137753|NCT01719757|3862915|FG000|COMPLETED|Overall Study||258
3137754|NCT01719757|3862915|FG000|NOT COMPLETED|Overall Study||101
3137755|NCT01719783|3862923|FG000|STARTED|Dose 1||30
3137756|NCT01719783|3862924|FG001|STARTED|Dose 1||10
3137757|NCT01719783|3862923|FG000|COMPLETED|Dose 1||30
3137758|NCT01719783|3862924|FG001|COMPLETED|Dose 1||10
3137759|NCT01719783|3862923|FG000|NOT COMPLETED|Dose 1||0
3137760|NCT01719783|3862924|FG001|NOT COMPLETED|Dose 1||0
3137761|NCT01719783|3862923|FG000|STARTED|Dose 2||30
3137762|NCT01719783|3862924|FG001|STARTED|Dose 2||10
3137763|NCT01719783|3862923|FG000|COMPLETED|Dose 2||29
3137764|NCT01719783|3862924|FG001|COMPLETED|Dose 2||10
3137765|NCT01719783|3862923|FG000|NOT COMPLETED|Dose 2||1
3137766|NCT01719783|3862924|FG001|NOT COMPLETED|Dose 2||0
3137767|NCT01719861|3862950|FG000|STARTED|Cycle 1||6
3137768|NCT01719861|3862950|FG000|COMPLETED|Cycle 1||2
3137769|NCT01719861|3862950|FG000|NOT COMPLETED|Cycle 1||4
3137770|NCT01719861|3862950|FG000|STARTED|Cycle 2||2
3137771|NCT01719861|3862950|FG000|COMPLETED|Cycle 2||1
3137772|NCT01719861|3862950|FG000|NOT COMPLETED|Cycle 2||1
3137773|NCT01719900|3862957|FG000|STARTED|Overall Study||29
3137774|NCT01719900|3862958|FG001|STARTED|Overall Study||24
3137775|NCT01719900|3862957|FG000|COMPLETED|Overall Study||22
3137776|NCT01719900|3862958|FG001|COMPLETED|Overall Study||22
3137777|NCT01719900|3862957|FG000|NOT COMPLETED|Overall Study||7
3137778|NCT01719900|3862958|FG001|NOT COMPLETED|Overall Study||2
3137779|NCT01720043|3862964|FG000|STARTED|Overall Study||8
3137780|NCT01720043|3862964|FG000|COMPLETED|Overall Study||7
3137781|NCT01720043|3862964|FG000|NOT COMPLETED|Overall Study||1
3137782|NCT01720069|3862971|FG000|STARTED|Overall Study||62
3137783|NCT01720069|3862972|FG001|STARTED|Overall Study||71
3137784|NCT01720069|3862973|FG002|STARTED|Overall Study||63
3137785|NCT01720069|3862971|FG000|Full Anaylsis Set|Overall Study||62
3137786|NCT01720069|3862972|FG001|Full Anaylsis Set|Overall Study||71
3137787|NCT01720069|3862973|FG002|Full Anaylsis Set|Overall Study||63
3137788|NCT01720069|3862971|FG000|COMPLETED|Overall Study||57
3137789|NCT01720069|3862972|FG001|COMPLETED|Overall Study||56
3137790|NCT01720069|3862973|FG002|COMPLETED|Overall Study||48
3137791|NCT01720069|3862971|FG000|NOT COMPLETED|Overall Study||5
3137792|NCT01720069|3862972|FG001|NOT COMPLETED|Overall Study||15
3137793|NCT01720069|3862973|FG002|NOT COMPLETED|Overall Study||15
3137794|NCT01720173|3862981|FG000|STARTED|Overall Study||30
3137795|NCT01720173|3862981|FG000|COMPLETED|Overall Study||30
3137796|NCT01720173|3862981|FG000|NOT COMPLETED|Overall Study||0
3137797|NCT01720225|3862987|FG000|STARTED|Overall Study||73
3137798|NCT01720225|3862988|FG001|STARTED|Overall Study||40
3137799|NCT01720225|3862987|FG000|COMPLETED|Overall Study||70
3137800|NCT01720225|3862988|FG001|COMPLETED|Overall Study||39
3137801|NCT01720225|3862987|FG000|NOT COMPLETED|Overall Study||3
3137802|NCT01720225|3862988|FG001|NOT COMPLETED|Overall Study||1
3137803|NCT01720251|3862997|FG000|STARTED|Overall Study||79
3137804|NCT01720251|3862998|FG001|STARTED|Overall Study||79
3137805|NCT01720251|3862999|FG002|STARTED|Overall Study||82
3137806|NCT01720251|3862997|FG000|COMPLETED|Overall Study||78
3137807|NCT01720251|3862998|FG001|COMPLETED|Overall Study||77
3137808|NCT01720251|3862999|FG002|COMPLETED|Overall Study||82
3137809|NCT01720251|3862997|FG000|NOT COMPLETED|Overall Study||1
3137810|NCT01720251|3862998|FG001|NOT COMPLETED|Overall Study||2
3137811|NCT01720251|3862999|FG002|NOT COMPLETED|Overall Study||0
3137812|NCT01720264|3863007|FG000|STARTED|Transplant With Sitagliptin for 15 Days||15
3137813|NCT01720264|3863007|FG000|COMPLETED|Transplant With Sitagliptin for 15 Days||14
3137814|NCT01720264|3863007|FG000|NOT COMPLETED|Transplant With Sitagliptin for 15 Days||1
3137815|NCT01720264|3863007|FG000|STARTED|Post-transplant (Day 16) to 1 Year||14
3137816|NCT01720264|3863007|FG000|COMPLETED|Post-transplant (Day 16) to 1 Year||2
3137817|NCT01720264|3863007|FG000|NOT COMPLETED|Post-transplant (Day 16) to 1 Year||12
3137818|NCT01720277|3863013|FG000|STARTED|Overall Study||1461
3137819|NCT01720277|3863014|FG001|STARTED|Overall Study||1496
3137820|NCT01720277|3863013|FG000|COMPLETED|Overall Study|intent-to-treat approach|958
3137821|NCT01720277|3863014|FG001|COMPLETED|Overall Study|intent-to-treat approach|938
3137822|NCT01720277|3863013|FG000|NOT COMPLETED|Overall Study||503
3137823|NCT01720277|3863014|FG001|NOT COMPLETED|Overall Study||558
3137824|NCT01720316|3863024|FG000|STARTED|Double-Blind Glycine Placebo Crossover||1
3137825|NCT01720316|3863025|FG001|STARTED|Double-Blind Glycine Placebo Crossover||1
3137826|NCT01720316|3863024|FG000|COMPLETED|Double-Blind Glycine Placebo Crossover||1
3137827|NCT01720316|3863025|FG001|COMPLETED|Double-Blind Glycine Placebo Crossover||1
3137828|NCT01720316|3863024|FG000|NOT COMPLETED|Double-Blind Glycine Placebo Crossover||0
3137829|NCT01720316|3863025|FG001|NOT COMPLETED|Double-Blind Glycine Placebo Crossover||0
3137830|NCT01720316|3863024|FG000|STARTED|Open-label Glycine||1
3137831|NCT01720316|3863025|FG001|STARTED|Open-label Glycine||1
3137832|NCT01720316|3863024|FG000|COMPLETED|Open-label Glycine||1
3137833|NCT01720316|3863025|FG001|COMPLETED|Open-label Glycine||1
3137834|NCT01720316|3863024|FG000|NOT COMPLETED|Open-label Glycine||0
3137835|NCT01720316|3863025|FG001|NOT COMPLETED|Open-label Glycine||0
3137836|NCT01720446|3863061|FG000|STARTED|Overall Study||826
3137837|NCT01720446|3863062|FG001|STARTED|Overall Study||822
3137838|NCT01720446|3863063|FG002|STARTED|Overall Study||824
3137839|NCT01720446|3863064|FG003|STARTED|Overall Study||825
3137840|NCT01720446|3863061|FG000|Premature Treatment Discontinuers|Overall Study|Premature treatment discontinuers were allowed to continue participation in the trial.|164
3137841|NCT01720446|3863062|FG001|Premature Treatment Discontinuers|Overall Study|Premature treatment discontinuers were allowed to continue participation in the trial.|186
3137842|NCT01720446|3863063|FG002|Premature Treatment Discontinuers|Overall Study|Premature treatment discontinuers were allowed to continue participation in the trial.|151
3137843|NCT01720446|3863064|FG003|Premature Treatment Discontinuers|Overall Study|Premature treatment discontinuers were allowed to continue participation in the trial.|159
3137844|NCT01720446|3863061|FG000|COMPLETED|Overall Study|Subjects who did not permanently discontinue treatment prematurely.|812
3137845|NCT01720446|3863062|FG001|COMPLETED|Overall Study|Subjects who did not permanently discontinue treatment prematurely.|811
3137846|NCT01720446|3863063|FG002|COMPLETED|Overall Study|Subjects who did not permanently discontinue treatment prematurely.|804
3137847|NCT01720446|3863064|FG003|COMPLETED|Overall Study|Subjects who did not permanently discontinue treatment prematurely.|805
3137848|NCT01720446|3863061|FG000|NOT COMPLETED|Overall Study||14
3137849|NCT01720446|3863062|FG001|NOT COMPLETED|Overall Study||11
3137850|NCT01720446|3863063|FG002|NOT COMPLETED|Overall Study||20
3137851|NCT01720446|3863064|FG003|NOT COMPLETED|Overall Study||20
3137852|NCT01720524|3863079|FG000|STARTED|Part A||29
3137853|NCT01720524|3863080|FG001|STARTED|Part A||30
3137854|NCT01720524|3863079|FG000|COMPLETED|Part A||22
3137855|NCT01720524|3863080|FG001|COMPLETED|Part A||18
3137856|NCT01720524|3863079|FG000|NOT COMPLETED|Part A||7
3137857|NCT01720524|3863080|FG001|NOT COMPLETED|Part A||12
3137858|NCT01720524|3863079|FG000|STARTED|Part B|Participants who did not complete Part A could also participate in Part B.|27
3137859|NCT01720524|3863080|FG001|STARTED|Part B|Participants who did not complete Part A could also participate in Part B.|26
3137860|NCT01720524|3863079|FG000|COMPLETED|Part B||22
3137861|NCT01720524|3863080|FG001|COMPLETED|Part B||17
3137862|NCT01720524|3863079|FG000|NOT COMPLETED|Part B||5
3137863|NCT01720524|3863080|FG001|NOT COMPLETED|Part B||9
3137864|NCT01720602|3863088|FG000|STARTED|Overall Study||15
3137865|NCT01720602|3863088|FG000|COMPLETED|Overall Study||10
3137866|NCT01720602|3863088|FG000|NOT COMPLETED|Overall Study||5
3137867|NCT01720667|3863094|FG000|STARTED|Overall Study||64
3137868|NCT01720667|3863095|FG001|STARTED|Overall Study||42
3137869|NCT01720667|3863094|FG000|Recieved Second Infusion of Same Drug|Overall Study||50
3137870|NCT01720667|3863095|FG001|Recieved Second Infusion of Same Drug|Overall Study||20
3137871|NCT01720667|3863094|FG000|Recieved Alternate Intervention|Overall Study||45
3137872|NCT01720667|3863095|FG001|Recieved Alternate Intervention|Overall Study||10
3137873|NCT01720667|3863094|FG000|Received 2nd Infusion of Alternate Drug|Overall Study||27
3137874|NCT01720667|3863095|FG001|Received 2nd Infusion of Alternate Drug|Overall Study||6
3137875|NCT01720667|3863094|FG000|Modified ITT|Overall Study||53
3137876|NCT01720667|3863095|FG001|Modified ITT|Overall Study||30
3137877|NCT01720667|3863094|FG000|COMPLETED|Overall Study||60
3137878|NCT01720667|3863095|FG001|COMPLETED|Overall Study||41
3137879|NCT01720667|3863094|FG000|NOT COMPLETED|Overall Study||4
3137880|NCT01720667|3863095|FG001|NOT COMPLETED|Overall Study||1
3137881|NCT01720797|3863105|FG000|STARTED|Overall Study||12
3137882|NCT01720797|3863106|FG001|STARTED|Overall Study||9
3137883|NCT01720797|3863105|FG000|COMPLETED|Overall Study||9
3137884|NCT01720797|3863106|FG001|COMPLETED|Overall Study||9
3137885|NCT01720797|3863105|FG000|NOT COMPLETED|Overall Study||3
3137886|NCT01720797|3863106|FG001|NOT COMPLETED|Overall Study||0
3137887|NCT01721044|3863115|FG000|STARTED|Treatment Period||176
3137888|NCT01721044|3863116|FG001|STARTED|Treatment Period|Randomized to 4mg (N=11) but received 2mg due to moderate renal impairment were included in 4mg arm|174
3137889|NCT01721044|3863117|FG002|STARTED|Treatment Period||177
3137890|NCT01721044|3863115|FG000|Rescue Week 16-24|Treatment Period||56
3137891|NCT01721044|3863116|FG001|Rescue Week 16-24|Treatment Period||38
3137892|NCT01721044|3863117|FG002|Rescue Week 16-24|Treatment Period||33
3137893|NCT01721044|3863115|FG000|COMPLETED|Treatment Period||144
3137894|NCT01721044|3863116|FG001|COMPLETED|Treatment Period||157
3137895|NCT01721044|3863117|FG002|COMPLETED|Treatment Period||158
3137896|NCT01721044|3863115|FG000|NOT COMPLETED|Treatment Period||32
3137897|NCT01721044|3863116|FG001|NOT COMPLETED|Treatment Period||17
3137898|NCT01721044|3863117|FG002|NOT COMPLETED|Treatment Period||19
3137899|NCT01721044|3863115|FG000|STARTED|Follow Up|Participants from treatment who entered the post-treatment follow-up period.|19
3137900|NCT01721044|3863116|FG001|STARTED|Follow Up|Participants from treatment who entered the post-treatment follow-up period.|9
3137901|NCT01721044|3863117|FG002|STARTED|Follow Up|Participants from treatment and rescue who entered the post-treatment follow-up period.|20
3137902|NCT01721044|3863115|FG000|COMPLETED|Follow Up||19
3137903|NCT01721044|3863116|FG001|COMPLETED|Follow Up||9
3137904|NCT01721044|3863117|FG002|COMPLETED|Follow Up||20
3137905|NCT01721044|3863115|FG000|NOT COMPLETED|Follow Up||0
3137906|NCT01721044|3863116|FG001|NOT COMPLETED|Follow Up||0
3137907|NCT01721044|3863117|FG002|NOT COMPLETED|Follow Up||0
3137908|NCT01721057|3863139|FG000|STARTED|Treatment Period||228
3137909|NCT01721057|3863140|FG001|STARTED|Treatment Period||229
3137910|NCT01721057|3863141|FG002|STARTED|Treatment Period||227
3137911|NCT01721057|3863142|FG003|STARTED|Treatment Period||0
3137912|NCT01721057|3863143|FG004|STARTED|Treatment Period||0
3137913|NCT01721057|3863144|FG005|STARTED|Treatment Period||0
3137914|NCT01721057|3863145|FG006|STARTED|Treatment Period||0
3137915|NCT01721057|3863139|FG000|Received at Least 1 Dose of Study Drug|Treatment Period||228
3137916|NCT01721057|3863140|FG001|Received at Least 1 Dose of Study Drug|Treatment Period||229
3137917|NCT01721057|3863141|FG002|Received at Least 1 Dose of Study Drug|Treatment Period||227
3137918|NCT01721057|3863142|FG003|Received at Least 1 Dose of Study Drug|Treatment Period||0
3137919|NCT01721057|3863143|FG004|Received at Least 1 Dose of Study Drug|Treatment Period||0
3137920|NCT01721057|3863144|FG005|Received at Least 1 Dose of Study Drug|Treatment Period||0
3137921|NCT01721057|3863145|FG006|Received at Least 1 Dose of Study Drug|Treatment Period||0
3137922|NCT01721057|3863139|FG000|Rescued|Treatment Period||55
3137923|NCT01721057|3863140|FG001|Rescued|Treatment Period||21
3137924|NCT01721057|3863141|FG002|Rescued|Treatment Period||15
3137925|NCT01721057|3863142|FG003|Rescued|Treatment Period||0
3137926|NCT01721057|3863143|FG004|Rescued|Treatment Period||0
3137927|NCT01721057|3863144|FG005|Rescued|Treatment Period||0
3137928|NCT01721057|3863145|FG006|Rescued|Treatment Period||0
3137929|NCT01721057|3863139|FG000|COMPLETED|Treatment Period|"Completers include rescued participants."|200
3137930|NCT01721057|3863140|FG001|COMPLETED|Treatment Period|"Completers include rescued participants."|210
3137931|NCT01721057|3863141|FG002|COMPLETED|Treatment Period|"Completers include rescued participants."|204
3137932|NCT01721057|3863142|FG003|COMPLETED|Treatment Period||0
3137933|NCT01721057|3863143|FG004|COMPLETED|Treatment Period||0
3137934|NCT01721057|3863144|FG005|COMPLETED|Treatment Period||0
3137935|NCT01721057|3863145|FG006|COMPLETED|Treatment Period||0
3137936|NCT01721057|3863139|FG000|NOT COMPLETED|Treatment Period||28
3137937|NCT01721057|3863140|FG001|NOT COMPLETED|Treatment Period||19
3137938|NCT01721057|3863141|FG002|NOT COMPLETED|Treatment Period||23
3137939|NCT01721057|3863142|FG003|NOT COMPLETED|Treatment Period||0
3137940|NCT01721057|3863143|FG004|NOT COMPLETED|Treatment Period||0
3137941|NCT01721057|3863144|FG005|NOT COMPLETED|Treatment Period||0
3137942|NCT01721057|3863145|FG006|NOT COMPLETED|Treatment Period||0
3137943|NCT01721057|3863139|FG000|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
3137944|NCT01721057|3863140|FG001|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
3137945|NCT01721057|3863141|FG002|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
3137946|NCT01721057|3863142|FG003|STARTED|Rescue Period|Participants who were determined to be nonresponders based on tender/swollen joint count.|91
3137947|NCT01721057|3863143|FG004|STARTED|Rescue Period||0
3137948|NCT01721057|3863144|FG005|STARTED|Rescue Period||0
3137949|NCT01721057|3863145|FG006|STARTED|Rescue Period||0
3137950|NCT01721057|3863139|FG000|COMPLETED|Rescue Period||0
3137951|NCT01721057|3863140|FG001|COMPLETED|Rescue Period||0
3137952|NCT01721057|3863141|FG002|COMPLETED|Rescue Period||0
3137953|NCT01721057|3863142|FG003|COMPLETED|Rescue Period||88
3137954|NCT01721057|3863143|FG004|COMPLETED|Rescue Period||0
3137955|NCT01721057|3863144|FG005|COMPLETED|Rescue Period||0
3137956|NCT01721057|3863145|FG006|COMPLETED|Rescue Period||0
3137957|NCT01721057|3863139|FG000|NOT COMPLETED|Rescue Period||0
3137958|NCT01721057|3863140|FG001|NOT COMPLETED|Rescue Period||0
3137959|NCT01721057|3863141|FG002|NOT COMPLETED|Rescue Period||0
3137960|NCT01721057|3863142|FG003|NOT COMPLETED|Rescue Period||3
3137961|NCT01721057|3863143|FG004|NOT COMPLETED|Rescue Period||0
3137962|NCT01721057|3863144|FG005|NOT COMPLETED|Rescue Period||0
3137963|NCT01721057|3863145|FG006|NOT COMPLETED|Rescue Period||0
3137964|NCT01721057|3863139|FG000|STARTED|Follow Up||0
3137965|NCT01721057|3863140|FG001|STARTED|Follow Up||0
3137966|NCT01721057|3863141|FG002|STARTED|Follow Up||0
3137967|NCT01721057|3863142|FG003|STARTED|Follow Up|Rescued participants who entered post-treatment follow-up are included in Baricitinib 4 mg FollowUp|0
3137968|NCT01721057|3863143|FG004|STARTED|Follow Up|Participants from treatment who entered the post-treatment follow-up period.|17
3137969|NCT01721057|3863144|FG005|STARTED|Follow Up|Participants from treatment who entered the post-treatment follow-up period.|19
3137970|NCT01721057|3863145|FG006|STARTED|Follow Up|Participants from treatment and rescue who entered the post-treatment follow-up period.|22
3137971|NCT01721057|3863139|FG000|COMPLETED|Follow Up||0
3137972|NCT01721057|3863140|FG001|COMPLETED|Follow Up||0
3137973|NCT01721057|3863141|FG002|COMPLETED|Follow Up||0
3137974|NCT01721057|3863142|FG003|COMPLETED|Follow Up||0
3137975|NCT01721057|3863143|FG004|COMPLETED|Follow Up||17
3137976|NCT01721057|3863144|FG005|COMPLETED|Follow Up||19
3137977|NCT01721057|3863145|FG006|COMPLETED|Follow Up||22
3137978|NCT01721057|3863139|FG000|NOT COMPLETED|Follow Up||0
3137979|NCT01721057|3863140|FG001|NOT COMPLETED|Follow Up||0
3137980|NCT01721057|3863141|FG002|NOT COMPLETED|Follow Up||0
3137981|NCT01721057|3863142|FG003|NOT COMPLETED|Follow Up||0
3137982|NCT01721057|3863143|FG004|NOT COMPLETED|Follow Up||0
3180485|NCT01991483|3908858|FG001|Receive at Least One Dose of Study Drug|Dose Level 600 mg||0
3180486|NCT01991483|3908859|FG002|Receive at Least One Dose of Study Drug|Dose Level 600 mg||11
3180487|NCT01991483|3908860|FG003|Receive at Least One Dose of Study Drug|Dose Level 600 mg||0
3180488|NCT01991483|3908857|FG000|COMPLETED|Dose Level 600 mg||0
3180489|NCT01991483|3908858|FG001|COMPLETED|Dose Level 600 mg||0
3180490|NCT01991483|3908859|FG002|COMPLETED|Dose Level 600 mg||9
3180491|NCT01991483|3908860|FG003|COMPLETED|Dose Level 600 mg||0
3137983|NCT01721057|3863144|FG005|NOT COMPLETED|Follow Up||0
3137984|NCT01721057|3863145|FG006|NOT COMPLETED|Follow Up||0
3137985|NCT01721070|3863172|FG000|STARTED|SUF NT 15 mcg||19
3137986|NCT01721070|3863172|FG000|COMPLETED|SUF NT 15 mcg||19
3137987|NCT01721070|3863172|FG000|NOT COMPLETED|SUF NT 15 mcg||0
3137988|NCT01721070|3863172|FG000|STARTED|Ketoconazole 400 mg and SUF NT 15 mcg||19
3137989|NCT01721070|3863172|FG000|COMPLETED|Ketoconazole 400 mg and SUF NT 15 mcg||18
3137990|NCT01721070|3863172|FG000|NOT COMPLETED|Ketoconazole 400 mg and SUF NT 15 mcg||1
3137991|NCT01721096|3863181|FG000|STARTED|Overall Study||323
3137992|NCT01721096|3863182|FG001|STARTED|Overall Study||213
3137993|NCT01721096|3863181|FG000|COMPLETED|Overall Study||3
3137994|NCT01721096|3863182|FG001|COMPLETED|Overall Study||9
3137995|NCT01721096|3863181|FG000|NOT COMPLETED|Overall Study||320
3137996|NCT01721096|3863182|FG001|NOT COMPLETED|Overall Study||204
3137997|NCT01721109|3863190|FG000|STARTED|Overall Study||50
3137998|NCT01721109|3863190|FG000|COMPLETED|Overall Study|34 participants transitioned to commercial Stribild or to an individual patient use (IPU) program|43
3137999|NCT01721109|3863190|FG000|NOT COMPLETED|Overall Study||7
3138000|NCT01721161|3863196|FG000|STARTED|Overall Study||41
3138001|NCT01721161|3863197|FG001|STARTED|Overall Study||41
3138002|NCT01721161|3863196|FG000|COMPLETED|Overall Study||37
3138003|NCT01721161|3863197|FG001|COMPLETED|Overall Study||34
3138004|NCT01721161|3863196|FG000|NOT COMPLETED|Overall Study||4
3138005|NCT01721161|3863197|FG001|NOT COMPLETED|Overall Study||7
3138006|NCT01721200|3863206|FG000|STARTED|Overall Study||62
3138007|NCT01721200|3863207|FG001|STARTED|Overall Study||63
3138008|NCT01721200|3863206|FG000|Completed 2 Week Follow-up|Overall Study||60
3138009|NCT01721200|3863207|FG001|Completed 2 Week Follow-up|Overall Study||61
3138010|NCT01721200|3863206|FG000|COMPLETED|Overall Study||59
3138011|NCT01721200|3863207|FG001|COMPLETED|Overall Study||58
3138012|NCT01721200|3863206|FG000|NOT COMPLETED|Overall Study||3
3138013|NCT01721200|3863207|FG001|NOT COMPLETED|Overall Study||5
3138014|NCT01721226|3863220|FG000|STARTED|Overall Study||55
3138015|NCT01721226|3863221|FG001|STARTED|Overall Study||57
3138016|NCT01721226|3863220|FG000|Baseline|Overall Study||53
3138017|NCT01721226|3863221|FG001|Baseline|Overall Study||57
3138018|NCT01721226|3863220|FG000|Week 12|Overall Study||48
3138019|NCT01721226|3863221|FG001|Week 12|Overall Study||53
3138020|NCT01721226|3863220|FG000|Week 24|Overall Study||50
3138021|NCT01721226|3863221|FG001|Week 24|Overall Study||50
3138022|NCT01721226|3863220|FG000|COMPLETED|Overall Study||50
3138023|NCT01721226|3863221|FG001|COMPLETED|Overall Study||50
3138024|NCT01721226|3863220|FG000|NOT COMPLETED|Overall Study||5
3138025|NCT01721226|3863221|FG001|NOT COMPLETED|Overall Study||7
3138026|NCT01721317|3863229|FG000|STARTED|Overall Study||2
3138027|NCT01721317|3863230|FG001|STARTED|Overall Study||4
3138028|NCT01721317|3863229|FG000|COMPLETED|Overall Study||0
3138029|NCT01721317|3863230|FG001|COMPLETED|Overall Study||0
3138030|NCT01721317|3863229|FG000|NOT COMPLETED|Overall Study||2
3138031|NCT01721317|3863230|FG001|NOT COMPLETED|Overall Study||4
3138032|NCT01721330|3863238|FG000|STARTED|Overall Study||1
3138033|NCT01721330|3863239|FG001|STARTED|Overall Study||2
3138034|NCT01721330|3863238|FG000|COMPLETED|Overall Study||1
3138035|NCT01721330|3863239|FG001|COMPLETED|Overall Study||1
3138036|NCT01721330|3863238|FG000|NOT COMPLETED|Overall Study||0
3138037|NCT01721330|3863239|FG001|NOT COMPLETED|Overall Study||1
3138038|NCT01721369|3863245|FG000|STARTED|Overall Study||581
3138039|NCT01721369|3863245|FG000|COMPLETED|Overall Study||569
3138040|NCT01721369|3863245|FG000|NOT COMPLETED|Overall Study||12
3138041|NCT01721408|3863251|FG000|STARTED|Overall Study|Number of participants treated.|232
3138042|NCT01721408|3863252|FG001|STARTED|Overall Study|Number of participants treated.|231
3138043|NCT01721408|3863251|FG000|COMPLETED|Overall Study||196
3138044|NCT01721408|3863252|FG001|COMPLETED|Overall Study||207
3138045|NCT01721408|3863251|FG000|NOT COMPLETED|Overall Study||36
3138046|NCT01721408|3863252|FG001|NOT COMPLETED|Overall Study||24
3138047|NCT01721447|3863258|FG000|STARTED|Overall Study||100
3138048|NCT01721447|3863258|FG000|COMPLETED|Overall Study||100
3138049|NCT01721447|3863258|FG000|NOT COMPLETED|Overall Study||0
3138050|NCT01721460|3863263|FG000|STARTED|Overall Study||6
3138051|NCT01721460|3863263|FG000|COMPLETED|Overall Study||5
3138052|NCT01721460|3863263|FG000|NOT COMPLETED|Overall Study||1
3138053|NCT01721473|3863275|FG000|STARTED|Overall Study||47
3138054|NCT01721473|3863276|FG001|STARTED|Overall Study||22
3138055|NCT01721473|3863277|FG002|STARTED|Overall Study||41
3138056|NCT01721473|3863278|FG003|STARTED|Overall Study||34
3138057|NCT01721473|3863279|FG004|STARTED|Overall Study||22
3138058|NCT01721473|3863280|FG005|STARTED|Overall Study||18
3138059|NCT01721473|3863275|FG000|COMPLETED|Overall Study||47
3138060|NCT01721473|3863276|FG001|COMPLETED|Overall Study||22
3138061|NCT01721473|3863277|FG002|COMPLETED|Overall Study||41
3138062|NCT01721473|3863278|FG003|COMPLETED|Overall Study||34
3138063|NCT01721473|3863279|FG004|COMPLETED|Overall Study||22
3138064|NCT01721473|3863280|FG005|COMPLETED|Overall Study||18
3138065|NCT01721473|3863275|FG000|NOT COMPLETED|Overall Study||0
3138066|NCT01721473|3863276|FG001|NOT COMPLETED|Overall Study||0
3138067|NCT01721473|3863277|FG002|NOT COMPLETED|Overall Study||0
3138068|NCT01721473|3863278|FG003|NOT COMPLETED|Overall Study||0
3138069|NCT01721473|3863279|FG004|NOT COMPLETED|Overall Study||0
3138070|NCT01721473|3863280|FG005|NOT COMPLETED|Overall Study||0
3138071|NCT01721486|3863291|FG000|STARTED|Overall Study||21
3138072|NCT01721486|3863292|FG001|STARTED|Overall Study||20
3138073|NCT01721486|3863291|FG000|COMPLETED|Overall Study||20
3138074|NCT01721486|3863292|FG001|COMPLETED|Overall Study||19
3138075|NCT01721486|3863291|FG000|NOT COMPLETED|Overall Study||1
3138076|NCT01721486|3863292|FG001|NOT COMPLETED|Overall Study||1
3138077|NCT01721564|3863298|FG000|STARTED|Overall Study||8
3138078|NCT01721564|3863298|FG000|COMPLETED|Overall Study||8
3138079|NCT01721564|3863298|FG000|NOT COMPLETED|Overall Study||0
3138080|NCT01721603|3863302|FG000|STARTED|Overall Study||2
3138081|NCT01721603|3863302|FG000|COMPLETED|Overall Study||2
3138082|NCT01721603|3863302|FG000|NOT COMPLETED|Overall Study||0
3138083|NCT01721681|3863306|FG000|STARTED|Overall Study||9
3138084|NCT01721681|3863306|FG000|COMPLETED|Overall Study||9
3138085|NCT01721681|3863306|FG000|NOT COMPLETED|Overall Study||0
3138086|NCT01721746|3863312|FG000|STARTED|Treatment Period||268
3138087|NCT01721746|3863313|FG001|STARTED|Treatment Period||45
3138088|NCT01721746|3863314|FG002|STARTED|Treatment Period||57
3138089|NCT01721746|3863312|FG000|COMPLETED|Treatment Period|Completed=Continuing in Treatment Period|35
3138090|NCT01721746|3863313|FG001|COMPLETED|Treatment Period||0
3138091|NCT01721746|3863314|FG002|COMPLETED|Treatment Period||0
3138092|NCT01721746|3863312|FG000|NOT COMPLETED|Treatment Period||233
3138093|NCT01721746|3863313|FG001|NOT COMPLETED|Treatment Period||45
3138094|NCT01721746|3863314|FG002|NOT COMPLETED|Treatment Period||57
3138095|NCT01721746|3863312|FG000|STARTED|Follow-Up Period|Participants could enter follow-up after discontinuing treatment for safety assessments|92
3138096|NCT01721746|3863313|FG001|STARTED|Follow-Up Period|Participants could enter follow-up after discontinuing treatment for safety assessments|11
3180492|NCT01991483|3908857|FG000|NOT COMPLETED|Dose Level 600 mg||0
3138097|NCT01721746|3863314|FG002|STARTED|Follow-Up Period|Participants could enter follow-up after discontinuing treatment for safety assessments|19
3138098|NCT01721746|3863312|FG000|COMPLETED|Follow-Up Period|Completed=Continuing in Follow-up Period; Study on-going|92
3138099|NCT01721746|3863313|FG001|COMPLETED|Follow-Up Period|Completed=Continuing in Follow-up Period; Study on-going|11
3138100|NCT01721746|3863314|FG002|COMPLETED|Follow-Up Period|Completed=Continuing in Follow-up Period; Study on-going|19
3138101|NCT01721746|3863312|FG000|NOT COMPLETED|Follow-Up Period||0
3138102|NCT01721746|3863313|FG001|NOT COMPLETED|Follow-Up Period||0
3138103|NCT01721746|3863314|FG002|NOT COMPLETED|Follow-Up Period||0
3138104|NCT01721772|3863322|FG000|STARTED|Overall Study||206
3138105|NCT01721772|3863323|FG001|STARTED|Overall Study||205
3138106|NCT01721772|3863322|FG000|COMPLETED|Overall Study|Continuing in treatment period|95
3138107|NCT01721772|3863323|FG001|COMPLETED|Overall Study|Continuing in treatment period|13
3138108|NCT01721772|3863322|FG000|NOT COMPLETED|Overall Study||111
3138109|NCT01721772|3863323|FG001|NOT COMPLETED|Overall Study||192
3138110|NCT01721837|3863329|FG000|STARTED|Overall Study||2120
3138111|NCT01721837|3863329|FG000|COMPLETED|Overall Study||2120
3138112|NCT01721837|3863329|FG000|NOT COMPLETED|Overall Study||0
3138113|NCT01721876|3863335|FG000|STARTED|Overall Study||222
3138114|NCT01721876|3863336|FG001|STARTED|Overall Study||444
3138115|NCT01721876|3863335|FG000|Treated|Overall Study||221
3138116|NCT01721876|3863336|FG001|Treated|Overall Study||440
3138117|NCT01721876|3863335|FG000|COMPLETED|Overall Study||0
3138118|NCT01721876|3863336|FG001|COMPLETED|Overall Study||0
3138119|NCT01721876|3863335|FG000|NOT COMPLETED|Overall Study||222
3138120|NCT01721876|3863336|FG001|NOT COMPLETED|Overall Study||444
3138121|NCT01721954|3863344|FG000|STARTED|Overall Study||105
3138122|NCT01721954|3863345|FG001|STARTED|Overall Study||104
3138123|NCT01721954|3863344|FG000|COMPLETED|Overall Study||35
3138124|NCT01721954|3863345|FG001|COMPLETED|Overall Study||35
3138125|NCT01721954|3863344|FG000|NOT COMPLETED|Overall Study||70
3138126|NCT01721954|3863345|FG001|NOT COMPLETED|Overall Study||69
3138127|NCT01721967|3863351|FG000|STARTED|Overall Study||14
3138128|NCT01721967|3863351|FG000|COMPLETED|Overall Study||11
3138129|NCT01721967|3863351|FG000|NOT COMPLETED|Overall Study||3
3138130|NCT01722045|3863355|FG000|STARTED|Overall Study||154
3138131|NCT01722045|3863355|FG000|COMPLETED|Overall Study||126
3138132|NCT01722045|3863355|FG000|NOT COMPLETED|Overall Study||28
3138133|NCT01722071|3863359|FG000|STARTED|Overall Study||10
3138134|NCT01722071|3863360|FG001|STARTED|Overall Study||10
3138135|NCT01722071|3863359|FG000|COMPLETED|Overall Study||9
3138136|NCT01722071|3863360|FG001|COMPLETED|Overall Study||10
3138137|NCT01722071|3863359|FG000|NOT COMPLETED|Overall Study||1
3138138|NCT01722071|3863360|FG001|NOT COMPLETED|Overall Study||0
3180493|NCT01991483|3908858|FG001|NOT COMPLETED|Dose Level 600 mg||0
3180494|NCT01991483|3908859|FG002|NOT COMPLETED|Dose Level 600 mg||2
3180495|NCT01991483|3908860|FG003|NOT COMPLETED|Dose Level 600 mg||0
3180496|NCT01991483|3908857|FG000|STARTED|Dose Level 1000 mg||0
3180497|NCT01991483|3908858|FG001|STARTED|Dose Level 1000 mg||0
3180498|NCT01991483|3908859|FG002|STARTED|Dose Level 1000 mg|Multiple periods were added for each dose level to represent dose escalation.|0
3180499|NCT01991483|3908860|FG003|STARTED|Dose Level 1000 mg|Multiple periods were added for each dose level to represent dose escalation.|4
3180500|NCT01991483|3908857|FG000|Received at Least One Dose of Study Drug|Dose Level 1000 mg||0
3180501|NCT01991483|3908858|FG001|Received at Least One Dose of Study Drug|Dose Level 1000 mg||0
3180502|NCT01991483|3908859|FG002|Received at Least One Dose of Study Drug|Dose Level 1000 mg||0
3180503|NCT01991483|3908860|FG003|Received at Least One Dose of Study Drug|Dose Level 1000 mg||4
3180504|NCT01991483|3908857|FG000|COMPLETED|Dose Level 1000 mg||0
3180505|NCT01991483|3908858|FG001|COMPLETED|Dose Level 1000 mg||0
3180506|NCT01991483|3908859|FG002|COMPLETED|Dose Level 1000 mg||0
3180507|NCT01991483|3908860|FG003|COMPLETED|Dose Level 1000 mg||3
3180508|NCT01991483|3908857|FG000|NOT COMPLETED|Dose Level 1000 mg||0
3180509|NCT01991483|3908858|FG001|NOT COMPLETED|Dose Level 1000 mg||0
3180510|NCT01991483|3908859|FG002|NOT COMPLETED|Dose Level 1000 mg||0
3180511|NCT01991483|3908860|FG003|NOT COMPLETED|Dose Level 1000 mg||1
3180512|NCT01991522|3908875|FG000|STARTED|Overall Study||16
3180513|NCT01991522|3908876|FG001|STARTED|Overall Study||17
3180514|NCT01991522|3908875|FG000|COMPLETED|Overall Study||16
3180515|NCT01991522|3908876|FG001|COMPLETED|Overall Study||17
3180516|NCT01991522|3908875|FG000|NOT COMPLETED|Overall Study||0
3180517|NCT01991522|3908876|FG001|NOT COMPLETED|Overall Study||0
3180518|NCT01991548|3908882|FG000|STARTED|Overall Study||40
3180519|NCT01991548|3908882|FG000|COMPLETED|Overall Study||39
3180520|NCT01991548|3908882|FG000|NOT COMPLETED|Overall Study||1
3180521|NCT01991743|3908890|FG000|STARTED|Overall Study||60
3180522|NCT01991743|3908891|FG001|STARTED|Overall Study||60
3180523|NCT01991743|3908892|FG002|STARTED|Overall Study||60
3180524|NCT01991743|3908893|FG003|STARTED|Overall Study||60
3180525|NCT01991743|3908890|FG000|COMPLETED|Overall Study||60
3180526|NCT01991743|3908891|FG001|COMPLETED|Overall Study||60
3180527|NCT01991743|3908892|FG002|COMPLETED|Overall Study||59
3180528|NCT01991743|3908893|FG003|COMPLETED|Overall Study||60
3180529|NCT01991743|3908890|FG000|NOT COMPLETED|Overall Study||0
3180530|NCT01991743|3908891|FG001|NOT COMPLETED|Overall Study||0
3180531|NCT01991743|3908892|FG002|NOT COMPLETED|Overall Study||1
3180532|NCT01991743|3908893|FG003|NOT COMPLETED|Overall Study||0
3180533|NCT01991795|3908905|FG000|STARTED|Overall Study||9645
3180534|NCT01991795|3908906|FG001|STARTED|Overall Study||9626
3180535|NCT01991795|3908905|FG000|COMPLETED|Overall Study||9496
3138139|NCT01722097|3863368|FG000|STARTED|Overall Study||55
3138140|NCT01722097|3863369|FG001|STARTED|Overall Study||55
3138141|NCT01722097|3863368|FG000|COMPLETED|Overall Study||49
3138142|NCT01722097|3863369|FG001|COMPLETED|Overall Study||50
3138143|NCT01722097|3863368|FG000|NOT COMPLETED|Overall Study||6
3138144|NCT01722097|3863369|FG001|NOT COMPLETED|Overall Study||5
3138145|NCT01722162|3863377|FG000|STARTED|Overall Study||23
3138146|NCT01722162|3863378|FG001|STARTED|Overall Study||24
3138147|NCT01722162|3863377|FG000|COMPLETED|Overall Study||18
3138148|NCT01722162|3863378|FG001|COMPLETED|Overall Study||18
3138149|NCT01722162|3863377|FG000|NOT COMPLETED|Overall Study||5
3138150|NCT01722162|3863378|FG001|NOT COMPLETED|Overall Study||6
3138151|NCT01722266|3863388|FG000|STARTED|Overall Study||18
3138152|NCT01722266|3863389|FG001|STARTED|Overall Study||18
3138153|NCT01722266|3863390|FG002|STARTED|Overall Study||18
3138154|NCT01722266|3863391|FG003|STARTED|Overall Study|3 withdrew consent; 1 dropped out due to nausea|18
3138155|NCT01722266|3863388|FG000|COMPLETED|Overall Study||17
3138156|NCT01722266|3863389|FG001|COMPLETED|Overall Study||15
3138157|NCT01722266|3863390|FG002|COMPLETED|Overall Study||13
3138158|NCT01722266|3863391|FG003|COMPLETED|Overall Study|3 subjects randomized to 1.2 mg group and 1 to 1.8 mg group tolerated only 0.6 mg|18
3138159|NCT01722266|3863388|FG000|NOT COMPLETED|Overall Study||1
3138160|NCT01722266|3863389|FG001|NOT COMPLETED|Overall Study||3
3138161|NCT01722266|3863390|FG002|NOT COMPLETED|Overall Study||5
3138162|NCT01722266|3863391|FG003|NOT COMPLETED|Overall Study||0
3138163|NCT01722292|3863404|FG000|STARTED|Overall Study||6
3138164|NCT01722292|3863405|FG001|STARTED|Overall Study||6
3138165|NCT01722292|3863406|FG002|STARTED|Overall Study||14
3138166|NCT01722292|3863404|FG000|Received at Least One Dose of Study Drug|Overall Study||6
3138167|NCT01722292|3863405|FG001|Received at Least One Dose of Study Drug|Overall Study||6
3138168|NCT01722292|3863406|FG002|Received at Least One Dose of Study Drug|Overall Study||14
3138169|NCT01722292|3863404|FG000|COMPLETED|Overall Study||6
3138170|NCT01722292|3863405|FG001|COMPLETED|Overall Study||6
3138171|NCT01722292|3863406|FG002|COMPLETED|Overall Study||14
3138172|NCT01722292|3863404|FG000|NOT COMPLETED|Overall Study||0
3138173|NCT01722292|3863405|FG001|NOT COMPLETED|Overall Study||0
3138174|NCT01722292|3863406|FG002|NOT COMPLETED|Overall Study||0
3138175|NCT01722318|3863436|FG000|STARTED|Overall Study||86
3138176|NCT01722318|3863437|FG001|STARTED|Overall Study||85
3138177|NCT01722318|3863438|FG002|STARTED|Overall Study||86
3138178|NCT01722318|3863439|FG003|STARTED|Overall Study||85
3138179|NCT01722318|3863440|FG004|STARTED|Overall Study||86
3138180|NCT01722318|3863436|FG000|COMPLETED|Overall Study||72
3138181|NCT01722318|3863437|FG001|COMPLETED|Overall Study||65
3138182|NCT01722318|3863438|FG002|COMPLETED|Overall Study||66
3138183|NCT01722318|3863439|FG003|COMPLETED|Overall Study||65
3138184|NCT01722318|3863440|FG004|COMPLETED|Overall Study||68
3138185|NCT01722318|3863436|FG000|NOT COMPLETED|Overall Study||14
3138186|NCT01722318|3863437|FG001|NOT COMPLETED|Overall Study||20
3138187|NCT01722318|3863438|FG002|NOT COMPLETED|Overall Study||20
3138188|NCT01722318|3863439|FG003|NOT COMPLETED|Overall Study||20
3138189|NCT01722318|3863440|FG004|NOT COMPLETED|Overall Study||18
3138190|NCT01722331|3863455|FG000|STARTED|Part 1||308
3138191|NCT01722331|3863456|FG001|STARTED|Part 1||249
3138192|NCT01722331|3863457|FG002|STARTED|Part 1||41
3138193|NCT01722331|3863458|FG003|STARTED|Part 1||19
3138194|NCT01722331|3863459|FG004|STARTED|Part 1||9
3138195|NCT01722331|3863460|FG005|STARTED|Part 1||72
3138196|NCT01722331|3863461|FG006|STARTED|Part 1||74
3138197|NCT01722331|3863455|FG000|COMPLETED|Part 1||298
3138198|NCT01722331|3863456|FG001|COMPLETED|Part 1||249
3138199|NCT01722331|3863457|FG002|COMPLETED|Part 1||32
3138200|NCT01722331|3863458|FG003|COMPLETED|Part 1||19
3138201|NCT01722331|3863459|FG004|COMPLETED|Part 1||0
3138202|NCT01722331|3863460|FG005|COMPLETED|Part 1||72
3138203|NCT01722331|3863461|FG006|COMPLETED|Part 1||74
3138204|NCT01722331|3863455|FG000|NOT COMPLETED|Part 1||10
3138205|NCT01722331|3863456|FG001|NOT COMPLETED|Part 1||0
3138206|NCT01722331|3863457|FG002|NOT COMPLETED|Part 1||9
3138207|NCT01722331|3863458|FG003|NOT COMPLETED|Part 1||0
3138208|NCT01722331|3863459|FG004|NOT COMPLETED|Part 1||9
3138209|NCT01722331|3863460|FG005|NOT COMPLETED|Part 1||0
3138210|NCT01722331|3863461|FG006|NOT COMPLETED|Part 1||0
3138211|NCT01722331|3863455|FG000|STARTED|Part 2||298
3138212|NCT01722331|3863456|FG001|STARTED|Part 2||249
3138213|NCT01722331|3863457|FG002|STARTED|Part 2|1 participant who completed Part 1 did not enter Part 2|31
3138214|NCT01722331|3863458|FG003|STARTED|Part 2||19
3138215|NCT01722331|3863459|FG004|STARTED|Part 2||0
3138216|NCT01722331|3863460|FG005|STARTED|Part 2||72
3138217|NCT01722331|3863461|FG006|STARTED|Part 2||74
3138218|NCT01722331|3863455|FG000|COMPLETED|Part 2||279
3138219|NCT01722331|3863456|FG001|COMPLETED|Part 2||249
3138220|NCT01722331|3863457|FG002|COMPLETED|Part 2||0
3138221|NCT01722331|3863458|FG003|COMPLETED|Part 2||19
3138222|NCT01722331|3863459|FG004|COMPLETED|Part 2||0
3138223|NCT01722331|3863460|FG005|COMPLETED|Part 2||62
3138224|NCT01722331|3863461|FG006|COMPLETED|Part 2||67
3138225|NCT01722331|3863455|FG000|NOT COMPLETED|Part 2||19
3138226|NCT01722331|3863456|FG001|NOT COMPLETED|Part 2||0
3138227|NCT01722331|3863457|FG002|NOT COMPLETED|Part 2||31
3138228|NCT01722331|3863458|FG003|NOT COMPLETED|Part 2||0
3138229|NCT01722331|3863459|FG004|NOT COMPLETED|Part 2||0
3138230|NCT01722331|3863460|FG005|NOT COMPLETED|Part 2||10
3138231|NCT01722331|3863461|FG006|NOT COMPLETED|Part 2||7
3138232|NCT01722331|3863455|FG000|STARTED|Part 3||279
3138233|NCT01722331|3863456|FG001|STARTED|Part 3||249
3138234|NCT01722331|3863457|FG002|STARTED|Part 3||0
3138235|NCT01722331|3863458|FG003|STARTED|Part 3||19
3180536|NCT01991795|3908906|FG001|COMPLETED|Overall Study||9503
3180537|NCT01991795|3908905|FG000|NOT COMPLETED|Overall Study||149
3180538|NCT01991795|3908906|FG001|NOT COMPLETED|Overall Study||123
3180539|NCT01991808|3908912|FG000|STARTED|Overall Study||16
3180540|NCT01991808|3908912|FG000|COMPLETED|Overall Study||16
3180541|NCT01991808|3908912|FG000|NOT COMPLETED|Overall Study||0
3180542|NCT01991821|3908918|FG000|STARTED|Overall Study||169
3180543|NCT01991821|3908919|FG001|STARTED|Overall Study||178
3180544|NCT01991821|3908918|FG000|COMPLETED|Overall Study||6
3180545|NCT01991821|3908919|FG001|COMPLETED|Overall Study||11
3180546|NCT01991821|3908918|FG000|NOT COMPLETED|Overall Study||163
3180547|NCT01991821|3908919|FG001|NOT COMPLETED|Overall Study||167
3180548|NCT01991860|3908929|FG000|STARTED|Overall Study||176
3180549|NCT01991860|3908930|FG001|STARTED|Overall Study||166
3180550|NCT01991860|3908929|FG000|COMPLETED|Overall Study||172
3138236|NCT01722331|3863459|FG004|STARTED|Part 3||0
3138237|NCT01722331|3863460|FG005|STARTED|Part 3||62
3138238|NCT01722331|3863461|FG006|STARTED|Part 3||67
3138239|NCT01722331|3863455|FG000|COMPLETED|Part 3||264
3138240|NCT01722331|3863456|FG001|COMPLETED|Part 3||232
3138241|NCT01722331|3863457|FG002|COMPLETED|Part 3||0
3138242|NCT01722331|3863458|FG003|COMPLETED|Part 3||18
3138243|NCT01722331|3863459|FG004|COMPLETED|Part 3||0
3138244|NCT01722331|3863460|FG005|COMPLETED|Part 3||59
3138245|NCT01722331|3863461|FG006|COMPLETED|Part 3||65
3138246|NCT01722331|3863455|FG000|NOT COMPLETED|Part 3||15
3138247|NCT01722331|3863456|FG001|NOT COMPLETED|Part 3||17
3138248|NCT01722331|3863457|FG002|NOT COMPLETED|Part 3||0
3138249|NCT01722331|3863458|FG003|NOT COMPLETED|Part 3||1
3138250|NCT01722331|3863459|FG004|NOT COMPLETED|Part 3||0
3138251|NCT01722331|3863460|FG005|NOT COMPLETED|Part 3||3
3138252|NCT01722331|3863461|FG006|NOT COMPLETED|Part 3||2
3138253|NCT01722435|3863473|FG000|STARTED|Overall Study||78
3138254|NCT01722435|3863473|FG000|COMPLETED|Overall Study||78
3138255|NCT01722435|3863473|FG000|NOT COMPLETED|Overall Study||0
3138256|NCT01722487|3863483|FG000|STARTED|Overall Study||136
3138257|NCT01722487|3863484|FG001|STARTED|Overall Study||133
3138258|NCT01722487|3863483|FG000|COMPLETED|Overall Study|Participants who were still on study or died at study closure|134
3138259|NCT01722487|3863484|FG001|COMPLETED|Overall Study|Participants who were still on study or died at study closure|126
3138260|NCT01722487|3863483|FG000|NOT COMPLETED|Overall Study||2
3138261|NCT01722487|3863484|FG001|NOT COMPLETED|Overall Study||7
3138262|NCT01722552|3863491|FG000|STARTED|Overall Study|Number of subjects enrolled|120
3138263|NCT01722552|3863491|FG000|COMPLETED|Overall Study|Number of subjects who completed the intervention|116
3138264|NCT01722552|3863491|FG000|NOT COMPLETED|Overall Study||4
3138265|NCT01722604|3863499|FG000|STARTED|Overall Study||129
3138266|NCT01722604|3863500|FG001|STARTED|Overall Study||129
3138267|NCT01722604|3863499|FG000|COMPLETED|Overall Study||123
3138268|NCT01722604|3863500|FG001|COMPLETED|Overall Study||120
3138269|NCT01722604|3863499|FG000|NOT COMPLETED|Overall Study||6
3138270|NCT01722604|3863500|FG001|NOT COMPLETED|Overall Study||9
3138271|NCT01722643|3863508|FG000|STARTED|Overall Study||30
3138272|NCT01722643|3863509|FG001|STARTED|Overall Study||31
3138273|NCT01722643|3863508|FG000|COMPLETED|Overall Study||30
3138274|NCT01722643|3863509|FG001|COMPLETED|Overall Study||30
3138275|NCT01722643|3863508|FG000|NOT COMPLETED|Overall Study||0
3138276|NCT01722643|3863509|FG001|NOT COMPLETED|Overall Study||1
3138277|NCT01722669|3863521|FG000|STARTED|Overall Study||5
3138278|NCT01722669|3863522|FG001|STARTED|Overall Study||5
3138279|NCT01722669|3863523|FG002|STARTED|Overall Study||5
3138280|NCT01722669|3863524|FG003|STARTED|Overall Study||5
3138281|NCT01722669|3863525|FG004|STARTED|Overall Study||10
3138282|NCT01722669|3863526|FG005|STARTED|Overall Study|Antiphospholipid Antibody (ARM D): 6 evaluable and 2 withdrew consent without any data collected|8
3138283|NCT01722669|3863521|FG000|COMPLETED|Overall Study||5
3138284|NCT01722669|3863522|FG001|COMPLETED|Overall Study||5
3138285|NCT01722669|3863523|FG002|COMPLETED|Overall Study||5
3138286|NCT01722669|3863524|FG003|COMPLETED|Overall Study||5
3138287|NCT01722669|3863525|FG004|COMPLETED|Overall Study||10
3138288|NCT01722669|3863526|FG005|COMPLETED|Overall Study||6
3138289|NCT01722669|3863521|FG000|NOT COMPLETED|Overall Study||0
3138290|NCT01722669|3863522|FG001|NOT COMPLETED|Overall Study||0
3138291|NCT01722669|3863523|FG002|NOT COMPLETED|Overall Study||0
3138292|NCT01722669|3863524|FG003|NOT COMPLETED|Overall Study||0
3138293|NCT01722669|3863525|FG004|NOT COMPLETED|Overall Study||0
3138294|NCT01722669|3863526|FG005|NOT COMPLETED|Overall Study||2
3138295|NCT01722734|3863549|FG000|STARTED|Overall Study||554
3138296|NCT01722734|3863550|FG001|STARTED|Overall Study||277
3138297|NCT01722734|3863551|FG002|STARTED|Overall Study||309
3138298|NCT01722734|3863549|FG000|COMPLETED|Overall Study||552
3138299|NCT01722734|3863550|FG001|COMPLETED|Overall Study||276
3138300|NCT01722734|3863551|FG002|COMPLETED|Overall Study||307
3138301|NCT01722734|3863549|FG000|NOT COMPLETED|Overall Study||2
3138302|NCT01722734|3863550|FG001|NOT COMPLETED|Overall Study||1
3138303|NCT01722734|3863551|FG002|NOT COMPLETED|Overall Study||2
3138304|NCT01722877|3863559|FG000|STARTED|Overall Study||29
3138305|NCT01722877|3863559|FG000|COMPLETED|Overall Study||27
3138306|NCT01722877|3863559|FG000|NOT COMPLETED|Overall Study||2
3138307|NCT01722994|3863567|FG000|STARTED|Overall Study||49
3138308|NCT01722994|3863568|FG001|STARTED|Overall Study||48
3138309|NCT01722994|3863567|FG000|COMPLETED|Overall Study||24
3180551|NCT01991860|3908930|FG001|COMPLETED|Overall Study||164
3138310|NCT01722994|3863568|FG001|COMPLETED|Overall Study||31
3138311|NCT01722994|3863567|FG000|NOT COMPLETED|Overall Study||25
3138312|NCT01722994|3863568|FG001|NOT COMPLETED|Overall Study||17
3138313|NCT01723072|3863578|FG000|STARTED|Overall Study|28-week treatment period and 8-week follow-up period|44
3138314|NCT01723072|3863579|FG001|STARTED|Overall Study|28-week treatment period and 8-week follow-up period|47
3138315|NCT01723072|3863578|FG000|COMPLETED|Overall Study||33
3138316|NCT01723072|3863579|FG001|COMPLETED|Overall Study||26
3138317|NCT01723072|3863578|FG000|NOT COMPLETED|Overall Study||11
3138318|NCT01723072|3863579|FG001|NOT COMPLETED|Overall Study||21
3138319|NCT01723163|3863587|FG000|STARTED|Baseline||156
3138320|NCT01723163|3863588|FG001|STARTED|Baseline||154
3138321|NCT01723163|3863587|FG000|COMPLETED|Baseline||156
3138322|NCT01723163|3863588|FG001|COMPLETED|Baseline||154
3138323|NCT01723163|3863587|FG000|NOT COMPLETED|Baseline||0
3138324|NCT01723163|3863588|FG001|NOT COMPLETED|Baseline||0
3180552|NCT01991860|3908929|FG000|NOT COMPLETED|Overall Study||4
3180553|NCT01991860|3908930|FG001|NOT COMPLETED|Overall Study||2
3180554|NCT01991977|3908936|FG000|STARTED|Overall Study||91
3180555|NCT01991977|3908936|FG000|Received PET Tracer|Overall Study||84
3180556|NCT01991977|3908936|FG000|Received IMRT Treatment|Overall Study||79
3180557|NCT01991977|3908936|FG000|Evaluable for the Primary Outcome|Overall Study||39
3138325|NCT01723163|3863587|FG000|STARTED|Treatment Phase||156
3138326|NCT01723163|3863588|FG001|STARTED|Treatment Phase||154
3138327|NCT01723163|3863587|FG000|COMPLETED|Treatment Phase||137
3138328|NCT01723163|3863588|FG001|COMPLETED|Treatment Phase||147
3138329|NCT01723163|3863587|FG000|NOT COMPLETED|Treatment Phase||19
3138330|NCT01723163|3863588|FG001|NOT COMPLETED|Treatment Phase||7
3138331|NCT01723163|3863587|FG000|STARTED|3-Month Follow-up||137
3138332|NCT01723163|3863588|FG001|STARTED|3-Month Follow-up||147
3138333|NCT01723163|3863587|FG000|COMPLETED|3-Month Follow-up||124
3138334|NCT01723163|3863588|FG001|COMPLETED|3-Month Follow-up||128
3138335|NCT01723163|3863587|FG000|NOT COMPLETED|3-Month Follow-up||13
3138336|NCT01723163|3863588|FG001|NOT COMPLETED|3-Month Follow-up||19
3138337|NCT01723163|3863587|FG000|STARTED|6-Month Follow-up||136
3138338|NCT01723163|3863588|FG001|STARTED|6-Month Follow-up||147
3138339|NCT01723163|3863587|FG000|COMPLETED|6-Month Follow-up||118
3138340|NCT01723163|3863588|FG001|COMPLETED|6-Month Follow-up||132
3138341|NCT01723163|3863587|FG000|NOT COMPLETED|6-Month Follow-up||18
3138342|NCT01723163|3863588|FG001|NOT COMPLETED|6-Month Follow-up||15
3138343|NCT01723163|3863587|FG000|STARTED|12-Month Follow-up||135
3138344|NCT01723163|3863588|FG001|STARTED|12-Month Follow-up||147
3138345|NCT01723163|3863587|FG000|COMPLETED|12-Month Follow-up||111
3138346|NCT01723163|3863588|FG001|COMPLETED|12-Month Follow-up||119
3138347|NCT01723163|3863587|FG000|NOT COMPLETED|12-Month Follow-up||24
3138348|NCT01723163|3863588|FG001|NOT COMPLETED|12-Month Follow-up||28
3138349|NCT01723228|3863596|FG000|STARTED|Overall Study||86
3138350|NCT01723228|3863597|FG001|STARTED|Overall Study||84
3138351|NCT01723228|3863596|FG000|COMPLETED|Overall Study||78
3138352|NCT01723228|3863597|FG001|COMPLETED|Overall Study||73
3138353|NCT01723228|3863596|FG000|NOT COMPLETED|Overall Study||8
3138354|NCT01723228|3863597|FG001|NOT COMPLETED|Overall Study||11
3138355|NCT01723254|3863611|FG000|STARTED|Overall Study||6
3138356|NCT01723254|3863612|FG001|STARTED|Overall Study||21
3138357|NCT01723254|3863613|FG002|STARTED|Overall Study||20
3138358|NCT01723254|3863614|FG003|STARTED|Overall Study||20
3138359|NCT01723254|3863615|FG004|STARTED|Overall Study||20
3138360|NCT01723254|3863616|FG005|STARTED|Overall Study||20
3138361|NCT01723254|3863617|FG006|STARTED|Overall Study||20
3138362|NCT01723254|3863618|FG007|STARTED|Overall Study||63
3138363|NCT01723254|3863611|FG000|COMPLETED|Overall Study||5
3138364|NCT01723254|3863612|FG001|COMPLETED|Overall Study||18
3138365|NCT01723254|3863613|FG002|COMPLETED|Overall Study||17
3138366|NCT01723254|3863614|FG003|COMPLETED|Overall Study||18
3138367|NCT01723254|3863615|FG004|COMPLETED|Overall Study||18
3138368|NCT01723254|3863616|FG005|COMPLETED|Overall Study||18
3138369|NCT01723254|3863617|FG006|COMPLETED|Overall Study||19
3138370|NCT01723254|3863618|FG007|COMPLETED|Overall Study||60
3138371|NCT01723254|3863611|FG000|NOT COMPLETED|Overall Study||1
3138372|NCT01723254|3863612|FG001|NOT COMPLETED|Overall Study||3
3138373|NCT01723254|3863613|FG002|NOT COMPLETED|Overall Study||3
3138374|NCT01723254|3863614|FG003|NOT COMPLETED|Overall Study||2
3138375|NCT01723254|3863615|FG004|NOT COMPLETED|Overall Study||2
3138376|NCT01723254|3863616|FG005|NOT COMPLETED|Overall Study||2
3138377|NCT01723254|3863617|FG006|NOT COMPLETED|Overall Study||1
3138378|NCT01723254|3863618|FG007|NOT COMPLETED|Overall Study||3
3138379|NCT01723384|3863638|FG000|STARTED|Overall Study||15
3138380|NCT01723384|3863639|FG001|STARTED|Overall Study||15
3180558|NCT01991977|3908936|FG000|COMPLETED|Overall Study||79
3180559|NCT01991977|3908936|FG000|NOT COMPLETED|Overall Study||12
3180560|NCT01991990|3908942|FG000|STARTED|Overall Study||6
3180561|NCT01991990|3908943|FG001|STARTED|Overall Study||12
3180562|NCT01991990|3908942|FG000|COMPLETED|Overall Study||6
3180563|NCT01991990|3908943|FG001|COMPLETED|Overall Study||12
3180564|NCT01991990|3908942|FG000|NOT COMPLETED|Overall Study||0
3180565|NCT01991990|3908943|FG001|NOT COMPLETED|Overall Study||0
3138381|NCT01723384|3863638|FG000|COMPLETED|Overall Study||15
3138382|NCT01723384|3863639|FG001|COMPLETED|Overall Study||15
3138383|NCT01723384|3863638|FG000|NOT COMPLETED|Overall Study||0
3138384|NCT01723384|3863639|FG001|NOT COMPLETED|Overall Study||0
3138385|NCT01723397|3863647|FG000|STARTED|Study Period 1||7
3138386|NCT01723397|3863648|FG001|STARTED|Study Period 1||7
3138387|NCT01723397|3863647|FG000|COMPLETED|Study Period 1||7
3138388|NCT01723397|3863648|FG001|COMPLETED|Study Period 1||6
3138389|NCT01723397|3863647|FG000|NOT COMPLETED|Study Period 1||0
3138390|NCT01723397|3863648|FG001|NOT COMPLETED|Study Period 1||1
3138391|NCT01723397|3863647|FG000|STARTED|Washout||7
3138392|NCT01723397|3863648|FG001|STARTED|Washout||6
3138393|NCT01723397|3863647|FG000|COMPLETED|Washout||7
3138394|NCT01723397|3863648|FG001|COMPLETED|Washout||6
3138395|NCT01723397|3863647|FG000|NOT COMPLETED|Washout||0
3138396|NCT01723397|3863648|FG001|NOT COMPLETED|Washout||0
3138397|NCT01723397|3863647|FG000|STARTED|Study Period 2||7
3138398|NCT01723397|3863648|FG001|STARTED|Study Period 2||6
3138399|NCT01723397|3863647|FG000|COMPLETED|Study Period 2||7
3138400|NCT01723397|3863648|FG001|COMPLETED|Study Period 2||5
3138401|NCT01723397|3863647|FG000|NOT COMPLETED|Study Period 2||0
3138402|NCT01723397|3863648|FG001|NOT COMPLETED|Study Period 2||1
3138403|NCT01723514|3863662|FG000|STARTED|Overall Study||8
3138404|NCT01723514|3863663|FG001|STARTED|Overall Study||6
3138405|NCT01723514|3863664|FG002|STARTED|Overall Study||6
3138406|NCT01723514|3863665|FG003|STARTED|Overall Study||6
3138407|NCT01723514|3863666|FG004|STARTED|Overall Study||6
3138408|NCT01723514|3863667|FG005|STARTED|Overall Study||4
3138409|NCT01723514|3863668|FG006|STARTED|Overall Study||6
3138410|NCT01723514|3863669|FG007|STARTED|Overall Study||6
3138411|NCT01723514|3863662|FG000|COMPLETED|Overall Study||8
3138412|NCT01723514|3863663|FG001|COMPLETED|Overall Study||6
3138413|NCT01723514|3863664|FG002|COMPLETED|Overall Study||6
3138414|NCT01723514|3863665|FG003|COMPLETED|Overall Study||6
3138415|NCT01723514|3863666|FG004|COMPLETED|Overall Study||6
3138416|NCT01723514|3863667|FG005|COMPLETED|Overall Study||4
3138417|NCT01723514|3863668|FG006|COMPLETED|Overall Study||6
3138418|NCT01723514|3863669|FG007|COMPLETED|Overall Study||6
3138419|NCT01723514|3863662|FG000|NOT COMPLETED|Overall Study||0
3138420|NCT01723514|3863663|FG001|NOT COMPLETED|Overall Study||0
3138421|NCT01723514|3863664|FG002|NOT COMPLETED|Overall Study||0
3138422|NCT01723514|3863665|FG003|NOT COMPLETED|Overall Study||0
3138423|NCT01723514|3863666|FG004|NOT COMPLETED|Overall Study||0
3138424|NCT01723514|3863667|FG005|NOT COMPLETED|Overall Study||0
3138425|NCT01723514|3863668|FG006|NOT COMPLETED|Overall Study||0
3138426|NCT01723514|3863669|FG007|NOT COMPLETED|Overall Study||0
3138427|NCT01723696|3863689|FG000|STARTED|Overall Study||126
3138428|NCT01723696|3863690|FG001|STARTED|Overall Study||126
3138429|NCT01723696|3863689|FG000|COMPLETED|Overall Study||109
3138430|NCT01723696|3863690|FG001|COMPLETED|Overall Study||113
3138431|NCT01723696|3863689|FG000|NOT COMPLETED|Overall Study||17
3138432|NCT01723696|3863690|FG001|NOT COMPLETED|Overall Study||13
3138433|NCT01723722|3863700|FG000|STARTED|Overall Study||20
3138434|NCT01723722|3863701|FG001|STARTED|Overall Study||20
3138435|NCT01723722|3863700|FG000|COMPLETED|Overall Study||20
3138436|NCT01723722|3863701|FG001|COMPLETED|Overall Study||20
3138437|NCT01723722|3863700|FG000|NOT COMPLETED|Overall Study||0
3138438|NCT01723722|3863701|FG001|NOT COMPLETED|Overall Study||0
3138439|NCT01723826|3863711|FG000|STARTED|Overall Study||47
3138440|NCT01723826|3863712|FG001|STARTED|Overall Study||63
3138441|NCT01723826|3863713|FG002|STARTED|Overall Study||101
3138442|NCT01723826|3863714|FG003|STARTED|Overall Study||149
3138443|NCT01723826|3863711|FG000|COMPLETED|Overall Study||20
3138444|NCT01723826|3863712|FG001|COMPLETED|Overall Study||27
3138445|NCT01723826|3863713|FG002|COMPLETED|Overall Study||44
3138446|NCT01723826|3863714|FG003|COMPLETED|Overall Study||59
3138447|NCT01723826|3863711|FG000|NOT COMPLETED|Overall Study||27
3138448|NCT01723826|3863712|FG001|NOT COMPLETED|Overall Study||36
3138449|NCT01723826|3863713|FG002|NOT COMPLETED|Overall Study||57
3138450|NCT01723826|3863714|FG003|NOT COMPLETED|Overall Study||90
3138451|NCT01723904|3863724|FG000|STARTED|Overall Study||90
3138452|NCT01723904|3863724|FG000|COMPLETED|Overall Study||79
3138453|NCT01723904|3863724|FG000|NOT COMPLETED|Overall Study||11
3138454|NCT01724021|3863730|FG000|STARTED|Overall Study||371
3138455|NCT01724021|3863731|FG001|STARTED|Overall Study||369
3138456|NCT01724021|3863730|FG000|COMPLETED|Overall Study||244
3138457|NCT01724021|3863731|FG001|COMPLETED|Overall Study||236
3138458|NCT01724021|3863730|FG000|NOT COMPLETED|Overall Study||127
3138459|NCT01724021|3863731|FG001|NOT COMPLETED|Overall Study||133
3138460|NCT01724060|3863747|FG000|STARTED|Overall Study||10
3138461|NCT01724060|3863748|FG001|STARTED|Overall Study||10
3138462|NCT01724060|3863749|FG002|STARTED|Overall Study||10
3138463|NCT01724060|3863750|FG003|STARTED|Overall Study||10
3138464|NCT01724060|3863751|FG004|STARTED|Overall Study||10
3138465|NCT01724060|3863752|FG005|STARTED|Overall Study||10
3138466|NCT01724060|3863753|FG006|STARTED|Overall Study||10
3138467|NCT01724060|3863754|FG007|STARTED|Overall Study||10
3138468|NCT01724060|3863747|FG000|COMPLETED|Overall Study||10
3138469|NCT01724060|3863748|FG001|COMPLETED|Overall Study||10
3138470|NCT01724060|3863749|FG002|COMPLETED|Overall Study||10
3138471|NCT01724060|3863750|FG003|COMPLETED|Overall Study||10
3138472|NCT01724060|3863751|FG004|COMPLETED|Overall Study||10
3138473|NCT01724060|3863752|FG005|COMPLETED|Overall Study||10
3138474|NCT01724060|3863753|FG006|COMPLETED|Overall Study||10
3138475|NCT01724060|3863754|FG007|COMPLETED|Overall Study||10
3138476|NCT01724060|3863747|FG000|NOT COMPLETED|Overall Study||0
3138477|NCT01724060|3863748|FG001|NOT COMPLETED|Overall Study||0
3138478|NCT01724060|3863749|FG002|NOT COMPLETED|Overall Study||0
3138479|NCT01724060|3863750|FG003|NOT COMPLETED|Overall Study||0
3138480|NCT01724060|3863751|FG004|NOT COMPLETED|Overall Study||0
3138481|NCT01724060|3863752|FG005|NOT COMPLETED|Overall Study||0
3138482|NCT01724060|3863753|FG006|NOT COMPLETED|Overall Study||0
3138483|NCT01724060|3863754|FG007|NOT COMPLETED|Overall Study||0
3138484|NCT01724177|3863772|FG000|STARTED|Overall Study||26
3138485|NCT01724177|3863772|FG000|Safety Population|Overall Study|Safety Population includes participants who received at least one dose of lenalidomide|26
3138486|NCT01724177|3863772|FG000|COMPLETED|Overall Study||0
3138487|NCT01724177|3863772|FG000|NOT COMPLETED|Overall Study||26
3138488|NCT01724216|3863777|FG000|STARTED|Overall Study||11
3138489|NCT01724216|3863777|FG000|COMPLETED|Overall Study||10
3138490|NCT01724216|3863777|FG000|NOT COMPLETED|Overall Study||1
3138491|NCT01724359|3863781|FG000|STARTED|Overall Study||95
3138492|NCT01724359|3863781|FG000|COMPLETED|Overall Study||64
3138493|NCT01724359|3863781|FG000|NOT COMPLETED|Overall Study||31
3138494|NCT01724489|3863789|FG000|STARTED|Overall Study||39
3138495|NCT01724489|3863790|FG001|STARTED|Overall Study||38
3138496|NCT01724489|3863789|FG000|COMPLETED|Overall Study||23
3138497|NCT01724489|3863790|FG001|COMPLETED|Overall Study||26
3138498|NCT01724489|3863789|FG000|NOT COMPLETED|Overall Study||16
3138499|NCT01724489|3863790|FG001|NOT COMPLETED|Overall Study||12
3138500|NCT01724528|3863798|FG000|STARTED|Overall Study||173
3138501|NCT01724528|3863799|FG001|STARTED|Overall Study||173
3138502|NCT01724528|3863798|FG000|COMPLETED|Overall Study||169
3138503|NCT01724528|3863799|FG001|COMPLETED|Overall Study||170
3138504|NCT01724528|3863798|FG000|NOT COMPLETED|Overall Study||4
3138505|NCT01724528|3863799|FG001|NOT COMPLETED|Overall Study||3
3138506|NCT01725126|3863811|FG000|STARTED|Overall Study||4
3138507|NCT01725126|3863812|FG001|STARTED|Overall Study||11
3138508|NCT01725126|3863813|FG002|STARTED|Overall Study||6
3138509|NCT01725126|3863814|FG003|STARTED|Overall Study||14
3138510|NCT01725126|3863815|FG004|STARTED|Overall Study||6
3138511|NCT01725126|3863816|FG005|STARTED|Overall Study||12
3138512|NCT01725126|3863811|FG000|COMPLETED|Overall Study||4
3138513|NCT01725126|3863812|FG001|COMPLETED|Overall Study||10
3138514|NCT01725126|3863813|FG002|COMPLETED|Overall Study||6
3138515|NCT01725126|3863814|FG003|COMPLETED|Overall Study||13
3138516|NCT01725126|3863815|FG004|COMPLETED|Overall Study||6
3138517|NCT01725126|3863816|FG005|COMPLETED|Overall Study||12
3138518|NCT01725126|3863811|FG000|NOT COMPLETED|Overall Study||0
3138519|NCT01725126|3863812|FG001|NOT COMPLETED|Overall Study||1
3138520|NCT01725126|3863813|FG002|NOT COMPLETED|Overall Study||0
3138521|NCT01725126|3863814|FG003|NOT COMPLETED|Overall Study||1
3138522|NCT01725126|3863815|FG004|NOT COMPLETED|Overall Study||0
3138523|NCT01725126|3863816|FG005|NOT COMPLETED|Overall Study||0
3138524|NCT01725217|3863842|FG000|STARTED|Overall Study||66
3138525|NCT01725217|3863843|FG001|STARTED|Overall Study||66
3138526|NCT01725217|3863844|FG002|STARTED|Overall Study||66
3138527|NCT01725217|3863842|FG000|COMPLETED|Overall Study||65
3180566|NCT01992016|3908955|FG000|STARTED|Overall Study||4
3180567|NCT01992016|3908956|FG001|STARTED|Overall Study||7
3180568|NCT01992016|3908955|FG000|COMPLETED|Overall Study||4
3180569|NCT01992016|3908956|FG001|COMPLETED|Overall Study||7
3138528|NCT01725217|3863843|FG001|COMPLETED|Overall Study||66
3138529|NCT01725217|3863844|FG002|COMPLETED|Overall Study||66
3138530|NCT01725217|3863842|FG000|NOT COMPLETED|Overall Study||1
3138531|NCT01725217|3863843|FG001|NOT COMPLETED|Overall Study||0
3138532|NCT01725217|3863844|FG002|NOT COMPLETED|Overall Study||0
3138533|NCT01725282|3863865|FG000|STARTED|Overall Study||44
3138534|NCT01725282|3863866|FG001|STARTED|Overall Study||44
3138535|NCT01725282|3863867|FG002|STARTED|Overall Study||41
3138536|NCT01725282|3863868|FG003|STARTED|Overall Study||43
3138537|NCT01725282|3863865|FG000|COMPLETED|Overall Study||42
3138538|NCT01725282|3863866|FG001|COMPLETED|Overall Study||39
3138539|NCT01725282|3863867|FG002|COMPLETED|Overall Study||33
3138540|NCT01725282|3863868|FG003|COMPLETED|Overall Study||36
3138541|NCT01725282|3863865|FG000|NOT COMPLETED|Overall Study||2
3138542|NCT01725282|3863866|FG001|NOT COMPLETED|Overall Study||5
3138543|NCT01725282|3863867|FG002|NOT COMPLETED|Overall Study||8
3138544|NCT01725282|3863868|FG003|NOT COMPLETED|Overall Study||7
3138545|NCT01725308|3863881|FG000|STARTED|Treatment Period I||178
3138546|NCT01725308|3863882|FG001|STARTED|Treatment Period I||74
3138547|NCT01725308|3863883|FG002|STARTED|Treatment Period I||179
3138548|NCT01725308|3863881|FG000|Treated|Treatment Period I||177
3138549|NCT01725308|3863882|FG001|Treated|Treatment Period I||74
3138550|NCT01725308|3863883|FG002|Treated|Treatment Period I||179
3138551|NCT01725308|3863881|FG000|COMPLETED|Treatment Period I||134
3138552|NCT01725308|3863882|FG001|COMPLETED|Treatment Period I||60
3138553|NCT01725308|3863883|FG002|COMPLETED|Treatment Period I||138
3138554|NCT01725308|3863881|FG000|NOT COMPLETED|Treatment Period I||44
3138555|NCT01725308|3863882|FG001|NOT COMPLETED|Treatment Period I||14
3138556|NCT01725308|3863883|FG002|NOT COMPLETED|Treatment Period I||41
3138557|NCT01725308|3863881|FG000|STARTED|Treatment Period II||134
3138558|NCT01725308|3863882|FG001|STARTED|Treatment Period II||60
3138559|NCT01725308|3863883|FG002|STARTED|Treatment Period II||138
3138560|NCT01725308|3863881|FG000|Treated|Treatment Period II||120
3138561|NCT01725308|3863882|FG001|Treated|Treatment Period II||53
3138562|NCT01725308|3863883|FG002|Treated|Treatment Period II||130
3138563|NCT01725308|3863881|FG000|COMPLETED|Treatment Period II||79
3138564|NCT01725308|3863882|FG001|COMPLETED|Treatment Period II||31
3138565|NCT01725308|3863883|FG002|COMPLETED|Treatment Period II||74
3138566|NCT01725308|3863881|FG000|NOT COMPLETED|Treatment Period II||55
3180570|NCT01992016|3908955|FG000|NOT COMPLETED|Overall Study||0
3138567|NCT01725308|3863882|FG001|NOT COMPLETED|Treatment Period II||29
3138568|NCT01725308|3863883|FG002|NOT COMPLETED|Treatment Period II||64
3138569|NCT01725386|3863900|FG000|STARTED|Overall Study||188
3138570|NCT01725386|3863901|FG001|STARTED|Overall Study||63
3138571|NCT01725386|3863900|FG000|COMPLETED|Overall Study||13
3138572|NCT01725386|3863901|FG001|COMPLETED|Overall Study||17
3138573|NCT01725386|3863900|FG000|NOT COMPLETED|Overall Study||175
3138574|NCT01725386|3863901|FG001|NOT COMPLETED|Overall Study||46
3138575|NCT01725451|3863907|FG000|STARTED|Period 1||8
3138576|NCT01725451|3863908|FG001|STARTED|Period 1||7
3138577|NCT01725451|3863909|FG002|STARTED|Period 1||8
3138578|NCT01725451|3863910|FG003|STARTED|Period 1||7
3138579|NCT01725451|3863907|FG000|COMPLETED|Period 1||7
3138580|NCT01725451|3863908|FG001|COMPLETED|Period 1||7
3138581|NCT01725451|3863909|FG002|COMPLETED|Period 1||8
3138582|NCT01725451|3863910|FG003|COMPLETED|Period 1||7
3138583|NCT01725451|3863907|FG000|NOT COMPLETED|Period 1||1
3138584|NCT01725451|3863908|FG001|NOT COMPLETED|Period 1||0
3138585|NCT01725451|3863909|FG002|NOT COMPLETED|Period 1||0
3138586|NCT01725451|3863910|FG003|NOT COMPLETED|Period 1||0
3138587|NCT01725451|3863907|FG000|STARTED|Washout From Period 1||7
3138588|NCT01725451|3863908|FG001|STARTED|Washout From Period 1||7
3138589|NCT01725451|3863909|FG002|STARTED|Washout From Period 1||8
3138590|NCT01725451|3863910|FG003|STARTED|Washout From Period 1||7
3138591|NCT01725451|3863907|FG000|COMPLETED|Washout From Period 1||7
3138592|NCT01725451|3863908|FG001|COMPLETED|Washout From Period 1||7
3138593|NCT01725451|3863909|FG002|COMPLETED|Washout From Period 1||8
3138594|NCT01725451|3863910|FG003|COMPLETED|Washout From Period 1||7
3138595|NCT01725451|3863907|FG000|NOT COMPLETED|Washout From Period 1||0
3138596|NCT01725451|3863908|FG001|NOT COMPLETED|Washout From Period 1||0
3138597|NCT01725451|3863909|FG002|NOT COMPLETED|Washout From Period 1||0
3138598|NCT01725451|3863910|FG003|NOT COMPLETED|Washout From Period 1||0
3138599|NCT01725451|3863907|FG000|STARTED|Period 2||7
3138600|NCT01725451|3863908|FG001|STARTED|Period 2||7
3138601|NCT01725451|3863909|FG002|STARTED|Period 2||8
3138602|NCT01725451|3863910|FG003|STARTED|Period 2||7
3138603|NCT01725451|3863907|FG000|COMPLETED|Period 2||7
3138604|NCT01725451|3863908|FG001|COMPLETED|Period 2||7
3138605|NCT01725451|3863909|FG002|COMPLETED|Period 2||8
3138606|NCT01725451|3863910|FG003|COMPLETED|Period 2||7
3138607|NCT01725451|3863907|FG000|NOT COMPLETED|Period 2||0
3138608|NCT01725451|3863908|FG001|NOT COMPLETED|Period 2||0
3138609|NCT01725451|3863909|FG002|NOT COMPLETED|Period 2||0
3138610|NCT01725451|3863910|FG003|NOT COMPLETED|Period 2||0
3138611|NCT01725451|3863907|FG000|STARTED|Washout From Period 2||7
3138612|NCT01725451|3863908|FG001|STARTED|Washout From Period 2||7
3138613|NCT01725451|3863909|FG002|STARTED|Washout From Period 2||8
3138614|NCT01725451|3863910|FG003|STARTED|Washout From Period 2||7
3138615|NCT01725451|3863907|FG000|COMPLETED|Washout From Period 2||7
3138616|NCT01725451|3863908|FG001|COMPLETED|Washout From Period 2||7
3138617|NCT01725451|3863909|FG002|COMPLETED|Washout From Period 2||8
3138618|NCT01725451|3863910|FG003|COMPLETED|Washout From Period 2||7
3138619|NCT01725451|3863907|FG000|NOT COMPLETED|Washout From Period 2||0
3138620|NCT01725451|3863908|FG001|NOT COMPLETED|Washout From Period 2||0
3138621|NCT01725451|3863909|FG002|NOT COMPLETED|Washout From Period 2||0
3138622|NCT01725451|3863910|FG003|NOT COMPLETED|Washout From Period 2||0
3138623|NCT01725451|3863907|FG000|STARTED|Period 3||7
3138624|NCT01725451|3863908|FG001|STARTED|Period 3||7
3138625|NCT01725451|3863909|FG002|STARTED|Period 3||8
3138626|NCT01725451|3863910|FG003|STARTED|Period 3||7
3138627|NCT01725451|3863907|FG000|COMPLETED|Period 3||7
3138628|NCT01725451|3863908|FG001|COMPLETED|Period 3||7
3138629|NCT01725451|3863909|FG002|COMPLETED|Period 3||8
3138630|NCT01725451|3863910|FG003|COMPLETED|Period 3||7
3138631|NCT01725451|3863907|FG000|NOT COMPLETED|Period 3||0
3138632|NCT01725451|3863908|FG001|NOT COMPLETED|Period 3||0
3138633|NCT01725451|3863909|FG002|NOT COMPLETED|Period 3||0
3138634|NCT01725451|3863910|FG003|NOT COMPLETED|Period 3||0
3138635|NCT01725451|3863907|FG000|STARTED|Washout From Period 3||7
3138636|NCT01725451|3863908|FG001|STARTED|Washout From Period 3||7
3138637|NCT01725451|3863909|FG002|STARTED|Washout From Period 3||8
3138638|NCT01725451|3863910|FG003|STARTED|Washout From Period 3||7
3138639|NCT01725451|3863907|FG000|COMPLETED|Washout From Period 3||7
3138640|NCT01725451|3863908|FG001|COMPLETED|Washout From Period 3||6
3138641|NCT01725451|3863909|FG002|COMPLETED|Washout From Period 3||7
3138642|NCT01725451|3863910|FG003|COMPLETED|Washout From Period 3||7
3138643|NCT01725451|3863907|FG000|NOT COMPLETED|Washout From Period 3||0
3138644|NCT01725451|3863908|FG001|NOT COMPLETED|Washout From Period 3||1
3138645|NCT01725451|3863909|FG002|NOT COMPLETED|Washout From Period 3||1
3138646|NCT01725451|3863910|FG003|NOT COMPLETED|Washout From Period 3||0
3138647|NCT01725451|3863907|FG000|STARTED|Period 4||7
3138648|NCT01725451|3863908|FG001|STARTED|Period 4||6
3138649|NCT01725451|3863909|FG002|STARTED|Period 4||7
3138650|NCT01725451|3863910|FG003|STARTED|Period 4||7
3138651|NCT01725451|3863907|FG000|COMPLETED|Period 4||7
3138652|NCT01725451|3863908|FG001|COMPLETED|Period 4||6
3138653|NCT01725451|3863909|FG002|COMPLETED|Period 4||6
3138654|NCT01725451|3863910|FG003|COMPLETED|Period 4||7
3138655|NCT01725451|3863907|FG000|NOT COMPLETED|Period 4||0
3138656|NCT01725451|3863908|FG001|NOT COMPLETED|Period 4||0
3138657|NCT01725451|3863909|FG002|NOT COMPLETED|Period 4||1
3138658|NCT01725451|3863910|FG003|NOT COMPLETED|Period 4||0
3138659|NCT01725451|3863907|FG000|STARTED|Washout From Period 4||7
3138660|NCT01725451|3863908|FG001|STARTED|Washout From Period 4||6
3138661|NCT01725451|3863909|FG002|STARTED|Washout From Period 4||6
3138662|NCT01725451|3863910|FG003|STARTED|Washout From Period 4||7
3138663|NCT01725451|3863907|FG000|COMPLETED|Washout From Period 4||7
3138664|NCT01725451|3863908|FG001|COMPLETED|Washout From Period 4||6
3138665|NCT01725451|3863909|FG002|COMPLETED|Washout From Period 4||6
3138666|NCT01725451|3863910|FG003|COMPLETED|Washout From Period 4||7
3138667|NCT01725451|3863907|FG000|NOT COMPLETED|Washout From Period 4||0
3138668|NCT01725451|3863908|FG001|NOT COMPLETED|Washout From Period 4||0
3138669|NCT01725451|3863909|FG002|NOT COMPLETED|Washout From Period 4||0
3138670|NCT01725451|3863910|FG003|NOT COMPLETED|Washout From Period 4||0
3138671|NCT01725451|3863907|FG000|STARTED|Period 5||7
3138672|NCT01725451|3863908|FG001|STARTED|Period 5||6
3138673|NCT01725451|3863909|FG002|STARTED|Period 5||6
3138674|NCT01725451|3863910|FG003|STARTED|Period 5||7
3138675|NCT01725451|3863907|FG000|COMPLETED|Period 5||7
3138676|NCT01725451|3863908|FG001|COMPLETED|Period 5||6
3138677|NCT01725451|3863909|FG002|COMPLETED|Period 5||6
3138678|NCT01725451|3863910|FG003|COMPLETED|Period 5||7
3138679|NCT01725451|3863907|FG000|NOT COMPLETED|Period 5||0
3138680|NCT01725451|3863908|FG001|NOT COMPLETED|Period 5||0
3138681|NCT01725451|3863909|FG002|NOT COMPLETED|Period 5||0
3138682|NCT01725451|3863910|FG003|NOT COMPLETED|Period 5||0
3138683|NCT01725451|3863907|FG000|STARTED|Washout From Period 5||7
3138684|NCT01725451|3863908|FG001|STARTED|Washout From Period 5||6
3138685|NCT01725451|3863909|FG002|STARTED|Washout From Period 5||6
3138686|NCT01725451|3863910|FG003|STARTED|Washout From Period 5||7
3138687|NCT01725451|3863907|FG000|COMPLETED|Washout From Period 5||7
3138688|NCT01725451|3863908|FG001|COMPLETED|Washout From Period 5||6
3138689|NCT01725451|3863909|FG002|COMPLETED|Washout From Period 5||6
3138690|NCT01725451|3863910|FG003|COMPLETED|Washout From Period 5||7
3138691|NCT01725451|3863907|FG000|NOT COMPLETED|Washout From Period 5||0
3138692|NCT01725451|3863908|FG001|NOT COMPLETED|Washout From Period 5||0
3138693|NCT01725451|3863909|FG002|NOT COMPLETED|Washout From Period 5||0
3138694|NCT01725451|3863910|FG003|NOT COMPLETED|Washout From Period 5||0
3138695|NCT01725451|3863907|FG000|STARTED|Period 6||7
3138696|NCT01725451|3863908|FG001|STARTED|Period 6||6
3138697|NCT01725451|3863909|FG002|STARTED|Period 6||6
3138698|NCT01725451|3863910|FG003|STARTED|Period 6||7
3138699|NCT01725451|3863907|FG000|COMPLETED|Period 6||7
3138700|NCT01725451|3863908|FG001|COMPLETED|Period 6||6
3138701|NCT01725451|3863909|FG002|COMPLETED|Period 6||6
3138702|NCT01725451|3863910|FG003|COMPLETED|Period 6||7
3138703|NCT01725451|3863907|FG000|NOT COMPLETED|Period 6||0
3138704|NCT01725451|3863908|FG001|NOT COMPLETED|Period 6||0
3138705|NCT01725451|3863909|FG002|NOT COMPLETED|Period 6||0
3138706|NCT01725451|3863910|FG003|NOT COMPLETED|Period 6||0
3138707|NCT01725529|3863928|FG000|STARTED|Overall Study||152
3138708|NCT01725529|3863929|FG001|STARTED|Overall Study||153
3138709|NCT01725529|3863930|FG002|STARTED|Overall Study||152
3138710|NCT01725529|3863928|FG000|COMPLETED|Overall Study||137
3138711|NCT01725529|3863929|FG001|COMPLETED|Overall Study||137
3138712|NCT01725529|3863930|FG002|COMPLETED|Overall Study||142
3138713|NCT01725529|3863928|FG000|NOT COMPLETED|Overall Study||15
3138714|NCT01725529|3863929|FG001|NOT COMPLETED|Overall Study||16
3138715|NCT01725529|3863930|FG002|NOT COMPLETED|Overall Study||10
3138716|NCT01725750|3863940|FG000|STARTED|Overall Study||44
3138717|NCT01725750|3863941|FG001|STARTED|Overall Study||44
3138718|NCT01725750|3863940|FG000|COMPLETED|Overall Study||42
3138719|NCT01725750|3863941|FG001|COMPLETED|Overall Study||34
3138720|NCT01725750|3863940|FG000|NOT COMPLETED|Overall Study||2
3138721|NCT01725750|3863941|FG001|NOT COMPLETED|Overall Study||10
3138722|NCT01725815|3863951|FG000|STARTED|Overall Study||198
3138723|NCT01725815|3863952|FG001|STARTED|Overall Study||202
3138724|NCT01725815|3863951|FG000|COMPLETED|Overall Study||198
3138725|NCT01725815|3863952|FG001|COMPLETED|Overall Study||202
3138726|NCT01725815|3863951|FG000|NOT COMPLETED|Overall Study||0
3138727|NCT01725815|3863952|FG001|NOT COMPLETED|Overall Study||0
3138728|NCT01725984|3863960|FG000|STARTED|Overall Study||39
3138729|NCT01725984|3863961|FG001|STARTED|Overall Study||41
3138730|NCT01725984|3863960|FG000|COMPLETED|Overall Study||39
3138731|NCT01725984|3863961|FG001|COMPLETED|Overall Study||41
3138732|NCT01725984|3863960|FG000|NOT COMPLETED|Overall Study||0
3138733|NCT01725984|3863961|FG001|NOT COMPLETED|Overall Study||0
3138734|NCT01726023|3863969|FG000|STARTED|Overall Study||219
3138735|NCT01726023|3863970|FG001|STARTED|Overall Study||222
3138736|NCT01726023|3863969|FG000|COMPLETED|Overall Study||190
3138737|NCT01726023|3863970|FG001|COMPLETED|Overall Study||196
3138738|NCT01726023|3863969|FG000|NOT COMPLETED|Overall Study||29
3138739|NCT01726023|3863970|FG001|NOT COMPLETED|Overall Study||26
3138740|NCT01726036|3863985|FG000|STARTED|Overall Study||137
3138741|NCT01726036|3863986|FG001|STARTED|Overall Study||137
3138742|NCT01726036|3863985|FG000|COMPLETED|Overall Study||121
3138743|NCT01726036|3863986|FG001|COMPLETED|Overall Study||130
3138744|NCT01726036|3863985|FG000|NOT COMPLETED|Overall Study||16
3138745|NCT01726036|3863986|FG001|NOT COMPLETED|Overall Study||7
3138746|NCT01726049|3863994|FG000|STARTED|Overall Study||26
3138747|NCT01726049|3863995|FG001|STARTED|Overall Study||26
3138748|NCT01726049|3863994|FG000|COMPLETED|Overall Study||21
3138749|NCT01726049|3863995|FG001|COMPLETED|Overall Study||22
3138750|NCT01726049|3863994|FG000|NOT COMPLETED|Overall Study||5
3138751|NCT01726049|3863995|FG001|NOT COMPLETED|Overall Study||4
3138752|NCT01726270|3864001|FG000|STARTED|Part 1, Self-Selection Phase||689
3138753|NCT01726270|3864001|FG000|COMPLETED|Part 1, Self-Selection Phase||679
3138754|NCT01726270|3864001|FG000|NOT COMPLETED|Part 1, Self-Selection Phase||10
3138755|NCT01726270|3864001|FG000|STARTED|Eligibility for Part 2|No. of subjects potentially eligible for Part 2|389
3138756|NCT01726270|3864001|FG000|COMPLETED|Eligibility for Part 2||369
3138757|NCT01726270|3864001|FG000|NOT COMPLETED|Eligibility for Part 2||20
3138758|NCT01726270|3864001|FG000|STARTED|Part 2, Actual-Use Phase|20 subjects were eligible for Part 2 but did not enter Part 2|369
3138759|NCT01726270|3864001|FG000|COMPLETED|Part 2, Actual-Use Phase||330
3138760|NCT01726270|3864001|FG000|NOT COMPLETED|Part 2, Actual-Use Phase||39
3138761|NCT01726335|3864007|FG000|STARTED|Overall Study||53
3138762|NCT01726335|3864007|FG000|COMPLETED|Overall Study||29
3138763|NCT01726335|3864007|FG000|NOT COMPLETED|Overall Study||24
3138764|NCT01726504|3864013|FG000|STARTED|Overall Study||536
3138765|NCT01726504|3864014|FG001|STARTED|Overall Study||539
3138766|NCT01726504|3864013|FG000|COMPLETED|Overall Study||524
3138767|NCT01726504|3864014|FG001|COMPLETED|Overall Study||511
3138768|NCT01726504|3864013|FG000|NOT COMPLETED|Overall Study||12
3138769|NCT01726504|3864014|FG001|NOT COMPLETED|Overall Study||28
3138770|NCT01726517|3864025|FG000|STARTED|Overall Study||20
3138771|NCT01726517|3864026|FG001|STARTED|Overall Study||21
3138772|NCT01726517|3864027|FG002|STARTED|Overall Study||19
3138773|NCT01726517|3864028|FG003|STARTED|Overall Study||19
3138774|NCT01726517|3864029|FG004|STARTED|Overall Study||21
3138775|NCT01726517|3864025|FG000|COMPLETED|Overall Study||20
3138776|NCT01726517|3864026|FG001|COMPLETED|Overall Study||21
3138777|NCT01726517|3864027|FG002|COMPLETED|Overall Study||18
3138778|NCT01726517|3864028|FG003|COMPLETED|Overall Study||19
3138779|NCT01726517|3864029|FG004|COMPLETED|Overall Study||21
3138780|NCT01726517|3864025|FG000|NOT COMPLETED|Overall Study||0
3138781|NCT01726517|3864026|FG001|NOT COMPLETED|Overall Study||0
3138782|NCT01726517|3864027|FG002|NOT COMPLETED|Overall Study||1
3138783|NCT01726517|3864028|FG003|NOT COMPLETED|Overall Study||0
3138784|NCT01726517|3864029|FG004|NOT COMPLETED|Overall Study||0
3138785|NCT01726621|3864041|FG000|STARTED|Overall Study||55
3138786|NCT01726621|3864041|FG000|COMPLETED|Overall Study||51
3138787|NCT01726621|3864041|FG000|NOT COMPLETED|Overall Study||4
3138788|NCT01726673|3864047|FG000|STARTED|Overall Study||30
3138789|NCT01726673|3864048|FG001|STARTED|Overall Study||24
3138790|NCT01726673|3864047|FG000|COMPLETED|Overall Study||24
3138791|NCT01726673|3864048|FG001|COMPLETED|Overall Study||21
3138792|NCT01726673|3864047|FG000|NOT COMPLETED|Overall Study||6
3138793|NCT01726673|3864048|FG001|NOT COMPLETED|Overall Study||3
3138794|NCT01726738|3864054|FG000|STARTED|Overall Study||17
3138795|NCT01726738|3864054|FG000|COMPLETED|Overall Study||17
3138796|NCT01726738|3864054|FG000|NOT COMPLETED|Overall Study||0
3138797|NCT01726803|3864060|FG000|STARTED|Overall Study||112
3138798|NCT01726803|3864061|FG001|STARTED|Overall Study||108
3138799|NCT01726803|3864060|FG000|COMPLETED|Overall Study||105
3138800|NCT01726803|3864061|FG001|COMPLETED|Overall Study||107
3138801|NCT01726803|3864060|FG000|NOT COMPLETED|Overall Study||7
3138802|NCT01726803|3864061|FG001|NOT COMPLETED|Overall Study||1
3138803|NCT01727024|3864067|FG000|STARTED|Period 1||71
3138804|NCT01727024|3864068|FG001|STARTED|Period 1||68
3138805|NCT01727024|3864067|FG000|COMPLETED|Period 1||68
3138806|NCT01727024|3864068|FG001|COMPLETED|Period 1||64
3138807|NCT01727024|3864067|FG000|NOT COMPLETED|Period 1||3
3138808|NCT01727024|3864068|FG001|NOT COMPLETED|Period 1||4
3138809|NCT01727024|3864067|FG000|STARTED|Period 2||68
3138810|NCT01727024|3864068|FG001|STARTED|Period 2||64
3138811|NCT01727024|3864067|FG000|COMPLETED|Period 2||68
3138812|NCT01727024|3864068|FG001|COMPLETED|Period 2||64
3138813|NCT01727024|3864067|FG000|NOT COMPLETED|Period 2||0
3138814|NCT01727024|3864068|FG001|NOT COMPLETED|Period 2||0
3138815|NCT01727089|3864076|FG000|STARTED|Overall Study||29
3138816|NCT01727089|3864077|FG001|STARTED|Overall Study||30
3138817|NCT01727089|3864076|FG000|COMPLETED|Overall Study||29
3138818|NCT01727089|3864077|FG001|COMPLETED|Overall Study||30
3138819|NCT01727089|3864076|FG000|NOT COMPLETED|Overall Study||0
3138820|NCT01727089|3864077|FG001|NOT COMPLETED|Overall Study||0
3138821|NCT01727141|3864087|FG000|STARTED|Overall Study||260
3138822|NCT01727141|3864088|FG001|STARTED|Overall Study||260
3138823|NCT01727141|3864089|FG002|STARTED|Overall Study||261
3138824|NCT01727141|3864090|FG003|STARTED|Overall Study||261
3138825|NCT01727141|3864087|FG000|Safety Set|Overall Study||258
3138826|NCT01727141|3864088|FG001|Safety Set|Overall Study||260
3138827|NCT01727141|3864089|FG002|Safety Set|Overall Study||262
3138828|NCT01727141|3864090|FG003|Safety Set|Overall Study||260
3138829|NCT01727141|3864087|FG000|Full Analysis Set|Overall Study||258
3138830|NCT01727141|3864088|FG001|Full Analysis Set|Overall Study||260
3138831|NCT01727141|3864089|FG002|Full Analysis Set|Overall Study||261
3138832|NCT01727141|3864090|FG003|Full Analysis Set|Overall Study||261
3138833|NCT01727141|3864087|FG000|COMPLETED|Overall Study||255
3138834|NCT01727141|3864088|FG001|COMPLETED|Overall Study||251
3138835|NCT01727141|3864089|FG002|COMPLETED|Overall Study||258
3138836|NCT01727141|3864090|FG003|COMPLETED|Overall Study||246
3138837|NCT01727141|3864087|FG000|NOT COMPLETED|Overall Study||5
3138838|NCT01727141|3864088|FG001|NOT COMPLETED|Overall Study||9
3138839|NCT01727141|3864089|FG002|NOT COMPLETED|Overall Study||3
3138840|NCT01727141|3864090|FG003|NOT COMPLETED|Overall Study||15
3138841|NCT01727154|3864100|FG000|STARTED|Overall Study||139
3138842|NCT01727154|3864100|FG000|COMPLETED|Overall Study||80
3138843|NCT01727154|3864100|FG000|NOT COMPLETED|Overall Study||59
3138844|NCT01727180|3864104|FG000|STARTED|Overall Study||108
3138845|NCT01727180|3864104|FG000|COMPLETED|Overall Study||108
3138846|NCT01727180|3864104|FG000|NOT COMPLETED|Overall Study||0
3138847|NCT01727258|3864111|FG000|STARTED|Overall Study||51
3138848|NCT01727258|3864112|FG001|STARTED|Overall Study||51
3138849|NCT01727258|3864113|FG002|STARTED|Overall Study||51
3138850|NCT01727258|3864111|FG000|COMPLETED|Overall Study||49
3138851|NCT01727258|3864112|FG001|COMPLETED|Overall Study||48
3138852|NCT01727258|3864113|FG002|COMPLETED|Overall Study||50
3138853|NCT01727258|3864111|FG000|NOT COMPLETED|Overall Study||2
3138854|NCT01727258|3864112|FG001|NOT COMPLETED|Overall Study||3
3138855|NCT01727258|3864113|FG002|NOT COMPLETED|Overall Study||1
3138856|NCT01727297|3864121|FG000|STARTED|Overall Study||395
3138857|NCT01727297|3864122|FG001|STARTED|Overall Study||51
3138858|NCT01727297|3864121|FG000|COMPLETED|Overall Study||293
3138859|NCT01727297|3864122|FG001|COMPLETED|Overall Study||0
3138860|NCT01727297|3864121|FG000|NOT COMPLETED|Overall Study||102
3138861|NCT01727297|3864122|FG001|NOT COMPLETED|Overall Study||51
3138862|NCT01727336|3864141|FG000|STARTED|Part 1 Dalantercept Dose Escalation||6
3138863|NCT01727336|3864142|FG001|STARTED|Part 1 Dalantercept Dose Escalation||9
3138864|NCT01727336|3864143|FG002|STARTED|Part 1 Dalantercept Dose Escalation||14
3138865|NCT01727336|3864144|FG003|STARTED|Part 1 Dalantercept Dose Escalation||0
3138866|NCT01727336|3864145|FG004|STARTED|Part 1 Dalantercept Dose Escalation||0
3138867|NCT01727336|3864146|FG005|STARTED|Part 1 Dalantercept Dose Escalation||0
3138868|NCT01727336|3864141|FG000|COMPLETED|Part 1 Dalantercept Dose Escalation||3
3138869|NCT01727336|3864142|FG001|COMPLETED|Part 1 Dalantercept Dose Escalation||7
3138870|NCT01727336|3864143|FG002|COMPLETED|Part 1 Dalantercept Dose Escalation||6
3138871|NCT01727336|3864144|FG003|COMPLETED|Part 1 Dalantercept Dose Escalation||0
3138872|NCT01727336|3864145|FG004|COMPLETED|Part 1 Dalantercept Dose Escalation||0
3138873|NCT01727336|3864146|FG005|COMPLETED|Part 1 Dalantercept Dose Escalation||0
3138874|NCT01727336|3864141|FG000|NOT COMPLETED|Part 1 Dalantercept Dose Escalation||3
3138875|NCT01727336|3864142|FG001|NOT COMPLETED|Part 1 Dalantercept Dose Escalation||2
3138876|NCT01727336|3864143|FG002|NOT COMPLETED|Part 1 Dalantercept Dose Escalation||8
3138877|NCT01727336|3864144|FG003|NOT COMPLETED|Part 1 Dalantercept Dose Escalation||0
3138878|NCT01727336|3864145|FG004|NOT COMPLETED|Part 1 Dalantercept Dose Escalation||0
3138879|NCT01727336|3864146|FG005|NOT COMPLETED|Part 1 Dalantercept Dose Escalation||0
3138880|NCT01727336|3864141|FG000|STARTED|Part 2 Blinded||0
3138881|NCT01727336|3864142|FG001|STARTED|Part 2 Blinded||0
3138882|NCT01727336|3864143|FG002|STARTED|Part 2 Blinded||0
3138883|NCT01727336|3864144|FG003|STARTED|Part 2 Blinded||0
3138884|NCT01727336|3864145|FG004|STARTED|Part 2 Blinded||63
3138885|NCT01727336|3864146|FG005|STARTED|Part 2 Blinded||68
3138886|NCT01727336|3864141|FG000|COMPLETED|Part 2 Blinded||0
3138887|NCT01727336|3864142|FG001|COMPLETED|Part 2 Blinded||0
3138888|NCT01727336|3864143|FG002|COMPLETED|Part 2 Blinded||0
3138889|NCT01727336|3864144|FG003|COMPLETED|Part 2 Blinded||0
3138890|NCT01727336|3864145|FG004|COMPLETED|Part 2 Blinded||0
3138891|NCT01727336|3864146|FG005|COMPLETED|Part 2 Blinded||0
3138892|NCT01727336|3864141|FG000|NOT COMPLETED|Part 2 Blinded||0
3138893|NCT01727336|3864142|FG001|NOT COMPLETED|Part 2 Blinded||0
3138894|NCT01727336|3864143|FG002|NOT COMPLETED|Part 2 Blinded||0
3138895|NCT01727336|3864144|FG003|NOT COMPLETED|Part 2 Blinded||0
3138896|NCT01727336|3864145|FG004|NOT COMPLETED|Part 2 Blinded||63
3138897|NCT01727336|3864146|FG005|NOT COMPLETED|Part 2 Blinded||68
3138898|NCT01727414|3864168|FG000|STARTED|Overall Study||126
3138899|NCT01727414|3864169|FG001|STARTED|Overall Study||45
3138900|NCT01727414|3864168|FG000|COMPLETED|Overall Study||123
3138901|NCT01727414|3864169|FG001|COMPLETED|Overall Study||45
3138902|NCT01727414|3864168|FG000|NOT COMPLETED|Overall Study||3
3138903|NCT01727414|3864169|FG001|NOT COMPLETED|Overall Study||0
3138904|NCT01727505|3864175|FG000|STARTED|First 24 Hours||14
3138905|NCT01727505|3864176|FG001|STARTED|First 24 Hours||12
3138906|NCT01727505|3864175|FG000|COMPLETED|First 24 Hours||14
3138907|NCT01727505|3864176|FG001|COMPLETED|First 24 Hours||11
3138908|NCT01727505|3864175|FG000|NOT COMPLETED|First 24 Hours||0
3138909|NCT01727505|3864176|FG001|NOT COMPLETED|First 24 Hours||1
3138910|NCT01727505|3864175|FG000|STARTED|Second 24 Hours||14
3138911|NCT01727505|3864176|FG001|STARTED|Second 24 Hours||11
3138912|NCT01727505|3864175|FG000|COMPLETED|Second 24 Hours||14
3138913|NCT01727505|3864176|FG001|COMPLETED|Second 24 Hours||10
3138914|NCT01727505|3864175|FG000|NOT COMPLETED|Second 24 Hours||0
3138915|NCT01727505|3864176|FG001|NOT COMPLETED|Second 24 Hours||1
3138916|NCT01727700|3864185|FG000|STARTED|Overall Study||44
3138917|NCT01727700|3864186|FG001|STARTED|Overall Study||45
3138918|NCT01727700|3864187|FG002|STARTED|Overall Study||44
3138919|NCT01727700|3864185|FG000|COMPLETED|Overall Study||42
3138920|NCT01727700|3864186|FG001|COMPLETED|Overall Study||35
3138921|NCT01727700|3864187|FG002|COMPLETED|Overall Study||42
3138922|NCT01727700|3864185|FG000|NOT COMPLETED|Overall Study||2
3138923|NCT01727700|3864186|FG001|NOT COMPLETED|Overall Study||10
3138924|NCT01727700|3864187|FG002|NOT COMPLETED|Overall Study||2
3138925|NCT01727713|3864195|FG000|STARTED|Overall Study||110
3138926|NCT01727713|3864195|FG000|COMPLETED|Overall Study||75
3138927|NCT01727713|3864195|FG000|NOT COMPLETED|Overall Study||35
3138928|NCT01727726|3864202|FG000|STARTED|Overall Study||197
3138929|NCT01727726|3864203|FG001|STARTED|Overall Study||100
3138930|NCT01727726|3864204|FG002|STARTED|Overall Study||206
3138931|NCT01727726|3864202|FG000|COMPLETED|Overall Study||171
3138932|NCT01727726|3864203|FG001|COMPLETED|Overall Study||86
3138933|NCT01727726|3864204|FG002|COMPLETED|Overall Study||186
3138934|NCT01727726|3864202|FG000|NOT COMPLETED|Overall Study||26
3138935|NCT01727726|3864203|FG001|NOT COMPLETED|Overall Study||14
3138936|NCT01727726|3864204|FG002|NOT COMPLETED|Overall Study||20
3138937|NCT01727765|3864214|FG000|STARTED|Overall Study||8
3138938|NCT01727765|3864215|FG001|STARTED|Overall Study||8
3138939|NCT01727765|3864214|FG000|COMPLETED|Overall Study||8
3138940|NCT01727765|3864215|FG001|COMPLETED|Overall Study||8
3138941|NCT01727765|3864214|FG000|NOT COMPLETED|Overall Study||0
3138942|NCT01727765|3864215|FG001|NOT COMPLETED|Overall Study||0
3138943|NCT01727791|3864221|FG000|STARTED|Overall Study||10
3138944|NCT01727791|3864221|FG000|COMPLETED|Overall Study||10
3138945|NCT01727791|3864221|FG000|NOT COMPLETED|Overall Study||0
3138946|NCT01727895|3864227|FG000|STARTED|Overall Study||10
3138947|NCT01727895|3864228|FG001|STARTED|Overall Study||5
3138948|NCT01727895|3864227|FG000|COMPLETED|Overall Study||10
3138949|NCT01727895|3864228|FG001|COMPLETED|Overall Study||5
3138950|NCT01727895|3864227|FG000|NOT COMPLETED|Overall Study||0
3138951|NCT01727895|3864228|FG001|NOT COMPLETED|Overall Study||0
3138952|NCT01728077|3864236|FG000|STARTED|Overall Study||19
3138953|NCT01728077|3864237|FG001|STARTED|Overall Study||7
3138954|NCT01728077|3864236|FG000|COMPLETED|Overall Study||11
3138955|NCT01728077|3864237|FG001|COMPLETED|Overall Study||2
3138956|NCT01728077|3864236|FG000|NOT COMPLETED|Overall Study||8
3138957|NCT01728077|3864237|FG001|NOT COMPLETED|Overall Study||5
3138958|NCT01728116|3864246|FG000|STARTED|Overall Study|EndoBarrier mITT Subjects|213
3138959|NCT01728116|3864247|FG001|STARTED|Overall Study|Sham mITT subjects|107
3138960|NCT01728116|3864246|FG000|COMPLETED|Overall Study|Completed to Week 78|52
3138961|NCT01728116|3864247|FG001|COMPLETED|Overall Study|Completed to Week 52|60
3138962|NCT01728116|3864246|FG000|NOT COMPLETED|Overall Study||161
3138963|NCT01728116|3864247|FG001|NOT COMPLETED|Overall Study||47
3138964|NCT01728194|3864256|FG000|STARTED|Overall Study||54
3138965|NCT01728194|3864257|FG001|STARTED|Overall Study||67
3138966|NCT01728194|3864256|FG000|COMPLETED|Overall Study||34
3138967|NCT01728194|3864257|FG001|COMPLETED|Overall Study||61
3138968|NCT01728194|3864256|FG000|NOT COMPLETED|Overall Study||20
3138969|NCT01728194|3864257|FG001|NOT COMPLETED|Overall Study||6
3138970|NCT01728246|3864265|FG000|STARTED|Overall Study||242
3138971|NCT01728246|3864266|FG001|STARTED|Overall Study||231
3138972|NCT01728246|3864265|FG000|COMPLETED|Overall Study||206
3138973|NCT01728246|3864266|FG001|COMPLETED|Overall Study||195
3138974|NCT01728246|3864265|FG000|NOT COMPLETED|Overall Study||36
3138975|NCT01728246|3864266|FG001|NOT COMPLETED|Overall Study||36
3138976|NCT01728324|3864275|FG000|STARTED|Termination of DBV||211
3138977|NCT01728324|3864276|FG001|STARTED|Termination of DBV||213
3138978|NCT01728324|3864277|FG002|STARTED|Termination of DBV||72
3138979|NCT01728324|3864275|FG000|COMPLETED|Termination of DBV||173
3138980|NCT01728324|3864276|FG001|COMPLETED|Termination of DBV||177
3138981|NCT01728324|3864277|FG002|COMPLETED|Termination of DBV||58
3138982|NCT01728324|3864275|FG000|NOT COMPLETED|Termination of DBV||38
3138983|NCT01728324|3864276|FG001|NOT COMPLETED|Termination of DBV||36
3138984|NCT01728324|3864277|FG002|NOT COMPLETED|Termination of DBV||14
3138985|NCT01728324|3864275|FG000|STARTED|Termination of FDV||211
3138986|NCT01728324|3864276|FG001|STARTED|Termination of FDV||213
3138987|NCT01728324|3864277|FG002|STARTED|Termination of FDV||72
3138988|NCT01728324|3864275|FG000|COMPLETED|Termination of FDV||173
3138989|NCT01728324|3864276|FG001|COMPLETED|Termination of FDV||177
3138990|NCT01728324|3864277|FG002|COMPLETED|Termination of FDV||58
3138991|NCT01728324|3864275|FG000|NOT COMPLETED|Termination of FDV||38
3138992|NCT01728324|3864276|FG001|NOT COMPLETED|Termination of FDV||36
3138993|NCT01728324|3864277|FG002|NOT COMPLETED|Termination of FDV||14
3138994|NCT01728324|3864275|FG000|STARTED|Termination of RBV||211
3138995|NCT01728324|3864276|FG001|STARTED|Termination of RBV||213
3138996|NCT01728324|3864277|FG002|STARTED|Termination of RBV||72
3138997|NCT01728324|3864275|FG000|COMPLETED|Termination of RBV||172
3138998|NCT01728324|3864276|FG001|COMPLETED|Termination of RBV||176
3138999|NCT01728324|3864277|FG002|COMPLETED|Termination of RBV||57
3139000|NCT01728324|3864275|FG000|NOT COMPLETED|Termination of RBV||39
3139001|NCT01728324|3864276|FG001|NOT COMPLETED|Termination of RBV||37
3139002|NCT01728324|3864277|FG002|NOT COMPLETED|Termination of RBV||15
3139003|NCT01728337|3864287|FG000|STARTED|Overall Study||80
3139004|NCT01728337|3864287|FG000|COMPLETED|Overall Study||80
3139005|NCT01728337|3864287|FG000|NOT COMPLETED|Overall Study||0
3180571|NCT01992016|3908956|FG001|NOT COMPLETED|Overall Study||0
3180572|NCT01992094|3908965|FG000|STARTED|Overall Study||1335
3180573|NCT01992094|3908966|FG001|STARTED|Overall Study||676
3180574|NCT01992094|3908967|FG002|STARTED|Overall Study||669
3180575|NCT01992094|3908965|FG000|COMPLETED|Overall Study||1285
3180576|NCT01992094|3908966|FG001|COMPLETED|Overall Study||652
3180577|NCT01992094|3908967|FG002|COMPLETED|Overall Study||648
3180578|NCT01992094|3908965|FG000|NOT COMPLETED|Overall Study||50
3180579|NCT01992094|3908966|FG001|NOT COMPLETED|Overall Study||24
3180580|NCT01992094|3908967|FG002|NOT COMPLETED|Overall Study||21
3180581|NCT01992107|3908994|FG000|STARTED|Overall Study||1159
3139006|NCT01728376|3864299|FG000|STARTED|Overall Study||22
3139007|NCT01728376|3864300|FG001|STARTED|Overall Study||11
3139008|NCT01728376|3864301|FG002|STARTED|Overall Study||19
3139009|NCT01728376|3864302|FG003|STARTED|Overall Study||9
3139010|NCT01728376|3864303|FG004|STARTED|Overall Study||14
3139011|NCT01728376|3864304|FG005|STARTED|Overall Study||7
3139012|NCT01728376|3864299|FG000|Treated|Overall Study||22
3139013|NCT01728376|3864300|FG001|Treated|Overall Study||10
3139014|NCT01728376|3864301|FG002|Treated|Overall Study||19
3139015|NCT01728376|3864302|FG003|Treated|Overall Study||9
3139016|NCT01728376|3864303|FG004|Treated|Overall Study||14
3139017|NCT01728376|3864304|FG005|Treated|Overall Study||7
3139018|NCT01728376|3864299|FG000|COMPLETED|Overall Study||18
3139019|NCT01728376|3864300|FG001|COMPLETED|Overall Study||9
3139020|NCT01728376|3864301|FG002|COMPLETED|Overall Study||17
3139021|NCT01728376|3864302|FG003|COMPLETED|Overall Study||7
3139022|NCT01728376|3864303|FG004|COMPLETED|Overall Study||12
3139023|NCT01728376|3864304|FG005|COMPLETED|Overall Study||5
3139024|NCT01728376|3864299|FG000|NOT COMPLETED|Overall Study||4
3139025|NCT01728376|3864300|FG001|NOT COMPLETED|Overall Study||2
3139026|NCT01728376|3864301|FG002|NOT COMPLETED|Overall Study||2
3139027|NCT01728376|3864302|FG003|NOT COMPLETED|Overall Study||2
3139028|NCT01728376|3864303|FG004|NOT COMPLETED|Overall Study||2
3139029|NCT01728376|3864304|FG005|NOT COMPLETED|Overall Study||2
3139030|NCT01728454|3864321|FG000|STARTED|Stage 1 and 2||17
3139031|NCT01728454|3864322|FG001|STARTED|Stage 1 and 2||20
3139032|NCT01728454|3864323|FG002|STARTED|Stage 1 and 2||23
3139033|NCT01728454|3864321|FG000|COMPLETED|Stage 1 and 2||12
3139034|NCT01728454|3864322|FG001|COMPLETED|Stage 1 and 2||16
3139035|NCT01728454|3864323|FG002|COMPLETED|Stage 1 and 2||19
3139036|NCT01728454|3864321|FG000|NOT COMPLETED|Stage 1 and 2||5
3139037|NCT01728454|3864322|FG001|NOT COMPLETED|Stage 1 and 2||4
3139038|NCT01728454|3864323|FG002|NOT COMPLETED|Stage 1 and 2||4
3139039|NCT01728454|3864321|FG000|STARTED|Stage 3|Eligible participants who opted to participate in Stage 3.|6
3139040|NCT01728454|3864322|FG001|STARTED|Stage 3|Eligible participants who opted to participate in Stage 3.|5
3139041|NCT01728454|3864323|FG002|STARTED|Stage 3|Eligible participants who opted to participate in Stage 3.|11
3139042|NCT01728454|3864321|FG000|COMPLETED|Stage 3||3
3139043|NCT01728454|3864322|FG001|COMPLETED|Stage 3||1
3139044|NCT01728454|3864323|FG002|COMPLETED|Stage 3||7
3139045|NCT01728454|3864321|FG000|NOT COMPLETED|Stage 3||3
3139046|NCT01728454|3864322|FG001|NOT COMPLETED|Stage 3||4
3139047|NCT01728454|3864323|FG002|NOT COMPLETED|Stage 3||4
3139048|NCT01728584|3864338|FG000|STARTED|Overall Study|Randomized|36
3139049|NCT01728584|3864339|FG001|STARTED|Overall Study|Randomized - NMB/pressure conditions were changed in 7 (2 to Std/Std, 4 to Deep/Std, 1 to Deep/Low)|30
3139050|NCT01728584|3864340|FG002|STARTED|Overall Study|Randomized|31
3139051|NCT01728584|3864341|FG003|STARTED|Overall Study|Randomized - NMB/pressure conditions were changed in 5 (all to Deep/Std)|30
3139052|NCT01728584|3864338|FG000|COMPLETED|Overall Study||28
3139053|NCT01728584|3864339|FG001|COMPLETED|Overall Study||30
3139054|NCT01728584|3864340|FG002|COMPLETED|Overall Study||30
3139055|NCT01728584|3864341|FG003|COMPLETED|Overall Study||29
3139056|NCT01728584|3864338|FG000|NOT COMPLETED|Overall Study||8
3139057|NCT01728584|3864339|FG001|NOT COMPLETED|Overall Study||0
3139058|NCT01728584|3864340|FG002|NOT COMPLETED|Overall Study||1
3139059|NCT01728584|3864341|FG003|NOT COMPLETED|Overall Study||1
3139060|NCT01728623|3864358|FG000|STARTED|Overall Study||51
3139061|NCT01728623|3864358|FG000|DTC|Overall Study||25
3139062|NCT01728623|3864358|FG000|MTC|Overall Study||9
3139063|NCT01728623|3864358|FG000|ATC|Overall Study||17
3139064|NCT01728623|3864358|FG000|COMPLETED|Overall Study||23
3139065|NCT01728623|3864358|FG000|NOT COMPLETED|Overall Study||28
3139066|NCT01728636|3864367|FG000|STARTED|Overall Study||31
3139067|NCT01728636|3864368|FG001|STARTED|Overall Study||30
3139068|NCT01728636|3864367|FG000|COMPLETED|Overall Study||31
3139069|NCT01728636|3864368|FG001|COMPLETED|Overall Study||30
3139070|NCT01728636|3864367|FG000|NOT COMPLETED|Overall Study||0
3139071|NCT01728636|3864368|FG001|NOT COMPLETED|Overall Study||0
3139072|NCT01728779|3864374|FG000|STARTED|Overall Study||38
3139073|NCT01728779|3864374|FG000|COMPLETED|Overall Study||37
3139074|NCT01728779|3864374|FG000|NOT COMPLETED|Overall Study||1
3139075|NCT01728792|3864383|FG000|STARTED|Overall Study||14
3139076|NCT01728792|3864384|FG001|STARTED|Overall Study||16
3139077|NCT01728792|3864385|FG002|STARTED|Overall Study||17
3139078|NCT01728792|3864386|FG003|STARTED|Overall Study||17
3139079|NCT01728792|3864387|FG004|STARTED|Overall Study||16
3139080|NCT01728792|3864383|FG000|COMPLETED|Overall Study||11
3139081|NCT01728792|3864384|FG001|COMPLETED|Overall Study||14
3139082|NCT01728792|3864385|FG002|COMPLETED|Overall Study||13
3139083|NCT01728792|3864386|FG003|COMPLETED|Overall Study||14
3139084|NCT01728792|3864387|FG004|COMPLETED|Overall Study||16
3139085|NCT01728792|3864383|FG000|NOT COMPLETED|Overall Study||3
3139086|NCT01728792|3864384|FG001|NOT COMPLETED|Overall Study||2
3139087|NCT01728792|3864385|FG002|NOT COMPLETED|Overall Study||4
3139088|NCT01728792|3864386|FG003|NOT COMPLETED|Overall Study||3
3139089|NCT01728792|3864387|FG004|NOT COMPLETED|Overall Study||0
3139090|NCT01728805|3864401|FG000|STARTED|Randomization Period||186
3139091|NCT01728805|3864402|FG001|STARTED|Randomization Period||186
3139092|NCT01728805|3864403|FG002|STARTED|Randomization Period||0
3139093|NCT01728805|3864401|FG000|COMPLETED|Randomization Period||186
3139094|NCT01728805|3864402|FG001|COMPLETED|Randomization Period||186
3139095|NCT01728805|3864403|FG002|COMPLETED|Randomization Period||0
3139096|NCT01728805|3864401|FG000|NOT COMPLETED|Randomization Period||0
3139097|NCT01728805|3864402|FG001|NOT COMPLETED|Randomization Period||0
3139098|NCT01728805|3864403|FG002|NOT COMPLETED|Randomization Period||0
3139099|NCT01728805|3864401|FG000|STARTED|Crossover Period||0
3139100|NCT01728805|3864402|FG001|STARTED|Crossover Period||0
3139101|NCT01728805|3864403|FG002|STARTED|Crossover Period||136
3139102|NCT01728805|3864401|FG000|COMPLETED|Crossover Period||0
3139103|NCT01728805|3864402|FG001|COMPLETED|Crossover Period||0
3139104|NCT01728805|3864403|FG002|COMPLETED|Crossover Period||136
3139105|NCT01728805|3864401|FG000|NOT COMPLETED|Crossover Period||0
3139106|NCT01728805|3864402|FG001|NOT COMPLETED|Crossover Period||0
3139107|NCT01728805|3864403|FG002|NOT COMPLETED|Crossover Period||0
3139108|NCT01728844|3864414|FG000|STARTED|Overall Study||22
3139109|NCT01728844|3864415|FG001|STARTED|Overall Study||21
3139110|NCT01728844|3864416|FG002|STARTED|Overall Study||22
3139111|NCT01728844|3864417|FG003|STARTED|Overall Study||23
3139112|NCT01728844|3864414|FG000|COMPLETED|Overall Study||21
3139113|NCT01728844|3864415|FG001|COMPLETED|Overall Study||21
3139114|NCT01728844|3864416|FG002|COMPLETED|Overall Study||22
3139115|NCT01728844|3864417|FG003|COMPLETED|Overall Study||21
3139116|NCT01728844|3864414|FG000|NOT COMPLETED|Overall Study||1
3139117|NCT01728844|3864415|FG001|NOT COMPLETED|Overall Study||0
3139118|NCT01728844|3864416|FG002|NOT COMPLETED|Overall Study||0
3139119|NCT01728844|3864417|FG003|NOT COMPLETED|Overall Study||2
3139120|NCT01729026|3864429|FG000|STARTED|Randomization to 3-month Follow-up||9
3139121|NCT01729026|3864430|FG001|STARTED|Randomization to 3-month Follow-up||10
3139122|NCT01729026|3864429|FG000|COMPLETED|Randomization to 3-month Follow-up||7
3139123|NCT01729026|3864430|FG001|COMPLETED|Randomization to 3-month Follow-up||8
3139124|NCT01729026|3864429|FG000|NOT COMPLETED|Randomization to 3-month Follow-up||2
3139125|NCT01729026|3864430|FG001|NOT COMPLETED|Randomization to 3-month Follow-up||2
3139126|NCT01729026|3864429|FG000|STARTED|3-month to 6-month (Final) Follow-up||7
3139127|NCT01729026|3864430|FG001|STARTED|3-month to 6-month (Final) Follow-up||8
3139128|NCT01729026|3864429|FG000|COMPLETED|3-month to 6-month (Final) Follow-up||6
3139129|NCT01729026|3864430|FG001|COMPLETED|3-month to 6-month (Final) Follow-up||6
3139130|NCT01729026|3864429|FG000|NOT COMPLETED|3-month to 6-month (Final) Follow-up||1
3139131|NCT01729026|3864430|FG001|NOT COMPLETED|3-month to 6-month (Final) Follow-up||2
3139132|NCT01729039|3864441|FG000|STARTED|Overall Study||23
3139133|NCT01729039|3864442|FG001|STARTED|Overall Study||26
3139134|NCT01729039|3864441|FG000|COMPLETED|Overall Study||13
3139135|NCT01729039|3864442|FG001|COMPLETED|Overall Study||14
3139136|NCT01729039|3864441|FG000|NOT COMPLETED|Overall Study||10
3139137|NCT01729039|3864442|FG001|NOT COMPLETED|Overall Study||12
3139138|NCT01729156|3864454|FG000|STARTED|Overall Study||12
3139139|NCT01729156|3864455|FG001|STARTED|Overall Study||12
3139140|NCT01729156|3864456|FG002|STARTED|Overall Study||12
3139141|NCT01729156|3864454|FG000|COMPLETED|Overall Study||11
3139142|NCT01729156|3864455|FG001|COMPLETED|Overall Study||12
3139143|NCT01729156|3864456|FG002|COMPLETED|Overall Study||12
3139144|NCT01729156|3864454|FG000|NOT COMPLETED|Overall Study||1
3139145|NCT01729156|3864455|FG001|NOT COMPLETED|Overall Study||0
3139146|NCT01729156|3864456|FG002|NOT COMPLETED|Overall Study||0
3139147|NCT01729208|3864467|FG000|STARTED|Baseline||70
3139148|NCT01729208|3864468|FG001|STARTED|Baseline||74
3139149|NCT01729208|3864467|FG000|COMPLETED|Baseline||65
3139150|NCT01729208|3864468|FG001|COMPLETED|Baseline||70
3139151|NCT01729208|3864467|FG000|NOT COMPLETED|Baseline||5
3139152|NCT01729208|3864468|FG001|NOT COMPLETED|Baseline||4
3139153|NCT01729208|3864467|FG000|STARTED|12 Months Follow-up||65
3139154|NCT01729208|3864468|FG001|STARTED|12 Months Follow-up||70
3139155|NCT01729208|3864467|FG000|COMPLETED|12 Months Follow-up||58
3139156|NCT01729208|3864468|FG001|COMPLETED|12 Months Follow-up||60
3139157|NCT01729208|3864467|FG000|NOT COMPLETED|12 Months Follow-up||7
3139158|NCT01729208|3864468|FG001|NOT COMPLETED|12 Months Follow-up||10
3139159|NCT01729208|3864467|FG000|STARTED|24 Months Follow-up||58
3139160|NCT01729208|3864468|FG001|STARTED|24 Months Follow-up||60
3139161|NCT01729208|3864467|FG000|COMPLETED|24 Months Follow-up||55
3139162|NCT01729208|3864468|FG001|COMPLETED|24 Months Follow-up||60
3139163|NCT01729208|3864467|FG000|NOT COMPLETED|24 Months Follow-up||3
3139164|NCT01729208|3864468|FG001|NOT COMPLETED|24 Months Follow-up||0
3139165|NCT01729208|3864467|FG000|STARTED|36 Months Follow-up||55
3180582|NCT01992107|3908995|FG001|STARTED|Overall Study||593
3180583|NCT01992107|3908996|FG002|STARTED|Overall Study||581
3180584|NCT01992107|3908994|FG000|COMPLETED|Overall Study||1091
3180585|NCT01992107|3908995|FG001|COMPLETED|Overall Study||560
3180586|NCT01992107|3908996|FG002|COMPLETED|Overall Study||545
3180587|NCT01992107|3908994|FG000|NOT COMPLETED|Overall Study||68
3180588|NCT01992107|3908995|FG001|NOT COMPLETED|Overall Study||33
3180589|NCT01992107|3908996|FG002|NOT COMPLETED|Overall Study||36
3180590|NCT01992159|3909025|FG000|STARTED|Overall Study||63
3180591|NCT01992159|3909026|FG001|STARTED|Overall Study||63
3180592|NCT01992159|3909027|FG002|STARTED|Overall Study||63
3180593|NCT01992159|3909028|FG003|STARTED|Overall Study||63
3139166|NCT01729208|3864468|FG001|STARTED|36 Months Follow-up||60
3139167|NCT01729208|3864467|FG000|COMPLETED|36 Months Follow-up||52
3139168|NCT01729208|3864468|FG001|COMPLETED|36 Months Follow-up||56
3139169|NCT01729208|3864467|FG000|NOT COMPLETED|36 Months Follow-up||3
3139170|NCT01729208|3864468|FG001|NOT COMPLETED|36 Months Follow-up||4
3139171|NCT01729247|3864474|FG000|STARTED|Overall Study||50
3139172|NCT01729247|3864474|FG000|COMPLETED|Overall Study||50
3139173|NCT01729247|3864474|FG000|NOT COMPLETED|Overall Study||0
3139174|NCT01729338|3864485|FG000|STARTED|Overall Study||16
3180594|NCT01992159|3909025|FG000|Received Treatment|Overall Study||63
3180595|NCT01992159|3909026|FG001|Received Treatment|Overall Study||63
3180596|NCT01992159|3909027|FG002|Received Treatment|Overall Study||63
3139175|NCT01729338|3864485|FG000|COMPLETED|Overall Study||14
3139176|NCT01729338|3864485|FG000|NOT COMPLETED|Overall Study||2
3139177|NCT01729494|3864492|FG000|STARTED|Overall Study||107
3139178|NCT01729494|3864493|FG001|STARTED|Overall Study||104
3139179|NCT01729494|3864494|FG002|STARTED|Overall Study||105
3139180|NCT01729494|3864492|FG000|COMPLETED|Overall Study||97
3139181|NCT01729494|3864493|FG001|COMPLETED|Overall Study||93
3139182|NCT01729494|3864494|FG002|COMPLETED|Overall Study||94
3139183|NCT01729494|3864492|FG000|NOT COMPLETED|Overall Study||10
3139184|NCT01729494|3864493|FG001|NOT COMPLETED|Overall Study||11
3139185|NCT01729494|3864494|FG002|NOT COMPLETED|Overall Study||11
3139186|NCT01729559|3864504|FG000|STARTED|Overall Study||251
3139187|NCT01729559|3864505|FG001|STARTED|Overall Study||244
3139188|NCT01729559|3864504|FG000|COMPLETED|Overall Study||220
3139189|NCT01729559|3864505|FG001|COMPLETED|Overall Study||216
3139190|NCT01729559|3864504|FG000|NOT COMPLETED|Overall Study||31
3139191|NCT01729559|3864505|FG001|NOT COMPLETED|Overall Study||28
3139192|NCT01729598|3864513|FG000|STARTED|Overall Study||10
3139193|NCT01729598|3864514|FG001|STARTED|Overall Study||4
3139194|NCT01729598|3864513|FG000|COMPLETED|Overall Study||10
3139195|NCT01729598|3864514|FG001|COMPLETED|Overall Study||4
3139196|NCT01729598|3864513|FG000|NOT COMPLETED|Overall Study||0
3139197|NCT01729598|3864514|FG001|NOT COMPLETED|Overall Study||0
3139198|NCT01729728|3864523|FG000|STARTED|Overall Study||21
3139199|NCT01729728|3864524|FG001|STARTED|Overall Study||28
3139200|NCT01729728|3864525|FG002|STARTED|Overall Study||17
3139201|NCT01729728|3864523|FG000|COMPLETED|Overall Study||20
3139202|NCT01729728|3864524|FG001|COMPLETED|Overall Study||22
3139203|NCT01729728|3864525|FG002|COMPLETED|Overall Study||16
3139204|NCT01729728|3864523|FG000|NOT COMPLETED|Overall Study||1
3139205|NCT01729728|3864524|FG001|NOT COMPLETED|Overall Study||6
3139206|NCT01729728|3864525|FG002|NOT COMPLETED|Overall Study||1
3139207|NCT01729819|3864658|FG000|STARTED|Overall Study||49
3139208|NCT01729819|3864659|FG001|STARTED|Overall Study||57
3139209|NCT01729819|3864658|FG000|COMPLETED|Overall Study||43
3139210|NCT01729819|3864659|FG001|COMPLETED|Overall Study||50
3139211|NCT01729819|3864658|FG000|NOT COMPLETED|Overall Study||6
3139212|NCT01729819|3864659|FG001|NOT COMPLETED|Overall Study||7
3139213|NCT01729845|3864671|FG000|STARTED|Safety/Tolerability of Dec/MEC||6
3139214|NCT01729845|3864672|FG001|STARTED|Safety/Tolerability of Dec/MEC||34
3139215|NCT01729845|3864673|FG002|STARTED|Safety/Tolerability of Dec/MEC||12
3139216|NCT01729845|3864671|FG000|COMPLETED|Safety/Tolerability of Dec/MEC||6
3139217|NCT01729845|3864672|FG001|COMPLETED|Safety/Tolerability of Dec/MEC||34
3139218|NCT01729845|3864673|FG002|COMPLETED|Safety/Tolerability of Dec/MEC||12
3139219|NCT01729845|3864671|FG000|NOT COMPLETED|Safety/Tolerability of Dec/MEC||0
3139220|NCT01729845|3864672|FG001|NOT COMPLETED|Safety/Tolerability of Dec/MEC||0
3139221|NCT01729845|3864673|FG002|NOT COMPLETED|Safety/Tolerability of Dec/MEC||0
3139222|NCT01729845|3864671|FG000|STARTED|Efficacy of Dec/MEC||0
3139223|NCT01729845|3864672|FG001|STARTED|Efficacy of Dec/MEC||22
3139224|NCT01729845|3864673|FG002|STARTED|Efficacy of Dec/MEC||0
3139225|NCT01729845|3864671|FG000|COMPLETED|Efficacy of Dec/MEC||0
3139226|NCT01729845|3864672|FG001|COMPLETED|Efficacy of Dec/MEC||22
3139227|NCT01729845|3864673|FG002|COMPLETED|Efficacy of Dec/MEC||0
3139228|NCT01729845|3864671|FG000|NOT COMPLETED|Efficacy of Dec/MEC||0
3139229|NCT01729845|3864672|FG001|NOT COMPLETED|Efficacy of Dec/MEC||0
3139230|NCT01729845|3864673|FG002|NOT COMPLETED|Efficacy of Dec/MEC||0
3139231|NCT01729871|3864685|FG000|STARTED|Overall Study||124
3139232|NCT01729871|3864686|FG001|STARTED|Overall Study||124
3139233|NCT01729871|3864685|FG000|COMPLETED|Overall Study||112
3139234|NCT01729871|3864686|FG001|COMPLETED|Overall Study||101
3139235|NCT01729871|3864685|FG000|NOT COMPLETED|Overall Study||12
3139236|NCT01729871|3864686|FG001|NOT COMPLETED|Overall Study||23
3139237|NCT01729923|3864692|FG000|STARTED|Overall Study||27
3139238|NCT01729923|3864692|FG000|COMPLETED|Overall Study||0
3139239|NCT01729923|3864692|FG000|NOT COMPLETED|Overall Study||27
3139240|NCT01730040|3864703|FG000|STARTED|Overall Study||57
3139241|NCT01730040|3864704|FG001|STARTED|Overall Study||55
3139242|NCT01730040|3864705|FG002|STARTED|Overall Study||57
3139243|NCT01730040|3864706|FG003|STARTED|Overall Study||47
3139244|NCT01730040|3864707|FG004|STARTED|Overall Study||45
3139245|NCT01730040|3864708|FG005|STARTED|Overall Study||47
3139246|NCT01730040|3864709|FG006|STARTED|Overall Study||47
3139247|NCT01730040|3864703|FG000|Treated|Overall Study||57
3139248|NCT01730040|3864704|FG001|Treated|Overall Study||55
3139249|NCT01730040|3864705|FG002|Treated|Overall Study||57
3139250|NCT01730040|3864706|FG003|Treated|Overall Study||47
3139251|NCT01730040|3864707|FG004|Treated|Overall Study||45
3139252|NCT01730040|3864708|FG005|Treated|Overall Study||46
3139253|NCT01730040|3864709|FG006|Treated|Overall Study||47
3139254|NCT01730040|3864703|FG000|COMPLETED|Overall Study||44
3139255|NCT01730040|3864704|FG001|COMPLETED|Overall Study||40
3139256|NCT01730040|3864705|FG002|COMPLETED|Overall Study||46
3139257|NCT01730040|3864706|FG003|COMPLETED|Overall Study||39
3139258|NCT01730040|3864707|FG004|COMPLETED|Overall Study||39
3139259|NCT01730040|3864708|FG005|COMPLETED|Overall Study||40
3139260|NCT01730040|3864709|FG006|COMPLETED|Overall Study||38
3139261|NCT01730040|3864703|FG000|NOT COMPLETED|Overall Study||13
3139262|NCT01730040|3864704|FG001|NOT COMPLETED|Overall Study||15
3139263|NCT01730040|3864705|FG002|NOT COMPLETED|Overall Study||11
3139264|NCT01730040|3864706|FG003|NOT COMPLETED|Overall Study||8
3139265|NCT01730040|3864707|FG004|NOT COMPLETED|Overall Study||6
3139266|NCT01730040|3864708|FG005|NOT COMPLETED|Overall Study||7
3139267|NCT01730040|3864709|FG006|NOT COMPLETED|Overall Study||9
3180597|NCT01992159|3909028|FG003|Received Treatment|Overall Study||63
3139268|NCT01730053|3864731|FG000|STARTED|Overall Study||48
3139269|NCT01730053|3864732|FG001|STARTED|Overall Study||48
3139270|NCT01730053|3864733|FG002|STARTED|Overall Study||49
3139271|NCT01730053|3864734|FG003|STARTED|Overall Study||53
3139272|NCT01730053|3864735|FG004|STARTED|Overall Study||53
3139273|NCT01730053|3864736|FG005|STARTED|Overall Study||54
3139274|NCT01730053|3864731|FG000|Treated|Overall Study||48
3139275|NCT01730053|3864732|FG001|Treated|Overall Study||48
3139276|NCT01730053|3864733|FG002|Treated|Overall Study||49
3139277|NCT01730053|3864734|FG003|Treated|Overall Study||53
3139278|NCT01730053|3864735|FG004|Treated|Overall Study||53
3139279|NCT01730053|3864736|FG005|Treated|Overall Study||54
3139280|NCT01730053|3864731|FG000|COMPLETED|Overall Study||43
3139281|NCT01730053|3864732|FG001|COMPLETED|Overall Study||34
3139282|NCT01730053|3864733|FG002|COMPLETED|Overall Study||38
3139283|NCT01730053|3864734|FG003|COMPLETED|Overall Study||45
3139284|NCT01730053|3864735|FG004|COMPLETED|Overall Study||44
3139285|NCT01730053|3864736|FG005|COMPLETED|Overall Study||41
3139286|NCT01730053|3864731|FG000|NOT COMPLETED|Overall Study||5
3139287|NCT01730053|3864732|FG001|NOT COMPLETED|Overall Study||14
3139288|NCT01730053|3864733|FG002|NOT COMPLETED|Overall Study||11
3139289|NCT01730053|3864734|FG003|NOT COMPLETED|Overall Study||8
3139290|NCT01730053|3864735|FG004|NOT COMPLETED|Overall Study||9
3139291|NCT01730053|3864736|FG005|NOT COMPLETED|Overall Study||13
3139292|NCT01730339|3864753|FG000|STARTED|Overall Study||45
3139293|NCT01730339|3864754|FG001|STARTED|Overall Study||55
3139294|NCT01730339|3864753|FG000|COMPLETED|Overall Study||40
3139295|NCT01730339|3864754|FG001|COMPLETED|Overall Study||52
3139296|NCT01730339|3864753|FG000|NOT COMPLETED|Overall Study||5
3139297|NCT01730339|3864754|FG001|NOT COMPLETED|Overall Study||3
3139298|NCT01730378|3864772|FG000|STARTED|Overall Study||84
3139299|NCT01730378|3864773|FG001|STARTED|Overall Study||47
3139300|NCT01730378|3864772|FG000|COMPLETED|Overall Study||83
3139301|NCT01730378|3864773|FG001|COMPLETED|Overall Study||47
3139302|NCT01730378|3864772|FG000|NOT COMPLETED|Overall Study||1
3139303|NCT01730378|3864773|FG001|NOT COMPLETED|Overall Study||0
3139304|NCT01730534|3864782|FG000|STARTED|Overall Study||8582
3139305|NCT01730534|3864783|FG001|STARTED|Overall Study||8578
3139306|NCT01730534|3864782|FG000|COMPLETED|Overall Study||8473
3139307|NCT01730534|3864783|FG001|COMPLETED|Overall Study||8433
3139308|NCT01730534|3864782|FG000|NOT COMPLETED|Overall Study||109
3139309|NCT01730534|3864783|FG001|NOT COMPLETED|Overall Study||145
3139310|NCT01730586|3864789|FG000|STARTED|Overall Study||34
3139311|NCT01730586|3864789|FG000|COMPLETED|Overall Study||21
3139312|NCT01730586|3864789|FG000|NOT COMPLETED|Overall Study||13
3139313|NCT01730729|3864795|FG000|STARTED|Overall Study||20
3139314|NCT01730729|3864795|FG000|Completed 2 Cycles/Reached 1st Response|Overall Study||18
3139315|NCT01730729|3864795|FG000|Treated Cycle 3 and Beyond|Overall Study||6
3139316|NCT01730729|3864795|FG000|COMPLETED|Overall Study||6
3139317|NCT01730729|3864795|FG000|NOT COMPLETED|Overall Study||14
3139318|NCT01730846|3864802|FG000|STARTED|Overall Study||11
3139319|NCT01730846|3864803|FG001|STARTED|Overall Study||11
3139320|NCT01730846|3864804|FG002|STARTED|Overall Study||13
3139321|NCT01730846|3864802|FG000|COMPLETED|Overall Study||11
3139322|NCT01730846|3864803|FG001|COMPLETED|Overall Study||11
3139323|NCT01730846|3864804|FG002|COMPLETED|Overall Study||13
3139324|NCT01730846|3864802|FG000|NOT COMPLETED|Overall Study||0
3139325|NCT01730846|3864803|FG001|NOT COMPLETED|Overall Study||0
3139326|NCT01730846|3864804|FG002|NOT COMPLETED|Overall Study||0
3139327|NCT01730872|3864815|FG000|STARTED|Overall Study||8
3139328|NCT01730872|3864816|FG001|STARTED|Overall Study||5
3139329|NCT01730872|3864817|FG002|STARTED|Overall Study||3
3139330|NCT01730872|3864815|FG000|Full Analysis Set|Overall Study||8
3139331|NCT01730872|3864816|FG001|Full Analysis Set|Overall Study|1 subject did not complete the last post-CAE measurement on Day 6 and was excluded from the FAS|4
3139332|NCT01730872|3864817|FG002|Full Analysis Set|Overall Study||0
3139333|NCT01730872|3864815|FG000|COMPLETED|Overall Study||8
3139334|NCT01730872|3864816|FG001|COMPLETED|Overall Study||5
3139335|NCT01730872|3864817|FG002|COMPLETED|Overall Study||3
3139336|NCT01730872|3864815|FG000|NOT COMPLETED|Overall Study||0
3139337|NCT01730872|3864816|FG001|NOT COMPLETED|Overall Study||0
3139338|NCT01730872|3864817|FG002|NOT COMPLETED|Overall Study||0
3139339|NCT01730950|3864826|FG000|STARTED|Overall Study||90
3139340|NCT01730950|3864827|FG001|STARTED|Overall Study||92
3139341|NCT01730950|3864826|FG000|Eligible Population|Overall Study||84
3139342|NCT01730950|3864827|FG001|Eligible Population|Overall Study||86
3139343|NCT01730950|3864826|FG000|Adverse Event Population|Overall Study||76
3139344|NCT01730950|3864827|FG001|Adverse Event Population|Overall Study||83
3139345|NCT01730950|3864826|FG000|Response Population|Overall Study||78
3139346|NCT01730950|3864827|FG001|Response Population|Overall Study||77
3139347|NCT01730950|3864826|FG000|6-month Progression-free Analysis|Overall Study||79
3139348|NCT01730950|3864827|FG001|6-month Progression-free Analysis|Overall Study||81
3139349|NCT01730950|3864826|FG000|Delayed Toxicity Population|Overall Study||0
3139350|NCT01730950|3864827|FG001|Delayed Toxicity Population|Overall Study||83
3139351|NCT01730950|3864826|FG000|COMPLETED|Overall Study||84
3139352|NCT01730950|3864827|FG001|COMPLETED|Overall Study||86
3139353|NCT01730950|3864826|FG000|NOT COMPLETED|Overall Study||6
3139354|NCT01730950|3864827|FG001|NOT COMPLETED|Overall Study||6
3139355|NCT01731002|3864837|FG000|STARTED|Overall Study||75
3139356|NCT01731002|3864838|FG001|STARTED|Overall Study||72
3139357|NCT01731002|3864839|FG002|STARTED|Overall Study||77
3139358|NCT01731002|3864837|FG000|COMPLETED|Overall Study||71
3139359|NCT01731002|3864838|FG001|COMPLETED|Overall Study||68
3139360|NCT01731002|3864839|FG002|COMPLETED|Overall Study||74
3139361|NCT01731002|3864837|FG000|NOT COMPLETED|Overall Study||4
3139362|NCT01731002|3864838|FG001|NOT COMPLETED|Overall Study||4
3139363|NCT01731002|3864839|FG002|NOT COMPLETED|Overall Study||3
3139364|NCT01731041|3864849|FG000|STARTED|Overall Study||30
3139365|NCT01731041|3864850|FG001|STARTED|Overall Study||30
3139366|NCT01731041|3864849|FG000|COMPLETED|Overall Study||30
3139367|NCT01731041|3864850|FG001|COMPLETED|Overall Study||30
3139368|NCT01731041|3864849|FG000|NOT COMPLETED|Overall Study||0
3139369|NCT01731041|3864850|FG001|NOT COMPLETED|Overall Study||0
3139370|NCT01731119|3864856|FG000|STARTED|Overall Study||9
3139371|NCT01731119|3864856|FG000|COMPLETED|Overall Study||7
3139372|NCT01731119|3864856|FG000|NOT COMPLETED|Overall Study||2
3139373|NCT01731171|3864862|FG000|STARTED|Overall Study||33
3139374|NCT01731171|3864863|FG001|STARTED|Overall Study||33
3139375|NCT01731171|3864862|FG000|COMPLETED|Overall Study||26
3139376|NCT01731171|3864863|FG001|COMPLETED|Overall Study||26
3139377|NCT01731171|3864862|FG000|NOT COMPLETED|Overall Study||7
3139378|NCT01731171|3864863|FG001|NOT COMPLETED|Overall Study||7
3139379|NCT01731470|3864869|FG000|STARTED|Overall Study|Number of patients consented to participate in the study|16
3139380|NCT01731470|3864869|FG000|COMPLETED|Overall Study|Number of patients enrolled in the study|14
3139381|NCT01731470|3864869|FG000|NOT COMPLETED|Overall Study||2
3139382|NCT01731600|3864875|FG000|STARTED|Overall Study||34
3139383|NCT01731600|3864876|FG001|STARTED|Overall Study||34
3139384|NCT01731600|3864875|FG000|COMPLETED|Overall Study||28
3139385|NCT01731600|3864876|FG001|COMPLETED|Overall Study||34
3139386|NCT01731600|3864875|FG000|NOT COMPLETED|Overall Study||6
3139387|NCT01731600|3864876|FG001|NOT COMPLETED|Overall Study||0
3139388|NCT01731678|3864886|FG000|STARTED|Overall Study||39
3139389|NCT01731678|3864886|FG000|COMPLETED|Overall Study||32
3139390|NCT01731678|3864886|FG000|NOT COMPLETED|Overall Study||7
3139391|NCT01731691|3864893|FG000|STARTED|Overall Study||3
3139392|NCT01731691|3864894|FG001|STARTED|Overall Study||5
3139393|NCT01731691|3864895|FG002|STARTED|Overall Study||4
3139394|NCT01731691|3864893|FG000|COMPLETED|Overall Study||3
3139395|NCT01731691|3864894|FG001|COMPLETED|Overall Study||5
3139396|NCT01731691|3864895|FG002|COMPLETED|Overall Study||4
3139397|NCT01731691|3864893|FG000|NOT COMPLETED|Overall Study||0
3139398|NCT01731691|3864894|FG001|NOT COMPLETED|Overall Study||0
3139399|NCT01731691|3864895|FG002|NOT COMPLETED|Overall Study||0
3139400|NCT01731886|3864908|FG000|STARTED|Overall Study||31
3139401|NCT01731886|3864909|FG001|STARTED|Overall Study||29
3139402|NCT01731886|3864908|FG000|COMPLETED|Overall Study||29
3139403|NCT01731886|3864909|FG001|COMPLETED|Overall Study||28
3139404|NCT01731886|3864908|FG000|NOT COMPLETED|Overall Study||2
3139405|NCT01731886|3864909|FG001|NOT COMPLETED|Overall Study||1
3139406|NCT01731912|3864916|FG000|STARTED|Overall Study||16
3139407|NCT01731912|3864916|FG000|COMPLETED|Overall Study||14
3139408|NCT01731912|3864916|FG000|NOT COMPLETED|Overall Study||2
3139409|NCT01731938|3864924|FG000|STARTED|Preliminary Part I||51
3139410|NCT01731938|3864925|FG001|STARTED|Preliminary Part I||52
3139411|NCT01731938|3864924|FG000|COMPLETED|Preliminary Part I||48
3139412|NCT01731938|3864925|FG001|COMPLETED|Preliminary Part I||44
3139413|NCT01731938|3864924|FG000|NOT COMPLETED|Preliminary Part I||3
3139414|NCT01731938|3864925|FG001|NOT COMPLETED|Preliminary Part I||8
3139415|NCT01731938|3864924|FG000|STARTED|Primary Part II|Preliminary Part I was for study team familiarization with FS Grifols application.|116
3139416|NCT01731938|3864925|FG001|STARTED|Primary Part II|Subjects from Preliminary Part I were not carried over to Primary Part II to assess safety/efficacy.|108
3139417|NCT01731938|3864924|FG000|COMPLETED|Primary Part II||103
3139418|NCT01731938|3864925|FG001|COMPLETED|Primary Part II||95
3139419|NCT01731938|3864924|FG000|NOT COMPLETED|Primary Part II||13
3139420|NCT01731938|3864925|FG001|NOT COMPLETED|Primary Part II||13
3139421|NCT01731951|3864938|FG000|STARTED|Overall Study||19
3139422|NCT01731951|3864939|FG001|STARTED|Overall Study||16
3139423|NCT01731951|3864940|FG002|STARTED|Overall Study||9
3139424|NCT01731951|3864941|FG003|STARTED|Overall Study||9
3139425|NCT01731951|3864942|FG004|STARTED|Overall Study||18
3139426|NCT01731951|3864943|FG005|STARTED|Overall Study||9
3139427|NCT01731951|3864938|FG000|COMPLETED|Overall Study||2
3139428|NCT01731951|3864939|FG001|COMPLETED|Overall Study||1
3139429|NCT01731951|3864940|FG002|COMPLETED|Overall Study||0
3139430|NCT01731951|3864941|FG003|COMPLETED|Overall Study||0
3139431|NCT01731951|3864942|FG004|COMPLETED|Overall Study||6
3139432|NCT01731951|3864943|FG005|COMPLETED|Overall Study||0
3139433|NCT01731951|3864938|FG000|NOT COMPLETED|Overall Study||17
3139434|NCT01731951|3864939|FG001|NOT COMPLETED|Overall Study||15
3139435|NCT01731951|3864940|FG002|NOT COMPLETED|Overall Study||9
3139436|NCT01731951|3864941|FG003|NOT COMPLETED|Overall Study||9
3139437|NCT01731951|3864942|FG004|NOT COMPLETED|Overall Study||12
3139438|NCT01731951|3864943|FG005|NOT COMPLETED|Overall Study||9
3139439|NCT01731990|3864963|FG000|STARTED|Overall Study|"Started indicates Safety and Pharmacodynamics set ."|18
3139440|NCT01731990|3864964|FG001|STARTED|Overall Study||20
3139441|NCT01731990|3864963|FG000|COMPLETED|Overall Study||14
3139442|NCT01731990|3864964|FG001|COMPLETED|Overall Study||12
3139443|NCT01731990|3864963|FG000|NOT COMPLETED|Overall Study||4
3139444|NCT01731990|3864964|FG001|NOT COMPLETED|Overall Study||8
3139445|NCT01732107|3864970|FG000|STARTED|Overall Study||13
3139446|NCT01732107|3864970|FG000|COMPLETED|Overall Study||0
3139447|NCT01732107|3864970|FG000|NOT COMPLETED|Overall Study||13
3139448|NCT01732263|3864976|FG000|STARTED|Overall Study||23
3139449|NCT01732263|3864977|FG001|STARTED|Overall Study||20
3139450|NCT01732263|3864976|FG000|COMPLETED|Overall Study||23
3139451|NCT01732263|3864977|FG001|COMPLETED|Overall Study||20
3139452|NCT01732263|3864976|FG000|NOT COMPLETED|Overall Study||0
3139453|NCT01732263|3864977|FG001|NOT COMPLETED|Overall Study||0
3139454|NCT01732406|3864990|FG000|STARTED|Overall Study||31
3139455|NCT01732406|3864991|FG001|STARTED|Overall Study||60
3139456|NCT01732406|3864992|FG002|STARTED|Overall Study||35
3139457|NCT01732406|3864990|FG000|COMPLETED|Overall Study||31
3139458|NCT01732406|3864991|FG001|COMPLETED|Overall Study||60
3139459|NCT01732406|3864992|FG002|COMPLETED|Overall Study||35
3139460|NCT01732406|3864990|FG000|NOT COMPLETED|Overall Study||0
3139461|NCT01732406|3864991|FG001|NOT COMPLETED|Overall Study||0
3139462|NCT01732406|3864992|FG002|NOT COMPLETED|Overall Study||0
3139463|NCT01732419|3865006|FG000|STARTED|Overall Study||45
3139464|NCT01732419|3865007|FG001|STARTED|Overall Study||45
3139465|NCT01732419|3865006|FG000|COMPLETED|Overall Study||37
3139466|NCT01732419|3865007|FG001|COMPLETED|Overall Study||41
3139467|NCT01732419|3865006|FG000|NOT COMPLETED|Overall Study||8
3139468|NCT01732419|3865007|FG001|NOT COMPLETED|Overall Study||4
3139469|NCT01732445|3865013|FG000|STARTED|Overall Study||14
3139470|NCT01732445|3865013|FG000|COMPLETED|Overall Study||14
3139471|NCT01732445|3865013|FG000|NOT COMPLETED|Overall Study||0
3139472|NCT01732458|3865021|FG000|STARTED|Overall Study||60
3139473|NCT01732458|3865022|FG001|STARTED|Overall Study||58
3139474|NCT01732458|3865023|FG002|STARTED|Overall Study||58
3139475|NCT01732458|3865024|FG003|STARTED|Overall Study||52
3139476|NCT01732458|3865021|FG000|Treated|Overall Study||57
3139477|NCT01732458|3865022|FG001|Treated|Overall Study||55
3139478|NCT01732458|3865023|FG002|Treated|Overall Study||56
3139479|NCT01732458|3865024|FG003|Treated|Overall Study||52
3139480|NCT01732458|3865021|FG000|COMPLETED|Overall Study||57
3139481|NCT01732458|3865022|FG001|COMPLETED|Overall Study||53
3139482|NCT01732458|3865023|FG002|COMPLETED|Overall Study||55
3139483|NCT01732458|3865024|FG003|COMPLETED|Overall Study||50
3139484|NCT01732458|3865021|FG000|NOT COMPLETED|Overall Study||3
3139485|NCT01732458|3865022|FG001|NOT COMPLETED|Overall Study||5
3139486|NCT01732458|3865023|FG002|NOT COMPLETED|Overall Study||3
3139487|NCT01732458|3865024|FG003|NOT COMPLETED|Overall Study||2
3139488|NCT01732471|3865046|FG000|STARTED|Overall Study||90
3139489|NCT01732471|3865046|FG000|COMPLETED|Overall Study||89
3139490|NCT01732471|3865046|FG000|NOT COMPLETED|Overall Study||1
3139491|NCT01732484|3865050|FG000|STARTED|Overall Study||100
3139492|NCT01732484|3865050|FG000|Randomized|Overall Study|Randomized implantation SN60WF IOL in on eye and iMics NY-60 in the other eye.|100
3139493|NCT01732484|3865050|FG000|Allocation|Overall Study||100
3139494|NCT01732484|3865050|FG000|COMPLETED|Overall Study||74
3139495|NCT01732484|3865050|FG000|NOT COMPLETED|Overall Study||26
3139496|NCT01732510|3865063|FG000|STARTED|Overall Study||9
3139497|NCT01732510|3865064|FG001|STARTED|Overall Study||9
3139498|NCT01732510|3865065|FG002|STARTED|Overall Study||8
3139499|NCT01732510|3865066|FG003|STARTED|Overall Study||10
3139500|NCT01732510|3865067|FG004|STARTED|Overall Study||8
3139501|NCT01732510|3865068|FG005|STARTED|Overall Study||13
3139502|NCT01732510|3865069|FG006|STARTED|Overall Study||8
3139503|NCT01732510|3865063|FG000|COMPLETED|Overall Study||8
3139504|NCT01732510|3865064|FG001|COMPLETED|Overall Study||4
3139505|NCT01732510|3865065|FG002|COMPLETED|Overall Study||4
3139506|NCT01732510|3865066|FG003|COMPLETED|Overall Study||5
3139507|NCT01732510|3865067|FG004|COMPLETED|Overall Study||3
3139508|NCT01732510|3865068|FG005|COMPLETED|Overall Study||0
3139509|NCT01732510|3865069|FG006|COMPLETED|Overall Study||0
3139510|NCT01732510|3865063|FG000|NOT COMPLETED|Overall Study||1
3139511|NCT01732510|3865064|FG001|NOT COMPLETED|Overall Study||5
3139512|NCT01732510|3865065|FG002|NOT COMPLETED|Overall Study||4
3139513|NCT01732510|3865066|FG003|NOT COMPLETED|Overall Study||5
3139514|NCT01732510|3865067|FG004|NOT COMPLETED|Overall Study||5
3139515|NCT01732510|3865068|FG005|NOT COMPLETED|Overall Study||13
3139516|NCT01732510|3865069|FG006|NOT COMPLETED|Overall Study||8
3139517|NCT01732536|3865090|FG000|STARTED|Overall Study||53
3139518|NCT01732536|3865091|FG001|STARTED|Overall Study||47
3139519|NCT01732536|3865090|FG000|COMPLETED|Overall Study||52
3139520|NCT01732536|3865091|FG001|COMPLETED|Overall Study||46
3139521|NCT01732536|3865090|FG000|NOT COMPLETED|Overall Study||1
3139522|NCT01732536|3865091|FG001|NOT COMPLETED|Overall Study||1
3139523|NCT01732549|3865102|FG000|STARTED|Overall Study||71
3139524|NCT01732549|3865103|FG001|STARTED|Overall Study||73
3139525|NCT01732549|3865102|FG000|Ongoing in Treatment Period:Data Cut-off|Overall Study||12
3139526|NCT01732549|3865103|FG001|Ongoing in Treatment Period:Data Cut-off|Overall Study||12
3139527|NCT01732549|3865102|FG000|Withdrawn During Treatment:Data Cut-off|Overall Study|Withdrawn during treatment period 59 (AE 13, Consent withdrawn 13, Disease progression 31, Other 2)|59
3139528|NCT01732549|3865103|FG001|Withdrawn During Treatment:Data Cut-off|Overall Study|Withdrawn during treatment period 61 (AE 3, Consent withdrawn 6, Disease progression 46, Other 6)|61
3139529|NCT01732549|3865102|FG000|Ongoing Treatment Period:Final Analysis|Overall Study||0
3139530|NCT01732549|3865103|FG001|Ongoing Treatment Period:Final Analysis|Overall Study||0
3139531|NCT01732549|3865102|FG000|Withdrawn During Treatment:Final Analysi|Overall Study||71
3139532|NCT01732549|3865103|FG001|Withdrawn During Treatment:Final Analysi|Overall Study||73
3139533|NCT01732549|3865102|FG000|COMPLETED|Overall Study||0
3139534|NCT01732549|3865103|FG001|COMPLETED|Overall Study||0
3139535|NCT01732549|3865102|FG000|NOT COMPLETED|Overall Study||71
3139536|NCT01732549|3865103|FG001|NOT COMPLETED|Overall Study||73
3139537|NCT01732588|3865113|FG000|STARTED|First Intervention (7 Days)||4
3139538|NCT01732588|3865114|FG001|STARTED|First Intervention (7 Days)||3
3139539|NCT01732588|3865115|FG002|STARTED|First Intervention (7 Days)||4
3139540|NCT01732588|3865113|FG000|COMPLETED|First Intervention (7 Days)||4
3139541|NCT01732588|3865114|FG001|COMPLETED|First Intervention (7 Days)||2
3139542|NCT01732588|3865115|FG002|COMPLETED|First Intervention (7 Days)||4
3139543|NCT01732588|3865113|FG000|NOT COMPLETED|First Intervention (7 Days)||0
3139544|NCT01732588|3865114|FG001|NOT COMPLETED|First Intervention (7 Days)||1
3139545|NCT01732588|3865115|FG002|NOT COMPLETED|First Intervention (7 Days)||0
3139546|NCT01732588|3865113|FG000|STARTED|Second Intervention (7 Days)||4
3139547|NCT01732588|3865114|FG001|STARTED|Second Intervention (7 Days)||2
3139548|NCT01732588|3865115|FG002|STARTED|Second Intervention (7 Days)||4
3139549|NCT01732588|3865113|FG000|COMPLETED|Second Intervention (7 Days)||4
3139550|NCT01732588|3865114|FG001|COMPLETED|Second Intervention (7 Days)||2
3139551|NCT01732588|3865115|FG002|COMPLETED|Second Intervention (7 Days)||4
3139552|NCT01732588|3865113|FG000|NOT COMPLETED|Second Intervention (7 Days)||0
3139553|NCT01732588|3865114|FG001|NOT COMPLETED|Second Intervention (7 Days)||0
3139554|NCT01732588|3865115|FG002|NOT COMPLETED|Second Intervention (7 Days)||0
3139555|NCT01732588|3865113|FG000|STARTED|Third Intervention (7 Days)||4
3139556|NCT01732588|3865114|FG001|STARTED|Third Intervention (7 Days)||2
3139557|NCT01732588|3865115|FG002|STARTED|Third Intervention (7 Days)||4
3139558|NCT01732588|3865113|FG000|COMPLETED|Third Intervention (7 Days)||4
3139559|NCT01732588|3865114|FG001|COMPLETED|Third Intervention (7 Days)||2
3139560|NCT01732588|3865115|FG002|COMPLETED|Third Intervention (7 Days)||4
3139561|NCT01732588|3865113|FG000|NOT COMPLETED|Third Intervention (7 Days)||0
3139562|NCT01732588|3865114|FG001|NOT COMPLETED|Third Intervention (7 Days)||0
3139563|NCT01732588|3865115|FG002|NOT COMPLETED|Third Intervention (7 Days)||0
3139564|NCT01732627|3865125|FG000|STARTED|Overall Study||201
3139565|NCT01732627|3865126|FG001|STARTED|Overall Study||100
3139566|NCT01732627|3865125|FG000|Safety Analysis Set (SafAS)|Overall Study||199
3139567|NCT01732627|3865126|FG001|Safety Analysis Set (SafAS)|Overall Study||100
3139568|NCT01732627|3865125|FG000|COMPLETED|Overall Study||200
3139569|NCT01732627|3865126|FG001|COMPLETED|Overall Study||100
3139570|NCT01732627|3865125|FG000|NOT COMPLETED|Overall Study||1
3139571|NCT01732627|3865126|FG001|NOT COMPLETED|Overall Study||0
3139572|NCT01732640|3865132|FG000|STARTED|Overall Study||6
3139573|NCT01732640|3865133|FG001|STARTED|Overall Study||3
3139574|NCT01732640|3865132|FG000|COMPLETED|Overall Study||6
3139575|NCT01732640|3865133|FG001|COMPLETED|Overall Study||1
3139576|NCT01732640|3865132|FG000|NOT COMPLETED|Overall Study||0
3139577|NCT01732640|3865133|FG001|NOT COMPLETED|Overall Study||2
3139578|NCT01732692|3865145|FG000|STARTED|Overall Study||70
3139579|NCT01732692|3865146|FG001|STARTED|Overall Study||70
3139580|NCT01732692|3865145|FG000|COMPLETED|Overall Study||70
3139581|NCT01732692|3865146|FG001|COMPLETED|Overall Study||69
3139582|NCT01732692|3865145|FG000|NOT COMPLETED|Overall Study||0
3139583|NCT01732692|3865146|FG001|NOT COMPLETED|Overall Study||1
3139584|NCT01732718|3865152|FG000|STARTED|First Intervention||7
3139585|NCT01732718|3865153|FG001|STARTED|First Intervention||6
3139586|NCT01732718|3865152|FG000|COMPLETED|First Intervention||7
3139587|NCT01732718|3865153|FG001|COMPLETED|First Intervention||6
3139588|NCT01732718|3865152|FG000|NOT COMPLETED|First Intervention||0
3139589|NCT01732718|3865153|FG001|NOT COMPLETED|First Intervention||0
3139590|NCT01732718|3865152|FG000|STARTED|Washout (4 Weeks)||7
3139591|NCT01732718|3865153|FG001|STARTED|Washout (4 Weeks)||6
3139592|NCT01732718|3865152|FG000|COMPLETED|Washout (4 Weeks)||7
3139593|NCT01732718|3865153|FG001|COMPLETED|Washout (4 Weeks)||6
3139594|NCT01732718|3865152|FG000|NOT COMPLETED|Washout (4 Weeks)||0
3139595|NCT01732718|3865153|FG001|NOT COMPLETED|Washout (4 Weeks)||0
3139596|NCT01732718|3865152|FG000|STARTED|Second Intervention||7
3139597|NCT01732718|3865153|FG001|STARTED|Second Intervention||6
3139598|NCT01732718|3865152|FG000|COMPLETED|Second Intervention||7
3139599|NCT01732718|3865153|FG001|COMPLETED|Second Intervention||6
3139600|NCT01732718|3865152|FG000|NOT COMPLETED|Second Intervention||0
3139601|NCT01732718|3865153|FG001|NOT COMPLETED|Second Intervention||0
3139602|NCT01732757|3865168|FG000|STARTED|Overall Study||53
3139603|NCT01732757|3865169|FG001|STARTED|Overall Study||52
3139604|NCT01732757|3865170|FG002|STARTED|Overall Study||52
3139605|NCT01732757|3865168|FG000|COMPLETED|Overall Study||52
3139606|NCT01732757|3865169|FG001|COMPLETED|Overall Study||52
3139607|NCT01732757|3865170|FG002|COMPLETED|Overall Study||52
3139608|NCT01732757|3865168|FG000|NOT COMPLETED|Overall Study||1
3139609|NCT01732757|3865169|FG001|NOT COMPLETED|Overall Study||0
3139610|NCT01732757|3865170|FG002|NOT COMPLETED|Overall Study||0
3139611|NCT01732770|3865180|FG000|STARTED|Overall Study||322
3139612|NCT01732770|3865181|FG001|STARTED|Overall Study||321
3139613|NCT01732770|3865180|FG000|Received Study Treatment|Overall Study||320
3139614|NCT01732770|3865181|FG001|Received Study Treatment|Overall Study||320
3139615|NCT01732770|3865180|FG000|COMPLETED|Overall Study||312
3139616|NCT01732770|3865181|FG001|COMPLETED|Overall Study||313
3139617|NCT01732770|3865180|FG000|NOT COMPLETED|Overall Study||10
3139618|NCT01732770|3865181|FG001|NOT COMPLETED|Overall Study||8
3139619|NCT01732783|3865190|FG000|STARTED|Overall Study||164
3139620|NCT01732783|3865191|FG001|STARTED|Overall Study||37
3139621|NCT01732783|3865192|FG002|STARTED|Overall Study||12
3139622|NCT01732783|3865190|FG000|COMPLETED|Overall Study|Completed 12-month observation period.|29
3139623|NCT01732783|3865191|FG001|COMPLETED|Overall Study|Completed 12-month observation period.|5
3139624|NCT01732783|3865192|FG002|COMPLETED|Overall Study|Completed 12-month observation period.|2
3139625|NCT01732783|3865190|FG000|NOT COMPLETED|Overall Study||135
3139626|NCT01732783|3865191|FG001|NOT COMPLETED|Overall Study||32
3139627|NCT01732783|3865192|FG002|NOT COMPLETED|Overall Study||10
3139628|NCT01732796|3865203|FG000|STARTED|Overall Study||208
3139629|NCT01732796|3865204|FG001|STARTED|Overall Study||211
3139630|NCT01732796|3865205|FG002|STARTED|Overall Study||51
3139631|NCT01732796|3865203|FG000|COMPLETED|Overall Study||162
3139632|NCT01732796|3865204|FG001|COMPLETED|Overall Study||169
3139633|NCT01732796|3865205|FG002|COMPLETED|Overall Study||38
3139634|NCT01732796|3865203|FG000|NOT COMPLETED|Overall Study||46
3139635|NCT01732796|3865204|FG001|NOT COMPLETED|Overall Study||42
3139636|NCT01732796|3865205|FG002|NOT COMPLETED|Overall Study||13
3139637|NCT01732809|3865217|FG000|STARTED|Overall Study||9
3139638|NCT01732809|3865218|FG001|STARTED|Overall Study||10
3180598|NCT01992159|3909025|FG000|Completed First 12 Months of Study|Overall Study||59
3180599|NCT01992159|3909026|FG001|Completed First 12 Months of Study|Overall Study||56
3180600|NCT01992159|3909027|FG002|Completed First 12 Months of Study|Overall Study||63
3139639|NCT01732809|3865217|FG000|COMPLETED|Overall Study||9
3139640|NCT01732809|3865218|FG001|COMPLETED|Overall Study||9
3139641|NCT01732809|3865217|FG000|NOT COMPLETED|Overall Study||0
3139642|NCT01732809|3865218|FG001|NOT COMPLETED|Overall Study||1
3139643|NCT01732822|3865226|FG000|STARTED|Overall Study||6930
3139644|NCT01732822|3865227|FG001|STARTED|Overall Study||6955
3139645|NCT01732822|3865226|FG000|COMPLETED|Overall Study|Includes patients who did not withdraw informed consent prior to the PACD|6807
3139646|NCT01732822|3865227|FG001|COMPLETED|Overall Study|Includes patients who did not withdraw informed consent prior to the PACD|6842
3139647|NCT01732822|3865226|FG000|NOT COMPLETED|Overall Study||123
3139648|NCT01732822|3865227|FG001|NOT COMPLETED|Overall Study||113
3139649|NCT01732835|3865255|FG000|STARTED|6-month Primary Endpoint||68
3139650|NCT01732835|3865255|FG000|COMPLETED|6-month Primary Endpoint||44
3139651|NCT01732835|3865255|FG000|NOT COMPLETED|6-month Primary Endpoint||24
3139652|NCT01732835|3865255|FG000|STARTED|2-year Extended Follow-up||44
3139653|NCT01732835|3865255|FG000|COMPLETED|2-year Extended Follow-up||39
3139654|NCT01732835|3865255|FG000|NOT COMPLETED|2-year Extended Follow-up||5
3139655|NCT01732874|3865261|FG000|STARTED|Overall Study||16
3139656|NCT01732874|3865262|FG001|STARTED|Overall Study||11
3139657|NCT01732874|3865261|FG000|COMPLETED|Overall Study||8
3139658|NCT01732874|3865262|FG001|COMPLETED|Overall Study||8
3139659|NCT01732874|3865261|FG000|NOT COMPLETED|Overall Study||8
3139660|NCT01732874|3865262|FG001|NOT COMPLETED|Overall Study||3
3139661|NCT01733056|3865271|FG000|STARTED|Overall Study||21
3139662|NCT01733056|3865272|FG001|STARTED|Overall Study||10
3139663|NCT01733056|3865273|FG002|STARTED|Overall Study||12
3139664|NCT01733056|3865271|FG000|COMPLETED|Overall Study||21
3139665|NCT01733056|3865272|FG001|COMPLETED|Overall Study||10
3139666|NCT01733056|3865273|FG002|COMPLETED|Overall Study||12
3139667|NCT01733056|3865271|FG000|NOT COMPLETED|Overall Study||0
3139668|NCT01733056|3865272|FG001|NOT COMPLETED|Overall Study||0
3139669|NCT01733056|3865273|FG002|NOT COMPLETED|Overall Study||0
3139670|NCT01733069|3865286|FG000|STARTED|Overall Study||264
3139671|NCT01733069|3865287|FG001|STARTED|Overall Study||1598
3139672|NCT01733069|3865286|FG000|COMPLETED|Overall Study||264
3139673|NCT01733069|3865287|FG001|COMPLETED|Overall Study||1598
3139674|NCT01733069|3865286|FG000|NOT COMPLETED|Overall Study||0
3139675|NCT01733069|3865287|FG001|NOT COMPLETED|Overall Study||0
3139676|NCT01733121|3865295|FG000|STARTED|Double-Blind Period (Week 0 to 6)||51
3139677|NCT01733121|3865296|FG001|STARTED|Double-Blind Period (Week 0 to 6)||51
3139678|NCT01733121|3865295|FG000|COMPLETED|Double-Blind Period (Week 0 to 6)||44
3139679|NCT01733121|3865296|FG001|COMPLETED|Double-Blind Period (Week 0 to 6)||46
3139680|NCT01733121|3865295|FG000|NOT COMPLETED|Double-Blind Period (Week 0 to 6)||7
3139681|NCT01733121|3865296|FG001|NOT COMPLETED|Double-Blind Period (Week 0 to 6)||5
3139682|NCT01733121|3865295|FG000|STARTED|Follow-Up Period (Week 6 to 8)||44
3139683|NCT01733121|3865296|FG001|STARTED|Follow-Up Period (Week 6 to 8)||46
3139684|NCT01733121|3865295|FG000|COMPLETED|Follow-Up Period (Week 6 to 8)||44
3139685|NCT01733121|3865296|FG001|COMPLETED|Follow-Up Period (Week 6 to 8)||46
3139686|NCT01733121|3865295|FG000|NOT COMPLETED|Follow-Up Period (Week 6 to 8)||0
3139687|NCT01733121|3865296|FG001|NOT COMPLETED|Follow-Up Period (Week 6 to 8)||0
3139688|NCT01733186|3865306|FG000|STARTED|Overall Study||6
3180601|NCT01992159|3909028|FG003|Completed First 12 Months of Study|Overall Study||59
3180602|NCT01992159|3909025|FG000|COMPLETED|Overall Study||59
3180603|NCT01992159|3909026|FG001|COMPLETED|Overall Study||55
3180604|NCT01992159|3909027|FG002|COMPLETED|Overall Study||62
3180605|NCT01992159|3909028|FG003|COMPLETED|Overall Study||59
3180606|NCT01992159|3909025|FG000|NOT COMPLETED|Overall Study||4
3180607|NCT01992159|3909026|FG001|NOT COMPLETED|Overall Study||8
3180608|NCT01992159|3909027|FG002|NOT COMPLETED|Overall Study||1
3180609|NCT01992159|3909028|FG003|NOT COMPLETED|Overall Study||4
3180610|NCT01992172|3909040|FG000|STARTED|Overall Study||7
3180611|NCT01992172|3909041|FG001|STARTED|Overall Study||0
3180612|NCT01992172|3909040|FG000|COMPLETED|Overall Study||7
3180613|NCT01992172|3909041|FG001|COMPLETED|Overall Study||0
3139689|NCT01733186|3865307|FG001|STARTED|Overall Study||6
3139690|NCT01733186|3865306|FG000|COMPLETED|Overall Study||6
3139691|NCT01733186|3865307|FG001|COMPLETED|Overall Study||6
3139692|NCT01733186|3865306|FG000|NOT COMPLETED|Overall Study||0
3139693|NCT01733186|3865307|FG001|NOT COMPLETED|Overall Study||0
3139694|NCT01733212|3865315|FG000|STARTED|Overall Study||116
3139695|NCT01733212|3865316|FG001|STARTED|Overall Study||123
3139696|NCT01733212|3865315|FG000|COMPLETED|Overall Study||116
3139697|NCT01733212|3865316|FG001|COMPLETED|Overall Study||123
3139698|NCT01733212|3865315|FG000|NOT COMPLETED|Overall Study||0
3139699|NCT01733212|3865316|FG001|NOT COMPLETED|Overall Study||0
3139700|NCT01733238|3865322|FG000|STARTED|Overall Study||13
3139701|NCT01733238|3865322|FG000|COMPLETED|Overall Study|8 subjects completed the Induction Phase and 7 subjects started Maintenance Phase|8
3139702|NCT01733238|3865322|FG000|NOT COMPLETED|Overall Study||5
3139703|NCT01733277|3865328|FG000|STARTED|Overall Study||25
3139704|NCT01733277|3865329|FG001|STARTED|Overall Study||25
3139705|NCT01733277|3865328|FG000|COMPLETED|Overall Study||25
3139706|NCT01733277|3865329|FG001|COMPLETED|Overall Study||25
3139707|NCT01733277|3865328|FG000|NOT COMPLETED|Overall Study||0
3139708|NCT01733277|3865329|FG001|NOT COMPLETED|Overall Study||0
3139709|NCT01733316|3865335|FG000|STARTED|Cystagon® Phase||41
3139710|NCT01733316|3865335|FG000|COMPLETED|Cystagon® Phase||41
3139711|NCT01733316|3865335|FG000|NOT COMPLETED|Cystagon® Phase||0
3139712|NCT01733316|3865335|FG000|STARTED|RP103 Phase||41
3139713|NCT01733316|3865335|FG000|COMPLETED|RP103 Phase||40
3139714|NCT01733316|3865335|FG000|NOT COMPLETED|RP103 Phase||1
3139715|NCT01733316|3865335|FG000|STARTED|Long Term Extension Phase|Two participants did not enter the long term follow up period.|38
3139716|NCT01733316|3865335|FG000|COMPLETED|Long Term Extension Phase||33
3139717|NCT01733316|3865335|FG000|NOT COMPLETED|Long Term Extension Phase||5
3139718|NCT01733329|3865348|FG000|STARTED|Overall Study||62
3139719|NCT01733329|3865349|FG001|STARTED|Overall Study||61
3139720|NCT01733329|3865348|FG000|COMPLETED|Overall Study||60
3139721|NCT01733329|3865349|FG001|COMPLETED|Overall Study||60
3139722|NCT01733329|3865348|FG000|NOT COMPLETED|Overall Study||2
3139723|NCT01733329|3865349|FG001|NOT COMPLETED|Overall Study||1
3139724|NCT01733368|3865355|FG000|STARTED|Overall Study||198
3139725|NCT01733368|3865355|FG000|COMPLETED|Overall Study||167
3139726|NCT01733368|3865355|FG000|NOT COMPLETED|Overall Study||31
3139727|NCT01733407|3865363|FG000|STARTED|Overall Study||9
3139728|NCT01733407|3865364|FG001|STARTED|Overall Study||9
3139729|NCT01733407|3865363|FG000|COMPLETED|Overall Study||7
3139730|NCT01733407|3865364|FG001|COMPLETED|Overall Study||9
3139731|NCT01733407|3865363|FG000|NOT COMPLETED|Overall Study||2
3139732|NCT01733407|3865364|FG001|NOT COMPLETED|Overall Study||0
3139733|NCT01733472|3865372|FG000|STARTED|Overall Study||60
3139734|NCT01733472|3865373|FG001|STARTED|Overall Study||60
3139735|NCT01733472|3865372|FG000|COMPLETED|Overall Study||60
3139736|NCT01733472|3865373|FG001|COMPLETED|Overall Study||60
3139737|NCT01733472|3865372|FG000|NOT COMPLETED|Overall Study||0
3139738|NCT01733472|3865373|FG001|NOT COMPLETED|Overall Study||0
3139739|NCT01733628|3865380|FG000|STARTED|Overall Study||143
3139740|NCT01733628|3865380|FG000|COMPLETED|Overall Study||143
3139741|NCT01733628|3865380|FG000|NOT COMPLETED|Overall Study||0
3139742|NCT01733680|3865386|FG000|STARTED|Overall Study||2
3139743|NCT01733680|3865387|FG001|STARTED|Overall Study||1
3139744|NCT01733680|3865386|FG000|COMPLETED|Overall Study||2
3139745|NCT01733680|3865387|FG001|COMPLETED|Overall Study||0
3139746|NCT01733680|3865386|FG000|NOT COMPLETED|Overall Study||0
3139747|NCT01733680|3865387|FG001|NOT COMPLETED|Overall Study||1
3139748|NCT01733732|3865399|FG000|STARTED|Overall Study||27
3139749|NCT01733732|3865400|FG001|STARTED|Overall Study||27
3139750|NCT01733732|3865399|FG000|COMPLETED|Overall Study||25
3139751|NCT01733732|3865400|FG001|COMPLETED|Overall Study||27
3139752|NCT01733732|3865399|FG000|NOT COMPLETED|Overall Study||2
3139753|NCT01733732|3865400|FG001|NOT COMPLETED|Overall Study||0
3139754|NCT01733745|3865418|FG000|STARTED|Overall Study||13
3139755|NCT01733745|3865419|FG001|STARTED|Overall Study||13
3139756|NCT01733745|3865418|FG000|COMPLETED|Overall Study||13
3139757|NCT01733745|3865419|FG001|COMPLETED|Overall Study||13
3139758|NCT01733745|3865418|FG000|NOT COMPLETED|Overall Study||0
3139759|NCT01733745|3865419|FG001|NOT COMPLETED|Overall Study||0
3139760|NCT01733758|3865429|FG000|STARTED|Overall Study||77
3139761|NCT01733758|3865430|FG001|STARTED|Overall Study||160
3139762|NCT01733758|3865431|FG002|STARTED|Overall Study||150
3139763|NCT01733758|3865432|FG003|STARTED|Overall Study||103
3139764|NCT01733758|3865429|FG000|COMPLETED|Overall Study||62
3139765|NCT01733758|3865430|FG001|COMPLETED|Overall Study||148
3139766|NCT01733758|3865431|FG002|COMPLETED|Overall Study||135
3139767|NCT01733758|3865432|FG003|COMPLETED|Overall Study||95
3139768|NCT01733758|3865429|FG000|NOT COMPLETED|Overall Study||15
3139769|NCT01733758|3865430|FG001|NOT COMPLETED|Overall Study||12
3139770|NCT01733758|3865431|FG002|NOT COMPLETED|Overall Study||15
3139771|NCT01733758|3865432|FG003|NOT COMPLETED|Overall Study||8
3139772|NCT01733953|3865446|FG000|STARTED|Overall Study||14
3139773|NCT01733953|3865447|FG001|STARTED|Overall Study||13
3139774|NCT01733953|3865446|FG000|COMPLETED|Overall Study||9
3139775|NCT01733953|3865447|FG001|COMPLETED|Overall Study||6
3139776|NCT01733953|3865446|FG000|NOT COMPLETED|Overall Study||5
3139777|NCT01733953|3865447|FG001|NOT COMPLETED|Overall Study||7
3139778|NCT01734161|3865455|FG000|STARTED|Overall Study||61
3139779|NCT01734161|3865456|FG001|STARTED|Overall Study||61
3139780|NCT01734161|3865455|FG000|COMPLETED|Overall Study||55
3139781|NCT01734161|3865456|FG001|COMPLETED|Overall Study||53
3139782|NCT01734161|3865455|FG000|NOT COMPLETED|Overall Study||6
3139783|NCT01734161|3865456|FG001|NOT COMPLETED|Overall Study||8
3139784|NCT01734239|3865464|FG000|STARTED|Overall Study||52
3139785|NCT01734239|3865465|FG001|STARTED|Overall Study||50
3139786|NCT01734239|3865464|FG000|COMPLETED|Overall Study||52
3139787|NCT01734239|3865465|FG001|COMPLETED|Overall Study||50
3139788|NCT01734239|3865464|FG000|NOT COMPLETED|Overall Study||0
3139789|NCT01734239|3865465|FG001|NOT COMPLETED|Overall Study||0
3139790|NCT01734317|3865470|FG000|STARTED|Overall Study||10
3139791|NCT01734317|3865470|FG000|COMPLETED|Overall Study||10
3139792|NCT01734317|3865470|FG000|NOT COMPLETED|Overall Study||0
3139793|NCT01734382|3865478|FG000|STARTED|Part 1||19
3139794|NCT01734382|3865479|FG001|STARTED|Part 1||0
3139795|NCT01734382|3865480|FG002|STARTED|Part 1||0
3139796|NCT01734382|3865478|FG000|COMPLETED|Part 1||17
3139797|NCT01734382|3865479|FG001|COMPLETED|Part 1||0
3139798|NCT01734382|3865480|FG002|COMPLETED|Part 1||0
3139799|NCT01734382|3865478|FG000|NOT COMPLETED|Part 1||2
3139800|NCT01734382|3865479|FG001|NOT COMPLETED|Part 1||0
3139801|NCT01734382|3865480|FG002|NOT COMPLETED|Part 1||0
3139802|NCT01734382|3865478|FG000|STARTED|Part 2||0
3139803|NCT01734382|3865479|FG001|STARTED|Part 2||7
3139804|NCT01734382|3865480|FG002|STARTED|Part 2||15
3139805|NCT01734382|3865478|FG000|COMPLETED|Part 2||0
3139806|NCT01734382|3865479|FG001|COMPLETED|Part 2||5
3139807|NCT01734382|3865480|FG002|COMPLETED|Part 2||8
3139808|NCT01734382|3865478|FG000|NOT COMPLETED|Part 2||0
3139809|NCT01734382|3865479|FG001|NOT COMPLETED|Part 2||2
3139810|NCT01734382|3865480|FG002|NOT COMPLETED|Part 2||7
3139811|NCT01734395|3865492|FG000|STARTED|Overall Study||1882
3139812|NCT01734395|3865492|FG000|COMPLETED|Overall Study||1472
3139813|NCT01734395|3865492|FG000|NOT COMPLETED|Overall Study||410
3139814|NCT01734434|3865500|FG000|STARTED|Overall Study||500
3139815|NCT01734434|3865501|FG001|STARTED|Overall Study||500
3139816|NCT01734434|3865502|FG002|STARTED|Overall Study||1992
3139817|NCT01734434|3865503|FG003|STARTED|Overall Study||251
3139818|NCT01734434|3865500|FG000|COMPLETED|Overall Study||490
3139819|NCT01734434|3865501|FG001|COMPLETED|Overall Study||488
3139820|NCT01734434|3865502|FG002|COMPLETED|Overall Study||1863
3139821|NCT01734434|3865503|FG003|COMPLETED|Overall Study||228
3139822|NCT01734434|3865500|FG000|NOT COMPLETED|Overall Study||10
3139823|NCT01734434|3865501|FG001|NOT COMPLETED|Overall Study||12
3363516|NCT04067050|4094627|FG001|NOT COMPLETED|Two Month||0
3363517|NCT04066647|4094633|FG000|STARTED|Overall Study||7
3363518|NCT04066647|4094633|FG000|COMPLETED|Overall Study||7
3363519|NCT04066647|4094633|FG000|NOT COMPLETED|Overall Study||0
3363520|NCT04066426|4094641|FG000|STARTED|Overall Study||50
3363521|NCT04066426|4094642|FG001|STARTED|Overall Study||50
3363522|NCT04066426|4094643|FG002|STARTED|Overall Study||50
3363523|NCT04066426|4094644|FG003|STARTED|Overall Study||50
3363524|NCT04066426|4094641|FG000|COMPLETED|Overall Study||40
3363525|NCT04066426|4094642|FG001|COMPLETED|Overall Study||40
3363526|NCT04066426|4094643|FG002|COMPLETED|Overall Study||42
3363527|NCT04066426|4094644|FG003|COMPLETED|Overall Study||47
3139824|NCT01734434|3865502|FG002|NOT COMPLETED|Overall Study||129
3139825|NCT01734434|3865503|FG003|NOT COMPLETED|Overall Study||23
3139826|NCT01734512|3865521|FG000|STARTED|Overall Study||65
3139827|NCT01734512|3865521|FG000|COMPLETED|Overall Study||65
3139828|NCT01734512|3865521|FG000|NOT COMPLETED|Overall Study||0
3139829|NCT01734525|3865525|FG000|STARTED|Overall Study||85
3139830|NCT01734525|3865525|FG000|COMPLETED|Overall Study||85
3139831|NCT01734525|3865525|FG000|NOT COMPLETED|Overall Study||0
3139832|NCT01734551|3865531|FG000|STARTED|Overall Study||15
3139833|NCT01734551|3865532|FG001|STARTED|Overall Study||16
3139834|NCT01734551|3865531|FG000|COMPLETED|Overall Study||15
3139835|NCT01734551|3865532|FG001|COMPLETED|Overall Study||16
3139836|NCT01734551|3865531|FG000|NOT COMPLETED|Overall Study||0
3139837|NCT01734551|3865532|FG001|NOT COMPLETED|Overall Study||0
3139838|NCT01734655|3865538|FG000|STARTED|Overall Study||40
3139839|NCT01734655|3865538|FG000|COMPLETED|Overall Study||40
3139840|NCT01734655|3865538|FG000|NOT COMPLETED|Overall Study||0
3139841|NCT01734746|3865545|FG000|STARTED|Overall Study||22
3139842|NCT01734746|3865545|FG000|COMPLETED|Overall Study||21
3139843|NCT01734746|3865545|FG000|NOT COMPLETED|Overall Study||1
3139844|NCT01734772|3865552|FG000|STARTED|Overall Study||24
3139845|NCT01734772|3865553|FG001|STARTED|Overall Study||24
3139846|NCT01734772|3865552|FG000|COMPLETED|Overall Study||23
3139847|NCT01734772|3865553|FG001|COMPLETED|Overall Study||21
3139848|NCT01734772|3865552|FG000|NOT COMPLETED|Overall Study||1
3139849|NCT01734772|3865553|FG001|NOT COMPLETED|Overall Study||3
3139850|NCT01734785|3865568|FG000|STARTED|Open-Label Period||0
3139851|NCT01734785|3865569|FG001|STARTED|Open-Label Period||0
3139852|NCT01734785|3865570|FG002|STARTED|Open-Label Period||0
3139853|NCT01734785|3865571|FG003|STARTED|Open-Label Period||606
3139854|NCT01734785|3865568|FG000|COMPLETED|Open-Label Period||0
3139855|NCT01734785|3865569|FG001|COMPLETED|Open-Label Period||0
3139856|NCT01734785|3865570|FG002|COMPLETED|Open-Label Period||0
3139857|NCT01734785|3865571|FG003|COMPLETED|Open-Label Period||333
3139858|NCT01734785|3865568|FG000|NOT COMPLETED|Open-Label Period||0
3139859|NCT01734785|3865569|FG001|NOT COMPLETED|Open-Label Period||0
3139860|NCT01734785|3865570|FG002|NOT COMPLETED|Open-Label Period||0
3139861|NCT01734785|3865571|FG003|NOT COMPLETED|Open-Label Period||273
3139862|NCT01734785|3865568|FG000|STARTED|Double-Blind Period||111
3139863|NCT01734785|3865569|FG001|STARTED|Double-Blind Period||112
3139864|NCT01734785|3865570|FG002|STARTED|Double-Blind Period||110
3139865|NCT01734785|3865571|FG003|STARTED|Double-Blind Period||0
3363528|NCT04066426|4094641|FG000|NOT COMPLETED|Overall Study||10
3363529|NCT04066426|4094642|FG001|NOT COMPLETED|Overall Study||10
3139866|NCT01734785|3865568|FG000|COMPLETED|Double-Blind Period||106
3139867|NCT01734785|3865569|FG001|COMPLETED|Double-Blind Period||103
3139868|NCT01734785|3865570|FG002|COMPLETED|Double-Blind Period||105
3139869|NCT01734785|3865571|FG003|COMPLETED|Double-Blind Period||0
3139870|NCT01734785|3865568|FG000|NOT COMPLETED|Double-Blind Period||5
3139871|NCT01734785|3865569|FG001|NOT COMPLETED|Double-Blind Period||9
3139872|NCT01734785|3865570|FG002|NOT COMPLETED|Double-Blind Period||5
3139873|NCT01734785|3865571|FG003|NOT COMPLETED|Double-Blind Period||0
3139874|NCT01734811|3865582|FG000|STARTED|Overall Study||58
3139875|NCT01734811|3865583|FG001|STARTED|Overall Study||62
3139876|NCT01734811|3865582|FG000|COMPLETED|Overall Study||54
3139877|NCT01734811|3865583|FG001|COMPLETED|Overall Study||59
3139878|NCT01734811|3865582|FG000|NOT COMPLETED|Overall Study||4
3139879|NCT01734811|3865583|FG001|NOT COMPLETED|Overall Study||3
3139880|NCT01734850|3865592|FG000|STARTED|Overall Study||4
3139881|NCT01734850|3865593|FG001|STARTED|Overall Study||4
3139882|NCT01734850|3865594|FG002|STARTED|Overall Study||5
3139883|NCT01734850|3865592|FG000|COMPLETED|Overall Study||1
3139884|NCT01734850|3865593|FG001|COMPLETED|Overall Study||2
3139885|NCT01734850|3865594|FG002|COMPLETED|Overall Study||1
3139886|NCT01734850|3865592|FG000|NOT COMPLETED|Overall Study||3
3139887|NCT01734850|3865593|FG001|NOT COMPLETED|Overall Study||2
3139888|NCT01734850|3865594|FG002|NOT COMPLETED|Overall Study||4
3139889|NCT01734889|3865605|FG000|STARTED|Overall Study||18
3139890|NCT01734889|3865605|FG000|COMPLETED|Overall Study||18
3139891|NCT01734889|3865605|FG000|NOT COMPLETED|Overall Study||0
3139892|NCT01734902|3865612|FG000|STARTED|Overall Study||14
3139893|NCT01734902|3865613|FG001|STARTED|Overall Study||16
3139894|NCT01734902|3865612|FG000|COMPLETED|Overall Study||14
3139895|NCT01734902|3865613|FG001|COMPLETED|Overall Study||14
3139896|NCT01734902|3865612|FG000|NOT COMPLETED|Overall Study||0
3139897|NCT01734902|3865613|FG001|NOT COMPLETED|Overall Study||2
3139898|NCT01734993|3865619|FG000|STARTED|Overall Study||11
3139899|NCT01734993|3865619|FG000|COMPLETED|Overall Study||9
3139900|NCT01734993|3865619|FG000|NOT COMPLETED|Overall Study||2
3139901|NCT01735175|3865626|FG000|STARTED|Overall Study||159
3139902|NCT01735175|3865627|FG001|STARTED|Overall Study||157
3139903|NCT01735175|3865626|FG000|Completed All Cycles|Overall Study||141
3139904|NCT01735175|3865627|FG001|Completed All Cycles|Overall Study||150
3139905|NCT01735175|3865626|FG000|Completed All Treatments as Planned|Overall Study||140
3139906|NCT01735175|3865627|FG001|Completed All Treatments as Planned|Overall Study||150
3139907|NCT01735175|3865626|FG000|Completed the 6-month SFU Visit|Overall Study||120
3139908|NCT01735175|3865627|FG001|Completed the 6-month SFU Visit|Overall Study||138
3139909|NCT01735175|3865626|FG000|COMPLETED|Overall Study||130
3139910|NCT01735175|3865627|FG001|COMPLETED|Overall Study||144
3139911|NCT01735175|3865626|FG000|NOT COMPLETED|Overall Study||29
3139912|NCT01735175|3865627|FG001|NOT COMPLETED|Overall Study||13
3139913|NCT01735201|3865641|FG000|STARTED|Overall Study||45
3139914|NCT01735201|3865642|FG001|STARTED|Overall Study||44
3139915|NCT01735201|3865643|FG002|STARTED|Overall Study||44
3139916|NCT01735201|3865644|FG003|STARTED|Overall Study||44
3139917|NCT01735201|3865645|FG004|STARTED|Overall Study||45
3139918|NCT01735201|3865646|FG005|STARTED|Overall Study||45
3139919|NCT01735201|3865647|FG006|STARTED|Overall Study||45
3139920|NCT01735201|3865648|FG007|STARTED|Overall Study||44
3139921|NCT01735201|3865641|FG000|COMPLETED|Overall Study||42
3139922|NCT01735201|3865642|FG001|COMPLETED|Overall Study||43
3139923|NCT01735201|3865643|FG002|COMPLETED|Overall Study||44
3139924|NCT01735201|3865644|FG003|COMPLETED|Overall Study||42
3139925|NCT01735201|3865645|FG004|COMPLETED|Overall Study||44
3139926|NCT01735201|3865646|FG005|COMPLETED|Overall Study||40
3139927|NCT01735201|3865647|FG006|COMPLETED|Overall Study||42
3139928|NCT01735201|3865648|FG007|COMPLETED|Overall Study||42
3139929|NCT01735201|3865641|FG000|NOT COMPLETED|Overall Study||3
3139930|NCT01735201|3865642|FG001|NOT COMPLETED|Overall Study||1
3139931|NCT01735201|3865643|FG002|NOT COMPLETED|Overall Study||0
3139932|NCT01735201|3865644|FG003|NOT COMPLETED|Overall Study||2
3139933|NCT01735201|3865645|FG004|NOT COMPLETED|Overall Study||1
3139934|NCT01735201|3865646|FG005|NOT COMPLETED|Overall Study||5
3139935|NCT01735201|3865647|FG006|NOT COMPLETED|Overall Study||3
3139936|NCT01735201|3865648|FG007|NOT COMPLETED|Overall Study||2
3139937|NCT01735214|3865666|FG000|STARTED|Overall Study||358
3139938|NCT01735214|3865666|FG000|COMPLETED|Overall Study||358
3139939|NCT01735214|3865666|FG000|NOT COMPLETED|Overall Study||0
3139940|NCT01735279|3865672|FG000|STARTED|Overall Study||29
3139941|NCT01735279|3865673|FG001|STARTED|Overall Study||29
3139942|NCT01735279|3865672|FG000|COMPLETED|Overall Study||18
3139943|NCT01735279|3865673|FG001|COMPLETED|Overall Study||21
3139944|NCT01735279|3865672|FG000|NOT COMPLETED|Overall Study||11
3139945|NCT01735279|3865673|FG001|NOT COMPLETED|Overall Study||8
3139946|NCT01735396|3865679|FG000|STARTED|Overall Study||11
3139947|NCT01735396|3865679|FG000|COMPLETED|Overall Study||10
3139948|NCT01735396|3865679|FG000|NOT COMPLETED|Overall Study||1
3139949|NCT01735617|3865683|FG000|STARTED|Overall Study||16
3139950|NCT01735617|3865683|FG000|COMPLETED|Overall Study||16
3139951|NCT01735617|3865683|FG000|NOT COMPLETED|Overall Study||0
3139952|NCT01735630|3865692|FG000|STARTED|Overall Study||175
3139953|NCT01735630|3865693|FG001|STARTED|Overall Study||175
3139954|NCT01735630|3865692|FG000|COMPLETED|Overall Study||157
3139955|NCT01735630|3865693|FG001|COMPLETED|Overall Study||157
3139956|NCT01735630|3865692|FG000|NOT COMPLETED|Overall Study||18
3139957|NCT01735630|3865693|FG001|NOT COMPLETED|Overall Study||18
3139958|NCT01735877|3865701|FG000|STARTED|Overall Study||27
3139959|NCT01735877|3865702|FG001|STARTED|Overall Study||21
3139960|NCT01735877|3865701|FG000|COMPLETED|Overall Study||26
3139961|NCT01735877|3865702|FG001|COMPLETED|Overall Study||21
3139962|NCT01735877|3865701|FG000|NOT COMPLETED|Overall Study||1
3139963|NCT01735877|3865702|FG001|NOT COMPLETED|Overall Study||0
3139964|NCT01735916|3865711|FG000|STARTED|Overall Study||18
3139965|NCT01735916|3865712|FG001|STARTED|Overall Study||19
3139966|NCT01735916|3865713|FG002|STARTED|Overall Study||7
3139967|NCT01735916|3865711|FG000|COMPLETED|Overall Study||0
3139968|NCT01735916|3865712|FG001|COMPLETED|Overall Study|Study was cancelled before any subjects completed 24 months of follow-up or met any study endpoints.|0
3139969|NCT01735916|3865713|FG002|COMPLETED|Overall Study|Study was cancelled before any subjects completed 24 months of follow-up or met any study endpoints.|0
3139970|NCT01735916|3865711|FG000|NOT COMPLETED|Overall Study||18
3139971|NCT01735916|3865712|FG001|NOT COMPLETED|Overall Study||19
3139972|NCT01735916|3865713|FG002|NOT COMPLETED|Overall Study||7
3139973|NCT01735981|3865722|FG000|STARTED|Allocated||13
3139974|NCT01735981|3865723|FG001|STARTED|Allocated||11
3139975|NCT01735981|3865722|FG000|COMPLETED|Allocated||11
3139976|NCT01735981|3865723|FG001|COMPLETED|Allocated||8
3139977|NCT01735981|3865722|FG000|NOT COMPLETED|Allocated||2
3139978|NCT01735981|3865723|FG001|NOT COMPLETED|Allocated||3
3139979|NCT01735981|3865722|FG000|STARTED|Crossed Over||11
3139980|NCT01735981|3865723|FG001|STARTED|Crossed Over|N=1 lost to cross over before DDR intervention|7
3139981|NCT01735981|3865722|FG000|COMPLETED|Crossed Over||11
3139982|NCT01735981|3865723|FG001|COMPLETED|Crossed Over||7
3139983|NCT01735981|3865722|FG000|NOT COMPLETED|Crossed Over||0
3139984|NCT01735981|3865723|FG001|NOT COMPLETED|Crossed Over||0
3139985|NCT01735994|3865733|FG000|STARTED|Overall Study||263
3139986|NCT01735994|3865734|FG001|STARTED|Overall Study||218
3139987|NCT01735994|3865733|FG000|Post Intervention (3 Weeks)|Overall Study||239
3139988|NCT01735994|3865734|FG001|Post Intervention (3 Weeks)|Overall Study||198
3139989|NCT01735994|3865733|FG000|Follow-Up #1 (6 Months)|Overall Study||213
3139990|NCT01735994|3865734|FG001|Follow-Up #1 (6 Months)|Overall Study||163
3139991|NCT01735994|3865733|FG000|Follow-Up #2 (12 Months)|Overall Study||212
3139992|NCT01735994|3865734|FG001|Follow-Up #2 (12 Months)|Overall Study||174
3139993|NCT01735994|3865733|FG000|COMPLETED|Overall Study||200
3139994|NCT01735994|3865734|FG001|COMPLETED|Overall Study||152
3139995|NCT01735994|3865733|FG000|NOT COMPLETED|Overall Study||63
3139996|NCT01735994|3865734|FG001|NOT COMPLETED|Overall Study||66
3139997|NCT01736085|3865746|FG000|STARTED|Overall Study||529
3139998|NCT01736085|3865747|FG001|STARTED|Overall Study||530
3139999|NCT01736085|3865748|FG002|STARTED|Overall Study||793
3140000|NCT01736085|3865749|FG003|STARTED|Overall Study||530
3140001|NCT01736085|3865750|FG004|STARTED|Overall Study||530
3140002|NCT01736085|3865751|FG005|STARTED|Overall Study||794
3140003|NCT01736085|3865746|FG000|COMPLETED|Overall Study||529
3140004|NCT01736085|3865747|FG001|COMPLETED|Overall Study||530
3140005|NCT01736085|3865748|FG002|COMPLETED|Overall Study||793
3140006|NCT01736085|3865749|FG003|COMPLETED|Overall Study||530
3140007|NCT01736085|3865750|FG004|COMPLETED|Overall Study||530
3140008|NCT01736085|3865751|FG005|COMPLETED|Overall Study||794
3140009|NCT01736085|3865746|FG000|NOT COMPLETED|Overall Study||0
3140010|NCT01736085|3865747|FG001|NOT COMPLETED|Overall Study||0
3140011|NCT01736085|3865748|FG002|NOT COMPLETED|Overall Study||0
3140012|NCT01736085|3865749|FG003|NOT COMPLETED|Overall Study||0
3140013|NCT01736085|3865750|FG004|NOT COMPLETED|Overall Study||0
3140014|NCT01736085|3865751|FG005|NOT COMPLETED|Overall Study||0
3140015|NCT01736124|3865764|FG000|STARTED|Baseline||90
3140016|NCT01736124|3865765|FG001|STARTED|Baseline||90
3140017|NCT01736124|3865764|FG000|COMPLETED|Baseline||90
3140018|NCT01736124|3865765|FG001|COMPLETED|Baseline||90
3140019|NCT01736124|3865764|FG000|NOT COMPLETED|Baseline||0
3140020|NCT01736124|3865765|FG001|NOT COMPLETED|Baseline||0
3140021|NCT01736124|3865764|FG000|STARTED|Post-intervention Assessment||90
3140022|NCT01736124|3865765|FG001|STARTED|Post-intervention Assessment||90
3140023|NCT01736124|3865764|FG000|COMPLETED|Post-intervention Assessment||59
3140024|NCT01736124|3865765|FG001|COMPLETED|Post-intervention Assessment||69
3140025|NCT01736124|3865764|FG000|NOT COMPLETED|Post-intervention Assessment||31
3140026|NCT01736124|3865765|FG001|NOT COMPLETED|Post-intervention Assessment||21
3140027|NCT01736124|3865764|FG000|STARTED|6 Mo. Post-Intervention Assessment|"Includes 3 who were temporarily away at Period 2 who did not permanently withdraw from the study."|62
3140028|NCT01736124|3865765|FG001|STARTED|6 Mo. Post-Intervention Assessment|"Includes 1 who was temporarily away at Period 2 but did not permanently withdraw."|70
3140029|NCT01736124|3865764|FG000|COMPLETED|6 Mo. Post-Intervention Assessment||57
3140030|NCT01736124|3865765|FG001|COMPLETED|6 Mo. Post-Intervention Assessment||58
3140031|NCT01736124|3865764|FG000|NOT COMPLETED|6 Mo. Post-Intervention Assessment||5
3140032|NCT01736124|3865765|FG001|NOT COMPLETED|6 Mo. Post-Intervention Assessment||12
3140033|NCT01736124|3865764|FG000|STARTED|12 Mo. Post-Intervention Assessment|"Includes 1 who was temporarily away at Period 3 but did not permanently withdraw."|58
3140034|NCT01736124|3865765|FG001|STARTED|12 Mo. Post-Intervention Assessment|"Includes 4 who were temporarily away at Period 3 but did not permanently withdraw."|62
3140035|NCT01736124|3865764|FG000|COMPLETED|12 Mo. Post-Intervention Assessment||46
3140036|NCT01736124|3865765|FG001|COMPLETED|12 Mo. Post-Intervention Assessment||50
3140037|NCT01736124|3865764|FG000|NOT COMPLETED|12 Mo. Post-Intervention Assessment||12
3140038|NCT01736124|3865765|FG001|NOT COMPLETED|12 Mo. Post-Intervention Assessment||12
3180614|NCT01992172|3909040|FG000|NOT COMPLETED|Overall Study||0
3140039|NCT01736176|3865773|FG000|STARTED|Overall Study|Enrolled participants who underwent the PEG-J placement procedure|39
3140040|NCT01736176|3865773|FG000|Received LCIG|Overall Study||38
3140041|NCT01736176|3865773|FG000|COMPLETED|Overall Study||28
3140042|NCT01736176|3865773|FG000|NOT COMPLETED|Overall Study||11
3140043|NCT01736189|3865781|FG000|STARTED|Overall Study||346
3140044|NCT01736189|3865781|FG000|COMPLETED|Overall Study||300
3140045|NCT01736189|3865781|FG000|NOT COMPLETED|Overall Study||46
3140046|NCT01736215|3865785|FG000|STARTED|Overall Study||33
3140047|NCT01736215|3865785|FG000|Treated|Overall Study||25
3140048|NCT01736215|3865785|FG000|COMPLETED|Overall Study||19
3140049|NCT01736215|3865785|FG000|NOT COMPLETED|Overall Study||14
3140050|NCT01736241|3865796|FG000|STARTED|Overall Study||6
3140051|NCT01736241|3865797|FG001|STARTED|Overall Study||6
3140052|NCT01736241|3865798|FG002|STARTED|Overall Study||6
3140053|NCT01736241|3865799|FG003|STARTED|Overall Study||5
3140054|NCT01736241|3865800|FG004|STARTED|Overall Study||6
3140055|NCT01736241|3865801|FG005|STARTED|Overall Study||6
3140056|NCT01736241|3865802|FG006|STARTED|Overall Study||6
3140057|NCT01736241|3865796|FG000|Received at Least One Dose of Study Drug|Overall Study||6
3140058|NCT01736241|3865797|FG001|Received at Least One Dose of Study Drug|Overall Study||6
3140059|NCT01736241|3865798|FG002|Received at Least One Dose of Study Drug|Overall Study||6
3140060|NCT01736241|3865799|FG003|Received at Least One Dose of Study Drug|Overall Study||5
3140061|NCT01736241|3865800|FG004|Received at Least One Dose of Study Drug|Overall Study||6
3140062|NCT01736241|3865801|FG005|Received at Least One Dose of Study Drug|Overall Study||6
3140063|NCT01736241|3865802|FG006|Received at Least One Dose of Study Drug|Overall Study||6
3140064|NCT01736241|3865796|FG000|COMPLETED|Overall Study||6
3140065|NCT01736241|3865797|FG001|COMPLETED|Overall Study||6
3140066|NCT01736241|3865798|FG002|COMPLETED|Overall Study||6
3140067|NCT01736241|3865799|FG003|COMPLETED|Overall Study||5
3140068|NCT01736241|3865800|FG004|COMPLETED|Overall Study||6
3140069|NCT01736241|3865801|FG005|COMPLETED|Overall Study||6
3140070|NCT01736241|3865802|FG006|COMPLETED|Overall Study||6
3140071|NCT01736241|3865796|FG000|NOT COMPLETED|Overall Study||0
3140072|NCT01736241|3865797|FG001|NOT COMPLETED|Overall Study||0
3140073|NCT01736241|3865798|FG002|NOT COMPLETED|Overall Study||0
3140074|NCT01736241|3865799|FG003|NOT COMPLETED|Overall Study||0
3140075|NCT01736241|3865800|FG004|NOT COMPLETED|Overall Study||0
3140076|NCT01736241|3865801|FG005|NOT COMPLETED|Overall Study||0
3140077|NCT01736241|3865802|FG006|NOT COMPLETED|Overall Study||0
3140078|NCT01736254|3865819|FG000|STARTED|Period 1 (Day 1)||24
3140079|NCT01736254|3865819|FG000|Received at Least One Dose of Study Drug|Period 1 (Day 1)||24
3140080|NCT01736254|3865819|FG000|COMPLETED|Period 1 (Day 1)||24
3140081|NCT01736254|3865819|FG000|NOT COMPLETED|Period 1 (Day 1)||0
3140082|NCT01736254|3865819|FG000|STARTED|Period 2 (Days 2 to 12)||24
3140083|NCT01736254|3865819|FG000|COMPLETED|Period 2 (Days 2 to 12)||21
3140084|NCT01736254|3865819|FG000|NOT COMPLETED|Period 2 (Days 2 to 12)||3
3140085|NCT01736254|3865819|FG000|STARTED|Period 3 (Days 13 to 23)||21
3140086|NCT01736254|3865819|FG000|COMPLETED|Period 3 (Days 13 to 23)||20
3140087|NCT01736254|3865819|FG000|NOT COMPLETED|Period 3 (Days 13 to 23)||1
3180615|NCT01992172|3909041|FG001|NOT COMPLETED|Overall Study||0
3180616|NCT01992185|3909049|FG000|STARTED|Overall Study||7
3180617|NCT01992185|3909050|FG001|STARTED|Overall Study||8
3180618|NCT01992185|3909049|FG000|COMPLETED|Overall Study||7
3180619|NCT01992185|3909050|FG001|COMPLETED|Overall Study||8
3180620|NCT01992185|3909049|FG000|NOT COMPLETED|Overall Study||0
3180621|NCT01992185|3909050|FG001|NOT COMPLETED|Overall Study||0
3180622|NCT01992354|3909056|FG000|STARTED|Overall Study||4
3180623|NCT01992354|3909056|FG000|COMPLETED|Overall Study||4
3180624|NCT01992354|3909056|FG000|NOT COMPLETED|Overall Study||0
3180625|NCT01992380|3909064|FG000|STARTED|Overall Study||6
3180626|NCT01992380|3909065|FG001|STARTED|Overall Study||8
3180627|NCT01992380|3909066|FG002|STARTED|Overall Study||10
3180628|NCT01992380|3909064|FG000|COMPLETED|Overall Study||6
3180629|NCT01992380|3909065|FG001|COMPLETED|Overall Study||8
3180630|NCT01992380|3909066|FG002|COMPLETED|Overall Study||10
3180631|NCT01992380|3909064|FG000|NOT COMPLETED|Overall Study||0
3180632|NCT01992380|3909065|FG001|NOT COMPLETED|Overall Study||0
3180633|NCT01992380|3909066|FG002|NOT COMPLETED|Overall Study||0
3180634|NCT01992523|3909074|FG000|STARTED|Overall Study||41
3180635|NCT01992523|3909075|FG001|STARTED|Overall Study||41
3180636|NCT01992523|3909074|FG000|COMPLETED|Overall Study||41
3180637|NCT01992523|3909075|FG001|COMPLETED|Overall Study||41
3180638|NCT01992523|3909074|FG000|NOT COMPLETED|Overall Study||0
3180639|NCT01992523|3909075|FG001|NOT COMPLETED|Overall Study||0
3180640|NCT01992536|3909093|FG000|STARTED|Overall Study||26
3180641|NCT01992536|3909094|FG001|STARTED|Overall Study||25
3180642|NCT01992536|3909095|FG002|STARTED|Overall Study||17
3180643|NCT01992536|3909096|FG003|STARTED|Overall Study||24
3180644|NCT01992536|3909097|FG004|STARTED|Overall Study||11
3180645|NCT01992536|3909098|FG005|STARTED|Overall Study||21
3180646|NCT01992536|3909099|FG006|STARTED|Overall Study||7
3180647|NCT01992536|3909100|FG007|STARTED|Overall Study||21
3180648|NCT01992536|3909101|FG008|STARTED|Overall Study||19
3180649|NCT01992536|3909102|FG009|STARTED|Overall Study||19
3180650|NCT01992536|3909093|FG000|COMPLETED|Overall Study||22
3180651|NCT01992536|3909094|FG001|COMPLETED|Overall Study||22
3180652|NCT01992536|3909095|FG002|COMPLETED|Overall Study||16
3180653|NCT01992536|3909096|FG003|COMPLETED|Overall Study||22
3180654|NCT01992536|3909097|FG004|COMPLETED|Overall Study||11
3180655|NCT01992536|3909098|FG005|COMPLETED|Overall Study||20
3140088|NCT01736267|3865827|FG000|STARTED|Overall Study||3
3140089|NCT01736267|3865827|FG000|COMPLETED|Overall Study||3
3140090|NCT01736267|3865827|FG000|NOT COMPLETED|Overall Study||0
3140091|NCT01736358|3865833|FG000|STARTED|Overall Study||25
3140092|NCT01736358|3865834|FG001|STARTED|Overall Study||25
3140093|NCT01736358|3865833|FG000|COMPLETED|Overall Study||20
3140094|NCT01736358|3865834|FG001|COMPLETED|Overall Study||23
3140095|NCT01736358|3865833|FG000|NOT COMPLETED|Overall Study||5
3140096|NCT01736358|3865834|FG001|NOT COMPLETED|Overall Study||2
3140097|NCT01736397|3865842|FG000|STARTED|Overall Study||75
3140098|NCT01736397|3865843|FG001|STARTED|Overall Study||74
3140099|NCT01736397|3865842|FG000|COMPLETED|Overall Study||61
3140100|NCT01736397|3865843|FG001|COMPLETED|Overall Study||50
3140101|NCT01736397|3865842|FG000|NOT COMPLETED|Overall Study||14
3140102|NCT01736397|3865843|FG001|NOT COMPLETED|Overall Study||24
3140103|NCT01736475|3865851|FG000|STARTED|Overall Study||121
3140104|NCT01736475|3865852|FG001|STARTED|Overall Study||17
3140105|NCT01736475|3865851|FG000|COMPLETED|Overall Study||109
3140106|NCT01736475|3865852|FG001|COMPLETED|Overall Study||17
3140107|NCT01736475|3865851|FG000|NOT COMPLETED|Overall Study||12
3140108|NCT01736475|3865852|FG001|NOT COMPLETED|Overall Study||0
3140109|NCT01736527|3865869|FG000|STARTED|Overall Study||12
3140110|NCT01736527|3865869|FG000|COMPLETED|Overall Study||12
3140111|NCT01736527|3865869|FG000|NOT COMPLETED|Overall Study||0
3140112|NCT01736540|3865873|FG000|STARTED|Overall Study||243
3140113|NCT01736540|3865873|FG000|COMPLETED|Overall Study||228
3140114|NCT01736540|3865873|FG000|NOT COMPLETED|Overall Study||15
3140115|NCT01736553|3865886|FG000|STARTED|Overall Study||26
3140116|NCT01736553|3865887|FG001|STARTED|Overall Study||27
3140117|NCT01736553|3865886|FG000|COMPLETED|Overall Study||7
3140118|NCT01736553|3865887|FG001|COMPLETED|Overall Study||23
3140119|NCT01736553|3865886|FG000|NOT COMPLETED|Overall Study||19
3140120|NCT01736553|3865887|FG001|NOT COMPLETED|Overall Study||4
3140121|NCT01736566|3865916|FG000|STARTED|Main Study||51
3140122|NCT01736566|3865917|FG001|STARTED|Main Study||50
3140123|NCT01736566|3865918|FG002|STARTED|Main Study||50
3140124|NCT01736566|3865919|FG003|STARTED|Main Study||52
3140125|NCT01736566|3865920|FG004|STARTED|Main Study||10
3140126|NCT01736566|3865916|FG000|COMPLETED|Main Study||50
3140127|NCT01736566|3865917|FG001|COMPLETED|Main Study||50
3140128|NCT01736566|3865918|FG002|COMPLETED|Main Study||49
3140129|NCT01736566|3865919|FG003|COMPLETED|Main Study||51
3140130|NCT01736566|3865920|FG004|COMPLETED|Main Study||6
3140131|NCT01736566|3865916|FG000|NOT COMPLETED|Main Study||1
3140132|NCT01736566|3865917|FG001|NOT COMPLETED|Main Study||0
3140133|NCT01736566|3865918|FG002|NOT COMPLETED|Main Study||1
3140134|NCT01736566|3865919|FG003|NOT COMPLETED|Main Study||1
3140135|NCT01736566|3865920|FG004|NOT COMPLETED|Main Study||4
3140136|NCT01736566|3865916|FG000|STARTED|Long Term Follow-up||42
3140137|NCT01736566|3865917|FG001|STARTED|Long Term Follow-up||0
3140138|NCT01736566|3865918|FG002|STARTED|Long Term Follow-up||49
3140139|NCT01736566|3865919|FG003|STARTED|Long Term Follow-up||0
3140140|NCT01736566|3865920|FG004|STARTED|Long Term Follow-up||1
3140141|NCT01736566|3865916|FG000|COMPLETED|Long Term Follow-up||0
3140142|NCT01736566|3865917|FG001|COMPLETED|Long Term Follow-up||0
3140143|NCT01736566|3865918|FG002|COMPLETED|Long Term Follow-up||0
3140144|NCT01736566|3865919|FG003|COMPLETED|Long Term Follow-up||0
3140145|NCT01736566|3865920|FG004|COMPLETED|Long Term Follow-up||0
3140146|NCT01736566|3865916|FG000|NOT COMPLETED|Long Term Follow-up||42
3140147|NCT01736566|3865917|FG001|NOT COMPLETED|Long Term Follow-up||0
3140148|NCT01736566|3865918|FG002|NOT COMPLETED|Long Term Follow-up||49
3140149|NCT01736566|3865919|FG003|NOT COMPLETED|Long Term Follow-up||0
3140150|NCT01736566|3865920|FG004|NOT COMPLETED|Long Term Follow-up||1
3140151|NCT01736579|3865947|FG000|STARTED|Overall Study||2
3140152|NCT01736579|3865948|FG001|STARTED|Overall Study||2
3140153|NCT01736579|3865947|FG000|COMPLETED|Overall Study||0
3140154|NCT01736579|3865948|FG001|COMPLETED|Overall Study||0
3140155|NCT01736579|3865947|FG000|NOT COMPLETED|Overall Study||2
3140156|NCT01736579|3865948|FG001|NOT COMPLETED|Overall Study||2
3140157|NCT01736657|3865954|FG000|STARTED|Overall Study||73
3140158|NCT01736657|3865954|FG000|COMPLETED|Overall Study||72
3140159|NCT01736657|3865954|FG000|NOT COMPLETED|Overall Study||1
3140160|NCT01736683|3865963|FG000|STARTED|Overall Study||7
3140161|NCT01736683|3865964|FG001|STARTED|Overall Study||6
3140162|NCT01736683|3865965|FG002|STARTED|Overall Study||21
3140163|NCT01736683|3865966|FG003|STARTED|Overall Study||35
3140164|NCT01736683|3865967|FG004|STARTED|Overall Study||5
3140165|NCT01736683|3865963|FG000|COMPLETED|Overall Study|# who completed treatment|0
3140166|NCT01736683|3865964|FG001|COMPLETED|Overall Study|# who completed treatment|0
3140167|NCT01736683|3865965|FG002|COMPLETED|Overall Study|# who completed treatment|0
3140168|NCT01736683|3865966|FG003|COMPLETED|Overall Study|# who completed treatment|0
3140169|NCT01736683|3865967|FG004|COMPLETED|Overall Study|# who completed treatment|0
3140170|NCT01736683|3865963|FG000|NOT COMPLETED|Overall Study||7
3140171|NCT01736683|3865964|FG001|NOT COMPLETED|Overall Study||6
3140172|NCT01736683|3865965|FG002|NOT COMPLETED|Overall Study||21
3140173|NCT01736683|3865966|FG003|NOT COMPLETED|Overall Study||35
3140174|NCT01736683|3865967|FG004|NOT COMPLETED|Overall Study||5
3140175|NCT01736696|3865988|FG000|STARTED|Overall Study||5
3140176|NCT01736696|3865989|FG001|STARTED|Overall Study||5
3140177|NCT01736696|3865990|FG002|STARTED|Overall Study||10
3140178|NCT01736696|3865991|FG003|STARTED|Overall Study||9
3140179|NCT01736696|3865992|FG004|STARTED|Overall Study||9
3140180|NCT01736696|3865993|FG005|STARTED|Overall Study||8
3140181|NCT01736696|3865994|FG006|STARTED|Overall Study||13
3140182|NCT01736696|3865988|FG000|COMPLETED|Overall Study||5
3140183|NCT01736696|3865989|FG001|COMPLETED|Overall Study||5
3140184|NCT01736696|3865990|FG002|COMPLETED|Overall Study||9
3140185|NCT01736696|3865991|FG003|COMPLETED|Overall Study||9
3140186|NCT01736696|3865992|FG004|COMPLETED|Overall Study||9
3140187|NCT01736696|3865993|FG005|COMPLETED|Overall Study||8
3140188|NCT01736696|3865994|FG006|COMPLETED|Overall Study||13
3140189|NCT01736696|3865988|FG000|NOT COMPLETED|Overall Study||0
3140190|NCT01736696|3865989|FG001|NOT COMPLETED|Overall Study||0
3140191|NCT01736696|3865990|FG002|NOT COMPLETED|Overall Study||1
3140192|NCT01736696|3865991|FG003|NOT COMPLETED|Overall Study||0
3140193|NCT01736696|3865992|FG004|NOT COMPLETED|Overall Study||0
3140194|NCT01736696|3865993|FG005|NOT COMPLETED|Overall Study||0
3140195|NCT01736696|3865994|FG006|NOT COMPLETED|Overall Study||0
3140196|NCT01736852|3866020|FG000|STARTED|Overall Study||65
3140197|NCT01736852|3866021|FG001|STARTED|Overall Study||64
3140198|NCT01736852|3866020|FG000|COMPLETED|Overall Study||63
3140199|NCT01736852|3866021|FG001|COMPLETED|Overall Study||61
3140200|NCT01736852|3866020|FG000|NOT COMPLETED|Overall Study||2
3140201|NCT01736852|3866021|FG001|NOT COMPLETED|Overall Study||3
3140202|NCT01736865|3866029|FG000|STARTED|Overall Study||61
3140203|NCT01736865|3866030|FG001|STARTED|Overall Study||66
3140204|NCT01736865|3866029|FG000|COMPLETED|Overall Study||61
3140205|NCT01736865|3866030|FG001|COMPLETED|Overall Study||66
3140206|NCT01736865|3866029|FG000|NOT COMPLETED|Overall Study||0
3140207|NCT01736865|3866030|FG001|NOT COMPLETED|Overall Study||0
3140208|NCT01736917|3866036|FG000|STARTED|Overall Study||65
3140209|NCT01736917|3866036|FG000|COMPLETED|Overall Study||54
3140210|NCT01736917|3866036|FG000|NOT COMPLETED|Overall Study||11
3140211|NCT01736930|3866042|FG000|STARTED|Overall Study|Each night randomized to have either Predictive Low Glucose suspend or inactive (control).|20
3140212|NCT01736930|3866042|FG000|COMPLETED|Overall Study|Each night randomized to have either Predictive Low Glucose suspend or inactive (control).|19
3140213|NCT01736930|3866042|FG000|NOT COMPLETED|Overall Study||1
3140214|NCT01736943|3866048|FG000|STARTED|Overall Study||25
3140215|NCT01736943|3866048|FG000|COMPLETED|Overall Study||25
3140216|NCT01736943|3866048|FG000|NOT COMPLETED|Overall Study||0
3140217|NCT01737021|3866054|FG000|STARTED|Overall Study||22
3140218|NCT01737021|3866055|FG001|STARTED|Overall Study||9
3180656|NCT01992536|3909099|FG006|COMPLETED|Overall Study||0
3180657|NCT01992536|3909100|FG007|COMPLETED|Overall Study||21
3180658|NCT01992536|3909101|FG008|COMPLETED|Overall Study||18
3180659|NCT01992536|3909102|FG009|COMPLETED|Overall Study||18
3180660|NCT01992536|3909093|FG000|NOT COMPLETED|Overall Study||4
3180661|NCT01992536|3909094|FG001|NOT COMPLETED|Overall Study||3
3140219|NCT01737021|3866054|FG000|COMPLETED|Overall Study||17
3140220|NCT01737021|3866055|FG001|COMPLETED|Overall Study||6
3140221|NCT01737021|3866054|FG000|NOT COMPLETED|Overall Study||5
3140222|NCT01737021|3866055|FG001|NOT COMPLETED|Overall Study||3
3140223|NCT01737268|3866061|FG000|STARTED|Overall Study||20
3140224|NCT01737268|3866061|FG000|Treated|Overall Study||20
3140225|NCT01737268|3866061|FG000|COMPLETED|Overall Study||11
3140226|NCT01737268|3866061|FG000|NOT COMPLETED|Overall Study||9
3140227|NCT01737281|3866068|FG000|STARTED|Overall Study||969
3140228|NCT01737281|3866069|FG001|STARTED|Overall Study||969
3140229|NCT01737281|3866068|FG000|COMPLETED|Overall Study||603
3140230|NCT01737281|3866069|FG001|COMPLETED|Overall Study||689
3140231|NCT01737281|3866068|FG000|NOT COMPLETED|Overall Study||366
3140232|NCT01737281|3866069|FG001|NOT COMPLETED|Overall Study||280
3140233|NCT01737398|3866077|FG000|STARTED|Overall Study||113
3140234|NCT01737398|3866078|FG001|STARTED|Overall Study||60
3140235|NCT01737398|3866077|FG000|Received at Least 1 Dose of Study Drug|Overall Study||112
3140236|NCT01737398|3866078|FG001|Received at Least 1 Dose of Study Drug|Overall Study||60
3140237|NCT01737398|3866077|FG000|Safety Set|Overall Study||112
3140238|NCT01737398|3866078|FG001|Safety Set|Overall Study||60
3140239|NCT01737398|3866077|FG000|COMPLETED|Overall Study||87
3140240|NCT01737398|3866078|FG001|COMPLETED|Overall Study||52
3140241|NCT01737398|3866077|FG000|NOT COMPLETED|Overall Study||26
3140242|NCT01737398|3866078|FG001|NOT COMPLETED|Overall Study||8
3140243|NCT01737593|3866090|FG000|STARTED|Overall Study||37
3140244|NCT01737593|3866091|FG001|STARTED|Overall Study||32
3140245|NCT01737593|3866092|FG002|STARTED|Overall Study||39
3140246|NCT01737593|3866090|FG000|COMPLETED|Overall Study||37
3140247|NCT01737593|3866091|FG001|COMPLETED|Overall Study||32
3140248|NCT01737593|3866092|FG002|COMPLETED|Overall Study||39
3140249|NCT01737593|3866090|FG000|NOT COMPLETED|Overall Study||0
3140250|NCT01737593|3866091|FG001|NOT COMPLETED|Overall Study||0
3140251|NCT01737593|3866092|FG002|NOT COMPLETED|Overall Study||0
3140252|NCT01737684|3866105|FG000|STARTED|Overall Study||8
3140253|NCT01737684|3866106|FG001|STARTED|Overall Study||8
3140254|NCT01737684|3866107|FG002|STARTED|Overall Study|Participants with mild hepatic insufficiency were not enrolled in study.|0
3140255|NCT01737684|3866105|FG000|COMPLETED|Overall Study||8
3140256|NCT01737684|3866106|FG001|COMPLETED|Overall Study||8
3140257|NCT01737684|3866107|FG002|COMPLETED|Overall Study|Participants with mild hepatic insufficiency were not enrolled in study.|0
3140258|NCT01737684|3866105|FG000|NOT COMPLETED|Overall Study||0
3140259|NCT01737684|3866106|FG001|NOT COMPLETED|Overall Study||0
3140260|NCT01737684|3866107|FG002|NOT COMPLETED|Overall Study||0
3140261|NCT01737697|3866118|FG000|STARTED|Acute Phase-Initial 48 Hours||158
3140262|NCT01737697|3866119|FG001|STARTED|Acute Phase-Initial 48 Hours||154
3140263|NCT01737697|3866120|FG002|STARTED|Acute Phase-Initial 48 Hours||141
3140264|NCT01737697|3866121|FG003|STARTED|Acute Phase-Initial 48 Hours||158
3140265|NCT01737697|3866122|FG004|STARTED|Acute Phase-Initial 48 Hours||143
3140266|NCT01737697|3866123|FG005|STARTED|Acute Phase-Initial 48 Hours||0
3140267|NCT01737697|3866124|FG006|STARTED|Acute Phase-Initial 48 Hours||0
3140268|NCT01737697|3866125|FG007|STARTED|Acute Phase-Initial 48 Hours||0
3140269|NCT01737697|3866126|FG008|STARTED|Acute Phase-Initial 48 Hours||0
3140270|NCT01737697|3866127|FG009|STARTED|Acute Phase-Initial 48 Hours||0
3140271|NCT01737697|3866128|FG010|STARTED|Acute Phase-Initial 48 Hours||0
3140272|NCT01737697|3866129|FG011|STARTED|Acute Phase-Initial 48 Hours||0
3140273|NCT01737697|3866130|FG012|STARTED|Acute Phase-Initial 48 Hours||0
3140274|NCT01737697|3866131|FG013|STARTED|Acute Phase-Initial 48 Hours||0
3140275|NCT01737697|3866132|FG014|STARTED|Acute Phase-Initial 48 Hours||0
3140276|NCT01737697|3866118|FG000|COMPLETED|Acute Phase-Initial 48 Hours||157
3140277|NCT01737697|3866119|FG001|COMPLETED|Acute Phase-Initial 48 Hours||150
3140278|NCT01737697|3866120|FG002|COMPLETED|Acute Phase-Initial 48 Hours||137
3140279|NCT01737697|3866121|FG003|COMPLETED|Acute Phase-Initial 48 Hours||152
3140280|NCT01737697|3866122|FG004|COMPLETED|Acute Phase-Initial 48 Hours||140
3140281|NCT01737697|3866123|FG005|COMPLETED|Acute Phase-Initial 48 Hours||0
3140282|NCT01737697|3866124|FG006|COMPLETED|Acute Phase-Initial 48 Hours||0
3140283|NCT01737697|3866125|FG007|COMPLETED|Acute Phase-Initial 48 Hours||0
3140284|NCT01737697|3866126|FG008|COMPLETED|Acute Phase-Initial 48 Hours||0
3140285|NCT01737697|3866127|FG009|COMPLETED|Acute Phase-Initial 48 Hours||0
3140286|NCT01737697|3866128|FG010|COMPLETED|Acute Phase-Initial 48 Hours||0
3140287|NCT01737697|3866129|FG011|COMPLETED|Acute Phase-Initial 48 Hours||0
3140288|NCT01737697|3866130|FG012|COMPLETED|Acute Phase-Initial 48 Hours||0
3140289|NCT01737697|3866131|FG013|COMPLETED|Acute Phase-Initial 48 Hours||0
3140290|NCT01737697|3866132|FG014|COMPLETED|Acute Phase-Initial 48 Hours||0
3140291|NCT01737697|3866118|FG000|NOT COMPLETED|Acute Phase-Initial 48 Hours||1
3140292|NCT01737697|3866119|FG001|NOT COMPLETED|Acute Phase-Initial 48 Hours||4
3140293|NCT01737697|3866120|FG002|NOT COMPLETED|Acute Phase-Initial 48 Hours||4
3140294|NCT01737697|3866121|FG003|NOT COMPLETED|Acute Phase-Initial 48 Hours||6
3140295|NCT01737697|3866122|FG004|NOT COMPLETED|Acute Phase-Initial 48 Hours||3
3140296|NCT01737697|3866123|FG005|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
3140297|NCT01737697|3866124|FG006|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
3140298|NCT01737697|3866125|FG007|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
3140299|NCT01737697|3866126|FG008|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
3140300|NCT01737697|3866127|FG009|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
3140301|NCT01737697|3866128|FG010|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
3140302|NCT01737697|3866129|FG011|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
3140303|NCT01737697|3866130|FG012|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
3140304|NCT01737697|3866131|FG013|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
3140305|NCT01737697|3866132|FG014|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
3140306|NCT01737697|3866118|FG000|STARTED|Subacute Phase||0
3140307|NCT01737697|3866119|FG001|STARTED|Subacute Phase||0
3140308|NCT01737697|3866120|FG002|STARTED|Subacute Phase||0
3140309|NCT01737697|3866121|FG003|STARTED|Subacute Phase||0
3140310|NCT01737697|3866122|FG004|STARTED|Subacute Phase||0
3140311|NCT01737697|3866123|FG005|STARTED|Subacute Phase||41
3140312|NCT01737697|3866124|FG006|STARTED|Subacute Phase||49
3140313|NCT01737697|3866125|FG007|STARTED|Subacute Phase||46
3140314|NCT01737697|3866126|FG008|STARTED|Subacute Phase||54
3140315|NCT01737697|3866127|FG009|STARTED|Subacute Phase||68
3140316|NCT01737697|3866128|FG010|STARTED|Subacute Phase||65
3140317|NCT01737697|3866129|FG011|STARTED|Subacute Phase||61
3140318|NCT01737697|3866130|FG012|STARTED|Subacute Phase||63
3140319|NCT01737697|3866131|FG013|STARTED|Subacute Phase||46
3140320|NCT01737697|3866132|FG014|STARTED|Subacute Phase||50
3140321|NCT01737697|3866118|FG000|COMPLETED|Subacute Phase||0
3140322|NCT01737697|3866119|FG001|COMPLETED|Subacute Phase||0
3140323|NCT01737697|3866120|FG002|COMPLETED|Subacute Phase||0
3140324|NCT01737697|3866121|FG003|COMPLETED|Subacute Phase||0
3140325|NCT01737697|3866122|FG004|COMPLETED|Subacute Phase||0
3140326|NCT01737697|3866123|FG005|COMPLETED|Subacute Phase||38
3140327|NCT01737697|3866124|FG006|COMPLETED|Subacute Phase||48
3140328|NCT01737697|3866125|FG007|COMPLETED|Subacute Phase||43
3140329|NCT01737697|3866126|FG008|COMPLETED|Subacute Phase||52
3140330|NCT01737697|3866127|FG009|COMPLETED|Subacute Phase||66
3140331|NCT01737697|3866128|FG010|COMPLETED|Subacute Phase||59
3140332|NCT01737697|3866129|FG011|COMPLETED|Subacute Phase||58
3140333|NCT01737697|3866130|FG012|COMPLETED|Subacute Phase||61
3140334|NCT01737697|3866131|FG013|COMPLETED|Subacute Phase||44
3140335|NCT01737697|3866132|FG014|COMPLETED|Subacute Phase||49
3140336|NCT01737697|3866118|FG000|NOT COMPLETED|Subacute Phase||0
3140337|NCT01737697|3866119|FG001|NOT COMPLETED|Subacute Phase||0
3140338|NCT01737697|3866120|FG002|NOT COMPLETED|Subacute Phase||0
3140339|NCT01737697|3866121|FG003|NOT COMPLETED|Subacute Phase||0
3140340|NCT01737697|3866122|FG004|NOT COMPLETED|Subacute Phase||0
3140341|NCT01737697|3866123|FG005|NOT COMPLETED|Subacute Phase||3
3140342|NCT01737697|3866124|FG006|NOT COMPLETED|Subacute Phase||1
3140343|NCT01737697|3866125|FG007|NOT COMPLETED|Subacute Phase||3
3140344|NCT01737697|3866126|FG008|NOT COMPLETED|Subacute Phase||2
3140345|NCT01737697|3866127|FG009|NOT COMPLETED|Subacute Phase||2
3140346|NCT01737697|3866128|FG010|NOT COMPLETED|Subacute Phase||6
3140347|NCT01737697|3866129|FG011|NOT COMPLETED|Subacute Phase||3
3140348|NCT01737697|3866130|FG012|NOT COMPLETED|Subacute Phase||2
3140349|NCT01737697|3866131|FG013|NOT COMPLETED|Subacute Phase||2
3140350|NCT01737697|3866132|FG014|NOT COMPLETED|Subacute Phase||1
3140351|NCT01737710|3866170|FG000|STARTED|Overall Study||114
3140352|NCT01737710|3866171|FG001|STARTED|Overall Study||105
3140353|NCT01737710|3866172|FG002|STARTED|Overall Study||105
3140354|NCT01737710|3866173|FG003|STARTED|Overall Study||23
3140355|NCT01737710|3866174|FG004|STARTED|Overall Study||21
3140356|NCT01737710|3866170|FG000|COMPLETED|Overall Study||112
3140357|NCT01737710|3866171|FG001|COMPLETED|Overall Study||101
3140358|NCT01737710|3866172|FG002|COMPLETED|Overall Study||102
3140359|NCT01737710|3866173|FG003|COMPLETED|Overall Study||23
3140360|NCT01737710|3866174|FG004|COMPLETED|Overall Study||21
3140361|NCT01737710|3866170|FG000|NOT COMPLETED|Overall Study||2
3140362|NCT01737710|3866171|FG001|NOT COMPLETED|Overall Study||4
3140363|NCT01737710|3866172|FG002|NOT COMPLETED|Overall Study||3
3140364|NCT01737710|3866173|FG003|NOT COMPLETED|Overall Study||0
3140365|NCT01737710|3866174|FG004|NOT COMPLETED|Overall Study||0
3140366|NCT01737762|3866187|FG000|STARTED|Overall Study||77
3140367|NCT01737762|3866188|FG001|STARTED|Overall Study||78
3140368|NCT01737762|3866187|FG000|COMPLETED|Overall Study||57
3140369|NCT01737762|3866188|FG001|COMPLETED|Overall Study||61
3140370|NCT01737762|3866187|FG000|NOT COMPLETED|Overall Study||20
3140371|NCT01737762|3866188|FG001|NOT COMPLETED|Overall Study||17
3140372|NCT01737840|3866196|FG000|STARTED|Overall Study||35
3140373|NCT01737840|3866197|FG001|STARTED|Overall Study||35
3140374|NCT01737840|3866196|FG000|COMPLETED|Overall Study||33
3140375|NCT01737840|3866197|FG001|COMPLETED|Overall Study||33
3140376|NCT01737840|3866196|FG000|NOT COMPLETED|Overall Study||2
3140377|NCT01737840|3866197|FG001|NOT COMPLETED|Overall Study||2
3140378|NCT01737879|3866205|FG000|STARTED|Overall Study||41
3140379|NCT01737879|3866205|FG000|Received Peginesatide|Overall Study||34
3140380|NCT01737879|3866205|FG000|Transitioned to Epoetin Alfa|Overall Study||0
3140381|NCT01737879|3866205|FG000|COMPLETED|Overall Study||0
3140382|NCT01737879|3866205|FG000|NOT COMPLETED|Overall Study||41
3140383|NCT01737931|3866212|FG000|STARTED|Overall Study||38
3140384|NCT01737931|3866213|FG001|STARTED|Overall Study||40
3140385|NCT01737931|3866214|FG002|STARTED|Overall Study||39
3140386|NCT01737931|3866212|FG000|COMPLETED|Overall Study||38
3140387|NCT01737931|3866213|FG001|COMPLETED|Overall Study||38
3140388|NCT01737931|3866214|FG002|COMPLETED|Overall Study||38
3140389|NCT01737931|3866212|FG000|NOT COMPLETED|Overall Study||0
3140390|NCT01737931|3866213|FG001|NOT COMPLETED|Overall Study||2
3140391|NCT01737931|3866214|FG002|NOT COMPLETED|Overall Study||1
3140392|NCT01737944|3866224|FG000|STARTED|Overall Study||9
3140393|NCT01737944|3866225|FG001|STARTED|Overall Study||9
3140394|NCT01737944|3866226|FG002|STARTED|Overall Study|10 patients randomized, one patient discontinued before first study drug dose|9
3140395|NCT01737944|3866227|FG003|STARTED|Overall Study|10 patients randomized, one patient discontinued before first study drug dose|9
3140396|NCT01737944|3866224|FG000|COMPLETED|Overall Study||9
3140397|NCT01737944|3866225|FG001|COMPLETED|Overall Study||9
3140398|NCT01737944|3866226|FG002|COMPLETED|Overall Study||9
3140399|NCT01737944|3866227|FG003|COMPLETED|Overall Study||9
3140400|NCT01737944|3866224|FG000|NOT COMPLETED|Overall Study||0
3140401|NCT01737944|3866225|FG001|NOT COMPLETED|Overall Study||0
3140402|NCT01737944|3866226|FG002|NOT COMPLETED|Overall Study||0
3140403|NCT01737944|3866227|FG003|NOT COMPLETED|Overall Study||0
3140404|NCT01737996|3866239|FG000|STARTED|Overall Study||8
3140405|NCT01737996|3866240|FG001|STARTED|Overall Study||8
3140406|NCT01737996|3866241|FG002|STARTED|Overall Study||16
3140407|NCT01737996|3866239|FG000|COMPLETED|Overall Study||8
3140408|NCT01737996|3866240|FG001|COMPLETED|Overall Study||7
3140409|NCT01737996|3866241|FG002|COMPLETED|Overall Study|One patient withdrew consent after the first dose due to private reasons.|14
3140410|NCT01737996|3866239|FG000|NOT COMPLETED|Overall Study||0
3140411|NCT01737996|3866240|FG001|NOT COMPLETED|Overall Study||1
3140412|NCT01737996|3866241|FG002|NOT COMPLETED|Overall Study||2
3140413|NCT01738191|3866251|FG000|STARTED|Overall Study||15
3140414|NCT01738191|3866252|FG001|STARTED|Overall Study||15
3140415|NCT01738191|3866251|FG000|COMPLETED|Overall Study||11
3140416|NCT01738191|3866252|FG001|COMPLETED|Overall Study||14
3140417|NCT01738191|3866251|FG000|NOT COMPLETED|Overall Study||4
3140418|NCT01738191|3866252|FG001|NOT COMPLETED|Overall Study||1
3140419|NCT01738321|3866260|FG000|STARTED|Overall Study||33
3140420|NCT01738321|3866261|FG001|STARTED|Overall Study||30
3140421|NCT01738321|3866260|FG000|COMPLETED|Overall Study||33
3140422|NCT01738321|3866261|FG001|COMPLETED|Overall Study||30
3140423|NCT01738321|3866260|FG000|NOT COMPLETED|Overall Study||0
3140424|NCT01738321|3866261|FG001|NOT COMPLETED|Overall Study||0
3140425|NCT01738438|3866267|FG000|STARTED|Overall Study||35
3140426|NCT01738438|3866267|FG000|COMPLETED|Overall Study|Since treatment was not of fixed duration, all participants were considered as 'Not Completed'.|0
3140427|NCT01738438|3866267|FG000|NOT COMPLETED|Overall Study||35
3140428|NCT01738477|3866273|FG000|STARTED|Overall Study||37
3140429|NCT01738477|3866274|FG001|STARTED|Overall Study||128
3140430|NCT01738477|3866273|FG000|COMPLETED|Overall Study||36
3140431|NCT01738477|3866274|FG001|COMPLETED|Overall Study||124
3140432|NCT01738477|3866273|FG000|NOT COMPLETED|Overall Study||1
3140433|NCT01738477|3866274|FG001|NOT COMPLETED|Overall Study||4
3140434|NCT01738503|3866288|FG000|STARTED|Induction/Stabilization (Days -14 to -1)||124
3140435|NCT01738503|3866289|FG001|STARTED|Induction/Stabilization (Days -14 to -1)||0
3140436|NCT01738503|3866290|FG002|STARTED|Induction/Stabilization (Days -14 to -1)||0
3140437|NCT01738503|3866291|FG003|STARTED|Induction/Stabilization (Days -14 to -1)||0
3140438|NCT01738503|3866292|FG004|STARTED|Induction/Stabilization (Days -14 to -1)||0
3140439|NCT01738503|3866293|FG005|STARTED|Induction/Stabilization (Days -14 to -1)||0
3140440|NCT01738503|3866294|FG006|STARTED|Induction/Stabilization (Days -14 to -1)||0
3140441|NCT01738503|3866288|FG000|COMPLETED|Induction/Stabilization (Days -14 to -1)||89
3140442|NCT01738503|3866289|FG001|COMPLETED|Induction/Stabilization (Days -14 to -1)||0
3140443|NCT01738503|3866290|FG002|COMPLETED|Induction/Stabilization (Days -14 to -1)||0
3140444|NCT01738503|3866291|FG003|COMPLETED|Induction/Stabilization (Days -14 to -1)||0
3140445|NCT01738503|3866292|FG004|COMPLETED|Induction/Stabilization (Days -14 to -1)||0
3140446|NCT01738503|3866293|FG005|COMPLETED|Induction/Stabilization (Days -14 to -1)||0
3140447|NCT01738503|3866294|FG006|COMPLETED|Induction/Stabilization (Days -14 to -1)||0
3140448|NCT01738503|3866288|FG000|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||35
3140449|NCT01738503|3866289|FG001|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||0
3140450|NCT01738503|3866290|FG002|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||0
3140451|NCT01738503|3866291|FG003|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||0
3140452|NCT01738503|3866292|FG004|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||0
3140453|NCT01738503|3866293|FG005|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||0
3140454|NCT01738503|3866294|FG006|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||0
3140455|NCT01738503|3866288|FG000|STARTED|Treatment Period||0
3140456|NCT01738503|3866289|FG001|STARTED|Treatment Period||15
3140457|NCT01738503|3866290|FG002|STARTED|Treatment Period||15
3140458|NCT01738503|3866291|FG003|STARTED|Treatment Period||15
3140459|NCT01738503|3866292|FG004|STARTED|Treatment Period||15
3140460|NCT01738503|3866293|FG005|STARTED|Treatment Period||15
3140461|NCT01738503|3866294|FG006|STARTED|Treatment Period||14
3140462|NCT01738503|3866288|FG000|COMPLETED|Treatment Period||0
3140463|NCT01738503|3866289|FG001|COMPLETED|Treatment Period|Completed to Day 113 (4 injections)|10
3140464|NCT01738503|3866290|FG002|COMPLETED|Treatment Period|Completed to Day 113 (4 injections)|10
3140465|NCT01738503|3866291|FG003|COMPLETED|Treatment Period|Completed to Day 113 (4 injections)|9
3140466|NCT01738503|3866292|FG004|COMPLETED|Treatment Period|Completed to Day 113 (4 injections)|7
3140467|NCT01738503|3866293|FG005|COMPLETED|Treatment Period|Completed to Day 113 (4 injections)|9
3140468|NCT01738503|3866294|FG006|COMPLETED|Treatment Period|Completed to Day 113 (4 injections)|6
3140469|NCT01738503|3866288|FG000|NOT COMPLETED|Treatment Period||0
3140470|NCT01738503|3866289|FG001|NOT COMPLETED|Treatment Period||5
3140471|NCT01738503|3866290|FG002|NOT COMPLETED|Treatment Period||5
3140472|NCT01738503|3866291|FG003|NOT COMPLETED|Treatment Period||6
3140473|NCT01738503|3866292|FG004|NOT COMPLETED|Treatment Period||8
3140474|NCT01738503|3866293|FG005|NOT COMPLETED|Treatment Period||6
3140475|NCT01738503|3866294|FG006|NOT COMPLETED|Treatment Period||8
3140476|NCT01738503|3866288|FG000|STARTED|PET Imaging Sub-study||0
3140477|NCT01738503|3866289|FG001|STARTED|PET Imaging Sub-study||0
3140478|NCT01738503|3866290|FG002|STARTED|PET Imaging Sub-study||0
3180662|NCT01992536|3909095|FG002|NOT COMPLETED|Overall Study||1
3180663|NCT01992536|3909096|FG003|NOT COMPLETED|Overall Study||2
3180664|NCT01992536|3909097|FG004|NOT COMPLETED|Overall Study||0
3180665|NCT01992536|3909098|FG005|NOT COMPLETED|Overall Study||1
3180666|NCT01992536|3909099|FG006|NOT COMPLETED|Overall Study||7
3180667|NCT01992536|3909100|FG007|NOT COMPLETED|Overall Study||0
3180668|NCT01992536|3909101|FG008|NOT COMPLETED|Overall Study||1
3180669|NCT01992536|3909102|FG009|NOT COMPLETED|Overall Study||1
3180670|NCT01992549|3909144|FG000|STARTED|Overall Study||48
3180671|NCT01992549|3909144|FG000|SAF Population|Overall Study||48
3180672|NCT01992549|3909144|FG000|ITT Population|Overall Study||47
3180673|NCT01992549|3909144|FG000|PROPH Population|Overall Study||47
3180674|NCT01992549|3909144|FG000|BLEED Population|Overall Study||29
3140479|NCT01738503|3866291|FG003|STARTED|PET Imaging Sub-study||0
3140480|NCT01738503|3866292|FG004|STARTED|PET Imaging Sub-study||0
3140481|NCT01738503|3866293|FG005|STARTED|PET Imaging Sub-study||3
3140482|NCT01738503|3866294|FG006|STARTED|PET Imaging Sub-study||2
3140483|NCT01738503|3866288|FG000|COMPLETED|PET Imaging Sub-study||0
3140484|NCT01738503|3866289|FG001|COMPLETED|PET Imaging Sub-study||0
3140485|NCT01738503|3866290|FG002|COMPLETED|PET Imaging Sub-study||0
3140486|NCT01738503|3866291|FG003|COMPLETED|PET Imaging Sub-study||0
3140487|NCT01738503|3866292|FG004|COMPLETED|PET Imaging Sub-study||0
3140488|NCT01738503|3866293|FG005|COMPLETED|PET Imaging Sub-study|Completion defined as a total of 12 injections plus all PET images|1
3140489|NCT01738503|3866294|FG006|COMPLETED|PET Imaging Sub-study|Completion defined as a total of 6 injections plus all PET images|1
3140490|NCT01738503|3866288|FG000|NOT COMPLETED|PET Imaging Sub-study||0
3140491|NCT01738503|3866289|FG001|NOT COMPLETED|PET Imaging Sub-study||0
3140492|NCT01738503|3866290|FG002|NOT COMPLETED|PET Imaging Sub-study||0
3140493|NCT01738503|3866291|FG003|NOT COMPLETED|PET Imaging Sub-study||0
3140494|NCT01738503|3866292|FG004|NOT COMPLETED|PET Imaging Sub-study||0
3140495|NCT01738503|3866293|FG005|NOT COMPLETED|PET Imaging Sub-study||2
3140496|NCT01738503|3866294|FG006|NOT COMPLETED|PET Imaging Sub-study||1
3140497|NCT01738581|3866318|FG000|STARTED|Overall Study||5
3140498|NCT01738581|3866319|FG001|STARTED|Overall Study||4
3140499|NCT01738581|3866318|FG000|COMPLETED|Overall Study||4
3140500|NCT01738581|3866319|FG001|COMPLETED|Overall Study||4
3140501|NCT01738581|3866318|FG000|NOT COMPLETED|Overall Study||1
3140502|NCT01738581|3866319|FG001|NOT COMPLETED|Overall Study||0
3140503|NCT01738594|3866328|FG000|STARTED|Registration and Treatment Start||0
3140504|NCT01738594|3866329|FG001|STARTED|Registration and Treatment Start||3
3140505|NCT01738594|3866330|FG002|STARTED|Registration and Treatment Start||0
3140506|NCT01738594|3866331|FG003|STARTED|Registration and Treatment Start||0
3140507|NCT01738594|3866332|FG004|STARTED|Registration and Treatment Start||1
3140508|NCT01738594|3866333|FG005|STARTED|Registration and Treatment Start||3
3140509|NCT01738594|3866334|FG006|STARTED|Registration and Treatment Start||0
3140510|NCT01738594|3866335|FG007|STARTED|Registration and Treatment Start||0
3140511|NCT01738594|3866328|FG000|Registered to Study|Registration and Treatment Start||0
3140512|NCT01738594|3866329|FG001|Registered to Study|Registration and Treatment Start||3
3140513|NCT01738594|3866330|FG002|Registered to Study|Registration and Treatment Start||0
3140514|NCT01738594|3866331|FG003|Registered to Study|Registration and Treatment Start||0
3140515|NCT01738594|3866332|FG004|Registered to Study|Registration and Treatment Start||1
3140516|NCT01738594|3866333|FG005|Registered to Study|Registration and Treatment Start||3
3140517|NCT01738594|3866334|FG006|Registered to Study|Registration and Treatment Start||0
3140518|NCT01738594|3866335|FG007|Registered to Study|Registration and Treatment Start||0
3140519|NCT01738594|3866328|FG000|Treatment Started|Registration and Treatment Start||0
3140520|NCT01738594|3866329|FG001|Treatment Started|Registration and Treatment Start||2
3140521|NCT01738594|3866330|FG002|Treatment Started|Registration and Treatment Start||0
3140522|NCT01738594|3866331|FG003|Treatment Started|Registration and Treatment Start||0
3140523|NCT01738594|3866332|FG004|Treatment Started|Registration and Treatment Start||1
3140524|NCT01738594|3866333|FG005|Treatment Started|Registration and Treatment Start||3
3140525|NCT01738594|3866334|FG006|Treatment Started|Registration and Treatment Start||0
3140526|NCT01738594|3866335|FG007|Treatment Started|Registration and Treatment Start||0
3140527|NCT01738594|3866328|FG000|COMPLETED|Registration and Treatment Start||0
3140528|NCT01738594|3866329|FG001|COMPLETED|Registration and Treatment Start||2
3140529|NCT01738594|3866330|FG002|COMPLETED|Registration and Treatment Start||0
3140530|NCT01738594|3866331|FG003|COMPLETED|Registration and Treatment Start||0
3140531|NCT01738594|3866332|FG004|COMPLETED|Registration and Treatment Start||1
3140532|NCT01738594|3866333|FG005|COMPLETED|Registration and Treatment Start||3
3140533|NCT01738594|3866334|FG006|COMPLETED|Registration and Treatment Start||0
3140534|NCT01738594|3866335|FG007|COMPLETED|Registration and Treatment Start||0
3140535|NCT01738594|3866328|FG000|NOT COMPLETED|Registration and Treatment Start||0
3140536|NCT01738594|3866329|FG001|NOT COMPLETED|Registration and Treatment Start||1
3140537|NCT01738594|3866330|FG002|NOT COMPLETED|Registration and Treatment Start||0
3140538|NCT01738594|3866331|FG003|NOT COMPLETED|Registration and Treatment Start||0
3140539|NCT01738594|3866332|FG004|NOT COMPLETED|Registration and Treatment Start||0
3140540|NCT01738594|3866333|FG005|NOT COMPLETED|Registration and Treatment Start||0
3140541|NCT01738594|3866334|FG006|NOT COMPLETED|Registration and Treatment Start||0
3140542|NCT01738594|3866335|FG007|NOT COMPLETED|Registration and Treatment Start||0
3140543|NCT01738594|3866328|FG000|STARTED|Completed 2 Cycles/Reached 1st Response||0
3140544|NCT01738594|3866329|FG001|STARTED|Completed 2 Cycles/Reached 1st Response||2
3140545|NCT01738594|3866330|FG002|STARTED|Completed 2 Cycles/Reached 1st Response||0
3140546|NCT01738594|3866331|FG003|STARTED|Completed 2 Cycles/Reached 1st Response||0
3140547|NCT01738594|3866332|FG004|STARTED|Completed 2 Cycles/Reached 1st Response||1
3140548|NCT01738594|3866333|FG005|STARTED|Completed 2 Cycles/Reached 1st Response||3
3140549|NCT01738594|3866334|FG006|STARTED|Completed 2 Cycles/Reached 1st Response||0
3140550|NCT01738594|3866335|FG007|STARTED|Completed 2 Cycles/Reached 1st Response||0
3140551|NCT01738594|3866328|FG000|COMPLETED|Completed 2 Cycles/Reached 1st Response||0
3140552|NCT01738594|3866329|FG001|COMPLETED|Completed 2 Cycles/Reached 1st Response||2
3140553|NCT01738594|3866330|FG002|COMPLETED|Completed 2 Cycles/Reached 1st Response||0
3140554|NCT01738594|3866331|FG003|COMPLETED|Completed 2 Cycles/Reached 1st Response||0
3140555|NCT01738594|3866332|FG004|COMPLETED|Completed 2 Cycles/Reached 1st Response||1
3140556|NCT01738594|3866333|FG005|COMPLETED|Completed 2 Cycles/Reached 1st Response||2
3140557|NCT01738594|3866334|FG006|COMPLETED|Completed 2 Cycles/Reached 1st Response||0
3140558|NCT01738594|3866335|FG007|COMPLETED|Completed 2 Cycles/Reached 1st Response||0
3140559|NCT01738594|3866328|FG000|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0
3140560|NCT01738594|3866329|FG001|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0
3140561|NCT01738594|3866330|FG002|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0
3140562|NCT01738594|3866331|FG003|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0
3140563|NCT01738594|3866332|FG004|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0
3140564|NCT01738594|3866333|FG005|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||1
3140565|NCT01738594|3866334|FG006|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0
3140566|NCT01738594|3866335|FG007|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0
3140567|NCT01738594|3866328|FG000|STARTED|Completed 4 Cycles of Treatment||0
3140568|NCT01738594|3866329|FG001|STARTED|Completed 4 Cycles of Treatment||2
3140569|NCT01738594|3866330|FG002|STARTED|Completed 4 Cycles of Treatment||0
3140570|NCT01738594|3866331|FG003|STARTED|Completed 4 Cycles of Treatment||0
3140571|NCT01738594|3866332|FG004|STARTED|Completed 4 Cycles of Treatment||1
3140572|NCT01738594|3866333|FG005|STARTED|Completed 4 Cycles of Treatment||2
3140573|NCT01738594|3866334|FG006|STARTED|Completed 4 Cycles of Treatment||0
3140574|NCT01738594|3866335|FG007|STARTED|Completed 4 Cycles of Treatment||0
3140575|NCT01738594|3866328|FG000|COMPLETED|Completed 4 Cycles of Treatment||0
3140576|NCT01738594|3866329|FG001|COMPLETED|Completed 4 Cycles of Treatment||0
3140577|NCT01738594|3866330|FG002|COMPLETED|Completed 4 Cycles of Treatment||0
3140578|NCT01738594|3866331|FG003|COMPLETED|Completed 4 Cycles of Treatment||0
3140579|NCT01738594|3866332|FG004|COMPLETED|Completed 4 Cycles of Treatment||1
3140580|NCT01738594|3866333|FG005|COMPLETED|Completed 4 Cycles of Treatment||1
3140581|NCT01738594|3866334|FG006|COMPLETED|Completed 4 Cycles of Treatment||0
3140582|NCT01738594|3866335|FG007|COMPLETED|Completed 4 Cycles of Treatment||0
3140583|NCT01738594|3866328|FG000|NOT COMPLETED|Completed 4 Cycles of Treatment||0
3140584|NCT01738594|3866329|FG001|NOT COMPLETED|Completed 4 Cycles of Treatment||2
3140585|NCT01738594|3866330|FG002|NOT COMPLETED|Completed 4 Cycles of Treatment||0
3140586|NCT01738594|3866331|FG003|NOT COMPLETED|Completed 4 Cycles of Treatment||0
3140587|NCT01738594|3866332|FG004|NOT COMPLETED|Completed 4 Cycles of Treatment||0
3140588|NCT01738594|3866333|FG005|NOT COMPLETED|Completed 4 Cycles of Treatment||1
3140589|NCT01738594|3866334|FG006|NOT COMPLETED|Completed 4 Cycles of Treatment||0
3140590|NCT01738594|3866335|FG007|NOT COMPLETED|Completed 4 Cycles of Treatment||0
3140591|NCT01738594|3866328|FG000|STARTED|Went on to Continue Treatment Cycle 5||0
3140592|NCT01738594|3866329|FG001|STARTED|Went on to Continue Treatment Cycle 5||0
3140593|NCT01738594|3866330|FG002|STARTED|Went on to Continue Treatment Cycle 5||0
3140594|NCT01738594|3866331|FG003|STARTED|Went on to Continue Treatment Cycle 5||0
3140595|NCT01738594|3866332|FG004|STARTED|Went on to Continue Treatment Cycle 5||1
3140596|NCT01738594|3866333|FG005|STARTED|Went on to Continue Treatment Cycle 5||1
3140597|NCT01738594|3866334|FG006|STARTED|Went on to Continue Treatment Cycle 5||0
3140598|NCT01738594|3866335|FG007|STARTED|Went on to Continue Treatment Cycle 5||0
3140599|NCT01738594|3866328|FG000|COMPLETED|Went on to Continue Treatment Cycle 5||0
3140600|NCT01738594|3866329|FG001|COMPLETED|Went on to Continue Treatment Cycle 5||0
3140601|NCT01738594|3866330|FG002|COMPLETED|Went on to Continue Treatment Cycle 5||0
3140602|NCT01738594|3866331|FG003|COMPLETED|Went on to Continue Treatment Cycle 5||0
3140603|NCT01738594|3866332|FG004|COMPLETED|Went on to Continue Treatment Cycle 5||0
3140604|NCT01738594|3866333|FG005|COMPLETED|Went on to Continue Treatment Cycle 5||0
3140605|NCT01738594|3866334|FG006|COMPLETED|Went on to Continue Treatment Cycle 5||0
3140606|NCT01738594|3866335|FG007|COMPLETED|Went on to Continue Treatment Cycle 5||0
3140607|NCT01738594|3866328|FG000|NOT COMPLETED|Went on to Continue Treatment Cycle 5||0
3140608|NCT01738594|3866329|FG001|NOT COMPLETED|Went on to Continue Treatment Cycle 5||0
3140609|NCT01738594|3866330|FG002|NOT COMPLETED|Went on to Continue Treatment Cycle 5||0
3140610|NCT01738594|3866331|FG003|NOT COMPLETED|Went on to Continue Treatment Cycle 5||0
3140611|NCT01738594|3866332|FG004|NOT COMPLETED|Went on to Continue Treatment Cycle 5||1
3140612|NCT01738594|3866333|FG005|NOT COMPLETED|Went on to Continue Treatment Cycle 5||1
3140613|NCT01738594|3866334|FG006|NOT COMPLETED|Went on to Continue Treatment Cycle 5||0
3140614|NCT01738594|3866335|FG007|NOT COMPLETED|Went on to Continue Treatment Cycle 5||0
3140615|NCT01738594|3866328|FG000|STARTED|Follow up for 1 Year||0
3140616|NCT01738594|3866329|FG001|STARTED|Follow up for 1 Year||2
3140617|NCT01738594|3866330|FG002|STARTED|Follow up for 1 Year||0
3140618|NCT01738594|3866331|FG003|STARTED|Follow up for 1 Year||0
3140619|NCT01738594|3866332|FG004|STARTED|Follow up for 1 Year||1
3140620|NCT01738594|3866333|FG005|STARTED|Follow up for 1 Year||3
3140621|NCT01738594|3866334|FG006|STARTED|Follow up for 1 Year||0
3140622|NCT01738594|3866335|FG007|STARTED|Follow up for 1 Year||0
3140623|NCT01738594|3866328|FG000|COMPLETED|Follow up for 1 Year||0
3140624|NCT01738594|3866329|FG001|COMPLETED|Follow up for 1 Year||2
3140625|NCT01738594|3866330|FG002|COMPLETED|Follow up for 1 Year||0
3140626|NCT01738594|3866331|FG003|COMPLETED|Follow up for 1 Year||0
3140627|NCT01738594|3866332|FG004|COMPLETED|Follow up for 1 Year||1
3140628|NCT01738594|3866333|FG005|COMPLETED|Follow up for 1 Year||0
3140629|NCT01738594|3866334|FG006|COMPLETED|Follow up for 1 Year||0
3140630|NCT01738594|3866335|FG007|COMPLETED|Follow up for 1 Year||0
3140631|NCT01738594|3866328|FG000|NOT COMPLETED|Follow up for 1 Year||0
3140632|NCT01738594|3866329|FG001|NOT COMPLETED|Follow up for 1 Year||0
3140633|NCT01738594|3866330|FG002|NOT COMPLETED|Follow up for 1 Year||0
3140634|NCT01738594|3866331|FG003|NOT COMPLETED|Follow up for 1 Year||0
3140635|NCT01738594|3866332|FG004|NOT COMPLETED|Follow up for 1 Year||0
3140636|NCT01738594|3866333|FG005|NOT COMPLETED|Follow up for 1 Year||3
3140637|NCT01738594|3866334|FG006|NOT COMPLETED|Follow up for 1 Year||0
3140638|NCT01738594|3866335|FG007|NOT COMPLETED|Follow up for 1 Year||0
3140639|NCT01738646|3866345|FG000|STARTED|Overall Study||40
3140640|NCT01738646|3866345|FG000|COMPLETED|Overall Study|Participants who discontinued study drug for any reason.|38
3140641|NCT01738646|3866345|FG000|NOT COMPLETED|Overall Study||2
3140642|NCT01738672|3866350|FG000|STARTED|Overall Study||16
3140643|NCT01738672|3866350|FG000|COMPLETED|Overall Study||11
3140644|NCT01738672|3866350|FG000|NOT COMPLETED|Overall Study||5
3140645|NCT01738737|3866359|FG000|STARTED|Overall Study||29
3140646|NCT01738737|3866360|FG001|STARTED|Overall Study||29
3140647|NCT01738737|3866361|FG002|STARTED|Overall Study||29
3140648|NCT01738737|3866362|FG003|STARTED|Overall Study||29
3140649|NCT01738737|3866363|FG004|STARTED|Overall Study||29
3140650|NCT01738737|3866359|FG000|COMPLETED|Overall Study||25
3140651|NCT01738737|3866360|FG001|COMPLETED|Overall Study||25
3140652|NCT01738737|3866361|FG002|COMPLETED|Overall Study||25
3140653|NCT01738737|3866362|FG003|COMPLETED|Overall Study||25
3140654|NCT01738737|3866363|FG004|COMPLETED|Overall Study||25
3140655|NCT01738737|3866359|FG000|NOT COMPLETED|Overall Study||4
3140656|NCT01738737|3866360|FG001|NOT COMPLETED|Overall Study||4
3140657|NCT01738737|3866361|FG002|NOT COMPLETED|Overall Study||4
3140658|NCT01738737|3866362|FG003|NOT COMPLETED|Overall Study||4
3140659|NCT01738737|3866363|FG004|NOT COMPLETED|Overall Study||4
3140660|NCT01738750|3866377|FG000|STARTED|Overall Study||49
3140661|NCT01738750|3866378|FG001|STARTED|Overall Study||51
3140662|NCT01738750|3866377|FG000|COMPLETED|Overall Study||49
3140663|NCT01738750|3866378|FG001|COMPLETED|Overall Study||51
3140664|NCT01738750|3866377|FG000|NOT COMPLETED|Overall Study||0
3140665|NCT01738750|3866378|FG001|NOT COMPLETED|Overall Study||0
3140666|NCT01738919|3866388|FG000|STARTED|Overall Study||15
3140667|NCT01738919|3866389|FG001|STARTED|Overall Study||17
3140668|NCT01738919|3866388|FG000|COMPLETED|Overall Study||14
3140669|NCT01738919|3866389|FG001|COMPLETED|Overall Study||14
3140670|NCT01738919|3866388|FG000|NOT COMPLETED|Overall Study||1
3140671|NCT01738919|3866389|FG001|NOT COMPLETED|Overall Study||3
3140672|NCT01738971|3866400|FG000|STARTED|Overall Study|54 participants recruited to this arm|54
3140673|NCT01738971|3866401|FG001|STARTED|Overall Study|58 participants recruited to this arm|58
3140674|NCT01738971|3866402|FG002|STARTED|Overall Study|56 participants recruited to this arm|56
3140675|NCT01738971|3866400|FG000|COMPLETED|Overall Study|35 participants successfully contacted to complete telephone follow-up at 6-8 weeks.|35
3140676|NCT01738971|3866401|FG001|COMPLETED|Overall Study|28 participants successfully contacted to complete telephone follow-up at 6-8 weeks.|28
3140677|NCT01738971|3866402|FG002|COMPLETED|Overall Study|39 participants successfully contacted to complete telephone follow-up at 6-8 weeks.|39
3140678|NCT01738971|3866400|FG000|NOT COMPLETED|Overall Study||19
3140679|NCT01738971|3866401|FG001|NOT COMPLETED|Overall Study||30
3140680|NCT01738971|3866402|FG002|NOT COMPLETED|Overall Study||17
3140681|NCT01738984|3866412|FG000|STARTED|Overall Study||250
3140682|NCT01738984|3866413|FG001|STARTED|Overall Study||249
3140683|NCT01738984|3866412|FG000|COMPLETED|Overall Study||186
3140684|NCT01738984|3866413|FG001|COMPLETED|Overall Study||210
3140685|NCT01738984|3866412|FG000|NOT COMPLETED|Overall Study||64
3140686|NCT01738984|3866413|FG001|NOT COMPLETED|Overall Study||39
3140687|NCT01739231|3866425|FG000|STARTED|Part A||24
3140688|NCT01739231|3866426|FG001|STARTED|Part A||24
3140689|NCT01739231|3866427|FG002|STARTED|Part A||12
3140690|NCT01739231|3866428|FG003|STARTED|Part A||0
3140691|NCT01739231|3866425|FG000|Received All 3 Vaccinations|Part A||21
3140692|NCT01739231|3866426|FG001|Received All 3 Vaccinations|Part A||20
3140693|NCT01739231|3866427|FG002|Received All 3 Vaccinations|Part A||12
3140694|NCT01739231|3866428|FG003|Received All 3 Vaccinations|Part A||0
3140695|NCT01739231|3866425|FG000|COMPLETED|Part A||20
3140696|NCT01739231|3866426|FG001|COMPLETED|Part A||17
3140697|NCT01739231|3866427|FG002|COMPLETED|Part A||12
3140698|NCT01739231|3866428|FG003|COMPLETED|Part A||0
3140699|NCT01739231|3866425|FG000|NOT COMPLETED|Part A||4
3140700|NCT01739231|3866426|FG001|NOT COMPLETED|Part A||7
3140701|NCT01739231|3866427|FG002|NOT COMPLETED|Part A||0
3140702|NCT01739231|3866428|FG003|NOT COMPLETED|Part A||0
3140703|NCT01739231|3866425|FG000|STARTED|Part B||20
3140704|NCT01739231|3866426|FG001|STARTED|Part B||17
3140705|NCT01739231|3866427|FG002|STARTED|Part B||12
3140706|NCT01739231|3866428|FG003|STARTED|Part B||21
3140707|NCT01739231|3866425|FG000|Challenged|Part B||13
3140708|NCT01739231|3866426|FG001|Challenged|Part B||13
3140709|NCT01739231|3866427|FG002|Challenged|Part B||10
3140710|NCT01739231|3866428|FG003|Challenged|Part B||21
3140711|NCT01739231|3866425|FG000|COMPLETED|Part B||13
3140712|NCT01739231|3866426|FG001|COMPLETED|Part B||12
3140713|NCT01739231|3866427|FG002|COMPLETED|Part B||10
3140714|NCT01739231|3866428|FG003|COMPLETED|Part B||19
3140715|NCT01739231|3866425|FG000|NOT COMPLETED|Part B||7
3140716|NCT01739231|3866426|FG001|NOT COMPLETED|Part B||5
3140717|NCT01739231|3866427|FG002|NOT COMPLETED|Part B||2
3140718|NCT01739231|3866428|FG003|NOT COMPLETED|Part B||2
3140719|NCT01739309|3866446|FG000|STARTED|Overall Study||28
3140720|NCT01739309|3866446|FG000|Received at Least One Dose of Study Drug|Overall Study||28
3140721|NCT01739309|3866446|FG000|Death Due to Any Cause|Overall Study||17
3140722|NCT01739309|3866446|FG000|Alive and on Study, Off Treatment|Overall Study||8
3140723|NCT01739309|3866446|FG000|COMPLETED|Overall Study||25
3140724|NCT01739309|3866446|FG000|NOT COMPLETED|Overall Study||3
3140725|NCT01739335|3866454|FG000|STARTED|Overall Study||41
3140726|NCT01739335|3866455|FG001|STARTED|Overall Study||40
3140727|NCT01739335|3866454|FG000|COMPLETED|Overall Study||34
3140728|NCT01739335|3866455|FG001|COMPLETED|Overall Study||35
3140729|NCT01739335|3866454|FG000|NOT COMPLETED|Overall Study||7
3140730|NCT01739335|3866455|FG001|NOT COMPLETED|Overall Study||5
3140731|NCT01739348|3866469|FG000|STARTED|Part I (Base Study)||703
3140732|NCT01739348|3866470|FG001|STARTED|Part I (Base Study)||700
3140733|NCT01739348|3866471|FG002|STARTED|Part I (Base Study)||103
3140734|NCT01739348|3866472|FG003|STARTED|Part I (Base Study)||705
3140735|NCT01739348|3866469|FG000|Treated|Part I (Base Study)||702
3140736|NCT01739348|3866470|FG001|Treated|Part I (Base Study)||700
3140737|NCT01739348|3866471|FG002|Treated|Part I (Base Study)||103
3140738|NCT01739348|3866472|FG003|Treated|Part I (Base Study)||705
3140739|NCT01739348|3866469|FG000|COMPLETED|Part I (Base Study)||501
3140740|NCT01739348|3866470|FG001|COMPLETED|Part I (Base Study)||497
3140741|NCT01739348|3866471|FG002|COMPLETED|Part I (Base Study)||77
3140742|NCT01739348|3866472|FG003|COMPLETED|Part I (Base Study)||516
3140743|NCT01739348|3866469|FG000|NOT COMPLETED|Part I (Base Study)||202
3140744|NCT01739348|3866470|FG001|NOT COMPLETED|Part I (Base Study)||203
3140745|NCT01739348|3866471|FG002|NOT COMPLETED|Part I (Base Study)||26
3140746|NCT01739348|3866472|FG003|NOT COMPLETED|Part I (Base Study)||189
3180675|NCT01992549|3909144|FG000|SURG Population|Overall Study||3
3140747|NCT01739348|3866469|FG000|STARTED|Part II (Extension Study)|Number started refers only to participants completing Part I, volunteering to continue to Part II.|379
3140748|NCT01739348|3866470|FG001|STARTED|Part II (Extension Study)|Number started refers only to participants completing Part I, volunteering to continue to Part II.|366
3140749|NCT01739348|3866471|FG002|STARTED|Part II (Extension Study)|Number started refers only to participants completing Part I, volunteering to continue to Part II.|61
3140750|NCT01739348|3866472|FG003|STARTED|Part II (Extension Study)|Number started refers only to participants completing Part I, volunteering to continue to Part II.|396
3140751|NCT01739348|3866469|FG000|Treated|Part II (Extension Study)||379
3140752|NCT01739348|3866470|FG001|Treated|Part II (Extension Study)||365
3140753|NCT01739348|3866471|FG002|Treated|Part II (Extension Study)||61
3140754|NCT01739348|3866472|FG003|Treated|Part II (Extension Study)||394
3140755|NCT01739348|3866469|FG000|COMPLETED|Part II (Extension Study)||0
3140756|NCT01739348|3866470|FG001|COMPLETED|Part II (Extension Study)||0
3140757|NCT01739348|3866471|FG002|COMPLETED|Part II (Extension Study)||0
3140758|NCT01739348|3866472|FG003|COMPLETED|Part II (Extension Study)||0
3140759|NCT01739348|3866469|FG000|NOT COMPLETED|Part II (Extension Study)||379
3140760|NCT01739348|3866470|FG001|NOT COMPLETED|Part II (Extension Study)||366
3140761|NCT01739348|3866471|FG002|NOT COMPLETED|Part II (Extension Study)||61
3140762|NCT01739348|3866472|FG003|NOT COMPLETED|Part II (Extension Study)||396
3140763|NCT01739361|3866488|FG000|STARTED|Overall Study||21
3140764|NCT01739361|3866489|FG001|STARTED|Overall Study||23
3140765|NCT01739361|3866488|FG000|COMPLETED|Overall Study||18
3140766|NCT01739361|3866489|FG001|COMPLETED|Overall Study||22
3140767|NCT01739361|3866488|FG000|NOT COMPLETED|Overall Study||3
3140768|NCT01739361|3866489|FG001|NOT COMPLETED|Overall Study||1
3140769|NCT01739400|3866497|FG000|STARTED|Overall Study||109
3140770|NCT01739400|3866498|FG001|STARTED|Overall Study||108
3140771|NCT01739400|3866497|FG000|Treated With 10 mg Macitentan|Overall Study||109
3140772|NCT01739400|3866498|FG001|Treated With 10 mg Macitentan|Overall Study||108
3140773|NCT01739400|3866497|FG000|COMPLETED|Overall Study||92
3140774|NCT01739400|3866498|FG001|COMPLETED|Overall Study||99
3140775|NCT01739400|3866497|FG000|NOT COMPLETED|Overall Study||17
3140776|NCT01739400|3866498|FG001|NOT COMPLETED|Overall Study||9
3140777|NCT01739595|3866506|FG000|STARTED|Overall Study||112
3140778|NCT01739595|3866507|FG001|STARTED|Overall Study||22
3140779|NCT01739595|3866508|FG002|STARTED|Overall Study||47
3140780|NCT01739595|3866506|FG000|COMPLETED|Overall Study||99
3140781|NCT01739595|3866507|FG001|COMPLETED|Overall Study||21
3140782|NCT01739595|3866508|FG002|COMPLETED|Overall Study||45
3140783|NCT01739595|3866506|FG000|NOT COMPLETED|Overall Study||13
3140784|NCT01739595|3866507|FG001|NOT COMPLETED|Overall Study||1
3140785|NCT01739595|3866508|FG002|NOT COMPLETED|Overall Study||2
3140786|NCT01739699|3866517|FG000|STARTED|Overall Study||70
3140787|NCT01739699|3866518|FG001|STARTED|Overall Study||70
3140788|NCT01739699|3866517|FG000|COMPLETED|Overall Study||66
3140789|NCT01739699|3866518|FG001|COMPLETED|Overall Study||65
3140790|NCT01739699|3866517|FG000|NOT COMPLETED|Overall Study||4
3140791|NCT01739699|3866518|FG001|NOT COMPLETED|Overall Study||5
3140792|NCT01739764|3866527|FG000|STARTED|Overall Study||29
3140793|NCT01739764|3866528|FG001|STARTED|Overall Study||40
3140794|NCT01739764|3866529|FG002|STARTED|Overall Study||146
3140795|NCT01739764|3866527|FG000|COMPLETED|Overall Study||3
3140796|NCT01739764|3866528|FG001|COMPLETED|Overall Study||4
3140797|NCT01739764|3866529|FG002|COMPLETED|Overall Study||20
3140798|NCT01739764|3866527|FG000|NOT COMPLETED|Overall Study||26
3140799|NCT01739764|3866528|FG001|NOT COMPLETED|Overall Study||36
3140800|NCT01739764|3866529|FG002|NOT COMPLETED|Overall Study||126
3140801|NCT01739790|3866539|FG000|STARTED|Overall Study||24
3140802|NCT01739790|3866540|FG001|STARTED|Overall Study||27
3140803|NCT01739790|3866539|FG000|COMPLETED|Overall Study||22
3140804|NCT01739790|3866540|FG001|COMPLETED|Overall Study||23
3140805|NCT01739790|3866539|FG000|NOT COMPLETED|Overall Study||2
3140806|NCT01739790|3866540|FG001|NOT COMPLETED|Overall Study||4
3140807|NCT01739803|3866548|FG000|STARTED|Overall Study||76
3140808|NCT01739803|3866549|FG001|STARTED|Overall Study||74
3140809|NCT01739803|3866548|FG000|COMPLETED|Overall Study||67
3140810|NCT01739803|3866549|FG001|COMPLETED|Overall Study||68
3140811|NCT01739803|3866548|FG000|NOT COMPLETED|Overall Study||9
3140812|NCT01739803|3866549|FG001|NOT COMPLETED|Overall Study||6
3140813|NCT01739933|3866557|FG000|STARTED|Overall Study|Underwent randomization and received study drug|214
3140814|NCT01739933|3866558|FG001|STARTED|Overall Study|Underwent randomization and received study drug|208
3140815|NCT01739933|3866557|FG000|Discharged From Hospital and Eligible for Follow-up|Overall Study||140
3140816|NCT01739933|3866558|FG001|Discharged From Hospital and Eligible for Follow-up|Overall Study||147
3140817|NCT01739933|3866557|FG000|COMPLETED|Overall Study|97% of those eligible (alive and who did not withdraw)|108
3140818|NCT01739933|3866558|FG001|COMPLETED|Overall Study|91% of those eligible (alive and who did not withdraw)|101
3140819|NCT01739933|3866557|FG000|NOT COMPLETED|Overall Study||106
3140820|NCT01739933|3866558|FG001|NOT COMPLETED|Overall Study||107
3140821|NCT01740089|3866567|FG000|STARTED|First 12 Weeks of Treatment||50
3140822|NCT01740089|3866568|FG001|STARTED|First 12 Weeks of Treatment||50
3140823|NCT01740089|3866569|FG002|STARTED|First 12 Weeks of Treatment||50
3140824|NCT01740089|3866567|FG000|COMPLETED|First 12 Weeks of Treatment||50
3140825|NCT01740089|3866568|FG001|COMPLETED|First 12 Weeks of Treatment|"Withdrawn due to:~AE before W12 (n=1) Withdrew consent before W12 (n=1)"|48
3140826|NCT01740089|3866569|FG002|COMPLETED|First 12 Weeks of Treatment|"Withdrawn due to:~AE before W12 (n=2)"|48
3140827|NCT01740089|3866567|FG000|NOT COMPLETED|First 12 Weeks of Treatment||0
3140828|NCT01740089|3866568|FG001|NOT COMPLETED|First 12 Weeks of Treatment||2
3140829|NCT01740089|3866569|FG002|NOT COMPLETED|First 12 Weeks of Treatment||2
3140830|NCT01740089|3866567|FG000|STARTED|After 12 Weeks||50
3140831|NCT01740089|3866568|FG001|STARTED|After 12 Weeks||48
3140832|NCT01740089|3866569|FG002|STARTED|After 12 Weeks||48
3140833|NCT01740089|3866567|FG000|COMPLETED|After 12 Weeks|"Withdrawn due to:~No EVR (n=3) AE (n=2) No EOT (n=1) Non-compliance (n=1)"|43
3140834|NCT01740089|3866568|FG001|COMPLETED|After 12 Weeks|"Withdrawn due to:~Withdrawn consent (n=1) No EVR (n=1) Non-compliance (n=1)"|45
3140835|NCT01740089|3866569|FG002|COMPLETED|After 12 Weeks|"Withdrawn due to:~No EVR (n=4) AE (n=5) Non-attendance of visit (n=1) Withdrawn consent (n=1)"|37
3140836|NCT01740089|3866567|FG000|NOT COMPLETED|After 12 Weeks||7
3140837|NCT01740089|3866568|FG001|NOT COMPLETED|After 12 Weeks||3
3140838|NCT01740089|3866569|FG002|NOT COMPLETED|After 12 Weeks||11
3140839|NCT01740128|3866580|FG000|STARTED|Overall Study||10
3140840|NCT01740128|3866581|FG001|STARTED|Overall Study||11
3140841|NCT01740128|3866580|FG000|COMPLETED|Overall Study||4
3140842|NCT01740128|3866581|FG001|COMPLETED|Overall Study||4
3140843|NCT01740128|3866580|FG000|NOT COMPLETED|Overall Study||6
3140844|NCT01740128|3866581|FG001|NOT COMPLETED|Overall Study||7
3140845|NCT01740206|3866589|FG000|STARTED|Overall Study||14
3140846|NCT01740206|3866590|FG001|STARTED|Overall Study||34
3140847|NCT01740206|3866589|FG000|COMPLETED|Overall Study||14
3140848|NCT01740206|3866590|FG001|COMPLETED|Overall Study||34
3140849|NCT01740206|3866589|FG000|NOT COMPLETED|Overall Study||0
3140850|NCT01740206|3866590|FG001|NOT COMPLETED|Overall Study||0
3140851|NCT01740258|3866596|FG000|STARTED|Overall Study||68
3140852|NCT01740258|3866596|FG000|Entered Part A|Overall Study||68
3140853|NCT01740258|3866596|FG000|Entered Part B|Overall Study||62
3140854|NCT01740258|3866596|FG000|Entered Part C|Overall Study||20
3140855|NCT01740258|3866596|FG000|Entered Part D|Overall Study||42
3140856|NCT01740258|3866596|FG000|COMPLETED|Overall Study||68
3140857|NCT01740258|3866596|FG000|NOT COMPLETED|Overall Study||0
3140858|NCT01740297|3866603|FG000|STARTED|Overall Study||19
3140859|NCT01740297|3866604|FG001|STARTED|Overall Study||100
3140860|NCT01740297|3866605|FG002|STARTED|Overall Study||98
3140861|NCT01740297|3866603|FG000|Received Talimogene Laherparepvec|Overall Study||19
3140862|NCT01740297|3866604|FG001|Received Talimogene Laherparepvec|Overall Study||0
3140863|NCT01740297|3866605|FG002|Received Talimogene Laherparepvec|Overall Study||95
3140864|NCT01740297|3866603|FG000|Received Ipilimumab|Overall Study||18
3140865|NCT01740297|3866604|FG001|Received Ipilimumab|Overall Study||95
3140866|NCT01740297|3866605|FG002|Received Ipilimumab|Overall Study||92
3140867|NCT01740297|3866603|FG000|COMPLETED|Overall Study||0
3140868|NCT01740297|3866604|FG001|COMPLETED|Overall Study||0
3180676|NCT01992549|3909144|FG000|COMPLETED|Overall Study||44
3180677|NCT01992549|3909144|FG000|NOT COMPLETED|Overall Study||4
3180678|NCT01992757|3909154|FG000|STARTED|Overall Study||51
3180679|NCT01992757|3909154|FG000|COMPLETED|Overall Study||49
3180680|NCT01992757|3909154|FG000|NOT COMPLETED|Overall Study||2
3180681|NCT01992874|3909159|FG000|STARTED|Part A||21
3180682|NCT01992874|3909160|FG001|STARTED|Part A||17
3180683|NCT01992874|3909161|FG002|STARTED|Part A||0
3140869|NCT01740297|3866605|FG002|COMPLETED|Overall Study||0
3140870|NCT01740297|3866603|FG000|NOT COMPLETED|Overall Study||19
3140871|NCT01740297|3866604|FG001|NOT COMPLETED|Overall Study||100
3140872|NCT01740297|3866605|FG002|NOT COMPLETED|Overall Study||98
3140873|NCT01740323|3866617|FG000|STARTED|Overall Study||15
3140874|NCT01740323|3866618|FG001|STARTED|Overall Study||15
3140875|NCT01740323|3866617|FG000|COMPLETED|Overall Study||13
3140876|NCT01740323|3866618|FG001|COMPLETED|Overall Study||15
3140877|NCT01740323|3866617|FG000|NOT COMPLETED|Overall Study||2
3140878|NCT01740323|3866618|FG001|NOT COMPLETED|Overall Study||0
3140879|NCT01740362|3866628|FG000|STARTED|Overall Study||6
3140880|NCT01740362|3866629|FG001|STARTED|Overall Study||6
3140881|NCT01740362|3866630|FG002|STARTED|Overall Study||6
3140882|NCT01740362|3866631|FG003|STARTED|Overall Study||6
3140883|NCT01740362|3866628|FG000|COMPLETED|Overall Study||6
3140884|NCT01740362|3866629|FG001|COMPLETED|Overall Study||6
3140885|NCT01740362|3866630|FG002|COMPLETED|Overall Study||6
3140886|NCT01740362|3866631|FG003|COMPLETED|Overall Study||6
3140887|NCT01740362|3866628|FG000|NOT COMPLETED|Overall Study||0
3140888|NCT01740362|3866629|FG001|NOT COMPLETED|Overall Study||0
3140889|NCT01740362|3866630|FG002|NOT COMPLETED|Overall Study||0
3140890|NCT01740362|3866631|FG003|NOT COMPLETED|Overall Study||0
3140891|NCT01740388|3866643|FG000|STARTED|Overall Study||64
3140892|NCT01740388|3866644|FG001|STARTED|Overall Study||72
3140893|NCT01740388|3866643|FG000|COMPLETED|Overall Study||18
3140894|NCT01740388|3866644|FG001|COMPLETED|Overall Study||28
3140895|NCT01740388|3866643|FG000|NOT COMPLETED|Overall Study||46
3140896|NCT01740388|3866644|FG001|NOT COMPLETED|Overall Study||44
3140897|NCT01740401|3866650|FG000|STARTED|Overall Study||10
3140898|NCT01740401|3866650|FG000|COMPLETED|Overall Study||0
3140899|NCT01740401|3866650|FG000|NOT COMPLETED|Overall Study||10
3140900|NCT01740414|3866656|FG000|STARTED|Overall Study||12
3140901|NCT01740414|3866657|FG001|STARTED|Overall Study||16
3140902|NCT01740414|3866656|FG000|COMPLETED|Overall Study||3
3140903|NCT01740414|3866657|FG001|COMPLETED|Overall Study||8
3140904|NCT01740414|3866656|FG000|NOT COMPLETED|Overall Study||9
3140905|NCT01740414|3866657|FG001|NOT COMPLETED|Overall Study||8
3140906|NCT01740427|3866670|FG000|STARTED|Overall Study||444
3140907|NCT01740427|3866671|FG001|STARTED|Overall Study||222
3140908|NCT01740427|3866670|FG000|COMPLETED|Overall Study||0
3140909|NCT01740427|3866671|FG001|COMPLETED|Overall Study||0
3140910|NCT01740427|3866670|FG000|NOT COMPLETED|Overall Study||444
3140911|NCT01740427|3866671|FG001|NOT COMPLETED|Overall Study||222
3140912|NCT01740440|3866677|FG000|STARTED|Overall Study||30
3140913|NCT01740440|3866677|FG000|COMPLETED|Overall Study||27
3140914|NCT01740440|3866677|FG000|NOT COMPLETED|Overall Study||3
3140915|NCT01740713|3866685|FG000|STARTED|Overall Study||6
3140916|NCT01740713|3866686|FG001|STARTED|Overall Study||8
3140917|NCT01740713|3866687|FG002|STARTED|Overall Study||7
3140918|NCT01740713|3866685|FG000|COMPLETED|Overall Study||6
3140919|NCT01740713|3866686|FG001|COMPLETED|Overall Study||6
3140920|NCT01740713|3866687|FG002|COMPLETED|Overall Study||6
3140921|NCT01740713|3866685|FG000|NOT COMPLETED|Overall Study||0
3140922|NCT01740713|3866686|FG001|NOT COMPLETED|Overall Study||2
3140923|NCT01740713|3866687|FG002|NOT COMPLETED|Overall Study||1
3140924|NCT01740726|3866699|FG000|STARTED|Overall Study||0
3140925|NCT01740726|3866700|FG001|STARTED|Overall Study||1
3140926|NCT01740726|3866699|FG000|COMPLETED|Overall Study||0
3140927|NCT01740726|3866700|FG001|COMPLETED|Overall Study||1
3140928|NCT01740726|3866699|FG000|NOT COMPLETED|Overall Study||0
3140929|NCT01740726|3866700|FG001|NOT COMPLETED|Overall Study||0
3140930|NCT01740791|3866712|FG000|STARTED|Overall Study||22
3140931|NCT01740791|3866713|FG001|STARTED|Overall Study||7
3140932|NCT01740791|3866714|FG002|STARTED|Overall Study||17
3140933|NCT01740791|3866715|FG003|STARTED|Overall Study||14
3140934|NCT01740791|3866716|FG004|STARTED|Overall Study||9
3140935|NCT01740791|3866717|FG005|STARTED|Overall Study||34
3140936|NCT01740791|3866712|FG000|COMPLETED|Overall Study||10
3140937|NCT01740791|3866713|FG001|COMPLETED|Overall Study||4
3140938|NCT01740791|3866714|FG002|COMPLETED|Overall Study||11
3140939|NCT01740791|3866715|FG003|COMPLETED|Overall Study||7
3140940|NCT01740791|3866716|FG004|COMPLETED|Overall Study||6
3140941|NCT01740791|3866717|FG005|COMPLETED|Overall Study||23
3140942|NCT01740791|3866712|FG000|NOT COMPLETED|Overall Study||12
3140943|NCT01740791|3866713|FG001|NOT COMPLETED|Overall Study||3
3140944|NCT01740791|3866714|FG002|NOT COMPLETED|Overall Study||6
3140945|NCT01740791|3866715|FG003|NOT COMPLETED|Overall Study||7
3140946|NCT01740791|3866716|FG004|NOT COMPLETED|Overall Study||3
3140947|NCT01740791|3866717|FG005|NOT COMPLETED|Overall Study||11
3140948|NCT01740817|3866772|FG000|STARTED|First Intervention (48 h)||8
3140949|NCT01740817|3866773|FG001|STARTED|First Intervention (48 h)||4
3140950|NCT01740817|3866772|FG000|COMPLETED|First Intervention (48 h)||8
3140951|NCT01740817|3866773|FG001|COMPLETED|First Intervention (48 h)||4
3140952|NCT01740817|3866772|FG000|NOT COMPLETED|First Intervention (48 h)||0
3140953|NCT01740817|3866773|FG001|NOT COMPLETED|First Intervention (48 h)||0
3140954|NCT01740817|3866772|FG000|STARTED|Washout (4-6 Weeks)||8
3140955|NCT01740817|3866773|FG001|STARTED|Washout (4-6 Weeks)||4
3140956|NCT01740817|3866772|FG000|COMPLETED|Washout (4-6 Weeks)||8
3140957|NCT01740817|3866773|FG001|COMPLETED|Washout (4-6 Weeks)||4
3140958|NCT01740817|3866772|FG000|NOT COMPLETED|Washout (4-6 Weeks)||0
3140959|NCT01740817|3866773|FG001|NOT COMPLETED|Washout (4-6 Weeks)||0
3140960|NCT01740817|3866772|FG000|STARTED|Second Intervention (48 h)||8
3140961|NCT01740817|3866773|FG001|STARTED|Second Intervention (48 h)||4
3140962|NCT01740817|3866772|FG000|COMPLETED|Second Intervention (48 h)||8
3140963|NCT01740817|3866773|FG001|COMPLETED|Second Intervention (48 h)||4
3140964|NCT01740817|3866772|FG000|NOT COMPLETED|Second Intervention (48 h)||0
3140965|NCT01740817|3866773|FG001|NOT COMPLETED|Second Intervention (48 h)||0
3140966|NCT01741012|3866779|FG000|STARTED|Overall Study||37
3140967|NCT01741012|3866779|FG000|COMPLETED|Overall Study||34
3140968|NCT01741012|3866779|FG000|NOT COMPLETED|Overall Study||3
3140969|NCT01741259|3866786|FG000|STARTED|Overall Study||133
3140970|NCT01741259|3866787|FG001|STARTED|Overall Study||135
3140971|NCT01741259|3866786|FG000|COMPLETED|Overall Study||127
3140972|NCT01741259|3866787|FG001|COMPLETED|Overall Study||129
3140973|NCT01741259|3866786|FG000|NOT COMPLETED|Overall Study||6
3140974|NCT01741259|3866787|FG001|NOT COMPLETED|Overall Study||6
3140975|NCT01741272|3866795|FG000|STARTED|Overall Study||92
3140976|NCT01741272|3866796|FG001|STARTED|Overall Study||97
3140977|NCT01741272|3866795|FG000|COMPLETED|Overall Study||92
3140978|NCT01741272|3866796|FG001|COMPLETED|Overall Study||97
3140979|NCT01741272|3866795|FG000|NOT COMPLETED|Overall Study||0
3140980|NCT01741272|3866796|FG001|NOT COMPLETED|Overall Study||0
3140981|NCT01741350|3866804|FG000|STARTED|Study Intervention||149
3140982|NCT01741350|3866805|FG001|STARTED|Study Intervention||155
3140983|NCT01741350|3866804|FG000|COMPLETED|Study Intervention||149
3140984|NCT01741350|3866805|FG001|COMPLETED|Study Intervention||155
3140985|NCT01741350|3866804|FG000|NOT COMPLETED|Study Intervention||0
3140986|NCT01741350|3866805|FG001|NOT COMPLETED|Study Intervention||0
3140987|NCT01741350|3866804|FG000|STARTED|Post Intervention Assessment (at Week 4)||149
3140988|NCT01741350|3866805|FG001|STARTED|Post Intervention Assessment (at Week 4)||155
3140989|NCT01741350|3866804|FG000|COMPLETED|Post Intervention Assessment (at Week 4)||135
3140990|NCT01741350|3866805|FG001|COMPLETED|Post Intervention Assessment (at Week 4)||141
3140991|NCT01741350|3866804|FG000|NOT COMPLETED|Post Intervention Assessment (at Week 4)||14
3140992|NCT01741350|3866805|FG001|NOT COMPLETED|Post Intervention Assessment (at Week 4)||14
3140993|NCT01741350|3866804|FG000|STARTED|3-Month Follow-up Assessment||135
3140994|NCT01741350|3866805|FG001|STARTED|3-Month Follow-up Assessment||141
3140995|NCT01741350|3866804|FG000|COMPLETED|3-Month Follow-up Assessment||129
3140996|NCT01741350|3866805|FG001|COMPLETED|3-Month Follow-up Assessment||119
3140997|NCT01741350|3866804|FG000|NOT COMPLETED|3-Month Follow-up Assessment||6
3140998|NCT01741350|3866805|FG001|NOT COMPLETED|3-Month Follow-up Assessment||22
3140999|NCT01741350|3866804|FG000|STARTED|6-Month Follow-up Assessment||129
3141000|NCT01741350|3866805|FG001|STARTED|6-Month Follow-up Assessment||119
3141001|NCT01741350|3866804|FG000|COMPLETED|6-Month Follow-up Assessment||114
3141002|NCT01741350|3866805|FG001|COMPLETED|6-Month Follow-up Assessment||111
3141003|NCT01741350|3866804|FG000|NOT COMPLETED|6-Month Follow-up Assessment||15
3141004|NCT01741350|3866805|FG001|NOT COMPLETED|6-Month Follow-up Assessment||8
3141005|NCT01741350|3866804|FG000|STARTED|12-Month Follow-up Assessment||114
3141006|NCT01741350|3866805|FG001|STARTED|12-Month Follow-up Assessment||111
3141007|NCT01741350|3866804|FG000|COMPLETED|12-Month Follow-up Assessment||111
3141008|NCT01741350|3866805|FG001|COMPLETED|12-Month Follow-up Assessment||109
3141009|NCT01741350|3866804|FG000|NOT COMPLETED|12-Month Follow-up Assessment||3
3141010|NCT01741350|3866805|FG001|NOT COMPLETED|12-Month Follow-up Assessment||2
3141011|NCT01741454|3866815|FG000|STARTED|Overall Study||49
3141012|NCT01741454|3866816|FG001|STARTED|Overall Study||50
3141013|NCT01741454|3866817|FG002|STARTED|Overall Study||39
3141014|NCT01741454|3866818|FG003|STARTED|Overall Study||43
3141015|NCT01741454|3866815|FG000|COMPLETED|Overall Study||36
3141016|NCT01741454|3866816|FG001|COMPLETED|Overall Study||44
3141017|NCT01741454|3866817|FG002|COMPLETED|Overall Study||22
3141018|NCT01741454|3866818|FG003|COMPLETED|Overall Study||21
3141019|NCT01741454|3866815|FG000|NOT COMPLETED|Overall Study||13
3141020|NCT01741454|3866816|FG001|NOT COMPLETED|Overall Study||6
3141021|NCT01741454|3866817|FG002|NOT COMPLETED|Overall Study||17
3141022|NCT01741454|3866818|FG003|NOT COMPLETED|Overall Study||22
3141023|NCT01741480|3866834|FG000|STARTED|Overall Study||285
3141024|NCT01741480|3866835|FG001|STARTED|Overall Study||286
3141025|NCT01741480|3866834|FG000|COMPLETED|Overall Study||285
3141026|NCT01741480|3866835|FG001|COMPLETED|Overall Study||286
3141027|NCT01741480|3866834|FG000|NOT COMPLETED|Overall Study||0
3141028|NCT01741480|3866835|FG001|NOT COMPLETED|Overall Study||0
3141029|NCT01741532|3866843|FG000|STARTED|Overall Study||59
3141030|NCT01741532|3866844|FG001|STARTED|Overall Study||30
3141031|NCT01741532|3866843|FG000|Exposed|Overall Study||58
3141032|NCT01741532|3866844|FG001|Exposed|Overall Study||30
3141033|NCT01741532|3866843|FG000|Provided Post-baseline Efficacy Data|Overall Study||58
3141034|NCT01741532|3866844|FG001|Provided Post-baseline Efficacy Data|Overall Study||28
3141035|NCT01741532|3866843|FG000|COMPLETED|Overall Study||49
3141036|NCT01741532|3866844|FG001|COMPLETED|Overall Study||27
3141037|NCT01741532|3866843|FG000|NOT COMPLETED|Overall Study||10
3141038|NCT01741532|3866844|FG001|NOT COMPLETED|Overall Study||3
3141039|NCT01741545|3866856|FG000|STARTED|Treatment Period||12
3141040|NCT01741545|3866857|FG001|STARTED|Treatment Period||39
3141041|NCT01741545|3866856|FG000|COMPLETED|Treatment Period||11
3141042|NCT01741545|3866857|FG001|COMPLETED|Treatment Period||35
3141043|NCT01741545|3866856|FG000|NOT COMPLETED|Treatment Period||1
3141044|NCT01741545|3866857|FG001|NOT COMPLETED|Treatment Period||4
3141045|NCT01741545|3866856|FG000|STARTED|Follow-up Period (24 Weeks)|1 participant re-joined Cohort A in follow-up period.|12
3141046|NCT01741545|3866857|FG001|STARTED|Follow-up Period (24 Weeks)|4 participants re-joined Cohort B in follow-up period.|39
3141047|NCT01741545|3866856|FG000|COMPLETED|Follow-up Period (24 Weeks)||11
3141048|NCT01741545|3866857|FG001|COMPLETED|Follow-up Period (24 Weeks)||37
3141049|NCT01741545|3866856|FG000|NOT COMPLETED|Follow-up Period (24 Weeks)||1
3141050|NCT01741545|3866857|FG001|NOT COMPLETED|Follow-up Period (24 Weeks)||2
3141051|NCT01741688|3866863|FG000|STARTED|Overall Study||16
3141052|NCT01741688|3866863|FG000|COMPLETED|Overall Study||13
3141053|NCT01741688|3866863|FG000|NOT COMPLETED|Overall Study||3
3141054|NCT01741701|3866870|FG000|STARTED|Overall Study||18
3141055|NCT01741701|3866871|FG001|STARTED|Overall Study||15
3141056|NCT01741701|3866870|FG000|COMPLETED|Overall Study||13
3141057|NCT01741701|3866871|FG001|COMPLETED|Overall Study||13
3141058|NCT01741701|3866870|FG000|NOT COMPLETED|Overall Study||5
3141059|NCT01741701|3866871|FG001|NOT COMPLETED|Overall Study||2
3141060|NCT01741792|3866880|FG000|STARTED|Overall Study|3 participants were not considered evaluable and were replaced as specified in the protocol.|9
3141061|NCT01741792|3866881|FG001|STARTED|Overall Study|Cohort 2 was closed to enrollment on recommendation of the data monitoring committee|2
3141062|NCT01741792|3866882|FG002|STARTED|Overall Study||14
3141063|NCT01741792|3866880|FG000|Efficacy Set|Overall Study|Completed > 7 days of infusion on the highest intended dose level or discontinued due to progression|7
3141064|NCT01741792|3866881|FG001|Efficacy Set|Overall Study|Completed > 7 days of infusion on the highest intended dose level or discontinued due to progression|1
3141065|NCT01741792|3866882|FG002|Efficacy Set|Overall Study|Completed > 7 days of infusion on the highest intended dose level or discontinued due to progression|13
3141066|NCT01741792|3866880|FG000|COMPLETED|Overall Study||3
3141067|NCT01741792|3866881|FG001|COMPLETED|Overall Study||1
3141068|NCT01741792|3866882|FG002|COMPLETED|Overall Study||2
3141069|NCT01741792|3866880|FG000|NOT COMPLETED|Overall Study||6
3141070|NCT01741792|3866881|FG001|NOT COMPLETED|Overall Study||1
3141071|NCT01741792|3866882|FG002|NOT COMPLETED|Overall Study||12
3141072|NCT01742065|3866898|FG000|STARTED|Overall Study|20059 patients were analyzed in 13 clinics.|20059
3141073|NCT01742065|3866899|FG001|STARTED|Overall Study|21134 patients were analyzed in 13 clinics.|21134
3141074|NCT01742065|3866898|FG000|COMPLETED|Overall Study|20059 patients were analyzed in 13 clinics.|20059
3141075|NCT01742065|3866899|FG001|COMPLETED|Overall Study|21134 patients were analyzed in 13 clinics.|21134
3141076|NCT01742065|3866898|FG000|NOT COMPLETED|Overall Study||0
3141077|NCT01742065|3866899|FG001|NOT COMPLETED|Overall Study||0
3141078|NCT01742078|3866914|FG000|STARTED|Overall Study||6
3141079|NCT01742078|3866915|FG001|STARTED|Overall Study||6
3141080|NCT01742078|3866916|FG002|STARTED|Overall Study||6
3141081|NCT01742078|3866917|FG003|STARTED|Overall Study||6
3141082|NCT01742078|3866918|FG004|STARTED|Overall Study||6
3141083|NCT01742078|3866919|FG005|STARTED|Overall Study||6
3141084|NCT01742078|3866920|FG006|STARTED|Overall Study||6
3141085|NCT01742078|3866921|FG007|STARTED|Overall Study||6
3141086|NCT01742078|3866922|FG008|STARTED|Overall Study||12
3141087|NCT01742078|3866914|FG000|RECEIVED STUDY DRUG|Overall Study||6
3141088|NCT01742078|3866915|FG001|RECEIVED STUDY DRUG|Overall Study||6
3141089|NCT01742078|3866916|FG002|RECEIVED STUDY DRUG|Overall Study||6
3141090|NCT01742078|3866917|FG003|RECEIVED STUDY DRUG|Overall Study||6
3141091|NCT01742078|3866918|FG004|RECEIVED STUDY DRUG|Overall Study||6
3141092|NCT01742078|3866919|FG005|RECEIVED STUDY DRUG|Overall Study||6
3141093|NCT01742078|3866920|FG006|RECEIVED STUDY DRUG|Overall Study||6
3141094|NCT01742078|3866921|FG007|RECEIVED STUDY DRUG|Overall Study||6
3141095|NCT01742078|3866922|FG008|RECEIVED STUDY DRUG|Overall Study||12
3141096|NCT01742078|3866914|FG000|COMPLETED|Overall Study||6
3141097|NCT01742078|3866915|FG001|COMPLETED|Overall Study||6
3141098|NCT01742078|3866916|FG002|COMPLETED|Overall Study||6
3141099|NCT01742078|3866917|FG003|COMPLETED|Overall Study||5
3141100|NCT01742078|3866918|FG004|COMPLETED|Overall Study||6
3141101|NCT01742078|3866919|FG005|COMPLETED|Overall Study||6
3141102|NCT01742078|3866920|FG006|COMPLETED|Overall Study||6
3141103|NCT01742078|3866921|FG007|COMPLETED|Overall Study||6
3141104|NCT01742078|3866922|FG008|COMPLETED|Overall Study||12
3141105|NCT01742078|3866914|FG000|NOT COMPLETED|Overall Study||0
3141106|NCT01742078|3866915|FG001|NOT COMPLETED|Overall Study||0
3141107|NCT01742078|3866916|FG002|NOT COMPLETED|Overall Study||0
3141108|NCT01742078|3866917|FG003|NOT COMPLETED|Overall Study||1
3141109|NCT01742078|3866918|FG004|NOT COMPLETED|Overall Study||0
3141110|NCT01742078|3866919|FG005|NOT COMPLETED|Overall Study||0
3141111|NCT01742078|3866920|FG006|NOT COMPLETED|Overall Study||0
3141112|NCT01742078|3866921|FG007|NOT COMPLETED|Overall Study||0
3141113|NCT01742078|3866922|FG008|NOT COMPLETED|Overall Study||0
3141114|NCT01742091|3866950|FG000|STARTED|Overall Study||9
3141115|NCT01742091|3866951|FG001|STARTED|Overall Study||11
3141116|NCT01742091|3866952|FG002|STARTED|Overall Study||10
3141117|NCT01742091|3866953|FG003|STARTED|Overall Study||9
3141118|NCT01742091|3866954|FG004|STARTED|Overall Study||8
3141119|NCT01742091|3866955|FG005|STARTED|Overall Study||12
3141120|NCT01742091|3866950|FG000|RECEIVED STUDY DRUG|Overall Study||9
3141121|NCT01742091|3866951|FG001|RECEIVED STUDY DRUG|Overall Study||11
3141122|NCT01742091|3866952|FG002|RECEIVED STUDY DRUG|Overall Study||10
3141123|NCT01742091|3866953|FG003|RECEIVED STUDY DRUG|Overall Study||9
3141124|NCT01742091|3866954|FG004|RECEIVED STUDY DRUG|Overall Study||8
3141125|NCT01742091|3866955|FG005|RECEIVED STUDY DRUG|Overall Study||12
3141126|NCT01742091|3866950|FG000|COMPLETED|Overall Study||9
3141127|NCT01742091|3866951|FG001|COMPLETED|Overall Study||11
3141128|NCT01742091|3866952|FG002|COMPLETED|Overall Study||10
3141129|NCT01742091|3866953|FG003|COMPLETED|Overall Study||8
3141130|NCT01742091|3866954|FG004|COMPLETED|Overall Study||7
3141131|NCT01742091|3866955|FG005|COMPLETED|Overall Study||10
3141132|NCT01742091|3866950|FG000|NOT COMPLETED|Overall Study||0
3141133|NCT01742091|3866951|FG001|NOT COMPLETED|Overall Study||0
3141134|NCT01742091|3866952|FG002|NOT COMPLETED|Overall Study||0
3141135|NCT01742091|3866953|FG003|NOT COMPLETED|Overall Study||1
3141136|NCT01742091|3866954|FG004|NOT COMPLETED|Overall Study||1
3141137|NCT01742091|3866955|FG005|NOT COMPLETED|Overall Study||2
3141138|NCT01742117|3866971|FG000|STARTED|Overall Study||2641
3141139|NCT01742117|3866972|FG001|STARTED|Overall Study||2635
3141140|NCT01742117|3866971|FG000|COMPLETED|Overall Study||2641
3141141|NCT01742117|3866972|FG001|COMPLETED|Overall Study||2635
3141142|NCT01742117|3866971|FG000|NOT COMPLETED|Overall Study||0
3141143|NCT01742117|3866972|FG001|NOT COMPLETED|Overall Study||0
3141144|NCT01742208|3866981|FG000|STARTED|Overall Study||3
3141145|NCT01742208|3866982|FG001|STARTED|Overall Study||17
3141146|NCT01742208|3866983|FG002|STARTED|Overall Study||16
3141147|NCT01742208|3866981|FG000|COMPLETED|Overall Study||3
3141148|NCT01742208|3866982|FG001|COMPLETED|Overall Study||17
3141149|NCT01742208|3866983|FG002|COMPLETED|Overall Study||16
3141150|NCT01742208|3866981|FG000|NOT COMPLETED|Overall Study||0
3141151|NCT01742208|3866982|FG001|NOT COMPLETED|Overall Study||0
3141152|NCT01742208|3866983|FG002|NOT COMPLETED|Overall Study||0
3141153|NCT01742286|3867000|FG000|STARTED|Escalation Phase||5
3141154|NCT01742286|3867001|FG001|STARTED|Escalation Phase||12
3141155|NCT01742286|3867002|FG002|STARTED|Escalation Phase||6
3141156|NCT01742286|3867003|FG003|STARTED|Escalation Phase||2
3141157|NCT01742286|3867004|FG004|STARTED|Escalation Phase||4
3141158|NCT01742286|3867005|FG005|STARTED|Escalation Phase||5
3141159|NCT01742286|3867006|FG006|STARTED|Escalation Phase||6
3141160|NCT01742286|3867000|FG000|Ended Treatment = Not Completed)|Escalation Phase||5
3141161|NCT01742286|3867001|FG001|Ended Treatment = Not Completed)|Escalation Phase||12
3141162|NCT01742286|3867002|FG002|Ended Treatment = Not Completed)|Escalation Phase||6
3141163|NCT01742286|3867003|FG003|Ended Treatment = Not Completed)|Escalation Phase||2
3141164|NCT01742286|3867004|FG004|Ended Treatment = Not Completed)|Escalation Phase||4
3141165|NCT01742286|3867005|FG005|Ended Treatment = Not Completed)|Escalation Phase||5
3141166|NCT01742286|3867006|FG006|Ended Treatment = Not Completed)|Escalation Phase||6
3141167|NCT01742286|3867000|FG000|COMPLETED|Escalation Phase||0
3141168|NCT01742286|3867001|FG001|COMPLETED|Escalation Phase||0
3141169|NCT01742286|3867002|FG002|COMPLETED|Escalation Phase||0
3141170|NCT01742286|3867003|FG003|COMPLETED|Escalation Phase||0
3141171|NCT01742286|3867004|FG004|COMPLETED|Escalation Phase||0
3141172|NCT01742286|3867005|FG005|COMPLETED|Escalation Phase||0
3141173|NCT01742286|3867006|FG006|COMPLETED|Escalation Phase||0
3141174|NCT01742286|3867000|FG000|NOT COMPLETED|Escalation Phase||5
3141175|NCT01742286|3867001|FG001|NOT COMPLETED|Escalation Phase||12
3141176|NCT01742286|3867002|FG002|NOT COMPLETED|Escalation Phase||6
3141177|NCT01742286|3867003|FG003|NOT COMPLETED|Escalation Phase||2
3141178|NCT01742286|3867004|FG004|NOT COMPLETED|Escalation Phase||4
3141179|NCT01742286|3867005|FG005|NOT COMPLETED|Escalation Phase||5
3141180|NCT01742286|3867006|FG006|NOT COMPLETED|Escalation Phase||6
3141181|NCT01742286|3867000|FG000|STARTED|Expansion Phase||0
3141182|NCT01742286|3867001|FG001|STARTED|Expansion Phase||0
3141183|NCT01742286|3867002|FG002|STARTED|Expansion Phase||7
3141184|NCT01742286|3867003|FG003|STARTED|Expansion Phase||0
3141185|NCT01742286|3867004|FG004|STARTED|Expansion Phase||0
3141186|NCT01742286|3867005|FG005|STARTED|Expansion Phase||0
3141187|NCT01742286|3867006|FG006|STARTED|Expansion Phase||36
3141188|NCT01742286|3867000|FG000|End of Treatment = Not Ccompleted|Expansion Phase||0
3141189|NCT01742286|3867001|FG001|End of Treatment = Not Ccompleted|Expansion Phase||0
3141190|NCT01742286|3867002|FG002|End of Treatment = Not Ccompleted|Expansion Phase||7
3141191|NCT01742286|3867003|FG003|End of Treatment = Not Ccompleted|Expansion Phase||0
3141192|NCT01742286|3867004|FG004|End of Treatment = Not Ccompleted|Expansion Phase||0
3141193|NCT01742286|3867005|FG005|End of Treatment = Not Ccompleted|Expansion Phase||0
3141194|NCT01742286|3867006|FG006|End of Treatment = Not Ccompleted|Expansion Phase||36
3141195|NCT01742286|3867000|FG000|COMPLETED|Expansion Phase||0
3141196|NCT01742286|3867001|FG001|COMPLETED|Expansion Phase||0
3141197|NCT01742286|3867002|FG002|COMPLETED|Expansion Phase||0
3141198|NCT01742286|3867003|FG003|COMPLETED|Expansion Phase||0
3141199|NCT01742286|3867004|FG004|COMPLETED|Expansion Phase||0
3141200|NCT01742286|3867005|FG005|COMPLETED|Expansion Phase||0
3141201|NCT01742286|3867006|FG006|COMPLETED|Expansion Phase||0
3141202|NCT01742286|3867000|FG000|NOT COMPLETED|Expansion Phase||0
3141203|NCT01742286|3867001|FG001|NOT COMPLETED|Expansion Phase||0
3141204|NCT01742286|3867002|FG002|NOT COMPLETED|Expansion Phase||7
3141205|NCT01742286|3867003|FG003|NOT COMPLETED|Expansion Phase||0
3141206|NCT01742286|3867004|FG004|NOT COMPLETED|Expansion Phase||0
3141207|NCT01742286|3867005|FG005|NOT COMPLETED|Expansion Phase||0
3141208|NCT01742286|3867006|FG006|NOT COMPLETED|Expansion Phase||36
3141209|NCT01742364|3867033|FG000|STARTED|Overall Study||33
3141210|NCT01742364|3867034|FG001|STARTED|Overall Study||33
3141211|NCT01742364|3867035|FG002|STARTED|Overall Study||15
3141212|NCT01742364|3867036|FG003|STARTED|Overall Study||15
3141213|NCT01742364|3867033|FG000|COMPLETED|Overall Study||33
3141214|NCT01742364|3867034|FG001|COMPLETED|Overall Study||33
3141215|NCT01742364|3867035|FG002|COMPLETED|Overall Study||15
3141216|NCT01742364|3867036|FG003|COMPLETED|Overall Study||15
3141217|NCT01742364|3867033|FG000|NOT COMPLETED|Overall Study||0
3141218|NCT01742364|3867034|FG001|NOT COMPLETED|Overall Study||0
3141219|NCT01742364|3867035|FG002|NOT COMPLETED|Overall Study||0
3141220|NCT01742364|3867036|FG003|NOT COMPLETED|Overall Study||0
3141221|NCT01742832|3867049|FG000|STARTED|Overall Study||20
3141222|NCT01742832|3867050|FG001|STARTED|Overall Study||28
3141223|NCT01742832|3867049|FG000|COMPLETED|Overall Study||19
3141224|NCT01742832|3867050|FG001|COMPLETED|Overall Study||23
3141225|NCT01742832|3867049|FG000|NOT COMPLETED|Overall Study||1
3141226|NCT01742832|3867050|FG001|NOT COMPLETED|Overall Study||5
3141227|NCT01742897|3867056|FG000|STARTED|Overall Study||35
3141228|NCT01742897|3867056|FG000|Treated|Overall Study||33
3141229|NCT01742897|3867056|FG000|COMPLETED|Overall Study||30
3141230|NCT01742897|3867056|FG000|NOT COMPLETED|Overall Study||5
3141231|NCT01742936|3867062|FG000|STARTED|Overall Study||50
3141232|NCT01742936|3867063|FG001|STARTED|Overall Study||50
3141233|NCT01742936|3867062|FG000|COMPLETED|Overall Study||50
3141234|NCT01742936|3867063|FG001|COMPLETED|Overall Study||50
3141235|NCT01742936|3867062|FG000|NOT COMPLETED|Overall Study||0
3141236|NCT01742936|3867063|FG001|NOT COMPLETED|Overall Study||0
3141237|NCT01742949|3867069|FG000|STARTED|Overall Study||20
3141238|NCT01742949|3867070|FG001|STARTED|Overall Study||20
3141239|NCT01742949|3867069|FG000|COMPLETED|Overall Study||20
3141240|NCT01742949|3867070|FG001|COMPLETED|Overall Study||20
3141241|NCT01742949|3867069|FG000|NOT COMPLETED|Overall Study||0
3141242|NCT01742949|3867070|FG001|NOT COMPLETED|Overall Study||0
3141243|NCT01743001|3867081|FG000|STARTED|Overall Study||114
3141244|NCT01743001|3867082|FG001|STARTED|Overall Study||112
3141245|NCT01743001|3867081|FG000|COMPLETED|Overall Study||111
3180684|NCT01992874|3909159|FG000|COMPLETED|Part A||21
3180685|NCT01992874|3909160|FG001|COMPLETED|Part A||17
3180686|NCT01992874|3909161|FG002|COMPLETED|Part A||0
3141246|NCT01743001|3867082|FG001|COMPLETED|Overall Study||112
3141247|NCT01743001|3867081|FG000|NOT COMPLETED|Overall Study||3
3141248|NCT01743001|3867082|FG001|NOT COMPLETED|Overall Study||0
3141249|NCT01743027|3867092|FG000|STARTED|Overall Study||98
3141250|NCT01743027|3867093|FG001|STARTED|Overall Study||99
3141251|NCT01743027|3867094|FG002|STARTED|Overall Study||99
3141252|NCT01743027|3867095|FG003|STARTED|Overall Study||49
3141253|NCT01743027|3867092|FG000|COMPLETED|Overall Study||93
3141254|NCT01743027|3867093|FG001|COMPLETED|Overall Study||94
3141255|NCT01743027|3867094|FG002|COMPLETED|Overall Study||90
3180687|NCT01992874|3909159|FG000|NOT COMPLETED|Part A||0
3141256|NCT01743027|3867095|FG003|COMPLETED|Overall Study||48
3141257|NCT01743027|3867092|FG000|NOT COMPLETED|Overall Study||5
3141258|NCT01743027|3867093|FG001|NOT COMPLETED|Overall Study||5
3141259|NCT01743027|3867094|FG002|NOT COMPLETED|Overall Study||9
3141260|NCT01743027|3867095|FG003|NOT COMPLETED|Overall Study||1
3141261|NCT01743040|3867105|FG000|STARTED|Overall Study||1014
3141262|NCT01743040|3867105|FG000|CADence Testing|Overall Study||1013
3141263|NCT01743040|3867105|FG000|Nuclear Stress Test|Overall Study||992
3141264|NCT01743040|3867105|FG000|CT and/or Standard Angiogram|Overall Study||785
3141265|NCT01743040|3867105|FG000|COMPLETED|Overall Study||785
3141266|NCT01743040|3867105|FG000|NOT COMPLETED|Overall Study||229
3141267|NCT01743092|3867111|FG000|STARTED|Overall Study||33
3141268|NCT01743092|3867112|FG001|STARTED|Overall Study||26
3141269|NCT01743092|3867111|FG000|COMPLETED|Overall Study||19
3141270|NCT01743092|3867112|FG001|COMPLETED|Overall Study||11
3141271|NCT01743092|3867111|FG000|NOT COMPLETED|Overall Study||14
3141272|NCT01743092|3867112|FG001|NOT COMPLETED|Overall Study||15
3141273|NCT01743131|3867122|FG000|STARTED|Overall Study||73
3141274|NCT01743131|3867123|FG001|STARTED|Overall Study||69
3141275|NCT01743131|3867124|FG002|STARTED|Overall Study||43
3141276|NCT01743131|3867125|FG003|STARTED|Overall Study||1
3141277|NCT01743131|3867126|FG004|STARTED|Overall Study||127
3141278|NCT01743131|3867122|FG000|Not Included in Analysis|Overall Study||0
3141279|NCT01743131|3867123|FG001|Not Included in Analysis|Overall Study||0
3141280|NCT01743131|3867124|FG002|Not Included in Analysis|Overall Study||0
3141281|NCT01743131|3867125|FG003|Not Included in Analysis|Overall Study||1
3141282|NCT01743131|3867126|FG004|Not Included in Analysis|Overall Study||0
3141283|NCT01743131|3867122|FG000|COMPLETED|Overall Study||73
3141284|NCT01743131|3867123|FG001|COMPLETED|Overall Study||69
3141285|NCT01743131|3867124|FG002|COMPLETED|Overall Study||43
3141286|NCT01743131|3867125|FG003|COMPLETED|Overall Study||1
3141287|NCT01743131|3867126|FG004|COMPLETED|Overall Study||127
3141288|NCT01743131|3867122|FG000|NOT COMPLETED|Overall Study||0
3141289|NCT01743131|3867123|FG001|NOT COMPLETED|Overall Study||0
3141290|NCT01743131|3867124|FG002|NOT COMPLETED|Overall Study||0
3141291|NCT01743131|3867125|FG003|NOT COMPLETED|Overall Study||0
3141292|NCT01743131|3867126|FG004|NOT COMPLETED|Overall Study||0
3180688|NCT01992874|3909160|FG001|NOT COMPLETED|Part A||0
3180689|NCT01992874|3909161|FG002|NOT COMPLETED|Part A||0
3180690|NCT01992874|3909159|FG000|STARTED|Part B||0
3180691|NCT01992874|3909160|FG001|STARTED|Part B||0
3180692|NCT01992874|3909161|FG002|STARTED|Part B||38
3180693|NCT01992874|3909159|FG000|COMPLETED|Part B||0
3180694|NCT01992874|3909160|FG001|COMPLETED|Part B||0
3180695|NCT01992874|3909161|FG002|COMPLETED|Part B||38
3180696|NCT01992874|3909159|FG000|NOT COMPLETED|Part B||0
3180697|NCT01992874|3909160|FG001|NOT COMPLETED|Part B||0
3180698|NCT01992874|3909161|FG002|NOT COMPLETED|Part B||0
3180699|NCT01993017|3909174|FG000|STARTED|Overall Study||499
3180700|NCT01993017|3909175|FG001|STARTED|Overall Study||501
3180701|NCT01993017|3909176|FG002|STARTED|Overall Study||500
3180702|NCT01993017|3909174|FG000|COMPLETED|Overall Study||393
3180703|NCT01993017|3909175|FG001|COMPLETED|Overall Study||411
3180704|NCT01993017|3909176|FG002|COMPLETED|Overall Study||421
3180705|NCT01993017|3909174|FG000|NOT COMPLETED|Overall Study||106
3180706|NCT01993017|3909175|FG001|NOT COMPLETED|Overall Study||90
3180707|NCT01993017|3909176|FG002|NOT COMPLETED|Overall Study||79
3180708|NCT01993030|3909187|FG000|STARTED|Overall Study||36
3180709|NCT01993030|3909188|FG001|STARTED|Overall Study||35
3180710|NCT01993030|3909187|FG000|COMPLETED|Overall Study||36
3180711|NCT01993030|3909188|FG001|COMPLETED|Overall Study||31
3180712|NCT01993030|3909187|FG000|NOT COMPLETED|Overall Study||0
3180713|NCT01993030|3909188|FG001|NOT COMPLETED|Overall Study||4
3180714|NCT01993108|3909196|FG000|STARTED|Overall Study||11
3180715|NCT01993108|3909197|FG001|STARTED|Overall Study||12
3180716|NCT01993108|3909196|FG000|COMPLETED|Overall Study||11
3180717|NCT01993108|3909197|FG001|COMPLETED|Overall Study||12
3180718|NCT01993108|3909196|FG000|NOT COMPLETED|Overall Study||0
3180719|NCT01993108|3909197|FG001|NOT COMPLETED|Overall Study||0
3180720|NCT01993186|3909217|FG000|STARTED|Double-Blind Placebo-Controlled Period||25
3180721|NCT01993186|3909218|FG001|STARTED|Double-Blind Placebo-Controlled Period||11
3180722|NCT01993186|3909217|FG000|COMPLETED|Double-Blind Placebo-Controlled Period||23
3180723|NCT01993186|3909218|FG001|COMPLETED|Double-Blind Placebo-Controlled Period||11
3180724|NCT01993186|3909217|FG000|NOT COMPLETED|Double-Blind Placebo-Controlled Period||2
3180725|NCT01993186|3909218|FG001|NOT COMPLETED|Double-Blind Placebo-Controlled Period||0
3180726|NCT01993186|3909217|FG000|STARTED|Open-Label Extension Period||23
3180727|NCT01993186|3909218|FG001|STARTED|Open-Label Extension Period||11
3180728|NCT01993186|3909217|FG000|COMPLETED|Open-Label Extension Period||16
3180729|NCT01993186|3909218|FG001|COMPLETED|Open-Label Extension Period||5
3180730|NCT01993186|3909217|FG000|NOT COMPLETED|Open-Label Extension Period||7
3180731|NCT01993186|3909218|FG001|NOT COMPLETED|Open-Label Extension Period||6
3180732|NCT01993238|3909225|FG000|STARTED|Overall Study||11
3180733|NCT01993238|3909225|FG000|COMPLETED|Overall Study||11
3180734|NCT01993238|3909225|FG000|NOT COMPLETED|Overall Study||0
3180735|NCT01993329|3909235|FG000|STARTED|Period 1||3
3180736|NCT01993329|3909236|FG001|STARTED|Period 1||4
3180737|NCT01993329|3909237|FG002|STARTED|Period 1||3
3180738|NCT01993329|3909238|FG003|STARTED|Period 1||3
3180739|NCT01993329|3909239|FG004|STARTED|Period 1||3
3180740|NCT01993329|3909240|FG005|STARTED|Period 1||4
3180741|NCT01993329|3909235|FG000|COMPLETED|Period 1||3
3141293|NCT01743469|3867139|FG000|STARTED|Active Treatment Phase||53
3141294|NCT01743469|3867140|FG001|STARTED|Active Treatment Phase||55
3141295|NCT01743469|3867141|FG002|STARTED|Active Treatment Phase||38
3141296|NCT01743469|3867142|FG003|STARTED|Active Treatment Phase||21
3141297|NCT01743469|3867139|FG000|COMPLETED|Active Treatment Phase||0
3141298|NCT01743469|3867140|FG001|COMPLETED|Active Treatment Phase||0
3141299|NCT01743469|3867141|FG002|COMPLETED|Active Treatment Phase||0
3141300|NCT01743469|3867142|FG003|COMPLETED|Active Treatment Phase||0
3141301|NCT01743469|3867139|FG000|NOT COMPLETED|Active Treatment Phase||53
3141302|NCT01743469|3867140|FG001|NOT COMPLETED|Active Treatment Phase||55
3141303|NCT01743469|3867141|FG002|NOT COMPLETED|Active Treatment Phase||38
3141304|NCT01743469|3867142|FG003|NOT COMPLETED|Active Treatment Phase||21
3141305|NCT01743469|3867139|FG000|STARTED|Follow-up Period - Post-Treatment||51
3141306|NCT01743469|3867140|FG001|STARTED|Follow-up Period - Post-Treatment||53
3141307|NCT01743469|3867141|FG002|STARTED|Follow-up Period - Post-Treatment||37
3141308|NCT01743469|3867142|FG003|STARTED|Follow-up Period - Post-Treatment||21
3180742|NCT01993329|3909236|FG001|COMPLETED|Period 1||4
3180743|NCT01993329|3909237|FG002|COMPLETED|Period 1||3
3180744|NCT01993329|3909238|FG003|COMPLETED|Period 1||3
3141309|NCT01743469|3867139|FG000|COMPLETED|Follow-up Period - Post-Treatment||6
3141310|NCT01743469|3867140|FG001|COMPLETED|Follow-up Period - Post-Treatment||5
3141311|NCT01743469|3867141|FG002|COMPLETED|Follow-up Period - Post-Treatment||14
3141312|NCT01743469|3867142|FG003|COMPLETED|Follow-up Period - Post-Treatment||5
3141313|NCT01743469|3867139|FG000|NOT COMPLETED|Follow-up Period - Post-Treatment||45
3141314|NCT01743469|3867140|FG001|NOT COMPLETED|Follow-up Period - Post-Treatment||48
3141315|NCT01743469|3867141|FG002|NOT COMPLETED|Follow-up Period - Post-Treatment||23
3141316|NCT01743469|3867142|FG003|NOT COMPLETED|Follow-up Period - Post-Treatment||16
3141317|NCT01743521|3867156|FG000|STARTED|Overall Study||7
3141318|NCT01743521|3867157|FG001|STARTED|Overall Study||3
3141319|NCT01743521|3867158|FG002|STARTED|Overall Study||2
3141320|NCT01743521|3867159|FG003|STARTED|Overall Study||2
3141321|NCT01743521|3867156|FG000|COMPLETED|Overall Study||7
3141322|NCT01743521|3867157|FG001|COMPLETED|Overall Study||3
3141323|NCT01743521|3867158|FG002|COMPLETED|Overall Study||2
3141324|NCT01743521|3867159|FG003|COMPLETED|Overall Study||2
3141325|NCT01743521|3867156|FG000|NOT COMPLETED|Overall Study||0
3141326|NCT01743521|3867157|FG001|NOT COMPLETED|Overall Study||0
3141327|NCT01743521|3867158|FG002|NOT COMPLETED|Overall Study||0
3141328|NCT01743521|3867159|FG003|NOT COMPLETED|Overall Study||0
3141329|NCT01743560|3867167|FG000|STARTED|Overall Study||52
3141330|NCT01743560|3867167|FG000|Full Analysis Set (FAS)|Overall Study|≥ 1 dose study drug|49
3141331|NCT01743560|3867167|FG000|Safety Analysis Set (SAF)|Overall Study|≥ 1 dose study drug +1 post baseline safety assessment|49
3141332|NCT01743560|3867167|FG000|COMPLETED|Overall Study||9
3141333|NCT01743560|3867167|FG000|NOT COMPLETED|Overall Study||43
3141334|NCT01743677|3867180|FG000|STARTED|First Intervention Period||10
3141335|NCT01743677|3867181|FG001|STARTED|First Intervention Period||10
3141336|NCT01743677|3867182|FG002|STARTED|First Intervention Period||10
3141337|NCT01743677|3867183|FG003|STARTED|First Intervention Period||10
3141338|NCT01743677|3867184|FG004|STARTED|First Intervention Period||10
3141339|NCT01743677|3867185|FG005|STARTED|First Intervention Period||10
3141340|NCT01743677|3867180|FG000|COMPLETED|First Intervention Period||10
3141341|NCT01743677|3867181|FG001|COMPLETED|First Intervention Period||10
3141342|NCT01743677|3867182|FG002|COMPLETED|First Intervention Period||10
3141343|NCT01743677|3867183|FG003|COMPLETED|First Intervention Period||10
3141344|NCT01743677|3867184|FG004|COMPLETED|First Intervention Period||10
3141345|NCT01743677|3867185|FG005|COMPLETED|First Intervention Period||10
3141346|NCT01743677|3867180|FG000|NOT COMPLETED|First Intervention Period||0
3141347|NCT01743677|3867181|FG001|NOT COMPLETED|First Intervention Period||0
3141348|NCT01743677|3867182|FG002|NOT COMPLETED|First Intervention Period||0
3141349|NCT01743677|3867183|FG003|NOT COMPLETED|First Intervention Period||0
3141350|NCT01743677|3867184|FG004|NOT COMPLETED|First Intervention Period||0
3141351|NCT01743677|3867185|FG005|NOT COMPLETED|First Intervention Period||0
3141352|NCT01743677|3867180|FG000|STARTED|Washout Period 1 (at Least 7 Days)||10
3141353|NCT01743677|3867181|FG001|STARTED|Washout Period 1 (at Least 7 Days)||10
3141354|NCT01743677|3867182|FG002|STARTED|Washout Period 1 (at Least 7 Days)||10
3141355|NCT01743677|3867183|FG003|STARTED|Washout Period 1 (at Least 7 Days)||10
3141356|NCT01743677|3867184|FG004|STARTED|Washout Period 1 (at Least 7 Days)||10
3141357|NCT01743677|3867185|FG005|STARTED|Washout Period 1 (at Least 7 Days)||10
3141358|NCT01743677|3867180|FG000|COMPLETED|Washout Period 1 (at Least 7 Days)||10
3141359|NCT01743677|3867181|FG001|COMPLETED|Washout Period 1 (at Least 7 Days)||10
3141360|NCT01743677|3867182|FG002|COMPLETED|Washout Period 1 (at Least 7 Days)||10
3141361|NCT01743677|3867183|FG003|COMPLETED|Washout Period 1 (at Least 7 Days)||10
3141362|NCT01743677|3867184|FG004|COMPLETED|Washout Period 1 (at Least 7 Days)||10
3141363|NCT01743677|3867185|FG005|COMPLETED|Washout Period 1 (at Least 7 Days)||10
3141364|NCT01743677|3867180|FG000|NOT COMPLETED|Washout Period 1 (at Least 7 Days)||0
3141365|NCT01743677|3867181|FG001|NOT COMPLETED|Washout Period 1 (at Least 7 Days)||0
3141366|NCT01743677|3867182|FG002|NOT COMPLETED|Washout Period 1 (at Least 7 Days)||0
3141367|NCT01743677|3867183|FG003|NOT COMPLETED|Washout Period 1 (at Least 7 Days)||0
3141368|NCT01743677|3867184|FG004|NOT COMPLETED|Washout Period 1 (at Least 7 Days)||0
3141369|NCT01743677|3867185|FG005|NOT COMPLETED|Washout Period 1 (at Least 7 Days)||0
3141370|NCT01743677|3867180|FG000|STARTED|Second Intervention Period||10
3180745|NCT01993329|3909239|FG004|COMPLETED|Period 1||3
3141371|NCT01743677|3867181|FG001|STARTED|Second Intervention Period||10
3141372|NCT01743677|3867182|FG002|STARTED|Second Intervention Period||10
3141373|NCT01743677|3867183|FG003|STARTED|Second Intervention Period||10
3141374|NCT01743677|3867184|FG004|STARTED|Second Intervention Period||10
3141375|NCT01743677|3867185|FG005|STARTED|Second Intervention Period||10
3141376|NCT01743677|3867180|FG000|COMPLETED|Second Intervention Period||10
3141377|NCT01743677|3867181|FG001|COMPLETED|Second Intervention Period||10
3141378|NCT01743677|3867182|FG002|COMPLETED|Second Intervention Period||10
3141379|NCT01743677|3867183|FG003|COMPLETED|Second Intervention Period||10
3141380|NCT01743677|3867184|FG004|COMPLETED|Second Intervention Period||10
3141381|NCT01743677|3867185|FG005|COMPLETED|Second Intervention Period||10
3141382|NCT01743677|3867180|FG000|NOT COMPLETED|Second Intervention Period||0
3141383|NCT01743677|3867181|FG001|NOT COMPLETED|Second Intervention Period||0
3141384|NCT01743677|3867182|FG002|NOT COMPLETED|Second Intervention Period||0
3141385|NCT01743677|3867183|FG003|NOT COMPLETED|Second Intervention Period||0
3141386|NCT01743677|3867184|FG004|NOT COMPLETED|Second Intervention Period||0
3141387|NCT01743677|3867185|FG005|NOT COMPLETED|Second Intervention Period||0
3141388|NCT01743677|3867180|FG000|STARTED|Washout Period 2 (at Least 7 Days)||10
3141389|NCT01743677|3867181|FG001|STARTED|Washout Period 2 (at Least 7 Days)||10
3141390|NCT01743677|3867182|FG002|STARTED|Washout Period 2 (at Least 7 Days)||10
3141391|NCT01743677|3867183|FG003|STARTED|Washout Period 2 (at Least 7 Days)||10
3141392|NCT01743677|3867184|FG004|STARTED|Washout Period 2 (at Least 7 Days)||10
3141393|NCT01743677|3867185|FG005|STARTED|Washout Period 2 (at Least 7 Days)||10
3141394|NCT01743677|3867180|FG000|COMPLETED|Washout Period 2 (at Least 7 Days)||10
3141395|NCT01743677|3867181|FG001|COMPLETED|Washout Period 2 (at Least 7 Days)||10
3141396|NCT01743677|3867182|FG002|COMPLETED|Washout Period 2 (at Least 7 Days)||10
3141397|NCT01743677|3867183|FG003|COMPLETED|Washout Period 2 (at Least 7 Days)||10
3141398|NCT01743677|3867184|FG004|COMPLETED|Washout Period 2 (at Least 7 Days)||10
3141399|NCT01743677|3867185|FG005|COMPLETED|Washout Period 2 (at Least 7 Days)||10
3141400|NCT01743677|3867180|FG000|NOT COMPLETED|Washout Period 2 (at Least 7 Days)||0
3141401|NCT01743677|3867181|FG001|NOT COMPLETED|Washout Period 2 (at Least 7 Days)||0
3141402|NCT01743677|3867182|FG002|NOT COMPLETED|Washout Period 2 (at Least 7 Days)||0
3141403|NCT01743677|3867183|FG003|NOT COMPLETED|Washout Period 2 (at Least 7 Days)||0
3141404|NCT01743677|3867184|FG004|NOT COMPLETED|Washout Period 2 (at Least 7 Days)||0
3141405|NCT01743677|3867185|FG005|NOT COMPLETED|Washout Period 2 (at Least 7 Days)||0
3141406|NCT01743677|3867180|FG000|STARTED|Third Intervention Period||10
3141407|NCT01743677|3867181|FG001|STARTED|Third Intervention Period||10
3141408|NCT01743677|3867182|FG002|STARTED|Third Intervention Period||10
3141409|NCT01743677|3867183|FG003|STARTED|Third Intervention Period||10
3141410|NCT01743677|3867184|FG004|STARTED|Third Intervention Period||10
3141411|NCT01743677|3867185|FG005|STARTED|Third Intervention Period||10
3141412|NCT01743677|3867180|FG000|COMPLETED|Third Intervention Period||10
3141413|NCT01743677|3867181|FG001|COMPLETED|Third Intervention Period||10
3141414|NCT01743677|3867182|FG002|COMPLETED|Third Intervention Period||10
3141415|NCT01743677|3867183|FG003|COMPLETED|Third Intervention Period||10
3141416|NCT01743677|3867184|FG004|COMPLETED|Third Intervention Period||10
3141417|NCT01743677|3867185|FG005|COMPLETED|Third Intervention Period||10
3141418|NCT01743677|3867180|FG000|NOT COMPLETED|Third Intervention Period||0
3141419|NCT01743677|3867181|FG001|NOT COMPLETED|Third Intervention Period||0
3141420|NCT01743677|3867182|FG002|NOT COMPLETED|Third Intervention Period||0
3141421|NCT01743677|3867183|FG003|NOT COMPLETED|Third Intervention Period||0
3141422|NCT01743677|3867184|FG004|NOT COMPLETED|Third Intervention Period||0
3141423|NCT01743677|3867185|FG005|NOT COMPLETED|Third Intervention Period||0
3141424|NCT01743729|3867197|FG000|STARTED|Overall Study|One participant from placebo arm included in Lifitegrast arm for safety analysis set (N=359).|358
3141425|NCT01743729|3867198|FG001|STARTED|Overall Study|One placebo participant was considered for Lifitegrast arm; Placebo safety analysis set (N= 359).|360
3141426|NCT01743729|3867197|FG000|COMPLETED|Overall Study||321
3141427|NCT01743729|3867198|FG001|COMPLETED|Overall Study||348
3141428|NCT01743729|3867197|FG000|NOT COMPLETED|Overall Study||37
3141429|NCT01743729|3867198|FG001|NOT COMPLETED|Overall Study||12
3141430|NCT01743859|3867204|FG000|STARTED|Overall Study||37
3141431|NCT01743859|3867204|FG000|COMPLETED|Overall Study||28
3141432|NCT01743859|3867204|FG000|NOT COMPLETED|Overall Study||9
3141433|NCT01743963|3867210|FG000|STARTED|Overall Study||21
3141434|NCT01743963|3867211|FG001|STARTED|Overall Study||17
3141435|NCT01743963|3867210|FG000|COMPLETED|Overall Study||21
3141436|NCT01743963|3867211|FG001|COMPLETED|Overall Study||17
3141437|NCT01743963|3867210|FG000|NOT COMPLETED|Overall Study||0
3141438|NCT01743963|3867211|FG001|NOT COMPLETED|Overall Study||0
3141439|NCT01743976|3867219|FG000|STARTED|Overall Study||2
3141440|NCT01743976|3867220|FG001|STARTED|Overall Study||3
3141441|NCT01743976|3867219|FG000|COMPLETED|Overall Study||2
3141442|NCT01743976|3867220|FG001|COMPLETED|Overall Study||3
3141443|NCT01743976|3867219|FG000|NOT COMPLETED|Overall Study||0
3141444|NCT01743976|3867220|FG001|NOT COMPLETED|Overall Study||0
3141445|NCT01743989|3867229|FG000|STARTED|Treatment Phase||120
3141446|NCT01743989|3867230|FG001|STARTED|Treatment Phase||119
3141447|NCT01743989|3867231|FG002|STARTED|Treatment Phase||381
3141448|NCT01743989|3867229|FG000|Participants Who Signed Informed Consent|Treatment Phase||120
3141449|NCT01743989|3867230|FG001|Participants Who Signed Informed Consent|Treatment Phase||118
3141450|NCT01743989|3867231|FG002|Participants Who Signed Informed Consent|Treatment Phase||381
3141451|NCT01743989|3867229|FG000|COMPLETED|Treatment Phase||119
3141452|NCT01743989|3867230|FG001|COMPLETED|Treatment Phase||104
3141453|NCT01743989|3867231|FG002|COMPLETED|Treatment Phase||0
3141454|NCT01743989|3867229|FG000|NOT COMPLETED|Treatment Phase||1
3141455|NCT01743989|3867230|FG001|NOT COMPLETED|Treatment Phase||15
3141456|NCT01743989|3867231|FG002|NOT COMPLETED|Treatment Phase||381
3141457|NCT01743989|3867229|FG000|STARTED|TFR Phase||119
3141458|NCT01743989|3867230|FG001|STARTED|TFR Phase||104
3141459|NCT01743989|3867231|FG002|STARTED|TFR Phase||0
3141460|NCT01743989|3867229|FG000|COMPLETED|TFR Phase||37
3141461|NCT01743989|3867230|FG001|COMPLETED|TFR Phase||36
3141462|NCT01743989|3867231|FG002|COMPLETED|TFR Phase||0
3141463|NCT01743989|3867229|FG000|NOT COMPLETED|TFR Phase||82
3141464|NCT01743989|3867230|FG001|NOT COMPLETED|TFR Phase||68
3141465|NCT01743989|3867231|FG002|NOT COMPLETED|TFR Phase||0
3141466|NCT01743989|3867229|FG000|STARTED|Re-treatment Phase||74
3141467|NCT01743989|3867230|FG001|STARTED|Re-treatment Phase||55
3141468|NCT01743989|3867231|FG002|STARTED|Re-treatment Phase||0
3141469|NCT01743989|3867229|FG000|COMPLETED|Re-treatment Phase||58
3141470|NCT01743989|3867230|FG001|COMPLETED|Re-treatment Phase||46
3141471|NCT01743989|3867231|FG002|COMPLETED|Re-treatment Phase||0
3141472|NCT01743989|3867229|FG000|NOT COMPLETED|Re-treatment Phase||16
3141473|NCT01743989|3867230|FG001|NOT COMPLETED|Re-treatment Phase||9
3141474|NCT01743989|3867231|FG002|NOT COMPLETED|Re-treatment Phase||0
3141475|NCT01744093|3867244|FG000|STARTED|Overall Study||18
3141476|NCT01744093|3867245|FG001|STARTED|Overall Study||9
3141477|NCT01744093|3867244|FG000|COMPLETED|Overall Study||12
3141478|NCT01744093|3867245|FG001|COMPLETED|Overall Study||8
3141479|NCT01744093|3867244|FG000|NOT COMPLETED|Overall Study||6
3141480|NCT01744093|3867245|FG001|NOT COMPLETED|Overall Study||1
3141481|NCT01744197|3867255|FG000|STARTED|Overall Study||32
3141482|NCT01744197|3867256|FG001|STARTED|Overall Study||29
3141483|NCT01744197|3867255|FG000|COMPLETED|Overall Study||28
3141484|NCT01744197|3867256|FG001|COMPLETED|Overall Study||26
3141485|NCT01744197|3867255|FG000|NOT COMPLETED|Overall Study||4
3141486|NCT01744197|3867256|FG001|NOT COMPLETED|Overall Study||3
3141487|NCT01744340|3867264|FG000|STARTED|Overall Study||8
3141488|NCT01744340|3867265|FG001|STARTED|Overall Study||15
3141489|NCT01744340|3867264|FG000|COMPLETED|Overall Study||8
3141490|NCT01744340|3867265|FG001|COMPLETED|Overall Study||15
3141491|NCT01744340|3867264|FG000|NOT COMPLETED|Overall Study||0
3141492|NCT01744340|3867265|FG001|NOT COMPLETED|Overall Study||0
3141493|NCT01744353|3867274|FG000|STARTED|Overall Study||6
3141494|NCT01744353|3867275|FG001|STARTED|Overall Study||26
3141495|NCT01744353|3867276|FG002|STARTED|Overall Study||3
3141496|NCT01744353|3867274|FG000|COMPLETED|Overall Study||6
3141497|NCT01744353|3867275|FG001|COMPLETED|Overall Study||26
3141498|NCT01744353|3867276|FG002|COMPLETED|Overall Study||3
3141499|NCT01744353|3867274|FG000|NOT COMPLETED|Overall Study||0
3141500|NCT01744353|3867275|FG001|NOT COMPLETED|Overall Study||0
3141501|NCT01744353|3867276|FG002|NOT COMPLETED|Overall Study||0
3141502|NCT01744392|3867282|FG000|STARTED|Overall Study||23
3141503|NCT01744392|3867282|FG000|COMPLETED|Overall Study||22
3141504|NCT01744392|3867282|FG000|NOT COMPLETED|Overall Study||1
3141505|NCT01744483|3867290|FG000|STARTED|Overall Study||44
3141506|NCT01744483|3867291|FG001|STARTED|Overall Study||35
3141507|NCT01744483|3867292|FG002|STARTED|Overall Study||38
3141508|NCT01744483|3867290|FG000|COMPLETED|Overall Study||15
3141509|NCT01744483|3867291|FG001|COMPLETED|Overall Study||13
3141510|NCT01744483|3867292|FG002|COMPLETED|Overall Study||10
3141511|NCT01744483|3867290|FG000|NOT COMPLETED|Overall Study||29
3141512|NCT01744483|3867291|FG001|NOT COMPLETED|Overall Study||22
3141513|NCT01744483|3867292|FG002|NOT COMPLETED|Overall Study||28
3141514|NCT01744496|3867302|FG000|STARTED|Titration Period||33
3141515|NCT01744496|3867303|FG001|STARTED|Titration Period||35
3141516|NCT01744496|3867302|FG000|COMPLETED|Titration Period||31
3141517|NCT01744496|3867303|FG001|COMPLETED|Titration Period||33
3141518|NCT01744496|3867302|FG000|NOT COMPLETED|Titration Period||2
3141519|NCT01744496|3867303|FG001|NOT COMPLETED|Titration Period||2
3141520|NCT01744496|3867302|FG000|STARTED|Maintenance Period||31
3141521|NCT01744496|3867303|FG001|STARTED|Maintenance Period||33
3141522|NCT01744496|3867302|FG000|COMPLETED|Maintenance Period||27
3141523|NCT01744496|3867303|FG001|COMPLETED|Maintenance Period||29
3141524|NCT01744496|3867302|FG000|NOT COMPLETED|Maintenance Period||4
3141525|NCT01744496|3867303|FG001|NOT COMPLETED|Maintenance Period||4
3141526|NCT01744574|3867313|FG000|STARTED|Overall Study||57
3141527|NCT01744574|3867314|FG001|STARTED|Overall Study||56
3141528|NCT01744574|3867315|FG002|STARTED|Overall Study||52
3141529|NCT01744574|3867316|FG003|STARTED|Overall Study||51
3141530|NCT01744574|3867313|FG000|COMPLETED|Overall Study||33
3141531|NCT01744574|3867314|FG001|COMPLETED|Overall Study||31
3141532|NCT01744574|3867315|FG002|COMPLETED|Overall Study||32
3141533|NCT01744574|3867316|FG003|COMPLETED|Overall Study||40
3141534|NCT01744574|3867313|FG000|NOT COMPLETED|Overall Study||24
3141535|NCT01744574|3867314|FG001|NOT COMPLETED|Overall Study||25
3141536|NCT01744574|3867315|FG002|NOT COMPLETED|Overall Study||20
3141537|NCT01744574|3867316|FG003|NOT COMPLETED|Overall Study||11
3141538|NCT01744665|3867326|FG000|STARTED|Monitoring Phase||59
3141539|NCT01744665|3867326|FG000|COMPLETED|Monitoring Phase||41
3141540|NCT01744665|3867326|FG000|NOT COMPLETED|Monitoring Phase||18
3141541|NCT01744665|3867326|FG000|STARTED|Consolidation Phase||41
3141542|NCT01744665|3867326|FG000|COMPLETED|Consolidation Phase||22
3141543|NCT01744665|3867326|FG000|NOT COMPLETED|Consolidation Phase||19
3141544|NCT01744665|3867326|FG000|STARTED|Treatment Free Remission Phase||32
3141545|NCT01744665|3867326|FG000|COMPLETED|Treatment Free Remission Phase||32
3141546|NCT01744665|3867326|FG000|NOT COMPLETED|Treatment Free Remission Phase||0
3141547|NCT01744665|3867326|FG000|STARTED|Re-initiation Phase||17
3141548|NCT01744665|3867326|FG000|COMPLETED|Re-initiation Phase||4
3141549|NCT01744665|3867326|FG000|NOT COMPLETED|Re-initiation Phase||13
3141550|NCT01744691|3867333|FG000|STARTED|Overall Study|Participants who received study treatment|144
3141551|NCT01744691|3867333|FG000|COMPLETED|Overall Study|Participants who were on study treatment at the time of the primary analysis|101
3141552|NCT01744691|3867333|FG000|NOT COMPLETED|Overall Study||43
3141553|NCT01744704|3867349|FG000|STARTED|Overall Study||3
3141554|NCT01744704|3867350|FG001|STARTED|Overall Study||3
3141555|NCT01744704|3867351|FG002|STARTED|Overall Study||3
3141556|NCT01744704|3867352|FG003|STARTED|Overall Study||6
3141557|NCT01744704|3867353|FG004|STARTED|Overall Study||6
3141558|NCT01744704|3867354|FG005|STARTED|Overall Study||7
3141559|NCT01744704|3867355|FG006|STARTED|Overall Study||6
3141560|NCT01744704|3867356|FG007|STARTED|Overall Study||9
3141561|NCT01744704|3867357|FG008|STARTED|Overall Study||3
3141562|NCT01744704|3867358|FG009|STARTED|Overall Study||9
3141563|NCT01744704|3867359|FG010|STARTED|Overall Study||9
3141564|NCT01744704|3867360|FG011|STARTED|Overall Study||10
3141565|NCT01744704|3867349|FG000|COMPLETED|Overall Study||3
3141566|NCT01744704|3867350|FG001|COMPLETED|Overall Study||3
3141567|NCT01744704|3867351|FG002|COMPLETED|Overall Study||3
3141568|NCT01744704|3867352|FG003|COMPLETED|Overall Study||6
3141569|NCT01744704|3867353|FG004|COMPLETED|Overall Study||6
3141570|NCT01744704|3867354|FG005|COMPLETED|Overall Study||7
3141571|NCT01744704|3867355|FG006|COMPLETED|Overall Study||6
3141572|NCT01744704|3867356|FG007|COMPLETED|Overall Study||9
3141573|NCT01744704|3867357|FG008|COMPLETED|Overall Study||3
3141574|NCT01744704|3867358|FG009|COMPLETED|Overall Study||9
3141575|NCT01744704|3867359|FG010|COMPLETED|Overall Study||9
3141576|NCT01744704|3867360|FG011|COMPLETED|Overall Study||10
3141577|NCT01744704|3867349|FG000|NOT COMPLETED|Overall Study||0
3141578|NCT01744704|3867350|FG001|NOT COMPLETED|Overall Study||0
3141579|NCT01744704|3867351|FG002|NOT COMPLETED|Overall Study||0
3141580|NCT01744704|3867352|FG003|NOT COMPLETED|Overall Study||0
3141581|NCT01744704|3867353|FG004|NOT COMPLETED|Overall Study||0
3141582|NCT01744704|3867354|FG005|NOT COMPLETED|Overall Study||0
3141583|NCT01744704|3867355|FG006|NOT COMPLETED|Overall Study||0
3141584|NCT01744704|3867356|FG007|NOT COMPLETED|Overall Study||0
3141585|NCT01744704|3867357|FG008|NOT COMPLETED|Overall Study||0
3141586|NCT01744704|3867358|FG009|NOT COMPLETED|Overall Study||0
3141587|NCT01744704|3867359|FG010|NOT COMPLETED|Overall Study||0
3141588|NCT01744704|3867360|FG011|NOT COMPLETED|Overall Study||0
3141589|NCT01744730|3867392|FG000|STARTED|Overall Study||4
3141590|NCT01744730|3867393|FG001|STARTED|Overall Study||3
3141591|NCT01744730|3867394|FG002|STARTED|Overall Study||4
3141592|NCT01744730|3867395|FG003|STARTED|Overall Study||11
3141593|NCT01744730|3867396|FG004|STARTED|Overall Study|Please note this study (NCT01431326) is ongoing and data only represents a subset of this study.|178
3141594|NCT01744730|3867392|FG000|COMPLETED|Overall Study||4
3141595|NCT01744730|3867393|FG001|COMPLETED|Overall Study||3
3141596|NCT01744730|3867394|FG002|COMPLETED|Overall Study||4
3141597|NCT01744730|3867395|FG003|COMPLETED|Overall Study||11
3141598|NCT01744730|3867396|FG004|COMPLETED|Overall Study|Please note this study (NCT01431326) is ongoing and data only represents a subset of this study.|178
3141599|NCT01744730|3867392|FG000|NOT COMPLETED|Overall Study||0
3141600|NCT01744730|3867393|FG001|NOT COMPLETED|Overall Study||0
3141601|NCT01744730|3867394|FG002|NOT COMPLETED|Overall Study||0
3141602|NCT01744730|3867395|FG003|NOT COMPLETED|Overall Study||0
3141603|NCT01744730|3867396|FG004|NOT COMPLETED|Overall Study||0
3141604|NCT01744782|3867409|FG000|STARTED|Overall Study||17
3141605|NCT01744782|3867409|FG000|COMPLETED|Overall Study||16
3141606|NCT01744782|3867409|FG000|NOT COMPLETED|Overall Study||1
3141607|NCT01744821|3867417|FG000|STARTED|Overall Study||1
3141608|NCT01744821|3867418|FG001|STARTED|Overall Study||3
3141609|NCT01744821|3867419|FG002|STARTED|Overall Study||2
3141610|NCT01744821|3867420|FG003|STARTED|Overall Study||1
3141611|NCT01744821|3867417|FG000|COMPLETED|Overall Study||1
3141612|NCT01744821|3867418|FG001|COMPLETED|Overall Study||3
3141613|NCT01744821|3867419|FG002|COMPLETED|Overall Study||2
3141614|NCT01744821|3867420|FG003|COMPLETED|Overall Study||1
3141615|NCT01744821|3867417|FG000|NOT COMPLETED|Overall Study||0
3141616|NCT01744821|3867418|FG001|NOT COMPLETED|Overall Study||0
3141617|NCT01744821|3867419|FG002|NOT COMPLETED|Overall Study||0
3141618|NCT01744821|3867420|FG003|NOT COMPLETED|Overall Study||0
3141619|NCT01744860|3867430|FG000|STARTED|Overall Study||420
3141620|NCT01744860|3867430|FG000|COMPLETED|Overall Study||420
3141621|NCT01744860|3867430|FG000|NOT COMPLETED|Overall Study||0
3141622|NCT01744977|3867444|FG000|STARTED|Overall Study||120
3141623|NCT01744977|3867445|FG001|STARTED|Overall Study||120
3141624|NCT01744977|3867444|FG000|6 Month Completed|Overall Study||113
3141625|NCT01744977|3867445|FG001|6 Month Completed|Overall Study||115
3141626|NCT01744977|3867444|FG000|COMPLETED|Overall Study||109
3141627|NCT01744977|3867445|FG001|COMPLETED|Overall Study||115
3141628|NCT01744977|3867444|FG000|NOT COMPLETED|Overall Study||11
3141629|NCT01744977|3867445|FG001|NOT COMPLETED|Overall Study||5
3141630|NCT01745055|3867451|FG000|STARTED|Overall Study||12
3141631|NCT01745055|3867451|FG000|COMPLETED|Overall Study||12
3141632|NCT01745055|3867451|FG000|NOT COMPLETED|Overall Study||0
3141633|NCT01745094|3867464|FG000|STARTED|Overall Study||35
3141634|NCT01745094|3867465|FG001|STARTED|Overall Study||37
3141635|NCT01745094|3867466|FG002|STARTED|Overall Study||58
3141636|NCT01745094|3867467|FG003|STARTED|Overall Study||93
3141637|NCT01745094|3867464|FG000|COMPLETED|Overall Study||30
3141638|NCT01745094|3867465|FG001|COMPLETED|Overall Study||37
3141639|NCT01745094|3867466|FG002|COMPLETED|Overall Study||46
3141640|NCT01745094|3867467|FG003|COMPLETED|Overall Study||90
3141641|NCT01745094|3867464|FG000|NOT COMPLETED|Overall Study||5
3141642|NCT01745094|3867465|FG001|NOT COMPLETED|Overall Study||0
3141643|NCT01745094|3867466|FG002|NOT COMPLETED|Overall Study||12
3141644|NCT01745094|3867467|FG003|NOT COMPLETED|Overall Study||3
3141645|NCT01745120|3867482|FG000|STARTED|Overall Study||11
3141646|NCT01745120|3867483|FG001|STARTED|Overall Study||8
3141647|NCT01745120|3867482|FG000|COMPLETED|Overall Study||10
3141648|NCT01745120|3867483|FG001|COMPLETED|Overall Study||8
3141649|NCT01745120|3867482|FG000|NOT COMPLETED|Overall Study||1
3141650|NCT01745120|3867483|FG001|NOT COMPLETED|Overall Study||0
3141651|NCT01745133|3867495|FG000|STARTED|Overall Study||19
3141652|NCT01745133|3867496|FG001|STARTED|Overall Study||20
3141653|NCT01745133|3867497|FG002|STARTED|Overall Study||19
3141654|NCT01745133|3867495|FG000|COMPLETED|Overall Study||13
3141655|NCT01745133|3867496|FG001|COMPLETED|Overall Study||16
3141656|NCT01745133|3867497|FG002|COMPLETED|Overall Study||15
3141657|NCT01745133|3867495|FG000|NOT COMPLETED|Overall Study||6
3141658|NCT01745133|3867496|FG001|NOT COMPLETED|Overall Study||4
3141659|NCT01745133|3867497|FG002|NOT COMPLETED|Overall Study||4
3141660|NCT01745146|3867507|FG000|STARTED|Overall Study||30
3141661|NCT01745146|3867508|FG001|STARTED|Overall Study||60
3141662|NCT01745146|3867507|FG000|Allocation to Intervention|Overall Study||30
3141663|NCT01745146|3867508|FG001|Allocation to Intervention|Overall Study||60
3141664|NCT01745146|3867507|FG000|Primary Outcome Assessment|Overall Study||27
3141665|NCT01745146|3867508|FG001|Primary Outcome Assessment|Overall Study||57
3141666|NCT01745146|3867507|FG000|Analysis|Overall Study||27
3141667|NCT01745146|3867508|FG001|Analysis|Overall Study||57
3141668|NCT01745146|3867507|FG000|COMPLETED|Overall Study||27
3141669|NCT01745146|3867508|FG001|COMPLETED|Overall Study||57
3141670|NCT01745146|3867507|FG000|NOT COMPLETED|Overall Study||3
3141671|NCT01745146|3867508|FG001|NOT COMPLETED|Overall Study||3
3141672|NCT01745211|3867515|FG000|STARTED|Overall Study||45
3141673|NCT01745211|3867515|FG000|COMPLETED|Overall Study||27
3141674|NCT01745211|3867515|FG000|NOT COMPLETED|Overall Study||18
3141675|NCT01745367|3867521|FG000|STARTED|Overall Study||8
3180746|NCT01993329|3909240|FG005|COMPLETED|Period 1||4
3180747|NCT01993329|3909235|FG000|NOT COMPLETED|Period 1||0
3180748|NCT01993329|3909236|FG001|NOT COMPLETED|Period 1||0
3180749|NCT01993329|3909237|FG002|NOT COMPLETED|Period 1||0
3180750|NCT01993329|3909238|FG003|NOT COMPLETED|Period 1||0
3180751|NCT01993329|3909239|FG004|NOT COMPLETED|Period 1||0
3180752|NCT01993329|3909240|FG005|NOT COMPLETED|Period 1||0
3180753|NCT01993329|3909235|FG000|STARTED|Wash-out||3
3180754|NCT01993329|3909236|FG001|STARTED|Wash-out||4
3180755|NCT01993329|3909237|FG002|STARTED|Wash-out||3
3180756|NCT01993329|3909238|FG003|STARTED|Wash-out||3
3180757|NCT01993329|3909239|FG004|STARTED|Wash-out||3
3180758|NCT01993329|3909240|FG005|STARTED|Wash-out||4
3180759|NCT01993329|3909235|FG000|COMPLETED|Wash-out||3
3180760|NCT01993329|3909236|FG001|COMPLETED|Wash-out||4
3180761|NCT01993329|3909237|FG002|COMPLETED|Wash-out||3
3180762|NCT01993329|3909238|FG003|COMPLETED|Wash-out||3
3180763|NCT01993329|3909239|FG004|COMPLETED|Wash-out||3
3180764|NCT01993329|3909240|FG005|COMPLETED|Wash-out||4
3180765|NCT01993329|3909235|FG000|NOT COMPLETED|Wash-out||0
3180766|NCT01993329|3909236|FG001|NOT COMPLETED|Wash-out||0
3180767|NCT01993329|3909237|FG002|NOT COMPLETED|Wash-out||0
3180768|NCT01993329|3909238|FG003|NOT COMPLETED|Wash-out||0
3180769|NCT01993329|3909239|FG004|NOT COMPLETED|Wash-out||0
3180770|NCT01993329|3909240|FG005|NOT COMPLETED|Wash-out||0
3180771|NCT01993329|3909235|FG000|STARTED|Period 2||3
3180772|NCT01993329|3909236|FG001|STARTED|Period 2||4
3180773|NCT01993329|3909237|FG002|STARTED|Period 2||3
3180774|NCT01993329|3909238|FG003|STARTED|Period 2||3
3180775|NCT01993329|3909239|FG004|STARTED|Period 2||3
3180776|NCT01993329|3909240|FG005|STARTED|Period 2||4
3180777|NCT01993329|3909235|FG000|COMPLETED|Period 2||3
3180778|NCT01993329|3909236|FG001|COMPLETED|Period 2||4
3180779|NCT01993329|3909237|FG002|COMPLETED|Period 2||3
3180780|NCT01993329|3909238|FG003|COMPLETED|Period 2||3
3180781|NCT01993329|3909239|FG004|COMPLETED|Period 2||3
3180782|NCT01993329|3909240|FG005|COMPLETED|Period 2||3
3180783|NCT01993329|3909235|FG000|NOT COMPLETED|Period 2||0
3180784|NCT01993329|3909236|FG001|NOT COMPLETED|Period 2||0
3180785|NCT01993329|3909237|FG002|NOT COMPLETED|Period 2||0
3180786|NCT01993329|3909238|FG003|NOT COMPLETED|Period 2||0
3180787|NCT01993329|3909239|FG004|NOT COMPLETED|Period 2||0
3180788|NCT01993329|3909240|FG005|NOT COMPLETED|Period 2||1
3141676|NCT01745367|3867522|FG001|STARTED|Overall Study||22
3141677|NCT01745367|3867521|FG000|Treated|Overall Study||8
3180789|NCT01993329|3909235|FG000|STARTED|Wash-out||3
3180790|NCT01993329|3909236|FG001|STARTED|Wash-out||4
3180791|NCT01993329|3909237|FG002|STARTED|Wash-out||3
3180792|NCT01993329|3909238|FG003|STARTED|Wash-out||3
3180793|NCT01993329|3909239|FG004|STARTED|Wash-out||3
3180794|NCT01993329|3909240|FG005|STARTED|Wash-out||3
3180795|NCT01993329|3909235|FG000|COMPLETED|Wash-out||3
3180796|NCT01993329|3909236|FG001|COMPLETED|Wash-out||3
3141678|NCT01745367|3867522|FG001|Treated|Overall Study||21
3141679|NCT01745367|3867521|FG000|COMPLETED|Overall Study||0
3141680|NCT01745367|3867522|FG001|COMPLETED|Overall Study||0
3141681|NCT01745367|3867521|FG000|NOT COMPLETED|Overall Study||8
3141682|NCT01745367|3867522|FG001|NOT COMPLETED|Overall Study||22
3141683|NCT01745380|3867530|FG000|STARTED|Overall Study||100
3141684|NCT01745380|3867531|FG001|STARTED|Overall Study||50
3141685|NCT01745380|3867530|FG000|COMPLETED|Overall Study||99
3141686|NCT01745380|3867531|FG001|COMPLETED|Overall Study||49
3141687|NCT01745380|3867530|FG000|NOT COMPLETED|Overall Study||1
3141688|NCT01745380|3867531|FG001|NOT COMPLETED|Overall Study||1
3141689|NCT01745393|3867539|FG000|STARTED|Treatment to End-of-treatment Assessment||163
3141690|NCT01745393|3867540|FG001|STARTED|Treatment to End-of-treatment Assessment||164
3141691|NCT01745393|3867539|FG000|Received Treatment|Treatment to End-of-treatment Assessment|Behavioral counseling = TSE-reduction and cessation counseling via telephone|147
3141692|NCT01745393|3867540|FG001|Received Treatment|Treatment to End-of-treatment Assessment|Attention control = nutrition education via telephone|144
3141693|NCT01745393|3867539|FG000|COMPLETED|Treatment to End-of-treatment Assessment||142
3141694|NCT01745393|3867540|FG001|COMPLETED|Treatment to End-of-treatment Assessment||156
3141695|NCT01745393|3867539|FG000|NOT COMPLETED|Treatment to End-of-treatment Assessment||21
3141696|NCT01745393|3867540|FG001|NOT COMPLETED|Treatment to End-of-treatment Assessment||8
3141697|NCT01745393|3867539|FG000|STARTED|12-month Follow-up||142
3141698|NCT01745393|3867540|FG001|STARTED|12-month Follow-up||156
3141699|NCT01745393|3867539|FG000|COMPLETED|12-month Follow-up||136
3141700|NCT01745393|3867540|FG001|COMPLETED|12-month Follow-up||151
3141701|NCT01745393|3867539|FG000|NOT COMPLETED|12-month Follow-up||6
3141702|NCT01745393|3867540|FG001|NOT COMPLETED|12-month Follow-up||5
3141703|NCT01745627|3867546|FG000|STARTED|Overall Study||42
3141704|NCT01745627|3867546|FG000|COMPLETED|Overall Study||20
3141705|NCT01745627|3867546|FG000|NOT COMPLETED|Overall Study||22
3141706|NCT01745822|3867552|FG000|STARTED|Overall Study|168 mothers and 163 infants|331
3141707|NCT01745822|3867553|FG001|STARTED|Overall Study|163 mothers and 160 infants|323
3141708|NCT01745822|3867552|FG000|COMPLETED|Overall Study||331
3141709|NCT01745822|3867553|FG001|COMPLETED|Overall Study||323
3141710|NCT01745822|3867552|FG000|NOT COMPLETED|Overall Study||0
3141711|NCT01745822|3867553|FG001|NOT COMPLETED|Overall Study||0
3141712|NCT01745848|3867559|FG000|STARTED|Overall Study||26
3141713|NCT01745848|3867559|FG000|COMPLETED|Overall Study||20
3141714|NCT01745848|3867559|FG000|NOT COMPLETED|Overall Study||6
3141715|NCT01745952|3867563|FG000|STARTED|Overall Study||4
3141716|NCT01745952|3867564|FG001|STARTED|Overall Study||4
3141717|NCT01745952|3867565|FG002|STARTED|Overall Study||3
3141718|NCT01745952|3867563|FG000|COMPLETED|Overall Study||3
3141719|NCT01745952|3867564|FG001|COMPLETED|Overall Study|data of one patient not used due to no seizure diary entries on multiple occasions|3
3141720|NCT01745952|3867565|FG002|COMPLETED|Overall Study||3
3141721|NCT01745952|3867563|FG000|NOT COMPLETED|Overall Study||1
3141722|NCT01745952|3867564|FG001|NOT COMPLETED|Overall Study||1
3141723|NCT01745952|3867565|FG002|NOT COMPLETED|Overall Study||0
3141724|NCT01746017|3867590|FG000|STARTED|Period 1||2
3141725|NCT01746017|3867591|FG001|STARTED|Period 1||2
3141726|NCT01746017|3867592|FG002|STARTED|Period 1||2
3141727|NCT01746017|3867593|FG003|STARTED|Period 1||2
3141728|NCT01746017|3867594|FG004|STARTED|Period 1||2
3141729|NCT01746017|3867595|FG005|STARTED|Period 1||2
3141730|NCT01746017|3867596|FG006|STARTED|Period 1||3
3141731|NCT01746017|3867597|FG007|STARTED|Period 1||2
3141732|NCT01746017|3867598|FG008|STARTED|Period 1||3
3141733|NCT01746017|3867599|FG009|STARTED|Period 1||3
3141734|NCT01746017|3867600|FG010|STARTED|Period 1||3
3141735|NCT01746017|3867590|FG000|Received at Least 1 Dose of Study Drug|Period 1||2
3141736|NCT01746017|3867591|FG001|Received at Least 1 Dose of Study Drug|Period 1||2
3141737|NCT01746017|3867592|FG002|Received at Least 1 Dose of Study Drug|Period 1||2
3141738|NCT01746017|3867593|FG003|Received at Least 1 Dose of Study Drug|Period 1||2
3141739|NCT01746017|3867594|FG004|Received at Least 1 Dose of Study Drug|Period 1||2
3141740|NCT01746017|3867595|FG005|Received at Least 1 Dose of Study Drug|Period 1||2
3141741|NCT01746017|3867596|FG006|Received at Least 1 Dose of Study Drug|Period 1||3
3141742|NCT01746017|3867597|FG007|Received at Least 1 Dose of Study Drug|Period 1||2
3141743|NCT01746017|3867598|FG008|Received at Least 1 Dose of Study Drug|Period 1||3
3141744|NCT01746017|3867599|FG009|Received at Least 1 Dose of Study Drug|Period 1||3
3141745|NCT01746017|3867600|FG010|Received at Least 1 Dose of Study Drug|Period 1||3
3141746|NCT01746017|3867590|FG000|COMPLETED|Period 1||2
3141747|NCT01746017|3867591|FG001|COMPLETED|Period 1||2
3141748|NCT01746017|3867592|FG002|COMPLETED|Period 1||2
3141749|NCT01746017|3867593|FG003|COMPLETED|Period 1||2
3141750|NCT01746017|3867594|FG004|COMPLETED|Period 1||2
3141751|NCT01746017|3867595|FG005|COMPLETED|Period 1||2
3141752|NCT01746017|3867596|FG006|COMPLETED|Period 1||2
3141753|NCT01746017|3867597|FG007|COMPLETED|Period 1||2
3141754|NCT01746017|3867598|FG008|COMPLETED|Period 1||3
3141755|NCT01746017|3867599|FG009|COMPLETED|Period 1||3
3141756|NCT01746017|3867600|FG010|COMPLETED|Period 1||3
3141757|NCT01746017|3867590|FG000|NOT COMPLETED|Period 1||0
3141758|NCT01746017|3867591|FG001|NOT COMPLETED|Period 1||0
3141759|NCT01746017|3867592|FG002|NOT COMPLETED|Period 1||0
3141760|NCT01746017|3867593|FG003|NOT COMPLETED|Period 1||0
3141761|NCT01746017|3867594|FG004|NOT COMPLETED|Period 1||0
3141762|NCT01746017|3867595|FG005|NOT COMPLETED|Period 1||0
3141763|NCT01746017|3867596|FG006|NOT COMPLETED|Period 1||1
3141764|NCT01746017|3867597|FG007|NOT COMPLETED|Period 1||0
3141765|NCT01746017|3867598|FG008|NOT COMPLETED|Period 1||0
3141766|NCT01746017|3867599|FG009|NOT COMPLETED|Period 1||0
3141767|NCT01746017|3867600|FG010|NOT COMPLETED|Period 1||0
3141768|NCT01746017|3867590|FG000|STARTED|Period 2||2
3141769|NCT01746017|3867591|FG001|STARTED|Period 2||2
3141770|NCT01746017|3867592|FG002|STARTED|Period 2||2
3141771|NCT01746017|3867593|FG003|STARTED|Period 2||2
3141772|NCT01746017|3867594|FG004|STARTED|Period 2||2
3141773|NCT01746017|3867595|FG005|STARTED|Period 2||2
3141774|NCT01746017|3867596|FG006|STARTED|Period 2||2
3141775|NCT01746017|3867597|FG007|STARTED|Period 2||2
3141776|NCT01746017|3867598|FG008|STARTED|Period 2||3
3141777|NCT01746017|3867599|FG009|STARTED|Period 2||3
3141778|NCT01746017|3867600|FG010|STARTED|Period 2||3
3141779|NCT01746017|3867590|FG000|COMPLETED|Period 2||2
3141780|NCT01746017|3867591|FG001|COMPLETED|Period 2||2
3141781|NCT01746017|3867592|FG002|COMPLETED|Period 2||2
3141782|NCT01746017|3867593|FG003|COMPLETED|Period 2||2
3141783|NCT01746017|3867594|FG004|COMPLETED|Period 2||2
3141784|NCT01746017|3867595|FG005|COMPLETED|Period 2||2
3141785|NCT01746017|3867596|FG006|COMPLETED|Period 2||2
3141786|NCT01746017|3867597|FG007|COMPLETED|Period 2||2
3141787|NCT01746017|3867598|FG008|COMPLETED|Period 2||3
3141788|NCT01746017|3867599|FG009|COMPLETED|Period 2||3
3141789|NCT01746017|3867600|FG010|COMPLETED|Period 2||3
3141790|NCT01746017|3867590|FG000|NOT COMPLETED|Period 2||0
3141791|NCT01746017|3867591|FG001|NOT COMPLETED|Period 2||0
3141792|NCT01746017|3867592|FG002|NOT COMPLETED|Period 2||0
3141793|NCT01746017|3867593|FG003|NOT COMPLETED|Period 2||0
3141794|NCT01746017|3867594|FG004|NOT COMPLETED|Period 2||0
3141795|NCT01746017|3867595|FG005|NOT COMPLETED|Period 2||0
3141796|NCT01746017|3867596|FG006|NOT COMPLETED|Period 2||0
3141797|NCT01746017|3867597|FG007|NOT COMPLETED|Period 2||0
3141798|NCT01746017|3867598|FG008|NOT COMPLETED|Period 2||0
3141799|NCT01746017|3867599|FG009|NOT COMPLETED|Period 2||0
3141800|NCT01746017|3867600|FG010|NOT COMPLETED|Period 2||0
3141801|NCT01746017|3867590|FG000|STARTED|Period 3||2
3141802|NCT01746017|3867591|FG001|STARTED|Period 3||2
3141803|NCT01746017|3867592|FG002|STARTED|Period 3||2
3141804|NCT01746017|3867593|FG003|STARTED|Period 3||2
3141805|NCT01746017|3867594|FG004|STARTED|Period 3||2
3141806|NCT01746017|3867595|FG005|STARTED|Period 3||2
3141807|NCT01746017|3867596|FG006|STARTED|Period 3||2
3141808|NCT01746017|3867597|FG007|STARTED|Period 3||2
3141809|NCT01746017|3867598|FG008|STARTED|Period 3||3
3141810|NCT01746017|3867599|FG009|STARTED|Period 3||3
3141811|NCT01746017|3867600|FG010|STARTED|Period 3||3
3141812|NCT01746017|3867590|FG000|COMPLETED|Period 3||2
3141813|NCT01746017|3867591|FG001|COMPLETED|Period 3||2
3141814|NCT01746017|3867592|FG002|COMPLETED|Period 3||2
3141815|NCT01746017|3867593|FG003|COMPLETED|Period 3||2
3141816|NCT01746017|3867594|FG004|COMPLETED|Period 3||2
3141817|NCT01746017|3867595|FG005|COMPLETED|Period 3||1
3141818|NCT01746017|3867596|FG006|COMPLETED|Period 3||2
3141819|NCT01746017|3867597|FG007|COMPLETED|Period 3||2
3141820|NCT01746017|3867598|FG008|COMPLETED|Period 3||3
3141821|NCT01746017|3867599|FG009|COMPLETED|Period 3||3
3141822|NCT01746017|3867600|FG010|COMPLETED|Period 3||3
3141823|NCT01746017|3867590|FG000|NOT COMPLETED|Period 3||0
3141824|NCT01746017|3867591|FG001|NOT COMPLETED|Period 3||0
3141825|NCT01746017|3867592|FG002|NOT COMPLETED|Period 3||0
3141826|NCT01746017|3867593|FG003|NOT COMPLETED|Period 3||0
3141827|NCT01746017|3867594|FG004|NOT COMPLETED|Period 3||0
3141828|NCT01746017|3867595|FG005|NOT COMPLETED|Period 3||1
3141829|NCT01746017|3867596|FG006|NOT COMPLETED|Period 3||0
3141830|NCT01746017|3867597|FG007|NOT COMPLETED|Period 3||0
3141831|NCT01746017|3867598|FG008|NOT COMPLETED|Period 3||0
3141832|NCT01746017|3867599|FG009|NOT COMPLETED|Period 3||0
3141833|NCT01746017|3867600|FG010|NOT COMPLETED|Period 3||0
3141834|NCT01746017|3867590|FG000|STARTED|Period 4||2
3141835|NCT01746017|3867591|FG001|STARTED|Period 4||2
3141836|NCT01746017|3867592|FG002|STARTED|Period 4||2
3141837|NCT01746017|3867593|FG003|STARTED|Period 4||2
3141838|NCT01746017|3867594|FG004|STARTED|Period 4||2
3141839|NCT01746017|3867595|FG005|STARTED|Period 4||1
3141840|NCT01746017|3867596|FG006|STARTED|Period 4||2
3141841|NCT01746017|3867597|FG007|STARTED|Period 4||2
3141842|NCT01746017|3867598|FG008|STARTED|Period 4|Part B occurred only for 3 periods.|0
3141843|NCT01746017|3867599|FG009|STARTED|Period 4|Part B occurred only for 3 periods.|0
3141844|NCT01746017|3867600|FG010|STARTED|Period 4|Part B occurred only for 3 periods.|0
3141845|NCT01746017|3867590|FG000|COMPLETED|Period 4||2
3141846|NCT01746017|3867591|FG001|COMPLETED|Period 4||2
3141847|NCT01746017|3867592|FG002|COMPLETED|Period 4||2
3141848|NCT01746017|3867593|FG003|COMPLETED|Period 4||2
3141849|NCT01746017|3867594|FG004|COMPLETED|Period 4||2
3141850|NCT01746017|3867595|FG005|COMPLETED|Period 4||1
3141851|NCT01746017|3867596|FG006|COMPLETED|Period 4||2
3141852|NCT01746017|3867597|FG007|COMPLETED|Period 4||2
3141853|NCT01746017|3867598|FG008|COMPLETED|Period 4||0
3141854|NCT01746017|3867599|FG009|COMPLETED|Period 4||0
3141855|NCT01746017|3867600|FG010|COMPLETED|Period 4||0
3141856|NCT01746017|3867590|FG000|NOT COMPLETED|Period 4||0
3141857|NCT01746017|3867591|FG001|NOT COMPLETED|Period 4||0
3141858|NCT01746017|3867592|FG002|NOT COMPLETED|Period 4||0
3141859|NCT01746017|3867593|FG003|NOT COMPLETED|Period 4||0
3141860|NCT01746017|3867594|FG004|NOT COMPLETED|Period 4||0
3141861|NCT01746017|3867595|FG005|NOT COMPLETED|Period 4||0
3141862|NCT01746017|3867596|FG006|NOT COMPLETED|Period 4||0
3141863|NCT01746017|3867597|FG007|NOT COMPLETED|Period 4||0
3141864|NCT01746017|3867598|FG008|NOT COMPLETED|Period 4||0
3141865|NCT01746017|3867599|FG009|NOT COMPLETED|Period 4||0
3141866|NCT01746017|3867600|FG010|NOT COMPLETED|Period 4||0
3141867|NCT01746043|3867643|FG000|STARTED|Overall Study||5
3141868|NCT01746043|3867644|FG001|STARTED|Overall Study||4
3141869|NCT01746043|3867645|FG002|STARTED|Overall Study||5
3141870|NCT01746043|3867646|FG003|STARTED|Overall Study||5
3141871|NCT01746043|3867643|FG000|COMPLETED|Overall Study||5
3141872|NCT01746043|3867644|FG001|COMPLETED|Overall Study||4
3141873|NCT01746043|3867645|FG002|COMPLETED|Overall Study||5
3141874|NCT01746043|3867646|FG003|COMPLETED|Overall Study||5
3180797|NCT01993329|3909237|FG002|COMPLETED|Wash-out||3
3180798|NCT01993329|3909238|FG003|COMPLETED|Wash-out||3
3180799|NCT01993329|3909239|FG004|COMPLETED|Wash-out||3
3180800|NCT01993329|3909240|FG005|COMPLETED|Wash-out||3
3141875|NCT01746043|3867643|FG000|NOT COMPLETED|Overall Study||0
3141876|NCT01746043|3867644|FG001|NOT COMPLETED|Overall Study||0
3141877|NCT01746043|3867645|FG002|NOT COMPLETED|Overall Study||0
3141878|NCT01746043|3867646|FG003|NOT COMPLETED|Overall Study||0
3141879|NCT01746095|3867660|FG000|STARTED|Overall Study||20
3141880|NCT01746095|3867661|FG001|STARTED|Overall Study||20
3141881|NCT01746095|3867662|FG002|STARTED|Overall Study||24
3141882|NCT01746095|3867663|FG003|STARTED|Overall Study||23
3141883|NCT01746095|3867660|FG000|COMPLETED|Overall Study||16
3141884|NCT01746095|3867661|FG001|COMPLETED|Overall Study||16
3141885|NCT01746095|3867662|FG002|COMPLETED|Overall Study||11
3141886|NCT01746095|3867663|FG003|COMPLETED|Overall Study||15
3141887|NCT01746095|3867660|FG000|NOT COMPLETED|Overall Study||4
3141888|NCT01746095|3867661|FG001|NOT COMPLETED|Overall Study||4
3141889|NCT01746095|3867662|FG002|NOT COMPLETED|Overall Study||13
3141890|NCT01746095|3867663|FG003|NOT COMPLETED|Overall Study||8
3141891|NCT01746108|3867676|FG000|STARTED|Overall Study||18
3141892|NCT01746108|3867677|FG001|STARTED|Overall Study||28
3141893|NCT01746108|3867678|FG002|STARTED|Overall Study||6
3141894|NCT01746108|3867676|FG000|COMPLETED|Overall Study||18
3141895|NCT01746108|3867677|FG001|COMPLETED|Overall Study||24
3141896|NCT01746108|3867678|FG002|COMPLETED|Overall Study||6
3141897|NCT01746108|3867676|FG000|NOT COMPLETED|Overall Study||0
3141898|NCT01746108|3867677|FG001|NOT COMPLETED|Overall Study||4
3141899|NCT01746108|3867678|FG002|NOT COMPLETED|Overall Study||0
3141900|NCT01746173|3867694|FG000|STARTED|Overall Study||5
3141901|NCT01746173|3867694|FG000|COMPLETED|Overall Study||3
3141902|NCT01746173|3867694|FG000|NOT COMPLETED|Overall Study||2
3141903|NCT01746225|3867701|FG000|STARTED|Overall Study||83
3141904|NCT01746225|3867702|FG001|STARTED|Overall Study||86
3141905|NCT01746225|3867703|FG002|STARTED|Overall Study||86
3141906|NCT01746225|3867701|FG000|COMPLETED|Overall Study||43
3141907|NCT01746225|3867702|FG001|COMPLETED|Overall Study||40
3141908|NCT01746225|3867703|FG002|COMPLETED|Overall Study||43
3141909|NCT01746225|3867701|FG000|NOT COMPLETED|Overall Study||40
3141910|NCT01746225|3867702|FG001|NOT COMPLETED|Overall Study||46
3141911|NCT01746225|3867703|FG002|NOT COMPLETED|Overall Study||43
3141912|NCT01746264|3867711|FG000|STARTED|Overall Study||19
3141913|NCT01746264|3867711|FG000|COMPLETED|Overall Study||19
3141914|NCT01746264|3867711|FG000|NOT COMPLETED|Overall Study||0
3141915|NCT01746368|3867717|FG000|STARTED|Overall Study||33
3141916|NCT01746368|3867718|FG001|STARTED|Overall Study||17
3141917|NCT01746368|3867717|FG000|Recieved Allocated Intervention|Overall Study||31
3141918|NCT01746368|3867718|FG001|Recieved Allocated Intervention|Overall Study||8
3141919|NCT01746368|3867717|FG000|Assessment Completed|Overall Study||31
3141920|NCT01746368|3867718|FG001|Assessment Completed|Overall Study||16
3141921|NCT01746368|3867717|FG000|Analyzed for AD Completion Rate|Overall Study||32
3141922|NCT01746368|3867718|FG001|Analyzed for AD Completion Rate|Overall Study||17
3141923|NCT01746368|3867717|FG000|Analyzed for Satisfaction|Overall Study||30
3141924|NCT01746368|3867718|FG001|Analyzed for Satisfaction|Overall Study||16
3141925|NCT01746368|3867717|FG000|COMPLETED|Overall Study||31
3141926|NCT01746368|3867718|FG001|COMPLETED|Overall Study||16
3141927|NCT01746368|3867717|FG000|NOT COMPLETED|Overall Study||2
3141928|NCT01746368|3867718|FG001|NOT COMPLETED|Overall Study||1
3141929|NCT01746420|3867729|FG000|STARTED|Overall Study||20
3141930|NCT01746420|3867730|FG001|STARTED|Overall Study||20
3141931|NCT01746420|3867731|FG002|STARTED|Overall Study||20
3141932|NCT01746420|3867732|FG003|STARTED|Overall Study||20
3141933|NCT01746420|3867733|FG004|STARTED|Overall Study||20
3141934|NCT01746420|3867729|FG000|COMPLETED|Overall Study||17
3141935|NCT01746420|3867730|FG001|COMPLETED|Overall Study||18
3141936|NCT01746420|3867731|FG002|COMPLETED|Overall Study||17
3141937|NCT01746420|3867732|FG003|COMPLETED|Overall Study||20
3141938|NCT01746420|3867733|FG004|COMPLETED|Overall Study||20
3141939|NCT01746420|3867729|FG000|NOT COMPLETED|Overall Study||3
3141940|NCT01746420|3867730|FG001|NOT COMPLETED|Overall Study||2
3141941|NCT01746420|3867731|FG002|NOT COMPLETED|Overall Study||3
3141942|NCT01746420|3867732|FG003|NOT COMPLETED|Overall Study||0
3141943|NCT01746420|3867733|FG004|NOT COMPLETED|Overall Study||0
3141944|NCT01746511|3867748|FG000|STARTED|Overall Study||40
3141945|NCT01746511|3867749|FG001|STARTED|Overall Study||39
3141946|NCT01746511|3867748|FG000|COMPLETED|Overall Study||40
3141947|NCT01746511|3867749|FG001|COMPLETED|Overall Study||39
3141948|NCT01746511|3867748|FG000|NOT COMPLETED|Overall Study||0
3141949|NCT01746511|3867749|FG001|NOT COMPLETED|Overall Study||0
3180801|NCT01993329|3909235|FG000|NOT COMPLETED|Wash-out||0
3141950|NCT01746732|3867755|FG000|STARTED|Lead-In Period||23
3141951|NCT01746732|3867756|FG001|STARTED|Lead-In Period||0
3141952|NCT01746732|3867757|FG002|STARTED|Lead-In Period||0
3141953|NCT01746732|3867755|FG000|Participants Received at Least 1 Dose|Lead-In Period||22
3141954|NCT01746732|3867756|FG001|Participants Received at Least 1 Dose|Lead-In Period||0
3141955|NCT01746732|3867757|FG002|Participants Received at Least 1 Dose|Lead-In Period||0
3141956|NCT01746732|3867755|FG000|COMPLETED|Lead-In Period||22
3141957|NCT01746732|3867756|FG001|COMPLETED|Lead-In Period||0
3141958|NCT01746732|3867757|FG002|COMPLETED|Lead-In Period||0
3141959|NCT01746732|3867755|FG000|NOT COMPLETED|Lead-In Period||1
3141960|NCT01746732|3867756|FG001|NOT COMPLETED|Lead-In Period||0
3141961|NCT01746732|3867757|FG002|NOT COMPLETED|Lead-In Period||0
3141962|NCT01746732|3867755|FG000|STARTED|Period 1||0
3141963|NCT01746732|3867756|FG001|STARTED|Period 1||11
3141964|NCT01746732|3867757|FG002|STARTED|Period 1||11
3141965|NCT01746732|3867755|FG000|COMPLETED|Period 1||0
3141966|NCT01746732|3867756|FG001|COMPLETED|Period 1||10
3141967|NCT01746732|3867757|FG002|COMPLETED|Period 1||11
3141968|NCT01746732|3867755|FG000|NOT COMPLETED|Period 1||0
3141969|NCT01746732|3867756|FG001|NOT COMPLETED|Period 1||1
3141970|NCT01746732|3867757|FG002|NOT COMPLETED|Period 1||0
3141971|NCT01746732|3867755|FG000|STARTED|Period 2||0
3141972|NCT01746732|3867756|FG001|STARTED|Period 2||10
3141973|NCT01746732|3867757|FG002|STARTED|Period 2||11
3141974|NCT01746732|3867755|FG000|COMPLETED|Period 2||0
3141975|NCT01746732|3867756|FG001|COMPLETED|Period 2||10
3141976|NCT01746732|3867757|FG002|COMPLETED|Period 2||7
3141977|NCT01746732|3867755|FG000|NOT COMPLETED|Period 2||0
3141978|NCT01746732|3867756|FG001|NOT COMPLETED|Period 2||0
3141979|NCT01746732|3867757|FG002|NOT COMPLETED|Period 2||4
3141980|NCT01746745|3867765|FG000|STARTED|Overall Study||6
3141981|NCT01746745|3867765|FG000|Received Study Drug|Overall Study||6
3141982|NCT01746745|3867765|FG000|COMPLETED|Overall Study||6
3141983|NCT01746745|3867765|FG000|NOT COMPLETED|Overall Study||0
3141984|NCT01746784|3867774|FG000|STARTED|Overall Study||19
3141985|NCT01746784|3867775|FG001|STARTED|Overall Study||10
3141986|NCT01746784|3867776|FG002|STARTED|Overall Study||9
3141987|NCT01746784|3867777|FG003|STARTED|Overall Study||9
3141988|NCT01746784|3867778|FG004|STARTED|Overall Study||19
3141989|NCT01746784|3867774|FG000|Enrolled|Overall Study||19
3141990|NCT01746784|3867775|FG001|Enrolled|Overall Study||10
3141991|NCT01746784|3867776|FG002|Enrolled|Overall Study||9
3141992|NCT01746784|3867777|FG003|Enrolled|Overall Study||9
3141993|NCT01746784|3867778|FG004|Enrolled|Overall Study||19
3141994|NCT01746784|3867774|FG000|COMPLETED|Overall Study||19
3141995|NCT01746784|3867775|FG001|COMPLETED|Overall Study||10
3141996|NCT01746784|3867776|FG002|COMPLETED|Overall Study||9
3141997|NCT01746784|3867777|FG003|COMPLETED|Overall Study||9
3141998|NCT01746784|3867778|FG004|COMPLETED|Overall Study||19
3141999|NCT01746784|3867774|FG000|NOT COMPLETED|Overall Study||0
3142000|NCT01746784|3867775|FG001|NOT COMPLETED|Overall Study||0
3142001|NCT01746784|3867776|FG002|NOT COMPLETED|Overall Study||0
3142002|NCT01746784|3867777|FG003|NOT COMPLETED|Overall Study||0
3142003|NCT01746784|3867778|FG004|NOT COMPLETED|Overall Study||0
3142004|NCT01746862|3867801|FG000|STARTED|Overall Study||60
3142005|NCT01746862|3867802|FG001|STARTED|Overall Study||30
3142006|NCT01746862|3867801|FG000|Treated|Overall Study||59
3142007|NCT01746862|3867802|FG001|Treated|Overall Study||30
3142008|NCT01746862|3867801|FG000|COMPLETED|Overall Study||52
3142009|NCT01746862|3867802|FG001|COMPLETED|Overall Study||27
3142010|NCT01746862|3867801|FG000|NOT COMPLETED|Overall Study||8
3142011|NCT01746862|3867802|FG001|NOT COMPLETED|Overall Study||3
3142012|NCT01746901|3867809|FG000|STARTED|Naloxone Challenge Phase||75
3142013|NCT01746901|3867810|FG001|STARTED|Naloxone Challenge Phase||0
3142014|NCT01746901|3867811|FG002|STARTED|Naloxone Challenge Phase||0
3142015|NCT01746901|3867812|FG003|STARTED|Naloxone Challenge Phase||0
3142016|NCT01746901|3867813|FG004|STARTED|Naloxone Challenge Phase||0
3142017|NCT01746901|3867814|FG005|STARTED|Naloxone Challenge Phase||0
3142018|NCT01746901|3867815|FG006|STARTED|Naloxone Challenge Phase||0
3142019|NCT01746901|3867816|FG007|STARTED|Naloxone Challenge Phase||0
3142020|NCT01746901|3867817|FG008|STARTED|Naloxone Challenge Phase||0
3142021|NCT01746901|3867809|FG000|COMPLETED|Naloxone Challenge Phase||72
3142022|NCT01746901|3867810|FG001|COMPLETED|Naloxone Challenge Phase||0
3142023|NCT01746901|3867811|FG002|COMPLETED|Naloxone Challenge Phase||0
3142024|NCT01746901|3867812|FG003|COMPLETED|Naloxone Challenge Phase||0
3142025|NCT01746901|3867813|FG004|COMPLETED|Naloxone Challenge Phase||0
3142026|NCT01746901|3867814|FG005|COMPLETED|Naloxone Challenge Phase||0
3142027|NCT01746901|3867815|FG006|COMPLETED|Naloxone Challenge Phase||0
3142028|NCT01746901|3867816|FG007|COMPLETED|Naloxone Challenge Phase||0
3142029|NCT01746901|3867817|FG008|COMPLETED|Naloxone Challenge Phase||0
3142030|NCT01746901|3867809|FG000|NOT COMPLETED|Naloxone Challenge Phase||3
3142031|NCT01746901|3867810|FG001|NOT COMPLETED|Naloxone Challenge Phase||0
3142032|NCT01746901|3867811|FG002|NOT COMPLETED|Naloxone Challenge Phase||0
3142033|NCT01746901|3867812|FG003|NOT COMPLETED|Naloxone Challenge Phase||0
3142034|NCT01746901|3867813|FG004|NOT COMPLETED|Naloxone Challenge Phase||0
3142035|NCT01746901|3867814|FG005|NOT COMPLETED|Naloxone Challenge Phase||0
3142036|NCT01746901|3867815|FG006|NOT COMPLETED|Naloxone Challenge Phase||0
3142037|NCT01746901|3867816|FG007|NOT COMPLETED|Naloxone Challenge Phase||0
3142038|NCT01746901|3867817|FG008|NOT COMPLETED|Naloxone Challenge Phase||0
3142039|NCT01746901|3867809|FG000|STARTED|Drug Discrimination Phase: Day 1||0
3142040|NCT01746901|3867810|FG001|STARTED|Drug Discrimination Phase: Day 1||36
3142041|NCT01746901|3867811|FG002|STARTED|Drug Discrimination Phase: Day 1||36
3142042|NCT01746901|3867812|FG003|STARTED|Drug Discrimination Phase: Day 1||0
3142043|NCT01746901|3867813|FG004|STARTED|Drug Discrimination Phase: Day 1||0
3142044|NCT01746901|3867814|FG005|STARTED|Drug Discrimination Phase: Day 1||0
3142045|NCT01746901|3867815|FG006|STARTED|Drug Discrimination Phase: Day 1||0
3142046|NCT01746901|3867816|FG007|STARTED|Drug Discrimination Phase: Day 1||0
3142047|NCT01746901|3867817|FG008|STARTED|Drug Discrimination Phase: Day 1||0
3142048|NCT01746901|3867809|FG000|COMPLETED|Drug Discrimination Phase: Day 1||0
3142049|NCT01746901|3867810|FG001|COMPLETED|Drug Discrimination Phase: Day 1||33
3142050|NCT01746901|3867811|FG002|COMPLETED|Drug Discrimination Phase: Day 1||36
3142051|NCT01746901|3867812|FG003|COMPLETED|Drug Discrimination Phase: Day 1||0
3142052|NCT01746901|3867813|FG004|COMPLETED|Drug Discrimination Phase: Day 1||0
3142053|NCT01746901|3867814|FG005|COMPLETED|Drug Discrimination Phase: Day 1||0
3142054|NCT01746901|3867815|FG006|COMPLETED|Drug Discrimination Phase: Day 1||0
3142055|NCT01746901|3867816|FG007|COMPLETED|Drug Discrimination Phase: Day 1||0
3142056|NCT01746901|3867817|FG008|COMPLETED|Drug Discrimination Phase: Day 1||0
3142057|NCT01746901|3867809|FG000|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
3142058|NCT01746901|3867810|FG001|NOT COMPLETED|Drug Discrimination Phase: Day 1||3
3142059|NCT01746901|3867811|FG002|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
3142060|NCT01746901|3867812|FG003|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
3142061|NCT01746901|3867813|FG004|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
3142062|NCT01746901|3867814|FG005|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
3142063|NCT01746901|3867815|FG006|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
3142064|NCT01746901|3867816|FG007|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
3142065|NCT01746901|3867817|FG008|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
3142066|NCT01746901|3867809|FG000|STARTED|Drug Discrimination Phase: Day 2||0
3142067|NCT01746901|3867810|FG001|STARTED|Drug Discrimination Phase: Day 2||33
3142068|NCT01746901|3867811|FG002|STARTED|Drug Discrimination Phase: Day 2||36
3142069|NCT01746901|3867812|FG003|STARTED|Drug Discrimination Phase: Day 2||0
3142070|NCT01746901|3867813|FG004|STARTED|Drug Discrimination Phase: Day 2||0
3142071|NCT01746901|3867814|FG005|STARTED|Drug Discrimination Phase: Day 2||0
3142072|NCT01746901|3867815|FG006|STARTED|Drug Discrimination Phase: Day 2||0
3142073|NCT01746901|3867816|FG007|STARTED|Drug Discrimination Phase: Day 2||0
3142074|NCT01746901|3867817|FG008|STARTED|Drug Discrimination Phase: Day 2||0
3142075|NCT01746901|3867809|FG000|COMPLETED|Drug Discrimination Phase: Day 2||0
3142076|NCT01746901|3867810|FG001|COMPLETED|Drug Discrimination Phase: Day 2||19
3142077|NCT01746901|3867811|FG002|COMPLETED|Drug Discrimination Phase: Day 2||22
3142078|NCT01746901|3867812|FG003|COMPLETED|Drug Discrimination Phase: Day 2||0
3142079|NCT01746901|3867813|FG004|COMPLETED|Drug Discrimination Phase: Day 2||0
3142080|NCT01746901|3867814|FG005|COMPLETED|Drug Discrimination Phase: Day 2||0
3142081|NCT01746901|3867815|FG006|COMPLETED|Drug Discrimination Phase: Day 2||0
3142082|NCT01746901|3867816|FG007|COMPLETED|Drug Discrimination Phase: Day 2||0
3142083|NCT01746901|3867817|FG008|COMPLETED|Drug Discrimination Phase: Day 2||0
3142084|NCT01746901|3867809|FG000|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
3142085|NCT01746901|3867810|FG001|NOT COMPLETED|Drug Discrimination Phase: Day 2||14
3142086|NCT01746901|3867811|FG002|NOT COMPLETED|Drug Discrimination Phase: Day 2||14
3142087|NCT01746901|3867812|FG003|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
3142088|NCT01746901|3867813|FG004|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
3142089|NCT01746901|3867814|FG005|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
3142090|NCT01746901|3867815|FG006|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
3142091|NCT01746901|3867816|FG007|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
3142092|NCT01746901|3867817|FG008|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
3142093|NCT01746901|3867809|FG000|STARTED|Treatment Phase: First Intervention||0
3142094|NCT01746901|3867810|FG001|STARTED|Treatment Phase: First Intervention||0
3180802|NCT01993329|3909236|FG001|NOT COMPLETED|Wash-out||1
3180803|NCT01993329|3909237|FG002|NOT COMPLETED|Wash-out||0
3142095|NCT01746901|3867811|FG002|STARTED|Treatment Phase: First Intervention||0
3142096|NCT01746901|3867812|FG003|STARTED|Treatment Phase: First Intervention||6
3142097|NCT01746901|3867813|FG004|STARTED|Treatment Phase: First Intervention||6
3142098|NCT01746901|3867814|FG005|STARTED|Treatment Phase: First Intervention||7
3142099|NCT01746901|3867815|FG006|STARTED|Treatment Phase: First Intervention||8
3142100|NCT01746901|3867816|FG007|STARTED|Treatment Phase: First Intervention||7
3142101|NCT01746901|3867817|FG008|STARTED|Treatment Phase: First Intervention||7
3142102|NCT01746901|3867809|FG000|COMPLETED|Treatment Phase: First Intervention||0
3142103|NCT01746901|3867810|FG001|COMPLETED|Treatment Phase: First Intervention||0
3142104|NCT01746901|3867811|FG002|COMPLETED|Treatment Phase: First Intervention||0
3142105|NCT01746901|3867812|FG003|COMPLETED|Treatment Phase: First Intervention||6
3142106|NCT01746901|3867813|FG004|COMPLETED|Treatment Phase: First Intervention||6
3142107|NCT01746901|3867814|FG005|COMPLETED|Treatment Phase: First Intervention||7
3142108|NCT01746901|3867815|FG006|COMPLETED|Treatment Phase: First Intervention||7
3142109|NCT01746901|3867816|FG007|COMPLETED|Treatment Phase: First Intervention||7
3142110|NCT01746901|3867817|FG008|COMPLETED|Treatment Phase: First Intervention||7
3142111|NCT01746901|3867809|FG000|NOT COMPLETED|Treatment Phase: First Intervention||0
3142112|NCT01746901|3867810|FG001|NOT COMPLETED|Treatment Phase: First Intervention||0
3142113|NCT01746901|3867811|FG002|NOT COMPLETED|Treatment Phase: First Intervention||0
3142114|NCT01746901|3867812|FG003|NOT COMPLETED|Treatment Phase: First Intervention||0
3142115|NCT01746901|3867813|FG004|NOT COMPLETED|Treatment Phase: First Intervention||0
3142116|NCT01746901|3867814|FG005|NOT COMPLETED|Treatment Phase: First Intervention||0
3142117|NCT01746901|3867815|FG006|NOT COMPLETED|Treatment Phase: First Intervention||1
3142118|NCT01746901|3867816|FG007|NOT COMPLETED|Treatment Phase: First Intervention||0
3142119|NCT01746901|3867817|FG008|NOT COMPLETED|Treatment Phase: First Intervention||0
3142120|NCT01746901|3867809|FG000|STARTED|Treatment Phase: Washout Period 1||0
3142121|NCT01746901|3867810|FG001|STARTED|Treatment Phase: Washout Period 1||0
3142122|NCT01746901|3867811|FG002|STARTED|Treatment Phase: Washout Period 1||0
3142123|NCT01746901|3867812|FG003|STARTED|Treatment Phase: Washout Period 1||6
3142124|NCT01746901|3867813|FG004|STARTED|Treatment Phase: Washout Period 1||6
3142125|NCT01746901|3867814|FG005|STARTED|Treatment Phase: Washout Period 1||7
3142126|NCT01746901|3867815|FG006|STARTED|Treatment Phase: Washout Period 1||7
3142127|NCT01746901|3867816|FG007|STARTED|Treatment Phase: Washout Period 1||7
3142128|NCT01746901|3867817|FG008|STARTED|Treatment Phase: Washout Period 1||7
3142129|NCT01746901|3867809|FG000|COMPLETED|Treatment Phase: Washout Period 1||0
3142130|NCT01746901|3867810|FG001|COMPLETED|Treatment Phase: Washout Period 1||0
3142131|NCT01746901|3867811|FG002|COMPLETED|Treatment Phase: Washout Period 1||0
3142132|NCT01746901|3867812|FG003|COMPLETED|Treatment Phase: Washout Period 1||6
3142133|NCT01746901|3867813|FG004|COMPLETED|Treatment Phase: Washout Period 1||6
3142134|NCT01746901|3867814|FG005|COMPLETED|Treatment Phase: Washout Period 1||7
3142135|NCT01746901|3867815|FG006|COMPLETED|Treatment Phase: Washout Period 1||7
3142136|NCT01746901|3867816|FG007|COMPLETED|Treatment Phase: Washout Period 1||7
3142137|NCT01746901|3867817|FG008|COMPLETED|Treatment Phase: Washout Period 1||7
3142138|NCT01746901|3867809|FG000|NOT COMPLETED|Treatment Phase: Washout Period 1||0
3142139|NCT01746901|3867810|FG001|NOT COMPLETED|Treatment Phase: Washout Period 1||0
3142140|NCT01746901|3867811|FG002|NOT COMPLETED|Treatment Phase: Washout Period 1||0
3142141|NCT01746901|3867812|FG003|NOT COMPLETED|Treatment Phase: Washout Period 1||0
3142142|NCT01746901|3867813|FG004|NOT COMPLETED|Treatment Phase: Washout Period 1||0
3142143|NCT01746901|3867814|FG005|NOT COMPLETED|Treatment Phase: Washout Period 1||0
3142144|NCT01746901|3867815|FG006|NOT COMPLETED|Treatment Phase: Washout Period 1||0
3142145|NCT01746901|3867816|FG007|NOT COMPLETED|Treatment Phase: Washout Period 1||0
3142146|NCT01746901|3867817|FG008|NOT COMPLETED|Treatment Phase: Washout Period 1||0
3142147|NCT01746901|3867809|FG000|STARTED|Treatment Phase: Second Intervention||0
3142148|NCT01746901|3867810|FG001|STARTED|Treatment Phase: Second Intervention||0
3142149|NCT01746901|3867811|FG002|STARTED|Treatment Phase: Second Intervention||0
3142150|NCT01746901|3867812|FG003|STARTED|Treatment Phase: Second Intervention||6
3142151|NCT01746901|3867813|FG004|STARTED|Treatment Phase: Second Intervention||6
3142152|NCT01746901|3867814|FG005|STARTED|Treatment Phase: Second Intervention||7
3142153|NCT01746901|3867815|FG006|STARTED|Treatment Phase: Second Intervention||7
3142154|NCT01746901|3867816|FG007|STARTED|Treatment Phase: Second Intervention||7
3142155|NCT01746901|3867817|FG008|STARTED|Treatment Phase: Second Intervention||7
3142156|NCT01746901|3867809|FG000|COMPLETED|Treatment Phase: Second Intervention||0
3142157|NCT01746901|3867810|FG001|COMPLETED|Treatment Phase: Second Intervention||0
3142158|NCT01746901|3867811|FG002|COMPLETED|Treatment Phase: Second Intervention||0
3142159|NCT01746901|3867812|FG003|COMPLETED|Treatment Phase: Second Intervention||6
3142160|NCT01746901|3867813|FG004|COMPLETED|Treatment Phase: Second Intervention||6
3142161|NCT01746901|3867814|FG005|COMPLETED|Treatment Phase: Second Intervention||7
3142162|NCT01746901|3867815|FG006|COMPLETED|Treatment Phase: Second Intervention||7
3142163|NCT01746901|3867816|FG007|COMPLETED|Treatment Phase: Second Intervention||6
3142164|NCT01746901|3867817|FG008|COMPLETED|Treatment Phase: Second Intervention||7
3142165|NCT01746901|3867809|FG000|NOT COMPLETED|Treatment Phase: Second Intervention||0
3142166|NCT01746901|3867810|FG001|NOT COMPLETED|Treatment Phase: Second Intervention||0
3142167|NCT01746901|3867811|FG002|NOT COMPLETED|Treatment Phase: Second Intervention||0
3142168|NCT01746901|3867812|FG003|NOT COMPLETED|Treatment Phase: Second Intervention||0
3142169|NCT01746901|3867813|FG004|NOT COMPLETED|Treatment Phase: Second Intervention||0
3142170|NCT01746901|3867814|FG005|NOT COMPLETED|Treatment Phase: Second Intervention||0
3142171|NCT01746901|3867815|FG006|NOT COMPLETED|Treatment Phase: Second Intervention||0
3142172|NCT01746901|3867816|FG007|NOT COMPLETED|Treatment Phase: Second Intervention||1
3142173|NCT01746901|3867817|FG008|NOT COMPLETED|Treatment Phase: Second Intervention||0
3142174|NCT01746901|3867809|FG000|STARTED|Treatment Phase: Washout Period 2||0
3142175|NCT01746901|3867810|FG001|STARTED|Treatment Phase: Washout Period 2||0
3142176|NCT01746901|3867811|FG002|STARTED|Treatment Phase: Washout Period 2||0
3142177|NCT01746901|3867812|FG003|STARTED|Treatment Phase: Washout Period 2||6
3142178|NCT01746901|3867813|FG004|STARTED|Treatment Phase: Washout Period 2||6
3142179|NCT01746901|3867814|FG005|STARTED|Treatment Phase: Washout Period 2||7
3142180|NCT01746901|3867815|FG006|STARTED|Treatment Phase: Washout Period 2||7
3142181|NCT01746901|3867816|FG007|STARTED|Treatment Phase: Washout Period 2||6
3142182|NCT01746901|3867817|FG008|STARTED|Treatment Phase: Washout Period 2||7
3142183|NCT01746901|3867809|FG000|COMPLETED|Treatment Phase: Washout Period 2||0
3142184|NCT01746901|3867810|FG001|COMPLETED|Treatment Phase: Washout Period 2||0
3180804|NCT01993329|3909238|FG003|NOT COMPLETED|Wash-out||0
3180805|NCT01993329|3909239|FG004|NOT COMPLETED|Wash-out||0
3180806|NCT01993329|3909240|FG005|NOT COMPLETED|Wash-out||0
3180807|NCT01993329|3909235|FG000|STARTED|Period 3||3
3180808|NCT01993329|3909236|FG001|STARTED|Period 3||3
3180809|NCT01993329|3909237|FG002|STARTED|Period 3||3
3142185|NCT01746901|3867811|FG002|COMPLETED|Treatment Phase: Washout Period 2||0
3142186|NCT01746901|3867812|FG003|COMPLETED|Treatment Phase: Washout Period 2||6
3142187|NCT01746901|3867813|FG004|COMPLETED|Treatment Phase: Washout Period 2||6
3142188|NCT01746901|3867814|FG005|COMPLETED|Treatment Phase: Washout Period 2||7
3142189|NCT01746901|3867815|FG006|COMPLETED|Treatment Phase: Washout Period 2||7
3142190|NCT01746901|3867816|FG007|COMPLETED|Treatment Phase: Washout Period 2||6
3142191|NCT01746901|3867817|FG008|COMPLETED|Treatment Phase: Washout Period 2||7
3142192|NCT01746901|3867809|FG000|NOT COMPLETED|Treatment Phase: Washout Period 2||0
3142193|NCT01746901|3867810|FG001|NOT COMPLETED|Treatment Phase: Washout Period 2||0
3142194|NCT01746901|3867811|FG002|NOT COMPLETED|Treatment Phase: Washout Period 2||0
3142195|NCT01746901|3867812|FG003|NOT COMPLETED|Treatment Phase: Washout Period 2||0
3142196|NCT01746901|3867813|FG004|NOT COMPLETED|Treatment Phase: Washout Period 2||0
3142197|NCT01746901|3867814|FG005|NOT COMPLETED|Treatment Phase: Washout Period 2||0
3142198|NCT01746901|3867815|FG006|NOT COMPLETED|Treatment Phase: Washout Period 2||0
3142199|NCT01746901|3867816|FG007|NOT COMPLETED|Treatment Phase: Washout Period 2||0
3142200|NCT01746901|3867817|FG008|NOT COMPLETED|Treatment Phase: Washout Period 2||0
3142201|NCT01746901|3867809|FG000|STARTED|Treatment Phase: Third Intervention||0
3142202|NCT01746901|3867810|FG001|STARTED|Treatment Phase: Third Intervention||0
3142203|NCT01746901|3867811|FG002|STARTED|Treatment Phase: Third Intervention||0
3142204|NCT01746901|3867812|FG003|STARTED|Treatment Phase: Third Intervention||6
3142205|NCT01746901|3867813|FG004|STARTED|Treatment Phase: Third Intervention||6
3142206|NCT01746901|3867814|FG005|STARTED|Treatment Phase: Third Intervention||7
3142207|NCT01746901|3867815|FG006|STARTED|Treatment Phase: Third Intervention||7
3142208|NCT01746901|3867816|FG007|STARTED|Treatment Phase: Third Intervention||6
3142209|NCT01746901|3867817|FG008|STARTED|Treatment Phase: Third Intervention||7
3142210|NCT01746901|3867809|FG000|COMPLETED|Treatment Phase: Third Intervention||0
3142211|NCT01746901|3867810|FG001|COMPLETED|Treatment Phase: Third Intervention||0
3142212|NCT01746901|3867811|FG002|COMPLETED|Treatment Phase: Third Intervention||0
3142213|NCT01746901|3867812|FG003|COMPLETED|Treatment Phase: Third Intervention||6
3142214|NCT01746901|3867813|FG004|COMPLETED|Treatment Phase: Third Intervention||6
3142215|NCT01746901|3867814|FG005|COMPLETED|Treatment Phase: Third Intervention||6
3142216|NCT01746901|3867815|FG006|COMPLETED|Treatment Phase: Third Intervention||6
3142217|NCT01746901|3867816|FG007|COMPLETED|Treatment Phase: Third Intervention||6
3142218|NCT01746901|3867817|FG008|COMPLETED|Treatment Phase: Third Intervention||7
3142219|NCT01746901|3867809|FG000|NOT COMPLETED|Treatment Phase: Third Intervention||0
3142220|NCT01746901|3867810|FG001|NOT COMPLETED|Treatment Phase: Third Intervention||0
3142221|NCT01746901|3867811|FG002|NOT COMPLETED|Treatment Phase: Third Intervention||0
3142222|NCT01746901|3867812|FG003|NOT COMPLETED|Treatment Phase: Third Intervention||0
3142223|NCT01746901|3867813|FG004|NOT COMPLETED|Treatment Phase: Third Intervention||0
3142224|NCT01746901|3867814|FG005|NOT COMPLETED|Treatment Phase: Third Intervention||1
3142225|NCT01746901|3867815|FG006|NOT COMPLETED|Treatment Phase: Third Intervention||1
3142226|NCT01746901|3867816|FG007|NOT COMPLETED|Treatment Phase: Third Intervention||0
3142227|NCT01746901|3867817|FG008|NOT COMPLETED|Treatment Phase: Third Intervention||0
3142228|NCT01746901|3867809|FG000|STARTED|Treatment Phase: Washout Period 3||0
3142229|NCT01746901|3867810|FG001|STARTED|Treatment Phase: Washout Period 3||0
3142230|NCT01746901|3867811|FG002|STARTED|Treatment Phase: Washout Period 3||0
3142231|NCT01746901|3867812|FG003|STARTED|Treatment Phase: Washout Period 3||6
3142232|NCT01746901|3867813|FG004|STARTED|Treatment Phase: Washout Period 3||6
3142233|NCT01746901|3867814|FG005|STARTED|Treatment Phase: Washout Period 3||6
3142234|NCT01746901|3867815|FG006|STARTED|Treatment Phase: Washout Period 3||6
3142235|NCT01746901|3867816|FG007|STARTED|Treatment Phase: Washout Period 3||6
3142236|NCT01746901|3867817|FG008|STARTED|Treatment Phase: Washout Period 3||7
3142237|NCT01746901|3867809|FG000|COMPLETED|Treatment Phase: Washout Period 3||0
3142238|NCT01746901|3867810|FG001|COMPLETED|Treatment Phase: Washout Period 3||0
3142239|NCT01746901|3867811|FG002|COMPLETED|Treatment Phase: Washout Period 3||0
3142240|NCT01746901|3867812|FG003|COMPLETED|Treatment Phase: Washout Period 3||6
3142241|NCT01746901|3867813|FG004|COMPLETED|Treatment Phase: Washout Period 3||6
3142242|NCT01746901|3867814|FG005|COMPLETED|Treatment Phase: Washout Period 3||6
3142243|NCT01746901|3867815|FG006|COMPLETED|Treatment Phase: Washout Period 3||6
3142244|NCT01746901|3867816|FG007|COMPLETED|Treatment Phase: Washout Period 3||6
3142245|NCT01746901|3867817|FG008|COMPLETED|Treatment Phase: Washout Period 3||7
3142246|NCT01746901|3867809|FG000|NOT COMPLETED|Treatment Phase: Washout Period 3||0
3142247|NCT01746901|3867810|FG001|NOT COMPLETED|Treatment Phase: Washout Period 3||0
3142248|NCT01746901|3867811|FG002|NOT COMPLETED|Treatment Phase: Washout Period 3||0
3142249|NCT01746901|3867812|FG003|NOT COMPLETED|Treatment Phase: Washout Period 3||0
3142250|NCT01746901|3867813|FG004|NOT COMPLETED|Treatment Phase: Washout Period 3||0
3142251|NCT01746901|3867814|FG005|NOT COMPLETED|Treatment Phase: Washout Period 3||0
3142252|NCT01746901|3867815|FG006|NOT COMPLETED|Treatment Phase: Washout Period 3||0
3142253|NCT01746901|3867816|FG007|NOT COMPLETED|Treatment Phase: Washout Period 3||0
3142254|NCT01746901|3867817|FG008|NOT COMPLETED|Treatment Phase: Washout Period 3||0
3142255|NCT01746901|3867809|FG000|STARTED|Treatment Phase: Fourth Intervention||0
3142256|NCT01746901|3867810|FG001|STARTED|Treatment Phase: Fourth Intervention||0
3180810|NCT01993329|3909238|FG003|STARTED|Period 3||3
3180811|NCT01993329|3909239|FG004|STARTED|Period 3||3
3180812|NCT01993329|3909240|FG005|STARTED|Period 3||3
3180813|NCT01993329|3909235|FG000|COMPLETED|Period 3||3
3180814|NCT01993329|3909236|FG001|COMPLETED|Period 3||3
3180815|NCT01993329|3909237|FG002|COMPLETED|Period 3||3
3180816|NCT01993329|3909238|FG003|COMPLETED|Period 3||3
3180817|NCT01993329|3909239|FG004|COMPLETED|Period 3||3
3180818|NCT01993329|3909240|FG005|COMPLETED|Period 3||3
3180819|NCT01993329|3909235|FG000|NOT COMPLETED|Period 3||0
3180820|NCT01993329|3909236|FG001|NOT COMPLETED|Period 3||0
3180821|NCT01993329|3909237|FG002|NOT COMPLETED|Period 3||0
3142257|NCT01746901|3867811|FG002|STARTED|Treatment Phase: Fourth Intervention||0
3142258|NCT01746901|3867812|FG003|STARTED|Treatment Phase: Fourth Intervention||6
3142259|NCT01746901|3867813|FG004|STARTED|Treatment Phase: Fourth Intervention||6
3142260|NCT01746901|3867814|FG005|STARTED|Treatment Phase: Fourth Intervention||6
3142261|NCT01746901|3867815|FG006|STARTED|Treatment Phase: Fourth Intervention||6
3142262|NCT01746901|3867816|FG007|STARTED|Treatment Phase: Fourth Intervention||6
3142263|NCT01746901|3867817|FG008|STARTED|Treatment Phase: Fourth Intervention||7
3142264|NCT01746901|3867809|FG000|COMPLETED|Treatment Phase: Fourth Intervention||0
3142265|NCT01746901|3867810|FG001|COMPLETED|Treatment Phase: Fourth Intervention||0
3142266|NCT01746901|3867811|FG002|COMPLETED|Treatment Phase: Fourth Intervention||0
3142267|NCT01746901|3867812|FG003|COMPLETED|Treatment Phase: Fourth Intervention||5
3142268|NCT01746901|3867813|FG004|COMPLETED|Treatment Phase: Fourth Intervention||6
3142269|NCT01746901|3867814|FG005|COMPLETED|Treatment Phase: Fourth Intervention||5
3142270|NCT01746901|3867815|FG006|COMPLETED|Treatment Phase: Fourth Intervention||5
3142271|NCT01746901|3867816|FG007|COMPLETED|Treatment Phase: Fourth Intervention||6
3142272|NCT01746901|3867817|FG008|COMPLETED|Treatment Phase: Fourth Intervention||5
3142273|NCT01746901|3867809|FG000|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
3142274|NCT01746901|3867810|FG001|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
3142275|NCT01746901|3867811|FG002|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
3142276|NCT01746901|3867812|FG003|NOT COMPLETED|Treatment Phase: Fourth Intervention||1
3142277|NCT01746901|3867813|FG004|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
3142278|NCT01746901|3867814|FG005|NOT COMPLETED|Treatment Phase: Fourth Intervention||1
3142279|NCT01746901|3867815|FG006|NOT COMPLETED|Treatment Phase: Fourth Intervention||1
3142280|NCT01746901|3867816|FG007|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
3142281|NCT01746901|3867817|FG008|NOT COMPLETED|Treatment Phase: Fourth Intervention||2
3142282|NCT01746901|3867809|FG000|STARTED|Treatment Phase: Washout Period 4||0
3142283|NCT01746901|3867810|FG001|STARTED|Treatment Phase: Washout Period 4||0
3142284|NCT01746901|3867811|FG002|STARTED|Treatment Phase: Washout Period 4||0
3142285|NCT01746901|3867812|FG003|STARTED|Treatment Phase: Washout Period 4||5
3142286|NCT01746901|3867813|FG004|STARTED|Treatment Phase: Washout Period 4||6
3142287|NCT01746901|3867814|FG005|STARTED|Treatment Phase: Washout Period 4||5
3142288|NCT01746901|3867815|FG006|STARTED|Treatment Phase: Washout Period 4||5
3142289|NCT01746901|3867816|FG007|STARTED|Treatment Phase: Washout Period 4||6
3142290|NCT01746901|3867817|FG008|STARTED|Treatment Phase: Washout Period 4||5
3142291|NCT01746901|3867809|FG000|COMPLETED|Treatment Phase: Washout Period 4||0
3142292|NCT01746901|3867810|FG001|COMPLETED|Treatment Phase: Washout Period 4||0
3142293|NCT01746901|3867811|FG002|COMPLETED|Treatment Phase: Washout Period 4||0
3142294|NCT01746901|3867812|FG003|COMPLETED|Treatment Phase: Washout Period 4||5
3142295|NCT01746901|3867813|FG004|COMPLETED|Treatment Phase: Washout Period 4||6
3142296|NCT01746901|3867814|FG005|COMPLETED|Treatment Phase: Washout Period 4||5
3142297|NCT01746901|3867815|FG006|COMPLETED|Treatment Phase: Washout Period 4||5
3142298|NCT01746901|3867816|FG007|COMPLETED|Treatment Phase: Washout Period 4||6
3142299|NCT01746901|3867817|FG008|COMPLETED|Treatment Phase: Washout Period 4||5
3142300|NCT01746901|3867809|FG000|NOT COMPLETED|Treatment Phase: Washout Period 4||0
3142301|NCT01746901|3867810|FG001|NOT COMPLETED|Treatment Phase: Washout Period 4||0
3142302|NCT01746901|3867811|FG002|NOT COMPLETED|Treatment Phase: Washout Period 4||0
3142303|NCT01746901|3867812|FG003|NOT COMPLETED|Treatment Phase: Washout Period 4||0
3142304|NCT01746901|3867813|FG004|NOT COMPLETED|Treatment Phase: Washout Period 4||0
3142305|NCT01746901|3867814|FG005|NOT COMPLETED|Treatment Phase: Washout Period 4||0
3142306|NCT01746901|3867815|FG006|NOT COMPLETED|Treatment Phase: Washout Period 4||0
3142307|NCT01746901|3867816|FG007|NOT COMPLETED|Treatment Phase: Washout Period 4||0
3142308|NCT01746901|3867817|FG008|NOT COMPLETED|Treatment Phase: Washout Period 4||0
3142309|NCT01746901|3867809|FG000|STARTED|Treatment Phase: Fifth Intervention||0
3142310|NCT01746901|3867810|FG001|STARTED|Treatment Phase: Fifth Intervention||0
3142311|NCT01746901|3867811|FG002|STARTED|Treatment Phase: Fifth Intervention||0
3142312|NCT01746901|3867812|FG003|STARTED|Treatment Phase: Fifth Intervention||5
3142313|NCT01746901|3867813|FG004|STARTED|Treatment Phase: Fifth Intervention||6
3142314|NCT01746901|3867814|FG005|STARTED|Treatment Phase: Fifth Intervention||5
3142315|NCT01746901|3867815|FG006|STARTED|Treatment Phase: Fifth Intervention||5
3142316|NCT01746901|3867816|FG007|STARTED|Treatment Phase: Fifth Intervention||6
3142317|NCT01746901|3867817|FG008|STARTED|Treatment Phase: Fifth Intervention||5
3142318|NCT01746901|3867809|FG000|COMPLETED|Treatment Phase: Fifth Intervention||0
3142319|NCT01746901|3867810|FG001|COMPLETED|Treatment Phase: Fifth Intervention||0
3142320|NCT01746901|3867811|FG002|COMPLETED|Treatment Phase: Fifth Intervention||0
3142321|NCT01746901|3867812|FG003|COMPLETED|Treatment Phase: Fifth Intervention||5
3142322|NCT01746901|3867813|FG004|COMPLETED|Treatment Phase: Fifth Intervention||6
3142323|NCT01746901|3867814|FG005|COMPLETED|Treatment Phase: Fifth Intervention||5
3180822|NCT01993329|3909238|FG003|NOT COMPLETED|Period 3||0
3180823|NCT01993329|3909239|FG004|NOT COMPLETED|Period 3||0
3142324|NCT01746901|3867815|FG006|COMPLETED|Treatment Phase: Fifth Intervention||5
3142325|NCT01746901|3867816|FG007|COMPLETED|Treatment Phase: Fifth Intervention||6
3142326|NCT01746901|3867817|FG008|COMPLETED|Treatment Phase: Fifth Intervention||5
3142327|NCT01746901|3867809|FG000|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
3142328|NCT01746901|3867810|FG001|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
3142329|NCT01746901|3867811|FG002|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
3142330|NCT01746901|3867812|FG003|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
3142331|NCT01746901|3867813|FG004|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
3142332|NCT01746901|3867814|FG005|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
3142333|NCT01746901|3867815|FG006|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
3142334|NCT01746901|3867816|FG007|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
3142335|NCT01746901|3867817|FG008|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
3142336|NCT01746901|3867809|FG000|STARTED|Treatment Phase: Washout Period 5||0
3142337|NCT01746901|3867810|FG001|STARTED|Treatment Phase: Washout Period 5||0
3142338|NCT01746901|3867811|FG002|STARTED|Treatment Phase: Washout Period 5||0
3142339|NCT01746901|3867812|FG003|STARTED|Treatment Phase: Washout Period 5||5
3142340|NCT01746901|3867813|FG004|STARTED|Treatment Phase: Washout Period 5||6
3142341|NCT01746901|3867814|FG005|STARTED|Treatment Phase: Washout Period 5||5
3142342|NCT01746901|3867815|FG006|STARTED|Treatment Phase: Washout Period 5||5
3142343|NCT01746901|3867816|FG007|STARTED|Treatment Phase: Washout Period 5||6
3142344|NCT01746901|3867817|FG008|STARTED|Treatment Phase: Washout Period 5||5
3142345|NCT01746901|3867809|FG000|COMPLETED|Treatment Phase: Washout Period 5||0
3142346|NCT01746901|3867810|FG001|COMPLETED|Treatment Phase: Washout Period 5||0
3142347|NCT01746901|3867811|FG002|COMPLETED|Treatment Phase: Washout Period 5||0
3142348|NCT01746901|3867812|FG003|COMPLETED|Treatment Phase: Washout Period 5||5
3142349|NCT01746901|3867813|FG004|COMPLETED|Treatment Phase: Washout Period 5||6
3142350|NCT01746901|3867814|FG005|COMPLETED|Treatment Phase: Washout Period 5||5
3142351|NCT01746901|3867815|FG006|COMPLETED|Treatment Phase: Washout Period 5||5
3142352|NCT01746901|3867816|FG007|COMPLETED|Treatment Phase: Washout Period 5||6
3142353|NCT01746901|3867817|FG008|COMPLETED|Treatment Phase: Washout Period 5||5
3142354|NCT01746901|3867809|FG000|NOT COMPLETED|Treatment Phase: Washout Period 5||0
3142355|NCT01746901|3867810|FG001|NOT COMPLETED|Treatment Phase: Washout Period 5||0
3142356|NCT01746901|3867811|FG002|NOT COMPLETED|Treatment Phase: Washout Period 5||0
3142357|NCT01746901|3867812|FG003|NOT COMPLETED|Treatment Phase: Washout Period 5||0
3142358|NCT01746901|3867813|FG004|NOT COMPLETED|Treatment Phase: Washout Period 5||0
3142359|NCT01746901|3867814|FG005|NOT COMPLETED|Treatment Phase: Washout Period 5||0
3142360|NCT01746901|3867815|FG006|NOT COMPLETED|Treatment Phase: Washout Period 5||0
3142361|NCT01746901|3867816|FG007|NOT COMPLETED|Treatment Phase: Washout Period 5||0
3142362|NCT01746901|3867817|FG008|NOT COMPLETED|Treatment Phase: Washout Period 5||0
3142363|NCT01746901|3867809|FG000|STARTED|Treatment Phase: Sixth Intervention||0
3142364|NCT01746901|3867810|FG001|STARTED|Treatment Phase: Sixth Intervention||0
3142365|NCT01746901|3867811|FG002|STARTED|Treatment Phase: Sixth Intervention||0
3142366|NCT01746901|3867812|FG003|STARTED|Treatment Phase: Sixth Intervention||5
3142367|NCT01746901|3867813|FG004|STARTED|Treatment Phase: Sixth Intervention||6
3142368|NCT01746901|3867814|FG005|STARTED|Treatment Phase: Sixth Intervention||5
3142369|NCT01746901|3867815|FG006|STARTED|Treatment Phase: Sixth Intervention||5
3142370|NCT01746901|3867816|FG007|STARTED|Treatment Phase: Sixth Intervention||6
3142371|NCT01746901|3867817|FG008|STARTED|Treatment Phase: Sixth Intervention||5
3142372|NCT01746901|3867809|FG000|COMPLETED|Treatment Phase: Sixth Intervention||0
3142373|NCT01746901|3867810|FG001|COMPLETED|Treatment Phase: Sixth Intervention||0
3142374|NCT01746901|3867811|FG002|COMPLETED|Treatment Phase: Sixth Intervention||0
3142375|NCT01746901|3867812|FG003|COMPLETED|Treatment Phase: Sixth Intervention||5
3142376|NCT01746901|3867813|FG004|COMPLETED|Treatment Phase: Sixth Intervention||6
3142377|NCT01746901|3867814|FG005|COMPLETED|Treatment Phase: Sixth Intervention||5
3142378|NCT01746901|3867815|FG006|COMPLETED|Treatment Phase: Sixth Intervention||5
3142379|NCT01746901|3867816|FG007|COMPLETED|Treatment Phase: Sixth Intervention||6
3142380|NCT01746901|3867817|FG008|COMPLETED|Treatment Phase: Sixth Intervention||5
3142381|NCT01746901|3867809|FG000|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
3142382|NCT01746901|3867810|FG001|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
3142383|NCT01746901|3867811|FG002|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
3142384|NCT01746901|3867812|FG003|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
3142385|NCT01746901|3867813|FG004|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
3142386|NCT01746901|3867814|FG005|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
3142387|NCT01746901|3867815|FG006|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
3142388|NCT01746901|3867816|FG007|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
3142389|NCT01746901|3867817|FG008|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
3142390|NCT01746940|3867857|FG000|STARTED|Safety and Efficacy First Phase||39
3142391|NCT01746940|3867858|FG001|STARTED|Safety and Efficacy First Phase||41
3142392|NCT01746940|3867859|FG002|STARTED|Safety and Efficacy First Phase||40
3142393|NCT01746940|3867860|FG003|STARTED|Safety and Efficacy First Phase||3
3142394|NCT01746940|3867857|FG000|COMPLETED|Safety and Efficacy First Phase||39
3142395|NCT01746940|3867858|FG001|COMPLETED|Safety and Efficacy First Phase||41
3142396|NCT01746940|3867859|FG002|COMPLETED|Safety and Efficacy First Phase||40
3142397|NCT01746940|3867860|FG003|COMPLETED|Safety and Efficacy First Phase||0
3142398|NCT01746940|3867857|FG000|NOT COMPLETED|Safety and Efficacy First Phase||0
3142399|NCT01746940|3867858|FG001|NOT COMPLETED|Safety and Efficacy First Phase||0
3142400|NCT01746940|3867859|FG002|NOT COMPLETED|Safety and Efficacy First Phase||0
3142401|NCT01746940|3867860|FG003|NOT COMPLETED|Safety and Efficacy First Phase||3
3142402|NCT01746940|3867857|FG000|STARTED|Safety Second Phase||18
3142403|NCT01746940|3867858|FG001|STARTED|Safety Second Phase||18
3142404|NCT01746940|3867859|FG002|STARTED|Safety Second Phase||0
3142405|NCT01746940|3867860|FG003|STARTED|Safety Second Phase||0
3142406|NCT01746940|3867857|FG000|COMPLETED|Safety Second Phase||18
3142407|NCT01746940|3867858|FG001|COMPLETED|Safety Second Phase||18
3142408|NCT01746940|3867859|FG002|COMPLETED|Safety Second Phase||0
3142409|NCT01746940|3867860|FG003|COMPLETED|Safety Second Phase||0
3142410|NCT01746940|3867857|FG000|NOT COMPLETED|Safety Second Phase||0
3142411|NCT01746940|3867858|FG001|NOT COMPLETED|Safety Second Phase||0
3142412|NCT01746940|3867859|FG002|NOT COMPLETED|Safety Second Phase||0
3142413|NCT01746940|3867860|FG003|NOT COMPLETED|Safety Second Phase||0
3142414|NCT01746979|3867870|FG000|STARTED|Overall Study||346
3142415|NCT01746979|3867871|FG001|STARTED|Overall Study||347
3142416|NCT01746979|3867870|FG000|COMPLETED|Overall Study||0
3142417|NCT01746979|3867871|FG001|COMPLETED|Overall Study||0
3142418|NCT01746979|3867870|FG000|NOT COMPLETED|Overall Study||346
3142419|NCT01746979|3867871|FG001|NOT COMPLETED|Overall Study||347
3142420|NCT01747330|3867877|FG000|STARTED|Overall Study||40
3142421|NCT01747330|3867877|FG000|COMPLETED|Overall Study||40
3142422|NCT01747330|3867877|FG000|NOT COMPLETED|Overall Study||0
3142423|NCT01747343|3867881|FG000|STARTED|Baseline||4
3142424|NCT01747343|3867881|FG000|COMPLETED|Baseline||4
3142425|NCT01747343|3867881|FG000|NOT COMPLETED|Baseline||0
3142426|NCT01747343|3867881|FG000|STARTED|Underwear||4
3142427|NCT01747343|3867881|FG000|COMPLETED|Underwear||4
3142428|NCT01747343|3867881|FG000|NOT COMPLETED|Underwear||0
3142429|NCT01747343|3867881|FG000|STARTED|Underwear/Differential Reinforcement||4
3142430|NCT01747343|3867881|FG000|COMPLETED|Underwear/Differential Reinforcement||4
3142431|NCT01747343|3867881|FG000|NOT COMPLETED|Underwear/Differential Reinforcement||0
3142432|NCT01747486|3867887|FG000|STARTED|Stage 1||15
3142433|NCT01747486|3867888|FG001|STARTED|Stage 1||15
3142434|NCT01747486|3867887|FG000|COMPLETED|Stage 1||3
3142435|NCT01747486|3867888|FG001|COMPLETED|Stage 1||2
3142436|NCT01747486|3867887|FG000|NOT COMPLETED|Stage 1||12
3142437|NCT01747486|3867888|FG001|NOT COMPLETED|Stage 1||13
3142438|NCT01747486|3867887|FG000|STARTED|Stage 2||12
3142439|NCT01747486|3867888|FG001|STARTED|Stage 2||0
3142440|NCT01747486|3867887|FG000|COMPLETED|Stage 2||3
3142441|NCT01747486|3867888|FG001|COMPLETED|Stage 2||0
3142442|NCT01747486|3867887|FG000|NOT COMPLETED|Stage 2||9
3142443|NCT01747486|3867888|FG001|NOT COMPLETED|Stage 2||0
3142444|NCT01747499|3867899|FG000|STARTED|Overall Study||3
3142445|NCT01747499|3867900|FG001|STARTED|Overall Study||3
3142446|NCT01747499|3867901|FG002|STARTED|Overall Study||3
3142447|NCT01747499|3867902|FG003|STARTED|Overall Study||6
3142448|NCT01747499|3867903|FG004|STARTED|Overall Study||39
3142449|NCT01747499|3867899|FG000|COMPLETED|Overall Study||2
3142450|NCT01747499|3867900|FG001|COMPLETED|Overall Study||2
3142451|NCT01747499|3867901|FG002|COMPLETED|Overall Study||3
3142452|NCT01747499|3867902|FG003|COMPLETED|Overall Study||4
3142453|NCT01747499|3867903|FG004|COMPLETED|Overall Study||24
3142454|NCT01747499|3867899|FG000|NOT COMPLETED|Overall Study||1
3142455|NCT01747499|3867900|FG001|NOT COMPLETED|Overall Study||1
3142456|NCT01747499|3867901|FG002|NOT COMPLETED|Overall Study||0
3142457|NCT01747499|3867902|FG003|NOT COMPLETED|Overall Study||2
3142458|NCT01747499|3867903|FG004|NOT COMPLETED|Overall Study||15
3142459|NCT01747551|3867919|FG000|STARTED|Overall Study||43
3142460|NCT01747551|3867920|FG001|STARTED|Overall Study||21
3142461|NCT01747551|3867919|FG000|COMPLETED|Overall Study||0
3142462|NCT01747551|3867920|FG001|COMPLETED|Overall Study||0
3142463|NCT01747551|3867919|FG000|NOT COMPLETED|Overall Study||43
3142464|NCT01747551|3867920|FG001|NOT COMPLETED|Overall Study||21
3142465|NCT01747629|3867928|FG000|STARTED|Overall Study||85
3142466|NCT01747629|3867929|FG001|STARTED|Overall Study||75
3142467|NCT01747629|3867928|FG000|Treated|Overall Study|Safety set and full analysis set|84
3142468|NCT01747629|3867929|FG001|Treated|Overall Study|Safety set and full analysis set|75
3142469|NCT01747629|3867928|FG000|COMPLETED|Overall Study||77
3142470|NCT01747629|3867929|FG001|COMPLETED|Overall Study||69
3142471|NCT01747629|3867928|FG000|NOT COMPLETED|Overall Study||8
3142472|NCT01747629|3867929|FG001|NOT COMPLETED|Overall Study||6
3142473|NCT01747655|3867935|FG000|STARTED|Temporary Naso-jejunal Tube Period|Main Analysis Set (MAS): participants with baseline and 1 further visit and ≥ 1 Duodopa treatment|64
3142474|NCT01747655|3867936|FG001|STARTED|Temporary Naso-jejunal Tube Period||0
3142475|NCT01747655|3867935|FG000|COMPLETED|Temporary Naso-jejunal Tube Period||64
3142476|NCT01747655|3867936|FG001|COMPLETED|Temporary Naso-jejunal Tube Period||0
3142477|NCT01747655|3867935|FG000|NOT COMPLETED|Temporary Naso-jejunal Tube Period||0
3142478|NCT01747655|3867936|FG001|NOT COMPLETED|Temporary Naso-jejunal Tube Period||0
3142479|NCT01747655|3867935|FG000|STARTED|PEG-J Period (Duodopa Treatment)|Dudopa MAS: Participants in the MAS that received Duodopa via PEG-J.|58
3142480|NCT01747655|3867936|FG001|STARTED|PEG-J Period (Duodopa Treatment)|Participants in the MAS that returned to SoC (no PEG-J introduced; did not meet selection criteria)|6
3142481|NCT01747655|3867935|FG000|COMPLETED|PEG-J Period (Duodopa Treatment)||44
3142482|NCT01747655|3867936|FG001|COMPLETED|PEG-J Period (Duodopa Treatment)||6
3142483|NCT01747655|3867935|FG000|NOT COMPLETED|PEG-J Period (Duodopa Treatment)||14
3142484|NCT01747655|3867936|FG001|NOT COMPLETED|PEG-J Period (Duodopa Treatment)||0
3142485|NCT01747655|3867935|FG000|STARTED|PEG-J Period (Continued Treatment)||41
3142486|NCT01747655|3867936|FG001|STARTED|PEG-J Period (Continued Treatment)|SoC MAS: 6 SoC participants plus 9 participants who received Duodopa via PEG-J then returned to SoC|15
3142487|NCT01747655|3867935|FG000|COMPLETED|PEG-J Period (Continued Treatment)||41
3142488|NCT01747655|3867936|FG001|COMPLETED|PEG-J Period (Continued Treatment)||15
3142489|NCT01747655|3867935|FG000|NOT COMPLETED|PEG-J Period (Continued Treatment)||0
3142490|NCT01747655|3867936|FG001|NOT COMPLETED|PEG-J Period (Continued Treatment)||0
3142491|NCT01747772|3867942|FG000|STARTED|Overall Study||180
3142492|NCT01747772|3867942|FG000|Analysis Population|Overall Study|All participants who completed the study and had adequate SWE and liver biopsy data.|164
3142493|NCT01747772|3867942|FG000|COMPLETED|Overall Study||171
3142494|NCT01747772|3867942|FG000|NOT COMPLETED|Overall Study||9
3142495|NCT01747811|3867952|FG000|STARTED|Overall Study||16
3142496|NCT01747811|3867953|FG001|STARTED|Overall Study||16
3142497|NCT01747811|3867952|FG000|COMPLETED|Overall Study||14
3142498|NCT01747811|3867953|FG001|COMPLETED|Overall Study||12
3142499|NCT01747811|3867952|FG000|NOT COMPLETED|Overall Study||2
3142500|NCT01747811|3867953|FG001|NOT COMPLETED|Overall Study||4
3142501|NCT01747837|3867963|FG000|STARTED|Overall Study||25
3142502|NCT01747837|3867964|FG001|STARTED|Overall Study||23
3142503|NCT01747837|3867963|FG000|COMPLETED|Overall Study||16
3142504|NCT01747837|3867964|FG001|COMPLETED|Overall Study||17
3142505|NCT01747837|3867963|FG000|NOT COMPLETED|Overall Study||9
3142506|NCT01747837|3867964|FG001|NOT COMPLETED|Overall Study||6
3142507|NCT01747850|3867973|FG000|STARTED|Overall Study||5
3142508|NCT01747850|3867974|FG001|STARTED|Overall Study||20
3142509|NCT01747850|3867975|FG002|STARTED|Overall Study||20
3142510|NCT01747850|3867973|FG000|COMPLETED|Overall Study||4
3142511|NCT01747850|3867974|FG001|COMPLETED|Overall Study||13
3142512|NCT01747850|3867975|FG002|COMPLETED|Overall Study||14
3142513|NCT01747850|3867973|FG000|NOT COMPLETED|Overall Study||1
3142514|NCT01747850|3867974|FG001|NOT COMPLETED|Overall Study||7
3142515|NCT01747850|3867975|FG002|NOT COMPLETED|Overall Study||6
3142516|NCT01747876|3867998|FG000|STARTED|Overall Study||5
3142517|NCT01747876|3867999|FG001|STARTED|Overall Study||15
3142518|NCT01747876|3868000|FG002|STARTED|Overall Study||12
3142519|NCT01747876|3867998|FG000|COMPLETED|Overall Study||0
3142520|NCT01747876|3867999|FG001|COMPLETED|Overall Study||0
3142521|NCT01747876|3868000|FG002|COMPLETED|Overall Study||0
3142522|NCT01747876|3867998|FG000|NOT COMPLETED|Overall Study||5
3142523|NCT01747876|3867999|FG001|NOT COMPLETED|Overall Study||15
3142524|NCT01747876|3868000|FG002|NOT COMPLETED|Overall Study||12
3142525|NCT01747915|3868014|FG000|STARTED|Overall Study||75
3142526|NCT01747915|3868015|FG001|STARTED|Overall Study||72
3142527|NCT01747915|3868016|FG002|STARTED|Overall Study||72
3142528|NCT01747915|3868014|FG000|COMPLETED|Overall Study||60
3142529|NCT01747915|3868015|FG001|COMPLETED|Overall Study||61
3142530|NCT01747915|3868016|FG002|COMPLETED|Overall Study||66
3142531|NCT01747915|3868014|FG000|NOT COMPLETED|Overall Study||15
3142532|NCT01747915|3868015|FG001|NOT COMPLETED|Overall Study||11
3142533|NCT01747915|3868016|FG002|NOT COMPLETED|Overall Study||6
3142534|NCT01747928|3868032|FG000|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
3142535|NCT01747928|3868033|FG001|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
3142536|NCT01747928|3868034|FG002|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
3142537|NCT01747928|3868035|FG003|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
3142538|NCT01747928|3868036|FG004|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
3142539|NCT01747928|3868037|FG005|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
3142540|NCT01747928|3868038|FG006|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
3142541|NCT01747928|3868039|FG007|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
3142542|NCT01747928|3868032|FG000|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
3142543|NCT01747928|3868033|FG001|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
3142544|NCT01747928|3868034|FG002|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
3142545|NCT01747928|3868035|FG003|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
3142546|NCT01747928|3868036|FG004|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
3142547|NCT01747928|3868037|FG005|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
3142548|NCT01747928|3868038|FG006|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
3142549|NCT01747928|3868039|FG007|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
3142550|NCT01747928|3868032|FG000|NOT COMPLETED|Overall Study||0
3142551|NCT01747928|3868033|FG001|NOT COMPLETED|Overall Study||0
3142552|NCT01747928|3868034|FG002|NOT COMPLETED|Overall Study||0
3142553|NCT01747928|3868035|FG003|NOT COMPLETED|Overall Study||0
3142554|NCT01747928|3868036|FG004|NOT COMPLETED|Overall Study||0
3142555|NCT01747928|3868037|FG005|NOT COMPLETED|Overall Study||0
3142556|NCT01747928|3868038|FG006|NOT COMPLETED|Overall Study||0
3142557|NCT01747928|3868039|FG007|NOT COMPLETED|Overall Study||0
3142558|NCT01748045|3868060|FG000|STARTED|Overall Study||2
3142559|NCT01748045|3868061|FG001|STARTED|Overall Study||1
3142560|NCT01748045|3868060|FG000|COMPLETED|Overall Study||2
3142561|NCT01748045|3868061|FG001|COMPLETED|Overall Study||1
3142562|NCT01748045|3868060|FG000|NOT COMPLETED|Overall Study||0
3142563|NCT01748045|3868061|FG001|NOT COMPLETED|Overall Study||0
3142564|NCT01748071|3868076|FG000|STARTED|Overall Study||40
3142565|NCT01748071|3868077|FG001|STARTED|Overall Study||40
3142566|NCT01748071|3868078|FG002|STARTED|Overall Study||40
3142567|NCT01748071|3868076|FG000|COMPLETED|Overall Study||38
3142568|NCT01748071|3868077|FG001|COMPLETED|Overall Study||38
3142569|NCT01748071|3868078|FG002|COMPLETED|Overall Study||40
3142570|NCT01748071|3868076|FG000|NOT COMPLETED|Overall Study||2
3142571|NCT01748071|3868077|FG001|NOT COMPLETED|Overall Study||2
3142572|NCT01748071|3868078|FG002|NOT COMPLETED|Overall Study||0
3142573|NCT01748227|3868086|FG000|STARTED|Overall Study||20
3142574|NCT01748227|3868086|FG000|COMPLETED|Overall Study||17
3142575|NCT01748227|3868086|FG000|NOT COMPLETED|Overall Study||3
3142576|NCT01748240|3868091|FG000|STARTED|Overall Study||21
3142577|NCT01748240|3868091|FG000|COMPLETED|Overall Study||21
3142578|NCT01748240|3868091|FG000|NOT COMPLETED|Overall Study||0
3142579|NCT01748292|3868097|FG000|STARTED|Overall Study||20
3142580|NCT01748292|3868098|FG001|STARTED|Overall Study||40
3142581|NCT01748292|3868097|FG000|COMPLETED|Overall Study||18
3142582|NCT01748292|3868098|FG001|COMPLETED|Overall Study||28
3142583|NCT01748292|3868097|FG000|NOT COMPLETED|Overall Study||2
3142584|NCT01748292|3868098|FG001|NOT COMPLETED|Overall Study||12
3142585|NCT01748552|3868116|FG000|STARTED|Intervention Period 1 and Washout||3
3142586|NCT01748552|3868117|FG001|STARTED|Intervention Period 1 and Washout||3
3142587|NCT01748552|3868118|FG002|STARTED|Intervention Period 1 and Washout||3
3142588|NCT01748552|3868119|FG003|STARTED|Intervention Period 1 and Washout||3
3142589|NCT01748552|3868120|FG004|STARTED|Intervention Period 1 and Washout||3
3142590|NCT01748552|3868121|FG005|STARTED|Intervention Period 1 and Washout||3
3142591|NCT01748552|3868122|FG006|STARTED|Intervention Period 1 and Washout||3
3142592|NCT01748552|3868123|FG007|STARTED|Intervention Period 1 and Washout||3
3142593|NCT01748552|3868124|FG008|STARTED|Intervention Period 1 and Washout||3
3142594|NCT01748552|3868125|FG009|STARTED|Intervention Period 1 and Washout||3
3142595|NCT01748552|3868126|FG010|STARTED|Intervention Period 1 and Washout||3
3142596|NCT01748552|3868127|FG011|STARTED|Intervention Period 1 and Washout||3
3142597|NCT01748552|3868116|FG000|COMPLETED|Intervention Period 1 and Washout||3
3142598|NCT01748552|3868117|FG001|COMPLETED|Intervention Period 1 and Washout||3
3142599|NCT01748552|3868118|FG002|COMPLETED|Intervention Period 1 and Washout||3
3142600|NCT01748552|3868119|FG003|COMPLETED|Intervention Period 1 and Washout||3
3142601|NCT01748552|3868120|FG004|COMPLETED|Intervention Period 1 and Washout||3
3142602|NCT01748552|3868121|FG005|COMPLETED|Intervention Period 1 and Washout||3
3142603|NCT01748552|3868122|FG006|COMPLETED|Intervention Period 1 and Washout||3
3142604|NCT01748552|3868123|FG007|COMPLETED|Intervention Period 1 and Washout||3
3142605|NCT01748552|3868124|FG008|COMPLETED|Intervention Period 1 and Washout||3
3142606|NCT01748552|3868125|FG009|COMPLETED|Intervention Period 1 and Washout||3
3142607|NCT01748552|3868126|FG010|COMPLETED|Intervention Period 1 and Washout||3
3142608|NCT01748552|3868127|FG011|COMPLETED|Intervention Period 1 and Washout||3
3142609|NCT01748552|3868116|FG000|NOT COMPLETED|Intervention Period 1 and Washout||0
3142610|NCT01748552|3868117|FG001|NOT COMPLETED|Intervention Period 1 and Washout||0
3142611|NCT01748552|3868118|FG002|NOT COMPLETED|Intervention Period 1 and Washout||0
3180824|NCT01993329|3909240|FG005|NOT COMPLETED|Period 3||0
3180825|NCT01993615|3909254|FG000|STARTED|Overall Study||40
3142612|NCT01748552|3868119|FG003|NOT COMPLETED|Intervention Period 1 and Washout||0
3142613|NCT01748552|3868120|FG004|NOT COMPLETED|Intervention Period 1 and Washout||0
3142614|NCT01748552|3868121|FG005|NOT COMPLETED|Intervention Period 1 and Washout||0
3180826|NCT01993615|3909255|FG001|STARTED|Overall Study||40
3180827|NCT01993615|3909254|FG000|COMPLETED|Overall Study||39
3180828|NCT01993615|3909255|FG001|COMPLETED|Overall Study||40
3180829|NCT01993615|3909254|FG000|NOT COMPLETED|Overall Study||1
3180830|NCT01993615|3909255|FG001|NOT COMPLETED|Overall Study||0
3180831|NCT01993667|3909263|FG000|STARTED|Overall Study||64
3180832|NCT01993667|3909264|FG001|STARTED|Overall Study||66
3180833|NCT01993667|3909263|FG000|COMPLETED|Overall Study||43
3180834|NCT01993667|3909264|FG001|COMPLETED|Overall Study||47
3180835|NCT01993667|3909263|FG000|NOT COMPLETED|Overall Study||21
3180836|NCT01993667|3909264|FG001|NOT COMPLETED|Overall Study||19
3180837|NCT01993823|3909272|FG000|STARTED|Overall Study||95
3180838|NCT01993823|3909273|FG001|STARTED|Overall Study||95
3180839|NCT01993823|3909272|FG000|COMPLETED|Overall Study||88
3180840|NCT01993823|3909273|FG001|COMPLETED|Overall Study||79
3180841|NCT01993823|3909272|FG000|NOT COMPLETED|Overall Study||7
3180842|NCT01993823|3909273|FG001|NOT COMPLETED|Overall Study||16
3180843|NCT01993836|3909282|FG000|STARTED|Overall Study|This represents the number of enrolled patients who completed baseline cognitive testing|72
3180844|NCT01993836|3909283|FG001|STARTED|Overall Study||68
3180845|NCT01993836|3909284|FG002|STARTED|Overall Study||51
3180846|NCT01993836|3909282|FG000|COMPLETED|Overall Study||55
3180847|NCT01993836|3909283|FG001|COMPLETED|Overall Study||55
3180848|NCT01993836|3909284|FG002|COMPLETED|Overall Study||46
3180849|NCT01993836|3909282|FG000|NOT COMPLETED|Overall Study||17
3180850|NCT01993836|3909283|FG001|NOT COMPLETED|Overall Study||13
3180851|NCT01993836|3909284|FG002|NOT COMPLETED|Overall Study||5
3180852|NCT01993849|3909294|FG000|STARTED|Overall Study||12
3180853|NCT01993849|3909295|FG001|STARTED|Overall Study||11
3180854|NCT01993849|3909294|FG000|COMPLETED|Overall Study||9
3180855|NCT01993849|3909295|FG001|COMPLETED|Overall Study||9
3142615|NCT01748552|3868122|FG006|NOT COMPLETED|Intervention Period 1 and Washout||0
3142616|NCT01748552|3868123|FG007|NOT COMPLETED|Intervention Period 1 and Washout||0
3142617|NCT01748552|3868124|FG008|NOT COMPLETED|Intervention Period 1 and Washout||0
3142618|NCT01748552|3868125|FG009|NOT COMPLETED|Intervention Period 1 and Washout||0
3142619|NCT01748552|3868126|FG010|NOT COMPLETED|Intervention Period 1 and Washout||0
3142620|NCT01748552|3868127|FG011|NOT COMPLETED|Intervention Period 1 and Washout||0
3142621|NCT01748552|3868116|FG000|STARTED|Intervention Period 2 and Washout||3
3142622|NCT01748552|3868117|FG001|STARTED|Intervention Period 2 and Washout||3
3142623|NCT01748552|3868118|FG002|STARTED|Intervention Period 2 and Washout||3
3142624|NCT01748552|3868119|FG003|STARTED|Intervention Period 2 and Washout||3
3142625|NCT01748552|3868120|FG004|STARTED|Intervention Period 2 and Washout||3
3142626|NCT01748552|3868121|FG005|STARTED|Intervention Period 2 and Washout||3
3142627|NCT01748552|3868122|FG006|STARTED|Intervention Period 2 and Washout||3
3142628|NCT01748552|3868123|FG007|STARTED|Intervention Period 2 and Washout||3
3142629|NCT01748552|3868124|FG008|STARTED|Intervention Period 2 and Washout||3
3142630|NCT01748552|3868125|FG009|STARTED|Intervention Period 2 and Washout||3
3142631|NCT01748552|3868126|FG010|STARTED|Intervention Period 2 and Washout||3
3142632|NCT01748552|3868127|FG011|STARTED|Intervention Period 2 and Washout||3
3142633|NCT01748552|3868116|FG000|COMPLETED|Intervention Period 2 and Washout||3
3142634|NCT01748552|3868117|FG001|COMPLETED|Intervention Period 2 and Washout||3
3142635|NCT01748552|3868118|FG002|COMPLETED|Intervention Period 2 and Washout||2
3142636|NCT01748552|3868119|FG003|COMPLETED|Intervention Period 2 and Washout||3
3142637|NCT01748552|3868120|FG004|COMPLETED|Intervention Period 2 and Washout||3
3142638|NCT01748552|3868121|FG005|COMPLETED|Intervention Period 2 and Washout||3
3142639|NCT01748552|3868122|FG006|COMPLETED|Intervention Period 2 and Washout||0
3142640|NCT01748552|3868123|FG007|COMPLETED|Intervention Period 2 and Washout||0
3142641|NCT01748552|3868124|FG008|COMPLETED|Intervention Period 2 and Washout||0
3142642|NCT01748552|3868125|FG009|COMPLETED|Intervention Period 2 and Washout||3
3142643|NCT01748552|3868126|FG010|COMPLETED|Intervention Period 2 and Washout||3
3142644|NCT01748552|3868127|FG011|COMPLETED|Intervention Period 2 and Washout||3
3142645|NCT01748552|3868116|FG000|NOT COMPLETED|Intervention Period 2 and Washout||0
3142646|NCT01748552|3868117|FG001|NOT COMPLETED|Intervention Period 2 and Washout||0
3142647|NCT01748552|3868118|FG002|NOT COMPLETED|Intervention Period 2 and Washout||1
3142648|NCT01748552|3868119|FG003|NOT COMPLETED|Intervention Period 2 and Washout||0
3142649|NCT01748552|3868120|FG004|NOT COMPLETED|Intervention Period 2 and Washout||0
3142650|NCT01748552|3868121|FG005|NOT COMPLETED|Intervention Period 2 and Washout||0
3142651|NCT01748552|3868122|FG006|NOT COMPLETED|Intervention Period 2 and Washout||3
3142652|NCT01748552|3868123|FG007|NOT COMPLETED|Intervention Period 2 and Washout||3
3142653|NCT01748552|3868124|FG008|NOT COMPLETED|Intervention Period 2 and Washout||3
3142654|NCT01748552|3868125|FG009|NOT COMPLETED|Intervention Period 2 and Washout||0
3142655|NCT01748552|3868126|FG010|NOT COMPLETED|Intervention Period 2 and Washout||0
3142656|NCT01748552|3868127|FG011|NOT COMPLETED|Intervention Period 2 and Washout||0
3142657|NCT01748552|3868116|FG000|STARTED|Intervention Period 3 and Washout||3
3142658|NCT01748552|3868117|FG001|STARTED|Intervention Period 3 and Washout||3
3142659|NCT01748552|3868118|FG002|STARTED|Intervention Period 3 and Washout||2
3142660|NCT01748552|3868119|FG003|STARTED|Intervention Period 3 and Washout||3
3142661|NCT01748552|3868120|FG004|STARTED|Intervention Period 3 and Washout||3
3142662|NCT01748552|3868121|FG005|STARTED|Intervention Period 3 and Washout||3
3142663|NCT01748552|3868122|FG006|STARTED|Intervention Period 3 and Washout||0
3142664|NCT01748552|3868123|FG007|STARTED|Intervention Period 3 and Washout||0
3142665|NCT01748552|3868124|FG008|STARTED|Intervention Period 3 and Washout||0
3142666|NCT01748552|3868125|FG009|STARTED|Intervention Period 3 and Washout||3
3142667|NCT01748552|3868126|FG010|STARTED|Intervention Period 3 and Washout||3
3142668|NCT01748552|3868127|FG011|STARTED|Intervention Period 3 and Washout||3
3142669|NCT01748552|3868116|FG000|COMPLETED|Intervention Period 3 and Washout||3
3142670|NCT01748552|3868117|FG001|COMPLETED|Intervention Period 3 and Washout||3
3142671|NCT01748552|3868118|FG002|COMPLETED|Intervention Period 3 and Washout||2
3142672|NCT01748552|3868119|FG003|COMPLETED|Intervention Period 3 and Washout||3
3142673|NCT01748552|3868120|FG004|COMPLETED|Intervention Period 3 and Washout||3
3142674|NCT01748552|3868121|FG005|COMPLETED|Intervention Period 3 and Washout||3
3142675|NCT01748552|3868122|FG006|COMPLETED|Intervention Period 3 and Washout||0
3142676|NCT01748552|3868123|FG007|COMPLETED|Intervention Period 3 and Washout||0
3142677|NCT01748552|3868124|FG008|COMPLETED|Intervention Period 3 and Washout||0
3142678|NCT01748552|3868125|FG009|COMPLETED|Intervention Period 3 and Washout||3
3142679|NCT01748552|3868126|FG010|COMPLETED|Intervention Period 3 and Washout||3
3142680|NCT01748552|3868127|FG011|COMPLETED|Intervention Period 3 and Washout||3
3142681|NCT01748552|3868116|FG000|NOT COMPLETED|Intervention Period 3 and Washout||0
3142682|NCT01748552|3868117|FG001|NOT COMPLETED|Intervention Period 3 and Washout||0
3142683|NCT01748552|3868118|FG002|NOT COMPLETED|Intervention Period 3 and Washout||0
3142684|NCT01748552|3868119|FG003|NOT COMPLETED|Intervention Period 3 and Washout||0
3142685|NCT01748552|3868120|FG004|NOT COMPLETED|Intervention Period 3 and Washout||0
3142686|NCT01748552|3868121|FG005|NOT COMPLETED|Intervention Period 3 and Washout||0
3142687|NCT01748552|3868122|FG006|NOT COMPLETED|Intervention Period 3 and Washout||0
3142688|NCT01748552|3868123|FG007|NOT COMPLETED|Intervention Period 3 and Washout||0
3142689|NCT01748552|3868124|FG008|NOT COMPLETED|Intervention Period 3 and Washout||0
3142690|NCT01748552|3868125|FG009|NOT COMPLETED|Intervention Period 3 and Washout||0
3142691|NCT01748552|3868126|FG010|NOT COMPLETED|Intervention Period 3 and Washout||0
3142692|NCT01748552|3868127|FG011|NOT COMPLETED|Intervention Period 3 and Washout||0
3142693|NCT01748643|3868169|FG000|STARTED|Overall Study||30
3142694|NCT01748643|3868170|FG001|STARTED|Overall Study||30
3142695|NCT01748643|3868169|FG000|COMPLETED|Overall Study||30
3142696|NCT01748643|3868170|FG001|COMPLETED|Overall Study||30
3142697|NCT01748643|3868169|FG000|NOT COMPLETED|Overall Study||0
3142698|NCT01748643|3868170|FG001|NOT COMPLETED|Overall Study||0
3142699|NCT01748695|3868176|FG000|STARTED|First Intervention (4 Weeks)||14
3142700|NCT01748695|3868177|FG001|STARTED|First Intervention (4 Weeks)||11
3142701|NCT01748695|3868176|FG000|COMPLETED|First Intervention (4 Weeks)||14
3142702|NCT01748695|3868177|FG001|COMPLETED|First Intervention (4 Weeks)||11
3142703|NCT01748695|3868176|FG000|NOT COMPLETED|First Intervention (4 Weeks)||0
3142704|NCT01748695|3868177|FG001|NOT COMPLETED|First Intervention (4 Weeks)||0
3142705|NCT01748695|3868176|FG000|STARTED|Second Intervention (4 Weeks)||14
3142706|NCT01748695|3868177|FG001|STARTED|Second Intervention (4 Weeks)||11
3142707|NCT01748695|3868176|FG000|COMPLETED|Second Intervention (4 Weeks)||14
3142708|NCT01748695|3868177|FG001|COMPLETED|Second Intervention (4 Weeks)||11
3142709|NCT01748695|3868176|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||0
3142710|NCT01748695|3868177|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||0
3142711|NCT01748760|3868185|FG000|STARTED|Overall Study||25
3142712|NCT01748760|3868186|FG001|STARTED|Overall Study||25
3142713|NCT01748760|3868185|FG000|COMPLETED|Overall Study||19
3142714|NCT01748760|3868186|FG001|COMPLETED|Overall Study||23
3142715|NCT01748760|3868185|FG000|NOT COMPLETED|Overall Study||6
3142716|NCT01748760|3868186|FG001|NOT COMPLETED|Overall Study||2
3142717|NCT01748799|3868200|FG000|STARTED|Overall Study||6
3142718|NCT01748799|3868201|FG001|STARTED|Overall Study||1
3142719|NCT01748799|3868202|FG002|STARTED|Overall Study||1
3142720|NCT01748799|3868203|FG003|STARTED|Overall Study||2
3142721|NCT01748799|3868204|FG004|STARTED|Overall Study||1
3142722|NCT01748799|3868205|FG005|STARTED|Overall Study||2
3142723|NCT01748799|3868206|FG006|STARTED|Overall Study||2
3142724|NCT01748799|3868207|FG007|STARTED|Overall Study||1
3142725|NCT01748799|3868200|FG000|Completed SAU of Fixed Dose Placebo|Overall Study||2
3142726|NCT01748799|3868201|FG001|Completed SAU of Fixed Dose Placebo|Overall Study||1
3142727|NCT01748799|3868202|FG002|Completed SAU of Fixed Dose Placebo|Overall Study||1
3142728|NCT01748799|3868203|FG003|Completed SAU of Fixed Dose Placebo|Overall Study||2
3142729|NCT01748799|3868204|FG004|Completed SAU of Fixed Dose Placebo|Overall Study||1
3142730|NCT01748799|3868205|FG005|Completed SAU of Fixed Dose Placebo|Overall Study||1
3142731|NCT01748799|3868206|FG006|Completed SAU of Fixed Dose Placebo|Overall Study||1
3142732|NCT01748799|3868207|FG007|Completed SAU of Fixed Dose Placebo|Overall Study||1
3142733|NCT01748799|3868200|FG000|Completed Fixed Dose Placebo|Overall Study||2
3142734|NCT01748799|3868201|FG001|Completed Fixed Dose Placebo|Overall Study||1
3142735|NCT01748799|3868202|FG002|Completed Fixed Dose Placebo|Overall Study||1
3142736|NCT01748799|3868203|FG003|Completed Fixed Dose Placebo|Overall Study||2
3142737|NCT01748799|3868204|FG004|Completed Fixed Dose Placebo|Overall Study||1
3142738|NCT01748799|3868205|FG005|Completed Fixed Dose Placebo|Overall Study||1
3142739|NCT01748799|3868206|FG006|Completed Fixed Dose Placebo|Overall Study||1
3142740|NCT01748799|3868207|FG007|Completed Fixed Dose Placebo|Overall Study||1
3142741|NCT01748799|3868200|FG000|Completed SAU of Fixed Dose Sativex|Overall Study||1
3142742|NCT01748799|3868201|FG001|Completed SAU of Fixed Dose Sativex|Overall Study||1
3142743|NCT01748799|3868202|FG002|Completed SAU of Fixed Dose Sativex|Overall Study||1
3142744|NCT01748799|3868203|FG003|Completed SAU of Fixed Dose Sativex|Overall Study||2
3142745|NCT01748799|3868204|FG004|Completed SAU of Fixed Dose Sativex|Overall Study||1
3142746|NCT01748799|3868205|FG005|Completed SAU of Fixed Dose Sativex|Overall Study||1
3142747|NCT01748799|3868206|FG006|Completed SAU of Fixed Dose Sativex|Overall Study||1
3142748|NCT01748799|3868207|FG007|Completed SAU of Fixed Dose Sativex|Overall Study||1
3142749|NCT01748799|3868200|FG000|Completed Fixed Dose Sativex|Overall Study||1
3142750|NCT01748799|3868201|FG001|Completed Fixed Dose Sativex|Overall Study||1
3142751|NCT01748799|3868202|FG002|Completed Fixed Dose Sativex|Overall Study||1
3142752|NCT01748799|3868203|FG003|Completed Fixed Dose Sativex|Overall Study||2
3142753|NCT01748799|3868204|FG004|Completed Fixed Dose Sativex|Overall Study||1
3142754|NCT01748799|3868205|FG005|Completed Fixed Dose Sativex|Overall Study||1
3142755|NCT01748799|3868206|FG006|Completed Fixed Dose Sativex|Overall Study||1
3142756|NCT01748799|3868207|FG007|Completed Fixed Dose Sativex|Overall Study||1
3142757|NCT01748799|3868200|FG000|Completed SAU of Self-titrated Placebo|Overall Study||5
3142758|NCT01748799|3868201|FG001|Completed SAU of Self-titrated Placebo|Overall Study||1
3142759|NCT01748799|3868202|FG002|Completed SAU of Self-titrated Placebo|Overall Study||1
3142760|NCT01748799|3868203|FG003|Completed SAU of Self-titrated Placebo|Overall Study||2
3142761|NCT01748799|3868204|FG004|Completed SAU of Self-titrated Placebo|Overall Study||1
3142762|NCT01748799|3868205|FG005|Completed SAU of Self-titrated Placebo|Overall Study||2
3142763|NCT01748799|3868206|FG006|Completed SAU of Self-titrated Placebo|Overall Study||1
3142764|NCT01748799|3868207|FG007|Completed SAU of Self-titrated Placebo|Overall Study||1
3142765|NCT01748799|3868200|FG000|Completed Self-titrated Placebo|Overall Study||4
3142766|NCT01748799|3868201|FG001|Completed Self-titrated Placebo|Overall Study||1
3142767|NCT01748799|3868202|FG002|Completed Self-titrated Placebo|Overall Study||1
3142768|NCT01748799|3868203|FG003|Completed Self-titrated Placebo|Overall Study||2
3142769|NCT01748799|3868204|FG004|Completed Self-titrated Placebo|Overall Study||1
3142770|NCT01748799|3868205|FG005|Completed Self-titrated Placebo|Overall Study||2
3142771|NCT01748799|3868206|FG006|Completed Self-titrated Placebo|Overall Study||1
3142772|NCT01748799|3868207|FG007|Completed Self-titrated Placebo|Overall Study||1
3142773|NCT01748799|3868200|FG000|Completed SAU of Self-titrated Sativex|Overall Study||2
3142774|NCT01748799|3868201|FG001|Completed SAU of Self-titrated Sativex|Overall Study||1
3142775|NCT01748799|3868202|FG002|Completed SAU of Self-titrated Sativex|Overall Study||1
3142776|NCT01748799|3868203|FG003|Completed SAU of Self-titrated Sativex|Overall Study||2
3142777|NCT01748799|3868204|FG004|Completed SAU of Self-titrated Sativex|Overall Study||1
3142778|NCT01748799|3868205|FG005|Completed SAU of Self-titrated Sativex|Overall Study||2
3142779|NCT01748799|3868206|FG006|Completed SAU of Self-titrated Sativex|Overall Study||1
3142780|NCT01748799|3868207|FG007|Completed SAU of Self-titrated Sativex|Overall Study||1
3142781|NCT01748799|3868200|FG000|Completed Self-titrated Sativex|Overall Study||1
3142782|NCT01748799|3868201|FG001|Completed Self-titrated Sativex|Overall Study||1
3142783|NCT01748799|3868202|FG002|Completed Self-titrated Sativex|Overall Study||1
3142784|NCT01748799|3868203|FG003|Completed Self-titrated Sativex|Overall Study||2
3142785|NCT01748799|3868204|FG004|Completed Self-titrated Sativex|Overall Study||1
3142786|NCT01748799|3868205|FG005|Completed Self-titrated Sativex|Overall Study||1
3142787|NCT01748799|3868206|FG006|Completed Self-titrated Sativex|Overall Study||1
3142788|NCT01748799|3868207|FG007|Completed Self-titrated Sativex|Overall Study||1
3142789|NCT01748799|3868200|FG000|COMPLETED|Overall Study||1
3142790|NCT01748799|3868201|FG001|COMPLETED|Overall Study||1
3142791|NCT01748799|3868202|FG002|COMPLETED|Overall Study||1
3142792|NCT01748799|3868203|FG003|COMPLETED|Overall Study||2
3142793|NCT01748799|3868204|FG004|COMPLETED|Overall Study||1
3142794|NCT01748799|3868205|FG005|COMPLETED|Overall Study||1
3142795|NCT01748799|3868206|FG006|COMPLETED|Overall Study||1
3142796|NCT01748799|3868207|FG007|COMPLETED|Overall Study||1
3142797|NCT01748799|3868200|FG000|NOT COMPLETED|Overall Study||5
3142798|NCT01748799|3868201|FG001|NOT COMPLETED|Overall Study||0
3142799|NCT01748799|3868202|FG002|NOT COMPLETED|Overall Study||0
3142800|NCT01748799|3868203|FG003|NOT COMPLETED|Overall Study||0
3142801|NCT01748799|3868204|FG004|NOT COMPLETED|Overall Study||0
3142802|NCT01748799|3868205|FG005|NOT COMPLETED|Overall Study||1
3142803|NCT01748799|3868206|FG006|NOT COMPLETED|Overall Study||1
3142804|NCT01748799|3868207|FG007|NOT COMPLETED|Overall Study||0
3142805|NCT01748825|3868243|FG000|STARTED|Dose Escalation||6
3142806|NCT01748825|3868244|FG001|STARTED|Dose Escalation||4
3142807|NCT01748825|3868245|FG002|STARTED|Dose Escalation||6
3142808|NCT01748825|3868246|FG003|STARTED|Dose Escalation||3
3142809|NCT01748825|3868247|FG004|STARTED|Dose Escalation||3
3142810|NCT01748825|3868248|FG005|STARTED|Dose Escalation||6
3142811|NCT01748825|3868249|FG006|STARTED|Dose Escalation||3
3142812|NCT01748825|3868250|FG007|STARTED|Dose Escalation||3
3142813|NCT01748825|3868251|FG008|STARTED|Dose Escalation||0
3142814|NCT01748825|3868252|FG009|STARTED|Dose Escalation||0
3142815|NCT01748825|3868243|FG000|COMPLETED|Dose Escalation||4
3142816|NCT01748825|3868244|FG001|COMPLETED|Dose Escalation||2
3142817|NCT01748825|3868245|FG002|COMPLETED|Dose Escalation||6
3142818|NCT01748825|3868246|FG003|COMPLETED|Dose Escalation||2
3142819|NCT01748825|3868247|FG004|COMPLETED|Dose Escalation||2
3142820|NCT01748825|3868248|FG005|COMPLETED|Dose Escalation||4
3142821|NCT01748825|3868249|FG006|COMPLETED|Dose Escalation||2
3142822|NCT01748825|3868250|FG007|COMPLETED|Dose Escalation||3
3142823|NCT01748825|3868251|FG008|COMPLETED|Dose Escalation||0
3142824|NCT01748825|3868252|FG009|COMPLETED|Dose Escalation||0
3142825|NCT01748825|3868243|FG000|NOT COMPLETED|Dose Escalation||2
3142826|NCT01748825|3868244|FG001|NOT COMPLETED|Dose Escalation||2
3142827|NCT01748825|3868245|FG002|NOT COMPLETED|Dose Escalation||0
3142828|NCT01748825|3868246|FG003|NOT COMPLETED|Dose Escalation||1
3142829|NCT01748825|3868247|FG004|NOT COMPLETED|Dose Escalation||1
3142830|NCT01748825|3868248|FG005|NOT COMPLETED|Dose Escalation||2
3142831|NCT01748825|3868249|FG006|NOT COMPLETED|Dose Escalation||1
3142832|NCT01748825|3868250|FG007|NOT COMPLETED|Dose Escalation||0
3142833|NCT01748825|3868251|FG008|NOT COMPLETED|Dose Escalation||0
3142834|NCT01748825|3868252|FG009|NOT COMPLETED|Dose Escalation||0
3142835|NCT01748825|3868243|FG000|STARTED|Dose Expansion||0
3142836|NCT01748825|3868244|FG001|STARTED|Dose Expansion||0
3142837|NCT01748825|3868245|FG002|STARTED|Dose Expansion||0
3142838|NCT01748825|3868246|FG003|STARTED|Dose Expansion||0
3142839|NCT01748825|3868247|FG004|STARTED|Dose Expansion||0
3142840|NCT01748825|3868248|FG005|STARTED|Dose Expansion||0
3142841|NCT01748825|3868249|FG006|STARTED|Dose Expansion||0
3142842|NCT01748825|3868250|FG007|STARTED|Dose Expansion||0
3142843|NCT01748825|3868251|FG008|STARTED|Dose Expansion||13
3142844|NCT01748825|3868252|FG009|STARTED|Dose Expansion||20
3142845|NCT01748825|3868243|FG000|COMPLETED|Dose Expansion||0
3142846|NCT01748825|3868244|FG001|COMPLETED|Dose Expansion||0
3142847|NCT01748825|3868245|FG002|COMPLETED|Dose Expansion||0
3142848|NCT01748825|3868246|FG003|COMPLETED|Dose Expansion||0
3142849|NCT01748825|3868247|FG004|COMPLETED|Dose Expansion||0
3142850|NCT01748825|3868248|FG005|COMPLETED|Dose Expansion||0
3142851|NCT01748825|3868249|FG006|COMPLETED|Dose Expansion||0
3142852|NCT01748825|3868250|FG007|COMPLETED|Dose Expansion||0
3142853|NCT01748825|3868251|FG008|COMPLETED|Dose Expansion||11
3142854|NCT01748825|3868252|FG009|COMPLETED|Dose Expansion||15
3142855|NCT01748825|3868243|FG000|NOT COMPLETED|Dose Expansion||0
3142856|NCT01748825|3868244|FG001|NOT COMPLETED|Dose Expansion||0
3142857|NCT01748825|3868245|FG002|NOT COMPLETED|Dose Expansion||0
3142858|NCT01748825|3868246|FG003|NOT COMPLETED|Dose Expansion||0
3142859|NCT01748825|3868247|FG004|NOT COMPLETED|Dose Expansion||0
3142860|NCT01748825|3868248|FG005|NOT COMPLETED|Dose Expansion||0
3142861|NCT01748825|3868249|FG006|NOT COMPLETED|Dose Expansion||0
3142862|NCT01748825|3868250|FG007|NOT COMPLETED|Dose Expansion||0
3142863|NCT01748825|3868251|FG008|NOT COMPLETED|Dose Expansion||2
3142864|NCT01748825|3868252|FG009|NOT COMPLETED|Dose Expansion||5
3142865|NCT01748916|3868281|FG000|STARTED|Overall Study||2
3142866|NCT01748916|3868282|FG001|STARTED|Overall Study||3
3142867|NCT01748916|3868283|FG002|STARTED|Overall Study||2
3142868|NCT01748916|3868284|FG003|STARTED|Overall Study||3
3142869|NCT01748916|3868285|FG004|STARTED|Overall Study||3
3142870|NCT01748916|3868286|FG005|STARTED|Overall Study||3
3142871|NCT01748916|3868281|FG000|COMPLETED|Overall Study||2
3142872|NCT01748916|3868282|FG001|COMPLETED|Overall Study||3
3142873|NCT01748916|3868283|FG002|COMPLETED|Overall Study||2
3142874|NCT01748916|3868284|FG003|COMPLETED|Overall Study||3
3142875|NCT01748916|3868285|FG004|COMPLETED|Overall Study||3
3142876|NCT01748916|3868286|FG005|COMPLETED|Overall Study||3
3142877|NCT01748916|3868281|FG000|NOT COMPLETED|Overall Study||0
3142878|NCT01748916|3868282|FG001|NOT COMPLETED|Overall Study||0
3142879|NCT01748916|3868283|FG002|NOT COMPLETED|Overall Study||0
3142880|NCT01748916|3868284|FG003|NOT COMPLETED|Overall Study||0
3142881|NCT01748916|3868285|FG004|NOT COMPLETED|Overall Study||0
3142882|NCT01748916|3868286|FG005|NOT COMPLETED|Overall Study||0
3142883|NCT01748942|3868296|FG000|STARTED|Overall Study||39
3142884|NCT01748942|3868297|FG001|STARTED|Overall Study||37
3142885|NCT01748942|3868296|FG000|COMPLETED|Overall Study||35
3142886|NCT01748942|3868297|FG001|COMPLETED|Overall Study||33
3142887|NCT01748942|3868296|FG000|NOT COMPLETED|Overall Study||4
3142888|NCT01748942|3868297|FG001|NOT COMPLETED|Overall Study||4
3142889|NCT01748955|3868305|FG000|STARTED|Overall Study||6
3142890|NCT01748955|3868306|FG001|STARTED|Overall Study||9
3142891|NCT01748955|3868305|FG000|COMPLETED|Overall Study||3
3142892|NCT01748955|3868306|FG001|COMPLETED|Overall Study||4
3142893|NCT01748955|3868305|FG000|NOT COMPLETED|Overall Study||3
3180856|NCT01993849|3909294|FG000|NOT COMPLETED|Overall Study||3
3180857|NCT01993849|3909295|FG001|NOT COMPLETED|Overall Study||2
3180858|NCT01993875|3909305|FG000|STARTED|Overall Study||82
3180859|NCT01993875|3909306|FG001|STARTED|Overall Study||82
3142894|NCT01748955|3868306|FG001|NOT COMPLETED|Overall Study||5
3142895|NCT01748994|3868314|FG000|STARTED|Overall Study||31
3142896|NCT01748994|3868315|FG001|STARTED|Overall Study||32
3142897|NCT01748994|3868314|FG000|COMPLETED|Overall Study||23
3142898|NCT01748994|3868315|FG001|COMPLETED|Overall Study||26
3142899|NCT01748994|3868314|FG000|NOT COMPLETED|Overall Study||8
3142900|NCT01748994|3868315|FG001|NOT COMPLETED|Overall Study||6
3142901|NCT01749033|3868324|FG000|STARTED|Overall Study||150
3142902|NCT01749033|3868325|FG001|STARTED|Overall Study||150
3142903|NCT01749033|3868326|FG002|STARTED|Overall Study||150
3142904|NCT01749033|3868324|FG000|COMPLETED|Overall Study||147
3142905|NCT01749033|3868325|FG001|COMPLETED|Overall Study||145
3142906|NCT01749033|3868326|FG002|COMPLETED|Overall Study||149
3142907|NCT01749033|3868324|FG000|NOT COMPLETED|Overall Study||3
3142908|NCT01749033|3868325|FG001|NOT COMPLETED|Overall Study||5
3142909|NCT01749033|3868326|FG002|NOT COMPLETED|Overall Study||1
3142910|NCT01749215|3868337|FG000|STARTED|Overall Study||72
3142911|NCT01749215|3868338|FG001|STARTED|Overall Study||79
3142912|NCT01749215|3868337|FG000|COMPLETED|Overall Study||47
3142913|NCT01749215|3868338|FG001|COMPLETED|Overall Study||53
3142914|NCT01749215|3868337|FG000|NOT COMPLETED|Overall Study||25
3142915|NCT01749215|3868338|FG001|NOT COMPLETED|Overall Study||26
3142916|NCT01749293|3868344|FG000|STARTED|Overall Study||3
3142917|NCT01749293|3868344|FG000|COMPLETED|Overall Study||3
3142918|NCT01749293|3868344|FG000|NOT COMPLETED|Overall Study||0
3142919|NCT01749410|3868349|FG000|STARTED|Overall Study||33
3142920|NCT01749410|3868349|FG000|COMPLETED|Overall Study||33
3142921|NCT01749410|3868349|FG000|NOT COMPLETED|Overall Study||0
3142922|NCT01749501|3868355|FG000|STARTED|Overall Study||22
3142923|NCT01749501|3868356|FG001|STARTED|Overall Study||23
3142924|NCT01749501|3868355|FG000|COMPLETED|Overall Study||22
3142925|NCT01749501|3868356|FG001|COMPLETED|Overall Study||23
3142926|NCT01749501|3868355|FG000|NOT COMPLETED|Overall Study||0
3142927|NCT01749501|3868356|FG001|NOT COMPLETED|Overall Study||0
3142928|NCT01749605|3868364|FG000|STARTED|Overall Study||18
3142929|NCT01749605|3868365|FG001|STARTED|Overall Study||17
3142930|NCT01749605|3868364|FG000|COMPLETED|Overall Study||14
3142931|NCT01749605|3868365|FG001|COMPLETED|Overall Study||14
3142932|NCT01749605|3868364|FG000|NOT COMPLETED|Overall Study||4
3142933|NCT01749605|3868365|FG001|NOT COMPLETED|Overall Study||3
3142934|NCT01749631|3868371|FG000|STARTED|Overall Study||97
3142935|NCT01749631|3868371|FG000|COMPLETED|Overall Study||97
3142936|NCT01749631|3868371|FG000|NOT COMPLETED|Overall Study||0
3142937|NCT01749735|3868377|FG000|STARTED|Overall Study||2
3142938|NCT01749735|3868378|FG001|STARTED|Overall Study||0
3142939|NCT01749735|3868377|FG000|COMPLETED|Overall Study||1
3142940|NCT01749735|3868378|FG001|COMPLETED|Overall Study||0
3142941|NCT01749735|3868377|FG000|NOT COMPLETED|Overall Study||1
3142942|NCT01749735|3868378|FG001|NOT COMPLETED|Overall Study||0
3142943|NCT01749800|3868387|FG000|STARTED|Overall Study|3 subjects did not show significant attention span deficit (required inclusion criterion)|6
3142944|NCT01749800|3868388|FG001|STARTED|Overall Study|1 subject showed significant motor impairments but decided to undergo therapy (exclusion criterion)|1
3142945|NCT01749800|3868389|FG002|STARTED|Overall Study||0
3142946|NCT01749800|3868387|FG000|COMPLETED|Overall Study||3
3142947|NCT01749800|3868388|FG001|COMPLETED|Overall Study||0
3142948|NCT01749800|3868389|FG002|COMPLETED|Overall Study||0
3142949|NCT01749800|3868387|FG000|NOT COMPLETED|Overall Study||3
3142950|NCT01749800|3868388|FG001|NOT COMPLETED|Overall Study||1
3142951|NCT01749800|3868389|FG002|NOT COMPLETED|Overall Study||0
3142952|NCT01749904|3868399|FG000|STARTED|Overall Study|randomized population|286
3142953|NCT01749904|3868400|FG001|STARTED|Overall Study|randomized population|134
3142954|NCT01749904|3868399|FG000|COMPLETED|Overall Study|randomized population|264
3142955|NCT01749904|3868400|FG001|COMPLETED|Overall Study|randomized population|123
3142956|NCT01749904|3868399|FG000|NOT COMPLETED|Overall Study||22
3142957|NCT01749904|3868400|FG001|NOT COMPLETED|Overall Study||11
3142958|NCT01749930|3868412|FG000|STARTED|Overall Study|randomized population|283
3142959|NCT01749930|3868413|FG001|STARTED|Overall Study|randomized population|137
3142960|NCT01749930|3868412|FG000|COMPLETED|Overall Study|randomized population|253
3142961|NCT01749930|3868413|FG001|COMPLETED|Overall Study|randomized population|125
3142962|NCT01749930|3868412|FG000|NOT COMPLETED|Overall Study||30
3142963|NCT01749930|3868413|FG001|NOT COMPLETED|Overall Study||12
3142964|NCT01749956|3868423|FG000|STARTED|Overall Study||39
3142965|NCT01749956|3868423|FG000|COMPLETED|Overall Study||24
3142966|NCT01749956|3868423|FG000|NOT COMPLETED|Overall Study||15
3142967|NCT01749982|3868432|FG000|STARTED|Overall Study||15
3142968|NCT01749982|3868433|FG001|STARTED|Overall Study||15
3142969|NCT01749982|3868434|FG002|STARTED|Overall Study||15
3142970|NCT01749982|3868435|FG003|STARTED|Overall Study||15
3142971|NCT01749982|3868432|FG000|COMPLETED|Overall Study||15
3142972|NCT01749982|3868433|FG001|COMPLETED|Overall Study||15
3142973|NCT01749982|3868434|FG002|COMPLETED|Overall Study||15
3142974|NCT01749982|3868435|FG003|COMPLETED|Overall Study||12
3142975|NCT01749982|3868432|FG000|NOT COMPLETED|Overall Study||0
3142976|NCT01749982|3868433|FG001|NOT COMPLETED|Overall Study||0
3142977|NCT01749982|3868434|FG002|NOT COMPLETED|Overall Study||0
3142978|NCT01749982|3868435|FG003|NOT COMPLETED|Overall Study||3
3142979|NCT01749995|3868445|FG000|STARTED|Overall Study||200
3142980|NCT01749995|3868445|FG000|COMPLETED|Overall Study||196
3142981|NCT01749995|3868445|FG000|NOT COMPLETED|Overall Study||4
3142982|NCT01750086|3868451|FG000|STARTED|Overall Study||13
3142983|NCT01750086|3868452|FG001|STARTED|Overall Study||14
3142984|NCT01750086|3868451|FG000|COMPLETED|Overall Study||12
3142985|NCT01750086|3868452|FG001|COMPLETED|Overall Study||13
3142986|NCT01750086|3868451|FG000|NOT COMPLETED|Overall Study||1
3142987|NCT01750086|3868452|FG001|NOT COMPLETED|Overall Study||1
3142988|NCT01750190|3868460|FG000|STARTED|Overall Study||616
3142989|NCT01750190|3868461|FG001|STARTED|Overall Study||306
3142990|NCT01750190|3868460|FG000|Safety Population|Overall Study||611
3142991|NCT01750190|3868461|FG001|Safety Population|Overall Study||305
3142992|NCT01750190|3868460|FG000|Full Analysis Set (FAS)|Overall Study||608
3142993|NCT01750190|3868461|FG001|Full Analysis Set (FAS)|Overall Study||305
3142994|NCT01750190|3868460|FG000|COMPLETED|Overall Study||349
3142995|NCT01750190|3868461|FG001|COMPLETED|Overall Study||98
3142996|NCT01750190|3868460|FG000|NOT COMPLETED|Overall Study||267
3142997|NCT01750190|3868461|FG001|NOT COMPLETED|Overall Study||208
3180860|NCT01993875|3909305|FG000|COMPLETED|Overall Study||75
3180861|NCT01993875|3909306|FG001|COMPLETED|Overall Study||76
3180862|NCT01993875|3909305|FG000|NOT COMPLETED|Overall Study||7
3180863|NCT01993875|3909306|FG001|NOT COMPLETED|Overall Study||6
3180864|NCT01993888|3909315|FG000|STARTED|Overall Study||50
3180865|NCT01993888|3909316|FG001|STARTED|Overall Study||52
3180866|NCT01993888|3909315|FG000|COMPLETED|Overall Study||48
3180867|NCT01993888|3909316|FG001|COMPLETED|Overall Study||49
3180868|NCT01993888|3909315|FG000|NOT COMPLETED|Overall Study||2
3180869|NCT01993888|3909316|FG001|NOT COMPLETED|Overall Study||3
3180870|NCT01993927|3909322|FG000|STARTED|Overall Study||742
3180871|NCT01993927|3909322|FG000|COMPLETED|Overall Study||713
3180872|NCT01993927|3909322|FG000|NOT COMPLETED|Overall Study||29
3180873|NCT01993940|3909328|FG000|STARTED|Overall Study|Includes one participant who enrolled at two different sites|277
3180874|NCT01993940|3909329|FG001|STARTED|Overall Study|Includes two participants who each enrolled at two different sites|276
3180875|NCT01993940|3909328|FG000|Received Treatment|Overall Study||272
3180876|NCT01993940|3909329|FG001|Received Treatment|Overall Study||276
3180877|NCT01993940|3909328|FG000|COMPLETED|Overall Study||237
3180878|NCT01993940|3909329|FG001|COMPLETED|Overall Study||232
3180879|NCT01993940|3909328|FG000|NOT COMPLETED|Overall Study||40
3180880|NCT01993940|3909329|FG001|NOT COMPLETED|Overall Study||44
3180881|NCT01994109|3909338|FG000|STARTED|Double-blind Phase (Part A)||63
3180882|NCT01994109|3909339|FG001|STARTED|Double-blind Phase (Part A)||64
3180883|NCT01994109|3909340|FG002|STARTED|Double-blind Phase (Part A)||60
3180884|NCT01994109|3909341|FG003|STARTED|Double-blind Phase (Part A)||0
3180885|NCT01994109|3909338|FG000|COMPLETED|Double-blind Phase (Part A)||62
3180886|NCT01994109|3909339|FG001|COMPLETED|Double-blind Phase (Part A)||61
3180887|NCT01994109|3909340|FG002|COMPLETED|Double-blind Phase (Part A)||53
3180888|NCT01994109|3909341|FG003|COMPLETED|Double-blind Phase (Part A)||0
3180889|NCT01994109|3909338|FG000|NOT COMPLETED|Double-blind Phase (Part A)||1
3180890|NCT01994109|3909339|FG001|NOT COMPLETED|Double-blind Phase (Part A)||3
3180891|NCT01994109|3909340|FG002|NOT COMPLETED|Double-blind Phase (Part A)||7
3180892|NCT01994109|3909341|FG003|NOT COMPLETED|Double-blind Phase (Part A)||0
3180893|NCT01994109|3909338|FG000|STARTED|Open-label Phase (Part B)||0
3142998|NCT01750229|3868467|FG000|STARTED|Randomized Crossover Phase||30
3142999|NCT01750229|3868467|FG000|Subject Received Sham|Randomized Crossover Phase||24
3143000|NCT01750229|3868467|FG000|Subjects Received 1200 Hz|Randomized Crossover Phase||24
3143001|NCT01750229|3868467|FG000|Subjects Received 3030 Hz|Randomized Crossover Phase||24
3143002|NCT01750229|3868467|FG000|Subjects Received 5882 Hz|Randomized Crossover Phase||24
3143003|NCT01750229|3868467|FG000|Protocol Violation|Randomized Crossover Phase||4
3143004|NCT01750229|3868467|FG000|COMPLETED|Randomized Crossover Phase||28
3143005|NCT01750229|3868467|FG000|NOT COMPLETED|Randomized Crossover Phase||2
3143006|NCT01750229|3868467|FG000|STARTED|Long-term Follow-up Phase|Four subjects who had protocol violations continued to be followed in long-term follow-up phase.|28
3143007|NCT01750229|3868467|FG000|COMPLETED|Long-term Follow-up Phase||25
3143008|NCT01750229|3868467|FG000|NOT COMPLETED|Long-term Follow-up Phase||3
3143009|NCT01750242|3868477|FG000|STARTED|Overall Study||23
3143010|NCT01750242|3868477|FG000|Readable Images|Overall Study|Subjects with readable images were analyzed and there were 3 subjects with unreadable images.|20
3143011|NCT01750242|3868477|FG000|COMPLETED|Overall Study||20
3143012|NCT01750242|3868477|FG000|NOT COMPLETED|Overall Study||3
3143013|NCT01750255|3868484|FG000|STARTED|Overall Study||49
3143014|NCT01750255|3868485|FG001|STARTED|Overall Study||43
3143015|NCT01750255|3868484|FG000|COMPLETED|Overall Study||43
3143016|NCT01750255|3868485|FG001|COMPLETED|Overall Study||38
3143017|NCT01750255|3868484|FG000|NOT COMPLETED|Overall Study||6
3143018|NCT01750255|3868485|FG001|NOT COMPLETED|Overall Study||5
3143019|NCT01750268|3868494|FG000|STARTED|Overall Study||15
3143020|NCT01750268|3868495|FG001|STARTED|Overall Study||17
3143021|NCT01750268|3868494|FG000|COMPLETED|Overall Study||13
3143022|NCT01750268|3868495|FG001|COMPLETED|Overall Study||12
3143023|NCT01750268|3868494|FG000|NOT COMPLETED|Overall Study||2
3143024|NCT01750268|3868495|FG001|NOT COMPLETED|Overall Study||5
3143025|NCT01750294|3868501|FG000|STARTED|Overall Study||14
3143026|NCT01750294|3868501|FG000|COMPLETED|Overall Study||12
3143027|NCT01750294|3868501|FG000|NOT COMPLETED|Overall Study||2
3143028|NCT01750346|3868508|FG000|STARTED|Overall Study||3
3143029|NCT01750346|3868509|FG001|STARTED|Overall Study||2
3143030|NCT01750346|3868510|FG002|STARTED|Overall Study||3
3143031|NCT01750346|3868508|FG000|COMPLETED|Overall Study||2
3143032|NCT01750346|3868509|FG001|COMPLETED|Overall Study||2
3143033|NCT01750346|3868510|FG002|COMPLETED|Overall Study||3
3143034|NCT01750346|3868508|FG000|NOT COMPLETED|Overall Study||1
3143035|NCT01750346|3868509|FG001|NOT COMPLETED|Overall Study||0
3143036|NCT01750346|3868510|FG002|NOT COMPLETED|Overall Study||0
3143037|NCT01750398|3868518|FG000|STARTED|ADT Lead In Phase||33
3143038|NCT01750398|3868518|FG000|COMPLETED|ADT Lead In Phase||29
3143039|NCT01750398|3868518|FG000|NOT COMPLETED|ADT Lead In Phase||4
3143040|NCT01750398|3868518|FG000|STARTED|Bipolar Androgen Thearpy Phase||29
3143041|NCT01750398|3868518|FG000|COMPLETED|Bipolar Androgen Thearpy Phase||26
3143042|NCT01750398|3868518|FG000|NOT COMPLETED|Bipolar Androgen Thearpy Phase||3
3143043|NCT01750502|3868524|FG000|STARTED|Overall Study||70
3143044|NCT01750502|3868525|FG001|STARTED|Overall Study||186
3143045|NCT01750502|3868524|FG000|COMPLETED|Overall Study||70
3143046|NCT01750502|3868525|FG001|COMPLETED|Overall Study||186
3143047|NCT01750502|3868524|FG000|NOT COMPLETED|Overall Study||0
3143048|NCT01750502|3868525|FG001|NOT COMPLETED|Overall Study||0
3143049|NCT01750684|3868538|FG000|STARTED|Overall Study||6
3143050|NCT01750684|3868539|FG001|STARTED|Overall Study||7
3143051|NCT01750684|3868538|FG000|COMPLETED|Overall Study||4
3143052|NCT01750684|3868539|FG001|COMPLETED|Overall Study||5
3143053|NCT01750684|3868538|FG000|NOT COMPLETED|Overall Study||2
3143054|NCT01750684|3868539|FG001|NOT COMPLETED|Overall Study||2
3143055|NCT01750697|3868546|FG000|STARTED|Overall Study||25
3143056|NCT01750697|3868546|FG000|Completed|Overall Study||25
3143057|NCT01750697|3868546|FG000|Follow-up Phase|Overall Study|Completed required follow-up|24
3143058|NCT01750697|3868546|FG000|COMPLETED|Overall Study|Completed to CCO. 6 participants entered Extended Safety Follow-up, 10 participants completed Study.|16
3143059|NCT01750697|3868546|FG000|NOT COMPLETED|Overall Study||9
3143060|NCT01750840|3868553|FG000|STARTED|Overall Study||8
3143061|NCT01750840|3868553|FG000|COMPLETED|Overall Study||4
3143062|NCT01750840|3868553|FG000|NOT COMPLETED|Overall Study||4
3143063|NCT01750879|3868560|FG000|STARTED|Overall Study||30
3143064|NCT01750879|3868561|FG001|STARTED|Overall Study||11
3143065|NCT01750879|3868560|FG000|DBPCFC2|Overall Study||20
3143066|NCT01750879|3868561|FG001|DBPCFC2|Overall Study||8
3143067|NCT01750879|3868560|FG000|DBPCFC3|Overall Study||20
3143068|NCT01750879|3868561|FG001|DBPCFC3|Overall Study||0
3143069|NCT01750879|3868560|FG000|COMPLETED|Overall Study||20
3143070|NCT01750879|3868561|FG001|COMPLETED|Overall Study||8
3143071|NCT01750879|3868560|FG000|NOT COMPLETED|Overall Study||10
3143072|NCT01750879|3868561|FG001|NOT COMPLETED|Overall Study||3
3143073|NCT01750918|3868588|FG000|STARTED|Overall Study||3
3143074|NCT01750918|3868589|FG001|STARTED|Overall Study||4
3143075|NCT01750918|3868590|FG002|STARTED|Overall Study||36
3143076|NCT01750918|3868591|FG003|STARTED|Overall Study||50
3143077|NCT01750918|3868592|FG004|STARTED|Overall Study||13
3143078|NCT01750918|3868593|FG005|STARTED|Overall Study||20
3143079|NCT01750918|3868594|FG006|STARTED|Overall Study||20
3143080|NCT01750918|3868595|FG007|STARTED|Overall Study||20
3143081|NCT01750918|3868588|FG000|Pharmacokinetic Population|Overall Study||3
3143082|NCT01750918|3868589|FG001|Pharmacokinetic Population|Overall Study||4
3143083|NCT01750918|3868590|FG002|Pharmacokinetic Population|Overall Study||35
3143084|NCT01750918|3868591|FG003|Pharmacokinetic Population|Overall Study||48
3143085|NCT01750918|3868592|FG004|Pharmacokinetic Population|Overall Study||12
3143086|NCT01750918|3868593|FG005|Pharmacokinetic Population|Overall Study||19
3143087|NCT01750918|3868594|FG006|Pharmacokinetic Population|Overall Study||18
3143088|NCT01750918|3868595|FG007|Pharmacokinetic Population|Overall Study||20
3143089|NCT01750918|3868588|FG000|Biomarker Population|Overall Study||3
3143090|NCT01750918|3868589|FG001|Biomarker Population|Overall Study||4
3143091|NCT01750918|3868590|FG002|Biomarker Population|Overall Study||36
3143092|NCT01750918|3868591|FG003|Biomarker Population|Overall Study||50
3143093|NCT01750918|3868592|FG004|Biomarker Population|Overall Study||13
3143094|NCT01750918|3868593|FG005|Biomarker Population|Overall Study||17
3143095|NCT01750918|3868594|FG006|Biomarker Population|Overall Study||19
3143096|NCT01750918|3868595|FG007|Biomarker Population|Overall Study||20
3143097|NCT01750918|3868588|FG000|Crossover Population|Overall Study||0
3143098|NCT01750918|3868589|FG001|Crossover Population|Overall Study||0
3143099|NCT01750918|3868590|FG002|Crossover Population|Overall Study||0
3143100|NCT01750918|3868591|FG003|Crossover Population|Overall Study||0
3143101|NCT01750918|3868592|FG004|Crossover Population|Overall Study||4
3143102|NCT01750918|3868593|FG005|Crossover Population|Overall Study||2
3143103|NCT01750918|3868594|FG006|Crossover Population|Overall Study||5
3143104|NCT01750918|3868595|FG007|Crossover Population|Overall Study||5
3143105|NCT01750918|3868588|FG000|COMPLETED|Overall Study||3
3143106|NCT01750918|3868589|FG001|COMPLETED|Overall Study||4
3143107|NCT01750918|3868590|FG002|COMPLETED|Overall Study||28
3143108|NCT01750918|3868591|FG003|COMPLETED|Overall Study||44
3143109|NCT01750918|3868592|FG004|COMPLETED|Overall Study||12
3143110|NCT01750918|3868593|FG005|COMPLETED|Overall Study||17
3143111|NCT01750918|3868594|FG006|COMPLETED|Overall Study||17
3143112|NCT01750918|3868595|FG007|COMPLETED|Overall Study||16
3143113|NCT01750918|3868588|FG000|NOT COMPLETED|Overall Study||0
3143114|NCT01750918|3868589|FG001|NOT COMPLETED|Overall Study||0
3143115|NCT01750918|3868590|FG002|NOT COMPLETED|Overall Study||8
3143116|NCT01750918|3868591|FG003|NOT COMPLETED|Overall Study||6
3143117|NCT01750918|3868592|FG004|NOT COMPLETED|Overall Study||1
3143118|NCT01750918|3868593|FG005|NOT COMPLETED|Overall Study||3
3143119|NCT01750918|3868594|FG006|NOT COMPLETED|Overall Study||3
3143120|NCT01750918|3868595|FG007|NOT COMPLETED|Overall Study||4
3143121|NCT01750931|3868625|FG000|STARTED|Period 1||14
3143122|NCT01750931|3868626|FG001|STARTED|Period 1||14
3143123|NCT01750931|3868625|FG000|COMPLETED|Period 1||14
3143124|NCT01750931|3868626|FG001|COMPLETED|Period 1||14
3143125|NCT01750931|3868625|FG000|NOT COMPLETED|Period 1||0
3143126|NCT01750931|3868626|FG001|NOT COMPLETED|Period 1||0
3143127|NCT01750931|3868625|FG000|STARTED|Wash Out||14
3143128|NCT01750931|3868626|FG001|STARTED|Wash Out||14
3143129|NCT01750931|3868625|FG000|COMPLETED|Wash Out||14
3143130|NCT01750931|3868626|FG001|COMPLETED|Wash Out||14
3143131|NCT01750931|3868625|FG000|NOT COMPLETED|Wash Out||0
3143132|NCT01750931|3868626|FG001|NOT COMPLETED|Wash Out||0
3143133|NCT01750931|3868625|FG000|STARTED|Period 2||14
3143134|NCT01750931|3868626|FG001|STARTED|Period 2||14
3143135|NCT01750931|3868625|FG000|COMPLETED|Period 2||14
3143136|NCT01750931|3868626|FG001|COMPLETED|Period 2||14
3143137|NCT01750931|3868625|FG000|NOT COMPLETED|Period 2||0
3143138|NCT01750931|3868626|FG001|NOT COMPLETED|Period 2||0
3143139|NCT01751022|3868635|FG000|STARTED|Overall Study||499
3143140|NCT01751022|3868636|FG001|STARTED|Overall Study||326
3143141|NCT01751022|3868637|FG002|STARTED|Overall Study||300
3143142|NCT01751022|3868635|FG000|COMPLETED|Overall Study|6 month visit|443
3143143|NCT01751022|3868636|FG001|COMPLETED|Overall Study|6 month visit|282
3143144|NCT01751022|3868637|FG002|COMPLETED|Overall Study|6 month visit|273
3143145|NCT01751022|3868635|FG000|NOT COMPLETED|Overall Study||56
3143146|NCT01751022|3868636|FG001|NOT COMPLETED|Overall Study||44
3143147|NCT01751022|3868637|FG002|NOT COMPLETED|Overall Study||27
3143148|NCT01751061|3868666|FG000|STARTED|Overall Study||210
3143149|NCT01751061|3868667|FG001|STARTED|Overall Study||206
3143150|NCT01751061|3868666|FG000|COMPLETED|Overall Study||154
3143151|NCT01751061|3868667|FG001|COMPLETED|Overall Study||172
3143152|NCT01751061|3868666|FG000|NOT COMPLETED|Overall Study||56
3143153|NCT01751061|3868667|FG001|NOT COMPLETED|Overall Study||34
3143154|NCT01751087|3868676|FG000|STARTED|Overall Study||100
3143155|NCT01751087|3868677|FG001|STARTED|Overall Study||100
3143156|NCT01751087|3868678|FG002|STARTED|Overall Study||100
3143157|NCT01751087|3868676|FG000|COMPLETED|Overall Study||99
3143158|NCT01751087|3868677|FG001|COMPLETED|Overall Study||100
3143159|NCT01751087|3868678|FG002|COMPLETED|Overall Study||99
3143160|NCT01751087|3868676|FG000|NOT COMPLETED|Overall Study||1
3143161|NCT01751087|3868677|FG001|NOT COMPLETED|Overall Study||0
3143162|NCT01751087|3868678|FG002|NOT COMPLETED|Overall Study||1
3143163|NCT01751113|3868686|FG000|STARTED|Treatment Period 1 (4 Weeks)||8
3143164|NCT01751113|3868687|FG001|STARTED|Treatment Period 1 (4 Weeks)||8
3143165|NCT01751113|3868688|FG002|STARTED|Treatment Period 1 (4 Weeks)||9
3143166|NCT01751113|3868689|FG003|STARTED|Treatment Period 1 (4 Weeks)||9
3143167|NCT01751113|3868690|FG004|STARTED|Treatment Period 1 (4 Weeks)||9
3143168|NCT01751113|3868691|FG005|STARTED|Treatment Period 1 (4 Weeks)||10
3143169|NCT01751113|3868686|FG000|COMPLETED|Treatment Period 1 (4 Weeks)||8
3143170|NCT01751113|3868687|FG001|COMPLETED|Treatment Period 1 (4 Weeks)||8
3143171|NCT01751113|3868688|FG002|COMPLETED|Treatment Period 1 (4 Weeks)||9
3143172|NCT01751113|3868689|FG003|COMPLETED|Treatment Period 1 (4 Weeks)||8
3143173|NCT01751113|3868690|FG004|COMPLETED|Treatment Period 1 (4 Weeks)||8
3143174|NCT01751113|3868691|FG005|COMPLETED|Treatment Period 1 (4 Weeks)||10
3143175|NCT01751113|3868686|FG000|NOT COMPLETED|Treatment Period 1 (4 Weeks)||0
3143176|NCT01751113|3868687|FG001|NOT COMPLETED|Treatment Period 1 (4 Weeks)||0
3143177|NCT01751113|3868688|FG002|NOT COMPLETED|Treatment Period 1 (4 Weeks)||0
3143178|NCT01751113|3868689|FG003|NOT COMPLETED|Treatment Period 1 (4 Weeks)||1
3143179|NCT01751113|3868690|FG004|NOT COMPLETED|Treatment Period 1 (4 Weeks)||1
3143180|NCT01751113|3868691|FG005|NOT COMPLETED|Treatment Period 1 (4 Weeks)||0
3143181|NCT01751113|3868686|FG000|STARTED|Washout Period 1 (2 Weeks)||8
3143182|NCT01751113|3868687|FG001|STARTED|Washout Period 1 (2 Weeks)||8
3143183|NCT01751113|3868688|FG002|STARTED|Washout Period 1 (2 Weeks)||9
3143184|NCT01751113|3868689|FG003|STARTED|Washout Period 1 (2 Weeks)||8
3143185|NCT01751113|3868690|FG004|STARTED|Washout Period 1 (2 Weeks)||8
3143186|NCT01751113|3868691|FG005|STARTED|Washout Period 1 (2 Weeks)||10
3143187|NCT01751113|3868686|FG000|COMPLETED|Washout Period 1 (2 Weeks)||8
3143188|NCT01751113|3868687|FG001|COMPLETED|Washout Period 1 (2 Weeks)||8
3143189|NCT01751113|3868688|FG002|COMPLETED|Washout Period 1 (2 Weeks)||9
3143190|NCT01751113|3868689|FG003|COMPLETED|Washout Period 1 (2 Weeks)||8
3143191|NCT01751113|3868690|FG004|COMPLETED|Washout Period 1 (2 Weeks)||8
3143192|NCT01751113|3868691|FG005|COMPLETED|Washout Period 1 (2 Weeks)||10
3143193|NCT01751113|3868686|FG000|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
3143194|NCT01751113|3868687|FG001|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
3143195|NCT01751113|3868688|FG002|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
3143196|NCT01751113|3868689|FG003|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
3143197|NCT01751113|3868690|FG004|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
3143198|NCT01751113|3868691|FG005|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
3143199|NCT01751113|3868686|FG000|STARTED|Treatment Period 2 (4 Weeks)||8
3143200|NCT01751113|3868687|FG001|STARTED|Treatment Period 2 (4 Weeks)||8
3143201|NCT01751113|3868688|FG002|STARTED|Treatment Period 2 (4 Weeks)||9
3143202|NCT01751113|3868689|FG003|STARTED|Treatment Period 2 (4 Weeks)||8
3143203|NCT01751113|3868690|FG004|STARTED|Treatment Period 2 (4 Weeks)||8
3143204|NCT01751113|3868691|FG005|STARTED|Treatment Period 2 (4 Weeks)||10
3143205|NCT01751113|3868686|FG000|COMPLETED|Treatment Period 2 (4 Weeks)||8
3143206|NCT01751113|3868687|FG001|COMPLETED|Treatment Period 2 (4 Weeks)||8
3143207|NCT01751113|3868688|FG002|COMPLETED|Treatment Period 2 (4 Weeks)||9
3143208|NCT01751113|3868689|FG003|COMPLETED|Treatment Period 2 (4 Weeks)||8
3143209|NCT01751113|3868690|FG004|COMPLETED|Treatment Period 2 (4 Weeks)||8
3143210|NCT01751113|3868691|FG005|COMPLETED|Treatment Period 2 (4 Weeks)||10
3143211|NCT01751113|3868686|FG000|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
3143212|NCT01751113|3868687|FG001|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
3143213|NCT01751113|3868688|FG002|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
3143214|NCT01751113|3868689|FG003|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
3143215|NCT01751113|3868690|FG004|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
3143216|NCT01751113|3868691|FG005|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
3143217|NCT01751113|3868686|FG000|STARTED|Washout Period 2 (2 Weeks)||8
3143218|NCT01751113|3868687|FG001|STARTED|Washout Period 2 (2 Weeks)||8
3143219|NCT01751113|3868688|FG002|STARTED|Washout Period 2 (2 Weeks)||9
3143220|NCT01751113|3868689|FG003|STARTED|Washout Period 2 (2 Weeks)||8
3143221|NCT01751113|3868690|FG004|STARTED|Washout Period 2 (2 Weeks)||8
3143222|NCT01751113|3868691|FG005|STARTED|Washout Period 2 (2 Weeks)||10
3143223|NCT01751113|3868686|FG000|COMPLETED|Washout Period 2 (2 Weeks)||8
3143224|NCT01751113|3868687|FG001|COMPLETED|Washout Period 2 (2 Weeks)||8
3143225|NCT01751113|3868688|FG002|COMPLETED|Washout Period 2 (2 Weeks)||9
3143226|NCT01751113|3868689|FG003|COMPLETED|Washout Period 2 (2 Weeks)||8
3143227|NCT01751113|3868690|FG004|COMPLETED|Washout Period 2 (2 Weeks)||8
3143228|NCT01751113|3868691|FG005|COMPLETED|Washout Period 2 (2 Weeks)||10
3143229|NCT01751113|3868686|FG000|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
3143230|NCT01751113|3868687|FG001|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
3143231|NCT01751113|3868688|FG002|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
3143232|NCT01751113|3868689|FG003|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
3143233|NCT01751113|3868690|FG004|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
3143234|NCT01751113|3868691|FG005|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
3143235|NCT01751113|3868686|FG000|STARTED|Treatment Period 3 (4 Weeks)||8
3143236|NCT01751113|3868687|FG001|STARTED|Treatment Period 3 (4 Weeks)||8
3143237|NCT01751113|3868688|FG002|STARTED|Treatment Period 3 (4 Weeks)||9
3143238|NCT01751113|3868689|FG003|STARTED|Treatment Period 3 (4 Weeks)||8
3143239|NCT01751113|3868690|FG004|STARTED|Treatment Period 3 (4 Weeks)||8
3143240|NCT01751113|3868691|FG005|STARTED|Treatment Period 3 (4 Weeks)||10
3143241|NCT01751113|3868686|FG000|COMPLETED|Treatment Period 3 (4 Weeks)||8
3143242|NCT01751113|3868687|FG001|COMPLETED|Treatment Period 3 (4 Weeks)||8
3143243|NCT01751113|3868688|FG002|COMPLETED|Treatment Period 3 (4 Weeks)||9
3143244|NCT01751113|3868689|FG003|COMPLETED|Treatment Period 3 (4 Weeks)||8
3143245|NCT01751113|3868690|FG004|COMPLETED|Treatment Period 3 (4 Weeks)||8
3143246|NCT01751113|3868691|FG005|COMPLETED|Treatment Period 3 (4 Weeks)||9
3143247|NCT01751113|3868686|FG000|NOT COMPLETED|Treatment Period 3 (4 Weeks)||0
3143248|NCT01751113|3868687|FG001|NOT COMPLETED|Treatment Period 3 (4 Weeks)||0
3143249|NCT01751113|3868688|FG002|NOT COMPLETED|Treatment Period 3 (4 Weeks)||0
3143250|NCT01751113|3868689|FG003|NOT COMPLETED|Treatment Period 3 (4 Weeks)||0
3143251|NCT01751113|3868690|FG004|NOT COMPLETED|Treatment Period 3 (4 Weeks)||0
3143252|NCT01751113|3868691|FG005|NOT COMPLETED|Treatment Period 3 (4 Weeks)||1
3143253|NCT01751139|3868700|FG000|STARTED|Overall Study||3300
3143254|NCT01751139|3868700|FG000|COMPLETED|Overall Study||1033
3143255|NCT01751139|3868700|FG000|NOT COMPLETED|Overall Study||2267
3143256|NCT01751165|3868707|FG000|STARTED|Overall Study||119
3143257|NCT01751165|3868708|FG001|STARTED|Overall Study||119
3143258|NCT01751165|3868709|FG002|STARTED|Overall Study||116
3143259|NCT01751165|3868707|FG000|COMPLETED|Overall Study||117
3143260|NCT01751165|3868708|FG001|COMPLETED|Overall Study||116
3143261|NCT01751165|3868709|FG002|COMPLETED|Overall Study||113
3143262|NCT01751165|3868707|FG000|NOT COMPLETED|Overall Study||2
3143263|NCT01751165|3868708|FG001|NOT COMPLETED|Overall Study||3
3143264|NCT01751165|3868709|FG002|NOT COMPLETED|Overall Study||3
3143265|NCT01751178|3868722|FG000|STARTED|Overall Study||108
3143266|NCT01751178|3868723|FG001|STARTED|Overall Study||109
3143267|NCT01751178|3868724|FG002|STARTED|Overall Study||107
3143268|NCT01751178|3868722|FG000|COMPLETED|Overall Study||105
3143269|NCT01751178|3868723|FG001|COMPLETED|Overall Study||109
3143270|NCT01751178|3868724|FG002|COMPLETED|Overall Study||105
3143271|NCT01751178|3868722|FG000|NOT COMPLETED|Overall Study||3
3143272|NCT01751178|3868723|FG001|NOT COMPLETED|Overall Study||0
3143273|NCT01751178|3868724|FG002|NOT COMPLETED|Overall Study||2
3143274|NCT01751230|3868738|FG000|STARTED|Overall Study||20
3143275|NCT01751230|3868739|FG001|STARTED|Overall Study||20
3143276|NCT01751230|3868738|FG000|COMPLETED|Overall Study||19
3143277|NCT01751230|3868739|FG001|COMPLETED|Overall Study||16
3143278|NCT01751230|3868738|FG000|NOT COMPLETED|Overall Study||1
3143279|NCT01751230|3868739|FG001|NOT COMPLETED|Overall Study||4
3143280|NCT01751308|3868754|FG000|STARTED|Phase 1||6
3143281|NCT01751308|3868755|FG001|STARTED|Phase 1||3
3143282|NCT01751308|3868756|FG002|STARTED|Phase 1||7
3143283|NCT01751308|3868757|FG003|STARTED|Phase 1||7
3143284|NCT01751308|3868758|FG004|STARTED|Phase 1|Phase 1 and Phase 2 were separate populations.|0
3143285|NCT01751308|3868754|FG000|COMPLETED|Phase 1|DP, AE and death were considered as completed (defined in protocol)|6
3143286|NCT01751308|3868755|FG001|COMPLETED|Phase 1|DP, AE and death were considered as completed (defined in protocol)|3
3143287|NCT01751308|3868756|FG002|COMPLETED|Phase 1|DP, AE and death were considered as completed (defined in protocol)|7
3143288|NCT01751308|3868757|FG003|COMPLETED|Phase 1|DP, AE and death were considered as completed (defined in protocol)|7
3143289|NCT01751308|3868758|FG004|COMPLETED|Phase 1||0
3143290|NCT01751308|3868754|FG000|NOT COMPLETED|Phase 1||0
3143291|NCT01751308|3868755|FG001|NOT COMPLETED|Phase 1||0
3143292|NCT01751308|3868756|FG002|NOT COMPLETED|Phase 1||0
3143293|NCT01751308|3868757|FG003|NOT COMPLETED|Phase 1||0
3143294|NCT01751308|3868758|FG004|NOT COMPLETED|Phase 1||0
3143295|NCT01751308|3868754|FG000|STARTED|Phase 2||0
3143296|NCT01751308|3868755|FG001|STARTED|Phase 2||0
3143297|NCT01751308|3868756|FG002|STARTED|Phase 2||0
3143298|NCT01751308|3868757|FG003|STARTED|Phase 2||0
3143299|NCT01751308|3868758|FG004|STARTED|Phase 2|Phase 1 and Phase 2 were separate populations.|16
3143300|NCT01751308|3868754|FG000|COMPLETED|Phase 2||0
3143301|NCT01751308|3868755|FG001|COMPLETED|Phase 2||0
3143302|NCT01751308|3868756|FG002|COMPLETED|Phase 2||0
3143303|NCT01751308|3868757|FG003|COMPLETED|Phase 2||0
3143304|NCT01751308|3868758|FG004|COMPLETED|Phase 2|DP, AE and death were considered as completed (defined in protocol)|16
3143305|NCT01751308|3868754|FG000|NOT COMPLETED|Phase 2||0
3143306|NCT01751308|3868755|FG001|NOT COMPLETED|Phase 2||0
3143307|NCT01751308|3868756|FG002|NOT COMPLETED|Phase 2||0
3143308|NCT01751308|3868757|FG003|NOT COMPLETED|Phase 2||0
3143309|NCT01751308|3868758|FG004|NOT COMPLETED|Phase 2||0
3143310|NCT01751386|3868776|FG000|STARTED|Overall Study||20
3143311|NCT01751386|3868777|FG001|STARTED|Overall Study||19
3143312|NCT01751386|3868776|FG000|COMPLETED|Overall Study||18
3143313|NCT01751386|3868777|FG001|COMPLETED|Overall Study||16
3143314|NCT01751386|3868776|FG000|NOT COMPLETED|Overall Study||2
3143315|NCT01751386|3868777|FG001|NOT COMPLETED|Overall Study||3
3143316|NCT01751399|3868787|FG000|STARTED|Overall Study||12
3143317|NCT01751399|3868788|FG001|STARTED|Overall Study||8
3143318|NCT01751399|3868789|FG002|STARTED|Overall Study||8
3143319|NCT01751399|3868790|FG003|STARTED|Overall Study||7
3143320|NCT01751399|3868787|FG000|Received 1 Dose of Study Drug|Overall Study||12
3143321|NCT01751399|3868788|FG001|Received 1 Dose of Study Drug|Overall Study||8
3143322|NCT01751399|3868789|FG002|Received 1 Dose of Study Drug|Overall Study||8
3143323|NCT01751399|3868790|FG003|Received 1 Dose of Study Drug|Overall Study||7
3143324|NCT01751399|3868787|FG000|COMPLETED|Overall Study||12
3143325|NCT01751399|3868788|FG001|COMPLETED|Overall Study||8
3143326|NCT01751399|3868789|FG002|COMPLETED|Overall Study||8
3143327|NCT01751399|3868790|FG003|COMPLETED|Overall Study||7
3143328|NCT01751399|3868787|FG000|NOT COMPLETED|Overall Study||0
3143329|NCT01751399|3868788|FG001|NOT COMPLETED|Overall Study||0
3143330|NCT01751399|3868789|FG002|NOT COMPLETED|Overall Study||0
3143331|NCT01751399|3868790|FG003|NOT COMPLETED|Overall Study||0
3143332|NCT01751412|3868800|FG000|STARTED|Overall Study||12
3143333|NCT01751412|3868800|FG000|COMPLETED|Overall Study||11
3180894|NCT01994109|3909339|FG001|STARTED|Open-label Phase (Part B)||0
3180895|NCT01994109|3909340|FG002|STARTED|Open-label Phase (Part B)|No placebo group in Part B.|0
3143334|NCT01751412|3868800|FG000|NOT COMPLETED|Overall Study||1
3143335|NCT01751451|3868807|FG000|STARTED|Overall Study||42
3143336|NCT01751451|3868808|FG001|STARTED|Overall Study||40
3143337|NCT01751451|3868809|FG002|STARTED|Overall Study||42
3143338|NCT01751451|3868807|FG000|COMPLETED|Overall Study||42
3143339|NCT01751451|3868808|FG001|COMPLETED|Overall Study||40
3143340|NCT01751451|3868809|FG002|COMPLETED|Overall Study||42
3143341|NCT01751451|3868807|FG000|NOT COMPLETED|Overall Study||0
3143342|NCT01751451|3868808|FG001|NOT COMPLETED|Overall Study||0
3143343|NCT01751451|3868809|FG002|NOT COMPLETED|Overall Study||0
3143344|NCT01751568|3868820|FG000|STARTED|Overall Study||13
3143345|NCT01751568|3868821|FG001|STARTED|Overall Study||14
3143346|NCT01751568|3868822|FG002|STARTED|Overall Study||13
3143347|NCT01751568|3868820|FG000|COMPLETED|Overall Study||12
3143348|NCT01751568|3868821|FG001|COMPLETED|Overall Study||14
3143349|NCT01751568|3868822|FG002|COMPLETED|Overall Study||13
3143350|NCT01751568|3868820|FG000|NOT COMPLETED|Overall Study||1
3143351|NCT01751568|3868821|FG001|NOT COMPLETED|Overall Study||0
3143352|NCT01751568|3868822|FG002|NOT COMPLETED|Overall Study||0
3143353|NCT01751646|3868832|FG000|STARTED|Overall Study||109
3143354|NCT01751646|3868833|FG001|STARTED|Overall Study||105
3143355|NCT01751646|3868832|FG000|COMPLETED|Overall Study||98
3143356|NCT01751646|3868833|FG001|COMPLETED|Overall Study||87
3143357|NCT01751646|3868832|FG000|NOT COMPLETED|Overall Study||11
3143358|NCT01751646|3868833|FG001|NOT COMPLETED|Overall Study||18
3143359|NCT01751724|3868845|FG000|STARTED|Overall Study||42
3143360|NCT01751724|3868846|FG001|STARTED|Overall Study||44
3143361|NCT01751724|3868845|FG000|COMPLETED|Overall Study||41
3143362|NCT01751724|3868846|FG001|COMPLETED|Overall Study||42
3143363|NCT01751724|3868845|FG000|NOT COMPLETED|Overall Study||1
3143364|NCT01751724|3868846|FG001|NOT COMPLETED|Overall Study||2
3143365|NCT01751802|3868854|FG000|STARTED|Overall Study||5
3143366|NCT01751802|3868855|FG001|STARTED|Overall Study||4
3143367|NCT01751802|3868854|FG000|Completed Period 1|Overall Study||2
3143368|NCT01751802|3868855|FG001|Completed Period 1|Overall Study||4
3143369|NCT01751802|3868854|FG000|Completed Period 2|Overall Study||2
3143370|NCT01751802|3868855|FG001|Completed Period 2|Overall Study||1
3143371|NCT01751802|3868854|FG000|Completed Period 3|Overall Study||2
3143372|NCT01751802|3868855|FG001|Completed Period 3|Overall Study||1
3143373|NCT01751802|3868854|FG000|COMPLETED|Overall Study||1
3143374|NCT01751802|3868855|FG001|COMPLETED|Overall Study||2
3180896|NCT01994109|3909341|FG003|STARTED|Open-label Phase (Part B)|61 from 2500 U group, 57 from 3500 U group, 52 from Placebo group continued to Part B|170
3180897|NCT01994109|3909338|FG000|COMPLETED|Open-label Phase (Part B)||0
3180898|NCT01994109|3909339|FG001|COMPLETED|Open-label Phase (Part B)||0
3180899|NCT01994109|3909340|FG002|COMPLETED|Open-label Phase (Part B)|No placebo group in Part B.|0
3180900|NCT01994109|3909341|FG003|COMPLETED|Open-label Phase (Part B)||128
3180901|NCT01994109|3909338|FG000|NOT COMPLETED|Open-label Phase (Part B)||0
3180902|NCT01994109|3909339|FG001|NOT COMPLETED|Open-label Phase (Part B)||0
3180903|NCT01994109|3909340|FG002|NOT COMPLETED|Open-label Phase (Part B)||0
3180904|NCT01994109|3909341|FG003|NOT COMPLETED|Open-label Phase (Part B)||42
3180905|NCT01994226|3909353|FG000|STARTED|Overall Study||199
3180906|NCT01994226|3909354|FG001|STARTED|Overall Study||200
3180907|NCT01994226|3909353|FG000|COMPLETED|Overall Study||180
3180908|NCT01994226|3909354|FG001|COMPLETED|Overall Study||179
3180909|NCT01994226|3909353|FG000|NOT COMPLETED|Overall Study||19
3180910|NCT01994226|3909354|FG001|NOT COMPLETED|Overall Study||21
3180911|NCT01994291|3909363|FG000|STARTED|Overall Study||99
3180912|NCT01994291|3909364|FG001|STARTED|Overall Study||43
3180913|NCT01994291|3909365|FG002|STARTED|Overall Study||56
3180914|NCT01994291|3909363|FG000|Received Treatment|Overall Study||99
3180915|NCT01994291|3909364|FG001|Received Treatment|Overall Study||43
3180916|NCT01994291|3909365|FG002|Received Treatment|Overall Study||56
3180917|NCT01994291|3909363|FG000|COMPLETED|Overall Study||84
3180918|NCT01994291|3909364|FG001|COMPLETED|Overall Study||36
3180919|NCT01994291|3909365|FG002|COMPLETED|Overall Study||47
3180920|NCT01994291|3909363|FG000|NOT COMPLETED|Overall Study||15
3180921|NCT01994291|3909364|FG001|NOT COMPLETED|Overall Study||7
3180922|NCT01994291|3909365|FG002|NOT COMPLETED|Overall Study||9
3180923|NCT01994395|3909376|FG000|STARTED|Overall Study||26
3180924|NCT01994395|3909377|FG001|STARTED|Overall Study||27
3180925|NCT01994395|3909376|FG000|COMPLETED|Overall Study||25
3180926|NCT01994395|3909377|FG001|COMPLETED|Overall Study||25
3180927|NCT01994395|3909376|FG000|NOT COMPLETED|Overall Study||1
3180928|NCT01994395|3909377|FG001|NOT COMPLETED|Overall Study||2
3180929|NCT01994486|3909383|FG000|STARTED|Overall Study||20
3180930|NCT01994486|3909383|FG000|COMPLETED|Overall Study||20
3180931|NCT01994486|3909383|FG000|NOT COMPLETED|Overall Study||0
3180932|NCT01994538|3909391|FG000|STARTED|Overall Study||136
3180933|NCT01994538|3909392|FG001|STARTED|Overall Study||136
3180934|NCT01994538|3909391|FG000|COMPLETED|Overall Study||136
3180935|NCT01994538|3909392|FG001|COMPLETED|Overall Study||136
3180936|NCT01994538|3909391|FG000|NOT COMPLETED|Overall Study||0
3180937|NCT01994538|3909392|FG001|NOT COMPLETED|Overall Study||0
3180938|NCT01994590|3909398|FG000|STARTED|Overall Study||4
3180939|NCT01994590|3909398|FG000|COMPLETED|Overall Study||2
3180940|NCT01994590|3909398|FG000|NOT COMPLETED|Overall Study||2
3180941|NCT01994629|3909404|FG000|STARTED|Overall Study||100
3180942|NCT01994629|3909405|FG001|STARTED|Overall Study||102
3180943|NCT01994629|3909404|FG000|COMPLETED|Overall Study||99
3180944|NCT01994629|3909405|FG001|COMPLETED|Overall Study||99
3180945|NCT01994629|3909404|FG000|NOT COMPLETED|Overall Study||1
3180946|NCT01994629|3909405|FG001|NOT COMPLETED|Overall Study||3
3180947|NCT01994720|3909413|FG000|STARTED|Overall Study||6589
3180948|NCT01994720|3909414|FG001|STARTED|Overall Study||6610
3363530|NCT04066426|4094643|FG002|NOT COMPLETED|Overall Study||8
3143375|NCT01751802|3868854|FG000|NOT COMPLETED|Overall Study||4
3143376|NCT01751802|3868855|FG001|NOT COMPLETED|Overall Study||2
3143377|NCT01751867|3868869|FG000|STARTED|Overall Study||36
3143378|NCT01751867|3868870|FG001|STARTED|Overall Study||99
3143379|NCT01751867|3868869|FG000|Treated|Overall Study||34
3143380|NCT01751867|3868870|FG001|Treated|Overall Study||98
3143381|NCT01751867|3868869|FG000|COMPLETED|Overall Study||0
3143382|NCT01751867|3868870|FG001|COMPLETED|Overall Study||0
3143383|NCT01751867|3868869|FG000|NOT COMPLETED|Overall Study||36
3143384|NCT01751867|3868870|FG001|NOT COMPLETED|Overall Study||99
3143385|NCT01751906|3868878|FG000|STARTED|Overall Study||1322
3143386|NCT01751906|3868879|FG001|STARTED|Overall Study||686
3143387|NCT01751906|3868878|FG000|COMPLETED|Overall Study||1059
3143388|NCT01751906|3868879|FG001|COMPLETED|Overall Study||555
3143389|NCT01751906|3868878|FG000|NOT COMPLETED|Overall Study||263
3143390|NCT01751906|3868879|FG001|NOT COMPLETED|Overall Study||131
3143391|NCT01751971|3868887|FG000|STARTED|Overall Study||22
3143392|NCT01751971|3868888|FG001|STARTED|Overall Study||25
3143393|NCT01751971|3868887|FG000|COMPLETED|Overall Study||20
3143394|NCT01751971|3868888|FG001|COMPLETED|Overall Study||24
3143395|NCT01751971|3868887|FG000|NOT COMPLETED|Overall Study||2
3143396|NCT01751971|3868888|FG001|NOT COMPLETED|Overall Study||1
3143397|NCT01752036|3868900|FG000|STARTED|Overall Study||33
3143398|NCT01752036|3868900|FG000|COMPLETED|Overall Study||31
3143399|NCT01752036|3868900|FG000|NOT COMPLETED|Overall Study||2
3143400|NCT01752400|3868905|FG000|STARTED|Overall Study||6
3143401|NCT01752400|3868905|FG000|COMPLETED|Overall Study||6
3180949|NCT01994720|3909413|FG000|COMPLETED|Overall Study|Includes patients who did not withdraw informed consent prior to the Study Closure Visit|6543
3180950|NCT01994720|3909414|FG001|COMPLETED|Overall Study|Includes patients who did not withdraw informed consent prior to the Study Closure Visit|6554
3143402|NCT01752400|3868905|FG000|NOT COMPLETED|Overall Study||0
3143403|NCT01752413|3868911|FG000|STARTED|Overall Study||170
3143404|NCT01752413|3868912|FG001|STARTED|Overall Study||27
3143405|NCT01752413|3868911|FG000|COMPLETED|Overall Study||58
3143406|NCT01752413|3868912|FG001|COMPLETED|Overall Study||6
3143407|NCT01752413|3868911|FG000|NOT COMPLETED|Overall Study||112
3143408|NCT01752413|3868912|FG001|NOT COMPLETED|Overall Study||21
3143409|NCT01752426|3868918|FG000|STARTED|Overall Study||30
3143410|NCT01752426|3868918|FG000|COMPLETED|Overall Study||30
3143411|NCT01752426|3868918|FG000|NOT COMPLETED|Overall Study||0
3143412|NCT01752634|3868928|FG000|STARTED|Up to Week 24 (Primary Analysis)||99
3143413|NCT01752634|3868929|FG001|STARTED|Up to Week 24 (Primary Analysis)||100
3143414|NCT01752634|3868930|FG002|STARTED|Up to Week 24 (Primary Analysis)||100
3143415|NCT01752634|3868931|FG003|STARTED|Up to Week 24 (Primary Analysis)||43
3143416|NCT01752634|3868932|FG004|STARTED|Up to Week 24 (Primary Analysis)||45
3143417|NCT01752634|3868933|FG005|STARTED|Up to Week 24 (Primary Analysis)||10
3143418|NCT01752634|3868928|FG000|COMPLETED|Up to Week 24 (Primary Analysis)||93
3143419|NCT01752634|3868929|FG001|COMPLETED|Up to Week 24 (Primary Analysis)||95
3143420|NCT01752634|3868930|FG002|COMPLETED|Up to Week 24 (Primary Analysis)||97
3143421|NCT01752634|3868931|FG003|COMPLETED|Up to Week 24 (Primary Analysis)||43
3143422|NCT01752634|3868932|FG004|COMPLETED|Up to Week 24 (Primary Analysis)||45
3143423|NCT01752634|3868933|FG005|COMPLETED|Up to Week 24 (Primary Analysis)||0
3143424|NCT01752634|3868928|FG000|NOT COMPLETED|Up to Week 24 (Primary Analysis)||6
3143425|NCT01752634|3868929|FG001|NOT COMPLETED|Up to Week 24 (Primary Analysis)||5
3143426|NCT01752634|3868930|FG002|NOT COMPLETED|Up to Week 24 (Primary Analysis)||3
3143427|NCT01752634|3868931|FG003|NOT COMPLETED|Up to Week 24 (Primary Analysis)||0
3143428|NCT01752634|3868932|FG004|NOT COMPLETED|Up to Week 24 (Primary Analysis)||0
3143429|NCT01752634|3868933|FG005|NOT COMPLETED|Up to Week 24 (Primary Analysis)||10
3143430|NCT01752634|3868928|FG000|STARTED|Week 24 to Week 260||93
3143431|NCT01752634|3868929|FG001|STARTED|Week 24 to Week 260||95
3143432|NCT01752634|3868930|FG002|STARTED|Week 24 to Week 260||97
3143433|NCT01752634|3868931|FG003|STARTED|Week 24 to Week 260||43
3143434|NCT01752634|3868932|FG004|STARTED|Week 24 to Week 260||45
3143435|NCT01752634|3868933|FG005|STARTED|Week 24 to Week 260||0
3143436|NCT01752634|3868928|FG000|COMPLETED|Week 24 to Week 260||59
3143437|NCT01752634|3868929|FG001|COMPLETED|Week 24 to Week 260||65
3143438|NCT01752634|3868930|FG002|COMPLETED|Week 24 to Week 260||64
3143439|NCT01752634|3868931|FG003|COMPLETED|Week 24 to Week 260||29
3143440|NCT01752634|3868932|FG004|COMPLETED|Week 24 to Week 260||31
3143441|NCT01752634|3868933|FG005|COMPLETED|Week 24 to Week 260||0
3143442|NCT01752634|3868928|FG000|NOT COMPLETED|Week 24 to Week 260||34
3143443|NCT01752634|3868929|FG001|NOT COMPLETED|Week 24 to Week 260||30
3143444|NCT01752634|3868930|FG002|NOT COMPLETED|Week 24 to Week 260||33
3143445|NCT01752634|3868931|FG003|NOT COMPLETED|Week 24 to Week 260||14
3143446|NCT01752634|3868932|FG004|NOT COMPLETED|Week 24 to Week 260||14
3143447|NCT01752634|3868933|FG005|NOT COMPLETED|Week 24 to Week 260||0
3143448|NCT01752712|3868945|FG000|STARTED|Overall Study||31
3143449|NCT01752712|3868946|FG001|STARTED|Overall Study||31
3143450|NCT01752712|3868945|FG000|COMPLETED|Overall Study||22
3143451|NCT01752712|3868946|FG001|COMPLETED|Overall Study||21
3143452|NCT01752712|3868945|FG000|NOT COMPLETED|Overall Study||9
3143453|NCT01752712|3868946|FG001|NOT COMPLETED|Overall Study||10
3143454|NCT01752842|3868954|FG000|STARTED|Overall Study||34
3143455|NCT01752842|3868955|FG001|STARTED|Overall Study||36
3143456|NCT01752842|3868954|FG000|COMPLETED|Overall Study||31
3143457|NCT01752842|3868955|FG001|COMPLETED|Overall Study||34
3143458|NCT01752842|3868954|FG000|NOT COMPLETED|Overall Study||3
3143459|NCT01752842|3868955|FG001|NOT COMPLETED|Overall Study||2
3143460|NCT01752855|3868963|FG000|STARTED|Overall Study||44
3143461|NCT01752855|3868964|FG001|STARTED|Overall Study||44
3143462|NCT01752855|3868963|FG000|COMPLETED|Overall Study||43
3143463|NCT01752855|3868964|FG001|COMPLETED|Overall Study||40
3143464|NCT01752855|3868963|FG000|NOT COMPLETED|Overall Study||1
3143465|NCT01752855|3868964|FG001|NOT COMPLETED|Overall Study||4
3143466|NCT01752907|3868972|FG000|STARTED|Overall Study||151
3143467|NCT01752907|3868973|FG001|STARTED|Overall Study||153
3143468|NCT01752907|3868972|FG000|Received Pegfilgrastim|Overall Study||149
3143469|NCT01752907|3868973|FG001|Received Pegfilgrastim|Overall Study||151
3143470|NCT01752907|3868972|FG000|COMPLETED|Overall Study||139
3143471|NCT01752907|3868973|FG001|COMPLETED|Overall Study||133
3143472|NCT01752907|3868972|FG000|NOT COMPLETED|Overall Study||12
3143473|NCT01752907|3868973|FG001|NOT COMPLETED|Overall Study||20
3143474|NCT01752920|3868983|FG000|STARTED|Overall Study||29
3143475|NCT01752920|3868984|FG001|STARTED|Overall Study||13
3143476|NCT01752920|3868985|FG002|STARTED|Overall Study||19
3143477|NCT01752920|3868986|FG003|STARTED|Overall Study||58
3143478|NCT01752920|3868983|FG000|COMPLETED|Overall Study||0
3143479|NCT01752920|3868984|FG001|COMPLETED|Overall Study||0
3143480|NCT01752920|3868985|FG002|COMPLETED|Overall Study||0
3143481|NCT01752920|3868986|FG003|COMPLETED|Overall Study||0
3143482|NCT01752920|3868983|FG000|NOT COMPLETED|Overall Study||29
3143483|NCT01752920|3868984|FG001|NOT COMPLETED|Overall Study||13
3143484|NCT01752920|3868985|FG002|NOT COMPLETED|Overall Study||19
3143485|NCT01752920|3868986|FG003|NOT COMPLETED|Overall Study||58
3143486|NCT01752933|3869000|FG000|STARTED|Treatment|Includes all patients who received any treatment|4
3143487|NCT01752933|3869001|FG001|STARTED|Treatment|Includes all patients who received any treatment|46
3143488|NCT01752933|3869000|FG000|COMPLETED|Treatment|Completion not applicable for this survival study|0
3143489|NCT01752933|3869001|FG001|COMPLETED|Treatment|Completion not applicable for this survival study|0
3143490|NCT01752933|3869000|FG000|NOT COMPLETED|Treatment||4
3143491|NCT01752933|3869001|FG001|NOT COMPLETED|Treatment||46
3143492|NCT01752933|3869000|FG000|STARTED|Overall Study and Follow-up|Includes all patients who received any treatment|4
3143493|NCT01752933|3869001|FG001|STARTED|Overall Study and Follow-up|Includes all patients who received any treatment|46
3143494|NCT01752933|3869000|FG000|COMPLETED|Overall Study and Follow-up|Completion not applicable for this survival study|0
3143495|NCT01752933|3869001|FG001|COMPLETED|Overall Study and Follow-up|Completion not applicable for this survival study|0
3143496|NCT01752933|3869000|FG000|NOT COMPLETED|Overall Study and Follow-up||4
3143497|NCT01752933|3869001|FG001|NOT COMPLETED|Overall Study and Follow-up||46
3143498|NCT01752985|3869011|FG000|STARTED|Treatment Period||29
3143499|NCT01752985|3869012|FG001|STARTED|Treatment Period||30
3143500|NCT01752985|3869013|FG002|STARTED|Treatment Period||29
3143501|NCT01752985|3869011|FG000|COMPLETED|Treatment Period||25
3143502|NCT01752985|3869012|FG001|COMPLETED|Treatment Period||27
3143503|NCT01752985|3869013|FG002|COMPLETED|Treatment Period||24
3143504|NCT01752985|3869011|FG000|NOT COMPLETED|Treatment Period||4
3143505|NCT01752985|3869012|FG001|NOT COMPLETED|Treatment Period||3
3143506|NCT01752985|3869013|FG002|NOT COMPLETED|Treatment Period||5
3143507|NCT01752985|3869011|FG000|STARTED|Follow-up Period|Includes 25 participants in this period and 3 participants re-joined for follow-up|28
3143508|NCT01752985|3869012|FG001|STARTED|Follow-up Period||27
3143509|NCT01752985|3869013|FG002|STARTED|Follow-up Period|Includes 24 participants in this period and 2 participants re-joined for follow-up|26
3143510|NCT01752985|3869011|FG000|COMPLETED|Follow-up Period||28
3143511|NCT01752985|3869012|FG001|COMPLETED|Follow-up Period||27
3143512|NCT01752985|3869013|FG002|COMPLETED|Follow-up Period||26
3143513|NCT01752985|3869011|FG000|NOT COMPLETED|Follow-up Period||0
3143514|NCT01752985|3869012|FG001|NOT COMPLETED|Follow-up Period||0
3143515|NCT01752985|3869013|FG002|NOT COMPLETED|Follow-up Period||0
3143516|NCT01753076|3869023|FG000|STARTED|Overall Study||151
3143517|NCT01753076|3869024|FG001|STARTED|Overall Study||152
3143518|NCT01753076|3869023|FG000|COMPLETED|Overall Study||110
3143519|NCT01753076|3869024|FG001|COMPLETED|Overall Study||106
3143520|NCT01753076|3869023|FG000|NOT COMPLETED|Overall Study||41
3143521|NCT01753076|3869024|FG001|NOT COMPLETED|Overall Study||46
3143522|NCT01753115|3869035|FG000|STARTED|Overall Study||44
3143523|NCT01753115|3869036|FG001|STARTED|Overall Study||40
3143524|NCT01753115|3869037|FG002|STARTED|Overall Study||70
3143525|NCT01753115|3869035|FG000|Treated|Overall Study||38
3143526|NCT01753115|3869036|FG001|Treated|Overall Study||39
3143527|NCT01753115|3869037|FG002|Treated|Overall Study||67
3143528|NCT01753115|3869035|FG000|COMPLETED|Overall Study||32
3143529|NCT01753115|3869036|FG001|COMPLETED|Overall Study||25
3143530|NCT01753115|3869037|FG002|COMPLETED|Overall Study||56
3143531|NCT01753115|3869035|FG000|NOT COMPLETED|Overall Study||12
3143532|NCT01753115|3869036|FG001|NOT COMPLETED|Overall Study||15
3143533|NCT01753115|3869037|FG002|NOT COMPLETED|Overall Study||14
3143534|NCT01753193|3869045|FG000|STARTED|Overall Study||218
3143535|NCT01753193|3869045|FG000|COMPLETED|Overall Study||172
3143536|NCT01753193|3869045|FG000|NOT COMPLETED|Overall Study||46
3143537|NCT01753297|3869051|FG000|STARTED|Overall Study||117
3143538|NCT01753297|3869052|FG001|STARTED|Overall Study||109
3143539|NCT01753297|3869051|FG000|Received Triptorelin Treatment|Overall Study||0
3143540|NCT01753297|3869052|FG001|Received Triptorelin Treatment|Overall Study||105
3143541|NCT01753297|3869051|FG000|COMPLETED|Overall Study||76
3143542|NCT01753297|3869052|FG001|COMPLETED|Overall Study||73
3143543|NCT01753297|3869051|FG000|NOT COMPLETED|Overall Study||41
3143544|NCT01753297|3869052|FG001|NOT COMPLETED|Overall Study||36
3143545|NCT01753310|3869062|FG000|STARTED|Overall Study||89
3143546|NCT01753310|3869063|FG001|STARTED|Overall Study||45
3143547|NCT01753310|3869062|FG000|COMPLETED|Overall Study||57
3143548|NCT01753310|3869063|FG001|COMPLETED|Overall Study||21
3143549|NCT01753310|3869062|FG000|NOT COMPLETED|Overall Study||32
3143550|NCT01753310|3869063|FG001|NOT COMPLETED|Overall Study||24
3143551|NCT01753323|3869072|FG000|STARTED|Overall Study||11
3143552|NCT01753323|3869073|FG001|STARTED|Overall Study||10
3143553|NCT01753323|3869074|FG002|STARTED|Overall Study||22
3143554|NCT01753323|3869072|FG000|Pharmacodynamic (PD) Set|Overall Study||10
3143555|NCT01753323|3869073|FG001|Pharmacodynamic (PD) Set|Overall Study||10
3143556|NCT01753323|3869074|FG002|Pharmacodynamic (PD) Set|Overall Study||21
3143557|NCT01753323|3869072|FG000|Pharmacokinetic(PK) Set|Overall Study||10
3143558|NCT01753323|3869073|FG001|Pharmacokinetic(PK) Set|Overall Study||10
3143559|NCT01753323|3869074|FG002|Pharmacokinetic(PK) Set|Overall Study||21
3143560|NCT01753323|3869072|FG000|Safety Set|Overall Study||11
3143561|NCT01753323|3869073|FG001|Safety Set|Overall Study||10
3143562|NCT01753323|3869074|FG002|Safety Set|Overall Study||22
3143563|NCT01753323|3869072|FG000|Intent-to-treat Analysis Set|Overall Study||11
3143564|NCT01753323|3869073|FG001|Intent-to-treat Analysis Set|Overall Study||10
3143565|NCT01753323|3869074|FG002|Intent-to-treat Analysis Set|Overall Study||22
3143566|NCT01753323|3869072|FG000|COMPLETED|Overall Study||10
3143567|NCT01753323|3869073|FG001|COMPLETED|Overall Study||10
3143568|NCT01753323|3869074|FG002|COMPLETED|Overall Study||13
3143569|NCT01753323|3869072|FG000|NOT COMPLETED|Overall Study||1
3143570|NCT01753323|3869073|FG001|NOT COMPLETED|Overall Study||0
3143571|NCT01753323|3869074|FG002|NOT COMPLETED|Overall Study||9
3143572|NCT01753336|3869083|FG000|STARTED|Overall Study||112
3143573|NCT01753336|3869083|FG000|Cycle 1|Overall Study||112
3143574|NCT01753336|3869083|FG000|Cycle 2|Overall Study||98
3143575|NCT01753336|3869083|FG000|Cycle 3|Overall Study||93
3143576|NCT01753336|3869083|FG000|COMPLETED|Overall Study||92
3143577|NCT01753336|3869083|FG000|NOT COMPLETED|Overall Study||20
3143578|NCT01753362|3869089|FG000|STARTED|Overall Study||36
3143579|NCT01753362|3869090|FG001|STARTED|Overall Study||48
3143580|NCT01753362|3869089|FG000|COMPLETED|Overall Study||26
3143581|NCT01753362|3869090|FG001|COMPLETED|Overall Study||40
3143582|NCT01753362|3869089|FG000|NOT COMPLETED|Overall Study||10
3143583|NCT01753362|3869090|FG001|NOT COMPLETED|Overall Study||8
3143584|NCT01753401|3869098|FG000|STARTED|Double-blind Period (8 Weeks)||12
3143585|NCT01753401|3869099|FG001|STARTED|Double-blind Period (8 Weeks)||26
3143586|NCT01753401|3869100|FG002|STARTED|Double-blind Period (8 Weeks)|This arm was not included in the double-blind period|0
3143587|NCT01753401|3869101|FG003|STARTED|Double-blind Period (8 Weeks)|This arm was not included in the double-blind period|0
3143588|NCT01753401|3869098|FG000|Modified Intent to Treat (mITT)|Double-blind Period (8 Weeks)||11
3143589|NCT01753401|3869099|FG001|Modified Intent to Treat (mITT)|Double-blind Period (8 Weeks)||25
3143590|NCT01753401|3869100|FG002|Modified Intent to Treat (mITT)|Double-blind Period (8 Weeks)||0
3143591|NCT01753401|3869101|FG003|Modified Intent to Treat (mITT)|Double-blind Period (8 Weeks)||0
3143592|NCT01753401|3869098|FG000|COMPLETED|Double-blind Period (8 Weeks)||11
3143593|NCT01753401|3869099|FG001|COMPLETED|Double-blind Period (8 Weeks)||22
3143594|NCT01753401|3869100|FG002|COMPLETED|Double-blind Period (8 Weeks)||0
3143595|NCT01753401|3869101|FG003|COMPLETED|Double-blind Period (8 Weeks)||0
3143596|NCT01753401|3869098|FG000|NOT COMPLETED|Double-blind Period (8 Weeks)||1
3143597|NCT01753401|3869099|FG001|NOT COMPLETED|Double-blind Period (8 Weeks)||4
3143598|NCT01753401|3869100|FG002|NOT COMPLETED|Double-blind Period (8 Weeks)||0
3143599|NCT01753401|3869101|FG003|NOT COMPLETED|Double-blind Period (8 Weeks)||0
3143600|NCT01753401|3869098|FG000|STARTED|Open Label Period (44 Weeks)|This arm was not included in the open label period|0
3143601|NCT01753401|3869099|FG001|STARTED|Open Label Period (44 Weeks)|This arm was not included in the open label period|0
3143602|NCT01753401|3869100|FG002|STARTED|Open Label Period (44 Weeks)||11
3143603|NCT01753401|3869101|FG003|STARTED|Open Label Period (44 Weeks)||22
3143604|NCT01753401|3869098|FG000|mITT|Open Label Period (44 Weeks)||0
3143605|NCT01753401|3869099|FG001|mITT|Open Label Period (44 Weeks)||0
3143606|NCT01753401|3869100|FG002|mITT|Open Label Period (44 Weeks)||11
3143607|NCT01753401|3869101|FG003|mITT|Open Label Period (44 Weeks)||22
3143608|NCT01753401|3869098|FG000|Safety Analysis Set|Open Label Period (44 Weeks)||0
3143609|NCT01753401|3869099|FG001|Safety Analysis Set|Open Label Period (44 Weeks)||0
3143610|NCT01753401|3869100|FG002|Safety Analysis Set|Open Label Period (44 Weeks)||11
3143611|NCT01753401|3869101|FG003|Safety Analysis Set|Open Label Period (44 Weeks)||22
3143612|NCT01753401|3869098|FG000|COMPLETED|Open Label Period (44 Weeks)||0
3143613|NCT01753401|3869099|FG001|COMPLETED|Open Label Period (44 Weeks)||0
3143614|NCT01753401|3869100|FG002|COMPLETED|Open Label Period (44 Weeks)||7
3143615|NCT01753401|3869101|FG003|COMPLETED|Open Label Period (44 Weeks)||13
3143616|NCT01753401|3869098|FG000|NOT COMPLETED|Open Label Period (44 Weeks)||0
3143617|NCT01753401|3869099|FG001|NOT COMPLETED|Open Label Period (44 Weeks)||0
3143618|NCT01753401|3869100|FG002|NOT COMPLETED|Open Label Period (44 Weeks)||4
3143619|NCT01753401|3869101|FG003|NOT COMPLETED|Open Label Period (44 Weeks)||9
3143620|NCT01753518|3869113|FG000|STARTED|Intention-to-Treat Analysis||110
3143621|NCT01753518|3869114|FG001|STARTED|Intention-to-Treat Analysis||110
3143622|NCT01753518|3869113|FG000|COMPLETED|Intention-to-Treat Analysis||103
3143623|NCT01753518|3869114|FG001|COMPLETED|Intention-to-Treat Analysis||103
3143624|NCT01753518|3869113|FG000|NOT COMPLETED|Intention-to-Treat Analysis||7
3143625|NCT01753518|3869114|FG001|NOT COMPLETED|Intention-to-Treat Analysis||7
3143626|NCT01753518|3869113|FG000|STARTED|Postpartum Follow-up||103
3143627|NCT01753518|3869114|FG001|STARTED|Postpartum Follow-up||103
3143628|NCT01753518|3869113|FG000|COMPLETED|Postpartum Follow-up||81
3143629|NCT01753518|3869114|FG001|COMPLETED|Postpartum Follow-up||88
3143630|NCT01753518|3869113|FG000|NOT COMPLETED|Postpartum Follow-up||22
3143631|NCT01753518|3869114|FG001|NOT COMPLETED|Postpartum Follow-up||15
3143632|NCT01753557|3869122|FG000|STARTED|Overall Study||35
3143633|NCT01753557|3869123|FG001|STARTED|Overall Study||19
3143634|NCT01753557|3869122|FG000|COMPLETED|Overall Study||35
3143635|NCT01753557|3869123|FG001|COMPLETED|Overall Study||19
3143636|NCT01753557|3869122|FG000|NOT COMPLETED|Overall Study||0
3143637|NCT01753557|3869123|FG001|NOT COMPLETED|Overall Study||0
3143638|NCT01753570|3869133|FG000|STARTED|Overall Study||30
3143639|NCT01753570|3869134|FG001|STARTED|Overall Study||30
3143640|NCT01753570|3869135|FG002|STARTED|Overall Study||14
3143641|NCT01753570|3869133|FG000|COMPLETED|Overall Study||28
3143642|NCT01753570|3869134|FG001|COMPLETED|Overall Study||25
3143643|NCT01753570|3869135|FG002|COMPLETED|Overall Study||13
3143644|NCT01753570|3869133|FG000|NOT COMPLETED|Overall Study||2
3143645|NCT01753570|3869134|FG001|NOT COMPLETED|Overall Study||5
3143646|NCT01753570|3869135|FG002|NOT COMPLETED|Overall Study||1
3143647|NCT01753713|3869146|FG000|STARTED|Overall Study||14
3143648|NCT01753713|3869147|FG001|STARTED|Overall Study||19
3143649|NCT01753713|3869146|FG000|COMPLETED|Overall Study||14
3143650|NCT01753713|3869147|FG001|COMPLETED|Overall Study||19
3143651|NCT01753713|3869146|FG000|NOT COMPLETED|Overall Study||0
3143652|NCT01753713|3869147|FG001|NOT COMPLETED|Overall Study||0
3143653|NCT01753739|3869158|FG000|STARTED|Overall Study||124
3143654|NCT01753739|3869159|FG001|STARTED|Overall Study||123
3143655|NCT01753739|3869160|FG002|STARTED|Overall Study||123
3143656|NCT01753739|3869161|FG003|STARTED|Overall Study||124
3143657|NCT01753739|3869162|FG004|STARTED|Overall Study||123
3143658|NCT01753739|3869158|FG000|COMPLETED|Overall Study||120
3143659|NCT01753739|3869159|FG001|COMPLETED|Overall Study||118
3143660|NCT01753739|3869160|FG002|COMPLETED|Overall Study||118
3143661|NCT01753739|3869161|FG003|COMPLETED|Overall Study||117
3143662|NCT01753739|3869162|FG004|COMPLETED|Overall Study||120
3143663|NCT01753739|3869158|FG000|NOT COMPLETED|Overall Study||4
3143664|NCT01753739|3869159|FG001|NOT COMPLETED|Overall Study||5
3143665|NCT01753739|3869160|FG002|NOT COMPLETED|Overall Study||5
3143666|NCT01753739|3869161|FG003|NOT COMPLETED|Overall Study||7
3143667|NCT01753739|3869162|FG004|NOT COMPLETED|Overall Study||3
3143668|NCT01753830|3869176|FG000|STARTED|Overall Study||37
3143669|NCT01753830|3869177|FG001|STARTED|Overall Study||38
3143670|NCT01753830|3869176|FG000|COMPLETED|Overall Study||30
3143671|NCT01753830|3869177|FG001|COMPLETED|Overall Study||35
3143672|NCT01753830|3869176|FG000|NOT COMPLETED|Overall Study||7
3143673|NCT01753830|3869177|FG001|NOT COMPLETED|Overall Study||3
3143674|NCT01753856|3869185|FG000|STARTED|Overall Study||33
3143675|NCT01753856|3869186|FG001|STARTED|Overall Study||36
3143676|NCT01753856|3869185|FG000|Received at Least 1 Dose of Study Drug|Overall Study||33
3143677|NCT01753856|3869186|FG001|Received at Least 1 Dose of Study Drug|Overall Study||36
3143678|NCT01753856|3869185|FG000|Completed 3-Month Bone Biopsy|Overall Study||31
3143679|NCT01753856|3869186|FG001|Completed 3-Month Bone Biopsy|Overall Study||35
3143680|NCT01753856|3869185|FG000|COMPLETED|Overall Study||30
3143681|NCT01753856|3869186|FG001|COMPLETED|Overall Study||34
3143682|NCT01753856|3869185|FG000|NOT COMPLETED|Overall Study||3
3143683|NCT01753856|3869186|FG001|NOT COMPLETED|Overall Study||2
3143684|NCT01753999|3869195|FG000|STARTED|Period 1 - Initial Assignment||155
3143685|NCT01753999|3869196|FG001|STARTED|Period 1 - Initial Assignment||162
3143686|NCT01753999|3869195|FG000|Received Intervention|Period 1 - Initial Assignment||144
3143687|NCT01753999|3869196|FG001|Received Intervention|Period 1 - Initial Assignment||146
3143688|NCT01753999|3869195|FG000|COMPLETED|Period 1 - Initial Assignment||116
3143689|NCT01753999|3869196|FG001|COMPLETED|Period 1 - Initial Assignment||112
3143690|NCT01753999|3869195|FG000|NOT COMPLETED|Period 1 - Initial Assignment||39
3143691|NCT01753999|3869196|FG001|NOT COMPLETED|Period 1 - Initial Assignment||50
3143692|NCT01753999|3869195|FG000|STARTED|Period 2 -Cross to Alternate Arm||116
3143693|NCT01753999|3869196|FG001|STARTED|Period 2 -Cross to Alternate Arm||112
3143694|NCT01753999|3869195|FG000|Received Intervention|Period 2 -Cross to Alternate Arm||103
3143695|NCT01753999|3869196|FG001|Received Intervention|Period 2 -Cross to Alternate Arm||95
3143696|NCT01753999|3869195|FG000|COMPLETED|Period 2 -Cross to Alternate Arm||99
3143697|NCT01753999|3869196|FG001|COMPLETED|Period 2 -Cross to Alternate Arm||89
3143698|NCT01753999|3869195|FG000|NOT COMPLETED|Period 2 -Cross to Alternate Arm||17
3143699|NCT01753999|3869196|FG001|NOT COMPLETED|Period 2 -Cross to Alternate Arm||23
3143700|NCT01754129|3869207|FG000|STARTED|Overall Study||148
3143701|NCT01754129|3869207|FG000|Visit 1 (Enrollment Day)|Overall Study||145
3143702|NCT01754129|3869207|FG000|Visit 2 (Year 1)|Overall Study||129
3143703|NCT01754129|3869207|FG000|Visit 3 (Year 2)|Overall Study||115
3143704|NCT01754129|3869207|FG000|COMPLETED|Overall Study||115
3180951|NCT01994720|3909413|FG000|NOT COMPLETED|Overall Study||46
3180952|NCT01994720|3909414|FG001|NOT COMPLETED|Overall Study||56
3143705|NCT01754129|3869207|FG000|NOT COMPLETED|Overall Study||33
3143706|NCT01754194|3869220|FG000|STARTED|Overall Study||169
3143707|NCT01754194|3869221|FG001|STARTED|Overall Study||124
3143708|NCT01754194|3869220|FG000|COMPLETED|Overall Study||117
3143709|NCT01754194|3869221|FG001|COMPLETED|Overall Study||97
3143710|NCT01754194|3869220|FG000|NOT COMPLETED|Overall Study||52
3143711|NCT01754194|3869221|FG001|NOT COMPLETED|Overall Study||27
3180953|NCT01994746|3909420|FG000|STARTED|First Visit||39
3143712|NCT01754207|3869229|FG000|STARTED|Overall Study||20
3143713|NCT01754207|3869229|FG000|COMPLETED|Overall Study||17
3143714|NCT01754207|3869229|FG000|NOT COMPLETED|Overall Study||3
3143715|NCT01754259|3869235|FG000|STARTED|Overall Study||23
3143716|NCT01754259|3869236|FG001|STARTED|Overall Study||24
3143717|NCT01754259|3869235|FG000|COMPLETED|Overall Study||18
3143718|NCT01754259|3869236|FG001|COMPLETED|Overall Study||18
3143719|NCT01754259|3869235|FG000|NOT COMPLETED|Overall Study||5
3143720|NCT01754259|3869236|FG001|NOT COMPLETED|Overall Study||6
3143721|NCT01754350|3869244|FG000|STARTED|Overall Study||25
3143722|NCT01754350|3869245|FG001|STARTED|Overall Study||25
3143723|NCT01754350|3869244|FG000|COMPLETED|Overall Study||20
3143724|NCT01754350|3869245|FG001|COMPLETED|Overall Study||22
3143725|NCT01754350|3869244|FG000|NOT COMPLETED|Overall Study||5
3143726|NCT01754350|3869245|FG001|NOT COMPLETED|Overall Study||3
3143727|NCT01754376|3869251|FG000|STARTED|Overall Study||6
3143728|NCT01754376|3869251|FG000|Completed 2-week Lead in of Vemurafenib|Overall Study||6
3143729|NCT01754376|3869251|FG000|COMPLETED|Overall Study||3
3143730|NCT01754376|3869251|FG000|NOT COMPLETED|Overall Study||3
3143731|NCT01754389|3869259|FG000|STARTED|Overall Study||46
3143732|NCT01754389|3869260|FG001|STARTED|Overall Study||45
3180954|NCT01994746|3909421|FG001|STARTED|First Visit||38
3180955|NCT01994746|3909420|FG000|Received At Least 1 Dose|First Visit||39
3180956|NCT01994746|3909421|FG001|Received At Least 1 Dose|First Visit||38
3180957|NCT01994746|3909420|FG000|COMPLETED|First Visit||39
3180958|NCT01994746|3909421|FG001|COMPLETED|First Visit||38
3180959|NCT01994746|3909420|FG000|NOT COMPLETED|First Visit||0
3180960|NCT01994746|3909421|FG001|NOT COMPLETED|First Visit||0
3180961|NCT01994746|3909420|FG000|STARTED|Second Visit|One participant requested to withdraw after completing the first dosing visit.|38
3180962|NCT01994746|3909421|FG001|STARTED|Second Visit||38
3143733|NCT01754389|3869261|FG002|STARTED|Overall Study||47
3143734|NCT01754389|3869259|FG000|COMPLETED|Overall Study||46
3143735|NCT01754389|3869260|FG001|COMPLETED|Overall Study||45
3143736|NCT01754389|3869261|FG002|COMPLETED|Overall Study||47
3143737|NCT01754389|3869259|FG000|NOT COMPLETED|Overall Study||0
3143738|NCT01754389|3869260|FG001|NOT COMPLETED|Overall Study||0
3143739|NCT01754389|3869261|FG002|NOT COMPLETED|Overall Study||0
3143740|NCT01754402|3869272|FG000|STARTED|Overall Study||6
3143741|NCT01754402|3869273|FG001|STARTED|Overall Study||2
3143742|NCT01754402|3869274|FG002|STARTED|Overall Study||30
3143743|NCT01754402|3869272|FG000|COMPLETED|Overall Study||4
3143744|NCT01754402|3869273|FG001|COMPLETED|Overall Study||0
3143745|NCT01754402|3869274|FG002|COMPLETED|Overall Study||26
3143746|NCT01754402|3869272|FG000|NOT COMPLETED|Overall Study||2
3143747|NCT01754402|3869273|FG001|NOT COMPLETED|Overall Study||2
3143748|NCT01754402|3869274|FG002|NOT COMPLETED|Overall Study||4
3143749|NCT01754467|3869283|FG000|STARTED|Overall Study||9
3143750|NCT01754467|3869283|FG000|COMPLETED|Overall Study||8
3143751|NCT01754467|3869283|FG000|NOT COMPLETED|Overall Study||1
3143752|NCT01754480|3869289|FG000|STARTED|Part I + Part II (Overall Study)||163
3143753|NCT01754480|3869290|FG001|STARTED|Part I + Part II (Overall Study)||162
3143754|NCT01754480|3869289|FG000|Completed Study up to Week 6|Part I + Part II (Overall Study)||147
3143755|NCT01754480|3869290|FG001|Completed Study up to Week 6|Part I + Part II (Overall Study)||153
3143756|NCT01754480|3869289|FG000|COMPLETED|Part I + Part II (Overall Study)|Completed Virology follow-up visit at Month 3 or Month 6 (not required for 2 pediatric subjects)|138
3143757|NCT01754480|3869290|FG001|COMPLETED|Part I + Part II (Overall Study)|Completed Virology follow-up visit at Month 3 or Month 6 (not required for 3 pediatric subjects)|139
3143758|NCT01754480|3869289|FG000|NOT COMPLETED|Part I + Part II (Overall Study)||25
3143759|NCT01754480|3869290|FG001|NOT COMPLETED|Part I + Part II (Overall Study)||23
3143760|NCT01754480|3869289|FG000|STARTED|Primary Part II||111
3143761|NCT01754480|3869290|FG001|STARTED|Primary Part II||113
3143762|NCT01754480|3869289|FG000|Completed Study up to Week 6|Primary Part II||100
3143763|NCT01754480|3869290|FG001|Completed Study up to Week 6|Primary Part II||108
3143764|NCT01754480|3869289|FG000|COMPLETED|Primary Part II|Completed Virology follow-up visit at Month 3 or Month 6 (not required for pediatric subjects)|96
3143765|NCT01754480|3869290|FG001|COMPLETED|Primary Part II|Completed Virology follow-up visit at Month 3 or Month 6 (not required for pediatric subjects)|102
3143766|NCT01754480|3869289|FG000|NOT COMPLETED|Primary Part II||15
3143767|NCT01754480|3869290|FG001|NOT COMPLETED|Primary Part II||11
3143768|NCT01754493|3869297|FG000|STARTED|Overall Study||17
3143769|NCT01754493|3869297|FG000|COMPLETED|Overall Study||10
3143770|NCT01754493|3869297|FG000|NOT COMPLETED|Overall Study||7
3143771|NCT01754519|3869301|FG000|STARTED|Overall Study||1
3143772|NCT01754519|3869301|FG000|COMPLETED|Overall Study||1
3143773|NCT01754519|3869301|FG000|NOT COMPLETED|Overall Study||0
3143774|NCT01754623|3869305|FG000|STARTED|Overall Study||9
3143775|NCT01754623|3869305|FG000|COMPLETED|Overall Study||9
3143776|NCT01754623|3869305|FG000|NOT COMPLETED|Overall Study||0
3143777|NCT01754688|3869311|FG000|STARTED|Overall Study||624
3143778|NCT01754688|3869311|FG000|COMPLETED|Overall Study||624
3143779|NCT01754688|3869311|FG000|NOT COMPLETED|Overall Study||0
3143780|NCT01754714|3869320|FG000|STARTED|Overall Study||27
3143781|NCT01754714|3869321|FG001|STARTED|Overall Study||27
3143782|NCT01754714|3869322|FG002|STARTED|Overall Study||26
3143783|NCT01754714|3869323|FG003|STARTED|Overall Study||28
3143784|NCT01754714|3869320|FG000|COMPLETED|Overall Study||27
3180963|NCT01994746|3909420|FG000|Completed Both Dosing Visits|Second Visit||38
3143785|NCT01754714|3869321|FG001|COMPLETED|Overall Study||26
3143786|NCT01754714|3869322|FG002|COMPLETED|Overall Study||24
3143787|NCT01754714|3869323|FG003|COMPLETED|Overall Study||27
3143788|NCT01754714|3869320|FG000|NOT COMPLETED|Overall Study||0
3143789|NCT01754714|3869321|FG001|NOT COMPLETED|Overall Study||1
3143790|NCT01754714|3869322|FG002|NOT COMPLETED|Overall Study||2
3143791|NCT01754714|3869323|FG003|NOT COMPLETED|Overall Study||1
3143792|NCT01754727|3869334|FG000|STARTED|Overall Study||452
3143793|NCT01754727|3869334|FG000|COMPLETED|Overall Study||450
3143794|NCT01754727|3869334|FG000|NOT COMPLETED|Overall Study||2
3143795|NCT01754753|3869340|FG000|STARTED|Overall Study||78
3143796|NCT01754753|3869341|FG001|STARTED|Overall Study||79
3143797|NCT01754753|3869340|FG000|COMPLETED|Overall Study||26
3143798|NCT01754753|3869341|FG001|COMPLETED|Overall Study||30
3143799|NCT01754753|3869340|FG000|NOT COMPLETED|Overall Study||52
3143800|NCT01754753|3869341|FG001|NOT COMPLETED|Overall Study||49
3143801|NCT01754766|3869350|FG000|STARTED|Overall Study||31
3143802|NCT01754766|3869351|FG001|STARTED|Overall Study||29
3143803|NCT01754766|3869352|FG002|STARTED|Overall Study||30
3143804|NCT01754766|3869350|FG000|COMPLETED|Overall Study||30
3143805|NCT01754766|3869351|FG001|COMPLETED|Overall Study||28
3143806|NCT01754766|3869352|FG002|COMPLETED|Overall Study||30
3143807|NCT01754766|3869350|FG000|NOT COMPLETED|Overall Study||1
3143808|NCT01754766|3869351|FG001|NOT COMPLETED|Overall Study||1
3143809|NCT01754766|3869352|FG002|NOT COMPLETED|Overall Study||0
3143810|NCT01754909|3869362|FG000|STARTED|Overall Study||20
3143811|NCT01754909|3869363|FG001|STARTED|Overall Study||23
3143812|NCT01754909|3869362|FG000|COMPLETED|Overall Study||20
3143813|NCT01754909|3869363|FG001|COMPLETED|Overall Study||23
3143814|NCT01754909|3869362|FG000|NOT COMPLETED|Overall Study||0
3143815|NCT01754909|3869363|FG001|NOT COMPLETED|Overall Study||0
3143816|NCT01754922|3869371|FG000|STARTED|Overall Study||32
3143817|NCT01754922|3869372|FG001|STARTED|Overall Study||18
3143818|NCT01754922|3869371|FG000|COMPLETED|Overall Study||32
3143819|NCT01754922|3869372|FG001|COMPLETED|Overall Study||17
3143820|NCT01754922|3869371|FG000|NOT COMPLETED|Overall Study||0
3143821|NCT01754922|3869372|FG001|NOT COMPLETED|Overall Study||1
3143822|NCT01755026|3869381|FG000|STARTED|Overall Study||11
3143823|NCT01755026|3869382|FG001|STARTED|Overall Study||12
3143824|NCT01755026|3869381|FG000|COMPLETED|Overall Study||9
3143825|NCT01755026|3869382|FG001|COMPLETED|Overall Study||11
3143826|NCT01755026|3869381|FG000|NOT COMPLETED|Overall Study||2
3180964|NCT01994746|3909421|FG001|Completed Both Dosing Visits|Second Visit||38
3180965|NCT01994746|3909420|FG000|COMPLETED|Second Visit||38
3180966|NCT01994746|3909421|FG001|COMPLETED|Second Visit||38
3143827|NCT01755026|3869382|FG001|NOT COMPLETED|Overall Study||1
3143828|NCT01755091|3869391|FG000|STARTED|Overall Study||26
3143829|NCT01755091|3869392|FG001|STARTED|Overall Study||22
3180967|NCT01994746|3909420|FG000|NOT COMPLETED|Second Visit||0
3180968|NCT01994746|3909421|FG001|NOT COMPLETED|Second Visit||0
3363531|NCT04066426|4094644|FG003|NOT COMPLETED|Overall Study||3
3363532|NCT04061694|4094656|FG000|STARTED|Overall Study||21
3363533|NCT04061694|4094657|FG001|STARTED|Overall Study||25
3363534|NCT04061694|4094656|FG000|COMPLETED|Overall Study||19
3363535|NCT04061694|4094657|FG001|COMPLETED|Overall Study||25
3363536|NCT04061694|4094656|FG000|NOT COMPLETED|Overall Study||2
3363537|NCT04061694|4094657|FG001|NOT COMPLETED|Overall Study||0
3363538|NCT04060654|4094663|FG000|STARTED|Overall Study||17
3363539|NCT04060654|4094663|FG000|COMPLETED|Overall Study||11
3363540|NCT04060654|4094663|FG000|NOT COMPLETED|Overall Study||6
3363541|NCT04059250|4094667|FG000|STARTED|Overall Study||25
3363542|NCT04059250|4094668|FG001|STARTED|Overall Study||25
3363543|NCT04059250|4094667|FG000|COMPLETED|Overall Study||25
3363544|NCT04059250|4094668|FG001|COMPLETED|Overall Study||25
3363545|NCT04059250|4094667|FG000|NOT COMPLETED|Overall Study||0
3363546|NCT04059250|4094668|FG001|NOT COMPLETED|Overall Study||0
3363547|NCT04058353|4094676|FG000|STARTED|Overall Study||126
3363548|NCT04058353|4094677|FG001|STARTED|Overall Study||132
3363549|NCT04058353|4094676|FG000|COMPLETED|Overall Study||122
3363550|NCT04058353|4094677|FG001|COMPLETED|Overall Study||131
3363551|NCT04058353|4094676|FG000|NOT COMPLETED|Overall Study||4
3143830|NCT01755091|3869393|FG002|STARTED|Overall Study||27
3143831|NCT01755091|3869391|FG000|COMPLETED|Overall Study||17
3143832|NCT01755091|3869392|FG001|COMPLETED|Overall Study||19
3143833|NCT01755091|3869393|FG002|COMPLETED|Overall Study||20
3143834|NCT01755091|3869391|FG000|NOT COMPLETED|Overall Study||9
3143835|NCT01755091|3869392|FG001|NOT COMPLETED|Overall Study||3
3143836|NCT01755091|3869393|FG002|NOT COMPLETED|Overall Study||7
3143837|NCT01755143|3869403|FG000|STARTED|Overall Study||177
3143838|NCT01755143|3869404|FG001|STARTED|Overall Study||89
3363552|NCT04058353|4094677|FG001|NOT COMPLETED|Overall Study||1
3363553|NCT04057248|4094684|FG000|STARTED|Overall Study||14
3363554|NCT04057248|4094684|FG000|COMPLETED|Overall Study||12
3143839|NCT01755143|3869403|FG000|COMPLETED|Overall Study||166
3143840|NCT01755143|3869404|FG001|COMPLETED|Overall Study||86
3143841|NCT01755143|3869403|FG000|NOT COMPLETED|Overall Study||11
3143842|NCT01755143|3869404|FG001|NOT COMPLETED|Overall Study||3
3143843|NCT01755156|3869412|FG000|STARTED|Phase A (Weeks 0-24)||201
3143844|NCT01755156|3869413|FG001|STARTED|Phase A (Weeks 0-24)||201
3143845|NCT01755156|3869412|FG000|COMPLETED|Phase A (Weeks 0-24)||184
3143846|NCT01755156|3869413|FG001|COMPLETED|Phase A (Weeks 0-24)||177
3363555|NCT04057248|4094684|FG000|NOT COMPLETED|Overall Study||2
3363556|NCT04055519|4094688|FG000|STARTED|First Wear Period (30 Days)||16
3363557|NCT04055519|4094689|FG001|STARTED|First Wear Period (30 Days)||20
3143847|NCT01755156|3869412|FG000|NOT COMPLETED|Phase A (Weeks 0-24)||17
3143848|NCT01755156|3869413|FG001|NOT COMPLETED|Phase A (Weeks 0-24)||24
3143849|NCT01755156|3869412|FG000|STARTED|Phase B (Weeks 24-104)|1 participant who completed Phase A did not continue to Phase B.|183
3143850|NCT01755156|3869413|FG001|STARTED|Phase B (Weeks 24-104)||177
3143851|NCT01755156|3869412|FG000|COMPLETED|Phase B (Weeks 24-104)||144
3143852|NCT01755156|3869413|FG001|COMPLETED|Phase B (Weeks 24-104)||141
3143853|NCT01755156|3869412|FG000|NOT COMPLETED|Phase B (Weeks 24-104)||39
3143854|NCT01755156|3869413|FG001|NOT COMPLETED|Phase B (Weeks 24-104)||36
3143855|NCT01755169|3869427|FG000|STARTED|Overall Study||2
3143856|NCT01755169|3869428|FG001|STARTED|Overall Study||1
3143857|NCT01755169|3869429|FG002|STARTED|Overall Study||0
3143858|NCT01755169|3869430|FG003|STARTED|Overall Study||1
3143859|NCT01755169|3869427|FG000|COMPLETED|Overall Study||2
3143860|NCT01755169|3869428|FG001|COMPLETED|Overall Study||1
3143861|NCT01755169|3869429|FG002|COMPLETED|Overall Study||0
3143862|NCT01755169|3869430|FG003|COMPLETED|Overall Study||1
3143863|NCT01755169|3869427|FG000|NOT COMPLETED|Overall Study||0
3143864|NCT01755169|3869428|FG001|NOT COMPLETED|Overall Study||0
3143865|NCT01755169|3869429|FG002|NOT COMPLETED|Overall Study||0
3143866|NCT01755169|3869430|FG003|NOT COMPLETED|Overall Study||0
3143867|NCT01755195|3869440|FG000|STARTED|Overall Study||55
3143868|NCT01755195|3869440|FG000|COMPLETED|Overall Study||42
3143869|NCT01755195|3869440|FG000|NOT COMPLETED|Overall Study||13
3143870|NCT01755234|3869446|FG000|STARTED|Overall Study||45
3143871|NCT01755234|3869447|FG001|STARTED|Overall Study||45
3143872|NCT01755234|3869446|FG000|COMPLETED|Overall Study||30
3143873|NCT01755234|3869447|FG001|COMPLETED|Overall Study||37
3143874|NCT01755234|3869446|FG000|NOT COMPLETED|Overall Study||15
3143875|NCT01755234|3869447|FG001|NOT COMPLETED|Overall Study||8
3143876|NCT01755416|3869453|FG000|STARTED|First Intervention ( Upto 2 Days)||9
3143877|NCT01755416|3869454|FG001|STARTED|First Intervention ( Upto 2 Days)||9
3143878|NCT01755416|3869453|FG000|COMPLETED|First Intervention ( Upto 2 Days)||8
3143879|NCT01755416|3869454|FG001|COMPLETED|First Intervention ( Upto 2 Days)||7
3143880|NCT01755416|3869453|FG000|NOT COMPLETED|First Intervention ( Upto 2 Days)||1
3143881|NCT01755416|3869454|FG001|NOT COMPLETED|First Intervention ( Upto 2 Days)||2
3143882|NCT01755416|3869453|FG000|STARTED|Second Intervention (Upto 2 Days)||8
3143883|NCT01755416|3869454|FG001|STARTED|Second Intervention (Upto 2 Days)||7
3143884|NCT01755416|3869453|FG000|COMPLETED|Second Intervention (Upto 2 Days)||8
3143885|NCT01755416|3869454|FG001|COMPLETED|Second Intervention (Upto 2 Days)||7
3143886|NCT01755416|3869453|FG000|NOT COMPLETED|Second Intervention (Upto 2 Days)||0
3143887|NCT01755416|3869454|FG001|NOT COMPLETED|Second Intervention (Upto 2 Days)||0
3143888|NCT01755455|3869460|FG000|STARTED|First Intervention (6 Weeks)||11
3143889|NCT01755455|3869461|FG001|STARTED|First Intervention (6 Weeks)||11
3143890|NCT01755455|3869460|FG000|COMPLETED|First Intervention (6 Weeks)||11
3143891|NCT01755455|3869461|FG001|COMPLETED|First Intervention (6 Weeks)||11
3143892|NCT01755455|3869460|FG000|NOT COMPLETED|First Intervention (6 Weeks)||0
3143893|NCT01755455|3869461|FG001|NOT COMPLETED|First Intervention (6 Weeks)||0
3143894|NCT01755455|3869460|FG000|STARTED|Washout (4 Weeks)||11
3143895|NCT01755455|3869461|FG001|STARTED|Washout (4 Weeks)||11
3143896|NCT01755455|3869460|FG000|COMPLETED|Washout (4 Weeks)||11
3143897|NCT01755455|3869461|FG001|COMPLETED|Washout (4 Weeks)||11
3143898|NCT01755455|3869460|FG000|NOT COMPLETED|Washout (4 Weeks)||0
3143899|NCT01755455|3869461|FG001|NOT COMPLETED|Washout (4 Weeks)||0
3143900|NCT01755455|3869460|FG000|STARTED|Second Intervention (6 Weeks)||11
3143901|NCT01755455|3869461|FG001|STARTED|Second Intervention (6 Weeks)||11
3143902|NCT01755455|3869460|FG000|COMPLETED|Second Intervention (6 Weeks)||11
3143903|NCT01755455|3869461|FG001|COMPLETED|Second Intervention (6 Weeks)||11
3180969|NCT01994785|3909431|FG000|STARTED|Overall Study||109
3143904|NCT01755455|3869460|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||0
3143905|NCT01755455|3869461|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||0
3143906|NCT01755546|3869467|FG000|STARTED|Screened and Taper (Rollover and DeNovo)||304
3143907|NCT01755546|3869467|FG000|COMPLETED|Screened and Taper (Rollover and DeNovo)||294
3143908|NCT01755546|3869467|FG000|NOT COMPLETED|Screened and Taper (Rollover and DeNovo)||10
3143909|NCT01755546|3869467|FG000|STARTED|Titration Phase||294
3143910|NCT01755546|3869467|FG000|COMPLETED|Titration Phase||224
3143911|NCT01755546|3869467|FG000|NOT COMPLETED|Titration Phase||70
3143912|NCT01755546|3869467|FG000|STARTED|Long Term Treatment||224
3143913|NCT01755546|3869467|FG000|COMPLETED|Long Term Treatment||103
3143914|NCT01755546|3869467|FG000|NOT COMPLETED|Long Term Treatment||121
3143915|NCT01755598|3869473|FG000|STARTED|Overall Study||1786
3143916|NCT01755598|3869474|FG001|STARTED|Overall Study||1787
3143917|NCT01755598|3869473|FG000|COMPLETED|Overall Study||1521
3143918|NCT01755598|3869474|FG001|COMPLETED|Overall Study||1504
3143919|NCT01755598|3869473|FG000|NOT COMPLETED|Overall Study||265
3143920|NCT01755598|3869474|FG001|NOT COMPLETED|Overall Study||283
3143921|NCT01755637|3869480|FG000|STARTED|Period 1||28
3143922|NCT01755637|3869481|FG001|STARTED|Period 1||28
3143923|NCT01755637|3869480|FG000|COMPLETED|Period 1||28
3143924|NCT01755637|3869481|FG001|COMPLETED|Period 1||27
3143925|NCT01755637|3869480|FG000|NOT COMPLETED|Period 1||0
3143926|NCT01755637|3869481|FG001|NOT COMPLETED|Period 1||1
3143927|NCT01755637|3869480|FG000|STARTED|Period 2||28
3143928|NCT01755637|3869481|FG001|STARTED|Period 2||27
3143929|NCT01755637|3869480|FG000|COMPLETED|Period 2||28
3143930|NCT01755637|3869481|FG001|COMPLETED|Period 2||27
3143931|NCT01755637|3869480|FG000|NOT COMPLETED|Period 2||0
3143932|NCT01755637|3869481|FG001|NOT COMPLETED|Period 2||0
3143933|NCT01755702|3869493|FG000|STARTED|Period I||66
3143934|NCT01755702|3869493|FG000|Received Paracetamol|Period I||16
3143935|NCT01755702|3869493|FG000|Received Placebo|Period I||17
3143936|NCT01755702|3869493|FG000|Received Ibuprofen|Period I||16
3143937|NCT01755702|3869493|FG000|Received Paracetamol/Caffeine|Period I||17
3143938|NCT01755702|3869493|FG000|COMPLETED|Period I||66
3143939|NCT01755702|3869493|FG000|NOT COMPLETED|Period I||0
3143940|NCT01755702|3869493|FG000|STARTED|Wash Out Period I||66
3143941|NCT01755702|3869493|FG000|COMPLETED|Wash Out Period I||63
3143942|NCT01755702|3869493|FG000|NOT COMPLETED|Wash Out Period I||3
3143943|NCT01755702|3869493|FG000|STARTED|Period II||63
3143944|NCT01755702|3869493|FG000|Received Ibuprofen|Period II||11
3143945|NCT01755702|3869493|FG000|Received Placebo|Period II||15
3143946|NCT01755702|3869493|FG000|Received Paracetamol/Caffeine|Period II||20
3143947|NCT01755702|3869493|FG000|Received Paracetamol|Period II||17
3143948|NCT01755702|3869493|FG000|COMPLETED|Period II||63
3143949|NCT01755702|3869493|FG000|NOT COMPLETED|Period II||0
3143950|NCT01755702|3869493|FG000|STARTED|Washout Period II||63
3143951|NCT01755702|3869493|FG000|COMPLETED|Washout Period II||58
3143952|NCT01755702|3869493|FG000|NOT COMPLETED|Washout Period II||5
3143953|NCT01755702|3869493|FG000|STARTED|Period III||58
3143954|NCT01755702|3869493|FG000|Received Paracetamol|Period III||17
3143955|NCT01755702|3869493|FG000|Received Placebo|Period III||13
3143956|NCT01755702|3869493|FG000|Received Paracetamol/Caffeine|Period III||10
3143957|NCT01755702|3869493|FG000|Received Ibuprofen|Period III||18
3143958|NCT01755702|3869493|FG000|COMPLETED|Period III||58
3143959|NCT01755702|3869493|FG000|NOT COMPLETED|Period III||0
3143960|NCT01755767|3869507|FG000|STARTED|Overall Study||28
3143961|NCT01755767|3869508|FG001|STARTED|Overall Study||15
3143962|NCT01755767|3869509|FG002|STARTED|Overall Study||226
3143963|NCT01755767|3869510|FG003|STARTED|Overall Study||114
3143964|NCT01755767|3869507|FG000|COMPLETED|Overall Study||0
3143965|NCT01755767|3869508|FG001|COMPLETED|Overall Study||0
3143966|NCT01755767|3869509|FG002|COMPLETED|Overall Study||0
3143967|NCT01755767|3869510|FG003|COMPLETED|Overall Study||0
3143968|NCT01755767|3869507|FG000|NOT COMPLETED|Overall Study||28
3143969|NCT01755767|3869508|FG001|NOT COMPLETED|Overall Study||15
3143970|NCT01755767|3869509|FG002|NOT COMPLETED|Overall Study||226
3143971|NCT01755767|3869510|FG003|NOT COMPLETED|Overall Study||114
3143972|NCT01755858|3869522|FG000|STARTED|Overall Study||7
3143973|NCT01755858|3869523|FG001|STARTED|Overall Study||9
3143974|NCT01755858|3869522|FG000|COMPLETED|Overall Study||6
3143975|NCT01755858|3869523|FG001|COMPLETED|Overall Study||8
3143976|NCT01755858|3869522|FG000|NOT COMPLETED|Overall Study||1
3143977|NCT01755858|3869523|FG001|NOT COMPLETED|Overall Study||1
3143978|NCT01755949|3869537|FG000|STARTED|Overall Study||5
3143979|NCT01755949|3869538|FG001|STARTED|Overall Study||5
3143980|NCT01755949|3869539|FG002|STARTED|Overall Study||4
3143981|NCT01755949|3869540|FG003|STARTED|Overall Study||5
3143982|NCT01755949|3869541|FG004|STARTED|Overall Study||4
3143983|NCT01755949|3869542|FG005|STARTED|Overall Study||3
3143984|NCT01755949|3869537|FG000|COMPLETED|Overall Study||5
3143985|NCT01755949|3869538|FG001|COMPLETED|Overall Study||5
3143986|NCT01755949|3869539|FG002|COMPLETED|Overall Study||4
3143987|NCT01755949|3869540|FG003|COMPLETED|Overall Study||5
3143988|NCT01755949|3869541|FG004|COMPLETED|Overall Study||4
3143989|NCT01755949|3869542|FG005|COMPLETED|Overall Study||3
3143990|NCT01755949|3869537|FG000|NOT COMPLETED|Overall Study||0
3143991|NCT01755949|3869538|FG001|NOT COMPLETED|Overall Study||0
3143992|NCT01755949|3869539|FG002|NOT COMPLETED|Overall Study||0
3143993|NCT01755949|3869540|FG003|NOT COMPLETED|Overall Study||0
3143994|NCT01755949|3869541|FG004|NOT COMPLETED|Overall Study||0
3143995|NCT01755949|3869542|FG005|NOT COMPLETED|Overall Study||0
3143996|NCT01756053|3869556|FG000|STARTED|Period 1 (10 Days)||8
3143997|NCT01756053|3869557|FG001|STARTED|Period 1 (10 Days)||9
3143998|NCT01756053|3869556|FG000|COMPLETED|Period 1 (10 Days)||7
3143999|NCT01756053|3869557|FG001|COMPLETED|Period 1 (10 Days)||8
3144000|NCT01756053|3869556|FG000|NOT COMPLETED|Period 1 (10 Days)||1
3144001|NCT01756053|3869557|FG001|NOT COMPLETED|Period 1 (10 Days)||1
3144002|NCT01756053|3869556|FG000|STARTED|Washout Period (~21 Days)||7
3144003|NCT01756053|3869557|FG001|STARTED|Washout Period (~21 Days)||8
3144004|NCT01756053|3869556|FG000|COMPLETED|Washout Period (~21 Days)||7
3144005|NCT01756053|3869557|FG001|COMPLETED|Washout Period (~21 Days)||8
3144006|NCT01756053|3869556|FG000|NOT COMPLETED|Washout Period (~21 Days)||0
3144007|NCT01756053|3869557|FG001|NOT COMPLETED|Washout Period (~21 Days)||0
3144008|NCT01756053|3869556|FG000|STARTED|Period 2 (10 Days)||7
3144009|NCT01756053|3869557|FG001|STARTED|Period 2 (10 Days)||8
3144010|NCT01756053|3869556|FG000|COMPLETED|Period 2 (10 Days)||7
3144011|NCT01756053|3869557|FG001|COMPLETED|Period 2 (10 Days)||6
3144012|NCT01756053|3869556|FG000|NOT COMPLETED|Period 2 (10 Days)||0
3144013|NCT01756053|3869557|FG001|NOT COMPLETED|Period 2 (10 Days)||2
3180970|NCT01994785|3909432|FG001|STARTED|Overall Study||109
3180971|NCT01994785|3909433|FG002|STARTED|Overall Study||117
3180972|NCT01994785|3909434|FG003|STARTED|Overall Study||117
3180973|NCT01994785|3909431|FG000|COMPLETED|Overall Study||101
3180974|NCT01994785|3909432|FG001|COMPLETED|Overall Study||108
3180975|NCT01994785|3909433|FG002|COMPLETED|Overall Study||117
3180976|NCT01994785|3909434|FG003|COMPLETED|Overall Study||114
3180977|NCT01994785|3909431|FG000|NOT COMPLETED|Overall Study||8
3180978|NCT01994785|3909432|FG001|NOT COMPLETED|Overall Study||1
3180979|NCT01994785|3909433|FG002|NOT COMPLETED|Overall Study||0
3144014|NCT01756079|3869563|FG000|STARTED|Lead-in: Day 0 to Week 4||58
3144015|NCT01756079|3869563|FG000|COMPLETED|Lead-in: Day 0 to Week 4||58
3144016|NCT01756079|3869563|FG000|NOT COMPLETED|Lead-in: Day 0 to Week 4||0
3144017|NCT01756079|3869563|FG000|STARTED|Treatment / Follow-up: Week 4 to Week 72||58
3144018|NCT01756079|3869563|FG000|Treated in Treatment Period|Treatment / Follow-up: Week 4 to Week 72||54
3144019|NCT01756079|3869563|FG000|COMPLETED|Treatment / Follow-up: Week 4 to Week 72||23
3144020|NCT01756079|3869563|FG000|NOT COMPLETED|Treatment / Follow-up: Week 4 to Week 72||35
3144021|NCT01756157|3869568|FG000|STARTED|First Intervention Period||23
3144022|NCT01756157|3869569|FG001|STARTED|First Intervention Period||24
3144023|NCT01756157|3869568|FG000|COMPLETED|First Intervention Period||22
3144024|NCT01756157|3869569|FG001|COMPLETED|First Intervention Period||22
3144025|NCT01756157|3869568|FG000|NOT COMPLETED|First Intervention Period||1
3144026|NCT01756157|3869569|FG001|NOT COMPLETED|First Intervention Period||2
3144027|NCT01756157|3869568|FG000|STARTED|Washout Period (at Least 7 Days)||22
3144028|NCT01756157|3869569|FG001|STARTED|Washout Period (at Least 7 Days)||22
3144029|NCT01756157|3869568|FG000|COMPLETED|Washout Period (at Least 7 Days)||22
3144030|NCT01756157|3869569|FG001|COMPLETED|Washout Period (at Least 7 Days)||22
3144031|NCT01756157|3869568|FG000|NOT COMPLETED|Washout Period (at Least 7 Days)||0
3144032|NCT01756157|3869569|FG001|NOT COMPLETED|Washout Period (at Least 7 Days)||0
3144033|NCT01756157|3869568|FG000|STARTED|Second Intervention Period||22
3144034|NCT01756157|3869569|FG001|STARTED|Second Intervention Period||22
3144035|NCT01756157|3869568|FG000|COMPLETED|Second Intervention Period||22
3144036|NCT01756157|3869569|FG001|COMPLETED|Second Intervention Period||22
3144037|NCT01756157|3869568|FG000|NOT COMPLETED|Second Intervention Period||0
3144038|NCT01756157|3869569|FG001|NOT COMPLETED|Second Intervention Period||0
3144039|NCT01756209|3869579|FG000|STARTED|Overall Study||40
3144040|NCT01756209|3869580|FG001|STARTED|Overall Study||40
3144041|NCT01756209|3869581|FG002|STARTED|Overall Study||40
3144042|NCT01756209|3869582|FG003|STARTED|Overall Study||40
3144043|NCT01756209|3869579|FG000|COMPLETED|Overall Study||40
3144044|NCT01756209|3869580|FG001|COMPLETED|Overall Study||40
3144045|NCT01756209|3869581|FG002|COMPLETED|Overall Study||40
3144046|NCT01756209|3869582|FG003|COMPLETED|Overall Study||40
3144047|NCT01756209|3869579|FG000|NOT COMPLETED|Overall Study||0
3144048|NCT01756209|3869580|FG001|NOT COMPLETED|Overall Study||0
3144049|NCT01756209|3869581|FG002|NOT COMPLETED|Overall Study||0
3144050|NCT01756209|3869582|FG003|NOT COMPLETED|Overall Study||0
3144051|NCT01756235|3869592|FG000|STARTED|Overall Study||462
3144052|NCT01756235|3869592|FG000|COMPLETED|Overall Study||460
3144053|NCT01756235|3869592|FG000|NOT COMPLETED|Overall Study||2
3144054|NCT01756274|3869596|FG000|STARTED|Overall Study||162
3144055|NCT01756274|3869596|FG000|COMPLETED|Overall Study||159
3144056|NCT01756274|3869596|FG000|NOT COMPLETED|Overall Study||3
3144057|NCT01756300|3869601|FG000|STARTED|Overall Study|Subjects underwent renal denervation treatment with the study catheter.|35
3144058|NCT01756300|3869601|FG000|COMPLETED|Overall Study|Subjects with follow up available at 12 months|33
3144059|NCT01756300|3869601|FG000|NOT COMPLETED|Overall Study||2
3144060|NCT01756352|3869622|FG000|STARTED|Overall Study||13
3144061|NCT01756352|3869622|FG000|COMPLETED|Overall Study||12
3144062|NCT01756352|3869622|FG000|NOT COMPLETED|Overall Study||1
3144063|NCT01756391|3869626|FG000|STARTED|Overall Study||351
3144064|NCT01756391|3869626|FG000|COMPLETED|Overall Study||319
3144065|NCT01756391|3869626|FG000|NOT COMPLETED|Overall Study||32
3144066|NCT01756456|3869636|FG000|STARTED|Treatment Period: Phase I/II||7
3144067|NCT01756456|3869637|FG001|STARTED|Treatment Period: Phase I/II||7
3144068|NCT01756456|3869638|FG002|STARTED|Treatment Period: Phase I/II||4
3144069|NCT01756456|3869639|FG003|STARTED|Treatment Period: Phase I/II||52
3144070|NCT01756456|3869640|FG004|STARTED|Treatment Period: Phase I/II||52
3144071|NCT01756456|3869641|FG005|STARTED|Treatment Period: Phase I/II||52
3144072|NCT01756456|3869636|FG000|COMPLETED|Treatment Period: Phase I/II||6
3144073|NCT01756456|3869637|FG001|COMPLETED|Treatment Period: Phase I/II||6
3144074|NCT01756456|3869638|FG002|COMPLETED|Treatment Period: Phase I/II||2
3144075|NCT01756456|3869639|FG003|COMPLETED|Treatment Period: Phase I/II||45
3144076|NCT01756456|3869640|FG004|COMPLETED|Treatment Period: Phase I/II||39
3144077|NCT01756456|3869641|FG005|COMPLETED|Treatment Period: Phase I/II||48
3144078|NCT01756456|3869636|FG000|NOT COMPLETED|Treatment Period: Phase I/II||1
3144079|NCT01756456|3869637|FG001|NOT COMPLETED|Treatment Period: Phase I/II||1
3144080|NCT01756456|3869638|FG002|NOT COMPLETED|Treatment Period: Phase I/II||2
3144081|NCT01756456|3869639|FG003|NOT COMPLETED|Treatment Period: Phase I/II||7
3144082|NCT01756456|3869640|FG004|NOT COMPLETED|Treatment Period: Phase I/II||13
3144083|NCT01756456|3869641|FG005|NOT COMPLETED|Treatment Period: Phase I/II||4
3144084|NCT01756456|3869636|FG000|STARTED|Follow Up Period Phase I/II||6
3144085|NCT01756456|3869637|FG001|STARTED|Follow Up Period Phase I/II||6
3144086|NCT01756456|3869638|FG002|STARTED|Follow Up Period Phase I/II||2
3144087|NCT01756456|3869639|FG003|STARTED|Follow Up Period Phase I/II||45
3144088|NCT01756456|3869640|FG004|STARTED|Follow Up Period Phase I/II||39
3144089|NCT01756456|3869641|FG005|STARTED|Follow Up Period Phase I/II||48
3144090|NCT01756456|3869636|FG000|COMPLETED|Follow Up Period Phase I/II||5
3144091|NCT01756456|3869637|FG001|COMPLETED|Follow Up Period Phase I/II||5
3144092|NCT01756456|3869638|FG002|COMPLETED|Follow Up Period Phase I/II||1
3144093|NCT01756456|3869639|FG003|COMPLETED|Follow Up Period Phase I/II||12
3144094|NCT01756456|3869640|FG004|COMPLETED|Follow Up Period Phase I/II||13
3144095|NCT01756456|3869641|FG005|COMPLETED|Follow Up Period Phase I/II||15
3144096|NCT01756456|3869636|FG000|NOT COMPLETED|Follow Up Period Phase I/II||1
3144097|NCT01756456|3869637|FG001|NOT COMPLETED|Follow Up Period Phase I/II||1
3144098|NCT01756456|3869638|FG002|NOT COMPLETED|Follow Up Period Phase I/II||1
3144099|NCT01756456|3869639|FG003|NOT COMPLETED|Follow Up Period Phase I/II||33
3144100|NCT01756456|3869640|FG004|NOT COMPLETED|Follow Up Period Phase I/II||26
3144101|NCT01756456|3869641|FG005|NOT COMPLETED|Follow Up Period Phase I/II||33
3144102|NCT01756833|3869666|FG000|STARTED|Overall Study||133
3144103|NCT01756833|3869667|FG001|STARTED|Overall Study||128
3144104|NCT01756833|3869666|FG000|COMPLETED|Overall Study||129
3144105|NCT01756833|3869667|FG001|COMPLETED|Overall Study||125
3144106|NCT01756833|3869666|FG000|NOT COMPLETED|Overall Study||4
3144107|NCT01756833|3869667|FG001|NOT COMPLETED|Overall Study||3
3144108|NCT01756846|3869675|FG000|STARTED|Overall Study||1833
3144109|NCT01756846|3869676|FG001|STARTED|Overall Study||1833
3144110|NCT01756846|3869675|FG000|COMPLETED|Overall Study||1827
3144111|NCT01756846|3869676|FG001|COMPLETED|Overall Study||1821
3144112|NCT01756846|3869675|FG000|NOT COMPLETED|Overall Study||6
3144113|NCT01756846|3869676|FG001|NOT COMPLETED|Overall Study||12
3144114|NCT01756885|3869684|FG000|STARTED|Overall Study||102
3144115|NCT01756885|3869685|FG001|STARTED|Overall Study||105
3144116|NCT01756885|3869684|FG000|COMPLETED|Overall Study||79
3144117|NCT01756885|3869685|FG001|COMPLETED|Overall Study||79
3144118|NCT01756885|3869684|FG000|NOT COMPLETED|Overall Study||23
3144119|NCT01756885|3869685|FG001|NOT COMPLETED|Overall Study||26
3144120|NCT01756898|3869695|FG000|STARTED|Overall Study||92
3144121|NCT01756898|3869696|FG001|STARTED|Overall Study||92
3144122|NCT01756898|3869697|FG002|STARTED|Overall Study||93
3144123|NCT01756898|3869698|FG003|STARTED|Overall Study||93
3144124|NCT01756898|3869695|FG000|COMPLETED|Overall Study||73
3144125|NCT01756898|3869696|FG001|COMPLETED|Overall Study||73
3144126|NCT01756898|3869697|FG002|COMPLETED|Overall Study||76
3144127|NCT01756898|3869698|FG003|COMPLETED|Overall Study||77
3144128|NCT01756898|3869695|FG000|NOT COMPLETED|Overall Study||19
3144129|NCT01756898|3869696|FG001|NOT COMPLETED|Overall Study||19
3144130|NCT01756898|3869697|FG002|NOT COMPLETED|Overall Study||17
3144131|NCT01756898|3869698|FG003|NOT COMPLETED|Overall Study||16
3144132|NCT01756976|3869713|FG000|STARTED|Overall Study||76
3144133|NCT01756976|3869714|FG001|STARTED|Overall Study||8
3144134|NCT01756976|3869713|FG000|COMPLETED|Overall Study||73
3144135|NCT01756976|3869714|FG001|COMPLETED|Overall Study||8
3144136|NCT01756976|3869713|FG000|NOT COMPLETED|Overall Study||3
3144137|NCT01756976|3869714|FG001|NOT COMPLETED|Overall Study||0
3144138|NCT01757067|3869722|FG000|STARTED|Overall Study||2
3144139|NCT01757067|3869723|FG001|STARTED|Overall Study|The study was closed due to low enrollment.|1
3144140|NCT01757067|3869722|FG000|COMPLETED|Overall Study|The study was closed due to low enrollment.|2
3144141|NCT01757067|3869723|FG001|COMPLETED|Overall Study|The study was closed due to low enrollment.|1
3180980|NCT01994785|3909434|FG003|NOT COMPLETED|Overall Study||3
3180981|NCT01994837|3909444|FG000|STARTED|Overall Study||32
3144142|NCT01757067|3869722|FG000|NOT COMPLETED|Overall Study||0
3144143|NCT01757067|3869723|FG001|NOT COMPLETED|Overall Study||0
3144144|NCT01757171|3869731|FG000|STARTED|Overall Study||61
3144145|NCT01757171|3869732|FG001|STARTED|Overall Study||24
3144146|NCT01757171|3869731|FG000|COMPLETED|Overall Study||53
3144147|NCT01757171|3869732|FG001|COMPLETED|Overall Study||23
3144148|NCT01757171|3869731|FG000|NOT COMPLETED|Overall Study||8
3144149|NCT01757171|3869732|FG001|NOT COMPLETED|Overall Study||1
3144150|NCT01757184|3869740|FG000|STARTED|Double-blind Period||36
3144151|NCT01757184|3869741|FG001|STARTED|Double-blind Period||30
3144152|NCT01757184|3869742|FG002|STARTED|Double-blind Period||0
3144153|NCT01757184|3869743|FG003|STARTED|Double-blind Period||0
3144154|NCT01757184|3869740|FG000|Received at Least 1 Dose of Study Drug|Double-blind Period||36
3144155|NCT01757184|3869741|FG001|Received at Least 1 Dose of Study Drug|Double-blind Period||30
3144156|NCT01757184|3869742|FG002|Received at Least 1 Dose of Study Drug|Double-blind Period||0
3144157|NCT01757184|3869743|FG003|Received at Least 1 Dose of Study Drug|Double-blind Period||0
3144158|NCT01757184|3869740|FG000|COMPLETED|Double-blind Period||35
3144159|NCT01757184|3869741|FG001|COMPLETED|Double-blind Period||30
3144160|NCT01757184|3869742|FG002|COMPLETED|Double-blind Period||0
3144161|NCT01757184|3869743|FG003|COMPLETED|Double-blind Period||0
3144162|NCT01757184|3869740|FG000|NOT COMPLETED|Double-blind Period||1
3144163|NCT01757184|3869741|FG001|NOT COMPLETED|Double-blind Period||0
3144164|NCT01757184|3869742|FG002|NOT COMPLETED|Double-blind Period||0
3144165|NCT01757184|3869743|FG003|NOT COMPLETED|Double-blind Period||0
3144166|NCT01757184|3869740|FG000|STARTED|Open-label Period||0
3144167|NCT01757184|3869741|FG001|STARTED|Open-label Period||0
3144168|NCT01757184|3869742|FG002|STARTED|Open-label Period|1 participant who did not complete Double-blind Period due to AE rechallenged for Open-label Period|36
3144169|NCT01757184|3869743|FG003|STARTED|Open-label Period||30
3144170|NCT01757184|3869740|FG000|Received at Least 1 Dose of Study Drug|Open-label Period||0
3144171|NCT01757184|3869741|FG001|Received at Least 1 Dose of Study Drug|Open-label Period||0
3144172|NCT01757184|3869742|FG002|Received at Least 1 Dose of Study Drug|Open-label Period||36
3144173|NCT01757184|3869743|FG003|Received at Least 1 Dose of Study Drug|Open-label Period||30
3144174|NCT01757184|3869740|FG000|COMPLETED|Open-label Period||0
3144175|NCT01757184|3869741|FG001|COMPLETED|Open-label Period||0
3144176|NCT01757184|3869742|FG002|COMPLETED|Open-label Period||32
3144177|NCT01757184|3869743|FG003|COMPLETED|Open-label Period||27
3144178|NCT01757184|3869740|FG000|NOT COMPLETED|Open-label Period||0
3180982|NCT01994837|3909444|FG000|Treated|Overall Study||32
3144179|NCT01757184|3869741|FG001|NOT COMPLETED|Open-label Period||0
3144180|NCT01757184|3869742|FG002|NOT COMPLETED|Open-label Period||4
3144181|NCT01757184|3869743|FG003|NOT COMPLETED|Open-label Period||3
3144182|NCT01757197|3869757|FG000|STARTED|Overall Study||2
3144183|NCT01757197|3869757|FG000|COMPLETED|Overall Study||0
3144184|NCT01757197|3869757|FG000|NOT COMPLETED|Overall Study||2
3144185|NCT01757275|3869763|FG000|STARTED|Overall Study||111
3144186|NCT01757275|3869764|FG001|STARTED|Overall Study||111
3144187|NCT01757275|3869763|FG000|COMPLETED|Overall Study||102
3144188|NCT01757275|3869764|FG001|COMPLETED|Overall Study||98
3144189|NCT01757275|3869763|FG000|NOT COMPLETED|Overall Study||9
3144190|NCT01757275|3869764|FG001|NOT COMPLETED|Overall Study||13
3144191|NCT01757288|3869773|FG000|STARTED|Overall Study||6
3144192|NCT01757288|3869774|FG001|STARTED|Overall Study||46
3144193|NCT01757288|3869775|FG002|STARTED|Overall Study||46
3144194|NCT01757288|3869773|FG000|COMPLETED|Overall Study||6
3144195|NCT01757288|3869774|FG001|COMPLETED|Overall Study||38
3144196|NCT01757288|3869775|FG002|COMPLETED|Overall Study||37
3144197|NCT01757288|3869773|FG000|NOT COMPLETED|Overall Study||0
3144198|NCT01757288|3869774|FG001|NOT COMPLETED|Overall Study||8
3144199|NCT01757288|3869775|FG002|NOT COMPLETED|Overall Study||9
3144200|NCT01757301|3869786|FG000|STARTED|Overall Study||147
3144201|NCT01757301|3869787|FG001|STARTED|Overall Study||147
3144202|NCT01757301|3869786|FG000|COMPLETED|Overall Study||134
3144203|NCT01757301|3869787|FG001|COMPLETED|Overall Study||133
3144204|NCT01757301|3869786|FG000|NOT COMPLETED|Overall Study||13
3144205|NCT01757301|3869787|FG001|NOT COMPLETED|Overall Study||14
3144206|NCT01757392|3869795|FG000|STARTED|Overall Study||39
3144207|NCT01757392|3869795|FG000|COMPLETED|Overall Study||35
3144208|NCT01757392|3869795|FG000|NOT COMPLETED|Overall Study||4
3144209|NCT01757405|3869801|FG000|STARTED|Overall Study||18
3144210|NCT01757405|3869802|FG001|STARTED|Overall Study||20
3144211|NCT01757405|3869801|FG000|COMPLETED|Overall Study||17
3144212|NCT01757405|3869802|FG001|COMPLETED|Overall Study||18
3144213|NCT01757405|3869801|FG000|NOT COMPLETED|Overall Study||1
3144214|NCT01757405|3869802|FG001|NOT COMPLETED|Overall Study||2
3144215|NCT01757561|3869812|FG000|STARTED|Overall Study||38
3144216|NCT01757561|3869813|FG001|STARTED|Overall Study||34
3144217|NCT01757561|3869814|FG002|STARTED|Overall Study||38
3144218|NCT01757561|3869815|FG003|STARTED|Overall Study||34
3144219|NCT01757561|3869812|FG000|COMPLETED|Overall Study||32
3144220|NCT01757561|3869813|FG001|COMPLETED|Overall Study||28
3144221|NCT01757561|3869814|FG002|COMPLETED|Overall Study||31
3144222|NCT01757561|3869815|FG003|COMPLETED|Overall Study||25
3144223|NCT01757561|3869812|FG000|NOT COMPLETED|Overall Study||6
3144224|NCT01757561|3869813|FG001|NOT COMPLETED|Overall Study||6
3144225|NCT01757561|3869814|FG002|NOT COMPLETED|Overall Study||7
3144226|NCT01757561|3869815|FG003|NOT COMPLETED|Overall Study||9
3144227|NCT01757678|3869825|FG000|STARTED|Overall Study||276
3144228|NCT01757678|3869825|FG000|COMPLETED|Overall Study||276
3144229|NCT01757678|3869825|FG000|NOT COMPLETED|Overall Study||0
3144230|NCT01757691|3869833|FG000|STARTED|Overall Study||2
3144231|NCT01757691|3869834|FG001|STARTED|Overall Study||0
3144232|NCT01757691|3869833|FG000|COMPLETED|Overall Study||0
3144233|NCT01757691|3869834|FG001|COMPLETED|Overall Study||0
3144234|NCT01757691|3869833|FG000|NOT COMPLETED|Overall Study||2
3144235|NCT01757691|3869834|FG001|NOT COMPLETED|Overall Study||0
3144236|NCT01757704|3869842|FG000|STARTED|Overall Study|One patient was excluded at start of surgery due to opening of the pleurae during sternotomy.|11
3144237|NCT01757704|3869843|FG001|STARTED|Overall Study|Two patients excluded intraoperatively due to failure to obtain TCD signals and one due to adhesion.|13
3144238|NCT01757704|3869842|FG000|COMPLETED|Overall Study||10
3144239|NCT01757704|3869843|FG001|COMPLETED|Overall Study||10
3144240|NCT01757704|3869842|FG000|NOT COMPLETED|Overall Study||1
3144241|NCT01757704|3869843|FG001|NOT COMPLETED|Overall Study||3
3144242|NCT01757717|3869849|FG000|STARTED|Overall Study||3
3144243|NCT01757717|3869849|FG000|COMPLETED|Overall Study||3
3144244|NCT01757717|3869849|FG000|NOT COMPLETED|Overall Study||0
3144245|NCT01757821|3869853|FG000|STARTED|Overall Study|11 subjects|11
3144246|NCT01757821|3869853|FG000|COMPLETED|Overall Study|10 subjects|10
3144247|NCT01757821|3869853|FG000|NOT COMPLETED|Overall Study||1
3144248|NCT01757847|3869863|FG000|STARTED|Overall Study||44
3144249|NCT01757847|3869864|FG001|STARTED|Overall Study||46
3144250|NCT01757847|3869863|FG000|COMPLETED|Overall Study||41
3144251|NCT01757847|3869864|FG001|COMPLETED|Overall Study||42
3144252|NCT01757847|3869863|FG000|NOT COMPLETED|Overall Study||3
3144253|NCT01757847|3869864|FG001|NOT COMPLETED|Overall Study||4
3144254|NCT01757964|3869872|FG000|STARTED|Overall Study||9
3144255|NCT01757964|3869873|FG001|STARTED|Overall Study||4
3144256|NCT01757964|3869872|FG000|COMPLETED|Overall Study||9
3144257|NCT01757964|3869873|FG001|COMPLETED|Overall Study||4
3144258|NCT01757964|3869872|FG000|NOT COMPLETED|Overall Study||0
3144259|NCT01757964|3869873|FG001|NOT COMPLETED|Overall Study||0
3144260|NCT01758289|3869877|FG000|STARTED|Overall Study||105
3144261|NCT01758289|3869877|FG000|COMPLETED|Overall Study||52
3144262|NCT01758289|3869877|FG000|NOT COMPLETED|Overall Study||53
3144263|NCT01758432|3869892|FG000|STARTED|Overall Study||18
3144264|NCT01758432|3869893|FG001|STARTED|Overall Study||6
3144265|NCT01758432|3869894|FG002|STARTED|Overall Study||6
3144266|NCT01758432|3869895|FG003|STARTED|Overall Study||6
3144267|NCT01758432|3869896|FG004|STARTED|Overall Study||6
3144268|NCT01758432|3869897|FG005|STARTED|Overall Study||6
3144269|NCT01758432|3869898|FG006|STARTED|Overall Study||6
3144270|NCT01758432|3869892|FG000|COMPLETED|Overall Study||18
3144271|NCT01758432|3869893|FG001|COMPLETED|Overall Study||6
3144272|NCT01758432|3869894|FG002|COMPLETED|Overall Study||6
3144273|NCT01758432|3869895|FG003|COMPLETED|Overall Study||6
3144274|NCT01758432|3869896|FG004|COMPLETED|Overall Study||6
3144275|NCT01758432|3869897|FG005|COMPLETED|Overall Study||6
3144276|NCT01758432|3869898|FG006|COMPLETED|Overall Study||6
3144277|NCT01758432|3869892|FG000|NOT COMPLETED|Overall Study||0
3144278|NCT01758432|3869893|FG001|NOT COMPLETED|Overall Study||0
3144279|NCT01758432|3869894|FG002|NOT COMPLETED|Overall Study||0
3144280|NCT01758432|3869895|FG003|NOT COMPLETED|Overall Study||0
3144281|NCT01758432|3869896|FG004|NOT COMPLETED|Overall Study||0
3144282|NCT01758432|3869897|FG005|NOT COMPLETED|Overall Study||0
3144283|NCT01758432|3869898|FG006|NOT COMPLETED|Overall Study||0
3144284|NCT01758523|3869916|FG000|STARTED|Overall Study||74
3144285|NCT01758523|3869917|FG001|STARTED|Overall Study||68
3144286|NCT01758523|3869916|FG000|Attended >/= 1 Visit Post-randomization|Overall Study||68
3144287|NCT01758523|3869917|FG001|Attended >/= 1 Visit Post-randomization|Overall Study||67
3144288|NCT01758523|3869916|FG000|COMPLETED|Overall Study||53
3144289|NCT01758523|3869917|FG001|COMPLETED|Overall Study||54
3144290|NCT01758523|3869916|FG000|NOT COMPLETED|Overall Study||21
3144291|NCT01758523|3869917|FG001|NOT COMPLETED|Overall Study||14
3144292|NCT01758588|3869929|FG000|STARTED|Overall Study||5
3144293|NCT01758588|3869930|FG001|STARTED|Overall Study||3
3144294|NCT01758588|3869929|FG000|COMPLETED|Overall Study||5
3144295|NCT01758588|3869930|FG001|COMPLETED|Overall Study||3
3144296|NCT01758588|3869929|FG000|NOT COMPLETED|Overall Study||0
3144297|NCT01758588|3869930|FG001|NOT COMPLETED|Overall Study||0
3144298|NCT01758731|3869938|FG000|STARTED|Overall Study||17
3144299|NCT01758731|3869938|FG000|COMPLETED|Overall Study||16
3144300|NCT01758731|3869938|FG000|NOT COMPLETED|Overall Study||1
3144301|NCT01758900|3869944|FG000|STARTED|Overall Study||106
3144302|NCT01758900|3869945|FG001|STARTED|Overall Study||108
3144303|NCT01758900|3869944|FG000|COMPLETED|Overall Study||99
3144304|NCT01758900|3869945|FG001|COMPLETED|Overall Study||100
3144305|NCT01758900|3869944|FG000|NOT COMPLETED|Overall Study||7
3144306|NCT01758900|3869945|FG001|NOT COMPLETED|Overall Study||8
3144307|NCT01759160|3869953|FG000|STARTED|Overall Study||30
3144308|NCT01759160|3869954|FG001|STARTED|Overall Study||30
3144309|NCT01759160|3869953|FG000|COMPLETED|Overall Study||30
3144310|NCT01759160|3869954|FG001|COMPLETED|Overall Study||30
3144311|NCT01759160|3869953|FG000|NOT COMPLETED|Overall Study||0
3144312|NCT01759160|3869954|FG001|NOT COMPLETED|Overall Study||0
3144313|NCT01759251|3869960|FG000|STARTED|30 Days Treatment Period||309
3144314|NCT01759251|3869960|FG000|COMPLETED|30 Days Treatment Period||305
3144315|NCT01759251|3869960|FG000|NOT COMPLETED|30 Days Treatment Period||4
3144316|NCT01759251|3869960|FG000|STARTED|60 Days Treatment Period||305
3144317|NCT01759251|3869960|FG000|COMPLETED|60 Days Treatment Period||305
3144318|NCT01759251|3869960|FG000|NOT COMPLETED|60 Days Treatment Period||0
3144319|NCT01759251|3869960|FG000|STARTED|Follow-up Period||305
3144320|NCT01759251|3869960|FG000|COMPLETED|Follow-up Period||305
3144321|NCT01759251|3869960|FG000|NOT COMPLETED|Follow-up Period||0
3144322|NCT01759264|3869964|FG000|STARTED|Overall Study||101
3144323|NCT01759264|3869964|FG000|COMPLETED|Overall Study||91
3144324|NCT01759264|3869964|FG000|NOT COMPLETED|Overall Study||10
3144325|NCT01759277|3869971|FG000|STARTED|Overall Study||41
3144326|NCT01759277|3869972|FG001|STARTED|Overall Study||39
3144327|NCT01759277|3869971|FG000|COMPLETED|Overall Study||41
3144328|NCT01759277|3869972|FG001|COMPLETED|Overall Study||39
3144329|NCT01759277|3869971|FG000|NOT COMPLETED|Overall Study||0
3144330|NCT01759277|3869972|FG001|NOT COMPLETED|Overall Study||0
3144331|NCT01759290|3869980|FG000|STARTED|Overall Study||1800
3144332|NCT01759290|3869980|FG000|COMPLETED|Overall Study||1719
3144333|NCT01759290|3869980|FG000|NOT COMPLETED|Overall Study||81
3144334|NCT01759368|3869986|FG000|STARTED|Overall Study||47
3144335|NCT01759368|3869987|FG001|STARTED|Overall Study||47
3144336|NCT01759368|3869986|FG000|COMPLETED|Overall Study||46
3144337|NCT01759368|3869987|FG001|COMPLETED|Overall Study||47
3144338|NCT01759368|3869986|FG000|NOT COMPLETED|Overall Study||1
3144339|NCT01759368|3869987|FG001|NOT COMPLETED|Overall Study||0
3144340|NCT01759381|3869997|FG000|STARTED|Overall Study||8
3144341|NCT01759381|3869998|FG001|STARTED|Overall Study||11
3144342|NCT01759381|3869997|FG000|COMPLETED|Overall Study||7
3144343|NCT01759381|3869998|FG001|COMPLETED|Overall Study||11
3144344|NCT01759381|3869997|FG000|NOT COMPLETED|Overall Study||1
3144345|NCT01759381|3869998|FG001|NOT COMPLETED|Overall Study||0
3144346|NCT01759407|3870006|FG000|STARTED|Overall Study||10
3144347|NCT01759407|3870007|FG001|STARTED|Overall Study||9
3144348|NCT01759407|3870006|FG000|COMPLETED|Overall Study||10
3144349|NCT01759407|3870007|FG001|COMPLETED|Overall Study||7
3144350|NCT01759407|3870006|FG000|NOT COMPLETED|Overall Study||0
3144351|NCT01759407|3870007|FG001|NOT COMPLETED|Overall Study||2
3144352|NCT01759420|3870013|FG000|STARTED|Overall Study||28
3144353|NCT01759420|3870013|FG000|COMPLETED|Overall Study||22
3144354|NCT01759420|3870013|FG000|NOT COMPLETED|Overall Study||6
3144355|NCT01759446|3870022|FG000|STARTED|Overall Study||9
3144356|NCT01759446|3870023|FG001|STARTED|Overall Study||9
3144357|NCT01759446|3870024|FG002|STARTED|Overall Study||9
3144358|NCT01759446|3870025|FG003|STARTED|Overall Study||9
3144359|NCT01759446|3870026|FG004|STARTED|Overall Study||8
3144360|NCT01759446|3870022|FG000|COMPLETED|Overall Study||8
3144361|NCT01759446|3870023|FG001|COMPLETED|Overall Study||8
3144362|NCT01759446|3870024|FG002|COMPLETED|Overall Study||8
3144363|NCT01759446|3870025|FG003|COMPLETED|Overall Study||8
3144364|NCT01759446|3870026|FG004|COMPLETED|Overall Study||8
3144365|NCT01759446|3870022|FG000|NOT COMPLETED|Overall Study||1
3144366|NCT01759446|3870023|FG001|NOT COMPLETED|Overall Study||1
3144367|NCT01759446|3870024|FG002|NOT COMPLETED|Overall Study||1
3144368|NCT01759446|3870025|FG003|NOT COMPLETED|Overall Study||1
3144369|NCT01759446|3870026|FG004|NOT COMPLETED|Overall Study||0
3144370|NCT01759511|3870038|FG000|STARTED|Overall Study||34
3144371|NCT01759511|3870038|FG000|COMPLETED|Overall Study||0
3144372|NCT01759511|3870038|FG000|NOT COMPLETED|Overall Study||34
3144373|NCT01759602|3870042|FG000|STARTED|Overall Study||10
3144374|NCT01759602|3870042|FG000|COMPLETED|Overall Study||10
3144375|NCT01759602|3870042|FG000|NOT COMPLETED|Overall Study||0
3144376|NCT01759862|3870048|FG000|STARTED|Overall Study||23
3144377|NCT01759862|3870049|FG001|STARTED|Overall Study||27
3144378|NCT01759862|3870048|FG000|COMPLETED|Overall Study||20
3144379|NCT01759862|3870049|FG001|COMPLETED|Overall Study||25
3144380|NCT01759862|3870048|FG000|NOT COMPLETED|Overall Study||3
3144381|NCT01759862|3870049|FG001|NOT COMPLETED|Overall Study||2
3144382|NCT01760187|3870065|FG000|STARTED|Overall Study||20
3144383|NCT01760187|3870066|FG001|STARTED|Overall Study||12
3144384|NCT01760187|3870067|FG002|STARTED|Overall Study||12
3144385|NCT01760187|3870068|FG003|STARTED|Overall Study||12
3144386|NCT01760187|3870069|FG004|STARTED|Overall Study||16
3144387|NCT01760187|3870065|FG000|COMPLETED|Overall Study||19
3144388|NCT01760187|3870066|FG001|COMPLETED|Overall Study||12
3144389|NCT01760187|3870067|FG002|COMPLETED|Overall Study||12
3144390|NCT01760187|3870068|FG003|COMPLETED|Overall Study||10
3144391|NCT01760187|3870069|FG004|COMPLETED|Overall Study||16
3144392|NCT01760187|3870065|FG000|NOT COMPLETED|Overall Study||1
3144393|NCT01760187|3870066|FG001|NOT COMPLETED|Overall Study||0
3144394|NCT01760187|3870067|FG002|NOT COMPLETED|Overall Study||0
3144395|NCT01760187|3870068|FG003|NOT COMPLETED|Overall Study||2
3144396|NCT01760187|3870069|FG004|NOT COMPLETED|Overall Study||0
3144397|NCT01760239|3870091|FG000|STARTED|Overall Study||17037
3144398|NCT01760239|3870092|FG001|STARTED|Overall Study||14542
3144399|NCT01760239|3870091|FG000|COMPLETED|Overall Study||296
3144400|NCT01760239|3870092|FG001|COMPLETED|Overall Study||226
3144401|NCT01760239|3870091|FG000|NOT COMPLETED|Overall Study||16741
3144402|NCT01760239|3870092|FG001|NOT COMPLETED|Overall Study||14316
3144403|NCT01760291|3870099|FG000|STARTED|Overall Study||576
3144404|NCT01760291|3870099|FG000|COMPLETED|Overall Study||340
3144405|NCT01760291|3870099|FG000|NOT COMPLETED|Overall Study||236
3144406|NCT01760304|3870105|FG000|STARTED|Overall Study||2
3144407|NCT01760304|3870106|FG001|STARTED|Overall Study||3
3144408|NCT01760304|3870105|FG000|COMPLETED|Overall Study||2
3144409|NCT01760304|3870106|FG001|COMPLETED|Overall Study||3
3144410|NCT01760304|3870105|FG000|NOT COMPLETED|Overall Study||0
3144411|NCT01760304|3870106|FG001|NOT COMPLETED|Overall Study||0
3144412|NCT01760447|3870120|FG000|STARTED|Weeks 0-20|The first randomization for the participant who withdrew and re-randomized is not counted in the 62.|62
3144413|NCT01760447|3870121|FG001|STARTED|Weeks 0-20||62
3144414|NCT01760447|3870122|FG002|STARTED|Weeks 0-20||47
3144415|NCT01760447|3870123|FG003|STARTED|Weeks 0-20||51
3144416|NCT01760447|3870120|FG000|Treated|Weeks 0-20||62
3144417|NCT01760447|3870121|FG001|Treated|Weeks 0-20||62
3144418|NCT01760447|3870122|FG002|Treated|Weeks 0-20||45
3144419|NCT01760447|3870123|FG003|Treated|Weeks 0-20||51
3144420|NCT01760447|3870120|FG000|COMPLETED|Weeks 0-20||59
3144421|NCT01760447|3870121|FG001|COMPLETED|Weeks 0-20||62
3144422|NCT01760447|3870122|FG002|COMPLETED|Weeks 0-20||42
3144423|NCT01760447|3870123|FG003|COMPLETED|Weeks 0-20||47
3144424|NCT01760447|3870120|FG000|NOT COMPLETED|Weeks 0-20||3
3144425|NCT01760447|3870121|FG001|NOT COMPLETED|Weeks 0-20||0
3144426|NCT01760447|3870122|FG002|NOT COMPLETED|Weeks 0-20||5
3144427|NCT01760447|3870123|FG003|NOT COMPLETED|Weeks 0-20||4
3144428|NCT01760447|3870120|FG000|STARTED|Weeks 20-54|MK-0431A-170 added Weeks 20-54 via amendment, but not all participants were eligible for this period|28
3144429|NCT01760447|3870121|FG001|STARTED|Weeks 20-54|MK-0431A-170 added Weeks 20-54 via amendment, but not all participants were eligible for this period|30
3144430|NCT01760447|3870122|FG002|STARTED|Weeks 20-54||42
3144431|NCT01760447|3870123|FG003|STARTED|Weeks 20-54||47
3144432|NCT01760447|3870120|FG000|COMPLETED|Weeks 20-54||25
3144433|NCT01760447|3870121|FG001|COMPLETED|Weeks 20-54||28
3144434|NCT01760447|3870122|FG002|COMPLETED|Weeks 20-54||39
3144435|NCT01760447|3870123|FG003|COMPLETED|Weeks 20-54||43
3144436|NCT01760447|3870120|FG000|NOT COMPLETED|Weeks 20-54||3
3144437|NCT01760447|3870121|FG001|NOT COMPLETED|Weeks 20-54||2
3144438|NCT01760447|3870122|FG002|NOT COMPLETED|Weeks 20-54||3
3144439|NCT01760447|3870123|FG003|NOT COMPLETED|Weeks 20-54||4
3144440|NCT01760473|3870139|FG000|STARTED|Overall Study||27
3144441|NCT01760473|3870139|FG000|COMPLETED|Overall Study||12
3144442|NCT01760473|3870139|FG000|NOT COMPLETED|Overall Study||15
3144443|NCT01760733|3870151|FG000|STARTED|Waiting List|All patients included started in the waiting list group.|289
3144444|NCT01760733|3870151|FG000|COMPLETED|Waiting List|217 patients have been transplanted|217
3144445|NCT01760733|3870151|FG000|NOT COMPLETED|Waiting List||72
3144446|NCT01760733|3870151|FG000|STARTED|Transplanted||217
3144447|NCT01760733|3870151|FG000|COMPLETED|Transplanted||0
3144448|NCT01760733|3870151|FG000|NOT COMPLETED|Transplanted||217
3144449|NCT01760785|3870158|FG000|STARTED|Overall Study||23
3144450|NCT01760785|3870159|FG001|STARTED|Overall Study||27
3144451|NCT01760785|3870158|FG000|COMPLETED|Overall Study||23
3144452|NCT01760785|3870159|FG001|COMPLETED|Overall Study||27
3144453|NCT01760785|3870158|FG000|NOT COMPLETED|Overall Study||0
3144454|NCT01760785|3870159|FG001|NOT COMPLETED|Overall Study||0
3144455|NCT01760876|3870165|FG000|STARTED|Overall Study||106
3144456|NCT01760876|3870165|FG000|COMPLETED|Overall Study|12 months clinical FU of last patient in July 2015.|100
3144457|NCT01760876|3870165|FG000|NOT COMPLETED|Overall Study||6
3144458|NCT01760954|3870173|FG000|STARTED|Treatment Period (6 Months)||149
3144459|NCT01760954|3870174|FG001|STARTED|Treatment Period (6 Months)||138
3144460|NCT01760954|3870175|FG002|STARTED|Treatment Period (6 Months)||108
3144461|NCT01760954|3870176|FG003|STARTED|Treatment Period (6 Months)||109
3144462|NCT01760954|3870173|FG000|COMPLETED|Treatment Period (6 Months)||116
3144463|NCT01760954|3870174|FG001|COMPLETED|Treatment Period (6 Months)||110
3144464|NCT01760954|3870175|FG002|COMPLETED|Treatment Period (6 Months)||87
3144465|NCT01760954|3870176|FG003|COMPLETED|Treatment Period (6 Months)||83
3144466|NCT01760954|3870173|FG000|NOT COMPLETED|Treatment Period (6 Months)||33
3144467|NCT01760954|3870174|FG001|NOT COMPLETED|Treatment Period (6 Months)||28
3144468|NCT01760954|3870175|FG002|NOT COMPLETED|Treatment Period (6 Months)||21
3144469|NCT01760954|3870176|FG003|NOT COMPLETED|Treatment Period (6 Months)||26
3144470|NCT01760954|3870173|FG000|STARTED|Post-treatment Follow-up (12 Months)||126
3144471|NCT01760954|3870174|FG001|STARTED|Post-treatment Follow-up (12 Months)||118
3144472|NCT01760954|3870175|FG002|STARTED|Post-treatment Follow-up (12 Months)||86
3180983|NCT01994837|3909444|FG000|COMPLETED|Overall Study||0
3180984|NCT01994837|3909444|FG000|NOT COMPLETED|Overall Study||32
3180985|NCT01994850|3909448|FG000|STARTED|Overall Study||32
3180986|NCT01994850|3909448|FG000|COMPLETED|Overall Study||30
3180987|NCT01994850|3909448|FG000|NOT COMPLETED|Overall Study||2
3180988|NCT01994863|3909452|FG000|STARTED|Period 1||11
3144473|NCT01760954|3870176|FG003|STARTED|Post-treatment Follow-up (12 Months)||87
3144474|NCT01760954|3870173|FG000|COMPLETED|Post-treatment Follow-up (12 Months)||96
3144475|NCT01760954|3870174|FG001|COMPLETED|Post-treatment Follow-up (12 Months)||83
3144476|NCT01760954|3870175|FG002|COMPLETED|Post-treatment Follow-up (12 Months)||65
3144477|NCT01760954|3870176|FG003|COMPLETED|Post-treatment Follow-up (12 Months)||67
3144478|NCT01760954|3870173|FG000|NOT COMPLETED|Post-treatment Follow-up (12 Months)||30
3144479|NCT01760954|3870174|FG001|NOT COMPLETED|Post-treatment Follow-up (12 Months)||35
3144480|NCT01760954|3870175|FG002|NOT COMPLETED|Post-treatment Follow-up (12 Months)||21
3144481|NCT01760954|3870176|FG003|NOT COMPLETED|Post-treatment Follow-up (12 Months)||20
3144482|NCT01761019|3870186|FG000|STARTED|Overall Study||8
3144483|NCT01761019|3870186|FG000|COMPLETED|Overall Study||8
3144484|NCT01761019|3870186|FG000|NOT COMPLETED|Overall Study||0
3144485|NCT01761084|3870192|FG000|STARTED|Overall Study||71
3144486|NCT01761084|3870193|FG001|STARTED|Overall Study||70
3144487|NCT01761084|3870192|FG000|COMPLETED|Overall Study||66
3144488|NCT01761084|3870193|FG001|COMPLETED|Overall Study||64
3144489|NCT01761084|3870192|FG000|NOT COMPLETED|Overall Study||5
3144490|NCT01761084|3870193|FG001|NOT COMPLETED|Overall Study||6
3144491|NCT01761162|3870200|FG000|STARTED|Overall Study||229
3144492|NCT01761162|3870200|FG000|COMPLETED|Overall Study||226
3144493|NCT01761162|3870200|FG000|NOT COMPLETED|Overall Study||3
3144494|NCT01761175|3870206|FG000|STARTED|Overall Study||112
3144495|NCT01761175|3870207|FG001|STARTED|Overall Study||112
3144496|NCT01761175|3870206|FG000|COMPLETED|Overall Study||112
3144497|NCT01761175|3870207|FG001|COMPLETED|Overall Study||112
3144498|NCT01761175|3870206|FG000|NOT COMPLETED|Overall Study||0
3144499|NCT01761175|3870207|FG001|NOT COMPLETED|Overall Study||0
3144500|NCT01761266|3870216|FG000|STARTED|Overall Study||478
3144501|NCT01761266|3870217|FG001|STARTED|Overall Study||476
3180989|NCT01994863|3909453|FG001|STARTED|Period 1||12
3180990|NCT01994863|3909452|FG000|COMPLETED|Period 1||4
3180991|NCT01994863|3909453|FG001|COMPLETED|Period 1||9
3180992|NCT01994863|3909452|FG000|NOT COMPLETED|Period 1||7
3180993|NCT01994863|3909453|FG001|NOT COMPLETED|Period 1||3
3180994|NCT01994863|3909452|FG000|STARTED|Period 2||8
3180995|NCT01994863|3909453|FG001|STARTED|Period 2||9
3180996|NCT01994863|3909452|FG000|COMPLETED|Period 2||7
3180997|NCT01994863|3909453|FG001|COMPLETED|Period 2||5
3180998|NCT01994863|3909452|FG000|NOT COMPLETED|Period 2||1
3180999|NCT01994863|3909453|FG001|NOT COMPLETED|Period 2||4
3181000|NCT01994876|3909459|FG000|STARTED|Baseline - Own Product||9
3181001|NCT01994876|3909460|FG001|STARTED|Baseline - Own Product||9
3181002|NCT01994876|3909459|FG000|COMPLETED|Baseline - Own Product||9
3181003|NCT01994876|3909460|FG001|COMPLETED|Baseline - Own Product||9
3181004|NCT01994876|3909459|FG000|NOT COMPLETED|Baseline - Own Product||0
3181005|NCT01994876|3909460|FG001|NOT COMPLETED|Baseline - Own Product||0
3181006|NCT01994876|3909459|FG000|STARTED|Test Period 1||9
3181007|NCT01994876|3909460|FG001|STARTED|Test Period 1||9
3181008|NCT01994876|3909459|FG000|COMPLETED|Test Period 1||9
3181009|NCT01994876|3909460|FG001|COMPLETED|Test Period 1||7
3181010|NCT01994876|3909459|FG000|NOT COMPLETED|Test Period 1||0
3181011|NCT01994876|3909460|FG001|NOT COMPLETED|Test Period 1||2
3181012|NCT01994876|3909459|FG000|STARTED|Test Period 2||9
3181013|NCT01994876|3909460|FG001|STARTED|Test Period 2||7
3181014|NCT01994876|3909459|FG000|COMPLETED|Test Period 2||8
3181015|NCT01994876|3909460|FG001|COMPLETED|Test Period 2||6
3181016|NCT01994876|3909459|FG000|NOT COMPLETED|Test Period 2||1
3181017|NCT01994876|3909460|FG001|NOT COMPLETED|Test Period 2||1
3181018|NCT01994889|3909471|FG000|STARTED|Overall Study||88
3181019|NCT01994889|3909472|FG001|STARTED|Overall Study||176
3181020|NCT01994889|3909473|FG002|STARTED|Overall Study||177
3181021|NCT01994889|3909471|FG000|COMPLETED|Overall Study||60
3144502|NCT01761266|3870216|FG000|Treated|Overall Study||476
3144503|NCT01761266|3870217|FG001|Treated|Overall Study||475
3144504|NCT01761266|3870216|FG000|COMPLETED|Overall Study||0
3144505|NCT01761266|3870217|FG001|COMPLETED|Overall Study||0
3144506|NCT01761266|3870216|FG000|NOT COMPLETED|Overall Study||478
3144507|NCT01761266|3870217|FG001|NOT COMPLETED|Overall Study||476
3144508|NCT01761279|3870227|FG000|STARTED|Overall Study||84
3144509|NCT01761279|3870227|FG000|COMPLETED|Overall Study||84
3144510|NCT01761279|3870227|FG000|NOT COMPLETED|Overall Study||0
3144511|NCT01761292|3870235|FG000|STARTED|Part 1||20
3144512|NCT01761292|3870235|FG000|Patients Receiving Drug in Part 1|Part 1|One patient was enrolled in Part 1 and started treatment in Part 2.|19
3144513|NCT01761292|3870235|FG000|COMPLETED|Part 1||18
3144514|NCT01761292|3870235|FG000|NOT COMPLETED|Part 1||2
3144515|NCT01761292|3870235|FG000|STARTED|Part 2|1 pt was enrolled in Part 1 but started the treatment in Part 2. So 19 pts started Part 2.|19
3144516|NCT01761292|3870235|FG000|COMPLETED|Part 2||19
3144517|NCT01761292|3870235|FG000|NOT COMPLETED|Part 2||0
3144518|NCT01761292|3870235|FG000|STARTED|Extension 1||19
3144519|NCT01761292|3870235|FG000|COMPLETED|Extension 1||18
3144520|NCT01761292|3870235|FG000|NOT COMPLETED|Extension 1||1
3144521|NCT01761292|3870235|FG000|STARTED|Extension 2||18
3144522|NCT01761292|3870235|FG000|COMPLETED|Extension 2||18
3144523|NCT01761292|3870235|FG000|NOT COMPLETED|Extension 2||0
3144524|NCT01761292|3870235|FG000|STARTED|Extension 3||18
3144525|NCT01761292|3870235|FG000|COMPLETED|Extension 3||18
3144526|NCT01761292|3870235|FG000|NOT COMPLETED|Extension 3||0
3144527|NCT01761565|3870246|FG000|STARTED|Single Dose of SUF NT 15 mcg||40
3144528|NCT01761565|3870246|FG000|COMPLETED|Single Dose of SUF NT 15 mcg||40
3144529|NCT01761565|3870246|FG000|NOT COMPLETED|Single Dose of SUF NT 15 mcg||0
3144530|NCT01761565|3870246|FG000|STARTED|40 Consecutive Doses of SUF 15 mcg|Subject was withdrawn from the study prior to the second arm/period due to non-compliance|39
3144531|NCT01761565|3870246|FG000|COMPLETED|40 Consecutive Doses of SUF 15 mcg||38
3144532|NCT01761565|3870246|FG000|NOT COMPLETED|40 Consecutive Doses of SUF 15 mcg||1
3144533|NCT01761643|3870256|FG000|STARTED|Overall Study||198
3144534|NCT01761643|3870257|FG001|STARTED|Overall Study||200
3144535|NCT01761643|3870256|FG000|COMPLETED|Overall Study||166
3144536|NCT01761643|3870257|FG001|COMPLETED|Overall Study||158
3144537|NCT01761643|3870256|FG000|NOT COMPLETED|Overall Study||32
3144538|NCT01761643|3870257|FG001|NOT COMPLETED|Overall Study||42
3144539|NCT01761747|3870263|FG000|STARTED|Overall Study||3
3144540|NCT01761747|3870263|FG000|COMPLETED|Overall Study||2
3144541|NCT01761747|3870263|FG000|NOT COMPLETED|Overall Study||1
3144542|NCT01762059|3870267|FG000|STARTED|Overall Study||20
3144543|NCT01762059|3870267|FG000|COMPLETED|Overall Study||20
3144544|NCT01762059|3870267|FG000|NOT COMPLETED|Overall Study||0
3144545|NCT01762345|3870276|FG000|STARTED|Overall Study||83
3144546|NCT01762345|3870276|FG000|COMPLETED|Overall Study||76
3144547|NCT01762345|3870276|FG000|NOT COMPLETED|Overall Study||7
3144548|NCT01762501|3870283|FG000|STARTED|Overall Study||359
3144549|NCT01762501|3870284|FG001|STARTED|Overall Study||359
3144550|NCT01762501|3870283|FG000|COMPLETED|Overall Study||332
3144551|NCT01762501|3870284|FG001|COMPLETED|Overall Study||336
3144552|NCT01762501|3870283|FG000|NOT COMPLETED|Overall Study||27
3144553|NCT01762501|3870284|FG001|NOT COMPLETED|Overall Study||23
3144554|NCT01762631|3870292|FG000|STARTED|Overall Study||53
3144555|NCT01762631|3870293|FG001|STARTED|Overall Study||22
3144556|NCT01762631|3870292|FG000|COMPLETED|Overall Study||53
3144557|NCT01762631|3870293|FG001|COMPLETED|Overall Study||22
3144558|NCT01762631|3870292|FG000|NOT COMPLETED|Overall Study||0
3144559|NCT01762631|3870293|FG001|NOT COMPLETED|Overall Study||0
3144560|NCT01762722|3870301|FG000|STARTED|Overall Study||12
3144561|NCT01762722|3870302|FG001|STARTED|Overall Study||11
3144562|NCT01762722|3870301|FG000|COMPLETED|Overall Study||12
3144563|NCT01762722|3870302|FG001|COMPLETED|Overall Study||11
3144564|NCT01762722|3870301|FG000|NOT COMPLETED|Overall Study||0
3144565|NCT01762722|3870302|FG001|NOT COMPLETED|Overall Study||0
3144566|NCT01762800|3870310|FG000|STARTED|Overall Study||202
3144567|NCT01762800|3870311|FG001|STARTED|Overall Study||204
3144568|NCT01762800|3870310|FG000|COMPLETED|Overall Study||183
3144569|NCT01762800|3870311|FG001|COMPLETED|Overall Study||183
3144570|NCT01762800|3870310|FG000|NOT COMPLETED|Overall Study||19
3144571|NCT01762800|3870311|FG001|NOT COMPLETED|Overall Study||21
3144572|NCT01762904|3870323|FG000|STARTED|Overall Study|January, 2013|135
3144573|NCT01762904|3870323|FG000|COMPLETED|Overall Study|October, 2013|135
3144574|NCT01762904|3870323|FG000|NOT COMPLETED|Overall Study||0
3144575|NCT01762943|3870332|FG000|STARTED|Overall Study||19
3144576|NCT01762943|3870333|FG001|STARTED|Overall Study||17
3144577|NCT01762943|3870332|FG000|Hypogonadism|Overall Study||18
3144578|NCT01762943|3870333|FG001|Hypogonadism|Overall Study||15
3144579|NCT01762943|3870332|FG000|Addback|Overall Study||16
3144580|NCT01762943|3870333|FG001|Addback|Overall Study||15
3144581|NCT01762943|3870332|FG000|Withdrawal|Overall Study||15
3144582|NCT01762943|3870333|FG001|Withdrawal|Overall Study||15
3144583|NCT01762943|3870332|FG000|COMPLETED|Overall Study||15
3144584|NCT01762943|3870333|FG001|COMPLETED|Overall Study||15
3144585|NCT01762943|3870332|FG000|NOT COMPLETED|Overall Study||4
3144586|NCT01762943|3870333|FG001|NOT COMPLETED|Overall Study||2
3144587|NCT01762982|3870339|FG000|STARTED|Overall Study||36
3144588|NCT01762982|3870339|FG000|Received Saline Water|Overall Study||36
3144589|NCT01762982|3870339|FG000|Received Benzalkonium Chloride|Overall Study||36
3144590|NCT01762982|3870339|FG000|Received SLS|Overall Study||36
3144591|NCT01762982|3870339|FG000|Received Empty Finn Chamber|Overall Study||36
3144592|NCT01762982|3870339|FG000|COMPLETED|Overall Study||36
3144593|NCT01762982|3870339|FG000|NOT COMPLETED|Overall Study||0
3144594|NCT01763047|3870349|FG000|STARTED|Period 1||139
3144595|NCT01763047|3870350|FG001|STARTED|Period 1||137
3144596|NCT01763047|3870349|FG000|Myopes|Period 1||77
3144597|NCT01763047|3870350|FG001|Myopes|Period 1||76
3144598|NCT01763047|3870349|FG000|Hyperopes|Period 1||62
3144599|NCT01763047|3870350|FG001|Hyperopes|Period 1||61
3144600|NCT01763047|3870349|FG000|COMPLETED|Period 1||130
3144601|NCT01763047|3870350|FG001|COMPLETED|Period 1||126
3144602|NCT01763047|3870349|FG000|NOT COMPLETED|Period 1||9
3144603|NCT01763047|3870350|FG001|NOT COMPLETED|Period 1||11
3144604|NCT01763047|3870349|FG000|STARTED|Period 2||130
3144605|NCT01763047|3870350|FG001|STARTED|Period 2||126
3144606|NCT01763047|3870349|FG000|Myopes|Period 2||74
3144607|NCT01763047|3870350|FG001|Myopes|Period 2||72
3144608|NCT01763047|3870349|FG000|Hyperopes|Period 2||56
3144609|NCT01763047|3870350|FG001|Hyperopes|Period 2||54
3144610|NCT01763047|3870349|FG000|COMPLETED|Period 2||126
3144611|NCT01763047|3870350|FG001|COMPLETED|Period 2||121
3144612|NCT01763047|3870349|FG000|NOT COMPLETED|Period 2||4
3144613|NCT01763047|3870350|FG001|NOT COMPLETED|Period 2||5
3144614|NCT01763164|3870361|FG000|STARTED|Treatment Phase||269
3144615|NCT01763164|3870362|FG001|STARTED|Treatment Phase||133
3144616|NCT01763164|3870361|FG000|Treated/Safety Set|Treatment Phase||269
3144617|NCT01763164|3870362|FG001|Treated/Safety Set|Treatment Phase||114
3144618|NCT01763164|3870361|FG000|Full Analysis Set|Treatment Phase||269
3144619|NCT01763164|3870362|FG001|Full Analysis Set|Treatment Phase||133
3144620|NCT01763164|3870361|FG000|COMPLETED|Treatment Phase||0
3144621|NCT01763164|3870362|FG001|COMPLETED|Treatment Phase||0
3144622|NCT01763164|3870361|FG000|NOT COMPLETED|Treatment Phase||269
3144623|NCT01763164|3870362|FG001|NOT COMPLETED|Treatment Phase||133
3144624|NCT01763164|3870361|FG000|STARTED|Follow up Phase|Participants were followed up after completion or discontinuation of treatment.|200
3144625|NCT01763164|3870362|FG001|STARTED|Follow up Phase|Participants were followed up after completion or discontinuation of treatment.|78
3144626|NCT01763164|3870361|FG000|COMPLETED|Follow up Phase||3
3144627|NCT01763164|3870362|FG001|COMPLETED|Follow up Phase||3
3144628|NCT01763164|3870361|FG000|NOT COMPLETED|Follow up Phase||197
3144629|NCT01763164|3870362|FG001|NOT COMPLETED|Follow up Phase||75
3144630|NCT01763203|3870370|FG000|STARTED|Overall Study||241
3144631|NCT01763203|3870371|FG001|STARTED|Overall Study||246
3144632|NCT01763203|3870370|FG000|COMPLETED|Overall Study||208
3144633|NCT01763203|3870371|FG001|COMPLETED|Overall Study||204
3144634|NCT01763203|3870370|FG000|NOT COMPLETED|Overall Study||33
3144635|NCT01763203|3870371|FG001|NOT COMPLETED|Overall Study||42
3144636|NCT01763333|3870391|FG000|STARTED|Overall Study||6
3144637|NCT01763333|3870392|FG001|STARTED|Overall Study||6
3144638|NCT01763333|3870393|FG002|STARTED|Overall Study||6
3144639|NCT01763333|3870394|FG003|STARTED|Overall Study||6
3144640|NCT01763333|3870395|FG004|STARTED|Overall Study||4
3144641|NCT01763333|3870396|FG005|STARTED|Overall Study||6
3144642|NCT01763333|3870397|FG006|STARTED|Overall Study||5
3144643|NCT01763333|3870398|FG007|STARTED|Overall Study||6
3181022|NCT01994889|3909472|FG001|COMPLETED|Overall Study||113
3181023|NCT01994889|3909473|FG002|COMPLETED|Overall Study||85
3181024|NCT01994889|3909471|FG000|NOT COMPLETED|Overall Study||28
3181025|NCT01994889|3909472|FG001|NOT COMPLETED|Overall Study||63
3144644|NCT01763333|3870399|FG008|STARTED|Overall Study||5
3144645|NCT01763333|3870400|FG009|STARTED|Overall Study||18
3144646|NCT01763333|3870401|FG010|STARTED|Overall Study||3
3144647|NCT01763333|3870402|FG011|STARTED|Overall Study||3
3144648|NCT01763333|3870403|FG012|STARTED|Overall Study||3
3144649|NCT01763333|3870404|FG013|STARTED|Overall Study||3
3144650|NCT01763333|3870391|FG000|COMPLETED|Overall Study||6
3144651|NCT01763333|3870392|FG001|COMPLETED|Overall Study||6
3144652|NCT01763333|3870393|FG002|COMPLETED|Overall Study||6
3144653|NCT01763333|3870394|FG003|COMPLETED|Overall Study||6
3144654|NCT01763333|3870395|FG004|COMPLETED|Overall Study||4
3144655|NCT01763333|3870396|FG005|COMPLETED|Overall Study||6
3144656|NCT01763333|3870397|FG006|COMPLETED|Overall Study||5
3144657|NCT01763333|3870398|FG007|COMPLETED|Overall Study||6
3144658|NCT01763333|3870399|FG008|COMPLETED|Overall Study||5
3144659|NCT01763333|3870400|FG009|COMPLETED|Overall Study||18
3144660|NCT01763333|3870401|FG010|COMPLETED|Overall Study||3
3144661|NCT01763333|3870402|FG011|COMPLETED|Overall Study||3
3144662|NCT01763333|3870403|FG012|COMPLETED|Overall Study||3
3144663|NCT01763333|3870404|FG013|COMPLETED|Overall Study||3
3144664|NCT01763333|3870391|FG000|NOT COMPLETED|Overall Study||0
3144665|NCT01763333|3870392|FG001|NOT COMPLETED|Overall Study||0
3144666|NCT01763333|3870393|FG002|NOT COMPLETED|Overall Study||0
3144667|NCT01763333|3870394|FG003|NOT COMPLETED|Overall Study||0
3144668|NCT01763333|3870395|FG004|NOT COMPLETED|Overall Study||0
3144669|NCT01763333|3870396|FG005|NOT COMPLETED|Overall Study||0
3144670|NCT01763333|3870397|FG006|NOT COMPLETED|Overall Study||0
3144671|NCT01763333|3870398|FG007|NOT COMPLETED|Overall Study||0
3144672|NCT01763333|3870399|FG008|NOT COMPLETED|Overall Study||0
3144673|NCT01763333|3870400|FG009|NOT COMPLETED|Overall Study||0
3181026|NCT01994889|3909473|FG002|NOT COMPLETED|Overall Study||92
3181027|NCT01994902|3909480|FG000|STARTED|Test Period 1||63
3181028|NCT01994902|3909481|FG001|STARTED|Test Period 1|Randomisation mistake:a subject randomised to SenSura Convex Light but tested Coloplast test product|64
3144674|NCT01763333|3870401|FG010|NOT COMPLETED|Overall Study||0
3144675|NCT01763333|3870402|FG011|NOT COMPLETED|Overall Study||0
3144676|NCT01763333|3870403|FG012|NOT COMPLETED|Overall Study||0
3144677|NCT01763333|3870404|FG013|NOT COMPLETED|Overall Study||0
3144678|NCT01763346|3870440|FG000|STARTED|Overall Study|"Five subjects who enrolled in the study refused to initiate metformin therapy, thus did not start"|44
3144679|NCT01763346|3870441|FG001|STARTED|Overall Study|"Six subjects randomized to gastric banding refused the banding surgery and, thus, did not start"|44
3144680|NCT01763346|3870440|FG000|Received Intervention|Overall Study||39
3144681|NCT01763346|3870441|FG001|Received Intervention|Overall Study||38
3144682|NCT01763346|3870440|FG000|COMPLETED|Overall Study||34
3144683|NCT01763346|3870441|FG001|COMPLETED|Overall Study||36
3144684|NCT01763346|3870440|FG000|NOT COMPLETED|Overall Study||10
3144685|NCT01763346|3870441|FG001|NOT COMPLETED|Overall Study||8
3144686|NCT01763567|3870447|FG000|STARTED|Overall Study||19
3144687|NCT01763567|3870447|FG000|COMPLETED|Overall Study||19
3144688|NCT01763567|3870447|FG000|NOT COMPLETED|Overall Study||0
3144689|NCT01763606|3870453|FG000|STARTED|Overall Study||10
3144690|NCT01763606|3870454|FG001|STARTED|Overall Study||10
3144691|NCT01763606|3870453|FG000|COMPLETED|Overall Study||10
3144692|NCT01763606|3870454|FG001|COMPLETED|Overall Study||10
3144693|NCT01763606|3870453|FG000|NOT COMPLETED|Overall Study||0
3144694|NCT01763606|3870454|FG001|NOT COMPLETED|Overall Study||0
3144695|NCT01763645|3870463|FG000|STARTED|Overall Study||69
3144696|NCT01763645|3870464|FG001|STARTED|Overall Study||69
3144697|NCT01763645|3870463|FG000|Received at Least 1 Dose of Study Drug|Overall Study||68
3144698|NCT01763645|3870464|FG001|Received at Least 1 Dose of Study Drug|Overall Study||66
3144699|NCT01763645|3870463|FG000|COMPLETED|Overall Study|Completed the study according the protocol.|43
3144700|NCT01763645|3870464|FG001|COMPLETED|Overall Study|Completed the study according the protocol.|45
3144701|NCT01763645|3870463|FG000|NOT COMPLETED|Overall Study||26
3144702|NCT01763645|3870464|FG001|NOT COMPLETED|Overall Study||24
3144703|NCT01763684|3870473|FG000|STARTED|Overall Study||133
3144704|NCT01763684|3870474|FG001|STARTED|Overall Study||133
3144705|NCT01763684|3870473|FG000|Completed Surgery|Overall Study||126
3144706|NCT01763684|3870474|FG001|Completed Surgery|Overall Study||127
3144707|NCT01763684|3870473|FG000|COMPLETED|Overall Study||0
3144708|NCT01763684|3870474|FG001|COMPLETED|Overall Study||0
3144709|NCT01763684|3870473|FG000|NOT COMPLETED|Overall Study||133
3144710|NCT01763684|3870474|FG001|NOT COMPLETED|Overall Study||133
3144711|NCT01763827|3870486|FG000|STARTED|Overall Study||77
3144712|NCT01763827|3870487|FG001|STARTED|Overall Study||78
3144713|NCT01763827|3870488|FG002|STARTED|Overall Study||77
3144714|NCT01763827|3870489|FG003|STARTED|Overall Study||77
3144715|NCT01763827|3870490|FG004|STARTED|Overall Study||153
3144716|NCT01763827|3870491|FG005|STARTED|Overall Study||153
3144717|NCT01763827|3870486|FG000|Received at Least 1 Dose of Study Drug|Overall Study||76
3144718|NCT01763827|3870487|FG001|Received at Least 1 Dose of Study Drug|Overall Study||78
3144719|NCT01763827|3870488|FG002|Received at Least 1 Dose of Study Drug|Overall Study||77
3144720|NCT01763827|3870489|FG003|Received at Least 1 Dose of Study Drug|Overall Study||77
3144721|NCT01763827|3870490|FG004|Received at Least 1 Dose of Study Drug|Overall Study||153
3144722|NCT01763827|3870491|FG005|Received at Least 1 Dose of Study Drug|Overall Study||153
3144723|NCT01763827|3870486|FG000|COMPLETED|Overall Study||74
3144724|NCT01763827|3870487|FG001|COMPLETED|Overall Study||77
3144725|NCT01763827|3870488|FG002|COMPLETED|Overall Study||73
3144726|NCT01763827|3870489|FG003|COMPLETED|Overall Study||76
3144727|NCT01763827|3870490|FG004|COMPLETED|Overall Study||147
3144728|NCT01763827|3870491|FG005|COMPLETED|Overall Study||151
3144729|NCT01763827|3870486|FG000|NOT COMPLETED|Overall Study||3
3144730|NCT01763827|3870487|FG001|NOT COMPLETED|Overall Study||1
3144731|NCT01763827|3870488|FG002|NOT COMPLETED|Overall Study||4
3144732|NCT01763827|3870489|FG003|NOT COMPLETED|Overall Study||1
3144733|NCT01763827|3870490|FG004|NOT COMPLETED|Overall Study||6
3144734|NCT01763827|3870491|FG005|NOT COMPLETED|Overall Study||2
3144735|NCT01763866|3870529|FG000|STARTED|Overall Study||56
3144736|NCT01763866|3870530|FG001|STARTED|Overall Study||55
3144737|NCT01763866|3870531|FG002|STARTED|Overall Study||56
3144738|NCT01763866|3870532|FG003|STARTED|Overall Study||55
3144739|NCT01763866|3870533|FG004|STARTED|Overall Study||110
3144740|NCT01763866|3870534|FG005|STARTED|Overall Study||110
3144741|NCT01763866|3870535|FG006|STARTED|Overall Study||55
3144742|NCT01763866|3870536|FG007|STARTED|Overall Study||55
3144743|NCT01763866|3870537|FG008|STARTED|Overall Study||56
3144744|NCT01763866|3870538|FG009|STARTED|Overall Study||54
3144745|NCT01763866|3870539|FG010|STARTED|Overall Study||110
3144746|NCT01763866|3870540|FG011|STARTED|Overall Study||110
3144747|NCT01763866|3870541|FG012|STARTED|Overall Study||58
3144748|NCT01763866|3870542|FG013|STARTED|Overall Study||57
3144749|NCT01763866|3870543|FG014|STARTED|Overall Study||114
3144750|NCT01763866|3870544|FG015|STARTED|Overall Study||115
3144751|NCT01763866|3870545|FG016|STARTED|Overall Study||56
3144752|NCT01763866|3870546|FG017|STARTED|Overall Study||56
3144753|NCT01763866|3870547|FG018|STARTED|Overall Study||111
3144754|NCT01763866|3870548|FG019|STARTED|Overall Study||112
3144755|NCT01763866|3870549|FG020|STARTED|Overall Study||56
3144756|NCT01763866|3870550|FG021|STARTED|Overall Study||55
3144757|NCT01763866|3870551|FG022|STARTED|Overall Study||112
3144758|NCT01763866|3870552|FG023|STARTED|Overall Study||115
3144759|NCT01763866|3870529|FG000|Received Treatment|Overall Study||56
3144760|NCT01763866|3870530|FG001|Received Treatment|Overall Study||55
3144761|NCT01763866|3870531|FG002|Received Treatment|Overall Study||56
3144762|NCT01763866|3870532|FG003|Received Treatment|Overall Study||55
3144763|NCT01763866|3870533|FG004|Received Treatment|Overall Study||110
3144764|NCT01763866|3870534|FG005|Received Treatment|Overall Study||110
3144765|NCT01763866|3870535|FG006|Received Treatment|Overall Study||55
3144766|NCT01763866|3870536|FG007|Received Treatment|Overall Study||55
3144767|NCT01763866|3870537|FG008|Received Treatment|Overall Study||56
3144768|NCT01763866|3870538|FG009|Received Treatment|Overall Study||54
3144769|NCT01763866|3870539|FG010|Received Treatment|Overall Study||109
3144770|NCT01763866|3870540|FG011|Received Treatment|Overall Study||110
3144771|NCT01763866|3870541|FG012|Received Treatment|Overall Study||58
3144772|NCT01763866|3870542|FG013|Received Treatment|Overall Study||57
3144773|NCT01763866|3870543|FG014|Received Treatment|Overall Study||113
3144774|NCT01763866|3870544|FG015|Received Treatment|Overall Study||115
3144775|NCT01763866|3870545|FG016|Received Treatment|Overall Study||56
3144776|NCT01763866|3870546|FG017|Received Treatment|Overall Study||55
3144777|NCT01763866|3870547|FG018|Received Treatment|Overall Study||111
3144778|NCT01763866|3870548|FG019|Received Treatment|Overall Study||112
3144779|NCT01763866|3870549|FG020|Received Treatment|Overall Study||56
3144780|NCT01763866|3870550|FG021|Received Treatment|Overall Study||55
3144781|NCT01763866|3870551|FG022|Received Treatment|Overall Study||112
3144782|NCT01763866|3870552|FG023|Received Treatment|Overall Study||115
3144783|NCT01763866|3870529|FG000|COMPLETED|Overall Study||54
3144784|NCT01763866|3870530|FG001|COMPLETED|Overall Study||54
3144785|NCT01763866|3870531|FG002|COMPLETED|Overall Study||51
3144786|NCT01763866|3870532|FG003|COMPLETED|Overall Study||55
3144787|NCT01763866|3870533|FG004|COMPLETED|Overall Study||108
3144788|NCT01763866|3870534|FG005|COMPLETED|Overall Study||107
3144789|NCT01763866|3870535|FG006|COMPLETED|Overall Study||48
3144790|NCT01763866|3870536|FG007|COMPLETED|Overall Study||55
3144791|NCT01763866|3870537|FG008|COMPLETED|Overall Study||53
3144792|NCT01763866|3870538|FG009|COMPLETED|Overall Study||53
3144793|NCT01763866|3870539|FG010|COMPLETED|Overall Study||102
3144794|NCT01763866|3870540|FG011|COMPLETED|Overall Study||108
3144795|NCT01763866|3870541|FG012|COMPLETED|Overall Study||54
3144796|NCT01763866|3870542|FG013|COMPLETED|Overall Study||57
3144797|NCT01763866|3870543|FG014|COMPLETED|Overall Study||102
3144798|NCT01763866|3870544|FG015|COMPLETED|Overall Study||112
3144799|NCT01763866|3870545|FG016|COMPLETED|Overall Study||55
3144800|NCT01763866|3870546|FG017|COMPLETED|Overall Study||55
3144801|NCT01763866|3870547|FG018|COMPLETED|Overall Study||105
3144802|NCT01763866|3870548|FG019|COMPLETED|Overall Study||110
3144803|NCT01763866|3870549|FG020|COMPLETED|Overall Study||52
3144804|NCT01763866|3870550|FG021|COMPLETED|Overall Study||54
3144805|NCT01763866|3870551|FG022|COMPLETED|Overall Study||109
3144806|NCT01763866|3870552|FG023|COMPLETED|Overall Study||113
3144807|NCT01763866|3870529|FG000|NOT COMPLETED|Overall Study||2
3144808|NCT01763866|3870530|FG001|NOT COMPLETED|Overall Study||1
3144809|NCT01763866|3870531|FG002|NOT COMPLETED|Overall Study||5
3144810|NCT01763866|3870532|FG003|NOT COMPLETED|Overall Study||0
3144811|NCT01763866|3870533|FG004|NOT COMPLETED|Overall Study||2
3144812|NCT01763866|3870534|FG005|NOT COMPLETED|Overall Study||3
3144813|NCT01763866|3870535|FG006|NOT COMPLETED|Overall Study||7
3144814|NCT01763866|3870536|FG007|NOT COMPLETED|Overall Study||0
3144815|NCT01763866|3870537|FG008|NOT COMPLETED|Overall Study||3
3144816|NCT01763866|3870538|FG009|NOT COMPLETED|Overall Study||1
3144817|NCT01763866|3870539|FG010|NOT COMPLETED|Overall Study||8
3144818|NCT01763866|3870540|FG011|NOT COMPLETED|Overall Study||2
3181029|NCT01994902|3909480|FG000|COMPLETED|Test Period 1||57
3363558|NCT04055519|4094688|FG000|COMPLETED|First Wear Period (30 Days)||16
3144819|NCT01763866|3870541|FG012|NOT COMPLETED|Overall Study||4
3144820|NCT01763866|3870542|FG013|NOT COMPLETED|Overall Study||0
3144821|NCT01763866|3870543|FG014|NOT COMPLETED|Overall Study||12
3144822|NCT01763866|3870544|FG015|NOT COMPLETED|Overall Study||3
3144823|NCT01763866|3870545|FG016|NOT COMPLETED|Overall Study||1
3144824|NCT01763866|3870546|FG017|NOT COMPLETED|Overall Study||1
3144825|NCT01763866|3870547|FG018|NOT COMPLETED|Overall Study||6
3144826|NCT01763866|3870548|FG019|NOT COMPLETED|Overall Study||2
3144827|NCT01763866|3870549|FG020|NOT COMPLETED|Overall Study||4
3144828|NCT01763866|3870550|FG021|NOT COMPLETED|Overall Study||1
3144829|NCT01763866|3870551|FG022|NOT COMPLETED|Overall Study||3
3144830|NCT01763866|3870552|FG023|NOT COMPLETED|Overall Study||2
3144831|NCT01763905|3870606|FG000|STARTED|Overall Study||51
3144832|NCT01763905|3870607|FG001|STARTED|Overall Study||51
3144833|NCT01763905|3870608|FG002|STARTED|Overall Study||103
3144834|NCT01763905|3870609|FG003|STARTED|Overall Study||102
3144835|NCT01763905|3870606|FG000|COMPLETED|Overall Study||45
3144836|NCT01763905|3870607|FG001|COMPLETED|Overall Study||50
3144837|NCT01763905|3870608|FG002|COMPLETED|Overall Study||94
3144838|NCT01763905|3870609|FG003|COMPLETED|Overall Study||101
3144839|NCT01763905|3870606|FG000|NOT COMPLETED|Overall Study||6
3144840|NCT01763905|3870607|FG001|NOT COMPLETED|Overall Study||1
3144841|NCT01763905|3870608|FG002|NOT COMPLETED|Overall Study||9
3144842|NCT01763905|3870609|FG003|NOT COMPLETED|Overall Study||1
3144843|NCT01763918|3870623|FG000|STARTED|Overall Study||55
3144844|NCT01763918|3870624|FG001|STARTED|Overall Study||55
3144845|NCT01763918|3870625|FG002|STARTED|Overall Study||111
3144846|NCT01763918|3870626|FG003|STARTED|Overall Study||110
3144847|NCT01763918|3870623|FG000|Received Treatment|Overall Study||54
3144848|NCT01763918|3870624|FG001|Received Treatment|Overall Study||55
3144849|NCT01763918|3870625|FG002|Received Treatment|Overall Study||110
3144850|NCT01763918|3870626|FG003|Received Treatment|Overall Study||110
3144851|NCT01763918|3870623|FG000|COMPLETED|Overall Study||49
3144852|NCT01763918|3870624|FG001|COMPLETED|Overall Study||54
3144853|NCT01763918|3870625|FG002|COMPLETED|Overall Study||101
3144854|NCT01763918|3870626|FG003|COMPLETED|Overall Study||108
3144855|NCT01763918|3870623|FG000|NOT COMPLETED|Overall Study||6
3144856|NCT01763918|3870624|FG001|NOT COMPLETED|Overall Study||1
3144857|NCT01763918|3870625|FG002|NOT COMPLETED|Overall Study||10
3144858|NCT01763918|3870626|FG003|NOT COMPLETED|Overall Study||2
3144859|NCT01763931|3870638|FG000|STARTED|Overall Study||2
3144860|NCT01763931|3870639|FG001|STARTED|Overall Study||4
3144861|NCT01763931|3870638|FG000|COMPLETED|Overall Study||2
3144862|NCT01763931|3870639|FG001|COMPLETED|Overall Study||3
3144863|NCT01763931|3870638|FG000|NOT COMPLETED|Overall Study||0
3144864|NCT01763931|3870639|FG001|NOT COMPLETED|Overall Study||1
3144865|NCT01763970|3870645|FG000|STARTED|Overall Study||14
3144866|NCT01763970|3870645|FG000|COMPLETED|Overall Study||14
3144867|NCT01763970|3870645|FG000|NOT COMPLETED|Overall Study||0
3144868|NCT01763996|3870652|FG000|STARTED|Treatment Period 1||15
3144869|NCT01763996|3870653|FG001|STARTED|Treatment Period 1||15
3144870|NCT01763996|3870652|FG000|COMPLETED|Treatment Period 1||15
3144871|NCT01763996|3870653|FG001|COMPLETED|Treatment Period 1||15
3144872|NCT01763996|3870652|FG000|NOT COMPLETED|Treatment Period 1||0
3144873|NCT01763996|3870653|FG001|NOT COMPLETED|Treatment Period 1||0
3144874|NCT01763996|3870652|FG000|STARTED|Treatment Period 2||15
3144875|NCT01763996|3870653|FG001|STARTED|Treatment Period 2||15
3144876|NCT01763996|3870652|FG000|COMPLETED|Treatment Period 2||15
3144877|NCT01763996|3870653|FG001|COMPLETED|Treatment Period 2||14
3144878|NCT01763996|3870652|FG000|NOT COMPLETED|Treatment Period 2||0
3144879|NCT01763996|3870653|FG001|NOT COMPLETED|Treatment Period 2||1
3144880|NCT01764022|3870661|FG000|STARTED|Overall Study||115
3144881|NCT01764022|3870662|FG001|STARTED|Overall Study||110
3144882|NCT01764022|3870661|FG000|Received at Least 1 Dose of Study Drug|Overall Study||113
3144883|NCT01764022|3870662|FG001|Received at Least 1 Dose of Study Drug|Overall Study||110
3144884|NCT01764022|3870661|FG000|COMPLETED|Overall Study||107
3144885|NCT01764022|3870662|FG001|COMPLETED|Overall Study||96
3144886|NCT01764022|3870661|FG000|NOT COMPLETED|Overall Study||8
3144887|NCT01764022|3870662|FG001|NOT COMPLETED|Overall Study||14
3144888|NCT01764256|3870674|FG000|STARTED|Received All Vaccinations||12
3144889|NCT01764256|3870675|FG001|STARTED|Received All Vaccinations||12
3144890|NCT01764256|3870676|FG002|STARTED|Received All Vaccinations||12
3144891|NCT01764256|3870677|FG003|STARTED|Received All Vaccinations||12
3144892|NCT01764256|3870674|FG000|COMPLETED|Received All Vaccinations||10
3144893|NCT01764256|3870675|FG001|COMPLETED|Received All Vaccinations||11
3144894|NCT01764256|3870676|FG002|COMPLETED|Received All Vaccinations||11
3144895|NCT01764256|3870677|FG003|COMPLETED|Received All Vaccinations||12
3144896|NCT01764256|3870674|FG000|NOT COMPLETED|Received All Vaccinations||2
3144897|NCT01764256|3870675|FG001|NOT COMPLETED|Received All Vaccinations||1
3144898|NCT01764256|3870676|FG002|NOT COMPLETED|Received All Vaccinations||1
3144899|NCT01764256|3870677|FG003|NOT COMPLETED|Received All Vaccinations||0
3144900|NCT01764256|3870674|FG000|STARTED|Completed Study||10
3144901|NCT01764256|3870675|FG001|STARTED|Completed Study||11
3144902|NCT01764256|3870676|FG002|STARTED|Completed Study||11
3144903|NCT01764256|3870677|FG003|STARTED|Completed Study||12
3144904|NCT01764256|3870674|FG000|COMPLETED|Completed Study||10
3144905|NCT01764256|3870675|FG001|COMPLETED|Completed Study||11
3144906|NCT01764256|3870676|FG002|COMPLETED|Completed Study||11
3144907|NCT01764256|3870677|FG003|COMPLETED|Completed Study||11
3144908|NCT01764256|3870674|FG000|NOT COMPLETED|Completed Study||0
3144909|NCT01764256|3870675|FG001|NOT COMPLETED|Completed Study||0
3144910|NCT01764256|3870676|FG002|NOT COMPLETED|Completed Study||0
3144911|NCT01764256|3870677|FG003|NOT COMPLETED|Completed Study||1
3144912|NCT01764386|3870693|FG000|STARTED|Controlled Treatment Period (CTP)||153
3144913|NCT01764386|3870694|FG001|STARTED|Controlled Treatment Period (CTP)||89
3144914|NCT01764386|3870693|FG000|COMPLETED|Controlled Treatment Period (CTP)|Completed the 26-week Controlled Treatment Period.|71
3144915|NCT01764386|3870694|FG001|COMPLETED|Controlled Treatment Period (CTP)|Completed the 26-week Controlled Treatment Period.|82
3144916|NCT01764386|3870693|FG000|NOT COMPLETED|Controlled Treatment Period (CTP)||82
3144917|NCT01764386|3870694|FG001|NOT COMPLETED|Controlled Treatment Period (CTP)||7
3144918|NCT01764386|3870693|FG000|STARTED|Uncontrolled Treatment Period (UTP)||71
3144919|NCT01764386|3870694|FG001|STARTED|Uncontrolled Treatment Period (UTP)|One subject completed the 26-week CTP, but did not continue in the UTP.|81
3144920|NCT01764386|3870693|FG000|Completed 52 Weeks|Uncontrolled Treatment Period (UTP)||61
3144921|NCT01764386|3870694|FG001|Completed 52 Weeks|Uncontrolled Treatment Period (UTP)||35
3144922|NCT01764386|3870693|FG000|COMPLETED|Uncontrolled Treatment Period (UTP)|Completed the 78-week study.|55
3144923|NCT01764386|3870694|FG001|COMPLETED|Uncontrolled Treatment Period (UTP)|Completed the 78-week study.|28
3144924|NCT01764386|3870693|FG000|NOT COMPLETED|Uncontrolled Treatment Period (UTP)||16
3144925|NCT01764386|3870694|FG001|NOT COMPLETED|Uncontrolled Treatment Period (UTP)||53
3144926|NCT01764464|3870703|FG000|STARTED|First Intervention|Started Gralise|16
3144927|NCT01764464|3870704|FG001|STARTED|First Intervention|Started Placebo|16
3144928|NCT01764464|3870703|FG000|COMPLETED|First Intervention|Completed Gralise|14
3144929|NCT01764464|3870704|FG001|COMPLETED|First Intervention|Completed Placebo|13
3144930|NCT01764464|3870703|FG000|NOT COMPLETED|First Intervention||2
3144931|NCT01764464|3870704|FG001|NOT COMPLETED|First Intervention||3
3144932|NCT01764464|3870703|FG000|STARTED|Second Intervention (Cross-over)|Started Placebo|14
3144933|NCT01764464|3870704|FG001|STARTED|Second Intervention (Cross-over)|Started Gralise|13
3144934|NCT01764464|3870703|FG000|COMPLETED|Second Intervention (Cross-over)|Completed Placebo|12
3144935|NCT01764464|3870704|FG001|COMPLETED|Second Intervention (Cross-over)|Completed Gralise|13
3144936|NCT01764464|3870703|FG000|NOT COMPLETED|Second Intervention (Cross-over)||2
3144937|NCT01764464|3870704|FG001|NOT COMPLETED|Second Intervention (Cross-over)||0
3144938|NCT01764607|3870710|FG000|STARTED|Overall Study||1
3144939|NCT01764607|3870710|FG000|COMPLETED|Overall Study||1
3144940|NCT01764607|3870710|FG000|NOT COMPLETED|Overall Study||0
3181030|NCT01994902|3909481|FG001|COMPLETED|Test Period 1|The subject testing Coloplast test product discontinued due to device deficiency with adverse event|61
3181031|NCT01994902|3909480|FG000|NOT COMPLETED|Test Period 1||6
3181032|NCT01994902|3909481|FG001|NOT COMPLETED|Test Period 1||3
3181033|NCT01994902|3909480|FG000|STARTED|Test Period 2||57
3181034|NCT01994902|3909481|FG001|STARTED|Test Period 2||61
3181035|NCT01994902|3909480|FG000|COMPLETED|Test Period 2||57
3181036|NCT01994902|3909481|FG001|COMPLETED|Test Period 2||55
3181037|NCT01994902|3909480|FG000|NOT COMPLETED|Test Period 2||0
3181038|NCT01994902|3909481|FG001|NOT COMPLETED|Test Period 2||6
3181039|NCT01994954|3909489|FG000|STARTED|Overall Study||99
3181040|NCT01994954|3909490|FG001|STARTED|Overall Study||97
3181041|NCT01994954|3909489|FG000|COMPLETED|Overall Study||74
3181042|NCT01994954|3909490|FG001|COMPLETED|Overall Study||67
3181043|NCT01994954|3909489|FG000|NOT COMPLETED|Overall Study||25
3181044|NCT01994954|3909490|FG001|NOT COMPLETED|Overall Study||30
3181045|NCT01994993|3909507|FG000|STARTED|Overall Study||63
3181046|NCT01994993|3909508|FG001|STARTED|Overall Study||47
3181047|NCT01994993|3909509|FG002|STARTED|Overall Study||70
3181048|NCT01994993|3909510|FG003|STARTED|Overall Study||55
3181049|NCT01994993|3909511|FG004|STARTED|Overall Study||24
3181050|NCT01994993|3909507|FG000|COMPLETED|Overall Study||28
3181051|NCT01994993|3909508|FG001|COMPLETED|Overall Study||12
3181052|NCT01994993|3909509|FG002|COMPLETED|Overall Study||23
3181053|NCT01994993|3909510|FG003|COMPLETED|Overall Study||9
3181054|NCT01994993|3909511|FG004|COMPLETED|Overall Study||22
3181055|NCT01994993|3909507|FG000|NOT COMPLETED|Overall Study||35
3181056|NCT01994993|3909508|FG001|NOT COMPLETED|Overall Study||35
3181057|NCT01994993|3909509|FG002|NOT COMPLETED|Overall Study||47
3181058|NCT01994993|3909510|FG003|NOT COMPLETED|Overall Study||46
3181059|NCT01994993|3909511|FG004|NOT COMPLETED|Overall Study||2
3181060|NCT01995045|3909525|FG000|STARTED|Overall Study||29
3181061|NCT01995045|3909526|FG001|STARTED|Overall Study||28
3181062|NCT01995045|3909525|FG000|COMPLETED|Overall Study||29
3181063|NCT01995045|3909526|FG001|COMPLETED|Overall Study||28
3181064|NCT01995045|3909525|FG000|NOT COMPLETED|Overall Study||0
3181065|NCT01995045|3909526|FG001|NOT COMPLETED|Overall Study||0
3181066|NCT01995071|3909544|FG000|STARTED|Overall Study||8
3181067|NCT01995071|3909545|FG001|STARTED|Overall Study||8
3181068|NCT01995071|3909546|FG002|STARTED|Overall Study||9
3181069|NCT01995071|3909547|FG003|STARTED|Overall Study||8
3181070|NCT01995071|3909548|FG004|STARTED|Overall Study||8
3181071|NCT01995071|3909549|FG005|STARTED|Overall Study||8
3181072|NCT01995071|3909550|FG006|STARTED|Overall Study||8
3181073|NCT01995071|3909551|FG007|STARTED|Overall Study||8
3181074|NCT01995071|3909552|FG008|STARTED|Overall Study||8
3181075|NCT01995071|3909553|FG009|STARTED|Overall Study||8
3181076|NCT01995071|3909554|FG010|STARTED|Overall Study||8
3181077|NCT01995071|3909555|FG011|STARTED|Overall Study||0
3181078|NCT01995071|3909544|FG000|COMPLETED|Overall Study||7
3181079|NCT01995071|3909545|FG001|COMPLETED|Overall Study||8
3181080|NCT01995071|3909546|FG002|COMPLETED|Overall Study||8
3181081|NCT01995071|3909547|FG003|COMPLETED|Overall Study||8
3181082|NCT01995071|3909548|FG004|COMPLETED|Overall Study||7
3181083|NCT01995071|3909549|FG005|COMPLETED|Overall Study||8
3181084|NCT01995071|3909550|FG006|COMPLETED|Overall Study||7
3181085|NCT01995071|3909551|FG007|COMPLETED|Overall Study||6
3181086|NCT01995071|3909552|FG008|COMPLETED|Overall Study||7
3181087|NCT01995071|3909553|FG009|COMPLETED|Overall Study||8
3181088|NCT01995071|3909554|FG010|COMPLETED|Overall Study||7
3181089|NCT01995071|3909555|FG011|COMPLETED|Overall Study||0
3181090|NCT01995071|3909544|FG000|NOT COMPLETED|Overall Study||1
3181091|NCT01995071|3909545|FG001|NOT COMPLETED|Overall Study||0
3181092|NCT01995071|3909546|FG002|NOT COMPLETED|Overall Study||1
3181093|NCT01995071|3909547|FG003|NOT COMPLETED|Overall Study||0
3181094|NCT01995071|3909548|FG004|NOT COMPLETED|Overall Study||1
3181095|NCT01995071|3909549|FG005|NOT COMPLETED|Overall Study||0
3181096|NCT01995071|3909550|FG006|NOT COMPLETED|Overall Study||1
3181097|NCT01995071|3909551|FG007|NOT COMPLETED|Overall Study||2
3181098|NCT01995071|3909552|FG008|NOT COMPLETED|Overall Study||1
3181099|NCT01995071|3909553|FG009|NOT COMPLETED|Overall Study||0
3181100|NCT01995071|3909554|FG010|NOT COMPLETED|Overall Study||1
3181101|NCT01995071|3909555|FG011|NOT COMPLETED|Overall Study||0
3181102|NCT01995123|3909589|FG000|STARTED|Overall Study||63
3181103|NCT01995123|3909590|FG001|STARTED|Overall Study||61
3181104|NCT01995123|3909589|FG000|COMPLETED|Overall Study||45
3181105|NCT01995123|3909590|FG001|COMPLETED|Overall Study||46
3181106|NCT01995123|3909589|FG000|NOT COMPLETED|Overall Study||18
3181107|NCT01995123|3909590|FG001|NOT COMPLETED|Overall Study||15
3181108|NCT01995136|3909596|FG000|STARTED|Overall Study||32
3181109|NCT01995136|3909596|FG000|COMPLETED|Overall Study||31
3181110|NCT01995136|3909596|FG000|NOT COMPLETED|Overall Study||1
3144941|NCT01764633|3870716|FG000|STARTED|Overall Study||13780
3144942|NCT01764633|3870717|FG001|STARTED|Overall Study||13784
3144943|NCT01764633|3870716|FG000|Received Treatment|Overall Study||13756
3144944|NCT01764633|3870717|FG001|Received Treatment|Overall Study||13769
3144945|NCT01764633|3870716|FG000|COMPLETED|Overall Study||13662
3144946|NCT01764633|3870717|FG001|COMPLETED|Overall Study||13691
3144947|NCT01764633|3870716|FG000|NOT COMPLETED|Overall Study||118
3144948|NCT01764633|3870717|FG001|NOT COMPLETED|Overall Study||93
3144949|NCT01764659|3870723|FG000|STARTED|Overall Study||14
3144950|NCT01764659|3870723|FG000|COMPLETED|Overall Study||12
3144951|NCT01764659|3870723|FG000|NOT COMPLETED|Overall Study||2
3144952|NCT01764685|3870731|FG000|STARTED|Overall Study||0
3144953|NCT01764685|3870732|FG001|STARTED|Overall Study||4
3144954|NCT01764685|3870731|FG000|COMPLETED|Overall Study||0
3144955|NCT01764685|3870732|FG001|COMPLETED|Overall Study||3
3144956|NCT01764685|3870731|FG000|NOT COMPLETED|Overall Study||0
3144957|NCT01764685|3870732|FG001|NOT COMPLETED|Overall Study||1
3144958|NCT01764841|3870742|FG000|STARTED|Overall Study||141
3144959|NCT01764841|3870743|FG001|STARTED|Overall Study||137
3144960|NCT01764841|3870744|FG002|STARTED|Overall Study||70
3144961|NCT01764841|3870745|FG003|STARTED|Overall Study||68
3144962|NCT01764841|3870742|FG000|Participants Received Treatment|Overall Study|safety population|141
3144963|NCT01764841|3870743|FG001|Participants Received Treatment|Overall Study|safety population|136
3144964|NCT01764841|3870744|FG002|Participants Received Treatment|Overall Study|safety population|69
3144965|NCT01764841|3870745|FG003|Participants Received Treatment|Overall Study|safety population|68
3144966|NCT01764841|3870742|FG000|COMPLETED|Overall Study||118
3144967|NCT01764841|3870743|FG001|COMPLETED|Overall Study||111
3144968|NCT01764841|3870744|FG002|COMPLETED|Overall Study||56
3144969|NCT01764841|3870745|FG003|COMPLETED|Overall Study||49
3144970|NCT01764841|3870742|FG000|NOT COMPLETED|Overall Study||23
3144971|NCT01764841|3870743|FG001|NOT COMPLETED|Overall Study||26
3144972|NCT01764841|3870744|FG002|NOT COMPLETED|Overall Study||14
3144973|NCT01764841|3870745|FG003|NOT COMPLETED|Overall Study||19
3144974|NCT01764854|3870759|FG000|STARTED|Overall Study||8
3144975|NCT01764854|3870760|FG001|STARTED|Overall Study||8
3144976|NCT01764854|3870761|FG002|STARTED|Overall Study||37
3144977|NCT01764854|3870762|FG003|STARTED|Overall Study||35
3144978|NCT01764854|3870759|FG000|COMPLETED|Overall Study||8
3144979|NCT01764854|3870760|FG001|COMPLETED|Overall Study||8
3144980|NCT01764854|3870761|FG002|COMPLETED|Overall Study||31
3144981|NCT01764854|3870762|FG003|COMPLETED|Overall Study||33
3144982|NCT01764854|3870759|FG000|NOT COMPLETED|Overall Study||0
3144983|NCT01764854|3870760|FG001|NOT COMPLETED|Overall Study||0
3144984|NCT01764854|3870761|FG002|NOT COMPLETED|Overall Study||6
3144985|NCT01764854|3870762|FG003|NOT COMPLETED|Overall Study||2
3144986|NCT01764919|3870772|FG000|STARTED|Overall Study||4
3144987|NCT01764919|3870772|FG000|COMPLETED|Overall Study||4
3144988|NCT01764919|3870772|FG000|NOT COMPLETED|Overall Study||0
3144989|NCT01764945|3870784|FG000|STARTED|Overall Study||5
3144990|NCT01764945|3870785|FG001|STARTED|Overall Study||5
3144991|NCT01764945|3870786|FG002|STARTED|Overall Study||5
3144992|NCT01764945|3870787|FG003|STARTED|Overall Study||5
3144993|NCT01764945|3870788|FG004|STARTED|Overall Study||10
3144994|NCT01764945|3870789|FG005|STARTED|Overall Study||8
3144995|NCT01764945|3870790|FG006|STARTED|Overall Study||9
3144996|NCT01764945|3870791|FG007|STARTED|Overall Study||9
3144997|NCT01764945|3870784|FG000|COMPLETED|Overall Study||5
3144998|NCT01764945|3870785|FG001|COMPLETED|Overall Study||4
3144999|NCT01764945|3870786|FG002|COMPLETED|Overall Study||5
3145000|NCT01764945|3870787|FG003|COMPLETED|Overall Study||5
3145001|NCT01764945|3870788|FG004|COMPLETED|Overall Study||10
3145002|NCT01764945|3870789|FG005|COMPLETED|Overall Study||8
3145003|NCT01764945|3870790|FG006|COMPLETED|Overall Study||8
3145004|NCT01764945|3870791|FG007|COMPLETED|Overall Study||9
3145005|NCT01764945|3870784|FG000|NOT COMPLETED|Overall Study||0
3145006|NCT01764945|3870785|FG001|NOT COMPLETED|Overall Study||1
3145007|NCT01764945|3870786|FG002|NOT COMPLETED|Overall Study||0
3145008|NCT01764945|3870787|FG003|NOT COMPLETED|Overall Study||0
3145009|NCT01764945|3870788|FG004|NOT COMPLETED|Overall Study||0
3145010|NCT01764945|3870789|FG005|NOT COMPLETED|Overall Study||0
3145011|NCT01764945|3870790|FG006|NOT COMPLETED|Overall Study||1
3145012|NCT01764945|3870791|FG007|NOT COMPLETED|Overall Study||0
3145013|NCT01765153|3870811|FG000|STARTED|Training Phase 1||10
3145014|NCT01765153|3870812|FG001|STARTED|Training Phase 1||11
3145015|NCT01765153|3870811|FG000|COMPLETED|Training Phase 1||9
3145016|NCT01765153|3870812|FG001|COMPLETED|Training Phase 1||10
3145017|NCT01765153|3870811|FG000|NOT COMPLETED|Training Phase 1||1
3145018|NCT01765153|3870812|FG001|NOT COMPLETED|Training Phase 1||1
3145019|NCT01765153|3870811|FG000|STARTED|Rest Phase 1||9
3145020|NCT01765153|3870812|FG001|STARTED|Rest Phase 1||10
3145021|NCT01765153|3870811|FG000|COMPLETED|Rest Phase 1||9
3145022|NCT01765153|3870812|FG001|COMPLETED|Rest Phase 1||9
3145023|NCT01765153|3870811|FG000|NOT COMPLETED|Rest Phase 1||0
3145024|NCT01765153|3870812|FG001|NOT COMPLETED|Rest Phase 1||1
3145025|NCT01765153|3870811|FG000|STARTED|Training Phase 2|1st subject didn't use same training(phase 1) as subsequent participants Phase 1 and 2 data removed.|10
3145026|NCT01765153|3870812|FG001|STARTED|Training Phase 2||9
3145027|NCT01765153|3870811|FG000|COMPLETED|Training Phase 2||10
3145028|NCT01765153|3870812|FG001|COMPLETED|Training Phase 2||8
3145029|NCT01765153|3870811|FG000|NOT COMPLETED|Training Phase 2||0
3145030|NCT01765153|3870812|FG001|NOT COMPLETED|Training Phase 2||1
3145031|NCT01765153|3870811|FG000|STARTED|Rest Phase 2||10
3145032|NCT01765153|3870812|FG001|STARTED|Rest Phase 2||8
3145033|NCT01765153|3870811|FG000|COMPLETED|Rest Phase 2||8
3145034|NCT01765153|3870812|FG001|COMPLETED|Rest Phase 2||7
3145035|NCT01765153|3870811|FG000|NOT COMPLETED|Rest Phase 2||2
3145036|NCT01765153|3870812|FG001|NOT COMPLETED|Rest Phase 2||1
3145037|NCT01765179|3870822|FG000|STARTED|Overall Study||144
3145038|NCT01765179|3870822|FG000|COMPLETED|Overall Study||117
3145039|NCT01765179|3870822|FG000|NOT COMPLETED|Overall Study||27
3145040|NCT01765192|3870828|FG000|STARTED|Treatment Period 1||32
3145041|NCT01765192|3870829|FG001|STARTED|Treatment Period 1||32
3145042|NCT01765192|3870828|FG000|COMPLETED|Treatment Period 1||32
3145043|NCT01765192|3870829|FG001|COMPLETED|Treatment Period 1||31
3145044|NCT01765192|3870828|FG000|NOT COMPLETED|Treatment Period 1||0
3145045|NCT01765192|3870829|FG001|NOT COMPLETED|Treatment Period 1||1
3145046|NCT01765192|3870828|FG000|STARTED|Washout Period||32
3145047|NCT01765192|3870829|FG001|STARTED|Washout Period||31
3145048|NCT01765192|3870828|FG000|COMPLETED|Washout Period||30
3145049|NCT01765192|3870829|FG001|COMPLETED|Washout Period||30
3145050|NCT01765192|3870828|FG000|NOT COMPLETED|Washout Period||2
3145051|NCT01765192|3870829|FG001|NOT COMPLETED|Washout Period||1
3145052|NCT01765192|3870828|FG000|STARTED|Treatment Period 2||30
3145053|NCT01765192|3870829|FG001|STARTED|Treatment Period 2||30
3145054|NCT01765192|3870828|FG000|COMPLETED|Treatment Period 2||30
3145055|NCT01765192|3870829|FG001|COMPLETED|Treatment Period 2||28
3145056|NCT01765192|3870828|FG000|NOT COMPLETED|Treatment Period 2||0
3145057|NCT01765192|3870829|FG001|NOT COMPLETED|Treatment Period 2||2
3145058|NCT01765192|3870828|FG000|STARTED|End of Treatment Period 2 to Final Visit||30
3145059|NCT01765192|3870829|FG001|STARTED|End of Treatment Period 2 to Final Visit||28
3145060|NCT01765192|3870828|FG000|COMPLETED|End of Treatment Period 2 to Final Visit||30
3145061|NCT01765192|3870829|FG001|COMPLETED|End of Treatment Period 2 to Final Visit||27
3145062|NCT01765192|3870828|FG000|NOT COMPLETED|End of Treatment Period 2 to Final Visit||0
3145063|NCT01765192|3870829|FG001|NOT COMPLETED|End of Treatment Period 2 to Final Visit||1
3145064|NCT01765270|3870837|FG000|STARTED|Overall Study||5
3145065|NCT01765270|3870838|FG001|STARTED|Overall Study||7
3145066|NCT01765270|3870837|FG000|COMPLETED|Overall Study||4
3145067|NCT01765270|3870838|FG001|COMPLETED|Overall Study||6
3145068|NCT01765270|3870837|FG000|NOT COMPLETED|Overall Study||1
3145069|NCT01765270|3870838|FG001|NOT COMPLETED|Overall Study||1
3145070|NCT01765426|3870849|FG000|STARTED|Overall Study||18
3145071|NCT01765426|3870850|FG001|STARTED|Overall Study||17
3145072|NCT01765426|3870851|FG002|STARTED|Overall Study||17
3145073|NCT01765426|3870852|FG003|STARTED|Overall Study||15
3145074|NCT01765426|3870849|FG000|Completed All Vaccinations|Overall Study||17
3145075|NCT01765426|3870850|FG001|Completed All Vaccinations|Overall Study||16
3145076|NCT01765426|3870851|FG002|Completed All Vaccinations|Overall Study||17
3145077|NCT01765426|3870852|FG003|Completed All Vaccinations|Overall Study||15
3145078|NCT01765426|3870849|FG000|COMPLETED|Overall Study||18
3145079|NCT01765426|3870850|FG001|COMPLETED|Overall Study||16
3145080|NCT01765426|3870851|FG002|COMPLETED|Overall Study||17
3145081|NCT01765426|3870852|FG003|COMPLETED|Overall Study||15
3145082|NCT01765426|3870849|FG000|NOT COMPLETED|Overall Study||0
3145083|NCT01765426|3870850|FG001|NOT COMPLETED|Overall Study||1
3145084|NCT01765426|3870851|FG002|NOT COMPLETED|Overall Study||0
3145085|NCT01765426|3870852|FG003|NOT COMPLETED|Overall Study||0
3145086|NCT01765465|3870864|FG000|STARTED|Overall Study||71
3145087|NCT01765465|3870865|FG001|STARTED|Overall Study||67
3145088|NCT01765465|3870864|FG000|COMPLETED|Overall Study||64
3145089|NCT01765465|3870865|FG001|COMPLETED|Overall Study||63
3145090|NCT01765465|3870864|FG000|NOT COMPLETED|Overall Study||7
3145091|NCT01765465|3870865|FG001|NOT COMPLETED|Overall Study||4
3145092|NCT01765530|3870875|FG000|STARTED|Overall Study||37
3145093|NCT01765530|3870876|FG001|STARTED|Overall Study||37
3145094|NCT01765530|3870875|FG000|COMPLETED|Overall Study||36
3145095|NCT01765530|3870876|FG001|COMPLETED|Overall Study||36
3145096|NCT01765530|3870875|FG000|NOT COMPLETED|Overall Study||1
3145097|NCT01765530|3870876|FG001|NOT COMPLETED|Overall Study||1
3145098|NCT01765543|3870882|FG000|STARTED|Overall Study||27
3145099|NCT01765543|3870882|FG000|COMPLETED|Overall Study||24
3145100|NCT01765543|3870882|FG000|NOT COMPLETED|Overall Study||3
3145101|NCT01765569|3870890|FG000|STARTED|Period A||29
3145102|NCT01765569|3870890|FG000|COMPLETED|Period A||29
3145103|NCT01765569|3870890|FG000|NOT COMPLETED|Period A||0
3145104|NCT01765569|3870890|FG000|STARTED|Period B||29
3145105|NCT01765569|3870890|FG000|COMPLETED|Period B||28
3145106|NCT01765569|3870890|FG000|NOT COMPLETED|Period B||1
3145107|NCT01765569|3870890|FG000|STARTED|Period C||28
3145108|NCT01765569|3870890|FG000|COMPLETED|Period C||27
3145109|NCT01765569|3870890|FG000|NOT COMPLETED|Period C||1
3145110|NCT01765582|3870900|FG000|STARTED|Overall Study||93
3145111|NCT01765582|3870901|FG001|STARTED|Overall Study||92
3145112|NCT01765582|3870902|FG002|STARTED|Overall Study||95
3145113|NCT01765582|3870900|FG000|COMPLETED|Overall Study||0
3145114|NCT01765582|3870901|FG001|COMPLETED|Overall Study||0
3145115|NCT01765582|3870902|FG002|COMPLETED|Overall Study||0
3145116|NCT01765582|3870900|FG000|NOT COMPLETED|Overall Study||93
3145117|NCT01765582|3870901|FG001|NOT COMPLETED|Overall Study||92
3145118|NCT01765582|3870902|FG002|NOT COMPLETED|Overall Study||95
3145119|NCT01765647|3870911|FG000|STARTED|Overall Study|One began the run-in period, but was withdrawn prior to beginning treatment with AGY|10
3181111|NCT01995201|3909602|FG000|STARTED|From Baseline Until Week 24||74
3145120|NCT01765647|3870911|FG000|COMPLETED|Overall Study|10 entered the AGY treatment phase and all 10 completed treatment.|10
3181112|NCT01995201|3909603|FG001|STARTED|From Baseline Until Week 24||327
3181113|NCT01995201|3909604|FG002|STARTED|From Baseline Until Week 24||0
3181114|NCT01995201|3909605|FG003|STARTED|From Baseline Until Week 24||0
3181115|NCT01995201|3909606|FG004|STARTED|From Baseline Until Week 24||0
3181116|NCT01995201|3909607|FG005|STARTED|From Baseline Until Week 24||0
3181117|NCT01995201|3909608|FG006|STARTED|From Baseline Until Week 24||0
3181118|NCT01995201|3909602|FG000|COMPLETED|From Baseline Until Week 24||64
3145121|NCT01765647|3870911|FG000|NOT COMPLETED|Overall Study||0
3145122|NCT01765673|3870915|FG000|STARTED|Overall Study||12
3145123|NCT01765673|3870915|FG000|COMPLETED|Overall Study||11
3145124|NCT01765673|3870915|FG000|NOT COMPLETED|Overall Study||1
3145125|NCT01765712|3870924|FG000|STARTED|Overall Study||27
3145126|NCT01765712|3870925|FG001|STARTED|Overall Study||23
3145127|NCT01765712|3870924|FG000|COMPLETED|Overall Study||27
3145128|NCT01765712|3870925|FG001|COMPLETED|Overall Study||23
3145129|NCT01765712|3870924|FG000|NOT COMPLETED|Overall Study||0
3145130|NCT01765712|3870925|FG001|NOT COMPLETED|Overall Study||0
3145131|NCT01765751|3870934|FG000|STARTED|Overall Study||16
3145132|NCT01765751|3870935|FG001|STARTED|Overall Study||16
3145133|NCT01765751|3870936|FG002|STARTED|Overall Study||16
3145134|NCT01765751|3870934|FG000|COMPLETED|Overall Study||16
3145135|NCT01765751|3870935|FG001|COMPLETED|Overall Study||14
3145136|NCT01765751|3870936|FG002|COMPLETED|Overall Study||15
3145137|NCT01765751|3870934|FG000|NOT COMPLETED|Overall Study||0
3145138|NCT01765751|3870935|FG001|NOT COMPLETED|Overall Study||2
3145139|NCT01765751|3870936|FG002|NOT COMPLETED|Overall Study||1
3145140|NCT01765764|3870950|FG000|STARTED|Treatment Period||118
3145141|NCT01765764|3870951|FG001|STARTED|Treatment Period||118
3145142|NCT01765764|3870952|FG002|STARTED|Treatment Period||121
3145143|NCT01765764|3870950|FG000|COMPLETED|Treatment Period||115
3145144|NCT01765764|3870951|FG001|COMPLETED|Treatment Period||109
3145145|NCT01765764|3870952|FG002|COMPLETED|Treatment Period||115
3145146|NCT01765764|3870950|FG000|NOT COMPLETED|Treatment Period||3
3145147|NCT01765764|3870951|FG001|NOT COMPLETED|Treatment Period||9
3145148|NCT01765764|3870952|FG002|NOT COMPLETED|Treatment Period||6
3145149|NCT01765764|3870950|FG000|STARTED|Post-treatment Period|1 participant did not enter the Post-treatment Period. [Personal Reasons]|114
3145150|NCT01765764|3870951|FG001|STARTED|Post-treatment Period|2 participants did not enter the Post-treatment Period [2 Lost-to-Follow-up (LFU)]|107
3145151|NCT01765764|3870952|FG002|STARTED|Post-treatment Period|3 participants did not enter the Post-treatment Period [1 Personal Reasons,2 LFU].|112
3145152|NCT01765764|3870950|FG000|COMPLETED|Post-treatment Period||114
3145153|NCT01765764|3870951|FG001|COMPLETED|Post-treatment Period||107
3145154|NCT01765764|3870952|FG002|COMPLETED|Post-treatment Period||112
3145155|NCT01765764|3870950|FG000|NOT COMPLETED|Post-treatment Period||0
3145156|NCT01765764|3870951|FG001|NOT COMPLETED|Post-treatment Period||0
3145157|NCT01765764|3870952|FG002|NOT COMPLETED|Post-treatment Period||0
3145158|NCT01765803|3870960|FG000|STARTED|Overall Study||6
3145159|NCT01765803|3870960|FG000|COMPLETED|Overall Study||6
3145160|NCT01765803|3870960|FG000|NOT COMPLETED|Overall Study||0
3145161|NCT01765920|3870966|FG000|STARTED|Overall Study||169
3145162|NCT01765920|3870967|FG001|STARTED|Overall Study||173
3145163|NCT01765920|3870966|FG000|COMPLETED|Overall Study||167
3145164|NCT01765920|3870967|FG001|COMPLETED|Overall Study||167
3145165|NCT01765920|3870966|FG000|NOT COMPLETED|Overall Study||2
3145166|NCT01765920|3870967|FG001|NOT COMPLETED|Overall Study||6
3145167|NCT01765972|3870973|FG000|STARTED|Overall Study||6
3145168|NCT01765972|3870974|FG001|STARTED|Overall Study||6
3145169|NCT01765972|3870975|FG002|STARTED|Overall Study||6
3145170|NCT01765972|3870976|FG003|STARTED|Overall Study||6
3145171|NCT01765972|3870973|FG000|COMPLETED|Overall Study||6
3145172|NCT01765972|3870974|FG001|COMPLETED|Overall Study||6
3145173|NCT01765972|3870975|FG002|COMPLETED|Overall Study||6
3145174|NCT01765972|3870976|FG003|COMPLETED|Overall Study||6
3145175|NCT01765972|3870973|FG000|NOT COMPLETED|Overall Study||0
3145176|NCT01765972|3870974|FG001|NOT COMPLETED|Overall Study||0
3145177|NCT01765972|3870975|FG002|NOT COMPLETED|Overall Study||0
3145178|NCT01765972|3870976|FG003|NOT COMPLETED|Overall Study||0
3145179|NCT01766024|3870988|FG000|STARTED|Overall Study||16
3145180|NCT01766024|3870989|FG001|STARTED|Overall Study||16
3145181|NCT01766024|3870988|FG000|COMPLETED|Overall Study||16
3145182|NCT01766024|3870989|FG001|COMPLETED|Overall Study||16
3145183|NCT01766024|3870988|FG000|NOT COMPLETED|Overall Study||0
3145184|NCT01766024|3870989|FG001|NOT COMPLETED|Overall Study||0
3145185|NCT01766037|3870999|FG000|STARTED|Overall Study||111
3145186|NCT01766037|3871000|FG001|STARTED|Overall Study||60
3145187|NCT01766037|3870999|FG000|COMPLETED|Overall Study||82
3145188|NCT01766037|3871000|FG001|COMPLETED|Overall Study||31
3145189|NCT01766037|3870999|FG000|NOT COMPLETED|Overall Study||29
3145190|NCT01766037|3871000|FG001|NOT COMPLETED|Overall Study||29
3145191|NCT01766050|3871006|FG000|STARTED|Overall Study||22
3145192|NCT01766050|3871006|FG000|COMPLETED|Overall Study||18
3145193|NCT01766050|3871006|FG000|NOT COMPLETED|Overall Study||4
3145194|NCT01766076|3871026|FG000|STARTED|Overall Study||15
3145195|NCT01766076|3871027|FG001|STARTED|Overall Study||15
3145196|NCT01766076|3871026|FG000|COMPLETED|Overall Study||15
3145197|NCT01766076|3871027|FG001|COMPLETED|Overall Study||15
3145198|NCT01766076|3871026|FG000|NOT COMPLETED|Overall Study||0
3145199|NCT01766076|3871027|FG001|NOT COMPLETED|Overall Study||0
3145200|NCT01766102|3871035|FG000|STARTED|Overall Study||36
3145201|NCT01766102|3871036|FG001|STARTED|Overall Study||36
3145202|NCT01766102|3871035|FG000|COMPLETED|Overall Study||36
3145203|NCT01766102|3871036|FG001|COMPLETED|Overall Study||36
3145204|NCT01766102|3871035|FG000|NOT COMPLETED|Overall Study||0
3145205|NCT01766102|3871036|FG001|NOT COMPLETED|Overall Study||0
3145206|NCT01766206|3871042|FG000|STARTED|Overall Study||3939
3145207|NCT01766206|3871042|FG000|COMPLETED|Overall Study||3888
3145208|NCT01766206|3871042|FG000|NOT COMPLETED|Overall Study||51
3145209|NCT01766219|3871049|FG000|STARTED|Overall Study||4
3145210|NCT01766219|3871050|FG001|STARTED|Overall Study||2
3145211|NCT01766219|3871051|FG002|STARTED|Overall Study||11
3145212|NCT01766219|3871049|FG000|COMPLETED|Overall Study||4
3145213|NCT01766219|3871050|FG001|COMPLETED|Overall Study||2
3145214|NCT01766219|3871051|FG002|COMPLETED|Overall Study||11
3145215|NCT01766219|3871049|FG000|NOT COMPLETED|Overall Study||0
3145216|NCT01766219|3871050|FG001|NOT COMPLETED|Overall Study||0
3145217|NCT01766219|3871051|FG002|NOT COMPLETED|Overall Study||0
3145218|NCT01766310|3871062|FG000|STARTED|Overall Study||24
3145219|NCT01766310|3871063|FG001|STARTED|Overall Study||26
3145220|NCT01766310|3871062|FG000|COMPLETED|Overall Study||23
3145221|NCT01766310|3871063|FG001|COMPLETED|Overall Study||23
3145222|NCT01766310|3871062|FG000|NOT COMPLETED|Overall Study||1
3145223|NCT01766310|3871063|FG001|NOT COMPLETED|Overall Study||3
3145224|NCT01766336|3871071|FG000|STARTED|Overall Study||150
3145225|NCT01766336|3871072|FG001|STARTED|Overall Study||146
3145226|NCT01766336|3871071|FG000|COMPLETED|Overall Study||60
3145227|NCT01766336|3871072|FG001|COMPLETED|Overall Study||71
3145228|NCT01766336|3871071|FG000|NOT COMPLETED|Overall Study||90
3145229|NCT01766336|3871072|FG001|NOT COMPLETED|Overall Study||75
3145230|NCT01766401|3871080|FG000|STARTED|Overall Study||198
3145231|NCT01766401|3871081|FG001|STARTED|Overall Study||200
3145232|NCT01766401|3871080|FG000|COMPLETED|Overall Study||161
3145233|NCT01766401|3871081|FG001|COMPLETED|Overall Study||144
3145234|NCT01766401|3871080|FG000|NOT COMPLETED|Overall Study||37
3145235|NCT01766401|3871081|FG001|NOT COMPLETED|Overall Study||56
3145236|NCT01766440|3871087|FG000|STARTED|Overall Study||18
3145237|NCT01766440|3871087|FG000|COMPLETED|Overall Study||17
3145238|NCT01766440|3871087|FG000|NOT COMPLETED|Overall Study||1
3145239|NCT01766466|3871093|FG000|STARTED|Day 1||6
3145240|NCT01766466|3871094|FG001|STARTED|Day 1||0
3145241|NCT01766466|3871095|FG002|STARTED|Day 1||6
3145242|NCT01766466|3871096|FG003|STARTED|Day 1||0
3145243|NCT01766466|3871093|FG000|COMPLETED|Day 1||6
3145244|NCT01766466|3871094|FG001|COMPLETED|Day 1||0
3145245|NCT01766466|3871095|FG002|COMPLETED|Day 1||6
3145246|NCT01766466|3871096|FG003|COMPLETED|Day 1||0
3145247|NCT01766466|3871093|FG000|NOT COMPLETED|Day 1||0
3145248|NCT01766466|3871094|FG001|NOT COMPLETED|Day 1||0
3145249|NCT01766466|3871095|FG002|NOT COMPLETED|Day 1||0
3145250|NCT01766466|3871096|FG003|NOT COMPLETED|Day 1||0
3145251|NCT01766466|3871093|FG000|STARTED|Day 5||0
3145252|NCT01766466|3871094|FG001|STARTED|Day 5||6
3145253|NCT01766466|3871095|FG002|STARTED|Day 5||0
3145254|NCT01766466|3871096|FG003|STARTED|Day 5||6
3145255|NCT01766466|3871093|FG000|COMPLETED|Day 5||0
3145256|NCT01766466|3871094|FG001|COMPLETED|Day 5||6
3145257|NCT01766466|3871095|FG002|COMPLETED|Day 5||0
3145258|NCT01766466|3871096|FG003|COMPLETED|Day 5||6
3145259|NCT01766466|3871093|FG000|NOT COMPLETED|Day 5||0
3145260|NCT01766466|3871094|FG001|NOT COMPLETED|Day 5||0
3145261|NCT01766466|3871095|FG002|NOT COMPLETED|Day 5||0
3145262|NCT01766466|3871096|FG003|NOT COMPLETED|Day 5||0
3145263|NCT01766713|3871107|FG000|STARTED|Overall Study||25
3145264|NCT01766713|3871108|FG001|STARTED|Overall Study||25
3145265|NCT01766713|3871107|FG000|COMPLETED|Overall Study||23
3145266|NCT01766713|3871108|FG001|COMPLETED|Overall Study||22
3145267|NCT01766713|3871107|FG000|NOT COMPLETED|Overall Study||2
3145268|NCT01766713|3871108|FG001|NOT COMPLETED|Overall Study||3
3145269|NCT01766778|3871116|FG000|STARTED|Overall Study|Intent to treat population|56
3145270|NCT01766778|3871117|FG001|STARTED|Overall Study||61
3145271|NCT01766778|3871116|FG000|COMPLETED|Overall Study||51
3145272|NCT01766778|3871117|FG001|COMPLETED|Overall Study||57
3145273|NCT01766778|3871116|FG000|NOT COMPLETED|Overall Study||5
3145274|NCT01766778|3871117|FG001|NOT COMPLETED|Overall Study||4
3145275|NCT01766817|3871126|FG000|STARTED|Overall Study||48
3145276|NCT01766817|3871127|FG001|STARTED|Overall Study||48
3145277|NCT01766817|3871128|FG002|STARTED|Overall Study||47
3145278|NCT01766817|3871126|FG000|COMPLETED|Overall Study||37
3145279|NCT01766817|3871127|FG001|COMPLETED|Overall Study||37
3145280|NCT01766817|3871128|FG002|COMPLETED|Overall Study||34
3145281|NCT01766817|3871126|FG000|NOT COMPLETED|Overall Study||11
3145282|NCT01766817|3871127|FG001|NOT COMPLETED|Overall Study||11
3145283|NCT01766817|3871128|FG002|NOT COMPLETED|Overall Study||13
3145284|NCT01766921|3871138|FG000|STARTED|Overall Study||700
3145285|NCT01766921|3871139|FG001|STARTED|Overall Study||693
3145286|NCT01766921|3871138|FG000|COMPLETED|Overall Study||676
3145287|NCT01766921|3871139|FG001|COMPLETED|Overall Study||676
3145288|NCT01766921|3871138|FG000|NOT COMPLETED|Overall Study||24
3145289|NCT01766921|3871139|FG001|NOT COMPLETED|Overall Study||17
3145290|NCT01766986|3871149|FG000|STARTED|Overall Study||41
3145291|NCT01766986|3871150|FG001|STARTED|Overall Study||51
3145292|NCT01766986|3871151|FG002|STARTED|Overall Study||38
3145293|NCT01766986|3871149|FG000|COMPLETED|Overall Study||41
3145294|NCT01766986|3871150|FG001|COMPLETED|Overall Study||51
3145295|NCT01766986|3871151|FG002|COMPLETED|Overall Study||38
3145296|NCT01766986|3871149|FG000|NOT COMPLETED|Overall Study||0
3145297|NCT01766986|3871150|FG001|NOT COMPLETED|Overall Study||0
3145298|NCT01766986|3871151|FG002|NOT COMPLETED|Overall Study||0
3145299|NCT01767064|3871161|FG000|STARTED|Overall Study||7
3145300|NCT01767064|3871162|FG001|STARTED|Overall Study||7
3145301|NCT01767064|3871161|FG000|COMPLETED|Overall Study||7
3145302|NCT01767064|3871162|FG001|COMPLETED|Overall Study||7
3145303|NCT01767064|3871161|FG000|NOT COMPLETED|Overall Study||0
3145304|NCT01767064|3871162|FG001|NOT COMPLETED|Overall Study||0
3145305|NCT01767103|3871171|FG000|STARTED|Overall Study||7
3145306|NCT01767103|3871172|FG001|STARTED|Overall Study||7
3145307|NCT01767103|3871173|FG002|STARTED|Overall Study||7
3145308|NCT01767103|3871171|FG000|COMPLETED|Overall Study||7
3145309|NCT01767103|3871172|FG001|COMPLETED|Overall Study||7
3145310|NCT01767103|3871173|FG002|COMPLETED|Overall Study||7
3145311|NCT01767103|3871171|FG000|NOT COMPLETED|Overall Study||0
3145312|NCT01767103|3871172|FG001|NOT COMPLETED|Overall Study||0
3181119|NCT01995201|3909603|FG001|COMPLETED|From Baseline Until Week 24||281
3181120|NCT01995201|3909604|FG002|COMPLETED|From Baseline Until Week 24||0
3181121|NCT01995201|3909605|FG003|COMPLETED|From Baseline Until Week 24||0
3181122|NCT01995201|3909606|FG004|COMPLETED|From Baseline Until Week 24||0
3181123|NCT01995201|3909607|FG005|COMPLETED|From Baseline Until Week 24||0
3181124|NCT01995201|3909608|FG006|COMPLETED|From Baseline Until Week 24||0
3181125|NCT01995201|3909602|FG000|NOT COMPLETED|From Baseline Until Week 24||10
3181126|NCT01995201|3909603|FG001|NOT COMPLETED|From Baseline Until Week 24||46
3181127|NCT01995201|3909604|FG002|NOT COMPLETED|From Baseline Until Week 24||0
3181128|NCT01995201|3909605|FG003|NOT COMPLETED|From Baseline Until Week 24||0
3181129|NCT01995201|3909606|FG004|NOT COMPLETED|From Baseline Until Week 24||0
3181130|NCT01995201|3909607|FG005|NOT COMPLETED|From Baseline Until Week 24||0
3181131|NCT01995201|3909608|FG006|NOT COMPLETED|From Baseline Until Week 24||0
3181132|NCT01995201|3909602|FG000|STARTED|From Week 24 Until Week 48||0
3181133|NCT01995201|3909603|FG001|STARTED|From Week 24 Until Week 48||0
3181134|NCT01995201|3909604|FG002|STARTED|From Week 24 Until Week 48||89
3181135|NCT01995201|3909605|FG003|STARTED|From Week 24 Until Week 48||90
3181136|NCT01995201|3909606|FG004|STARTED|From Week 24 Until Week 48||95
3181137|NCT01995201|3909607|FG005|STARTED|From Week 24 Until Week 48||67
3181138|NCT01995201|3909608|FG006|STARTED|From Week 24 Until Week 48||2
3181139|NCT01995201|3909602|FG000|COMPLETED|From Week 24 Until Week 48||0
3181140|NCT01995201|3909603|FG001|COMPLETED|From Week 24 Until Week 48||0
3181141|NCT01995201|3909604|FG002|COMPLETED|From Week 24 Until Week 48||84
3181142|NCT01995201|3909605|FG003|COMPLETED|From Week 24 Until Week 48||89
3181143|NCT01995201|3909606|FG004|COMPLETED|From Week 24 Until Week 48||89
3181144|NCT01995201|3909607|FG005|COMPLETED|From Week 24 Until Week 48||59
3181145|NCT01995201|3909608|FG006|COMPLETED|From Week 24 Until Week 48||0
3181146|NCT01995201|3909602|FG000|NOT COMPLETED|From Week 24 Until Week 48||0
3181147|NCT01995201|3909603|FG001|NOT COMPLETED|From Week 24 Until Week 48||0
3181148|NCT01995201|3909604|FG002|NOT COMPLETED|From Week 24 Until Week 48||5
3181149|NCT01995201|3909605|FG003|NOT COMPLETED|From Week 24 Until Week 48||1
3181150|NCT01995201|3909606|FG004|NOT COMPLETED|From Week 24 Until Week 48||6
3181151|NCT01995201|3909607|FG005|NOT COMPLETED|From Week 24 Until Week 48||8
3181152|NCT01995201|3909608|FG006|NOT COMPLETED|From Week 24 Until Week 48||2
3181153|NCT01995266|3909629|FG000|STARTED|Overall Study||159
3181154|NCT01995266|3909629|FG000|COMPLETED|Overall Study||150
3181155|NCT01995266|3909629|FG000|NOT COMPLETED|Overall Study||9
3181156|NCT01995357|3909633|FG000|STARTED|Period 1||4
3181157|NCT01995357|3909634|FG001|STARTED|Period 1||3
3181158|NCT01995357|3909635|FG002|STARTED|Period 1||4
3181159|NCT01995357|3909636|FG003|STARTED|Period 1||3
3181160|NCT01995357|3909637|FG004|STARTED|Period 1||4
3181161|NCT01995357|3909638|FG005|STARTED|Period 1||4
3181162|NCT01995357|3909633|FG000|COMPLETED|Period 1||4
3181163|NCT01995357|3909634|FG001|COMPLETED|Period 1||3
3181164|NCT01995357|3909635|FG002|COMPLETED|Period 1||4
3181165|NCT01995357|3909636|FG003|COMPLETED|Period 1||3
3181166|NCT01995357|3909637|FG004|COMPLETED|Period 1||4
3181167|NCT01995357|3909638|FG005|COMPLETED|Period 1||4
3181168|NCT01995357|3909633|FG000|NOT COMPLETED|Period 1||0
3181169|NCT01995357|3909634|FG001|NOT COMPLETED|Period 1||0
3181170|NCT01995357|3909635|FG002|NOT COMPLETED|Period 1||0
3181171|NCT01995357|3909636|FG003|NOT COMPLETED|Period 1||0
3181172|NCT01995357|3909637|FG004|NOT COMPLETED|Period 1||0
3181173|NCT01995357|3909638|FG005|NOT COMPLETED|Period 1||0
3181174|NCT01995357|3909633|FG000|STARTED|Period 2||4
3181175|NCT01995357|3909634|FG001|STARTED|Period 2||3
3181176|NCT01995357|3909635|FG002|STARTED|Period 2||4
3181177|NCT01995357|3909636|FG003|STARTED|Period 2||3
3181178|NCT01995357|3909637|FG004|STARTED|Period 2||4
3181179|NCT01995357|3909638|FG005|STARTED|Period 2||4
3181180|NCT01995357|3909633|FG000|COMPLETED|Period 2||4
3181181|NCT01995357|3909634|FG001|COMPLETED|Period 2||3
3181182|NCT01995357|3909635|FG002|COMPLETED|Period 2||4
3181183|NCT01995357|3909636|FG003|COMPLETED|Period 2||3
3181184|NCT01995357|3909637|FG004|COMPLETED|Period 2||4
3181185|NCT01995357|3909638|FG005|COMPLETED|Period 2||4
3181186|NCT01995357|3909633|FG000|NOT COMPLETED|Period 2||0
3181187|NCT01995357|3909634|FG001|NOT COMPLETED|Period 2||0
3181188|NCT01995357|3909635|FG002|NOT COMPLETED|Period 2||0
3181189|NCT01995357|3909636|FG003|NOT COMPLETED|Period 2||0
3181190|NCT01995357|3909637|FG004|NOT COMPLETED|Period 2||0
3181191|NCT01995357|3909638|FG005|NOT COMPLETED|Period 2||0
3181192|NCT01995357|3909633|FG000|STARTED|Period 3||4
3181193|NCT01995357|3909634|FG001|STARTED|Period 3||3
3145313|NCT01767103|3871173|FG002|NOT COMPLETED|Overall Study||0
3145314|NCT01767116|3871184|FG000|STARTED|Overall Study||210
3145315|NCT01767116|3871185|FG001|STARTED|Overall Study||209
3145316|NCT01767116|3871184|FG000|COMPLETED|Overall Study||208
3145317|NCT01767116|3871185|FG001|COMPLETED|Overall Study||207
3145318|NCT01767116|3871184|FG000|NOT COMPLETED|Overall Study||2
3145319|NCT01767116|3871185|FG001|NOT COMPLETED|Overall Study||2
3145320|NCT01767142|3871191|FG000|STARTED|Overall Study|Each subject was treated on a single thigh. therefore the number of units is 40.|40
3145321|NCT01767142|3871191|FG000|COMPLETED|Overall Study||37
3145322|NCT01767142|3871191|FG000|NOT COMPLETED|Overall Study||3
3145323|NCT01767155|3871197|FG000|STARTED|Overall Study|Patients allocated to AEZS-108|256
3145324|NCT01767155|3871198|FG001|STARTED|Overall Study|Patients allocated to doxorubicin|255
3145325|NCT01767155|3871197|FG000|Modified ITT (mITT)|Overall Study||252
3145326|NCT01767155|3871198|FG001|Modified ITT (mITT)|Overall Study||249
3145327|NCT01767155|3871197|FG000|Safety Population (SAF)|Overall Study||252
3145328|NCT01767155|3871198|FG001|Safety Population (SAF)|Overall Study||249
3145329|NCT01767155|3871197|FG000|COMPLETED|Overall Study||243
3145330|NCT01767155|3871198|FG001|COMPLETED|Overall Study||240
3145331|NCT01767155|3871197|FG000|NOT COMPLETED|Overall Study||13
3145332|NCT01767155|3871198|FG001|NOT COMPLETED|Overall Study||15
3145333|NCT01767194|3871206|FG000|STARTED|Overall Study||19
3145334|NCT01767194|3871207|FG001|STARTED|Overall Study||54
3145335|NCT01767194|3871206|FG000|COMPLETED|Overall Study||1
3145336|NCT01767194|3871207|FG001|COMPLETED|Overall Study||11
3145337|NCT01767194|3871206|FG000|NOT COMPLETED|Overall Study||18
3145338|NCT01767194|3871207|FG001|NOT COMPLETED|Overall Study||43
3145339|NCT01767285|3871216|FG000|STARTED|Overall Study||29
3145340|NCT01767285|3871217|FG001|STARTED|Overall Study||30
3145341|NCT01767285|3871216|FG000|COMPLETED|Overall Study||22
3145342|NCT01767285|3871217|FG001|COMPLETED|Overall Study||24
3145343|NCT01767285|3871216|FG000|NOT COMPLETED|Overall Study||7
3145344|NCT01767285|3871217|FG001|NOT COMPLETED|Overall Study||6
3145345|NCT01767376|3871226|FG000|STARTED|Overall Study||231
3145346|NCT01767376|3871227|FG001|STARTED|Overall Study||228
3145347|NCT01767376|3871228|FG002|STARTED|Overall Study||232
3145348|NCT01767376|3871226|FG000|COMPLETED|Overall Study||227
3145349|NCT01767376|3871227|FG001|COMPLETED|Overall Study||225
3145350|NCT01767376|3871228|FG002|COMPLETED|Overall Study||232
3145351|NCT01767376|3871226|FG000|NOT COMPLETED|Overall Study||4
3145352|NCT01767376|3871227|FG001|NOT COMPLETED|Overall Study||3
3145353|NCT01767376|3871228|FG002|NOT COMPLETED|Overall Study||0
3145354|NCT01767415|3871238|FG000|STARTED|Overall Study||10
3145355|NCT01767415|3871238|FG000|COMPLETED|Overall Study||10
3145356|NCT01767415|3871238|FG000|NOT COMPLETED|Overall Study||0
3145357|NCT01767467|3871244|FG000|STARTED|Vaccination Phase (up to Month 2)||283
3145358|NCT01767467|3871245|FG001|STARTED|Vaccination Phase (up to Month 2)||279
3145359|NCT01767467|3871244|FG000|COMPLETED|Vaccination Phase (up to Month 2)||266
3145360|NCT01767467|3871245|FG001|COMPLETED|Vaccination Phase (up to Month 2)||259
3145361|NCT01767467|3871244|FG000|NOT COMPLETED|Vaccination Phase (up to Month 2)||17
3145362|NCT01767467|3871245|FG001|NOT COMPLETED|Vaccination Phase (up to Month 2)||20
3145363|NCT01767467|3871244|FG000|STARTED|End of Study Phase (up to Month 13)||283
3145364|NCT01767467|3871245|FG001|STARTED|End of Study Phase (up to Month 13)||279
3145365|NCT01767467|3871244|FG000|COMPLETED|End of Study Phase (up to Month 13)||236
3145366|NCT01767467|3871245|FG001|COMPLETED|End of Study Phase (up to Month 13)||216
3145367|NCT01767467|3871244|FG000|NOT COMPLETED|End of Study Phase (up to Month 13)||47
3145368|NCT01767467|3871245|FG001|NOT COMPLETED|End of Study Phase (up to Month 13)||63
3145369|NCT01767493|3871258|FG000|STARTED|Overall Study||19
3145370|NCT01767493|3871258|FG000|COMPLETED|Overall Study||16
3145371|NCT01767493|3871258|FG000|NOT COMPLETED|Overall Study||3
3145372|NCT01767506|3871264|FG000|STARTED|Overall Study|"26 communities were randomized to intervention group~The study was conducted at the community level."|
3145373|NCT01767506|3871265|FG001|STARTED|Overall Study|"26 communities were randomized to control group~The study was conducted at the community level."|
3145374|NCT01767506|3871264|FG000|COMPLETED|Overall Study|The study was conducted at the community level.|
3145375|NCT01767506|3871265|FG001|COMPLETED|Overall Study|The study was conducted at the community level.|
3145376|NCT01767506|3871264|FG000|NOT COMPLETED|Overall Study||
3145377|NCT01767506|3871265|FG001|NOT COMPLETED|Overall Study||
3145378|NCT01767519|3871274|FG000|STARTED|Overall Study||145
3145379|NCT01767519|3871275|FG001|STARTED|Overall Study||151
3145380|NCT01767519|3871276|FG002|STARTED|Overall Study||60
3145381|NCT01767519|3871274|FG000|COMPLETED|Overall Study||131
3145382|NCT01767519|3871275|FG001|COMPLETED|Overall Study||138
3145383|NCT01767519|3871276|FG002|COMPLETED|Overall Study||55
3145384|NCT01767519|3871274|FG000|NOT COMPLETED|Overall Study||14
3145385|NCT01767519|3871275|FG001|NOT COMPLETED|Overall Study||13
3181194|NCT01995357|3909635|FG002|STARTED|Period 3||4
3181195|NCT01995357|3909636|FG003|STARTED|Period 3||3
3181196|NCT01995357|3909637|FG004|STARTED|Period 3||4
3181197|NCT01995357|3909638|FG005|STARTED|Period 3||4
3363559|NCT04055519|4094689|FG001|COMPLETED|First Wear Period (30 Days)||20
3145386|NCT01767519|3871276|FG002|NOT COMPLETED|Overall Study||5
3145387|NCT01767597|3871286|FG000|STARTED|Overall Study||500
3145388|NCT01767597|3871287|FG001|STARTED|Overall Study||500
3145389|NCT01767597|3871286|FG000|COMPLETED|Overall Study||496
3145390|NCT01767597|3871287|FG001|COMPLETED|Overall Study||499
3145391|NCT01767597|3871286|FG000|NOT COMPLETED|Overall Study||4
3145392|NCT01767597|3871287|FG001|NOT COMPLETED|Overall Study||1
3181198|NCT01995357|3909633|FG000|COMPLETED|Period 3||4
3145393|NCT01767636|3871293|FG000|STARTED|Overall Study||38
3145394|NCT01767636|3871293|FG000|COMPLETED|Overall Study||35
3145395|NCT01767636|3871293|FG000|NOT COMPLETED|Overall Study||3
3145396|NCT01767688|3871299|FG000|STARTED|Overall Study||8
3145397|NCT01767688|3871300|FG001|STARTED|Overall Study||8
3145398|NCT01767688|3871299|FG000|COMPLETED|Overall Study||8
3145399|NCT01767688|3871300|FG001|COMPLETED|Overall Study||8
3145400|NCT01767688|3871299|FG000|NOT COMPLETED|Overall Study||0
3145401|NCT01767688|3871300|FG001|NOT COMPLETED|Overall Study||0
3145402|NCT01767701|3871306|FG000|STARTED|Overall Study|All 20 patients who entered the treatment phase completed the six months trial period.|20
3145403|NCT01767701|3871306|FG000|COMPLETED|Overall Study||20
3145404|NCT01767701|3871306|FG000|NOT COMPLETED|Overall Study||0
3145405|NCT01767792|3871311|FG000|STARTED|Overall Study||22
3145406|NCT01767792|3871311|FG000|COMPLETED|Overall Study||20
3145407|NCT01767792|3871311|FG000|NOT COMPLETED|Overall Study||2
3145408|NCT01767857|3871318|FG000|STARTED|Overall Study||430
3145409|NCT01767857|3871319|FG001|STARTED|Overall Study||213
3145410|NCT01767857|3871318|FG000|Treated|Overall Study||411
3145411|NCT01767857|3871319|FG001|Treated|Overall Study||200
3145412|NCT01767857|3871318|FG000|COMPLETED|Overall Study||0
3145413|NCT01767857|3871319|FG001|COMPLETED|Overall Study||0
3145414|NCT01767857|3871318|FG000|NOT COMPLETED|Overall Study||430
3145415|NCT01767857|3871319|FG001|NOT COMPLETED|Overall Study||213
3145416|NCT01767909|3871328|FG000|STARTED|Overall Study||121
3145417|NCT01767909|3871329|FG001|STARTED|Overall Study||119
3145418|NCT01767909|3871328|FG000|COMPLETED|Overall Study||108
3145419|NCT01767909|3871329|FG001|COMPLETED|Overall Study||107
3145420|NCT01767909|3871328|FG000|NOT COMPLETED|Overall Study||13
3145421|NCT01767909|3871329|FG001|NOT COMPLETED|Overall Study||12
3145422|NCT01767935|3871337|FG000|STARTED|Overall Study||1
3145423|NCT01767935|3871337|FG000|COMPLETED|Overall Study||1
3145424|NCT01767935|3871337|FG000|NOT COMPLETED|Overall Study||0
3145425|NCT01767987|3871343|FG000|STARTED|Overall Study||4
3145426|NCT01767987|3871344|FG001|STARTED|Overall Study||2
3145427|NCT01767987|3871343|FG000|COMPLETED|Overall Study||0
3145428|NCT01767987|3871344|FG001|COMPLETED|Overall Study||1
3145429|NCT01767987|3871343|FG000|NOT COMPLETED|Overall Study||4
3145430|NCT01767987|3871344|FG001|NOT COMPLETED|Overall Study||1
3145431|NCT01768000|3871354|FG000|STARTED|Overall Study||10
3145432|NCT01768000|3871355|FG001|STARTED|Overall Study||10
3145433|NCT01768000|3871356|FG002|STARTED|Overall Study||10
3145434|NCT01768000|3871357|FG003|STARTED|Overall Study||10
3145435|NCT01768000|3871354|FG000|COMPLETED|Overall Study||9
3145436|NCT01768000|3871355|FG001|COMPLETED|Overall Study||8
3145437|NCT01768000|3871356|FG002|COMPLETED|Overall Study||9
3145438|NCT01768000|3871357|FG003|COMPLETED|Overall Study||8
3145439|NCT01768000|3871354|FG000|NOT COMPLETED|Overall Study||1
3145440|NCT01768000|3871355|FG001|NOT COMPLETED|Overall Study||2
3145441|NCT01768000|3871356|FG002|NOT COMPLETED|Overall Study||1
3145442|NCT01768000|3871357|FG003|NOT COMPLETED|Overall Study||2
3145443|NCT01768013|3871369|FG000|STARTED|Overall Study||13
3145444|NCT01768013|3871369|FG000|COMPLETED|Overall Study||13
3145445|NCT01768013|3871369|FG000|NOT COMPLETED|Overall Study||0
3145446|NCT01768117|3871373|FG000|STARTED|Overall Study||13
3145447|NCT01768117|3871373|FG000|COMPLETED|Overall Study||7
3145448|NCT01768117|3871373|FG000|NOT COMPLETED|Overall Study||6
3145449|NCT01768286|3871381|FG000|STARTED|Overall Study||109
3145450|NCT01768286|3871382|FG001|STARTED|Overall Study||111
3145451|NCT01768286|3871383|FG002|STARTED|Overall Study||110
3145452|NCT01768286|3871384|FG003|STARTED|Overall Study||111
3145453|NCT01768286|3871381|FG000|COMPLETED|Overall Study||102
3145454|NCT01768286|3871382|FG001|COMPLETED|Overall Study||107
3145455|NCT01768286|3871383|FG002|COMPLETED|Overall Study||108
3145456|NCT01768286|3871384|FG003|COMPLETED|Overall Study||110
3145457|NCT01768286|3871381|FG000|NOT COMPLETED|Overall Study||7
3145458|NCT01768286|3871382|FG001|NOT COMPLETED|Overall Study||4
3145459|NCT01768286|3871383|FG002|NOT COMPLETED|Overall Study||2
3145460|NCT01768286|3871384|FG003|NOT COMPLETED|Overall Study||1
3145461|NCT01768325|3871396|FG000|STARTED|Overall Study||37
3145462|NCT01768325|3871397|FG001|STARTED|Overall Study||41
3145463|NCT01768325|3871396|FG000|COMPLETED|Overall Study||37
3145464|NCT01768325|3871397|FG001|COMPLETED|Overall Study||41
3145465|NCT01768325|3871396|FG000|NOT COMPLETED|Overall Study||0
3145466|NCT01768325|3871397|FG001|NOT COMPLETED|Overall Study||0
3145467|NCT01768520|3871408|FG000|STARTED|Overall Study||152
3145468|NCT01768520|3871409|FG001|STARTED|Overall Study||147
3145469|NCT01768520|3871410|FG002|STARTED|Overall Study||39
3145470|NCT01768520|3871408|FG000|COMPLETED|Overall Study||120
3145471|NCT01768520|3871409|FG001|COMPLETED|Overall Study||121
3145472|NCT01768520|3871410|FG002|COMPLETED|Overall Study||30
3145473|NCT01768520|3871408|FG000|NOT COMPLETED|Overall Study||32
3145474|NCT01768520|3871409|FG001|NOT COMPLETED|Overall Study||26
3145475|NCT01768520|3871410|FG002|NOT COMPLETED|Overall Study||9
3145476|NCT01768559|3871421|FG000|STARTED|Overall Study||298
3145477|NCT01768559|3871422|FG001|STARTED|Overall Study||298
3145478|NCT01768559|3871423|FG002|STARTED|Overall Study||298
3145479|NCT01768559|3871421|FG000|Treated|Overall Study||298
3145480|NCT01768559|3871422|FG001|Treated|Overall Study|1 participant received Insulin Glulisine TID (for more than 50%)|298
3145481|NCT01768559|3871423|FG002|Treated|Overall Study|4 participants received Insulin Glulisine QD (for more than 50%)|297
3145482|NCT01768559|3871421|FG000|COMPLETED|Overall Study||268
3145483|NCT01768559|3871422|FG001|COMPLETED|Overall Study||281
3145484|NCT01768559|3871423|FG002|COMPLETED|Overall Study||285
3145485|NCT01768559|3871421|FG000|NOT COMPLETED|Overall Study||30
3145486|NCT01768559|3871422|FG001|NOT COMPLETED|Overall Study||17
3145487|NCT01768559|3871423|FG002|NOT COMPLETED|Overall Study||13
3145488|NCT01768572|3871438|FG000|STARTED|Overall Study||49
3145489|NCT01768572|3871439|FG001|STARTED|Overall Study||51
3145490|NCT01768572|3871440|FG002|STARTED|Overall Study||102
3145491|NCT01768572|3871438|FG000|COMPLETED|Overall Study||40
3145492|NCT01768572|3871439|FG001|COMPLETED|Overall Study||39
3145493|NCT01768572|3871440|FG002|COMPLETED|Overall Study||96
3145494|NCT01768572|3871438|FG000|NOT COMPLETED|Overall Study||9
3145495|NCT01768572|3871439|FG001|NOT COMPLETED|Overall Study||12
3145496|NCT01768572|3871440|FG002|NOT COMPLETED|Overall Study||6
3145497|NCT01768637|3871450|FG000|STARTED|Overall Study||29
3145498|NCT01768637|3871451|FG001|STARTED|Overall Study||19
3145499|NCT01768637|3871450|FG000|Completed Visit 1|Overall Study||28
3145500|NCT01768637|3871451|FG001|Completed Visit 1|Overall Study||16
3145501|NCT01768637|3871450|FG000|Completed Visit 2|Overall Study||26
3145502|NCT01768637|3871451|FG001|Completed Visit 2|Overall Study||13
3145503|NCT01768637|3871450|FG000|COMPLETED|Overall Study||26
3145504|NCT01768637|3871451|FG001|COMPLETED|Overall Study||12
3145505|NCT01768637|3871450|FG000|NOT COMPLETED|Overall Study||3
3145506|NCT01768637|3871451|FG001|NOT COMPLETED|Overall Study||7
3145507|NCT01768676|3871459|FG000|STARTED|Overall Study||90
3145508|NCT01768676|3871460|FG001|STARTED|Overall Study||91
3145509|NCT01768676|3871459|FG000|COMPLETED|Overall Study||66
3145510|NCT01768676|3871460|FG001|COMPLETED|Overall Study||60
3145511|NCT01768676|3871459|FG000|NOT COMPLETED|Overall Study||24
3145512|NCT01768676|3871460|FG001|NOT COMPLETED|Overall Study||31
3145513|NCT01768832|3871469|FG000|STARTED|Overall Study||41
3145514|NCT01768832|3871470|FG001|STARTED|Overall Study||43
3145515|NCT01768832|3871471|FG002|STARTED|Overall Study||35
3145516|NCT01768832|3871469|FG000|COMPLETED|Overall Study||31
3145517|NCT01768832|3871470|FG001|COMPLETED|Overall Study||39
3145518|NCT01768832|3871471|FG002|COMPLETED|Overall Study||26
3145519|NCT01768832|3871469|FG000|NOT COMPLETED|Overall Study||10
3145520|NCT01768832|3871470|FG001|NOT COMPLETED|Overall Study||4
3145521|NCT01768832|3871471|FG002|NOT COMPLETED|Overall Study||9
3145522|NCT01768845|3871479|FG000|STARTED|Overall Study||34
3145523|NCT01768845|3871479|FG000|COMPLETED|Overall Study||11
3145524|NCT01768845|3871479|FG000|NOT COMPLETED|Overall Study||23
3145525|NCT01768858|3871483|FG000|STARTED|Overall Study||96
3145526|NCT01768858|3871483|FG000|COMPLETED|Overall Study||74
3145527|NCT01768858|3871483|FG000|NOT COMPLETED|Overall Study||22
3145528|NCT01769105|3871489|FG000|STARTED|First Intervention||16
3145529|NCT01769105|3871490|FG001|STARTED|First Intervention||19
3145530|NCT01769105|3871489|FG000|COMPLETED|First Intervention||14
3145531|NCT01769105|3871490|FG001|COMPLETED|First Intervention||17
3145532|NCT01769105|3871489|FG000|NOT COMPLETED|First Intervention||2
3145533|NCT01769105|3871490|FG001|NOT COMPLETED|First Intervention||2
3145534|NCT01769105|3871489|FG000|STARTED|Cross-over||14
3145535|NCT01769105|3871490|FG001|STARTED|Cross-over|Cross-over was only intended for the Lid margin hygiene group|0
3145536|NCT01769105|3871489|FG000|COMPLETED|Cross-over||9
3145537|NCT01769105|3871490|FG001|COMPLETED|Cross-over|Was not intended by the study protocol|0
3145538|NCT01769105|3871489|FG000|NOT COMPLETED|Cross-over||5
3145539|NCT01769105|3871490|FG001|NOT COMPLETED|Cross-over||0
3145540|NCT01769170|3871500|FG000|STARTED|Overall Study||303
3145541|NCT01769170|3871501|FG001|STARTED|Overall Study||149
3145542|NCT01769170|3871500|FG000|COMPLETED|Overall Study||232
3145543|NCT01769170|3871501|FG001|COMPLETED|Overall Study||122
3145544|NCT01769170|3871500|FG000|NOT COMPLETED|Overall Study||71
3145545|NCT01769170|3871501|FG001|NOT COMPLETED|Overall Study||27
3145546|NCT01769196|3871509|FG000|STARTED|Overall Study||272
3145547|NCT01769196|3871510|FG001|STARTED|Overall Study||272
3145548|NCT01769196|3871509|FG000|COMPLETED|Overall Study||0
3145549|NCT01769196|3871510|FG001|COMPLETED|Overall Study||0
3145550|NCT01769196|3871509|FG000|NOT COMPLETED|Overall Study||272
3145551|NCT01769196|3871510|FG001|NOT COMPLETED|Overall Study||272
3145552|NCT01769209|3871516|FG000|STARTED|Overall Study||18
3145553|NCT01769209|3871516|FG000|COMPLETED|Overall Study||18
3145554|NCT01769209|3871516|FG000|NOT COMPLETED|Overall Study||0
3145555|NCT01769222|3871522|FG000|STARTED|Overall Study||3
3145556|NCT01769222|3871523|FG001|STARTED|Overall Study||0
3145557|NCT01769222|3871522|FG000|COMPLETED|Overall Study||3
3145558|NCT01769222|3871523|FG001|COMPLETED|Overall Study||0
3145559|NCT01769222|3871522|FG000|NOT COMPLETED|Overall Study||0
3145560|NCT01769222|3871523|FG001|NOT COMPLETED|Overall Study||0
3145561|NCT01769248|3871531|FG000|STARTED|Overall Study||70
3145562|NCT01769248|3871532|FG001|STARTED|Overall Study||70
3145563|NCT01769248|3871531|FG000|Participants Who Crossed-over|Overall Study||28
3145564|NCT01769248|3871532|FG001|Participants Who Crossed-over|Overall Study||12
3145565|NCT01769248|3871531|FG000|COMPLETED|Overall Study||42
3145566|NCT01769248|3871532|FG001|COMPLETED|Overall Study||58
3145567|NCT01769248|3871531|FG000|NOT COMPLETED|Overall Study||28
3145568|NCT01769248|3871532|FG001|NOT COMPLETED|Overall Study||12
3145569|NCT01769274|3871540|FG000|STARTED|Part A||5
3145570|NCT01769274|3871541|FG001|STARTED|Part A||0
3145571|NCT01769274|3871542|FG002|STARTED|Part A||0
3145572|NCT01769274|3871540|FG000|COMPLETED|Part A||5
3145573|NCT01769274|3871541|FG001|COMPLETED|Part A||0
3145574|NCT01769274|3871542|FG002|COMPLETED|Part A||0
3145575|NCT01769274|3871540|FG000|NOT COMPLETED|Part A||0
3145576|NCT01769274|3871541|FG001|NOT COMPLETED|Part A||0
3145577|NCT01769274|3871542|FG002|NOT COMPLETED|Part A||0
3145578|NCT01769274|3871540|FG000|STARTED|Part B:Treatment Session1-Period1||0
3145579|NCT01769274|3871541|FG001|STARTED|Part B:Treatment Session1-Period1||2
3145580|NCT01769274|3871542|FG002|STARTED|Part B:Treatment Session1-Period1||3
3145581|NCT01769274|3871540|FG000|COMPLETED|Part B:Treatment Session1-Period1||0
3145582|NCT01769274|3871541|FG001|COMPLETED|Part B:Treatment Session1-Period1||2
3145583|NCT01769274|3871542|FG002|COMPLETED|Part B:Treatment Session1-Period1||3
3145584|NCT01769274|3871540|FG000|NOT COMPLETED|Part B:Treatment Session1-Period1||0
3145585|NCT01769274|3871541|FG001|NOT COMPLETED|Part B:Treatment Session1-Period1||0
3145586|NCT01769274|3871542|FG002|NOT COMPLETED|Part B:Treatment Session1-Period1||0
3145587|NCT01769274|3871540|FG000|STARTED|Washout Period||0
3145588|NCT01769274|3871541|FG001|STARTED|Washout Period||2
3145589|NCT01769274|3871542|FG002|STARTED|Washout Period||3
3145590|NCT01769274|3871540|FG000|COMPLETED|Washout Period||0
3145591|NCT01769274|3871541|FG001|COMPLETED|Washout Period||2
3145592|NCT01769274|3871542|FG002|COMPLETED|Washout Period||3
3145593|NCT01769274|3871540|FG000|NOT COMPLETED|Washout Period||0
3145594|NCT01769274|3871541|FG001|NOT COMPLETED|Washout Period||0
3145595|NCT01769274|3871542|FG002|NOT COMPLETED|Washout Period||0
3145596|NCT01769274|3871540|FG000|STARTED|Part B:Treatment Session1-Period2||0
3145597|NCT01769274|3871541|FG001|STARTED|Part B:Treatment Session1-Period2||2
3145598|NCT01769274|3871542|FG002|STARTED|Part B:Treatment Session1-Period2||3
3145599|NCT01769274|3871540|FG000|COMPLETED|Part B:Treatment Session1-Period2||0
3145600|NCT01769274|3871541|FG001|COMPLETED|Part B:Treatment Session1-Period2||2
3145601|NCT01769274|3871542|FG002|COMPLETED|Part B:Treatment Session1-Period2||3
3145602|NCT01769274|3871540|FG000|NOT COMPLETED|Part B:Treatment Session1-Period2||0
3145603|NCT01769274|3871541|FG001|NOT COMPLETED|Part B:Treatment Session1-Period2||0
3145604|NCT01769274|3871542|FG002|NOT COMPLETED|Part B:Treatment Session1-Period2||0
3145605|NCT01769274|3871540|FG000|STARTED|Washout Period||0
3145606|NCT01769274|3871541|FG001|STARTED|Washout Period||2
3145607|NCT01769274|3871542|FG002|STARTED|Washout Period||3
3145608|NCT01769274|3871540|FG000|COMPLETED|Washout Period||0
3145609|NCT01769274|3871541|FG001|COMPLETED|Washout Period||2
3145610|NCT01769274|3871542|FG002|COMPLETED|Washout Period||3
3145611|NCT01769274|3871540|FG000|NOT COMPLETED|Washout Period||0
3145612|NCT01769274|3871541|FG001|NOT COMPLETED|Washout Period||0
3145613|NCT01769274|3871542|FG002|NOT COMPLETED|Washout Period||0
3145614|NCT01769274|3871540|FG000|STARTED|Part B:Treatment Session2-Period3||0
3145615|NCT01769274|3871541|FG001|STARTED|Part B:Treatment Session2-Period3||2
3145616|NCT01769274|3871542|FG002|STARTED|Part B:Treatment Session2-Period3||3
3145617|NCT01769274|3871540|FG000|COMPLETED|Part B:Treatment Session2-Period3||0
3145618|NCT01769274|3871541|FG001|COMPLETED|Part B:Treatment Session2-Period3||2
3145619|NCT01769274|3871542|FG002|COMPLETED|Part B:Treatment Session2-Period3||3
3145620|NCT01769274|3871540|FG000|NOT COMPLETED|Part B:Treatment Session2-Period3||0
3145621|NCT01769274|3871541|FG001|NOT COMPLETED|Part B:Treatment Session2-Period3||0
3145622|NCT01769274|3871542|FG002|NOT COMPLETED|Part B:Treatment Session2-Period3||0
3145623|NCT01769274|3871540|FG000|STARTED|Washout Period||0
3145624|NCT01769274|3871541|FG001|STARTED|Washout Period||2
3145625|NCT01769274|3871542|FG002|STARTED|Washout Period||3
3145626|NCT01769274|3871540|FG000|COMPLETED|Washout Period||0
3145627|NCT01769274|3871541|FG001|COMPLETED|Washout Period||2
3145628|NCT01769274|3871542|FG002|COMPLETED|Washout Period||3
3145629|NCT01769274|3871540|FG000|NOT COMPLETED|Washout Period||0
3145630|NCT01769274|3871541|FG001|NOT COMPLETED|Washout Period||0
3145631|NCT01769274|3871542|FG002|NOT COMPLETED|Washout Period||0
3145632|NCT01769274|3871540|FG000|STARTED|Part B:Treatment Session2-Period4||0
3145633|NCT01769274|3871541|FG001|STARTED|Part B:Treatment Session2-Period4||2
3145634|NCT01769274|3871542|FG002|STARTED|Part B:Treatment Session2-Period4||3
3145635|NCT01769274|3871540|FG000|COMPLETED|Part B:Treatment Session2-Period4||0
3145636|NCT01769274|3871541|FG001|COMPLETED|Part B:Treatment Session2-Period4||2
3145637|NCT01769274|3871542|FG002|COMPLETED|Part B:Treatment Session2-Period4||3
3145638|NCT01769274|3871540|FG000|NOT COMPLETED|Part B:Treatment Session2-Period4||0
3145639|NCT01769274|3871541|FG001|NOT COMPLETED|Part B:Treatment Session2-Period4||0
3145640|NCT01769274|3871542|FG002|NOT COMPLETED|Part B:Treatment Session2-Period4||0
3145641|NCT01769326|3871557|FG000|STARTED|Overall Study||11
3145642|NCT01769326|3871558|FG001|STARTED|Overall Study||12
3145643|NCT01769326|3871559|FG002|STARTED|Overall Study||9
3145644|NCT01769326|3871560|FG003|STARTED|Overall Study||8
3145645|NCT01769326|3871557|FG000|COMPLETED|Overall Study||9
3145646|NCT01769326|3871558|FG001|COMPLETED|Overall Study||8
3145647|NCT01769326|3871559|FG002|COMPLETED|Overall Study||8
3145648|NCT01769326|3871560|FG003|COMPLETED|Overall Study||8
3145649|NCT01769326|3871557|FG000|NOT COMPLETED|Overall Study||2
3145650|NCT01769326|3871558|FG001|NOT COMPLETED|Overall Study||4
3145651|NCT01769326|3871559|FG002|NOT COMPLETED|Overall Study||1
3145652|NCT01769326|3871560|FG003|NOT COMPLETED|Overall Study||0
3145653|NCT01769339|3871570|FG000|STARTED|Overall Study||115
3145654|NCT01769339|3871570|FG000|COMPLETED|Overall Study||72
3145655|NCT01769339|3871570|FG000|NOT COMPLETED|Overall Study||43
3145656|NCT01769352|3871578|FG000|STARTED|Overall Study||13
3145657|NCT01769352|3871579|FG001|STARTED|Overall Study||12
3145658|NCT01769352|3871580|FG002|STARTED|Overall Study||9
3145659|NCT01769352|3871581|FG003|STARTED|Overall Study||8
3145660|NCT01769352|3871578|FG000|COMPLETED|Overall Study||13
3145661|NCT01769352|3871579|FG001|COMPLETED|Overall Study||12
3145662|NCT01769352|3871580|FG002|COMPLETED|Overall Study||9
3145663|NCT01769352|3871581|FG003|COMPLETED|Overall Study||8
3145664|NCT01769352|3871578|FG000|NOT COMPLETED|Overall Study||0
3145665|NCT01769352|3871579|FG001|NOT COMPLETED|Overall Study||0
3145666|NCT01769352|3871580|FG002|NOT COMPLETED|Overall Study||0
3145667|NCT01769352|3871581|FG003|NOT COMPLETED|Overall Study||0
3145668|NCT01769365|3871595|FG000|STARTED|Overall Study||102
3145669|NCT01769365|3871596|FG001|STARTED|Overall Study||102
3145670|NCT01769365|3871597|FG002|STARTED|Overall Study||103
3145671|NCT01769365|3871595|FG000|COMPLETED|Overall Study||102
3145672|NCT01769365|3871596|FG001|COMPLETED|Overall Study||100
3145673|NCT01769365|3871597|FG002|COMPLETED|Overall Study||101
3145674|NCT01769365|3871595|FG000|NOT COMPLETED|Overall Study||0
3145675|NCT01769365|3871596|FG001|NOT COMPLETED|Overall Study||2
3145676|NCT01769365|3871597|FG002|NOT COMPLETED|Overall Study||2
3145677|NCT01769378|3871607|FG000|STARTED|Overall Study||240
3145678|NCT01769378|3871608|FG001|STARTED|Overall Study||60
3145679|NCT01769378|3871607|FG000|Received at Least 1 Dose of Study Drug|Overall Study||239
3145680|NCT01769378|3871608|FG001|Received at Least 1 Dose of Study Drug|Overall Study||60
3145681|NCT01769378|3871607|FG000|COMPLETED|Overall Study|Completed the study on study treatment|215
3145682|NCT01769378|3871608|FG001|COMPLETED|Overall Study|Completed the study on study treatment|56
3145683|NCT01769378|3871607|FG000|NOT COMPLETED|Overall Study||25
3145684|NCT01769378|3871608|FG001|NOT COMPLETED|Overall Study||4
3145685|NCT01769391|3871616|FG000|STARTED|Overall Study||110
3145686|NCT01769391|3871617|FG001|STARTED|Overall Study||57
3145687|NCT01769391|3871616|FG000|Received at Least One Dose of Study Drug|Overall Study||106
3145688|NCT01769391|3871617|FG001|Received at Least One Dose of Study Drug|Overall Study||55
3145689|NCT01769391|3871616|FG000|COMPLETED|Overall Study||93
3145690|NCT01769391|3871617|FG001|COMPLETED|Overall Study||48
3145691|NCT01769391|3871616|FG000|NOT COMPLETED|Overall Study||17
3145692|NCT01769391|3871617|FG001|NOT COMPLETED|Overall Study||9
3145693|NCT01769404|3871629|FG000|STARTED|Treatment Period 1||12
3145694|NCT01769404|3871630|FG001|STARTED|Treatment Period 1||13
3145695|NCT01769404|3871629|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 1||9
3145696|NCT01769404|3871630|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 1||13
3145697|NCT01769404|3871629|FG000|COMPLETED|Treatment Period 1||7
3145698|NCT01769404|3871630|FG001|COMPLETED|Treatment Period 1||13
3145699|NCT01769404|3871629|FG000|NOT COMPLETED|Treatment Period 1||5
3145700|NCT01769404|3871630|FG001|NOT COMPLETED|Treatment Period 1||0
3145701|NCT01769404|3871629|FG000|STARTED|Treatment Period 2||7
3145702|NCT01769404|3871630|FG001|STARTED|Treatment Period 2||13
3145703|NCT01769404|3871629|FG000|COMPLETED|Treatment Period 2||0
3145704|NCT01769404|3871630|FG001|COMPLETED|Treatment Period 2||13
3145705|NCT01769404|3871629|FG000|NOT COMPLETED|Treatment Period 2||7
3145706|NCT01769404|3871630|FG001|NOT COMPLETED|Treatment Period 2||0
3145707|NCT01769456|3871638|FG000|STARTED|Overall Study|1 subject inadvertently enrolled, discontin'd after baseline, re-enrolled later and completed study|78
3145708|NCT01769456|3871638|FG000|COMPLETED|Overall Study||41
3145709|NCT01769456|3871638|FG000|NOT COMPLETED|Overall Study||37
3145710|NCT01769469|3871643|FG000|STARTED|Overall Study||101
3145711|NCT01769469|3871643|FG000|COMPLETED|Overall Study||66
3145712|NCT01769469|3871643|FG000|NOT COMPLETED|Overall Study||35
3145713|NCT01769508|3871649|FG000|STARTED|Overall Study||12
3145714|NCT01769508|3871649|FG000|COMPLETED|Overall Study||6
3145715|NCT01769508|3871649|FG000|NOT COMPLETED|Overall Study||6
3145716|NCT01769573|3871658|FG000|STARTED|Overall Study||10
3181199|NCT01995357|3909634|FG001|COMPLETED|Period 3||3
3181200|NCT01995357|3909635|FG002|COMPLETED|Period 3||4
3181201|NCT01995357|3909636|FG003|COMPLETED|Period 3||3
3181202|NCT01995357|3909637|FG004|COMPLETED|Period 3||4
3181203|NCT01995357|3909638|FG005|COMPLETED|Period 3||4
3181204|NCT01995357|3909633|FG000|NOT COMPLETED|Period 3||0
3181205|NCT01995357|3909634|FG001|NOT COMPLETED|Period 3||0
3181206|NCT01995357|3909635|FG002|NOT COMPLETED|Period 3||0
3181207|NCT01995357|3909636|FG003|NOT COMPLETED|Period 3||0
3181208|NCT01995357|3909637|FG004|NOT COMPLETED|Period 3||0
3181209|NCT01995357|3909638|FG005|NOT COMPLETED|Period 3||0
3181210|NCT01995357|3909633|FG000|STARTED|Period 4||4
3181211|NCT01995357|3909634|FG001|STARTED|Period 4||3
3181212|NCT01995357|3909635|FG002|STARTED|Period 4|The subject who did not complete period 5, erroneously used product A when B should have been used.|4
3181213|NCT01995357|3909636|FG003|STARTED|Period 4||3
3181214|NCT01995357|3909637|FG004|STARTED|Period 4||4
3181215|NCT01995357|3909638|FG005|STARTED|Period 4||4
3181216|NCT01995357|3909633|FG000|COMPLETED|Period 4||4
3181217|NCT01995357|3909634|FG001|COMPLETED|Period 4||3
3181218|NCT01995357|3909635|FG002|COMPLETED|Period 4||4
3181219|NCT01995357|3909636|FG003|COMPLETED|Period 4||3
3181220|NCT01995357|3909637|FG004|COMPLETED|Period 4||4
3181221|NCT01995357|3909638|FG005|COMPLETED|Period 4||4
3181222|NCT01995357|3909633|FG000|NOT COMPLETED|Period 4||0
3145717|NCT01769573|3871659|FG001|STARTED|Overall Study||6
3145718|NCT01769573|3871660|FG002|STARTED|Overall Study||10
3145719|NCT01769573|3871661|FG003|STARTED|Overall Study||0
3145720|NCT01769573|3871662|FG004|STARTED|Overall Study||10
3145721|NCT01769573|3871658|FG000|COMPLETED|Overall Study||10
3145722|NCT01769573|3871659|FG001|COMPLETED|Overall Study||6
3145723|NCT01769573|3871660|FG002|COMPLETED|Overall Study||10
3145724|NCT01769573|3871661|FG003|COMPLETED|Overall Study||0
3145725|NCT01769573|3871662|FG004|COMPLETED|Overall Study||10
3145726|NCT01769573|3871658|FG000|NOT COMPLETED|Overall Study||0
3181223|NCT01995357|3909634|FG001|NOT COMPLETED|Period 4||0
3145727|NCT01769573|3871659|FG001|NOT COMPLETED|Overall Study||0
3145728|NCT01769573|3871660|FG002|NOT COMPLETED|Overall Study||0
3145729|NCT01769573|3871661|FG003|NOT COMPLETED|Overall Study||0
3145730|NCT01769573|3871662|FG004|NOT COMPLETED|Overall Study||0
3145731|NCT01769586|3871676|FG000|STARTED|Overall Study||100
3145732|NCT01769586|3871677|FG001|STARTED|Overall Study||100
3145733|NCT01769586|3871676|FG000|COMPLETED|Overall Study||100
3145734|NCT01769586|3871677|FG001|COMPLETED|Overall Study||100
3145735|NCT01769586|3871676|FG000|NOT COMPLETED|Overall Study||0
3145736|NCT01769586|3871677|FG001|NOT COMPLETED|Overall Study||0
3145737|NCT01769612|3871683|FG000|STARTED|Overall Study||168
3145738|NCT01769612|3871683|FG000|COMPLETED|Overall Study||168
3145739|NCT01769612|3871683|FG000|NOT COMPLETED|Overall Study||0
3145740|NCT01770145|3871689|FG000|STARTED|Baseline||127
3145741|NCT01770145|3871689|FG000|COMPLETED|Baseline||101
3145742|NCT01770145|3871689|FG000|NOT COMPLETED|Baseline||26
3145743|NCT01770145|3871689|FG000|STARTED|Treatment||101
3145744|NCT01770145|3871689|FG000|COMPLETED|Treatment||97
3145745|NCT01770145|3871689|FG000|NOT COMPLETED|Treatment||4
3145746|NCT01770314|3871695|FG000|STARTED|Overall Study||86
3145747|NCT01770314|3871696|FG001|STARTED|Overall Study||90
3145748|NCT01770314|3871695|FG000|Contributed Data to Baseline|Overall Study||68
3145749|NCT01770314|3871696|FG001|Contributed Data to Baseline|Overall Study||72
3145750|NCT01770314|3871695|FG000|Contributed Data to Post-test|Overall Study||65
3145751|NCT01770314|3871696|FG001|Contributed Data to Post-test|Overall Study||67
3145752|NCT01770314|3871695|FG000|Contributed Data to One-month Follow-up|Overall Study||61
3145753|NCT01770314|3871696|FG001|Contributed Data to One-month Follow-up|Overall Study||66
3145754|NCT01770314|3871695|FG000|COMPLETED|Overall Study||86
3145755|NCT01770314|3871696|FG001|COMPLETED|Overall Study||90
3145756|NCT01770314|3871695|FG000|NOT COMPLETED|Overall Study||0
3145757|NCT01770314|3871696|FG001|NOT COMPLETED|Overall Study||0
3145758|NCT01770353|3871704|FG000|STARTED|Overall Study||15
3145759|NCT01770353|3871705|FG001|STARTED|Overall Study||30
3145760|NCT01770353|3871704|FG000|Received FMX|Overall Study|2 subjects excluded from MM-398 safety population.|15
3145761|NCT01770353|3871705|FG001|Received FMX|Overall Study|1 subject excluded from MM-398 safety population.|30
3145762|NCT01770353|3871704|FG000|Received FMX and MM-398|Overall Study||13
3145763|NCT01770353|3871705|FG001|Received FMX and MM-398|Overall Study||29
3145764|NCT01770353|3871704|FG000|COMPLETED|Overall Study||9
3145765|NCT01770353|3871705|FG001|COMPLETED|Overall Study||18
3145766|NCT01770353|3871704|FG000|NOT COMPLETED|Overall Study||6
3145767|NCT01770353|3871705|FG001|NOT COMPLETED|Overall Study||12
3181224|NCT01995357|3909635|FG002|NOT COMPLETED|Period 4||0
3181225|NCT01995357|3909636|FG003|NOT COMPLETED|Period 4||0
3181226|NCT01995357|3909637|FG004|NOT COMPLETED|Period 4||0
3181227|NCT01995357|3909638|FG005|NOT COMPLETED|Period 4||0
3181228|NCT01995357|3909633|FG000|STARTED|Period 5|The two discontinued subjects tested zero planned B products in period 5.|4
3181229|NCT01995357|3909634|FG001|STARTED|Period 5||3
3181230|NCT01995357|3909635|FG002|STARTED|Period 5||4
3181231|NCT01995357|3909636|FG003|STARTED|Period 5||3
3181232|NCT01995357|3909637|FG004|STARTED|Period 5|1 subject terminated due to an adverse event. Subject counted as completed as some B products tested|4
3181233|NCT01995357|3909638|FG005|STARTED|Period 5||4
3181234|NCT01995357|3909633|FG000|COMPLETED|Period 5||2
3181235|NCT01995357|3909634|FG001|COMPLETED|Period 5||3
3181236|NCT01995357|3909635|FG002|COMPLETED|Period 5||3
3181237|NCT01995357|3909636|FG003|COMPLETED|Period 5||3
3181238|NCT01995357|3909637|FG004|COMPLETED|Period 5||4
3181239|NCT01995357|3909638|FG005|COMPLETED|Period 5||4
3181240|NCT01995357|3909633|FG000|NOT COMPLETED|Period 5||2
3181241|NCT01995357|3909634|FG001|NOT COMPLETED|Period 5||0
3181242|NCT01995357|3909635|FG002|NOT COMPLETED|Period 5||1
3181243|NCT01995357|3909636|FG003|NOT COMPLETED|Period 5||0
3181244|NCT01995357|3909637|FG004|NOT COMPLETED|Period 5||0
3181245|NCT01995357|3909638|FG005|NOT COMPLETED|Period 5||0
3181246|NCT01995461|3909654|FG000|STARTED|Overall Study||26
3181247|NCT01995461|3909654|FG000|COMPLETED|Overall Study||21
3181248|NCT01995461|3909654|FG000|NOT COMPLETED|Overall Study||5
3181249|NCT01995487|3909660|FG000|STARTED|Overall Study||958
3181250|NCT01995487|3909661|FG001|STARTED|Overall Study||961
3181251|NCT01995487|3909660|FG000|COMPLETED|Overall Study||884
3181252|NCT01995487|3909661|FG001|COMPLETED|Overall Study||878
3181253|NCT01995487|3909660|FG000|NOT COMPLETED|Overall Study||74
3181254|NCT01995487|3909661|FG001|NOT COMPLETED|Overall Study||83
3181255|NCT01995513|3909667|FG000|STARTED|Open Label Treatment Period||509
3181256|NCT01995513|3909668|FG001|STARTED|Open Label Treatment Period||0
3181257|NCT01995513|3909669|FG002|STARTED|Open Label Treatment Period||0
3181258|NCT01995513|3909667|FG000|COMPLETED|Open Label Treatment Period||251
3181259|NCT01995513|3909668|FG001|COMPLETED|Open Label Treatment Period||0
3181260|NCT01995513|3909669|FG002|COMPLETED|Open Label Treatment Period||0
3181261|NCT01995513|3909667|FG000|NOT COMPLETED|Open Label Treatment Period||258
3181262|NCT01995513|3909668|FG001|NOT COMPLETED|Open Label Treatment Period||0
3181263|NCT01995513|3909669|FG002|NOT COMPLETED|Open Label Treatment Period||0
3181264|NCT01995513|3909667|FG000|STARTED|Double Blind Treatment Period||0
3181265|NCT01995513|3909668|FG001|STARTED|Double Blind Treatment Period||126
3181266|NCT01995513|3909669|FG002|STARTED|Double Blind Treatment Period||125
3181267|NCT01995513|3909667|FG000|Treated|Double Blind Treatment Period||0
3181268|NCT01995513|3909668|FG001|Treated|Double Blind Treatment Period||125
3181269|NCT01995513|3909669|FG002|Treated|Double Blind Treatment Period||124
3145768|NCT01770366|3871721|FG000|STARTED|Overall Study||4
3145769|NCT01770366|3871722|FG001|STARTED|Overall Study||6
3145770|NCT01770366|3871721|FG000|COMPLETED|Overall Study||2
3145771|NCT01770366|3871722|FG001|COMPLETED|Overall Study||4
3145772|NCT01770366|3871721|FG000|NOT COMPLETED|Overall Study||2
3145773|NCT01770366|3871722|FG001|NOT COMPLETED|Overall Study||2
3145774|NCT01770379|3871731|FG000|STARTED|Overall Study||80
3145775|NCT01770379|3871732|FG001|STARTED|Overall Study||81
3145776|NCT01770379|3871733|FG002|STARTED|Overall Study||81
3145777|NCT01770379|3871731|FG000|COMPLETED|Overall Study||41
3145778|NCT01770379|3871732|FG001|COMPLETED|Overall Study||37
3145779|NCT01770379|3871733|FG002|COMPLETED|Overall Study||39
3145780|NCT01770379|3871731|FG000|NOT COMPLETED|Overall Study||39
3145781|NCT01770379|3871732|FG001|NOT COMPLETED|Overall Study||44
3145782|NCT01770379|3871733|FG002|NOT COMPLETED|Overall Study||42
3145783|NCT01770392|3871743|FG000|STARTED|Nintedanib||26
3145784|NCT01770392|3871743|FG000|COMPLETED|Nintedanib||26
3145785|NCT01770392|3871743|FG000|NOT COMPLETED|Nintedanib||0
3145786|NCT01770392|3871743|FG000|STARTED|Washout Period of at Least 14 Days||26
3145787|NCT01770392|3871743|FG000|COMPLETED|Washout Period of at Least 14 Days||25
3145788|NCT01770392|3871743|FG000|NOT COMPLETED|Washout Period of at Least 14 Days||1
3145789|NCT01770392|3871743|FG000|STARTED|Nintedanib+ Rifampicin||25
3145790|NCT01770392|3871743|FG000|COMPLETED|Nintedanib+ Rifampicin||25
3145791|NCT01770392|3871743|FG000|NOT COMPLETED|Nintedanib+ Rifampicin||0
3145792|NCT01770431|3871755|FG000|STARTED|Overall Study||696
3145793|NCT01770431|3871756|FG001|STARTED|Overall Study||348
3145794|NCT01770431|3871755|FG000|COMPLETED|Overall Study||686
3145795|NCT01770431|3871756|FG001|COMPLETED|Overall Study||316
3145796|NCT01770431|3871755|FG000|NOT COMPLETED|Overall Study||10
3145797|NCT01770431|3871756|FG001|NOT COMPLETED|Overall Study||32
3145798|NCT01770483|3871765|FG000|STARTED|Overall Study||33
3145799|NCT01770483|3871766|FG001|STARTED|Overall Study||33
3145800|NCT01770483|3871765|FG000|COMPLETED|Overall Study||33
3145801|NCT01770483|3871766|FG001|COMPLETED|Overall Study||33
3145802|NCT01770483|3871765|FG000|NOT COMPLETED|Overall Study||0
3145803|NCT01770483|3871766|FG001|NOT COMPLETED|Overall Study||0
3145804|NCT01770509|3871774|FG000|STARTED|Overall Study||12
3145805|NCT01770509|3871775|FG001|STARTED|Overall Study||17
3145806|NCT01770509|3871774|FG000|COMPLETED|Overall Study||11
3145807|NCT01770509|3871775|FG001|COMPLETED|Overall Study||14
3145808|NCT01770509|3871774|FG000|NOT COMPLETED|Overall Study||1
3145809|NCT01770509|3871775|FG001|NOT COMPLETED|Overall Study||3
3145810|NCT01770652|3871785|FG000|STARTED|Overall Study||8
3145811|NCT01770652|3871786|FG001|STARTED|Overall Study||8
3145812|NCT01770652|3871787|FG002|STARTED|Overall Study||8
3145813|NCT01770652|3871788|FG003|STARTED|Overall Study||8
3145814|NCT01770652|3871785|FG000|COMPLETED|Overall Study||8
3145815|NCT01770652|3871786|FG001|COMPLETED|Overall Study||8
3145816|NCT01770652|3871787|FG002|COMPLETED|Overall Study||8
3145817|NCT01770652|3871788|FG003|COMPLETED|Overall Study||8
3145818|NCT01770652|3871785|FG000|NOT COMPLETED|Overall Study||0
3145819|NCT01770652|3871786|FG001|NOT COMPLETED|Overall Study||0
3145820|NCT01770652|3871787|FG002|NOT COMPLETED|Overall Study||0
3145821|NCT01770652|3871788|FG003|NOT COMPLETED|Overall Study||0
3145822|NCT01770691|3871802|FG000|STARTED|Overall Study||7
3145823|NCT01770691|3871802|FG000|COMPLETED|Overall Study||7
3145824|NCT01770691|3871802|FG000|NOT COMPLETED|Overall Study||0
3145825|NCT01770743|3871814|FG000|STARTED|Overall Study||44
3145826|NCT01770743|3871815|FG001|STARTED|Overall Study||34
3145827|NCT01770743|3871816|FG002|STARTED|Overall Study||23
3145828|NCT01770743|3871817|FG003|STARTED|Overall Study||44
3145829|NCT01770743|3871818|FG004|STARTED|Overall Study||23
3145830|NCT01770743|3871814|FG000|Treated|Overall Study||44
3145831|NCT01770743|3871815|FG001|Treated|Overall Study||34
3145832|NCT01770743|3871816|FG002|Treated|Overall Study||23
3145833|NCT01770743|3871817|FG003|Treated|Overall Study||44
3145834|NCT01770743|3871818|FG004|Treated|Overall Study||23
3145835|NCT01770743|3871814|FG000|COMPLETED|Overall Study||42
3145836|NCT01770743|3871815|FG001|COMPLETED|Overall Study||31
3145837|NCT01770743|3871816|FG002|COMPLETED|Overall Study||22
3145838|NCT01770743|3871817|FG003|COMPLETED|Overall Study||42
3145839|NCT01770743|3871818|FG004|COMPLETED|Overall Study||21
3145840|NCT01770743|3871814|FG000|NOT COMPLETED|Overall Study||2
3145841|NCT01770743|3871815|FG001|NOT COMPLETED|Overall Study||3
3145842|NCT01770743|3871816|FG002|NOT COMPLETED|Overall Study||1
3145843|NCT01770743|3871817|FG003|NOT COMPLETED|Overall Study||2
3145844|NCT01770743|3871818|FG004|NOT COMPLETED|Overall Study||2
3145845|NCT01770860|3871830|FG000|STARTED|Overall Study|Forty-six subjects were enrolled but one subject withdrew before randomization.|46
3145846|NCT01770860|3871830|FG000|Randomization|Overall Study|One participant withdrew before randomization|45
3145847|NCT01770860|3871830|FG000|COMPLETED|Overall Study||40
3145848|NCT01770860|3871830|FG000|NOT COMPLETED|Overall Study||6
3145849|NCT01770912|3871840|FG000|STARTED|Overall Study||12
3145850|NCT01770912|3871841|FG001|STARTED|Overall Study||12
3145851|NCT01770912|3871840|FG000|COMPLETED|Overall Study||10
3145852|NCT01770912|3871841|FG001|COMPLETED|Overall Study||12
3145853|NCT01770912|3871840|FG000|NOT COMPLETED|Overall Study||2
3145854|NCT01770912|3871841|FG001|NOT COMPLETED|Overall Study||0
3145855|NCT01771055|3871849|FG000|STARTED|Overall Study||4
3145856|NCT01771055|3871850|FG001|STARTED|Overall Study||3
3145857|NCT01771055|3871849|FG000|COMPLETED|Overall Study||4
3145858|NCT01771055|3871850|FG001|COMPLETED|Overall Study||3
3145859|NCT01771055|3871849|FG000|NOT COMPLETED|Overall Study||0
3145860|NCT01771055|3871850|FG001|NOT COMPLETED|Overall Study||0
3145861|NCT01771172|3871856|FG000|STARTED|Overall Study||48
3145862|NCT01771172|3871856|FG000|COMPLETED|Overall Study||46
3145863|NCT01771172|3871856|FG000|NOT COMPLETED|Overall Study||2
3145864|NCT01771250|3871860|FG000|STARTED|Period 1||8
3145865|NCT01771250|3871861|FG001|STARTED|Period 1||7
3145866|NCT01771250|3871860|FG000|Received at Least One Dose of Study Drug|Period 1||7
3145867|NCT01771250|3871861|FG001|Received at Least One Dose of Study Drug|Period 1||7
3145868|NCT01771250|3871860|FG000|COMPLETED|Period 1||7
3145869|NCT01771250|3871861|FG001|COMPLETED|Period 1||7
3145870|NCT01771250|3871860|FG000|NOT COMPLETED|Period 1||1
3145871|NCT01771250|3871861|FG001|NOT COMPLETED|Period 1||0
3145872|NCT01771250|3871860|FG000|STARTED|Period 2||7
3145873|NCT01771250|3871861|FG001|STARTED|Period 2||7
3145874|NCT01771250|3871860|FG000|COMPLETED|Period 2||7
3145875|NCT01771250|3871861|FG001|COMPLETED|Period 2||7
3145876|NCT01771250|3871860|FG000|NOT COMPLETED|Period 2||0
3145877|NCT01771250|3871861|FG001|NOT COMPLETED|Period 2||0
3145878|NCT01771627|3871869|FG000|STARTED|Overall Study||200
3145879|NCT01771627|3871870|FG001|STARTED|Overall Study||100
3145880|NCT01771627|3871869|FG000|COMPLETED|Overall Study||92
3145881|NCT01771627|3871870|FG001|COMPLETED|Overall Study||50
3145882|NCT01771627|3871869|FG000|NOT COMPLETED|Overall Study||108
3145883|NCT01771627|3871870|FG001|NOT COMPLETED|Overall Study||50
3145884|NCT01771666|3871876|FG000|STARTED|Overall Study||23
3145885|NCT01771666|3871876|FG000|COMPLETED|Overall Study||23
3145886|NCT01771666|3871876|FG000|NOT COMPLETED|Overall Study||0
3145887|NCT01771731|3871882|FG000|STARTED|Overall Study||13
3145888|NCT01771731|3871883|FG001|STARTED|Overall Study||14
3145889|NCT01771731|3871882|FG000|COMPLETED|Overall Study||11
3145890|NCT01771731|3871883|FG001|COMPLETED|Overall Study||12
3145891|NCT01771731|3871882|FG000|NOT COMPLETED|Overall Study||2
3145892|NCT01771731|3871883|FG001|NOT COMPLETED|Overall Study||2
3145893|NCT01771809|3871891|FG000|STARTED|Overall Study||164
3145894|NCT01771809|3871892|FG001|STARTED|Overall Study||166
3145895|NCT01771809|3871891|FG000|COMPLETED|Overall Study||93
3145896|NCT01771809|3871892|FG001|COMPLETED|Overall Study||83
3145897|NCT01771809|3871891|FG000|NOT COMPLETED|Overall Study||71
3145898|NCT01771809|3871892|FG001|NOT COMPLETED|Overall Study||83
3145899|NCT01771913|3871900|FG000|STARTED|Overall Study||9
3145900|NCT01771913|3871901|FG001|STARTED|Overall Study||11
3145901|NCT01771913|3871900|FG000|COMPLETED|Overall Study||8
3145902|NCT01771913|3871901|FG001|COMPLETED|Overall Study||11
3145903|NCT01771913|3871900|FG000|NOT COMPLETED|Overall Study||1
3145904|NCT01771913|3871901|FG001|NOT COMPLETED|Overall Study||0
3145905|NCT01771952|3871909|FG000|STARTED|Overall Study||45
3145906|NCT01771952|3871910|FG001|STARTED|Overall Study||41
3145907|NCT01771952|3871909|FG000|COMPLETED|Overall Study||42
3145908|NCT01771952|3871910|FG001|COMPLETED|Overall Study||38
3145909|NCT01771952|3871909|FG000|NOT COMPLETED|Overall Study||3
3145910|NCT01771952|3871910|FG001|NOT COMPLETED|Overall Study||3
3145911|NCT01771965|3871918|FG000|STARTED|Overall Study||10
3145912|NCT01771965|3871919|FG001|STARTED|Overall Study||9
3145913|NCT01771965|3871918|FG000|COMPLETED|Overall Study||7
3145914|NCT01771965|3871919|FG001|COMPLETED|Overall Study||4
3145915|NCT01771965|3871918|FG000|NOT COMPLETED|Overall Study||3
3145916|NCT01771965|3871919|FG001|NOT COMPLETED|Overall Study||5
3145917|NCT01771991|3871927|FG000|STARTED|Overall Study||38
3145918|NCT01771991|3871928|FG001|STARTED|Overall Study||36
3145919|NCT01771991|3871927|FG000|Started Treatment|Overall Study||37
3145920|NCT01771991|3871928|FG001|Started Treatment|Overall Study||34
3145921|NCT01771991|3871927|FG000|COMPLETED|Overall Study||30
3145922|NCT01771991|3871928|FG001|COMPLETED|Overall Study||30
3145923|NCT01771991|3871927|FG000|NOT COMPLETED|Overall Study||8
3145924|NCT01771991|3871928|FG001|NOT COMPLETED|Overall Study||6
3145925|NCT01772134|3871938|FG000|STARTED|Overall Study|These participants were randomized but did not all receive study treatment.|207
3145926|NCT01772134|3871939|FG001|STARTED|Overall Study|These participants were randomized but did not all receive study treatment.|204
3145927|NCT01772134|3871940|FG002|STARTED|Overall Study|These participants were randomized but did not all receive study treatment.|206
3145928|NCT01772134|3871938|FG000|Received Randomized Study Medication|Overall Study||205
3145929|NCT01772134|3871939|FG001|Received Randomized Study Medication|Overall Study||204
3145930|NCT01772134|3871940|FG002|Received Randomized Study Medication|Overall Study||205
3145931|NCT01772134|3871938|FG000|COMPLETED|Overall Study||178
3145932|NCT01772134|3871939|FG001|COMPLETED|Overall Study||190
3145933|NCT01772134|3871940|FG002|COMPLETED|Overall Study||184
3145934|NCT01772134|3871938|FG000|NOT COMPLETED|Overall Study||29
3145935|NCT01772134|3871939|FG001|NOT COMPLETED|Overall Study||14
3145936|NCT01772134|3871940|FG002|NOT COMPLETED|Overall Study||22
3145937|NCT01772147|3871951|FG000|STARTED|Overall Study||201
3145938|NCT01772147|3871952|FG001|STARTED|Overall Study||203
3145939|NCT01772147|3871953|FG002|STARTED|Overall Study||202
3145940|NCT01772147|3871951|FG000|COMPLETED|Overall Study||170
3145941|NCT01772147|3871952|FG001|COMPLETED|Overall Study||178
3145942|NCT01772147|3871953|FG002|COMPLETED|Overall Study||184
3145943|NCT01772147|3871951|FG000|NOT COMPLETED|Overall Study||31
3145944|NCT01772147|3871952|FG001|NOT COMPLETED|Overall Study||25
3145945|NCT01772147|3871953|FG002|NOT COMPLETED|Overall Study||18
3145946|NCT01772160|3871961|FG000|STARTED|Overall Study||394
3145947|NCT01772160|3871961|FG000|COMPLETED|Overall Study||346
3145948|NCT01772160|3871961|FG000|NOT COMPLETED|Overall Study||48
3145949|NCT01772316|3871965|FG000|STARTED|Overall Study||47
3145950|NCT01772316|3871965|FG000|COMPLETED|Overall Study||40
3145951|NCT01772316|3871965|FG000|NOT COMPLETED|Overall Study||7
3145952|NCT01772368|3871969|FG000|STARTED|Overall Study||72
3145953|NCT01772368|3871969|FG000|Received Fp MDPI 100 mcg|Overall Study||67
3145954|NCT01772368|3871969|FG000|Received FS MDPI 100/6.25 mcg|Overall Study||68
3145955|NCT01772368|3871969|FG000|Received FS MDPI 100/12.5mcg|Overall Study||69
3145956|NCT01772368|3871969|FG000|Received FS MDPI 100/25 mcg|Overall Study||67
3145957|NCT01772368|3871969|FG000|Received FS MDPI 100/50 mcg|Overall Study||68
3145958|NCT01772368|3871969|FG000|Received Advair Diskus 100/50 mcg|Overall Study||66
3145959|NCT01772368|3871969|FG000|COMPLETED|Overall Study||65
3145960|NCT01772368|3871969|FG000|NOT COMPLETED|Overall Study||7
3145961|NCT01772537|3871988|FG000|STARTED|Overall Study||5
3145962|NCT01772537|3871989|FG001|STARTED|Overall Study||3
3145963|NCT01772537|3871990|FG002|STARTED|Overall Study||6
3145964|NCT01772537|3871988|FG000|COMPLETED|Overall Study||4
3145965|NCT01772537|3871989|FG001|COMPLETED|Overall Study||3
3145966|NCT01772537|3871990|FG002|COMPLETED|Overall Study||6
3145967|NCT01772537|3871988|FG000|NOT COMPLETED|Overall Study||1
3145968|NCT01772537|3871989|FG001|NOT COMPLETED|Overall Study||0
3145969|NCT01772537|3871990|FG002|NOT COMPLETED|Overall Study||0
3145970|NCT01772550|3872003|FG000|STARTED|Overall Study||102
3145971|NCT01772550|3872004|FG001|STARTED|Overall Study||103
3145972|NCT01772550|3872005|FG002|STARTED|Overall Study||33
3145973|NCT01772550|3872003|FG000|CT Pancreas|Overall Study||40
3145974|NCT01772550|3872004|FG001|CT Pancreas|Overall Study||36
3145975|NCT01772550|3872005|FG002|CT Pancreas|Overall Study||8
3145976|NCT01772550|3872003|FG000|CT Angiogram|Overall Study||24
3145977|NCT01772550|3872004|FG001|CT Angiogram|Overall Study||25
3145978|NCT01772550|3872005|FG002|CT Angiogram|Overall Study||4
3145979|NCT01772550|3872003|FG000|CT Liver|Overall Study||18
3145980|NCT01772550|3872004|FG001|CT Liver|Overall Study||14
3145981|NCT01772550|3872005|FG002|CT Liver|Overall Study||8
3145982|NCT01772550|3872003|FG000|CT Kidney|Overall Study||12
3145983|NCT01772550|3872004|FG001|CT Kidney|Overall Study||19
3145984|NCT01772550|3872005|FG002|CT Kidney|Overall Study||6
3145985|NCT01772550|3872003|FG000|CT Cardiac|Overall Study||7
3145986|NCT01772550|3872004|FG001|CT Cardiac|Overall Study||7
3145987|NCT01772550|3872005|FG002|CT Cardiac|Overall Study||1
3145988|NCT01772550|3872003|FG000|COMPLETED|Overall Study||101
3145989|NCT01772550|3872004|FG001|COMPLETED|Overall Study||102
3145990|NCT01772550|3872005|FG002|COMPLETED|Overall Study||27
3145991|NCT01772550|3872003|FG000|NOT COMPLETED|Overall Study||1
3145992|NCT01772550|3872004|FG001|NOT COMPLETED|Overall Study||1
3145993|NCT01772550|3872005|FG002|NOT COMPLETED|Overall Study||6
3145994|NCT01772576|3872013|FG000|STARTED|Overall Study||167
3145995|NCT01772576|3872013|FG000|COMPLETED|Overall Study||133
3145996|NCT01772576|3872013|FG000|NOT COMPLETED|Overall Study||34
3145997|NCT01772654|3872019|FG000|STARTED|Overall Study||2
3145998|NCT01772654|3872020|FG001|STARTED|Overall Study||15
3145999|NCT01772654|3872019|FG000|COMPLETED|Overall Study||2
3146000|NCT01772654|3872020|FG001|COMPLETED|Overall Study||15
3146001|NCT01772654|3872019|FG000|NOT COMPLETED|Overall Study||0
3146002|NCT01772654|3872020|FG001|NOT COMPLETED|Overall Study||0
3146003|NCT01772693|3872028|FG000|STARTED|Overall Study||20
3146004|NCT01772693|3872029|FG001|STARTED|Overall Study||7
3146005|NCT01772693|3872028|FG000|COMPLETED|Overall Study||14
3146006|NCT01772693|3872029|FG001|COMPLETED|Overall Study||6
3146007|NCT01772693|3872028|FG000|NOT COMPLETED|Overall Study||6
3146008|NCT01772693|3872029|FG001|NOT COMPLETED|Overall Study||1
3146009|NCT01772758|3872039|FG000|STARTED|Overall Study||18
3146010|NCT01772758|3872040|FG001|STARTED|Overall Study||17
3146011|NCT01772758|3872041|FG002|STARTED|Overall Study||12
3146012|NCT01772758|3872042|FG003|STARTED|Overall Study||17
3146013|NCT01772758|3872039|FG000|COMPLETED|Overall Study||18
3146014|NCT01772758|3872040|FG001|COMPLETED|Overall Study||17
3146015|NCT01772758|3872041|FG002|COMPLETED|Overall Study||12
3146016|NCT01772758|3872042|FG003|COMPLETED|Overall Study||17
3146017|NCT01772758|3872039|FG000|NOT COMPLETED|Overall Study||0
3146018|NCT01772758|3872040|FG001|NOT COMPLETED|Overall Study||0
3146019|NCT01772758|3872041|FG002|NOT COMPLETED|Overall Study||0
3146020|NCT01772758|3872042|FG003|NOT COMPLETED|Overall Study||0
3146021|NCT01772823|3872054|FG000|STARTED|Behavioral Intervention (BL -3MV or PCC)||128
3146022|NCT01772823|3872055|FG001|STARTED|Behavioral Intervention (BL -3MV or PCC)||72
3146023|NCT01772823|3872054|FG000|COMPLETED|Behavioral Intervention (BL -3MV or PCC)||116
3146024|NCT01772823|3872055|FG001|COMPLETED|Behavioral Intervention (BL -3MV or PCC)||70
3146025|NCT01772823|3872054|FG000|NOT COMPLETED|Behavioral Intervention (BL -3MV or PCC)||12
3146026|NCT01772823|3872055|FG001|NOT COMPLETED|Behavioral Intervention (BL -3MV or PCC)||2
3146027|NCT01772823|3872054|FG000|STARTED|Treatment Phase (Week 0- Week 48)||116
3146028|NCT01772823|3872055|FG001|STARTED|Treatment Phase (Week 0- Week 48)||70
3146029|NCT01772823|3872054|FG000|COMPLETED|Treatment Phase (Week 0- Week 48)||88
3146030|NCT01772823|3872055|FG001|COMPLETED|Treatment Phase (Week 0- Week 48)||52
3181270|NCT01995513|3909667|FG000|COMPLETED|Double Blind Treatment Period||0
3181271|NCT01995513|3909668|FG001|COMPLETED|Double Blind Treatment Period||0
3181272|NCT01995513|3909669|FG002|COMPLETED|Double Blind Treatment Period||0
3181273|NCT01995513|3909667|FG000|NOT COMPLETED|Double Blind Treatment Period||0
3181274|NCT01995513|3909668|FG001|NOT COMPLETED|Double Blind Treatment Period||126
3181275|NCT01995513|3909669|FG002|NOT COMPLETED|Double Blind Treatment Period||125
3181276|NCT01995526|3909679|FG000|STARTED|Overall Study||11
3146031|NCT01772823|3872054|FG000|NOT COMPLETED|Treatment Phase (Week 0- Week 48)||28
3146032|NCT01772823|3872055|FG001|NOT COMPLETED|Treatment Phase (Week 0- Week 48)||18
3146033|NCT01772823|3872054|FG000|STARTED|Extension Phase (Visits 24,48wks Post tx|25 of the 88 subjects that completed the Treatment Phase were not eligible for the Extension Phase|63
3146034|NCT01772823|3872055|FG001|STARTED|Extension Phase (Visits 24,48wks Post tx|10 of the 52 subjects that completed the Treatment Phase were not eligible for the Extension Phase|42
3146035|NCT01772823|3872054|FG000|COMPLETED|Extension Phase (Visits 24,48wks Post tx||53
3146036|NCT01772823|3872055|FG001|COMPLETED|Extension Phase (Visits 24,48wks Post tx||33
3146037|NCT01772823|3872054|FG000|NOT COMPLETED|Extension Phase (Visits 24,48wks Post tx||10
3146038|NCT01772823|3872055|FG001|NOT COMPLETED|Extension Phase (Visits 24,48wks Post tx||9
3146039|NCT01773070|3872066|FG000|STARTED|Overall Study||478
3146040|NCT01773070|3872066|FG000|COMPLETED|Overall Study||397
3146041|NCT01773070|3872066|FG000|NOT COMPLETED|Overall Study||81
3146042|NCT01773109|3872070|FG000|STARTED|Overall Study||40
3146043|NCT01773109|3872070|FG000|COMPLETED|Overall Study||37
3146044|NCT01773109|3872070|FG000|NOT COMPLETED|Overall Study||3
3146045|NCT01773122|3872078|FG000|STARTED|Overall Study||20
3146046|NCT01773122|3872079|FG001|STARTED|Overall Study||19
3146047|NCT01773122|3872080|FG002|STARTED|Overall Study||19
3146048|NCT01773122|3872081|FG003|STARTED|Overall Study||19
3146049|NCT01773122|3872078|FG000|COMPLETED|Overall Study||17
3146050|NCT01773122|3872079|FG001|COMPLETED|Overall Study||18
3146051|NCT01773122|3872080|FG002|COMPLETED|Overall Study||19
3146052|NCT01773122|3872081|FG003|COMPLETED|Overall Study||18
3146053|NCT01773122|3872078|FG000|NOT COMPLETED|Overall Study||3
3146054|NCT01773122|3872079|FG001|NOT COMPLETED|Overall Study||1
3146055|NCT01773122|3872080|FG002|NOT COMPLETED|Overall Study||0
3146056|NCT01773122|3872081|FG003|NOT COMPLETED|Overall Study||1
3146057|NCT01773135|3872093|FG000|STARTED|Overall Study||262
3146058|NCT01773135|3872093|FG000|COMPLETED|Overall Study||262
3146059|NCT01773135|3872093|FG000|NOT COMPLETED|Overall Study||0
3146060|NCT01773187|3872100|FG000|STARTED|Overall Study||220
3146061|NCT01773187|3872101|FG001|STARTED|Overall Study||107
3146062|NCT01773187|3872100|FG000|COMPLETED|Overall Study||167
3146063|NCT01773187|3872101|FG001|COMPLETED|Overall Study||75
3146064|NCT01773187|3872100|FG000|NOT COMPLETED|Overall Study||53
3146065|NCT01773187|3872101|FG001|NOT COMPLETED|Overall Study||32
3146066|NCT01773226|3872107|FG000|STARTED|Overall Study||11
3146067|NCT01773226|3872107|FG000|COMPLETED|Overall Study|Withdrawal of one subject after one-month assessment due to persistent OA symptoms|10
3146068|NCT01773226|3872107|FG000|NOT COMPLETED|Overall Study||1
3146069|NCT01773291|3872114|FG000|STARTED|Overall Study||8
3146070|NCT01773291|3872115|FG001|STARTED|Overall Study||9
3146071|NCT01773291|3872116|FG002|STARTED|Overall Study||7
3146072|NCT01773291|3872114|FG000|COMPLETED|Overall Study||7
3146073|NCT01773291|3872115|FG001|COMPLETED|Overall Study||9
3146074|NCT01773291|3872116|FG002|COMPLETED|Overall Study||6
3146075|NCT01773291|3872114|FG000|NOT COMPLETED|Overall Study||1
3146076|NCT01773291|3872115|FG001|NOT COMPLETED|Overall Study||0
3146077|NCT01773291|3872116|FG002|NOT COMPLETED|Overall Study||1
3146078|NCT01773421|3872129|FG000|STARTED|Treatment Phase||7
3146079|NCT01773421|3872130|FG001|STARTED|Treatment Phase||8
3146080|NCT01773421|3872131|FG002|STARTED|Treatment Phase||19
3146081|NCT01773421|3872132|FG003|STARTED|Treatment Phase||7
3146082|NCT01773421|3872133|FG004|STARTED|Treatment Phase||0
3146083|NCT01773421|3872134|FG005|STARTED|Treatment Phase||0
3146084|NCT01773421|3872135|FG006|STARTED|Treatment Phase||0
3146085|NCT01773421|3872129|FG000|COMPLETED|Treatment Phase||7
3146086|NCT01773421|3872130|FG001|COMPLETED|Treatment Phase||8
3146087|NCT01773421|3872131|FG002|COMPLETED|Treatment Phase||13
3146088|NCT01773421|3872132|FG003|COMPLETED|Treatment Phase||5
3146089|NCT01773421|3872133|FG004|COMPLETED|Treatment Phase||0
3146090|NCT01773421|3872134|FG005|COMPLETED|Treatment Phase||0
3146091|NCT01773421|3872135|FG006|COMPLETED|Treatment Phase||0
3146092|NCT01773421|3872129|FG000|NOT COMPLETED|Treatment Phase||0
3146093|NCT01773421|3872130|FG001|NOT COMPLETED|Treatment Phase||0
3146094|NCT01773421|3872131|FG002|NOT COMPLETED|Treatment Phase||6
3146095|NCT01773421|3872132|FG003|NOT COMPLETED|Treatment Phase||2
3146096|NCT01773421|3872133|FG004|NOT COMPLETED|Treatment Phase||0
3146097|NCT01773421|3872134|FG005|NOT COMPLETED|Treatment Phase||0
3146098|NCT01773421|3872135|FG006|NOT COMPLETED|Treatment Phase||0
3146099|NCT01773421|3872129|FG000|STARTED|Extension Phase||0
3146100|NCT01773421|3872130|FG001|STARTED|Extension Phase||0
3146101|NCT01773421|3872131|FG002|STARTED|Extension Phase||0
3146102|NCT01773421|3872132|FG003|STARTED|Extension Phase||0
3146103|NCT01773421|3872133|FG004|STARTED|Extension Phase||15
3146104|NCT01773421|3872134|FG005|STARTED|Extension Phase||3
3146105|NCT01773421|3872135|FG006|STARTED|Extension Phase||0
3146106|NCT01773421|3872129|FG000|COMPLETED|Extension Phase||0
3146107|NCT01773421|3872130|FG001|COMPLETED|Extension Phase||0
3146108|NCT01773421|3872131|FG002|COMPLETED|Extension Phase||0
3146109|NCT01773421|3872132|FG003|COMPLETED|Extension Phase||0
3146110|NCT01773421|3872133|FG004|COMPLETED|Extension Phase||12
3146111|NCT01773421|3872134|FG005|COMPLETED|Extension Phase||1
3146112|NCT01773421|3872135|FG006|COMPLETED|Extension Phase||0
3146113|NCT01773421|3872129|FG000|NOT COMPLETED|Extension Phase||0
3146114|NCT01773421|3872130|FG001|NOT COMPLETED|Extension Phase||0
3146115|NCT01773421|3872131|FG002|NOT COMPLETED|Extension Phase||0
3146116|NCT01773421|3872132|FG003|NOT COMPLETED|Extension Phase||0
3146117|NCT01773421|3872133|FG004|NOT COMPLETED|Extension Phase||3
3146118|NCT01773421|3872134|FG005|NOT COMPLETED|Extension Phase||2
3146119|NCT01773421|3872135|FG006|NOT COMPLETED|Extension Phase||0
3146120|NCT01773473|3872153|FG000|STARTED|Overall Study||207
3146121|NCT01773473|3872154|FG001|STARTED|Overall Study||196
3146122|NCT01773473|3872153|FG000|Received at Least 1 Dose of Study Drug|Overall Study||207
3146123|NCT01773473|3872154|FG001|Received at Least 1 Dose of Study Drug|Overall Study||196
3146124|NCT01773473|3872153|FG000|COMPLETED|Overall Study||191
3146125|NCT01773473|3872154|FG001|COMPLETED|Overall Study||177
3146126|NCT01773473|3872153|FG000|NOT COMPLETED|Overall Study||16
3146127|NCT01773473|3872154|FG001|NOT COMPLETED|Overall Study||19
3146128|NCT01773889|3872160|FG000|STARTED|Overall Study||2
3146129|NCT01773889|3872160|FG000|COMPLETED|Overall Study||0
3146130|NCT01773889|3872160|FG000|NOT COMPLETED|Overall Study||2
3146131|NCT01773954|3872164|FG000|STARTED|Overall Study||40
3146132|NCT01773954|3872164|FG000|COMPLETED|Overall Study||31
3146133|NCT01773954|3872164|FG000|NOT COMPLETED|Overall Study||9
3146134|NCT01773967|3872170|FG000|STARTED|Overall Study||483
3146135|NCT01773967|3872171|FG001|STARTED|Overall Study||488
3146136|NCT01773967|3872170|FG000|COMPLETED|Overall Study||468
3146137|NCT01773967|3872171|FG001|COMPLETED|Overall Study||475
3146138|NCT01773967|3872170|FG000|NOT COMPLETED|Overall Study||15
3146139|NCT01773967|3872171|FG001|NOT COMPLETED|Overall Study||13
3146140|NCT01773993|3872177|FG000|STARTED|Overall Study||534
3146141|NCT01773993|3872177|FG000|COMPLETED|Overall Study|Number of participants whose survey form were collected and included in analyses is shown.|499
3146142|NCT01773993|3872177|FG000|NOT COMPLETED|Overall Study||35
3146143|NCT01774045|3872183|FG000|STARTED|Overall Study||23
3146144|NCT01774045|3872184|FG001|STARTED|Overall Study||7
3146145|NCT01774045|3872183|FG000|COMPLETED|Overall Study||23
3146146|NCT01774045|3872184|FG001|COMPLETED|Overall Study||7
3146147|NCT01774045|3872183|FG000|NOT COMPLETED|Overall Study||0
3146148|NCT01774045|3872184|FG001|NOT COMPLETED|Overall Study||0
3146149|NCT01774084|3872193|FG000|STARTED|Overall Study||11
3146150|NCT01774084|3872194|FG001|STARTED|Overall Study||12
3146151|NCT01774084|3872193|FG000|COMPLETED|Overall Study||10
3146152|NCT01774084|3872194|FG001|COMPLETED|Overall Study||12
3146153|NCT01774084|3872193|FG000|NOT COMPLETED|Overall Study||1
3146154|NCT01774084|3872194|FG001|NOT COMPLETED|Overall Study||0
3146155|NCT01774097|3872202|FG000|STARTED|Overall Study||40
3146156|NCT01774097|3872203|FG001|STARTED|Overall Study||42
3146157|NCT01774097|3872202|FG000|COMPLETED|Overall Study||38
3146158|NCT01774097|3872203|FG001|COMPLETED|Overall Study||40
3146159|NCT01774097|3872202|FG000|NOT COMPLETED|Overall Study||2
3146160|NCT01774097|3872203|FG001|NOT COMPLETED|Overall Study||2
3146161|NCT01774110|3872211|FG000|STARTED|Overall Study||12
3146162|NCT01774110|3872211|FG000|COMPLETED|Overall Study||5
3146163|NCT01774110|3872211|FG000|NOT COMPLETED|Overall Study||7
3146164|NCT01774149|3872218|FG000|STARTED|Overall Study||15
3146165|NCT01774149|3872219|FG001|STARTED|Overall Study||15
3146166|NCT01774149|3872218|FG000|COMPLETED|Overall Study||14
3146167|NCT01774149|3872219|FG001|COMPLETED|Overall Study||12
3146168|NCT01774149|3872218|FG000|NOT COMPLETED|Overall Study||1
3146169|NCT01774149|3872219|FG001|NOT COMPLETED|Overall Study||3
3181277|NCT01995526|3909679|FG000|Received One Dose of Study Drug|Overall Study||11
3181278|NCT01995526|3909679|FG000|COMPLETED|Overall Study||10
3181279|NCT01995526|3909679|FG000|NOT COMPLETED|Overall Study||1
3181280|NCT01995539|3909683|FG000|STARTED|Overall Study||181
3181281|NCT01995539|3909683|FG000|COMPLETED|Overall Study||148
3181282|NCT01995539|3909683|FG000|NOT COMPLETED|Overall Study||33
3181283|NCT01995552|3909687|FG000|STARTED|Overall Study|There were 249 patients were included for Baseline cohort and 233 in analysis cohort|250
3181284|NCT01995552|3909687|FG000|COMPLETED|Overall Study|There were 233 patients who were eligible for primary objective analysis|233
3181285|NCT01995552|3909687|FG000|NOT COMPLETED|Overall Study||17
3181286|NCT01995825|3909695|FG000|STARTED|Overall Study||18
3181287|NCT01995825|3909696|FG001|STARTED|Overall Study||17
3181288|NCT01995825|3909695|FG000|COMPLETED|Overall Study||17
3181289|NCT01995825|3909696|FG001|COMPLETED|Overall Study||17
3181290|NCT01995825|3909695|FG000|NOT COMPLETED|Overall Study||1
3181291|NCT01995825|3909696|FG001|NOT COMPLETED|Overall Study||0
3181292|NCT01995838|3909709|FG000|STARTED|Overall Study||56
3181293|NCT01995838|3909710|FG001|STARTED|Overall Study||32
3181294|NCT01995838|3909711|FG002|STARTED|Overall Study||27
3181295|NCT01995838|3909712|FG003|STARTED|Overall Study||38
3181296|NCT01995838|3909713|FG004|STARTED|Overall Study||32
3181297|NCT01995838|3909714|FG005|STARTED|Overall Study||56
3181298|NCT01995838|3909715|FG006|STARTED|Overall Study||50
3181299|NCT01995838|3909709|FG000|COMPLETED|Overall Study||51
3181300|NCT01995838|3909710|FG001|COMPLETED|Overall Study||30
3181301|NCT01995838|3909711|FG002|COMPLETED|Overall Study||27
3181302|NCT01995838|3909712|FG003|COMPLETED|Overall Study||36
3181303|NCT01995838|3909713|FG004|COMPLETED|Overall Study||30
3181304|NCT01995838|3909714|FG005|COMPLETED|Overall Study||54
3181305|NCT01995838|3909715|FG006|COMPLETED|Overall Study||45
3181306|NCT01995838|3909709|FG000|NOT COMPLETED|Overall Study||5
3146170|NCT01774253|3872225|FG000|STARTED|Overall Study||9
3146171|NCT01774253|3872225|FG000|COMPLETED|Overall Study||0
3146172|NCT01774253|3872225|FG000|NOT COMPLETED|Overall Study||9
3146173|NCT01774305|3872231|FG000|STARTED|Overall Study||71
3181307|NCT01995838|3909710|FG001|NOT COMPLETED|Overall Study||2
3181308|NCT01995838|3909711|FG002|NOT COMPLETED|Overall Study||0
3181309|NCT01995838|3909712|FG003|NOT COMPLETED|Overall Study||2
3181310|NCT01995838|3909713|FG004|NOT COMPLETED|Overall Study||2
3181311|NCT01995838|3909714|FG005|NOT COMPLETED|Overall Study||2
3146174|NCT01774305|3872232|FG001|STARTED|Overall Study||71
3146175|NCT01774305|3872231|FG000|COMPLETED|Overall Study||70
3146176|NCT01774305|3872232|FG001|COMPLETED|Overall Study||71
3146177|NCT01774305|3872231|FG000|NOT COMPLETED|Overall Study||1
3146178|NCT01774305|3872232|FG001|NOT COMPLETED|Overall Study||0
3146179|NCT01774344|3872240|FG000|STARTED|Overall Study||194
3146180|NCT01774344|3872241|FG001|STARTED|Overall Study||379
3146181|NCT01774344|3872240|FG000|Treated|Overall Study||193
3146182|NCT01774344|3872241|FG001|Treated|Overall Study||374
3146183|NCT01774344|3872240|FG000|Entered Survival FU|Overall Study||145
3146184|NCT01774344|3872241|FG001|Entered Survival FU|Overall Study||291
3146185|NCT01774344|3872240|FG000|COMPLETED|Overall Study||132
3146186|NCT01774344|3872241|FG001|COMPLETED|Overall Study||258
3146187|NCT01774344|3872240|FG000|NOT COMPLETED|Overall Study||62
3146188|NCT01774344|3872241|FG001|NOT COMPLETED|Overall Study||121
3146189|NCT01774591|3872249|FG000|STARTED|Overall Study||10
3146190|NCT01774591|3872250|FG001|STARTED|Overall Study||11
3146191|NCT01774591|3872249|FG000|COMPLETED|Overall Study||9
3146192|NCT01774591|3872250|FG001|COMPLETED|Overall Study||7
3146193|NCT01774591|3872249|FG000|NOT COMPLETED|Overall Study||1
3146194|NCT01774591|3872250|FG001|NOT COMPLETED|Overall Study||4
3146195|NCT01774604|3872258|FG000|STARTED|Overall Study||223
3146196|NCT01774604|3872259|FG001|STARTED|Overall Study||226
3146197|NCT01774604|3872258|FG000|COMPLETED|Overall Study||223
3146198|NCT01774604|3872259|FG001|COMPLETED|Overall Study||226
3146199|NCT01774604|3872258|FG000|NOT COMPLETED|Overall Study||0
3146200|NCT01774604|3872259|FG001|NOT COMPLETED|Overall Study||0
3146201|NCT01774760|3872265|FG000|STARTED|Overall Study||10
3146202|NCT01774760|3872265|FG000|COMPLETED|Overall Study||10
3146203|NCT01774760|3872265|FG000|NOT COMPLETED|Overall Study||0
3146204|NCT01774786|3872271|FG000|STARTED|Overall Study||388
3146205|NCT01774786|3872272|FG001|STARTED|Overall Study||392
3146206|NCT01774786|3872271|FG000|Did Not Receive Any Study Treatment|Overall Study|2 patients found ineligible after enrollment and 2 patients died before treatment.|4
3146207|NCT01774786|3872272|FG001|Did Not Receive Any Study Treatment|Overall Study|All 3 patients found ineligible for the study after enrollment and before treatment.|3
3146208|NCT01774786|3872271|FG000|Received at Least One Dose of Pertuzumab|Overall Study||384
3146209|NCT01774786|3872272|FG001|Received at Least One Dose of Pertuzumab|Overall Study|One participant randomized to placebo arm received 1 dose of pertuzumab by error.|1
3146210|NCT01774786|3872271|FG000|Received Placebo (No Pertuzumab)|Overall Study||0
3146211|NCT01774786|3872272|FG001|Received Placebo (No Pertuzumab)|Overall Study||388
3146212|NCT01774786|3872271|FG000|COMPLETED|Overall Study||60
3146213|NCT01774786|3872272|FG001|COMPLETED|Overall Study||46
3146214|NCT01774786|3872271|FG000|NOT COMPLETED|Overall Study||328
3146215|NCT01774786|3872272|FG001|NOT COMPLETED|Overall Study||346
3146216|NCT01774799|3872282|FG000|STARTED|Overall Study||212
3146217|NCT01774799|3872283|FG001|STARTED|Overall Study||190
3146218|NCT01774799|3872284|FG002|STARTED|Overall Study||212
3146219|NCT01774799|3872285|FG003|STARTED|Overall Study||190
3146220|NCT01774799|3872282|FG000|COMPLETED|Overall Study||211
3146221|NCT01774799|3872283|FG001|COMPLETED|Overall Study||189
3146222|NCT01774799|3872284|FG002|COMPLETED|Overall Study||212
3146223|NCT01774799|3872285|FG003|COMPLETED|Overall Study||190
3146224|NCT01774799|3872282|FG000|NOT COMPLETED|Overall Study||1
3146225|NCT01774799|3872283|FG001|NOT COMPLETED|Overall Study||1
3146226|NCT01774799|3872284|FG002|NOT COMPLETED|Overall Study||0
3146227|NCT01774799|3872285|FG003|NOT COMPLETED|Overall Study||0
3146228|NCT01774851|3872293|FG000|STARTED|Overall Study||42
3146229|NCT01774851|3872294|FG001|STARTED|Overall Study||42
3146230|NCT01774851|3872293|FG000|COMPLETED|Overall Study||42
3146231|NCT01774851|3872294|FG001|COMPLETED|Overall Study||42
3146232|NCT01774851|3872293|FG000|NOT COMPLETED|Overall Study||0
3146233|NCT01774851|3872294|FG001|NOT COMPLETED|Overall Study||0
3146234|NCT01774903|3872300|FG000|STARTED|Overall Study||45
3146235|NCT01774903|3872300|FG000|COMPLETED|Overall Study||34
3146236|NCT01774903|3872300|FG000|NOT COMPLETED|Overall Study||11
3146237|NCT01774929|3872305|FG000|STARTED|Overall Study||35
3146238|NCT01774929|3872305|FG000|COMPLETED|Overall Study||32
3146239|NCT01774929|3872305|FG000|NOT COMPLETED|Overall Study||3
3146240|NCT01774968|3872311|FG000|STARTED|Overall Study||162
3146241|NCT01774968|3872312|FG001|STARTED|Overall Study||163
3146242|NCT01774968|3872311|FG000|Received at Least 1 Dose of Study Drug|Overall Study||162
3146243|NCT01774968|3872312|FG001|Received at Least 1 Dose of Study Drug|Overall Study||161
3146244|NCT01774968|3872311|FG000|COMPLETED|Overall Study||132
3146245|NCT01774968|3872312|FG001|COMPLETED|Overall Study||128
3146246|NCT01774968|3872311|FG000|NOT COMPLETED|Overall Study||30
3146247|NCT01774968|3872312|FG001|NOT COMPLETED|Overall Study||35
3146248|NCT01774981|3872326|FG000|STARTED|Overall Study||3
3146249|NCT01774981|3872327|FG001|STARTED|Overall Study||4
3146250|NCT01774981|3872328|FG002|STARTED|Overall Study||4
3146251|NCT01774981|3872329|FG003|STARTED|Overall Study||4
3146252|NCT01774981|3872330|FG004|STARTED|Overall Study||6
3146253|NCT01774981|3872331|FG005|STARTED|Overall Study||14
3146254|NCT01774981|3872332|FG006|STARTED|Overall Study||13
3146255|NCT01774981|3872333|FG007|STARTED|Overall Study||12
3146256|NCT01774981|3872326|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
3146257|NCT01774981|3872327|FG001|Received at Least 1 Dose of Study Drug|Overall Study||4
3146258|NCT01774981|3872328|FG002|Received at Least 1 Dose of Study Drug|Overall Study||4
3146259|NCT01774981|3872329|FG003|Received at Least 1 Dose of Study Drug|Overall Study||4
3146260|NCT01774981|3872330|FG004|Received at Least 1 Dose of Study Drug|Overall Study||6
3146261|NCT01774981|3872331|FG005|Received at Least 1 Dose of Study Drug|Overall Study||14
3146262|NCT01774981|3872332|FG006|Received at Least 1 Dose of Study Drug|Overall Study||13
3146263|NCT01774981|3872333|FG007|Received at Least 1 Dose of Study Drug|Overall Study||12
3146264|NCT01774981|3872326|FG000|COMPLETED|Overall Study||3
3146265|NCT01774981|3872327|FG001|COMPLETED|Overall Study||4
3146266|NCT01774981|3872328|FG002|COMPLETED|Overall Study||4
3146267|NCT01774981|3872329|FG003|COMPLETED|Overall Study||4
3146268|NCT01774981|3872330|FG004|COMPLETED|Overall Study||5
3146269|NCT01774981|3872331|FG005|COMPLETED|Overall Study||13
3146270|NCT01774981|3872332|FG006|COMPLETED|Overall Study||13
3146271|NCT01774981|3872333|FG007|COMPLETED|Overall Study||11
3146272|NCT01774981|3872326|FG000|NOT COMPLETED|Overall Study||0
3146273|NCT01774981|3872327|FG001|NOT COMPLETED|Overall Study||0
3146274|NCT01774981|3872328|FG002|NOT COMPLETED|Overall Study||0
3146275|NCT01774981|3872329|FG003|NOT COMPLETED|Overall Study||0
3146276|NCT01774981|3872330|FG004|NOT COMPLETED|Overall Study||1
3146277|NCT01774981|3872331|FG005|NOT COMPLETED|Overall Study||1
3146278|NCT01774981|3872332|FG006|NOT COMPLETED|Overall Study||0
3146279|NCT01774981|3872333|FG007|NOT COMPLETED|Overall Study||1
3146280|NCT01775124|3872358|FG000|STARTED|Core Period||168
3146281|NCT01775124|3872359|FG001|STARTED|Core Period||166
3146282|NCT01775124|3872358|FG000|Full Analysis Set|Core Period||167
3146283|NCT01775124|3872359|FG001|Full Analysis Set|Core Period||166
3146284|NCT01775124|3872358|FG000|Per Protocol Set|Core Period||157
3146285|NCT01775124|3872359|FG001|Per Protocol Set|Core Period||155
3146286|NCT01775124|3872358|FG000|Safety Set|Core Period|1 patient was mis-randomized & 1 patient discontinued due to AE. No treatment given|166
3146287|NCT01775124|3872359|FG001|Safety Set|Core Period||166
3146288|NCT01775124|3872358|FG000|COMPLETED|Core Period||157
3146289|NCT01775124|3872359|FG001|COMPLETED|Core Period||156
3146290|NCT01775124|3872358|FG000|NOT COMPLETED|Core Period||11
3146291|NCT01775124|3872359|FG001|NOT COMPLETED|Core Period||10
3146292|NCT01775124|3872358|FG000|STARTED|Extension Period||157
3146293|NCT01775124|3872359|FG001|STARTED|Extension Period||156
3146294|NCT01775124|3872358|FG000|COMPLETED|Extension Period||145
3146295|NCT01775124|3872359|FG001|COMPLETED|Extension Period||138
3146296|NCT01775124|3872358|FG000|NOT COMPLETED|Extension Period||12
3146297|NCT01775124|3872359|FG001|NOT COMPLETED|Extension Period||18
3146298|NCT01775137|3872366|FG000|STARTED|Overall Study||45
3146299|NCT01775137|3872366|FG000|COMPLETED|Overall Study||34
3146300|NCT01775137|3872366|FG000|NOT COMPLETED|Overall Study||11
3146301|NCT01775189|3872373|FG000|STARTED|Naloxone Challenge Phase||45
3146302|NCT01775189|3872374|FG001|STARTED|Naloxone Challenge Phase||0
3146303|NCT01775189|3872375|FG002|STARTED|Naloxone Challenge Phase||0
3146304|NCT01775189|3872376|FG003|STARTED|Naloxone Challenge Phase||0
3146305|NCT01775189|3872377|FG004|STARTED|Naloxone Challenge Phase||0
3146306|NCT01775189|3872378|FG005|STARTED|Naloxone Challenge Phase||0
3146307|NCT01775189|3872379|FG006|STARTED|Naloxone Challenge Phase||0
3146308|NCT01775189|3872373|FG000|COMPLETED|Naloxone Challenge Phase||45
3146309|NCT01775189|3872374|FG001|COMPLETED|Naloxone Challenge Phase||0
3146310|NCT01775189|3872375|FG002|COMPLETED|Naloxone Challenge Phase||0
3146311|NCT01775189|3872376|FG003|COMPLETED|Naloxone Challenge Phase||0
3146312|NCT01775189|3872377|FG004|COMPLETED|Naloxone Challenge Phase||0
3146313|NCT01775189|3872378|FG005|COMPLETED|Naloxone Challenge Phase||0
3146314|NCT01775189|3872379|FG006|COMPLETED|Naloxone Challenge Phase||0
3146315|NCT01775189|3872373|FG000|NOT COMPLETED|Naloxone Challenge Phase||0
3146316|NCT01775189|3872374|FG001|NOT COMPLETED|Naloxone Challenge Phase||0
3181312|NCT01995838|3909715|FG006|NOT COMPLETED|Overall Study||5
3181313|NCT01996033|3909732|FG000|STARTED|Overall Study||25
3181314|NCT01996033|3909732|FG000|COMPLETED|Overall Study||16
3181315|NCT01996033|3909732|FG000|NOT COMPLETED|Overall Study||9
3181316|NCT01996241|3909738|FG000|STARTED|Overall Study||1164
3181317|NCT01996241|3909739|FG001|STARTED|Overall Study||1111
3181318|NCT01996241|3909738|FG000|COMPLETED|Overall Study||912
3181319|NCT01996241|3909739|FG001|COMPLETED|Overall Study||876
3181320|NCT01996241|3909738|FG000|NOT COMPLETED|Overall Study||252
3181321|NCT01996241|3909739|FG001|NOT COMPLETED|Overall Study||235
3181322|NCT01996254|3909749|FG000|STARTED|Overall Study||5
3181323|NCT01996254|3909750|FG001|STARTED|Overall Study||14
3181324|NCT01996254|3909751|FG002|STARTED|Overall Study||14
3181325|NCT01996254|3909749|FG000|Safety Set|Overall Study||5
3181326|NCT01996254|3909750|FG001|Safety Set|Overall Study||14
3181327|NCT01996254|3909751|FG002|Safety Set|Overall Study||14
3181328|NCT01996254|3909749|FG000|Full Analysis Set|Overall Study||0
3181329|NCT01996254|3909750|FG001|Full Analysis Set|Overall Study||12
3181330|NCT01996254|3909751|FG002|Full Analysis Set|Overall Study||14
3181331|NCT01996254|3909749|FG000|Long Term Analysis Set|Overall Study||0
3181332|NCT01996254|3909750|FG001|Long Term Analysis Set|Overall Study||12
3181333|NCT01996254|3909751|FG002|Long Term Analysis Set|Overall Study||14
3181334|NCT01996254|3909749|FG000|Per Protocol Set|Overall Study||0
3181335|NCT01996254|3909750|FG001|Per Protocol Set|Overall Study||10
3181336|NCT01996254|3909751|FG002|Per Protocol Set|Overall Study||13
3181337|NCT01996254|3909749|FG000|COMPLETED|Overall Study||4
3181338|NCT01996254|3909750|FG001|COMPLETED|Overall Study||9
3181339|NCT01996254|3909751|FG002|COMPLETED|Overall Study||6
3181340|NCT01996254|3909749|FG000|NOT COMPLETED|Overall Study||1
3181341|NCT01996254|3909750|FG001|NOT COMPLETED|Overall Study||5
3181342|NCT01996254|3909751|FG002|NOT COMPLETED|Overall Study||8
3181343|NCT01996319|3909763|FG000|STARTED|Overall Study||96
3181344|NCT01996319|3909764|FG001|STARTED|Overall Study||98
3146317|NCT01775189|3872375|FG002|NOT COMPLETED|Naloxone Challenge Phase||0
3146318|NCT01775189|3872376|FG003|NOT COMPLETED|Naloxone Challenge Phase||0
3146319|NCT01775189|3872377|FG004|NOT COMPLETED|Naloxone Challenge Phase||0
3146320|NCT01775189|3872378|FG005|NOT COMPLETED|Naloxone Challenge Phase||0
3146321|NCT01775189|3872379|FG006|NOT COMPLETED|Naloxone Challenge Phase||0
3146322|NCT01775189|3872373|FG000|STARTED|Drug Discrimination Phase: Day 1||0
3146323|NCT01775189|3872374|FG001|STARTED|Drug Discrimination Phase: Day 1||22
3146324|NCT01775189|3872375|FG002|STARTED|Drug Discrimination Phase: Day 1||23
3181345|NCT01996319|3909763|FG000|COMPLETED|Overall Study||88
3181346|NCT01996319|3909764|FG001|COMPLETED|Overall Study||95
3181347|NCT01996319|3909763|FG000|NOT COMPLETED|Overall Study||8
3181348|NCT01996319|3909764|FG001|NOT COMPLETED|Overall Study||3
3181349|NCT01996332|3909770|FG000|STARTED|Overall Study||1805
3146325|NCT01775189|3872376|FG003|STARTED|Drug Discrimination Phase: Day 1||0
3146326|NCT01775189|3872377|FG004|STARTED|Drug Discrimination Phase: Day 1||0
3146327|NCT01775189|3872378|FG005|STARTED|Drug Discrimination Phase: Day 1||0
3146328|NCT01775189|3872379|FG006|STARTED|Drug Discrimination Phase: Day 1||0
3146329|NCT01775189|3872373|FG000|COMPLETED|Drug Discrimination Phase: Day 1||0
3146330|NCT01775189|3872374|FG001|COMPLETED|Drug Discrimination Phase: Day 1||19
3146331|NCT01775189|3872375|FG002|COMPLETED|Drug Discrimination Phase: Day 1||23
3146332|NCT01775189|3872376|FG003|COMPLETED|Drug Discrimination Phase: Day 1||0
3146333|NCT01775189|3872377|FG004|COMPLETED|Drug Discrimination Phase: Day 1||0
3146334|NCT01775189|3872378|FG005|COMPLETED|Drug Discrimination Phase: Day 1||0
3146335|NCT01775189|3872379|FG006|COMPLETED|Drug Discrimination Phase: Day 1||0
3146336|NCT01775189|3872373|FG000|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
3146337|NCT01775189|3872374|FG001|NOT COMPLETED|Drug Discrimination Phase: Day 1||3
3146338|NCT01775189|3872375|FG002|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
3146339|NCT01775189|3872376|FG003|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
3146340|NCT01775189|3872377|FG004|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
3146341|NCT01775189|3872378|FG005|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
3146342|NCT01775189|3872379|FG006|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
3146343|NCT01775189|3872373|FG000|STARTED|Drug Discrimination Phase: Day 2||0
3146344|NCT01775189|3872374|FG001|STARTED|Drug Discrimination Phase: Day 2||19
3146345|NCT01775189|3872375|FG002|STARTED|Drug Discrimination Phase: Day 2||23
3146346|NCT01775189|3872376|FG003|STARTED|Drug Discrimination Phase: Day 2||0
3146347|NCT01775189|3872377|FG004|STARTED|Drug Discrimination Phase: Day 2||0
3146348|NCT01775189|3872378|FG005|STARTED|Drug Discrimination Phase: Day 2||0
3146349|NCT01775189|3872379|FG006|STARTED|Drug Discrimination Phase: Day 2||0
3146350|NCT01775189|3872373|FG000|COMPLETED|Drug Discrimination Phase: Day 2||0
3146351|NCT01775189|3872374|FG001|COMPLETED|Drug Discrimination Phase: Day 2||16
3146352|NCT01775189|3872375|FG002|COMPLETED|Drug Discrimination Phase: Day 2||16
3146353|NCT01775189|3872376|FG003|COMPLETED|Drug Discrimination Phase: Day 2||0
3146354|NCT01775189|3872377|FG004|COMPLETED|Drug Discrimination Phase: Day 2||0
3146355|NCT01775189|3872378|FG005|COMPLETED|Drug Discrimination Phase: Day 2||0
3146356|NCT01775189|3872379|FG006|COMPLETED|Drug Discrimination Phase: Day 2||0
3146357|NCT01775189|3872373|FG000|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
3146358|NCT01775189|3872374|FG001|NOT COMPLETED|Drug Discrimination Phase: Day 2||3
3146359|NCT01775189|3872375|FG002|NOT COMPLETED|Drug Discrimination Phase: Day 2||7
3146360|NCT01775189|3872376|FG003|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
3146361|NCT01775189|3872377|FG004|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
3146362|NCT01775189|3872378|FG005|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
3146363|NCT01775189|3872379|FG006|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
3146364|NCT01775189|3872373|FG000|STARTED|Treatment Phase: First Intervention||0
3146365|NCT01775189|3872374|FG001|STARTED|Treatment Phase: First Intervention||0
3146366|NCT01775189|3872375|FG002|STARTED|Treatment Phase: First Intervention||0
3146367|NCT01775189|3872376|FG003|STARTED|Treatment Phase: First Intervention||8
3146368|NCT01775189|3872377|FG004|STARTED|Treatment Phase: First Intervention||8
3146369|NCT01775189|3872378|FG005|STARTED|Treatment Phase: First Intervention||8
3146370|NCT01775189|3872379|FG006|STARTED|Treatment Phase: First Intervention||8
3146371|NCT01775189|3872373|FG000|COMPLETED|Treatment Phase: First Intervention||0
3146372|NCT01775189|3872374|FG001|COMPLETED|Treatment Phase: First Intervention||0
3146373|NCT01775189|3872375|FG002|COMPLETED|Treatment Phase: First Intervention||0
3146374|NCT01775189|3872376|FG003|COMPLETED|Treatment Phase: First Intervention||8
3146375|NCT01775189|3872377|FG004|COMPLETED|Treatment Phase: First Intervention||8
3146376|NCT01775189|3872378|FG005|COMPLETED|Treatment Phase: First Intervention||8
3181350|NCT01996332|3909770|FG000|COMPLETED|Overall Study||0
3181351|NCT01996332|3909770|FG000|NOT COMPLETED|Overall Study||1805
3181352|NCT01996592|3909774|FG000|STARTED|Overall Study||575
3181353|NCT01996592|3909774|FG000|COMPLETED|Overall Study||530
3181354|NCT01996592|3909774|FG000|NOT COMPLETED|Overall Study||45
3181355|NCT01996644|3909785|FG000|STARTED|Overall Study||20
3181356|NCT01996644|3909786|FG001|STARTED|Overall Study||16
3181357|NCT01996644|3909785|FG000|COMPLETED|Overall Study||20
3181358|NCT01996644|3909786|FG001|COMPLETED|Overall Study||16
3181359|NCT01996644|3909785|FG000|NOT COMPLETED|Overall Study||0
3181360|NCT01996644|3909786|FG001|NOT COMPLETED|Overall Study||0
3181361|NCT01996657|3909798|FG000|STARTED|Overall Study||250
3181362|NCT01996657|3909799|FG001|STARTED|Overall Study||250
3181363|NCT01996657|3909800|FG002|STARTED|Overall Study||248
3181364|NCT01996657|3909798|FG000|COMPLETED|Overall Study||237
3146377|NCT01775189|3872379|FG006|COMPLETED|Treatment Phase: First Intervention||8
3146378|NCT01775189|3872373|FG000|NOT COMPLETED|Treatment Phase: First Intervention||0
3146379|NCT01775189|3872374|FG001|NOT COMPLETED|Treatment Phase: First Intervention||0
3146380|NCT01775189|3872375|FG002|NOT COMPLETED|Treatment Phase: First Intervention||0
3146381|NCT01775189|3872376|FG003|NOT COMPLETED|Treatment Phase: First Intervention||0
3146382|NCT01775189|3872377|FG004|NOT COMPLETED|Treatment Phase: First Intervention||0
3146383|NCT01775189|3872378|FG005|NOT COMPLETED|Treatment Phase: First Intervention||0
3146384|NCT01775189|3872379|FG006|NOT COMPLETED|Treatment Phase: First Intervention||0
3146385|NCT01775189|3872373|FG000|STARTED|Treatment Phase: Washout Period 1||0
3146386|NCT01775189|3872374|FG001|STARTED|Treatment Phase: Washout Period 1||0
3146387|NCT01775189|3872375|FG002|STARTED|Treatment Phase: Washout Period 1||0
3146388|NCT01775189|3872376|FG003|STARTED|Treatment Phase: Washout Period 1||8
3146389|NCT01775189|3872377|FG004|STARTED|Treatment Phase: Washout Period 1||8
3146390|NCT01775189|3872378|FG005|STARTED|Treatment Phase: Washout Period 1||8
3146391|NCT01775189|3872379|FG006|STARTED|Treatment Phase: Washout Period 1||8
3146392|NCT01775189|3872373|FG000|COMPLETED|Treatment Phase: Washout Period 1||0
3146393|NCT01775189|3872374|FG001|COMPLETED|Treatment Phase: Washout Period 1||0
3146394|NCT01775189|3872375|FG002|COMPLETED|Treatment Phase: Washout Period 1||0
3146395|NCT01775189|3872376|FG003|COMPLETED|Treatment Phase: Washout Period 1||8
3146396|NCT01775189|3872377|FG004|COMPLETED|Treatment Phase: Washout Period 1||8
3146397|NCT01775189|3872378|FG005|COMPLETED|Treatment Phase: Washout Period 1||7
3146398|NCT01775189|3872379|FG006|COMPLETED|Treatment Phase: Washout Period 1||8
3146399|NCT01775189|3872373|FG000|NOT COMPLETED|Treatment Phase: Washout Period 1||0
3146400|NCT01775189|3872374|FG001|NOT COMPLETED|Treatment Phase: Washout Period 1||0
3146401|NCT01775189|3872375|FG002|NOT COMPLETED|Treatment Phase: Washout Period 1||0
3146402|NCT01775189|3872376|FG003|NOT COMPLETED|Treatment Phase: Washout Period 1||0
3146403|NCT01775189|3872377|FG004|NOT COMPLETED|Treatment Phase: Washout Period 1||0
3146404|NCT01775189|3872378|FG005|NOT COMPLETED|Treatment Phase: Washout Period 1||1
3146405|NCT01775189|3872379|FG006|NOT COMPLETED|Treatment Phase: Washout Period 1||0
3146406|NCT01775189|3872373|FG000|STARTED|Treatment Phase: Second Intervention||0
3146407|NCT01775189|3872374|FG001|STARTED|Treatment Phase: Second Intervention||0
3146408|NCT01775189|3872375|FG002|STARTED|Treatment Phase: Second Intervention||0
3146409|NCT01775189|3872376|FG003|STARTED|Treatment Phase: Second Intervention||8
3146410|NCT01775189|3872377|FG004|STARTED|Treatment Phase: Second Intervention||8
3146411|NCT01775189|3872378|FG005|STARTED|Treatment Phase: Second Intervention||7
3146412|NCT01775189|3872379|FG006|STARTED|Treatment Phase: Second Intervention||8
3146413|NCT01775189|3872373|FG000|COMPLETED|Treatment Phase: Second Intervention||0
3146414|NCT01775189|3872374|FG001|COMPLETED|Treatment Phase: Second Intervention||0
3146415|NCT01775189|3872375|FG002|COMPLETED|Treatment Phase: Second Intervention||0
3146416|NCT01775189|3872376|FG003|COMPLETED|Treatment Phase: Second Intervention||8
3146417|NCT01775189|3872377|FG004|COMPLETED|Treatment Phase: Second Intervention||8
3146418|NCT01775189|3872378|FG005|COMPLETED|Treatment Phase: Second Intervention||7
3146419|NCT01775189|3872379|FG006|COMPLETED|Treatment Phase: Second Intervention||8
3146420|NCT01775189|3872373|FG000|NOT COMPLETED|Treatment Phase: Second Intervention||0
3146421|NCT01775189|3872374|FG001|NOT COMPLETED|Treatment Phase: Second Intervention||0
3146422|NCT01775189|3872375|FG002|NOT COMPLETED|Treatment Phase: Second Intervention||0
3146423|NCT01775189|3872376|FG003|NOT COMPLETED|Treatment Phase: Second Intervention||0
3146424|NCT01775189|3872377|FG004|NOT COMPLETED|Treatment Phase: Second Intervention||0
3146425|NCT01775189|3872378|FG005|NOT COMPLETED|Treatment Phase: Second Intervention||0
3146426|NCT01775189|3872379|FG006|NOT COMPLETED|Treatment Phase: Second Intervention||0
3146427|NCT01775189|3872373|FG000|STARTED|Treatment Phase: Washout Period 2||0
3146428|NCT01775189|3872374|FG001|STARTED|Treatment Phase: Washout Period 2||0
3146429|NCT01775189|3872375|FG002|STARTED|Treatment Phase: Washout Period 2||0
3146430|NCT01775189|3872376|FG003|STARTED|Treatment Phase: Washout Period 2||8
3146431|NCT01775189|3872377|FG004|STARTED|Treatment Phase: Washout Period 2||8
3146432|NCT01775189|3872378|FG005|STARTED|Treatment Phase: Washout Period 2||7
3146433|NCT01775189|3872379|FG006|STARTED|Treatment Phase: Washout Period 2||8
3146434|NCT01775189|3872373|FG000|COMPLETED|Treatment Phase: Washout Period 2||0
3146435|NCT01775189|3872374|FG001|COMPLETED|Treatment Phase: Washout Period 2||0
3146436|NCT01775189|3872375|FG002|COMPLETED|Treatment Phase: Washout Period 2||0
3146437|NCT01775189|3872376|FG003|COMPLETED|Treatment Phase: Washout Period 2||7
3146438|NCT01775189|3872377|FG004|COMPLETED|Treatment Phase: Washout Period 2||8
3146439|NCT01775189|3872378|FG005|COMPLETED|Treatment Phase: Washout Period 2||7
3146440|NCT01775189|3872379|FG006|COMPLETED|Treatment Phase: Washout Period 2||8
3146441|NCT01775189|3872373|FG000|NOT COMPLETED|Treatment Phase: Washout Period 2||0
3146442|NCT01775189|3872374|FG001|NOT COMPLETED|Treatment Phase: Washout Period 2||0
3146443|NCT01775189|3872375|FG002|NOT COMPLETED|Treatment Phase: Washout Period 2||0
3146444|NCT01775189|3872376|FG003|NOT COMPLETED|Treatment Phase: Washout Period 2||1
3146445|NCT01775189|3872377|FG004|NOT COMPLETED|Treatment Phase: Washout Period 2||0
3146446|NCT01775189|3872378|FG005|NOT COMPLETED|Treatment Phase: Washout Period 2||0
3146447|NCT01775189|3872379|FG006|NOT COMPLETED|Treatment Phase: Washout Period 2||0
3146448|NCT01775189|3872373|FG000|STARTED|Treatment Phase: Third Intervention||0
3146449|NCT01775189|3872374|FG001|STARTED|Treatment Phase: Third Intervention||0
3146450|NCT01775189|3872375|FG002|STARTED|Treatment Phase: Third Intervention||0
3146451|NCT01775189|3872376|FG003|STARTED|Treatment Phase: Third Intervention||7
3146452|NCT01775189|3872377|FG004|STARTED|Treatment Phase: Third Intervention||8
3146453|NCT01775189|3872378|FG005|STARTED|Treatment Phase: Third Intervention||7
3146454|NCT01775189|3872379|FG006|STARTED|Treatment Phase: Third Intervention||8
3146455|NCT01775189|3872373|FG000|COMPLETED|Treatment Phase: Third Intervention||0
3181365|NCT01996657|3909799|FG001|COMPLETED|Overall Study||239
3181366|NCT01996657|3909800|FG002|COMPLETED|Overall Study||234
3181367|NCT01996657|3909798|FG000|NOT COMPLETED|Overall Study||13
3181368|NCT01996657|3909799|FG001|NOT COMPLETED|Overall Study||11
3181369|NCT01996657|3909800|FG002|NOT COMPLETED|Overall Study||14
3181370|NCT01996709|3909810|FG000|STARTED|Overall Study||66
3181371|NCT01996709|3909811|FG001|STARTED|Overall Study||68
3181372|NCT01996709|3909810|FG000|COMPLETED|Overall Study||61
3181373|NCT01996709|3909811|FG001|COMPLETED|Overall Study||67
3181374|NCT01996709|3909810|FG000|NOT COMPLETED|Overall Study||5
3181375|NCT01996709|3909811|FG001|NOT COMPLETED|Overall Study||1
3181376|NCT01996748|3909823|FG000|STARTED|Overall Study||66
3181377|NCT01996748|3909824|FG001|STARTED|Overall Study||69
3181378|NCT01996748|3909823|FG000|COMPLETED|Overall Study||58
3146456|NCT01775189|3872374|FG001|COMPLETED|Treatment Phase: Third Intervention||0
3146457|NCT01775189|3872375|FG002|COMPLETED|Treatment Phase: Third Intervention||0
3146458|NCT01775189|3872376|FG003|COMPLETED|Treatment Phase: Third Intervention||7
3146459|NCT01775189|3872377|FG004|COMPLETED|Treatment Phase: Third Intervention||8
3146460|NCT01775189|3872378|FG005|COMPLETED|Treatment Phase: Third Intervention||7
3146461|NCT01775189|3872379|FG006|COMPLETED|Treatment Phase: Third Intervention||8
3146462|NCT01775189|3872373|FG000|NOT COMPLETED|Treatment Phase: Third Intervention||0
3146463|NCT01775189|3872374|FG001|NOT COMPLETED|Treatment Phase: Third Intervention||0
3146464|NCT01775189|3872375|FG002|NOT COMPLETED|Treatment Phase: Third Intervention||0
3146465|NCT01775189|3872376|FG003|NOT COMPLETED|Treatment Phase: Third Intervention||0
3146466|NCT01775189|3872377|FG004|NOT COMPLETED|Treatment Phase: Third Intervention||0
3146467|NCT01775189|3872378|FG005|NOT COMPLETED|Treatment Phase: Third Intervention||0
3146468|NCT01775189|3872379|FG006|NOT COMPLETED|Treatment Phase: Third Intervention||0
3146469|NCT01775189|3872373|FG000|STARTED|Treatment Phase: Washout Period 3||0
3146470|NCT01775189|3872374|FG001|STARTED|Treatment Phase: Washout Period 3||0
3146471|NCT01775189|3872375|FG002|STARTED|Treatment Phase: Washout Period 3||0
3146472|NCT01775189|3872376|FG003|STARTED|Treatment Phase: Washout Period 3||7
3146473|NCT01775189|3872377|FG004|STARTED|Treatment Phase: Washout Period 3||8
3146474|NCT01775189|3872378|FG005|STARTED|Treatment Phase: Washout Period 3||7
3146475|NCT01775189|3872379|FG006|STARTED|Treatment Phase: Washout Period 3||8
3146476|NCT01775189|3872373|FG000|COMPLETED|Treatment Phase: Washout Period 3||0
3146477|NCT01775189|3872374|FG001|COMPLETED|Treatment Phase: Washout Period 3||0
3146478|NCT01775189|3872375|FG002|COMPLETED|Treatment Phase: Washout Period 3||0
3146479|NCT01775189|3872376|FG003|COMPLETED|Treatment Phase: Washout Period 3||6
3146480|NCT01775189|3872377|FG004|COMPLETED|Treatment Phase: Washout Period 3||8
3146481|NCT01775189|3872378|FG005|COMPLETED|Treatment Phase: Washout Period 3||7
3146482|NCT01775189|3872379|FG006|COMPLETED|Treatment Phase: Washout Period 3||7
3146483|NCT01775189|3872373|FG000|NOT COMPLETED|Treatment Phase: Washout Period 3||0
3146484|NCT01775189|3872374|FG001|NOT COMPLETED|Treatment Phase: Washout Period 3||0
3146485|NCT01775189|3872375|FG002|NOT COMPLETED|Treatment Phase: Washout Period 3||0
3146486|NCT01775189|3872376|FG003|NOT COMPLETED|Treatment Phase: Washout Period 3||1
3146487|NCT01775189|3872377|FG004|NOT COMPLETED|Treatment Phase: Washout Period 3||0
3146488|NCT01775189|3872378|FG005|NOT COMPLETED|Treatment Phase: Washout Period 3||0
3146489|NCT01775189|3872379|FG006|NOT COMPLETED|Treatment Phase: Washout Period 3||1
3146490|NCT01775189|3872373|FG000|STARTED|Treatment Phase: Fourth Intervention||0
3146491|NCT01775189|3872374|FG001|STARTED|Treatment Phase: Fourth Intervention||0
3146492|NCT01775189|3872375|FG002|STARTED|Treatment Phase: Fourth Intervention||0
3146493|NCT01775189|3872376|FG003|STARTED|Treatment Phase: Fourth Intervention||6
3146494|NCT01775189|3872377|FG004|STARTED|Treatment Phase: Fourth Intervention||8
3146495|NCT01775189|3872378|FG005|STARTED|Treatment Phase: Fourth Intervention||7
3146496|NCT01775189|3872379|FG006|STARTED|Treatment Phase: Fourth Intervention||7
3146497|NCT01775189|3872373|FG000|COMPLETED|Treatment Phase: Fourth Intervention||0
3146498|NCT01775189|3872374|FG001|COMPLETED|Treatment Phase: Fourth Intervention||0
3146499|NCT01775189|3872375|FG002|COMPLETED|Treatment Phase: Fourth Intervention||0
3146500|NCT01775189|3872376|FG003|COMPLETED|Treatment Phase: Fourth Intervention||6
3146501|NCT01775189|3872377|FG004|COMPLETED|Treatment Phase: Fourth Intervention||8
3146502|NCT01775189|3872378|FG005|COMPLETED|Treatment Phase: Fourth Intervention||7
3146503|NCT01775189|3872379|FG006|COMPLETED|Treatment Phase: Fourth Intervention||7
3146504|NCT01775189|3872373|FG000|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
3146505|NCT01775189|3872374|FG001|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
3146506|NCT01775189|3872375|FG002|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
3146507|NCT01775189|3872376|FG003|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
3146508|NCT01775189|3872377|FG004|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
3146509|NCT01775189|3872378|FG005|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
3146510|NCT01775189|3872379|FG006|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
3181379|NCT01996748|3909824|FG001|COMPLETED|Overall Study||63
3181380|NCT01996748|3909823|FG000|NOT COMPLETED|Overall Study||8
3181381|NCT01996748|3909824|FG001|NOT COMPLETED|Overall Study||6
3146511|NCT01775371|3872409|FG000|STARTED|Overall Study||306
3146512|NCT01775371|3872410|FG001|STARTED|Overall Study||330
3146513|NCT01775371|3872409|FG000|COMPLETED|Overall Study||306
3146514|NCT01775371|3872410|FG001|COMPLETED|Overall Study||330
3146515|NCT01775371|3872409|FG000|NOT COMPLETED|Overall Study||0
3146516|NCT01775371|3872410|FG001|NOT COMPLETED|Overall Study||0
3146517|NCT01775410|3872418|FG000|STARTED|Overall Study||4
3146518|NCT01775410|3872418|FG000|COMPLETED|Overall Study||4
3146519|NCT01775410|3872418|FG000|NOT COMPLETED|Overall Study||0
3146520|NCT01775501|3872422|FG000|STARTED|Overall Study||40
3146521|NCT01775501|3872422|FG000|COMPLETED|Overall Study||39
3146522|NCT01775501|3872422|FG000|NOT COMPLETED|Overall Study||1
3146523|NCT01775553|3872426|FG000|STARTED|Overall Study||13
3146524|NCT01775553|3872426|FG000|COMPLETED|Overall Study||0
3146525|NCT01775553|3872426|FG000|NOT COMPLETED|Overall Study||13
3146526|NCT01775670|3872432|FG000|STARTED|Overall Study||1
3146527|NCT01775670|3872433|FG001|STARTED|Overall Study||3
3146528|NCT01775670|3872432|FG000|COMPLETED|Overall Study||0
3146529|NCT01775670|3872433|FG001|COMPLETED|Overall Study||2
3146530|NCT01775670|3872432|FG000|NOT COMPLETED|Overall Study||1
3146531|NCT01775670|3872433|FG001|NOT COMPLETED|Overall Study||1
3146532|NCT01775722|3872439|FG000|STARTED|Overall Study||22
3146533|NCT01775722|3872439|FG000|COMPLETED|Overall Study||20
3146534|NCT01775722|3872439|FG000|NOT COMPLETED|Overall Study||2
3146535|NCT01775735|3872447|FG000|STARTED|Intervention (6 Months)||8
3146536|NCT01775735|3872448|FG001|STARTED|Intervention (6 Months)||7
3146537|NCT01775735|3872447|FG000|COMPLETED|Intervention (6 Months)||8
3146538|NCT01775735|3872448|FG001|COMPLETED|Intervention (6 Months)||7
3146539|NCT01775735|3872447|FG000|NOT COMPLETED|Intervention (6 Months)||0
3146540|NCT01775735|3872448|FG001|NOT COMPLETED|Intervention (6 Months)||0
3146541|NCT01775735|3872447|FG000|STARTED|Open Label (24 Months)||8
3146542|NCT01775735|3872448|FG001|STARTED|Open Label (24 Months)||7
3146543|NCT01775735|3872447|FG000|COMPLETED|Open Label (24 Months)||7
3146544|NCT01775735|3872448|FG001|COMPLETED|Open Label (24 Months)||3
3146545|NCT01775735|3872447|FG000|NOT COMPLETED|Open Label (24 Months)||1
3146546|NCT01775735|3872448|FG001|NOT COMPLETED|Open Label (24 Months)||4
3146547|NCT01775774|3872457|FG000|STARTED|Overall Study||3
3146548|NCT01775774|3872458|FG001|STARTED|Overall Study||3
3146549|NCT01775774|3872459|FG002|STARTED|Overall Study||3
3146550|NCT01775774|3872457|FG000|COMPLETED|Overall Study||3
3146551|NCT01775774|3872458|FG001|COMPLETED|Overall Study||3
3146552|NCT01775774|3872459|FG002|COMPLETED|Overall Study||3
3146553|NCT01775774|3872457|FG000|NOT COMPLETED|Overall Study||0
3146554|NCT01775774|3872458|FG001|NOT COMPLETED|Overall Study||0
3146555|NCT01775774|3872459|FG002|NOT COMPLETED|Overall Study||0
3146556|NCT01775787|3872467|FG000|STARTED|First 7-10 Days||13
3146557|NCT01775787|3872468|FG001|STARTED|First 7-10 Days||14
3146558|NCT01775787|3872467|FG000|COMPLETED|First 7-10 Days||12
3146559|NCT01775787|3872468|FG001|COMPLETED|First 7-10 Days||8
3146560|NCT01775787|3872467|FG000|NOT COMPLETED|First 7-10 Days||1
3146561|NCT01775787|3872468|FG001|NOT COMPLETED|First 7-10 Days||6
3146562|NCT01775787|3872467|FG000|STARTED|Second 7-10 Days||12
3146563|NCT01775787|3872468|FG001|STARTED|Second 7-10 Days||8
3146564|NCT01775787|3872467|FG000|COMPLETED|Second 7-10 Days||12
3146565|NCT01775787|3872468|FG001|COMPLETED|Second 7-10 Days||6
3146566|NCT01775787|3872467|FG000|NOT COMPLETED|Second 7-10 Days||0
3146567|NCT01775787|3872468|FG001|NOT COMPLETED|Second 7-10 Days||2
3146568|NCT01775800|3872478|FG000|STARTED|Overall Study||8
3146569|NCT01775800|3872479|FG001|STARTED|Overall Study||8
3146570|NCT01775800|3872478|FG000|COMPLETED|Overall Study||8
3146571|NCT01775800|3872479|FG001|COMPLETED|Overall Study||8
3146572|NCT01775800|3872478|FG000|NOT COMPLETED|Overall Study||0
3146573|NCT01775800|3872479|FG001|NOT COMPLETED|Overall Study||0
3146574|NCT01775852|3872488|FG000|STARTED|Overall Study||31
3146575|NCT01775852|3872489|FG001|STARTED|Overall Study||14
3146576|NCT01775852|3872488|FG000|COMPLETED|Overall Study||31
3146577|NCT01775852|3872489|FG001|COMPLETED|Overall Study||13
3146578|NCT01775852|3872488|FG000|NOT COMPLETED|Overall Study||0
3146579|NCT01775852|3872489|FG001|NOT COMPLETED|Overall Study||1
3146580|NCT01775865|3872498|FG000|STARTED|Overall Study||14
3146581|NCT01775865|3872499|FG001|STARTED|Overall Study||14
3146582|NCT01775865|3872500|FG002|STARTED|Overall Study||17
3146583|NCT01775865|3872498|FG000|COMPLETED|Overall Study||11
3146584|NCT01775865|3872499|FG001|COMPLETED|Overall Study||13
3146585|NCT01775865|3872500|FG002|COMPLETED|Overall Study||17
3146586|NCT01775865|3872498|FG000|NOT COMPLETED|Overall Study||3
3146587|NCT01775865|3872499|FG001|NOT COMPLETED|Overall Study||1
3146588|NCT01775865|3872500|FG002|NOT COMPLETED|Overall Study||0
3146589|NCT01775904|3872513|FG000|STARTED|LY2886721 ODT (no Water, Fasting)||26
3146590|NCT01775904|3872513|FG000|Received at Least One Dose of Drug|LY2886721 ODT (no Water, Fasting)||26
3146591|NCT01775904|3872513|FG000|COMPLETED|LY2886721 ODT (no Water, Fasting)||26
3146592|NCT01775904|3872513|FG000|NOT COMPLETED|LY2886721 ODT (no Water, Fasting)||0
3146593|NCT01775904|3872513|FG000|STARTED|First Washout (7 Days)||26
3146594|NCT01775904|3872513|FG000|COMPLETED|First Washout (7 Days)||26
3146595|NCT01775904|3872513|FG000|NOT COMPLETED|First Washout (7 Days)||0
3146596|NCT01775904|3872513|FG000|STARTED|LY2886721 Capsule (Water, Fasting)||26
3146597|NCT01775904|3872513|FG000|Received at Least One Dose of Drug|LY2886721 Capsule (Water, Fasting)||26
3146598|NCT01775904|3872513|FG000|COMPLETED|LY2886721 Capsule (Water, Fasting)||25
3146599|NCT01775904|3872513|FG000|NOT COMPLETED|LY2886721 Capsule (Water, Fasting)||1
3146600|NCT01775904|3872513|FG000|STARTED|Second Washout (7 Days)||25
3146601|NCT01775904|3872513|FG000|COMPLETED|Second Washout (7 Days)||25
3146602|NCT01775904|3872513|FG000|NOT COMPLETED|Second Washout (7 Days)||0
3146603|NCT01775904|3872513|FG000|STARTED|LY2886721 ODT (Water, Fed)||25
3146604|NCT01775904|3872513|FG000|Received at Least One Dose of Drug|LY2886721 ODT (Water, Fed)||25
3146605|NCT01775904|3872513|FG000|COMPLETED|LY2886721 ODT (Water, Fed)||25
3146606|NCT01775904|3872513|FG000|NOT COMPLETED|LY2886721 ODT (Water, Fed)||0
3146607|NCT01775904|3872513|FG000|STARTED|Third Washout (7 Days)||25
3146608|NCT01775904|3872513|FG000|COMPLETED|Third Washout (7 Days)||25
3146609|NCT01775904|3872513|FG000|NOT COMPLETED|Third Washout (7 Days)||0
3146610|NCT01775904|3872513|FG000|STARTED|LY2886721 ODT (Water, Fasting)||25
3181382|NCT01996813|3909834|FG000|STARTED|Overall Study||23
3181383|NCT01996813|3909835|FG001|STARTED|Overall Study||24
3181384|NCT01996813|3909834|FG000|COMPLETED|Overall Study||23
3181385|NCT01996813|3909835|FG001|COMPLETED|Overall Study||24
3181386|NCT01996813|3909834|FG000|NOT COMPLETED|Overall Study||0
3181387|NCT01996813|3909835|FG001|NOT COMPLETED|Overall Study||0
3181388|NCT01996826|3909843|FG000|STARTED|Overall Study||39
3181389|NCT01996826|3909844|FG001|STARTED|Overall Study||36
3181390|NCT01996826|3909843|FG000|COMPLETED|Overall Study||32
3181391|NCT01996826|3909844|FG001|COMPLETED|Overall Study||33
3181392|NCT01996826|3909843|FG000|NOT COMPLETED|Overall Study||7
3181393|NCT01996826|3909844|FG001|NOT COMPLETED|Overall Study||3
3181394|NCT01996839|3909853|FG000|STARTED|Overall Study||172
3181395|NCT01996839|3909854|FG001|STARTED|Overall Study||171
3181396|NCT01996839|3909855|FG002|STARTED|Overall Study||171
3181397|NCT01996839|3909853|FG000|COMPLETED|Overall Study||80
3181398|NCT01996839|3909854|FG001|COMPLETED|Overall Study||133
3181399|NCT01996839|3909855|FG002|COMPLETED|Overall Study||139
3181400|NCT01996839|3909853|FG000|NOT COMPLETED|Overall Study||92
3181401|NCT01996839|3909854|FG001|NOT COMPLETED|Overall Study||38
3181402|NCT01996839|3909855|FG002|NOT COMPLETED|Overall Study||32
3181403|NCT01996904|3909865|FG000|STARTED|Overall Study||139
3181404|NCT01996904|3909866|FG001|STARTED|Overall Study||117
3181405|NCT01996904|3909865|FG000|COMPLETED|Overall Study||101
3181406|NCT01996904|3909866|FG001|COMPLETED|Overall Study||90
3181407|NCT01996904|3909865|FG000|NOT COMPLETED|Overall Study||38
3181408|NCT01996904|3909866|FG001|NOT COMPLETED|Overall Study||27
3181409|NCT01996917|3909872|FG000|STARTED|Overall Study||21
3181410|NCT01996917|3909872|FG000|COMPLETED|Overall Study||21
3181411|NCT01996917|3909872|FG000|NOT COMPLETED|Overall Study||0
3181412|NCT01996943|3909879|FG000|STARTED|Overall Study||50
3181413|NCT01996943|3909880|FG001|STARTED|Overall Study||50
3181414|NCT01996943|3909879|FG000|COMPLETED|Overall Study||50
3181415|NCT01996943|3909880|FG001|COMPLETED|Overall Study||50
3181416|NCT01996943|3909879|FG000|NOT COMPLETED|Overall Study||0
3181417|NCT01996943|3909880|FG001|NOT COMPLETED|Overall Study||0
3181418|NCT01997125|3909886|FG000|STARTED|Overall Study||1
3181419|NCT01997125|3909886|FG000|COMPLETED|Overall Study||1
3181420|NCT01997125|3909886|FG000|NOT COMPLETED|Overall Study||0
3181421|NCT01997216|3909890|FG000|STARTED|First 9 Hours||18
3181422|NCT01997216|3909891|FG001|STARTED|First 9 Hours||21
3181423|NCT01997216|3909890|FG000|COMPLETED|First 9 Hours||18
3181424|NCT01997216|3909891|FG001|COMPLETED|First 9 Hours||21
3181425|NCT01997216|3909890|FG000|NOT COMPLETED|First 9 Hours||0
3181426|NCT01997216|3909891|FG001|NOT COMPLETED|First 9 Hours||0
3181427|NCT01997216|3909890|FG000|STARTED|Second 9 Hours|One participant was not exposed to Pair 1 due to product unavailability, but was exposed to Pair 2.|19
3181428|NCT01997216|3909891|FG001|STARTED|Second 9 Hours||21
3181429|NCT01997216|3909890|FG000|COMPLETED|Second 9 Hours||19
3181430|NCT01997216|3909891|FG001|COMPLETED|Second 9 Hours||21
3181431|NCT01997216|3909890|FG000|NOT COMPLETED|Second 9 Hours||0
3181432|NCT01997216|3909891|FG001|NOT COMPLETED|Second 9 Hours||0
3181433|NCT01997229|3909899|FG000|STARTED|Overall Study||62
3181434|NCT01997229|3909900|FG001|STARTED|Overall Study||63
3181435|NCT01997229|3909899|FG000|COMPLETED|Overall Study||57
3363560|NCT04055519|4094688|FG000|NOT COMPLETED|First Wear Period (30 Days)||0
3363561|NCT04055519|4094689|FG001|NOT COMPLETED|First Wear Period (30 Days)||0
3363562|NCT04055519|4094688|FG000|STARTED|Second Wear Period (30 Days)||16
3363563|NCT04055519|4094689|FG001|STARTED|Second Wear Period (30 Days)||20
3363564|NCT04055519|4094688|FG000|COMPLETED|Second Wear Period (30 Days)||16
3363565|NCT04055519|4094689|FG001|COMPLETED|Second Wear Period (30 Days)||20
3363566|NCT04055519|4094688|FG000|NOT COMPLETED|Second Wear Period (30 Days)||0
3363567|NCT04055519|4094689|FG001|NOT COMPLETED|Second Wear Period (30 Days)||0
3363568|NCT04055675|4094700|FG000|STARTED|Overall Study||96
3363569|NCT04055675|4094701|FG001|STARTED|Overall Study||104
3363570|NCT04055675|4094700|FG000|COMPLETED|Overall Study||96
3363571|NCT04055675|4094701|FG001|COMPLETED|Overall Study||104
3363572|NCT04055675|4094700|FG000|NOT COMPLETED|Overall Study||0
3363573|NCT04055675|4094701|FG001|NOT COMPLETED|Overall Study||0
3363574|NCT04054765|4094709|FG000|STARTED|Baseline||155
3363575|NCT04054765|4094710|FG001|STARTED|Baseline||132
3363576|NCT04054765|4094709|FG000|COMPLETED|Baseline||150
3181436|NCT01997229|3909900|FG001|COMPLETED|Overall Study||61
3181437|NCT01997229|3909899|FG000|NOT COMPLETED|Overall Study||5
3181438|NCT01997229|3909900|FG001|NOT COMPLETED|Overall Study||2
3363577|NCT04054765|4094710|FG001|COMPLETED|Baseline||129
3181439|NCT01997281|3909908|FG000|STARTED|Overall Study||7
3363578|NCT04054765|4094709|FG000|NOT COMPLETED|Baseline||5
3363579|NCT04054765|4094710|FG001|NOT COMPLETED|Baseline||3
3146611|NCT01775904|3872513|FG000|Received at Least One Dose of Drug|LY2886721 ODT (Water, Fasting)|One participant was not dosed in this period due to an adverse event (AE).|24
3146612|NCT01775904|3872513|FG000|COMPLETED|LY2886721 ODT (Water, Fasting)||24
3146613|NCT01775904|3872513|FG000|NOT COMPLETED|LY2886721 ODT (Water, Fasting)||1
3146614|NCT01775930|3872523|FG000|STARTED|Overall Study||10
3146615|NCT01775930|3872523|FG000|COMPLETED|Overall Study||9
3146616|NCT01775930|3872523|FG000|NOT COMPLETED|Overall Study||1
3146617|NCT01775995|3872529|FG000|STARTED|Overall Study||21
3146618|NCT01775995|3872530|FG001|STARTED|Overall Study||14
3146619|NCT01775995|3872529|FG000|COMPLETED|Overall Study|One experimental participant was unable to reach at 26 week follow up|20
3146620|NCT01775995|3872530|FG001|COMPLETED|Overall Study|One control participant was unable to reach at 26 week follow up|13
3146621|NCT01775995|3872529|FG000|NOT COMPLETED|Overall Study||1
3146622|NCT01775995|3872530|FG001|NOT COMPLETED|Overall Study||1
3146623|NCT01776008|3872536|FG000|STARTED|Overall Study||16
3146624|NCT01776008|3872536|FG000|COMPLETED|Overall Study||14
3146625|NCT01776008|3872536|FG000|NOT COMPLETED|Overall Study||2
3146626|NCT01776268|3872542|FG000|STARTED|Overall Study||48
3146627|NCT01776268|3872543|FG001|STARTED|Overall Study||51
3146628|NCT01776268|3872542|FG000|COMPLETED|Overall Study||48
3146629|NCT01776268|3872543|FG001|COMPLETED|Overall Study||51
3146630|NCT01776268|3872542|FG000|NOT COMPLETED|Overall Study||0
3146631|NCT01776268|3872543|FG001|NOT COMPLETED|Overall Study||0
3146632|NCT01776307|3872553|FG000|STARTED|Overall Study||49
3146633|NCT01776307|3872554|FG001|STARTED|Overall Study||75
3146634|NCT01776307|3872555|FG002|STARTED|Overall Study||76
3146635|NCT01776307|3872553|FG000|COMPLETED|Overall Study||49
3146636|NCT01776307|3872554|FG001|COMPLETED|Overall Study||75
3146637|NCT01776307|3872555|FG002|COMPLETED|Overall Study||75
3146638|NCT01776307|3872553|FG000|NOT COMPLETED|Overall Study||0
3146639|NCT01776307|3872554|FG001|NOT COMPLETED|Overall Study||0
3146640|NCT01776307|3872555|FG002|NOT COMPLETED|Overall Study||1
3146641|NCT01776424|3872587|FG000|STARTED|Overall Study||9152
3146642|NCT01776424|3872588|FG001|STARTED|Overall Study||9117
3146643|NCT01776424|3872589|FG002|STARTED|Overall Study||9126
3146644|NCT01776424|3872587|FG000|Treated|Overall Study||9134
3146645|NCT01776424|3872588|FG001|Treated|Overall Study||9110
3146646|NCT01776424|3872589|FG002|Treated|Overall Study||9107
3146647|NCT01776424|3872587|FG000|COMPLETED|Overall Study||9132
3146648|NCT01776424|3872588|FG001|COMPLETED|Overall Study||9098
3146649|NCT01776424|3872589|FG002|COMPLETED|Overall Study||9102
3146650|NCT01776424|3872587|FG000|NOT COMPLETED|Overall Study||20
3146651|NCT01776424|3872588|FG001|NOT COMPLETED|Overall Study||19
3146652|NCT01776424|3872589|FG002|NOT COMPLETED|Overall Study||24
3146653|NCT01776541|3872599|FG000|STARTED|Overall Study||488
3146654|NCT01776541|3872600|FG001|STARTED|Overall Study||491
3146655|NCT01776541|3872599|FG000|COMPLETED|Overall Study||432
3146656|NCT01776541|3872600|FG001|COMPLETED|Overall Study||416
3146657|NCT01776541|3872599|FG000|NOT COMPLETED|Overall Study||56
3181440|NCT01997281|3909909|FG001|STARTED|Overall Study||7
3181441|NCT01997281|3909908|FG000|Withdrawal|Overall Study||1
3181442|NCT01997281|3909909|FG001|Withdrawal|Overall Study||0
3181443|NCT01997281|3909908|FG000|COMPLETED|Overall Study||6
3146658|NCT01776541|3872600|FG001|NOT COMPLETED|Overall Study||75
3146659|NCT01776554|3872609|FG000|STARTED|Overall Study||332
3146660|NCT01776554|3872610|FG001|STARTED|Overall Study||330
3146661|NCT01776554|3872609|FG000|COMPLETED|Overall Study||315
3146662|NCT01776554|3872610|FG001|COMPLETED|Overall Study||307
3146663|NCT01776554|3872609|FG000|NOT COMPLETED|Overall Study||17
3146664|NCT01776554|3872610|FG001|NOT COMPLETED|Overall Study||23
3146665|NCT01776632|3872619|FG000|STARTED|Overall Study||217
3146666|NCT01776632|3872620|FG001|STARTED|Overall Study||219
3146667|NCT01776632|3872619|FG000|COMPLETED|Overall Study||190
3146668|NCT01776632|3872620|FG001|COMPLETED|Overall Study||190
3146669|NCT01776632|3872619|FG000|NOT COMPLETED|Overall Study||27
3146670|NCT01776632|3872620|FG001|NOT COMPLETED|Overall Study||29
3146671|NCT01776645|3872628|FG000|STARTED|Overall Study||28
3146672|NCT01776645|3872629|FG001|STARTED|Overall Study||28
3146673|NCT01776645|3872628|FG000|COMPLETED|Overall Study||14
3146674|NCT01776645|3872629|FG001|COMPLETED|Overall Study||14
3146675|NCT01776645|3872628|FG000|NOT COMPLETED|Overall Study||14
3146676|NCT01776645|3872629|FG001|NOT COMPLETED|Overall Study||14
3146677|NCT01777126|3872636|FG000|STARTED|Overall Study||48
3146678|NCT01777126|3872637|FG001|STARTED|Overall Study||46
3146679|NCT01777126|3872636|FG000|COMPLETED|Overall Study||48
3146680|NCT01777126|3872637|FG001|COMPLETED|Overall Study||46
3146681|NCT01777126|3872636|FG000|NOT COMPLETED|Overall Study||0
3146682|NCT01777126|3872637|FG001|NOT COMPLETED|Overall Study||0
3146683|NCT01777139|3872645|FG000|STARTED|Primary Reporting Phase (Up to 4 Years)||30
3146684|NCT01777139|3872646|FG001|STARTED|Primary Reporting Phase (Up to 4 Years)||0
3146685|NCT01777139|3872645|FG000|COMPLETED|Primary Reporting Phase (Up to 4 Years)||0
3146686|NCT01777139|3872646|FG001|COMPLETED|Primary Reporting Phase (Up to 4 Years)||0
3146687|NCT01777139|3872645|FG000|NOT COMPLETED|Primary Reporting Phase (Up to 4 Years)||30
3146688|NCT01777139|3872646|FG001|NOT COMPLETED|Primary Reporting Phase (Up to 4 Years)||0
3146689|NCT01777139|3872645|FG000|STARTED|SFUCP (Up to 1.4 Years)||0
3146690|NCT01777139|3872646|FG001|STARTED|SFUCP (Up to 1.4 Years)||4
3146691|NCT01777139|3872645|FG000|COMPLETED|SFUCP (Up to 1.4 Years)||0
3146692|NCT01777139|3872646|FG001|COMPLETED|SFUCP (Up to 1.4 Years)||0
3146693|NCT01777139|3872645|FG000|NOT COMPLETED|SFUCP (Up to 1.4 Years)||0
3146694|NCT01777139|3872646|FG001|NOT COMPLETED|SFUCP (Up to 1.4 Years)||4
3146695|NCT01777152|3872655|FG000|STARTED|Overall Study||226
3146696|NCT01777152|3872656|FG001|STARTED|Overall Study||226
3146697|NCT01777152|3872655|FG000|COMPLETED|Overall Study||131
3181444|NCT01997281|3909909|FG001|COMPLETED|Overall Study||7
3181445|NCT01997281|3909908|FG000|NOT COMPLETED|Overall Study||1
3181446|NCT01997281|3909909|FG001|NOT COMPLETED|Overall Study||0
3181447|NCT01997333|3909917|FG000|STARTED|Randomization and Treatment||109
3181448|NCT01997333|3909918|FG001|STARTED|Randomization and Treatment||218
3181449|NCT01997333|3909917|FG000|COMPLETED|Randomization and Treatment||6
3181450|NCT01997333|3909918|FG001|COMPLETED|Randomization and Treatment||15
3181451|NCT01997333|3909917|FG000|NOT COMPLETED|Randomization and Treatment||103
3181452|NCT01997333|3909918|FG001|NOT COMPLETED|Randomization and Treatment||203
3181453|NCT01997333|3909917|FG000|STARTED|Survival Follow up||92
3181454|NCT01997333|3909918|FG001|STARTED|Survival Follow up||213
3181455|NCT01997333|3909917|FG000|COMPLETED|Survival Follow up||76
3181456|NCT01997333|3909918|FG001|COMPLETED|Survival Follow up||199
3181457|NCT01997333|3909917|FG000|NOT COMPLETED|Survival Follow up||16
3181458|NCT01997333|3909918|FG001|NOT COMPLETED|Survival Follow up||14
3181459|NCT01997398|3909926|FG000|STARTED|Overall Study||35
3181460|NCT01997398|3909926|FG000|COMPLETED|Overall Study|One patient took PD meds 3 hours prior to 6 mo. UPDRS testing and was excluded from the analysis.|34
3181461|NCT01997398|3909926|FG000|NOT COMPLETED|Overall Study||1
3181462|NCT01997411|3909940|FG000|STARTED|Overall Study||6
3181463|NCT01997411|3909941|FG001|STARTED|Overall Study||6
3181464|NCT01997411|3909942|FG002|STARTED|Overall Study||6
3181465|NCT01997411|3909943|FG003|STARTED|Overall Study||6
3146698|NCT01777152|3872656|FG001|COMPLETED|Overall Study||116
3146699|NCT01777152|3872655|FG000|NOT COMPLETED|Overall Study||95
3146700|NCT01777152|3872656|FG001|NOT COMPLETED|Overall Study||110
3146701|NCT01777191|3872665|FG000|STARTED|Treatment Period (Per) (Week 0-Week 12)||102
3146702|NCT01777191|3872666|FG001|STARTED|Treatment Period (Per) (Week 0-Week 12)||102
3146703|NCT01777191|3872665|FG000|COMPLETED|Treatment Period (Per) (Week 0-Week 12)||96
3146704|NCT01777191|3872666|FG001|COMPLETED|Treatment Period (Per) (Week 0-Week 12)||94
3146705|NCT01777191|3872665|FG000|NOT COMPLETED|Treatment Period (Per) (Week 0-Week 12)||6
3146706|NCT01777191|3872666|FG001|NOT COMPLETED|Treatment Period (Per) (Week 0-Week 12)||8
3146707|NCT01777191|3872665|FG000|STARTED|Safety Extension Per (Week 12-Week 48)|Participation in the safety extension period was optional.|94
3146708|NCT01777191|3872666|FG001|STARTED|Safety Extension Per (Week 12-Week 48)|Participation in the safety extension period was optional.|91
3146709|NCT01777191|3872665|FG000|COMPLETED|Safety Extension Per (Week 12-Week 48)||85
3146710|NCT01777191|3872666|FG001|COMPLETED|Safety Extension Per (Week 12-Week 48)||78
3146711|NCT01777191|3872665|FG000|NOT COMPLETED|Safety Extension Per (Week 12-Week 48)||9
3146712|NCT01777191|3872666|FG001|NOT COMPLETED|Safety Extension Per (Week 12-Week 48)||13
3146713|NCT01777217|3872677|FG000|STARTED|Overall Study||4
3146714|NCT01777217|3872678|FG001|STARTED|Overall Study||4
3146715|NCT01777217|3872677|FG000|COMPLETED|Overall Study||4
3146716|NCT01777217|3872678|FG001|COMPLETED|Overall Study||4
3146717|NCT01777217|3872677|FG000|NOT COMPLETED|Overall Study||0
3146718|NCT01777217|3872678|FG001|NOT COMPLETED|Overall Study||0
3146719|NCT01777269|3872686|FG000|STARTED|Overall Study||246
3146720|NCT01777269|3872687|FG001|STARTED|Overall Study||243
3146721|NCT01777269|3872686|FG000|COMPLETED|Overall Study||191
3146722|NCT01777269|3872687|FG001|COMPLETED|Overall Study||184
3146723|NCT01777269|3872686|FG000|NOT COMPLETED|Overall Study||55
3146724|NCT01777269|3872687|FG001|NOT COMPLETED|Overall Study||59
3146725|NCT01777282|3872698|FG000|STARTED|Overall Study||120
3146726|NCT01777282|3872699|FG001|STARTED|Overall Study||67
3146727|NCT01777282|3872700|FG002|STARTED|Overall Study||65
3146728|NCT01777282|3872701|FG003|STARTED|Overall Study||61
3146729|NCT01777282|3872702|FG004|STARTED|Overall Study||61
3146730|NCT01777282|3872698|FG000|Completing Treatment Period|Overall Study||109
3146731|NCT01777282|3872699|FG001|Completing Treatment Period|Overall Study||63
3146732|NCT01777282|3872700|FG002|Completing Treatment Period|Overall Study||59
3146733|NCT01777282|3872701|FG003|Completing Treatment Period|Overall Study||59
3146734|NCT01777282|3872702|FG004|Completing Treatment Period|Overall Study||54
3146735|NCT01777282|3872698|FG000|Completing Follow-up Period|Overall Study||109
3146736|NCT01777282|3872699|FG001|Completing Follow-up Period|Overall Study||63
3146737|NCT01777282|3872700|FG002|Completing Follow-up Period|Overall Study||59
3146738|NCT01777282|3872701|FG003|Completing Follow-up Period|Overall Study||59
3146739|NCT01777282|3872702|FG004|Completing Follow-up Period|Overall Study||54
3146740|NCT01777282|3872698|FG000|COMPLETED|Overall Study||109
3146741|NCT01777282|3872699|FG001|COMPLETED|Overall Study||63
3146742|NCT01777282|3872700|FG002|COMPLETED|Overall Study||59
3146743|NCT01777282|3872701|FG003|COMPLETED|Overall Study||59
3146744|NCT01777282|3872702|FG004|COMPLETED|Overall Study||54
3146745|NCT01777282|3872698|FG000|NOT COMPLETED|Overall Study||11
3146746|NCT01777282|3872699|FG001|NOT COMPLETED|Overall Study||4
3146747|NCT01777282|3872700|FG002|NOT COMPLETED|Overall Study||6
3146748|NCT01777282|3872701|FG003|NOT COMPLETED|Overall Study||2
3146749|NCT01777282|3872702|FG004|NOT COMPLETED|Overall Study||7
3146750|NCT01777308|3872716|FG000|STARTED|Overall Study||119
3146751|NCT01777308|3872717|FG001|STARTED|Overall Study||37
3146752|NCT01777308|3872716|FG000|Completed up to Month 73|Overall Study||118
3146753|NCT01777308|3872717|FG001|Completed up to Month 73|Overall Study||37
3146754|NCT01777308|3872716|FG000|COMPLETED|Overall Study||105
3146755|NCT01777308|3872717|FG001|COMPLETED|Overall Study||34
3146756|NCT01777308|3872716|FG000|NOT COMPLETED|Overall Study||14
3146757|NCT01777308|3872717|FG001|NOT COMPLETED|Overall Study||3
3146758|NCT01777321|3872726|FG000|STARTED|Overall Study||30
3146759|NCT01777321|3872727|FG001|STARTED|Overall Study||30
3146760|NCT01777321|3872726|FG000|COMPLETED|Overall Study||30
3146761|NCT01777321|3872727|FG001|COMPLETED|Overall Study||29
3146762|NCT01777321|3872726|FG000|NOT COMPLETED|Overall Study||0
3146763|NCT01777321|3872727|FG001|NOT COMPLETED|Overall Study||1
3181466|NCT01997411|3909944|FG004|STARTED|Overall Study||6
3181467|NCT01997411|3909945|FG005|STARTED|Overall Study||6
3181468|NCT01997411|3909946|FG006|STARTED|Overall Study||6
3181469|NCT01997411|3909947|FG007|STARTED|Overall Study||6
3181470|NCT01997411|3909940|FG000|COMPLETED|Overall Study||6
3181471|NCT01997411|3909941|FG001|COMPLETED|Overall Study||6
3181472|NCT01997411|3909942|FG002|COMPLETED|Overall Study||6
3181473|NCT01997411|3909943|FG003|COMPLETED|Overall Study||6
3181474|NCT01997411|3909944|FG004|COMPLETED|Overall Study||6
3181475|NCT01997411|3909945|FG005|COMPLETED|Overall Study||5
3181476|NCT01997411|3909946|FG006|COMPLETED|Overall Study||6
3181477|NCT01997411|3909947|FG007|COMPLETED|Overall Study||6
3181478|NCT01997411|3909940|FG000|NOT COMPLETED|Overall Study||0
3181479|NCT01997411|3909941|FG001|NOT COMPLETED|Overall Study||0
3181480|NCT01997411|3909942|FG002|NOT COMPLETED|Overall Study||0
3181481|NCT01997411|3909943|FG003|NOT COMPLETED|Overall Study||0
3181482|NCT01997411|3909944|FG004|NOT COMPLETED|Overall Study||0
3181483|NCT01997411|3909945|FG005|NOT COMPLETED|Overall Study||1
3181484|NCT01997411|3909946|FG006|NOT COMPLETED|Overall Study||0
3181485|NCT01997411|3909947|FG007|NOT COMPLETED|Overall Study||0
3181486|NCT01997437|3909965|FG000|STARTED|Overall Study||6
3181487|NCT01997437|3909965|FG000|COMPLETED|Overall Study||6
3181488|NCT01997437|3909965|FG000|NOT COMPLETED|Overall Study||0
3181489|NCT01997515|3909971|FG000|STARTED|Overall Study||40
3181490|NCT01997515|3909972|FG001|STARTED|Overall Study||40
3181491|NCT01997515|3909971|FG000|COMPLETED|Overall Study||36
3181492|NCT01997515|3909972|FG001|COMPLETED|Overall Study||35
3181493|NCT01997515|3909971|FG000|NOT COMPLETED|Overall Study||4
3181494|NCT01997515|3909972|FG001|NOT COMPLETED|Overall Study||5
3181495|NCT01997723|3909978|FG000|STARTED|Overall Study||75
3181496|NCT01997723|3909978|FG000|COMPLETED|Overall Study||75
3181497|NCT01997723|3909978|FG000|NOT COMPLETED|Overall Study||0
3181498|NCT01997892|3909982|FG000|STARTED|Overall Study||1027
3181499|NCT01997892|3909982|FG000|Received Darbepoetin Alfa|Overall Study||987
3181500|NCT01997892|3909982|FG000|COMPLETED|Overall Study||959
3181501|NCT01997892|3909982|FG000|NOT COMPLETED|Overall Study||68
3181502|NCT01997905|3909991|FG000|STARTED|Overall Study||13
3181503|NCT01997905|3909991|FG000|Baseline Completed|Overall Study||11
3181504|NCT01997905|3909991|FG000|COMPLETED|Overall Study||10
3181505|NCT01997905|3909991|FG000|NOT COMPLETED|Overall Study||3
3181506|NCT01998243|3909997|FG000|STARTED|Overall Study||42
3181507|NCT01998243|3909998|FG001|STARTED|Overall Study||39
3181508|NCT01998243|3909997|FG000|COMPLETED|Overall Study||34
3181509|NCT01998243|3909998|FG001|COMPLETED|Overall Study||32
3181510|NCT01998243|3909997|FG000|NOT COMPLETED|Overall Study||8
3181511|NCT01998243|3909998|FG001|NOT COMPLETED|Overall Study||7
3181512|NCT01998269|3910006|FG000|STARTED|Overall Study||193
3181513|NCT01998269|3910006|FG000|COMPLETED|Overall Study||193
3181514|NCT01998269|3910006|FG000|NOT COMPLETED|Overall Study||0
3181515|NCT01998360|3910012|FG000|STARTED|Overall Study||50
3181516|NCT01998360|3910013|FG001|STARTED|Overall Study||50
3181517|NCT01998360|3910012|FG000|COMPLETED|Overall Study||50
3181518|NCT01998360|3910013|FG001|COMPLETED|Overall Study||50
3181519|NCT01998360|3910012|FG000|NOT COMPLETED|Overall Study||0
3181520|NCT01998360|3910013|FG001|NOT COMPLETED|Overall Study||0
3181521|NCT01998399|3910021|FG000|STARTED|Overall Study||12
3181522|NCT01998399|3910022|FG001|STARTED|Overall Study||13
3181523|NCT01998399|3910021|FG000|COMPLETED|Overall Study||4
3181524|NCT01998399|3910022|FG001|COMPLETED|Overall Study||4
3181525|NCT01998399|3910021|FG000|NOT COMPLETED|Overall Study||8
3181526|NCT01998399|3910022|FG001|NOT COMPLETED|Overall Study||9
3181527|NCT01998438|3910031|FG000|STARTED|Overall Study||319
3181528|NCT01998438|3910032|FG001|STARTED|Overall Study||318
3181529|NCT01998438|3910033|FG002|STARTED|Overall Study||318
3181530|NCT01998438|3910031|FG000|COMPLETED|Overall Study||319
3181531|NCT01998438|3910032|FG001|COMPLETED|Overall Study||318
3181532|NCT01998438|3910033|FG002|COMPLETED|Overall Study||318
3181533|NCT01998438|3910031|FG000|NOT COMPLETED|Overall Study||0
3181534|NCT01998438|3910032|FG001|NOT COMPLETED|Overall Study||0
3181535|NCT01998438|3910033|FG002|NOT COMPLETED|Overall Study||0
3181536|NCT01998477|3910043|FG000|STARTED|Overall Study||282
3181537|NCT01998477|3910044|FG001|STARTED|Overall Study||148
3181538|NCT01998477|3910043|FG000|COMPLETED|Overall Study||272
3181539|NCT01998477|3910044|FG001|COMPLETED|Overall Study||143
3181540|NCT01998477|3910043|FG000|NOT COMPLETED|Overall Study||10
3181541|NCT01998477|3910044|FG001|NOT COMPLETED|Overall Study||5
3181542|NCT01998581|3910077|FG000|STARTED|Overall Study||169
3181543|NCT01998581|3910078|FG001|STARTED|Overall Study||56
3181544|NCT01998581|3910077|FG000|COMPLETED|Overall Study||123
3181545|NCT01998581|3910078|FG001|COMPLETED|Overall Study||44
3181546|NCT01998581|3910077|FG000|NOT COMPLETED|Overall Study||46
3181547|NCT01998581|3910078|FG001|NOT COMPLETED|Overall Study||12
3181548|NCT01998633|3910087|FG000|STARTED|Overall Study||47
3181549|NCT01998633|3910087|FG000|COMPLETED|Overall Study||46
3146764|NCT01777334|3872735|FG000|STARTED|Overall Study||454
3146765|NCT01777334|3872736|FG001|STARTED|Overall Study||451
3146766|NCT01777334|3872735|FG000|COMPLETED|Overall Study||401
3146767|NCT01777334|3872736|FG001|COMPLETED|Overall Study||388
3146768|NCT01777334|3872735|FG000|NOT COMPLETED|Overall Study||53
3146769|NCT01777334|3872736|FG001|NOT COMPLETED|Overall Study||63
3146770|NCT01777412|3872742|FG000|STARTED|Overall Study||10
3146771|NCT01777412|3872742|FG000|COMPLETED|Overall Study||10
3146772|NCT01777412|3872742|FG000|NOT COMPLETED|Overall Study||0
3146773|NCT01777425|3872746|FG000|STARTED|Overall Study||389
3146774|NCT01777425|3872746|FG000|COMPLETED|Overall Study||389
3146775|NCT01777425|3872746|FG000|NOT COMPLETED|Overall Study||0
3146776|NCT01777438|3872753|FG000|STARTED|Overall Study||352
3146777|NCT01777438|3872754|FG001|STARTED|Overall Study||82
3146778|NCT01777438|3872753|FG000|COMPLETED|Overall Study||352
3146779|NCT01777438|3872754|FG001|COMPLETED|Overall Study||82
3146780|NCT01777438|3872753|FG000|NOT COMPLETED|Overall Study||0
3146781|NCT01777438|3872754|FG001|NOT COMPLETED|Overall Study||0
3146782|NCT01777490|3872764|FG000|STARTED|Overall Study||123
3146783|NCT01777490|3872765|FG001|STARTED|Overall Study||123
3146784|NCT01777490|3872766|FG002|STARTED|Overall Study||119
3146785|NCT01777490|3872767|FG003|STARTED|Overall Study||119
3146786|NCT01777490|3872764|FG000|COMPLETED|Overall Study||123
3146787|NCT01777490|3872765|FG001|COMPLETED|Overall Study||123
3146788|NCT01777490|3872766|FG002|COMPLETED|Overall Study||118
3146789|NCT01777490|3872767|FG003|COMPLETED|Overall Study||118
3146790|NCT01777490|3872764|FG000|NOT COMPLETED|Overall Study||0
3146791|NCT01777490|3872765|FG001|NOT COMPLETED|Overall Study||0
3146792|NCT01777490|3872766|FG002|NOT COMPLETED|Overall Study||1
3146793|NCT01777490|3872767|FG003|NOT COMPLETED|Overall Study||1
3146794|NCT01777542|3872779|FG000|STARTED|First Intervention (20 Weeks)||15
3146795|NCT01777542|3872780|FG001|STARTED|First Intervention (20 Weeks)||15
3146796|NCT01777542|3872779|FG000|COMPLETED|First Intervention (20 Weeks)||15
3146797|NCT01777542|3872780|FG001|COMPLETED|First Intervention (20 Weeks)||15
3146798|NCT01777542|3872779|FG000|NOT COMPLETED|First Intervention (20 Weeks)||0
3146799|NCT01777542|3872780|FG001|NOT COMPLETED|First Intervention (20 Weeks)||0
3146800|NCT01777542|3872779|FG000|STARTED|Washout Period (28 +/- 2 Weeks)||15
3146801|NCT01777542|3872780|FG001|STARTED|Washout Period (28 +/- 2 Weeks)||15
3146802|NCT01777542|3872779|FG000|COMPLETED|Washout Period (28 +/- 2 Weeks)||15
3146803|NCT01777542|3872780|FG001|COMPLETED|Washout Period (28 +/- 2 Weeks)||15
3146804|NCT01777542|3872779|FG000|NOT COMPLETED|Washout Period (28 +/- 2 Weeks)||0
3146805|NCT01777542|3872780|FG001|NOT COMPLETED|Washout Period (28 +/- 2 Weeks)||0
3146806|NCT01777542|3872779|FG000|STARTED|Second Intervention (20 Weeks)||15
3146807|NCT01777542|3872780|FG001|STARTED|Second Intervention (20 Weeks)||15
3146808|NCT01777542|3872779|FG000|COMPLETED|Second Intervention (20 Weeks)||15
3146809|NCT01777542|3872780|FG001|COMPLETED|Second Intervention (20 Weeks)||14
3146810|NCT01777542|3872779|FG000|NOT COMPLETED|Second Intervention (20 Weeks)||0
3146811|NCT01777542|3872780|FG001|NOT COMPLETED|Second Intervention (20 Weeks)||1
3181550|NCT01998633|3910087|FG000|NOT COMPLETED|Overall Study||1
3181551|NCT01998737|3910097|FG000|STARTED|Overall Study||911
3181552|NCT01998737|3910098|FG001|STARTED|Overall Study||100
3181553|NCT01998737|3910097|FG000|COMPLETED|Overall Study||888
3181554|NCT01998737|3910098|FG001|COMPLETED|Overall Study||100
3181555|NCT01998737|3910097|FG000|NOT COMPLETED|Overall Study||23
3181556|NCT01998737|3910098|FG001|NOT COMPLETED|Overall Study||0
3181557|NCT01998880|3910106|FG000|STARTED|Overall Study||233
3146812|NCT01777568|3872789|FG000|STARTED|Overall Study||2853
3146813|NCT01777568|3872790|FG001|STARTED|Overall Study||2896
3146814|NCT01777568|3872789|FG000|COMPLETED|Overall Study||2853
3146815|NCT01777568|3872790|FG001|COMPLETED|Overall Study||2896
3146816|NCT01777568|3872789|FG000|NOT COMPLETED|Overall Study||0
3146817|NCT01777568|3872790|FG001|NOT COMPLETED|Overall Study||0
3146818|NCT01777581|3872798|FG000|STARTED|Overall Study|Includes one subject screened/consented but not assigned to either arm.|8
3146819|NCT01777581|3872799|FG001|STARTED|Overall Study|Includes one subject screened/consented but not assigned to either arm.|5
3146820|NCT01777581|3872798|FG000|COMPLETED|Overall Study||5
3146821|NCT01777581|3872799|FG001|COMPLETED|Overall Study||3
3146822|NCT01777581|3872798|FG000|NOT COMPLETED|Overall Study||3
3146823|NCT01777581|3872799|FG001|NOT COMPLETED|Overall Study||2
3146824|NCT01777620|3872807|FG000|STARTED|Overall Study||63
3146825|NCT01777620|3872808|FG001|STARTED|Overall Study||62
3146826|NCT01777620|3872807|FG000|COMPLETED|Overall Study||62
3146827|NCT01777620|3872808|FG001|COMPLETED|Overall Study||62
3146828|NCT01777620|3872807|FG000|NOT COMPLETED|Overall Study||1
3146829|NCT01777620|3872808|FG001|NOT COMPLETED|Overall Study||0
3146830|NCT01777763|3872816|FG000|STARTED|Overall Study||20
3146831|NCT01777763|3872817|FG001|STARTED|Overall Study||210
3146832|NCT01777763|3872816|FG000|COMPLETED|Overall Study||16
3146833|NCT01777763|3872817|FG001|COMPLETED|Overall Study||163
3146834|NCT01777763|3872816|FG000|NOT COMPLETED|Overall Study||4
3146835|NCT01777763|3872817|FG001|NOT COMPLETED|Overall Study||47
3146836|NCT01777776|3872827|FG000|STARTED|Overall Study||6
3146837|NCT01777776|3872828|FG001|STARTED|Overall Study||12
3146838|NCT01777776|3872829|FG002|STARTED|Overall Study||6
3146839|NCT01777776|3872830|FG003|STARTED|Overall Study||4
3146840|NCT01777776|3872827|FG000|COMPLETED|Overall Study||0
3146841|NCT01777776|3872828|FG001|COMPLETED|Overall Study||0
3146842|NCT01777776|3872829|FG002|COMPLETED|Overall Study||0
3146843|NCT01777776|3872830|FG003|COMPLETED|Overall Study||0
3146844|NCT01777776|3872827|FG000|NOT COMPLETED|Overall Study||6
3146845|NCT01777776|3872828|FG001|NOT COMPLETED|Overall Study||12
3146846|NCT01777776|3872829|FG002|NOT COMPLETED|Overall Study||6
3146847|NCT01777776|3872830|FG003|NOT COMPLETED|Overall Study||4
3146848|NCT01777932|3872849|FG000|STARTED|Overall Study||220
3146849|NCT01777932|3872849|FG000|COMPLETED|Overall Study||15
3146850|NCT01777932|3872849|FG000|NOT COMPLETED|Overall Study||205
3146851|NCT01777945|3872853|FG000|STARTED|Overall Study||46
3146852|NCT01777945|3872853|FG000|Evaluable Participants|Overall Study||45
3146853|NCT01777945|3872853|FG000|COMPLETED|Overall Study||46
3146854|NCT01777945|3872853|FG000|NOT COMPLETED|Overall Study||0
3146855|NCT01777997|3872857|FG000|STARTED|12 Week lead-in of no ART||38
3146856|NCT01777997|3872857|FG000|COMPLETED|12 Week lead-in of no ART||36
3146857|NCT01777997|3872857|FG000|NOT COMPLETED|12 Week lead-in of no ART||2
3146858|NCT01777997|3872857|FG000|STARTED|Weeks 0 to 24/48 on ART||36
3146859|NCT01777997|3872857|FG000|COMPLETED|Weeks 0 to 24/48 on ART|7 of these participants opted not to continue ART into next period|35
3146860|NCT01777997|3872857|FG000|NOT COMPLETED|Weeks 0 to 24/48 on ART||1
3146861|NCT01777997|3872857|FG000|STARTED|Weeks 48 to 72/96 on ART||28
3146862|NCT01777997|3872857|FG000|COMPLETED|Weeks 48 to 72/96 on ART||26
3146863|NCT01777997|3872857|FG000|NOT COMPLETED|Weeks 48 to 72/96 on ART||2
3146864|NCT01778010|3872861|FG000|STARTED|Overall Study||13
3146865|NCT01778010|3872861|FG000|COMPLETED|Overall Study||8
3146866|NCT01778010|3872861|FG000|NOT COMPLETED|Overall Study||5
3146867|NCT01778023|3872880|FG000|STARTED|Overall Study||36
3146868|NCT01778023|3872881|FG001|STARTED|Overall Study||18
3146869|NCT01778023|3872880|FG000|Exposed|Overall Study||36
3146870|NCT01778023|3872881|FG001|Exposed|Overall Study||15
3146871|NCT01778023|3872880|FG000|COMPLETED|Overall Study||36
3146872|NCT01778023|3872881|FG001|COMPLETED|Overall Study||15
3146873|NCT01778023|3872880|FG000|NOT COMPLETED|Overall Study||0
3146874|NCT01778023|3872881|FG001|NOT COMPLETED|Overall Study||3
3146875|NCT01778049|3872889|FG000|STARTED|Open Label Treatment Period||354
3146876|NCT01778049|3872890|FG001|STARTED|Open Label Treatment Period||355
3146877|NCT01778049|3872891|FG002|STARTED|Open Label Treatment Period||0
3146878|NCT01778049|3872892|FG003|STARTED|Open Label Treatment Period||0
3146879|NCT01778049|3872893|FG004|STARTED|Open Label Treatment Period||0
3146880|NCT01778049|3872894|FG005|STARTED|Open Label Treatment Period||0
3146881|NCT01778049|3872889|FG000|COMPLETED|Open Label Treatment Period||256
3146882|NCT01778049|3872890|FG001|COMPLETED|Open Label Treatment Period||226
3146883|NCT01778049|3872891|FG002|COMPLETED|Open Label Treatment Period||0
3146884|NCT01778049|3872892|FG003|COMPLETED|Open Label Treatment Period||0
3146885|NCT01778049|3872893|FG004|COMPLETED|Open Label Treatment Period||0
3146886|NCT01778049|3872894|FG005|COMPLETED|Open Label Treatment Period||0
3146887|NCT01778049|3872889|FG000|NOT COMPLETED|Open Label Treatment Period||98
3146888|NCT01778049|3872890|FG001|NOT COMPLETED|Open Label Treatment Period||129
3146889|NCT01778049|3872891|FG002|NOT COMPLETED|Open Label Treatment Period||0
3146890|NCT01778049|3872892|FG003|NOT COMPLETED|Open Label Treatment Period||0
3146891|NCT01778049|3872893|FG004|NOT COMPLETED|Open Label Treatment Period||0
3146892|NCT01778049|3872894|FG005|NOT COMPLETED|Open Label Treatment Period||0
3146893|NCT01778049|3872889|FG000|STARTED|Double Blind Treatment Period||0
3146894|NCT01778049|3872890|FG001|STARTED|Double Blind Treatment Period||0
3146895|NCT01778049|3872891|FG002|STARTED|Double Blind Treatment Period||126
3146896|NCT01778049|3872892|FG003|STARTED|Double Blind Treatment Period||130
3146897|NCT01778049|3872893|FG004|STARTED|Double Blind Treatment Period||114
3146898|NCT01778049|3872894|FG005|STARTED|Double Blind Treatment Period||112
3146899|NCT01778049|3872889|FG000|COMPLETED|Double Blind Treatment Period||0
3146900|NCT01778049|3872890|FG001|COMPLETED|Double Blind Treatment Period||0
3146901|NCT01778049|3872891|FG002|COMPLETED|Double Blind Treatment Period||111
3146902|NCT01778049|3872892|FG003|COMPLETED|Double Blind Treatment Period||118
3181558|NCT01998880|3910107|FG001|STARTED|Overall Study||118
3181559|NCT01998880|3910106|FG000|Received Study Drug|Overall Study||230
3181560|NCT01998880|3910107|FG001|Received Study Drug|Overall Study||116
3181561|NCT01998880|3910106|FG000|COMPLETED|Overall Study|Completed=Completed treatment.|205
3181562|NCT01998880|3910107|FG001|COMPLETED|Overall Study||78
3181563|NCT01998880|3910106|FG000|NOT COMPLETED|Overall Study||28
3181564|NCT01998880|3910107|FG001|NOT COMPLETED|Overall Study||40
3181565|NCT01998893|3910113|FG000|STARTED|Overall Study||38
3181566|NCT01998893|3910113|FG000|1st Treatment Cycle Completed Until PD|Overall Study|Progressive disease (PD)|30
3181567|NCT01998893|3910113|FG000|2nd Treatment Cycle Started|Overall Study||5
3181568|NCT01998893|3910113|FG000|2nd Treatment Cycle Completed Until PD|Overall Study||3
3181569|NCT01998893|3910113|FG000|COMPLETED|Overall Study||21
3181570|NCT01998893|3910113|FG000|NOT COMPLETED|Overall Study||17
3181571|NCT01998906|3910120|FG000|STARTED|Overall Study||115
3181572|NCT01998906|3910121|FG001|STARTED|Overall Study||116
3181573|NCT01998906|3910122|FG002|STARTED|Overall Study||99
3181574|NCT01998906|3910120|FG000|COMPLETED|Overall Study||1
3181575|NCT01998906|3910121|FG001|COMPLETED|Overall Study||2
3146903|NCT01778049|3872893|FG004|COMPLETED|Double Blind Treatment Period||102
3146904|NCT01778049|3872894|FG005|COMPLETED|Double Blind Treatment Period||105
3146905|NCT01778049|3872889|FG000|NOT COMPLETED|Double Blind Treatment Period||0
3146906|NCT01778049|3872890|FG001|NOT COMPLETED|Double Blind Treatment Period||0
3146907|NCT01778049|3872891|FG002|NOT COMPLETED|Double Blind Treatment Period||15
3146908|NCT01778049|3872892|FG003|NOT COMPLETED|Double Blind Treatment Period||12
3181576|NCT01998906|3910122|FG002|COMPLETED|Overall Study||1
3181577|NCT01998906|3910120|FG000|NOT COMPLETED|Overall Study||114
3146909|NCT01778049|3872893|FG004|NOT COMPLETED|Double Blind Treatment Period||12
3146910|NCT01778049|3872894|FG005|NOT COMPLETED|Double Blind Treatment Period||7
3146911|NCT01778062|3872908|FG000|STARTED|Overall Study||68
3146912|NCT01778062|3872909|FG001|STARTED|Overall Study||68
3146913|NCT01778062|3872908|FG000|Safety Set|Overall Study||68
3146914|NCT01778062|3872909|FG001|Safety Set|Overall Study||68
3146915|NCT01778062|3872908|FG000|Intent to Treat (ITT)|Overall Study||68
3146916|NCT01778062|3872909|FG001|Intent to Treat (ITT)|Overall Study|One failed to perform primary efficacy evaluation and was excluded, 135 were included in the ITT set|67
3146917|NCT01778062|3872908|FG000|COMPLETED|Overall Study||62
3146918|NCT01778062|3872909|FG001|COMPLETED|Overall Study||57
3146919|NCT01778062|3872908|FG000|NOT COMPLETED|Overall Study||6
3146920|NCT01778062|3872909|FG001|NOT COMPLETED|Overall Study||11
3146921|NCT01778127|3872918|FG000|STARTED|Overall Study||33
3146922|NCT01778127|3872919|FG001|STARTED|Overall Study||33
3146923|NCT01778127|3872920|FG002|STARTED|Overall Study||32
3146924|NCT01778127|3872918|FG000|COMPLETED|Overall Study||25
3146925|NCT01778127|3872919|FG001|COMPLETED|Overall Study||31
3146926|NCT01778127|3872920|FG002|COMPLETED|Overall Study||26
3146927|NCT01778127|3872918|FG000|NOT COMPLETED|Overall Study||8
3146928|NCT01778127|3872919|FG001|NOT COMPLETED|Overall Study||2
3146929|NCT01778127|3872920|FG002|NOT COMPLETED|Overall Study||6
3146930|NCT01778179|3872930|FG000|STARTED|Overall Study||25
3146931|NCT01778179|3872931|FG001|STARTED|Overall Study||25
3146932|NCT01778179|3872930|FG000|COMPLETED|Overall Study||23
3146933|NCT01778179|3872931|FG001|COMPLETED|Overall Study||22
3146934|NCT01778179|3872930|FG000|NOT COMPLETED|Overall Study||2
3146935|NCT01778179|3872931|FG001|NOT COMPLETED|Overall Study||3
3146936|NCT01778296|3872937|FG000|STARTED|Overall Study|There were 12 patients included in the study in the initial stage.|12
3146937|NCT01778296|3872937|FG000|COMPLETED|Overall Study|No patient was lost to follow-up.|12
3146938|NCT01778296|3872937|FG000|NOT COMPLETED|Overall Study||0
3146939|NCT01778426|3872943|FG000|STARTED|Overall Study - Full Analysis Set (FAS)||264
3146940|NCT01778426|3872944|FG001|STARTED|Overall Study - Full Analysis Set (FAS)||138
3146941|NCT01778426|3872943|FG000|COMPLETED|Overall Study - Full Analysis Set (FAS)||208
3146942|NCT01778426|3872944|FG001|COMPLETED|Overall Study - Full Analysis Set (FAS)||113
3146943|NCT01778426|3872943|FG000|NOT COMPLETED|Overall Study - Full Analysis Set (FAS)||56
3146944|NCT01778426|3872944|FG001|NOT COMPLETED|Overall Study - Full Analysis Set (FAS)||25
3146945|NCT01778426|3872943|FG000|STARTED|Intention-To-Treat (ITT) - Completer||198
3146946|NCT01778426|3872944|FG001|STARTED|Intention-To-Treat (ITT) - Completer|Not applicable: ITT-completer contains only primo-implant subjects.|0
3146947|NCT01778426|3872943|FG000|COMPLETED|Intention-To-Treat (ITT) - Completer||198
3146948|NCT01778426|3872944|FG001|COMPLETED|Intention-To-Treat (ITT) - Completer|Not applicable: ITT-completer contains only primo-implant subjects.|0
3146949|NCT01778426|3872943|FG000|NOT COMPLETED|Intention-To-Treat (ITT) - Completer||0
3146950|NCT01778426|3872944|FG001|NOT COMPLETED|Intention-To-Treat (ITT) - Completer||0
3146951|NCT01778465|3872953|FG000|STARTED|First Intervention (7 Days)||3
3146952|NCT01778465|3872954|FG001|STARTED|First Intervention (7 Days)||4
3146953|NCT01778465|3872953|FG000|COMPLETED|First Intervention (7 Days)||3
3146954|NCT01778465|3872954|FG001|COMPLETED|First Intervention (7 Days)||4
3146955|NCT01778465|3872953|FG000|NOT COMPLETED|First Intervention (7 Days)||0
3146956|NCT01778465|3872954|FG001|NOT COMPLETED|First Intervention (7 Days)||0
3146957|NCT01778465|3872953|FG000|STARTED|Second Intervention (7 Days)||3
3146958|NCT01778465|3872954|FG001|STARTED|Second Intervention (7 Days)||4
3146959|NCT01778465|3872953|FG000|COMPLETED|Second Intervention (7 Days)||3
3146960|NCT01778465|3872954|FG001|COMPLETED|Second Intervention (7 Days)||4
3146961|NCT01778465|3872953|FG000|NOT COMPLETED|Second Intervention (7 Days)||0
3146962|NCT01778465|3872954|FG001|NOT COMPLETED|Second Intervention (7 Days)||0
3146963|NCT01778530|3872963|FG000|STARTED|Overall Study||2
3146964|NCT01778530|3872963|FG000|COMPLETED|Overall Study||0
3146965|NCT01778530|3872963|FG000|NOT COMPLETED|Overall Study||2
3146966|NCT01778556|3872969|FG000|STARTED|Intervention 1 (5 Days)||15
3146967|NCT01778556|3872970|FG001|STARTED|Intervention 1 (5 Days)||10
3146968|NCT01778556|3872969|FG000|COMPLETED|Intervention 1 (5 Days)||15
3146969|NCT01778556|3872970|FG001|COMPLETED|Intervention 1 (5 Days)||8
3146970|NCT01778556|3872969|FG000|NOT COMPLETED|Intervention 1 (5 Days)||0
3146971|NCT01778556|3872970|FG001|NOT COMPLETED|Intervention 1 (5 Days)||2
3146972|NCT01778556|3872969|FG000|STARTED|Intervention 2 (14 Days)||15
3146973|NCT01778556|3872970|FG001|STARTED|Intervention 2 (14 Days)||8
3146974|NCT01778556|3872969|FG000|COMPLETED|Intervention 2 (14 Days)||14
3146975|NCT01778556|3872970|FG001|COMPLETED|Intervention 2 (14 Days)||8
3146976|NCT01778556|3872969|FG000|NOT COMPLETED|Intervention 2 (14 Days)||1
3146977|NCT01778556|3872970|FG001|NOT COMPLETED|Intervention 2 (14 Days)||0
3146978|NCT01778556|3872969|FG000|STARTED|Long-term Follow-up||15
3146979|NCT01778556|3872970|FG001|STARTED|Long-term Follow-up|no long-term follow-up period in on-leptin arm|0
3146980|NCT01778556|3872969|FG000|COMPLETED|Long-term Follow-up||14
3146981|NCT01778556|3872970|FG001|COMPLETED|Long-term Follow-up|no long-term follow-up period in on-leptin arm|0
3146982|NCT01778556|3872969|FG000|NOT COMPLETED|Long-term Follow-up||1
3146983|NCT01778556|3872970|FG001|NOT COMPLETED|Long-term Follow-up||0
3146984|NCT01778634|3872981|FG000|STARTED|Overall Study||61
3146985|NCT01778634|3872982|FG001|STARTED|Overall Study||60
3181578|NCT01998906|3910121|FG001|NOT COMPLETED|Overall Study||114
3146986|NCT01778634|3872981|FG000|COMPLETED|Overall Study||61
3146987|NCT01778634|3872982|FG001|COMPLETED|Overall Study||60
3146988|NCT01778634|3872981|FG000|NOT COMPLETED|Overall Study||0
3146989|NCT01778634|3872982|FG001|NOT COMPLETED|Overall Study||0
3146990|NCT01778751|3872991|FG000|STARTED|Overall Study||25
3146991|NCT01778751|3872992|FG001|STARTED|Overall Study||25
3146992|NCT01778751|3872991|FG000|COMPLETED|Overall Study||23
3146993|NCT01778751|3872992|FG001|COMPLETED|Overall Study||23
3146994|NCT01778751|3872991|FG000|NOT COMPLETED|Overall Study||2
3146995|NCT01778751|3872992|FG001|NOT COMPLETED|Overall Study||2
3146996|NCT01778855|3873000|FG000|STARTED|Overall Study||2
3146997|NCT01778855|3873001|FG001|STARTED|Overall Study||4
3146998|NCT01778855|3873000|FG000|COMPLETED|Overall Study||2
3146999|NCT01778855|3873001|FG001|COMPLETED|Overall Study||3
3147000|NCT01778855|3873000|FG000|NOT COMPLETED|Overall Study||0
3147001|NCT01778855|3873001|FG001|NOT COMPLETED|Overall Study||1
3147002|NCT01778985|3873009|FG000|STARTED|Overall Study||15
3147003|NCT01778985|3873010|FG001|STARTED|Overall Study||15
3147004|NCT01778985|3873009|FG000|COMPLETED|Overall Study||8
3147005|NCT01778985|3873010|FG001|COMPLETED|Overall Study||12
3147006|NCT01778985|3873009|FG000|NOT COMPLETED|Overall Study||7
3147007|NCT01778985|3873010|FG001|NOT COMPLETED|Overall Study||3
3147008|NCT01779024|3873016|FG000|STARTED|1st Visit - Alcohol Self-Administration||8
3147009|NCT01779024|3873017|FG001|STARTED|1st Visit - Alcohol Self-Administration||9
3147010|NCT01779024|3873016|FG000|COMPLETED|1st Visit - Alcohol Self-Administration||8
3147011|NCT01779024|3873017|FG001|COMPLETED|1st Visit - Alcohol Self-Administration||9
3147012|NCT01779024|3873016|FG000|NOT COMPLETED|1st Visit - Alcohol Self-Administration||0
3147013|NCT01779024|3873017|FG001|NOT COMPLETED|1st Visit - Alcohol Self-Administration||0
3147014|NCT01779024|3873016|FG000|STARTED|2nd Visit - Alcohol Self-Administration||8
3147015|NCT01779024|3873017|FG001|STARTED|2nd Visit - Alcohol Self-Administration||9
3147016|NCT01779024|3873016|FG000|COMPLETED|2nd Visit - Alcohol Self-Administration||6
3147017|NCT01779024|3873017|FG001|COMPLETED|2nd Visit - Alcohol Self-Administration||9
3147018|NCT01779024|3873016|FG000|NOT COMPLETED|2nd Visit - Alcohol Self-Administration||2
3147019|NCT01779024|3873017|FG001|NOT COMPLETED|2nd Visit - Alcohol Self-Administration||0
3147020|NCT01779024|3873016|FG000|STARTED|1st Visit - Functional MRI||6
3147021|NCT01779024|3873017|FG001|STARTED|1st Visit - Functional MRI||7
3147022|NCT01779024|3873016|FG000|COMPLETED|1st Visit - Functional MRI||4
3147023|NCT01779024|3873017|FG001|COMPLETED|1st Visit - Functional MRI||5
3147024|NCT01779024|3873016|FG000|NOT COMPLETED|1st Visit - Functional MRI||2
3147025|NCT01779024|3873017|FG001|NOT COMPLETED|1st Visit - Functional MRI||2
3147026|NCT01779024|3873016|FG000|STARTED|2nd Visit - Functional MRI||5
3147027|NCT01779024|3873017|FG001|STARTED|2nd Visit - Functional MRI||6
3147028|NCT01779024|3873016|FG000|COMPLETED|2nd Visit - Functional MRI||5
3147029|NCT01779024|3873017|FG001|COMPLETED|2nd Visit - Functional MRI||6
3147030|NCT01779024|3873016|FG000|NOT COMPLETED|2nd Visit - Functional MRI||0
3147031|NCT01779024|3873017|FG001|NOT COMPLETED|2nd Visit - Functional MRI||0
3147032|NCT01779141|3873023|FG000|STARTED|Overall Study||481
3147033|NCT01779141|3873023|FG000|COMPLETED|Overall Study||300
3147034|NCT01779141|3873023|FG000|NOT COMPLETED|Overall Study||181
3147035|NCT01779167|3873027|FG000|STARTED|Overall Study||4
3147036|NCT01779167|3873027|FG000|COMPLETED|Overall Study||3
3147037|NCT01779167|3873027|FG000|NOT COMPLETED|Overall Study||1
3147038|NCT01779219|3873033|FG000|STARTED|Overall Study|First interim analysis|21
3147039|NCT01779219|3873034|FG001|STARTED|Overall Study|First interim analysis|21
3181579|NCT01998906|3910122|FG002|NOT COMPLETED|Overall Study||98
3181580|NCT01998919|3910135|FG000|STARTED|Overall Study||79
3181581|NCT01998919|3910136|FG001|STARTED|Overall Study||74
3181582|NCT01998919|3910135|FG000|Randomized|Overall Study|1 participant randomized to erlotinib didn't receive study drug; analyzed in placebo for safety|78
3147040|NCT01779219|3873033|FG000|COMPLETED|Overall Study|First interim analysis|21
3147041|NCT01779219|3873034|FG001|COMPLETED|Overall Study|First interim analysis|21
3147042|NCT01779219|3873033|FG000|NOT COMPLETED|Overall Study||0
3147043|NCT01779219|3873034|FG001|NOT COMPLETED|Overall Study||0
3147044|NCT01779375|3873042|FG000|STARTED|Overall Study||47
3147045|NCT01779375|3873043|FG001|STARTED|Overall Study||44
3147046|NCT01779375|3873042|FG000|COMPLETED|Overall Study||45
3147047|NCT01779375|3873043|FG001|COMPLETED|Overall Study||41
3147048|NCT01779375|3873042|FG000|NOT COMPLETED|Overall Study||2
3147049|NCT01779375|3873043|FG001|NOT COMPLETED|Overall Study||3
3147050|NCT01779440|3873053|FG000|STARTED|Overall Study||30
3147051|NCT01779440|3873054|FG001|STARTED|Overall Study||28
3147052|NCT01779440|3873053|FG000|COMPLETED|Overall Study||27
3147053|NCT01779440|3873054|FG001|COMPLETED|Overall Study||23
3147054|NCT01779440|3873053|FG000|NOT COMPLETED|Overall Study||3
3147055|NCT01779440|3873054|FG001|NOT COMPLETED|Overall Study||5
3147056|NCT01779648|3873062|FG000|STARTED|Overall Study||28
3147057|NCT01779648|3873063|FG001|STARTED|Overall Study||27
3147058|NCT01779648|3873062|FG000|COMPLETED|Overall Study||27
3147059|NCT01779648|3873063|FG001|COMPLETED|Overall Study||27
3147060|NCT01779648|3873062|FG000|NOT COMPLETED|Overall Study||1
3147061|NCT01779648|3873063|FG001|NOT COMPLETED|Overall Study||0
3147062|NCT01779700|3873071|FG000|STARTED|Overall Study||18
3147063|NCT01779700|3873072|FG001|STARTED|Overall Study||22
3147064|NCT01779700|3873071|FG000|COMPLETED|Overall Study||14
3147065|NCT01779700|3873072|FG001|COMPLETED|Overall Study||17
3147066|NCT01779700|3873071|FG000|NOT COMPLETED|Overall Study||4
3147067|NCT01779700|3873072|FG001|NOT COMPLETED|Overall Study||5
3147068|NCT01779856|3873078|FG000|STARTED|Overall Study||81
3147069|NCT01779856|3873078|FG000|COMPLETED|Overall Study||57
3147070|NCT01779856|3873078|FG000|NOT COMPLETED|Overall Study||24
3147071|NCT01779869|3873089|FG000|STARTED|Overall Study||16
3147072|NCT01779869|3873089|FG000|COMPLETED|Overall Study||14
3147073|NCT01779869|3873089|FG000|NOT COMPLETED|Overall Study||2
3147074|NCT01780324|3873095|FG000|STARTED|Overall Study||41
3147075|NCT01780324|3873096|FG001|STARTED|Overall Study||39
3147076|NCT01780324|3873095|FG000|COMPLETED|Overall Study||40
3147077|NCT01780324|3873096|FG001|COMPLETED|Overall Study||33
3147078|NCT01780324|3873095|FG000|NOT COMPLETED|Overall Study||1
3147079|NCT01780324|3873096|FG001|NOT COMPLETED|Overall Study||6
3147080|NCT01780337|3873104|FG000|STARTED|Overall Study||6
3147081|NCT01780337|3873105|FG001|STARTED|Overall Study||6
3147082|NCT01780337|3873104|FG000|COMPLETED|Overall Study||6
3147083|NCT01780337|3873105|FG001|COMPLETED|Overall Study||6
3147084|NCT01780337|3873104|FG000|NOT COMPLETED|Overall Study||0
3147085|NCT01780337|3873105|FG001|NOT COMPLETED|Overall Study||0
3147086|NCT01780350|3873111|FG000|STARTED|Overall Study||200
3147087|NCT01780350|3873111|FG000|COMPLETED|Overall Study||200
3147088|NCT01780350|3873111|FG000|NOT COMPLETED|Overall Study||0
3147089|NCT01780389|3873115|FG000|STARTED|Overall Study||5
3147090|NCT01780389|3873115|FG000|COMPLETED|Overall Study|One patient discontinued due to adverse event.|4
3147091|NCT01780389|3873115|FG000|NOT COMPLETED|Overall Study||1
3181583|NCT01998919|3910136|FG001|Randomized|Overall Study|One participant withdrew consent prior to 1st dose and was excluded from safety analysis population.|76
3181584|NCT01998919|3910135|FG000|COMPLETED|Overall Study||37
3181585|NCT01998919|3910136|FG001|COMPLETED|Overall Study||39
3181586|NCT01998919|3910135|FG000|NOT COMPLETED|Overall Study||42
3181587|NCT01998919|3910136|FG001|NOT COMPLETED|Overall Study||35
3181588|NCT01998958|3910149|FG000|STARTED|Period 1 (Panel A and B)||33
3181589|NCT01998958|3910150|FG001|STARTED|Period 1 (Panel A and B)||11
3181590|NCT01998958|3910151|FG002|STARTED|Period 1 (Panel A and B)||11
3181591|NCT01998958|3910152|FG003|STARTED|Period 1 (Panel A and B)||12
3181592|NCT01998958|3910153|FG004|STARTED|Period 1 (Panel A and B)||21
3181593|NCT01998958|3910154|FG005|STARTED|Period 1 (Panel A and B)||11
3181594|NCT01998958|3910155|FG006|STARTED|Period 1 (Panel A and B)||9
3181595|NCT01998958|3910156|FG007|STARTED|Period 1 (Panel A and B)||0
3181596|NCT01998958|3910157|FG008|STARTED|Period 1 (Panel A and B)||0
3181597|NCT01998958|3910158|FG009|STARTED|Period 1 (Panel A and B)||0
3181598|NCT01998958|3910159|FG010|STARTED|Period 1 (Panel A and B)||0
3181599|NCT01998958|3910160|FG011|STARTED|Period 1 (Panel A and B)||0
3181600|NCT01998958|3910161|FG012|STARTED|Period 1 (Panel A and B)||0
3181601|NCT01998958|3910162|FG013|STARTED|Period 1 (Panel A and B)||0
3181602|NCT01998958|3910163|FG014|STARTED|Period 1 (Panel A and B)||0
3181603|NCT01998958|3910164|FG015|STARTED|Period 1 (Panel A and B)||0
3181604|NCT01998958|3910165|FG016|STARTED|Period 1 (Panel A and B)||0
3181605|NCT01998958|3910166|FG017|STARTED|Period 1 (Panel A and B)||0
3181606|NCT01998958|3910167|FG018|STARTED|Period 1 (Panel A and B)||0
3181607|NCT01998958|3910168|FG019|STARTED|Period 1 (Panel A and B)||0
3181608|NCT01998958|3910169|FG020|STARTED|Period 1 (Panel A and B)||0
3181609|NCT01998958|3910170|FG021|STARTED|Period 1 (Panel A and B)||0
3181610|NCT01998958|3910171|FG022|STARTED|Period 1 (Panel A and B)||0
3181611|NCT01998958|3910172|FG023|STARTED|Period 1 (Panel A and B)||0
3181612|NCT01998958|3910173|FG024|STARTED|Period 1 (Panel A and B)||0
3181613|NCT01998958|3910174|FG025|STARTED|Period 1 (Panel A and B)||0
3181614|NCT01998958|3910175|FG026|STARTED|Period 1 (Panel A and B)||0
3181615|NCT01998958|3910176|FG027|STARTED|Period 1 (Panel A and B)||0
3181616|NCT01998958|3910177|FG028|STARTED|Period 1 (Panel A and B)||0
3181617|NCT01998958|3910178|FG029|STARTED|Period 1 (Panel A and B)||0
3181618|NCT01998958|3910179|FG030|STARTED|Period 1 (Panel A and B)||0
3181619|NCT01998958|3910180|FG031|STARTED|Period 1 (Panel A and B)||0
3181620|NCT01998958|3910149|FG000|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||9
3181621|NCT01998958|3910150|FG001|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
3181622|NCT01998958|3910151|FG002|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
3181623|NCT01998958|3910152|FG003|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
3181624|NCT01998958|3910153|FG004|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
3181625|NCT01998958|3910154|FG005|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
3181626|NCT01998958|3910155|FG006|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
3181627|NCT01998958|3910156|FG007|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
3181628|NCT01998958|3910157|FG008|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
3181629|NCT01998958|3910158|FG009|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
3181630|NCT01998958|3910159|FG010|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
3181631|NCT01998958|3910160|FG011|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
3181632|NCT01998958|3910161|FG012|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
3181633|NCT01998958|3910162|FG013|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
3181634|NCT01998958|3910163|FG014|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
3181635|NCT01998958|3910164|FG015|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
3181636|NCT01998958|3910165|FG016|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
3181637|NCT01998958|3910166|FG017|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
3181638|NCT01998958|3910167|FG018|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
3181639|NCT01998958|3910168|FG019|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
3181640|NCT01998958|3910169|FG020|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
3181641|NCT01998958|3910170|FG021|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
3363580|NCT04054765|4094709|FG000|STARTED|Post-Gameplay / 1-week Follow up||150
3147092|NCT01780454|3873120|FG000|STARTED|Overall Study||2
3147093|NCT01780454|3873120|FG000|COMPLETED|Overall Study||2
3147094|NCT01780454|3873120|FG000|NOT COMPLETED|Overall Study||0
3147095|NCT01780506|3873126|FG000|STARTED|Double-Blind Phase||438
3147096|NCT01780506|3873127|FG001|STARTED|Double-Blind Phase||434
3147097|NCT01780506|3873126|FG000|COMPLETED|Double-Blind Phase||368
3147098|NCT01780506|3873127|FG001|COMPLETED|Double-Blind Phase||356
3147099|NCT01780506|3873126|FG000|NOT COMPLETED|Double-Blind Phase||70
3147100|NCT01780506|3873127|FG001|NOT COMPLETED|Double-Blind Phase||78
3147101|NCT01780506|3873126|FG000|STARTED|Open-Label Extension Phase|278 participants completed the Double-Blind Phase but did not enter the Open-Label Extension Phase|90
3147102|NCT01780506|3873127|FG001|STARTED|Open-Label Extension Phase|261 participants completed the Double-Blind Phase but did not enter the Open-Label Extension Phase|95
3147103|NCT01780506|3873126|FG000|COMPLETED|Open-Label Extension Phase||90
3147104|NCT01780506|3873127|FG001|COMPLETED|Open-Label Extension Phase||94
3147105|NCT01780506|3873126|FG000|NOT COMPLETED|Open-Label Extension Phase||0
3147106|NCT01780506|3873127|FG001|NOT COMPLETED|Open-Label Extension Phase||1
3147107|NCT01780545|3873137|FG000|STARTED|Overall Study||99
3147108|NCT01780545|3873138|FG001|STARTED|Overall Study||101
3147109|NCT01780545|3873137|FG000|COMPLETED|Overall Study||95
3147110|NCT01780545|3873138|FG001|COMPLETED|Overall Study||99
3147111|NCT01780545|3873137|FG000|NOT COMPLETED|Overall Study||4
3147112|NCT01780545|3873138|FG001|NOT COMPLETED|Overall Study||2
3147113|NCT01780584|3873150|FG000|STARTED|Overall Study||15
3147114|NCT01780584|3873151|FG001|STARTED|Overall Study||15
3147115|NCT01780584|3873152|FG002|STARTED|Overall Study||15
3147116|NCT01780584|3873150|FG000|COMPLETED|Overall Study||14
3147117|NCT01780584|3873151|FG001|COMPLETED|Overall Study||14
3147118|NCT01780584|3873152|FG002|COMPLETED|Overall Study||13
3147119|NCT01780584|3873150|FG000|NOT COMPLETED|Overall Study||1
3147120|NCT01780584|3873151|FG001|NOT COMPLETED|Overall Study||1
3147121|NCT01780584|3873152|FG002|NOT COMPLETED|Overall Study||2
3147122|NCT01780662|3873163|FG000|STARTED|Overall Study||3
3147123|NCT01780662|3873164|FG001|STARTED|Overall Study||13
3147124|NCT01780662|3873165|FG002|STARTED|Overall Study||30
3147125|NCT01780662|3873163|FG000|COMPLETED|Overall Study||2
3147126|NCT01780662|3873164|FG001|COMPLETED|Overall Study||7
3147127|NCT01780662|3873165|FG002|COMPLETED|Overall Study||20
3147128|NCT01780662|3873163|FG000|NOT COMPLETED|Overall Study||1
3147129|NCT01780662|3873164|FG001|NOT COMPLETED|Overall Study||6
3147130|NCT01780662|3873165|FG002|NOT COMPLETED|Overall Study||10
3147131|NCT01780831|3873178|FG000|STARTED|Overall Study||10
3147132|NCT01780831|3873179|FG001|STARTED|Overall Study||6
3147133|NCT01780831|3873180|FG002|STARTED|Overall Study||26
3147134|NCT01780831|3873181|FG003|STARTED|Overall Study||10
3147135|NCT01780831|3873178|FG000|COMPLETED|Overall Study||10
3147136|NCT01780831|3873179|FG001|COMPLETED|Overall Study||6
3147137|NCT01780831|3873180|FG002|COMPLETED|Overall Study||22
3147138|NCT01780831|3873181|FG003|COMPLETED|Overall Study||9
3147139|NCT01780831|3873178|FG000|NOT COMPLETED|Overall Study||0
3147140|NCT01780831|3873179|FG001|NOT COMPLETED|Overall Study||0
3147141|NCT01780831|3873180|FG002|NOT COMPLETED|Overall Study||4
3147142|NCT01780831|3873181|FG003|NOT COMPLETED|Overall Study||1
3147143|NCT01780870|3873240|FG000|STARTED|Overall Study||0
3147144|NCT01780870|3873241|FG001|STARTED|Overall Study||5
3147145|NCT01780870|3873240|FG000|COMPLETED|Overall Study||0
3147146|NCT01780870|3873241|FG001|COMPLETED|Overall Study||5
3147147|NCT01780870|3873240|FG000|NOT COMPLETED|Overall Study||0
3147148|NCT01780870|3873241|FG001|NOT COMPLETED|Overall Study||0
3147149|NCT01780922|3873247|FG000|STARTED|First Intervention (1 Day)||2
3147150|NCT01780922|3873248|FG001|STARTED|First Intervention (1 Day)||2
3147151|NCT01780922|3873249|FG002|STARTED|First Intervention (1 Day)||2
3147152|NCT01780922|3873250|FG003|STARTED|First Intervention (1 Day)||2
3147153|NCT01780922|3873251|FG004|STARTED|First Intervention (1 Day)||2
3147154|NCT01780922|3873252|FG005|STARTED|First Intervention (1 Day)||2
3147155|NCT01780922|3873247|FG000|COMPLETED|First Intervention (1 Day)||2
3147156|NCT01780922|3873248|FG001|COMPLETED|First Intervention (1 Day)||2
3147157|NCT01780922|3873249|FG002|COMPLETED|First Intervention (1 Day)||2
3147158|NCT01780922|3873250|FG003|COMPLETED|First Intervention (1 Day)||2
3147159|NCT01780922|3873251|FG004|COMPLETED|First Intervention (1 Day)||2
3147160|NCT01780922|3873252|FG005|COMPLETED|First Intervention (1 Day)||2
3147161|NCT01780922|3873247|FG000|NOT COMPLETED|First Intervention (1 Day)||0
3147162|NCT01780922|3873248|FG001|NOT COMPLETED|First Intervention (1 Day)||0
3147163|NCT01780922|3873249|FG002|NOT COMPLETED|First Intervention (1 Day)||0
3147164|NCT01780922|3873250|FG003|NOT COMPLETED|First Intervention (1 Day)||0
3147165|NCT01780922|3873251|FG004|NOT COMPLETED|First Intervention (1 Day)||0
3147166|NCT01780922|3873252|FG005|NOT COMPLETED|First Intervention (1 Day)||0
3181642|NCT01998958|3910171|FG022|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
3181643|NCT01998958|3910172|FG023|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
3181644|NCT01998958|3910173|FG024|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
3181645|NCT01998958|3910174|FG025|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
3181646|NCT01998958|3910175|FG026|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
3181647|NCT01998958|3910176|FG027|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
3181648|NCT01998958|3910177|FG028|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
3181649|NCT01998958|3910178|FG029|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
3181650|NCT01998958|3910179|FG030|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
3181651|NCT01998958|3910180|FG031|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
3147167|NCT01780922|3873247|FG000|STARTED|Washout (7 Days)||2
3147168|NCT01780922|3873248|FG001|STARTED|Washout (7 Days)||2
3147169|NCT01780922|3873249|FG002|STARTED|Washout (7 Days)||2
3147170|NCT01780922|3873250|FG003|STARTED|Washout (7 Days)||2
3147171|NCT01780922|3873251|FG004|STARTED|Washout (7 Days)||2
3147172|NCT01780922|3873252|FG005|STARTED|Washout (7 Days)||2
3147173|NCT01780922|3873247|FG000|COMPLETED|Washout (7 Days)||2
3147174|NCT01780922|3873248|FG001|COMPLETED|Washout (7 Days)||2
3147175|NCT01780922|3873249|FG002|COMPLETED|Washout (7 Days)||2
3147176|NCT01780922|3873250|FG003|COMPLETED|Washout (7 Days)||2
3147177|NCT01780922|3873251|FG004|COMPLETED|Washout (7 Days)||2
3147178|NCT01780922|3873252|FG005|COMPLETED|Washout (7 Days)||2
3147179|NCT01780922|3873247|FG000|NOT COMPLETED|Washout (7 Days)||0
3147180|NCT01780922|3873248|FG001|NOT COMPLETED|Washout (7 Days)||0
3147181|NCT01780922|3873249|FG002|NOT COMPLETED|Washout (7 Days)||0
3147182|NCT01780922|3873250|FG003|NOT COMPLETED|Washout (7 Days)||0
3147183|NCT01780922|3873251|FG004|NOT COMPLETED|Washout (7 Days)||0
3147184|NCT01780922|3873252|FG005|NOT COMPLETED|Washout (7 Days)||0
3147185|NCT01780922|3873247|FG000|STARTED|Second Intervention (1 Day)||2
3147186|NCT01780922|3873248|FG001|STARTED|Second Intervention (1 Day)||2
3147187|NCT01780922|3873249|FG002|STARTED|Second Intervention (1 Day)||2
3147188|NCT01780922|3873250|FG003|STARTED|Second Intervention (1 Day)||2
3147189|NCT01780922|3873251|FG004|STARTED|Second Intervention (1 Day)||2
3147190|NCT01780922|3873252|FG005|STARTED|Second Intervention (1 Day)||2
3147191|NCT01780922|3873247|FG000|COMPLETED|Second Intervention (1 Day)||2
3147192|NCT01780922|3873248|FG001|COMPLETED|Second Intervention (1 Day)||2
3147193|NCT01780922|3873249|FG002|COMPLETED|Second Intervention (1 Day)||2
3147194|NCT01780922|3873250|FG003|COMPLETED|Second Intervention (1 Day)||2
3147195|NCT01780922|3873251|FG004|COMPLETED|Second Intervention (1 Day)||2
3147196|NCT01780922|3873252|FG005|COMPLETED|Second Intervention (1 Day)||2
3147197|NCT01780922|3873247|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
3147198|NCT01780922|3873248|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
3147199|NCT01780922|3873249|FG002|NOT COMPLETED|Second Intervention (1 Day)||0
3147200|NCT01780922|3873250|FG003|NOT COMPLETED|Second Intervention (1 Day)||0
3147201|NCT01780922|3873251|FG004|NOT COMPLETED|Second Intervention (1 Day)||0
3147202|NCT01780922|3873252|FG005|NOT COMPLETED|Second Intervention (1 Day)||0
3147203|NCT01780922|3873247|FG000|STARTED|Washout (7 Days)||2
3147204|NCT01780922|3873248|FG001|STARTED|Washout (7 Days)||2
3147205|NCT01780922|3873249|FG002|STARTED|Washout (7 Days)||2
3147206|NCT01780922|3873250|FG003|STARTED|Washout (7 Days)||2
3147207|NCT01780922|3873251|FG004|STARTED|Washout (7 Days)||2
3147208|NCT01780922|3873252|FG005|STARTED|Washout (7 Days)||2
3147209|NCT01780922|3873247|FG000|COMPLETED|Washout (7 Days)||2
3147210|NCT01780922|3873248|FG001|COMPLETED|Washout (7 Days)||2
3147211|NCT01780922|3873249|FG002|COMPLETED|Washout (7 Days)||2
3147212|NCT01780922|3873250|FG003|COMPLETED|Washout (7 Days)||2
3147213|NCT01780922|3873251|FG004|COMPLETED|Washout (7 Days)||2
3147214|NCT01780922|3873252|FG005|COMPLETED|Washout (7 Days)||2
3147215|NCT01780922|3873247|FG000|NOT COMPLETED|Washout (7 Days)||0
3147216|NCT01780922|3873248|FG001|NOT COMPLETED|Washout (7 Days)||0
3147217|NCT01780922|3873249|FG002|NOT COMPLETED|Washout (7 Days)||0
3147218|NCT01780922|3873250|FG003|NOT COMPLETED|Washout (7 Days)||0
3147219|NCT01780922|3873251|FG004|NOT COMPLETED|Washout (7 Days)||0
3147220|NCT01780922|3873252|FG005|NOT COMPLETED|Washout (7 Days)||0
3147221|NCT01780922|3873247|FG000|STARTED|Third Intervention (1 Day)||2
3147222|NCT01780922|3873248|FG001|STARTED|Third Intervention (1 Day)||2
3147223|NCT01780922|3873249|FG002|STARTED|Third Intervention (1 Day)||2
3147224|NCT01780922|3873250|FG003|STARTED|Third Intervention (1 Day)||2
3147225|NCT01780922|3873251|FG004|STARTED|Third Intervention (1 Day)||2
3147226|NCT01780922|3873252|FG005|STARTED|Third Intervention (1 Day)||2
3147227|NCT01780922|3873247|FG000|COMPLETED|Third Intervention (1 Day)||2
3147228|NCT01780922|3873248|FG001|COMPLETED|Third Intervention (1 Day)||2
3147229|NCT01780922|3873249|FG002|COMPLETED|Third Intervention (1 Day)||2
3147230|NCT01780922|3873250|FG003|COMPLETED|Third Intervention (1 Day)||2
3147231|NCT01780922|3873251|FG004|COMPLETED|Third Intervention (1 Day)||2
3147232|NCT01780922|3873252|FG005|COMPLETED|Third Intervention (1 Day)||2
3147233|NCT01780922|3873247|FG000|NOT COMPLETED|Third Intervention (1 Day)||0
3147234|NCT01780922|3873248|FG001|NOT COMPLETED|Third Intervention (1 Day)||0
3147235|NCT01780922|3873249|FG002|NOT COMPLETED|Third Intervention (1 Day)||0
3147236|NCT01780922|3873250|FG003|NOT COMPLETED|Third Intervention (1 Day)||0
3147237|NCT01780922|3873251|FG004|NOT COMPLETED|Third Intervention (1 Day)||0
3147238|NCT01780922|3873252|FG005|NOT COMPLETED|Third Intervention (1 Day)||0
3147239|NCT01780935|3873262|FG000|STARTED|Overall Study||335
3147240|NCT01780935|3873263|FG001|STARTED|Overall Study||336
3147241|NCT01780935|3873262|FG000|Safety Set|Overall Study||334
3147242|NCT01780935|3873263|FG001|Safety Set|Overall Study||336
3147243|NCT01780935|3873262|FG000|COMPLETED|Overall Study||0
3147244|NCT01780935|3873263|FG001|COMPLETED|Overall Study||0
3147245|NCT01780935|3873262|FG000|NOT COMPLETED|Overall Study||335
3147246|NCT01780935|3873263|FG001|NOT COMPLETED|Overall Study||336
3147247|NCT01780974|3873271|FG000|STARTED|Overall Study||21
3147248|NCT01780974|3873272|FG001|STARTED|Overall Study||21
3147249|NCT01780974|3873271|FG000|COMPLETED|Overall Study||19
3147250|NCT01780974|3873272|FG001|COMPLETED|Overall Study||18
3147251|NCT01780974|3873271|FG000|NOT COMPLETED|Overall Study||2
3147252|NCT01780974|3873272|FG001|NOT COMPLETED|Overall Study||3
3147253|NCT01780987|3873280|FG000|STARTED|Overall Study||40
3147254|NCT01780987|3873281|FG001|STARTED|Overall Study|Including one participant who withdrew from the study prior to receiving any study medication.|40
3147255|NCT01780987|3873280|FG000|COMPLETED|Overall Study||37
3147256|NCT01780987|3873281|FG001|COMPLETED|Overall Study||34
3147257|NCT01780987|3873280|FG000|NOT COMPLETED|Overall Study||3
3147258|NCT01780987|3873281|FG001|NOT COMPLETED|Overall Study||6
3147259|NCT01781078|3873289|FG000|STARTED|Overall Study|Randomized post implantation|229
3147260|NCT01781078|3873290|FG001|STARTED|Overall Study|Randomized post implantation|118
3147261|NCT01781078|3873291|FG002|STARTED|Overall Study||16
3181652|NCT01998958|3910149|FG000|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||8
3181653|NCT01998958|3910150|FG001|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
3181654|NCT01998958|3910151|FG002|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
3181655|NCT01998958|3910152|FG003|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
3181656|NCT01998958|3910153|FG004|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
3181657|NCT01998958|3910154|FG005|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
3181658|NCT01998958|3910155|FG006|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
3181659|NCT01998958|3910156|FG007|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
3181660|NCT01998958|3910157|FG008|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
3181661|NCT01998958|3910158|FG009|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
3181662|NCT01998958|3910159|FG010|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
3181663|NCT01998958|3910160|FG011|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
3181664|NCT01998958|3910161|FG012|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
3181665|NCT01998958|3910162|FG013|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
3181666|NCT01998958|3910163|FG014|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
3181667|NCT01998958|3910164|FG015|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
3181668|NCT01998958|3910165|FG016|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
3181669|NCT01998958|3910166|FG017|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
3181670|NCT01998958|3910167|FG018|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
3181671|NCT01998958|3910168|FG019|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
3181672|NCT01998958|3910169|FG020|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
3181673|NCT01998958|3910170|FG021|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
3181674|NCT01998958|3910171|FG022|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
3181675|NCT01998958|3910172|FG023|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
3181676|NCT01998958|3910173|FG024|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
3181677|NCT01998958|3910174|FG025|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
3181678|NCT01998958|3910175|FG026|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
3181679|NCT01998958|3910176|FG027|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
3181680|NCT01998958|3910177|FG028|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
3181681|NCT01998958|3910178|FG029|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
3181682|NCT01998958|3910179|FG030|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
3181683|NCT01998958|3910180|FG031|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
3181684|NCT01998958|3910149|FG000|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||5
3181685|NCT01998958|3910150|FG001|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
3181686|NCT01998958|3910151|FG002|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
3181687|NCT01998958|3910152|FG003|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
3181688|NCT01998958|3910153|FG004|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
3181689|NCT01998958|3910154|FG005|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
3181690|NCT01998958|3910155|FG006|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
3181691|NCT01998958|3910156|FG007|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
3181692|NCT01998958|3910157|FG008|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
3181693|NCT01998958|3910158|FG009|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
3181694|NCT01998958|3910159|FG010|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
3181695|NCT01998958|3910160|FG011|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
3181696|NCT01998958|3910161|FG012|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
3181697|NCT01998958|3910162|FG013|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
3181698|NCT01998958|3910163|FG014|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
3181699|NCT01998958|3910164|FG015|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
3181700|NCT01998958|3910165|FG016|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
3181701|NCT01998958|3910166|FG017|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
3181702|NCT01998958|3910167|FG018|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
3181703|NCT01998958|3910168|FG019|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
3181704|NCT01998958|3910169|FG020|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
3181705|NCT01998958|3910170|FG021|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
3181706|NCT01998958|3910171|FG022|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
3181707|NCT01998958|3910172|FG023|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
3181708|NCT01998958|3910173|FG024|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
3181709|NCT01998958|3910174|FG025|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
3181710|NCT01998958|3910175|FG026|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
3181711|NCT01998958|3910176|FG027|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
3181712|NCT01998958|3910177|FG028|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
3181713|NCT01998958|3910178|FG029|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
3147262|NCT01781078|3873289|FG000|COMPLETED|Overall Study|Patients having completed the MRI + 1 month (Primary endpoint assessment)|217
3147263|NCT01781078|3873290|FG001|COMPLETED|Overall Study|Patients having completed the MRI + 1 month (Primary endpoint assessment)|113
3147264|NCT01781078|3873291|FG002|COMPLETED|Overall Study||0
3147265|NCT01781078|3873289|FG000|NOT COMPLETED|Overall Study||12
3147266|NCT01781078|3873290|FG001|NOT COMPLETED|Overall Study||5
3147267|NCT01781078|3873291|FG002|NOT COMPLETED|Overall Study||16
3147268|NCT01781169|3873302|FG000|STARTED|Overall Study||22
3147269|NCT01781169|3873303|FG001|STARTED|Overall Study||21
3147270|NCT01781169|3873302|FG000|COMPLETED|Overall Study||21
3147271|NCT01781169|3873303|FG001|COMPLETED|Overall Study||21
3147272|NCT01781169|3873302|FG000|NOT COMPLETED|Overall Study||1
3147273|NCT01781169|3873303|FG001|NOT COMPLETED|Overall Study||0
3147274|NCT01781208|3873309|FG000|STARTED|Overall Study||62
3147275|NCT01781208|3873309|FG000|Overall Study|Overall Study||62
3147276|NCT01781208|3873309|FG000|COMPLETED|Overall Study||62
3147277|NCT01781208|3873309|FG000|NOT COMPLETED|Overall Study||0
3147278|NCT01781234|3873316|FG000|STARTED|Overall Study||27
3147279|NCT01781234|3873317|FG001|STARTED|Overall Study||24
3147280|NCT01781234|3873316|FG000|COMPLETED|Overall Study||18
3147281|NCT01781234|3873317|FG001|COMPLETED|Overall Study||21
3147282|NCT01781234|3873316|FG000|NOT COMPLETED|Overall Study||9
3147283|NCT01781234|3873317|FG001|NOT COMPLETED|Overall Study||3
3147284|NCT01781286|3873325|FG000|STARTED|Overall Study||7
3147285|NCT01781286|3873326|FG001|STARTED|Overall Study||4
3147286|NCT01781286|3873327|FG002|STARTED|Overall Study||9
3147287|NCT01781286|3873328|FG003|STARTED|Overall Study||8
3147288|NCT01781286|3873329|FG004|STARTED|Overall Study||6
3147289|NCT01781286|3873330|FG005|STARTED|Overall Study||3
3147290|NCT01781286|3873325|FG000|Started 1st Intervention|Overall Study||6
3147291|NCT01781286|3873326|FG001|Started 1st Intervention|Overall Study||4
3147292|NCT01781286|3873327|FG002|Started 1st Intervention|Overall Study||9
3147293|NCT01781286|3873328|FG003|Started 1st Intervention|Overall Study||8
3147294|NCT01781286|3873329|FG004|Started 1st Intervention|Overall Study||6
3147295|NCT01781286|3873330|FG005|Started 1st Intervention|Overall Study||2
3147296|NCT01781286|3873325|FG000|Started 2nd Intervention|Overall Study||5
3147297|NCT01781286|3873326|FG001|Started 2nd Intervention|Overall Study||4
3147298|NCT01781286|3873327|FG002|Started 2nd Intervention|Overall Study||9
3147299|NCT01781286|3873328|FG003|Started 2nd Intervention|Overall Study||8
3147300|NCT01781286|3873329|FG004|Started 2nd Intervention|Overall Study||6
3147301|NCT01781286|3873330|FG005|Started 2nd Intervention|Overall Study||2
3147302|NCT01781286|3873325|FG000|Started 3rd Intervention|Overall Study||5
3147303|NCT01781286|3873326|FG001|Started 3rd Intervention|Overall Study||4
3147304|NCT01781286|3873327|FG002|Started 3rd Intervention|Overall Study||7
3147305|NCT01781286|3873328|FG003|Started 3rd Intervention|Overall Study||7
3147306|NCT01781286|3873329|FG004|Started 3rd Intervention|Overall Study||6
3147307|NCT01781286|3873330|FG005|Started 3rd Intervention|Overall Study||2
3147308|NCT01781286|3873325|FG000|COMPLETED|Overall Study||5
3147309|NCT01781286|3873326|FG001|COMPLETED|Overall Study||4
3147310|NCT01781286|3873327|FG002|COMPLETED|Overall Study||7
3147311|NCT01781286|3873328|FG003|COMPLETED|Overall Study||7
3147312|NCT01781286|3873329|FG004|COMPLETED|Overall Study||6
3147313|NCT01781286|3873330|FG005|COMPLETED|Overall Study||2
3147314|NCT01781286|3873325|FG000|NOT COMPLETED|Overall Study||2
3147315|NCT01781286|3873326|FG001|NOT COMPLETED|Overall Study||0
3147316|NCT01781286|3873327|FG002|NOT COMPLETED|Overall Study||2
3147317|NCT01781286|3873328|FG003|NOT COMPLETED|Overall Study||1
3147318|NCT01781286|3873329|FG004|NOT COMPLETED|Overall Study||0
3147319|NCT01781286|3873330|FG005|NOT COMPLETED|Overall Study||1
3147320|NCT01781299|3873342|FG000|STARTED|Overall Study||4
3147321|NCT01781299|3873343|FG001|STARTED|Overall Study||5
3147322|NCT01781299|3873342|FG000|COMPLETED|Overall Study||4
3147323|NCT01781299|3873343|FG001|COMPLETED|Overall Study||4
3147324|NCT01781299|3873342|FG000|NOT COMPLETED|Overall Study||0
3147325|NCT01781299|3873343|FG001|NOT COMPLETED|Overall Study||1
3147326|NCT01781403|3873349|FG000|STARTED|Overall Study||2
3147327|NCT01781403|3873350|FG001|STARTED|Overall Study||2
3147328|NCT01781403|3873351|FG002|STARTED|Overall Study||18
3147329|NCT01781403|3873349|FG000|COMPLETED|Overall Study||2
3181714|NCT01998958|3910179|FG030|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
3181715|NCT01998958|3910180|FG031|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
3181716|NCT01998958|3910149|FG000|COMPLETED|Period 1 (Panel A and B)||32
3181717|NCT01998958|3910150|FG001|COMPLETED|Period 1 (Panel A and B)||8
3181718|NCT01998958|3910151|FG002|COMPLETED|Period 1 (Panel A and B)||11
3181719|NCT01998958|3910152|FG003|COMPLETED|Period 1 (Panel A and B)||12
3181720|NCT01998958|3910153|FG004|COMPLETED|Period 1 (Panel A and B)||21
3181721|NCT01998958|3910154|FG005|COMPLETED|Period 1 (Panel A and B)||11
3181722|NCT01998958|3910155|FG006|COMPLETED|Period 1 (Panel A and B)||9
3181723|NCT01998958|3910156|FG007|COMPLETED|Period 1 (Panel A and B)||0
3181724|NCT01998958|3910157|FG008|COMPLETED|Period 1 (Panel A and B)||0
3181725|NCT01998958|3910158|FG009|COMPLETED|Period 1 (Panel A and B)||0
3181726|NCT01998958|3910159|FG010|COMPLETED|Period 1 (Panel A and B)||0
3147330|NCT01781403|3873350|FG001|COMPLETED|Overall Study||2
3147331|NCT01781403|3873351|FG002|COMPLETED|Overall Study||18
3147332|NCT01781403|3873349|FG000|NOT COMPLETED|Overall Study||0
3147333|NCT01781403|3873350|FG001|NOT COMPLETED|Overall Study||0
3147334|NCT01781403|3873351|FG002|NOT COMPLETED|Overall Study||0
3147335|NCT01781429|3873376|FG000|STARTED|Overall Study||1
3147336|NCT01781429|3873377|FG001|STARTED|Overall Study||1
3147337|NCT01781429|3873378|FG002|STARTED|Overall Study||1
3147338|NCT01781429|3873379|FG003|STARTED|Overall Study||1
3147339|NCT01781429|3873380|FG004|STARTED|Overall Study||1
3147340|NCT01781429|3873381|FG005|STARTED|Overall Study||4
3147341|NCT01781429|3873382|FG006|STARTED|Overall Study||7
3147342|NCT01781429|3873383|FG007|STARTED|Overall Study||4
3147343|NCT01781429|3873384|FG008|STARTED|Overall Study||7
3147344|NCT01781429|3873385|FG009|STARTED|Overall Study||24
3147345|NCT01781429|3873386|FG010|STARTED|Overall Study||18
3147346|NCT01781429|3873387|FG011|STARTED|Overall Study||21
3147347|NCT01781429|3873388|FG012|STARTED|Overall Study||22
3147348|NCT01781429|3873389|FG013|STARTED|Overall Study||8
3147349|NCT01781429|3873390|FG014|STARTED|Overall Study||16
3147350|NCT01781429|3873391|FG015|STARTED|Overall Study||0
3147351|NCT01781429|3873376|FG000|COMPLETED|Overall Study||0
3147352|NCT01781429|3873377|FG001|COMPLETED|Overall Study||0
3147353|NCT01781429|3873378|FG002|COMPLETED|Overall Study||0
3147354|NCT01781429|3873379|FG003|COMPLETED|Overall Study||0
3147355|NCT01781429|3873380|FG004|COMPLETED|Overall Study||0
3147356|NCT01781429|3873381|FG005|COMPLETED|Overall Study||0
3147357|NCT01781429|3873382|FG006|COMPLETED|Overall Study||0
3147358|NCT01781429|3873383|FG007|COMPLETED|Overall Study||0
3147359|NCT01781429|3873384|FG008|COMPLETED|Overall Study||0
3147360|NCT01781429|3873385|FG009|COMPLETED|Overall Study||0
3147361|NCT01781429|3873386|FG010|COMPLETED|Overall Study||0
3147362|NCT01781429|3873387|FG011|COMPLETED|Overall Study||0
3147363|NCT01781429|3873388|FG012|COMPLETED|Overall Study||0
3147364|NCT01781429|3873389|FG013|COMPLETED|Overall Study||0
3147365|NCT01781429|3873390|FG014|COMPLETED|Overall Study||0
3147366|NCT01781429|3873391|FG015|COMPLETED|Overall Study||0
3147367|NCT01781429|3873376|FG000|NOT COMPLETED|Overall Study||1
3147368|NCT01781429|3873377|FG001|NOT COMPLETED|Overall Study||1
3181727|NCT01998958|3910160|FG011|COMPLETED|Period 1 (Panel A and B)||0
3181728|NCT01998958|3910161|FG012|COMPLETED|Period 1 (Panel A and B)||0
3181729|NCT01998958|3910162|FG013|COMPLETED|Period 1 (Panel A and B)||0
3181730|NCT01998958|3910163|FG014|COMPLETED|Period 1 (Panel A and B)||0
3181731|NCT01998958|3910164|FG015|COMPLETED|Period 1 (Panel A and B)||0
3181732|NCT01998958|3910165|FG016|COMPLETED|Period 1 (Panel A and B)||0
3181733|NCT01998958|3910166|FG017|COMPLETED|Period 1 (Panel A and B)||0
3181734|NCT01998958|3910167|FG018|COMPLETED|Period 1 (Panel A and B)||0
3181735|NCT01998958|3910168|FG019|COMPLETED|Period 1 (Panel A and B)||0
3181736|NCT01998958|3910169|FG020|COMPLETED|Period 1 (Panel A and B)||0
3181737|NCT01998958|3910170|FG021|COMPLETED|Period 1 (Panel A and B)||0
3181738|NCT01998958|3910171|FG022|COMPLETED|Period 1 (Panel A and B)||0
3181739|NCT01998958|3910172|FG023|COMPLETED|Period 1 (Panel A and B)||0
3181740|NCT01998958|3910173|FG024|COMPLETED|Period 1 (Panel A and B)||0
3181741|NCT01998958|3910174|FG025|COMPLETED|Period 1 (Panel A and B)||0
3181742|NCT01998958|3910175|FG026|COMPLETED|Period 1 (Panel A and B)||0
3181743|NCT01998958|3910176|FG027|COMPLETED|Period 1 (Panel A and B)||0
3181744|NCT01998958|3910177|FG028|COMPLETED|Period 1 (Panel A and B)||0
3181745|NCT01998958|3910178|FG029|COMPLETED|Period 1 (Panel A and B)||0
3181746|NCT01998958|3910179|FG030|COMPLETED|Period 1 (Panel A and B)||0
3181747|NCT01998958|3910180|FG031|COMPLETED|Period 1 (Panel A and B)||0
3181748|NCT01998958|3910149|FG000|NOT COMPLETED|Period 1 (Panel A and B)||1
3181749|NCT01998958|3910150|FG001|NOT COMPLETED|Period 1 (Panel A and B)||3
3181750|NCT01998958|3910151|FG002|NOT COMPLETED|Period 1 (Panel A and B)||0
3181751|NCT01998958|3910152|FG003|NOT COMPLETED|Period 1 (Panel A and B)||0
3181752|NCT01998958|3910153|FG004|NOT COMPLETED|Period 1 (Panel A and B)||0
3181753|NCT01998958|3910154|FG005|NOT COMPLETED|Period 1 (Panel A and B)||0
3181754|NCT01998958|3910155|FG006|NOT COMPLETED|Period 1 (Panel A and B)||0
3181755|NCT01998958|3910156|FG007|NOT COMPLETED|Period 1 (Panel A and B)||0
3181756|NCT01998958|3910157|FG008|NOT COMPLETED|Period 1 (Panel A and B)||0
3181757|NCT01998958|3910158|FG009|NOT COMPLETED|Period 1 (Panel A and B)||0
3181758|NCT01998958|3910159|FG010|NOT COMPLETED|Period 1 (Panel A and B)||0
3181759|NCT01998958|3910160|FG011|NOT COMPLETED|Period 1 (Panel A and B)||0
3181760|NCT01998958|3910161|FG012|NOT COMPLETED|Period 1 (Panel A and B)||0
3181761|NCT01998958|3910162|FG013|NOT COMPLETED|Period 1 (Panel A and B)||0
3181762|NCT01998958|3910163|FG014|NOT COMPLETED|Period 1 (Panel A and B)||0
3181763|NCT01998958|3910164|FG015|NOT COMPLETED|Period 1 (Panel A and B)||0
3181764|NCT01998958|3910165|FG016|NOT COMPLETED|Period 1 (Panel A and B)||0
3181765|NCT01998958|3910166|FG017|NOT COMPLETED|Period 1 (Panel A and B)||0
3181766|NCT01998958|3910167|FG018|NOT COMPLETED|Period 1 (Panel A and B)||0
3181767|NCT01998958|3910168|FG019|NOT COMPLETED|Period 1 (Panel A and B)||0
3181768|NCT01998958|3910169|FG020|NOT COMPLETED|Period 1 (Panel A and B)||0
3181769|NCT01998958|3910170|FG021|NOT COMPLETED|Period 1 (Panel A and B)||0
3181770|NCT01998958|3910171|FG022|NOT COMPLETED|Period 1 (Panel A and B)||0
3181771|NCT01998958|3910172|FG023|NOT COMPLETED|Period 1 (Panel A and B)||0
3181772|NCT01998958|3910173|FG024|NOT COMPLETED|Period 1 (Panel A and B)||0
3181773|NCT01998958|3910174|FG025|NOT COMPLETED|Period 1 (Panel A and B)||0
3181774|NCT01998958|3910175|FG026|NOT COMPLETED|Period 1 (Panel A and B)||0
3147369|NCT01781429|3873378|FG002|NOT COMPLETED|Overall Study||1
3147370|NCT01781429|3873379|FG003|NOT COMPLETED|Overall Study||1
3147371|NCT01781429|3873380|FG004|NOT COMPLETED|Overall Study||1
3147372|NCT01781429|3873381|FG005|NOT COMPLETED|Overall Study||4
3147373|NCT01781429|3873382|FG006|NOT COMPLETED|Overall Study||7
3147374|NCT01781429|3873383|FG007|NOT COMPLETED|Overall Study||4
3147375|NCT01781429|3873384|FG008|NOT COMPLETED|Overall Study||7
3147376|NCT01781429|3873385|FG009|NOT COMPLETED|Overall Study||24
3147377|NCT01781429|3873386|FG010|NOT COMPLETED|Overall Study||18
3147378|NCT01781429|3873387|FG011|NOT COMPLETED|Overall Study||21
3147379|NCT01781429|3873388|FG012|NOT COMPLETED|Overall Study||22
3147380|NCT01781429|3873389|FG013|NOT COMPLETED|Overall Study||8
3147381|NCT01781429|3873390|FG014|NOT COMPLETED|Overall Study||16
3147382|NCT01781429|3873391|FG015|NOT COMPLETED|Overall Study||0
3147383|NCT01781468|3873427|FG000|STARTED|Overall Study||109
3147384|NCT01781468|3873428|FG001|STARTED|Overall Study||110
3147385|NCT01781468|3873429|FG002|STARTED|Overall Study||109
3147386|NCT01781468|3873427|FG000|COMPLETED|Overall Study||103
3147387|NCT01781468|3873428|FG001|COMPLETED|Overall Study||97
3147388|NCT01781468|3873429|FG002|COMPLETED|Overall Study||97
3147389|NCT01781468|3873427|FG000|NOT COMPLETED|Overall Study||6
3147390|NCT01781468|3873428|FG001|NOT COMPLETED|Overall Study||13
3147391|NCT01781468|3873429|FG002|NOT COMPLETED|Overall Study||12
3147392|NCT01781481|3873438|FG000|STARTED|Overall Study||148
3147393|NCT01781481|3873438|FG000|COMPLETED|Overall Study||148
3147394|NCT01781481|3873438|FG000|NOT COMPLETED|Overall Study||0
3147395|NCT01781572|3873494|FG000|STARTED|MEK162 45mg BID+LEE011 200mg||16
3147396|NCT01781572|3873495|FG001|STARTED|MEK162 45mg BID+LEE011 200mg||6
3147397|NCT01781572|3873496|FG002|STARTED|MEK162 45mg BID+LEE011 200mg||41
3147398|NCT01781572|3873494|FG000|COMPLETED|MEK162 45mg BID+LEE011 200mg||0
3147399|NCT01781572|3873495|FG001|COMPLETED|MEK162 45mg BID+LEE011 200mg||0
3147400|NCT01781572|3873496|FG002|COMPLETED|MEK162 45mg BID+LEE011 200mg||0
3147401|NCT01781572|3873494|FG000|NOT COMPLETED|MEK162 45mg BID+LEE011 200mg||16
3147402|NCT01781572|3873495|FG001|NOT COMPLETED|MEK162 45mg BID+LEE011 200mg||6
3147403|NCT01781572|3873496|FG002|NOT COMPLETED|MEK162 45mg BID+LEE011 200mg||41
3147404|NCT01781572|3873494|FG000|STARTED|MEK162 45mg BID+LEE011 250mg||3
3147405|NCT01781572|3873495|FG001|STARTED|MEK162 45mg BID+LEE011 250mg||0
3147406|NCT01781572|3873496|FG002|STARTED|MEK162 45mg BID+LEE011 250mg||0
3147407|NCT01781572|3873494|FG000|COMPLETED|MEK162 45mg BID+LEE011 250mg||0
3147408|NCT01781572|3873495|FG001|COMPLETED|MEK162 45mg BID+LEE011 250mg||0
3147409|NCT01781572|3873496|FG002|COMPLETED|MEK162 45mg BID+LEE011 250mg||0
3147410|NCT01781572|3873494|FG000|NOT COMPLETED|MEK162 45mg BID+LEE011 250mg||3
3147411|NCT01781572|3873495|FG001|NOT COMPLETED|MEK162 45mg BID+LEE011 250mg||0
3147412|NCT01781572|3873496|FG002|NOT COMPLETED|MEK162 45mg BID+LEE011 250mg||0
3147413|NCT01781572|3873494|FG000|STARTED|MEK162 30mg BID+LEE011 300mg||4
3147414|NCT01781572|3873495|FG001|STARTED|MEK162 30mg BID+LEE011 300mg||2
3147415|NCT01781572|3873496|FG002|STARTED|MEK162 30mg BID+LEE011 300mg||0
3147416|NCT01781572|3873494|FG000|COMPLETED|MEK162 30mg BID+LEE011 300mg||0
3147417|NCT01781572|3873495|FG001|COMPLETED|MEK162 30mg BID+LEE011 300mg||0
3147418|NCT01781572|3873496|FG002|COMPLETED|MEK162 30mg BID+LEE011 300mg||0
3147419|NCT01781572|3873494|FG000|NOT COMPLETED|MEK162 30mg BID+LEE011 300mg||4
3147420|NCT01781572|3873495|FG001|NOT COMPLETED|MEK162 30mg BID+LEE011 300mg||2
3147421|NCT01781572|3873496|FG002|NOT COMPLETED|MEK162 30mg BID+LEE011 300mg||0
3147422|NCT01781572|3873494|FG000|STARTED|MEK162 45mg BID+LEE011 300mg||6
3147423|NCT01781572|3873495|FG001|STARTED|MEK162 45mg BID+LEE011 300mg||4
3147424|NCT01781572|3873496|FG002|STARTED|MEK162 45mg BID+LEE011 300mg||0
3181775|NCT01998958|3910176|FG027|NOT COMPLETED|Period 1 (Panel A and B)||0
3181776|NCT01998958|3910177|FG028|NOT COMPLETED|Period 1 (Panel A and B)||0
3181777|NCT01998958|3910178|FG029|NOT COMPLETED|Period 1 (Panel A and B)||0
3181778|NCT01998958|3910179|FG030|NOT COMPLETED|Period 1 (Panel A and B)||0
3181779|NCT01998958|3910180|FG031|NOT COMPLETED|Period 1 (Panel A and B)||0
3181780|NCT01998958|3910149|FG000|STARTED|Period 2 (Panel A and B)||0
3181781|NCT01998958|3910150|FG001|STARTED|Period 2 (Panel A and B)||0
3181782|NCT01998958|3910151|FG002|STARTED|Period 2 (Panel A and B)||0
3181783|NCT01998958|3910152|FG003|STARTED|Period 2 (Panel A and B)||0
3181784|NCT01998958|3910153|FG004|STARTED|Period 2 (Panel A and B)||0
3181785|NCT01998958|3910154|FG005|STARTED|Period 2 (Panel A and B)||0
3181786|NCT01998958|3910155|FG006|STARTED|Period 2 (Panel A and B)||0
3181787|NCT01998958|3910156|FG007|STARTED|Period 2 (Panel A and B)||6
3181788|NCT01998958|3910157|FG008|STARTED|Period 2 (Panel A and B)||4
3181789|NCT01998958|3910158|FG009|STARTED|Period 2 (Panel A and B)||8
3181790|NCT01998958|3910159|FG010|STARTED|Period 2 (Panel A and B)||9
3181791|NCT01998958|3910160|FG011|STARTED|Period 2 (Panel A and B)||5
3181792|NCT01998958|3910161|FG012|STARTED|Period 2 (Panel A and B)||8
3181793|NCT01998958|3910162|FG013|STARTED|Period 2 (Panel A and B)||11
3181794|NCT01998958|3910163|FG014|STARTED|Period 2 (Panel A and B)||12
3181795|NCT01998958|3910164|FG015|STARTED|Period 2 (Panel A and B)||5
3181796|NCT01998958|3910165|FG016|STARTED|Period 2 (Panel A and B)||8
3181797|NCT01998958|3910166|FG017|STARTED|Period 2 (Panel A and B)||5
3181798|NCT01998958|3910167|FG018|STARTED|Period 2 (Panel A and B)||3
3181799|NCT01998958|3910168|FG019|STARTED|Period 2 (Panel A and B)||11
3181800|NCT01998958|3910169|FG020|STARTED|Period 2 (Panel A and B)||9
3181801|NCT01998958|3910170|FG021|STARTED|Period 2 (Panel A and B)||0
3181802|NCT01998958|3910171|FG022|STARTED|Period 2 (Panel A and B)||0
3181803|NCT01998958|3910172|FG023|STARTED|Period 2 (Panel A and B)||0
3181804|NCT01998958|3910173|FG024|STARTED|Period 2 (Panel A and B)||0
3147425|NCT01781572|3873494|FG000|COMPLETED|MEK162 45mg BID+LEE011 300mg||0
3147426|NCT01781572|3873495|FG001|COMPLETED|MEK162 45mg BID+LEE011 300mg||0
3147427|NCT01781572|3873496|FG002|COMPLETED|MEK162 45mg BID+LEE011 300mg||0
3147428|NCT01781572|3873494|FG000|NOT COMPLETED|MEK162 45mg BID+LEE011 300mg||6
3147429|NCT01781572|3873495|FG001|NOT COMPLETED|MEK162 45mg BID+LEE011 300mg||4
3147430|NCT01781572|3873496|FG002|NOT COMPLETED|MEK162 45mg BID+LEE011 300mg||0
3147431|NCT01781572|3873494|FG000|STARTED|MEK162 30mg LEE011 200mg||0
3147432|NCT01781572|3873495|FG001|STARTED|MEK162 30mg LEE011 200mg||5
3147433|NCT01781572|3873496|FG002|STARTED|MEK162 30mg LEE011 200mg||0
3147434|NCT01781572|3873494|FG000|COMPLETED|MEK162 30mg LEE011 200mg||0
3147435|NCT01781572|3873495|FG001|COMPLETED|MEK162 30mg LEE011 200mg||0
3147436|NCT01781572|3873496|FG002|COMPLETED|MEK162 30mg LEE011 200mg||0
3147437|NCT01781572|3873494|FG000|NOT COMPLETED|MEK162 30mg LEE011 200mg||0
3147438|NCT01781572|3873495|FG001|NOT COMPLETED|MEK162 30mg LEE011 200mg||5
3147439|NCT01781572|3873496|FG002|NOT COMPLETED|MEK162 30mg LEE011 200mg||0
3147440|NCT01781572|3873494|FG000|STARTED|MEK162 45mg LEE011 450mg||0
3147441|NCT01781572|3873495|FG001|STARTED|MEK162 45mg LEE011 450mg||9
3147442|NCT01781572|3873496|FG002|STARTED|MEK162 45mg LEE011 450mg||0
3147443|NCT01781572|3873494|FG000|COMPLETED|MEK162 45mg LEE011 450mg||0
3147444|NCT01781572|3873495|FG001|COMPLETED|MEK162 45mg LEE011 450mg||0
3147445|NCT01781572|3873496|FG002|COMPLETED|MEK162 45mg LEE011 450mg||0
3147446|NCT01781572|3873494|FG000|NOT COMPLETED|MEK162 45mg LEE011 450mg||0
3147447|NCT01781572|3873495|FG001|NOT COMPLETED|MEK162 45mg LEE011 450mg||9
3147448|NCT01781572|3873496|FG002|NOT COMPLETED|MEK162 45mg LEE011 450mg||0
3147449|NCT01781572|3873494|FG000|STARTED|MEK162 45mg LEE011 600mg||0
3147450|NCT01781572|3873495|FG001|STARTED|MEK162 45mg LEE011 600mg||6
3147451|NCT01781572|3873496|FG002|STARTED|MEK162 45mg LEE011 600mg||0
3147452|NCT01781572|3873494|FG000|COMPLETED|MEK162 45mg LEE011 600mg||0
3147453|NCT01781572|3873495|FG001|COMPLETED|MEK162 45mg LEE011 600mg||0
3147454|NCT01781572|3873496|FG002|COMPLETED|MEK162 45mg LEE011 600mg||0
3147455|NCT01781572|3873494|FG000|NOT COMPLETED|MEK162 45mg LEE011 600mg||0
3147456|NCT01781572|3873495|FG001|NOT COMPLETED|MEK162 45mg LEE011 600mg||6
3147457|NCT01781572|3873496|FG002|NOT COMPLETED|MEK162 45mg LEE011 600mg||0
3147458|NCT01781611|3873527|FG000|STARTED|Overall Study||13
3147459|NCT01781611|3873528|FG001|STARTED|Overall Study||5
3147460|NCT01781611|3873527|FG000|COMPLETED|Overall Study||9
3147461|NCT01781611|3873528|FG001|COMPLETED|Overall Study||5
3147462|NCT01781611|3873527|FG000|NOT COMPLETED|Overall Study||4
3147463|NCT01781611|3873528|FG001|NOT COMPLETED|Overall Study||0
3147464|NCT01781806|3873536|FG000|STARTED|Overall Study||297
3147465|NCT01781806|3873537|FG001|STARTED|Overall Study||4
3147466|NCT01781806|3873536|FG000|Week 0|Overall Study||297
3147467|NCT01781806|3873537|FG001|Week 0|Overall Study||4
3147468|NCT01781806|3873536|FG000|Week 4|Overall Study||284
3147469|NCT01781806|3873537|FG001|Week 4|Overall Study||4
3147470|NCT01781806|3873536|FG000|Week 8|Overall Study||278
3147471|NCT01781806|3873537|FG001|Week 8|Overall Study||4
3147472|NCT01781806|3873536|FG000|Week 12|Overall Study||272
3147473|NCT01781806|3873537|FG001|Week 12|Overall Study||2
3147474|NCT01781806|3873536|FG000|Week 24|Overall Study||260
3147475|NCT01781806|3873537|FG001|Week 24|Overall Study||1
3147476|NCT01781806|3873536|FG000|Week 36|Overall Study||247
3147477|NCT01781806|3873537|FG001|Week 36|Overall Study||1
3147478|NCT01781806|3873536|FG000|Week 48|Overall Study||222
3147479|NCT01781806|3873537|FG001|Week 48|Overall Study||1
3147480|NCT01781806|3873536|FG000|COMPLETED|Overall Study||218
3147481|NCT01781806|3873537|FG001|COMPLETED|Overall Study||1
3147482|NCT01781806|3873536|FG000|NOT COMPLETED|Overall Study||79
3147483|NCT01781806|3873537|FG001|NOT COMPLETED|Overall Study||3
3147484|NCT01781832|3873544|FG000|STARTED|Overall Study||26
3147485|NCT01781832|3873544|FG000|COMPLETED|Overall Study||25
3147486|NCT01781832|3873544|FG000|NOT COMPLETED|Overall Study||1
3147487|NCT01781962|3873548|FG000|STARTED|Overall Study||206
3147488|NCT01781962|3873548|FG000|COMPLETED|Overall Study||201
3147489|NCT01781962|3873548|FG000|NOT COMPLETED|Overall Study||5
3147490|NCT01781975|3873554|FG000|STARTED|Overall Study||45
3147491|NCT01781975|3873555|FG001|STARTED|Overall Study||22
3147492|NCT01781975|3873554|FG000|Treatment Period|Overall Study||44
3147493|NCT01781975|3873555|FG001|Treatment Period|Overall Study||22
3147494|NCT01781975|3873554|FG000|Follow-Up Period|Overall Study||43
3147495|NCT01781975|3873555|FG001|Follow-Up Period|Overall Study||21
3181805|NCT01998958|3910174|FG025|STARTED|Period 2 (Panel A and B)||0
3181806|NCT01998958|3910175|FG026|STARTED|Period 2 (Panel A and B)||0
3181807|NCT01998958|3910176|FG027|STARTED|Period 2 (Panel A and B)||0
3181808|NCT01998958|3910177|FG028|STARTED|Period 2 (Panel A and B)||0
3181809|NCT01998958|3910178|FG029|STARTED|Period 2 (Panel A and B)||0
3181810|NCT01998958|3910179|FG030|STARTED|Period 2 (Panel A and B)||0
3181811|NCT01998958|3910180|FG031|STARTED|Period 2 (Panel A and B)||0
3181812|NCT01998958|3910149|FG000|COMPLETED|Period 2 (Panel A and B)||0
3181813|NCT01998958|3910150|FG001|COMPLETED|Period 2 (Panel A and B)||0
3181814|NCT01998958|3910151|FG002|COMPLETED|Period 2 (Panel A and B)||0
3181815|NCT01998958|3910152|FG003|COMPLETED|Period 2 (Panel A and B)||0
3181816|NCT01998958|3910153|FG004|COMPLETED|Period 2 (Panel A and B)||0
3181817|NCT01998958|3910154|FG005|COMPLETED|Period 2 (Panel A and B)||0
3181818|NCT01998958|3910155|FG006|COMPLETED|Period 2 (Panel A and B)||0
3181819|NCT01998958|3910156|FG007|COMPLETED|Period 2 (Panel A and B)||6
3181820|NCT01998958|3910157|FG008|COMPLETED|Period 2 (Panel A and B)||4
3181821|NCT01998958|3910158|FG009|COMPLETED|Period 2 (Panel A and B)||8
3181822|NCT01998958|3910159|FG010|COMPLETED|Period 2 (Panel A and B)||8
3363581|NCT04054765|4094710|FG001|STARTED|Post-Gameplay / 1-week Follow up||129
3147496|NCT01781975|3873554|FG000|COMPLETED|Overall Study||43
3147497|NCT01781975|3873555|FG001|COMPLETED|Overall Study||21
3147498|NCT01781975|3873554|FG000|NOT COMPLETED|Overall Study||2
3147499|NCT01781975|3873555|FG001|NOT COMPLETED|Overall Study||1
3147500|NCT01782131|3873563|FG000|STARTED|Overall Study||293
3147501|NCT01782131|3873564|FG001|STARTED|Overall Study||292
3147502|NCT01782131|3873563|FG000|Treated|Overall Study||288
3147503|NCT01782131|3873564|FG001|Treated|Overall Study||287
3147504|NCT01782131|3873563|FG000|COMPLETED|Overall Study||184
3147505|NCT01782131|3873564|FG001|COMPLETED|Overall Study||177
3147506|NCT01782131|3873563|FG000|NOT COMPLETED|Overall Study||109
3147507|NCT01782131|3873564|FG001|NOT COMPLETED|Overall Study||115
3147508|NCT01782209|3873570|FG000|STARTED|Overall Study||335
3147509|NCT01782209|3873570|FG000|COMPLETED|Overall Study||225
3147510|NCT01782209|3873570|FG000|NOT COMPLETED|Overall Study||110
3147511|NCT01782222|3873577|FG000|STARTED|Overall Study||40
3147512|NCT01782222|3873578|FG001|STARTED|Overall Study||41
3147513|NCT01782222|3873579|FG002|STARTED|Overall Study||41
3147514|NCT01782222|3873577|FG000|COMPLETED|Overall Study||32
3147515|NCT01782222|3873578|FG001|COMPLETED|Overall Study||30
3147516|NCT01782222|3873579|FG002|COMPLETED|Overall Study||37
3147517|NCT01782222|3873577|FG000|NOT COMPLETED|Overall Study||8
3147518|NCT01782222|3873578|FG001|NOT COMPLETED|Overall Study||11
3147519|NCT01782222|3873579|FG002|NOT COMPLETED|Overall Study||4
3147520|NCT01782313|3873587|FG000|STARTED|Reached First Response/Completed 2 Cycle||58
3147521|NCT01782313|3873587|FG000|COMPLETED|Reached First Response/Completed 2 Cycle||52
3147522|NCT01782313|3873587|FG000|NOT COMPLETED|Reached First Response/Completed 2 Cycle||6
3147523|NCT01782313|3873587|FG000|STARTED|Treated Cycle 3||52
3147524|NCT01782313|3873587|FG000|COMPLETED|Treated Cycle 3||31
3147525|NCT01782313|3873587|FG000|NOT COMPLETED|Treated Cycle 3||21
3147526|NCT01782313|3873587|FG000|STARTED|Treated Cycle 4/Reached 16 Week Response||31
3147527|NCT01782313|3873587|FG000|COMPLETED|Treated Cycle 4/Reached 16 Week Response||25
3147528|NCT01782313|3873587|FG000|NOT COMPLETED|Treated Cycle 4/Reached 16 Week Response||6
3147529|NCT01782313|3873587|FG000|STARTED|Continued Treatment After 16 Weeks||25
3147530|NCT01782313|3873587|FG000|COMPLETED|Continued Treatment After 16 Weeks||18
3147531|NCT01782313|3873587|FG000|NOT COMPLETED|Continued Treatment After 16 Weeks||7
3147532|NCT01782313|3873587|FG000|STARTED|Survival Follow up||58
3147533|NCT01782313|3873587|FG000|COMPLETED|Survival Follow up||57
3147534|NCT01782313|3873587|FG000|NOT COMPLETED|Survival Follow up||1
3147535|NCT01782326|3873593|FG000|STARTED|Planned Treatment Epoch||1680
3147536|NCT01782326|3873594|FG001|STARTED|Planned Treatment Epoch||1682
3147537|NCT01782326|3873593|FG000|Full Analysis Set (FAS)|Planned Treatment Epoch||1675
3147538|NCT01782326|3873594|FG001|Full Analysis Set (FAS)|Planned Treatment Epoch||1679
3147539|NCT01782326|3873593|FG000|Per-protocol Set (PPS)|Planned Treatment Epoch||1528
3147540|NCT01782326|3873594|FG001|Per-protocol Set (PPS)|Planned Treatment Epoch||1556
3147541|NCT01782326|3873593|FG000|Serial Spirometry Set|Planned Treatment Epoch||280
3147542|NCT01782326|3873594|FG001|Serial Spirometry Set|Planned Treatment Epoch||279
3147543|NCT01782326|3873593|FG000|Safety Set (SAF)|Planned Treatment Epoch||1678
3147544|NCT01782326|3873594|FG001|Safety Set (SAF)|Planned Treatment Epoch||1680
3147545|NCT01782326|3873593|FG000|Urine Cortisol Set|Planned Treatment Epoch||266
3147546|NCT01782326|3873594|FG001|Urine Cortisol Set|Planned Treatment Epoch||269
3147547|NCT01782326|3873593|FG000|COMPLETED|Planned Treatment Epoch||1478
3147548|NCT01782326|3873594|FG001|COMPLETED|Planned Treatment Epoch||1474
3147549|NCT01782326|3873593|FG000|NOT COMPLETED|Planned Treatment Epoch||202
3147550|NCT01782326|3873594|FG001|NOT COMPLETED|Planned Treatment Epoch||208
3147551|NCT01782326|3873593|FG000|STARTED|Double-blind Treatment||1678
3147552|NCT01782326|3873594|FG001|STARTED|Double-blind Treatment||1680
3147553|NCT01782326|3873593|FG000|COMPLETED|Double-blind Treatment||1400
3147554|NCT01782326|3873594|FG001|COMPLETED|Double-blind Treatment||1360
3147555|NCT01782326|3873593|FG000|NOT COMPLETED|Double-blind Treatment||278
3147556|NCT01782326|3873594|FG001|NOT COMPLETED|Double-blind Treatment||320
3147557|NCT01782378|3873602|FG000|STARTED|First Series||32
3147558|NCT01782378|3873603|FG001|STARTED|First Series||31
3147559|NCT01782378|3873602|FG000|COMPLETED|First Series||25
3147560|NCT01782378|3873603|FG001|COMPLETED|First Series||23
3147561|NCT01782378|3873602|FG000|NOT COMPLETED|First Series||7
3147562|NCT01782378|3873603|FG001|NOT COMPLETED|First Series||8
3147563|NCT01782378|3873602|FG000|STARTED|Second Series||31
3147564|NCT01782378|3873603|FG001|STARTED|Second Series||32
3147565|NCT01782378|3873602|FG000|COMPLETED|Second Series||5
3147566|NCT01782378|3873603|FG001|COMPLETED|Second Series||0
3147567|NCT01782378|3873602|FG000|NOT COMPLETED|Second Series||26
3147568|NCT01782378|3873603|FG001|NOT COMPLETED|Second Series||32
3147569|NCT01782469|3873609|FG000|STARTED|Overall Study||16
3147570|NCT01782469|3873609|FG000|COMPLETED|Overall Study||15
3147571|NCT01782469|3873609|FG000|NOT COMPLETED|Overall Study||1
3147572|NCT01782482|3873615|FG000|STARTED|Overall Study||281
3147573|NCT01782482|3873616|FG001|STARTED|Overall Study||280
3147574|NCT01782482|3873615|FG000|COMPLETED|Overall Study||271
3147575|NCT01782482|3873616|FG001|COMPLETED|Overall Study||270
3147576|NCT01782482|3873615|FG000|NOT COMPLETED|Overall Study||10
3147577|NCT01782482|3873616|FG001|NOT COMPLETED|Overall Study||10
3147578|NCT01782495|3873633|FG000|STARTED|Overall Study||34
3147579|NCT01782495|3873634|FG001|STARTED|Overall Study||27
3147580|NCT01782495|3873635|FG002|STARTED|Overall Study||13
3147581|NCT01782495|3873636|FG003|STARTED|Overall Study||4
3147582|NCT01782495|3873637|FG004|STARTED|Overall Study||2
3147583|NCT01782495|3873638|FG005|STARTED|Overall Study||22
3147584|NCT01782495|3873639|FG006|STARTED|Overall Study||12
3147585|NCT01782495|3873640|FG007|STARTED|Overall Study||9
3147586|NCT01782495|3873641|FG008|STARTED|Overall Study||3
3147587|NCT01782495|3873642|FG009|STARTED|Overall Study||2
3147588|NCT01782495|3873643|FG010|STARTED|Overall Study||1
3147589|NCT01782495|3873633|FG000|COMPLETED|Overall Study||34
3147590|NCT01782495|3873634|FG001|COMPLETED|Overall Study||26
3147591|NCT01782495|3873635|FG002|COMPLETED|Overall Study||13
3147592|NCT01782495|3873636|FG003|COMPLETED|Overall Study||4
3147593|NCT01782495|3873637|FG004|COMPLETED|Overall Study||2
3147594|NCT01782495|3873638|FG005|COMPLETED|Overall Study||22
3147595|NCT01782495|3873639|FG006|COMPLETED|Overall Study||12
3147596|NCT01782495|3873640|FG007|COMPLETED|Overall Study||6
3147597|NCT01782495|3873641|FG008|COMPLETED|Overall Study||3
3147598|NCT01782495|3873642|FG009|COMPLETED|Overall Study||2
3147599|NCT01782495|3873643|FG010|COMPLETED|Overall Study||1
3147600|NCT01782495|3873633|FG000|NOT COMPLETED|Overall Study||0
3147601|NCT01782495|3873634|FG001|NOT COMPLETED|Overall Study||1
3147602|NCT01782495|3873635|FG002|NOT COMPLETED|Overall Study||0
3147603|NCT01782495|3873636|FG003|NOT COMPLETED|Overall Study||0
3147604|NCT01782495|3873637|FG004|NOT COMPLETED|Overall Study||0
3147605|NCT01782495|3873638|FG005|NOT COMPLETED|Overall Study||0
3147606|NCT01782495|3873639|FG006|NOT COMPLETED|Overall Study||0
3147607|NCT01782495|3873640|FG007|NOT COMPLETED|Overall Study||3
3147608|NCT01782495|3873641|FG008|NOT COMPLETED|Overall Study||0
3147609|NCT01782495|3873642|FG009|NOT COMPLETED|Overall Study||0
3147610|NCT01782495|3873643|FG010|NOT COMPLETED|Overall Study||0
3147611|NCT01782664|3873673|FG000|STARTED|Overall Study||14
3147612|NCT01782664|3873674|FG001|STARTED|Overall Study||15
3147613|NCT01782664|3873675|FG002|STARTED|Overall Study||16
3147614|NCT01782664|3873676|FG003|STARTED|Overall Study||14
3147615|NCT01782664|3873677|FG004|STARTED|Overall Study||6
3147616|NCT01782664|3873678|FG005|STARTED|Overall Study||2
3147617|NCT01782664|3873673|FG000|COMPLETED|Overall Study||8
3147618|NCT01782664|3873674|FG001|COMPLETED|Overall Study||10
3147619|NCT01782664|3873675|FG002|COMPLETED|Overall Study||12
3147620|NCT01782664|3873676|FG003|COMPLETED|Overall Study||9
3147621|NCT01782664|3873677|FG004|COMPLETED|Overall Study||6
3147622|NCT01782664|3873678|FG005|COMPLETED|Overall Study||2
3147623|NCT01782664|3873673|FG000|NOT COMPLETED|Overall Study||6
3147624|NCT01782664|3873674|FG001|NOT COMPLETED|Overall Study||5
3147625|NCT01782664|3873675|FG002|NOT COMPLETED|Overall Study||4
3147626|NCT01782664|3873676|FG003|NOT COMPLETED|Overall Study||5
3147627|NCT01782664|3873677|FG004|NOT COMPLETED|Overall Study||0
3147628|NCT01782664|3873678|FG005|NOT COMPLETED|Overall Study||0
3147629|NCT01782690|3873692|FG000|STARTED|Overall Study||338
3147630|NCT01782690|3873692|FG000|COMPLETED|Overall Study||39
3147631|NCT01782690|3873692|FG000|NOT COMPLETED|Overall Study||299
3147632|NCT01782742|3873698|FG000|STARTED|Double-blind Treatment Phase||16
3147633|NCT01782742|3873699|FG001|STARTED|Double-blind Treatment Phase||4
3147634|NCT01782742|3873698|FG000|COMPLETED|Double-blind Treatment Phase||15
3147635|NCT01782742|3873699|FG001|COMPLETED|Double-blind Treatment Phase||4
3181823|NCT01998958|3910160|FG011|COMPLETED|Period 2 (Panel A and B)||5
3181824|NCT01998958|3910161|FG012|COMPLETED|Period 2 (Panel A and B)||8
3181825|NCT01998958|3910162|FG013|COMPLETED|Period 2 (Panel A and B)||11
3181826|NCT01998958|3910163|FG014|COMPLETED|Period 2 (Panel A and B)||10
3181827|NCT01998958|3910164|FG015|COMPLETED|Period 2 (Panel A and B)||5
3181828|NCT01998958|3910165|FG016|COMPLETED|Period 2 (Panel A and B)||8
3181829|NCT01998958|3910166|FG017|COMPLETED|Period 2 (Panel A and B)||5
3181830|NCT01998958|3910167|FG018|COMPLETED|Period 2 (Panel A and B)||2
3181831|NCT01998958|3910168|FG019|COMPLETED|Period 2 (Panel A and B)||11
3181832|NCT01998958|3910169|FG020|COMPLETED|Period 2 (Panel A and B)||9
3181833|NCT01998958|3910170|FG021|COMPLETED|Period 2 (Panel A and B)||0
3181834|NCT01998958|3910171|FG022|COMPLETED|Period 2 (Panel A and B)||0
3363582|NCT04054765|4094709|FG000|COMPLETED|Post-Gameplay / 1-week Follow up||142
3363583|NCT04054765|4094710|FG001|COMPLETED|Post-Gameplay / 1-week Follow up||126
3363584|NCT04054765|4094709|FG000|NOT COMPLETED|Post-Gameplay / 1-week Follow up||8
3363585|NCT04054765|4094710|FG001|NOT COMPLETED|Post-Gameplay / 1-week Follow up||3
3363586|NCT04054765|4094709|FG000|STARTED|3-month Follow up||142
3363587|NCT04054765|4094710|FG001|STARTED|3-month Follow up||126
3363588|NCT04054765|4094709|FG000|COMPLETED|3-month Follow up||142
3363589|NCT04054765|4094710|FG001|COMPLETED|3-month Follow up||123
3363590|NCT04054765|4094709|FG000|NOT COMPLETED|3-month Follow up||0
3363591|NCT04054765|4094710|FG001|NOT COMPLETED|3-month Follow up||3
3363592|NCT04054765|4094709|FG000|STARTED|6-month Follow up||142
3363593|NCT04054765|4094710|FG001|STARTED|6-month Follow up||123
3363594|NCT04054765|4094709|FG000|COMPLETED|6-month Follow up||110
3363595|NCT04054765|4094710|FG001|COMPLETED|6-month Follow up||91
3363596|NCT04054765|4094709|FG000|NOT COMPLETED|6-month Follow up||32
3363597|NCT04054765|4094710|FG001|NOT COMPLETED|6-month Follow up||32
3363598|NCT04054011|4094716|FG000|STARTED|Overall Study||15
3363599|NCT04054011|4094716|FG000|COMPLETED|Overall Study||12
3363600|NCT04054011|4094716|FG000|NOT COMPLETED|Overall Study||3
3363601|NCT04059094|4094727|FG000|STARTED|Overall Study||18
3363602|NCT04059094|4094728|FG001|STARTED|Overall Study||6
3147636|NCT01782742|3873698|FG000|NOT COMPLETED|Double-blind Treatment Phase||1
3147637|NCT01782742|3873699|FG001|NOT COMPLETED|Double-blind Treatment Phase||0
3147638|NCT01782742|3873698|FG000|STARTED|Open Label Phase||19
3363603|NCT04059094|4094729|FG002|STARTED|Overall Study||5
3363604|NCT04059094|4094730|FG003|STARTED|Overall Study||5
3363605|NCT04059094|4094731|FG004|STARTED|Overall Study||18
3147639|NCT01782742|3873699|FG001|STARTED|Open Label Phase||0
3147640|NCT01782742|3873698|FG000|COMPLETED|Open Label Phase||19
3147641|NCT01782742|3873699|FG001|COMPLETED|Open Label Phase||0
3147642|NCT01782742|3873698|FG000|NOT COMPLETED|Open Label Phase||0
3147643|NCT01782742|3873699|FG001|NOT COMPLETED|Open Label Phase||0
3147644|NCT01782833|3873707|FG000|STARTED|Overall Study||3635
3147645|NCT01782833|3873707|FG000|COMPLETED|Overall Study||3365
3147646|NCT01782833|3873707|FG000|NOT COMPLETED|Overall Study||270
3147647|NCT01782859|3873713|FG000|STARTED|Overall Study||20
3147648|NCT01782859|3873714|FG001|STARTED|Overall Study||20
3147649|NCT01782859|3873713|FG000|COMPLETED|Overall Study||14
3147650|NCT01782859|3873714|FG001|COMPLETED|Overall Study||13
3147651|NCT01782859|3873713|FG000|NOT COMPLETED|Overall Study||6
3147652|NCT01782859|3873714|FG001|NOT COMPLETED|Overall Study||7
3147653|NCT01782872|3873725|FG000|STARTED|Overall Study||20
3147654|NCT01782872|3873726|FG001|STARTED|Overall Study||20
3147655|NCT01782872|3873727|FG002|STARTED|Overall Study||20
3147656|NCT01782872|3873728|FG003|STARTED|Overall Study||20
3147657|NCT01782872|3873725|FG000|COMPLETED|Overall Study||20
3147658|NCT01782872|3873726|FG001|COMPLETED|Overall Study||19
3147659|NCT01782872|3873727|FG002|COMPLETED|Overall Study||20
3147660|NCT01782872|3873728|FG003|COMPLETED|Overall Study||19
3147661|NCT01782872|3873725|FG000|NOT COMPLETED|Overall Study||0
3147662|NCT01782872|3873726|FG001|NOT COMPLETED|Overall Study||1
3147663|NCT01782872|3873727|FG002|NOT COMPLETED|Overall Study||0
3147664|NCT01782872|3873728|FG003|NOT COMPLETED|Overall Study||1
3147665|NCT01782885|3873740|FG000|STARTED|Overall Study||36
3147666|NCT01782885|3873741|FG001|STARTED|Overall Study||39
3147667|NCT01782885|3873740|FG000|COMPLETED|Overall Study||32
3147668|NCT01782885|3873741|FG001|COMPLETED|Overall Study||33
3147669|NCT01782885|3873740|FG000|NOT COMPLETED|Overall Study||4
3147670|NCT01782885|3873741|FG001|NOT COMPLETED|Overall Study||6
3147671|NCT01782898|3873749|FG000|STARTED|Overall Study||35
3147672|NCT01782898|3873750|FG001|STARTED|Overall Study||35
3147673|NCT01782898|3873749|FG000|COMPLETED|Overall Study||29
3147674|NCT01782898|3873750|FG001|COMPLETED|Overall Study||29
3147675|NCT01782898|3873749|FG000|NOT COMPLETED|Overall Study||6
3147676|NCT01782898|3873750|FG001|NOT COMPLETED|Overall Study||6
3147677|NCT01782963|3873756|FG000|STARTED|Overall Study||50
3147678|NCT01782963|3873756|FG000|COMPLETED|Overall Study||50
3147679|NCT01782963|3873756|FG000|NOT COMPLETED|Overall Study||0
3147680|NCT01783054|3873764|FG000|STARTED|Overall Study||2
3147681|NCT01783054|3873764|FG000|COMPLETED|Overall Study||2
3147682|NCT01783054|3873764|FG000|NOT COMPLETED|Overall Study||0
3147683|NCT01783080|3873768|FG000|STARTED|Overall Study||16
3147684|NCT01783080|3873768|FG000|COMPLETED|Overall Study||16
3147685|NCT01783080|3873768|FG000|NOT COMPLETED|Overall Study||0
3147686|NCT01783236|3873774|FG000|STARTED|Overall Study||8
3147687|NCT01783236|3873775|FG001|STARTED|Overall Study||8
3147688|NCT01783236|3873774|FG000|COMPLETED|Overall Study||6
3147689|NCT01783236|3873775|FG001|COMPLETED|Overall Study||8
3147690|NCT01783236|3873774|FG000|NOT COMPLETED|Overall Study||2
3147691|NCT01783236|3873775|FG001|NOT COMPLETED|Overall Study||0
3147692|NCT01783418|3873783|FG000|STARTED|Overall Study||8
3147693|NCT01783418|3873784|FG001|STARTED|Overall Study||6
3147694|NCT01783418|3873783|FG000|COMPLETED|Overall Study||7
3147695|NCT01783418|3873784|FG001|COMPLETED|Overall Study||6
3147696|NCT01783418|3873783|FG000|NOT COMPLETED|Overall Study||1
3147697|NCT01783418|3873784|FG001|NOT COMPLETED|Overall Study||0
3147698|NCT01783444|3873793|FG000|STARTED|Treatment Phase||104
3147699|NCT01783444|3873794|FG001|STARTED|Treatment Phase||103
3147700|NCT01783444|3873795|FG002|STARTED|Treatment Phase||102
3147701|NCT01783444|3873793|FG000|Safety Set|Treatment Phase||104
3147702|NCT01783444|3873794|FG001|Safety Set|Treatment Phase||103
3147703|NCT01783444|3873795|FG002|Safety Set|Treatment Phase||102
3147704|NCT01783444|3873793|FG000|COMPLETED|Treatment Phase||0
3147705|NCT01783444|3873794|FG001|COMPLETED|Treatment Phase||0
3147706|NCT01783444|3873795|FG002|COMPLETED|Treatment Phase||0
3147707|NCT01783444|3873793|FG000|NOT COMPLETED|Treatment Phase||104
3147708|NCT01783444|3873794|FG001|NOT COMPLETED|Treatment Phase||103
3147709|NCT01783444|3873795|FG002|NOT COMPLETED|Treatment Phase||102
3147710|NCT01783444|3873793|FG000|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Follow-Up Phase|96
3147711|NCT01783444|3873794|FG001|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Follow-Up Phase|93
3147712|NCT01783444|3873795|FG002|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Follow-Up Phase|91
3147713|NCT01783444|3873793|FG000|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
3147714|NCT01783444|3873794|FG001|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
3147715|NCT01783444|3873795|FG002|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
3147716|NCT01783444|3873793|FG000|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||96
3147717|NCT01783444|3873794|FG001|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||93
3147718|NCT01783444|3873795|FG002|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||91
3147719|NCT01783470|3873804|FG000|STARTED|Overall Study||6
3147720|NCT01783470|3873805|FG001|STARTED|Overall Study|Single-dose|6
3147721|NCT01783470|3873804|FG000|COMPLETED|Overall Study||6
3147722|NCT01783470|3873805|FG001|COMPLETED|Overall Study||6
3147723|NCT01783470|3873804|FG000|NOT COMPLETED|Overall Study||0
3147724|NCT01783470|3873805|FG001|NOT COMPLETED|Overall Study||0
3147725|NCT01783483|3873814|FG000|STARTED|Overall Study||120
3147726|NCT01783483|3873815|FG001|STARTED|Overall Study||116
3147727|NCT01783483|3873814|FG000|COMPLETED|Overall Study||100
3147728|NCT01783483|3873815|FG001|COMPLETED|Overall Study||101
3147729|NCT01783483|3873814|FG000|NOT COMPLETED|Overall Study||20
3147730|NCT01783483|3873815|FG001|NOT COMPLETED|Overall Study||15
3147731|NCT01783496|3873827|FG000|STARTED|Overall Study||10
3147732|NCT01783496|3873828|FG001|STARTED|Overall Study||10
3147733|NCT01783496|3873829|FG002|STARTED|Overall Study||10
3147734|NCT01783496|3873830|FG003|STARTED|Overall Study||10
3147735|NCT01783496|3873831|FG004|STARTED|Overall Study||5
3147736|NCT01783496|3873832|FG005|STARTED|Overall Study||5
3147737|NCT01783496|3873827|FG000|COMPLETED|Overall Study||9
3181835|NCT01998958|3910172|FG023|COMPLETED|Period 2 (Panel A and B)||0
3181836|NCT01998958|3910173|FG024|COMPLETED|Period 2 (Panel A and B)||0
3181837|NCT01998958|3910174|FG025|COMPLETED|Period 2 (Panel A and B)||0
3181838|NCT01998958|3910175|FG026|COMPLETED|Period 2 (Panel A and B)||0
3181839|NCT01998958|3910176|FG027|COMPLETED|Period 2 (Panel A and B)||0
3181840|NCT01998958|3910177|FG028|COMPLETED|Period 2 (Panel A and B)||0
3181841|NCT01998958|3910178|FG029|COMPLETED|Period 2 (Panel A and B)||0
3181842|NCT01998958|3910179|FG030|COMPLETED|Period 2 (Panel A and B)||0
3181843|NCT01998958|3910180|FG031|COMPLETED|Period 2 (Panel A and B)||0
3181844|NCT01998958|3910149|FG000|NOT COMPLETED|Period 2 (Panel A and B)||0
3181845|NCT01998958|3910150|FG001|NOT COMPLETED|Period 2 (Panel A and B)||0
3181846|NCT01998958|3910151|FG002|NOT COMPLETED|Period 2 (Panel A and B)||0
3181847|NCT01998958|3910152|FG003|NOT COMPLETED|Period 2 (Panel A and B)||0
3181848|NCT01998958|3910153|FG004|NOT COMPLETED|Period 2 (Panel A and B)||0
3181849|NCT01998958|3910154|FG005|NOT COMPLETED|Period 2 (Panel A and B)||0
3181850|NCT01998958|3910155|FG006|NOT COMPLETED|Period 2 (Panel A and B)||0
3181851|NCT01998958|3910156|FG007|NOT COMPLETED|Period 2 (Panel A and B)||0
3181852|NCT01998958|3910157|FG008|NOT COMPLETED|Period 2 (Panel A and B)||0
3181853|NCT01998958|3910158|FG009|NOT COMPLETED|Period 2 (Panel A and B)||0
3181854|NCT01998958|3910159|FG010|NOT COMPLETED|Period 2 (Panel A and B)||1
3181855|NCT01998958|3910160|FG011|NOT COMPLETED|Period 2 (Panel A and B)||0
3181856|NCT01998958|3910161|FG012|NOT COMPLETED|Period 2 (Panel A and B)||0
3181857|NCT01998958|3910162|FG013|NOT COMPLETED|Period 2 (Panel A and B)||0
3181858|NCT01998958|3910163|FG014|NOT COMPLETED|Period 2 (Panel A and B)||2
3181859|NCT01998958|3910164|FG015|NOT COMPLETED|Period 2 (Panel A and B)||0
3181860|NCT01998958|3910165|FG016|NOT COMPLETED|Period 2 (Panel A and B)||0
3181861|NCT01998958|3910166|FG017|NOT COMPLETED|Period 2 (Panel A and B)||0
3181862|NCT01998958|3910167|FG018|NOT COMPLETED|Period 2 (Panel A and B)||1
3181863|NCT01998958|3910168|FG019|NOT COMPLETED|Period 2 (Panel A and B)||0
3181864|NCT01998958|3910169|FG020|NOT COMPLETED|Period 2 (Panel A and B)||0
3181865|NCT01998958|3910170|FG021|NOT COMPLETED|Period 2 (Panel A and B)||0
3181866|NCT01998958|3910171|FG022|NOT COMPLETED|Period 2 (Panel A and B)||0
3181867|NCT01998958|3910172|FG023|NOT COMPLETED|Period 2 (Panel A and B)||0
3181868|NCT01998958|3910173|FG024|NOT COMPLETED|Period 2 (Panel A and B)||0
3181869|NCT01998958|3910174|FG025|NOT COMPLETED|Period 2 (Panel A and B)||0
3181870|NCT01998958|3910175|FG026|NOT COMPLETED|Period 2 (Panel A and B)||0
3181871|NCT01998958|3910176|FG027|NOT COMPLETED|Period 2 (Panel A and B)||0
3181872|NCT01998958|3910177|FG028|NOT COMPLETED|Period 2 (Panel A and B)||0
3181873|NCT01998958|3910178|FG029|NOT COMPLETED|Period 2 (Panel A and B)||0
3181874|NCT01998958|3910179|FG030|NOT COMPLETED|Period 2 (Panel A and B)||0
3181875|NCT01998958|3910180|FG031|NOT COMPLETED|Period 2 (Panel A and B)||0
3181876|NCT01998958|3910149|FG000|STARTED|Open Label Phase (Optional)||0
3181877|NCT01998958|3910150|FG001|STARTED|Open Label Phase (Optional)||0
3181878|NCT01998958|3910151|FG002|STARTED|Open Label Phase (Optional)||0
3181879|NCT01998958|3910152|FG003|STARTED|Open Label Phase (Optional)||0
3181880|NCT01998958|3910153|FG004|STARTED|Open Label Phase (Optional)||0
3181881|NCT01998958|3910154|FG005|STARTED|Open Label Phase (Optional)||0
3181882|NCT01998958|3910155|FG006|STARTED|Open Label Phase (Optional)||0
3181883|NCT01998958|3910156|FG007|STARTED|Open Label Phase (Optional)||0
3181884|NCT01998958|3910157|FG008|STARTED|Open Label Phase (Optional)||0
3181885|NCT01998958|3910158|FG009|STARTED|Open Label Phase (Optional)||0
3181886|NCT01998958|3910159|FG010|STARTED|Open Label Phase (Optional)||0
3181887|NCT01998958|3910160|FG011|STARTED|Open Label Phase (Optional)||0
3181888|NCT01998958|3910161|FG012|STARTED|Open Label Phase (Optional)||0
3181889|NCT01998958|3910162|FG013|STARTED|Open Label Phase (Optional)||0
3181890|NCT01998958|3910163|FG014|STARTED|Open Label Phase (Optional)||0
3181891|NCT01998958|3910164|FG015|STARTED|Open Label Phase (Optional)||0
3181892|NCT01998958|3910165|FG016|STARTED|Open Label Phase (Optional)||0
3181893|NCT01998958|3910166|FG017|STARTED|Open Label Phase (Optional)||0
3181894|NCT01998958|3910167|FG018|STARTED|Open Label Phase (Optional)||0
3181895|NCT01998958|3910168|FG019|STARTED|Open Label Phase (Optional)||0
3181896|NCT01998958|3910169|FG020|STARTED|Open Label Phase (Optional)||0
3181897|NCT01998958|3910170|FG021|STARTED|Open Label Phase (Optional)||10
3181898|NCT01998958|3910171|FG022|STARTED|Open Label Phase (Optional)||20
3181899|NCT01998958|3910172|FG023|STARTED|Open Label Phase (Optional)||27
3181900|NCT01998958|3910173|FG024|STARTED|Open Label Phase (Optional)||13
3181901|NCT01998958|3910174|FG025|STARTED|Open Label Phase (Optional)||7
3181902|NCT01998958|3910175|FG026|STARTED|Open Label Phase (Optional)||19
3181903|NCT01998958|3910176|FG027|STARTED|Open Label Phase (Optional)||0
3181904|NCT01998958|3910177|FG028|STARTED|Open Label Phase (Optional)||0
3181905|NCT01998958|3910178|FG029|STARTED|Open Label Phase (Optional)||0
3181906|NCT01998958|3910179|FG030|STARTED|Open Label Phase (Optional)||0
3147738|NCT01783496|3873828|FG001|COMPLETED|Overall Study||10
3147739|NCT01783496|3873829|FG002|COMPLETED|Overall Study||10
3147740|NCT01783496|3873830|FG003|COMPLETED|Overall Study||8
3147741|NCT01783496|3873831|FG004|COMPLETED|Overall Study||5
3147742|NCT01783496|3873832|FG005|COMPLETED|Overall Study||4
3147743|NCT01783496|3873827|FG000|NOT COMPLETED|Overall Study||1
3147744|NCT01783496|3873828|FG001|NOT COMPLETED|Overall Study||0
3147745|NCT01783496|3873829|FG002|NOT COMPLETED|Overall Study||0
3147746|NCT01783496|3873830|FG003|NOT COMPLETED|Overall Study||2
3147747|NCT01783496|3873831|FG004|NOT COMPLETED|Overall Study||0
3147748|NCT01783496|3873832|FG005|NOT COMPLETED|Overall Study||1
3147749|NCT01783522|3873848|FG000|STARTED|Overall Study||4
3147750|NCT01783522|3873849|FG001|STARTED|Overall Study||5
3147751|NCT01783522|3873848|FG000|COMPLETED|Overall Study||4
3147752|NCT01783522|3873849|FG001|COMPLETED|Overall Study||5
3147753|NCT01783522|3873848|FG000|NOT COMPLETED|Overall Study||0
3147754|NCT01783522|3873849|FG001|NOT COMPLETED|Overall Study||0
3147755|NCT01783548|3873857|FG000|STARTED|Overall Study|Randomized|362
3147756|NCT01783548|3873858|FG001|STARTED|Overall Study|Randomized|185
3147757|NCT01783548|3873857|FG000|Full Analysis Set (FAS)|Overall Study||358
3147758|NCT01783548|3873858|FG001|Full Analysis Set (FAS)|Overall Study||184
3147759|NCT01783548|3873857|FG000|COMPLETED|Overall Study||328
3147760|NCT01783548|3873858|FG001|COMPLETED|Overall Study||167
3147761|NCT01783548|3873857|FG000|NOT COMPLETED|Overall Study||34
3147762|NCT01783548|3873858|FG001|NOT COMPLETED|Overall Study||18
3147763|NCT01783561|3873866|FG000|STARTED|Overall Study||11
3147764|NCT01783561|3873867|FG001|STARTED|Overall Study||10
3147765|NCT01783561|3873866|FG000|COMPLETED|Overall Study||11
3147766|NCT01783561|3873867|FG001|COMPLETED|Overall Study||10
3147767|NCT01783561|3873866|FG000|NOT COMPLETED|Overall Study||0
3147768|NCT01783561|3873867|FG001|NOT COMPLETED|Overall Study||0
3147769|NCT01783574|3873875|FG000|STARTED|Overall Study||51
3147770|NCT01783574|3873876|FG001|STARTED|Overall Study||50
3147771|NCT01783574|3873875|FG000|COMPLETED|Overall Study||46
3147772|NCT01783574|3873876|FG001|COMPLETED|Overall Study||41
3147773|NCT01783574|3873875|FG000|NOT COMPLETED|Overall Study||5
3147774|NCT01783574|3873876|FG001|NOT COMPLETED|Overall Study||9
3181907|NCT01998958|3910180|FG031|STARTED|Open Label Phase (Optional)||0
3181908|NCT01998958|3910149|FG000|COMPLETED|Open Label Phase (Optional)||0
3181909|NCT01998958|3910150|FG001|COMPLETED|Open Label Phase (Optional)||0
3181910|NCT01998958|3910151|FG002|COMPLETED|Open Label Phase (Optional)||0
3181911|NCT01998958|3910152|FG003|COMPLETED|Open Label Phase (Optional)||0
3181912|NCT01998958|3910153|FG004|COMPLETED|Open Label Phase (Optional)||0
3181913|NCT01998958|3910154|FG005|COMPLETED|Open Label Phase (Optional)||0
3181914|NCT01998958|3910155|FG006|COMPLETED|Open Label Phase (Optional)||0
3181915|NCT01998958|3910156|FG007|COMPLETED|Open Label Phase (Optional)||0
3181916|NCT01998958|3910157|FG008|COMPLETED|Open Label Phase (Optional)||0
3181917|NCT01998958|3910158|FG009|COMPLETED|Open Label Phase (Optional)||0
3181918|NCT01998958|3910159|FG010|COMPLETED|Open Label Phase (Optional)||0
3181919|NCT01998958|3910160|FG011|COMPLETED|Open Label Phase (Optional)||0
3181920|NCT01998958|3910161|FG012|COMPLETED|Open Label Phase (Optional)||0
3181921|NCT01998958|3910162|FG013|COMPLETED|Open Label Phase (Optional)||0
3181922|NCT01998958|3910163|FG014|COMPLETED|Open Label Phase (Optional)||0
3181923|NCT01998958|3910164|FG015|COMPLETED|Open Label Phase (Optional)||0
3181924|NCT01998958|3910165|FG016|COMPLETED|Open Label Phase (Optional)||0
3181925|NCT01998958|3910166|FG017|COMPLETED|Open Label Phase (Optional)||0
3181926|NCT01998958|3910167|FG018|COMPLETED|Open Label Phase (Optional)||0
3181927|NCT01998958|3910168|FG019|COMPLETED|Open Label Phase (Optional)||0
3181928|NCT01998958|3910169|FG020|COMPLETED|Open Label Phase (Optional)||0
3181929|NCT01998958|3910170|FG021|COMPLETED|Open Label Phase (Optional)||7
3181930|NCT01998958|3910171|FG022|COMPLETED|Open Label Phase (Optional)||11
3181931|NCT01998958|3910172|FG023|COMPLETED|Open Label Phase (Optional)||23
3181932|NCT01998958|3910173|FG024|COMPLETED|Open Label Phase (Optional)||13
3181933|NCT01998958|3910174|FG025|COMPLETED|Open Label Phase (Optional)||7
3181934|NCT01998958|3910175|FG026|COMPLETED|Open Label Phase (Optional)||19
3181935|NCT01998958|3910176|FG027|COMPLETED|Open Label Phase (Optional)||0
3181936|NCT01998958|3910177|FG028|COMPLETED|Open Label Phase (Optional)||0
3181937|NCT01998958|3910178|FG029|COMPLETED|Open Label Phase (Optional)||0
3181938|NCT01998958|3910179|FG030|COMPLETED|Open Label Phase (Optional)||0
3181939|NCT01998958|3910180|FG031|COMPLETED|Open Label Phase (Optional)||0
3181940|NCT01998958|3910149|FG000|NOT COMPLETED|Open Label Phase (Optional)||0
3181941|NCT01998958|3910150|FG001|NOT COMPLETED|Open Label Phase (Optional)||0
3181942|NCT01998958|3910151|FG002|NOT COMPLETED|Open Label Phase (Optional)||0
3181943|NCT01998958|3910152|FG003|NOT COMPLETED|Open Label Phase (Optional)||0
3181944|NCT01998958|3910153|FG004|NOT COMPLETED|Open Label Phase (Optional)||0
3181945|NCT01998958|3910154|FG005|NOT COMPLETED|Open Label Phase (Optional)||0
3181946|NCT01998958|3910155|FG006|NOT COMPLETED|Open Label Phase (Optional)||0
3181947|NCT01998958|3910156|FG007|NOT COMPLETED|Open Label Phase (Optional)||0
3181948|NCT01998958|3910157|FG008|NOT COMPLETED|Open Label Phase (Optional)||0
3181949|NCT01998958|3910158|FG009|NOT COMPLETED|Open Label Phase (Optional)||0
3181950|NCT01998958|3910159|FG010|NOT COMPLETED|Open Label Phase (Optional)||0
3181951|NCT01998958|3910160|FG011|NOT COMPLETED|Open Label Phase (Optional)||0
3181952|NCT01998958|3910161|FG012|NOT COMPLETED|Open Label Phase (Optional)||0
3181953|NCT01998958|3910162|FG013|NOT COMPLETED|Open Label Phase (Optional)||0
3181954|NCT01998958|3910163|FG014|NOT COMPLETED|Open Label Phase (Optional)||0
3147775|NCT01783639|3873882|FG000|STARTED|Overall Study||120
3147776|NCT01783639|3873882|FG000|COMPLETED|Overall Study||120
3147777|NCT01783639|3873882|FG000|NOT COMPLETED|Overall Study||0
3147778|NCT01783678|3873892|FG000|STARTED|Overall Study||19
3147779|NCT01783678|3873893|FG001|STARTED|Overall Study||112
3147780|NCT01783678|3873894|FG002|STARTED|Overall Study||6
3147781|NCT01783678|3873895|FG003|STARTED|Overall Study||58
3147782|NCT01783678|3873896|FG004|STARTED|Overall Study||49
3147783|NCT01783678|3873897|FG005|STARTED|Overall Study||31
3147784|NCT01783678|3873892|FG000|COMPLETED|Overall Study||17
3147785|NCT01783678|3873893|FG001|COMPLETED|Overall Study||94
3147786|NCT01783678|3873894|FG002|COMPLETED|Overall Study||5
3147787|NCT01783678|3873895|FG003|COMPLETED|Overall Study||50
3147788|NCT01783678|3873896|FG004|COMPLETED|Overall Study||42
3147789|NCT01783678|3873897|FG005|COMPLETED|Overall Study||26
3147790|NCT01783678|3873892|FG000|NOT COMPLETED|Overall Study||2
3147791|NCT01783678|3873893|FG001|NOT COMPLETED|Overall Study||18
3147792|NCT01783678|3873894|FG002|NOT COMPLETED|Overall Study||1
3147793|NCT01783678|3873895|FG003|NOT COMPLETED|Overall Study||8
3147794|NCT01783678|3873896|FG004|NOT COMPLETED|Overall Study||7
3147795|NCT01783678|3873897|FG005|NOT COMPLETED|Overall Study||5
3147796|NCT01783730|3873912|FG000|STARTED|Overall Study||163
3147797|NCT01783730|3873912|FG000|COMPLETED|Overall Study||157
3147798|NCT01783730|3873912|FG000|NOT COMPLETED|Overall Study||6
3147799|NCT01783743|3873918|FG000|STARTED|Screening of Subjects by CTA During MDA||13509
3147800|NCT01783743|3873919|FG001|STARTED|Screening of Subjects by CTA During MDA||13964
3147801|NCT01783743|3873918|FG000|COMPLETED|Screening of Subjects by CTA During MDA||10082
3147802|NCT01783743|3873919|FG001|COMPLETED|Screening of Subjects by CTA During MDA||9525
3147803|NCT01783743|3873918|FG000|NOT COMPLETED|Screening of Subjects by CTA During MDA||3427
3147804|NCT01783743|3873919|FG001|NOT COMPLETED|Screening of Subjects by CTA During MDA||4439
3147805|NCT01783743|3873918|FG000|STARTED|Rescreening of Subjects by Senior Grader||13509
3147806|NCT01783743|3873919|FG001|STARTED|Rescreening of Subjects by Senior Grader||13964
3147807|NCT01783743|3873918|FG000|TT Positive Cases Screened by CTA|Rescreening of Subjects by Senior Grader||46
3147808|NCT01783743|3873919|FG001|TT Positive Cases Screened by CTA|Rescreening of Subjects by Senior Grader||409
3147809|NCT01783743|3873918|FG000|Random Sample From Non TT Cases by CTA|Rescreening of Subjects by Senior Grader||1721
3147810|NCT01783743|3873919|FG001|Random Sample From Non TT Cases by CTA|Rescreening of Subjects by Senior Grader||1786
3147811|NCT01783743|3873918|FG000|Random Sample From Subject Absent at MDA|Rescreening of Subjects by Senior Grader||846
3147812|NCT01783743|3873919|FG001|Random Sample From Subject Absent at MDA|Rescreening of Subjects by Senior Grader||849
3147813|NCT01783743|3873918|FG000|COMPLETED|Rescreening of Subjects by Senior Grader||2613
3147814|NCT01783743|3873919|FG001|COMPLETED|Rescreening of Subjects by Senior Grader||3044
3147815|NCT01783743|3873918|FG000|NOT COMPLETED|Rescreening of Subjects by Senior Grader||10896
3147816|NCT01783743|3873919|FG001|NOT COMPLETED|Rescreening of Subjects by Senior Grader||10920
3147817|NCT01783821|3873927|FG000|STARTED|Overall Study||30
3147818|NCT01783821|3873928|FG001|STARTED|Overall Study||31
3147819|NCT01783821|3873927|FG000|COMPLETED|Overall Study||29
3147820|NCT01783821|3873928|FG001|COMPLETED|Overall Study||30
3147821|NCT01783821|3873927|FG000|NOT COMPLETED|Overall Study||1
3147822|NCT01783821|3873928|FG001|NOT COMPLETED|Overall Study||1
3147823|NCT01783847|3873937|FG000|STARTED|Overall Study||85
3147824|NCT01783847|3873938|FG001|STARTED|Overall Study||16
3147825|NCT01783847|3873939|FG002|STARTED|Overall Study||16
3147826|NCT01783847|3873937|FG000|COMPLETED|Overall Study||69
3147827|NCT01783847|3873938|FG001|COMPLETED|Overall Study||15
3147828|NCT01783847|3873939|FG002|COMPLETED|Overall Study||16
3147829|NCT01783847|3873937|FG000|NOT COMPLETED|Overall Study||16
3147830|NCT01783847|3873938|FG001|NOT COMPLETED|Overall Study||1
3147831|NCT01783847|3873939|FG002|NOT COMPLETED|Overall Study||0
3147832|NCT01783860|3873952|FG000|STARTED|Overall Study||50
3147833|NCT01783860|3873953|FG001|STARTED|Overall Study||50
3147834|NCT01783860|3873952|FG000|COMPLETED|Overall Study||50
3147835|NCT01783860|3873953|FG001|COMPLETED|Overall Study||50
3147836|NCT01783860|3873952|FG000|NOT COMPLETED|Overall Study||0
3181955|NCT01998958|3910164|FG015|NOT COMPLETED|Open Label Phase (Optional)||0
3181956|NCT01998958|3910165|FG016|NOT COMPLETED|Open Label Phase (Optional)||0
3181957|NCT01998958|3910166|FG017|NOT COMPLETED|Open Label Phase (Optional)||0
3181958|NCT01998958|3910167|FG018|NOT COMPLETED|Open Label Phase (Optional)||0
3181959|NCT01998958|3910168|FG019|NOT COMPLETED|Open Label Phase (Optional)||0
3181960|NCT01998958|3910169|FG020|NOT COMPLETED|Open Label Phase (Optional)||0
3181961|NCT01998958|3910170|FG021|NOT COMPLETED|Open Label Phase (Optional)||3
3181962|NCT01998958|3910171|FG022|NOT COMPLETED|Open Label Phase (Optional)||9
3181963|NCT01998958|3910172|FG023|NOT COMPLETED|Open Label Phase (Optional)||4
3181964|NCT01998958|3910173|FG024|NOT COMPLETED|Open Label Phase (Optional)||0
3181965|NCT01998958|3910174|FG025|NOT COMPLETED|Open Label Phase (Optional)||0
3181966|NCT01998958|3910175|FG026|NOT COMPLETED|Open Label Phase (Optional)||0
3181967|NCT01998958|3910176|FG027|NOT COMPLETED|Open Label Phase (Optional)||0
3181968|NCT01998958|3910177|FG028|NOT COMPLETED|Open Label Phase (Optional)||0
3181969|NCT01998958|3910178|FG029|NOT COMPLETED|Open Label Phase (Optional)||0
3181970|NCT01998958|3910179|FG030|NOT COMPLETED|Open Label Phase (Optional)||0
3181971|NCT01998958|3910180|FG031|NOT COMPLETED|Open Label Phase (Optional)||0
3181972|NCT01998958|3910149|FG000|STARTED|Follow-up Phase||0
3181973|NCT01998958|3910150|FG001|STARTED|Follow-up Phase||0
3181974|NCT01998958|3910151|FG002|STARTED|Follow-up Phase||0
3181975|NCT01998958|3910152|FG003|STARTED|Follow-up Phase||0
3181976|NCT01998958|3910153|FG004|STARTED|Follow-up Phase||0
3147837|NCT01783860|3873953|FG001|NOT COMPLETED|Overall Study||0
3147838|NCT01783886|3873962|FG000|STARTED|Overall Study||127
3147839|NCT01783886|3873963|FG001|STARTED|Overall Study||127
3147840|NCT01783886|3873964|FG002|STARTED|Overall Study||127
3147841|NCT01783886|3873962|FG000|Participants Received Treatment|Overall Study||127
3147842|NCT01783886|3873963|FG001|Participants Received Treatment|Overall Study||127
3147843|NCT01783886|3873964|FG002|Participants Received Treatment|Overall Study||124
3147844|NCT01783886|3873962|FG000|COMPLETED|Overall Study||122
3147845|NCT01783886|3873963|FG001|COMPLETED|Overall Study||116
3147846|NCT01783886|3873964|FG002|COMPLETED|Overall Study||117
3147847|NCT01783886|3873962|FG000|NOT COMPLETED|Overall Study||5
3147848|NCT01783886|3873963|FG001|NOT COMPLETED|Overall Study||11
3147849|NCT01783886|3873964|FG002|NOT COMPLETED|Overall Study||10
3147850|NCT01783912|3873975|FG000|STARTED|Overall Study||118
3147851|NCT01783912|3873976|FG001|STARTED|Overall Study||104
3147852|NCT01783912|3873977|FG002|STARTED|Overall Study||48
3147853|NCT01783912|3873975|FG000|COMPLETED|Overall Study||88
3147854|NCT01783912|3873976|FG001|COMPLETED|Overall Study||58
3147855|NCT01783912|3873977|FG002|COMPLETED|Overall Study||25
3147856|NCT01783912|3873975|FG000|NOT COMPLETED|Overall Study||30
3147857|NCT01783912|3873976|FG001|NOT COMPLETED|Overall Study||46
3147858|NCT01783912|3873977|FG002|NOT COMPLETED|Overall Study||23
3147859|NCT01783938|3873987|FG000|STARTED|Overall Study||68
3147860|NCT01783938|3873988|FG001|STARTED|Overall Study||70
3147861|NCT01783938|3873987|FG000|COMPLETED|Overall Study||11
3147862|NCT01783938|3873988|FG001|COMPLETED|Overall Study||9
3147863|NCT01783938|3873987|FG000|NOT COMPLETED|Overall Study||57
3147864|NCT01783938|3873988|FG001|NOT COMPLETED|Overall Study||61
3147865|NCT01783990|3873996|FG000|STARTED|Overall Study||130
3147866|NCT01783990|3873997|FG001|STARTED|Overall Study||20
3147867|NCT01783990|3873996|FG000|COMPLETED|Overall Study||125
3147868|NCT01783990|3873997|FG001|COMPLETED|Overall Study||18
3147869|NCT01783990|3873996|FG000|NOT COMPLETED|Overall Study||5
3147870|NCT01783990|3873997|FG001|NOT COMPLETED|Overall Study||2
3147871|NCT01784029|3874008|FG000|STARTED|Overall Study||61
3147872|NCT01784029|3874009|FG001|STARTED|Overall Study||59
3147873|NCT01784029|3874010|FG002|STARTED|Overall Study||63
3147874|NCT01784029|3874008|FG000|COMPLETED|Overall Study||42
3147875|NCT01784029|3874009|FG001|COMPLETED|Overall Study||39
3147876|NCT01784029|3874010|FG002|COMPLETED|Overall Study||41
3147877|NCT01784029|3874008|FG000|NOT COMPLETED|Overall Study||19
3147878|NCT01784029|3874009|FG001|NOT COMPLETED|Overall Study||20
3147879|NCT01784029|3874010|FG002|NOT COMPLETED|Overall Study||22
3147880|NCT01784055|3874018|FG000|STARTED|Overall Study||126
3147881|NCT01784055|3874018|FG000|COMPLETED|Overall Study||100
3147882|NCT01784055|3874018|FG000|NOT COMPLETED|Overall Study||26
3147883|NCT01784068|3874022|FG000|STARTED|NTCS Phase||215
3147884|NCT01784068|3874023|FG001|STARTED|NTCS Phase||0
3147885|NCT01784068|3874022|FG000|NTRI Phase|NTCS Phase||86
3147886|NCT01784068|3874023|FG001|NTRI Phase|NTCS Phase||0
3147887|NCT01784068|3874022|FG000|NTCT Phase|NTCS Phase||13
3147888|NCT01784068|3874023|FG001|NTCT Phase|NTCS Phase||0
3147889|NCT01784068|3874022|FG000|TFR-2 Phase|NTCS Phase||8
3147890|NCT01784068|3874023|FG001|TFR-2 Phase|NTCS Phase||0
3147891|NCT01784068|3874022|FG000|NTCT-P Phase|NTCS Phase||2
3147892|NCT01784068|3874023|FG001|NTCT-P Phase|NTCS Phase||0
3147893|NCT01784068|3874022|FG000|NTRI-2|NTCS Phase||0
3147894|NCT01784068|3874023|FG001|NTRI-2|NTCS Phase||0
3147895|NCT01784068|3874022|FG000|COMPLETED|NTCS Phase||0
3147896|NCT01784068|3874023|FG001|COMPLETED|NTCS Phase||0
3147897|NCT01784068|3874022|FG000|NOT COMPLETED|NTCS Phase||215
3147898|NCT01784068|3874023|FG001|NOT COMPLETED|NTCS Phase||0
3147899|NCT01784068|3874022|FG000|STARTED|TFR Phase||0
3147900|NCT01784068|3874023|FG001|STARTED|TFR Phase||190
3147901|NCT01784068|3874022|FG000|COMPLETED|TFR Phase||0
3147902|NCT01784068|3874023|FG001|COMPLETED|TFR Phase||97
3147903|NCT01784068|3874022|FG000|NOT COMPLETED|TFR Phase||0
3147904|NCT01784068|3874023|FG001|NOT COMPLETED|TFR Phase||93
3147905|NCT01784211|3874036|FG000|STARTED|Part A (Days 1-15)||38
3147906|NCT01784211|3874037|FG001|STARTED|Part A (Days 1-15)||38
3147907|NCT01784211|3874038|FG002|STARTED|Part A (Days 1-15)||0
3147908|NCT01784211|3874039|FG003|STARTED|Part A (Days 1-15)||0
3147909|NCT01784211|3874040|FG004|STARTED|Part A (Days 1-15)||0
3147910|NCT01784211|3874041|FG005|STARTED|Part A (Days 1-15)||0
3147911|NCT01784211|3874036|FG000|Received at Least 1 Dose of Study Drug|Part A (Days 1-15)||37
3147912|NCT01784211|3874037|FG001|Received at Least 1 Dose of Study Drug|Part A (Days 1-15)||38
3147913|NCT01784211|3874038|FG002|Received at Least 1 Dose of Study Drug|Part A (Days 1-15)||0
3147914|NCT01784211|3874039|FG003|Received at Least 1 Dose of Study Drug|Part A (Days 1-15)||0
3147915|NCT01784211|3874040|FG004|Received at Least 1 Dose of Study Drug|Part A (Days 1-15)||0
3147916|NCT01784211|3874041|FG005|Received at Least 1 Dose of Study Drug|Part A (Days 1-15)||0
3147917|NCT01784211|3874036|FG000|Entered Part B|Part A (Days 1-15)|Participants who completed Part A and met certain criteria had the option of continuing to Part B.|19
3147918|NCT01784211|3874037|FG001|Entered Part B|Part A (Days 1-15)|Participants who completed Part A and met certain criteria had the option of continuing to Part B.|21
3147919|NCT01784211|3874038|FG002|Entered Part B|Part A (Days 1-15)||0
3147920|NCT01784211|3874039|FG003|Entered Part B|Part A (Days 1-15)||0
3147921|NCT01784211|3874040|FG004|Entered Part B|Part A (Days 1-15)||0
3147922|NCT01784211|3874041|FG005|Entered Part B|Part A (Days 1-15)||0
3147923|NCT01784211|3874036|FG000|COMPLETED|Part A (Days 1-15)||35
3147924|NCT01784211|3874037|FG001|COMPLETED|Part A (Days 1-15)||36
3147925|NCT01784211|3874038|FG002|COMPLETED|Part A (Days 1-15)||0
3147926|NCT01784211|3874039|FG003|COMPLETED|Part A (Days 1-15)||0
3147927|NCT01784211|3874040|FG004|COMPLETED|Part A (Days 1-15)||0
3147928|NCT01784211|3874041|FG005|COMPLETED|Part A (Days 1-15)||0
3147929|NCT01784211|3874036|FG000|NOT COMPLETED|Part A (Days 1-15)||3
3147930|NCT01784211|3874037|FG001|NOT COMPLETED|Part A (Days 1-15)||2
3147931|NCT01784211|3874038|FG002|NOT COMPLETED|Part A (Days 1-15)||0
3147932|NCT01784211|3874039|FG003|NOT COMPLETED|Part A (Days 1-15)||0
3181977|NCT01998958|3910154|FG005|STARTED|Follow-up Phase||0
3181978|NCT01998958|3910155|FG006|STARTED|Follow-up Phase||0
3181979|NCT01998958|3910156|FG007|STARTED|Follow-up Phase||0
3181980|NCT01998958|3910157|FG008|STARTED|Follow-up Phase||0
3181981|NCT01998958|3910158|FG009|STARTED|Follow-up Phase||0
3181982|NCT01998958|3910159|FG010|STARTED|Follow-up Phase||0
3181983|NCT01998958|3910160|FG011|STARTED|Follow-up Phase||0
3181984|NCT01998958|3910161|FG012|STARTED|Follow-up Phase||0
3181985|NCT01998958|3910162|FG013|STARTED|Follow-up Phase||0
3181986|NCT01998958|3910163|FG014|STARTED|Follow-up Phase||0
3181987|NCT01998958|3910164|FG015|STARTED|Follow-up Phase||0
3181988|NCT01998958|3910165|FG016|STARTED|Follow-up Phase||0
3181989|NCT01998958|3910166|FG017|STARTED|Follow-up Phase||0
3181990|NCT01998958|3910167|FG018|STARTED|Follow-up Phase||0
3181991|NCT01998958|3910168|FG019|STARTED|Follow-up Phase||0
3181992|NCT01998958|3910169|FG020|STARTED|Follow-up Phase||0
3181993|NCT01998958|3910170|FG021|STARTED|Follow-up Phase||0
3181994|NCT01998958|3910171|FG022|STARTED|Follow-up Phase||0
3181995|NCT01998958|3910172|FG023|STARTED|Follow-up Phase||0
3181996|NCT01998958|3910173|FG024|STARTED|Follow-up Phase||0
3181997|NCT01998958|3910174|FG025|STARTED|Follow-up Phase||0
3181998|NCT01998958|3910175|FG026|STARTED|Follow-up Phase||0
3181999|NCT01998958|3910176|FG027|STARTED|Follow-up Phase||1
3182000|NCT01998958|3910177|FG028|STARTED|Follow-up Phase||4
3182001|NCT01998958|3910178|FG029|STARTED|Follow-up Phase||12
3182002|NCT01998958|3910179|FG030|STARTED|Follow-up Phase||39
3182003|NCT01998958|3910180|FG031|STARTED|Follow-up Phase||42
3182004|NCT01998958|3910149|FG000|COMPLETED|Follow-up Phase||0
3182005|NCT01998958|3910150|FG001|COMPLETED|Follow-up Phase||0
3182006|NCT01998958|3910151|FG002|COMPLETED|Follow-up Phase||0
3182007|NCT01998958|3910152|FG003|COMPLETED|Follow-up Phase||0
3182008|NCT01998958|3910153|FG004|COMPLETED|Follow-up Phase||0
3182009|NCT01998958|3910154|FG005|COMPLETED|Follow-up Phase||0
3182010|NCT01998958|3910155|FG006|COMPLETED|Follow-up Phase||0
3182011|NCT01998958|3910156|FG007|COMPLETED|Follow-up Phase||0
3182012|NCT01998958|3910157|FG008|COMPLETED|Follow-up Phase||0
3182013|NCT01998958|3910158|FG009|COMPLETED|Follow-up Phase||0
3182014|NCT01998958|3910159|FG010|COMPLETED|Follow-up Phase||0
3182015|NCT01998958|3910160|FG011|COMPLETED|Follow-up Phase||0
3182016|NCT01998958|3910161|FG012|COMPLETED|Follow-up Phase||0
3182017|NCT01998958|3910162|FG013|COMPLETED|Follow-up Phase||0
3182018|NCT01998958|3910163|FG014|COMPLETED|Follow-up Phase||0
3363606|NCT04059094|4094727|FG000|COMPLETED|Overall Study||18
3363607|NCT04059094|4094728|FG001|COMPLETED|Overall Study||4
3363608|NCT04059094|4094729|FG002|COMPLETED|Overall Study||5
3363609|NCT04059094|4094730|FG003|COMPLETED|Overall Study||5
3363610|NCT04059094|4094731|FG004|COMPLETED|Overall Study||17
3363611|NCT04059094|4094727|FG000|NOT COMPLETED|Overall Study||0
3363612|NCT04059094|4094728|FG001|NOT COMPLETED|Overall Study||2
3363613|NCT04059094|4094729|FG002|NOT COMPLETED|Overall Study||0
3363614|NCT04059094|4094730|FG003|NOT COMPLETED|Overall Study||0
3363615|NCT04059094|4094731|FG004|NOT COMPLETED|Overall Study||1
3363616|NCT04051684|4094749|FG000|STARTED|Overall Study||12
3363617|NCT04051684|4094750|FG001|STARTED|Overall Study||11
3363618|NCT04051684|4094749|FG000|COMPLETED|Overall Study||12
3363619|NCT04051684|4094750|FG001|COMPLETED|Overall Study||11
3363620|NCT04051684|4094749|FG000|NOT COMPLETED|Overall Study||0
3363621|NCT04051684|4094750|FG001|NOT COMPLETED|Overall Study||0
3363622|NCT04046341|4094756|FG000|STARTED|Overall Study||15
3363623|NCT04046341|4094756|FG000|COMPLETED|Overall Study||12
3363624|NCT04046341|4094756|FG000|NOT COMPLETED|Overall Study||3
3363625|NCT04045964|4094762|FG000|STARTED|Overall Study||16
3147933|NCT01784211|3874040|FG004|NOT COMPLETED|Part A (Days 1-15)||0
3147934|NCT01784211|3874041|FG005|NOT COMPLETED|Part A (Days 1-15)||0
3147935|NCT01784211|3874036|FG000|STARTED|Part B (Days 16-21)|Participants who completed Part A and met certain criteria had the option of continuing to Part B.|0
3147936|NCT01784211|3874037|FG001|STARTED|Part B (Days 16-21)|Participants who completed Part A and met certain criteria had the option of continuing to Part B.|0
3147937|NCT01784211|3874038|FG002|STARTED|Part B (Days 16-21)||10
3147938|NCT01784211|3874039|FG003|STARTED|Part B (Days 16-21)||9
3147939|NCT01784211|3874040|FG004|STARTED|Part B (Days 16-21)||11
3147940|NCT01784211|3874041|FG005|STARTED|Part B (Days 16-21)||10
3147941|NCT01784211|3874036|FG000|COMPLETED|Part B (Days 16-21)||0
3147942|NCT01784211|3874037|FG001|COMPLETED|Part B (Days 16-21)||0
3147943|NCT01784211|3874038|FG002|COMPLETED|Part B (Days 16-21)||10
3147944|NCT01784211|3874039|FG003|COMPLETED|Part B (Days 16-21)||9
3147945|NCT01784211|3874040|FG004|COMPLETED|Part B (Days 16-21)||11
3147946|NCT01784211|3874041|FG005|COMPLETED|Part B (Days 16-21)||10
3147947|NCT01784211|3874036|FG000|NOT COMPLETED|Part B (Days 16-21)||0
3147948|NCT01784211|3874037|FG001|NOT COMPLETED|Part B (Days 16-21)||0
3182019|NCT01998958|3910164|FG015|COMPLETED|Follow-up Phase||0
3182020|NCT01998958|3910165|FG016|COMPLETED|Follow-up Phase||0
3182021|NCT01998958|3910166|FG017|COMPLETED|Follow-up Phase||0
3182022|NCT01998958|3910167|FG018|COMPLETED|Follow-up Phase||0
3182023|NCT01998958|3910168|FG019|COMPLETED|Follow-up Phase||0
3147949|NCT01784211|3874038|FG002|NOT COMPLETED|Part B (Days 16-21)||0
3147950|NCT01784211|3874039|FG003|NOT COMPLETED|Part B (Days 16-21)||0
3147951|NCT01784211|3874040|FG004|NOT COMPLETED|Part B (Days 16-21)||0
3147952|NCT01784211|3874041|FG005|NOT COMPLETED|Part B (Days 16-21)||0
3147953|NCT01784419|3874053|FG000|STARTED|Overall Study||10
3147954|NCT01784419|3874053|FG000|COMPLETED|Overall Study||7
3147955|NCT01784419|3874053|FG000|NOT COMPLETED|Overall Study||3
3147956|NCT01784523|3874059|FG000|STARTED|Overall Study||7
3147957|NCT01784523|3874060|FG001|STARTED|Overall Study||4
3147958|NCT01784523|3874059|FG000|COMPLETED|Overall Study||0
3147959|NCT01784523|3874060|FG001|COMPLETED|Overall Study||0
3147960|NCT01784523|3874059|FG000|NOT COMPLETED|Overall Study||7
3147961|NCT01784523|3874060|FG001|NOT COMPLETED|Overall Study||4
3147962|NCT01784588|3874068|FG000|STARTED|Overall Study||141
3147963|NCT01784588|3874069|FG001|STARTED|Overall Study||140
3147964|NCT01784588|3874068|FG000|COMPLETED|Overall Study||104
3147965|NCT01784588|3874069|FG001|COMPLETED|Overall Study||108
3147966|NCT01784588|3874068|FG000|NOT COMPLETED|Overall Study||37
3147967|NCT01784588|3874069|FG001|NOT COMPLETED|Overall Study||32
3147968|NCT01784614|3874075|FG000|STARTED|Period 1||3
3147969|NCT01784614|3874076|FG001|STARTED|Period 1||3
3147970|NCT01784614|3874077|FG002|STARTED|Period 1||3
3147971|NCT01784614|3874078|FG003|STARTED|Period 1||3
3147972|NCT01784614|3874079|FG004|STARTED|Period 1||3
3147973|NCT01784614|3874080|FG005|STARTED|Period 1||3
3147974|NCT01784614|3874081|FG006|STARTED|Period 1||3
3147975|NCT01784614|3874082|FG007|STARTED|Period 1||3
3147976|NCT01784614|3874075|FG000|Received at Least 1 Dose of Study Drug|Period 1||3
3147977|NCT01784614|3874076|FG001|Received at Least 1 Dose of Study Drug|Period 1||3
3147978|NCT01784614|3874077|FG002|Received at Least 1 Dose of Study Drug|Period 1||3
3147979|NCT01784614|3874078|FG003|Received at Least 1 Dose of Study Drug|Period 1||3
3147980|NCT01784614|3874079|FG004|Received at Least 1 Dose of Study Drug|Period 1||3
3147981|NCT01784614|3874080|FG005|Received at Least 1 Dose of Study Drug|Period 1||3
3147982|NCT01784614|3874081|FG006|Received at Least 1 Dose of Study Drug|Period 1||3
3147983|NCT01784614|3874082|FG007|Received at Least 1 Dose of Study Drug|Period 1||3
3147984|NCT01784614|3874075|FG000|COMPLETED|Period 1||3
3147985|NCT01784614|3874076|FG001|COMPLETED|Period 1||3
3147986|NCT01784614|3874077|FG002|COMPLETED|Period 1||3
3147987|NCT01784614|3874078|FG003|COMPLETED|Period 1||3
3147988|NCT01784614|3874079|FG004|COMPLETED|Period 1||3
3147989|NCT01784614|3874080|FG005|COMPLETED|Period 1||3
3147990|NCT01784614|3874081|FG006|COMPLETED|Period 1||3
3147991|NCT01784614|3874082|FG007|COMPLETED|Period 1|One participant withdrew consent after completed Period 1 and did not enter Period 2.|3
3147992|NCT01784614|3874075|FG000|NOT COMPLETED|Period 1||0
3147993|NCT01784614|3874076|FG001|NOT COMPLETED|Period 1||0
3147994|NCT01784614|3874077|FG002|NOT COMPLETED|Period 1||0
3147995|NCT01784614|3874078|FG003|NOT COMPLETED|Period 1||0
3147996|NCT01784614|3874079|FG004|NOT COMPLETED|Period 1||0
3147997|NCT01784614|3874080|FG005|NOT COMPLETED|Period 1||0
3147998|NCT01784614|3874081|FG006|NOT COMPLETED|Period 1||0
3147999|NCT01784614|3874082|FG007|NOT COMPLETED|Period 1||0
3148000|NCT01784614|3874075|FG000|STARTED|Period 2||3
3148001|NCT01784614|3874076|FG001|STARTED|Period 2||3
3148002|NCT01784614|3874077|FG002|STARTED|Period 2||3
3148003|NCT01784614|3874078|FG003|STARTED|Period 2||3
3148004|NCT01784614|3874079|FG004|STARTED|Period 2||3
3148005|NCT01784614|3874080|FG005|STARTED|Period 2||3
3148006|NCT01784614|3874081|FG006|STARTED|Period 2||3
3148007|NCT01784614|3874082|FG007|STARTED|Period 2||2
3148008|NCT01784614|3874075|FG000|COMPLETED|Period 2||3
3148009|NCT01784614|3874076|FG001|COMPLETED|Period 2|One participant withdrew consent after completed Period 2 and did not enter Period 3.|3
3148010|NCT01784614|3874077|FG002|COMPLETED|Period 2||3
3148011|NCT01784614|3874078|FG003|COMPLETED|Period 2||3
3148012|NCT01784614|3874079|FG004|COMPLETED|Period 2||3
3148013|NCT01784614|3874080|FG005|COMPLETED|Period 2||3
3148014|NCT01784614|3874081|FG006|COMPLETED|Period 2||3
3148015|NCT01784614|3874082|FG007|COMPLETED|Period 2||2
3148016|NCT01784614|3874075|FG000|NOT COMPLETED|Period 2||0
3148017|NCT01784614|3874076|FG001|NOT COMPLETED|Period 2||0
3148018|NCT01784614|3874077|FG002|NOT COMPLETED|Period 2||0
3148019|NCT01784614|3874078|FG003|NOT COMPLETED|Period 2||0
3148020|NCT01784614|3874079|FG004|NOT COMPLETED|Period 2||0
3148021|NCT01784614|3874080|FG005|NOT COMPLETED|Period 2||0
3148022|NCT01784614|3874081|FG006|NOT COMPLETED|Period 2||0
3148023|NCT01784614|3874082|FG007|NOT COMPLETED|Period 2||0
3148024|NCT01784614|3874075|FG000|STARTED|Period 3||3
3148025|NCT01784614|3874076|FG001|STARTED|Period 3||2
3148026|NCT01784614|3874077|FG002|STARTED|Period 3||3
3148027|NCT01784614|3874078|FG003|STARTED|Period 3||3
3148028|NCT01784614|3874079|FG004|STARTED|Period 3||3
3182024|NCT01998958|3910169|FG020|COMPLETED|Follow-up Phase||0
3182025|NCT01998958|3910170|FG021|COMPLETED|Follow-up Phase||0
3182026|NCT01998958|3910171|FG022|COMPLETED|Follow-up Phase||0
3148029|NCT01784614|3874080|FG005|STARTED|Period 3||3
3148030|NCT01784614|3874081|FG006|STARTED|Period 3||3
3148031|NCT01784614|3874082|FG007|STARTED|Period 3||2
3148032|NCT01784614|3874075|FG000|COMPLETED|Period 3||3
3148033|NCT01784614|3874076|FG001|COMPLETED|Period 3||2
3148034|NCT01784614|3874077|FG002|COMPLETED|Period 3||3
3148035|NCT01784614|3874078|FG003|COMPLETED|Period 3||3
3148036|NCT01784614|3874079|FG004|COMPLETED|Period 3||3
3148037|NCT01784614|3874080|FG005|COMPLETED|Period 3||3
3148038|NCT01784614|3874081|FG006|COMPLETED|Period 3||3
3148039|NCT01784614|3874082|FG007|COMPLETED|Period 3||2
3148040|NCT01784614|3874075|FG000|NOT COMPLETED|Period 3||0
3148041|NCT01784614|3874076|FG001|NOT COMPLETED|Period 3||0
3148042|NCT01784614|3874077|FG002|NOT COMPLETED|Period 3||0
3148043|NCT01784614|3874078|FG003|NOT COMPLETED|Period 3||0
3148044|NCT01784614|3874079|FG004|NOT COMPLETED|Period 3||0
3148045|NCT01784614|3874080|FG005|NOT COMPLETED|Period 3||0
3148046|NCT01784614|3874081|FG006|NOT COMPLETED|Period 3||0
3148047|NCT01784614|3874082|FG007|NOT COMPLETED|Period 3||0
3148048|NCT01784614|3874075|FG000|STARTED|Period 4||3
3148049|NCT01784614|3874076|FG001|STARTED|Period 4||2
3148050|NCT01784614|3874077|FG002|STARTED|Period 4||3
3148051|NCT01784614|3874078|FG003|STARTED|Period 4||3
3148052|NCT01784614|3874079|FG004|STARTED|Period 4||3
3148053|NCT01784614|3874080|FG005|STARTED|Period 4||3
3148054|NCT01784614|3874081|FG006|STARTED|Period 4||3
3148055|NCT01784614|3874082|FG007|STARTED|Period 4||2
3148056|NCT01784614|3874075|FG000|COMPLETED|Period 4||3
3148057|NCT01784614|3874076|FG001|COMPLETED|Period 4||2
3148058|NCT01784614|3874077|FG002|COMPLETED|Period 4||3
3148059|NCT01784614|3874078|FG003|COMPLETED|Period 4||3
3148060|NCT01784614|3874079|FG004|COMPLETED|Period 4||3
3148061|NCT01784614|3874080|FG005|COMPLETED|Period 4||3
3148062|NCT01784614|3874081|FG006|COMPLETED|Period 4||3
3148063|NCT01784614|3874082|FG007|COMPLETED|Period 4||2
3148064|NCT01784614|3874075|FG000|NOT COMPLETED|Period 4||0
3148065|NCT01784614|3874076|FG001|NOT COMPLETED|Period 4||0
3148066|NCT01784614|3874077|FG002|NOT COMPLETED|Period 4||0
3148067|NCT01784614|3874078|FG003|NOT COMPLETED|Period 4||0
3148068|NCT01784614|3874079|FG004|NOT COMPLETED|Period 4||0
3148069|NCT01784614|3874080|FG005|NOT COMPLETED|Period 4||0
3148070|NCT01784614|3874081|FG006|NOT COMPLETED|Period 4||0
3148071|NCT01784614|3874082|FG007|NOT COMPLETED|Period 4||0
3148072|NCT01784666|3874105|FG000|STARTED|Overall Study||1
3148073|NCT01784666|3874106|FG001|STARTED|Overall Study||0
3148074|NCT01784666|3874107|FG002|STARTED|Overall Study||1
3148075|NCT01784666|3874105|FG000|COMPLETED|Overall Study||1
3148076|NCT01784666|3874106|FG001|COMPLETED|Overall Study||0
3148077|NCT01784666|3874107|FG002|COMPLETED|Overall Study||1
3148078|NCT01784666|3874105|FG000|NOT COMPLETED|Overall Study||0
3148079|NCT01784666|3874106|FG001|NOT COMPLETED|Overall Study||0
3148080|NCT01784666|3874107|FG002|NOT COMPLETED|Overall Study||0
3148081|NCT01784770|3874115|FG000|STARTED|Overall Study||21
3148082|NCT01784770|3874115|FG000|COMPLETED|Overall Study||21
3148083|NCT01784770|3874115|FG000|NOT COMPLETED|Overall Study||0
3148084|NCT01784796|3874121|FG000|STARTED|Overall Study|These are participants who provided informed consent|87
3148085|NCT01784796|3874122|FG001|STARTED|Overall Study|These are participants who provided informed consent|77
3148086|NCT01784796|3874121|FG000|Baseline Data Collected|Overall Study||75
3148087|NCT01784796|3874122|FG001|Baseline Data Collected|Overall Study||61
3148088|NCT01784796|3874121|FG000|4 Week Data Collection|Overall Study||48
3148089|NCT01784796|3874122|FG001|4 Week Data Collection|Overall Study||41
3148090|NCT01784796|3874121|FG000|8 wk Data Collection|Overall Study||50
3148091|NCT01784796|3874122|FG001|8 wk Data Collection|Overall Study||46
3148092|NCT01784796|3874121|FG000|COMPLETED|Overall Study||39
3148093|NCT01784796|3874122|FG001|COMPLETED|Overall Study||34
3182027|NCT01998958|3910172|FG023|COMPLETED|Follow-up Phase||0
3182028|NCT01998958|3910173|FG024|COMPLETED|Follow-up Phase||0
3182029|NCT01998958|3910174|FG025|COMPLETED|Follow-up Phase||0
3182030|NCT01998958|3910175|FG026|COMPLETED|Follow-up Phase||0
3182031|NCT01998958|3910176|FG027|COMPLETED|Follow-up Phase||1
3182032|NCT01998958|3910177|FG028|COMPLETED|Follow-up Phase||4
3182033|NCT01998958|3910178|FG029|COMPLETED|Follow-up Phase||12
3182034|NCT01998958|3910179|FG030|COMPLETED|Follow-up Phase||39
3182035|NCT01998958|3910180|FG031|COMPLETED|Follow-up Phase||42
3182036|NCT01998958|3910149|FG000|NOT COMPLETED|Follow-up Phase||0
3182037|NCT01998958|3910150|FG001|NOT COMPLETED|Follow-up Phase||0
3182038|NCT01998958|3910151|FG002|NOT COMPLETED|Follow-up Phase||0
3182039|NCT01998958|3910152|FG003|NOT COMPLETED|Follow-up Phase||0
3182040|NCT01998958|3910153|FG004|NOT COMPLETED|Follow-up Phase||0
3182041|NCT01998958|3910154|FG005|NOT COMPLETED|Follow-up Phase||0
3182042|NCT01998958|3910155|FG006|NOT COMPLETED|Follow-up Phase||0
3182043|NCT01998958|3910156|FG007|NOT COMPLETED|Follow-up Phase||0
3182044|NCT01998958|3910157|FG008|NOT COMPLETED|Follow-up Phase||0
3182045|NCT01998958|3910158|FG009|NOT COMPLETED|Follow-up Phase||0
3182046|NCT01998958|3910159|FG010|NOT COMPLETED|Follow-up Phase||0
3182047|NCT01998958|3910160|FG011|NOT COMPLETED|Follow-up Phase||0
3148094|NCT01784796|3874121|FG000|NOT COMPLETED|Overall Study||48
3148095|NCT01784796|3874122|FG001|NOT COMPLETED|Overall Study||43
3148096|NCT01784848|3874131|FG000|STARTED|Overall Study||50
3148097|NCT01784848|3874132|FG001|STARTED|Overall Study||50
3148098|NCT01784848|3874131|FG000|COMPLETED|Overall Study||49
3148099|NCT01784848|3874132|FG001|COMPLETED|Overall Study||47
3148100|NCT01784848|3874131|FG000|NOT COMPLETED|Overall Study||1
3148101|NCT01784848|3874132|FG001|NOT COMPLETED|Overall Study||3
3148102|NCT01784861|3874144|FG000|STARTED|Overall Study||3
3148103|NCT01784861|3874145|FG001|STARTED|Overall Study||3
3148104|NCT01784861|3874146|FG002|STARTED|Overall Study||4
3148105|NCT01784861|3874147|FG003|STARTED|Overall Study||8
3148106|NCT01784861|3874148|FG004|STARTED|Overall Study||3
3182048|NCT01998958|3910161|FG012|NOT COMPLETED|Follow-up Phase||0
3182049|NCT01998958|3910162|FG013|NOT COMPLETED|Follow-up Phase||0
3182050|NCT01998958|3910163|FG014|NOT COMPLETED|Follow-up Phase||0
3182051|NCT01998958|3910164|FG015|NOT COMPLETED|Follow-up Phase||0
3182052|NCT01998958|3910165|FG016|NOT COMPLETED|Follow-up Phase||0
3148107|NCT01784861|3874149|FG005|STARTED|Overall Study||2
3148108|NCT01784861|3874144|FG000|COMPLETED|Overall Study||3
3148109|NCT01784861|3874145|FG001|COMPLETED|Overall Study||3
3148110|NCT01784861|3874146|FG002|COMPLETED|Overall Study||3
3148111|NCT01784861|3874147|FG003|COMPLETED|Overall Study||3
3148112|NCT01784861|3874148|FG004|COMPLETED|Overall Study||2
3148113|NCT01784861|3874149|FG005|COMPLETED|Overall Study||1
3148114|NCT01784861|3874144|FG000|NOT COMPLETED|Overall Study||0
3148115|NCT01784861|3874145|FG001|NOT COMPLETED|Overall Study||0
3148116|NCT01784861|3874146|FG002|NOT COMPLETED|Overall Study||1
3148117|NCT01784861|3874147|FG003|NOT COMPLETED|Overall Study||5
3148118|NCT01784861|3874148|FG004|NOT COMPLETED|Overall Study||1
3148119|NCT01784861|3874149|FG005|NOT COMPLETED|Overall Study||1
3148120|NCT01784926|3874167|FG000|STARTED|Overall Study||54
3148121|NCT01784926|3874168|FG001|STARTED|Overall Study||50
3148122|NCT01784926|3874167|FG000|COMPLETED|Overall Study||43
3148123|NCT01784926|3874168|FG001|COMPLETED|Overall Study||42
3148124|NCT01784926|3874167|FG000|NOT COMPLETED|Overall Study||11
3148125|NCT01784926|3874168|FG001|NOT COMPLETED|Overall Study||8
3148126|NCT01784965|3874176|FG000|STARTED|Overall Study||33
3148127|NCT01784965|3874177|FG001|STARTED|Overall Study||35
3148128|NCT01784965|3874176|FG000|COMPLETED|Overall Study||27
3148129|NCT01784965|3874177|FG001|COMPLETED|Overall Study||24
3148130|NCT01784965|3874176|FG000|NOT COMPLETED|Overall Study||6
3148131|NCT01784965|3874177|FG001|NOT COMPLETED|Overall Study||11
3148132|NCT01785069|3874189|FG000|STARTED|Overall Study||107
3148133|NCT01785069|3874190|FG001|STARTED|Overall Study||76
3148134|NCT01785069|3874191|FG002|STARTED|Overall Study||104
3148135|NCT01785069|3874192|FG003|STARTED|Overall Study||68
3148136|NCT01785069|3874189|FG000|COMPLETED|Overall Study||95
3148137|NCT01785069|3874190|FG001|COMPLETED|Overall Study||64
3148138|NCT01785069|3874191|FG002|COMPLETED|Overall Study||91
3148139|NCT01785069|3874192|FG003|COMPLETED|Overall Study||54
3148140|NCT01785069|3874189|FG000|NOT COMPLETED|Overall Study||12
3148141|NCT01785069|3874190|FG001|NOT COMPLETED|Overall Study||12
3148142|NCT01785069|3874191|FG002|NOT COMPLETED|Overall Study||13
3148143|NCT01785069|3874192|FG003|NOT COMPLETED|Overall Study||14
3148144|NCT01785095|3874202|FG000|STARTED|Overall Study||27
3148145|NCT01785095|3874202|FG000|COMPLETED|Overall Study||24
3148146|NCT01785095|3874202|FG000|NOT COMPLETED|Overall Study||3
3148147|NCT01785134|3874211|FG000|STARTED|Overall Study||41
3148148|NCT01785134|3874212|FG001|STARTED|Overall Study||40
3148149|NCT01785134|3874211|FG000|COMPLETED|Overall Study||29
3148150|NCT01785134|3874212|FG001|COMPLETED|Overall Study||33
3148151|NCT01785134|3874211|FG000|NOT COMPLETED|Overall Study||12
3148152|NCT01785134|3874212|FG001|NOT COMPLETED|Overall Study||7
3148153|NCT01785160|3874218|FG000|STARTED|Treatment Period 1: Raltegravir||25
3148154|NCT01785160|3874218|FG000|COMPLETED|Treatment Period 1: Raltegravir||24
3148155|NCT01785160|3874218|FG000|NOT COMPLETED|Treatment Period 1: Raltegravir||1
3148156|NCT01785160|3874218|FG000|STARTED|Washout Period of at Least 7 Days||24
3148157|NCT01785160|3874218|FG000|COMPLETED|Washout Period of at Least 7 Days||23
3148158|NCT01785160|3874218|FG000|NOT COMPLETED|Washout Period of at Least 7 Days||1
3148159|NCT01785160|3874218|FG000|STARTED|Treatment Period 2: Raltegravir + Faldap||23
3148160|NCT01785160|3874218|FG000|COMPLETED|Treatment Period 2: Raltegravir + Faldap||23
3148161|NCT01785160|3874218|FG000|NOT COMPLETED|Treatment Period 2: Raltegravir + Faldap||0
3148162|NCT01785186|3874229|FG000|STARTED|Overall Study||59
3148163|NCT01785186|3874230|FG001|STARTED|Overall Study||63
3148164|NCT01785186|3874231|FG002|STARTED|Overall Study||57
3148165|NCT01785186|3874232|FG003|STARTED|Overall Study||63
3148166|NCT01785186|3874233|FG004|STARTED|Overall Study||123
3148167|NCT01785186|3874229|FG000|COMPLETED|Overall Study||53
3148168|NCT01785186|3874230|FG001|COMPLETED|Overall Study||57
3148169|NCT01785186|3874231|FG002|COMPLETED|Overall Study||52
3148170|NCT01785186|3874232|FG003|COMPLETED|Overall Study||58
3148171|NCT01785186|3874233|FG004|COMPLETED|Overall Study||117
3148172|NCT01785186|3874229|FG000|NOT COMPLETED|Overall Study||6
3148173|NCT01785186|3874230|FG001|NOT COMPLETED|Overall Study||6
3148174|NCT01785186|3874231|FG002|NOT COMPLETED|Overall Study||5
3148175|NCT01785186|3874232|FG003|NOT COMPLETED|Overall Study||5
3148176|NCT01785186|3874233|FG004|NOT COMPLETED|Overall Study||6
3148177|NCT01785459|3874249|FG000|STARTED|Overall Study||11
3148178|NCT01785459|3874250|FG001|STARTED|Overall Study||12
3182053|NCT01998958|3910166|FG017|NOT COMPLETED|Follow-up Phase||0
3182054|NCT01998958|3910167|FG018|NOT COMPLETED|Follow-up Phase||0
3182055|NCT01998958|3910168|FG019|NOT COMPLETED|Follow-up Phase||0
3182056|NCT01998958|3910169|FG020|NOT COMPLETED|Follow-up Phase||0
3148179|NCT01785459|3874249|FG000|COMPLETED|Overall Study||11
3148180|NCT01785459|3874250|FG001|COMPLETED|Overall Study||12
3148181|NCT01785459|3874249|FG000|NOT COMPLETED|Overall Study||0
3148182|NCT01785459|3874250|FG001|NOT COMPLETED|Overall Study||0
3148183|NCT01785472|3874259|FG000|STARTED|Overall Study||479
3148184|NCT01785472|3874260|FG001|STARTED|Overall Study||473
3148185|NCT01785472|3874261|FG002|STARTED|Overall Study||486
3148186|NCT01785472|3874259|FG000|Full Analysis Set (FAS)|Overall Study||479
3148187|NCT01785472|3874260|FG001|Full Analysis Set (FAS)|Overall Study||472
3148188|NCT01785472|3874261|FG002|Full Analysis Set (FAS)|Overall Study||484
3148189|NCT01785472|3874259|FG000|Safety Set (SAF)|Overall Study||478
3148190|NCT01785472|3874260|FG001|Safety Set (SAF)|Overall Study||472
3148191|NCT01785472|3874261|FG002|Safety Set (SAF)|Overall Study||484
3148192|NCT01785472|3874259|FG000|COMPLETED|Overall Study||455
3182057|NCT01998958|3910170|FG021|NOT COMPLETED|Follow-up Phase||0
3148193|NCT01785472|3874260|FG001|COMPLETED|Overall Study||454
3148194|NCT01785472|3874261|FG002|COMPLETED|Overall Study||464
3148195|NCT01785472|3874259|FG000|NOT COMPLETED|Overall Study||24
3148196|NCT01785472|3874260|FG001|NOT COMPLETED|Overall Study||19
3148197|NCT01785472|3874261|FG002|NOT COMPLETED|Overall Study||22
3148198|NCT01785524|3874273|FG000|STARTED|Overall Study||7
3148199|NCT01785524|3874274|FG001|STARTED|Overall Study||4
3148200|NCT01785524|3874273|FG000|COMPLETED|Overall Study||5
3148201|NCT01785524|3874274|FG001|COMPLETED|Overall Study||2
3148202|NCT01785524|3874273|FG000|NOT COMPLETED|Overall Study||2
3148203|NCT01785524|3874274|FG001|NOT COMPLETED|Overall Study||2
3148204|NCT01785602|3874282|FG000|STARTED|Overall Study||76
3148205|NCT01785602|3874283|FG001|STARTED|Overall Study||27
3148206|NCT01785602|3874282|FG000|COMPLETED|Overall Study||63
3148207|NCT01785602|3874283|FG001|COMPLETED|Overall Study||18
3148208|NCT01785602|3874282|FG000|NOT COMPLETED|Overall Study||13
3148209|NCT01785602|3874283|FG001|NOT COMPLETED|Overall Study||9
3148210|NCT01785615|3874292|FG000|STARTED|Dietary Phase||0
3148211|NCT01785615|3874293|FG001|STARTED|Dietary Phase||0
3148212|NCT01785615|3874294|FG002|STARTED|Dietary Phase||35
3148213|NCT01785615|3874295|FG003|STARTED|Dietary Phase||140
3148214|NCT01785615|3874292|FG000|COMPLETED|Dietary Phase||0
3148215|NCT01785615|3874293|FG001|COMPLETED|Dietary Phase||0
3148216|NCT01785615|3874294|FG002|COMPLETED|Dietary Phase||35
3148217|NCT01785615|3874295|FG003|COMPLETED|Dietary Phase||116
3148218|NCT01785615|3874292|FG000|NOT COMPLETED|Dietary Phase||0
3148219|NCT01785615|3874293|FG001|NOT COMPLETED|Dietary Phase||0
3182058|NCT01998958|3910171|FG022|NOT COMPLETED|Follow-up Phase||0
3182059|NCT01998958|3910172|FG023|NOT COMPLETED|Follow-up Phase||0
3182060|NCT01998958|3910173|FG024|NOT COMPLETED|Follow-up Phase||0
3182061|NCT01998958|3910174|FG025|NOT COMPLETED|Follow-up Phase||0
3182062|NCT01998958|3910175|FG026|NOT COMPLETED|Follow-up Phase||0
3182063|NCT01998958|3910176|FG027|NOT COMPLETED|Follow-up Phase||0
3182064|NCT01998958|3910177|FG028|NOT COMPLETED|Follow-up Phase||0
3182065|NCT01998958|3910178|FG029|NOT COMPLETED|Follow-up Phase||0
3182066|NCT01998958|3910179|FG030|NOT COMPLETED|Follow-up Phase||0
3182067|NCT01998958|3910180|FG031|NOT COMPLETED|Follow-up Phase||0
3182068|NCT01998984|3910234|FG000|STARTED|Overall Study||55
3182069|NCT01998984|3910235|FG001|STARTED|Overall Study||59
3182070|NCT01998984|3910236|FG002|STARTED|Overall Study||49
3182071|NCT01998984|3910237|FG003|STARTED|Overall Study||61
3182072|NCT01998984|3910234|FG000|COMPLETED|Overall Study||55
3182073|NCT01998984|3910235|FG001|COMPLETED|Overall Study||58
3182074|NCT01998984|3910236|FG002|COMPLETED|Overall Study||48
3182075|NCT01998984|3910237|FG003|COMPLETED|Overall Study||58
3182076|NCT01998984|3910234|FG000|NOT COMPLETED|Overall Study||0
3182077|NCT01998984|3910235|FG001|NOT COMPLETED|Overall Study||1
3182078|NCT01998984|3910236|FG002|NOT COMPLETED|Overall Study||1
3182079|NCT01998984|3910237|FG003|NOT COMPLETED|Overall Study||3
3182080|NCT01999114|3910252|FG000|STARTED|Overall Study||66
3182081|NCT01999114|3910253|FG001|STARTED|Overall Study||66
3182082|NCT01999114|3910254|FG002|STARTED|Overall Study||66
3182083|NCT01999114|3910255|FG003|STARTED|Overall Study||65
3182084|NCT01999114|3910256|FG004|STARTED|Overall Study||65
3182085|NCT01999114|3910252|FG000|COMPLETED|Overall Study||58
3182086|NCT01999114|3910253|FG001|COMPLETED|Overall Study||59
3182087|NCT01999114|3910254|FG002|COMPLETED|Overall Study||61
3182088|NCT01999114|3910255|FG003|COMPLETED|Overall Study||62
3182089|NCT01999114|3910256|FG004|COMPLETED|Overall Study||61
3182090|NCT01999114|3910252|FG000|NOT COMPLETED|Overall Study||8
3182091|NCT01999114|3910253|FG001|NOT COMPLETED|Overall Study||7
3182092|NCT01999114|3910254|FG002|NOT COMPLETED|Overall Study||5
3182093|NCT01999114|3910255|FG003|NOT COMPLETED|Overall Study||3
3182094|NCT01999114|3910256|FG004|NOT COMPLETED|Overall Study||4
3182095|NCT01999192|3910286|FG000|STARTED|Main Phase I||83
3182096|NCT01999192|3910287|FG001|STARTED|Main Phase I||80
3182097|NCT01999192|3910288|FG002|STARTED|Main Phase I||78
3182098|NCT01999192|3910289|FG003|STARTED|Main Phase I||80
3182099|NCT01999192|3910286|FG000|COMPLETED|Main Phase I||72
3182100|NCT01999192|3910287|FG001|COMPLETED|Main Phase I||70
3182101|NCT01999192|3910288|FG002|COMPLETED|Main Phase I||70
3182102|NCT01999192|3910289|FG003|COMPLETED|Main Phase I||72
3182103|NCT01999192|3910286|FG000|NOT COMPLETED|Main Phase I||11
3182104|NCT01999192|3910287|FG001|NOT COMPLETED|Main Phase I||10
3182105|NCT01999192|3910288|FG002|NOT COMPLETED|Main Phase I||8
3182106|NCT01999192|3910289|FG003|NOT COMPLETED|Main Phase I||8
3182107|NCT01999192|3910286|FG000|STARTED|Main Phase II|Non-responders were switched to higher dose Level after Main Phase 1, started = completed -switched.|64
3182108|NCT01999192|3910287|FG001|STARTED|Main Phase II|started Patient = completed patients + switched patients (non-responder) from other arms.|75
3182109|NCT01999192|3910288|FG002|STARTED|Main Phase II|started Patient = completed patients + switched patients (non-responder) from other arms.|98
3182110|NCT01999192|3910289|FG003|STARTED|Main Phase II|non-responders were switched to higher dose Level after Main Phase 1, started = completed -switched|44
3182111|NCT01999192|3910286|FG000|COMPLETED|Main Phase II||55
3182112|NCT01999192|3910287|FG001|COMPLETED|Main Phase II||66
3182113|NCT01999192|3910288|FG002|COMPLETED|Main Phase II||76
3182114|NCT01999192|3910289|FG003|COMPLETED|Main Phase II||43
3182115|NCT01999192|3910286|FG000|NOT COMPLETED|Main Phase II||9
3182116|NCT01999192|3910287|FG001|NOT COMPLETED|Main Phase II||9
3182117|NCT01999192|3910288|FG002|NOT COMPLETED|Main Phase II||22
3182118|NCT01999192|3910289|FG003|NOT COMPLETED|Main Phase II||1
3148220|NCT01785615|3874294|FG002|NOT COMPLETED|Dietary Phase||0
3148221|NCT01785615|3874295|FG003|NOT COMPLETED|Dietary Phase||24
3148222|NCT01785615|3874292|FG000|STARTED|Atorvastatin Phase||44
3148223|NCT01785615|3874293|FG001|STARTED|Atorvastatin Phase||44
3148224|NCT01785615|3874294|FG002|STARTED|Atorvastatin Phase||0
3148225|NCT01785615|3874295|FG003|STARTED|Atorvastatin Phase||0
3148226|NCT01785615|3874292|FG000|COMPLETED|Atorvastatin Phase||44
3148227|NCT01785615|3874293|FG001|COMPLETED|Atorvastatin Phase||44
3148228|NCT01785615|3874294|FG002|COMPLETED|Atorvastatin Phase||0
3148229|NCT01785615|3874295|FG003|COMPLETED|Atorvastatin Phase||0
3148230|NCT01785615|3874292|FG000|NOT COMPLETED|Atorvastatin Phase||0
3148231|NCT01785615|3874293|FG001|NOT COMPLETED|Atorvastatin Phase||0
3148232|NCT01785615|3874294|FG002|NOT COMPLETED|Atorvastatin Phase||0
3148233|NCT01785615|3874295|FG003|NOT COMPLETED|Atorvastatin Phase||0
3148234|NCT01785628|3874309|FG000|STARTED|Overall Study||15
3148235|NCT01785628|3874310|FG001|STARTED|Overall Study||15
3148236|NCT01785628|3874309|FG000|COMPLETED|Overall Study||13
3148237|NCT01785628|3874310|FG001|COMPLETED|Overall Study||12
3148238|NCT01785628|3874309|FG000|NOT COMPLETED|Overall Study||2
3148239|NCT01785628|3874310|FG001|NOT COMPLETED|Overall Study||3
3148240|NCT01785680|3874318|FG000|STARTED|Overall Study||1100
3148241|NCT01785680|3874319|FG001|STARTED|Overall Study||857
3148242|NCT01785680|3874318|FG000|COMPLETED|Overall Study||1100
3148243|NCT01785680|3874319|FG001|COMPLETED|Overall Study||857
3148244|NCT01785680|3874318|FG000|NOT COMPLETED|Overall Study||0
3148245|NCT01785680|3874319|FG001|NOT COMPLETED|Overall Study||0
3148246|NCT01785810|3874325|FG000|STARTED|Overall Study||37
3148247|NCT01785810|3874325|FG000|COMPLETED|Overall Study||29
3148248|NCT01785810|3874325|FG000|NOT COMPLETED|Overall Study||8
3148249|NCT01785849|3874331|FG000|STARTED|Overall Study||254
3148250|NCT01785849|3874332|FG001|STARTED|Overall Study||254
3148251|NCT01785849|3874331|FG000|Received Treatment|Overall Study||254
3148252|NCT01785849|3874332|FG001|Received Treatment|Overall Study||251
3148253|NCT01785849|3874331|FG000|COMPLETED|Overall Study||193
3148254|NCT01785849|3874332|FG001|COMPLETED|Overall Study||220
3148255|NCT01785849|3874331|FG000|NOT COMPLETED|Overall Study||61
3148256|NCT01785849|3874332|FG001|NOT COMPLETED|Overall Study||34
3148257|NCT01785875|3874338|FG000|STARTED|Overall Study||384
3148258|NCT01785875|3874339|FG001|STARTED|Overall Study||384
3148259|NCT01785875|3874340|FG002|STARTED|Overall Study||123
3148260|NCT01785875|3874338|FG000|Received Etelcalcetide|Overall Study||383
3148261|NCT01785875|3874339|FG001|Received Etelcalcetide|Overall Study||384
3148262|NCT01785875|3874340|FG002|Received Etelcalcetide|Overall Study||123
3148263|NCT01785875|3874338|FG000|COMPLETED|Overall Study|Completed etelcalcetide and the 30-day safety follow-up period|90
3148264|NCT01785875|3874339|FG001|COMPLETED|Overall Study|Completed etelcalcetide and the 30-day safety follow-up period|95
3148265|NCT01785875|3874340|FG002|COMPLETED|Overall Study|Completed etelcalcetide and the 30-day safety follow-up period|16
3148266|NCT01785875|3874338|FG000|NOT COMPLETED|Overall Study||294
3148267|NCT01785875|3874339|FG001|NOT COMPLETED|Overall Study||289
3148268|NCT01785875|3874340|FG002|NOT COMPLETED|Overall Study||107
3148269|NCT01786109|3874354|FG000|STARTED|Overall Study||24
3148270|NCT01786109|3874355|FG001|STARTED|Overall Study||24
3148271|NCT01786109|3874356|FG002|STARTED|Overall Study||27
3182119|NCT01999192|3910286|FG000|STARTED|Extension Phase|Some patients terminated or were switched to higher dose Level after Main Phase 2.|54
3182120|NCT01999192|3910287|FG001|STARTED|Extension Phase|Some patients terminated or were switched to higher dose Level after Main Phase 2.|56
3182121|NCT01999192|3910288|FG002|STARTED|Extension Phase|Some patients terminated after Main Phase 2.|68
3182122|NCT01999192|3910289|FG003|STARTED|Extension Phase|No Placebo arm for Extension Phase, all patients terminated or were switched to tregalizumab Groups.|0
3182123|NCT01999192|3910286|FG000|COMPLETED|Extension Phase||41
3182124|NCT01999192|3910287|FG001|COMPLETED|Extension Phase||38
3182125|NCT01999192|3910288|FG002|COMPLETED|Extension Phase||44
3182126|NCT01999192|3910289|FG003|COMPLETED|Extension Phase||0
3182127|NCT01999192|3910286|FG000|NOT COMPLETED|Extension Phase||13
3182128|NCT01999192|3910287|FG001|NOT COMPLETED|Extension Phase||18
3182129|NCT01999192|3910288|FG002|NOT COMPLETED|Extension Phase||24
3182130|NCT01999192|3910289|FG003|NOT COMPLETED|Extension Phase||0
3182131|NCT01999218|3910302|FG000|STARTED|Overall Study||448
3182132|NCT01999218|3910303|FG001|STARTED|Overall Study||441
3182133|NCT01999218|3910304|FG002|STARTED|Overall Study||437
3182134|NCT01999218|3910302|FG000|Treated|Overall Study||448
3182135|NCT01999218|3910303|FG001|Treated|Overall Study||440
3182136|NCT01999218|3910304|FG002|Treated|Overall Study||437
3182137|NCT01999218|3910302|FG000|Site Issue|Overall Study||445
3182138|NCT01999218|3910303|FG001|Site Issue|Overall Study||435
3182139|NCT01999218|3910304|FG002|Site Issue|Overall Study||435
3182140|NCT01999218|3910302|FG000|COMPLETED|Overall Study||339
3182141|NCT01999218|3910303|FG001|COMPLETED|Overall Study||340
3182142|NCT01999218|3910304|FG002|COMPLETED|Overall Study||327
3182143|NCT01999218|3910302|FG000|NOT COMPLETED|Overall Study||109
3182144|NCT01999218|3910303|FG001|NOT COMPLETED|Overall Study||101
3182145|NCT01999218|3910304|FG002|NOT COMPLETED|Overall Study||110
3182146|NCT01999231|3910316|FG000|STARTED|Overall Study||6
3182147|NCT01999231|3910317|FG001|STARTED|Overall Study||6
3182148|NCT01999231|3910318|FG002|STARTED|Overall Study||6
3182149|NCT01999231|3910319|FG003|STARTED|Overall Study||6
3182150|NCT01999231|3910316|FG000|COMPLETED|Overall Study||6
3182151|NCT01999231|3910317|FG001|COMPLETED|Overall Study||6
3182152|NCT01999231|3910318|FG002|COMPLETED|Overall Study||6
3148272|NCT01786109|3874354|FG000|COMPLETED|Overall Study||23
3148273|NCT01786109|3874355|FG001|COMPLETED|Overall Study||24
3148274|NCT01786109|3874356|FG002|COMPLETED|Overall Study||25
3148275|NCT01786109|3874354|FG000|NOT COMPLETED|Overall Study||1
3148276|NCT01786109|3874355|FG001|NOT COMPLETED|Overall Study||0
3148277|NCT01786109|3874356|FG002|NOT COMPLETED|Overall Study||2
3148278|NCT01786148|3874366|FG000|STARTED|Overall Study||77
3148279|NCT01786148|3874367|FG001|STARTED|Overall Study||72
3148280|NCT01786148|3874366|FG000|COMPLETED|Overall Study||55
3148281|NCT01786148|3874367|FG001|COMPLETED|Overall Study||50
3148282|NCT01786148|3874366|FG000|NOT COMPLETED|Overall Study||22
3148283|NCT01786148|3874367|FG001|NOT COMPLETED|Overall Study||22
3148284|NCT01786161|3874375|FG000|STARTED|Overall Study||22
3148285|NCT01786161|3874376|FG001|STARTED|Overall Study||22
3148286|NCT01786161|3874375|FG000|COMPLETED|Overall Study||22
3148287|NCT01786161|3874376|FG001|COMPLETED|Overall Study||22
3148288|NCT01786161|3874375|FG000|NOT COMPLETED|Overall Study||0
3148289|NCT01786161|3874376|FG001|NOT COMPLETED|Overall Study||0
3148290|NCT01786174|3874386|FG000|STARTED|Overall Study||18
3148291|NCT01786174|3874387|FG001|STARTED|Overall Study||10
3148292|NCT01786174|3874386|FG000|Randomized|Overall Study||19
3148293|NCT01786174|3874387|FG001|Randomized|Overall Study||11
3148294|NCT01786174|3874386|FG000|COMPLETED|Overall Study||16
3148295|NCT01786174|3874387|FG001|COMPLETED|Overall Study||10
3148296|NCT01786174|3874386|FG000|NOT COMPLETED|Overall Study||2
3148297|NCT01786174|3874387|FG001|NOT COMPLETED|Overall Study||0
3148298|NCT01786187|3874395|FG000|STARTED|Overall Study||40
3148299|NCT01786187|3874396|FG001|STARTED|Overall Study||47
3148300|NCT01786187|3874395|FG000|COMPLETED|Overall Study||35
3148301|NCT01786187|3874396|FG001|COMPLETED|Overall Study||37
3148302|NCT01786187|3874395|FG000|NOT COMPLETED|Overall Study||5
3148303|NCT01786187|3874396|FG001|NOT COMPLETED|Overall Study||10
3148304|NCT01786239|3874407|FG000|STARTED|Overall Study||25
3148305|NCT01786239|3874408|FG001|STARTED|Overall Study||25
3148306|NCT01786239|3874407|FG000|COMPLETED|Overall Study||14
3148307|NCT01786239|3874408|FG001|COMPLETED|Overall Study||14
3148308|NCT01786239|3874407|FG000|NOT COMPLETED|Overall Study||11
3148309|NCT01786239|3874408|FG001|NOT COMPLETED|Overall Study||11
3148310|NCT01786252|3874416|FG000|STARTED|Overall Study||7
3148311|NCT01786252|3874417|FG001|STARTED|Overall Study||8
3148312|NCT01786252|3874416|FG000|COMPLETED|Overall Study||7
3148313|NCT01786252|3874417|FG001|COMPLETED|Overall Study||8
3148314|NCT01786252|3874416|FG000|NOT COMPLETED|Overall Study||0
3148315|NCT01786252|3874417|FG001|NOT COMPLETED|Overall Study||0
3148316|NCT01786330|3874425|FG000|STARTED|Overall Study||30
3148317|NCT01786330|3874426|FG001|STARTED|Overall Study||30
3148318|NCT01786330|3874425|FG000|COMPLETED|Overall Study||29
3148319|NCT01786330|3874426|FG001|COMPLETED|Overall Study||27
3148320|NCT01786330|3874425|FG000|NOT COMPLETED|Overall Study||1
3148321|NCT01786330|3874426|FG001|NOT COMPLETED|Overall Study||3
3148322|NCT01786343|3874434|FG000|STARTED|Overall Study||28
3148323|NCT01786343|3874435|FG001|STARTED|Overall Study||46
3148324|NCT01786343|3874434|FG000|COMPLETED|Overall Study||28
3148325|NCT01786343|3874435|FG001|COMPLETED|Overall Study||46
3148326|NCT01786343|3874434|FG000|NOT COMPLETED|Overall Study||0
3148327|NCT01786343|3874435|FG001|NOT COMPLETED|Overall Study||0
3148328|NCT01786512|3874452|FG000|STARTED|Overall Study||11
3148329|NCT01786512|3874453|FG001|STARTED|Overall Study||11
3148330|NCT01786512|3874454|FG002|STARTED|Overall Study||14
3148331|NCT01786512|3874455|FG003|STARTED|Overall Study||13
3148332|NCT01786512|3874456|FG004|STARTED|Overall Study||10
3148333|NCT01786512|3874457|FG005|STARTED|Overall Study||11
3148334|NCT01786512|3874458|FG006|STARTED|Overall Study||12
3148335|NCT01786512|3874459|FG007|STARTED|Overall Study||14
3148336|NCT01786512|3874460|FG008|STARTED|Overall Study||149
3182153|NCT01999231|3910319|FG003|COMPLETED|Overall Study||6
3182154|NCT01999231|3910316|FG000|NOT COMPLETED|Overall Study||0
3182155|NCT01999231|3910317|FG001|NOT COMPLETED|Overall Study||0
3182156|NCT01999231|3910318|FG002|NOT COMPLETED|Overall Study||0
3182157|NCT01999231|3910319|FG003|NOT COMPLETED|Overall Study||0
3182158|NCT01999322|3910333|FG000|STARTED|Overall Study||25
3182159|NCT01999322|3910334|FG001|STARTED|Overall Study||12
3182160|NCT01999322|3910333|FG000|COMPLETED|Overall Study||24
3182161|NCT01999322|3910334|FG001|COMPLETED|Overall Study||12
3182162|NCT01999322|3910333|FG000|NOT COMPLETED|Overall Study||1
3182163|NCT01999322|3910334|FG001|NOT COMPLETED|Overall Study||0
3182164|NCT01999335|3910345|FG000|STARTED|Overall Study||3
3182165|NCT01999335|3910346|FG001|STARTED|Overall Study||1
3182166|NCT01999335|3910347|FG002|STARTED|Overall Study||7
3182167|NCT01999335|3910348|FG003|STARTED|Overall Study||10
3182168|NCT01999335|3910349|FG004|STARTED|Overall Study||12
3182169|NCT01999335|3910345|FG000|Received Study Treatment|Overall Study||3
3182170|NCT01999335|3910346|FG001|Received Study Treatment|Overall Study||1
3148337|NCT01786512|3874461|FG009|STARTED|Overall Study||150
3148338|NCT01786512|3874462|FG010|STARTED|Overall Study||149
3148339|NCT01786512|3874452|FG000|Received Study Treatment|Overall Study||11
3148340|NCT01786512|3874453|FG001|Received Study Treatment|Overall Study||10
3148341|NCT01786512|3874454|FG002|Received Study Treatment|Overall Study||14
3148342|NCT01786512|3874455|FG003|Received Study Treatment|Overall Study||13
3148343|NCT01786512|3874456|FG004|Received Study Treatment|Overall Study||10
3182171|NCT01999335|3910347|FG002|Received Study Treatment|Overall Study||7
3182172|NCT01999335|3910348|FG003|Received Study Treatment|Overall Study||10
3148344|NCT01786512|3874457|FG005|Received Study Treatment|Overall Study||11
3182173|NCT01999335|3910349|FG004|Received Study Treatment|Overall Study||10
3182174|NCT01999335|3910345|FG000|COMPLETED|Overall Study||3
3182175|NCT01999335|3910346|FG001|COMPLETED|Overall Study||1
3182176|NCT01999335|3910347|FG002|COMPLETED|Overall Study||7
3148345|NCT01786512|3874458|FG006|Received Study Treatment|Overall Study||11
3148346|NCT01786512|3874459|FG007|Received Study Treatment|Overall Study||14
3148347|NCT01786512|3874460|FG008|Received Study Treatment|Overall Study||149
3148348|NCT01786512|3874461|FG009|Received Study Treatment|Overall Study||150
3148349|NCT01786512|3874462|FG010|Received Study Treatment|Overall Study||146
3148350|NCT01786512|3874452|FG000|COMPLETED|Overall Study||11
3148351|NCT01786512|3874453|FG001|COMPLETED|Overall Study||10
3148352|NCT01786512|3874454|FG002|COMPLETED|Overall Study||14
3148353|NCT01786512|3874455|FG003|COMPLETED|Overall Study||13
3148354|NCT01786512|3874456|FG004|COMPLETED|Overall Study||10
3148355|NCT01786512|3874457|FG005|COMPLETED|Overall Study||11
3148356|NCT01786512|3874458|FG006|COMPLETED|Overall Study||11
3148357|NCT01786512|3874459|FG007|COMPLETED|Overall Study||14
3148358|NCT01786512|3874460|FG008|COMPLETED|Overall Study||145
3148359|NCT01786512|3874461|FG009|COMPLETED|Overall Study||145
3148360|NCT01786512|3874462|FG010|COMPLETED|Overall Study||137
3148361|NCT01786512|3874452|FG000|NOT COMPLETED|Overall Study||0
3148362|NCT01786512|3874453|FG001|NOT COMPLETED|Overall Study||1
3148363|NCT01786512|3874454|FG002|NOT COMPLETED|Overall Study||0
3148364|NCT01786512|3874455|FG003|NOT COMPLETED|Overall Study||0
3148365|NCT01786512|3874456|FG004|NOT COMPLETED|Overall Study||0
3148366|NCT01786512|3874457|FG005|NOT COMPLETED|Overall Study||0
3148367|NCT01786512|3874458|FG006|NOT COMPLETED|Overall Study||1
3148368|NCT01786512|3874459|FG007|NOT COMPLETED|Overall Study||0
3148369|NCT01786512|3874460|FG008|NOT COMPLETED|Overall Study||4
3148370|NCT01786512|3874461|FG009|NOT COMPLETED|Overall Study||5
3148371|NCT01786512|3874462|FG010|NOT COMPLETED|Overall Study||12
3148372|NCT01786551|3874494|FG000|STARTED|Overall Study||16
3148373|NCT01786551|3874494|FG000|COMPLETED|Overall Study||14
3148374|NCT01786551|3874494|FG000|NOT COMPLETED|Overall Study||2
3148375|NCT01786564|3874498|FG000|STARTED|Overall Study||120
3148376|NCT01786564|3874498|FG000|COMPLETED|Overall Study||56
3148377|NCT01786564|3874498|FG000|NOT COMPLETED|Overall Study||64
3148378|NCT01786603|3874504|FG000|STARTED|Overall Study||60
3148379|NCT01786603|3874505|FG001|STARTED|Overall Study||20
3148380|NCT01786603|3874504|FG000|COMPLETED|Overall Study||42
3148381|NCT01786603|3874505|FG001|COMPLETED|Overall Study||8
3148382|NCT01786603|3874504|FG000|NOT COMPLETED|Overall Study||18
3148383|NCT01786603|3874505|FG001|NOT COMPLETED|Overall Study||12
3148384|NCT01786629|3874513|FG000|STARTED|Overall Study||169
3148385|NCT01786629|3874514|FG001|STARTED|Overall Study||169
3148386|NCT01786629|3874513|FG000|COMPLETED|Overall Study||169
3148387|NCT01786629|3874514|FG001|COMPLETED|Overall Study||164
3148388|NCT01786629|3874513|FG000|NOT COMPLETED|Overall Study||0
3148389|NCT01786629|3874514|FG001|NOT COMPLETED|Overall Study||5
3148390|NCT01786668|3874524|FG000|STARTED|Overall Study||52
3148391|NCT01786668|3874525|FG001|STARTED|Overall Study||52
3148392|NCT01786668|3874526|FG002|STARTED|Overall Study||52
3148393|NCT01786668|3874527|FG003|STARTED|Overall Study||51
3148394|NCT01786668|3874524|FG000|COMPLETED|Overall Study||51
3148395|NCT01786668|3874525|FG001|COMPLETED|Overall Study||51
3148396|NCT01786668|3874526|FG002|COMPLETED|Overall Study||47
3148397|NCT01786668|3874527|FG003|COMPLETED|Overall Study||47
3148398|NCT01786668|3874524|FG000|NOT COMPLETED|Overall Study||1
3148399|NCT01786668|3874525|FG001|NOT COMPLETED|Overall Study||1
3148400|NCT01786668|3874526|FG002|NOT COMPLETED|Overall Study||5
3148401|NCT01786668|3874527|FG003|NOT COMPLETED|Overall Study||4
3148402|NCT01786707|3874539|FG000|STARTED|Overall Study||1
3148403|NCT01786707|3874540|FG001|STARTED|Overall Study||1
3148404|NCT01786707|3874539|FG000|COMPLETED|Overall Study||0
3148405|NCT01786707|3874540|FG001|COMPLETED|Overall Study||0
3148406|NCT01786707|3874539|FG000|NOT COMPLETED|Overall Study||1
3148407|NCT01786707|3874540|FG001|NOT COMPLETED|Overall Study||1
3148408|NCT01786876|3874546|FG000|STARTED|Overall Study||6
3148409|NCT01786876|3874546|FG000|COMPLETED|Overall Study||6
3148410|NCT01786876|3874546|FG000|NOT COMPLETED|Overall Study||0
3148411|NCT01786902|3874552|FG000|STARTED|Overall Study||36
3148412|NCT01786902|3874553|FG001|STARTED|Overall Study||34
3148413|NCT01786902|3874552|FG000|COMPLETED|Overall Study||32
3148414|NCT01786902|3874553|FG001|COMPLETED|Overall Study||31
3148415|NCT01786902|3874552|FG000|NOT COMPLETED|Overall Study||4
3148416|NCT01786902|3874553|FG001|NOT COMPLETED|Overall Study||3
3148417|NCT01786954|3874559|FG000|STARTED|Overall Study||34
3148418|NCT01786954|3874560|FG001|STARTED|Overall Study||34
3148419|NCT01786954|3874559|FG000|COMPLETED|Overall Study||34
3148420|NCT01786954|3874560|FG001|COMPLETED|Overall Study||34
3148421|NCT01786954|3874559|FG000|NOT COMPLETED|Overall Study||0
3148422|NCT01786954|3874560|FG001|NOT COMPLETED|Overall Study||0
3148423|NCT01786967|3874570|FG000|STARTED|Overall Study||61
3148424|NCT01786967|3874570|FG000|Extensive Metabolizers|Overall Study||54
3148425|NCT01786967|3874570|FG000|Poor Metabolizers|Overall Study||4
3148426|NCT01786967|3874570|FG000|Metabolizer Status Undetermined|Overall Study||3
3148427|NCT01786967|3874570|FG000|COMPLETED|Overall Study||61
3148428|NCT01786967|3874570|FG000|NOT COMPLETED|Overall Study||0
3148429|NCT01786993|3874581|FG000|STARTED|Overall Study||201
3148430|NCT01786993|3874582|FG001|STARTED|Overall Study||180
3182177|NCT01999335|3910348|FG003|COMPLETED|Overall Study||10
3148431|NCT01786993|3874581|FG000|Per Protocol Population at 9 Months|Overall Study||189
3148432|NCT01786993|3874582|FG001|Per Protocol Population at 9 Months|Overall Study||170
3148433|NCT01786993|3874581|FG000|COMPLETED|Overall Study||189
3148434|NCT01786993|3874582|FG001|COMPLETED|Overall Study||170
3148435|NCT01786993|3874581|FG000|NOT COMPLETED|Overall Study||12
3148436|NCT01786993|3874582|FG001|NOT COMPLETED|Overall Study||10
3148437|NCT01787006|3874591|FG000|STARTED|Overall Study||35
3148438|NCT01787006|3874592|FG001|STARTED|Overall Study||39
3148439|NCT01787006|3874591|FG000|COMPLETED|Overall Study||32
3148440|NCT01787006|3874592|FG001|COMPLETED|Overall Study||36
3148441|NCT01787006|3874591|FG000|NOT COMPLETED|Overall Study||3
3148442|NCT01787006|3874592|FG001|NOT COMPLETED|Overall Study||3
3148443|NCT01787032|3874604|FG000|STARTED|Overall Study||3
3148444|NCT01787032|3874605|FG001|STARTED|Overall Study||3
3182178|NCT01999335|3910349|FG004|COMPLETED|Overall Study||10
3182179|NCT01999335|3910345|FG000|NOT COMPLETED|Overall Study||0
3182180|NCT01999335|3910346|FG001|NOT COMPLETED|Overall Study||0
3182181|NCT01999335|3910347|FG002|NOT COMPLETED|Overall Study||0
3182182|NCT01999335|3910348|FG003|NOT COMPLETED|Overall Study||0
3182183|NCT01999335|3910349|FG004|NOT COMPLETED|Overall Study||2
3182184|NCT01999348|3910364|FG000|STARTED|Overall Study||1553
3182185|NCT01999348|3910364|FG000|COMPLETED|Overall Study||1433
3182186|NCT01999348|3910364|FG000|NOT COMPLETED|Overall Study||120
3182187|NCT01999400|3910368|FG000|STARTED|First Intervention (1 Day)||6
3182188|NCT01999400|3910369|FG001|STARTED|First Intervention (1 Day)||6
3182189|NCT01999400|3910370|FG002|STARTED|First Intervention (1 Day)||5
3182190|NCT01999400|3910371|FG003|STARTED|First Intervention (1 Day)||5
3182191|NCT01999400|3910372|FG004|STARTED|First Intervention (1 Day)||4
3182192|NCT01999400|3910373|FG005|STARTED|First Intervention (1 Day)||4
3182193|NCT01999400|3910368|FG000|COMPLETED|First Intervention (1 Day)||4
3182194|NCT01999400|3910369|FG001|COMPLETED|First Intervention (1 Day)||4
3182195|NCT01999400|3910370|FG002|COMPLETED|First Intervention (1 Day)||3
3182196|NCT01999400|3910371|FG003|COMPLETED|First Intervention (1 Day)||2
3182197|NCT01999400|3910372|FG004|COMPLETED|First Intervention (1 Day)||4
3182198|NCT01999400|3910373|FG005|COMPLETED|First Intervention (1 Day)||3
3182199|NCT01999400|3910368|FG000|NOT COMPLETED|First Intervention (1 Day)||2
3182200|NCT01999400|3910369|FG001|NOT COMPLETED|First Intervention (1 Day)||2
3182201|NCT01999400|3910370|FG002|NOT COMPLETED|First Intervention (1 Day)||2
3182202|NCT01999400|3910371|FG003|NOT COMPLETED|First Intervention (1 Day)||3
3182203|NCT01999400|3910372|FG004|NOT COMPLETED|First Intervention (1 Day)||0
3182204|NCT01999400|3910373|FG005|NOT COMPLETED|First Intervention (1 Day)||1
3182205|NCT01999400|3910368|FG000|STARTED|Washout (10 Days)||5
3182206|NCT01999400|3910369|FG001|STARTED|Washout (10 Days)||4
3182207|NCT01999400|3910370|FG002|STARTED|Washout (10 Days)||3
3182208|NCT01999400|3910371|FG003|STARTED|Washout (10 Days)||2
3182209|NCT01999400|3910372|FG004|STARTED|Washout (10 Days)||3
3182210|NCT01999400|3910373|FG005|STARTED|Washout (10 Days)||3
3182211|NCT01999400|3910368|FG000|COMPLETED|Washout (10 Days)||5
3182212|NCT01999400|3910369|FG001|COMPLETED|Washout (10 Days)||4
3182213|NCT01999400|3910370|FG002|COMPLETED|Washout (10 Days)||3
3182214|NCT01999400|3910371|FG003|COMPLETED|Washout (10 Days)||2
3182215|NCT01999400|3910372|FG004|COMPLETED|Washout (10 Days)||3
3182216|NCT01999400|3910373|FG005|COMPLETED|Washout (10 Days)||3
3182217|NCT01999400|3910368|FG000|NOT COMPLETED|Washout (10 Days)||0
3182218|NCT01999400|3910369|FG001|NOT COMPLETED|Washout (10 Days)||0
3182219|NCT01999400|3910370|FG002|NOT COMPLETED|Washout (10 Days)||0
3182220|NCT01999400|3910371|FG003|NOT COMPLETED|Washout (10 Days)||0
3182221|NCT01999400|3910372|FG004|NOT COMPLETED|Washout (10 Days)||0
3182222|NCT01999400|3910373|FG005|NOT COMPLETED|Washout (10 Days)||0
3182223|NCT01999400|3910368|FG000|STARTED|Second Intervention (1 Day)||5
3182224|NCT01999400|3910369|FG001|STARTED|Second Intervention (1 Day)||4
3182225|NCT01999400|3910370|FG002|STARTED|Second Intervention (1 Day)||3
3182226|NCT01999400|3910371|FG003|STARTED|Second Intervention (1 Day)||2
3182227|NCT01999400|3910372|FG004|STARTED|Second Intervention (1 Day)||3
3182228|NCT01999400|3910373|FG005|STARTED|Second Intervention (1 Day)||3
3182229|NCT01999400|3910368|FG000|COMPLETED|Second Intervention (1 Day)||5
3182230|NCT01999400|3910369|FG001|COMPLETED|Second Intervention (1 Day)||4
3182231|NCT01999400|3910370|FG002|COMPLETED|Second Intervention (1 Day)||3
3182232|NCT01999400|3910371|FG003|COMPLETED|Second Intervention (1 Day)||2
3182233|NCT01999400|3910372|FG004|COMPLETED|Second Intervention (1 Day)||3
3182234|NCT01999400|3910373|FG005|COMPLETED|Second Intervention (1 Day)||3
3182235|NCT01999400|3910368|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
3182236|NCT01999400|3910369|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
3182237|NCT01999400|3910370|FG002|NOT COMPLETED|Second Intervention (1 Day)||0
3182238|NCT01999400|3910371|FG003|NOT COMPLETED|Second Intervention (1 Day)||0
3182239|NCT01999400|3910372|FG004|NOT COMPLETED|Second Intervention (1 Day)||0
3182240|NCT01999400|3910373|FG005|NOT COMPLETED|Second Intervention (1 Day)||0
3182241|NCT01999400|3910368|FG000|STARTED|Washout (10 Days)||2
3182242|NCT01999400|3910369|FG001|STARTED|Washout (10 Days)||0
3148445|NCT01787032|3874606|FG002|STARTED|Overall Study||3
3182243|NCT01999400|3910370|FG002|STARTED|Washout (10 Days)||1
3182244|NCT01999400|3910371|FG003|STARTED|Washout (10 Days)||1
3182245|NCT01999400|3910372|FG004|STARTED|Washout (10 Days)||1
3182246|NCT01999400|3910373|FG005|STARTED|Washout (10 Days)||1
3182247|NCT01999400|3910368|FG000|COMPLETED|Washout (10 Days)||2
3182248|NCT01999400|3910369|FG001|COMPLETED|Washout (10 Days)||0
3182249|NCT01999400|3910370|FG002|COMPLETED|Washout (10 Days)||1
3148446|NCT01787032|3874607|FG003|STARTED|Overall Study||3
3148447|NCT01787032|3874608|FG004|STARTED|Overall Study||4
3148448|NCT01787032|3874609|FG005|STARTED|Overall Study||4
3148449|NCT01787032|3874604|FG000|Received R|Overall Study||3
3148450|NCT01787032|3874605|FG001|Received R|Overall Study||3
3148451|NCT01787032|3874606|FG002|Received R|Overall Study||3
3148452|NCT01787032|3874607|FG003|Received R|Overall Study||3
3148453|NCT01787032|3874608|FG004|Received R|Overall Study||4
3148454|NCT01787032|3874609|FG005|Received R|Overall Study||3
3148455|NCT01787032|3874604|FG000|Received T1|Overall Study||3
3148456|NCT01787032|3874605|FG001|Received T1|Overall Study||3
3148457|NCT01787032|3874606|FG002|Received T1|Overall Study||3
3148458|NCT01787032|3874607|FG003|Received T1|Overall Study||3
3148459|NCT01787032|3874608|FG004|Received T1|Overall Study||3
3148460|NCT01787032|3874609|FG005|Received T1|Overall Study||4
3148461|NCT01787032|3874604|FG000|Received T2|Overall Study||3
3148462|NCT01787032|3874605|FG001|Received T2|Overall Study||3
3148463|NCT01787032|3874606|FG002|Received T2|Overall Study||3
3148464|NCT01787032|3874607|FG003|Received T2|Overall Study||3
3148465|NCT01787032|3874608|FG004|Received T2|Overall Study||4
3148466|NCT01787032|3874609|FG005|Received T2|Overall Study||4
3148467|NCT01787032|3874604|FG000|COMPLETED|Overall Study||3
3148468|NCT01787032|3874605|FG001|COMPLETED|Overall Study||3
3148469|NCT01787032|3874606|FG002|COMPLETED|Overall Study||3
3148470|NCT01787032|3874607|FG003|COMPLETED|Overall Study||3
3148471|NCT01787032|3874608|FG004|COMPLETED|Overall Study||3
3148472|NCT01787032|3874609|FG005|COMPLETED|Overall Study||3
3148473|NCT01787032|3874604|FG000|NOT COMPLETED|Overall Study||0
3148474|NCT01787032|3874605|FG001|NOT COMPLETED|Overall Study||0
3148475|NCT01787032|3874606|FG002|NOT COMPLETED|Overall Study||0
3148476|NCT01787032|3874607|FG003|NOT COMPLETED|Overall Study||0
3148477|NCT01787032|3874608|FG004|NOT COMPLETED|Overall Study||1
3148478|NCT01787032|3874609|FG005|NOT COMPLETED|Overall Study||1
3148479|NCT01787097|3874619|FG000|STARTED|Overall Study|Study started in 2012/2013|8
3148480|NCT01787097|3874620|FG001|STARTED|Overall Study||7
3148481|NCT01787097|3874621|FG002|STARTED|Overall Study||7
3148482|NCT01787097|3874622|FG003|STARTED|Overall Study||9
3148483|NCT01787097|3874619|FG000|COMPLETED|Overall Study|Study completed|7
3148484|NCT01787097|3874620|FG001|COMPLETED|Overall Study||7
3148485|NCT01787097|3874621|FG002|COMPLETED|Overall Study||7
3148486|NCT01787097|3874622|FG003|COMPLETED|Overall Study||9
3148487|NCT01787097|3874619|FG000|NOT COMPLETED|Overall Study||1
3148488|NCT01787097|3874620|FG001|NOT COMPLETED|Overall Study||0
3148489|NCT01787097|3874621|FG002|NOT COMPLETED|Overall Study||0
3148490|NCT01787097|3874622|FG003|NOT COMPLETED|Overall Study||0
3148491|NCT01787175|3874644|FG000|STARTED|Overall Study||30
3148492|NCT01787175|3874645|FG001|STARTED|Overall Study||28
3148493|NCT01787175|3874644|FG000|COMPLETED|Overall Study||30
3148494|NCT01787175|3874645|FG001|COMPLETED|Overall Study||28
3148495|NCT01787175|3874644|FG000|NOT COMPLETED|Overall Study||0
3148496|NCT01787175|3874645|FG001|NOT COMPLETED|Overall Study||0
3148497|NCT01787188|3874654|FG000|STARTED|Overall Study||139
3148498|NCT01787188|3874655|FG001|STARTED|Overall Study||130
3148499|NCT01787188|3874656|FG002|STARTED|Overall Study||134
3148500|NCT01787188|3874654|FG000|COMPLETED|Overall Study||122
3148501|NCT01787188|3874655|FG001|COMPLETED|Overall Study||112
3148502|NCT01787188|3874656|FG002|COMPLETED|Overall Study||116
3148503|NCT01787188|3874654|FG000|NOT COMPLETED|Overall Study||17
3148504|NCT01787188|3874655|FG001|NOT COMPLETED|Overall Study||18
3148505|NCT01787188|3874656|FG002|NOT COMPLETED|Overall Study||18
3148506|NCT01787240|3874666|FG000|STARTED|Overall Study||15
3148507|NCT01787240|3874667|FG001|STARTED|Overall Study||5
3148508|NCT01787240|3874666|FG000|COMPLETED|Overall Study||10
3182250|NCT01999400|3910371|FG003|COMPLETED|Washout (10 Days)||1
3182251|NCT01999400|3910372|FG004|COMPLETED|Washout (10 Days)||1
3182252|NCT01999400|3910373|FG005|COMPLETED|Washout (10 Days)||1
3182253|NCT01999400|3910368|FG000|NOT COMPLETED|Washout (10 Days)||0
3182254|NCT01999400|3910369|FG001|NOT COMPLETED|Washout (10 Days)||0
3182255|NCT01999400|3910370|FG002|NOT COMPLETED|Washout (10 Days)||0
3182256|NCT01999400|3910371|FG003|NOT COMPLETED|Washout (10 Days)||0
3182257|NCT01999400|3910372|FG004|NOT COMPLETED|Washout (10 Days)||0
3182258|NCT01999400|3910373|FG005|NOT COMPLETED|Washout (10 Days)||0
3182259|NCT01999400|3910368|FG000|STARTED|Third Intervention (1 Day)||2
3182260|NCT01999400|3910369|FG001|STARTED|Third Intervention (1 Day)||0
3148509|NCT01787240|3874667|FG001|COMPLETED|Overall Study||4
3148510|NCT01787240|3874666|FG000|NOT COMPLETED|Overall Study||5
3148511|NCT01787240|3874667|FG001|NOT COMPLETED|Overall Study||1
3148512|NCT01787279|3874676|FG000|STARTED|Overall Study||59
3148513|NCT01787279|3874676|FG000|COMPLETED|Overall Study||56
3148514|NCT01787279|3874676|FG000|NOT COMPLETED|Overall Study||3
3148515|NCT01787292|3874680|FG000|STARTED|Crossover Exercise Interventions|Participants in this group performed aerobic training prior to cross-over to balance training.|17
3148516|NCT01787292|3874681|FG001|STARTED|Crossover Exercise Interventions|Participants in this group performed balance training prior to cross-over to aerobic training.|16
3148517|NCT01787292|3874680|FG000|COMPLETED|Crossover Exercise Interventions|Participants completed the 12-week in-house program and cross-over into the balance program.|15
3148518|NCT01787292|3874681|FG001|COMPLETED|Crossover Exercise Interventions|These participants completed the 12-week in-house program and cross-over into the balance program.|14
3148519|NCT01787292|3874680|FG000|NOT COMPLETED|Crossover Exercise Interventions||2
3182261|NCT01999400|3910370|FG002|STARTED|Third Intervention (1 Day)||1
3182262|NCT01999400|3910371|FG003|STARTED|Third Intervention (1 Day)||1
3148520|NCT01787292|3874681|FG001|NOT COMPLETED|Crossover Exercise Interventions||2
3148521|NCT01787292|3874680|FG000|STARTED|Home Based Exercise Program||15
3148522|NCT01787292|3874681|FG001|STARTED|Home Based Exercise Program||14
3148523|NCT01787292|3874680|FG000|COMPLETED|Home Based Exercise Program||12
3148524|NCT01787292|3874681|FG001|COMPLETED|Home Based Exercise Program||13
3148525|NCT01787292|3874680|FG000|NOT COMPLETED|Home Based Exercise Program||3
3148526|NCT01787292|3874681|FG001|NOT COMPLETED|Home Based Exercise Program||1
3148527|NCT01787331|3874692|FG000|STARTED|Overall Study||21
3148528|NCT01787331|3874692|FG000|COMPLETED|Overall Study||19
3148529|NCT01787331|3874692|FG000|NOT COMPLETED|Overall Study||2
3148530|NCT01787383|3874698|FG000|STARTED|Overall Study||101
3148531|NCT01787383|3874699|FG001|STARTED|Overall Study||98
3148532|NCT01787383|3874698|FG000|COMPLETED|Overall Study||92
3148533|NCT01787383|3874699|FG001|COMPLETED|Overall Study||76
3148534|NCT01787383|3874698|FG000|NOT COMPLETED|Overall Study||9
3148535|NCT01787383|3874699|FG001|NOT COMPLETED|Overall Study||22
3148536|NCT01787461|3874715|FG000|STARTED|Overall Study||96
3148537|NCT01787461|3874716|FG001|STARTED|Overall Study||98
3148538|NCT01787461|3874715|FG000|COMPLETED|Overall Study||82
3148539|NCT01787461|3874716|FG001|COMPLETED|Overall Study||89
3148540|NCT01787461|3874715|FG000|NOT COMPLETED|Overall Study||14
3148541|NCT01787461|3874716|FG001|NOT COMPLETED|Overall Study||9
3148542|NCT01787591|3874724|FG000|STARTED|Period 1 (Cross-over Arm 1)||5
3148543|NCT01787591|3874725|FG001|STARTED|Period 1 (Cross-over Arm 1)||5
3148544|NCT01787591|3874726|FG002|STARTED|Period 1 (Cross-over Arm 1)||5
3148545|NCT01787591|3874727|FG003|STARTED|Period 1 (Cross-over Arm 1)||6
3148546|NCT01787591|3874724|FG000|COMPLETED|Period 1 (Cross-over Arm 1)||5
3148547|NCT01787591|3874725|FG001|COMPLETED|Period 1 (Cross-over Arm 1)||5
3148548|NCT01787591|3874726|FG002|COMPLETED|Period 1 (Cross-over Arm 1)||5
3148549|NCT01787591|3874727|FG003|COMPLETED|Period 1 (Cross-over Arm 1)||5
3148550|NCT01787591|3874724|FG000|NOT COMPLETED|Period 1 (Cross-over Arm 1)||0
3148551|NCT01787591|3874725|FG001|NOT COMPLETED|Period 1 (Cross-over Arm 1)||0
3148552|NCT01787591|3874726|FG002|NOT COMPLETED|Period 1 (Cross-over Arm 1)||0
3148553|NCT01787591|3874727|FG003|NOT COMPLETED|Period 1 (Cross-over Arm 1)||1
3148554|NCT01787591|3874724|FG000|STARTED|Period 2 (Cross-over Arm 2)||5
3148555|NCT01787591|3874725|FG001|STARTED|Period 2 (Cross-over Arm 2)||5
3148556|NCT01787591|3874726|FG002|STARTED|Period 2 (Cross-over Arm 2)||5
3148557|NCT01787591|3874727|FG003|STARTED|Period 2 (Cross-over Arm 2)||5
3148558|NCT01787591|3874724|FG000|COMPLETED|Period 2 (Cross-over Arm 2)||5
3148559|NCT01787591|3874725|FG001|COMPLETED|Period 2 (Cross-over Arm 2)||5
3148560|NCT01787591|3874726|FG002|COMPLETED|Period 2 (Cross-over Arm 2)||5
3148561|NCT01787591|3874727|FG003|COMPLETED|Period 2 (Cross-over Arm 2)||5
3148562|NCT01787591|3874724|FG000|NOT COMPLETED|Period 2 (Cross-over Arm 2)||0
3148563|NCT01787591|3874725|FG001|NOT COMPLETED|Period 2 (Cross-over Arm 2)||0
3148564|NCT01787591|3874726|FG002|NOT COMPLETED|Period 2 (Cross-over Arm 2)||0
3148565|NCT01787591|3874727|FG003|NOT COMPLETED|Period 2 (Cross-over Arm 2)||0
3148566|NCT01787591|3874724|FG000|STARTED|Period 3 (Cross-over Arm 3)||5
3148567|NCT01787591|3874725|FG001|STARTED|Period 3 (Cross-over Arm 3)||5
3148568|NCT01787591|3874726|FG002|STARTED|Period 3 (Cross-over Arm 3)||5
3148569|NCT01787591|3874727|FG003|STARTED|Period 3 (Cross-over Arm 3)||5
3148570|NCT01787591|3874724|FG000|COMPLETED|Period 3 (Cross-over Arm 3)||5
3148571|NCT01787591|3874725|FG001|COMPLETED|Period 3 (Cross-over Arm 3)||5
3148572|NCT01787591|3874726|FG002|COMPLETED|Period 3 (Cross-over Arm 3)||5
3148573|NCT01787591|3874727|FG003|COMPLETED|Period 3 (Cross-over Arm 3)||5
3148574|NCT01787591|3874724|FG000|NOT COMPLETED|Period 3 (Cross-over Arm 3)||0
3148575|NCT01787591|3874725|FG001|NOT COMPLETED|Period 3 (Cross-over Arm 3)||0
3148576|NCT01787591|3874726|FG002|NOT COMPLETED|Period 3 (Cross-over Arm 3)||0
3148577|NCT01787591|3874727|FG003|NOT COMPLETED|Period 3 (Cross-over Arm 3)||0
3148578|NCT01787591|3874724|FG000|STARTED|Period 4 (Cross-over Arm 4)||5
3148579|NCT01787591|3874725|FG001|STARTED|Period 4 (Cross-over Arm 4)||5
3148580|NCT01787591|3874726|FG002|STARTED|Period 4 (Cross-over Arm 4)||5
3148581|NCT01787591|3874727|FG003|STARTED|Period 4 (Cross-over Arm 4)||5
3148582|NCT01787591|3874724|FG000|COMPLETED|Period 4 (Cross-over Arm 4)||5
3148583|NCT01787591|3874725|FG001|COMPLETED|Period 4 (Cross-over Arm 4)||5
3148584|NCT01787591|3874726|FG002|COMPLETED|Period 4 (Cross-over Arm 4)||5
3148585|NCT01787591|3874727|FG003|COMPLETED|Period 4 (Cross-over Arm 4)||5
3148586|NCT01787591|3874724|FG000|NOT COMPLETED|Period 4 (Cross-over Arm 4)||0
3148587|NCT01787591|3874725|FG001|NOT COMPLETED|Period 4 (Cross-over Arm 4)||0
3148588|NCT01787591|3874726|FG002|NOT COMPLETED|Period 4 (Cross-over Arm 4)||0
3148589|NCT01787591|3874727|FG003|NOT COMPLETED|Period 4 (Cross-over Arm 4)||0
3148590|NCT01787604|3874740|FG000|STARTED|Overall Study||32
3148591|NCT01787604|3874741|FG001|STARTED|Overall Study||32
3148592|NCT01787604|3874740|FG000|COMPLETED|Overall Study||28
3148593|NCT01787604|3874741|FG001|COMPLETED|Overall Study||28
3148594|NCT01787604|3874740|FG000|NOT COMPLETED|Overall Study||4
3148595|NCT01787604|3874741|FG001|NOT COMPLETED|Overall Study||4
3148596|NCT01787760|3874750|FG000|STARTED|Overall Study||51
3148597|NCT01787760|3874751|FG001|STARTED|Overall Study||50
3148598|NCT01787760|3874752|FG002|STARTED|Overall Study||51
3148599|NCT01787760|3874750|FG000|COMPLETED|Overall Study||25
3148600|NCT01787760|3874751|FG001|COMPLETED|Overall Study||34
3148601|NCT01787760|3874752|FG002|COMPLETED|Overall Study||46
3148602|NCT01787760|3874750|FG000|NOT COMPLETED|Overall Study||26
3148603|NCT01787760|3874751|FG001|NOT COMPLETED|Overall Study||16
3148604|NCT01787760|3874752|FG002|NOT COMPLETED|Overall Study||5
3148605|NCT01787799|3874761|FG000|STARTED|Overall Study||100
3148606|NCT01787799|3874761|FG000|COMPLETED|Overall Study||100
3148607|NCT01787799|3874761|FG000|NOT COMPLETED|Overall Study||0
3148608|NCT01787825|3874765|FG000|STARTED|Overall Study||60
3148609|NCT01787825|3874766|FG001|STARTED|Overall Study||61
3148610|NCT01787825|3874765|FG000|COMPLETED|Overall Study||54
3182263|NCT01999400|3910372|FG004|STARTED|Third Intervention (1 Day)||1
3182264|NCT01999400|3910373|FG005|STARTED|Third Intervention (1 Day)||1
3182265|NCT01999400|3910368|FG000|COMPLETED|Third Intervention (1 Day)||2
3182266|NCT01999400|3910369|FG001|COMPLETED|Third Intervention (1 Day)||0
3182267|NCT01999400|3910370|FG002|COMPLETED|Third Intervention (1 Day)||1
3182268|NCT01999400|3910371|FG003|COMPLETED|Third Intervention (1 Day)||1
3182269|NCT01999400|3910372|FG004|COMPLETED|Third Intervention (1 Day)||1
3182270|NCT01999400|3910373|FG005|COMPLETED|Third Intervention (1 Day)||0
3182271|NCT01999400|3910368|FG000|NOT COMPLETED|Third Intervention (1 Day)||0
3182272|NCT01999400|3910369|FG001|NOT COMPLETED|Third Intervention (1 Day)||0
3182273|NCT01999400|3910370|FG002|NOT COMPLETED|Third Intervention (1 Day)||0
3182274|NCT01999400|3910371|FG003|NOT COMPLETED|Third Intervention (1 Day)||0
3182275|NCT01999400|3910372|FG004|NOT COMPLETED|Third Intervention (1 Day)||0
3182276|NCT01999400|3910373|FG005|NOT COMPLETED|Third Intervention (1 Day)||1
3182277|NCT01999400|3910368|FG000|STARTED|Washout (10 Days)||1
3182278|NCT01999400|3910369|FG001|STARTED|Washout (10 Days)||0
3182279|NCT01999400|3910370|FG002|STARTED|Washout (10 Days)||1
3182280|NCT01999400|3910371|FG003|STARTED|Washout (10 Days)||0
3182281|NCT01999400|3910372|FG004|STARTED|Washout (10 Days)||0
3182282|NCT01999400|3910373|FG005|STARTED|Washout (10 Days)||0
3182283|NCT01999400|3910368|FG000|COMPLETED|Washout (10 Days)||1
3182284|NCT01999400|3910369|FG001|COMPLETED|Washout (10 Days)||0
3182285|NCT01999400|3910370|FG002|COMPLETED|Washout (10 Days)||1
3182286|NCT01999400|3910371|FG003|COMPLETED|Washout (10 Days)||0
3182287|NCT01999400|3910372|FG004|COMPLETED|Washout (10 Days)||0
3182288|NCT01999400|3910373|FG005|COMPLETED|Washout (10 Days)||0
3182289|NCT01999400|3910368|FG000|NOT COMPLETED|Washout (10 Days)||0
3182290|NCT01999400|3910369|FG001|NOT COMPLETED|Washout (10 Days)||0
3182291|NCT01999400|3910370|FG002|NOT COMPLETED|Washout (10 Days)||0
3182292|NCT01999400|3910371|FG003|NOT COMPLETED|Washout (10 Days)||0
3182293|NCT01999400|3910372|FG004|NOT COMPLETED|Washout (10 Days)||0
3182294|NCT01999400|3910373|FG005|NOT COMPLETED|Washout (10 Days)||0
3182295|NCT01999400|3910368|FG000|STARTED|Fourth Intervention (1 Day)||1
3182296|NCT01999400|3910369|FG001|STARTED|Fourth Intervention (1 Day)||0
3182297|NCT01999400|3910370|FG002|STARTED|Fourth Intervention (1 Day)||1
3182298|NCT01999400|3910371|FG003|STARTED|Fourth Intervention (1 Day)||0
3182299|NCT01999400|3910372|FG004|STARTED|Fourth Intervention (1 Day)||0
3182300|NCT01999400|3910373|FG005|STARTED|Fourth Intervention (1 Day)||0
3182301|NCT01999400|3910368|FG000|COMPLETED|Fourth Intervention (1 Day)||1
3182302|NCT01999400|3910369|FG001|COMPLETED|Fourth Intervention (1 Day)||0
3182303|NCT01999400|3910370|FG002|COMPLETED|Fourth Intervention (1 Day)||1
3182304|NCT01999400|3910371|FG003|COMPLETED|Fourth Intervention (1 Day)||0
3182305|NCT01999400|3910372|FG004|COMPLETED|Fourth Intervention (1 Day)||0
3148611|NCT01787825|3874766|FG001|COMPLETED|Overall Study||60
3148612|NCT01787825|3874765|FG000|NOT COMPLETED|Overall Study||6
3148613|NCT01787825|3874766|FG001|NOT COMPLETED|Overall Study||1
3148614|NCT01787838|3874773|FG000|STARTED|Overall Study|This is the number who met Centers for Disease Control and Prevention guidelines for vaccine.|2509
3148615|NCT01787838|3874773|FG000|COMPLETED|Overall Study|This is the number of patients successfully immunized in a one year period.|1096
3148616|NCT01787838|3874773|FG000|NOT COMPLETED|Overall Study||1413
3148617|NCT01787916|3874777|FG000|STARTED|First Intervention (24 Weeks)||8
3148618|NCT01787916|3874778|FG001|STARTED|First Intervention (24 Weeks)||7
3148619|NCT01787916|3874777|FG000|COMPLETED|First Intervention (24 Weeks)||8
3148620|NCT01787916|3874778|FG001|COMPLETED|First Intervention (24 Weeks)||7
3148621|NCT01787916|3874777|FG000|NOT COMPLETED|First Intervention (24 Weeks)||0
3148622|NCT01787916|3874778|FG001|NOT COMPLETED|First Intervention (24 Weeks)||0
3148623|NCT01787916|3874777|FG000|STARTED|Washout (4 Weeks)||8
3148624|NCT01787916|3874778|FG001|STARTED|Washout (4 Weeks)||7
3148625|NCT01787916|3874777|FG000|COMPLETED|Washout (4 Weeks)||8
3148626|NCT01787916|3874778|FG001|COMPLETED|Washout (4 Weeks)||7
3148627|NCT01787916|3874777|FG000|NOT COMPLETED|Washout (4 Weeks)||0
3148628|NCT01787916|3874778|FG001|NOT COMPLETED|Washout (4 Weeks)||0
3148629|NCT01787916|3874777|FG000|STARTED|Second Intervention (24 Weeks)||8
3148630|NCT01787916|3874778|FG001|STARTED|Second Intervention (24 Weeks)||7
3148631|NCT01787916|3874777|FG000|COMPLETED|Second Intervention (24 Weeks)||8
3148632|NCT01787916|3874778|FG001|COMPLETED|Second Intervention (24 Weeks)||7
3148633|NCT01787916|3874777|FG000|NOT COMPLETED|Second Intervention (24 Weeks)||0
3148634|NCT01787916|3874778|FG001|NOT COMPLETED|Second Intervention (24 Weeks)||0
3148635|NCT01788046|3874786|FG000|STARTED|Overall Study||260
3148636|NCT01788046|3874787|FG001|STARTED|Overall Study||255
3148637|NCT01788046|3874786|FG000|Received Treatment|Overall Study||259
3148638|NCT01788046|3874787|FG001|Received Treatment|Overall Study||252
3148639|NCT01788046|3874786|FG000|COMPLETED|Overall Study||204
3148640|NCT01788046|3874787|FG001|COMPLETED|Overall Study||218
3148641|NCT01788046|3874786|FG000|NOT COMPLETED|Overall Study||56
3148642|NCT01788046|3874787|FG001|NOT COMPLETED|Overall Study||37
3148643|NCT01788150|3874795|FG000|STARTED|Overall Study||108
3148644|NCT01788150|3874796|FG001|STARTED|Overall Study||51
3148645|NCT01788150|3874795|FG000|COMPLETED|Overall Study||95
3148646|NCT01788150|3874796|FG001|COMPLETED|Overall Study||48
3148647|NCT01788150|3874795|FG000|NOT COMPLETED|Overall Study||13
3148648|NCT01788150|3874796|FG001|NOT COMPLETED|Overall Study||3
3148649|NCT01788163|3874811|FG000|STARTED|Overall Study||1458
3148650|NCT01788163|3874812|FG001|STARTED|Overall Study||271
3148651|NCT01788163|3874813|FG002|STARTED|Overall Study||62
3148652|NCT01788163|3874814|FG003|STARTED|Overall Study||71
3148653|NCT01788163|3874815|FG004|STARTED|Overall Study||94
3148654|NCT01788163|3874816|FG005|STARTED|Overall Study||102
3148655|NCT01788163|3874817|FG006|STARTED|Overall Study||50
3148656|NCT01788163|3874818|FG007|STARTED|Overall Study||302
3182306|NCT01999400|3910373|FG005|COMPLETED|Fourth Intervention (1 Day)||0
3182307|NCT01999400|3910368|FG000|NOT COMPLETED|Fourth Intervention (1 Day)||0
3182308|NCT01999400|3910369|FG001|NOT COMPLETED|Fourth Intervention (1 Day)||0
3148657|NCT01788163|3874819|FG008|STARTED|Overall Study||972
3148658|NCT01788163|3874811|FG000|COMPLETED|Overall Study||1403
3148659|NCT01788163|3874812|FG001|COMPLETED|Overall Study||271
3148660|NCT01788163|3874813|FG002|COMPLETED|Overall Study||62
3148661|NCT01788163|3874814|FG003|COMPLETED|Overall Study||71
3148662|NCT01788163|3874815|FG004|COMPLETED|Overall Study||94
3148663|NCT01788163|3874816|FG005|COMPLETED|Overall Study||95
3148664|NCT01788163|3874817|FG006|COMPLETED|Overall Study||49
3148665|NCT01788163|3874818|FG007|COMPLETED|Overall Study||254
3148666|NCT01788163|3874819|FG008|COMPLETED|Overall Study||956
3148667|NCT01788163|3874811|FG000|NOT COMPLETED|Overall Study||55
3148668|NCT01788163|3874812|FG001|NOT COMPLETED|Overall Study||0
3148669|NCT01788163|3874813|FG002|NOT COMPLETED|Overall Study||0
3148670|NCT01788163|3874814|FG003|NOT COMPLETED|Overall Study||0
3148671|NCT01788163|3874815|FG004|NOT COMPLETED|Overall Study||0
3148672|NCT01788163|3874816|FG005|NOT COMPLETED|Overall Study||7
3148673|NCT01788163|3874817|FG006|NOT COMPLETED|Overall Study||1
3148674|NCT01788163|3874818|FG007|NOT COMPLETED|Overall Study||48
3148675|NCT01788163|3874819|FG008|NOT COMPLETED|Overall Study||16
3148676|NCT01788215|3874900|FG000|STARTED|Overall Study||5
3148677|NCT01788215|3874901|FG001|STARTED|Overall Study||5
3148678|NCT01788215|3874900|FG000|12 Weeks of Doxycycline or Placebo|Overall Study||5
3148679|NCT01788215|3874901|FG001|12 Weeks of Doxycycline or Placebo|Overall Study||5
3148680|NCT01788215|3874900|FG000|COMPLETED|Overall Study||3
3148681|NCT01788215|3874901|FG001|COMPLETED|Overall Study||4
3148682|NCT01788215|3874900|FG000|NOT COMPLETED|Overall Study||2
3148683|NCT01788215|3874901|FG001|NOT COMPLETED|Overall Study||1
3148684|NCT01788228|3874909|FG000|STARTED|Overall Study||49
3148685|NCT01788228|3874910|FG001|STARTED|Overall Study||1
3148686|NCT01788228|3874909|FG000|COMPLETED|Overall Study||48
3148687|NCT01788228|3874910|FG001|COMPLETED|Overall Study||1
3148688|NCT01788228|3874909|FG000|NOT COMPLETED|Overall Study||1
3148689|NCT01788228|3874910|FG001|NOT COMPLETED|Overall Study||0
3148690|NCT01788358|3874919|FG000|STARTED|Overall Study||508
3148691|NCT01788358|3874919|FG000|Treated|Overall Study||508
3148692|NCT01788358|3874919|FG000|Completed Week 28|Overall Study||417
3148693|NCT01788358|3874919|FG000|Entered Extension to Week 52|Overall Study|Only the first 200 subjects who completed Week 28 visit, continued treatment up to 52 weeks.|200
3148694|NCT01788358|3874919|FG000|Completed Week 52|Overall Study||193
3148695|NCT01788358|3874919|FG000|COMPLETED|Overall Study|217 subjects completed the study at Week 28 while the remaining 193 subjects completed at Week 52|410
3148696|NCT01788358|3874919|FG000|NOT COMPLETED|Overall Study||98
3148697|NCT01788423|3874926|FG000|STARTED|Overall Study||53
3148698|NCT01788423|3874927|FG001|STARTED|Overall Study||55
3148699|NCT01788423|3874928|FG002|STARTED|Overall Study||55
3148700|NCT01788423|3874926|FG000|COMPLETED|Overall Study||53
3148701|NCT01788423|3874927|FG001|COMPLETED|Overall Study|Four participants were unable to self-select hearing aids.|51
3148702|NCT01788423|3874928|FG002|COMPLETED|Overall Study|Three people developed unrelated health problems and two were unable to fit/use hearing aids.|50
3148703|NCT01788423|3874926|FG000|NOT COMPLETED|Overall Study||0
3148704|NCT01788423|3874927|FG001|NOT COMPLETED|Overall Study||4
3148705|NCT01788423|3874928|FG002|NOT COMPLETED|Overall Study||5
3148706|NCT01788566|3874936|FG000|STARTED|Overall Study||61
3148707|NCT01788566|3874936|FG000|COMPLETED|Overall Study||53
3148708|NCT01788566|3874936|FG000|NOT COMPLETED|Overall Study||8
3148709|NCT01788631|3874942|FG000|STARTED|Overall Study||52
3148710|NCT01788631|3874943|FG001|STARTED|Overall Study||44
3148711|NCT01788631|3874942|FG000|Randomized|Overall Study||53
3148712|NCT01788631|3874943|FG001|Randomized|Overall Study||47
3148713|NCT01788631|3874942|FG000|COMPLETED|Overall Study||49
3148714|NCT01788631|3874943|FG001|COMPLETED|Overall Study||43
3148715|NCT01788631|3874942|FG000|NOT COMPLETED|Overall Study||3
3148716|NCT01788631|3874943|FG001|NOT COMPLETED|Overall Study||1
3148717|NCT01788943|3874951|FG000|STARTED|Overall Study|Recruitment for study began.|13
3148718|NCT01788943|3874952|FG001|STARTED|Overall Study||12
3182309|NCT01999400|3910370|FG002|NOT COMPLETED|Fourth Intervention (1 Day)||0
3182310|NCT01999400|3910371|FG003|NOT COMPLETED|Fourth Intervention (1 Day)||0
3182311|NCT01999400|3910372|FG004|NOT COMPLETED|Fourth Intervention (1 Day)||0
3182312|NCT01999400|3910373|FG005|NOT COMPLETED|Fourth Intervention (1 Day)||0
3182313|NCT01999465|3910385|FG000|STARTED|Overall Study||10
3182314|NCT01999465|3910386|FG001|STARTED|Overall Study||10
3148719|NCT01788943|3874951|FG000|COMPLETED|Overall Study|2FA-PET Brain Image Analysis Completion Date|12
3148720|NCT01788943|3874952|FG001|COMPLETED|Overall Study||12
3148721|NCT01788943|3874951|FG000|NOT COMPLETED|Overall Study||1
3148722|NCT01788943|3874952|FG001|NOT COMPLETED|Overall Study||0
3148723|NCT01789047|3874960|FG000|STARTED|Overall Study||21
3148724|NCT01789047|3874961|FG001|STARTED|Overall Study||21
3148725|NCT01789047|3874960|FG000|COMPLETED|Overall Study||17
3148726|NCT01789047|3874961|FG001|COMPLETED|Overall Study||17
3148727|NCT01789047|3874960|FG000|NOT COMPLETED|Overall Study||4
3148728|NCT01789047|3874961|FG001|NOT COMPLETED|Overall Study||4
3148729|NCT01789138|3874969|FG000|STARTED|Overall Study||254
3148730|NCT01789138|3874970|FG001|STARTED|Overall Study||258
3148731|NCT01789138|3874969|FG000|COMPLETED|Overall Study||213
3148732|NCT01789138|3874970|FG001|COMPLETED|Overall Study||206
3148733|NCT01789138|3874969|FG000|NOT COMPLETED|Overall Study||41
3148734|NCT01789138|3874970|FG001|NOT COMPLETED|Overall Study||52
3148735|NCT01789203|3874978|FG000|STARTED|Overall Study||133
3148736|NCT01789203|3874979|FG001|STARTED|Overall Study||67
3148737|NCT01789203|3874978|FG000|COMPLETED|Overall Study||124
3148738|NCT01789203|3874979|FG001|COMPLETED|Overall Study||63
3148739|NCT01789203|3874978|FG000|NOT COMPLETED|Overall Study||9
3148740|NCT01789203|3874979|FG001|NOT COMPLETED|Overall Study||4
3148741|NCT01789255|3874987|FG000|STARTED|Overall Study||12
3148742|NCT01789255|3874987|FG000|COMPLETED|Overall Study||12
3148743|NCT01789255|3874987|FG000|NOT COMPLETED|Overall Study||0
3148744|NCT01789281|3874993|FG000|STARTED|Overall Study||22
3148745|NCT01789281|3874994|FG001|STARTED|Overall Study||12
3148746|NCT01789281|3874993|FG000|COMPLETED|Overall Study||0
3148747|NCT01789281|3874994|FG001|COMPLETED|Overall Study||2
3148748|NCT01789281|3874993|FG000|NOT COMPLETED|Overall Study||22
3148749|NCT01789281|3874994|FG001|NOT COMPLETED|Overall Study||10
3148750|NCT01789320|3875001|FG000|STARTED|Overall Study||11
3148751|NCT01789320|3875001|FG000|COMPLETED|Overall Study||9
3148752|NCT01789320|3875001|FG000|NOT COMPLETED|Overall Study||2
3148753|NCT01789476|3875007|FG000|STARTED|Overall Study||34
3148754|NCT01789476|3875008|FG001|STARTED|Overall Study||17
3148755|NCT01789476|3875007|FG000|COMPLETED|Overall Study||26
3148756|NCT01789476|3875008|FG001|COMPLETED|Overall Study||15
3148757|NCT01789476|3875007|FG000|NOT COMPLETED|Overall Study||8
3148758|NCT01789476|3875008|FG001|NOT COMPLETED|Overall Study||2
3148759|NCT01789567|3875014|FG000|STARTED|Overall Study||20
3148760|NCT01789567|3875014|FG000|COMPLETED|Overall Study||14
3148761|NCT01789567|3875014|FG000|NOT COMPLETED|Overall Study||6
3148762|NCT01789606|3875020|FG000|STARTED|Overall Study||251
3148763|NCT01789606|3875021|FG001|STARTED|Overall Study||832
3148764|NCT01789606|3875020|FG000|COMPLETED|Overall Study||228
3148765|NCT01789606|3875021|FG001|COMPLETED|Overall Study||382
3148766|NCT01789606|3875020|FG000|NOT COMPLETED|Overall Study||23
3148767|NCT01789606|3875021|FG001|NOT COMPLETED|Overall Study||450
3148768|NCT01789775|3875028|FG000|STARTED|Overall Study||55
3148769|NCT01789775|3875029|FG001|STARTED|Overall Study||57
3148770|NCT01789775|3875028|FG000|COMPLETED|Overall Study||53
3148771|NCT01789775|3875029|FG001|COMPLETED|Overall Study||50
3148772|NCT01789775|3875028|FG000|NOT COMPLETED|Overall Study||2
3148773|NCT01789775|3875029|FG001|NOT COMPLETED|Overall Study||7
3182315|NCT01999465|3910385|FG000|COMPLETED|Overall Study||10
3182316|NCT01999465|3910386|FG001|COMPLETED|Overall Study||7
3182317|NCT01999465|3910385|FG000|NOT COMPLETED|Overall Study||0
3182318|NCT01999465|3910386|FG001|NOT COMPLETED|Overall Study||3
3182319|NCT01999517|3910394|FG000|STARTED|Overall Study||68
3182320|NCT01999517|3910395|FG001|STARTED|Overall Study||54
3182321|NCT01999517|3910394|FG000|COMPLETED|Overall Study||68
3182322|NCT01999517|3910395|FG001|COMPLETED|Overall Study||54
3182323|NCT01999517|3910394|FG000|NOT COMPLETED|Overall Study||0
3182324|NCT01999517|3910395|FG001|NOT COMPLETED|Overall Study||0
3182325|NCT01999530|3910401|FG000|STARTED|Overall Study||20
3182326|NCT01999530|3910401|FG000|COMPLETED|Overall Study||7
3182327|NCT01999530|3910401|FG000|NOT COMPLETED|Overall Study||13
3182328|NCT01999569|3910405|FG000|STARTED|Control Cycle|First cycle no meds|10
3182329|NCT01999569|3910405|FG000|COMPLETED|Control Cycle||10
3182330|NCT01999569|3910405|FG000|NOT COMPLETED|Control Cycle||0
3182331|NCT01999569|3910405|FG000|STARTED|Letrozole Treatment Cycle||10
3182332|NCT01999569|3910405|FG000|COMPLETED|Letrozole Treatment Cycle||10
3182333|NCT01999569|3910405|FG000|NOT COMPLETED|Letrozole Treatment Cycle||0
3182334|NCT01999777|3910414|FG000|STARTED|Overall Study||31
3182335|NCT01999777|3910415|FG001|STARTED|Overall Study||31
3182336|NCT01999777|3910414|FG000|COMPLETED|Overall Study||31
3182337|NCT01999777|3910415|FG001|COMPLETED|Overall Study||31
3182338|NCT01999777|3910414|FG000|NOT COMPLETED|Overall Study||0
3182339|NCT01999777|3910415|FG001|NOT COMPLETED|Overall Study||0
3182340|NCT01999868|3910424|FG000|STARTED|Lead-in Phase (Week 0 - 12)||45
3182341|NCT01999868|3910425|FG001|STARTED|Lead-in Phase (Week 0 - 12)||46
3182342|NCT01999868|3910426|FG002|STARTED|Lead-in Phase (Week 0 - 12)||17
3182343|NCT01999868|3910424|FG000|COMPLETED|Lead-in Phase (Week 0 - 12)||45
3182344|NCT01999868|3910425|FG001|COMPLETED|Lead-in Phase (Week 0 - 12)||46
3182345|NCT01999868|3910426|FG002|COMPLETED|Lead-in Phase (Week 0 - 12)||12
3182346|NCT01999868|3910424|FG000|NOT COMPLETED|Lead-in Phase (Week 0 - 12)||0
3182347|NCT01999868|3910425|FG001|NOT COMPLETED|Lead-in Phase (Week 0 - 12)||0
3182348|NCT01999868|3910426|FG002|NOT COMPLETED|Lead-in Phase (Week 0 - 12)||5
3182349|NCT01999868|3910424|FG000|STARTED|Blinded Treatment Phase (Week 12 - 40)||45
3182350|NCT01999868|3910425|FG001|STARTED|Blinded Treatment Phase (Week 12 - 40)||46
3182351|NCT01999868|3910426|FG002|STARTED|Blinded Treatment Phase (Week 12 - 40)|Participants didn't meet eligibility requirements for randomization or withdrew prior to Week 12.|0
3182352|NCT01999868|3910424|FG000|COMPLETED|Blinded Treatment Phase (Week 12 - 40)||27
3148774|NCT01789814|3875037|FG000|STARTED|Overall Study||12
3148775|NCT01789814|3875038|FG001|STARTED|Overall Study||12
3148776|NCT01789814|3875037|FG000|COMPLETED|Overall Study||12
3148777|NCT01789814|3875038|FG001|COMPLETED|Overall Study||12
3148778|NCT01789814|3875037|FG000|NOT COMPLETED|Overall Study||0
3148779|NCT01789814|3875038|FG001|NOT COMPLETED|Overall Study||0
3148780|NCT01789840|3875046|FG000|STARTED|Overall Study||52
3148781|NCT01789840|3875047|FG001|STARTED|Overall Study||7
3148782|NCT01789840|3875046|FG000|COMPLETED|Overall Study||52
3148783|NCT01789840|3875047|FG001|COMPLETED|Overall Study||6
3148784|NCT01789840|3875046|FG000|NOT COMPLETED|Overall Study||0
3148785|NCT01789840|3875047|FG001|NOT COMPLETED|Overall Study||1
3148786|NCT01789905|3875055|FG000|STARTED|Overall Study||116
3148787|NCT01789905|3875055|FG000|COMPLETED|Overall Study||116
3148788|NCT01789905|3875055|FG000|NOT COMPLETED|Overall Study||0
3148789|NCT01789970|3875061|FG000|STARTED|Open-label Titration Period||625
3148790|NCT01789970|3875062|FG001|STARTED|Open-label Titration Period||0
3148791|NCT01789970|3875063|FG002|STARTED|Open-label Titration Period||0
3148792|NCT01789970|3875061|FG000|Safety Analysis Set|Open-label Titration Period|Two enrolled patients were not treated|623
3148793|NCT01789970|3875062|FG001|Safety Analysis Set|Open-label Titration Period||0
3148794|NCT01789970|3875063|FG002|Safety Analysis Set|Open-label Titration Period||0
3148795|NCT01789970|3875061|FG000|COMPLETED|Open-label Titration Period||371
3148796|NCT01789970|3875062|FG001|COMPLETED|Open-label Titration Period||0
3148797|NCT01789970|3875063|FG002|COMPLETED|Open-label Titration Period||0
3148798|NCT01789970|3875061|FG000|NOT COMPLETED|Open-label Titration Period||254
3148799|NCT01789970|3875062|FG001|NOT COMPLETED|Open-label Titration Period||0
3148800|NCT01789970|3875063|FG002|NOT COMPLETED|Open-label Titration Period||0
3148801|NCT01789970|3875061|FG000|STARTED|Double-blind Treatment Period (12 Weeks)||0
3148802|NCT01789970|3875062|FG001|STARTED|Double-blind Treatment Period (12 Weeks)||180
3148803|NCT01789970|3875063|FG002|STARTED|Double-blind Treatment Period (12 Weeks)||191
3148804|NCT01789970|3875061|FG000|Full Analysis Set and Safety Set|Double-blind Treatment Period (12 Weeks)||0
3148805|NCT01789970|3875062|FG001|Full Analysis Set and Safety Set|Double-blind Treatment Period (12 Weeks)|One participant was randomized but not treated.|179
3148806|NCT01789970|3875063|FG002|Full Analysis Set and Safety Set|Double-blind Treatment Period (12 Weeks)||191
3148807|NCT01789970|3875061|FG000|COMPLETED|Double-blind Treatment Period (12 Weeks)||0
3148808|NCT01789970|3875062|FG001|COMPLETED|Double-blind Treatment Period (12 Weeks)||130
3148809|NCT01789970|3875063|FG002|COMPLETED|Double-blind Treatment Period (12 Weeks)||147
3148810|NCT01789970|3875061|FG000|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||0
3148811|NCT01789970|3875062|FG001|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||50
3148812|NCT01789970|3875063|FG002|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||44
3148813|NCT01790048|3875079|FG000|STARTED|Overall Study||1156
3148814|NCT01790048|3875080|FG001|STARTED|Overall Study||1103
3148815|NCT01790048|3875079|FG000|COMPLETED|Overall Study||1144
3148816|NCT01790048|3875080|FG001|COMPLETED|Overall Study||1086
3148817|NCT01790048|3875079|FG000|NOT COMPLETED|Overall Study||12
3148818|NCT01790048|3875080|FG001|NOT COMPLETED|Overall Study||17
3148819|NCT01790113|3875090|FG000|STARTED|Overall Study||79
3148820|NCT01790113|3875091|FG001|STARTED|Overall Study||224
3148821|NCT01790113|3875090|FG000|COMPLETED|Overall Study||76
3148822|NCT01790113|3875091|FG001|COMPLETED|Overall Study||149
3148823|NCT01790113|3875090|FG000|NOT COMPLETED|Overall Study||3
3148824|NCT01790113|3875091|FG001|NOT COMPLETED|Overall Study||75
3148825|NCT01790126|3875100|FG000|STARTED|Overall Study||30
3148826|NCT01790126|3875101|FG001|STARTED|Overall Study||29
3148827|NCT01790126|3875102|FG002|STARTED|Overall Study||31
3148828|NCT01790126|3875100|FG000|Treated|Overall Study||29
3148829|NCT01790126|3875101|FG001|Treated|Overall Study||29
3148830|NCT01790126|3875102|FG002|Treated|Overall Study||31
3148831|NCT01790126|3875100|FG000|COMPLETED|Overall Study||0
3148832|NCT01790126|3875101|FG001|COMPLETED|Overall Study||0
3182353|NCT01999868|3910425|FG001|COMPLETED|Blinded Treatment Phase (Week 12 - 40)||35
3182354|NCT01999868|3910426|FG002|COMPLETED|Blinded Treatment Phase (Week 12 - 40)||0
3182355|NCT01999868|3910424|FG000|NOT COMPLETED|Blinded Treatment Phase (Week 12 - 40)||18
3182356|NCT01999868|3910425|FG001|NOT COMPLETED|Blinded Treatment Phase (Week 12 - 40)||11
3182357|NCT01999868|3910426|FG002|NOT COMPLETED|Blinded Treatment Phase (Week 12 - 40)||0
3182358|NCT01999868|3910424|FG000|STARTED|Blinded Observation Phase (Week 40 - 88)||27
3182359|NCT01999868|3910425|FG001|STARTED|Blinded Observation Phase (Week 40 - 88)||35
3182360|NCT01999868|3910426|FG002|STARTED|Blinded Observation Phase (Week 40 - 88)||0
3182361|NCT01999868|3910424|FG000|COMPLETED|Blinded Observation Phase (Week 40 - 88)||4
3182362|NCT01999868|3910425|FG001|COMPLETED|Blinded Observation Phase (Week 40 - 88)||6
3182363|NCT01999868|3910426|FG002|COMPLETED|Blinded Observation Phase (Week 40 - 88)||0
3182364|NCT01999868|3910424|FG000|NOT COMPLETED|Blinded Observation Phase (Week 40 - 88)||23
3182365|NCT01999868|3910425|FG001|NOT COMPLETED|Blinded Observation Phase (Week 40 - 88)||29
3182366|NCT01999868|3910426|FG002|NOT COMPLETED|Blinded Observation Phase (Week 40 - 88)||0
3182367|NCT01999894|3910434|FG000|STARTED|Overall Study||102
3182368|NCT01999894|3910434|FG000|COMPLETED|Overall Study||66
3182369|NCT01999894|3910434|FG000|NOT COMPLETED|Overall Study||36
3182370|NCT01999920|3910441|FG000|STARTED|Overall Study||13
3182371|NCT01999920|3910442|FG001|STARTED|Overall Study||11
3182372|NCT01999920|3910441|FG000|COMPLETED|Overall Study||7
3182373|NCT01999920|3910442|FG001|COMPLETED|Overall Study||9
3182374|NCT01999920|3910441|FG000|NOT COMPLETED|Overall Study||6
3148833|NCT01790126|3875102|FG002|COMPLETED|Overall Study||0
3148834|NCT01790126|3875100|FG000|NOT COMPLETED|Overall Study||30
3148835|NCT01790126|3875101|FG001|NOT COMPLETED|Overall Study||29
3148836|NCT01790126|3875102|FG002|NOT COMPLETED|Overall Study||31
3148837|NCT01790178|3875113|FG000|STARTED|Overall Study||16
3148838|NCT01790178|3875114|FG001|STARTED|Overall Study||24
3148839|NCT01790178|3875113|FG000|COMPLETED|Overall Study||16
3148840|NCT01790178|3875114|FG001|COMPLETED|Overall Study||24
3148841|NCT01790178|3875113|FG000|NOT COMPLETED|Overall Study||0
3148842|NCT01790178|3875114|FG001|NOT COMPLETED|Overall Study||0
3148843|NCT01790243|3875122|FG000|STARTED|Overall Study||1029
3148844|NCT01790243|3875123|FG001|STARTED|Overall Study||160
3148845|NCT01790243|3875122|FG000|COMPLETED|Overall Study||739
3148846|NCT01790243|3875123|FG001|COMPLETED|Overall Study||117
3148847|NCT01790243|3875122|FG000|NOT COMPLETED|Overall Study||290
3148848|NCT01790243|3875123|FG001|NOT COMPLETED|Overall Study||43
3148849|NCT01790295|3875129|FG000|STARTED|Overall Study||21
3148850|NCT01790295|3875129|FG000|COMPLETED|Overall Study||10
3148851|NCT01790295|3875129|FG000|NOT COMPLETED|Overall Study||11
3148852|NCT01790438|3875136|FG000|STARTED|Overall Study||428
3148853|NCT01790438|3875137|FG001|STARTED|Overall Study||213
3148854|NCT01790438|3875136|FG000|Received at Least One Dose of Study Drug|Overall Study||427
3148855|NCT01790438|3875137|FG001|Received at Least One Dose of Study Drug|Overall Study||212
3148856|NCT01790438|3875136|FG000|COMPLETED|Overall Study||393
3148857|NCT01790438|3875137|FG001|COMPLETED|Overall Study||202
3148858|NCT01790438|3875136|FG000|NOT COMPLETED|Overall Study||35
3148859|NCT01790438|3875137|FG001|NOT COMPLETED|Overall Study||11
3148860|NCT01790490|3875148|FG000|STARTED|Overall Study||3
3148861|NCT01790490|3875149|FG001|STARTED|Overall Study||3
3148862|NCT01790490|3875150|FG002|STARTED|Overall Study||2
3148863|NCT01790490|3875148|FG000|COMPLETED|Overall Study||3
3148864|NCT01790490|3875149|FG001|COMPLETED|Overall Study||3
3148865|NCT01790490|3875150|FG002|COMPLETED|Overall Study||2
3148866|NCT01790490|3875148|FG000|NOT COMPLETED|Overall Study||0
3148867|NCT01790490|3875149|FG001|NOT COMPLETED|Overall Study||0
3148868|NCT01790490|3875150|FG002|NOT COMPLETED|Overall Study||0
3148869|NCT01790503|3875172|FG000|STARTED|Overall Study||3
3148870|NCT01790503|3875173|FG001|STARTED|Overall Study||1
3148871|NCT01790503|3875174|FG002|STARTED|Overall Study||1
3148872|NCT01790503|3875175|FG003|STARTED|Overall Study||2
3148873|NCT01790503|3875176|FG004|STARTED|Overall Study||5
3148874|NCT01790503|3875177|FG005|STARTED|Overall Study||5
3148875|NCT01790503|3875178|FG006|STARTED|Overall Study||1
3148876|NCT01790503|3875179|FG007|STARTED|Overall Study||1
3148877|NCT01790503|3875180|FG008|STARTED|Overall Study||3
3148878|NCT01790503|3875181|FG009|STARTED|Overall Study||27
3148879|NCT01790503|3875182|FG010|STARTED|Overall Study||16
3148880|NCT01790503|3875172|FG000|COMPLETED|Overall Study||0
3148881|NCT01790503|3875173|FG001|COMPLETED|Overall Study||0
3148882|NCT01790503|3875174|FG002|COMPLETED|Overall Study||0
3148883|NCT01790503|3875175|FG003|COMPLETED|Overall Study||0
3148884|NCT01790503|3875176|FG004|COMPLETED|Overall Study||0
3148885|NCT01790503|3875177|FG005|COMPLETED|Overall Study||0
3148886|NCT01790503|3875178|FG006|COMPLETED|Overall Study||0
3148887|NCT01790503|3875179|FG007|COMPLETED|Overall Study||0
3148888|NCT01790503|3875180|FG008|COMPLETED|Overall Study||0
3148889|NCT01790503|3875181|FG009|COMPLETED|Overall Study||1
3148890|NCT01790503|3875182|FG010|COMPLETED|Overall Study||0
3148891|NCT01790503|3875172|FG000|NOT COMPLETED|Overall Study||3
3148892|NCT01790503|3875173|FG001|NOT COMPLETED|Overall Study||1
3148893|NCT01790503|3875174|FG002|NOT COMPLETED|Overall Study||1
3148894|NCT01790503|3875175|FG003|NOT COMPLETED|Overall Study||2
3148895|NCT01790503|3875176|FG004|NOT COMPLETED|Overall Study||5
3148896|NCT01790503|3875177|FG005|NOT COMPLETED|Overall Study||5
3148897|NCT01790503|3875178|FG006|NOT COMPLETED|Overall Study||1
3148898|NCT01790503|3875179|FG007|NOT COMPLETED|Overall Study||1
3148899|NCT01790503|3875180|FG008|NOT COMPLETED|Overall Study||3
3148900|NCT01790503|3875181|FG009|NOT COMPLETED|Overall Study||26
3148901|NCT01790503|3875182|FG010|NOT COMPLETED|Overall Study||16
3148902|NCT01790516|3875221|FG000|STARTED|Overall Study||1
3148903|NCT01790516|3875222|FG001|STARTED|Overall Study||1
3148904|NCT01790516|3875221|FG000|COMPLETED|Overall Study||0
3182375|NCT01999920|3910442|FG001|NOT COMPLETED|Overall Study||2
3182376|NCT01999946|3910451|FG000|STARTED|Overall Study||61
3182377|NCT01999946|3910452|FG001|STARTED|Overall Study||58
3182378|NCT01999946|3910453|FG002|STARTED|Overall Study||79
3182379|NCT01999946|3910451|FG000|COMPLETED|Overall Study||59
3363626|NCT04045964|4094763|FG001|STARTED|Overall Study||16
3363627|NCT04045964|4094762|FG000|Intervention Visit(s)|Overall Study||15
3363628|NCT04045964|4094763|FG001|Intervention Visit(s)|Overall Study||16
3363629|NCT04045964|4094762|FG000|Follow up Visit 1|Overall Study||15
3363630|NCT04045964|4094763|FG001|Follow up Visit 1|Overall Study||15
3363631|NCT04045964|4094762|FG000|Follow up Visit 2|Overall Study||15
3363632|NCT04045964|4094763|FG001|Follow up Visit 2|Overall Study||15
3363633|NCT04045964|4094762|FG000|COMPLETED|Overall Study||15
3363634|NCT04045964|4094763|FG001|COMPLETED|Overall Study||15
3363635|NCT04045964|4094762|FG000|NOT COMPLETED|Overall Study||1
3148905|NCT01790516|3875222|FG001|COMPLETED|Overall Study||1
3148906|NCT01790516|3875221|FG000|NOT COMPLETED|Overall Study||1
3148907|NCT01790516|3875222|FG001|NOT COMPLETED|Overall Study||0
3148908|NCT01790568|3875228|FG000|STARTED|Overall Study||12
3148909|NCT01790568|3875229|FG001|STARTED|Overall Study||26
3148910|NCT01790568|3875228|FG000|COMPLETED|Overall Study||12
3148911|NCT01790568|3875229|FG001|COMPLETED|Overall Study||25
3148912|NCT01790568|3875228|FG000|NOT COMPLETED|Overall Study||0
3148913|NCT01790568|3875229|FG001|NOT COMPLETED|Overall Study||1
3148914|NCT01790581|3875235|FG000|STARTED|Overall Study||12
3148915|NCT01790581|3875236|FG001|STARTED|Overall Study||12
3148916|NCT01790581|3875235|FG000|COMPLETED|Overall Study||12
3148917|NCT01790581|3875236|FG001|COMPLETED|Overall Study||12
3148918|NCT01790581|3875235|FG000|NOT COMPLETED|Overall Study||0
3148919|NCT01790581|3875236|FG001|NOT COMPLETED|Overall Study||0
3148920|NCT01790594|3875244|FG000|STARTED|Overall Study||22
3148921|NCT01790594|3875245|FG001|STARTED|Overall Study||21
3148922|NCT01790594|3875246|FG002|STARTED|Overall Study||3
3148923|NCT01790594|3875244|FG000|COMPLETED|Overall Study||17
3148924|NCT01790594|3875245|FG001|COMPLETED|Overall Study||18
3148925|NCT01790594|3875246|FG002|COMPLETED|Overall Study||0
3148926|NCT01790594|3875244|FG000|NOT COMPLETED|Overall Study||5
3148927|NCT01790594|3875245|FG001|NOT COMPLETED|Overall Study||3
3148928|NCT01790594|3875246|FG002|NOT COMPLETED|Overall Study||3
3148929|NCT01790633|3875255|FG000|STARTED|Overall Study||163
3148930|NCT01790633|3875256|FG001|STARTED|Overall Study||164
3148931|NCT01790633|3875255|FG000|COMPLETED|Overall Study||115
3148932|NCT01790633|3875256|FG001|COMPLETED|Overall Study||159
3148933|NCT01790633|3875255|FG000|NOT COMPLETED|Overall Study||48
3148934|NCT01790633|3875256|FG001|NOT COMPLETED|Overall Study||5
3148935|NCT01790659|3875265|FG000|STARTED|Overall Study||201
3148936|NCT01790659|3875266|FG001|STARTED|Overall Study||198
3148937|NCT01790659|3875265|FG000|COMPLETED|Overall Study||195
3148938|NCT01790659|3875266|FG001|COMPLETED|Overall Study||192
3148939|NCT01790659|3875265|FG000|NOT COMPLETED|Overall Study||6
3148940|NCT01790659|3875266|FG001|NOT COMPLETED|Overall Study||6
3148941|NCT01790685|3875274|FG000|STARTED|Overall Study||23
3148942|NCT01790685|3875275|FG001|STARTED|Overall Study||17
3148943|NCT01790685|3875274|FG000|COMPLETED|Overall Study||23
3148944|NCT01790685|3875275|FG001|COMPLETED|Overall Study||17
3148945|NCT01790685|3875274|FG000|NOT COMPLETED|Overall Study||0
3148946|NCT01790685|3875275|FG001|NOT COMPLETED|Overall Study||0
3148947|NCT01790750|3875281|FG000|STARTED|Overall Study||50
3148948|NCT01790750|3875281|FG000|COMPLETED|Overall Study||50
3148949|NCT01790750|3875281|FG000|NOT COMPLETED|Overall Study||0
3148950|NCT01790828|3875286|FG000|STARTED|Overall Study||42
3148951|NCT01790828|3875286|FG000|COMPLETED|Overall Study||8
3148952|NCT01790828|3875286|FG000|NOT COMPLETED|Overall Study||34
3148953|NCT01790932|3875290|FG000|STARTED|Overall Study||50
3148954|NCT01790932|3875290|FG000|COMPLETED|Overall Study||0
3148955|NCT01790932|3875290|FG000|NOT COMPLETED|Overall Study||50
3148956|NCT01790984|3875296|FG000|STARTED|First Dietary Intervention (12 Weeks)||6
3148957|NCT01790984|3875297|FG001|STARTED|First Dietary Intervention (12 Weeks)||8
3148958|NCT01790984|3875298|FG002|STARTED|First Dietary Intervention (12 Weeks)||6
3148959|NCT01790984|3875299|FG003|STARTED|First Dietary Intervention (12 Weeks)||7
3148960|NCT01790984|3875296|FG000|COMPLETED|First Dietary Intervention (12 Weeks)||5
3148961|NCT01790984|3875297|FG001|COMPLETED|First Dietary Intervention (12 Weeks)||7
3148962|NCT01790984|3875298|FG002|COMPLETED|First Dietary Intervention (12 Weeks)||6
3148963|NCT01790984|3875299|FG003|COMPLETED|First Dietary Intervention (12 Weeks)||7
3148964|NCT01790984|3875296|FG000|NOT COMPLETED|First Dietary Intervention (12 Weeks)||1
3148965|NCT01790984|3875297|FG001|NOT COMPLETED|First Dietary Intervention (12 Weeks)||1
3148966|NCT01790984|3875298|FG002|NOT COMPLETED|First Dietary Intervention (12 Weeks)||0
3148967|NCT01790984|3875299|FG003|NOT COMPLETED|First Dietary Intervention (12 Weeks)||0
3148968|NCT01790984|3875296|FG000|STARTED|Wash-out (4 Weeks)||5
3148969|NCT01790984|3875297|FG001|STARTED|Wash-out (4 Weeks)||7
3148970|NCT01790984|3875298|FG002|STARTED|Wash-out (4 Weeks)||6
3148971|NCT01790984|3875299|FG003|STARTED|Wash-out (4 Weeks)||7
3148972|NCT01790984|3875296|FG000|COMPLETED|Wash-out (4 Weeks)||5
3148973|NCT01790984|3875297|FG001|COMPLETED|Wash-out (4 Weeks)||7
3148974|NCT01790984|3875298|FG002|COMPLETED|Wash-out (4 Weeks)||6
3148975|NCT01790984|3875299|FG003|COMPLETED|Wash-out (4 Weeks)||7
3148976|NCT01790984|3875296|FG000|NOT COMPLETED|Wash-out (4 Weeks)||0
3148977|NCT01790984|3875297|FG001|NOT COMPLETED|Wash-out (4 Weeks)||0
3148978|NCT01790984|3875298|FG002|NOT COMPLETED|Wash-out (4 Weeks)||0
3148979|NCT01790984|3875299|FG003|NOT COMPLETED|Wash-out (4 Weeks)||0
3148980|NCT01790984|3875296|FG000|STARTED|Second Dietary Intervention (12 Weeks)||5
3148981|NCT01790984|3875297|FG001|STARTED|Second Dietary Intervention (12 Weeks)||7
3148982|NCT01790984|3875298|FG002|STARTED|Second Dietary Intervention (12 Weeks)||6
3148983|NCT01790984|3875299|FG003|STARTED|Second Dietary Intervention (12 Weeks)||7
3148984|NCT01790984|3875296|FG000|COMPLETED|Second Dietary Intervention (12 Weeks)||5
3148985|NCT01790984|3875297|FG001|COMPLETED|Second Dietary Intervention (12 Weeks)||7
3148986|NCT01790984|3875298|FG002|COMPLETED|Second Dietary Intervention (12 Weeks)||6
3148987|NCT01790984|3875299|FG003|COMPLETED|Second Dietary Intervention (12 Weeks)||7
3148988|NCT01790984|3875296|FG000|NOT COMPLETED|Second Dietary Intervention (12 Weeks)||0
3148989|NCT01790984|3875297|FG001|NOT COMPLETED|Second Dietary Intervention (12 Weeks)||0
3148990|NCT01790984|3875298|FG002|NOT COMPLETED|Second Dietary Intervention (12 Weeks)||0
3148991|NCT01790984|3875299|FG003|NOT COMPLETED|Second Dietary Intervention (12 Weeks)||0
3148992|NCT01791127|3875322|FG000|STARTED|Overall Study||1758
3148993|NCT01791127|3875322|FG000|COMPLETED|Overall Study||286
3148994|NCT01791127|3875322|FG000|NOT COMPLETED|Overall Study||1472
3148995|NCT01791153|3875343|FG000|STARTED|Part 1: Blinded Period||100
3148996|NCT01791153|3875344|FG001|STARTED|Part 1: Blinded Period||49
3148997|NCT01791153|3875345|FG002|STARTED|Part 1: Blinded Period||50
3148998|NCT01791153|3875346|FG003|STARTED|Part 1: Blinded Period||51
3148999|NCT01791153|3875347|FG004|STARTED|Part 1: Blinded Period||0
3149000|NCT01791153|3875348|FG005|STARTED|Part 1: Blinded Period||0
3149001|NCT01791153|3875349|FG006|STARTED|Part 1: Blinded Period||0
3149002|NCT01791153|3875350|FG007|STARTED|Part 1: Blinded Period||0
3149003|NCT01791153|3875343|FG000|COMPLETED|Part 1: Blinded Period|Completed Study to Week 52|85
3149004|NCT01791153|3875344|FG001|COMPLETED|Part 1: Blinded Period|Completed Study to Week 52|41
3149005|NCT01791153|3875345|FG002|COMPLETED|Part 1: Blinded Period|Completed Study to Week 52|44
3149006|NCT01791153|3875346|FG003|COMPLETED|Part 1: Blinded Period|Completed Study to Week 52|46
3149007|NCT01791153|3875347|FG004|COMPLETED|Part 1: Blinded Period||0
3149008|NCT01791153|3875348|FG005|COMPLETED|Part 1: Blinded Period||0
3149009|NCT01791153|3875349|FG006|COMPLETED|Part 1: Blinded Period||0
3149010|NCT01791153|3875350|FG007|COMPLETED|Part 1: Blinded Period||0
3149011|NCT01791153|3875343|FG000|NOT COMPLETED|Part 1: Blinded Period||15
3149012|NCT01791153|3875344|FG001|NOT COMPLETED|Part 1: Blinded Period||8
3149013|NCT01791153|3875345|FG002|NOT COMPLETED|Part 1: Blinded Period||6
3149014|NCT01791153|3875346|FG003|NOT COMPLETED|Part 1: Blinded Period||5
3149015|NCT01791153|3875347|FG004|NOT COMPLETED|Part 1: Blinded Period||0
3149016|NCT01791153|3875348|FG005|NOT COMPLETED|Part 1: Blinded Period||0
3149017|NCT01791153|3875349|FG006|NOT COMPLETED|Part 1: Blinded Period||0
3149018|NCT01791153|3875350|FG007|NOT COMPLETED|Part 1: Blinded Period||0
3149019|NCT01791153|3875343|FG000|STARTED|Part 2: Open-label Period||0
3149020|NCT01791153|3875344|FG001|STARTED|Part 2: Open-label Period||0
3149021|NCT01791153|3875345|FG002|STARTED|Part 2: Open-label Period||0
3149022|NCT01791153|3875346|FG003|STARTED|Part 2: Open-label Period||0
3149023|NCT01791153|3875347|FG004|STARTED|Part 2: Open-label Period||40
3182380|NCT01999946|3910452|FG001|COMPLETED|Overall Study||56
3182381|NCT01999946|3910453|FG002|COMPLETED|Overall Study||0
3182382|NCT01999946|3910451|FG000|NOT COMPLETED|Overall Study||2
3182383|NCT01999946|3910452|FG001|NOT COMPLETED|Overall Study||2
3182384|NCT01999946|3910453|FG002|NOT COMPLETED|Overall Study||79
3182385|NCT01999972|3910466|FG000|STARTED|Dose Escalation Part||5
3182386|NCT01999972|3910467|FG001|STARTED|Dose Escalation Part||3
3182387|NCT01999972|3910468|FG002|STARTED|Dose Escalation Part||5
3182388|NCT01999972|3910469|FG003|STARTED|Dose Escalation Part||11
3182389|NCT01999972|3910470|FG004|STARTED|Dose Escalation Part||0
3182390|NCT01999972|3910471|FG005|STARTED|Dose Escalation Part||0
3182391|NCT01999972|3910466|FG000|Treated|Dose Escalation Part||5
3182392|NCT01999972|3910467|FG001|Treated|Dose Escalation Part||3
3182393|NCT01999972|3910468|FG002|Treated|Dose Escalation Part||4
3182394|NCT01999972|3910469|FG003|Treated|Dose Escalation Part||10
3182395|NCT01999972|3910470|FG004|Treated|Dose Escalation Part||0
3182396|NCT01999972|3910471|FG005|Treated|Dose Escalation Part||0
3182397|NCT01999972|3910466|FG000|COMPLETED|Dose Escalation Part||0
3182398|NCT01999972|3910467|FG001|COMPLETED|Dose Escalation Part||0
3182399|NCT01999972|3910468|FG002|COMPLETED|Dose Escalation Part||0
3182400|NCT01999972|3910469|FG003|COMPLETED|Dose Escalation Part||0
3182401|NCT01999972|3910470|FG004|COMPLETED|Dose Escalation Part||0
3182402|NCT01999972|3910471|FG005|COMPLETED|Dose Escalation Part||0
3182403|NCT01999972|3910466|FG000|NOT COMPLETED|Dose Escalation Part||5
3182404|NCT01999972|3910467|FG001|NOT COMPLETED|Dose Escalation Part||3
3182405|NCT01999972|3910468|FG002|NOT COMPLETED|Dose Escalation Part||5
3182406|NCT01999972|3910469|FG003|NOT COMPLETED|Dose Escalation Part||11
3182407|NCT01999972|3910470|FG004|NOT COMPLETED|Dose Escalation Part||0
3182408|NCT01999972|3910471|FG005|NOT COMPLETED|Dose Escalation Part||0
3182409|NCT01999972|3910466|FG000|STARTED|Dose Expansion Part||0
3182410|NCT01999972|3910467|FG001|STARTED|Dose Expansion Part||0
3182411|NCT01999972|3910468|FG002|STARTED|Dose Expansion Part||0
3182412|NCT01999972|3910469|FG003|STARTED|Dose Expansion Part||0
3182413|NCT01999972|3910470|FG004|STARTED|Dose Expansion Part||21
3182414|NCT01999972|3910471|FG005|STARTED|Dose Expansion Part||7
3182415|NCT01999972|3910466|FG000|Treated|Dose Expansion Part||0
3182416|NCT01999972|3910467|FG001|Treated|Dose Expansion Part||0
3182417|NCT01999972|3910468|FG002|Treated|Dose Expansion Part||0
3182418|NCT01999972|3910469|FG003|Treated|Dose Expansion Part||0
3182419|NCT01999972|3910470|FG004|Treated|Dose Expansion Part||21
3182420|NCT01999972|3910471|FG005|Treated|Dose Expansion Part||7
3182421|NCT01999972|3910466|FG000|COMPLETED|Dose Expansion Part||0
3182422|NCT01999972|3910467|FG001|COMPLETED|Dose Expansion Part||0
3182423|NCT01999972|3910468|FG002|COMPLETED|Dose Expansion Part||0
3182424|NCT01999972|3910469|FG003|COMPLETED|Dose Expansion Part||0
3182425|NCT01999972|3910470|FG004|COMPLETED|Dose Expansion Part||0
3182426|NCT01999972|3910471|FG005|COMPLETED|Dose Expansion Part||0
3182427|NCT01999972|3910466|FG000|NOT COMPLETED|Dose Expansion Part||0
3182428|NCT01999972|3910467|FG001|NOT COMPLETED|Dose Expansion Part||0
3182429|NCT01999972|3910468|FG002|NOT COMPLETED|Dose Expansion Part||0
3182430|NCT01999972|3910469|FG003|NOT COMPLETED|Dose Expansion Part||0
3182431|NCT01999972|3910470|FG004|NOT COMPLETED|Dose Expansion Part||21
3182432|NCT01999972|3910471|FG005|NOT COMPLETED|Dose Expansion Part||7
3182433|NCT01999985|3910487|FG000|STARTED|Overall Study||8
3182434|NCT01999985|3910488|FG001|STARTED|Overall Study||3
3182435|NCT01999985|3910489|FG002|STARTED|Overall Study||14
3149024|NCT01791153|3875348|FG005|STARTED|Part 2: Open-label Period||58
3149025|NCT01791153|3875349|FG006|STARTED|Part 2: Open-label Period||50
3149026|NCT01791153|3875350|FG007|STARTED|Part 2: Open-label Period||67
3149027|NCT01791153|3875343|FG000|COMPLETED|Part 2: Open-label Period||0
3149028|NCT01791153|3875344|FG001|COMPLETED|Part 2: Open-label Period||0
3149029|NCT01791153|3875345|FG002|COMPLETED|Part 2: Open-label Period||0
3149030|NCT01791153|3875346|FG003|COMPLETED|Part 2: Open-label Period||0
3149031|NCT01791153|3875347|FG004|COMPLETED|Part 2: Open-label Period||38
3149032|NCT01791153|3875348|FG005|COMPLETED|Part 2: Open-label Period||54
3149033|NCT01791153|3875349|FG006|COMPLETED|Part 2: Open-label Period||44
3149034|NCT01791153|3875350|FG007|COMPLETED|Part 2: Open-label Period||61
3149035|NCT01791153|3875343|FG000|NOT COMPLETED|Part 2: Open-label Period||0
3149036|NCT01791153|3875344|FG001|NOT COMPLETED|Part 2: Open-label Period||0
3149037|NCT01791153|3875345|FG002|NOT COMPLETED|Part 2: Open-label Period||0
3149038|NCT01791153|3875346|FG003|NOT COMPLETED|Part 2: Open-label Period||0
3149039|NCT01791153|3875347|FG004|NOT COMPLETED|Part 2: Open-label Period||2
3149040|NCT01791153|3875348|FG005|NOT COMPLETED|Part 2: Open-label Period||4
3149041|NCT01791153|3875349|FG006|NOT COMPLETED|Part 2: Open-label Period||6
3149042|NCT01791153|3875350|FG007|NOT COMPLETED|Part 2: Open-label Period||6
3149043|NCT01791205|3875367|FG000|STARTED|Phase I||152
3149044|NCT01791205|3875368|FG001|STARTED|Phase I||152
3149045|NCT01791205|3875367|FG000|COMPLETED|Phase I||152
3149046|NCT01791205|3875368|FG001|COMPLETED|Phase I||152
3149047|NCT01791205|3875367|FG000|NOT COMPLETED|Phase I||0
3149048|NCT01791205|3875368|FG001|NOT COMPLETED|Phase I||0
3149049|NCT01791205|3875367|FG000|STARTED|Phase II|Participants who received tocilizumab monotherapy in Phase I was observed in Phase II.|104
3149050|NCT01791205|3875368|FG001|STARTED|Phase II||0
3149051|NCT01791205|3875367|FG000|COMPLETED|Phase II||92
3149052|NCT01791205|3875368|FG001|COMPLETED|Phase II||0
3149053|NCT01791205|3875367|FG000|NOT COMPLETED|Phase II||12
3149054|NCT01791205|3875368|FG001|NOT COMPLETED|Phase II||0
3149055|NCT01791244|3875376|FG000|STARTED|Overall Study||46
3149056|NCT01791244|3875377|FG001|STARTED|Overall Study||47
3149057|NCT01791244|3875376|FG000|Intent to Treat (ITT)|Overall Study||38
3149058|NCT01791244|3875377|FG001|Intent to Treat (ITT)|Overall Study||39
3149059|NCT01791244|3875376|FG000|COMPLETED|Overall Study||31
3149060|NCT01791244|3875377|FG001|COMPLETED|Overall Study||29
3149061|NCT01791244|3875376|FG000|NOT COMPLETED|Overall Study||15
3149062|NCT01791244|3875377|FG001|NOT COMPLETED|Overall Study||18
3149063|NCT01791413|3875387|FG000|STARTED|Overall Study||20
3149064|NCT01791413|3875388|FG001|STARTED|Overall Study||20
3149065|NCT01791413|3875387|FG000|COMPLETED|Overall Study||15
3149066|NCT01791413|3875388|FG001|COMPLETED|Overall Study||19
3149067|NCT01791413|3875387|FG000|NOT COMPLETED|Overall Study||5
3149068|NCT01791413|3875388|FG001|NOT COMPLETED|Overall Study||1
3149069|NCT01791465|3875395|FG000|STARTED|Overall Study||6
3149070|NCT01791465|3875395|FG000|COMPLETED|Overall Study||6
3149071|NCT01791465|3875395|FG000|NOT COMPLETED|Overall Study||0
3149072|NCT01791491|3875400|FG000|STARTED|Overall Study|Reasons for enrollment and non-treatment: 1 withdrew consent and 6 no longer met study criteria.|9
3149073|NCT01791491|3875400|FG000|COMPLETED|Overall Study||9
3149074|NCT01791491|3875400|FG000|NOT COMPLETED|Overall Study||0
3149075|NCT01791517|3875407|FG000|STARTED|Phase I: Period 1||19
3149076|NCT01791517|3875408|FG001|STARTED|Phase I: Period 1||20
3182436|NCT01999985|3910487|FG000|COMPLETED|Overall Study||8
3182437|NCT01999985|3910488|FG001|COMPLETED|Overall Study||3
3182438|NCT01999985|3910489|FG002|COMPLETED|Overall Study||14
3149077|NCT01791517|3875409|FG002|STARTED|Phase I: Period 1||20
3149078|NCT01791517|3875410|FG003|STARTED|Phase I: Period 1||19
3149079|NCT01791517|3875411|FG004|STARTED|Phase I: Period 1||20
3149080|NCT01791517|3875412|FG005|STARTED|Phase I: Period 1||20
3149081|NCT01791517|3875413|FG006|STARTED|Phase I: Period 1||20
3149082|NCT01791517|3875414|FG007|STARTED|Phase I: Period 1||20
3149083|NCT01791517|3875415|FG008|STARTED|Phase I: Period 1||20
3149084|NCT01791517|3875416|FG009|STARTED|Phase I: Period 1||20
3149085|NCT01791517|3875417|FG010|STARTED|Phase I: Period 1||18
3149086|NCT01791517|3875418|FG011|STARTED|Phase I: Period 1||20
3149087|NCT01791517|3875407|FG000|COMPLETED|Phase I: Period 1||18
3149088|NCT01791517|3875408|FG001|COMPLETED|Phase I: Period 1||18
3149089|NCT01791517|3875409|FG002|COMPLETED|Phase I: Period 1||18
3149090|NCT01791517|3875410|FG003|COMPLETED|Phase I: Period 1||17
3149091|NCT01791517|3875411|FG004|COMPLETED|Phase I: Period 1||19
3149092|NCT01791517|3875412|FG005|COMPLETED|Phase I: Period 1||19
3149093|NCT01791517|3875413|FG006|COMPLETED|Phase I: Period 1||19
3149094|NCT01791517|3875414|FG007|COMPLETED|Phase I: Period 1||20
3149095|NCT01791517|3875415|FG008|COMPLETED|Phase I: Period 1||19
3149096|NCT01791517|3875416|FG009|COMPLETED|Phase I: Period 1||19
3149097|NCT01791517|3875417|FG010|COMPLETED|Phase I: Period 1||18
3149098|NCT01791517|3875418|FG011|COMPLETED|Phase I: Period 1||19
3149099|NCT01791517|3875407|FG000|NOT COMPLETED|Phase I: Period 1||1
3149100|NCT01791517|3875408|FG001|NOT COMPLETED|Phase I: Period 1||2
3149101|NCT01791517|3875409|FG002|NOT COMPLETED|Phase I: Period 1||2
3149102|NCT01791517|3875410|FG003|NOT COMPLETED|Phase I: Period 1||2
3149103|NCT01791517|3875411|FG004|NOT COMPLETED|Phase I: Period 1||1
3149104|NCT01791517|3875412|FG005|NOT COMPLETED|Phase I: Period 1||1
3182439|NCT01999985|3910487|FG000|NOT COMPLETED|Overall Study||0
3363636|NCT04045964|4094763|FG001|NOT COMPLETED|Overall Study||1
3149105|NCT01791517|3875413|FG006|NOT COMPLETED|Phase I: Period 1||1
3149106|NCT01791517|3875414|FG007|NOT COMPLETED|Phase I: Period 1||0
3149107|NCT01791517|3875415|FG008|NOT COMPLETED|Phase I: Period 1||1
3182440|NCT01999985|3910488|FG001|NOT COMPLETED|Overall Study||0
3149108|NCT01791517|3875416|FG009|NOT COMPLETED|Phase I: Period 1||1
3149109|NCT01791517|3875417|FG010|NOT COMPLETED|Phase I: Period 1||0
3149110|NCT01791517|3875418|FG011|NOT COMPLETED|Phase I: Period 1||1
3149111|NCT01791517|3875407|FG000|STARTED|Phase I: Period 2||18
3149112|NCT01791517|3875408|FG001|STARTED|Phase I: Period 2||18
3149113|NCT01791517|3875409|FG002|STARTED|Phase I: Period 2||18
3149114|NCT01791517|3875410|FG003|STARTED|Phase I: Period 2||17
3149115|NCT01791517|3875411|FG004|STARTED|Phase I: Period 2||19
3182441|NCT01999985|3910489|FG002|NOT COMPLETED|Overall Study||0
3182442|NCT02000115|3910498|FG000|STARTED|Overall Study||381
3363637|NCT04043416|4094771|FG000|STARTED|Campaign 1||14
3149116|NCT01791517|3875412|FG005|STARTED|Phase I: Period 2||19
3149117|NCT01791517|3875413|FG006|STARTED|Phase I: Period 2||19
3149118|NCT01791517|3875414|FG007|STARTED|Phase I: Period 2||20
3149119|NCT01791517|3875415|FG008|STARTED|Phase I: Period 2||19
3149120|NCT01791517|3875416|FG009|STARTED|Phase I: Period 2||19
3149121|NCT01791517|3875417|FG010|STARTED|Phase I: Period 2||18
3149122|NCT01791517|3875418|FG011|STARTED|Phase I: Period 2||19
3149123|NCT01791517|3875407|FG000|COMPLETED|Phase I: Period 2||17
3149124|NCT01791517|3875408|FG001|COMPLETED|Phase I: Period 2||15
3149125|NCT01791517|3875409|FG002|COMPLETED|Phase I: Period 2||16
3149126|NCT01791517|3875410|FG003|COMPLETED|Phase I: Period 2||16
3149127|NCT01791517|3875411|FG004|COMPLETED|Phase I: Period 2||19
3149128|NCT01791517|3875412|FG005|COMPLETED|Phase I: Period 2||18
3149129|NCT01791517|3875413|FG006|COMPLETED|Phase I: Period 2||19
3149130|NCT01791517|3875414|FG007|COMPLETED|Phase I: Period 2||20
3149131|NCT01791517|3875415|FG008|COMPLETED|Phase I: Period 2||19
3149132|NCT01791517|3875416|FG009|COMPLETED|Phase I: Period 2||18
3149133|NCT01791517|3875417|FG010|COMPLETED|Phase I: Period 2||16
3149134|NCT01791517|3875418|FG011|COMPLETED|Phase I: Period 2||19
3149135|NCT01791517|3875407|FG000|NOT COMPLETED|Phase I: Period 2||1
3149136|NCT01791517|3875408|FG001|NOT COMPLETED|Phase I: Period 2||3
3149137|NCT01791517|3875409|FG002|NOT COMPLETED|Phase I: Period 2||2
3149138|NCT01791517|3875410|FG003|NOT COMPLETED|Phase I: Period 2||1
3149139|NCT01791517|3875411|FG004|NOT COMPLETED|Phase I: Period 2||0
3149140|NCT01791517|3875412|FG005|NOT COMPLETED|Phase I: Period 2||1
3149141|NCT01791517|3875413|FG006|NOT COMPLETED|Phase I: Period 2||0
3149142|NCT01791517|3875414|FG007|NOT COMPLETED|Phase I: Period 2||0
3149143|NCT01791517|3875415|FG008|NOT COMPLETED|Phase I: Period 2||0
3149144|NCT01791517|3875416|FG009|NOT COMPLETED|Phase I: Period 2||1
3149145|NCT01791517|3875417|FG010|NOT COMPLETED|Phase I: Period 2||2
3149146|NCT01791517|3875418|FG011|NOT COMPLETED|Phase I: Period 2||0
3149147|NCT01791517|3875407|FG000|STARTED|Phase I: Period 3||17
3149148|NCT01791517|3875408|FG001|STARTED|Phase I: Period 3||15
3149149|NCT01791517|3875409|FG002|STARTED|Phase I: Period 3||16
3149150|NCT01791517|3875410|FG003|STARTED|Phase I: Period 3||16
3149151|NCT01791517|3875411|FG004|STARTED|Phase I: Period 3||19
3149152|NCT01791517|3875412|FG005|STARTED|Phase I: Period 3||18
3149153|NCT01791517|3875413|FG006|STARTED|Phase I: Period 3||19
3149154|NCT01791517|3875414|FG007|STARTED|Phase I: Period 3||20
3149155|NCT01791517|3875415|FG008|STARTED|Phase I: Period 3||19
3149156|NCT01791517|3875416|FG009|STARTED|Phase I: Period 3||18
3149157|NCT01791517|3875417|FG010|STARTED|Phase I: Period 3||16
3149158|NCT01791517|3875418|FG011|STARTED|Phase I: Period 3||19
3149159|NCT01791517|3875407|FG000|COMPLETED|Phase I: Period 3||17
3149160|NCT01791517|3875408|FG001|COMPLETED|Phase I: Period 3||14
3149161|NCT01791517|3875409|FG002|COMPLETED|Phase I: Period 3||16
3149162|NCT01791517|3875410|FG003|COMPLETED|Phase I: Period 3||15
3149163|NCT01791517|3875411|FG004|COMPLETED|Phase I: Period 3||18
3149164|NCT01791517|3875412|FG005|COMPLETED|Phase I: Period 3||18
3149165|NCT01791517|3875413|FG006|COMPLETED|Phase I: Period 3||19
3149166|NCT01791517|3875414|FG007|COMPLETED|Phase I: Period 3||20
3149167|NCT01791517|3875415|FG008|COMPLETED|Phase I: Period 3||19
3149168|NCT01791517|3875416|FG009|COMPLETED|Phase I: Period 3||18
3149169|NCT01791517|3875417|FG010|COMPLETED|Phase I: Period 3||16
3149170|NCT01791517|3875418|FG011|COMPLETED|Phase I: Period 3||18
3149171|NCT01791517|3875407|FG000|NOT COMPLETED|Phase I: Period 3||0
3149172|NCT01791517|3875408|FG001|NOT COMPLETED|Phase I: Period 3||1
3149173|NCT01791517|3875409|FG002|NOT COMPLETED|Phase I: Period 3||0
3149174|NCT01791517|3875410|FG003|NOT COMPLETED|Phase I: Period 3||1
3149175|NCT01791517|3875411|FG004|NOT COMPLETED|Phase I: Period 3||1
3149176|NCT01791517|3875412|FG005|NOT COMPLETED|Phase I: Period 3||0
3149177|NCT01791517|3875413|FG006|NOT COMPLETED|Phase I: Period 3||0
3149178|NCT01791517|3875414|FG007|NOT COMPLETED|Phase I: Period 3||0
3149179|NCT01791517|3875415|FG008|NOT COMPLETED|Phase I: Period 3||0
3149180|NCT01791517|3875416|FG009|NOT COMPLETED|Phase I: Period 3||0
3149181|NCT01791517|3875417|FG010|NOT COMPLETED|Phase I: Period 3||0
3149182|NCT01791517|3875418|FG011|NOT COMPLETED|Phase I: Period 3||1
3149183|NCT01791517|3875407|FG000|STARTED|Phase I: Period 4||17
3149184|NCT01791517|3875408|FG001|STARTED|Phase I: Period 4||14
3149185|NCT01791517|3875409|FG002|STARTED|Phase I: Period 4||16
3149186|NCT01791517|3875410|FG003|STARTED|Phase I: Period 4||15
3149187|NCT01791517|3875411|FG004|STARTED|Phase I: Period 4||18
3149188|NCT01791517|3875412|FG005|STARTED|Phase I: Period 4||18
3149189|NCT01791517|3875413|FG006|STARTED|Phase I: Period 4||19
3149190|NCT01791517|3875414|FG007|STARTED|Phase I: Period 4||20
3149191|NCT01791517|3875415|FG008|STARTED|Phase I: Period 4||19
3149192|NCT01791517|3875416|FG009|STARTED|Phase I: Period 4||18
3149193|NCT01791517|3875417|FG010|STARTED|Phase I: Period 4||16
3149194|NCT01791517|3875418|FG011|STARTED|Phase I: Period 4||18
3182443|NCT02000115|3910499|FG001|STARTED|Overall Study||369
3182444|NCT02000115|3910500|FG002|STARTED|Overall Study||100
3149195|NCT01791517|3875407|FG000|COMPLETED|Phase I: Period 4||17
3182445|NCT02000115|3910501|FG003|STARTED|Overall Study||53
3182446|NCT02000115|3910498|FG000|COMPLETED|Overall Study|6 subjects missed the One-year follow-up visit|302
3182447|NCT02000115|3910499|FG001|COMPLETED|Overall Study|8 subjects missed the One-year follow-up visit|301
3182448|NCT02000115|3910500|FG002|COMPLETED|Overall Study|1 subject missed the 30 day follow-up visit|99
3182449|NCT02000115|3910501|FG003|COMPLETED|Overall Study||0
3182450|NCT02000115|3910498|FG000|NOT COMPLETED|Overall Study||79
3182451|NCT02000115|3910499|FG001|NOT COMPLETED|Overall Study||68
3182452|NCT02000115|3910500|FG002|NOT COMPLETED|Overall Study||1
3182453|NCT02000115|3910501|FG003|NOT COMPLETED|Overall Study||53
3182454|NCT02000154|3910510|FG000|STARTED|Overall Study||1
3182455|NCT02000154|3910510|FG000|COMPLETED|Overall Study||1
3149196|NCT01791517|3875408|FG001|COMPLETED|Phase I: Period 4||14
3149197|NCT01791517|3875409|FG002|COMPLETED|Phase I: Period 4||16
3149198|NCT01791517|3875410|FG003|COMPLETED|Phase I: Period 4||15
3149199|NCT01791517|3875411|FG004|COMPLETED|Phase I: Period 4||18
3149200|NCT01791517|3875412|FG005|COMPLETED|Phase I: Period 4||18
3149201|NCT01791517|3875413|FG006|COMPLETED|Phase I: Period 4||19
3149202|NCT01791517|3875414|FG007|COMPLETED|Phase I: Period 4||20
3149203|NCT01791517|3875415|FG008|COMPLETED|Phase I: Period 4||19
3149204|NCT01791517|3875416|FG009|COMPLETED|Phase I: Period 4||18
3149205|NCT01791517|3875417|FG010|COMPLETED|Phase I: Period 4||16
3149206|NCT01791517|3875418|FG011|COMPLETED|Phase I: Period 4||18
3149207|NCT01791517|3875407|FG000|NOT COMPLETED|Phase I: Period 4||0
3149208|NCT01791517|3875408|FG001|NOT COMPLETED|Phase I: Period 4||0
3149209|NCT01791517|3875409|FG002|NOT COMPLETED|Phase I: Period 4||0
3149210|NCT01791517|3875410|FG003|NOT COMPLETED|Phase I: Period 4||0
3149211|NCT01791517|3875411|FG004|NOT COMPLETED|Phase I: Period 4||0
3149212|NCT01791517|3875412|FG005|NOT COMPLETED|Phase I: Period 4||0
3149213|NCT01791517|3875413|FG006|NOT COMPLETED|Phase I: Period 4||0
3149214|NCT01791517|3875414|FG007|NOT COMPLETED|Phase I: Period 4||0
3149215|NCT01791517|3875415|FG008|NOT COMPLETED|Phase I: Period 4||0
3149216|NCT01791517|3875416|FG009|NOT COMPLETED|Phase I: Period 4||0
3149217|NCT01791517|3875417|FG010|NOT COMPLETED|Phase I: Period 4||0
3149218|NCT01791517|3875418|FG011|NOT COMPLETED|Phase I: Period 4||0
3149219|NCT01791517|3875407|FG000|STARTED|Phase II||17
3149220|NCT01791517|3875408|FG001|STARTED|Phase II||14
3149221|NCT01791517|3875409|FG002|STARTED|Phase II||16
3149222|NCT01791517|3875410|FG003|STARTED|Phase II||15
3149223|NCT01791517|3875411|FG004|STARTED|Phase II||18
3149224|NCT01791517|3875412|FG005|STARTED|Phase II||18
3149225|NCT01791517|3875413|FG006|STARTED|Phase II||19
3149226|NCT01791517|3875414|FG007|STARTED|Phase II||20
3149227|NCT01791517|3875415|FG008|STARTED|Phase II||19
3149228|NCT01791517|3875416|FG009|STARTED|Phase II||18
3149229|NCT01791517|3875417|FG010|STARTED|Phase II||16
3149230|NCT01791517|3875418|FG011|STARTED|Phase II||18
3149231|NCT01791517|3875407|FG000|COMPLETED|Phase II||15
3149232|NCT01791517|3875408|FG001|COMPLETED|Phase II||14
3149233|NCT01791517|3875409|FG002|COMPLETED|Phase II||15
3149234|NCT01791517|3875410|FG003|COMPLETED|Phase II||15
3149235|NCT01791517|3875411|FG004|COMPLETED|Phase II||16
3149236|NCT01791517|3875412|FG005|COMPLETED|Phase II||14
3149237|NCT01791517|3875413|FG006|COMPLETED|Phase II||17
3149238|NCT01791517|3875414|FG007|COMPLETED|Phase II||17
3149239|NCT01791517|3875415|FG008|COMPLETED|Phase II||17
3149240|NCT01791517|3875416|FG009|COMPLETED|Phase II||15
3149241|NCT01791517|3875417|FG010|COMPLETED|Phase II||15
3149242|NCT01791517|3875418|FG011|COMPLETED|Phase II||17
3149243|NCT01791517|3875407|FG000|NOT COMPLETED|Phase II||2
3149244|NCT01791517|3875408|FG001|NOT COMPLETED|Phase II||0
3149245|NCT01791517|3875409|FG002|NOT COMPLETED|Phase II||1
3149246|NCT01791517|3875410|FG003|NOT COMPLETED|Phase II||0
3149247|NCT01791517|3875411|FG004|NOT COMPLETED|Phase II||2
3149248|NCT01791517|3875412|FG005|NOT COMPLETED|Phase II||4
3149249|NCT01791517|3875413|FG006|NOT COMPLETED|Phase II||2
3149250|NCT01791517|3875414|FG007|NOT COMPLETED|Phase II||3
3149251|NCT01791517|3875415|FG008|NOT COMPLETED|Phase II||2
3149252|NCT01791517|3875416|FG009|NOT COMPLETED|Phase II||3
3149253|NCT01791517|3875417|FG010|NOT COMPLETED|Phase II||1
3149254|NCT01791517|3875418|FG011|NOT COMPLETED|Phase II||1
3149255|NCT01791725|3875439|FG000|STARTED|Overall Study||12
3149256|NCT01791725|3875440|FG001|STARTED|Overall Study||5
3149257|NCT01791725|3875441|FG002|STARTED|Overall Study||6
3149258|NCT01791725|3875439|FG000|COMPLETED|Overall Study||12
3149259|NCT01791725|3875440|FG001|COMPLETED|Overall Study||4
3149260|NCT01791725|3875441|FG002|COMPLETED|Overall Study||6
3149261|NCT01791725|3875439|FG000|NOT COMPLETED|Overall Study||0
3149262|NCT01791725|3875440|FG001|NOT COMPLETED|Overall Study||1
3149263|NCT01791725|3875441|FG002|NOT COMPLETED|Overall Study||0
3149264|NCT01791803|3875453|FG000|STARTED|Overall Study||41
3149265|NCT01791803|3875454|FG001|STARTED|Overall Study||41
3149266|NCT01791803|3875455|FG002|STARTED|Overall Study||40
3149267|NCT01791803|3875456|FG003|STARTED|Overall Study||42
3149268|NCT01791803|3875453|FG000|COMPLETED|Overall Study||41
3149269|NCT01791803|3875454|FG001|COMPLETED|Overall Study||39
3182456|NCT02000154|3910510|FG000|NOT COMPLETED|Overall Study||0
3182457|NCT02000180|3910516|FG000|STARTED|Overall Study||18
3182458|NCT02000180|3910517|FG001|STARTED|Overall Study||19
3182459|NCT02000180|3910516|FG000|COMPLETED|Overall Study||18
3149270|NCT01791803|3875455|FG002|COMPLETED|Overall Study||38
3149271|NCT01791803|3875456|FG003|COMPLETED|Overall Study||37
3149272|NCT01791803|3875453|FG000|NOT COMPLETED|Overall Study||0
3149273|NCT01791803|3875454|FG001|NOT COMPLETED|Overall Study||2
3149274|NCT01791803|3875455|FG002|NOT COMPLETED|Overall Study||2
3149275|NCT01791803|3875456|FG003|NOT COMPLETED|Overall Study||5
3149276|NCT01791894|3875469|FG000|STARTED|Overall Study||5
3149277|NCT01791894|3875469|FG000|COMPLETED|Overall Study||4
3149278|NCT01791894|3875469|FG000|NOT COMPLETED|Overall Study||1
3149279|NCT01791972|3875476|FG000|STARTED|Overall Study||19
3149280|NCT01791972|3875477|FG001|STARTED|Overall Study||19
3149281|NCT01791972|3875476|FG000|COMPLETED|Overall Study||19
3149282|NCT01791972|3875477|FG001|COMPLETED|Overall Study||19
3149283|NCT01791972|3875476|FG000|NOT COMPLETED|Overall Study||0
3149284|NCT01791972|3875477|FG001|NOT COMPLETED|Overall Study||0
3149285|NCT01792024|3875483|FG000|STARTED|Overall Study||27
3149286|NCT01792024|3875483|FG000|COMPLETED|Overall Study||27
3149287|NCT01792024|3875483|FG000|NOT COMPLETED|Overall Study||0
3149288|NCT01792115|3875490|FG000|STARTED|Overall Study||7
3149289|NCT01792115|3875491|FG001|STARTED|Overall Study||7
3149290|NCT01792115|3875492|FG002|STARTED|Overall Study||8
3149291|NCT01792115|3875490|FG000|COMPLETED|Overall Study||7
3149292|NCT01792115|3875491|FG001|COMPLETED|Overall Study||6
3149293|NCT01792115|3875492|FG002|COMPLETED|Overall Study||8
3149294|NCT01792115|3875490|FG000|NOT COMPLETED|Overall Study||0
3149295|NCT01792115|3875491|FG001|NOT COMPLETED|Overall Study||1
3149296|NCT01792115|3875492|FG002|NOT COMPLETED|Overall Study||0
3149297|NCT01792284|3875500|FG000|STARTED|Lead-in Period||212
3149298|NCT01792284|3875501|FG001|STARTED|Lead-in Period||0
3149299|NCT01792284|3875502|FG002|STARTED|Lead-in Period||0
3149300|NCT01792284|3875500|FG000|COMPLETED|Lead-in Period|Participants that completed the Lead-in Period were randomized and entered Randomization Period 1.|182
3149301|NCT01792284|3875501|FG001|COMPLETED|Lead-in Period||0
3149302|NCT01792284|3875502|FG002|COMPLETED|Lead-in Period||0
3149303|NCT01792284|3875500|FG000|NOT COMPLETED|Lead-in Period||30
3149304|NCT01792284|3875501|FG001|NOT COMPLETED|Lead-in Period||0
3149305|NCT01792284|3875502|FG002|NOT COMPLETED|Lead-in Period||0
3149306|NCT01792284|3875500|FG000|STARTED|Randomization Period 1||0
3149307|NCT01792284|3875501|FG001|STARTED|Randomization Period 1||92
3149308|NCT01792284|3875502|FG002|STARTED|Randomization Period 1||90
3149309|NCT01792284|3875500|FG000|Received at Least 1 Dose of Study Drug|Randomization Period 1||0
3149310|NCT01792284|3875501|FG001|Received at Least 1 Dose of Study Drug|Randomization Period 1||92
3149311|NCT01792284|3875502|FG002|Received at Least 1 Dose of Study Drug|Randomization Period 1||90
3149312|NCT01792284|3875500|FG000|COMPLETED|Randomization Period 1||0
3149313|NCT01792284|3875501|FG001|COMPLETED|Randomization Period 1||90
3149314|NCT01792284|3875502|FG002|COMPLETED|Randomization Period 1||85
3149315|NCT01792284|3875500|FG000|NOT COMPLETED|Randomization Period 1||0
3149316|NCT01792284|3875501|FG001|NOT COMPLETED|Randomization Period 1||2
3149317|NCT01792284|3875502|FG002|NOT COMPLETED|Randomization Period 1||5
3149318|NCT01792284|3875500|FG000|STARTED|Randomization Period 2||0
3149319|NCT01792284|3875501|FG001|STARTED|Randomization Period 2||90
3149320|NCT01792284|3875502|FG002|STARTED|Randomization Period 2||85
3149321|NCT01792284|3875500|FG000|Received at Least 1 Dose of Study Drug|Randomization Period 2||0
3149322|NCT01792284|3875501|FG001|Received at Least 1 Dose of Study Drug|Randomization Period 2||90
3149323|NCT01792284|3875502|FG002|Received at Least 1 Dose of Study Drug|Randomization Period 2||85
3149324|NCT01792284|3875500|FG000|COMPLETED|Randomization Period 2||0
3149325|NCT01792284|3875501|FG001|COMPLETED|Randomization Period 2||87
3149326|NCT01792284|3875502|FG002|COMPLETED|Randomization Period 2||85
3149327|NCT01792284|3875500|FG000|NOT COMPLETED|Randomization Period 2||0
3149328|NCT01792284|3875501|FG001|NOT COMPLETED|Randomization Period 2||3
3149329|NCT01792284|3875502|FG002|NOT COMPLETED|Randomization Period 2||0
3149330|NCT01792518|3875512|FG000|STARTED|Overall Study||178
3149331|NCT01792518|3875513|FG001|STARTED|Overall Study||182
3149332|NCT01792518|3875512|FG000|COMPLETED|Overall Study||170
3149333|NCT01792518|3875513|FG001|COMPLETED|Overall Study||175
3149334|NCT01792518|3875512|FG000|NOT COMPLETED|Overall Study||8
3149335|NCT01792518|3875513|FG001|NOT COMPLETED|Overall Study||7
3149336|NCT01792635|3875522|FG000|STARTED|Part A||6
3149337|NCT01792635|3875523|FG001|STARTED|Part A||0
3149338|NCT01792635|3875524|FG002|STARTED|Part A||0
3149339|NCT01792635|3875522|FG000|COMPLETED|Part A||6
3149340|NCT01792635|3875523|FG001|COMPLETED|Part A||0
3182460|NCT02000180|3910517|FG001|COMPLETED|Overall Study||19
3182461|NCT02000180|3910516|FG000|NOT COMPLETED|Overall Study||0
3182462|NCT02000180|3910517|FG001|NOT COMPLETED|Overall Study||0
3182463|NCT02000440|3910523|FG000|STARTED|Overall Study||17
3182464|NCT02000440|3910523|FG000|COMPLETED|Overall Study||13
3182465|NCT02000440|3910523|FG000|NOT COMPLETED|Overall Study||4
3182466|NCT02000531|3910529|FG000|STARTED|Overall Study||21
3182467|NCT02000531|3910530|FG001|STARTED|Overall Study||24
3182468|NCT02000531|3910529|FG000|Safety Population|Overall Study||21
3182469|NCT02000531|3910530|FG001|Safety Population|Overall Study||24
3182470|NCT02000531|3910529|FG000|COMPLETED|Overall Study||17
3182471|NCT02000531|3910530|FG001|COMPLETED|Overall Study||16
3182472|NCT02000531|3910529|FG000|NOT COMPLETED|Overall Study||4
3182473|NCT02000531|3910530|FG001|NOT COMPLETED|Overall Study||8
3182474|NCT02000583|3910538|FG000|STARTED|Overall Study||78
3182475|NCT02000583|3910539|FG001|STARTED|Overall Study||39
3182476|NCT02000583|3910538|FG000|COMPLETED|Overall Study||75
3182477|NCT02000583|3910539|FG001|COMPLETED|Overall Study||34
3149341|NCT01792635|3875524|FG002|COMPLETED|Part A||0
3149342|NCT01792635|3875522|FG000|NOT COMPLETED|Part A||0
3149343|NCT01792635|3875523|FG001|NOT COMPLETED|Part A||0
3149344|NCT01792635|3875524|FG002|NOT COMPLETED|Part A||0
3149345|NCT01792635|3875522|FG000|STARTED|Part B||0
3149346|NCT01792635|3875523|FG001|STARTED|Part B||6
3149347|NCT01792635|3875524|FG002|STARTED|Part B||7
3149348|NCT01792635|3875522|FG000|COMPLETED|Part B||0
3149349|NCT01792635|3875523|FG001|COMPLETED|Part B||2
3149350|NCT01792635|3875524|FG002|COMPLETED|Part B||3
3149351|NCT01792635|3875522|FG000|NOT COMPLETED|Part B||0
3149352|NCT01792635|3875523|FG001|NOT COMPLETED|Part B||4
3149353|NCT01792635|3875524|FG002|NOT COMPLETED|Part B||4
3149354|NCT01792817|3875535|FG000|STARTED|Phase 1 Double Blind Period||77
3149355|NCT01792817|3875536|FG001|STARTED|Phase 1 Double Blind Period||73
3149356|NCT01792817|3875537|FG002|STARTED|Phase 1 Double Blind Period||0
3149357|NCT01792817|3875535|FG000|COMPLETED|Phase 1 Double Blind Period||58
3149358|NCT01792817|3875536|FG001|COMPLETED|Phase 1 Double Blind Period||42
3149359|NCT01792817|3875537|FG002|COMPLETED|Phase 1 Double Blind Period||0
3149360|NCT01792817|3875535|FG000|NOT COMPLETED|Phase 1 Double Blind Period||19
3149361|NCT01792817|3875536|FG001|NOT COMPLETED|Phase 1 Double Blind Period||31
3149362|NCT01792817|3875537|FG002|NOT COMPLETED|Phase 1 Double Blind Period||0
3149363|NCT01792817|3875535|FG000|STARTED|Phase 2 Open Label||0
3149364|NCT01792817|3875536|FG001|STARTED|Phase 2 Open Label||0
3149365|NCT01792817|3875537|FG002|STARTED|Phase 2 Open Label||100
3149366|NCT01792817|3875535|FG000|COMPLETED|Phase 2 Open Label||0
3149367|NCT01792817|3875536|FG001|COMPLETED|Phase 2 Open Label||0
3149368|NCT01792817|3875537|FG002|COMPLETED|Phase 2 Open Label||74
3149369|NCT01792817|3875535|FG000|NOT COMPLETED|Phase 2 Open Label||0
3149370|NCT01792817|3875536|FG001|NOT COMPLETED|Phase 2 Open Label||0
3149371|NCT01792817|3875537|FG002|NOT COMPLETED|Phase 2 Open Label||26
3149372|NCT01792830|3875555|FG000|STARTED|Overall Study||84
3149373|NCT01792830|3875556|FG001|STARTED|Overall Study||3
3149374|NCT01792830|3875557|FG002|STARTED|Overall Study||4
3149375|NCT01792830|3875558|FG003|STARTED|Overall Study||21
3149376|NCT01792830|3875559|FG004|STARTED|Overall Study||2
3149377|NCT01792830|3875560|FG005|STARTED|Overall Study||4
3149378|NCT01792830|3875561|FG006|STARTED|Overall Study||14
3149379|NCT01792830|3875562|FG007|STARTED|Overall Study||7
3149380|NCT01792830|3875563|FG008|STARTED|Overall Study||20
3149381|NCT01792830|3875564|FG009|STARTED|Overall Study||4
3149382|NCT01792830|3875565|FG010|STARTED|Overall Study||12
3149383|NCT01792830|3875555|FG000|COMPLETED|Overall Study||59
3149384|NCT01792830|3875556|FG001|COMPLETED|Overall Study||3
3149385|NCT01792830|3875557|FG002|COMPLETED|Overall Study||4
3149386|NCT01792830|3875558|FG003|COMPLETED|Overall Study||18
3149387|NCT01792830|3875559|FG004|COMPLETED|Overall Study||1
3149388|NCT01792830|3875560|FG005|COMPLETED|Overall Study||3
3149389|NCT01792830|3875561|FG006|COMPLETED|Overall Study||12
3149390|NCT01792830|3875562|FG007|COMPLETED|Overall Study||6
3149391|NCT01792830|3875563|FG008|COMPLETED|Overall Study||11
3149392|NCT01792830|3875564|FG009|COMPLETED|Overall Study||4
3149393|NCT01792830|3875565|FG010|COMPLETED|Overall Study||9
3149394|NCT01792830|3875555|FG000|NOT COMPLETED|Overall Study||25
3149395|NCT01792830|3875556|FG001|NOT COMPLETED|Overall Study||0
3149396|NCT01792830|3875557|FG002|NOT COMPLETED|Overall Study||0
3149397|NCT01792830|3875558|FG003|NOT COMPLETED|Overall Study||3
3149398|NCT01792830|3875559|FG004|NOT COMPLETED|Overall Study||1
3149399|NCT01792830|3875560|FG005|NOT COMPLETED|Overall Study||1
3149400|NCT01792830|3875561|FG006|NOT COMPLETED|Overall Study||2
3149401|NCT01792830|3875562|FG007|NOT COMPLETED|Overall Study||1
3149402|NCT01792830|3875563|FG008|NOT COMPLETED|Overall Study||9
3149403|NCT01792830|3875564|FG009|NOT COMPLETED|Overall Study||0
3149404|NCT01792830|3875565|FG010|NOT COMPLETED|Overall Study||3
3149405|NCT01792986|3875595|FG000|STARTED|Overall Study||12
3149406|NCT01792986|3875595|FG000|COMPLETED|Overall Study||12
3149407|NCT01792986|3875595|FG000|NOT COMPLETED|Overall Study||0
3149408|NCT01793051|3875601|FG000|STARTED|Overall Study||43
3149409|NCT01793051|3875602|FG001|STARTED|Overall Study||44
3149410|NCT01793051|3875601|FG000|COMPLETED|Overall Study||33
3149411|NCT01793051|3875602|FG001|COMPLETED|Overall Study||36
3149412|NCT01793051|3875601|FG000|NOT COMPLETED|Overall Study||10
3149413|NCT01793051|3875602|FG001|NOT COMPLETED|Overall Study||8
3149414|NCT01793142|3875608|FG000|STARTED|Overall Study||3430
3182478|NCT02000583|3910538|FG000|NOT COMPLETED|Overall Study||3
3182479|NCT02000583|3910539|FG001|NOT COMPLETED|Overall Study||5
3363638|NCT04043416|4094772|FG001|STARTED|Campaign 1||14
3363639|NCT04043416|4094771|FG000|COMPLETED|Campaign 1||14
3149415|NCT01793142|3875608|FG000|Treated|Overall Study||3423
3149416|NCT01793142|3875608|FG000|COMPLETED|Overall Study||3423
3149417|NCT01793142|3875608|FG000|NOT COMPLETED|Overall Study||7
3149418|NCT01793285|3875612|FG000|STARTED|Overall Study||85
3149419|NCT01793285|3875612|FG000|COMPLETED|Overall Study||85
3149420|NCT01793285|3875612|FG000|NOT COMPLETED|Overall Study||0
3149421|NCT01793688|3875616|FG000|STARTED|Overall Study||982
3149422|NCT01793688|3875616|FG000|COMPLETED|Overall Study||980
3149423|NCT01793688|3875616|FG000|NOT COMPLETED|Overall Study||2
3149424|NCT01793792|3875620|FG000|STARTED|Overall Study|153 treated: 1 attempted no device implanted, 152 device implanted.|153
3149425|NCT01793792|3875620|FG000|Treated|Overall Study|153 Treated, 152 implanted with device, 1 attempted no device implanted|153
3149426|NCT01793792|3875620|FG000|COMPLETED|Overall Study||141
3363640|NCT04043416|4094772|FG001|COMPLETED|Campaign 1||14
3149427|NCT01793792|3875620|FG000|NOT COMPLETED|Overall Study||12
3149428|NCT01793883|3875627|FG000|STARTED|Overall Study||213
3149429|NCT01793883|3875628|FG001|STARTED|Overall Study||214
3149430|NCT01793883|3875629|FG002|STARTED|Overall Study||212
3149431|NCT01793883|3875627|FG000|COMPLETED|Overall Study||201
3149432|NCT01793883|3875628|FG001|COMPLETED|Overall Study||204
3149433|NCT01793883|3875629|FG002|COMPLETED|Overall Study||204
3149434|NCT01793883|3875627|FG000|NOT COMPLETED|Overall Study||12
3149435|NCT01793883|3875628|FG001|NOT COMPLETED|Overall Study||10
3149436|NCT01793883|3875629|FG002|NOT COMPLETED|Overall Study||8
3149437|NCT01793909|3875639|FG000|STARTED|Overall Study||30
3149438|NCT01793909|3875640|FG001|STARTED|Overall Study||25
3149439|NCT01793909|3875639|FG000|COMPLETED|Overall Study||20
3149440|NCT01793909|3875640|FG001|COMPLETED|Overall Study||20
3149441|NCT01793909|3875639|FG000|NOT COMPLETED|Overall Study||10
3149442|NCT01793909|3875640|FG001|NOT COMPLETED|Overall Study||5
3149443|NCT01793935|3875648|FG000|STARTED|Overall Study||34
3149444|NCT01793935|3875649|FG001|STARTED|Overall Study||34
3149445|NCT01793935|3875648|FG000|COMPLETED|Overall Study||28
3149446|NCT01793935|3875649|FG001|COMPLETED|Overall Study||31
3149447|NCT01793935|3875648|FG000|NOT COMPLETED|Overall Study||6
3149448|NCT01793935|3875649|FG001|NOT COMPLETED|Overall Study||3
3149449|NCT01794000|3875657|FG000|STARTED|Double-Blind Phase (DBP)||171
3149450|NCT01794000|3875658|FG001|STARTED|Double-Blind Phase (DBP)||170
3149451|NCT01794000|3875657|FG000|Received at Least One Dose of Drug|Double-Blind Phase (DBP)||170
3149452|NCT01794000|3875658|FG001|Received at Least One Dose of Drug|Double-Blind Phase (DBP)||170
3149453|NCT01794000|3875657|FG000|Discontinued During Double Blind Phase|Double-Blind Phase (DBP)||169
3149454|NCT01794000|3875658|FG001|Discontinued During Double Blind Phase|Double-Blind Phase (DBP)||166
3149455|NCT01794000|3875657|FG000|COMPLETED|Double-Blind Phase (DBP)||2
3149456|NCT01794000|3875658|FG001|COMPLETED|Double-Blind Phase (DBP)||4
3149457|NCT01794000|3875657|FG000|NOT COMPLETED|Double-Blind Phase (DBP)||169
3149458|NCT01794000|3875658|FG001|NOT COMPLETED|Double-Blind Phase (DBP)||166
3149459|NCT01794000|3875657|FG000|STARTED|Open-Label Extension Phase (OLE)|Pts. who had not permanently discontinued study drug and concluded DBP were eligible to enter OLE|3
3149460|NCT01794000|3875658|FG001|STARTED|Open-Label Extension Phase (OLE)|Placebo arm was not applicable to Open-Label Extension Phase|0
3149461|NCT01794000|3875657|FG000|COMPLETED|Open-Label Extension Phase (OLE)||0
3149462|NCT01794000|3875658|FG001|COMPLETED|Open-Label Extension Phase (OLE)||0
3149463|NCT01794000|3875657|FG000|NOT COMPLETED|Open-Label Extension Phase (OLE)||3
3149464|NCT01794000|3875658|FG001|NOT COMPLETED|Open-Label Extension Phase (OLE)||0
3149465|NCT01794039|3875667|FG000|STARTED|Overall Study||5
3149466|NCT01794039|3875668|FG001|STARTED|Overall Study||4
3149467|NCT01794039|3875667|FG000|COMPLETED|Overall Study||5
3149468|NCT01794039|3875668|FG001|COMPLETED|Overall Study||4
3149469|NCT01794039|3875667|FG000|NOT COMPLETED|Overall Study||0
3149470|NCT01794039|3875668|FG001|NOT COMPLETED|Overall Study||0
3149471|NCT01794117|3875680|FG000|STARTED|Overall Study||1
3149472|NCT01794117|3875681|FG001|STARTED|Overall Study||3
3149473|NCT01794117|3875682|FG002|STARTED|Overall Study||2
3149474|NCT01794117|3875683|FG003|STARTED|Overall Study||12
3149475|NCT01794117|3875680|FG000|COMPLETED|Overall Study||0
3149476|NCT01794117|3875681|FG001|COMPLETED|Overall Study||0
3149477|NCT01794117|3875682|FG002|COMPLETED|Overall Study||2
3149478|NCT01794117|3875683|FG003|COMPLETED|Overall Study||12
3149479|NCT01794117|3875680|FG000|NOT COMPLETED|Overall Study||1
3149480|NCT01794117|3875681|FG001|NOT COMPLETED|Overall Study||3
3149481|NCT01794117|3875682|FG002|NOT COMPLETED|Overall Study||0
3149482|NCT01794117|3875683|FG003|NOT COMPLETED|Overall Study||0
3149483|NCT01794299|3875694|FG000|STARTED|Overall Study||31
3149484|NCT01794299|3875694|FG000|COMPLETED|Overall Study||9
3149485|NCT01794299|3875694|FG000|NOT COMPLETED|Overall Study||22
3149486|NCT01794312|3875700|FG000|STARTED|Overall Study||74
3149487|NCT01794312|3875701|FG001|STARTED|Overall Study||78
3149488|NCT01794312|3875700|FG000|COMPLETED|Overall Study||68
3149489|NCT01794312|3875701|FG001|COMPLETED|Overall Study||67
3149490|NCT01794312|3875700|FG000|NOT COMPLETED|Overall Study||6
3149491|NCT01794312|3875701|FG001|NOT COMPLETED|Overall Study||11
3149492|NCT01794455|3875709|FG000|STARTED|Overall Study||0
3149493|NCT01794455|3875710|FG001|STARTED|Overall Study||1
3149494|NCT01794455|3875709|FG000|COMPLETED|Overall Study||0
3149495|NCT01794455|3875710|FG001|COMPLETED|Overall Study||1
3149496|NCT01794455|3875709|FG000|NOT COMPLETED|Overall Study||0
3149497|NCT01794455|3875710|FG001|NOT COMPLETED|Overall Study||0
3149498|NCT01794689|3875720|FG000|STARTED|Intervention 1 (2 Nights)||25
3149499|NCT01794689|3875721|FG001|STARTED|Intervention 1 (2 Nights)||29
3149500|NCT01794689|3875722|FG002|STARTED|Intervention 1 (2 Nights)||24
3149501|NCT01794689|3875723|FG003|STARTED|Intervention 1 (2 Nights)||22
3149502|NCT01794689|3875720|FG000|COMPLETED|Intervention 1 (2 Nights)||20
3149503|NCT01794689|3875721|FG001|COMPLETED|Intervention 1 (2 Nights)||27
3149504|NCT01794689|3875722|FG002|COMPLETED|Intervention 1 (2 Nights)||21
3149505|NCT01794689|3875723|FG003|COMPLETED|Intervention 1 (2 Nights)||18
3149506|NCT01794689|3875720|FG000|NOT COMPLETED|Intervention 1 (2 Nights)||5
3182480|NCT02000622|3910547|FG000|STARTED|Overall Study||205
3149507|NCT01794689|3875721|FG001|NOT COMPLETED|Intervention 1 (2 Nights)||2
3149508|NCT01794689|3875722|FG002|NOT COMPLETED|Intervention 1 (2 Nights)||3
3149509|NCT01794689|3875723|FG003|NOT COMPLETED|Intervention 1 (2 Nights)||4
3149510|NCT01794689|3875720|FG000|STARTED|Washout (2 Weeks)||20
3149511|NCT01794689|3875721|FG001|STARTED|Washout (2 Weeks)||27
3149512|NCT01794689|3875722|FG002|STARTED|Washout (2 Weeks)||21
3149513|NCT01794689|3875723|FG003|STARTED|Washout (2 Weeks)||18
3149514|NCT01794689|3875720|FG000|COMPLETED|Washout (2 Weeks)||20
3149515|NCT01794689|3875721|FG001|COMPLETED|Washout (2 Weeks)||27
3149516|NCT01794689|3875722|FG002|COMPLETED|Washout (2 Weeks)||21
3149517|NCT01794689|3875723|FG003|COMPLETED|Washout (2 Weeks)||18
3149518|NCT01794689|3875720|FG000|NOT COMPLETED|Washout (2 Weeks)||0
3149519|NCT01794689|3875721|FG001|NOT COMPLETED|Washout (2 Weeks)||0
3149520|NCT01794689|3875722|FG002|NOT COMPLETED|Washout (2 Weeks)||0
3149521|NCT01794689|3875723|FG003|NOT COMPLETED|Washout (2 Weeks)||0
3149522|NCT01794689|3875720|FG000|STARTED|Intervention 2 (2 Nights)||20
3149523|NCT01794689|3875721|FG001|STARTED|Intervention 2 (2 Nights)||27
3149524|NCT01794689|3875722|FG002|STARTED|Intervention 2 (2 Nights)||21
3149525|NCT01794689|3875723|FG003|STARTED|Intervention 2 (2 Nights)||18
3149526|NCT01794689|3875720|FG000|COMPLETED|Intervention 2 (2 Nights)||20
3149527|NCT01794689|3875721|FG001|COMPLETED|Intervention 2 (2 Nights)||27
3149528|NCT01794689|3875722|FG002|COMPLETED|Intervention 2 (2 Nights)||21
3149529|NCT01794689|3875723|FG003|COMPLETED|Intervention 2 (2 Nights)||18
3149530|NCT01794689|3875720|FG000|NOT COMPLETED|Intervention 2 (2 Nights)||0
3149531|NCT01794689|3875721|FG001|NOT COMPLETED|Intervention 2 (2 Nights)||0
3149532|NCT01794689|3875722|FG002|NOT COMPLETED|Intervention 2 (2 Nights)||0
3149533|NCT01794689|3875723|FG003|NOT COMPLETED|Intervention 2 (2 Nights)||0
3149534|NCT01794702|3875742|FG000|STARTED|Overall Study||18
3149535|NCT01794702|3875743|FG001|STARTED|Overall Study||0
3149536|NCT01794702|3875744|FG002|STARTED|Overall Study||47
3149537|NCT01794702|3875742|FG000|COMPLETED|Overall Study||18
3149538|NCT01794702|3875743|FG001|COMPLETED|Overall Study||0
3149539|NCT01794702|3875744|FG002|COMPLETED|Overall Study||47
3149540|NCT01794702|3875742|FG000|NOT COMPLETED|Overall Study||0
3149541|NCT01794702|3875743|FG001|NOT COMPLETED|Overall Study||0
3149542|NCT01794702|3875744|FG002|NOT COMPLETED|Overall Study||0
3149543|NCT01794741|3875754|FG000|STARTED|Overall Study||304
3149544|NCT01794741|3875755|FG001|STARTED|Overall Study||101
3149545|NCT01794741|3875754|FG000|COMPLETED|Overall Study||285
3149546|NCT01794741|3875755|FG001|COMPLETED|Overall Study||92
3182481|NCT02000622|3910548|FG001|STARTED|Overall Study||97
3182482|NCT02000622|3910547|FG000|COMPLETED|Overall Study||36
3182483|NCT02000622|3910548|FG001|COMPLETED|Overall Study||17
3182484|NCT02000622|3910547|FG000|NOT COMPLETED|Overall Study||169
3182485|NCT02000622|3910548|FG001|NOT COMPLETED|Overall Study||80
3182486|NCT02000752|3910556|FG000|STARTED|Overall Study||60
3182487|NCT02000752|3910557|FG001|STARTED|Overall Study||60
3182488|NCT02000752|3910556|FG000|COMPLETED|Overall Study||29
3182489|NCT02000752|3910557|FG001|COMPLETED|Overall Study||47
3182490|NCT02000752|3910556|FG000|NOT COMPLETED|Overall Study||31
3182491|NCT02000752|3910557|FG001|NOT COMPLETED|Overall Study||13
3182492|NCT02000817|3910567|FG000|STARTED|Overall Study||6
3182493|NCT02000817|3910568|FG001|STARTED|Overall Study||9
3182494|NCT02000817|3910569|FG002|STARTED|Overall Study||8
3182495|NCT02000817|3910570|FG003|STARTED|Overall Study||7
3182496|NCT02000817|3910567|FG000|COMPLETED|Overall Study||4
3182497|NCT02000817|3910568|FG001|COMPLETED|Overall Study||8
3182498|NCT02000817|3910569|FG002|COMPLETED|Overall Study||7
3182499|NCT02000817|3910570|FG003|COMPLETED|Overall Study||7
3182500|NCT02000817|3910567|FG000|NOT COMPLETED|Overall Study||2
3182501|NCT02000817|3910568|FG001|NOT COMPLETED|Overall Study||1
3182502|NCT02000817|3910569|FG002|NOT COMPLETED|Overall Study||1
3182503|NCT02000817|3910570|FG003|NOT COMPLETED|Overall Study||0
3182504|NCT02000908|3910585|FG000|STARTED|Overall Study||30
3182505|NCT02000908|3910586|FG001|STARTED|Overall Study||40
3182506|NCT02000908|3910585|FG000|COMPLETED|Overall Study||28
3182507|NCT02000908|3910586|FG001|COMPLETED|Overall Study||36
3182508|NCT02000908|3910585|FG000|NOT COMPLETED|Overall Study||2
3182509|NCT02000908|3910586|FG001|NOT COMPLETED|Overall Study||4
3182510|NCT02000921|3910595|FG000|STARTED|Overall Study||27
3182511|NCT02000921|3910596|FG001|STARTED|Overall Study||53
3182512|NCT02000921|3910597|FG002|STARTED|Overall Study||56
3182513|NCT02000921|3910595|FG000|COMPLETED|Overall Study||22
3182514|NCT02000921|3910596|FG001|COMPLETED|Overall Study||37
3182515|NCT02000921|3910597|FG002|COMPLETED|Overall Study||46
3182516|NCT02000921|3910595|FG000|NOT COMPLETED|Overall Study||5
3182517|NCT02000921|3910596|FG001|NOT COMPLETED|Overall Study||16
3182518|NCT02000921|3910597|FG002|NOT COMPLETED|Overall Study||10
3182519|NCT02000973|3910609|FG000|STARTED|Overall Study||20
3182520|NCT02000973|3910610|FG001|STARTED|Overall Study||20
3182521|NCT02000973|3910611|FG002|STARTED|Overall Study||20
3149547|NCT01794741|3875754|FG000|NOT COMPLETED|Overall Study||19
3149548|NCT01794741|3875755|FG001|NOT COMPLETED|Overall Study||9
3149549|NCT01794780|3875769|FG000|STARTED|Overall Study||32
3149550|NCT01794780|3875770|FG001|STARTED|Overall Study||276
3149551|NCT01794780|3875771|FG002|STARTED|Overall Study||813
3149552|NCT01794780|3875772|FG003|STARTED|Overall Study||283
3149553|NCT01794780|3875773|FG004|STARTED|Overall Study||9
3149554|NCT01794780|3875774|FG005|STARTED|Overall Study||632
3149555|NCT01794780|3875775|FG006|STARTED|Overall Study||154
3149556|NCT01794780|3875776|FG007|STARTED|Overall Study||30
3149557|NCT01794780|3875769|FG000|COMPLETED|Overall Study||15
3182522|NCT02000973|3910612|FG003|STARTED|Overall Study||20
3182523|NCT02000973|3910609|FG000|COMPLETED|Overall Study||20
3182524|NCT02000973|3910610|FG001|COMPLETED|Overall Study||20
3182525|NCT02000973|3910611|FG002|COMPLETED|Overall Study||20
3182526|NCT02000973|3910612|FG003|COMPLETED|Overall Study||20
3149558|NCT01794780|3875770|FG001|COMPLETED|Overall Study||180
3149559|NCT01794780|3875771|FG002|COMPLETED|Overall Study||571
3149560|NCT01794780|3875772|FG003|COMPLETED|Overall Study||200
3149561|NCT01794780|3875773|FG004|COMPLETED|Overall Study||6
3149562|NCT01794780|3875774|FG005|COMPLETED|Overall Study||452
3149563|NCT01794780|3875775|FG006|COMPLETED|Overall Study||112
3149564|NCT01794780|3875776|FG007|COMPLETED|Overall Study||21
3149565|NCT01794780|3875769|FG000|NOT COMPLETED|Overall Study||17
3149566|NCT01794780|3875770|FG001|NOT COMPLETED|Overall Study||96
3149567|NCT01794780|3875771|FG002|NOT COMPLETED|Overall Study||242
3149568|NCT01794780|3875772|FG003|NOT COMPLETED|Overall Study||83
3149569|NCT01794780|3875773|FG004|NOT COMPLETED|Overall Study||3
3149570|NCT01794780|3875774|FG005|NOT COMPLETED|Overall Study||180
3149571|NCT01794780|3875775|FG006|NOT COMPLETED|Overall Study||42
3149572|NCT01794780|3875776|FG007|NOT COMPLETED|Overall Study||9
3149573|NCT01794806|3875803|FG000|STARTED|Overall Study||31
3149574|NCT01794806|3875804|FG001|STARTED|Overall Study||28
3149575|NCT01794806|3875803|FG000|1 Week|Overall Study||28
3149576|NCT01794806|3875804|FG001|1 Week|Overall Study||28
3149577|NCT01794806|3875803|FG000|4 Weeks|Overall Study||26
3149578|NCT01794806|3875804|FG001|4 Weeks|Overall Study||27
3149579|NCT01794806|3875803|FG000|COMPLETED|Overall Study||26
3149580|NCT01794806|3875804|FG001|COMPLETED|Overall Study||27
3149581|NCT01794806|3875803|FG000|NOT COMPLETED|Overall Study||5
3149582|NCT01794806|3875804|FG001|NOT COMPLETED|Overall Study||1
3149583|NCT01794845|3875810|FG000|STARTED|Overall Study||5
3149584|NCT01794845|3875810|FG000|COMPLETED|Overall Study||4
3149585|NCT01794845|3875810|FG000|NOT COMPLETED|Overall Study||1
3149586|NCT01794923|3875817|FG000|STARTED|Overall Study||83
3149587|NCT01794923|3875818|FG001|STARTED|Overall Study||60
3149588|NCT01794923|3875819|FG002|STARTED|Overall Study||62
3149589|NCT01794923|3875817|FG000|COMPLETED|Overall Study||83
3149590|NCT01794923|3875818|FG001|COMPLETED|Overall Study||60
3149591|NCT01794923|3875819|FG002|COMPLETED|Overall Study||61
3149592|NCT01794923|3875817|FG000|NOT COMPLETED|Overall Study||0
3149593|NCT01794923|3875818|FG001|NOT COMPLETED|Overall Study||0
3149594|NCT01794923|3875819|FG002|NOT COMPLETED|Overall Study||1
3149595|NCT01794949|3875829|FG000|STARTED|Overall Study||7
3149596|NCT01794949|3875830|FG001|STARTED|Overall Study||1
3149597|NCT01794949|3875829|FG000|6 Month Follow-up|Overall Study||6
3149598|NCT01794949|3875830|FG001|6 Month Follow-up|Overall Study||1
3149599|NCT01794949|3875829|FG000|COMPLETED|Overall Study||6
3149600|NCT01794949|3875830|FG001|COMPLETED|Overall Study||1
3149601|NCT01794949|3875829|FG000|NOT COMPLETED|Overall Study||1
3149602|NCT01794949|3875830|FG001|NOT COMPLETED|Overall Study||0
3149603|NCT01795079|3875838|FG000|STARTED|Overall Study||16
3149604|NCT01795079|3875839|FG001|STARTED|Overall Study||15
3149605|NCT01795079|3875838|FG000|COMPLETED|Overall Study||13
3149606|NCT01795079|3875839|FG001|COMPLETED|Overall Study||12
3149607|NCT01795079|3875838|FG000|NOT COMPLETED|Overall Study||3
3149608|NCT01795079|3875839|FG001|NOT COMPLETED|Overall Study||3
3149609|NCT01795105|3875845|FG000|STARTED|Overall Study||692
3149610|NCT01795105|3875845|FG000|COMPLETED|Overall Study||648
3149611|NCT01795105|3875845|FG000|NOT COMPLETED|Overall Study||44
3149612|NCT01795495|3875853|FG000|STARTED|Overall Study||20
3149613|NCT01795495|3875854|FG001|STARTED|Overall Study||22
3149614|NCT01795495|3875855|FG002|STARTED|Overall Study||21
3149615|NCT01795495|3875853|FG000|COMPLETED|Overall Study||19
3149616|NCT01795495|3875854|FG001|COMPLETED|Overall Study||22
3149617|NCT01795495|3875855|FG002|COMPLETED|Overall Study||19
3149618|NCT01795495|3875853|FG000|NOT COMPLETED|Overall Study||1
3149619|NCT01795495|3875854|FG001|NOT COMPLETED|Overall Study||0
3149620|NCT01795495|3875855|FG002|NOT COMPLETED|Overall Study||2
3149621|NCT01795534|3875863|FG000|STARTED|First Intervention (First Shot)||5
3149622|NCT01795534|3875864|FG001|STARTED|First Intervention (First Shot)||5
3149623|NCT01795534|3875863|FG000|COMPLETED|First Intervention (First Shot)||5
3149624|NCT01795534|3875864|FG001|COMPLETED|First Intervention (First Shot)||5
3149625|NCT01795534|3875863|FG000|NOT COMPLETED|First Intervention (First Shot)||0
3149626|NCT01795534|3875864|FG001|NOT COMPLETED|First Intervention (First Shot)||0
3149627|NCT01795534|3875863|FG000|STARTED|Wash Out Period (4 Days)||5
3149628|NCT01795534|3875864|FG001|STARTED|Wash Out Period (4 Days)||5
3149629|NCT01795534|3875863|FG000|COMPLETED|Wash Out Period (4 Days)||5
3149630|NCT01795534|3875864|FG001|COMPLETED|Wash Out Period (4 Days)||5
3182527|NCT02000973|3910609|FG000|NOT COMPLETED|Overall Study||0
3182528|NCT02000973|3910610|FG001|NOT COMPLETED|Overall Study||0
3182529|NCT02000973|3910611|FG002|NOT COMPLETED|Overall Study||0
3182530|NCT02000973|3910612|FG003|NOT COMPLETED|Overall Study||0
3182531|NCT02001051|3910624|FG000|STARTED|Overall Study||2
3182532|NCT02001051|3910625|FG001|STARTED|Overall Study||2
3182533|NCT02001051|3910624|FG000|COMPLETED|Overall Study||2
3182534|NCT02001051|3910625|FG001|COMPLETED|Overall Study||1
3182535|NCT02001051|3910624|FG000|NOT COMPLETED|Overall Study||0
3182536|NCT02001051|3910625|FG001|NOT COMPLETED|Overall Study||1
3182537|NCT02001064|3910633|FG000|STARTED|Overall Study||30
3182538|NCT02001064|3910634|FG001|STARTED|Overall Study||30
3182539|NCT02001064|3910633|FG000|COMPLETED|Overall Study||28
3149631|NCT01795534|3875863|FG000|NOT COMPLETED|Wash Out Period (4 Days)||0
3149632|NCT01795534|3875864|FG001|NOT COMPLETED|Wash Out Period (4 Days)||0
3149633|NCT01795534|3875863|FG000|STARTED|Second Intervention (Second Shot)||5
3149634|NCT01795534|3875864|FG001|STARTED|Second Intervention (Second Shot)||5
3182540|NCT02001064|3910634|FG001|COMPLETED|Overall Study||29
3149635|NCT01795534|3875863|FG000|COMPLETED|Second Intervention (Second Shot)||5
3149636|NCT01795534|3875864|FG001|COMPLETED|Second Intervention (Second Shot)||5
3149637|NCT01795534|3875863|FG000|NOT COMPLETED|Second Intervention (Second Shot)||0
3149638|NCT01795534|3875864|FG001|NOT COMPLETED|Second Intervention (Second Shot)||0
3149639|NCT01795547|3875872|FG000|STARTED|Overall Study||148
3149640|NCT01795547|3875873|FG001|STARTED|Overall Study||147
3149641|NCT01795547|3875872|FG000|COMPLETED|Overall Study||100
3149642|NCT01795547|3875873|FG001|COMPLETED|Overall Study||83
3149643|NCT01795547|3875872|FG000|NOT COMPLETED|Overall Study||48
3149644|NCT01795547|3875873|FG001|NOT COMPLETED|Overall Study||64
3149645|NCT01795638|3875883|FG000|STARTED|Overall Study||27
3149646|NCT01795638|3875884|FG001|STARTED|Overall Study||26
3149647|NCT01795638|3875883|FG000|COMPLETED|Overall Study||14
3149648|NCT01795638|3875884|FG001|COMPLETED|Overall Study||15
3149649|NCT01795638|3875883|FG000|NOT COMPLETED|Overall Study||13
3149650|NCT01795638|3875884|FG001|NOT COMPLETED|Overall Study||11
3149651|NCT01795716|3875892|FG000|STARTED|First Intervention (13 Days)||10
3149652|NCT01795716|3875893|FG001|STARTED|First Intervention (13 Days)||11
3149653|NCT01795716|3875892|FG000|COMPLETED|First Intervention (13 Days)||10
3149654|NCT01795716|3875893|FG001|COMPLETED|First Intervention (13 Days)||11
3149655|NCT01795716|3875892|FG000|NOT COMPLETED|First Intervention (13 Days)||0
3149656|NCT01795716|3875893|FG001|NOT COMPLETED|First Intervention (13 Days)||0
3149657|NCT01795716|3875892|FG000|STARTED|Washout (10 Days)||10
3149658|NCT01795716|3875893|FG001|STARTED|Washout (10 Days)||11
3149659|NCT01795716|3875892|FG000|COMPLETED|Washout (10 Days)||10
3149660|NCT01795716|3875893|FG001|COMPLETED|Washout (10 Days)||11
3149661|NCT01795716|3875892|FG000|NOT COMPLETED|Washout (10 Days)||0
3149662|NCT01795716|3875893|FG001|NOT COMPLETED|Washout (10 Days)||0
3149663|NCT01795716|3875892|FG000|STARTED|Second Intervention (13 Days)||10
3149664|NCT01795716|3875893|FG001|STARTED|Second Intervention (13 Days)||11
3149665|NCT01795716|3875892|FG000|COMPLETED|Second Intervention (13 Days)||10
3149666|NCT01795716|3875893|FG001|COMPLETED|Second Intervention (13 Days)||11
3149667|NCT01795716|3875892|FG000|NOT COMPLETED|Second Intervention (13 Days)||0
3149668|NCT01795716|3875893|FG001|NOT COMPLETED|Second Intervention (13 Days)||0
3149669|NCT01795833|3875903|FG000|STARTED|Overall Study||1031
3149670|NCT01795833|3875904|FG001|STARTED|Overall Study||1031
3149671|NCT01795833|3875903|FG000|COMPLETED|Overall Study||881
3149672|NCT01795833|3875904|FG001|COMPLETED|Overall Study||882
3149673|NCT01795833|3875903|FG000|NOT COMPLETED|Overall Study||150
3149674|NCT01795833|3875904|FG001|NOT COMPLETED|Overall Study||149
3149675|NCT01795859|3875912|FG000|STARTED|Overall Study||45
3149676|NCT01795859|3875913|FG001|STARTED|Overall Study||45
3149677|NCT01795859|3875912|FG000|COMPLETED|Overall Study||44
3149678|NCT01795859|3875913|FG001|COMPLETED|Overall Study||43
3149679|NCT01795859|3875912|FG000|NOT COMPLETED|Overall Study||1
3149680|NCT01795859|3875913|FG001|NOT COMPLETED|Overall Study||2
3149681|NCT01795898|3875919|FG000|STARTED|Overall Study||237
3149682|NCT01795898|3875919|FG000|COMPLETED|Overall Study||177
3149683|NCT01795898|3875919|FG000|NOT COMPLETED|Overall Study||60
3149684|NCT01795937|3875926|FG000|STARTED|Overall Study||18
3149685|NCT01795937|3875927|FG001|STARTED|Overall Study||16
3149686|NCT01795937|3875928|FG002|STARTED|Overall Study||17
3149687|NCT01795937|3875926|FG000|COMPLETED|Overall Study||17
3149688|NCT01795937|3875927|FG001|COMPLETED|Overall Study||15
3149689|NCT01795937|3875928|FG002|COMPLETED|Overall Study||17
3149690|NCT01795937|3875926|FG000|NOT COMPLETED|Overall Study||1
3149691|NCT01795937|3875927|FG001|NOT COMPLETED|Overall Study||1
3149692|NCT01795937|3875928|FG002|NOT COMPLETED|Overall Study||0
3149693|NCT01796236|3875946|FG000|STARTED|Overall Study||51
3149694|NCT01796236|3875947|FG001|STARTED|Overall Study||52
3149695|NCT01796236|3875946|FG000|COMPLETED|Overall Study||49
3149696|NCT01796236|3875947|FG001|COMPLETED|Overall Study||50
3149697|NCT01796236|3875946|FG000|NOT COMPLETED|Overall Study||2
3149698|NCT01796236|3875947|FG001|NOT COMPLETED|Overall Study||2
3149699|NCT01796301|3875956|FG000|STARTED|Overall Study||218
3149700|NCT01796301|3875957|FG001|STARTED|Overall Study||218
3149701|NCT01796301|3875956|FG000|Received Treatment|Overall Study||214
3149702|NCT01796301|3875957|FG001|Received Treatment|Overall Study||218
3149703|NCT01796301|3875956|FG000|COMPLETED|Overall Study||200
3149704|NCT01796301|3875957|FG001|COMPLETED|Overall Study||198
3149705|NCT01796301|3875956|FG000|NOT COMPLETED|Overall Study||18
3149706|NCT01796301|3875957|FG001|NOT COMPLETED|Overall Study||20
3149707|NCT01796392|3875965|FG000|STARTED|Overall Study||128
3149708|NCT01796392|3875966|FG001|STARTED|Overall Study||62
3149709|NCT01796392|3875965|FG000|COMPLETED|Overall Study|119 active subjects at 12-months|119
3149710|NCT01796392|3875966|FG001|COMPLETED|Overall Study|59 active subjects at 12-months|59
3149711|NCT01796392|3875965|FG000|NOT COMPLETED|Overall Study||9
3149712|NCT01796392|3875966|FG001|NOT COMPLETED|Overall Study||3
3149713|NCT01796470|3875977|FG000|STARTED|Overall Study||35
3149714|NCT01796470|3875978|FG001|STARTED|Overall Study||14
3149715|NCT01796470|3875979|FG002|STARTED|Overall Study||6
3149716|NCT01796470|3875980|FG003|STARTED|Overall Study||3
3149717|NCT01796470|3875981|FG004|STARTED|Overall Study||8
3149718|NCT01796470|3875977|FG000|Entospletinib Monotherapy|Overall Study||4
3149719|NCT01796470|3875978|FG001|Entospletinib Monotherapy|Overall Study||4
3149720|NCT01796470|3875979|FG002|Entospletinib Monotherapy|Overall Study||0
3149721|NCT01796470|3875980|FG003|Entospletinib Monotherapy|Overall Study||0
3149722|NCT01796470|3875981|FG004|Entospletinib Monotherapy|Overall Study||0
3149723|NCT01796470|3875977|FG000|COMPLETED|Overall Study||0
3149724|NCT01796470|3875978|FG001|COMPLETED|Overall Study||0
3149725|NCT01796470|3875979|FG002|COMPLETED|Overall Study||0
3149726|NCT01796470|3875980|FG003|COMPLETED|Overall Study||0
3149727|NCT01796470|3875981|FG004|COMPLETED|Overall Study||0
3149728|NCT01796470|3875977|FG000|NOT COMPLETED|Overall Study||35
3149729|NCT01796470|3875978|FG001|NOT COMPLETED|Overall Study||14
3149730|NCT01796470|3875979|FG002|NOT COMPLETED|Overall Study||6
3149731|NCT01796470|3875980|FG003|NOT COMPLETED|Overall Study||3
3149732|NCT01796470|3875981|FG004|NOT COMPLETED|Overall Study||8
3149733|NCT01796548|3875997|FG000|STARTED|Overall Study||17
3149734|NCT01796548|3875997|FG000|Treated|Overall Study||15
3149735|NCT01796548|3875997|FG000|COMPLETED|Overall Study||14
3149736|NCT01796548|3875997|FG000|NOT COMPLETED|Overall Study||3
3149737|NCT01796665|3876004|FG000|STARTED|Overall Study||474
3149738|NCT01796665|3876005|FG001|STARTED|Overall Study||469
3149739|NCT01796665|3876006|FG002|STARTED|Overall Study||237
3149740|NCT01796665|3876004|FG000|COMPLETED|Overall Study||416
3149741|NCT01796665|3876005|FG001|COMPLETED|Overall Study||396
3149742|NCT01796665|3876006|FG002|COMPLETED|Overall Study||195
3149743|NCT01796665|3876004|FG000|NOT COMPLETED|Overall Study||58
3149744|NCT01796665|3876005|FG001|NOT COMPLETED|Overall Study||73
3149745|NCT01796665|3876006|FG002|NOT COMPLETED|Overall Study||42
3149746|NCT01796860|3876014|FG000|STARTED|Overall Study||10
3149747|NCT01796860|3876014|FG000|COMPLETED|Overall Study||7
3149748|NCT01796860|3876014|FG000|NOT COMPLETED|Overall Study||3
3149749|NCT01796912|3876018|FG000|STARTED|First Intervention||10
3149750|NCT01796912|3876019|FG001|STARTED|First Intervention||10
3149751|NCT01796912|3876018|FG000|COMPLETED|First Intervention||10
3149752|NCT01796912|3876019|FG001|COMPLETED|First Intervention||10
3149753|NCT01796912|3876018|FG000|NOT COMPLETED|First Intervention||0
3182541|NCT02001064|3910633|FG000|NOT COMPLETED|Overall Study||2
3182542|NCT02001064|3910634|FG001|NOT COMPLETED|Overall Study||1
3363641|NCT04043416|4094771|FG000|NOT COMPLETED|Campaign 1||0
3363642|NCT04043416|4094772|FG001|NOT COMPLETED|Campaign 1||0
3363643|NCT04043416|4094771|FG000|STARTED|Washout||14
3363644|NCT04043416|4094772|FG001|STARTED|Washout||14
3363645|NCT04043416|4094771|FG000|COMPLETED|Washout||14
3363646|NCT04043416|4094772|FG001|COMPLETED|Washout||13
3363647|NCT04043416|4094771|FG000|NOT COMPLETED|Washout||0
3363648|NCT04043416|4094772|FG001|NOT COMPLETED|Washout||1
3363649|NCT04043416|4094771|FG000|STARTED|Campaign 2||14
3363650|NCT04043416|4094772|FG001|STARTED|Campaign 2||13
3363651|NCT04043416|4094771|FG000|COMPLETED|Campaign 2||14
3363652|NCT04043416|4094772|FG001|COMPLETED|Campaign 2||13
3363653|NCT04043416|4094771|FG000|NOT COMPLETED|Campaign 2||0
3363654|NCT04043416|4094772|FG001|NOT COMPLETED|Campaign 2||0
3363655|NCT04057768|4094781|FG000|STARTED|Overall Study||10
3363656|NCT04057768|4094781|FG000|COMPLETED|Overall Study||10
3363657|NCT04057768|4094781|FG000|NOT COMPLETED|Overall Study||0
3363658|NCT04052542|4094797|FG000|STARTED|Overall Study||116
3363659|NCT04052542|4094798|FG001|STARTED|Overall Study||28
3363660|NCT04052542|4094799|FG002|STARTED|Overall Study||146
3363661|NCT04052542|4094800|FG003|STARTED|Overall Study||188
3363662|NCT04052542|4094801|FG004|STARTED|Overall Study||24
3363663|NCT04052542|4094802|FG005|STARTED|Overall Study||183
3363664|NCT04052542|4094803|FG006|STARTED|Overall Study||275
3363665|NCT04052542|4094804|FG007|STARTED|Overall Study||27
3363666|NCT04052542|4094805|FG008|STARTED|Overall Study||276
3363667|NCT04052542|4094806|FG009|STARTED|Overall Study||22
3363668|NCT04052542|4094807|FG010|STARTED|Overall Study||31
3363669|NCT04052542|4094808|FG011|STARTED|Overall Study||12
3363670|NCT04052542|4094797|FG000|COMPLETED|Overall Study||116
3363671|NCT04052542|4094798|FG001|COMPLETED|Overall Study||28
3363672|NCT04052542|4094799|FG002|COMPLETED|Overall Study||146
3363673|NCT04052542|4094800|FG003|COMPLETED|Overall Study||188
3363674|NCT04052542|4094801|FG004|COMPLETED|Overall Study||24
3363675|NCT04052542|4094802|FG005|COMPLETED|Overall Study||183
3363676|NCT04052542|4094803|FG006|COMPLETED|Overall Study||275
3363677|NCT04052542|4094804|FG007|COMPLETED|Overall Study||27
3363678|NCT04052542|4094805|FG008|COMPLETED|Overall Study||276
3363679|NCT04052542|4094806|FG009|COMPLETED|Overall Study||22
3363680|NCT04052542|4094807|FG010|COMPLETED|Overall Study||31
3363681|NCT04052542|4094808|FG011|COMPLETED|Overall Study||12
3363682|NCT04052542|4094797|FG000|NOT COMPLETED|Overall Study||0
3363683|NCT04052542|4094798|FG001|NOT COMPLETED|Overall Study||0
3363684|NCT04052542|4094799|FG002|NOT COMPLETED|Overall Study||0
3363685|NCT04052542|4094800|FG003|NOT COMPLETED|Overall Study||0
3363686|NCT04052542|4094801|FG004|NOT COMPLETED|Overall Study||0
3363687|NCT04052542|4094802|FG005|NOT COMPLETED|Overall Study||0
3363688|NCT04052542|4094803|FG006|NOT COMPLETED|Overall Study||0
3363689|NCT04052542|4094804|FG007|NOT COMPLETED|Overall Study||0
3363690|NCT04052542|4094805|FG008|NOT COMPLETED|Overall Study||0
3363691|NCT04052542|4094806|FG009|NOT COMPLETED|Overall Study||0
3363692|NCT04052542|4094807|FG010|NOT COMPLETED|Overall Study||0
3363693|NCT04052542|4094808|FG011|NOT COMPLETED|Overall Study||0
3363694|NCT04054193|4094834|FG000|STARTED|Cycle 1||103
3149754|NCT01796912|3876019|FG001|NOT COMPLETED|First Intervention||0
3363695|NCT04054193|4094834|FG000|Treated (≥1 Dose)|Cycle 1||100
3363696|NCT04054193|4094834|FG000|COMPLETED|Cycle 1||98
3363697|NCT04054193|4094834|FG000|NOT COMPLETED|Cycle 1||5
3363698|NCT04054193|4094834|FG000|STARTED|Cycles 2-3|Participation in Cycles 2-3 was optional after completing Cycle 1.|69
3363699|NCT04054193|4094834|FG000|COMPLETED|Cycles 2-3||48
3363700|NCT04054193|4094834|FG000|NOT COMPLETED|Cycles 2-3||21
3149755|NCT01796912|3876018|FG000|STARTED|Washout||10
3149756|NCT01796912|3876019|FG001|STARTED|Washout||10
3149757|NCT01796912|3876018|FG000|COMPLETED|Washout||10
3149758|NCT01796912|3876019|FG001|COMPLETED|Washout||10
3149759|NCT01796912|3876018|FG000|NOT COMPLETED|Washout||0
3149760|NCT01796912|3876019|FG001|NOT COMPLETED|Washout||0
3149761|NCT01796912|3876018|FG000|STARTED|Second Intervention||10
3149762|NCT01796912|3876019|FG001|STARTED|Second Intervention||10
3149763|NCT01796912|3876018|FG000|COMPLETED|Second Intervention||10
3149764|NCT01796912|3876019|FG001|COMPLETED|Second Intervention||10
3149765|NCT01796912|3876018|FG000|NOT COMPLETED|Second Intervention||0
3149766|NCT01796912|3876019|FG001|NOT COMPLETED|Second Intervention||0
3149767|NCT01796964|3876029|FG000|STARTED|Overall Study||44
3149768|NCT01796964|3876030|FG001|STARTED|Overall Study||45
3149769|NCT01796964|3876029|FG000|COMPLETED|Overall Study||41
3149770|NCT01796964|3876030|FG001|COMPLETED|Overall Study||42
3149771|NCT01796964|3876029|FG000|NOT COMPLETED|Overall Study||3
3149772|NCT01796964|3876030|FG001|NOT COMPLETED|Overall Study||3
3149773|NCT01796977|3876037|FG000|STARTED|Overall Study||27
3149774|NCT01796977|3876037|FG000|COMPLETED|Overall Study||27
3149775|NCT01796977|3876037|FG000|NOT COMPLETED|Overall Study||0
3149776|NCT01797029|3876048|FG000|STARTED|Overall Study||1174
3149777|NCT01797029|3876049|FG001|STARTED|Overall Study||587
3149778|NCT01797029|3876048|FG000|COMPLETED|Overall Study||1015
3149779|NCT01797029|3876049|FG001|COMPLETED|Overall Study||526
3149780|NCT01797029|3876048|FG000|NOT COMPLETED|Overall Study||159
3149781|NCT01797029|3876049|FG001|NOT COMPLETED|Overall Study||61
3149782|NCT01797081|3876059|FG000|STARTED|Overall Study||104
3149783|NCT01797081|3876060|FG001|STARTED|Overall Study||99
3149784|NCT01797081|3876061|FG002|STARTED|Overall Study||48
3149785|NCT01797081|3876062|FG003|STARTED|Overall Study||49
3149786|NCT01797081|3876059|FG000|COMPLETED|Overall Study||90
3149787|NCT01797081|3876060|FG001|COMPLETED|Overall Study||95
3149788|NCT01797081|3876061|FG002|COMPLETED|Overall Study||43
3182543|NCT02001181|3910642|FG000|STARTED|Overall Study||35
3182544|NCT02001181|3910643|FG001|STARTED|Overall Study||34
3182545|NCT02001181|3910642|FG000|COMPLETED|Overall Study||34
3182546|NCT02001181|3910643|FG001|COMPLETED|Overall Study||31
3182547|NCT02001181|3910642|FG000|NOT COMPLETED|Overall Study||1
3182548|NCT02001181|3910643|FG001|NOT COMPLETED|Overall Study||3
3182549|NCT02001194|3910653|FG000|STARTED|Intervention Period (13 Weeks)|17 teams|68
3182550|NCT02001194|3910654|FG001|STARTED|Intervention Period (13 Weeks)|20 teams|80
3182551|NCT02001194|3910655|FG002|STARTED|Intervention Period (13 Weeks)|19 teams|76
3182552|NCT02001194|3910656|FG003|STARTED|Intervention Period (13 Weeks)|20 teams|80
3182553|NCT02001194|3910653|FG000|COMPLETED|Intervention Period (13 Weeks)|16 teams|67
3182554|NCT02001194|3910654|FG001|COMPLETED|Intervention Period (13 Weeks)|20 teams|80
3182555|NCT02001194|3910655|FG002|COMPLETED|Intervention Period (13 Weeks)|19 teams|74
3182556|NCT02001194|3910656|FG003|COMPLETED|Intervention Period (13 Weeks)|20 teams|78
3182557|NCT02001194|3910653|FG000|NOT COMPLETED|Intervention Period (13 Weeks)||1
3182558|NCT02001194|3910654|FG001|NOT COMPLETED|Intervention Period (13 Weeks)||0
3182559|NCT02001194|3910655|FG002|NOT COMPLETED|Intervention Period (13 Weeks)||2
3182560|NCT02001194|3910656|FG003|NOT COMPLETED|Intervention Period (13 Weeks)||2
3182561|NCT02001194|3910653|FG000|STARTED|Follow-Up Period (13 Weeks)||67
3182562|NCT02001194|3910654|FG001|STARTED|Follow-Up Period (13 Weeks)||80
3182563|NCT02001194|3910655|FG002|STARTED|Follow-Up Period (13 Weeks)||74
3182564|NCT02001194|3910656|FG003|STARTED|Follow-Up Period (13 Weeks)||78
3182565|NCT02001194|3910653|FG000|COMPLETED|Follow-Up Period (13 Weeks)||64
3182566|NCT02001194|3910654|FG001|COMPLETED|Follow-Up Period (13 Weeks)||78
3182567|NCT02001194|3910655|FG002|COMPLETED|Follow-Up Period (13 Weeks)||73
3182568|NCT02001194|3910656|FG003|COMPLETED|Follow-Up Period (13 Weeks)||78
3182569|NCT02001194|3910653|FG000|NOT COMPLETED|Follow-Up Period (13 Weeks)||3
3182570|NCT02001194|3910654|FG001|NOT COMPLETED|Follow-Up Period (13 Weeks)||2
3182571|NCT02001194|3910655|FG002|NOT COMPLETED|Follow-Up Period (13 Weeks)||1
3182572|NCT02001194|3910656|FG003|NOT COMPLETED|Follow-Up Period (13 Weeks)||0
3182573|NCT02001558|3910668|FG000|STARTED|Overall Study||32
3182574|NCT02001558|3910669|FG001|STARTED|Overall Study||33
3182575|NCT02001558|3910668|FG000|COMPLETED|Overall Study||24
3182576|NCT02001558|3910669|FG001|COMPLETED|Overall Study||19
3182577|NCT02001558|3910668|FG000|NOT COMPLETED|Overall Study||8
3182578|NCT02001558|3910669|FG001|NOT COMPLETED|Overall Study||14
3182579|NCT02001688|3910678|FG000|STARTED|Overall Study||12
3182580|NCT02001688|3910679|FG001|STARTED|Overall Study||12
3182581|NCT02001688|3910680|FG002|STARTED|Overall Study||12
3182582|NCT02001688|3910678|FG000|COMPLETED|Overall Study||12
3182583|NCT02001688|3910679|FG001|COMPLETED|Overall Study||11
3182584|NCT02001688|3910680|FG002|COMPLETED|Overall Study||11
3182585|NCT02001688|3910678|FG000|NOT COMPLETED|Overall Study||0
3182586|NCT02001688|3910679|FG001|NOT COMPLETED|Overall Study||1
3182587|NCT02001688|3910680|FG002|NOT COMPLETED|Overall Study||1
3182588|NCT02001714|3910691|FG000|STARTED|Overall Study||232
3182589|NCT02001714|3910692|FG001|STARTED|Overall Study||231
3182590|NCT02001714|3910691|FG000|COMPLETED|Overall Study||210
3182591|NCT02001714|3910692|FG001|COMPLETED|Overall Study||219
3182592|NCT02001714|3910691|FG000|NOT COMPLETED|Overall Study||22
3182593|NCT02001714|3910692|FG001|NOT COMPLETED|Overall Study||12
3182594|NCT02001987|3910698|FG000|STARTED|Core Study Period (24 Weeks)||139
3182595|NCT02001987|3910698|FG000|COMPLETED|Core Study Period (24 Weeks)||116
3149789|NCT01797081|3876062|FG003|COMPLETED|Overall Study||40
3149790|NCT01797081|3876059|FG000|NOT COMPLETED|Overall Study||14
3149791|NCT01797081|3876060|FG001|NOT COMPLETED|Overall Study||4
3149792|NCT01797081|3876061|FG002|NOT COMPLETED|Overall Study||5
3149793|NCT01797081|3876062|FG003|NOT COMPLETED|Overall Study||9
3149794|NCT01797094|3876072|FG000|STARTED|Overall Study||48
3149795|NCT01797094|3876073|FG001|STARTED|Overall Study||53
3149796|NCT01797094|3876072|FG000|COMPLETED|Overall Study||42
3149797|NCT01797094|3876073|FG001|COMPLETED|Overall Study||51
3149798|NCT01797094|3876072|FG000|NOT COMPLETED|Overall Study||6
3149799|NCT01797094|3876073|FG001|NOT COMPLETED|Overall Study||2
3149800|NCT01797120|3876081|FG000|STARTED|Overall Study||66
3149801|NCT01797120|3876082|FG001|STARTED|Overall Study||65
3149802|NCT01797120|3876081|FG000|COMPLETED|Overall Study||0
3149803|NCT01797120|3876082|FG001|COMPLETED|Overall Study||0
3149804|NCT01797120|3876081|FG000|NOT COMPLETED|Overall Study||66
3149805|NCT01797120|3876082|FG001|NOT COMPLETED|Overall Study||65
3149806|NCT01797159|3876088|FG000|STARTED|Overall Study||20
3149807|NCT01797159|3876088|FG000|COMPLETED|Overall Study||20
3149808|NCT01797159|3876088|FG000|NOT COMPLETED|Overall Study||0
3149809|NCT01797185|3876096|FG000|STARTED|Overall Study||162
3149810|NCT01797185|3876097|FG001|STARTED|Overall Study||163
3149811|NCT01797185|3876098|FG002|STARTED|Overall Study||50
3149812|NCT01797185|3876096|FG000|COMPLETED|Overall Study||134
3149813|NCT01797185|3876097|FG001|COMPLETED|Overall Study||125
3149814|NCT01797185|3876098|FG002|COMPLETED|Overall Study||38
3149815|NCT01797185|3876096|FG000|NOT COMPLETED|Overall Study||28
3149816|NCT01797185|3876097|FG001|NOT COMPLETED|Overall Study||38
3149817|NCT01797185|3876098|FG002|NOT COMPLETED|Overall Study||12
3149818|NCT01797263|3876108|FG000|STARTED|Overall Study||129
3149819|NCT01797263|3876109|FG001|STARTED|Overall Study||127
3149820|NCT01797263|3876108|FG000|1 Month|Overall Study||96
3149821|NCT01797263|3876109|FG001|1 Month|Overall Study||87
3149822|NCT01797263|3876108|FG000|3 Month|Overall Study||87
3149823|NCT01797263|3876109|FG001|3 Month|Overall Study||84
3149824|NCT01797263|3876108|FG000|6 Month|Overall Study||90
3149825|NCT01797263|3876109|FG001|6 Month|Overall Study||85
3149826|NCT01797263|3876108|FG000|9 Month|Overall Study||92
3149827|NCT01797263|3876109|FG001|9 Month|Overall Study||87
3149828|NCT01797263|3876108|FG000|COMPLETED|Overall Study||92
3149829|NCT01797263|3876109|FG001|COMPLETED|Overall Study||87
3149830|NCT01797263|3876108|FG000|NOT COMPLETED|Overall Study||37
3149831|NCT01797263|3876109|FG001|NOT COMPLETED|Overall Study||40
3149832|NCT01797302|3876118|FG000|STARTED|Overall Study||75
3149833|NCT01797302|3876119|FG001|STARTED|Overall Study||74
3149834|NCT01797302|3876120|FG002|STARTED|Overall Study||76
3149835|NCT01797302|3876118|FG000|3 Month Visit|Overall Study||60
3149836|NCT01797302|3876119|FG001|3 Month Visit|Overall Study||57
3149837|NCT01797302|3876120|FG002|3 Month Visit|Overall Study||57
3149838|NCT01797302|3876118|FG000|COMPLETED|Overall Study||58
3149839|NCT01797302|3876119|FG001|COMPLETED|Overall Study||48
3149840|NCT01797302|3876120|FG002|COMPLETED|Overall Study||50
3149841|NCT01797302|3876118|FG000|NOT COMPLETED|Overall Study||17
3149842|NCT01797302|3876119|FG001|NOT COMPLETED|Overall Study||26
3149843|NCT01797302|3876120|FG002|NOT COMPLETED|Overall Study||26
3149844|NCT01797328|3876130|FG000|STARTED|Overall Study||16
3149845|NCT01797328|3876131|FG001|STARTED|Overall Study||12
3149846|NCT01797328|3876130|FG000|COMPLETED|Overall Study||14
3149847|NCT01797328|3876131|FG001|COMPLETED|Overall Study||12
3149848|NCT01797328|3876130|FG000|NOT COMPLETED|Overall Study||2
3149849|NCT01797328|3876131|FG001|NOT COMPLETED|Overall Study||0
3149850|NCT01797432|3876137|FG000|STARTED|Overall Study||14
3149851|NCT01797432|3876137|FG000|COMPLETED|Overall Study||10
3182596|NCT02001987|3910698|FG000|NOT COMPLETED|Core Study Period (24 Weeks)||23
3182597|NCT02001987|3910698|FG000|STARTED|LTE Period (52 Weeks)||116
3182598|NCT02001987|3910698|FG000|COMPLETED|LTE Period (52 Weeks)||107
3182599|NCT02001987|3910698|FG000|NOT COMPLETED|LTE Period (52 Weeks)||9
3182600|NCT02002091|3910709|FG000|STARTED|Screening||122
3182601|NCT02002091|3910710|FG001|STARTED|Screening||205
3182602|NCT02002091|3910709|FG000|COMPLETED|Screening||109
3182603|NCT02002091|3910710|FG001|COMPLETED|Screening||191
3182604|NCT02002091|3910709|FG000|NOT COMPLETED|Screening||13
3182605|NCT02002091|3910710|FG001|NOT COMPLETED|Screening||14
3182606|NCT02002091|3910709|FG000|STARTED|One Year Follow up||109
3182607|NCT02002091|3910710|FG001|STARTED|One Year Follow up||191
3182608|NCT02002091|3910709|FG000|COMPLETED|One Year Follow up||109
3182609|NCT02002091|3910710|FG001|COMPLETED|One Year Follow up||191
3182610|NCT02002091|3910709|FG000|NOT COMPLETED|One Year Follow up||0
3182611|NCT02002091|3910710|FG001|NOT COMPLETED|One Year Follow up||0
3182612|NCT02002182|3910747|FG000|STARTED|Overall Study||9
3182613|NCT02002182|3910748|FG001|STARTED|Overall Study||6
3182614|NCT02002182|3910747|FG000|COMPLETED|Overall Study||4
3182615|NCT02002182|3910748|FG001|COMPLETED|Overall Study||5
3182616|NCT02002182|3910747|FG000|NOT COMPLETED|Overall Study||5
3182617|NCT02002182|3910748|FG001|NOT COMPLETED|Overall Study||1
3182618|NCT02002208|3910756|FG000|STARTED|Overall Study||69
3182619|NCT02002208|3910757|FG001|STARTED|Overall Study||70
3182620|NCT02002208|3910756|FG000|COMPLETED|Overall Study||32
3149852|NCT01797432|3876137|FG000|NOT COMPLETED|Overall Study||4
3149853|NCT01797445|3876143|FG000|STARTED|Double-Blind Phase||435
3149854|NCT01797445|3876144|FG001|STARTED|Double-Blind Phase||437
3149855|NCT01797445|3876143|FG000|COMPLETED|Double-Blind Phase||348
3149856|NCT01797445|3876144|FG001|COMPLETED|Double-Blind Phase||348
3149857|NCT01797445|3876143|FG000|NOT COMPLETED|Double-Blind Phase||87
3182621|NCT02002208|3910757|FG001|COMPLETED|Overall Study||30
3149858|NCT01797445|3876144|FG001|NOT COMPLETED|Double-Blind Phase||89
3149859|NCT01797445|3876143|FG000|STARTED|Open-Label Extension Phase|207 participants completed the Double-Blind Phase, but did not enter the Open-Label Extension Phase.|141
3149860|NCT01797445|3876144|FG001|STARTED|Open-Label Extension Phase|229 participants completed the Double-Blind Phase, but did not enter the Open-Label Extension Phase.|119
3149861|NCT01797445|3876143|FG000|COMPLETED|Open-Label Extension Phase||140
3149862|NCT01797445|3876144|FG001|COMPLETED|Open-Label Extension Phase||119
3149863|NCT01797445|3876143|FG000|NOT COMPLETED|Open-Label Extension Phase||1
3149864|NCT01797445|3876144|FG001|NOT COMPLETED|Open-Label Extension Phase||0
3149865|NCT01797458|3876155|FG000|STARTED|Overall Study||52
3149866|NCT01797458|3876156|FG001|STARTED|Overall Study||52
3149867|NCT01797458|3876157|FG002|STARTED|Overall Study||65
3149868|NCT01797458|3876155|FG000|COMPLETED|Overall Study||40
3149869|NCT01797458|3876156|FG001|COMPLETED|Overall Study||43
3149870|NCT01797458|3876157|FG002|COMPLETED|Overall Study||58
3149871|NCT01797458|3876155|FG000|NOT COMPLETED|Overall Study||12
3149872|NCT01797458|3876156|FG001|NOT COMPLETED|Overall Study||9
3149873|NCT01797458|3876157|FG002|NOT COMPLETED|Overall Study||7
3149874|NCT01797471|3876174|FG000|STARTED|Overall Study||1
3149875|NCT01797471|3876174|FG000|COMPLETED|Overall Study||1
3149876|NCT01797471|3876174|FG000|NOT COMPLETED|Overall Study||0
3182622|NCT02002208|3910756|FG000|NOT COMPLETED|Overall Study||37
3182623|NCT02002208|3910757|FG001|NOT COMPLETED|Overall Study||40
3182624|NCT02002221|3910765|FG000|STARTED|Overall Study||78
3182625|NCT02002221|3910766|FG001|STARTED|Overall Study||78
3182626|NCT02002221|3910765|FG000|COMPLETED|Overall Study||76
3182627|NCT02002221|3910766|FG001|COMPLETED|Overall Study||75
3182628|NCT02002221|3910765|FG000|NOT COMPLETED|Overall Study||2
3182629|NCT02002221|3910766|FG001|NOT COMPLETED|Overall Study||3
3182630|NCT02002494|3910772|FG000|STARTED|Overall Study||27
3182631|NCT02002494|3910772|FG000|COMPLETED|Overall Study||27
3182632|NCT02002494|3910772|FG000|NOT COMPLETED|Overall Study||0
3182633|NCT02002533|3910789|FG000|STARTED|Overall Study||34
3182634|NCT02002533|3910790|FG001|STARTED|Overall Study||37
3182635|NCT02002533|3910789|FG000|COMPLETED|Overall Study||28
3182636|NCT02002533|3910790|FG001|COMPLETED|Overall Study||19
3182637|NCT02002533|3910789|FG000|NOT COMPLETED|Overall Study||6
3182638|NCT02002533|3910790|FG001|NOT COMPLETED|Overall Study||18
3182639|NCT02002650|3910799|FG000|STARTED|Overall Study||1297
3182640|NCT02002650|3910800|FG001|STARTED|Overall Study||1303
3182641|NCT02002650|3910799|FG000|COMPLETED|Overall Study||1297
3182642|NCT02002650|3910800|FG001|COMPLETED|Overall Study||1303
3182643|NCT02002650|3910799|FG000|NOT COMPLETED|Overall Study||0
3182644|NCT02002650|3910800|FG001|NOT COMPLETED|Overall Study||0
3182645|NCT02002689|3910807|FG000|STARTED|Overall Study||10
3182646|NCT02002689|3910807|FG000|COMPLETED|Overall Study||0
3182647|NCT02002689|3910807|FG000|NOT COMPLETED|Overall Study||10
3182648|NCT02002702|3910814|FG000|STARTED|Overall Study||16
3182649|NCT02002702|3910815|FG001|STARTED|Overall Study||15
3182650|NCT02002702|3910816|FG002|STARTED|Overall Study||15
3182651|NCT02002702|3910814|FG000|COMPLETED|Overall Study||16
3182652|NCT02002702|3910815|FG001|COMPLETED|Overall Study||15
3182653|NCT02002702|3910816|FG002|COMPLETED|Overall Study||15
3182654|NCT02002702|3910814|FG000|NOT COMPLETED|Overall Study||0
3182655|NCT02002702|3910815|FG001|NOT COMPLETED|Overall Study||0
3182656|NCT02002702|3910816|FG002|NOT COMPLETED|Overall Study||0
3182657|NCT02002767|3910826|FG000|STARTED|Overall Study||9
3182658|NCT02002767|3910827|FG001|STARTED|Overall Study||10
3182659|NCT02002767|3910826|FG000|COMPLETED|Overall Study||9
3182660|NCT02002767|3910827|FG001|COMPLETED|Overall Study||10
3182661|NCT02002767|3910826|FG000|NOT COMPLETED|Overall Study||0
3182662|NCT02002767|3910827|FG001|NOT COMPLETED|Overall Study||0
3182663|NCT02002832|3910835|FG000|STARTED|Overall Study||194
3182664|NCT02002832|3910836|FG001|STARTED|Overall Study||194
3182665|NCT02002832|3910835|FG000|COMPLETED|Overall Study||166
3182666|NCT02002832|3910836|FG001|COMPLETED|Overall Study||168
3182667|NCT02002832|3910835|FG000|NOT COMPLETED|Overall Study||28
3182668|NCT02002832|3910836|FG001|NOT COMPLETED|Overall Study||26
3182669|NCT02002871|3910843|FG000|STARTED|Overall Study||21
3182670|NCT02002871|3910843|FG000|COMPLETED|Overall Study||20
3182671|NCT02002871|3910843|FG000|NOT COMPLETED|Overall Study||1
3182672|NCT02002884|3910851|FG000|STARTED|Main Period (MP)||87
3182673|NCT02002884|3910852|FG001|STARTED|Main Period (MP)||88
3182674|NCT02002884|3910853|FG002|STARTED|Main Period (MP)||176
3182675|NCT02002884|3910854|FG003|STARTED|Main Period (MP)||0
3182676|NCT02002884|3910851|FG000|Treated|Main Period (MP)||87
3182677|NCT02002884|3910852|FG001|Treated|Main Period (MP)||87
3182678|NCT02002884|3910853|FG002|Treated|Main Period (MP)||176
3182679|NCT02002884|3910854|FG003|Treated|Main Period (MP)||0
3182680|NCT02002884|3910851|FG000|COMPLETED|Main Period (MP)||81
3182681|NCT02002884|3910852|FG001|COMPLETED|Main Period (MP)||82
3182682|NCT02002884|3910853|FG002|COMPLETED|Main Period (MP)||168
3182683|NCT02002884|3910854|FG003|COMPLETED|Main Period (MP)||0
3182684|NCT02002884|3910851|FG000|NOT COMPLETED|Main Period (MP)||6
3182685|NCT02002884|3910852|FG001|NOT COMPLETED|Main Period (MP)||6
3182686|NCT02002884|3910853|FG002|NOT COMPLETED|Main Period (MP)||8
3182687|NCT02002884|3910854|FG003|NOT COMPLETED|Main Period (MP)||0
3182688|NCT02002884|3910851|FG000|STARTED|Open-Label Extension Period (OLEX)||0
3182689|NCT02002884|3910852|FG001|STARTED|Open-Label Extension Period (OLEX)||0
3182690|NCT02002884|3910853|FG002|STARTED|Open-Label Extension Period (OLEX)||0
3182691|NCT02002884|3910854|FG003|STARTED|Open-Label Extension Period (OLEX)||331
3149877|NCT01797484|3876180|FG000|STARTED|Overall Study||10
3149878|NCT01797484|3876181|FG001|STARTED|Overall Study||10
3149879|NCT01797484|3876180|FG000|COMPLETED|Overall Study||10
3149880|NCT01797484|3876181|FG001|COMPLETED|Overall Study||10
3149881|NCT01797484|3876180|FG000|NOT COMPLETED|Overall Study||0
3149882|NCT01797484|3876181|FG001|NOT COMPLETED|Overall Study||0
3149883|NCT01797536|3876191|FG000|STARTED|Overall Study||8
3149884|NCT01797536|3876192|FG001|STARTED|Overall Study|Includes 3 participants from mild arm who were mistakenly re-enrolled and also dosed in moderate arm|11
3149885|NCT01797536|3876193|FG002|STARTED|Overall Study||7
3149886|NCT01797536|3876194|FG003|STARTED|Overall Study||8
3149887|NCT01797536|3876191|FG000|COMPLETED|Overall Study||8
3149888|NCT01797536|3876192|FG001|COMPLETED|Overall Study||10
3149889|NCT01797536|3876193|FG002|COMPLETED|Overall Study||7
3149890|NCT01797536|3876194|FG003|COMPLETED|Overall Study||8
3149891|NCT01797536|3876191|FG000|NOT COMPLETED|Overall Study||0
3149892|NCT01797536|3876192|FG001|NOT COMPLETED|Overall Study||1
3149893|NCT01797536|3876193|FG002|NOT COMPLETED|Overall Study||0
3149894|NCT01797536|3876194|FG003|NOT COMPLETED|Overall Study||0
3149895|NCT01797562|3876204|FG000|STARTED|Overall Study||116
3149896|NCT01797562|3876204|FG000|COMPLETED|Overall Study||111
3149897|NCT01797562|3876204|FG000|NOT COMPLETED|Overall Study||5
3149898|NCT01797575|3876213|FG000|STARTED|Baseline Allocation||5
3149899|NCT01797575|3876214|FG001|STARTED|Baseline Allocation||9
3149900|NCT01797575|3876215|FG002|STARTED|Baseline Allocation||9
3149901|NCT01797575|3876216|FG003|STARTED|Baseline Allocation||15
3149902|NCT01797575|3876213|FG000|COMPLETED|Baseline Allocation||4
3149903|NCT01797575|3876214|FG001|COMPLETED|Baseline Allocation||8
3149904|NCT01797575|3876215|FG002|COMPLETED|Baseline Allocation||4
3149905|NCT01797575|3876216|FG003|COMPLETED|Baseline Allocation||8
3149906|NCT01797575|3876213|FG000|NOT COMPLETED|Baseline Allocation||1
3149907|NCT01797575|3876214|FG001|NOT COMPLETED|Baseline Allocation||1
3149908|NCT01797575|3876215|FG002|NOT COMPLETED|Baseline Allocation||5
3149909|NCT01797575|3876216|FG003|NOT COMPLETED|Baseline Allocation||7
3149910|NCT01797575|3876213|FG000|STARTED|Week 8 Re-Randomization|Non-responders during Period 1 were re-randomized at week 8 into a new treatment arm.|4
3149911|NCT01797575|3876214|FG001|STARTED|Week 8 Re-Randomization|Non-responders during Period 1 were re-randomized at week 8 into a new treatment arm.|5
3149912|NCT01797575|3876215|FG002|STARTED|Week 8 Re-Randomization|Non-responders during Period 1 were re-randomized at week 8 into a new treatment arm.|5
3149913|NCT01797575|3876216|FG003|STARTED|Week 8 Re-Randomization|Non-responders during Period 1 were re-randomized at week 8 into a new treatment arm.|10
3149914|NCT01797575|3876213|FG000|COMPLETED|Week 8 Re-Randomization||4
3149915|NCT01797575|3876214|FG001|COMPLETED|Week 8 Re-Randomization||5
3149916|NCT01797575|3876215|FG002|COMPLETED|Week 8 Re-Randomization||4
3149917|NCT01797575|3876216|FG003|COMPLETED|Week 8 Re-Randomization||7
3149918|NCT01797575|3876213|FG000|NOT COMPLETED|Week 8 Re-Randomization||0
3149919|NCT01797575|3876214|FG001|NOT COMPLETED|Week 8 Re-Randomization||0
3149920|NCT01797575|3876215|FG002|NOT COMPLETED|Week 8 Re-Randomization||1
3149921|NCT01797575|3876216|FG003|NOT COMPLETED|Week 8 Re-Randomization||3
3149922|NCT01797705|3876230|FG000|STARTED|Overall Study||33
3149923|NCT01797705|3876230|FG000|COMPLETED|Overall Study||28
3149924|NCT01797705|3876230|FG000|NOT COMPLETED|Overall Study||5
3149925|NCT01797731|3876236|FG000|STARTED|Overall Study||50
3149926|NCT01797731|3876237|FG001|STARTED|Overall Study||50
3149927|NCT01797731|3876236|FG000|COMPLETED|Overall Study|3 were excluded due to not having proper radiographs for adequate follow up|47
3149928|NCT01797731|3876237|FG001|COMPLETED|Overall Study|3 excluded due to not having proper radiographs for adequate follow up|47
3149929|NCT01797731|3876236|FG000|NOT COMPLETED|Overall Study||3
3149930|NCT01797731|3876237|FG001|NOT COMPLETED|Overall Study||3
3149931|NCT01797783|3876245|FG000|STARTED|Overall Study||52
3149932|NCT01797783|3876246|FG001|STARTED|Overall Study||27
3149933|NCT01797783|3876245|FG000|COMPLETED|Overall Study||50
3149934|NCT01797783|3876246|FG001|COMPLETED|Overall Study||26
3149935|NCT01797783|3876245|FG000|NOT COMPLETED|Overall Study||2
3182692|NCT02002884|3910851|FG000|COMPLETED|Open-Label Extension Period (OLEX)||0
3182693|NCT02002884|3910852|FG001|COMPLETED|Open-Label Extension Period (OLEX)||0
3182694|NCT02002884|3910853|FG002|COMPLETED|Open-Label Extension Period (OLEX)||0
3182695|NCT02002884|3910854|FG003|COMPLETED|Open-Label Extension Period (OLEX)||281
3182696|NCT02002884|3910851|FG000|NOT COMPLETED|Open-Label Extension Period (OLEX)||0
3182697|NCT02002884|3910852|FG001|NOT COMPLETED|Open-Label Extension Period (OLEX)||0
3182698|NCT02002884|3910853|FG002|NOT COMPLETED|Open-Label Extension Period (OLEX)||0
3182699|NCT02002884|3910854|FG003|NOT COMPLETED|Open-Label Extension Period (OLEX)||50
3182700|NCT02002936|3910864|FG000|STARTED|Overall Study||1
3182701|NCT02002936|3910864|FG000|COMPLETED|Overall Study||1
3182702|NCT02002936|3910864|FG000|NOT COMPLETED|Overall Study||0
3182703|NCT02002975|3910868|FG000|STARTED|Overall Study||18223
3182704|NCT02002975|3910868|FG000|COMPLETED|Overall Study||17651
3182705|NCT02002975|3910868|FG000|NOT COMPLETED|Overall Study||572
3182706|NCT02003014|3910872|FG000|STARTED|Overall Study||899
3182707|NCT02003014|3910872|FG000|COMPLETED|Overall Study||880
3182708|NCT02003014|3910872|FG000|NOT COMPLETED|Overall Study||19
3182709|NCT02003053|3910878|FG000|STARTED|Overall Study||4
3182710|NCT02003053|3910879|FG001|STARTED|Overall Study||3
3182711|NCT02003053|3910878|FG000|COMPLETED|Overall Study||4
3182712|NCT02003053|3910879|FG001|COMPLETED|Overall Study||3
3182713|NCT02003053|3910878|FG000|NOT COMPLETED|Overall Study||0
3182714|NCT02003053|3910879|FG001|NOT COMPLETED|Overall Study||0
3182715|NCT02003183|3910887|FG000|STARTED|Overall Study||7
3149936|NCT01797783|3876246|FG001|NOT COMPLETED|Overall Study||1
3149937|NCT01797822|3876260|FG000|STARTED|Overall Study||20
3149938|NCT01797822|3876260|FG000|COMPLETED|Overall Study|The protocol is now closed.|20
3149939|NCT01797822|3876260|FG000|NOT COMPLETED|Overall Study||0
3149940|NCT01797835|3876268|FG000|STARTED|Overall Study||153
3149941|NCT01797835|3876269|FG001|STARTED|Overall Study||141
3149942|NCT01797835|3876268|FG000|COMPLETED|Overall Study||122
3149943|NCT01797835|3876269|FG001|COMPLETED|Overall Study||114
3149944|NCT01797835|3876268|FG000|NOT COMPLETED|Overall Study||31
3149945|NCT01797835|3876269|FG001|NOT COMPLETED|Overall Study||27
3149946|NCT01797965|3876279|FG000|STARTED|Overall Study||597
3149947|NCT01797965|3876280|FG001|STARTED|Overall Study||607
3149948|NCT01797965|3876281|FG002|STARTED|Overall Study||70
3149949|NCT01797965|3876282|FG003|STARTED|Overall Study||227
3149950|NCT01797965|3876279|FG000|COMPLETED|Overall Study||48
3149951|NCT01797965|3876280|FG001|COMPLETED|Overall Study||38
3149952|NCT01797965|3876281|FG002|COMPLETED|Overall Study||62
3149953|NCT01797965|3876282|FG003|COMPLETED|Overall Study||154
3149954|NCT01797965|3876279|FG000|NOT COMPLETED|Overall Study||549
3149955|NCT01797965|3876280|FG001|NOT COMPLETED|Overall Study||569
3149956|NCT01797965|3876281|FG002|NOT COMPLETED|Overall Study||8
3149957|NCT01797965|3876282|FG003|NOT COMPLETED|Overall Study||73
3149958|NCT01798004|3876293|FG000|STARTED|Overall Study||150
3149959|NCT01798004|3876293|FG000|COMPLETED|Overall Study||63
3149960|NCT01798004|3876293|FG000|NOT COMPLETED|Overall Study||87
3149961|NCT01798056|3876299|FG000|STARTED|Overall Study||117
3149962|NCT01798056|3876300|FG001|STARTED|Overall Study||115
3149963|NCT01798056|3876299|FG000|COMPLETED|Overall Study||90
3149964|NCT01798056|3876300|FG001|COMPLETED|Overall Study||90
3149965|NCT01798056|3876299|FG000|NOT COMPLETED|Overall Study||27
3149966|NCT01798056|3876300|FG001|NOT COMPLETED|Overall Study||25
3149967|NCT01798134|3876308|FG000|STARTED|Overall Study||25
3149968|NCT01798134|3876308|FG000|COMPLETED|Overall Study||9
3149969|NCT01798134|3876308|FG000|NOT COMPLETED|Overall Study||16
3149970|NCT01798186|3876316|FG000|STARTED|Overall Study||6
3149971|NCT01798186|3876317|FG001|STARTED|Overall Study||6
3149972|NCT01798186|3876318|FG002|STARTED|Overall Study||6
3149973|NCT01798186|3876319|FG003|STARTED|Overall Study||8
3149974|NCT01798186|3876316|FG000|COMPLETED|Overall Study||6
3149975|NCT01798186|3876317|FG001|COMPLETED|Overall Study||6
3149976|NCT01798186|3876318|FG002|COMPLETED|Overall Study||6
3149977|NCT01798186|3876319|FG003|COMPLETED|Overall Study||8
3149978|NCT01798186|3876316|FG000|NOT COMPLETED|Overall Study||0
3149979|NCT01798186|3876317|FG001|NOT COMPLETED|Overall Study||0
3149980|NCT01798186|3876318|FG002|NOT COMPLETED|Overall Study||0
3149981|NCT01798186|3876319|FG003|NOT COMPLETED|Overall Study||0
3149982|NCT01798225|3876334|FG000|STARTED|Overall Study||57
3149983|NCT01798225|3876335|FG001|STARTED|Overall Study||56
3149984|NCT01798225|3876334|FG000|COMPLETED|Overall Study||57
3149985|NCT01798225|3876335|FG001|COMPLETED|Overall Study||53
3149986|NCT01798225|3876334|FG000|NOT COMPLETED|Overall Study||0
3149987|NCT01798225|3876335|FG001|NOT COMPLETED|Overall Study||3
3149988|NCT01798264|3876345|FG000|STARTED|Overall Study||12
3149989|NCT01798264|3876346|FG001|STARTED|Overall Study||11
3149990|NCT01798264|3876347|FG002|STARTED|Overall Study||10
3149991|NCT01798264|3876348|FG003|STARTED|Overall Study||11
3149992|NCT01798264|3876345|FG000|COMPLETED|Overall Study||11
3149993|NCT01798264|3876346|FG001|COMPLETED|Overall Study||11
3149994|NCT01798264|3876347|FG002|COMPLETED|Overall Study||10
3149995|NCT01798264|3876348|FG003|COMPLETED|Overall Study||7
3149996|NCT01798264|3876345|FG000|NOT COMPLETED|Overall Study||1
3149997|NCT01798264|3876346|FG001|NOT COMPLETED|Overall Study||0
3149998|NCT01798264|3876347|FG002|NOT COMPLETED|Overall Study||0
3149999|NCT01798264|3876348|FG003|NOT COMPLETED|Overall Study||4
3150000|NCT01798316|3876360|FG000|STARTED|Overall Study||52
3150001|NCT01798316|3876361|FG001|STARTED|Overall Study||53
3150002|NCT01798316|3876360|FG000|COMPLETED|Overall Study||52
3150003|NCT01798316|3876361|FG001|COMPLETED|Overall Study||53
3150004|NCT01798316|3876360|FG000|NOT COMPLETED|Overall Study||0
3182716|NCT02003183|3910888|FG001|STARTED|Overall Study||17
3182717|NCT02003183|3910887|FG000|COMPLETED|Overall Study||7
3150005|NCT01798316|3876361|FG001|NOT COMPLETED|Overall Study||0
3150006|NCT01798394|3876371|FG000|STARTED|Overall Study||24
3150007|NCT01798394|3876372|FG001|STARTED|Overall Study||22
3150008|NCT01798394|3876371|FG000|COMPLETED|Overall Study||21
3150009|NCT01798394|3876372|FG001|COMPLETED|Overall Study||19
3150010|NCT01798394|3876371|FG000|NOT COMPLETED|Overall Study||3
3150011|NCT01798394|3876372|FG001|NOT COMPLETED|Overall Study||3
3150012|NCT01798485|3876380|FG000|STARTED|Overall Study||347
3150013|NCT01798485|3876381|FG001|STARTED|Overall Study||349
3150014|NCT01798485|3876380|FG000|Safety Population as of 23 Dec 2015|Overall Study||338
3150015|NCT01798485|3876381|FG001|Safety Population as of 23 Dec 2015|Overall Study||342
3150016|NCT01798485|3876380|FG000|Randomized as of 19 October 2015|Overall Study||335
3150017|NCT01798485|3876381|FG001|Randomized as of 19 October 2015|Overall Study||337
3150018|NCT01798485|3876380|FG000|COMPLETED|Overall Study||1
3150019|NCT01798485|3876381|FG001|COMPLETED|Overall Study||59
3150020|NCT01798485|3876380|FG000|NOT COMPLETED|Overall Study||346
3182718|NCT02003183|3910888|FG001|COMPLETED|Overall Study||15
3150021|NCT01798485|3876381|FG001|NOT COMPLETED|Overall Study||290
3150022|NCT01798550|3876389|FG000|STARTED|Overall Study||30
3150023|NCT01798550|3876390|FG001|STARTED|Overall Study||32
3150024|NCT01798550|3876389|FG000|COMPLETED|Overall Study||28
3150025|NCT01798550|3876390|FG001|COMPLETED|Overall Study||26
3150026|NCT01798550|3876389|FG000|NOT COMPLETED|Overall Study||2
3150027|NCT01798550|3876390|FG001|NOT COMPLETED|Overall Study||6
3150028|NCT01798589|3876396|FG000|STARTED|Overall Study||16
3150029|NCT01798589|3876396|FG000|COMPLETED|Overall Study||16
3150030|NCT01798589|3876396|FG000|NOT COMPLETED|Overall Study||0
3150031|NCT01798641|3876406|FG000|STARTED|First Intervention (6 Weeks)||19
3150032|NCT01798641|3876407|FG001|STARTED|First Intervention (6 Weeks)||19
3150033|NCT01798641|3876406|FG000|COMPLETED|First Intervention (6 Weeks)||19
3150034|NCT01798641|3876407|FG001|COMPLETED|First Intervention (6 Weeks)||19
3150035|NCT01798641|3876406|FG000|NOT COMPLETED|First Intervention (6 Weeks)||0
3150036|NCT01798641|3876407|FG001|NOT COMPLETED|First Intervention (6 Weeks)||0
3150037|NCT01798641|3876406|FG000|STARTED|Second Intervention (6 Weeks)||19
3150038|NCT01798641|3876407|FG001|STARTED|Second Intervention (6 Weeks)||19
3150039|NCT01798641|3876406|FG000|COMPLETED|Second Intervention (6 Weeks)||19
3150040|NCT01798641|3876407|FG001|COMPLETED|Second Intervention (6 Weeks)||19
3150041|NCT01798641|3876406|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||0
3150042|NCT01798641|3876407|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||0
3150043|NCT01798706|3876416|FG000|STARTED|Overall Study||176
3150044|NCT01798706|3876417|FG001|STARTED|Overall Study||174
3150045|NCT01798706|3876416|FG000|COMPLETED|Overall Study||155
3150046|NCT01798706|3876417|FG001|COMPLETED|Overall Study||153
3150047|NCT01798706|3876416|FG000|NOT COMPLETED|Overall Study||21
3150048|NCT01798706|3876417|FG001|NOT COMPLETED|Overall Study||21
3182719|NCT02003183|3910887|FG000|NOT COMPLETED|Overall Study||0
3182720|NCT02003183|3910888|FG001|NOT COMPLETED|Overall Study||2
3182721|NCT02003352|3910894|FG000|STARTED|Overall Study||98
3182722|NCT02003352|3910894|FG000|COMPLETED|Overall Study||98
3182723|NCT02003352|3910894|FG000|NOT COMPLETED|Overall Study||0
3182724|NCT02003365|3910901|FG000|STARTED|Overall Study||10
3182725|NCT02003365|3910902|FG001|STARTED|Overall Study||30
3182726|NCT02003365|3910903|FG002|STARTED|Overall Study||10
3182727|NCT02003365|3910901|FG000|COMPLETED|Overall Study||10
3182728|NCT02003365|3910902|FG001|COMPLETED|Overall Study||30
3182729|NCT02003365|3910903|FG002|COMPLETED|Overall Study||9
3182730|NCT02003365|3910901|FG000|NOT COMPLETED|Overall Study||0
3182731|NCT02003365|3910902|FG001|NOT COMPLETED|Overall Study||0
3182732|NCT02003365|3910903|FG002|NOT COMPLETED|Overall Study||1
3182733|NCT02003391|3910913|FG000|STARTED|Overall Study||81
3182734|NCT02003391|3910914|FG001|STARTED|Overall Study||75
3182735|NCT02003391|3910913|FG000|Safety Population|Overall Study||81
3182736|NCT02003391|3910914|FG001|Safety Population|Overall Study||75
3182737|NCT02003391|3910913|FG000|Intent to Treat Population|Overall Study||78
3182738|NCT02003391|3910914|FG001|Intent to Treat Population|Overall Study||73
3182739|NCT02003391|3910913|FG000|COMPLETED|Overall Study||78
3182740|NCT02003391|3910914|FG001|COMPLETED|Overall Study||73
3182741|NCT02003391|3910913|FG000|NOT COMPLETED|Overall Study||3
3182742|NCT02003391|3910914|FG001|NOT COMPLETED|Overall Study||2
3182743|NCT02003404|3910920|FG000|STARTED|Overall Study||17
3182744|NCT02003404|3910920|FG000|COMPLETED|Overall Study||17
3182745|NCT02003404|3910920|FG000|NOT COMPLETED|Overall Study||0
3182746|NCT02003508|3910928|FG000|STARTED|Overall Study||179
3182747|NCT02003508|3910929|FG001|STARTED|Overall Study||166
3182748|NCT02003508|3910928|FG000|COMPLETED|Overall Study||179
3182749|NCT02003508|3910929|FG001|COMPLETED|Overall Study||166
3182750|NCT02003508|3910928|FG000|NOT COMPLETED|Overall Study||0
3182751|NCT02003508|3910929|FG001|NOT COMPLETED|Overall Study||0
3182752|NCT02003534|3910935|FG000|STARTED|Overall Study||376
3182753|NCT02003534|3910935|FG000|COMPLETED|Overall Study||329
3182754|NCT02003534|3910935|FG000|NOT COMPLETED|Overall Study||47
3182755|NCT02003573|3910942|FG000|STARTED|Overall Study|Started are treated patients|3
3182756|NCT02003573|3910943|FG001|STARTED|Overall Study|Started are treated patients|4
3182757|NCT02003573|3910944|FG002|STARTED|Overall Study|Started are treated patients|6
3182758|NCT02003573|3910942|FG000|COMPLETED|Overall Study||0
3182759|NCT02003573|3910943|FG001|COMPLETED|Overall Study||0
3182760|NCT02003573|3910944|FG002|COMPLETED|Overall Study||0
3182761|NCT02003573|3910942|FG000|NOT COMPLETED|Overall Study||3
3182762|NCT02003573|3910943|FG001|NOT COMPLETED|Overall Study||4
3182763|NCT02003573|3910944|FG002|NOT COMPLETED|Overall Study||6
3182764|NCT02003625|3910956|FG000|STARTED|Overall Study||15
3150049|NCT01798849|3876426|FG000|STARTED|Overall Study||8
3150050|NCT01798849|3876427|FG001|STARTED|Overall Study||8
3182765|NCT02003625|3910957|FG001|STARTED|Overall Study||15
3182766|NCT02003625|3910956|FG000|Received Transplant|Overall Study||14
3182767|NCT02003625|3910957|FG001|Received Transplant|Overall Study||12
3182768|NCT02003625|3910956|FG000|COMPLETED|Overall Study||14
3182769|NCT02003625|3910957|FG001|COMPLETED|Overall Study||12
3182770|NCT02003625|3910956|FG000|NOT COMPLETED|Overall Study||1
3182771|NCT02003625|3910957|FG001|NOT COMPLETED|Overall Study||3
3182772|NCT02003638|3910965|FG000|STARTED|Overall Study||6
3182773|NCT02003638|3910966|FG001|STARTED|Overall Study||3
3182774|NCT02003638|3910965|FG000|COMPLETED|Overall Study|1 withdrew after developing bacterial pharyngitis. Not considered treatment-emergent.|5
3182775|NCT02003638|3910966|FG001|COMPLETED|Overall Study||3
3182776|NCT02003638|3910965|FG000|NOT COMPLETED|Overall Study||1
3182777|NCT02003638|3910966|FG001|NOT COMPLETED|Overall Study||0
3182778|NCT02003898|3910972|FG000|STARTED|Overall Study||372
3182779|NCT02003898|3910972|FG000|COMPLETED|Overall Study||305
3182780|NCT02003898|3910972|FG000|NOT COMPLETED|Overall Study||67
3182781|NCT02003911|3910978|FG000|STARTED|Overall Study||80
3150051|NCT01798849|3876428|FG002|STARTED|Overall Study|1 participant discontinued after Period 1 and was replaced for Periods 2-4|9
3150052|NCT01798849|3876426|FG000|COMPLETED|Overall Study||8
3150053|NCT01798849|3876427|FG001|COMPLETED|Overall Study||8
3150054|NCT01798849|3876428|FG002|COMPLETED|Overall Study||8
3150055|NCT01798849|3876426|FG000|NOT COMPLETED|Overall Study||0
3150056|NCT01798849|3876427|FG001|NOT COMPLETED|Overall Study||0
3150057|NCT01798849|3876428|FG002|NOT COMPLETED|Overall Study||1
3150058|NCT01798927|3876465|FG000|STARTED|Overall Study||4
3150059|NCT01798927|3876465|FG000|COMPLETED|Overall Study||3
3150060|NCT01798927|3876465|FG000|NOT COMPLETED|Overall Study||1
3150061|NCT01798966|3876469|FG000|STARTED|Overall Study||10
3150062|NCT01798966|3876469|FG000|COMPLETED|Overall Study||10
3150063|NCT01798966|3876469|FG000|NOT COMPLETED|Overall Study||0
3150064|NCT01798992|3876478|FG000|STARTED|Overall Study||4
3150065|NCT01798992|3876479|FG001|STARTED|Overall Study||19
3150066|NCT01798992|3876480|FG002|STARTED|Overall Study||16
3150067|NCT01798992|3876481|FG003|STARTED|Overall Study||17
3150068|NCT01798992|3876478|FG000|COMPLETED|Overall Study||4
3150069|NCT01798992|3876479|FG001|COMPLETED|Overall Study||17
3150070|NCT01798992|3876480|FG002|COMPLETED|Overall Study||14
3150071|NCT01798992|3876481|FG003|COMPLETED|Overall Study||16
3150072|NCT01798992|3876478|FG000|NOT COMPLETED|Overall Study||0
3150073|NCT01798992|3876479|FG001|NOT COMPLETED|Overall Study||2
3150074|NCT01798992|3876480|FG002|NOT COMPLETED|Overall Study||2
3150075|NCT01798992|3876481|FG003|NOT COMPLETED|Overall Study||1
3150076|NCT01799135|3876490|FG000|STARTED|Overall Study||6
3150077|NCT01799135|3876490|FG000|COMPLETED|Overall Study||6
3150078|NCT01799135|3876490|FG000|NOT COMPLETED|Overall Study||0
3150079|NCT01799213|3876496|FG000|STARTED|Overall Study||180
3150080|NCT01799213|3876497|FG001|STARTED|Overall Study||184
3150081|NCT01799213|3876496|FG000|COMPLETED|Overall Study||173
3150082|NCT01799213|3876497|FG001|COMPLETED|Overall Study||178
3150083|NCT01799213|3876496|FG000|NOT COMPLETED|Overall Study||7
3150084|NCT01799213|3876497|FG001|NOT COMPLETED|Overall Study||6
3150085|NCT01799226|3876511|FG000|STARTED|Overall Study||16
3150086|NCT01799226|3876512|FG001|STARTED|Overall Study||16
3150087|NCT01799226|3876511|FG000|Right Stent Side|Overall Study||8
3150088|NCT01799226|3876512|FG001|Right Stent Side|Overall Study||8
3150089|NCT01799226|3876511|FG000|Left Stent Side|Overall Study||8
3150090|NCT01799226|3876512|FG001|Left Stent Side|Overall Study||8
3150091|NCT01799226|3876511|FG000|COMPLETED|Overall Study||14
3150092|NCT01799226|3876512|FG001|COMPLETED|Overall Study||16
3150093|NCT01799226|3876511|FG000|NOT COMPLETED|Overall Study||2
3150094|NCT01799226|3876512|FG001|NOT COMPLETED|Overall Study||0
3150095|NCT01799239|3876518|FG000|STARTED|Period 1 (7 Days)|It was uncertain in which order the product were tested for 1 subject. Subject is excl from analysis|15
3150096|NCT01799239|3876519|FG001|STARTED|Period 1 (7 Days)|It was uncertain in which order the product were tested for 1 subject. Subject is excl from analysis|16
3150097|NCT01799239|3876518|FG000|COMPLETED|Period 1 (7 Days)||12
3150098|NCT01799239|3876519|FG001|COMPLETED|Period 1 (7 Days)||15
3150099|NCT01799239|3876518|FG000|NOT COMPLETED|Period 1 (7 Days)||3
3150100|NCT01799239|3876519|FG001|NOT COMPLETED|Period 1 (7 Days)||1
3150101|NCT01799239|3876518|FG000|STARTED|Period 2 (7 Days)||13
3150102|NCT01799239|3876519|FG001|STARTED|Period 2 (7 Days)||15
3150103|NCT01799239|3876518|FG000|COMPLETED|Period 2 (7 Days)||11
3150104|NCT01799239|3876519|FG001|COMPLETED|Period 2 (7 Days)||14
3150105|NCT01799239|3876518|FG000|NOT COMPLETED|Period 2 (7 Days)||2
3150106|NCT01799239|3876519|FG001|NOT COMPLETED|Period 2 (7 Days)||1
3150107|NCT01799278|3876525|FG000|STARTED|Overall Study||60
3150108|NCT01799278|3876525|FG000|COMPLETED|Overall Study||60
3150109|NCT01799278|3876525|FG000|NOT COMPLETED|Overall Study||0
3150110|NCT01799590|3876536|FG000|STARTED|Overall Study||111
3150111|NCT01799590|3876537|FG001|STARTED|Overall Study||94
3150112|NCT01799590|3876538|FG002|STARTED|Overall Study||91
3150113|NCT01799590|3876536|FG000|COMPLETED|Overall Study||85
3150114|NCT01799590|3876537|FG001|COMPLETED|Overall Study||78
3150115|NCT01799590|3876538|FG002|COMPLETED|Overall Study||77
3150116|NCT01799590|3876536|FG000|NOT COMPLETED|Overall Study||26
3150117|NCT01799590|3876537|FG001|NOT COMPLETED|Overall Study||16
3150118|NCT01799590|3876538|FG002|NOT COMPLETED|Overall Study||14
3150119|NCT01799720|3876549|FG000|STARTED|Overall Study||20
3150120|NCT01799720|3876550|FG001|STARTED|Overall Study||18
3150121|NCT01799720|3876551|FG002|STARTED|Overall Study||19
3150122|NCT01799720|3876549|FG000|Began the Treatment|Overall Study||20
3150123|NCT01799720|3876550|FG001|Began the Treatment|Overall Study||18
3150124|NCT01799720|3876551|FG002|Began the Treatment|Overall Study||19
3150125|NCT01799720|3876549|FG000|Began the Treatment and Finished it|Overall Study||17
3150126|NCT01799720|3876550|FG001|Began the Treatment and Finished it|Overall Study||17
3150127|NCT01799720|3876551|FG002|Began the Treatment and Finished it|Overall Study||18
3150128|NCT01799720|3876549|FG000|COMPLETED|Overall Study||17
3150129|NCT01799720|3876550|FG001|COMPLETED|Overall Study||17
3150130|NCT01799720|3876551|FG002|COMPLETED|Overall Study||18
3150131|NCT01799720|3876549|FG000|NOT COMPLETED|Overall Study||3
3150132|NCT01799720|3876550|FG001|NOT COMPLETED|Overall Study||1
3150133|NCT01799720|3876551|FG002|NOT COMPLETED|Overall Study||1
3150134|NCT01799889|3876571|FG000|STARTED|Overall Study||41
3150135|NCT01799889|3876572|FG001|STARTED|Overall Study||41
3150136|NCT01799889|3876573|FG002|STARTED|Overall Study||44
3182782|NCT02003911|3910979|FG001|STARTED|Overall Study||79
3182783|NCT02003911|3910978|FG000|COMPLETED|Overall Study||78
3150137|NCT01799889|3876574|FG003|STARTED|Overall Study||39
3150138|NCT01799889|3876575|FG004|STARTED|Overall Study||49
3150139|NCT01799889|3876576|FG005|STARTED|Overall Study||20
3150140|NCT01799889|3876577|FG006|STARTED|Overall Study||21
3150141|NCT01799889|3876578|FG007|STARTED|Overall Study||20
3150142|NCT01799889|3876579|FG008|STARTED|Overall Study||33
3150143|NCT01799889|3876580|FG009|STARTED|Overall Study||8
3150144|NCT01799889|3876581|FG010|STARTED|Overall Study||7
3150145|NCT01799889|3876582|FG011|STARTED|Overall Study||3
3150146|NCT01799889|3876571|FG000|COMPLETED|Overall Study||0
3150147|NCT01799889|3876572|FG001|COMPLETED|Overall Study||0
3150148|NCT01799889|3876573|FG002|COMPLETED|Overall Study||0
3150149|NCT01799889|3876574|FG003|COMPLETED|Overall Study||0
3150150|NCT01799889|3876575|FG004|COMPLETED|Overall Study||0
3150151|NCT01799889|3876576|FG005|COMPLETED|Overall Study||0
3150152|NCT01799889|3876577|FG006|COMPLETED|Overall Study||0
3150153|NCT01799889|3876578|FG007|COMPLETED|Overall Study||0
3150154|NCT01799889|3876579|FG008|COMPLETED|Overall Study||0
3150155|NCT01799889|3876580|FG009|COMPLETED|Overall Study||0
3150156|NCT01799889|3876581|FG010|COMPLETED|Overall Study||0
3150157|NCT01799889|3876582|FG011|COMPLETED|Overall Study||0
3150158|NCT01799889|3876571|FG000|NOT COMPLETED|Overall Study||41
3150159|NCT01799889|3876572|FG001|NOT COMPLETED|Overall Study||41
3150160|NCT01799889|3876573|FG002|NOT COMPLETED|Overall Study||44
3150161|NCT01799889|3876574|FG003|NOT COMPLETED|Overall Study||39
3150162|NCT01799889|3876575|FG004|NOT COMPLETED|Overall Study||49
3150163|NCT01799889|3876576|FG005|NOT COMPLETED|Overall Study||20
3150164|NCT01799889|3876577|FG006|NOT COMPLETED|Overall Study||21
3150165|NCT01799889|3876578|FG007|NOT COMPLETED|Overall Study||20
3150166|NCT01799889|3876579|FG008|NOT COMPLETED|Overall Study||33
3150167|NCT01799889|3876580|FG009|NOT COMPLETED|Overall Study||8
3150168|NCT01799889|3876581|FG010|NOT COMPLETED|Overall Study||7
3150169|NCT01799889|3876582|FG011|NOT COMPLETED|Overall Study||3
3150170|NCT01799941|3876619|FG000|STARTED|Overall Study||367
3150171|NCT01799941|3876619|FG000|COMPLETED|Overall Study||271
3150172|NCT01799941|3876619|FG000|NOT COMPLETED|Overall Study||96
3150173|NCT01799993|3876631|FG000|STARTED|Overall Study||362
3150174|NCT01799993|3876632|FG001|STARTED|Overall Study||363
3150175|NCT01799993|3876631|FG000|ITT Population|Overall Study||354
3150176|NCT01799993|3876632|FG001|ITT Population|Overall Study||358
3150177|NCT01799993|3876631|FG000|mITT Population|Overall Study||255
3150178|NCT01799993|3876632|FG001|mITT Population|Overall Study||253
3150179|NCT01799993|3876631|FG000|COMPLETED|Overall Study||229
3150180|NCT01799993|3876632|FG001|COMPLETED|Overall Study||235
3150181|NCT01799993|3876631|FG000|NOT COMPLETED|Overall Study||133
3150182|NCT01799993|3876632|FG001|NOT COMPLETED|Overall Study||128
3150183|NCT01800058|3876638|FG000|STARTED|Overall Study||66
3150184|NCT01800058|3876638|FG000|COMPLETED|Overall Study||65
3150185|NCT01800058|3876638|FG000|NOT COMPLETED|Overall Study||1
3150186|NCT01800201|3876645|FG000|STARTED|Overall Study||506
3150187|NCT01800201|3876646|FG001|STARTED|Overall Study||1003
3150188|NCT01800201|3876645|FG000|COMPLETED|Overall Study||503
3150189|NCT01800201|3876646|FG001|COMPLETED|Overall Study||1000
3150190|NCT01800201|3876645|FG000|NOT COMPLETED|Overall Study||3
3150191|NCT01800201|3876646|FG001|NOT COMPLETED|Overall Study||3
3150192|NCT01800318|3876657|FG000|STARTED|Overall Study||39
3150193|NCT01800318|3876658|FG001|STARTED|Overall Study||42
3150194|NCT01800318|3876659|FG002|STARTED|Overall Study||41
3150195|NCT01800318|3876660|FG003|STARTED|Overall Study||40
3150196|NCT01800318|3876657|FG000|COMPLETED|Overall Study||37
3150197|NCT01800318|3876658|FG001|COMPLETED|Overall Study||37
3150198|NCT01800318|3876659|FG002|COMPLETED|Overall Study||40
3150199|NCT01800318|3876660|FG003|COMPLETED|Overall Study||39
3150200|NCT01800318|3876657|FG000|NOT COMPLETED|Overall Study||2
3150201|NCT01800318|3876658|FG001|NOT COMPLETED|Overall Study||5
3150202|NCT01800318|3876659|FG002|NOT COMPLETED|Overall Study||1
3150203|NCT01800318|3876660|FG003|NOT COMPLETED|Overall Study||1
3150204|NCT01800786|3876676|FG000|STARTED|Overall Study||17
3150205|NCT01800786|3876677|FG001|STARTED|Overall Study||16
3150206|NCT01800786|3876676|FG000|COMPLETED|Overall Study||15
3150207|NCT01800786|3876677|FG001|COMPLETED|Overall Study||15
3150208|NCT01800786|3876676|FG000|NOT COMPLETED|Overall Study||2
3150209|NCT01800786|3876677|FG001|NOT COMPLETED|Overall Study||1
3150210|NCT01800838|3876687|FG000|STARTED|Overall Study||1
3150211|NCT01800838|3876688|FG001|STARTED|Overall Study||1
3150212|NCT01800838|3876689|FG002|STARTED|Overall Study||7
3150213|NCT01800838|3876690|FG003|STARTED|Overall Study||2
3150214|NCT01800838|3876687|FG000|COMPLETED|Overall Study||1
3150215|NCT01800838|3876688|FG001|COMPLETED|Overall Study||1
3150216|NCT01800838|3876689|FG002|COMPLETED|Overall Study||7
3150217|NCT01800838|3876690|FG003|COMPLETED|Overall Study||2
3182784|NCT02003911|3910979|FG001|COMPLETED|Overall Study||72
3182785|NCT02003911|3910978|FG000|NOT COMPLETED|Overall Study||2
3182786|NCT02003911|3910979|FG001|NOT COMPLETED|Overall Study||7
3182787|NCT02003963|3910987|FG000|STARTED|Overall Study||22
3182788|NCT02003963|3910988|FG001|STARTED|Overall Study||19
3150218|NCT01800838|3876687|FG000|NOT COMPLETED|Overall Study||0
3150219|NCT01800838|3876688|FG001|NOT COMPLETED|Overall Study||0
3150220|NCT01800838|3876689|FG002|NOT COMPLETED|Overall Study||0
3150221|NCT01800838|3876690|FG003|NOT COMPLETED|Overall Study||0
3150222|NCT01800877|3876696|FG000|STARTED|Overall Study||60
3150223|NCT01800877|3876697|FG001|STARTED|Overall Study||60
3150224|NCT01800877|3876696|FG000|COMPLETED|Overall Study||58
3150225|NCT01800877|3876697|FG001|COMPLETED|Overall Study||60
3150226|NCT01800877|3876696|FG000|NOT COMPLETED|Overall Study||2
3150227|NCT01800877|3876697|FG001|NOT COMPLETED|Overall Study||0
3150228|NCT01800890|3876703|FG000|STARTED|Test Period 1||3
3150229|NCT01800890|3876704|FG001|STARTED|Test Period 1||3
3150230|NCT01800890|3876705|FG002|STARTED|Test Period 1||3
3150231|NCT01800890|3876706|FG003|STARTED|Test Period 1||3
3150232|NCT01800890|3876707|FG004|STARTED|Test Period 1||4
3150233|NCT01800890|3876708|FG005|STARTED|Test Period 1||4
3150234|NCT01800890|3876709|FG006|STARTED|Test Period 1||3
3150235|NCT01800890|3876710|FG007|STARTED|Test Period 1||3
3150236|NCT01800890|3876711|FG008|STARTED|Test Period 1||3
3150237|NCT01800890|3876703|FG000|COMPLETED|Test Period 1||3
3150238|NCT01800890|3876704|FG001|COMPLETED|Test Period 1||3
3150239|NCT01800890|3876705|FG002|COMPLETED|Test Period 1||3
3150240|NCT01800890|3876706|FG003|COMPLETED|Test Period 1||2
3150241|NCT01800890|3876707|FG004|COMPLETED|Test Period 1||4
3150242|NCT01800890|3876708|FG005|COMPLETED|Test Period 1||4
3150243|NCT01800890|3876709|FG006|COMPLETED|Test Period 1||3
3150244|NCT01800890|3876710|FG007|COMPLETED|Test Period 1||3
3150245|NCT01800890|3876711|FG008|COMPLETED|Test Period 1||3
3150246|NCT01800890|3876703|FG000|NOT COMPLETED|Test Period 1||0
3150247|NCT01800890|3876704|FG001|NOT COMPLETED|Test Period 1||0
3150248|NCT01800890|3876705|FG002|NOT COMPLETED|Test Period 1||0
3150249|NCT01800890|3876706|FG003|NOT COMPLETED|Test Period 1||1
3150250|NCT01800890|3876707|FG004|NOT COMPLETED|Test Period 1||0
3150251|NCT01800890|3876708|FG005|NOT COMPLETED|Test Period 1||0
3150252|NCT01800890|3876709|FG006|NOT COMPLETED|Test Period 1||0
3150253|NCT01800890|3876710|FG007|NOT COMPLETED|Test Period 1||0
3150254|NCT01800890|3876711|FG008|NOT COMPLETED|Test Period 1||0
3150255|NCT01800890|3876703|FG000|STARTED|Test Period 2||3
3150256|NCT01800890|3876704|FG001|STARTED|Test Period 2||3
3150257|NCT01800890|3876705|FG002|STARTED|Test Period 2||3
3150258|NCT01800890|3876706|FG003|STARTED|Test Period 2||2
3150259|NCT01800890|3876707|FG004|STARTED|Test Period 2||4
3150260|NCT01800890|3876708|FG005|STARTED|Test Period 2||4
3150261|NCT01800890|3876709|FG006|STARTED|Test Period 2||3
3150262|NCT01800890|3876710|FG007|STARTED|Test Period 2||3
3150263|NCT01800890|3876711|FG008|STARTED|Test Period 2||3
3150264|NCT01800890|3876703|FG000|COMPLETED|Test Period 2||3
3150265|NCT01800890|3876704|FG001|COMPLETED|Test Period 2||3
3150266|NCT01800890|3876705|FG002|COMPLETED|Test Period 2||3
3150267|NCT01800890|3876706|FG003|COMPLETED|Test Period 2||2
3150268|NCT01800890|3876707|FG004|COMPLETED|Test Period 2||4
3150269|NCT01800890|3876708|FG005|COMPLETED|Test Period 2||4
3150270|NCT01800890|3876709|FG006|COMPLETED|Test Period 2||3
3150271|NCT01800890|3876710|FG007|COMPLETED|Test Period 2||3
3150272|NCT01800890|3876711|FG008|COMPLETED|Test Period 2||3
3150273|NCT01800890|3876703|FG000|NOT COMPLETED|Test Period 2||0
3150274|NCT01800890|3876704|FG001|NOT COMPLETED|Test Period 2||0
3150275|NCT01800890|3876705|FG002|NOT COMPLETED|Test Period 2||0
3150276|NCT01800890|3876706|FG003|NOT COMPLETED|Test Period 2||0
3150277|NCT01800890|3876707|FG004|NOT COMPLETED|Test Period 2||0
3150278|NCT01800890|3876708|FG005|NOT COMPLETED|Test Period 2||0
3150279|NCT01800890|3876709|FG006|NOT COMPLETED|Test Period 2||0
3150280|NCT01800890|3876710|FG007|NOT COMPLETED|Test Period 2||0
3150281|NCT01800890|3876711|FG008|NOT COMPLETED|Test Period 2||0
3150282|NCT01800890|3876703|FG000|STARTED|Test Period 3||3
3150283|NCT01800890|3876704|FG001|STARTED|Test Period 3||3
3150284|NCT01800890|3876705|FG002|STARTED|Test Period 3||3
3150285|NCT01800890|3876706|FG003|STARTED|Test Period 3||2
3150286|NCT01800890|3876707|FG004|STARTED|Test Period 3||4
3150287|NCT01800890|3876708|FG005|STARTED|Test Period 3||4
3150288|NCT01800890|3876709|FG006|STARTED|Test Period 3||3
3150289|NCT01800890|3876710|FG007|STARTED|Test Period 3||3
3150290|NCT01800890|3876711|FG008|STARTED|Test Period 3||3
3150291|NCT01800890|3876703|FG000|COMPLETED|Test Period 3||3
3150292|NCT01800890|3876704|FG001|COMPLETED|Test Period 3||3
3150293|NCT01800890|3876705|FG002|COMPLETED|Test Period 3||3
3150294|NCT01800890|3876706|FG003|COMPLETED|Test Period 3||2
3150295|NCT01800890|3876707|FG004|COMPLETED|Test Period 3||4
3150296|NCT01800890|3876708|FG005|COMPLETED|Test Period 3||4
3150297|NCT01800890|3876709|FG006|COMPLETED|Test Period 3||3
3150298|NCT01800890|3876710|FG007|COMPLETED|Test Period 3||3
3150299|NCT01800890|3876711|FG008|COMPLETED|Test Period 3||3
3150300|NCT01800890|3876703|FG000|NOT COMPLETED|Test Period 3||0
3150301|NCT01800890|3876704|FG001|NOT COMPLETED|Test Period 3||0
3150302|NCT01800890|3876705|FG002|NOT COMPLETED|Test Period 3||0
3150303|NCT01800890|3876706|FG003|NOT COMPLETED|Test Period 3||0
3150304|NCT01800890|3876707|FG004|NOT COMPLETED|Test Period 3||0
3150305|NCT01800890|3876708|FG005|NOT COMPLETED|Test Period 3||0
3150306|NCT01800890|3876709|FG006|NOT COMPLETED|Test Period 3||0
3150307|NCT01800890|3876710|FG007|NOT COMPLETED|Test Period 3||0
3150308|NCT01800890|3876711|FG008|NOT COMPLETED|Test Period 3||0
3150309|NCT01800903|3876721|FG000|STARTED|First Test Period||7
3150310|NCT01800903|3876722|FG001|STARTED|First Test Period||6
3150311|NCT01800903|3876723|FG002|STARTED|First Test Period||4
3150312|NCT01800903|3876724|FG003|STARTED|First Test Period||7
3150313|NCT01800903|3876725|FG004|STARTED|First Test Period||6
3150314|NCT01800903|3876726|FG005|STARTED|First Test Period||6
3150315|NCT01800903|3876721|FG000|COMPLETED|First Test Period||7
3150316|NCT01800903|3876722|FG001|COMPLETED|First Test Period||6
3150317|NCT01800903|3876723|FG002|COMPLETED|First Test Period||4
3150318|NCT01800903|3876724|FG003|COMPLETED|First Test Period||7
3150319|NCT01800903|3876725|FG004|COMPLETED|First Test Period||6
3150320|NCT01800903|3876726|FG005|COMPLETED|First Test Period||6
3150321|NCT01800903|3876721|FG000|NOT COMPLETED|First Test Period||0
3150322|NCT01800903|3876722|FG001|NOT COMPLETED|First Test Period||0
3150323|NCT01800903|3876723|FG002|NOT COMPLETED|First Test Period||0
3150324|NCT01800903|3876724|FG003|NOT COMPLETED|First Test Period||0
3150325|NCT01800903|3876725|FG004|NOT COMPLETED|First Test Period||0
3150326|NCT01800903|3876726|FG005|NOT COMPLETED|First Test Period||0
3150327|NCT01800903|3876721|FG000|STARTED|Second Test Period||7
3150328|NCT01800903|3876722|FG001|STARTED|Second Test Period||6
3150329|NCT01800903|3876723|FG002|STARTED|Second Test Period||4
3150330|NCT01800903|3876724|FG003|STARTED|Second Test Period||7
3150331|NCT01800903|3876725|FG004|STARTED|Second Test Period||6
3150332|NCT01800903|3876726|FG005|STARTED|Second Test Period||6
3150333|NCT01800903|3876721|FG000|COMPLETED|Second Test Period||6
3150334|NCT01800903|3876722|FG001|COMPLETED|Second Test Period||6
3150335|NCT01800903|3876723|FG002|COMPLETED|Second Test Period||4
3150336|NCT01800903|3876724|FG003|COMPLETED|Second Test Period||7
3150337|NCT01800903|3876725|FG004|COMPLETED|Second Test Period||6
3150338|NCT01800903|3876726|FG005|COMPLETED|Second Test Period||6
3150339|NCT01800903|3876721|FG000|NOT COMPLETED|Second Test Period||1
3150340|NCT01800903|3876722|FG001|NOT COMPLETED|Second Test Period||0
3150341|NCT01800903|3876723|FG002|NOT COMPLETED|Second Test Period||0
3150342|NCT01800903|3876724|FG003|NOT COMPLETED|Second Test Period||0
3150343|NCT01800903|3876725|FG004|NOT COMPLETED|Second Test Period||0
3150344|NCT01800903|3876726|FG005|NOT COMPLETED|Second Test Period||0
3150345|NCT01800903|3876721|FG000|STARTED|Third Test Period||6
3150346|NCT01800903|3876722|FG001|STARTED|Third Test Period||6
3150347|NCT01800903|3876723|FG002|STARTED|Third Test Period||4
3150348|NCT01800903|3876724|FG003|STARTED|Third Test Period||7
3150349|NCT01800903|3876725|FG004|STARTED|Third Test Period||6
3150350|NCT01800903|3876726|FG005|STARTED|Third Test Period||6
3150351|NCT01800903|3876721|FG000|COMPLETED|Third Test Period||6
3150352|NCT01800903|3876722|FG001|COMPLETED|Third Test Period||6
3150353|NCT01800903|3876723|FG002|COMPLETED|Third Test Period||4
3150354|NCT01800903|3876724|FG003|COMPLETED|Third Test Period||7
3150355|NCT01800903|3876725|FG004|COMPLETED|Third Test Period||6
3150356|NCT01800903|3876726|FG005|COMPLETED|Third Test Period||6
3150357|NCT01800903|3876721|FG000|NOT COMPLETED|Third Test Period||0
3150358|NCT01800903|3876722|FG001|NOT COMPLETED|Third Test Period||0
3150359|NCT01800903|3876723|FG002|NOT COMPLETED|Third Test Period||0
3150360|NCT01800903|3876724|FG003|NOT COMPLETED|Third Test Period||0
3150361|NCT01800903|3876725|FG004|NOT COMPLETED|Third Test Period||0
3150362|NCT01800903|3876726|FG005|NOT COMPLETED|Third Test Period||0
3150363|NCT01800916|3876732|FG000|STARTED|Test Period 1 (1 Week)||7
3150364|NCT01800916|3876733|FG001|STARTED|Test Period 1 (1 Week)||7
3150365|NCT01800916|3876734|FG002|STARTED|Test Period 1 (1 Week)||7
3150366|NCT01800916|3876735|FG003|STARTED|Test Period 1 (1 Week)||7
3150367|NCT01800916|3876736|FG004|STARTED|Test Period 1 (1 Week)||8
3150368|NCT01800916|3876737|FG005|STARTED|Test Period 1 (1 Week)||7
3150369|NCT01800916|3876738|FG006|STARTED|Test Period 1 (1 Week)||7
3150370|NCT01800916|3876739|FG007|STARTED|Test Period 1 (1 Week)||7
3150371|NCT01800916|3876740|FG008|STARTED|Test Period 1 (1 Week)||7
3150372|NCT01800916|3876732|FG000|COMPLETED|Test Period 1 (1 Week)||7
3150373|NCT01800916|3876733|FG001|COMPLETED|Test Period 1 (1 Week)||7
3150374|NCT01800916|3876734|FG002|COMPLETED|Test Period 1 (1 Week)||7
3150375|NCT01800916|3876735|FG003|COMPLETED|Test Period 1 (1 Week)||6
3150376|NCT01800916|3876736|FG004|COMPLETED|Test Period 1 (1 Week)||7
3150377|NCT01800916|3876737|FG005|COMPLETED|Test Period 1 (1 Week)||7
3150378|NCT01800916|3876738|FG006|COMPLETED|Test Period 1 (1 Week)||7
3150379|NCT01800916|3876739|FG007|COMPLETED|Test Period 1 (1 Week)||7
3150380|NCT01800916|3876740|FG008|COMPLETED|Test Period 1 (1 Week)||7
3150381|NCT01800916|3876732|FG000|NOT COMPLETED|Test Period 1 (1 Week)||0
3150382|NCT01800916|3876733|FG001|NOT COMPLETED|Test Period 1 (1 Week)||0
3150383|NCT01800916|3876734|FG002|NOT COMPLETED|Test Period 1 (1 Week)||0
3150384|NCT01800916|3876735|FG003|NOT COMPLETED|Test Period 1 (1 Week)||1
3150385|NCT01800916|3876736|FG004|NOT COMPLETED|Test Period 1 (1 Week)||1
3150386|NCT01800916|3876737|FG005|NOT COMPLETED|Test Period 1 (1 Week)||0
3150387|NCT01800916|3876738|FG006|NOT COMPLETED|Test Period 1 (1 Week)||0
3150388|NCT01800916|3876739|FG007|NOT COMPLETED|Test Period 1 (1 Week)||0
3150389|NCT01800916|3876740|FG008|NOT COMPLETED|Test Period 1 (1 Week)||0
3150390|NCT01800916|3876732|FG000|STARTED|Test Period 2 (1 Week)||7
3150391|NCT01800916|3876733|FG001|STARTED|Test Period 2 (1 Week)||7
3150392|NCT01800916|3876734|FG002|STARTED|Test Period 2 (1 Week)||7
3150393|NCT01800916|3876735|FG003|STARTED|Test Period 2 (1 Week)||6
3150394|NCT01800916|3876736|FG004|STARTED|Test Period 2 (1 Week)||7
3150395|NCT01800916|3876737|FG005|STARTED|Test Period 2 (1 Week)||7
3150396|NCT01800916|3876738|FG006|STARTED|Test Period 2 (1 Week)||7
3150397|NCT01800916|3876739|FG007|STARTED|Test Period 2 (1 Week)||7
3150398|NCT01800916|3876740|FG008|STARTED|Test Period 2 (1 Week)||7
3150399|NCT01800916|3876732|FG000|COMPLETED|Test Period 2 (1 Week)||7
3150400|NCT01800916|3876733|FG001|COMPLETED|Test Period 2 (1 Week)||7
3150401|NCT01800916|3876734|FG002|COMPLETED|Test Period 2 (1 Week)||7
3150402|NCT01800916|3876735|FG003|COMPLETED|Test Period 2 (1 Week)||6
3150403|NCT01800916|3876736|FG004|COMPLETED|Test Period 2 (1 Week)||7
3150404|NCT01800916|3876737|FG005|COMPLETED|Test Period 2 (1 Week)||7
3150405|NCT01800916|3876738|FG006|COMPLETED|Test Period 2 (1 Week)||7
3150406|NCT01800916|3876739|FG007|COMPLETED|Test Period 2 (1 Week)||7
3150407|NCT01800916|3876740|FG008|COMPLETED|Test Period 2 (1 Week)||7
3150408|NCT01800916|3876732|FG000|NOT COMPLETED|Test Period 2 (1 Week)||0
3150409|NCT01800916|3876733|FG001|NOT COMPLETED|Test Period 2 (1 Week)||0
3150410|NCT01800916|3876734|FG002|NOT COMPLETED|Test Period 2 (1 Week)||0
3150411|NCT01800916|3876735|FG003|NOT COMPLETED|Test Period 2 (1 Week)||0
3150412|NCT01800916|3876736|FG004|NOT COMPLETED|Test Period 2 (1 Week)||0
3150413|NCT01800916|3876737|FG005|NOT COMPLETED|Test Period 2 (1 Week)||0
3150414|NCT01800916|3876738|FG006|NOT COMPLETED|Test Period 2 (1 Week)||0
3150415|NCT01800916|3876739|FG007|NOT COMPLETED|Test Period 2 (1 Week)||0
3150416|NCT01800916|3876740|FG008|NOT COMPLETED|Test Period 2 (1 Week)||0
3150417|NCT01800916|3876732|FG000|STARTED|Test Period 3 (1 Week)||7
3150418|NCT01800916|3876733|FG001|STARTED|Test Period 3 (1 Week)||7
3150419|NCT01800916|3876734|FG002|STARTED|Test Period 3 (1 Week)||7
3150420|NCT01800916|3876735|FG003|STARTED|Test Period 3 (1 Week)||6
3150421|NCT01800916|3876736|FG004|STARTED|Test Period 3 (1 Week)||7
3150422|NCT01800916|3876737|FG005|STARTED|Test Period 3 (1 Week)||7
3150423|NCT01800916|3876738|FG006|STARTED|Test Period 3 (1 Week)||7
3150424|NCT01800916|3876739|FG007|STARTED|Test Period 3 (1 Week)||7
3150425|NCT01800916|3876740|FG008|STARTED|Test Period 3 (1 Week)||7
3150426|NCT01800916|3876732|FG000|COMPLETED|Test Period 3 (1 Week)||7
3150427|NCT01800916|3876733|FG001|COMPLETED|Test Period 3 (1 Week)||7
3150428|NCT01800916|3876734|FG002|COMPLETED|Test Period 3 (1 Week)||7
3150429|NCT01800916|3876735|FG003|COMPLETED|Test Period 3 (1 Week)||6
3150430|NCT01800916|3876736|FG004|COMPLETED|Test Period 3 (1 Week)||7
3150431|NCT01800916|3876737|FG005|COMPLETED|Test Period 3 (1 Week)||7
3150432|NCT01800916|3876738|FG006|COMPLETED|Test Period 3 (1 Week)||7
3150433|NCT01800916|3876739|FG007|COMPLETED|Test Period 3 (1 Week)||7
3150434|NCT01800916|3876740|FG008|COMPLETED|Test Period 3 (1 Week)||7
3150435|NCT01800916|3876732|FG000|NOT COMPLETED|Test Period 3 (1 Week)||0
3150436|NCT01800916|3876733|FG001|NOT COMPLETED|Test Period 3 (1 Week)||0
3150437|NCT01800916|3876734|FG002|NOT COMPLETED|Test Period 3 (1 Week)||0
3150438|NCT01800916|3876735|FG003|NOT COMPLETED|Test Period 3 (1 Week)||0
3150439|NCT01800916|3876736|FG004|NOT COMPLETED|Test Period 3 (1 Week)||0
3150440|NCT01800916|3876737|FG005|NOT COMPLETED|Test Period 3 (1 Week)||0
3150441|NCT01800916|3876738|FG006|NOT COMPLETED|Test Period 3 (1 Week)||0
3150442|NCT01800916|3876739|FG007|NOT COMPLETED|Test Period 3 (1 Week)||0
3150443|NCT01800916|3876740|FG008|NOT COMPLETED|Test Period 3 (1 Week)||0
3150444|NCT01800968|3876752|FG000|STARTED|Overall Study||154
3150445|NCT01800968|3876753|FG001|STARTED|Overall Study||146
3150446|NCT01800968|3876752|FG000|COMPLETED|Overall Study||118
3150447|NCT01800968|3876753|FG001|COMPLETED|Overall Study||114
3150448|NCT01800968|3876752|FG000|NOT COMPLETED|Overall Study||36
3150449|NCT01800968|3876753|FG001|NOT COMPLETED|Overall Study||32
3150450|NCT01801007|3876759|FG000|STARTED|Overall Study||145
3150451|NCT01801007|3876759|FG000|COMPLETED|Overall Study||134
3150452|NCT01801007|3876759|FG000|NOT COMPLETED|Overall Study||11
3150453|NCT01801111|3876763|FG000|STARTED|Overall Study||138
3150454|NCT01801111|3876763|FG000|COMPLETED|Overall Study||0
3150455|NCT01801111|3876763|FG000|NOT COMPLETED|Overall Study||138
3150456|NCT01801124|3876767|FG000|STARTED|Overall Study||13
3150457|NCT01801124|3876767|FG000|COMPLETED|Overall Study||13
3150458|NCT01801124|3876767|FG000|NOT COMPLETED|Overall Study||0
3150459|NCT01801241|3876773|FG000|STARTED|Overall Study||29
3150460|NCT01801241|3876774|FG001|STARTED|Overall Study||27
3150461|NCT01801241|3876773|FG000|COMPLETED|Overall Study||21
3150462|NCT01801241|3876774|FG001|COMPLETED|Overall Study||25
3150463|NCT01801241|3876773|FG000|NOT COMPLETED|Overall Study||8
3150464|NCT01801241|3876774|FG001|NOT COMPLETED|Overall Study||2
3150465|NCT01801280|3876784|FG000|STARTED|Period 1|Each period lasted 10-14 weeks|5
3150466|NCT01801280|3876785|FG001|STARTED|Period 1||5
3150467|NCT01801280|3876786|FG002|STARTED|Period 1||5
3150468|NCT01801280|3876787|FG003|STARTED|Period 1||5
3150469|NCT01801280|3876784|FG000|COMPLETED|Period 1||5
3150470|NCT01801280|3876785|FG001|COMPLETED|Period 1||4
3150471|NCT01801280|3876786|FG002|COMPLETED|Period 1||5
3150472|NCT01801280|3876787|FG003|COMPLETED|Period 1||5
3150473|NCT01801280|3876784|FG000|NOT COMPLETED|Period 1||0
3150474|NCT01801280|3876785|FG001|NOT COMPLETED|Period 1||1
3150475|NCT01801280|3876786|FG002|NOT COMPLETED|Period 1||0
3150476|NCT01801280|3876787|FG003|NOT COMPLETED|Period 1||0
3150477|NCT01801280|3876784|FG000|STARTED|Period 2||5
3150478|NCT01801280|3876785|FG001|STARTED|Period 2||4
3150479|NCT01801280|3876786|FG002|STARTED|Period 2||5
3150480|NCT01801280|3876787|FG003|STARTED|Period 2||5
3150481|NCT01801280|3876784|FG000|COMPLETED|Period 2||4
3150482|NCT01801280|3876785|FG001|COMPLETED|Period 2||4
3150483|NCT01801280|3876786|FG002|COMPLETED|Period 2||5
3150484|NCT01801280|3876787|FG003|COMPLETED|Period 2||5
3150485|NCT01801280|3876784|FG000|NOT COMPLETED|Period 2||1
3150486|NCT01801280|3876785|FG001|NOT COMPLETED|Period 2||0
3150487|NCT01801280|3876786|FG002|NOT COMPLETED|Period 2||0
3150488|NCT01801280|3876787|FG003|NOT COMPLETED|Period 2||0
3150489|NCT01801280|3876784|FG000|STARTED|Period 3||4
3150490|NCT01801280|3876785|FG001|STARTED|Period 3||4
3150491|NCT01801280|3876786|FG002|STARTED|Period 3||5
3150492|NCT01801280|3876787|FG003|STARTED|Period 3||5
3150493|NCT01801280|3876784|FG000|COMPLETED|Period 3||4
3150494|NCT01801280|3876785|FG001|COMPLETED|Period 3||4
3150495|NCT01801280|3876786|FG002|COMPLETED|Period 3||5
3150496|NCT01801280|3876787|FG003|COMPLETED|Period 3||5
3150497|NCT01801280|3876784|FG000|NOT COMPLETED|Period 3||0
3150498|NCT01801280|3876785|FG001|NOT COMPLETED|Period 3||0
3150499|NCT01801280|3876786|FG002|NOT COMPLETED|Period 3||0
3150500|NCT01801280|3876787|FG003|NOT COMPLETED|Period 3||0
3150501|NCT01801280|3876784|FG000|STARTED|Period 4||4
3150502|NCT01801280|3876785|FG001|STARTED|Period 4||4
3150503|NCT01801280|3876786|FG002|STARTED|Period 4||5
3150504|NCT01801280|3876787|FG003|STARTED|Period 4||5
3150505|NCT01801280|3876784|FG000|COMPLETED|Period 4||4
3150506|NCT01801280|3876785|FG001|COMPLETED|Period 4||4
3150507|NCT01801280|3876786|FG002|COMPLETED|Period 4||4
3150508|NCT01801280|3876787|FG003|COMPLETED|Period 4||5
3150509|NCT01801280|3876784|FG000|NOT COMPLETED|Period 4||0
3150510|NCT01801280|3876785|FG001|NOT COMPLETED|Period 4||0
3150511|NCT01801280|3876786|FG002|NOT COMPLETED|Period 4||1
3150512|NCT01801280|3876787|FG003|NOT COMPLETED|Period 4||0
3150513|NCT01801358|3876803|FG000|STARTED|Overall Study||6
3150514|NCT01801358|3876804|FG001|STARTED|Overall Study||6
3150515|NCT01801358|3876805|FG002|STARTED|Overall Study||6
3150516|NCT01801358|3876806|FG003|STARTED|Overall Study||6
3150517|NCT01801358|3876807|FG004|STARTED|Overall Study||6
3150518|NCT01801358|3876808|FG005|STARTED|Overall Study||8
3150519|NCT01801358|3876803|FG000|COMPLETED|Overall Study||0
3150520|NCT01801358|3876804|FG001|COMPLETED|Overall Study||0
3150521|NCT01801358|3876805|FG002|COMPLETED|Overall Study||0
3150522|NCT01801358|3876806|FG003|COMPLETED|Overall Study||0
3150523|NCT01801358|3876807|FG004|COMPLETED|Overall Study||0
3150524|NCT01801358|3876808|FG005|COMPLETED|Overall Study||0
3150525|NCT01801358|3876803|FG000|NOT COMPLETED|Overall Study||6
3150526|NCT01801358|3876804|FG001|NOT COMPLETED|Overall Study||6
3150527|NCT01801358|3876805|FG002|NOT COMPLETED|Overall Study||6
3150528|NCT01801358|3876806|FG003|NOT COMPLETED|Overall Study||6
3150529|NCT01801358|3876807|FG004|NOT COMPLETED|Overall Study||6
3150530|NCT01801358|3876808|FG005|NOT COMPLETED|Overall Study||8
3150531|NCT01801436|3876843|FG000|STARTED|Overall Study||14
3150532|NCT01801436|3876843|FG000|COMPLETED|Overall Study||5
3150533|NCT01801436|3876843|FG000|NOT COMPLETED|Overall Study||9
3150534|NCT01801449|3876847|FG000|STARTED|Overall Study||6
3150535|NCT01801449|3876847|FG000|COMPLETED|Overall Study||6
3150536|NCT01801449|3876847|FG000|NOT COMPLETED|Overall Study||0
3150537|NCT01801475|3876855|FG000|STARTED|Overall Study||10
3150538|NCT01801475|3876856|FG001|STARTED|Overall Study||30
3150539|NCT01801475|3876857|FG002|STARTED|Overall Study||10
3150540|NCT01801475|3876858|FG003|STARTED|Overall Study||10
3150541|NCT01801475|3876859|FG004|STARTED|Overall Study||40
3150542|NCT01801475|3876855|FG000|COMPLETED|Overall Study||10
3150543|NCT01801475|3876856|FG001|COMPLETED|Overall Study||30
3150544|NCT01801475|3876857|FG002|COMPLETED|Overall Study||10
3150545|NCT01801475|3876858|FG003|COMPLETED|Overall Study||10
3150546|NCT01801475|3876859|FG004|COMPLETED|Overall Study||39
3150547|NCT01801475|3876855|FG000|NOT COMPLETED|Overall Study||0
3150548|NCT01801475|3876856|FG001|NOT COMPLETED|Overall Study||0
3150549|NCT01801475|3876857|FG002|NOT COMPLETED|Overall Study||0
3150550|NCT01801475|3876858|FG003|NOT COMPLETED|Overall Study||0
3150551|NCT01801475|3876859|FG004|NOT COMPLETED|Overall Study||1
3150552|NCT01801735|3876868|FG000|STARTED|Overall Study||600
3150553|NCT01801735|3876868|FG000|COMPLETED|Overall Study||390
3150554|NCT01801735|3876868|FG000|NOT COMPLETED|Overall Study||210
3150555|NCT01801865|3876872|FG000|STARTED|Overall Study||657
3150556|NCT01801865|3876872|FG000|COMPLETED|Overall Study||615
3150557|NCT01801865|3876872|FG000|NOT COMPLETED|Overall Study||42
3150558|NCT01801917|3876880|FG000|STARTED|Period 1 - Randomized||7
3150559|NCT01801917|3876881|FG001|STARTED|Period 1 - Randomized||2
3150560|NCT01801917|3876882|FG002|STARTED|Period 1 - Randomized||4
3150561|NCT01801917|3876883|FG003|STARTED|Period 1 - Randomized||1
3150562|NCT01801917|3876880|FG000|COMPLETED|Period 1 - Randomized||6
3150563|NCT01801917|3876881|FG001|COMPLETED|Period 1 - Randomized||2
3150564|NCT01801917|3876882|FG002|COMPLETED|Period 1 - Randomized||3
3150565|NCT01801917|3876883|FG003|COMPLETED|Period 1 - Randomized||1
3150566|NCT01801917|3876880|FG000|NOT COMPLETED|Period 1 - Randomized||1
3150567|NCT01801917|3876881|FG001|NOT COMPLETED|Period 1 - Randomized||0
3182789|NCT02003963|3910987|FG000|COMPLETED|Overall Study|2 participants dropped out: 1 due to lack of interest and 1 due to a mental health hospitalization.|20
3182790|NCT02003963|3910988|FG001|COMPLETED|Overall Study|1 participant was removed from analysis for completing final visit outside of visit window.|18
3182791|NCT02003963|3910987|FG000|NOT COMPLETED|Overall Study||2
3182792|NCT02003963|3910988|FG001|NOT COMPLETED|Overall Study||1
3182793|NCT02004093|3910998|FG000|STARTED|Overall Study|Includes 1 participant who was randomized to chemotherapy group but received pertuzumab+chemotherapy|75
3182794|NCT02004093|3910999|FG001|STARTED|Overall Study||74
3182795|NCT02004093|3910998|FG000|COMPLETED|Overall Study||1
3182796|NCT02004093|3910999|FG001|COMPLETED|Overall Study||1
3182797|NCT02004093|3910998|FG000|NOT COMPLETED|Overall Study||74
3150568|NCT01801917|3876882|FG002|NOT COMPLETED|Period 1 - Randomized||1
3150569|NCT01801917|3876883|FG003|NOT COMPLETED|Period 1 - Randomized||0
3150570|NCT01801917|3876880|FG000|STARTED|Extension - All Active||6
3150571|NCT01801917|3876881|FG001|STARTED|Extension - All Active||0
3150572|NCT01801917|3876882|FG002|STARTED|Extension - All Active||3
3150573|NCT01801917|3876883|FG003|STARTED|Extension - All Active||0
3150574|NCT01801917|3876880|FG000|COMPLETED|Extension - All Active||6
3150575|NCT01801917|3876881|FG001|COMPLETED|Extension - All Active||0
3150576|NCT01801917|3876882|FG002|COMPLETED|Extension - All Active||3
3150577|NCT01801917|3876883|FG003|COMPLETED|Extension - All Active||0
3150578|NCT01801917|3876880|FG000|NOT COMPLETED|Extension - All Active||0
3150579|NCT01801917|3876881|FG001|NOT COMPLETED|Extension - All Active||0
3150580|NCT01801917|3876882|FG002|NOT COMPLETED|Extension - All Active||0
3150581|NCT01801917|3876883|FG003|NOT COMPLETED|Extension - All Active||0
3150582|NCT01801930|3876898|FG000|STARTED|Overall Study||6
3150583|NCT01801930|3876899|FG001|STARTED|Overall Study||6
3150584|NCT01801930|3876900|FG002|STARTED|Overall Study||6
3150585|NCT01801930|3876901|FG003|STARTED|Overall Study||6
3150586|NCT01801930|3876898|FG000|COMPLETED|Overall Study||0
3150587|NCT01801930|3876899|FG001|COMPLETED|Overall Study||0
3150588|NCT01801930|3876900|FG002|COMPLETED|Overall Study||0
3150589|NCT01801930|3876901|FG003|COMPLETED|Overall Study||0
3150590|NCT01801930|3876898|FG000|NOT COMPLETED|Overall Study||6
3150591|NCT01801930|3876899|FG001|NOT COMPLETED|Overall Study||6
3150592|NCT01801930|3876900|FG002|NOT COMPLETED|Overall Study||6
3150593|NCT01801930|3876901|FG003|NOT COMPLETED|Overall Study||6
3150594|NCT01801982|3876911|FG000|STARTED|Overall Study||1
3150595|NCT01801982|3876911|FG000|COMPLETED|Overall Study||0
3150596|NCT01801982|3876911|FG000|NOT COMPLETED|Overall Study||1
3150597|NCT01802073|3876917|FG000|STARTED|Overall Study||14
3150598|NCT01802073|3876918|FG001|STARTED|Overall Study||20
3150599|NCT01802073|3876917|FG000|COMPLETED|Overall Study||9
3150600|NCT01802073|3876918|FG001|COMPLETED|Overall Study||9
3150601|NCT01802073|3876917|FG000|NOT COMPLETED|Overall Study||5
3150602|NCT01802073|3876918|FG001|NOT COMPLETED|Overall Study||11
3150603|NCT01802151|3876928|FG000|STARTED|Overall Study||20
3150604|NCT01802151|3876929|FG001|STARTED|Overall Study||21
3150605|NCT01802151|3876930|FG002|STARTED|Overall Study||22
3150606|NCT01802151|3876931|FG003|STARTED|Overall Study||20
3150607|NCT01802151|3876928|FG000|COMPLETED|Overall Study|Participants were enrolled and randomized in five waves. The final wave's data collection ended 9/20|20
3150608|NCT01802151|3876929|FG001|COMPLETED|Overall Study|Participants were enrolled and randomized in five waves. The final wave's data collection ended 9/20|21
3150609|NCT01802151|3876930|FG002|COMPLETED|Overall Study|Participants were enrolled and randomized in five waves. The final wave's data collection ended 9/20|20
3150610|NCT01802151|3876931|FG003|COMPLETED|Overall Study|Participants were enrolled and randomized in five waves. The final wave's data collection ended 9/20|20
3150611|NCT01802151|3876928|FG000|NOT COMPLETED|Overall Study||0
3150612|NCT01802151|3876929|FG001|NOT COMPLETED|Overall Study||0
3150613|NCT01802151|3876930|FG002|NOT COMPLETED|Overall Study||2
3150614|NCT01802151|3876931|FG003|NOT COMPLETED|Overall Study||0
3150615|NCT01802216|3876943|FG000|STARTED|Baseline||17
3150616|NCT01802216|3876944|FG001|STARTED|Baseline||34
3150617|NCT01802216|3876943|FG000|COMPLETED|Baseline||17
3150618|NCT01802216|3876944|FG001|COMPLETED|Baseline||34
3150619|NCT01802216|3876943|FG000|NOT COMPLETED|Baseline||0
3150620|NCT01802216|3876944|FG001|NOT COMPLETED|Baseline||0
3150621|NCT01802216|3876943|FG000|STARTED|4 Month Visit||17
3150622|NCT01802216|3876944|FG001|STARTED|4 Month Visit||34
3150623|NCT01802216|3876943|FG000|COMPLETED|4 Month Visit||14
3150624|NCT01802216|3876944|FG001|COMPLETED|4 Month Visit||30
3150625|NCT01802216|3876943|FG000|NOT COMPLETED|4 Month Visit||3
3150626|NCT01802216|3876944|FG001|NOT COMPLETED|4 Month Visit||4
3150627|NCT01802216|3876943|FG000|STARTED|8 Month Visit||17
3150628|NCT01802216|3876944|FG001|STARTED|8 Month Visit||34
3150629|NCT01802216|3876943|FG000|COMPLETED|8 Month Visit||14
3150630|NCT01802216|3876944|FG001|COMPLETED|8 Month Visit||29
3150631|NCT01802216|3876943|FG000|NOT COMPLETED|8 Month Visit||3
3150632|NCT01802216|3876944|FG001|NOT COMPLETED|8 Month Visit||5
3150633|NCT01802216|3876943|FG000|STARTED|12 Month Visit||17
3150634|NCT01802216|3876944|FG001|STARTED|12 Month Visit||34
3150635|NCT01802216|3876943|FG000|COMPLETED|12 Month Visit||14
3150636|NCT01802216|3876944|FG001|COMPLETED|12 Month Visit||30
3150637|NCT01802216|3876943|FG000|NOT COMPLETED|12 Month Visit||3
3150638|NCT01802216|3876944|FG001|NOT COMPLETED|12 Month Visit||4
3150639|NCT01802281|3876952|FG000|STARTED|Overall Study||93
3150640|NCT01802281|3876953|FG001|STARTED|Overall Study||90
3182798|NCT02004093|3910999|FG001|NOT COMPLETED|Overall Study||73
3182799|NCT02004132|3911008|FG000|STARTED|Overall Study||12
3182800|NCT02004132|3911008|FG000|Received Study Drug|Overall Study||12
3182801|NCT02004132|3911008|FG000|COMPLETED|Overall Study||12
3182802|NCT02004132|3911008|FG000|NOT COMPLETED|Overall Study||0
3182803|NCT02004158|3911012|FG000|STARTED|Overall Study||23
3182804|NCT02004158|3911012|FG000|COMPLETED|Overall Study||20
3182805|NCT02004158|3911012|FG000|NOT COMPLETED|Overall Study||3
3182806|NCT02004236|3911021|FG000|STARTED|Overall Study||75
3182807|NCT02004236|3911022|FG001|STARTED|Overall Study||75
3182808|NCT02004236|3911023|FG002|STARTED|Overall Study||75
3182809|NCT02004236|3911021|FG000|COMPLETED|Overall Study||75
3182810|NCT02004236|3911022|FG001|COMPLETED|Overall Study||75
3182811|NCT02004236|3911023|FG002|COMPLETED|Overall Study|Leave the group because the parents does't find any clinical improvement.|59
3182812|NCT02004236|3911021|FG000|NOT COMPLETED|Overall Study||0
3182813|NCT02004236|3911022|FG001|NOT COMPLETED|Overall Study||0
3182814|NCT02004236|3911023|FG002|NOT COMPLETED|Overall Study||16
3182815|NCT02004262|3911038|FG000|STARTED|Overall Study||73
3182816|NCT02004262|3911039|FG001|STARTED|Overall Study||68
3182817|NCT02004262|3911040|FG002|STARTED|Overall Study||72
3182818|NCT02004262|3911041|FG003|STARTED|Overall Study||29
3182819|NCT02004262|3911042|FG004|STARTED|Overall Study||31
3182820|NCT02004262|3911043|FG005|STARTED|Overall Study||30
3182821|NCT02004262|3911038|FG000|Treated|Overall Study||68
3182822|NCT02004262|3911039|FG001|Treated|Overall Study||58
3150641|NCT01802281|3876952|FG000|Eligible and Received Randomized Treatment|Overall Study||88
3150642|NCT01802281|3876953|FG001|Eligible and Received Randomized Treatment|Overall Study||87
3150643|NCT01802281|3876952|FG000|Completed Year 1 Follow-up|Overall Study||88
3150644|NCT01802281|3876953|FG001|Completed Year 1 Follow-up|Overall Study||86
3150645|NCT01802281|3876952|FG000|Completed Year 2 Follow-up|Overall Study||87
3150646|NCT01802281|3876953|FG001|Completed Year 2 Follow-up|Overall Study||84
3150647|NCT01802281|3876952|FG000|COMPLETED|Overall Study||85
3150648|NCT01802281|3876953|FG001|COMPLETED|Overall Study||84
3150649|NCT01802281|3876952|FG000|NOT COMPLETED|Overall Study||8
3150650|NCT01802281|3876953|FG001|NOT COMPLETED|Overall Study||6
3150651|NCT01802320|3876959|FG000|STARTED|Overall Study||18
3150652|NCT01802320|3876959|FG000|COMPLETED|Overall Study||16
3150653|NCT01802320|3876959|FG000|NOT COMPLETED|Overall Study||2
3150654|NCT01802333|3876966|FG000|STARTED|Overall Study||263
3150655|NCT01802333|3876967|FG001|STARTED|Overall Study||267
3150656|NCT01802333|3876968|FG002|STARTED|Overall Study||224
3150657|NCT01802333|3876966|FG000|High Risk Patients|Overall Study||60
3150658|NCT01802333|3876967|FG001|High Risk Patients|Overall Study||61
3150659|NCT01802333|3876968|FG002|High Risk Patients|Overall Study||38
3150660|NCT01802333|3876966|FG000|High Risk Patients Achieved CR/CRi|Overall Study||38
3150661|NCT01802333|3876967|FG001|High Risk Patients Achieved CR/CRi|Overall Study||40
3150662|NCT01802333|3876968|FG002|High Risk Patients Achieved CR/CRi|Overall Study||29
3150663|NCT01802333|3876966|FG000|Known NPM1 Status at Baseline|Overall Study||169
3150664|NCT01802333|3876967|FG001|Known NPM1 Status at Baseline|Overall Study||156
3150665|NCT01802333|3876968|FG002|Known NPM1 Status at Baseline|Overall Study||142
3150666|NCT01802333|3876966|FG000|Known Cytogenetic Risk at Baseline|Overall Study||252
3150667|NCT01802333|3876967|FG001|Known Cytogenetic Risk at Baseline|Overall Study||250
3150668|NCT01802333|3876968|FG002|Known Cytogenetic Risk at Baseline|Overall Study||210
3150669|NCT01802333|3876966|FG000|COMPLETED|Overall Study||214
3150670|NCT01802333|3876967|FG001|COMPLETED|Overall Study||206
3150671|NCT01802333|3876968|FG002|COMPLETED|Overall Study||161
3150672|NCT01802333|3876966|FG000|NOT COMPLETED|Overall Study||49
3150673|NCT01802333|3876967|FG001|NOT COMPLETED|Overall Study||61
3150674|NCT01802333|3876968|FG002|NOT COMPLETED|Overall Study||63
3150675|NCT01802385|3876984|FG000|STARTED|Overall Study||231
3150676|NCT01802385|3876985|FG001|STARTED|Overall Study||229
3150677|NCT01802385|3876984|FG000|COMPLETED|Overall Study||125
3150678|NCT01802385|3876985|FG001|COMPLETED|Overall Study||109
3150679|NCT01802385|3876984|FG000|NOT COMPLETED|Overall Study||106
3150680|NCT01802385|3876985|FG001|NOT COMPLETED|Overall Study||120
3150681|NCT01802411|3876993|FG000|STARTED|Overall Study||96
3150682|NCT01802411|3876994|FG001|STARTED|Overall Study||95
3150683|NCT01802411|3876993|FG000|COMPLETED|Overall Study||82
3150684|NCT01802411|3876994|FG001|COMPLETED|Overall Study||74
3150685|NCT01802411|3876993|FG000|NOT COMPLETED|Overall Study||14
3150686|NCT01802411|3876994|FG001|NOT COMPLETED|Overall Study||21
3150687|NCT01802437|3877002|FG000|STARTED|Overall Study||20
3150688|NCT01802437|3877003|FG001|STARTED|Overall Study||20
3150689|NCT01802437|3877002|FG000|COMPLETED|Overall Study||16
3150690|NCT01802437|3877003|FG001|COMPLETED|Overall Study||16
3150691|NCT01802437|3877002|FG000|NOT COMPLETED|Overall Study||4
3150692|NCT01802437|3877003|FG001|NOT COMPLETED|Overall Study||4
3150693|NCT01802515|3877012|FG000|STARTED|Overall Study||5
3150694|NCT01802515|3877013|FG001|STARTED|Overall Study||5
3150695|NCT01802515|3877014|FG002|STARTED|Overall Study||4
3150696|NCT01802515|3877012|FG000|COMPLETED|Overall Study||2
3150697|NCT01802515|3877013|FG001|COMPLETED|Overall Study||5
3150698|NCT01802515|3877014|FG002|COMPLETED|Overall Study||4
3150699|NCT01802515|3877012|FG000|NOT COMPLETED|Overall Study||3
3150700|NCT01802515|3877013|FG001|NOT COMPLETED|Overall Study||0
3150701|NCT01802515|3877014|FG002|NOT COMPLETED|Overall Study||0
3150702|NCT01802554|3877024|FG000|STARTED|Overall Study||51
3150703|NCT01802554|3877025|FG001|STARTED|Overall Study||49
3150704|NCT01802554|3877024|FG000|COMPLETED|Overall Study||43
3182823|NCT02004262|3911040|FG002|Treated|Overall Study||43
3182824|NCT02004262|3911041|FG003|Treated|Overall Study||26
3182825|NCT02004262|3911042|FG004|Treated|Overall Study||29
3182826|NCT02004262|3911043|FG005|Treated|Overall Study||11
3182827|NCT02004262|3911038|FG000|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/consent withdrawn/death, so no subjects completed study."|0
3182828|NCT02004262|3911039|FG001|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/consent withdrawn/death, so no subjects completed study."|0
3182829|NCT02004262|3911040|FG002|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/consent withdrawn/death, so no subjects completed study."|0
3182830|NCT02004262|3911041|FG003|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/consent withdrawn/death, so no subjects completed study."|0
3182831|NCT02004262|3911042|FG004|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/consent withdrawn/death, so no subjects completed study."|0
3182832|NCT02004262|3911043|FG005|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/consent withdrawn/death, so no subjects completed study."|0
3182833|NCT02004262|3911038|FG000|NOT COMPLETED|Overall Study||73
3182834|NCT02004262|3911039|FG001|NOT COMPLETED|Overall Study||68
3182835|NCT02004262|3911040|FG002|NOT COMPLETED|Overall Study||72
3182836|NCT02004262|3911041|FG003|NOT COMPLETED|Overall Study||29
3150705|NCT01802554|3877025|FG001|COMPLETED|Overall Study||43
3150706|NCT01802554|3877024|FG000|NOT COMPLETED|Overall Study||8
3150707|NCT01802554|3877025|FG001|NOT COMPLETED|Overall Study||6
3150708|NCT01802580|3877033|FG000|STARTED|Overall Study||20
3150709|NCT01802580|3877034|FG001|STARTED|Overall Study||20
3150710|NCT01802580|3877033|FG000|COMPLETED|Overall Study||11
3150711|NCT01802580|3877034|FG001|COMPLETED|Overall Study||9
3150712|NCT01802580|3877033|FG000|NOT COMPLETED|Overall Study||9
3150713|NCT01802580|3877034|FG001|NOT COMPLETED|Overall Study||11
3150714|NCT01802710|3877042|FG000|STARTED|From T0 to T1||76
3150715|NCT01802710|3877043|FG001|STARTED|From T0 to T1||82
3150716|NCT01802710|3877042|FG000|COMPLETED|From T0 to T1||60
3150717|NCT01802710|3877043|FG001|COMPLETED|From T0 to T1||72
3150718|NCT01802710|3877042|FG000|NOT COMPLETED|From T0 to T1||16
3150719|NCT01802710|3877043|FG001|NOT COMPLETED|From T0 to T1||10
3150720|NCT01802710|3877042|FG000|STARTED|From T1 to T2||60
3150721|NCT01802710|3877043|FG001|STARTED|From T1 to T2||72
3150722|NCT01802710|3877042|FG000|COMPLETED|From T1 to T2||58
3150723|NCT01802710|3877043|FG001|COMPLETED|From T1 to T2||70
3150724|NCT01802710|3877042|FG000|NOT COMPLETED|From T1 to T2||2
3150725|NCT01802710|3877043|FG001|NOT COMPLETED|From T1 to T2||2
3150726|NCT01802775|3877053|FG000|STARTED|Overall Study||102
3150727|NCT01802775|3877054|FG001|STARTED|Overall Study||101
3150728|NCT01802775|3877053|FG000|Received Drug (Safety Analysis Set)|Overall Study||101
3150729|NCT01802775|3877054|FG001|Received Drug (Safety Analysis Set)|Overall Study||100
3150730|NCT01802775|3877053|FG000|COMPLETED|Overall Study||96
3150731|NCT01802775|3877054|FG001|COMPLETED|Overall Study||89
3150732|NCT01802775|3877053|FG000|NOT COMPLETED|Overall Study||6
3150733|NCT01802775|3877054|FG001|NOT COMPLETED|Overall Study||12
3150734|NCT01802879|3877060|FG000|STARTED|Overall Study||8
3150735|NCT01802879|3877060|FG000|COMPLETED|Overall Study||0
3150736|NCT01802879|3877060|FG000|NOT COMPLETED|Overall Study||8
3150737|NCT01803074|3877078|FG000|STARTED|Period 1: Part A (HIV-1 Clade B)||8
3150738|NCT01803074|3877079|FG001|STARTED|Period 1: Part A (HIV-1 Clade B)||8
3150739|NCT01803074|3877080|FG002|STARTED|Period 1: Part A (HIV-1 Clade B)||8
3150740|NCT01803074|3877081|FG003|STARTED|Period 1: Part A (HIV-1 Clade B)||8
3150741|NCT01803074|3877082|FG004|STARTED|Period 1: Part A (HIV-1 Clade B)||8
3150742|NCT01803074|3877083|FG005|STARTED|Period 1: Part A (HIV-1 Clade B)||8
3150743|NCT01803074|3877084|FG006|STARTED|Period 1: Part A (HIV-1 Clade B)||12
3150744|NCT01803074|3877085|FG007|STARTED|Period 1: Part A (HIV-1 Clade B)||0
3150745|NCT01803074|3877086|FG008|STARTED|Period 1: Part A (HIV-1 Clade B)||0
3150746|NCT01803074|3877087|FG009|STARTED|Period 1: Part A (HIV-1 Clade B)||0
3150747|NCT01803074|3877088|FG010|STARTED|Period 1: Part A (HIV-1 Clade B)||0
3150748|NCT01803074|3877089|FG011|STARTED|Period 1: Part A (HIV-1 Clade B)||0
3150749|NCT01803074|3877090|FG012|STARTED|Period 1: Part A (HIV-1 Clade B)||0
3150750|NCT01803074|3877091|FG013|STARTED|Period 1: Part A (HIV-1 Clade B)||0
3150751|NCT01803074|3877078|FG000|COMPLETED|Period 1: Part A (HIV-1 Clade B)||8
3150752|NCT01803074|3877079|FG001|COMPLETED|Period 1: Part A (HIV-1 Clade B)||8
3150753|NCT01803074|3877080|FG002|COMPLETED|Period 1: Part A (HIV-1 Clade B)||8
3150754|NCT01803074|3877081|FG003|COMPLETED|Period 1: Part A (HIV-1 Clade B)||8
3150755|NCT01803074|3877082|FG004|COMPLETED|Period 1: Part A (HIV-1 Clade B)||8
3150756|NCT01803074|3877083|FG005|COMPLETED|Period 1: Part A (HIV-1 Clade B)||8
3150757|NCT01803074|3877084|FG006|COMPLETED|Period 1: Part A (HIV-1 Clade B)||12
3150758|NCT01803074|3877085|FG007|COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
3150759|NCT01803074|3877086|FG008|COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
3150760|NCT01803074|3877087|FG009|COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
3150761|NCT01803074|3877088|FG010|COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
3150762|NCT01803074|3877089|FG011|COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
3150763|NCT01803074|3877090|FG012|COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
3150764|NCT01803074|3877091|FG013|COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
3150765|NCT01803074|3877078|FG000|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
3150766|NCT01803074|3877079|FG001|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
3150767|NCT01803074|3877080|FG002|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
3150768|NCT01803074|3877081|FG003|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
3150769|NCT01803074|3877082|FG004|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
3150770|NCT01803074|3877083|FG005|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
3150771|NCT01803074|3877084|FG006|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
3150772|NCT01803074|3877085|FG007|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
3150773|NCT01803074|3877086|FG008|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
3150774|NCT01803074|3877087|FG009|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
3150775|NCT01803074|3877088|FG010|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
3150776|NCT01803074|3877089|FG011|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
3150777|NCT01803074|3877090|FG012|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
3150778|NCT01803074|3877091|FG013|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
3150779|NCT01803074|3877078|FG000|STARTED|Period 2: Part B (HIV-1 Clade B)||0
3150780|NCT01803074|3877079|FG001|STARTED|Period 2: Part B (HIV-1 Clade B)||0
3150781|NCT01803074|3877080|FG002|STARTED|Period 2: Part B (HIV-1 Clade B)||0
3150782|NCT01803074|3877081|FG003|STARTED|Period 2: Part B (HIV-1 Clade B)||0
3150783|NCT01803074|3877082|FG004|STARTED|Period 2: Part B (HIV-1 Clade B)||0
3150784|NCT01803074|3877083|FG005|STARTED|Period 2: Part B (HIV-1 Clade B)||0
3150785|NCT01803074|3877084|FG006|STARTED|Period 2: Part B (HIV-1 Clade B)||0
3150786|NCT01803074|3877085|FG007|STARTED|Period 2: Part B (HIV-1 Clade B)||8
3150787|NCT01803074|3877086|FG008|STARTED|Period 2: Part B (HIV-1 Clade B)||8
3150788|NCT01803074|3877087|FG009|STARTED|Period 2: Part B (HIV-1 Clade B)||4
3150789|NCT01803074|3877088|FG010|STARTED|Period 2: Part B (HIV-1 Clade B)||8
3150790|NCT01803074|3877089|FG011|STARTED|Period 2: Part B (HIV-1 Clade B)||0
3150791|NCT01803074|3877090|FG012|STARTED|Period 2: Part B (HIV-1 Clade B)||0
3150792|NCT01803074|3877091|FG013|STARTED|Period 2: Part B (HIV-1 Clade B)||0
3150793|NCT01803074|3877078|FG000|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
3150794|NCT01803074|3877079|FG001|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
3150795|NCT01803074|3877080|FG002|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
3150796|NCT01803074|3877081|FG003|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
3150797|NCT01803074|3877082|FG004|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
3150798|NCT01803074|3877083|FG005|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
3150799|NCT01803074|3877084|FG006|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
3150800|NCT01803074|3877085|FG007|COMPLETED|Period 2: Part B (HIV-1 Clade B)||8
3150801|NCT01803074|3877086|FG008|COMPLETED|Period 2: Part B (HIV-1 Clade B)||8
3150802|NCT01803074|3877087|FG009|COMPLETED|Period 2: Part B (HIV-1 Clade B)||4
3150803|NCT01803074|3877088|FG010|COMPLETED|Period 2: Part B (HIV-1 Clade B)||8
3150804|NCT01803074|3877089|FG011|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
3150805|NCT01803074|3877090|FG012|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
3150806|NCT01803074|3877091|FG013|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
3150807|NCT01803074|3877078|FG000|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
3150808|NCT01803074|3877079|FG001|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
3150809|NCT01803074|3877080|FG002|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
3150810|NCT01803074|3877081|FG003|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
3150811|NCT01803074|3877082|FG004|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
3150812|NCT01803074|3877083|FG005|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
3150813|NCT01803074|3877084|FG006|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
3150814|NCT01803074|3877085|FG007|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
3150815|NCT01803074|3877086|FG008|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
3150816|NCT01803074|3877087|FG009|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
3182837|NCT02004262|3911042|FG004|NOT COMPLETED|Overall Study||31
3182838|NCT02004262|3911043|FG005|NOT COMPLETED|Overall Study||30
3182839|NCT02004288|3911059|FG000|STARTED|Overall Study||15
3182840|NCT02004288|3911060|FG001|STARTED|Overall Study||16
3182841|NCT02004288|3911059|FG000|COMPLETED|Overall Study||14
3182842|NCT02004288|3911060|FG001|COMPLETED|Overall Study||15
3182843|NCT02004288|3911059|FG000|NOT COMPLETED|Overall Study||1
3182844|NCT02004288|3911060|FG001|NOT COMPLETED|Overall Study||1
3182845|NCT02004353|3911066|FG000|STARTED|Overall Study||1518
3182846|NCT02004353|3911066|FG000|COMPLETED|Overall Study||184
3182847|NCT02004353|3911066|FG000|NOT COMPLETED|Overall Study||1334
3182848|NCT02004366|3911075|FG000|STARTED|In-hospital||128
3182849|NCT02004366|3911076|FG001|STARTED|In-hospital||122
3182850|NCT02004366|3911077|FG002|STARTED|In-hospital||0
3182851|NCT02004366|3911078|FG003|STARTED|In-hospital||0
3182852|NCT02004366|3911079|FG004|STARTED|In-hospital||0
3182853|NCT02004366|3911075|FG000|COMPLETED|In-hospital||128
3182854|NCT02004366|3911076|FG001|COMPLETED|In-hospital||122
3182855|NCT02004366|3911077|FG002|COMPLETED|In-hospital||0
3182856|NCT02004366|3911078|FG003|COMPLETED|In-hospital||0
3182857|NCT02004366|3911079|FG004|COMPLETED|In-hospital||0
3182858|NCT02004366|3911075|FG000|NOT COMPLETED|In-hospital||0
3182859|NCT02004366|3911076|FG001|NOT COMPLETED|In-hospital||0
3182860|NCT02004366|3911077|FG002|NOT COMPLETED|In-hospital||0
3182861|NCT02004366|3911078|FG003|NOT COMPLETED|In-hospital||0
3182862|NCT02004366|3911079|FG004|NOT COMPLETED|In-hospital||0
3182863|NCT02004366|3911075|FG000|STARTED|On Discharge||0
3182864|NCT02004366|3911076|FG001|STARTED|On Discharge||0
3182865|NCT02004366|3911077|FG002|STARTED|On Discharge||92
3182866|NCT02004366|3911078|FG003|STARTED|On Discharge||93
3182867|NCT02004366|3911079|FG004|STARTED|On Discharge||39
3182868|NCT02004366|3911075|FG000|COMPLETED|On Discharge||0
3182869|NCT02004366|3911076|FG001|COMPLETED|On Discharge||0
3182870|NCT02004366|3911077|FG002|COMPLETED|On Discharge||92
3182871|NCT02004366|3911078|FG003|COMPLETED|On Discharge||93
3182872|NCT02004366|3911079|FG004|COMPLETED|On Discharge||39
3182873|NCT02004366|3911075|FG000|NOT COMPLETED|On Discharge||0
3182874|NCT02004366|3911076|FG001|NOT COMPLETED|On Discharge||0
3182875|NCT02004366|3911077|FG002|NOT COMPLETED|On Discharge||0
3182876|NCT02004366|3911078|FG003|NOT COMPLETED|On Discharge||0
3182877|NCT02004366|3911079|FG004|NOT COMPLETED|On Discharge||0
3182878|NCT02004613|3911094|FG000|STARTED|Overall Study||400
3182879|NCT02004613|3911095|FG001|STARTED|Overall Study||398
3182880|NCT02004613|3911094|FG000|COMPLETED|Overall Study||398
3182881|NCT02004613|3911095|FG001|COMPLETED|Overall Study||396
3182882|NCT02004613|3911094|FG000|NOT COMPLETED|Overall Study||2
3182883|NCT02004613|3911095|FG001|NOT COMPLETED|Overall Study||2
3182884|NCT02004847|3911103|FG000|STARTED|Overall Study||24
3182885|NCT02004847|3911104|FG001|STARTED|Overall Study||23
3182886|NCT02004847|3911103|FG000|COMPLETED|Overall Study||23
3182887|NCT02004847|3911104|FG001|COMPLETED|Overall Study||22
3182888|NCT02004847|3911103|FG000|NOT COMPLETED|Overall Study||1
3182889|NCT02004847|3911104|FG001|NOT COMPLETED|Overall Study||1
3182890|NCT02004873|3911119|FG000|STARTED|Overall Study|Micra Implant Attempt|725
3182891|NCT02004873|3911119|FG000|Micra Implant Success|Overall Study||719
3182892|NCT02004873|3911119|FG000|COMPLETED|Overall Study|6-Month Follow-up|301
3182893|NCT02004873|3911119|FG000|NOT COMPLETED|Overall Study||424
3182894|NCT02004886|3911130|FG000|STARTED|Overall Study||19
3182895|NCT02004886|3911131|FG001|STARTED|Overall Study||18
3182896|NCT02004886|3911132|FG002|STARTED|Overall Study||18
3182897|NCT02004886|3911133|FG003|STARTED|Overall Study||19
3150817|NCT01803074|3877088|FG010|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
3150818|NCT01803074|3877089|FG011|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
3150819|NCT01803074|3877090|FG012|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
3150820|NCT01803074|3877091|FG013|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
3150821|NCT01803074|3877078|FG000|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
3150822|NCT01803074|3877079|FG001|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
3150823|NCT01803074|3877080|FG002|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
3150824|NCT01803074|3877081|FG003|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
3150825|NCT01803074|3877082|FG004|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
3150826|NCT01803074|3877083|FG005|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
3150827|NCT01803074|3877084|FG006|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
3150828|NCT01803074|3877085|FG007|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
3150829|NCT01803074|3877086|FG008|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
3150830|NCT01803074|3877087|FG009|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
3150831|NCT01803074|3877088|FG010|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
3150832|NCT01803074|3877089|FG011|STARTED|Period 3: Part C (HIV-1 Clade C Only)||8
3150833|NCT01803074|3877090|FG012|STARTED|Period 3: Part C (HIV-1 Clade C Only)||7
3150834|NCT01803074|3877091|FG013|STARTED|Period 3: Part C (HIV-1 Clade C Only)||4
3150835|NCT01803074|3877078|FG000|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
3150836|NCT01803074|3877079|FG001|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
3150837|NCT01803074|3877080|FG002|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
3150838|NCT01803074|3877081|FG003|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
3150839|NCT01803074|3877082|FG004|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
3150840|NCT01803074|3877083|FG005|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
3150841|NCT01803074|3877084|FG006|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
3150842|NCT01803074|3877085|FG007|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
3150843|NCT01803074|3877086|FG008|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
3150844|NCT01803074|3877087|FG009|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
3150845|NCT01803074|3877088|FG010|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
3150846|NCT01803074|3877089|FG011|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||8
3150847|NCT01803074|3877090|FG012|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||7
3150848|NCT01803074|3877091|FG013|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||4
3150849|NCT01803074|3877078|FG000|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
3150850|NCT01803074|3877079|FG001|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
3150851|NCT01803074|3877080|FG002|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
3150852|NCT01803074|3877081|FG003|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
3150853|NCT01803074|3877082|FG004|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
3150854|NCT01803074|3877083|FG005|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
3150855|NCT01803074|3877084|FG006|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
3150856|NCT01803074|3877085|FG007|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
3150857|NCT01803074|3877086|FG008|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
3150858|NCT01803074|3877087|FG009|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
3150859|NCT01803074|3877088|FG010|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
3150860|NCT01803074|3877089|FG011|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
3150861|NCT01803074|3877090|FG012|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
3150862|NCT01803074|3877091|FG013|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
3150863|NCT01803204|3877132|FG000|STARTED|Overall Study||20
3150864|NCT01803204|3877133|FG001|STARTED|Overall Study||20
3150865|NCT01803204|3877132|FG000|COMPLETED|Overall Study||20
3150866|NCT01803204|3877133|FG001|COMPLETED|Overall Study||20
3150867|NCT01803204|3877132|FG000|NOT COMPLETED|Overall Study||0
3150868|NCT01803204|3877133|FG001|NOT COMPLETED|Overall Study||0
3150869|NCT01803269|3877142|FG000|STARTED|Overall Study||7
3150870|NCT01803269|3877143|FG001|STARTED|Overall Study||8
3150871|NCT01803269|3877144|FG002|STARTED|Overall Study||14
3150872|NCT01803269|3877142|FG000|COMPLETED|Overall Study||4
3150873|NCT01803269|3877143|FG001|COMPLETED|Overall Study||8
3150874|NCT01803269|3877144|FG002|COMPLETED|Overall Study||14
3150875|NCT01803269|3877142|FG000|NOT COMPLETED|Overall Study||3
3150876|NCT01803269|3877143|FG001|NOT COMPLETED|Overall Study||0
3150877|NCT01803269|3877144|FG002|NOT COMPLETED|Overall Study||0
3150878|NCT01803282|3877164|FG000|STARTED|Overall Study||4
3150879|NCT01803282|3877165|FG001|STARTED|Overall Study||3
3150880|NCT01803282|3877166|FG002|STARTED|Overall Study||6
3150881|NCT01803282|3877167|FG003|STARTED|Overall Study||36
3150882|NCT01803282|3877168|FG004|STARTED|Overall Study||11
3150883|NCT01803282|3877169|FG005|STARTED|Overall Study||10
3150884|NCT01803282|3877170|FG006|STARTED|Overall Study||41
3150885|NCT01803282|3877171|FG007|STARTED|Overall Study||46
3150886|NCT01803282|3877172|FG008|STARTED|Overall Study||11
3150887|NCT01803282|3877173|FG009|STARTED|Overall Study||45
3150888|NCT01803282|3877174|FG010|STARTED|Overall Study||8
3150889|NCT01803282|3877175|FG011|STARTED|Overall Study||15
3150890|NCT01803282|3877164|FG000|COMPLETED|Overall Study||0
3150891|NCT01803282|3877165|FG001|COMPLETED|Overall Study||0
3150892|NCT01803282|3877166|FG002|COMPLETED|Overall Study||0
3150893|NCT01803282|3877167|FG003|COMPLETED|Overall Study||0
3150894|NCT01803282|3877168|FG004|COMPLETED|Overall Study||0
3150895|NCT01803282|3877169|FG005|COMPLETED|Overall Study||0
3150896|NCT01803282|3877170|FG006|COMPLETED|Overall Study||0
3150897|NCT01803282|3877171|FG007|COMPLETED|Overall Study||0
3150898|NCT01803282|3877172|FG008|COMPLETED|Overall Study||0
3150899|NCT01803282|3877173|FG009|COMPLETED|Overall Study||0
3150900|NCT01803282|3877174|FG010|COMPLETED|Overall Study||0
3150901|NCT01803282|3877175|FG011|COMPLETED|Overall Study||0
3150902|NCT01803282|3877164|FG000|NOT COMPLETED|Overall Study||4
3150903|NCT01803282|3877165|FG001|NOT COMPLETED|Overall Study||3
3150904|NCT01803282|3877166|FG002|NOT COMPLETED|Overall Study||6
3150905|NCT01803282|3877167|FG003|NOT COMPLETED|Overall Study||36
3150906|NCT01803282|3877168|FG004|NOT COMPLETED|Overall Study||11
3150907|NCT01803282|3877169|FG005|NOT COMPLETED|Overall Study||10
3150908|NCT01803282|3877170|FG006|NOT COMPLETED|Overall Study||41
3150909|NCT01803282|3877171|FG007|NOT COMPLETED|Overall Study||46
3150910|NCT01803282|3877172|FG008|NOT COMPLETED|Overall Study||11
3150911|NCT01803282|3877173|FG009|NOT COMPLETED|Overall Study||45
3150912|NCT01803282|3877174|FG010|NOT COMPLETED|Overall Study||8
3150913|NCT01803282|3877175|FG011|NOT COMPLETED|Overall Study||15
3150914|NCT01803464|3877205|FG000|STARTED|Overall Study||5
3150915|NCT01803464|3877206|FG001|STARTED|Overall Study||4
3150916|NCT01803464|3877207|FG002|STARTED|Overall Study||10
3150917|NCT01803464|3877208|FG003|STARTED|Overall Study||10
3150918|NCT01803464|3877205|FG000|COMPLETED|Overall Study||4
3150919|NCT01803464|3877206|FG001|COMPLETED|Overall Study||4
3150920|NCT01803464|3877207|FG002|COMPLETED|Overall Study||6
3150921|NCT01803464|3877208|FG003|COMPLETED|Overall Study||10
3150922|NCT01803464|3877205|FG000|NOT COMPLETED|Overall Study||1
3150923|NCT01803464|3877206|FG001|NOT COMPLETED|Overall Study||0
3150924|NCT01803464|3877207|FG002|NOT COMPLETED|Overall Study||4
3150925|NCT01803464|3877208|FG003|NOT COMPLETED|Overall Study||0
3150926|NCT01803607|3877224|FG000|STARTED|Overall Study||68
3150927|NCT01803607|3877225|FG001|STARTED|Overall Study||67
3150928|NCT01803607|3877224|FG000|COMPLETED|Overall Study||0
3150929|NCT01803607|3877225|FG001|COMPLETED|Overall Study||0
3150930|NCT01803607|3877224|FG000|NOT COMPLETED|Overall Study||68
3150931|NCT01803607|3877225|FG001|NOT COMPLETED|Overall Study||67
3150932|NCT01803646|3877233|FG000|STARTED|Overall Study||204
3150933|NCT01803646|3877234|FG001|STARTED|Overall Study||139
3150934|NCT01803646|3877233|FG000|COMPLETED|Overall Study||187
3150935|NCT01803646|3877234|FG001|COMPLETED|Overall Study||129
3150936|NCT01803646|3877233|FG000|NOT COMPLETED|Overall Study||17
3150937|NCT01803646|3877234|FG001|NOT COMPLETED|Overall Study||10
3150938|NCT01803737|3877242|FG000|STARTED|Overall Study||13
3150939|NCT01803737|3877243|FG001|STARTED|Overall Study||13
3150940|NCT01803737|3877242|FG000|COMPLETED|Overall Study||12
3150941|NCT01803737|3877243|FG001|COMPLETED|Overall Study||10
3150942|NCT01803737|3877242|FG000|NOT COMPLETED|Overall Study||1
3150943|NCT01803737|3877243|FG001|NOT COMPLETED|Overall Study||3
3150944|NCT01803880|3877252|FG000|STARTED|Overall Study||19
3150945|NCT01803880|3877253|FG001|STARTED|Overall Study||28
3150946|NCT01803880|3877254|FG002|STARTED|Overall Study||29
3150947|NCT01803880|3877252|FG000|COMPLETED|Overall Study||13
3150948|NCT01803880|3877253|FG001|COMPLETED|Overall Study||18
3150949|NCT01803880|3877254|FG002|COMPLETED|Overall Study||14
3150950|NCT01803880|3877252|FG000|NOT COMPLETED|Overall Study||6
3150951|NCT01803880|3877253|FG001|NOT COMPLETED|Overall Study||10
3150952|NCT01803880|3877254|FG002|NOT COMPLETED|Overall Study||15
3150953|NCT01804036|3877266|FG000|STARTED|Overall Study||31
3150954|NCT01804036|3877267|FG001|STARTED|Overall Study||41
3150955|NCT01804036|3877266|FG000|COMPLETED|Overall Study||18
3150956|NCT01804036|3877267|FG001|COMPLETED|Overall Study||21
3150957|NCT01804036|3877266|FG000|NOT COMPLETED|Overall Study||13
3150958|NCT01804036|3877267|FG001|NOT COMPLETED|Overall Study||20
3150959|NCT01804049|3877276|FG000|STARTED|Overall Study||43
3150960|NCT01804049|3877277|FG001|STARTED|Overall Study||77
3150961|NCT01804049|3877276|FG000|COMPLETED|Overall Study||32
3150962|NCT01804049|3877277|FG001|COMPLETED|Overall Study||45
3150963|NCT01804049|3877276|FG000|NOT COMPLETED|Overall Study||11
3150964|NCT01804049|3877277|FG001|NOT COMPLETED|Overall Study||32
3150965|NCT01804062|3877285|FG000|STARTED|Overall Study||30
3150966|NCT01804062|3877285|FG000|COMPLETED|Overall Study||30
3150967|NCT01804062|3877285|FG000|NOT COMPLETED|Overall Study||0
3150968|NCT01804075|3877291|FG000|STARTED|Overall Study||15
3150969|NCT01804075|3877292|FG001|STARTED|Overall Study||16
3150970|NCT01804075|3877291|FG000|COMPLETED|Overall Study||15
3150971|NCT01804075|3877292|FG001|COMPLETED|Overall Study||16
3150972|NCT01804075|3877291|FG000|NOT COMPLETED|Overall Study||0
3150973|NCT01804075|3877292|FG001|NOT COMPLETED|Overall Study||0
3182898|NCT02004886|3911130|FG000|COMPLETED|Overall Study||18
3182899|NCT02004886|3911131|FG001|COMPLETED|Overall Study||17
3182900|NCT02004886|3911132|FG002|COMPLETED|Overall Study||18
3182901|NCT02004886|3911133|FG003|COMPLETED|Overall Study||19
3182902|NCT02004886|3911130|FG000|NOT COMPLETED|Overall Study||1
3182903|NCT02004886|3911131|FG001|NOT COMPLETED|Overall Study||1
3182904|NCT02004886|3911132|FG002|NOT COMPLETED|Overall Study||0
3150974|NCT01804101|3877302|FG000|STARTED|Overall Study||38
3150975|NCT01804101|3877303|FG001|STARTED|Overall Study||10
3150976|NCT01804101|3877302|FG000|COMPLETED|Overall Study||38
3150977|NCT01804101|3877303|FG001|COMPLETED|Overall Study||10
3150978|NCT01804101|3877302|FG000|NOT COMPLETED|Overall Study||0
3150979|NCT01804101|3877303|FG001|NOT COMPLETED|Overall Study||0
3150980|NCT01804114|3877313|FG000|STARTED|Overall Study||17
3150981|NCT01804114|3877314|FG001|STARTED|Overall Study||12
3150982|NCT01804114|3877313|FG000|COMPLETED|Overall Study||17
3182905|NCT02004886|3911133|FG003|NOT COMPLETED|Overall Study||0
3150983|NCT01804114|3877314|FG001|COMPLETED|Overall Study||12
3150984|NCT01804114|3877313|FG000|NOT COMPLETED|Overall Study||0
3150985|NCT01804114|3877314|FG001|NOT COMPLETED|Overall Study||0
3150986|NCT01804140|3877320|FG000|STARTED|Overall Study|This includes all the participants who were enrolled for this study.|662
3150987|NCT01804140|3877320|FG000|COMPLETED|Overall Study|This includes all the participants with mutation results from the sampling or biopsy procedures.|548
3150988|NCT01804140|3877320|FG000|NOT COMPLETED|Overall Study||114
3150989|NCT01804257|3877324|FG000|STARTED|Overall Study||28
3150990|NCT01804257|3877324|FG000|COMPLETED|Overall Study||27
3150991|NCT01804257|3877324|FG000|NOT COMPLETED|Overall Study||1
3150992|NCT01804465|3877330|FG000|STARTED|Overall Study||24
3150993|NCT01804465|3877331|FG001|STARTED|Overall Study||26
3150994|NCT01804465|3877330|FG000|COMPLETED|Overall Study||24
3150995|NCT01804465|3877331|FG001|COMPLETED|Overall Study||26
3150996|NCT01804465|3877330|FG000|NOT COMPLETED|Overall Study||0
3150997|NCT01804465|3877331|FG001|NOT COMPLETED|Overall Study||0
3150998|NCT01804582|3877339|FG000|STARTED|Overall Study||177
3150999|NCT01804582|3877340|FG001|STARTED|Overall Study||173
3151000|NCT01804582|3877339|FG000|COMPLETED|Overall Study||128
3151001|NCT01804582|3877340|FG001|COMPLETED|Overall Study||117
3151002|NCT01804582|3877339|FG000|NOT COMPLETED|Overall Study||49
3151003|NCT01804582|3877340|FG001|NOT COMPLETED|Overall Study||56
3151004|NCT01804673|3877347|FG000|STARTED|Overall Study||174
3151005|NCT01804673|3877347|FG000|Completed Hour 24|Overall Study||170
3151006|NCT01804673|3877347|FG000|Completed Hour 48|Overall Study||79
3151007|NCT01804673|3877347|FG000|Completed Hour 72|Overall Study||36
3151008|NCT01804673|3877347|FG000|COMPLETED|Overall Study||34
3151009|NCT01804673|3877347|FG000|NOT COMPLETED|Overall Study||140
3151010|NCT01804842|3877354|FG000|STARTED|Overall Study||9
3151011|NCT01804842|3877355|FG001|STARTED|Overall Study||8
3151012|NCT01804842|3877356|FG002|STARTED|Overall Study||9
3151013|NCT01804842|3877354|FG000|Completed Treatment A|Overall Study||9
3151014|NCT01804842|3877355|FG001|Completed Treatment A|Overall Study||6
3151015|NCT01804842|3877356|FG002|Completed Treatment A|Overall Study||8
3151016|NCT01804842|3877354|FG000|Completed Treatment B|Overall Study||8
3151017|NCT01804842|3877355|FG001|Completed Treatment B|Overall Study||8
3151018|NCT01804842|3877356|FG002|Completed Treatment B|Overall Study||8
3151019|NCT01804842|3877354|FG000|Completed Treatment C|Overall Study||7
3151020|NCT01804842|3877355|FG001|Completed Treatment C|Overall Study||7
3151021|NCT01804842|3877356|FG002|Completed Treatment C|Overall Study||9
3151022|NCT01804842|3877354|FG000|COMPLETED|Overall Study||6
3151023|NCT01804842|3877355|FG001|COMPLETED|Overall Study||6
3151024|NCT01804842|3877356|FG002|COMPLETED|Overall Study||8
3151025|NCT01804842|3877354|FG000|NOT COMPLETED|Overall Study||3
3151026|NCT01804842|3877355|FG001|NOT COMPLETED|Overall Study||2
3151027|NCT01804842|3877356|FG002|NOT COMPLETED|Overall Study||1
3151028|NCT01804881|3877366|FG000|STARTED|Overall Study||16
3151029|NCT01804881|3877367|FG001|STARTED|Overall Study||14
3151030|NCT01804881|3877366|FG000|COMPLETED|Overall Study||11
3151031|NCT01804881|3877367|FG001|COMPLETED|Overall Study||10
3151032|NCT01804881|3877366|FG000|NOT COMPLETED|Overall Study||5
3151033|NCT01804881|3877367|FG001|NOT COMPLETED|Overall Study||4
3151034|NCT01804946|3877377|FG000|STARTED|Overall Study||81
3151035|NCT01804946|3877378|FG001|STARTED|Overall Study||80
3151036|NCT01804946|3877377|FG000|COMPLETED|Overall Study||79
3151037|NCT01804946|3877378|FG001|COMPLETED|Overall Study||76
3151038|NCT01804946|3877377|FG000|NOT COMPLETED|Overall Study||2
3151039|NCT01804946|3877378|FG001|NOT COMPLETED|Overall Study||4
3151040|NCT01805024|3877390|FG000|STARTED|Overall Study||4
3151041|NCT01805024|3877391|FG001|STARTED|Overall Study||4
3151042|NCT01805024|3877392|FG002|STARTED|Overall Study||4
3151043|NCT01805024|3877393|FG003|STARTED|Overall Study||8
3151044|NCT01805024|3877390|FG000|COMPLETED|Overall Study||4
3151045|NCT01805024|3877391|FG001|COMPLETED|Overall Study||4
3151046|NCT01805024|3877392|FG002|COMPLETED|Overall Study||4
3151047|NCT01805024|3877393|FG003|COMPLETED|Overall Study||8
3151048|NCT01805024|3877390|FG000|NOT COMPLETED|Overall Study||0
3151049|NCT01805024|3877391|FG001|NOT COMPLETED|Overall Study||0
3151050|NCT01805024|3877392|FG002|NOT COMPLETED|Overall Study||0
3151051|NCT01805024|3877393|FG003|NOT COMPLETED|Overall Study||0
3182906|NCT02004977|3911145|FG000|STARTED|Overall Study||463
3182907|NCT02004977|3911146|FG001|STARTED|Overall Study||441
3182908|NCT02004977|3911145|FG000|COMPLETED|Overall Study||409
3182909|NCT02004977|3911146|FG001|COMPLETED|Overall Study||436
3182910|NCT02004977|3911145|FG000|NOT COMPLETED|Overall Study||54
3182911|NCT02004977|3911146|FG001|NOT COMPLETED|Overall Study||5
3182912|NCT02004990|3911152|FG000|STARTED|Overall Study||12
3182913|NCT02004990|3911152|FG000|COMPLETED|Overall Study||12
3182914|NCT02004990|3911152|FG000|NOT COMPLETED|Overall Study||0
3182915|NCT02005016|3911156|FG000|STARTED|Overall Study||46
3182916|NCT02005016|3911156|FG000|COMPLETED|Overall Study||44
3182917|NCT02005016|3911156|FG000|NOT COMPLETED|Overall Study||2
3182918|NCT02005029|3911162|FG000|STARTED|First Intervention (1 Day)||5
3182919|NCT02005029|3911163|FG001|STARTED|First Intervention (1 Day)||5
3182920|NCT02005029|3911162|FG000|COMPLETED|First Intervention (1 Day)||4
3182921|NCT02005029|3911163|FG001|COMPLETED|First Intervention (1 Day)||5
3182922|NCT02005029|3911162|FG000|NOT COMPLETED|First Intervention (1 Day)||1
3182923|NCT02005029|3911163|FG001|NOT COMPLETED|First Intervention (1 Day)||0
3182924|NCT02005029|3911162|FG000|STARTED|Washout (2 Weeks)||4
3182925|NCT02005029|3911163|FG001|STARTED|Washout (2 Weeks)||5
3151052|NCT01805037|3877403|FG000|STARTED|Induction (4 Weeks)||0
3151053|NCT01805037|3877404|FG001|STARTED|Induction (4 Weeks)||20
3151054|NCT01805037|3877403|FG000|Received Dose of Study Drug|Induction (4 Weeks)||0
3151055|NCT01805037|3877404|FG001|Received Dose of Study Drug|Induction (4 Weeks)||20
3151056|NCT01805037|3877403|FG000|COMPLETED|Induction (4 Weeks)||0
3151057|NCT01805037|3877404|FG001|COMPLETED|Induction (4 Weeks)||20
3151058|NCT01805037|3877403|FG000|NOT COMPLETED|Induction (4 Weeks)||0
3151059|NCT01805037|3877404|FG001|NOT COMPLETED|Induction (4 Weeks)||0
3151060|NCT01805037|3877403|FG000|STARTED|Consolidation (Optional, 4 Weeks)||0
3151061|NCT01805037|3877404|FG001|STARTED|Consolidation (Optional, 4 Weeks)|Consolidation is optional for patients who have a partial or complete response during induction.|6
3151062|NCT01805037|3877403|FG000|Received Dose of Study Drug|Consolidation (Optional, 4 Weeks)||0
3151063|NCT01805037|3877404|FG001|Received Dose of Study Drug|Consolidation (Optional, 4 Weeks)||6
3151064|NCT01805037|3877403|FG000|COMPLETED|Consolidation (Optional, 4 Weeks)||0
3151065|NCT01805037|3877404|FG001|COMPLETED|Consolidation (Optional, 4 Weeks)||6
3151066|NCT01805037|3877403|FG000|NOT COMPLETED|Consolidation (Optional, 4 Weeks)||0
3151067|NCT01805037|3877404|FG001|NOT COMPLETED|Consolidation (Optional, 4 Weeks)||0
3151068|NCT01805037|3877403|FG000|STARTED|1st Cycle of Maintenance (3 Weeks)||0
3151069|NCT01805037|3877404|FG001|STARTED|1st Cycle of Maintenance (3 Weeks)|Consolidation is optional for patients who have a partial or complete response during induction|20
3151070|NCT01805037|3877403|FG000|Received Dose of Study Drug|1st Cycle of Maintenance (3 Weeks)||0
3151071|NCT01805037|3877404|FG001|Received Dose of Study Drug|1st Cycle of Maintenance (3 Weeks)||14
3151072|NCT01805037|3877403|FG000|COMPLETED|1st Cycle of Maintenance (3 Weeks)||0
3151073|NCT01805037|3877404|FG001|COMPLETED|1st Cycle of Maintenance (3 Weeks)||14
3151074|NCT01805037|3877403|FG000|NOT COMPLETED|1st Cycle of Maintenance (3 Weeks)||0
3151075|NCT01805037|3877404|FG001|NOT COMPLETED|1st Cycle of Maintenance (3 Weeks)||6
3151076|NCT01805037|3877403|FG000|STARTED|2nd Cycle of Maintenance and Beyond||0
3151077|NCT01805037|3877404|FG001|STARTED|2nd Cycle of Maintenance and Beyond||14
3151078|NCT01805037|3877403|FG000|Received Dose of Study Drug|2nd Cycle of Maintenance and Beyond||0
3151079|NCT01805037|3877404|FG001|Received Dose of Study Drug|2nd Cycle of Maintenance and Beyond||14
3151080|NCT01805037|3877403|FG000|COMPLETED|2nd Cycle of Maintenance and Beyond||0
3151081|NCT01805037|3877404|FG001|COMPLETED|2nd Cycle of Maintenance and Beyond||2
3151082|NCT01805037|3877403|FG000|NOT COMPLETED|2nd Cycle of Maintenance and Beyond||0
3151083|NCT01805037|3877404|FG001|NOT COMPLETED|2nd Cycle of Maintenance and Beyond||12
3151084|NCT01805037|3877403|FG000|STARTED|Follow Up (up to 3 Years)||0
3151085|NCT01805037|3877404|FG001|STARTED|Follow Up (up to 3 Years)|Patients who received at least one dose of study treatment go into follow-up.|20
3151086|NCT01805037|3877403|FG000|COMPLETED|Follow Up (up to 3 Years)||0
3151087|NCT01805037|3877404|FG001|COMPLETED|Follow Up (up to 3 Years)||14
3151088|NCT01805037|3877403|FG000|NOT COMPLETED|Follow Up (up to 3 Years)||0
3151089|NCT01805037|3877404|FG001|NOT COMPLETED|Follow Up (up to 3 Years)||6
3151090|NCT01805089|3877410|FG000|STARTED|Overall Study||48
3151091|NCT01805089|3877411|FG001|STARTED|Overall Study||47
3151092|NCT01805089|3877410|FG000|COMPLETED|Overall Study||43
3151093|NCT01805089|3877411|FG001|COMPLETED|Overall Study||43
3151094|NCT01805089|3877410|FG000|NOT COMPLETED|Overall Study||5
3151095|NCT01805089|3877411|FG001|NOT COMPLETED|Overall Study||4
3151096|NCT01805154|3877417|FG000|STARTED|Overall Study||1529
3151097|NCT01805154|3877417|FG000|COMPLETED|Overall Study||1175
3151098|NCT01805154|3877417|FG000|NOT COMPLETED|Overall Study||354
3151099|NCT01805180|3877426|FG000|STARTED|Lead-in Donor Phase||7
3151100|NCT01805180|3877427|FG001|STARTED|Lead-in Donor Phase|pivotal trial subjects were not screened or enrolled in this period.|0
3151101|NCT01805180|3877428|FG002|STARTED|Lead-in Donor Phase|pivotal trial subjects were not screened or enrolled in this period.|0
3151102|NCT01805180|3877426|FG000|COMPLETED|Lead-in Donor Phase||6
3151103|NCT01805180|3877427|FG001|COMPLETED|Lead-in Donor Phase||0
3151104|NCT01805180|3877428|FG002|COMPLETED|Lead-in Donor Phase||0
3151105|NCT01805180|3877426|FG000|NOT COMPLETED|Lead-in Donor Phase||1
3151106|NCT01805180|3877427|FG001|NOT COMPLETED|Lead-in Donor Phase||0
3151107|NCT01805180|3877428|FG002|NOT COMPLETED|Lead-in Donor Phase||0
3151108|NCT01805180|3877426|FG000|STARTED|Pivotal Randomization Through Study Exit|lead-in donors were not randomized and did not participate in this period.|0
3151109|NCT01805180|3877427|FG001|STARTED|Pivotal Randomization Through Study Exit||22
3151110|NCT01805180|3877428|FG002|STARTED|Pivotal Randomization Through Study Exit||20
3151111|NCT01805180|3877426|FG000|COMPLETED|Pivotal Randomization Through Study Exit||0
3151112|NCT01805180|3877427|FG001|COMPLETED|Pivotal Randomization Through Study Exit||17
3151113|NCT01805180|3877428|FG002|COMPLETED|Pivotal Randomization Through Study Exit||15
3151114|NCT01805180|3877426|FG000|NOT COMPLETED|Pivotal Randomization Through Study Exit||0
3151115|NCT01805180|3877427|FG001|NOT COMPLETED|Pivotal Randomization Through Study Exit||5
3151116|NCT01805180|3877428|FG002|NOT COMPLETED|Pivotal Randomization Through Study Exit||5
3151117|NCT01805297|3877438|FG000|STARTED|Overall Study||6
3151118|NCT01805297|3877439|FG001|STARTED|Overall Study||6
3151119|NCT01805297|3877438|FG000|COMPLETED|Overall Study||4
3151120|NCT01805297|3877439|FG001|COMPLETED|Overall Study||3
3151121|NCT01805297|3877438|FG000|NOT COMPLETED|Overall Study||2
3151122|NCT01805297|3877439|FG001|NOT COMPLETED|Overall Study||3
3151123|NCT01805323|3877446|FG000|STARTED|Overall Study||101
3151124|NCT01805323|3877446|FG000|COMPLETED|Overall Study||101
3151125|NCT01805323|3877446|FG000|NOT COMPLETED|Overall Study||0
3151126|NCT01805440|3877453|FG000|STARTED|Overall Study||19
3151127|NCT01805440|3877454|FG001|STARTED|Overall Study||17
3151128|NCT01805440|3877455|FG002|STARTED|Overall Study||26
3151129|NCT01805440|3877453|FG000|COMPLETED|Overall Study||18
3151130|NCT01805440|3877454|FG001|COMPLETED|Overall Study||17
3151131|NCT01805440|3877455|FG002|COMPLETED|Overall Study||26
3151132|NCT01805440|3877453|FG000|NOT COMPLETED|Overall Study||1
3151133|NCT01805440|3877454|FG001|NOT COMPLETED|Overall Study||0
3151134|NCT01805440|3877455|FG002|NOT COMPLETED|Overall Study||0
3151135|NCT01805687|3877462|FG000|STARTED|Overall Study||25
3151136|NCT01805687|3877462|FG000|COMPLETED|Overall Study||25
3151137|NCT01805687|3877462|FG000|NOT COMPLETED|Overall Study||0
3151138|NCT01805791|3877469|FG000|STARTED|Overall Study||66
3151139|NCT01805791|3877470|FG001|STARTED|Overall Study||67
3151140|NCT01805791|3877471|FG002|STARTED|Overall Study||68
3151141|NCT01805791|3877469|FG000|COMPLETED|Overall Study||44
3151142|NCT01805791|3877470|FG001|COMPLETED|Overall Study||50
3151143|NCT01805791|3877471|FG002|COMPLETED|Overall Study||48
3151144|NCT01805791|3877469|FG000|NOT COMPLETED|Overall Study||22
3151145|NCT01805791|3877470|FG001|NOT COMPLETED|Overall Study||17
3151146|NCT01805791|3877471|FG002|NOT COMPLETED|Overall Study||20
3151147|NCT01805882|3877488|FG000|STARTED|Overall Study||20
3151148|NCT01805882|3877489|FG001|STARTED|Overall Study||20
3151149|NCT01805882|3877490|FG002|STARTED|Overall Study||20
3151150|NCT01805882|3877491|FG003|STARTED|Overall Study||34
3151151|NCT01805882|3877492|FG004|STARTED|Overall Study||14
3151152|NCT01805882|3877493|FG005|STARTED|Overall Study||21
3151153|NCT01805882|3877494|FG006|STARTED|Overall Study||50
3151154|NCT01805882|3877495|FG007|STARTED|Overall Study||25
3151155|NCT01805882|3877496|FG008|STARTED|Overall Study||25
3151156|NCT01805882|3877488|FG000|COMPLETED|Overall Study||20
3151157|NCT01805882|3877489|FG001|COMPLETED|Overall Study||20
3151158|NCT01805882|3877490|FG002|COMPLETED|Overall Study||19
3151159|NCT01805882|3877491|FG003|COMPLETED|Overall Study||32
3151160|NCT01805882|3877492|FG004|COMPLETED|Overall Study||14
3151161|NCT01805882|3877493|FG005|COMPLETED|Overall Study||20
3151162|NCT01805882|3877494|FG006|COMPLETED|Overall Study||48
3151163|NCT01805882|3877495|FG007|COMPLETED|Overall Study||25
3151164|NCT01805882|3877496|FG008|COMPLETED|Overall Study||24
3151165|NCT01805882|3877488|FG000|NOT COMPLETED|Overall Study||0
3151166|NCT01805882|3877489|FG001|NOT COMPLETED|Overall Study||0
3151167|NCT01805882|3877490|FG002|NOT COMPLETED|Overall Study||1
3151168|NCT01805882|3877491|FG003|NOT COMPLETED|Overall Study||2
3151169|NCT01805882|3877492|FG004|NOT COMPLETED|Overall Study||0
3151170|NCT01805882|3877493|FG005|NOT COMPLETED|Overall Study||1
3151171|NCT01805882|3877494|FG006|NOT COMPLETED|Overall Study||2
3151172|NCT01805882|3877495|FG007|NOT COMPLETED|Overall Study||0
3151173|NCT01805882|3877496|FG008|NOT COMPLETED|Overall Study||1
3151174|NCT01805895|3877518|FG000|STARTED|Overall Study||8
3151175|NCT01805895|3877519|FG001|STARTED|Overall Study||8
3151176|NCT01805895|3877518|FG000|COMPLETED|Overall Study||8
3151177|NCT01805895|3877519|FG001|COMPLETED|Overall Study||8
3151178|NCT01805895|3877518|FG000|NOT COMPLETED|Overall Study||0
3151179|NCT01805895|3877519|FG001|NOT COMPLETED|Overall Study||0
3151180|NCT01806064|3877530|FG000|STARTED|Overall Study||3
3151181|NCT01806064|3877531|FG001|STARTED|Overall Study||15
3151182|NCT01806064|3877532|FG002|STARTED|Overall Study||5
3151183|NCT01806064|3877533|FG003|STARTED|Overall Study||75
3151184|NCT01806064|3877534|FG004|STARTED|Overall Study||75
3151185|NCT01806064|3877530|FG000|COMPLETED|Overall Study||3
3151186|NCT01806064|3877531|FG001|COMPLETED|Overall Study||15
3151187|NCT01806064|3877532|FG002|COMPLETED|Overall Study||5
3151188|NCT01806064|3877533|FG003|COMPLETED|Overall Study||74
3151189|NCT01806064|3877534|FG004|COMPLETED|Overall Study||73
3151190|NCT01806064|3877530|FG000|NOT COMPLETED|Overall Study||0
3151191|NCT01806064|3877531|FG001|NOT COMPLETED|Overall Study||0
3151192|NCT01806064|3877532|FG002|NOT COMPLETED|Overall Study||0
3151193|NCT01806064|3877533|FG003|NOT COMPLETED|Overall Study||1
3151194|NCT01806064|3877534|FG004|NOT COMPLETED|Overall Study||2
3151195|NCT01806168|3877553|FG000|STARTED|Overall Study||11
3151196|NCT01806168|3877554|FG001|STARTED|Overall Study||10
3151197|NCT01806168|3877555|FG002|STARTED|Overall Study||10
3151198|NCT01806168|3877553|FG000|Received Allocated Intervention|Overall Study||11
3151199|NCT01806168|3877554|FG001|Received Allocated Intervention|Overall Study||9
3151200|NCT01806168|3877555|FG002|Received Allocated Intervention|Overall Study||9
3151201|NCT01806168|3877553|FG000|COMPLETED|Overall Study||10
3151202|NCT01806168|3877554|FG001|COMPLETED|Overall Study||9
3151203|NCT01806168|3877555|FG002|COMPLETED|Overall Study||7
3151204|NCT01806168|3877553|FG000|NOT COMPLETED|Overall Study||1
3151205|NCT01806168|3877554|FG001|NOT COMPLETED|Overall Study||1
3151206|NCT01806168|3877555|FG002|NOT COMPLETED|Overall Study||3
3151207|NCT01806259|3877568|FG000|STARTED|Overall Study||96
3151208|NCT01806259|3877569|FG001|STARTED|Overall Study||107
3151209|NCT01806259|3877568|FG000|COMPLETED|Overall Study||96
3151210|NCT01806259|3877569|FG001|COMPLETED|Overall Study||107
3151211|NCT01806259|3877568|FG000|NOT COMPLETED|Overall Study||0
3151212|NCT01806259|3877569|FG001|NOT COMPLETED|Overall Study||0
3151213|NCT01806298|3877576|FG000|STARTED|Overall Study||78
3151214|NCT01806298|3877576|FG000|COMPLETED|Overall Study||68
3151215|NCT01806298|3877576|FG000|NOT COMPLETED|Overall Study||10
3151216|NCT01806389|3877580|FG000|STARTED|Overall Study||14
3151217|NCT01806389|3877580|FG000|COMPLETED|Overall Study||10
3151218|NCT01806389|3877580|FG000|NOT COMPLETED|Overall Study||4
3151219|NCT01806506|3877596|FG000|STARTED|Overall Study||36
3151220|NCT01806506|3877597|FG001|STARTED|Overall Study||36
3151221|NCT01806506|3877596|FG000|1 Month|Overall Study||36
3151222|NCT01806506|3877597|FG001|1 Month|Overall Study||36
3151223|NCT01806506|3877596|FG000|3 Months|Overall Study|1 patient (reason - lost contact)|35
3151224|NCT01806506|3877597|FG001|3 Months|Overall Study||36
3151225|NCT01806506|3877596|FG000|6 Months|Overall Study|1 patient (reason - lost contact)|34
3151226|NCT01806506|3877597|FG001|6 Months|Overall Study||36
3151227|NCT01806506|3877596|FG000|9 Months|Overall Study||34
3151228|NCT01806506|3877597|FG001|9 Months|Overall Study|1 patient (reason - lost contact)|35
3151229|NCT01806506|3877596|FG000|COMPLETED|Overall Study||34
3151230|NCT01806506|3877597|FG001|COMPLETED|Overall Study||35
3151231|NCT01806506|3877596|FG000|NOT COMPLETED|Overall Study||2
3151232|NCT01806506|3877597|FG001|NOT COMPLETED|Overall Study||1
3151233|NCT01806545|3877605|FG000|STARTED|Overall Study||29
3151234|NCT01806545|3877606|FG001|STARTED|Overall Study||35
3151235|NCT01806545|3877605|FG000|COMPLETED|Overall Study||23
3151236|NCT01806545|3877606|FG001|COMPLETED|Overall Study||30
3151237|NCT01806545|3877605|FG000|NOT COMPLETED|Overall Study||6
3151238|NCT01806545|3877606|FG001|NOT COMPLETED|Overall Study||5
3151239|NCT01806571|3877612|FG000|STARTED|Overall Study||34
3151240|NCT01806571|3877612|FG000|COMPLETED|Overall Study||34
3151241|NCT01806571|3877612|FG000|NOT COMPLETED|Overall Study||0
3151242|NCT01806584|3877618|FG000|STARTED|Overall Study||14
3151243|NCT01806584|3877619|FG001|STARTED|Overall Study||18
3151244|NCT01806584|3877618|FG000|COMPLETED|Overall Study||0
3151245|NCT01806584|3877619|FG001|COMPLETED|Overall Study||0
3151246|NCT01806584|3877618|FG000|NOT COMPLETED|Overall Study||14
3151247|NCT01806584|3877619|FG001|NOT COMPLETED|Overall Study||18
3151248|NCT01806597|3877628|FG000|STARTED|Period 1 (Baseline to Week 16)||68
3151249|NCT01806597|3877629|FG001|STARTED|Period 1 (Baseline to Week 16)||69
3151250|NCT01806597|3877630|FG002|STARTED|Period 1 (Baseline to Week 16)||0
3151251|NCT01806597|3877631|FG003|STARTED|Period 1 (Baseline to Week 16)||0
3151252|NCT01806597|3877632|FG004|STARTED|Period 1 (Baseline to Week 16)||68
3151253|NCT01806597|3877633|FG005|STARTED|Period 1 (Baseline to Week 16)||0
3151254|NCT01806597|3877628|FG000|COMPLETED|Period 1 (Baseline to Week 16)||63
3151255|NCT01806597|3877629|FG001|COMPLETED|Period 1 (Baseline to Week 16)||64
3151256|NCT01806597|3877630|FG002|COMPLETED|Period 1 (Baseline to Week 16)||0
3151257|NCT01806597|3877631|FG003|COMPLETED|Period 1 (Baseline to Week 16)||0
3151258|NCT01806597|3877632|FG004|COMPLETED|Period 1 (Baseline to Week 16)||63
3151259|NCT01806597|3877633|FG005|COMPLETED|Period 1 (Baseline to Week 16)||0
3151260|NCT01806597|3877628|FG000|NOT COMPLETED|Period 1 (Baseline to Week 16)||5
3151261|NCT01806597|3877629|FG001|NOT COMPLETED|Period 1 (Baseline to Week 16)||5
3151262|NCT01806597|3877630|FG002|NOT COMPLETED|Period 1 (Baseline to Week 16)||0
3151263|NCT01806597|3877631|FG003|NOT COMPLETED|Period 1 (Baseline to Week 16)||0
3151264|NCT01806597|3877632|FG004|NOT COMPLETED|Period 1 (Baseline to Week 16)||5
3151265|NCT01806597|3877633|FG005|NOT COMPLETED|Period 1 (Baseline to Week 16)||0
3151266|NCT01806597|3877628|FG000|STARTED|Treatment Period 2 (Week 16 to Week 132)||63
3151267|NCT01806597|3877629|FG001|STARTED|Treatment Period 2 (Week 16 to Week 132)||64
3151268|NCT01806597|3877630|FG002|STARTED|Treatment Period 2 (Week 16 to Week 132)||31
3151269|NCT01806597|3877631|FG003|STARTED|Treatment Period 2 (Week 16 to Week 132)||31
3151270|NCT01806597|3877632|FG004|STARTED|Treatment Period 2 (Week 16 to Week 132)||1
3151271|NCT01806597|3877633|FG005|STARTED|Treatment Period 2 (Week 16 to Week 132)||0
3151272|NCT01806597|3877628|FG000|COMPLETED|Treatment Period 2 (Week 16 to Week 132)||24
3151273|NCT01806597|3877629|FG001|COMPLETED|Treatment Period 2 (Week 16 to Week 132)||44
3151274|NCT01806597|3877630|FG002|COMPLETED|Treatment Period 2 (Week 16 to Week 132)||17
3151275|NCT01806597|3877631|FG003|COMPLETED|Treatment Period 2 (Week 16 to Week 132)||20
3151276|NCT01806597|3877632|FG004|COMPLETED|Treatment Period 2 (Week 16 to Week 132)||0
3151277|NCT01806597|3877633|FG005|COMPLETED|Treatment Period 2 (Week 16 to Week 132)||0
3151278|NCT01806597|3877628|FG000|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 132)||39
3151279|NCT01806597|3877629|FG001|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 132)||20
3151280|NCT01806597|3877630|FG002|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 132)||14
3151281|NCT01806597|3877631|FG003|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 132)||11
3151282|NCT01806597|3877632|FG004|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 132)||1
3151283|NCT01806597|3877633|FG005|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 132)||0
3151284|NCT01806597|3877628|FG000|STARTED|Follow-up Period (Week 132 to Week 140)||0
3151285|NCT01806597|3877629|FG001|STARTED|Follow-up Period (Week 132 to Week 140)||0
3151286|NCT01806597|3877630|FG002|STARTED|Follow-up Period (Week 132 to Week 140)||0
3151287|NCT01806597|3877631|FG003|STARTED|Follow-up Period (Week 132 to Week 140)||0
3151288|NCT01806597|3877632|FG004|STARTED|Follow-up Period (Week 132 to Week 140)||3
3151289|NCT01806597|3877633|FG005|STARTED|Follow-up Period (Week 132 to Week 140)||161
3151290|NCT01806597|3877628|FG000|COMPLETED|Follow-up Period (Week 132 to Week 140)||0
3151291|NCT01806597|3877629|FG001|COMPLETED|Follow-up Period (Week 132 to Week 140)||0
3151292|NCT01806597|3877630|FG002|COMPLETED|Follow-up Period (Week 132 to Week 140)||0
3151293|NCT01806597|3877631|FG003|COMPLETED|Follow-up Period (Week 132 to Week 140)||0
3151294|NCT01806597|3877632|FG004|COMPLETED|Follow-up Period (Week 132 to Week 140)||3
3151295|NCT01806597|3877633|FG005|COMPLETED|Follow-up Period (Week 132 to Week 140)||149
3151296|NCT01806597|3877628|FG000|NOT COMPLETED|Follow-up Period (Week 132 to Week 140)||0
3151297|NCT01806597|3877629|FG001|NOT COMPLETED|Follow-up Period (Week 132 to Week 140)||0
3151298|NCT01806597|3877630|FG002|NOT COMPLETED|Follow-up Period (Week 132 to Week 140)||0
3151299|NCT01806597|3877631|FG003|NOT COMPLETED|Follow-up Period (Week 132 to Week 140)||0
3151300|NCT01806597|3877632|FG004|NOT COMPLETED|Follow-up Period (Week 132 to Week 140)||0
3151301|NCT01806597|3877633|FG005|NOT COMPLETED|Follow-up Period (Week 132 to Week 140)||12
3151302|NCT01806623|3877647|FG000|STARTED|Overall Study||157
3151303|NCT01806623|3877647|FG000|COMPLETED|Overall Study||99
3151304|NCT01806623|3877647|FG000|NOT COMPLETED|Overall Study||58
3151305|NCT01806662|3877651|FG000|STARTED|First Intervention (Weeks 0-16)||16
3151306|NCT01806662|3877652|FG001|STARTED|First Intervention (Weeks 0-16)||16
3151307|NCT01806662|3877651|FG000|Received Intervention|First Intervention (Weeks 0-16)||12
3151308|NCT01806662|3877652|FG001|Received Intervention|First Intervention (Weeks 0-16)||15
3151309|NCT01806662|3877651|FG000|COMPLETED|First Intervention (Weeks 0-16)||12
3151310|NCT01806662|3877652|FG001|COMPLETED|First Intervention (Weeks 0-16)||15
3151311|NCT01806662|3877651|FG000|NOT COMPLETED|First Intervention (Weeks 0-16)||4
3151312|NCT01806662|3877652|FG001|NOT COMPLETED|First Intervention (Weeks 0-16)||1
3151313|NCT01806662|3877651|FG000|STARTED|Second Intervention (Weeks 16-32)||12
3151314|NCT01806662|3877652|FG001|STARTED|Second Intervention (Weeks 16-32)||15
3151315|NCT01806662|3877651|FG000|COMPLETED|Second Intervention (Weeks 16-32)||10
3151316|NCT01806662|3877652|FG001|COMPLETED|Second Intervention (Weeks 16-32)||11
3151317|NCT01806662|3877651|FG000|NOT COMPLETED|Second Intervention (Weeks 16-32)||2
3151318|NCT01806662|3877652|FG001|NOT COMPLETED|Second Intervention (Weeks 16-32)||4
3151319|NCT01806675|3877661|FG000|STARTED|Overall Study||11
3151320|NCT01806675|3877662|FG001|STARTED|Overall Study||6
3151321|NCT01806675|3877663|FG002|STARTED|Overall Study||8
3151322|NCT01806675|3877661|FG000|COMPLETED|Overall Study||11
3151323|NCT01806675|3877662|FG001|COMPLETED|Overall Study||6
3151324|NCT01806675|3877663|FG002|COMPLETED|Overall Study||8
3151325|NCT01806675|3877661|FG000|NOT COMPLETED|Overall Study||0
3151326|NCT01806675|3877662|FG001|NOT COMPLETED|Overall Study||0
3151327|NCT01806675|3877663|FG002|NOT COMPLETED|Overall Study||0
3151328|NCT01806688|3877673|FG000|STARTED|First Intervention Seed Study|"Participants received one of the following:~experimental snack #1 gluten-free high protein snack a 30 g serving of buckwheat groats~placebo comparator reference product, a gluten-free snack with similar energy density but 1/2 the protein as the experimental snack, a 32g serving of corn nuts~placebo comparator non-caloric control water"|38
3151329|NCT01806688|3877674|FG001|STARTED|First Intervention Seed Study|"Participants received one of the following:~experimental snack #1 gluten-free high protein snack a 30 g serving of buckwheat groats~placebo comparator reference product, a gluten-free snack with similar energy density but 1/2 the protein as the experimental snack, a 32g serving of corn nuts~placebo comparator non-caloric control water"|0
3151330|NCT01806688|3877673|FG000|Experimental Snack #1|First Intervention Seed Study|Received experimental snack #1 at the first visit, a 30g serving of buckwheat groats|13
3151331|NCT01806688|3877674|FG001|Experimental Snack #1|First Intervention Seed Study|Received experimental snack #1 at the first visit, a 30g serving of buckwheat groats|0
3151332|NCT01806688|3877673|FG000|Placebo Comparator Reference Product #1|First Intervention Seed Study|Received the placebo comparator reference product #1 at the first visit, a 32g serving of corn nuts|13
3151333|NCT01806688|3877674|FG001|Placebo Comparator Reference Product #1|First Intervention Seed Study|Received the placebo comparator reference product #1 at the first visit, a 32g serving of corn nuts|0
3151334|NCT01806688|3877673|FG000|Placebo Comparator Non-caloric Control #1|First Intervention Seed Study|Received water, the placebo comparator non-caloric control #1 at the first visit|12
3151335|NCT01806688|3877674|FG001|Placebo Comparator Non-caloric Control #1|First Intervention Seed Study|Received water, the placebo comparator non-caloric control #1 at the first visit|0
3151336|NCT01806688|3877673|FG000|COMPLETED|First Intervention Seed Study||38
3151337|NCT01806688|3877674|FG001|COMPLETED|First Intervention Seed Study||0
3151338|NCT01806688|3877673|FG000|NOT COMPLETED|First Intervention Seed Study||0
3151339|NCT01806688|3877674|FG001|NOT COMPLETED|First Intervention Seed Study||0
3182926|NCT02005029|3911162|FG000|COMPLETED|Washout (2 Weeks)||4
3182927|NCT02005029|3911163|FG001|COMPLETED|Washout (2 Weeks)||5
3182928|NCT02005029|3911162|FG000|NOT COMPLETED|Washout (2 Weeks)||0
3182929|NCT02005029|3911163|FG001|NOT COMPLETED|Washout (2 Weeks)||0
3182930|NCT02005029|3911162|FG000|STARTED|Second Intervention (1 Day)||4
3182931|NCT02005029|3911163|FG001|STARTED|Second Intervention (1 Day)||5
3182932|NCT02005029|3911162|FG000|COMPLETED|Second Intervention (1 Day)||4
3182933|NCT02005029|3911163|FG001|COMPLETED|Second Intervention (1 Day)||5
3182934|NCT02005029|3911162|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
3182935|NCT02005029|3911163|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
3182936|NCT02005211|3911194|FG000|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||6
3182937|NCT02005211|3911195|FG001|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||6
3182938|NCT02005211|3911196|FG002|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||6
3182939|NCT02005211|3911197|FG003|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||6
3182940|NCT02005211|3911198|FG004|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||0
3182941|NCT02005211|3911199|FG005|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||0
3182942|NCT02005211|3911200|FG006|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||0
3182943|NCT02005211|3911194|FG000|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||6
3182944|NCT02005211|3911195|FG001|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||6
3182945|NCT02005211|3911196|FG002|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||6
3182946|NCT02005211|3911197|FG003|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||6
3182947|NCT02005211|3911198|FG004|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
3182948|NCT02005211|3911199|FG005|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
3182949|NCT02005211|3911200|FG006|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
3182950|NCT02005211|3911194|FG000|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
3182951|NCT02005211|3911195|FG001|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
3151340|NCT01806688|3877673|FG000|STARTED|Second Intervention Seed Study|"Participants received one of the following they hadn't previously received at visit 1:~experimental snack #1 gluten-free high protein snack a 30 g serving of buckwheat groats~placebo comparator reference product #1, a gluten-free snack with similar energy density but 1/2 the protein as the experimental snack, a 32g serving of corn nuts~placebo comparator non-caloric control #1, water"|38
3151341|NCT01806688|3877674|FG001|STARTED|Second Intervention Seed Study|"Participants received one of the following they hadn't previously received at visit 1:~experimental snack #1 gluten-free high protein snack a 30 g serving of buckwheat groats~placebo comparator reference product #1, a gluten-free snack with similar energy density but 1/2 the protein as the experimental snack, a 32g serving of corn nuts~placebo comparator non-caloric control #1, water"|0
3151342|NCT01806688|3877673|FG000|Experimental Snack #1|Second Intervention Seed Study|Received the experimental snack #1, a 30g serving of buckwheat groats at visit 2|13
3151343|NCT01806688|3877674|FG001|Experimental Snack #1|Second Intervention Seed Study|Received the experimental snack #1, a 30g serving of buckwheat groats at visit 2|0
3151344|NCT01806688|3877673|FG000|Placebo Comparator Reference Product #1|Second Intervention Seed Study|Received the Placebo comparator reference product #1, a 32g serving of corn nuts at visit 2|13
3151345|NCT01806688|3877674|FG001|Placebo Comparator Reference Product #1|Second Intervention Seed Study|Received the Placebo comparator reference product #1, a 32g serving of corn nuts at visit 2|0
3151346|NCT01806688|3877673|FG000|Placebo Comparator Non-caloric Control #1|Second Intervention Seed Study|Received water, the placebo comparator non-caloric control #1 at visit 2|12
3151347|NCT01806688|3877674|FG001|Placebo Comparator Non-caloric Control #1|Second Intervention Seed Study|Received water, the placebo comparator non-caloric control #1 at visit 2|0
3151348|NCT01806688|3877673|FG000|COMPLETED|Second Intervention Seed Study||38
3151349|NCT01806688|3877674|FG001|COMPLETED|Second Intervention Seed Study||0
3151350|NCT01806688|3877673|FG000|NOT COMPLETED|Second Intervention Seed Study||0
3151351|NCT01806688|3877674|FG001|NOT COMPLETED|Second Intervention Seed Study||0
3151352|NCT01806688|3877673|FG000|STARTED|Third Intervention Seed Study|"Participants received one of the following they hadn't previously received at visit 1 or visit 2:~experimental snack #1 gluten-free high protein snack a 30 g serving of buckwheat groats~placebo comparator reference product, a gluten-free snack with similar energy density but 1/2 the protein as the experimental snack, a 32g serving of corn nuts~placebo comparator non-caloric control water"|38
3151353|NCT01806688|3877674|FG001|STARTED|Third Intervention Seed Study|"Participants received one of the following they hadn't previously received at visit 1 or visit 2:~experimental snack #1 gluten-free high protein snack a 30 g serving of buckwheat groats~placebo comparator reference product, a gluten-free snack with similar energy density but 1/2 the protein as the experimental snack, a 32g serving of corn nuts~placebo comparator non-caloric control water"|0
3151354|NCT01806688|3877673|FG000|Experimental Snack #1|Third Intervention Seed Study|Received the Experimental snack #1, a 30g serving of buckwheat groats at visit 3|12
3151355|NCT01806688|3877674|FG001|Experimental Snack #1|Third Intervention Seed Study|Received the Experimental snack #1, a 30g serving of buckwheat groats at visit 3|0
3151356|NCT01806688|3877673|FG000|Placebo Comparator Reference Product #1|Third Intervention Seed Study|Received the placebo comparator reference product #1, a 32g serving of corn nuts at visit 3|12
3151357|NCT01806688|3877674|FG001|Placebo Comparator Reference Product #1|Third Intervention Seed Study|Received the placebo comparator reference product #1, a 32g serving of corn nuts at visit 3|0
3151358|NCT01806688|3877673|FG000|Placebo Comparator Non-caloric Control #1|Third Intervention Seed Study|Received water, the placebo comparator non-caloric control #1 at visit 3|14
3151359|NCT01806688|3877674|FG001|Placebo Comparator Non-caloric Control #1|Third Intervention Seed Study|Received water, the placebo comparator non-caloric control #1 at visit 3|0
3151360|NCT01806688|3877673|FG000|COMPLETED|Third Intervention Seed Study||38
3151361|NCT01806688|3877674|FG001|COMPLETED|Third Intervention Seed Study||0
3151362|NCT01806688|3877673|FG000|NOT COMPLETED|Third Intervention Seed Study||0
3151363|NCT01806688|3877674|FG001|NOT COMPLETED|Third Intervention Seed Study||0
3151364|NCT01806688|3877673|FG000|STARTED|First Intervention Pita Study|"Participants received one of the following:~experimental snack #2 gluten-free high protein and high fibre snack a 50 g serving of buckwheat and pinto bean flour pita bread~placebo comparator reference product, a gluten-free snack with similar energy density but less protein and fibre as the experimental snack, a 50g serving of rice bread~placebo comparator non-caloric control water"|0
3151365|NCT01806688|3877674|FG001|STARTED|First Intervention Pita Study|"Participants received one of the following:~experimental snack #2 gluten-free high protein and high fibre snack a 50 g serving of buckwheat and pinto bean flour pita bread~placebo comparator reference product, a gluten-free snack with similar energy density but less protein and fibre as the experimental snack, a 50g serving of rice bread~placebo comparator non-caloric control water"|38
3151366|NCT01806688|3877673|FG000|Experimental Snack #2|First Intervention Pita Study|Received the Experimental snack #2, a 50 g serving of buckwheat and pinto bean flour pita bread at the first visit|0
3151367|NCT01806688|3877674|FG001|Experimental Snack #2|First Intervention Pita Study|Received the Experimental snack #2, a 50 g serving of buckwheat and pinto bean flour pita bread at the first visit|14
3151368|NCT01806688|3877673|FG000|Placebo Comparator Reference Product #2|First Intervention Pita Study|Received the placebo comparator reference product #2 at the first visit, a 50g serving of rice bread|0
3151369|NCT01806688|3877674|FG001|Placebo Comparator Reference Product #2|First Intervention Pita Study|Received the placebo comparator reference product #2 at the first visit, a 50g serving of rice bread|12
3151370|NCT01806688|3877673|FG000|Placebo Comparator Non-caloric Control #2|First Intervention Pita Study|Received water, the placebo comparator non-caloric control #2 at the first visit|0
3151371|NCT01806688|3877674|FG001|Placebo Comparator Non-caloric Control #2|First Intervention Pita Study|Received water, the placebo comparator non-caloric control #2 at the first visit|12
3151372|NCT01806688|3877673|FG000|COMPLETED|First Intervention Pita Study||0
3151373|NCT01806688|3877674|FG001|COMPLETED|First Intervention Pita Study||38
3151374|NCT01806688|3877673|FG000|NOT COMPLETED|First Intervention Pita Study||0
3151375|NCT01806688|3877674|FG001|NOT COMPLETED|First Intervention Pita Study||0
3151376|NCT01806688|3877673|FG000|STARTED|Second Intervention Pita Study|"Participants received one of the following:~experimental snack #2 gluten-free high protein and high fibre snack a 50 g serving of buckwheat and pinto bean flour pita bread~placebo comparator reference product, a gluten-free snack with similar energy density but less protein and fibre as the experimental snack, a 50g serving of rice bread~placebo comparator non-caloric control water"|0
3151377|NCT01806688|3877674|FG001|STARTED|Second Intervention Pita Study|"Participants received one of the following:~experimental snack #2 gluten-free high protein and high fibre snack a 50 g serving of buckwheat and pinto bean flour pita bread~placebo comparator reference product, a gluten-free snack with similar energy density but less protein and fibre as the experimental snack, a 50g serving of rice bread~placebo comparator non-caloric control water"|38
3151378|NCT01806688|3877673|FG000|Experimental Snack #2|Second Intervention Pita Study|Received the Experimental snack #2, a 50 g serving of buckwheat and pinto bean flour pita bread at the second visit|0
3151379|NCT01806688|3877674|FG001|Experimental Snack #2|Second Intervention Pita Study|Received the Experimental snack #2, a 50 g serving of buckwheat and pinto bean flour pita bread at the second visit|12
3151380|NCT01806688|3877673|FG000|Placebo Comparator Reference Product #2|Second Intervention Pita Study|Received the placebo comparator reference product #2 at the second visit, a 50g serving of rice bread|0
3151381|NCT01806688|3877674|FG001|Placebo Comparator Reference Product #2|Second Intervention Pita Study|Received the placebo comparator reference product #2 at the second visit, a 50g serving of rice bread|13
3151382|NCT01806688|3877673|FG000|Placebo Comparator Non-caloric Control #2|Second Intervention Pita Study|Received water, the placebo comparator non-caloric control #2 at the second visit|0
3151383|NCT01806688|3877674|FG001|Placebo Comparator Non-caloric Control #2|Second Intervention Pita Study|Received water, the placebo comparator non-caloric control #2 at the second visit|13
3151384|NCT01806688|3877673|FG000|COMPLETED|Second Intervention Pita Study||0
3151385|NCT01806688|3877674|FG001|COMPLETED|Second Intervention Pita Study||38
3151386|NCT01806688|3877673|FG000|NOT COMPLETED|Second Intervention Pita Study||0
3151387|NCT01806688|3877674|FG001|NOT COMPLETED|Second Intervention Pita Study||0
3151388|NCT01806688|3877673|FG000|STARTED|Third Intervention Pita Study|"Participants received one of the following:~experimental snack #2 gluten-free high protein and high fibre snack a 50 g serving of buckwheat and pinto bean flour pita bread placebo comparator reference product, a gluten-free snack with similar energy density but less protein and fibre as the experimental snack, a 50g serving of rice bread placebo comparator non-caloric control water"|0
3151389|NCT01806688|3877674|FG001|STARTED|Third Intervention Pita Study|"Participants received one of the following:~experimental snack #2 gluten-free high protein and high fibre snack a 50 g serving of buckwheat and pinto bean flour pita bread placebo comparator reference product, a gluten-free snack with similar energy density but less protein and fibre as the experimental snack, a 50g serving of rice bread placebo comparator non-caloric control water"|38
3151390|NCT01806688|3877673|FG000|Experimental Snack #2|Third Intervention Pita Study|Received the Experimental snack #2, a 50 g serving of buckwheat and pinto bean flour pita bread at the third visit|0
3151391|NCT01806688|3877674|FG001|Experimental Snack #2|Third Intervention Pita Study|Received the Experimental snack #2, a 50 g serving of buckwheat and pinto bean flour pita bread at the third visit|12
3151392|NCT01806688|3877673|FG000|Placebo Comparator Reference Product #2|Third Intervention Pita Study|Received the placebo comparator reference product #2 at the third visit, a 50g serving of rice bread|0
3151393|NCT01806688|3877674|FG001|Placebo Comparator Reference Product #2|Third Intervention Pita Study|Received the placebo comparator reference product #2 at the third visit, a 50g serving of rice bread|13
3151394|NCT01806688|3877673|FG000|Placebo Comparator Non-caloric Control #2|Third Intervention Pita Study|Received water, the placebo comparator non-caloric control #2 at the third visit|0
3151395|NCT01806688|3877674|FG001|Placebo Comparator Non-caloric Control #2|Third Intervention Pita Study|Received water, the placebo comparator non-caloric control #2 at the third visit|13
3151396|NCT01806688|3877673|FG000|COMPLETED|Third Intervention Pita Study||0
3151397|NCT01806688|3877674|FG001|COMPLETED|Third Intervention Pita Study||38
3151398|NCT01806688|3877673|FG000|NOT COMPLETED|Third Intervention Pita Study||0
3151399|NCT01806688|3877674|FG001|NOT COMPLETED|Third Intervention Pita Study||0
3151400|NCT01806714|3877685|FG000|STARTED|Overall Study||2093
3151401|NCT01806714|3877686|FG001|STARTED|Overall Study||2089
3151402|NCT01806714|3877685|FG000|COMPLETED|Overall Study||1893
3151403|NCT01806714|3877686|FG001|COMPLETED|Overall Study||1919
3151404|NCT01806714|3877685|FG000|NOT COMPLETED|Overall Study||200
3151405|NCT01806714|3877686|FG001|NOT COMPLETED|Overall Study||170
3151406|NCT01806740|3877692|FG000|STARTED|Overall Study||37
3151407|NCT01806740|3877692|FG000|COMPLETED|Overall Study||31
3151408|NCT01806740|3877692|FG000|NOT COMPLETED|Overall Study||6
3151409|NCT01806779|3877701|FG000|STARTED|Overall Study||90
3151410|NCT01806779|3877702|FG001|STARTED|Overall Study||84
3151411|NCT01806779|3877703|FG002|STARTED|Overall Study|All 197 subjects received nicotine patches but 23 dropped before receiving other study drugs.|23
3151412|NCT01806779|3877701|FG000|Completed SE Quest. After Using Patches|Overall Study|SE quest. = Side Effects Questionnaire|90
3151413|NCT01806779|3877702|FG001|Completed SE Quest. After Using Patches|Overall Study|SE quest. = Side Effects Questionnaire|84
3151414|NCT01806779|3877703|FG002|Completed SE Quest. After Using Patches|Overall Study|SE quest. = Side Effects Questionnaire|2
3151415|NCT01806779|3877701|FG000|Randomized at Visit 2|Overall Study||90
3151416|NCT01806779|3877702|FG001|Randomized at Visit 2|Overall Study||84
3151417|NCT01806779|3877703|FG002|Randomized at Visit 2|Overall Study||0
3151418|NCT01806779|3877701|FG000|Completed SE Quest. After Randomization|Overall Study|SE quest. = Side Effects Questionnaire|87
3151419|NCT01806779|3877702|FG001|Completed SE Quest. After Randomization|Overall Study|SE quest. = Side Effects Questionnaire|83
3151420|NCT01806779|3877703|FG002|Completed SE Quest. After Randomization|Overall Study|SE quest. = Side Effects Questionnaire|0
3151421|NCT01806779|3877701|FG000|COMPLETED|Overall Study||48
3151422|NCT01806779|3877702|FG001|COMPLETED|Overall Study||40
3151423|NCT01806779|3877703|FG002|COMPLETED|Overall Study||0
3151424|NCT01806779|3877701|FG000|NOT COMPLETED|Overall Study||42
3151425|NCT01806779|3877702|FG001|NOT COMPLETED|Overall Study||44
3151426|NCT01806779|3877703|FG002|NOT COMPLETED|Overall Study||23
3151427|NCT01806857|3877710|FG000|STARTED|Overall Study||31
3151428|NCT01806857|3877711|FG001|STARTED|Overall Study||29
3151429|NCT01806857|3877710|FG000|COMPLETED|Overall Study||30
3151430|NCT01806857|3877711|FG001|COMPLETED|Overall Study||29
3151431|NCT01806857|3877710|FG000|NOT COMPLETED|Overall Study||1
3151432|NCT01806857|3877711|FG001|NOT COMPLETED|Overall Study||0
3151433|NCT01806896|3877720|FG000|STARTED|Overall Study||20
3151434|NCT01806896|3877721|FG001|STARTED|Overall Study||17
3151435|NCT01806896|3877720|FG000|Received Treatment|Overall Study||19
3151436|NCT01806896|3877721|FG001|Received Treatment|Overall Study||17
3151437|NCT01806896|3877720|FG000|COMPLETED|Overall Study||17
3151438|NCT01806896|3877721|FG001|COMPLETED|Overall Study||17
3151439|NCT01806896|3877720|FG000|NOT COMPLETED|Overall Study||3
3151440|NCT01806896|3877721|FG001|NOT COMPLETED|Overall Study||0
3151441|NCT01807000|3877727|FG000|STARTED|Overall Study||6
3151442|NCT01807000|3877727|FG000|COMPLETED|Overall Study||6
3151443|NCT01807000|3877727|FG000|NOT COMPLETED|Overall Study||0
3151444|NCT01807026|3877737|FG000|STARTED|Overall Study||10
3151445|NCT01807026|3877738|FG001|STARTED|Overall Study||2
3151446|NCT01807026|3877739|FG002|STARTED|Overall Study||10
3151447|NCT01807026|3877740|FG003|STARTED|Overall Study||2
3151448|NCT01807026|3877741|FG004|STARTED|Overall Study||9
3151449|NCT01807026|3877742|FG005|STARTED|Overall Study||3
3151450|NCT01807026|3877737|FG000|Received at Least One Dose of Study Drug|Overall Study||10
3151451|NCT01807026|3877738|FG001|Received at Least One Dose of Study Drug|Overall Study||2
3151452|NCT01807026|3877739|FG002|Received at Least One Dose of Study Drug|Overall Study||10
3151453|NCT01807026|3877740|FG003|Received at Least One Dose of Study Drug|Overall Study||2
3151454|NCT01807026|3877741|FG004|Received at Least One Dose of Study Drug|Overall Study||9
3151455|NCT01807026|3877742|FG005|Received at Least One Dose of Study Drug|Overall Study||3
3151456|NCT01807026|3877737|FG000|COMPLETED|Overall Study||10
3151457|NCT01807026|3877738|FG001|COMPLETED|Overall Study||2
3151458|NCT01807026|3877739|FG002|COMPLETED|Overall Study||10
3151459|NCT01807026|3877740|FG003|COMPLETED|Overall Study||2
3151460|NCT01807026|3877741|FG004|COMPLETED|Overall Study||9
3151461|NCT01807026|3877742|FG005|COMPLETED|Overall Study||3
3151462|NCT01807026|3877737|FG000|NOT COMPLETED|Overall Study||0
3151463|NCT01807026|3877738|FG001|NOT COMPLETED|Overall Study||0
3151464|NCT01807026|3877739|FG002|NOT COMPLETED|Overall Study||0
3151465|NCT01807026|3877740|FG003|NOT COMPLETED|Overall Study||0
3151466|NCT01807026|3877741|FG004|NOT COMPLETED|Overall Study||0
3151467|NCT01807026|3877742|FG005|NOT COMPLETED|Overall Study||0
3151468|NCT01807065|3877763|FG000|STARTED|Overall Study||25
3151469|NCT01807065|3877764|FG001|STARTED|Overall Study||26
3151470|NCT01807065|3877763|FG000|COMPLETED|Overall Study||24
3151471|NCT01807065|3877764|FG001|COMPLETED|Overall Study||25
3151472|NCT01807065|3877763|FG000|NOT COMPLETED|Overall Study||1
3151473|NCT01807065|3877764|FG001|NOT COMPLETED|Overall Study||1
3151474|NCT01807091|3877770|FG000|STARTED|Overall Study||17
3151475|NCT01807091|3877770|FG000|COMPLETED|Overall Study||17
3151476|NCT01807091|3877770|FG000|NOT COMPLETED|Overall Study||0
3151477|NCT01807104|3877776|FG000|STARTED|Overall Study||43
3151478|NCT01807104|3877777|FG001|STARTED|Overall Study||44
3151479|NCT01807104|3877776|FG000|COMPLETED|Overall Study||39
3151480|NCT01807104|3877777|FG001|COMPLETED|Overall Study||40
3151481|NCT01807104|3877776|FG000|NOT COMPLETED|Overall Study||4
3151482|NCT01807104|3877777|FG001|NOT COMPLETED|Overall Study||4
3151483|NCT01807156|3877783|FG000|STARTED|Overall Study||7
3182952|NCT02005211|3911196|FG002|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
3182953|NCT02005211|3911197|FG003|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
3182954|NCT02005211|3911198|FG004|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
3182955|NCT02005211|3911199|FG005|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
3182956|NCT02005211|3911200|FG006|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
3182957|NCT02005211|3911194|FG000|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
3182958|NCT02005211|3911195|FG001|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
3182959|NCT02005211|3911196|FG002|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
3182960|NCT02005211|3911197|FG003|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
3182961|NCT02005211|3911198|FG004|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||6
3182962|NCT02005211|3911199|FG005|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||6
3182963|NCT02005211|3911200|FG006|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||4
3182964|NCT02005211|3911194|FG000|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
3182965|NCT02005211|3911195|FG001|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
3182966|NCT02005211|3911196|FG002|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
3182967|NCT02005211|3911197|FG003|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
3182968|NCT02005211|3911198|FG004|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||5
3182969|NCT02005211|3911199|FG005|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||6
3151484|NCT01807156|3877783|FG000|COMPLETED|Overall Study||6
3151485|NCT01807156|3877783|FG000|NOT COMPLETED|Overall Study||1
3151486|NCT01807221|3877793|FG000|STARTED|Overall Study||224
3151487|NCT01807221|3877794|FG001|STARTED|Overall Study||173
3151488|NCT01807221|3877795|FG002|STARTED|Overall Study||165
3151489|NCT01807221|3877796|FG003|STARTED|Overall Study||169
3151490|NCT01807221|3877797|FG004|STARTED|Overall Study||170
3151491|NCT01807221|3877798|FG005|STARTED|Overall Study||165
3151492|NCT01807221|3877793|FG000|Participants Received Study Treatment and Valid for Safety Analysis Set|Overall Study||221
3151493|NCT01807221|3877794|FG001|Participants Received Study Treatment and Valid for Safety Analysis Set|Overall Study||172
3151494|NCT01807221|3877795|FG002|Participants Received Study Treatment and Valid for Safety Analysis Set|Overall Study||163
3151495|NCT01807221|3877796|FG003|Participants Received Study Treatment and Valid for Safety Analysis Set|Overall Study||167
3151496|NCT01807221|3877797|FG004|Participants Received Study Treatment and Valid for Safety Analysis Set|Overall Study||169
3151497|NCT01807221|3877798|FG005|Participants Received Study Treatment and Valid for Safety Analysis Set|Overall Study||163
3151498|NCT01807221|3877793|FG000|COMPLETED|Overall Study||144
3151499|NCT01807221|3877794|FG001|COMPLETED|Overall Study||121
3151500|NCT01807221|3877795|FG002|COMPLETED|Overall Study||122
3151501|NCT01807221|3877796|FG003|COMPLETED|Overall Study||123
3151502|NCT01807221|3877797|FG004|COMPLETED|Overall Study||134
3151503|NCT01807221|3877798|FG005|COMPLETED|Overall Study||124
3151504|NCT01807221|3877793|FG000|NOT COMPLETED|Overall Study||80
3151505|NCT01807221|3877794|FG001|NOT COMPLETED|Overall Study||52
3151506|NCT01807221|3877795|FG002|NOT COMPLETED|Overall Study||43
3151507|NCT01807221|3877796|FG003|NOT COMPLETED|Overall Study||46
3151508|NCT01807221|3877797|FG004|NOT COMPLETED|Overall Study||36
3151509|NCT01807221|3877798|FG005|NOT COMPLETED|Overall Study||41
3151510|NCT01807234|3877818|FG000|STARTED|Overall Study||12
3151511|NCT01807234|3877819|FG001|STARTED|Overall Study||12
3151512|NCT01807234|3877820|FG002|STARTED|Overall Study||12
3151513|NCT01807234|3877821|FG003|STARTED|Overall Study||12
3151514|NCT01807234|3877822|FG004|STARTED|Overall Study||12
3151515|NCT01807234|3877823|FG005|STARTED|Overall Study||12
3151516|NCT01807234|3877818|FG000|Randomized, But Did Not Take Drug|Overall Study||3
3151517|NCT01807234|3877819|FG001|Randomized, But Did Not Take Drug|Overall Study||5
3151518|NCT01807234|3877820|FG002|Randomized, But Did Not Take Drug|Overall Study||2
3151519|NCT01807234|3877821|FG003|Randomized, But Did Not Take Drug|Overall Study||1
3151520|NCT01807234|3877822|FG004|Randomized, But Did Not Take Drug|Overall Study||4
3151521|NCT01807234|3877823|FG005|Randomized, But Did Not Take Drug|Overall Study||3
3151522|NCT01807234|3877818|FG000|Completed Only 1 Attack|Overall Study||2
3151523|NCT01807234|3877819|FG001|Completed Only 1 Attack|Overall Study||1
3151524|NCT01807234|3877820|FG002|Completed Only 1 Attack|Overall Study||0
3151525|NCT01807234|3877821|FG003|Completed Only 1 Attack|Overall Study||1
3151526|NCT01807234|3877822|FG004|Completed Only 1 Attack|Overall Study||0
3151527|NCT01807234|3877823|FG005|Completed Only 1 Attack|Overall Study||1
3151528|NCT01807234|3877818|FG000|COMPLETED|Overall Study||7
3151529|NCT01807234|3877819|FG001|COMPLETED|Overall Study||6
3151530|NCT01807234|3877820|FG002|COMPLETED|Overall Study||10
3151531|NCT01807234|3877821|FG003|COMPLETED|Overall Study||10
3151532|NCT01807234|3877822|FG004|COMPLETED|Overall Study||8
3151533|NCT01807234|3877823|FG005|COMPLETED|Overall Study||8
3151534|NCT01807234|3877818|FG000|NOT COMPLETED|Overall Study||5
3151535|NCT01807234|3877819|FG001|NOT COMPLETED|Overall Study||6
3151536|NCT01807234|3877820|FG002|NOT COMPLETED|Overall Study||2
3151537|NCT01807234|3877821|FG003|NOT COMPLETED|Overall Study||2
3151538|NCT01807234|3877822|FG004|NOT COMPLETED|Overall Study||4
3151539|NCT01807234|3877823|FG005|NOT COMPLETED|Overall Study||4
3151540|NCT01807299|3877837|FG000|STARTED|Overall Study||14
3151541|NCT01807299|3877838|FG001|STARTED|Overall Study||14
3151542|NCT01807299|3877839|FG002|STARTED|Overall Study||12
3151543|NCT01807299|3877840|FG003|STARTED|Overall Study||13
3151544|NCT01807299|3877837|FG000|COMPLETED|Overall Study||11
3151545|NCT01807299|3877838|FG001|COMPLETED|Overall Study||13
3151546|NCT01807299|3877839|FG002|COMPLETED|Overall Study||12
3151547|NCT01807299|3877840|FG003|COMPLETED|Overall Study||11
3151548|NCT01807299|3877837|FG000|NOT COMPLETED|Overall Study||3
3151549|NCT01807299|3877838|FG001|NOT COMPLETED|Overall Study||1
3151550|NCT01807299|3877839|FG002|NOT COMPLETED|Overall Study||0
3151551|NCT01807299|3877840|FG003|NOT COMPLETED|Overall Study||2
3151552|NCT01807455|3877850|FG000|STARTED|Overall Study||12
3151553|NCT01807455|3877850|FG000|COMPLETED|Overall Study||12
3151554|NCT01807455|3877850|FG000|NOT COMPLETED|Overall Study||0
3151555|NCT01807520|3877857|FG000|STARTED|Treatment Period 1 (0-16 Weeks)||67
3151556|NCT01807520|3877858|FG001|STARTED|Treatment Period 1 (0-16 Weeks)||66
3151557|NCT01807520|3877859|FG002|STARTED|Treatment Period 1 (0-16 Weeks)||65
3151558|NCT01807520|3877860|FG003|STARTED|Treatment Period 1 (0-16 Weeks)||0
3151559|NCT01807520|3877861|FG004|STARTED|Treatment Period 1 (0-16 Weeks)||0
3151560|NCT01807520|3877862|FG005|STARTED|Treatment Period 1 (0-16 Weeks)||0
3151561|NCT01807520|3877863|FG006|STARTED|Treatment Period 1 (0-16 Weeks)||0
3151562|NCT01807520|3877857|FG000|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||67
3151563|NCT01807520|3877858|FG001|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||66
3151564|NCT01807520|3877859|FG002|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||65
3151565|NCT01807520|3877860|FG003|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||0
3151566|NCT01807520|3877861|FG004|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||0
3151567|NCT01807520|3877862|FG005|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||0
3151568|NCT01807520|3877863|FG006|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||0
3151569|NCT01807520|3877857|FG000|Safety Set|Treatment Period 1 (0-16 Weeks)||67
3151570|NCT01807520|3877858|FG001|Safety Set|Treatment Period 1 (0-16 Weeks)||65
3151571|NCT01807520|3877859|FG002|Safety Set|Treatment Period 1 (0-16 Weeks)||65
3151572|NCT01807520|3877860|FG003|Safety Set|Treatment Period 1 (0-16 Weeks)||0
3151573|NCT01807520|3877861|FG004|Safety Set|Treatment Period 1 (0-16 Weeks)||0
3182970|NCT02005211|3911200|FG006|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||4
3182971|NCT02005211|3911194|FG000|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
3182972|NCT02005211|3911195|FG001|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
3182973|NCT02005211|3911196|FG002|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
3182974|NCT02005211|3911197|FG003|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
3182975|NCT02005211|3911198|FG004|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||1
3182976|NCT02005211|3911199|FG005|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
3182977|NCT02005211|3911200|FG006|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
3182978|NCT02005250|3911225|FG000|STARTED|Overall Study||61
3182979|NCT02005250|3911226|FG001|STARTED|Overall Study||32
3182980|NCT02005250|3911225|FG000|COMPLETED|Overall Study||46
3182981|NCT02005250|3911226|FG001|COMPLETED|Overall Study||27
3182982|NCT02005250|3911225|FG000|NOT COMPLETED|Overall Study||15
3363701|NCT04050618|4094841|FG000|STARTED|First Intervention||58
3363702|NCT04050618|4094842|FG001|STARTED|First Intervention||56
3363703|NCT04050618|4094841|FG000|COMPLETED|First Intervention||56
3363704|NCT04050618|4094842|FG001|COMPLETED|First Intervention||56
3363705|NCT04050618|4094841|FG000|NOT COMPLETED|First Intervention||2
3363706|NCT04050618|4094842|FG001|NOT COMPLETED|First Intervention||0
3363707|NCT04050618|4094841|FG000|STARTED|Second Intervention||56
3363708|NCT04050618|4094842|FG001|STARTED|Second Intervention||56
3363709|NCT04050618|4094841|FG000|COMPLETED|Second Intervention||55
3363710|NCT04050618|4094842|FG001|COMPLETED|Second Intervention||56
3363711|NCT04050618|4094841|FG000|NOT COMPLETED|Second Intervention||1
3363712|NCT04050618|4094842|FG001|NOT COMPLETED|Second Intervention||0
3363713|NCT04053465|4094855|FG000|STARTED|Overall Study||22
3363714|NCT04053465|4094856|FG001|STARTED|Overall Study||12
3363715|NCT04053465|4094855|FG000|COMPLETED|Overall Study||18
3363716|NCT04053465|4094856|FG001|COMPLETED|Overall Study||8
3363717|NCT04053465|4094855|FG000|NOT COMPLETED|Overall Study||4
3363718|NCT04053465|4094856|FG001|NOT COMPLETED|Overall Study||4
3363719|NCT04053270|4094864|FG000|STARTED|Overall Study||49
3363720|NCT04053270|4094865|FG001|STARTED|Overall Study||51
3363721|NCT04053270|4094864|FG000|COMPLETED|Overall Study||47
3363722|NCT04053270|4094865|FG001|COMPLETED|Overall Study||46
3363723|NCT04053270|4094864|FG000|NOT COMPLETED|Overall Study||2
3363724|NCT04053270|4094865|FG001|NOT COMPLETED|Overall Study||5
3363725|NCT04049552|4094875|FG000|STARTED|Overall Study||4
3363726|NCT04049552|4094875|FG000|COMPLETED|Overall Study||3
3363727|NCT04049552|4094875|FG000|NOT COMPLETED|Overall Study||1
3363728|NCT04053023|4094883|FG000|STARTED|Part A: Period 1 (Day 1 to Day 19)||19
3363729|NCT04053023|4094884|FG001|STARTED|Part A: Period 1 (Day 1 to Day 19)||0
3363730|NCT04053023|4094883|FG000|COMPLETED|Part A: Period 1 (Day 1 to Day 19)||19
3363731|NCT04053023|4094884|FG001|COMPLETED|Part A: Period 1 (Day 1 to Day 19)||0
3363732|NCT04053023|4094883|FG000|NOT COMPLETED|Part A: Period 1 (Day 1 to Day 19)||0
3363733|NCT04053023|4094884|FG001|NOT COMPLETED|Part A: Period 1 (Day 1 to Day 19)||0
3363734|NCT04053023|4094883|FG000|STARTED|Part A: Period 2 (Day 20 to Day 38)||19
3363735|NCT04053023|4094884|FG001|STARTED|Part A: Period 2 (Day 20 to Day 38)||0
3363736|NCT04053023|4094883|FG000|COMPLETED|Part A: Period 2 (Day 20 to Day 38)||18
3363737|NCT04053023|4094884|FG001|COMPLETED|Part A: Period 2 (Day 20 to Day 38)||0
3363738|NCT04053023|4094883|FG000|NOT COMPLETED|Part A: Period 2 (Day 20 to Day 38)||1
3363739|NCT04053023|4094884|FG001|NOT COMPLETED|Part A: Period 2 (Day 20 to Day 38)||0
3151574|NCT01807520|3877862|FG005|Safety Set|Treatment Period 1 (0-16 Weeks)||0
3151575|NCT01807520|3877863|FG006|Safety Set|Treatment Period 1 (0-16 Weeks)||0
3151576|NCT01807520|3877857|FG000|COMPLETED|Treatment Period 1 (0-16 Weeks)||63
3151577|NCT01807520|3877858|FG001|COMPLETED|Treatment Period 1 (0-16 Weeks)||65
3151578|NCT01807520|3877859|FG002|COMPLETED|Treatment Period 1 (0-16 Weeks)||58
3151579|NCT01807520|3877860|FG003|COMPLETED|Treatment Period 1 (0-16 Weeks)||0
3151580|NCT01807520|3877861|FG004|COMPLETED|Treatment Period 1 (0-16 Weeks)||0
3151581|NCT01807520|3877862|FG005|COMPLETED|Treatment Period 1 (0-16 Weeks)||0
3151582|NCT01807520|3877863|FG006|COMPLETED|Treatment Period 1 (0-16 Weeks)||0
3151583|NCT01807520|3877857|FG000|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||4
3151584|NCT01807520|3877858|FG001|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||1
3151585|NCT01807520|3877859|FG002|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||7
3151586|NCT01807520|3877860|FG003|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||0
3151587|NCT01807520|3877861|FG004|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||0
3151588|NCT01807520|3877862|FG005|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||0
3151589|NCT01807520|3877863|FG006|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||0
3151590|NCT01807520|3877857|FG000|STARTED|Treatment Period 2 (16-132 Weeks)||63
3151591|NCT01807520|3877858|FG001|STARTED|Treatment Period 2 (16-132 Weeks)||65
3151592|NCT01807520|3877859|FG002|STARTED|Treatment Period 2 (16-132 Weeks)||0
3151593|NCT01807520|3877860|FG003|STARTED|Treatment Period 2 (16-132 Weeks)||29
3151594|NCT01807520|3877861|FG004|STARTED|Treatment Period 2 (16-132 Weeks)||29
3151595|NCT01807520|3877862|FG005|STARTED|Treatment Period 2 (16-132 Weeks)||0
3363740|NCT04053023|4094883|FG000|STARTED|Part B: Period 1 (Day 1 to Day 19)||0
3151596|NCT01807520|3877863|FG006|STARTED|Treatment Period 2 (16-132 Weeks)||0
3151597|NCT01807520|3877857|FG000|Safety Set|Treatment Period 2 (16-132 Weeks)||63
3151598|NCT01807520|3877858|FG001|Safety Set|Treatment Period 2 (16-132 Weeks)||65
3151599|NCT01807520|3877859|FG002|Safety Set|Treatment Period 2 (16-132 Weeks)||0
3151600|NCT01807520|3877860|FG003|Safety Set|Treatment Period 2 (16-132 Weeks)||29
3151601|NCT01807520|3877861|FG004|Safety Set|Treatment Period 2 (16-132 Weeks)||29
3151602|NCT01807520|3877862|FG005|Safety Set|Treatment Period 2 (16-132 Weeks)||0
3151603|NCT01807520|3877863|FG006|Safety Set|Treatment Period 2 (16-132 Weeks)||0
3151604|NCT01807520|3877857|FG000|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||67
3151605|NCT01807520|3877858|FG001|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||66
3151606|NCT01807520|3877859|FG002|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||0
3151607|NCT01807520|3877860|FG003|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||29
3151608|NCT01807520|3877861|FG004|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||29
3151609|NCT01807520|3877862|FG005|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||0
3151610|NCT01807520|3877863|FG006|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||0
3151611|NCT01807520|3877857|FG000|COMPLETED|Treatment Period 2 (16-132 Weeks)||38
3151612|NCT01807520|3877858|FG001|COMPLETED|Treatment Period 2 (16-132 Weeks)||47
3151613|NCT01807520|3877859|FG002|COMPLETED|Treatment Period 2 (16-132 Weeks)||0
3151614|NCT01807520|3877860|FG003|COMPLETED|Treatment Period 2 (16-132 Weeks)||22
3151615|NCT01807520|3877861|FG004|COMPLETED|Treatment Period 2 (16-132 Weeks)||24
3151616|NCT01807520|3877862|FG005|COMPLETED|Treatment Period 2 (16-132 Weeks)||0
3151617|NCT01807520|3877863|FG006|COMPLETED|Treatment Period 2 (16-132 Weeks)||0
3151618|NCT01807520|3877857|FG000|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||25
3151619|NCT01807520|3877858|FG001|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||18
3151620|NCT01807520|3877859|FG002|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||0
3151621|NCT01807520|3877860|FG003|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||7
3151622|NCT01807520|3877861|FG004|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||5
3151623|NCT01807520|3877862|FG005|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||0
3151624|NCT01807520|3877863|FG006|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||0
3151625|NCT01807520|3877857|FG000|STARTED|Follow-up Period (132-140 Weeks)||0
3151626|NCT01807520|3877858|FG001|STARTED|Follow-up Period (132-140 Weeks)||0
3151627|NCT01807520|3877859|FG002|STARTED|Follow-up Period (132-140 Weeks)|These participants discontinued from Treatment Period 1.|2
3151628|NCT01807520|3877860|FG003|STARTED|Follow-up Period (132-140 Weeks)||0
3151629|NCT01807520|3877861|FG004|STARTED|Follow-up Period (132-140 Weeks)||0
3151630|NCT01807520|3877862|FG005|STARTED|Follow-up Period (132-140 Weeks)|These participants received AIN457150mg during treatment period 1 and/or treatment period 2.|81
3151631|NCT01807520|3877863|FG006|STARTED|Follow-up Period (132-140 Weeks)|These participants received AIN457 300mg during treatment period 1 and/or treatment period 2.|76
3151632|NCT01807520|3877857|FG000|COMPLETED|Follow-up Period (132-140 Weeks)||0
3151633|NCT01807520|3877858|FG001|COMPLETED|Follow-up Period (132-140 Weeks)||0
3151634|NCT01807520|3877859|FG002|COMPLETED|Follow-up Period (132-140 Weeks)||2
3151635|NCT01807520|3877860|FG003|COMPLETED|Follow-up Period (132-140 Weeks)||0
3151636|NCT01807520|3877861|FG004|COMPLETED|Follow-up Period (132-140 Weeks)||0
3151637|NCT01807520|3877862|FG005|COMPLETED|Follow-up Period (132-140 Weeks)||77
3151638|NCT01807520|3877863|FG006|COMPLETED|Follow-up Period (132-140 Weeks)||75
3151639|NCT01807520|3877857|FG000|NOT COMPLETED|Follow-up Period (132-140 Weeks)||0
3151640|NCT01807520|3877858|FG001|NOT COMPLETED|Follow-up Period (132-140 Weeks)||0
3151641|NCT01807520|3877859|FG002|NOT COMPLETED|Follow-up Period (132-140 Weeks)||0
3151642|NCT01807520|3877860|FG003|NOT COMPLETED|Follow-up Period (132-140 Weeks)||0
3151643|NCT01807520|3877861|FG004|NOT COMPLETED|Follow-up Period (132-140 Weeks)||0
3151644|NCT01807520|3877862|FG005|NOT COMPLETED|Follow-up Period (132-140 Weeks)||4
3151645|NCT01807520|3877863|FG006|NOT COMPLETED|Follow-up Period (132-140 Weeks)||1
3151646|NCT01807585|3877877|FG000|STARTED|Overall Study||20
3151647|NCT01807585|3877878|FG001|STARTED|Overall Study||108
3151648|NCT01807585|3877879|FG002|STARTED|Overall Study||114
3151649|NCT01807585|3877877|FG000|3 Mos|Overall Study||20
3151650|NCT01807585|3877878|FG001|3 Mos|Overall Study||108
3151651|NCT01807585|3877879|FG002|3 Mos|Overall Study||113
3182983|NCT02005250|3911226|FG001|NOT COMPLETED|Overall Study||5
3182984|NCT02005276|3911236|FG000|STARTED|Overall Study||65
3182985|NCT02005276|3911237|FG001|STARTED|Overall Study||41
3182986|NCT02005276|3911238|FG002|STARTED|Overall Study||59
3182987|NCT02005276|3911239|FG003|STARTED|Overall Study||44
3151652|NCT01807585|3877877|FG000|COMPLETED|Overall Study||19
3151653|NCT01807585|3877878|FG001|COMPLETED|Overall Study||104
3151654|NCT01807585|3877879|FG002|COMPLETED|Overall Study||108
3151655|NCT01807585|3877877|FG000|NOT COMPLETED|Overall Study||1
3151656|NCT01807585|3877878|FG001|NOT COMPLETED|Overall Study||4
3151657|NCT01807585|3877879|FG002|NOT COMPLETED|Overall Study||6
3151658|NCT01807598|3877890|FG000|STARTED|Overall Study||10
3151659|NCT01807598|3877890|FG000|COMPLETED|Overall Study||4
3151660|NCT01807598|3877890|FG000|NOT COMPLETED|Overall Study||6
3151661|NCT01807624|3877894|FG000|STARTED|Overall Study||24
3151662|NCT01807624|3877894|FG000|COMPLETED|Overall Study||24
3151663|NCT01807624|3877894|FG000|NOT COMPLETED|Overall Study||0
3151664|NCT01807637|3877900|FG000|STARTED|Baseline||4
3151665|NCT01807637|3877901|FG001|STARTED|Baseline||2
3151666|NCT01807637|3877900|FG000|COMPLETED|Baseline||4
3151667|NCT01807637|3877901|FG001|COMPLETED|Baseline||2
3151668|NCT01807637|3877900|FG000|NOT COMPLETED|Baseline||0
3151669|NCT01807637|3877901|FG001|NOT COMPLETED|Baseline||0
3151670|NCT01807637|3877900|FG000|STARTED|One Week||4
3151671|NCT01807637|3877901|FG001|STARTED|One Week||2
3151672|NCT01807637|3877900|FG000|COMPLETED|One Week||4
3151673|NCT01807637|3877901|FG001|COMPLETED|One Week||2
3151674|NCT01807637|3877900|FG000|NOT COMPLETED|One Week||0
3151675|NCT01807637|3877901|FG001|NOT COMPLETED|One Week||0
3151676|NCT01807637|3877900|FG000|STARTED|One Month||4
3151677|NCT01807637|3877901|FG001|STARTED|One Month||2
3151678|NCT01807637|3877900|FG000|COMPLETED|One Month||4
3151679|NCT01807637|3877901|FG001|COMPLETED|One Month||2
3151680|NCT01807637|3877900|FG000|NOT COMPLETED|One Month||0
3151681|NCT01807637|3877901|FG001|NOT COMPLETED|One Month||0
3151682|NCT01807650|3877909|FG000|STARTED|Overall Study||112
3182988|NCT02005276|3911236|FG000|Completed Intervention|Overall Study||61
3182989|NCT02005276|3911237|FG001|Completed Intervention|Overall Study||39
3182990|NCT02005276|3911238|FG002|Completed Intervention|Overall Study||56
3182991|NCT02005276|3911239|FG003|Completed Intervention|Overall Study||42
3182992|NCT02005276|3911236|FG000|COMPLETED|Overall Study||60
3182993|NCT02005276|3911237|FG001|COMPLETED|Overall Study||39
3182994|NCT02005276|3911238|FG002|COMPLETED|Overall Study||56
3182995|NCT02005276|3911239|FG003|COMPLETED|Overall Study||41
3182996|NCT02005276|3911236|FG000|NOT COMPLETED|Overall Study||5
3182997|NCT02005276|3911237|FG001|NOT COMPLETED|Overall Study||2
3182998|NCT02005276|3911238|FG002|NOT COMPLETED|Overall Study||3
3182999|NCT02005276|3911239|FG003|NOT COMPLETED|Overall Study||3
3183000|NCT02005354|3911253|FG000|STARTED|Overall Study||35
3183001|NCT02005354|3911254|FG001|STARTED|Overall Study||35
3183002|NCT02005354|3911253|FG000|COMPLETED|Overall Study||35
3183003|NCT02005354|3911254|FG001|COMPLETED|Overall Study||35
3183004|NCT02005354|3911253|FG000|NOT COMPLETED|Overall Study||0
3183005|NCT02005354|3911254|FG001|NOT COMPLETED|Overall Study||0
3183006|NCT02005393|3911260|FG000|STARTED|Overall Study||20
3183007|NCT02005393|3911260|FG000|COMPLETED|Overall Study||20
3183008|NCT02005393|3911260|FG000|NOT COMPLETED|Overall Study||0
3183009|NCT02005484|3911264|FG000|STARTED|Overall Study||6
3183010|NCT02005484|3911264|FG000|COMPLETED|Overall Study||2
3183011|NCT02005484|3911264|FG000|NOT COMPLETED|Overall Study||4
3183012|NCT02005510|3911270|FG000|STARTED|Randomized (Round 1)|Excludes 163 determined to be ineligible post-randomization due to delays in data warehouse update.|8120
3183013|NCT02005510|3911271|FG001|STARTED|Randomized (Round 1)|Excludes 196 determined to be ineligible post-randomization due to delays in data warehouse update.|8111
3183014|NCT02005510|3911270|FG000|COMPLETED|Randomized (Round 1)||8120
3183015|NCT02005510|3911271|FG001|COMPLETED|Randomized (Round 1)||8111
3183016|NCT02005510|3911270|FG000|NOT COMPLETED|Randomized (Round 1)||0
3183017|NCT02005510|3911271|FG001|NOT COMPLETED|Randomized (Round 1)||0
3183018|NCT02005510|3911270|FG000|STARTED|Rerandomized (Round 2)|Excludes 10 determined to be ineligible post-randomization due to delays in data warehouse update.|1631
3183019|NCT02005510|3911271|FG001|STARTED|Rerandomized (Round 2)|Excludes 5 determined to be ineligible post-randomization due to delays in data warehouse update.|1585
3183020|NCT02005510|3911270|FG000|COMPLETED|Rerandomized (Round 2)||1631
3183021|NCT02005510|3911271|FG001|COMPLETED|Rerandomized (Round 2)||1585
3183022|NCT02005510|3911270|FG000|NOT COMPLETED|Rerandomized (Round 2)||0
3183023|NCT02005510|3911271|FG001|NOT COMPLETED|Rerandomized (Round 2)||0
3183024|NCT02005510|3911270|FG000|STARTED|Rerandomized (Round 3)|Excludes 5 determined to be ineligible post-randomization due to delays in data warehouse update.|209
3183025|NCT02005510|3911271|FG001|STARTED|Rerandomized (Round 3)||195
3183026|NCT02005510|3911270|FG000|COMPLETED|Rerandomized (Round 3)||209
3183027|NCT02005510|3911271|FG001|COMPLETED|Rerandomized (Round 3)||195
3183028|NCT02005510|3911270|FG000|NOT COMPLETED|Rerandomized (Round 3)||0
3183029|NCT02005510|3911271|FG001|NOT COMPLETED|Rerandomized (Round 3)||0
3183030|NCT02005536|3911277|FG000|STARTED|Overall Study||60
3183031|NCT02005536|3911277|FG000|COMPLETED|Overall Study||60
3183032|NCT02005536|3911277|FG000|NOT COMPLETED|Overall Study||0
3183033|NCT02005549|3911281|FG000|STARTED|Overall Study||18
3183034|NCT02005549|3911281|FG000|COMPLETED|Overall Study||18
3183035|NCT02005549|3911281|FG000|NOT COMPLETED|Overall Study||0
3183036|NCT02005562|3911287|FG000|STARTED|Overall Study||127
3183037|NCT02005562|3911288|FG001|STARTED|Overall Study||125
3183038|NCT02005562|3911287|FG000|Transplanted|Overall Study||126
3183039|NCT02005562|3911288|FG001|Transplanted|Overall Study||121
3183040|NCT02005562|3911287|FG000|COMPLETED|Overall Study||115
3183041|NCT02005562|3911288|FG001|COMPLETED|Overall Study||110
3183042|NCT02005562|3911287|FG000|NOT COMPLETED|Overall Study||12
3183043|NCT02005562|3911288|FG001|NOT COMPLETED|Overall Study||15
3183044|NCT02005601|3911296|FG000|STARTED|Overall Study||53
3183045|NCT02005601|3911297|FG001|STARTED|Overall Study||53
3183046|NCT02005601|3911296|FG000|COMPLETED|Overall Study||53
3183047|NCT02005601|3911297|FG001|COMPLETED|Overall Study||53
3183048|NCT02005601|3911296|FG000|NOT COMPLETED|Overall Study||0
3183049|NCT02005601|3911297|FG001|NOT COMPLETED|Overall Study||0
3183050|NCT02005627|3911305|FG000|STARTED|Overall Study||23
3183051|NCT02005627|3911306|FG001|STARTED|Overall Study||23
3183052|NCT02005627|3911305|FG000|COMPLETED|Overall Study||21
3183053|NCT02005627|3911306|FG001|COMPLETED|Overall Study||19
3151683|NCT01807650|3877909|FG000|COMPLETED|Overall Study||92
3151684|NCT01807650|3877909|FG000|NOT COMPLETED|Overall Study||20
3151685|NCT01807871|3877952|FG000|STARTED|Overall Study||356
3151686|NCT01807871|3877953|FG001|STARTED|Overall Study||345
3151687|NCT01807871|3877952|FG000|COMPLETED|Overall Study||178
3151688|NCT01807871|3877953|FG001|COMPLETED|Overall Study||127
3151689|NCT01807871|3877952|FG000|NOT COMPLETED|Overall Study||178
3151690|NCT01807871|3877953|FG001|NOT COMPLETED|Overall Study||218
3151691|NCT01807923|3877962|FG000|STARTED|Overall Study||187
3151692|NCT01807923|3877963|FG001|STARTED|Overall Study||185
3151693|NCT01807923|3877964|FG002|STARTED|Overall Study||187
3151694|NCT01807923|3877962|FG000|COMPLETED|Overall Study||182
3151695|NCT01807923|3877963|FG001|COMPLETED|Overall Study||179
3151696|NCT01807923|3877964|FG002|COMPLETED|Overall Study||176
3151697|NCT01807923|3877962|FG000|NOT COMPLETED|Overall Study||5
3151698|NCT01807923|3877963|FG001|NOT COMPLETED|Overall Study||6
3151699|NCT01807923|3877964|FG002|NOT COMPLETED|Overall Study||11
3151700|NCT01807949|3877977|FG000|STARTED|Overall Study||187
3151701|NCT01807949|3877978|FG001|STARTED|Overall Study||187
3151702|NCT01807949|3877979|FG002|STARTED|Overall Study||189
3151703|NCT01807949|3877977|FG000|COMPLETED|Overall Study||185
3151704|NCT01807949|3877978|FG001|COMPLETED|Overall Study||180
3151705|NCT01807949|3877979|FG002|COMPLETED|Overall Study||180
3151706|NCT01807949|3877977|FG000|NOT COMPLETED|Overall Study||2
3151707|NCT01807949|3877978|FG001|NOT COMPLETED|Overall Study||7
3151708|NCT01807949|3877979|FG002|NOT COMPLETED|Overall Study||9
3151709|NCT01808066|3877989|FG000|STARTED|Overall Study||21
3151710|NCT01808066|3877989|FG000|COMPLETED|Overall Study||6
3151711|NCT01808066|3877989|FG000|NOT COMPLETED|Overall Study||15
3151712|NCT01808092|3877996|FG000|STARTED|Overall Study||409
3151713|NCT01808092|3877997|FG001|STARTED|Overall Study||408
3151714|NCT01808092|3877996|FG000|COMPLETED|Overall Study||355
3151715|NCT01808092|3877997|FG001|COMPLETED|Overall Study||363
3151716|NCT01808092|3877996|FG000|NOT COMPLETED|Overall Study||54
3151717|NCT01808092|3877997|FG001|NOT COMPLETED|Overall Study||45
3151718|NCT01808118|3878003|FG000|STARTED|Period 1||673
3151719|NCT01808118|3878004|FG001|STARTED|Period 1||0
3151720|NCT01808118|3878005|FG002|STARTED|Period 1||0
3151721|NCT01808118|3878003|FG000|COMPLETED|Period 1||305
3151722|NCT01808118|3878004|FG001|COMPLETED|Period 1||0
3151723|NCT01808118|3878005|FG002|COMPLETED|Period 1||0
3151724|NCT01808118|3878003|FG000|NOT COMPLETED|Period 1||368
3151725|NCT01808118|3878004|FG001|NOT COMPLETED|Period 1||0
3151726|NCT01808118|3878005|FG002|NOT COMPLETED|Period 1||0
3151727|NCT01808118|3878003|FG000|STARTED|Period 2||0
3151728|NCT01808118|3878004|FG001|STARTED|Period 2||153
3151729|NCT01808118|3878005|FG002|STARTED|Period 2||152
3151730|NCT01808118|3878003|FG000|COMPLETED|Period 2||0
3151731|NCT01808118|3878004|FG001|COMPLETED|Period 2||140
3151732|NCT01808118|3878005|FG002|COMPLETED|Period 2||144
3151733|NCT01808118|3878003|FG000|NOT COMPLETED|Period 2||0
3151734|NCT01808118|3878004|FG001|NOT COMPLETED|Period 2||13
3151735|NCT01808118|3878005|FG002|NOT COMPLETED|Period 2||8
3151736|NCT01808144|3878021|FG000|STARTED|Overall Study||97
3151737|NCT01808144|3878022|FG001|STARTED|Overall Study||99
3151738|NCT01808144|3878021|FG000|COMPLETED|Overall Study||57
3151739|NCT01808144|3878022|FG001|COMPLETED|Overall Study||51
3151740|NCT01808144|3878021|FG000|NOT COMPLETED|Overall Study||40
3151741|NCT01808144|3878022|FG001|NOT COMPLETED|Overall Study||48
3151742|NCT01808196|3878028|FG000|STARTED|Overall Study||6
3151743|NCT01808196|3878028|FG000|COMPLETED|Overall Study||5
3151744|NCT01808196|3878028|FG000|NOT COMPLETED|Overall Study||1
3151745|NCT01808209|3878034|FG000|STARTED|Overall Study||33
3151746|NCT01808209|3878035|FG001|STARTED|Overall Study||27
3151747|NCT01808209|3878034|FG000|COMPLETED|Overall Study||33
3151748|NCT01808209|3878035|FG001|COMPLETED|Overall Study||26
3183054|NCT02005627|3911305|FG000|NOT COMPLETED|Overall Study||2
3183055|NCT02005627|3911306|FG001|NOT COMPLETED|Overall Study||4
3183056|NCT02005666|3911316|FG000|STARTED|Overall Study||338
3183057|NCT02005666|3911317|FG001|STARTED|Overall Study||343
3183058|NCT02005666|3911318|FG002|STARTED|Overall Study||169
3183059|NCT02005666|3911316|FG000|COMPLETED|Overall Study||311
3183060|NCT02005666|3911317|FG001|COMPLETED|Overall Study||299
3183061|NCT02005666|3911318|FG002|COMPLETED|Overall Study||160
3183062|NCT02005666|3911316|FG000|NOT COMPLETED|Overall Study||27
3183063|NCT02005666|3911317|FG001|NOT COMPLETED|Overall Study||44
3183064|NCT02005666|3911318|FG002|NOT COMPLETED|Overall Study||9
3183065|NCT02005692|3911326|FG000|STARTED|Overall Study||70
3183066|NCT02005692|3911326|FG000|COMPLETED|Overall Study||63
3183067|NCT02005692|3911326|FG000|NOT COMPLETED|Overall Study||7
3183068|NCT02005887|3911333|FG000|STARTED|Overall Study||26
3183069|NCT02005887|3911334|FG001|STARTED|Overall Study||25
3183070|NCT02005887|3911333|FG000|COMPLETED|Overall Study||26
3183071|NCT02005887|3911334|FG001|COMPLETED|Overall Study||23
3363741|NCT04053023|4094884|FG001|STARTED|Part B: Period 1 (Day 1 to Day 19)||0
3363742|NCT04053023|4094883|FG000|COMPLETED|Part B: Period 1 (Day 1 to Day 19)||0
3363743|NCT04053023|4094884|FG001|COMPLETED|Part B: Period 1 (Day 1 to Day 19)||0
3363744|NCT04053023|4094883|FG000|NOT COMPLETED|Part B: Period 1 (Day 1 to Day 19)||0
3363745|NCT04053023|4094884|FG001|NOT COMPLETED|Part B: Period 1 (Day 1 to Day 19)||0
3363746|NCT04053023|4094883|FG000|STARTED|Part B: Period 2 (Day 20 to Day 38)||0
3363747|NCT04053023|4094884|FG001|STARTED|Part B: Period 2 (Day 20 to Day 38)||0
3151749|NCT01808209|3878034|FG000|NOT COMPLETED|Overall Study||0
3151750|NCT01808209|3878035|FG001|NOT COMPLETED|Overall Study||1
3151751|NCT01808222|3878045|FG000|STARTED|Overall Study||25
3151752|NCT01808222|3878045|FG000|Completed Fluciclovine PET-CT Scan|Overall Study||25
3183072|NCT02005887|3911333|FG000|NOT COMPLETED|Overall Study||0
3183073|NCT02005887|3911334|FG001|NOT COMPLETED|Overall Study||2
3183074|NCT02006056|3911342|FG000|STARTED|Overall Study||26
3183075|NCT02006056|3911343|FG001|STARTED|Overall Study||4
3151753|NCT01808222|3878045|FG000|Completed mpMR Scan|Overall Study||24
3151754|NCT01808222|3878045|FG000|COMPLETED|Overall Study||24
3151755|NCT01808222|3878045|FG000|NOT COMPLETED|Overall Study||1
3151756|NCT01808248|3878051|FG000|STARTED|Overall Study||47
3151757|NCT01808248|3878051|FG000|Completed Posttreatment Week 12 Visit|Overall Study||45
3151758|NCT01808248|3878051|FG000|COMPLETED|Overall Study||42
3151759|NCT01808248|3878051|FG000|NOT COMPLETED|Overall Study||5
3151760|NCT01808313|3878057|FG000|STARTED|Overall Study||133
3151761|NCT01808313|3878057|FG000|COMPLETED|Overall Study||123
3151762|NCT01808313|3878057|FG000|NOT COMPLETED|Overall Study||10
3151763|NCT01808326|3878061|FG000|STARTED|Overall Study||5
3151764|NCT01808326|3878061|FG000|COMPLETED|Overall Study||5
3151765|NCT01808326|3878061|FG000|NOT COMPLETED|Overall Study||0
3151766|NCT01808339|3878065|FG000|STARTED|Treatment Period 1 (14 Days)||4
3151767|NCT01808339|3878066|FG001|STARTED|Treatment Period 1 (14 Days)||4
3151768|NCT01808339|3878067|FG002|STARTED|Treatment Period 1 (14 Days)||4
3151769|NCT01808339|3878068|FG003|STARTED|Treatment Period 1 (14 Days)||4
3151770|NCT01808339|3878069|FG004|STARTED|Treatment Period 1 (14 Days)||6
3151771|NCT01808339|3878070|FG005|STARTED|Treatment Period 1 (14 Days)||6
3151772|NCT01808339|3878065|FG000|COMPLETED|Treatment Period 1 (14 Days)||4
3151773|NCT01808339|3878066|FG001|COMPLETED|Treatment Period 1 (14 Days)||3
3151774|NCT01808339|3878067|FG002|COMPLETED|Treatment Period 1 (14 Days)||4
3151775|NCT01808339|3878068|FG003|COMPLETED|Treatment Period 1 (14 Days)||2
3183076|NCT02006056|3911342|FG000|COMPLETED|Overall Study||26
3183077|NCT02006056|3911343|FG001|COMPLETED|Overall Study||4
3183078|NCT02006056|3911342|FG000|NOT COMPLETED|Overall Study||0
3183079|NCT02006056|3911343|FG001|NOT COMPLETED|Overall Study||0
3183080|NCT02006108|3911349|FG000|STARTED|Overall Study||21
3183081|NCT02006108|3911349|FG000|MR Imaging|Overall Study||19
3183082|NCT02006108|3911349|FG000|COMPLETED|Overall Study||19
3183083|NCT02006108|3911349|FG000|NOT COMPLETED|Overall Study||2
3183084|NCT02006121|3911355|FG000|STARTED|Double Blind Phase||54
3183085|NCT02006121|3911356|FG001|STARTED|Double Blind Phase||53
3183086|NCT02006121|3911355|FG000|COMPLETED|Double Blind Phase|Early switching to open label: 1 for lack of efficacy, 1 could not tolerate 3 mg/hour minimum rate|42
3183087|NCT02006121|3911356|FG001|COMPLETED|Double Blind Phase|16 placebo-treated patients early switched to open label phase due to lack of efficacy|29
3183088|NCT02006121|3911355|FG000|NOT COMPLETED|Double Blind Phase||12
3183089|NCT02006121|3911356|FG001|NOT COMPLETED|Double Blind Phase||24
3183090|NCT02006121|3911355|FG000|STARTED|Open Label Phase|From Apo: 38 completers and 2 early switched; From Placebo: 28 completers and 16 early switched|84
3183091|NCT02006121|3911356|FG001|STARTED|Open Label Phase|No patients received placebo in the open label phase|0
3183092|NCT02006121|3911355|FG000|COMPLETED|Open Label Phase|30 who continued on apomorphine from blinded phase, 29 who switched to apomorphine from placebo|59
3183093|NCT02006121|3911356|FG001|COMPLETED|Open Label Phase||0
3183094|NCT02006121|3911355|FG000|NOT COMPLETED|Open Label Phase||25
3183095|NCT02006121|3911356|FG001|NOT COMPLETED|Open Label Phase||0
3183096|NCT02006160|3911368|FG000|STARTED|Overall Study||45
3183097|NCT02006160|3911369|FG001|STARTED|Overall Study||16
3183098|NCT02006160|3911368|FG000|COMPLETED|Overall Study||41
3183099|NCT02006160|3911369|FG001|COMPLETED|Overall Study||16
3183100|NCT02006160|3911368|FG000|NOT COMPLETED|Overall Study||4
3183101|NCT02006160|3911369|FG001|NOT COMPLETED|Overall Study||0
3183102|NCT02006264|3911377|FG000|STARTED|Overall Study||15
3183103|NCT02006264|3911378|FG001|STARTED|Overall Study||15
3183104|NCT02006264|3911377|FG000|COMPLETED|Overall Study||14
3183105|NCT02006264|3911378|FG001|COMPLETED|Overall Study||15
3183106|NCT02006264|3911377|FG000|NOT COMPLETED|Overall Study||1
3183107|NCT02006264|3911378|FG001|NOT COMPLETED|Overall Study||0
3183108|NCT02006342|3911386|FG000|STARTED|Overall Study||20
3183109|NCT02006342|3911387|FG001|STARTED|Overall Study||20
3183110|NCT02006342|3911386|FG000|COMPLETED|Overall Study||19
3183111|NCT02006342|3911387|FG001|COMPLETED|Overall Study||20
3183112|NCT02006342|3911386|FG000|NOT COMPLETED|Overall Study||1
3183113|NCT02006342|3911387|FG001|NOT COMPLETED|Overall Study||0
3183114|NCT02006420|3911395|FG000|STARTED|Overall Study||24
3183115|NCT02006420|3911396|FG001|STARTED|Overall Study||21
3183116|NCT02006420|3911395|FG000|COMPLETED|Overall Study||24
3183117|NCT02006420|3911396|FG001|COMPLETED|Overall Study||21
3183118|NCT02006420|3911395|FG000|NOT COMPLETED|Overall Study||0
3183119|NCT02006420|3911396|FG001|NOT COMPLETED|Overall Study||0
3183120|NCT02006472|3911413|FG000|STARTED|Period 1 (Through Week 26)||82
3183121|NCT02006472|3911414|FG001|STARTED|Period 1 (Through Week 26)||81
3183122|NCT02006472|3911415|FG002|STARTED|Period 1 (Through Week 26)||82
3183123|NCT02006472|3911416|FG003|STARTED|Period 1 (Through Week 26)||81
3183124|NCT02006472|3911417|FG004|STARTED|Period 1 (Through Week 26)||82
3183125|NCT02006472|3911413|FG000|ITT|Period 1 (Through Week 26)||82
3183126|NCT02006472|3911414|FG001|ITT|Period 1 (Through Week 26)||81
3183127|NCT02006472|3911415|FG002|ITT|Period 1 (Through Week 26)||82
3183128|NCT02006472|3911416|FG003|ITT|Period 1 (Through Week 26)||81
3183129|NCT02006472|3911417|FG004|ITT|Period 1 (Through Week 26)||82
3183130|NCT02006472|3911413|FG000|FAS|Period 1 (Through Week 26)||81
3183131|NCT02006472|3911414|FG001|FAS|Period 1 (Through Week 26)||75
3183132|NCT02006472|3911415|FG002|FAS|Period 1 (Through Week 26)||79
3183133|NCT02006472|3911416|FG003|FAS|Period 1 (Through Week 26)||81
3183134|NCT02006472|3911417|FG004|FAS|Period 1 (Through Week 26)||81
3183135|NCT02006472|3911413|FG000|Safety Set|Period 1 (Through Week 26)||82
3183136|NCT02006472|3911414|FG001|Safety Set|Period 1 (Through Week 26)||81
3151776|NCT01808339|3878069|FG004|COMPLETED|Treatment Period 1 (14 Days)||4
3151777|NCT01808339|3878070|FG005|COMPLETED|Treatment Period 1 (14 Days)||5
3151778|NCT01808339|3878065|FG000|NOT COMPLETED|Treatment Period 1 (14 Days)||0
3151779|NCT01808339|3878066|FG001|NOT COMPLETED|Treatment Period 1 (14 Days)||1
3151780|NCT01808339|3878067|FG002|NOT COMPLETED|Treatment Period 1 (14 Days)||0
3151781|NCT01808339|3878068|FG003|NOT COMPLETED|Treatment Period 1 (14 Days)||2
3151782|NCT01808339|3878069|FG004|NOT COMPLETED|Treatment Period 1 (14 Days)||2
3151783|NCT01808339|3878070|FG005|NOT COMPLETED|Treatment Period 1 (14 Days)||1
3151784|NCT01808339|3878065|FG000|STARTED|Washout Period 1 (14-21 Days)||4
3151785|NCT01808339|3878066|FG001|STARTED|Washout Period 1 (14-21 Days)||3
3151786|NCT01808339|3878067|FG002|STARTED|Washout Period 1 (14-21 Days)||4
3151787|NCT01808339|3878068|FG003|STARTED|Washout Period 1 (14-21 Days)||2
3151788|NCT01808339|3878069|FG004|STARTED|Washout Period 1 (14-21 Days)||4
3151789|NCT01808339|3878070|FG005|STARTED|Washout Period 1 (14-21 Days)||5
3151790|NCT01808339|3878065|FG000|COMPLETED|Washout Period 1 (14-21 Days)||4
3151791|NCT01808339|3878066|FG001|COMPLETED|Washout Period 1 (14-21 Days)||3
3151792|NCT01808339|3878067|FG002|COMPLETED|Washout Period 1 (14-21 Days)||4
3151793|NCT01808339|3878068|FG003|COMPLETED|Washout Period 1 (14-21 Days)||2
3151794|NCT01808339|3878069|FG004|COMPLETED|Washout Period 1 (14-21 Days)||4
3151795|NCT01808339|3878070|FG005|COMPLETED|Washout Period 1 (14-21 Days)||5
3151796|NCT01808339|3878065|FG000|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
3151797|NCT01808339|3878066|FG001|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
3151798|NCT01808339|3878067|FG002|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
3151799|NCT01808339|3878068|FG003|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
3151800|NCT01808339|3878069|FG004|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
3151801|NCT01808339|3878070|FG005|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
3151802|NCT01808339|3878065|FG000|STARTED|Treatment Period 2 (14 Days)||4
3151803|NCT01808339|3878066|FG001|STARTED|Treatment Period 2 (14 Days)||3
3151804|NCT01808339|3878067|FG002|STARTED|Treatment Period 2 (14 Days)||4
3151805|NCT01808339|3878068|FG003|STARTED|Treatment Period 2 (14 Days)||2
3151806|NCT01808339|3878069|FG004|STARTED|Treatment Period 2 (14 Days)||4
3151807|NCT01808339|3878070|FG005|STARTED|Treatment Period 2 (14 Days)||5
3151808|NCT01808339|3878065|FG000|COMPLETED|Treatment Period 2 (14 Days)||4
3151809|NCT01808339|3878066|FG001|COMPLETED|Treatment Period 2 (14 Days)||3
3151810|NCT01808339|3878067|FG002|COMPLETED|Treatment Period 2 (14 Days)||4
3151811|NCT01808339|3878068|FG003|COMPLETED|Treatment Period 2 (14 Days)||2
3151812|NCT01808339|3878069|FG004|COMPLETED|Treatment Period 2 (14 Days)||4
3151813|NCT01808339|3878070|FG005|COMPLETED|Treatment Period 2 (14 Days)||5
3151814|NCT01808339|3878065|FG000|NOT COMPLETED|Treatment Period 2 (14 Days)||0
3151815|NCT01808339|3878066|FG001|NOT COMPLETED|Treatment Period 2 (14 Days)||0
3151816|NCT01808339|3878067|FG002|NOT COMPLETED|Treatment Period 2 (14 Days)||0
3151817|NCT01808339|3878068|FG003|NOT COMPLETED|Treatment Period 2 (14 Days)||0
3151818|NCT01808339|3878069|FG004|NOT COMPLETED|Treatment Period 2 (14 Days)||0
3151819|NCT01808339|3878070|FG005|NOT COMPLETED|Treatment Period 2 (14 Days)||0
3151820|NCT01808339|3878065|FG000|STARTED|Washout Period 2 (14-21 Days)||4
3151821|NCT01808339|3878066|FG001|STARTED|Washout Period 2 (14-21 Days)||3
3151822|NCT01808339|3878067|FG002|STARTED|Washout Period 2 (14-21 Days)||4
3151823|NCT01808339|3878068|FG003|STARTED|Washout Period 2 (14-21 Days)||2
3151824|NCT01808339|3878069|FG004|STARTED|Washout Period 2 (14-21 Days)||4
3151825|NCT01808339|3878070|FG005|STARTED|Washout Period 2 (14-21 Days)||5
3151826|NCT01808339|3878065|FG000|COMPLETED|Washout Period 2 (14-21 Days)||4
3151827|NCT01808339|3878066|FG001|COMPLETED|Washout Period 2 (14-21 Days)||3
3151828|NCT01808339|3878067|FG002|COMPLETED|Washout Period 2 (14-21 Days)||4
3151829|NCT01808339|3878068|FG003|COMPLETED|Washout Period 2 (14-21 Days)||2
3151830|NCT01808339|3878069|FG004|COMPLETED|Washout Period 2 (14-21 Days)||4
3151831|NCT01808339|3878070|FG005|COMPLETED|Washout Period 2 (14-21 Days)||5
3151832|NCT01808339|3878065|FG000|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
3151833|NCT01808339|3878066|FG001|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
3151834|NCT01808339|3878067|FG002|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
3151835|NCT01808339|3878068|FG003|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
3151836|NCT01808339|3878069|FG004|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
3151837|NCT01808339|3878070|FG005|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
3151838|NCT01808339|3878065|FG000|STARTED|Treatment Period 3 (14 Days)||4
3151839|NCT01808339|3878066|FG001|STARTED|Treatment Period 3 (14 Days)||3
3151840|NCT01808339|3878067|FG002|STARTED|Treatment Period 3 (14 Days)||4
3151841|NCT01808339|3878068|FG003|STARTED|Treatment Period 3 (14 Days)||2
3151842|NCT01808339|3878069|FG004|STARTED|Treatment Period 3 (14 Days)||4
3151843|NCT01808339|3878070|FG005|STARTED|Treatment Period 3 (14 Days)||5
3151844|NCT01808339|3878065|FG000|COMPLETED|Treatment Period 3 (14 Days)||4
3151845|NCT01808339|3878066|FG001|COMPLETED|Treatment Period 3 (14 Days)||3
3151846|NCT01808339|3878067|FG002|COMPLETED|Treatment Period 3 (14 Days)||3
3151847|NCT01808339|3878068|FG003|COMPLETED|Treatment Period 3 (14 Days)||2
3151848|NCT01808339|3878069|FG004|COMPLETED|Treatment Period 3 (14 Days)||4
3151849|NCT01808339|3878070|FG005|COMPLETED|Treatment Period 3 (14 Days)||5
3151850|NCT01808339|3878065|FG000|NOT COMPLETED|Treatment Period 3 (14 Days)||0
3151851|NCT01808339|3878066|FG001|NOT COMPLETED|Treatment Period 3 (14 Days)||0
3151852|NCT01808339|3878067|FG002|NOT COMPLETED|Treatment Period 3 (14 Days)||1
3151853|NCT01808339|3878068|FG003|NOT COMPLETED|Treatment Period 3 (14 Days)||0
3151854|NCT01808339|3878069|FG004|NOT COMPLETED|Treatment Period 3 (14 Days)||0
3151855|NCT01808339|3878070|FG005|NOT COMPLETED|Treatment Period 3 (14 Days)||0
3151856|NCT01808508|3878081|FG000|STARTED|Overall Study||11
3151857|NCT01808508|3878082|FG001|STARTED|Overall Study||9
3151858|NCT01808508|3878083|FG002|STARTED|Overall Study||3
3151859|NCT01808508|3878081|FG000|COMPLETED|Overall Study||10
3151860|NCT01808508|3878082|FG001|COMPLETED|Overall Study||9
3151861|NCT01808508|3878083|FG002|COMPLETED|Overall Study||3
3151862|NCT01808508|3878081|FG000|NOT COMPLETED|Overall Study||1
3151863|NCT01808508|3878082|FG001|NOT COMPLETED|Overall Study||0
3151864|NCT01808508|3878083|FG002|NOT COMPLETED|Overall Study||0
3151865|NCT01808534|3878091|FG000|STARTED|Overall Study||5
3151866|NCT01808534|3878091|FG000|COMPLETED|Overall Study||1
3151867|NCT01808534|3878091|FG000|NOT COMPLETED|Overall Study||4
3151868|NCT01808547|3878097|FG000|STARTED|Overall Study||174
3151869|NCT01808547|3878098|FG001|STARTED|Overall Study||94
3151870|NCT01808547|3878097|FG000|Safety Population|Overall Study||170
3151871|NCT01808547|3878098|FG001|Safety Population|Overall Study||85
3151872|NCT01808547|3878097|FG000|mITT Population|Overall Study||168
3151873|NCT01808547|3878098|FG001|mITT Population|Overall Study||85
3151874|NCT01808547|3878097|FG000|COMPLETED|Overall Study||137
3151875|NCT01808547|3878098|FG001|COMPLETED|Overall Study||48
3151876|NCT01808547|3878097|FG000|NOT COMPLETED|Overall Study||37
3151877|NCT01808547|3878098|FG001|NOT COMPLETED|Overall Study||46
3151878|NCT01808560|3878107|FG000|STARTED|Randomization and Treatment Allocation||18
3151879|NCT01808560|3878108|FG001|STARTED|Randomization and Treatment Allocation||16
3151880|NCT01808560|3878109|FG002|STARTED|Randomization and Treatment Allocation||0
3151881|NCT01808560|3878107|FG000|COMPLETED|Randomization and Treatment Allocation||18
3151882|NCT01808560|3878108|FG001|COMPLETED|Randomization and Treatment Allocation||16
3151883|NCT01808560|3878109|FG002|COMPLETED|Randomization and Treatment Allocation||0
3151884|NCT01808560|3878107|FG000|NOT COMPLETED|Randomization and Treatment Allocation||0
3151885|NCT01808560|3878108|FG001|NOT COMPLETED|Randomization and Treatment Allocation||0
3151886|NCT01808560|3878109|FG002|NOT COMPLETED|Randomization and Treatment Allocation||0
3151887|NCT01808560|3878107|FG000|STARTED|1-Month After Cataract Surgery|ITT: 2 subjects withdrew b/c they were unable to complete cataract surgery scheduled for both eyes|16
3151888|NCT01808560|3878108|FG001|STARTED|1-Month After Cataract Surgery|ITT: 3 subjects withdrew b/c they were unable to complete cataract surgery scheduled for both eyes|13
3151889|NCT01808560|3878109|FG002|STARTED|1-Month After Cataract Surgery||0
3151890|NCT01808560|3878107|FG000|COMPLETED|1-Month After Cataract Surgery||16
3151891|NCT01808560|3878108|FG001|COMPLETED|1-Month After Cataract Surgery||13
3151892|NCT01808560|3878109|FG002|COMPLETED|1-Month After Cataract Surgery||0
3151893|NCT01808560|3878107|FG000|NOT COMPLETED|1-Month After Cataract Surgery||0
3151894|NCT01808560|3878108|FG001|NOT COMPLETED|1-Month After Cataract Surgery||0
3151895|NCT01808560|3878109|FG002|NOT COMPLETED|1-Month After Cataract Surgery||0
3151896|NCT01808560|3878107|FG000|STARTED|3-Month After Cataract Surgery||17
3151897|NCT01808560|3878108|FG001|STARTED|3-Month After Cataract Surgery||13
3151898|NCT01808560|3878109|FG002|STARTED|3-Month After Cataract Surgery||0
3151899|NCT01808560|3878107|FG000|COMPLETED|3-Month After Cataract Surgery||17
3151900|NCT01808560|3878108|FG001|COMPLETED|3-Month After Cataract Surgery||13
3151901|NCT01808560|3878109|FG002|COMPLETED|3-Month After Cataract Surgery||0
3151902|NCT01808560|3878107|FG000|NOT COMPLETED|3-Month After Cataract Surgery||0
3151903|NCT01808560|3878108|FG001|NOT COMPLETED|3-Month After Cataract Surgery||0
3151904|NCT01808560|3878109|FG002|NOT COMPLETED|3-Month After Cataract Surgery||0
3151905|NCT01808560|3878107|FG000|STARTED|Crossover Treatment||0
3151906|NCT01808560|3878108|FG001|STARTED|Crossover Treatment||0
3151907|NCT01808560|3878109|FG002|STARTED|Crossover Treatment|Post-Treatment Group Received Crossover LipiFlow treatment 3 Months after cataract surgery|13
3151908|NCT01808560|3878107|FG000|COMPLETED|Crossover Treatment||0
3151909|NCT01808560|3878108|FG001|COMPLETED|Crossover Treatment||0
3151910|NCT01808560|3878109|FG002|COMPLETED|Crossover Treatment||13
3151911|NCT01808560|3878107|FG000|NOT COMPLETED|Crossover Treatment||0
3151912|NCT01808560|3878108|FG001|NOT COMPLETED|Crossover Treatment||0
3151913|NCT01808560|3878109|FG002|NOT COMPLETED|Crossover Treatment||0
3151914|NCT01808560|3878107|FG000|STARTED|4-Month After Cataract Surgery||0
3151915|NCT01808560|3878108|FG001|STARTED|4-Month After Cataract Surgery||0
3151916|NCT01808560|3878109|FG002|STARTED|4-Month After Cataract Surgery||13
3151917|NCT01808560|3878107|FG000|COMPLETED|4-Month After Cataract Surgery||0
3151918|NCT01808560|3878108|FG001|COMPLETED|4-Month After Cataract Surgery||0
3151919|NCT01808560|3878109|FG002|COMPLETED|4-Month After Cataract Surgery||13
3151920|NCT01808560|3878107|FG000|NOT COMPLETED|4-Month After Cataract Surgery||0
3151921|NCT01808560|3878108|FG001|NOT COMPLETED|4-Month After Cataract Surgery||0
3151922|NCT01808560|3878109|FG002|NOT COMPLETED|4-Month After Cataract Surgery||0
3151923|NCT01808573|3878119|FG000|STARTED|Overall Study||307
3151924|NCT01808573|3878120|FG001|STARTED|Overall Study||314
3151925|NCT01808573|3878119|FG000|Received Treatment|Overall Study||303
3151926|NCT01808573|3878120|FG001|Received Treatment|Overall Study||311
3151927|NCT01808573|3878119|FG000|COMPLETED|Overall Study||0
3151928|NCT01808573|3878120|FG001|COMPLETED|Overall Study||0
3151929|NCT01808573|3878119|FG000|NOT COMPLETED|Overall Study||307
3151930|NCT01808573|3878120|FG001|NOT COMPLETED|Overall Study||314
3151931|NCT01808612|3878129|FG000|STARTED|Treatment Period||169
3151932|NCT01808612|3878130|FG001|STARTED|Treatment Period||84
3151933|NCT01808612|3878131|FG002|STARTED|Treatment Period||260
3151934|NCT01808612|3878129|FG000|Received at Least 1 Dose of Study Drug|Treatment Period|Only these participants were included in the study analyses (ie, Full Analysis Set).|168
3151935|NCT01808612|3878130|FG001|Received at Least 1 Dose of Study Drug|Treatment Period|Only these participants were included in the study analyses (ie, Full Analysis Set).|83
3151936|NCT01808612|3878131|FG002|Received at Least 1 Dose of Study Drug|Treatment Period|Only these participants were included in the study analyses (ie, Full Analysis Set).|259
3151937|NCT01808612|3878129|FG000|COMPLETED|Treatment Period|67 participants who completed the Treatment Period did not enter the Discontinuation Period.|154
3151938|NCT01808612|3878130|FG001|COMPLETED|Treatment Period|39 participants who completed the Treatment Period did not enter the Discontinuation Period.|77
3151939|NCT01808612|3878131|FG002|COMPLETED|Treatment Period|101 participants who completed the Treatment Period did not enter the Discontinuation Period.|246
3151940|NCT01808612|3878129|FG000|NOT COMPLETED|Treatment Period||15
3151941|NCT01808612|3878130|FG001|NOT COMPLETED|Treatment Period||7
3151942|NCT01808612|3878131|FG002|NOT COMPLETED|Treatment Period||14
3151943|NCT01808612|3878129|FG000|STARTED|Discontinuation Period||87
3151944|NCT01808612|3878130|FG001|STARTED|Discontinuation Period||38
3151945|NCT01808612|3878131|FG002|STARTED|Discontinuation Period||145
3151946|NCT01808612|3878129|FG000|COMPLETED|Discontinuation Period||85
3151947|NCT01808612|3878130|FG001|COMPLETED|Discontinuation Period||37
3151948|NCT01808612|3878131|FG002|COMPLETED|Discontinuation Period||145
3151949|NCT01808612|3878129|FG000|NOT COMPLETED|Discontinuation Period||2
3151950|NCT01808612|3878130|FG001|NOT COMPLETED|Discontinuation Period||1
3151951|NCT01808612|3878131|FG002|NOT COMPLETED|Discontinuation Period||0
3151952|NCT01808651|3878145|FG000|STARTED|Study Period 1||99
3151953|NCT01808651|3878146|FG001|STARTED|Study Period 1||65
3151954|NCT01808651|3878147|FG002|STARTED|Study Period 1||36
3151955|NCT01808651|3878145|FG000|Received at Least One Dose of Study Drug|Study Period 1||98
3151956|NCT01808651|3878146|FG001|Received at Least One Dose of Study Drug|Study Period 1||65
3151957|NCT01808651|3878147|FG002|Received at Least One Dose of Study Drug|Study Period 1||36
3151958|NCT01808651|3878145|FG000|COMPLETED|Study Period 1||73
3151959|NCT01808651|3878146|FG001|COMPLETED|Study Period 1||48
3151960|NCT01808651|3878147|FG002|COMPLETED|Study Period 1||31
3151961|NCT01808651|3878145|FG000|NOT COMPLETED|Study Period 1||26
3151962|NCT01808651|3878146|FG001|NOT COMPLETED|Study Period 1||17
3151963|NCT01808651|3878147|FG002|NOT COMPLETED|Study Period 1||5
3151964|NCT01808651|3878145|FG000|STARTED|Study Period 2||77
3151965|NCT01808651|3878146|FG001|STARTED|Study Period 2||52
3151966|NCT01808651|3878147|FG002|STARTED|Study Period 2||33
3151967|NCT01808651|3878145|FG000|COMPLETED|Study Period 2|9 Pts who DC'd from Study Period 1 and 68 Pts who completed Study Period 1 entered Study Period 2.|77
3151968|NCT01808651|3878146|FG001|COMPLETED|Study Period 2|5 Pts who DC'd from Study Period 1 and 47 Pts who completed Study Period 1 entered Study Period 2.|52
3151969|NCT01808651|3878147|FG002|COMPLETED|Study Period 2|3 Pts who DC'd from Study Period 1 and 30 pts who completed Study Period 1 entered Study Period 2.|33
3151970|NCT01808651|3878145|FG000|NOT COMPLETED|Study Period 2||0
3151971|NCT01808651|3878146|FG001|NOT COMPLETED|Study Period 2||0
3151972|NCT01808651|3878147|FG002|NOT COMPLETED|Study Period 2||0
3151973|NCT01808690|3878160|FG000|STARTED|Overall Study||25
3151974|NCT01808690|3878161|FG001|STARTED|Overall Study||23
3151975|NCT01808690|3878160|FG000|COMPLETED|Overall Study||24
3151976|NCT01808690|3878161|FG001|COMPLETED|Overall Study||21
3151977|NCT01808690|3878160|FG000|NOT COMPLETED|Overall Study||1
3151978|NCT01808690|3878161|FG001|NOT COMPLETED|Overall Study||2
3151979|NCT01808755|3878167|FG000|STARTED|Overall Study||30
3151980|NCT01808755|3878168|FG001|STARTED|Overall Study||30
3151981|NCT01808755|3878167|FG000|COMPLETED|Overall Study||30
3151982|NCT01808755|3878168|FG001|COMPLETED|Overall Study||30
3183137|NCT02006472|3911415|FG002|Safety Set|Period 1 (Through Week 26)||82
3183138|NCT02006472|3911416|FG003|Safety Set|Period 1 (Through Week 26)||81
3183139|NCT02006472|3911417|FG004|Safety Set|Period 1 (Through Week 26)||82
3183140|NCT02006472|3911413|FG000|COMPLETED|Period 1 (Through Week 26)||70
3183141|NCT02006472|3911414|FG001|COMPLETED|Period 1 (Through Week 26)||59
3183142|NCT02006472|3911415|FG002|COMPLETED|Period 1 (Through Week 26)||65
3183143|NCT02006472|3911416|FG003|COMPLETED|Period 1 (Through Week 26)||67
3183144|NCT02006472|3911417|FG004|COMPLETED|Period 1 (Through Week 26)||62
3183145|NCT02006472|3911413|FG000|NOT COMPLETED|Period 1 (Through Week 26)||12
3183146|NCT02006472|3911414|FG001|NOT COMPLETED|Period 1 (Through Week 26)||22
3183147|NCT02006472|3911415|FG002|NOT COMPLETED|Period 1 (Through Week 26)||17
3183148|NCT02006472|3911416|FG003|NOT COMPLETED|Period 1 (Through Week 26)||14
3183149|NCT02006472|3911417|FG004|NOT COMPLETED|Period 1 (Through Week 26)||20
3183150|NCT02006472|3911413|FG000|STARTED|Period 2 (Through Week 52)||57
3183151|NCT02006472|3911414|FG001|STARTED|Period 2 (Through Week 52)||49
3183152|NCT02006472|3911415|FG002|STARTED|Period 2 (Through Week 52)||54
3183153|NCT02006472|3911416|FG003|STARTED|Period 2 (Through Week 52)||56
3183154|NCT02006472|3911417|FG004|STARTED|Period 2 (Through Week 52)||46
3183155|NCT02006472|3911413|FG000|Started Treatment in Period 2|Period 2 (Through Week 52)||57
3183156|NCT02006472|3911414|FG001|Started Treatment in Period 2|Period 2 (Through Week 52)||49
3183157|NCT02006472|3911415|FG002|Started Treatment in Period 2|Period 2 (Through Week 52)||52
3183158|NCT02006472|3911416|FG003|Started Treatment in Period 2|Period 2 (Through Week 52)||56
3183159|NCT02006472|3911417|FG004|Started Treatment in Period 2|Period 2 (Through Week 52)||46
3183160|NCT02006472|3911413|FG000|COMPLETED|Period 2 (Through Week 52)||52
3183161|NCT02006472|3911414|FG001|COMPLETED|Period 2 (Through Week 52)||43
3151983|NCT01808755|3878167|FG000|NOT COMPLETED|Overall Study||0
3151984|NCT01808755|3878168|FG001|NOT COMPLETED|Overall Study||0
3151985|NCT01808963|3878173|FG000|STARTED|Overall Study||13
3151986|NCT01808963|3878173|FG000|COMPLETED|Overall Study||13
3151987|NCT01808963|3878173|FG000|NOT COMPLETED|Overall Study||0
3151988|NCT01809054|3878179|FG000|STARTED|Overall Study||27
3151989|NCT01809054|3878180|FG001|STARTED|Overall Study||22
3151990|NCT01809054|3878179|FG000|COMPLETED|Overall Study||27
3151991|NCT01809054|3878180|FG001|COMPLETED|Overall Study||22
3151992|NCT01809054|3878179|FG000|NOT COMPLETED|Overall Study||0
3151993|NCT01809054|3878180|FG001|NOT COMPLETED|Overall Study||0
3151994|NCT01809106|3878190|FG000|STARTED|Overall Study||130
3151995|NCT01809106|3878191|FG001|STARTED|Overall Study||130
3151996|NCT01809106|3878192|FG002|STARTED|Overall Study||130
3151997|NCT01809106|3878193|FG003|STARTED|Overall Study||128
3151998|NCT01809106|3878190|FG000|COMPLETED|Overall Study||122
3151999|NCT01809106|3878191|FG001|COMPLETED|Overall Study||125
3152000|NCT01809106|3878192|FG002|COMPLETED|Overall Study||127
3152001|NCT01809106|3878193|FG003|COMPLETED|Overall Study||124
3152002|NCT01809106|3878190|FG000|NOT COMPLETED|Overall Study||8
3152003|NCT01809106|3878191|FG001|NOT COMPLETED|Overall Study||5
3152004|NCT01809106|3878192|FG002|NOT COMPLETED|Overall Study||3
3152005|NCT01809106|3878193|FG003|NOT COMPLETED|Overall Study||4
3152006|NCT01809132|3878206|FG000|STARTED|Overall Study||53
3152007|NCT01809132|3878207|FG001|STARTED|Overall Study||50
3152008|NCT01809132|3878208|FG002|STARTED|Overall Study|Subject was consented but withdrew prior to randomization and initiation of treatment.|1
3152009|NCT01809132|3878206|FG000|COMPLETED|Overall Study||53
3183162|NCT02006472|3911415|FG002|COMPLETED|Period 2 (Through Week 52)||44
3183163|NCT02006472|3911416|FG003|COMPLETED|Period 2 (Through Week 52)||53
3183164|NCT02006472|3911417|FG004|COMPLETED|Period 2 (Through Week 52)||44
3152010|NCT01809132|3878207|FG001|COMPLETED|Overall Study||50
3152011|NCT01809132|3878208|FG002|COMPLETED|Overall Study||0
3152012|NCT01809132|3878206|FG000|NOT COMPLETED|Overall Study||0
3152013|NCT01809132|3878207|FG001|NOT COMPLETED|Overall Study||0
3152014|NCT01809132|3878208|FG002|NOT COMPLETED|Overall Study||1
3152015|NCT01809197|3878218|FG000|STARTED|Overall Study||187
3152016|NCT01809197|3878219|FG001|STARTED|Overall Study||185
3152017|NCT01809197|3878218|FG000|COMPLETED|Overall Study||177
3152018|NCT01809197|3878219|FG001|COMPLETED|Overall Study||177
3152019|NCT01809197|3878218|FG000|NOT COMPLETED|Overall Study||10
3152020|NCT01809197|3878219|FG001|NOT COMPLETED|Overall Study||8
3152021|NCT01809210|3878232|FG000|STARTED|Overall Study||3
3152022|NCT01809210|3878233|FG001|STARTED|Overall Study||9
3152023|NCT01809210|3878234|FG002|STARTED|Overall Study||7
3152024|NCT01809210|3878235|FG003|STARTED|Overall Study||3
3152025|NCT01809210|3878236|FG004|STARTED|Overall Study||6
3152026|NCT01809210|3878237|FG005|STARTED|Overall Study||15
3152027|NCT01809210|3878238|FG006|STARTED|Overall Study||12
3152028|NCT01809210|3878232|FG000|COMPLETED|Overall Study||2
3152029|NCT01809210|3878233|FG001|COMPLETED|Overall Study||8
3152030|NCT01809210|3878234|FG002|COMPLETED|Overall Study||4
3152031|NCT01809210|3878235|FG003|COMPLETED|Overall Study||2
3152032|NCT01809210|3878236|FG004|COMPLETED|Overall Study||4
3152033|NCT01809210|3878237|FG005|COMPLETED|Overall Study||12
3152034|NCT01809210|3878238|FG006|COMPLETED|Overall Study||7
3152035|NCT01809210|3878232|FG000|NOT COMPLETED|Overall Study||1
3152036|NCT01809210|3878233|FG001|NOT COMPLETED|Overall Study||1
3152037|NCT01809210|3878234|FG002|NOT COMPLETED|Overall Study||3
3152038|NCT01809210|3878235|FG003|NOT COMPLETED|Overall Study||1
3152039|NCT01809210|3878236|FG004|NOT COMPLETED|Overall Study||2
3152040|NCT01809210|3878237|FG005|NOT COMPLETED|Overall Study||3
3152041|NCT01809210|3878238|FG006|NOT COMPLETED|Overall Study||5
3152042|NCT01809262|3878254|FG000|STARTED|Period 1 (First Dose + Washout)||4
3152043|NCT01809262|3878255|FG001|STARTED|Period 1 (First Dose + Washout)||4
3183165|NCT02006472|3911413|FG000|NOT COMPLETED|Period 2 (Through Week 52)||5
3183166|NCT02006472|3911414|FG001|NOT COMPLETED|Period 2 (Through Week 52)||6
3183167|NCT02006472|3911415|FG002|NOT COMPLETED|Period 2 (Through Week 52)||10
3183168|NCT02006472|3911416|FG003|NOT COMPLETED|Period 2 (Through Week 52)||3
3183169|NCT02006472|3911417|FG004|NOT COMPLETED|Period 2 (Through Week 52)||2
3183170|NCT02006576|3911437|FG000|STARTED|Overall Study||35
3183171|NCT02006576|3911438|FG001|STARTED|Overall Study||51
3183172|NCT02006576|3911439|FG002|STARTED|Overall Study||32
3183173|NCT02006576|3911437|FG000|COMPLETED|Overall Study||17
3183174|NCT02006576|3911438|FG001|COMPLETED|Overall Study||44
3183175|NCT02006576|3911439|FG002|COMPLETED|Overall Study||15
3183176|NCT02006576|3911437|FG000|NOT COMPLETED|Overall Study||18
3183177|NCT02006576|3911438|FG001|NOT COMPLETED|Overall Study||7
3183178|NCT02006576|3911439|FG002|NOT COMPLETED|Overall Study||17
3183179|NCT02006628|3911449|FG000|STARTED|Overall Study||43
3183180|NCT02006628|3911450|FG001|STARTED|Overall Study||45
3183181|NCT02006628|3911449|FG000|Received at Least 1 Dose of Study Drug|Overall Study||43
3183182|NCT02006628|3911450|FG001|Received at Least 1 Dose of Study Drug|Overall Study||45
3183183|NCT02006628|3911449|FG000|Intention to Treat (ITT) Analysis Set|Overall Study||42
3183184|NCT02006628|3911450|FG001|Intention to Treat (ITT) Analysis Set|Overall Study||44
3183185|NCT02006628|3911449|FG000|COMPLETED|Overall Study||40
3183186|NCT02006628|3911450|FG001|COMPLETED|Overall Study||43
3152044|NCT01809262|3878256|FG002|STARTED|Period 1 (First Dose + Washout)||4
3152045|NCT01809262|3878257|FG003|STARTED|Period 1 (First Dose + Washout)||3
3152046|NCT01809262|3878258|FG004|STARTED|Period 1 (First Dose + Washout)||4
3152047|NCT01809262|3878259|FG005|STARTED|Period 1 (First Dose + Washout)||3
3152048|NCT01809262|3878260|FG006|STARTED|Period 1 (First Dose + Washout)||3
3152049|NCT01809262|3878261|FG007|STARTED|Period 1 (First Dose + Washout)||4
3152050|NCT01809262|3878262|FG008|STARTED|Period 1 (First Dose + Washout)||3
3152051|NCT01809262|3878263|FG009|STARTED|Period 1 (First Dose + Washout)||4
3152052|NCT01809262|3878254|FG000|COMPLETED|Period 1 (First Dose + Washout)||4
3152053|NCT01809262|3878255|FG001|COMPLETED|Period 1 (First Dose + Washout)||4
3152054|NCT01809262|3878256|FG002|COMPLETED|Period 1 (First Dose + Washout)||4
3152055|NCT01809262|3878257|FG003|COMPLETED|Period 1 (First Dose + Washout)||3
3152056|NCT01809262|3878258|FG004|COMPLETED|Period 1 (First Dose + Washout)||3
3152057|NCT01809262|3878259|FG005|COMPLETED|Period 1 (First Dose + Washout)||3
3152058|NCT01809262|3878260|FG006|COMPLETED|Period 1 (First Dose + Washout)||3
3152059|NCT01809262|3878261|FG007|COMPLETED|Period 1 (First Dose + Washout)||4
3152060|NCT01809262|3878262|FG008|COMPLETED|Period 1 (First Dose + Washout)||3
3152061|NCT01809262|3878263|FG009|COMPLETED|Period 1 (First Dose + Washout)||4
3152062|NCT01809262|3878254|FG000|NOT COMPLETED|Period 1 (First Dose + Washout)||0
3152063|NCT01809262|3878255|FG001|NOT COMPLETED|Period 1 (First Dose + Washout)||0
3152064|NCT01809262|3878256|FG002|NOT COMPLETED|Period 1 (First Dose + Washout)||0
3152065|NCT01809262|3878257|FG003|NOT COMPLETED|Period 1 (First Dose + Washout)||0
3152066|NCT01809262|3878258|FG004|NOT COMPLETED|Period 1 (First Dose + Washout)||1
3152067|NCT01809262|3878259|FG005|NOT COMPLETED|Period 1 (First Dose + Washout)||0
3152068|NCT01809262|3878260|FG006|NOT COMPLETED|Period 1 (First Dose + Washout)||0
3152069|NCT01809262|3878261|FG007|NOT COMPLETED|Period 1 (First Dose + Washout)||0
3152070|NCT01809262|3878262|FG008|NOT COMPLETED|Period 1 (First Dose + Washout)||0
3152071|NCT01809262|3878263|FG009|NOT COMPLETED|Period 1 (First Dose + Washout)||0
3152072|NCT01809262|3878254|FG000|STARTED|Period 2 (Second Dose + Washout)||4
3183187|NCT02006628|3911449|FG000|NOT COMPLETED|Overall Study||3
3183188|NCT02006628|3911450|FG001|NOT COMPLETED|Overall Study||2
3152073|NCT01809262|3878255|FG001|STARTED|Period 2 (Second Dose + Washout)||4
3152074|NCT01809262|3878256|FG002|STARTED|Period 2 (Second Dose + Washout)||4
3152075|NCT01809262|3878257|FG003|STARTED|Period 2 (Second Dose + Washout)||3
3152076|NCT01809262|3878258|FG004|STARTED|Period 2 (Second Dose + Washout)||3
3152077|NCT01809262|3878259|FG005|STARTED|Period 2 (Second Dose + Washout)||3
3152078|NCT01809262|3878260|FG006|STARTED|Period 2 (Second Dose + Washout)||3
3152079|NCT01809262|3878261|FG007|STARTED|Period 2 (Second Dose + Washout)||4
3152080|NCT01809262|3878262|FG008|STARTED|Period 2 (Second Dose + Washout)||3
3152081|NCT01809262|3878263|FG009|STARTED|Period 2 (Second Dose + Washout)||4
3152082|NCT01809262|3878254|FG000|COMPLETED|Period 2 (Second Dose + Washout)||4
3152083|NCT01809262|3878255|FG001|COMPLETED|Period 2 (Second Dose + Washout)||4
3152084|NCT01809262|3878256|FG002|COMPLETED|Period 2 (Second Dose + Washout)||4
3152085|NCT01809262|3878257|FG003|COMPLETED|Period 2 (Second Dose + Washout)||3
3152086|NCT01809262|3878258|FG004|COMPLETED|Period 2 (Second Dose + Washout)||3
3152087|NCT01809262|3878259|FG005|COMPLETED|Period 2 (Second Dose + Washout)||3
3152088|NCT01809262|3878260|FG006|COMPLETED|Period 2 (Second Dose + Washout)||3
3152089|NCT01809262|3878261|FG007|COMPLETED|Period 2 (Second Dose + Washout)||4
3152090|NCT01809262|3878262|FG008|COMPLETED|Period 2 (Second Dose + Washout)||3
3152091|NCT01809262|3878263|FG009|COMPLETED|Period 2 (Second Dose + Washout)||4
3152092|NCT01809262|3878254|FG000|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
3152093|NCT01809262|3878255|FG001|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
3152094|NCT01809262|3878256|FG002|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
3152095|NCT01809262|3878257|FG003|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
3152096|NCT01809262|3878258|FG004|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
3152097|NCT01809262|3878259|FG005|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
3152098|NCT01809262|3878260|FG006|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
3152099|NCT01809262|3878261|FG007|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
3152100|NCT01809262|3878262|FG008|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
3152101|NCT01809262|3878263|FG009|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
3152102|NCT01809262|3878254|FG000|STARTED|Period 3 (Third Dose + Washout)||4
3152103|NCT01809262|3878255|FG001|STARTED|Period 3 (Third Dose + Washout)||4
3152104|NCT01809262|3878256|FG002|STARTED|Period 3 (Third Dose + Washout)||4
3152105|NCT01809262|3878257|FG003|STARTED|Period 3 (Third Dose + Washout)||3
3152106|NCT01809262|3878258|FG004|STARTED|Period 3 (Third Dose + Washout)||3
3152107|NCT01809262|3878259|FG005|STARTED|Period 3 (Third Dose + Washout)||3
3152108|NCT01809262|3878260|FG006|STARTED|Period 3 (Third Dose + Washout)||3
3152109|NCT01809262|3878261|FG007|STARTED|Period 3 (Third Dose + Washout)||4
3152110|NCT01809262|3878262|FG008|STARTED|Period 3 (Third Dose + Washout)||3
3152111|NCT01809262|3878263|FG009|STARTED|Period 3 (Third Dose + Washout)||4
3152112|NCT01809262|3878254|FG000|COMPLETED|Period 3 (Third Dose + Washout)||4
3152113|NCT01809262|3878255|FG001|COMPLETED|Period 3 (Third Dose + Washout)||3
3152114|NCT01809262|3878256|FG002|COMPLETED|Period 3 (Third Dose + Washout)||4
3152115|NCT01809262|3878257|FG003|COMPLETED|Period 3 (Third Dose + Washout)||3
3152116|NCT01809262|3878258|FG004|COMPLETED|Period 3 (Third Dose + Washout)||3
3152117|NCT01809262|3878259|FG005|COMPLETED|Period 3 (Third Dose + Washout)||3
3152118|NCT01809262|3878260|FG006|COMPLETED|Period 3 (Third Dose + Washout)||3
3152119|NCT01809262|3878261|FG007|COMPLETED|Period 3 (Third Dose + Washout)||4
3152120|NCT01809262|3878262|FG008|COMPLETED|Period 3 (Third Dose + Washout)||3
3152121|NCT01809262|3878263|FG009|COMPLETED|Period 3 (Third Dose + Washout)||4
3152122|NCT01809262|3878254|FG000|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
3183189|NCT02006641|3911459|FG000|STARTED|Overall Study||284
3152123|NCT01809262|3878255|FG001|NOT COMPLETED|Period 3 (Third Dose + Washout)||1
3152124|NCT01809262|3878256|FG002|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
3152125|NCT01809262|3878257|FG003|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
3152126|NCT01809262|3878258|FG004|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
3152127|NCT01809262|3878259|FG005|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
3152128|NCT01809262|3878260|FG006|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
3152129|NCT01809262|3878261|FG007|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
3152130|NCT01809262|3878262|FG008|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
3152131|NCT01809262|3878263|FG009|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
3152132|NCT01809262|3878254|FG000|STARTED|Period 4 (Fourth Dose + Washout)||4
3152133|NCT01809262|3878255|FG001|STARTED|Period 4 (Fourth Dose + Washout)||3
3152134|NCT01809262|3878256|FG002|STARTED|Period 4 (Fourth Dose + Washout)||4
3152135|NCT01809262|3878257|FG003|STARTED|Period 4 (Fourth Dose + Washout)||3
3152136|NCT01809262|3878258|FG004|STARTED|Period 4 (Fourth Dose + Washout)||3
3152137|NCT01809262|3878259|FG005|STARTED|Period 4 (Fourth Dose + Washout)||3
3152138|NCT01809262|3878260|FG006|STARTED|Period 4 (Fourth Dose + Washout)||3
3152139|NCT01809262|3878261|FG007|STARTED|Period 4 (Fourth Dose + Washout)||4
3152140|NCT01809262|3878262|FG008|STARTED|Period 4 (Fourth Dose + Washout)||3
3152141|NCT01809262|3878263|FG009|STARTED|Period 4 (Fourth Dose + Washout)||4
3152142|NCT01809262|3878254|FG000|COMPLETED|Period 4 (Fourth Dose + Washout)||4
3152143|NCT01809262|3878255|FG001|COMPLETED|Period 4 (Fourth Dose + Washout)||3
3152144|NCT01809262|3878256|FG002|COMPLETED|Period 4 (Fourth Dose + Washout)||4
3152145|NCT01809262|3878257|FG003|COMPLETED|Period 4 (Fourth Dose + Washout)||3
3152146|NCT01809262|3878258|FG004|COMPLETED|Period 4 (Fourth Dose + Washout)||3
3152147|NCT01809262|3878259|FG005|COMPLETED|Period 4 (Fourth Dose + Washout)||3
3152148|NCT01809262|3878260|FG006|COMPLETED|Period 4 (Fourth Dose + Washout)||3
3152149|NCT01809262|3878261|FG007|COMPLETED|Period 4 (Fourth Dose + Washout)||4
3152150|NCT01809262|3878262|FG008|COMPLETED|Period 4 (Fourth Dose + Washout)||3
3152151|NCT01809262|3878263|FG009|COMPLETED|Period 4 (Fourth Dose + Washout)||4
3152152|NCT01809262|3878254|FG000|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
3152153|NCT01809262|3878255|FG001|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
3152154|NCT01809262|3878256|FG002|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
3152155|NCT01809262|3878257|FG003|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
3152156|NCT01809262|3878258|FG004|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
3152157|NCT01809262|3878259|FG005|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
3152158|NCT01809262|3878260|FG006|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
3152159|NCT01809262|3878261|FG007|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
3152160|NCT01809262|3878262|FG008|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
3152161|NCT01809262|3878263|FG009|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
3152162|NCT01809262|3878254|FG000|STARTED|Period 5 (Fifth Dose + Washout)||4
3152163|NCT01809262|3878255|FG001|STARTED|Period 5 (Fifth Dose + Washout)||3
3152164|NCT01809262|3878256|FG002|STARTED|Period 5 (Fifth Dose + Washout)||4
3152165|NCT01809262|3878257|FG003|STARTED|Period 5 (Fifth Dose + Washout)||3
3152166|NCT01809262|3878258|FG004|STARTED|Period 5 (Fifth Dose + Washout)||3
3152167|NCT01809262|3878259|FG005|STARTED|Period 5 (Fifth Dose + Washout)||3
3152168|NCT01809262|3878260|FG006|STARTED|Period 5 (Fifth Dose + Washout)||3
3152169|NCT01809262|3878261|FG007|STARTED|Period 5 (Fifth Dose + Washout)||4
3152170|NCT01809262|3878262|FG008|STARTED|Period 5 (Fifth Dose + Washout)||3
3152171|NCT01809262|3878263|FG009|STARTED|Period 5 (Fifth Dose + Washout)||4
3152172|NCT01809262|3878254|FG000|COMPLETED|Period 5 (Fifth Dose + Washout)||4
3152173|NCT01809262|3878255|FG001|COMPLETED|Period 5 (Fifth Dose + Washout)||3
3183190|NCT02006641|3911460|FG001|STARTED|Overall Study||290
3183191|NCT02006641|3911461|FG002|STARTED|Overall Study||284
3183192|NCT02006641|3911459|FG000|Treated|Overall Study||282
3183193|NCT02006641|3911460|FG001|Treated|Overall Study||285
3183194|NCT02006641|3911461|FG002|Treated|Overall Study||281
3183195|NCT02006641|3911459|FG000|COMPLETED|Overall Study||258
3183196|NCT02006641|3911460|FG001|COMPLETED|Overall Study||257
3183197|NCT02006641|3911461|FG002|COMPLETED|Overall Study||248
3183198|NCT02006641|3911459|FG000|NOT COMPLETED|Overall Study||26
3183199|NCT02006641|3911460|FG001|NOT COMPLETED|Overall Study||33
3183200|NCT02006641|3911461|FG002|NOT COMPLETED|Overall Study||36
3183201|NCT02006654|3911471|FG000|STARTED|Overall Study||369
3183202|NCT02006654|3911472|FG001|STARTED|Overall Study||365
3183203|NCT02006654|3911471|FG000|Treated|Overall Study||365
3183204|NCT02006654|3911472|FG001|Treated|Overall Study||363
3183205|NCT02006654|3911471|FG000|COMPLETED|Overall Study||324
3183206|NCT02006654|3911472|FG001|COMPLETED|Overall Study||321
3183207|NCT02006654|3911471|FG000|NOT COMPLETED|Overall Study||45
3183208|NCT02006654|3911472|FG001|NOT COMPLETED|Overall Study||44
3183209|NCT02006667|3911479|FG000|STARTED|Overall Study||13
3183210|NCT02006667|3911479|FG000|COMPLETED|Overall Study||7
3183211|NCT02006667|3911479|FG000|NOT COMPLETED|Overall Study||6
3183212|NCT02006693|3911485|FG000|STARTED|Overall Study||112
3183213|NCT02006693|3911486|FG001|STARTED|Overall Study||87
3183214|NCT02006693|3911485|FG000|COMPLETED|Overall Study||84
3183215|NCT02006693|3911486|FG001|COMPLETED|Overall Study||74
3183216|NCT02006693|3911485|FG000|NOT COMPLETED|Overall Study||28
3183217|NCT02006693|3911486|FG001|NOT COMPLETED|Overall Study||13
3183218|NCT02006706|3911492|FG000|STARTED|Overall Study||15
3183219|NCT02006706|3911492|FG000|COMPLETED|Overall Study||14
3183220|NCT02006706|3911492|FG000|NOT COMPLETED|Overall Study||1
3183221|NCT02006719|3911498|FG000|STARTED|Overall Study||237
3152174|NCT01809262|3878256|FG002|COMPLETED|Period 5 (Fifth Dose + Washout)||4
3152175|NCT01809262|3878257|FG003|COMPLETED|Period 5 (Fifth Dose + Washout)||3
3152176|NCT01809262|3878258|FG004|COMPLETED|Period 5 (Fifth Dose + Washout)||3
3152177|NCT01809262|3878259|FG005|COMPLETED|Period 5 (Fifth Dose + Washout)||3
3152178|NCT01809262|3878260|FG006|COMPLETED|Period 5 (Fifth Dose + Washout)||3
3152179|NCT01809262|3878261|FG007|COMPLETED|Period 5 (Fifth Dose + Washout)||4
3152180|NCT01809262|3878262|FG008|COMPLETED|Period 5 (Fifth Dose + Washout)||3
3152181|NCT01809262|3878263|FG009|COMPLETED|Period 5 (Fifth Dose + Washout)||4
3152182|NCT01809262|3878254|FG000|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
3152183|NCT01809262|3878255|FG001|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
3152184|NCT01809262|3878256|FG002|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
3152185|NCT01809262|3878257|FG003|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
3152186|NCT01809262|3878258|FG004|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
3152187|NCT01809262|3878259|FG005|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
3152188|NCT01809262|3878260|FG006|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
3152189|NCT01809262|3878261|FG007|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
3152190|NCT01809262|3878262|FG008|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
3152191|NCT01809262|3878263|FG009|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
3152192|NCT01809314|3878275|FG000|STARTED|Overall Study||1167
3152193|NCT01809314|3878275|FG000|COMPLETED|Overall Study||422
3152194|NCT01809314|3878275|FG000|NOT COMPLETED|Overall Study||745
3152195|NCT01809327|3878284|FG000|STARTED|Overall Study||237
3152196|NCT01809327|3878285|FG001|STARTED|Overall Study||237
3152197|NCT01809327|3878286|FG002|STARTED|Overall Study||238
3152198|NCT01809327|3878287|FG003|STARTED|Overall Study||237
3152199|NCT01809327|3878288|FG004|STARTED|Overall Study||237
3152200|NCT01809327|3878284|FG000|COMPLETED|Overall Study||205
3152201|NCT01809327|3878285|FG001|COMPLETED|Overall Study||211
3152202|NCT01809327|3878286|FG002|COMPLETED|Overall Study||216
3152203|NCT01809327|3878287|FG003|COMPLETED|Overall Study||225
3152204|NCT01809327|3878288|FG004|COMPLETED|Overall Study||212
3152205|NCT01809327|3878284|FG000|NOT COMPLETED|Overall Study||32
3152206|NCT01809327|3878285|FG001|NOT COMPLETED|Overall Study||26
3152207|NCT01809327|3878286|FG002|NOT COMPLETED|Overall Study||22
3152208|NCT01809327|3878287|FG003|NOT COMPLETED|Overall Study||12
3152209|NCT01809327|3878288|FG004|NOT COMPLETED|Overall Study||25
3152210|NCT01809639|3878302|FG000|STARTED|Overall Study||18
3152211|NCT01809639|3878303|FG001|STARTED|Overall Study||7
3152212|NCT01809639|3878302|FG000|COMPLETED|Overall Study||18
3152213|NCT01809639|3878303|FG001|COMPLETED|Overall Study||7
3152214|NCT01809639|3878302|FG000|NOT COMPLETED|Overall Study||0
3152215|NCT01809639|3878303|FG001|NOT COMPLETED|Overall Study||0
3152216|NCT01809834|3878309|FG000|STARTED|Overall Study||44
3152217|NCT01809834|3878309|FG000|COMPLETED|Overall Study||44
3152218|NCT01809834|3878309|FG000|NOT COMPLETED|Overall Study||0
3152219|NCT01809938|3878315|FG000|STARTED|First Intervention (170 Minutes)||5
3152220|NCT01809938|3878316|FG001|STARTED|First Intervention (170 Minutes)||5
3152221|NCT01809938|3878315|FG000|COMPLETED|First Intervention (170 Minutes)||5
3152222|NCT01809938|3878316|FG001|COMPLETED|First Intervention (170 Minutes)||5
3152223|NCT01809938|3878315|FG000|NOT COMPLETED|First Intervention (170 Minutes)||0
3152224|NCT01809938|3878316|FG001|NOT COMPLETED|First Intervention (170 Minutes)||0
3152225|NCT01809938|3878315|FG000|STARTED|Washout (Not Less Than 24 Hours)||5
3152226|NCT01809938|3878316|FG001|STARTED|Washout (Not Less Than 24 Hours)||5
3152227|NCT01809938|3878315|FG000|COMPLETED|Washout (Not Less Than 24 Hours)||5
3152228|NCT01809938|3878316|FG001|COMPLETED|Washout (Not Less Than 24 Hours)||5
3152229|NCT01809938|3878315|FG000|NOT COMPLETED|Washout (Not Less Than 24 Hours)||0
3152230|NCT01809938|3878316|FG001|NOT COMPLETED|Washout (Not Less Than 24 Hours)||0
3152231|NCT01809938|3878315|FG000|STARTED|Second Intervention (170 Minutes)||5
3152232|NCT01809938|3878316|FG001|STARTED|Second Intervention (170 Minutes)||5
3152233|NCT01809938|3878315|FG000|COMPLETED|Second Intervention (170 Minutes)||5
3152234|NCT01809938|3878316|FG001|COMPLETED|Second Intervention (170 Minutes)||5
3152235|NCT01809938|3878315|FG000|NOT COMPLETED|Second Intervention (170 Minutes)||0
3152236|NCT01809938|3878316|FG001|NOT COMPLETED|Second Intervention (170 Minutes)||0
3152237|NCT01810016|3878324|FG000|STARTED|Overall Study||5
3152238|NCT01810016|3878325|FG001|STARTED|Overall Study||2
3152239|NCT01810016|3878326|FG002|STARTED|Overall Study||1
3152240|NCT01810016|3878324|FG000|COMPLETED|Overall Study||4
3152241|NCT01810016|3878325|FG001|COMPLETED|Overall Study||1
3152242|NCT01810016|3878326|FG002|COMPLETED|Overall Study||0
3152243|NCT01810016|3878324|FG000|NOT COMPLETED|Overall Study||1
3152244|NCT01810016|3878325|FG001|NOT COMPLETED|Overall Study||1
3152245|NCT01810016|3878326|FG002|NOT COMPLETED|Overall Study||1
3152246|NCT01810042|3878334|FG000|STARTED|Overall Study||49
3152247|NCT01810042|3878334|FG000|COMPLETED|Overall Study||39
3152248|NCT01810042|3878334|FG000|NOT COMPLETED|Overall Study||10
3152249|NCT01810263|3878340|FG000|STARTED|Overall Study||16
3152250|NCT01810263|3878341|FG001|STARTED|Overall Study||18
3152251|NCT01810263|3878340|FG000|COMPLETED|Overall Study|2014 July|8
3152252|NCT01810263|3878341|FG001|COMPLETED|Overall Study||11
3152253|NCT01810263|3878340|FG000|NOT COMPLETED|Overall Study||8
3152254|NCT01810263|3878341|FG001|NOT COMPLETED|Overall Study||7
3183222|NCT02006719|3911499|FG001|STARTED|Overall Study||85
3183223|NCT02006719|3911498|FG000|COMPLETED|Overall Study||219
3183224|NCT02006719|3911499|FG001|COMPLETED|Overall Study||80
3183225|NCT02006719|3911498|FG000|NOT COMPLETED|Overall Study||18
3183226|NCT02006719|3911499|FG001|NOT COMPLETED|Overall Study||5
3152255|NCT01810289|3878349|FG000|STARTED|Overall Study||7277
3152256|NCT01810289|3878350|FG001|STARTED|Overall Study||4747
3152257|NCT01810289|3878349|FG000|COMPLETED|Overall Study||7277
3152258|NCT01810289|3878350|FG001|COMPLETED|Overall Study||4747
3152259|NCT01810289|3878349|FG000|NOT COMPLETED|Overall Study||0
3152260|NCT01810289|3878350|FG001|NOT COMPLETED|Overall Study||0
3152261|NCT01810380|3878359|FG000|STARTED|Overall Study||163
3152262|NCT01810380|3878360|FG001|STARTED|Overall Study||151
3152263|NCT01810380|3878361|FG002|STARTED|Overall Study||154
3152264|NCT01810380|3878359|FG000|Treated|Overall Study||161
3152265|NCT01810380|3878360|FG001|Treated|Overall Study||150
3152266|NCT01810380|3878361|FG002|Treated|Overall Study||153
3152267|NCT01810380|3878359|FG000|COMPLETED|Overall Study||108
3152268|NCT01810380|3878360|FG001|COMPLETED|Overall Study||113
3152269|NCT01810380|3878361|FG002|COMPLETED|Overall Study||122
3152270|NCT01810380|3878359|FG000|NOT COMPLETED|Overall Study||55
3152271|NCT01810380|3878360|FG001|NOT COMPLETED|Overall Study||38
3152272|NCT01810380|3878361|FG002|NOT COMPLETED|Overall Study||32
3152273|NCT01810432|3878369|FG000|STARTED|Period 1||20
3152274|NCT01810432|3878370|FG001|STARTED|Period 1||20
3152275|NCT01810432|3878369|FG000|Received at Least 1 Dose of Study Drug|Period 1||20
3152276|NCT01810432|3878370|FG001|Received at Least 1 Dose of Study Drug|Period 1||20
3152277|NCT01810432|3878369|FG000|COMPLETED|Period 1||20
3152278|NCT01810432|3878370|FG001|COMPLETED|Period 1||20
3152279|NCT01810432|3878369|FG000|NOT COMPLETED|Period 1||0
3152280|NCT01810432|3878370|FG001|NOT COMPLETED|Period 1||0
3152281|NCT01810432|3878369|FG000|STARTED|Washout||20
3152282|NCT01810432|3878370|FG001|STARTED|Washout||20
3152283|NCT01810432|3878369|FG000|COMPLETED|Washout||19
3152284|NCT01810432|3878370|FG001|COMPLETED|Washout||19
3152285|NCT01810432|3878369|FG000|NOT COMPLETED|Washout||1
3152286|NCT01810432|3878370|FG001|NOT COMPLETED|Washout||1
3152287|NCT01810432|3878369|FG000|STARTED|Period 2||19
3152288|NCT01810432|3878370|FG001|STARTED|Period 2||19
3152289|NCT01810432|3878369|FG000|Received at Least 1 Dose of Study Drug|Period 2||19
3152290|NCT01810432|3878370|FG001|Received at Least 1 Dose of Study Drug|Period 2||19
3152291|NCT01810432|3878369|FG000|COMPLETED|Period 2||15
3152292|NCT01810432|3878370|FG001|COMPLETED|Period 2||17
3152293|NCT01810432|3878369|FG000|NOT COMPLETED|Period 2||4
3152294|NCT01810432|3878370|FG001|NOT COMPLETED|Period 2||2
3152295|NCT01810666|3878376|FG000|STARTED|Overall Study||30
3152296|NCT01810666|3878376|FG000|COMPLETED|Overall Study||30
3152297|NCT01810666|3878376|FG000|NOT COMPLETED|Overall Study||0
3152298|NCT01810692|3878382|FG000|STARTED|Overall Study||77
3152299|NCT01810692|3878383|FG001|STARTED|Overall Study||77
3152300|NCT01810692|3878382|FG000|COMPLETED|Overall Study||77
3152301|NCT01810692|3878383|FG001|COMPLETED|Overall Study||77
3152302|NCT01810692|3878382|FG000|NOT COMPLETED|Overall Study||0
3152303|NCT01810692|3878383|FG001|NOT COMPLETED|Overall Study||0
3152304|NCT01810783|3878389|FG000|STARTED|Overall Study||210
3152305|NCT01810783|3878389|FG000|COMPLETED|Overall Study||101
3152306|NCT01810783|3878389|FG000|NOT COMPLETED|Overall Study||109
3152307|NCT01810939|3878393|FG000|STARTED|Part A Treatment Period||243
3152308|NCT01810939|3878394|FG001|STARTED|Part A Treatment Period||0
3152309|NCT01810939|3878395|FG002|STARTED|Part A Treatment Period||0
3152310|NCT01810939|3878393|FG000|COMPLETED|Part A Treatment Period||219
3152311|NCT01810939|3878394|FG001|COMPLETED|Part A Treatment Period||0
3152312|NCT01810939|3878395|FG002|COMPLETED|Part A Treatment Period||0
3152313|NCT01810939|3878393|FG000|NOT COMPLETED|Part A Treatment Period||24
3152314|NCT01810939|3878394|FG001|NOT COMPLETED|Part A Treatment Period||0
3152315|NCT01810939|3878395|FG002|NOT COMPLETED|Part A Treatment Period||0
3152316|NCT01810939|3878393|FG000|STARTED|Part B Placebo-Controlled Withdrawal||0
3152317|NCT01810939|3878394|FG001|STARTED|Part B Placebo-Controlled Withdrawal|Part A participants with Part A baseline serum potassium ≥ 5.5 mEq/L who responded to treatment|55
3152318|NCT01810939|3878395|FG002|STARTED|Part B Placebo-Controlled Withdrawal|Part A participants with Part A baseline serum potassium ≥ 5.5 mEq/L who responded to treatment|52
3152319|NCT01810939|3878393|FG000|COMPLETED|Part B Placebo-Controlled Withdrawal||0
3152320|NCT01810939|3878394|FG001|COMPLETED|Part B Placebo-Controlled Withdrawal||45
3152321|NCT01810939|3878395|FG002|COMPLETED|Part B Placebo-Controlled Withdrawal||30
3152322|NCT01810939|3878393|FG000|NOT COMPLETED|Part B Placebo-Controlled Withdrawal||0
3152323|NCT01810939|3878394|FG001|NOT COMPLETED|Part B Placebo-Controlled Withdrawal||10
3152324|NCT01810939|3878395|FG002|NOT COMPLETED|Part B Placebo-Controlled Withdrawal||22
3152325|NCT01810952|3878406|FG000|STARTED|Overall Study||20
3183227|NCT02006732|3911509|FG000|STARTED|Overall Study||202
3183228|NCT02006732|3911510|FG001|STARTED|Overall Study||203
3183229|NCT02006732|3911511|FG002|STARTED|Overall Study||202
3183230|NCT02006732|3911512|FG003|STARTED|Overall Study||202
3183231|NCT02006732|3911509|FG000|COMPLETED|Overall Study||182
3183232|NCT02006732|3911510|FG001|COMPLETED|Overall Study||191
3183233|NCT02006732|3911511|FG002|COMPLETED|Overall Study||193
3183234|NCT02006732|3911512|FG003|COMPLETED|Overall Study||198
3183235|NCT02006732|3911509|FG000|NOT COMPLETED|Overall Study||20
3183236|NCT02006732|3911510|FG001|NOT COMPLETED|Overall Study||12
3183237|NCT02006732|3911511|FG002|NOT COMPLETED|Overall Study||9
3183238|NCT02006732|3911512|FG003|NOT COMPLETED|Overall Study||4
3183239|NCT02006758|3911522|FG000|STARTED|Overall Study|Total number of enrolled participants|68
3152326|NCT01810952|3878407|FG001|STARTED|Overall Study||17
3152327|NCT01810952|3878406|FG000|COMPLETED|Overall Study||20
3152328|NCT01810952|3878407|FG001|COMPLETED|Overall Study||17
3152329|NCT01810952|3878406|FG000|NOT COMPLETED|Overall Study||0
3152330|NCT01810952|3878407|FG001|NOT COMPLETED|Overall Study||0
3152331|NCT01810991|3878419|FG000|STARTED|Overall Study||19
3152332|NCT01810991|3878419|FG000|COMPLETED|Overall Study||17
3152333|NCT01810991|3878419|FG000|NOT COMPLETED|Overall Study||2
3152334|NCT01811004|3878425|FG000|STARTED|Overall Study||9
3152335|NCT01811004|3878426|FG001|STARTED|Overall Study||8
3152336|NCT01811004|3878425|FG000|COMPLETED|Overall Study||8
3152337|NCT01811004|3878426|FG001|COMPLETED|Overall Study||5
3152338|NCT01811004|3878425|FG000|NOT COMPLETED|Overall Study||1
3152339|NCT01811004|3878426|FG001|NOT COMPLETED|Overall Study||3
3152340|NCT01811030|3878434|FG000|STARTED|Overall Study||33
3152341|NCT01811030|3878434|FG000|COMPLETED|Overall Study||20
3152342|NCT01811030|3878434|FG000|NOT COMPLETED|Overall Study||13
3152343|NCT01811147|3878442|FG000|STARTED|Overall Study||51
3152344|NCT01811147|3878443|FG001|STARTED|Overall Study||56
3152345|NCT01811147|3878444|FG002|STARTED|Overall Study||49
3152346|NCT01811147|3878445|FG003|STARTED|Overall Study||33
3152347|NCT01811147|3878442|FG000|COMPLETED|Overall Study||15
3152348|NCT01811147|3878443|FG001|COMPLETED|Overall Study||11
3152349|NCT01811147|3878444|FG002|COMPLETED|Overall Study||6
3152350|NCT01811147|3878445|FG003|COMPLETED|Overall Study||4
3152351|NCT01811147|3878442|FG000|NOT COMPLETED|Overall Study||36
3152352|NCT01811147|3878443|FG001|NOT COMPLETED|Overall Study||45
3152353|NCT01811147|3878444|FG002|NOT COMPLETED|Overall Study||43
3152354|NCT01811147|3878445|FG003|NOT COMPLETED|Overall Study||29
3152355|NCT01811186|3878457|FG000|STARTED|Overall Study||132
3152356|NCT01811186|3878458|FG001|STARTED|Overall Study||126
3152357|NCT01811186|3878457|FG000|COMPLETED|Overall Study||61
3152358|NCT01811186|3878458|FG001|COMPLETED|Overall Study||64
3152359|NCT01811186|3878457|FG000|NOT COMPLETED|Overall Study||71
3152360|NCT01811186|3878458|FG001|NOT COMPLETED|Overall Study||62
3152361|NCT01811212|3878468|FG000|STARTED|Overall Study||25
3152362|NCT01811212|3878468|FG000|COMPLETED|Overall Study||25
3152363|NCT01811212|3878468|FG000|NOT COMPLETED|Overall Study||0
3152364|NCT01811225|3878472|FG000|STARTED|Treatment Period 1||49
3152365|NCT01811225|3878473|FG001|STARTED|Treatment Period 1||46
3152366|NCT01811225|3878472|FG000|COMPLETED|Treatment Period 1|53 completed one arm of the cross-over and 43 completed two arms of the cross-over|24
3152367|NCT01811225|3878473|FG001|COMPLETED|Treatment Period 1||29
3152368|NCT01811225|3878472|FG000|NOT COMPLETED|Treatment Period 1||25
3152369|NCT01811225|3878473|FG001|NOT COMPLETED|Treatment Period 1||17
3152370|NCT01811225|3878472|FG000|STARTED|Treatment Period 2||24
3152371|NCT01811225|3878473|FG001|STARTED|Treatment Period 2||29
3152372|NCT01811225|3878472|FG000|COMPLETED|Treatment Period 2||20
3152373|NCT01811225|3878473|FG001|COMPLETED|Treatment Period 2||23
3152374|NCT01811225|3878472|FG000|NOT COMPLETED|Treatment Period 2||4
3152375|NCT01811225|3878473|FG001|NOT COMPLETED|Treatment Period 2||6
3152376|NCT01811238|3878479|FG000|STARTED|Overall Study|First patient was recruited on 26 Sep. 2012.|240
3152377|NCT01811238|3878479|FG000|Safety Set|Overall Study|20 subjects excluded from the safety set due to study drug not administered.|220
3152378|NCT01811238|3878479|FG000|ITT Set|Overall Study|11 subjects excluded from ITT set due to no primary efficacy assessment(5) and IC/EC violation(6).|209
3152379|NCT01811238|3878479|FG000|PP Set|Overall Study|89 subjects excluded from PP set due to various reasons.|120
3152380|NCT01811238|3878479|FG000|COMPLETED|Overall Study|159 subjects regardless PP set completed study visit.|159
3152381|NCT01811238|3878479|FG000|NOT COMPLETED|Overall Study||81
3183240|NCT02006758|3911522|FG000|Underwent Renal Denervation|Overall Study|Underwent renal denervation|67
3183241|NCT02006758|3911522|FG000|1-month Follow up|Overall Study|1-month follow up completed|66
3183242|NCT02006758|3911522|FG000|6-month Follow up|Overall Study|6-month follow up completed|60
3183243|NCT02006758|3911522|FG000|12-month Follow up|Overall Study|12-month follow up completed|55
3183244|NCT02006758|3911522|FG000|COMPLETED|Overall Study||55
3183245|NCT02006758|3911522|FG000|NOT COMPLETED|Overall Study||13
3183246|NCT02006836|3911530|FG000|STARTED|Case-control Period: Month 1- Month 6||20
3183247|NCT02006836|3911531|FG001|STARTED|Case-control Period: Month 1- Month 6||20
3183248|NCT02006836|3911532|FG002|STARTED|Case-control Period: Month 1- Month 6||0
3183249|NCT02006836|3911530|FG000|COMPLETED|Case-control Period: Month 1- Month 6||20
3183250|NCT02006836|3911531|FG001|COMPLETED|Case-control Period: Month 1- Month 6||20
3183251|NCT02006836|3911532|FG002|COMPLETED|Case-control Period: Month 1- Month 6||0
3183252|NCT02006836|3911530|FG000|NOT COMPLETED|Case-control Period: Month 1- Month 6||0
3183253|NCT02006836|3911531|FG001|NOT COMPLETED|Case-control Period: Month 1- Month 6||0
3183254|NCT02006836|3911532|FG002|NOT COMPLETED|Case-control Period: Month 1- Month 6||0
3183255|NCT02006836|3911530|FG000|STARTED|Self-control Period: Month 7-month 12||0
3183256|NCT02006836|3911531|FG001|STARTED|Self-control Period: Month 7-month 12||0
3183257|NCT02006836|3911532|FG002|STARTED|Self-control Period: Month 7-month 12||19
3183258|NCT02006836|3911530|FG000|COMPLETED|Self-control Period: Month 7-month 12||0
3183259|NCT02006836|3911531|FG001|COMPLETED|Self-control Period: Month 7-month 12||0
3183260|NCT02006836|3911532|FG002|COMPLETED|Self-control Period: Month 7-month 12||19
3183261|NCT02006836|3911530|FG000|NOT COMPLETED|Self-control Period: Month 7-month 12||0
3183262|NCT02006836|3911531|FG001|NOT COMPLETED|Self-control Period: Month 7-month 12||0
3183263|NCT02006836|3911532|FG002|NOT COMPLETED|Self-control Period: Month 7-month 12||0
3183264|NCT02006888|3911545|FG000|STARTED|Overall Study||158
3183265|NCT02006888|3911546|FG001|STARTED|Overall Study||156
3183266|NCT02006888|3911547|FG002|STARTED|Overall Study||80
3183267|NCT02006888|3911545|FG000|COMPLETED|Overall Study||122
3183268|NCT02006888|3911546|FG001|COMPLETED|Overall Study||122
3152382|NCT01811303|3878484|FG000|STARTED|First Intervention (1 Day)||4
3152383|NCT01811303|3878485|FG001|STARTED|First Intervention (1 Day)||4
3152384|NCT01811303|3878486|FG002|STARTED|First Intervention (1 Day)||4
3152385|NCT01811303|3878487|FG003|STARTED|First Intervention (1 Day)||2
3152386|NCT01811303|3878484|FG000|COMPLETED|First Intervention (1 Day)||4
3152387|NCT01811303|3878485|FG001|COMPLETED|First Intervention (1 Day)||4
3152388|NCT01811303|3878486|FG002|COMPLETED|First Intervention (1 Day)||4
3152389|NCT01811303|3878487|FG003|COMPLETED|First Intervention (1 Day)||2
3152390|NCT01811303|3878484|FG000|NOT COMPLETED|First Intervention (1 Day)||0
3152391|NCT01811303|3878485|FG001|NOT COMPLETED|First Intervention (1 Day)||0
3152392|NCT01811303|3878486|FG002|NOT COMPLETED|First Intervention (1 Day)||0
3152393|NCT01811303|3878487|FG003|NOT COMPLETED|First Intervention (1 Day)||0
3152394|NCT01811303|3878484|FG000|STARTED|Washout (2 Days or More)||4
3152395|NCT01811303|3878485|FG001|STARTED|Washout (2 Days or More)||4
3152396|NCT01811303|3878486|FG002|STARTED|Washout (2 Days or More)||4
3152397|NCT01811303|3878487|FG003|STARTED|Washout (2 Days or More)||2
3152398|NCT01811303|3878484|FG000|COMPLETED|Washout (2 Days or More)||4
3152399|NCT01811303|3878485|FG001|COMPLETED|Washout (2 Days or More)||4
3152400|NCT01811303|3878486|FG002|COMPLETED|Washout (2 Days or More)||4
3152401|NCT01811303|3878487|FG003|COMPLETED|Washout (2 Days or More)||2
3152402|NCT01811303|3878484|FG000|NOT COMPLETED|Washout (2 Days or More)||0
3152403|NCT01811303|3878485|FG001|NOT COMPLETED|Washout (2 Days or More)||0
3152404|NCT01811303|3878486|FG002|NOT COMPLETED|Washout (2 Days or More)||0
3152405|NCT01811303|3878487|FG003|NOT COMPLETED|Washout (2 Days or More)||0
3152406|NCT01811303|3878484|FG000|STARTED|Second Intervention (1 Day)||4
3152407|NCT01811303|3878485|FG001|STARTED|Second Intervention (1 Day)||4
3152408|NCT01811303|3878486|FG002|STARTED|Second Intervention (1 Day)||4
3152409|NCT01811303|3878487|FG003|STARTED|Second Intervention (1 Day)||2
3152410|NCT01811303|3878484|FG000|COMPLETED|Second Intervention (1 Day)||4
3152411|NCT01811303|3878485|FG001|COMPLETED|Second Intervention (1 Day)||4
3152412|NCT01811303|3878486|FG002|COMPLETED|Second Intervention (1 Day)||4
3152413|NCT01811303|3878487|FG003|COMPLETED|Second Intervention (1 Day)||2
3152414|NCT01811303|3878484|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
3152415|NCT01811303|3878485|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
3152416|NCT01811303|3878486|FG002|NOT COMPLETED|Second Intervention (1 Day)||0
3152417|NCT01811303|3878487|FG003|NOT COMPLETED|Second Intervention (1 Day)||0
3152418|NCT01811303|3878484|FG000|STARTED|Washout (2 Days or More)||4
3152419|NCT01811303|3878485|FG001|STARTED|Washout (2 Days or More)||4
3152420|NCT01811303|3878486|FG002|STARTED|Washout (2 Days or More)||4
3152421|NCT01811303|3878487|FG003|STARTED|Washout (2 Days or More)||2
3152422|NCT01811303|3878484|FG000|COMPLETED|Washout (2 Days or More)||4
3152423|NCT01811303|3878485|FG001|COMPLETED|Washout (2 Days or More)||4
3152424|NCT01811303|3878486|FG002|COMPLETED|Washout (2 Days or More)||4
3152425|NCT01811303|3878487|FG003|COMPLETED|Washout (2 Days or More)||2
3152426|NCT01811303|3878484|FG000|NOT COMPLETED|Washout (2 Days or More)||0
3152427|NCT01811303|3878485|FG001|NOT COMPLETED|Washout (2 Days or More)||0
3152428|NCT01811303|3878486|FG002|NOT COMPLETED|Washout (2 Days or More)||0
3183269|NCT02006888|3911547|FG002|COMPLETED|Overall Study||58
3183270|NCT02006888|3911545|FG000|NOT COMPLETED|Overall Study||36
3183271|NCT02006888|3911546|FG001|NOT COMPLETED|Overall Study||34
3183272|NCT02006888|3911547|FG002|NOT COMPLETED|Overall Study||22
3183273|NCT02006979|3911557|FG000|STARTED|Overall Study||14
3183274|NCT02006979|3911558|FG001|STARTED|Overall Study||13
3183275|NCT02006979|3911557|FG000|COMPLETED|Overall Study||13
3183276|NCT02006979|3911558|FG001|COMPLETED|Overall Study||11
3183277|NCT02006979|3911557|FG000|NOT COMPLETED|Overall Study||1
3183278|NCT02006979|3911558|FG001|NOT COMPLETED|Overall Study||2
3183279|NCT02007070|3911564|FG000|STARTED|Overall Study||38
3183280|NCT02007070|3911564|FG000|COMPLETED|Overall Study|Completed 2 years of treatment.|5
3183281|NCT02007070|3911564|FG000|NOT COMPLETED|Overall Study||33
3183282|NCT02007096|3911570|FG000|STARTED|Overall Study||63
3183283|NCT02007096|3911571|FG001|STARTED|Overall Study||64
3183284|NCT02007096|3911570|FG000|COMPLETED|Overall Study||52
3183285|NCT02007096|3911571|FG001|COMPLETED|Overall Study||48
3183286|NCT02007096|3911570|FG000|NOT COMPLETED|Overall Study||11
3183287|NCT02007096|3911571|FG001|NOT COMPLETED|Overall Study||16
3183288|NCT02007109|3911577|FG000|STARTED|Overall Study||193
3183289|NCT02007109|3911577|FG000|PACU Analysis|Overall Study||184
3183290|NCT02007109|3911577|FG000|COMPLETED|Overall Study||82
3183291|NCT02007109|3911577|FG000|NOT COMPLETED|Overall Study||111
3183292|NCT02007200|3911584|FG000|STARTED|Overall Study||55
3183293|NCT02007200|3911584|FG000|COMPLETED|Overall Study||55
3183294|NCT02007200|3911584|FG000|NOT COMPLETED|Overall Study||0
3183295|NCT02007252|3911590|FG000|STARTED|Overall Study||31
3183296|NCT02007252|3911591|FG001|STARTED|Overall Study||33
3183297|NCT02007252|3911590|FG000|Safety Analysis Set|Overall Study||31
3183298|NCT02007252|3911591|FG001|Safety Analysis Set|Overall Study||33
3183299|NCT02007252|3911590|FG000|Pharmacodynamic Analysis Set|Overall Study||31
3183300|NCT02007252|3911591|FG001|Pharmacodynamic Analysis Set|Overall Study||33
3183301|NCT02007252|3911590|FG000|COMPLETED|Overall Study||20
3183302|NCT02007252|3911591|FG001|COMPLETED|Overall Study||22
3183303|NCT02007252|3911590|FG000|NOT COMPLETED|Overall Study||11
3183304|NCT02007252|3911591|FG001|NOT COMPLETED|Overall Study||11
3183305|NCT02007278|3911599|FG000|STARTED|Overall Study||20
3183306|NCT02007278|3911600|FG001|STARTED|Overall Study||20
3183307|NCT02007278|3911599|FG000|COMPLETED|Overall Study||18
3152429|NCT01811303|3878487|FG003|NOT COMPLETED|Washout (2 Days or More)||0
3152430|NCT01811303|3878484|FG000|STARTED|Third Intervention (1 Day)||4
3152431|NCT01811303|3878485|FG001|STARTED|Third Intervention (1 Day)||4
3152432|NCT01811303|3878486|FG002|STARTED|Third Intervention (1 Day)||4
3152433|NCT01811303|3878487|FG003|STARTED|Third Intervention (1 Day)||2
3152434|NCT01811303|3878484|FG000|COMPLETED|Third Intervention (1 Day)||4
3152435|NCT01811303|3878485|FG001|COMPLETED|Third Intervention (1 Day)||4
3152436|NCT01811303|3878486|FG002|COMPLETED|Third Intervention (1 Day)||4
3152437|NCT01811303|3878487|FG003|COMPLETED|Third Intervention (1 Day)||2
3152438|NCT01811303|3878484|FG000|NOT COMPLETED|Third Intervention (1 Day)||0
3152439|NCT01811303|3878485|FG001|NOT COMPLETED|Third Intervention (1 Day)||0
3152440|NCT01811303|3878486|FG002|NOT COMPLETED|Third Intervention (1 Day)||0
3152441|NCT01811303|3878487|FG003|NOT COMPLETED|Third Intervention (1 Day)||0
3152442|NCT01811303|3878484|FG000|STARTED|Washout (2 Days or More)||4
3152443|NCT01811303|3878485|FG001|STARTED|Washout (2 Days or More)||4
3152444|NCT01811303|3878486|FG002|STARTED|Washout (2 Days or More)||4
3152445|NCT01811303|3878487|FG003|STARTED|Washout (2 Days or More)||2
3152446|NCT01811303|3878484|FG000|COMPLETED|Washout (2 Days or More)||4
3152447|NCT01811303|3878485|FG001|COMPLETED|Washout (2 Days or More)||4
3152448|NCT01811303|3878486|FG002|COMPLETED|Washout (2 Days or More)||4
3152449|NCT01811303|3878487|FG003|COMPLETED|Washout (2 Days or More)||2
3152450|NCT01811303|3878484|FG000|NOT COMPLETED|Washout (2 Days or More)||0
3152451|NCT01811303|3878485|FG001|NOT COMPLETED|Washout (2 Days or More)||0
3152452|NCT01811303|3878486|FG002|NOT COMPLETED|Washout (2 Days or More)||0
3152453|NCT01811303|3878487|FG003|NOT COMPLETED|Washout (2 Days or More)||0
3152454|NCT01811303|3878484|FG000|STARTED|Fourth Intervention (1 Day)||4
3152455|NCT01811303|3878485|FG001|STARTED|Fourth Intervention (1 Day)||4
3152456|NCT01811303|3878486|FG002|STARTED|Fourth Intervention (1 Day)||4
3152457|NCT01811303|3878487|FG003|STARTED|Fourth Intervention (1 Day)||2
3152458|NCT01811303|3878484|FG000|COMPLETED|Fourth Intervention (1 Day)||4
3152459|NCT01811303|3878485|FG001|COMPLETED|Fourth Intervention (1 Day)||4
3152460|NCT01811303|3878486|FG002|COMPLETED|Fourth Intervention (1 Day)||4
3152461|NCT01811303|3878487|FG003|COMPLETED|Fourth Intervention (1 Day)||2
3152462|NCT01811303|3878484|FG000|NOT COMPLETED|Fourth Intervention (1 Day)||0
3152463|NCT01811303|3878485|FG001|NOT COMPLETED|Fourth Intervention (1 Day)||0
3152464|NCT01811303|3878486|FG002|NOT COMPLETED|Fourth Intervention (1 Day)||0
3152465|NCT01811303|3878487|FG003|NOT COMPLETED|Fourth Intervention (1 Day)||0
3152466|NCT01811316|3878498|FG000|STARTED|Overall Study||21
3152467|NCT01811316|3878499|FG001|STARTED|Overall Study||22
3152468|NCT01811316|3878500|FG002|STARTED|Overall Study||19
3152469|NCT01811316|3878498|FG000|Visit 4 Weeks|Overall Study||19
3152470|NCT01811316|3878499|FG001|Visit 4 Weeks|Overall Study||22
3152471|NCT01811316|3878500|FG002|Visit 4 Weeks|Overall Study||19
3152472|NCT01811316|3878498|FG000|Visit 12 Weeks|Overall Study||18
3152473|NCT01811316|3878499|FG001|Visit 12 Weeks|Overall Study||22
3152474|NCT01811316|3878500|FG002|Visit 12 Weeks|Overall Study||19
3152475|NCT01811316|3878498|FG000|COMPLETED|Overall Study||18
3152476|NCT01811316|3878499|FG001|COMPLETED|Overall Study||22
3152477|NCT01811316|3878500|FG002|COMPLETED|Overall Study||19
3152478|NCT01811316|3878498|FG000|NOT COMPLETED|Overall Study||3
3152479|NCT01811316|3878499|FG001|NOT COMPLETED|Overall Study||0
3152480|NCT01811316|3878500|FG002|NOT COMPLETED|Overall Study||0
3152481|NCT01811355|3878508|FG000|STARTED|First Dose||11
3152482|NCT01811355|3878509|FG001|STARTED|First Dose||12
3152483|NCT01811355|3878508|FG000|COMPLETED|First Dose||9
3152484|NCT01811355|3878509|FG001|COMPLETED|First Dose||12
3152485|NCT01811355|3878508|FG000|NOT COMPLETED|First Dose||2
3152486|NCT01811355|3878509|FG001|NOT COMPLETED|First Dose||0
3152487|NCT01811355|3878508|FG000|STARTED|Washout||9
3152488|NCT01811355|3878509|FG001|STARTED|Washout||12
3152489|NCT01811355|3878508|FG000|COMPLETED|Washout||9
3152490|NCT01811355|3878509|FG001|COMPLETED|Washout||12
3152491|NCT01811355|3878508|FG000|NOT COMPLETED|Washout||0
3152492|NCT01811355|3878509|FG001|NOT COMPLETED|Washout||0
3152493|NCT01811355|3878508|FG000|STARTED|Second Dose||9
3152494|NCT01811355|3878509|FG001|STARTED|Second Dose||12
3152495|NCT01811355|3878508|FG000|COMPLETED|Second Dose||9
3152496|NCT01811355|3878509|FG001|COMPLETED|Second Dose||12
3152497|NCT01811355|3878508|FG000|NOT COMPLETED|Second Dose||0
3152498|NCT01811355|3878509|FG001|NOT COMPLETED|Second Dose||0
3152499|NCT01811472|3878520|FG000|STARTED|Overall Study||20
3152500|NCT01811472|3878521|FG001|STARTED|Overall Study||11
3152501|NCT01811472|3878522|FG002|STARTED|Overall Study||21
3152502|NCT01811472|3878520|FG000|COMPLETED|Overall Study||18
3152503|NCT01811472|3878521|FG001|COMPLETED|Overall Study||11
3152504|NCT01811472|3878522|FG002|COMPLETED|Overall Study||16
3152505|NCT01811472|3878520|FG000|NOT COMPLETED|Overall Study||2
3152506|NCT01811472|3878521|FG001|NOT COMPLETED|Overall Study||0
3183308|NCT02007278|3911600|FG001|COMPLETED|Overall Study||17
3183309|NCT02007278|3911599|FG000|NOT COMPLETED|Overall Study||2
3183310|NCT02007278|3911600|FG001|NOT COMPLETED|Overall Study||3
3152507|NCT01811472|3878522|FG002|NOT COMPLETED|Overall Study||5
3152508|NCT01811485|3878534|FG000|STARTED|Overall Study|"Started indicates randomized patients"|56
3152509|NCT01811485|3878535|FG001|STARTED|Overall Study||59
3152510|NCT01811485|3878536|FG002|STARTED|Overall Study||56
3152511|NCT01811485|3878534|FG000|COMPLETED|Overall Study||54
3152512|NCT01811485|3878535|FG001|COMPLETED|Overall Study||55
3152513|NCT01811485|3878536|FG002|COMPLETED|Overall Study||51
3183311|NCT02007291|3911606|FG000|STARTED|Overall Study||48
3152514|NCT01811485|3878534|FG000|NOT COMPLETED|Overall Study||2
3152515|NCT01811485|3878535|FG001|NOT COMPLETED|Overall Study||4
3152516|NCT01811485|3878536|FG002|NOT COMPLETED|Overall Study||5
3152517|NCT01811563|3878549|FG000|STARTED|Overall Study||25
3152518|NCT01811563|3878550|FG001|STARTED|Overall Study||23
3152519|NCT01811563|3878549|FG000|COMPLETED|Overall Study||20
3152520|NCT01811563|3878550|FG001|COMPLETED|Overall Study||20
3152521|NCT01811563|3878549|FG000|NOT COMPLETED|Overall Study||5
3152522|NCT01811563|3878550|FG001|NOT COMPLETED|Overall Study||3
3152523|NCT01811654|3878558|FG000|STARTED|Overall Study||14
3152524|NCT01811654|3878559|FG001|STARTED|Overall Study||16
3152525|NCT01811654|3878558|FG000|COMPLETED|Overall Study||14
3152526|NCT01811654|3878559|FG001|COMPLETED|Overall Study||16
3152527|NCT01811654|3878558|FG000|NOT COMPLETED|Overall Study||0
3152528|NCT01811654|3878559|FG001|NOT COMPLETED|Overall Study||0
3152529|NCT01811680|3878565|FG000|STARTED|Overall Study||10
3152530|NCT01811680|3878565|FG000|COMPLETED|Overall Study||10
3152531|NCT01811680|3878565|FG000|NOT COMPLETED|Overall Study||0
3152532|NCT01811693|3878573|FG000|STARTED|Overall Study||4
3152533|NCT01811693|3878574|FG001|STARTED|Overall Study||0
3152534|NCT01811693|3878575|FG002|STARTED|Overall Study||0
3152535|NCT01811693|3878573|FG000|COMPLETED|Overall Study||4
3152536|NCT01811693|3878574|FG001|COMPLETED|Overall Study||0
3152537|NCT01811693|3878575|FG002|COMPLETED|Overall Study||0
3152538|NCT01811693|3878573|FG000|NOT COMPLETED|Overall Study||0
3152539|NCT01811693|3878574|FG001|NOT COMPLETED|Overall Study||0
3152540|NCT01811693|3878575|FG002|NOT COMPLETED|Overall Study||0
3152541|NCT01811706|3878579|FG000|STARTED|First Intervention ( 4 Weeks)||10
3152542|NCT01811706|3878580|FG001|STARTED|First Intervention ( 4 Weeks)||10
3152543|NCT01811706|3878579|FG000|COMPLETED|First Intervention ( 4 Weeks)||9
3152544|NCT01811706|3878580|FG001|COMPLETED|First Intervention ( 4 Weeks)||10
3152545|NCT01811706|3878579|FG000|NOT COMPLETED|First Intervention ( 4 Weeks)||1
3152546|NCT01811706|3878580|FG001|NOT COMPLETED|First Intervention ( 4 Weeks)||0
3152547|NCT01811706|3878579|FG000|STARTED|Washout ( 2 Weeks)||9
3152548|NCT01811706|3878580|FG001|STARTED|Washout ( 2 Weeks)||10
3152549|NCT01811706|3878579|FG000|COMPLETED|Washout ( 2 Weeks)||9
3152550|NCT01811706|3878580|FG001|COMPLETED|Washout ( 2 Weeks)||10
3183312|NCT02007291|3911607|FG001|STARTED|Overall Study||23
3183313|NCT02007291|3911606|FG000|COMPLETED|Overall Study||48
3183314|NCT02007291|3911607|FG001|COMPLETED|Overall Study||23
3183315|NCT02007291|3911606|FG000|NOT COMPLETED|Overall Study||0
3183316|NCT02007291|3911607|FG001|NOT COMPLETED|Overall Study||0
3183317|NCT02007369|3911616|FG000|STARTED|Overall Study||42
3183318|NCT02007369|3911617|FG001|STARTED|Overall Study||40
3183319|NCT02007369|3911618|FG002|STARTED|Overall Study||54
3183320|NCT02007369|3911616|FG000|COMPLETED|Overall Study||42
3183321|NCT02007369|3911617|FG001|COMPLETED|Overall Study||40
3183322|NCT02007369|3911618|FG002|COMPLETED|Overall Study||54
3183323|NCT02007369|3911616|FG000|NOT COMPLETED|Overall Study||0
3183324|NCT02007369|3911617|FG001|NOT COMPLETED|Overall Study||0
3183325|NCT02007369|3911618|FG002|NOT COMPLETED|Overall Study||0
3183326|NCT02007434|3911634|FG000|STARTED|Overall Study||17
3183327|NCT02007434|3911635|FG001|STARTED|Overall Study||4
3183328|NCT02007434|3911636|FG002|STARTED|Overall Study||17
3183329|NCT02007434|3911637|FG003|STARTED|Overall Study||4
3183330|NCT02007434|3911638|FG004|STARTED|Overall Study||16
3183331|NCT02007434|3911639|FG005|STARTED|Overall Study||4
3183332|NCT02007434|3911640|FG006|STARTED|Overall Study||18
3183333|NCT02007434|3911641|FG007|STARTED|Overall Study||4
3183334|NCT02007434|3911634|FG000|Received Treatment|Overall Study||17
3183335|NCT02007434|3911635|FG001|Received Treatment|Overall Study||3
3183336|NCT02007434|3911636|FG002|Received Treatment|Overall Study||17
3183337|NCT02007434|3911637|FG003|Received Treatment|Overall Study||4
3183338|NCT02007434|3911638|FG004|Received Treatment|Overall Study||16
3183339|NCT02007434|3911639|FG005|Received Treatment|Overall Study||4
3183340|NCT02007434|3911640|FG006|Received Treatment|Overall Study||18
3183341|NCT02007434|3911641|FG007|Received Treatment|Overall Study||4
3183342|NCT02007434|3911634|FG000|COMPLETED|Overall Study||16
3183343|NCT02007434|3911635|FG001|COMPLETED|Overall Study||3
3183344|NCT02007434|3911636|FG002|COMPLETED|Overall Study||16
3183345|NCT02007434|3911637|FG003|COMPLETED|Overall Study||4
3183346|NCT02007434|3911638|FG004|COMPLETED|Overall Study||16
3183347|NCT02007434|3911639|FG005|COMPLETED|Overall Study||4
3183348|NCT02007434|3911640|FG006|COMPLETED|Overall Study||18
3183349|NCT02007434|3911641|FG007|COMPLETED|Overall Study||4
3183350|NCT02007434|3911634|FG000|NOT COMPLETED|Overall Study||1
3183351|NCT02007434|3911635|FG001|NOT COMPLETED|Overall Study||1
3183352|NCT02007434|3911636|FG002|NOT COMPLETED|Overall Study||1
3183353|NCT02007434|3911637|FG003|NOT COMPLETED|Overall Study||0
3183354|NCT02007434|3911638|FG004|NOT COMPLETED|Overall Study||0
3183355|NCT02007434|3911639|FG005|NOT COMPLETED|Overall Study||0
3183356|NCT02007434|3911640|FG006|NOT COMPLETED|Overall Study||0
3183357|NCT02007434|3911641|FG007|NOT COMPLETED|Overall Study||0
3183358|NCT02007512|3911664|FG000|STARTED|Double Blind Treatment Period||63
3183359|NCT02007512|3911665|FG001|STARTED|Double Blind Treatment Period||64
3152551|NCT01811706|3878579|FG000|NOT COMPLETED|Washout ( 2 Weeks)||0
3152552|NCT01811706|3878580|FG001|NOT COMPLETED|Washout ( 2 Weeks)||0
3183360|NCT02007512|3911666|FG002|STARTED|Double Blind Treatment Period||60
3183361|NCT02007512|3911667|FG003|STARTED|Double Blind Treatment Period||60
3183362|NCT02007512|3911664|FG000|Treated|Double Blind Treatment Period||62
3183363|NCT02007512|3911665|FG001|Treated|Double Blind Treatment Period||63
3152553|NCT01811706|3878579|FG000|STARTED|Second Intervention (4 Weeks)||9
3152554|NCT01811706|3878580|FG001|STARTED|Second Intervention (4 Weeks)||10
3152555|NCT01811706|3878579|FG000|COMPLETED|Second Intervention (4 Weeks)||9
3152556|NCT01811706|3878580|FG001|COMPLETED|Second Intervention (4 Weeks)||10
3152557|NCT01811706|3878579|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||0
3152558|NCT01811706|3878580|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||0
3152559|NCT01811732|3878590|FG000|STARTED|Overall Study||331
3152560|NCT01811732|3878591|FG001|STARTED|Overall Study||329
3152561|NCT01811732|3878590|FG000|COMPLETED|Overall Study||276
3152562|NCT01811732|3878591|FG001|COMPLETED|Overall Study||271
3152563|NCT01811732|3878590|FG000|NOT COMPLETED|Overall Study||55
3152564|NCT01811732|3878591|FG001|NOT COMPLETED|Overall Study||58
3152565|NCT01811875|3878598|FG000|STARTED|Overall Study||7
3152566|NCT01811875|3878598|FG000|COMPLETED|Overall Study||5
3152567|NCT01811875|3878598|FG000|NOT COMPLETED|Overall Study||2
3152568|NCT01811940|3878604|FG000|STARTED|Overall Study||64
3152569|NCT01811940|3878605|FG001|STARTED|Overall Study||63
3152570|NCT01811940|3878604|FG000|COMPLETED|Overall Study||42
3152571|NCT01811940|3878605|FG001|COMPLETED|Overall Study||37
3152572|NCT01811940|3878604|FG000|NOT COMPLETED|Overall Study||22
3152573|NCT01811940|3878605|FG001|NOT COMPLETED|Overall Study||26
3152574|NCT01811953|3878617|FG000|STARTED|Overall Study||6
3152575|NCT01811953|3878618|FG001|STARTED|Overall Study||6
3152576|NCT01811953|3878619|FG002|STARTED|Overall Study||6
3152577|NCT01811953|3878620|FG003|STARTED|Overall Study||6
3152578|NCT01811953|3878621|FG004|STARTED|Overall Study||12
3152579|NCT01811953|3878622|FG005|STARTED|Overall Study||12
3152580|NCT01811953|3878617|FG000|COMPLETED|Overall Study||6
3152581|NCT01811953|3878618|FG001|COMPLETED|Overall Study||6
3152582|NCT01811953|3878619|FG002|COMPLETED|Overall Study||6
3152583|NCT01811953|3878620|FG003|COMPLETED|Overall Study||5
3152584|NCT01811953|3878621|FG004|COMPLETED|Overall Study||11
3152585|NCT01811953|3878622|FG005|COMPLETED|Overall Study||11
3152586|NCT01811953|3878617|FG000|NOT COMPLETED|Overall Study||0
3152587|NCT01811953|3878618|FG001|NOT COMPLETED|Overall Study||0
3152588|NCT01811953|3878619|FG002|NOT COMPLETED|Overall Study||0
3152589|NCT01811953|3878620|FG003|NOT COMPLETED|Overall Study||1
3152590|NCT01811953|3878621|FG004|NOT COMPLETED|Overall Study||1
3152591|NCT01811953|3878622|FG005|NOT COMPLETED|Overall Study||1
3152592|NCT01812005|3878638|FG000|STARTED|Overall Study||1
3152593|NCT01812005|3878639|FG001|STARTED|Overall Study||13
3183364|NCT02007512|3911666|FG002|Treated|Double Blind Treatment Period||60
3183365|NCT02007512|3911667|FG003|Treated|Double Blind Treatment Period||60
3183366|NCT02007512|3911664|FG000|COMPLETED|Double Blind Treatment Period||0
3183367|NCT02007512|3911665|FG001|COMPLETED|Double Blind Treatment Period||0
3183368|NCT02007512|3911666|FG002|COMPLETED|Double Blind Treatment Period||0
3183369|NCT02007512|3911667|FG003|COMPLETED|Double Blind Treatment Period||0
3183370|NCT02007512|3911664|FG000|NOT COMPLETED|Double Blind Treatment Period||63
3183371|NCT02007512|3911665|FG001|NOT COMPLETED|Double Blind Treatment Period||64
3183372|NCT02007512|3911666|FG002|NOT COMPLETED|Double Blind Treatment Period||60
3183373|NCT02007512|3911667|FG003|NOT COMPLETED|Double Blind Treatment Period||60
3183374|NCT02007512|3911664|FG000|STARTED|Open Label Treatment Period||0
3183375|NCT02007512|3911665|FG001|STARTED|Open Label Treatment Period|Of the participants with disease progression in double blind period, 21 entered open label period.|21
3183376|NCT02007512|3911666|FG002|STARTED|Open Label Treatment Period||0
3183377|NCT02007512|3911667|FG003|STARTED|Open Label Treatment Period|Of the participants with disease progression in double blind period, 12 entered open label period.|12
3183378|NCT02007512|3911664|FG000|COMPLETED|Open Label Treatment Period||0
3183379|NCT02007512|3911665|FG001|COMPLETED|Open Label Treatment Period||0
3183380|NCT02007512|3911666|FG002|COMPLETED|Open Label Treatment Period||0
3183381|NCT02007512|3911667|FG003|COMPLETED|Open Label Treatment Period||0
3183382|NCT02007512|3911664|FG000|NOT COMPLETED|Open Label Treatment Period||0
3183383|NCT02007512|3911665|FG001|NOT COMPLETED|Open Label Treatment Period||21
3183384|NCT02007512|3911666|FG002|NOT COMPLETED|Open Label Treatment Period||0
3183385|NCT02007512|3911667|FG003|NOT COMPLETED|Open Label Treatment Period||12
3183386|NCT02007577|3911682|FG000|STARTED|Overall Study||27
3183387|NCT02007577|3911683|FG001|STARTED|Overall Study||14
3183388|NCT02007577|3911682|FG000|COMPLETED|Overall Study||26
3183389|NCT02007577|3911683|FG001|COMPLETED|Overall Study||13
3183390|NCT02007577|3911682|FG000|NOT COMPLETED|Overall Study||1
3183391|NCT02007577|3911683|FG001|NOT COMPLETED|Overall Study||1
3183392|NCT02007720|3911691|FG000|STARTED|Overall Study||436
3183393|NCT02007720|3911692|FG001|STARTED|Overall Study||440
3183394|NCT02007720|3911691|FG000|Full Analysis Set|Overall Study||433
3183395|NCT02007720|3911692|FG001|Full Analysis Set|Overall Study||437
3152594|NCT01812005|3878638|FG000|COMPLETED|Overall Study||1
3152595|NCT01812005|3878639|FG001|COMPLETED|Overall Study||13
3152596|NCT01812005|3878638|FG000|NOT COMPLETED|Overall Study||0
3152597|NCT01812005|3878639|FG001|NOT COMPLETED|Overall Study||0
3152598|NCT01812044|3878648|FG000|STARTED|Overall Study||17
3152599|NCT01812044|3878649|FG001|STARTED|Overall Study||17
3152600|NCT01812044|3878650|FG002|STARTED|Overall Study||16
3152601|NCT01812044|3878648|FG000|COMPLETED|Overall Study||17
3152602|NCT01812044|3878649|FG001|COMPLETED|Overall Study||17
3152603|NCT01812044|3878650|FG002|COMPLETED|Overall Study||16
3152604|NCT01812044|3878648|FG000|NOT COMPLETED|Overall Study||0
3152605|NCT01812044|3878649|FG001|NOT COMPLETED|Overall Study||0
3152606|NCT01812044|3878650|FG002|NOT COMPLETED|Overall Study||0
3152607|NCT01812057|3878660|FG000|STARTED|Overall Study||25
3152608|NCT01812057|3878661|FG001|STARTED|Overall Study||24
3152609|NCT01812057|3878660|FG000|COMPLETED|Overall Study||23
3152610|NCT01812057|3878661|FG001|COMPLETED|Overall Study||24
3152611|NCT01812057|3878660|FG000|NOT COMPLETED|Overall Study||2
3152612|NCT01812057|3878661|FG001|NOT COMPLETED|Overall Study||0
3152613|NCT01812109|3878671|FG000|STARTED|Overall Study||154
3152614|NCT01812109|3878671|FG000|With Torsion|Overall Study||36
3152615|NCT01812109|3878671|FG000|Without Torsion|Overall Study||85
3152616|NCT01812109|3878671|FG000|COMPLETED|Overall Study||121
3152617|NCT01812109|3878671|FG000|NOT COMPLETED|Overall Study||33
3152618|NCT01812473|3878677|FG000|STARTED|Overall Study||22
3152619|NCT01812473|3878678|FG001|STARTED|Overall Study||13
3152620|NCT01812473|3878677|FG000|COMPLETED|Overall Study||22
3152621|NCT01812473|3878678|FG001|COMPLETED|Overall Study||13
3152622|NCT01812473|3878677|FG000|NOT COMPLETED|Overall Study||0
3183396|NCT02007720|3911691|FG000|Safety Set|Overall Study||426
3183397|NCT02007720|3911692|FG001|Safety Set|Overall Study||432
3183398|NCT02007720|3911691|FG000|COMPLETED|Overall Study||354
3152623|NCT01812473|3878678|FG001|NOT COMPLETED|Overall Study||0
3152624|NCT01812655|3878687|FG000|STARTED|Overall Study|Virtual Reality-Patients used an interactive VR program during their burn wound care procedure.|9
3152625|NCT01812655|3878688|FG001|STARTED|Overall Study|Passive Distraction-Patients watched a movie during their burn wound care.|11
3152626|NCT01812655|3878689|FG002|STARTED|Overall Study|Nurses provided their usual, standard care throughout the entire burn wound care.|10
3152627|NCT01812655|3878687|FG000|COMPLETED|Overall Study||8
3152628|NCT01812655|3878688|FG001|COMPLETED|Overall Study||10
3152629|NCT01812655|3878689|FG002|COMPLETED|Overall Study||10
3152630|NCT01812655|3878687|FG000|NOT COMPLETED|Overall Study||1
3152631|NCT01812655|3878688|FG001|NOT COMPLETED|Overall Study||1
3152632|NCT01812655|3878689|FG002|NOT COMPLETED|Overall Study||0
3152633|NCT01812668|3878700|FG000|STARTED|Overall Study||20
3152634|NCT01812668|3878700|FG000|COMPLETED|Overall Study||20
3152635|NCT01812668|3878700|FG000|NOT COMPLETED|Overall Study||0
3152636|NCT01812681|3878706|FG000|STARTED|Overall Study||60
3152637|NCT01812681|3878707|FG001|STARTED|Overall Study||24
3152638|NCT01812681|3878706|FG000|COMPLETED|Overall Study||57
3152639|NCT01812681|3878707|FG001|COMPLETED|Overall Study||24
3152640|NCT01812681|3878706|FG000|NOT COMPLETED|Overall Study||3
3152641|NCT01812681|3878707|FG001|NOT COMPLETED|Overall Study||0
3152642|NCT01812707|3878717|FG000|STARTED|Overall Study||25
3152643|NCT01812707|3878718|FG001|STARTED|Overall Study||25
3152644|NCT01812707|3878719|FG002|STARTED|Overall Study||25
3152645|NCT01812707|3878720|FG003|STARTED|Overall Study||25
3152646|NCT01812707|3878717|FG000|Treated|Overall Study||25
3152647|NCT01812707|3878718|FG001|Treated|Overall Study||25
3152648|NCT01812707|3878719|FG002|Treated|Overall Study||25
3152649|NCT01812707|3878720|FG003|Treated|Overall Study||25
3152650|NCT01812707|3878717|FG000|COMPLETED|Overall Study||23
3152651|NCT01812707|3878718|FG001|COMPLETED|Overall Study||25
3152652|NCT01812707|3878719|FG002|COMPLETED|Overall Study||25
3152653|NCT01812707|3878720|FG003|COMPLETED|Overall Study||23
3152654|NCT01812707|3878717|FG000|NOT COMPLETED|Overall Study||2
3152655|NCT01812707|3878718|FG001|NOT COMPLETED|Overall Study||0
3152656|NCT01812707|3878719|FG002|NOT COMPLETED|Overall Study||0
3152657|NCT01812707|3878720|FG003|NOT COMPLETED|Overall Study||2
3152658|NCT01812759|3878734|FG000|STARTED|Overall Study||1
3152659|NCT01812759|3878735|FG001|STARTED|Overall Study||1
3152660|NCT01812759|3878736|FG002|STARTED|Overall Study||1
3152661|NCT01812759|3878734|FG000|COMPLETED|Overall Study||1
3152662|NCT01812759|3878735|FG001|COMPLETED|Overall Study||1
3152663|NCT01812759|3878736|FG002|COMPLETED|Overall Study||0
3183399|NCT02007720|3911692|FG001|COMPLETED|Overall Study||368
3183400|NCT02007720|3911691|FG000|NOT COMPLETED|Overall Study||82
3183401|NCT02007720|3911692|FG001|NOT COMPLETED|Overall Study||72
3363748|NCT04053023|4094883|FG000|COMPLETED|Part B: Period 2 (Day 20 to Day 38)||0
3363749|NCT04053023|4094884|FG001|COMPLETED|Part B: Period 2 (Day 20 to Day 38)||0
3363750|NCT04053023|4094883|FG000|NOT COMPLETED|Part B: Period 2 (Day 20 to Day 38)||0
3363751|NCT04053023|4094884|FG001|NOT COMPLETED|Part B: Period 2 (Day 20 to Day 38)||0
3363752|NCT04051710|4094897|FG000|STARTED|Overall Study||620
3363753|NCT04051710|4094898|FG001|STARTED|Overall Study||620
3363754|NCT04051710|4094899|FG002|STARTED|Overall Study||310
3363755|NCT04051710|4094897|FG000|COMPLETED|Overall Study||616
3363756|NCT04051710|4094898|FG001|COMPLETED|Overall Study||612
3363757|NCT04051710|4094899|FG002|COMPLETED|Overall Study||306
3363758|NCT04051710|4094897|FG000|NOT COMPLETED|Overall Study||4
3363759|NCT04051710|4094898|FG001|NOT COMPLETED|Overall Study||8
3363760|NCT04051710|4094899|FG002|NOT COMPLETED|Overall Study||4
3363761|NCT04050865|4094909|FG000|STARTED|Overall Study||48
3363762|NCT04050865|4094910|FG001|STARTED|Overall Study||48
3363763|NCT04050865|4094909|FG000|COMPLETED|Overall Study||44
3363764|NCT04050865|4094910|FG001|COMPLETED|Overall Study||43
3363765|NCT04050865|4094909|FG000|NOT COMPLETED|Overall Study||4
3363766|NCT04050865|4094910|FG001|NOT COMPLETED|Overall Study||5
3363767|NCT04050605|4094916|FG000|STARTED|Overall Study||40
3363768|NCT04050605|4094916|FG000|COMPLETED|Overall Study||40
3152664|NCT01812759|3878734|FG000|NOT COMPLETED|Overall Study||0
3152665|NCT01812759|3878735|FG001|NOT COMPLETED|Overall Study||0
3152666|NCT01812759|3878736|FG002|NOT COMPLETED|Overall Study||1
3152667|NCT01812837|3878747|FG000|STARTED|Overall Study||17
3152668|NCT01812837|3878748|FG001|STARTED|Overall Study||17
3152669|NCT01812837|3878749|FG002|STARTED|Overall Study||17
3152670|NCT01812837|3878747|FG000|COMPLETED|Overall Study||15
3152671|NCT01812837|3878748|FG001|COMPLETED|Overall Study||16
3152672|NCT01812837|3878749|FG002|COMPLETED|Overall Study||17
3152673|NCT01812837|3878747|FG000|NOT COMPLETED|Overall Study||2
3152674|NCT01812837|3878748|FG001|NOT COMPLETED|Overall Study||1
3152675|NCT01812837|3878749|FG002|NOT COMPLETED|Overall Study||0
3152676|NCT01813019|3878759|FG000|STARTED|Overall Study||24
3152677|NCT01813019|3878760|FG001|STARTED|Overall Study||26
3152678|NCT01813019|3878759|FG000|COMPLETED|Overall Study||17
3152679|NCT01813019|3878760|FG001|COMPLETED|Overall Study||20
3152680|NCT01813019|3878759|FG000|NOT COMPLETED|Overall Study||7
3152681|NCT01813019|3878760|FG001|NOT COMPLETED|Overall Study||6
3152682|NCT01813058|3878768|FG000|STARTED|Overall Study||60
3152683|NCT01813058|3878769|FG001|STARTED|Overall Study||60
3152684|NCT01813058|3878768|FG000|COMPLETED|Overall Study||55
3152685|NCT01813058|3878769|FG001|COMPLETED|Overall Study||56
3152686|NCT01813058|3878768|FG000|NOT COMPLETED|Overall Study||5
3152687|NCT01813058|3878769|FG001|NOT COMPLETED|Overall Study||4
3152688|NCT01813071|3878784|FG000|STARTED|Overall Study||10
3152689|NCT01813071|3878785|FG001|STARTED|Overall Study||10
3152690|NCT01813071|3878786|FG002|STARTED|Overall Study||10
3152691|NCT01813071|3878787|FG003|STARTED|Overall Study||9
3152692|NCT01813071|3878788|FG004|STARTED|Overall Study||12
3152693|NCT01813071|3878789|FG005|STARTED|Overall Study||12
3152694|NCT01813071|3878790|FG006|STARTED|Overall Study||12
3152695|NCT01813071|3878791|FG007|STARTED|Overall Study||12
3152696|NCT01813071|3878792|FG008|STARTED|Overall Study||16
3152697|NCT01813071|3878784|FG000|COMPLETED|Overall Study||10
3152698|NCT01813071|3878785|FG001|COMPLETED|Overall Study||10
3152699|NCT01813071|3878786|FG002|COMPLETED|Overall Study||10
3152700|NCT01813071|3878787|FG003|COMPLETED|Overall Study||9
3152701|NCT01813071|3878788|FG004|COMPLETED|Overall Study||11
3152702|NCT01813071|3878789|FG005|COMPLETED|Overall Study||5
3152703|NCT01813071|3878790|FG006|COMPLETED|Overall Study||9
3152704|NCT01813071|3878791|FG007|COMPLETED|Overall Study||7
3152705|NCT01813071|3878792|FG008|COMPLETED|Overall Study||13
3152706|NCT01813071|3878784|FG000|NOT COMPLETED|Overall Study||0
3152707|NCT01813071|3878785|FG001|NOT COMPLETED|Overall Study||0
3152708|NCT01813071|3878786|FG002|NOT COMPLETED|Overall Study||0
3152709|NCT01813071|3878787|FG003|NOT COMPLETED|Overall Study||0
3152710|NCT01813071|3878788|FG004|NOT COMPLETED|Overall Study||1
3152711|NCT01813071|3878789|FG005|NOT COMPLETED|Overall Study||7
3152712|NCT01813071|3878790|FG006|NOT COMPLETED|Overall Study||3
3152713|NCT01813071|3878791|FG007|NOT COMPLETED|Overall Study||5
3152714|NCT01813071|3878792|FG008|NOT COMPLETED|Overall Study||3
3152715|NCT01813110|3878826|FG000|STARTED|Overall Study||10
3152716|NCT01813110|3878827|FG001|STARTED|Overall Study||11
3152717|NCT01813110|3878826|FG000|COMPLETED|Overall Study||10
3152718|NCT01813110|3878827|FG001|COMPLETED|Overall Study||10
3152719|NCT01813110|3878826|FG000|NOT COMPLETED|Overall Study||0
3152720|NCT01813110|3878827|FG001|NOT COMPLETED|Overall Study||1
3152721|NCT01813149|3878836|FG000|STARTED|Overall Study||90
3152722|NCT01813149|3878837|FG001|STARTED|Overall Study||38
3152723|NCT01813149|3878836|FG000|COMPLETED|Overall Study||90
3152724|NCT01813149|3878837|FG001|COMPLETED|Overall Study||38
3152725|NCT01813149|3878836|FG000|NOT COMPLETED|Overall Study||0
3152726|NCT01813149|3878837|FG001|NOT COMPLETED|Overall Study||0
3152727|NCT01813214|3878850|FG000|STARTED|Overall Study||3
3152728|NCT01813214|3878851|FG001|STARTED|Overall Study||2
3152729|NCT01813214|3878850|FG000|COMPLETED|Overall Study||3
3152730|NCT01813214|3878851|FG001|COMPLETED|Overall Study||2
3152731|NCT01813214|3878850|FG000|NOT COMPLETED|Overall Study||0
3152732|NCT01813214|3878851|FG001|NOT COMPLETED|Overall Study||0
3152733|NCT01813357|3878859|FG000|STARTED|Overall Study||40
3152734|NCT01813357|3878860|FG001|STARTED|Overall Study||44
3152735|NCT01813357|3878859|FG000|COMPLETED|Overall Study||35
3152736|NCT01813357|3878860|FG001|COMPLETED|Overall Study||38
3152737|NCT01813357|3878859|FG000|NOT COMPLETED|Overall Study||5
3152738|NCT01813357|3878860|FG001|NOT COMPLETED|Overall Study||6
3152739|NCT01813422|3878868|FG000|STARTED|Overall Study||486
3152740|NCT01813422|3878869|FG001|STARTED|Overall Study||484
3152741|NCT01813422|3878868|FG000|Received Treatment|Overall Study||484
3152742|NCT01813422|3878869|FG001|Received Treatment|Overall Study||484
3152743|NCT01813422|3878868|FG000|COMPLETED|Overall Study||466
3152744|NCT01813422|3878869|FG001|COMPLETED|Overall Study||468
3152745|NCT01813422|3878868|FG000|NOT COMPLETED|Overall Study||20
3152746|NCT01813422|3878869|FG001|NOT COMPLETED|Overall Study||16
3152747|NCT01813435|3878877|FG000|STARTED|Overall Study|12 participants withdrew consent or objected to use further use of data|7980
3152748|NCT01813435|3878878|FG001|STARTED|Overall Study|11 participants withdrew consent or objected to use further use of data|7988
3152749|NCT01813435|3878877|FG000|COMPLETED|Overall Study||5810
3152750|NCT01813435|3878878|FG001|COMPLETED|Overall Study||6981
3152751|NCT01813435|3878877|FG000|NOT COMPLETED|Overall Study||2170
3152752|NCT01813435|3878878|FG001|NOT COMPLETED|Overall Study||1007
3152753|NCT01813474|3878887|FG000|STARTED|Overall Study||4
3152754|NCT01813474|3878888|FG001|STARTED|Overall Study||7
3152755|NCT01813474|3878889|FG002|STARTED|Overall Study||12
3152756|NCT01813474|3878887|FG000|COMPLETED|Overall Study|ongoing study at final data cut off|1
3152757|NCT01813474|3878888|FG001|COMPLETED|Overall Study||0
3152758|NCT01813474|3878889|FG002|COMPLETED|Overall Study|ongoing study at final data cut off|1
3152759|NCT01813474|3878887|FG000|NOT COMPLETED|Overall Study||3
3152760|NCT01813474|3878888|FG001|NOT COMPLETED|Overall Study||7
3152761|NCT01813474|3878889|FG002|NOT COMPLETED|Overall Study||11
3152762|NCT01813721|3878898|FG000|STARTED|Overall Study|Indicates number of participants enrolled|1007
3152763|NCT01813721|3878898|FG000|COMPLETED|Overall Study||943
3152764|NCT01813721|3878898|FG000|NOT COMPLETED|Overall Study||64
3152765|NCT01813734|3878920|FG000|STARTED|Overall Study||9
3152766|NCT01813734|3878920|FG000|COMPLETED|Overall Study||9
3152767|NCT01813734|3878920|FG000|NOT COMPLETED|Overall Study||0
3152768|NCT01813890|3878927|FG000|STARTED|Overall Study||20
3152769|NCT01813890|3878928|FG001|STARTED|Overall Study||21
3152770|NCT01813890|3878929|FG002|STARTED|Overall Study||19
3152771|NCT01813890|3878927|FG000|COMPLETED|Overall Study||11
3152772|NCT01813890|3878928|FG001|COMPLETED|Overall Study||17
3152773|NCT01813890|3878929|FG002|COMPLETED|Overall Study||13
3152774|NCT01813890|3878927|FG000|NOT COMPLETED|Overall Study||9
3152775|NCT01813890|3878928|FG001|NOT COMPLETED|Overall Study||4
3152776|NCT01813890|3878929|FG002|NOT COMPLETED|Overall Study||6
3152777|NCT01814007|3878937|FG000|STARTED|Overall Study||35
3152778|NCT01814007|3878937|FG000|COMPLETED|Overall Study||34
3152779|NCT01814007|3878937|FG000|NOT COMPLETED|Overall Study||1
3152780|NCT01814046|3878944|FG000|STARTED|Drug Administration||22
3152781|NCT01814046|3878945|FG001|STARTED|Drug Administration||2
3152782|NCT01814046|3878946|FG002|STARTED|Drug Administration||0
3152783|NCT01814046|3878944|FG000|COMPLETED|Drug Administration||21
3152784|NCT01814046|3878945|FG001|COMPLETED|Drug Administration||2
3152785|NCT01814046|3878946|FG002|COMPLETED|Drug Administration||0
3152786|NCT01814046|3878944|FG000|NOT COMPLETED|Drug Administration||1
3152787|NCT01814046|3878945|FG001|NOT COMPLETED|Drug Administration||0
3152788|NCT01814046|3878946|FG002|NOT COMPLETED|Drug Administration||0
3152789|NCT01814046|3878944|FG000|STARTED|Retreatment||0
3152790|NCT01814046|3878945|FG001|STARTED|Retreatment||0
3152791|NCT01814046|3878946|FG002|STARTED|Retreatment||3
3152792|NCT01814046|3878944|FG000|COMPLETED|Retreatment||0
3152793|NCT01814046|3878945|FG001|COMPLETED|Retreatment||0
3152794|NCT01814046|3878946|FG002|COMPLETED|Retreatment||3
3152795|NCT01814046|3878944|FG000|NOT COMPLETED|Retreatment||0
3183402|NCT02007863|3911699|FG000|STARTED|Overall Study||2
3183403|NCT02007863|3911699|FG000|COMPLETED|Overall Study||2
3183404|NCT02007863|3911699|FG000|NOT COMPLETED|Overall Study||0
3183405|NCT02007954|3911703|FG000|STARTED|Overall Study|A total of 32 participants were consented, with 8 patients screened out prior to treatment.|24
3183406|NCT02007954|3911703|FG000|Completed First TACE|Overall Study||24
3183407|NCT02007954|3911703|FG000|Completed First Clinical and Imaging|Overall Study|1 patient exited prior to first imaging follow-up due to unrelated serious adverse event and death|23
3183408|NCT02007954|3911703|FG000|COMPLETED|Overall Study||17
3183409|NCT02007954|3911703|FG000|NOT COMPLETED|Overall Study||7
3183410|NCT02008149|3911710|FG000|STARTED|Overall Study||7
3183411|NCT02008149|3911711|FG001|STARTED|Overall Study||1
3183412|NCT02008149|3911712|FG002|STARTED|Overall Study||1
3183413|NCT02008149|3911710|FG000|COMPLETED|Overall Study||4
3183414|NCT02008149|3911711|FG001|COMPLETED|Overall Study||0
3183415|NCT02008149|3911712|FG002|COMPLETED|Overall Study||1
3183416|NCT02008149|3911710|FG000|NOT COMPLETED|Overall Study||3
3183417|NCT02008149|3911711|FG001|NOT COMPLETED|Overall Study||1
3183418|NCT02008149|3911712|FG002|NOT COMPLETED|Overall Study||0
3183419|NCT02008227|3911722|FG000|STARTED|Overall Study||612
3183420|NCT02008227|3911723|FG001|STARTED|Overall Study||613
3183421|NCT02008227|3911722|FG000|Treated|Overall Study||579
3183422|NCT02008227|3911723|FG001|Treated|Overall Study||608
3183423|NCT02008227|3911722|FG000|COMPLETED|Overall Study||0
3183424|NCT02008227|3911723|FG001|COMPLETED|Overall Study||0
3183425|NCT02008227|3911722|FG000|NOT COMPLETED|Overall Study||612
3183426|NCT02008227|3911723|FG001|NOT COMPLETED|Overall Study||613
3183427|NCT02008318|3911732|FG000|STARTED|Overall Study||41
3183428|NCT02008318|3911733|FG001|STARTED|Overall Study||2
3183429|NCT02008318|3911732|FG000|Received At Least 1 Dose of Study Drug|Overall Study||41
3183430|NCT02008318|3911733|FG001|Received At Least 1 Dose of Study Drug|Overall Study||2
3183431|NCT02008318|3911732|FG000|COMPLETED|Overall Study||29
3183432|NCT02008318|3911733|FG001|COMPLETED|Overall Study||1
3183433|NCT02008318|3911732|FG000|NOT COMPLETED|Overall Study||12
3183434|NCT02008318|3911733|FG001|NOT COMPLETED|Overall Study||1
3183435|NCT02008526|3911745|FG000|STARTED|Overall Study||94
3183436|NCT02008526|3911746|FG001|STARTED|Overall Study||99
3183437|NCT02008526|3911747|FG002|STARTED|Overall Study||93
3183438|NCT02008526|3911745|FG000|COMPLETED|Overall Study||86
3183439|NCT02008526|3911746|FG001|COMPLETED|Overall Study||85
3183440|NCT02008526|3911747|FG002|COMPLETED|Overall Study||84
3183441|NCT02008526|3911745|FG000|NOT COMPLETED|Overall Study||8
3183442|NCT02008526|3911746|FG001|NOT COMPLETED|Overall Study||14
3183443|NCT02008526|3911747|FG002|NOT COMPLETED|Overall Study||9
3183444|NCT02008565|3911759|FG000|STARTED|Overall Study||86
3183445|NCT02008565|3911760|FG001|STARTED|Overall Study||84
3183446|NCT02008565|3911761|FG002|STARTED|Overall Study||88
3183447|NCT02008565|3911762|FG003|STARTED|Overall Study||42
3183448|NCT02008565|3911759|FG000|COMPLETED|Overall Study||85
3183449|NCT02008565|3911760|FG001|COMPLETED|Overall Study||83
3183450|NCT02008565|3911761|FG002|COMPLETED|Overall Study||86
3183451|NCT02008565|3911762|FG003|COMPLETED|Overall Study||42
3183452|NCT02008565|3911759|FG000|NOT COMPLETED|Overall Study||1
3152796|NCT01814046|3878945|FG001|NOT COMPLETED|Retreatment||0
3152797|NCT01814046|3878946|FG002|NOT COMPLETED|Retreatment||0
3152798|NCT01814072|3878985|FG000|STARTED|Overall Study||18
3152799|NCT01814072|3878986|FG001|STARTED|Overall Study||18
3152800|NCT01814072|3878987|FG002|STARTED|Overall Study||18
3152801|NCT01814072|3878988|FG003|STARTED|Overall Study||18
3152802|NCT01814072|3878989|FG004|STARTED|Overall Study||18
3152803|NCT01814072|3878990|FG005|STARTED|Overall Study||18
3152804|NCT01814072|3878991|FG006|STARTED|Overall Study||18
3152805|NCT01814072|3878992|FG007|STARTED|Overall Study||18
3152806|NCT01814072|3878993|FG008|STARTED|Overall Study||19
3152807|NCT01814072|3878994|FG009|STARTED|Overall Study||18
3152808|NCT01814072|3878995|FG010|STARTED|Overall Study||18
3152809|NCT01814072|3878996|FG011|STARTED|Overall Study||18
3152810|NCT01814072|3878997|FG012|STARTED|Overall Study||18
3152811|NCT01814072|3878998|FG013|STARTED|Overall Study||18
3152812|NCT01814072|3878999|FG014|STARTED|Overall Study||18
3152813|NCT01814072|3879000|FG015|STARTED|Overall Study||18
3152814|NCT01814072|3879001|FG016|STARTED|Overall Study||17
3152815|NCT01814072|3879002|FG017|STARTED|Overall Study||18
3152816|NCT01814072|3879003|FG018|STARTED|Overall Study||17
3152817|NCT01814072|3879004|FG019|STARTED|Overall Study||16
3152818|NCT01814072|3879005|FG020|STARTED|Overall Study||16
3152819|NCT01814072|3879006|FG021|STARTED|Overall Study||17
3152820|NCT01814072|3879007|FG022|STARTED|Overall Study||17
3152821|NCT01814072|3879008|FG023|STARTED|Overall Study||18
3152822|NCT01814072|3879009|FG024|STARTED|Overall Study||17
3152823|NCT01814072|3879010|FG025|STARTED|Overall Study||16
3152824|NCT01814072|3879011|FG026|STARTED|Overall Study||18
3152825|NCT01814072|3879012|FG027|STARTED|Overall Study||17
3152826|NCT01814072|3879013|FG028|STARTED|Overall Study||18
3152827|NCT01814072|3879014|FG029|STARTED|Overall Study||17
3152828|NCT01814072|3879015|FG030|STARTED|Overall Study||17
3152829|NCT01814072|3879016|FG031|STARTED|Overall Study||17
3152830|NCT01814072|3878985|FG000|3-mo Visit|Overall Study||15
3152831|NCT01814072|3878986|FG001|3-mo Visit|Overall Study||18
3152832|NCT01814072|3878987|FG002|3-mo Visit|Overall Study||16
3152833|NCT01814072|3878988|FG003|3-mo Visit|Overall Study||18
3152834|NCT01814072|3878989|FG004|3-mo Visit|Overall Study||15
3152835|NCT01814072|3878990|FG005|3-mo Visit|Overall Study||15
3152836|NCT01814072|3878991|FG006|3-mo Visit|Overall Study||16
3152837|NCT01814072|3878992|FG007|3-mo Visit|Overall Study||18
3152838|NCT01814072|3878993|FG008|3-mo Visit|Overall Study||18
3152839|NCT01814072|3878994|FG009|3-mo Visit|Overall Study||15
3152840|NCT01814072|3878995|FG010|3-mo Visit|Overall Study||18
3152841|NCT01814072|3878996|FG011|3-mo Visit|Overall Study||17
3152842|NCT01814072|3878997|FG012|3-mo Visit|Overall Study||16
3152843|NCT01814072|3878998|FG013|3-mo Visit|Overall Study||16
3152844|NCT01814072|3878999|FG014|3-mo Visit|Overall Study||16
3152845|NCT01814072|3879000|FG015|3-mo Visit|Overall Study||16
3152846|NCT01814072|3879001|FG016|3-mo Visit|Overall Study||16
3152847|NCT01814072|3879002|FG017|3-mo Visit|Overall Study||16
3152848|NCT01814072|3879003|FG018|3-mo Visit|Overall Study||14
3152849|NCT01814072|3879004|FG019|3-mo Visit|Overall Study||13
3152850|NCT01814072|3879005|FG020|3-mo Visit|Overall Study||15
3152851|NCT01814072|3879006|FG021|3-mo Visit|Overall Study||17
3152852|NCT01814072|3879007|FG022|3-mo Visit|Overall Study||15
3152853|NCT01814072|3879008|FG023|3-mo Visit|Overall Study||18
3152854|NCT01814072|3879009|FG024|3-mo Visit|Overall Study||13
3152855|NCT01814072|3879010|FG025|3-mo Visit|Overall Study||14
3152856|NCT01814072|3879011|FG026|3-mo Visit|Overall Study||17
3152857|NCT01814072|3879012|FG027|3-mo Visit|Overall Study||14
3152858|NCT01814072|3879013|FG028|3-mo Visit|Overall Study||15
3152859|NCT01814072|3879014|FG029|3-mo Visit|Overall Study||16
3152860|NCT01814072|3879015|FG030|3-mo Visit|Overall Study||16
3152861|NCT01814072|3879016|FG031|3-mo Visit|Overall Study||17
3152862|NCT01814072|3878985|FG000|Intent to Treat|Overall Study||4
3152863|NCT01814072|3878986|FG001|Intent to Treat|Overall Study||2
3183453|NCT02008565|3911760|FG001|NOT COMPLETED|Overall Study||1
3183454|NCT02008565|3911761|FG002|NOT COMPLETED|Overall Study||2
3183455|NCT02008565|3911762|FG003|NOT COMPLETED|Overall Study||0
3183456|NCT02008617|3911776|FG000|STARTED|Overall Study||8
3183457|NCT02008617|3911777|FG001|STARTED|Overall Study||10
3183458|NCT02008617|3911776|FG000|COMPLETED|Overall Study||8
3183459|NCT02008617|3911777|FG001|COMPLETED|Overall Study||10
3183460|NCT02008617|3911776|FG000|NOT COMPLETED|Overall Study||0
3183461|NCT02008617|3911777|FG001|NOT COMPLETED|Overall Study||0
3183462|NCT02008682|3911785|FG000|STARTED|Overall Study||184
3183463|NCT02008682|3911786|FG001|STARTED|Overall Study||184
3183464|NCT02008682|3911785|FG000|Exposed|Overall Study|1 subject withdrawn before exposure to trial product|183
3183465|NCT02008682|3911786|FG001|Exposed|Overall Study||184
3183466|NCT02008682|3911785|FG000|COMPLETED|Overall Study|Completed without discontinuation of trial product|157
3183467|NCT02008682|3911786|FG001|COMPLETED|Overall Study|Completed without discontinuation of trial product|170
3183468|NCT02008682|3911785|FG000|NOT COMPLETED|Overall Study||27
3183469|NCT02008682|3911786|FG001|NOT COMPLETED|Overall Study||14
3183470|NCT02008773|3911796|FG000|STARTED|Overall Study||40
3183471|NCT02008773|3911797|FG001|STARTED|Overall Study||34
3152864|NCT01814072|3878987|FG002|Intent to Treat|Overall Study||3
3152865|NCT01814072|3878988|FG003|Intent to Treat|Overall Study||0
3152866|NCT01814072|3878989|FG004|Intent to Treat|Overall Study||4
3152867|NCT01814072|3878990|FG005|Intent to Treat|Overall Study||6
3152868|NCT01814072|3878991|FG006|Intent to Treat|Overall Study||4
3152869|NCT01814072|3878992|FG007|Intent to Treat|Overall Study||1
3152870|NCT01814072|3878993|FG008|Intent to Treat|Overall Study||3
3152871|NCT01814072|3878994|FG009|Intent to Treat|Overall Study||5
3152872|NCT01814072|3878995|FG010|Intent to Treat|Overall Study||1
3152873|NCT01814072|3878996|FG011|Intent to Treat|Overall Study||2
3152874|NCT01814072|3878997|FG012|Intent to Treat|Overall Study||3
3152875|NCT01814072|3878998|FG013|Intent to Treat|Overall Study||2
3152876|NCT01814072|3878999|FG014|Intent to Treat|Overall Study||3
3152877|NCT01814072|3879000|FG015|Intent to Treat|Overall Study||2
3152878|NCT01814072|3879001|FG016|Intent to Treat|Overall Study||3
3152879|NCT01814072|3879002|FG017|Intent to Treat|Overall Study||1
3152880|NCT01814072|3879003|FG018|Intent to Treat|Overall Study||3
3152881|NCT01814072|3879004|FG019|Intent to Treat|Overall Study||5
3152882|NCT01814072|3879005|FG020|Intent to Treat|Overall Study||2
3152883|NCT01814072|3879006|FG021|Intent to Treat|Overall Study||1
3152884|NCT01814072|3879007|FG022|Intent to Treat|Overall Study||4
3152885|NCT01814072|3879008|FG023|Intent to Treat|Overall Study||1
3152886|NCT01814072|3879009|FG024|Intent to Treat|Overall Study||6
3152887|NCT01814072|3879010|FG025|Intent to Treat|Overall Study||2
3152888|NCT01814072|3879011|FG026|Intent to Treat|Overall Study||2
3152889|NCT01814072|3879012|FG027|Intent to Treat|Overall Study||4
3152890|NCT01814072|3879013|FG028|Intent to Treat|Overall Study||4
3152891|NCT01814072|3879014|FG029|Intent to Treat|Overall Study||3
3152892|NCT01814072|3879015|FG030|Intent to Treat|Overall Study||2
3152893|NCT01814072|3879016|FG031|Intent to Treat|Overall Study||0
3152894|NCT01814072|3878985|FG000|COMPLETED|Overall Study||14
3152895|NCT01814072|3878986|FG001|COMPLETED|Overall Study||16
3152896|NCT01814072|3878987|FG002|COMPLETED|Overall Study||15
3152897|NCT01814072|3878988|FG003|COMPLETED|Overall Study||18
3152898|NCT01814072|3878989|FG004|COMPLETED|Overall Study||14
3152899|NCT01814072|3878990|FG005|COMPLETED|Overall Study||12
3152900|NCT01814072|3878991|FG006|COMPLETED|Overall Study||14
3152901|NCT01814072|3878992|FG007|COMPLETED|Overall Study||17
3152902|NCT01814072|3878993|FG008|COMPLETED|Overall Study||16
3152903|NCT01814072|3878994|FG009|COMPLETED|Overall Study||13
3152904|NCT01814072|3878995|FG010|COMPLETED|Overall Study||17
3152905|NCT01814072|3878996|FG011|COMPLETED|Overall Study||16
3152906|NCT01814072|3878997|FG012|COMPLETED|Overall Study||15
3152907|NCT01814072|3878998|FG013|COMPLETED|Overall Study||16
3152908|NCT01814072|3878999|FG014|COMPLETED|Overall Study||15
3152909|NCT01814072|3879000|FG015|COMPLETED|Overall Study||16
3152910|NCT01814072|3879001|FG016|COMPLETED|Overall Study||14
3152911|NCT01814072|3879002|FG017|COMPLETED|Overall Study||17
3152912|NCT01814072|3879003|FG018|COMPLETED|Overall Study||14
3152913|NCT01814072|3879004|FG019|COMPLETED|Overall Study||11
3152914|NCT01814072|3879005|FG020|COMPLETED|Overall Study||14
3152915|NCT01814072|3879006|FG021|COMPLETED|Overall Study||16
3152916|NCT01814072|3879007|FG022|COMPLETED|Overall Study||13
3152917|NCT01814072|3879008|FG023|COMPLETED|Overall Study||17
3152918|NCT01814072|3879009|FG024|COMPLETED|Overall Study||11
3152919|NCT01814072|3879010|FG025|COMPLETED|Overall Study||14
3152920|NCT01814072|3879011|FG026|COMPLETED|Overall Study||16
3152921|NCT01814072|3879012|FG027|COMPLETED|Overall Study||13
3152922|NCT01814072|3879013|FG028|COMPLETED|Overall Study||14
3152923|NCT01814072|3879014|FG029|COMPLETED|Overall Study||14
3152924|NCT01814072|3879015|FG030|COMPLETED|Overall Study||15
3152925|NCT01814072|3879016|FG031|COMPLETED|Overall Study||17
3152926|NCT01814072|3878985|FG000|NOT COMPLETED|Overall Study||4
3152927|NCT01814072|3878986|FG001|NOT COMPLETED|Overall Study||2
3152928|NCT01814072|3878987|FG002|NOT COMPLETED|Overall Study||3
3152929|NCT01814072|3878988|FG003|NOT COMPLETED|Overall Study||0
3152930|NCT01814072|3878989|FG004|NOT COMPLETED|Overall Study||4
3152931|NCT01814072|3878990|FG005|NOT COMPLETED|Overall Study||6
3152932|NCT01814072|3878991|FG006|NOT COMPLETED|Overall Study||4
3152933|NCT01814072|3878992|FG007|NOT COMPLETED|Overall Study||1
3152934|NCT01814072|3878993|FG008|NOT COMPLETED|Overall Study||3
3152935|NCT01814072|3878994|FG009|NOT COMPLETED|Overall Study||5
3152936|NCT01814072|3878995|FG010|NOT COMPLETED|Overall Study||1
3152937|NCT01814072|3878996|FG011|NOT COMPLETED|Overall Study||2
3152938|NCT01814072|3878997|FG012|NOT COMPLETED|Overall Study||3
3152939|NCT01814072|3878998|FG013|NOT COMPLETED|Overall Study||2
3152940|NCT01814072|3878999|FG014|NOT COMPLETED|Overall Study||3
3152941|NCT01814072|3879000|FG015|NOT COMPLETED|Overall Study||2
3152942|NCT01814072|3879001|FG016|NOT COMPLETED|Overall Study||3
3152943|NCT01814072|3879002|FG017|NOT COMPLETED|Overall Study||1
3152944|NCT01814072|3879003|FG018|NOT COMPLETED|Overall Study||3
3152945|NCT01814072|3879004|FG019|NOT COMPLETED|Overall Study||5
3152946|NCT01814072|3879005|FG020|NOT COMPLETED|Overall Study||2
3152947|NCT01814072|3879006|FG021|NOT COMPLETED|Overall Study||1
3152948|NCT01814072|3879007|FG022|NOT COMPLETED|Overall Study||4
3152949|NCT01814072|3879008|FG023|NOT COMPLETED|Overall Study||1
3152950|NCT01814072|3879009|FG024|NOT COMPLETED|Overall Study||6
3152951|NCT01814072|3879010|FG025|NOT COMPLETED|Overall Study||2
3152952|NCT01814072|3879011|FG026|NOT COMPLETED|Overall Study||2
3152953|NCT01814072|3879012|FG027|NOT COMPLETED|Overall Study||4
3152954|NCT01814072|3879013|FG028|NOT COMPLETED|Overall Study||4
3152955|NCT01814072|3879014|FG029|NOT COMPLETED|Overall Study||3
3152956|NCT01814072|3879015|FG030|NOT COMPLETED|Overall Study||2
3152957|NCT01814072|3879016|FG031|NOT COMPLETED|Overall Study||0
3152958|NCT01814137|3879058|FG000|STARTED|Overall Study||20
3183472|NCT02008773|3911798|FG002|STARTED|Overall Study||46
3152959|NCT01814137|3879059|FG001|STARTED|Overall Study||20
3152960|NCT01814137|3879058|FG000|COMPLETED|Overall Study||15
3152961|NCT01814137|3879059|FG001|COMPLETED|Overall Study||15
3152962|NCT01814137|3879058|FG000|NOT COMPLETED|Overall Study||5
3152963|NCT01814137|3879059|FG001|NOT COMPLETED|Overall Study||5
3152964|NCT01814241|3879065|FG000|STARTED|Overall Study||20
3152965|NCT01814241|3879065|FG000|COMPLETED|Overall Study||16
3152966|NCT01814241|3879065|FG000|NOT COMPLETED|Overall Study||4
3152967|NCT01814332|3879072|FG000|STARTED|Overall Study||63
3152968|NCT01814332|3879073|FG001|STARTED|Overall Study||65
3152969|NCT01814332|3879072|FG000|COMPLETED|Overall Study||47
3152970|NCT01814332|3879073|FG001|COMPLETED|Overall Study||49
3152971|NCT01814332|3879072|FG000|NOT COMPLETED|Overall Study||16
3152972|NCT01814332|3879073|FG001|NOT COMPLETED|Overall Study||16
3152973|NCT01814371|3879081|FG000|STARTED|Overall Study||248
3152974|NCT01814371|3879082|FG001|STARTED|Overall Study||226
3152975|NCT01814371|3879081|FG000|COMPLETED|Overall Study||218
3152976|NCT01814371|3879082|FG001|COMPLETED|Overall Study||199
3152977|NCT01814371|3879081|FG000|NOT COMPLETED|Overall Study||30
3152978|NCT01814371|3879082|FG001|NOT COMPLETED|Overall Study||27
3152979|NCT01814397|3879091|FG000|STARTED|Overall Study||50
3152980|NCT01814397|3879091|FG000|3 Month Evaluation|Overall Study||43
3152981|NCT01814397|3879091|FG000|COMPLETED|Overall Study||36
3152982|NCT01814397|3879091|FG000|NOT COMPLETED|Overall Study||14
3152983|NCT01814553|3879097|FG000|STARTED|Overall Study||18
3152984|NCT01814553|3879098|FG001|STARTED|Overall Study||22
3152985|NCT01814553|3879097|FG000|COMPLETED|Overall Study||0
3152986|NCT01814553|3879098|FG001|COMPLETED|Overall Study||0
3152987|NCT01814553|3879097|FG000|NOT COMPLETED|Overall Study||18
3152988|NCT01814553|3879098|FG001|NOT COMPLETED|Overall Study||22
3152989|NCT01814670|3879104|FG000|STARTED|Overall Study||185
3152990|NCT01814670|3879104|FG000|COMPLETED|Overall Study||173
3152991|NCT01814670|3879104|FG000|NOT COMPLETED|Overall Study||12
3152992|NCT01814696|3879110|FG000|STARTED|Overall Study||15
3152993|NCT01814696|3879111|FG001|STARTED|Overall Study||11
3152994|NCT01814696|3879110|FG000|COMPLETED|Overall Study||13
3152995|NCT01814696|3879111|FG001|COMPLETED|Overall Study||11
3152996|NCT01814696|3879110|FG000|NOT COMPLETED|Overall Study||2
3152997|NCT01814696|3879111|FG001|NOT COMPLETED|Overall Study||0
3152998|NCT01814748|3879119|FG000|STARTED|Overall Study||102
3152999|NCT01814748|3879120|FG001|STARTED|Overall Study||101
3153000|NCT01814748|3879119|FG000|COMPLETED|Overall Study||94
3153001|NCT01814748|3879120|FG001|COMPLETED|Overall Study||94
3153002|NCT01814748|3879119|FG000|NOT COMPLETED|Overall Study||8
3153003|NCT01814748|3879120|FG001|NOT COMPLETED|Overall Study||7
3153004|NCT01814761|3879128|FG000|STARTED|Overall Study||42
3153005|NCT01814761|3879129|FG001|STARTED|Overall Study||270
3153006|NCT01814761|3879128|FG000|COMPLETED|Overall Study||34
3153007|NCT01814761|3879129|FG001|COMPLETED|Overall Study||240
3153008|NCT01814761|3879128|FG000|NOT COMPLETED|Overall Study||8
3153009|NCT01814761|3879129|FG001|NOT COMPLETED|Overall Study||30
3153010|NCT01814774|3879135|FG000|STARTED|Overall Study||48
3153011|NCT01814774|3879135|FG000|COMPLETED|Overall Study||48
3153012|NCT01814774|3879135|FG000|NOT COMPLETED|Overall Study||0
3153013|NCT01814787|3879143|FG000|STARTED|Overall Study||685
3153014|NCT01814787|3879144|FG001|STARTED|Overall Study||684
3153015|NCT01814787|3879143|FG000|COMPLETED|Overall Study||685
3153016|NCT01814787|3879144|FG001|COMPLETED|Overall Study||684
3153017|NCT01814787|3879143|FG000|NOT COMPLETED|Overall Study||0
3153018|NCT01814787|3879144|FG001|NOT COMPLETED|Overall Study||0
3153019|NCT01814800|3879150|FG000|STARTED|Overall Study||59
3183473|NCT02008773|3911799|FG003|STARTED|Overall Study||50
3183474|NCT02008773|3911796|FG000|COMPLETED|Overall Study||27
3183475|NCT02008773|3911797|FG001|COMPLETED|Overall Study||25
3183476|NCT02008773|3911798|FG002|COMPLETED|Overall Study||32
3183477|NCT02008773|3911799|FG003|COMPLETED|Overall Study||38
3183478|NCT02008773|3911796|FG000|NOT COMPLETED|Overall Study||13
3183479|NCT02008773|3911797|FG001|NOT COMPLETED|Overall Study||9
3183480|NCT02008773|3911798|FG002|NOT COMPLETED|Overall Study||14
3183481|NCT02008773|3911799|FG003|NOT COMPLETED|Overall Study||12
3183482|NCT02008877|3911807|FG000|STARTED|Overall Study||3
3183483|NCT02008877|3911808|FG001|STARTED|Overall Study||7
3183484|NCT02008877|3911809|FG002|STARTED|Overall Study||10
3183485|NCT02008877|3911807|FG000|COMPLETED|Overall Study||3
3183486|NCT02008877|3911808|FG001|COMPLETED|Overall Study||6
3183487|NCT02008877|3911809|FG002|COMPLETED|Overall Study||10
3183488|NCT02008877|3911807|FG000|NOT COMPLETED|Overall Study||0
3183489|NCT02008877|3911808|FG001|NOT COMPLETED|Overall Study||1
3183490|NCT02008877|3911809|FG002|NOT COMPLETED|Overall Study||0
3183491|NCT02008890|3911821|FG000|STARTED|Period 1||80
3183492|NCT02008890|3911822|FG001|STARTED|Period 1||79
3183493|NCT02008890|3911823|FG002|STARTED|Period 1||78
3183494|NCT02008890|3911824|FG003|STARTED|Period 1||0
3183495|NCT02008890|3911825|FG004|STARTED|Period 1||0
3183496|NCT02008890|3911821|FG000|COMPLETED|Period 1||65
3153020|NCT01814800|3879150|FG000|COMPLETED|Overall Study||54
3153021|NCT01814800|3879150|FG000|NOT COMPLETED|Overall Study||5
3153022|NCT01814813|3879157|FG000|STARTED|Overall Study||29
3153023|NCT01814813|3879158|FG001|STARTED|Overall Study||30
3153024|NCT01814813|3879159|FG002|STARTED|Overall Study||31
3153025|NCT01814813|3879157|FG000|COMPLETED|Overall Study||29
3153026|NCT01814813|3879158|FG001|COMPLETED|Overall Study||30
3153027|NCT01814813|3879159|FG002|COMPLETED|Overall Study||31
3153028|NCT01814813|3879157|FG000|NOT COMPLETED|Overall Study||0
3153029|NCT01814813|3879158|FG001|NOT COMPLETED|Overall Study||0
3153030|NCT01814813|3879159|FG002|NOT COMPLETED|Overall Study||0
3153031|NCT01814878|3879169|FG000|STARTED|Overall Study||162
3183497|NCT02008890|3911822|FG001|COMPLETED|Period 1||64
3183498|NCT02008890|3911823|FG002|COMPLETED|Period 1||66
3153032|NCT01814878|3879170|FG001|STARTED|Overall Study||158
3153033|NCT01814878|3879169|FG000|COMPLETED|Overall Study||116
3153034|NCT01814878|3879170|FG001|COMPLETED|Overall Study||128
3153035|NCT01814878|3879169|FG000|NOT COMPLETED|Overall Study||46
3153036|NCT01814878|3879170|FG001|NOT COMPLETED|Overall Study||30
3153037|NCT01815008|3879176|FG000|STARTED|Overall Study|Had difficulty in completing enrollment|19
3153038|NCT01815008|3879176|FG000|COMPLETED|Overall Study|transcriptomic data was available on 9 participants only|15
3153039|NCT01815008|3879176|FG000|NOT COMPLETED|Overall Study||4
3183499|NCT02008890|3911824|FG003|COMPLETED|Period 1||0
3183500|NCT02008890|3911825|FG004|COMPLETED|Period 1||0
3183501|NCT02008890|3911821|FG000|NOT COMPLETED|Period 1||15
3183502|NCT02008890|3911822|FG001|NOT COMPLETED|Period 1||15
3183503|NCT02008890|3911823|FG002|NOT COMPLETED|Period 1||12
3183504|NCT02008890|3911824|FG003|NOT COMPLETED|Period 1||0
3183505|NCT02008890|3911825|FG004|NOT COMPLETED|Period 1||0
3183506|NCT02008890|3911821|FG000|STARTED|Period 2||65
3183507|NCT02008890|3911822|FG001|STARTED|Period 2||64
3183508|NCT02008890|3911823|FG002|STARTED|Period 2||10
3183509|NCT02008890|3911824|FG003|STARTED|Period 2||27
3183510|NCT02008890|3911825|FG004|STARTED|Period 2||28
3183511|NCT02008890|3911821|FG000|COMPLETED|Period 2||38
3183512|NCT02008890|3911822|FG001|COMPLETED|Period 2||49
3183513|NCT02008890|3911823|FG002|COMPLETED|Period 2||9
3183514|NCT02008890|3911824|FG003|COMPLETED|Period 2||13
3183515|NCT02008890|3911825|FG004|COMPLETED|Period 2||20
3183516|NCT02008890|3911821|FG000|NOT COMPLETED|Period 2||27
3183517|NCT02008890|3911822|FG001|NOT COMPLETED|Period 2||15
3183518|NCT02008890|3911823|FG002|NOT COMPLETED|Period 2||1
3183519|NCT02008890|3911824|FG003|NOT COMPLETED|Period 2||14
3183520|NCT02008890|3911825|FG004|NOT COMPLETED|Period 2||8
3183521|NCT02008890|3911821|FG000|STARTED|Extension Period||31
3183522|NCT02008890|3911822|FG001|STARTED|Extension Period||36
3183523|NCT02008890|3911823|FG002|STARTED|Extension Period||0
3183524|NCT02008890|3911824|FG003|STARTED|Extension Period||10
3183525|NCT02008890|3911825|FG004|STARTED|Extension Period||17
3183526|NCT02008890|3911821|FG000|COMPLETED|Extension Period||26
3183527|NCT02008890|3911822|FG001|COMPLETED|Extension Period||31
3183528|NCT02008890|3911823|FG002|COMPLETED|Extension Period||0
3183529|NCT02008890|3911824|FG003|COMPLETED|Extension Period||6
3183530|NCT02008890|3911825|FG004|COMPLETED|Extension Period||13
3183531|NCT02008890|3911821|FG000|NOT COMPLETED|Extension Period||5
3183532|NCT02008890|3911822|FG001|NOT COMPLETED|Extension Period||5
3183533|NCT02008890|3911823|FG002|NOT COMPLETED|Extension Period||0
3183534|NCT02008890|3911824|FG003|NOT COMPLETED|Extension Period||4
3183535|NCT02008890|3911825|FG004|NOT COMPLETED|Extension Period||4
3183536|NCT02008916|3911843|FG000|STARTED|Primary Assessment (up to Week 16)||74
3183537|NCT02008916|3911844|FG001|STARTED|Primary Assessment (up to Week 16)||76
3183538|NCT02008916|3911845|FG002|STARTED|Primary Assessment (up to Week 16)||76
3183539|NCT02008916|3911843|FG000|FAS|Primary Assessment (up to Week 16)||74
3183540|NCT02008916|3911844|FG001|FAS|Primary Assessment (up to Week 16)||76
3183541|NCT02008916|3911845|FG002|FAS|Primary Assessment (up to Week 16)||76
3183542|NCT02008916|3911843|FG000|Safety Set|Primary Assessment (up to Week 16)||74
3183543|NCT02008916|3911844|FG001|Safety Set|Primary Assessment (up to Week 16)||76
3183544|NCT02008916|3911845|FG002|Safety Set|Primary Assessment (up to Week 16)||75
3183545|NCT02008916|3911843|FG000|COMPLETED|Primary Assessment (up to Week 16)||74
3183546|NCT02008916|3911844|FG001|COMPLETED|Primary Assessment (up to Week 16)||75
3183547|NCT02008916|3911845|FG002|COMPLETED|Primary Assessment (up to Week 16)||73
3183548|NCT02008916|3911843|FG000|NOT COMPLETED|Primary Assessment (up to Week 16)||0
3183549|NCT02008916|3911844|FG001|NOT COMPLETED|Primary Assessment (up to Week 16)||1
3183550|NCT02008916|3911845|FG002|NOT COMPLETED|Primary Assessment (up to Week 16)||3
3183551|NCT02008916|3911843|FG000|STARTED|Week 16 - 156||74
3183552|NCT02008916|3911844|FG001|STARTED|Week 16 - 156||75
3183553|NCT02008916|3911845|FG002|STARTED|Week 16 - 156||73
3183554|NCT02008916|3911843|FG000|COMPLETED|Week 16 - 156||55
3183555|NCT02008916|3911844|FG001|COMPLETED|Week 16 - 156||62
3183556|NCT02008916|3911845|FG002|COMPLETED|Week 16 - 156||63
3183557|NCT02008916|3911843|FG000|NOT COMPLETED|Week 16 - 156||19
3183558|NCT02008916|3911844|FG001|NOT COMPLETED|Week 16 - 156||13
3183559|NCT02008916|3911845|FG002|NOT COMPLETED|Week 16 - 156||10
3183560|NCT02008942|3911854|FG000|STARTED|First Intervention||27
3183561|NCT02008942|3911855|FG001|STARTED|First Intervention||30
3183562|NCT02008942|3911854|FG000|COMPLETED|First Intervention||27
3183563|NCT02008942|3911855|FG001|COMPLETED|First Intervention||30
3183564|NCT02008942|3911854|FG000|NOT COMPLETED|First Intervention||0
3183565|NCT02008942|3911855|FG001|NOT COMPLETED|First Intervention||0
3183566|NCT02008942|3911854|FG000|STARTED|Second Intervention||26
3183567|NCT02008942|3911855|FG001|STARTED|Second Intervention||30
3183568|NCT02008942|3911854|FG000|COMPLETED|Second Intervention||25
3183569|NCT02008942|3911855|FG001|COMPLETED|Second Intervention||30
3183570|NCT02008942|3911854|FG000|NOT COMPLETED|Second Intervention||1
3183571|NCT02008942|3911855|FG001|NOT COMPLETED|Second Intervention||0
3183572|NCT02009046|3911863|FG000|STARTED|Overall Study||1025
3183573|NCT02009046|3911864|FG001|STARTED|Overall Study||884
3183574|NCT02009046|3911863|FG000|SEI Curriculum Only|Overall Study||461
3183575|NCT02009046|3911864|FG001|SEI Curriculum Only|Overall Study||0
3183576|NCT02009046|3911863|FG000|SEI Curriculum + 3 SchoolWide Components|Overall Study||544
3183577|NCT02009046|3911864|FG001|SEI Curriculum + 3 SchoolWide Components|Overall Study||0
3183578|NCT02009046|3911863|FG000|Ctrl Curriculum Only|Overall Study||0
3153040|NCT01815099|3879182|FG000|STARTED|Overall Study||4
3153041|NCT01815099|3879182|FG000|Began rTMS Treatment|Overall Study||3
3153042|NCT01815099|3879182|FG000|COMPLETED|Overall Study||2
3153043|NCT01815099|3879182|FG000|NOT COMPLETED|Overall Study||2
3153044|NCT01815138|3879189|FG000|STARTED|Overall Study||34
3153045|NCT01815138|3879190|FG001|STARTED|Overall Study||37
3153046|NCT01815138|3879189|FG000|COMPLETED|Overall Study||26
3153047|NCT01815138|3879190|FG001|COMPLETED|Overall Study||31
3153048|NCT01815138|3879189|FG000|NOT COMPLETED|Overall Study||8
3153049|NCT01815138|3879190|FG001|NOT COMPLETED|Overall Study||6
3153050|NCT01815229|3879199|FG000|STARTED|Overall Study||13
3153051|NCT01815229|3879200|FG001|STARTED|Overall Study||18
3153052|NCT01815229|3879201|FG002|STARTED|Overall Study||51
3153053|NCT01815229|3879199|FG000|COMPLETED|Overall Study||13
3153054|NCT01815229|3879200|FG001|COMPLETED|Overall Study||18
3153055|NCT01815229|3879201|FG002|COMPLETED|Overall Study||0
3153056|NCT01815229|3879199|FG000|NOT COMPLETED|Overall Study||0
3153057|NCT01815229|3879200|FG001|NOT COMPLETED|Overall Study||0
3153058|NCT01815229|3879201|FG002|NOT COMPLETED|Overall Study||51
3153059|NCT01815333|3879208|FG000|STARTED|Overall Study||10
3153060|NCT01815333|3879208|FG000|COMPLETED|Overall Study||10
3153061|NCT01815333|3879208|FG000|NOT COMPLETED|Overall Study||0
3153062|NCT01815424|3879215|FG000|STARTED|Week 0 to 16||90
3153063|NCT01815424|3879216|FG001|STARTED|Week 0 to 16||88
3153064|NCT01815424|3879217|FG002|STARTED|Week 0 to 16||88
3153065|NCT01815424|3879218|FG003|STARTED|Week 0 to 16||0
3153066|NCT01815424|3879219|FG004|STARTED|Week 0 to 16||0
3153067|NCT01815424|3879215|FG000|COMPLETED|Week 0 to 16||83
3153068|NCT01815424|3879216|FG001|COMPLETED|Week 0 to 16||84
3153069|NCT01815424|3879217|FG002|COMPLETED|Week 0 to 16||77
3153070|NCT01815424|3879218|FG003|COMPLETED|Week 0 to 16||0
3153071|NCT01815424|3879219|FG004|COMPLETED|Week 0 to 16||0
3153072|NCT01815424|3879215|FG000|NOT COMPLETED|Week 0 to 16||7
3153073|NCT01815424|3879216|FG001|NOT COMPLETED|Week 0 to 16||4
3153074|NCT01815424|3879217|FG002|NOT COMPLETED|Week 0 to 16||11
3153075|NCT01815424|3879218|FG003|NOT COMPLETED|Week 0 to 16||0
3153076|NCT01815424|3879219|FG004|NOT COMPLETED|Week 0 to 16||0
3153077|NCT01815424|3879215|FG000|STARTED|Week 16 to 52||83
3153078|NCT01815424|3879216|FG001|STARTED|Week 16 to 52||84
3153079|NCT01815424|3879217|FG002|STARTED|Week 16 to 52||0
3153080|NCT01815424|3879218|FG003|STARTED|Week 16 to 52||38
3153081|NCT01815424|3879219|FG004|STARTED|Week 16 to 52||39
3153082|NCT01815424|3879215|FG000|COMPLETED|Week 16 to 52||81
3153083|NCT01815424|3879216|FG001|COMPLETED|Week 16 to 52||79
3153084|NCT01815424|3879217|FG002|COMPLETED|Week 16 to 52||0
3153085|NCT01815424|3879218|FG003|COMPLETED|Week 16 to 52||35
3153086|NCT01815424|3879219|FG004|COMPLETED|Week 16 to 52||36
3153087|NCT01815424|3879215|FG000|NOT COMPLETED|Week 16 to 52||2
3153088|NCT01815424|3879216|FG001|NOT COMPLETED|Week 16 to 52||5
3153089|NCT01815424|3879217|FG002|NOT COMPLETED|Week 16 to 52||0
3153090|NCT01815424|3879218|FG003|NOT COMPLETED|Week 16 to 52||3
3153091|NCT01815424|3879219|FG004|NOT COMPLETED|Week 16 to 52||3
3153092|NCT01815502|3879234|FG000|STARTED|Overall Study||10
3153093|NCT01815502|3879235|FG001|STARTED|Overall Study||10
3153094|NCT01815502|3879234|FG000|COMPLETED|Overall Study||10
3153095|NCT01815502|3879235|FG001|COMPLETED|Overall Study||10
3153096|NCT01815502|3879234|FG000|NOT COMPLETED|Overall Study||0
3153097|NCT01815502|3879235|FG001|NOT COMPLETED|Overall Study||0
3153098|NCT01815515|3879244|FG000|STARTED|Overall Study||17
3153099|NCT01815515|3879244|FG000|COMPLETED|Overall Study||17
3153100|NCT01815515|3879244|FG000|NOT COMPLETED|Overall Study||0
3153101|NCT01815645|3879250|FG000|STARTED|Overall Study||32
3153102|NCT01815645|3879251|FG001|STARTED|Overall Study||33
3153103|NCT01815645|3879250|FG000|COMPLETED|Overall Study||32
3153104|NCT01815645|3879251|FG001|COMPLETED|Overall Study||33
3153105|NCT01815645|3879250|FG000|NOT COMPLETED|Overall Study||0
3153106|NCT01815645|3879251|FG001|NOT COMPLETED|Overall Study||0
3153107|NCT01815671|3879261|FG000|STARTED|Overall Study||88
3153108|NCT01815671|3879262|FG001|STARTED|Overall Study||85
3153109|NCT01815671|3879261|FG000|COMPLETED|Overall Study||88
3153110|NCT01815671|3879262|FG001|COMPLETED|Overall Study||85
3153111|NCT01815671|3879261|FG000|NOT COMPLETED|Overall Study||0
3153112|NCT01815671|3879262|FG001|NOT COMPLETED|Overall Study||0
3153113|NCT01815736|3879270|FG000|STARTED|Randomized Treatment Phase-Up to Week 96||963
3153114|NCT01815736|3879271|FG001|STARTED|Randomized Treatment Phase-Up to Week 96||480
3153115|NCT01815736|3879270|FG000|COMPLETED|Randomized Treatment Phase-Up to Week 96||914
3153116|NCT01815736|3879271|FG001|COMPLETED|Randomized Treatment Phase-Up to Week 96||445
3153117|NCT01815736|3879270|FG000|NOT COMPLETED|Randomized Treatment Phase-Up to Week 96||49
3153118|NCT01815736|3879271|FG001|NOT COMPLETED|Randomized Treatment Phase-Up to Week 96||35
3153119|NCT01815736|3879270|FG000|STARTED|Extension Treatment Phase- After Week 96|9 participants who completed the Randomized Treatment Phase did not continue in the Extension E/C/F/TAF Treatment Phase.|905
3153120|NCT01815736|3879271|FG001|STARTED|Extension Treatment Phase- After Week 96|21 participants who completed the Randomized Treatment Phase did not continue in the Extension E/C/F/TAF Treatment Phase.|424
3153121|NCT01815736|3879270|FG000|COMPLETED|Extension Treatment Phase- After Week 96||854
3153122|NCT01815736|3879271|FG001|COMPLETED|Extension Treatment Phase- After Week 96||398
3153123|NCT01815736|3879270|FG000|NOT COMPLETED|Extension Treatment Phase- After Week 96||51
3153124|NCT01815736|3879271|FG001|NOT COMPLETED|Extension Treatment Phase- After Week 96||26
3153125|NCT01815840|3879281|FG000|STARTED|Overall Study||116
3153126|NCT01815840|3879282|FG001|STARTED|Overall Study||113
3153127|NCT01815840|3879281|FG000|COMPLETED|Overall Study||57
3153128|NCT01815840|3879282|FG001|COMPLETED|Overall Study||50
3153129|NCT01815840|3879281|FG000|NOT COMPLETED|Overall Study||59
3153130|NCT01815840|3879282|FG001|NOT COMPLETED|Overall Study||63
3153131|NCT01815918|3879290|FG000|STARTED|Overall Study||30
3153132|NCT01815918|3879291|FG001|STARTED|Overall Study||30
3153133|NCT01815918|3879290|FG000|COMPLETED|Overall Study||12
3153134|NCT01815918|3879291|FG001|COMPLETED|Overall Study||11
3153135|NCT01815918|3879290|FG000|NOT COMPLETED|Overall Study||18
3153136|NCT01815918|3879291|FG001|NOT COMPLETED|Overall Study||19
3153137|NCT01816048|3879301|FG000|STARTED|Overall Study||8
3153138|NCT01816048|3879301|FG000|COMPLETED|Overall Study||2
3153139|NCT01816048|3879301|FG000|NOT COMPLETED|Overall Study||6
3153140|NCT01816061|3879308|FG000|STARTED|Overall Study||40
3153141|NCT01816061|3879309|FG001|STARTED|Overall Study||51
3153142|NCT01816061|3879308|FG000|COMPLETED|Overall Study||27
3153143|NCT01816061|3879309|FG001|COMPLETED|Overall Study||27
3153144|NCT01816061|3879308|FG000|NOT COMPLETED|Overall Study||13
3153145|NCT01816061|3879309|FG001|NOT COMPLETED|Overall Study||24
3153146|NCT01816074|3879319|FG000|STARTED|Phase 1||11
3153147|NCT01816074|3879320|FG001|STARTED|Phase 1||9
3153148|NCT01816074|3879321|FG002|STARTED|Phase 1||11
3153149|NCT01816074|3879322|FG003|STARTED|Phase 1||10
3153150|NCT01816074|3879319|FG000|COMPLETED|Phase 1||11
3153151|NCT01816074|3879320|FG001|COMPLETED|Phase 1||9
3153152|NCT01816074|3879321|FG002|COMPLETED|Phase 1||10
3153153|NCT01816074|3879322|FG003|COMPLETED|Phase 1||10
3153154|NCT01816074|3879319|FG000|NOT COMPLETED|Phase 1||0
3153155|NCT01816074|3879320|FG001|NOT COMPLETED|Phase 1||0
3153156|NCT01816074|3879321|FG002|NOT COMPLETED|Phase 1||1
3153157|NCT01816074|3879322|FG003|NOT COMPLETED|Phase 1||0
3153158|NCT01816074|3879319|FG000|STARTED|Phase 2||11
3153159|NCT01816074|3879320|FG001|STARTED|Phase 2||9
3153160|NCT01816074|3879321|FG002|STARTED|Phase 2||10
3153161|NCT01816074|3879322|FG003|STARTED|Phase 2||10
3153162|NCT01816074|3879319|FG000|COMPLETED|Phase 2||9
3153163|NCT01816074|3879320|FG001|COMPLETED|Phase 2||7
3153164|NCT01816074|3879321|FG002|COMPLETED|Phase 2||10
3153165|NCT01816074|3879322|FG003|COMPLETED|Phase 2||9
3153166|NCT01816074|3879319|FG000|NOT COMPLETED|Phase 2||2
3153167|NCT01816074|3879320|FG001|NOT COMPLETED|Phase 2||2
3153168|NCT01816074|3879321|FG002|NOT COMPLETED|Phase 2||0
3153169|NCT01816074|3879322|FG003|NOT COMPLETED|Phase 2||1
3153170|NCT01816230|3879346|FG000|STARTED|Overall Study||36
3153171|NCT01816230|3879346|FG000|COMPLETED|Overall Study||36
3153172|NCT01816230|3879346|FG000|NOT COMPLETED|Overall Study||0
3153173|NCT01816243|3879350|FG000|STARTED|Overall Study||39
3153174|NCT01816243|3879350|FG000|COMPLETED|Overall Study||27
3153175|NCT01816243|3879350|FG000|NOT COMPLETED|Overall Study||12
3153176|NCT01816295|3879356|FG000|STARTED|Double Blind Phase||357
3153177|NCT01816295|3879357|FG001|STARTED|Double Blind Phase||358
3153178|NCT01816295|3879356|FG000|Received Study Drug|Double Blind Phase||356
3153179|NCT01816295|3879357|FG001|Received Study Drug|Double Blind Phase||354
3153180|NCT01816295|3879356|FG000|COMPLETED|Double Blind Phase||294
3153181|NCT01816295|3879357|FG001|COMPLETED|Double Blind Phase||302
3153182|NCT01816295|3879356|FG000|NOT COMPLETED|Double Blind Phase||63
3153183|NCT01816295|3879357|FG001|NOT COMPLETED|Double Blind Phase||56
3153184|NCT01816295|3879356|FG000|STARTED|OLE Phase|Participants who completed the DBP and still met eligibility criteria had option to enroll in OLE.|275
3153185|NCT01816295|3879357|FG001|STARTED|OLE Phase|Participants who completed the DBP and still met eligibility criteria had option to enroll in OLE.|283
3153186|NCT01816295|3879356|FG000|COMPLETED|OLE Phase||222
3153187|NCT01816295|3879357|FG001|COMPLETED|OLE Phase||227
3153188|NCT01816295|3879356|FG000|NOT COMPLETED|OLE Phase||53
3153189|NCT01816295|3879357|FG001|NOT COMPLETED|OLE Phase||56
3153190|NCT01816451|3879367|FG000|STARTED|Overall Study||13
3153191|NCT01816451|3879368|FG001|STARTED|Overall Study||11
3153192|NCT01816451|3879369|FG002|STARTED|Overall Study||8
3153193|NCT01816451|3879367|FG000|COMPLETED|Overall Study||13
3153194|NCT01816451|3879368|FG001|COMPLETED|Overall Study||11
3153195|NCT01816451|3879369|FG002|COMPLETED|Overall Study||8
3153196|NCT01816451|3879367|FG000|NOT COMPLETED|Overall Study||0
3153197|NCT01816451|3879368|FG001|NOT COMPLETED|Overall Study||0
3153198|NCT01816451|3879369|FG002|NOT COMPLETED|Overall Study||0
3153199|NCT01816477|3879381|FG000|STARTED|Overall Study||43
3153200|NCT01816477|3879382|FG001|STARTED|Overall Study||42
3153201|NCT01816477|3879381|FG000|COMPLETED|Overall Study||27
3153202|NCT01816477|3879382|FG001|COMPLETED|Overall Study||41
3153203|NCT01816477|3879381|FG000|NOT COMPLETED|Overall Study||16
3153204|NCT01816477|3879382|FG001|NOT COMPLETED|Overall Study||1
3153205|NCT01816594|3879390|FG000|STARTED|Overall Study||25
3153206|NCT01816594|3879391|FG001|STARTED|Overall Study||25
3153207|NCT01816594|3879390|FG000|Randomized to the wt Cohort|Overall Study|wt = PIK3CA wild-type|21
3153208|NCT01816594|3879391|FG001|Randomized to the wt Cohort|Overall Study|wt = PIK3CA wild-type|21
3153209|NCT01816594|3879390|FG000|Randomized to the mt Cohort|Overall Study|mt = PIK3CA mutant|4
3153210|NCT01816594|3879391|FG001|Randomized to the mt Cohort|Overall Study|mt = PIK3CA mutant|4
3153211|NCT01816594|3879390|FG000|COMPLETED|Overall Study||14
3153212|NCT01816594|3879391|FG001|COMPLETED|Overall Study||23
3153213|NCT01816594|3879390|FG000|NOT COMPLETED|Overall Study||11
3153214|NCT01816594|3879391|FG001|NOT COMPLETED|Overall Study||2
3153215|NCT01816685|3879405|FG000|STARTED|Overall Study||68
3153216|NCT01816685|3879406|FG001|STARTED|Overall Study||67
3153217|NCT01816685|3879405|FG000|COMPLETED|Overall Study||58
3183579|NCT02009046|3911864|FG001|Ctrl Curriculum Only|Overall Study||456
3183580|NCT02009046|3911863|FG000|Ctrl Curriculm +1 SchoolWide Component|Overall Study||0
3183581|NCT02009046|3911864|FG001|Ctrl Curriculm +1 SchoolWide Component|Overall Study||428
3183582|NCT02009046|3911863|FG000|COMPLETED|Overall Study||769
3183583|NCT02009046|3911864|FG001|COMPLETED|Overall Study||678
3183584|NCT02009046|3911863|FG000|NOT COMPLETED|Overall Study||256
3153218|NCT01816685|3879406|FG001|COMPLETED|Overall Study||56
3153219|NCT01816685|3879405|FG000|NOT COMPLETED|Overall Study||10
3153220|NCT01816685|3879406|FG001|NOT COMPLETED|Overall Study||11
3153221|NCT01816711|3879414|FG000|STARTED|Overall Study||121
3153222|NCT01816711|3879415|FG001|STARTED|Overall Study||83
3153223|NCT01816711|3879414|FG000|COMPLETED|Overall Study||121
3153224|NCT01816711|3879415|FG001|COMPLETED|Overall Study||83
3153225|NCT01816711|3879414|FG000|NOT COMPLETED|Overall Study||0
3183585|NCT02009046|3911864|FG001|NOT COMPLETED|Overall Study||206
3183586|NCT02009163|3911878|FG000|STARTED|Open-label Period (Non-randomized)||418
3183587|NCT02009163|3911879|FG001|STARTED|Open-label Period (Non-randomized)||0
3183588|NCT02009163|3911880|FG002|STARTED|Open-label Period (Non-randomized)||0
3183589|NCT02009163|3911878|FG000|COMPLETED|Open-label Period (Non-randomized)||275
3183590|NCT02009163|3911879|FG001|COMPLETED|Open-label Period (Non-randomized)||0
3183591|NCT02009163|3911880|FG002|COMPLETED|Open-label Period (Non-randomized)||0
3183592|NCT02009163|3911878|FG000|NOT COMPLETED|Open-label Period (Non-randomized)||143
3183593|NCT02009163|3911879|FG001|NOT COMPLETED|Open-label Period (Non-randomized)||0
3183594|NCT02009163|3911880|FG002|NOT COMPLETED|Open-label Period (Non-randomized)||0
3363769|NCT04050605|4094916|FG000|NOT COMPLETED|Overall Study||0
3363770|NCT04050371|4094928|FG000|STARTED|Overall Study||24
3363771|NCT04050371|4094929|FG001|STARTED|Overall Study||24
3363772|NCT04050371|4094928|FG000|COMPLETED|Overall Study||23
3363773|NCT04050371|4094929|FG001|COMPLETED|Overall Study||24
3363774|NCT04050371|4094928|FG000|NOT COMPLETED|Overall Study||1
3363775|NCT04050371|4094929|FG001|NOT COMPLETED|Overall Study||0
3363776|NCT04048460|4094935|FG000|STARTED|Overall Study||10
3363777|NCT04048460|4094935|FG000|COMPLETED|Overall Study||10
3363778|NCT04048460|4094935|FG000|NOT COMPLETED|Overall Study||0
3363779|NCT04048681|4094939|FG000|STARTED|Overall Study||1
3363780|NCT04048681|4094940|FG001|STARTED|Overall Study||1
3363781|NCT04048681|4094941|FG002|STARTED|Overall Study||1
3363782|NCT04048681|4094942|FG003|STARTED|Overall Study||1
3363783|NCT04048681|4094943|FG004|STARTED|Overall Study||1
3363784|NCT04048681|4094939|FG000|COMPLETED|Overall Study||1
3363785|NCT04048681|4094940|FG001|COMPLETED|Overall Study||1
3363786|NCT04048681|4094941|FG002|COMPLETED|Overall Study||1
3363787|NCT04048681|4094942|FG003|COMPLETED|Overall Study||0
3363788|NCT04048681|4094943|FG004|COMPLETED|Overall Study||1
3363789|NCT04048681|4094939|FG000|NOT COMPLETED|Overall Study||0
3363790|NCT04048681|4094940|FG001|NOT COMPLETED|Overall Study||0
3363791|NCT04048681|4094941|FG002|NOT COMPLETED|Overall Study||0
3363792|NCT04048681|4094942|FG003|NOT COMPLETED|Overall Study||1
3363793|NCT04048681|4094943|FG004|NOT COMPLETED|Overall Study||0
3363794|NCT04046250|4094953|FG000|STARTED|Overall Study||11
3363795|NCT04046250|4094954|FG001|STARTED|Overall Study||11
3363796|NCT04046250|4094953|FG000|COMPLETED|Overall Study|Four Methotrexate + TK-112690 Treatments|8
3363797|NCT04046250|4094954|FG001|COMPLETED|Overall Study|Four Methotrexate + TK-12260 Placebo Treatments|7
3153226|NCT01816711|3879415|FG001|NOT COMPLETED|Overall Study||0
3153227|NCT01816763|3879424|FG000|STARTED|Overall Study||195
3153228|NCT01816763|3879425|FG001|STARTED|Overall Study||194
3153229|NCT01816763|3879426|FG002|STARTED|Overall Study||180
3153230|NCT01816763|3879424|FG000|COMPLETED|Overall Study||191
3153231|NCT01816763|3879425|FG001|COMPLETED|Overall Study||179
3153232|NCT01816763|3879426|FG002|COMPLETED|Overall Study||169
3153233|NCT01816763|3879424|FG000|NOT COMPLETED|Overall Study||4
3153234|NCT01816763|3879425|FG001|NOT COMPLETED|Overall Study||15
3153235|NCT01816763|3879426|FG002|NOT COMPLETED|Overall Study||11
3153236|NCT01816776|3879439|FG000|STARTED|Overall Study||73
3153237|NCT01816776|3879440|FG001|STARTED|Overall Study||78
3153238|NCT01816776|3879439|FG000|6 Month Primary Effectiveness Assessed|Overall Study||68
3153239|NCT01816776|3879440|FG001|6 Month Primary Effectiveness Assessed|Overall Study||73
3153240|NCT01816776|3879439|FG000|COMPLETED|Overall Study||60
3153241|NCT01816776|3879440|FG001|COMPLETED|Overall Study||70
3153242|NCT01816776|3879439|FG000|NOT COMPLETED|Overall Study||13
3153243|NCT01816776|3879440|FG001|NOT COMPLETED|Overall Study||8
3153244|NCT01816893|3879448|FG000|STARTED|Euglycemic Clamp/ Hypoglycemic Clamp||11
3153245|NCT01816893|3879449|FG001|STARTED|Euglycemic Clamp/ Hypoglycemic Clamp||11
3153246|NCT01816893|3879448|FG000|COMPLETED|Euglycemic Clamp/ Hypoglycemic Clamp||11
3153247|NCT01816893|3879449|FG001|COMPLETED|Euglycemic Clamp/ Hypoglycemic Clamp||11
3153248|NCT01816893|3879448|FG000|NOT COMPLETED|Euglycemic Clamp/ Hypoglycemic Clamp||0
3153249|NCT01816893|3879449|FG001|NOT COMPLETED|Euglycemic Clamp/ Hypoglycemic Clamp||0
3153250|NCT01816893|3879448|FG000|STARTED|Washout Period||11
3153251|NCT01816893|3879449|FG001|STARTED|Washout Period||11
3153252|NCT01816893|3879448|FG000|COMPLETED|Washout Period||9
3153253|NCT01816893|3879449|FG001|COMPLETED|Washout Period||11
3153254|NCT01816893|3879448|FG000|NOT COMPLETED|Washout Period||2
3153255|NCT01816893|3879449|FG001|NOT COMPLETED|Washout Period||0
3153256|NCT01816893|3879448|FG000|STARTED|Hypoglycemic Clamp/ Euglycemic Clamp||9
3153257|NCT01816893|3879449|FG001|STARTED|Hypoglycemic Clamp/ Euglycemic Clamp||11
3153258|NCT01816893|3879448|FG000|COMPLETED|Hypoglycemic Clamp/ Euglycemic Clamp||9
3153259|NCT01816893|3879449|FG001|COMPLETED|Hypoglycemic Clamp/ Euglycemic Clamp||11
3153260|NCT01816893|3879448|FG000|NOT COMPLETED|Hypoglycemic Clamp/ Euglycemic Clamp||0
3153261|NCT01816893|3879449|FG001|NOT COMPLETED|Hypoglycemic Clamp/ Euglycemic Clamp||0
3153262|NCT01816906|3879457|FG000|STARTED|Six Months||41
3153263|NCT01816906|3879458|FG001|STARTED|Six Months||41
3153264|NCT01816906|3879457|FG000|COMPLETED|Six Months||20
3153265|NCT01816906|3879458|FG001|COMPLETED|Six Months||19
3153266|NCT01816906|3879457|FG000|NOT COMPLETED|Six Months||21
3153267|NCT01816906|3879458|FG001|NOT COMPLETED|Six Months||22
3153268|NCT01816906|3879457|FG000|STARTED|12 Months||20
3153269|NCT01816906|3879458|FG001|STARTED|12 Months||19
3153270|NCT01816906|3879457|FG000|COMPLETED|12 Months||16
3153271|NCT01816906|3879458|FG001|COMPLETED|12 Months||14
3153272|NCT01816906|3879457|FG000|NOT COMPLETED|12 Months||4
3153273|NCT01816906|3879458|FG001|NOT COMPLETED|12 Months||5
3153274|NCT01816945|3879467|FG000|STARTED|Overall Study||23
3153275|NCT01816945|3879468|FG001|STARTED|Overall Study||24
3153276|NCT01816945|3879467|FG000|COMPLETED|Overall Study||21
3153277|NCT01816945|3879468|FG001|COMPLETED|Overall Study||19
3153278|NCT01816945|3879467|FG000|NOT COMPLETED|Overall Study||2
3153279|NCT01816945|3879468|FG001|NOT COMPLETED|Overall Study||5
3153280|NCT01816984|3879474|FG000|STARTED|Overall Study||12
3153281|NCT01816984|3879474|FG000|COMPLETED|Overall Study||11
3153282|NCT01816984|3879474|FG000|NOT COMPLETED|Overall Study||1
3153283|NCT01817075|3879480|FG000|STARTED|Overall Study||88
3153284|NCT01817075|3879481|FG001|STARTED|Overall Study||89
3153285|NCT01817075|3879480|FG000|COMPLETED|Overall Study||41
3153286|NCT01817075|3879481|FG001|COMPLETED|Overall Study||54
3153287|NCT01817075|3879480|FG000|NOT COMPLETED|Overall Study||47
3153288|NCT01817075|3879481|FG001|NOT COMPLETED|Overall Study||35
3153289|NCT01817374|3879487|FG000|STARTED|Overall Study||6
3153290|NCT01817374|3879487|FG000|COMPLETED|Overall Study||6
3153291|NCT01817374|3879487|FG000|NOT COMPLETED|Overall Study||0
3153292|NCT01817491|3879495|FG000|STARTED|Overall Study||32
3153293|NCT01817491|3879496|FG001|STARTED|Overall Study||28
3153294|NCT01817491|3879495|FG000|COMPLETED|Overall Study||28
3153295|NCT01817491|3879496|FG001|COMPLETED|Overall Study||28
3153296|NCT01817491|3879495|FG000|NOT COMPLETED|Overall Study||4
3153297|NCT01817491|3879496|FG001|NOT COMPLETED|Overall Study||0
3153298|NCT01817530|3879511|FG000|STARTED|Overall Study||65
3153299|NCT01817530|3879512|FG001|STARTED|Overall Study||65
3153300|NCT01817530|3879513|FG002|STARTED|Overall Study||64
3153301|NCT01817530|3879514|FG003|STARTED|Overall Study||65
3153302|NCT01817530|3879515|FG004|STARTED|Overall Study||78
3153303|NCT01817530|3879516|FG005|STARTED|Overall Study||77
3153304|NCT01817530|3879517|FG006|STARTED|Overall Study||76
3153305|NCT01817530|3879518|FG007|STARTED|Overall Study||77
3153306|NCT01817530|3879511|FG000|COMPLETED|Overall Study||50
3153307|NCT01817530|3879512|FG001|COMPLETED|Overall Study||52
3153308|NCT01817530|3879513|FG002|COMPLETED|Overall Study||53
3153309|NCT01817530|3879514|FG003|COMPLETED|Overall Study||52
3153310|NCT01817530|3879515|FG004|COMPLETED|Overall Study||67
3153311|NCT01817530|3879516|FG005|COMPLETED|Overall Study||58
3153312|NCT01817530|3879517|FG006|COMPLETED|Overall Study||53
3153313|NCT01817530|3879518|FG007|COMPLETED|Overall Study||53
3153314|NCT01817530|3879511|FG000|NOT COMPLETED|Overall Study||15
3153315|NCT01817530|3879512|FG001|NOT COMPLETED|Overall Study||13
3153316|NCT01817530|3879513|FG002|NOT COMPLETED|Overall Study||11
3153317|NCT01817530|3879514|FG003|NOT COMPLETED|Overall Study||13
3153318|NCT01817530|3879515|FG004|NOT COMPLETED|Overall Study||11
3153319|NCT01817530|3879516|FG005|NOT COMPLETED|Overall Study||19
3153320|NCT01817530|3879517|FG006|NOT COMPLETED|Overall Study||23
3153321|NCT01817530|3879518|FG007|NOT COMPLETED|Overall Study||24
3153322|NCT01817582|3879539|FG000|STARTED|Overall Study||33
3153323|NCT01817582|3879540|FG001|STARTED|Overall Study||36
3153324|NCT01817582|3879541|FG002|STARTED|Overall Study||33
3153325|NCT01817582|3879539|FG000|Received at Least 1 Dose of Study Drug|Overall Study||33
3153326|NCT01817582|3879540|FG001|Received at Least 1 Dose of Study Drug|Overall Study||36
3153327|NCT01817582|3879541|FG002|Received at Least 1 Dose of Study Drug|Overall Study||33
3153328|NCT01817582|3879539|FG000|COMPLETED|Overall Study||31
3153329|NCT01817582|3879540|FG001|COMPLETED|Overall Study||35
3153330|NCT01817582|3879541|FG002|COMPLETED|Overall Study||33
3153331|NCT01817582|3879539|FG000|NOT COMPLETED|Overall Study||2
3153332|NCT01817582|3879540|FG001|NOT COMPLETED|Overall Study||1
3153333|NCT01817582|3879541|FG002|NOT COMPLETED|Overall Study||0
3153334|NCT01817712|3879551|FG000|STARTED|Overall Study||271
3153335|NCT01817712|3879552|FG001|STARTED|Overall Study||270
3153336|NCT01817712|3879551|FG000|COMPLETED|Overall Study|Primary Outcome Assessed over 18 months|250
3153337|NCT01817712|3879552|FG001|COMPLETED|Overall Study|Primary Outcome assessed over 18 months|240
3153338|NCT01817712|3879551|FG000|NOT COMPLETED|Overall Study||21
3153339|NCT01817712|3879552|FG001|NOT COMPLETED|Overall Study||30
3153340|NCT01817725|3879558|FG000|STARTED|Overall Study||20
3153341|NCT01817725|3879558|FG000|COMPLETED|Overall Study||19
3153342|NCT01817725|3879558|FG000|NOT COMPLETED|Overall Study||1
3153343|NCT01817751|3879562|FG000|STARTED|Overall Study||47
3153344|NCT01817751|3879562|FG000|COMPLETED|Overall Study||46
3153345|NCT01817751|3879562|FG000|NOT COMPLETED|Overall Study||1
3153346|NCT01817764|3879568|FG000|STARTED|Overall Study||353
3153347|NCT01817764|3879569|FG001|STARTED|Overall Study||353
3153348|NCT01817764|3879568|FG000|COMPLETED|Overall Study||319
3153349|NCT01817764|3879569|FG001|COMPLETED|Overall Study||315
3183595|NCT02009163|3911878|FG000|STARTED|Randomized-withdrawal Period|The open-label treatment group is not an arm of the randomized-withdrawal period.|0
3183596|NCT02009163|3911879|FG001|STARTED|Randomized-withdrawal Period|The total who started the Placebo and SPD489 arms equals those who completed the open-label period.|138
3183597|NCT02009163|3911880|FG002|STARTED|Randomized-withdrawal Period|The total who started the Placebo and SPD489 arms equals those who completed the open-label period.|137
3183598|NCT02009163|3911878|FG000|COMPLETED|Randomized-withdrawal Period||0
3183599|NCT02009163|3911879|FG001|COMPLETED|Randomized-withdrawal Period||50
3153350|NCT01817764|3879568|FG000|NOT COMPLETED|Overall Study||34
3153351|NCT01817764|3879569|FG001|NOT COMPLETED|Overall Study||38
3153352|NCT01817777|3879577|FG000|STARTED|Observational Phase (8 Weeks)||36
3153353|NCT01817777|3879578|FG001|STARTED|Observational Phase (8 Weeks)||0
3153354|NCT01817777|3879579|FG002|STARTED|Observational Phase (8 Weeks)||0
3153355|NCT01817777|3879577|FG000|COMPLETED|Observational Phase (8 Weeks)||31
3153356|NCT01817777|3879578|FG001|COMPLETED|Observational Phase (8 Weeks)||0
3153357|NCT01817777|3879579|FG002|COMPLETED|Observational Phase (8 Weeks)||0
3153358|NCT01817777|3879577|FG000|NOT COMPLETED|Observational Phase (8 Weeks)||5
3153359|NCT01817777|3879578|FG001|NOT COMPLETED|Observational Phase (8 Weeks)||0
3153360|NCT01817777|3879579|FG002|NOT COMPLETED|Observational Phase (8 Weeks)||0
3153361|NCT01817777|3879577|FG000|STARTED|Interventional Phase (20 Weeks)||0
3153362|NCT01817777|3879578|FG001|STARTED|Interventional Phase (20 Weeks)||16
3153363|NCT01817777|3879579|FG002|STARTED|Interventional Phase (20 Weeks)||15
3153364|NCT01817777|3879577|FG000|COMPLETED|Interventional Phase (20 Weeks)||0
3153365|NCT01817777|3879578|FG001|COMPLETED|Interventional Phase (20 Weeks)||11
3153366|NCT01817777|3879579|FG002|COMPLETED|Interventional Phase (20 Weeks)||10
3153367|NCT01817777|3879577|FG000|NOT COMPLETED|Interventional Phase (20 Weeks)||0
3153368|NCT01817777|3879578|FG001|NOT COMPLETED|Interventional Phase (20 Weeks)||5
3153369|NCT01817777|3879579|FG002|NOT COMPLETED|Interventional Phase (20 Weeks)||5
3153370|NCT01817790|3879587|FG000|STARTED|Overall Study||314
3153371|NCT01817790|3879588|FG001|STARTED|Overall Study||312
3153372|NCT01817790|3879587|FG000|COMPLETED|Overall Study||310
3153373|NCT01817790|3879588|FG001|COMPLETED|Overall Study||304
3153374|NCT01817790|3879587|FG000|NOT COMPLETED|Overall Study||4
3153375|NCT01817790|3879588|FG001|NOT COMPLETED|Overall Study||8
3153376|NCT01817855|3879600|FG000|STARTED|Overall Study||23
3153377|NCT01817855|3879601|FG001|STARTED|Overall Study||8
3153378|NCT01817855|3879602|FG002|STARTED|Overall Study||11
3153379|NCT01817855|3879603|FG003|STARTED|Overall Study||5
3153380|NCT01817855|3879600|FG000|COMPLETED|Overall Study||23
3153381|NCT01817855|3879601|FG001|COMPLETED|Overall Study||6
3153382|NCT01817855|3879602|FG002|COMPLETED|Overall Study||9
3153383|NCT01817855|3879603|FG003|COMPLETED|Overall Study||5
3153384|NCT01817855|3879600|FG000|NOT COMPLETED|Overall Study||0
3153385|NCT01817855|3879601|FG001|NOT COMPLETED|Overall Study||2
3153386|NCT01817855|3879602|FG002|NOT COMPLETED|Overall Study||2
3153387|NCT01817855|3879603|FG003|NOT COMPLETED|Overall Study||0
3153388|NCT01817907|3879621|FG000|STARTED|First Intervention||8
3153389|NCT01817907|3879622|FG001|STARTED|First Intervention||7
3153390|NCT01817907|3879621|FG000|COMPLETED|First Intervention||8
3153391|NCT01817907|3879622|FG001|COMPLETED|First Intervention||7
3153392|NCT01817907|3879621|FG000|NOT COMPLETED|First Intervention||0
3153393|NCT01817907|3879622|FG001|NOT COMPLETED|First Intervention||0
3153394|NCT01817907|3879621|FG000|STARTED|Washout Period||8
3153395|NCT01817907|3879622|FG001|STARTED|Washout Period||7
3153396|NCT01817907|3879621|FG000|COMPLETED|Washout Period||8
3153397|NCT01817907|3879622|FG001|COMPLETED|Washout Period||7
3153398|NCT01817907|3879621|FG000|NOT COMPLETED|Washout Period||0
3153399|NCT01817907|3879622|FG001|NOT COMPLETED|Washout Period||0
3153400|NCT01817907|3879621|FG000|STARTED|Second Intervention||8
3153401|NCT01817907|3879622|FG001|STARTED|Second Intervention||7
3153402|NCT01817907|3879621|FG000|COMPLETED|Second Intervention||8
3153403|NCT01817907|3879622|FG001|COMPLETED|Second Intervention||7
3153404|NCT01817907|3879621|FG000|NOT COMPLETED|Second Intervention||0
3153405|NCT01817907|3879622|FG001|NOT COMPLETED|Second Intervention||0
3153406|NCT01817959|3879630|FG000|STARTED|Overall Study||29
3153407|NCT01817959|3879631|FG001|STARTED|Overall Study||19
3153408|NCT01817959|3879630|FG000|COMPLETED|Overall Study||25
3153409|NCT01817959|3879631|FG001|COMPLETED|Overall Study||16
3153410|NCT01817959|3879630|FG000|NOT COMPLETED|Overall Study||4
3153411|NCT01817959|3879631|FG001|NOT COMPLETED|Overall Study||3
3183600|NCT02009163|3911880|FG002|COMPLETED|Randomized-withdrawal Period||102
3183601|NCT02009163|3911878|FG000|NOT COMPLETED|Randomized-withdrawal Period||0
3183602|NCT02009163|3911879|FG001|NOT COMPLETED|Randomized-withdrawal Period||88
3183603|NCT02009163|3911880|FG002|NOT COMPLETED|Randomized-withdrawal Period||35
3183604|NCT02009332|3911896|FG000|STARTED|Phase 1: Dose Level 1 (Weeks 1-10)||3
3183605|NCT02009332|3911897|FG001|STARTED|Phase 1: Dose Level 1 (Weeks 1-10)||0
3183606|NCT02009332|3911898|FG002|STARTED|Phase 1: Dose Level 1 (Weeks 1-10)||0
3183607|NCT02009332|3911899|FG003|STARTED|Phase 1: Dose Level 1 (Weeks 1-10)||0
3183608|NCT02009332|3911900|FG004|STARTED|Phase 1: Dose Level 1 (Weeks 1-10)||0
3183609|NCT02009332|3911901|FG005|STARTED|Phase 1: Dose Level 1 (Weeks 1-10)||0
3183610|NCT02009332|3911896|FG000|COMPLETED|Phase 1: Dose Level 1 (Weeks 1-10)|Cohort 1 completed 6-week treatment.|3
3183611|NCT02009332|3911897|FG001|COMPLETED|Phase 1: Dose Level 1 (Weeks 1-10)||0
3183612|NCT02009332|3911898|FG002|COMPLETED|Phase 1: Dose Level 1 (Weeks 1-10)||0
3363798|NCT04046250|4094953|FG000|NOT COMPLETED|Overall Study||3
3153412|NCT01818063|3879639|FG000|STARTED|Overall Study||5
3153413|NCT01818063|3879640|FG001|STARTED|Overall Study||4
3153414|NCT01818063|3879639|FG000|COMPLETED|Overall Study||5
3153415|NCT01818063|3879640|FG001|COMPLETED|Overall Study||4
3153416|NCT01818063|3879639|FG000|NOT COMPLETED|Overall Study||0
3153417|NCT01818063|3879640|FG001|NOT COMPLETED|Overall Study||0
3153418|NCT01818141|3879648|FG000|STARTED|Overall Study||18
3153419|NCT01818141|3879649|FG001|STARTED|Overall Study||16
3153420|NCT01818141|3879648|FG000|COMPLETED|Overall Study||15
3153421|NCT01818141|3879649|FG001|COMPLETED|Overall Study||13
3153422|NCT01818141|3879648|FG000|NOT COMPLETED|Overall Study||3
3183613|NCT02009332|3911899|FG003|COMPLETED|Phase 1: Dose Level 1 (Weeks 1-10)||0
3183614|NCT02009332|3911900|FG004|COMPLETED|Phase 1: Dose Level 1 (Weeks 1-10)||0
3183615|NCT02009332|3911901|FG005|COMPLETED|Phase 1: Dose Level 1 (Weeks 1-10)||0
3183616|NCT02009332|3911896|FG000|NOT COMPLETED|Phase 1: Dose Level 1 (Weeks 1-10)||0
3183617|NCT02009332|3911897|FG001|NOT COMPLETED|Phase 1: Dose Level 1 (Weeks 1-10)||0
3183618|NCT02009332|3911898|FG002|NOT COMPLETED|Phase 1: Dose Level 1 (Weeks 1-10)||0
3183619|NCT02009332|3911899|FG003|NOT COMPLETED|Phase 1: Dose Level 1 (Weeks 1-10)||0
3183620|NCT02009332|3911900|FG004|NOT COMPLETED|Phase 1: Dose Level 1 (Weeks 1-10)||0
3183621|NCT02009332|3911901|FG005|NOT COMPLETED|Phase 1: Dose Level 1 (Weeks 1-10)||0
3183622|NCT02009332|3911896|FG000|STARTED|Phase 1: Dose Level 2/2b (Wks 11-29)||0
3183623|NCT02009332|3911897|FG001|STARTED|Phase 1: Dose Level 2/2b (Wks 11-29)||4
3183624|NCT02009332|3911898|FG002|STARTED|Phase 1: Dose Level 2/2b (Wks 11-29)||1
3183625|NCT02009332|3911899|FG003|STARTED|Phase 1: Dose Level 2/2b (Wks 11-29)||0
3183626|NCT02009332|3911900|FG004|STARTED|Phase 1: Dose Level 2/2b (Wks 11-29)||0
3183627|NCT02009332|3911901|FG005|STARTED|Phase 1: Dose Level 2/2b (Wks 11-29)||0
3183628|NCT02009332|3911896|FG000|COMPLETED|Phase 1: Dose Level 2/2b (Wks 11-29)||0
3183629|NCT02009332|3911897|FG001|COMPLETED|Phase 1: Dose Level 2/2b (Wks 11-29)|Cohort 2 completed 6-week treatment.|3
3183630|NCT02009332|3911898|FG002|COMPLETED|Phase 1: Dose Level 2/2b (Wks 11-29)|Cohort 2b stopped due to lack of enrollment.|1
3183631|NCT02009332|3911899|FG003|COMPLETED|Phase 1: Dose Level 2/2b (Wks 11-29)||0
3183632|NCT02009332|3911900|FG004|COMPLETED|Phase 1: Dose Level 2/2b (Wks 11-29)||0
3183633|NCT02009332|3911901|FG005|COMPLETED|Phase 1: Dose Level 2/2b (Wks 11-29)||0
3183634|NCT02009332|3911896|FG000|NOT COMPLETED|Phase 1: Dose Level 2/2b (Wks 11-29)||0
3183635|NCT02009332|3911897|FG001|NOT COMPLETED|Phase 1: Dose Level 2/2b (Wks 11-29)||1
3183636|NCT02009332|3911898|FG002|NOT COMPLETED|Phase 1: Dose Level 2/2b (Wks 11-29)||0
3183637|NCT02009332|3911899|FG003|NOT COMPLETED|Phase 1: Dose Level 2/2b (Wks 11-29)||0
3183638|NCT02009332|3911900|FG004|NOT COMPLETED|Phase 1: Dose Level 2/2b (Wks 11-29)||0
3183639|NCT02009332|3911901|FG005|NOT COMPLETED|Phase 1: Dose Level 2/2b (Wks 11-29)||0
3183640|NCT02009332|3911896|FG000|STARTED|Phase 1: Dose Level 3 (Weeks 30-47)||0
3183641|NCT02009332|3911897|FG001|STARTED|Phase 1: Dose Level 3 (Weeks 30-47)||0
3183642|NCT02009332|3911898|FG002|STARTED|Phase 1: Dose Level 3 (Weeks 30-47)||0
3183643|NCT02009332|3911899|FG003|STARTED|Phase 1: Dose Level 3 (Weeks 30-47)||3
3183644|NCT02009332|3911900|FG004|STARTED|Phase 1: Dose Level 3 (Weeks 30-47)||0
3183645|NCT02009332|3911901|FG005|STARTED|Phase 1: Dose Level 3 (Weeks 30-47)||0
3183646|NCT02009332|3911896|FG000|COMPLETED|Phase 1: Dose Level 3 (Weeks 30-47)||0
3183647|NCT02009332|3911897|FG001|COMPLETED|Phase 1: Dose Level 3 (Weeks 30-47)||0
3183648|NCT02009332|3911898|FG002|COMPLETED|Phase 1: Dose Level 3 (Weeks 30-47)||0
3183649|NCT02009332|3911899|FG003|COMPLETED|Phase 1: Dose Level 3 (Weeks 30-47)|Cohort 3 completed 6-week treatment.|3
3183650|NCT02009332|3911900|FG004|COMPLETED|Phase 1: Dose Level 3 (Weeks 30-47)||0
3183651|NCT02009332|3911901|FG005|COMPLETED|Phase 1: Dose Level 3 (Weeks 30-47)||0
3183652|NCT02009332|3911896|FG000|NOT COMPLETED|Phase 1: Dose Level 3 (Weeks 30-47)||0
3183653|NCT02009332|3911897|FG001|NOT COMPLETED|Phase 1: Dose Level 3 (Weeks 30-47)||0
3183654|NCT02009332|3911898|FG002|NOT COMPLETED|Phase 1: Dose Level 3 (Weeks 30-47)||0
3183655|NCT02009332|3911899|FG003|NOT COMPLETED|Phase 1: Dose Level 3 (Weeks 30-47)||0
3183656|NCT02009332|3911900|FG004|NOT COMPLETED|Phase 1: Dose Level 3 (Weeks 30-47)||0
3183657|NCT02009332|3911901|FG005|NOT COMPLETED|Phase 1: Dose Level 3 (Weeks 30-47)||0
3183658|NCT02009332|3911896|FG000|STARTED|Phase 1: Dose Level 4 (Weeks 48-77)||0
3183659|NCT02009332|3911897|FG001|STARTED|Phase 1: Dose Level 4 (Weeks 48-77)||0
3183660|NCT02009332|3911898|FG002|STARTED|Phase 1: Dose Level 4 (Weeks 48-77)||0
3183661|NCT02009332|3911899|FG003|STARTED|Phase 1: Dose Level 4 (Weeks 48-77)||0
3183662|NCT02009332|3911900|FG004|STARTED|Phase 1: Dose Level 4 (Weeks 48-77)||4
3183663|NCT02009332|3911901|FG005|STARTED|Phase 1: Dose Level 4 (Weeks 48-77)||0
3183664|NCT02009332|3911896|FG000|COMPLETED|Phase 1: Dose Level 4 (Weeks 48-77)||0
3183665|NCT02009332|3911897|FG001|COMPLETED|Phase 1: Dose Level 4 (Weeks 48-77)||0
3183666|NCT02009332|3911898|FG002|COMPLETED|Phase 1: Dose Level 4 (Weeks 48-77)||0
3183667|NCT02009332|3911899|FG003|COMPLETED|Phase 1: Dose Level 4 (Weeks 48-77)||0
3183668|NCT02009332|3911900|FG004|COMPLETED|Phase 1: Dose Level 4 (Weeks 48-77)|Cohort 4 completed 6-week treatment.|3
3183669|NCT02009332|3911901|FG005|COMPLETED|Phase 1: Dose Level 4 (Weeks 48-77)||0
3183670|NCT02009332|3911896|FG000|NOT COMPLETED|Phase 1: Dose Level 4 (Weeks 48-77)||0
3183671|NCT02009332|3911897|FG001|NOT COMPLETED|Phase 1: Dose Level 4 (Weeks 48-77)||0
3183672|NCT02009332|3911898|FG002|NOT COMPLETED|Phase 1: Dose Level 4 (Weeks 48-77)||0
3183673|NCT02009332|3911899|FG003|NOT COMPLETED|Phase 1: Dose Level 4 (Weeks 48-77)||0
3183674|NCT02009332|3911900|FG004|NOT COMPLETED|Phase 1: Dose Level 4 (Weeks 48-77)||1
3183675|NCT02009332|3911901|FG005|NOT COMPLETED|Phase 1: Dose Level 4 (Weeks 48-77)||0
3153423|NCT01818141|3879649|FG001|NOT COMPLETED|Overall Study||3
3153424|NCT01818245|3879657|FG000|STARTED|Intervention A||30
3153425|NCT01818245|3879658|FG001|STARTED|Intervention A|Participants didn't participate in separate interventions and received 1 dose of LY2605541 on Day 1.|22
3153426|NCT01818245|3879657|FG000|Received One Dose of Study Drug|Intervention A||30
3153427|NCT01818245|3879658|FG001|Received One Dose of Study Drug|Intervention A||22
3153428|NCT01818245|3879657|FG000|COMPLETED|Intervention A||30
3153429|NCT01818245|3879658|FG001|COMPLETED|Intervention A||22
3153430|NCT01818245|3879657|FG000|NOT COMPLETED|Intervention A||0
3153431|NCT01818245|3879658|FG001|NOT COMPLETED|Intervention A||0
3153432|NCT01818245|3879657|FG000|STARTED|Washout (16-28 Days)||30
3153433|NCT01818245|3879658|FG001|STARTED|Washout (16-28 Days)||0
3153434|NCT01818245|3879657|FG000|COMPLETED|Washout (16-28 Days)||30
3153435|NCT01818245|3879658|FG001|COMPLETED|Washout (16-28 Days)||0
3153436|NCT01818245|3879657|FG000|NOT COMPLETED|Washout (16-28 Days)||0
3153437|NCT01818245|3879658|FG001|NOT COMPLETED|Washout (16-28 Days)||0
3153438|NCT01818245|3879657|FG000|STARTED|Intervention B||30
3153439|NCT01818245|3879658|FG001|STARTED|Intervention B||0
3153440|NCT01818245|3879657|FG000|COMPLETED|Intervention B||30
3153441|NCT01818245|3879658|FG001|COMPLETED|Intervention B||0
3153442|NCT01818245|3879657|FG000|NOT COMPLETED|Intervention B||0
3153443|NCT01818245|3879658|FG001|NOT COMPLETED|Intervention B||0
3153444|NCT01818245|3879657|FG000|STARTED|Washout (16-28 Days)||30
3153445|NCT01818245|3879658|FG001|STARTED|Washout (16-28 Days)||0
3153446|NCT01818245|3879657|FG000|COMPLETED|Washout (16-28 Days)||30
3153447|NCT01818245|3879658|FG001|COMPLETED|Washout (16-28 Days)||0
3153448|NCT01818245|3879657|FG000|NOT COMPLETED|Washout (16-28 Days)||0
3153449|NCT01818245|3879658|FG001|NOT COMPLETED|Washout (16-28 Days)||0
3153450|NCT01818245|3879657|FG000|STARTED|Intervention C||30
3153451|NCT01818245|3879658|FG001|STARTED|Intervention C||0
3153452|NCT01818245|3879657|FG000|COMPLETED|Intervention C||30
3153453|NCT01818245|3879658|FG001|COMPLETED|Intervention C||0
3153454|NCT01818245|3879657|FG000|NOT COMPLETED|Intervention C||0
3153455|NCT01818245|3879658|FG001|NOT COMPLETED|Intervention C||0
3153456|NCT01818258|3879671|FG000|STARTED|Overall Study||25
3153457|NCT01818258|3879672|FG001|STARTED|Overall Study||27
3153458|NCT01818258|3879671|FG000|COMPLETED|Overall Study||22
3153459|NCT01818258|3879672|FG001|COMPLETED|Overall Study||24
3153460|NCT01818258|3879671|FG000|NOT COMPLETED|Overall Study||3
3153461|NCT01818258|3879672|FG001|NOT COMPLETED|Overall Study||3
3153462|NCT01818284|3879681|FG000|STARTED|Overall Study||11
3153463|NCT01818284|3879682|FG001|STARTED|Overall Study||11
3153464|NCT01818284|3879681|FG000|COMPLETED|Overall Study||7
3153465|NCT01818284|3879682|FG001|COMPLETED|Overall Study||5
3153466|NCT01818284|3879681|FG000|NOT COMPLETED|Overall Study||4
3153467|NCT01818284|3879682|FG001|NOT COMPLETED|Overall Study||6
3153468|NCT01818297|3879689|FG000|STARTED|Blinded Phase (Randomization - 3 Months)||32
3153469|NCT01818297|3879690|FG001|STARTED|Blinded Phase (Randomization - 3 Months)||30
3153470|NCT01818297|3879689|FG000|Week 1|Blinded Phase (Randomization - 3 Months)||32
3153471|NCT01818297|3879690|FG001|Week 1|Blinded Phase (Randomization - 3 Months)||30
3153472|NCT01818297|3879689|FG000|Week 6|Blinded Phase (Randomization - 3 Months)||32
3153473|NCT01818297|3879690|FG001|Week 6|Blinded Phase (Randomization - 3 Months)||29
3153474|NCT01818297|3879689|FG000|COMPLETED|Blinded Phase (Randomization - 3 Months)||32
3153475|NCT01818297|3879690|FG001|COMPLETED|Blinded Phase (Randomization - 3 Months)||29
3153476|NCT01818297|3879689|FG000|NOT COMPLETED|Blinded Phase (Randomization - 3 Months)||0
3153477|NCT01818297|3879690|FG001|NOT COMPLETED|Blinded Phase (Randomization - 3 Months)||1
3153478|NCT01818297|3879689|FG000|STARTED|Open Label Phase (3-12 Months)||32
3153479|NCT01818297|3879690|FG001|STARTED|Open Label Phase (3-12 Months)||29
3153480|NCT01818297|3879689|FG000|COMPLETED|Open Label Phase (3-12 Months)||14
3153481|NCT01818297|3879690|FG001|COMPLETED|Open Label Phase (3-12 Months)||19
3153482|NCT01818297|3879689|FG000|NOT COMPLETED|Open Label Phase (3-12 Months)||18
3153483|NCT01818297|3879690|FG001|NOT COMPLETED|Open Label Phase (3-12 Months)||10
3153484|NCT01818336|3879696|FG000|STARTED|Overall Study||391
3153485|NCT01818336|3879697|FG001|STARTED|Overall Study||59
3153486|NCT01818336|3879696|FG000|COMPLETED|Overall Study||391
3153487|NCT01818336|3879697|FG001|COMPLETED|Overall Study||47
3153488|NCT01818336|3879696|FG000|NOT COMPLETED|Overall Study||0
3183676|NCT02009332|3911896|FG000|STARTED|Phase 2 (Weeks 206-252)||0
3183677|NCT02009332|3911897|FG001|STARTED|Phase 2 (Weeks 206-252)||0
3183678|NCT02009332|3911898|FG002|STARTED|Phase 2 (Weeks 206-252)||0
3183679|NCT02009332|3911899|FG003|STARTED|Phase 2 (Weeks 206-252)||0
3183680|NCT02009332|3911900|FG004|STARTED|Phase 2 (Weeks 206-252)||0
3183681|NCT02009332|3911901|FG005|STARTED|Phase 2 (Weeks 206-252)||6
3183682|NCT02009332|3911896|FG000|COMPLETED|Phase 2 (Weeks 206-252)||0
3183683|NCT02009332|3911897|FG001|COMPLETED|Phase 2 (Weeks 206-252)||0
3183684|NCT02009332|3911898|FG002|COMPLETED|Phase 2 (Weeks 206-252)||0
3183685|NCT02009332|3911899|FG003|COMPLETED|Phase 2 (Weeks 206-252)||0
3183686|NCT02009332|3911900|FG004|COMPLETED|Phase 2 (Weeks 206-252)||0
3183687|NCT02009332|3911901|FG005|COMPLETED|Phase 2 (Weeks 206-252)|Phase 2 stopped due to lack of efficacy.|5
3183688|NCT02009332|3911896|FG000|NOT COMPLETED|Phase 2 (Weeks 206-252)||0
3183689|NCT02009332|3911897|FG001|NOT COMPLETED|Phase 2 (Weeks 206-252)||0
3183690|NCT02009332|3911898|FG002|NOT COMPLETED|Phase 2 (Weeks 206-252)||0
3183691|NCT02009332|3911899|FG003|NOT COMPLETED|Phase 2 (Weeks 206-252)||0
3183692|NCT02009332|3911900|FG004|NOT COMPLETED|Phase 2 (Weeks 206-252)||0
3183693|NCT02009332|3911901|FG005|NOT COMPLETED|Phase 2 (Weeks 206-252)||1
3183694|NCT02009397|3911915|FG000|STARTED|Overall Study||26
3153489|NCT01818336|3879697|FG001|NOT COMPLETED|Overall Study||12
3153490|NCT01818414|3879705|FG000|STARTED|Overall Study||14
3153491|NCT01818414|3879706|FG001|STARTED|Overall Study||15
3153492|NCT01818414|3879705|FG000|COMPLETED|Overall Study||14
3153493|NCT01818414|3879706|FG001|COMPLETED|Overall Study||15
3153494|NCT01818414|3879705|FG000|NOT COMPLETED|Overall Study||0
3153495|NCT01818414|3879706|FG001|NOT COMPLETED|Overall Study||0
3153496|NCT01818427|3879716|FG000|STARTED|Overall Study||239
3153497|NCT01818427|3879717|FG001|STARTED|Overall Study||284
3153498|NCT01818427|3879716|FG000|COMPLETED|Overall Study||230
3153499|NCT01818427|3879717|FG001|COMPLETED|Overall Study||271
3153500|NCT01818427|3879716|FG000|NOT COMPLETED|Overall Study||9
3153501|NCT01818427|3879717|FG001|NOT COMPLETED|Overall Study||13
3153502|NCT01818492|3879723|FG000|STARTED|Overall Study||45
3153503|NCT01818492|3879723|FG000|COMPLETED|Overall Study||35
3153504|NCT01818492|3879723|FG000|NOT COMPLETED|Overall Study||10
3153505|NCT01818518|3879734|FG000|STARTED|Overall Study||310
3153506|NCT01818518|3879735|FG001|STARTED|Overall Study||263
3153507|NCT01818518|3879736|FG002|STARTED|Overall Study||288
3153508|NCT01818518|3879737|FG003|STARTED|Overall Study||59
3153509|NCT01818518|3879738|FG004|STARTED|Overall Study||38
3153510|NCT01818518|3879739|FG005|STARTED|Overall Study||37
3153511|NCT01818518|3879734|FG000|COMPLETED|Overall Study||310
3153512|NCT01818518|3879735|FG001|COMPLETED|Overall Study||263
3153513|NCT01818518|3879736|FG002|COMPLETED|Overall Study||288
3153514|NCT01818518|3879737|FG003|COMPLETED|Overall Study||59
3153515|NCT01818518|3879738|FG004|COMPLETED|Overall Study||38
3153516|NCT01818518|3879739|FG005|COMPLETED|Overall Study||37
3153517|NCT01818518|3879734|FG000|NOT COMPLETED|Overall Study||0
3153518|NCT01818518|3879735|FG001|NOT COMPLETED|Overall Study||0
3153519|NCT01818518|3879736|FG002|NOT COMPLETED|Overall Study||0
3153520|NCT01818518|3879737|FG003|NOT COMPLETED|Overall Study||0
3153521|NCT01818518|3879738|FG004|NOT COMPLETED|Overall Study||0
3153522|NCT01818518|3879739|FG005|NOT COMPLETED|Overall Study||0
3153523|NCT01818531|3879755|FG000|STARTED|Overall Study||75
3153524|NCT01818531|3879756|FG001|STARTED|Overall Study||75
3153525|NCT01818531|3879755|FG000|COMPLETED|Overall Study||74
3153526|NCT01818531|3879756|FG001|COMPLETED|Overall Study||73
3153527|NCT01818531|3879755|FG000|NOT COMPLETED|Overall Study||1
3153528|NCT01818531|3879756|FG001|NOT COMPLETED|Overall Study||2
3153529|NCT01818596|3879764|FG000|STARTED|Overall Study||246
3153530|NCT01818596|3879765|FG001|STARTED|Overall Study||6
3153531|NCT01818596|3879764|FG000|COMPLETED|Overall Study||215
3153532|NCT01818596|3879765|FG001|COMPLETED|Overall Study||6
3153533|NCT01818596|3879764|FG000|NOT COMPLETED|Overall Study||31
3153534|NCT01818596|3879765|FG001|NOT COMPLETED|Overall Study||0
3153535|NCT01818700|3879772|FG000|STARTED|Overall Study|The No. of enrolled patients|245
3153536|NCT01818700|3879772|FG000|Safety Set|Overall Study|4 subjects were not study drug administered.|241
3153537|NCT01818700|3879772|FG000|FAS Set|Overall Study|31 subjects excluded from FAS due to no assessment of primary efficacy(26) and IC/EC violation(5).|210
3153538|NCT01818700|3879772|FG000|PP Set|Overall Study|105 subjects excluded from PP set due to various reasons.|105
3153539|NCT01818700|3879772|FG000|COMPLETED|Overall Study|104 subjects dropped out this study prior to study completion.|141
3153540|NCT01818700|3879772|FG000|NOT COMPLETED|Overall Study||104
3153541|NCT01818726|3879780|FG000|STARTED|Overall Study||10
3153542|NCT01818726|3879781|FG001|STARTED|Overall Study||5
3153543|NCT01818726|3879780|FG000|COMPLETED|Overall Study||4
3153544|NCT01818726|3879781|FG001|COMPLETED|Overall Study||3
3153545|NCT01818726|3879780|FG000|NOT COMPLETED|Overall Study||6
3153546|NCT01818726|3879781|FG001|NOT COMPLETED|Overall Study||2
3153547|NCT01818739|3879787|FG000|STARTED|Overall Study||204
3153548|NCT01818739|3879787|FG000|COMPLETED|Overall Study||204
3153549|NCT01818739|3879787|FG000|NOT COMPLETED|Overall Study||0
3153550|NCT01818752|3879794|FG000|STARTED|Overall Study||477
3153551|NCT01818752|3879795|FG001|STARTED|Overall Study||478
3153552|NCT01818752|3879794|FG000|Received Treatment|Overall Study||470
3153553|NCT01818752|3879795|FG001|Received Treatment|Overall Study||474
3153554|NCT01818752|3879794|FG000|COMPLETED|Overall Study|Completed treatment|290
3153555|NCT01818752|3879795|FG001|COMPLETED|Overall Study|Completed treatment|280
3153556|NCT01818752|3879794|FG000|NOT COMPLETED|Overall Study||187
3153557|NCT01818752|3879795|FG001|NOT COMPLETED|Overall Study||198
3153558|NCT01818765|3879801|FG000|STARTED|Overall Study||20
3153559|NCT01818765|3879801|FG000|COMPLETED|Overall Study||18
3153560|NCT01818765|3879801|FG000|NOT COMPLETED|Overall Study||2
3153561|NCT01818804|3879808|FG000|STARTED|Overall Study||73
3153562|NCT01818804|3879809|FG001|STARTED|Overall Study||72
3153563|NCT01818804|3879808|FG000|COMPLETED|Overall Study||68
3153564|NCT01818804|3879809|FG001|COMPLETED|Overall Study||65
3153565|NCT01818804|3879808|FG000|NOT COMPLETED|Overall Study||5
3153566|NCT01818804|3879809|FG001|NOT COMPLETED|Overall Study||7
3153567|NCT01819129|3879817|FG000|STARTED|Overall Study||345
3153568|NCT01819129|3879818|FG001|STARTED|Overall Study||344
3153569|NCT01819129|3879817|FG000|Exposed|Overall Study||341
3153570|NCT01819129|3879818|FG001|Exposed|Overall Study||341
3153571|NCT01819129|3879817|FG000|COMPLETED|Overall Study||301
3153572|NCT01819129|3879818|FG001|COMPLETED|Overall Study||305
3153573|NCT01819129|3879817|FG000|NOT COMPLETED|Overall Study||44
3153574|NCT01819129|3879818|FG001|NOT COMPLETED|Overall Study||39
3153575|NCT01819194|3879824|FG000|STARTED|Overall Study||62
3153576|NCT01819194|3879824|FG000|COMPLETED|Overall Study||60
3153577|NCT01819194|3879824|FG000|NOT COMPLETED|Overall Study||2
3153578|NCT01819233|3879828|FG000|STARTED|Overall Study||38
3153579|NCT01819233|3879828|FG000|COMPLETED|Overall Study||32
3153580|NCT01819233|3879828|FG000|NOT COMPLETED|Overall Study||6
3153581|NCT01819272|3879838|FG000|STARTED|Overall Study||41
3153582|NCT01819272|3879839|FG001|STARTED|Overall Study||39
3153583|NCT01819272|3879840|FG002|STARTED|Overall Study||40
3153584|NCT01819272|3879841|FG003|STARTED|Overall Study||40
3153585|NCT01819272|3879842|FG004|STARTED|Overall Study||40
3153586|NCT01819272|3879843|FG005|STARTED|Overall Study||40
3153587|NCT01819272|3879838|FG000|COMPLETED|Overall Study||35
3153588|NCT01819272|3879839|FG001|COMPLETED|Overall Study||36
3153589|NCT01819272|3879840|FG002|COMPLETED|Overall Study||37
3153590|NCT01819272|3879841|FG003|COMPLETED|Overall Study||35
3153591|NCT01819272|3879842|FG004|COMPLETED|Overall Study||36
3153592|NCT01819272|3879843|FG005|COMPLETED|Overall Study||33
3153593|NCT01819272|3879838|FG000|NOT COMPLETED|Overall Study||6
3153594|NCT01819272|3879839|FG001|NOT COMPLETED|Overall Study||3
3153595|NCT01819272|3879840|FG002|NOT COMPLETED|Overall Study||3
3153596|NCT01819272|3879841|FG003|NOT COMPLETED|Overall Study||5
3153597|NCT01819272|3879842|FG004|NOT COMPLETED|Overall Study||4
3183695|NCT02009397|3911915|FG000|COMPLETED|Overall Study||6
3183696|NCT02009397|3911915|FG000|NOT COMPLETED|Overall Study||20
3183697|NCT02009501|3911921|FG000|STARTED|Overall Study||9
3183698|NCT02009501|3911922|FG001|STARTED|Overall Study||11
3183699|NCT02009501|3911921|FG000|COMPLETED|Overall Study||9
3183700|NCT02009501|3911922|FG001|COMPLETED|Overall Study||11
3183701|NCT02009501|3911921|FG000|NOT COMPLETED|Overall Study||0
3183702|NCT02009501|3911922|FG001|NOT COMPLETED|Overall Study||0
3183703|NCT02009696|3911928|FG000|STARTED|Overall Study||221
3183704|NCT02009696|3911928|FG000|COMPLETED|Overall Study||219
3183705|NCT02009696|3911928|FG000|NOT COMPLETED|Overall Study||2
3183706|NCT02009722|3911934|FG000|STARTED|Overall Study||41
3183707|NCT02009722|3911935|FG001|STARTED|Overall Study||43
3183708|NCT02009722|3911934|FG000|Received Intervention|Overall Study||41
3183709|NCT02009722|3911935|FG001|Received Intervention|Overall Study||42
3183710|NCT02009722|3911934|FG000|COMPLETED|Overall Study||40
3183711|NCT02009722|3911935|FG001|COMPLETED|Overall Study||40
3183712|NCT02009722|3911934|FG000|NOT COMPLETED|Overall Study||1
3183713|NCT02009722|3911935|FG001|NOT COMPLETED|Overall Study||3
3183714|NCT02009865|3911943|FG000|STARTED|Overall Study||81
3183715|NCT02009865|3911944|FG001|STARTED|Overall Study||81
3183716|NCT02009865|3911943|FG000|COMPLETED|Overall Study||80
3183717|NCT02009865|3911944|FG001|COMPLETED|Overall Study||76
3183718|NCT02009865|3911943|FG000|NOT COMPLETED|Overall Study||1
3183719|NCT02009865|3911944|FG001|NOT COMPLETED|Overall Study||5
3183720|NCT02009878|3911953|FG000|STARTED|Overall Study||10
3183721|NCT02009878|3911954|FG001|STARTED|Overall Study||11
3183722|NCT02009878|3911955|FG002|STARTED|Overall Study||9
3183723|NCT02009878|3911953|FG000|COMPLETED|Overall Study||10
3183724|NCT02009878|3911954|FG001|COMPLETED|Overall Study||10
3183725|NCT02009878|3911955|FG002|COMPLETED|Overall Study||9
3183726|NCT02009878|3911953|FG000|NOT COMPLETED|Overall Study||0
3183727|NCT02009878|3911954|FG001|NOT COMPLETED|Overall Study||1
3183728|NCT02009878|3911955|FG002|NOT COMPLETED|Overall Study||0
3183729|NCT02009930|3911963|FG000|STARTED|Overall Study|5 withdrawn|112
3183730|NCT02009930|3911963|FG000|COMPLETED|Overall Study||107
3183731|NCT02009930|3911963|FG000|NOT COMPLETED|Overall Study||5
3183732|NCT02010021|3911976|FG000|STARTED|Overall Study||10
3183733|NCT02010021|3911977|FG001|STARTED|Overall Study||7
3183734|NCT02010021|3911976|FG000|COMPLETED|Overall Study||10
3183735|NCT02010021|3911977|FG001|COMPLETED|Overall Study||7
3183736|NCT02010021|3911976|FG000|NOT COMPLETED|Overall Study||0
3183737|NCT02010021|3911977|FG001|NOT COMPLETED|Overall Study||0
3183738|NCT02010151|3911985|FG000|STARTED|Overall Study|January 2013 to December 2017|1498
3183739|NCT02010151|3911986|FG001|STARTED|Overall Study|January 2013 to December 2017|1696
3183740|NCT02010151|3911985|FG000|COMPLETED|Overall Study|Text message (TM) sent: 0|1498
3183741|NCT02010151|3911986|FG001|COMPLETED|Overall Study|TM sent: 598|1696
3183742|NCT02010151|3911985|FG000|NOT COMPLETED|Overall Study||0
3183743|NCT02010151|3911986|FG001|NOT COMPLETED|Overall Study||0
3183744|NCT02010203|3911997|FG000|STARTED|Overall Study||10
3183745|NCT02010203|3911998|FG001|STARTED|Overall Study||26
3183746|NCT02010203|3911999|FG002|STARTED|Overall Study||26
3183747|NCT02010203|3912000|FG003|STARTED|Overall Study||26
3183748|NCT02010203|3912001|FG004|STARTED|Overall Study||16
3183749|NCT02010203|3911997|FG000|COMPLETED|Overall Study||10
3183750|NCT02010203|3911998|FG001|COMPLETED|Overall Study||17
3183751|NCT02010203|3911999|FG002|COMPLETED|Overall Study||16
3183752|NCT02010203|3912000|FG003|COMPLETED|Overall Study||23
3183753|NCT02010203|3912001|FG004|COMPLETED|Overall Study||3
3183754|NCT02010203|3911997|FG000|NOT COMPLETED|Overall Study||0
3183755|NCT02010203|3911998|FG001|NOT COMPLETED|Overall Study||9
3183756|NCT02010203|3911999|FG002|NOT COMPLETED|Overall Study||10
3183757|NCT02010203|3912000|FG003|NOT COMPLETED|Overall Study||3
3183758|NCT02010203|3912001|FG004|NOT COMPLETED|Overall Study||13
3183759|NCT02010216|3912013|FG000|STARTED|Overall Study||23
3183760|NCT02010216|3912013|FG000|COMPLETED|Overall Study||23
3183761|NCT02010216|3912013|FG000|NOT COMPLETED|Overall Study||0
3183762|NCT02010255|3912031|FG000|STARTED|Overall Study||28
3183763|NCT02010255|3912032|FG001|STARTED|Overall Study||28
3153598|NCT01819272|3879843|FG005|NOT COMPLETED|Overall Study||7
3153599|NCT01819311|3879859|FG000|STARTED|Treatment Phase (4 Weeks)||33
3153600|NCT01819311|3879860|FG001|STARTED|Treatment Phase (4 Weeks)||31
3183764|NCT02010255|3912033|FG002|STARTED|Overall Study||25
3153601|NCT01819311|3879859|FG000|COMPLETED|Treatment Phase (4 Weeks)||31
3153602|NCT01819311|3879860|FG001|COMPLETED|Treatment Phase (4 Weeks)||30
3153603|NCT01819311|3879859|FG000|NOT COMPLETED|Treatment Phase (4 Weeks)||2
3153604|NCT01819311|3879860|FG001|NOT COMPLETED|Treatment Phase (4 Weeks)||1
3153605|NCT01819311|3879859|FG000|STARTED|Follow-up Phase (8 Weeks)||31
3153606|NCT01819311|3879860|FG001|STARTED|Follow-up Phase (8 Weeks)||30
3153607|NCT01819311|3879859|FG000|COMPLETED|Follow-up Phase (8 Weeks)||24
3153608|NCT01819311|3879860|FG001|COMPLETED|Follow-up Phase (8 Weeks)||23
3153609|NCT01819311|3879859|FG000|NOT COMPLETED|Follow-up Phase (8 Weeks)||7
3153610|NCT01819311|3879860|FG001|NOT COMPLETED|Follow-up Phase (8 Weeks)||7
3153611|NCT01819415|3879870|FG000|STARTED|Overall Study||10
3153612|NCT01819415|3879871|FG001|STARTED|Overall Study||10
3153613|NCT01819415|3879872|FG002|STARTED|Overall Study||10
3153614|NCT01819415|3879873|FG003|STARTED|Overall Study||10
3153615|NCT01819415|3879870|FG000|COMPLETED|Overall Study||7
3153616|NCT01819415|3879871|FG001|COMPLETED|Overall Study||6
3153617|NCT01819415|3879872|FG002|COMPLETED|Overall Study||9
3153618|NCT01819415|3879873|FG003|COMPLETED|Overall Study||8
3153619|NCT01819415|3879870|FG000|NOT COMPLETED|Overall Study||3
3153620|NCT01819415|3879871|FG001|NOT COMPLETED|Overall Study||4
3153621|NCT01819415|3879872|FG002|NOT COMPLETED|Overall Study||1
3153622|NCT01819415|3879873|FG003|NOT COMPLETED|Overall Study||2
3153623|NCT01819506|3879885|FG000|STARTED|Overall Study||51
3153624|NCT01819506|3879886|FG001|STARTED|Overall Study||52
3153625|NCT01819506|3879885|FG000|COMPLETED|Overall Study||43
3153626|NCT01819506|3879886|FG001|COMPLETED|Overall Study||47
3153627|NCT01819506|3879885|FG000|NOT COMPLETED|Overall Study||8
3153628|NCT01819506|3879886|FG001|NOT COMPLETED|Overall Study||5
3153629|NCT01819597|3879892|FG000|STARTED|Overall Study||52
3153630|NCT01819597|3879892|FG000|COMPLETED|Overall Study||52
3153631|NCT01819597|3879892|FG000|NOT COMPLETED|Overall Study||0
3153632|NCT01819727|3879898|FG000|STARTED|Overall Study||131
3153633|NCT01819727|3879899|FG001|STARTED|Overall Study||130
3153634|NCT01819727|3879898|FG000|COMPLETED|Overall Study||111
3153635|NCT01819727|3879899|FG001|COMPLETED|Overall Study||102
3153636|NCT01819727|3879898|FG000|NOT COMPLETED|Overall Study||20
3153637|NCT01819727|3879899|FG001|NOT COMPLETED|Overall Study||28
3153638|NCT01819844|3879905|FG000|STARTED|Overall Study||12
3153639|NCT01819844|3879905|FG000|COMPLETED|Overall Study||12
3153640|NCT01819844|3879905|FG000|NOT COMPLETED|Overall Study||0
3153641|NCT01819883|3879912|FG000|STARTED|Overall Study||20
3153642|NCT01819883|3879913|FG001|STARTED|Overall Study||20
3153643|NCT01819883|3879912|FG000|COMPLETED|Overall Study||16
3153644|NCT01819883|3879913|FG001|COMPLETED|Overall Study||20
3153645|NCT01819883|3879912|FG000|NOT COMPLETED|Overall Study||4
3153646|NCT01819883|3879913|FG001|NOT COMPLETED|Overall Study||0
3153647|NCT01819922|3879918|FG000|STARTED|First Intervention Period (1 Day)||6
3153648|NCT01819922|3879919|FG001|STARTED|First Intervention Period (1 Day)||6
3153649|NCT01819922|3879918|FG000|COMPLETED|First Intervention Period (1 Day)||6
3153650|NCT01819922|3879919|FG001|COMPLETED|First Intervention Period (1 Day)||6
3153651|NCT01819922|3879918|FG000|NOT COMPLETED|First Intervention Period (1 Day)||0
3153652|NCT01819922|3879919|FG001|NOT COMPLETED|First Intervention Period (1 Day)||0
3153653|NCT01819922|3879918|FG000|STARTED|Washout Period (at Least 7-10 Days)||6
3153654|NCT01819922|3879919|FG001|STARTED|Washout Period (at Least 7-10 Days)||6
3153655|NCT01819922|3879918|FG000|COMPLETED|Washout Period (at Least 7-10 Days)||6
3153656|NCT01819922|3879919|FG001|COMPLETED|Washout Period (at Least 7-10 Days)||6
3153657|NCT01819922|3879918|FG000|NOT COMPLETED|Washout Period (at Least 7-10 Days)||0
3153658|NCT01819922|3879919|FG001|NOT COMPLETED|Washout Period (at Least 7-10 Days)||0
3153659|NCT01819922|3879918|FG000|STARTED|Second Intervention Period (1 Day)||6
3153660|NCT01819922|3879919|FG001|STARTED|Second Intervention Period (1 Day)||6
3153661|NCT01819922|3879918|FG000|COMPLETED|Second Intervention Period (1 Day)||6
3153662|NCT01819922|3879919|FG001|COMPLETED|Second Intervention Period (1 Day)||6
3153663|NCT01819922|3879918|FG000|NOT COMPLETED|Second Intervention Period (1 Day)||0
3153664|NCT01819922|3879919|FG001|NOT COMPLETED|Second Intervention Period (1 Day)||0
3153665|NCT01819935|3879927|FG000|STARTED|Overall Study||328
3153666|NCT01819935|3879928|FG001|STARTED|Overall Study||4943
3153667|NCT01819935|3879927|FG000|COMPLETED|Overall Study||328
3153668|NCT01819935|3879928|FG001|COMPLETED|Overall Study||4943
3153669|NCT01819935|3879927|FG000|NOT COMPLETED|Overall Study||0
3153670|NCT01819935|3879928|FG001|NOT COMPLETED|Overall Study||0
3153671|NCT01820260|3879948|FG000|STARTED|Phase 1 (Part 1)||3
3153672|NCT01820260|3879949|FG001|STARTED|Phase 1 (Part 1)||12
3153673|NCT01820260|3879950|FG002|STARTED|Phase 1 (Part 1)||10
3153674|NCT01820260|3879951|FG003|STARTED|Phase 1 (Part 1)||12
3153675|NCT01820260|3879952|FG004|STARTED|Phase 1 (Part 1)||12
3153676|NCT01820260|3879953|FG005|STARTED|Phase 1 (Part 1)||10
3153677|NCT01820260|3879954|FG006|STARTED|Phase 1 (Part 1)||12
3153678|NCT01820260|3879955|FG007|STARTED|Phase 1 (Part 1)||11
3153679|NCT01820260|3879956|FG008|STARTED|Phase 1 (Part 1)||0
3153680|NCT01820260|3879957|FG009|STARTED|Phase 1 (Part 1)||0
3153681|NCT01820260|3879958|FG010|STARTED|Phase 1 (Part 1)||0
3153682|NCT01820260|3879959|FG011|STARTED|Phase 1 (Part 1)||0
3153683|NCT01820260|3879960|FG012|STARTED|Phase 1 (Part 1)||0
3153684|NCT01820260|3879961|FG013|STARTED|Phase 1 (Part 1)||0
3153685|NCT01820260|3879948|FG000|COMPLETED|Phase 1 (Part 1)||3
3153686|NCT01820260|3879949|FG001|COMPLETED|Phase 1 (Part 1)||12
3153687|NCT01820260|3879950|FG002|COMPLETED|Phase 1 (Part 1)||10
3153688|NCT01820260|3879951|FG003|COMPLETED|Phase 1 (Part 1)||12
3153689|NCT01820260|3879952|FG004|COMPLETED|Phase 1 (Part 1)||12
3153690|NCT01820260|3879953|FG005|COMPLETED|Phase 1 (Part 1)||10
3153691|NCT01820260|3879954|FG006|COMPLETED|Phase 1 (Part 1)||11
3153692|NCT01820260|3879955|FG007|COMPLETED|Phase 1 (Part 1)||11
3153693|NCT01820260|3879956|FG008|COMPLETED|Phase 1 (Part 1)||0
3153694|NCT01820260|3879957|FG009|COMPLETED|Phase 1 (Part 1)||0
3153695|NCT01820260|3879958|FG010|COMPLETED|Phase 1 (Part 1)||0
3153696|NCT01820260|3879959|FG011|COMPLETED|Phase 1 (Part 1)||0
3153697|NCT01820260|3879960|FG012|COMPLETED|Phase 1 (Part 1)||0
3153698|NCT01820260|3879961|FG013|COMPLETED|Phase 1 (Part 1)||0
3153699|NCT01820260|3879948|FG000|NOT COMPLETED|Phase 1 (Part 1)||0
3153700|NCT01820260|3879949|FG001|NOT COMPLETED|Phase 1 (Part 1)||0
3153701|NCT01820260|3879950|FG002|NOT COMPLETED|Phase 1 (Part 1)||0
3153702|NCT01820260|3879951|FG003|NOT COMPLETED|Phase 1 (Part 1)||0
3153703|NCT01820260|3879952|FG004|NOT COMPLETED|Phase 1 (Part 1)||0
3153704|NCT01820260|3879953|FG005|NOT COMPLETED|Phase 1 (Part 1)||0
3153705|NCT01820260|3879954|FG006|NOT COMPLETED|Phase 1 (Part 1)||1
3153706|NCT01820260|3879955|FG007|NOT COMPLETED|Phase 1 (Part 1)||0
3153707|NCT01820260|3879956|FG008|NOT COMPLETED|Phase 1 (Part 1)||0
3153708|NCT01820260|3879957|FG009|NOT COMPLETED|Phase 1 (Part 1)||0
3183765|NCT02010255|3912034|FG003|STARTED|Overall Study||26
3183766|NCT02010255|3912035|FG004|STARTED|Overall Study||52
3183767|NCT02010255|3912036|FG005|STARTED|Overall Study||49
3183768|NCT02010255|3912037|FG006|STARTED|Overall Study||34
3183769|NCT02010255|3912038|FG007|STARTED|Overall Study||33
3183770|NCT02010255|3912039|FG008|STARTED|Overall Study||22
3183771|NCT02010255|3912040|FG009|STARTED|Overall Study||23
3183772|NCT02010255|3912041|FG010|STARTED|Overall Study||3
3183773|NCT02010255|3912042|FG011|STARTED|Overall Study||5
3183774|NCT02010255|3912043|FG012|STARTED|Overall Study||3
3183775|NCT02010255|3912044|FG013|STARTED|Overall Study||3
3183776|NCT02010255|3912031|FG000|COMPLETED|Overall Study||22
3183777|NCT02010255|3912032|FG001|COMPLETED|Overall Study||26
3183778|NCT02010255|3912033|FG002|COMPLETED|Overall Study||18
3183779|NCT02010255|3912034|FG003|COMPLETED|Overall Study||20
3183780|NCT02010255|3912035|FG004|COMPLETED|Overall Study||48
3183781|NCT02010255|3912036|FG005|COMPLETED|Overall Study||49
3183782|NCT02010255|3912037|FG006|COMPLETED|Overall Study||33
3183783|NCT02010255|3912038|FG007|COMPLETED|Overall Study||32
3183784|NCT02010255|3912039|FG008|COMPLETED|Overall Study||21
3183785|NCT02010255|3912040|FG009|COMPLETED|Overall Study||23
3183786|NCT02010255|3912041|FG010|COMPLETED|Overall Study||1
3183787|NCT02010255|3912042|FG011|COMPLETED|Overall Study||4
3183788|NCT02010255|3912043|FG012|COMPLETED|Overall Study||3
3183789|NCT02010255|3912044|FG013|COMPLETED|Overall Study||2
3183790|NCT02010255|3912031|FG000|NOT COMPLETED|Overall Study||6
3183791|NCT02010255|3912032|FG001|NOT COMPLETED|Overall Study||2
3183792|NCT02010255|3912033|FG002|NOT COMPLETED|Overall Study||7
3183793|NCT02010255|3912034|FG003|NOT COMPLETED|Overall Study||6
3183794|NCT02010255|3912035|FG004|NOT COMPLETED|Overall Study||4
3183795|NCT02010255|3912036|FG005|NOT COMPLETED|Overall Study||0
3183796|NCT02010255|3912037|FG006|NOT COMPLETED|Overall Study||1
3183797|NCT02010255|3912038|FG007|NOT COMPLETED|Overall Study||1
3183798|NCT02010255|3912039|FG008|NOT COMPLETED|Overall Study||1
3183799|NCT02010255|3912040|FG009|NOT COMPLETED|Overall Study||0
3183800|NCT02010255|3912041|FG010|NOT COMPLETED|Overall Study||2
3183801|NCT02010255|3912042|FG011|NOT COMPLETED|Overall Study||1
3183802|NCT02010255|3912043|FG012|NOT COMPLETED|Overall Study||0
3183803|NCT02010255|3912044|FG013|NOT COMPLETED|Overall Study||1
3183804|NCT02010359|3912101|FG000|STARTED|Overall Study||15
3183805|NCT02010359|3912102|FG001|STARTED|Overall Study||14
3183806|NCT02010359|3912101|FG000|COMPLETED|Overall Study||13
3183807|NCT02010359|3912102|FG001|COMPLETED|Overall Study||12
3183808|NCT02010359|3912101|FG000|NOT COMPLETED|Overall Study||2
3183809|NCT02010359|3912102|FG001|NOT COMPLETED|Overall Study||2
3183810|NCT02010567|3912113|FG000|STARTED|Overall Study||3
3183811|NCT02010567|3912114|FG001|STARTED|Overall Study||6
3183812|NCT02010567|3912115|FG002|STARTED|Overall Study||14
3183813|NCT02010567|3912116|FG003|STARTED|Overall Study||3
3183814|NCT02010567|3912117|FG004|STARTED|Overall Study||6
3183815|NCT02010567|3912113|FG000|COMPLETED|Overall Study||3
3183816|NCT02010567|3912114|FG001|COMPLETED|Overall Study||6
3183817|NCT02010567|3912115|FG002|COMPLETED|Overall Study||13
3183818|NCT02010567|3912116|FG003|COMPLETED|Overall Study||3
3183819|NCT02010567|3912117|FG004|COMPLETED|Overall Study||5
3183820|NCT02010567|3912113|FG000|NOT COMPLETED|Overall Study||0
3183821|NCT02010567|3912114|FG001|NOT COMPLETED|Overall Study||0
3183822|NCT02010567|3912115|FG002|NOT COMPLETED|Overall Study||1
3183823|NCT02010567|3912116|FG003|NOT COMPLETED|Overall Study||0
3183824|NCT02010567|3912117|FG004|NOT COMPLETED|Overall Study||1
3183825|NCT02010632|3912127|FG000|STARTED|First Intervention (7 Days)||16
3183826|NCT02010632|3912128|FG001|STARTED|First Intervention (7 Days)||16
3183827|NCT02010632|3912127|FG000|COMPLETED|First Intervention (7 Days)||16
3183828|NCT02010632|3912128|FG001|COMPLETED|First Intervention (7 Days)||16
3183829|NCT02010632|3912127|FG000|NOT COMPLETED|First Intervention (7 Days)||0
3183830|NCT02010632|3912128|FG001|NOT COMPLETED|First Intervention (7 Days)||0
3183831|NCT02010632|3912127|FG000|STARTED|Wash Out Period (14 Days)||16
3183832|NCT02010632|3912128|FG001|STARTED|Wash Out Period (14 Days)||16
3183833|NCT02010632|3912127|FG000|COMPLETED|Wash Out Period (14 Days)||16
3183834|NCT02010632|3912128|FG001|COMPLETED|Wash Out Period (14 Days)||16
3183835|NCT02010632|3912127|FG000|NOT COMPLETED|Wash Out Period (14 Days)||0
3153709|NCT01820260|3879958|FG010|NOT COMPLETED|Phase 1 (Part 1)||0
3153710|NCT01820260|3879959|FG011|NOT COMPLETED|Phase 1 (Part 1)||0
3153711|NCT01820260|3879960|FG012|NOT COMPLETED|Phase 1 (Part 1)||0
3153712|NCT01820260|3879961|FG013|NOT COMPLETED|Phase 1 (Part 1)||0
3183836|NCT02010632|3912128|FG001|NOT COMPLETED|Wash Out Period (14 Days)||0
3183837|NCT02010632|3912127|FG000|STARTED|Second Intervention (7 Days)||16
3183838|NCT02010632|3912128|FG001|STARTED|Second Intervention (7 Days)||16
3183839|NCT02010632|3912127|FG000|COMPLETED|Second Intervention (7 Days)||15
3153713|NCT01820260|3879948|FG000|STARTED|Phase 2 (Part 2)||0
3153714|NCT01820260|3879949|FG001|STARTED|Phase 2 (Part 2)||0
3153715|NCT01820260|3879950|FG002|STARTED|Phase 2 (Part 2)||0
3153716|NCT01820260|3879951|FG003|STARTED|Phase 2 (Part 2)||0
3153717|NCT01820260|3879952|FG004|STARTED|Phase 2 (Part 2)||0
3153718|NCT01820260|3879953|FG005|STARTED|Phase 2 (Part 2)||0
3153719|NCT01820260|3879954|FG006|STARTED|Phase 2 (Part 2)||0
3153720|NCT01820260|3879955|FG007|STARTED|Phase 2 (Part 2)||0
3153721|NCT01820260|3879956|FG008|STARTED|Phase 2 (Part 2)||64
3153722|NCT01820260|3879957|FG009|STARTED|Phase 2 (Part 2)||62
3153723|NCT01820260|3879958|FG010|STARTED|Phase 2 (Part 2)||61
3153724|NCT01820260|3879959|FG011|STARTED|Phase 2 (Part 2)||64
3153725|NCT01820260|3879960|FG012|STARTED|Phase 2 (Part 2)||31
3153726|NCT01820260|3879961|FG013|STARTED|Phase 2 (Part 2)||31
3153727|NCT01820260|3879948|FG000|COMPLETED|Phase 2 (Part 2)||0
3153728|NCT01820260|3879949|FG001|COMPLETED|Phase 2 (Part 2)||0
3153729|NCT01820260|3879950|FG002|COMPLETED|Phase 2 (Part 2)||0
3153730|NCT01820260|3879951|FG003|COMPLETED|Phase 2 (Part 2)||0
3153731|NCT01820260|3879952|FG004|COMPLETED|Phase 2 (Part 2)||0
3153732|NCT01820260|3879953|FG005|COMPLETED|Phase 2 (Part 2)||0
3153733|NCT01820260|3879954|FG006|COMPLETED|Phase 2 (Part 2)||0
3153734|NCT01820260|3879955|FG007|COMPLETED|Phase 2 (Part 2)||0
3153735|NCT01820260|3879956|FG008|COMPLETED|Phase 2 (Part 2)||64
3153736|NCT01820260|3879957|FG009|COMPLETED|Phase 2 (Part 2)||61
3153737|NCT01820260|3879958|FG010|COMPLETED|Phase 2 (Part 2)||61
3153738|NCT01820260|3879959|FG011|COMPLETED|Phase 2 (Part 2)||64
3153739|NCT01820260|3879960|FG012|COMPLETED|Phase 2 (Part 2)||31
3153740|NCT01820260|3879961|FG013|COMPLETED|Phase 2 (Part 2)||31
3153741|NCT01820260|3879948|FG000|NOT COMPLETED|Phase 2 (Part 2)||0
3153742|NCT01820260|3879949|FG001|NOT COMPLETED|Phase 2 (Part 2)||0
3153743|NCT01820260|3879950|FG002|NOT COMPLETED|Phase 2 (Part 2)||0
3153744|NCT01820260|3879951|FG003|NOT COMPLETED|Phase 2 (Part 2)||0
3153745|NCT01820260|3879952|FG004|NOT COMPLETED|Phase 2 (Part 2)||0
3153746|NCT01820260|3879953|FG005|NOT COMPLETED|Phase 2 (Part 2)||0
3153747|NCT01820260|3879954|FG006|NOT COMPLETED|Phase 2 (Part 2)||0
3153748|NCT01820260|3879955|FG007|NOT COMPLETED|Phase 2 (Part 2)||0
3153749|NCT01820260|3879956|FG008|NOT COMPLETED|Phase 2 (Part 2)||0
3153750|NCT01820260|3879957|FG009|NOT COMPLETED|Phase 2 (Part 2)||1
3153751|NCT01820260|3879958|FG010|NOT COMPLETED|Phase 2 (Part 2)||0
3153752|NCT01820260|3879959|FG011|NOT COMPLETED|Phase 2 (Part 2)||0
3153753|NCT01820260|3879960|FG012|NOT COMPLETED|Phase 2 (Part 2)||0
3153754|NCT01820260|3879961|FG013|NOT COMPLETED|Phase 2 (Part 2)||0
3153755|NCT01820364|3879997|FG000|STARTED|Part I: LGX818||15
3153756|NCT01820364|3879998|FG001|STARTED|Part I: LGX818||0
3153757|NCT01820364|3879997|FG000|COMPLETED|Part I: LGX818||1
3153758|NCT01820364|3879998|FG001|COMPLETED|Part I: LGX818||0
3153759|NCT01820364|3879997|FG000|NOT COMPLETED|Part I: LGX818||14
3153760|NCT01820364|3879998|FG001|NOT COMPLETED|Part I: LGX818||0
3153761|NCT01820364|3879997|FG000|STARTED|Part II: LGX818 + MEK162||0
3153762|NCT01820364|3879998|FG001|STARTED|Part II: LGX818 + MEK162||1
3153763|NCT01820364|3879997|FG000|COMPLETED|Part II: LGX818 + MEK162||0
3153764|NCT01820364|3879998|FG001|COMPLETED|Part II: LGX818 + MEK162||0
3153765|NCT01820364|3879997|FG000|NOT COMPLETED|Part II: LGX818 + MEK162||0
3153766|NCT01820364|3879998|FG001|NOT COMPLETED|Part II: LGX818 + MEK162||1
3153767|NCT01820416|3880007|FG000|STARTED|Overall Study||12
3153768|NCT01820416|3880008|FG001|STARTED|Overall Study||12
3153769|NCT01820416|3880009|FG002|STARTED|Overall Study||11
3153770|NCT01820416|3880007|FG000|COMPLETED|Overall Study||9
3153771|NCT01820416|3880008|FG001|COMPLETED|Overall Study||10
3153772|NCT01820416|3880009|FG002|COMPLETED|Overall Study||11
3153773|NCT01820416|3880007|FG000|NOT COMPLETED|Overall Study||3
3153774|NCT01820416|3880008|FG001|NOT COMPLETED|Overall Study||2
3153775|NCT01820416|3880009|FG002|NOT COMPLETED|Overall Study||0
3153776|NCT01820559|3880020|FG000|STARTED|Overall Study||136
3153777|NCT01820559|3880021|FG001|STARTED|Overall Study||135
3153778|NCT01820559|3880022|FG002|STARTED|Overall Study||139
3153779|NCT01820559|3880020|FG000|Randomized and Treated|Overall Study||136
3153780|NCT01820559|3880021|FG001|Randomized and Treated|Overall Study||135
3153781|NCT01820559|3880022|FG002|Randomized and Treated|Overall Study||139
3153782|NCT01820559|3880020|FG000|Completed Tutration Period|Overall Study||130
3153783|NCT01820559|3880021|FG001|Completed Tutration Period|Overall Study||134
3153784|NCT01820559|3880022|FG002|Completed Tutration Period|Overall Study||131
3153785|NCT01820559|3880020|FG000|Entered Maintenance Period|Overall Study||129
3153786|NCT01820559|3880021|FG001|Entered Maintenance Period|Overall Study||133
3153787|NCT01820559|3880022|FG002|Entered Maintenance Period|Overall Study||129
3153788|NCT01820559|3880020|FG000|Completed Maintenance Period|Overall Study||122
3153789|NCT01820559|3880021|FG001|Completed Maintenance Period|Overall Study||123
3153790|NCT01820559|3880022|FG002|Completed Maintenance Period|Overall Study||110
3153791|NCT01820559|3880020|FG000|COMPLETED|Overall Study||122
3153792|NCT01820559|3880021|FG001|COMPLETED|Overall Study||122
3153793|NCT01820559|3880022|FG002|COMPLETED|Overall Study||110
3153794|NCT01820559|3880020|FG000|NOT COMPLETED|Overall Study||14
3153795|NCT01820559|3880021|FG001|NOT COMPLETED|Overall Study||13
3153796|NCT01820559|3880022|FG002|NOT COMPLETED|Overall Study||29
3153797|NCT01820572|3880032|FG000|STARTED|Randomization||223
3153798|NCT01820572|3880033|FG001|STARTED|Randomization||223
3153799|NCT01820572|3880032|FG000|COMPLETED|Randomization||221
3153800|NCT01820572|3880033|FG001|COMPLETED|Randomization||222
3153801|NCT01820572|3880032|FG000|NOT COMPLETED|Randomization||2
3153802|NCT01820572|3880033|FG001|NOT COMPLETED|Randomization||1
3153803|NCT01820572|3880032|FG000|STARTED|Treatment Period||221
3153804|NCT01820572|3880033|FG001|STARTED|Treatment Period||222
3153805|NCT01820572|3880032|FG000|COMPLETED|Treatment Period||195
3153806|NCT01820572|3880033|FG001|COMPLETED|Treatment Period||186
3153807|NCT01820572|3880032|FG000|NOT COMPLETED|Treatment Period||26
3153808|NCT01820572|3880033|FG001|NOT COMPLETED|Treatment Period||36
3153809|NCT01820585|3880043|FG000|STARTED|Overall Study||131
3153810|NCT01820585|3880044|FG001|STARTED|Overall Study||130
3153811|NCT01820585|3880045|FG002|STARTED|Overall Study||135
3153812|NCT01820585|3880046|FG003|STARTED|Overall Study||132
3153813|NCT01820585|3880043|FG000|Randomized and Treated|Overall Study||131
3153814|NCT01820585|3880044|FG001|Randomized and Treated|Overall Study||130
3153815|NCT01820585|3880045|FG002|Randomized and Treated|Overall Study||135
3153816|NCT01820585|3880046|FG003|Randomized and Treated|Overall Study||132
3153817|NCT01820585|3880043|FG000|Full Analysis Set|Overall Study||131
3153818|NCT01820585|3880044|FG001|Full Analysis Set|Overall Study||130
3153819|NCT01820585|3880045|FG002|Full Analysis Set|Overall Study||135
3153820|NCT01820585|3880046|FG003|Full Analysis Set|Overall Study||129
3153821|NCT01820585|3880043|FG000|Completed Titration Period|Overall Study||128
3153822|NCT01820585|3880044|FG001|Completed Titration Period|Overall Study||125
3153823|NCT01820585|3880045|FG002|Completed Titration Period|Overall Study||131
3153824|NCT01820585|3880046|FG003|Completed Titration Period|Overall Study||126
3153825|NCT01820585|3880043|FG000|Entered Maintenance Period|Overall Study||128
3153826|NCT01820585|3880044|FG001|Entered Maintenance Period|Overall Study||124
3153827|NCT01820585|3880045|FG002|Entered Maintenance Period|Overall Study||131
3153828|NCT01820585|3880046|FG003|Entered Maintenance Period|Overall Study||123
3153829|NCT01820585|3880043|FG000|Completed Maintenance Period|Overall Study||105
3153830|NCT01820585|3880044|FG001|Completed Maintenance Period|Overall Study||98
3153831|NCT01820585|3880045|FG002|Completed Maintenance Period|Overall Study||101
3153832|NCT01820585|3880046|FG003|Completed Maintenance Period|Overall Study||84
3153833|NCT01820585|3880043|FG000|COMPLETED|Overall Study||104
3153834|NCT01820585|3880044|FG001|COMPLETED|Overall Study||98
3153835|NCT01820585|3880045|FG002|COMPLETED|Overall Study||101
3153836|NCT01820585|3880046|FG003|COMPLETED|Overall Study||83
3153837|NCT01820585|3880043|FG000|NOT COMPLETED|Overall Study||27
3153838|NCT01820585|3880044|FG001|NOT COMPLETED|Overall Study||32
3153839|NCT01820585|3880045|FG002|NOT COMPLETED|Overall Study||34
3153840|NCT01820585|3880046|FG003|NOT COMPLETED|Overall Study||49
3153841|NCT01820637|3880056|FG000|STARTED|Overall Study||57
3153842|NCT01820637|3880056|FG000|COMPLETED|Overall Study||54
3153843|NCT01820637|3880056|FG000|NOT COMPLETED|Overall Study||3
3153844|NCT01820754|3880060|FG000|STARTED|Overall Study||24
3153845|NCT01820754|3880060|FG000|COMPLETED|Overall Study||24
3153846|NCT01820754|3880060|FG000|NOT COMPLETED|Overall Study||0
3153847|NCT01821105|3880064|FG000|STARTED|Overall Study||21
3153848|NCT01821105|3880064|FG000|COMPLETED|Overall Study||21
3153849|NCT01821105|3880064|FG000|NOT COMPLETED|Overall Study||0
3153850|NCT01821118|3880070|FG000|STARTED|Overall Study||24
3153851|NCT01821118|3880071|FG001|STARTED|Overall Study||12
3153852|NCT01821118|3880070|FG000|COMPLETED|Overall Study||24
3153853|NCT01821118|3880071|FG001|COMPLETED|Overall Study||11
3153854|NCT01821118|3880070|FG000|NOT COMPLETED|Overall Study||0
3153855|NCT01821118|3880071|FG001|NOT COMPLETED|Overall Study||1
3153856|NCT01821300|3880079|FG000|STARTED|Overall Study||154
3153857|NCT01821300|3880080|FG001|STARTED|Overall Study||103
3153858|NCT01821300|3880079|FG000|COMPLETED|Overall Study||154
3153859|NCT01821300|3880080|FG001|COMPLETED|Overall Study||103
3153860|NCT01821300|3880079|FG000|NOT COMPLETED|Overall Study||0
3153861|NCT01821300|3880080|FG001|NOT COMPLETED|Overall Study||0
3153862|NCT01821326|3880092|FG000|STARTED|Overall Study||339
3153863|NCT01821326|3880092|FG000|COMPLETED|Overall Study||339
3153864|NCT01821326|3880092|FG000|NOT COMPLETED|Overall Study||0
3153865|NCT01821352|3880098|FG000|STARTED|Overall Study||28
3153866|NCT01821352|3880099|FG001|STARTED|Overall Study||25
3153867|NCT01821352|3880098|FG000|COMPLETED|Overall Study||28
3153868|NCT01821352|3880099|FG001|COMPLETED|Overall Study||25
3183840|NCT02010632|3912128|FG001|COMPLETED|Second Intervention (7 Days)||16
3183841|NCT02010632|3912127|FG000|NOT COMPLETED|Second Intervention (7 Days)||1
3183842|NCT02010632|3912128|FG001|NOT COMPLETED|Second Intervention (7 Days)||0
3183843|NCT02010645|3912134|FG000|STARTED|Overall Study||6
3153869|NCT01821352|3880098|FG000|NOT COMPLETED|Overall Study||0
3153870|NCT01821352|3880099|FG001|NOT COMPLETED|Overall Study||0
3153871|NCT01821378|3880108|FG000|STARTED|Overall Study||101
3153872|NCT01821378|3880109|FG001|STARTED|Overall Study||199
3153873|NCT01821378|3880110|FG002|STARTED|Overall Study||112
3153874|NCT01821378|3880108|FG000|COMPLETED|Overall Study||74
3153875|NCT01821378|3880109|FG001|COMPLETED|Overall Study||145
3153876|NCT01821378|3880110|FG002|COMPLETED|Overall Study||70
3153877|NCT01821378|3880108|FG000|NOT COMPLETED|Overall Study||27
3153878|NCT01821378|3880109|FG001|NOT COMPLETED|Overall Study||54
3153879|NCT01821378|3880110|FG002|NOT COMPLETED|Overall Study||42
3153880|NCT01821391|3880125|FG000|STARTED|Overall Study||108
3153881|NCT01821391|3880126|FG001|STARTED|Overall Study||23
3153882|NCT01821391|3880125|FG000|COMPLETED|Overall Study||107
3153883|NCT01821391|3880126|FG001|COMPLETED|Overall Study||23
3153884|NCT01821391|3880125|FG000|NOT COMPLETED|Overall Study||1
3153885|NCT01821391|3880126|FG001|NOT COMPLETED|Overall Study||0
3153886|NCT01821417|3880136|FG000|STARTED|Overall Study||37
3153887|NCT01821417|3880137|FG001|STARTED|Overall Study||31
3153888|NCT01821417|3880136|FG000|COMPLETED|Overall Study||37
3153889|NCT01821417|3880137|FG001|COMPLETED|Overall Study||31
3153890|NCT01821417|3880136|FG000|NOT COMPLETED|Overall Study||0
3153891|NCT01821417|3880137|FG001|NOT COMPLETED|Overall Study||0
3153892|NCT01821534|3880143|FG000|STARTED|Overall Study||201
3153893|NCT01821534|3880143|FG000|COMPLETED|Overall Study||201
3153894|NCT01821534|3880143|FG000|NOT COMPLETED|Overall Study||0
3153895|NCT01821560|3880149|FG000|STARTED|Overall Study||22
3153896|NCT01821560|3880150|FG001|STARTED|Overall Study||22
3153897|NCT01821560|3880149|FG000|COMPLETED|Overall Study||16
3153898|NCT01821560|3880150|FG001|COMPLETED|Overall Study||15
3153899|NCT01821560|3880149|FG000|NOT COMPLETED|Overall Study||6
3153900|NCT01821560|3880150|FG001|NOT COMPLETED|Overall Study||7
3153901|NCT01821625|3880156|FG000|STARTED|Overall Study||7
3153902|NCT01821625|3880156|FG000|COMPLETED|Overall Study||1
3153903|NCT01821625|3880156|FG000|NOT COMPLETED|Overall Study||6
3153904|NCT01821729|3880160|FG000|STARTED|Overall Study||50
3153905|NCT01821729|3880160|FG000|Received Chemoradiotherapy|Overall Study||45
3153906|NCT01821729|3880160|FG000|Underwent Attempted Surgery|Overall Study||42
3153907|NCT01821729|3880160|FG000|COMPLETED|Overall Study||49
3153908|NCT01821729|3880160|FG000|NOT COMPLETED|Overall Study||1
3153909|NCT01821807|3880166|FG000|STARTED|Overall Study||150
3153910|NCT01821807|3880167|FG001|STARTED|Overall Study||110
3153911|NCT01821807|3880166|FG000|COMPLETED|Overall Study||147
3153912|NCT01821807|3880167|FG001|COMPLETED|Overall Study||109
3153913|NCT01821807|3880166|FG000|NOT COMPLETED|Overall Study||3
3153914|NCT01821807|3880167|FG001|NOT COMPLETED|Overall Study||1
3153915|NCT01821937|3880175|FG000|STARTED|Overall Study||10
3153916|NCT01821937|3880176|FG001|STARTED|Overall Study||15
3153917|NCT01821937|3880175|FG000|COMPLETED|Overall Study||10
3153918|NCT01821937|3880176|FG001|COMPLETED|Overall Study|2 patients discontinued during Single dose period,1 Patient discontinued during Multiple dose period|12
3153919|NCT01821937|3880175|FG000|NOT COMPLETED|Overall Study||0
3153920|NCT01821937|3880176|FG001|NOT COMPLETED|Overall Study||3
3153921|NCT01822119|3880184|FG000|STARTED|Overall Study||27
3153922|NCT01822119|3880184|FG000|COMPLETED|Overall Study||27
3153923|NCT01822119|3880184|FG000|NOT COMPLETED|Overall Study||0
3153924|NCT01822132|3880190|FG000|STARTED|Overall Study||25
3153925|NCT01822132|3880191|FG001|STARTED|Overall Study||27
3153926|NCT01822132|3880190|FG000|COMPLETED|Overall Study||21
3183844|NCT02010645|3912134|FG000|COMPLETED|Overall Study||6
3183845|NCT02010645|3912134|FG000|NOT COMPLETED|Overall Study||0
3183846|NCT02010684|3912140|FG000|STARTED|Overall Study||39
3183847|NCT02010684|3912141|FG001|STARTED|Overall Study||82
3183848|NCT02010684|3912140|FG000|COMPLETED|Overall Study||27
3183849|NCT02010684|3912141|FG001|COMPLETED|Overall Study||59
3183850|NCT02010684|3912140|FG000|NOT COMPLETED|Overall Study||12
3183851|NCT02010684|3912141|FG001|NOT COMPLETED|Overall Study||23
3183852|NCT02010697|3912150|FG000|STARTED|Overall Study||1044
3183853|NCT02010697|3912151|FG001|STARTED|Overall Study||1038
3183854|NCT02010697|3912152|FG002|STARTED|Overall Study||1043
3183855|NCT02010697|3912150|FG000|COMPLETED|Overall Study||1044
3183856|NCT02010697|3912151|FG001|COMPLETED|Overall Study||1038
3183857|NCT02010697|3912152|FG002|COMPLETED|Overall Study||1043
3183858|NCT02010697|3912150|FG000|NOT COMPLETED|Overall Study||0
3183859|NCT02010697|3912151|FG001|NOT COMPLETED|Overall Study||0
3183860|NCT02010697|3912152|FG002|NOT COMPLETED|Overall Study||0
3183861|NCT02010775|3912165|FG000|STARTED|Overall Study||38
3183862|NCT02010775|3912166|FG001|STARTED|Overall Study||38
3183863|NCT02010775|3912167|FG002|STARTED|Overall Study||37
3183864|NCT02010775|3912168|FG003|STARTED|Overall Study||37
3183865|NCT02010775|3912169|FG004|STARTED|Overall Study||37
3183866|NCT02010775|3912165|FG000|COMPLETED|Overall Study||33
3183867|NCT02010775|3912166|FG001|COMPLETED|Overall Study||35
3183868|NCT02010775|3912167|FG002|COMPLETED|Overall Study||34
3183869|NCT02010775|3912168|FG003|COMPLETED|Overall Study||34
3183870|NCT02010775|3912169|FG004|COMPLETED|Overall Study||31
3183871|NCT02010775|3912165|FG000|NOT COMPLETED|Overall Study||5
3183872|NCT02010775|3912166|FG001|NOT COMPLETED|Overall Study||3
3153927|NCT01822132|3880191|FG001|COMPLETED|Overall Study||25
3153928|NCT01822132|3880190|FG000|NOT COMPLETED|Overall Study||4
3153929|NCT01822132|3880191|FG001|NOT COMPLETED|Overall Study||2
3153930|NCT01822197|3880203|FG000|STARTED|Overall Study||30
3153931|NCT01822197|3880203|FG000|COMPLETED|Overall Study||30
3153932|NCT01822197|3880203|FG000|NOT COMPLETED|Overall Study||0
3153933|NCT01822223|3880209|FG000|STARTED|Overall Study||10
3153934|NCT01822223|3880210|FG001|STARTED|Overall Study||10
3183873|NCT02010775|3912167|FG002|NOT COMPLETED|Overall Study||3
3183874|NCT02010775|3912168|FG003|NOT COMPLETED|Overall Study||3
3153935|NCT01822223|3880209|FG000|COMPLETED|Overall Study||10
3153936|NCT01822223|3880210|FG001|COMPLETED|Overall Study||9
3183875|NCT02010775|3912169|FG004|NOT COMPLETED|Overall Study||6
3183876|NCT02010996|3912183|FG000|STARTED|Overall Study||36
3183877|NCT02010996|3912184|FG001|STARTED|Overall Study||36
3183878|NCT02010996|3912183|FG000|COMPLETED|Overall Study||36
3183879|NCT02010996|3912184|FG001|COMPLETED|Overall Study||36
3183880|NCT02010996|3912183|FG000|NOT COMPLETED|Overall Study||0
3153937|NCT01822223|3880209|FG000|NOT COMPLETED|Overall Study||0
3153938|NCT01822223|3880210|FG001|NOT COMPLETED|Overall Study||1
3153939|NCT01822301|3880218|FG000|STARTED|Overall Study||5
3153940|NCT01822301|3880218|FG000|COMPLETED|Overall Study||5
3153941|NCT01822301|3880218|FG000|NOT COMPLETED|Overall Study||0
3153942|NCT01822353|3880231|FG000|STARTED|Overall Study||10
3153943|NCT01822353|3880232|FG001|STARTED|Overall Study||9
3153944|NCT01822353|3880233|FG002|STARTED|Overall Study||4
3153945|NCT01822353|3880231|FG000|COMPLETED|Overall Study||6
3153946|NCT01822353|3880232|FG001|COMPLETED|Overall Study||4
3153947|NCT01822353|3880233|FG002|COMPLETED|Overall Study||3
3153948|NCT01822353|3880231|FG000|NOT COMPLETED|Overall Study||4
3153949|NCT01822353|3880232|FG001|NOT COMPLETED|Overall Study||5
3153950|NCT01822353|3880233|FG002|NOT COMPLETED|Overall Study||1
3153951|NCT01822366|3880248|FG000|STARTED|Overall Study||320
3153952|NCT01822366|3880249|FG001|STARTED|Overall Study||320
3153953|NCT01822366|3880250|FG002|STARTED|Overall Study||320
3153954|NCT01822366|3880251|FG003|STARTED|Overall Study||320
3153955|NCT01822366|3880248|FG000|COMPLETED|Overall Study||315
3153956|NCT01822366|3880249|FG001|COMPLETED|Overall Study||298
3153957|NCT01822366|3880250|FG002|COMPLETED|Overall Study||315
3153958|NCT01822366|3880251|FG003|COMPLETED|Overall Study||298
3153959|NCT01822366|3880248|FG000|NOT COMPLETED|Overall Study||5
3153960|NCT01822366|3880249|FG001|NOT COMPLETED|Overall Study||22
3153961|NCT01822366|3880250|FG002|NOT COMPLETED|Overall Study||5
3153962|NCT01822366|3880251|FG003|NOT COMPLETED|Overall Study||22
3153963|NCT01822457|3880281|FG000|STARTED|Overall Study||20
3153964|NCT01822457|3880282|FG001|STARTED|Overall Study||17
3153965|NCT01822457|3880281|FG000|COMPLETED|Overall Study||16
3153966|NCT01822457|3880282|FG001|COMPLETED|Overall Study||12
3153967|NCT01822457|3880281|FG000|NOT COMPLETED|Overall Study||4
3153968|NCT01822457|3880282|FG001|NOT COMPLETED|Overall Study||5
3153969|NCT01822496|3880292|FG000|STARTED|Overall Study||16
3153970|NCT01822496|3880293|FG001|STARTED|Overall Study||23
3153971|NCT01822496|3880294|FG002|STARTED|Overall Study||9
3153972|NCT01822496|3880295|FG003|STARTED|Overall Study||11
3153973|NCT01822496|3880292|FG000|Eligible|Overall Study||14
3153974|NCT01822496|3880293|FG001|Eligible|Overall Study||21
3153975|NCT01822496|3880294|FG002|Eligible|Overall Study||9
3153976|NCT01822496|3880295|FG003|Eligible|Overall Study||7
3153977|NCT01822496|3880292|FG000|Eligible With Disease Assessment|Overall Study||10
3153978|NCT01822496|3880293|FG001|Eligible With Disease Assessment|Overall Study||15
3153979|NCT01822496|3880294|FG002|Eligible With Disease Assessment|Overall Study||6
3153980|NCT01822496|3880295|FG003|Eligible With Disease Assessment|Overall Study||4
3153981|NCT01822496|3880292|FG000|Eligible and Started Study Treatment|Overall Study||14
3153982|NCT01822496|3880293|FG001|Eligible and Started Study Treatment|Overall Study||20
3153983|NCT01822496|3880294|FG002|Eligible and Started Study Treatment|Overall Study||9
3153984|NCT01822496|3880295|FG003|Eligible and Started Study Treatment|Overall Study||7
3153985|NCT01822496|3880292|FG000|COMPLETED|Overall Study||14
3153986|NCT01822496|3880293|FG001|COMPLETED|Overall Study||21
3153987|NCT01822496|3880294|FG002|COMPLETED|Overall Study||9
3153988|NCT01822496|3880295|FG003|COMPLETED|Overall Study||7
3153989|NCT01822496|3880292|FG000|NOT COMPLETED|Overall Study||2
3153990|NCT01822496|3880293|FG001|NOT COMPLETED|Overall Study||2
3153991|NCT01822496|3880294|FG002|NOT COMPLETED|Overall Study||0
3153992|NCT01822496|3880295|FG003|NOT COMPLETED|Overall Study||4
3153993|NCT01822535|3880307|FG000|STARTED|Visit 1 - Tetraplegia and Able-Bodied||17
3153994|NCT01822535|3880308|FG001|STARTED|Visit 1 - Tetraplegia and Able-Bodied||13
3153995|NCT01822535|3880307|FG000|COMPLETED|Visit 1 - Tetraplegia and Able-Bodied||11
3153996|NCT01822535|3880308|FG001|COMPLETED|Visit 1 - Tetraplegia and Able-Bodied||11
3153997|NCT01822535|3880307|FG000|NOT COMPLETED|Visit 1 - Tetraplegia and Able-Bodied||6
3153998|NCT01822535|3880308|FG001|NOT COMPLETED|Visit 1 - Tetraplegia and Able-Bodied||2
3153999|NCT01822535|3880307|FG000|STARTED|Visit 2 - Tetraplegia Only - Drug|These subjects were individuals who completed Visit 1 of testing.|11
3154000|NCT01822535|3880308|FG001|STARTED|Visit 2 - Tetraplegia Only - Drug|Able-bodied subjects were not enrolled for a second visit.|0
3154001|NCT01822535|3880307|FG000|COMPLETED|Visit 2 - Tetraplegia Only - Drug||10
3154002|NCT01822535|3880308|FG001|COMPLETED|Visit 2 - Tetraplegia Only - Drug||0
3154003|NCT01822535|3880307|FG000|NOT COMPLETED|Visit 2 - Tetraplegia Only - Drug||1
3154004|NCT01822535|3880308|FG001|NOT COMPLETED|Visit 2 - Tetraplegia Only - Drug||0
3183881|NCT02010996|3912184|FG001|NOT COMPLETED|Overall Study||0
3183882|NCT02011113|3912194|FG000|STARTED|Overall Study||36
3183883|NCT02011113|3912194|FG000|COMPLETED|Overall Study|Completed = participants with progressive disease were considered as completed.|0
3183884|NCT02011113|3912194|FG000|NOT COMPLETED|Overall Study||36
3183885|NCT02011386|3912199|FG000|STARTED|Overall Study||53
3183886|NCT02011386|3912199|FG000|COMPLETED|Overall Study||48
3183887|NCT02011386|3912199|FG000|NOT COMPLETED|Overall Study||5
3183888|NCT02011464|3912205|FG000|STARTED|Overall Study||10
3183889|NCT02011464|3912206|FG001|STARTED|Overall Study||10
3183890|NCT02011464|3912205|FG000|COMPLETED|Overall Study||10
3183891|NCT02011464|3912206|FG001|COMPLETED|Overall Study||10
3183892|NCT02011464|3912205|FG000|NOT COMPLETED|Overall Study||0
3154005|NCT01822548|3880319|FG000|STARTED|Overall Study|Received allocated intervention n=38 Did not receive allocated intervention (only metformin) n=2|40
3154006|NCT01822548|3880320|FG001|STARTED|Overall Study||24
3154007|NCT01822548|3880319|FG000|Discontinued Intervention|Overall Study||0
3154008|NCT01822548|3880320|FG001|Discontinued Intervention|Overall Study||5
3154009|NCT01822548|3880319|FG000|COMPLETED|Overall Study||40
3154010|NCT01822548|3880320|FG001|COMPLETED|Overall Study||24
3154011|NCT01822548|3880319|FG000|NOT COMPLETED|Overall Study||0
3154012|NCT01822548|3880320|FG001|NOT COMPLETED|Overall Study||0
3154013|NCT01822561|3880326|FG000|STARTED|Overall Study||15
3154014|NCT01822561|3880326|FG000|COMPLETED|Overall Study||13
3154015|NCT01822561|3880326|FG000|NOT COMPLETED|Overall Study||2
3154016|NCT01822574|3880337|FG000|STARTED|Overall Study||30
3154017|NCT01822574|3880338|FG001|STARTED|Overall Study||30
3154018|NCT01822574|3880339|FG002|STARTED|Overall Study||30
3154019|NCT01822574|3880337|FG000|COMPLETED|Overall Study||30
3154020|NCT01822574|3880338|FG001|COMPLETED|Overall Study||30
3154021|NCT01822574|3880339|FG002|COMPLETED|Overall Study||30
3154022|NCT01822574|3880337|FG000|NOT COMPLETED|Overall Study||0
3154023|NCT01822574|3880338|FG001|NOT COMPLETED|Overall Study||0
3154024|NCT01822574|3880339|FG002|NOT COMPLETED|Overall Study||0
3154025|NCT01822587|3880350|FG000|STARTED|Overall Study||59
3154026|NCT01822587|3880351|FG001|STARTED|Overall Study||60
3154027|NCT01822587|3880352|FG002|STARTED|Overall Study||62
3154028|NCT01822587|3880350|FG000|COMPLETED|Overall Study||43
3154029|NCT01822587|3880351|FG001|COMPLETED|Overall Study||45
3154030|NCT01822587|3880352|FG002|COMPLETED|Overall Study||44
3154031|NCT01822587|3880350|FG000|NOT COMPLETED|Overall Study||16
3154032|NCT01822587|3880351|FG001|NOT COMPLETED|Overall Study||15
3154033|NCT01822587|3880352|FG002|NOT COMPLETED|Overall Study||18
3154034|NCT01822665|3880360|FG000|STARTED|Overall Study||28
3154035|NCT01822665|3880360|FG000|Received Ibuprofen Tablet (400 mg)|Overall Study|5 participants did not complete; Period 3(2:adverse events;1:other reason); Period 4(2:other reason)|23
3154036|NCT01822665|3880360|FG000|Received Placebo Tablet|Overall Study|5 participants did not complete; Period 2(1:other reason); Period 4(3:adverse event; 1:other reason)|23
3154037|NCT01822665|3880360|FG000|Received Ibuprofen Capsule (400 mg)|Overall Study|Two participants, each in period 3 and period 4 did not complete treatment for 'other reason'.|24
3154038|NCT01822665|3880360|FG000|Received Paracetamol Tablet (1000 mg)|Overall Study||28
3154039|NCT01822665|3880360|FG000|COMPLETED|Overall Study||20
3154040|NCT01822665|3880360|FG000|NOT COMPLETED|Overall Study||8
3154041|NCT01822678|3880381|FG000|STARTED|Overall Study||57
3154042|NCT01822678|3880382|FG001|STARTED|Overall Study||64
3154043|NCT01822678|3880383|FG002|STARTED|Overall Study||40
3154044|NCT01822678|3880381|FG000|Treated|Overall Study||57
3154045|NCT01822678|3880382|FG001|Treated|Overall Study||64
3154046|NCT01822678|3880383|FG002|Treated|Overall Study||40
3154047|NCT01822678|3880381|FG000|Safety Population|Overall Study||57
3154048|NCT01822678|3880382|FG001|Safety Population|Overall Study||64
3154049|NCT01822678|3880383|FG002|Safety Population|Overall Study||40
3154050|NCT01822678|3880381|FG000|Intention-to-Treat Population (ITT)|Overall Study||57
3154051|NCT01822678|3880382|FG001|Intention-to-Treat Population (ITT)|Overall Study|1 patient was excluded from the ITT population because he did not have post baseline efficacy data|63
3154052|NCT01822678|3880383|FG002|Intention-to-Treat Population (ITT)|Overall Study||40
3154053|NCT01822678|3880381|FG000|Per Protocol Population|Overall Study||45
3154054|NCT01822678|3880382|FG001|Per Protocol Population|Overall Study||52
3154055|NCT01822678|3880383|FG002|Per Protocol Population|Overall Study||34
3154056|NCT01822678|3880381|FG000|COMPLETED|Overall Study||45
3154057|NCT01822678|3880382|FG001|COMPLETED|Overall Study||49
3154058|NCT01822678|3880383|FG002|COMPLETED|Overall Study||29
3154059|NCT01822678|3880381|FG000|NOT COMPLETED|Overall Study||12
3154060|NCT01822678|3880382|FG001|NOT COMPLETED|Overall Study||15
3154061|NCT01822678|3880383|FG002|NOT COMPLETED|Overall Study||11
3154062|NCT01822691|3880391|FG000|STARTED|Overall Study||15
3154063|NCT01822691|3880391|FG000|COMPLETED|Overall Study||13
3154064|NCT01822691|3880391|FG000|NOT COMPLETED|Overall Study||2
3154065|NCT01822756|3880400|FG000|STARTED|Overall Study||16
3154066|NCT01822756|3880401|FG001|STARTED|Overall Study||4
3154067|NCT01822756|3880402|FG002|STARTED|Overall Study||10
3154068|NCT01822756|3880403|FG003|STARTED|Overall Study||4
3154069|NCT01822756|3880404|FG004|STARTED|Overall Study||8
3154070|NCT01822756|3880400|FG000|Discontinued From the Study|Overall Study||16
3154071|NCT01822756|3880401|FG001|Discontinued From the Study|Overall Study||4
3154072|NCT01822756|3880402|FG002|Discontinued From the Study|Overall Study||10
3154073|NCT01822756|3880403|FG003|Discontinued From the Study|Overall Study||4
3154074|NCT01822756|3880404|FG004|Discontinued From the Study|Overall Study||7
3154075|NCT01822756|3880400|FG000|COMPLETED|Overall Study||0
3154076|NCT01822756|3880401|FG001|COMPLETED|Overall Study||0
3154077|NCT01822756|3880402|FG002|COMPLETED|Overall Study||0
3154078|NCT01822756|3880403|FG003|COMPLETED|Overall Study||0
3154079|NCT01822756|3880404|FG004|COMPLETED|Overall Study||1
3154080|NCT01822756|3880400|FG000|NOT COMPLETED|Overall Study||16
3183893|NCT02011464|3912206|FG001|NOT COMPLETED|Overall Study||0
3183894|NCT02011490|3912227|FG000|STARTED|Part 1||8
3183895|NCT02011490|3912228|FG001|STARTED|Part 1||8
3183896|NCT02011490|3912229|FG002|STARTED|Part 1||8
3183897|NCT02011490|3912230|FG003|STARTED|Part 1||0
3154081|NCT01822756|3880401|FG001|NOT COMPLETED|Overall Study||4
3154082|NCT01822756|3880402|FG002|NOT COMPLETED|Overall Study||10
3154083|NCT01822756|3880403|FG003|NOT COMPLETED|Overall Study||4
3183898|NCT02011490|3912231|FG004|STARTED|Part 1||0
3154084|NCT01822756|3880404|FG004|NOT COMPLETED|Overall Study||7
3154085|NCT01822821|3880418|FG000|STARTED|Overall Study||75
3154086|NCT01822821|3880419|FG001|STARTED|Overall Study||75
3154087|NCT01822821|3880418|FG000|COMPLETED|Overall Study||73
3154088|NCT01822821|3880419|FG001|COMPLETED|Overall Study||74
3154089|NCT01822821|3880418|FG000|NOT COMPLETED|Overall Study||2
3154090|NCT01822821|3880419|FG001|NOT COMPLETED|Overall Study||1
3154091|NCT01822886|3880425|FG000|STARTED|Overall Study||20
3154092|NCT01822886|3880425|FG000|COMPLETED|Overall Study||5
3154093|NCT01822886|3880425|FG000|NOT COMPLETED|Overall Study||15
3154094|NCT01822899|3880431|FG000|STARTED|Overall Study||358
3154095|NCT01822899|3880432|FG001|STARTED|Overall Study||358
3154096|NCT01822899|3880431|FG000|COMPLETED|Overall Study||334
3154097|NCT01822899|3880432|FG001|COMPLETED|Overall Study||340
3154098|NCT01822899|3880431|FG000|NOT COMPLETED|Overall Study||24
3154099|NCT01822899|3880432|FG001|NOT COMPLETED|Overall Study||18
3154100|NCT01822925|3880442|FG000|STARTED|Overall Study||32
3154101|NCT01822925|3880443|FG001|STARTED|Overall Study||32
3154102|NCT01822925|3880444|FG002|STARTED|Overall Study||32
3154103|NCT01822925|3880445|FG003|STARTED|Overall Study||32
3154104|NCT01822925|3880442|FG000|COMPLETED|Overall Study||26
3154105|NCT01822925|3880443|FG001|COMPLETED|Overall Study||30
3154106|NCT01822925|3880444|FG002|COMPLETED|Overall Study||29
3154107|NCT01822925|3880445|FG003|COMPLETED|Overall Study||27
3154108|NCT01822925|3880442|FG000|NOT COMPLETED|Overall Study||6
3154109|NCT01822925|3880443|FG001|NOT COMPLETED|Overall Study||2
3154110|NCT01822925|3880444|FG002|NOT COMPLETED|Overall Study||3
3154111|NCT01822925|3880445|FG003|NOT COMPLETED|Overall Study||5
3154112|NCT01823107|3880455|FG000|STARTED|Overall Study||25
3154113|NCT01823107|3880455|FG000|COMPLETED|Overall Study||24
3154114|NCT01823107|3880455|FG000|NOT COMPLETED|Overall Study||1
3154115|NCT01823146|3880461|FG000|STARTED|Overall Study||55
3154116|NCT01823146|3880462|FG001|STARTED|Overall Study||51
3154117|NCT01823146|3880461|FG000|COMPLETED|Overall Study||53
3154118|NCT01823146|3880462|FG001|COMPLETED|Overall Study||49
3154119|NCT01823146|3880461|FG000|NOT COMPLETED|Overall Study||2
3154120|NCT01823146|3880462|FG001|NOT COMPLETED|Overall Study||2
3154121|NCT01823224|3880470|FG000|STARTED|Overall Study||34
3154122|NCT01823224|3880471|FG001|STARTED|Overall Study||33
3154123|NCT01823224|3880470|FG000|COMPLETED|Overall Study||28
3154124|NCT01823224|3880471|FG001|COMPLETED|Overall Study||22
3154125|NCT01823224|3880470|FG000|NOT COMPLETED|Overall Study||6
3154126|NCT01823224|3880471|FG001|NOT COMPLETED|Overall Study||11
3154127|NCT01823289|3880479|FG000|STARTED|Overall Study||71
3154128|NCT01823289|3880479|FG000|COMPLETED|Overall Study||47
3154129|NCT01823289|3880479|FG000|NOT COMPLETED|Overall Study||24
3154130|NCT01823328|3880485|FG000|STARTED|Overall Study||70
3154131|NCT01823328|3880486|FG001|STARTED|Overall Study||73
3154132|NCT01823328|3880485|FG000|COMPLETED|Overall Study||62
3154133|NCT01823328|3880486|FG001|COMPLETED|Overall Study||67
3154134|NCT01823328|3880485|FG000|NOT COMPLETED|Overall Study||8
3154135|NCT01823328|3880486|FG001|NOT COMPLETED|Overall Study||6
3154136|NCT01823341|3880492|FG000|STARTED|Overall Study||97
3154137|NCT01823341|3880492|FG000|COMPLETED|Overall Study||82
3154138|NCT01823341|3880492|FG000|NOT COMPLETED|Overall Study||15
3154139|NCT01823497|3880501|FG000|STARTED|Overall Study||19
3154140|NCT01823497|3880502|FG001|STARTED|Overall Study||17
3154141|NCT01823497|3880501|FG000|COMPLETED|Overall Study||16
3154142|NCT01823497|3880502|FG001|COMPLETED|Overall Study||9
3154143|NCT01823497|3880501|FG000|NOT COMPLETED|Overall Study||3
3154144|NCT01823497|3880502|FG001|NOT COMPLETED|Overall Study||8
3154145|NCT01823510|3880508|FG000|STARTED|Days 1-7||10
3154146|NCT01823510|3880509|FG001|STARTED|Days 1-7||10
3154147|NCT01823510|3880508|FG000|COMPLETED|Days 1-7||10
3154148|NCT01823510|3880509|FG001|COMPLETED|Days 1-7||10
3154149|NCT01823510|3880508|FG000|NOT COMPLETED|Days 1-7||0
3154150|NCT01823510|3880509|FG001|NOT COMPLETED|Days 1-7||0
3154151|NCT01823510|3880508|FG000|STARTED|Days 8-21||10
3154152|NCT01823510|3880509|FG001|STARTED|Days 8-21||10
3154153|NCT01823510|3880508|FG000|COMPLETED|Days 8-21||10
3154154|NCT01823510|3880509|FG001|COMPLETED|Days 8-21||10
3154155|NCT01823510|3880508|FG000|NOT COMPLETED|Days 8-21||0
3154156|NCT01823510|3880509|FG001|NOT COMPLETED|Days 8-21||0
3154157|NCT01823510|3880508|FG000|STARTED|Days 22-28||10
3154158|NCT01823510|3880509|FG001|STARTED|Days 22-28||10
3154159|NCT01823510|3880508|FG000|COMPLETED|Days 22-28||10
3154160|NCT01823510|3880509|FG001|COMPLETED|Days 22-28||10
3154161|NCT01823510|3880508|FG000|NOT COMPLETED|Days 22-28||0
3183899|NCT02011490|3912232|FG005|STARTED|Part 1||0
3183900|NCT02011490|3912227|FG000|COMPLETED|Part 1||8
3183901|NCT02011490|3912228|FG001|COMPLETED|Part 1||8
3183902|NCT02011490|3912229|FG002|COMPLETED|Part 1||8
3183903|NCT02011490|3912230|FG003|COMPLETED|Part 1||0
3183904|NCT02011490|3912231|FG004|COMPLETED|Part 1||0
3154162|NCT01823510|3880509|FG001|NOT COMPLETED|Days 22-28||0
3154163|NCT01823536|3880521|FG000|STARTED|Overall Study||73
3154164|NCT01823536|3880522|FG001|STARTED|Overall Study||103
3154165|NCT01823536|3880523|FG002|STARTED|Overall Study||120
3154166|NCT01823536|3880524|FG003|STARTED|Overall Study||66
3154167|NCT01823536|3880525|FG004|STARTED|Overall Study||101
3154168|NCT01823536|3880526|FG005|STARTED|Overall Study||2
3154169|NCT01823536|3880521|FG000|COMPLETED|Overall Study||71
3154170|NCT01823536|3880522|FG001|COMPLETED|Overall Study||101
3154171|NCT01823536|3880523|FG002|COMPLETED|Overall Study||119
3154172|NCT01823536|3880524|FG003|COMPLETED|Overall Study||64
3183905|NCT02011490|3912232|FG005|COMPLETED|Part 1||0
3154173|NCT01823536|3880525|FG004|COMPLETED|Overall Study||99
3154174|NCT01823536|3880526|FG005|COMPLETED|Overall Study||2
3154175|NCT01823536|3880521|FG000|NOT COMPLETED|Overall Study||2
3154176|NCT01823536|3880522|FG001|NOT COMPLETED|Overall Study||2
3154177|NCT01823536|3880523|FG002|NOT COMPLETED|Overall Study||1
3154178|NCT01823536|3880524|FG003|NOT COMPLETED|Overall Study||2
3154179|NCT01823536|3880525|FG004|NOT COMPLETED|Overall Study||2
3154180|NCT01823536|3880526|FG005|NOT COMPLETED|Overall Study||0
3154181|NCT01823614|3880545|FG000|STARTED|Overall Study||179
3154182|NCT01823614|3880546|FG001|STARTED|Overall Study||140
3154183|NCT01823614|3880547|FG002|STARTED|Overall Study||176
3154184|NCT01823614|3880548|FG003|STARTED|Overall Study||122
3154185|NCT01823614|3880549|FG004|STARTED|Overall Study||172
3154186|NCT01823614|3880550|FG005|STARTED|Overall Study||154
3154187|NCT01823614|3880545|FG000|COMPLETED|Overall Study||179
3154188|NCT01823614|3880546|FG001|COMPLETED|Overall Study||140
3154189|NCT01823614|3880547|FG002|COMPLETED|Overall Study||176
3154190|NCT01823614|3880548|FG003|COMPLETED|Overall Study||122
3154191|NCT01823614|3880549|FG004|COMPLETED|Overall Study||172
3154192|NCT01823614|3880550|FG005|COMPLETED|Overall Study||154
3154193|NCT01823614|3880545|FG000|NOT COMPLETED|Overall Study||0
3154194|NCT01823614|3880546|FG001|NOT COMPLETED|Overall Study||0
3154195|NCT01823614|3880547|FG002|NOT COMPLETED|Overall Study||0
3154196|NCT01823614|3880548|FG003|NOT COMPLETED|Overall Study||0
3154197|NCT01823614|3880549|FG004|NOT COMPLETED|Overall Study||0
3154198|NCT01823614|3880550|FG005|NOT COMPLETED|Overall Study||0
3154199|NCT01823653|3880570|FG000|STARTED|Overall Study||60
3154200|NCT01823653|3880570|FG000|COMPLETED|Overall Study||60
3154201|NCT01823653|3880570|FG000|NOT COMPLETED|Overall Study||0
3154202|NCT01823679|3880577|FG000|STARTED|Overall Study||2
3154203|NCT01823679|3880577|FG000|COMPLETED|Overall Study||1
3154204|NCT01823679|3880577|FG000|NOT COMPLETED|Overall Study||1
3154205|NCT01823835|3880597|FG000|STARTED|Overall Study||3
3154206|NCT01823835|3880598|FG001|STARTED|Overall Study||4
3154207|NCT01823835|3880599|FG002|STARTED|Overall Study||4
3154208|NCT01823835|3880600|FG003|STARTED|Overall Study||6
3154209|NCT01823835|3880601|FG004|STARTED|Overall Study||6
3154210|NCT01823835|3880602|FG005|STARTED|Overall Study||6
3154211|NCT01823835|3880603|FG006|STARTED|Overall Study||6
3154212|NCT01823835|3880604|FG007|STARTED|Overall Study||3
3154213|NCT01823835|3880605|FG008|STARTED|Overall Study||3
3154214|NCT01823835|3880606|FG009|STARTED|Overall Study||19
3154215|NCT01823835|3880607|FG010|STARTED|Overall Study||10
3154216|NCT01823835|3880608|FG011|STARTED|Overall Study||53
3154217|NCT01823835|3880609|FG012|STARTED|Overall Study||19
3154218|NCT01823835|3880610|FG013|STARTED|Overall Study||4
3154219|NCT01823835|3880611|FG014|STARTED|Overall Study||6
3154220|NCT01823835|3880597|FG000|COMPLETED|Overall Study||0
3154221|NCT01823835|3880598|FG001|COMPLETED|Overall Study||0
3154222|NCT01823835|3880599|FG002|COMPLETED|Overall Study||0
3154223|NCT01823835|3880600|FG003|COMPLETED|Overall Study||0
3154224|NCT01823835|3880601|FG004|COMPLETED|Overall Study||0
3154225|NCT01823835|3880602|FG005|COMPLETED|Overall Study||0
3154226|NCT01823835|3880603|FG006|COMPLETED|Overall Study||0
3154227|NCT01823835|3880604|FG007|COMPLETED|Overall Study||0
3154228|NCT01823835|3880605|FG008|COMPLETED|Overall Study||0
3154229|NCT01823835|3880606|FG009|COMPLETED|Overall Study||0
3154230|NCT01823835|3880607|FG010|COMPLETED|Overall Study||0
3154231|NCT01823835|3880608|FG011|COMPLETED|Overall Study||0
3154232|NCT01823835|3880609|FG012|COMPLETED|Overall Study||0
3154233|NCT01823835|3880610|FG013|COMPLETED|Overall Study||0
3154234|NCT01823835|3880611|FG014|COMPLETED|Overall Study||0
3154235|NCT01823835|3880597|FG000|NOT COMPLETED|Overall Study||3
3154236|NCT01823835|3880598|FG001|NOT COMPLETED|Overall Study||4
3154237|NCT01823835|3880599|FG002|NOT COMPLETED|Overall Study||4
3154238|NCT01823835|3880600|FG003|NOT COMPLETED|Overall Study||6
3154239|NCT01823835|3880601|FG004|NOT COMPLETED|Overall Study||6
3154240|NCT01823835|3880602|FG005|NOT COMPLETED|Overall Study||6
3154241|NCT01823835|3880603|FG006|NOT COMPLETED|Overall Study||6
3154242|NCT01823835|3880604|FG007|NOT COMPLETED|Overall Study||3
3154243|NCT01823835|3880605|FG008|NOT COMPLETED|Overall Study||3
3154244|NCT01823835|3880606|FG009|NOT COMPLETED|Overall Study||19
3154245|NCT01823835|3880607|FG010|NOT COMPLETED|Overall Study||10
3154246|NCT01823835|3880608|FG011|NOT COMPLETED|Overall Study||53
3154247|NCT01823835|3880609|FG012|NOT COMPLETED|Overall Study||19
3154248|NCT01823835|3880610|FG013|NOT COMPLETED|Overall Study||4
3154249|NCT01823835|3880611|FG014|NOT COMPLETED|Overall Study||6
3154250|NCT01823861|3880653|FG000|STARTED|4 Month Follow up||249
3154251|NCT01823861|3880654|FG001|STARTED|4 Month Follow up||251
3154252|NCT01823861|3880653|FG000|COMPLETED|4 Month Follow up||211
3154253|NCT01823861|3880654|FG001|COMPLETED|4 Month Follow up||220
3154254|NCT01823861|3880653|FG000|NOT COMPLETED|4 Month Follow up||38
3154255|NCT01823861|3880654|FG001|NOT COMPLETED|4 Month Follow up||31
3154256|NCT01823861|3880653|FG000|STARTED|12 Month Follow up||211
3154257|NCT01823861|3880654|FG001|STARTED|12 Month Follow up||220
3154258|NCT01823861|3880653|FG000|COMPLETED|12 Month Follow up||169
3154259|NCT01823861|3880654|FG001|COMPLETED|12 Month Follow up||159
3154260|NCT01823861|3880653|FG000|NOT COMPLETED|12 Month Follow up||42
3154261|NCT01823861|3880654|FG001|NOT COMPLETED|12 Month Follow up||61
3154262|NCT01823991|3880662|FG000|STARTED|Overall Study||18
3154263|NCT01823991|3880663|FG001|STARTED|Overall Study||18
3154264|NCT01823991|3880662|FG000|COMPLETED|Overall Study||10
3154265|NCT01823991|3880663|FG001|COMPLETED|Overall Study||13
3154266|NCT01823991|3880662|FG000|NOT COMPLETED|Overall Study||8
3154267|NCT01823991|3880663|FG001|NOT COMPLETED|Overall Study||5
3154268|NCT01824082|3880675|FG000|STARTED|Initial Treatment||71
3154269|NCT01824082|3880676|FG001|STARTED|Initial Treatment||73
3154270|NCT01824082|3880675|FG000|COMPLETED|Initial Treatment||71
3154271|NCT01824082|3880676|FG001|COMPLETED|Initial Treatment||73
3154272|NCT01824082|3880675|FG000|NOT COMPLETED|Initial Treatment||0
3154273|NCT01824082|3880676|FG001|NOT COMPLETED|Initial Treatment||0
3154274|NCT01824082|3880675|FG000|STARTED|Optional Crossover Treatment||40
3154275|NCT01824082|3880676|FG001|STARTED|Optional Crossover Treatment||25
3154276|NCT01824082|3880675|FG000|COMPLETED|Optional Crossover Treatment||40
3154277|NCT01824082|3880676|FG001|COMPLETED|Optional Crossover Treatment||25
3154278|NCT01824082|3880675|FG000|NOT COMPLETED|Optional Crossover Treatment||0
3154279|NCT01824082|3880676|FG001|NOT COMPLETED|Optional Crossover Treatment||0
3154280|NCT01824160|3880686|FG000|STARTED|Overall Study||50
3154281|NCT01824160|3880686|FG000|COMPLETED|Overall Study||50
3154282|NCT01824160|3880686|FG000|NOT COMPLETED|Overall Study||0
3154283|NCT01824290|3880692|FG000|STARTED|Period 1: Double Blind||18
3154284|NCT01824290|3880693|FG001|STARTED|Period 1: Double Blind||17
3154285|NCT01824290|3880694|FG002|STARTED|Period 1: Double Blind||0
3154286|NCT01824290|3880695|FG003|STARTED|Period 1: Double Blind||0
3154287|NCT01824290|3880692|FG000|Received at Least One Dose of Study Drug|Period 1: Double Blind||18
3154288|NCT01824290|3880693|FG001|Received at Least One Dose of Study Drug|Period 1: Double Blind||17
3154289|NCT01824290|3880694|FG002|Received at Least One Dose of Study Drug|Period 1: Double Blind||0
3154290|NCT01824290|3880695|FG003|Received at Least One Dose of Study Drug|Period 1: Double Blind||0
3154291|NCT01824290|3880692|FG000|Received 20 mg|Period 1: Double Blind||0
3154292|NCT01824290|3880693|FG001|Received 20 mg|Period 1: Double Blind||4
3154293|NCT01824290|3880694|FG002|Received 20 mg|Period 1: Double Blind||0
3154294|NCT01824290|3880695|FG003|Received 20 mg|Period 1: Double Blind||0
3154295|NCT01824290|3880692|FG000|Received 40 mg|Period 1: Double Blind||0
3154296|NCT01824290|3880693|FG001|Received 40 mg|Period 1: Double Blind||13
3154297|NCT01824290|3880694|FG002|Received 40 mg|Period 1: Double Blind||0
3154298|NCT01824290|3880695|FG003|Received 40 mg|Period 1: Double Blind||0
3154299|NCT01824290|3880692|FG000|COMPLETED|Period 1: Double Blind||15
3154300|NCT01824290|3880693|FG001|COMPLETED|Period 1: Double Blind||15
3154301|NCT01824290|3880694|FG002|COMPLETED|Period 1: Double Blind||0
3154302|NCT01824290|3880695|FG003|COMPLETED|Period 1: Double Blind||0
3154303|NCT01824290|3880692|FG000|NOT COMPLETED|Period 1: Double Blind||3
3154304|NCT01824290|3880693|FG001|NOT COMPLETED|Period 1: Double Blind||2
3154305|NCT01824290|3880694|FG002|NOT COMPLETED|Period 1: Double Blind||0
3154306|NCT01824290|3880695|FG003|NOT COMPLETED|Period 1: Double Blind||0
3154307|NCT01824290|3880692|FG000|STARTED|Period 2: Open-Label Treatment||0
3154308|NCT01824290|3880693|FG001|STARTED|Period 2: Open-Label Treatment||0
3154309|NCT01824290|3880694|FG002|STARTED|Period 2: Open-Label Treatment|As per the protocol, period 2 eligibility were participants who completed period 1 or experienced clinical worsening (CW) in period 1. 1 participant that had CW in period 1 continued to period 2.|16
3154310|NCT01824290|3880695|FG003|STARTED|Period 2: Open-Label Treatment|As per the protocol, period 2 eligibility were participants who completed period 1 or experienced clinical worsening (CW) in period 1. 1 participant that had CW in period 1 continued to period 2.|16
3154311|NCT01824290|3880692|FG000|Received 20 mg|Period 2: Open-Label Treatment||0
3154312|NCT01824290|3880693|FG001|Received 20 mg|Period 2: Open-Label Treatment||0
3154313|NCT01824290|3880694|FG002|Received 20 mg|Period 2: Open-Label Treatment||3
3154314|NCT01824290|3880695|FG003|Received 20 mg|Period 2: Open-Label Treatment||3
3154315|NCT01824290|3880692|FG000|Received 40 mg|Period 2: Open-Label Treatment||0
3154316|NCT01824290|3880693|FG001|Received 40 mg|Period 2: Open-Label Treatment||0
3154317|NCT01824290|3880694|FG002|Received 40 mg|Period 2: Open-Label Treatment||13
3154318|NCT01824290|3880695|FG003|Received 40 mg|Period 2: Open-Label Treatment||13
3154319|NCT01824290|3880692|FG000|COMPLETED|Period 2: Open-Label Treatment||0
3154320|NCT01824290|3880693|FG001|COMPLETED|Period 2: Open-Label Treatment||0
3154321|NCT01824290|3880694|FG002|COMPLETED|Period 2: Open-Label Treatment||13
3154322|NCT01824290|3880695|FG003|COMPLETED|Period 2: Open-Label Treatment||13
3154323|NCT01824290|3880692|FG000|NOT COMPLETED|Period 2: Open-Label Treatment||0
3154324|NCT01824290|3880693|FG001|NOT COMPLETED|Period 2: Open-Label Treatment||0
3154325|NCT01824290|3880694|FG002|NOT COMPLETED|Period 2: Open-Label Treatment||3
3154326|NCT01824290|3880695|FG003|NOT COMPLETED|Period 2: Open-Label Treatment||3
3154327|NCT01824303|3880709|FG000|STARTED|Randomized Study||16
3154328|NCT01824303|3880710|FG001|STARTED|Randomized Study||14
3154329|NCT01824303|3880709|FG000|COMPLETED|Randomized Study||14
3154330|NCT01824303|3880710|FG001|COMPLETED|Randomized Study||13
3154331|NCT01824303|3880709|FG000|NOT COMPLETED|Randomized Study||2
3154332|NCT01824303|3880710|FG001|NOT COMPLETED|Randomized Study||1
3154333|NCT01824303|3880709|FG000|STARTED|Open Label Extension|2 participants completed the Randomized Study but did not enter the Open Label Extension.|12
3183906|NCT02011490|3912227|FG000|NOT COMPLETED|Part 1||0
3183907|NCT02011490|3912228|FG001|NOT COMPLETED|Part 1||0
3183908|NCT02011490|3912229|FG002|NOT COMPLETED|Part 1||0
3183909|NCT02011490|3912230|FG003|NOT COMPLETED|Part 1||0
3183910|NCT02011490|3912231|FG004|NOT COMPLETED|Part 1||0
3183911|NCT02011490|3912232|FG005|NOT COMPLETED|Part 1||0
3183912|NCT02011490|3912227|FG000|STARTED|Part 2||0
3183913|NCT02011490|3912228|FG001|STARTED|Part 2||0
3183914|NCT02011490|3912229|FG002|STARTED|Part 2||0
3363799|NCT04046250|4094954|FG001|NOT COMPLETED|Overall Study||4
3154334|NCT01824303|3880710|FG001|STARTED|Open Label Extension|2 participants completed the Randomized Study but did not enter the Open Label Extension.|11
3154335|NCT01824303|3880709|FG000|COMPLETED|Open Label Extension||12
3154336|NCT01824303|3880710|FG001|COMPLETED|Open Label Extension||11
3154337|NCT01824303|3880709|FG000|NOT COMPLETED|Open Label Extension||0
3154338|NCT01824303|3880710|FG001|NOT COMPLETED|Open Label Extension||0
3154339|NCT01824342|3880720|FG000|STARTED|Overall Study||11
3154340|NCT01824342|3880721|FG001|STARTED|Overall Study||7
3154341|NCT01824342|3880720|FG000|COMPLETED|Overall Study||2
3154342|NCT01824342|3880721|FG001|COMPLETED|Overall Study||2
3154343|NCT01824342|3880720|FG000|NOT COMPLETED|Overall Study||9
3154344|NCT01824342|3880721|FG001|NOT COMPLETED|Overall Study||5
3154345|NCT01824355|3880727|FG000|STARTED|Overall Study||113
3154346|NCT01824355|3880727|FG000|COMPLETED|Overall Study||110
3154347|NCT01824355|3880727|FG000|NOT COMPLETED|Overall Study||3
3154348|NCT01824394|3880734|FG000|STARTED|Overall Study||174
3154349|NCT01824394|3880735|FG001|STARTED|Overall Study||169
3154350|NCT01824394|3880736|FG002|STARTED|Overall Study||125
3154351|NCT01824394|3880734|FG000|Intent to Treat Population|Overall Study||151
3154352|NCT01824394|3880735|FG001|Intent to Treat Population|Overall Study||149
3154353|NCT01824394|3880736|FG002|Intent to Treat Population|Overall Study|Calibration Roll-in patients are not included in the ITT|0
3154354|NCT01824394|3880734|FG000|Safety Population|Overall Study||151
3154355|NCT01824394|3880735|FG001|Safety Population|Overall Study||149
3154356|NCT01824394|3880736|FG002|Safety Population|Overall Study|Calibration Roll-in patients are included in the safety population|104
3154357|NCT01824394|3880734|FG000|Per-Protocol Population|Overall Study||150
3154358|NCT01824394|3880735|FG001|Per-Protocol Population|Overall Study||148
3154359|NCT01824394|3880736|FG002|Per-Protocol Population|Overall Study|Calibration Roll-in patients are not included in the per protocol population|0
3154360|NCT01824394|3880734|FG000|COMPLETED|Overall Study||55
3154361|NCT01824394|3880735|FG001|COMPLETED|Overall Study||53
3154362|NCT01824394|3880736|FG002|COMPLETED|Overall Study||51
3154363|NCT01824394|3880734|FG000|NOT COMPLETED|Overall Study||119
3154364|NCT01824394|3880735|FG001|NOT COMPLETED|Overall Study||116
3154365|NCT01824394|3880736|FG002|NOT COMPLETED|Overall Study||74
3154366|NCT01824446|3880744|FG000|STARTED|Overall Study||6
3154367|NCT01824446|3880744|FG000|COMPLETED|Overall Study||6
3154368|NCT01824446|3880744|FG000|NOT COMPLETED|Overall Study||0
3154369|NCT01824472|3880751|FG000|STARTED|Overall Study||17
3154370|NCT01824472|3880752|FG001|STARTED|Overall Study||13
3154371|NCT01824472|3880753|FG002|STARTED|Overall Study||15
3154372|NCT01824472|3880751|FG000|COMPLETED|Overall Study||16
3154373|NCT01824472|3880752|FG001|COMPLETED|Overall Study||6
3154374|NCT01824472|3880753|FG002|COMPLETED|Overall Study||11
3154375|NCT01824472|3880751|FG000|NOT COMPLETED|Overall Study||1
3154376|NCT01824472|3880752|FG001|NOT COMPLETED|Overall Study||7
3154377|NCT01824472|3880753|FG002|NOT COMPLETED|Overall Study||4
3183915|NCT02011490|3912230|FG003|STARTED|Part 2|4 had also participated in Part 1 (all in severe group)|6
3183916|NCT02011490|3912231|FG004|STARTED|Part 2|3 had also participated in Part 1 (2 in moderate, 1 in severe groups)|6
3183917|NCT02011490|3912232|FG005|STARTED|Part 2|2 had also participated in Part 1 (both in healthy group)|6
3183918|NCT02011490|3912227|FG000|COMPLETED|Part 2||0
3183919|NCT02011490|3912228|FG001|COMPLETED|Part 2||0
3183920|NCT02011490|3912229|FG002|COMPLETED|Part 2||0
3183921|NCT02011490|3912230|FG003|COMPLETED|Part 2||6
3183922|NCT02011490|3912231|FG004|COMPLETED|Part 2||6
3183923|NCT02011490|3912232|FG005|COMPLETED|Part 2||6
3183924|NCT02011490|3912227|FG000|NOT COMPLETED|Part 2||0
3183925|NCT02011490|3912228|FG001|NOT COMPLETED|Part 2||0
3183926|NCT02011490|3912229|FG002|NOT COMPLETED|Part 2||0
3183927|NCT02011490|3912230|FG003|NOT COMPLETED|Part 2||0
3183928|NCT02011490|3912231|FG004|NOT COMPLETED|Part 2||0
3183929|NCT02011490|3912232|FG005|NOT COMPLETED|Part 2||0
3183930|NCT02011516|3912248|FG000|STARTED|Overall Study||8
3183931|NCT02011516|3912249|FG001|STARTED|Overall Study||8
3183932|NCT02011516|3912248|FG000|COMPLETED|Overall Study||4
3183933|NCT02011516|3912249|FG001|COMPLETED|Overall Study||6
3183934|NCT02011516|3912248|FG000|NOT COMPLETED|Overall Study||4
3183935|NCT02011516|3912249|FG001|NOT COMPLETED|Overall Study||2
3183936|NCT02011893|3912255|FG000|STARTED|Enrollment to Randomization||173
3183937|NCT02011893|3912256|FG001|STARTED|Enrollment to Randomization||0
3183938|NCT02011893|3912257|FG002|STARTED|Enrollment to Randomization||0
3183939|NCT02011893|3912255|FG000|Baseline|Enrollment to Randomization||141
3183940|NCT02011893|3912256|FG001|Baseline|Enrollment to Randomization||0
3183941|NCT02011893|3912257|FG002|Baseline|Enrollment to Randomization||0
3183942|NCT02011893|3912255|FG000|Trial Stimulation Implant|Enrollment to Randomization||121
3183943|NCT02011893|3912256|FG001|Trial Stimulation Implant|Enrollment to Randomization||0
3183944|NCT02011893|3912257|FG002|Trial Stimulation Implant|Enrollment to Randomization||0
3183945|NCT02011893|3912255|FG000|Permanent Stimulation Implant|Enrollment to Randomization||101
3183946|NCT02011893|3912256|FG001|Permanent Stimulation Implant|Enrollment to Randomization||0
3183947|NCT02011893|3912257|FG002|Permanent Stimulation Implant|Enrollment to Randomization||0
3183948|NCT02011893|3912255|FG000|Randomization|Enrollment to Randomization||100
3183949|NCT02011893|3912256|FG001|Randomization|Enrollment to Randomization||0
3183950|NCT02011893|3912257|FG002|Randomization|Enrollment to Randomization||0
3183951|NCT02011893|3912255|FG000|COMPLETED|Enrollment to Randomization||100
3183952|NCT02011893|3912256|FG001|COMPLETED|Enrollment to Randomization||0
3183953|NCT02011893|3912257|FG002|COMPLETED|Enrollment to Randomization||0
3183954|NCT02011893|3912255|FG000|NOT COMPLETED|Enrollment to Randomization||73
3154378|NCT01824498|3880767|FG000|STARTED|1st Intervention (8 Weeks)||5
3154379|NCT01824498|3880768|FG001|STARTED|1st Intervention (8 Weeks)||2
3154380|NCT01824498|3880769|FG002|STARTED|1st Intervention (8 Weeks)||6
3154381|NCT01824498|3880770|FG003|STARTED|1st Intervention (8 Weeks)||3
3154382|NCT01824498|3880771|FG004|STARTED|1st Intervention (8 Weeks)||4
3154383|NCT01824498|3880772|FG005|STARTED|1st Intervention (8 Weeks)||4
3154384|NCT01824498|3880767|FG000|COMPLETED|1st Intervention (8 Weeks)||5
3154385|NCT01824498|3880768|FG001|COMPLETED|1st Intervention (8 Weeks)||2
3154386|NCT01824498|3880769|FG002|COMPLETED|1st Intervention (8 Weeks)||6
3154387|NCT01824498|3880770|FG003|COMPLETED|1st Intervention (8 Weeks)||3
3154388|NCT01824498|3880771|FG004|COMPLETED|1st Intervention (8 Weeks)||4
3154389|NCT01824498|3880772|FG005|COMPLETED|1st Intervention (8 Weeks)||4
3154390|NCT01824498|3880767|FG000|NOT COMPLETED|1st Intervention (8 Weeks)||0
3154391|NCT01824498|3880768|FG001|NOT COMPLETED|1st Intervention (8 Weeks)||0
3154392|NCT01824498|3880769|FG002|NOT COMPLETED|1st Intervention (8 Weeks)||0
3154393|NCT01824498|3880770|FG003|NOT COMPLETED|1st Intervention (8 Weeks)||0
3154394|NCT01824498|3880771|FG004|NOT COMPLETED|1st Intervention (8 Weeks)||0
3154395|NCT01824498|3880772|FG005|NOT COMPLETED|1st Intervention (8 Weeks)||0
3154396|NCT01824498|3880767|FG000|STARTED|Washout (8 Weeks)|2 dropped out|5
3154397|NCT01824498|3880768|FG001|STARTED|Washout (8 Weeks)||2
3154398|NCT01824498|3880769|FG002|STARTED|Washout (8 Weeks)|2 dropped out|6
3154399|NCT01824498|3880770|FG003|STARTED|Washout (8 Weeks)|1 dropped out|3
3154400|NCT01824498|3880771|FG004|STARTED|Washout (8 Weeks)|1 dropped out|4
3154401|NCT01824498|3880772|FG005|STARTED|Washout (8 Weeks)||4
3154402|NCT01824498|3880767|FG000|COMPLETED|Washout (8 Weeks)||3
3154403|NCT01824498|3880768|FG001|COMPLETED|Washout (8 Weeks)||2
3154404|NCT01824498|3880769|FG002|COMPLETED|Washout (8 Weeks)||4
3154405|NCT01824498|3880770|FG003|COMPLETED|Washout (8 Weeks)||2
3154406|NCT01824498|3880771|FG004|COMPLETED|Washout (8 Weeks)||3
3154407|NCT01824498|3880772|FG005|COMPLETED|Washout (8 Weeks)||4
3154408|NCT01824498|3880767|FG000|NOT COMPLETED|Washout (8 Weeks)||2
3154409|NCT01824498|3880768|FG001|NOT COMPLETED|Washout (8 Weeks)||0
3154410|NCT01824498|3880769|FG002|NOT COMPLETED|Washout (8 Weeks)||2
3154411|NCT01824498|3880770|FG003|NOT COMPLETED|Washout (8 Weeks)||1
3154412|NCT01824498|3880771|FG004|NOT COMPLETED|Washout (8 Weeks)||1
3154413|NCT01824498|3880772|FG005|NOT COMPLETED|Washout (8 Weeks)||0
3154414|NCT01824498|3880767|FG000|STARTED|2nd Intervention (8 Weeks)||3
3154415|NCT01824498|3880768|FG001|STARTED|2nd Intervention (8 Weeks)||2
3154416|NCT01824498|3880769|FG002|STARTED|2nd Intervention (8 Weeks)||4
3154417|NCT01824498|3880770|FG003|STARTED|2nd Intervention (8 Weeks)||2
3154418|NCT01824498|3880771|FG004|STARTED|2nd Intervention (8 Weeks)||3
3154419|NCT01824498|3880772|FG005|STARTED|2nd Intervention (8 Weeks)||4
3154420|NCT01824498|3880767|FG000|COMPLETED|2nd Intervention (8 Weeks)||3
3154421|NCT01824498|3880768|FG001|COMPLETED|2nd Intervention (8 Weeks)||2
3154422|NCT01824498|3880769|FG002|COMPLETED|2nd Intervention (8 Weeks)||4
3154423|NCT01824498|3880770|FG003|COMPLETED|2nd Intervention (8 Weeks)||2
3154424|NCT01824498|3880771|FG004|COMPLETED|2nd Intervention (8 Weeks)||3
3154425|NCT01824498|3880772|FG005|COMPLETED|2nd Intervention (8 Weeks)||4
3154426|NCT01824498|3880767|FG000|NOT COMPLETED|2nd Intervention (8 Weeks)||0
3154427|NCT01824498|3880768|FG001|NOT COMPLETED|2nd Intervention (8 Weeks)||0
3154428|NCT01824498|3880769|FG002|NOT COMPLETED|2nd Intervention (8 Weeks)||0
3154429|NCT01824498|3880770|FG003|NOT COMPLETED|2nd Intervention (8 Weeks)||0
3154430|NCT01824498|3880771|FG004|NOT COMPLETED|2nd Intervention (8 Weeks)||0
3154431|NCT01824498|3880772|FG005|NOT COMPLETED|2nd Intervention (8 Weeks)||0
3154432|NCT01824498|3880767|FG000|STARTED|Washout (8 Weeks)||3
3154433|NCT01824498|3880768|FG001|STARTED|Washout (8 Weeks)||2
3183955|NCT02011893|3912256|FG001|NOT COMPLETED|Enrollment to Randomization||0
3183956|NCT02011893|3912257|FG002|NOT COMPLETED|Enrollment to Randomization||0
3183957|NCT02011893|3912255|FG000|STARTED|Period 1 (Randomization to 12 Weeks)||0
3183958|NCT02011893|3912256|FG001|STARTED|Period 1 (Randomization to 12 Weeks)||45
3183959|NCT02011893|3912257|FG002|STARTED|Period 1 (Randomization to 12 Weeks)||55
3183960|NCT02011893|3912255|FG000|6 Week Follow-up|Period 1 (Randomization to 12 Weeks)||0
3183961|NCT02011893|3912256|FG001|6 Week Follow-up|Period 1 (Randomization to 12 Weeks)||45
3183962|NCT02011893|3912257|FG002|6 Week Follow-up|Period 1 (Randomization to 12 Weeks)||52
3183963|NCT02011893|3912255|FG000|12 Week Follow-up|Period 1 (Randomization to 12 Weeks)||0
3183964|NCT02011893|3912256|FG001|12 Week Follow-up|Period 1 (Randomization to 12 Weeks)||45
3183965|NCT02011893|3912257|FG002|12 Week Follow-up|Period 1 (Randomization to 12 Weeks)||52
3183966|NCT02011893|3912255|FG000|COMPLETED|Period 1 (Randomization to 12 Weeks)||0
3183967|NCT02011893|3912256|FG001|COMPLETED|Period 1 (Randomization to 12 Weeks)||45
3183968|NCT02011893|3912257|FG002|COMPLETED|Period 1 (Randomization to 12 Weeks)||52
3183969|NCT02011893|3912255|FG000|NOT COMPLETED|Period 1 (Randomization to 12 Weeks)||0
3183970|NCT02011893|3912256|FG001|NOT COMPLETED|Period 1 (Randomization to 12 Weeks)||0
3183971|NCT02011893|3912257|FG002|NOT COMPLETED|Period 1 (Randomization to 12 Weeks)||3
3183972|NCT02011893|3912255|FG000|STARTED|Period 2 (12 Weeks to 24 Weeks)||0
3183973|NCT02011893|3912256|FG001|STARTED|Period 2 (12 Weeks to 24 Weeks)||45
3183974|NCT02011893|3912257|FG002|STARTED|Period 2 (12 Weeks to 24 Weeks)||52
3183975|NCT02011893|3912255|FG000|18 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||0
3183976|NCT02011893|3912256|FG001|18 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||44
3183977|NCT02011893|3912257|FG002|18 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||51
3363800|NCT04047342|4094962|FG000|STARTED|Overall Study||409
3363801|NCT04047342|4094963|FG001|STARTED|Overall Study||415
3154434|NCT01824498|3880769|FG002|STARTED|Washout (8 Weeks)||4
3154435|NCT01824498|3880770|FG003|STARTED|Washout (8 Weeks)||2
3154436|NCT01824498|3880771|FG004|STARTED|Washout (8 Weeks)||3
3154437|NCT01824498|3880772|FG005|STARTED|Washout (8 Weeks)||4
3154438|NCT01824498|3880767|FG000|COMPLETED|Washout (8 Weeks)||3
3154439|NCT01824498|3880768|FG001|COMPLETED|Washout (8 Weeks)||2
3154440|NCT01824498|3880769|FG002|COMPLETED|Washout (8 Weeks)||4
3154441|NCT01824498|3880770|FG003|COMPLETED|Washout (8 Weeks)||2
3154442|NCT01824498|3880771|FG004|COMPLETED|Washout (8 Weeks)||3
3154443|NCT01824498|3880772|FG005|COMPLETED|Washout (8 Weeks)||4
3154444|NCT01824498|3880767|FG000|NOT COMPLETED|Washout (8 Weeks)||0
3154445|NCT01824498|3880768|FG001|NOT COMPLETED|Washout (8 Weeks)||0
3154446|NCT01824498|3880769|FG002|NOT COMPLETED|Washout (8 Weeks)||0
3154447|NCT01824498|3880770|FG003|NOT COMPLETED|Washout (8 Weeks)||0
3154448|NCT01824498|3880771|FG004|NOT COMPLETED|Washout (8 Weeks)||0
3154449|NCT01824498|3880772|FG005|NOT COMPLETED|Washout (8 Weeks)||0
3154450|NCT01824498|3880767|FG000|STARTED|3rd Intervention (8 Weeks)||3
3154451|NCT01824498|3880768|FG001|STARTED|3rd Intervention (8 Weeks)||2
3154452|NCT01824498|3880769|FG002|STARTED|3rd Intervention (8 Weeks)||4
3154453|NCT01824498|3880770|FG003|STARTED|3rd Intervention (8 Weeks)||2
3154454|NCT01824498|3880771|FG004|STARTED|3rd Intervention (8 Weeks)||3
3154455|NCT01824498|3880772|FG005|STARTED|3rd Intervention (8 Weeks)||4
3154456|NCT01824498|3880767|FG000|COMPLETED|3rd Intervention (8 Weeks)||3
3154457|NCT01824498|3880768|FG001|COMPLETED|3rd Intervention (8 Weeks)||2
3154458|NCT01824498|3880769|FG002|COMPLETED|3rd Intervention (8 Weeks)||4
3154459|NCT01824498|3880770|FG003|COMPLETED|3rd Intervention (8 Weeks)||2
3154460|NCT01824498|3880771|FG004|COMPLETED|3rd Intervention (8 Weeks)||3
3154461|NCT01824498|3880772|FG005|COMPLETED|3rd Intervention (8 Weeks)||4
3154462|NCT01824498|3880767|FG000|NOT COMPLETED|3rd Intervention (8 Weeks)||0
3154463|NCT01824498|3880768|FG001|NOT COMPLETED|3rd Intervention (8 Weeks)||0
3154464|NCT01824498|3880769|FG002|NOT COMPLETED|3rd Intervention (8 Weeks)||0
3154465|NCT01824498|3880770|FG003|NOT COMPLETED|3rd Intervention (8 Weeks)||0
3154466|NCT01824498|3880771|FG004|NOT COMPLETED|3rd Intervention (8 Weeks)||0
3154467|NCT01824498|3880772|FG005|NOT COMPLETED|3rd Intervention (8 Weeks)||0
3154468|NCT01824576|3880780|FG000|STARTED|Overall Study||9
3154469|NCT01824576|3880780|FG000|COMPLETED|Overall Study||7
3154470|NCT01824576|3880780|FG000|NOT COMPLETED|Overall Study||2
3154471|NCT01824589|3880788|FG000|STARTED|Overall Study||1
3154472|NCT01824589|3880789|FG001|STARTED|Overall Study||0
3154473|NCT01824589|3880790|FG002|STARTED|Overall Study||0
3154474|NCT01824589|3880791|FG003|STARTED|Overall Study||0
3154475|NCT01824589|3880788|FG000|COMPLETED|Overall Study||1
3154476|NCT01824589|3880789|FG001|COMPLETED|Overall Study||0
3154477|NCT01824589|3880790|FG002|COMPLETED|Overall Study||0
3154478|NCT01824589|3880791|FG003|COMPLETED|Overall Study||0
3154479|NCT01824589|3880788|FG000|NOT COMPLETED|Overall Study||0
3154480|NCT01824589|3880789|FG001|NOT COMPLETED|Overall Study||0
3154481|NCT01824589|3880790|FG002|NOT COMPLETED|Overall Study||0
3154482|NCT01824589|3880791|FG003|NOT COMPLETED|Overall Study||0
3154483|NCT01824602|3880805|FG000|STARTED|Overall Study||11
3154484|NCT01824602|3880806|FG001|STARTED|Overall Study||8
3154485|NCT01824602|3880807|FG002|STARTED|Overall Study||9
3154486|NCT01824602|3880808|FG003|STARTED|Overall Study||10
3154487|NCT01824602|3880805|FG000|Safety Population|Overall Study||11
3154488|NCT01824602|3880806|FG001|Safety Population|Overall Study||8
3154489|NCT01824602|3880807|FG002|Safety Population|Overall Study||9
3154490|NCT01824602|3880808|FG003|Safety Population|Overall Study||10
3154491|NCT01824602|3880805|FG000|Intent-to-treat Population|Overall Study||11
3154492|NCT01824602|3880806|FG001|Intent-to-treat Population|Overall Study||8
3154493|NCT01824602|3880807|FG002|Intent-to-treat Population|Overall Study||9
3154494|NCT01824602|3880808|FG003|Intent-to-treat Population|Overall Study||9
3154495|NCT01824602|3880805|FG000|COMPLETED|Overall Study||10
3154496|NCT01824602|3880806|FG001|COMPLETED|Overall Study||8
3154497|NCT01824602|3880807|FG002|COMPLETED|Overall Study||5
3154498|NCT01824602|3880808|FG003|COMPLETED|Overall Study||5
3154499|NCT01824602|3880805|FG000|NOT COMPLETED|Overall Study||1
3154500|NCT01824602|3880806|FG001|NOT COMPLETED|Overall Study||0
3154501|NCT01824602|3880807|FG002|NOT COMPLETED|Overall Study||4
3154502|NCT01824602|3880808|FG003|NOT COMPLETED|Overall Study||5
3154503|NCT01824693|3880821|FG000|STARTED|Overall Study||6
3154504|NCT01824693|3880822|FG001|STARTED|Overall Study||9
3154505|NCT01824693|3880823|FG002|STARTED|Overall Study||15
3154506|NCT01824693|3880821|FG000|COMPLETED|Overall Study||5
3154507|NCT01824693|3880822|FG001|COMPLETED|Overall Study||2
3154508|NCT01824693|3880823|FG002|COMPLETED|Overall Study||0
3154509|NCT01824693|3880821|FG000|NOT COMPLETED|Overall Study||1
3154510|NCT01824693|3880822|FG001|NOT COMPLETED|Overall Study||7
3154511|NCT01824693|3880823|FG002|NOT COMPLETED|Overall Study||15
3154512|NCT01824823|3880832|FG000|STARTED|Overall Study||2
3154513|NCT01824823|3880833|FG001|STARTED|Overall Study||1
3154514|NCT01824823|3880832|FG000|COMPLETED|Overall Study||0
3154515|NCT01824823|3880833|FG001|COMPLETED|Overall Study||0
3154516|NCT01824823|3880832|FG000|NOT COMPLETED|Overall Study||2
3154517|NCT01824823|3880833|FG001|NOT COMPLETED|Overall Study||1
3154518|NCT01824901|3880839|FG000|STARTED|Overall Study||2
3154519|NCT01824901|3880840|FG001|STARTED|Overall Study||0
3154520|NCT01824901|3880841|FG002|STARTED|Overall Study||0
3154521|NCT01824901|3880842|FG003|STARTED|Overall Study||0
3154522|NCT01824901|3880839|FG000|COMPLETED|Overall Study||2
3154523|NCT01824901|3880840|FG001|COMPLETED|Overall Study||0
3154524|NCT01824901|3880841|FG002|COMPLETED|Overall Study||0
3154525|NCT01824901|3880842|FG003|COMPLETED|Overall Study||0
3154526|NCT01824901|3880839|FG000|NOT COMPLETED|Overall Study||0
3154527|NCT01824901|3880840|FG001|NOT COMPLETED|Overall Study||0
3154528|NCT01824901|3880841|FG002|NOT COMPLETED|Overall Study||0
3154529|NCT01824901|3880842|FG003|NOT COMPLETED|Overall Study||0
3154530|NCT01824979|3880848|FG000|STARTED|Overall Study||50
3154531|NCT01824979|3880849|FG001|STARTED|Overall Study||50
3154532|NCT01824979|3880848|FG000|COMPLETED|Overall Study||37
3154533|NCT01824979|3880849|FG001|COMPLETED|Overall Study||37
3154534|NCT01824979|3880848|FG000|NOT COMPLETED|Overall Study||13
3154535|NCT01824979|3880849|FG001|NOT COMPLETED|Overall Study||13
3154536|NCT01825057|3880858|FG000|STARTED|Patient Study Flow||336
3154537|NCT01825057|3880859|FG001|STARTED|Patient Study Flow||379
3154538|NCT01825057|3880860|FG002|STARTED|Patient Study Flow||458
3154539|NCT01825057|3880858|FG000|COMPLETED|Patient Study Flow||336
3154540|NCT01825057|3880859|FG001|COMPLETED|Patient Study Flow||379
3154541|NCT01825057|3880860|FG002|COMPLETED|Patient Study Flow||458
3154542|NCT01825057|3880858|FG000|NOT COMPLETED|Patient Study Flow||0
3154543|NCT01825057|3880859|FG001|NOT COMPLETED|Patient Study Flow||0
3183978|NCT02011893|3912255|FG000|24 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||0
3183979|NCT02011893|3912256|FG001|24 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||45
3183980|NCT02011893|3912257|FG002|24 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||51
3183981|NCT02011893|3912255|FG000|COMPLETED|Period 2 (12 Weeks to 24 Weeks)||0
3183982|NCT02011893|3912256|FG001|COMPLETED|Period 2 (12 Weeks to 24 Weeks)||45
3183983|NCT02011893|3912257|FG002|COMPLETED|Period 2 (12 Weeks to 24 Weeks)||51
3183984|NCT02011893|3912255|FG000|NOT COMPLETED|Period 2 (12 Weeks to 24 Weeks)||0
3183985|NCT02011893|3912256|FG001|NOT COMPLETED|Period 2 (12 Weeks to 24 Weeks)||0
3183986|NCT02011893|3912257|FG002|NOT COMPLETED|Period 2 (12 Weeks to 24 Weeks)||1
3183987|NCT02011945|3912265|FG000|STARTED|Overall Study||2
3183988|NCT02011945|3912266|FG001|STARTED|Overall Study||13
3183989|NCT02011945|3912267|FG002|STARTED|Overall Study||16
3183990|NCT02011945|3912265|FG000|COMPLETED|Overall Study||0
3183991|NCT02011945|3912266|FG001|COMPLETED|Overall Study||3
3183992|NCT02011945|3912267|FG002|COMPLETED|Overall Study||6
3183993|NCT02011945|3912265|FG000|NOT COMPLETED|Overall Study||2
3183994|NCT02011945|3912266|FG001|NOT COMPLETED|Overall Study||10
3183995|NCT02011945|3912267|FG002|NOT COMPLETED|Overall Study||10
3183996|NCT02012192|3912277|FG000|STARTED|Overall Study||90
3183997|NCT02012192|3912278|FG001|STARTED|Overall Study||43
3183998|NCT02012192|3912277|FG000|COMPLETED|Overall Study||63
3183999|NCT02012192|3912278|FG001|COMPLETED|Overall Study||43
3184000|NCT02012192|3912277|FG000|NOT COMPLETED|Overall Study||27
3184001|NCT02012192|3912278|FG001|NOT COMPLETED|Overall Study||0
3184002|NCT02012218|3912289|FG000|STARTED|Overall Study||12
3184003|NCT02012218|3912290|FG001|STARTED|Overall Study||11
3184004|NCT02012218|3912291|FG002|STARTED|Overall Study||13
3184005|NCT02012218|3912292|FG003|STARTED|Overall Study||19
3184006|NCT02012218|3912293|FG004|STARTED|Overall Study||6
3184007|NCT02012218|3912289|FG000|COMPLETED|Overall Study||8
3184008|NCT02012218|3912290|FG001|COMPLETED|Overall Study||10
3184009|NCT02012218|3912291|FG002|COMPLETED|Overall Study||11
3184010|NCT02012218|3912292|FG003|COMPLETED|Overall Study||17
3184011|NCT02012218|3912293|FG004|COMPLETED|Overall Study||5
3184012|NCT02012218|3912289|FG000|NOT COMPLETED|Overall Study||4
3184013|NCT02012218|3912290|FG001|NOT COMPLETED|Overall Study||1
3184014|NCT02012218|3912291|FG002|NOT COMPLETED|Overall Study||2
3184015|NCT02012218|3912292|FG003|NOT COMPLETED|Overall Study||2
3184016|NCT02012218|3912293|FG004|NOT COMPLETED|Overall Study||1
3184017|NCT02012283|3912307|FG000|STARTED|First Intervention||10
3184018|NCT02012283|3912308|FG001|STARTED|First Intervention||10
3184019|NCT02012283|3912307|FG000|COMPLETED|First Intervention||10
3184020|NCT02012283|3912308|FG001|COMPLETED|First Intervention||10
3184021|NCT02012283|3912307|FG000|NOT COMPLETED|First Intervention||0
3184022|NCT02012283|3912308|FG001|NOT COMPLETED|First Intervention||0
3184023|NCT02012283|3912307|FG000|STARTED|Second Intervention||10
3184024|NCT02012283|3912308|FG001|STARTED|Second Intervention||10
3184025|NCT02012283|3912307|FG000|COMPLETED|Second Intervention||10
3184026|NCT02012283|3912308|FG001|COMPLETED|Second Intervention||10
3184027|NCT02012283|3912307|FG000|NOT COMPLETED|Second Intervention||0
3184028|NCT02012283|3912308|FG001|NOT COMPLETED|Second Intervention||0
3184029|NCT02012283|3912307|FG000|STARTED|Third Intervention||10
3184030|NCT02012283|3912308|FG001|STARTED|Third Intervention||10
3184031|NCT02012283|3912307|FG000|COMPLETED|Third Intervention||10
3184032|NCT02012283|3912308|FG001|COMPLETED|Third Intervention||10
3184033|NCT02012283|3912307|FG000|NOT COMPLETED|Third Intervention||0
3184034|NCT02012283|3912308|FG001|NOT COMPLETED|Third Intervention||0
3184035|NCT02012348|3912322|FG000|STARTED|Overall Study||10
3184036|NCT02012348|3912323|FG001|STARTED|Overall Study||10
3154544|NCT01825057|3880860|FG002|NOT COMPLETED|Patient Study Flow||0
3154545|NCT01825057|3880858|FG000|STARTED|Provider Study Flow||13
3154546|NCT01825057|3880859|FG001|STARTED|Provider Study Flow||12
3184037|NCT02012348|3912324|FG002|STARTED|Overall Study||10
3184038|NCT02012348|3912322|FG000|COMPLETED|Overall Study||10
3184039|NCT02012348|3912323|FG001|COMPLETED|Overall Study||10
3184040|NCT02012348|3912324|FG002|COMPLETED|Overall Study||10
3184041|NCT02012348|3912322|FG000|NOT COMPLETED|Overall Study||0
3184042|NCT02012348|3912323|FG001|NOT COMPLETED|Overall Study||0
3184043|NCT02012348|3912324|FG002|NOT COMPLETED|Overall Study||0
3154547|NCT01825057|3880860|FG002|STARTED|Provider Study Flow||13
3154548|NCT01825057|3880858|FG000|COMPLETED|Provider Study Flow||13
3154549|NCT01825057|3880859|FG001|COMPLETED|Provider Study Flow||12
3154550|NCT01825057|3880860|FG002|COMPLETED|Provider Study Flow||13
3154551|NCT01825057|3880858|FG000|NOT COMPLETED|Provider Study Flow||0
3154552|NCT01825057|3880859|FG001|NOT COMPLETED|Provider Study Flow||0
3154553|NCT01825057|3880860|FG002|NOT COMPLETED|Provider Study Flow||0
3154554|NCT01825122|3880873|FG000|STARTED|Overall Study||77
3154555|NCT01825122|3880874|FG001|STARTED|Overall Study||78
3154556|NCT01825122|3880873|FG000|COMPLETED|Overall Study||67
3154557|NCT01825122|3880874|FG001|COMPLETED|Overall Study||59
3154558|NCT01825122|3880873|FG000|NOT COMPLETED|Overall Study||10
3154559|NCT01825122|3880874|FG001|NOT COMPLETED|Overall Study||19
3154560|NCT01825200|3880882|FG000|STARTED|Overall Study||1319
3154561|NCT01825200|3880883|FG001|STARTED|Overall Study||1321
3154562|NCT01825200|3880882|FG000|COMPLETED|Overall Study||1314
3154563|NCT01825200|3880883|FG001|COMPLETED|Overall Study||1314
3154564|NCT01825200|3880882|FG000|NOT COMPLETED|Overall Study||5
3154565|NCT01825200|3880883|FG001|NOT COMPLETED|Overall Study||7
3154566|NCT01825408|3880893|FG000|STARTED|Overall Study||7
3154567|NCT01825408|3880894|FG001|STARTED|Overall Study||7
3154568|NCT01825408|3880895|FG002|STARTED|Overall Study||14
3154569|NCT01825408|3880896|FG003|STARTED|Overall Study||12
3154570|NCT01825408|3880893|FG000|COMPLETED|Overall Study||7
3154571|NCT01825408|3880894|FG001|COMPLETED|Overall Study||7
3154572|NCT01825408|3880895|FG002|COMPLETED|Overall Study||14
3154573|NCT01825408|3880896|FG003|COMPLETED|Overall Study||12
3154574|NCT01825408|3880893|FG000|NOT COMPLETED|Overall Study||0
3154575|NCT01825408|3880894|FG001|NOT COMPLETED|Overall Study||0
3154576|NCT01825408|3880895|FG002|NOT COMPLETED|Overall Study||0
3154577|NCT01825408|3880896|FG003|NOT COMPLETED|Overall Study||0
3154578|NCT01825512|3880908|FG000|STARTED|Baseline||194
3154579|NCT01825512|3880909|FG001|STARTED|Baseline||199
3154580|NCT01825512|3880908|FG000|COMPLETED|Baseline||193
3154581|NCT01825512|3880909|FG001|COMPLETED|Baseline||197
3154582|NCT01825512|3880908|FG000|NOT COMPLETED|Baseline||1
3154583|NCT01825512|3880909|FG001|NOT COMPLETED|Baseline||2
3154584|NCT01825512|3880908|FG000|STARTED|Treatment||193
3154585|NCT01825512|3880909|FG001|STARTED|Treatment||197
3154586|NCT01825512|3880908|FG000|COMPLETED|Treatment||140
3154587|NCT01825512|3880909|FG001|COMPLETED|Treatment||170
3154588|NCT01825512|3880908|FG000|NOT COMPLETED|Treatment||53
3154589|NCT01825512|3880909|FG001|NOT COMPLETED|Treatment||27
3154590|NCT01825577|3880915|FG000|STARTED|Overall Study||14
3154591|NCT01825577|3880915|FG000|COMPLETED|Overall Study||6
3154592|NCT01825577|3880915|FG000|NOT COMPLETED|Overall Study||8
3154593|NCT01825655|3880921|FG000|STARTED|Overall Study||0
3154594|NCT01825655|3880922|FG001|STARTED|Overall Study||2
3154595|NCT01825655|3880921|FG000|COMPLETED|Overall Study||0
3154596|NCT01825655|3880922|FG001|COMPLETED|Overall Study||2
3154597|NCT01825655|3880921|FG000|NOT COMPLETED|Overall Study||0
3154598|NCT01825655|3880922|FG001|NOT COMPLETED|Overall Study||0
3154599|NCT01825785|3880935|FG000|STARTED|Overall Study||12
3154600|NCT01825785|3880936|FG001|STARTED|Overall Study||6
3154601|NCT01825785|3880937|FG002|STARTED|Overall Study||6
3154602|NCT01825785|3880938|FG003|STARTED|Overall Study||6
3154603|NCT01825785|3880939|FG004|STARTED|Overall Study||6
3154604|NCT01825785|3880940|FG005|STARTED|Overall Study||6
3154605|NCT01825785|3880941|FG006|STARTED|Overall Study||6
3154606|NCT01825785|3880935|FG000|COMPLETED|Overall Study||12
3154607|NCT01825785|3880936|FG001|COMPLETED|Overall Study||6
3154608|NCT01825785|3880937|FG002|COMPLETED|Overall Study||6
3154609|NCT01825785|3880938|FG003|COMPLETED|Overall Study||6
3154610|NCT01825785|3880939|FG004|COMPLETED|Overall Study||4
3154611|NCT01825785|3880940|FG005|COMPLETED|Overall Study||5
3154612|NCT01825785|3880941|FG006|COMPLETED|Overall Study||6
3154613|NCT01825785|3880935|FG000|NOT COMPLETED|Overall Study||0
3154614|NCT01825785|3880936|FG001|NOT COMPLETED|Overall Study||0
3154615|NCT01825785|3880937|FG002|NOT COMPLETED|Overall Study||0
3154616|NCT01825785|3880938|FG003|NOT COMPLETED|Overall Study||0
3154617|NCT01825785|3880939|FG004|NOT COMPLETED|Overall Study||2
3154618|NCT01825785|3880940|FG005|NOT COMPLETED|Overall Study||1
3154619|NCT01825785|3880941|FG006|NOT COMPLETED|Overall Study||0
3154620|NCT01825798|3880965|FG000|STARTED|Overall Study||32
3154621|NCT01825798|3880966|FG001|STARTED|Overall Study||28
3154622|NCT01825798|3880965|FG000|COMPLETED|Overall Study||30
3154623|NCT01825798|3880966|FG001|COMPLETED|Overall Study||23
3154624|NCT01825798|3880965|FG000|NOT COMPLETED|Overall Study||2
3154625|NCT01825798|3880966|FG001|NOT COMPLETED|Overall Study||5
3154626|NCT01825837|3880976|FG000|STARTED|PART I||0
3154627|NCT01825837|3880977|FG001|STARTED|PART I||0
3154628|NCT01825837|3880978|FG002|STARTED|PART I||0
3154629|NCT01825837|3880979|FG003|STARTED|PART I||104
3154630|NCT01825837|3880976|FG000|Enrolled|PART I||0
3154631|NCT01825837|3880977|FG001|Enrolled|PART I||0
3154632|NCT01825837|3880978|FG002|Enrolled|PART I||0
3154633|NCT01825837|3880979|FG003|Enrolled|PART I||104
3154634|NCT01825837|3880976|FG000|Safety Population (Open-Label)|PART I||0
3154635|NCT01825837|3880977|FG001|Safety Population (Open-Label)|PART I||0
3154636|NCT01825837|3880978|FG002|Safety Population (Open-Label)|PART I||0
3154637|NCT01825837|3880979|FG003|Safety Population (Open-Label)|PART I||104
3154638|NCT01825837|3880976|FG000|COMPLETED|PART I||0
3154639|NCT01825837|3880977|FG001|COMPLETED|PART I||0
3154640|NCT01825837|3880978|FG002|COMPLETED|PART I||0
3154641|NCT01825837|3880979|FG003|COMPLETED|PART I||87
3154642|NCT01825837|3880976|FG000|NOT COMPLETED|PART I||0
3154643|NCT01825837|3880977|FG001|NOT COMPLETED|PART I||0
3154644|NCT01825837|3880978|FG002|NOT COMPLETED|PART I||0
3154645|NCT01825837|3880979|FG003|NOT COMPLETED|PART I||17
3154646|NCT01825837|3880976|FG000|STARTED|PART II||35
3154647|NCT01825837|3880977|FG001|STARTED|PART II||26
3154648|NCT01825837|3880978|FG002|STARTED|PART II||26
3154649|NCT01825837|3880979|FG003|STARTED|PART II||0
3154650|NCT01825837|3880976|FG000|Randomized Patients|PART II||35
3154651|NCT01825837|3880977|FG001|Randomized Patients|PART II||26
3154652|NCT01825837|3880978|FG002|Randomized Patients|PART II||26
3154653|NCT01825837|3880979|FG003|Randomized Patients|PART II||0
3154654|NCT01825837|3880976|FG000|Safety Population (Double-Blind)|PART II||35
3154655|NCT01825837|3880977|FG001|Safety Population (Double-Blind)|PART II||26
3154656|NCT01825837|3880978|FG002|Safety Population (Double-Blind)|PART II||26
3154657|NCT01825837|3880979|FG003|Safety Population (Double-Blind)|PART II||0
3154658|NCT01825837|3880976|FG000|Intent-to-Treat Population|PART II||34
3154659|NCT01825837|3880977|FG001|Intent-to-Treat Population|PART II||25
3154660|NCT01825837|3880978|FG002|Intent-to-Treat Population|PART II||26
3154661|NCT01825837|3880979|FG003|Intent-to-Treat Population|PART II||0
3154662|NCT01825837|3880976|FG000|Per-Protocol Population|PART II||32
3154663|NCT01825837|3880977|FG001|Per-Protocol Population|PART II||23
3154664|NCT01825837|3880978|FG002|Per-Protocol Population|PART II||24
3154665|NCT01825837|3880979|FG003|Per-Protocol Population|PART II||0
3154666|NCT01825837|3880976|FG000|COMPLETED|PART II||16
3154667|NCT01825837|3880977|FG001|COMPLETED|PART II||12
3154668|NCT01825837|3880978|FG002|COMPLETED|PART II||7
3154669|NCT01825837|3880979|FG003|COMPLETED|PART II||0
3154670|NCT01825837|3880976|FG000|NOT COMPLETED|PART II||19
3154671|NCT01825837|3880977|FG001|NOT COMPLETED|PART II||14
3184044|NCT02012452|3912334|FG000|STARTED|Overall Study||7
3184045|NCT02012452|3912335|FG001|STARTED|Overall Study||2
3184046|NCT02012452|3912334|FG000|COMPLETED|Overall Study||1
3184047|NCT02012452|3912335|FG001|COMPLETED|Overall Study||1
3184048|NCT02012452|3912334|FG000|NOT COMPLETED|Overall Study||6
3184049|NCT02012452|3912335|FG001|NOT COMPLETED|Overall Study||1
3184050|NCT02012491|3912343|FG000|STARTED|Overall Study||151
3184051|NCT02012491|3912344|FG001|STARTED|Overall Study||149
3184052|NCT02012491|3912343|FG000|COMPLETED|Overall Study||149
3184053|NCT02012491|3912344|FG001|COMPLETED|Overall Study||148
3184054|NCT02012491|3912343|FG000|NOT COMPLETED|Overall Study||2
3184055|NCT02012491|3912344|FG001|NOT COMPLETED|Overall Study||1
3184056|NCT02012582|3912354|FG000|STARTED|Overall Study||8
3184057|NCT02012582|3912355|FG001|STARTED|Overall Study||8
3184058|NCT02012582|3912356|FG002|STARTED|Overall Study||8
3184059|NCT02012582|3912357|FG003|STARTED|Overall Study||8
3184060|NCT02012582|3912354|FG000|COMPLETED|Overall Study||8
3184061|NCT02012582|3912355|FG001|COMPLETED|Overall Study||8
3184062|NCT02012582|3912356|FG002|COMPLETED|Overall Study||8
3184063|NCT02012582|3912357|FG003|COMPLETED|Overall Study||7
3184064|NCT02012582|3912354|FG000|NOT COMPLETED|Overall Study||0
3184065|NCT02012582|3912355|FG001|NOT COMPLETED|Overall Study||0
3184066|NCT02012582|3912356|FG002|NOT COMPLETED|Overall Study||0
3184067|NCT02012582|3912357|FG003|NOT COMPLETED|Overall Study||1
3184068|NCT02012621|3912367|FG000|STARTED|Overall Study||807
3184069|NCT02012621|3912367|FG000|Visit 1 Completed|Overall Study||807
3184070|NCT02012621|3912367|FG000|Visit 2 Completed|Overall Study||688
3184071|NCT02012621|3912367|FG000|Visit 3 Completed|Overall Study||444
3184072|NCT02012621|3912367|FG000|COMPLETED|Overall Study||807
3184073|NCT02012621|3912367|FG000|NOT COMPLETED|Overall Study||0
3184074|NCT02012686|3912373|FG000|STARTED|Overall Study||50
3184075|NCT02012686|3912374|FG001|STARTED|Overall Study||50
3184076|NCT02012686|3912373|FG000|COMPLETED|Overall Study||50
3184077|NCT02012686|3912374|FG001|COMPLETED|Overall Study||48
3184078|NCT02012686|3912373|FG000|NOT COMPLETED|Overall Study||0
3154672|NCT01825837|3880978|FG002|NOT COMPLETED|PART II||19
3154673|NCT01825837|3880979|FG003|NOT COMPLETED|PART II||0
3154674|NCT01825876|3880987|FG000|STARTED|Period 1||17
3184079|NCT02012686|3912374|FG001|NOT COMPLETED|Overall Study||2
3184080|NCT02012959|3912380|FG000|STARTED|Treatment Phase A||9
3184081|NCT02012959|3912381|FG001|STARTED|Treatment Phase A|Zero participants noted because participants did not start Phase B yet|0
3184082|NCT02012959|3912382|FG002|STARTED|Treatment Phase A|Zero participants noted because participants did not start Phase B yet|0
3184083|NCT02012959|3912383|FG003|STARTED|Treatment Phase A|Zero participants noted because participants did not start Phase B yet|0
3184084|NCT02012959|3912384|FG004|STARTED|Treatment Phase A|Zero participants noted because participants did not start Phase B yet|0
3184085|NCT02012959|3912380|FG000|Received At Least 1 Dose of Study Drug|Treatment Phase A||9
3184086|NCT02012959|3912381|FG001|Received At Least 1 Dose of Study Drug|Treatment Phase A||0
3184087|NCT02012959|3912382|FG002|Received At Least 1 Dose of Study Drug|Treatment Phase A||0
3184088|NCT02012959|3912383|FG003|Received At Least 1 Dose of Study Drug|Treatment Phase A||0
3184089|NCT02012959|3912384|FG004|Received At Least 1 Dose of Study Drug|Treatment Phase A||0
3184090|NCT02012959|3912380|FG000|COMPLETED|Treatment Phase A||7
3184091|NCT02012959|3912381|FG001|COMPLETED|Treatment Phase A||0
3184092|NCT02012959|3912382|FG002|COMPLETED|Treatment Phase A||0
3184093|NCT02012959|3912383|FG003|COMPLETED|Treatment Phase A||0
3184094|NCT02012959|3912384|FG004|COMPLETED|Treatment Phase A||0
3184095|NCT02012959|3912380|FG000|NOT COMPLETED|Treatment Phase A||2
3184096|NCT02012959|3912381|FG001|NOT COMPLETED|Treatment Phase A||0
3184097|NCT02012959|3912382|FG002|NOT COMPLETED|Treatment Phase A||0
3184098|NCT02012959|3912383|FG003|NOT COMPLETED|Treatment Phase A||0
3154675|NCT01825876|3880988|FG001|STARTED|Period 1||0
3154676|NCT01825876|3880987|FG000|Received 1 Dose of Study Drug|Period 1||17
3154677|NCT01825876|3880988|FG001|Received 1 Dose of Study Drug|Period 1||0
3154678|NCT01825876|3880987|FG000|COMPLETED|Period 1||17
3154679|NCT01825876|3880988|FG001|COMPLETED|Period 1||0
3154680|NCT01825876|3880987|FG000|NOT COMPLETED|Period 1||0
3154681|NCT01825876|3880988|FG001|NOT COMPLETED|Period 1||0
3154682|NCT01825876|3880987|FG000|STARTED|Period 2|Participants received a different treatment in Period 2.|0
3154683|NCT01825876|3880988|FG001|STARTED|Period 2|Participants received a different treatment in Period 1.|17
3154684|NCT01825876|3880987|FG000|Received 1 Dose of Study Drug|Period 2||0
3154685|NCT01825876|3880988|FG001|Received 1 Dose of Study Drug|Period 2||17
3154686|NCT01825876|3880987|FG000|COMPLETED|Period 2||0
3154687|NCT01825876|3880988|FG001|COMPLETED|Period 2||16
3154688|NCT01825876|3880987|FG000|NOT COMPLETED|Period 2||0
3154689|NCT01825876|3880988|FG001|NOT COMPLETED|Period 2||1
3154690|NCT01825889|3880999|FG000|STARTED|Overall Study||10
3154691|NCT01825889|3881000|FG001|STARTED|Overall Study||10
3154692|NCT01825889|3880999|FG000|Received One Dose of Study Drug|Overall Study||10
3154693|NCT01825889|3881000|FG001|Received One Dose of Study Drug|Overall Study||10
3154694|NCT01825889|3880999|FG000|COMPLETED|Overall Study||10
3154695|NCT01825889|3881000|FG001|COMPLETED|Overall Study||10
3154696|NCT01825889|3880999|FG000|NOT COMPLETED|Overall Study||0
3154697|NCT01825889|3881000|FG001|NOT COMPLETED|Overall Study||0
3154698|NCT01825941|3881008|FG000|STARTED|Overall Study||104
3154699|NCT01825941|3881009|FG001|STARTED|Overall Study||104
3154700|NCT01825941|3881008|FG000|COMPLETED|Overall Study||100
3154701|NCT01825941|3881009|FG001|COMPLETED|Overall Study||103
3154702|NCT01825941|3881008|FG000|NOT COMPLETED|Overall Study||4
3154703|NCT01825941|3881009|FG001|NOT COMPLETED|Overall Study||1
3154704|NCT01826201|3881015|FG000|STARTED|Overall Study|Subjects in each arm are same|21
3154705|NCT01826201|3881015|FG000|COMPLETED|Overall Study||17
3154706|NCT01826201|3881015|FG000|NOT COMPLETED|Overall Study||4
3184099|NCT02012959|3912384|FG004|NOT COMPLETED|Treatment Phase A||0
3184100|NCT02012959|3912380|FG000|STARTED|Treatment Phase B|Zero participants noted because participants had completed Phase A|0
3184101|NCT02012959|3912381|FG001|STARTED|Treatment Phase B|Participants in this group continued treatment with the study drug|2
3184102|NCT02012959|3912382|FG002|STARTED|Treatment Phase B|Participants in this group did not receive additional study drug after Phase A|3
3184103|NCT02012959|3912383|FG003|STARTED|Treatment Phase B|Participants in this group could continue study drug treatment, per the investigator's discretion|1
3184104|NCT02012959|3912384|FG004|STARTED|Treatment Phase B|Participants in this group could receive the investigator's preferred standard of care|1
3184105|NCT02012959|3912380|FG000|Received At Least 1 Dose of Study Drug|Treatment Phase B||0
3184106|NCT02012959|3912381|FG001|Received At Least 1 Dose of Study Drug|Treatment Phase B||2
3184107|NCT02012959|3912382|FG002|Received At Least 1 Dose of Study Drug|Treatment Phase B||3
3184108|NCT02012959|3912383|FG003|Received At Least 1 Dose of Study Drug|Treatment Phase B||1
3184109|NCT02012959|3912384|FG004|Received At Least 1 Dose of Study Drug|Treatment Phase B||1
3184110|NCT02012959|3912380|FG000|COMPLETED|Treatment Phase B||0
3184111|NCT02012959|3912381|FG001|COMPLETED|Treatment Phase B||2
3184112|NCT02012959|3912382|FG002|COMPLETED|Treatment Phase B||3
3184113|NCT02012959|3912383|FG003|COMPLETED|Treatment Phase B||1
3184114|NCT02012959|3912384|FG004|COMPLETED|Treatment Phase B||1
3184115|NCT02012959|3912380|FG000|NOT COMPLETED|Treatment Phase B||0
3184116|NCT02012959|3912381|FG001|NOT COMPLETED|Treatment Phase B||0
3184117|NCT02012959|3912382|FG002|NOT COMPLETED|Treatment Phase B||0
3184118|NCT02012959|3912383|FG003|NOT COMPLETED|Treatment Phase B||0
3184119|NCT02012959|3912384|FG004|NOT COMPLETED|Treatment Phase B||0
3184120|NCT02013037|3912394|FG000|STARTED|Overall Study||36
3184121|NCT02013037|3912394|FG000|COMPLETED|Overall Study||20
3184122|NCT02013037|3912394|FG000|NOT COMPLETED|Overall Study||16
3184123|NCT02013050|3912403|FG000|STARTED|Overall Study||42
3184124|NCT02013050|3912404|FG001|STARTED|Overall Study||41
3184125|NCT02013050|3912405|FG002|STARTED|Overall Study||3
3184126|NCT02013050|3912406|FG003|STARTED|Overall Study||23
3184127|NCT02013050|3912403|FG000|COMPLETED|Overall Study||38
3184128|NCT02013050|3912404|FG001|COMPLETED|Overall Study||36
3184129|NCT02013050|3912405|FG002|COMPLETED|Overall Study||3
3184130|NCT02013050|3912406|FG003|COMPLETED|Overall Study||19
3184131|NCT02013050|3912403|FG000|NOT COMPLETED|Overall Study||4
3184132|NCT02013050|3912404|FG001|NOT COMPLETED|Overall Study||5
3184133|NCT02013050|3912405|FG002|NOT COMPLETED|Overall Study||0
3184134|NCT02013050|3912406|FG003|NOT COMPLETED|Overall Study||4
3184135|NCT02013180|3912418|FG000|STARTED|Overall Study||119
3184136|NCT02013180|3912419|FG001|STARTED|Overall Study||361
3184137|NCT02013180|3912418|FG000|COMPLETED|Overall Study||119
3184138|NCT02013180|3912419|FG001|COMPLETED|Overall Study||361
3184139|NCT02013180|3912418|FG000|NOT COMPLETED|Overall Study||0
3184140|NCT02013180|3912419|FG001|NOT COMPLETED|Overall Study||0
3184141|NCT02013206|3912427|FG000|STARTED|Overall Study||29
3184142|NCT02013206|3912428|FG001|STARTED|Overall Study||23
3184143|NCT02013206|3912427|FG000|Received Study Drug|Overall Study||26
3184144|NCT02013206|3912428|FG001|Received Study Drug|Overall Study||23
3184145|NCT02013206|3912427|FG000|COMPLETED|Overall Study|3 Patients were on-going at clinical cut-off. Not Completed=patients who discontinued treatment.|2
3184146|NCT02013206|3912428|FG001|COMPLETED|Overall Study||1
3184147|NCT02013206|3912427|FG000|NOT COMPLETED|Overall Study||27
3184148|NCT02013206|3912428|FG001|NOT COMPLETED|Overall Study||22
3184149|NCT02013245|3912438|FG000|STARTED|Overall Study||9
3154707|NCT01826214|3881023|FG000|STARTED|Overall Study||35
3154708|NCT01826214|3881024|FG001|STARTED|Overall Study|35 patients were randomized but only 34 patients received at least one dose of study drug|34
3154709|NCT01826214|3881023|FG000|Untreated|Overall Study|Untreated = did not receive study drug|0
3154710|NCT01826214|3881024|FG001|Untreated|Overall Study|Untreated = did not receive study drug|1
3154711|NCT01826214|3881023|FG000|Treated|Overall Study|Treated = received at least one dose of study drug|35
3154712|NCT01826214|3881024|FG001|Treated|Overall Study|Treated = received at least one dose of study drug|34
3154713|NCT01826214|3881023|FG000|COMPLETED|Overall Study||0
3154714|NCT01826214|3881024|FG001|COMPLETED|Overall Study||0
3154715|NCT01826214|3881023|FG000|NOT COMPLETED|Overall Study||35
3154716|NCT01826214|3881024|FG001|NOT COMPLETED|Overall Study||34
3154717|NCT01826227|3881030|FG000|STARTED|Overall Study||5
3154718|NCT01826227|3881030|FG000|COMPLETED|Overall Study||5
3154719|NCT01826227|3881030|FG000|NOT COMPLETED|Overall Study||0
3154720|NCT01826370|3881034|FG000|STARTED|Overall Study||678
3154721|NCT01826370|3881034|FG000|COMPLETED|Overall Study||658
3154722|NCT01826370|3881034|FG000|NOT COMPLETED|Overall Study||20
3154723|NCT01826422|3881040|FG000|STARTED|Overall Study||18
3154724|NCT01826422|3881041|FG001|STARTED|Overall Study||22
3154725|NCT01826422|3881040|FG000|COMPLETED|Overall Study||17
3154726|NCT01826422|3881041|FG001|COMPLETED|Overall Study||19
3154727|NCT01826422|3881040|FG000|NOT COMPLETED|Overall Study||1
3154728|NCT01826422|3881041|FG001|NOT COMPLETED|Overall Study||3
3154729|NCT01826448|3881049|FG000|STARTED|Overall Study||4
3154730|NCT01826448|3881050|FG001|STARTED|Overall Study||9
3154731|NCT01826448|3881049|FG000|COMPLETED|Overall Study||0
3154732|NCT01826448|3881050|FG001|COMPLETED|Overall Study||0
3154733|NCT01826448|3881049|FG000|NOT COMPLETED|Overall Study||4
3154734|NCT01826448|3881050|FG001|NOT COMPLETED|Overall Study||9
3154735|NCT01826487|3881058|FG000|STARTED|Overall Study||115
3154736|NCT01826487|3881059|FG001|STARTED|Overall Study||115
3154737|NCT01826487|3881058|FG000|As-treated Population|Overall Study||115
3154738|NCT01826487|3881059|FG001|As-treated Population|Overall Study||115
3154739|NCT01826487|3881058|FG000|ITT Population|Overall Study||114
3154740|NCT01826487|3881059|FG001|ITT Population|Overall Study||114
3154741|NCT01826487|3881058|FG000|COMPLETED|Overall Study||111
3154742|NCT01826487|3881059|FG001|COMPLETED|Overall Study||110
3154743|NCT01826487|3881058|FG000|NOT COMPLETED|Overall Study||4
3154744|NCT01826487|3881059|FG001|NOT COMPLETED|Overall Study||5
3154745|NCT01826513|3881069|FG000|STARTED|Overall Study||5
3154746|NCT01826513|3881070|FG001|STARTED|Overall Study||10
3154747|NCT01826513|3881071|FG002|STARTED|Overall Study||10
3154748|NCT01826513|3881069|FG000|COMPLETED|Overall Study||5
3154749|NCT01826513|3881070|FG001|COMPLETED|Overall Study||10
3154750|NCT01826513|3881071|FG002|COMPLETED|Overall Study||10
3154751|NCT01826513|3881069|FG000|NOT COMPLETED|Overall Study||0
3154752|NCT01826513|3881070|FG001|NOT COMPLETED|Overall Study||0
3154753|NCT01826513|3881071|FG002|NOT COMPLETED|Overall Study||0
3154754|NCT01826604|3881080|FG000|STARTED|Overall Study||144
3154755|NCT01826604|3881081|FG001|STARTED|Overall Study||157
3154756|NCT01826604|3881080|FG000|COMPLETED|Overall Study||136
3154757|NCT01826604|3881081|FG001|COMPLETED|Overall Study||148
3154758|NCT01826604|3881080|FG000|NOT COMPLETED|Overall Study||8
3154759|NCT01826604|3881081|FG001|NOT COMPLETED|Overall Study||9
3154760|NCT01826812|3881089|FG000|STARTED|Overall Study||167
3154761|NCT01826812|3881090|FG001|STARTED|Overall Study||33
3154762|NCT01826812|3881089|FG000|COMPLETED|Overall Study||167
3154763|NCT01826812|3881090|FG001|COMPLETED|Overall Study||32
3154764|NCT01826812|3881089|FG000|NOT COMPLETED|Overall Study||0
3154765|NCT01826812|3881090|FG001|NOT COMPLETED|Overall Study||1
3154766|NCT01826825|3881100|FG000|STARTED|Overall Study||100
3154767|NCT01826825|3881101|FG001|STARTED|Overall Study||100
3154768|NCT01826825|3881100|FG000|COMPLETED|Overall Study||100
3154769|NCT01826825|3881101|FG001|COMPLETED|Overall Study||98
3154770|NCT01826825|3881100|FG000|NOT COMPLETED|Overall Study||0
3154771|NCT01826825|3881101|FG001|NOT COMPLETED|Overall Study||2
3154772|NCT01826851|3881111|FG000|STARTED|Overall Study||38
3154773|NCT01826851|3881112|FG001|STARTED|Overall Study||41
3154774|NCT01826851|3881111|FG000|COMPLETED|Overall Study||38
3154775|NCT01826851|3881112|FG001|COMPLETED|Overall Study||41
3154776|NCT01826851|3881111|FG000|NOT COMPLETED|Overall Study||0
3184150|NCT02013245|3912439|FG001|STARTED|Overall Study||9
3184151|NCT02013245|3912440|FG002|STARTED|Overall Study||9
3184152|NCT02013245|3912441|FG003|STARTED|Overall Study||9
3184153|NCT02013245|3912438|FG000|COMPLETED|Overall Study||9
3184154|NCT02013245|3912439|FG001|COMPLETED|Overall Study||8
3184155|NCT02013245|3912440|FG002|COMPLETED|Overall Study||9
3184156|NCT02013245|3912441|FG003|COMPLETED|Overall Study||9
3154777|NCT01826851|3881112|FG001|NOT COMPLETED|Overall Study||0
3154778|NCT01826981|3881133|FG000|STARTED|Overall Study||19
3154779|NCT01826981|3881134|FG001|STARTED|Overall Study||10
3154780|NCT01826981|3881135|FG002|STARTED|Overall Study||25
3154781|NCT01826981|3881136|FG003|STARTED|Overall Study||26
3154782|NCT01826981|3881137|FG004|STARTED|Overall Study||25
3154783|NCT01826981|3881138|FG005|STARTED|Overall Study||26
3154784|NCT01826981|3881139|FG006|STARTED|Overall Study||25
3154785|NCT01826981|3881140|FG007|STARTED|Overall Study||51
3154786|NCT01826981|3881141|FG008|STARTED|Overall Study||20
3184157|NCT02013245|3912438|FG000|NOT COMPLETED|Overall Study||0
3184158|NCT02013245|3912439|FG001|NOT COMPLETED|Overall Study||1
3154787|NCT01826981|3881142|FG009|STARTED|Overall Study||27
3154788|NCT01826981|3881143|FG010|STARTED|Overall Study||24
3154789|NCT01826981|3881144|FG011|STARTED|Overall Study||27
3154790|NCT01826981|3881145|FG012|STARTED|Overall Study||26
3154791|NCT01826981|3881146|FG013|STARTED|Overall Study||20
3154792|NCT01826981|3881147|FG014|STARTED|Overall Study||8
3154793|NCT01826981|3881133|FG000|COMPLETED|Overall Study||19
3154794|NCT01826981|3881134|FG001|COMPLETED|Overall Study||9
3154795|NCT01826981|3881135|FG002|COMPLETED|Overall Study||25
3154796|NCT01826981|3881136|FG003|COMPLETED|Overall Study||26
3154797|NCT01826981|3881137|FG004|COMPLETED|Overall Study||18
3154798|NCT01826981|3881138|FG005|COMPLETED|Overall Study||25
3154799|NCT01826981|3881139|FG006|COMPLETED|Overall Study||24
3154800|NCT01826981|3881140|FG007|COMPLETED|Overall Study||40
3154801|NCT01826981|3881141|FG008|COMPLETED|Overall Study||13
3154802|NCT01826981|3881142|FG009|COMPLETED|Overall Study||26
3154803|NCT01826981|3881143|FG010|COMPLETED|Overall Study||22
3154804|NCT01826981|3881144|FG011|COMPLETED|Overall Study||25
3154805|NCT01826981|3881145|FG012|COMPLETED|Overall Study||25
3154806|NCT01826981|3881146|FG013|COMPLETED|Overall Study||15
3154807|NCT01826981|3881147|FG014|COMPLETED|Overall Study||8
3154808|NCT01826981|3881133|FG000|NOT COMPLETED|Overall Study||0
3154809|NCT01826981|3881134|FG001|NOT COMPLETED|Overall Study||1
3154810|NCT01826981|3881135|FG002|NOT COMPLETED|Overall Study||0
3154811|NCT01826981|3881136|FG003|NOT COMPLETED|Overall Study||0
3154812|NCT01826981|3881137|FG004|NOT COMPLETED|Overall Study||7
3154813|NCT01826981|3881138|FG005|NOT COMPLETED|Overall Study||1
3154814|NCT01826981|3881139|FG006|NOT COMPLETED|Overall Study||1
3154815|NCT01826981|3881140|FG007|NOT COMPLETED|Overall Study||11
3184159|NCT02013245|3912440|FG002|NOT COMPLETED|Overall Study||0
3184160|NCT02013245|3912441|FG003|NOT COMPLETED|Overall Study||0
3184161|NCT02013375|3912451|FG000|STARTED|Overall Study||2
3184162|NCT02013375|3912451|FG000|COMPLETED|Overall Study||0
3184163|NCT02013375|3912451|FG000|NOT COMPLETED|Overall Study||2
3184164|NCT02013388|3912464|FG000|STARTED|Overall Study||9
3184165|NCT02013388|3912465|FG001|STARTED|Overall Study||6
3184166|NCT02013388|3912466|FG002|STARTED|Overall Study||6
3184167|NCT02013388|3912467|FG003|STARTED|Overall Study||6
3184168|NCT02013388|3912468|FG004|STARTED|Overall Study||6
3184169|NCT02013388|3912469|FG005|STARTED|Overall Study||6
3184170|NCT02013388|3912470|FG006|STARTED|Overall Study||6
3184171|NCT02013388|3912471|FG007|STARTED|Overall Study||4
3184172|NCT02013388|3912464|FG000|COMPLETED|Overall Study||8
3184173|NCT02013388|3912465|FG001|COMPLETED|Overall Study||6
3184174|NCT02013388|3912466|FG002|COMPLETED|Overall Study||6
3184175|NCT02013388|3912467|FG003|COMPLETED|Overall Study||6
3184176|NCT02013388|3912468|FG004|COMPLETED|Overall Study||5
3184177|NCT02013388|3912469|FG005|COMPLETED|Overall Study||6
3184178|NCT02013388|3912470|FG006|COMPLETED|Overall Study||6
3184179|NCT02013388|3912471|FG007|COMPLETED|Overall Study||4
3184180|NCT02013388|3912464|FG000|NOT COMPLETED|Overall Study||1
3184181|NCT02013388|3912465|FG001|NOT COMPLETED|Overall Study||0
3184182|NCT02013388|3912466|FG002|NOT COMPLETED|Overall Study||0
3184183|NCT02013388|3912467|FG003|NOT COMPLETED|Overall Study||0
3184184|NCT02013388|3912468|FG004|NOT COMPLETED|Overall Study||1
3184185|NCT02013388|3912469|FG005|NOT COMPLETED|Overall Study||0
3184186|NCT02013388|3912470|FG006|NOT COMPLETED|Overall Study||0
3184187|NCT02013388|3912471|FG007|NOT COMPLETED|Overall Study||0
3184188|NCT02013531|3912493|FG000|STARTED|Overall Study||37
3184189|NCT02013531|3912493|FG000|COMPLETED|Overall Study||32
3184190|NCT02013531|3912493|FG000|NOT COMPLETED|Overall Study||5
3184191|NCT02013544|3912499|FG000|STARTED|Overall Study||182
3184192|NCT02013544|3912500|FG001|STARTED|Overall Study||376
3184193|NCT02013544|3912499|FG000|Safety Population|Overall Study||180
3184194|NCT02013544|3912500|FG001|Safety Population|Overall Study||374
3363802|NCT04047342|4094962|FG000|COMPLETED|Overall Study||409
3363803|NCT04047342|4094963|FG001|COMPLETED|Overall Study||415
3363804|NCT04047342|4094962|FG000|NOT COMPLETED|Overall Study||0
3363805|NCT04047342|4094963|FG001|NOT COMPLETED|Overall Study||0
3363806|NCT04044352|4094969|FG000|STARTED|Overall Study||76
3363807|NCT04044352|4094969|FG000|COMPLETED|Overall Study||65
3363808|NCT04044352|4094969|FG000|NOT COMPLETED|Overall Study||11
3363809|NCT04043728|4094977|FG000|STARTED|Overall Study||6
3363810|NCT04043728|4094978|FG001|STARTED|Overall Study||6
3363811|NCT04043728|4094979|FG002|STARTED|Overall Study||6
3363812|NCT04043728|4094977|FG000|COMPLETED|Overall Study||5
3363813|NCT04043728|4094978|FG001|COMPLETED|Overall Study||4
3363814|NCT04043728|4094979|FG002|COMPLETED|Overall Study||6
3363815|NCT04043728|4094977|FG000|NOT COMPLETED|Overall Study||1
3363816|NCT04043728|4094978|FG001|NOT COMPLETED|Overall Study||2
3363817|NCT04043728|4094979|FG002|NOT COMPLETED|Overall Study||0
3154816|NCT01826981|3881141|FG008|NOT COMPLETED|Overall Study||7
3154817|NCT01826981|3881142|FG009|NOT COMPLETED|Overall Study||1
3154818|NCT01826981|3881143|FG010|NOT COMPLETED|Overall Study||2
3363818|NCT04041453|4094991|FG000|STARTED|Overall Study||38
3363819|NCT04041453|4094992|FG001|STARTED|Overall Study||57
3363820|NCT04041453|4094993|FG002|STARTED|Overall Study||23
3154819|NCT01826981|3881144|FG011|NOT COMPLETED|Overall Study||2
3154820|NCT01826981|3881145|FG012|NOT COMPLETED|Overall Study||1
3154821|NCT01826981|3881146|FG013|NOT COMPLETED|Overall Study||5
3154822|NCT01826981|3881147|FG014|NOT COMPLETED|Overall Study||0
3184195|NCT02013544|3912499|FG000|ITT Population|Overall Study||157
3363821|NCT04041453|4094994|FG003|STARTED|Overall Study||58
3363822|NCT04041453|4094991|FG000|Safety Population|Overall Study||38
3154823|NCT01827046|3881185|FG000|STARTED|Overall Study||250
3154824|NCT01827046|3881186|FG001|STARTED|Overall Study||249
3154825|NCT01827046|3881185|FG000|COMPLETED|Overall Study||249
3154826|NCT01827046|3881186|FG001|COMPLETED|Overall Study||240
3154827|NCT01827046|3881185|FG000|NOT COMPLETED|Overall Study||1
3154828|NCT01827046|3881186|FG001|NOT COMPLETED|Overall Study||9
3154829|NCT01827163|3881192|FG000|STARTED|Overall Study||20
3154830|NCT01827163|3881192|FG000|COMPLETED|Overall Study||9
3154831|NCT01827163|3881192|FG000|NOT COMPLETED|Overall Study||11
3154832|NCT01827254|3881196|FG000|STARTED|Overall Study||61
3154833|NCT01827254|3881196|FG000|Evaluable Population|Overall Study||52
3154834|NCT01827254|3881196|FG000|COMPLETED|Overall Study||2
3154835|NCT01827254|3881196|FG000|NOT COMPLETED|Overall Study||59
3154836|NCT01827267|3881206|FG000|STARTED|Overall Study|18 subjects were randomized but 17 received treatment.|18
3154837|NCT01827267|3881207|FG001|STARTED|Overall Study|44 subjects were randomized; 43 subjects were treated.|44
3154838|NCT01827267|3881206|FG000|Received Study Drug|Overall Study||17
3154839|NCT01827267|3881207|FG001|Received Study Drug|Overall Study||43
3154840|NCT01827267|3881206|FG000|Crossed Over to Neratinib + Temsirolimus|Overall Study||11
3154841|NCT01827267|3881207|FG001|Crossed Over to Neratinib + Temsirolimus|Overall Study||0
3154842|NCT01827267|3881206|FG000|COMPLETED|Overall Study||13
3154843|NCT01827267|3881207|FG001|COMPLETED|Overall Study||32
3154844|NCT01827267|3881206|FG000|NOT COMPLETED|Overall Study||5
3154845|NCT01827267|3881207|FG001|NOT COMPLETED|Overall Study||12
3154846|NCT01827306|3881216|FG000|STARTED|Overall Study||21
3154847|NCT01827306|3881217|FG001|STARTED|Overall Study||13
3154848|NCT01827306|3881216|FG000|COMPLETED|Overall Study||10
3154849|NCT01827306|3881217|FG001|COMPLETED|Overall Study||8
3154850|NCT01827306|3881216|FG000|NOT COMPLETED|Overall Study||11
3154851|NCT01827306|3881217|FG001|NOT COMPLETED|Overall Study||5
3154852|NCT01827319|3881223|FG000|STARTED|Overall Study||203
3154853|NCT01827319|3881223|FG000|COMPLETED|Overall Study||200
3154854|NCT01827319|3881223|FG000|NOT COMPLETED|Overall Study||3
3154855|NCT01827332|3881229|FG000|STARTED|Overall Study||8
3154856|NCT01827332|3881230|FG001|STARTED|Overall Study||8
3154857|NCT01827332|3881229|FG000|COMPLETED|Overall Study||6
3154858|NCT01827332|3881230|FG001|COMPLETED|Overall Study||7
3154859|NCT01827332|3881229|FG000|NOT COMPLETED|Overall Study||2
3154860|NCT01827332|3881230|FG001|NOT COMPLETED|Overall Study||1
3154861|NCT01827358|3881238|FG000|STARTED|Overall Study||80
3154862|NCT01827358|3881239|FG001|STARTED|Overall Study||75
3154863|NCT01827358|3881238|FG000|COMPLETED|Overall Study||45
3154864|NCT01827358|3881239|FG001|COMPLETED|Overall Study||44
3154865|NCT01827358|3881238|FG000|NOT COMPLETED|Overall Study||35
3154866|NCT01827358|3881239|FG001|NOT COMPLETED|Overall Study||31
3154867|NCT01827371|3881249|FG000|STARTED|Overall Study||115
3154868|NCT01827371|3881250|FG001|STARTED|Overall Study||96
3154869|NCT01827371|3881251|FG002|STARTED|Overall Study||104
3154870|NCT01827371|3881252|FG003|STARTED|Overall Study||120
3154871|NCT01827371|3881249|FG000|COMPLETED|Overall Study||102
3154872|NCT01827371|3881250|FG001|COMPLETED|Overall Study||89
3154873|NCT01827371|3881251|FG002|COMPLETED|Overall Study||93
3154874|NCT01827371|3881252|FG003|COMPLETED|Overall Study||97
3154875|NCT01827371|3881249|FG000|NOT COMPLETED|Overall Study||13
3154876|NCT01827371|3881250|FG001|NOT COMPLETED|Overall Study||7
3154877|NCT01827371|3881251|FG002|NOT COMPLETED|Overall Study||11
3154878|NCT01827371|3881252|FG003|NOT COMPLETED|Overall Study||23
3154879|NCT01827462|3881265|FG000|STARTED|Overall Study||59
3154880|NCT01827462|3881266|FG001|STARTED|Overall Study||37
3154881|NCT01827462|3881267|FG002|STARTED|Overall Study||40
3154882|NCT01827462|3881265|FG000|COMPLETED|Overall Study||18
3154883|NCT01827462|3881266|FG001|COMPLETED|Overall Study||19
3154884|NCT01827462|3881267|FG002|COMPLETED|Overall Study||12
3154885|NCT01827462|3881265|FG000|NOT COMPLETED|Overall Study||41
3154886|NCT01827462|3881266|FG001|NOT COMPLETED|Overall Study||18
3154887|NCT01827462|3881267|FG002|NOT COMPLETED|Overall Study||28
3154888|NCT01827475|3881281|FG000|STARTED|Overall Study||30
3154889|NCT01827475|3881282|FG001|STARTED|Overall Study||30
3154890|NCT01827475|3881283|FG002|STARTED|Overall Study||30
3154891|NCT01827475|3881281|FG000|COMPLETED|Overall Study||30
3154892|NCT01827475|3881282|FG001|COMPLETED|Overall Study||30
3154893|NCT01827475|3881283|FG002|COMPLETED|Overall Study||30
3154894|NCT01827475|3881281|FG000|NOT COMPLETED|Overall Study||0
3154895|NCT01827475|3881282|FG001|NOT COMPLETED|Overall Study||0
3154896|NCT01827475|3881283|FG002|NOT COMPLETED|Overall Study||0
3154897|NCT01827592|3881294|FG000|STARTED|Overall Study|Randomized patients.|126
3154898|NCT01827592|3881295|FG001|STARTED|Overall Study|Randomized patients.|126
3154899|NCT01827592|3881296|FG002|STARTED|Overall Study|Randomized patients.|124
3154900|NCT01827592|3881294|FG000|Safety Analysis Set|Overall Study|1 patient withdrew consent before getting the treatment.|125
3154901|NCT01827592|3881295|FG001|Safety Analysis Set|Overall Study||126
3154902|NCT01827592|3881296|FG002|Safety Analysis Set|Overall Study||124
3154903|NCT01827592|3881294|FG000|COMPLETED|Overall Study||52
3154904|NCT01827592|3881295|FG001|COMPLETED|Overall Study||46
3154905|NCT01827592|3881296|FG002|COMPLETED|Overall Study||48
3154906|NCT01827592|3881294|FG000|NOT COMPLETED|Overall Study||74
3154907|NCT01827592|3881295|FG001|NOT COMPLETED|Overall Study||80
3154908|NCT01827592|3881296|FG002|NOT COMPLETED|Overall Study||76
3154909|NCT01827670|3881306|FG000|STARTED|Overall Study||60
3154910|NCT01827670|3881307|FG001|STARTED|Overall Study||59
3154911|NCT01827670|3881306|FG000|COMPLETED|Overall Study||57
3154912|NCT01827670|3881307|FG001|COMPLETED|Overall Study||56
3154913|NCT01827670|3881306|FG000|NOT COMPLETED|Overall Study||3
3154914|NCT01827670|3881307|FG001|NOT COMPLETED|Overall Study||3
3154915|NCT01827787|3881320|FG000|STARTED|Overall Study||45
3154916|NCT01827787|3881321|FG001|STARTED|Overall Study||38
3154917|NCT01827787|3881320|FG000|COMPLETED|Overall Study||45
3154918|NCT01827787|3881321|FG001|COMPLETED|Overall Study||38
3154919|NCT01827787|3881320|FG000|NOT COMPLETED|Overall Study||0
3154920|NCT01827787|3881321|FG001|NOT COMPLETED|Overall Study||0
3154921|NCT01827839|3881330|FG000|STARTED|Overall Study||96
3154922|NCT01827839|3881330|FG000|COMPLETED|Overall Study||93
3154923|NCT01827839|3881330|FG000|NOT COMPLETED|Overall Study||3
3154924|NCT01827930|3881344|FG000|STARTED|Overall Study||24
3154925|NCT01827930|3881345|FG001|STARTED|Overall Study||25
3154926|NCT01827930|3881346|FG002|STARTED|Overall Study||19
3154927|NCT01827930|3881344|FG000|COMPLETED|Overall Study||24
3154928|NCT01827930|3881345|FG001|COMPLETED|Overall Study||25
3154929|NCT01827930|3881346|FG002|COMPLETED|Overall Study||19
3154930|NCT01827930|3881344|FG000|NOT COMPLETED|Overall Study||0
3154931|NCT01827930|3881345|FG001|NOT COMPLETED|Overall Study||0
3154932|NCT01827930|3881346|FG002|NOT COMPLETED|Overall Study||0
3154933|NCT01827943|3881354|FG000|STARTED|Overall Study||54
3154934|NCT01827943|3881354|FG000|Safety Population|Overall Study||53
3154935|NCT01827943|3881354|FG000|COMPLETED|Overall Study||45
3154936|NCT01827943|3881354|FG000|NOT COMPLETED|Overall Study||9
3154937|NCT01828034|3881362|FG000|STARTED|Overall Study||3
3154938|NCT01828034|3881363|FG001|STARTED|Overall Study||6
3154939|NCT01828034|3881364|FG002|STARTED|Overall Study||3
3154940|NCT01828034|3881365|FG003|STARTED|Overall Study||30
3154941|NCT01828034|3881362|FG000|COMPLETED|Overall Study||3
3154942|NCT01828034|3881363|FG001|COMPLETED|Overall Study||6
3154943|NCT01828034|3881364|FG002|COMPLETED|Overall Study||3
3154944|NCT01828034|3881365|FG003|COMPLETED|Overall Study||29
3154945|NCT01828034|3881362|FG000|NOT COMPLETED|Overall Study||0
3184196|NCT02013544|3912500|FG001|ITT Population|Overall Study||325
3184197|NCT02013544|3912499|FG000|COMPLETED|Overall Study||171
3184198|NCT02013544|3912500|FG001|COMPLETED|Overall Study||356
3184199|NCT02013544|3912499|FG000|NOT COMPLETED|Overall Study||11
3184200|NCT02013544|3912500|FG001|NOT COMPLETED|Overall Study||20
3184201|NCT02013609|3912506|FG000|STARTED|Overall Study|One participant out of 48 participants enrolled had discontinued before receiving study medication.|47
3184202|NCT02013609|3912506|FG000|COMPLETED|Overall Study||29
3184203|NCT02013609|3912506|FG000|NOT COMPLETED|Overall Study||18
3184204|NCT02013622|3912510|FG000|STARTED|Overall Study||49
3184205|NCT02013622|3912510|FG000|COMPLETED|Overall Study||25
3184206|NCT02013622|3912510|FG000|NOT COMPLETED|Overall Study||24
3184207|NCT02013674|3912516|FG000|STARTED|Overall Study||15
3184208|NCT02013674|3912517|FG001|STARTED|Overall Study||15
3184209|NCT02013674|3912516|FG000|COMPLETED|Overall Study||14
3184210|NCT02013674|3912517|FG001|COMPLETED|Overall Study||14
3184211|NCT02013674|3912516|FG000|NOT COMPLETED|Overall Study||1
3184212|NCT02013674|3912517|FG001|NOT COMPLETED|Overall Study||1
3184213|NCT02013687|3912527|FG000|STARTED|Overall Study||6
3184214|NCT02013687|3912528|FG001|STARTED|Overall Study||6
3184215|NCT02013687|3912529|FG002|STARTED|Overall Study||16
3184216|NCT02013687|3912530|FG003|STARTED|Overall Study||16
3184217|NCT02013687|3912527|FG000|COMPLETED|Overall Study||6
3184218|NCT02013687|3912528|FG001|COMPLETED|Overall Study||6
3184219|NCT02013687|3912529|FG002|COMPLETED|Overall Study||14
3184220|NCT02013687|3912530|FG003|COMPLETED|Overall Study||14
3184221|NCT02013687|3912527|FG000|NOT COMPLETED|Overall Study||0
3184222|NCT02013687|3912528|FG001|NOT COMPLETED|Overall Study||0
3184223|NCT02013687|3912529|FG002|NOT COMPLETED|Overall Study||2
3184224|NCT02013687|3912530|FG003|NOT COMPLETED|Overall Study||2
3184225|NCT02013765|3912544|FG000|STARTED|Overall Study||5
3184226|NCT02013765|3912544|FG000|COMPLETED|Overall Study||4
3184227|NCT02013765|3912544|FG000|NOT COMPLETED|Overall Study||1
3184228|NCT02013778|3912548|FG000|STARTED|Overall Study||8
3184229|NCT02013778|3912548|FG000|COMPLETED|Overall Study||1
3184230|NCT02013778|3912548|FG000|NOT COMPLETED|Overall Study||7
3184231|NCT02013791|3912561|FG000|STARTED|Period 1||8
3184232|NCT02013791|3912562|FG001|STARTED|Period 1||8
3184233|NCT02013791|3912563|FG002|STARTED|Period 1||4
3184234|NCT02013791|3912564|FG003|STARTED|Period 1||8
3184235|NCT02013791|3912565|FG004|STARTED|Period 1||4
3184236|NCT02013791|3912566|FG005|STARTED|Period 1||8
3184237|NCT02013791|3912567|FG006|STARTED|Period 1||4
3184238|NCT02013791|3912568|FG007|STARTED|Period 1||8
3184239|NCT02013791|3912569|FG008|STARTED|Period 1||3
3184240|NCT02013791|3912561|FG000|COMPLETED|Period 1||8
3154946|NCT01828034|3881363|FG001|NOT COMPLETED|Overall Study||0
3154947|NCT01828034|3881364|FG002|NOT COMPLETED|Overall Study||0
3154948|NCT01828034|3881365|FG003|NOT COMPLETED|Overall Study||1
3154949|NCT01828073|3881374|FG000|STARTED|Overall Study||22
3154950|NCT01828073|3881375|FG001|STARTED|Overall Study||18
3154951|NCT01828073|3881374|FG000|COMPLETED|Overall Study||21
3154952|NCT01828073|3881375|FG001|COMPLETED|Overall Study||16
3184241|NCT02013791|3912562|FG001|COMPLETED|Period 1||6
3184242|NCT02013791|3912563|FG002|COMPLETED|Period 1||4
3184243|NCT02013791|3912564|FG003|COMPLETED|Period 1||7
3184244|NCT02013791|3912565|FG004|COMPLETED|Period 1||4
3184245|NCT02013791|3912566|FG005|COMPLETED|Period 1||8
3184246|NCT02013791|3912567|FG006|COMPLETED|Period 1||3
3184247|NCT02013791|3912568|FG007|COMPLETED|Period 1||7
3154953|NCT01828073|3881374|FG000|NOT COMPLETED|Overall Study||1
3154954|NCT01828073|3881375|FG001|NOT COMPLETED|Overall Study||2
3154955|NCT01828112|3881389|FG000|STARTED|Overall Study||115
3154956|NCT01828112|3881390|FG001|STARTED|Overall Study||116
3154957|NCT01828112|3881389|FG000|Entered Extension Treatment Phase|Overall Study||0
3154958|NCT01828112|3881390|FG001|Entered Extension Treatment Phase|Overall Study||74
3154959|NCT01828112|3881389|FG000|Entered Post-treatment Follow-up Phase|Overall Study||7
3154960|NCT01828112|3881390|FG001|Entered Post-treatment Follow-up Phase|Overall Study||5
3154961|NCT01828112|3881389|FG000|Entered Survival Follow-up Phase|Overall Study||61
3154962|NCT01828112|3881390|FG001|Entered Survival Follow-up Phase|Overall Study||19
3154963|NCT01828112|3881389|FG000|Discontinued From Study|Overall Study||14
3154964|NCT01828112|3881390|FG001|Discontinued From Study|Overall Study||10
3154965|NCT01828112|3881389|FG000|Untreated Patients|Overall Study||0
3154966|NCT01828112|3881390|FG001|Untreated Patients|Overall Study|untreated = did not receive study drug|3
3154967|NCT01828112|3881389|FG000|Untreated|Overall Study||0
3154968|NCT01828112|3881390|FG001|Untreated|Overall Study||3
3154969|NCT01828112|3881389|FG000|Treated|Overall Study||115
3154970|NCT01828112|3881390|FG001|Treated|Overall Study||113
3154971|NCT01828112|3881389|FG000|COMPLETED|Overall Study|Completed = Ongoing at time of data cut-off of 26-Jan-2016|33
3154972|NCT01828112|3881390|FG001|COMPLETED|Overall Study|Completed = Ongoing at time of data cut-off of 26-Jan-2016|8
3154973|NCT01828112|3881389|FG000|NOT COMPLETED|Overall Study||82
3154974|NCT01828112|3881390|FG001|NOT COMPLETED|Overall Study||108
3154975|NCT01828164|3881396|FG000|STARTED|Overall Study|11 out of 60 subjects did not meet inclusion criteria after enrollment.|49
3154976|NCT01828164|3881396|FG000|COMPLETED|Overall Study||32
3154977|NCT01828164|3881396|FG000|NOT COMPLETED|Overall Study||17
3154978|NCT01828216|3881406|FG000|STARTED|Overall Study||159
3154979|NCT01828216|3881407|FG001|STARTED|Overall Study||157
3154980|NCT01828216|3881406|FG000|COMPLETED|Overall Study||159
3154981|NCT01828216|3881407|FG001|COMPLETED|Overall Study||157
3154982|NCT01828216|3881406|FG000|NOT COMPLETED|Overall Study||0
3154983|NCT01828216|3881407|FG001|NOT COMPLETED|Overall Study||0
3154984|NCT01828255|3881417|FG000|STARTED|Overall Study||20
3154985|NCT01828255|3881418|FG001|STARTED|Overall Study||20
3154986|NCT01828255|3881417|FG000|COMPLETED|Overall Study||20
3154987|NCT01828255|3881418|FG001|COMPLETED|Overall Study||20
3154988|NCT01828255|3881417|FG000|NOT COMPLETED|Overall Study||0
3154989|NCT01828255|3881418|FG001|NOT COMPLETED|Overall Study||0
3154990|NCT01828281|3881428|FG000|STARTED|Overall Study||45
3154991|NCT01828281|3881429|FG001|STARTED|Overall Study||45
3154992|NCT01828281|3881428|FG000|COMPLETED|Overall Study||44
3154993|NCT01828281|3881429|FG001|COMPLETED|Overall Study||45
3154994|NCT01828281|3881428|FG000|NOT COMPLETED|Overall Study||1
3154995|NCT01828281|3881429|FG001|NOT COMPLETED|Overall Study||0
3154996|NCT01828476|3881438|FG000|STARTED|Overall Study||13
3154997|NCT01828476|3881439|FG001|STARTED|Overall Study||0
3154998|NCT01828476|3881438|FG000|COMPLETED|Overall Study||13
3154999|NCT01828476|3881439|FG001|COMPLETED|Overall Study||0
3155000|NCT01828476|3881438|FG000|NOT COMPLETED|Overall Study||0
3155001|NCT01828476|3881439|FG001|NOT COMPLETED|Overall Study||0
3155002|NCT01828515|3881447|FG000|STARTED|First Intervention (19 Days)||13
3155003|NCT01828515|3881448|FG001|STARTED|First Intervention (19 Days)||11
3155004|NCT01828515|3881447|FG000|COMPLETED|First Intervention (19 Days)||11
3155005|NCT01828515|3881448|FG001|COMPLETED|First Intervention (19 Days)||9
3155006|NCT01828515|3881447|FG000|NOT COMPLETED|First Intervention (19 Days)||2
3155007|NCT01828515|3881448|FG001|NOT COMPLETED|First Intervention (19 Days)||2
3184248|NCT02013791|3912569|FG008|COMPLETED|Period 1||3
3184249|NCT02013791|3912561|FG000|NOT COMPLETED|Period 1||0
3184250|NCT02013791|3912562|FG001|NOT COMPLETED|Period 1||2
3184251|NCT02013791|3912563|FG002|NOT COMPLETED|Period 1||0
3184252|NCT02013791|3912564|FG003|NOT COMPLETED|Period 1||1
3184253|NCT02013791|3912565|FG004|NOT COMPLETED|Period 1||0
3184254|NCT02013791|3912566|FG005|NOT COMPLETED|Period 1||0
3184255|NCT02013791|3912567|FG006|NOT COMPLETED|Period 1||1
3184256|NCT02013791|3912568|FG007|NOT COMPLETED|Period 1||1
3184257|NCT02013791|3912569|FG008|NOT COMPLETED|Period 1||0
3184258|NCT02013791|3912561|FG000|STARTED|Period 2||0
3184259|NCT02013791|3912562|FG001|STARTED|Period 2||0
3184260|NCT02013791|3912563|FG002|STARTED|Period 2||2
3184261|NCT02013791|3912564|FG003|STARTED|Period 2||0
3184262|NCT02013791|3912565|FG004|STARTED|Period 2||0
3184263|NCT02013791|3912566|FG005|STARTED|Period 2||0
3184264|NCT02013791|3912567|FG006|STARTED|Period 2||3
3184265|NCT02013791|3912568|FG007|STARTED|Period 2||0
3184266|NCT02013791|3912569|FG008|STARTED|Period 2||0
3184267|NCT02013791|3912561|FG000|COMPLETED|Period 2||0
3184268|NCT02013791|3912562|FG001|COMPLETED|Period 2||0
3184269|NCT02013791|3912563|FG002|COMPLETED|Period 2||2
3184270|NCT02013791|3912564|FG003|COMPLETED|Period 2||0
3184271|NCT02013791|3912565|FG004|COMPLETED|Period 2||0
3184272|NCT02013791|3912566|FG005|COMPLETED|Period 2||0
3184273|NCT02013791|3912567|FG006|COMPLETED|Period 2||3
3184274|NCT02013791|3912568|FG007|COMPLETED|Period 2||0
3184275|NCT02013791|3912569|FG008|COMPLETED|Period 2||0
3184276|NCT02013791|3912561|FG000|NOT COMPLETED|Period 2||0
3184277|NCT02013791|3912562|FG001|NOT COMPLETED|Period 2||0
3184278|NCT02013791|3912563|FG002|NOT COMPLETED|Period 2||0
3184279|NCT02013791|3912564|FG003|NOT COMPLETED|Period 2||0
3184280|NCT02013791|3912565|FG004|NOT COMPLETED|Period 2||0
3184281|NCT02013791|3912566|FG005|NOT COMPLETED|Period 2||0
3184282|NCT02013791|3912567|FG006|NOT COMPLETED|Period 2||0
3155008|NCT01828515|3881447|FG000|STARTED|Washout (23 Days)||11
3155009|NCT01828515|3881448|FG001|STARTED|Washout (23 Days)||9
3155010|NCT01828515|3881447|FG000|COMPLETED|Washout (23 Days)||6
3155011|NCT01828515|3881448|FG001|COMPLETED|Washout (23 Days)||8
3155012|NCT01828515|3881447|FG000|NOT COMPLETED|Washout (23 Days)||5
3155013|NCT01828515|3881448|FG001|NOT COMPLETED|Washout (23 Days)||1
3155014|NCT01828515|3881447|FG000|STARTED|Second Intervention (19 Days)||6
3155015|NCT01828515|3881448|FG001|STARTED|Second Intervention (19 Days)||8
3155016|NCT01828515|3881447|FG000|COMPLETED|Second Intervention (19 Days)||6
3155017|NCT01828515|3881448|FG001|COMPLETED|Second Intervention (19 Days)||5
3155018|NCT01828515|3881447|FG000|NOT COMPLETED|Second Intervention (19 Days)||0
3155019|NCT01828515|3881448|FG001|NOT COMPLETED|Second Intervention (19 Days)||3
3155020|NCT01828554|3881454|FG000|STARTED|Overall Study||8
3155021|NCT01828554|3881454|FG000|COMPLETED|Overall Study||8
3155022|NCT01828554|3881454|FG000|NOT COMPLETED|Overall Study||0
3155023|NCT01828567|3881460|FG000|STARTED|Overall Study||208
3155024|NCT01828567|3881461|FG001|STARTED|Overall Study||209
3155025|NCT01828567|3881460|FG000|1 Month|Overall Study||172
3155026|NCT01828567|3881461|FG001|1 Month|Overall Study||192
3155027|NCT01828567|3881460|FG000|COMPLETED|Overall Study||177
3155028|NCT01828567|3881461|FG001|COMPLETED|Overall Study||199
3155029|NCT01828567|3881460|FG000|NOT COMPLETED|Overall Study||31
3155030|NCT01828567|3881461|FG001|NOT COMPLETED|Overall Study||10
3155031|NCT01828593|3881470|FG000|STARTED|Placebo-Controlled Phase||36
3155032|NCT01828593|3881471|FG001|STARTED|Placebo-Controlled Phase||34
3155033|NCT01828593|3881472|FG002|STARTED|Placebo-Controlled Phase||33
3155034|NCT01828593|3881470|FG000|COMPLETED|Placebo-Controlled Phase||36
3155035|NCT01828593|3881471|FG001|COMPLETED|Placebo-Controlled Phase||34
3155036|NCT01828593|3881472|FG002|COMPLETED|Placebo-Controlled Phase||32
3155037|NCT01828593|3881470|FG000|NOT COMPLETED|Placebo-Controlled Phase||0
3155038|NCT01828593|3881471|FG001|NOT COMPLETED|Placebo-Controlled Phase||0
3155039|NCT01828593|3881472|FG002|NOT COMPLETED|Placebo-Controlled Phase||1
3155040|NCT01828593|3881470|FG000|STARTED|Placebo-Free Phase|Placebo subjects took either SBI 2.5 or 5.0 g in the placebo-free phase|0
3155041|NCT01828593|3881471|FG001|STARTED|Placebo-Free Phase|SBI 2.5 g includes SBI 2.5 plus placebo who started taking SBI at Wk 4|55
3155042|NCT01828593|3881472|FG002|STARTED|Placebo-Free Phase|SBI 5.0 g includes SBI 5.0 plus placebo who started taking SBI at Wk 4|47
3155043|NCT01828593|3881470|FG000|COMPLETED|Placebo-Free Phase|Placebo subjects took either SBI 2.5 or 5.0 g in the placebo-free phase|0
3155044|NCT01828593|3881471|FG001|COMPLETED|Placebo-Free Phase|SBI 2.5 g includes SBI 2.5 plus placebo who started taking SBI at Wk 4|49
3155045|NCT01828593|3881472|FG002|COMPLETED|Placebo-Free Phase|SBI 5.0 g includes SBI 5.0 plus placebo who started taking SBI at Wk 4|41
3155046|NCT01828593|3881470|FG000|NOT COMPLETED|Placebo-Free Phase||0
3155047|NCT01828593|3881471|FG001|NOT COMPLETED|Placebo-Free Phase||6
3155048|NCT01828593|3881472|FG002|NOT COMPLETED|Placebo-Free Phase||6
3155049|NCT01828983|3881485|FG000|STARTED|Overall Study||80
3155050|NCT01828983|3881486|FG001|STARTED|Overall Study||81
3155051|NCT01828983|3881485|FG000|COMPLETED|Overall Study||80
3155052|NCT01828983|3881486|FG001|COMPLETED|Overall Study||81
3155053|NCT01828983|3881485|FG000|NOT COMPLETED|Overall Study||0
3155054|NCT01828983|3881486|FG001|NOT COMPLETED|Overall Study||0
3155055|NCT01829048|3881497|FG000|STARTED|Overall Study||6
3155056|NCT01829048|3881498|FG001|STARTED|Overall Study||8
3155057|NCT01829048|3881499|FG002|STARTED|Overall Study||7
3155058|NCT01829048|3881500|FG003|STARTED|Overall Study||14
3155059|NCT01829048|3881501|FG004|STARTED|Overall Study||2
3155060|NCT01829048|3881497|FG000|COMPLETED|Overall Study||6
3155061|NCT01829048|3881498|FG001|COMPLETED|Overall Study||8
3155062|NCT01829048|3881499|FG002|COMPLETED|Overall Study||7
3155063|NCT01829048|3881500|FG003|COMPLETED|Overall Study||12
3155064|NCT01829048|3881501|FG004|COMPLETED|Overall Study||2
3155065|NCT01829048|3881497|FG000|NOT COMPLETED|Overall Study||0
3155066|NCT01829048|3881498|FG001|NOT COMPLETED|Overall Study||0
3155067|NCT01829048|3881499|FG002|NOT COMPLETED|Overall Study||0
3155068|NCT01829048|3881500|FG003|NOT COMPLETED|Overall Study||2
3155069|NCT01829048|3881501|FG004|NOT COMPLETED|Overall Study||0
3155070|NCT01829113|3881516|FG000|STARTED|Overall Study|Three patients were enrolled and randomized but never received treatment.|77
3155071|NCT01829113|3881517|FG001|STARTED|Overall Study|Two patients were enrolled and randomized but never received treatment.|78
3155072|NCT01829113|3881516|FG000|COMPLETED|Overall Study||0
3155073|NCT01829113|3881517|FG001|COMPLETED|Overall Study||0
3155074|NCT01829113|3881516|FG000|NOT COMPLETED|Overall Study||77
3155075|NCT01829113|3881517|FG001|NOT COMPLETED|Overall Study||78
3155076|NCT01829165|3881527|FG000|STARTED|Overall Study||20
3155077|NCT01829165|3881528|FG001|STARTED|Overall Study||13
3155078|NCT01829165|3881527|FG000|COMPLETED|Overall Study||18
3155079|NCT01829165|3881528|FG001|COMPLETED|Overall Study||13
3155080|NCT01829165|3881527|FG000|NOT COMPLETED|Overall Study||2
3155081|NCT01829165|3881528|FG001|NOT COMPLETED|Overall Study||0
3155082|NCT01829191|3881536|FG000|STARTED|Overall Study||63
3155083|NCT01829191|3881537|FG001|STARTED|Overall Study||64
3155084|NCT01829191|3881536|FG000|COMPLETED|Overall Study||56
3155085|NCT01829191|3881537|FG001|COMPLETED|Overall Study||50
3155086|NCT01829191|3881536|FG000|NOT COMPLETED|Overall Study||7
3155087|NCT01829191|3881537|FG001|NOT COMPLETED|Overall Study||14
3184283|NCT02013791|3912568|FG007|NOT COMPLETED|Period 2||0
3184284|NCT02013791|3912569|FG008|NOT COMPLETED|Period 2||0
3184285|NCT02013817|3912590|FG000|STARTED|Overall Study||43
3184286|NCT02013817|3912590|FG000|COMPLETED|Overall Study||16
3155088|NCT01829217|3881542|FG000|STARTED|Overall Study||13
3155089|NCT01829217|3881542|FG000|COMPLETED|Overall Study||13
3155090|NCT01829217|3881542|FG000|NOT COMPLETED|Overall Study||0
3155091|NCT01829230|3881548|FG000|STARTED|Overall Study||40
3155092|NCT01829230|3881549|FG001|STARTED|Overall Study||42
3155093|NCT01829230|3881548|FG000|COMPLETED|Overall Study||39
3155094|NCT01829230|3881549|FG001|COMPLETED|Overall Study||38
3155095|NCT01829230|3881548|FG000|NOT COMPLETED|Overall Study||1
3155096|NCT01829230|3881549|FG001|NOT COMPLETED|Overall Study||4
3155097|NCT01829243|3881555|FG000|STARTED|First Intervention||11
3155098|NCT01829243|3881556|FG001|STARTED|First Intervention||15
3155099|NCT01829243|3881555|FG000|COMPLETED|First Intervention||7
3155100|NCT01829243|3881556|FG001|COMPLETED|First Intervention||13
3155101|NCT01829243|3881555|FG000|NOT COMPLETED|First Intervention||4
3155102|NCT01829243|3881556|FG001|NOT COMPLETED|First Intervention||2
3155103|NCT01829243|3881555|FG000|STARTED|Washout Period of 1 Week||7
3155104|NCT01829243|3881556|FG001|STARTED|Washout Period of 1 Week||13
3155105|NCT01829243|3881555|FG000|COMPLETED|Washout Period of 1 Week||7
3155106|NCT01829243|3881556|FG001|COMPLETED|Washout Period of 1 Week||13
3155107|NCT01829243|3881555|FG000|NOT COMPLETED|Washout Period of 1 Week||0
3155108|NCT01829243|3881556|FG001|NOT COMPLETED|Washout Period of 1 Week||0
3155109|NCT01829243|3881555|FG000|STARTED|Second Intervention||7
3155110|NCT01829243|3881556|FG001|STARTED|Second Intervention||13
3155111|NCT01829243|3881555|FG000|COMPLETED|Second Intervention||7
3155112|NCT01829243|3881556|FG001|COMPLETED|Second Intervention||13
3155113|NCT01829243|3881555|FG000|NOT COMPLETED|Second Intervention||0
3155114|NCT01829243|3881556|FG001|NOT COMPLETED|Second Intervention||0
3155115|NCT01829295|3881566|FG000|STARTED|0-6 Months||107
3155116|NCT01829295|3881567|FG001|STARTED|0-6 Months||109
3155117|NCT01829295|3881568|FG002|STARTED|0-6 Months||0
3155118|NCT01829295|3881569|FG003|STARTED|0-6 Months||0
3155119|NCT01829295|3881566|FG000|COMPLETED|0-6 Months||96
3155120|NCT01829295|3881567|FG001|COMPLETED|0-6 Months||98
3155121|NCT01829295|3881568|FG002|COMPLETED|0-6 Months||0
3155122|NCT01829295|3881569|FG003|COMPLETED|0-6 Months||0
3155123|NCT01829295|3881566|FG000|NOT COMPLETED|0-6 Months||11
3155124|NCT01829295|3881567|FG001|NOT COMPLETED|0-6 Months||11
3155125|NCT01829295|3881568|FG002|NOT COMPLETED|0-6 Months||0
3155126|NCT01829295|3881569|FG003|NOT COMPLETED|0-6 Months||0
3155127|NCT01829295|3881566|FG000|STARTED|6-12 Months|64 patients were a treatment success on methotrexate at 6 mo and had the option to continue|64
3155128|NCT01829295|3881567|FG001|STARTED|6-12 Months|56 patients were a treatment success on mycophenolate mofetil at 6 mo and had the option to continue|56
3155129|NCT01829295|3881568|FG002|STARTED|6-12 Months|32 patients failed methotrexate within the first 6 months|32
3155130|NCT01829295|3881569|FG003|STARTED|6-12 Months|42 patients failed on mycophenolate mofetil within the first 6 months|42
3155131|NCT01829295|3881566|FG000|COMPLETED|6-12 Months||60
3155132|NCT01829295|3881567|FG001|COMPLETED|6-12 Months||54
3155133|NCT01829295|3881568|FG002|COMPLETED|6-12 Months||20
3155134|NCT01829295|3881569|FG003|COMPLETED|6-12 Months||29
3155135|NCT01829295|3881566|FG000|NOT COMPLETED|6-12 Months||4
3155136|NCT01829295|3881567|FG001|NOT COMPLETED|6-12 Months||2
3155137|NCT01829295|3881568|FG002|NOT COMPLETED|6-12 Months||12
3155138|NCT01829295|3881569|FG003|NOT COMPLETED|6-12 Months||13
3155139|NCT01829347|3881581|FG000|STARTED|VTI-210||9
3155140|NCT01829347|3881582|FG001|STARTED|VTI-210||9
3155141|NCT01829347|3881581|FG000|COMPLETED|VTI-210||3
3155142|NCT01829347|3881582|FG001|COMPLETED|VTI-210||6
3155143|NCT01829347|3881581|FG000|NOT COMPLETED|VTI-210||6
3155144|NCT01829347|3881582|FG001|NOT COMPLETED|VTI-210||3
3155145|NCT01829347|3881581|FG000|STARTED|VTI-210E||3
3155146|NCT01829347|3881582|FG001|STARTED|VTI-210E||6
3155147|NCT01829347|3881581|FG000|COMPLETED|VTI-210E||0
3155148|NCT01829347|3881582|FG001|COMPLETED|VTI-210E||0
3155149|NCT01829347|3881581|FG000|NOT COMPLETED|VTI-210E||3
3155150|NCT01829347|3881582|FG001|NOT COMPLETED|VTI-210E||6
3155151|NCT01829360|3881592|FG000|STARTED|Overall Study||8
3155152|NCT01829360|3881593|FG001|STARTED|Overall Study||9
3155153|NCT01829360|3881594|FG002|STARTED|Overall Study||10
3155154|NCT01829360|3881595|FG003|STARTED|Overall Study||8
3155155|NCT01829360|3881592|FG000|COMPLETED|Overall Study||8
3155156|NCT01829360|3881593|FG001|COMPLETED|Overall Study||9
3155157|NCT01829360|3881594|FG002|COMPLETED|Overall Study||9
3184287|NCT02013817|3912590|FG000|NOT COMPLETED|Overall Study||27
3184288|NCT02013830|3912594|FG000|STARTED|Overall Study||45
3184289|NCT02013830|3912594|FG000|COMPLETED|Overall Study||15
3155158|NCT01829360|3881595|FG003|COMPLETED|Overall Study||8
3155159|NCT01829360|3881592|FG000|NOT COMPLETED|Overall Study||0
3155160|NCT01829360|3881593|FG001|NOT COMPLETED|Overall Study||0
3155161|NCT01829360|3881594|FG002|NOT COMPLETED|Overall Study||1
3155162|NCT01829360|3881595|FG003|NOT COMPLETED|Overall Study||0
3155163|NCT01829399|3881611|FG000|STARTED|Visit 1||12
3155164|NCT01829399|3881612|FG001|STARTED|Visit 1||12
3155165|NCT01829399|3881611|FG000|COMPLETED|Visit 1||12
3155166|NCT01829399|3881612|FG001|COMPLETED|Visit 1||12
3155167|NCT01829399|3881611|FG000|NOT COMPLETED|Visit 1||0
3155168|NCT01829399|3881612|FG001|NOT COMPLETED|Visit 1||0
3155169|NCT01829399|3881611|FG000|STARTED|Visit 2 (One Month Later)||12
3155170|NCT01829399|3881612|FG001|STARTED|Visit 2 (One Month Later)||12
3155171|NCT01829399|3881611|FG000|COMPLETED|Visit 2 (One Month Later)||12
3184290|NCT02013830|3912594|FG000|NOT COMPLETED|Overall Study||30
3155172|NCT01829399|3881612|FG001|COMPLETED|Visit 2 (One Month Later)||12
3155173|NCT01829399|3881611|FG000|NOT COMPLETED|Visit 2 (One Month Later)||0
3155174|NCT01829399|3881612|FG001|NOT COMPLETED|Visit 2 (One Month Later)||0
3155175|NCT01829425|3881622|FG000|STARTED|Overall Study||78
3155176|NCT01829425|3881623|FG001|STARTED|Overall Study||74
3155177|NCT01829425|3881622|FG000|COMPLETED|Overall Study|completed primary outcome 2 month f/u N=72|72
3155178|NCT01829425|3881623|FG001|COMPLETED|Overall Study|completed primary outcome 2 month f/u N=70|70
3155179|NCT01829425|3881622|FG000|NOT COMPLETED|Overall Study||6
3155180|NCT01829425|3881623|FG001|NOT COMPLETED|Overall Study||4
3155181|NCT01829464|3881632|FG000|STARTED|Overall Study||30
3155182|NCT01829464|3881633|FG001|STARTED|Overall Study||31
3155183|NCT01829464|3881634|FG002|STARTED|Overall Study||29
3155184|NCT01829464|3881632|FG000|COMPLETED|Overall Study||2
3155185|NCT01829464|3881633|FG001|COMPLETED|Overall Study||2
3155186|NCT01829464|3881634|FG002|COMPLETED|Overall Study||3
3155187|NCT01829464|3881632|FG000|NOT COMPLETED|Overall Study||28
3155188|NCT01829464|3881633|FG001|NOT COMPLETED|Overall Study||29
3155189|NCT01829464|3881634|FG002|NOT COMPLETED|Overall Study||26
3155190|NCT01829503|3881642|FG000|STARTED|Overall Study||44
3155191|NCT01829503|3881642|FG000|COMPLETED|Overall Study||44
3155192|NCT01829503|3881642|FG000|NOT COMPLETED|Overall Study||0
3155193|NCT01829516|3881648|FG000|STARTED|First Intervention||18
3155194|NCT01829516|3881649|FG001|STARTED|First Intervention||14
3155195|NCT01829516|3881648|FG000|COMPLETED|First Intervention||18
3155196|NCT01829516|3881649|FG001|COMPLETED|First Intervention||14
3155197|NCT01829516|3881648|FG000|NOT COMPLETED|First Intervention||0
3155198|NCT01829516|3881649|FG001|NOT COMPLETED|First Intervention||0
3155199|NCT01829516|3881648|FG000|STARTED|Washout Period - 1 Week||18
3155200|NCT01829516|3881649|FG001|STARTED|Washout Period - 1 Week||14
3155201|NCT01829516|3881648|FG000|COMPLETED|Washout Period - 1 Week||18
3155202|NCT01829516|3881649|FG001|COMPLETED|Washout Period - 1 Week||14
3155203|NCT01829516|3881648|FG000|NOT COMPLETED|Washout Period - 1 Week||0
3155204|NCT01829516|3881649|FG001|NOT COMPLETED|Washout Period - 1 Week||0
3155205|NCT01829516|3881648|FG000|STARTED|2nd Intervention||18
3155206|NCT01829516|3881649|FG001|STARTED|2nd Intervention||14
3155207|NCT01829516|3881648|FG000|COMPLETED|2nd Intervention||18
3155208|NCT01829516|3881649|FG001|COMPLETED|2nd Intervention||14
3155209|NCT01829516|3881648|FG000|NOT COMPLETED|2nd Intervention||0
3155210|NCT01829516|3881649|FG001|NOT COMPLETED|2nd Intervention||0
3155211|NCT01829919|3881657|FG000|STARTED|Overall Study||24
3155212|NCT01829919|3881657|FG000|COMPLETED|Overall Study||24
3155213|NCT01829919|3881657|FG000|NOT COMPLETED|Overall Study||0
3155214|NCT01829997|3881661|FG000|STARTED|Overall Study||22
3155215|NCT01829997|3881661|FG000|COMPLETED|Overall Study||16
3155216|NCT01829997|3881661|FG000|NOT COMPLETED|Overall Study||6
3155217|NCT01830127|3881667|FG000|STARTED|Overall Study||18
3155218|NCT01830127|3881668|FG001|STARTED|Overall Study||17
3155219|NCT01830127|3881667|FG000|COMPLETED|Overall Study||13
3155220|NCT01830127|3881668|FG001|COMPLETED|Overall Study||8
3155221|NCT01830127|3881667|FG000|NOT COMPLETED|Overall Study||5
3155222|NCT01830127|3881668|FG001|NOT COMPLETED|Overall Study||9
3155223|NCT01830140|3881676|FG000|STARTED|Overall Study||233
3155224|NCT01830140|3881677|FG001|STARTED|Overall Study||233
3155225|NCT01830140|3881676|FG000|COMPLETED|Overall Study||226
3155226|NCT01830140|3881677|FG001|COMPLETED|Overall Study||229
3155227|NCT01830140|3881676|FG000|NOT COMPLETED|Overall Study||7
3155228|NCT01830140|3881677|FG001|NOT COMPLETED|Overall Study||4
3155229|NCT01830205|3881687|FG000|STARTED|Overall Study||12
3155230|NCT01830205|3881688|FG001|STARTED|Overall Study||6
3155231|NCT01830205|3881689|FG002|STARTED|Overall Study||6
3155232|NCT01830205|3881690|FG003|STARTED|Overall Study||12
3155233|NCT01830205|3881687|FG000|COMPLETED|Overall Study||12
3155234|NCT01830205|3881688|FG001|COMPLETED|Overall Study||6
3155235|NCT01830205|3881689|FG002|COMPLETED|Overall Study||6
3155236|NCT01830205|3881690|FG003|COMPLETED|Overall Study||12
3155237|NCT01830205|3881687|FG000|NOT COMPLETED|Overall Study||0
3155238|NCT01830205|3881688|FG001|NOT COMPLETED|Overall Study||0
3155239|NCT01830205|3881689|FG002|NOT COMPLETED|Overall Study||0
3155240|NCT01830205|3881690|FG003|NOT COMPLETED|Overall Study||0
3155241|NCT01830543|3881714|FG000|STARTED|Overall Study||709
3155242|NCT01830543|3881715|FG001|STARTED|Overall Study||709
3155243|NCT01830543|3881716|FG002|STARTED|Overall Study||706
3155244|NCT01830543|3881714|FG000|Treated|Overall Study||696
3155245|NCT01830543|3881715|FG001|Treated|Overall Study||706
3155246|NCT01830543|3881716|FG002|Treated|Overall Study||697
3155247|NCT01830543|3881714|FG000|COMPLETED|Overall Study||550
3155248|NCT01830543|3881715|FG001|COMPLETED|Overall Study||557
3155249|NCT01830543|3881716|FG002|COMPLETED|Overall Study||492
3155250|NCT01830543|3881714|FG000|NOT COMPLETED|Overall Study||159
3155251|NCT01830543|3881715|FG001|NOT COMPLETED|Overall Study||152
3155252|NCT01830543|3881716|FG002|NOT COMPLETED|Overall Study||214
3155253|NCT01830595|3881724|FG000|STARTED|First Period||26
3155254|NCT01830595|3881725|FG001|STARTED|First Period||28
3155255|NCT01830595|3881724|FG000|Received at Least One Dose|First Period||26
3155256|NCT01830595|3881725|FG001|Received at Least One Dose|First Period||28
3155257|NCT01830595|3881724|FG000|COMPLETED|First Period||25
3155258|NCT01830595|3881725|FG001|COMPLETED|First Period||25
3155259|NCT01830595|3881724|FG000|NOT COMPLETED|First Period||1
3155260|NCT01830595|3881725|FG001|NOT COMPLETED|First Period||3
3155261|NCT01830595|3881724|FG000|STARTED|Washout||25
3155262|NCT01830595|3881725|FG001|STARTED|Washout||25
3155263|NCT01830595|3881724|FG000|COMPLETED|Washout||23
3155264|NCT01830595|3881725|FG001|COMPLETED|Washout||23
3155265|NCT01830595|3881724|FG000|NOT COMPLETED|Washout||2
3155266|NCT01830595|3881725|FG001|NOT COMPLETED|Washout||2
3155267|NCT01830595|3881724|FG000|STARTED|Second Period||23
3155268|NCT01830595|3881725|FG001|STARTED|Second Period||23
3155269|NCT01830595|3881724|FG000|COMPLETED|Second Period||23
3155270|NCT01830595|3881725|FG001|COMPLETED|Second Period||23
3155271|NCT01830595|3881724|FG000|NOT COMPLETED|Second Period||0
3155272|NCT01830595|3881725|FG001|NOT COMPLETED|Second Period||0
3155273|NCT01830621|3881733|FG000|STARTED|Overall Study||138
3155274|NCT01830621|3881734|FG001|STARTED|Overall Study||144
3155275|NCT01830621|3881733|FG000|COMPLETED|Overall Study||138
3155276|NCT01830621|3881734|FG001|COMPLETED|Overall Study||144
3184291|NCT02014051|3912598|FG000|STARTED|Overall Study||3
3184292|NCT02014051|3912599|FG001|STARTED|Overall Study||6
3184293|NCT02014051|3912598|FG000|COMPLETED|Overall Study||2
3184294|NCT02014051|3912599|FG001|COMPLETED|Overall Study||5
3184295|NCT02014051|3912598|FG000|NOT COMPLETED|Overall Study||1
3184296|NCT02014051|3912599|FG001|NOT COMPLETED|Overall Study||1
3184297|NCT02014116|3912615|FG000|STARTED|Overall Study||3
3184298|NCT02014116|3912616|FG001|STARTED|Overall Study||4
3184299|NCT02014116|3912617|FG002|STARTED|Overall Study||3
3184300|NCT02014116|3912618|FG003|STARTED|Overall Study||7
3184301|NCT02014116|3912619|FG004|STARTED|Overall Study||2
3184302|NCT02014116|3912620|FG005|STARTED|Overall Study||16
3184303|NCT02014116|3912621|FG006|STARTED|Overall Study||1
3184304|NCT02014116|3912622|FG007|STARTED|Overall Study||5
3184305|NCT02014116|3912623|FG008|STARTED|Overall Study||10
3184306|NCT02014116|3912615|FG000|Received at Least One Dose of Study Drug|Overall Study||3
3184307|NCT02014116|3912616|FG001|Received at Least One Dose of Study Drug|Overall Study||4
3184308|NCT02014116|3912617|FG002|Received at Least One Dose of Study Drug|Overall Study||3
3184309|NCT02014116|3912618|FG003|Received at Least One Dose of Study Drug|Overall Study||7
3184310|NCT02014116|3912619|FG004|Received at Least One Dose of Study Drug|Overall Study||2
3184311|NCT02014116|3912620|FG005|Received at Least One Dose of Study Drug|Overall Study||16
3184312|NCT02014116|3912621|FG006|Received at Least One Dose of Study Drug|Overall Study||1
3184313|NCT02014116|3912622|FG007|Received at Least One Dose of Study Drug|Overall Study||5
3184314|NCT02014116|3912623|FG008|Received at Least One Dose of Study Drug|Overall Study||10
3184315|NCT02014116|3912615|FG000|COMPLETED|Overall Study||0
3184316|NCT02014116|3912616|FG001|COMPLETED|Overall Study||0
3184317|NCT02014116|3912617|FG002|COMPLETED|Overall Study||0
3184318|NCT02014116|3912618|FG003|COMPLETED|Overall Study||0
3184319|NCT02014116|3912619|FG004|COMPLETED|Overall Study||0
3184320|NCT02014116|3912620|FG005|COMPLETED|Overall Study||0
3184321|NCT02014116|3912621|FG006|COMPLETED|Overall Study||0
3184322|NCT02014116|3912622|FG007|COMPLETED|Overall Study||0
3184323|NCT02014116|3912623|FG008|COMPLETED|Overall Study||0
3184324|NCT02014116|3912615|FG000|NOT COMPLETED|Overall Study||3
3184325|NCT02014116|3912616|FG001|NOT COMPLETED|Overall Study||4
3184326|NCT02014116|3912617|FG002|NOT COMPLETED|Overall Study||3
3184327|NCT02014116|3912618|FG003|NOT COMPLETED|Overall Study||7
3184328|NCT02014116|3912619|FG004|NOT COMPLETED|Overall Study||2
3184329|NCT02014116|3912620|FG005|NOT COMPLETED|Overall Study||16
3184330|NCT02014116|3912621|FG006|NOT COMPLETED|Overall Study||1
3184331|NCT02014116|3912622|FG007|NOT COMPLETED|Overall Study||5
3184332|NCT02014116|3912623|FG008|NOT COMPLETED|Overall Study||10
3184333|NCT02014129|3912649|FG000|STARTED|Overall Study||3
3184334|NCT02014129|3912650|FG001|STARTED|Overall Study||3
3184335|NCT02014129|3912651|FG002|STARTED|Overall Study||6
3184336|NCT02014129|3912649|FG000|Received at Least One Dose of Study Drug|Overall Study||3
3184337|NCT02014129|3912650|FG001|Received at Least One Dose of Study Drug|Overall Study||3
3184338|NCT02014129|3912651|FG002|Received at Least One Dose of Study Drug|Overall Study||6
3184339|NCT02014129|3912649|FG000|COMPLETED|Overall Study||3
3184340|NCT02014129|3912650|FG001|COMPLETED|Overall Study||3
3184341|NCT02014129|3912651|FG002|COMPLETED|Overall Study||6
3184342|NCT02014129|3912649|FG000|NOT COMPLETED|Overall Study||0
3184343|NCT02014129|3912650|FG001|NOT COMPLETED|Overall Study||0
3184344|NCT02014129|3912651|FG002|NOT COMPLETED|Overall Study||0
3184345|NCT02014272|3912659|FG000|STARTED|Intervention Period 1||14
3184346|NCT02014272|3912660|FG001|STARTED|Intervention Period 1||14
3184347|NCT02014272|3912659|FG000|COMPLETED|Intervention Period 1||13
3184348|NCT02014272|3912660|FG001|COMPLETED|Intervention Period 1||13
3184349|NCT02014272|3912659|FG000|NOT COMPLETED|Intervention Period 1||1
3184350|NCT02014272|3912660|FG001|NOT COMPLETED|Intervention Period 1||1
3184351|NCT02014272|3912659|FG000|STARTED|Washout Period 1 (7 Days)||13
3184352|NCT02014272|3912660|FG001|STARTED|Washout Period 1 (7 Days)||13
3184353|NCT02014272|3912659|FG000|COMPLETED|Washout Period 1 (7 Days)||13
3184354|NCT02014272|3912660|FG001|COMPLETED|Washout Period 1 (7 Days)||13
3184355|NCT02014272|3912659|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0
3184356|NCT02014272|3912660|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0
3184357|NCT02014272|3912659|FG000|STARTED|Intervention Period 2||13
3184358|NCT02014272|3912660|FG001|STARTED|Intervention Period 2||13
3184359|NCT02014272|3912659|FG000|COMPLETED|Intervention Period 2||13
3184360|NCT02014272|3912660|FG001|COMPLETED|Intervention Period 2||13
3155277|NCT01830621|3881733|FG000|NOT COMPLETED|Overall Study||0
3184361|NCT02014272|3912659|FG000|NOT COMPLETED|Intervention Period 2||0
3184362|NCT02014272|3912660|FG001|NOT COMPLETED|Intervention Period 2||0
3184363|NCT02014363|3912669|FG000|STARTED|Overall Study||55
3155278|NCT01830621|3881734|FG001|NOT COMPLETED|Overall Study||0
3155279|NCT01830699|3881742|FG000|STARTED|Overall Study||13
3155280|NCT01830699|3881743|FG001|STARTED|Overall Study||20
3155281|NCT01830699|3881742|FG000|COMPLETED|Overall Study||13
3155282|NCT01830699|3881743|FG001|COMPLETED|Overall Study||20
3155283|NCT01830699|3881742|FG000|NOT COMPLETED|Overall Study||0
3155284|NCT01830699|3881743|FG001|NOT COMPLETED|Overall Study||0
3155285|NCT01830816|3881752|FG000|STARTED|Overall Study||20
3155286|NCT01830816|3881753|FG001|STARTED|Overall Study||14
3155287|NCT01830816|3881754|FG002|STARTED|Overall Study||7
3155288|NCT01830816|3881752|FG000|Pharmacokinetic-Evaluable Population|Overall Study|Participants are considered to have completed study treatment if they are PK evaluable.|18
3155289|NCT01830816|3881753|FG001|Pharmacokinetic-Evaluable Population|Overall Study||14
3155290|NCT01830816|3881754|FG002|Pharmacokinetic-Evaluable Population|Overall Study||6
3155291|NCT01830816|3881752|FG000|COMPLETED|Overall Study||0
3155292|NCT01830816|3881753|FG001|COMPLETED|Overall Study||0
3155293|NCT01830816|3881754|FG002|COMPLETED|Overall Study||0
3155294|NCT01830816|3881752|FG000|NOT COMPLETED|Overall Study||20
3155295|NCT01830816|3881753|FG001|NOT COMPLETED|Overall Study||14
3155296|NCT01830816|3881754|FG002|NOT COMPLETED|Overall Study||7
3155297|NCT01830842|3881767|FG000|STARTED|Overall Study||30
3155298|NCT01830842|3881768|FG001|STARTED|Overall Study||24
3155299|NCT01830842|3881767|FG000|COMPLETED|Overall Study||25
3155300|NCT01830842|3881768|FG001|COMPLETED|Overall Study||22
3155301|NCT01830842|3881767|FG000|NOT COMPLETED|Overall Study||5
3155302|NCT01830842|3881768|FG001|NOT COMPLETED|Overall Study||2
3155303|NCT01830855|3881778|FG000|STARTED|Overall Study||1508
3155304|NCT01830855|3881779|FG001|STARTED|Overall Study||598
3155305|NCT01830855|3881780|FG002|STARTED|Overall Study||587
3155306|NCT01830855|3881781|FG003|STARTED|Overall Study||897
3155307|NCT01830855|3881778|FG000|COMPLETED|Overall Study||1353
3155308|NCT01830855|3881779|FG001|COMPLETED|Overall Study||537
3155309|NCT01830855|3881780|FG002|COMPLETED|Overall Study||521
3155310|NCT01830855|3881781|FG003|COMPLETED|Overall Study||815
3155311|NCT01830855|3881778|FG000|NOT COMPLETED|Overall Study||155
3155312|NCT01830855|3881779|FG001|NOT COMPLETED|Overall Study||61
3155313|NCT01830855|3881780|FG002|NOT COMPLETED|Overall Study||66
3155314|NCT01830855|3881781|FG003|NOT COMPLETED|Overall Study||82
3155315|NCT01830881|3881798|FG000|STARTED|Overall Study||62
3155316|NCT01830881|3881799|FG001|STARTED|Overall Study||62
3155317|NCT01830881|3881798|FG000|COMPLETED|Overall Study||62
3155318|NCT01830881|3881799|FG001|COMPLETED|Overall Study||61
3155319|NCT01830881|3881798|FG000|NOT COMPLETED|Overall Study||0
3155320|NCT01830881|3881799|FG001|NOT COMPLETED|Overall Study||1
3155321|NCT01830920|3881812|FG000|STARTED|Overall Study||126
3155322|NCT01830920|3881813|FG001|STARTED|Overall Study||46
3155323|NCT01830920|3881814|FG002|STARTED|Overall Study||48
3155324|NCT01830920|3881815|FG003|STARTED|Overall Study||125
3155325|NCT01830920|3881816|FG004|STARTED|Overall Study||107
3155326|NCT01830920|3881812|FG000|Received Allocated Drug|Overall Study||115
3155327|NCT01830920|3881813|FG001|Received Allocated Drug|Overall Study||45
3155328|NCT01830920|3881814|FG002|Received Allocated Drug|Overall Study||47
3155329|NCT01830920|3881815|FG003|Received Allocated Drug|Overall Study||119
3155330|NCT01830920|3881816|FG004|Received Allocated Drug|Overall Study||105
3155331|NCT01830920|3881812|FG000|COMPLETED|Overall Study||105
3155332|NCT01830920|3881813|FG001|COMPLETED|Overall Study||40
3155333|NCT01830920|3881814|FG002|COMPLETED|Overall Study||40
3155334|NCT01830920|3881815|FG003|COMPLETED|Overall Study||109
3155335|NCT01830920|3881816|FG004|COMPLETED|Overall Study||99
3155336|NCT01830920|3881812|FG000|NOT COMPLETED|Overall Study||21
3155337|NCT01830920|3881813|FG001|NOT COMPLETED|Overall Study||6
3155338|NCT01830920|3881814|FG002|NOT COMPLETED|Overall Study||8
3155339|NCT01830920|3881815|FG003|NOT COMPLETED|Overall Study||16
3155340|NCT01830920|3881816|FG004|NOT COMPLETED|Overall Study||8
3155341|NCT01830933|3881830|FG000|STARTED|Overall Study||823
3155342|NCT01830933|3881831|FG001|STARTED|Overall Study||812
3155343|NCT01830933|3881830|FG000|Completed Meet-up|Overall Study||675
3155344|NCT01830933|3881831|FG001|Completed Meet-up|Overall Study||603
3155345|NCT01830933|3881830|FG000|COMPLETED|Overall Study||655
3155346|NCT01830933|3881831|FG001|COMPLETED|Overall Study||580
3155347|NCT01830933|3881830|FG000|NOT COMPLETED|Overall Study||168
3155348|NCT01830933|3881831|FG001|NOT COMPLETED|Overall Study||232
3184364|NCT02014363|3912670|FG001|STARTED|Overall Study||54
3184365|NCT02014363|3912671|FG002|STARTED|Overall Study||55
3184366|NCT02014363|3912669|FG000|COMPLETED|Overall Study||38
3184367|NCT02014363|3912670|FG001|COMPLETED|Overall Study||35
3184368|NCT02014363|3912671|FG002|COMPLETED|Overall Study||31
3184369|NCT02014363|3912669|FG000|NOT COMPLETED|Overall Study||17
3184370|NCT02014363|3912670|FG001|NOT COMPLETED|Overall Study||19
3184371|NCT02014363|3912671|FG002|NOT COMPLETED|Overall Study||24
3184372|NCT02014376|3912682|FG000|STARTED|Overall Study||15
3184373|NCT02014376|3912683|FG001|STARTED|Overall Study||16
3184374|NCT02014376|3912684|FG002|STARTED|Overall Study||17
3184375|NCT02014376|3912682|FG000|Received at Least 1 Dose of Study Drug|Overall Study||15
3184376|NCT02014376|3912683|FG001|Received at Least 1 Dose of Study Drug|Overall Study||16
3184377|NCT02014376|3912684|FG002|Received at Least 1 Dose of Study Drug|Overall Study||17
3184378|NCT02014376|3912682|FG000|COMPLETED|Overall Study||12
3184379|NCT02014376|3912683|FG001|COMPLETED|Overall Study||15
3155349|NCT01830972|3881839|FG000|STARTED|Part I||46
3155350|NCT01830972|3881840|FG001|STARTED|Part I|Not applicable; participants in this arm entered during Part 2.|0
3155351|NCT01830972|3881839|FG000|COMPLETED|Part I||46
3155352|NCT01830972|3881840|FG001|COMPLETED|Part I|Not applicable; participants in this arm entered during Part 2.|0
3155353|NCT01830972|3881839|FG000|NOT COMPLETED|Part I||0
3155354|NCT01830972|3881840|FG001|NOT COMPLETED|Part I||0
3155355|NCT01830972|3881839|FG000|STARTED|Part II||46
3155356|NCT01830972|3881840|FG001|STARTED|Part II|Entered study at Part 2|13
3155357|NCT01830972|3881839|FG000|COMPLETED|Part II||44
3155358|NCT01830972|3881840|FG001|COMPLETED|Part II||11
3155359|NCT01830972|3881839|FG000|NOT COMPLETED|Part II||2
3155360|NCT01830972|3881840|FG001|NOT COMPLETED|Part II||2
3155361|NCT01830972|3881839|FG000|STARTED|Part III|2 participants withdrew consent and did not enter Part 3|44
3155362|NCT01830972|3881840|FG001|STARTED|Part III||11
3155363|NCT01830972|3881839|FG000|COMPLETED|Part III||42
3155364|NCT01830972|3881840|FG001|COMPLETED|Part III||11
3155365|NCT01830972|3881839|FG000|NOT COMPLETED|Part III||2
3155366|NCT01830972|3881840|FG001|NOT COMPLETED|Part III||0
3155367|NCT01830972|3881839|FG000|STARTED|Part IV||42
3155368|NCT01830972|3881840|FG001|STARTED|Part IV||11
3155369|NCT01830972|3881839|FG000|COMPLETED|Part IV||39
3155370|NCT01830972|3881840|FG001|COMPLETED|Part IV||10
3155371|NCT01830972|3881839|FG000|NOT COMPLETED|Part IV||3
3155372|NCT01830972|3881840|FG001|NOT COMPLETED|Part IV||1
3155373|NCT01831076|3881858|FG000|STARTED|Overall Study||31
3155374|NCT01831076|3881859|FG001|STARTED|Overall Study||5
3155375|NCT01831076|3881858|FG000|COMPLETED|Overall Study||30
3155376|NCT01831076|3881859|FG001|COMPLETED|Overall Study||4
3155377|NCT01831076|3881858|FG000|NOT COMPLETED|Overall Study||1
3155378|NCT01831076|3881859|FG001|NOT COMPLETED|Overall Study||1
3155379|NCT01831089|3881871|FG000|STARTED|Cohort I: Dose Level 1||3
3155380|NCT01831089|3881872|FG001|STARTED|Cohort I: Dose Level 1||0
3155381|NCT01831089|3881873|FG002|STARTED|Cohort I: Dose Level 1||0
3155382|NCT01831089|3881874|FG003|STARTED|Cohort I: Dose Level 1||0
3155383|NCT01831089|3881875|FG004|STARTED|Cohort I: Dose Level 1||0
3155384|NCT01831089|3881876|FG005|STARTED|Cohort I: Dose Level 1||0
3155385|NCT01831089|3881871|FG000|COMPLETED|Cohort I: Dose Level 1||0
3155386|NCT01831089|3881872|FG001|COMPLETED|Cohort I: Dose Level 1||0
3155387|NCT01831089|3881873|FG002|COMPLETED|Cohort I: Dose Level 1||0
3155388|NCT01831089|3881874|FG003|COMPLETED|Cohort I: Dose Level 1||0
3155389|NCT01831089|3881875|FG004|COMPLETED|Cohort I: Dose Level 1||0
3155390|NCT01831089|3881876|FG005|COMPLETED|Cohort I: Dose Level 1||0
3155391|NCT01831089|3881871|FG000|NOT COMPLETED|Cohort I: Dose Level 1||3
3155392|NCT01831089|3881872|FG001|NOT COMPLETED|Cohort I: Dose Level 1||0
3155393|NCT01831089|3881873|FG002|NOT COMPLETED|Cohort I: Dose Level 1||0
3155394|NCT01831089|3881874|FG003|NOT COMPLETED|Cohort I: Dose Level 1||0
3155395|NCT01831089|3881875|FG004|NOT COMPLETED|Cohort I: Dose Level 1||0
3155396|NCT01831089|3881876|FG005|NOT COMPLETED|Cohort I: Dose Level 1||0
3155397|NCT01831089|3881871|FG000|STARTED|Cohort II: Dose Level 2||0
3155398|NCT01831089|3881872|FG001|STARTED|Cohort II: Dose Level 2||3
3155399|NCT01831089|3881873|FG002|STARTED|Cohort II: Dose Level 2||0
3155400|NCT01831089|3881874|FG003|STARTED|Cohort II: Dose Level 2||0
3155401|NCT01831089|3881875|FG004|STARTED|Cohort II: Dose Level 2||0
3155402|NCT01831089|3881876|FG005|STARTED|Cohort II: Dose Level 2||0
3155403|NCT01831089|3881871|FG000|COMPLETED|Cohort II: Dose Level 2||0
3155404|NCT01831089|3881872|FG001|COMPLETED|Cohort II: Dose Level 2||0
3155405|NCT01831089|3881873|FG002|COMPLETED|Cohort II: Dose Level 2||0
3155406|NCT01831089|3881874|FG003|COMPLETED|Cohort II: Dose Level 2||0
3155407|NCT01831089|3881875|FG004|COMPLETED|Cohort II: Dose Level 2||0
3155408|NCT01831089|3881876|FG005|COMPLETED|Cohort II: Dose Level 2||0
3155409|NCT01831089|3881871|FG000|NOT COMPLETED|Cohort II: Dose Level 2||0
3155410|NCT01831089|3881872|FG001|NOT COMPLETED|Cohort II: Dose Level 2||3
3155411|NCT01831089|3881873|FG002|NOT COMPLETED|Cohort II: Dose Level 2||0
3155412|NCT01831089|3881874|FG003|NOT COMPLETED|Cohort II: Dose Level 2||0
3155413|NCT01831089|3881875|FG004|NOT COMPLETED|Cohort II: Dose Level 2||0
3155414|NCT01831089|3881876|FG005|NOT COMPLETED|Cohort II: Dose Level 2||0
3155415|NCT01831089|3881871|FG000|STARTED|Cohort III: Dose Level 3||0
3155416|NCT01831089|3881872|FG001|STARTED|Cohort III: Dose Level 3||0
3155417|NCT01831089|3881873|FG002|STARTED|Cohort III: Dose Level 3||6
3155418|NCT01831089|3881874|FG003|STARTED|Cohort III: Dose Level 3||0
3155419|NCT01831089|3881875|FG004|STARTED|Cohort III: Dose Level 3||0
3155420|NCT01831089|3881876|FG005|STARTED|Cohort III: Dose Level 3||0
3155421|NCT01831089|3881871|FG000|COMPLETED|Cohort III: Dose Level 3||0
3155422|NCT01831089|3881872|FG001|COMPLETED|Cohort III: Dose Level 3||0
3155423|NCT01831089|3881873|FG002|COMPLETED|Cohort III: Dose Level 3||0
3155424|NCT01831089|3881874|FG003|COMPLETED|Cohort III: Dose Level 3||0
3155425|NCT01831089|3881875|FG004|COMPLETED|Cohort III: Dose Level 3||0
3155426|NCT01831089|3881876|FG005|COMPLETED|Cohort III: Dose Level 3||0
3155427|NCT01831089|3881871|FG000|NOT COMPLETED|Cohort III: Dose Level 3||0
3155428|NCT01831089|3881872|FG001|NOT COMPLETED|Cohort III: Dose Level 3||0
3155429|NCT01831089|3881873|FG002|NOT COMPLETED|Cohort III: Dose Level 3||6
3155430|NCT01831089|3881874|FG003|NOT COMPLETED|Cohort III: Dose Level 3||0
3155431|NCT01831089|3881875|FG004|NOT COMPLETED|Cohort III: Dose Level 3||0
3155432|NCT01831089|3881876|FG005|NOT COMPLETED|Cohort III: Dose Level 3||0
3155433|NCT01831089|3881871|FG000|STARTED|Cohort IV: Dose Level 4||0
3155434|NCT01831089|3881872|FG001|STARTED|Cohort IV: Dose Level 4||0
3155435|NCT01831089|3881873|FG002|STARTED|Cohort IV: Dose Level 4||0
3155436|NCT01831089|3881874|FG003|STARTED|Cohort IV: Dose Level 4||6
3155437|NCT01831089|3881875|FG004|STARTED|Cohort IV: Dose Level 4||0
3155438|NCT01831089|3881876|FG005|STARTED|Cohort IV: Dose Level 4||0
3155439|NCT01831089|3881871|FG000|COMPLETED|Cohort IV: Dose Level 4||0
3155440|NCT01831089|3881872|FG001|COMPLETED|Cohort IV: Dose Level 4||0
3155441|NCT01831089|3881873|FG002|COMPLETED|Cohort IV: Dose Level 4||0
3155442|NCT01831089|3881874|FG003|COMPLETED|Cohort IV: Dose Level 4||0
3155443|NCT01831089|3881875|FG004|COMPLETED|Cohort IV: Dose Level 4||0
3155444|NCT01831089|3881876|FG005|COMPLETED|Cohort IV: Dose Level 4||0
3155445|NCT01831089|3881871|FG000|NOT COMPLETED|Cohort IV: Dose Level 4||0
3155446|NCT01831089|3881872|FG001|NOT COMPLETED|Cohort IV: Dose Level 4||0
3155447|NCT01831089|3881873|FG002|NOT COMPLETED|Cohort IV: Dose Level 4||0
3155448|NCT01831089|3881874|FG003|NOT COMPLETED|Cohort IV: Dose Level 4||6
3155449|NCT01831089|3881875|FG004|NOT COMPLETED|Cohort IV: Dose Level 4||0
3155450|NCT01831089|3881876|FG005|NOT COMPLETED|Cohort IV: Dose Level 4||0
3155451|NCT01831089|3881871|FG000|STARTED|Cohort V: Dose Level 5||0
3155452|NCT01831089|3881872|FG001|STARTED|Cohort V: Dose Level 5||0
3155453|NCT01831089|3881873|FG002|STARTED|Cohort V: Dose Level 5||0
3155454|NCT01831089|3881874|FG003|STARTED|Cohort V: Dose Level 5||0
3155455|NCT01831089|3881875|FG004|STARTED|Cohort V: Dose Level 5||37
3155456|NCT01831089|3881876|FG005|STARTED|Cohort V: Dose Level 5||0
3155457|NCT01831089|3881871|FG000|COMPLETED|Cohort V: Dose Level 5||0
3155458|NCT01831089|3881872|FG001|COMPLETED|Cohort V: Dose Level 5||0
3155459|NCT01831089|3881873|FG002|COMPLETED|Cohort V: Dose Level 5||0
3155460|NCT01831089|3881874|FG003|COMPLETED|Cohort V: Dose Level 5||0
3155461|NCT01831089|3881875|FG004|COMPLETED|Cohort V: Dose Level 5||0
3155462|NCT01831089|3881876|FG005|COMPLETED|Cohort V: Dose Level 5||0
3155463|NCT01831089|3881871|FG000|NOT COMPLETED|Cohort V: Dose Level 5||0
3155464|NCT01831089|3881872|FG001|NOT COMPLETED|Cohort V: Dose Level 5||0
3155465|NCT01831089|3881873|FG002|NOT COMPLETED|Cohort V: Dose Level 5||0
3155466|NCT01831089|3881874|FG003|NOT COMPLETED|Cohort V: Dose Level 5||0
3155467|NCT01831089|3881875|FG004|NOT COMPLETED|Cohort V: Dose Level 5||37
3155468|NCT01831089|3881876|FG005|NOT COMPLETED|Cohort V: Dose Level 5||0
3155469|NCT01831089|3881871|FG000|STARTED|Cohort B: Arm B||0
3155470|NCT01831089|3881872|FG001|STARTED|Cohort B: Arm B||0
3155471|NCT01831089|3881873|FG002|STARTED|Cohort B: Arm B||0
3155472|NCT01831089|3881874|FG003|STARTED|Cohort B: Arm B||0
3155473|NCT01831089|3881875|FG004|STARTED|Cohort B: Arm B||0
3155474|NCT01831089|3881876|FG005|STARTED|Cohort B: Arm B||14
3155475|NCT01831089|3881871|FG000|COMPLETED|Cohort B: Arm B||0
3155476|NCT01831089|3881872|FG001|COMPLETED|Cohort B: Arm B||0
3155477|NCT01831089|3881873|FG002|COMPLETED|Cohort B: Arm B||0
3155478|NCT01831089|3881874|FG003|COMPLETED|Cohort B: Arm B||0
3155479|NCT01831089|3881875|FG004|COMPLETED|Cohort B: Arm B||0
3155480|NCT01831089|3881876|FG005|COMPLETED|Cohort B: Arm B||0
3155481|NCT01831089|3881871|FG000|NOT COMPLETED|Cohort B: Arm B||0
3155482|NCT01831089|3881872|FG001|NOT COMPLETED|Cohort B: Arm B||0
3155483|NCT01831089|3881873|FG002|NOT COMPLETED|Cohort B: Arm B||0
3155484|NCT01831089|3881874|FG003|NOT COMPLETED|Cohort B: Arm B||0
3155485|NCT01831089|3881875|FG004|NOT COMPLETED|Cohort B: Arm B||0
3155486|NCT01831089|3881876|FG005|NOT COMPLETED|Cohort B: Arm B||14
3155487|NCT01831154|3881894|FG000|STARTED|Overall Study|Study Institutional Review Board (IRB) approval 11-11-2009, first subjects enrolled 6-7-2010|15
3155488|NCT01831154|3881895|FG001|STARTED|Overall Study|Study IRB approval 11-11-2009, first subjects enrolled 6-7-2010|11
3155489|NCT01831154|3881896|FG002|STARTED|Overall Study|Study IRB approval 11-11-2009, first subjects enrolled 6-7-2010|11
3155490|NCT01831154|3881894|FG000|COMPLETED|Overall Study||15
3155491|NCT01831154|3881895|FG001|COMPLETED|Overall Study||11
3155492|NCT01831154|3881896|FG002|COMPLETED|Overall Study||11
3155493|NCT01831154|3881894|FG000|NOT COMPLETED|Overall Study||0
3155494|NCT01831154|3881895|FG001|NOT COMPLETED|Overall Study||0
3155495|NCT01831154|3881896|FG002|NOT COMPLETED|Overall Study||0
3155496|NCT01831219|3881906|FG000|STARTED|Overall Study||73
3155497|NCT01831219|3881907|FG001|STARTED|Overall Study||45
3155498|NCT01831219|3881906|FG000|COMPLETED|Overall Study||40
3155499|NCT01831219|3881907|FG001|COMPLETED|Overall Study||21
3155500|NCT01831219|3881906|FG000|NOT COMPLETED|Overall Study||33
3155501|NCT01831219|3881907|FG001|NOT COMPLETED|Overall Study||24
3155502|NCT01831232|3881913|FG000|STARTED|Overall Study||24
3155503|NCT01831232|3881913|FG000|COMPLETED|Overall Study||24
3155504|NCT01831232|3881913|FG000|NOT COMPLETED|Overall Study||0
3184380|NCT02014376|3912684|FG002|COMPLETED|Overall Study||17
3184381|NCT02014376|3912682|FG000|NOT COMPLETED|Overall Study||3
3184382|NCT02014376|3912683|FG001|NOT COMPLETED|Overall Study||1
3184383|NCT02014376|3912684|FG002|NOT COMPLETED|Overall Study||0
3184384|NCT02014402|3912696|FG000|STARTED|Overall Study||31
3184385|NCT02014402|3912697|FG001|STARTED|Overall Study||30
3184386|NCT02014402|3912698|FG002|STARTED|Overall Study||35
3184387|NCT02014402|3912699|FG003|STARTED|Overall Study||85
3184388|NCT02014402|3912696|FG000|Human Thrombin|Overall Study||20
3184389|NCT02014402|3912697|FG001|Human Thrombin|Overall Study||20
3184390|NCT02014402|3912698|FG002|Human Thrombin|Overall Study||23
3184391|NCT02014402|3912699|FG003|Human Thrombin|Overall Study||57
3184392|NCT02014402|3912696|FG000|Bovine Thrombin|Overall Study||11
3184393|NCT02014402|3912697|FG001|Bovine Thrombin|Overall Study||10
3184394|NCT02014402|3912698|FG002|Bovine Thrombin|Overall Study||12
3184395|NCT02014402|3912699|FG003|Bovine Thrombin|Overall Study||28
3184396|NCT02014402|3912696|FG000|COMPLETED|Overall Study||29
3184397|NCT02014402|3912697|FG001|COMPLETED|Overall Study||27
3184398|NCT02014402|3912698|FG002|COMPLETED|Overall Study||32
3184399|NCT02014402|3912699|FG003|COMPLETED|Overall Study||82
3184400|NCT02014402|3912696|FG000|NOT COMPLETED|Overall Study||2
3184401|NCT02014402|3912697|FG001|NOT COMPLETED|Overall Study||3
3155505|NCT01831258|3881917|FG000|STARTED|Overall Study||35
3155506|NCT01831258|3881918|FG001|STARTED|Overall Study||35
3155507|NCT01831258|3881917|FG000|COMPLETED|Overall Study||30
3155508|NCT01831258|3881918|FG001|COMPLETED|Overall Study||32
3155509|NCT01831258|3881917|FG000|NOT COMPLETED|Overall Study||5
3184402|NCT02014402|3912698|FG002|NOT COMPLETED|Overall Study||3
3184403|NCT02014402|3912699|FG003|NOT COMPLETED|Overall Study||3
3184404|NCT02014441|3912716|FG000|STARTED|Overall Study||61
3184405|NCT02014441|3912716|FG000|Received Treatment|Overall Study||60
3184406|NCT02014441|3912716|FG000|COMPLETED|Overall Study||49
3184407|NCT02014441|3912716|FG000|NOT COMPLETED|Overall Study||12
3184408|NCT02014467|3912724|FG000|STARTED|Overall Study||365
3184409|NCT02014467|3912725|FG001|STARTED|Overall Study||119
3184410|NCT02014467|3912724|FG000|COMPLETED|Overall Study||340
3184411|NCT02014467|3912725|FG001|COMPLETED|Overall Study||112
3184412|NCT02014467|3912724|FG000|NOT COMPLETED|Overall Study||25
3184413|NCT02014467|3912725|FG001|NOT COMPLETED|Overall Study||7
3184414|NCT02014480|3912731|FG000|STARTED|Treatment Period 1 (14 Days)||35
3184415|NCT02014480|3912732|FG001|STARTED|Treatment Period 1 (14 Days)||35
3184416|NCT02014480|3912733|FG002|STARTED|Treatment Period 1 (14 Days)||34
3184417|NCT02014480|3912734|FG003|STARTED|Treatment Period 1 (14 Days)||34
3184418|NCT02014480|3912735|FG004|STARTED|Treatment Period 1 (14 Days)||35
3184419|NCT02014480|3912736|FG005|STARTED|Treatment Period 1 (14 Days)|One participant randomized to Sequence 6 actually received UMEC in Treatment Periods 2 and 3.|34
3184420|NCT02014480|3912731|FG000|COMPLETED|Treatment Period 1 (14 Days)||35
3184421|NCT02014480|3912732|FG001|COMPLETED|Treatment Period 1 (14 Days)||34
3184422|NCT02014480|3912733|FG002|COMPLETED|Treatment Period 1 (14 Days)||33
3184423|NCT02014480|3912734|FG003|COMPLETED|Treatment Period 1 (14 Days)||32
3184424|NCT02014480|3912735|FG004|COMPLETED|Treatment Period 1 (14 Days)||34
3184425|NCT02014480|3912736|FG005|COMPLETED|Treatment Period 1 (14 Days)||34
3184426|NCT02014480|3912731|FG000|NOT COMPLETED|Treatment Period 1 (14 Days)||0
3184427|NCT02014480|3912732|FG001|NOT COMPLETED|Treatment Period 1 (14 Days)||1
3184428|NCT02014480|3912733|FG002|NOT COMPLETED|Treatment Period 1 (14 Days)||1
3184429|NCT02014480|3912734|FG003|NOT COMPLETED|Treatment Period 1 (14 Days)||2
3184430|NCT02014480|3912735|FG004|NOT COMPLETED|Treatment Period 1 (14 Days)||1
3184431|NCT02014480|3912736|FG005|NOT COMPLETED|Treatment Period 1 (14 Days)||0
3184432|NCT02014480|3912731|FG000|STARTED|Washout Period 1 (10 to 14 Days)||35
3184433|NCT02014480|3912732|FG001|STARTED|Washout Period 1 (10 to 14 Days)||34
3184434|NCT02014480|3912733|FG002|STARTED|Washout Period 1 (10 to 14 Days)||33
3184435|NCT02014480|3912734|FG003|STARTED|Washout Period 1 (10 to 14 Days)||32
3184436|NCT02014480|3912735|FG004|STARTED|Washout Period 1 (10 to 14 Days)||34
3184437|NCT02014480|3912736|FG005|STARTED|Washout Period 1 (10 to 14 Days)||34
3184438|NCT02014480|3912731|FG000|COMPLETED|Washout Period 1 (10 to 14 Days)||35
3184439|NCT02014480|3912732|FG001|COMPLETED|Washout Period 1 (10 to 14 Days)||34
3184440|NCT02014480|3912733|FG002|COMPLETED|Washout Period 1 (10 to 14 Days)||32
3184441|NCT02014480|3912734|FG003|COMPLETED|Washout Period 1 (10 to 14 Days)||32
3184442|NCT02014480|3912735|FG004|COMPLETED|Washout Period 1 (10 to 14 Days)||34
3184443|NCT02014480|3912736|FG005|COMPLETED|Washout Period 1 (10 to 14 Days)||34
3184444|NCT02014480|3912731|FG000|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
3184445|NCT02014480|3912732|FG001|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
3184446|NCT02014480|3912733|FG002|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||1
3184447|NCT02014480|3912734|FG003|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
3184448|NCT02014480|3912735|FG004|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
3184449|NCT02014480|3912736|FG005|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
3184450|NCT02014480|3912731|FG000|STARTED|Treatment Period 2 (14 Days)||35
3184451|NCT02014480|3912732|FG001|STARTED|Treatment Period 2 (14 Days)||34
3184452|NCT02014480|3912733|FG002|STARTED|Treatment Period 2 (14 Days)||32
3184453|NCT02014480|3912734|FG003|STARTED|Treatment Period 2 (14 Days)||32
3184454|NCT02014480|3912735|FG004|STARTED|Treatment Period 2 (14 Days)||34
3184455|NCT02014480|3912736|FG005|STARTED|Treatment Period 2 (14 Days)||34
3184456|NCT02014480|3912731|FG000|COMPLETED|Treatment Period 2 (14 Days)||34
3184457|NCT02014480|3912732|FG001|COMPLETED|Treatment Period 2 (14 Days)||33
3184458|NCT02014480|3912733|FG002|COMPLETED|Treatment Period 2 (14 Days)||30
3184459|NCT02014480|3912734|FG003|COMPLETED|Treatment Period 2 (14 Days)||31
3184460|NCT02014480|3912735|FG004|COMPLETED|Treatment Period 2 (14 Days)||34
3184461|NCT02014480|3912736|FG005|COMPLETED|Treatment Period 2 (14 Days)||34
3184462|NCT02014480|3912731|FG000|NOT COMPLETED|Treatment Period 2 (14 Days)||1
3184463|NCT02014480|3912732|FG001|NOT COMPLETED|Treatment Period 2 (14 Days)||1
3184464|NCT02014480|3912733|FG002|NOT COMPLETED|Treatment Period 2 (14 Days)||2
3184465|NCT02014480|3912734|FG003|NOT COMPLETED|Treatment Period 2 (14 Days)||1
3184466|NCT02014480|3912735|FG004|NOT COMPLETED|Treatment Period 2 (14 Days)||0
3184467|NCT02014480|3912736|FG005|NOT COMPLETED|Treatment Period 2 (14 Days)||0
3184468|NCT02014480|3912731|FG000|STARTED|Washout Period 2 (10 to 14 Days)||34
3184469|NCT02014480|3912732|FG001|STARTED|Washout Period 2 (10 to 14 Days)||33
3184470|NCT02014480|3912733|FG002|STARTED|Washout Period 2 (10 to 14 Days)||30
3155510|NCT01831258|3881918|FG001|NOT COMPLETED|Overall Study||3
3155511|NCT01831427|3881937|FG000|STARTED|Overall Study||5
3155512|NCT01831427|3881938|FG001|STARTED|Overall Study||5
3155513|NCT01831427|3881939|FG002|STARTED|Overall Study||5
3155514|NCT01831427|3881940|FG003|STARTED|Overall Study||5
3155515|NCT01831427|3881941|FG004|STARTED|Overall Study||4
3155516|NCT01831427|3881942|FG005|STARTED|Overall Study||8
3155517|NCT01831427|3881943|FG006|STARTED|Overall Study||8
3155518|NCT01831427|3881944|FG007|STARTED|Overall Study||8
3155519|NCT01831427|3881945|FG008|STARTED|Overall Study||8
3155520|NCT01831427|3881946|FG009|STARTED|Overall Study||10
3155521|NCT01831427|3881947|FG010|STARTED|Overall Study||8
3155522|NCT01831427|3881937|FG000|COMPLETED|Overall Study||5
3155523|NCT01831427|3881938|FG001|COMPLETED|Overall Study||4
3155524|NCT01831427|3881939|FG002|COMPLETED|Overall Study||5
3155525|NCT01831427|3881940|FG003|COMPLETED|Overall Study||4
3155526|NCT01831427|3881941|FG004|COMPLETED|Overall Study||4
3155527|NCT01831427|3881942|FG005|COMPLETED|Overall Study||7
3155528|NCT01831427|3881943|FG006|COMPLETED|Overall Study||6
3155529|NCT01831427|3881944|FG007|COMPLETED|Overall Study||7
3155530|NCT01831427|3881945|FG008|COMPLETED|Overall Study||8
3155531|NCT01831427|3881946|FG009|COMPLETED|Overall Study||9
3155532|NCT01831427|3881947|FG010|COMPLETED|Overall Study||5
3184471|NCT02014480|3912734|FG003|STARTED|Washout Period 2 (10 to 14 Days)||31
3184472|NCT02014480|3912735|FG004|STARTED|Washout Period 2 (10 to 14 Days)||34
3184473|NCT02014480|3912736|FG005|STARTED|Washout Period 2 (10 to 14 Days)||34
3184474|NCT02014480|3912731|FG000|COMPLETED|Washout Period 2 (10 to 14 Days)||34
3184475|NCT02014480|3912732|FG001|COMPLETED|Washout Period 2 (10 to 14 Days)||33
3184476|NCT02014480|3912733|FG002|COMPLETED|Washout Period 2 (10 to 14 Days)||30
3184477|NCT02014480|3912734|FG003|COMPLETED|Washout Period 2 (10 to 14 Days)||31
3184478|NCT02014480|3912735|FG004|COMPLETED|Washout Period 2 (10 to 14 Days)||34
3184479|NCT02014480|3912736|FG005|COMPLETED|Washout Period 2 (10 to 14 Days)||34
3184480|NCT02014480|3912731|FG000|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
3184481|NCT02014480|3912732|FG001|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
3184482|NCT02014480|3912733|FG002|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
3184483|NCT02014480|3912734|FG003|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
3184484|NCT02014480|3912735|FG004|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
3184485|NCT02014480|3912736|FG005|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
3184486|NCT02014480|3912731|FG000|STARTED|Treatment Period 3 (14 Days)||34
3184487|NCT02014480|3912732|FG001|STARTED|Treatment Period 3 (14 Days)||33
3184488|NCT02014480|3912733|FG002|STARTED|Treatment Period 3 (14 Days)||30
3184489|NCT02014480|3912734|FG003|STARTED|Treatment Period 3 (14 Days)||31
3184490|NCT02014480|3912735|FG004|STARTED|Treatment Period 3 (14 Days)||34
3184491|NCT02014480|3912736|FG005|STARTED|Treatment Period 3 (14 Days)||34
3184492|NCT02014480|3912731|FG000|COMPLETED|Treatment Period 3 (14 Days)||34
3184493|NCT02014480|3912732|FG001|COMPLETED|Treatment Period 3 (14 Days)||32
3184494|NCT02014480|3912733|FG002|COMPLETED|Treatment Period 3 (14 Days)||29
3184495|NCT02014480|3912734|FG003|COMPLETED|Treatment Period 3 (14 Days)||31
3184496|NCT02014480|3912735|FG004|COMPLETED|Treatment Period 3 (14 Days)||34
3184497|NCT02014480|3912736|FG005|COMPLETED|Treatment Period 3 (14 Days)||32
3184498|NCT02014480|3912731|FG000|NOT COMPLETED|Treatment Period 3 (14 Days)||0
3184499|NCT02014480|3912732|FG001|NOT COMPLETED|Treatment Period 3 (14 Days)||1
3184500|NCT02014480|3912733|FG002|NOT COMPLETED|Treatment Period 3 (14 Days)||1
3184501|NCT02014480|3912734|FG003|NOT COMPLETED|Treatment Period 3 (14 Days)||0
3184502|NCT02014480|3912735|FG004|NOT COMPLETED|Treatment Period 3 (14 Days)||0
3184503|NCT02014480|3912736|FG005|NOT COMPLETED|Treatment Period 3 (14 Days)||2
3184504|NCT02014519|3912744|FG000|STARTED|Overall Study||2000
3184505|NCT02014519|3912744|FG000|COMPLETED|Overall Study||2000
3184506|NCT02014519|3912744|FG000|NOT COMPLETED|Overall Study||0
3184507|NCT02014584|3912758|FG000|STARTED|Double-Blind Period (24 Weeks)||59
3184508|NCT02014584|3912759|FG001|STARTED|Double-Blind Period (24 Weeks)||58
3184509|NCT02014584|3912760|FG002|STARTED|Double-Blind Period (24 Weeks)||0
3184510|NCT02014584|3912761|FG003|STARTED|Double-Blind Period (24 Weeks)||0
3184511|NCT02014584|3912762|FG004|STARTED|Double-Blind Period (24 Weeks)||0
3184512|NCT02014584|3912763|FG005|STARTED|Double-Blind Period (24 Weeks)||0
3184513|NCT02014584|3912758|FG000|COMPLETED|Double-Blind Period (24 Weeks)||57
3184514|NCT02014584|3912759|FG001|COMPLETED|Double-Blind Period (24 Weeks)||52
3184515|NCT02014584|3912760|FG002|COMPLETED|Double-Blind Period (24 Weeks)||0
3184516|NCT02014584|3912761|FG003|COMPLETED|Double-Blind Period (24 Weeks)||0
3184517|NCT02014584|3912762|FG004|COMPLETED|Double-Blind Period (24 Weeks)||0
3184518|NCT02014584|3912763|FG005|COMPLETED|Double-Blind Period (24 Weeks)||0
3184519|NCT02014584|3912758|FG000|NOT COMPLETED|Double-Blind Period (24 Weeks)||2
3184520|NCT02014584|3912759|FG001|NOT COMPLETED|Double-Blind Period (24 Weeks)||6
3184521|NCT02014584|3912760|FG002|NOT COMPLETED|Double-Blind Period (24 Weeks)||0
3184522|NCT02014584|3912761|FG003|NOT COMPLETED|Double-Blind Period (24 Weeks)||0
3184523|NCT02014584|3912762|FG004|NOT COMPLETED|Double-Blind Period (24 Weeks)||0
3184524|NCT02014584|3912763|FG005|NOT COMPLETED|Double-Blind Period (24 Weeks)||0
3184525|NCT02014584|3912758|FG000|STARTED|Open-Label Period (24 Weeks)||0
3184526|NCT02014584|3912759|FG001|STARTED|Open-Label Period (24 Weeks)||0
3184527|NCT02014584|3912760|FG002|STARTED|Open-Label Period (24 Weeks)||49
3184528|NCT02014584|3912761|FG003|STARTED|Open-Label Period (24 Weeks)||48
3184529|NCT02014584|3912762|FG004|STARTED|Open-Label Period (24 Weeks)||0
3184530|NCT02014584|3912763|FG005|STARTED|Open-Label Period (24 Weeks)||0
3184531|NCT02014584|3912758|FG000|COMPLETED|Open-Label Period (24 Weeks)||0
3155533|NCT01831427|3881937|FG000|NOT COMPLETED|Overall Study||0
3155534|NCT01831427|3881938|FG001|NOT COMPLETED|Overall Study||1
3155535|NCT01831427|3881939|FG002|NOT COMPLETED|Overall Study||0
3155536|NCT01831427|3881940|FG003|NOT COMPLETED|Overall Study||1
3155537|NCT01831427|3881941|FG004|NOT COMPLETED|Overall Study||0
3155538|NCT01831427|3881942|FG005|NOT COMPLETED|Overall Study||1
3155539|NCT01831427|3881943|FG006|NOT COMPLETED|Overall Study||2
3155540|NCT01831427|3881944|FG007|NOT COMPLETED|Overall Study||1
3155541|NCT01831427|3881945|FG008|NOT COMPLETED|Overall Study||0
3155542|NCT01831427|3881946|FG009|NOT COMPLETED|Overall Study||1
3155543|NCT01831427|3881947|FG010|NOT COMPLETED|Overall Study||3
3155544|NCT01831466|3881994|FG000|STARTED|Overall Study|Treated|71
3155545|NCT01831466|3881995|FG001|STARTED|Overall Study|Treated|70
3155546|NCT01831466|3881996|FG002|STARTED|Overall Study|Treated|71
3155547|NCT01831466|3881997|FG003|STARTED|Overall Study|Treated|70
3155548|NCT01831466|3881998|FG004|STARTED|Overall Study|Treated|74
3155549|NCT01831466|3881999|FG005|STARTED|Overall Study|Treated|74
3155550|NCT01831466|3882000|FG006|STARTED|Overall Study|Treated|7
3155551|NCT01831466|3882001|FG007|STARTED|Overall Study|Treated|7
3155552|NCT01831466|3882002|FG008|STARTED|Overall Study|Treated|7
3155553|NCT01831466|3882003|FG009|STARTED|Overall Study|Treated|7
3155554|NCT01831466|3882004|FG010|STARTED|Overall Study|Treated|6
3155555|NCT01831466|3882005|FG011|STARTED|Overall Study|Treated|7
3155556|NCT01831466|3881994|FG000|COMPLETED|Overall Study||55
3155557|NCT01831466|3881995|FG001|COMPLETED|Overall Study||52
3155558|NCT01831466|3881996|FG002|COMPLETED|Overall Study||48
3155559|NCT01831466|3881997|FG003|COMPLETED|Overall Study||51
3155560|NCT01831466|3881998|FG004|COMPLETED|Overall Study||57
3155561|NCT01831466|3881999|FG005|COMPLETED|Overall Study||48
3155562|NCT01831466|3882000|FG006|COMPLETED|Overall Study||6
3155563|NCT01831466|3882001|FG007|COMPLETED|Overall Study||5
3155564|NCT01831466|3882002|FG008|COMPLETED|Overall Study||4
3155565|NCT01831466|3882003|FG009|COMPLETED|Overall Study||2
3155566|NCT01831466|3882004|FG010|COMPLETED|Overall Study||4
3155567|NCT01831466|3882005|FG011|COMPLETED|Overall Study||3
3155568|NCT01831466|3881994|FG000|NOT COMPLETED|Overall Study||16
3155569|NCT01831466|3881995|FG001|NOT COMPLETED|Overall Study||18
3155570|NCT01831466|3881996|FG002|NOT COMPLETED|Overall Study||23
3155571|NCT01831466|3881997|FG003|NOT COMPLETED|Overall Study||19
3155572|NCT01831466|3881998|FG004|NOT COMPLETED|Overall Study||17
3155573|NCT01831466|3881999|FG005|NOT COMPLETED|Overall Study||26
3155574|NCT01831466|3882000|FG006|NOT COMPLETED|Overall Study||1
3155575|NCT01831466|3882001|FG007|NOT COMPLETED|Overall Study||2
3155576|NCT01831466|3882002|FG008|NOT COMPLETED|Overall Study||3
3155577|NCT01831466|3882003|FG009|NOT COMPLETED|Overall Study||5
3155578|NCT01831466|3882004|FG010|NOT COMPLETED|Overall Study||2
3155579|NCT01831466|3882005|FG011|NOT COMPLETED|Overall Study||4
3155580|NCT01831544|3882025|FG000|STARTED|Overall Study||11
3155581|NCT01831544|3882025|FG000|COMPLETED|Overall Study||8
3155582|NCT01831544|3882025|FG000|NOT COMPLETED|Overall Study||3
3155583|NCT01831726|3882029|FG000|STARTED|Overall Study||80
3155584|NCT01831726|3882029|FG000|COMPLETED|Overall Study||0
3155585|NCT01831726|3882029|FG000|NOT COMPLETED|Overall Study||80
3155586|NCT01831765|3882036|FG000|STARTED|Overall Study||381
3155587|NCT01831765|3882037|FG001|STARTED|Overall Study||382
3155588|NCT01831765|3882038|FG002|STARTED|Overall Study||380
3155589|NCT01831765|3882036|FG000|Completed 26 Weeks|Overall Study||351
3155590|NCT01831765|3882037|FG001|Completed 26 Weeks|Overall Study||355
3155591|NCT01831765|3882038|FG002|Completed 26 Weeks|Overall Study||356
3155592|NCT01831765|3882036|FG000|Completed 52 Weeks|Overall Study||337
3155593|NCT01831765|3882037|FG001|Completed 52 Weeks|Overall Study|This arm did not continue in the trial after 26 weeks ( 26 to 52 weeks).|0
3155594|NCT01831765|3882038|FG002|Completed 52 Weeks|Overall Study||338
3155595|NCT01831765|3882036|FG000|COMPLETED|Overall Study||337
3155596|NCT01831765|3882037|FG001|COMPLETED|Overall Study||355
3155597|NCT01831765|3882038|FG002|COMPLETED|Overall Study||338
3155598|NCT01831765|3882036|FG000|NOT COMPLETED|Overall Study||44
3155599|NCT01831765|3882037|FG001|NOT COMPLETED|Overall Study||27
3155600|NCT01831765|3882038|FG002|NOT COMPLETED|Overall Study||42
3155601|NCT01831791|3882048|FG000|STARTED|Overall Study||120
3155602|NCT01831791|3882048|FG000|COMPLETED|Overall Study||110
3155603|NCT01831791|3882048|FG000|NOT COMPLETED|Overall Study||10
3155604|NCT01831804|3882061|FG000|STARTED|Overall Study||4
3155605|NCT01831804|3882062|FG001|STARTED|Overall Study||3
3155606|NCT01831804|3882063|FG002|STARTED|Overall Study||9
3155607|NCT01831804|3882064|FG003|STARTED|Overall Study||5
3155608|NCT01831804|3882065|FG004|STARTED|Overall Study||5
3155609|NCT01831804|3882066|FG005|STARTED|Overall Study||3
3155610|NCT01831804|3882067|FG006|STARTED|Overall Study||4
3155611|NCT01831804|3882068|FG007|STARTED|Overall Study||26
3155612|NCT01831804|3882069|FG008|STARTED|Overall Study||4
3155613|NCT01831804|3882061|FG000|COMPLETED|Overall Study||3
3155614|NCT01831804|3882062|FG001|COMPLETED|Overall Study||1
3155615|NCT01831804|3882063|FG002|COMPLETED|Overall Study||3
3155616|NCT01831804|3882064|FG003|COMPLETED|Overall Study||5
3155617|NCT01831804|3882065|FG004|COMPLETED|Overall Study||3
3155618|NCT01831804|3882066|FG005|COMPLETED|Overall Study||3
3155619|NCT01831804|3882067|FG006|COMPLETED|Overall Study||3
3155620|NCT01831804|3882068|FG007|COMPLETED|Overall Study||23
3155621|NCT01831804|3882069|FG008|COMPLETED|Overall Study||2
3155622|NCT01831804|3882061|FG000|NOT COMPLETED|Overall Study||1
3155623|NCT01831804|3882062|FG001|NOT COMPLETED|Overall Study||2
3155624|NCT01831804|3882063|FG002|NOT COMPLETED|Overall Study||6
3155625|NCT01831804|3882064|FG003|NOT COMPLETED|Overall Study||0
3155626|NCT01831804|3882065|FG004|NOT COMPLETED|Overall Study||2
3155627|NCT01831804|3882066|FG005|NOT COMPLETED|Overall Study||0
3155628|NCT01831804|3882067|FG006|NOT COMPLETED|Overall Study||1
3155629|NCT01831804|3882068|FG007|NOT COMPLETED|Overall Study||3
3155630|NCT01831804|3882069|FG008|NOT COMPLETED|Overall Study||2
3155631|NCT01831817|3882102|FG000|STARTED|Overall Study||35
3155632|NCT01831817|3882103|FG001|STARTED|Overall Study||34
3155633|NCT01831817|3882104|FG002|STARTED|Overall Study||35
3155634|NCT01831817|3882105|FG003|STARTED|Overall Study||36
3155635|NCT01831817|3882102|FG000|COMPLETED|Overall Study||31
3155636|NCT01831817|3882103|FG001|COMPLETED|Overall Study||34
3155637|NCT01831817|3882104|FG002|COMPLETED|Overall Study||35
3155638|NCT01831817|3882105|FG003|COMPLETED|Overall Study||36
3155639|NCT01831817|3882102|FG000|NOT COMPLETED|Overall Study||4
3155640|NCT01831817|3882103|FG001|NOT COMPLETED|Overall Study||0
3155641|NCT01831817|3882104|FG002|NOT COMPLETED|Overall Study||0
3155642|NCT01831817|3882105|FG003|NOT COMPLETED|Overall Study||0
3155643|NCT01831856|3882117|FG000|STARTED|Overall Study||67
3155644|NCT01831856|3882118|FG001|STARTED|Overall Study||67
3155645|NCT01831856|3882117|FG000|COMPLETED|Overall Study||33
3155646|NCT01831856|3882118|FG001|COMPLETED|Overall Study||30
3155647|NCT01831856|3882117|FG000|NOT COMPLETED|Overall Study||34
3155648|NCT01831856|3882118|FG001|NOT COMPLETED|Overall Study||37
3155649|NCT01831921|3882126|FG000|STARTED|Overall Study||150
3155650|NCT01831921|3882127|FG001|STARTED|Overall Study||75
3155651|NCT01831921|3882126|FG000|6 Months|Overall Study||122
3155652|NCT01831921|3882127|FG001|6 Months|Overall Study||63
3155653|NCT01831921|3882126|FG000|12 Months|Overall Study|All participants were followed for 12 months to 24 months, depending on date of randomization.|120
3155654|NCT01831921|3882127|FG001|12 Months|Overall Study||62
3155655|NCT01831921|3882126|FG000|18 Months|Overall Study|Of 118 eligible for this visit.|90
3155656|NCT01831921|3882127|FG001|18 Months|Overall Study|Of 59 eligible for this visit.|49
3155657|NCT01831921|3882126|FG000|COMPLETED|Overall Study|Of 85 eligible for this visit.|66
3155658|NCT01831921|3882127|FG001|COMPLETED|Overall Study|Of 42 eligible for this visit.|36
3155659|NCT01831921|3882126|FG000|NOT COMPLETED|Overall Study||84
3155660|NCT01831921|3882127|FG001|NOT COMPLETED|Overall Study||39
3155661|NCT01831934|3882138|FG000|STARTED|Overall Study||12
3155662|NCT01831934|3882139|FG001|STARTED|Overall Study||10
3155663|NCT01831934|3882138|FG000|COMPLETED|Overall Study|Volunteer consented but not enrolled after reporting a prior bad reaction to influenza vaccine.|11
3155664|NCT01831934|3882139|FG001|COMPLETED|Overall Study||10
3155665|NCT01831934|3882138|FG000|NOT COMPLETED|Overall Study||1
3155666|NCT01831934|3882139|FG001|NOT COMPLETED|Overall Study||0
3155667|NCT01831960|3882147|FG000|STARTED|Overall Study||20
3155668|NCT01831960|3882148|FG001|STARTED|Overall Study||22
3155669|NCT01831960|3882147|FG000|COMPLETED|Overall Study||20
3155670|NCT01831960|3882148|FG001|COMPLETED|Overall Study||22
3155671|NCT01831960|3882147|FG000|NOT COMPLETED|Overall Study||0
3155672|NCT01831960|3882148|FG001|NOT COMPLETED|Overall Study||0
3155673|NCT01832038|3882155|FG000|STARTED|Overall Study||473
3155674|NCT01832038|3882155|FG000|COMPLETED|Overall Study||238
3155675|NCT01832038|3882155|FG000|NOT COMPLETED|Overall Study||235
3155676|NCT01832090|3882162|FG000|STARTED|Overall Study||89
3155677|NCT01832090|3882163|FG001|STARTED|Overall Study||29
3155678|NCT01832090|3882162|FG000|COMPLETED|Overall Study||83
3155679|NCT01832090|3882163|FG001|COMPLETED|Overall Study||28
3155680|NCT01832090|3882162|FG000|NOT COMPLETED|Overall Study||6
3155681|NCT01832090|3882163|FG001|NOT COMPLETED|Overall Study||1
3155682|NCT01832155|3882191|FG000|STARTED|Beginning of Study: Baseline at 0 Week||18
3155683|NCT01832155|3882192|FG001|STARTED|Beginning of Study: Baseline at 0 Week||18
3155684|NCT01832155|3882191|FG000|COMPLETED|Beginning of Study: Baseline at 0 Week||17
3155685|NCT01832155|3882192|FG001|COMPLETED|Beginning of Study: Baseline at 0 Week||18
3155686|NCT01832155|3882191|FG000|NOT COMPLETED|Beginning of Study: Baseline at 0 Week||1
3155687|NCT01832155|3882192|FG001|NOT COMPLETED|Beginning of Study: Baseline at 0 Week||0
3155688|NCT01832155|3882191|FG000|STARTED|Mid-point of Study: 0 - 4 Weeks||17
3155689|NCT01832155|3882192|FG001|STARTED|Mid-point of Study: 0 - 4 Weeks||18
3155690|NCT01832155|3882191|FG000|COMPLETED|Mid-point of Study: 0 - 4 Weeks||16
3155691|NCT01832155|3882192|FG001|COMPLETED|Mid-point of Study: 0 - 4 Weeks||18
3155692|NCT01832155|3882191|FG000|NOT COMPLETED|Mid-point of Study: 0 - 4 Weeks||1
3155693|NCT01832155|3882192|FG001|NOT COMPLETED|Mid-point of Study: 0 - 4 Weeks||0
3155694|NCT01832155|3882191|FG000|STARTED|End of Study: 4 - 8 Weeks||16
3155695|NCT01832155|3882192|FG001|STARTED|End of Study: 4 - 8 Weeks||18
3155696|NCT01832155|3882191|FG000|COMPLETED|End of Study: 4 - 8 Weeks||16
3155697|NCT01832155|3882192|FG001|COMPLETED|End of Study: 4 - 8 Weeks||18
3155698|NCT01832155|3882191|FG000|NOT COMPLETED|End of Study: 4 - 8 Weeks||0
3155699|NCT01832155|3882192|FG001|NOT COMPLETED|End of Study: 4 - 8 Weeks||0
3155700|NCT01832259|3882206|FG000|STARTED|Overall Study||15
3155701|NCT01832259|3882207|FG001|STARTED|Overall Study||15
3155702|NCT01832259|3882206|FG000|COMPLETED|Overall Study||15
3155703|NCT01832259|3882207|FG001|COMPLETED|Overall Study||15
3155704|NCT01832259|3882206|FG000|NOT COMPLETED|Overall Study||0
3155705|NCT01832259|3882207|FG001|NOT COMPLETED|Overall Study||0
3155706|NCT01832402|3882215|FG000|STARTED|Overall Study||19
3155707|NCT01832402|3882216|FG001|STARTED|Overall Study||16
3155708|NCT01832402|3882215|FG000|Received Allocated Medication|Overall Study||12
3155709|NCT01832402|3882216|FG001|Received Allocated Medication|Overall Study||12
3155710|NCT01832402|3882215|FG000|Completed Study With Correct Dose|Overall Study||10
3155711|NCT01832402|3882216|FG001|Completed Study With Correct Dose|Overall Study||9
3155712|NCT01832402|3882215|FG000|Completed Study With Incorrect Dose|Overall Study||2
3155713|NCT01832402|3882216|FG001|Completed Study With Incorrect Dose|Overall Study||3
3155714|NCT01832402|3882215|FG000|COMPLETED|Overall Study||12
3155715|NCT01832402|3882216|FG001|COMPLETED|Overall Study||12
3155716|NCT01832402|3882215|FG000|NOT COMPLETED|Overall Study||7
3155717|NCT01832402|3882216|FG001|NOT COMPLETED|Overall Study||4
3155718|NCT01832480|3882228|FG000|STARTED|Overall Study||311
3184532|NCT02014584|3912759|FG001|COMPLETED|Open-Label Period (24 Weeks)||0
3184533|NCT02014584|3912760|FG002|COMPLETED|Open-Label Period (24 Weeks)||44
3184534|NCT02014584|3912761|FG003|COMPLETED|Open-Label Period (24 Weeks)||47
3184535|NCT02014584|3912762|FG004|COMPLETED|Open-Label Period (24 Weeks)||0
3184536|NCT02014584|3912763|FG005|COMPLETED|Open-Label Period (24 Weeks)||0
3184537|NCT02014584|3912758|FG000|NOT COMPLETED|Open-Label Period (24 Weeks)||0
3184538|NCT02014584|3912759|FG001|NOT COMPLETED|Open-Label Period (24 Weeks)||0
3184539|NCT02014584|3912760|FG002|NOT COMPLETED|Open-Label Period (24 Weeks)||5
3184540|NCT02014584|3912761|FG003|NOT COMPLETED|Open-Label Period (24 Weeks)||1
3184541|NCT02014584|3912762|FG004|NOT COMPLETED|Open-Label Period (24 Weeks)||0
3184542|NCT02014584|3912763|FG005|NOT COMPLETED|Open-Label Period (24 Weeks)||0
3184543|NCT02014584|3912758|FG000|STARTED|Target Follow-up (F/U) Period (24 Weeks)||0
3184544|NCT02014584|3912759|FG001|STARTED|Target Follow-up (F/U) Period (24 Weeks)||0
3184545|NCT02014584|3912760|FG002|STARTED|Target Follow-up (F/U) Period (24 Weeks)||0
3184546|NCT02014584|3912761|FG003|STARTED|Target Follow-up (F/U) Period (24 Weeks)||0
3184547|NCT02014584|3912762|FG004|STARTED|Target Follow-up (F/U) Period (24 Weeks)||3
3184548|NCT02014584|3912763|FG005|STARTED|Target Follow-up (F/U) Period (24 Weeks)||2
3184549|NCT02014584|3912758|FG000|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
3184550|NCT02014584|3912759|FG001|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
3184551|NCT02014584|3912760|FG002|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
3184552|NCT02014584|3912761|FG003|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
3184553|NCT02014584|3912762|FG004|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||2
3184554|NCT02014584|3912763|FG005|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||2
3184555|NCT02014584|3912758|FG000|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
3184556|NCT02014584|3912759|FG001|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
3184557|NCT02014584|3912760|FG002|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
3184558|NCT02014584|3912761|FG003|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
3184559|NCT02014584|3912762|FG004|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||1
3184560|NCT02014584|3912763|FG005|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
3184561|NCT02014597|3912777|FG000|STARTED|Overall Study||12
3184562|NCT02014597|3912778|FG001|STARTED|Overall Study||11
3184563|NCT02014597|3912777|FG000|COMPLETED|Overall Study||10
3184564|NCT02014597|3912778|FG001|COMPLETED|Overall Study||10
3363823|NCT04041453|4094992|FG001|Safety Population|Overall Study||56
3363824|NCT04041453|4094993|FG002|Safety Population|Overall Study||23
3363825|NCT04041453|4094994|FG003|Safety Population|Overall Study||58
3363826|NCT04041453|4094991|FG000|COMPLETED|Overall Study||24
3363827|NCT04041453|4094992|FG001|COMPLETED|Overall Study||35
3363828|NCT04041453|4094993|FG002|COMPLETED|Overall Study||18
3363829|NCT04041453|4094994|FG003|COMPLETED|Overall Study||40
3363830|NCT04041453|4094991|FG000|NOT COMPLETED|Overall Study||14
3363831|NCT04041453|4094992|FG001|NOT COMPLETED|Overall Study||22
3363832|NCT04041453|4094993|FG002|NOT COMPLETED|Overall Study||5
3363833|NCT04041453|4094994|FG003|NOT COMPLETED|Overall Study||18
3363834|NCT04041414|4095008|FG000|STARTED|Overall Study||27
3363835|NCT04041414|4095009|FG001|STARTED|Overall Study||20
3363836|NCT04041414|4095008|FG000|COMPLETED|Overall Study||26
3363837|NCT04041414|4095009|FG001|COMPLETED|Overall Study||18
3363838|NCT04041414|4095008|FG000|NOT COMPLETED|Overall Study||1
3363839|NCT04041414|4095009|FG001|NOT COMPLETED|Overall Study||2
3363840|NCT04041219|4095018|FG000|STARTED|Overall Study||10
3363841|NCT04041219|4095018|FG000|COMPLETED|Overall Study||10
3363842|NCT04041219|4095018|FG000|NOT COMPLETED|Overall Study||0
3363843|NCT04041700|4095022|FG000|STARTED|Overall Study||29
3363844|NCT04041700|4095022|FG000|COMPLETED|Overall Study||27
3363845|NCT04041700|4095022|FG000|NOT COMPLETED|Overall Study||2
3363846|NCT04040933|4095026|FG000|STARTED|Overall Study||36
3363847|NCT04040933|4095026|FG000|Treated|Overall Study||36
3363848|NCT04040933|4095026|FG000|COMPLETED|Overall Study||33
3363849|NCT04040933|4095026|FG000|NOT COMPLETED|Overall Study||3
3363850|NCT04039867|4095037|FG000|STARTED|Overall Study||17
3363851|NCT04039867|4095037|FG000|COMPLETED|Overall Study||17
3363852|NCT04039867|4095037|FG000|NOT COMPLETED|Overall Study||0
3363853|NCT04039412|4095044|FG000|STARTED|Overall Study||110
3363854|NCT04039412|4095045|FG001|STARTED|Overall Study||110
3363855|NCT04039412|4095046|FG002|STARTED|Overall Study||110
3363856|NCT04039412|4095044|FG000|COMPLETED|Overall Study||109
3363857|NCT04039412|4095045|FG001|COMPLETED|Overall Study||107
3363858|NCT04039412|4095046|FG002|COMPLETED|Overall Study||108
3155719|NCT01832480|3882229|FG001|STARTED|Overall Study||312
3155720|NCT01832480|3882228|FG000|COMPLETED|Overall Study||270
3155721|NCT01832480|3882229|FG001|COMPLETED|Overall Study||270
3155722|NCT01832480|3882228|FG000|NOT COMPLETED|Overall Study||41
3155723|NCT01832480|3882229|FG001|NOT COMPLETED|Overall Study||42
3155724|NCT01832493|3882235|FG000|STARTED|Overall Study||50
3155725|NCT01832493|3882235|FG000|COMPLETED|Overall Study||42
3155726|NCT01832493|3882235|FG000|NOT COMPLETED|Overall Study||8
3155727|NCT01832506|3882242|FG000|STARTED|Overall Study||3
3155728|NCT01832506|3882243|FG001|STARTED|Overall Study||3
3155729|NCT01832506|3882244|FG002|STARTED|Overall Study||6
3155730|NCT01832506|3882242|FG000|COMPLETED|Overall Study||3
3155731|NCT01832506|3882243|FG001|COMPLETED|Overall Study||3
3155732|NCT01832506|3882244|FG002|COMPLETED|Overall Study||6
3155733|NCT01832506|3882242|FG000|NOT COMPLETED|Overall Study||0
3155734|NCT01832506|3882243|FG001|NOT COMPLETED|Overall Study||0
3155735|NCT01832506|3882244|FG002|NOT COMPLETED|Overall Study||0
3155736|NCT01832532|3882259|FG000|STARTED|Overall Study||23
3155737|NCT01832532|3882260|FG001|STARTED|Overall Study||11
3155738|NCT01832532|3882259|FG000|COMPLETED|Overall Study||18
3155739|NCT01832532|3882260|FG001|COMPLETED|Overall Study||9
3155740|NCT01832532|3882259|FG000|NOT COMPLETED|Overall Study||5
3155741|NCT01832532|3882260|FG001|NOT COMPLETED|Overall Study||2
3155742|NCT01832610|3882266|FG000|STARTED|Overall Study||101
3155743|NCT01832610|3882266|FG000|COMPLETED|Overall Study||97
3155744|NCT01832610|3882266|FG000|NOT COMPLETED|Overall Study||4
3155745|NCT01832727|3882279|FG000|STARTED|Overall Study||9
3155746|NCT01832727|3882280|FG001|STARTED|Overall Study||7
3155747|NCT01832727|3882281|FG002|STARTED|Overall Study||3
3155748|NCT01832727|3882282|FG003|STARTED|Overall Study||4
3155749|NCT01832727|3882283|FG004|STARTED|Overall Study||4
3155750|NCT01832727|3882284|FG005|STARTED|Overall Study||6
3155751|NCT01832727|3882285|FG006|STARTED|Overall Study||8
3155752|NCT01832727|3882286|FG007|STARTED|Overall Study||6
3155753|NCT01832727|3882287|FG008|STARTED|Overall Study||18
3155754|NCT01832727|3882279|FG000|COMPLETED|Overall Study||0
3155755|NCT01832727|3882280|FG001|COMPLETED|Overall Study||0
3155756|NCT01832727|3882281|FG002|COMPLETED|Overall Study||0
3155757|NCT01832727|3882282|FG003|COMPLETED|Overall Study||0
3155758|NCT01832727|3882283|FG004|COMPLETED|Overall Study||0
3155759|NCT01832727|3882284|FG005|COMPLETED|Overall Study||0
3155760|NCT01832727|3882285|FG006|COMPLETED|Overall Study||0
3155761|NCT01832727|3882286|FG007|COMPLETED|Overall Study||0
3155762|NCT01832727|3882287|FG008|COMPLETED|Overall Study||0
3155763|NCT01832727|3882279|FG000|NOT COMPLETED|Overall Study||9
3184565|NCT02014597|3912777|FG000|NOT COMPLETED|Overall Study||2
3184566|NCT02014597|3912778|FG001|NOT COMPLETED|Overall Study||1
3184567|NCT02014740|3912786|FG000|STARTED|Overall Study||55
3184568|NCT02014740|3912787|FG001|STARTED|Overall Study||45
3184569|NCT02014740|3912786|FG000|COMPLETED|Overall Study||49
3184570|NCT02014740|3912787|FG001|COMPLETED|Overall Study||40
3184571|NCT02014740|3912786|FG000|NOT COMPLETED|Overall Study||6
3184572|NCT02014740|3912787|FG001|NOT COMPLETED|Overall Study||5
3184573|NCT02015039|3912795|FG000|STARTED|Overall Study||6
3184574|NCT02015039|3912796|FG001|STARTED|Overall Study||7
3184575|NCT02015039|3912795|FG000|COMPLETED|Overall Study||6
3184576|NCT02015039|3912796|FG001|COMPLETED|Overall Study||6
3184577|NCT02015039|3912795|FG000|NOT COMPLETED|Overall Study||0
3184578|NCT02015039|3912796|FG001|NOT COMPLETED|Overall Study||1
3184579|NCT02015065|3912805|FG000|STARTED|Overall Study||2
3184580|NCT02015065|3912806|FG001|STARTED|Overall Study||5
3184581|NCT02015065|3912807|FG002|STARTED|Overall Study||2
3184582|NCT02015065|3912805|FG000|COMPLETED|Overall Study||1
3184583|NCT02015065|3912806|FG001|COMPLETED|Overall Study||3
3184584|NCT02015065|3912807|FG002|COMPLETED|Overall Study||1
3184585|NCT02015065|3912805|FG000|NOT COMPLETED|Overall Study||1
3184586|NCT02015065|3912806|FG001|NOT COMPLETED|Overall Study||2
3184587|NCT02015065|3912807|FG002|NOT COMPLETED|Overall Study||1
3184588|NCT02015104|3912817|FG000|STARTED|Overall Study||16
3184589|NCT02015104|3912818|FG001|STARTED|Overall Study||16
3184590|NCT02015104|3912817|FG000|COMPLETED|Overall Study||15
3184591|NCT02015104|3912818|FG001|COMPLETED|Overall Study||15
3184592|NCT02015104|3912817|FG000|NOT COMPLETED|Overall Study||1
3184593|NCT02015104|3912818|FG001|NOT COMPLETED|Overall Study||1
3184594|NCT02015195|3912834|FG000|STARTED|Overall Study||16
3184595|NCT02015195|3912835|FG001|STARTED|Overall Study||16
3184596|NCT02015195|3912836|FG002|STARTED|Overall Study||16
3184597|NCT02015195|3912837|FG003|STARTED|Overall Study||1
3184598|NCT02015195|3912838|FG004|STARTED|Overall Study||16
3184599|NCT02015195|3912839|FG005|STARTED|Overall Study||16
3184600|NCT02015195|3912840|FG006|STARTED|Overall Study||16
3184601|NCT02015195|3912834|FG000|COMPLETED|Overall Study||16
3184602|NCT02015195|3912835|FG001|COMPLETED|Overall Study||16
3184603|NCT02015195|3912836|FG002|COMPLETED|Overall Study||16
3184604|NCT02015195|3912837|FG003|COMPLETED|Overall Study||0
3184605|NCT02015195|3912838|FG004|COMPLETED|Overall Study||16
3184606|NCT02015195|3912839|FG005|COMPLETED|Overall Study||16
3184607|NCT02015195|3912840|FG006|COMPLETED|Overall Study||16
3155764|NCT01832727|3882280|FG001|NOT COMPLETED|Overall Study||7
3155765|NCT01832727|3882281|FG002|NOT COMPLETED|Overall Study||3
3155766|NCT01832727|3882282|FG003|NOT COMPLETED|Overall Study||4
3155767|NCT01832727|3882283|FG004|NOT COMPLETED|Overall Study||4
3155768|NCT01832727|3882284|FG005|NOT COMPLETED|Overall Study||6
3155769|NCT01832727|3882285|FG006|NOT COMPLETED|Overall Study||8
3155770|NCT01832727|3882286|FG007|NOT COMPLETED|Overall Study||6
3155771|NCT01832727|3882287|FG008|NOT COMPLETED|Overall Study||18
3155772|NCT01832753|3882319|FG000|STARTED|Observation Phase (Months 0-6)||5
3155773|NCT01832753|3882320|FG001|STARTED|Observation Phase (Months 0-6)||4
3155774|NCT01832753|3882321|FG002|STARTED|Observation Phase (Months 0-6)||3
3155775|NCT01832753|3882319|FG000|COMPLETED|Observation Phase (Months 0-6)||5
3155776|NCT01832753|3882320|FG001|COMPLETED|Observation Phase (Months 0-6)||4
3184608|NCT02015195|3912834|FG000|NOT COMPLETED|Overall Study||0
3184609|NCT02015195|3912835|FG001|NOT COMPLETED|Overall Study||0
3184610|NCT02015195|3912836|FG002|NOT COMPLETED|Overall Study||0
3184611|NCT02015195|3912837|FG003|NOT COMPLETED|Overall Study||1
3155777|NCT01832753|3882321|FG002|COMPLETED|Observation Phase (Months 0-6)||1
3155778|NCT01832753|3882319|FG000|NOT COMPLETED|Observation Phase (Months 0-6)||0
3155779|NCT01832753|3882320|FG001|NOT COMPLETED|Observation Phase (Months 0-6)||0
3155780|NCT01832753|3882321|FG002|NOT COMPLETED|Observation Phase (Months 0-6)||2
3155781|NCT01832753|3882319|FG000|STARTED|Randomization Phase (Months 6-12)||5
3155782|NCT01832753|3882320|FG001|STARTED|Randomization Phase (Months 6-12)||4
3155783|NCT01832753|3882321|FG002|STARTED|Randomization Phase (Months 6-12)|1 subject was not randomized as they did not meet inclusion criteria at the end of observation phase|0
3155784|NCT01832753|3882319|FG000|COMPLETED|Randomization Phase (Months 6-12)||4
3155785|NCT01832753|3882320|FG001|COMPLETED|Randomization Phase (Months 6-12)||3
3155786|NCT01832753|3882321|FG002|COMPLETED|Randomization Phase (Months 6-12)||0
3155787|NCT01832753|3882319|FG000|NOT COMPLETED|Randomization Phase (Months 6-12)||1
3155788|NCT01832753|3882320|FG001|NOT COMPLETED|Randomization Phase (Months 6-12)||1
3155789|NCT01832753|3882321|FG002|NOT COMPLETED|Randomization Phase (Months 6-12)||0
3155790|NCT01832753|3882319|FG000|STARTED|Open Label Dose Phase (Months 12-18)||3
3155791|NCT01832753|3882320|FG001|STARTED|Open Label Dose Phase (Months 12-18)||3
3155792|NCT01832753|3882321|FG002|STARTED|Open Label Dose Phase (Months 12-18)||0
3155793|NCT01832753|3882319|FG000|COMPLETED|Open Label Dose Phase (Months 12-18)||3
3155794|NCT01832753|3882320|FG001|COMPLETED|Open Label Dose Phase (Months 12-18)||3
3155795|NCT01832753|3882321|FG002|COMPLETED|Open Label Dose Phase (Months 12-18)||0
3155796|NCT01832753|3882319|FG000|NOT COMPLETED|Open Label Dose Phase (Months 12-18)||0
3155797|NCT01832753|3882320|FG001|NOT COMPLETED|Open Label Dose Phase (Months 12-18)||0
3155798|NCT01832753|3882321|FG002|NOT COMPLETED|Open Label Dose Phase (Months 12-18)||0
3155799|NCT01832766|3882330|FG000|STARTED|First Intervention||7
3155800|NCT01832766|3882331|FG001|STARTED|First Intervention||6
3155801|NCT01832766|3882330|FG000|COMPLETED|First Intervention||7
3155802|NCT01832766|3882331|FG001|COMPLETED|First Intervention|one participant did not return for cross over visit|6
3155803|NCT01832766|3882330|FG000|NOT COMPLETED|First Intervention||0
3155804|NCT01832766|3882331|FG001|NOT COMPLETED|First Intervention||0
3155805|NCT01832766|3882330|FG000|STARTED|Washout||7
3155806|NCT01832766|3882331|FG001|STARTED|Washout||6
3155807|NCT01832766|3882330|FG000|COMPLETED|Washout||7
3155808|NCT01832766|3882331|FG001|COMPLETED|Washout||5
3155809|NCT01832766|3882330|FG000|NOT COMPLETED|Washout||0
3155810|NCT01832766|3882331|FG001|NOT COMPLETED|Washout||1
3155811|NCT01832766|3882330|FG000|STARTED|Second Intervention||7
3155812|NCT01832766|3882331|FG001|STARTED|Second Intervention||5
3155813|NCT01832766|3882330|FG000|COMPLETED|Second Intervention||7
3155814|NCT01832766|3882331|FG001|COMPLETED|Second Intervention||5
3155815|NCT01832766|3882330|FG000|NOT COMPLETED|Second Intervention||0
3155816|NCT01832766|3882331|FG001|NOT COMPLETED|Second Intervention||0
3155817|NCT01832818|3882337|FG000|STARTED|Overall Study||14
3155818|NCT01832818|3882337|FG000|COMPLETED|Overall Study||8
3155819|NCT01832818|3882337|FG000|NOT COMPLETED|Overall Study||6
3155820|NCT01832961|3882341|FG000|STARTED|First Intervention||8
3155821|NCT01832961|3882342|FG001|STARTED|First Intervention||7
3155822|NCT01832961|3882341|FG000|COMPLETED|First Intervention||8
3155823|NCT01832961|3882342|FG001|COMPLETED|First Intervention||7
3155824|NCT01832961|3882341|FG000|NOT COMPLETED|First Intervention||0
3155825|NCT01832961|3882342|FG001|NOT COMPLETED|First Intervention||0
3155826|NCT01832961|3882341|FG000|STARTED|Washout||8
3155827|NCT01832961|3882342|FG001|STARTED|Washout||7
3155828|NCT01832961|3882341|FG000|COMPLETED|Washout||8
3155829|NCT01832961|3882342|FG001|COMPLETED|Washout||7
3155830|NCT01832961|3882341|FG000|NOT COMPLETED|Washout||0
3155831|NCT01832961|3882342|FG001|NOT COMPLETED|Washout||0
3155832|NCT01832961|3882341|FG000|STARTED|Second Intervention||8
3155833|NCT01832961|3882342|FG001|STARTED|Second Intervention||7
3155834|NCT01832961|3882341|FG000|COMPLETED|Second Intervention||8
3155835|NCT01832961|3882342|FG001|COMPLETED|Second Intervention||7
3155836|NCT01832961|3882341|FG000|NOT COMPLETED|Second Intervention||0
3155837|NCT01832961|3882342|FG001|NOT COMPLETED|Second Intervention||0
3155838|NCT01832961|3882341|FG000|STARTED|Third Intervention||8
3155839|NCT01832961|3882342|FG001|STARTED|Third Intervention||7
3184612|NCT02015195|3912838|FG004|NOT COMPLETED|Overall Study||0
3184613|NCT02015195|3912839|FG005|NOT COMPLETED|Overall Study||0
3184614|NCT02015195|3912840|FG006|NOT COMPLETED|Overall Study||0
3184615|NCT02015221|3912857|FG000|STARTED|Overall Study||41
3184616|NCT02015221|3912858|FG001|STARTED|Overall Study||40
3184617|NCT02015221|3912857|FG000|COMPLETED|Overall Study||32
3155840|NCT01832961|3882341|FG000|COMPLETED|Third Intervention||8
3155841|NCT01832961|3882342|FG001|COMPLETED|Third Intervention||7
3155842|NCT01832961|3882341|FG000|NOT COMPLETED|Third Intervention||0
3155843|NCT01832961|3882342|FG001|NOT COMPLETED|Third Intervention||0
3155844|NCT01833026|3882359|FG000|STARTED|Overall Study||22
3155845|NCT01833026|3882360|FG001|STARTED|Overall Study||34
3155846|NCT01833026|3882359|FG000|COMPLETED|Overall Study||22
3155847|NCT01833026|3882360|FG001|COMPLETED|Overall Study||34
3155848|NCT01833026|3882359|FG000|NOT COMPLETED|Overall Study||0
3155849|NCT01833026|3882360|FG001|NOT COMPLETED|Overall Study||0
3155850|NCT01833065|3882369|FG000|STARTED|Overall Study|Randomized patients - As treated|65
3155851|NCT01833065|3882370|FG001|STARTED|Overall Study|Randomized patients - As treated|53
3155852|NCT01833065|3882371|FG002|STARTED|Overall Study|Randomized patients - As treated|35
3155853|NCT01833065|3882372|FG003|STARTED|Overall Study|Randomized patients - As treated|50
3155854|NCT01833065|3882373|FG004|STARTED|Overall Study|Randomized patients - As treated|110
3155855|NCT01833065|3882369|FG000|Intention-to-treat Analysis Set|Overall Study|Randomized patients|50
3155856|NCT01833065|3882370|FG001|Intention-to-treat Analysis Set|Overall Study|Randomized patients|53
3155857|NCT01833065|3882371|FG002|Intention-to-treat Analysis Set|Overall Study|Randomized patients|50
3155858|NCT01833065|3882372|FG003|Intention-to-treat Analysis Set|Overall Study|Randomized patients|50
3155859|NCT01833065|3882373|FG004|Intention-to-treat Analysis Set|Overall Study|Randomized patients|111
3155860|NCT01833065|3882369|FG000|COMPLETED|Overall Study||41
3155861|NCT01833065|3882370|FG001|COMPLETED|Overall Study||40
3155862|NCT01833065|3882371|FG002|COMPLETED|Overall Study||23
3155863|NCT01833065|3882372|FG003|COMPLETED|Overall Study||41
3155864|NCT01833065|3882373|FG004|COMPLETED|Overall Study||74
3155865|NCT01833065|3882369|FG000|NOT COMPLETED|Overall Study||24
3155866|NCT01833065|3882370|FG001|NOT COMPLETED|Overall Study||13
3155867|NCT01833065|3882371|FG002|NOT COMPLETED|Overall Study||12
3155868|NCT01833065|3882372|FG003|NOT COMPLETED|Overall Study||9
3155869|NCT01833065|3882373|FG004|NOT COMPLETED|Overall Study||36
3155870|NCT01833078|3882383|FG000|STARTED|Overall Study||5
3155871|NCT01833078|3882383|FG000|COMPLETED|Overall Study||5
3155872|NCT01833078|3882383|FG000|NOT COMPLETED|Overall Study||0
3155873|NCT01833117|3882389|FG000|STARTED|Overall Study||43
3155874|NCT01833117|3882390|FG001|STARTED|Overall Study||19
3155875|NCT01833117|3882389|FG000|COMPLETED|Overall Study||43
3155876|NCT01833117|3882390|FG001|COMPLETED|Overall Study||19
3155877|NCT01833117|3882389|FG000|NOT COMPLETED|Overall Study||0
3155878|NCT01833117|3882390|FG001|NOT COMPLETED|Overall Study||0
3155879|NCT01833130|3882398|FG000|STARTED|Overall Study||25
3155880|NCT01833130|3882399|FG001|STARTED|Overall Study||27
3155881|NCT01833130|3882398|FG000|COMPLETED|Overall Study||15
3155882|NCT01833130|3882399|FG001|COMPLETED|Overall Study||8
3155883|NCT01833130|3882398|FG000|NOT COMPLETED|Overall Study||10
3155884|NCT01833130|3882399|FG001|NOT COMPLETED|Overall Study||19
3155885|NCT01833143|3882405|FG000|STARTED|Overall Study||17
3155886|NCT01833143|3882405|FG000|COMPLETED|Overall Study||16
3155887|NCT01833143|3882405|FG000|NOT COMPLETED|Overall Study||1
3155888|NCT01833169|3882409|FG000|STARTED|Overall Study||146
3155889|NCT01833169|3882409|FG000|Consented to be Followed for Survival|Overall Study||128
3155890|NCT01833169|3882409|FG000|COMPLETED|Overall Study||0
3155891|NCT01833169|3882409|FG000|NOT COMPLETED|Overall Study||146
3155892|NCT01833247|3882413|FG000|STARTED|Overall Study||12
3155893|NCT01833247|3882413|FG000|COMPLETED|Overall Study||12
3155894|NCT01833247|3882413|FG000|NOT COMPLETED|Overall Study||0
3155895|NCT01833403|3882417|FG000|STARTED|Overall Study||4
3155896|NCT01833403|3882417|FG000|COMPLETED|Overall Study||4
3155897|NCT01833403|3882417|FG000|NOT COMPLETED|Overall Study||0
3155898|NCT01833455|3882424|FG000|STARTED|Overall Study||4
3155899|NCT01833455|3882425|FG001|STARTED|Overall Study||4
3155900|NCT01833455|3882424|FG000|Completed 1st Baseline|Overall Study||4
3155901|NCT01833455|3882425|FG001|Completed 1st Baseline|Overall Study||4
3155902|NCT01833455|3882424|FG000|Completed 1st Intervention|Overall Study||3
3155903|NCT01833455|3882425|FG001|Completed 1st Intervention|Overall Study||4
3155904|NCT01833455|3882424|FG000|Completed 2nd Baseline (Washout)|Overall Study||3
3155905|NCT01833455|3882425|FG001|Completed 2nd Baseline (Washout)|Overall Study||4
3155906|NCT01833455|3882424|FG000|COMPLETED|Overall Study||3
3155907|NCT01833455|3882425|FG001|COMPLETED|Overall Study||4
3155908|NCT01833455|3882424|FG000|NOT COMPLETED|Overall Study||1
3155909|NCT01833455|3882425|FG001|NOT COMPLETED|Overall Study||0
3155910|NCT01833481|3882446|FG000|STARTED|Overall Study||10
3155911|NCT01833481|3882447|FG001|STARTED|Overall Study||10
3155912|NCT01833481|3882448|FG002|STARTED|Overall Study||10
3155913|NCT01833481|3882446|FG000|COMPLETED|Overall Study||10
3155914|NCT01833481|3882447|FG001|COMPLETED|Overall Study||10
3155915|NCT01833481|3882448|FG002|COMPLETED|Overall Study||10
3155916|NCT01833481|3882446|FG000|NOT COMPLETED|Overall Study||0
3155917|NCT01833481|3882447|FG001|NOT COMPLETED|Overall Study||0
3155918|NCT01833481|3882448|FG002|NOT COMPLETED|Overall Study||0
3155919|NCT01833494|3882456|FG000|STARTED|Overall Study||161
3155920|NCT01833494|3882456|FG000|COMPLETED|Overall Study||116
3155921|NCT01833494|3882456|FG000|NOT COMPLETED|Overall Study||45
3184618|NCT02015221|3912858|FG001|COMPLETED|Overall Study||34
3184619|NCT02015221|3912857|FG000|NOT COMPLETED|Overall Study||9
3184620|NCT02015221|3912858|FG001|NOT COMPLETED|Overall Study||6
3184621|NCT02015234|3912866|FG000|STARTED|Overall Study||79
3184622|NCT02015234|3912867|FG001|STARTED|Overall Study||79
3155922|NCT01833520|3882462|FG000|STARTED|Overall Study||3
3155923|NCT01833520|3882463|FG001|STARTED|Overall Study||3
3155924|NCT01833520|3882464|FG002|STARTED|Overall Study||9
3155925|NCT01833520|3882465|FG003|STARTED|Overall Study||3
3155926|NCT01833520|3882462|FG000|COMPLETED|Overall Study||0
3155927|NCT01833520|3882463|FG001|COMPLETED|Overall Study||0
3155928|NCT01833520|3882464|FG002|COMPLETED|Overall Study||1
3155929|NCT01833520|3882465|FG003|COMPLETED|Overall Study||0
3155930|NCT01833520|3882462|FG000|NOT COMPLETED|Overall Study||3
3155931|NCT01833520|3882463|FG001|NOT COMPLETED|Overall Study||3
3155932|NCT01833520|3882464|FG002|NOT COMPLETED|Overall Study||8
3155933|NCT01833520|3882465|FG003|NOT COMPLETED|Overall Study||3
3155934|NCT01833533|3882479|FG000|STARTED|Overall Study||100
3155935|NCT01833533|3882480|FG001|STARTED|Overall Study||205
3155936|NCT01833533|3882479|FG000|COMPLETED|Overall Study||94
3155937|NCT01833533|3882480|FG001|COMPLETED|Overall Study||184
3155938|NCT01833533|3882479|FG000|NOT COMPLETED|Overall Study||6
3155939|NCT01833533|3882480|FG001|NOT COMPLETED|Overall Study||21
3155940|NCT01833546|3882490|FG000|STARTED|Overall Study||3
3155941|NCT01833546|3882491|FG001|STARTED|Overall Study||3
3155942|NCT01833546|3882492|FG002|STARTED|Overall Study||8
3155943|NCT01833546|3882493|FG003|STARTED|Overall Study||6
3155944|NCT01833546|3882490|FG000|COMPLETED|Overall Study||3
3155945|NCT01833546|3882491|FG001|COMPLETED|Overall Study||3
3155946|NCT01833546|3882492|FG002|COMPLETED|Overall Study||8
3155947|NCT01833546|3882493|FG003|COMPLETED|Overall Study||6
3155948|NCT01833546|3882490|FG000|NOT COMPLETED|Overall Study||0
3155949|NCT01833546|3882491|FG001|NOT COMPLETED|Overall Study||0
3155950|NCT01833546|3882492|FG002|NOT COMPLETED|Overall Study||0
3155951|NCT01833546|3882493|FG003|NOT COMPLETED|Overall Study||0
3155952|NCT01833741|3882504|FG000|STARTED|Overall Study||1137
3155953|NCT01833741|3882504|FG000|COMPLETED|Overall Study||997
3155954|NCT01833741|3882504|FG000|NOT COMPLETED|Overall Study||140
3155955|NCT01833754|3882511|FG000|STARTED|Overall Study||8
3155956|NCT01833754|3882512|FG001|STARTED|Overall Study||8
3155957|NCT01833754|3882513|FG002|STARTED|Overall Study||8
3155958|NCT01833754|3882511|FG000|COMPLETED|Overall Study||8
3155959|NCT01833754|3882512|FG001|COMPLETED|Overall Study||8
3155960|NCT01833754|3882513|FG002|COMPLETED|Overall Study||8
3155961|NCT01833754|3882511|FG000|NOT COMPLETED|Overall Study||0
3155962|NCT01833754|3882512|FG001|NOT COMPLETED|Overall Study||0
3155963|NCT01833754|3882513|FG002|NOT COMPLETED|Overall Study||0
3155964|NCT01833832|3882521|FG000|STARTED|Overall Study||11
3155965|NCT01833832|3882521|FG000|COMPLETED|Overall Study||10
3155966|NCT01833832|3882521|FG000|NOT COMPLETED|Overall Study||1
3155967|NCT01833845|3882525|FG000|STARTED|Overall Study||4
3155968|NCT01833845|3882525|FG000|COMPLETED|Overall Study||4
3155969|NCT01833845|3882525|FG000|NOT COMPLETED|Overall Study||0
3155970|NCT01833897|3882529|FG000|STARTED|Overall Study||8
3155971|NCT01833897|3882529|FG000|COMPLETED|Overall Study||7
3155972|NCT01833897|3882529|FG000|NOT COMPLETED|Overall Study||1
3155973|NCT01833936|3882535|FG000|STARTED|Overall Study||20
3155974|NCT01833936|3882536|FG001|STARTED|Overall Study||20
3155975|NCT01833936|3882535|FG000|COMPLETED|Overall Study||16
3155976|NCT01833936|3882536|FG001|COMPLETED|Overall Study||18
3155977|NCT01833936|3882535|FG000|NOT COMPLETED|Overall Study||4
3155978|NCT01833936|3882536|FG001|NOT COMPLETED|Overall Study||2
3155979|NCT01833988|3882542|FG000|STARTED|Overall Study||16
3155980|NCT01833988|3882543|FG001|STARTED|Overall Study||16
3155981|NCT01833988|3882542|FG000|COMPLETED|Overall Study||16
3155982|NCT01833988|3882543|FG001|COMPLETED|Overall Study||16
3155983|NCT01833988|3882542|FG000|NOT COMPLETED|Overall Study||0
3155984|NCT01833988|3882543|FG001|NOT COMPLETED|Overall Study||0
3155985|NCT01834027|3882556|FG000|STARTED|Overall Study||28
3155986|NCT01834027|3882557|FG001|STARTED|Overall Study||28
3155987|NCT01834027|3882556|FG000|COMPLETED|Overall Study||28
3155988|NCT01834027|3882557|FG001|COMPLETED|Overall Study||28
3155989|NCT01834027|3882556|FG000|NOT COMPLETED|Overall Study||0
3155990|NCT01834027|3882557|FG001|NOT COMPLETED|Overall Study||0
3155991|NCT01834222|3882563|FG000|STARTED|Overall Study||659
3155992|NCT01834222|3882563|FG000|Treated|Overall Study||658
3155993|NCT01834222|3882563|FG000|COMPLETED|Overall Study||658
3155994|NCT01834222|3882563|FG000|NOT COMPLETED|Overall Study||1
3155995|NCT01834261|3882569|FG000|STARTED|MIT fMRI and MEG Resting State Study||11
3155996|NCT01834261|3882570|FG001|STARTED|MIT fMRI and MEG Resting State Study||10
3155997|NCT01834261|3882569|FG000|COMPLETED|MIT fMRI and MEG Resting State Study|Enrollment completed in March 2014.|10
3155998|NCT01834261|3882570|FG001|COMPLETED|MIT fMRI and MEG Resting State Study||9
3155999|NCT01834261|3882569|FG000|NOT COMPLETED|MIT fMRI and MEG Resting State Study||1
3156000|NCT01834261|3882570|FG001|NOT COMPLETED|MIT fMRI and MEG Resting State Study||1
3156001|NCT01834261|3882569|FG000|STARTED|MGH Rest + Nueroeconomic Task fMRI|Subjects who dropped out/were excluded (10), did so before they received either Oxytocin or Placebo.|10
3156002|NCT01834261|3882570|FG001|STARTED|MGH Rest + Nueroeconomic Task fMRI||10
3156003|NCT01834261|3882569|FG000|COMPLETED|MGH Rest + Nueroeconomic Task fMRI|Enrollment completed in May 2015.|10
3156004|NCT01834261|3882570|FG001|COMPLETED|MGH Rest + Nueroeconomic Task fMRI||10
3156005|NCT01834261|3882569|FG000|NOT COMPLETED|MGH Rest + Nueroeconomic Task fMRI||0
3156006|NCT01834261|3882570|FG001|NOT COMPLETED|MGH Rest + Nueroeconomic Task fMRI||0
3156007|NCT01834274|3882578|FG000|STARTED|Overall Study||50
3156008|NCT01834274|3882579|FG001|STARTED|Overall Study||46
3156009|NCT01834274|3882578|FG000|COMPLETED|Overall Study||3
3156010|NCT01834274|3882579|FG001|COMPLETED|Overall Study||5
3156011|NCT01834274|3882578|FG000|NOT COMPLETED|Overall Study||47
3156012|NCT01834274|3882579|FG001|NOT COMPLETED|Overall Study||41
3156013|NCT01834326|3882587|FG000|STARTED|Overall Study||10
3156014|NCT01834326|3882588|FG001|STARTED|Overall Study||8
3156015|NCT01834326|3882587|FG000|COMPLETED|Overall Study||8
3156016|NCT01834326|3882588|FG001|COMPLETED|Overall Study||2
3156017|NCT01834326|3882587|FG000|NOT COMPLETED|Overall Study||2
3156018|NCT01834326|3882588|FG001|NOT COMPLETED|Overall Study||6
3156019|NCT01834404|3882596|FG000|STARTED|Overall Study||12
3156020|NCT01834404|3882597|FG001|STARTED|Overall Study||12
3156021|NCT01834404|3882596|FG000|COMPLETED|Overall Study||12
3156022|NCT01834404|3882597|FG001|COMPLETED|Overall Study||12
3156023|NCT01834404|3882596|FG000|NOT COMPLETED|Overall Study||0
3156024|NCT01834404|3882597|FG001|NOT COMPLETED|Overall Study||0
3156025|NCT01834586|3882603|FG000|STARTED|Overall Study||30
3156026|NCT01834586|3882603|FG000|COMPLETED|Overall Study||29
3156027|NCT01834586|3882603|FG000|NOT COMPLETED|Overall Study||1
3156028|NCT01834651|3882607|FG000|STARTED|Overall Study||17
3156029|NCT01834651|3882607|FG000|COMPLETED|Overall Study|Evaluable for primary outcome assessment at 12 weeks|16
3156030|NCT01834651|3882607|FG000|NOT COMPLETED|Overall Study||1
3156031|NCT01834716|3882615|FG000|STARTED|Overall Study||4
3156032|NCT01834716|3882616|FG001|STARTED|Overall Study||12
3156033|NCT01834716|3882615|FG000|COMPLETED|Overall Study||4
3156034|NCT01834716|3882616|FG001|COMPLETED|Overall Study||11
3156035|NCT01834716|3882615|FG000|NOT COMPLETED|Overall Study||0
3156036|NCT01834716|3882616|FG001|NOT COMPLETED|Overall Study||1
3156037|NCT01834729|3882626|FG000|STARTED|Overall Study||18
3156038|NCT01834729|3882627|FG001|STARTED|Overall Study||20
3156039|NCT01834729|3882628|FG002|STARTED|Overall Study||18
3156040|NCT01834729|3882629|FG003|STARTED|Overall Study||18
3156041|NCT01834729|3882626|FG000|COMPLETED|Overall Study||17
3184623|NCT02015234|3912866|FG000|COMPLETED|Overall Study||43
3184624|NCT02015234|3912867|FG001|COMPLETED|Overall Study||54
3184625|NCT02015234|3912866|FG000|NOT COMPLETED|Overall Study||36
3184626|NCT02015234|3912867|FG001|NOT COMPLETED|Overall Study||25
3184627|NCT02015390|3912877|FG000|STARTED|Overall Study||9
3184628|NCT02015390|3912878|FG001|STARTED|Overall Study||7
3184629|NCT02015390|3912877|FG000|COMPLETED|Overall Study||8
3184630|NCT02015390|3912878|FG001|COMPLETED|Overall Study||3
3184631|NCT02015390|3912877|FG000|NOT COMPLETED|Overall Study||1
3184632|NCT02015390|3912878|FG001|NOT COMPLETED|Overall Study||4
3184633|NCT02015442|3912885|FG000|STARTED|First Intervention (7 Days)||5
3184634|NCT02015442|3912886|FG001|STARTED|First Intervention (7 Days)||4
3184635|NCT02015442|3912885|FG000|COMPLETED|First Intervention (7 Days)||5
3184636|NCT02015442|3912886|FG001|COMPLETED|First Intervention (7 Days)||4
3184637|NCT02015442|3912885|FG000|NOT COMPLETED|First Intervention (7 Days)||0
3184638|NCT02015442|3912886|FG001|NOT COMPLETED|First Intervention (7 Days)||0
3184639|NCT02015442|3912885|FG000|STARTED|Wash-out (4 Weeks)||5
3184640|NCT02015442|3912886|FG001|STARTED|Wash-out (4 Weeks)||4
3184641|NCT02015442|3912885|FG000|COMPLETED|Wash-out (4 Weeks)||5
3184642|NCT02015442|3912886|FG001|COMPLETED|Wash-out (4 Weeks)||4
3184643|NCT02015442|3912885|FG000|NOT COMPLETED|Wash-out (4 Weeks)||0
3184644|NCT02015442|3912886|FG001|NOT COMPLETED|Wash-out (4 Weeks)||0
3184645|NCT02015442|3912885|FG000|STARTED|Second Intervention (7 Days)||5
3184646|NCT02015442|3912886|FG001|STARTED|Second Intervention (7 Days)||4
3184647|NCT02015442|3912885|FG000|COMPLETED|Second Intervention (7 Days)||5
3184648|NCT02015442|3912886|FG001|COMPLETED|Second Intervention (7 Days)||4
3184649|NCT02015442|3912885|FG000|NOT COMPLETED|Second Intervention (7 Days)||0
3184650|NCT02015442|3912886|FG001|NOT COMPLETED|Second Intervention (7 Days)||0
3184651|NCT02015481|3912892|FG000|STARTED|Overall Study||25
3184652|NCT02015481|3912892|FG000|COMPLETED|Overall Study||24
3184653|NCT02015481|3912892|FG000|NOT COMPLETED|Overall Study||1
3184654|NCT02015520|3912901|FG000|STARTED|Overall Study||40
3184655|NCT02015520|3912902|FG001|STARTED|Overall Study||21
3184656|NCT02015520|3912903|FG002|STARTED|Overall Study||42
3184657|NCT02015520|3912904|FG003|STARTED|Overall Study||40
3184658|NCT02015520|3912901|FG000|COMPLETED|Overall Study||35
3184659|NCT02015520|3912902|FG001|COMPLETED|Overall Study||17
3184660|NCT02015520|3912903|FG002|COMPLETED|Overall Study||35
3184661|NCT02015520|3912904|FG003|COMPLETED|Overall Study||36
3184662|NCT02015520|3912901|FG000|NOT COMPLETED|Overall Study||5
3184663|NCT02015520|3912902|FG001|NOT COMPLETED|Overall Study||4
3184664|NCT02015520|3912903|FG002|NOT COMPLETED|Overall Study||7
3184665|NCT02015520|3912904|FG003|NOT COMPLETED|Overall Study||4
3184666|NCT02015546|3912917|FG000|STARTED|Overall Study||23
3184667|NCT02015546|3912918|FG001|STARTED|Overall Study||21
3184668|NCT02015546|3912919|FG002|STARTED|Overall Study||26
3184669|NCT02015546|3912917|FG000|COMPLETED|Overall Study||20
3184670|NCT02015546|3912918|FG001|COMPLETED|Overall Study||19
3184671|NCT02015546|3912919|FG002|COMPLETED|Overall Study||22
3184672|NCT02015546|3912917|FG000|NOT COMPLETED|Overall Study||3
3184673|NCT02015546|3912918|FG001|NOT COMPLETED|Overall Study||2
3184674|NCT02015546|3912919|FG002|NOT COMPLETED|Overall Study||4
3184675|NCT02015637|3912929|FG000|STARTED|Overall Study||306
3184676|NCT02015637|3912930|FG001|STARTED|Overall Study||154
3184677|NCT02015637|3912929|FG000|COMPLETED|Overall Study||298
3184678|NCT02015637|3912930|FG001|COMPLETED|Overall Study||149
3184679|NCT02015637|3912929|FG000|NOT COMPLETED|Overall Study||8
3184680|NCT02015637|3912930|FG001|NOT COMPLETED|Overall Study||5
3184681|NCT02015676|3912939|FG000|STARTED|Overall Study||15
3184682|NCT02015676|3912940|FG001|STARTED|Overall Study||48
3184683|NCT02015676|3912941|FG002|STARTED|Overall Study||6
3184684|NCT02015676|3912939|FG000|COMPLETED|Overall Study||6
3184685|NCT02015676|3912940|FG001|COMPLETED|Overall Study||14
3184686|NCT02015676|3912941|FG002|COMPLETED|Overall Study||3
3184687|NCT02015676|3912939|FG000|NOT COMPLETED|Overall Study||9
3184688|NCT02015676|3912940|FG001|NOT COMPLETED|Overall Study||34
3184689|NCT02015676|3912941|FG002|NOT COMPLETED|Overall Study||3
3184690|NCT02015754|3912945|FG000|STARTED|Overall Study|17 participants were consented, but 3 participants were screened out prior to treatment|14
3184691|NCT02015754|3912945|FG000|Completed First TACE|Overall Study||14
3184692|NCT02015754|3912945|FG000|Completed First Clinical and Imaging|Overall Study|1 patient exited prior to follow-up|13
3184693|NCT02015754|3912945|FG000|COMPLETED|Overall Study||3
3184694|NCT02015754|3912945|FG000|NOT COMPLETED|Overall Study||11
3156042|NCT01834729|3882627|FG001|COMPLETED|Overall Study||19
3156043|NCT01834729|3882628|FG002|COMPLETED|Overall Study||15
3156044|NCT01834729|3882629|FG003|COMPLETED|Overall Study||16
3363859|NCT04039412|4095044|FG000|NOT COMPLETED|Overall Study||1
3156045|NCT01834729|3882626|FG000|NOT COMPLETED|Overall Study||1
3156046|NCT01834729|3882627|FG001|NOT COMPLETED|Overall Study||1
3156047|NCT01834729|3882628|FG002|NOT COMPLETED|Overall Study||3
3156048|NCT01834729|3882629|FG003|NOT COMPLETED|Overall Study||2
3156049|NCT01835015|3882645|FG000|STARTED|Overall Study||6
3156050|NCT01835015|3882646|FG001|STARTED|Overall Study||6
3156051|NCT01835015|3882647|FG002|STARTED|Overall Study||7
3156052|NCT01835015|3882648|FG003|STARTED|Overall Study||6
3156053|NCT01835015|3882649|FG004|STARTED|Overall Study||6
3156054|NCT01835015|3882645|FG000|COMPLETED|Overall Study||6
3156055|NCT01835015|3882646|FG001|COMPLETED|Overall Study||6
3156056|NCT01835015|3882647|FG002|COMPLETED|Overall Study||6
3156057|NCT01835015|3882648|FG003|COMPLETED|Overall Study||6
3156058|NCT01835015|3882649|FG004|COMPLETED|Overall Study||6
3156059|NCT01835015|3882645|FG000|NOT COMPLETED|Overall Study||0
3156060|NCT01835015|3882646|FG001|NOT COMPLETED|Overall Study||0
3156061|NCT01835015|3882647|FG002|NOT COMPLETED|Overall Study||1
3156062|NCT01835015|3882648|FG003|NOT COMPLETED|Overall Study||0
3156063|NCT01835015|3882649|FG004|NOT COMPLETED|Overall Study||0
3156064|NCT01835132|3882662|FG000|STARTED|Initial Phase||8
3156065|NCT01835132|3882662|FG000|COMPLETED|Initial Phase||6
3156066|NCT01835132|3882662|FG000|NOT COMPLETED|Initial Phase||2
3156067|NCT01835132|3882662|FG000|STARTED|1st Extension Phase||6
3156068|NCT01835132|3882662|FG000|COMPLETED|1st Extension Phase|Completed 52 Weeks|6
3156069|NCT01835132|3882662|FG000|NOT COMPLETED|1st Extension Phase||0
3156070|NCT01835132|3882662|FG000|STARTED|2nd Extension Phase - As Needed (PRN)|PRN extension - Participants starting this phase may not equal those who completed the 1st extension|3
3156071|NCT01835132|3882662|FG000|COMPLETED|2nd Extension Phase - As Needed (PRN)||3
3156072|NCT01835132|3882662|FG000|NOT COMPLETED|2nd Extension Phase - As Needed (PRN)||0
3156073|NCT01835158|3882668|FG000|STARTED|Overall Study||79
3156074|NCT01835158|3882669|FG001|STARTED|Overall Study||78
3156075|NCT01835158|3882668|FG000|COMPLETED|Overall Study||78
3156076|NCT01835158|3882669|FG001|COMPLETED|Overall Study||72
3156077|NCT01835158|3882668|FG000|NOT COMPLETED|Overall Study||1
3156078|NCT01835158|3882669|FG001|NOT COMPLETED|Overall Study||6
3156079|NCT01835223|3882677|FG000|STARTED|Overall Study||30
3156080|NCT01835223|3882678|FG001|STARTED|Overall Study||3
3156081|NCT01835223|3882677|FG000|COMPLETED|Overall Study||21
3156082|NCT01835223|3882678|FG001|COMPLETED|Overall Study||2
3156083|NCT01835223|3882677|FG000|NOT COMPLETED|Overall Study||9
3156084|NCT01835223|3882678|FG001|NOT COMPLETED|Overall Study||1
3156085|NCT01835262|3882688|FG000|STARTED|Overall Study||45
3156086|NCT01835262|3882689|FG001|STARTED|Overall Study||45
3156087|NCT01835262|3882688|FG000|COMPLETED|Overall Study||45
3184695|NCT02015793|3912951|FG000|STARTED|Overall Study||15
3184696|NCT02015793|3912952|FG001|STARTED|Overall Study||15
3184697|NCT02015793|3912951|FG000|Completed Double-Blind Period|Overall Study||14
3184698|NCT02015793|3912952|FG001|Completed Double-Blind Period|Overall Study||14
3184699|NCT02015793|3912951|FG000|Entered Open-label Extension Period|Overall Study||13
3184700|NCT02015793|3912952|FG001|Entered Open-label Extension Period|Overall Study||14
3184701|NCT02015793|3912951|FG000|COMPLETED|Overall Study||11
3184702|NCT02015793|3912952|FG001|COMPLETED|Overall Study||11
3184703|NCT02015793|3912951|FG000|NOT COMPLETED|Overall Study||4
3184704|NCT02015793|3912952|FG001|NOT COMPLETED|Overall Study||4
3184705|NCT02015819|3912968|FG000|STARTED|Overall Study||3
3184706|NCT02015819|3912969|FG001|STARTED|Overall Study||3
3184707|NCT02015819|3912970|FG002|STARTED|Overall Study||3
3184708|NCT02015819|3912971|FG003|STARTED|Overall Study||7
3184709|NCT02015819|3912968|FG000|COMPLETED|Overall Study||3
3184710|NCT02015819|3912969|FG001|COMPLETED|Overall Study||3
3184711|NCT02015819|3912970|FG002|COMPLETED|Overall Study||3
3184712|NCT02015819|3912971|FG003|COMPLETED|Overall Study||6
3184713|NCT02015819|3912968|FG000|NOT COMPLETED|Overall Study||0
3184714|NCT02015819|3912969|FG001|NOT COMPLETED|Overall Study||0
3184715|NCT02015819|3912970|FG002|NOT COMPLETED|Overall Study||0
3184716|NCT02015819|3912971|FG003|NOT COMPLETED|Overall Study||1
3156088|NCT01835262|3882689|FG001|COMPLETED|Overall Study||45
3156089|NCT01835262|3882688|FG000|NOT COMPLETED|Overall Study||0
3156090|NCT01835262|3882689|FG001|NOT COMPLETED|Overall Study||0
3156091|NCT01835379|3882697|FG000|STARTED|Overall Study||41
3156092|NCT01835379|3882698|FG001|STARTED|Overall Study||41
3156093|NCT01835379|3882697|FG000|COMPLETED|Overall Study||41
3156094|NCT01835379|3882698|FG001|COMPLETED|Overall Study||41
3156095|NCT01835379|3882697|FG000|NOT COMPLETED|Overall Study||0
3156096|NCT01835379|3882698|FG001|NOT COMPLETED|Overall Study||0
3156097|NCT01835431|3882706|FG000|STARTED|Overall Study||182
3156098|NCT01835431|3882707|FG001|STARTED|Overall Study||180
3156099|NCT01835431|3882706|FG000|Exposed|Overall Study|One subject was withdrawn before exposure.|181
3156100|NCT01835431|3882707|FG001|Exposed|Overall Study|One subject was withdrawn before exposure|179
3156101|NCT01835431|3882706|FG000|COMPLETED|Overall Study||174
3156102|NCT01835431|3882707|FG001|COMPLETED|Overall Study||168
3156103|NCT01835431|3882706|FG000|NOT COMPLETED|Overall Study||8
3156104|NCT01835431|3882707|FG001|NOT COMPLETED|Overall Study||12
3156105|NCT01835470|3882713|FG000|STARTED|Short Term Treatment Period (to Week 16)||20
3156106|NCT01835470|3882713|FG000|COMPLETED|Short Term Treatment Period (to Week 16)||20
3156107|NCT01835470|3882713|FG000|NOT COMPLETED|Short Term Treatment Period (to Week 16)||0
3184717|NCT02016105|3912987|FG000|STARTED|TREATMENT PERIOD 1||231
3184718|NCT02016105|3912988|FG001|STARTED|TREATMENT PERIOD 1||234
3363860|NCT04039412|4095045|FG001|NOT COMPLETED|Overall Study||3
3156108|NCT01835470|3882713|FG000|STARTED|Long Term Treatment Period||20
3156109|NCT01835470|3882713|FG000|COMPLETED|Long Term Treatment Period|Completed LT period|16
3156110|NCT01835470|3882713|FG000|NOT COMPLETED|Long Term Treatment Period||4
3156111|NCT01835496|3882718|FG000|STARTED|Overall Study||8
3156112|NCT01835496|3882718|FG000|COMPLETED|Overall Study||8
3156113|NCT01835496|3882718|FG000|NOT COMPLETED|Overall Study||0
3156114|NCT01835548|3882724|FG000|STARTED|Screening/Washout Period||0
3156115|NCT01835548|3882725|FG001|STARTED|Screening/Washout Period||0
3156116|NCT01835548|3882726|FG002|STARTED|Screening/Washout Period||87
3156117|NCT01835548|3882724|FG000|COMPLETED|Screening/Washout Period||0
3156118|NCT01835548|3882725|FG001|COMPLETED|Screening/Washout Period||0
3156119|NCT01835548|3882726|FG002|COMPLETED|Screening/Washout Period||87
3156120|NCT01835548|3882724|FG000|NOT COMPLETED|Screening/Washout Period||0
3156121|NCT01835548|3882725|FG001|NOT COMPLETED|Screening/Washout Period||0
3156122|NCT01835548|3882726|FG002|NOT COMPLETED|Screening/Washout Period||0
3156123|NCT01835548|3882724|FG000|STARTED|Dose Optimization Period||0
3156124|NCT01835548|3882725|FG001|STARTED|Dose Optimization Period||0
3156125|NCT01835548|3882726|FG002|STARTED|Dose Optimization Period||87
3156126|NCT01835548|3882724|FG000|COMPLETED|Dose Optimization Period||0
3156127|NCT01835548|3882725|FG001|COMPLETED|Dose Optimization Period||0
3156128|NCT01835548|3882726|FG002|COMPLETED|Dose Optimization Period||85
3156129|NCT01835548|3882724|FG000|NOT COMPLETED|Dose Optimization Period||0
3156130|NCT01835548|3882725|FG001|NOT COMPLETED|Dose Optimization Period||0
3156131|NCT01835548|3882726|FG002|NOT COMPLETED|Dose Optimization Period||2
3156132|NCT01835548|3882724|FG000|STARTED|Dose Stabilization Period||0
3156133|NCT01835548|3882725|FG001|STARTED|Dose Stabilization Period||0
3156134|NCT01835548|3882726|FG002|STARTED|Dose Stabilization Period||85
3156135|NCT01835548|3882724|FG000|COMPLETED|Dose Stabilization Period||0
3156136|NCT01835548|3882725|FG001|COMPLETED|Dose Stabilization Period||0
3156137|NCT01835548|3882726|FG002|COMPLETED|Dose Stabilization Period||85
3156138|NCT01835548|3882724|FG000|NOT COMPLETED|Dose Stabilization Period||0
3156139|NCT01835548|3882725|FG001|NOT COMPLETED|Dose Stabilization Period||0
3156140|NCT01835548|3882726|FG002|NOT COMPLETED|Dose Stabilization Period||0
3156141|NCT01835548|3882724|FG000|STARTED|Double-Blind Treatment Period||44
3156142|NCT01835548|3882725|FG001|STARTED|Double-Blind Treatment Period||41
3156143|NCT01835548|3882726|FG002|STARTED|Double-Blind Treatment Period||0
3156144|NCT01835548|3882724|FG000|COMPLETED|Double-Blind Treatment Period||44
3156145|NCT01835548|3882725|FG001|COMPLETED|Double-Blind Treatment Period||39
3156146|NCT01835548|3882726|FG002|COMPLETED|Double-Blind Treatment Period||0
3156147|NCT01835548|3882724|FG000|NOT COMPLETED|Double-Blind Treatment Period||0
3156148|NCT01835548|3882725|FG001|NOT COMPLETED|Double-Blind Treatment Period||2
3156149|NCT01835548|3882726|FG002|NOT COMPLETED|Double-Blind Treatment Period||0
3156150|NCT01835587|3882742|FG000|STARTED|Overall Study||3
3156151|NCT01835587|3882743|FG001|STARTED|Overall Study||4
3156152|NCT01835587|3882744|FG002|STARTED|Overall Study||4
3156153|NCT01835587|3882745|FG003|STARTED|Overall Study||19
3156154|NCT01835587|3882742|FG000|COMPLETED|Overall Study||1
3156155|NCT01835587|3882743|FG001|COMPLETED|Overall Study||0
3156156|NCT01835587|3882744|FG002|COMPLETED|Overall Study||2
3156157|NCT01835587|3882745|FG003|COMPLETED|Overall Study||10
3156158|NCT01835587|3882742|FG000|NOT COMPLETED|Overall Study||2
3156159|NCT01835587|3882743|FG001|NOT COMPLETED|Overall Study||4
3156160|NCT01835587|3882744|FG002|NOT COMPLETED|Overall Study||2
3156161|NCT01835587|3882745|FG003|NOT COMPLETED|Overall Study||9
3156162|NCT01835626|3882762|FG000|STARTED|Overall Study||24
3156163|NCT01835626|3882762|FG000|COMPLETED|Overall Study||17
3156164|NCT01835626|3882762|FG000|NOT COMPLETED|Overall Study||7
3156165|NCT01835743|3882768|FG000|STARTED|Overall Study||37
3156166|NCT01835743|3882769|FG001|STARTED|Overall Study||32
3156167|NCT01835743|3882768|FG000|COMPLETED|Overall Study||37
3156168|NCT01835743|3882769|FG001|COMPLETED|Overall Study||32
3156169|NCT01835743|3882768|FG000|NOT COMPLETED|Overall Study||0
3156170|NCT01835743|3882769|FG001|NOT COMPLETED|Overall Study||0
3156171|NCT01835756|3882777|FG000|STARTED|Overall Study||31
3156172|NCT01835756|3882778|FG001|STARTED|Overall Study||31
3156173|NCT01835756|3882777|FG000|COMPLETED|Overall Study||31
3156174|NCT01835756|3882778|FG001|COMPLETED|Overall Study||31
3156175|NCT01835756|3882777|FG000|NOT COMPLETED|Overall Study||0
3156176|NCT01835756|3882778|FG001|NOT COMPLETED|Overall Study||0
3156177|NCT01835899|3882789|FG000|STARTED|Overall Study||6
3156178|NCT01835899|3882790|FG001|STARTED|Overall Study||9
3156179|NCT01835899|3882791|FG002|STARTED|Overall Study||9
3156180|NCT01835899|3882789|FG000|COMPLETED|Overall Study||6
3156181|NCT01835899|3882790|FG001|COMPLETED|Overall Study||8
3156182|NCT01835899|3882791|FG002|COMPLETED|Overall Study||8
3156183|NCT01835899|3882789|FG000|NOT COMPLETED|Overall Study||0
3156184|NCT01835899|3882790|FG001|NOT COMPLETED|Overall Study||1
3156185|NCT01835899|3882791|FG002|NOT COMPLETED|Overall Study||1
3156186|NCT01835912|3882801|FG000|STARTED|Overall Study||10
3156187|NCT01835912|3882801|FG000|Acute|Overall Study||10
3156188|NCT01835912|3882801|FG000|Acute Placebo|Overall Study||10
3156189|NCT01835912|3882801|FG000|Chronic|Overall Study||10
3156190|NCT01835912|3882801|FG000|Chronic Placebo|Overall Study||10
3156191|NCT01835912|3882801|FG000|COMPLETED|Overall Study||10
3156192|NCT01835912|3882801|FG000|NOT COMPLETED|Overall Study||0
3156193|NCT01836029|3882813|FG000|STARTED|Overall Study||100
3156194|NCT01836029|3882814|FG001|STARTED|Overall Study||95
3156195|NCT01836029|3882813|FG000|COMPLETED|Overall Study||100
3156196|NCT01836029|3882814|FG001|COMPLETED|Overall Study||95
3156197|NCT01836029|3882813|FG000|NOT COMPLETED|Overall Study||0
3156198|NCT01836029|3882814|FG001|NOT COMPLETED|Overall Study||0
3156199|NCT01836042|3882823|FG000|STARTED|Overall Study||51
3156200|NCT01836042|3882824|FG001|STARTED|Overall Study||35
3156201|NCT01836042|3882825|FG002|STARTED|Overall Study||22
3156202|NCT01836042|3882823|FG000|COMPLETED|Overall Study||51
3156203|NCT01836042|3882824|FG001|COMPLETED|Overall Study||35
3156204|NCT01836042|3882825|FG002|COMPLETED|Overall Study||22
3156205|NCT01836042|3882823|FG000|NOT COMPLETED|Overall Study||0
3156206|NCT01836042|3882824|FG001|NOT COMPLETED|Overall Study||0
3156207|NCT01836042|3882825|FG002|NOT COMPLETED|Overall Study||0
3156208|NCT01836133|3882833|FG000|STARTED|Overall Study||70
3156209|NCT01836133|3882833|FG000|COMPLETED|Overall Study||70
3156210|NCT01836133|3882833|FG000|NOT COMPLETED|Overall Study||0
3156211|NCT01836185|3882841|FG000|STARTED|Overall Study||10
3156212|NCT01836185|3882842|FG001|STARTED|Overall Study||8
3156213|NCT01836185|3882843|FG002|STARTED|Overall Study||8
3156214|NCT01836185|3882844|FG003|STARTED|Overall Study||6
3156215|NCT01836185|3882841|FG000|Received Single Dose of Study Treatment|Overall Study||10
3184719|NCT02016105|3912989|FG002|STARTED|TREATMENT PERIOD 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
3184720|NCT02016105|3912990|FG003|STARTED|TREATMENT PERIOD 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
3184721|NCT02016105|3912991|FG004|STARTED|TREATMENT PERIOD 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
3184722|NCT02016105|3912992|FG005|STARTED|TREATMENT PERIOD 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
3184723|NCT02016105|3912987|FG000|COMPLETED|TREATMENT PERIOD 1|12 patients did not proceed into Treatment Period 2|201
3184724|NCT02016105|3912988|FG001|COMPLETED|TREATMENT PERIOD 1|11 patients did not proceed into Treatment Period 2|201
3184725|NCT02016105|3912989|FG002|COMPLETED|TREATMENT PERIOD 1||0
3184726|NCT02016105|3912990|FG003|COMPLETED|TREATMENT PERIOD 1||0
3184727|NCT02016105|3912991|FG004|COMPLETED|TREATMENT PERIOD 1||0
3184728|NCT02016105|3912992|FG005|COMPLETED|TREATMENT PERIOD 1||0
3184729|NCT02016105|3912987|FG000|NOT COMPLETED|TREATMENT PERIOD 1||30
3184730|NCT02016105|3912988|FG001|NOT COMPLETED|TREATMENT PERIOD 1||33
3184731|NCT02016105|3912989|FG002|NOT COMPLETED|TREATMENT PERIOD 1||0
3184732|NCT02016105|3912990|FG003|NOT COMPLETED|TREATMENT PERIOD 1||0
3184733|NCT02016105|3912991|FG004|NOT COMPLETED|TREATMENT PERIOD 1||0
3184734|NCT02016105|3912992|FG005|NOT COMPLETED|TREATMENT PERIOD 1||0
3184735|NCT02016105|3912987|FG000|STARTED|TREATMENT PERIOD 2|Treatment arm applicable for Treatment Period 1 only (patients re-randomized in Treatment Period 2)|0
3184736|NCT02016105|3912988|FG001|STARTED|TREATMENT PERIOD 2|Treatment arm applicable for Treatment Period 1 only (patients re-randomized in Treatment Period 2)|0
3184737|NCT02016105|3912989|FG002|STARTED|TREATMENT PERIOD 2|"Patients re-randomized from Humira ® adalimumab treatment arm in Treatment Period 1"|63
3184738|NCT02016105|3912990|FG003|STARTED|TREATMENT PERIOD 2|"Patients re-randomized from Humira ® adalimumab treatment arm in Treatment Period 1"|127
3184739|NCT02016105|3912991|FG004|STARTED|TREATMENT PERIOD 2|"Patients re-randomized from GP2017 adalimumab treatment arm in Treatment Period 1"|63
3184740|NCT02016105|3912992|FG005|STARTED|TREATMENT PERIOD 2|"Patients re-randomized from GP2017 adalimumab treatment arm in Treatment Period 1"|126
3184741|NCT02016105|3912987|FG000|COMPLETED|TREATMENT PERIOD 2||0
3184742|NCT02016105|3912988|FG001|COMPLETED|TREATMENT PERIOD 2||0
3184743|NCT02016105|3912989|FG002|COMPLETED|TREATMENT PERIOD 2||57
3184744|NCT02016105|3912990|FG003|COMPLETED|TREATMENT PERIOD 2||116
3184745|NCT02016105|3912991|FG004|COMPLETED|TREATMENT PERIOD 2||59
3184746|NCT02016105|3912992|FG005|COMPLETED|TREATMENT PERIOD 2||112
3184747|NCT02016105|3912987|FG000|NOT COMPLETED|TREATMENT PERIOD 2||0
3184748|NCT02016105|3912988|FG001|NOT COMPLETED|TREATMENT PERIOD 2||0
3184749|NCT02016105|3912989|FG002|NOT COMPLETED|TREATMENT PERIOD 2||6
3184750|NCT02016105|3912990|FG003|NOT COMPLETED|TREATMENT PERIOD 2||11
3184751|NCT02016105|3912991|FG004|NOT COMPLETED|TREATMENT PERIOD 2||4
3184752|NCT02016105|3912992|FG005|NOT COMPLETED|TREATMENT PERIOD 2||14
3184753|NCT02016105|3912987|FG000|STARTED|EXTENSION PERIOD||0
3184754|NCT02016105|3912988|FG001|STARTED|EXTENSION PERIOD||0
3184755|NCT02016105|3912989|FG002|STARTED|EXTENSION PERIOD|5 patients did not proceed from Treatment Period 2 into Extension Period|52
3184756|NCT02016105|3912990|FG003|STARTED|EXTENSION PERIOD|7 patients did not proceed from Treatment Period 2 into Extension Period|109
3184757|NCT02016105|3912991|FG004|STARTED|EXTENSION PERIOD|3 patients did not proceed from Treatment Period 2 into Extension Period|56
3184758|NCT02016105|3912992|FG005|STARTED|EXTENSION PERIOD|6 patients did not proceed from Treatment Period 2 into Extension Period|106
3184759|NCT02016105|3912987|FG000|COMPLETED|EXTENSION PERIOD||0
3184760|NCT02016105|3912988|FG001|COMPLETED|EXTENSION PERIOD||0
3184761|NCT02016105|3912989|FG002|COMPLETED|EXTENSION PERIOD||47
3184762|NCT02016105|3912990|FG003|COMPLETED|EXTENSION PERIOD||104
3184763|NCT02016105|3912991|FG004|COMPLETED|EXTENSION PERIOD||50
3184764|NCT02016105|3912992|FG005|COMPLETED|EXTENSION PERIOD||100
3184765|NCT02016105|3912987|FG000|NOT COMPLETED|EXTENSION PERIOD||0
3184766|NCT02016105|3912988|FG001|NOT COMPLETED|EXTENSION PERIOD||0
3184767|NCT02016105|3912989|FG002|NOT COMPLETED|EXTENSION PERIOD||5
3184768|NCT02016105|3912990|FG003|NOT COMPLETED|EXTENSION PERIOD||5
3156216|NCT01836185|3882842|FG001|Received Single Dose of Study Treatment|Overall Study||8
3156217|NCT01836185|3882843|FG002|Received Single Dose of Study Treatment|Overall Study||8
3156218|NCT01836185|3882844|FG003|Received Single Dose of Study Treatment|Overall Study||6
3156219|NCT01836185|3882841|FG000|COMPLETED|Overall Study||10
3156220|NCT01836185|3882842|FG001|COMPLETED|Overall Study||8
3156221|NCT01836185|3882843|FG002|COMPLETED|Overall Study||8
3156222|NCT01836185|3882844|FG003|COMPLETED|Overall Study||6
3156223|NCT01836185|3882841|FG000|NOT COMPLETED|Overall Study||0
3156224|NCT01836185|3882842|FG001|NOT COMPLETED|Overall Study||0
3156225|NCT01836185|3882843|FG002|NOT COMPLETED|Overall Study||0
3156226|NCT01836185|3882844|FG003|NOT COMPLETED|Overall Study||0
3156227|NCT01836198|3882856|FG000|STARTED|Part A, Period 1||15
3156228|NCT01836198|3882857|FG001|STARTED|Part A, Period 1||15
3156229|NCT01836198|3882858|FG002|STARTED|Part A, Period 1||0
3156230|NCT01836198|3882856|FG000|Received at Least 1 Dose of Study Drug|Part A, Period 1||15
3156231|NCT01836198|3882857|FG001|Received at Least 1 Dose of Study Drug|Part A, Period 1||15
3156232|NCT01836198|3882858|FG002|Received at Least 1 Dose of Study Drug|Part A, Period 1||0
3156233|NCT01836198|3882856|FG000|COMPLETED|Part A, Period 1||15
3156234|NCT01836198|3882857|FG001|COMPLETED|Part A, Period 1||15
3156235|NCT01836198|3882858|FG002|COMPLETED|Part A, Period 1||0
3156236|NCT01836198|3882856|FG000|NOT COMPLETED|Part A, Period 1||0
3156237|NCT01836198|3882857|FG001|NOT COMPLETED|Part A, Period 1||0
3156238|NCT01836198|3882858|FG002|NOT COMPLETED|Part A, Period 1||0
3156239|NCT01836198|3882856|FG000|STARTED|Part A, Period 2||15
3156240|NCT01836198|3882857|FG001|STARTED|Part A, Period 2||15
3156241|NCT01836198|3882858|FG002|STARTED|Part A, Period 2||0
3156242|NCT01836198|3882856|FG000|Completed Part A, Entered Part B|Part A, Period 2||6
3156243|NCT01836198|3882857|FG001|Completed Part A, Entered Part B|Part A, Period 2||6
3156244|NCT01836198|3882858|FG002|Completed Part A, Entered Part B|Part A, Period 2||0
3156245|NCT01836198|3882856|FG000|COMPLETED|Part A, Period 2||15
3156246|NCT01836198|3882857|FG001|COMPLETED|Part A, Period 2||14
3156247|NCT01836198|3882858|FG002|COMPLETED|Part A, Period 2||0
3156248|NCT01836198|3882856|FG000|NOT COMPLETED|Part A, Period 2||0
3156249|NCT01836198|3882857|FG001|NOT COMPLETED|Part A, Period 2||1
3156250|NCT01836198|3882858|FG002|NOT COMPLETED|Part A, Period 2||0
3156251|NCT01836198|3882856|FG000|STARTED|Part B||0
3156252|NCT01836198|3882857|FG001|STARTED|Part B||0
3156253|NCT01836198|3882858|FG002|STARTED|Part B||12
3156254|NCT01836198|3882856|FG000|Received at Least 1 Dose of Study Drug|Part B||0
3156255|NCT01836198|3882857|FG001|Received at Least 1 Dose of Study Drug|Part B||0
3156256|NCT01836198|3882858|FG002|Received at Least 1 Dose of Study Drug|Part B||12
3156257|NCT01836198|3882856|FG000|COMPLETED|Part B||0
3156258|NCT01836198|3882857|FG001|COMPLETED|Part B||0
3156259|NCT01836198|3882858|FG002|COMPLETED|Part B||12
3156260|NCT01836198|3882856|FG000|NOT COMPLETED|Part B||0
3156261|NCT01836198|3882857|FG001|NOT COMPLETED|Part B||0
3156262|NCT01836198|3882858|FG002|NOT COMPLETED|Part B||0
3156263|NCT01836276|3882876|FG000|STARTED|Overall Study||224
3156264|NCT01836276|3882877|FG001|STARTED|Overall Study||225
3156265|NCT01836276|3882876|FG000|Week 4|Overall Study||198
3156266|NCT01836276|3882877|FG001|Week 4|Overall Study||186
3156267|NCT01836276|3882876|FG000|Week 12|Overall Study||183
3156268|NCT01836276|3882877|FG001|Week 12|Overall Study||165
3156269|NCT01836276|3882876|FG000|COMPLETED|Overall Study||196
3156270|NCT01836276|3882877|FG001|COMPLETED|Overall Study||174
3156271|NCT01836276|3882876|FG000|NOT COMPLETED|Overall Study||28
3156272|NCT01836276|3882877|FG001|NOT COMPLETED|Overall Study||51
3156273|NCT01836445|3882885|FG000|STARTED|Intervention Modules||445
3156274|NCT01836445|3882886|FG001|STARTED|Intervention Modules||456
3156275|NCT01836445|3882885|FG000|COMPLETED|Intervention Modules||375
3156276|NCT01836445|3882886|FG001|COMPLETED|Intervention Modules||434
3156277|NCT01836445|3882885|FG000|NOT COMPLETED|Intervention Modules||70
3156278|NCT01836445|3882886|FG001|NOT COMPLETED|Intervention Modules||22
3156279|NCT01836445|3882885|FG000|STARTED|3 Month Follow-up Assessment|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|445
3156280|NCT01836445|3882886|FG001|STARTED|3 Month Follow-up Assessment|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|456
3156281|NCT01836445|3882885|FG000|COMPLETED|3 Month Follow-up Assessment||348
3156282|NCT01836445|3882886|FG001|COMPLETED|3 Month Follow-up Assessment||409
3156283|NCT01836445|3882885|FG000|NOT COMPLETED|3 Month Follow-up Assessment||97
3156284|NCT01836445|3882886|FG001|NOT COMPLETED|3 Month Follow-up Assessment||47
3156285|NCT01836445|3882885|FG000|STARTED|6 Month Follow-up Assessment|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|445
3156286|NCT01836445|3882886|FG001|STARTED|6 Month Follow-up Assessment|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|455
3156287|NCT01836445|3882885|FG000|COMPLETED|6 Month Follow-up Assessment||342
3156288|NCT01836445|3882886|FG001|COMPLETED|6 Month Follow-up Assessment||380
3156289|NCT01836445|3882885|FG000|NOT COMPLETED|6 Month Follow-up Assessment||103
3156290|NCT01836445|3882886|FG001|NOT COMPLETED|6 Month Follow-up Assessment||75
3156291|NCT01836445|3882885|FG000|STARTED|12 Month Follow-up Assessment|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|445
3156292|NCT01836445|3882886|FG001|STARTED|12 Month Follow-up Assessment|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|455
3156293|NCT01836445|3882885|FG000|COMPLETED|12 Month Follow-up Assessment||370
3156294|NCT01836445|3882886|FG001|COMPLETED|12 Month Follow-up Assessment||391
3156295|NCT01836445|3882885|FG000|NOT COMPLETED|12 Month Follow-up Assessment||75
3156296|NCT01836445|3882886|FG001|NOT COMPLETED|12 Month Follow-up Assessment||64
3156297|NCT01836445|3882885|FG000|STARTED|12 Month STI Testing|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|445
3156298|NCT01836445|3882886|FG001|STARTED|12 Month STI Testing|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|455
3156299|NCT01836445|3882885|FG000|COMPLETED|12 Month STI Testing||365
3156300|NCT01836445|3882886|FG001|COMPLETED|12 Month STI Testing||378
3156301|NCT01836445|3882885|FG000|NOT COMPLETED|12 Month STI Testing||80
3156302|NCT01836445|3882886|FG001|NOT COMPLETED|12 Month STI Testing||77
3156303|NCT01836458|3882896|FG000|STARTED|Overall Study||7
3156304|NCT01836458|3882897|FG001|STARTED|Overall Study||4
3156305|NCT01836458|3882898|FG002|STARTED|Overall Study||7
3156306|NCT01836458|3882899|FG003|STARTED|Overall Study||7
3156307|NCT01836458|3882896|FG000|COMPLETED|Overall Study||4
3156308|NCT01836458|3882897|FG001|COMPLETED|Overall Study||2
3156309|NCT01836458|3882898|FG002|COMPLETED|Overall Study||2
3156310|NCT01836458|3882899|FG003|COMPLETED|Overall Study||1
3156311|NCT01836458|3882896|FG000|NOT COMPLETED|Overall Study||3
3156312|NCT01836458|3882897|FG001|NOT COMPLETED|Overall Study||2
3156313|NCT01836458|3882898|FG002|NOT COMPLETED|Overall Study||5
3156314|NCT01836458|3882899|FG003|NOT COMPLETED|Overall Study||6
3156315|NCT01836471|3882914|FG000|STARTED|Overall Study||93
3156316|NCT01836471|3882915|FG001|STARTED|Overall Study||94
3156317|NCT01836471|3882916|FG002|STARTED|Overall Study||51
3156318|NCT01836471|3882917|FG003|STARTED|Overall Study||42
3156319|NCT01836471|3882918|FG004|STARTED|Overall Study||54
3184769|NCT02016105|3912991|FG004|NOT COMPLETED|EXTENSION PERIOD||6
3184770|NCT02016105|3912992|FG005|NOT COMPLETED|EXTENSION PERIOD||6
3184771|NCT02016170|3913009|FG000|STARTED|Overall Study||27
3184772|NCT02016170|3913010|FG001|STARTED|Overall Study||28
3184773|NCT02016170|3913011|FG002|STARTED|Overall Study||27
3184774|NCT02016170|3913009|FG000|COMPLETED|Overall Study||25
3184775|NCT02016170|3913010|FG001|COMPLETED|Overall Study||27
3184776|NCT02016170|3913011|FG002|COMPLETED|Overall Study||27
3184777|NCT02016170|3913009|FG000|NOT COMPLETED|Overall Study||2
3184778|NCT02016170|3913010|FG001|NOT COMPLETED|Overall Study||1
3184779|NCT02016170|3913011|FG002|NOT COMPLETED|Overall Study||0
3184780|NCT02016183|3913018|FG000|STARTED|Overall Study||3222
3184781|NCT02016183|3913018|FG000|COMPLETED|Overall Study||3157
3184782|NCT02016183|3913018|FG000|NOT COMPLETED|Overall Study||65
3184783|NCT02016235|3913025|FG000|STARTED|Overall Study||10
3184784|NCT02016235|3913026|FG001|STARTED|Overall Study||10
3184785|NCT02016235|3913027|FG002|STARTED|Overall Study||10
3184786|NCT02016235|3913025|FG000|COMPLETED|Overall Study||10
3184787|NCT02016235|3913026|FG001|COMPLETED|Overall Study||10
3184788|NCT02016235|3913027|FG002|COMPLETED|Overall Study||10
3184789|NCT02016235|3913025|FG000|NOT COMPLETED|Overall Study||0
3184790|NCT02016235|3913026|FG001|NOT COMPLETED|Overall Study||0
3184791|NCT02016235|3913027|FG002|NOT COMPLETED|Overall Study||0
3184792|NCT02016300|3913037|FG000|STARTED|Overall Study||12
3184793|NCT02016300|3913038|FG001|STARTED|Overall Study||12
3184794|NCT02016300|3913037|FG000|COMPLETED|Overall Study||12
3184795|NCT02016300|3913038|FG001|COMPLETED|Overall Study||9
3184796|NCT02016300|3913037|FG000|NOT COMPLETED|Overall Study||0
3184797|NCT02016300|3913038|FG001|NOT COMPLETED|Overall Study||3
3184798|NCT02016482|3913046|FG000|STARTED|Period A||108
3184799|NCT02016482|3913047|FG001|STARTED|Period A||109
3184800|NCT02016482|3913046|FG000|COMPLETED|Period A|56 participants early escaped to the end of Period A and 38 continued to the end of Period A.|94
3184801|NCT02016482|3913047|FG001|COMPLETED|Period A|8 participants early escaped to the end of Period A and 86 continued to the end of Period A.|94
3184802|NCT02016482|3913046|FG000|NOT COMPLETED|Period A||14
3184803|NCT02016482|3913047|FG001|NOT COMPLETED|Period A||15
3184804|NCT02016482|3913046|FG000|STARTED|Period B||94
3184805|NCT02016482|3913047|FG001|STARTED|Period B||94
3184806|NCT02016482|3913046|FG000|COMPLETED|Period B||81
3184807|NCT02016482|3913047|FG001|COMPLETED|Period B||87
3184808|NCT02016482|3913046|FG000|NOT COMPLETED|Period B||13
3184809|NCT02016482|3913047|FG001|NOT COMPLETED|Period B||7
3184810|NCT02016560|3913061|FG000|STARTED|Exploratory Phase||16
3184811|NCT02016560|3913062|FG001|STARTED|Exploratory Phase||58
3184812|NCT02016560|3913063|FG002|STARTED|Exploratory Phase||98
3184813|NCT02016560|3913064|FG003|STARTED|Exploratory Phase||51
3184814|NCT02016560|3913065|FG004|STARTED|Exploratory Phase||0
3184815|NCT02016560|3913066|FG005|STARTED|Exploratory Phase||0
3184816|NCT02016560|3913061|FG000|COMPLETED|Exploratory Phase||16
3184817|NCT02016560|3913062|FG001|COMPLETED|Exploratory Phase||54
3156320|NCT01836471|3882914|FG000|COMPLETED|Overall Study||82
3156321|NCT01836471|3882915|FG001|COMPLETED|Overall Study||85
3156322|NCT01836471|3882916|FG002|COMPLETED|Overall Study||49
3156323|NCT01836471|3882917|FG003|COMPLETED|Overall Study||40
3184818|NCT02016560|3913063|FG002|COMPLETED|Exploratory Phase||62
3184819|NCT02016560|3913064|FG003|COMPLETED|Exploratory Phase||35
3184820|NCT02016560|3913065|FG004|COMPLETED|Exploratory Phase||0
3184821|NCT02016560|3913066|FG005|COMPLETED|Exploratory Phase||0
3184822|NCT02016560|3913061|FG000|NOT COMPLETED|Exploratory Phase||0
3184823|NCT02016560|3913062|FG001|NOT COMPLETED|Exploratory Phase||4
3184824|NCT02016560|3913063|FG002|NOT COMPLETED|Exploratory Phase||36
3184825|NCT02016560|3913064|FG003|NOT COMPLETED|Exploratory Phase||16
3184826|NCT02016560|3913065|FG004|NOT COMPLETED|Exploratory Phase||0
3184827|NCT02016560|3913066|FG005|NOT COMPLETED|Exploratory Phase||0
3184828|NCT02016560|3913061|FG000|STARTED|Confirmatory Phase||0
3184829|NCT02016560|3913062|FG001|STARTED|Confirmatory Phase||0
3184830|NCT02016560|3913063|FG002|STARTED|Confirmatory Phase||0
3184831|NCT02016560|3913064|FG003|STARTED|Confirmatory Phase||0
3184832|NCT02016560|3913065|FG004|STARTED|Confirmatory Phase||98
3184833|NCT02016560|3913066|FG005|STARTED|Confirmatory Phase||62
3184834|NCT02016560|3913061|FG000|COMPLETED|Confirmatory Phase||0
3156324|NCT01836471|3882918|FG004|COMPLETED|Overall Study||49
3156325|NCT01836471|3882914|FG000|NOT COMPLETED|Overall Study||11
3156326|NCT01836471|3882915|FG001|NOT COMPLETED|Overall Study||9
3156327|NCT01836471|3882916|FG002|NOT COMPLETED|Overall Study||2
3156328|NCT01836471|3882917|FG003|NOT COMPLETED|Overall Study||2
3156329|NCT01836471|3882918|FG004|NOT COMPLETED|Overall Study||5
3156330|NCT01836523|3882935|FG000|STARTED|Overall Study||351
3156331|NCT01836523|3882936|FG001|STARTED|Overall Study||350
3156332|NCT01836523|3882937|FG002|STARTED|Overall Study||349
3156333|NCT01836523|3882938|FG003|STARTED|Overall Study||348
3156334|NCT01836523|3882935|FG000|Exposed|Overall Study||350
3156335|NCT01836523|3882936|FG001|Exposed|Overall Study||348
3156336|NCT01836523|3882937|FG002|Exposed|Overall Study||347
3156337|NCT01836523|3882938|FG003|Exposed|Overall Study||348
3156338|NCT01836523|3882935|FG000|COMPLETED|Overall Study||300
3156339|NCT01836523|3882936|FG001|COMPLETED|Overall Study||265
3156340|NCT01836523|3882937|FG002|COMPLETED|Overall Study||258
3156341|NCT01836523|3882938|FG003|COMPLETED|Overall Study||274
3156342|NCT01836523|3882935|FG000|NOT COMPLETED|Overall Study||51
3156343|NCT01836523|3882936|FG001|NOT COMPLETED|Overall Study||85
3156344|NCT01836523|3882937|FG002|NOT COMPLETED|Overall Study||91
3156345|NCT01836523|3882938|FG003|NOT COMPLETED|Overall Study||74
3156346|NCT01836549|3882954|FG000|STARTED|Overall Study||1
3156347|NCT01836549|3882955|FG001|STARTED|Overall Study||1
3156348|NCT01836549|3882956|FG002|STARTED|Overall Study||1
3156349|NCT01836549|3882957|FG003|STARTED|Overall Study||9
3156350|NCT01836549|3882958|FG004|STARTED|Overall Study||18
3156351|NCT01836549|3882959|FG005|STARTED|Overall Study||4
3156352|NCT01836549|3882960|FG006|STARTED|Overall Study||9
3156353|NCT01836549|3882954|FG000|COMPLETED|Overall Study||1
3156354|NCT01836549|3882955|FG001|COMPLETED|Overall Study||1
3156355|NCT01836549|3882956|FG002|COMPLETED|Overall Study||0
3156356|NCT01836549|3882957|FG003|COMPLETED|Overall Study||8
3156357|NCT01836549|3882958|FG004|COMPLETED|Overall Study||18
3156358|NCT01836549|3882959|FG005|COMPLETED|Overall Study||4
3156359|NCT01836549|3882960|FG006|COMPLETED|Overall Study||8
3156360|NCT01836549|3882954|FG000|NOT COMPLETED|Overall Study||0
3156361|NCT01836549|3882955|FG001|NOT COMPLETED|Overall Study||0
3156362|NCT01836549|3882956|FG002|NOT COMPLETED|Overall Study||1
3156363|NCT01836549|3882957|FG003|NOT COMPLETED|Overall Study||1
3156364|NCT01836549|3882958|FG004|NOT COMPLETED|Overall Study||0
3156365|NCT01836549|3882959|FG005|NOT COMPLETED|Overall Study||0
3156366|NCT01836549|3882960|FG006|NOT COMPLETED|Overall Study||1
3156367|NCT01837069|3882978|FG000|STARTED|Overall Study||103
3156368|NCT01837069|3882979|FG001|STARTED|Overall Study||95
3156369|NCT01837069|3882978|FG000|COMPLETED|Overall Study||103
3156370|NCT01837069|3882979|FG001|COMPLETED|Overall Study||95
3156371|NCT01837069|3882978|FG000|NOT COMPLETED|Overall Study||0
3156372|NCT01837069|3882979|FG001|NOT COMPLETED|Overall Study||0
3156373|NCT01837524|3882987|FG000|STARTED|Overall Study||28
3156374|NCT01837524|3882988|FG001|STARTED|Overall Study||27
3156375|NCT01837524|3882987|FG000|COMPLETED|Overall Study||25
3156376|NCT01837524|3882988|FG001|COMPLETED|Overall Study||25
3156377|NCT01837524|3882987|FG000|NOT COMPLETED|Overall Study||3
3156378|NCT01837524|3882988|FG001|NOT COMPLETED|Overall Study||2
3156379|NCT01837537|3882994|FG000|STARTED|Overall Study||90
3156380|NCT01837537|3882994|FG000|COMPLETED|Overall Study||90
3156381|NCT01837537|3882994|FG000|NOT COMPLETED|Overall Study||0
3156382|NCT01837550|3883000|FG000|STARTED|T0-T1, 5 Weeks||37
3156383|NCT01837550|3883001|FG001|STARTED|T0-T1, 5 Weeks||37
3156384|NCT01837550|3883000|FG000|COMPLETED|T0-T1, 5 Weeks||37
3156385|NCT01837550|3883001|FG001|COMPLETED|T0-T1, 5 Weeks||37
3156386|NCT01837550|3883000|FG000|NOT COMPLETED|T0-T1, 5 Weeks||0
3156387|NCT01837550|3883001|FG001|NOT COMPLETED|T0-T1, 5 Weeks||0
3156388|NCT01837550|3883000|FG000|STARTED|T0-T2, 6 Months Follow-up||37
3156389|NCT01837550|3883001|FG001|STARTED|T0-T2, 6 Months Follow-up||37
3156390|NCT01837550|3883000|FG000|COMPLETED|T0-T2, 6 Months Follow-up||37
3156391|NCT01837550|3883001|FG001|COMPLETED|T0-T2, 6 Months Follow-up||37
3156392|NCT01837550|3883000|FG000|NOT COMPLETED|T0-T2, 6 Months Follow-up||0
3156393|NCT01837550|3883001|FG001|NOT COMPLETED|T0-T2, 6 Months Follow-up||0
3156394|NCT01837654|3883009|FG000|STARTED|Overall Study||11
3156395|NCT01837654|3883010|FG001|STARTED|Overall Study||11
3156396|NCT01837654|3883009|FG000|COMPLETED|Overall Study||11
3156397|NCT01837654|3883010|FG001|COMPLETED|Overall Study||11
3156398|NCT01837654|3883009|FG000|NOT COMPLETED|Overall Study||0
3156399|NCT01837654|3883010|FG001|NOT COMPLETED|Overall Study||0
3156400|NCT01837680|3883018|FG000|STARTED|Overall Study||52
3156401|NCT01837680|3883019|FG001|STARTED|Overall Study||53
3156402|NCT01837680|3883018|FG000|COMPLETED|Overall Study||42
3156403|NCT01837680|3883019|FG001|COMPLETED|Overall Study||45
3156404|NCT01837680|3883018|FG000|NOT COMPLETED|Overall Study||10
3156405|NCT01837680|3883019|FG001|NOT COMPLETED|Overall Study||8
3156406|NCT01837719|3883025|FG000|STARTED|Period 1: Days 1-7 (Treatment A or B)|Received treatment|64
3156407|NCT01837719|3883025|FG000|COMPLETED|Period 1: Days 1-7 (Treatment A or B)||64
3156408|NCT01837719|3883025|FG000|NOT COMPLETED|Period 1: Days 1-7 (Treatment A or B)||0
3156409|NCT01837719|3883025|FG000|STARTED|Period 2: Days 8-14 (Treatment B or A)||64
3156410|NCT01837719|3883025|FG000|COMPLETED|Period 2: Days 8-14 (Treatment B or A)||63
3156411|NCT01837719|3883025|FG000|NOT COMPLETED|Period 2: Days 8-14 (Treatment B or A)||1
3156412|NCT01837719|3883025|FG000|STARTED|Period 3: Days 15-21 (Treatment C or D)||63
3156413|NCT01837719|3883025|FG000|COMPLETED|Period 3: Days 15-21 (Treatment C or D)||63
3156414|NCT01837719|3883025|FG000|NOT COMPLETED|Period 3: Days 15-21 (Treatment C or D)||0
3156415|NCT01837719|3883025|FG000|STARTED|Period 4: Days 22-28 (Treatment D or C)||63
3156416|NCT01837719|3883025|FG000|COMPLETED|Period 4: Days 22-28 (Treatment D or C)|Number finishing period; 32 patients were discharged following Period 4, as per protocol|63
3156417|NCT01837719|3883025|FG000|NOT COMPLETED|Period 4: Days 22-28 (Treatment D or C)||0
3156418|NCT01837719|3883025|FG000|STARTED|Period 5: Days 29-31 (Treatment E)|Reflects the 31 patients remaining after 32 were discharged at the end of Period 4, as per protocol|31
3156419|NCT01837719|3883025|FG000|COMPLETED|Period 5: Days 29-31 (Treatment E)||30
3156420|NCT01837719|3883025|FG000|NOT COMPLETED|Period 5: Days 29-31 (Treatment E)||1
3156421|NCT01837797|3883043|FG000|STARTED|Period 1||129
3156422|NCT01837797|3883044|FG001|STARTED|Period 1||0
3156423|NCT01837797|3883045|FG002|STARTED|Period 1||0
3156424|NCT01837797|3883046|FG003|STARTED|Period 1||0
3156425|NCT01837797|3883047|FG004|STARTED|Period 1||0
3156426|NCT01837797|3883043|FG000|COMPLETED|Period 1||27
3156427|NCT01837797|3883044|FG001|COMPLETED|Period 1||0
3156428|NCT01837797|3883045|FG002|COMPLETED|Period 1||0
3156429|NCT01837797|3883046|FG003|COMPLETED|Period 1||0
3156430|NCT01837797|3883047|FG004|COMPLETED|Period 1||0
3156431|NCT01837797|3883043|FG000|NOT COMPLETED|Period 1||102
3156432|NCT01837797|3883044|FG001|NOT COMPLETED|Period 1||0
3156433|NCT01837797|3883045|FG002|NOT COMPLETED|Period 1||0
3156434|NCT01837797|3883046|FG003|NOT COMPLETED|Period 1||0
3156435|NCT01837797|3883047|FG004|NOT COMPLETED|Period 1||0
3156436|NCT01837797|3883043|FG000|STARTED|Period 2||0
3156437|NCT01837797|3883044|FG001|STARTED|Period 2||6
3156438|NCT01837797|3883045|FG002|STARTED|Period 2||3
3156439|NCT01837797|3883046|FG003|STARTED|Period 2||6
3156440|NCT01837797|3883047|FG004|STARTED|Period 2||0
3156441|NCT01837797|3883043|FG000|COMPLETED|Period 2||0
3156442|NCT01837797|3883044|FG001|COMPLETED|Period 2||1
3184835|NCT02016560|3913062|FG001|COMPLETED|Confirmatory Phase||0
3184836|NCT02016560|3913063|FG002|COMPLETED|Confirmatory Phase||0
3184837|NCT02016560|3913064|FG003|COMPLETED|Confirmatory Phase||0
3184838|NCT02016560|3913065|FG004|COMPLETED|Confirmatory Phase||76
3184839|NCT02016560|3913066|FG005|COMPLETED|Confirmatory Phase||35
3184840|NCT02016560|3913061|FG000|NOT COMPLETED|Confirmatory Phase||0
3184841|NCT02016560|3913062|FG001|NOT COMPLETED|Confirmatory Phase||0
3184842|NCT02016560|3913063|FG002|NOT COMPLETED|Confirmatory Phase||0
3184843|NCT02016560|3913064|FG003|NOT COMPLETED|Confirmatory Phase||0
3184844|NCT02016560|3913065|FG004|NOT COMPLETED|Confirmatory Phase||22
3184845|NCT02016560|3913066|FG005|NOT COMPLETED|Confirmatory Phase||27
3184846|NCT02016612|3913092|FG000|STARTED|Overall Study||25
3184847|NCT02016612|3913093|FG001|STARTED|Overall Study||25
3184848|NCT02016612|3913094|FG002|STARTED|Overall Study||26
3184849|NCT02016612|3913095|FG003|STARTED|Overall Study||61
3184850|NCT02016612|3913092|FG000|COMPLETED|Overall Study||25
3184851|NCT02016612|3913093|FG001|COMPLETED|Overall Study||25
3184852|NCT02016612|3913094|FG002|COMPLETED|Overall Study||26
3184853|NCT02016612|3913095|FG003|COMPLETED|Overall Study||61
3184854|NCT02016612|3913092|FG000|NOT COMPLETED|Overall Study||0
3184855|NCT02016612|3913093|FG001|NOT COMPLETED|Overall Study||0
3184856|NCT02016612|3913094|FG002|NOT COMPLETED|Overall Study||0
3184857|NCT02016612|3913095|FG003|NOT COMPLETED|Overall Study||0
3184858|NCT02016625|3913107|FG000|STARTED|Cyclo or Tac (Single Dose, Day 1)||16
3184859|NCT02016625|3913108|FG001|STARTED|Cyclo or Tac (Single Dose, Day 1)||16
3184860|NCT02016625|3913107|FG000|COMPLETED|Cyclo or Tac (Single Dose, Day 1)||16
3184861|NCT02016625|3913108|FG001|COMPLETED|Cyclo or Tac (Single Dose, Day 1)||15
3184862|NCT02016625|3913107|FG000|NOT COMPLETED|Cyclo or Tac (Single Dose, Day 1)||0
3184863|NCT02016625|3913108|FG001|NOT COMPLETED|Cyclo or Tac (Single Dose, Day 1)||1
3184864|NCT02016625|3913107|FG000|STARTED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||16
3184865|NCT02016625|3913108|FG001|STARTED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||15
3184866|NCT02016625|3913107|FG000|COMPLETED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||13
3184867|NCT02016625|3913108|FG001|COMPLETED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||15
3184868|NCT02016625|3913107|FG000|NOT COMPLETED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||3
3184869|NCT02016625|3913108|FG001|NOT COMPLETED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||0
3184870|NCT02016690|3913124|FG000|STARTED|Overall Study||312
3184871|NCT02016690|3913124|FG000|Treated|Overall Study||312
3184872|NCT02016690|3913124|FG000|Safety Analysis Set (SAS)|Overall Study||304
3184873|NCT02016690|3913124|FG000|COMPLETED|Overall Study|(Effectiveness analysis set)|288
3184874|NCT02016690|3913124|FG000|NOT COMPLETED|Overall Study||24
3184875|NCT02016716|3913131|FG000|STARTED|Overall Study||53
3184876|NCT02016716|3913132|FG001|STARTED|Overall Study||118
3184877|NCT02016716|3913133|FG002|STARTED|Overall Study||123
3184878|NCT02016716|3913131|FG000|Received Study Treatment|Overall Study||53
3184879|NCT02016716|3913132|FG001|Received Study Treatment|Overall Study||118
3184880|NCT02016716|3913133|FG002|Received Study Treatment|Overall Study||123
3184881|NCT02016716|3913131|FG000|COMPLETED|Overall Study||47
3184882|NCT02016716|3913132|FG001|COMPLETED|Overall Study||110
3184883|NCT02016716|3913133|FG002|COMPLETED|Overall Study||117
3184884|NCT02016716|3913131|FG000|NOT COMPLETED|Overall Study||6
3184885|NCT02016716|3913132|FG001|NOT COMPLETED|Overall Study||8
3184886|NCT02016716|3913133|FG002|NOT COMPLETED|Overall Study||6
3184887|NCT02016755|3913142|FG000|STARTED|Overall Study||10
3184888|NCT02016755|3913142|FG000|Completed Month 18 Clinic Visit|Overall Study||5
3184889|NCT02016755|3913142|FG000|Completed Month 36 LTFU Questionnaire|Overall Study||3
3184890|NCT02016755|3913142|FG000|COMPLETED|Overall Study||3
3156443|NCT01837797|3883045|FG002|COMPLETED|Period 2||1
3156444|NCT01837797|3883046|FG003|COMPLETED|Period 2||1
3156445|NCT01837797|3883047|FG004|COMPLETED|Period 2||0
3156446|NCT01837797|3883043|FG000|NOT COMPLETED|Period 2||0
3156447|NCT01837797|3883044|FG001|NOT COMPLETED|Period 2||5
3156448|NCT01837797|3883045|FG002|NOT COMPLETED|Period 2||2
3156449|NCT01837797|3883046|FG003|NOT COMPLETED|Period 2||5
3156450|NCT01837797|3883047|FG004|NOT COMPLETED|Period 2||0
3156451|NCT01837797|3883043|FG000|STARTED|Period 3||0
3156452|NCT01837797|3883044|FG001|STARTED|Period 3||0
3156453|NCT01837797|3883045|FG002|STARTED|Period 3||0
3156454|NCT01837797|3883046|FG003|STARTED|Period 3||0
3156455|NCT01837797|3883047|FG004|STARTED|Period 3||47
3156456|NCT01837797|3883043|FG000|COMPLETED|Period 3||0
3156457|NCT01837797|3883044|FG001|COMPLETED|Period 3||0
3156458|NCT01837797|3883045|FG002|COMPLETED|Period 3||0
3156459|NCT01837797|3883046|FG003|COMPLETED|Period 3||0
3156460|NCT01837797|3883047|FG004|COMPLETED|Period 3||24
3156461|NCT01837797|3883043|FG000|NOT COMPLETED|Period 3||0
3156462|NCT01837797|3883044|FG001|NOT COMPLETED|Period 3||0
3156463|NCT01837797|3883045|FG002|NOT COMPLETED|Period 3||0
3156464|NCT01837797|3883046|FG003|NOT COMPLETED|Period 3||0
3156465|NCT01837797|3883047|FG004|NOT COMPLETED|Period 3||23
3156466|NCT01837823|3883055|FG000|STARTED|Overall Study||91
3156467|NCT01837823|3883055|FG000|COMPLETED|Overall Study||85
3156468|NCT01837823|3883055|FG000|NOT COMPLETED|Overall Study||6
3156469|NCT01837901|3883066|FG000|STARTED|Overall Study||22
3156470|NCT01837901|3883067|FG001|STARTED|Overall Study||21
3156471|NCT01837901|3883068|FG002|STARTED|Overall Study||20
3156472|NCT01837901|3883066|FG000|COMPLETED|Overall Study||20
3156473|NCT01837901|3883067|FG001|COMPLETED|Overall Study||15
3156474|NCT01837901|3883068|FG002|COMPLETED|Overall Study||17
3156475|NCT01837901|3883066|FG000|NOT COMPLETED|Overall Study||2
3156476|NCT01837901|3883067|FG001|NOT COMPLETED|Overall Study||6
3156477|NCT01837901|3883068|FG002|NOT COMPLETED|Overall Study||3
3156478|NCT01837966|3883078|FG000|STARTED|Overall Study||47
3156479|NCT01837966|3883079|FG001|STARTED|Overall Study||46
3156480|NCT01837966|3883078|FG000|COMPLETED|Overall Study||45
3156481|NCT01837966|3883079|FG001|COMPLETED|Overall Study||45
3156482|NCT01837966|3883078|FG000|NOT COMPLETED|Overall Study||2
3156483|NCT01837966|3883079|FG001|NOT COMPLETED|Overall Study||1
3156484|NCT01838044|3883087|FG000|STARTED|Overall Study||89
3156485|NCT01838044|3883088|FG001|STARTED|Overall Study||91
3156486|NCT01838044|3883087|FG000|COMPLETED|Overall Study||81
3156487|NCT01838044|3883088|FG001|COMPLETED|Overall Study||75
3156488|NCT01838044|3883087|FG000|NOT COMPLETED|Overall Study||8
3156489|NCT01838044|3883088|FG001|NOT COMPLETED|Overall Study||16
3156490|NCT01838200|3883097|FG000|STARTED|Overall Study||3
3156491|NCT01838200|3883098|FG001|STARTED|Overall Study||2
3156492|NCT01838200|3883097|FG000|COMPLETED|Overall Study||0
3156493|NCT01838200|3883098|FG001|COMPLETED|Overall Study||0
3156494|NCT01838200|3883097|FG000|NOT COMPLETED|Overall Study||3
3156495|NCT01838200|3883098|FG001|NOT COMPLETED|Overall Study||2
3184891|NCT02016755|3913142|FG000|NOT COMPLETED|Overall Study||7
3184892|NCT02016885|3913151|FG000|STARTED|Overall Study||38
3184893|NCT02016885|3913152|FG001|STARTED|Overall Study||40
3184894|NCT02016885|3913153|FG002|STARTED|Overall Study||40
3184895|NCT02016885|3913154|FG003|STARTED|Overall Study||40
3184896|NCT02016885|3913155|FG004|STARTED|Overall Study||40
3184897|NCT02016885|3913151|FG000|COMPLETED|Overall Study||34
3184898|NCT02016885|3913152|FG001|COMPLETED|Overall Study||36
3184899|NCT02016885|3913153|FG002|COMPLETED|Overall Study||39
3184900|NCT02016885|3913154|FG003|COMPLETED|Overall Study||30
3184901|NCT02016885|3913155|FG004|COMPLETED|Overall Study||39
3184902|NCT02016885|3913151|FG000|NOT COMPLETED|Overall Study||4
3184903|NCT02016885|3913152|FG001|NOT COMPLETED|Overall Study||4
3184904|NCT02016885|3913153|FG002|NOT COMPLETED|Overall Study||1
3184905|NCT02016885|3913154|FG003|NOT COMPLETED|Overall Study||10
3184906|NCT02016885|3913155|FG004|NOT COMPLETED|Overall Study||1
3184907|NCT02016898|3913169|FG000|STARTED|Overall Study||50
3184908|NCT02016898|3913170|FG001|STARTED|Overall Study||45
3184909|NCT02016898|3913169|FG000|COMPLETED|Overall Study||45
3184910|NCT02016898|3913170|FG001|COMPLETED|Overall Study||40
3184911|NCT02016898|3913169|FG000|NOT COMPLETED|Overall Study||5
3184912|NCT02016898|3913170|FG001|NOT COMPLETED|Overall Study||5
3184913|NCT02016963|3913176|FG000|STARTED|Overall Study||20
3184914|NCT02016963|3913176|FG000|COMPLETED|Overall Study||20
3184915|NCT02016963|3913176|FG000|NOT COMPLETED|Overall Study||0
3184916|NCT02017015|3913181|FG000|STARTED|Overall Study||83
3184917|NCT02017015|3913181|FG000|Safety Population|Overall Study||83
3184918|NCT02017015|3913181|FG000|COMPLETED|Overall Study|Completed = Participants remaining on treatment at the time of the data cut-off of 01 Jun 2015|14
3184919|NCT02017015|3913181|FG000|NOT COMPLETED|Overall Study||69
3184920|NCT02017093|3913188|FG000|STARTED|Overall Study||4
3184921|NCT02017093|3913189|FG001|STARTED|Overall Study||3
3184922|NCT02017093|3913188|FG000|COMPLETED|Overall Study||4
3184923|NCT02017093|3913189|FG001|COMPLETED|Overall Study||3
3184924|NCT02017093|3913188|FG000|NOT COMPLETED|Overall Study||0
3184925|NCT02017093|3913189|FG001|NOT COMPLETED|Overall Study||0
3184926|NCT02017171|3913199|FG000|STARTED|Overall Study||267
3184927|NCT02017171|3913200|FG001|STARTED|Overall Study||263
3184928|NCT02017171|3913199|FG000|COMPLETED|Overall Study||205
3184929|NCT02017171|3913200|FG001|COMPLETED|Overall Study||217
3184930|NCT02017171|3913199|FG000|NOT COMPLETED|Overall Study||62
3184931|NCT02017171|3913200|FG001|NOT COMPLETED|Overall Study||46
3184932|NCT02017210|3913210|FG000|STARTED|Overall Study||17
3156496|NCT01838213|3883106|FG000|STARTED|Overall Study||247
3156497|NCT01838213|3883107|FG001|STARTED|Overall Study||453
3156498|NCT01838213|3883106|FG000|COMPLETED|Overall Study||81
3156499|NCT01838213|3883107|FG001|COMPLETED|Overall Study||262
3156500|NCT01838213|3883106|FG000|NOT COMPLETED|Overall Study||166
3156501|NCT01838213|3883107|FG001|NOT COMPLETED|Overall Study||191
3156502|NCT01838226|3883115|FG000|STARTED|Overall Study||202
3156503|NCT01838226|3883116|FG001|STARTED|Overall Study||199
3156504|NCT01838226|3883115|FG000|COMPLETED|Overall Study||126
3156505|NCT01838226|3883116|FG001|COMPLETED|Overall Study||128
3156506|NCT01838226|3883115|FG000|NOT COMPLETED|Overall Study||76
3156507|NCT01838226|3883116|FG001|NOT COMPLETED|Overall Study||71
3156508|NCT01838304|3883124|FG000|STARTED|Overall Study||20
3156509|NCT01838304|3883125|FG001|STARTED|Overall Study||20
3156510|NCT01838304|3883124|FG000|COMPLETED|Overall Study||19
3156511|NCT01838304|3883125|FG001|COMPLETED|Overall Study||20
3156512|NCT01838304|3883124|FG000|NOT COMPLETED|Overall Study||1
3156513|NCT01838304|3883125|FG001|NOT COMPLETED|Overall Study||0
3156514|NCT01838317|3883133|FG000|STARTED|Overall Study||9
3156515|NCT01838317|3883134|FG001|STARTED|Overall Study||5
3156516|NCT01838317|3883133|FG000|COMPLETED|Overall Study||9
3156517|NCT01838317|3883134|FG001|COMPLETED|Overall Study||5
3156518|NCT01838317|3883133|FG000|NOT COMPLETED|Overall Study||0
3156519|NCT01838317|3883134|FG001|NOT COMPLETED|Overall Study||0
3156520|NCT01838447|3883142|FG000|STARTED|Overall Study||22
3156521|NCT01838447|3883143|FG001|STARTED|Overall Study||24
3156522|NCT01838447|3883142|FG000|COMPLETED|Overall Study||20
3156523|NCT01838447|3883143|FG001|COMPLETED|Overall Study||21
3156524|NCT01838447|3883142|FG000|NOT COMPLETED|Overall Study||2
3156525|NCT01838447|3883143|FG001|NOT COMPLETED|Overall Study||3
3156526|NCT01838499|3883151|FG000|STARTED|Overall Study||55
3156527|NCT01838499|3883152|FG001|STARTED|Overall Study||54
3156528|NCT01838499|3883151|FG000|COMPLETED|Overall Study||31
3156529|NCT01838499|3883152|FG001|COMPLETED|Overall Study||37
3156530|NCT01838499|3883151|FG000|NOT COMPLETED|Overall Study||24
3156531|NCT01838499|3883152|FG001|NOT COMPLETED|Overall Study||17
3156532|NCT01838551|3883158|FG000|STARTED|Overall Study|94 subjects were enrolled and received at least 1 dose of levoketoconazole|94
3156533|NCT01838551|3883158|FG000|COMPLETED|Overall Study|46 subjects completed the Extended Evaluation phase|46
3156534|NCT01838551|3883158|FG000|NOT COMPLETED|Overall Study||48
3156535|NCT01838590|3883166|FG000|STARTED|Overall Study||52
3184933|NCT02017210|3913211|FG001|STARTED|Overall Study||20
3184934|NCT02017210|3913212|FG002|STARTED|Overall Study||20
3184935|NCT02017210|3913210|FG000|COMPLETED|Overall Study||17
3156536|NCT01838590|3883167|FG001|STARTED|Overall Study||51
3156537|NCT01838590|3883166|FG000|COMPLETED|Overall Study||40
3156538|NCT01838590|3883167|FG001|COMPLETED|Overall Study||46
3156539|NCT01838590|3883166|FG000|NOT COMPLETED|Overall Study||12
3156540|NCT01838590|3883167|FG001|NOT COMPLETED|Overall Study||5
3156541|NCT01838616|3883179|FG000|STARTED|Titration Period||130
3156542|NCT01838616|3883180|FG001|STARTED|Titration Period||128
3156543|NCT01838616|3883179|FG000|No Post Baseline Pain Intensity Values|Titration Period||0
3156544|NCT01838616|3883180|FG001|No Post Baseline Pain Intensity Values|Titration Period||2
3156545|NCT01838616|3883179|FG000|Major Protocol Deviations|Titration Period||13
3156546|NCT01838616|3883180|FG001|Major Protocol Deviations|Titration Period||16
3156547|NCT01838616|3883179|FG000|Switched to Pick-up Arm|Titration Period||0
3156548|NCT01838616|3883180|FG001|Switched to Pick-up Arm|Titration Period||43
3156549|NCT01838616|3883179|FG000|Full Analysis Set|Titration Period||130
3156550|NCT01838616|3883180|FG001|Full Analysis Set|Titration Period||128
3156551|NCT01838616|3883179|FG000|Per Protocol Set|Titration Period||117
3156552|NCT01838616|3883180|FG001|Per Protocol Set|Titration Period||112
3156553|NCT01838616|3883179|FG000|COMPLETED|Titration Period||100
3156554|NCT01838616|3883180|FG001|COMPLETED|Titration Period||62
3156555|NCT01838616|3883179|FG000|NOT COMPLETED|Titration Period||30
3156556|NCT01838616|3883180|FG001|NOT COMPLETED|Titration Period||66
3156557|NCT01838616|3883179|FG000|STARTED|Continuation Period||100
3156558|NCT01838616|3883180|FG001|STARTED|Continuation Period||62
3156559|NCT01838616|3883179|FG000|Switched to Pick-up Arm|Continuation Period||0
3156560|NCT01838616|3883180|FG001|Switched to Pick-up Arm|Continuation Period||7
3156561|NCT01838616|3883179|FG000|COMPLETED|Continuation Period||86
3156562|NCT01838616|3883180|FG001|COMPLETED|Continuation Period||48
3156563|NCT01838616|3883179|FG000|NOT COMPLETED|Continuation Period||14
3156564|NCT01838616|3883180|FG001|NOT COMPLETED|Continuation Period||14
3156565|NCT01838616|3883179|FG000|STARTED|Pick-up Arm|Switch to Tapentadol (PR) after Oxycodone/Naloxone (PR) treatment discontinuation.|50
3156566|NCT01838616|3883180|FG001|STARTED|Pick-up Arm||0
3156567|NCT01838616|3883179|FG000|Full Analysis Set|Pick-up Arm||49
3156568|NCT01838616|3883180|FG001|Full Analysis Set|Pick-up Arm||0
3184936|NCT02017210|3913211|FG001|COMPLETED|Overall Study||20
3184937|NCT02017210|3913212|FG002|COMPLETED|Overall Study||20
3184938|NCT02017210|3913210|FG000|NOT COMPLETED|Overall Study||0
3184939|NCT02017210|3913211|FG001|NOT COMPLETED|Overall Study||0
3184940|NCT02017210|3913212|FG002|NOT COMPLETED|Overall Study||0
3184941|NCT02017223|3913223|FG000|STARTED|Overall Study||12
3184942|NCT02017223|3913223|FG000|COMPLETED|Overall Study||10
3184943|NCT02017223|3913223|FG000|NOT COMPLETED|Overall Study||2
3156569|NCT01838616|3883179|FG000|COMPLETED|Pick-up Arm|Participants completed the tapentadol pick-up arm after initially on oxycodone/naloxone PR treatment|35
3156570|NCT01838616|3883180|FG001|COMPLETED|Pick-up Arm||0
3184944|NCT02017327|3913230|FG000|STARTED|Overall Study||122
3156571|NCT01838616|3883179|FG000|NOT COMPLETED|Pick-up Arm||15
3156572|NCT01838616|3883180|FG001|NOT COMPLETED|Pick-up Arm||0
3156573|NCT01838642|3883191|FG000|STARTED|Overall Study||3
3156574|NCT01838642|3883191|FG000|COMPLETED|Overall Study||2
3156575|NCT01838642|3883191|FG000|NOT COMPLETED|Overall Study||1
3156576|NCT01838655|3883196|FG000|STARTED|Overall Study||5
3156577|NCT01838655|3883196|FG000|COMPLETED|Overall Study||5
3156578|NCT01838655|3883196|FG000|NOT COMPLETED|Overall Study||0
3156579|NCT01838681|3883200|FG000|STARTED|Period A||1986
3156580|NCT01838681|3883201|FG001|STARTED|Period A||0
3156581|NCT01838681|3883202|FG002|STARTED|Period A||0
3156582|NCT01838681|3883203|FG003|STARTED|Period A||0
3156583|NCT01838681|3883200|FG000|COMPLETED|Period A||1661
3156584|NCT01838681|3883201|FG001|COMPLETED|Period A||0
3156585|NCT01838681|3883202|FG002|COMPLETED|Period A||0
3156586|NCT01838681|3883203|FG003|COMPLETED|Period A||0
3156587|NCT01838681|3883200|FG000|NOT COMPLETED|Period A||325
3156588|NCT01838681|3883201|FG001|NOT COMPLETED|Period A||0
3156589|NCT01838681|3883202|FG002|NOT COMPLETED|Period A||0
3156590|NCT01838681|3883203|FG003|NOT COMPLETED|Period A||0
3156591|NCT01838681|3883200|FG000|STARTED|Period B/A+||0
3156592|NCT01838681|3883201|FG001|STARTED|Period B/A+||442
3156593|NCT01838681|3883202|FG002|STARTED|Period B/A+||444
3156594|NCT01838681|3883203|FG003|STARTED|Period B/A+||770
3156595|NCT01838681|3883200|FG000|COMPLETED|Period B/A+||0
3184945|NCT02017327|3913231|FG001|STARTED|Overall Study||125
3184946|NCT02017327|3913232|FG002|STARTED|Overall Study||132
3184947|NCT02017327|3913230|FG000|COMPLETED|Overall Study||106
3184948|NCT02017327|3913231|FG001|COMPLETED|Overall Study||113
3184949|NCT02017327|3913232|FG002|COMPLETED|Overall Study||117
3184950|NCT02017327|3913230|FG000|NOT COMPLETED|Overall Study||16
3184951|NCT02017327|3913231|FG001|NOT COMPLETED|Overall Study||12
3184952|NCT02017327|3913232|FG002|NOT COMPLETED|Overall Study||15
3184953|NCT02017444|3913242|FG000|STARTED|Overall Study||14
3184954|NCT02017444|3913243|FG001|STARTED|Overall Study||17
3184955|NCT02017444|3913242|FG000|COMPLETED|Overall Study||12
3184956|NCT02017444|3913243|FG001|COMPLETED|Overall Study|NB: One participant did not complete primary outcome.|17
3184957|NCT02017444|3913242|FG000|NOT COMPLETED|Overall Study||2
3184958|NCT02017444|3913243|FG001|NOT COMPLETED|Overall Study||0
3184959|NCT02017535|3913253|FG000|STARTED|Overall Study||9
3184960|NCT02017535|3913254|FG001|STARTED|Overall Study||3
3184961|NCT02017535|3913255|FG002|STARTED|Overall Study||2
3184962|NCT02017535|3913256|FG003|STARTED|Overall Study||1
3184963|NCT02017535|3913253|FG000|COMPLETED|Overall Study||8
3184964|NCT02017535|3913254|FG001|COMPLETED|Overall Study||3
3184965|NCT02017535|3913255|FG002|COMPLETED|Overall Study||2
3184966|NCT02017535|3913256|FG003|COMPLETED|Overall Study||1
3184967|NCT02017535|3913253|FG000|NOT COMPLETED|Overall Study||1
3184968|NCT02017535|3913254|FG001|NOT COMPLETED|Overall Study||0
3184969|NCT02017535|3913255|FG002|NOT COMPLETED|Overall Study||0
3184970|NCT02017535|3913256|FG003|NOT COMPLETED|Overall Study||0
3184971|NCT02017574|3913268|FG000|STARTED|Overall Study||12
3184972|NCT02017574|3913269|FG001|STARTED|Overall Study||12
3184973|NCT02017574|3913268|FG000|COMPLETED|Overall Study||12
3184974|NCT02017574|3913269|FG001|COMPLETED|Overall Study||12
3184975|NCT02017574|3913268|FG000|NOT COMPLETED|Overall Study||0
3184976|NCT02017574|3913269|FG001|NOT COMPLETED|Overall Study||0
3184977|NCT02017860|3913275|FG000|STARTED|Overall Study||4
3184978|NCT02017860|3913275|FG000|COMPLETED|Overall Study||2
3184979|NCT02017860|3913275|FG000|NOT COMPLETED|Overall Study||2
3184980|NCT02017899|3913285|FG000|STARTED|Overall Study||8
3184981|NCT02017899|3913286|FG001|STARTED|Overall Study||9
3184982|NCT02017899|3913287|FG002|STARTED|Overall Study||8
3184983|NCT02017899|3913288|FG003|STARTED|Overall Study||8
3184984|NCT02017899|3913289|FG004|STARTED|Overall Study||9
3184985|NCT02017899|3913290|FG005|STARTED|Overall Study||8
3184986|NCT02017899|3913285|FG000|COMPLETED|Overall Study||8
3184987|NCT02017899|3913286|FG001|COMPLETED|Overall Study||9
3184988|NCT02017899|3913287|FG002|COMPLETED|Overall Study||8
3184989|NCT02017899|3913288|FG003|COMPLETED|Overall Study||7
3184990|NCT02017899|3913289|FG004|COMPLETED|Overall Study||8
3184991|NCT02017899|3913290|FG005|COMPLETED|Overall Study||8
3184992|NCT02017899|3913285|FG000|NOT COMPLETED|Overall Study||0
3184993|NCT02017899|3913286|FG001|NOT COMPLETED|Overall Study||0
3184994|NCT02017899|3913287|FG002|NOT COMPLETED|Overall Study||0
3184995|NCT02017899|3913288|FG003|NOT COMPLETED|Overall Study||1
3184996|NCT02017899|3913289|FG004|NOT COMPLETED|Overall Study||1
3184997|NCT02017899|3913290|FG005|NOT COMPLETED|Overall Study||0
3184998|NCT02018042|3913304|FG000|STARTED|Overall Study||15
3184999|NCT02018042|3913304|FG000|COMPLETED|Overall Study||14
3185000|NCT02018042|3913304|FG000|NOT COMPLETED|Overall Study||1
3185001|NCT02018107|3913308|FG000|STARTED|Overall Study||27
3185002|NCT02018107|3913308|FG000|COMPLETED|Overall Study||27
3185003|NCT02018107|3913308|FG000|NOT COMPLETED|Overall Study||0
3185004|NCT02018315|3913312|FG000|STARTED|Overall Study||14
3185005|NCT02018315|3913312|FG000|COMPLETED|Overall Study||14
3185006|NCT02018315|3913312|FG000|NOT COMPLETED|Overall Study||0
3185007|NCT02018445|3913316|FG000|STARTED|Overall Study||36
3185008|NCT02018445|3913316|FG000|COMPLETED|Overall Study||29
3185009|NCT02018445|3913316|FG000|NOT COMPLETED|Overall Study||7
3185010|NCT02018458|3913323|FG000|STARTED|Overall Study||10
3185011|NCT02018458|3913323|FG000|COMPLETED|Overall Study||6
3156596|NCT01838681|3883201|FG001|COMPLETED|Period B/A+||380
3156597|NCT01838681|3883202|FG002|COMPLETED|Period B/A+||349
3156598|NCT01838681|3883203|FG003|COMPLETED|Period B/A+||653
3156599|NCT01838681|3883200|FG000|NOT COMPLETED|Period B/A+||0
3156600|NCT01838681|3883201|FG001|NOT COMPLETED|Period B/A+||62
3156601|NCT01838681|3883202|FG002|NOT COMPLETED|Period B/A+||95
3156602|NCT01838681|3883203|FG003|NOT COMPLETED|Period B/A+||117
3156603|NCT01838694|3883211|FG000|STARTED|Overall Study||8
3156604|NCT01838694|3883212|FG001|STARTED|Overall Study||22
3156605|NCT01838694|3883211|FG000|COMPLETED|Overall Study||8
3156606|NCT01838694|3883212|FG001|COMPLETED|Overall Study||21
3156607|NCT01838694|3883211|FG000|NOT COMPLETED|Overall Study||0
3156608|NCT01838694|3883212|FG001|NOT COMPLETED|Overall Study||1
3156609|NCT01838785|3883221|FG000|STARTED|Overall Study||25
3156610|NCT01838785|3883221|FG000|COMPLETED|Overall Study||25
3185012|NCT02018458|3913323|FG000|NOT COMPLETED|Overall Study||4
3185013|NCT02018562|3913329|FG000|STARTED|Overall Study||25
3185014|NCT02018562|3913330|FG001|STARTED|Overall Study||25
3185015|NCT02018562|3913329|FG000|COMPLETED|Overall Study||22
3185016|NCT02018562|3913330|FG001|COMPLETED|Overall Study||25
3185017|NCT02018562|3913329|FG000|NOT COMPLETED|Overall Study||3
3185018|NCT02018562|3913330|FG001|NOT COMPLETED|Overall Study||0
3185019|NCT02018627|3913338|FG000|STARTED|Overall Study||7
3185020|NCT02018627|3913339|FG001|STARTED|Overall Study||6
3185021|NCT02018627|3913338|FG000|COMPLETED|Overall Study||7
3185022|NCT02018627|3913339|FG001|COMPLETED|Overall Study||6
3185023|NCT02018627|3913338|FG000|NOT COMPLETED|Overall Study||0
3185024|NCT02018627|3913339|FG001|NOT COMPLETED|Overall Study||0
3185025|NCT02018653|3913347|FG000|STARTED|Overall Study||1
3185026|NCT02018653|3913348|FG001|STARTED|Overall Study||1
3185027|NCT02018653|3913347|FG000|COMPLETED|Overall Study||1
3185028|NCT02018653|3913348|FG001|COMPLETED|Overall Study||0
3185029|NCT02018653|3913347|FG000|NOT COMPLETED|Overall Study||0
3185030|NCT02018653|3913348|FG001|NOT COMPLETED|Overall Study||1
3185031|NCT02018809|3913358|FG000|STARTED|Overall Study||50
3185032|NCT02018809|3913359|FG001|STARTED|Overall Study||50
3185033|NCT02018809|3913360|FG002|STARTED|Overall Study||50
3185034|NCT02018809|3913361|FG003|STARTED|Overall Study||50
3185035|NCT02018809|3913358|FG000|COMPLETED|Overall Study||50
3185036|NCT02018809|3913359|FG001|COMPLETED|Overall Study||50
3185037|NCT02018809|3913360|FG002|COMPLETED|Overall Study||50
3185038|NCT02018809|3913361|FG003|COMPLETED|Overall Study||50
3185039|NCT02018809|3913358|FG000|NOT COMPLETED|Overall Study||0
3185040|NCT02018809|3913359|FG001|NOT COMPLETED|Overall Study||0
3185041|NCT02018809|3913360|FG002|NOT COMPLETED|Overall Study||0
3185042|NCT02018809|3913361|FG003|NOT COMPLETED|Overall Study||0
3185043|NCT02018822|3913373|FG000|STARTED|Overall Study||50
3185044|NCT02018822|3913374|FG001|STARTED|Overall Study||50
3185045|NCT02018822|3913375|FG002|STARTED|Overall Study||35
3185046|NCT02018822|3913373|FG000|COMPLETED|Overall Study||44
3185047|NCT02018822|3913374|FG001|COMPLETED|Overall Study||42
3185048|NCT02018822|3913375|FG002|COMPLETED|Overall Study||29
3185049|NCT02018822|3913373|FG000|NOT COMPLETED|Overall Study||6
3185050|NCT02018822|3913374|FG001|NOT COMPLETED|Overall Study||8
3185051|NCT02018822|3913375|FG002|NOT COMPLETED|Overall Study||6
3185052|NCT02018887|3913394|FG000|STARTED|Part A: Cohorts 1-2: Period 1||9
3185053|NCT02018887|3913395|FG001|STARTED|Part A: Cohorts 1-2: Period 1||9
3185054|NCT02018887|3913396|FG002|STARTED|Part A: Cohorts 1-2: Period 1|Placebo was not administered in this period.|0
3185055|NCT02018887|3913397|FG003|STARTED|Part A: Cohorts 1-2: Period 1|This dose was not administered in this period.|0
3185056|NCT02018887|3913398|FG004|STARTED|Part A: Cohorts 1-2: Period 1|This dose was not administered in this period.|0
3185057|NCT02018887|3913399|FG005|STARTED|Part A: Cohorts 1-2: Period 1|This dose was not administered in this period.|0
3185058|NCT02018887|3913400|FG006|STARTED|Part A: Cohorts 1-2: Period 1|This dose was not administered in this period.|0
3185059|NCT02018887|3913401|FG007|STARTED|Part A: Cohorts 1-2: Period 1|This dose was not administered in this period.|0
3185060|NCT02018887|3913402|FG008|STARTED|Part A: Cohorts 1-2: Period 1|Placebo was not administered in this period.|0
3185061|NCT02018887|3913403|FG009|STARTED|Part A: Cohorts 1-2: Period 1|This dose was not administered in this period.|0
3185062|NCT02018887|3913404|FG010|STARTED|Part A: Cohorts 1-2: Period 1|This dose was not administered in this period.|0
3185063|NCT02018887|3913394|FG000|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||9
3185064|NCT02018887|3913395|FG001|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||9
3185065|NCT02018887|3913396|FG002|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
3185066|NCT02018887|3913397|FG003|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
3185067|NCT02018887|3913398|FG004|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
3185068|NCT02018887|3913399|FG005|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
3185069|NCT02018887|3913400|FG006|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
3185070|NCT02018887|3913401|FG007|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
3185071|NCT02018887|3913402|FG008|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
3185072|NCT02018887|3913403|FG009|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
3185073|NCT02018887|3913404|FG010|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
3185074|NCT02018887|3913394|FG000|COMPLETED|Part A: Cohorts 1-2: Period 1||9
3185075|NCT02018887|3913395|FG001|COMPLETED|Part A: Cohorts 1-2: Period 1||9
3185076|NCT02018887|3913396|FG002|COMPLETED|Part A: Cohorts 1-2: Period 1||0
3156611|NCT01838785|3883221|FG000|NOT COMPLETED|Overall Study||0
3156612|NCT01838863|3883227|FG000|STARTED|Overall Study||75
3156613|NCT01838863|3883228|FG001|STARTED|Overall Study||69
3156614|NCT01838863|3883227|FG000|COMPLETED|Overall Study||65
3156615|NCT01838863|3883228|FG001|COMPLETED|Overall Study||60
3156616|NCT01838863|3883227|FG000|NOT COMPLETED|Overall Study||10
3156617|NCT01838863|3883228|FG001|NOT COMPLETED|Overall Study||9
3156618|NCT01838876|3883234|FG000|STARTED|Overall Study||442
3156619|NCT01838876|3883234|FG000|Safety Population; Received Study Drug|Overall Study||345
3156620|NCT01838876|3883234|FG000|Entered Safety Follow-up Period|Overall Study||287
3156621|NCT01838876|3883234|FG000|COMPLETED|Overall Study||209
3156622|NCT01838876|3883234|FG000|NOT COMPLETED|Overall Study||233
3156623|NCT01838941|3883240|FG000|STARTED|Overall Study||12
3156624|NCT01838941|3883240|FG000|COMPLETED|Overall Study||10
3156625|NCT01838941|3883240|FG000|NOT COMPLETED|Overall Study||2
3156626|NCT01838980|3883245|FG000|STARTED|Overall Study||15
3156627|NCT01838980|3883245|FG000|COMPLETED|Overall Study||15
3156628|NCT01838980|3883245|FG000|NOT COMPLETED|Overall Study||0
3156629|NCT01839058|3883251|FG000|STARTED|Overall Study||21
3156630|NCT01839058|3883252|FG001|STARTED|Overall Study||19
3156631|NCT01839058|3883251|FG000|COMPLETED|Overall Study||17
3156632|NCT01839058|3883252|FG001|COMPLETED|Overall Study||16
3156633|NCT01839058|3883251|FG000|NOT COMPLETED|Overall Study||4
3156634|NCT01839058|3883252|FG001|NOT COMPLETED|Overall Study||3
3156635|NCT01839110|3883261|FG000|STARTED|Overall Study||7
3156636|NCT01839110|3883262|FG001|STARTED|Overall Study||6
3156637|NCT01839110|3883263|FG002|STARTED|Overall Study||9
3156638|NCT01839110|3883261|FG000|COMPLETED|Overall Study||4
3156639|NCT01839110|3883262|FG001|COMPLETED|Overall Study||4
3156640|NCT01839110|3883263|FG002|COMPLETED|Overall Study||6
3156641|NCT01839110|3883261|FG000|NOT COMPLETED|Overall Study||3
3156642|NCT01839110|3883262|FG001|NOT COMPLETED|Overall Study||2
3156643|NCT01839110|3883263|FG002|NOT COMPLETED|Overall Study||3
3156644|NCT01839188|3883271|FG000|STARTED|Overall Study||385
3156645|NCT01839188|3883271|FG000|Treated|Overall Study||385
3156646|NCT01839188|3883271|FG000|COMPLETED|Overall Study|N=1 treated participant withdrew before receiving V3|384
3156647|NCT01839188|3883271|FG000|NOT COMPLETED|Overall Study||1
3156648|NCT01839279|3883283|FG000|STARTED|Overall Study||72
3156649|NCT01839279|3883284|FG001|STARTED|Overall Study||32
3156650|NCT01839279|3883285|FG002|STARTED|Overall Study||32
3156651|NCT01839279|3883283|FG000|QT/QTc Analysis Set|Overall Study||72
3156652|NCT01839279|3883284|FG001|QT/QTc Analysis Set|Overall Study||32
3156653|NCT01839279|3883285|FG002|QT/QTc Analysis Set|Overall Study||32
3156654|NCT01839279|3883283|FG000|PK Analysis Set|Overall Study||70
3156655|NCT01839279|3883284|FG001|PK Analysis Set|Overall Study||0
3156656|NCT01839279|3883285|FG002|PK Analysis Set|Overall Study||0
3156657|NCT01839279|3883283|FG000|Moxifloxacin/Placebo Analysis Set|Overall Study||0
3156658|NCT01839279|3883284|FG001|Moxifloxacin/Placebo Analysis Set|Overall Study||31
3156659|NCT01839279|3883285|FG002|Moxifloxacin/Placebo Analysis Set|Overall Study||30
3156660|NCT01839279|3883283|FG000|PK/QTc Analysis Set|Overall Study||70
3156661|NCT01839279|3883284|FG001|PK/QTc Analysis Set|Overall Study||0
3156662|NCT01839279|3883285|FG002|PK/QTc Analysis Set|Overall Study||0
3156663|NCT01839279|3883283|FG000|COMPLETED|Overall Study||59
3156664|NCT01839279|3883284|FG001|COMPLETED|Overall Study||30
3156665|NCT01839279|3883285|FG002|COMPLETED|Overall Study||30
3156666|NCT01839279|3883283|FG000|NOT COMPLETED|Overall Study||13
3156667|NCT01839279|3883284|FG001|NOT COMPLETED|Overall Study||2
3156668|NCT01839279|3883285|FG002|NOT COMPLETED|Overall Study||2
3156669|NCT01839318|3883300|FG000|STARTED|Period 1, First Day of Wear||4
3156670|NCT01839318|3883301|FG001|STARTED|Period 1, First Day of Wear||4
3156671|NCT01839318|3883302|FG002|STARTED|Period 1, First Day of Wear||5
3156672|NCT01839318|3883303|FG003|STARTED|Period 1, First Day of Wear||6
3156673|NCT01839318|3883304|FG004|STARTED|Period 1, First Day of Wear||7
3156674|NCT01839318|3883305|FG005|STARTED|Period 1, First Day of Wear||2
3156675|NCT01839318|3883300|FG000|COMPLETED|Period 1, First Day of Wear||4
3156676|NCT01839318|3883301|FG001|COMPLETED|Period 1, First Day of Wear||4
3156677|NCT01839318|3883302|FG002|COMPLETED|Period 1, First Day of Wear||5
3156678|NCT01839318|3883303|FG003|COMPLETED|Period 1, First Day of Wear||6
3156679|NCT01839318|3883304|FG004|COMPLETED|Period 1, First Day of Wear||7
3156680|NCT01839318|3883305|FG005|COMPLETED|Period 1, First Day of Wear||2
3156681|NCT01839318|3883300|FG000|NOT COMPLETED|Period 1, First Day of Wear||0
3156682|NCT01839318|3883301|FG001|NOT COMPLETED|Period 1, First Day of Wear||0
3156683|NCT01839318|3883302|FG002|NOT COMPLETED|Period 1, First Day of Wear||0
3156684|NCT01839318|3883303|FG003|NOT COMPLETED|Period 1, First Day of Wear||0
3156685|NCT01839318|3883304|FG004|NOT COMPLETED|Period 1, First Day of Wear||0
3156686|NCT01839318|3883305|FG005|NOT COMPLETED|Period 1, First Day of Wear||0
3156687|NCT01839318|3883300|FG000|STARTED|Period 2, Second Day of Wear||4
3156688|NCT01839318|3883301|FG001|STARTED|Period 2, Second Day of Wear||4
3156689|NCT01839318|3883302|FG002|STARTED|Period 2, Second Day of Wear||5
3156690|NCT01839318|3883303|FG003|STARTED|Period 2, Second Day of Wear||6
3156691|NCT01839318|3883304|FG004|STARTED|Period 2, Second Day of Wear||7
3156692|NCT01839318|3883305|FG005|STARTED|Period 2, Second Day of Wear||2
3156693|NCT01839318|3883300|FG000|COMPLETED|Period 2, Second Day of Wear||4
3156694|NCT01839318|3883301|FG001|COMPLETED|Period 2, Second Day of Wear||4
3156695|NCT01839318|3883302|FG002|COMPLETED|Period 2, Second Day of Wear||5
3156696|NCT01839318|3883303|FG003|COMPLETED|Period 2, Second Day of Wear||6
3156697|NCT01839318|3883304|FG004|COMPLETED|Period 2, Second Day of Wear||7
3156698|NCT01839318|3883305|FG005|COMPLETED|Period 2, Second Day of Wear||2
3156699|NCT01839318|3883300|FG000|NOT COMPLETED|Period 2, Second Day of Wear||0
3156700|NCT01839318|3883301|FG001|NOT COMPLETED|Period 2, Second Day of Wear||0
3156701|NCT01839318|3883302|FG002|NOT COMPLETED|Period 2, Second Day of Wear||0
3185077|NCT02018887|3913397|FG003|COMPLETED|Part A: Cohorts 1-2: Period 1||0
3185078|NCT02018887|3913398|FG004|COMPLETED|Part A: Cohorts 1-2: Period 1||0
3185079|NCT02018887|3913399|FG005|COMPLETED|Part A: Cohorts 1-2: Period 1||0
3185080|NCT02018887|3913400|FG006|COMPLETED|Part A: Cohorts 1-2: Period 1||0
3185081|NCT02018887|3913401|FG007|COMPLETED|Part A: Cohorts 1-2: Period 1||0
3185082|NCT02018887|3913402|FG008|COMPLETED|Part A: Cohorts 1-2: Period 1||0
3156702|NCT01839318|3883303|FG003|NOT COMPLETED|Period 2, Second Day of Wear||0
3156703|NCT01839318|3883304|FG004|NOT COMPLETED|Period 2, Second Day of Wear||0
3156704|NCT01839318|3883305|FG005|NOT COMPLETED|Period 2, Second Day of Wear||0
3156705|NCT01839318|3883300|FG000|STARTED|Period 3, Third Day of Wear||4
3156706|NCT01839318|3883301|FG001|STARTED|Period 3, Third Day of Wear||4
3156707|NCT01839318|3883302|FG002|STARTED|Period 3, Third Day of Wear||5
3156708|NCT01839318|3883303|FG003|STARTED|Period 3, Third Day of Wear||6
3156709|NCT01839318|3883304|FG004|STARTED|Period 3, Third Day of Wear||7
3156710|NCT01839318|3883305|FG005|STARTED|Period 3, Third Day of Wear||2
3156711|NCT01839318|3883300|FG000|COMPLETED|Period 3, Third Day of Wear||4
3156712|NCT01839318|3883301|FG001|COMPLETED|Period 3, Third Day of Wear||4
3156713|NCT01839318|3883302|FG002|COMPLETED|Period 3, Third Day of Wear||5
3156714|NCT01839318|3883303|FG003|COMPLETED|Period 3, Third Day of Wear||6
3156715|NCT01839318|3883304|FG004|COMPLETED|Period 3, Third Day of Wear||7
3156716|NCT01839318|3883305|FG005|COMPLETED|Period 3, Third Day of Wear||2
3156717|NCT01839318|3883300|FG000|NOT COMPLETED|Period 3, Third Day of Wear||0
3156718|NCT01839318|3883301|FG001|NOT COMPLETED|Period 3, Third Day of Wear||0
3156719|NCT01839318|3883302|FG002|NOT COMPLETED|Period 3, Third Day of Wear||0
3156720|NCT01839318|3883303|FG003|NOT COMPLETED|Period 3, Third Day of Wear||0
3156721|NCT01839318|3883304|FG004|NOT COMPLETED|Period 3, Third Day of Wear||0
3156722|NCT01839318|3883305|FG005|NOT COMPLETED|Period 3, Third Day of Wear||0
3156723|NCT01839487|3883315|FG000|STARTED|Run-in Phase (Maximum Exposure:295 Days)||16
3156724|NCT01839487|3883316|FG001|STARTED|Run-in Phase (Maximum Exposure:295 Days)||7
3156725|NCT01839487|3883317|FG002|STARTED|Run-in Phase (Maximum Exposure:295 Days)||0
3156726|NCT01839487|3883318|FG003|STARTED|Run-in Phase (Maximum Exposure:295 Days)||0
3156727|NCT01839487|3883319|FG004|STARTED|Run-in Phase (Maximum Exposure:295 Days)||0
3156728|NCT01839487|3883320|FG005|STARTED|Run-in Phase (Maximum Exposure:295 Days)||0
3156729|NCT01839487|3883315|FG000|COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0
3156730|NCT01839487|3883316|FG001|COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0
3156731|NCT01839487|3883317|FG002|COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0
3156732|NCT01839487|3883318|FG003|COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0
3156733|NCT01839487|3883319|FG004|COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0
3156734|NCT01839487|3883320|FG005|COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0
3156735|NCT01839487|3883315|FG000|NOT COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||16
3156736|NCT01839487|3883316|FG001|NOT COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||7
3156737|NCT01839487|3883317|FG002|NOT COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0
3185083|NCT02018887|3913403|FG009|COMPLETED|Part A: Cohorts 1-2: Period 1||0
3185084|NCT02018887|3913404|FG010|COMPLETED|Part A: Cohorts 1-2: Period 1||0
3185085|NCT02018887|3913394|FG000|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
3185086|NCT02018887|3913395|FG001|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
3185087|NCT02018887|3913396|FG002|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
3185088|NCT02018887|3913397|FG003|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
3185089|NCT02018887|3913398|FG004|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
3185090|NCT02018887|3913399|FG005|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
3185091|NCT02018887|3913400|FG006|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
3185092|NCT02018887|3913401|FG007|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
3185093|NCT02018887|3913402|FG008|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
3185094|NCT02018887|3913403|FG009|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
3185095|NCT02018887|3913404|FG010|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
3185096|NCT02018887|3913394|FG000|STARTED|Part A: Cohorts 1-2: Period 2||9
3185097|NCT02018887|3913395|FG001|STARTED|Part A: Cohorts 1-2: Period 2||9
3185098|NCT02018887|3913396|FG002|STARTED|Part A: Cohorts 1-2: Period 2|Placebo was not administered in this period.|0
3185099|NCT02018887|3913397|FG003|STARTED|Part A: Cohorts 1-2: Period 2|This dose was not administered in this period.|0
3185100|NCT02018887|3913398|FG004|STARTED|Part A: Cohorts 1-2: Period 2|This dose was not administered in this period.|0
3185101|NCT02018887|3913399|FG005|STARTED|Part A: Cohorts 1-2: Period 2|This dose was not administered in this period.|0
3185102|NCT02018887|3913400|FG006|STARTED|Part A: Cohorts 1-2: Period 2|This dose was not administered in this period.|0
3185103|NCT02018887|3913401|FG007|STARTED|Part A: Cohorts 1-2: Period 2|This dose was not administered in this period.|0
3185104|NCT02018887|3913402|FG008|STARTED|Part A: Cohorts 1-2: Period 2|Placebo was not administered in this period.|0
3185105|NCT02018887|3913403|FG009|STARTED|Part A: Cohorts 1-2: Period 2|This dose was not administered in this period.|0
3185106|NCT02018887|3913404|FG010|STARTED|Part A: Cohorts 1-2: Period 2|This dose was not administered in this period.|0
3185107|NCT02018887|3913394|FG000|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||9
3185108|NCT02018887|3913395|FG001|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||9
3185109|NCT02018887|3913396|FG002|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
3185110|NCT02018887|3913397|FG003|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
3156738|NCT01839487|3883318|FG003|NOT COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0
3156739|NCT01839487|3883319|FG004|NOT COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0
3156740|NCT01839487|3883320|FG005|NOT COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0
3156741|NCT01839487|3883315|FG000|STARTED|Phase 2 (Maximum Exposure:935 Days)||0
3156742|NCT01839487|3883316|FG001|STARTED|Phase 2 (Maximum Exposure:935 Days)||0
3156743|NCT01839487|3883317|FG002|STARTED|Phase 2 (Maximum Exposure:935 Days)||61
3156744|NCT01839487|3883318|FG003|STARTED|Phase 2 (Maximum Exposure:935 Days)||62
3156745|NCT01839487|3883319|FG004|STARTED|Phase 2 (Maximum Exposure:935 Days)||89
3156746|NCT01839487|3883320|FG005|STARTED|Phase 2 (Maximum Exposure:935 Days)||44
3156747|NCT01839487|3883315|FG000|COMPLETED|Phase 2 (Maximum Exposure:935 Days)||0
3156748|NCT01839487|3883316|FG001|COMPLETED|Phase 2 (Maximum Exposure:935 Days)||0
3156749|NCT01839487|3883317|FG002|COMPLETED|Phase 2 (Maximum Exposure:935 Days)||0
3156750|NCT01839487|3883318|FG003|COMPLETED|Phase 2 (Maximum Exposure:935 Days)||0
3156751|NCT01839487|3883319|FG004|COMPLETED|Phase 2 (Maximum Exposure:935 Days)||1
3156752|NCT01839487|3883320|FG005|COMPLETED|Phase 2 (Maximum Exposure:935 Days)||0
3156753|NCT01839487|3883315|FG000|NOT COMPLETED|Phase 2 (Maximum Exposure:935 Days)||0
3156754|NCT01839487|3883316|FG001|NOT COMPLETED|Phase 2 (Maximum Exposure:935 Days)||0
3156755|NCT01839487|3883317|FG002|NOT COMPLETED|Phase 2 (Maximum Exposure:935 Days)||61
3156756|NCT01839487|3883318|FG003|NOT COMPLETED|Phase 2 (Maximum Exposure:935 Days)||62
3156757|NCT01839487|3883319|FG004|NOT COMPLETED|Phase 2 (Maximum Exposure:935 Days)||88
3156758|NCT01839487|3883320|FG005|NOT COMPLETED|Phase 2 (Maximum Exposure:935 Days)||44
3156759|NCT01839604|3883333|FG000|STARTED|Overall Study||6
3156760|NCT01839604|3883334|FG001|STARTED|Overall Study||6
3156761|NCT01839604|3883335|FG002|STARTED|Overall Study||7
3156762|NCT01839604|3883336|FG003|STARTED|Overall Study||5
3156763|NCT01839604|3883337|FG004|STARTED|Overall Study||15
3156764|NCT01839604|3883333|FG000|COMPLETED|Overall Study||6
3156765|NCT01839604|3883334|FG001|COMPLETED|Overall Study||6
3156766|NCT01839604|3883335|FG002|COMPLETED|Overall Study||7
3156767|NCT01839604|3883336|FG003|COMPLETED|Overall Study||5
3156768|NCT01839604|3883337|FG004|COMPLETED|Overall Study||15
3156769|NCT01839604|3883333|FG000|NOT COMPLETED|Overall Study||0
3156770|NCT01839604|3883334|FG001|NOT COMPLETED|Overall Study||0
3156771|NCT01839604|3883335|FG002|NOT COMPLETED|Overall Study||0
3156772|NCT01839604|3883336|FG003|NOT COMPLETED|Overall Study||0
3156773|NCT01839604|3883337|FG004|NOT COMPLETED|Overall Study||0
3156774|NCT01839656|3883351|FG000|STARTED|Overall Study||5
3156775|NCT01839656|3883352|FG001|STARTED|Overall Study||16
3156776|NCT01839656|3883351|FG000|Completed Loading Dose Period|Overall Study||4
3156777|NCT01839656|3883352|FG001|Completed Loading Dose Period|Overall Study||15
3156778|NCT01839656|3883351|FG000|COMPLETED|Overall Study||2
3156779|NCT01839656|3883352|FG001|COMPLETED|Overall Study||0
3156780|NCT01839656|3883351|FG000|NOT COMPLETED|Overall Study||3
3156781|NCT01839656|3883352|FG001|NOT COMPLETED|Overall Study||16
3156782|NCT01839695|3883358|FG000|STARTED|Overall Study||9
3156783|NCT01839695|3883358|FG000|COMPLETED|Overall Study||9
3156784|NCT01839695|3883358|FG000|NOT COMPLETED|Overall Study||0
3156785|NCT01839708|3883364|FG000|STARTED|Overall Study||387
3156786|NCT01839708|3883365|FG001|STARTED|Overall Study||182
3156787|NCT01839708|3883364|FG000|COMPLETED|Overall Study||311
3156788|NCT01839708|3883365|FG001|COMPLETED|Overall Study||115
3156789|NCT01839708|3883364|FG000|NOT COMPLETED|Overall Study||76
3156790|NCT01839708|3883365|FG001|NOT COMPLETED|Overall Study||67
3156791|NCT01839799|3883373|FG000|STARTED|Overall Study||17
3156792|NCT01839799|3883374|FG001|STARTED|Overall Study||15
3156793|NCT01839799|3883373|FG000|COMPLETED|Overall Study||17
3156794|NCT01839799|3883374|FG001|COMPLETED|Overall Study||15
3156795|NCT01839799|3883373|FG000|NOT COMPLETED|Overall Study||0
3156796|NCT01839799|3883374|FG001|NOT COMPLETED|Overall Study||0
3156797|NCT01839916|3883380|FG000|STARTED|Overall Study||77
3156798|NCT01839916|3883380|FG000|COMPLETED|Overall Study||36
3156799|NCT01839916|3883380|FG000|NOT COMPLETED|Overall Study||41
3156800|NCT01840072|3883386|FG000|STARTED|Overall Study||2038
3156801|NCT01840072|3883387|FG001|STARTED|Overall Study||2033
3156802|NCT01840072|3883386|FG000|COMPLETED|Overall Study||2031
3156803|NCT01840072|3883387|FG001|COMPLETED|Overall Study||1986
3156804|NCT01840072|3883386|FG000|NOT COMPLETED|Overall Study||7
3156805|NCT01840072|3883387|FG001|NOT COMPLETED|Overall Study||47
3156806|NCT01840163|3883397|FG000|STARTED|First Follow up -Primary Outcome||267
3156807|NCT01840163|3883398|FG001|STARTED|First Follow up -Primary Outcome||270
3156808|NCT01840163|3883397|FG000|COMPLETED|First Follow up -Primary Outcome||248
3156809|NCT01840163|3883398|FG001|COMPLETED|First Follow up -Primary Outcome||254
3156810|NCT01840163|3883397|FG000|NOT COMPLETED|First Follow up -Primary Outcome||19
3156811|NCT01840163|3883398|FG001|NOT COMPLETED|First Follow up -Primary Outcome||16
3156812|NCT01840163|3883397|FG000|STARTED|Systemic Follow Up-secondary Outcome|From primary outcome to secondary outcome prd 1 participant withdrew and 1 became deceased|265
3156813|NCT01840163|3883398|FG001|STARTED|Systemic Follow Up-secondary Outcome|4 participants became unreachable and lost to follow up before sending 9 mo follow up|266
3156814|NCT01840163|3883397|FG000|COMPLETED|Systemic Follow Up-secondary Outcome||174
3156815|NCT01840163|3883398|FG001|COMPLETED|Systemic Follow Up-secondary Outcome||191
3156816|NCT01840163|3883397|FG000|NOT COMPLETED|Systemic Follow Up-secondary Outcome||91
3156817|NCT01840163|3883398|FG001|NOT COMPLETED|Systemic Follow Up-secondary Outcome||75
3156818|NCT01840228|3883406|FG000|STARTED|Overall Study||19
3156819|NCT01840228|3883407|FG001|STARTED|Overall Study||19
3156820|NCT01840228|3883406|FG000|COMPLETED|Overall Study||18
3156821|NCT01840228|3883407|FG001|COMPLETED|Overall Study||18
3156822|NCT01840228|3883406|FG000|NOT COMPLETED|Overall Study||1
3156823|NCT01840228|3883407|FG001|NOT COMPLETED|Overall Study||1
3156824|NCT01840319|3883417|FG000|STARTED|Overall Study||156
3156825|NCT01840319|3883417|FG000|COMPLETED|Overall Study||156
3156826|NCT01840319|3883417|FG000|NOT COMPLETED|Overall Study||0
3156827|NCT01840345|3883421|FG000|STARTED|Overall Study||11
3156828|NCT01840345|3883421|FG000|COMPLETED|Overall Study||10
3156829|NCT01840345|3883421|FG000|NOT COMPLETED|Overall Study||1
3156830|NCT01840410|3883427|FG000|STARTED|Overall Study||119
3156831|NCT01840410|3883428|FG001|STARTED|Overall Study||59
3156832|NCT01840410|3883427|FG000|Safety Set|Overall Study||119
3156833|NCT01840410|3883428|FG001|Safety Set|Overall Study|52 received ranibizumab at or after Month 2;7 did not receive ranibizumab any time during the study|59
3156834|NCT01840410|3883427|FG000|Full Analysis Set|Overall Study||119
3156835|NCT01840410|3883428|FG001|Full Analysis Set|Overall Study||59
3156836|NCT01840410|3883427|FG000|COMPLETED|Overall Study||112
3156837|NCT01840410|3883428|FG001|COMPLETED|Overall Study||55
3156838|NCT01840410|3883427|FG000|NOT COMPLETED|Overall Study||7
3156839|NCT01840410|3883428|FG001|NOT COMPLETED|Overall Study||4
3156840|NCT01840579|3883446|FG000|STARTED|Overall Study||3
3156841|NCT01840579|3883447|FG001|STARTED|Overall Study||7
3156842|NCT01840579|3883448|FG002|STARTED|Overall Study||6
3156843|NCT01840579|3883449|FG003|STARTED|Overall Study||6
3156844|NCT01840579|3883450|FG004|STARTED|Overall Study||8
3156845|NCT01840579|3883451|FG005|STARTED|Overall Study||6
3156846|NCT01840579|3883452|FG006|STARTED|Overall Study||6
3156847|NCT01840579|3883453|FG007|STARTED|Overall Study||6
3156848|NCT01840579|3883454|FG008|STARTED|Overall Study||6
3156849|NCT01840579|3883455|FG009|STARTED|Overall Study||3
3156850|NCT01840579|3883446|FG000|COMPLETED|Overall Study||0
3156851|NCT01840579|3883447|FG001|COMPLETED|Overall Study||0
3156852|NCT01840579|3883448|FG002|COMPLETED|Overall Study||4
3156853|NCT01840579|3883449|FG003|COMPLETED|Overall Study||3
3156854|NCT01840579|3883450|FG004|COMPLETED|Overall Study||4
3156855|NCT01840579|3883451|FG005|COMPLETED|Overall Study||2
3156856|NCT01840579|3883452|FG006|COMPLETED|Overall Study||4
3156857|NCT01840579|3883453|FG007|COMPLETED|Overall Study||3
3156858|NCT01840579|3883454|FG008|COMPLETED|Overall Study||3
3156859|NCT01840579|3883455|FG009|COMPLETED|Overall Study||0
3156860|NCT01840579|3883446|FG000|NOT COMPLETED|Overall Study||3
3156861|NCT01840579|3883447|FG001|NOT COMPLETED|Overall Study||7
3156862|NCT01840579|3883448|FG002|NOT COMPLETED|Overall Study||2
3156863|NCT01840579|3883449|FG003|NOT COMPLETED|Overall Study||3
3156864|NCT01840579|3883450|FG004|NOT COMPLETED|Overall Study||4
3156865|NCT01840579|3883451|FG005|NOT COMPLETED|Overall Study||4
3156866|NCT01840579|3883452|FG006|NOT COMPLETED|Overall Study||2
3156867|NCT01840579|3883453|FG007|NOT COMPLETED|Overall Study||3
3156868|NCT01840579|3883454|FG008|NOT COMPLETED|Overall Study||3
3156869|NCT01840579|3883455|FG009|NOT COMPLETED|Overall Study||3
3156870|NCT01840605|3883491|FG000|STARTED|Overall Study||151
3156871|NCT01840605|3883492|FG001|STARTED|Overall Study||152
3156872|NCT01840605|3883491|FG000|COMPLETED|Overall Study||149
3156873|NCT01840605|3883492|FG001|COMPLETED|Overall Study||150
3156874|NCT01840605|3883491|FG000|NOT COMPLETED|Overall Study||2
3156875|NCT01840605|3883492|FG001|NOT COMPLETED|Overall Study||2
3156876|NCT01840722|3883500|FG000|STARTED|Overall Study||201
3156877|NCT01840722|3883501|FG001|STARTED|Overall Study||199
3156878|NCT01840722|3883500|FG000|COMPLETED|Overall Study||201
3156879|NCT01840722|3883501|FG001|COMPLETED|Overall Study||130
3156880|NCT01840722|3883500|FG000|NOT COMPLETED|Overall Study||0
3156881|NCT01840722|3883501|FG001|NOT COMPLETED|Overall Study||69
3156882|NCT01840943|3883509|FG000|STARTED|Overall Study||14
3156883|NCT01840943|3883510|FG001|STARTED|Overall Study||12
3156884|NCT01840943|3883509|FG000|COMPLETED|Overall Study||1
3156885|NCT01840943|3883510|FG001|COMPLETED|Overall Study||0
3156886|NCT01840943|3883509|FG000|NOT COMPLETED|Overall Study||13
3156887|NCT01840943|3883510|FG001|NOT COMPLETED|Overall Study||12
3156888|NCT01841021|3883516|FG000|STARTED|Overall Study||1
3156889|NCT01841021|3883516|FG000|COMPLETED|Overall Study||1
3156890|NCT01841021|3883516|FG000|NOT COMPLETED|Overall Study||0
3156891|NCT01841047|3883520|FG000|STARTED|Overall Study||48
3156892|NCT01841047|3883520|FG000|COMPLETED|Overall Study||48
3156893|NCT01841047|3883520|FG000|NOT COMPLETED|Overall Study||0
3156894|NCT01841060|3883524|FG000|STARTED|Overall Study||42
3156895|NCT01841060|3883524|FG000|COMPLETED|Overall Study||32
3156896|NCT01841060|3883524|FG000|NOT COMPLETED|Overall Study||10
3156897|NCT01841073|3883530|FG000|STARTED|Overall Study||22
3156898|NCT01841073|3883531|FG001|STARTED|Overall Study||22
3156899|NCT01841073|3883530|FG000|COMPLETED|Overall Study||20
3156900|NCT01841073|3883531|FG001|COMPLETED|Overall Study||19
3156901|NCT01841073|3883530|FG000|NOT COMPLETED|Overall Study||2
3156902|NCT01841073|3883531|FG001|NOT COMPLETED|Overall Study||3
3156903|NCT01841216|3883541|FG000|STARTED|Overall Study||15
3156904|NCT01841216|3883542|FG001|STARTED|Overall Study||15
3156905|NCT01841216|3883541|FG000|COMPLETED|Overall Study||15
3156906|NCT01841216|3883542|FG001|COMPLETED|Overall Study||15
3156907|NCT01841216|3883541|FG000|NOT COMPLETED|Overall Study||0
3156908|NCT01841216|3883542|FG001|NOT COMPLETED|Overall Study||0
3156909|NCT01841281|3883550|FG000|STARTED|First Intervention (12 Weeks)||11
3156910|NCT01841281|3883551|FG001|STARTED|First Intervention (12 Weeks)||12
3156911|NCT01841281|3883552|FG002|STARTED|First Intervention (12 Weeks)||13
3156912|NCT01841281|3883553|FG003|STARTED|First Intervention (12 Weeks)||14
3156913|NCT01841281|3883550|FG000|COMPLETED|First Intervention (12 Weeks)||11
3156914|NCT01841281|3883551|FG001|COMPLETED|First Intervention (12 Weeks)||12
3156915|NCT01841281|3883552|FG002|COMPLETED|First Intervention (12 Weeks)||13
3156916|NCT01841281|3883553|FG003|COMPLETED|First Intervention (12 Weeks)||14
3156917|NCT01841281|3883550|FG000|NOT COMPLETED|First Intervention (12 Weeks)||0
3156918|NCT01841281|3883551|FG001|NOT COMPLETED|First Intervention (12 Weeks)||0
3156919|NCT01841281|3883552|FG002|NOT COMPLETED|First Intervention (12 Weeks)||0
3156920|NCT01841281|3883553|FG003|NOT COMPLETED|First Intervention (12 Weeks)||0
3156921|NCT01841281|3883550|FG000|STARTED|Washout (6 Weeks)||11
3156922|NCT01841281|3883551|FG001|STARTED|Washout (6 Weeks)||12
3156923|NCT01841281|3883552|FG002|STARTED|Washout (6 Weeks)||13
3156924|NCT01841281|3883553|FG003|STARTED|Washout (6 Weeks)||14
3156925|NCT01841281|3883550|FG000|COMPLETED|Washout (6 Weeks)||9
3156926|NCT01841281|3883551|FG001|COMPLETED|Washout (6 Weeks)||9
3156927|NCT01841281|3883552|FG002|COMPLETED|Washout (6 Weeks)||10
3156928|NCT01841281|3883553|FG003|COMPLETED|Washout (6 Weeks)||13
3156929|NCT01841281|3883550|FG000|NOT COMPLETED|Washout (6 Weeks)||2
3156930|NCT01841281|3883551|FG001|NOT COMPLETED|Washout (6 Weeks)||3
3156931|NCT01841281|3883552|FG002|NOT COMPLETED|Washout (6 Weeks)||3
3156932|NCT01841281|3883553|FG003|NOT COMPLETED|Washout (6 Weeks)||1
3156933|NCT01841281|3883550|FG000|STARTED|Second Intervention (12 Weeks)||9
3156934|NCT01841281|3883551|FG001|STARTED|Second Intervention (12 Weeks)||9
3156935|NCT01841281|3883552|FG002|STARTED|Second Intervention (12 Weeks)||10
3156936|NCT01841281|3883553|FG003|STARTED|Second Intervention (12 Weeks)||13
3156937|NCT01841281|3883550|FG000|COMPLETED|Second Intervention (12 Weeks)||9
3156938|NCT01841281|3883551|FG001|COMPLETED|Second Intervention (12 Weeks)||6
3156939|NCT01841281|3883552|FG002|COMPLETED|Second Intervention (12 Weeks)||10
3156940|NCT01841281|3883553|FG003|COMPLETED|Second Intervention (12 Weeks)||13
3156941|NCT01841281|3883550|FG000|NOT COMPLETED|Second Intervention (12 Weeks)||0
3156942|NCT01841281|3883551|FG001|NOT COMPLETED|Second Intervention (12 Weeks)||3
3156943|NCT01841281|3883552|FG002|NOT COMPLETED|Second Intervention (12 Weeks)||0
3156944|NCT01841281|3883553|FG003|NOT COMPLETED|Second Intervention (12 Weeks)||0
3156945|NCT01841554|3883569|FG000|STARTED|Overall Study||61
3156946|NCT01841554|3883569|FG000|Implanted|Overall Study||60
3156947|NCT01841554|3883569|FG000|1 Year Follow Up|Overall Study||42
3156948|NCT01841554|3883569|FG000|COMPLETED|Overall Study||42
3156949|NCT01841554|3883569|FG000|NOT COMPLETED|Overall Study||19
3156950|NCT01841567|3883573|FG000|STARTED|Overall Study||60
3156951|NCT01841567|3883573|FG000|COMPLETED|Overall Study||57
3156952|NCT01841567|3883573|FG000|NOT COMPLETED|Overall Study||3
3156953|NCT01841593|3883579|FG000|STARTED|First Intervention (Days 1 to 7)||12
3156954|NCT01841593|3883580|FG001|STARTED|First Intervention (Days 1 to 7)||7
3156955|NCT01841593|3883579|FG000|COMPLETED|First Intervention (Days 1 to 7)||12
3156956|NCT01841593|3883580|FG001|COMPLETED|First Intervention (Days 1 to 7)||6
3156957|NCT01841593|3883579|FG000|NOT COMPLETED|First Intervention (Days 1 to 7)||0
3156958|NCT01841593|3883580|FG001|NOT COMPLETED|First Intervention (Days 1 to 7)||1
3156959|NCT01841593|3883579|FG000|STARTED|Second Intervention (Days 8 to 14)||12
3156960|NCT01841593|3883580|FG001|STARTED|Second Intervention (Days 8 to 14)||6
3156961|NCT01841593|3883579|FG000|COMPLETED|Second Intervention (Days 8 to 14)||11
3156962|NCT01841593|3883580|FG001|COMPLETED|Second Intervention (Days 8 to 14)||6
3156963|NCT01841593|3883579|FG000|NOT COMPLETED|Second Intervention (Days 8 to 14)||1
3156964|NCT01841593|3883580|FG001|NOT COMPLETED|Second Intervention (Days 8 to 14)||0
3156965|NCT01841593|3883579|FG000|STARTED|Third Intervention (Days 15 to 21)||11
3156966|NCT01841593|3883580|FG001|STARTED|Third Intervention (Days 15 to 21)||6
3156967|NCT01841593|3883579|FG000|COMPLETED|Third Intervention (Days 15 to 21)||11
3156968|NCT01841593|3883580|FG001|COMPLETED|Third Intervention (Days 15 to 21)||6
3156969|NCT01841593|3883579|FG000|NOT COMPLETED|Third Intervention (Days 15 to 21)||0
3156970|NCT01841593|3883580|FG001|NOT COMPLETED|Third Intervention (Days 15 to 21)||0
3156971|NCT01841606|3883592|FG000|STARTED|Overall Study||25
3156972|NCT01841606|3883593|FG001|STARTED|Overall Study||27
3156973|NCT01841606|3883592|FG000|COMPLETED|Overall Study||25
3156974|NCT01841606|3883593|FG001|COMPLETED|Overall Study||27
3156975|NCT01841606|3883592|FG000|NOT COMPLETED|Overall Study||0
3156976|NCT01841606|3883593|FG001|NOT COMPLETED|Overall Study||0
3156977|NCT01841619|3883599|FG000|STARTED|Overall Study||16
3156978|NCT01841619|3883599|FG000|COMPLETED|Overall Study||16
3156979|NCT01841619|3883599|FG000|NOT COMPLETED|Overall Study||0
3156980|NCT01841632|3883603|FG000|STARTED|Overall Study||3
3156981|NCT01841632|3883603|FG000|COMPLETED|Overall Study||3
3156982|NCT01841632|3883603|FG000|NOT COMPLETED|Overall Study||0
3156983|NCT01841697|3883609|FG000|STARTED|Overall Study||322
3156984|NCT01841697|3883610|FG001|STARTED|Overall Study||320
3156985|NCT01841697|3883609|FG000|COMPLETED|Overall Study||302
3156986|NCT01841697|3883610|FG001|COMPLETED|Overall Study||302
3156987|NCT01841697|3883609|FG000|NOT COMPLETED|Overall Study||20
3156988|NCT01841697|3883610|FG001|NOT COMPLETED|Overall Study||18
3156989|NCT01841762|3883616|FG000|STARTED|Screening Period||335
3156990|NCT01841762|3883616|FG000|COMPLETED|Screening Period||284
3156991|NCT01841762|3883616|FG000|NOT COMPLETED|Screening Period||51
3156992|NCT01841762|3883616|FG000|STARTED|Treatment Period||284
3156993|NCT01841762|3883616|FG000|COMPLETED|Treatment Period||252
3185111|NCT02018887|3913398|FG004|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
3185112|NCT02018887|3913399|FG005|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
3185113|NCT02018887|3913400|FG006|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
3156994|NCT01841762|3883616|FG000|NOT COMPLETED|Treatment Period||32
3156995|NCT01841762|3883616|FG000|STARTED|Post-Treatment Safety Follow-Up Period||284
3156996|NCT01841762|3883616|FG000|COMPLETED|Post-Treatment Safety Follow-Up Period||269
3156997|NCT01841762|3883616|FG000|NOT COMPLETED|Post-Treatment Safety Follow-Up Period||15
3156998|NCT01841970|3883620|FG000|STARTED|Overall Study||20
3156999|NCT01841970|3883620|FG000|COMPLETED|Overall Study||9
3157000|NCT01841970|3883620|FG000|NOT COMPLETED|Overall Study||11
3157001|NCT01842061|3883629|FG000|STARTED|Overall Study||13
3157002|NCT01842061|3883630|FG001|STARTED|Overall Study||12
3157003|NCT01842061|3883629|FG000|COMPLETED|Overall Study||12
3157004|NCT01842061|3883630|FG001|COMPLETED|Overall Study||8
3157005|NCT01842061|3883629|FG000|NOT COMPLETED|Overall Study||1
3157006|NCT01842061|3883630|FG001|NOT COMPLETED|Overall Study||4
3157007|NCT01842308|3883641|FG000|STARTED|Overall Study||6
3157008|NCT01842308|3883642|FG001|STARTED|Overall Study||3
3157009|NCT01842308|3883643|FG002|STARTED|Overall Study||3
3157010|NCT01842308|3883644|FG003|STARTED|Overall Study||2
3157011|NCT01842308|3883645|FG004|STARTED|Overall Study||36
3157012|NCT01842308|3883641|FG000|COMPLETED|Overall Study||6
3157013|NCT01842308|3883642|FG001|COMPLETED|Overall Study||3
3157014|NCT01842308|3883643|FG002|COMPLETED|Overall Study||3
3157015|NCT01842308|3883644|FG003|COMPLETED|Overall Study||2
3157016|NCT01842308|3883645|FG004|COMPLETED|Overall Study||35
3157017|NCT01842308|3883641|FG000|NOT COMPLETED|Overall Study||0
3157018|NCT01842308|3883642|FG001|NOT COMPLETED|Overall Study||0
3157019|NCT01842308|3883643|FG002|NOT COMPLETED|Overall Study||0
3157020|NCT01842308|3883644|FG003|NOT COMPLETED|Overall Study||0
3157021|NCT01842308|3883645|FG004|NOT COMPLETED|Overall Study||1
3157022|NCT01842334|3883660|FG000|STARTED|Overall Study||5
3157023|NCT01842334|3883661|FG001|STARTED|Overall Study||7
3157024|NCT01842334|3883660|FG000|COMPLETED|Overall Study||2
3157025|NCT01842334|3883661|FG001|COMPLETED|Overall Study||3
3157026|NCT01842334|3883660|FG000|NOT COMPLETED|Overall Study||3
3157027|NCT01842334|3883661|FG001|NOT COMPLETED|Overall Study||4
3157028|NCT01842438|3883669|FG000|STARTED|T1: Immediately After the Intervention||42
3157029|NCT01842438|3883670|FG001|STARTED|T1: Immediately After the Intervention||44
3157030|NCT01842438|3883669|FG000|COMPLETED|T1: Immediately After the Intervention||36
3157031|NCT01842438|3883670|FG001|COMPLETED|T1: Immediately After the Intervention||36
3157032|NCT01842438|3883669|FG000|NOT COMPLETED|T1: Immediately After the Intervention||6
3157033|NCT01842438|3883670|FG001|NOT COMPLETED|T1: Immediately After the Intervention||8
3157034|NCT01842438|3883669|FG000|STARTED|T2: 6month Follow-up||36
3157035|NCT01842438|3883670|FG001|STARTED|T2: 6month Follow-up||36
3185114|NCT02018887|3913401|FG007|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
3185115|NCT02018887|3913402|FG008|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
3185116|NCT02018887|3913403|FG009|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
3185117|NCT02018887|3913404|FG010|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
3185118|NCT02018887|3913394|FG000|COMPLETED|Part A: Cohorts 1-2: Period 2||9
3185119|NCT02018887|3913395|FG001|COMPLETED|Part A: Cohorts 1-2: Period 2||9
3185120|NCT02018887|3913396|FG002|COMPLETED|Part A: Cohorts 1-2: Period 2||0
3185121|NCT02018887|3913397|FG003|COMPLETED|Part A: Cohorts 1-2: Period 2||0
3185122|NCT02018887|3913398|FG004|COMPLETED|Part A: Cohorts 1-2: Period 2||0
3185123|NCT02018887|3913399|FG005|COMPLETED|Part A: Cohorts 1-2: Period 2||0
3185124|NCT02018887|3913400|FG006|COMPLETED|Part A: Cohorts 1-2: Period 2||0
3185125|NCT02018887|3913401|FG007|COMPLETED|Part A: Cohorts 1-2: Period 2||0
3185126|NCT02018887|3913402|FG008|COMPLETED|Part A: Cohorts 1-2: Period 2||0
3185127|NCT02018887|3913403|FG009|COMPLETED|Part A: Cohorts 1-2: Period 2||0
3185128|NCT02018887|3913404|FG010|COMPLETED|Part A: Cohorts 1-2: Period 2||0
3185129|NCT02018887|3913394|FG000|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
3185130|NCT02018887|3913395|FG001|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
3185131|NCT02018887|3913396|FG002|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
3185132|NCT02018887|3913397|FG003|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
3185133|NCT02018887|3913398|FG004|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
3185134|NCT02018887|3913399|FG005|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
3185135|NCT02018887|3913400|FG006|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
3185136|NCT02018887|3913401|FG007|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
3185137|NCT02018887|3913402|FG008|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
3185138|NCT02018887|3913403|FG009|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
3185139|NCT02018887|3913404|FG010|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
3185140|NCT02018887|3913394|FG000|STARTED|Part A: Cohorts 1-2: Period 3||9
3185141|NCT02018887|3913395|FG001|STARTED|Part A: Cohorts 1-2: Period 3||9
3185142|NCT02018887|3913396|FG002|STARTED|Part A: Cohorts 1-2: Period 3|Placebo was not administered in this period.|0
3185143|NCT02018887|3913397|FG003|STARTED|Part A: Cohorts 1-2: Period 3|This dose was not administered in this period.|0
3185144|NCT02018887|3913398|FG004|STARTED|Part A: Cohorts 1-2: Period 3|This dose was not administered in this period.|0
3185145|NCT02018887|3913399|FG005|STARTED|Part A: Cohorts 1-2: Period 3|This dose was not administered in this period.|0
3185146|NCT02018887|3913400|FG006|STARTED|Part A: Cohorts 1-2: Period 3|This dose was not administered in this period.|0
3363861|NCT04039412|4095046|FG002|NOT COMPLETED|Overall Study||2
3157036|NCT01842438|3883669|FG000|COMPLETED|T2: 6month Follow-up||32
3157037|NCT01842438|3883670|FG001|COMPLETED|T2: 6month Follow-up||32
3157038|NCT01842438|3883669|FG000|NOT COMPLETED|T2: 6month Follow-up||4
3157039|NCT01842438|3883670|FG001|NOT COMPLETED|T2: 6month Follow-up||4
3157040|NCT01842464|3883680|FG000|STARTED|Overall Study||44
3157041|NCT01842464|3883680|FG000|COMPLETED|Overall Study||44
3157042|NCT01842464|3883680|FG000|NOT COMPLETED|Overall Study||0
3157043|NCT01842581|3883687|FG000|STARTED|Overall Study||113
3157044|NCT01842581|3883688|FG001|STARTED|Overall Study||109
3157045|NCT01842581|3883687|FG000|Received at Least 1 Dose of Study Drug|Overall Study||113
3157046|NCT01842581|3883688|FG001|Received at Least 1 Dose of Study Drug|Overall Study||108
3157047|NCT01842581|3883687|FG000|COMPLETED|Overall Study||69
3157048|NCT01842581|3883688|FG001|COMPLETED|Overall Study||79
3157049|NCT01842581|3883687|FG000|NOT COMPLETED|Overall Study||44
3157050|NCT01842581|3883688|FG001|NOT COMPLETED|Overall Study||30
3157051|NCT01842594|3883694|FG000|STARTED|Overall Study||13
3157052|NCT01842594|3883694|FG000|COMPLETED|Overall Study||10
3157053|NCT01842594|3883694|FG000|NOT COMPLETED|Overall Study||3
3157054|NCT01842607|3883698|FG000|STARTED|Overall Study||651
3157055|NCT01842607|3883698|FG000|COMPLETED|Overall Study||585
3157056|NCT01842607|3883698|FG000|NOT COMPLETED|Overall Study||66
3157057|NCT01842620|3883702|FG000|STARTED|Period 1||13
3157058|NCT01842620|3883703|FG001|STARTED|Period 1||12
3157059|NCT01842620|3883702|FG000|COMPLETED|Period 1||12
3157060|NCT01842620|3883703|FG001|COMPLETED|Period 1||12
3157061|NCT01842620|3883702|FG000|NOT COMPLETED|Period 1||1
3157062|NCT01842620|3883703|FG001|NOT COMPLETED|Period 1||0
3157063|NCT01842620|3883702|FG000|STARTED|Washout Period||12
3157064|NCT01842620|3883703|FG001|STARTED|Washout Period||12
3157065|NCT01842620|3883702|FG000|COMPLETED|Washout Period||12
3157066|NCT01842620|3883703|FG001|COMPLETED|Washout Period||12
3157067|NCT01842620|3883702|FG000|NOT COMPLETED|Washout Period||0
3157068|NCT01842620|3883703|FG001|NOT COMPLETED|Washout Period||0
3157069|NCT01842620|3883702|FG000|STARTED|Period 2||12
3157070|NCT01842620|3883703|FG001|STARTED|Period 2||12
3157071|NCT01842620|3883702|FG000|COMPLETED|Period 2||12
3157072|NCT01842620|3883703|FG001|COMPLETED|Period 2||12
3157073|NCT01842620|3883702|FG000|NOT COMPLETED|Period 2||0
3157074|NCT01842620|3883703|FG001|NOT COMPLETED|Period 2||0
3157075|NCT01842633|3883712|FG000|STARTED|Overall Study||65
3157076|NCT01842633|3883713|FG001|STARTED|Overall Study||66
3157077|NCT01842633|3883714|FG002|STARTED|Overall Study||34
3157078|NCT01842633|3883712|FG000|COMPLETED|Overall Study||62
3157079|NCT01842633|3883713|FG001|COMPLETED|Overall Study||64
3157080|NCT01842633|3883714|FG002|COMPLETED|Overall Study||34
3157081|NCT01842633|3883712|FG000|NOT COMPLETED|Overall Study||3
3157082|NCT01842633|3883713|FG001|NOT COMPLETED|Overall Study||2
3157083|NCT01842633|3883714|FG002|NOT COMPLETED|Overall Study||0
3157084|NCT01842646|3883724|FG000|STARTED|Overall Study||35
3157085|NCT01842646|3883724|FG000|COMPLETED|Overall Study||35
3157086|NCT01842646|3883724|FG000|NOT COMPLETED|Overall Study||0
3157087|NCT01842789|3883730|FG000|STARTED|Overall Study||10
3157088|NCT01842789|3883731|FG001|STARTED|Overall Study||8
3157089|NCT01842789|3883730|FG000|COMPLETED|Overall Study||10
3157090|NCT01842789|3883731|FG001|COMPLETED|Overall Study||8
3157091|NCT01842789|3883730|FG000|NOT COMPLETED|Overall Study||0
3157092|NCT01842789|3883731|FG001|NOT COMPLETED|Overall Study||0
3157093|NCT01842815|3883738|FG000|STARTED|Overall Study||20
3157094|NCT01842815|3883738|FG000|COMPLETED|Overall Study||16
3157095|NCT01842815|3883738|FG000|NOT COMPLETED|Overall Study||4
3157096|NCT01842841|3883743|FG000|STARTED|Overall Study||5
3157097|NCT01842841|3883743|FG000|COMPLETED|Overall Study||5
3157098|NCT01842841|3883743|FG000|NOT COMPLETED|Overall Study||0
3157099|NCT01842906|3883749|FG000|STARTED|Overall Study||115
3157100|NCT01842906|3883750|FG001|STARTED|Overall Study||104
3157101|NCT01842906|3883749|FG000|COMPLETED|Overall Study||115
3157102|NCT01842906|3883750|FG001|COMPLETED|Overall Study||104
3157103|NCT01842906|3883749|FG000|NOT COMPLETED|Overall Study||0
3157104|NCT01842906|3883750|FG001|NOT COMPLETED|Overall Study||0
3185147|NCT02018887|3913401|FG007|STARTED|Part A: Cohorts 1-2: Period 3|This dose was not administered in this period.|0
3185148|NCT02018887|3913402|FG008|STARTED|Part A: Cohorts 1-2: Period 3|Placebo was not administered in this period.|0
3185149|NCT02018887|3913403|FG009|STARTED|Part A: Cohorts 1-2: Period 3|This dose was not administered in this period.|0
3185150|NCT02018887|3913404|FG010|STARTED|Part A: Cohorts 1-2: Period 3|This dose was not administered in this period.|0
3185151|NCT02018887|3913394|FG000|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||8
3185152|NCT02018887|3913395|FG001|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||9
3185153|NCT02018887|3913396|FG002|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
3185154|NCT02018887|3913397|FG003|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
3185155|NCT02018887|3913398|FG004|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
3185156|NCT02018887|3913399|FG005|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
3185157|NCT02018887|3913400|FG006|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
3185158|NCT02018887|3913401|FG007|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
3185159|NCT02018887|3913402|FG008|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
3185160|NCT02018887|3913403|FG009|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
3185161|NCT02018887|3913404|FG010|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
3157105|NCT01842958|3883758|FG000|STARTED|Overall Study||25
3157106|NCT01842958|3883759|FG001|STARTED|Overall Study||25
3157107|NCT01842958|3883758|FG000|Randomized|Overall Study|One subject was randomized to 3.3 mm implant, but received the 4.1 mm implant.|25
3157108|NCT01842958|3883759|FG001|Randomized|Overall Study||25
3157109|NCT01842958|3883758|FG000|COMPLETED|Overall Study||24
3157110|NCT01842958|3883759|FG001|COMPLETED|Overall Study||24
3157111|NCT01842958|3883758|FG000|NOT COMPLETED|Overall Study||1
3157112|NCT01842958|3883759|FG001|NOT COMPLETED|Overall Study||1
3157113|NCT01843023|3883767|FG000|STARTED|Overall Study||144
3157114|NCT01843023|3883768|FG001|STARTED|Overall Study||144
3157115|NCT01843023|3883767|FG000|3 Months|Overall Study||110
3157116|NCT01843023|3883768|FG001|3 Months|Overall Study||114
3157117|NCT01843023|3883767|FG000|COMPLETED|Overall Study||111
3157118|NCT01843023|3883768|FG001|COMPLETED|Overall Study||109
3157119|NCT01843023|3883767|FG000|NOT COMPLETED|Overall Study||33
3157120|NCT01843023|3883768|FG001|NOT COMPLETED|Overall Study||35
3157121|NCT01843062|3883776|FG000|STARTED|Overall Study||155
3157122|NCT01843062|3883777|FG001|STARTED|Overall Study||78
3157123|NCT01843062|3883776|FG000|Intention to Treat (ITT) Analysis Set|Overall Study||155
3157124|NCT01843062|3883777|FG001|Intention to Treat (ITT) Analysis Set|Overall Study||78
3157125|NCT01843062|3883776|FG000|Safety Analysis Set|Overall Study||154
3157126|NCT01843062|3883777|FG001|Safety Analysis Set|Overall Study||77
3157127|NCT01843062|3883776|FG000|BRAF/NRAS Mutation Positive Analysis Set|Overall Study||91
3157128|NCT01843062|3883777|FG001|BRAF/NRAS Mutation Positive Analysis Set|Overall Study||51
3157129|NCT01843062|3883776|FG000|Ongoing at Primary Analysis Data Cut-off|Overall Study||134
3157130|NCT01843062|3883777|FG001|Ongoing at Primary Analysis Data Cut-off|Overall Study||71
3157131|NCT01843062|3883776|FG000|COMPLETED|Overall Study||133
3157132|NCT01843062|3883777|FG001|COMPLETED|Overall Study||69
3157133|NCT01843062|3883776|FG000|NOT COMPLETED|Overall Study||22
3157134|NCT01843062|3883777|FG001|NOT COMPLETED|Overall Study||9
3157135|NCT01843192|3883786|FG000|STARTED|Overall Study||26
3157136|NCT01843192|3883787|FG001|STARTED|Overall Study||34
3157137|NCT01843192|3883788|FG002|STARTED|Overall Study||11
3157138|NCT01843192|3883786|FG000|COMPLETED|Overall Study||24
3157139|NCT01843192|3883787|FG001|COMPLETED|Overall Study||28
3157140|NCT01843192|3883788|FG002|COMPLETED|Overall Study||9
3157141|NCT01843192|3883786|FG000|NOT COMPLETED|Overall Study||2
3157142|NCT01843192|3883787|FG001|NOT COMPLETED|Overall Study||6
3157143|NCT01843192|3883788|FG002|NOT COMPLETED|Overall Study||2
3157144|NCT01843205|3883796|FG000|STARTED|First Treatment (11 Days)||5
3157145|NCT01843205|3883797|FG001|STARTED|First Treatment (11 Days)||4
3157146|NCT01843205|3883796|FG000|COMPLETED|First Treatment (11 Days)|4 completing subjects switched to buspirone for Condition 2.|4
3157147|NCT01843205|3883797|FG001|COMPLETED|First Treatment (11 Days)|4 completing subjects switched to placebo for Condition 2.|4
3157148|NCT01843205|3883796|FG000|NOT COMPLETED|First Treatment (11 Days)||1
3157149|NCT01843205|3883797|FG001|NOT COMPLETED|First Treatment (11 Days)||0
3157150|NCT01843205|3883796|FG000|STARTED|Second Treatment (11 Days)||4
3157151|NCT01843205|3883797|FG001|STARTED|Second Treatment (11 Days)||4
3157152|NCT01843205|3883796|FG000|COMPLETED|Second Treatment (11 Days)||4
3157153|NCT01843205|3883797|FG001|COMPLETED|Second Treatment (11 Days)||4
3157154|NCT01843205|3883796|FG000|NOT COMPLETED|Second Treatment (11 Days)||0
3157155|NCT01843205|3883797|FG001|NOT COMPLETED|Second Treatment (11 Days)||0
3157156|NCT01843348|3883806|FG000|STARTED|Overall Study||205
3157157|NCT01843348|3883807|FG001|STARTED|Overall Study||208
3157158|NCT01843348|3883808|FG002|STARTED|Overall Study||199
3157159|NCT01843348|3883806|FG000|Safety Analysis Set (SAS)|Overall Study|One participant received TAC + Certican in error - analyzed with TAC + Certican arm|204
3157160|NCT01843348|3883807|FG001|Safety Analysis Set (SAS)|Overall Study|Two participants received TAC + Certican in other arms in errorr - analyzed with TAC + Certican arm|210
3157161|NCT01843348|3883808|FG002|Safety Analysis Set (SAS)|Overall Study|One participant received TAC + Certican in error - analyzed with TAC + Certican arm|198
3157162|NCT01843348|3883806|FG000|Full Analysis Set (FAS)|Overall Study|Participants in the FAS received at least one dose of study drug|205
3157163|NCT01843348|3883807|FG001|Full Analysis Set (FAS)|Overall Study|Participants in the FAS received at least one dose of study drug|208
3185162|NCT02018887|3913394|FG000|COMPLETED|Part A: Cohorts 1-2: Period 3||8
3185163|NCT02018887|3913395|FG001|COMPLETED|Part A: Cohorts 1-2: Period 3||9
3185164|NCT02018887|3913396|FG002|COMPLETED|Part A: Cohorts 1-2: Period 3||0
3185165|NCT02018887|3913397|FG003|COMPLETED|Part A: Cohorts 1-2: Period 3||0
3185166|NCT02018887|3913398|FG004|COMPLETED|Part A: Cohorts 1-2: Period 3||0
3185167|NCT02018887|3913399|FG005|COMPLETED|Part A: Cohorts 1-2: Period 3||0
3363862|NCT04035161|4095057|FG000|STARTED|Overall Study||1121
3363863|NCT04035161|4095057|FG000|Treated With Investigational Product|Overall Study||609
3363864|NCT04035161|4095057|FG000|Treated With Reference Standard|Overall Study||419
3363865|NCT04035161|4095057|FG000|Treated With Active Control|Overall Study||609
3363866|NCT04035161|4095057|FG000|Treated With Negative Control|Overall Study||605
3363867|NCT04035161|4095057|FG000|COMPLETED|Overall Study||1121
3363868|NCT04035161|4095057|FG000|NOT COMPLETED|Overall Study||0
3363869|NCT04029519|4095067|FG000|STARTED|Overall Study||84
3363870|NCT04029519|4095067|FG000|COMPLETED|Overall Study||79
3363871|NCT04029519|4095067|FG000|NOT COMPLETED|Overall Study||5
3363872|NCT04024228|4095073|FG000|STARTED|Overall Study||774
3363873|NCT04024228|4095074|FG001|STARTED|Overall Study||765
3363874|NCT04024228|4095073|FG000|Vaccinated|Overall Study||772
3363875|NCT04024228|4095074|FG001|Vaccinated|Overall Study||761
3363876|NCT04024228|4095073|FG000|Full Analysis Set (FAS)|Overall Study|377 participants (60-64 years) and 392 participants (>=65 years).|769
3363877|NCT04024228|4095074|FG001|Full Analysis Set (FAS)|Overall Study|377 participants (60-64 years) and 381 participants (>=65 years).|758
3157164|NCT01843348|3883808|FG002|Full Analysis Set (FAS)|Overall Study|Participants in the FAS received at least one dose of study drug|199
3157165|NCT01843348|3883806|FG000|Per Protocol Set (PPS)|Overall Study|Participants in the FAS without major protocol deviations|147
3157166|NCT01843348|3883807|FG001|Per Protocol Set (PPS)|Overall Study|Participants in the FAS without major protocol deviations|111
3157167|NCT01843348|3883808|FG002|Per Protocol Set (PPS)|Overall Study|Participants in the FAS without major protocol deviations|80
3157168|NCT01843348|3883806|FG000|COMPLETED|Overall Study||182
3157169|NCT01843348|3883807|FG001|COMPLETED|Overall Study||168
3157170|NCT01843348|3883808|FG002|COMPLETED|Overall Study||158
3157171|NCT01843348|3883806|FG000|NOT COMPLETED|Overall Study||23
3157172|NCT01843348|3883807|FG001|NOT COMPLETED|Overall Study||40
3157173|NCT01843348|3883808|FG002|NOT COMPLETED|Overall Study||41
3157174|NCT01843374|3883820|FG000|STARTED|Overall Study||189
3157175|NCT01843374|3883821|FG001|STARTED|Overall Study||382
3157176|NCT01843374|3883820|FG000|RANDOMIZED|Overall Study||189
3157177|NCT01843374|3883821|FG001|RANDOMIZED|Overall Study||382
3157178|NCT01843374|3883820|FG000|COMPLETED|Overall Study||0
3157179|NCT01843374|3883821|FG001|COMPLETED|Overall Study||3
3157180|NCT01843374|3883820|FG000|NOT COMPLETED|Overall Study||189
3157181|NCT01843374|3883821|FG001|NOT COMPLETED|Overall Study||379
3157182|NCT01843465|3883830|FG000|STARTED|Overall Study|This study had no follow-up. It focused in the acute setting of cryoballoon ablation.|34
3157183|NCT01843465|3883830|FG000|COMPLETED|Overall Study||34
3157184|NCT01843465|3883830|FG000|NOT COMPLETED|Overall Study||0
3157185|NCT01843621|3883834|FG000|STARTED|Overall Study||7
3157186|NCT01843621|3883834|FG000|COMPLETED|Overall Study||7
3157187|NCT01843621|3883834|FG000|NOT COMPLETED|Overall Study||0
3157188|NCT01843660|3883846|FG000|STARTED|Overall Study||1059
3157189|NCT01843660|3883846|FG000|COMPLETED|Overall Study||1029
3157190|NCT01843660|3883846|FG000|NOT COMPLETED|Overall Study||30
3157191|NCT01843673|3883850|FG000|STARTED|Overall Study||16
3157192|NCT01843673|3883850|FG000|COMPLETED|Overall Study||10
3157193|NCT01843673|3883850|FG000|NOT COMPLETED|Overall Study||6
3157194|NCT01843751|3883858|FG000|STARTED|Overall Study||11
3157195|NCT01843751|3883859|FG001|STARTED|Overall Study||10
3157196|NCT01843751|3883858|FG000|COMPLETED|Overall Study||0
3157197|NCT01843751|3883859|FG001|COMPLETED|Overall Study||3
3157198|NCT01843751|3883858|FG000|NOT COMPLETED|Overall Study||11
3157199|NCT01843751|3883859|FG001|NOT COMPLETED|Overall Study||7
3157200|NCT01843777|3883867|FG000|STARTED|Overall Study|Number of participants randomized to standard-of-care.|11
3157201|NCT01843777|3883868|FG001|STARTED|Overall Study|Number of participants randomized to treatment.|10
3157202|NCT01843777|3883867|FG000|Per Protocol Population|Overall Study||11
3157203|NCT01843777|3883868|FG001|Per Protocol Population|Overall Study|A subject was randomized to treatment but received standard of care and is not in the analyses.|9
3157204|NCT01843777|3883867|FG000|COMPLETED|Overall Study|Final number of standard-of-care participants.|10
3157205|NCT01843777|3883868|FG001|COMPLETED|Overall Study|Number of subjects who received the treatment that completed collection of outcome measures|10
3157206|NCT01843777|3883867|FG000|NOT COMPLETED|Overall Study||1
3157207|NCT01843777|3883868|FG001|NOT COMPLETED|Overall Study||0
3157208|NCT01843803|3883876|FG000|STARTED|Overall Study||137
3157209|NCT01843803|3883877|FG001|STARTED|Overall Study||139
3157210|NCT01843803|3883876|FG000|COMPLETED|Overall Study||136
3157211|NCT01843803|3883877|FG001|COMPLETED|Overall Study||136
3157212|NCT01843803|3883876|FG000|NOT COMPLETED|Overall Study||1
3157213|NCT01843803|3883877|FG001|NOT COMPLETED|Overall Study||3
3157214|NCT01843842|3883885|FG000|STARTED|Overall Study||154
3157215|NCT01843842|3883886|FG001|STARTED|Overall Study||152
3157216|NCT01843842|3883885|FG000|COMPLETED|Overall Study||153
3157217|NCT01843842|3883886|FG001|COMPLETED|Overall Study||151
3157218|NCT01843842|3883885|FG000|NOT COMPLETED|Overall Study||1
3157219|NCT01843842|3883886|FG001|NOT COMPLETED|Overall Study||1
3157220|NCT01843920|3883894|FG000|STARTED|Overall Study||12
3157221|NCT01843920|3883895|FG001|STARTED|Overall Study||9
3157222|NCT01843920|3883894|FG000|COMPLETED|Overall Study||12
3157223|NCT01843920|3883895|FG001|COMPLETED|Overall Study||9
3157224|NCT01843920|3883894|FG000|NOT COMPLETED|Overall Study||0
3157225|NCT01843920|3883895|FG001|NOT COMPLETED|Overall Study||0
3157226|NCT01843933|3883903|FG000|STARTED|Overall Study||104
3157227|NCT01843933|3883904|FG001|STARTED|Overall Study||107
3157228|NCT01843933|3883903|FG000|COMPLETED|Overall Study||98
3157229|NCT01843933|3883904|FG001|COMPLETED|Overall Study||103
3157230|NCT01843933|3883903|FG000|NOT COMPLETED|Overall Study||6
3157231|NCT01843933|3883904|FG001|NOT COMPLETED|Overall Study||4
3157232|NCT01843972|3883920|FG000|STARTED|Overall Study||13
3157233|NCT01843972|3883921|FG001|STARTED|Overall Study||6
3185168|NCT02018887|3913400|FG006|COMPLETED|Part A: Cohorts 1-2: Period 3||0
3185169|NCT02018887|3913401|FG007|COMPLETED|Part A: Cohorts 1-2: Period 3||0
3185170|NCT02018887|3913402|FG008|COMPLETED|Part A: Cohorts 1-2: Period 3||0
3185171|NCT02018887|3913403|FG009|COMPLETED|Part A: Cohorts 1-2: Period 3||0
3185172|NCT02018887|3913404|FG010|COMPLETED|Part A: Cohorts 1-2: Period 3||0
3185173|NCT02018887|3913394|FG000|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||1
3185174|NCT02018887|3913395|FG001|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
3185175|NCT02018887|3913396|FG002|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
3185176|NCT02018887|3913397|FG003|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
3185177|NCT02018887|3913398|FG004|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
3185178|NCT02018887|3913399|FG005|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
3185179|NCT02018887|3913400|FG006|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
3157234|NCT01843972|3883922|FG002|STARTED|Overall Study||5
3157235|NCT01843972|3883923|FG003|STARTED|Overall Study||6
3157236|NCT01843972|3883924|FG004|STARTED|Overall Study||6
3157237|NCT01843972|3883925|FG005|STARTED|Overall Study||6
3157238|NCT01843972|3883926|FG006|STARTED|Overall Study||5
3157239|NCT01843972|3883927|FG007|STARTED|Overall Study||5
3157240|NCT01843972|3883928|FG008|STARTED|Overall Study||17
3157241|NCT01843972|3883929|FG009|STARTED|Overall Study||12
3157242|NCT01843972|3883920|FG000|COMPLETED|Overall Study||13
3157243|NCT01843972|3883921|FG001|COMPLETED|Overall Study||6
3157244|NCT01843972|3883922|FG002|COMPLETED|Overall Study||5
3157245|NCT01843972|3883923|FG003|COMPLETED|Overall Study||6
3157246|NCT01843972|3883924|FG004|COMPLETED|Overall Study||5
3157247|NCT01843972|3883925|FG005|COMPLETED|Overall Study||6
3157248|NCT01843972|3883926|FG006|COMPLETED|Overall Study||5
3157249|NCT01843972|3883927|FG007|COMPLETED|Overall Study||5
3157250|NCT01843972|3883928|FG008|COMPLETED|Overall Study||17
3157251|NCT01843972|3883929|FG009|COMPLETED|Overall Study||12
3157252|NCT01843972|3883920|FG000|NOT COMPLETED|Overall Study||0
3157253|NCT01843972|3883921|FG001|NOT COMPLETED|Overall Study||0
3157254|NCT01843972|3883922|FG002|NOT COMPLETED|Overall Study||0
3157255|NCT01843972|3883923|FG003|NOT COMPLETED|Overall Study||0
3157256|NCT01843972|3883924|FG004|NOT COMPLETED|Overall Study||1
3157257|NCT01843972|3883925|FG005|NOT COMPLETED|Overall Study||0
3157258|NCT01843972|3883926|FG006|NOT COMPLETED|Overall Study||0
3157259|NCT01843972|3883927|FG007|NOT COMPLETED|Overall Study||0
3157260|NCT01843972|3883928|FG008|NOT COMPLETED|Overall Study||0
3157261|NCT01843972|3883929|FG009|NOT COMPLETED|Overall Study||0
3157262|NCT01844076|3883969|FG000|STARTED|Overall Study||3
3157263|NCT01844076|3883970|FG001|STARTED|Overall Study||6
3157264|NCT01844076|3883971|FG002|STARTED|Overall Study||3
3157265|NCT01844076|3883972|FG003|STARTED|Overall Study||7
3157266|NCT01844076|3883969|FG000|COMPLETED|Overall Study||1
3157267|NCT01844076|3883970|FG001|COMPLETED|Overall Study||6
3157268|NCT01844076|3883971|FG002|COMPLETED|Overall Study||3
3157269|NCT01844076|3883972|FG003|COMPLETED|Overall Study||7
3157270|NCT01844076|3883969|FG000|NOT COMPLETED|Overall Study||2
3157271|NCT01844076|3883970|FG001|NOT COMPLETED|Overall Study||0
3157272|NCT01844076|3883971|FG002|NOT COMPLETED|Overall Study||0
3157273|NCT01844076|3883972|FG003|NOT COMPLETED|Overall Study||0
3157274|NCT01844115|3883984|FG000|STARTED|Overall Study||202
3157275|NCT01844115|3883985|FG001|STARTED|Overall Study||202
3157276|NCT01844115|3883984|FG000|COMPLETED|Overall Study||163
3157277|NCT01844115|3883985|FG001|COMPLETED|Overall Study||144
3157278|NCT01844115|3883984|FG000|NOT COMPLETED|Overall Study||39
3157279|NCT01844115|3883985|FG001|NOT COMPLETED|Overall Study||58
3157280|NCT01844193|3883993|FG000|STARTED|Overall Study||19
3157281|NCT01844193|3883994|FG001|STARTED|Overall Study||21
3157282|NCT01844193|3883993|FG000|COMPLETED|Overall Study||13
3157283|NCT01844193|3883994|FG001|COMPLETED|Overall Study||15
3157284|NCT01844193|3883993|FG000|NOT COMPLETED|Overall Study||6
3157285|NCT01844193|3883994|FG001|NOT COMPLETED|Overall Study||6
3157286|NCT01844284|3884002|FG000|STARTED|Overall Study|Intent-to-treat (ITT) population|266
3157287|NCT01844284|3884003|FG001|STARTED|Overall Study|Intent-to-treat (ITT) population|134
3157288|NCT01844284|3884002|FG000|COMPLETED|Overall Study||254
3157289|NCT01844284|3884003|FG001|COMPLETED|Overall Study||127
3157290|NCT01844284|3884002|FG000|NOT COMPLETED|Overall Study||12
3157291|NCT01844284|3884003|FG001|NOT COMPLETED|Overall Study||7
3157292|NCT01844375|3884011|FG000|STARTED|Overall Study||35
3157293|NCT01844375|3884012|FG001|STARTED|Overall Study||35
3157294|NCT01844375|3884011|FG000|COMPLETED|Overall Study||34
3157295|NCT01844375|3884012|FG001|COMPLETED|Overall Study||34
3157296|NCT01844375|3884011|FG000|NOT COMPLETED|Overall Study||1
3157297|NCT01844375|3884012|FG001|NOT COMPLETED|Overall Study||1
3157298|NCT01844388|3884020|FG000|STARTED|Overall Study||244
3157299|NCT01844388|3884021|FG001|STARTED|Overall Study||121
3157300|NCT01844388|3884020|FG000|COMPLETED|Overall Study||236
3157301|NCT01844388|3884021|FG001|COMPLETED|Overall Study||114
3157302|NCT01844388|3884020|FG000|NOT COMPLETED|Overall Study||8
3157303|NCT01844388|3884021|FG001|NOT COMPLETED|Overall Study||7
3157304|NCT01844479|3884027|FG000|STARTED|First Intervention up to 30 Minutes||14
3157305|NCT01844479|3884028|FG001|STARTED|First Intervention up to 30 Minutes||13
3157306|NCT01844479|3884027|FG000|COMPLETED|First Intervention up to 30 Minutes||14
3157307|NCT01844479|3884028|FG001|COMPLETED|First Intervention up to 30 Minutes||13
3157308|NCT01844479|3884027|FG000|NOT COMPLETED|First Intervention up to 30 Minutes||0
3157309|NCT01844479|3884028|FG001|NOT COMPLETED|First Intervention up to 30 Minutes||0
3157310|NCT01844479|3884027|FG000|STARTED|Second Intervention up to 30 Minutes||14
3157311|NCT01844479|3884028|FG001|STARTED|Second Intervention up to 30 Minutes||13
3157312|NCT01844479|3884027|FG000|COMPLETED|Second Intervention up to 30 Minutes||14
3157313|NCT01844479|3884028|FG001|COMPLETED|Second Intervention up to 30 Minutes||13
3157314|NCT01844479|3884027|FG000|NOT COMPLETED|Second Intervention up to 30 Minutes||0
3157315|NCT01844479|3884028|FG001|NOT COMPLETED|Second Intervention up to 30 Minutes||0
3157316|NCT01844531|3884039|FG000|STARTED|Overall Study||6
3157317|NCT01844531|3884040|FG001|STARTED|Overall Study||6
3157318|NCT01844531|3884041|FG002|STARTED|Overall Study||6
3157319|NCT01844531|3884042|FG003|STARTED|Overall Study||6
3157320|NCT01844531|3884039|FG000|COMPLETED|Overall Study||6
3157321|NCT01844531|3884040|FG001|COMPLETED|Overall Study||5
3157322|NCT01844531|3884041|FG002|COMPLETED|Overall Study||6
3157323|NCT01844531|3884042|FG003|COMPLETED|Overall Study||6
3157324|NCT01844531|3884039|FG000|NOT COMPLETED|Overall Study||0
3157325|NCT01844531|3884040|FG001|NOT COMPLETED|Overall Study||1
3157326|NCT01844531|3884041|FG002|NOT COMPLETED|Overall Study||0
3157327|NCT01844531|3884042|FG003|NOT COMPLETED|Overall Study||0
3157328|NCT01844583|3884054|FG000|STARTED|Overall Study||26
3157329|NCT01844583|3884055|FG001|STARTED|Overall Study||29
3157330|NCT01844583|3884054|FG000|COMPLETED|Overall Study|Completed=Completed protocol-specified dosing and PK/ECG assessment.|18
3157331|NCT01844583|3884055|FG001|COMPLETED|Overall Study||19
3157332|NCT01844583|3884054|FG000|NOT COMPLETED|Overall Study||8
3157333|NCT01844583|3884055|FG001|NOT COMPLETED|Overall Study||10
3157334|NCT01844687|3884066|FG000|STARTED|Visit 1||50
3157335|NCT01844687|3884066|FG000|COMPLETED|Visit 1||42
3157336|NCT01844687|3884066|FG000|NOT COMPLETED|Visit 1||8
3157337|NCT01844687|3884066|FG000|STARTED|Visit 2||42
3157338|NCT01844687|3884066|FG000|COMPLETED|Visit 2||40
3157339|NCT01844687|3884066|FG000|NOT COMPLETED|Visit 2||2
3157340|NCT01844687|3884066|FG000|STARTED|Visit 3||40
3157341|NCT01844687|3884066|FG000|COMPLETED|Visit 3||35
3157342|NCT01844687|3884066|FG000|NOT COMPLETED|Visit 3||5
3157343|NCT01844687|3884066|FG000|STARTED|Visit 4||35
3157344|NCT01844687|3884066|FG000|COMPLETED|Visit 4||31
3157345|NCT01844687|3884066|FG000|NOT COMPLETED|Visit 4||4
3157346|NCT01844687|3884066|FG000|STARTED|Visit 5||31
3157347|NCT01844687|3884066|FG000|COMPLETED|Visit 5||31
3157348|NCT01844687|3884066|FG000|NOT COMPLETED|Visit 5||0
3157349|NCT01844687|3884066|FG000|STARTED|Visit 6||31
3157350|NCT01844687|3884066|FG000|COMPLETED|Visit 6||31
3157351|NCT01844687|3884066|FG000|NOT COMPLETED|Visit 6||0
3157352|NCT01844687|3884066|FG000|STARTED|Visit 7||31
3157353|NCT01844687|3884066|FG000|COMPLETED|Visit 7||31
3157354|NCT01844687|3884066|FG000|NOT COMPLETED|Visit 7||0
3157355|NCT01844687|3884066|FG000|STARTED|Visit 8||31
3157356|NCT01844687|3884066|FG000|COMPLETED|Visit 8||31
3157357|NCT01844687|3884066|FG000|NOT COMPLETED|Visit 8||0
3157358|NCT01844700|3884090|FG000|STARTED|Overall Study||4
3157359|NCT01844700|3884091|FG001|STARTED|Overall Study||3
3157360|NCT01844700|3884090|FG000|COMPLETED|Overall Study||1
3157361|NCT01844700|3884091|FG001|COMPLETED|Overall Study||2
3157362|NCT01844700|3884090|FG000|NOT COMPLETED|Overall Study||3
3157363|NCT01844700|3884091|FG001|NOT COMPLETED|Overall Study||1
3157364|NCT01844765|3884099|FG000|STARTED|Overall Study||34
3157365|NCT01844765|3884100|FG001|STARTED|Overall Study||25
3157366|NCT01844765|3884099|FG000|Treated|Overall Study||33
3157367|NCT01844765|3884100|FG001|Treated|Overall Study||25
3157368|NCT01844765|3884099|FG000|Untreated|Overall Study|Did not receive study drug due to adverse event (AE).|1
3157369|NCT01844765|3884100|FG001|Untreated|Overall Study||0
3157370|NCT01844765|3884099|FG000|COMPLETED|Overall Study||19
3157371|NCT01844765|3884100|FG001|COMPLETED|Overall Study||10
3157372|NCT01844765|3884099|FG000|NOT COMPLETED|Overall Study||15
3157373|NCT01844765|3884100|FG001|NOT COMPLETED|Overall Study||15
3185180|NCT02018887|3913401|FG007|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
3185181|NCT02018887|3913402|FG008|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
3185182|NCT02018887|3913403|FG009|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
3185183|NCT02018887|3913404|FG010|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
3185184|NCT02018887|3913394|FG000|STARTED|Part B: Cohorts 3-7 Overall|Column for Part A data only.|0
3185185|NCT02018887|3913395|FG001|STARTED|Part B: Cohorts 3-7 Overall|Column for Part A data only.|0
3185186|NCT02018887|3913396|FG002|STARTED|Part B: Cohorts 3-7 Overall||15
3185187|NCT02018887|3913397|FG003|STARTED|Part B: Cohorts 3-7 Overall||9
3185188|NCT02018887|3913398|FG004|STARTED|Part B: Cohorts 3-7 Overall||9
3185189|NCT02018887|3913399|FG005|STARTED|Part B: Cohorts 3-7 Overall||9
3185190|NCT02018887|3913400|FG006|STARTED|Part B: Cohorts 3-7 Overall||9
3185191|NCT02018887|3913401|FG007|STARTED|Part B: Cohorts 3-7 Overall||9
3185192|NCT02018887|3913402|FG008|STARTED|Part B: Cohorts 3-7 Overall|Placebo was not administered in this period.|0
3185193|NCT02018887|3913403|FG009|STARTED|Part B: Cohorts 3-7 Overall|This dose was not administered in this period.|0
3185194|NCT02018887|3913404|FG010|STARTED|Part B: Cohorts 3-7 Overall|This dose was not administered in this period.|0
3185195|NCT02018887|3913394|FG000|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||0
3185196|NCT02018887|3913395|FG001|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||0
3185197|NCT02018887|3913396|FG002|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||15
3185198|NCT02018887|3913397|FG003|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||9
3185199|NCT02018887|3913398|FG004|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||9
3185200|NCT02018887|3913399|FG005|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||9
3185201|NCT02018887|3913400|FG006|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||9
3185202|NCT02018887|3913401|FG007|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||9
3185203|NCT02018887|3913402|FG008|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||0
3185204|NCT02018887|3913403|FG009|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||0
3185205|NCT02018887|3913404|FG010|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||0
3185206|NCT02018887|3913394|FG000|COMPLETED|Part B: Cohorts 3-7 Overall||0
3185207|NCT02018887|3913395|FG001|COMPLETED|Part B: Cohorts 3-7 Overall||0
3185208|NCT02018887|3913396|FG002|COMPLETED|Part B: Cohorts 3-7 Overall||15
3185209|NCT02018887|3913397|FG003|COMPLETED|Part B: Cohorts 3-7 Overall||9
3157374|NCT01844778|3884114|FG000|STARTED|Overall Study||14
3157375|NCT01844778|3884115|FG001|STARTED|Overall Study||28
3157376|NCT01844778|3884116|FG002|STARTED|Overall Study||18
3157377|NCT01844778|3884114|FG000|Safety Set 1 (at Least 1 Dose, Cycle 1)|Overall Study||14
3157378|NCT01844778|3884115|FG001|Safety Set 1 (at Least 1 Dose, Cycle 1)|Overall Study||28
3157379|NCT01844778|3884116|FG002|Safety Set 1 (at Least 1 Dose, Cycle 1)|Overall Study||18
3157380|NCT01844778|3884114|FG000|Safety Set 2 (at Least 1 Dose, Cycle 2)|Overall Study||12
3157381|NCT01844778|3884115|FG001|Safety Set 2 (at Least 1 Dose, Cycle 2)|Overall Study||25
3157382|NCT01844778|3884116|FG002|Safety Set 2 (at Least 1 Dose, Cycle 2)|Overall Study||15
3157383|NCT01844778|3884114|FG000|COMPLETED|Overall Study||12
3157384|NCT01844778|3884115|FG001|COMPLETED|Overall Study||25
3157385|NCT01844778|3884116|FG002|COMPLETED|Overall Study||14
3157386|NCT01844778|3884114|FG000|NOT COMPLETED|Overall Study||2
3157387|NCT01844778|3884115|FG001|NOT COMPLETED|Overall Study||3
3157388|NCT01844778|3884116|FG002|NOT COMPLETED|Overall Study||4
3157389|NCT01844817|3884130|FG000|STARTED|Enrolled and Randomized||66
3157390|NCT01844817|3884131|FG001|STARTED|Enrolled and Randomized||66
3157391|NCT01844817|3884130|FG000|COMPLETED|Enrolled and Randomized||64
3157392|NCT01844817|3884131|FG001|COMPLETED|Enrolled and Randomized||63
3157393|NCT01844817|3884130|FG000|NOT COMPLETED|Enrolled and Randomized||2
3157394|NCT01844817|3884131|FG001|NOT COMPLETED|Enrolled and Randomized||3
3157395|NCT01844817|3884130|FG000|STARTED|Treatment||64
3157396|NCT01844817|3884131|FG001|STARTED|Treatment||63
3157397|NCT01844817|3884130|FG000|COMPLETED|Treatment||0
3157398|NCT01844817|3884131|FG001|COMPLETED|Treatment||0
3157399|NCT01844817|3884130|FG000|NOT COMPLETED|Treatment||64
3157400|NCT01844817|3884131|FG001|NOT COMPLETED|Treatment||63
3157401|NCT01844830|3884140|FG000|STARTED|Overall Study||60
3157402|NCT01844830|3884141|FG001|STARTED|Overall Study||30
3157403|NCT01844830|3884140|FG000|100 µL Dose|Overall Study||16
3157404|NCT01844830|3884141|FG001|100 µL Dose|Overall Study||8
3157405|NCT01844830|3884140|FG000|200 µL Dose|Overall Study||24
3157406|NCT01844830|3884141|FG001|200 µL Dose|Overall Study||12
3157407|NCT01844830|3884140|FG000|400 µL Dose|Overall Study||20
3157408|NCT01844830|3884141|FG001|400 µL Dose|Overall Study||10
3157409|NCT01844830|3884140|FG000|COMPLETED|Overall Study||59
3157410|NCT01844830|3884141|FG001|COMPLETED|Overall Study||30
3157411|NCT01844830|3884140|FG000|NOT COMPLETED|Overall Study||1
3157412|NCT01844830|3884141|FG001|NOT COMPLETED|Overall Study||0
3157413|NCT01844895|3884147|FG000|STARTED|Day 1 to Day 28 - Pre-filled Syringe||120
3157414|NCT01844895|3884147|FG000|COMPLETED|Day 1 to Day 28 - Pre-filled Syringe||117
3157415|NCT01844895|3884147|FG000|NOT COMPLETED|Day 1 to Day 28 - Pre-filled Syringe||3
3157416|NCT01844895|3884147|FG000|STARTED|Day 29 - Day113 - Autoinjector||117
3157417|NCT01844895|3884147|FG000|COMPLETED|Day 29 - Day113 - Autoinjector||111
3157418|NCT01844895|3884147|FG000|NOT COMPLETED|Day 29 - Day113 - Autoinjector||6
3157419|NCT01845025|3884162|FG000|STARTED|Overall Study||411
3157420|NCT01845025|3884163|FG001|STARTED|Overall Study||409
3157421|NCT01845025|3884162|FG000|COMPLETED|Overall Study||326
3157422|NCT01845025|3884163|FG001|COMPLETED|Overall Study||332
3157423|NCT01845025|3884162|FG000|NOT COMPLETED|Overall Study||85
3157424|NCT01845025|3884163|FG001|NOT COMPLETED|Overall Study||77
3157425|NCT01845077|3884172|FG000|STARTED|Treatment Period 1||12
3157426|NCT01845077|3884173|FG001|STARTED|Treatment Period 1||12
3157427|NCT01845077|3884174|FG002|STARTED|Treatment Period 1||12
3157428|NCT01845077|3884175|FG003|STARTED|Treatment Period 1||12
3157429|NCT01845077|3884176|FG004|STARTED|Treatment Period 1||12
3157430|NCT01845077|3884177|FG005|STARTED|Treatment Period 1||12
3157431|NCT01845077|3884172|FG000|COMPLETED|Treatment Period 1||12
3157432|NCT01845077|3884173|FG001|COMPLETED|Treatment Period 1||12
3157433|NCT01845077|3884174|FG002|COMPLETED|Treatment Period 1||12
3157434|NCT01845077|3884175|FG003|COMPLETED|Treatment Period 1||12
3157435|NCT01845077|3884176|FG004|COMPLETED|Treatment Period 1||12
3157436|NCT01845077|3884177|FG005|COMPLETED|Treatment Period 1||12
3157437|NCT01845077|3884172|FG000|NOT COMPLETED|Treatment Period 1||0
3157438|NCT01845077|3884173|FG001|NOT COMPLETED|Treatment Period 1||0
3185210|NCT02018887|3913398|FG004|COMPLETED|Part B: Cohorts 3-7 Overall||8
3185211|NCT02018887|3913399|FG005|COMPLETED|Part B: Cohorts 3-7 Overall||9
3185212|NCT02018887|3913400|FG006|COMPLETED|Part B: Cohorts 3-7 Overall||8
3185213|NCT02018887|3913401|FG007|COMPLETED|Part B: Cohorts 3-7 Overall||5
3185214|NCT02018887|3913402|FG008|COMPLETED|Part B: Cohorts 3-7 Overall||0
3185215|NCT02018887|3913403|FG009|COMPLETED|Part B: Cohorts 3-7 Overall||0
3185216|NCT02018887|3913404|FG010|COMPLETED|Part B: Cohorts 3-7 Overall||0
3185217|NCT02018887|3913394|FG000|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0
3185218|NCT02018887|3913395|FG001|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0
3185219|NCT02018887|3913396|FG002|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0
3185220|NCT02018887|3913397|FG003|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0
3185221|NCT02018887|3913398|FG004|NOT COMPLETED|Part B: Cohorts 3-7 Overall||1
3185222|NCT02018887|3913399|FG005|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0
3185223|NCT02018887|3913400|FG006|NOT COMPLETED|Part B: Cohorts 3-7 Overall||1
3185224|NCT02018887|3913401|FG007|NOT COMPLETED|Part B: Cohorts 3-7 Overall||4
3185225|NCT02018887|3913402|FG008|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0
3185226|NCT02018887|3913403|FG009|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0
3185227|NCT02018887|3913404|FG010|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0
3185228|NCT02018887|3913394|FG000|STARTED|Part C: Cohort 8 Overall||0
3185229|NCT02018887|3913395|FG001|STARTED|Part C: Cohort 8 Overall||0
3363878|NCT04024228|4095073|FG000|COMPLETED|Overall Study||770
3157439|NCT01845077|3884174|FG002|NOT COMPLETED|Treatment Period 1||0
3157440|NCT01845077|3884175|FG003|NOT COMPLETED|Treatment Period 1||0
3157441|NCT01845077|3884176|FG004|NOT COMPLETED|Treatment Period 1||0
3157442|NCT01845077|3884177|FG005|NOT COMPLETED|Treatment Period 1||0
3157443|NCT01845077|3884172|FG000|STARTED|Washout Period||12
3157444|NCT01845077|3884173|FG001|STARTED|Washout Period||12
3157445|NCT01845077|3884174|FG002|STARTED|Washout Period||12
3157446|NCT01845077|3884175|FG003|STARTED|Washout Period||12
3157447|NCT01845077|3884176|FG004|STARTED|Washout Period||12
3157448|NCT01845077|3884177|FG005|STARTED|Washout Period||12
3157449|NCT01845077|3884172|FG000|COMPLETED|Washout Period||11
3157450|NCT01845077|3884173|FG001|COMPLETED|Washout Period||11
3157451|NCT01845077|3884174|FG002|COMPLETED|Washout Period||11
3157452|NCT01845077|3884175|FG003|COMPLETED|Washout Period||10
3157453|NCT01845077|3884176|FG004|COMPLETED|Washout Period||11
3157454|NCT01845077|3884177|FG005|COMPLETED|Washout Period||11
3157455|NCT01845077|3884172|FG000|NOT COMPLETED|Washout Period||1
3157456|NCT01845077|3884173|FG001|NOT COMPLETED|Washout Period||1
3157457|NCT01845077|3884174|FG002|NOT COMPLETED|Washout Period||1
3157458|NCT01845077|3884175|FG003|NOT COMPLETED|Washout Period||2
3185230|NCT02018887|3913396|FG002|STARTED|Part C: Cohort 8 Overall|Placebo was not administered in this period.|0
3185231|NCT02018887|3913397|FG003|STARTED|Part C: Cohort 8 Overall|This dose was not administered in this period.|0
3185232|NCT02018887|3913398|FG004|STARTED|Part C: Cohort 8 Overall|This dose was not administered in this period.|0
3185233|NCT02018887|3913399|FG005|STARTED|Part C: Cohort 8 Overall|This dose was not administered in this period.|0
3185234|NCT02018887|3913400|FG006|STARTED|Part C: Cohort 8 Overall|This dose was not administered in this period.|0
3185235|NCT02018887|3913401|FG007|STARTED|Part C: Cohort 8 Overall|This dose was not administered in this period.|0
3185236|NCT02018887|3913402|FG008|STARTED|Part C: Cohort 8 Overall||10
3185237|NCT02018887|3913403|FG009|STARTED|Part C: Cohort 8 Overall||4
3185238|NCT02018887|3913404|FG010|STARTED|Part C: Cohort 8 Overall||7
3185239|NCT02018887|3913394|FG000|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0
3185240|NCT02018887|3913395|FG001|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0
3185241|NCT02018887|3913396|FG002|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0
3185242|NCT02018887|3913397|FG003|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0
3185243|NCT02018887|3913398|FG004|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0
3185244|NCT02018887|3913399|FG005|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0
3185245|NCT02018887|3913400|FG006|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0
3185246|NCT02018887|3913401|FG007|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0
3185247|NCT02018887|3913402|FG008|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||10
3185248|NCT02018887|3913403|FG009|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||4
3185249|NCT02018887|3913404|FG010|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||7
3185250|NCT02018887|3913394|FG000|COMPLETED|Part C: Cohort 8 Overall||0
3185251|NCT02018887|3913395|FG001|COMPLETED|Part C: Cohort 8 Overall||0
3185252|NCT02018887|3913396|FG002|COMPLETED|Part C: Cohort 8 Overall||0
3185253|NCT02018887|3913397|FG003|COMPLETED|Part C: Cohort 8 Overall||0
3185254|NCT02018887|3913398|FG004|COMPLETED|Part C: Cohort 8 Overall||0
3185255|NCT02018887|3913399|FG005|COMPLETED|Part C: Cohort 8 Overall||0
3185256|NCT02018887|3913400|FG006|COMPLETED|Part C: Cohort 8 Overall||0
3185257|NCT02018887|3913401|FG007|COMPLETED|Part C: Cohort 8 Overall||0
3185258|NCT02018887|3913402|FG008|COMPLETED|Part C: Cohort 8 Overall||7
3185259|NCT02018887|3913403|FG009|COMPLETED|Part C: Cohort 8 Overall||1
3185260|NCT02018887|3913404|FG010|COMPLETED|Part C: Cohort 8 Overall||6
3185261|NCT02018887|3913394|FG000|NOT COMPLETED|Part C: Cohort 8 Overall||0
3185262|NCT02018887|3913395|FG001|NOT COMPLETED|Part C: Cohort 8 Overall||0
3185263|NCT02018887|3913396|FG002|NOT COMPLETED|Part C: Cohort 8 Overall||0
3185264|NCT02018887|3913397|FG003|NOT COMPLETED|Part C: Cohort 8 Overall||0
3185265|NCT02018887|3913398|FG004|NOT COMPLETED|Part C: Cohort 8 Overall||0
3185266|NCT02018887|3913399|FG005|NOT COMPLETED|Part C: Cohort 8 Overall||0
3185267|NCT02018887|3913400|FG006|NOT COMPLETED|Part C: Cohort 8 Overall||0
3185268|NCT02018887|3913401|FG007|NOT COMPLETED|Part C: Cohort 8 Overall||0
3185269|NCT02018887|3913402|FG008|NOT COMPLETED|Part C: Cohort 8 Overall||3
3185270|NCT02018887|3913403|FG009|NOT COMPLETED|Part C: Cohort 8 Overall||3
3185271|NCT02018887|3913404|FG010|NOT COMPLETED|Part C: Cohort 8 Overall||1
3185272|NCT02019069|3913470|FG000|STARTED|Overall Study||11
3185273|NCT02019069|3913470|FG000|COMPLETED|Overall Study||11
3185274|NCT02019069|3913470|FG000|NOT COMPLETED|Overall Study||0
3185275|NCT02019108|3913476|FG000|STARTED|Overall Study||40
3185276|NCT02019108|3913477|FG001|STARTED|Overall Study||39
3185277|NCT02019108|3913476|FG000|Baseline (Week 0)|Overall Study||40
3185278|NCT02019108|3913477|FG001|Baseline (Week 0)|Overall Study||39
3185279|NCT02019108|3913476|FG000|Follow-up (Week 17)|Overall Study||38
3185280|NCT02019108|3913477|FG001|Follow-up (Week 17)|Overall Study||36
3185281|NCT02019108|3913476|FG000|Retention (Week 21)|Overall Study||35
3185282|NCT02019108|3913477|FG001|Retention (Week 21)|Overall Study||32
3185283|NCT02019108|3913476|FG000|COMPLETED|Overall Study||35
3157459|NCT01845077|3884176|FG004|NOT COMPLETED|Washout Period||1
3157460|NCT01845077|3884177|FG005|NOT COMPLETED|Washout Period||1
3157461|NCT01845077|3884172|FG000|STARTED|Treatment Period 2||11
3157462|NCT01845077|3884173|FG001|STARTED|Treatment Period 2||11
3185284|NCT02019108|3913477|FG001|COMPLETED|Overall Study||32
3185285|NCT02019108|3913476|FG000|NOT COMPLETED|Overall Study||5
3185286|NCT02019108|3913477|FG001|NOT COMPLETED|Overall Study||7
3157463|NCT01845077|3884174|FG002|STARTED|Treatment Period 2||11
3157464|NCT01845077|3884175|FG003|STARTED|Treatment Period 2||10
3157465|NCT01845077|3884176|FG004|STARTED|Treatment Period 2||11
3157466|NCT01845077|3884177|FG005|STARTED|Treatment Period 2||11
3157467|NCT01845077|3884172|FG000|COMPLETED|Treatment Period 2||11
3157468|NCT01845077|3884173|FG001|COMPLETED|Treatment Period 2||11
3157469|NCT01845077|3884174|FG002|COMPLETED|Treatment Period 2||11
3157470|NCT01845077|3884175|FG003|COMPLETED|Treatment Period 2||10
3157471|NCT01845077|3884176|FG004|COMPLETED|Treatment Period 2||11
3157472|NCT01845077|3884177|FG005|COMPLETED|Treatment Period 2||11
3157473|NCT01845077|3884172|FG000|NOT COMPLETED|Treatment Period 2||0
3157474|NCT01845077|3884173|FG001|NOT COMPLETED|Treatment Period 2||0
3157475|NCT01845077|3884174|FG002|NOT COMPLETED|Treatment Period 2||0
3157476|NCT01845077|3884175|FG003|NOT COMPLETED|Treatment Period 2||0
3157477|NCT01845077|3884176|FG004|NOT COMPLETED|Treatment Period 2||0
3157478|NCT01845077|3884177|FG005|NOT COMPLETED|Treatment Period 2||0
3157479|NCT01845103|3884192|FG000|STARTED|Overall Study||1
3157480|NCT01845103|3884192|FG000|COMPLETED|Overall Study||1
3157481|NCT01845103|3884192|FG000|NOT COMPLETED|Overall Study||0
3157482|NCT01845155|3884198|FG000|STARTED|Overall Study||146
3157483|NCT01845155|3884199|FG001|STARTED|Overall Study||144
3157484|NCT01845155|3884198|FG000|COMPLETED|Overall Study||145
3157485|NCT01845155|3884199|FG001|COMPLETED|Overall Study||144
3157486|NCT01845155|3884198|FG000|NOT COMPLETED|Overall Study||1
3157487|NCT01845155|3884199|FG001|NOT COMPLETED|Overall Study||0
3157488|NCT01845220|3884205|FG000|STARTED|Overall Study||30
3157489|NCT01845220|3884206|FG001|STARTED|Overall Study||30
3157490|NCT01845220|3884205|FG000|COMPLETED|Overall Study||30
3157491|NCT01845220|3884206|FG001|COMPLETED|Overall Study||30
3157492|NCT01845220|3884205|FG000|NOT COMPLETED|Overall Study||0
3157493|NCT01845220|3884206|FG001|NOT COMPLETED|Overall Study||0
3157494|NCT01845636|3884212|FG000|STARTED|Overall Study||41
3157495|NCT01845636|3884212|FG000|COMPLETED|Overall Study||37
3157496|NCT01845636|3884212|FG000|NOT COMPLETED|Overall Study||4
3157497|NCT01845792|3884218|FG000|STARTED|Overall Study||5
3157498|NCT01845792|3884219|FG001|STARTED|Overall Study||2
3157499|NCT01845792|3884218|FG000|COMPLETED|Overall Study||5
3157500|NCT01845792|3884219|FG001|COMPLETED|Overall Study||2
3157501|NCT01845792|3884218|FG000|NOT COMPLETED|Overall Study||0
3157502|NCT01845792|3884219|FG001|NOT COMPLETED|Overall Study||0
3157503|NCT01845818|3884227|FG000|STARTED|Overall Study||126
3157504|NCT01845818|3884228|FG001|STARTED|Overall Study||57
3157505|NCT01845818|3884227|FG000|COMPLETED|Overall Study||81
3157506|NCT01845818|3884228|FG001|COMPLETED|Overall Study||40
3157507|NCT01845818|3884227|FG000|NOT COMPLETED|Overall Study||45
3157508|NCT01845818|3884228|FG001|NOT COMPLETED|Overall Study||17
3157509|NCT01845831|3884238|FG000|STARTED|Inpatient Phase||140
3157510|NCT01845831|3884239|FG001|STARTED|Inpatient Phase||139
3157511|NCT01845831|3884240|FG002|STARTED|Inpatient Phase||0
3157512|NCT01845831|3884241|FG003|STARTED|Inpatient Phase||0
3157513|NCT01845831|3884242|FG004|STARTED|Inpatient Phase||0
3185287|NCT02019264|3913485|FG000|STARTED|Overall Study||6000
3185288|NCT02019264|3913486|FG001|STARTED|Overall Study||6000
3185289|NCT02019264|3913485|FG000|Safety Analysis Set|Overall Study||5992
3185290|NCT02019264|3913486|FG001|Safety Analysis Set|Overall Study||5995
3185291|NCT02019264|3913485|FG000|COMPLETED|Overall Study||5752
3185292|NCT02019264|3913486|FG001|COMPLETED|Overall Study||5793
3185293|NCT02019264|3913485|FG000|NOT COMPLETED|Overall Study||248
3185294|NCT02019264|3913486|FG001|NOT COMPLETED|Overall Study||207
3185295|NCT02019277|3913492|FG000|STARTED|Overall Study||50
3185296|NCT02019277|3913492|FG000|COMPLETED|Overall Study||38
3185297|NCT02019277|3913492|FG000|NOT COMPLETED|Overall Study||12
3185298|NCT02019420|3913498|FG000|STARTED|Overall Study||366
3185299|NCT02019420|3913499|FG001|STARTED|Overall Study||360
3185300|NCT02019420|3913498|FG000|Treated|Overall Study||361
3185301|NCT02019420|3913499|FG001|Treated|Overall Study||357
3185302|NCT02019420|3913498|FG000|COMPLETED|Overall Study||258
3185303|NCT02019420|3913499|FG001|COMPLETED|Overall Study||254
3185304|NCT02019420|3913498|FG000|NOT COMPLETED|Overall Study||108
3185305|NCT02019420|3913499|FG001|NOT COMPLETED|Overall Study||106
3185306|NCT02019472|3913508|FG000|STARTED|Overall Study||186
3185307|NCT02019472|3913509|FG001|STARTED|Overall Study||186
3185308|NCT02019472|3913510|FG002|STARTED|Overall Study||187
3185309|NCT02019472|3913508|FG000|COMPLETED|Overall Study||149
3185310|NCT02019472|3913509|FG001|COMPLETED|Overall Study||134
3185311|NCT02019472|3913510|FG002|COMPLETED|Overall Study||145
3185312|NCT02019472|3913508|FG000|NOT COMPLETED|Overall Study||37
3185313|NCT02019472|3913509|FG001|NOT COMPLETED|Overall Study||52
3185314|NCT02019472|3913510|FG002|NOT COMPLETED|Overall Study||42
3185315|NCT02019550|3913524|FG000|STARTED|Treatment Period 1 (4 Weeks)||46
3185316|NCT02019550|3913525|FG001|STARTED|Treatment Period 1 (4 Weeks)||51
3363879|NCT04024228|4095074|FG001|COMPLETED|Overall Study||759
3363880|NCT04024228|4095073|FG000|NOT COMPLETED|Overall Study||4
3363881|NCT04024228|4095074|FG001|NOT COMPLETED|Overall Study||6
3363882|NCT04039919|4095087|FG000|STARTED|Treatment Period 1||7
3363883|NCT04039919|4095088|FG001|STARTED|Treatment Period 1||6
3157514|NCT01845831|3884238|FG000|COMPLETED|Inpatient Phase||139
3157515|NCT01845831|3884239|FG001|COMPLETED|Inpatient Phase||138
3157516|NCT01845831|3884240|FG002|COMPLETED|Inpatient Phase||0
3157517|NCT01845831|3884241|FG003|COMPLETED|Inpatient Phase||0
3157518|NCT01845831|3884242|FG004|COMPLETED|Inpatient Phase||0
3157519|NCT01845831|3884238|FG000|NOT COMPLETED|Inpatient Phase||1
3157520|NCT01845831|3884239|FG001|NOT COMPLETED|Inpatient Phase||1
3157521|NCT01845831|3884240|FG002|NOT COMPLETED|Inpatient Phase||0
3157522|NCT01845831|3884241|FG003|NOT COMPLETED|Inpatient Phase||0
3157523|NCT01845831|3884242|FG004|NOT COMPLETED|Inpatient Phase||0
3157524|NCT01845831|3884238|FG000|STARTED|Outpatient Phase||0
3157525|NCT01845831|3884239|FG001|STARTED|Outpatient Phase||0
3157526|NCT01845831|3884240|FG002|STARTED|Outpatient Phase||68
3157527|NCT01845831|3884241|FG003|STARTED|Outpatient Phase||98
3157528|NCT01845831|3884242|FG004|STARTED|Outpatient Phase||87
3157529|NCT01845831|3884238|FG000|COMPLETED|Outpatient Phase||0
3157530|NCT01845831|3884239|FG001|COMPLETED|Outpatient Phase||0
3157531|NCT01845831|3884240|FG002|COMPLETED|Outpatient Phase||68
3157532|NCT01845831|3884241|FG003|COMPLETED|Outpatient Phase||98
3157533|NCT01845831|3884242|FG004|COMPLETED|Outpatient Phase||87
3157534|NCT01845831|3884238|FG000|NOT COMPLETED|Outpatient Phase||0
3157535|NCT01845831|3884239|FG001|NOT COMPLETED|Outpatient Phase||0
3157536|NCT01845831|3884240|FG002|NOT COMPLETED|Outpatient Phase||0
3157537|NCT01845831|3884241|FG003|NOT COMPLETED|Outpatient Phase||0
3157538|NCT01845831|3884242|FG004|NOT COMPLETED|Outpatient Phase||0
3157539|NCT01845974|3884255|FG000|STARTED|Overall Study||4
3157540|NCT01845974|3884256|FG001|STARTED|Overall Study||9
3157541|NCT01845974|3884255|FG000|COMPLETED|Overall Study||3
3157542|NCT01845974|3884256|FG001|COMPLETED|Overall Study||9
3157543|NCT01845974|3884255|FG000|NOT COMPLETED|Overall Study||1
3157544|NCT01845974|3884256|FG001|NOT COMPLETED|Overall Study||0
3157545|NCT01846039|3884262|FG000|STARTED|Overall Study||29
3157546|NCT01846039|3884262|FG000|COMPLETED|Overall Study||27
3157547|NCT01846039|3884262|FG000|NOT COMPLETED|Overall Study||2
3157548|NCT01846104|3884266|FG000|STARTED|Overall Study||4
3157549|NCT01846104|3884266|FG000|COMPLETED|Overall Study||3
3157550|NCT01846104|3884266|FG000|NOT COMPLETED|Overall Study||1
3157551|NCT01846208|3884273|FG000|STARTED|Overall Study||28
3157552|NCT01846208|3884274|FG001|STARTED|Overall Study||24
3157553|NCT01846208|3884275|FG002|STARTED|Overall Study||40
3157554|NCT01846208|3884273|FG000|Initiatiated Treatment|Overall Study||27
3157555|NCT01846208|3884274|FG001|Initiatiated Treatment|Overall Study||23
3157556|NCT01846208|3884275|FG002|Initiatiated Treatment|Overall Study||39
3157557|NCT01846208|3884273|FG000|Year 1 Desensitization OFC|Overall Study||23
3157558|NCT01846208|3884274|FG001|Year 1 Desensitization OFC|Overall Study||20
3157559|NCT01846208|3884275|FG002|Year 1 Desensitization OFC|Overall Study||34
3157560|NCT01846208|3884273|FG000|Year 2 Desensitization OFC|Overall Study||19
3157561|NCT01846208|3884274|FG001|Year 2 Desensitization OFC|Overall Study||20
3157562|NCT01846208|3884275|FG002|Year 2 Desensitization OFC|Overall Study||33
3157563|NCT01846208|3884273|FG000|Year 2 Sustained Unresponsiveness OFC|Overall Study||4
3157564|NCT01846208|3884274|FG001|Year 2 Sustained Unresponsiveness OFC|Overall Study||18
3157565|NCT01846208|3884275|FG002|Year 2 Sustained Unresponsiveness OFC|Overall Study||21
3157566|NCT01846208|3884273|FG000|COMPLETED|Overall Study||19
3157567|NCT01846208|3884274|FG001|COMPLETED|Overall Study||20
3157568|NCT01846208|3884275|FG002|COMPLETED|Overall Study||32
3157569|NCT01846208|3884273|FG000|NOT COMPLETED|Overall Study||9
3157570|NCT01846208|3884274|FG001|NOT COMPLETED|Overall Study||4
3157571|NCT01846208|3884275|FG002|NOT COMPLETED|Overall Study||8
3157572|NCT01846221|3884285|FG000|STARTED|Overall Study||50
3157573|NCT01846221|3884286|FG001|STARTED|Overall Study||51
3157574|NCT01846221|3884285|FG000|COMPLETED|Overall Study||47
3157575|NCT01846221|3884286|FG001|COMPLETED|Overall Study||51
3157576|NCT01846221|3884285|FG000|NOT COMPLETED|Overall Study||3
3157577|NCT01846221|3884286|FG001|NOT COMPLETED|Overall Study||0
3157578|NCT01846299|3884294|FG000|STARTED|Overall Study||118
3157579|NCT01846299|3884295|FG001|STARTED|Overall Study||60
3157580|NCT01846299|3884294|FG000|Full Analysis Set|Overall Study|One participant did not receive study treatment prior to discontinuation.|117
3157581|NCT01846299|3884295|FG001|Full Analysis Set|Overall Study||60
3157582|NCT01846299|3884294|FG000|Safety Set|Overall Study|Two participants randomized to sham received ranibizumab at Month 1.|119
3157583|NCT01846299|3884295|FG001|Safety Set|Overall Study||58
3157584|NCT01846299|3884294|FG000|COMPLETED|Overall Study||106
3157585|NCT01846299|3884295|FG001|COMPLETED|Overall Study||50
3157586|NCT01846299|3884294|FG000|NOT COMPLETED|Overall Study||12
3157587|NCT01846299|3884295|FG001|NOT COMPLETED|Overall Study||10
3157588|NCT01846416|3884306|FG000|STARTED|Treatment Phase||31
3185317|NCT02019550|3913524|FG000|COMPLETED|Treatment Period 1 (4 Weeks)||46
3185318|NCT02019550|3913525|FG001|COMPLETED|Treatment Period 1 (4 Weeks)||50
3185319|NCT02019550|3913524|FG000|NOT COMPLETED|Treatment Period 1 (4 Weeks)||0
3185320|NCT02019550|3913525|FG001|NOT COMPLETED|Treatment Period 1 (4 Weeks)||1
3185321|NCT02019550|3913524|FG000|STARTED|Treatment Period 2 (4 Weeks)||46
3185322|NCT02019550|3913525|FG001|STARTED|Treatment Period 2 (4 Weeks)||50
3185323|NCT02019550|3913524|FG000|COMPLETED|Treatment Period 2 (4 Weeks)||46
3185324|NCT02019550|3913525|FG001|COMPLETED|Treatment Period 2 (4 Weeks)||50
3185325|NCT02019550|3913524|FG000|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
3185326|NCT02019550|3913525|FG001|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
3185327|NCT02019563|3913535|FG000|STARTED|Overall Study|100 incisors were treated in the MTA/FS pulpotomy group|40
3185328|NCT02019563|3913536|FG001|STARTED|Overall Study|72 incisors were treated in the RCT group|30
3185329|NCT02019563|3913535|FG000|COMPLETED|Overall Study|100 incisors were treated in the MTA/FS pulpotomy group|40
3185330|NCT02019563|3913536|FG001|COMPLETED|Overall Study|72 incisors were treated in the RCT group|30
3185331|NCT02019563|3913535|FG000|NOT COMPLETED|Overall Study||0
3185332|NCT02019563|3913536|FG001|NOT COMPLETED|Overall Study||0
3157589|NCT01846416|3884307|FG001|STARTED|Treatment Phase||93
3157590|NCT01846416|3884308|FG002|STARTED|Treatment Phase||13
3157591|NCT01846416|3884306|FG000|COMPLETED|Treatment Phase||0
3157592|NCT01846416|3884307|FG001|COMPLETED|Treatment Phase||0
3157593|NCT01846416|3884308|FG002|COMPLETED|Treatment Phase||0
3157594|NCT01846416|3884306|FG000|NOT COMPLETED|Treatment Phase||31
3157595|NCT01846416|3884307|FG001|NOT COMPLETED|Treatment Phase||93
3157596|NCT01846416|3884308|FG002|NOT COMPLETED|Treatment Phase||13
3157597|NCT01846416|3884306|FG000|STARTED|Survival Follow-up||28
3157598|NCT01846416|3884307|FG001|STARTED|Survival Follow-up||80
3157599|NCT01846416|3884308|FG002|STARTED|Survival Follow-up||12
3157600|NCT01846416|3884306|FG000|COMPLETED|Survival Follow-up||0
3157601|NCT01846416|3884307|FG001|COMPLETED|Survival Follow-up||0
3157602|NCT01846416|3884308|FG002|COMPLETED|Survival Follow-up||0
3157603|NCT01846416|3884306|FG000|NOT COMPLETED|Survival Follow-up||28
3157604|NCT01846416|3884307|FG001|NOT COMPLETED|Survival Follow-up||80
3157605|NCT01846416|3884308|FG002|NOT COMPLETED|Survival Follow-up||12
3157606|NCT01846442|3884321|FG000|STARTED|Overall Study||54
3157607|NCT01846442|3884322|FG001|STARTED|Overall Study||54
3157608|NCT01846442|3884323|FG002|STARTED|Overall Study||56
3157609|NCT01846442|3884324|FG003|STARTED|Overall Study||54
3157610|NCT01846442|3884321|FG000|Safety Population|Overall Study||54
3157611|NCT01846442|3884322|FG001|Safety Population|Overall Study||53
3157612|NCT01846442|3884323|FG002|Safety Population|Overall Study||56
3157613|NCT01846442|3884324|FG003|Safety Population|Overall Study||54
3157614|NCT01846442|3884321|FG000|ITT Population|Overall Study||53
3157615|NCT01846442|3884322|FG001|ITT Population|Overall Study||53
3157616|NCT01846442|3884323|FG002|ITT Population|Overall Study||56
3157617|NCT01846442|3884324|FG003|ITT Population|Overall Study||54
3157618|NCT01846442|3884321|FG000|COMPLETED|Overall Study||48
3157619|NCT01846442|3884322|FG001|COMPLETED|Overall Study||48
3157620|NCT01846442|3884323|FG002|COMPLETED|Overall Study||52
3157621|NCT01846442|3884324|FG003|COMPLETED|Overall Study||51
3157622|NCT01846442|3884321|FG000|NOT COMPLETED|Overall Study||6
3157623|NCT01846442|3884322|FG001|NOT COMPLETED|Overall Study||6
3157624|NCT01846442|3884323|FG002|NOT COMPLETED|Overall Study||4
3157625|NCT01846442|3884324|FG003|NOT COMPLETED|Overall Study||3
3157626|NCT01846455|3884339|FG000|STARTED|Overall Study||9
3157627|NCT01846455|3884340|FG001|STARTED|Overall Study||8
3157628|NCT01846455|3884341|FG002|STARTED|Overall Study||8
3157629|NCT01846455|3884342|FG003|STARTED|Overall Study||10
3157630|NCT01846455|3884343|FG004|STARTED|Overall Study||8
3157631|NCT01846455|3884339|FG000|PK Population|Overall Study||6
3157632|NCT01846455|3884340|FG001|PK Population|Overall Study||7
3157633|NCT01846455|3884341|FG002|PK Population|Overall Study||6
3157634|NCT01846455|3884342|FG003|PK Population|Overall Study||6
3157635|NCT01846455|3884343|FG004|PK Population|Overall Study||8
3157636|NCT01846455|3884339|FG000|COMPLETED|Overall Study||9
3157637|NCT01846455|3884340|FG001|COMPLETED|Overall Study||8
3157638|NCT01846455|3884341|FG002|COMPLETED|Overall Study||8
3157639|NCT01846455|3884342|FG003|COMPLETED|Overall Study||10
3157640|NCT01846455|3884343|FG004|COMPLETED|Overall Study||8
3157641|NCT01846455|3884339|FG000|NOT COMPLETED|Overall Study||0
3157642|NCT01846455|3884340|FG001|NOT COMPLETED|Overall Study||0
3157643|NCT01846455|3884341|FG002|NOT COMPLETED|Overall Study||0
3157644|NCT01846455|3884342|FG003|NOT COMPLETED|Overall Study||0
3157645|NCT01846455|3884343|FG004|NOT COMPLETED|Overall Study||0
3157646|NCT01846494|3884357|FG000|STARTED|Overall Study||50
3157647|NCT01846494|3884358|FG001|STARTED|Overall Study||63
3157648|NCT01846494|3884357|FG000|COMPLETED|Overall Study||20
3157649|NCT01846494|3884358|FG001|COMPLETED|Overall Study||25
3157650|NCT01846494|3884357|FG000|NOT COMPLETED|Overall Study||30
3157651|NCT01846494|3884358|FG001|NOT COMPLETED|Overall Study||38
3157652|NCT01846507|3884364|FG000|STARTED|Overall Study||32
3157653|NCT01846507|3884364|FG000|COMPLETED|Overall Study||25
3157654|NCT01846507|3884364|FG000|NOT COMPLETED|Overall Study||7
3157655|NCT01846611|3884372|FG000|STARTED|Overall Study||289
3157656|NCT01846611|3884373|FG001|STARTED|Overall Study||287
3157657|NCT01846611|3884372|FG000|Treated|Overall Study||286
3157658|NCT01846611|3884373|FG001|Treated|Overall Study||282
3157659|NCT01846611|3884372|FG000|COMPLETED|Overall Study||251
3185333|NCT02019602|3913546|FG000|STARTED|Screening Period||21
3185334|NCT02019602|3913547|FG001|STARTED|Screening Period||16
3185335|NCT02019602|3913546|FG000|COMPLETED|Screening Period||16
3185336|NCT02019602|3913547|FG001|COMPLETED|Screening Period||16
3185337|NCT02019602|3913546|FG000|NOT COMPLETED|Screening Period||5
3185338|NCT02019602|3913547|FG001|NOT COMPLETED|Screening Period||0
3185339|NCT02019602|3913546|FG000|STARTED|Sampling Period||16
3185340|NCT02019602|3913547|FG001|STARTED|Sampling Period||16
3185341|NCT02019602|3913546|FG000|COMPLETED|Sampling Period||16
3185342|NCT02019602|3913547|FG001|COMPLETED|Sampling Period||16
3185343|NCT02019602|3913546|FG000|NOT COMPLETED|Sampling Period||0
3185344|NCT02019602|3913547|FG001|NOT COMPLETED|Sampling Period||0
3185345|NCT02019667|3913554|FG000|STARTED|First Intervention (6 Months)||10
3185346|NCT02019667|3913555|FG001|STARTED|First Intervention (6 Months)||9
3185347|NCT02019667|3913554|FG000|COMPLETED|First Intervention (6 Months)||10
3185348|NCT02019667|3913555|FG001|COMPLETED|First Intervention (6 Months)||8
3185349|NCT02019667|3913554|FG000|NOT COMPLETED|First Intervention (6 Months)||0
3157660|NCT01846611|3884373|FG001|COMPLETED|Overall Study||244
3157661|NCT01846611|3884372|FG000|NOT COMPLETED|Overall Study||38
3157662|NCT01846611|3884373|FG001|NOT COMPLETED|Overall Study||43
3157663|NCT01846624|3884379|FG000|STARTED|Overall Study||13
3157664|NCT01846624|3884379|FG000|COMPLETED|Overall Study||12
3157665|NCT01846624|3884379|FG000|NOT COMPLETED|Overall Study||1
3157666|NCT01846702|3884390|FG000|STARTED|Overall Study||6
3157667|NCT01846702|3884391|FG001|STARTED|Overall Study||6
3157668|NCT01846702|3884392|FG002|STARTED|Overall Study||7
3157669|NCT01846702|3884393|FG003|STARTED|Overall Study||6
3157670|NCT01846702|3884394|FG004|STARTED|Overall Study||6
3157671|NCT01846702|3884395|FG005|STARTED|Overall Study||6
3157672|NCT01846702|3884396|FG006|STARTED|Overall Study||6
3157673|NCT01846702|3884390|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6
3157674|NCT01846702|3884391|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6
3157675|NCT01846702|3884392|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
3157676|NCT01846702|3884393|FG003|Received at Least 1 Dose of Study Drug|Overall Study||6
3157677|NCT01846702|3884394|FG004|Received at Least 1 Dose of Study Drug|Overall Study||6
3157678|NCT01846702|3884395|FG005|Received at Least 1 Dose of Study Drug|Overall Study||6
3157679|NCT01846702|3884396|FG006|Received at Least 1 Dose of Study Drug|Overall Study||6
3157680|NCT01846702|3884390|FG000|COMPLETED|Overall Study||6
3157681|NCT01846702|3884391|FG001|COMPLETED|Overall Study||6
3157682|NCT01846702|3884392|FG002|COMPLETED|Overall Study||6
3157683|NCT01846702|3884393|FG003|COMPLETED|Overall Study||6
3157684|NCT01846702|3884394|FG004|COMPLETED|Overall Study||6
3157685|NCT01846702|3884395|FG005|COMPLETED|Overall Study||6
3157686|NCT01846702|3884396|FG006|COMPLETED|Overall Study||6
3157687|NCT01846702|3884390|FG000|NOT COMPLETED|Overall Study||0
3157688|NCT01846702|3884391|FG001|NOT COMPLETED|Overall Study||0
3157689|NCT01846702|3884392|FG002|NOT COMPLETED|Overall Study||1
3157690|NCT01846702|3884393|FG003|NOT COMPLETED|Overall Study||0
3157691|NCT01846702|3884394|FG004|NOT COMPLETED|Overall Study||0
3157692|NCT01846702|3884395|FG005|NOT COMPLETED|Overall Study||0
3157693|NCT01846702|3884396|FG006|NOT COMPLETED|Overall Study||0
3157694|NCT01846728|3884420|FG000|STARTED|Overall Study||6
3157695|NCT01846728|3884420|FG000|COMPLETED|Overall Study||6
3157696|NCT01846728|3884420|FG000|NOT COMPLETED|Overall Study||0
3157697|NCT01846741|3884424|FG000|STARTED|Baseline Visit||22
3157698|NCT01846741|3884424|FG000|COMPLETED|Baseline Visit||20
3157699|NCT01846741|3884424|FG000|NOT COMPLETED|Baseline Visit||2
3157700|NCT01846741|3884424|FG000|STARTED|Implantation to 18-Month/End of Study||20
3157701|NCT01846741|3884424|FG000|COMPLETED|Implantation to 18-Month/End of Study||20
3157702|NCT01846741|3884424|FG000|NOT COMPLETED|Implantation to 18-Month/End of Study||0
3157703|NCT01846871|3884463|FG000|STARTED|Overall Study||10
3157704|NCT01846871|3884463|FG000|COMPLETED|Overall Study||10
3157705|NCT01846871|3884463|FG000|NOT COMPLETED|Overall Study||0
3157706|NCT01846988|3884474|FG000|STARTED|APAP Pressurize Comparison (4-8 Weeks)||15
3157707|NCT01846988|3884475|FG001|STARTED|APAP Pressurize Comparison (4-8 Weeks)||0
3157708|NCT01846988|3884476|FG002|STARTED|APAP Pressurize Comparison (4-8 Weeks)||0
3157709|NCT01846988|3884474|FG000|COMPLETED|APAP Pressurize Comparison (4-8 Weeks)||15
3157710|NCT01846988|3884475|FG001|COMPLETED|APAP Pressurize Comparison (4-8 Weeks)||0
3157711|NCT01846988|3884476|FG002|COMPLETED|APAP Pressurize Comparison (4-8 Weeks)||0
3157712|NCT01846988|3884474|FG000|NOT COMPLETED|APAP Pressurize Comparison (4-8 Weeks)||0
3157713|NCT01846988|3884475|FG001|NOT COMPLETED|APAP Pressurize Comparison (4-8 Weeks)||0
3157714|NCT01846988|3884476|FG002|NOT COMPLETED|APAP Pressurize Comparison (4-8 Weeks)||0
3157715|NCT01846988|3884474|FG000|STARTED|Intervention #1 - 4 Weeks||0
3157716|NCT01846988|3884475|FG001|STARTED|Intervention #1 - 4 Weeks|Only 10 of 15 participants completing Comparison period started periods 1 & 2|5
3157717|NCT01846988|3884476|FG002|STARTED|Intervention #1 - 4 Weeks||5
3157718|NCT01846988|3884474|FG000|COMPLETED|Intervention #1 - 4 Weeks||0
3157719|NCT01846988|3884475|FG001|COMPLETED|Intervention #1 - 4 Weeks||5
3157720|NCT01846988|3884476|FG002|COMPLETED|Intervention #1 - 4 Weeks||5
3157721|NCT01846988|3884474|FG000|NOT COMPLETED|Intervention #1 - 4 Weeks||0
3157722|NCT01846988|3884475|FG001|NOT COMPLETED|Intervention #1 - 4 Weeks||0
3157723|NCT01846988|3884476|FG002|NOT COMPLETED|Intervention #1 - 4 Weeks||0
3157724|NCT01846988|3884474|FG000|STARTED|Intervention #2 - 4 Weeks||0
3157725|NCT01846988|3884475|FG001|STARTED|Intervention #2 - 4 Weeks||5
3157726|NCT01846988|3884476|FG002|STARTED|Intervention #2 - 4 Weeks||5
3157727|NCT01846988|3884474|FG000|COMPLETED|Intervention #2 - 4 Weeks||0
3157728|NCT01846988|3884475|FG001|COMPLETED|Intervention #2 - 4 Weeks||5
3157729|NCT01846988|3884476|FG002|COMPLETED|Intervention #2 - 4 Weeks||5
3157730|NCT01846988|3884474|FG000|NOT COMPLETED|Intervention #2 - 4 Weeks||0
3157731|NCT01846988|3884475|FG001|NOT COMPLETED|Intervention #2 - 4 Weeks||0
3157732|NCT01846988|3884476|FG002|NOT COMPLETED|Intervention #2 - 4 Weeks||0
3157733|NCT01847001|3884493|FG000|STARTED|Overall Study||10
3157734|NCT01847001|3884493|FG000|COMPLETED|Overall Study||10
3157735|NCT01847001|3884493|FG000|NOT COMPLETED|Overall Study||0
3185350|NCT02019667|3913555|FG001|NOT COMPLETED|First Intervention (6 Months)||1
3185351|NCT02019667|3913554|FG000|STARTED|Washout Period (9 Weeks)||10
3185352|NCT02019667|3913555|FG001|STARTED|Washout Period (9 Weeks)||8
3185353|NCT02019667|3913554|FG000|COMPLETED|Washout Period (9 Weeks)||10
3185354|NCT02019667|3913555|FG001|COMPLETED|Washout Period (9 Weeks)||8
3185355|NCT02019667|3913554|FG000|NOT COMPLETED|Washout Period (9 Weeks)||0
3185356|NCT02019667|3913555|FG001|NOT COMPLETED|Washout Period (9 Weeks)||0
3185357|NCT02019667|3913554|FG000|STARTED|2nd Intervention (6 Months)||10
3185358|NCT02019667|3913555|FG001|STARTED|2nd Intervention (6 Months)||8
3185359|NCT02019667|3913554|FG000|COMPLETED|2nd Intervention (6 Months)||10
3157736|NCT01847014|3884498|FG000|STARTED|Baseline Extension Visit||4
3157737|NCT01847014|3884498|FG000|COMPLETED|Baseline Extension Visit||4
3157738|NCT01847014|3884498|FG000|NOT COMPLETED|Baseline Extension Visit||0
3157739|NCT01847014|3884498|FG000|STARTED|Completion of Extension Study||4
3157740|NCT01847014|3884498|FG000|COMPLETED|Completion of Extension Study||0
3157741|NCT01847014|3884498|FG000|NOT COMPLETED|Completion of Extension Study||4
3157742|NCT01847027|3884504|FG000|STARTED|Overall Study||11
3157743|NCT01847027|3884505|FG001|STARTED|Overall Study||12
3157744|NCT01847027|3884504|FG000|COMPLETED|Overall Study||10
3157745|NCT01847027|3884505|FG001|COMPLETED|Overall Study||10
3157746|NCT01847027|3884504|FG000|NOT COMPLETED|Overall Study||1
3157747|NCT01847027|3884505|FG001|NOT COMPLETED|Overall Study||2
3157748|NCT01847092|3884513|FG000|STARTED|Overall Study||77
3157749|NCT01847092|3884514|FG001|STARTED|Overall Study||77
3157750|NCT01847092|3884513|FG000|COMPLETED|Overall Study||51
3157751|NCT01847092|3884514|FG001|COMPLETED|Overall Study||66
3157752|NCT01847092|3884513|FG000|NOT COMPLETED|Overall Study||26
3157753|NCT01847092|3884514|FG001|NOT COMPLETED|Overall Study||11
3157754|NCT01847131|3884522|FG000|STARTED|Overall Study||25
3157755|NCT01847131|3884523|FG001|STARTED|Overall Study||25
3157756|NCT01847131|3884522|FG000|COMPLETED|Overall Study||25
3157757|NCT01847131|3884523|FG001|COMPLETED|Overall Study||25
3157758|NCT01847131|3884522|FG000|NOT COMPLETED|Overall Study||0
3157759|NCT01847131|3884523|FG001|NOT COMPLETED|Overall Study||0
3157760|NCT01847196|3884529|FG000|STARTED|Overall Study|Includes all subjects in which Angel Catheter placement was attempted.|5
3157761|NCT01847196|3884529|FG000|COMPLETED|Overall Study||5
3157762|NCT01847196|3884529|FG000|NOT COMPLETED|Overall Study||0
3157763|NCT01847209|3884533|FG000|STARTED|Overall Study||25
3157764|NCT01847209|3884533|FG000|COMPLETED|Overall Study||23
3157765|NCT01847209|3884533|FG000|NOT COMPLETED|Overall Study||2
3157766|NCT01847313|3884539|FG000|STARTED|Overall Study||10
3157767|NCT01847313|3884540|FG001|STARTED|Overall Study||10
3157768|NCT01847313|3884539|FG000|COMPLETED|Overall Study||10
3157769|NCT01847313|3884540|FG001|COMPLETED|Overall Study||8
3157770|NCT01847313|3884539|FG000|NOT COMPLETED|Overall Study||0
3157771|NCT01847313|3884540|FG001|NOT COMPLETED|Overall Study||2
3157772|NCT01847430|3884546|FG000|STARTED|Overall Study||302
3157773|NCT01847430|3884546|FG000|COMPLETED|Overall Study||302
3157774|NCT01847430|3884546|FG000|NOT COMPLETED|Overall Study||0
3157775|NCT01847443|3884550|FG000|STARTED|Study Period 1||21
3157776|NCT01847443|3884551|FG001|STARTED|Study Period 1||21
3157777|NCT01847443|3884552|FG002|STARTED|Study Period 1||21
3157778|NCT01847443|3884553|FG003|STARTED|Study Period 1||21
3157779|NCT01847443|3884550|FG000|COMPLETED|Study Period 1||21
3157780|NCT01847443|3884551|FG001|COMPLETED|Study Period 1||20
3157781|NCT01847443|3884552|FG002|COMPLETED|Study Period 1||21
3157782|NCT01847443|3884553|FG003|COMPLETED|Study Period 1||21
3157783|NCT01847443|3884550|FG000|NOT COMPLETED|Study Period 1||0
3157784|NCT01847443|3884551|FG001|NOT COMPLETED|Study Period 1||1
3157785|NCT01847443|3884552|FG002|NOT COMPLETED|Study Period 1||0
3157786|NCT01847443|3884553|FG003|NOT COMPLETED|Study Period 1||0
3157787|NCT01847443|3884550|FG000|STARTED|Washout Period Before Study Period 2||21
3157788|NCT01847443|3884551|FG001|STARTED|Washout Period Before Study Period 2||20
3157789|NCT01847443|3884552|FG002|STARTED|Washout Period Before Study Period 2||21
3157790|NCT01847443|3884553|FG003|STARTED|Washout Period Before Study Period 2||21
3157791|NCT01847443|3884550|FG000|COMPLETED|Washout Period Before Study Period 2||19
3157792|NCT01847443|3884551|FG001|COMPLETED|Washout Period Before Study Period 2||19
3157793|NCT01847443|3884552|FG002|COMPLETED|Washout Period Before Study Period 2||21
3157794|NCT01847443|3884553|FG003|COMPLETED|Washout Period Before Study Period 2||21
3157795|NCT01847443|3884550|FG000|NOT COMPLETED|Washout Period Before Study Period 2||2
3157796|NCT01847443|3884551|FG001|NOT COMPLETED|Washout Period Before Study Period 2||1
3157797|NCT01847443|3884552|FG002|NOT COMPLETED|Washout Period Before Study Period 2||0
3157798|NCT01847443|3884553|FG003|NOT COMPLETED|Washout Period Before Study Period 2||0
3157799|NCT01847443|3884550|FG000|STARTED|Study Period 2||19
3157800|NCT01847443|3884551|FG001|STARTED|Study Period 2||19
3157801|NCT01847443|3884552|FG002|STARTED|Study Period 2||21
3157802|NCT01847443|3884553|FG003|STARTED|Study Period 2||21
3157803|NCT01847443|3884550|FG000|COMPLETED|Study Period 2||19
3157804|NCT01847443|3884551|FG001|COMPLETED|Study Period 2||19
3157805|NCT01847443|3884552|FG002|COMPLETED|Study Period 2||21
3157806|NCT01847443|3884553|FG003|COMPLETED|Study Period 2||21
3157807|NCT01847443|3884550|FG000|NOT COMPLETED|Study Period 2||0
3157808|NCT01847443|3884551|FG001|NOT COMPLETED|Study Period 2||0
3157809|NCT01847443|3884552|FG002|NOT COMPLETED|Study Period 2||0
3157810|NCT01847443|3884553|FG003|NOT COMPLETED|Study Period 2||0
3157811|NCT01847443|3884550|FG000|STARTED|Washout Period Before Study Period 3||19
3157812|NCT01847443|3884551|FG001|STARTED|Washout Period Before Study Period 3||19
3157813|NCT01847443|3884552|FG002|STARTED|Washout Period Before Study Period 3||21
3157814|NCT01847443|3884553|FG003|STARTED|Washout Period Before Study Period 3||21
3157815|NCT01847443|3884550|FG000|COMPLETED|Washout Period Before Study Period 3||18
3157816|NCT01847443|3884551|FG001|COMPLETED|Washout Period Before Study Period 3||19
3157817|NCT01847443|3884552|FG002|COMPLETED|Washout Period Before Study Period 3||21
3157818|NCT01847443|3884553|FG003|COMPLETED|Washout Period Before Study Period 3||21
3157819|NCT01847443|3884550|FG000|NOT COMPLETED|Washout Period Before Study Period 3||1
3157820|NCT01847443|3884551|FG001|NOT COMPLETED|Washout Period Before Study Period 3||0
3157821|NCT01847443|3884552|FG002|NOT COMPLETED|Washout Period Before Study Period 3||0
3157822|NCT01847443|3884553|FG003|NOT COMPLETED|Washout Period Before Study Period 3||0
3157823|NCT01847443|3884550|FG000|STARTED|Study Period 3||18
3157824|NCT01847443|3884551|FG001|STARTED|Study Period 3||19
3157825|NCT01847443|3884552|FG002|STARTED|Study Period 3||21
3157826|NCT01847443|3884553|FG003|STARTED|Study Period 3||21
3157827|NCT01847443|3884550|FG000|COMPLETED|Study Period 3||18
3157828|NCT01847443|3884551|FG001|COMPLETED|Study Period 3||19
3157829|NCT01847443|3884552|FG002|COMPLETED|Study Period 3||21
3157830|NCT01847443|3884553|FG003|COMPLETED|Study Period 3||21
3157831|NCT01847443|3884550|FG000|NOT COMPLETED|Study Period 3||0
3157832|NCT01847443|3884551|FG001|NOT COMPLETED|Study Period 3||0
3157833|NCT01847443|3884552|FG002|NOT COMPLETED|Study Period 3||0
3157834|NCT01847443|3884553|FG003|NOT COMPLETED|Study Period 3||0
3157835|NCT01847443|3884550|FG000|STARTED|Washout Period Before Study Period 4||18
3157836|NCT01847443|3884551|FG001|STARTED|Washout Period Before Study Period 4||19
3157837|NCT01847443|3884552|FG002|STARTED|Washout Period Before Study Period 4||21
3157838|NCT01847443|3884553|FG003|STARTED|Washout Period Before Study Period 4||21
3157839|NCT01847443|3884550|FG000|COMPLETED|Washout Period Before Study Period 4||16
3157840|NCT01847443|3884551|FG001|COMPLETED|Washout Period Before Study Period 4||19
3157841|NCT01847443|3884552|FG002|COMPLETED|Washout Period Before Study Period 4||21
3157842|NCT01847443|3884553|FG003|COMPLETED|Washout Period Before Study Period 4||21
3157843|NCT01847443|3884550|FG000|NOT COMPLETED|Washout Period Before Study Period 4||2
3157844|NCT01847443|3884551|FG001|NOT COMPLETED|Washout Period Before Study Period 4||0
3157845|NCT01847443|3884552|FG002|NOT COMPLETED|Washout Period Before Study Period 4||0
3157846|NCT01847443|3884553|FG003|NOT COMPLETED|Washout Period Before Study Period 4||0
3157847|NCT01847443|3884550|FG000|STARTED|Study Period 4||16
3157848|NCT01847443|3884551|FG001|STARTED|Study Period 4||19
3157849|NCT01847443|3884552|FG002|STARTED|Study Period 4||21
3157850|NCT01847443|3884553|FG003|STARTED|Study Period 4||21
3157851|NCT01847443|3884550|FG000|COMPLETED|Study Period 4||16
3185360|NCT02019667|3913555|FG001|COMPLETED|2nd Intervention (6 Months)||6
3185361|NCT02019667|3913554|FG000|NOT COMPLETED|2nd Intervention (6 Months)||0
3185362|NCT02019667|3913555|FG001|NOT COMPLETED|2nd Intervention (6 Months)||2
3185363|NCT02019667|3913554|FG000|STARTED|Washout Period (9 Weeks)||10
3185364|NCT02019667|3913555|FG001|STARTED|Washout Period (9 Weeks)||6
3185365|NCT02019667|3913554|FG000|COMPLETED|Washout Period (9 Weeks)||10
3185366|NCT02019667|3913555|FG001|COMPLETED|Washout Period (9 Weeks)||6
3185367|NCT02019667|3913554|FG000|NOT COMPLETED|Washout Period (9 Weeks)||0
3185368|NCT02019667|3913555|FG001|NOT COMPLETED|Washout Period (9 Weeks)||0
3185369|NCT02019719|3913568|FG000|STARTED|Overall Study||19
3185370|NCT02019719|3913569|FG001|STARTED|Overall Study||19
3185371|NCT02019719|3913570|FG002|STARTED|Overall Study||20
3185372|NCT02019719|3913571|FG003|STARTED|Overall Study||19
3185373|NCT02019719|3913572|FG004|STARTED|Overall Study||20
3185374|NCT02019719|3913568|FG000|COMPLETED|Overall Study||13
3185375|NCT02019719|3913569|FG001|COMPLETED|Overall Study||18
3185376|NCT02019719|3913570|FG002|COMPLETED|Overall Study||20
3185377|NCT02019719|3913571|FG003|COMPLETED|Overall Study||17
3185378|NCT02019719|3913572|FG004|COMPLETED|Overall Study||18
3185379|NCT02019719|3913568|FG000|NOT COMPLETED|Overall Study||6
3185380|NCT02019719|3913569|FG001|NOT COMPLETED|Overall Study||1
3185381|NCT02019719|3913570|FG002|NOT COMPLETED|Overall Study||0
3185382|NCT02019719|3913571|FG003|NOT COMPLETED|Overall Study||2
3185383|NCT02019719|3913572|FG004|NOT COMPLETED|Overall Study||2
3185384|NCT02019758|3913593|FG000|STARTED|Overall Study|64 received intervention; 1 did not receive intervention|65
3185385|NCT02019758|3913594|FG001|STARTED|Overall Study|63 received intervention; 1 did not receive intervention|64
3185386|NCT02019758|3913593|FG000|Received Intervention|Overall Study||64
3185387|NCT02019758|3913594|FG001|Received Intervention|Overall Study||63
3185388|NCT02019758|3913593|FG000|Did Not Receive Intervention|Overall Study||1
3185389|NCT02019758|3913594|FG001|Did Not Receive Intervention|Overall Study||1
3185390|NCT02019758|3913593|FG000|Lost to Follow-up|Overall Study|8 were lost to follow-up and did not undergo week 8 endoscopy or other outcome assessments|8
3185391|NCT02019758|3913594|FG001|Lost to Follow-up|Overall Study|8 were lost to follow-up and did not undergo week 8 endoscopy or other outcome assessments|8
3185392|NCT02019758|3913593|FG000|COMPLETED|Overall Study||56
3185393|NCT02019758|3913594|FG001|COMPLETED|Overall Study|8 were lost to follow-up and did not undergo week 8 endoscopy or other outcome assessments|55
3185394|NCT02019758|3913593|FG000|NOT COMPLETED|Overall Study||9
3185395|NCT02019758|3913594|FG001|NOT COMPLETED|Overall Study||9
3185396|NCT02019888|3913603|FG000|STARTED|Overall Study||148
3185397|NCT02019888|3913604|FG001|STARTED|Overall Study||113
3185398|NCT02019888|3913605|FG002|STARTED|Overall Study||59
3185399|NCT02019888|3913603|FG000|COMPLETED|Overall Study||108
3185400|NCT02019888|3913604|FG001|COMPLETED|Overall Study||83
3185401|NCT02019888|3913605|FG002|COMPLETED|Overall Study||54
3185402|NCT02019888|3913603|FG000|NOT COMPLETED|Overall Study||40
3185403|NCT02019888|3913604|FG001|NOT COMPLETED|Overall Study||30
3185404|NCT02019888|3913605|FG002|NOT COMPLETED|Overall Study||5
3185405|NCT02019927|3913619|FG000|STARTED|Overall Study||46
3185406|NCT02019927|3913620|FG001|STARTED|Overall Study||23
3185407|NCT02019927|3913621|FG002|STARTED|Overall Study||9
3185408|NCT02019927|3913622|FG003|STARTED|Overall Study||5
3185409|NCT02019927|3913623|FG004|STARTED|Overall Study||10
3185410|NCT02019927|3913624|FG005|STARTED|Overall Study||4
3185411|NCT02019927|3913619|FG000|COMPLETED|Overall Study||44
3185412|NCT02019927|3913620|FG001|COMPLETED|Overall Study||19
3157852|NCT01847443|3884551|FG001|COMPLETED|Study Period 4||19
3157853|NCT01847443|3884552|FG002|COMPLETED|Study Period 4||21
3157854|NCT01847443|3884553|FG003|COMPLETED|Study Period 4||21
3157855|NCT01847443|3884550|FG000|NOT COMPLETED|Study Period 4||0
3157856|NCT01847443|3884551|FG001|NOT COMPLETED|Study Period 4||0
3157857|NCT01847443|3884552|FG002|NOT COMPLETED|Study Period 4||0
3157858|NCT01847443|3884553|FG003|NOT COMPLETED|Study Period 4||0
3157859|NCT01847469|3884567|FG000|STARTED|Overall Study||18
3157860|NCT01847469|3884568|FG001|STARTED|Overall Study||6
3157861|NCT01847469|3884567|FG000|COMPLETED|Overall Study||9
3157862|NCT01847469|3884568|FG001|COMPLETED|Overall Study||3
3157863|NCT01847469|3884567|FG000|NOT COMPLETED|Overall Study||9
3157864|NCT01847469|3884568|FG001|NOT COMPLETED|Overall Study||3
3157865|NCT01847547|3884576|FG000|STARTED|Overall Study||2991
3157866|NCT01847547|3884577|FG001|STARTED|Overall Study||2991
3157867|NCT01847547|3884576|FG000|COMPLETED|Overall Study||2991
3157868|NCT01847547|3884577|FG001|COMPLETED|Overall Study||2991
3157869|NCT01847547|3884576|FG000|NOT COMPLETED|Overall Study||0
3157870|NCT01847547|3884577|FG001|NOT COMPLETED|Overall Study||0
3157871|NCT01847560|3884594|FG000|STARTED|Overall Study||13464
3157872|NCT01847560|3884595|FG001|STARTED|Overall Study||19955
3157873|NCT01847560|3884596|FG002|STARTED|Overall Study||9731
3157874|NCT01847560|3884597|FG003|STARTED|Overall Study||56655
3157875|NCT01847560|3884598|FG004|STARTED|Overall Study||27731
3157876|NCT01847560|3884599|FG005|STARTED|Overall Study||28343
3157877|NCT01847560|3884600|FG006|STARTED|Overall Study||40971
3157878|NCT01847560|3884601|FG007|STARTED|Overall Study||19829
3157879|NCT01847560|3884602|FG008|STARTED|Overall Study||77547
3157880|NCT01847560|3884603|FG009|STARTED|Overall Study||39438
3157881|NCT01847560|3884594|FG000|COMPLETED|Overall Study||13464
3157882|NCT01847560|3884595|FG001|COMPLETED|Overall Study||19955
3157883|NCT01847560|3884596|FG002|COMPLETED|Overall Study||9731
3157884|NCT01847560|3884597|FG003|COMPLETED|Overall Study||56655
3157885|NCT01847560|3884598|FG004|COMPLETED|Overall Study||27731
3157886|NCT01847560|3884599|FG005|COMPLETED|Overall Study||28343
3157887|NCT01847560|3884600|FG006|COMPLETED|Overall Study||40971
3157888|NCT01847560|3884601|FG007|COMPLETED|Overall Study||19829
3157889|NCT01847560|3884602|FG008|COMPLETED|Overall Study||77547
3157890|NCT01847560|3884603|FG009|COMPLETED|Overall Study||39438
3157891|NCT01847560|3884594|FG000|NOT COMPLETED|Overall Study||0
3157892|NCT01847560|3884595|FG001|NOT COMPLETED|Overall Study||0
3157893|NCT01847560|3884596|FG002|NOT COMPLETED|Overall Study||0
3157894|NCT01847560|3884597|FG003|NOT COMPLETED|Overall Study||0
3157895|NCT01847560|3884598|FG004|NOT COMPLETED|Overall Study||0
3157896|NCT01847560|3884599|FG005|NOT COMPLETED|Overall Study||0
3157897|NCT01847560|3884600|FG006|NOT COMPLETED|Overall Study||0
3157898|NCT01847560|3884601|FG007|NOT COMPLETED|Overall Study||0
3157899|NCT01847560|3884602|FG008|NOT COMPLETED|Overall Study||0
3157900|NCT01847560|3884603|FG009|NOT COMPLETED|Overall Study||0
3157901|NCT01847638|3884647|FG000|STARTED|Overall Study||25
3157902|NCT01847638|3884648|FG001|STARTED|Overall Study||25
3157903|NCT01847638|3884647|FG000|COMPLETED|Overall Study||25
3157904|NCT01847638|3884648|FG001|COMPLETED|Overall Study||25
3157905|NCT01847638|3884647|FG000|NOT COMPLETED|Overall Study||0
3157906|NCT01847638|3884648|FG001|NOT COMPLETED|Overall Study||0
3157907|NCT01847755|3884654|FG000|STARTED|Overall Study||18
3157908|NCT01847755|3884654|FG000|COMPLETED|Overall Study||13
3157909|NCT01847755|3884654|FG000|NOT COMPLETED|Overall Study||5
3157910|NCT01847885|3884660|FG000|STARTED|Initial Enrollment (Consented)||88
3157911|NCT01847885|3884661|FG001|STARTED|Initial Enrollment (Consented)||0
3157912|NCT01847885|3884662|FG002|STARTED|Initial Enrollment (Consented)||0
3157913|NCT01847885|3884660|FG000|Randomized|Initial Enrollment (Consented)||46
3157914|NCT01847885|3884661|FG001|Randomized|Initial Enrollment (Consented)||0
3157915|NCT01847885|3884662|FG002|Randomized|Initial Enrollment (Consented)||0
3157916|NCT01847885|3884660|FG000|Full Analysis Set|Initial Enrollment (Consented)||43
3157917|NCT01847885|3884661|FG001|Full Analysis Set|Initial Enrollment (Consented)||0
3157918|NCT01847885|3884662|FG002|Full Analysis Set|Initial Enrollment (Consented)||0
3157919|NCT01847885|3884660|FG000|Safety Set|Initial Enrollment (Consented)||41
3157920|NCT01847885|3884661|FG001|Safety Set|Initial Enrollment (Consented)||0
3157921|NCT01847885|3884662|FG002|Safety Set|Initial Enrollment (Consented)||0
3157922|NCT01847885|3884660|FG000|Per Protocol Set|Initial Enrollment (Consented)||40
3157923|NCT01847885|3884661|FG001|Per Protocol Set|Initial Enrollment (Consented)||0
3157924|NCT01847885|3884662|FG002|Per Protocol Set|Initial Enrollment (Consented)||0
3157925|NCT01847885|3884660|FG000|COMPLETED|Initial Enrollment (Consented)||40
3157926|NCT01847885|3884661|FG001|COMPLETED|Initial Enrollment (Consented)||0
3157927|NCT01847885|3884662|FG002|COMPLETED|Initial Enrollment (Consented)||0
3157928|NCT01847885|3884660|FG000|NOT COMPLETED|Initial Enrollment (Consented)||48
3157929|NCT01847885|3884661|FG001|NOT COMPLETED|Initial Enrollment (Consented)||0
3157930|NCT01847885|3884662|FG002|NOT COMPLETED|Initial Enrollment (Consented)||0
3157931|NCT01847885|3884660|FG000|STARTED|Randomization||0
3157932|NCT01847885|3884661|FG001|STARTED|Randomization||31
3157933|NCT01847885|3884662|FG002|STARTED|Randomization||15
3157934|NCT01847885|3884660|FG000|Full Analysis Set|Randomization||0
3157935|NCT01847885|3884661|FG001|Full Analysis Set|Randomization||28
3157936|NCT01847885|3884662|FG002|Full Analysis Set|Randomization||15
3157937|NCT01847885|3884660|FG000|Safety Set|Randomization||0
3157938|NCT01847885|3884661|FG001|Safety Set|Randomization||28
3157939|NCT01847885|3884662|FG002|Safety Set|Randomization||13
3157940|NCT01847885|3884660|FG000|Per Protocol Set|Randomization||0
3157941|NCT01847885|3884661|FG001|Per Protocol Set|Randomization||27
3157942|NCT01847885|3884662|FG002|Per Protocol Set|Randomization||13
3157943|NCT01847885|3884660|FG000|COMPLETED|Randomization||0
3157944|NCT01847885|3884661|FG001|COMPLETED|Randomization||27
3157945|NCT01847885|3884662|FG002|COMPLETED|Randomization||13
3157946|NCT01847885|3884660|FG000|NOT COMPLETED|Randomization||0
3157947|NCT01847885|3884661|FG001|NOT COMPLETED|Randomization||4
3157948|NCT01847885|3884662|FG002|NOT COMPLETED|Randomization||2
3157949|NCT01848041|3884677|FG000|STARTED|Overall Study||15
3157950|NCT01848041|3884678|FG001|STARTED|Overall Study||16
3157951|NCT01848041|3884679|FG002|STARTED|Overall Study||15
3157952|NCT01848041|3884677|FG000|COMPLETED|Overall Study||15
3157953|NCT01848041|3884678|FG001|COMPLETED|Overall Study||16
3157954|NCT01848041|3884679|FG002|COMPLETED|Overall Study||15
3157955|NCT01848041|3884677|FG000|NOT COMPLETED|Overall Study||0
3157956|NCT01848041|3884678|FG001|NOT COMPLETED|Overall Study||0
3157957|NCT01848041|3884679|FG002|NOT COMPLETED|Overall Study||0
3157958|NCT01848054|3884692|FG000|STARTED|Induction Phase||155
3157959|NCT01848054|3884693|FG001|STARTED|Induction Phase||155
3157960|NCT01848054|3884692|FG000|COMPLETED|Induction Phase||132
3157961|NCT01848054|3884693|FG001|COMPLETED|Induction Phase||147
3157962|NCT01848054|3884692|FG000|NOT COMPLETED|Induction Phase||23
3157963|NCT01848054|3884693|FG001|NOT COMPLETED|Induction Phase||8
3157964|NCT01848054|3884692|FG000|STARTED|Stabilization/Maintenance||132
3157965|NCT01848054|3884693|FG001|STARTED|Stabilization/Maintenance||147
3185413|NCT02019927|3913621|FG002|COMPLETED|Overall Study||8
3185414|NCT02019927|3913622|FG003|COMPLETED|Overall Study||3
3185415|NCT02019927|3913623|FG004|COMPLETED|Overall Study||7
3185416|NCT02019927|3913624|FG005|COMPLETED|Overall Study||3
3185417|NCT02019927|3913619|FG000|NOT COMPLETED|Overall Study||2
3185418|NCT02019927|3913620|FG001|NOT COMPLETED|Overall Study||4
3185419|NCT02019927|3913621|FG002|NOT COMPLETED|Overall Study||1
3185420|NCT02019927|3913622|FG003|NOT COMPLETED|Overall Study||2
3185421|NCT02019927|3913623|FG004|NOT COMPLETED|Overall Study||3
3185422|NCT02019927|3913624|FG005|NOT COMPLETED|Overall Study||1
3185423|NCT02019940|3913642|FG000|STARTED|Overall Study||18
3185424|NCT02019940|3913642|FG000|COMPLETED|Overall Study||8
3185425|NCT02019940|3913642|FG000|NOT COMPLETED|Overall Study||10
3185426|NCT02019979|3913646|FG000|STARTED|Overall Study||14
3185427|NCT02019979|3913646|FG000|COMPLETED|Overall Study||0
3185428|NCT02019979|3913646|FG000|NOT COMPLETED|Overall Study||14
3185429|NCT02020018|3913652|FG000|STARTED|Overall Study||272
3185430|NCT02020018|3913653|FG001|STARTED|Overall Study||1597
3185431|NCT02020018|3913652|FG000|COMPLETED|Overall Study||272
3185432|NCT02020018|3913653|FG001|COMPLETED|Overall Study||1597
3185433|NCT02020018|3913652|FG000|NOT COMPLETED|Overall Study||0
3185434|NCT02020018|3913653|FG001|NOT COMPLETED|Overall Study||0
3185435|NCT02020031|3913661|FG000|STARTED|Overall Study||11
3185436|NCT02020031|3913662|FG001|STARTED|Overall Study||11
3185437|NCT02020031|3913661|FG000|COMPLETED|Overall Study||10
3185438|NCT02020031|3913662|FG001|COMPLETED|Overall Study||10
3185439|NCT02020031|3913661|FG000|NOT COMPLETED|Overall Study||1
3185440|NCT02020031|3913662|FG001|NOT COMPLETED|Overall Study||1
3185441|NCT02020135|3913670|FG000|STARTED|Overall Study||9
3185442|NCT02020135|3913670|FG000|COMPLETED|Overall Study||0
3185443|NCT02020135|3913670|FG000|NOT COMPLETED|Overall Study||9
3185444|NCT02020252|3913676|FG000|STARTED|Overall Study||120
3185445|NCT02020252|3913676|FG000|COMPLETED|Overall Study||120
3185446|NCT02020252|3913676|FG000|NOT COMPLETED|Overall Study||0
3185447|NCT02020278|3913680|FG000|STARTED|Core Safety Follow-up Component||3
3185448|NCT02020278|3913680|FG000|COMPLETED|Core Safety Follow-up Component||3
3185449|NCT02020278|3913680|FG000|NOT COMPLETED|Core Safety Follow-up Component||0
3185450|NCT02020278|3913680|FG000|STARTED|Optional Tolvaptan Treatment Component||0
3185451|NCT02020278|3913680|FG000|COMPLETED|Optional Tolvaptan Treatment Component||0
3185452|NCT02020278|3913680|FG000|NOT COMPLETED|Optional Tolvaptan Treatment Component||0
3185453|NCT02020304|3913688|FG000|STARTED|Overall Study||30
3185454|NCT02020304|3913689|FG001|STARTED|Overall Study||28
3185455|NCT02020304|3913688|FG000|COMPLETED|Overall Study||27
3185456|NCT02020304|3913689|FG001|COMPLETED|Overall Study||26
3185457|NCT02020304|3913688|FG000|NOT COMPLETED|Overall Study||3
3185458|NCT02020304|3913689|FG001|NOT COMPLETED|Overall Study||2
3185459|NCT02020369|3913697|FG000|STARTED|Overall Study||14
3185460|NCT02020369|3913698|FG001|STARTED|Overall Study||13
3185461|NCT02020369|3913697|FG000|COMPLETED|Overall Study||11
3185462|NCT02020369|3913698|FG001|COMPLETED|Overall Study||11
3185463|NCT02020369|3913697|FG000|NOT COMPLETED|Overall Study||3
3185464|NCT02020369|3913698|FG001|NOT COMPLETED|Overall Study||2
3185465|NCT02020408|3913707|FG000|STARTED|Overall Study||88
3185466|NCT02020408|3913707|FG000|COMPLETED|Overall Study||85
3185467|NCT02020408|3913707|FG000|NOT COMPLETED|Overall Study||3
3185468|NCT02020512|3913717|FG000|STARTED|Overall Study||87
3185469|NCT02020512|3913717|FG000|COMPLETED|Overall Study||79
3185470|NCT02020512|3913717|FG000|NOT COMPLETED|Overall Study||8
3185471|NCT02020577|3913723|FG000|STARTED|Overall Study||3
3157966|NCT01848054|3884692|FG000|COMPLETED|Stabilization/Maintenance||92
3157967|NCT01848054|3884693|FG001|COMPLETED|Stabilization/Maintenance||107
3157968|NCT01848054|3884692|FG000|NOT COMPLETED|Stabilization/Maintenance||40
3157969|NCT01848054|3884693|FG001|NOT COMPLETED|Stabilization/Maintenance||40
3157970|NCT01848067|3884703|FG000|STARTED|Overall Study||9
3157971|NCT01848067|3884703|FG000|COMPLETED|Overall Study||9
3157972|NCT01848067|3884703|FG000|NOT COMPLETED|Overall Study||0
3157973|NCT01848145|3884707|FG000|STARTED|Infusion 1: Week 1, Day 1 - 226 Minutes||34
3157974|NCT01848145|3884707|FG000|Completed Within 15min of Infusion Time|Infusion 1: Week 1, Day 1 - 226 Minutes|Number of patients who completed within 15 minutes (min) of infusion time.|1
3157975|NCT01848145|3884707|FG000|COMPLETED|Infusion 1: Week 1, Day 1 - 226 Minutes|Includes participants that completed Infusion 1 and proceeded to the next infusion, Infusion 2.|33
3157976|NCT01848145|3884707|FG000|NOT COMPLETED|Infusion 1: Week 1, Day 1 - 226 Minutes||1
3157977|NCT01848145|3884707|FG000|STARTED|Infusion 2: Week 1, Day 3 - 167 Minutes||33
3157978|NCT01848145|3884707|FG000|Completed Within 15min of Infusion Time|Infusion 2: Week 1, Day 3 - 167 Minutes||24
3157979|NCT01848145|3884707|FG000|COMPLETED|Infusion 2: Week 1, Day 3 - 167 Minutes|Includes participants that completed Infusion 2 and proceeded to the next infusion, Infusion 3.|31
3157980|NCT01848145|3884707|FG000|NOT COMPLETED|Infusion 2: Week 1, Day 3 - 167 Minutes||2
3157981|NCT01848145|3884707|FG000|STARTED|Infusion 3: Week 2, Day 1 - 120 Minutes||31
3157982|NCT01848145|3884707|FG000|Completed Within 15min of Infusion Time|Infusion 3: Week 2, Day 1 - 120 Minutes||26
3157983|NCT01848145|3884707|FG000|COMPLETED|Infusion 3: Week 2, Day 1 - 120 Minutes||30
3157984|NCT01848145|3884707|FG000|NOT COMPLETED|Infusion 3: Week 2, Day 1 - 120 Minutes||1
3157985|NCT01848145|3884707|FG000|STARTED|Subsequent Infusions: Weeks 3-8||30
3157986|NCT01848145|3884707|FG000|COMPLETED|Subsequent Infusions: Weeks 3-8||20
3157987|NCT01848145|3884707|FG000|NOT COMPLETED|Subsequent Infusions: Weeks 3-8||10
3157988|NCT01848158|3884713|FG000|STARTED|Overall Study||10
3157989|NCT01848158|3884714|FG001|STARTED|Overall Study||7
3157990|NCT01848158|3884713|FG000|COMPLETED|Overall Study||10
3157991|NCT01848158|3884714|FG001|COMPLETED|Overall Study||7
3157992|NCT01848158|3884713|FG000|NOT COMPLETED|Overall Study||0
3157993|NCT01848158|3884714|FG001|NOT COMPLETED|Overall Study||0
3157994|NCT01848184|3884720|FG000|STARTED|Overall Study||126
3157995|NCT01848184|3884720|FG000|COMPLETED|Overall Study||100
3157996|NCT01848184|3884720|FG000|NOT COMPLETED|Overall Study||26
3157997|NCT01848210|3884732|FG000|STARTED|Overall Study||411
3157998|NCT01848210|3884733|FG001|STARTED|Overall Study||418
3157999|NCT01848210|3884732|FG000|Safety Population-Received Study Drug|Overall Study||394
3158000|NCT01848210|3884733|FG001|Safety Population-Received Study Drug|Overall Study||398
3158001|NCT01848210|3884732|FG000|Intent-to-Treat (ITT) Population|Overall Study||383
3158002|NCT01848210|3884733|FG001|Intent-to-Treat (ITT) Population|Overall Study||388
3158003|NCT01848210|3884732|FG000|Per Protocol Population|Overall Study||222
3158004|NCT01848210|3884733|FG001|Per Protocol Population|Overall Study||245
3158005|NCT01848210|3884732|FG000|COMPLETED|Overall Study||323
3158006|NCT01848210|3884733|FG001|COMPLETED|Overall Study||340
3158007|NCT01848210|3884732|FG000|NOT COMPLETED|Overall Study||88
3158008|NCT01848210|3884733|FG001|NOT COMPLETED|Overall Study||78
3158009|NCT01848288|3884739|FG000|STARTED|Overall Study||100
3158010|NCT01848288|3884739|FG000|COMPLETED|Overall Study|Two subjects were discontinued prior to undergoing surgery.|97
3158011|NCT01848288|3884739|FG000|NOT COMPLETED|Overall Study||3
3158012|NCT01848353|3884748|FG000|STARTED|Phase 1||38
3158013|NCT01848353|3884749|FG001|STARTED|Phase 1||43
3158014|NCT01848353|3884750|FG002|STARTED|Phase 1||20
3158015|NCT01848353|3884751|FG003|STARTED|Phase 1||19
3158016|NCT01848353|3884748|FG000|COMPLETED|Phase 1||35
3158017|NCT01848353|3884749|FG001|COMPLETED|Phase 1||42
3158018|NCT01848353|3884750|FG002|COMPLETED|Phase 1||20
3158019|NCT01848353|3884751|FG003|COMPLETED|Phase 1||19
3158020|NCT01848353|3884748|FG000|NOT COMPLETED|Phase 1||3
3158021|NCT01848353|3884749|FG001|NOT COMPLETED|Phase 1||1
3158022|NCT01848353|3884750|FG002|NOT COMPLETED|Phase 1||0
3158023|NCT01848353|3884751|FG003|NOT COMPLETED|Phase 1||0
3158024|NCT01848353|3884748|FG000|STARTED|Phase 2|26 participants from Phase 1 intervention (both groups) withdrew and did not complete Phase 2|23
3158025|NCT01848353|3884749|FG001|STARTED|Phase 2|26 participants from Phase 1 intervention (both groups) withdrew and did not complete Phase 2|28
3158026|NCT01848353|3884750|FG002|STARTED|Phase 2|Normal weight participants only completed baseline testing in Phase 1.|0
3158027|NCT01848353|3884751|FG003|STARTED|Phase 2|Normal weight participants only completed baseline testing in Phase 1.|0
3158028|NCT01848353|3884748|FG000|COMPLETED|Phase 2||20
3158029|NCT01848353|3884749|FG001|COMPLETED|Phase 2||26
3158030|NCT01848353|3884750|FG002|COMPLETED|Phase 2||0
3158031|NCT01848353|3884751|FG003|COMPLETED|Phase 2||0
3158032|NCT01848353|3884748|FG000|NOT COMPLETED|Phase 2||3
3158033|NCT01848353|3884749|FG001|NOT COMPLETED|Phase 2||2
3158034|NCT01848353|3884750|FG002|NOT COMPLETED|Phase 2||0
3158035|NCT01848353|3884751|FG003|NOT COMPLETED|Phase 2||0
3158036|NCT01848353|3884748|FG000|STARTED|Phase 3|31 participants from Phase 2 intervention (both groups) withdrew and did not complete Phase 3|5
3158037|NCT01848353|3884749|FG001|STARTED|Phase 3|31 participants from Phase 2 intervention (both groups) withdrew and did not complete Phase 3|10
3158038|NCT01848353|3884750|FG002|STARTED|Phase 3|Normal weight participants only completed baseline testing in Phase 1.|0
3158039|NCT01848353|3884751|FG003|STARTED|Phase 3|Normal weight participants only completed baseline testing in Phase 1.|0
3158040|NCT01848353|3884748|FG000|COMPLETED|Phase 3||4
3158041|NCT01848353|3884749|FG001|COMPLETED|Phase 3||9
3158042|NCT01848353|3884750|FG002|COMPLETED|Phase 3||0
3158043|NCT01848353|3884751|FG003|COMPLETED|Phase 3||0
3158044|NCT01848353|3884748|FG000|NOT COMPLETED|Phase 3||1
3158045|NCT01848353|3884749|FG001|NOT COMPLETED|Phase 3||1
3158046|NCT01848353|3884750|FG002|NOT COMPLETED|Phase 3||0
3158047|NCT01848353|3884751|FG003|NOT COMPLETED|Phase 3||0
3158048|NCT01848366|3884769|FG000|STARTED|Overall Study||8
3158049|NCT01848366|3884769|FG000|COMPLETED|Overall Study||8
3158050|NCT01848366|3884769|FG000|NOT COMPLETED|Overall Study||0
3158051|NCT01848457|3884777|FG000|STARTED|Overall Study||4
3158052|NCT01848457|3884778|FG001|STARTED|Overall Study||3
3158053|NCT01848457|3884779|FG002|STARTED|Overall Study||3
3158054|NCT01848457|3884780|FG003|STARTED|Overall Study||3
3158055|NCT01848457|3884777|FG000|Baseline|Overall Study||4
3158056|NCT01848457|3884778|FG001|Baseline|Overall Study||3
3158057|NCT01848457|3884779|FG002|Baseline|Overall Study||3
3185472|NCT02020577|3913724|FG001|STARTED|Overall Study||55
3185473|NCT02020577|3913723|FG000|COMPLETED|Overall Study||0
3185474|NCT02020577|3913724|FG001|COMPLETED|Overall Study||0
3185475|NCT02020577|3913723|FG000|NOT COMPLETED|Overall Study||3
3185476|NCT02020577|3913724|FG001|NOT COMPLETED|Overall Study||55
3185477|NCT02020590|3913732|FG000|STARTED|Overall Study||22
3185478|NCT02020590|3913732|FG000|COMPLETED|Overall Study||22
3185479|NCT02020590|3913732|FG000|NOT COMPLETED|Overall Study||0
3185480|NCT02020616|3913743|FG000|STARTED|Overall Study||10
3185481|NCT02020616|3913744|FG001|STARTED|Overall Study||8
3185482|NCT02020616|3913745|FG002|STARTED|Overall Study||8
3185483|NCT02020616|3913746|FG003|STARTED|Overall Study||8
3185484|NCT02020616|3913747|FG004|STARTED|Overall Study||8
3185485|NCT02020616|3913748|FG005|STARTED|Overall Study||8
3185486|NCT02020616|3913749|FG006|STARTED|Overall Study||10
3185487|NCT02020616|3913743|FG000|Received at Least One Dose of Study Drug|Overall Study||10
3185488|NCT02020616|3913744|FG001|Received at Least One Dose of Study Drug|Overall Study||8
3185489|NCT02020616|3913745|FG002|Received at Least One Dose of Study Drug|Overall Study||8
3185490|NCT02020616|3913746|FG003|Received at Least One Dose of Study Drug|Overall Study||7
3185491|NCT02020616|3913747|FG004|Received at Least One Dose of Study Drug|Overall Study||8
3185492|NCT02020616|3913748|FG005|Received at Least One Dose of Study Drug|Overall Study||8
3185493|NCT02020616|3913749|FG006|Received at Least One Dose of Study Drug|Overall Study||10
3185494|NCT02020616|3913743|FG000|COMPLETED|Overall Study||10
3185495|NCT02020616|3913744|FG001|COMPLETED|Overall Study||7
3185496|NCT02020616|3913745|FG002|COMPLETED|Overall Study||6
3185497|NCT02020616|3913746|FG003|COMPLETED|Overall Study||6
3185498|NCT02020616|3913747|FG004|COMPLETED|Overall Study||6
3185499|NCT02020616|3913748|FG005|COMPLETED|Overall Study||3
3185500|NCT02020616|3913749|FG006|COMPLETED|Overall Study||6
3185501|NCT02020616|3913743|FG000|NOT COMPLETED|Overall Study||0
3185502|NCT02020616|3913744|FG001|NOT COMPLETED|Overall Study||1
3185503|NCT02020616|3913745|FG002|NOT COMPLETED|Overall Study||2
3185504|NCT02020616|3913746|FG003|NOT COMPLETED|Overall Study||2
3185505|NCT02020616|3913747|FG004|NOT COMPLETED|Overall Study||2
3185506|NCT02020616|3913748|FG005|NOT COMPLETED|Overall Study||5
3185507|NCT02020616|3913749|FG006|NOT COMPLETED|Overall Study||4
3185508|NCT02020785|3913781|FG000|STARTED|First Intervention (3 Weeks)||15
3185509|NCT02020785|3913782|FG001|STARTED|First Intervention (3 Weeks)||16
3185510|NCT02020785|3913781|FG000|COMPLETED|First Intervention (3 Weeks)||15
3185511|NCT02020785|3913782|FG001|COMPLETED|First Intervention (3 Weeks)||16
3185512|NCT02020785|3913781|FG000|NOT COMPLETED|First Intervention (3 Weeks)||0
3185513|NCT02020785|3913782|FG001|NOT COMPLETED|First Intervention (3 Weeks)||0
3185514|NCT02020785|3913781|FG000|STARTED|Second Intervention (3 Weeks)||15
3185515|NCT02020785|3913782|FG001|STARTED|Second Intervention (3 Weeks)||16
3185516|NCT02020785|3913781|FG000|COMPLETED|Second Intervention (3 Weeks)||15
3185517|NCT02020785|3913782|FG001|COMPLETED|Second Intervention (3 Weeks)||16
3185518|NCT02020785|3913781|FG000|NOT COMPLETED|Second Intervention (3 Weeks)||0
3185519|NCT02020785|3913782|FG001|NOT COMPLETED|Second Intervention (3 Weeks)||0
3185520|NCT02020863|3913788|FG000|STARTED|Overall Study||40
3185521|NCT02020863|3913788|FG000|COMPLETED|Overall Study||35
3185522|NCT02020863|3913788|FG000|NOT COMPLETED|Overall Study||5
3185523|NCT02020889|3913794|FG000|STARTED|Overall Study||68
3185524|NCT02020889|3913795|FG001|STARTED|Overall Study||68
3185525|NCT02020889|3913794|FG000|COMPLETED|Overall Study||61
3185526|NCT02020889|3913795|FG001|COMPLETED|Overall Study||65
3185527|NCT02020889|3913794|FG000|NOT COMPLETED|Overall Study||7
3185528|NCT02020889|3913795|FG001|NOT COMPLETED|Overall Study||3
3185529|NCT02020941|3913801|FG000|STARTED|Overall Study||10
3185530|NCT02020941|3913801|FG000|COMPLETED|Overall Study||2
3185531|NCT02020941|3913801|FG000|NOT COMPLETED|Overall Study||8
3185532|NCT02020967|3913807|FG000|STARTED|Overall Study||367
3185533|NCT02020967|3913807|FG000|Examined Participants|Overall Study||329
3185534|NCT02020967|3913807|FG000|COMPLETED|Overall Study||316
3185535|NCT02020967|3913807|FG000|NOT COMPLETED|Overall Study||51
3185536|NCT02021071|3913815|FG000|STARTED|Overall Study||12
3185537|NCT02021071|3913816|FG001|STARTED|Overall Study||12
3185538|NCT02021071|3913815|FG000|COMPLETED|Overall Study||12
3185539|NCT02021071|3913816|FG001|COMPLETED|Overall Study||12
3185540|NCT02021071|3913815|FG000|NOT COMPLETED|Overall Study||0
3363884|NCT04039919|4095089|FG002|STARTED|Treatment Period 1||5
3158058|NCT01848457|3884780|FG003|Baseline|Overall Study||3
3158059|NCT01848457|3884777|FG000|Cycle 1|Overall Study||4
3158060|NCT01848457|3884778|FG001|Cycle 1|Overall Study||3
3158061|NCT01848457|3884779|FG002|Cycle 1|Overall Study||3
3158062|NCT01848457|3884780|FG003|Cycle 1|Overall Study||3
3158063|NCT01848457|3884777|FG000|Cycle 2|Overall Study||3
3158064|NCT01848457|3884778|FG001|Cycle 2|Overall Study||3
3158065|NCT01848457|3884779|FG002|Cycle 2|Overall Study||3
3158066|NCT01848457|3884780|FG003|Cycle 2|Overall Study||3
3185541|NCT02021071|3913816|FG001|NOT COMPLETED|Overall Study||0
3185542|NCT02021292|3913825|FG000|STARTED|Overall Study||40
3185543|NCT02021292|3913826|FG001|STARTED|Overall Study||40
3185544|NCT02021292|3913825|FG000|COMPLETED|Overall Study||40
3158067|NCT01848457|3884777|FG000|Cycle 3|Overall Study||3
3158068|NCT01848457|3884778|FG001|Cycle 3|Overall Study||3
3158069|NCT01848457|3884779|FG002|Cycle 3|Overall Study||3
3158070|NCT01848457|3884780|FG003|Cycle 3|Overall Study||3
3158071|NCT01848457|3884777|FG000|Cycle 4|Overall Study||3
3158072|NCT01848457|3884778|FG001|Cycle 4|Overall Study||3
3158073|NCT01848457|3884779|FG002|Cycle 4|Overall Study||3
3158074|NCT01848457|3884780|FG003|Cycle 4|Overall Study||3
3158075|NCT01848457|3884777|FG000|COMPLETED|Overall Study||3
3158076|NCT01848457|3884778|FG001|COMPLETED|Overall Study||3
3158077|NCT01848457|3884779|FG002|COMPLETED|Overall Study||3
3158078|NCT01848457|3884780|FG003|COMPLETED|Overall Study||3
3158079|NCT01848457|3884777|FG000|NOT COMPLETED|Overall Study||1
3158080|NCT01848457|3884778|FG001|NOT COMPLETED|Overall Study||0
3158081|NCT01848457|3884779|FG002|NOT COMPLETED|Overall Study||0
3158082|NCT01848457|3884780|FG003|NOT COMPLETED|Overall Study||0
3158083|NCT01848483|3884800|FG000|STARTED|Overall Study||61
3158084|NCT01848483|3884801|FG001|STARTED|Overall Study||60
3158085|NCT01848483|3884800|FG000|COMPLETED|Overall Study||50
3158086|NCT01848483|3884801|FG001|COMPLETED|Overall Study||49
3158087|NCT01848483|3884800|FG000|NOT COMPLETED|Overall Study||11
3158088|NCT01848483|3884801|FG001|NOT COMPLETED|Overall Study||11
3158089|NCT01848756|3884808|FG000|STARTED|Overall Study||15
3158090|NCT01848756|3884808|FG000|COMPLETED|Overall Study|Cycle 1|12
3158091|NCT01848756|3884808|FG000|NOT COMPLETED|Overall Study||3
3158092|NCT01848821|3884815|FG000|STARTED|Overall Study||7
3158093|NCT01848821|3884816|FG001|STARTED|Overall Study||7
3158094|NCT01848821|3884815|FG000|COMPLETED|Overall Study||7
3158095|NCT01848821|3884816|FG001|COMPLETED|Overall Study||7
3158096|NCT01848821|3884815|FG000|NOT COMPLETED|Overall Study||0
3158097|NCT01848821|3884816|FG001|NOT COMPLETED|Overall Study||0
3158098|NCT01848834|3884827|FG000|STARTED|Overall Study||32
3158099|NCT01848834|3884828|FG001|STARTED|Overall Study||61
3158100|NCT01848834|3884829|FG002|STARTED|Overall Study||33
3158101|NCT01848834|3884830|FG003|STARTED|Overall Study||39
3158102|NCT01848834|3884831|FG004|STARTED|Overall Study||132
3158103|NCT01848834|3884827|FG000|Treated|Overall Study||32
3158104|NCT01848834|3884828|FG001|Treated|Overall Study||60
3158105|NCT01848834|3884829|FG002|Treated|Overall Study||33
3158106|NCT01848834|3884830|FG003|Treated|Overall Study||39
3158107|NCT01848834|3884831|FG004|Treated|Overall Study||132
3158108|NCT01848834|3884827|FG000|COMPLETED|Overall Study|Completed means two-year treatment completed|13
3158109|NCT01848834|3884828|FG001|COMPLETED|Overall Study|Completed means two-year treatment completed|13
3158110|NCT01848834|3884829|FG002|COMPLETED|Overall Study|Completed means two-year treatment completed|9
3158111|NCT01848834|3884830|FG003|COMPLETED|Overall Study|Completed means two-year treatment completed|13
3158112|NCT01848834|3884831|FG004|COMPLETED|Overall Study|Completed means two-year treatment completed|38
3158113|NCT01848834|3884827|FG000|NOT COMPLETED|Overall Study||19
3158114|NCT01848834|3884828|FG001|NOT COMPLETED|Overall Study||48
3158115|NCT01848834|3884829|FG002|NOT COMPLETED|Overall Study||24
3158116|NCT01848834|3884830|FG003|NOT COMPLETED|Overall Study||26
3158117|NCT01848834|3884831|FG004|NOT COMPLETED|Overall Study||94
3158118|NCT01848847|3884849|FG000|STARTED|Overall Study||51
3158119|NCT01848847|3884850|FG001|STARTED|Overall Study||51
3158120|NCT01848847|3884849|FG000|COMPLETED|Overall Study||49
3158121|NCT01848847|3884850|FG001|COMPLETED|Overall Study||48
3158122|NCT01848847|3884849|FG000|NOT COMPLETED|Overall Study||2
3158123|NCT01848847|3884850|FG001|NOT COMPLETED|Overall Study||3
3158124|NCT01848899|3884858|FG000|STARTED|Overall Study||50
3158125|NCT01848899|3884859|FG001|STARTED|Overall Study||50
3158126|NCT01848899|3884858|FG000|COMPLETED|Overall Study||50
3158127|NCT01848899|3884859|FG001|COMPLETED|Overall Study||50
3158128|NCT01848899|3884858|FG000|NOT COMPLETED|Overall Study||0
3158129|NCT01848899|3884859|FG001|NOT COMPLETED|Overall Study||0
3158130|NCT01848938|3884867|FG000|STARTED|Overall Study||62
3158131|NCT01848938|3884868|FG001|STARTED|Overall Study||61
3158132|NCT01848938|3884867|FG000|COMPLETED|Overall Study||61
3158133|NCT01848938|3884868|FG001|COMPLETED|Overall Study||60
3158134|NCT01848938|3884867|FG000|NOT COMPLETED|Overall Study||1
3158135|NCT01848938|3884868|FG001|NOT COMPLETED|Overall Study||1
3158136|NCT01848977|3884874|FG000|STARTED|Overall Study||20
3158137|NCT01848977|3884874|FG000|COMPLETED|Overall Study||20
3158138|NCT01848977|3884874|FG000|NOT COMPLETED|Overall Study||0
3158139|NCT01848990|3884886|FG000|STARTED|Overall Study||227
3158140|NCT01848990|3884887|FG001|STARTED|Overall Study||115
3158141|NCT01848990|3884888|FG002|STARTED|Overall Study|One participant was randomized and withdrew consent before start of study treatment.|114
3158142|NCT01848990|3884886|FG000|Received at Least 1 Dose of Study Drug|Overall Study||227
3158143|NCT01848990|3884887|FG001|Received at Least 1 Dose of Study Drug|Overall Study||115
3158144|NCT01848990|3884888|FG002|Received at Least 1 Dose of Study Drug|Overall Study||113
3158145|NCT01848990|3884886|FG000|Completed Month 6|Overall Study||194
3158146|NCT01848990|3884887|FG001|Completed Month 6|Overall Study||106
3158147|NCT01848990|3884888|FG002|Completed Month 6|Overall Study||103
3158148|NCT01848990|3884886|FG000|COMPLETED|Overall Study||181
3158149|NCT01848990|3884887|FG001|COMPLETED|Overall Study||95
3158150|NCT01848990|3884888|FG002|COMPLETED|Overall Study||98
3158151|NCT01848990|3884886|FG000|NOT COMPLETED|Overall Study||46
3158152|NCT01848990|3884887|FG001|NOT COMPLETED|Overall Study||20
3158153|NCT01848990|3884888|FG002|NOT COMPLETED|Overall Study||16
3158154|NCT01849055|3884906|FG000|STARTED|Overall Study||8
3158155|NCT01849055|3884907|FG001|STARTED|Overall Study||8
3158156|NCT01849055|3884908|FG002|STARTED|Overall Study||8
3158157|NCT01849055|3884909|FG003|STARTED|Overall Study||8
3158158|NCT01849055|3884910|FG004|STARTED|Overall Study||8
3158159|NCT01849055|3884911|FG005|STARTED|Overall Study||8
3158160|NCT01849055|3884906|FG000|COMPLETED|Overall Study||8
3158161|NCT01849055|3884907|FG001|COMPLETED|Overall Study||8
3158162|NCT01849055|3884908|FG002|COMPLETED|Overall Study||7
3158163|NCT01849055|3884909|FG003|COMPLETED|Overall Study||8
3158164|NCT01849055|3884910|FG004|COMPLETED|Overall Study||8
3158165|NCT01849055|3884911|FG005|COMPLETED|Overall Study||8
3158166|NCT01849055|3884906|FG000|NOT COMPLETED|Overall Study||0
3158167|NCT01849055|3884907|FG001|NOT COMPLETED|Overall Study||0
3158168|NCT01849055|3884908|FG002|NOT COMPLETED|Overall Study||1
3158169|NCT01849055|3884909|FG003|NOT COMPLETED|Overall Study||0
3158170|NCT01849055|3884910|FG004|NOT COMPLETED|Overall Study||0
3158171|NCT01849055|3884911|FG005|NOT COMPLETED|Overall Study||0
3158172|NCT01849068|3884931|FG000|STARTED|Overall Study||10
3158173|NCT01849068|3884932|FG001|STARTED|Overall Study||10
3158174|NCT01849068|3884931|FG000|COMPLETED|Overall Study||10
3158175|NCT01849068|3884932|FG001|COMPLETED|Overall Study||10
3158176|NCT01849068|3884931|FG000|NOT COMPLETED|Overall Study||0
3158177|NCT01849068|3884932|FG001|NOT COMPLETED|Overall Study||0
3158178|NCT01849172|3884940|FG000|STARTED|Overall Study||180
3158179|NCT01849172|3884941|FG001|STARTED|Overall Study||180
3158180|NCT01849172|3884940|FG000|COMPLETED|Overall Study||173
3185545|NCT02021292|3913826|FG001|COMPLETED|Overall Study||37
3185546|NCT02021292|3913825|FG000|NOT COMPLETED|Overall Study||0
3185547|NCT02021292|3913826|FG001|NOT COMPLETED|Overall Study||3
3185548|NCT02021318|3913836|FG000|STARTED|Overall Study||323
3185549|NCT02021318|3913837|FG001|STARTED|Overall Study||293
3185550|NCT02021318|3913836|FG000|COMPLETED|Overall Study||250
3185551|NCT02021318|3913837|FG001|COMPLETED|Overall Study||230
3185552|NCT02021318|3913836|FG000|NOT COMPLETED|Overall Study||73
3185553|NCT02021318|3913837|FG001|NOT COMPLETED|Overall Study||63
3185554|NCT02021331|3913846|FG000|STARTED|Overall Study||2
3185555|NCT02021331|3913847|FG001|STARTED|Overall Study||3
3185556|NCT02021331|3913846|FG000|COMPLETED|Overall Study||2
3185557|NCT02021331|3913847|FG001|COMPLETED|Overall Study||1
3185558|NCT02021331|3913846|FG000|NOT COMPLETED|Overall Study||0
3185559|NCT02021331|3913847|FG001|NOT COMPLETED|Overall Study||2
3185560|NCT02021461|3913853|FG000|STARTED|Overall Study||38
3185561|NCT02021461|3913853|FG000|COMPLETED|Overall Study||38
3185562|NCT02021461|3913853|FG000|NOT COMPLETED|Overall Study||0
3185563|NCT02021565|3913861|FG000|STARTED|Baseline Through Intervention||72
3185564|NCT02021565|3913862|FG001|STARTED|Baseline Through Intervention||54
3185565|NCT02021565|3913861|FG000|Caregivers|Baseline Through Intervention||36
3185566|NCT02021565|3913862|FG001|Caregivers|Baseline Through Intervention||27
3185567|NCT02021565|3913861|FG000|Care Recipients|Baseline Through Intervention||36
3185568|NCT02021565|3913862|FG001|Care Recipients|Baseline Through Intervention||27
3185569|NCT02021565|3913861|FG000|COMPLETED|Baseline Through Intervention||60
3185570|NCT02021565|3913862|FG001|COMPLETED|Baseline Through Intervention||36
3185571|NCT02021565|3913861|FG000|NOT COMPLETED|Baseline Through Intervention||12
3185572|NCT02021565|3913862|FG001|NOT COMPLETED|Baseline Through Intervention||18
3185573|NCT02021565|3913861|FG000|STARTED|3-month Follow-up||60
3185574|NCT02021565|3913862|FG001|STARTED|3-month Follow-up||36
3185575|NCT02021565|3913861|FG000|Caregivers|3-month Follow-up||30
3185576|NCT02021565|3913862|FG001|Caregivers|3-month Follow-up||18
3185577|NCT02021565|3913861|FG000|Care Recipients|3-month Follow-up||30
3185578|NCT02021565|3913862|FG001|Care Recipients|3-month Follow-up||18
3185579|NCT02021565|3913861|FG000|COMPLETED|3-month Follow-up||50
3185580|NCT02021565|3913862|FG001|COMPLETED|3-month Follow-up||34
3185581|NCT02021565|3913861|FG000|NOT COMPLETED|3-month Follow-up||10
3185582|NCT02021565|3913862|FG001|NOT COMPLETED|3-month Follow-up||2
3185583|NCT02021643|3913876|FG000|STARTED|Overall Study||156
3185584|NCT02021643|3913877|FG001|STARTED|Overall Study||290
3185585|NCT02021643|3913878|FG002|STARTED|Overall Study||11
3185586|NCT02021643|3913879|FG003|STARTED|Overall Study||230
3185587|NCT02021643|3913876|FG000|COMPLETED|Overall Study||147
3185588|NCT02021643|3913877|FG001|COMPLETED|Overall Study||280
3185589|NCT02021643|3913878|FG002|COMPLETED|Overall Study||11
3185590|NCT02021643|3913879|FG003|COMPLETED|Overall Study||218
3363885|NCT04039919|4095090|FG003|STARTED|Treatment Period 1||6
3363886|NCT04039919|4095091|FG004|STARTED|Treatment Period 1||16
3363887|NCT04039919|4095087|FG000|COMPLETED|Treatment Period 1||6
3363888|NCT04039919|4095088|FG001|COMPLETED|Treatment Period 1||6
3363889|NCT04039919|4095089|FG002|COMPLETED|Treatment Period 1||5
3363890|NCT04039919|4095090|FG003|COMPLETED|Treatment Period 1||6
3158181|NCT01849172|3884941|FG001|COMPLETED|Overall Study||174
3158182|NCT01849172|3884940|FG000|NOT COMPLETED|Overall Study||7
3185591|NCT02021643|3913876|FG000|NOT COMPLETED|Overall Study||9
3185592|NCT02021643|3913877|FG001|NOT COMPLETED|Overall Study||10
3158183|NCT01849172|3884941|FG001|NOT COMPLETED|Overall Study||6
3158184|NCT01849276|3884947|FG000|STARTED|Registered to the Study||2
3158185|NCT01849276|3884947|FG000|COMPLETED|Registered to the Study||2
3185593|NCT02021643|3913878|FG002|NOT COMPLETED|Overall Study||0
3158186|NCT01849276|3884947|FG000|NOT COMPLETED|Registered to the Study||0
3158187|NCT01849276|3884947|FG000|STARTED|Completed Treatment||2
3158188|NCT01849276|3884947|FG000|COMPLETED|Completed Treatment||2
3158189|NCT01849276|3884947|FG000|NOT COMPLETED|Completed Treatment||0
3158190|NCT01849276|3884947|FG000|STARTED|Followed for Survival for 5 Years||2
3158191|NCT01849276|3884947|FG000|COMPLETED|Followed for Survival for 5 Years||0
3158192|NCT01849276|3884947|FG000|NOT COMPLETED|Followed for Survival for 5 Years||2
3158193|NCT01849289|3884953|FG000|STARTED|Overall Study||555
3158194|NCT01849289|3884954|FG001|STARTED|Overall Study||278
3158195|NCT01849289|3884953|FG000|Exposed|Overall Study|2 subjects withdrew prior to exposure of trial products|553
3158196|NCT01849289|3884954|FG001|Exposed|Overall Study||278
3158197|NCT01849289|3884953|FG000|COMPLETED|Overall Study||523
3158198|NCT01849289|3884954|FG001|COMPLETED|Overall Study||254
3158199|NCT01849289|3884953|FG000|NOT COMPLETED|Overall Study||32
3158200|NCT01849289|3884954|FG001|NOT COMPLETED|Overall Study||24
3158201|NCT01849419|3884960|FG000|STARTED|Overall Study||65
3158202|NCT01849419|3884960|FG000|COMPLETED|Overall Study||65
3158203|NCT01849419|3884960|FG000|NOT COMPLETED|Overall Study||0
3158204|NCT01849458|3884965|FG000|STARTED|Overall Study||50
3158205|NCT01849458|3884965|FG000|6 Months Follow-up|Overall Study||50
3158206|NCT01849458|3884965|FG000|COMPLETED|Overall Study||46
3158207|NCT01849458|3884965|FG000|NOT COMPLETED|Overall Study||4
3158208|NCT01849497|3884971|FG000|STARTED|Overall Study||75
3158209|NCT01849497|3884972|FG001|STARTED|Overall Study||74
3158210|NCT01849497|3884971|FG000|Received Treatment|Overall Study||75
3158211|NCT01849497|3884972|FG001|Received Treatment|Overall Study||74
3158212|NCT01849497|3884971|FG000|COMPLETED|Overall Study||74
3158213|NCT01849497|3884972|FG001|COMPLETED|Overall Study||70
3158214|NCT01849497|3884971|FG000|NOT COMPLETED|Overall Study||1
3158215|NCT01849497|3884972|FG001|NOT COMPLETED|Overall Study||4
3158216|NCT01849562|3884981|FG000|STARTED|Overall Study||10
3158217|NCT01849562|3884982|FG001|STARTED|Overall Study||10
3158218|NCT01849562|3884983|FG002|STARTED|Overall Study||10
3158219|NCT01849562|3884981|FG000|COMPLETED|Overall Study||8
3158220|NCT01849562|3884982|FG001|COMPLETED|Overall Study||10
3158221|NCT01849562|3884983|FG002|COMPLETED|Overall Study||10
3158222|NCT01849562|3884981|FG000|NOT COMPLETED|Overall Study||2
3158223|NCT01849562|3884982|FG001|NOT COMPLETED|Overall Study||0
3158224|NCT01849562|3884983|FG002|NOT COMPLETED|Overall Study||0
3158225|NCT01849575|3884994|FG000|STARTED|Overall Study||1749
3158226|NCT01849575|3884995|FG001|STARTED|Overall Study||1783
3158227|NCT01849575|3884994|FG000|COMPLETED|Overall Study||1599
3158228|NCT01849575|3884995|FG001|COMPLETED|Overall Study||1576
3158229|NCT01849575|3884994|FG000|NOT COMPLETED|Overall Study||150
3158230|NCT01849575|3884995|FG001|NOT COMPLETED|Overall Study||207
3158231|NCT01849588|3885003|FG000|STARTED|Overall Study||3
3158232|NCT01849588|3885003|FG000|COMPLETED|Overall Study||0
3158233|NCT01849588|3885003|FG000|NOT COMPLETED|Overall Study||3
3158234|NCT01849692|3885009|FG000|STARTED|Overall Study||10
3158235|NCT01849692|3885010|FG001|STARTED|Overall Study||3
3158236|NCT01849692|3885011|FG002|STARTED|Overall Study||10
3158237|NCT01849692|3885012|FG003|STARTED|Overall Study||3
3158238|NCT01849692|3885013|FG004|STARTED|Overall Study||10
3158239|NCT01849692|3885014|FG005|STARTED|Overall Study||3
3158240|NCT01849692|3885015|FG006|STARTED|Overall Study||10
3158241|NCT01849692|3885016|FG007|STARTED|Overall Study||3
3158242|NCT01849692|3885009|FG000|COMPLETED|Overall Study||10
3158243|NCT01849692|3885010|FG001|COMPLETED|Overall Study||3
3158244|NCT01849692|3885011|FG002|COMPLETED|Overall Study||10
3158245|NCT01849692|3885012|FG003|COMPLETED|Overall Study||3
3158246|NCT01849692|3885013|FG004|COMPLETED|Overall Study||10
3158247|NCT01849692|3885014|FG005|COMPLETED|Overall Study||3
3158248|NCT01849692|3885015|FG006|COMPLETED|Overall Study||10
3158249|NCT01849692|3885016|FG007|COMPLETED|Overall Study||3
3158250|NCT01849692|3885009|FG000|NOT COMPLETED|Overall Study||0
3158251|NCT01849692|3885010|FG001|NOT COMPLETED|Overall Study||0
3158252|NCT01849692|3885011|FG002|NOT COMPLETED|Overall Study||0
3158253|NCT01849692|3885012|FG003|NOT COMPLETED|Overall Study||0
3158254|NCT01849692|3885013|FG004|NOT COMPLETED|Overall Study||0
3158255|NCT01849692|3885014|FG005|NOT COMPLETED|Overall Study||0
3158256|NCT01849692|3885015|FG006|NOT COMPLETED|Overall Study||0
3158257|NCT01849692|3885016|FG007|NOT COMPLETED|Overall Study||0
3158258|NCT01849770|3885040|FG000|STARTED|Overall Study||20
3158259|NCT01849770|3885041|FG001|STARTED|Overall Study||19
3158260|NCT01849770|3885042|FG002|STARTED|Overall Study||20
3158261|NCT01849770|3885040|FG000|COMPLETED|Overall Study||20
3158262|NCT01849770|3885041|FG001|COMPLETED|Overall Study||15
3158263|NCT01849770|3885042|FG002|COMPLETED|Overall Study||19
3158264|NCT01849770|3885040|FG000|NOT COMPLETED|Overall Study||0
3158265|NCT01849770|3885041|FG001|NOT COMPLETED|Overall Study||4
3158266|NCT01849770|3885042|FG002|NOT COMPLETED|Overall Study||1
3158267|NCT01849822|3885052|FG000|STARTED|Overall Study||1
3158268|NCT01849822|3885052|FG000|COMPLETED|Overall Study||1
3158269|NCT01849822|3885052|FG000|NOT COMPLETED|Overall Study||0
3158270|NCT01849848|3885056|FG000|STARTED|Overall Study||17
3158271|NCT01849848|3885056|FG000|COMPLETED|Overall Study||13
3158272|NCT01849848|3885056|FG000|NOT COMPLETED|Overall Study||4
3158273|NCT01849874|3885062|FG000|STARTED|Overall Study||201
3158274|NCT01849874|3885063|FG001|STARTED|Overall Study||102
3158275|NCT01849874|3885062|FG000|Treated|Overall Study||200
3158276|NCT01849874|3885063|FG001|Treated|Overall Study||94
3158277|NCT01849874|3885062|FG000|COMPLETED|Overall Study||0
3158278|NCT01849874|3885063|FG001|COMPLETED|Overall Study||0
3158279|NCT01849874|3885062|FG000|NOT COMPLETED|Overall Study||201
3158280|NCT01849874|3885063|FG001|NOT COMPLETED|Overall Study||102
3158281|NCT01850030|3885071|FG000|STARTED|Overall Study||520
3158282|NCT01850030|3885072|FG001|STARTED|Overall Study||511
3158283|NCT01850030|3885071|FG000|COMPLETED|Overall Study||173
3158284|NCT01850030|3885072|FG001|COMPLETED|Overall Study||142
3158285|NCT01850030|3885071|FG000|NOT COMPLETED|Overall Study||347
3158286|NCT01850030|3885072|FG001|NOT COMPLETED|Overall Study||369
3158287|NCT01850394|3885081|FG000|STARTED|Overall Study||45
3158288|NCT01850394|3885082|FG001|STARTED|Overall Study||45
3158289|NCT01850394|3885083|FG002|STARTED|Overall Study||45
3158290|NCT01850394|3885081|FG000|COMPLETED|Overall Study||45
3158291|NCT01850394|3885082|FG001|COMPLETED|Overall Study||45
3158292|NCT01850394|3885083|FG002|COMPLETED|Overall Study||45
3158293|NCT01850394|3885081|FG000|NOT COMPLETED|Overall Study||0
3158294|NCT01850394|3885082|FG001|NOT COMPLETED|Overall Study||0
3158295|NCT01850394|3885083|FG002|NOT COMPLETED|Overall Study||0
3158296|NCT01850446|3885093|FG000|STARTED|Overall Study||92
3158297|NCT01850446|3885094|FG001|STARTED|Overall Study||92
3158298|NCT01850446|3885093|FG000|COMPLETED|Overall Study||87
3158299|NCT01850446|3885094|FG001|COMPLETED|Overall Study||90
3158300|NCT01850446|3885093|FG000|NOT COMPLETED|Overall Study||5
3158301|NCT01850446|3885094|FG001|NOT COMPLETED|Overall Study||2
3158302|NCT01850485|3885102|FG000|STARTED|Overall Study||9
3158303|NCT01850485|3885103|FG001|STARTED|Overall Study||13
3158304|NCT01850485|3885102|FG000|COMPLETED|Overall Study||9
3158305|NCT01850485|3885103|FG001|COMPLETED|Overall Study||13
3158306|NCT01850485|3885102|FG000|NOT COMPLETED|Overall Study||0
3158307|NCT01850485|3885103|FG001|NOT COMPLETED|Overall Study||0
3158308|NCT01850524|3885111|FG000|STARTED|Overall Study||354
3158309|NCT01850524|3885112|FG001|STARTED|Overall Study||351
3158310|NCT01850524|3885111|FG000|Intent-to-Treat (ITT) Population|Overall Study||354
3158311|NCT01850524|3885112|FG001|Intent-to-Treat (ITT) Population|Overall Study||351
3158312|NCT01850524|3885111|FG000|Safety Population|Overall Study|1 participant in this arm who withdrew from the study was not included in the safety population.|349
3158313|NCT01850524|3885112|FG001|Safety Population|Overall Study|Included 4 participants from placebo who received ixazomib; 1 participant who withdrew was excluded.|354
3158314|NCT01850524|3885111|FG000|Participants Completed Study Treatment Per Protocol|Overall Study||270
3158315|NCT01850524|3885112|FG001|Participants Completed Study Treatment Per Protocol|Overall Study||264
3158316|NCT01850524|3885111|FG000|Per Protocol (PP) Population|Overall Study||295
3158317|NCT01850524|3885112|FG001|Per Protocol (PP) Population|Overall Study||298
3158318|NCT01850524|3885111|FG000|Participants With Exposure of ≥ 19 Cycles|Overall Study||189
3158319|NCT01850524|3885112|FG001|Participants With Exposure of ≥ 19 Cycles|Overall Study||191
3158320|NCT01850524|3885111|FG000|COMPLETED|Overall Study||0
3158321|NCT01850524|3885112|FG001|COMPLETED|Overall Study||0
3158322|NCT01850524|3885111|FG000|NOT COMPLETED|Overall Study||354
3158323|NCT01850524|3885112|FG001|NOT COMPLETED|Overall Study||351
3158324|NCT01850550|3885122|FG000|STARTED|Overall Study||40
3185594|NCT02021643|3913879|FG003|NOT COMPLETED|Overall Study||12
3185595|NCT02021656|3913895|FG000|STARTED|Overall Study||384
3185596|NCT02021656|3913895|FG000|COMPLETED|Overall Study||378
3185597|NCT02021656|3913895|FG000|NOT COMPLETED|Overall Study||6
3185598|NCT02021669|3913905|FG000|STARTED|Overall Study||71
3185599|NCT02021669|3913906|FG001|STARTED|Overall Study||73
3185600|NCT02021669|3913905|FG000|COMPLETED|Overall Study||64
3185601|NCT02021669|3913906|FG001|COMPLETED|Overall Study||70
3185602|NCT02021669|3913905|FG000|NOT COMPLETED|Overall Study||7
3185603|NCT02021669|3913906|FG001|NOT COMPLETED|Overall Study||3
3185604|NCT02021812|3913912|FG000|STARTED|Overall Study||31
3185605|NCT02021812|3913912|FG000|COMPLETED|Overall Study||9
3185606|NCT02021812|3913912|FG000|NOT COMPLETED|Overall Study||22
3185607|NCT02021929|3913918|FG000|STARTED|Overall Study||16
3185608|NCT02021929|3913919|FG001|STARTED|Overall Study||12
3185609|NCT02021929|3913918|FG000|COMPLETED|Overall Study||14
3185610|NCT02021929|3913919|FG001|COMPLETED|Overall Study||11
3185611|NCT02021929|3913918|FG000|NOT COMPLETED|Overall Study||2
3185612|NCT02021929|3913919|FG001|NOT COMPLETED|Overall Study||1
3185613|NCT02021942|3913925|FG000|STARTED|Overall Study||16
3185614|NCT02021942|3913925|FG000|COMPLETED|Overall Study||16
3185615|NCT02021942|3913925|FG000|NOT COMPLETED|Overall Study||0
3185616|NCT02021955|3913932|FG000|STARTED|Step 0|Provider attrition=2; Provider addition=3; Patient discharges=14|210
3185617|NCT02021955|3913933|FG001|STARTED|Step 0|Provider attrition=0; Provider addition=0; Patient discharges=0|0
3185618|NCT02021955|3913932|FG000|COMPLETED|Step 0||210
3185619|NCT02021955|3913933|FG001|COMPLETED|Step 0||0
3185620|NCT02021955|3913932|FG000|NOT COMPLETED|Step 0||0
3185621|NCT02021955|3913933|FG001|NOT COMPLETED|Step 0||0
3185622|NCT02021955|3913932|FG000|STARTED|Step 1|Provider attrition=20; Provider addition=2; Patient discharges=14|193
3185623|NCT02021955|3913933|FG001|STARTED|Step 1|Provider attrition=7; Provider addition=0; Patient discharges: 0|18
3185624|NCT02021955|3913932|FG000|COMPLETED|Step 1||193
3185625|NCT02021955|3913933|FG001|COMPLETED|Step 1||18
3185626|NCT02021955|3913932|FG000|NOT COMPLETED|Step 1||0
3185627|NCT02021955|3913933|FG001|NOT COMPLETED|Step 1||0
3158325|NCT01850550|3885123|FG001|STARTED|Overall Study||40
3158326|NCT01850550|3885122|FG000|COMPLETED|Overall Study||40
3185628|NCT02021955|3913932|FG000|STARTED|Step 2|Provider attrition=5; Provider addition=21; Patient discharges=12|165
3185629|NCT02021955|3913933|FG001|STARTED|Step 2|Provider attrition=2; Provider addition=5; Patient discharges=2|21
3158327|NCT01850550|3885123|FG001|COMPLETED|Overall Study||37
3158328|NCT01850550|3885122|FG000|NOT COMPLETED|Overall Study||0
3158329|NCT01850550|3885123|FG001|NOT COMPLETED|Overall Study||3
3158330|NCT01850589|3885131|FG000|STARTED|Overall Study||22
3158331|NCT01850589|3885132|FG001|STARTED|Overall Study||22
3158332|NCT01850589|3885131|FG000|COMPLETED|Overall Study||14
3158333|NCT01850589|3885132|FG001|COMPLETED|Overall Study||22
3158334|NCT01850589|3885131|FG000|NOT COMPLETED|Overall Study||8
3158335|NCT01850589|3885132|FG001|NOT COMPLETED|Overall Study||0
3158336|NCT01850602|3885140|FG000|STARTED|Overall Study||108
3158337|NCT01850602|3885141|FG001|STARTED|Overall Study||105
3158338|NCT01850602|3885140|FG000|COMPLETED|Overall Study||94
3158339|NCT01850602|3885141|FG001|COMPLETED|Overall Study||87
3158340|NCT01850602|3885140|FG000|NOT COMPLETED|Overall Study||14
3158341|NCT01850602|3885141|FG001|NOT COMPLETED|Overall Study||18
3158342|NCT01850615|3885149|FG000|STARTED|Overall Study||116
3158343|NCT01850615|3885150|FG001|STARTED|Overall Study||120
3158344|NCT01850615|3885149|FG000|Exposed|Overall Study||115
3158345|NCT01850615|3885150|FG001|Exposed|Overall Study||120
3158346|NCT01850615|3885149|FG000|COMPLETED|Overall Study||107
3158347|NCT01850615|3885150|FG001|COMPLETED|Overall Study||115
3158348|NCT01850615|3885149|FG000|NOT COMPLETED|Overall Study||9
3158349|NCT01850615|3885150|FG001|NOT COMPLETED|Overall Study||5
3158350|NCT01850641|3885156|FG000|STARTED|Overall Study||35
3158351|NCT01850641|3885156|FG000|COMPLETED|Overall Study||30
3158352|NCT01850641|3885156|FG000|NOT COMPLETED|Overall Study||5
3158353|NCT01850745|3885163|FG000|STARTED|Overall Study||147
3158354|NCT01850745|3885164|FG001|STARTED|Overall Study||169
3158355|NCT01850745|3885165|FG002|STARTED|Overall Study||131
3158356|NCT01850745|3885163|FG000|COMPLETED|Overall Study||147
3158357|NCT01850745|3885164|FG001|COMPLETED|Overall Study||169
3158358|NCT01850745|3885165|FG002|COMPLETED|Overall Study||131
3158359|NCT01850745|3885163|FG000|NOT COMPLETED|Overall Study||0
3158360|NCT01850745|3885164|FG001|NOT COMPLETED|Overall Study||0
3158361|NCT01850745|3885165|FG002|NOT COMPLETED|Overall Study||0
3158362|NCT01850823|3885176|FG000|STARTED|Overall Study||175
3158363|NCT01850823|3885177|FG001|STARTED|Overall Study||350
3158364|NCT01850823|3885178|FG002|STARTED|Overall Study||355
3158365|NCT01850823|3885176|FG000|COMPLETED|Overall Study||172
3158366|NCT01850823|3885177|FG001|COMPLETED|Overall Study||347
3158367|NCT01850823|3885178|FG002|COMPLETED|Overall Study||345
3158368|NCT01850823|3885176|FG000|NOT COMPLETED|Overall Study||3
3158369|NCT01850823|3885177|FG001|NOT COMPLETED|Overall Study||3
3158370|NCT01850823|3885178|FG002|NOT COMPLETED|Overall Study||10
3158371|NCT01851330|3885191|FG000|STARTED|Overall Study||215
3158372|NCT01851330|3885192|FG001|STARTED|Overall Study||216
3158373|NCT01851330|3885193|FG002|STARTED|Overall Study||216
3158374|NCT01851330|3885191|FG000|COMPLETED|Overall Study||202
3158375|NCT01851330|3885192|FG001|COMPLETED|Overall Study||200
3158376|NCT01851330|3885193|FG002|COMPLETED|Overall Study||204
3158377|NCT01851330|3885191|FG000|NOT COMPLETED|Overall Study||13
3158378|NCT01851330|3885192|FG001|NOT COMPLETED|Overall Study||16
3158379|NCT01851330|3885193|FG002|NOT COMPLETED|Overall Study||12
3158380|NCT01851590|3885204|FG000|STARTED|Overall Study|In addition to clinical control visits, patients were contacted by phone during weeks 6, 13, and 29.|23
3158381|NCT01851590|3885205|FG001|STARTED|Overall Study|In addition to clinical control visits, patients were contacted by phone during weeks 6, 13, and 29.|25
3158382|NCT01851590|3885206|FG002|STARTED|Overall Study|In addition to clinical control visits, patients were contacted by phone during weeks 6, 13, and 29.|25
3158383|NCT01851590|3885204|FG000|At 3 Month: End of Terbinafine Treatment|Overall Study|Topical Resin Lacquer treatment continues ->|23
3158384|NCT01851590|3885205|FG001|At 3 Month: End of Terbinafine Treatment|Overall Study|Topical Amorolfine Lacquer Treatment continues ->|24
3158385|NCT01851590|3885206|FG002|At 3 Month: End of Terbinafine Treatment|Overall Study|End of oral Terbinafine treatment. Washout period of the Terbinafine treatment arm begins.|22
3158386|NCT01851590|3885204|FG000|At 4 Month: Follow-up Visit and Control|Overall Study|Clinical response to treatment, toenails samples and laboratory exams were controlled.|23
3158387|NCT01851590|3885205|FG001|At 4 Month: Follow-up Visit and Control|Overall Study|Clinical response to treatment, toenails samples and laboratory exams were controlled.|24
3158388|NCT01851590|3885206|FG002|At 4 Month: Follow-up Visit and Control|Overall Study|Clinical response to treatment, toenails samples and laboratory exams were controlled.|22
3158389|NCT01851590|3885204|FG000|At 9 Month: End of Topical Treatments|Overall Study|End of topical Resin Lacquer treatment. Washout period of the Resin Lacquer treatment arm begins.|23
3158390|NCT01851590|3885205|FG001|At 9 Month: End of Topical Treatments|Overall Study|End of topical Amorolfine Lacquer treatment. Washout period of the Amorolfine treatment arm begins.|24
3158391|NCT01851590|3885206|FG002|At 9 Month: End of Topical Treatments|Overall Study|Washout period of the Terbinafine treatment arm continues.|22
3158392|NCT01851590|3885204|FG000|At 10 Month: Follow-up Visit and Control|Overall Study|Study completed. Clinical response to treatment, toenails samples and lab. exams were controlled.|23
3185630|NCT02021955|3913932|FG000|COMPLETED|Step 2||165
3185631|NCT02021955|3913933|FG001|COMPLETED|Step 2||21
3185632|NCT02021955|3913932|FG000|NOT COMPLETED|Step 2||0
3185633|NCT02021955|3913933|FG001|NOT COMPLETED|Step 2||0
3185634|NCT02021955|3913932|FG000|STARTED|Step 3|Provider attrition=2; Provider addition=4; Patient discharges=5|175
3158393|NCT01851590|3885205|FG001|At 10 Month: Follow-up Visit and Control|Overall Study|Study completed. Clinical response to treatment, toenails samples and lab. exams were controlled.|24
3158394|NCT01851590|3885206|FG002|At 10 Month: Follow-up Visit and Control|Overall Study|Study completed. Clinical response to treatment, toenails samples and lab. exams were controlled.|22
3158395|NCT01851590|3885204|FG000|COMPLETED|Overall Study|All patients (23) were included in the ITT population and final outcome analyses.|23
3158396|NCT01851590|3885205|FG001|COMPLETED|Overall Study|All patients (25) were included in the ITT population and final outcome analyses.|24
3158397|NCT01851590|3885206|FG002|COMPLETED|Overall Study|All patients (25) were included in the ITT population and final outcome analyses.|22
3158398|NCT01851590|3885204|FG000|NOT COMPLETED|Overall Study||0
3158399|NCT01851590|3885205|FG001|NOT COMPLETED|Overall Study||1
3158400|NCT01851590|3885206|FG002|NOT COMPLETED|Overall Study||3
3158401|NCT01851655|3885220|FG000|STARTED|Overall Study||12
3158402|NCT01851655|3885221|FG001|STARTED|Overall Study||12
3158403|NCT01851655|3885220|FG000|COMPLETED|Overall Study||12
3158404|NCT01851655|3885221|FG001|COMPLETED|Overall Study||12
3158405|NCT01851655|3885220|FG000|NOT COMPLETED|Overall Study||0
3158406|NCT01851655|3885221|FG001|NOT COMPLETED|Overall Study||0
3158407|NCT01851720|3885229|FG000|STARTED|Overall Study||0
3158408|NCT01851720|3885230|FG001|STARTED|Overall Study||1
3158409|NCT01851720|3885229|FG000|COMPLETED|Overall Study||0
3158410|NCT01851720|3885230|FG001|COMPLETED|Overall Study||0
3158411|NCT01851720|3885229|FG000|NOT COMPLETED|Overall Study||0
3158412|NCT01851720|3885230|FG001|NOT COMPLETED|Overall Study||1
3158413|NCT01851772|3885236|FG000|STARTED|Overall Study||3
3158414|NCT01851772|3885236|FG000|COMPLETED|Overall Study||3
3158415|NCT01851772|3885236|FG000|NOT COMPLETED|Overall Study||0
3185635|NCT02021955|3913933|FG001|STARTED|Step 3|Provider attrition=0; Provider addition=3; Patient discharges=3|30
3185636|NCT02021955|3913932|FG000|COMPLETED|Step 3||175
3185637|NCT02021955|3913933|FG001|COMPLETED|Step 3||30
3185638|NCT02021955|3913932|FG000|NOT COMPLETED|Step 3||0
3185639|NCT02021955|3913933|FG001|NOT COMPLETED|Step 3||0
3185640|NCT02021955|3913932|FG000|STARTED|Step 4|Provider attrition=0; Provider addition=3; Patient discharges: 13|173
3185641|NCT02021955|3913933|FG001|STARTED|Step 4|Provider attrition=0; Provider addition=1; Patient discharges=0|37
3185642|NCT02021955|3913932|FG000|COMPLETED|Step 4||173
3185643|NCT02021955|3913933|FG001|COMPLETED|Step 4||37
3185644|NCT02021955|3913932|FG000|NOT COMPLETED|Step 4||0
3185645|NCT02021955|3913933|FG001|NOT COMPLETED|Step 4||0
3185646|NCT02021955|3913932|FG000|STARTED|Step 5|Provider attrition=3; Provider addition=0; Patient discharges=11|174
3185647|NCT02021955|3913933|FG001|STARTED|Step 5|Provider attrition=0; Provider addition=0; Patient discharges=2|40
3185648|NCT02021955|3913932|FG000|COMPLETED|Step 5||174
3185649|NCT02021955|3913933|FG001|COMPLETED|Step 5||40
3185650|NCT02021955|3913932|FG000|NOT COMPLETED|Step 5||0
3185651|NCT02021955|3913933|FG001|NOT COMPLETED|Step 5||0
3185652|NCT02021955|3913932|FG000|STARTED|Step 6|Provider attrition=0; Provider addition=2; Patient discharges=6|158
3185653|NCT02021955|3913933|FG001|STARTED|Step 6|Provider attrition=0; Provider addition=1; Patient discharges=1|53
3185654|NCT02021955|3913932|FG000|COMPLETED|Step 6||158
3185655|NCT02021955|3913933|FG001|COMPLETED|Step 6||53
3185656|NCT02021955|3913932|FG000|NOT COMPLETED|Step 6||0
3185657|NCT02021955|3913933|FG001|NOT COMPLETED|Step 6||0
3185658|NCT02021955|3913932|FG000|STARTED|Step 7|Provider attrition=0; Provider addition=2; Patient discharges=13|157
3185659|NCT02021955|3913933|FG001|STARTED|Step 7|Provider attrition=0; Provider addition=1; Patient discharges=2|57
3185660|NCT02021955|3913932|FG000|COMPLETED|Step 7||157
3185661|NCT02021955|3913933|FG001|COMPLETED|Step 7||57
3185662|NCT02021955|3913932|FG000|NOT COMPLETED|Step 7||0
3185663|NCT02021955|3913933|FG001|NOT COMPLETED|Step 7||0
3185664|NCT02021955|3913932|FG000|STARTED|Step 8|Provider attrition=1; Provider addition=0; Patient discharges=9|144
3185665|NCT02021955|3913933|FG001|STARTED|Step 8|Provider attrition=0; Provider addition=0; Patient discharges=11|73
3185666|NCT02021955|3913932|FG000|COMPLETED|Step 8||144
3185667|NCT02021955|3913933|FG001|COMPLETED|Step 8||73
3185668|NCT02021955|3913932|FG000|NOT COMPLETED|Step 8||0
3185669|NCT02021955|3913933|FG001|NOT COMPLETED|Step 8||0
3185670|NCT02021955|3913932|FG000|STARTED|Step 9|Provider attrition=2; Provider addition=1; Patient discharges=9|139
3185671|NCT02021955|3913933|FG001|STARTED|Step 9|Provider attrition=1; Provider addition=0; Patient discharges=8|77
3185672|NCT02021955|3913932|FG000|COMPLETED|Step 9||139
3185673|NCT02021955|3913933|FG001|COMPLETED|Step 9||77
3185674|NCT02021955|3913932|FG000|NOT COMPLETED|Step 9||0
3185675|NCT02021955|3913933|FG001|NOT COMPLETED|Step 9||0
3185676|NCT02021955|3913932|FG000|STARTED|Step 10|Provider attrition=0; Provider addition=1; Patient discharges: 8|135
3185677|NCT02021955|3913933|FG001|STARTED|Step 10|Provider attrition=1; Provider addition=0; Patient discharges=5|79
3185678|NCT02021955|3913932|FG000|COMPLETED|Step 10||135
3185679|NCT02021955|3913933|FG001|COMPLETED|Step 10||79
3185680|NCT02021955|3913932|FG000|NOT COMPLETED|Step 10||0
3185681|NCT02021955|3913933|FG001|NOT COMPLETED|Step 10||0
3185682|NCT02021955|3913932|FG000|STARTED|Step 11|Provider attrition=1; Provider addition=0; Patient discharges=11|126
3185683|NCT02021955|3913933|FG001|STARTED|Step 11|Provider attrition=2; Provider addition=2; Patient discharges=7|88
3185684|NCT02021955|3913932|FG000|COMPLETED|Step 11||126
3185685|NCT02021955|3913933|FG001|COMPLETED|Step 11||88
3185686|NCT02021955|3913932|FG000|NOT COMPLETED|Step 11||0
3185687|NCT02021955|3913933|FG001|NOT COMPLETED|Step 11||0
3185688|NCT02021955|3913932|FG000|STARTED|Step 12|Provider attrition=1; Provider addition=0; Patient discharges=3|123
3185689|NCT02021955|3913933|FG001|STARTED|Step 12|Provider attrition=0; Provider addition=2; Patient discharges=1|90
3185690|NCT02021955|3913932|FG000|COMPLETED|Step 12||123
3185691|NCT02021955|3913933|FG001|COMPLETED|Step 12||90
3185692|NCT02021955|3913932|FG000|NOT COMPLETED|Step 12||0
3185693|NCT02021955|3913933|FG001|NOT COMPLETED|Step 12||0
3185694|NCT02021955|3913932|FG000|STARTED|Step 13|Provider attrition=10; Provider addition=0; Patient discharges=4|118
3158416|NCT01851863|3885244|FG000|STARTED|Overall Study||65
3158417|NCT01851863|3885245|FG001|STARTED|Overall Study||66
3158418|NCT01851863|3885246|FG002|STARTED|Overall Study||65
3158419|NCT01851863|3885247|FG003|STARTED|Overall Study||66
3158420|NCT01851863|3885244|FG000|COMPLETED|Overall Study||60
3158421|NCT01851863|3885245|FG001|COMPLETED|Overall Study||57
3158422|NCT01851863|3885246|FG002|COMPLETED|Overall Study||60
3158423|NCT01851863|3885247|FG003|COMPLETED|Overall Study||63
3158424|NCT01851863|3885244|FG000|NOT COMPLETED|Overall Study||5
3158425|NCT01851863|3885245|FG001|NOT COMPLETED|Overall Study||9
3158426|NCT01851863|3885246|FG002|NOT COMPLETED|Overall Study||5
3158427|NCT01851863|3885247|FG003|NOT COMPLETED|Overall Study||3
3158428|NCT01851876|3885262|FG000|STARTED|Overall Study||56
3158429|NCT01851876|3885263|FG001|STARTED|Overall Study||62
3158430|NCT01851876|3885262|FG000|COMPLETED|Overall Study||56
3158431|NCT01851876|3885263|FG001|COMPLETED|Overall Study||62
3158432|NCT01851876|3885262|FG000|NOT COMPLETED|Overall Study||0
3158433|NCT01851876|3885263|FG001|NOT COMPLETED|Overall Study||0
3158434|NCT01852019|3885271|FG000|STARTED|Day 1||3
3158435|NCT01852019|3885272|FG001|STARTED|Day 1||3
3158436|NCT01852019|3885273|FG002|STARTED|Day 1||6
3158437|NCT01852019|3885274|FG003|STARTED|Day 1||0
3158438|NCT01852019|3885275|FG004|STARTED|Day 1||0
3158439|NCT01852019|3885271|FG000|COMPLETED|Day 1||3
3158440|NCT01852019|3885272|FG001|COMPLETED|Day 1||3
3158441|NCT01852019|3885273|FG002|COMPLETED|Day 1||6
3158442|NCT01852019|3885274|FG003|COMPLETED|Day 1||0
3158443|NCT01852019|3885275|FG004|COMPLETED|Day 1||0
3158444|NCT01852019|3885271|FG000|NOT COMPLETED|Day 1||0
3158445|NCT01852019|3885272|FG001|NOT COMPLETED|Day 1||0
3158446|NCT01852019|3885273|FG002|NOT COMPLETED|Day 1||0
3158447|NCT01852019|3885274|FG003|NOT COMPLETED|Day 1||0
3158448|NCT01852019|3885275|FG004|NOT COMPLETED|Day 1||0
3158449|NCT01852019|3885271|FG000|STARTED|Day 8||0
3158450|NCT01852019|3885272|FG001|STARTED|Day 8||0
3158451|NCT01852019|3885273|FG002|STARTED|Day 8||0
3158452|NCT01852019|3885274|FG003|STARTED|Day 8||6
3158453|NCT01852019|3885275|FG004|STARTED|Day 8||6
3158454|NCT01852019|3885271|FG000|COMPLETED|Day 8||0
3158455|NCT01852019|3885272|FG001|COMPLETED|Day 8||0
3158456|NCT01852019|3885273|FG002|COMPLETED|Day 8||0
3158457|NCT01852019|3885274|FG003|COMPLETED|Day 8||6
3158458|NCT01852019|3885275|FG004|COMPLETED|Day 8||6
3158459|NCT01852019|3885271|FG000|NOT COMPLETED|Day 8||0
3158460|NCT01852019|3885272|FG001|NOT COMPLETED|Day 8||0
3158461|NCT01852019|3885273|FG002|NOT COMPLETED|Day 8||0
3158462|NCT01852019|3885274|FG003|NOT COMPLETED|Day 8||0
3158463|NCT01852019|3885275|FG004|NOT COMPLETED|Day 8||0
3158464|NCT01852032|3885288|FG000|STARTED|Overall Study||23
3158465|NCT01852032|3885288|FG000|COMPLETED|Overall Study||23
3158466|NCT01852032|3885288|FG000|NOT COMPLETED|Overall Study||0
3158467|NCT01852045|3885295|FG000|STARTED|Overall Study||39
3158468|NCT01852045|3885296|FG001|STARTED|Overall Study||45
3158469|NCT01852045|3885297|FG002|STARTED|Overall Study||30
3185695|NCT02021955|3913933|FG001|STARTED|Step 13|Provider attrition=4; Provider addition=0; Patient discharges=5|96
3185696|NCT02021955|3913932|FG000|COMPLETED|Step 13||118
3185697|NCT02021955|3913933|FG001|COMPLETED|Step 13||96
3185698|NCT02021955|3913932|FG000|NOT COMPLETED|Step 13||0
3185699|NCT02021955|3913933|FG001|NOT COMPLETED|Step 13||0
3185700|NCT02021955|3913932|FG000|STARTED|Step 14|Provider attrition=1; Provider addition=9; Patient discharges=7|105
3185701|NCT02021955|3913933|FG001|STARTED|Step 14|Provider attrition=7; Provider addition=11; Patient discharges=3|95
3185702|NCT02021955|3913932|FG000|COMPLETED|Step 14||105
3185703|NCT02021955|3913933|FG001|COMPLETED|Step 14||95
3185704|NCT02021955|3913932|FG000|NOT COMPLETED|Step 14||0
3185705|NCT02021955|3913933|FG001|NOT COMPLETED|Step 14||0
3185706|NCT02021955|3913932|FG000|STARTED|Step 15|Provider attrition=0; Provider addition=0; Patient discharges=4|110
3185707|NCT02021955|3913933|FG001|STARTED|Step 15|Provider attrition=0; Provider addition=5; Patient discharges=5|102
3185708|NCT02021955|3913932|FG000|COMPLETED|Step 15||110
3185709|NCT02021955|3913933|FG001|COMPLETED|Step 15||102
3185710|NCT02021955|3913932|FG000|NOT COMPLETED|Step 15||0
3185711|NCT02021955|3913933|FG001|NOT COMPLETED|Step 15||0
3185712|NCT02021955|3913932|FG000|STARTED|Step 16|Provider attrition=0; Provider addition=0; Patient discharges=2|103
3185713|NCT02021955|3913933|FG001|STARTED|Step 16|Provider attrition=0; Provider addition=3; Patient discharges=3|114
3185714|NCT02021955|3913932|FG000|COMPLETED|Step 16||103
3185715|NCT02021955|3913933|FG001|COMPLETED|Step 16||114
3185716|NCT02021955|3913932|FG000|NOT COMPLETED|Step 16||0
3185717|NCT02021955|3913933|FG001|NOT COMPLETED|Step 16||0
3185718|NCT02021955|3913932|FG000|STARTED|Step 17|Provider attrition=0; Provider addition=0; Patient discharges=8|99
3185719|NCT02021955|3913933|FG001|STARTED|Step 17|Provider attrition=0; Provider addition=0; Patient discharges=3|121
3185720|NCT02021955|3913932|FG000|COMPLETED|Step 17||99
3185721|NCT02021955|3913933|FG001|COMPLETED|Step 17||121
3185722|NCT02021955|3913932|FG000|NOT COMPLETED|Step 17||0
3185723|NCT02021955|3913933|FG001|NOT COMPLETED|Step 17||0
3185724|NCT02021955|3913932|FG000|STARTED|Step 18|Provider attrition=0; Provider addition=0; Patient discharges=6|96
3185725|NCT02021955|3913933|FG001|STARTED|Step 18|Provider attrition=0; Provider addition=0; Patient discharges=7|124
3185726|NCT02021955|3913932|FG000|COMPLETED|Step 18||96
3185727|NCT02021955|3913933|FG001|COMPLETED|Step 18||124
3158470|NCT01852045|3885295|FG000|mITT Population|Overall Study||38
3158471|NCT01852045|3885296|FG001|mITT Population|Overall Study||45
3158472|NCT01852045|3885297|FG002|mITT Population|Overall Study||30
3158473|NCT01852045|3885295|FG000|Safety Population|Overall Study||38
3158474|NCT01852045|3885296|FG001|Safety Population|Overall Study||45
3158475|NCT01852045|3885297|FG002|Safety Population|Overall Study||30
3158476|NCT01852045|3885295|FG000|COMPLETED|Overall Study||33
3158477|NCT01852045|3885296|FG001|COMPLETED|Overall Study||41
3158478|NCT01852045|3885297|FG002|COMPLETED|Overall Study||26
3158479|NCT01852045|3885295|FG000|NOT COMPLETED|Overall Study||6
3158480|NCT01852045|3885296|FG001|NOT COMPLETED|Overall Study||4
3158481|NCT01852045|3885297|FG002|NOT COMPLETED|Overall Study||4
3158482|NCT01852058|3885308|FG000|STARTED|Treatment Cycle 1, Occurred in Study 120||31
3185728|NCT02021955|3913932|FG000|NOT COMPLETED|Step 18||0
3185729|NCT02021955|3913933|FG001|NOT COMPLETED|Step 18||0
3185730|NCT02021955|3913932|FG000|STARTED|Step 19|Provider attrition=0; Provider addition=0; Patient discharges=5|94
3185731|NCT02021955|3913933|FG001|STARTED|Step 19|Provider attrition=0; Provider addition=0; Patient discharges=9|126
3185732|NCT02021955|3913932|FG000|COMPLETED|Step 19||94
3185733|NCT02021955|3913933|FG001|COMPLETED|Step 19||126
3185734|NCT02021955|3913932|FG000|NOT COMPLETED|Step 19||0
3185735|NCT02021955|3913933|FG001|NOT COMPLETED|Step 19||0
3185736|NCT02021955|3913932|FG000|STARTED|Step 20|Provider attrition=0; Provider addition=1; Patient discharges=9|92
3185737|NCT02021955|3913933|FG001|STARTED|Step 20|Provider attrition=0; Provider addition=1; Patient discharges=9|128
3185738|NCT02021955|3913932|FG000|COMPLETED|Step 20||92
3185739|NCT02021955|3913933|FG001|COMPLETED|Step 20||128
3185740|NCT02021955|3913932|FG000|NOT COMPLETED|Step 20||0
3185741|NCT02021955|3913933|FG001|NOT COMPLETED|Step 20||0
3185742|NCT02021955|3913932|FG000|STARTED|Step 21|Provider attrition=0; Provider addition=7; Patient discharges=1|88
3185743|NCT02021955|3913933|FG001|STARTED|Step 21|Provider attrition=0; Provider addition=12; Patient discharges=9|134
3185744|NCT02021955|3913932|FG000|COMPLETED|Step 21||88
3185745|NCT02021955|3913933|FG001|COMPLETED|Step 21||134
3185746|NCT02021955|3913932|FG000|NOT COMPLETED|Step 21||0
3185747|NCT02021955|3913933|FG001|NOT COMPLETED|Step 21||0
3185748|NCT02021955|3913932|FG000|STARTED|Step 22|Provider attrition=0; Provider addition=0; Patient discharges=8|89
3185749|NCT02021955|3913933|FG001|STARTED|Step 22|Provider attrition=0; Provider addition=3; Patient discharges=8|152
3185750|NCT02021955|3913932|FG000|COMPLETED|Step 22||89
3185751|NCT02021955|3913933|FG001|COMPLETED|Step 22||152
3185752|NCT02021955|3913932|FG000|NOT COMPLETED|Step 22||0
3185753|NCT02021955|3913933|FG001|NOT COMPLETED|Step 22||0
3185754|NCT02021955|3913932|FG000|STARTED|Step 23|Provider attrition=0; Provider addition=1; Patient discharges=3|69
3185755|NCT02021955|3913933|FG001|STARTED|Step 23|Provider attrition=0; Provider addition=0; Patient discharges=7|175
3185756|NCT02021955|3913932|FG000|COMPLETED|Step 23||69
3185757|NCT02021955|3913933|FG001|COMPLETED|Step 23||175
3185758|NCT02021955|3913932|FG000|NOT COMPLETED|Step 23||0
3185759|NCT02021955|3913933|FG001|NOT COMPLETED|Step 23||0
3185760|NCT02021955|3913932|FG000|STARTED|Step 24|Provider attrition=0; Provider addition=0; Patient discharges=4|62
3185761|NCT02021955|3913933|FG001|STARTED|Step 24|Provider attrition=1; Provider addition=1; Patient discharges=8|183
3185762|NCT02021955|3913932|FG000|COMPLETED|Step 24||62
3185763|NCT02021955|3913933|FG001|COMPLETED|Step 24||183
3185764|NCT02021955|3913932|FG000|NOT COMPLETED|Step 24||0
3185765|NCT02021955|3913933|FG001|NOT COMPLETED|Step 24||0
3185766|NCT02021955|3913932|FG000|STARTED|Step 25|Provider attrition=0; Provider addition=1; Patient discharges=0|37
3185767|NCT02021955|3913933|FG001|STARTED|Step 25|Provider attrition=1; Provider addition=0; Patient discharges=5|208
3185768|NCT02021955|3913932|FG000|COMPLETED|Step 25||37
3185769|NCT02021955|3913933|FG001|COMPLETED|Step 25||208
3185770|NCT02021955|3913932|FG000|NOT COMPLETED|Step 25||0
3185771|NCT02021955|3913933|FG001|NOT COMPLETED|Step 25||0
3185772|NCT02021955|3913932|FG000|STARTED|Step 26|Provider attrition=0; Provider addition=0; Patient discharges=2|30
3185773|NCT02021955|3913933|FG001|STARTED|Step 26|Provider attrition=0; Provider addition=23; Patient discharges=9|215
3185774|NCT02021955|3913932|FG000|COMPLETED|Step 26||30
3185775|NCT02021955|3913933|FG001|COMPLETED|Step 26||215
3185776|NCT02021955|3913932|FG000|NOT COMPLETED|Step 26||0
3185777|NCT02021955|3913933|FG001|NOT COMPLETED|Step 26||0
3185778|NCT02021955|3913932|FG000|STARTED|Step 27|Provider attrition=1; Provider addition=1; Patient discharges=0|25
3185779|NCT02021955|3913933|FG001|STARTED|Step 27|Provider attrition=1; Provider addition=4; Patient discharges=4|243
3185780|NCT02021955|3913932|FG000|COMPLETED|Step 27||25
3185781|NCT02021955|3913933|FG001|COMPLETED|Step 27||243
3185782|NCT02021955|3913932|FG000|NOT COMPLETED|Step 27||0
3185783|NCT02021955|3913933|FG001|NOT COMPLETED|Step 27||0
3185784|NCT02021955|3913932|FG000|STARTED|Step 28|Provider attrition=0; Provider addition=2; Patient discharges=0|15
3185785|NCT02021955|3913933|FG001|STARTED|Step 28|Provider attrition=3; Provider addition=6; Patient discharges=6|256
3185786|NCT02021955|3913932|FG000|COMPLETED|Step 28||15
3185787|NCT02021955|3913933|FG001|COMPLETED|Step 28||256
3185788|NCT02021955|3913932|FG000|NOT COMPLETED|Step 28||0
3185789|NCT02021955|3913933|FG001|NOT COMPLETED|Step 28||0
3185790|NCT02021955|3913932|FG000|STARTED|Step 29|Provider attrition=0; Provider addition=0; Patient discharges=0|10
3185791|NCT02021955|3913933|FG001|STARTED|Step 29|Provider attrition=1; Provider addition=2; Patient discharges=8|266
3185792|NCT02021955|3913932|FG000|COMPLETED|Step 29||10
3185793|NCT02021955|3913933|FG001|COMPLETED|Step 29||266
3185794|NCT02021955|3913932|FG000|NOT COMPLETED|Step 29||0
3185795|NCT02021955|3913933|FG001|NOT COMPLETED|Step 29||0
3185796|NCT02021955|3913932|FG000|STARTED|Step 30|Provider attrition=0; Provider addition=0; Patient discharges=0|0
3185797|NCT02021955|3913933|FG001|STARTED|Step 30|Provider attrition=0; Provider addition=1; Patient discharges=11|277
3185798|NCT02021955|3913932|FG000|COMPLETED|Step 30||0
3185799|NCT02021955|3913933|FG001|COMPLETED|Step 30||277
3158483|NCT01852058|3885309|FG001|STARTED|Treatment Cycle 1, Occurred in Study 120||39
3158484|NCT01852058|3885310|FG002|STARTED|Treatment Cycle 1, Occurred in Study 120||25
3158485|NCT01852058|3885311|FG003|STARTED|Treatment Cycle 1, Occurred in Study 120||0
3158486|NCT01852058|3885312|FG004|STARTED|Treatment Cycle 1, Occurred in Study 120||0
3158487|NCT01852058|3885313|FG005|STARTED|Treatment Cycle 1, Occurred in Study 120||0
3158488|NCT01852058|3885314|FG006|STARTED|Treatment Cycle 1, Occurred in Study 120||0
3158489|NCT01852058|3885315|FG007|STARTED|Treatment Cycle 1, Occurred in Study 120||0
3158490|NCT01852058|3885316|FG008|STARTED|Treatment Cycle 1, Occurred in Study 120||0
3158491|NCT01852058|3885317|FG009|STARTED|Treatment Cycle 1, Occurred in Study 120||0
3158492|NCT01852058|3885318|FG010|STARTED|Treatment Cycle 1, Occurred in Study 120||0
3158493|NCT01852058|3885319|FG011|STARTED|Treatment Cycle 1, Occurred in Study 120||0
3158494|NCT01852058|3885308|FG000|COMPLETED|Treatment Cycle 1, Occurred in Study 120||30
3158495|NCT01852058|3885309|FG001|COMPLETED|Treatment Cycle 1, Occurred in Study 120||39
3158496|NCT01852058|3885310|FG002|COMPLETED|Treatment Cycle 1, Occurred in Study 120||25
3158497|NCT01852058|3885311|FG003|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
3158498|NCT01852058|3885312|FG004|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
3158499|NCT01852058|3885313|FG005|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
3158500|NCT01852058|3885314|FG006|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
3158501|NCT01852058|3885315|FG007|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
3158502|NCT01852058|3885316|FG008|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
3158503|NCT01852058|3885317|FG009|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
3158504|NCT01852058|3885318|FG010|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
3158505|NCT01852058|3885319|FG011|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
3158506|NCT01852058|3885308|FG000|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||1
3158507|NCT01852058|3885309|FG001|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
3158508|NCT01852058|3885310|FG002|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
3158509|NCT01852058|3885311|FG003|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
3158510|NCT01852058|3885312|FG004|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
3158511|NCT01852058|3885313|FG005|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
3158512|NCT01852058|3885314|FG006|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
3158513|NCT01852058|3885315|FG007|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
3158514|NCT01852058|3885316|FG008|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
3158515|NCT01852058|3885317|FG009|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
3158516|NCT01852058|3885318|FG010|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
3158517|NCT01852058|3885319|FG011|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
3158518|NCT01852058|3885308|FG000|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0
3158519|NCT01852058|3885309|FG001|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0
3158520|NCT01852058|3885310|FG002|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0
3158521|NCT01852058|3885311|FG003|STARTED|Treatment Cycle2:Retreatment 1,Study 121||9
3158522|NCT01852058|3885312|FG004|STARTED|Treatment Cycle2:Retreatment 1,Study 121||45
3158523|NCT01852058|3885313|FG005|STARTED|Treatment Cycle2:Retreatment 1,Study 121||36
3158524|NCT01852058|3885314|FG006|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0
3158525|NCT01852058|3885315|FG007|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0
3158526|NCT01852058|3885316|FG008|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0
3158527|NCT01852058|3885317|FG009|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0
3158528|NCT01852058|3885318|FG010|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0
3158529|NCT01852058|3885319|FG011|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0
3158530|NCT01852058|3885308|FG000|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
3158531|NCT01852058|3885309|FG001|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
3158532|NCT01852058|3885310|FG002|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
3158533|NCT01852058|3885311|FG003|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||8
3158534|NCT01852058|3885312|FG004|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||38
3158535|NCT01852058|3885313|FG005|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||27
3158536|NCT01852058|3885314|FG006|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
3158537|NCT01852058|3885315|FG007|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
3158538|NCT01852058|3885316|FG008|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
3158539|NCT01852058|3885317|FG009|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
3158540|NCT01852058|3885318|FG010|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
3158541|NCT01852058|3885319|FG011|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
3158542|NCT01852058|3885308|FG000|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
3158543|NCT01852058|3885309|FG001|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
3158544|NCT01852058|3885310|FG002|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
3158545|NCT01852058|3885311|FG003|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||1
3158546|NCT01852058|3885312|FG004|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||7
3158547|NCT01852058|3885313|FG005|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||9
3158548|NCT01852058|3885314|FG006|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
3158549|NCT01852058|3885315|FG007|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
3158550|NCT01852058|3885316|FG008|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
3158551|NCT01852058|3885317|FG009|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
3185800|NCT02021955|3913932|FG000|NOT COMPLETED|Step 30||0
3185801|NCT02021955|3913933|FG001|NOT COMPLETED|Step 30||0
3185802|NCT02022007|3913942|FG000|STARTED|Overall Study||13
3185803|NCT02022007|3913943|FG001|STARTED|Overall Study||12
3158552|NCT01852058|3885318|FG010|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
3158553|NCT01852058|3885319|FG011|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
3158554|NCT01852058|3885308|FG000|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0
3158555|NCT01852058|3885309|FG001|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0
3158556|NCT01852058|3885310|FG002|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0
3158557|NCT01852058|3885311|FG003|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0
3158558|NCT01852058|3885312|FG004|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0
3158559|NCT01852058|3885313|FG005|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0
3158560|NCT01852058|3885314|FG006|STARTED|Treatment Cycle3:Retreatment 2,Study 121||5
3158561|NCT01852058|3885315|FG007|STARTED|Treatment Cycle3:Retreatment 2,Study 121||16
3158562|NCT01852058|3885316|FG008|STARTED|Treatment Cycle3:Retreatment 2,Study 121||34
3158563|NCT01852058|3885317|FG009|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0
3158564|NCT01852058|3885318|FG010|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0
3158565|NCT01852058|3885319|FG011|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0
3158566|NCT01852058|3885308|FG000|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
3158567|NCT01852058|3885309|FG001|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
3158568|NCT01852058|3885310|FG002|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
3158569|NCT01852058|3885311|FG003|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
3158570|NCT01852058|3885312|FG004|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
3158571|NCT01852058|3885313|FG005|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
3158572|NCT01852058|3885314|FG006|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||5
3158573|NCT01852058|3885315|FG007|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||15
3158574|NCT01852058|3885316|FG008|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||33
3158575|NCT01852058|3885317|FG009|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
3158576|NCT01852058|3885318|FG010|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
3158577|NCT01852058|3885319|FG011|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
3158578|NCT01852058|3885308|FG000|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
3158579|NCT01852058|3885309|FG001|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
3158580|NCT01852058|3885310|FG002|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
3158581|NCT01852058|3885311|FG003|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
3158582|NCT01852058|3885312|FG004|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
3158583|NCT01852058|3885313|FG005|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
3158584|NCT01852058|3885314|FG006|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
3158585|NCT01852058|3885315|FG007|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||1
3158586|NCT01852058|3885316|FG008|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||1
3158587|NCT01852058|3885317|FG009|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
3158588|NCT01852058|3885318|FG010|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
3158589|NCT01852058|3885319|FG011|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
3158590|NCT01852058|3885308|FG000|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0
3158591|NCT01852058|3885309|FG001|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0
3158592|NCT01852058|3885310|FG002|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0
3158593|NCT01852058|3885311|FG003|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0
3158594|NCT01852058|3885312|FG004|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0
3158595|NCT01852058|3885313|FG005|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0
3158596|NCT01852058|3885314|FG006|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0
3158597|NCT01852058|3885315|FG007|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0
3158598|NCT01852058|3885316|FG008|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0
3158599|NCT01852058|3885317|FG009|STARTED|Treatment Cycle4:Retreatment 3,Study 121||3
3158600|NCT01852058|3885318|FG010|STARTED|Treatment Cycle4:Retreatment 3,Study 121||4
3158601|NCT01852058|3885319|FG011|STARTED|Treatment Cycle4:Retreatment 3,Study 121||4
3158602|NCT01852058|3885308|FG000|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
3158603|NCT01852058|3885309|FG001|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
3158604|NCT01852058|3885310|FG002|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
3158605|NCT01852058|3885311|FG003|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
3158606|NCT01852058|3885312|FG004|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
3158607|NCT01852058|3885313|FG005|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
3158608|NCT01852058|3885314|FG006|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
3158609|NCT01852058|3885315|FG007|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
3158610|NCT01852058|3885316|FG008|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
3158611|NCT01852058|3885317|FG009|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||3
3158612|NCT01852058|3885318|FG010|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||4
3158613|NCT01852058|3885319|FG011|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||4
3185804|NCT02022007|3913944|FG002|STARTED|Overall Study||13
3185805|NCT02022007|3913942|FG000|COMPLETED|Overall Study||12
3185806|NCT02022007|3913943|FG001|COMPLETED|Overall Study||11
3185807|NCT02022007|3913944|FG002|COMPLETED|Overall Study||11
3185808|NCT02022007|3913942|FG000|NOT COMPLETED|Overall Study||1
3185809|NCT02022007|3913943|FG001|NOT COMPLETED|Overall Study||1
3185810|NCT02022007|3913944|FG002|NOT COMPLETED|Overall Study||2
3185811|NCT02022020|3913952|FG000|STARTED|Overall Study||220
3185812|NCT02022020|3913952|FG000|COMPLETED|Overall Study||220
3185813|NCT02022020|3913952|FG000|NOT COMPLETED|Overall Study||0
3185814|NCT02022033|3913956|FG000|STARTED|Overall Study||25
3185815|NCT02022033|3913956|FG000|COMPLETED|Overall Study||24
3158614|NCT01852058|3885308|FG000|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
3158615|NCT01852058|3885309|FG001|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
3158616|NCT01852058|3885310|FG002|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
3158617|NCT01852058|3885311|FG003|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
3158618|NCT01852058|3885312|FG004|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
3158619|NCT01852058|3885313|FG005|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
3158620|NCT01852058|3885314|FG006|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
3158621|NCT01852058|3885315|FG007|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
3158622|NCT01852058|3885316|FG008|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
3158623|NCT01852058|3885317|FG009|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
3158624|NCT01852058|3885318|FG010|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
3158625|NCT01852058|3885319|FG011|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
3158626|NCT01852071|3885356|FG000|STARTED|Overall Study||20
3158627|NCT01852071|3885357|FG001|STARTED|Overall Study||26
3158628|NCT01852071|3885356|FG000|COMPLETED|Overall Study||20
3158629|NCT01852071|3885357|FG001|COMPLETED|Overall Study||26
3158630|NCT01852071|3885356|FG000|NOT COMPLETED|Overall Study||0
3158631|NCT01852071|3885357|FG001|NOT COMPLETED|Overall Study||0
3158632|NCT01852084|3885373|FG000|STARTED|Overall Study||79
3158633|NCT01852084|3885374|FG001|STARTED|Overall Study||80
3158634|NCT01852084|3885375|FG002|STARTED|Overall Study||20
3158635|NCT01852084|3885376|FG003|STARTED|Overall Study||12
3158636|NCT01852084|3885373|FG000|COMPLETED|Overall Study||79
3158637|NCT01852084|3885374|FG001|COMPLETED|Overall Study||80
3158638|NCT01852084|3885375|FG002|COMPLETED|Overall Study||18
3158639|NCT01852084|3885376|FG003|COMPLETED|Overall Study||12
3158640|NCT01852084|3885373|FG000|NOT COMPLETED|Overall Study||0
3158641|NCT01852084|3885374|FG001|NOT COMPLETED|Overall Study||0
3158642|NCT01852084|3885375|FG002|NOT COMPLETED|Overall Study||2
3158643|NCT01852084|3885376|FG003|NOT COMPLETED|Overall Study||0
3158644|NCT01852110|3885388|FG000|STARTED|Overall Study||120
3158645|NCT01852110|3885389|FG001|STARTED|Overall Study||120
3158646|NCT01852110|3885390|FG002|STARTED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
3158647|NCT01852110|3885391|FG003|STARTED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
3158648|NCT01852110|3885392|FG004|STARTED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
3158649|NCT01852110|3885393|FG005|STARTED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
3158650|NCT01852110|3885388|FG000|Treated|Overall Study||119
3158651|NCT01852110|3885389|FG001|Treated|Overall Study||120
3158652|NCT01852110|3885390|FG002|Treated|Overall Study||0
3158653|NCT01852110|3885391|FG003|Treated|Overall Study||0
3158654|NCT01852110|3885392|FG004|Treated|Overall Study||0
3158655|NCT01852110|3885393|FG005|Treated|Overall Study||0
3158656|NCT01852110|3885388|FG000|COMPLETED|Overall Study||70
3158657|NCT01852110|3885389|FG001|COMPLETED|Overall Study||74
3158658|NCT01852110|3885390|FG002|COMPLETED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
3158659|NCT01852110|3885391|FG003|COMPLETED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
3158660|NCT01852110|3885392|FG004|COMPLETED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
3158661|NCT01852110|3885393|FG005|COMPLETED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
3158662|NCT01852110|3885388|FG000|NOT COMPLETED|Overall Study||50
3158663|NCT01852110|3885389|FG001|NOT COMPLETED|Overall Study||46
3158664|NCT01852110|3885390|FG002|NOT COMPLETED|Overall Study||0
3158665|NCT01852110|3885391|FG003|NOT COMPLETED|Overall Study||0
3158666|NCT01852110|3885392|FG004|NOT COMPLETED|Overall Study||0
3158667|NCT01852110|3885393|FG005|NOT COMPLETED|Overall Study||0
3158668|NCT01852162|3885409|FG000|STARTED|Overall Study||18
3158669|NCT01852162|3885410|FG001|STARTED|Overall Study||17
3158670|NCT01852162|3885409|FG000|COMPLETED|Overall Study||14
3158671|NCT01852162|3885410|FG001|COMPLETED|Overall Study||16
3158672|NCT01852162|3885409|FG000|NOT COMPLETED|Overall Study||4
3158673|NCT01852162|3885410|FG001|NOT COMPLETED|Overall Study||1
3158674|NCT01852175|3885418|FG000|STARTED|Overall Study||55
3158675|NCT01852175|3885419|FG001|STARTED|Overall Study||55
3158676|NCT01852175|3885418|FG000|COMPLETED|Overall Study||55
3158677|NCT01852175|3885419|FG001|COMPLETED|Overall Study||55
3158678|NCT01852175|3885418|FG000|NOT COMPLETED|Overall Study||0
3158679|NCT01852175|3885419|FG001|NOT COMPLETED|Overall Study||0
3158680|NCT01852201|3885427|FG000|STARTED|Overall Study||21
3158681|NCT01852201|3885428|FG001|STARTED|Overall Study||12
3158682|NCT01852201|3885427|FG000|COMPLETED|Overall Study||21
3158683|NCT01852201|3885428|FG001|COMPLETED|Overall Study||12
3158684|NCT01852201|3885427|FG000|NOT COMPLETED|Overall Study||0
3158685|NCT01852201|3885428|FG001|NOT COMPLETED|Overall Study||0
3158686|NCT01852214|3885435|FG000|STARTED|Period 1||26
3158687|NCT01852214|3885436|FG001|STARTED|Period 1||24
3158688|NCT01852214|3885435|FG000|COMPLETED|Period 1||25
3158689|NCT01852214|3885436|FG001|COMPLETED|Period 1||21
3158690|NCT01852214|3885435|FG000|NOT COMPLETED|Period 1||1
3158691|NCT01852214|3885436|FG001|NOT COMPLETED|Period 1||3
3158692|NCT01852214|3885435|FG000|STARTED|Washout Period||25
3158693|NCT01852214|3885436|FG001|STARTED|Washout Period||21
3158694|NCT01852214|3885435|FG000|COMPLETED|Washout Period||25
3158695|NCT01852214|3885436|FG001|COMPLETED|Washout Period||20
3158696|NCT01852214|3885435|FG000|NOT COMPLETED|Washout Period||0
3185816|NCT02022033|3913956|FG000|NOT COMPLETED|Overall Study||1
3158697|NCT01852214|3885436|FG001|NOT COMPLETED|Washout Period||1
3158698|NCT01852214|3885435|FG000|STARTED|Period 2||25
3158699|NCT01852214|3885436|FG001|STARTED|Period 2||20
3158700|NCT01852214|3885435|FG000|COMPLETED|Period 2||25
3158701|NCT01852214|3885436|FG001|COMPLETED|Period 2||20
3158702|NCT01852214|3885435|FG000|NOT COMPLETED|Period 2||0
3158703|NCT01852214|3885436|FG001|NOT COMPLETED|Period 2||0
3158704|NCT01852292|3885445|FG000|STARTED|Overall Study||79
3158705|NCT01852292|3885446|FG001|STARTED|Overall Study||79
3158706|NCT01852292|3885445|FG000|COMPLETED|Overall Study|Completed = participants who were ongoing and did not discontinue study treatment per protocol|0
3158707|NCT01852292|3885446|FG001|COMPLETED|Overall Study|Completed = participants who were ongoing and did not discontinue study treatment per protocol|0
3158708|NCT01852292|3885445|FG000|NOT COMPLETED|Overall Study||79
3185817|NCT02022085|3913960|FG000|STARTED|Overall Study||54
3185818|NCT02022085|3913960|FG000|COMPLETED|Overall Study||53
3185819|NCT02022085|3913960|FG000|NOT COMPLETED|Overall Study||1
3185820|NCT02022111|3913966|FG000|STARTED|Overall Study||196
3185821|NCT02022111|3913967|FG001|STARTED|Overall Study||208
3185822|NCT02022111|3913966|FG000|COMPLETED|Overall Study||186
3185823|NCT02022111|3913967|FG001|COMPLETED|Overall Study||193
3185824|NCT02022111|3913966|FG000|NOT COMPLETED|Overall Study||10
3185825|NCT02022111|3913967|FG001|NOT COMPLETED|Overall Study||15
3185826|NCT02022657|3913975|FG000|STARTED|Overall Study||10
3185827|NCT02022657|3913976|FG001|STARTED|Overall Study||8
3185828|NCT02022657|3913977|FG002|STARTED|Overall Study||9
3185829|NCT02022657|3913978|FG003|STARTED|Overall Study||8
3185830|NCT02022657|3913979|FG004|STARTED|Overall Study||8
3185831|NCT02022657|3913980|FG005|STARTED|Overall Study||9
3185832|NCT02022657|3913975|FG000|COMPLETED|Overall Study||8
3185833|NCT02022657|3913976|FG001|COMPLETED|Overall Study||8
3185834|NCT02022657|3913977|FG002|COMPLETED|Overall Study||8
3185835|NCT02022657|3913978|FG003|COMPLETED|Overall Study||8
3185836|NCT02022657|3913979|FG004|COMPLETED|Overall Study||8
3185837|NCT02022657|3913980|FG005|COMPLETED|Overall Study||8
3185838|NCT02022657|3913975|FG000|NOT COMPLETED|Overall Study||2
3185839|NCT02022657|3913976|FG001|NOT COMPLETED|Overall Study||0
3185840|NCT02022657|3913977|FG002|NOT COMPLETED|Overall Study||1
3185841|NCT02022657|3913978|FG003|NOT COMPLETED|Overall Study||0
3185842|NCT02022657|3913979|FG004|NOT COMPLETED|Overall Study||0
3185843|NCT02022657|3913980|FG005|NOT COMPLETED|Overall Study||1
3185844|NCT02022670|3913989|FG000|STARTED|Overall Study||11
3185845|NCT02022670|3913990|FG001|STARTED|Overall Study||10
3185846|NCT02022670|3913991|FG002|STARTED|Overall Study||12
3185847|NCT02022670|3913989|FG000|COMPLETED|Overall Study||10
3185848|NCT02022670|3913990|FG001|COMPLETED|Overall Study||10
3185849|NCT02022670|3913991|FG002|COMPLETED|Overall Study||11
3185850|NCT02022670|3913989|FG000|NOT COMPLETED|Overall Study||1
3185851|NCT02022670|3913990|FG001|NOT COMPLETED|Overall Study||0
3185852|NCT02022670|3913991|FG002|NOT COMPLETED|Overall Study||1
3185853|NCT02022735|3914000|FG000|STARTED|Overall Study||22
3185854|NCT02022735|3914000|FG000|COMPLETED|Overall Study||22
3185855|NCT02022735|3914000|FG000|NOT COMPLETED|Overall Study||0
3185856|NCT02022748|3914012|FG000|STARTED|Overall Study||8
3185857|NCT02022748|3914013|FG001|STARTED|Overall Study||6
3185858|NCT02022748|3914014|FG002|STARTED|Overall Study||13
3185859|NCT02022748|3914012|FG000|Subject Who Started Treatment|Overall Study||8
3185860|NCT02022748|3914013|FG001|Subject Who Started Treatment|Overall Study||6
3185861|NCT02022748|3914014|FG002|Subject Who Started Treatment|Overall Study||13
3185862|NCT02022748|3914012|FG000|Subjects Who Completed Treatment|Overall Study||7
3185863|NCT02022748|3914013|FG001|Subjects Who Completed Treatment|Overall Study||4
3185864|NCT02022748|3914014|FG002|Subjects Who Completed Treatment|Overall Study||13
3185865|NCT02022748|3914012|FG000|COMPLETED|Overall Study||7
3185866|NCT02022748|3914013|FG001|COMPLETED|Overall Study||4
3185867|NCT02022748|3914014|FG002|COMPLETED|Overall Study||13
3185868|NCT02022748|3914012|FG000|NOT COMPLETED|Overall Study||1
3185869|NCT02022748|3914013|FG001|NOT COMPLETED|Overall Study||2
3185870|NCT02022748|3914014|FG002|NOT COMPLETED|Overall Study||0
3185871|NCT02022826|3914022|FG000|STARTED|Overall Study||167
3185872|NCT02022826|3914022|FG000|COMPLETED|Overall Study||139
3185873|NCT02022826|3914022|FG000|NOT COMPLETED|Overall Study||28
3185874|NCT02023099|3914029|FG000|STARTED|Overall Study||215
3185875|NCT02023099|3914030|FG001|STARTED|Overall Study||106
3185876|NCT02023099|3914031|FG002|STARTED|Overall Study||42
3185877|NCT02023099|3914029|FG000|COMPLETED|Overall Study||212
3185878|NCT02023099|3914030|FG001|COMPLETED|Overall Study||106
3185879|NCT02023099|3914031|FG002|COMPLETED|Overall Study||39
3185880|NCT02023099|3914029|FG000|NOT COMPLETED|Overall Study||3
3185881|NCT02023099|3914030|FG001|NOT COMPLETED|Overall Study||0
3185882|NCT02023099|3914031|FG002|NOT COMPLETED|Overall Study||3
3185883|NCT02023112|3914041|FG000|STARTED|Overall Study||85
3185884|NCT02023112|3914042|FG001|STARTED|Overall Study||86
3185885|NCT02023112|3914041|FG000|COMPLETED|Overall Study||83
3158709|NCT01852292|3885446|FG001|NOT COMPLETED|Overall Study||79
3185886|NCT02023112|3914042|FG001|COMPLETED|Overall Study||85
3185887|NCT02023112|3914041|FG000|NOT COMPLETED|Overall Study||2
3185888|NCT02023112|3914042|FG001|NOT COMPLETED|Overall Study||1
3185889|NCT02023125|3914052|FG000|STARTED|Period 1||9
3185890|NCT02023125|3914053|FG001|STARTED|Period 1||9
3185891|NCT02023125|3914054|FG002|STARTED|Period 1||24
3185892|NCT02023125|3914052|FG000|COMPLETED|Period 1||9
3185893|NCT02023125|3914053|FG001|COMPLETED|Period 1||9
3158710|NCT01852344|3885456|FG000|STARTED|Overall Study||27
3158711|NCT01852344|3885457|FG001|STARTED|Overall Study||27
3158712|NCT01852344|3885458|FG002|STARTED|Overall Study||27
3158713|NCT01852344|3885459|FG003|STARTED|Overall Study||27
3158714|NCT01852344|3885456|FG000|Actual Participation in First Assignment|Overall Study||27
3158715|NCT01852344|3885457|FG001|Actual Participation in First Assignment|Overall Study||27
3158716|NCT01852344|3885458|FG002|Actual Participation in First Assignment|Overall Study||27
3158717|NCT01852344|3885459|FG003|Actual Participation in First Assignment|Overall Study||27
3158718|NCT01852344|3885456|FG000|COMPLETED|Overall Study||27
3158719|NCT01852344|3885457|FG001|COMPLETED|Overall Study||27
3158720|NCT01852344|3885458|FG002|COMPLETED|Overall Study||27
3158721|NCT01852344|3885459|FG003|COMPLETED|Overall Study||27
3158722|NCT01852344|3885456|FG000|NOT COMPLETED|Overall Study||0
3158723|NCT01852344|3885457|FG001|NOT COMPLETED|Overall Study||0
3158724|NCT01852344|3885458|FG002|NOT COMPLETED|Overall Study||0
3158725|NCT01852344|3885459|FG003|NOT COMPLETED|Overall Study||0
3158726|NCT01852383|3885470|FG000|STARTED|Overall Study||30
3158727|NCT01852383|3885470|FG000|COMPLETED|Overall Study||19
3158728|NCT01852383|3885470|FG000|NOT COMPLETED|Overall Study||11
3158729|NCT01852513|3885477|FG000|STARTED|Overall Study||20
3158730|NCT01852513|3885478|FG001|STARTED|Overall Study||19
3158731|NCT01852513|3885477|FG000|COMPLETED|Overall Study||20
3158732|NCT01852513|3885478|FG001|COMPLETED|Overall Study||19
3158733|NCT01852513|3885477|FG000|NOT COMPLETED|Overall Study||0
3158734|NCT01852513|3885478|FG001|NOT COMPLETED|Overall Study||0
3158735|NCT01852591|3885484|FG000|STARTED|Overall Study||8
3158736|NCT01852591|3885484|FG000|COMPLETED|Overall Study||5
3158737|NCT01852591|3885484|FG000|NOT COMPLETED|Overall Study||3
3158738|NCT01852669|3885490|FG000|STARTED|Overall Study||71
3158739|NCT01852669|3885491|FG001|STARTED|Overall Study||69
3158740|NCT01852669|3885490|FG000|COMPLETED|Overall Study||71
3158741|NCT01852669|3885491|FG001|COMPLETED|Overall Study|Randomisation error. Patient has protocol violation which necessitated exclusion from analysis|68
3158742|NCT01852669|3885490|FG000|NOT COMPLETED|Overall Study||0
3158743|NCT01852669|3885491|FG001|NOT COMPLETED|Overall Study||1
3158744|NCT01852799|3885497|FG000|STARTED|Overall Study||18
3158745|NCT01852799|3885497|FG000|COMPLETED|Overall Study||0
3158746|NCT01852799|3885497|FG000|NOT COMPLETED|Overall Study||18
3158747|NCT01852825|3885504|FG000|STARTED|Overall Study||16
3158748|NCT01852825|3885505|FG001|STARTED|Overall Study||7
3158749|NCT01852825|3885506|FG002|STARTED|Overall Study||3
3158750|NCT01852825|3885504|FG000|COMPLETED|Overall Study||14
3158751|NCT01852825|3885505|FG001|COMPLETED|Overall Study||7
3158752|NCT01852825|3885506|FG002|COMPLETED|Overall Study||3
3158753|NCT01852825|3885504|FG000|NOT COMPLETED|Overall Study||2
3158754|NCT01852825|3885505|FG001|NOT COMPLETED|Overall Study||0
3158755|NCT01852825|3885506|FG002|NOT COMPLETED|Overall Study||0
3158756|NCT01852942|3885516|FG000|STARTED|Overall Study||25
3158757|NCT01852942|3885517|FG001|STARTED|Overall Study||27
3158758|NCT01852942|3885516|FG000|COMPLETED|Overall Study||20
3158759|NCT01852942|3885517|FG001|COMPLETED|Overall Study||21
3158760|NCT01852942|3885516|FG000|NOT COMPLETED|Overall Study||5
3158761|NCT01852942|3885517|FG001|NOT COMPLETED|Overall Study||6
3158762|NCT01852955|3885526|FG000|STARTED|Overall Study||35
3158763|NCT01852955|3885527|FG001|STARTED|Overall Study||35
3158764|NCT01852955|3885526|FG000|COMPLETED|Overall Study||33
3158765|NCT01852955|3885527|FG001|COMPLETED|Overall Study||32
3158766|NCT01852955|3885526|FG000|NOT COMPLETED|Overall Study||2
3158767|NCT01852955|3885527|FG001|NOT COMPLETED|Overall Study||3
3158768|NCT01853046|3885535|FG000|STARTED|Overall Study||18
3158769|NCT01853046|3885536|FG001|STARTED|Overall Study||6
3158770|NCT01853046|3885535|FG000|Received Treatment|Overall Study||18
3158771|NCT01853046|3885536|FG001|Received Treatment|Overall Study||6
3158772|NCT01853046|3885535|FG000|COMPLETED|Overall Study||0
3158773|NCT01853046|3885536|FG001|COMPLETED|Overall Study||0
3158774|NCT01853046|3885535|FG000|NOT COMPLETED|Overall Study||18
3158775|NCT01853046|3885536|FG001|NOT COMPLETED|Overall Study||6
3158776|NCT01853072|3885545|FG000|STARTED|Overall Study||308
3158777|NCT01853072|3885546|FG001|STARTED|Overall Study||307
3158778|NCT01853072|3885545|FG000|Randomized|Overall Study||308
3158779|NCT01853072|3885546|FG001|Randomized|Overall Study||307
3158780|NCT01853072|3885545|FG000|Treated (Safety Analysis Set)|Overall Study||301
3158781|NCT01853072|3885546|FG001|Treated (Safety Analysis Set)|Overall Study||302
3158782|NCT01853072|3885545|FG000|Full Analysis Set|Overall Study||298
3158783|NCT01853072|3885546|FG001|Full Analysis Set|Overall Study||300
3158784|NCT01853072|3885545|FG000|COMPLETED|Overall Study||296
3158785|NCT01853072|3885546|FG001|COMPLETED|Overall Study||286
3158786|NCT01853072|3885545|FG000|NOT COMPLETED|Overall Study||12
3158787|NCT01853072|3885546|FG001|NOT COMPLETED|Overall Study||21
3158788|NCT01853085|3885554|FG000|STARTED|Overall Study||1830
3158789|NCT01853085|3885554|FG000|COMPLETED|Overall Study||1595
3158790|NCT01853085|3885554|FG000|NOT COMPLETED|Overall Study||235
3158791|NCT01853137|3885560|FG000|STARTED|Overall Study||25
3158792|NCT01853137|3885561|FG001|STARTED|Overall Study||18
3158793|NCT01853137|3885560|FG000|COMPLETED|Overall Study||21
3158794|NCT01853137|3885561|FG001|COMPLETED|Overall Study||17
3158795|NCT01853137|3885560|FG000|NOT COMPLETED|Overall Study||4
3158796|NCT01853137|3885561|FG001|NOT COMPLETED|Overall Study||1
3158797|NCT01853215|3885568|FG000|STARTED|Overall Study||24
3158798|NCT01853215|3885568|FG000|COMPLETED|Overall Study||24
3158799|NCT01853215|3885568|FG000|NOT COMPLETED|Overall Study||0
3158800|NCT01853228|3885573|FG000|STARTED|Phase 1||9
3158801|NCT01853228|3885574|FG001|STARTED|Phase 1||7
3158802|NCT01853228|3885573|FG000|COMPLETED|Phase 1||0
3185894|NCT02023125|3914054|FG002|COMPLETED|Period 1||24
3185895|NCT02023125|3914052|FG000|NOT COMPLETED|Period 1||0
3185896|NCT02023125|3914053|FG001|NOT COMPLETED|Period 1||0
3185897|NCT02023125|3914054|FG002|NOT COMPLETED|Period 1||0
3185898|NCT02023125|3914052|FG000|STARTED|Washout Period||9
3185899|NCT02023125|3914053|FG001|STARTED|Washout Period||9
3185900|NCT02023125|3914054|FG002|STARTED|Washout Period||24
3185901|NCT02023125|3914052|FG000|COMPLETED|Washout Period||9
3185902|NCT02023125|3914053|FG001|COMPLETED|Washout Period||9
3185903|NCT02023125|3914054|FG002|COMPLETED|Washout Period||24
3185904|NCT02023125|3914052|FG000|NOT COMPLETED|Washout Period||0
3185905|NCT02023125|3914053|FG001|NOT COMPLETED|Washout Period||0
3185906|NCT02023125|3914054|FG002|NOT COMPLETED|Washout Period||0
3185907|NCT02023125|3914052|FG000|STARTED|Period 2||9
3185908|NCT02023125|3914053|FG001|STARTED|Period 2||9
3185909|NCT02023125|3914054|FG002|STARTED|Period 2||24
3185910|NCT02023125|3914052|FG000|COMPLETED|Period 2||9
3185911|NCT02023125|3914053|FG001|COMPLETED|Period 2||9
3185912|NCT02023125|3914054|FG002|COMPLETED|Period 2||24
3185913|NCT02023125|3914052|FG000|NOT COMPLETED|Period 2||0
3185914|NCT02023125|3914053|FG001|NOT COMPLETED|Period 2||0
3185915|NCT02023125|3914054|FG002|NOT COMPLETED|Period 2||0
3185916|NCT02023151|3914066|FG000|STARTED|Overall Study||17
3185917|NCT02023151|3914066|FG000|COMPLETED|Overall Study||13
3185918|NCT02023151|3914066|FG000|NOT COMPLETED|Overall Study||4
3185919|NCT02023242|3914072|FG000|STARTED|Overall Study||75
3185920|NCT02023242|3914073|FG001|STARTED|Overall Study||77
3185921|NCT02023242|3914072|FG000|COMPLETED|Overall Study||72
3185922|NCT02023242|3914073|FG001|COMPLETED|Overall Study||75
3185923|NCT02023242|3914072|FG000|NOT COMPLETED|Overall Study||3
3185924|NCT02023242|3914073|FG001|NOT COMPLETED|Overall Study||2
3363891|NCT04039919|4095091|FG004|COMPLETED|Treatment Period 1||0
3363892|NCT04039919|4095087|FG000|NOT COMPLETED|Treatment Period 1||1
3363893|NCT04039919|4095088|FG001|NOT COMPLETED|Treatment Period 1||0
3363894|NCT04039919|4095089|FG002|NOT COMPLETED|Treatment Period 1||0
3363895|NCT04039919|4095090|FG003|NOT COMPLETED|Treatment Period 1||0
3363896|NCT04039919|4095091|FG004|NOT COMPLETED|Treatment Period 1||16
3363897|NCT04039919|4095087|FG000|STARTED|Treatment Period 2||6
3363898|NCT04039919|4095088|FG001|STARTED|Treatment Period 2||6
3363899|NCT04039919|4095089|FG002|STARTED|Treatment Period 2||5
3363900|NCT04039919|4095090|FG003|STARTED|Treatment Period 2||6
3363901|NCT04039919|4095091|FG004|STARTED|Treatment Period 2||0
3363902|NCT04039919|4095087|FG000|COMPLETED|Treatment Period 2||6
3363903|NCT04039919|4095088|FG001|COMPLETED|Treatment Period 2||6
3363904|NCT04039919|4095089|FG002|COMPLETED|Treatment Period 2||5
3363905|NCT04039919|4095090|FG003|COMPLETED|Treatment Period 2||6
3363906|NCT04039919|4095091|FG004|COMPLETED|Treatment Period 2||0
3363907|NCT04039919|4095087|FG000|NOT COMPLETED|Treatment Period 2||0
3363908|NCT04039919|4095088|FG001|NOT COMPLETED|Treatment Period 2||0
3363909|NCT04039919|4095089|FG002|NOT COMPLETED|Treatment Period 2||0
3363910|NCT04039919|4095090|FG003|NOT COMPLETED|Treatment Period 2||0
3363911|NCT04039919|4095091|FG004|NOT COMPLETED|Treatment Period 2||0
3363912|NCT04039919|4095087|FG000|STARTED|Treatment Period 3||6
3363913|NCT04039919|4095088|FG001|STARTED|Treatment Period 3||6
3363914|NCT04039919|4095089|FG002|STARTED|Treatment Period 3||5
3363915|NCT04039919|4095090|FG003|STARTED|Treatment Period 3||6
3363916|NCT04039919|4095091|FG004|STARTED|Treatment Period 3||0
3363917|NCT04039919|4095087|FG000|COMPLETED|Treatment Period 3||6
3158803|NCT01853228|3885574|FG001|COMPLETED|Phase 1|Participants who completed Phase 1 moved to Phase 2.|7
3158804|NCT01853228|3885573|FG000|NOT COMPLETED|Phase 1||9
3158805|NCT01853228|3885574|FG001|NOT COMPLETED|Phase 1||0
3158806|NCT01853228|3885573|FG000|STARTED|Phase 2||0
3158807|NCT01853228|3885574|FG001|STARTED|Phase 2|1 additional participant was enrolled, making total of 8 participants evaluable in Phase 2.|8
3158808|NCT01853228|3885573|FG000|COMPLETED|Phase 2||0
3158809|NCT01853228|3885574|FG001|COMPLETED|Phase 2||0
3158810|NCT01853228|3885573|FG000|NOT COMPLETED|Phase 2||0
3158811|NCT01853228|3885574|FG001|NOT COMPLETED|Phase 2||8
3158812|NCT01853254|3885579|FG000|STARTED|Overall Study||272
3363918|NCT04039919|4095088|FG001|COMPLETED|Treatment Period 3||6
3363919|NCT04039919|4095089|FG002|COMPLETED|Treatment Period 3||5
3363920|NCT04039919|4095090|FG003|COMPLETED|Treatment Period 3||6
3363921|NCT04039919|4095091|FG004|COMPLETED|Treatment Period 3||0
3363922|NCT04039919|4095087|FG000|NOT COMPLETED|Treatment Period 3||0
3363923|NCT04039919|4095088|FG001|NOT COMPLETED|Treatment Period 3||0
3363924|NCT04039919|4095089|FG002|NOT COMPLETED|Treatment Period 3||0
3363925|NCT04039919|4095090|FG003|NOT COMPLETED|Treatment Period 3||0
3363926|NCT04039919|4095091|FG004|NOT COMPLETED|Treatment Period 3||0
3363927|NCT04039919|4095087|FG000|STARTED|Treatment Period 4||6
3363928|NCT04039919|4095088|FG001|STARTED|Treatment Period 4||6
3363929|NCT04039919|4095089|FG002|STARTED|Treatment Period 4||5
3363930|NCT04039919|4095090|FG003|STARTED|Treatment Period 4||6
3363931|NCT04039919|4095091|FG004|STARTED|Treatment Period 4||0
3363932|NCT04039919|4095087|FG000|COMPLETED|Treatment Period 4||6
3363933|NCT04039919|4095088|FG001|COMPLETED|Treatment Period 4||6
3363934|NCT04039919|4095089|FG002|COMPLETED|Treatment Period 4||5
3363935|NCT04039919|4095090|FG003|COMPLETED|Treatment Period 4||6
3363936|NCT04039919|4095091|FG004|COMPLETED|Treatment Period 4||0
3363937|NCT04039919|4095087|FG000|NOT COMPLETED|Treatment Period 4||0
3158813|NCT01853254|3885579|FG000|COMPLETED|Overall Study||168
3158814|NCT01853254|3885579|FG000|NOT COMPLETED|Overall Study||104
3158815|NCT01853280|3885585|FG000|STARTED|Overall Study||22
3158816|NCT01853280|3885586|FG001|STARTED|Overall Study||22
3158817|NCT01853280|3885585|FG000|COMPLETED|Overall Study||20
3158818|NCT01853280|3885586|FG001|COMPLETED|Overall Study||16
3158819|NCT01853280|3885585|FG000|NOT COMPLETED|Overall Study||2
3158820|NCT01853280|3885586|FG001|NOT COMPLETED|Overall Study||6
3158821|NCT01853332|3885592|FG000|STARTED|Overall Study||210
3158822|NCT01853332|3885592|FG000|COMPLETED|Overall Study||151
3158823|NCT01853332|3885592|FG000|NOT COMPLETED|Overall Study||59
3158824|NCT01853371|3885599|FG000|STARTED|Overall Study||10
3158825|NCT01853371|3885600|FG001|STARTED|Overall Study||10
3158826|NCT01853371|3885599|FG000|COMPLETED|Overall Study||10
3158827|NCT01853371|3885600|FG001|COMPLETED|Overall Study||8
3158828|NCT01853371|3885599|FG000|NOT COMPLETED|Overall Study||0
3158829|NCT01853371|3885600|FG001|NOT COMPLETED|Overall Study||2
3158830|NCT01853384|3885608|FG000|STARTED|Randomized||131
3158831|NCT01853384|3885609|FG001|STARTED|Randomized||121
3158832|NCT01853384|3885608|FG000|COMPLETED|Randomized||69
3158833|NCT01853384|3885609|FG001|COMPLETED|Randomized||75
3158834|NCT01853384|3885608|FG000|NOT COMPLETED|Randomized||62
3158835|NCT01853384|3885609|FG001|NOT COMPLETED|Randomized||46
3158836|NCT01853384|3885608|FG000|STARTED|Enrolled in Follow up Period||96
3158837|NCT01853384|3885609|FG001|STARTED|Enrolled in Follow up Period||94
3158838|NCT01853384|3885608|FG000|Not Enrolled in Follow-up|Enrolled in Follow up Period||35
3158839|NCT01853384|3885609|FG001|Not Enrolled in Follow-up|Enrolled in Follow up Period||27
3158840|NCT01853384|3885608|FG000|COMPLETED|Enrolled in Follow up Period||96
3158841|NCT01853384|3885609|FG001|COMPLETED|Enrolled in Follow up Period||94
3158842|NCT01853384|3885608|FG000|NOT COMPLETED|Enrolled in Follow up Period||0
3158843|NCT01853384|3885609|FG001|NOT COMPLETED|Enrolled in Follow up Period||0
3158844|NCT01853384|3885608|FG000|STARTED|Completed Follow up Visit 1||96
3158845|NCT01853384|3885609|FG001|STARTED|Completed Follow up Visit 1||94
3158846|NCT01853384|3885608|FG000|COMPLETED|Completed Follow up Visit 1||82
3158847|NCT01853384|3885609|FG001|COMPLETED|Completed Follow up Visit 1||85
3158848|NCT01853384|3885608|FG000|NOT COMPLETED|Completed Follow up Visit 1||14
3158849|NCT01853384|3885609|FG001|NOT COMPLETED|Completed Follow up Visit 1||9
3158850|NCT01853384|3885608|FG000|STARTED|Completed Follow up Visit 2||96
3158851|NCT01853384|3885609|FG001|STARTED|Completed Follow up Visit 2||94
3158852|NCT01853384|3885608|FG000|COMPLETED|Completed Follow up Visit 2||93
3158853|NCT01853384|3885609|FG001|COMPLETED|Completed Follow up Visit 2||91
3158854|NCT01853384|3885608|FG000|NOT COMPLETED|Completed Follow up Visit 2||3
3158855|NCT01853384|3885609|FG001|NOT COMPLETED|Completed Follow up Visit 2||3
3158856|NCT01853397|3885619|FG000|STARTED|Overall Study||18
3158857|NCT01853397|3885620|FG001|STARTED|Overall Study||20
3158858|NCT01853397|3885621|FG002|STARTED|Overall Study||17
3158859|NCT01853397|3885622|FG003|STARTED|Overall Study||17
3158860|NCT01853397|3885619|FG000|COMPLETED|Overall Study||18
3158861|NCT01853397|3885620|FG001|COMPLETED|Overall Study||20
3158862|NCT01853397|3885621|FG002|COMPLETED|Overall Study||17
3158863|NCT01853397|3885622|FG003|COMPLETED|Overall Study||15
3158864|NCT01853397|3885619|FG000|NOT COMPLETED|Overall Study||0
3158865|NCT01853397|3885620|FG001|NOT COMPLETED|Overall Study||0
3158866|NCT01853397|3885621|FG002|NOT COMPLETED|Overall Study||0
3158867|NCT01853397|3885622|FG003|NOT COMPLETED|Overall Study||2
3158868|NCT01853462|3885634|FG000|STARTED|Overall Study||11
3158869|NCT01853462|3885635|FG001|STARTED|Overall Study||11
3158870|NCT01853462|3885634|FG000|COMPLETED|Overall Study||10
3158871|NCT01853462|3885635|FG001|COMPLETED|Overall Study||10
3158872|NCT01853462|3885634|FG000|NOT COMPLETED|Overall Study||1
3158873|NCT01853462|3885635|FG001|NOT COMPLETED|Overall Study||1
3158874|NCT01853475|3885646|FG000|STARTED|Overall Study||8
3158875|NCT01853475|3885647|FG001|STARTED|Overall Study||8
3158876|NCT01853475|3885648|FG002|STARTED|Overall Study||8
3158877|NCT01853475|3885646|FG000|COMPLETED|Overall Study||8
3158878|NCT01853475|3885647|FG001|COMPLETED|Overall Study||7
3158879|NCT01853475|3885648|FG002|COMPLETED|Overall Study||8
3158880|NCT01853475|3885646|FG000|NOT COMPLETED|Overall Study||0
3158881|NCT01853475|3885647|FG001|NOT COMPLETED|Overall Study||1
3158882|NCT01853475|3885648|FG002|NOT COMPLETED|Overall Study||0
3158883|NCT01853553|3885658|FG000|STARTED|Overall Study||29
3158884|NCT01853553|3885659|FG001|STARTED|Overall Study||32
3158885|NCT01853553|3885658|FG000|COMPLETED|Overall Study||28
3158886|NCT01853553|3885659|FG001|COMPLETED|Overall Study||32
3158887|NCT01853553|3885658|FG000|NOT COMPLETED|Overall Study||1
3158888|NCT01853553|3885659|FG001|NOT COMPLETED|Overall Study||0
3158889|NCT01853605|3885669|FG000|STARTED|Overall Study||1939
3158890|NCT01853605|3885670|FG001|STARTED|Overall Study||693
3158891|NCT01853605|3885671|FG002|STARTED|Overall Study||751
3158892|NCT01853605|3885672|FG003|STARTED|Overall Study||428
3158893|NCT01853605|3885669|FG000|COMPLETED|Overall Study||1939
3158894|NCT01853605|3885670|FG001|COMPLETED|Overall Study||693
3158895|NCT01853605|3885671|FG002|COMPLETED|Overall Study||751
3158896|NCT01853605|3885672|FG003|COMPLETED|Overall Study||428
3158897|NCT01853605|3885669|FG000|NOT COMPLETED|Overall Study||0
3158898|NCT01853605|3885670|FG001|NOT COMPLETED|Overall Study||0
3158899|NCT01853605|3885671|FG002|NOT COMPLETED|Overall Study||0
3158900|NCT01853605|3885672|FG003|NOT COMPLETED|Overall Study||0
3158901|NCT01853618|3885687|FG000|STARTED|Overall Study||8
3158902|NCT01853618|3885688|FG001|STARTED|Overall Study||12
3158903|NCT01853618|3885689|FG002|STARTED|Overall Study||12
3158904|NCT01853618|3885690|FG003|STARTED|Overall Study||9
3158905|NCT01853618|3885691|FG004|STARTED|Overall Study||20
3158906|NCT01853618|3885687|FG000|COMPLETED|Overall Study||6
3158907|NCT01853618|3885688|FG001|COMPLETED|Overall Study||10
3158908|NCT01853618|3885689|FG002|COMPLETED|Overall Study||10
3158909|NCT01853618|3885690|FG003|COMPLETED|Overall Study||8
3158910|NCT01853618|3885691|FG004|COMPLETED|Overall Study||17
3158911|NCT01853618|3885687|FG000|NOT COMPLETED|Overall Study||2
3158912|NCT01853618|3885688|FG001|NOT COMPLETED|Overall Study||2
3158913|NCT01853618|3885689|FG002|NOT COMPLETED|Overall Study||2
3158914|NCT01853618|3885690|FG003|NOT COMPLETED|Overall Study||1
3158915|NCT01853618|3885691|FG004|NOT COMPLETED|Overall Study||3
3158916|NCT01853644|3885704|FG000|STARTED|Registration and Treatment Start||31
3158917|NCT01853644|3885704|FG000|Registered|Registration and Treatment Start||31
3158918|NCT01853644|3885704|FG000|Started Treatment|Registration and Treatment Start||30
3158919|NCT01853644|3885704|FG000|COMPLETED|Registration and Treatment Start||30
3158920|NCT01853644|3885704|FG000|NOT COMPLETED|Registration and Treatment Start||1
3158921|NCT01853644|3885704|FG000|STARTED|Reached First Response/Complete 2 Cycles||30
3158922|NCT01853644|3885704|FG000|COMPLETED|Reached First Response/Complete 2 Cycles||24
3158923|NCT01853644|3885704|FG000|NOT COMPLETED|Reached First Response/Complete 2 Cycles||6
3158924|NCT01853644|3885704|FG000|STARTED|Continued Treatment After First Response||24
3158925|NCT01853644|3885704|FG000|COMPLETED|Continued Treatment After First Response||12
3158926|NCT01853644|3885704|FG000|NOT COMPLETED|Continued Treatment After First Response||12
3158927|NCT01853644|3885704|FG000|STARTED|Follow up for 3 Years or Until Death|All patients that are treated on the study go into the follow up period|30
3158928|NCT01853644|3885704|FG000|COMPLETED|Follow up for 3 Years or Until Death||30
3158929|NCT01853644|3885704|FG000|NOT COMPLETED|Follow up for 3 Years or Until Death||0
3158930|NCT01853696|3885710|FG000|STARTED|Overall Study||84
3158931|NCT01853696|3885711|FG001|STARTED|Overall Study||83
3158932|NCT01853696|3885710|FG000|COMPLETED|Overall Study||78
3158933|NCT01853696|3885711|FG001|COMPLETED|Overall Study||78
3158934|NCT01853696|3885710|FG000|NOT COMPLETED|Overall Study||6
3158935|NCT01853696|3885711|FG001|NOT COMPLETED|Overall Study||5
3158936|NCT01853774|3885719|FG000|STARTED|Overall Study||257
3185925|NCT02023268|3914081|FG000|STARTED|Overall Study||52
3185926|NCT02023268|3914082|FG001|STARTED|Overall Study||53
3185927|NCT02023268|3914081|FG000|COMPLETED|Overall Study||52
3185928|NCT02023268|3914082|FG001|COMPLETED|Overall Study||49
3185929|NCT02023268|3914081|FG000|NOT COMPLETED|Overall Study||0
3185930|NCT02023268|3914082|FG001|NOT COMPLETED|Overall Study||4
3185931|NCT02023411|3914090|FG000|STARTED|Overall Study||10
3185932|NCT02023411|3914091|FG001|STARTED|Overall Study||10
3185933|NCT02023411|3914090|FG000|COMPLETED|Overall Study||10
3185934|NCT02023411|3914091|FG001|COMPLETED|Overall Study||10
3185935|NCT02023411|3914090|FG000|NOT COMPLETED|Overall Study||0
3185936|NCT02023411|3914091|FG001|NOT COMPLETED|Overall Study||0
3185937|NCT02023515|3914100|FG000|STARTED|Overall Study||24
3185938|NCT02023515|3914101|FG001|STARTED|Overall Study||25
3185939|NCT02023515|3914100|FG000|COMPLETED|Overall Study||23
3185940|NCT02023515|3914101|FG001|COMPLETED|Overall Study||22
3185941|NCT02023515|3914100|FG000|NOT COMPLETED|Overall Study||1
3185942|NCT02023515|3914101|FG001|NOT COMPLETED|Overall Study||3
3185943|NCT02023697|3914110|FG000|STARTED|Treatment Period||130
3185944|NCT02023697|3914111|FG001|STARTED|Treatment Period||130
3185945|NCT02023697|3914112|FG002|STARTED|Treatment Period||131
3185946|NCT02023697|3914110|FG000|Received Treatment|Treatment Period||125
3185947|NCT02023697|3914111|FG001|Received Treatment|Treatment Period||124
3185948|NCT02023697|3914112|FG002|Received Treatment|Treatment Period||121
3185949|NCT02023697|3914110|FG000|COMPLETED|Treatment Period||84
3185950|NCT02023697|3914111|FG001|COMPLETED|Treatment Period||67
3185951|NCT02023697|3914112|FG002|COMPLETED|Treatment Period||29
3185952|NCT02023697|3914110|FG000|NOT COMPLETED|Treatment Period||46
3185953|NCT02023697|3914111|FG001|NOT COMPLETED|Treatment Period||63
3185954|NCT02023697|3914112|FG002|NOT COMPLETED|Treatment Period||102
3185955|NCT02023697|3914110|FG000|STARTED|Active Follow-up Period|Not all participants in ITT entered active follow-up.|120
3185956|NCT02023697|3914111|FG001|STARTED|Active Follow-up Period|Not all participants in ITT entered active follow-up.|120
3185957|NCT02023697|3914112|FG002|STARTED|Active Follow-up Period|Not all participants in ITT entered active follow-up.|116
3185958|NCT02023697|3914110|FG000|COMPLETED|Active Follow-up Period||28
3185959|NCT02023697|3914111|FG001|COMPLETED|Active Follow-up Period||21
3185960|NCT02023697|3914112|FG002|COMPLETED|Active Follow-up Period||17
3185961|NCT02023697|3914110|FG000|NOT COMPLETED|Active Follow-up Period||92
3185962|NCT02023697|3914111|FG001|NOT COMPLETED|Active Follow-up Period||99
3185963|NCT02023697|3914112|FG002|NOT COMPLETED|Active Follow-up Period||99
3185964|NCT02023697|3914110|FG000|STARTED|Long-term Follow-up Period||28
3185965|NCT02023697|3914111|FG001|STARTED|Long-term Follow-up Period||21
3185966|NCT02023697|3914112|FG002|STARTED|Long-term Follow-up Period||17
3185967|NCT02023697|3914110|FG000|COMPLETED|Long-term Follow-up Period||0
3185968|NCT02023697|3914111|FG001|COMPLETED|Long-term Follow-up Period||0
3185969|NCT02023697|3914112|FG002|COMPLETED|Long-term Follow-up Period||0
3185970|NCT02023697|3914110|FG000|NOT COMPLETED|Long-term Follow-up Period||28
3185971|NCT02023697|3914111|FG001|NOT COMPLETED|Long-term Follow-up Period||21
3185972|NCT02023697|3914112|FG002|NOT COMPLETED|Long-term Follow-up Period||17
3185973|NCT02023801|3914127|FG000|STARTED|Overall Study|Treatment Attempted|24
3158937|NCT01853774|3885720|FG001|STARTED|Overall Study||162
3158938|NCT01853774|3885719|FG000|COMPLETED|Overall Study||211
3158939|NCT01853774|3885720|FG001|COMPLETED|Overall Study||134
3158940|NCT01853774|3885719|FG000|NOT COMPLETED|Overall Study||46
3158941|NCT01853774|3885720|FG001|NOT COMPLETED|Overall Study||28
3158942|NCT01853839|3885728|FG000|STARTED|Overall Study||2092
3158943|NCT01853839|3885728|FG000|COMPLETED|Overall Study||1663
3158944|NCT01853839|3885728|FG000|NOT COMPLETED|Overall Study||429
3158945|NCT01853878|3885738|FG000|STARTED|Overall Study||86
3158946|NCT01853878|3885739|FG001|STARTED|Overall Study||47
3158947|NCT01853878|3885738|FG000|COMPLETED|Overall Study||23
3158948|NCT01853878|3885739|FG001|COMPLETED|Overall Study||3
3158949|NCT01853878|3885738|FG000|NOT COMPLETED|Overall Study||63
3158950|NCT01853878|3885739|FG001|NOT COMPLETED|Overall Study||44
3158951|NCT01853930|3885747|FG000|STARTED|Overall Study||25
3158952|NCT01853930|3885748|FG001|STARTED|Overall Study||8
3158953|NCT01853930|3885747|FG000|COMPLETED|Overall Study||25
3158954|NCT01853930|3885748|FG001|COMPLETED|Overall Study||8
3158955|NCT01853930|3885747|FG000|NOT COMPLETED|Overall Study||0
3158956|NCT01853930|3885748|FG001|NOT COMPLETED|Overall Study||0
3158957|NCT01854034|3885754|FG000|STARTED|Overall Study||29
3158958|NCT01854034|3885754|FG000|COMPLETED|Overall Study||29
3158959|NCT01854034|3885754|FG000|NOT COMPLETED|Overall Study||0
3158960|NCT01854047|3885763|FG000|STARTED|Overall Study||158
3158961|NCT01854047|3885764|FG001|STARTED|Overall Study||157
3158962|NCT01854047|3885765|FG002|STARTED|Overall Study||150
3158963|NCT01854047|3885766|FG003|STARTED|Overall Study||157
3158964|NCT01854047|3885767|FG004|STARTED|Overall Study||154
3158965|NCT01854047|3885763|FG000|Treated|Overall Study||158
3158966|NCT01854047|3885764|FG001|Treated|Overall Study||156
3158967|NCT01854047|3885765|FG002|Treated|Overall Study||148
3158968|NCT01854047|3885766|FG003|Treated|Overall Study||157
3158969|NCT01854047|3885767|FG004|Treated|Overall Study||150
3158970|NCT01854047|3885763|FG000|Completed 12-week Study Treatment|Overall Study||153
3158971|NCT01854047|3885764|FG001|Completed 12-week Study Treatment|Overall Study||149
3158972|NCT01854047|3885765|FG002|Completed 12-week Study Treatment|Overall Study||141
3158973|NCT01854047|3885766|FG003|Completed 12-week Study Treatment|Overall Study||146
3158974|NCT01854047|3885767|FG004|Completed 12-week Study Treatment|Overall Study||143
3158975|NCT01854047|3885763|FG000|COMPLETED|Overall Study||146
3158976|NCT01854047|3885764|FG001|COMPLETED|Overall Study||149
3158977|NCT01854047|3885765|FG002|COMPLETED|Overall Study||137
3158978|NCT01854047|3885766|FG003|COMPLETED|Overall Study||142
3158979|NCT01854047|3885767|FG004|COMPLETED|Overall Study||135
3158980|NCT01854047|3885763|FG000|NOT COMPLETED|Overall Study||12
3158981|NCT01854047|3885764|FG001|NOT COMPLETED|Overall Study||8
3158982|NCT01854047|3885765|FG002|NOT COMPLETED|Overall Study||13
3158983|NCT01854047|3885766|FG003|NOT COMPLETED|Overall Study||15
3158984|NCT01854047|3885767|FG004|NOT COMPLETED|Overall Study||19
3158985|NCT01854138|3885781|FG000|STARTED|Overall Study|historical control with waiver of authorization; no informed consent signed|400
3158986|NCT01854138|3885782|FG001|STARTED|Overall Study||248
3158987|NCT01854138|3885781|FG000|COMPLETED|Overall Study||400
3158988|NCT01854138|3885782|FG001|COMPLETED|Overall Study||196
3158989|NCT01854138|3885781|FG000|NOT COMPLETED|Overall Study||0
3158990|NCT01854138|3885782|FG001|NOT COMPLETED|Overall Study||52
3158991|NCT01854177|3885789|FG000|STARTED|Overall Study||10
3158992|NCT01854177|3885789|FG000|COMPLETED|Overall Study||10
3158993|NCT01854177|3885789|FG000|NOT COMPLETED|Overall Study||0
3158994|NCT01854242|3885795|FG000|STARTED|Overall Study||50
3158995|NCT01854242|3885795|FG000|COMPLETED|Overall Study||50
3158996|NCT01854242|3885795|FG000|NOT COMPLETED|Overall Study||0
3158997|NCT01854281|3885803|FG000|STARTED|Overall Study||15
3158998|NCT01854281|3885804|FG001|STARTED|Overall Study||19
3158999|NCT01854281|3885805|FG002|STARTED|Overall Study||5
3159000|NCT01854281|3885806|FG003|STARTED|Overall Study||8
3159001|NCT01854281|3885803|FG000|COMPLETED|Overall Study||15
3159002|NCT01854281|3885804|FG001|COMPLETED|Overall Study||19
3159003|NCT01854281|3885805|FG002|COMPLETED|Overall Study||5
3159004|NCT01854281|3885806|FG003|COMPLETED|Overall Study||8
3159005|NCT01854281|3885803|FG000|NOT COMPLETED|Overall Study||0
3159006|NCT01854281|3885804|FG001|NOT COMPLETED|Overall Study||0
3159007|NCT01854281|3885805|FG002|NOT COMPLETED|Overall Study||0
3159008|NCT01854281|3885806|FG003|NOT COMPLETED|Overall Study||0
3159009|NCT01854359|3885818|FG000|STARTED|Overall Study||31
3159010|NCT01854359|3885819|FG001|STARTED|Overall Study||30
3159011|NCT01854359|3885818|FG000|COMPLETED|Overall Study||26
3159012|NCT01854359|3885819|FG001|COMPLETED|Overall Study||22
3159013|NCT01854359|3885818|FG000|NOT COMPLETED|Overall Study||5
3159014|NCT01854359|3885819|FG001|NOT COMPLETED|Overall Study||8
3159015|NCT01854528|3885835|FG000|STARTED|Overall Study||101
3159016|NCT01854528|3885836|FG001|STARTED|Overall Study||47
3159017|NCT01854528|3885835|FG000|COMPLETED|Overall Study||101
3159018|NCT01854528|3885836|FG001|COMPLETED|Overall Study||32
3159019|NCT01854528|3885835|FG000|NOT COMPLETED|Overall Study||0
3159020|NCT01854528|3885836|FG001|NOT COMPLETED|Overall Study||15
3159021|NCT01854593|3885844|FG000|STARTED|Overall Study||34
3159022|NCT01854593|3885845|FG001|STARTED|Overall Study||35
3159023|NCT01854593|3885844|FG000|COMPLETED|Overall Study||32
3159024|NCT01854593|3885845|FG001|COMPLETED|Overall Study||34
3159025|NCT01854593|3885844|FG000|NOT COMPLETED|Overall Study||2
3159026|NCT01854593|3885845|FG001|NOT COMPLETED|Overall Study||1
3159027|NCT01854632|3885854|FG000|STARTED|Overall Study||1174
3159028|NCT01854632|3885855|FG001|STARTED|Overall Study||587
3159029|NCT01854632|3885854|FG000|COMPLETED|Overall Study||1148
3159030|NCT01854632|3885855|FG001|COMPLETED|Overall Study||574
3159031|NCT01854632|3885854|FG000|NOT COMPLETED|Overall Study||26
3159032|NCT01854632|3885855|FG001|NOT COMPLETED|Overall Study||13
3159033|NCT01854645|3885866|FG000|STARTED|Overall Study||527
3159034|NCT01854645|3885867|FG001|STARTED|Overall Study||451
3159035|NCT01854645|3885868|FG002|STARTED|Overall Study||452
3159036|NCT01854645|3885869|FG003|STARTED|Overall Study||453
3159037|NCT01854645|3885870|FG004|STARTED|Overall Study||220
3159038|NCT01854645|3885866|FG000|COMPLETED|Overall Study||429
3159039|NCT01854645|3885867|FG001|COMPLETED|Overall Study||345
3159040|NCT01854645|3885868|FG002|COMPLETED|Overall Study||370
3159041|NCT01854645|3885869|FG003|COMPLETED|Overall Study||391
3159042|NCT01854645|3885870|FG004|COMPLETED|Overall Study||160
3159043|NCT01854645|3885866|FG000|NOT COMPLETED|Overall Study||98
3159044|NCT01854645|3885867|FG001|NOT COMPLETED|Overall Study||106
3159045|NCT01854645|3885868|FG002|NOT COMPLETED|Overall Study||82
3159046|NCT01854645|3885869|FG003|NOT COMPLETED|Overall Study||62
3159047|NCT01854645|3885870|FG004|NOT COMPLETED|Overall Study||60
3159048|NCT01854658|3885886|FG000|STARTED|Overall Study||439
3159049|NCT01854658|3885887|FG001|STARTED|Overall Study||440
3159050|NCT01854658|3885888|FG002|STARTED|Overall Study||512
3159051|NCT01854658|3885889|FG003|STARTED|Overall Study||224
3159052|NCT01854658|3885886|FG000|COMPLETED|Overall Study||346
3159053|NCT01854658|3885887|FG001|COMPLETED|Overall Study||365
3159054|NCT01854658|3885888|FG002|COMPLETED|Overall Study||432
3159055|NCT01854658|3885889|FG003|COMPLETED|Overall Study||165
3185974|NCT02023801|3914127|FG000|Treated|Overall Study|Treatment Completed|24
3185975|NCT02023801|3914127|FG000|COMPLETED|Overall Study|Completed 12 Month Follow-up|24
3185976|NCT02023801|3914127|FG000|NOT COMPLETED|Overall Study||0
3185977|NCT02023866|3914131|FG000|STARTED|Overall Study||36
3185978|NCT02023866|3914131|FG000|COMPLETED|Overall Study||30
3185979|NCT02023866|3914131|FG000|NOT COMPLETED|Overall Study||6
3185980|NCT02023879|3914138|FG000|STARTED|Period 1: 24-Week Double-blind Treatment||58
3185981|NCT02023879|3914139|FG001|STARTED|Period 1: 24-Week Double-blind Treatment||116
3185982|NCT02023879|3914140|FG002|STARTED|Period 1: 24-Week Double-blind Treatment||59
3185983|NCT02023879|3914138|FG000|Treated|Period 1: 24-Week Double-blind Treatment||58
3185984|NCT02023879|3914139|FG001|Treated|Period 1: 24-Week Double-blind Treatment||115
3185985|NCT02023879|3914140|FG002|Treated|Period 1: 24-Week Double-blind Treatment||58
3185986|NCT02023879|3914138|FG000|COMPLETED|Period 1: 24-Week Double-blind Treatment||54
3185987|NCT02023879|3914139|FG001|COMPLETED|Period 1: 24-Week Double-blind Treatment||107
3185988|NCT02023879|3914140|FG002|COMPLETED|Period 1: 24-Week Double-blind Treatment||50
3185989|NCT02023879|3914138|FG000|NOT COMPLETED|Period 1: 24-Week Double-blind Treatment||4
3185990|NCT02023879|3914139|FG001|NOT COMPLETED|Period 1: 24-Week Double-blind Treatment||9
3185991|NCT02023879|3914140|FG002|NOT COMPLETED|Period 1: 24-Week Double-blind Treatment||9
3185992|NCT02023879|3914138|FG000|STARTED|Extension Open Label Treatment|The open-label extension period was optional for participants who completed the double-blind period.|51
3185993|NCT02023879|3914139|FG001|STARTED|Extension Open Label Treatment|The open-label extension period was optional for participants who completed the double-blind period.|106
3185994|NCT02023879|3914140|FG002|STARTED|Extension Open Label Treatment|The open-label extension period was optional for participants who completed the double-blind period.|48
3185995|NCT02023879|3914138|FG000|COMPLETED|Extension Open Label Treatment||46
3185996|NCT02023879|3914139|FG001|COMPLETED|Extension Open Label Treatment||89
3185997|NCT02023879|3914140|FG002|COMPLETED|Extension Open Label Treatment||43
3185998|NCT02023879|3914138|FG000|NOT COMPLETED|Extension Open Label Treatment||5
3185999|NCT02023879|3914139|FG001|NOT COMPLETED|Extension Open Label Treatment||17
3186000|NCT02023879|3914140|FG002|NOT COMPLETED|Extension Open Label Treatment||5
3186001|NCT02023918|3914155|FG000|STARTED|Overall Study||6
3186002|NCT02023918|3914155|FG000|COMPLETED|Overall Study||6
3186003|NCT02023918|3914155|FG000|NOT COMPLETED|Overall Study||0
3186004|NCT02023944|3914161|FG000|STARTED|Overall Study||25
3186005|NCT02023944|3914162|FG001|STARTED|Overall Study||25
3186006|NCT02023944|3914161|FG000|COMPLETED|Overall Study||25
3186007|NCT02023944|3914162|FG001|COMPLETED|Overall Study||24
3186008|NCT02023944|3914161|FG000|NOT COMPLETED|Overall Study||0
3186009|NCT02023944|3914162|FG001|NOT COMPLETED|Overall Study||1
3186010|NCT02023983|3914171|FG000|STARTED|Overall Study||76
3186011|NCT02023983|3914172|FG001|STARTED|Overall Study||75
3186012|NCT02023983|3914171|FG000|COMPLETED|Overall Study||76
3186013|NCT02023983|3914172|FG001|COMPLETED|Overall Study||75
3186014|NCT02023983|3914171|FG000|NOT COMPLETED|Overall Study||0
3186015|NCT02023983|3914172|FG001|NOT COMPLETED|Overall Study||0
3186016|NCT02024087|3914180|FG000|STARTED|Overall Study||5
3186017|NCT02024087|3914181|FG001|STARTED|Overall Study|Dose change to 0.4 mg/kg and cohort expanded to 16 participants in total at this dose level|16
3186018|NCT02024087|3914180|FG000|COMPLETED|Overall Study||5
3186019|NCT02024087|3914181|FG001|COMPLETED|Overall Study||16
3186020|NCT02024087|3914180|FG000|NOT COMPLETED|Overall Study||0
3186021|NCT02024087|3914181|FG001|NOT COMPLETED|Overall Study||0
3186022|NCT02024165|3914188|FG000|STARTED|Overall Study||71
3186023|NCT02024165|3914188|FG000|COMPLETED|Overall Study||71
3186024|NCT02024165|3914188|FG000|NOT COMPLETED|Overall Study||0
3186025|NCT02024204|3914195|FG000|STARTED|Overall Study||49
3186026|NCT02024204|3914196|FG001|STARTED|Overall Study||11
3159056|NCT01854658|3885886|FG000|NOT COMPLETED|Overall Study||93
3159057|NCT01854658|3885887|FG001|NOT COMPLETED|Overall Study||75
3159058|NCT01854658|3885888|FG002|NOT COMPLETED|Overall Study||80
3159059|NCT01854658|3885889|FG003|NOT COMPLETED|Overall Study||59
3159060|NCT01854697|3885904|FG000|STARTED|Overall Study||69
3159061|NCT01854697|3885905|FG001|STARTED|Overall Study||34
3159062|NCT01854697|3885906|FG002|STARTED|Overall Study||84
3159063|NCT01854697|3885907|FG003|STARTED|Overall Study||83
3159064|NCT01854697|3885908|FG004|STARTED|Overall Study||41
3159065|NCT01854697|3885904|FG000|COMPLETED|Overall Study||63
3159066|NCT01854697|3885905|FG001|COMPLETED|Overall Study||31
3159067|NCT01854697|3885906|FG002|COMPLETED|Overall Study||82
3159068|NCT01854697|3885907|FG003|COMPLETED|Overall Study||80
3159069|NCT01854697|3885908|FG004|COMPLETED|Overall Study||39
3159070|NCT01854697|3885904|FG000|NOT COMPLETED|Overall Study||6
3159071|NCT01854697|3885905|FG001|NOT COMPLETED|Overall Study||3
3159072|NCT01854697|3885906|FG002|NOT COMPLETED|Overall Study||2
3159073|NCT01854697|3885907|FG003|NOT COMPLETED|Overall Study||3
3159074|NCT01854697|3885908|FG004|NOT COMPLETED|Overall Study||2
3159075|NCT01854710|3885918|FG000|STARTED|Overall Study||10
3159076|NCT01854710|3885919|FG001|STARTED|Overall Study||10
3159077|NCT01854710|3885920|FG002|STARTED|Overall Study||10
3159078|NCT01854710|3885921|FG003|STARTED|Overall Study||10
3159079|NCT01854710|3885922|FG004|STARTED|Overall Study||10
3159080|NCT01854710|3885923|FG005|STARTED|Overall Study||10
3159081|NCT01854710|3885918|FG000|COMPLETED|Overall Study||6
3159082|NCT01854710|3885919|FG001|COMPLETED|Overall Study||7
3159083|NCT01854710|3885920|FG002|COMPLETED|Overall Study||8
3159084|NCT01854710|3885921|FG003|COMPLETED|Overall Study||8
3159085|NCT01854710|3885922|FG004|COMPLETED|Overall Study||8
3159086|NCT01854710|3885923|FG005|COMPLETED|Overall Study||8
3159087|NCT01854710|3885918|FG000|NOT COMPLETED|Overall Study||4
3159088|NCT01854710|3885919|FG001|NOT COMPLETED|Overall Study||3
3159089|NCT01854710|3885920|FG002|NOT COMPLETED|Overall Study||2
3159090|NCT01854710|3885921|FG003|NOT COMPLETED|Overall Study||2
3159091|NCT01854710|3885922|FG004|NOT COMPLETED|Overall Study||2
3159092|NCT01854710|3885923|FG005|NOT COMPLETED|Overall Study||2
3159093|NCT01854775|3885936|FG000|STARTED|Treatment Phase (48 Weeks)||50
3159094|NCT01854775|3885937|FG001|STARTED|Treatment Phase (48 Weeks)||52
3159095|NCT01854775|3885938|FG002|STARTED|Treatment Phase (48 Weeks)||27
3159096|NCT01854775|3885936|FG000|COMPLETED|Treatment Phase (48 Weeks)||48
3159097|NCT01854775|3885937|FG001|COMPLETED|Treatment Phase (48 Weeks)||51
3159098|NCT01854775|3885938|FG002|COMPLETED|Treatment Phase (48 Weeks)||18
3159099|NCT01854775|3885936|FG000|NOT COMPLETED|Treatment Phase (48 Weeks)||2
3159100|NCT01854775|3885937|FG001|NOT COMPLETED|Treatment Phase (48 Weeks)||1
3159101|NCT01854775|3885938|FG002|NOT COMPLETED|Treatment Phase (48 Weeks)||9
3159102|NCT01854775|3885936|FG000|STARTED|Extension Phase||48
3159103|NCT01854775|3885937|FG001|STARTED|Extension Phase||50
3159104|NCT01854775|3885938|FG002|STARTED|Extension Phase||18
3159105|NCT01854775|3885936|FG000|COMPLETED|Extension Phase||9
3159106|NCT01854775|3885937|FG001|COMPLETED|Extension Phase||3
3159107|NCT01854775|3885938|FG002|COMPLETED|Extension Phase||0
3159108|NCT01854775|3885936|FG000|NOT COMPLETED|Extension Phase||39
3159109|NCT01854775|3885937|FG001|NOT COMPLETED|Extension Phase||47
3159110|NCT01854775|3885938|FG002|NOT COMPLETED|Extension Phase||18
3159111|NCT01854827|3885946|FG000|STARTED|Overall Study||30
3159112|NCT01854827|3885946|FG000|COMPLETED|Overall Study||29
3159113|NCT01854827|3885946|FG000|NOT COMPLETED|Overall Study||1
3159114|NCT01854879|3885950|FG000|STARTED|Overall Study|97 consented|97
3159115|NCT01854879|3885950|FG000|COMPLETED|Overall Study|92 had matched endpoint data|92
3159116|NCT01854879|3885950|FG000|NOT COMPLETED|Overall Study||5
3159117|NCT01854905|3885954|FG000|STARTED|Overall Study||400
3159118|NCT01854905|3885954|FG000|COMPLETED|Overall Study||400
3159119|NCT01854905|3885954|FG000|NOT COMPLETED|Overall Study||0
3159120|NCT01854918|3885960|FG000|STARTED|SOC-controlled Period (Year 1)||1227
3159121|NCT01854918|3885961|FG001|STARTED|SOC-controlled Period (Year 1)||2454
3159122|NCT01854918|3885960|FG000|Received Evolocumab|SOC-controlled Period (Year 1)|5 participants received evolocumab in error|5
3159123|NCT01854918|3885961|FG001|Received Evolocumab|SOC-controlled Period (Year 1)||2452
3159124|NCT01854918|3885960|FG000|COMPLETED|SOC-controlled Period (Year 1)||1197
3159125|NCT01854918|3885961|FG001|COMPLETED|SOC-controlled Period (Year 1)||2391
3159126|NCT01854918|3885960|FG000|NOT COMPLETED|SOC-controlled Period (Year 1)||30
3159127|NCT01854918|3885961|FG001|NOT COMPLETED|SOC-controlled Period (Year 1)||63
3159128|NCT01854918|3885960|FG000|STARTED|All-IP Period (Years 2 and 3)||1197
3159129|NCT01854918|3885961|FG001|STARTED|All-IP Period (Years 2 and 3)||2391
3159130|NCT01854918|3885960|FG000|Received Evolocumab|All-IP Period (Years 2 and 3)||1152
3159131|NCT01854918|3885961|FG001|Received Evolocumab|All-IP Period (Years 2 and 3)||2291
3159132|NCT01854918|3885960|FG000|COMPLETED|All-IP Period (Years 2 and 3)||1079
3159133|NCT01854918|3885961|FG001|COMPLETED|All-IP Period (Years 2 and 3)||2196
3159134|NCT01854918|3885960|FG000|NOT COMPLETED|All-IP Period (Years 2 and 3)||118
3159135|NCT01854918|3885961|FG001|NOT COMPLETED|All-IP Period (Years 2 and 3)||195
3159136|NCT01854944|3885977|FG000|STARTED|Overall Study||4
3159137|NCT01854944|3885978|FG001|STARTED|Overall Study||4
3159138|NCT01854944|3885979|FG002|STARTED|Overall Study||4
3159139|NCT01854944|3885977|FG000|COMPLETED|Overall Study||4
3159140|NCT01854944|3885978|FG001|COMPLETED|Overall Study||4
3159141|NCT01854944|3885979|FG002|COMPLETED|Overall Study||3
3159142|NCT01854944|3885977|FG000|NOT COMPLETED|Overall Study||0
3159143|NCT01854944|3885978|FG001|NOT COMPLETED|Overall Study||0
3159144|NCT01854944|3885979|FG002|NOT COMPLETED|Overall Study||1
3159145|NCT01855048|3886007|FG000|STARTED|Overall Study||9
3159146|NCT01855048|3886008|FG001|STARTED|Overall Study||3
3159147|NCT01855048|3886009|FG002|STARTED|Overall Study||6
3159148|NCT01855048|3886010|FG003|STARTED|Overall Study||6
3159149|NCT01855048|3886011|FG004|STARTED|Overall Study||6
3159150|NCT01855048|3886012|FG005|STARTED|Overall Study||6
3159151|NCT01855048|3886007|FG000|COMPLETED|Overall Study||9
3159152|NCT01855048|3886008|FG001|COMPLETED|Overall Study||2
3159153|NCT01855048|3886009|FG002|COMPLETED|Overall Study||6
3159154|NCT01855048|3886010|FG003|COMPLETED|Overall Study||6
3159155|NCT01855048|3886011|FG004|COMPLETED|Overall Study||5
3159156|NCT01855048|3886012|FG005|COMPLETED|Overall Study||6
3159157|NCT01855048|3886007|FG000|NOT COMPLETED|Overall Study||0
3159158|NCT01855048|3886008|FG001|NOT COMPLETED|Overall Study||1
3159159|NCT01855048|3886009|FG002|NOT COMPLETED|Overall Study||0
3159160|NCT01855048|3886010|FG003|NOT COMPLETED|Overall Study||0
3159161|NCT01855048|3886011|FG004|NOT COMPLETED|Overall Study||1
3159162|NCT01855048|3886012|FG005|NOT COMPLETED|Overall Study||0
3159163|NCT01855074|3886036|FG000|STARTED|Overall Study||80
3159164|NCT01855074|3886036|FG000|Treated|Overall Study||79
3159165|NCT01855074|3886036|FG000|COMPLETED|Overall Study||66
3159166|NCT01855074|3886036|FG000|NOT COMPLETED|Overall Study||14
3159167|NCT01855126|3886042|FG000|STARTED|First Intervention (8 Weeks)||24
3159168|NCT01855126|3886043|FG001|STARTED|First Intervention (8 Weeks)||22
3159169|NCT01855126|3886042|FG000|COMPLETED|First Intervention (8 Weeks)||20
3159170|NCT01855126|3886043|FG001|COMPLETED|First Intervention (8 Weeks)||16
3159171|NCT01855126|3886042|FG000|NOT COMPLETED|First Intervention (8 Weeks)||4
3159172|NCT01855126|3886043|FG001|NOT COMPLETED|First Intervention (8 Weeks)||6
3159173|NCT01855126|3886042|FG000|STARTED|Washout Period (2 Weeks)||20
3159174|NCT01855126|3886043|FG001|STARTED|Washout Period (2 Weeks)||16
3159175|NCT01855126|3886042|FG000|COMPLETED|Washout Period (2 Weeks)||20
3159176|NCT01855126|3886043|FG001|COMPLETED|Washout Period (2 Weeks)||16
3159177|NCT01855126|3886042|FG000|NOT COMPLETED|Washout Period (2 Weeks)||0
3159178|NCT01855126|3886043|FG001|NOT COMPLETED|Washout Period (2 Weeks)||0
3159179|NCT01855126|3886042|FG000|STARTED|Second Intervention (8 Weeks)||20
3159180|NCT01855126|3886043|FG001|STARTED|Second Intervention (8 Weeks)||16
3159181|NCT01855126|3886042|FG000|COMPLETED|Second Intervention (8 Weeks)||18
3159182|NCT01855126|3886043|FG001|COMPLETED|Second Intervention (8 Weeks)||14
3159183|NCT01855126|3886042|FG000|NOT COMPLETED|Second Intervention (8 Weeks)||2
3159184|NCT01855126|3886043|FG001|NOT COMPLETED|Second Intervention (8 Weeks)||2
3159185|NCT01855243|3886056|FG000|STARTED|Overall Study||20
3159186|NCT01855243|3886057|FG001|STARTED|Overall Study||21
3159187|NCT01855243|3886058|FG002|STARTED|Overall Study||22
3159188|NCT01855243|3886056|FG000|COMPLETED|Overall Study||19
3159189|NCT01855243|3886057|FG001|COMPLETED|Overall Study||21
3159190|NCT01855243|3886058|FG002|COMPLETED|Overall Study||22
3159191|NCT01855243|3886056|FG000|NOT COMPLETED|Overall Study||1
3159192|NCT01855243|3886057|FG001|NOT COMPLETED|Overall Study||0
3159193|NCT01855243|3886058|FG002|NOT COMPLETED|Overall Study||0
3159194|NCT01855360|3886066|FG000|STARTED|Overall Study||40
3159195|NCT01855360|3886066|FG000|COMPLETED|Overall Study||30
3159196|NCT01855360|3886066|FG000|NOT COMPLETED|Overall Study||10
3159197|NCT01855399|3886072|FG000|STARTED|6 Month||146
3159198|NCT01855399|3886073|FG001|STARTED|6 Month||144
3159199|NCT01855399|3886072|FG000|COMPLETED|6 Month||126
3159200|NCT01855399|3886073|FG001|COMPLETED|6 Month||129
3159201|NCT01855399|3886072|FG000|NOT COMPLETED|6 Month||20
3159202|NCT01855399|3886073|FG001|NOT COMPLETED|6 Month||15
3159203|NCT01855399|3886072|FG000|STARTED|12 Month||126
3159204|NCT01855399|3886073|FG001|STARTED|12 Month||129
3159205|NCT01855399|3886072|FG000|COMPLETED|12 Month||119
3186027|NCT02024204|3914195|FG000|COMPLETED|Overall Study||49
3186028|NCT02024204|3914196|FG001|COMPLETED|Overall Study||11
3186029|NCT02024204|3914195|FG000|NOT COMPLETED|Overall Study||0
3186030|NCT02024204|3914196|FG001|NOT COMPLETED|Overall Study||0
3186031|NCT02024386|3914205|FG000|STARTED|Overall Study||6
3186032|NCT02024386|3914206|FG001|STARTED|Overall Study||11
3186033|NCT02024386|3914207|FG002|STARTED|Overall Study||5
3186034|NCT02024386|3914205|FG000|COMPLETED|Overall Study||6
3186035|NCT02024386|3914206|FG001|COMPLETED|Overall Study||11
3186036|NCT02024386|3914207|FG002|COMPLETED|Overall Study||5
3186037|NCT02024386|3914205|FG000|NOT COMPLETED|Overall Study||0
3186038|NCT02024386|3914206|FG001|NOT COMPLETED|Overall Study||0
3186039|NCT02024386|3914207|FG002|NOT COMPLETED|Overall Study||0
3186040|NCT02024477|3914218|FG000|STARTED|Overall Study||21
3186041|NCT02024477|3914219|FG001|STARTED|Overall Study||21
3186042|NCT02024477|3914218|FG000|COMPLETED|Overall Study||21
3186043|NCT02024477|3914219|FG001|COMPLETED|Overall Study||21
3186044|NCT02024477|3914218|FG000|NOT COMPLETED|Overall Study||0
3186045|NCT02024477|3914219|FG001|NOT COMPLETED|Overall Study||0
3186046|NCT02024607|3914232|FG000|STARTED|Overall Study||115
3186047|NCT02024607|3914233|FG001|STARTED|Overall Study||41
3186048|NCT02024607|3914234|FG002|STARTED|Overall Study||87
3186049|NCT02024607|3914235|FG003|STARTED|Overall Study||156
3186050|NCT02024607|3914236|FG004|STARTED|Overall Study||40
3186051|NCT02024607|3914237|FG005|STARTED|Overall Study||54
3186052|NCT02024607|3914238|FG006|STARTED|Overall Study||2
3186053|NCT02024607|3914232|FG000|COMPLETED|Overall Study||115
3186054|NCT02024607|3914233|FG001|COMPLETED|Overall Study||41
3186055|NCT02024607|3914234|FG002|COMPLETED|Overall Study||87
3159206|NCT01855399|3886073|FG001|COMPLETED|12 Month||118
3159207|NCT01855399|3886072|FG000|NOT COMPLETED|12 Month||7
3159208|NCT01855399|3886073|FG001|NOT COMPLETED|12 Month||11
3186056|NCT02024607|3914235|FG003|COMPLETED|Overall Study||156
3159209|NCT01855412|3886082|FG000|STARTED|Overall Study||501
3159210|NCT01855412|3886083|FG001|STARTED|Overall Study||603
3159211|NCT01855412|3886084|FG002|STARTED|Overall Study||100
3159212|NCT01855412|3886082|FG000|COMPLETED|Overall Study||289
3159213|NCT01855412|3886083|FG001|COMPLETED|Overall Study||260
3159214|NCT01855412|3886084|FG002|COMPLETED|Overall Study||24
3159215|NCT01855412|3886082|FG000|NOT COMPLETED|Overall Study||212
3159216|NCT01855412|3886083|FG001|NOT COMPLETED|Overall Study||343
3159217|NCT01855412|3886084|FG002|NOT COMPLETED|Overall Study||76
3159218|NCT01855425|3886098|FG000|STARTED|Overall Study||96
3159219|NCT01855425|3886098|FG000|COMPLETED|Overall Study||76
3159220|NCT01855425|3886098|FG000|NOT COMPLETED|Overall Study||20
3159221|NCT01855750|3886104|FG000|STARTED|Overall Study||419
3159222|NCT01855750|3886105|FG001|STARTED|Overall Study||419
3159223|NCT01855750|3886104|FG000|Treated|Overall Study|3 participants not treated:2 withdrew consent and 1 not treated per Sponsor/investigator's decision.|416
3159224|NCT01855750|3886105|FG001|Treated|Overall Study|1 participant not treated: withdrew consent.|418
3159225|NCT01855750|3886104|FG000|COMPLETED|Overall Study||0
3159226|NCT01855750|3886105|FG001|COMPLETED|Overall Study||0
3159227|NCT01855750|3886104|FG000|NOT COMPLETED|Overall Study||419
3159228|NCT01855750|3886105|FG001|NOT COMPLETED|Overall Study||419
3159229|NCT01855789|3886111|FG000|STARTED|1) Baseline up to Week 24||718
3159230|NCT01855789|3886112|FG001|STARTED|1) Baseline up to Week 24||0
3159231|NCT01855789|3886113|FG002|STARTED|1) Baseline up to Week 24||0
3159232|NCT01855789|3886114|FG003|STARTED|1) Baseline up to Week 24||0
3159233|NCT01855789|3886111|FG000|COMPLETED|1) Baseline up to Week 24||602
3159234|NCT01855789|3886112|FG001|COMPLETED|1) Baseline up to Week 24||0
3159235|NCT01855789|3886113|FG002|COMPLETED|1) Baseline up to Week 24||0
3159236|NCT01855789|3886114|FG003|COMPLETED|1) Baseline up to Week 24||0
3159237|NCT01855789|3886111|FG000|NOT COMPLETED|1) Baseline up to Week 24||116
3159238|NCT01855789|3886112|FG001|NOT COMPLETED|1) Baseline up to Week 24||0
3159239|NCT01855789|3886113|FG002|NOT COMPLETED|1) Baseline up to Week 24||0
3159240|NCT01855789|3886114|FG003|NOT COMPLETED|1) Baseline up to Week 24||0
3159241|NCT01855789|3886111|FG000|STARTED|2) Week 24 up to End of Study||0
3159242|NCT01855789|3886112|FG001|STARTED|2) Week 24 up to End of Study||147
3159243|NCT01855789|3886113|FG002|STARTED|2) Week 24 up to End of Study||147
3159244|NCT01855789|3886114|FG003|STARTED|2) Week 24 up to End of Study||308
3159245|NCT01855789|3886111|FG000|COMPLETED|2) Week 24 up to End of Study||0
3159246|NCT01855789|3886112|FG001|COMPLETED|2) Week 24 up to End of Study||132
3159247|NCT01855789|3886113|FG002|COMPLETED|2) Week 24 up to End of Study||129
3159248|NCT01855789|3886114|FG003|COMPLETED|2) Week 24 up to End of Study||250
3159249|NCT01855789|3886111|FG000|NOT COMPLETED|2) Week 24 up to End of Study||0
3159250|NCT01855789|3886112|FG001|NOT COMPLETED|2) Week 24 up to End of Study||15
3159251|NCT01855789|3886113|FG002|NOT COMPLETED|2) Week 24 up to End of Study||18
3159252|NCT01855789|3886114|FG003|NOT COMPLETED|2) Week 24 up to End of Study||58
3159253|NCT01855828|3886120|FG000|STARTED|Overall Study||50
3159254|NCT01855828|3886120|FG000|COMPLETED|Overall Study||48
3159255|NCT01855828|3886120|FG000|NOT COMPLETED|Overall Study||2
3159256|NCT01855919|3886131|FG000|STARTED|Overall Study||232
3159257|NCT01855919|3886132|FG001|STARTED|Overall Study||226
3159258|NCT01855919|3886131|FG000|Received at Least 1 Dose of Study Drug|Overall Study||232
3159259|NCT01855919|3886132|FG001|Received at Least 1 Dose of Study Drug|Overall Study||226
3159260|NCT01855919|3886131|FG000|COMPLETED|Overall Study||209
3159261|NCT01855919|3886132|FG001|COMPLETED|Overall Study||200
3159262|NCT01855919|3886131|FG000|NOT COMPLETED|Overall Study||23
3159263|NCT01855919|3886132|FG001|NOT COMPLETED|Overall Study||26
3159264|NCT01855945|3886151|FG000|STARTED|Overall Study||54
3159265|NCT01855945|3886152|FG001|STARTED|Overall Study||55
3159266|NCT01855945|3886153|FG002|STARTED|Overall Study||51
3159267|NCT01855945|3886154|FG003|STARTED|Overall Study||53
3159268|NCT01855945|3886155|FG004|STARTED|Overall Study||51
3159269|NCT01855945|3886156|FG005|STARTED|Overall Study||53
3159270|NCT01855945|3886157|FG006|STARTED|Overall Study||53
3159271|NCT01855945|3886158|FG007|STARTED|Overall Study||55
3159272|NCT01855945|3886159|FG008|STARTED|Overall Study||48
3159273|NCT01855945|3886160|FG009|STARTED|Overall Study||51
3159274|NCT01855945|3886161|FG010|STARTED|Overall Study||51
3159275|NCT01855945|3886162|FG011|STARTED|Overall Study||52
3159276|NCT01855945|3886151|FG000|COMPLETED|Overall Study||38
3159277|NCT01855945|3886152|FG001|COMPLETED|Overall Study||44
3159278|NCT01855945|3886153|FG002|COMPLETED|Overall Study||39
3159279|NCT01855945|3886154|FG003|COMPLETED|Overall Study||49
3159280|NCT01855945|3886155|FG004|COMPLETED|Overall Study||50
3186057|NCT02024607|3914236|FG004|COMPLETED|Overall Study||40
3186058|NCT02024607|3914237|FG005|COMPLETED|Overall Study||54
3186059|NCT02024607|3914238|FG006|COMPLETED|Overall Study||2
3186060|NCT02024607|3914232|FG000|NOT COMPLETED|Overall Study||0
3186061|NCT02024607|3914233|FG001|NOT COMPLETED|Overall Study||0
3186062|NCT02024607|3914234|FG002|NOT COMPLETED|Overall Study||0
3186063|NCT02024607|3914235|FG003|NOT COMPLETED|Overall Study||0
3186064|NCT02024607|3914236|FG004|NOT COMPLETED|Overall Study||0
3186065|NCT02024607|3914237|FG005|NOT COMPLETED|Overall Study||0
3186066|NCT02024607|3914238|FG006|NOT COMPLETED|Overall Study||0
3186067|NCT02024646|3914275|FG000|STARTED|Overall Study||163
3186068|NCT02024646|3914276|FG001|STARTED|Overall Study||160
3363938|NCT04039919|4095088|FG001|NOT COMPLETED|Treatment Period 4||0
3186069|NCT02024646|3914277|FG002|STARTED|Overall Study||161
3186070|NCT02024646|3914275|FG000|COMPLETED|Overall Study||131
3159281|NCT01855945|3886156|FG005|COMPLETED|Overall Study||50
3159282|NCT01855945|3886157|FG006|COMPLETED|Overall Study||43
3159283|NCT01855945|3886158|FG007|COMPLETED|Overall Study||47
3159284|NCT01855945|3886159|FG008|COMPLETED|Overall Study||46
3159285|NCT01855945|3886160|FG009|COMPLETED|Overall Study||49
3159286|NCT01855945|3886161|FG010|COMPLETED|Overall Study||46
3159287|NCT01855945|3886162|FG011|COMPLETED|Overall Study||49
3159288|NCT01855945|3886151|FG000|NOT COMPLETED|Overall Study||16
3159289|NCT01855945|3886152|FG001|NOT COMPLETED|Overall Study||11
3159290|NCT01855945|3886153|FG002|NOT COMPLETED|Overall Study||12
3159291|NCT01855945|3886154|FG003|NOT COMPLETED|Overall Study||4
3159292|NCT01855945|3886155|FG004|NOT COMPLETED|Overall Study||1
3159293|NCT01855945|3886156|FG005|NOT COMPLETED|Overall Study||3
3159294|NCT01855945|3886157|FG006|NOT COMPLETED|Overall Study||10
3159295|NCT01855945|3886158|FG007|NOT COMPLETED|Overall Study||8
3159296|NCT01855945|3886159|FG008|NOT COMPLETED|Overall Study||2
3159297|NCT01855945|3886160|FG009|NOT COMPLETED|Overall Study||2
3159298|NCT01855945|3886161|FG010|NOT COMPLETED|Overall Study||5
3159299|NCT01855945|3886162|FG011|NOT COMPLETED|Overall Study||3
3159300|NCT01855958|3886227|FG000|STARTED|Overall Study||13
3159301|NCT01855958|3886228|FG001|STARTED|Overall Study||13
3159302|NCT01855958|3886227|FG000|COMPLETED|Overall Study||12
3159303|NCT01855958|3886228|FG001|COMPLETED|Overall Study||13
3159304|NCT01855958|3886227|FG000|NOT COMPLETED|Overall Study||1
3159305|NCT01855958|3886228|FG001|NOT COMPLETED|Overall Study||0
3159306|NCT01855997|3886236|FG000|STARTED|Overall Study||1669
3159307|NCT01855997|3886236|FG000|COMPLETED|Overall Study||1669
3159308|NCT01855997|3886236|FG000|NOT COMPLETED|Overall Study||0
3159309|NCT01856114|3886250|FG000|STARTED|Overall Study||11
3159310|NCT01856114|3886251|FG001|STARTED|Overall Study||11
3159311|NCT01856114|3886250|FG000|COMPLETED|Overall Study||9
3159312|NCT01856114|3886251|FG001|COMPLETED|Overall Study||11
3159313|NCT01856114|3886250|FG000|NOT COMPLETED|Overall Study||2
3159314|NCT01856114|3886251|FG001|NOT COMPLETED|Overall Study||0
3159315|NCT01856218|3886257|FG000|STARTED|First Phase||3
3159316|NCT01856218|3886257|FG000|COMPLETED|First Phase||3
3159317|NCT01856218|3886257|FG000|NOT COMPLETED|First Phase||0
3159318|NCT01856218|3886257|FG000|STARTED|Long-Term Extension Phase||3
3159319|NCT01856218|3886257|FG000|COMPLETED|Long-Term Extension Phase||3
3159320|NCT01856218|3886257|FG000|NOT COMPLETED|Long-Term Extension Phase||0
3159321|NCT01856257|3886264|FG000|STARTED|Overall Study||29
3159322|NCT01856257|3886265|FG001|STARTED|Overall Study||29
3159323|NCT01856257|3886266|FG002|STARTED|Overall Study||11
3159324|NCT01856257|3886267|FG003|STARTED|Overall Study||2
3159325|NCT01856257|3886264|FG000|COMPLETED|Overall Study||26
3159326|NCT01856257|3886265|FG001|COMPLETED|Overall Study||28
3159327|NCT01856257|3886266|FG002|COMPLETED|Overall Study||11
3159328|NCT01856257|3886267|FG003|COMPLETED|Overall Study||0
3159329|NCT01856257|3886264|FG000|NOT COMPLETED|Overall Study||3
3159330|NCT01856257|3886265|FG001|NOT COMPLETED|Overall Study||1
3159331|NCT01856257|3886266|FG002|NOT COMPLETED|Overall Study||0
3159332|NCT01856257|3886267|FG003|NOT COMPLETED|Overall Study||2
3159333|NCT01856309|3886280|FG000|STARTED|Overall Study||305
3159334|NCT01856309|3886281|FG001|STARTED|Overall Study||291
3159335|NCT01856309|3886282|FG002|STARTED|Overall Study||606
3159336|NCT01856309|3886283|FG003|STARTED|Overall Study||618
3159337|NCT01856309|3886280|FG000|Participants From Study CNTO136ARA3002|Overall Study||197
3159338|NCT01856309|3886281|FG001|Participants From Study CNTO136ARA3002|Overall Study||187
3159339|NCT01856309|3886282|FG002|Participants From Study CNTO136ARA3002|Overall Study||405
3159340|NCT01856309|3886283|FG003|Participants From Study CNTO136ARA3002|Overall Study||412
3159341|NCT01856309|3886280|FG000|Participants From Study CNTO136ARA3003|Overall Study||108
3159342|NCT01856309|3886281|FG001|Participants From Study CNTO136ARA3003|Overall Study||104
3159343|NCT01856309|3886282|FG002|Participants From Study CNTO136ARA3003|Overall Study||201
3159344|NCT01856309|3886283|FG003|Participants From Study CNTO136ARA3003|Overall Study||206
3159345|NCT01856309|3886280|FG000|Treated Partcipants|Overall Study||305
3159346|NCT01856309|3886281|FG001|Treated Partcipants|Overall Study||290
3159347|NCT01856309|3886282|FG002|Treated Partcipants|Overall Study||605
3159348|NCT01856309|3886283|FG003|Treated Partcipants|Overall Study||618
3159349|NCT01856309|3886280|FG000|COMPLETED|Overall Study||6
3159350|NCT01856309|3886281|FG001|COMPLETED|Overall Study||3
3159351|NCT01856309|3886282|FG002|COMPLETED|Overall Study||11
3159352|NCT01856309|3886283|FG003|COMPLETED|Overall Study||9
3159353|NCT01856309|3886280|FG000|NOT COMPLETED|Overall Study||299
3159354|NCT01856309|3886281|FG001|NOT COMPLETED|Overall Study||288
3159355|NCT01856309|3886282|FG002|NOT COMPLETED|Overall Study||595
3159356|NCT01856309|3886283|FG003|NOT COMPLETED|Overall Study||609
3159357|NCT01856491|3886293|FG000|STARTED|Overall Study||167
3159358|NCT01856491|3886293|FG000|COMPLETED|Overall Study||152
3159359|NCT01856491|3886293|FG000|NOT COMPLETED|Overall Study||15
3159360|NCT01856530|3886299|FG000|STARTED|Overall Study||27
3159361|NCT01856530|3886300|FG001|STARTED|Overall Study||27
3159362|NCT01856530|3886299|FG000|COMPLETED|Overall Study||27
3159363|NCT01856530|3886300|FG001|COMPLETED|Overall Study||27
3159364|NCT01856530|3886299|FG000|NOT COMPLETED|Overall Study||0
3159365|NCT01856530|3886300|FG001|NOT COMPLETED|Overall Study||0
3159366|NCT01856543|3886308|FG000|STARTED|Overall Study||73
3159367|NCT01856543|3886309|FG001|STARTED|Overall Study||70
3159368|NCT01856543|3886308|FG000|COMPLETED|Overall Study||60
3159369|NCT01856543|3886309|FG001|COMPLETED|Overall Study||64
3159370|NCT01856543|3886308|FG000|NOT COMPLETED|Overall Study||13
3159371|NCT01856543|3886309|FG001|NOT COMPLETED|Overall Study||6
3159372|NCT01856569|3886316|FG000|STARTED|Overall Study||152
3159373|NCT01856569|3886316|FG000|Full Analysis Set|Overall Study||144
3159374|NCT01856569|3886316|FG000|COMPLETED|Overall Study||139
3159375|NCT01856569|3886316|FG000|NOT COMPLETED|Overall Study||13
3159376|NCT01856582|3886320|FG000|STARTED|Overall Study||23
3159377|NCT01856582|3886320|FG000|COMPLETED|Overall Study||22
3159378|NCT01856582|3886320|FG000|NOT COMPLETED|Overall Study||1
3159379|NCT01856595|3886333|FG000|STARTED|Overall Study||18
3159380|NCT01856595|3886334|FG001|STARTED|Overall Study||12
3159381|NCT01856595|3886335|FG002|STARTED|Overall Study||12
3159382|NCT01856595|3886336|FG003|STARTED|Overall Study||12
3159383|NCT01856595|3886337|FG004|STARTED|Overall Study||14
3159384|NCT01856595|3886338|FG005|STARTED|Overall Study||12
3159385|NCT01856595|3886339|FG006|STARTED|Overall Study||13
3159386|NCT01856595|3886340|FG007|STARTED|Overall Study||10
3159387|NCT01856595|3886341|FG008|STARTED|Overall Study||14
3159388|NCT01856595|3886333|FG000|COMPLETED|Overall Study||18
3159389|NCT01856595|3886334|FG001|COMPLETED|Overall Study||11
3159390|NCT01856595|3886335|FG002|COMPLETED|Overall Study||12
3159391|NCT01856595|3886336|FG003|COMPLETED|Overall Study||12
3159392|NCT01856595|3886337|FG004|COMPLETED|Overall Study||14
3159393|NCT01856595|3886338|FG005|COMPLETED|Overall Study||12
3159394|NCT01856595|3886339|FG006|COMPLETED|Overall Study||12
3159395|NCT01856595|3886340|FG007|COMPLETED|Overall Study||10
3159396|NCT01856595|3886341|FG008|COMPLETED|Overall Study||14
3159397|NCT01856595|3886333|FG000|NOT COMPLETED|Overall Study||0
3159398|NCT01856595|3886334|FG001|NOT COMPLETED|Overall Study||1
3159399|NCT01856595|3886335|FG002|NOT COMPLETED|Overall Study||0
3159400|NCT01856595|3886336|FG003|NOT COMPLETED|Overall Study||0
3159401|NCT01856595|3886337|FG004|NOT COMPLETED|Overall Study||0
3159402|NCT01856595|3886338|FG005|NOT COMPLETED|Overall Study||0
3159403|NCT01856595|3886339|FG006|NOT COMPLETED|Overall Study||1
3159404|NCT01856595|3886340|FG007|NOT COMPLETED|Overall Study||0
3159405|NCT01856595|3886341|FG008|NOT COMPLETED|Overall Study||0
3159406|NCT01856673|3886379|FG000|STARTED|Overall Study||175
3159407|NCT01856673|3886380|FG001|STARTED|Overall Study||175
3159408|NCT01856673|3886381|FG002|STARTED|Overall Study||171
3159409|NCT01856673|3886379|FG000|Buenaventura Participants|Overall Study||92
3159410|NCT01856673|3886380|FG001|Buenaventura Participants|Overall Study||89
3159411|NCT01856673|3886381|FG002|Buenaventura Participants|Overall Study||88
3159412|NCT01856673|3886379|FG000|Quibdó Participants|Overall Study||83
3159413|NCT01856673|3886380|FG001|Quibdó Participants|Overall Study||86
3159414|NCT01856673|3886381|FG002|Quibdó Participants|Overall Study||83
3159415|NCT01856673|3886379|FG000|COMPLETED|Overall Study|A percentage of 75.1% completed the follow-up (exit survey)|80
3159416|NCT01856673|3886380|FG001|COMPLETED|Overall Study|A percentage of 80.9% completed the follow-up (exit survey)|90
3159417|NCT01856673|3886381|FG002|COMPLETED|Overall Study||137
3159418|NCT01856673|3886379|FG000|NOT COMPLETED|Overall Study||95
3159419|NCT01856673|3886380|FG001|NOT COMPLETED|Overall Study||85
3159420|NCT01856673|3886381|FG002|NOT COMPLETED|Overall Study||34
3363939|NCT04039919|4095089|FG002|NOT COMPLETED|Treatment Period 4||0
3159421|NCT01856686|3886391|FG000|STARTED|Overall Study||31
3159422|NCT01856686|3886392|FG001|STARTED|Overall Study||33
3159423|NCT01856686|3886391|FG000|COMPLETED|Overall Study||26
3159424|NCT01856686|3886392|FG001|COMPLETED|Overall Study||22
3159425|NCT01856686|3886391|FG000|NOT COMPLETED|Overall Study||5
3159426|NCT01856686|3886392|FG001|NOT COMPLETED|Overall Study||11
3159427|NCT01856712|3886400|FG000|STARTED|Overall Study||23
3159428|NCT01856712|3886401|FG001|STARTED|Overall Study|1 received oral in error thus randomized.|22
3159429|NCT01856712|3886400|FG000|Lost to 14 Day Follow up|Overall Study||6
3159430|NCT01856712|3886401|FG001|Lost to 14 Day Follow up|Overall Study||2
3159431|NCT01856712|3886400|FG000|Lost to 45 Day Follow up|Overall Study||1
3159432|NCT01856712|3886401|FG001|Lost to 45 Day Follow up|Overall Study||1
3159433|NCT01856712|3886400|FG000|COMPLETED|Overall Study||16
3159434|NCT01856712|3886401|FG001|COMPLETED|Overall Study||19
3159435|NCT01856712|3886400|FG000|NOT COMPLETED|Overall Study||7
3159436|NCT01856712|3886401|FG001|NOT COMPLETED|Overall Study||3
3159437|NCT01856764|3886413|FG000|STARTED|Overall Study||20
3159438|NCT01856764|3886414|FG001|STARTED|Overall Study||20
3159439|NCT01856764|3886413|FG000|COMPLETED|Overall Study||20
3159440|NCT01856764|3886414|FG001|COMPLETED|Overall Study||20
3159441|NCT01856764|3886413|FG000|NOT COMPLETED|Overall Study||0
3159442|NCT01856764|3886414|FG001|NOT COMPLETED|Overall Study||0
3159443|NCT01856790|3886420|FG000|STARTED|Closed Loop Control||15
3159444|NCT01856790|3886420|FG000|COMPLETED|Closed Loop Control||13
3159445|NCT01856790|3886420|FG000|NOT COMPLETED|Closed Loop Control||2
3159446|NCT01856790|3886420|FG000|STARTED|Closed Loop Control + Liraglutide||13
3159447|NCT01856790|3886420|FG000|COMPLETED|Closed Loop Control + Liraglutide||11
3159448|NCT01856790|3886420|FG000|NOT COMPLETED|Closed Loop Control + Liraglutide||2
3159449|NCT01856907|3886434|FG000|STARTED|Overall Study||12
3159450|NCT01856907|3886435|FG001|STARTED|Overall Study||12
3159451|NCT01856907|3886436|FG002|STARTED|Overall Study||12
3159452|NCT01856907|3886434|FG000|COMPLETED|Overall Study||12
3159453|NCT01856907|3886435|FG001|COMPLETED|Overall Study||9
3159454|NCT01856907|3886436|FG002|COMPLETED|Overall Study||12
3159455|NCT01856907|3886434|FG000|NOT COMPLETED|Overall Study||0
3159456|NCT01856907|3886435|FG001|NOT COMPLETED|Overall Study||3
3159457|NCT01856907|3886436|FG002|NOT COMPLETED|Overall Study||0
3159458|NCT01856933|3886447|FG000|STARTED|Overall Study||6
3186071|NCT02024646|3914276|FG001|COMPLETED|Overall Study||135
3186072|NCT02024646|3914277|FG002|COMPLETED|Overall Study||133
3186073|NCT02024646|3914275|FG000|NOT COMPLETED|Overall Study||32
3186074|NCT02024646|3914276|FG001|NOT COMPLETED|Overall Study||25
3186075|NCT02024646|3914277|FG002|NOT COMPLETED|Overall Study||28
3186076|NCT02024698|3914285|FG000|STARTED|First Intervention (7 Days)||16
3186077|NCT02024698|3914286|FG001|STARTED|First Intervention (7 Days)||27
3186078|NCT02024698|3914285|FG000|COMPLETED|First Intervention (7 Days)||16
3159459|NCT01856933|3886447|FG000|COMPLETED|Overall Study||6
3159460|NCT01856933|3886447|FG000|NOT COMPLETED|Overall Study||0
3159461|NCT01857102|3886451|FG000|STARTED|Period 1||58
3159462|NCT01857102|3886452|FG001|STARTED|Period 1||56
3159463|NCT01857102|3886451|FG000|Habitual Users|Period 1||51
3159464|NCT01857102|3886452|FG001|Habitual Users|Period 1||52
3159465|NCT01857102|3886451|FG000|Neophtyes|Period 1||7
3159466|NCT01857102|3886452|FG001|Neophtyes|Period 1||4
3159467|NCT01857102|3886451|FG000|COMPLETED|Period 1||55
3159468|NCT01857102|3886452|FG001|COMPLETED|Period 1||51
3159469|NCT01857102|3886451|FG000|NOT COMPLETED|Period 1||3
3159470|NCT01857102|3886452|FG001|NOT COMPLETED|Period 1||5
3159471|NCT01857102|3886451|FG000|STARTED|Period 2||55
3159472|NCT01857102|3886452|FG001|STARTED|Period 2||51
3159473|NCT01857102|3886451|FG000|Habitual Users|Period 2||48
3159474|NCT01857102|3886452|FG001|Habitual Users|Period 2||47
3159475|NCT01857102|3886451|FG000|Neophytes|Period 2||7
3159476|NCT01857102|3886452|FG001|Neophytes|Period 2||4
3159477|NCT01857102|3886451|FG000|COMPLETED|Period 2||53
3159478|NCT01857102|3886452|FG001|COMPLETED|Period 2||51
3159479|NCT01857102|3886451|FG000|NOT COMPLETED|Period 2||2
3159480|NCT01857102|3886452|FG001|NOT COMPLETED|Period 2||0
3159481|NCT01857206|3886462|FG000|STARTED|Overall Study||1372
3159482|NCT01857206|3886463|FG001|STARTED|Overall Study||683
3159483|NCT01857206|3886462|FG000|COMPLETED|Overall Study||1359
3159484|NCT01857206|3886463|FG001|COMPLETED|Overall Study||673
3159485|NCT01857206|3886462|FG000|NOT COMPLETED|Overall Study||13
3159486|NCT01857206|3886463|FG001|NOT COMPLETED|Overall Study||10
3186079|NCT02024698|3914286|FG001|COMPLETED|First Intervention (7 Days)||26
3186080|NCT02024698|3914285|FG000|NOT COMPLETED|First Intervention (7 Days)||0
3186081|NCT02024698|3914286|FG001|NOT COMPLETED|First Intervention (7 Days)||1
3186082|NCT02024698|3914285|FG000|STARTED|Second Intervention (7 Days)||16
3186083|NCT02024698|3914286|FG001|STARTED|Second Intervention (7 Days)||26
3186084|NCT02024698|3914285|FG000|Received Etafilcon A Twice|Second Intervention (7 Days)||1
3186085|NCT02024698|3914286|FG001|Received Etafilcon A Twice|Second Intervention (7 Days)||0
3186086|NCT02024698|3914285|FG000|COMPLETED|Second Intervention (7 Days)||16
3186087|NCT02024698|3914286|FG001|COMPLETED|Second Intervention (7 Days)||26
3186088|NCT02024698|3914285|FG000|NOT COMPLETED|Second Intervention (7 Days)||0
3186089|NCT02024698|3914286|FG001|NOT COMPLETED|Second Intervention (7 Days)||0
3186090|NCT02024711|3914294|FG000|STARTED|Overall Study||130
3186091|NCT02024711|3914295|FG001|STARTED|Overall Study||132
3186092|NCT02024711|3914294|FG000|COMPLETED|Overall Study||129
3186093|NCT02024711|3914295|FG001|COMPLETED|Overall Study||128
3186094|NCT02024711|3914294|FG000|NOT COMPLETED|Overall Study||1
3186095|NCT02024711|3914295|FG001|NOT COMPLETED|Overall Study||4
3186096|NCT02024724|3914303|FG000|STARTED|Overall Study||30
3186097|NCT02024724|3914304|FG001|STARTED|Overall Study||30
3186098|NCT02024724|3914303|FG000|COMPLETED|Overall Study||29
3186099|NCT02024724|3914304|FG001|COMPLETED|Overall Study||30
3186100|NCT02024724|3914303|FG000|NOT COMPLETED|Overall Study||1
3186101|NCT02024724|3914304|FG001|NOT COMPLETED|Overall Study||0
3186102|NCT02024750|3914312|FG000|STARTED|Overall Study||106
3186103|NCT02024750|3914313|FG001|STARTED|Overall Study||108
3186104|NCT02024750|3914312|FG000|COMPLETED|Overall Study||104
3186105|NCT02024750|3914313|FG001|COMPLETED|Overall Study||107
3186106|NCT02024750|3914312|FG000|NOT COMPLETED|Overall Study||2
3186107|NCT02024750|3914313|FG001|NOT COMPLETED|Overall Study||1
3186108|NCT02024867|3914321|FG000|STARTED|Overall Study||134
3186109|NCT02024867|3914322|FG001|STARTED|Overall Study||131
3186110|NCT02024867|3914321|FG000|COMPLETED|Overall Study||125
3186111|NCT02024867|3914322|FG001|COMPLETED|Overall Study||124
3186112|NCT02024867|3914321|FG000|NOT COMPLETED|Overall Study||9
3186113|NCT02024867|3914322|FG001|NOT COMPLETED|Overall Study||7
3186114|NCT02024932|3914334|FG000|STARTED|Overall Study||2
3186115|NCT02024932|3914335|FG001|STARTED|Overall Study||4
3186116|NCT02024932|3914336|FG002|STARTED|Overall Study||2
3186117|NCT02024932|3914337|FG003|STARTED|Overall Study||2
3186118|NCT02024932|3914338|FG004|STARTED|Overall Study||18
3186119|NCT02024932|3914339|FG005|STARTED|Overall Study||9
3186120|NCT02024932|3914334|FG000|Safety Analysis Set|Overall Study||2
3186121|NCT02024932|3914335|FG001|Safety Analysis Set|Overall Study||4
3186122|NCT02024932|3914336|FG002|Safety Analysis Set|Overall Study||2
3186123|NCT02024932|3914337|FG003|Safety Analysis Set|Overall Study||2
3186124|NCT02024932|3914338|FG004|Safety Analysis Set|Overall Study||18
3186125|NCT02024932|3914339|FG005|Safety Analysis Set|Overall Study||9
3186126|NCT02024932|3914334|FG000|Pharmacokinetic (PK) Analysis Set|Overall Study||2
3186127|NCT02024932|3914335|FG001|Pharmacokinetic (PK) Analysis Set|Overall Study||4
3186128|NCT02024932|3914336|FG002|Pharmacokinetic (PK) Analysis Set|Overall Study||0
3186129|NCT02024932|3914337|FG003|Pharmacokinetic (PK) Analysis Set|Overall Study||2
3186130|NCT02024932|3914338|FG004|Pharmacokinetic (PK) Analysis Set|Overall Study||18
3186131|NCT02024932|3914339|FG005|Pharmacokinetic (PK) Analysis Set|Overall Study||0
3186132|NCT02024932|3914334|FG000|Pharmacodynamic (PD) Analysis Set|Overall Study||2
3159487|NCT01857232|3886478|FG000|STARTED|Overall Study||69
3159488|NCT01857232|3886479|FG001|STARTED|Overall Study||67
3159489|NCT01857232|3886480|FG002|STARTED|Overall Study||67
3159490|NCT01857232|3886481|FG003|STARTED|Overall Study||70
3159491|NCT01857232|3886482|FG004|STARTED|Overall Study||69
3159492|NCT01857232|3886478|FG000|Evaluable ITT|Overall Study||66
3159493|NCT01857232|3886479|FG001|Evaluable ITT|Overall Study||66
3159494|NCT01857232|3886480|FG002|Evaluable ITT|Overall Study||63
3159495|NCT01857232|3886481|FG003|Evaluable ITT|Overall Study||68
3159496|NCT01857232|3886482|FG004|Evaluable ITT|Overall Study||65
3159497|NCT01857232|3886478|FG000|COMPLETED|Overall Study||61
3363940|NCT04039919|4095090|FG003|NOT COMPLETED|Treatment Period 4||0
3363941|NCT04039919|4095091|FG004|NOT COMPLETED|Treatment Period 4||0
3363942|NCT04039919|4095087|FG000|STARTED|Treatment Period 5||6
3363943|NCT04039919|4095088|FG001|STARTED|Treatment Period 5||6
3363944|NCT04039919|4095089|FG002|STARTED|Treatment Period 5||5
3363945|NCT04039919|4095090|FG003|STARTED|Treatment Period 5||6
3363946|NCT04039919|4095091|FG004|STARTED|Treatment Period 5||0
3363947|NCT04039919|4095087|FG000|COMPLETED|Treatment Period 5||5
3363948|NCT04039919|4095088|FG001|COMPLETED|Treatment Period 5||6
3363949|NCT04039919|4095089|FG002|COMPLETED|Treatment Period 5||5
3363950|NCT04039919|4095090|FG003|COMPLETED|Treatment Period 5||6
3363951|NCT04039919|4095091|FG004|COMPLETED|Treatment Period 5||0
3363952|NCT04039919|4095087|FG000|NOT COMPLETED|Treatment Period 5||1
3363953|NCT04039919|4095088|FG001|NOT COMPLETED|Treatment Period 5||0
3363954|NCT04039919|4095089|FG002|NOT COMPLETED|Treatment Period 5||0
3363955|NCT04039919|4095090|FG003|NOT COMPLETED|Treatment Period 5||0
3363956|NCT04039919|4095091|FG004|NOT COMPLETED|Treatment Period 5||0
3159498|NCT01857232|3886479|FG001|COMPLETED|Overall Study||65
3159499|NCT01857232|3886480|FG002|COMPLETED|Overall Study||63
3159500|NCT01857232|3886481|FG003|COMPLETED|Overall Study||68
3159501|NCT01857232|3886482|FG004|COMPLETED|Overall Study||63
3159502|NCT01857232|3886478|FG000|NOT COMPLETED|Overall Study||8
3159503|NCT01857232|3886479|FG001|NOT COMPLETED|Overall Study||2
3159504|NCT01857232|3886480|FG002|NOT COMPLETED|Overall Study||4
3159505|NCT01857232|3886481|FG003|NOT COMPLETED|Overall Study||2
3159506|NCT01857232|3886482|FG004|NOT COMPLETED|Overall Study||6
3159507|NCT01857258|3886497|FG000|STARTED|First Intervention (3 h Postprandially)||8
3159508|NCT01857258|3886498|FG001|STARTED|First Intervention (3 h Postprandially)||7
3159509|NCT01857258|3886497|FG000|COMPLETED|First Intervention (3 h Postprandially)||8
3159510|NCT01857258|3886498|FG001|COMPLETED|First Intervention (3 h Postprandially)||7
3159511|NCT01857258|3886497|FG000|NOT COMPLETED|First Intervention (3 h Postprandially)||0
3159512|NCT01857258|3886498|FG001|NOT COMPLETED|First Intervention (3 h Postprandially)||0
3159513|NCT01857258|3886497|FG000|STARTED|Wash-out Period (7 Days)||8
3159514|NCT01857258|3886498|FG001|STARTED|Wash-out Period (7 Days)||7
3159515|NCT01857258|3886497|FG000|COMPLETED|Wash-out Period (7 Days)||8
3159516|NCT01857258|3886498|FG001|COMPLETED|Wash-out Period (7 Days)||7
3159517|NCT01857258|3886497|FG000|NOT COMPLETED|Wash-out Period (7 Days)||0
3159518|NCT01857258|3886498|FG001|NOT COMPLETED|Wash-out Period (7 Days)||0
3159519|NCT01857258|3886497|FG000|STARTED|Second Intervention (3 h Postprandially)||8
3159520|NCT01857258|3886498|FG001|STARTED|Second Intervention (3 h Postprandially)||7
3159521|NCT01857258|3886497|FG000|COMPLETED|Second Intervention (3 h Postprandially)||8
3159522|NCT01857258|3886498|FG001|COMPLETED|Second Intervention (3 h Postprandially)||7
3159523|NCT01857258|3886497|FG000|NOT COMPLETED|Second Intervention (3 h Postprandially)||0
3159524|NCT01857258|3886498|FG001|NOT COMPLETED|Second Intervention (3 h Postprandially)||0
3159525|NCT01857297|3886508|FG000|STARTED|Overall Study||60
3159526|NCT01857297|3886509|FG001|STARTED|Overall Study||60
3159527|NCT01857297|3886508|FG000|COMPLETED|Overall Study||60
3159528|NCT01857297|3886509|FG001|COMPLETED|Overall Study||60
3159529|NCT01857297|3886508|FG000|NOT COMPLETED|Overall Study||0
3159530|NCT01857297|3886509|FG001|NOT COMPLETED|Overall Study||0
3159531|NCT01857310|3886517|FG000|STARTED|Primary Analysis: Live Birth|Male partner|1185
3159532|NCT01857310|3886518|FG001|STARTED|Primary Analysis: Live Birth|Male partner|1185
3159533|NCT01857310|3886517|FG000|COMPLETED|Primary Analysis: Live Birth|Chart abstraction of whether live birth occurred|1185
3159534|NCT01857310|3886518|FG001|COMPLETED|Primary Analysis: Live Birth|Chart abstraction of whether live birth occurred|1185
3159535|NCT01857310|3886517|FG000|NOT COMPLETED|Primary Analysis: Live Birth||0
3159536|NCT01857310|3886518|FG001|NOT COMPLETED|Primary Analysis: Live Birth||0
3159537|NCT01857310|3886517|FG000|STARTED|Secondary Analysis: Semen Quality at 6m|Male partner|1185
3159538|NCT01857310|3886518|FG001|STARTED|Secondary Analysis: Semen Quality at 6m|Male partner|1185
3159539|NCT01857310|3886517|FG000|COMPLETED|Secondary Analysis: Semen Quality at 6m|Completed 6-month study visit|870
3159540|NCT01857310|3886518|FG001|COMPLETED|Secondary Analysis: Semen Quality at 6m|Completed 6-month study visit|903
3159541|NCT01857310|3886517|FG000|NOT COMPLETED|Secondary Analysis: Semen Quality at 6m||315
3159542|NCT01857310|3886518|FG001|NOT COMPLETED|Secondary Analysis: Semen Quality at 6m||282
3159543|NCT01857323|3886524|FG000|STARTED|Overall Study|36 day treatment cohort: 45 participants 50 day treatment cohort: 272 participants|317
3159544|NCT01857323|3886524|FG000|Safety Population|Overall Study|One enrolled participant was lost to follow-up.|316
3159545|NCT01857323|3886524|FG000|COMPLETED|Overall Study||253
3159546|NCT01857323|3886524|FG000|NOT COMPLETED|Overall Study||64
3159547|NCT01857362|3886528|FG000|STARTED|Overall Study||6
3159548|NCT01857362|3886529|FG001|STARTED|Overall Study||6
3159549|NCT01857362|3886528|FG000|COMPLETED|Overall Study||6
3159550|NCT01857362|3886529|FG001|COMPLETED|Overall Study||6
3159551|NCT01857362|3886528|FG000|NOT COMPLETED|Overall Study||0
3159552|NCT01857362|3886529|FG001|NOT COMPLETED|Overall Study||0
3159553|NCT01857531|3886535|FG000|STARTED|Overall Study||16
3159554|NCT01857531|3886535|FG000|COMPLETED|Overall Study||12
3159555|NCT01857531|3886535|FG000|NOT COMPLETED|Overall Study||4
3159556|NCT01857583|3886543|FG000|STARTED|Overall Study||30
3159557|NCT01857583|3886544|FG001|STARTED|Overall Study||7
3159558|NCT01857583|3886545|FG002|STARTED|Overall Study||22
3159559|NCT01857583|3886546|FG003|STARTED|Overall Study||21
3159560|NCT01857583|3886543|FG000|Safety Analysis Population|Overall Study||30
3159561|NCT01857583|3886544|FG001|Safety Analysis Population|Overall Study||7
3159562|NCT01857583|3886545|FG002|Safety Analysis Population|Overall Study||22
3159563|NCT01857583|3886546|FG003|Safety Analysis Population|Overall Study||20
3159564|NCT01857583|3886543|FG000|COMPLETED|Overall Study||29
3159565|NCT01857583|3886544|FG001|COMPLETED|Overall Study||6
3159566|NCT01857583|3886545|FG002|COMPLETED|Overall Study||19
3159567|NCT01857583|3886546|FG003|COMPLETED|Overall Study||17
3159568|NCT01857583|3886543|FG000|NOT COMPLETED|Overall Study||1
3159569|NCT01857583|3886544|FG001|NOT COMPLETED|Overall Study||1
3159570|NCT01857583|3886545|FG002|NOT COMPLETED|Overall Study||3
3159571|NCT01857583|3886546|FG003|NOT COMPLETED|Overall Study||4
3159572|NCT01857622|3886559|FG000|STARTED|Overall Study||50
3159573|NCT01857622|3886560|FG001|STARTED|Overall Study||22
3159574|NCT01857622|3886561|FG002|STARTED|Overall Study||21
3159575|NCT01857622|3886559|FG000|COMPLETED|Overall Study||39
3159576|NCT01857622|3886560|FG001|COMPLETED|Overall Study||21
3159577|NCT01857622|3886561|FG002|COMPLETED|Overall Study||19
3159578|NCT01857622|3886559|FG000|NOT COMPLETED|Overall Study||11
3159579|NCT01857622|3886560|FG001|NOT COMPLETED|Overall Study||1
3159580|NCT01857622|3886561|FG002|NOT COMPLETED|Overall Study||2
3159581|NCT01857713|3886569|FG000|STARTED|Overall Study||95
3159582|NCT01857713|3886569|FG000|COMPLETED|Overall Study||89
3159583|NCT01857713|3886569|FG000|NOT COMPLETED|Overall Study||6
3159584|NCT01857869|3886585|FG000|STARTED|Primary/Challenge Phase||34
3159585|NCT01857869|3886586|FG001|STARTED|Primary/Challenge Phase||17
3159586|NCT01857869|3886587|FG002|STARTED|Primary/Challenge Phase||12
3159587|NCT01857869|3886588|FG003|STARTED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
3159588|NCT01857869|3886589|FG004|STARTED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
3159589|NCT01857869|3886590|FG005|STARTED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
3159590|NCT01857869|3886591|FG006|STARTED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
3159591|NCT01857869|3886592|FG007|STARTED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
3159592|NCT01857869|3886593|FG008|STARTED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
3159593|NCT01857869|3886594|FG009|STARTED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
3159594|NCT01857869|3886585|FG000|COMPLETED|Primary/Challenge Phase||29
3159595|NCT01857869|3886586|FG001|COMPLETED|Primary/Challenge Phase||16
3159596|NCT01857869|3886587|FG002|COMPLETED|Primary/Challenge Phase||12
3159597|NCT01857869|3886588|FG003|COMPLETED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
3159598|NCT01857869|3886589|FG004|COMPLETED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
3159599|NCT01857869|3886590|FG005|COMPLETED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
3159600|NCT01857869|3886591|FG006|COMPLETED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
3159601|NCT01857869|3886592|FG007|COMPLETED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
3159602|NCT01857869|3886593|FG008|COMPLETED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
3159603|NCT01857869|3886594|FG009|COMPLETED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
3159604|NCT01857869|3886585|FG000|NOT COMPLETED|Primary/Challenge Phase||5
3159605|NCT01857869|3886586|FG001|NOT COMPLETED|Primary/Challenge Phase||1
3159606|NCT01857869|3886587|FG002|NOT COMPLETED|Primary/Challenge Phase||0
3159607|NCT01857869|3886588|FG003|NOT COMPLETED|Primary/Challenge Phase||0
3159608|NCT01857869|3886589|FG004|NOT COMPLETED|Primary/Challenge Phase||0
3159609|NCT01857869|3886590|FG005|NOT COMPLETED|Primary/Challenge Phase||0
3159610|NCT01857869|3886591|FG006|NOT COMPLETED|Primary/Challenge Phase||0
3159611|NCT01857869|3886592|FG007|NOT COMPLETED|Primary/Challenge Phase||0
3159612|NCT01857869|3886593|FG008|NOT COMPLETED|Primary/Challenge Phase||0
3159613|NCT01857869|3886594|FG009|NOT COMPLETED|Primary/Challenge Phase||0
3159614|NCT01857869|3886585|FG000|STARTED|Booster/Rechallenge Phase|GSK257049-0,1,7M, GSK257049-0,1,2M and Infectivity Control Groups were not included in Booster phase|0
3159615|NCT01857869|3886586|FG001|STARTED|Booster/Rechallenge Phase|GSK257049-0,1,7M, GSK257049-0,1,2M and Infectivity Control Groups were not included in Booster phase|0
3159616|NCT01857869|3886587|FG002|STARTED|Booster/Rechallenge Phase|GSK257049-0,1,7M, GSK257049-0,1,2M and Infectivity Control Groups were not included in Booster phase|0
3159617|NCT01857869|3886588|FG003|STARTED|Booster/Rechallenge Phase||9
3159618|NCT01857869|3886589|FG004|STARTED|Booster/Rechallenge Phase||10
3159619|NCT01857869|3886590|FG005|STARTED|Booster/Rechallenge Phase||2
3159620|NCT01857869|3886591|FG006|STARTED|Booster/Rechallenge Phase||5
3159621|NCT01857869|3886592|FG007|STARTED|Booster/Rechallenge Phase||4
3159622|NCT01857869|3886593|FG008|STARTED|Booster/Rechallenge Phase||3
3159623|NCT01857869|3886594|FG009|STARTED|Booster/Rechallenge Phase||6
3159624|NCT01857869|3886585|FG000|COMPLETED|Booster/Rechallenge Phase|GSK257049-0,1,7M, GSK257049-0,1,2M and Infectivity Control Groups were not included in Booster phase|0
3159625|NCT01857869|3886586|FG001|COMPLETED|Booster/Rechallenge Phase|GSK257049-0,1,7M, GSK257049-0,1,2M and Infectivity Control Groups were not included in Booster phase|0
3159626|NCT01857869|3886587|FG002|COMPLETED|Booster/Rechallenge Phase|GSK257049-0,1,7M, GSK257049-0,1,2M and Infectivity Control Groups were not included in Booster phase|0
3159627|NCT01857869|3886588|FG003|COMPLETED|Booster/Rechallenge Phase||7
3159628|NCT01857869|3886589|FG004|COMPLETED|Booster/Rechallenge Phase||10
3159629|NCT01857869|3886590|FG005|COMPLETED|Booster/Rechallenge Phase||2
3159630|NCT01857869|3886591|FG006|COMPLETED|Booster/Rechallenge Phase||5
3159631|NCT01857869|3886592|FG007|COMPLETED|Booster/Rechallenge Phase||4
3159632|NCT01857869|3886593|FG008|COMPLETED|Booster/Rechallenge Phase||3
3159633|NCT01857869|3886594|FG009|COMPLETED|Booster/Rechallenge Phase||6
3159634|NCT01857869|3886585|FG000|NOT COMPLETED|Booster/Rechallenge Phase||0
3159635|NCT01857869|3886586|FG001|NOT COMPLETED|Booster/Rechallenge Phase||0
3159636|NCT01857869|3886587|FG002|NOT COMPLETED|Booster/Rechallenge Phase||0
3159637|NCT01857869|3886588|FG003|NOT COMPLETED|Booster/Rechallenge Phase||2
3159638|NCT01857869|3886589|FG004|NOT COMPLETED|Booster/Rechallenge Phase||0
3159639|NCT01857869|3886590|FG005|NOT COMPLETED|Booster/Rechallenge Phase||0
3159640|NCT01857869|3886591|FG006|NOT COMPLETED|Booster/Rechallenge Phase||0
3159641|NCT01857869|3886592|FG007|NOT COMPLETED|Booster/Rechallenge Phase||0
3159642|NCT01857869|3886593|FG008|NOT COMPLETED|Booster/Rechallenge Phase||0
3159643|NCT01857869|3886594|FG009|NOT COMPLETED|Booster/Rechallenge Phase||0
3186133|NCT02024932|3914335|FG001|Pharmacodynamic (PD) Analysis Set|Overall Study||4
3186134|NCT02024932|3914336|FG002|Pharmacodynamic (PD) Analysis Set|Overall Study||2
3186135|NCT02024932|3914337|FG003|Pharmacodynamic (PD) Analysis Set|Overall Study||2
3186136|NCT02024932|3914338|FG004|Pharmacodynamic (PD) Analysis Set|Overall Study||18
3186137|NCT02024932|3914339|FG005|Pharmacodynamic (PD) Analysis Set|Overall Study||9
3186138|NCT02024932|3914334|FG000|COMPLETED|Overall Study||0
3186139|NCT02024932|3914335|FG001|COMPLETED|Overall Study||1
3186140|NCT02024932|3914336|FG002|COMPLETED|Overall Study||2
3186141|NCT02024932|3914337|FG003|COMPLETED|Overall Study||0
3186142|NCT02024932|3914338|FG004|COMPLETED|Overall Study||16
3186143|NCT02024932|3914339|FG005|COMPLETED|Overall Study||9
3186144|NCT02024932|3914334|FG000|NOT COMPLETED|Overall Study||2
3186145|NCT02024932|3914335|FG001|NOT COMPLETED|Overall Study||3
3186146|NCT02024932|3914336|FG002|NOT COMPLETED|Overall Study||0
3186147|NCT02024932|3914337|FG003|NOT COMPLETED|Overall Study||2
3186148|NCT02024932|3914338|FG004|NOT COMPLETED|Overall Study||2
3186149|NCT02024932|3914339|FG005|NOT COMPLETED|Overall Study||0
3186150|NCT02024971|3914359|FG000|STARTED|Overall Study||1103
3186151|NCT02024971|3914359|FG000|Safety Analysis Set|Overall Study|All participants with available data who were enrolled prior to Day 15 of the start of treatment.|1067
3186152|NCT02024971|3914359|FG000|COMPLETED|Overall Study|Including 162 patients with missing efficacy data at two or more time points.|1067
3186153|NCT02024971|3914359|FG000|NOT COMPLETED|Overall Study||36
3186154|NCT02025075|3914365|FG000|STARTED|Overall Study||16
3186155|NCT02025075|3914366|FG001|STARTED|Overall Study||21
3186156|NCT02025075|3914365|FG000|COMPLETED|Overall Study||16
3186157|NCT02025075|3914366|FG001|COMPLETED|Overall Study||19
3186158|NCT02025075|3914365|FG000|NOT COMPLETED|Overall Study||0
3186159|NCT02025075|3914366|FG001|NOT COMPLETED|Overall Study||2
3186160|NCT02025179|3914381|FG000|STARTED|Overall Study||8
3186161|NCT02025179|3914382|FG001|STARTED|Overall Study||9
3186162|NCT02025179|3914383|FG002|STARTED|Overall Study||8
3186163|NCT02025179|3914381|FG000|COMPLETED|Overall Study||8
3186164|NCT02025179|3914382|FG001|COMPLETED|Overall Study||9
3186165|NCT02025179|3914383|FG002|COMPLETED|Overall Study||7
3186166|NCT02025179|3914381|FG000|NOT COMPLETED|Overall Study||0
3186167|NCT02025179|3914382|FG001|NOT COMPLETED|Overall Study||0
3186168|NCT02025179|3914383|FG002|NOT COMPLETED|Overall Study||1
3186169|NCT02025205|3914393|FG000|STARTED|Overall Study||43
3186170|NCT02025205|3914394|FG001|STARTED|Overall Study||50
3186171|NCT02025205|3914393|FG000|COMPLETED|Overall Study||40
3186172|NCT02025205|3914394|FG001|COMPLETED|Overall Study||47
3186173|NCT02025205|3914393|FG000|NOT COMPLETED|Overall Study||3
3186174|NCT02025205|3914394|FG001|NOT COMPLETED|Overall Study||3
3186175|NCT02025426|3914402|FG000|STARTED|Overall Study||9
3186176|NCT02025426|3914403|FG001|STARTED|Overall Study||4
3186177|NCT02025426|3914402|FG000|COMPLETED|Overall Study||9
3186178|NCT02025426|3914403|FG001|COMPLETED|Overall Study||4
3186179|NCT02025426|3914402|FG000|NOT COMPLETED|Overall Study||0
3186180|NCT02025426|3914403|FG001|NOT COMPLETED|Overall Study||0
3186181|NCT02025439|3914411|FG000|STARTED|Overall Study||2
3186182|NCT02025439|3914412|FG001|STARTED|Overall Study||2
3186183|NCT02025439|3914411|FG000|COMPLETED|Overall Study||2
3186184|NCT02025439|3914412|FG001|COMPLETED|Overall Study||2
3186185|NCT02025439|3914411|FG000|NOT COMPLETED|Overall Study||0
3186186|NCT02025439|3914412|FG001|NOT COMPLETED|Overall Study||0
3186187|NCT02025530|3914422|FG000|STARTED|Overall Study||296
3186188|NCT02025530|3914423|FG001|STARTED|Overall Study||734
3186189|NCT02025530|3914422|FG000|COMPLETED|Overall Study||291
3186190|NCT02025530|3914423|FG001|COMPLETED|Overall Study||733
3186191|NCT02025530|3914422|FG000|NOT COMPLETED|Overall Study||5
3186192|NCT02025530|3914423|FG001|NOT COMPLETED|Overall Study||1
3186193|NCT02025621|3914431|FG000|STARTED|Overall Study||442
3186194|NCT02025621|3914432|FG001|STARTED|Overall Study||440
3186195|NCT02025621|3914431|FG000|COMPLETED|Overall Study||428
3186196|NCT02025621|3914432|FG001|COMPLETED|Overall Study||421
3186197|NCT02025621|3914431|FG000|NOT COMPLETED|Overall Study||14
3186198|NCT02025621|3914432|FG001|NOT COMPLETED|Overall Study||19
3186199|NCT02025634|3914440|FG000|STARTED|Overall Study||65
3186200|NCT02025634|3914441|FG001|STARTED|Overall Study||54
3186201|NCT02025634|3914440|FG000|COMPLETED|Overall Study||65
3186202|NCT02025634|3914441|FG001|COMPLETED|Overall Study||54
3186203|NCT02025634|3914440|FG000|NOT COMPLETED|Overall Study||0
3186204|NCT02025634|3914441|FG001|NOT COMPLETED|Overall Study||0
3186205|NCT02025647|3914447|FG000|STARTED|Overall Study||139
3186206|NCT02025647|3914447|FG000|Session 1 (Narrative Module)|Overall Study||139
3186207|NCT02025647|3914447|FG000|Immediate Retest (Rating Module: 5 Min)|Overall Study|"27 did not generate IRS~15 technology issues or administered wrong session"|97
3186208|NCT02025647|3914447|FG000|Session 2 (Narrative Module: 24-48 Hrs)|Overall Study|"19 lost to follow up or technology issues~3 administered wrong session"|117
3186209|NCT02025647|3914447|FG000|Session 3 (Rating Module: 30-45 Days)|Overall Study|"27 did not generate IRS~36 lost to follow up"|76
3186210|NCT02025647|3914447|FG000|COMPLETED|Overall Study||139
3186211|NCT02025647|3914447|FG000|NOT COMPLETED|Overall Study||0
3186212|NCT02025725|3914453|FG000|STARTED|Overall Study||102
3186213|NCT02025725|3914454|FG001|STARTED|Overall Study||103
3186214|NCT02025725|3914453|FG000|COMPLETED|Overall Study||91
3186215|NCT02025725|3914454|FG001|COMPLETED|Overall Study||99
3186216|NCT02025725|3914453|FG000|NOT COMPLETED|Overall Study||11
3186217|NCT02025725|3914454|FG001|NOT COMPLETED|Overall Study||4
3186218|NCT02025751|3914464|FG000|STARTED|Overall Study||26
3186219|NCT02025751|3914465|FG001|STARTED|Overall Study||27
3186220|NCT02025751|3914464|FG000|COMPLETED|Overall Study||25
3186221|NCT02025751|3914465|FG001|COMPLETED|Overall Study||24
3186222|NCT02025751|3914464|FG000|NOT COMPLETED|Overall Study||1
3186223|NCT02025751|3914465|FG001|NOT COMPLETED|Overall Study||3
3186224|NCT02025829|3914473|FG000|STARTED|Overall Study||3
3186225|NCT02025829|3914474|FG001|STARTED|Overall Study||11
3186226|NCT02025829|3914473|FG000|COMPLETED|Overall Study||3
3186227|NCT02025829|3914474|FG001|COMPLETED|Overall Study||11
3186228|NCT02025829|3914473|FG000|NOT COMPLETED|Overall Study||0
3186229|NCT02025829|3914474|FG001|NOT COMPLETED|Overall Study||0
3186230|NCT02025907|3914483|FG000|STARTED|Overall Study|Participant flow is presented for safety population.|108
3186231|NCT02025907|3914484|FG001|STARTED|Overall Study|Participant flow is presented for safety population.|108
3186232|NCT02025907|3914483|FG000|COMPLETED|Overall Study||81
3186233|NCT02025907|3914484|FG001|COMPLETED|Overall Study||96
3186234|NCT02025907|3914483|FG000|NOT COMPLETED|Overall Study||27
3186235|NCT02025907|3914484|FG001|NOT COMPLETED|Overall Study||12
3186236|NCT02025985|3914495|FG000|STARTED|Overall Study||25
3186237|NCT02025985|3914496|FG001|STARTED|Overall Study||23
3186238|NCT02025985|3914497|FG002|STARTED|Overall Study||25
3186239|NCT02025985|3914498|FG003|STARTED|Overall Study||21
3186240|NCT02025985|3914499|FG004|STARTED|Overall Study||20
3186241|NCT02025985|3914495|FG000|Modified Intent-to-treat(mITT)Population|Overall Study||23
3186242|NCT02025985|3914496|FG001|Modified Intent-to-treat(mITT)Population|Overall Study||22
3186243|NCT02025985|3914497|FG002|Modified Intent-to-treat(mITT)Population|Overall Study||25
3186244|NCT02025985|3914498|FG003|Modified Intent-to-treat(mITT)Population|Overall Study||21
3186245|NCT02025985|3914499|FG004|Modified Intent-to-treat(mITT)Population|Overall Study||20
3186246|NCT02025985|3914495|FG000|COMPLETED|Overall Study||0
3186247|NCT02025985|3914496|FG001|COMPLETED|Overall Study||0
3186248|NCT02025985|3914497|FG002|COMPLETED|Overall Study||0
3186249|NCT02025985|3914498|FG003|COMPLETED|Overall Study||0
3186250|NCT02025985|3914499|FG004|COMPLETED|Overall Study||0
3186251|NCT02025985|3914495|FG000|NOT COMPLETED|Overall Study||25
3186252|NCT02025985|3914496|FG001|NOT COMPLETED|Overall Study||23
3186253|NCT02025985|3914497|FG002|NOT COMPLETED|Overall Study||25
3186254|NCT02025985|3914498|FG003|NOT COMPLETED|Overall Study||21
3186255|NCT02025985|3914499|FG004|NOT COMPLETED|Overall Study||20
3186256|NCT02026011|3914515|FG000|STARTED|Allocation 1 (First Set of Medication)||46
3186257|NCT02026011|3914516|FG001|STARTED|Allocation 1 (First Set of Medication)||41
3186258|NCT02026011|3914515|FG000|COMPLETED|Allocation 1 (First Set of Medication)||38
3186259|NCT02026011|3914516|FG001|COMPLETED|Allocation 1 (First Set of Medication)||39
3186260|NCT02026011|3914515|FG000|NOT COMPLETED|Allocation 1 (First Set of Medication)||8
3186261|NCT02026011|3914516|FG001|NOT COMPLETED|Allocation 1 (First Set of Medication)||2
3186262|NCT02026011|3914515|FG000|STARTED|Allocation 2 (Second Set of Medication)||38
3186263|NCT02026011|3914516|FG001|STARTED|Allocation 2 (Second Set of Medication)||37
3186264|NCT02026011|3914515|FG000|COMPLETED|Allocation 2 (Second Set of Medication)||37
3186265|NCT02026011|3914516|FG001|COMPLETED|Allocation 2 (Second Set of Medication)||35
3186266|NCT02026011|3914515|FG000|NOT COMPLETED|Allocation 2 (Second Set of Medication)||1
3186267|NCT02026011|3914516|FG001|NOT COMPLETED|Allocation 2 (Second Set of Medication)||2
3363957|NCT04039919|4095087|FG000|STARTED|Treatment Period 6||5
3363958|NCT04039919|4095088|FG001|STARTED|Treatment Period 6||6
3363959|NCT04039919|4095089|FG002|STARTED|Treatment Period 6||5
3363960|NCT04039919|4095090|FG003|STARTED|Treatment Period 6||6
3363961|NCT04039919|4095091|FG004|STARTED|Treatment Period 6||0
3186268|NCT02026063|3914527|FG000|STARTED|Overall Study||22
3186269|NCT02026063|3914528|FG001|STARTED|Overall Study||102
3186270|NCT02026063|3914527|FG000|COMPLETED|Overall Study||13
3186271|NCT02026063|3914528|FG001|COMPLETED|Overall Study||53
3186272|NCT02026063|3914527|FG000|NOT COMPLETED|Overall Study||9
3186273|NCT02026063|3914528|FG001|NOT COMPLETED|Overall Study||49
3186274|NCT02026141|3914537|FG000|STARTED|Overall Study||20
3186275|NCT02026141|3914538|FG001|STARTED|Overall Study||20
3186276|NCT02026141|3914537|FG000|COMPLETED|Overall Study||20
3186277|NCT02026141|3914538|FG001|COMPLETED|Overall Study||19
3186278|NCT02026141|3914537|FG000|NOT COMPLETED|Overall Study||0
3186279|NCT02026141|3914538|FG001|NOT COMPLETED|Overall Study||1
3186280|NCT02026193|3914546|FG000|STARTED|Overall Study||3
3186281|NCT02026193|3914547|FG001|STARTED|Overall Study||8
3186282|NCT02026193|3914546|FG000|COMPLETED|Overall Study||3
3186283|NCT02026193|3914547|FG001|COMPLETED|Overall Study||8
3186284|NCT02026193|3914546|FG000|NOT COMPLETED|Overall Study||0
3186285|NCT02026193|3914547|FG001|NOT COMPLETED|Overall Study||0
3186286|NCT02026206|3914555|FG000|STARTED|Overall Study||44
3186287|NCT02026206|3914556|FG001|STARTED|Overall Study||44
3186288|NCT02026206|3914555|FG000|COMPLETED|Overall Study||40
3186289|NCT02026206|3914556|FG001|COMPLETED|Overall Study||36
3186290|NCT02026206|3914555|FG000|NOT COMPLETED|Overall Study||4
3186291|NCT02026206|3914556|FG001|NOT COMPLETED|Overall Study||8
3186292|NCT02026258|3914564|FG000|STARTED|Randomized||20
3186293|NCT02026258|3914565|FG001|STARTED|Randomized||21
3186294|NCT02026258|3914564|FG000|COMPLETED|Randomized||16
3186295|NCT02026258|3914565|FG001|COMPLETED|Randomized||19
3186296|NCT02026258|3914564|FG000|NOT COMPLETED|Randomized||4
3186297|NCT02026258|3914565|FG001|NOT COMPLETED|Randomized||2
3186298|NCT02026258|3914564|FG000|STARTED|Recieved Allocated Intervention||16
3186299|NCT02026258|3914565|FG001|STARTED|Recieved Allocated Intervention||19
3186300|NCT02026258|3914564|FG000|COMPLETED|Recieved Allocated Intervention||15
3186301|NCT02026258|3914565|FG001|COMPLETED|Recieved Allocated Intervention||17
3186302|NCT02026258|3914564|FG000|NOT COMPLETED|Recieved Allocated Intervention||1
3186303|NCT02026258|3914565|FG001|NOT COMPLETED|Recieved Allocated Intervention||2
3186304|NCT02026297|3914574|FG000|STARTED|Overall Study||7
3186305|NCT02026297|3914575|FG001|STARTED|Overall Study||13
3186306|NCT02026297|3914574|FG000|COMPLETED|Overall Study||7
3186307|NCT02026297|3914575|FG001|COMPLETED|Overall Study||13
3186308|NCT02026297|3914574|FG000|NOT COMPLETED|Overall Study||0
3186309|NCT02026297|3914575|FG001|NOT COMPLETED|Overall Study||0
3186310|NCT02026453|3914584|FG000|STARTED|Overall Study||101
3186311|NCT02026453|3914585|FG001|STARTED|Overall Study||103
3186312|NCT02026453|3914586|FG002|STARTED|Overall Study||102
3186313|NCT02026453|3914584|FG000|COMPLETED|Overall Study||95
3186314|NCT02026453|3914585|FG001|COMPLETED|Overall Study||94
3186315|NCT02026453|3914586|FG002|COMPLETED|Overall Study||89
3186316|NCT02026453|3914584|FG000|NOT COMPLETED|Overall Study||6
3186317|NCT02026453|3914585|FG001|NOT COMPLETED|Overall Study||9
3186318|NCT02026453|3914586|FG002|NOT COMPLETED|Overall Study||13
3186319|NCT02026687|3914596|FG000|STARTED|Overall Study||40
3186320|NCT02026687|3914597|FG001|STARTED|Overall Study||40
3186321|NCT02026687|3914596|FG000|COMPLETED|Overall Study||39
3186322|NCT02026687|3914597|FG001|COMPLETED|Overall Study||38
3186323|NCT02026687|3914596|FG000|NOT COMPLETED|Overall Study||1
3186324|NCT02026687|3914597|FG001|NOT COMPLETED|Overall Study||2
3186325|NCT02027025|3914606|FG000|STARTED|Overall Study||48
3186326|NCT02027025|3914607|FG001|STARTED|Overall Study||47
3186327|NCT02027025|3914608|FG002|STARTED|Overall Study||47
3186328|NCT02027025|3914606|FG000|COMPLETED|Overall Study||47
3186329|NCT02027025|3914607|FG001|COMPLETED|Overall Study||42
3186330|NCT02027025|3914608|FG002|COMPLETED|Overall Study||46
3186331|NCT02027025|3914606|FG000|NOT COMPLETED|Overall Study||1
3186332|NCT02027025|3914607|FG001|NOT COMPLETED|Overall Study||5
3186333|NCT02027025|3914608|FG002|NOT COMPLETED|Overall Study||1
3186334|NCT02027311|3914629|FG000|STARTED|Overall Study||33
3186335|NCT02027311|3914630|FG001|STARTED|Overall Study||35
3186336|NCT02027311|3914629|FG000|COMPLETED|Overall Study|1 case was dropped due to hypotension and 2 were desaturation.|30
3186337|NCT02027311|3914630|FG001|COMPLETED|Overall Study|1 cases was dropped due to tachycardia and 1 were desaturation.|33
3186338|NCT02027311|3914629|FG000|NOT COMPLETED|Overall Study||3
3186339|NCT02027311|3914630|FG001|NOT COMPLETED|Overall Study||2
3186340|NCT02027376|3914638|FG000|STARTED|Overall Study||5
3186341|NCT02027376|3914639|FG001|STARTED|Overall Study||4
3186342|NCT02027376|3914640|FG002|STARTED|Overall Study||3
3186343|NCT02027376|3914638|FG000|COMPLETED|Overall Study||4
3186344|NCT02027376|3914639|FG001|COMPLETED|Overall Study||4
3186345|NCT02027376|3914640|FG002|COMPLETED|Overall Study||3
3186346|NCT02027376|3914638|FG000|NOT COMPLETED|Overall Study||1
3186347|NCT02027376|3914639|FG001|NOT COMPLETED|Overall Study||0
3186348|NCT02027376|3914640|FG002|NOT COMPLETED|Overall Study||0
3186349|NCT02027402|3914652|FG000|STARTED|Overall Study||98
3186350|NCT02027402|3914653|FG001|STARTED|Overall Study||100
3186351|NCT02027402|3914652|FG000|COMPLETED|Overall Study||94
3186352|NCT02027402|3914653|FG001|COMPLETED|Overall Study||99
3186353|NCT02027402|3914652|FG000|NOT COMPLETED|Overall Study||4
3186354|NCT02027402|3914653|FG001|NOT COMPLETED|Overall Study||1
3186355|NCT02027428|3914663|FG000|STARTED|Induction||427
3186356|NCT02027428|3914664|FG001|STARTED|Induction||0
3186357|NCT02027428|3914665|FG002|STARTED|Induction||0
3186358|NCT02027428|3914663|FG000|Received Study Drug|Induction||420
3186359|NCT02027428|3914664|FG001|Received Study Drug|Induction||0
3186360|NCT02027428|3914665|FG002|Received Study Drug|Induction||0
3186361|NCT02027428|3914663|FG000|COMPLETED|Induction|If radiologically CR, PR or SD after 4 cycles of treatment, participants continue on to Maintenance.|202
3186362|NCT02027428|3914664|FG001|COMPLETED|Induction||0
3186363|NCT02027428|3914665|FG002|COMPLETED|Induction||0
3186364|NCT02027428|3914663|FG000|NOT COMPLETED|Induction||225
3186365|NCT02027428|3914664|FG001|NOT COMPLETED|Induction||0
3186366|NCT02027428|3914665|FG002|NOT COMPLETED|Induction||0
3186367|NCT02027428|3914663|FG000|STARTED|Maintenance||0
3186368|NCT02027428|3914664|FG001|STARTED|Maintenance||136
3186369|NCT02027428|3914665|FG002|STARTED|Maintenance||66
3186370|NCT02027428|3914663|FG000|COMPLETED|Maintenance||0
3186371|NCT02027428|3914664|FG001|COMPLETED|Maintenance||12
3186372|NCT02027428|3914665|FG002|COMPLETED|Maintenance||6
3186373|NCT02027428|3914663|FG000|NOT COMPLETED|Maintenance||0
3186374|NCT02027428|3914664|FG001|NOT COMPLETED|Maintenance||124
3186375|NCT02027428|3914665|FG002|NOT COMPLETED|Maintenance||60
3186376|NCT02027428|3914663|FG000|STARTED|Survival Follow-up||0
3186377|NCT02027428|3914664|FG001|STARTED|Survival Follow-up|Participants are not taking study intervention but are on appropriate standard of care.|117
3186378|NCT02027428|3914665|FG002|STARTED|Survival Follow-up|Participants are not taking study intervention but are on appropriate standard of care.|55
3186379|NCT02027428|3914663|FG000|COMPLETED|Survival Follow-up||0
3186380|NCT02027428|3914664|FG001|COMPLETED|Survival Follow-up||38
3186381|NCT02027428|3914665|FG002|COMPLETED|Survival Follow-up||9
3186382|NCT02027428|3914663|FG000|NOT COMPLETED|Survival Follow-up||0
3186383|NCT02027428|3914664|FG001|NOT COMPLETED|Survival Follow-up||79
3186384|NCT02027428|3914665|FG002|NOT COMPLETED|Survival Follow-up||46
3186385|NCT02027545|3914690|FG000|STARTED|Overall Study||261
3186386|NCT02027545|3914691|FG001|STARTED|Overall Study||175
3186387|NCT02027545|3914690|FG000|COMPLETED|Overall Study||259
3186388|NCT02027545|3914691|FG001|COMPLETED|Overall Study||173
3186389|NCT02027545|3914690|FG000|NOT COMPLETED|Overall Study||2
3186390|NCT02027545|3914691|FG001|NOT COMPLETED|Overall Study||2
3186391|NCT02027558|3914699|FG000|STARTED|Overall Study||62
3186392|NCT02027558|3914700|FG001|STARTED|Overall Study||63
3186393|NCT02027558|3914699|FG000|Post-treatment|Overall Study||49
3186394|NCT02027558|3914700|FG001|Post-treatment|Overall Study||60
3186395|NCT02027558|3914699|FG000|3-month Follow-up|Overall Study||53
3186396|NCT02027558|3914700|FG001|3-month Follow-up|Overall Study||58
3186397|NCT02027558|3914699|FG000|6-month Follow-up|Overall Study||53
3186398|NCT02027558|3914700|FG001|6-month Follow-up|Overall Study||61
3186399|NCT02027558|3914699|FG000|COMPLETED|Overall Study||53
3186400|NCT02027558|3914700|FG001|COMPLETED|Overall Study||61
3186401|NCT02027558|3914699|FG000|NOT COMPLETED|Overall Study||9
3186402|NCT02027558|3914700|FG001|NOT COMPLETED|Overall Study||2
3186403|NCT02027623|3914710|FG000|STARTED|Overall Study||77
3186404|NCT02027623|3914711|FG001|STARTED|Overall Study||77
3186405|NCT02027623|3914710|FG000|COMPLETED|Overall Study||68
3186406|NCT02027623|3914711|FG001|COMPLETED|Overall Study||65
3186407|NCT02027623|3914710|FG000|NOT COMPLETED|Overall Study||9
3186408|NCT02027623|3914711|FG001|NOT COMPLETED|Overall Study||12
3186409|NCT02027701|3914718|FG000|STARTED|Overall Study||82
3186410|NCT02027701|3914718|FG000|COMPLETED|Overall Study||66
3186411|NCT02027701|3914718|FG000|NOT COMPLETED|Overall Study||16
3186412|NCT02027844|3914727|FG000|STARTED|Overall Study||39
3186413|NCT02027844|3914728|FG001|STARTED|Overall Study||39
3186414|NCT02027844|3914729|FG002|STARTED|Overall Study||39
3186415|NCT02027844|3914727|FG000|COMPLETED|Overall Study||34
3186416|NCT02027844|3914728|FG001|COMPLETED|Overall Study||33
3186417|NCT02027844|3914729|FG002|COMPLETED|Overall Study||37
3186418|NCT02027844|3914727|FG000|NOT COMPLETED|Overall Study||5
3186419|NCT02027844|3914728|FG001|NOT COMPLETED|Overall Study||6
3186420|NCT02027844|3914729|FG002|NOT COMPLETED|Overall Study||2
3186421|NCT02027883|3914739|FG000|STARTED|Overall Study||50
3186422|NCT02027883|3914740|FG001|STARTED|Overall Study||50
3186423|NCT02027883|3914739|FG000|COMPLETED|Overall Study||50
3186424|NCT02027883|3914740|FG001|COMPLETED|Overall Study||50
3186425|NCT02027883|3914739|FG000|NOT COMPLETED|Overall Study||0
3186426|NCT02027883|3914740|FG001|NOT COMPLETED|Overall Study||0
3186427|NCT02028065|3914753|FG000|STARTED|Randomization Through Start Treatment|Randomized|76
3186428|NCT02028065|3914754|FG001|STARTED|Randomization Through Start Treatment|Randomized|154
3186429|NCT02028065|3914755|FG002|STARTED|Randomization Through Start Treatment|Randomized|152
3186430|NCT02028065|3914753|FG000|COMPLETED|Randomization Through Start Treatment||75
3186431|NCT02028065|3914754|FG001|COMPLETED|Randomization Through Start Treatment||151
3186432|NCT02028065|3914755|FG002|COMPLETED|Randomization Through Start Treatment||149
3186433|NCT02028065|3914753|FG000|NOT COMPLETED|Randomization Through Start Treatment||1
3186434|NCT02028065|3914754|FG001|NOT COMPLETED|Randomization Through Start Treatment||3
3186435|NCT02028065|3914755|FG002|NOT COMPLETED|Randomization Through Start Treatment||3
3186436|NCT02028065|3914753|FG000|STARTED|Treatment Through Study Completion|Includes 1 participant randomized to sugammadex 16 mg/kg who actually received placebo|76
3186437|NCT02028065|3914754|FG001|STARTED|Treatment Through Study Completion||151
3186438|NCT02028065|3914755|FG002|STARTED|Treatment Through Study Completion|Does not include the 1 participant randomized to sugammadex 16 mg/kg who actually received placebo|148
3186439|NCT02028065|3914753|FG000|Received First Dose|Treatment Through Study Completion||76
3186440|NCT02028065|3914754|FG001|Received First Dose|Treatment Through Study Completion||151
3186441|NCT02028065|3914755|FG002|Received First Dose|Treatment Through Study Completion||148
3186442|NCT02028065|3914753|FG000|Received Second Dose|Treatment Through Study Completion||69
3186443|NCT02028065|3914754|FG001|Received Second Dose|Treatment Through Study Completion||140
3186444|NCT02028065|3914755|FG002|Received Second Dose|Treatment Through Study Completion||138
3186445|NCT02028065|3914753|FG000|Received Third Dose|Treatment Through Study Completion||64
3186446|NCT02028065|3914754|FG001|Received Third Dose|Treatment Through Study Completion||136
3186447|NCT02028065|3914755|FG002|Received Third Dose|Treatment Through Study Completion||134
3186448|NCT02028065|3914753|FG000|COMPLETED|Treatment Through Study Completion||64
3186449|NCT02028065|3914754|FG001|COMPLETED|Treatment Through Study Completion||136
3186450|NCT02028065|3914755|FG002|COMPLETED|Treatment Through Study Completion||134
3186451|NCT02028065|3914753|FG000|NOT COMPLETED|Treatment Through Study Completion||12
3186452|NCT02028065|3914754|FG001|NOT COMPLETED|Treatment Through Study Completion||15
3186453|NCT02028065|3914755|FG002|NOT COMPLETED|Treatment Through Study Completion||14
3186454|NCT02028169|3914763|FG000|STARTED|Overall Study||120
3186455|NCT02028169|3914763|FG000|COMPLETED|Overall Study||92
3186456|NCT02028169|3914763|FG000|NOT COMPLETED|Overall Study||28
3186457|NCT02028182|3914767|FG000|STARTED|Overall Study||22
3186458|NCT02028182|3914767|FG000|COMPLETED|Overall Study||20
3186459|NCT02028182|3914767|FG000|NOT COMPLETED|Overall Study||2
3186460|NCT02028208|3914775|FG000|STARTED|Overall Study||21
3186461|NCT02028208|3914776|FG001|STARTED|Overall Study||13
3186462|NCT02028208|3914777|FG002|STARTED|Overall Study||22
3186463|NCT02028208|3914775|FG000|COMPLETED|Overall Study||21
3186464|NCT02028208|3914776|FG001|COMPLETED|Overall Study||13
3186465|NCT02028208|3914777|FG002|COMPLETED|Overall Study||21
3186466|NCT02028208|3914775|FG000|NOT COMPLETED|Overall Study||0
3186467|NCT02028208|3914776|FG001|NOT COMPLETED|Overall Study||0
3186468|NCT02028208|3914777|FG002|NOT COMPLETED|Overall Study||1
3186469|NCT02028221|3914787|FG000|STARTED|Overall Study||75
3186470|NCT02028221|3914788|FG001|STARTED|Overall Study||76
3186471|NCT02028221|3914787|FG000|COMPLETED|Overall Study||62
3186472|NCT02028221|3914788|FG001|COMPLETED|Overall Study||56
3186473|NCT02028221|3914787|FG000|NOT COMPLETED|Overall Study||13
3186474|NCT02028221|3914788|FG001|NOT COMPLETED|Overall Study||20
3186475|NCT02028247|3914797|FG000|STARTED|Overall Study||77
3186476|NCT02028247|3914798|FG001|STARTED|Overall Study||71
3186477|NCT02028247|3914799|FG002|STARTED|Overall Study||19
3186478|NCT02028247|3914797|FG000|COMPLETED|Overall Study||67
3186479|NCT02028247|3914798|FG001|COMPLETED|Overall Study||59
3186480|NCT02028247|3914799|FG002|COMPLETED|Overall Study||15
3186481|NCT02028247|3914797|FG000|NOT COMPLETED|Overall Study||10
3186482|NCT02028247|3914798|FG001|NOT COMPLETED|Overall Study||12
3186483|NCT02028247|3914799|FG002|NOT COMPLETED|Overall Study||4
3186484|NCT02028325|3914807|FG000|STARTED|Overall Study||136
3186485|NCT02028325|3914807|FG000|COMPLETED|Overall Study||126
3186486|NCT02028325|3914807|FG000|NOT COMPLETED|Overall Study||10
3186487|NCT02028676|3914820|FG000|STARTED|Initial Enrolment: CDM vs LCM|Factorial randomization at enrolment: Number of eligible children randomized to this group in ARROW|606
3186488|NCT02028676|3914821|FG001|STARTED|Initial Enrolment: CDM vs LCM|Factorial randomization at enrolment: Number of eligible children randomized to this group in ARROW|600
3186489|NCT02028676|3914822|FG002|STARTED|Initial Enrolment: CDM vs LCM|Factorial randomization at enrolment: Number of eligible children randomized to this group in ARROW|0
3186490|NCT02028676|3914823|FG003|STARTED|Initial Enrolment: CDM vs LCM|Factorial randomization at enrolment: Number of eligible children randomized to this group in ARROW|0
3186491|NCT02028676|3914824|FG004|STARTED|Initial Enrolment: CDM vs LCM|Factorial randomization at enrolment: Number of eligible children randomized to this group in ARROW|0
3186492|NCT02028676|3914825|FG005|STARTED|Initial Enrolment: CDM vs LCM|Secondary partial factorial randomization: Only a subset of ARROW children were eligible|0
3186493|NCT02028676|3914826|FG006|STARTED|Initial Enrolment: CDM vs LCM|Secondary partial factorial randomization: Only a subset of ARROW children were eligible|0
3186494|NCT02028676|3914827|FG007|STARTED|Initial Enrolment: CDM vs LCM|Secondary partial factorial randomization: Only a subset of ARROW children were eligible|0
3186495|NCT02028676|3914828|FG008|STARTED|Initial Enrolment: CDM vs LCM|Secondary partial factorial randomization: Only a subset of ARROW children were eligible|0
3186496|NCT02028676|3914820|FG000|COMPLETED|Initial Enrolment: CDM vs LCM||606
3186497|NCT02028676|3914821|FG001|COMPLETED|Initial Enrolment: CDM vs LCM||600
3186498|NCT02028676|3914822|FG002|COMPLETED|Initial Enrolment: CDM vs LCM||0
3186499|NCT02028676|3914823|FG003|COMPLETED|Initial Enrolment: CDM vs LCM||0
3186500|NCT02028676|3914824|FG004|COMPLETED|Initial Enrolment: CDM vs LCM||0
3186501|NCT02028676|3914825|FG005|COMPLETED|Initial Enrolment: CDM vs LCM||0
3186502|NCT02028676|3914826|FG006|COMPLETED|Initial Enrolment: CDM vs LCM||0
3186503|NCT02028676|3914827|FG007|COMPLETED|Initial Enrolment: CDM vs LCM||0
3186504|NCT02028676|3914828|FG008|COMPLETED|Initial Enrolment: CDM vs LCM||0
3186505|NCT02028676|3914820|FG000|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
3186506|NCT02028676|3914821|FG001|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
3186507|NCT02028676|3914822|FG002|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
3186508|NCT02028676|3914823|FG003|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
3186509|NCT02028676|3914824|FG004|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
3186510|NCT02028676|3914825|FG005|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
3186511|NCT02028676|3914826|FG006|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
3186512|NCT02028676|3914827|FG007|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
3186513|NCT02028676|3914828|FG008|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
3186514|NCT02028676|3914820|FG000|STARTED|Initial Enrolment: Induction ART||0
3186515|NCT02028676|3914821|FG001|STARTED|Initial Enrolment: Induction ART||0
3186516|NCT02028676|3914822|FG002|STARTED|Initial Enrolment: Induction ART||397
3186517|NCT02028676|3914823|FG003|STARTED|Initial Enrolment: Induction ART||404
3186518|NCT02028676|3914824|FG004|STARTED|Initial Enrolment: Induction ART||405
3186519|NCT02028676|3914825|FG005|STARTED|Initial Enrolment: Induction ART||0
3186520|NCT02028676|3914826|FG006|STARTED|Initial Enrolment: Induction ART||0
3186521|NCT02028676|3914827|FG007|STARTED|Initial Enrolment: Induction ART||0
3186522|NCT02028676|3914828|FG008|STARTED|Initial Enrolment: Induction ART||0
3186523|NCT02028676|3914820|FG000|COMPLETED|Initial Enrolment: Induction ART||0
3186524|NCT02028676|3914821|FG001|COMPLETED|Initial Enrolment: Induction ART||0
3186525|NCT02028676|3914822|FG002|COMPLETED|Initial Enrolment: Induction ART||397
3186526|NCT02028676|3914823|FG003|COMPLETED|Initial Enrolment: Induction ART||404
3186527|NCT02028676|3914824|FG004|COMPLETED|Initial Enrolment: Induction ART||405
3186528|NCT02028676|3914825|FG005|COMPLETED|Initial Enrolment: Induction ART||0
3186529|NCT02028676|3914826|FG006|COMPLETED|Initial Enrolment: Induction ART||0
3186530|NCT02028676|3914827|FG007|COMPLETED|Initial Enrolment: Induction ART||0
3186531|NCT02028676|3914828|FG008|COMPLETED|Initial Enrolment: Induction ART||0
3186532|NCT02028676|3914820|FG000|NOT COMPLETED|Initial Enrolment: Induction ART||0
3186533|NCT02028676|3914821|FG001|NOT COMPLETED|Initial Enrolment: Induction ART||0
3186534|NCT02028676|3914822|FG002|NOT COMPLETED|Initial Enrolment: Induction ART||0
3186535|NCT02028676|3914823|FG003|NOT COMPLETED|Initial Enrolment: Induction ART||0
3186536|NCT02028676|3914824|FG004|NOT COMPLETED|Initial Enrolment: Induction ART||0
3186537|NCT02028676|3914825|FG005|NOT COMPLETED|Initial Enrolment: Induction ART||0
3186538|NCT02028676|3914826|FG006|NOT COMPLETED|Initial Enrolment: Induction ART||0
3186539|NCT02028676|3914827|FG007|NOT COMPLETED|Initial Enrolment: Induction ART||0
3186540|NCT02028676|3914828|FG008|NOT COMPLETED|Initial Enrolment: Induction ART||0
3186541|NCT02028676|3914820|FG000|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
3186542|NCT02028676|3914821|FG001|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
3186543|NCT02028676|3914822|FG002|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
3186544|NCT02028676|3914823|FG003|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
3186545|NCT02028676|3914824|FG004|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
3186546|NCT02028676|3914825|FG005|STARTED|Subsequent Once vs Twice Daily ABC+3TC||336
3186547|NCT02028676|3914826|FG006|STARTED|Subsequent Once vs Twice Daily ABC+3TC||333
3186548|NCT02028676|3914827|FG007|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
3186549|NCT02028676|3914828|FG008|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
3186550|NCT02028676|3914820|FG000|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
3186551|NCT02028676|3914821|FG001|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
3186552|NCT02028676|3914822|FG002|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
3186553|NCT02028676|3914823|FG003|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
3186554|NCT02028676|3914824|FG004|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
3186555|NCT02028676|3914825|FG005|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||336
3186556|NCT02028676|3914826|FG006|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||333
3186557|NCT02028676|3914827|FG007|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
3186558|NCT02028676|3914828|FG008|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
3186559|NCT02028676|3914820|FG000|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
3186560|NCT02028676|3914821|FG001|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
3186561|NCT02028676|3914822|FG002|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
3186562|NCT02028676|3914823|FG003|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
3186563|NCT02028676|3914824|FG004|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
3186564|NCT02028676|3914825|FG005|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
3186565|NCT02028676|3914826|FG006|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
3186566|NCT02028676|3914827|FG007|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
3186567|NCT02028676|3914828|FG008|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
3186568|NCT02028676|3914820|FG000|STARTED|Subsequent Cotrimoxazole Randomization||0
3186569|NCT02028676|3914821|FG001|STARTED|Subsequent Cotrimoxazole Randomization||0
3186570|NCT02028676|3914822|FG002|STARTED|Subsequent Cotrimoxazole Randomization||0
3186571|NCT02028676|3914823|FG003|STARTED|Subsequent Cotrimoxazole Randomization||0
3186572|NCT02028676|3914824|FG004|STARTED|Subsequent Cotrimoxazole Randomization||0
3186573|NCT02028676|3914825|FG005|STARTED|Subsequent Cotrimoxazole Randomization||0
3186574|NCT02028676|3914826|FG006|STARTED|Subsequent Cotrimoxazole Randomization||0
3186575|NCT02028676|3914827|FG007|STARTED|Subsequent Cotrimoxazole Randomization||376
3186576|NCT02028676|3914828|FG008|STARTED|Subsequent Cotrimoxazole Randomization||382
3186577|NCT02028676|3914820|FG000|COMPLETED|Subsequent Cotrimoxazole Randomization||0
3186578|NCT02028676|3914821|FG001|COMPLETED|Subsequent Cotrimoxazole Randomization||0
3186579|NCT02028676|3914822|FG002|COMPLETED|Subsequent Cotrimoxazole Randomization||0
3186580|NCT02028676|3914823|FG003|COMPLETED|Subsequent Cotrimoxazole Randomization||0
3186581|NCT02028676|3914824|FG004|COMPLETED|Subsequent Cotrimoxazole Randomization||0
3186582|NCT02028676|3914825|FG005|COMPLETED|Subsequent Cotrimoxazole Randomization||0
3186583|NCT02028676|3914826|FG006|COMPLETED|Subsequent Cotrimoxazole Randomization||0
3186584|NCT02028676|3914827|FG007|COMPLETED|Subsequent Cotrimoxazole Randomization||376
3186585|NCT02028676|3914828|FG008|COMPLETED|Subsequent Cotrimoxazole Randomization||382
3363962|NCT04039919|4095087|FG000|COMPLETED|Treatment Period 6||5
3186586|NCT02028676|3914820|FG000|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
3186587|NCT02028676|3914821|FG001|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
3186588|NCT02028676|3914822|FG002|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
3186589|NCT02028676|3914823|FG003|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
3186590|NCT02028676|3914824|FG004|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
3186591|NCT02028676|3914825|FG005|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
3186592|NCT02028676|3914826|FG006|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
3186593|NCT02028676|3914827|FG007|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
3186594|NCT02028676|3914828|FG008|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
3186595|NCT02028715|3914854|FG000|STARTED|Overall Study||34
3186596|NCT02028715|3914855|FG001|STARTED|Overall Study||34
3186597|NCT02028715|3914854|FG000|COMPLETED|Overall Study||29
3186598|NCT02028715|3914855|FG001|COMPLETED|Overall Study||30
3186599|NCT02028715|3914854|FG000|NOT COMPLETED|Overall Study||5
3186600|NCT02028715|3914855|FG001|NOT COMPLETED|Overall Study||4
3186601|NCT02028754|3914863|FG000|STARTED|Overall Study||90
3186602|NCT02028754|3914864|FG001|STARTED|Overall Study||90
3186603|NCT02028754|3914863|FG000|COMPLETED|Overall Study||83
3186604|NCT02028754|3914864|FG001|COMPLETED|Overall Study||82
3186605|NCT02028754|3914863|FG000|NOT COMPLETED|Overall Study||7
3186606|NCT02028754|3914864|FG001|NOT COMPLETED|Overall Study||8
3186607|NCT02028767|3914870|FG000|STARTED|Treatment Period 1||16
3186608|NCT02028767|3914871|FG001|STARTED|Treatment Period 1||16
3186609|NCT02028767|3914870|FG000|COMPLETED|Treatment Period 1||16
3186610|NCT02028767|3914871|FG001|COMPLETED|Treatment Period 1||16
3186611|NCT02028767|3914870|FG000|NOT COMPLETED|Treatment Period 1||0
3186612|NCT02028767|3914871|FG001|NOT COMPLETED|Treatment Period 1||0
3186613|NCT02028767|3914870|FG000|STARTED|Treatment Period 2||16
3186614|NCT02028767|3914871|FG001|STARTED|Treatment Period 2||16
3186615|NCT02028767|3914870|FG000|COMPLETED|Treatment Period 2||14
3186616|NCT02028767|3914871|FG001|COMPLETED|Treatment Period 2||16
3186617|NCT02028767|3914870|FG000|NOT COMPLETED|Treatment Period 2||2
3186618|NCT02028767|3914871|FG001|NOT COMPLETED|Treatment Period 2||0
3186619|NCT02028780|3914889|FG000|STARTED|Observation Phase||6
3186620|NCT02028780|3914890|FG001|STARTED|Observation Phase||2
3186621|NCT02028780|3914891|FG002|STARTED|Observation Phase||6
3186622|NCT02028780|3914892|FG003|STARTED|Observation Phase||6
3186623|NCT02028780|3914893|FG004|STARTED|Observation Phase||6
3186624|NCT02028780|3914894|FG005|STARTED|Observation Phase||6
3186625|NCT02028780|3914895|FG006|STARTED|Observation Phase||9
3186626|NCT02028780|3914896|FG007|STARTED|Observation Phase||3
3186627|NCT02028780|3914897|FG008|STARTED|Observation Phase||9
3186628|NCT02028780|3914898|FG009|STARTED|Observation Phase||9
3186629|NCT02028780|3914899|FG010|STARTED|Observation Phase||9
3186630|NCT02028780|3914900|FG011|STARTED|Observation Phase||9
3186631|NCT02028780|3914889|FG000|COMPLETED|Observation Phase||6
3186632|NCT02028780|3914890|FG001|COMPLETED|Observation Phase||2
3186633|NCT02028780|3914891|FG002|COMPLETED|Observation Phase||6
3186634|NCT02028780|3914892|FG003|COMPLETED|Observation Phase||6
3186635|NCT02028780|3914893|FG004|COMPLETED|Observation Phase||6
3186636|NCT02028780|3914894|FG005|COMPLETED|Observation Phase||6
3186637|NCT02028780|3914895|FG006|COMPLETED|Observation Phase||9
3186638|NCT02028780|3914896|FG007|COMPLETED|Observation Phase||3
3186639|NCT02028780|3914897|FG008|COMPLETED|Observation Phase||9
3186640|NCT02028780|3914898|FG009|COMPLETED|Observation Phase||9
3186641|NCT02028780|3914899|FG010|COMPLETED|Observation Phase||9
3186642|NCT02028780|3914900|FG011|COMPLETED|Observation Phase||9
3186643|NCT02028780|3914889|FG000|NOT COMPLETED|Observation Phase||0
3186644|NCT02028780|3914890|FG001|NOT COMPLETED|Observation Phase||0
3186645|NCT02028780|3914891|FG002|NOT COMPLETED|Observation Phase||0
3186646|NCT02028780|3914892|FG003|NOT COMPLETED|Observation Phase||0
3186647|NCT02028780|3914893|FG004|NOT COMPLETED|Observation Phase||0
3186648|NCT02028780|3914894|FG005|NOT COMPLETED|Observation Phase||0
3186649|NCT02028780|3914895|FG006|NOT COMPLETED|Observation Phase||0
3186650|NCT02028780|3914896|FG007|NOT COMPLETED|Observation Phase||0
3186651|NCT02028780|3914897|FG008|NOT COMPLETED|Observation Phase||0
3186652|NCT02028780|3914898|FG009|NOT COMPLETED|Observation Phase||0
3186653|NCT02028780|3914899|FG010|NOT COMPLETED|Observation Phase||0
3186654|NCT02028780|3914900|FG011|NOT COMPLETED|Observation Phase||0
3186655|NCT02028780|3914889|FG000|STARTED|Follow up Phase||6
3186656|NCT02028780|3914890|FG001|STARTED|Follow up Phase||2
3186657|NCT02028780|3914891|FG002|STARTED|Follow up Phase||6
3186658|NCT02028780|3914892|FG003|STARTED|Follow up Phase||6
3186659|NCT02028780|3914893|FG004|STARTED|Follow up Phase||6
3186660|NCT02028780|3914894|FG005|STARTED|Follow up Phase||6
3186661|NCT02028780|3914895|FG006|STARTED|Follow up Phase||9
3186662|NCT02028780|3914896|FG007|STARTED|Follow up Phase||3
3186663|NCT02028780|3914897|FG008|STARTED|Follow up Phase||9
3186664|NCT02028780|3914898|FG009|STARTED|Follow up Phase||9
3186665|NCT02028780|3914899|FG010|STARTED|Follow up Phase||9
3186666|NCT02028780|3914900|FG011|STARTED|Follow up Phase||9
3186667|NCT02028780|3914889|FG000|COMPLETED|Follow up Phase||6
3186668|NCT02028780|3914890|FG001|COMPLETED|Follow up Phase||2
3186669|NCT02028780|3914891|FG002|COMPLETED|Follow up Phase||6
3186670|NCT02028780|3914892|FG003|COMPLETED|Follow up Phase||6
3186671|NCT02028780|3914893|FG004|COMPLETED|Follow up Phase||6
3186672|NCT02028780|3914894|FG005|COMPLETED|Follow up Phase||6
3186673|NCT02028780|3914895|FG006|COMPLETED|Follow up Phase||9
3186674|NCT02028780|3914896|FG007|COMPLETED|Follow up Phase||3
3186675|NCT02028780|3914897|FG008|COMPLETED|Follow up Phase||9
3186676|NCT02028780|3914898|FG009|COMPLETED|Follow up Phase||9
3186677|NCT02028780|3914899|FG010|COMPLETED|Follow up Phase||9
3186678|NCT02028780|3914900|FG011|COMPLETED|Follow up Phase||9
3186679|NCT02028780|3914889|FG000|NOT COMPLETED|Follow up Phase||0
3186680|NCT02028780|3914890|FG001|NOT COMPLETED|Follow up Phase||0
3186681|NCT02028780|3914891|FG002|NOT COMPLETED|Follow up Phase||0
3186682|NCT02028780|3914892|FG003|NOT COMPLETED|Follow up Phase||0
3186683|NCT02028780|3914893|FG004|NOT COMPLETED|Follow up Phase||0
3186684|NCT02028780|3914894|FG005|NOT COMPLETED|Follow up Phase||0
3186685|NCT02028780|3914895|FG006|NOT COMPLETED|Follow up Phase||0
3186686|NCT02028780|3914896|FG007|NOT COMPLETED|Follow up Phase||0
3186687|NCT02028780|3914897|FG008|NOT COMPLETED|Follow up Phase||0
3186688|NCT02028780|3914898|FG009|NOT COMPLETED|Follow up Phase||0
3186689|NCT02028780|3914899|FG010|NOT COMPLETED|Follow up Phase||0
3186690|NCT02028780|3914900|FG011|NOT COMPLETED|Follow up Phase||0
3186691|NCT02028871|3914946|FG000|STARTED|Overall Study||14
3186692|NCT02028871|3914947|FG001|STARTED|Overall Study||12
3186693|NCT02028871|3914946|FG000|COMPLETED|Overall Study||10
3186694|NCT02028871|3914947|FG001|COMPLETED|Overall Study||9
3186695|NCT02028871|3914946|FG000|NOT COMPLETED|Overall Study||4
3186696|NCT02028871|3914947|FG001|NOT COMPLETED|Overall Study||3
3186697|NCT02029040|3914958|FG000|STARTED|Overall Study||27
3186698|NCT02029040|3914959|FG001|STARTED|Overall Study||25
3186699|NCT02029040|3914958|FG000|COMPLETED|Overall Study||27
3186700|NCT02029040|3914959|FG001|COMPLETED|Overall Study||25
3186701|NCT02029040|3914958|FG000|NOT COMPLETED|Overall Study||0
3186702|NCT02029040|3914959|FG001|NOT COMPLETED|Overall Study||0
3186703|NCT02029196|3914967|FG000|STARTED|Overall Study||306
3186704|NCT02029196|3914968|FG001|STARTED|Overall Study||102
3186705|NCT02029196|3914967|FG000|COMPLETED|Overall Study||286
3186706|NCT02029196|3914968|FG001|COMPLETED|Overall Study||101
3186707|NCT02029196|3914967|FG000|NOT COMPLETED|Overall Study||20
3186708|NCT02029196|3914968|FG001|NOT COMPLETED|Overall Study||1
3186709|NCT02029235|3914976|FG000|STARTED|Overall Study||34
3186710|NCT02029235|3914977|FG001|STARTED|Overall Study||31
3186711|NCT02029235|3914976|FG000|COMPLETED|Overall Study||30
3186712|NCT02029235|3914977|FG001|COMPLETED|Overall Study||30
3186713|NCT02029235|3914976|FG000|NOT COMPLETED|Overall Study||4
3186714|NCT02029235|3914977|FG001|NOT COMPLETED|Overall Study||1
3186715|NCT02029274|3914987|FG000|STARTED|Overall Study||5
3186716|NCT02029274|3914988|FG001|STARTED|Overall Study||4
3186717|NCT02029274|3914989|FG002|STARTED|Overall Study||4
3186718|NCT02029274|3914990|FG003|STARTED|Overall Study||4
3186719|NCT02029274|3914987|FG000|Fixed Dose Period 2|Overall Study||5
3186720|NCT02029274|3914988|FG001|Fixed Dose Period 2|Overall Study||4
3186721|NCT02029274|3914989|FG002|Fixed Dose Period 2|Overall Study||4
3186722|NCT02029274|3914990|FG003|Fixed Dose Period 2|Overall Study||4
3186723|NCT02029274|3914987|FG000|COMPLETED|Overall Study||4
3186724|NCT02029274|3914988|FG001|COMPLETED|Overall Study||4
3186725|NCT02029274|3914989|FG002|COMPLETED|Overall Study||2
3186726|NCT02029274|3914990|FG003|COMPLETED|Overall Study||2
3186727|NCT02029274|3914987|FG000|NOT COMPLETED|Overall Study||1
3186728|NCT02029274|3914988|FG001|NOT COMPLETED|Overall Study||0
3186729|NCT02029274|3914989|FG002|NOT COMPLETED|Overall Study||2
3186730|NCT02029274|3914990|FG003|NOT COMPLETED|Overall Study||2
3186731|NCT02029417|3915004|FG000|STARTED|Overall Study||2
3186732|NCT02029417|3915004|FG000|COMPLETED|Overall Study||0
3186733|NCT02029417|3915004|FG000|NOT COMPLETED|Overall Study||2
3186734|NCT02029495|3915011|FG000|STARTED|Overall Study||159
3186735|NCT02029495|3915012|FG001|STARTED|Overall Study||158
3186736|NCT02029495|3915013|FG002|STARTED|Overall Study||161
3186737|NCT02029495|3915011|FG000|COMPLETED|Overall Study||158
3186738|NCT02029495|3915012|FG001|COMPLETED|Overall Study||158
3186739|NCT02029495|3915013|FG002|COMPLETED|Overall Study||159
3186740|NCT02029495|3915011|FG000|NOT COMPLETED|Overall Study||1
3186741|NCT02029495|3915012|FG001|NOT COMPLETED|Overall Study||0
3186742|NCT02029495|3915013|FG002|NOT COMPLETED|Overall Study||2
3186743|NCT02029521|3915023|FG000|STARTED|Overall Study||24
3186744|NCT02029521|3915024|FG001|STARTED|Overall Study||23
3186745|NCT02029521|3915023|FG000|COMPLETED|Overall Study||22
3186746|NCT02029521|3915024|FG001|COMPLETED|Overall Study||22
3186747|NCT02029521|3915023|FG000|NOT COMPLETED|Overall Study||2
3186748|NCT02029521|3915024|FG001|NOT COMPLETED|Overall Study||1
3186749|NCT02029638|3915036|FG000|STARTED|Overall Study||2
3186750|NCT02029638|3915037|FG001|STARTED|Overall Study||1
3186751|NCT02029638|3915038|FG002|STARTED|Overall Study||1
3186752|NCT02029638|3915036|FG000|COMPLETED|Overall Study||0
3186753|NCT02029638|3915037|FG001|COMPLETED|Overall Study||1
3186754|NCT02029638|3915038|FG002|COMPLETED|Overall Study||0
3186755|NCT02029638|3915036|FG000|NOT COMPLETED|Overall Study||2
3186756|NCT02029638|3915037|FG001|NOT COMPLETED|Overall Study||0
3186757|NCT02029638|3915038|FG002|NOT COMPLETED|Overall Study||1
3186758|NCT02029703|3915048|FG000|STARTED|Overall Study||20
3186759|NCT02029703|3915049|FG001|STARTED|Overall Study||22
3186760|NCT02029703|3915048|FG000|COMPLETED|Overall Study||20
3186761|NCT02029703|3915049|FG001|COMPLETED|Overall Study||22
3186762|NCT02029703|3915048|FG000|NOT COMPLETED|Overall Study||0
3186763|NCT02029703|3915049|FG001|NOT COMPLETED|Overall Study||0
3186764|NCT02029755|3915058|FG000|STARTED|Overall Study||36
3186765|NCT02029755|3915059|FG001|STARTED|Overall Study||36
3186766|NCT02029755|3915060|FG002|STARTED|Overall Study||36
3186767|NCT02029755|3915058|FG000|COMPLETED|Overall Study||36
3186768|NCT02029755|3915059|FG001|COMPLETED|Overall Study||36
3186769|NCT02029755|3915060|FG002|COMPLETED|Overall Study||36
3186770|NCT02029755|3915058|FG000|NOT COMPLETED|Overall Study||0
3186771|NCT02029755|3915059|FG001|NOT COMPLETED|Overall Study||0
3186772|NCT02029755|3915060|FG002|NOT COMPLETED|Overall Study||0
3186773|NCT02029872|3915070|FG000|STARTED|Overall Study||9
3186774|NCT02029872|3915071|FG001|STARTED|Overall Study||9
3186775|NCT02029872|3915070|FG000|COMPLETED|Overall Study||7
3186776|NCT02029872|3915071|FG001|COMPLETED|Overall Study||6
3186777|NCT02029872|3915070|FG000|NOT COMPLETED|Overall Study||2
3186778|NCT02029872|3915071|FG001|NOT COMPLETED|Overall Study||3
3186779|NCT02029911|3915077|FG000|STARTED|Overall Study|Treatment Attempted|60
3186780|NCT02029911|3915077|FG000|Treated|Overall Study|Treatment Completed|60
3186781|NCT02029911|3915077|FG000|COMPLETED|Overall Study|Completed 12 Month Follow-up|60
3186782|NCT02029911|3915077|FG000|NOT COMPLETED|Overall Study||0
3186783|NCT02029976|3915083|FG000|STARTED|YR-1 Post Intervention vs Baseline||132
3186784|NCT02029976|3915084|FG001|STARTED|YR-1 Post Intervention vs Baseline||132
3186785|NCT02029976|3915083|FG000|COMPLETED|YR-1 Post Intervention vs Baseline||120
3186786|NCT02029976|3915084|FG001|COMPLETED|YR-1 Post Intervention vs Baseline||124
3186787|NCT02029976|3915083|FG000|NOT COMPLETED|YR-1 Post Intervention vs Baseline||12
3186788|NCT02029976|3915084|FG001|NOT COMPLETED|YR-1 Post Intervention vs Baseline||8
3186789|NCT02029976|3915083|FG000|STARTED|YR-2 Follow Up vs Baseline|Attrition at end of year 2 was calculated based on baseline enrollment|132
3186790|NCT02029976|3915084|FG001|STARTED|YR-2 Follow Up vs Baseline|Attrition at end of year 2 was calculated based on baseline enrollment|132
3186791|NCT02029976|3915083|FG000|COMPLETED|YR-2 Follow Up vs Baseline||122
3186792|NCT02029976|3915084|FG001|COMPLETED|YR-2 Follow Up vs Baseline||124
3186793|NCT02029976|3915083|FG000|NOT COMPLETED|YR-2 Follow Up vs Baseline||10
3186794|NCT02029976|3915084|FG001|NOT COMPLETED|YR-2 Follow Up vs Baseline||8
3186795|NCT02029989|3915092|FG000|STARTED|Overall Study|A subject was given the same ID# as withdrawn subject (ID # counted twice) causing N=61 discrepancy.|61
3186796|NCT02029989|3915093|FG001|STARTED|Overall Study||60
3186797|NCT02029989|3915092|FG000|COMPLETED|Overall Study||45
3186798|NCT02029989|3915093|FG001|COMPLETED|Overall Study||49
3186799|NCT02029989|3915092|FG000|NOT COMPLETED|Overall Study||16
3186800|NCT02029989|3915093|FG001|NOT COMPLETED|Overall Study||11
3186801|NCT02030002|3915099|FG000|STARTED|Enrollment||49
3186802|NCT02030002|3915099|FG000|COMPLETED|Enrollment||44
3186803|NCT02030002|3915099|FG000|NOT COMPLETED|Enrollment||5
3186804|NCT02030002|3915099|FG000|STARTED|APC Flash-Free Adhesive Coated Appliance||44
3186805|NCT02030002|3915099|FG000|COMPLETED|APC Flash-Free Adhesive Coated Appliance||44
3186806|NCT02030002|3915099|FG000|NOT COMPLETED|APC Flash-Free Adhesive Coated Appliance||0
3186807|NCT02030002|3915099|FG000|STARTED|APC II Adhesive Coated Appliance System||44
3186808|NCT02030002|3915099|FG000|COMPLETED|APC II Adhesive Coated Appliance System||44
3186809|NCT02030002|3915099|FG000|NOT COMPLETED|APC II Adhesive Coated Appliance System||0
3186810|NCT02030002|3915099|FG000|STARTED|Follow-up||44
3186811|NCT02030002|3915099|FG000|COMPLETED|Follow-up||42
3186812|NCT02030002|3915099|FG000|NOT COMPLETED|Follow-up||2
3186813|NCT02030041|3915108|FG000|STARTED|Overall Study||11
3186814|NCT02030041|3915109|FG001|STARTED|Overall Study||11
3186815|NCT02030041|3915110|FG002|STARTED|Overall Study||11
3186816|NCT02030041|3915108|FG000|COMPLETED|Overall Study||9
3186817|NCT02030041|3915109|FG001|COMPLETED|Overall Study||9
3186818|NCT02030041|3915110|FG002|COMPLETED|Overall Study||10
3186819|NCT02030041|3915108|FG000|NOT COMPLETED|Overall Study||2
3186820|NCT02030041|3915109|FG001|NOT COMPLETED|Overall Study||2
3186821|NCT02030041|3915110|FG002|NOT COMPLETED|Overall Study||1
3186822|NCT02030080|3915122|FG000|STARTED|Overall Study|25 teams|100
3186823|NCT02030080|3915123|FG001|STARTED|Overall Study|16 teams|64
3186824|NCT02030080|3915124|FG002|STARTED|Overall Study|20 teams|80
3186825|NCT02030080|3915125|FG003|STARTED|Overall Study|11 teams|44
3186826|NCT02030080|3915122|FG000|COMPLETED|Overall Study||100
3186827|NCT02030080|3915123|FG001|COMPLETED|Overall Study||64
3186828|NCT02030080|3915124|FG002|COMPLETED|Overall Study||80
3186829|NCT02030080|3915125|FG003|COMPLETED|Overall Study||42
3186830|NCT02030080|3915122|FG000|NOT COMPLETED|Overall Study||0
3186831|NCT02030080|3915123|FG001|NOT COMPLETED|Overall Study||0
3186832|NCT02030080|3915124|FG002|NOT COMPLETED|Overall Study||0
3186833|NCT02030080|3915125|FG003|NOT COMPLETED|Overall Study||2
3186834|NCT02030119|3915139|FG000|STARTED|Overall Study||70
3186835|NCT02030119|3915140|FG001|STARTED|Overall Study||70
3186836|NCT02030119|3915141|FG002|STARTED|Overall Study||71
3186837|NCT02030119|3915142|FG003|STARTED|Overall Study||70
3186838|NCT02030119|3915139|FG000|COMPLETED|Overall Study||67
3186839|NCT02030119|3915140|FG001|COMPLETED|Overall Study||68
3186840|NCT02030119|3915141|FG002|COMPLETED|Overall Study||65
3186841|NCT02030119|3915142|FG003|COMPLETED|Overall Study||67
3186842|NCT02030119|3915139|FG000|NOT COMPLETED|Overall Study||3
3186843|NCT02030119|3915140|FG001|NOT COMPLETED|Overall Study||2
3186844|NCT02030119|3915141|FG002|NOT COMPLETED|Overall Study||6
3186845|NCT02030119|3915142|FG003|NOT COMPLETED|Overall Study||3
3186846|NCT02030288|3915154|FG000|STARTED|Overall Study||89
3186847|NCT02030288|3915155|FG001|STARTED|Overall Study||89
3186848|NCT02030288|3915154|FG000|COMPLETED|Overall Study||89
3186849|NCT02030288|3915155|FG001|COMPLETED|Overall Study||89
3186850|NCT02030288|3915154|FG000|NOT COMPLETED|Overall Study||0
3186851|NCT02030288|3915155|FG001|NOT COMPLETED|Overall Study||0
3186852|NCT02030405|3915165|FG000|STARTED|Overall Study||4
3186853|NCT02030405|3915165|FG000|COMPLETED|Overall Study||2
3186854|NCT02030405|3915165|FG000|NOT COMPLETED|Overall Study||2
3186855|NCT02030535|3915170|FG000|STARTED|Treatment Period 1 (1 Day)||53
3186856|NCT02030535|3915170|FG000|COMPLETED|Treatment Period 1 (1 Day)||53
3186857|NCT02030535|3915170|FG000|NOT COMPLETED|Treatment Period 1 (1 Day)||0
3186858|NCT02030535|3915170|FG000|STARTED|Washout Period 1 (21 Days)||53
3186859|NCT02030535|3915170|FG000|COMPLETED|Washout Period 1 (21 Days)||52
3186860|NCT02030535|3915170|FG000|NOT COMPLETED|Washout Period 1 (21 Days)||1
3186861|NCT02030535|3915170|FG000|STARTED|Treatment Period 2 (1 Day)||52
3186862|NCT02030535|3915170|FG000|COMPLETED|Treatment Period 2 (1 Day)||52
3186863|NCT02030535|3915170|FG000|NOT COMPLETED|Treatment Period 2 (1 Day)||0
3186864|NCT02030535|3915170|FG000|STARTED|Washout Period 2 (21 Days)||52
3186865|NCT02030535|3915170|FG000|COMPLETED|Washout Period 2 (21 Days)||52
3186866|NCT02030535|3915170|FG000|NOT COMPLETED|Washout Period 2 (21 Days)||0
3186867|NCT02030535|3915170|FG000|STARTED|Treatment Period 3 (1 Day)||52
3186868|NCT02030535|3915170|FG000|COMPLETED|Treatment Period 3 (1 Day)||52
3186869|NCT02030535|3915170|FG000|NOT COMPLETED|Treatment Period 3 (1 Day)||0
3186870|NCT02030574|3915184|FG000|STARTED|Overall Study||2
3186871|NCT02030574|3915184|FG000|COMPLETED|Overall Study||2
3186872|NCT02030574|3915184|FG000|NOT COMPLETED|Overall Study||0
3186873|NCT02030600|3915190|FG000|STARTED|Treatment Period 1||361
3186874|NCT02030600|3915191|FG001|STARTED|Treatment Period 1||360
3186875|NCT02030600|3915190|FG000|Exposed|Treatment Period 1||356
3186876|NCT02030600|3915191|FG001|Exposed|Treatment Period 1||357
3186877|NCT02030600|3915190|FG000|COMPLETED|Treatment Period 1||308
3186878|NCT02030600|3915191|FG001|COMPLETED|Treatment Period 1||315
3186879|NCT02030600|3915190|FG000|NOT COMPLETED|Treatment Period 1||53
3186880|NCT02030600|3915191|FG001|NOT COMPLETED|Treatment Period 1||45
3186881|NCT02030600|3915190|FG000|STARTED|Treatment Period 2||308
3186882|NCT02030600|3915191|FG001|STARTED|Treatment Period 2||315
3186883|NCT02030600|3915190|FG000|COMPLETED|Treatment Period 2||283
3186884|NCT02030600|3915191|FG001|COMPLETED|Treatment Period 2||297
3186885|NCT02030600|3915190|FG000|NOT COMPLETED|Treatment Period 2||25
3186886|NCT02030600|3915191|FG001|NOT COMPLETED|Treatment Period 2||18
3186887|NCT02030821|3915203|FG000|STARTED|Overall Study||48
3186888|NCT02030821|3915204|FG001|STARTED|Overall Study||46
3186889|NCT02030821|3915205|FG002|STARTED|Overall Study||78
3186890|NCT02030821|3915206|FG003|STARTED|Overall Study||74
3186891|NCT02030821|3915203|FG000|COMPLETED|Overall Study||46
3186892|NCT02030821|3915204|FG001|COMPLETED|Overall Study||44
3186893|NCT02030821|3915205|FG002|COMPLETED|Overall Study||73
3186894|NCT02030821|3915206|FG003|COMPLETED|Overall Study||72
3186895|NCT02030821|3915203|FG000|NOT COMPLETED|Overall Study||2
3186896|NCT02030821|3915204|FG001|NOT COMPLETED|Overall Study||2
3186897|NCT02030821|3915205|FG002|NOT COMPLETED|Overall Study||5
3186898|NCT02030821|3915206|FG003|NOT COMPLETED|Overall Study||2
3186899|NCT02030834|3915219|FG000|STARTED|Overall Study||50
3186900|NCT02030834|3915220|FG001|STARTED|Overall Study||3
3186901|NCT02030834|3915221|FG002|STARTED|Overall Study||10
3186902|NCT02030834|3915219|FG000|COMPLETED|Overall Study||39
3186903|NCT02030834|3915220|FG001|COMPLETED|Overall Study||3
3186904|NCT02030834|3915221|FG002|COMPLETED|Overall Study||7
3186905|NCT02030834|3915219|FG000|NOT COMPLETED|Overall Study||11
3186906|NCT02030834|3915220|FG001|NOT COMPLETED|Overall Study||0
3186907|NCT02030834|3915221|FG002|NOT COMPLETED|Overall Study||3
3186908|NCT02030847|3915229|FG000|STARTED|Overall Study||42
3186909|NCT02030847|3915229|FG000|COMPLETED|Overall Study||5
3186910|NCT02030847|3915229|FG000|NOT COMPLETED|Overall Study||37
3186911|NCT02030886|3915236|FG000|STARTED|Overall Study||14
3186912|NCT02030886|3915237|FG001|STARTED|Overall Study||6
3186913|NCT02030886|3915236|FG000|COMPLETED|Overall Study||14
3186914|NCT02030886|3915237|FG001|COMPLETED|Overall Study||6
3186915|NCT02030886|3915236|FG000|NOT COMPLETED|Overall Study||0
3186916|NCT02030886|3915237|FG001|NOT COMPLETED|Overall Study||0
3186917|NCT02031146|3915247|FG000|STARTED|Overall Study||11
3186918|NCT02031146|3915248|FG001|STARTED|Overall Study||3
3186919|NCT02031146|3915249|FG002|STARTED|Overall Study||18
3186920|NCT02031146|3915250|FG003|STARTED|Overall Study||148
3186921|NCT02031146|3915251|FG004|STARTED|Overall Study||42
3186922|NCT02031146|3915252|FG005|STARTED|Overall Study||4
3186923|NCT02031146|3915253|FG006|STARTED|Overall Study||5
3186924|NCT02031146|3915247|FG000|Considered in Analysis|Overall Study||11
3186925|NCT02031146|3915248|FG001|Considered in Analysis|Overall Study||3
3186926|NCT02031146|3915249|FG002|Considered in Analysis|Overall Study||18
3186927|NCT02031146|3915250|FG003|Considered in Analysis|Overall Study||48
3186928|NCT02031146|3915251|FG004|Considered in Analysis|Overall Study||16
3186929|NCT02031146|3915252|FG005|Considered in Analysis|Overall Study||0
3186930|NCT02031146|3915253|FG006|Considered in Analysis|Overall Study||0
3186931|NCT02031146|3915247|FG000|COMPLETED|Overall Study||11
3186932|NCT02031146|3915248|FG001|COMPLETED|Overall Study||3
3186933|NCT02031146|3915249|FG002|COMPLETED|Overall Study||18
3186934|NCT02031146|3915250|FG003|COMPLETED|Overall Study||48
3186935|NCT02031146|3915251|FG004|COMPLETED|Overall Study||16
3186936|NCT02031146|3915252|FG005|COMPLETED|Overall Study||0
3186937|NCT02031146|3915253|FG006|COMPLETED|Overall Study||0
3186938|NCT02031146|3915247|FG000|NOT COMPLETED|Overall Study||0
3186939|NCT02031146|3915248|FG001|NOT COMPLETED|Overall Study||0
3186940|NCT02031146|3915249|FG002|NOT COMPLETED|Overall Study||0
3186941|NCT02031146|3915250|FG003|NOT COMPLETED|Overall Study||100
3186942|NCT02031146|3915251|FG004|NOT COMPLETED|Overall Study||26
3186943|NCT02031146|3915252|FG005|NOT COMPLETED|Overall Study||4
3186944|NCT02031146|3915253|FG006|NOT COMPLETED|Overall Study||5
3186945|NCT02031237|3915265|FG000|STARTED|Overall Study||14
3186946|NCT02031237|3915266|FG001|STARTED|Overall Study||35
3186947|NCT02031237|3915267|FG002|STARTED|Overall Study||3
3186948|NCT02031237|3915265|FG000|COMPLETED|Overall Study||9
3186949|NCT02031237|3915266|FG001|COMPLETED|Overall Study||21
3186950|NCT02031237|3915267|FG002|COMPLETED|Overall Study||0
3186951|NCT02031237|3915265|FG000|NOT COMPLETED|Overall Study||5
3186952|NCT02031237|3915266|FG001|NOT COMPLETED|Overall Study||14
3186953|NCT02031237|3915267|FG002|NOT COMPLETED|Overall Study||3
3363963|NCT04039919|4095088|FG001|COMPLETED|Treatment Period 6||6
3363964|NCT04039919|4095089|FG002|COMPLETED|Treatment Period 6||5
3363965|NCT04039919|4095090|FG003|COMPLETED|Treatment Period 6||6
3363966|NCT04039919|4095091|FG004|COMPLETED|Treatment Period 6||0
3363967|NCT04039919|4095087|FG000|NOT COMPLETED|Treatment Period 6||0
3363968|NCT04039919|4095088|FG001|NOT COMPLETED|Treatment Period 6||0
3363969|NCT04039919|4095089|FG002|NOT COMPLETED|Treatment Period 6||0
3363970|NCT04039919|4095090|FG003|NOT COMPLETED|Treatment Period 6||0
3363971|NCT04039919|4095091|FG004|NOT COMPLETED|Treatment Period 6||0
3363972|NCT04037969|4095127|FG000|STARTED|Overall Study||10
3363973|NCT04037969|4095128|FG001|STARTED|Overall Study||10
3363974|NCT04037969|4095127|FG000|COMPLETED|Overall Study||10
3363975|NCT04037969|4095128|FG001|COMPLETED|Overall Study||10
3363976|NCT04037969|4095127|FG000|NOT COMPLETED|Overall Study||0
3363977|NCT04037969|4095128|FG001|NOT COMPLETED|Overall Study||0
3363978|NCT04037865|4095133|FG000|STARTED|Overall Study||8
3363979|NCT04037865|4095133|FG000|COMPLETED|Overall Study||8
3363980|NCT04037865|4095133|FG000|NOT COMPLETED|Overall Study||0
3363981|NCT04037748|4095140|FG000|STARTED|Treatment Period 1||36
3363982|NCT04037748|4095141|FG001|STARTED|Treatment Period 1||36
3363983|NCT04037748|4095140|FG000|COMPLETED|Treatment Period 1||28
3363984|NCT04037748|4095141|FG001|COMPLETED|Treatment Period 1||30
3363985|NCT04037748|4095140|FG000|NOT COMPLETED|Treatment Period 1||8
3363986|NCT04037748|4095141|FG001|NOT COMPLETED|Treatment Period 1||6
3363987|NCT04037748|4095140|FG000|STARTED|Treatment Period 2||28
3363988|NCT04037748|4095141|FG001|STARTED|Treatment Period 2||30
3363989|NCT04037748|4095140|FG000|COMPLETED|Treatment Period 2||26
3363990|NCT04037748|4095141|FG001|COMPLETED|Treatment Period 2||29
3363991|NCT04037748|4095140|FG000|NOT COMPLETED|Treatment Period 2||2
3363992|NCT04037748|4095141|FG001|NOT COMPLETED|Treatment Period 2||1
3363993|NCT04036838|4095147|FG000|STARTED|Overall Study||415
3363994|NCT04036838|4095147|FG000|COMPLETED|Overall Study||324
3363995|NCT04036838|4095147|FG000|NOT COMPLETED|Overall Study||91
3363996|NCT04034121|4095151|FG000|STARTED|European Cohort|The European Cohort enrolled 30 patients|30
3363997|NCT04034121|4095151|FG000|COMPLETED|European Cohort||30
3363998|NCT04034121|4095151|FG000|NOT COMPLETED|European Cohort||0
3363999|NCT04034121|4095151|FG000|STARTED|Brazil Cohort|The Brazil Cohort enrolled 20 patients|20
3364000|NCT04034121|4095151|FG000|COMPLETED|Brazil Cohort||20
3364001|NCT04034121|4095151|FG000|NOT COMPLETED|Brazil Cohort||0
3364002|NCT04027686|4095158|FG000|STARTED|Overall Study||17
3364003|NCT04027686|4095159|FG001|STARTED|Overall Study||6
3364004|NCT04027686|4095158|FG000|COMPLETED|Overall Study||15
3364005|NCT04027686|4095159|FG001|COMPLETED|Overall Study||5
3364006|NCT04027686|4095158|FG000|NOT COMPLETED|Overall Study||2
3364007|NCT04027686|4095159|FG001|NOT COMPLETED|Overall Study||1
3364008|NCT04022694|4095171|FG000|STARTED|Overall Study||167
3364009|NCT04022694|4095172|FG001|STARTED|Overall Study||145
3364010|NCT04022694|4095173|FG002|STARTED|Overall Study|This was a cross-sectional study, so participants at baseline -- were not the same as exposure.|143
3364011|NCT04022694|4095174|FG003|STARTED|Overall Study|This was a cross-sectional study, so participants at baseline -- were not the same as exposure.|173
3364012|NCT04022694|4095171|FG000|COMPLETED|Overall Study||167
3364013|NCT04022694|4095172|FG001|COMPLETED|Overall Study||145
3364014|NCT04022694|4095173|FG002|COMPLETED|Overall Study||143
3364015|NCT04022694|4095174|FG003|COMPLETED|Overall Study||173
3364016|NCT04022694|4095171|FG000|NOT COMPLETED|Overall Study||0
3364017|NCT04022694|4095172|FG001|NOT COMPLETED|Overall Study||0
3364018|NCT04022694|4095173|FG002|NOT COMPLETED|Overall Study||0
3364019|NCT04022694|4095174|FG003|NOT COMPLETED|Overall Study||0
3364020|NCT04036110|4095189|FG000|STARTED|Overall Study||12
3364021|NCT04036110|4095190|FG001|STARTED|Overall Study||12
3364022|NCT04036110|4095191|FG002|STARTED|Overall Study||12
3364023|NCT04036110|4095189|FG000|COMPLETED|Overall Study||5
3364024|NCT04036110|4095190|FG001|COMPLETED|Overall Study||5
3364025|NCT04036110|4095191|FG002|COMPLETED|Overall Study||10
3364026|NCT04036110|4095189|FG000|NOT COMPLETED|Overall Study||7
3364027|NCT04036110|4095190|FG001|NOT COMPLETED|Overall Study||7
3364028|NCT04036110|4095191|FG002|NOT COMPLETED|Overall Study||2
3364029|NCT04035694|4095201|FG000|STARTED|Overall Study||374
3364030|NCT04035694|4095202|FG001|STARTED|Overall Study||216
3364031|NCT04035694|4095201|FG000|COMPLETED|Overall Study||374
3364032|NCT04035694|4095202|FG001|COMPLETED|Overall Study||216
3364033|NCT04035694|4095201|FG000|NOT COMPLETED|Overall Study||0
3364034|NCT04035694|4095202|FG001|NOT COMPLETED|Overall Study||0
3364035|NCT04035577|4095208|FG000|STARTED|Overall Study|One participant withdrew after signing the consent but before initiating any study activities.|21
3364036|NCT04035577|4095208|FG000|COMPLETED|Overall Study||19
3364037|NCT04035577|4095208|FG000|NOT COMPLETED|Overall Study||2
3364038|NCT04035564|4095216|FG000|STARTED|Overall Study||27
3364039|NCT04035564|4095217|FG001|STARTED|Overall Study||25
3364040|NCT04035564|4095216|FG000|COMPLETED|Overall Study||23
3364041|NCT04035564|4095217|FG001|COMPLETED|Overall Study||19
3364042|NCT04035564|4095216|FG000|NOT COMPLETED|Overall Study||4
3364043|NCT04035564|4095217|FG001|NOT COMPLETED|Overall Study||6
3364044|NCT04032977|4095225|FG000|STARTED|Overall Study||80
3364045|NCT04032977|4095226|FG001|STARTED|Overall Study||78
3186954|NCT02031276|3915277|FG000|STARTED|Period 1 Double-blind IV||39
3186955|NCT02031276|3915278|FG001|STARTED|Period 1 Double-blind IV||41
3186956|NCT02031276|3915279|FG002|STARTED|Period 1 Double-blind IV||41
3186957|NCT02031276|3915277|FG000|COMPLETED|Period 1 Double-blind IV||33
3186958|NCT02031276|3915278|FG001|COMPLETED|Period 1 Double-blind IV||35
3186959|NCT02031276|3915279|FG002|COMPLETED|Period 1 Double-blind IV||40
3186960|NCT02031276|3915277|FG000|NOT COMPLETED|Period 1 Double-blind IV||6
3186961|NCT02031276|3915278|FG001|NOT COMPLETED|Period 1 Double-blind IV||6
3186962|NCT02031276|3915279|FG002|NOT COMPLETED|Period 1 Double-blind IV||1
3186963|NCT02031276|3915277|FG000|STARTED|Period 2 Open-label Risankizumab IV||33
3186964|NCT02031276|3915278|FG001|STARTED|Period 2 Open-label Risankizumab IV||35
3186965|NCT02031276|3915279|FG002|STARTED|Period 2 Open-label Risankizumab IV|1 participant did not enter Period 2 (declined open-label treatment in Period 2)|39
3186966|NCT02031276|3915277|FG000|COMPLETED|Period 2 Open-label Risankizumab IV||29
3186967|NCT02031276|3915278|FG001|COMPLETED|Period 2 Open-label Risankizumab IV||33
3186968|NCT02031276|3915279|FG002|COMPLETED|Period 2 Open-label Risankizumab IV||38
3186969|NCT02031276|3915277|FG000|NOT COMPLETED|Period 2 Open-label Risankizumab IV||4
3186970|NCT02031276|3915278|FG001|NOT COMPLETED|Period 2 Open-label Risankizumab IV||2
3186971|NCT02031276|3915279|FG002|NOT COMPLETED|Period 2 Open-label Risankizumab IV||1
3186972|NCT02031276|3915277|FG000|STARTED|Period 3 Open-label Risankizumab SC|10 participants did not enter period 3 (not in clinical remission)|19
3186973|NCT02031276|3915278|FG001|STARTED|Period 3 Open-label Risankizumab SC|11 participants did not enter period 3 (not in clinical remission)|22
3186974|NCT02031276|3915279|FG002|STARTED|Period 3 Open-label Risankizumab SC|17 participants did not enter period 3 (not in clinical remission)|21
3186975|NCT02031276|3915277|FG000|COMPLETED|Period 3 Open-label Risankizumab SC||16
3186976|NCT02031276|3915278|FG001|COMPLETED|Period 3 Open-label Risankizumab SC||19
3186977|NCT02031276|3915279|FG002|COMPLETED|Period 3 Open-label Risankizumab SC||19
3186978|NCT02031276|3915277|FG000|NOT COMPLETED|Period 3 Open-label Risankizumab SC||3
3186979|NCT02031276|3915278|FG001|NOT COMPLETED|Period 3 Open-label Risankizumab SC||3
3186980|NCT02031276|3915279|FG002|NOT COMPLETED|Period 3 Open-label Risankizumab SC||2
3186981|NCT02031302|3915293|FG000|STARTED|Overall Study||1014
3186982|NCT02031302|3915294|FG001|STARTED|Overall Study||50
3186983|NCT02031302|3915293|FG000|COMPLETED|Overall Study||850
3186984|NCT02031302|3915294|FG001|COMPLETED|Overall Study||50
3186985|NCT02031302|3915293|FG000|NOT COMPLETED|Overall Study||164
3186986|NCT02031302|3915294|FG001|NOT COMPLETED|Overall Study||0
3186987|NCT02031432|3915301|FG000|STARTED|Overall Study||76
3186988|NCT02031432|3915301|FG000|Completing the Titration Phase|Overall Study||67
3186989|NCT02031432|3915301|FG000|Completing the Treatment|Overall Study||39
3186990|NCT02031432|3915301|FG000|COMPLETED|Overall Study||38
3186991|NCT02031432|3915301|FG000|NOT COMPLETED|Overall Study||38
3186992|NCT02031458|3915308|FG000|STARTED|May 8, 2015 to January 11, 2019||138
3186993|NCT02031458|3915309|FG001|STARTED|May 8, 2015 to January 11, 2019||269
3186994|NCT02031458|3915310|FG002|STARTED|May 8, 2015 to January 11, 2019||252
3186995|NCT02031458|3915308|FG000|COMPLETED|May 8, 2015 to January 11, 2019||0
3186996|NCT02031458|3915309|FG001|COMPLETED|May 8, 2015 to January 11, 2019||0
3186997|NCT02031458|3915310|FG002|COMPLETED|May 8, 2015 to January 11, 2019||0
3186998|NCT02031458|3915308|FG000|NOT COMPLETED|May 8, 2015 to January 11, 2019||138
3186999|NCT02031458|3915309|FG001|NOT COMPLETED|May 8, 2015 to January 11, 2019||269
3187000|NCT02031458|3915310|FG002|NOT COMPLETED|May 8, 2015 to January 11, 2019||252
3187001|NCT02031458|3915308|FG000|STARTED|Baseline to May 8, 2015||139
3187002|NCT02031458|3915309|FG001|STARTED|Baseline to May 8, 2015||267
3187003|NCT02031458|3915310|FG002|STARTED|Baseline to May 8, 2015||253
3187004|NCT02031458|3915308|FG000|COMPLETED|Baseline to May 8, 2015||0
3187005|NCT02031458|3915309|FG001|COMPLETED|Baseline to May 8, 2015||0
3187006|NCT02031458|3915310|FG002|COMPLETED|Baseline to May 8, 2015||0
3187007|NCT02031458|3915308|FG000|NOT COMPLETED|Baseline to May 8, 2015||139
3187008|NCT02031458|3915309|FG001|NOT COMPLETED|Baseline to May 8, 2015||267
3187009|NCT02031458|3915310|FG002|NOT COMPLETED|Baseline to May 8, 2015||253
3187010|NCT02031471|3915320|FG000|STARTED|24 Week Treatment Period||57
3187011|NCT02031471|3915320|FG000|COMPLETED|24 Week Treatment Period||46
3187012|NCT02031471|3915320|FG000|NOT COMPLETED|24 Week Treatment Period||11
3187013|NCT02031471|3915320|FG000|STARTED|Long Term Extension (LTE) Period|Only participants who achieved at least a moderate EULAR response at Week 24 entered the LTE Period.|39
3187014|NCT02031471|3915320|FG000|COMPLETED|Long Term Extension (LTE) Period||37
3187015|NCT02031471|3915320|FG000|NOT COMPLETED|Long Term Extension (LTE) Period||2
3187016|NCT02031536|3915326|FG000|STARTED|Overall Study||2
3187017|NCT02031536|3915327|FG001|STARTED|Overall Study||0
3187018|NCT02031536|3915326|FG000|COMPLETED|Overall Study||1
3187019|NCT02031536|3915327|FG001|COMPLETED|Overall Study||0
3187020|NCT02031536|3915326|FG000|NOT COMPLETED|Overall Study||1
3187021|NCT02031536|3915327|FG001|NOT COMPLETED|Overall Study||0
3187022|NCT02031627|3915336|FG000|STARTED|Overall Study||7
3187023|NCT02031627|3915337|FG001|STARTED|Overall Study||7
3187024|NCT02031627|3915338|FG002|STARTED|Overall Study||7
3187025|NCT02031627|3915336|FG000|COMPLETED|Overall Study||7
3187026|NCT02031627|3915337|FG001|COMPLETED|Overall Study||7
3187027|NCT02031627|3915338|FG002|COMPLETED|Overall Study||7
3187028|NCT02031627|3915336|FG000|NOT COMPLETED|Overall Study||0
3187029|NCT02031627|3915337|FG001|NOT COMPLETED|Overall Study||0
3187030|NCT02031627|3915338|FG002|NOT COMPLETED|Overall Study||0
3187031|NCT02031640|3915351|FG000|STARTED|Screening Period|Consented|1113
3187032|NCT02031640|3915352|FG001|STARTED|Screening Period||0
3187033|NCT02031640|3915353|FG002|STARTED|Screening Period||0
3187034|NCT02031640|3915354|FG003|STARTED|Screening Period||0
3187035|NCT02031640|3915355|FG004|STARTED|Screening Period||0
3187036|NCT02031640|3915356|FG005|STARTED|Screening Period||0
3187037|NCT02031640|3915351|FG000|COMPLETED|Screening Period||701
3187038|NCT02031640|3915352|FG001|COMPLETED|Screening Period||0
3187039|NCT02031640|3915353|FG002|COMPLETED|Screening Period||0
3187040|NCT02031640|3915354|FG003|COMPLETED|Screening Period||0
3187041|NCT02031640|3915355|FG004|COMPLETED|Screening Period||0
3187042|NCT02031640|3915356|FG005|COMPLETED|Screening Period||0
3187043|NCT02031640|3915351|FG000|NOT COMPLETED|Screening Period||412
3187044|NCT02031640|3915352|FG001|NOT COMPLETED|Screening Period||0
3187045|NCT02031640|3915353|FG002|NOT COMPLETED|Screening Period||0
3187046|NCT02031640|3915354|FG003|NOT COMPLETED|Screening Period||0
3187047|NCT02031640|3915355|FG004|NOT COMPLETED|Screening Period||0
3187048|NCT02031640|3915356|FG005|NOT COMPLETED|Screening Period||0
3187049|NCT02031640|3915351|FG000|STARTED|Run-In Period||701
3187050|NCT02031640|3915352|FG001|STARTED|Run-In Period||0
3187051|NCT02031640|3915353|FG002|STARTED|Run-In Period||0
3187052|NCT02031640|3915354|FG003|STARTED|Run-In Period||0
3187053|NCT02031640|3915355|FG004|STARTED|Run-In Period||0
3187054|NCT02031640|3915356|FG005|STARTED|Run-In Period||0
3187055|NCT02031640|3915351|FG000|COMPLETED|Run-In Period||532
3187056|NCT02031640|3915352|FG001|COMPLETED|Run-In Period||0
3187057|NCT02031640|3915353|FG002|COMPLETED|Run-In Period||0
3187058|NCT02031640|3915354|FG003|COMPLETED|Run-In Period||0
3187059|NCT02031640|3915355|FG004|COMPLETED|Run-In Period||0
3187060|NCT02031640|3915356|FG005|COMPLETED|Run-In Period||0
3187061|NCT02031640|3915351|FG000|NOT COMPLETED|Run-In Period||169
3187062|NCT02031640|3915352|FG001|NOT COMPLETED|Run-In Period||0
3187063|NCT02031640|3915353|FG002|NOT COMPLETED|Run-In Period||0
3187064|NCT02031640|3915354|FG003|NOT COMPLETED|Run-In Period||0
3187065|NCT02031640|3915355|FG004|NOT COMPLETED|Run-In Period||0
3187066|NCT02031640|3915356|FG005|NOT COMPLETED|Run-In Period||0
3187067|NCT02031640|3915351|FG000|STARTED|Double-blind Treatment Period||0
3187068|NCT02031640|3915352|FG001|STARTED|Double-blind Treatment Period||106
3187069|NCT02031640|3915353|FG002|STARTED|Double-blind Treatment Period||106
3187070|NCT02031640|3915354|FG003|STARTED|Double-blind Treatment Period||106
3187071|NCT02031640|3915355|FG004|STARTED|Double-blind Treatment Period||107
3187072|NCT02031640|3915356|FG005|STARTED|Double-blind Treatment Period||107
3187073|NCT02031640|3915351|FG000|Full Analysis Set|Double-blind Treatment Period||0
3187074|NCT02031640|3915352|FG001|Full Analysis Set|Double-blind Treatment Period||106
3187075|NCT02031640|3915353|FG002|Full Analysis Set|Double-blind Treatment Period||104
3187076|NCT02031640|3915354|FG003|Full Analysis Set|Double-blind Treatment Period||106
3187077|NCT02031640|3915355|FG004|Full Analysis Set|Double-blind Treatment Period||106
3187078|NCT02031640|3915356|FG005|Full Analysis Set|Double-blind Treatment Period||107
3187079|NCT02031640|3915351|FG000|COMPLETED|Double-blind Treatment Period||0
3187080|NCT02031640|3915352|FG001|COMPLETED|Double-blind Treatment Period||84
3187081|NCT02031640|3915353|FG002|COMPLETED|Double-blind Treatment Period||100
3187082|NCT02031640|3915354|FG003|COMPLETED|Double-blind Treatment Period||99
3187083|NCT02031640|3915355|FG004|COMPLETED|Double-blind Treatment Period||96
3187084|NCT02031640|3915356|FG005|COMPLETED|Double-blind Treatment Period||104
3187085|NCT02031640|3915351|FG000|NOT COMPLETED|Double-blind Treatment Period||0
3187086|NCT02031640|3915352|FG001|NOT COMPLETED|Double-blind Treatment Period||22
3187087|NCT02031640|3915353|FG002|NOT COMPLETED|Double-blind Treatment Period||6
3187088|NCT02031640|3915354|FG003|NOT COMPLETED|Double-blind Treatment Period||7
3187089|NCT02031640|3915355|FG004|NOT COMPLETED|Double-blind Treatment Period||11
3187090|NCT02031640|3915356|FG005|NOT COMPLETED|Double-blind Treatment Period||3
3187091|NCT02031679|3915377|FG000|STARTED|Overall Study||14
3187092|NCT02031679|3915378|FG001|STARTED|Overall Study||14
3187093|NCT02031679|3915377|FG000|COMPLETED|Overall Study||14
3187094|NCT02031679|3915378|FG001|COMPLETED|Overall Study||12
3187095|NCT02031679|3915377|FG000|NOT COMPLETED|Overall Study||0
3187096|NCT02031679|3915378|FG001|NOT COMPLETED|Overall Study||2
3187097|NCT02031770|3915384|FG000|STARTED|Overall Study||10
3187098|NCT02031770|3915385|FG001|STARTED|Overall Study||10
3187099|NCT02031770|3915384|FG000|COMPLETED|Overall Study||9
3187100|NCT02031770|3915385|FG001|COMPLETED|Overall Study||9
3187101|NCT02031770|3915384|FG000|NOT COMPLETED|Overall Study||1
3187102|NCT02031770|3915385|FG001|NOT COMPLETED|Overall Study||1
3187103|NCT02031978|3915391|FG000|STARTED|Overall Study||4367
3187104|NCT02031978|3915391|FG000|COMPLETED|Overall Study||4367
3187105|NCT02031978|3915391|FG000|NOT COMPLETED|Overall Study||0
3187106|NCT02032173|3915395|FG000|STARTED|Overall Study||31
3187107|NCT02032173|3915395|FG000|Included Population - Main Group|Overall Study||31
3187108|NCT02032173|3915395|FG000|Rescue Group|Overall Study|1 participant moved to Rescue Group at M6 and trial discontinued before any data was collected.|1
3187109|NCT02032173|3915395|FG000|COMPLETED|Overall Study||0
3187110|NCT02032173|3915395|FG000|NOT COMPLETED|Overall Study||31
3187111|NCT02032212|3915403|FG000|STARTED|Overall Study||3
3187112|NCT02032212|3915404|FG001|STARTED|Overall Study||3
3187113|NCT02032212|3915405|FG002|STARTED|Overall Study||3
3187114|NCT02032212|3915406|FG003|STARTED|Overall Study||3
3187115|NCT02032212|3915403|FG000|COMPLETED|Overall Study||3
3187116|NCT02032212|3915404|FG001|COMPLETED|Overall Study||3
3187117|NCT02032212|3915405|FG002|COMPLETED|Overall Study||3
3187118|NCT02032212|3915406|FG003|COMPLETED|Overall Study||3
3187119|NCT02032212|3915403|FG000|NOT COMPLETED|Overall Study||0
3187120|NCT02032212|3915404|FG001|NOT COMPLETED|Overall Study||0
3187121|NCT02032212|3915405|FG002|NOT COMPLETED|Overall Study||0
3187122|NCT02032212|3915406|FG003|NOT COMPLETED|Overall Study||0
3187123|NCT02032238|3915418|FG000|STARTED|Overall Study||12
3187124|NCT02032238|3915419|FG001|STARTED|Overall Study|Study Terminated due to slow enrollment, no subjects enrolled in this study arm|0
3187125|NCT02032238|3915418|FG000|COMPLETED|Overall Study||10
3187126|NCT02032238|3915419|FG001|COMPLETED|Overall Study||0
3187127|NCT02032238|3915418|FG000|NOT COMPLETED|Overall Study||2
3187128|NCT02032238|3915419|FG001|NOT COMPLETED|Overall Study||0
3187129|NCT02032407|3915425|FG000|STARTED|Overall Study||68
3187130|NCT02032407|3915425|FG000|COMPLETED|Overall Study||63
3187131|NCT02032407|3915425|FG000|NOT COMPLETED|Overall Study||5
3187132|NCT02032420|3915431|FG000|STARTED|Overall Study||18
3187133|NCT02032420|3915432|FG001|STARTED|Overall Study||17
3187134|NCT02032420|3915431|FG000|COMPLETED|Overall Study||18
3187135|NCT02032420|3915432|FG001|COMPLETED|Overall Study||17
3187136|NCT02032420|3915431|FG000|NOT COMPLETED|Overall Study||0
3187137|NCT02032420|3915432|FG001|NOT COMPLETED|Overall Study||0
3187138|NCT02032433|3915440|FG000|STARTED|Overall Study||283
3187139|NCT02032433|3915441|FG001|STARTED|Overall Study||287
3187140|NCT02032433|3915440|FG000|COMPLETED|Overall Study||205
3187141|NCT02032433|3915441|FG001|COMPLETED|Overall Study||225
3187142|NCT02032433|3915440|FG000|NOT COMPLETED|Overall Study||78
3187143|NCT02032433|3915441|FG001|NOT COMPLETED|Overall Study||62
3187144|NCT02032550|3915449|FG000|STARTED|Overall Study||371
3187145|NCT02032550|3915450|FG001|STARTED|Overall Study||372
3187146|NCT02032550|3915449|FG000|COMPLETED|Overall Study||343
3187147|NCT02032550|3915450|FG001|COMPLETED|Overall Study||350
3187148|NCT02032550|3915449|FG000|NOT COMPLETED|Overall Study||28
3187149|NCT02032550|3915450|FG001|NOT COMPLETED|Overall Study||22
3187150|NCT02032641|3915456|FG000|STARTED|Overall Study|18 Brows enrolled for evaluation|9
3187151|NCT02032641|3915456|FG000|COMPLETED|Overall Study|16 brows completed study (half underwent treatment, half were control)|8
3187152|NCT02032641|3915456|FG000|NOT COMPLETED|Overall Study||1
3187153|NCT02032680|3915464|FG000|STARTED|Overall Study||22
3187154|NCT02032680|3915465|FG001|STARTED|Overall Study||8
3187155|NCT02032680|3915464|FG000|COMPLETED|Overall Study||16
3187156|NCT02032680|3915465|FG001|COMPLETED|Overall Study||7
3187157|NCT02032680|3915464|FG000|NOT COMPLETED|Overall Study||6
3187158|NCT02032680|3915465|FG001|NOT COMPLETED|Overall Study||1
3187159|NCT02032706|3915471|FG000|STARTED|Overall Study||36
3187160|NCT02032706|3915471|FG000|COMPLETED|Overall Study||30
3187161|NCT02032706|3915471|FG000|NOT COMPLETED|Overall Study||6
3187162|NCT02032758|3915477|FG000|STARTED|Overall Study||27
3187163|NCT02032758|3915478|FG001|STARTED|Overall Study||11
3187164|NCT02032758|3915477|FG000|COMPLETED|Overall Study||27
3187165|NCT02032758|3915478|FG001|COMPLETED|Overall Study||11
3187166|NCT02032758|3915477|FG000|NOT COMPLETED|Overall Study||0
3187167|NCT02032758|3915478|FG001|NOT COMPLETED|Overall Study||0
3187168|NCT02032810|3915486|FG000|STARTED|Overall Study||6
3187169|NCT02032810|3915487|FG001|STARTED|Overall Study||11
3187170|NCT02032810|3915486|FG000|COMPLETED|Overall Study||6
3187171|NCT02032810|3915487|FG001|COMPLETED|Overall Study||11
3187172|NCT02032810|3915486|FG000|NOT COMPLETED|Overall Study||0
3187173|NCT02032810|3915487|FG001|NOT COMPLETED|Overall Study||0
3187174|NCT02032875|3915499|FG000|STARTED|Treatment Period||53
3187175|NCT02032875|3915500|FG001|STARTED|Treatment Period||60
3187176|NCT02032875|3915499|FG000|COMPLETED|Treatment Period||52
3187177|NCT02032875|3915500|FG001|COMPLETED|Treatment Period||56
3187178|NCT02032875|3915499|FG000|NOT COMPLETED|Treatment Period||1
3187179|NCT02032875|3915500|FG001|NOT COMPLETED|Treatment Period||4
3187180|NCT02032875|3915499|FG000|STARTED|Follow-up Period|Out of 53 participants who entered the treatment period, all 53 continued in the follow-up period.|53
3187181|NCT02032875|3915500|FG001|STARTED|Follow-up Period|Of 60 participants in treatment period, 57 continued in follow-up, 3 entered treatment extension.|57
3187182|NCT02032875|3915499|FG000|COMPLETED|Follow-up Period||50
3187183|NCT02032875|3915500|FG001|COMPLETED|Follow-up Period||46
3187184|NCT02032875|3915499|FG000|NOT COMPLETED|Follow-up Period||3
3187185|NCT02032875|3915500|FG001|NOT COMPLETED|Follow-up Period||11
3187186|NCT02032888|3915510|FG000|STARTED|Treatment Period||101
3187187|NCT02032888|3915511|FG001|STARTED|Treatment Period||50
3187188|NCT02032888|3915512|FG002|STARTED|Treatment Period||52
3187189|NCT02032888|3915510|FG000|COMPLETED|Treatment Period||99
3187190|NCT02032888|3915511|FG001|COMPLETED|Treatment Period||48
3187191|NCT02032888|3915512|FG002|COMPLETED|Treatment Period||52
3187192|NCT02032888|3915510|FG000|NOT COMPLETED|Treatment Period||2
3187193|NCT02032888|3915511|FG001|NOT COMPLETED|Treatment Period||2
3187194|NCT02032888|3915512|FG002|NOT COMPLETED|Treatment Period||0
3187195|NCT02032888|3915510|FG000|STARTED|Follow-up Period|All patients who received study drug and not a nonstudy HCV therapy before treatment Week 4|100
3187196|NCT02032888|3915511|FG001|STARTED|Follow-up Period|All patients who received study drug and not a nonstudy HCV therapy before treatment Week 4|49
3187197|NCT02032888|3915512|FG002|STARTED|Follow-up Period||52
3187198|NCT02032888|3915510|FG000|COMPLETED|Follow-up Period||97
3187199|NCT02032888|3915511|FG001|COMPLETED|Follow-up Period||47
3187200|NCT02032888|3915512|FG002|COMPLETED|Follow-up Period||52
3187201|NCT02032888|3915510|FG000|NOT COMPLETED|Follow-up Period||3
3187202|NCT02032888|3915511|FG001|NOT COMPLETED|Follow-up Period||2
3187203|NCT02032888|3915512|FG002|NOT COMPLETED|Follow-up Period||0
3187204|NCT02032901|3915531|FG000|STARTED|Treatment Period (12 Weeks)||101
3187205|NCT02032901|3915532|FG001|STARTED|Treatment Period (12 Weeks)||51
3187206|NCT02032901|3915531|FG000|COMPLETED|Treatment Period (12 Weeks)||100
3187207|NCT02032901|3915532|FG001|COMPLETED|Treatment Period (12 Weeks)||51
3187208|NCT02032901|3915531|FG000|NOT COMPLETED|Treatment Period (12 Weeks)||1
3187209|NCT02032901|3915532|FG001|NOT COMPLETED|Treatment Period (12 Weeks)||0
3187210|NCT02032901|3915531|FG000|STARTED|Follow-Up Period (24 Weeks)|Participant could enter follow up period even if the treatment period was not completed.|101
3187211|NCT02032901|3915532|FG001|STARTED|Follow-Up Period (24 Weeks)||51
3187212|NCT02032901|3915531|FG000|COMPLETED|Follow-Up Period (24 Weeks)||101
3187213|NCT02032901|3915532|FG001|COMPLETED|Follow-Up Period (24 Weeks)||50
3187214|NCT02032901|3915531|FG000|NOT COMPLETED|Follow-Up Period (24 Weeks)||0
3187215|NCT02032901|3915532|FG001|NOT COMPLETED|Follow-Up Period (24 Weeks)||1
3187216|NCT02033005|3915543|FG000|STARTED|Overall Study||80
3187217|NCT02033005|3915544|FG001|STARTED|Overall Study||9
3187218|NCT02033005|3915545|FG002|STARTED|Overall Study||35
3187219|NCT02033005|3915543|FG000|COMPLETED|Overall Study||36
3187220|NCT02033005|3915544|FG001|COMPLETED|Overall Study||9
3187221|NCT02033005|3915545|FG002|COMPLETED|Overall Study||25
3187222|NCT02033005|3915543|FG000|NOT COMPLETED|Overall Study||44
3187223|NCT02033005|3915544|FG001|NOT COMPLETED|Overall Study||0
3187224|NCT02033005|3915545|FG002|NOT COMPLETED|Overall Study||10
3187225|NCT02033083|3915556|FG000|STARTED|Overall Study||90
3187226|NCT02033083|3915557|FG001|STARTED|Overall Study||90
3187227|NCT02033083|3915556|FG000|COMPLETED|Overall Study||89
3187228|NCT02033083|3915557|FG001|COMPLETED|Overall Study||89
3187229|NCT02033083|3915556|FG000|NOT COMPLETED|Overall Study||1
3187230|NCT02033083|3915557|FG001|NOT COMPLETED|Overall Study||1
3187231|NCT02033174|3915563|FG000|STARTED|First Intervention||8
3187232|NCT02033174|3915564|FG001|STARTED|First Intervention||8
3187233|NCT02033174|3915563|FG000|COMPLETED|First Intervention||8
3187234|NCT02033174|3915564|FG001|COMPLETED|First Intervention||8
3187235|NCT02033174|3915563|FG000|NOT COMPLETED|First Intervention||0
3187236|NCT02033174|3915564|FG001|NOT COMPLETED|First Intervention||0
3187237|NCT02033174|3915563|FG000|STARTED|Washout (1 Week)||8
3187238|NCT02033174|3915564|FG001|STARTED|Washout (1 Week)||8
3187239|NCT02033174|3915563|FG000|COMPLETED|Washout (1 Week)||8
3187240|NCT02033174|3915564|FG001|COMPLETED|Washout (1 Week)||8
3187241|NCT02033174|3915563|FG000|NOT COMPLETED|Washout (1 Week)||0
3187242|NCT02033174|3915564|FG001|NOT COMPLETED|Washout (1 Week)||0
3187243|NCT02033174|3915563|FG000|STARTED|Second Intervention||8
3187244|NCT02033174|3915564|FG001|STARTED|Second Intervention||8
3187245|NCT02033174|3915563|FG000|COMPLETED|Second Intervention||8
3187246|NCT02033174|3915564|FG001|COMPLETED|Second Intervention||8
3187247|NCT02033174|3915563|FG000|NOT COMPLETED|Second Intervention||0
3187248|NCT02033174|3915564|FG001|NOT COMPLETED|Second Intervention||0
3187249|NCT02033200|3915572|FG000|STARTED|Overall Study||40
3187250|NCT02033200|3915573|FG001|STARTED|Overall Study||40
3187251|NCT02033200|3915572|FG000|COMPLETED|Overall Study||40
3187252|NCT02033200|3915573|FG001|COMPLETED|Overall Study||40
3187253|NCT02033200|3915572|FG000|NOT COMPLETED|Overall Study||0
3187254|NCT02033200|3915573|FG001|NOT COMPLETED|Overall Study||0
3187255|NCT02033213|3915581|FG000|STARTED|Overall Study||8
3187256|NCT02033213|3915582|FG001|STARTED|Overall Study||8
3187257|NCT02033213|3915581|FG000|COMPLETED|Overall Study||8
3187258|NCT02033213|3915582|FG001|COMPLETED|Overall Study||8
3187259|NCT02033213|3915581|FG000|NOT COMPLETED|Overall Study||0
3187260|NCT02033213|3915582|FG001|NOT COMPLETED|Overall Study||0
3187261|NCT02033317|3915590|FG000|STARTED|Overall Study||6
3187262|NCT02033317|3915590|FG000|COMPLETED|Overall Study||6
3187263|NCT02033317|3915590|FG000|NOT COMPLETED|Overall Study||0
3187264|NCT02033369|3915596|FG000|STARTED|Overall Study||26
3187265|NCT02033369|3915597|FG001|STARTED|Overall Study||26
3187266|NCT02033369|3915596|FG000|COMPLETED|Overall Study||21
3187267|NCT02033369|3915597|FG001|COMPLETED|Overall Study||21
3187268|NCT02033369|3915596|FG000|NOT COMPLETED|Overall Study||5
3187269|NCT02033369|3915597|FG001|NOT COMPLETED|Overall Study||5
3187270|NCT02033382|3915603|FG000|STARTED|Overall Study||83
3187271|NCT02033382|3915604|FG001|STARTED|Overall Study||82
3187272|NCT02033382|3915603|FG000|COMPLETED|Overall Study||32
3187273|NCT02033382|3915604|FG001|COMPLETED|Overall Study||36
3187274|NCT02033382|3915603|FG000|NOT COMPLETED|Overall Study||51
3187275|NCT02033382|3915604|FG001|NOT COMPLETED|Overall Study||46
3187276|NCT02033499|3915617|FG000|STARTED|Overall Study||152
3187277|NCT02033499|3915618|FG001|STARTED|Overall Study||150
3187278|NCT02033499|3915619|FG002|STARTED|Overall Study||148
3187279|NCT02033499|3915617|FG000|COMPLETED|Overall Study||147
3187280|NCT02033499|3915618|FG001|COMPLETED|Overall Study||142
3187281|NCT02033499|3915619|FG002|COMPLETED|Overall Study||139
3187282|NCT02033499|3915617|FG000|NOT COMPLETED|Overall Study||5
3187283|NCT02033499|3915618|FG001|NOT COMPLETED|Overall Study||8
3187284|NCT02033499|3915619|FG002|NOT COMPLETED|Overall Study||9
3187285|NCT02033694|3915628|FG000|STARTED|Overall Study||1271
3187286|NCT02033694|3915628|FG000|COMPLETED|Overall Study||1271
3187287|NCT02033694|3915628|FG000|NOT COMPLETED|Overall Study||0
3187288|NCT02033759|3915635|FG000|STARTED|Overall Study||22
3187289|NCT02033759|3915636|FG001|STARTED|Overall Study||21
3187290|NCT02033759|3915635|FG000|COMPLETED|Overall Study||19
3187291|NCT02033759|3915636|FG001|COMPLETED|Overall Study||19
3187292|NCT02033759|3915635|FG000|NOT COMPLETED|Overall Study||3
3187293|NCT02033759|3915636|FG001|NOT COMPLETED|Overall Study||2
3187294|NCT02033850|3915644|FG000|STARTED|Overall Study||23
3187295|NCT02033850|3915645|FG001|STARTED|Overall Study||23
3187296|NCT02033850|3915644|FG000|COMPLETED|Overall Study||21
3187297|NCT02033850|3915645|FG001|COMPLETED|Overall Study||22
3187298|NCT02033850|3915644|FG000|NOT COMPLETED|Overall Study||2
3187299|NCT02033850|3915645|FG001|NOT COMPLETED|Overall Study||1
3187300|NCT02033876|3915653|FG000|STARTED|Overall Study||12
3187301|NCT02033876|3915654|FG001|STARTED|Overall Study||12
3187302|NCT02033876|3915653|FG000|COMPLETED|Overall Study||12
3187303|NCT02033876|3915654|FG001|COMPLETED|Overall Study||12
3187304|NCT02033876|3915653|FG000|NOT COMPLETED|Overall Study||0
3187305|NCT02033876|3915654|FG001|NOT COMPLETED|Overall Study||0
3187306|NCT02033889|3915663|FG000|STARTED|Overall Study||209
3187307|NCT02033889|3915664|FG001|STARTED|Overall Study||207
3187308|NCT02033889|3915665|FG002|STARTED|Overall Study||205
3187309|NCT02033889|3915663|FG000|COMPLETED|Overall Study||175
3187310|NCT02033889|3915664|FG001|COMPLETED|Overall Study||187
3187311|NCT02033889|3915665|FG002|COMPLETED|Overall Study||180
3187312|NCT02033889|3915663|FG000|NOT COMPLETED|Overall Study||34
3187313|NCT02033889|3915664|FG001|NOT COMPLETED|Overall Study||20
3187314|NCT02033889|3915665|FG002|NOT COMPLETED|Overall Study||25
3187315|NCT02033993|3915675|FG000|STARTED|Overall Study||99
3187316|NCT02033993|3915676|FG001|STARTED|Overall Study||100
3187317|NCT02033993|3915675|FG000|COMPLETED|Overall Study||96
3187318|NCT02033993|3915676|FG001|COMPLETED|Overall Study||91
3187319|NCT02033993|3915675|FG000|NOT COMPLETED|Overall Study||3
3187320|NCT02033993|3915676|FG001|NOT COMPLETED|Overall Study||9
3187321|NCT02034006|3915684|FG000|STARTED|Overall Study||200
3187322|NCT02034006|3915684|FG000|Once Treated Patients|Overall Study||70
3187323|NCT02034006|3915684|FG000|Re-treated Patients|Overall Study||130
3187324|NCT02034006|3915684|FG000|COMPLETED|Overall Study||186
3187325|NCT02034006|3915684|FG000|NOT COMPLETED|Overall Study||14
3187326|NCT02034019|3915693|FG000|STARTED|Overall Study||164
3187327|NCT02034019|3915694|FG001|STARTED|Overall Study||83
3187328|NCT02034019|3915693|FG000|COMPLETED|Overall Study||163
3187329|NCT02034019|3915694|FG001|COMPLETED|Overall Study||81
3187330|NCT02034019|3915693|FG000|NOT COMPLETED|Overall Study||1
3187331|NCT02034019|3915694|FG001|NOT COMPLETED|Overall Study||2
3187332|NCT02034058|3915700|FG000|STARTED|Overall Study|Study stopped early per pre-defined criteria for interim analysis.|152
3187333|NCT02034058|3915700|FG000|COMPLETED|Overall Study||149
3187334|NCT02034058|3915700|FG000|NOT COMPLETED|Overall Study||3
3187335|NCT02034162|3915706|FG000|STARTED|Double-blind||146
3187336|NCT02034162|3915707|FG001|STARTED|Double-blind||149
3187337|NCT02034162|3915708|FG002|STARTED|Double-blind||0
3187338|NCT02034162|3915706|FG000|COMPLETED|Double-blind||137
3187339|NCT02034162|3915707|FG001|COMPLETED|Double-blind||141
3187340|NCT02034162|3915708|FG002|COMPLETED|Double-blind||0
3187341|NCT02034162|3915706|FG000|NOT COMPLETED|Double-blind||9
3187342|NCT02034162|3915707|FG001|NOT COMPLETED|Double-blind||8
3187343|NCT02034162|3915708|FG002|NOT COMPLETED|Double-blind||0
3187344|NCT02034162|3915706|FG000|STARTED|Open-label||0
3187345|NCT02034162|3915707|FG001|STARTED|Open-label||0
3187346|NCT02034162|3915708|FG002|STARTED|Open-label||278
3187347|NCT02034162|3915706|FG000|COMPLETED|Open-label||0
3187348|NCT02034162|3915707|FG001|COMPLETED|Open-label||0
3187349|NCT02034162|3915708|FG002|COMPLETED|Open-label||278
3187350|NCT02034162|3915706|FG000|NOT COMPLETED|Open-label||0
3187351|NCT02034162|3915707|FG001|NOT COMPLETED|Open-label||0
3187352|NCT02034162|3915708|FG002|NOT COMPLETED|Open-label||0
3187353|NCT02034175|3915719|FG000|STARTED|Overall Study||190
3187354|NCT02034175|3915719|FG000|COMPLETED|Overall Study||190
3187355|NCT02034175|3915719|FG000|NOT COMPLETED|Overall Study||0
3187356|NCT02034409|3915725|FG000|STARTED|Sham Run-in Period||140
3187357|NCT02034409|3915726|FG001|STARTED|Sham Run-in Period|Number started is zero because there is no PLIUS arm in Sham Run-in Period|0
3187358|NCT02034409|3915725|FG000|COMPLETED|Sham Run-in Period||136
3187359|NCT02034409|3915726|FG001|COMPLETED|Sham Run-in Period|Number started is zero because there is no PLIUS arm in Sham Run-in Period|0
3187360|NCT02034409|3915725|FG000|NOT COMPLETED|Sham Run-in Period||4
3187361|NCT02034409|3915726|FG001|NOT COMPLETED|Sham Run-in Period||0
3187362|NCT02034409|3915725|FG000|STARTED|Sham-Controlled Treatment Period|Number started in Sham Arm of Sham-Controlled Treatment Period Milestone not equal to Sham Run-in Period Milestone because participants in this Milestone are randomly assigned to either Sham or PLIUS treatment arm.|67
3187363|NCT02034409|3915726|FG001|STARTED|Sham-Controlled Treatment Period|Number started in PLIUS Arm of Sham-Controlled Treatment Period Milestone not equal to Sham Run-in Period Milestone because participants in this Milestone are randomly assigned to either Sham or PLIUS treatment arm.|69
3187364|NCT02034409|3915725|FG000|COMPLETED|Sham-Controlled Treatment Period||55
3187365|NCT02034409|3915726|FG001|COMPLETED|Sham-Controlled Treatment Period||54
3187366|NCT02034409|3915725|FG000|NOT COMPLETED|Sham-Controlled Treatment Period||12
3187367|NCT02034409|3915726|FG001|NOT COMPLETED|Sham-Controlled Treatment Period||15
3187368|NCT02034435|3915734|FG000|STARTED|Overall Study||13
3187369|NCT02034435|3915735|FG001|STARTED|Overall Study||15
3187370|NCT02034435|3915736|FG002|STARTED|Overall Study||7
3187371|NCT02034435|3915737|FG003|STARTED|Overall Study||9
3187372|NCT02034435|3915734|FG000|Aim 1|Overall Study||13
3187373|NCT02034435|3915735|FG001|Aim 1|Overall Study||15
3187374|NCT02034435|3915736|FG002|Aim 1|Overall Study||0
3187375|NCT02034435|3915737|FG003|Aim 1|Overall Study||0
3187376|NCT02034435|3915734|FG000|Aim 2|Overall Study||0
3187377|NCT02034435|3915735|FG001|Aim 2|Overall Study||0
3187378|NCT02034435|3915736|FG002|Aim 2|Overall Study||7
3187379|NCT02034435|3915737|FG003|Aim 2|Overall Study||9
3187380|NCT02034435|3915734|FG000|COMPLETED|Overall Study||11
3187381|NCT02034435|3915735|FG001|COMPLETED|Overall Study||13
3187382|NCT02034435|3915736|FG002|COMPLETED|Overall Study||7
3187383|NCT02034435|3915737|FG003|COMPLETED|Overall Study||8
3187384|NCT02034435|3915734|FG000|NOT COMPLETED|Overall Study||2
3187385|NCT02034435|3915735|FG001|NOT COMPLETED|Overall Study||2
3187386|NCT02034435|3915736|FG002|NOT COMPLETED|Overall Study||0
3187387|NCT02034435|3915737|FG003|NOT COMPLETED|Overall Study||1
3187388|NCT02034474|3915749|FG000|STARTED|Overall Study||19
3187389|NCT02034474|3915750|FG001|STARTED|Overall Study||17
3187390|NCT02034474|3915749|FG000|1 Dose|Overall Study||2
3187391|NCT02034474|3915750|FG001|1 Dose|Overall Study||4
3187392|NCT02034474|3915749|FG000|2 Doses|Overall Study||2
3187393|NCT02034474|3915750|FG001|2 Doses|Overall Study||0
3187394|NCT02034474|3915749|FG000|3 Doses|Overall Study||15
3187395|NCT02034474|3915750|FG001|3 Doses|Overall Study||13
3187396|NCT02034474|3915749|FG000|COMPLETED|Overall Study||15
3187397|NCT02034474|3915750|FG001|COMPLETED|Overall Study||13
3187398|NCT02034474|3915749|FG000|NOT COMPLETED|Overall Study||4
3187399|NCT02034474|3915750|FG001|NOT COMPLETED|Overall Study||4
3187400|NCT02034513|3915760|FG000|STARTED|Overall Study||249
3187401|NCT02034513|3915761|FG001|STARTED|Overall Study||252
3187402|NCT02034513|3915760|FG000|Exposed|Overall Study||249
3187403|NCT02034513|3915761|FG001|Exposed|Overall Study||251
3187404|NCT02034513|3915760|FG000|COMPLETED|Overall Study||200
3187405|NCT02034513|3915761|FG001|COMPLETED|Overall Study||195
3187406|NCT02034513|3915760|FG000|NOT COMPLETED|Overall Study||49
3187407|NCT02034513|3915761|FG001|NOT COMPLETED|Overall Study||57
3187408|NCT02034552|3915772|FG000|STARTED|Overall Study||22
3187409|NCT02034552|3915773|FG001|STARTED|Overall Study||24
3187410|NCT02034552|3915774|FG002|STARTED|Overall Study||22
3187411|NCT02034552|3915772|FG000|Received Treatment|Overall Study||19
3187412|NCT02034552|3915773|FG001|Received Treatment|Overall Study||22
3187413|NCT02034552|3915774|FG002|Received Treatment|Overall Study||22
3187414|NCT02034552|3915772|FG000|COMPLETED|Overall Study||8
3187415|NCT02034552|3915773|FG001|COMPLETED|Overall Study||4
3187416|NCT02034552|3915774|FG002|COMPLETED|Overall Study||5
3187417|NCT02034552|3915772|FG000|NOT COMPLETED|Overall Study||14
3187418|NCT02034552|3915773|FG001|NOT COMPLETED|Overall Study||20
3187419|NCT02034552|3915774|FG002|NOT COMPLETED|Overall Study||17
3187420|NCT02034565|3915782|FG000|STARTED|Overall Study||7
3187421|NCT02034565|3915783|FG001|STARTED|Overall Study||7
3187422|NCT02034565|3915782|FG000|COMPLETED|Overall Study||6
3187423|NCT02034565|3915783|FG001|COMPLETED|Overall Study||7
3187424|NCT02034565|3915782|FG000|NOT COMPLETED|Overall Study||1
3187425|NCT02034565|3915783|FG001|NOT COMPLETED|Overall Study||0
3187426|NCT02034578|3915791|FG000|STARTED|Overall Study||4
3187427|NCT02034578|3915792|FG001|STARTED|Overall Study||3
3187428|NCT02034578|3915793|FG002|STARTED|Overall Study||4
3187429|NCT02034578|3915794|FG003|STARTED|Overall Study||3
3187430|NCT02034578|3915795|FG004|STARTED|Overall Study||4
3187431|NCT02034578|3915796|FG005|STARTED|Overall Study||3
3187432|NCT02034578|3915791|FG000|COMPLETED|Overall Study||4
3187433|NCT02034578|3915792|FG001|COMPLETED|Overall Study||3
3187434|NCT02034578|3915793|FG002|COMPLETED|Overall Study||4
3187435|NCT02034578|3915794|FG003|COMPLETED|Overall Study||3
3187436|NCT02034578|3915795|FG004|COMPLETED|Overall Study||4
3187437|NCT02034578|3915796|FG005|COMPLETED|Overall Study||3
3187438|NCT02034578|3915791|FG000|NOT COMPLETED|Overall Study||0
3187439|NCT02034578|3915792|FG001|NOT COMPLETED|Overall Study||0
3187440|NCT02034578|3915793|FG002|NOT COMPLETED|Overall Study||0
3187441|NCT02034578|3915794|FG003|NOT COMPLETED|Overall Study||0
3187442|NCT02034578|3915795|FG004|NOT COMPLETED|Overall Study||0
3187443|NCT02034578|3915796|FG005|NOT COMPLETED|Overall Study||0
3187444|NCT02034591|3915805|FG000|STARTED|Overall Study||4
3187445|NCT02034591|3915806|FG001|STARTED|Overall Study||3
3187446|NCT02034591|3915807|FG002|STARTED|Overall Study||4
3187447|NCT02034591|3915808|FG003|STARTED|Overall Study||3
3187448|NCT02034591|3915809|FG004|STARTED|Overall Study||4
3187449|NCT02034591|3915810|FG005|STARTED|Overall Study||3
3187450|NCT02034591|3915805|FG000|COMPLETED|Overall Study||4
3187451|NCT02034591|3915806|FG001|COMPLETED|Overall Study||3
3187452|NCT02034591|3915807|FG002|COMPLETED|Overall Study||4
3187453|NCT02034591|3915808|FG003|COMPLETED|Overall Study||3
3187454|NCT02034591|3915809|FG004|COMPLETED|Overall Study||3
3187455|NCT02034591|3915810|FG005|COMPLETED|Overall Study||3
3187456|NCT02034591|3915805|FG000|NOT COMPLETED|Overall Study||0
3187457|NCT02034591|3915806|FG001|NOT COMPLETED|Overall Study||0
3187458|NCT02034591|3915807|FG002|NOT COMPLETED|Overall Study||0
3187459|NCT02034591|3915808|FG003|NOT COMPLETED|Overall Study||0
3187460|NCT02034591|3915809|FG004|NOT COMPLETED|Overall Study||1
3187461|NCT02034591|3915810|FG005|NOT COMPLETED|Overall Study||0
3187462|NCT02034708|3915821|FG000|STARTED|First Contrast Agent Injection (1 Day)||138
3187463|NCT02034708|3915822|FG001|STARTED|First Contrast Agent Injection (1 Day)||130
3187464|NCT02034708|3915821|FG000|COMPLETED|First Contrast Agent Injection (1 Day)||138
3187465|NCT02034708|3915822|FG001|COMPLETED|First Contrast Agent Injection (1 Day)||130
3187466|NCT02034708|3915821|FG000|NOT COMPLETED|First Contrast Agent Injection (1 Day)||0
3187467|NCT02034708|3915822|FG001|NOT COMPLETED|First Contrast Agent Injection (1 Day)||0
3187468|NCT02034708|3915821|FG000|STARTED|Wash-out (From 2 Days up to 14 Days)||138
3187469|NCT02034708|3915822|FG001|STARTED|Wash-out (From 2 Days up to 14 Days)||130
3187470|NCT02034708|3915821|FG000|COMPLETED|Wash-out (From 2 Days up to 14 Days)||129
3187471|NCT02034708|3915822|FG001|COMPLETED|Wash-out (From 2 Days up to 14 Days)||120
3187472|NCT02034708|3915821|FG000|NOT COMPLETED|Wash-out (From 2 Days up to 14 Days)||9
3187473|NCT02034708|3915822|FG001|NOT COMPLETED|Wash-out (From 2 Days up to 14 Days)||10
3187474|NCT02034708|3915821|FG000|STARTED|Second Contrast Agent Injection (1 Day)||129
3187475|NCT02034708|3915822|FG001|STARTED|Second Contrast Agent Injection (1 Day)||120
3187476|NCT02034708|3915821|FG000|COMPLETED|Second Contrast Agent Injection (1 Day)||129
3187477|NCT02034708|3915822|FG001|COMPLETED|Second Contrast Agent Injection (1 Day)||120
3187478|NCT02034708|3915821|FG000|NOT COMPLETED|Second Contrast Agent Injection (1 Day)||0
3187479|NCT02034708|3915822|FG001|NOT COMPLETED|Second Contrast Agent Injection (1 Day)||0
3187480|NCT02034799|3915835|FG000|STARTED|Overall Study||129
3187481|NCT02034799|3915836|FG001|STARTED|Overall Study||127
3187482|NCT02034799|3915835|FG000|COMPLETED|Overall Study||127
3187483|NCT02034799|3915836|FG001|COMPLETED|Overall Study||123
3187484|NCT02034799|3915835|FG000|NOT COMPLETED|Overall Study||2
3187485|NCT02034799|3915836|FG001|NOT COMPLETED|Overall Study||4
3187486|NCT02034877|3915844|FG000|STARTED|Overall Study||200
3187487|NCT02034877|3915845|FG001|STARTED|Overall Study||999
3187488|NCT02034877|3915844|FG000|COMPLETED|Overall Study||200
3187489|NCT02034877|3915845|FG001|COMPLETED|Overall Study||993
3187490|NCT02034877|3915844|FG000|NOT COMPLETED|Overall Study||0
3187491|NCT02034877|3915845|FG001|NOT COMPLETED|Overall Study||6
3187492|NCT02034916|3915853|FG000|STARTED|Overall Study||49
3187493|NCT02034916|3915854|FG001|STARTED|Overall Study||35
3187494|NCT02034916|3915853|FG000|Treated|Overall Study||48
3187495|NCT02034916|3915854|FG001|Treated|Overall Study||35
3187496|NCT02034916|3915853|FG000|COMPLETED|Overall Study||0
3187497|NCT02034916|3915854|FG001|COMPLETED|Overall Study||0
3187498|NCT02034916|3915853|FG000|NOT COMPLETED|Overall Study||49
3187499|NCT02034916|3915854|FG001|NOT COMPLETED|Overall Study||35
3187500|NCT02035202|3915864|FG000|STARTED|Overall Study||85
3187501|NCT02035202|3915865|FG001|STARTED|Overall Study||85
3187502|NCT02035202|3915866|FG002|STARTED|Overall Study||85
3187503|NCT02035202|3915864|FG000|COMPLETED|Overall Study||77
3187504|NCT02035202|3915865|FG001|COMPLETED|Overall Study||69
3187505|NCT02035202|3915866|FG002|COMPLETED|Overall Study||83
3187506|NCT02035202|3915864|FG000|NOT COMPLETED|Overall Study||8
3187507|NCT02035202|3915865|FG001|NOT COMPLETED|Overall Study||16
3187508|NCT02035202|3915866|FG002|NOT COMPLETED|Overall Study||2
3187509|NCT02035267|3915878|FG000|STARTED|Overall Study||31
3187510|NCT02035267|3915879|FG001|STARTED|Overall Study||16
3187511|NCT02035267|3915880|FG002|STARTED|Overall Study||30
3187512|NCT02035267|3915881|FG003|STARTED|Overall Study||16
3187513|NCT02035267|3915878|FG000|COMPLETED|Overall Study||31
3187514|NCT02035267|3915879|FG001|COMPLETED|Overall Study||15
3187515|NCT02035267|3915880|FG002|COMPLETED|Overall Study||28
3187516|NCT02035267|3915881|FG003|COMPLETED|Overall Study||15
3187517|NCT02035267|3915878|FG000|NOT COMPLETED|Overall Study||0
3187518|NCT02035267|3915879|FG001|NOT COMPLETED|Overall Study||1
3187519|NCT02035267|3915880|FG002|NOT COMPLETED|Overall Study||2
3187520|NCT02035267|3915881|FG003|NOT COMPLETED|Overall Study||1
3187521|NCT02035332|3915893|FG000|STARTED|Overall Study|Treatment Attempted|21
3187522|NCT02035332|3915893|FG000|Treated|Overall Study|Treatment Completed|20
3187523|NCT02035332|3915893|FG000|COMPLETED|Overall Study|Completed 12 Month Follow-up|20
3187524|NCT02035332|3915893|FG000|NOT COMPLETED|Overall Study||1
3187525|NCT02035345|3915897|FG000|STARTED|Overall Study||15
3187526|NCT02035345|3915897|FG000|COMPLETED|Overall Study||15
3187527|NCT02035345|3915897|FG000|NOT COMPLETED|Overall Study||0
3187528|NCT02035475|3915902|FG000|STARTED|Overall Study|120 subjects were consented for participation in the study.|120
3187529|NCT02035475|3915902|FG000|COMPLETED|Overall Study|Six subjects did not complete the study due to withdrawal of consent.|114
3187530|NCT02035475|3915902|FG000|NOT COMPLETED|Overall Study||6
3187531|NCT02035553|3915910|FG000|STARTED|Overall Study||91
3187532|NCT02035553|3915911|FG001|STARTED|Overall Study||90
3187533|NCT02035553|3915910|FG000|COMPLETED|Overall Study||73
3187534|NCT02035553|3915911|FG001|COMPLETED|Overall Study||67
3187535|NCT02035553|3915910|FG000|NOT COMPLETED|Overall Study||18
3187536|NCT02035553|3915911|FG001|NOT COMPLETED|Overall Study||23
3187537|NCT02035696|3915921|FG000|STARTED|Overall Study||174
3187538|NCT02035696|3915922|FG001|STARTED|Overall Study||166
3187539|NCT02035696|3915923|FG002|STARTED|Overall Study||167
3187540|NCT02035696|3915924|FG003|STARTED|Overall Study||164
3187541|NCT02035696|3915921|FG000|COMPLETED|Overall Study||171
3187542|NCT02035696|3915922|FG001|COMPLETED|Overall Study||163
3187543|NCT02035696|3915923|FG002|COMPLETED|Overall Study||164
3187544|NCT02035696|3915924|FG003|COMPLETED|Overall Study||161
3187545|NCT02035696|3915921|FG000|NOT COMPLETED|Overall Study||3
3187546|NCT02035696|3915922|FG001|NOT COMPLETED|Overall Study||3
3187547|NCT02035696|3915923|FG002|NOT COMPLETED|Overall Study||3
3187548|NCT02035696|3915924|FG003|NOT COMPLETED|Overall Study||3
3187549|NCT02035748|3915938|FG000|STARTED|Overall Study||468
3187550|NCT02035748|3915938|FG000|COMPLETED|Overall Study||448
3187551|NCT02035748|3915938|FG000|NOT COMPLETED|Overall Study||20
3187552|NCT02036294|3915945|FG000|STARTED|Overall Study||120
3187553|NCT02036294|3915946|FG001|STARTED|Overall Study||120
3187554|NCT02036294|3915945|FG000|COMPLETED|Overall Study||111
3187555|NCT02036294|3915946|FG001|COMPLETED|Overall Study||109
3187556|NCT02036294|3915945|FG000|NOT COMPLETED|Overall Study||9
3187557|NCT02036294|3915946|FG001|NOT COMPLETED|Overall Study||11
3187558|NCT02036320|3915952|FG000|STARTED|Period 1||95
3187559|NCT02036320|3915953|FG001|STARTED|Period 1||95
3187560|NCT02036320|3915952|FG000|COMPLETED|Period 1||95
3187561|NCT02036320|3915953|FG001|COMPLETED|Period 1||95
3187562|NCT02036320|3915952|FG000|NOT COMPLETED|Period 1||0
3187563|NCT02036320|3915953|FG001|NOT COMPLETED|Period 1||0
3187564|NCT02036320|3915952|FG000|STARTED|Period 2||95
3187565|NCT02036320|3915953|FG001|STARTED|Period 2||95
3187566|NCT02036320|3915952|FG000|COMPLETED|Period 2||95
3187567|NCT02036320|3915953|FG001|COMPLETED|Period 2||95
3187568|NCT02036320|3915952|FG000|NOT COMPLETED|Period 2||0
3187569|NCT02036320|3915953|FG001|NOT COMPLETED|Period 2||0
3187570|NCT02036424|3915961|FG000|STARTED|Overall Study|23 study eyes, not number of subjects|23
3187571|NCT02036424|3915962|FG001|STARTED|Overall Study|27 study eyes, not number of subjects|27
3187572|NCT02036424|3915961|FG000|COMPLETED|Overall Study|23 study eyes, not number of subjects|23
3187573|NCT02036424|3915962|FG001|COMPLETED|Overall Study|27 study eyes, not number of subjects|27
3187574|NCT02036424|3915961|FG000|NOT COMPLETED|Overall Study||0
3187575|NCT02036424|3915962|FG001|NOT COMPLETED|Overall Study||0
3187576|NCT02036502|3915976|FG000|STARTED|Part 1:Dose Determination/Escalation||6
3187577|NCT02036502|3915977|FG001|STARTED|Part 1:Dose Determination/Escalation||4
3187578|NCT02036502|3915978|FG002|STARTED|Part 1:Dose Determination/Escalation||0
3187579|NCT02036502|3915979|FG003|STARTED|Part 1:Dose Determination/Escalation||0
3187580|NCT02036502|3915980|FG004|STARTED|Part 1:Dose Determination/Escalation||0
3187581|NCT02036502|3915981|FG005|STARTED|Part 1:Dose Determination/Escalation||0
3187582|NCT02036502|3915982|FG006|STARTED|Part 1:Dose Determination/Escalation||0
3187583|NCT02036502|3915983|FG007|STARTED|Part 1:Dose Determination/Escalation||0
3187584|NCT02036502|3915976|FG000|Treated|Part 1:Dose Determination/Escalation||6
3187585|NCT02036502|3915977|FG001|Treated|Part 1:Dose Determination/Escalation||3
3187586|NCT02036502|3915978|FG002|Treated|Part 1:Dose Determination/Escalation||0
3187587|NCT02036502|3915979|FG003|Treated|Part 1:Dose Determination/Escalation||0
3187588|NCT02036502|3915980|FG004|Treated|Part 1:Dose Determination/Escalation||0
3187589|NCT02036502|3915981|FG005|Treated|Part 1:Dose Determination/Escalation||0
3187590|NCT02036502|3915982|FG006|Treated|Part 1:Dose Determination/Escalation||0
3187591|NCT02036502|3915983|FG007|Treated|Part 1:Dose Determination/Escalation||0
3187592|NCT02036502|3915976|FG000|COMPLETED|Part 1:Dose Determination/Escalation||0
3187593|NCT02036502|3915977|FG001|COMPLETED|Part 1:Dose Determination/Escalation||0
3187594|NCT02036502|3915978|FG002|COMPLETED|Part 1:Dose Determination/Escalation||0
3187595|NCT02036502|3915979|FG003|COMPLETED|Part 1:Dose Determination/Escalation||0
3187596|NCT02036502|3915980|FG004|COMPLETED|Part 1:Dose Determination/Escalation||0
3187597|NCT02036502|3915981|FG005|COMPLETED|Part 1:Dose Determination/Escalation||0
3187598|NCT02036502|3915982|FG006|COMPLETED|Part 1:Dose Determination/Escalation||0
3187599|NCT02036502|3915983|FG007|COMPLETED|Part 1:Dose Determination/Escalation||0
3187600|NCT02036502|3915976|FG000|NOT COMPLETED|Part 1:Dose Determination/Escalation||6
3187601|NCT02036502|3915977|FG001|NOT COMPLETED|Part 1:Dose Determination/Escalation||4
3187602|NCT02036502|3915978|FG002|NOT COMPLETED|Part 1:Dose Determination/Escalation||0
3187603|NCT02036502|3915979|FG003|NOT COMPLETED|Part 1:Dose Determination/Escalation||0
3187604|NCT02036502|3915980|FG004|NOT COMPLETED|Part 1:Dose Determination/Escalation||0
3187605|NCT02036502|3915981|FG005|NOT COMPLETED|Part 1:Dose Determination/Escalation||0
3187606|NCT02036502|3915982|FG006|NOT COMPLETED|Part 1:Dose Determination/Escalation||0
3187607|NCT02036502|3915983|FG007|NOT COMPLETED|Part 1:Dose Determination/Escalation||0
3187608|NCT02036502|3915976|FG000|STARTED|Part 2:Dose Confirmation||0
3187609|NCT02036502|3915977|FG001|STARTED|Part 2:Dose Confirmation||0
3187610|NCT02036502|3915978|FG002|STARTED|Part 2:Dose Confirmation|Participants added to study for dose confirmation.|6
3187611|NCT02036502|3915979|FG003|STARTED|Part 2:Dose Confirmation|Participants added to study for dose confirmation.|2
3187612|NCT02036502|3915980|FG004|STARTED|Part 2:Dose Confirmation|Participants added to study for dose confirmation.|1
3187613|NCT02036502|3915981|FG005|STARTED|Part 2:Dose Confirmation||0
3187614|NCT02036502|3915982|FG006|STARTED|Part 2:Dose Confirmation||0
3187615|NCT02036502|3915983|FG007|STARTED|Part 2:Dose Confirmation||0
3187616|NCT02036502|3915976|FG000|Treated|Part 2:Dose Confirmation||0
3187617|NCT02036502|3915977|FG001|Treated|Part 2:Dose Confirmation||0
3187618|NCT02036502|3915978|FG002|Treated|Part 2:Dose Confirmation||6
3187619|NCT02036502|3915979|FG003|Treated|Part 2:Dose Confirmation||1
3187620|NCT02036502|3915980|FG004|Treated|Part 2:Dose Confirmation||1
3187621|NCT02036502|3915981|FG005|Treated|Part 2:Dose Confirmation||0
3187622|NCT02036502|3915982|FG006|Treated|Part 2:Dose Confirmation||0
3187623|NCT02036502|3915983|FG007|Treated|Part 2:Dose Confirmation||0
3187624|NCT02036502|3915976|FG000|COMPLETED|Part 2:Dose Confirmation||0
3187625|NCT02036502|3915977|FG001|COMPLETED|Part 2:Dose Confirmation||0
3187626|NCT02036502|3915978|FG002|COMPLETED|Part 2:Dose Confirmation||0
3187627|NCT02036502|3915979|FG003|COMPLETED|Part 2:Dose Confirmation||0
3187628|NCT02036502|3915980|FG004|COMPLETED|Part 2:Dose Confirmation||0
3187629|NCT02036502|3915981|FG005|COMPLETED|Part 2:Dose Confirmation||0
3187630|NCT02036502|3915982|FG006|COMPLETED|Part 2:Dose Confirmation||0
3187631|NCT02036502|3915983|FG007|COMPLETED|Part 2:Dose Confirmation||0
3187632|NCT02036502|3915976|FG000|NOT COMPLETED|Part 2:Dose Confirmation||0
3187633|NCT02036502|3915977|FG001|NOT COMPLETED|Part 2:Dose Confirmation||0
3187634|NCT02036502|3915978|FG002|NOT COMPLETED|Part 2:Dose Confirmation||6
3187635|NCT02036502|3915979|FG003|NOT COMPLETED|Part 2:Dose Confirmation||2
3187636|NCT02036502|3915980|FG004|NOT COMPLETED|Part 2:Dose Confirmation||1
3187637|NCT02036502|3915981|FG005|NOT COMPLETED|Part 2:Dose Confirmation||0
3187638|NCT02036502|3915982|FG006|NOT COMPLETED|Part 2:Dose Confirmation||0
3187639|NCT02036502|3915983|FG007|NOT COMPLETED|Part 2:Dose Confirmation||0
3187640|NCT02036502|3915976|FG000|STARTED|Part 3:Dose Expansion||0
3187641|NCT02036502|3915977|FG001|STARTED|Part 3:Dose Expansion||0
3187642|NCT02036502|3915978|FG002|STARTED|Part 3:Dose Expansion||0
3187643|NCT02036502|3915979|FG003|STARTED|Part 3:Dose Expansion||0
3187644|NCT02036502|3915980|FG004|STARTED|Part 3:Dose Expansion||0
3187645|NCT02036502|3915981|FG005|STARTED|Part 3:Dose Expansion|Participants added to study for dose expansion|47
3187646|NCT02036502|3915982|FG006|STARTED|Part 3:Dose Expansion|Participants added to study for dose expansion|1
3187647|NCT02036502|3915983|FG007|STARTED|Part 3:Dose Expansion|Participants added to study for dose expansion|10
3187648|NCT02036502|3915976|FG000|Treated|Part 3:Dose Expansion||0
3187649|NCT02036502|3915977|FG001|Treated|Part 3:Dose Expansion||0
3187650|NCT02036502|3915978|FG002|Treated|Part 3:Dose Expansion||0
3187651|NCT02036502|3915979|FG003|Treated|Part 3:Dose Expansion||0
3187652|NCT02036502|3915980|FG004|Treated|Part 3:Dose Expansion||0
3187653|NCT02036502|3915981|FG005|Treated|Part 3:Dose Expansion||45
3187654|NCT02036502|3915982|FG006|Treated|Part 3:Dose Expansion||1
3187655|NCT02036502|3915983|FG007|Treated|Part 3:Dose Expansion||10
3187656|NCT02036502|3915976|FG000|COMPLETED|Part 3:Dose Expansion||0
3187657|NCT02036502|3915977|FG001|COMPLETED|Part 3:Dose Expansion||0
3187658|NCT02036502|3915978|FG002|COMPLETED|Part 3:Dose Expansion||0
3187659|NCT02036502|3915979|FG003|COMPLETED|Part 3:Dose Expansion||0
3187660|NCT02036502|3915980|FG004|COMPLETED|Part 3:Dose Expansion||0
3187661|NCT02036502|3915981|FG005|COMPLETED|Part 3:Dose Expansion||0
3187662|NCT02036502|3915982|FG006|COMPLETED|Part 3:Dose Expansion||0
3187663|NCT02036502|3915983|FG007|COMPLETED|Part 3:Dose Expansion||0
3187664|NCT02036502|3915976|FG000|NOT COMPLETED|Part 3:Dose Expansion||0
3187665|NCT02036502|3915977|FG001|NOT COMPLETED|Part 3:Dose Expansion||0
3187666|NCT02036502|3915978|FG002|NOT COMPLETED|Part 3:Dose Expansion||0
3187667|NCT02036502|3915979|FG003|NOT COMPLETED|Part 3:Dose Expansion||0
3187668|NCT02036502|3915980|FG004|NOT COMPLETED|Part 3:Dose Expansion||0
3187669|NCT02036502|3915981|FG005|NOT COMPLETED|Part 3:Dose Expansion||47
3187670|NCT02036502|3915982|FG006|NOT COMPLETED|Part 3:Dose Expansion||1
3187671|NCT02036502|3915983|FG007|NOT COMPLETED|Part 3:Dose Expansion||10
3187672|NCT02036515|3916006|FG000|STARTED|Overall Study||156
3187673|NCT02036515|3916007|FG001|STARTED|Overall Study||155
3187674|NCT02036515|3916008|FG002|STARTED|Overall Study||153
3187675|NCT02036515|3916006|FG000|Treated|Overall Study||156
3187676|NCT02036515|3916007|FG001|Treated|Overall Study||153
3187677|NCT02036515|3916008|FG002|Treated|Overall Study||153
3187678|NCT02036515|3916006|FG000|COMPLETED|Overall Study||151
3187679|NCT02036515|3916007|FG001|COMPLETED|Overall Study||143
3187680|NCT02036515|3916008|FG002|COMPLETED|Overall Study||139
3187681|NCT02036515|3916006|FG000|NOT COMPLETED|Overall Study||5
3187682|NCT02036515|3916007|FG001|NOT COMPLETED|Overall Study||12
3187683|NCT02036515|3916008|FG002|NOT COMPLETED|Overall Study||14
3187684|NCT02036541|3916016|FG000|STARTED|Overall Study||65
3187685|NCT02036541|3916016|FG000|Completed Endpoint Visit|Overall Study||54
3187686|NCT02036541|3916016|FG000|COMPLETED|Overall Study||49
3187687|NCT02036541|3916016|FG000|NOT COMPLETED|Overall Study||16
3187688|NCT02036580|3916023|FG000|STARTED|Overall Study||8
3187689|NCT02036580|3916024|FG001|STARTED|Overall Study||8
3187690|NCT02036580|3916025|FG002|STARTED|Overall Study||4
3187691|NCT02036580|3916023|FG000|COMPLETED|Overall Study||7
3187692|NCT02036580|3916024|FG001|COMPLETED|Overall Study||7
3187693|NCT02036580|3916025|FG002|COMPLETED|Overall Study||4
3187694|NCT02036580|3916023|FG000|NOT COMPLETED|Overall Study||1
3187695|NCT02036580|3916024|FG001|NOT COMPLETED|Overall Study||1
3187696|NCT02036580|3916025|FG002|NOT COMPLETED|Overall Study||0
3187697|NCT02036645|3916045|FG000|STARTED|SAD Cohorts : Study Part 1|Pooled across cohorts 1-5 (2 per cohort)|12
3187698|NCT02036645|3916046|FG001|STARTED|SAD Cohorts : Study Part 1||3
3187699|NCT02036645|3916047|FG002|STARTED|SAD Cohorts : Study Part 1||6
3187700|NCT02036645|3916048|FG003|STARTED|SAD Cohorts : Study Part 1||6
3187701|NCT02036645|3916049|FG004|STARTED|SAD Cohorts : Study Part 1||6
3187702|NCT02036645|3916050|FG005|STARTED|SAD Cohorts : Study Part 1||6
3187703|NCT02036645|3916051|FG006|STARTED|SAD Cohorts : Study Part 1||6
3187704|NCT02036645|3916052|FG007|STARTED|SAD Cohorts : Study Part 1||0
3187705|NCT02036645|3916053|FG008|STARTED|SAD Cohorts : Study Part 1||0
3187706|NCT02036645|3916054|FG009|STARTED|SAD Cohorts : Study Part 1||0
3187707|NCT02036645|3916055|FG010|STARTED|SAD Cohorts : Study Part 1||0
3187708|NCT02036645|3916056|FG011|STARTED|SAD Cohorts : Study Part 1||0
3187709|NCT02036645|3916045|FG000|COMPLETED|SAD Cohorts : Study Part 1||12
3187710|NCT02036645|3916046|FG001|COMPLETED|SAD Cohorts : Study Part 1||3
3187711|NCT02036645|3916047|FG002|COMPLETED|SAD Cohorts : Study Part 1||6
3187712|NCT02036645|3916048|FG003|COMPLETED|SAD Cohorts : Study Part 1||5
3187713|NCT02036645|3916049|FG004|COMPLETED|SAD Cohorts : Study Part 1||6
3187714|NCT02036645|3916050|FG005|COMPLETED|SAD Cohorts : Study Part 1||6
3187715|NCT02036645|3916051|FG006|COMPLETED|SAD Cohorts : Study Part 1||5
3187716|NCT02036645|3916052|FG007|COMPLETED|SAD Cohorts : Study Part 1||0
3187717|NCT02036645|3916053|FG008|COMPLETED|SAD Cohorts : Study Part 1||0
3187718|NCT02036645|3916054|FG009|COMPLETED|SAD Cohorts : Study Part 1||0
3187719|NCT02036645|3916055|FG010|COMPLETED|SAD Cohorts : Study Part 1||0
3187720|NCT02036645|3916056|FG011|COMPLETED|SAD Cohorts : Study Part 1||0
3187721|NCT02036645|3916045|FG000|NOT COMPLETED|SAD Cohorts : Study Part 1||0
3187722|NCT02036645|3916046|FG001|NOT COMPLETED|SAD Cohorts : Study Part 1||0
3187723|NCT02036645|3916047|FG002|NOT COMPLETED|SAD Cohorts : Study Part 1||0
3187724|NCT02036645|3916048|FG003|NOT COMPLETED|SAD Cohorts : Study Part 1||1
3187725|NCT02036645|3916049|FG004|NOT COMPLETED|SAD Cohorts : Study Part 1||0
3187726|NCT02036645|3916050|FG005|NOT COMPLETED|SAD Cohorts : Study Part 1||0
3187727|NCT02036645|3916051|FG006|NOT COMPLETED|SAD Cohorts : Study Part 1||1
3187728|NCT02036645|3916052|FG007|NOT COMPLETED|SAD Cohorts : Study Part 1||0
3187729|NCT02036645|3916053|FG008|NOT COMPLETED|SAD Cohorts : Study Part 1||0
3187730|NCT02036645|3916054|FG009|NOT COMPLETED|SAD Cohorts : Study Part 1||0
3187731|NCT02036645|3916055|FG010|NOT COMPLETED|SAD Cohorts : Study Part 1||0
3187732|NCT02036645|3916056|FG011|NOT COMPLETED|SAD Cohorts : Study Part 1||0
3187733|NCT02036645|3916045|FG000|STARTED|MAD Cohorts: Study Part 2|Pooled across Cohorts 7 to 9 (2 per cohort)|0
3187734|NCT02036645|3916046|FG001|STARTED|MAD Cohorts: Study Part 2||0
3187735|NCT02036645|3916047|FG002|STARTED|MAD Cohorts: Study Part 2||0
3187736|NCT02036645|3916048|FG003|STARTED|MAD Cohorts: Study Part 2||0
3187737|NCT02036645|3916049|FG004|STARTED|MAD Cohorts: Study Part 2||0
3187738|NCT02036645|3916050|FG005|STARTED|MAD Cohorts: Study Part 2||0
3187739|NCT02036645|3916051|FG006|STARTED|MAD Cohorts: Study Part 2||0
3187740|NCT02036645|3916052|FG007|STARTED|MAD Cohorts: Study Part 2||8
3187741|NCT02036645|3916053|FG008|STARTED|MAD Cohorts: Study Part 2||6
3187742|NCT02036645|3916054|FG009|STARTED|MAD Cohorts: Study Part 2||6
3187743|NCT02036645|3916055|FG010|STARTED|MAD Cohorts: Study Part 2||6
3187744|NCT02036645|3916056|FG011|STARTED|MAD Cohorts: Study Part 2||6
3187745|NCT02036645|3916045|FG000|COMPLETED|MAD Cohorts: Study Part 2||0
3187746|NCT02036645|3916046|FG001|COMPLETED|MAD Cohorts: Study Part 2||0
3187747|NCT02036645|3916047|FG002|COMPLETED|MAD Cohorts: Study Part 2||0
3187748|NCT02036645|3916048|FG003|COMPLETED|MAD Cohorts: Study Part 2||0
3187749|NCT02036645|3916049|FG004|COMPLETED|MAD Cohorts: Study Part 2||0
3187750|NCT02036645|3916050|FG005|COMPLETED|MAD Cohorts: Study Part 2||0
3187751|NCT02036645|3916051|FG006|COMPLETED|MAD Cohorts: Study Part 2||0
3187752|NCT02036645|3916052|FG007|COMPLETED|MAD Cohorts: Study Part 2||8
3187753|NCT02036645|3916053|FG008|COMPLETED|MAD Cohorts: Study Part 2||6
3187754|NCT02036645|3916054|FG009|COMPLETED|MAD Cohorts: Study Part 2||6
3187755|NCT02036645|3916055|FG010|COMPLETED|MAD Cohorts: Study Part 2||6
3187756|NCT02036645|3916056|FG011|COMPLETED|MAD Cohorts: Study Part 2||6
3187757|NCT02036645|3916045|FG000|NOT COMPLETED|MAD Cohorts: Study Part 2||0
3187758|NCT02036645|3916046|FG001|NOT COMPLETED|MAD Cohorts: Study Part 2||0
3187759|NCT02036645|3916047|FG002|NOT COMPLETED|MAD Cohorts: Study Part 2||0
3187760|NCT02036645|3916048|FG003|NOT COMPLETED|MAD Cohorts: Study Part 2||0
3187761|NCT02036645|3916049|FG004|NOT COMPLETED|MAD Cohorts: Study Part 2||0
3187762|NCT02036645|3916050|FG005|NOT COMPLETED|MAD Cohorts: Study Part 2||0
3187763|NCT02036645|3916051|FG006|NOT COMPLETED|MAD Cohorts: Study Part 2||0
3187764|NCT02036645|3916052|FG007|NOT COMPLETED|MAD Cohorts: Study Part 2||0
3187765|NCT02036645|3916053|FG008|NOT COMPLETED|MAD Cohorts: Study Part 2||0
3187766|NCT02036645|3916054|FG009|NOT COMPLETED|MAD Cohorts: Study Part 2||0
3187767|NCT02036645|3916055|FG010|NOT COMPLETED|MAD Cohorts: Study Part 2||0
3187768|NCT02036645|3916056|FG011|NOT COMPLETED|MAD Cohorts: Study Part 2||0
3187769|NCT02036775|3916094|FG000|STARTED|Treatment Period 1 (6 Days)||4
3187770|NCT02036775|3916095|FG001|STARTED|Treatment Period 1 (6 Days)||4
3187771|NCT02036775|3916096|FG002|STARTED|Treatment Period 1 (6 Days)||4
3187772|NCT02036775|3916097|FG003|STARTED|Treatment Period 1 (6 Days)||4
3187773|NCT02036775|3916098|FG004|STARTED|Treatment Period 1 (6 Days)||4
3187774|NCT02036775|3916099|FG005|STARTED|Treatment Period 1 (6 Days)||4
3187775|NCT02036775|3916094|FG000|COMPLETED|Treatment Period 1 (6 Days)||4
3187776|NCT02036775|3916095|FG001|COMPLETED|Treatment Period 1 (6 Days)||4
3187777|NCT02036775|3916096|FG002|COMPLETED|Treatment Period 1 (6 Days)||4
3187778|NCT02036775|3916097|FG003|COMPLETED|Treatment Period 1 (6 Days)||4
3187779|NCT02036775|3916098|FG004|COMPLETED|Treatment Period 1 (6 Days)||4
3187780|NCT02036775|3916099|FG005|COMPLETED|Treatment Period 1 (6 Days)||4
3187781|NCT02036775|3916094|FG000|NOT COMPLETED|Treatment Period 1 (6 Days)||0
3187782|NCT02036775|3916095|FG001|NOT COMPLETED|Treatment Period 1 (6 Days)||0
3187783|NCT02036775|3916096|FG002|NOT COMPLETED|Treatment Period 1 (6 Days)||0
3187784|NCT02036775|3916097|FG003|NOT COMPLETED|Treatment Period 1 (6 Days)||0
3187785|NCT02036775|3916098|FG004|NOT COMPLETED|Treatment Period 1 (6 Days)||0
3187786|NCT02036775|3916099|FG005|NOT COMPLETED|Treatment Period 1 (6 Days)||0
3187787|NCT02036775|3916094|FG000|STARTED|Treatment Period 2 (6 Days)||4
3187788|NCT02036775|3916095|FG001|STARTED|Treatment Period 2 (6 Days)||4
3187789|NCT02036775|3916096|FG002|STARTED|Treatment Period 2 (6 Days)||4
3187790|NCT02036775|3916097|FG003|STARTED|Treatment Period 2 (6 Days)||4
3187791|NCT02036775|3916098|FG004|STARTED|Treatment Period 2 (6 Days)||4
3187792|NCT02036775|3916099|FG005|STARTED|Treatment Period 2 (6 Days)||4
3187793|NCT02036775|3916094|FG000|COMPLETED|Treatment Period 2 (6 Days)||4
3187794|NCT02036775|3916095|FG001|COMPLETED|Treatment Period 2 (6 Days)||4
3187795|NCT02036775|3916096|FG002|COMPLETED|Treatment Period 2 (6 Days)||4
3187796|NCT02036775|3916097|FG003|COMPLETED|Treatment Period 2 (6 Days)||4
3187797|NCT02036775|3916098|FG004|COMPLETED|Treatment Period 2 (6 Days)||4
3187798|NCT02036775|3916099|FG005|COMPLETED|Treatment Period 2 (6 Days)||3
3187799|NCT02036775|3916094|FG000|NOT COMPLETED|Treatment Period 2 (6 Days)||0
3187800|NCT02036775|3916095|FG001|NOT COMPLETED|Treatment Period 2 (6 Days)||0
3187801|NCT02036775|3916096|FG002|NOT COMPLETED|Treatment Period 2 (6 Days)||0
3187802|NCT02036775|3916097|FG003|NOT COMPLETED|Treatment Period 2 (6 Days)||0
3187803|NCT02036775|3916098|FG004|NOT COMPLETED|Treatment Period 2 (6 Days)||0
3187804|NCT02036775|3916099|FG005|NOT COMPLETED|Treatment Period 2 (6 Days)||1
3187805|NCT02036775|3916094|FG000|STARTED|Treatment Period 3 (6 Days)||4
3187806|NCT02036775|3916095|FG001|STARTED|Treatment Period 3 (6 Days)||4
3187807|NCT02036775|3916096|FG002|STARTED|Treatment Period 3 (6 Days)||4
3187808|NCT02036775|3916097|FG003|STARTED|Treatment Period 3 (6 Days)||4
3187809|NCT02036775|3916098|FG004|STARTED|Treatment Period 3 (6 Days)||4
3187810|NCT02036775|3916099|FG005|STARTED|Treatment Period 3 (6 Days)||3
3187811|NCT02036775|3916094|FG000|COMPLETED|Treatment Period 3 (6 Days)||4
3187812|NCT02036775|3916095|FG001|COMPLETED|Treatment Period 3 (6 Days)||4
3187813|NCT02036775|3916096|FG002|COMPLETED|Treatment Period 3 (6 Days)||4
3187814|NCT02036775|3916097|FG003|COMPLETED|Treatment Period 3 (6 Days)||4
3187815|NCT02036775|3916098|FG004|COMPLETED|Treatment Period 3 (6 Days)||4
3187816|NCT02036775|3916099|FG005|COMPLETED|Treatment Period 3 (6 Days)||3
3187817|NCT02036775|3916094|FG000|NOT COMPLETED|Treatment Period 3 (6 Days)||0
3187818|NCT02036775|3916095|FG001|NOT COMPLETED|Treatment Period 3 (6 Days)||0
3187819|NCT02036775|3916096|FG002|NOT COMPLETED|Treatment Period 3 (6 Days)||0
3187820|NCT02036775|3916097|FG003|NOT COMPLETED|Treatment Period 3 (6 Days)||0
3187821|NCT02036775|3916098|FG004|NOT COMPLETED|Treatment Period 3 (6 Days)||0
3187822|NCT02036775|3916099|FG005|NOT COMPLETED|Treatment Period 3 (6 Days)||0
3187823|NCT02036840|3916107|FG000|STARTED|Overall Study||513
3187824|NCT02036840|3916107|FG000|COMPLETED|Overall Study||513
3187825|NCT02036840|3916107|FG000|NOT COMPLETED|Overall Study||0
3187826|NCT02036853|3916113|FG000|STARTED|Overall Study||6
3187827|NCT02036853|3916114|FG001|STARTED|Overall Study||14
3187828|NCT02036853|3916113|FG000|COMPLETED|Overall Study||6
3187829|NCT02036853|3916114|FG001|COMPLETED|Overall Study||8
3187830|NCT02036853|3916113|FG000|NOT COMPLETED|Overall Study||0
3187831|NCT02036853|3916114|FG001|NOT COMPLETED|Overall Study||6
3187832|NCT02037061|3916122|FG000|STARTED|Overall Study||22
3187833|NCT02037061|3916123|FG001|STARTED|Overall Study||24
3187834|NCT02037061|3916122|FG000|COMPLETED|Overall Study||22
3187835|NCT02037061|3916123|FG001|COMPLETED|Overall Study||24
3187836|NCT02037061|3916122|FG000|NOT COMPLETED|Overall Study||0
3187837|NCT02037061|3916123|FG001|NOT COMPLETED|Overall Study||0
3187838|NCT02037165|3916136|FG000|STARTED|Period 1 (2 Days)|randomized subjects|5
3187839|NCT02037165|3916137|FG001|STARTED|Period 1 (2 Days)|randomized subjects|5
3187840|NCT02037165|3916138|FG002|STARTED|Period 1 (2 Days)|randomized subjects|5
3187841|NCT02037165|3916139|FG003|STARTED|Period 1 (2 Days)|randomized subjects|5
3187842|NCT02037165|3916140|FG004|STARTED|Period 1 (2 Days)|randomized subjects|5
3187843|NCT02037165|3916136|FG000|COMPLETED|Period 1 (2 Days)||5
3187844|NCT02037165|3916137|FG001|COMPLETED|Period 1 (2 Days)||5
3187845|NCT02037165|3916138|FG002|COMPLETED|Period 1 (2 Days)||5
3187846|NCT02037165|3916139|FG003|COMPLETED|Period 1 (2 Days)||5
3187847|NCT02037165|3916140|FG004|COMPLETED|Period 1 (2 Days)||5
3187848|NCT02037165|3916136|FG000|NOT COMPLETED|Period 1 (2 Days)||0
3187849|NCT02037165|3916137|FG001|NOT COMPLETED|Period 1 (2 Days)||0
3187850|NCT02037165|3916138|FG002|NOT COMPLETED|Period 1 (2 Days)||0
3187851|NCT02037165|3916139|FG003|NOT COMPLETED|Period 1 (2 Days)||0
3187852|NCT02037165|3916140|FG004|NOT COMPLETED|Period 1 (2 Days)||0
3187853|NCT02037165|3916136|FG000|STARTED|Washout Period 1 (6 Days)||5
3187854|NCT02037165|3916137|FG001|STARTED|Washout Period 1 (6 Days)||5
3187855|NCT02037165|3916138|FG002|STARTED|Washout Period 1 (6 Days)||5
3187856|NCT02037165|3916139|FG003|STARTED|Washout Period 1 (6 Days)||5
3187857|NCT02037165|3916140|FG004|STARTED|Washout Period 1 (6 Days)||5
3187858|NCT02037165|3916136|FG000|COMPLETED|Washout Period 1 (6 Days)||5
3187859|NCT02037165|3916137|FG001|COMPLETED|Washout Period 1 (6 Days)||5
3187860|NCT02037165|3916138|FG002|COMPLETED|Washout Period 1 (6 Days)||5
3187861|NCT02037165|3916139|FG003|COMPLETED|Washout Period 1 (6 Days)||5
3187862|NCT02037165|3916140|FG004|COMPLETED|Washout Period 1 (6 Days)||5
3187863|NCT02037165|3916136|FG000|NOT COMPLETED|Washout Period 1 (6 Days)||0
3187864|NCT02037165|3916137|FG001|NOT COMPLETED|Washout Period 1 (6 Days)||0
3187865|NCT02037165|3916138|FG002|NOT COMPLETED|Washout Period 1 (6 Days)||0
3187866|NCT02037165|3916139|FG003|NOT COMPLETED|Washout Period 1 (6 Days)||0
3187867|NCT02037165|3916140|FG004|NOT COMPLETED|Washout Period 1 (6 Days)||0
3187868|NCT02037165|3916136|FG000|STARTED|Period 2 (2 Days)||5
3187869|NCT02037165|3916137|FG001|STARTED|Period 2 (2 Days)||5
3187870|NCT02037165|3916138|FG002|STARTED|Period 2 (2 Days)||5
3187871|NCT02037165|3916139|FG003|STARTED|Period 2 (2 Days)||5
3187872|NCT02037165|3916140|FG004|STARTED|Period 2 (2 Days)||5
3187873|NCT02037165|3916136|FG000|COMPLETED|Period 2 (2 Days)||5
3187874|NCT02037165|3916137|FG001|COMPLETED|Period 2 (2 Days)||5
3187875|NCT02037165|3916138|FG002|COMPLETED|Period 2 (2 Days)||5
3187876|NCT02037165|3916139|FG003|COMPLETED|Period 2 (2 Days)||5
3187877|NCT02037165|3916140|FG004|COMPLETED|Period 2 (2 Days)||5
3187878|NCT02037165|3916136|FG000|NOT COMPLETED|Period 2 (2 Days)||0
3187879|NCT02037165|3916137|FG001|NOT COMPLETED|Period 2 (2 Days)||0
3187880|NCT02037165|3916138|FG002|NOT COMPLETED|Period 2 (2 Days)||0
3187881|NCT02037165|3916139|FG003|NOT COMPLETED|Period 2 (2 Days)||0
3187882|NCT02037165|3916140|FG004|NOT COMPLETED|Period 2 (2 Days)||0
3187883|NCT02037165|3916136|FG000|STARTED|Washout Period 2 (6 Days)||5
3187884|NCT02037165|3916137|FG001|STARTED|Washout Period 2 (6 Days)||5
3187885|NCT02037165|3916138|FG002|STARTED|Washout Period 2 (6 Days)||5
3187886|NCT02037165|3916139|FG003|STARTED|Washout Period 2 (6 Days)||5
3187887|NCT02037165|3916140|FG004|STARTED|Washout Period 2 (6 Days)||5
3187888|NCT02037165|3916136|FG000|COMPLETED|Washout Period 2 (6 Days)||5
3187889|NCT02037165|3916137|FG001|COMPLETED|Washout Period 2 (6 Days)||5
3187890|NCT02037165|3916138|FG002|COMPLETED|Washout Period 2 (6 Days)||5
3187891|NCT02037165|3916139|FG003|COMPLETED|Washout Period 2 (6 Days)||5
3187892|NCT02037165|3916140|FG004|COMPLETED|Washout Period 2 (6 Days)||5
3187893|NCT02037165|3916136|FG000|NOT COMPLETED|Washout Period 2 (6 Days)||0
3187894|NCT02037165|3916137|FG001|NOT COMPLETED|Washout Period 2 (6 Days)||0
3187895|NCT02037165|3916138|FG002|NOT COMPLETED|Washout Period 2 (6 Days)||0
3187896|NCT02037165|3916139|FG003|NOT COMPLETED|Washout Period 2 (6 Days)||0
3187897|NCT02037165|3916140|FG004|NOT COMPLETED|Washout Period 2 (6 Days)||0
3187898|NCT02037165|3916136|FG000|STARTED|Period 3 (2 Days)||5
3187899|NCT02037165|3916137|FG001|STARTED|Period 3 (2 Days)||5
3187900|NCT02037165|3916138|FG002|STARTED|Period 3 (2 Days)||5
3187901|NCT02037165|3916139|FG003|STARTED|Period 3 (2 Days)||5
3187902|NCT02037165|3916140|FG004|STARTED|Period 3 (2 Days)||5
3187903|NCT02037165|3916136|FG000|COMPLETED|Period 3 (2 Days)||5
3187904|NCT02037165|3916137|FG001|COMPLETED|Period 3 (2 Days)||5
3187905|NCT02037165|3916138|FG002|COMPLETED|Period 3 (2 Days)||5
3187906|NCT02037165|3916139|FG003|COMPLETED|Period 3 (2 Days)||5
3187907|NCT02037165|3916140|FG004|COMPLETED|Period 3 (2 Days)||5
3187908|NCT02037165|3916136|FG000|NOT COMPLETED|Period 3 (2 Days)||0
3187909|NCT02037165|3916137|FG001|NOT COMPLETED|Period 3 (2 Days)||0
3187910|NCT02037165|3916138|FG002|NOT COMPLETED|Period 3 (2 Days)||0
3187911|NCT02037165|3916139|FG003|NOT COMPLETED|Period 3 (2 Days)||0
3187912|NCT02037165|3916140|FG004|NOT COMPLETED|Period 3 (2 Days)||0
3187913|NCT02037165|3916136|FG000|STARTED|Washout Period 3 (6 Days)||5
3187914|NCT02037165|3916137|FG001|STARTED|Washout Period 3 (6 Days)||5
3187915|NCT02037165|3916138|FG002|STARTED|Washout Period 3 (6 Days)||5
3187916|NCT02037165|3916139|FG003|STARTED|Washout Period 3 (6 Days)||5
3187917|NCT02037165|3916140|FG004|STARTED|Washout Period 3 (6 Days)||5
3187918|NCT02037165|3916136|FG000|COMPLETED|Washout Period 3 (6 Days)||5
3187919|NCT02037165|3916137|FG001|COMPLETED|Washout Period 3 (6 Days)||5
3187920|NCT02037165|3916138|FG002|COMPLETED|Washout Period 3 (6 Days)||5
3187921|NCT02037165|3916139|FG003|COMPLETED|Washout Period 3 (6 Days)||5
3187922|NCT02037165|3916140|FG004|COMPLETED|Washout Period 3 (6 Days)||5
3187923|NCT02037165|3916136|FG000|NOT COMPLETED|Washout Period 3 (6 Days)||0
3187924|NCT02037165|3916137|FG001|NOT COMPLETED|Washout Period 3 (6 Days)||0
3187925|NCT02037165|3916138|FG002|NOT COMPLETED|Washout Period 3 (6 Days)||0
3187926|NCT02037165|3916139|FG003|NOT COMPLETED|Washout Period 3 (6 Days)||0
3187927|NCT02037165|3916140|FG004|NOT COMPLETED|Washout Period 3 (6 Days)||0
3187928|NCT02037165|3916136|FG000|STARTED|Period 4 (2 Days)||5
3187929|NCT02037165|3916137|FG001|STARTED|Period 4 (2 Days)||5
3187930|NCT02037165|3916138|FG002|STARTED|Period 4 (2 Days)||5
3187931|NCT02037165|3916139|FG003|STARTED|Period 4 (2 Days)||5
3187932|NCT02037165|3916140|FG004|STARTED|Period 4 (2 Days)||5
3187933|NCT02037165|3916136|FG000|COMPLETED|Period 4 (2 Days)||5
3187934|NCT02037165|3916137|FG001|COMPLETED|Period 4 (2 Days)||5
3187935|NCT02037165|3916138|FG002|COMPLETED|Period 4 (2 Days)||5
3187936|NCT02037165|3916139|FG003|COMPLETED|Period 4 (2 Days)||5
3187937|NCT02037165|3916140|FG004|COMPLETED|Period 4 (2 Days)||5
3187938|NCT02037165|3916136|FG000|NOT COMPLETED|Period 4 (2 Days)||0
3187939|NCT02037165|3916137|FG001|NOT COMPLETED|Period 4 (2 Days)||0
3187940|NCT02037165|3916138|FG002|NOT COMPLETED|Period 4 (2 Days)||0
3187941|NCT02037165|3916139|FG003|NOT COMPLETED|Period 4 (2 Days)||0
3187942|NCT02037165|3916140|FG004|NOT COMPLETED|Period 4 (2 Days)||0
3187943|NCT02037165|3916136|FG000|STARTED|Washout Period 4 (6 Days)||5
3187944|NCT02037165|3916137|FG001|STARTED|Washout Period 4 (6 Days)||5
3187945|NCT02037165|3916138|FG002|STARTED|Washout Period 4 (6 Days)||5
3187946|NCT02037165|3916139|FG003|STARTED|Washout Period 4 (6 Days)||5
3187947|NCT02037165|3916140|FG004|STARTED|Washout Period 4 (6 Days)||5
3187948|NCT02037165|3916136|FG000|COMPLETED|Washout Period 4 (6 Days)||5
3187949|NCT02037165|3916137|FG001|COMPLETED|Washout Period 4 (6 Days)||5
3187950|NCT02037165|3916138|FG002|COMPLETED|Washout Period 4 (6 Days)||5
3187951|NCT02037165|3916139|FG003|COMPLETED|Washout Period 4 (6 Days)||5
3187952|NCT02037165|3916140|FG004|COMPLETED|Washout Period 4 (6 Days)||4
3187953|NCT02037165|3916136|FG000|NOT COMPLETED|Washout Period 4 (6 Days)||0
3187954|NCT02037165|3916137|FG001|NOT COMPLETED|Washout Period 4 (6 Days)||0
3187955|NCT02037165|3916138|FG002|NOT COMPLETED|Washout Period 4 (6 Days)||0
3187956|NCT02037165|3916139|FG003|NOT COMPLETED|Washout Period 4 (6 Days)||0
3187957|NCT02037165|3916140|FG004|NOT COMPLETED|Washout Period 4 (6 Days)||1
3187958|NCT02037165|3916136|FG000|STARTED|Period 5 (2 Days)||5
3187959|NCT02037165|3916137|FG001|STARTED|Period 5 (2 Days)||5
3187960|NCT02037165|3916138|FG002|STARTED|Period 5 (2 Days)||5
3187961|NCT02037165|3916139|FG003|STARTED|Period 5 (2 Days)||5
3187962|NCT02037165|3916140|FG004|STARTED|Period 5 (2 Days)||4
3187963|NCT02037165|3916136|FG000|COMPLETED|Period 5 (2 Days)||5
3187964|NCT02037165|3916137|FG001|COMPLETED|Period 5 (2 Days)||5
3187965|NCT02037165|3916138|FG002|COMPLETED|Period 5 (2 Days)||5
3187966|NCT02037165|3916139|FG003|COMPLETED|Period 5 (2 Days)||5
3187967|NCT02037165|3916140|FG004|COMPLETED|Period 5 (2 Days)||4
3187968|NCT02037165|3916136|FG000|NOT COMPLETED|Period 5 (2 Days)||0
3187969|NCT02037165|3916137|FG001|NOT COMPLETED|Period 5 (2 Days)||0
3187970|NCT02037165|3916138|FG002|NOT COMPLETED|Period 5 (2 Days)||0
3187971|NCT02037165|3916139|FG003|NOT COMPLETED|Period 5 (2 Days)||0
3187972|NCT02037165|3916140|FG004|NOT COMPLETED|Period 5 (2 Days)||0
3187973|NCT02037204|3916156|FG000|STARTED|Overall Study||35
3187974|NCT02037204|3916156|FG000|COMPLETED|Overall Study||35
3187975|NCT02037204|3916156|FG000|NOT COMPLETED|Overall Study||0
3187976|NCT02037230|3916165|FG000|STARTED|Overall Study||1
3187977|NCT02037230|3916166|FG001|STARTED|Overall Study||13
3187978|NCT02037230|3916167|FG002|STARTED|Overall Study||9
3187979|NCT02037230|3916168|FG003|STARTED|Overall Study||11
3187980|NCT02037230|3916165|FG000|Completed 4 Cycles of Treatment|Overall Study||1
3187981|NCT02037230|3916166|FG001|Completed 4 Cycles of Treatment|Overall Study||9
3187982|NCT02037230|3916167|FG002|Completed 4 Cycles of Treatment|Overall Study||7
3187983|NCT02037230|3916168|FG003|Completed 4 Cycles of Treatment|Overall Study||9
3187984|NCT02037230|3916165|FG000|COMPLETED|Overall Study||0
3187985|NCT02037230|3916166|FG001|COMPLETED|Overall Study||7
3187986|NCT02037230|3916167|FG002|COMPLETED|Overall Study||3
3187987|NCT02037230|3916168|FG003|COMPLETED|Overall Study||5
3187988|NCT02037230|3916165|FG000|NOT COMPLETED|Overall Study||1
3187989|NCT02037230|3916166|FG001|NOT COMPLETED|Overall Study||6
3187990|NCT02037230|3916167|FG002|NOT COMPLETED|Overall Study||6
3187991|NCT02037230|3916168|FG003|NOT COMPLETED|Overall Study||6
3187992|NCT02037256|3916181|FG000|STARTED|Overall Study||3
3187993|NCT02037256|3916182|FG001|STARTED|Overall Study||20
3187994|NCT02037256|3916181|FG000|COMPLETED|Overall Study||3
3187995|NCT02037256|3916182|FG001|COMPLETED|Overall Study||17
3187996|NCT02037256|3916181|FG000|NOT COMPLETED|Overall Study||0
3187997|NCT02037256|3916182|FG001|NOT COMPLETED|Overall Study||3
3187998|NCT02037295|3916194|FG000|STARTED|Phase 1: Crossover UF and OF||9
3187999|NCT02037295|3916195|FG001|STARTED|Phase 1: Crossover UF and OF||7
3188000|NCT02037295|3916196|FG002|STARTED|Phase 1: Crossover UF and OF||4
3188001|NCT02037295|3916197|FG003|STARTED|Phase 1: Crossover UF and OF||7
3188002|NCT02037295|3916194|FG000|COMPLETED|Phase 1: Crossover UF and OF||9
3188003|NCT02037295|3916195|FG001|COMPLETED|Phase 1: Crossover UF and OF||7
3188004|NCT02037295|3916196|FG002|COMPLETED|Phase 1: Crossover UF and OF||4
3188005|NCT02037295|3916197|FG003|COMPLETED|Phase 1: Crossover UF and OF||7
3188006|NCT02037295|3916194|FG000|NOT COMPLETED|Phase 1: Crossover UF and OF||0
3188007|NCT02037295|3916195|FG001|NOT COMPLETED|Phase 1: Crossover UF and OF||0
3188008|NCT02037295|3916196|FG002|NOT COMPLETED|Phase 1: Crossover UF and OF||0
3188009|NCT02037295|3916197|FG003|NOT COMPLETED|Phase 1: Crossover UF and OF||0
3188010|NCT02037295|3916194|FG000|STARTED|Phase 2: Vancomycin and Placebo||9
3188011|NCT02037295|3916195|FG001|STARTED|Phase 2: Vancomycin and Placebo||7
3188012|NCT02037295|3916196|FG002|STARTED|Phase 2: Vancomycin and Placebo||4
3188013|NCT02037295|3916197|FG003|STARTED|Phase 2: Vancomycin and Placebo||7
3188014|NCT02037295|3916194|FG000|COMPLETED|Phase 2: Vancomycin and Placebo||8
3188015|NCT02037295|3916195|FG001|COMPLETED|Phase 2: Vancomycin and Placebo||7
3188016|NCT02037295|3916196|FG002|COMPLETED|Phase 2: Vancomycin and Placebo||4
3188017|NCT02037295|3916197|FG003|COMPLETED|Phase 2: Vancomycin and Placebo||6
3188018|NCT02037295|3916194|FG000|NOT COMPLETED|Phase 2: Vancomycin and Placebo||1
3188019|NCT02037295|3916195|FG001|NOT COMPLETED|Phase 2: Vancomycin and Placebo||0
3188020|NCT02037295|3916196|FG002|NOT COMPLETED|Phase 2: Vancomycin and Placebo||0
3188021|NCT02037295|3916197|FG003|NOT COMPLETED|Phase 2: Vancomycin and Placebo||1
3188022|NCT02037347|3916209|FG000|STARTED|Overall Study||1
3188023|NCT02037347|3916209|FG000|COMPLETED|Overall Study||1
3188024|NCT02037347|3916209|FG000|NOT COMPLETED|Overall Study||0
3188025|NCT02037425|3916213|FG000|STARTED|Overall Study||44
3188026|NCT02037425|3916213|FG000|Randomized to Treatment|Overall Study||32
3188027|NCT02037425|3916213|FG000|COMPLETED|Overall Study||18
3188028|NCT02037425|3916213|FG000|NOT COMPLETED|Overall Study||26
3188029|NCT02037438|3916221|FG000|STARTED|Overall Study||920
3188030|NCT02037438|3916222|FG001|STARTED|Overall Study||916
3188031|NCT02037438|3916221|FG000|COMPLETED|Overall Study||574
3188032|NCT02037438|3916222|FG001|COMPLETED|Overall Study||561
3188033|NCT02037438|3916221|FG000|NOT COMPLETED|Overall Study||346
3188034|NCT02037438|3916222|FG001|NOT COMPLETED|Overall Study||355
3188035|NCT02037477|3916232|FG000|STARTED|Treatment Period 1||5
3188036|NCT02037477|3916233|FG001|STARTED|Treatment Period 1||5
3188037|NCT02037477|3916234|FG002|STARTED|Treatment Period 1||5
3188038|NCT02037477|3916235|FG003|STARTED|Treatment Period 1||5
3188039|NCT02037477|3916232|FG000|COMPLETED|Treatment Period 1||5
3188040|NCT02037477|3916233|FG001|COMPLETED|Treatment Period 1||5
3188041|NCT02037477|3916234|FG002|COMPLETED|Treatment Period 1||4
3188042|NCT02037477|3916235|FG003|COMPLETED|Treatment Period 1||5
3188043|NCT02037477|3916232|FG000|NOT COMPLETED|Treatment Period 1||0
3188044|NCT02037477|3916233|FG001|NOT COMPLETED|Treatment Period 1||0
3188045|NCT02037477|3916234|FG002|NOT COMPLETED|Treatment Period 1||1
3188046|NCT02037477|3916235|FG003|NOT COMPLETED|Treatment Period 1||0
3188047|NCT02037477|3916232|FG000|STARTED|Treatment Period 2||5
3188048|NCT02037477|3916233|FG001|STARTED|Treatment Period 2||5
3188049|NCT02037477|3916234|FG002|STARTED|Treatment Period 2||4
3188050|NCT02037477|3916235|FG003|STARTED|Treatment Period 2||5
3188051|NCT02037477|3916232|FG000|COMPLETED|Treatment Period 2||5
3188052|NCT02037477|3916233|FG001|COMPLETED|Treatment Period 2||5
3188053|NCT02037477|3916234|FG002|COMPLETED|Treatment Period 2||4
3188054|NCT02037477|3916235|FG003|COMPLETED|Treatment Period 2||5
3188055|NCT02037477|3916232|FG000|NOT COMPLETED|Treatment Period 2||0
3188056|NCT02037477|3916233|FG001|NOT COMPLETED|Treatment Period 2||0
3188057|NCT02037477|3916234|FG002|NOT COMPLETED|Treatment Period 2||0
3188058|NCT02037477|3916235|FG003|NOT COMPLETED|Treatment Period 2||0
3188059|NCT02037555|3916247|FG000|STARTED|Overall Study||213
3188060|NCT02037555|3916248|FG001|STARTED|Overall Study||212
3188061|NCT02037555|3916247|FG000|Dosed|Overall Study||201
3188062|NCT02037555|3916248|FG001|Dosed|Overall Study||198
3188063|NCT02037555|3916247|FG000|Dosed and Operated On|Overall Study||200
3188064|NCT02037555|3916248|FG001|Dosed and Operated On|Overall Study||196
3188065|NCT02037555|3916247|FG000|COMPLETED|Overall Study||190
3188066|NCT02037555|3916248|FG001|COMPLETED|Overall Study||191
3188067|NCT02037555|3916247|FG000|NOT COMPLETED|Overall Study||23
3188068|NCT02037555|3916248|FG001|NOT COMPLETED|Overall Study||21
3188069|NCT02037568|3916256|FG000|STARTED|Overall Study||83
3188070|NCT02037568|3916257|FG001|STARTED|Overall Study||76
3188071|NCT02037568|3916256|FG000|Month 1.5 (Post Transplantation)|Overall Study||79
3188072|NCT02037568|3916257|FG001|Month 1.5 (Post Transplantation)|Overall Study||76
3188073|NCT02037568|3916256|FG000|Month 3 (Post Transplantation)|Overall Study||66
3188074|NCT02037568|3916257|FG001|Month 3 (Post Transplantation)|Overall Study||62
3188075|NCT02037568|3916256|FG000|Month 6 (Post Transplantation)|Overall Study||63
3188076|NCT02037568|3916257|FG001|Month 6 (Post Transplantation)|Overall Study||52
3188077|NCT02037568|3916256|FG000|COMPLETED|Overall Study||47
3188078|NCT02037568|3916257|FG001|COMPLETED|Overall Study||37
3188079|NCT02037568|3916256|FG000|NOT COMPLETED|Overall Study||36
3188080|NCT02037568|3916257|FG001|NOT COMPLETED|Overall Study||39
3188081|NCT02037607|3916263|FG000|STARTED|Overall Study||100
3188082|NCT02037607|3916263|FG000|COMPLETED|Overall Study||91
3188083|NCT02037607|3916263|FG000|NOT COMPLETED|Overall Study||9
3188084|NCT02037776|3916269|FG000|STARTED|Overall Study||61
3188085|NCT02037776|3916270|FG001|STARTED|Overall Study||64
3188086|NCT02037776|3916269|FG000|COMPLETED|Overall Study||56
3188087|NCT02037776|3916270|FG001|COMPLETED|Overall Study||60
3188088|NCT02037776|3916269|FG000|NOT COMPLETED|Overall Study||5
3188089|NCT02037776|3916270|FG001|NOT COMPLETED|Overall Study||4
3188090|NCT02037893|3916280|FG000|STARTED|Overall Study||32
3188091|NCT02037893|3916281|FG001|STARTED|Overall Study||25
3188092|NCT02037893|3916282|FG002|STARTED|Overall Study||27
3188093|NCT02037893|3916283|FG003|STARTED|Overall Study||28
3188094|NCT02037893|3916280|FG000|COMPLETED|Overall Study||32
3188095|NCT02037893|3916281|FG001|COMPLETED|Overall Study||25
3188096|NCT02037893|3916282|FG002|COMPLETED|Overall Study||26
3188097|NCT02037893|3916283|FG003|COMPLETED|Overall Study||28
3188098|NCT02037893|3916280|FG000|NOT COMPLETED|Overall Study||0
3188099|NCT02037893|3916281|FG001|NOT COMPLETED|Overall Study||0
3188100|NCT02037893|3916282|FG002|NOT COMPLETED|Overall Study||1
3188101|NCT02037893|3916283|FG003|NOT COMPLETED|Overall Study||0
3188102|NCT02037984|3916301|FG000|STARTED|Overall Study||20
3188103|NCT02037984|3916302|FG001|STARTED|Overall Study||20
3188104|NCT02037984|3916303|FG002|STARTED|Overall Study||50
3188105|NCT02037984|3916304|FG003|STARTED|Overall Study||51
3188106|NCT02037984|3916305|FG004|STARTED|Overall Study||50
3188107|NCT02037984|3916306|FG005|STARTED|Overall Study||49
3364046|NCT04032977|4095225|FG000|COMPLETED|Overall Study||71
3364047|NCT04032977|4095226|FG001|COMPLETED|Overall Study||70
3364048|NCT04032977|4095225|FG000|NOT COMPLETED|Overall Study||9
3364049|NCT04032977|4095226|FG001|NOT COMPLETED|Overall Study||8
3364050|NCT04032652|4095234|FG000|STARTED|Overall Study||1
3364051|NCT04032652|4095235|FG001|STARTED|Overall Study||1
3364052|NCT04032652|4095234|FG000|COMPLETED|Overall Study||0
3364053|NCT04032652|4095235|FG001|COMPLETED|Overall Study||0
3364054|NCT04032652|4095234|FG000|NOT COMPLETED|Overall Study||1
3364055|NCT04032652|4095235|FG001|NOT COMPLETED|Overall Study||1
3364056|NCT04024501|4095241|FG000|STARTED|Overall Study||25
3364057|NCT04024501|4095241|FG000|COMPLETED|Overall Study||25
3364058|NCT04024501|4095241|FG000|NOT COMPLETED|Overall Study||0
3364059|NCT04032613|4095255|FG000|STARTED|Overall Study||21
3364060|NCT04032613|4095256|FG001|STARTED|Overall Study||25
3364061|NCT04032613|4095255|FG000|COMPLETED|Overall Study||16
3364062|NCT04032613|4095256|FG001|COMPLETED|Overall Study||23
3364063|NCT04032613|4095255|FG000|NOT COMPLETED|Overall Study||5
3364064|NCT04032613|4095256|FG001|NOT COMPLETED|Overall Study||2
3364065|NCT04032171|4095264|FG000|STARTED|Overall Study||1
3364066|NCT04032171|4095265|FG001|STARTED|Overall Study||0
3364067|NCT04032171|4095264|FG000|COMPLETED|Overall Study||0
3364068|NCT04032171|4095265|FG001|COMPLETED|Overall Study||0
3364069|NCT04032171|4095264|FG000|NOT COMPLETED|Overall Study||1
3364070|NCT04032171|4095265|FG001|NOT COMPLETED|Overall Study||0
3364071|NCT04032158|4095273|FG000|STARTED|Overall Study||2
3364072|NCT04032158|4095274|FG001|STARTED|Overall Study||1
3364073|NCT04032158|4095273|FG000|COMPLETED|Overall Study||0
3364074|NCT04032158|4095274|FG001|COMPLETED|Overall Study||0
3364075|NCT04032158|4095273|FG000|NOT COMPLETED|Overall Study||2
3364076|NCT04032158|4095274|FG001|NOT COMPLETED|Overall Study||1
3364077|NCT04031404|4095280|FG000|STARTED|Baseline||10
3364078|NCT04031404|4095281|FG001|STARTED|Baseline||13
3364079|NCT04031404|4095280|FG000|COMPLETED|Baseline||8
3364080|NCT04031404|4095281|FG001|COMPLETED|Baseline||8
3364081|NCT04031404|4095280|FG000|NOT COMPLETED|Baseline||2
3364082|NCT04031404|4095281|FG001|NOT COMPLETED|Baseline||5
3364083|NCT04031404|4095280|FG000|STARTED|Pre-randomization||8
3364084|NCT04031404|4095281|FG001|STARTED|Pre-randomization||8
3364085|NCT04031404|4095280|FG000|COMPLETED|Pre-randomization||6
3364086|NCT04031404|4095281|FG001|COMPLETED|Pre-randomization||5
3364087|NCT04031404|4095280|FG000|NOT COMPLETED|Pre-randomization||2
3364088|NCT04031404|4095281|FG001|NOT COMPLETED|Pre-randomization||3
3364089|NCT04031404|4095280|FG000|STARTED|First Drink Visit||6
3364090|NCT04031404|4095281|FG001|STARTED|First Drink Visit||5
3364091|NCT04031404|4095280|FG000|COMPLETED|First Drink Visit||6
3364092|NCT04031404|4095281|FG001|COMPLETED|First Drink Visit||5
3188108|NCT02037984|3916307|FG006|STARTED|Overall Study||50
3188109|NCT02037984|3916308|FG007|STARTED|Overall Study||51
3188110|NCT02037984|3916301|FG000|COMPLETED|Overall Study||19
3188111|NCT02037984|3916302|FG001|COMPLETED|Overall Study||20
3188112|NCT02037984|3916303|FG002|COMPLETED|Overall Study||38
3188113|NCT02037984|3916304|FG003|COMPLETED|Overall Study||30
3188114|NCT02037984|3916305|FG004|COMPLETED|Overall Study||38
3188115|NCT02037984|3916306|FG005|COMPLETED|Overall Study||37
3188116|NCT02037984|3916307|FG006|COMPLETED|Overall Study||33
3188117|NCT02037984|3916308|FG007|COMPLETED|Overall Study||39
3188118|NCT02037984|3916301|FG000|NOT COMPLETED|Overall Study||1
3188119|NCT02037984|3916302|FG001|NOT COMPLETED|Overall Study||0
3188120|NCT02037984|3916303|FG002|NOT COMPLETED|Overall Study||12
3188121|NCT02037984|3916304|FG003|NOT COMPLETED|Overall Study||21
3188122|NCT02037984|3916305|FG004|NOT COMPLETED|Overall Study||12
3188123|NCT02037984|3916306|FG005|NOT COMPLETED|Overall Study||12
3188124|NCT02037984|3916307|FG006|NOT COMPLETED|Overall Study||17
3188125|NCT02037984|3916308|FG007|NOT COMPLETED|Overall Study||12
3188126|NCT02038010|3916336|FG000|STARTED|Completed 1st Cycle and Started Cycle 2||11
3188127|NCT02038010|3916337|FG001|STARTED|Completed 1st Cycle and Started Cycle 2||6
3188128|NCT02038010|3916338|FG002|STARTED|Completed 1st Cycle and Started Cycle 2|Due to safety data, dose was de-escalated and no patients enrolled at this dose.|0
3188129|NCT02038010|3916339|FG003|STARTED|Completed 1st Cycle and Started Cycle 2|Due to safety data, dose was de-escalated and no patients enrolled at this dose.|0
3188130|NCT02038010|3916336|FG000|Completed 1st Cycle|Completed 1st Cycle and Started Cycle 2||11
3188131|NCT02038010|3916337|FG001|Completed 1st Cycle|Completed 1st Cycle and Started Cycle 2||5
3188132|NCT02038010|3916338|FG002|Completed 1st Cycle|Completed 1st Cycle and Started Cycle 2||0
3188133|NCT02038010|3916339|FG003|Completed 1st Cycle|Completed 1st Cycle and Started Cycle 2||0
3188134|NCT02038010|3916336|FG000|Continued on to Cycle 2|Completed 1st Cycle and Started Cycle 2||10
3188135|NCT02038010|3916337|FG001|Continued on to Cycle 2|Completed 1st Cycle and Started Cycle 2||4
3188136|NCT02038010|3916338|FG002|Continued on to Cycle 2|Completed 1st Cycle and Started Cycle 2||0
3188137|NCT02038010|3916339|FG003|Continued on to Cycle 2|Completed 1st Cycle and Started Cycle 2||0
3188138|NCT02038010|3916336|FG000|COMPLETED|Completed 1st Cycle and Started Cycle 2||10
3188139|NCT02038010|3916337|FG001|COMPLETED|Completed 1st Cycle and Started Cycle 2||4
3188140|NCT02038010|3916338|FG002|COMPLETED|Completed 1st Cycle and Started Cycle 2||0
3188141|NCT02038010|3916339|FG003|COMPLETED|Completed 1st Cycle and Started Cycle 2||0
3188142|NCT02038010|3916336|FG000|NOT COMPLETED|Completed 1st Cycle and Started Cycle 2||1
3188143|NCT02038010|3916337|FG001|NOT COMPLETED|Completed 1st Cycle and Started Cycle 2||2
3188144|NCT02038010|3916338|FG002|NOT COMPLETED|Completed 1st Cycle and Started Cycle 2||0
3188145|NCT02038010|3916339|FG003|NOT COMPLETED|Completed 1st Cycle and Started Cycle 2||0
3188146|NCT02038010|3916336|FG000|STARTED|Completed 3 Cycles/Reached 1st Response||10
3188147|NCT02038010|3916337|FG001|STARTED|Completed 3 Cycles/Reached 1st Response||4
3188148|NCT02038010|3916338|FG002|STARTED|Completed 3 Cycles/Reached 1st Response||0
3188149|NCT02038010|3916339|FG003|STARTED|Completed 3 Cycles/Reached 1st Response||0
3188150|NCT02038010|3916336|FG000|Completed 3 Cycles|Completed 3 Cycles/Reached 1st Response||10
3188151|NCT02038010|3916337|FG001|Completed 3 Cycles|Completed 3 Cycles/Reached 1st Response||4
3188152|NCT02038010|3916338|FG002|Completed 3 Cycles|Completed 3 Cycles/Reached 1st Response||0
3188153|NCT02038010|3916339|FG003|Completed 3 Cycles|Completed 3 Cycles/Reached 1st Response||0
3188154|NCT02038010|3916336|FG000|Continued to Cycle 4|Completed 3 Cycles/Reached 1st Response||9
3188155|NCT02038010|3916337|FG001|Continued to Cycle 4|Completed 3 Cycles/Reached 1st Response||3
3188156|NCT02038010|3916338|FG002|Continued to Cycle 4|Completed 3 Cycles/Reached 1st Response||0
3188157|NCT02038010|3916339|FG003|Continued to Cycle 4|Completed 3 Cycles/Reached 1st Response||0
3188158|NCT02038010|3916336|FG000|COMPLETED|Completed 3 Cycles/Reached 1st Response||9
3188159|NCT02038010|3916337|FG001|COMPLETED|Completed 3 Cycles/Reached 1st Response||3
3188160|NCT02038010|3916338|FG002|COMPLETED|Completed 3 Cycles/Reached 1st Response||0
3188161|NCT02038010|3916339|FG003|COMPLETED|Completed 3 Cycles/Reached 1st Response||0
3188162|NCT02038010|3916336|FG000|NOT COMPLETED|Completed 3 Cycles/Reached 1st Response||1
3188163|NCT02038010|3916337|FG001|NOT COMPLETED|Completed 3 Cycles/Reached 1st Response||1
3188164|NCT02038010|3916338|FG002|NOT COMPLETED|Completed 3 Cycles/Reached 1st Response||0
3188165|NCT02038010|3916339|FG003|NOT COMPLETED|Completed 3 Cycles/Reached 1st Response||0
3188166|NCT02038010|3916336|FG000|STARTED|Follow Up||11
3188167|NCT02038010|3916337|FG001|STARTED|Follow Up||6
3188168|NCT02038010|3916338|FG002|STARTED|Follow Up||0
3188169|NCT02038010|3916339|FG003|STARTED|Follow Up||0
3188170|NCT02038010|3916336|FG000|COMPLETED|Follow Up||4
3188171|NCT02038010|3916337|FG001|COMPLETED|Follow Up||3
3188172|NCT02038010|3916338|FG002|COMPLETED|Follow Up||0
3188173|NCT02038010|3916339|FG003|COMPLETED|Follow Up||0
3188174|NCT02038010|3916336|FG000|NOT COMPLETED|Follow Up||7
3188175|NCT02038010|3916337|FG001|NOT COMPLETED|Follow Up||3
3188176|NCT02038010|3916338|FG002|NOT COMPLETED|Follow Up||0
3188177|NCT02038010|3916339|FG003|NOT COMPLETED|Follow Up||0
3188178|NCT02038023|3916347|FG000|STARTED|Overall Study||74
3188179|NCT02038023|3916347|FG000|COMPLETED|Overall Study||73
3188180|NCT02038023|3916347|FG000|NOT COMPLETED|Overall Study||1
3188181|NCT02038036|3916355|FG000|STARTED|Core Study||74
3188182|NCT02038036|3916356|FG001|STARTED|Core Study||75
3188183|NCT02038036|3916355|FG000|Full Analysis Set|Core Study||74
3188184|NCT02038036|3916356|FG001|Full Analysis Set|Core Study||75
3188185|NCT02038036|3916355|FG000|Crossover Set|Core Study||0
3188186|NCT02038036|3916356|FG001|Crossover Set|Core Study||58
3188187|NCT02038036|3916355|FG000|COMPLETED|Core Study||59
3188188|NCT02038036|3916356|FG001|COMPLETED|Core Study||61
3188189|NCT02038036|3916355|FG000|NOT COMPLETED|Core Study||15
3188190|NCT02038036|3916356|FG001|NOT COMPLETED|Core Study||14
3188191|NCT02038036|3916355|FG000|STARTED|Crossover Period||0
3188192|NCT02038036|3916356|FG001|STARTED|Crossover Period|58 participants were eligible to crossover to the ruxolitinib arm|58
3188193|NCT02038036|3916355|FG000|COMPLETED|Crossover Period||0
3188194|NCT02038036|3916356|FG001|COMPLETED|Crossover Period||38
3188195|NCT02038036|3916355|FG000|NOT COMPLETED|Crossover Period||0
3188196|NCT02038036|3916356|FG001|NOT COMPLETED|Crossover Period||20
3188197|NCT02038049|3916367|FG000|STARTED|Overall Study||4
3188198|NCT02038049|3916368|FG001|STARTED|Overall Study||4
3188199|NCT02038049|3916367|FG000|Pharmacodynamic (PD) Analysis Set|Overall Study||4
3188200|NCT02038049|3916368|FG001|Pharmacodynamic (PD) Analysis Set|Overall Study||4
3188201|NCT02038049|3916367|FG000|COMPLETED|Overall Study||3
3188202|NCT02038049|3916368|FG001|COMPLETED|Overall Study||4
3188203|NCT02038049|3916367|FG000|NOT COMPLETED|Overall Study||1
3188204|NCT02038049|3916368|FG001|NOT COMPLETED|Overall Study||0
3188205|NCT02038075|3916380|FG000|STARTED|Overall Study||76
3188206|NCT02038075|3916381|FG001|STARTED|Overall Study||76
3188207|NCT02038075|3916380|FG000|COMPLETED|Overall Study||73
3188208|NCT02038075|3916381|FG001|COMPLETED|Overall Study||76
3188209|NCT02038075|3916380|FG000|NOT COMPLETED|Overall Study||3
3188210|NCT02038075|3916381|FG001|NOT COMPLETED|Overall Study||0
3188211|NCT02038179|3916387|FG000|STARTED|Phase 1 (4 Weeks)||52
3188212|NCT02038179|3916388|FG001|STARTED|Phase 1 (4 Weeks)||47
3188213|NCT02038179|3916387|FG000|COMPLETED|Phase 1 (4 Weeks)||48
3188214|NCT02038179|3916388|FG001|COMPLETED|Phase 1 (4 Weeks)||42
3188215|NCT02038179|3916387|FG000|NOT COMPLETED|Phase 1 (4 Weeks)||4
3188216|NCT02038179|3916388|FG001|NOT COMPLETED|Phase 1 (4 Weeks)||5
3188217|NCT02038179|3916387|FG000|STARTED|Washout (2-4 Weeks)||48
3188218|NCT02038179|3916388|FG001|STARTED|Washout (2-4 Weeks)||42
3188219|NCT02038179|3916387|FG000|COMPLETED|Washout (2-4 Weeks)||46
3188220|NCT02038179|3916388|FG001|COMPLETED|Washout (2-4 Weeks)||40
3188221|NCT02038179|3916387|FG000|NOT COMPLETED|Washout (2-4 Weeks)||2
3188222|NCT02038179|3916388|FG001|NOT COMPLETED|Washout (2-4 Weeks)||2
3188223|NCT02038179|3916387|FG000|STARTED|Phase 2 (4 Weeks)||46
3188224|NCT02038179|3916388|FG001|STARTED|Phase 2 (4 Weeks)||40
3188225|NCT02038179|3916387|FG000|COMPLETED|Phase 2 (4 Weeks)||44
3188226|NCT02038179|3916388|FG001|COMPLETED|Phase 2 (4 Weeks)||38
3188227|NCT02038179|3916387|FG000|NOT COMPLETED|Phase 2 (4 Weeks)||2
3188228|NCT02038179|3916388|FG001|NOT COMPLETED|Phase 2 (4 Weeks)||2
3188229|NCT02038218|3916396|FG000|STARTED|Overall Study|Drug tolerated - Arm 1: No liver disease - 98.7 mg/m2. No alterations of liver functions.|22
3188230|NCT02038218|3916397|FG001|STARTED|Overall Study|Drug tolerated - Arm 2: liver involvement - 85.5 mg/m2. No alterations of liver functions.|7
3188231|NCT02038218|3916396|FG000|COMPLETED|Overall Study|22 patients are included in a publication in progress|22
3188232|NCT02038218|3916397|FG001|COMPLETED|Overall Study|5 patients are included in a publication in progress|7
3188233|NCT02038218|3916396|FG000|NOT COMPLETED|Overall Study||0
3188234|NCT02038218|3916397|FG001|NOT COMPLETED|Overall Study||0
3364093|NCT04031404|4095280|FG000|NOT COMPLETED|First Drink Visit||0
3364094|NCT04031404|4095281|FG001|NOT COMPLETED|First Drink Visit||0
3364095|NCT04031404|4095280|FG000|STARTED|Washout (5 Day Min)||6
3364096|NCT04031404|4095281|FG001|STARTED|Washout (5 Day Min)||5
3364097|NCT04031404|4095280|FG000|COMPLETED|Washout (5 Day Min)||5
3364098|NCT04031404|4095281|FG001|COMPLETED|Washout (5 Day Min)||5
3364099|NCT04031404|4095280|FG000|NOT COMPLETED|Washout (5 Day Min)||1
3364100|NCT04031404|4095281|FG001|NOT COMPLETED|Washout (5 Day Min)||0
3364101|NCT04031404|4095280|FG000|STARTED|Second Drink Visit||5
3364102|NCT04031404|4095281|FG001|STARTED|Second Drink Visit||5
3364103|NCT04031404|4095280|FG000|COMPLETED|Second Drink Visit||5
3364104|NCT04031404|4095281|FG001|COMPLETED|Second Drink Visit||5
3364105|NCT04031404|4095280|FG000|NOT COMPLETED|Second Drink Visit||0
3364106|NCT04031404|4095281|FG001|NOT COMPLETED|Second Drink Visit||0
3364107|NCT04031885|4095297|FG000|STARTED|Overall Study||1
3364108|NCT04031885|4095298|FG001|STARTED|Overall Study||3
3364109|NCT04031885|4095297|FG000|Received Any Quantity of Study Treatment|Overall Study||1
3364110|NCT04031885|4095298|FG001|Received Any Quantity of Study Treatment|Overall Study||1
3364111|NCT04031885|4095297|FG000|COMPLETED|Overall Study||1
3364112|NCT04031885|4095298|FG001|COMPLETED|Overall Study||3
3364113|NCT04031885|4095297|FG000|NOT COMPLETED|Overall Study||0
3364114|NCT04031885|4095298|FG001|NOT COMPLETED|Overall Study||0
3364115|NCT04018924|4095304|FG000|STARTED|Overall Study|The total number of participants is 90 and the patient is control of themselves.|90
3364116|NCT04018924|4095304|FG000|Standard Of Care Intervention|Overall Study||90
3364117|NCT04018924|4095304|FG000|EmoLED Intervention|Overall Study||90
3364118|NCT04018924|4095304|FG000|COMPLETED|Overall Study||84
3364119|NCT04018924|4095304|FG000|NOT COMPLETED|Overall Study||6
3364120|NCT04015440|4095310|FG000|STARTED|Overall Study||117
3364121|NCT04015440|4095311|FG001|STARTED|Overall Study||112
3364122|NCT04015440|4095310|FG000|COMPLETED|Overall Study||109
3364123|NCT04015440|4095311|FG001|COMPLETED|Overall Study||108
3364124|NCT04015440|4095310|FG000|NOT COMPLETED|Overall Study||8
3364125|NCT04015440|4095311|FG001|NOT COMPLETED|Overall Study||4
3364126|NCT04030104|4095317|FG000|STARTED|Overall Study||480
3364127|NCT04030104|4095317|FG000|COMPLETED|Overall Study||480
3364128|NCT04030104|4095317|FG000|NOT COMPLETED|Overall Study||0
3188235|NCT02038543|3916407|FG000|STARTED|Overall Study||7
3188236|NCT02038543|3916408|FG001|STARTED|Overall Study||4
3188237|NCT02038543|3916409|FG002|STARTED|Overall Study||8
3188238|NCT02038543|3916410|FG003|STARTED|Overall Study||3
3188239|NCT02038543|3916407|FG000|COMPLETED|Overall Study||7
3188240|NCT02038543|3916408|FG001|COMPLETED|Overall Study||4
3188241|NCT02038543|3916409|FG002|COMPLETED|Overall Study||8
3188242|NCT02038543|3916410|FG003|COMPLETED|Overall Study||1
3188243|NCT02038543|3916407|FG000|NOT COMPLETED|Overall Study||0
3188244|NCT02038543|3916408|FG001|NOT COMPLETED|Overall Study||0
3188245|NCT02038543|3916409|FG002|NOT COMPLETED|Overall Study||0
3188246|NCT02038543|3916410|FG003|NOT COMPLETED|Overall Study||2
3188247|NCT02038569|3916420|FG000|STARTED|Overall Study||107
3188248|NCT02038569|3916420|FG000|COMPLETED|Overall Study||102
3188249|NCT02038569|3916420|FG000|NOT COMPLETED|Overall Study||5
3188250|NCT02038647|3916427|FG000|STARTED|Overall Study||89
3188251|NCT02038647|3916428|FG001|STARTED|Overall Study||89
3188252|NCT02038647|3916427|FG000|COMPLETED|Overall Study||0
3188253|NCT02038647|3916428|FG001|COMPLETED|Overall Study||0
3188254|NCT02038647|3916427|FG000|NOT COMPLETED|Overall Study||89
3188255|NCT02038647|3916428|FG001|NOT COMPLETED|Overall Study||89
3188256|NCT02038764|3916439|FG000|STARTED|Overall Study||7
3188257|NCT02038764|3916440|FG001|STARTED|Overall Study||8
3188258|NCT02038764|3916441|FG002|STARTED|Overall Study||9
3188259|NCT02038764|3916442|FG003|STARTED|Overall Study||5
3188260|NCT02038764|3916443|FG004|STARTED|Overall Study||8
3188261|NCT02038764|3916439|FG000|COMPLETED|Overall Study||6
3188262|NCT02038764|3916440|FG001|COMPLETED|Overall Study||7
3188263|NCT02038764|3916441|FG002|COMPLETED|Overall Study||7
3188264|NCT02038764|3916442|FG003|COMPLETED|Overall Study||5
3188265|NCT02038764|3916443|FG004|COMPLETED|Overall Study||7
3188266|NCT02038764|3916439|FG000|NOT COMPLETED|Overall Study||1
3188267|NCT02038764|3916440|FG001|NOT COMPLETED|Overall Study||1
3188268|NCT02038764|3916441|FG002|NOT COMPLETED|Overall Study||2
3188269|NCT02038764|3916442|FG003|NOT COMPLETED|Overall Study||0
3188270|NCT02038764|3916443|FG004|NOT COMPLETED|Overall Study||1
3188271|NCT02038790|3916459|FG000|STARTED|Day 0 - First Treatment||16
3188272|NCT02038790|3916460|FG001|STARTED|Day 0 - First Treatment||17
3188273|NCT02038790|3916459|FG000|COMPLETED|Day 0 - First Treatment||15
3188274|NCT02038790|3916460|FG001|COMPLETED|Day 0 - First Treatment||16
3188275|NCT02038790|3916459|FG000|NOT COMPLETED|Day 0 - First Treatment||1
3188276|NCT02038790|3916460|FG001|NOT COMPLETED|Day 0 - First Treatment||1
3188277|NCT02038790|3916459|FG000|STARTED|Day 1 - Second Treatment||15
3188278|NCT02038790|3916460|FG001|STARTED|Day 1 - Second Treatment||16
3188279|NCT02038790|3916459|FG000|COMPLETED|Day 1 - Second Treatment||15
3188280|NCT02038790|3916460|FG001|COMPLETED|Day 1 - Second Treatment||16
3188281|NCT02038790|3916459|FG000|NOT COMPLETED|Day 1 - Second Treatment||0
3188282|NCT02038790|3916460|FG001|NOT COMPLETED|Day 1 - Second Treatment||0
3188283|NCT02038829|3916467|FG000|STARTED|Treatment Period 1||8
3188284|NCT02038829|3916468|FG001|STARTED|Treatment Period 1||8
3188285|NCT02038829|3916469|FG002|STARTED|Treatment Period 1||8
3188286|NCT02038829|3916470|FG003|STARTED|Treatment Period 1||8
3188287|NCT02038829|3916471|FG004|STARTED|Treatment Period 1||8
3188288|NCT02038829|3916472|FG005|STARTED|Treatment Period 1||8
3188289|NCT02038829|3916473|FG006|STARTED|Treatment Period 1||8
3188290|NCT02038829|3916474|FG007|STARTED|Treatment Period 1||8
3188291|NCT02038829|3916475|FG008|STARTED|Treatment Period 1||8
3188292|NCT02038829|3916476|FG009|STARTED|Treatment Period 1||8
3188293|NCT02038829|3916477|FG010|STARTED|Treatment Period 1||8
3188294|NCT02038829|3916478|FG011|STARTED|Treatment Period 1||8
3188295|NCT02038829|3916467|FG000|COMPLETED|Treatment Period 1||8
3188296|NCT02038829|3916468|FG001|COMPLETED|Treatment Period 1||8
3188297|NCT02038829|3916469|FG002|COMPLETED|Treatment Period 1||8
3188298|NCT02038829|3916470|FG003|COMPLETED|Treatment Period 1||8
3188299|NCT02038829|3916471|FG004|COMPLETED|Treatment Period 1||8
3188300|NCT02038829|3916472|FG005|COMPLETED|Treatment Period 1||8
3188301|NCT02038829|3916473|FG006|COMPLETED|Treatment Period 1||8
3188302|NCT02038829|3916474|FG007|COMPLETED|Treatment Period 1||8
3188303|NCT02038829|3916475|FG008|COMPLETED|Treatment Period 1||8
3188304|NCT02038829|3916476|FG009|COMPLETED|Treatment Period 1||8
3188305|NCT02038829|3916477|FG010|COMPLETED|Treatment Period 1||8
3188306|NCT02038829|3916478|FG011|COMPLETED|Treatment Period 1||8
3188307|NCT02038829|3916467|FG000|NOT COMPLETED|Treatment Period 1||0
3188308|NCT02038829|3916468|FG001|NOT COMPLETED|Treatment Period 1||0
3188309|NCT02038829|3916469|FG002|NOT COMPLETED|Treatment Period 1||0
3188310|NCT02038829|3916470|FG003|NOT COMPLETED|Treatment Period 1||0
3188311|NCT02038829|3916471|FG004|NOT COMPLETED|Treatment Period 1||0
3188312|NCT02038829|3916472|FG005|NOT COMPLETED|Treatment Period 1||0
3188313|NCT02038829|3916473|FG006|NOT COMPLETED|Treatment Period 1||0
3188314|NCT02038829|3916474|FG007|NOT COMPLETED|Treatment Period 1||0
3188315|NCT02038829|3916475|FG008|NOT COMPLETED|Treatment Period 1||0
3188316|NCT02038829|3916476|FG009|NOT COMPLETED|Treatment Period 1||0
3188317|NCT02038829|3916477|FG010|NOT COMPLETED|Treatment Period 1||0
3188318|NCT02038829|3916478|FG011|NOT COMPLETED|Treatment Period 1||0
3188319|NCT02038829|3916467|FG000|STARTED|Washout Period 1||8
3188320|NCT02038829|3916468|FG001|STARTED|Washout Period 1||8
3188321|NCT02038829|3916469|FG002|STARTED|Washout Period 1||8
3188322|NCT02038829|3916470|FG003|STARTED|Washout Period 1||8
3188323|NCT02038829|3916471|FG004|STARTED|Washout Period 1||8
3188324|NCT02038829|3916472|FG005|STARTED|Washout Period 1||8
3188325|NCT02038829|3916473|FG006|STARTED|Washout Period 1||8
3188326|NCT02038829|3916474|FG007|STARTED|Washout Period 1||8
3188327|NCT02038829|3916475|FG008|STARTED|Washout Period 1||8
3188328|NCT02038829|3916476|FG009|STARTED|Washout Period 1||8
3188329|NCT02038829|3916477|FG010|STARTED|Washout Period 1||8
3188330|NCT02038829|3916478|FG011|STARTED|Washout Period 1||8
3188331|NCT02038829|3916467|FG000|COMPLETED|Washout Period 1||8
3188332|NCT02038829|3916468|FG001|COMPLETED|Washout Period 1||8
3188333|NCT02038829|3916469|FG002|COMPLETED|Washout Period 1||8
3188334|NCT02038829|3916470|FG003|COMPLETED|Washout Period 1||8
3188335|NCT02038829|3916471|FG004|COMPLETED|Washout Period 1||7
3188336|NCT02038829|3916472|FG005|COMPLETED|Washout Period 1||8
3188337|NCT02038829|3916473|FG006|COMPLETED|Washout Period 1||8
3188338|NCT02038829|3916474|FG007|COMPLETED|Washout Period 1||8
3188339|NCT02038829|3916475|FG008|COMPLETED|Washout Period 1||8
3188340|NCT02038829|3916476|FG009|COMPLETED|Washout Period 1||8
3188341|NCT02038829|3916477|FG010|COMPLETED|Washout Period 1||8
3188342|NCT02038829|3916478|FG011|COMPLETED|Washout Period 1||8
3188343|NCT02038829|3916467|FG000|NOT COMPLETED|Washout Period 1||0
3188344|NCT02038829|3916468|FG001|NOT COMPLETED|Washout Period 1||0
3188345|NCT02038829|3916469|FG002|NOT COMPLETED|Washout Period 1||0
3188346|NCT02038829|3916470|FG003|NOT COMPLETED|Washout Period 1||0
3188347|NCT02038829|3916471|FG004|NOT COMPLETED|Washout Period 1||1
3188348|NCT02038829|3916472|FG005|NOT COMPLETED|Washout Period 1||0
3188349|NCT02038829|3916473|FG006|NOT COMPLETED|Washout Period 1||0
3188350|NCT02038829|3916474|FG007|NOT COMPLETED|Washout Period 1||0
3188351|NCT02038829|3916475|FG008|NOT COMPLETED|Washout Period 1||0
3188352|NCT02038829|3916476|FG009|NOT COMPLETED|Washout Period 1||0
3188353|NCT02038829|3916477|FG010|NOT COMPLETED|Washout Period 1||0
3188354|NCT02038829|3916478|FG011|NOT COMPLETED|Washout Period 1||0
3188355|NCT02038829|3916467|FG000|STARTED|Treatment Period 2||8
3188356|NCT02038829|3916468|FG001|STARTED|Treatment Period 2||8
3188357|NCT02038829|3916469|FG002|STARTED|Treatment Period 2||8
3188358|NCT02038829|3916470|FG003|STARTED|Treatment Period 2||8
3188359|NCT02038829|3916471|FG004|STARTED|Treatment Period 2||7
3188360|NCT02038829|3916472|FG005|STARTED|Treatment Period 2||8
3188361|NCT02038829|3916473|FG006|STARTED|Treatment Period 2||8
3188362|NCT02038829|3916474|FG007|STARTED|Treatment Period 2||8
3188363|NCT02038829|3916475|FG008|STARTED|Treatment Period 2||8
3188364|NCT02038829|3916476|FG009|STARTED|Treatment Period 2||8
3188365|NCT02038829|3916477|FG010|STARTED|Treatment Period 2||8
3188366|NCT02038829|3916478|FG011|STARTED|Treatment Period 2||8
3188367|NCT02038829|3916467|FG000|COMPLETED|Treatment Period 2||7
3188368|NCT02038829|3916468|FG001|COMPLETED|Treatment Period 2||8
3188369|NCT02038829|3916469|FG002|COMPLETED|Treatment Period 2||8
3188370|NCT02038829|3916470|FG003|COMPLETED|Treatment Period 2||8
3188371|NCT02038829|3916471|FG004|COMPLETED|Treatment Period 2||7
3188372|NCT02038829|3916472|FG005|COMPLETED|Treatment Period 2||8
3188373|NCT02038829|3916473|FG006|COMPLETED|Treatment Period 2||8
3188374|NCT02038829|3916474|FG007|COMPLETED|Treatment Period 2||8
3188375|NCT02038829|3916475|FG008|COMPLETED|Treatment Period 2||8
3188376|NCT02038829|3916476|FG009|COMPLETED|Treatment Period 2||8
3188377|NCT02038829|3916477|FG010|COMPLETED|Treatment Period 2||7
3188378|NCT02038829|3916478|FG011|COMPLETED|Treatment Period 2||8
3188379|NCT02038829|3916467|FG000|NOT COMPLETED|Treatment Period 2||1
3188380|NCT02038829|3916468|FG001|NOT COMPLETED|Treatment Period 2||0
3188381|NCT02038829|3916469|FG002|NOT COMPLETED|Treatment Period 2||0
3188382|NCT02038829|3916470|FG003|NOT COMPLETED|Treatment Period 2||0
3188383|NCT02038829|3916471|FG004|NOT COMPLETED|Treatment Period 2||0
3188384|NCT02038829|3916472|FG005|NOT COMPLETED|Treatment Period 2||0
3188385|NCT02038829|3916473|FG006|NOT COMPLETED|Treatment Period 2||0
3188386|NCT02038829|3916474|FG007|NOT COMPLETED|Treatment Period 2||0
3188387|NCT02038829|3916475|FG008|NOT COMPLETED|Treatment Period 2||0
3188388|NCT02038829|3916476|FG009|NOT COMPLETED|Treatment Period 2||0
3188389|NCT02038829|3916477|FG010|NOT COMPLETED|Treatment Period 2||1
3188390|NCT02038829|3916478|FG011|NOT COMPLETED|Treatment Period 2||0
3188391|NCT02038829|3916467|FG000|STARTED|Washout Period 2||7
3188392|NCT02038829|3916468|FG001|STARTED|Washout Period 2||8
3188393|NCT02038829|3916469|FG002|STARTED|Washout Period 2||8
3188394|NCT02038829|3916470|FG003|STARTED|Washout Period 2||8
3188395|NCT02038829|3916471|FG004|STARTED|Washout Period 2||7
3188396|NCT02038829|3916472|FG005|STARTED|Washout Period 2||8
3188397|NCT02038829|3916473|FG006|STARTED|Washout Period 2||8
3188398|NCT02038829|3916474|FG007|STARTED|Washout Period 2||8
3188399|NCT02038829|3916475|FG008|STARTED|Washout Period 2||8
3188400|NCT02038829|3916476|FG009|STARTED|Washout Period 2||8
3188401|NCT02038829|3916477|FG010|STARTED|Washout Period 2||7
3188402|NCT02038829|3916478|FG011|STARTED|Washout Period 2||8
3188403|NCT02038829|3916467|FG000|COMPLETED|Washout Period 2||7
3188404|NCT02038829|3916468|FG001|COMPLETED|Washout Period 2||8
3188405|NCT02038829|3916469|FG002|COMPLETED|Washout Period 2||8
3188406|NCT02038829|3916470|FG003|COMPLETED|Washout Period 2||8
3188407|NCT02038829|3916471|FG004|COMPLETED|Washout Period 2||7
3188408|NCT02038829|3916472|FG005|COMPLETED|Washout Period 2||7
3188409|NCT02038829|3916473|FG006|COMPLETED|Washout Period 2||8
3188410|NCT02038829|3916474|FG007|COMPLETED|Washout Period 2||8
3188411|NCT02038829|3916475|FG008|COMPLETED|Washout Period 2||7
3188412|NCT02038829|3916476|FG009|COMPLETED|Washout Period 2||8
3188413|NCT02038829|3916477|FG010|COMPLETED|Washout Period 2||7
3188414|NCT02038829|3916478|FG011|COMPLETED|Washout Period 2||8
3188415|NCT02038829|3916467|FG000|NOT COMPLETED|Washout Period 2||0
3188416|NCT02038829|3916468|FG001|NOT COMPLETED|Washout Period 2||0
3188417|NCT02038829|3916469|FG002|NOT COMPLETED|Washout Period 2||0
3188418|NCT02038829|3916470|FG003|NOT COMPLETED|Washout Period 2||0
3188419|NCT02038829|3916471|FG004|NOT COMPLETED|Washout Period 2||0
3188420|NCT02038829|3916472|FG005|NOT COMPLETED|Washout Period 2||1
3188421|NCT02038829|3916473|FG006|NOT COMPLETED|Washout Period 2||0
3188422|NCT02038829|3916474|FG007|NOT COMPLETED|Washout Period 2||0
3188423|NCT02038829|3916475|FG008|NOT COMPLETED|Washout Period 2||1
3188424|NCT02038829|3916476|FG009|NOT COMPLETED|Washout Period 2||0
3188425|NCT02038829|3916477|FG010|NOT COMPLETED|Washout Period 2||0
3188426|NCT02038829|3916478|FG011|NOT COMPLETED|Washout Period 2||0
3188427|NCT02038829|3916467|FG000|STARTED|Treatment Period 3||7
3188428|NCT02038829|3916468|FG001|STARTED|Treatment Period 3||8
3188429|NCT02038829|3916469|FG002|STARTED|Treatment Period 3||8
3188430|NCT02038829|3916470|FG003|STARTED|Treatment Period 3||8
3188431|NCT02038829|3916471|FG004|STARTED|Treatment Period 3||7
3188432|NCT02038829|3916472|FG005|STARTED|Treatment Period 3||7
3188433|NCT02038829|3916473|FG006|STARTED|Treatment Period 3||8
3188434|NCT02038829|3916474|FG007|STARTED|Treatment Period 3||8
3188435|NCT02038829|3916475|FG008|STARTED|Treatment Period 3||7
3188436|NCT02038829|3916476|FG009|STARTED|Treatment Period 3||8
3188437|NCT02038829|3916477|FG010|STARTED|Treatment Period 3||7
3188438|NCT02038829|3916478|FG011|STARTED|Treatment Period 3||8
3188439|NCT02038829|3916467|FG000|COMPLETED|Treatment Period 3||7
3188440|NCT02038829|3916468|FG001|COMPLETED|Treatment Period 3||8
3188441|NCT02038829|3916469|FG002|COMPLETED|Treatment Period 3||8
3188442|NCT02038829|3916470|FG003|COMPLETED|Treatment Period 3||8
3188443|NCT02038829|3916471|FG004|COMPLETED|Treatment Period 3||7
3188444|NCT02038829|3916472|FG005|COMPLETED|Treatment Period 3||7
3188445|NCT02038829|3916473|FG006|COMPLETED|Treatment Period 3||8
3188446|NCT02038829|3916474|FG007|COMPLETED|Treatment Period 3||8
3188447|NCT02038829|3916475|FG008|COMPLETED|Treatment Period 3||7
3188448|NCT02038829|3916476|FG009|COMPLETED|Treatment Period 3||8
3188449|NCT02038829|3916477|FG010|COMPLETED|Treatment Period 3||7
3188450|NCT02038829|3916478|FG011|COMPLETED|Treatment Period 3||8
3188451|NCT02038829|3916467|FG000|NOT COMPLETED|Treatment Period 3||0
3188452|NCT02038829|3916468|FG001|NOT COMPLETED|Treatment Period 3||0
3188453|NCT02038829|3916469|FG002|NOT COMPLETED|Treatment Period 3||0
3188454|NCT02038829|3916470|FG003|NOT COMPLETED|Treatment Period 3||0
3188455|NCT02038829|3916471|FG004|NOT COMPLETED|Treatment Period 3||0
3188456|NCT02038829|3916472|FG005|NOT COMPLETED|Treatment Period 3||0
3188457|NCT02038829|3916473|FG006|NOT COMPLETED|Treatment Period 3||0
3188458|NCT02038829|3916474|FG007|NOT COMPLETED|Treatment Period 3||0
3188459|NCT02038829|3916475|FG008|NOT COMPLETED|Treatment Period 3||0
3188460|NCT02038829|3916476|FG009|NOT COMPLETED|Treatment Period 3||0
3188461|NCT02038829|3916477|FG010|NOT COMPLETED|Treatment Period 3||0
3188462|NCT02038829|3916478|FG011|NOT COMPLETED|Treatment Period 3||0
3188463|NCT02038829|3916467|FG000|STARTED|Washout Period 3||7
3188464|NCT02038829|3916468|FG001|STARTED|Washout Period 3||8
3188465|NCT02038829|3916469|FG002|STARTED|Washout Period 3||8
3188466|NCT02038829|3916470|FG003|STARTED|Washout Period 3||8
3188467|NCT02038829|3916471|FG004|STARTED|Washout Period 3||7
3188468|NCT02038829|3916472|FG005|STARTED|Washout Period 3||7
3188469|NCT02038829|3916473|FG006|STARTED|Washout Period 3||8
3188470|NCT02038829|3916474|FG007|STARTED|Washout Period 3||8
3188471|NCT02038829|3916475|FG008|STARTED|Washout Period 3||7
3188472|NCT02038829|3916476|FG009|STARTED|Washout Period 3||8
3188473|NCT02038829|3916477|FG010|STARTED|Washout Period 3||7
3188474|NCT02038829|3916478|FG011|STARTED|Washout Period 3||8
3188475|NCT02038829|3916467|FG000|COMPLETED|Washout Period 3||7
3188476|NCT02038829|3916468|FG001|COMPLETED|Washout Period 3||8
3188477|NCT02038829|3916469|FG002|COMPLETED|Washout Period 3||8
3188478|NCT02038829|3916470|FG003|COMPLETED|Washout Period 3||8
3188479|NCT02038829|3916471|FG004|COMPLETED|Washout Period 3||7
3188480|NCT02038829|3916472|FG005|COMPLETED|Washout Period 3||7
3188481|NCT02038829|3916473|FG006|COMPLETED|Washout Period 3||8
3188482|NCT02038829|3916474|FG007|COMPLETED|Washout Period 3||8
3188483|NCT02038829|3916475|FG008|COMPLETED|Washout Period 3||7
3188484|NCT02038829|3916476|FG009|COMPLETED|Washout Period 3||8
3188485|NCT02038829|3916477|FG010|COMPLETED|Washout Period 3||7
3188486|NCT02038829|3916478|FG011|COMPLETED|Washout Period 3||8
3188487|NCT02038829|3916467|FG000|NOT COMPLETED|Washout Period 3||0
3188488|NCT02038829|3916468|FG001|NOT COMPLETED|Washout Period 3||0
3188489|NCT02038829|3916469|FG002|NOT COMPLETED|Washout Period 3||0
3188490|NCT02038829|3916470|FG003|NOT COMPLETED|Washout Period 3||0
3188491|NCT02038829|3916471|FG004|NOT COMPLETED|Washout Period 3||0
3188492|NCT02038829|3916472|FG005|NOT COMPLETED|Washout Period 3||0
3188493|NCT02038829|3916473|FG006|NOT COMPLETED|Washout Period 3||0
3188494|NCT02038829|3916474|FG007|NOT COMPLETED|Washout Period 3||0
3188495|NCT02038829|3916475|FG008|NOT COMPLETED|Washout Period 3||0
3188496|NCT02038829|3916476|FG009|NOT COMPLETED|Washout Period 3||0
3188497|NCT02038829|3916477|FG010|NOT COMPLETED|Washout Period 3||0
3188498|NCT02038829|3916478|FG011|NOT COMPLETED|Washout Period 3||0
3188499|NCT02038829|3916467|FG000|STARTED|Treatment Period 4||7
3188500|NCT02038829|3916468|FG001|STARTED|Treatment Period 4||8
3188501|NCT02038829|3916469|FG002|STARTED|Treatment Period 4||8
3188502|NCT02038829|3916470|FG003|STARTED|Treatment Period 4||8
3188503|NCT02038829|3916471|FG004|STARTED|Treatment Period 4||7
3188504|NCT02038829|3916472|FG005|STARTED|Treatment Period 4||7
3188505|NCT02038829|3916473|FG006|STARTED|Treatment Period 4||8
3188506|NCT02038829|3916474|FG007|STARTED|Treatment Period 4||8
3188507|NCT02038829|3916475|FG008|STARTED|Treatment Period 4||7
3188508|NCT02038829|3916476|FG009|STARTED|Treatment Period 4||8
3188509|NCT02038829|3916477|FG010|STARTED|Treatment Period 4||7
3188510|NCT02038829|3916478|FG011|STARTED|Treatment Period 4||8
3188511|NCT02038829|3916467|FG000|COMPLETED|Treatment Period 4||7
3188512|NCT02038829|3916468|FG001|COMPLETED|Treatment Period 4||7
3188513|NCT02038829|3916469|FG002|COMPLETED|Treatment Period 4||8
3188514|NCT02038829|3916470|FG003|COMPLETED|Treatment Period 4||8
3188515|NCT02038829|3916471|FG004|COMPLETED|Treatment Period 4||7
3188516|NCT02038829|3916472|FG005|COMPLETED|Treatment Period 4||7
3188517|NCT02038829|3916473|FG006|COMPLETED|Treatment Period 4||8
3188518|NCT02038829|3916474|FG007|COMPLETED|Treatment Period 4||8
3188519|NCT02038829|3916475|FG008|COMPLETED|Treatment Period 4||7
3188520|NCT02038829|3916476|FG009|COMPLETED|Treatment Period 4||8
3188521|NCT02038829|3916477|FG010|COMPLETED|Treatment Period 4||7
3188522|NCT02038829|3916478|FG011|COMPLETED|Treatment Period 4||8
3188523|NCT02038829|3916467|FG000|NOT COMPLETED|Treatment Period 4||0
3188524|NCT02038829|3916468|FG001|NOT COMPLETED|Treatment Period 4||1
3188525|NCT02038829|3916469|FG002|NOT COMPLETED|Treatment Period 4||0
3188526|NCT02038829|3916470|FG003|NOT COMPLETED|Treatment Period 4||0
3188527|NCT02038829|3916471|FG004|NOT COMPLETED|Treatment Period 4||0
3188528|NCT02038829|3916472|FG005|NOT COMPLETED|Treatment Period 4||0
3188529|NCT02038829|3916473|FG006|NOT COMPLETED|Treatment Period 4||0
3188530|NCT02038829|3916474|FG007|NOT COMPLETED|Treatment Period 4||0
3188531|NCT02038829|3916475|FG008|NOT COMPLETED|Treatment Period 4||0
3188532|NCT02038829|3916476|FG009|NOT COMPLETED|Treatment Period 4||0
3188533|NCT02038829|3916477|FG010|NOT COMPLETED|Treatment Period 4||0
3188534|NCT02038829|3916478|FG011|NOT COMPLETED|Treatment Period 4||0
3188535|NCT02038829|3916467|FG000|STARTED|Washout Period 4||7
3188536|NCT02038829|3916468|FG001|STARTED|Washout Period 4||7
3188537|NCT02038829|3916469|FG002|STARTED|Washout Period 4||8
3188538|NCT02038829|3916470|FG003|STARTED|Washout Period 4||8
3188539|NCT02038829|3916471|FG004|STARTED|Washout Period 4||7
3188540|NCT02038829|3916472|FG005|STARTED|Washout Period 4||7
3188541|NCT02038829|3916473|FG006|STARTED|Washout Period 4||8
3188542|NCT02038829|3916474|FG007|STARTED|Washout Period 4||8
3188543|NCT02038829|3916475|FG008|STARTED|Washout Period 4||7
3188544|NCT02038829|3916476|FG009|STARTED|Washout Period 4||8
3188545|NCT02038829|3916477|FG010|STARTED|Washout Period 4||7
3188546|NCT02038829|3916478|FG011|STARTED|Washout Period 4||8
3188547|NCT02038829|3916467|FG000|COMPLETED|Washout Period 4||7
3188548|NCT02038829|3916468|FG001|COMPLETED|Washout Period 4||7
3188549|NCT02038829|3916469|FG002|COMPLETED|Washout Period 4||8
3188550|NCT02038829|3916470|FG003|COMPLETED|Washout Period 4||8
3188551|NCT02038829|3916471|FG004|COMPLETED|Washout Period 4||7
3188552|NCT02038829|3916472|FG005|COMPLETED|Washout Period 4||7
3188553|NCT02038829|3916473|FG006|COMPLETED|Washout Period 4||7
3188554|NCT02038829|3916474|FG007|COMPLETED|Washout Period 4||8
3188555|NCT02038829|3916475|FG008|COMPLETED|Washout Period 4||7
3188556|NCT02038829|3916476|FG009|COMPLETED|Washout Period 4||8
3188557|NCT02038829|3916477|FG010|COMPLETED|Washout Period 4||7
3188558|NCT02038829|3916478|FG011|COMPLETED|Washout Period 4||8
3188559|NCT02038829|3916467|FG000|NOT COMPLETED|Washout Period 4||0
3188560|NCT02038829|3916468|FG001|NOT COMPLETED|Washout Period 4||0
3188561|NCT02038829|3916469|FG002|NOT COMPLETED|Washout Period 4||0
3188562|NCT02038829|3916470|FG003|NOT COMPLETED|Washout Period 4||0
3188563|NCT02038829|3916471|FG004|NOT COMPLETED|Washout Period 4||0
3188564|NCT02038829|3916472|FG005|NOT COMPLETED|Washout Period 4||0
3188565|NCT02038829|3916473|FG006|NOT COMPLETED|Washout Period 4||1
3188566|NCT02038829|3916474|FG007|NOT COMPLETED|Washout Period 4||0
3188567|NCT02038829|3916475|FG008|NOT COMPLETED|Washout Period 4||0
3188568|NCT02038829|3916476|FG009|NOT COMPLETED|Washout Period 4||0
3188569|NCT02038829|3916477|FG010|NOT COMPLETED|Washout Period 4||0
3188570|NCT02038829|3916478|FG011|NOT COMPLETED|Washout Period 4||0
3188571|NCT02038829|3916467|FG000|STARTED|Treatment Period 5||7
3188572|NCT02038829|3916468|FG001|STARTED|Treatment Period 5||7
3188573|NCT02038829|3916469|FG002|STARTED|Treatment Period 5||8
3188574|NCT02038829|3916470|FG003|STARTED|Treatment Period 5||8
3188575|NCT02038829|3916471|FG004|STARTED|Treatment Period 5||7
3188576|NCT02038829|3916472|FG005|STARTED|Treatment Period 5||7
3188577|NCT02038829|3916473|FG006|STARTED|Treatment Period 5||7
3188578|NCT02038829|3916474|FG007|STARTED|Treatment Period 5||8
3188579|NCT02038829|3916475|FG008|STARTED|Treatment Period 5||7
3188580|NCT02038829|3916476|FG009|STARTED|Treatment Period 5||8
3188581|NCT02038829|3916477|FG010|STARTED|Treatment Period 5||7
3188582|NCT02038829|3916478|FG011|STARTED|Treatment Period 5||8
3188583|NCT02038829|3916467|FG000|COMPLETED|Treatment Period 5||7
3188584|NCT02038829|3916468|FG001|COMPLETED|Treatment Period 5||7
3188585|NCT02038829|3916469|FG002|COMPLETED|Treatment Period 5||8
3188586|NCT02038829|3916470|FG003|COMPLETED|Treatment Period 5||8
3188587|NCT02038829|3916471|FG004|COMPLETED|Treatment Period 5||7
3188588|NCT02038829|3916472|FG005|COMPLETED|Treatment Period 5||7
3188589|NCT02038829|3916473|FG006|COMPLETED|Treatment Period 5||7
3188590|NCT02038829|3916474|FG007|COMPLETED|Treatment Period 5||8
3188591|NCT02038829|3916475|FG008|COMPLETED|Treatment Period 5||7
3188592|NCT02038829|3916476|FG009|COMPLETED|Treatment Period 5||8
3188593|NCT02038829|3916477|FG010|COMPLETED|Treatment Period 5||7
3188594|NCT02038829|3916478|FG011|COMPLETED|Treatment Period 5||8
3188595|NCT02038829|3916467|FG000|NOT COMPLETED|Treatment Period 5||0
3188596|NCT02038829|3916468|FG001|NOT COMPLETED|Treatment Period 5||0
3188597|NCT02038829|3916469|FG002|NOT COMPLETED|Treatment Period 5||0
3188598|NCT02038829|3916470|FG003|NOT COMPLETED|Treatment Period 5||0
3188599|NCT02038829|3916471|FG004|NOT COMPLETED|Treatment Period 5||0
3188600|NCT02038829|3916472|FG005|NOT COMPLETED|Treatment Period 5||0
3188601|NCT02038829|3916473|FG006|NOT COMPLETED|Treatment Period 5||0
3188602|NCT02038829|3916474|FG007|NOT COMPLETED|Treatment Period 5||0
3188603|NCT02038829|3916475|FG008|NOT COMPLETED|Treatment Period 5||0
3188604|NCT02038829|3916476|FG009|NOT COMPLETED|Treatment Period 5||0
3188605|NCT02038829|3916477|FG010|NOT COMPLETED|Treatment Period 5||0
3188606|NCT02038829|3916478|FG011|NOT COMPLETED|Treatment Period 5||0
3188607|NCT02038829|3916467|FG000|STARTED|Washout Period 5||7
3188608|NCT02038829|3916468|FG001|STARTED|Washout Period 5||7
3188609|NCT02038829|3916469|FG002|STARTED|Washout Period 5||8
3188610|NCT02038829|3916470|FG003|STARTED|Washout Period 5||8
3188611|NCT02038829|3916471|FG004|STARTED|Washout Period 5||7
3188612|NCT02038829|3916472|FG005|STARTED|Washout Period 5||7
3188613|NCT02038829|3916473|FG006|STARTED|Washout Period 5||7
3188614|NCT02038829|3916474|FG007|STARTED|Washout Period 5||8
3188615|NCT02038829|3916475|FG008|STARTED|Washout Period 5||7
3188616|NCT02038829|3916476|FG009|STARTED|Washout Period 5||8
3188617|NCT02038829|3916477|FG010|STARTED|Washout Period 5||7
3188618|NCT02038829|3916478|FG011|STARTED|Washout Period 5||8
3188619|NCT02038829|3916467|FG000|COMPLETED|Washout Period 5||7
3188620|NCT02038829|3916468|FG001|COMPLETED|Washout Period 5||7
3188621|NCT02038829|3916469|FG002|COMPLETED|Washout Period 5||8
3188622|NCT02038829|3916470|FG003|COMPLETED|Washout Period 5||8
3188623|NCT02038829|3916471|FG004|COMPLETED|Washout Period 5||7
3188624|NCT02038829|3916472|FG005|COMPLETED|Washout Period 5||7
3188625|NCT02038829|3916473|FG006|COMPLETED|Washout Period 5||7
3188626|NCT02038829|3916474|FG007|COMPLETED|Washout Period 5||8
3188627|NCT02038829|3916475|FG008|COMPLETED|Washout Period 5||7
3188628|NCT02038829|3916476|FG009|COMPLETED|Washout Period 5||8
3188629|NCT02038829|3916477|FG010|COMPLETED|Washout Period 5||7
3188630|NCT02038829|3916478|FG011|COMPLETED|Washout Period 5||8
3188631|NCT02038829|3916467|FG000|NOT COMPLETED|Washout Period 5||0
3188632|NCT02038829|3916468|FG001|NOT COMPLETED|Washout Period 5||0
3188633|NCT02038829|3916469|FG002|NOT COMPLETED|Washout Period 5||0
3188634|NCT02038829|3916470|FG003|NOT COMPLETED|Washout Period 5||0
3188635|NCT02038829|3916471|FG004|NOT COMPLETED|Washout Period 5||0
3188636|NCT02038829|3916472|FG005|NOT COMPLETED|Washout Period 5||0
3188637|NCT02038829|3916473|FG006|NOT COMPLETED|Washout Period 5||0
3188638|NCT02038829|3916474|FG007|NOT COMPLETED|Washout Period 5||0
3188639|NCT02038829|3916475|FG008|NOT COMPLETED|Washout Period 5||0
3188640|NCT02038829|3916476|FG009|NOT COMPLETED|Washout Period 5||0
3188641|NCT02038829|3916477|FG010|NOT COMPLETED|Washout Period 5||0
3188642|NCT02038829|3916478|FG011|NOT COMPLETED|Washout Period 5||0
3188643|NCT02038829|3916467|FG000|STARTED|Treatment Period 6||7
3188644|NCT02038829|3916468|FG001|STARTED|Treatment Period 6||7
3188645|NCT02038829|3916469|FG002|STARTED|Treatment Period 6||8
3188646|NCT02038829|3916470|FG003|STARTED|Treatment Period 6||8
3188647|NCT02038829|3916471|FG004|STARTED|Treatment Period 6||7
3188648|NCT02038829|3916472|FG005|STARTED|Treatment Period 6||7
3188649|NCT02038829|3916473|FG006|STARTED|Treatment Period 6||7
3188650|NCT02038829|3916474|FG007|STARTED|Treatment Period 6||8
3188651|NCT02038829|3916475|FG008|STARTED|Treatment Period 6||7
3188652|NCT02038829|3916476|FG009|STARTED|Treatment Period 6||8
3188653|NCT02038829|3916477|FG010|STARTED|Treatment Period 6||7
3188654|NCT02038829|3916478|FG011|STARTED|Treatment Period 6||8
3188655|NCT02038829|3916467|FG000|COMPLETED|Treatment Period 6||7
3188656|NCT02038829|3916468|FG001|COMPLETED|Treatment Period 6||7
3188657|NCT02038829|3916469|FG002|COMPLETED|Treatment Period 6||7
3188658|NCT02038829|3916470|FG003|COMPLETED|Treatment Period 6||8
3188659|NCT02038829|3916471|FG004|COMPLETED|Treatment Period 6||7
3188660|NCT02038829|3916472|FG005|COMPLETED|Treatment Period 6||7
3188661|NCT02038829|3916473|FG006|COMPLETED|Treatment Period 6||7
3188662|NCT02038829|3916474|FG007|COMPLETED|Treatment Period 6||8
3188663|NCT02038829|3916475|FG008|COMPLETED|Treatment Period 6||7
3188664|NCT02038829|3916476|FG009|COMPLETED|Treatment Period 6||8
3188665|NCT02038829|3916477|FG010|COMPLETED|Treatment Period 6||7
3188666|NCT02038829|3916478|FG011|COMPLETED|Treatment Period 6||8
3188667|NCT02038829|3916467|FG000|NOT COMPLETED|Treatment Period 6||0
3188668|NCT02038829|3916468|FG001|NOT COMPLETED|Treatment Period 6||0
3188669|NCT02038829|3916469|FG002|NOT COMPLETED|Treatment Period 6||1
3188670|NCT02038829|3916470|FG003|NOT COMPLETED|Treatment Period 6||0
3188671|NCT02038829|3916471|FG004|NOT COMPLETED|Treatment Period 6||0
3188672|NCT02038829|3916472|FG005|NOT COMPLETED|Treatment Period 6||0
3188673|NCT02038829|3916473|FG006|NOT COMPLETED|Treatment Period 6||0
3188674|NCT02038829|3916474|FG007|NOT COMPLETED|Treatment Period 6||0
3188675|NCT02038829|3916475|FG008|NOT COMPLETED|Treatment Period 6||0
3188676|NCT02038829|3916476|FG009|NOT COMPLETED|Treatment Period 6||0
3188677|NCT02038829|3916477|FG010|NOT COMPLETED|Treatment Period 6||0
3188678|NCT02038829|3916478|FG011|NOT COMPLETED|Treatment Period 6||0
3188679|NCT02038881|3916496|FG000|STARTED|Overall Study||27
3188680|NCT02038881|3916497|FG001|STARTED|Overall Study||29
3188681|NCT02038881|3916498|FG002|STARTED|Overall Study||31
3188682|NCT02038881|3916496|FG000|COMPLETED|Overall Study||24
3188683|NCT02038881|3916497|FG001|COMPLETED|Overall Study||29
3188684|NCT02038881|3916498|FG002|COMPLETED|Overall Study||30
3188685|NCT02038881|3916496|FG000|NOT COMPLETED|Overall Study||3
3188686|NCT02038881|3916497|FG001|NOT COMPLETED|Overall Study||0
3188687|NCT02038881|3916498|FG002|NOT COMPLETED|Overall Study||1
3188688|NCT02038894|3916511|FG000|STARTED|Overall Study||60
3188689|NCT02038894|3916512|FG001|STARTED|Overall Study||58
3188690|NCT02038894|3916513|FG002|STARTED|Overall Study||61
3188691|NCT02038894|3916511|FG000|COMPLETED|Overall Study||60
3188692|NCT02038894|3916512|FG001|COMPLETED|Overall Study||58
3188693|NCT02038894|3916513|FG002|COMPLETED|Overall Study||61
3188694|NCT02038894|3916511|FG000|NOT COMPLETED|Overall Study||0
3188695|NCT02038894|3916512|FG001|NOT COMPLETED|Overall Study||0
3188696|NCT02038894|3916513|FG002|NOT COMPLETED|Overall Study||0
3188697|NCT02038907|3916539|FG000|STARTED|Overall Study||30
3188698|NCT02038907|3916540|FG001|STARTED|Overall Study||30
3188699|NCT02038907|3916541|FG002|STARTED|Overall Study||30
3188700|NCT02038907|3916542|FG003|STARTED|Overall Study||31
3188701|NCT02038907|3916543|FG004|STARTED|Overall Study||30
3188702|NCT02038907|3916544|FG005|STARTED|Overall Study||31
3188703|NCT02038907|3916545|FG006|STARTED|Overall Study||30
3188704|NCT02038907|3916546|FG007|STARTED|Overall Study||32
3188705|NCT02038907|3916547|FG008|STARTED|Overall Study||29
3188706|NCT02038907|3916548|FG009|STARTED|Overall Study||30
3188707|NCT02038907|3916549|FG010|STARTED|Overall Study||29
3188708|NCT02038907|3916550|FG011|STARTED|Overall Study||28
3188709|NCT02038907|3916551|FG012|STARTED|Overall Study||29
3188710|NCT02038907|3916552|FG013|STARTED|Overall Study||31
3188711|NCT02038907|3916539|FG000|COMPLETED|Overall Study||30
3188712|NCT02038907|3916540|FG001|COMPLETED|Overall Study||30
3188713|NCT02038907|3916541|FG002|COMPLETED|Overall Study||30
3188714|NCT02038907|3916542|FG003|COMPLETED|Overall Study||31
3188715|NCT02038907|3916543|FG004|COMPLETED|Overall Study||30
3188716|NCT02038907|3916544|FG005|COMPLETED|Overall Study||31
3188717|NCT02038907|3916545|FG006|COMPLETED|Overall Study||30
3188718|NCT02038907|3916546|FG007|COMPLETED|Overall Study||32
3188719|NCT02038907|3916547|FG008|COMPLETED|Overall Study||29
3188720|NCT02038907|3916548|FG009|COMPLETED|Overall Study||30
3188721|NCT02038907|3916549|FG010|COMPLETED|Overall Study||27
3188722|NCT02038907|3916550|FG011|COMPLETED|Overall Study||28
3188723|NCT02038907|3916551|FG012|COMPLETED|Overall Study||29
3188724|NCT02038907|3916552|FG013|COMPLETED|Overall Study||31
3188725|NCT02038907|3916539|FG000|NOT COMPLETED|Overall Study||0
3188726|NCT02038907|3916540|FG001|NOT COMPLETED|Overall Study||0
3188727|NCT02038907|3916541|FG002|NOT COMPLETED|Overall Study||0
3188728|NCT02038907|3916542|FG003|NOT COMPLETED|Overall Study||0
3188729|NCT02038907|3916543|FG004|NOT COMPLETED|Overall Study||0
3188730|NCT02038907|3916544|FG005|NOT COMPLETED|Overall Study||0
3188731|NCT02038907|3916545|FG006|NOT COMPLETED|Overall Study||0
3188732|NCT02038907|3916546|FG007|NOT COMPLETED|Overall Study||0
3188733|NCT02038907|3916547|FG008|NOT COMPLETED|Overall Study||0
3188734|NCT02038907|3916548|FG009|NOT COMPLETED|Overall Study||0
3188735|NCT02038907|3916549|FG010|NOT COMPLETED|Overall Study||2
3188736|NCT02038907|3916550|FG011|NOT COMPLETED|Overall Study||0
3188737|NCT02038907|3916551|FG012|NOT COMPLETED|Overall Study||0
3188738|NCT02038907|3916552|FG013|NOT COMPLETED|Overall Study||0
3188739|NCT02038920|3916586|FG000|STARTED|Induction Phase (Week 0 to 14)||79
3188740|NCT02038920|3916587|FG001|STARTED|Induction Phase (Week 0 to 14)||78
3188741|NCT02038920|3916588|FG002|STARTED|Induction Phase (Week 0 to 14)||0
3188742|NCT02038920|3916589|FG003|STARTED|Induction Phase (Week 0 to 14)||0
3188743|NCT02038920|3916590|FG004|STARTED|Induction Phase (Week 0 to 14)||0
3188744|NCT02038920|3916591|FG005|STARTED|Induction Phase (Week 0 to 14)||0
3188745|NCT02038920|3916586|FG000|COMPLETED|Induction Phase (Week 0 to 14)||73
3188746|NCT02038920|3916587|FG001|COMPLETED|Induction Phase (Week 0 to 14)||66
3188747|NCT02038920|3916588|FG002|COMPLETED|Induction Phase (Week 0 to 14)||0
3188748|NCT02038920|3916589|FG003|COMPLETED|Induction Phase (Week 0 to 14)||0
3188749|NCT02038920|3916590|FG004|COMPLETED|Induction Phase (Week 0 to 14)||0
3188750|NCT02038920|3916591|FG005|COMPLETED|Induction Phase (Week 0 to 14)||0
3188751|NCT02038920|3916586|FG000|NOT COMPLETED|Induction Phase (Week 0 to 14)||6
3188752|NCT02038920|3916587|FG001|NOT COMPLETED|Induction Phase (Week 0 to 14)||12
3188753|NCT02038920|3916588|FG002|NOT COMPLETED|Induction Phase (Week 0 to 14)||0
3188754|NCT02038920|3916589|FG003|NOT COMPLETED|Induction Phase (Week 0 to 14)||0
3188755|NCT02038920|3916590|FG004|NOT COMPLETED|Induction Phase (Week 0 to 14)||0
3188756|NCT02038920|3916591|FG005|NOT COMPLETED|Induction Phase (Week 0 to 14)||0
3188757|NCT02038920|3916586|FG000|STARTED|Maintenance Phase (Week 14 to 60)||0
3188758|NCT02038920|3916587|FG001|STARTED|Maintenance Phase (Week 14 to 60)||0
3188759|NCT02038920|3916588|FG002|STARTED|Maintenance Phase (Week 14 to 60)||12
3188760|NCT02038920|3916589|FG003|STARTED|Maintenance Phase (Week 14 to 60)||12
3188761|NCT02038920|3916590|FG004|STARTED|Maintenance Phase (Week 14 to 60)||17
3188762|NCT02038920|3916591|FG005|STARTED|Maintenance Phase (Week 14 to 60)||0
3188763|NCT02038920|3916586|FG000|COMPLETED|Maintenance Phase (Week 14 to 60)||0
3188764|NCT02038920|3916587|FG001|COMPLETED|Maintenance Phase (Week 14 to 60)||0
3188765|NCT02038920|3916588|FG002|COMPLETED|Maintenance Phase (Week 14 to 60)||7
3188766|NCT02038920|3916589|FG003|COMPLETED|Maintenance Phase (Week 14 to 60)||4
3188767|NCT02038920|3916590|FG004|COMPLETED|Maintenance Phase (Week 14 to 60)||5
3188768|NCT02038920|3916591|FG005|COMPLETED|Maintenance Phase (Week 14 to 60)||0
3188769|NCT02038920|3916586|FG000|NOT COMPLETED|Maintenance Phase (Week 14 to 60)||0
3188770|NCT02038920|3916587|FG001|NOT COMPLETED|Maintenance Phase (Week 14 to 60)||0
3188771|NCT02038920|3916588|FG002|NOT COMPLETED|Maintenance Phase (Week 14 to 60)||5
3188772|NCT02038920|3916589|FG003|NOT COMPLETED|Maintenance Phase (Week 14 to 60)||8
3188773|NCT02038920|3916590|FG004|NOT COMPLETED|Maintenance Phase (Week 14 to 60)||12
3188774|NCT02038920|3916591|FG005|NOT COMPLETED|Maintenance Phase (Week 14 to 60)||0
3188775|NCT02038920|3916586|FG000|STARTED|Open Label Cohort (Week 10 to 154)||0
3188776|NCT02038920|3916587|FG001|STARTED|Open Label Cohort (Week 10 to 154)||0
3188777|NCT02038920|3916588|FG002|STARTED|Open Label Cohort (Week 10 to 154)||0
3188778|NCT02038920|3916589|FG003|STARTED|Open Label Cohort (Week 10 to 154)||0
3188779|NCT02038920|3916590|FG004|STARTED|Open Label Cohort (Week 10 to 154)||0
3188780|NCT02038920|3916591|FG005|STARTED|Open Label Cohort (Week 10 to 154)||134
3188781|NCT02038920|3916586|FG000|COMPLETED|Open Label Cohort (Week 10 to 154)||0
3188782|NCT02038920|3916587|FG001|COMPLETED|Open Label Cohort (Week 10 to 154)||0
3188783|NCT02038920|3916588|FG002|COMPLETED|Open Label Cohort (Week 10 to 154)||0
3188784|NCT02038920|3916589|FG003|COMPLETED|Open Label Cohort (Week 10 to 154)||0
3188785|NCT02038920|3916590|FG004|COMPLETED|Open Label Cohort (Week 10 to 154)||0
3188786|NCT02038920|3916591|FG005|COMPLETED|Open Label Cohort (Week 10 to 154)||57
3188787|NCT02038920|3916586|FG000|NOT COMPLETED|Open Label Cohort (Week 10 to 154)||0
3188788|NCT02038920|3916587|FG001|NOT COMPLETED|Open Label Cohort (Week 10 to 154)||0
3188789|NCT02038920|3916588|FG002|NOT COMPLETED|Open Label Cohort (Week 10 to 154)||0
3188790|NCT02038920|3916589|FG003|NOT COMPLETED|Open Label Cohort (Week 10 to 154)||0
3188791|NCT02038920|3916590|FG004|NOT COMPLETED|Open Label Cohort (Week 10 to 154)||0
3188792|NCT02038920|3916591|FG005|NOT COMPLETED|Open Label Cohort (Week 10 to 154)||77
3188793|NCT02038933|3916610|FG000|STARTED|Overall Study||121
3188794|NCT02038933|3916610|FG000|COMPLETED|Overall Study||0
3188795|NCT02038933|3916610|FG000|NOT COMPLETED|Overall Study||121
3188796|NCT02038959|3916617|FG000|STARTED|Overall Study||98
3188797|NCT02038959|3916618|FG001|STARTED|Overall Study||97
3188798|NCT02038959|3916617|FG000|COMPLETED|Overall Study||92
3188799|NCT02038959|3916618|FG001|COMPLETED|Overall Study||89
3188800|NCT02038959|3916617|FG000|NOT COMPLETED|Overall Study||6
3188801|NCT02038959|3916618|FG001|NOT COMPLETED|Overall Study||8
3188802|NCT02039115|3916626|FG000|STARTED|Overall Study||1
3188803|NCT02039115|3916627|FG001|STARTED|Overall Study||0
3188804|NCT02039115|3916626|FG000|COMPLETED|Overall Study||1
3188805|NCT02039115|3916627|FG001|COMPLETED|Overall Study||0
3188806|NCT02039115|3916626|FG000|NOT COMPLETED|Overall Study||0
3188807|NCT02039115|3916627|FG001|NOT COMPLETED|Overall Study||0
3188808|NCT02039219|3916635|FG000|STARTED|Treatment||11
3188809|NCT02039219|3916636|FG001|STARTED|Treatment||8
3188810|NCT02039219|3916635|FG000|COMPLETED|Treatment||7
3188811|NCT02039219|3916636|FG001|COMPLETED|Treatment||6
3188812|NCT02039219|3916635|FG000|NOT COMPLETED|Treatment||4
3188813|NCT02039219|3916636|FG001|NOT COMPLETED|Treatment||2
3188814|NCT02039219|3916635|FG000|STARTED|Follow up||7
3188815|NCT02039219|3916636|FG001|STARTED|Follow up||6
3188816|NCT02039219|3916635|FG000|COMPLETED|Follow up||7
3188817|NCT02039219|3916636|FG001|COMPLETED|Follow up||5
3188818|NCT02039219|3916635|FG000|NOT COMPLETED|Follow up||0
3188819|NCT02039219|3916636|FG001|NOT COMPLETED|Follow up||1
3188820|NCT02039375|3916642|FG000|STARTED|Overall Study||35
3188821|NCT02039375|3916642|FG000|COMPLETED|Overall Study||33
3188822|NCT02039375|3916642|FG000|NOT COMPLETED|Overall Study||2
3188823|NCT02039414|3916648|FG000|STARTED|Overall Study||22
3188824|NCT02039414|3916649|FG001|STARTED|Overall Study||18
3188825|NCT02039414|3916648|FG000|COMPLETED|Overall Study||16
3188826|NCT02039414|3916649|FG001|COMPLETED|Overall Study||16
3188827|NCT02039414|3916648|FG000|NOT COMPLETED|Overall Study||6
3188828|NCT02039414|3916649|FG001|NOT COMPLETED|Overall Study||2
3188829|NCT02039427|3916659|FG000|STARTED|Overall Study||48
3188830|NCT02039427|3916660|FG001|STARTED|Overall Study||48
3188831|NCT02039427|3916661|FG002|STARTED|Overall Study||48
3188832|NCT02039427|3916662|FG003|STARTED|Overall Study||48
3188833|NCT02039427|3916659|FG000|COMPLETED|Overall Study||45
3188834|NCT02039427|3916660|FG001|COMPLETED|Overall Study||47
3188835|NCT02039427|3916661|FG002|COMPLETED|Overall Study||45
3188836|NCT02039427|3916662|FG003|COMPLETED|Overall Study||43
3188837|NCT02039427|3916659|FG000|NOT COMPLETED|Overall Study||3
3188838|NCT02039427|3916660|FG001|NOT COMPLETED|Overall Study||1
3188839|NCT02039427|3916661|FG002|NOT COMPLETED|Overall Study||3
3188840|NCT02039427|3916662|FG003|NOT COMPLETED|Overall Study||5
3188841|NCT02039505|3916679|FG000|STARTED|Induction Phase (Week 0 to Week 14)||82
3188842|NCT02039505|3916680|FG001|STARTED|Induction Phase (Week 0 to Week 14)||164
3188843|NCT02039505|3916681|FG002|STARTED|Induction Phase (Week 0 to Week 14)||46
3188844|NCT02039505|3916682|FG003|STARTED|Induction Phase (Week 0 to Week 14)||0
3188845|NCT02039505|3916683|FG004|STARTED|Induction Phase (Week 0 to Week 14)||0
3188846|NCT02039505|3916684|FG005|STARTED|Induction Phase (Week 0 to Week 14)||0
3188847|NCT02039505|3916685|FG006|STARTED|Induction Phase (Week 0 to Week 14)||0
3188848|NCT02039505|3916679|FG000|COMPLETED|Induction Phase (Week 0 to Week 14)||78
3188849|NCT02039505|3916680|FG001|COMPLETED|Induction Phase (Week 0 to Week 14)||155
3188850|NCT02039505|3916681|FG002|COMPLETED|Induction Phase (Week 0 to Week 14)||36
3188851|NCT02039505|3916682|FG003|COMPLETED|Induction Phase (Week 0 to Week 14)||0
3188852|NCT02039505|3916683|FG004|COMPLETED|Induction Phase (Week 0 to Week 14)||0
3188853|NCT02039505|3916684|FG005|COMPLETED|Induction Phase (Week 0 to Week 14)||0
3188854|NCT02039505|3916685|FG006|COMPLETED|Induction Phase (Week 0 to Week 14)||0
3188855|NCT02039505|3916679|FG000|NOT COMPLETED|Induction Phase (Week 0 to Week 14)||4
3188856|NCT02039505|3916680|FG001|NOT COMPLETED|Induction Phase (Week 0 to Week 14)||9
3188857|NCT02039505|3916681|FG002|NOT COMPLETED|Induction Phase (Week 0 to Week 14)||10
3188858|NCT02039505|3916682|FG003|NOT COMPLETED|Induction Phase (Week 0 to Week 14)||0
3188859|NCT02039505|3916683|FG004|NOT COMPLETED|Induction Phase (Week 0 to Week 14)||0
3188860|NCT02039505|3916684|FG005|NOT COMPLETED|Induction Phase (Week 0 to Week 14)||0
3188861|NCT02039505|3916685|FG006|NOT COMPLETED|Induction Phase (Week 0 to Week 14)||0
3188862|NCT02039505|3916679|FG000|STARTED|Maintenance Phase (Week 14 to Week 60)||0
3188863|NCT02039505|3916680|FG001|STARTED|Maintenance Phase (Week 14 to Week 60)||0
3188864|NCT02039505|3916681|FG002|STARTED|Maintenance Phase (Week 14 to Week 60)||0
3188865|NCT02039505|3916682|FG003|STARTED|Maintenance Phase (Week 14 to Week 60)||42
3188866|NCT02039505|3916683|FG004|STARTED|Maintenance Phase (Week 14 to Week 60)||41
3188867|NCT02039505|3916684|FG005|STARTED|Maintenance Phase (Week 14 to Week 60)||26
3188868|NCT02039505|3916685|FG006|STARTED|Maintenance Phase (Week 14 to Week 60)||0
3188869|NCT02039505|3916679|FG000|COMPLETED|Maintenance Phase (Week 14 to Week 60)||0
3188870|NCT02039505|3916680|FG001|COMPLETED|Maintenance Phase (Week 14 to Week 60)||0
3188871|NCT02039505|3916681|FG002|COMPLETED|Maintenance Phase (Week 14 to Week 60)||0
3188872|NCT02039505|3916682|FG003|COMPLETED|Maintenance Phase (Week 14 to Week 60)||18
3188873|NCT02039505|3916683|FG004|COMPLETED|Maintenance Phase (Week 14 to Week 60)||30
3188874|NCT02039505|3916684|FG005|COMPLETED|Maintenance Phase (Week 14 to Week 60)||12
3188875|NCT02039505|3916685|FG006|COMPLETED|Maintenance Phase (Week 14 to Week 60)||0
3188876|NCT02039505|3916679|FG000|NOT COMPLETED|Maintenance Phase (Week 14 to Week 60)||0
3188877|NCT02039505|3916680|FG001|NOT COMPLETED|Maintenance Phase (Week 14 to Week 60)||0
3188878|NCT02039505|3916681|FG002|NOT COMPLETED|Maintenance Phase (Week 14 to Week 60)||0
3188879|NCT02039505|3916682|FG003|NOT COMPLETED|Maintenance Phase (Week 14 to Week 60)||24
3188880|NCT02039505|3916683|FG004|NOT COMPLETED|Maintenance Phase (Week 14 to Week 60)||11
3188881|NCT02039505|3916684|FG005|NOT COMPLETED|Maintenance Phase (Week 14 to Week 60)||14
3188882|NCT02039505|3916685|FG006|NOT COMPLETED|Maintenance Phase (Week 14 to Week 60)||0
3188883|NCT02039505|3916679|FG000|STARTED|Open-Label (Week 10 up to Week 154)||0
3188884|NCT02039505|3916680|FG001|STARTED|Open-Label (Week 10 up to Week 154)||0
3188885|NCT02039505|3916681|FG002|STARTED|Open-Label (Week 10 up to Week 154)||0
3188886|NCT02039505|3916682|FG003|STARTED|Open-Label (Week 10 up to Week 154)||0
3188887|NCT02039505|3916683|FG004|STARTED|Open-Label (Week 10 up to Week 154)||0
3188888|NCT02039505|3916684|FG005|STARTED|Open-Label (Week 10 up to Week 154)||0
3188889|NCT02039505|3916685|FG006|STARTED|Open-Label (Week 10 up to Week 154)||259
3188890|NCT02039505|3916679|FG000|COMPLETED|Open-Label (Week 10 up to Week 154)||0
3188891|NCT02039505|3916680|FG001|COMPLETED|Open-Label (Week 10 up to Week 154)||0
3188892|NCT02039505|3916681|FG002|COMPLETED|Open-Label (Week 10 up to Week 154)||0
3188893|NCT02039505|3916682|FG003|COMPLETED|Open-Label (Week 10 up to Week 154)||0
3188894|NCT02039505|3916683|FG004|COMPLETED|Open-Label (Week 10 up to Week 154)||0
3188895|NCT02039505|3916684|FG005|COMPLETED|Open-Label (Week 10 up to Week 154)||0
3188896|NCT02039505|3916685|FG006|COMPLETED|Open-Label (Week 10 up to Week 154)||188
3188897|NCT02039505|3916679|FG000|NOT COMPLETED|Open-Label (Week 10 up to Week 154)||0
3188898|NCT02039505|3916680|FG001|NOT COMPLETED|Open-Label (Week 10 up to Week 154)||0
3188899|NCT02039505|3916681|FG002|NOT COMPLETED|Open-Label (Week 10 up to Week 154)||0
3188900|NCT02039505|3916682|FG003|NOT COMPLETED|Open-Label (Week 10 up to Week 154)||0
3188901|NCT02039505|3916683|FG004|NOT COMPLETED|Open-Label (Week 10 up to Week 154)||0
3188902|NCT02039505|3916684|FG005|NOT COMPLETED|Open-Label (Week 10 up to Week 154)||0
3188903|NCT02039505|3916685|FG006|NOT COMPLETED|Open-Label (Week 10 up to Week 154)||71
3188904|NCT02039674|3916719|FG000|STARTED|Overall Study||13
3188905|NCT02039674|3916720|FG001|STARTED|Overall Study||12
3188906|NCT02039674|3916721|FG002|STARTED|Overall Study||12
3188907|NCT02039674|3916722|FG003|STARTED|Overall Study||13
3188908|NCT02039674|3916723|FG004|STARTED|Overall Study||12
3188909|NCT02039674|3916724|FG005|STARTED|Overall Study||12
3188910|NCT02039674|3916725|FG006|STARTED|Overall Study||3
3188911|NCT02039674|3916726|FG007|STARTED|Overall Study||3
3188912|NCT02039674|3916727|FG008|STARTED|Overall Study||12
3188913|NCT02039674|3916728|FG009|STARTED|Overall Study||12
3188914|NCT02039674|3916729|FG010|STARTED|Overall Study||7
3188915|NCT02039674|3916730|FG011|STARTED|Overall Study||60
3188916|NCT02039674|3916731|FG012|STARTED|Overall Study||63
3188917|NCT02039674|3916732|FG013|STARTED|Overall Study||33
3188918|NCT02039674|3916719|FG000|Treated|Overall Study||13
3188919|NCT02039674|3916720|FG001|Treated|Overall Study||12
3188920|NCT02039674|3916721|FG002|Treated|Overall Study||11
3188921|NCT02039674|3916722|FG003|Treated|Overall Study||13
3188922|NCT02039674|3916723|FG004|Treated|Overall Study||12
3188923|NCT02039674|3916724|FG005|Treated|Overall Study||12
3188924|NCT02039674|3916725|FG006|Treated|Overall Study||3
3188925|NCT02039674|3916726|FG007|Treated|Overall Study||3
3364129|NCT04029961|4095326|FG000|STARTED|Overall Study||13
3364130|NCT04029961|4095327|FG001|STARTED|Overall Study||13
3364131|NCT04029961|4095326|FG000|COMPLETED|Overall Study||12
3364132|NCT04029961|4095327|FG001|COMPLETED|Overall Study||12
3364133|NCT04029961|4095326|FG000|NOT COMPLETED|Overall Study||1
3364134|NCT04029961|4095327|FG001|NOT COMPLETED|Overall Study||1
3364135|NCT04025684|4095337|FG000|STARTED|Overall Study||20
3364136|NCT04025684|4095338|FG001|STARTED|Overall Study||19
3364137|NCT04025684|4095339|FG002|STARTED|Overall Study||20
3188926|NCT02039674|3916727|FG008|Treated|Overall Study||12
3188927|NCT02039674|3916728|FG009|Treated|Overall Study||12
3188928|NCT02039674|3916729|FG010|Treated|Overall Study||7
3188929|NCT02039674|3916730|FG011|Treated|Overall Study||59
3188930|NCT02039674|3916731|FG012|Treated|Overall Study||62
3188931|NCT02039674|3916732|FG013|Treated|Overall Study||33
3188932|NCT02039674|3916719|FG000|COMPLETED|Overall Study||1
3188933|NCT02039674|3916720|FG001|COMPLETED|Overall Study||0
3188934|NCT02039674|3916721|FG002|COMPLETED|Overall Study||0
3188935|NCT02039674|3916722|FG003|COMPLETED|Overall Study||0
3188936|NCT02039674|3916723|FG004|COMPLETED|Overall Study||0
3188937|NCT02039674|3916724|FG005|COMPLETED|Overall Study||0
3188938|NCT02039674|3916725|FG006|COMPLETED|Overall Study||0
3188939|NCT02039674|3916726|FG007|COMPLETED|Overall Study||0
3188940|NCT02039674|3916727|FG008|COMPLETED|Overall Study||0
3188941|NCT02039674|3916728|FG009|COMPLETED|Overall Study||0
3188942|NCT02039674|3916729|FG010|COMPLETED|Overall Study||0
3188943|NCT02039674|3916730|FG011|COMPLETED|Overall Study||0
3188944|NCT02039674|3916731|FG012|COMPLETED|Overall Study||0
3188945|NCT02039674|3916732|FG013|COMPLETED|Overall Study||0
3188946|NCT02039674|3916719|FG000|NOT COMPLETED|Overall Study||12
3188947|NCT02039674|3916720|FG001|NOT COMPLETED|Overall Study||12
3188948|NCT02039674|3916721|FG002|NOT COMPLETED|Overall Study||12
3188949|NCT02039674|3916722|FG003|NOT COMPLETED|Overall Study||13
3188950|NCT02039674|3916723|FG004|NOT COMPLETED|Overall Study||12
3188951|NCT02039674|3916724|FG005|NOT COMPLETED|Overall Study||12
3188952|NCT02039674|3916725|FG006|NOT COMPLETED|Overall Study||3
3188953|NCT02039674|3916726|FG007|NOT COMPLETED|Overall Study||3
3188954|NCT02039674|3916727|FG008|NOT COMPLETED|Overall Study||12
3188955|NCT02039674|3916728|FG009|NOT COMPLETED|Overall Study||12
3188956|NCT02039674|3916729|FG010|NOT COMPLETED|Overall Study||7
3188957|NCT02039674|3916730|FG011|NOT COMPLETED|Overall Study||60
3188958|NCT02039674|3916731|FG012|NOT COMPLETED|Overall Study||63
3188959|NCT02039674|3916732|FG013|NOT COMPLETED|Overall Study||33
3188960|NCT02039687|3916769|FG000|STARTED|Overall Study||16
3188961|NCT02039687|3916770|FG001|STARTED|Overall Study||16
3188962|NCT02039687|3916771|FG002|STARTED|Overall Study||16
3188963|NCT02039687|3916772|FG003|STARTED|Overall Study||16
3188964|NCT02039687|3916769|FG000|COMPLETED|Overall Study||16
3188965|NCT02039687|3916770|FG001|COMPLETED|Overall Study||15
3188966|NCT02039687|3916771|FG002|COMPLETED|Overall Study||13
3188967|NCT02039687|3916772|FG003|COMPLETED|Overall Study||16
3188968|NCT02039687|3916769|FG000|NOT COMPLETED|Overall Study||0
3188969|NCT02039687|3916770|FG001|NOT COMPLETED|Overall Study||1
3188970|NCT02039687|3916771|FG002|NOT COMPLETED|Overall Study||3
3188971|NCT02039687|3916772|FG003|NOT COMPLETED|Overall Study||0
3188972|NCT02039726|3916784|FG000|STARTED|Overall Study||245
3188973|NCT02039726|3916785|FG001|STARTED|Overall Study||122
3188974|NCT02039726|3916784|FG000|Ongoing (as of Data Cutoff)|Overall Study||45
3188975|NCT02039726|3916785|FG001|Ongoing (as of Data Cutoff)|Overall Study||16
3188976|NCT02039726|3916784|FG000|Did Not Receive Treatment|Overall Study||4
3188977|NCT02039726|3916785|FG001|Did Not Receive Treatment|Overall Study||28
3188978|NCT02039726|3916784|FG000|COMPLETED|Overall Study||200
3188979|NCT02039726|3916785|FG001|COMPLETED|Overall Study||106
3188980|NCT02039726|3916784|FG000|NOT COMPLETED|Overall Study||45
3188981|NCT02039726|3916785|FG001|NOT COMPLETED|Overall Study||16
3188982|NCT02039778|3916791|FG000|STARTED|Overall Study||4
3188983|NCT02039778|3916791|FG000|COMPLETED|Overall Study||0
3188984|NCT02039778|3916791|FG000|NOT COMPLETED|Overall Study||4
3188985|NCT02039817|3916797|FG000|STARTED|Overall Study||8
3188986|NCT02039817|3916798|FG001|STARTED|Overall Study||8
3188987|NCT02039817|3916797|FG000|COMPLETED|Overall Study||8
3188988|NCT02039817|3916798|FG001|COMPLETED|Overall Study||8
3188989|NCT02039817|3916797|FG000|NOT COMPLETED|Overall Study||0
3188990|NCT02039817|3916798|FG001|NOT COMPLETED|Overall Study||0
3188991|NCT02039856|3916805|FG000|STARTED|Overall Study||2720
3188992|NCT02039856|3916806|FG001|STARTED|Overall Study||1180
3188993|NCT02039856|3916805|FG000|Baseline Started - Patients|Overall Study||2183
3188994|NCT02039856|3916806|FG001|Baseline Started - Patients|Overall Study||919
3188995|NCT02039856|3916805|FG000|Baseline Completed - Patients|Overall Study||953
3188996|NCT02039856|3916806|FG001|Baseline Completed - Patients|Overall Study||442
3188997|NCT02039856|3916805|FG000|Baseline Started - Providers/Staff|Overall Study||537
3188998|NCT02039856|3916806|FG001|Baseline Started - Providers/Staff|Overall Study||261
3188999|NCT02039856|3916805|FG000|Baseline Completed -Providers/Staff|Overall Study||194
3189000|NCT02039856|3916806|FG001|Baseline Completed -Providers/Staff|Overall Study||94
3189001|NCT02039856|3916805|FG000|Total Baseline Completed|Overall Study||1147
3189002|NCT02039856|3916806|FG001|Total Baseline Completed|Overall Study||536
3189003|NCT02039856|3916805|FG000|12-month Started-patients|Overall Study||953
3189004|NCT02039856|3916806|FG001|12-month Started-patients|Overall Study||442
3189005|NCT02039856|3916805|FG000|12-month Completed- Patients|Overall Study||580
3189006|NCT02039856|3916806|FG001|12-month Completed- Patients|Overall Study||241
3189007|NCT02039856|3916805|FG000|12-month Providers/Staff|Overall Study||0
3189008|NCT02039856|3916806|FG001|12-month Providers/Staff|Overall Study||0
3189009|NCT02039856|3916805|FG000|24-month Started|Overall Study||1518
3189010|NCT02039856|3916806|FG001|24-month Started|Overall Study||746
3189011|NCT02039856|3916805|FG000|24-month Started - Patients|Overall Study||953
3189012|NCT02039856|3916806|FG001|24-month Started - Patients|Overall Study||442
3189013|NCT02039856|3916805|FG000|24-month Completed - Patients|Overall Study||519
3364138|NCT04025684|4095340|FG003|STARTED|Overall Study||21
3189014|NCT02039856|3916806|FG001|24-month Completed - Patients|Overall Study||222
3189015|NCT02039856|3916805|FG000|24-month Started Providers/Staff|Overall Study||565
3189016|NCT02039856|3916806|FG001|24-month Started Providers/Staff|Overall Study||304
3189017|NCT02039856|3916805|FG000|24-month Completed Providers/Staff|Overall Study||174
3189018|NCT02039856|3916806|FG001|24-month Completed Providers/Staff|Overall Study||105
3189019|NCT02039856|3916805|FG000|Total 24-month Completed|Overall Study||693
3189020|NCT02039856|3916806|FG001|Total 24-month Completed|Overall Study||327
3189021|NCT02039856|3916805|FG000|COMPLETED|Overall Study||693
3189022|NCT02039856|3916806|FG001|COMPLETED|Overall Study||327
3189023|NCT02039856|3916805|FG000|NOT COMPLETED|Overall Study||2027
3189024|NCT02039856|3916806|FG001|NOT COMPLETED|Overall Study||853
3189025|NCT02039908|3916814|FG000|STARTED|Phase 1-Summer||129
3189026|NCT02039908|3916815|FG001|STARTED|Phase 1-Summer||138
3189027|NCT02039908|3916816|FG002|STARTED|Phase 1-Summer||0
3189028|NCT02039908|3916817|FG003|STARTED|Phase 1-Summer||0
3189029|NCT02039908|3916814|FG000|COMPLETED|Phase 1-Summer||116
3189030|NCT02039908|3916815|FG001|COMPLETED|Phase 1-Summer||132
3189031|NCT02039908|3916816|FG002|COMPLETED|Phase 1-Summer||0
3189032|NCT02039908|3916817|FG003|COMPLETED|Phase 1-Summer||0
3189033|NCT02039908|3916814|FG000|NOT COMPLETED|Phase 1-Summer||13
3189034|NCT02039908|3916815|FG001|NOT COMPLETED|Phase 1-Summer||6
3189035|NCT02039908|3916816|FG002|NOT COMPLETED|Phase 1-Summer||0
3189036|NCT02039908|3916817|FG003|NOT COMPLETED|Phase 1-Summer||0
3189037|NCT02039908|3916814|FG000|STARTED|Phase 2-School Year||0
3189038|NCT02039908|3916815|FG001|STARTED|Phase 2-School Year||0
3189039|NCT02039908|3916816|FG002|STARTED|Phase 2-School Year||121
3189040|NCT02039908|3916817|FG003|STARTED|Phase 2-School Year||124
3189041|NCT02039908|3916814|FG000|COMPLETED|Phase 2-School Year||0
3189042|NCT02039908|3916815|FG001|COMPLETED|Phase 2-School Year||0
3189043|NCT02039908|3916816|FG002|COMPLETED|Phase 2-School Year||109
3189044|NCT02039908|3916817|FG003|COMPLETED|Phase 2-School Year||116
3189045|NCT02039908|3916814|FG000|NOT COMPLETED|Phase 2-School Year||0
3189046|NCT02039908|3916815|FG001|NOT COMPLETED|Phase 2-School Year||0
3189047|NCT02039908|3916816|FG002|NOT COMPLETED|Phase 2-School Year||12
3189048|NCT02039908|3916817|FG003|NOT COMPLETED|Phase 2-School Year||8
3189049|NCT02039947|3916829|FG000|STARTED|Overall Study||76
3189050|NCT02039947|3916830|FG001|STARTED|Overall Study||16
3189051|NCT02039947|3916831|FG002|STARTED|Overall Study||16
3189052|NCT02039947|3916832|FG003|STARTED|Overall Study||17
3189053|NCT02039947|3916829|FG000|COMPLETED|Overall Study||76
3189054|NCT02039947|3916830|FG001|COMPLETED|Overall Study||16
3189055|NCT02039947|3916831|FG002|COMPLETED|Overall Study||16
3189056|NCT02039947|3916832|FG003|COMPLETED|Overall Study||17
3189057|NCT02039947|3916829|FG000|NOT COMPLETED|Overall Study||0
3189058|NCT02039947|3916830|FG001|NOT COMPLETED|Overall Study||0
3189059|NCT02039947|3916831|FG002|NOT COMPLETED|Overall Study||0
3189060|NCT02039947|3916832|FG003|NOT COMPLETED|Overall Study||0
3189061|NCT02040077|3916849|FG000|STARTED|Overall Study||27
3189062|NCT02040077|3916850|FG001|STARTED|Overall Study||24
3189063|NCT02040077|3916851|FG002|STARTED|Overall Study||25
3189064|NCT02040077|3916849|FG000|COMPLETED|Overall Study||27
3189065|NCT02040077|3916850|FG001|COMPLETED|Overall Study||24
3189066|NCT02040077|3916851|FG002|COMPLETED|Overall Study||25
3189067|NCT02040077|3916849|FG000|NOT COMPLETED|Overall Study||0
3189068|NCT02040077|3916850|FG001|NOT COMPLETED|Overall Study||0
3189069|NCT02040077|3916851|FG002|NOT COMPLETED|Overall Study||0
3189070|NCT02040090|3916862|FG000|STARTED|Overall Study||59
3189071|NCT02040090|3916863|FG001|STARTED|Overall Study||59
3189072|NCT02040090|3916862|FG000|COMPLETED|Overall Study||56
3189073|NCT02040090|3916863|FG001|COMPLETED|Overall Study||57
3189074|NCT02040090|3916862|FG000|NOT COMPLETED|Overall Study||3
3189075|NCT02040090|3916863|FG001|NOT COMPLETED|Overall Study||2
3189076|NCT02040116|3916869|FG000|STARTED|Overall Study||19
3189077|NCT02040116|3916869|FG000|COMPLETED|Overall Study||19
3189078|NCT02040116|3916869|FG000|NOT COMPLETED|Overall Study||0
3189079|NCT02040259|3916877|FG000|STARTED|Overall Study||2008
3189080|NCT02040259|3916877|FG000|COMPLETED|Overall Study||1645
3189081|NCT02040259|3916877|FG000|NOT COMPLETED|Overall Study||363
3189082|NCT02040298|3916885|FG000|STARTED|First Intervention (3 Months)||25
3189083|NCT02040298|3916886|FG001|STARTED|First Intervention (3 Months)||25
3189084|NCT02040298|3916885|FG000|COMPLETED|First Intervention (3 Months)||25
3189085|NCT02040298|3916886|FG001|COMPLETED|First Intervention (3 Months)||25
3189086|NCT02040298|3916885|FG000|NOT COMPLETED|First Intervention (3 Months)||0
3189087|NCT02040298|3916886|FG001|NOT COMPLETED|First Intervention (3 Months)||0
3189088|NCT02040298|3916885|FG000|STARTED|Second Intervention (2 Months)||25
3189089|NCT02040298|3916886|FG001|STARTED|Second Intervention (2 Months)||25
3189090|NCT02040298|3916885|FG000|COMPLETED|Second Intervention (2 Months)||25
3189091|NCT02040298|3916886|FG001|COMPLETED|Second Intervention (2 Months)||25
3189092|NCT02040298|3916885|FG000|NOT COMPLETED|Second Intervention (2 Months)||0
3189093|NCT02040298|3916886|FG001|NOT COMPLETED|Second Intervention (2 Months)||0
3189094|NCT02040428|3916900|FG000|STARTED|Overall Study||75
3189095|NCT02040428|3916901|FG001|STARTED|Overall Study||81
3189096|NCT02040428|3916900|FG000|Intent to Treat (Randomized Subjects)|Overall Study||76
3189097|NCT02040428|3916901|FG001|Intent to Treat (Randomized Subjects)|Overall Study||80
3189098|NCT02040428|3916900|FG000|COMPLETED|Overall Study||70
3189099|NCT02040428|3916901|FG001|COMPLETED|Overall Study||77
3189100|NCT02040428|3916900|FG000|NOT COMPLETED|Overall Study||5
3189101|NCT02040428|3916901|FG001|NOT COMPLETED|Overall Study||4
3189102|NCT02040532|3916907|FG000|STARTED|Overall Study||32
3189103|NCT02040532|3916907|FG000|Received at Least One Dose of Medication|Overall Study||26
3189104|NCT02040532|3916907|FG000|COMPLETED|Overall Study||20
3189105|NCT02040532|3916907|FG000|NOT COMPLETED|Overall Study||12
3189106|NCT02040623|3916914|FG000|STARTED|Overall Study||11
3189107|NCT02040623|3916915|FG001|STARTED|Overall Study||12
3189108|NCT02040623|3916916|FG002|STARTED|Overall Study||12
3189109|NCT02040623|3916914|FG000|COMPLETED|Overall Study||7
3189110|NCT02040623|3916915|FG001|COMPLETED|Overall Study||6
3189111|NCT02040623|3916916|FG002|COMPLETED|Overall Study||10
3189112|NCT02040623|3916914|FG000|NOT COMPLETED|Overall Study||4
3189113|NCT02040623|3916915|FG001|NOT COMPLETED|Overall Study||6
3189114|NCT02040623|3916916|FG002|NOT COMPLETED|Overall Study||2
3189115|NCT02040766|3916929|FG000|STARTED|Overall Study||127
3189116|NCT02040766|3916930|FG001|STARTED|Overall Study||126
3189117|NCT02040766|3916931|FG002|STARTED|Overall Study||125
3189118|NCT02040766|3916932|FG003|STARTED|Overall Study||125
3189119|NCT02040766|3916933|FG004|STARTED|Overall Study||125
3189120|NCT02040766|3916929|FG000|COMPLETED|Overall Study||109
3189121|NCT02040766|3916930|FG001|COMPLETED|Overall Study||116
3189122|NCT02040766|3916931|FG002|COMPLETED|Overall Study||113
3189123|NCT02040766|3916932|FG003|COMPLETED|Overall Study||112
3189124|NCT02040766|3916933|FG004|COMPLETED|Overall Study||112
3189125|NCT02040766|3916929|FG000|NOT COMPLETED|Overall Study||18
3189126|NCT02040766|3916930|FG001|NOT COMPLETED|Overall Study||10
3189127|NCT02040766|3916931|FG002|NOT COMPLETED|Overall Study||12
3189128|NCT02040766|3916932|FG003|NOT COMPLETED|Overall Study||13
3189129|NCT02040766|3916933|FG004|NOT COMPLETED|Overall Study||13
3189130|NCT02040779|3916949|FG000|STARTED|Overall Study||91
3189131|NCT02040779|3916950|FG001|STARTED|Overall Study||90
3189132|NCT02040779|3916951|FG002|STARTED|Overall Study||92
3189133|NCT02040779|3916949|FG000|Full Analysis Set (FAS)|Overall Study||90
3189134|NCT02040779|3916950|FG001|Full Analysis Set (FAS)|Overall Study||88
3189135|NCT02040779|3916951|FG002|Full Analysis Set (FAS)|Overall Study||92
3189136|NCT02040779|3916949|FG000|COMPLETED|Overall Study||79
3189137|NCT02040779|3916950|FG001|COMPLETED|Overall Study||83
3189138|NCT02040779|3916951|FG002|COMPLETED|Overall Study||88
3189139|NCT02040779|3916949|FG000|NOT COMPLETED|Overall Study||12
3189140|NCT02040779|3916950|FG001|NOT COMPLETED|Overall Study||7
3189141|NCT02040779|3916951|FG002|NOT COMPLETED|Overall Study||4
3189142|NCT02040805|3916961|FG000|STARTED|Overall Study||160
3189143|NCT02040805|3916962|FG001|STARTED|Overall Study||163
3364139|NCT04025684|4095337|FG000|COMPLETED|Overall Study||18
3364140|NCT04025684|4095338|FG001|COMPLETED|Overall Study||15
3364141|NCT04025684|4095339|FG002|COMPLETED|Overall Study||20
3364142|NCT04025684|4095340|FG003|COMPLETED|Overall Study||20
3364143|NCT04025684|4095337|FG000|NOT COMPLETED|Overall Study||2
3364144|NCT04025684|4095338|FG001|NOT COMPLETED|Overall Study||4
3364145|NCT04025684|4095339|FG002|NOT COMPLETED|Overall Study||0
3364146|NCT04025684|4095340|FG003|NOT COMPLETED|Overall Study||1
3364147|NCT04019054|4095352|FG000|STARTED|Overall Study||11
3364148|NCT04019054|4095353|FG001|STARTED|Overall Study||11
3364149|NCT04019054|4095352|FG000|COMPLETED|Overall Study||8
3364150|NCT04019054|4095353|FG001|COMPLETED|Overall Study||9
3364151|NCT04019054|4095352|FG000|NOT COMPLETED|Overall Study||3
3364152|NCT04019054|4095353|FG001|NOT COMPLETED|Overall Study||2
3364153|NCT04029545|4095362|FG000|STARTED|Overall Study||2
3364154|NCT04029545|4095363|FG001|STARTED|Overall Study||1
3364155|NCT04029545|4095364|FG002|STARTED|Overall Study||2
3364156|NCT04029545|4095362|FG000|COMPLETED|Overall Study||2
3364157|NCT04029545|4095363|FG001|COMPLETED|Overall Study||1
3364158|NCT04029545|4095364|FG002|COMPLETED|Overall Study||2
3364159|NCT04029545|4095362|FG000|NOT COMPLETED|Overall Study||0
3364160|NCT04029545|4095363|FG001|NOT COMPLETED|Overall Study||0
3364161|NCT04029545|4095364|FG002|NOT COMPLETED|Overall Study||0
3364162|NCT04029584|4095372|FG000|STARTED|Uninduced Study 1st Intervention (1 Day)||4
3364163|NCT04029584|4095373|FG001|STARTED|Uninduced Study 1st Intervention (1 Day)||6
3364164|NCT04029584|4095372|FG000|COMPLETED|Uninduced Study 1st Intervention (1 Day)||4
3364165|NCT04029584|4095373|FG001|COMPLETED|Uninduced Study 1st Intervention (1 Day)||6
3364166|NCT04029584|4095372|FG000|NOT COMPLETED|Uninduced Study 1st Intervention (1 Day)||0
3364167|NCT04029584|4095373|FG001|NOT COMPLETED|Uninduced Study 1st Intervention (1 Day)||0
3364168|NCT04029584|4095372|FG000|STARTED|Uninduced Washout (1 Day)||4
3364169|NCT04029584|4095373|FG001|STARTED|Uninduced Washout (1 Day)||6
3364170|NCT04029584|4095372|FG000|COMPLETED|Uninduced Washout (1 Day)||4
3364171|NCT04029584|4095373|FG001|COMPLETED|Uninduced Washout (1 Day)||6
3364172|NCT04029584|4095372|FG000|NOT COMPLETED|Uninduced Washout (1 Day)||0
3364173|NCT04029584|4095373|FG001|NOT COMPLETED|Uninduced Washout (1 Day)||0
3364174|NCT04029584|4095372|FG000|STARTED|Uninduced Study 2nd Intervention (1 Day)||4
3364175|NCT04029584|4095373|FG001|STARTED|Uninduced Study 2nd Intervention (1 Day)||6
3364176|NCT04029584|4095372|FG000|COMPLETED|Uninduced Study 2nd Intervention (1 Day)||4
3364177|NCT04029584|4095373|FG001|COMPLETED|Uninduced Study 2nd Intervention (1 Day)||6
3364178|NCT04029584|4095372|FG000|NOT COMPLETED|Uninduced Study 2nd Intervention (1 Day)||0
3364179|NCT04029584|4095373|FG001|NOT COMPLETED|Uninduced Study 2nd Intervention (1 Day)||0
3364180|NCT04029584|4095372|FG000|STARTED|Washout Between (>1 Week)||4
3364181|NCT04029584|4095373|FG001|STARTED|Washout Between (>1 Week)||6
3364182|NCT04029584|4095372|FG000|COMPLETED|Washout Between (>1 Week)||4
3189144|NCT02040805|3916961|FG000|COMPLETED|Overall Study||118
3189145|NCT02040805|3916962|FG001|COMPLETED|Overall Study||113
3189146|NCT02040805|3916961|FG000|NOT COMPLETED|Overall Study||42
3189147|NCT02040805|3916962|FG001|NOT COMPLETED|Overall Study||50
3189148|NCT02040844|3916971|FG000|STARTED|Overall Study||138
3189149|NCT02040844|3916972|FG001|STARTED|Overall Study||148
3189150|NCT02040844|3916973|FG002|STARTED|Overall Study||144
3189151|NCT02040844|3916971|FG000|COMPLETED|Overall Study||88
3189152|NCT02040844|3916972|FG001|COMPLETED|Overall Study||109
3189153|NCT02040844|3916973|FG002|COMPLETED|Overall Study||97
3189154|NCT02040844|3916971|FG000|NOT COMPLETED|Overall Study||50
3189155|NCT02040844|3916972|FG001|NOT COMPLETED|Overall Study||39
3189156|NCT02040844|3916973|FG002|NOT COMPLETED|Overall Study||47
3189157|NCT02040857|3916981|FG000|STARTED|Overall Study||162
3189158|NCT02040857|3916981|FG000|Treatment Discontinuation Evaluable|Overall Study|Evaluable population excludes participants who discontinue early for reasons unrelated to treatment.|152
3189159|NCT02040857|3916981|FG000|COMPLETED|Overall Study||102
3189160|NCT02040857|3916981|FG000|NOT COMPLETED|Overall Study||60
3189161|NCT02040870|3916988|FG000|STARTED|Overall Study||103
3189162|NCT02040870|3916988|FG000|Entered Post-treatment Follow-up|Overall Study||2
3189163|NCT02040870|3916988|FG000|Entered Survival Follow-up|Overall Study||75
3189164|NCT02040870|3916988|FG000|Discontinue From Study|Overall Study||26
3189165|NCT02040870|3916988|FG000|COMPLETED|Overall Study||0
3189166|NCT02040870|3916988|FG000|NOT COMPLETED|Overall Study||103
3189167|NCT02041091|3916994|FG000|STARTED|Treatment||112
3189168|NCT02041091|3916995|FG001|STARTED|Treatment||114
3189169|NCT02041091|3916994|FG000|Received At Least One Dose of Study Drug|Treatment||112
3189170|NCT02041091|3916995|FG001|Received At Least One Dose of Study Drug|Treatment||114
3189171|NCT02041091|3916994|FG000|Participated in Follow Up|Treatment||106
3189172|NCT02041091|3916995|FG001|Participated in Follow Up|Treatment||96
3189173|NCT02041091|3916994|FG000|COMPLETED|Treatment||90
3189174|NCT02041091|3916995|FG001|COMPLETED|Treatment||91
3189175|NCT02041091|3916994|FG000|NOT COMPLETED|Treatment||22
3189176|NCT02041091|3916995|FG001|NOT COMPLETED|Treatment||23
3189177|NCT02041091|3916994|FG000|STARTED|Optional Safety Extension Period|Participation was optional for the Safety Extension Period.|85
3189178|NCT02041091|3916995|FG001|STARTED|Optional Safety Extension Period|Participation was optional for the Safety Extension Period.|82
3189179|NCT02041091|3916994|FG000|COMPLETED|Optional Safety Extension Period||0
3189180|NCT02041091|3916995|FG001|COMPLETED|Optional Safety Extension Period||0
3189181|NCT02041091|3916994|FG000|NOT COMPLETED|Optional Safety Extension Period||85
3189182|NCT02041091|3916995|FG001|NOT COMPLETED|Optional Safety Extension Period||82
3189183|NCT02041104|3917009|FG000|STARTED|Overall Study||28
3189184|NCT02041104|3917010|FG001|STARTED|Overall Study||23
3189185|NCT02041104|3917009|FG000|COMPLETED|Overall Study||27
3189186|NCT02041104|3917010|FG001|COMPLETED|Overall Study||16
3189187|NCT02041104|3917009|FG000|NOT COMPLETED|Overall Study||1
3189188|NCT02041104|3917010|FG001|NOT COMPLETED|Overall Study||7
3189189|NCT02041221|3917024|FG000|STARTED|Part 1||6
3189190|NCT02041221|3917025|FG001|STARTED|Part 1||6
3189191|NCT02041221|3917026|FG002|STARTED|Part 1||6
3189192|NCT02041221|3917027|FG003|STARTED|Part 1||6
3189193|NCT02041221|3917028|FG004|STARTED|Part 1||6
3189194|NCT02041221|3917029|FG005|STARTED|Part 1||10
3189195|NCT02041221|3917024|FG000|COMPLETED|Part 1||6
3189196|NCT02041221|3917025|FG001|COMPLETED|Part 1||6
3189197|NCT02041221|3917026|FG002|COMPLETED|Part 1||6
3189198|NCT02041221|3917027|FG003|COMPLETED|Part 1||6
3189199|NCT02041221|3917028|FG004|COMPLETED|Part 1||6
3189200|NCT02041221|3917029|FG005|COMPLETED|Part 1||10
3189201|NCT02041221|3917024|FG000|NOT COMPLETED|Part 1||0
3189202|NCT02041221|3917025|FG001|NOT COMPLETED|Part 1||0
3189203|NCT02041221|3917026|FG002|NOT COMPLETED|Part 1||0
3189204|NCT02041221|3917027|FG003|NOT COMPLETED|Part 1||0
3189205|NCT02041221|3917028|FG004|NOT COMPLETED|Part 1||0
3189206|NCT02041221|3917029|FG005|NOT COMPLETED|Part 1||0
3189207|NCT02041221|3917024|FG000|STARTED|Part 2||6
3189208|NCT02041221|3917025|FG001|STARTED|Part 2||6
3189209|NCT02041221|3917026|FG002|STARTED|Part 2||6
3189210|NCT02041221|3917027|FG003|STARTED|Part 2|Part 1 data fields are by default copied in Part 2. There is no dose 4 and 5 actually.|0
3189211|NCT02041221|3917028|FG004|STARTED|Part 2|Part 1 data fields are by default copied in Part 2. There is no dose 4 and 5 actually|0
3189212|NCT02041221|3917029|FG005|STARTED|Part 2||6
3189213|NCT02041221|3917024|FG000|COMPLETED|Part 2||6
3189214|NCT02041221|3917025|FG001|COMPLETED|Part 2||6
3189215|NCT02041221|3917026|FG002|COMPLETED|Part 2||5
3189216|NCT02041221|3917027|FG003|COMPLETED|Part 2|Part 1 data fields are by default copied in Part 2. There is no dose 4 and 5 actually|0
3189217|NCT02041221|3917028|FG004|COMPLETED|Part 2|Part 1 data fields are by default copied in Part 2. There is no dose 4 and 5 actually|0
3189218|NCT02041221|3917029|FG005|COMPLETED|Part 2||6
3189219|NCT02041221|3917024|FG000|NOT COMPLETED|Part 2||0
3189220|NCT02041221|3917025|FG001|NOT COMPLETED|Part 2||0
3189221|NCT02041221|3917026|FG002|NOT COMPLETED|Part 2||1
3189222|NCT02041221|3917027|FG003|NOT COMPLETED|Part 2||0
3189223|NCT02041221|3917028|FG004|NOT COMPLETED|Part 2||0
3189224|NCT02041221|3917029|FG005|NOT COMPLETED|Part 2||0
3189225|NCT02041286|3917043|FG000|STARTED|Overall Study||136
3189226|NCT02041286|3917043|FG000|COMPLETED|Overall Study|One subject discontinued from testing after low BG fingerstick result (hypoglycemia AE).|135
3189227|NCT02041286|3917043|FG000|NOT COMPLETED|Overall Study||1
3189228|NCT02041299|3917051|FG000|STARTED|Overall Study||152
3189229|NCT02041299|3917052|FG001|STARTED|Overall Study|Two participants double-enrolled under different subject numbers so were each counted twice.|78
3189230|NCT02041299|3917051|FG000|COMPLETED|Overall Study||106
3189231|NCT02041299|3917052|FG001|COMPLETED|Overall Study||58
3189232|NCT02041299|3917051|FG000|NOT COMPLETED|Overall Study||46
3189233|NCT02041299|3917052|FG001|NOT COMPLETED|Overall Study||20
3189234|NCT02041325|3917064|FG000|STARTED|Overall Study||22
3189235|NCT02041325|3917065|FG001|STARTED|Overall Study||16
3189236|NCT02041325|3917064|FG000|COMPLETED|Overall Study||19
3189237|NCT02041325|3917065|FG001|COMPLETED|Overall Study||13
3189238|NCT02041325|3917064|FG000|NOT COMPLETED|Overall Study||3
3189239|NCT02041325|3917065|FG001|NOT COMPLETED|Overall Study||3
3189240|NCT02041377|3917075|FG000|STARTED|Overall Study||134
3189241|NCT02041377|3917075|FG000|COMPLETED|Overall Study||134
3189242|NCT02041377|3917075|FG000|NOT COMPLETED|Overall Study||0
3189243|NCT02041429|3917083|FG000|STARTED|Overall Study||3
3189244|NCT02041429|3917084|FG001|STARTED|Overall Study||4
3189245|NCT02041429|3917085|FG002|STARTED|Overall Study||7
3189246|NCT02041429|3917086|FG003|STARTED|Overall Study||6
3189247|NCT02041429|3917083|FG000|Treated|Overall Study||3
3189248|NCT02041429|3917084|FG001|Treated|Overall Study||3
3189249|NCT02041429|3917085|FG002|Treated|Overall Study||7
3189250|NCT02041429|3917086|FG003|Treated|Overall Study||6
3189251|NCT02041429|3917083|FG000|Evaluable for Dose Limiting Toxicity|Overall Study||3
3189252|NCT02041429|3917084|FG001|Evaluable for Dose Limiting Toxicity|Overall Study||3
3189253|NCT02041429|3917085|FG002|Evaluable for Dose Limiting Toxicity|Overall Study||6
3189254|NCT02041429|3917086|FG003|Evaluable for Dose Limiting Toxicity|Overall Study||6
3189255|NCT02041429|3917083|FG000|COMPLETED|Overall Study||0
3189256|NCT02041429|3917084|FG001|COMPLETED|Overall Study||0
3189257|NCT02041429|3917085|FG002|COMPLETED|Overall Study||0
3189258|NCT02041429|3917086|FG003|COMPLETED|Overall Study||0
3189259|NCT02041429|3917083|FG000|NOT COMPLETED|Overall Study||3
3189260|NCT02041429|3917084|FG001|NOT COMPLETED|Overall Study||4
3189261|NCT02041429|3917085|FG002|NOT COMPLETED|Overall Study||7
3189262|NCT02041429|3917086|FG003|NOT COMPLETED|Overall Study||6
3189263|NCT02041494|3917103|FG000|STARTED|Overall Study||82
3189264|NCT02041494|3917104|FG001|STARTED|Overall Study||83
3189265|NCT02041494|3917103|FG000|COMPLETED|Overall Study||63
3189266|NCT02041494|3917104|FG001|COMPLETED|Overall Study||63
3189267|NCT02041494|3917103|FG000|NOT COMPLETED|Overall Study||19
3189268|NCT02041494|3917104|FG001|NOT COMPLETED|Overall Study||20
3189269|NCT02041520|3917113|FG000|STARTED|Overall Study|35 patients randomly assigned to omega 3 fatty acids|35
3189270|NCT02041520|3917114|FG001|STARTED|Overall Study|35 patients randomly assigned to placebo|35
3189271|NCT02041520|3917113|FG000|COMPLETED|Overall Study||29
3189272|NCT02041520|3917114|FG001|COMPLETED|Overall Study||28
3189273|NCT02041520|3917113|FG000|NOT COMPLETED|Overall Study||6
3189274|NCT02041520|3917114|FG001|NOT COMPLETED|Overall Study||7
3189275|NCT02041533|3917124|FG000|STARTED|Overall Study||271
3189276|NCT02041533|3917125|FG001|STARTED|Overall Study||270
3189277|NCT02041533|3917124|FG000|Began Treatment|Overall Study||267
3189278|NCT02041533|3917125|FG001|Began Treatment|Overall Study||263
3189279|NCT02041533|3917124|FG000|COMPLETED|Overall Study|Completed = Participants continuing in the treatment period|43
3189280|NCT02041533|3917125|FG001|COMPLETED|Overall Study|Completed = Participants continuing in the treatment period|12
3189281|NCT02041533|3917124|FG000|NOT COMPLETED|Overall Study||228
3189282|NCT02041533|3917125|FG001|NOT COMPLETED|Overall Study||258
3189283|NCT02041702|3917133|FG000|STARTED|Overall Study||140
3189284|NCT02041702|3917134|FG001|STARTED|Overall Study||143
3189285|NCT02041702|3917133|FG000|Pre MRI Scan/ Pre Waitng|Overall Study||129
3189286|NCT02041702|3917134|FG001|Pre MRI Scan/ Pre Waitng|Overall Study||140
3189287|NCT02041702|3917133|FG000|Post MRI Scan/ Post Waiting|Overall Study||129
3189288|NCT02041702|3917134|FG001|Post MRI Scan/ Post Waiting|Overall Study||140
3189289|NCT02041702|3917133|FG000|COMPLETED|Overall Study||129
3189290|NCT02041702|3917134|FG001|COMPLETED|Overall Study||134
3189291|NCT02041702|3917133|FG000|NOT COMPLETED|Overall Study||11
3189292|NCT02041702|3917134|FG001|NOT COMPLETED|Overall Study||9
3189293|NCT02041923|3917142|FG000|STARTED|Overall Study||102
3189294|NCT02041923|3917143|FG001|STARTED|Overall Study||96
3189295|NCT02041923|3917142|FG000|COMPLETED|Overall Study||76
3189296|NCT02041923|3917143|FG001|COMPLETED|Overall Study||66
3189297|NCT02041923|3917142|FG000|NOT COMPLETED|Overall Study||26
3189298|NCT02041923|3917143|FG001|NOT COMPLETED|Overall Study||30
3189299|NCT02041962|3917153|FG000|STARTED|Overall Study||123
3189300|NCT02041962|3917154|FG001|STARTED|Overall Study||115
3189301|NCT02041962|3917153|FG000|Participants Completing 6 mo. f/up|Overall Study||69
3189302|NCT02041962|3917154|FG001|Participants Completing 6 mo. f/up|Overall Study||44
3189303|NCT02041962|3917153|FG000|Participants Completing 12 mo. f/up|Overall Study||42
3189304|NCT02041962|3917154|FG001|Participants Completing 12 mo. f/up|Overall Study||31
3189305|NCT02041962|3917153|FG000|COMPLETED|Overall Study||42
3189306|NCT02041962|3917154|FG001|COMPLETED|Overall Study||31
3189307|NCT02041962|3917153|FG000|NOT COMPLETED|Overall Study||81
3189308|NCT02041962|3917154|FG001|NOT COMPLETED|Overall Study||84
3189309|NCT02042014|3917160|FG000|STARTED|Overall Study||8
3189310|NCT02042014|3917160|FG000|COMPLETED|Overall Study||0
3189311|NCT02042014|3917160|FG000|NOT COMPLETED|Overall Study||8
3189312|NCT02042131|3917167|FG000|STARTED|Overall Study||32
3189313|NCT02042131|3917168|FG001|STARTED|Overall Study||32
3189314|NCT02042131|3917169|FG002|STARTED|Overall Study||33
3189315|NCT02042131|3917167|FG000|COMPLETED|Overall Study||32
3189316|NCT02042131|3917168|FG001|COMPLETED|Overall Study||32
3189317|NCT02042131|3917169|FG002|COMPLETED|Overall Study||33
3189318|NCT02042131|3917167|FG000|NOT COMPLETED|Overall Study||0
3189319|NCT02042131|3917168|FG001|NOT COMPLETED|Overall Study||0
3189320|NCT02042131|3917169|FG002|NOT COMPLETED|Overall Study||0
3189321|NCT02042183|3917181|FG000|STARTED|Overall Study||404
3189322|NCT02042183|3917182|FG001|STARTED|Overall Study||202
3189323|NCT02042183|3917181|FG000|Safety Population|Overall Study||400
3189324|NCT02042183|3917182|FG001|Safety Population|Overall Study||195
3189325|NCT02042183|3917181|FG000|Modified Intent-to-treat (mITT)|Overall Study||399
3189326|NCT02042183|3917182|FG001|Modified Intent-to-treat (mITT)|Overall Study||195
3189327|NCT02042183|3917181|FG000|COMPLETED|Overall Study||339
3189328|NCT02042183|3917182|FG001|COMPLETED|Overall Study||166
3189329|NCT02042183|3917181|FG000|NOT COMPLETED|Overall Study||65
3189330|NCT02042183|3917182|FG001|NOT COMPLETED|Overall Study||36
3189331|NCT02042274|3917190|FG000|STARTED|Overall Study||12
3189332|NCT02042274|3917190|FG000|COMPLETED|Overall Study||12
3189333|NCT02042274|3917190|FG000|NOT COMPLETED|Overall Study||0
3189334|NCT02042404|3917194|FG000|STARTED|Overall Study|Enrollment was stopped after 43 were enrolled, had approval to enroll 45 primary cohort subjects|43
3189335|NCT02042404|3917195|FG001|STARTED|Overall Study||5
3189336|NCT02042404|3917194|FG000|COMPLETED|Overall Study|39 subjects completed 30 days evaluation. 38 subjects completed 120 days evaluation.|38
3189337|NCT02042404|3917195|FG001|COMPLETED|Overall Study||5
3189338|NCT02042404|3917194|FG000|NOT COMPLETED|Overall Study||5
3189339|NCT02042404|3917195|FG001|NOT COMPLETED|Overall Study||0
3189340|NCT02042443|3917204|FG000|STARTED|Overall Study||27
3189341|NCT02042443|3917205|FG001|STARTED|Overall Study||26
3189342|NCT02042443|3917204|FG000|Eligible and Analyzable|Overall Study||24
3189343|NCT02042443|3917205|FG001|Eligible and Analyzable|Overall Study||20
3189344|NCT02042443|3917204|FG000|COMPLETED|Overall Study||0
3189345|NCT02042443|3917205|FG001|COMPLETED|Overall Study||0
3189346|NCT02042443|3917204|FG000|NOT COMPLETED|Overall Study||27
3189347|NCT02042443|3917205|FG001|NOT COMPLETED|Overall Study||26
3189348|NCT02042534|3917214|FG000|STARTED|Overall Study||101
3189349|NCT02042534|3917215|FG001|STARTED|Overall Study||94
3189350|NCT02042534|3917214|FG000|COMPLETED|Overall Study||101
3189351|NCT02042534|3917215|FG001|COMPLETED|Overall Study||94
3189352|NCT02042534|3917214|FG000|NOT COMPLETED|Overall Study||0
3189353|NCT02042534|3917215|FG001|NOT COMPLETED|Overall Study||0
3189354|NCT02042872|3917223|FG000|STARTED|Overall Study||8
3189355|NCT02042872|3917224|FG001|STARTED|Overall Study||13
3189356|NCT02042872|3917223|FG000|COMPLETED|Overall Study||8
3189357|NCT02042872|3917224|FG001|COMPLETED|Overall Study||8
3189358|NCT02042872|3917223|FG000|NOT COMPLETED|Overall Study||0
3189359|NCT02042872|3917224|FG001|NOT COMPLETED|Overall Study||5
3189360|NCT02042911|3917230|FG000|STARTED|Overall Study||10
3189361|NCT02042911|3917230|FG000|COMPLETED|Overall Study||9
3189362|NCT02042911|3917230|FG000|NOT COMPLETED|Overall Study||1
3189363|NCT02043015|3917234|FG000|STARTED|Overall Study||115
3189364|NCT02043015|3917234|FG000|COMPLETED|Overall Study||87
3189365|NCT02043015|3917234|FG000|NOT COMPLETED|Overall Study||28
3189366|NCT02043132|3917242|FG000|STARTED|Overall Study||58
3189367|NCT02043132|3917243|FG001|STARTED|Overall Study||58
3189368|NCT02043132|3917242|FG000|COMPLETED|Overall Study||53
3189369|NCT02043132|3917243|FG001|COMPLETED|Overall Study||49
3189370|NCT02043132|3917242|FG000|NOT COMPLETED|Overall Study||5
3189371|NCT02043132|3917243|FG001|NOT COMPLETED|Overall Study||9
3189372|NCT02043145|3917252|FG000|STARTED|Overall Study||55
3189373|NCT02043145|3917253|FG001|STARTED|Overall Study||247
3189374|NCT02043145|3917254|FG002|STARTED|Overall Study||425
3189375|NCT02043145|3917252|FG000|COMPLETED|Overall Study||55
3189376|NCT02043145|3917253|FG001|COMPLETED|Overall Study||247
3189377|NCT02043145|3917254|FG002|COMPLETED|Overall Study||425
3189378|NCT02043145|3917252|FG000|NOT COMPLETED|Overall Study||0
3189379|NCT02043145|3917253|FG001|NOT COMPLETED|Overall Study||0
3189380|NCT02043145|3917254|FG002|NOT COMPLETED|Overall Study||0
3189381|NCT02043197|3917264|FG000|STARTED|Overall Study||300
3189382|NCT02043197|3917264|FG000|COMPLETED|Overall Study||292
3189383|NCT02043197|3917264|FG000|NOT COMPLETED|Overall Study||8
3189384|NCT02043301|3917271|FG000|STARTED|Overall Study||25
3189385|NCT02043301|3917272|FG001|STARTED|Overall Study||25
3189386|NCT02043301|3917273|FG002|STARTED|Overall Study||25
3189387|NCT02043301|3917271|FG000|COMPLETED|Overall Study||25
3189388|NCT02043301|3917272|FG001|COMPLETED|Overall Study||24
3189389|NCT02043301|3917273|FG002|COMPLETED|Overall Study||25
3189390|NCT02043301|3917271|FG000|NOT COMPLETED|Overall Study||0
3189391|NCT02043301|3917272|FG001|NOT COMPLETED|Overall Study||1
3189392|NCT02043301|3917273|FG002|NOT COMPLETED|Overall Study||0
3189393|NCT02043366|3917287|FG000|STARTED|Overall Study||30
3189394|NCT02043366|3917288|FG001|STARTED|Overall Study||30
3189395|NCT02043366|3917289|FG002|STARTED|Overall Study||30
3189396|NCT02043366|3917290|FG003|STARTED|Overall Study||30
3189397|NCT02043366|3917291|FG004|STARTED|Overall Study||30
3189398|NCT02043366|3917292|FG005|STARTED|Overall Study||30
3189399|NCT02043366|3917287|FG000|COMPLETED|Overall Study||28
3189400|NCT02043366|3917288|FG001|COMPLETED|Overall Study||28
3189401|NCT02043366|3917289|FG002|COMPLETED|Overall Study||28
3189402|NCT02043366|3917290|FG003|COMPLETED|Overall Study||28
3189403|NCT02043366|3917291|FG004|COMPLETED|Overall Study||28
3189404|NCT02043366|3917292|FG005|COMPLETED|Overall Study||28
3189405|NCT02043366|3917287|FG000|NOT COMPLETED|Overall Study||2
3189406|NCT02043366|3917288|FG001|NOT COMPLETED|Overall Study||2
3189407|NCT02043366|3917289|FG002|NOT COMPLETED|Overall Study||2
3189408|NCT02043366|3917290|FG003|NOT COMPLETED|Overall Study||2
3189409|NCT02043366|3917291|FG004|NOT COMPLETED|Overall Study||2
3189410|NCT02043366|3917292|FG005|NOT COMPLETED|Overall Study||2
3189411|NCT02043379|3917310|FG000|STARTED|Overall Study||30
3189412|NCT02043379|3917311|FG001|STARTED|Overall Study||20
3189413|NCT02043379|3917310|FG000|COMPLETED|Overall Study||30
3189414|NCT02043379|3917311|FG001|COMPLETED|Overall Study||20
3189415|NCT02043379|3917310|FG000|NOT COMPLETED|Overall Study||0
3189416|NCT02043379|3917311|FG001|NOT COMPLETED|Overall Study||0
3189417|NCT02043509|3917319|FG000|STARTED|Baseline to 1st Follow-up||203
3189418|NCT02043509|3917320|FG001|STARTED|Baseline to 1st Follow-up||204
3189419|NCT02043509|3917319|FG000|COMPLETED|Baseline to 1st Follow-up||138
3189420|NCT02043509|3917320|FG001|COMPLETED|Baseline to 1st Follow-up||157
3189421|NCT02043509|3917319|FG000|NOT COMPLETED|Baseline to 1st Follow-up||65
3189422|NCT02043509|3917320|FG001|NOT COMPLETED|Baseline to 1st Follow-up||47
3189423|NCT02043509|3917319|FG000|STARTED|Baseline to 2nd Follow-up||203
3189424|NCT02043509|3917320|FG001|STARTED|Baseline to 2nd Follow-up||204
3189425|NCT02043509|3917319|FG000|COMPLETED|Baseline to 2nd Follow-up||129
3189426|NCT02043509|3917320|FG001|COMPLETED|Baseline to 2nd Follow-up||132
3189427|NCT02043509|3917319|FG000|NOT COMPLETED|Baseline to 2nd Follow-up||74
3189428|NCT02043509|3917320|FG001|NOT COMPLETED|Baseline to 2nd Follow-up||72
3189429|NCT02043548|3917328|FG000|STARTED|Overall Study||18
3189430|NCT02043548|3917329|FG001|STARTED|Overall Study||18
3189431|NCT02043548|3917328|FG000|COMPLETED|Overall Study||17
3189432|NCT02043548|3917329|FG001|COMPLETED|Overall Study||17
3189433|NCT02043548|3917328|FG000|NOT COMPLETED|Overall Study||1
3189434|NCT02043548|3917329|FG001|NOT COMPLETED|Overall Study||1
3189435|NCT02043574|3917337|FG000|STARTED|Overall Study||25
3189436|NCT02043574|3917338|FG001|STARTED|Overall Study||26
3189437|NCT02043574|3917337|FG000|COMPLETED|Overall Study||19
3189438|NCT02043574|3917338|FG001|COMPLETED|Overall Study||20
3189439|NCT02043574|3917337|FG000|NOT COMPLETED|Overall Study||6
3189440|NCT02043574|3917338|FG001|NOT COMPLETED|Overall Study||6
3189441|NCT02043652|3917345|FG000|STARTED|Overall Study||119
3189442|NCT02043652|3917345|FG000|COMPLETED|Overall Study||93
3189443|NCT02043652|3917345|FG000|NOT COMPLETED|Overall Study||26
3189444|NCT02043704|3917351|FG000|STARTED|Overall Study||50
3189445|NCT02043704|3917352|FG001|STARTED|Overall Study||50
3189446|NCT02043704|3917351|FG000|COMPLETED|Overall Study||47
3189447|NCT02043704|3917352|FG001|COMPLETED|Overall Study||43
3189448|NCT02043704|3917351|FG000|NOT COMPLETED|Overall Study||3
3189449|NCT02043704|3917352|FG001|NOT COMPLETED|Overall Study||7
3189450|NCT02043782|3917358|FG000|STARTED|Period 1||7
3189451|NCT02043782|3917359|FG001|STARTED|Period 1||6
3189452|NCT02043782|3917360|FG002|STARTED|Period 1||7
3189453|NCT02043782|3917361|FG003|STARTED|Period 1||6
3189454|NCT02043782|3917362|FG004|STARTED|Period 1||6
3189455|NCT02043782|3917363|FG005|STARTED|Period 1||6
3189456|NCT02043782|3917358|FG000|COMPLETED|Period 1||7
3189457|NCT02043782|3917359|FG001|COMPLETED|Period 1||6
3189458|NCT02043782|3917360|FG002|COMPLETED|Period 1|One subject discontinued due to an adverse event while testing own product|6
3189459|NCT02043782|3917361|FG003|COMPLETED|Period 1||6
3189460|NCT02043782|3917362|FG004|COMPLETED|Period 1||6
3189461|NCT02043782|3917363|FG005|COMPLETED|Period 1||6
3189462|NCT02043782|3917358|FG000|NOT COMPLETED|Period 1||0
3189463|NCT02043782|3917359|FG001|NOT COMPLETED|Period 1||0
3189464|NCT02043782|3917360|FG002|NOT COMPLETED|Period 1||1
3189465|NCT02043782|3917361|FG003|NOT COMPLETED|Period 1||0
3189466|NCT02043782|3917362|FG004|NOT COMPLETED|Period 1||0
3189467|NCT02043782|3917363|FG005|NOT COMPLETED|Period 1||0
3189468|NCT02043782|3917358|FG000|STARTED|Period 2||7
3189469|NCT02043782|3917359|FG001|STARTED|Period 2||6
3189470|NCT02043782|3917360|FG002|STARTED|Period 2||6
3189471|NCT02043782|3917361|FG003|STARTED|Period 2||6
3189472|NCT02043782|3917362|FG004|STARTED|Period 2||6
3189473|NCT02043782|3917363|FG005|STARTED|Period 2||6
3189474|NCT02043782|3917358|FG000|COMPLETED|Period 2||7
3189475|NCT02043782|3917359|FG001|COMPLETED|Period 2||6
3189476|NCT02043782|3917360|FG002|COMPLETED|Period 2||6
3189477|NCT02043782|3917361|FG003|COMPLETED|Period 2||6
3189478|NCT02043782|3917362|FG004|COMPLETED|Period 2||6
3189479|NCT02043782|3917363|FG005|COMPLETED|Period 2||6
3189480|NCT02043782|3917358|FG000|NOT COMPLETED|Period 2||0
3189481|NCT02043782|3917359|FG001|NOT COMPLETED|Period 2||0
3189482|NCT02043782|3917360|FG002|NOT COMPLETED|Period 2||0
3189483|NCT02043782|3917361|FG003|NOT COMPLETED|Period 2||0
3189484|NCT02043782|3917362|FG004|NOT COMPLETED|Period 2||0
3189485|NCT02043782|3917363|FG005|NOT COMPLETED|Period 2||0
3189486|NCT02043782|3917358|FG000|STARTED|Period 3||7
3189487|NCT02043782|3917359|FG001|STARTED|Period 3||6
3189488|NCT02043782|3917360|FG002|STARTED|Period 3||6
3189489|NCT02043782|3917361|FG003|STARTED|Period 3||6
3189490|NCT02043782|3917362|FG004|STARTED|Period 3||6
3189491|NCT02043782|3917363|FG005|STARTED|Period 3||6
3189492|NCT02043782|3917358|FG000|COMPLETED|Period 3||7
3189493|NCT02043782|3917359|FG001|COMPLETED|Period 3||6
3189494|NCT02043782|3917360|FG002|COMPLETED|Period 3||6
3189495|NCT02043782|3917361|FG003|COMPLETED|Period 3||6
3189496|NCT02043782|3917362|FG004|COMPLETED|Period 3||6
3189497|NCT02043782|3917363|FG005|COMPLETED|Period 3||6
3189498|NCT02043782|3917358|FG000|NOT COMPLETED|Period 3||0
3189499|NCT02043782|3917359|FG001|NOT COMPLETED|Period 3||0
3189500|NCT02043782|3917360|FG002|NOT COMPLETED|Period 3||0
3189501|NCT02043782|3917361|FG003|NOT COMPLETED|Period 3||0
3189502|NCT02043782|3917362|FG004|NOT COMPLETED|Period 3||0
3189503|NCT02043782|3917363|FG005|NOT COMPLETED|Period 3||0
3189504|NCT02043808|3917373|FG000|STARTED|Overall Study||12793
3189505|NCT02043808|3917374|FG001|STARTED|Overall Study||12793
3189506|NCT02043808|3917373|FG000|COMPLETED|Overall Study||12793
3189507|NCT02043808|3917374|FG001|COMPLETED|Overall Study||12793
3189508|NCT02043808|3917373|FG000|NOT COMPLETED|Overall Study||0
3189509|NCT02043808|3917374|FG001|NOT COMPLETED|Overall Study||0
3189510|NCT02043899|3917380|FG000|STARTED|Overall Study||36
3189511|NCT02043899|3917380|FG000|Underwent Routine [123I]mIBG Planar and SPECT/CT Imaging|Overall Study||32
3189512|NCT02043899|3917380|FG000|Underwent [124I]mIBG PET/CT Imaging|Overall Study||9
3189513|NCT02043899|3917380|FG000|COMPLETED|Overall Study||9
3189514|NCT02043899|3917380|FG000|NOT COMPLETED|Overall Study||27
3189515|NCT02043938|3917384|FG000|STARTED|Overall Study||46
3189516|NCT02043938|3917384|FG000|COMPLETED|Overall Study||36
3189517|NCT02043938|3917384|FG000|NOT COMPLETED|Overall Study||10
3189518|NCT02044094|3917391|FG000|STARTED|RBP-6000 Injection 1 (Day 1 to Day 28)||39
3189519|NCT02044094|3917391|FG000|Intent to Treat Population|RBP-6000 Injection 1 (Day 1 to Day 28)|Subjects who receive >=1 dose of RBP-6000 and have >=1 complete sequence of hydromorphone challenges|38
3189520|NCT02044094|3917391|FG000|Completers Population|RBP-6000 Injection 1 (Day 1 to Day 28)|Subjects that reached Day 28 + completed all challenges at Week 4 were considered study completers.|30
3189521|NCT02044094|3917391|FG000|COMPLETED|RBP-6000 Injection 1 (Day 1 to Day 28)||30
3189522|NCT02044094|3917391|FG000|NOT COMPLETED|RBP-6000 Injection 1 (Day 1 to Day 28)||9
3189523|NCT02044094|3917391|FG000|STARTED|RBP-6000 Injection 2 (Day 29 to Week 12)||30
3189524|NCT02044094|3917391|FG000|COMPLETED|RBP-6000 Injection 2 (Day 29 to Week 12)||17
3189525|NCT02044094|3917391|FG000|NOT COMPLETED|RBP-6000 Injection 2 (Day 29 to Week 12)||13
3189526|NCT02044159|3917408|FG000|STARTED|Overall Study||27
3189527|NCT02044159|3917409|FG001|STARTED|Overall Study||30
3189528|NCT02044159|3917408|FG000|COMPLETED|Overall Study||23
3189529|NCT02044159|3917409|FG001|COMPLETED|Overall Study||26
3189530|NCT02044159|3917408|FG000|NOT COMPLETED|Overall Study||4
3189531|NCT02044159|3917409|FG001|NOT COMPLETED|Overall Study||4
3189532|NCT02044367|3917418|FG000|STARTED|Overall Study||9
3189533|NCT02044367|3917419|FG001|STARTED|Overall Study||9
3189534|NCT02044367|3917420|FG002|STARTED|Overall Study||9
3189535|NCT02044367|3917421|FG003|STARTED|Overall Study||9
3189536|NCT02044367|3917422|FG004|STARTED|Overall Study||9
3189537|NCT02044367|3917423|FG005|STARTED|Overall Study||9
3189538|NCT02044367|3917418|FG000|COMPLETED|Overall Study||9
3189539|NCT02044367|3917419|FG001|COMPLETED|Overall Study||9
3189540|NCT02044367|3917420|FG002|COMPLETED|Overall Study||9
3189541|NCT02044367|3917421|FG003|COMPLETED|Overall Study||9
3189542|NCT02044367|3917422|FG004|COMPLETED|Overall Study||9
3189543|NCT02044367|3917423|FG005|COMPLETED|Overall Study||9
3189544|NCT02044367|3917418|FG000|NOT COMPLETED|Overall Study||0
3189545|NCT02044367|3917419|FG001|NOT COMPLETED|Overall Study||0
3189546|NCT02044367|3917420|FG002|NOT COMPLETED|Overall Study||0
3189547|NCT02044367|3917421|FG003|NOT COMPLETED|Overall Study||0
3189548|NCT02044367|3917422|FG004|NOT COMPLETED|Overall Study||0
3189549|NCT02044367|3917423|FG005|NOT COMPLETED|Overall Study||0
3189550|NCT02044380|3917435|FG000|STARTED|Overall Study|Started are the treated patients|14
3189551|NCT02044380|3917435|FG000|COMPLETED|Overall Study||14
3189552|NCT02044380|3917435|FG000|NOT COMPLETED|Overall Study||0
3189553|NCT02044393|3917441|FG000|STARTED|Period 1||10
3189554|NCT02044393|3917442|FG001|STARTED|Period 1||10
3189555|NCT02044393|3917441|FG000|COMPLETED|Period 1||10
3189556|NCT02044393|3917442|FG001|COMPLETED|Period 1||10
3189557|NCT02044393|3917441|FG000|NOT COMPLETED|Period 1||0
3189558|NCT02044393|3917442|FG001|NOT COMPLETED|Period 1||0
3189559|NCT02044393|3917441|FG000|STARTED|Period 2||10
3189560|NCT02044393|3917442|FG001|STARTED|Period 2||10
3189561|NCT02044393|3917441|FG000|COMPLETED|Period 2||10
3189562|NCT02044393|3917442|FG001|COMPLETED|Period 2||10
3189563|NCT02044393|3917441|FG000|NOT COMPLETED|Period 2||0
3189564|NCT02044393|3917442|FG001|NOT COMPLETED|Period 2||0
3189565|NCT02044419|3917455|FG000|STARTED|First Intervention||11
3189566|NCT02044419|3917456|FG001|STARTED|First Intervention||10
3189567|NCT02044419|3917457|FG002|STARTED|First Intervention||11
3189568|NCT02044419|3917455|FG000|COMPLETED|First Intervention||11
3189569|NCT02044419|3917456|FG001|COMPLETED|First Intervention||9
3189570|NCT02044419|3917457|FG002|COMPLETED|First Intervention||10
3189571|NCT02044419|3917455|FG000|NOT COMPLETED|First Intervention||0
3189572|NCT02044419|3917456|FG001|NOT COMPLETED|First Intervention||1
3189573|NCT02044419|3917457|FG002|NOT COMPLETED|First Intervention||1
3189574|NCT02044419|3917455|FG000|STARTED|Second Intervention||11
3189575|NCT02044419|3917456|FG001|STARTED|Second Intervention||9
3189576|NCT02044419|3917457|FG002|STARTED|Second Intervention||10
3189577|NCT02044419|3917455|FG000|COMPLETED|Second Intervention||11
3189578|NCT02044419|3917456|FG001|COMPLETED|Second Intervention||9
3189579|NCT02044419|3917457|FG002|COMPLETED|Second Intervention||10
3189580|NCT02044419|3917455|FG000|NOT COMPLETED|Second Intervention||0
3189581|NCT02044419|3917456|FG001|NOT COMPLETED|Second Intervention||0
3189582|NCT02044419|3917457|FG002|NOT COMPLETED|Second Intervention||0
3189583|NCT02044419|3917455|FG000|STARTED|Third Intervention||11
3189584|NCT02044419|3917456|FG001|STARTED|Third Intervention||9
3189585|NCT02044419|3917457|FG002|STARTED|Third Intervention||10
3189586|NCT02044419|3917455|FG000|COMPLETED|Third Intervention||11
3189587|NCT02044419|3917456|FG001|COMPLETED|Third Intervention||9
3189588|NCT02044419|3917457|FG002|COMPLETED|Third Intervention||10
3189589|NCT02044419|3917455|FG000|NOT COMPLETED|Third Intervention||0
3189590|NCT02044419|3917456|FG001|NOT COMPLETED|Third Intervention||0
3189591|NCT02044419|3917457|FG002|NOT COMPLETED|Third Intervention||0
3189592|NCT02044458|3917467|FG000|STARTED|Overall Study||65
3189593|NCT02044458|3917468|FG001|STARTED|Overall Study||69
3189594|NCT02044458|3917467|FG000|COMPLETED|Overall Study||62
3189595|NCT02044458|3917468|FG001|COMPLETED|Overall Study||61
3189596|NCT02044458|3917467|FG000|NOT COMPLETED|Overall Study||3
3189597|NCT02044458|3917468|FG001|NOT COMPLETED|Overall Study||8
3189598|NCT02044510|3917476|FG000|STARTED|Overall Study||16
3189599|NCT02044510|3917477|FG001|STARTED|Overall Study||16
3189600|NCT02044510|3917476|FG000|COMPLETED|Overall Study||15
3189601|NCT02044510|3917477|FG001|COMPLETED|Overall Study||14
3189602|NCT02044510|3917476|FG000|NOT COMPLETED|Overall Study||1
3189603|NCT02044510|3917477|FG001|NOT COMPLETED|Overall Study||2
3189604|NCT02044796|3917485|FG000|STARTED|Overall Study||9
3189605|NCT02044796|3917486|FG001|STARTED|Overall Study||9
3189606|NCT02044796|3917487|FG002|STARTED|Overall Study||9
3189607|NCT02044796|3917488|FG003|STARTED|Overall Study||6
3189608|NCT02044796|3917489|FG004|STARTED|Overall Study||10
3189609|NCT02044796|3917490|FG005|STARTED|Overall Study||6
3189610|NCT02044796|3917491|FG006|STARTED|Overall Study||6
3189611|NCT02044796|3917492|FG007|STARTED|Overall Study||4
3189612|NCT02044796|3917493|FG008|STARTED|Overall Study||106
3189613|NCT02044796|3917494|FG009|STARTED|Overall Study||34
3189614|NCT02044796|3917485|FG000|COMPLETED|Overall Study||9
3189615|NCT02044796|3917486|FG001|COMPLETED|Overall Study||9
3189616|NCT02044796|3917487|FG002|COMPLETED|Overall Study||9
3189617|NCT02044796|3917488|FG003|COMPLETED|Overall Study||6
3189618|NCT02044796|3917489|FG004|COMPLETED|Overall Study||10
3189619|NCT02044796|3917490|FG005|COMPLETED|Overall Study||6
3189620|NCT02044796|3917491|FG006|COMPLETED|Overall Study||6
3189621|NCT02044796|3917492|FG007|COMPLETED|Overall Study||4
3189622|NCT02044796|3917493|FG008|COMPLETED|Overall Study||106
3189623|NCT02044796|3917494|FG009|COMPLETED|Overall Study||34
3189624|NCT02044796|3917485|FG000|NOT COMPLETED|Overall Study||0
3189625|NCT02044796|3917486|FG001|NOT COMPLETED|Overall Study||0
3189626|NCT02044796|3917487|FG002|NOT COMPLETED|Overall Study||0
3189627|NCT02044796|3917488|FG003|NOT COMPLETED|Overall Study||0
3189628|NCT02044796|3917489|FG004|NOT COMPLETED|Overall Study||0
3189629|NCT02044796|3917490|FG005|NOT COMPLETED|Overall Study||0
3189630|NCT02044796|3917491|FG006|NOT COMPLETED|Overall Study||0
3189631|NCT02044796|3917492|FG007|NOT COMPLETED|Overall Study||0
3189632|NCT02044796|3917493|FG008|NOT COMPLETED|Overall Study||0
3189633|NCT02044796|3917494|FG009|NOT COMPLETED|Overall Study||0
3189634|NCT02044874|3917515|FG000|STARTED|Overall Study||201
3189635|NCT02044874|3917516|FG001|STARTED|Overall Study||202
3189636|NCT02044874|3917517|FG002|STARTED|Overall Study||200
3189637|NCT02044874|3917515|FG000|COMPLETED|Overall Study||171
3189638|NCT02044874|3917516|FG001|COMPLETED|Overall Study||147
3189639|NCT02044874|3917517|FG002|COMPLETED|Overall Study||140
3189640|NCT02044874|3917515|FG000|NOT COMPLETED|Overall Study||30
3189641|NCT02044874|3917516|FG001|NOT COMPLETED|Overall Study||55
3189642|NCT02044874|3917517|FG002|NOT COMPLETED|Overall Study||60
3189643|NCT02044991|3917529|FG000|STARTED|Overall Study||2
3189644|NCT02044991|3917530|FG001|STARTED|Overall Study||0
3189645|NCT02044991|3917529|FG000|COMPLETED|Overall Study||2
3189646|NCT02044991|3917530|FG001|COMPLETED|Overall Study||0
3189647|NCT02044991|3917529|FG000|NOT COMPLETED|Overall Study||0
3189648|NCT02044991|3917530|FG001|NOT COMPLETED|Overall Study||0
3189649|NCT02045095|3917536|FG000|STARTED|Overall Study||3
3189650|NCT02045095|3917537|FG001|STARTED|Overall Study||4
3189651|NCT02045095|3917538|FG002|STARTED|Overall Study||4
3189652|NCT02045095|3917539|FG003|STARTED|Overall Study||4
3189653|NCT02045095|3917540|FG004|STARTED|Overall Study||5
3189654|NCT02045095|3917541|FG005|STARTED|Overall Study||8
3189655|NCT02045095|3917542|FG006|STARTED|Overall Study||1
3189656|NCT02045095|3917536|FG000|COMPLETED|Overall Study||0
3189657|NCT02045095|3917537|FG001|COMPLETED|Overall Study||0
3189658|NCT02045095|3917538|FG002|COMPLETED|Overall Study||0
3189659|NCT02045095|3917539|FG003|COMPLETED|Overall Study||0
3189660|NCT02045095|3917540|FG004|COMPLETED|Overall Study||0
3189661|NCT02045095|3917541|FG005|COMPLETED|Overall Study||0
3189662|NCT02045095|3917542|FG006|COMPLETED|Overall Study||0
3189663|NCT02045095|3917536|FG000|NOT COMPLETED|Overall Study||3
3189664|NCT02045095|3917537|FG001|NOT COMPLETED|Overall Study||4
3189665|NCT02045095|3917538|FG002|NOT COMPLETED|Overall Study||4
3189666|NCT02045095|3917539|FG003|NOT COMPLETED|Overall Study||4
3189667|NCT02045095|3917540|FG004|NOT COMPLETED|Overall Study||5
3189668|NCT02045095|3917541|FG005|NOT COMPLETED|Overall Study||8
3189669|NCT02045095|3917542|FG006|NOT COMPLETED|Overall Study||1
3189670|NCT02045108|3917562|FG000|STARTED|Overall Study||22
3189671|NCT02045108|3917563|FG001|STARTED|Overall Study||15
3189672|NCT02045108|3917564|FG002|STARTED|Overall Study||20
3189673|NCT02045108|3917565|FG003|STARTED|Overall Study||20
3189674|NCT02045108|3917562|FG000|COMPLETED|Overall Study||21
3189675|NCT02045108|3917563|FG001|COMPLETED|Overall Study||12
3189676|NCT02045108|3917564|FG002|COMPLETED|Overall Study||18
3189677|NCT02045108|3917565|FG003|COMPLETED|Overall Study||19
3189678|NCT02045108|3917562|FG000|NOT COMPLETED|Overall Study||1
3189679|NCT02045108|3917563|FG001|NOT COMPLETED|Overall Study||3
3189680|NCT02045108|3917564|FG002|NOT COMPLETED|Overall Study||2
3189681|NCT02045108|3917565|FG003|NOT COMPLETED|Overall Study||1
3189682|NCT02045212|3917577|FG000|STARTED|Overall Study||13
3189683|NCT02045212|3917578|FG001|STARTED|Overall Study||9
3189684|NCT02045212|3917577|FG000|COMPLETED|Overall Study||11
3189685|NCT02045212|3917578|FG001|COMPLETED|Overall Study||8
3189686|NCT02045212|3917577|FG000|NOT COMPLETED|Overall Study||2
3189687|NCT02045212|3917578|FG001|NOT COMPLETED|Overall Study||1
3189688|NCT02045238|3917590|FG000|STARTED|Overall Study||16
3189689|NCT02045238|3917591|FG001|STARTED|Overall Study||15
3189690|NCT02045238|3917590|FG000|COMPLETED|Overall Study||9
3189691|NCT02045238|3917591|FG001|COMPLETED|Overall Study||14
3189692|NCT02045238|3917590|FG000|NOT COMPLETED|Overall Study||7
3189693|NCT02045238|3917591|FG001|NOT COMPLETED|Overall Study||1
3189694|NCT02045264|3917597|FG000|STARTED|Overall Study||12
3189695|NCT02045264|3917597|FG000|COMPLETED|Overall Study||12
3189696|NCT02045264|3917597|FG000|NOT COMPLETED|Overall Study||0
3189697|NCT02045277|3917605|FG000|STARTED|Overall Study||59
3189698|NCT02045277|3917606|FG001|STARTED|Overall Study||63
3189699|NCT02045277|3917607|FG002|STARTED|Overall Study||59
3189700|NCT02045277|3917608|FG003|STARTED|Overall Study||31
3189701|NCT02045277|3917605|FG000|COMPLETED|Overall Study||55
3189702|NCT02045277|3917606|FG001|COMPLETED|Overall Study||62
3189703|NCT02045277|3917607|FG002|COMPLETED|Overall Study||47
3189704|NCT02045277|3917608|FG003|COMPLETED|Overall Study||29
3189705|NCT02045277|3917605|FG000|NOT COMPLETED|Overall Study||4
3189706|NCT02045277|3917606|FG001|NOT COMPLETED|Overall Study||1
3189707|NCT02045277|3917607|FG002|NOT COMPLETED|Overall Study||12
3189708|NCT02045277|3917608|FG003|NOT COMPLETED|Overall Study||2
3189709|NCT02045433|3917618|FG000|STARTED|Overall Study||16
3189710|NCT02045433|3917618|FG000|COMPLETED|Overall Study|Study was Prematurely ended due to toxicity|15
3189711|NCT02045433|3917618|FG000|NOT COMPLETED|Overall Study||1
3189712|NCT02045511|3917624|FG000|STARTED|Overall Study||8
3189713|NCT02045511|3917625|FG001|STARTED|Overall Study||7
3189714|NCT02045511|3917624|FG000|COMPLETED|Overall Study||8
3189715|NCT02045511|3917625|FG001|COMPLETED|Overall Study||7
3189716|NCT02045511|3917624|FG000|NOT COMPLETED|Overall Study||0
3189717|NCT02045511|3917625|FG001|NOT COMPLETED|Overall Study||0
3189718|NCT02045732|3917633|FG000|STARTED|Overall Study||1
3189719|NCT02045732|3917634|FG001|STARTED|Overall Study||3
3189720|NCT02045732|3917633|FG000|COMPLETED|Overall Study||0
3189721|NCT02045732|3917634|FG001|COMPLETED|Overall Study||2
3189722|NCT02045732|3917633|FG000|NOT COMPLETED|Overall Study||1
3189723|NCT02045732|3917634|FG001|NOT COMPLETED|Overall Study||1
3189724|NCT02045836|3917642|FG000|STARTED|Overall Study||432
3189725|NCT02045836|3917643|FG001|STARTED|Overall Study||433
3189726|NCT02045836|3917642|FG000|COMPLETED|Overall Study||423
3189727|NCT02045836|3917643|FG001|COMPLETED|Overall Study||419
3189728|NCT02045836|3917642|FG000|NOT COMPLETED|Overall Study||9
3189729|NCT02045836|3917643|FG001|NOT COMPLETED|Overall Study||14
3364183|NCT04029584|4095373|FG001|COMPLETED|Washout Between (>1 Week)||6
3364184|NCT04029584|4095372|FG000|NOT COMPLETED|Washout Between (>1 Week)||0
3364185|NCT04029584|4095373|FG001|NOT COMPLETED|Washout Between (>1 Week)||0
3364186|NCT04029584|4095372|FG000|STARTED|Induced Study 1st Intervention (1 Day)||2
3364187|NCT04029584|4095373|FG001|STARTED|Induced Study 1st Intervention (1 Day)||8
3364188|NCT04029584|4095372|FG000|COMPLETED|Induced Study 1st Intervention (1 Day)||2
3364189|NCT04029584|4095373|FG001|COMPLETED|Induced Study 1st Intervention (1 Day)||8
3364190|NCT04029584|4095372|FG000|NOT COMPLETED|Induced Study 1st Intervention (1 Day)||0
3364191|NCT04029584|4095373|FG001|NOT COMPLETED|Induced Study 1st Intervention (1 Day)||0
3364192|NCT04029584|4095372|FG000|STARTED|Induced Washout (1 Day)||2
3364193|NCT04029584|4095373|FG001|STARTED|Induced Washout (1 Day)||8
3364194|NCT04029584|4095372|FG000|COMPLETED|Induced Washout (1 Day)||2
3364195|NCT04029584|4095373|FG001|COMPLETED|Induced Washout (1 Day)||8
3364196|NCT04029584|4095372|FG000|NOT COMPLETED|Induced Washout (1 Day)||0
3364197|NCT04029584|4095373|FG001|NOT COMPLETED|Induced Washout (1 Day)||0
3364198|NCT04029584|4095372|FG000|STARTED|Induced Study 2nd Intervention (1 Day)||2
3364199|NCT04029584|4095373|FG001|STARTED|Induced Study 2nd Intervention (1 Day)||8
3364200|NCT04029584|4095372|FG000|COMPLETED|Induced Study 2nd Intervention (1 Day)||2
3364201|NCT04029584|4095373|FG001|COMPLETED|Induced Study 2nd Intervention (1 Day)||8
3364202|NCT04029584|4095372|FG000|NOT COMPLETED|Induced Study 2nd Intervention (1 Day)||0
3364203|NCT04029584|4095373|FG001|NOT COMPLETED|Induced Study 2nd Intervention (1 Day)||0
3364204|NCT04029311|4095385|FG000|STARTED|Overall Study||15
3364205|NCT04029311|4095386|FG001|STARTED|Overall Study||13
3364206|NCT04029311|4095385|FG000|COMPLETED|Overall Study||12
3364207|NCT04029311|4095386|FG001|COMPLETED|Overall Study||13
3364208|NCT04029311|4095385|FG000|NOT COMPLETED|Overall Study||3
3364209|NCT04029311|4095386|FG001|NOT COMPLETED|Overall Study||0
3189730|NCT02045862|3917653|FG000|STARTED|Overall Study||306
3189731|NCT02045862|3917654|FG001|STARTED|Overall Study||305
3189732|NCT02045862|3917655|FG002|STARTED|Overall Study||1218
3189733|NCT02045862|3917653|FG000|Treated|Overall Study||306
3189734|NCT02045862|3917654|FG001|Treated|Overall Study||303
3189735|NCT02045862|3917655|FG002|Treated|Overall Study||1210
3189736|NCT02045862|3917653|FG000|COMPLETED|Overall Study||267
3189737|NCT02045862|3917654|FG001|COMPLETED|Overall Study||265
3189738|NCT02045862|3917655|FG002|COMPLETED|Overall Study||1092
3189739|NCT02045862|3917653|FG000|NOT COMPLETED|Overall Study||39
3189740|NCT02045862|3917654|FG001|NOT COMPLETED|Overall Study||40
3189741|NCT02045862|3917655|FG002|NOT COMPLETED|Overall Study||126
3189742|NCT02045875|3917665|FG000|STARTED|Overall Study||27
3189743|NCT02045875|3917666|FG001|STARTED|Overall Study||23
3189744|NCT02045875|3917665|FG000|COMPLETED|Overall Study||20
3189745|NCT02045875|3917666|FG001|COMPLETED|Overall Study||20
3189746|NCT02045875|3917665|FG000|NOT COMPLETED|Overall Study||7
3189747|NCT02045875|3917666|FG001|NOT COMPLETED|Overall Study||3
3189748|NCT02045979|3917675|FG000|STARTED|Overall Study|1 subject (not included to the 108) was randomized but did never take any study medication.|108
3189749|NCT02045979|3917676|FG001|STARTED|Overall Study|1 subject (not included to the 108) was randomized but did never take any study medication..|108
3189750|NCT02045979|3917677|FG002|STARTED|Overall Study|1 subject (not included to the 108) was randomized but did never take any study medication.|108
3189751|NCT02045979|3917675|FG000|COMPLETED|Overall Study||106
3189752|NCT02045979|3917676|FG001|COMPLETED|Overall Study||107
3189753|NCT02045979|3917677|FG002|COMPLETED|Overall Study||107
3189754|NCT02045979|3917675|FG000|NOT COMPLETED|Overall Study||2
3189755|NCT02045979|3917676|FG001|NOT COMPLETED|Overall Study||1
3189756|NCT02045979|3917677|FG002|NOT COMPLETED|Overall Study||1
3189757|NCT02046005|3917688|FG000|STARTED|Overall Study||80
3189758|NCT02046005|3917689|FG001|STARTED|Overall Study||78
3189759|NCT02046005|3917690|FG002|STARTED|Overall Study||80
3189760|NCT02046005|3917688|FG000|COMPLETED|Overall Study||72
3189761|NCT02046005|3917689|FG001|COMPLETED|Overall Study||71
3189762|NCT02046005|3917690|FG002|COMPLETED|Overall Study||70
3189763|NCT02046005|3917688|FG000|NOT COMPLETED|Overall Study||8
3189764|NCT02046005|3917689|FG001|NOT COMPLETED|Overall Study||7
3189765|NCT02046005|3917690|FG002|NOT COMPLETED|Overall Study||10
3189766|NCT02046070|3917701|FG000|STARTED|Overall Study||36
3189767|NCT02046070|3917702|FG001|STARTED|Overall Study||34
3189768|NCT02046070|3917703|FG002|STARTED|Overall Study||78
3189769|NCT02046070|3917701|FG000|COMPLETED|Overall Study||4
3189770|NCT02046070|3917702|FG001|COMPLETED|Overall Study||6
3189771|NCT02046070|3917703|FG002|COMPLETED|Overall Study||8
3189772|NCT02046070|3917701|FG000|NOT COMPLETED|Overall Study||32
3189773|NCT02046070|3917702|FG001|NOT COMPLETED|Overall Study||28
3189774|NCT02046070|3917703|FG002|NOT COMPLETED|Overall Study||70
3189775|NCT02046122|3917711|FG000|STARTED|Overall Study||17
3189776|NCT02046122|3917711|FG000|COMPLETED|Overall Study||8
3189777|NCT02046122|3917711|FG000|NOT COMPLETED|Overall Study||9
3189778|NCT02046135|3917717|FG000|STARTED|Overall Study||26
3189779|NCT02046135|3917718|FG001|STARTED|Overall Study||25
3189780|NCT02046135|3917717|FG000|COMPLETED|Overall Study||26
3189781|NCT02046135|3917718|FG001|COMPLETED|Overall Study||25
3189782|NCT02046135|3917717|FG000|NOT COMPLETED|Overall Study||0
3189783|NCT02046135|3917718|FG001|NOT COMPLETED|Overall Study||0
3189784|NCT02046148|3917726|FG000|STARTED|Overall Study||49
3189785|NCT02046148|3917727|FG001|STARTED|Overall Study||26
3189786|NCT02046148|3917726|FG000|COMPLETED|Overall Study||48
3189787|NCT02046148|3917727|FG001|COMPLETED|Overall Study||23
3189788|NCT02046148|3917726|FG000|NOT COMPLETED|Overall Study||1
3189789|NCT02046148|3917727|FG001|NOT COMPLETED|Overall Study||3
3189790|NCT02046174|3917733|FG000|STARTED|Overall Study||42
3189791|NCT02046174|3917734|FG001|STARTED|Overall Study||3
3189792|NCT02046174|3917733|FG000|COMPLETED|Overall Study||41
3189793|NCT02046174|3917734|FG001|COMPLETED|Overall Study||3
3189794|NCT02046174|3917733|FG000|NOT COMPLETED|Overall Study||1
3189795|NCT02046174|3917734|FG001|NOT COMPLETED|Overall Study||0
3189796|NCT02046200|3917819|FG000|STARTED|First Intervention (1 Day)||5
3189797|NCT02046200|3917820|FG001|STARTED|First Intervention (1 Day)||6
3189798|NCT02046200|3917819|FG000|COMPLETED|First Intervention (1 Day)||5
3189799|NCT02046200|3917820|FG001|COMPLETED|First Intervention (1 Day)||6
3189800|NCT02046200|3917819|FG000|NOT COMPLETED|First Intervention (1 Day)||0
3189801|NCT02046200|3917820|FG001|NOT COMPLETED|First Intervention (1 Day)||0
3189802|NCT02046200|3917819|FG000|STARTED|Second Intervention (1 Day)||5
3189803|NCT02046200|3917820|FG001|STARTED|Second Intervention (1 Day)||6
3189804|NCT02046200|3917819|FG000|COMPLETED|Second Intervention (1 Day)||5
3189805|NCT02046200|3917820|FG001|COMPLETED|Second Intervention (1 Day)||6
3189806|NCT02046200|3917819|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
3189807|NCT02046200|3917820|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
3189808|NCT02046265|3917838|FG000|STARTED|Overall Study||17
3189809|NCT02046265|3917839|FG001|STARTED|Overall Study||17
3189810|NCT02046265|3917840|FG002|STARTED|Overall Study||12
3189811|NCT02046265|3917841|FG003|STARTED|Overall Study||14
3189812|NCT02046265|3917838|FG000|COMPLETED|Overall Study||16
3189813|NCT02046265|3917839|FG001|COMPLETED|Overall Study||15
3189814|NCT02046265|3917840|FG002|COMPLETED|Overall Study||10
3189815|NCT02046265|3917841|FG003|COMPLETED|Overall Study||12
3189816|NCT02046265|3917838|FG000|NOT COMPLETED|Overall Study||1
3189817|NCT02046265|3917839|FG001|NOT COMPLETED|Overall Study||2
3189818|NCT02046265|3917840|FG002|NOT COMPLETED|Overall Study||2
3189819|NCT02046265|3917841|FG003|NOT COMPLETED|Overall Study||2
3189820|NCT02046317|3917853|FG000|STARTED|Overall Study||4
3189821|NCT02046317|3917854|FG001|STARTED|Overall Study||8
3189822|NCT02046317|3917853|FG000|COMPLETED|Overall Study||4
3189823|NCT02046317|3917854|FG001|COMPLETED|Overall Study||8
3189824|NCT02046317|3917853|FG000|NOT COMPLETED|Overall Study||0
3189825|NCT02046317|3917854|FG001|NOT COMPLETED|Overall Study||0
3189826|NCT02046369|3917862|FG000|STARTED|Overall Study||176
3189827|NCT02046369|3917863|FG001|STARTED|Overall Study||174
3189828|NCT02046369|3917862|FG000|COMPLETED|Overall Study||162
3189829|NCT02046369|3917863|FG001|COMPLETED|Overall Study||156
3189830|NCT02046369|3917862|FG000|NOT COMPLETED|Overall Study||14
3189831|NCT02046369|3917863|FG001|NOT COMPLETED|Overall Study||18
3189832|NCT02046382|3917871|FG000|STARTED|Overall Study||65
3189833|NCT02046382|3917872|FG001|STARTED|Overall Study||67
3189834|NCT02046382|3917871|FG000|COMPLETED|Overall Study||57
3189835|NCT02046382|3917872|FG001|COMPLETED|Overall Study||47
3189836|NCT02046382|3917871|FG000|NOT COMPLETED|Overall Study||8
3189837|NCT02046382|3917872|FG001|NOT COMPLETED|Overall Study||20
3189838|NCT02046525|3917880|FG000|STARTED|Overall Study||5
3189839|NCT02046525|3917881|FG001|STARTED|Overall Study||5
3189840|NCT02046525|3917880|FG000|COMPLETED|Overall Study||5
3189841|NCT02046525|3917881|FG001|COMPLETED|Overall Study||5
3189842|NCT02046525|3917880|FG000|NOT COMPLETED|Overall Study||0
3189843|NCT02046525|3917881|FG001|NOT COMPLETED|Overall Study||0
3189844|NCT02046564|3917889|FG000|STARTED|Overall Study||209
3189845|NCT02046564|3917890|FG001|STARTED|Overall Study||203
3189846|NCT02046564|3917889|FG000|COMPLETED|Overall Study||194
3189847|NCT02046564|3917890|FG001|COMPLETED|Overall Study||183
3189848|NCT02046564|3917889|FG000|NOT COMPLETED|Overall Study||15
3189849|NCT02046564|3917890|FG001|NOT COMPLETED|Overall Study||20
3189850|NCT02046603|3917898|FG000|STARTED|Overall Study||22
3189851|NCT02046603|3917899|FG001|STARTED|Overall Study||140
3189852|NCT02046603|3917898|FG000|Received at Least 1 Dose of Tocilizumab|Overall Study||21
3189853|NCT02046603|3917899|FG001|Received at Least 1 Dose of Tocilizumab|Overall Study||140
3189854|NCT02046603|3917898|FG000|COMPLETED|Overall Study||7
3189855|NCT02046603|3917899|FG001|COMPLETED|Overall Study||65
3189856|NCT02046603|3917898|FG000|NOT COMPLETED|Overall Study||15
3189857|NCT02046603|3917899|FG001|NOT COMPLETED|Overall Study||75
3189858|NCT02046616|3917906|FG000|STARTED|24-Week Treatment Period||133
3189859|NCT02046616|3917906|FG000|COMPLETED|24-Week Treatment Period||114
3189860|NCT02046616|3917906|FG000|NOT COMPLETED|24-Week Treatment Period||19
3189861|NCT02046616|3917906|FG000|STARTED|8-Week FU Period||114
3189862|NCT02046616|3917906|FG000|COMPLETED|8-Week FU Period||113
3189863|NCT02046616|3917906|FG000|NOT COMPLETED|8-Week FU Period||1
3189864|NCT02046772|3917912|FG000|STARTED|Overall Study||30
3189865|NCT02046772|3917913|FG001|STARTED|Overall Study||33
3189866|NCT02046772|3917912|FG000|COMPLETED|Overall Study||30
3189867|NCT02046772|3917913|FG001|COMPLETED|Overall Study||33
3189868|NCT02046772|3917912|FG000|NOT COMPLETED|Overall Study||0
3189869|NCT02046772|3917913|FG001|NOT COMPLETED|Overall Study||0
3189870|NCT02046863|3917919|FG000|STARTED|Overall Study||7
3189871|NCT02046863|3917919|FG000|COMPLETED|Overall Study||7
3189872|NCT02046863|3917919|FG000|NOT COMPLETED|Overall Study||0
3189873|NCT02046902|3917926|FG000|STARTED|Overall Study||336
3189874|NCT02046902|3917927|FG001|STARTED|Overall Study||113
3189875|NCT02046902|3917928|FG002|STARTED|Overall Study||137
3189876|NCT02046902|3917926|FG000|COMPLETED|Overall Study||336
3189877|NCT02046902|3917927|FG001|COMPLETED|Overall Study||113
3189878|NCT02046902|3917928|FG002|COMPLETED|Overall Study||137
3189879|NCT02046902|3917926|FG000|NOT COMPLETED|Overall Study||0
3189880|NCT02046902|3917927|FG001|NOT COMPLETED|Overall Study||0
3189881|NCT02046902|3917928|FG002|NOT COMPLETED|Overall Study||0
3189882|NCT02046941|3917936|FG000|STARTED|Overall Study||17
3189883|NCT02046941|3917936|FG000|COMPLETED|Overall Study||10
3189884|NCT02046941|3917936|FG000|NOT COMPLETED|Overall Study||7
3189885|NCT02046980|3917943|FG000|STARTED|Overall Study||72
3189886|NCT02046980|3917944|FG001|STARTED|Overall Study||72
3189887|NCT02046980|3917945|FG002|STARTED|Overall Study||73
3189888|NCT02046980|3917943|FG000|COMPLETED|Overall Study||70
3189889|NCT02046980|3917944|FG001|COMPLETED|Overall Study||67
3189890|NCT02046980|3917945|FG002|COMPLETED|Overall Study||72
3189891|NCT02046980|3917943|FG000|NOT COMPLETED|Overall Study||2
3189892|NCT02046980|3917944|FG001|NOT COMPLETED|Overall Study||5
3189893|NCT02046980|3917945|FG002|NOT COMPLETED|Overall Study||1
3189894|NCT02046993|3917955|FG000|STARTED|Overall Study||105
3189895|NCT02046993|3917956|FG001|STARTED|Overall Study||105
3189896|NCT02046993|3917955|FG000|3rd Month|Overall Study||104
3189897|NCT02046993|3917956|FG001|3rd Month|Overall Study||97
3189898|NCT02046993|3917955|FG000|6th Month|Overall Study||102
3189899|NCT02046993|3917956|FG001|6th Month|Overall Study||94
3189900|NCT02046993|3917955|FG000|COMPLETED|Overall Study||102
3189901|NCT02046993|3917956|FG001|COMPLETED|Overall Study||94
3189902|NCT02046993|3917955|FG000|NOT COMPLETED|Overall Study||3
3189903|NCT02046993|3917956|FG001|NOT COMPLETED|Overall Study||11
3189904|NCT02047032|3917966|FG000|STARTED|Overall Study||250
3189905|NCT02047032|3917967|FG001|STARTED|Overall Study||250
3189906|NCT02047032|3917966|FG000|COMPLETED|Overall Study||245
3189907|NCT02047032|3917967|FG001|COMPLETED|Overall Study||235
3189908|NCT02047032|3917966|FG000|NOT COMPLETED|Overall Study||5
3189909|NCT02047032|3917967|FG001|NOT COMPLETED|Overall Study||15
3189910|NCT02047045|3917977|FG000|STARTED|Baseline||280
3189911|NCT02047045|3917978|FG001|STARTED|Baseline||280
3189912|NCT02047045|3917977|FG000|COMPLETED|Baseline||277
3189913|NCT02047045|3917978|FG001|COMPLETED|Baseline||278
3189914|NCT02047045|3917977|FG000|NOT COMPLETED|Baseline||3
3189915|NCT02047045|3917978|FG001|NOT COMPLETED|Baseline||2
3189916|NCT02047045|3917977|FG000|STARTED|Treatment Period (8 Weeks )||277
3189917|NCT02047045|3917978|FG001|STARTED|Treatment Period (8 Weeks )||278
3189918|NCT02047045|3917977|FG000|COMPLETED|Treatment Period (8 Weeks )||266
3189919|NCT02047045|3917978|FG001|COMPLETED|Treatment Period (8 Weeks )||263
3189920|NCT02047045|3917977|FG000|NOT COMPLETED|Treatment Period (8 Weeks )||11
3189921|NCT02047045|3917978|FG001|NOT COMPLETED|Treatment Period (8 Weeks )||15
3189922|NCT02047045|3917977|FG000|STARTED|Follow-up Period (24 Weeks)||266
3189923|NCT02047045|3917978|FG001|STARTED|Follow-up Period (24 Weeks)||263
3189924|NCT02047045|3917977|FG000|COMPLETED|Follow-up Period (24 Weeks)||265
3189925|NCT02047045|3917978|FG001|COMPLETED|Follow-up Period (24 Weeks)||262
3189926|NCT02047045|3917977|FG000|NOT COMPLETED|Follow-up Period (24 Weeks)||1
3189927|NCT02047045|3917978|FG001|NOT COMPLETED|Follow-up Period (24 Weeks)||1
3189928|NCT02047110|3917988|FG000|STARTED|DB Treatment Period up to Week 24|Started are the treated patients|40
3189929|NCT02047110|3917989|FG001|STARTED|DB Treatment Period up to Week 24|Started are the treated patients|40
3189930|NCT02047110|3917990|FG002|STARTED|DB Treatment Period up to Week 24|Started are the treated patients|39
3189931|NCT02047110|3917991|FG003|STARTED|DB Treatment Period up to Week 24|Started are the treated patients|40
3189932|NCT02047110|3917988|FG000|COMPLETED|DB Treatment Period up to Week 24||35
3189933|NCT02047110|3917989|FG001|COMPLETED|DB Treatment Period up to Week 24||38
3189934|NCT02047110|3917990|FG002|COMPLETED|DB Treatment Period up to Week 24||36
3189935|NCT02047110|3917991|FG003|COMPLETED|DB Treatment Period up to Week 24||38
3189936|NCT02047110|3917988|FG000|NOT COMPLETED|DB Treatment Period up to Week 24||5
3189937|NCT02047110|3917989|FG001|NOT COMPLETED|DB Treatment Period up to Week 24||2
3189938|NCT02047110|3917990|FG002|NOT COMPLETED|DB Treatment Period up to Week 24||3
3189939|NCT02047110|3917991|FG003|NOT COMPLETED|DB Treatment Period up to Week 24||2
3189940|NCT02047110|3917988|FG000|STARTED|DB (Week 12 up to Week 24)|Patients who continued treatment in the DB treatment period up to Week 24|9
3189941|NCT02047110|3917989|FG001|STARTED|DB (Week 12 up to Week 24)|Patients who continued treatment in the DB treatment period up to Week 24|17
3189942|NCT02047110|3917990|FG002|STARTED|DB (Week 12 up to Week 24)|Patients who continued treatment in the DB treatment period up to Week 24|13
3189943|NCT02047110|3917991|FG003|STARTED|DB (Week 12 up to Week 24)|Patients who continued treatment in the DB treatment period up to Week 24|12
3189944|NCT02047110|3917988|FG000|COMPLETED|DB (Week 12 up to Week 24)||9
3189945|NCT02047110|3917989|FG001|COMPLETED|DB (Week 12 up to Week 24)||15
3189946|NCT02047110|3917990|FG002|COMPLETED|DB (Week 12 up to Week 24)||12
3189947|NCT02047110|3917991|FG003|COMPLETED|DB (Week 12 up to Week 24)||12
3189948|NCT02047110|3917988|FG000|NOT COMPLETED|DB (Week 12 up to Week 24)||0
3189949|NCT02047110|3917989|FG001|NOT COMPLETED|DB (Week 12 up to Week 24)||2
3189950|NCT02047110|3917990|FG002|NOT COMPLETED|DB (Week 12 up to Week 24)||1
3189951|NCT02047110|3917991|FG003|NOT COMPLETED|DB (Week 12 up to Week 24)||0
3189952|NCT02047110|3917988|FG000|STARTED|Escape Treatment Period|Assessment in SpondyloArthritis international Society (ASAS) 20 nonresponders|26
3189953|NCT02047110|3917989|FG001|STARTED|Escape Treatment Period|ASAS 20 nonresponders|21
3189954|NCT02047110|3917990|FG002|STARTED|Escape Treatment Period|ASAS 20 nonresponders|23
3189955|NCT02047110|3917991|FG003|STARTED|Escape Treatment Period|ASAS 20 nonresponders|26
3189956|NCT02047110|3917988|FG000|COMPLETED|Escape Treatment Period||23
3189957|NCT02047110|3917989|FG001|COMPLETED|Escape Treatment Period||15
3189958|NCT02047110|3917990|FG002|COMPLETED|Escape Treatment Period||20
3189959|NCT02047110|3917991|FG003|COMPLETED|Escape Treatment Period||24
3189960|NCT02047110|3917988|FG000|NOT COMPLETED|Escape Treatment Period||3
3189961|NCT02047110|3917989|FG001|NOT COMPLETED|Escape Treatment Period||6
3189962|NCT02047110|3917990|FG002|NOT COMPLETED|Escape Treatment Period||3
3189963|NCT02047110|3917991|FG003|NOT COMPLETED|Escape Treatment Period||2
3189964|NCT02047110|3917988|FG000|STARTED|OLE Treatment Period|Patients with loss of ASAS 20 response compared with baseline|4
3189965|NCT02047110|3917989|FG001|STARTED|OLE Treatment Period|Patients with loss of ASAS 20 response compared with baseline|8
3189966|NCT02047110|3917990|FG002|STARTED|OLE Treatment Period|Patients with loss of ASAS 20 response compared with baseline|5
3189967|NCT02047110|3917991|FG003|STARTED|OLE Treatment Period|Patients with loss of ASAS 20 response compared with baseline|9
3189968|NCT02047110|3917988|FG000|COMPLETED|OLE Treatment Period||4
3189969|NCT02047110|3917989|FG001|COMPLETED|OLE Treatment Period||8
3189970|NCT02047110|3917990|FG002|COMPLETED|OLE Treatment Period||4
3189971|NCT02047110|3917991|FG003|COMPLETED|OLE Treatment Period||9
3189972|NCT02047110|3917988|FG000|NOT COMPLETED|OLE Treatment Period||0
3189973|NCT02047110|3917989|FG001|NOT COMPLETED|OLE Treatment Period||0
3189974|NCT02047110|3917990|FG002|NOT COMPLETED|OLE Treatment Period||1
3189975|NCT02047110|3917991|FG003|NOT COMPLETED|OLE Treatment Period||0
3189976|NCT02047227|3918010|FG000|STARTED|Overall Study||462
3189977|NCT02047227|3918011|FG001|STARTED|Overall Study||477
3189978|NCT02047227|3918010|FG000|Completed Ovarian Stimulation Phase|Overall Study||424
3189979|NCT02047227|3918011|FG001|Completed Ovarian Stimulation Phase|Overall Study||440
3189980|NCT02047227|3918010|FG000|COMPLETED|Overall Study||318
3189981|NCT02047227|3918011|FG001|COMPLETED|Overall Study||347
3189982|NCT02047227|3918010|FG000|NOT COMPLETED|Overall Study||144
3189983|NCT02047227|3918011|FG001|NOT COMPLETED|Overall Study||130
3189984|NCT02047253|3918017|FG000|STARTED|Overall Study||28
3189985|NCT02047253|3918017|FG000|COMPLETED|Overall Study||20
3189986|NCT02047253|3918017|FG000|NOT COMPLETED|Overall Study||8
3189987|NCT02047305|3918021|FG000|STARTED|Overall Study||96
3189988|NCT02047305|3918021|FG000|COMPLETED|Overall Study||96
3189989|NCT02047305|3918021|FG000|NOT COMPLETED|Overall Study||0
3189990|NCT02047318|3918025|FG000|STARTED|Core Study Period||19
3189991|NCT02047318|3918025|FG000|Received MRX 14 ug/kg/Day|Core Study Period||6
3189992|NCT02047318|3918025|FG000|Received MRX 35 ug/kg/Day|Core Study Period||6
3189993|NCT02047318|3918025|FG000|Received MRX 70 ug/kg/Day|Core Study Period||6
3189994|NCT02047318|3918025|FG000|Received MRX 140 ug/kg/Day|Core Study Period||11
3189995|NCT02047318|3918025|FG000|Received MRX 280 ug/kg/Day|Core Study Period||19
3189996|NCT02047318|3918025|FG000|COMPLETED|Core Study Period||7
3189997|NCT02047318|3918025|FG000|NOT COMPLETED|Core Study Period||12
3189998|NCT02047318|3918025|FG000|STARTED|52-week Follow-up Treatment Period||6
3189999|NCT02047318|3918025|FG000|COMPLETED|52-week Follow-up Treatment Period||6
3190000|NCT02047318|3918025|FG000|NOT COMPLETED|52-week Follow-up Treatment Period||0
3190001|NCT02047318|3918025|FG000|STARTED|Long-term Follow-up Treatment Period||7
3190002|NCT02047318|3918025|FG000|Received MRX 280 ug/kg/Day|Long-term Follow-up Treatment Period||7
3190003|NCT02047318|3918025|FG000|Received 420 ug/kg/Day|Long-term Follow-up Treatment Period||5
3190004|NCT02047318|3918025|FG000|Received 560 ug/kg/Day|Long-term Follow-up Treatment Period||5
3190005|NCT02047318|3918025|FG000|COMPLETED|Long-term Follow-up Treatment Period||6
3190006|NCT02047318|3918025|FG000|NOT COMPLETED|Long-term Follow-up Treatment Period||1
3190007|NCT02047344|3918042|FG000|STARTED|Overall Study|one patient is not evaluable in process. however, evaluable to safety report.|16
3190008|NCT02047344|3918043|FG001|STARTED|Overall Study||15
3190009|NCT02047344|3918042|FG000|COMPLETED|Overall Study||16
3190010|NCT02047344|3918043|FG001|COMPLETED|Overall Study||15
3190011|NCT02047344|3918042|FG000|NOT COMPLETED|Overall Study||0
3190012|NCT02047344|3918043|FG001|NOT COMPLETED|Overall Study||0
3190013|NCT02047500|3918055|FG000|STARTED|Overall Study||19
3190014|NCT02047500|3918055|FG000|COMPLETED|Overall Study||0
3190015|NCT02047500|3918055|FG000|NOT COMPLETED|Overall Study||19
3190016|NCT02047604|3918065|FG000|STARTED|Overall Study||6
3190017|NCT02047604|3918066|FG001|STARTED|Overall Study||7
3190018|NCT02047604|3918067|FG002|STARTED|Overall Study||6
3190019|NCT02047604|3918068|FG003|STARTED|Overall Study||6
3190020|NCT02047604|3918069|FG004|STARTED|Overall Study||6
3190021|NCT02047604|3918070|FG005|STARTED|Overall Study||10
3190022|NCT02047604|3918065|FG000|COMPLETED|Overall Study||6
3190023|NCT02047604|3918066|FG001|COMPLETED|Overall Study||7
3190024|NCT02047604|3918067|FG002|COMPLETED|Overall Study||6
3190025|NCT02047604|3918068|FG003|COMPLETED|Overall Study||6
3190026|NCT02047604|3918069|FG004|COMPLETED|Overall Study||5
3190027|NCT02047604|3918070|FG005|COMPLETED|Overall Study||9
3190028|NCT02047604|3918065|FG000|NOT COMPLETED|Overall Study||0
3190029|NCT02047604|3918066|FG001|NOT COMPLETED|Overall Study||0
3190030|NCT02047604|3918067|FG002|NOT COMPLETED|Overall Study||0
3190031|NCT02047604|3918068|FG003|NOT COMPLETED|Overall Study||0
3190032|NCT02047604|3918069|FG004|NOT COMPLETED|Overall Study||1
3190033|NCT02047604|3918070|FG005|NOT COMPLETED|Overall Study||1
3190034|NCT02047643|3918084|FG000|STARTED|Overall Study||9
3190035|NCT02047643|3918085|FG001|STARTED|Overall Study||9
3190036|NCT02047643|3918084|FG000|COMPLETED|Overall Study||9
3190037|NCT02047643|3918085|FG001|COMPLETED|Overall Study||9
3190038|NCT02047643|3918084|FG000|NOT COMPLETED|Overall Study||0
3190039|NCT02047643|3918085|FG001|NOT COMPLETED|Overall Study||0
3190040|NCT02047734|3918094|FG000|STARTED|Overall Study||443
3190041|NCT02047734|3918095|FG001|STARTED|Overall Study||443
3190042|NCT02047734|3918096|FG002|STARTED|Overall Study||434
3190043|NCT02047734|3918094|FG000|Received Treatment|Overall Study|One participant received ozanimod 0.5 mg in error|441
3190044|NCT02047734|3918095|FG001|Received Treatment|Overall Study|One participant received ozanimod 1.0 mg in error|439
3190045|NCT02047734|3918096|FG002|Received Treatment|Overall Study||433
3190046|NCT02047734|3918094|FG000|COMPLETED|Overall Study||376
3190047|NCT02047734|3918095|FG001|COMPLETED|Overall Study||374
3190048|NCT02047734|3918096|FG002|COMPLETED|Overall Study||388
3190049|NCT02047734|3918094|FG000|NOT COMPLETED|Overall Study||67
3190050|NCT02047734|3918095|FG001|NOT COMPLETED|Overall Study||69
3190051|NCT02047734|3918096|FG002|NOT COMPLETED|Overall Study||46
3190052|NCT02047903|3918104|FG000|STARTED|Overall Study||161
3190053|NCT02047903|3918104|FG000|Treated|Overall Study||152
3190054|NCT02047903|3918104|FG000|COMPLETED|Overall Study||102
3190055|NCT02047903|3918104|FG000|NOT COMPLETED|Overall Study||59
3190056|NCT02047929|3918111|FG000|STARTED|Overall Study||1503
3190057|NCT02047929|3918112|FG001|STARTED|Overall Study||2523
3190058|NCT02047929|3918113|FG002|STARTED|Overall Study||2248
3190059|NCT02047929|3918111|FG000|Practice Rollout|Overall Study||1503
3190060|NCT02047929|3918112|FG001|Practice Rollout|Overall Study||2523
3190061|NCT02047929|3918113|FG002|Practice Rollout|Overall Study|Per protocol, practice did not receive any intervention from practice facilitator|0
3190062|NCT02047929|3918111|FG000|Practice Refresher|Overall Study||1503
3190063|NCT02047929|3918112|FG001|Practice Refresher|Overall Study||2523
3190064|NCT02047929|3918113|FG002|Practice Refresher|Overall Study|Per protocol, practices did not receive any interaction from practice facilitator|0
3190065|NCT02047929|3918111|FG000|Surveys Collected|Overall Study||1503
3190066|NCT02047929|3918112|FG001|Surveys Collected|Overall Study||2523
3190067|NCT02047929|3918113|FG002|Surveys Collected|Overall Study|Per protocol, practice did not receive any interaction from practice facilitator|0
3190068|NCT02047929|3918111|FG000|COMPLETED|Overall Study||1503
3190069|NCT02047929|3918112|FG001|COMPLETED|Overall Study||2523
3190070|NCT02047929|3918113|FG002|COMPLETED|Overall Study||2248
3190071|NCT02047929|3918111|FG000|NOT COMPLETED|Overall Study||0
3190072|NCT02047929|3918112|FG001|NOT COMPLETED|Overall Study||0
3190073|NCT02047929|3918113|FG002|NOT COMPLETED|Overall Study||0
3190074|NCT02047981|3918126|FG000|STARTED|MORDOR Stage I Year 1-2||97047
3190075|NCT02047981|3918127|FG001|STARTED|MORDOR Stage I Year 1-2||93191
3190076|NCT02047981|3918126|FG000|COMPLETED|MORDOR Stage I Year 1-2||87650
3190077|NCT02047981|3918127|FG001|COMPLETED|MORDOR Stage I Year 1-2||84474
3190078|NCT02047981|3918126|FG000|NOT COMPLETED|MORDOR Stage I Year 1-2||9397
3190079|NCT02047981|3918127|FG001|NOT COMPLETED|MORDOR Stage I Year 1-2||8717
3190080|NCT02047981|3918126|FG000|STARTED|MORDOR Stage II Year 3||37497
3190081|NCT02047981|3918127|FG001|STARTED|MORDOR Stage II Year 3||33294
3190082|NCT02047981|3918126|FG000|COMPLETED|MORDOR Stage II Year 3||34611
3190083|NCT02047981|3918127|FG001|COMPLETED|MORDOR Stage II Year 3||30931
3190084|NCT02047981|3918126|FG000|NOT COMPLETED|MORDOR Stage II Year 3||2886
3190085|NCT02047981|3918127|FG001|NOT COMPLETED|MORDOR Stage II Year 3||2363
3190086|NCT02048072|3918133|FG000|STARTED|Overall Study||33
3190087|NCT02048072|3918133|FG000|COMPLETED|Overall Study||29
3190088|NCT02048072|3918133|FG000|NOT COMPLETED|Overall Study||4
3190089|NCT02048241|3918139|FG000|STARTED|Overall Study||5
3190090|NCT02048241|3918140|FG001|STARTED|Overall Study||6
3190091|NCT02048241|3918139|FG000|COMPLETED|Overall Study||5
3190092|NCT02048241|3918140|FG001|COMPLETED|Overall Study||5
3190093|NCT02048241|3918139|FG000|NOT COMPLETED|Overall Study||0
3190094|NCT02048241|3918140|FG001|NOT COMPLETED|Overall Study||1
3190095|NCT02048670|3918148|FG000|STARTED|Overall Study||6
3190096|NCT02048670|3918149|FG001|STARTED|Overall Study||6
3190097|NCT02048670|3918148|FG000|COMPLETED|Overall Study||6
3190098|NCT02048670|3918149|FG001|COMPLETED|Overall Study||6
3190099|NCT02048670|3918148|FG000|NOT COMPLETED|Overall Study||0
3190100|NCT02048670|3918149|FG001|NOT COMPLETED|Overall Study||0
3190101|NCT02048722|3918155|FG000|STARTED|2 Cycles of Treatment||31
3190102|NCT02048722|3918155|FG000|Attempted 1st Cycle|2 Cycles of Treatment||31
3190103|NCT02048722|3918155|FG000|Attempted 2nd Cycle|2 Cycles of Treatment||23
3190104|NCT02048722|3918155|FG000|COMPLETED|2 Cycles of Treatment||23
3190105|NCT02048722|3918155|FG000|NOT COMPLETED|2 Cycles of Treatment||8
3190106|NCT02048722|3918155|FG000|STARTED|Reached 1st Response/Continued Treatment||23
3190107|NCT02048722|3918155|FG000|Assessed for First Response|Reached 1st Response/Continued Treatment||23
3190108|NCT02048722|3918155|FG000|Went on to Cycle 3 and Beyond|Reached 1st Response/Continued Treatment||13
3190109|NCT02048722|3918155|FG000|COMPLETED|Reached 1st Response/Continued Treatment||13
3190110|NCT02048722|3918155|FG000|NOT COMPLETED|Reached 1st Response/Continued Treatment||10
3190111|NCT02048722|3918155|FG000|STARTED|Follow up for 5 Years|2 patients remain on treatment and have not gone into follow up phase yet.|29
3364210|NCT04028960|4095394|FG000|STARTED|Overall Study||2
3364211|NCT04028960|4095395|FG001|STARTED|Overall Study||2
3364212|NCT04028960|4095394|FG000|COMPLETED|Overall Study||2
3364213|NCT04028960|4095395|FG001|COMPLETED|Overall Study||2
3364214|NCT04028960|4095394|FG000|NOT COMPLETED|Overall Study||0
3364215|NCT04028960|4095395|FG001|NOT COMPLETED|Overall Study||0
3364216|NCT04026399|4095403|FG000|STARTED|Overall Study||6
3364217|NCT04026399|4095404|FG001|STARTED|Overall Study||6
3364218|NCT04026399|4095403|FG000|COMPLETED|Overall Study||1
3364219|NCT04026399|4095404|FG001|COMPLETED|Overall Study||3
3364220|NCT04026399|4095403|FG000|NOT COMPLETED|Overall Study||5
3364221|NCT04026399|4095404|FG001|NOT COMPLETED|Overall Study||3
3364222|NCT04023578|4095410|FG000|STARTED|Overall Study||15
3364223|NCT04023578|4095410|FG000|COMPLETED|Overall Study||13
3364224|NCT04023578|4095410|FG000|NOT COMPLETED|Overall Study||2
3364225|NCT04023695|4095417|FG000|STARTED|Overall Study||57
3364226|NCT04023695|4095418|FG001|STARTED|Overall Study||53
3364227|NCT04023695|4095417|FG000|COMPLETED|Overall Study||57
3364228|NCT04023695|4095418|FG001|COMPLETED|Overall Study||53
3364229|NCT04023695|4095417|FG000|NOT COMPLETED|Overall Study||0
3364230|NCT04023695|4095418|FG001|NOT COMPLETED|Overall Study||0
3364231|NCT04018664|4095432|FG000|STARTED|Overall Study||14
3364232|NCT04018664|4095433|FG001|STARTED|Overall Study||6
3364233|NCT04018664|4095434|FG002|STARTED|Overall Study||6
3364234|NCT04018664|4095435|FG003|STARTED|Overall Study||6
3364235|NCT04018664|4095436|FG004|STARTED|Overall Study||6
3364236|NCT04018664|4095437|FG005|STARTED|Overall Study||6
3364237|NCT04018664|4095438|FG006|STARTED|Overall Study||6
3364238|NCT04018664|4095439|FG007|STARTED|Overall Study||6
3364239|NCT04018664|4095432|FG000|COMPLETED|Overall Study||14
3364240|NCT04018664|4095433|FG001|COMPLETED|Overall Study||6
3364241|NCT04018664|4095434|FG002|COMPLETED|Overall Study||6
3364242|NCT04018664|4095435|FG003|COMPLETED|Overall Study||6
3364243|NCT04018664|4095436|FG004|COMPLETED|Overall Study||6
3364244|NCT04018664|4095437|FG005|COMPLETED|Overall Study||6
3364245|NCT04018664|4095438|FG006|COMPLETED|Overall Study||6
3364246|NCT04018664|4095439|FG007|COMPLETED|Overall Study||6
3364247|NCT04018664|4095432|FG000|NOT COMPLETED|Overall Study||0
3364248|NCT04018664|4095433|FG001|NOT COMPLETED|Overall Study||0
3364249|NCT04018664|4095434|FG002|NOT COMPLETED|Overall Study||0
3364250|NCT04018664|4095435|FG003|NOT COMPLETED|Overall Study||0
3364251|NCT04018664|4095436|FG004|NOT COMPLETED|Overall Study||0
3364252|NCT04018664|4095437|FG005|NOT COMPLETED|Overall Study||0
3364253|NCT04018664|4095438|FG006|NOT COMPLETED|Overall Study||0
3364254|NCT04018664|4095439|FG007|NOT COMPLETED|Overall Study||0
3364255|NCT04016259|4095459|FG000|STARTED|Overall Study||15
3190112|NCT02048722|3918155|FG000|COMPLETED|Follow up for 5 Years||0
3190113|NCT02048722|3918155|FG000|NOT COMPLETED|Follow up for 5 Years||29
3190114|NCT02048826|3918161|FG000|STARTED|Overall Study||16
3190115|NCT02048826|3918162|FG001|STARTED|Overall Study||15
3190116|NCT02048826|3918161|FG000|COMPLETED|Overall Study||15
3190117|NCT02048826|3918162|FG001|COMPLETED|Overall Study||15
3190118|NCT02048826|3918161|FG000|NOT COMPLETED|Overall Study||1
3190119|NCT02048826|3918162|FG001|NOT COMPLETED|Overall Study||0
3190120|NCT02048878|3918170|FG000|STARTED|Overall Study||13
3190121|NCT02048878|3918171|FG001|STARTED|Overall Study||15
3190122|NCT02048878|3918170|FG000|COMPLETED|Overall Study||12
3190123|NCT02048878|3918171|FG001|COMPLETED|Overall Study||12
3190124|NCT02048878|3918170|FG000|NOT COMPLETED|Overall Study||1
3190125|NCT02048878|3918171|FG001|NOT COMPLETED|Overall Study||3
3190126|NCT02048891|3918179|FG000|STARTED|Overall Study||2
3190127|NCT02048891|3918180|FG001|STARTED|Overall Study||1
3190128|NCT02048891|3918179|FG000|COMPLETED|Overall Study||2
3190129|NCT02048891|3918180|FG001|COMPLETED|Overall Study||1
3190130|NCT02048891|3918179|FG000|NOT COMPLETED|Overall Study||0
3190131|NCT02048891|3918180|FG001|NOT COMPLETED|Overall Study||0
3190132|NCT02049151|3918188|FG000|STARTED|Overall Study|2 subjects did not receive treatment|15
3190133|NCT02049151|3918189|FG001|STARTED|Overall Study|1 subject did not receive treatment|17
3190134|NCT02049151|3918188|FG000|COMPLETED|Overall Study||15
3190135|NCT02049151|3918189|FG001|COMPLETED|Overall Study||17
3190136|NCT02049151|3918188|FG000|NOT COMPLETED|Overall Study||0
3190137|NCT02049151|3918189|FG001|NOT COMPLETED|Overall Study||0
3190138|NCT02049307|3918197|FG000|STARTED|Overall Study||52
3190139|NCT02049307|3918198|FG001|STARTED|Overall Study||56
3190140|NCT02049307|3918197|FG000|COMPLETED|Overall Study||50
3190141|NCT02049307|3918198|FG001|COMPLETED|Overall Study||55
3190142|NCT02049307|3918197|FG000|NOT COMPLETED|Overall Study||2
3190143|NCT02049307|3918198|FG001|NOT COMPLETED|Overall Study||1
3190144|NCT02049385|3918206|FG000|STARTED|First Intervention||4
3190145|NCT02049385|3918207|FG001|STARTED|First Intervention||2
3190146|NCT02049385|3918206|FG000|COMPLETED|First Intervention||1
3190147|NCT02049385|3918207|FG001|COMPLETED|First Intervention||2
3190148|NCT02049385|3918206|FG000|NOT COMPLETED|First Intervention||3
3190149|NCT02049385|3918207|FG001|NOT COMPLETED|First Intervention||0
3190150|NCT02049385|3918206|FG000|STARTED|Second Intervention||1
3190151|NCT02049385|3918207|FG001|STARTED|Second Intervention||2
3190152|NCT02049385|3918206|FG000|COMPLETED|Second Intervention||1
3190153|NCT02049385|3918207|FG001|COMPLETED|Second Intervention||0
3190154|NCT02049385|3918206|FG000|NOT COMPLETED|Second Intervention||0
3190155|NCT02049385|3918207|FG001|NOT COMPLETED|Second Intervention||2
3190156|NCT02049437|3918215|FG000|STARTED|Period 1||17
3190157|NCT02049437|3918216|FG001|STARTED|Period 1||17
3190158|NCT02049437|3918215|FG000|COMPLETED|Period 1||15
3190159|NCT02049437|3918216|FG001|COMPLETED|Period 1|Dropout due to low trough levels|16
3190160|NCT02049437|3918215|FG000|NOT COMPLETED|Period 1||2
3190161|NCT02049437|3918216|FG001|NOT COMPLETED|Period 1||1
3190162|NCT02049437|3918215|FG000|STARTED|Washout 1||15
3190163|NCT02049437|3918216|FG001|STARTED|Washout 1||16
3190164|NCT02049437|3918215|FG000|COMPLETED|Washout 1||15
3190165|NCT02049437|3918216|FG001|COMPLETED|Washout 1||16
3190166|NCT02049437|3918215|FG000|NOT COMPLETED|Washout 1||0
3190167|NCT02049437|3918216|FG001|NOT COMPLETED|Washout 1||0
3190168|NCT02049437|3918215|FG000|STARTED|Period 2||15
3190169|NCT02049437|3918216|FG001|STARTED|Period 2||16
3190170|NCT02049437|3918215|FG000|COMPLETED|Period 2||15
3190171|NCT02049437|3918216|FG001|COMPLETED|Period 2||16
3190172|NCT02049437|3918215|FG000|NOT COMPLETED|Period 2||0
3190173|NCT02049437|3918216|FG001|NOT COMPLETED|Period 2||0
3190174|NCT02049437|3918215|FG000|STARTED|Washout 2||15
3190175|NCT02049437|3918216|FG001|STARTED|Washout 2||16
3190176|NCT02049437|3918215|FG000|COMPLETED|Washout 2||15
3190177|NCT02049437|3918216|FG001|COMPLETED|Washout 2||16
3190178|NCT02049437|3918215|FG000|NOT COMPLETED|Washout 2||0
3190179|NCT02049437|3918216|FG001|NOT COMPLETED|Washout 2||0
3190180|NCT02049450|3918222|FG000|STARTED|Overall Study||30
3190181|NCT02049450|3918222|FG000|Discontinued Treatment Prior to Week 30|Overall Study||4
3190182|NCT02049450|3918222|FG000|Entered Extension Phase|Overall Study|Of 26 who completed Core phase 18 moved into Ext. phase; All 18 eventually discontinued Ext. phase|18
3190183|NCT02049450|3918222|FG000|COMPLETED|Overall Study|Completed = Completed Core phase of study|26
3190184|NCT02049450|3918222|FG000|NOT COMPLETED|Overall Study||4
3190185|NCT02049476|3918233|FG000|STARTED|Overall Study|First patient enrolled on 1/31/2014|20
3190186|NCT02049476|3918233|FG000|COMPLETED|Overall Study|20th patient completed the study|20
3190187|NCT02049476|3918233|FG000|NOT COMPLETED|Overall Study||0
3190188|NCT02049502|3918237|FG000|STARTED|Overall Study||8
3190189|NCT02049502|3918237|FG000|COMPLETED|Overall Study||8
3190190|NCT02049502|3918237|FG000|NOT COMPLETED|Overall Study||0
3190191|NCT02049749|3918243|FG000|STARTED|Overall Study|40 children plus 40 caregivers|80
3190192|NCT02049749|3918244|FG001|STARTED|Overall Study|80 children plus 80 caregivers|160
3190193|NCT02049749|3918243|FG000|COMPLETED|Overall Study||80
3190194|NCT02049749|3918244|FG001|COMPLETED|Overall Study|80 children plus 80 caregivers|160
3190195|NCT02049749|3918243|FG000|NOT COMPLETED|Overall Study||0
3190196|NCT02049749|3918244|FG001|NOT COMPLETED|Overall Study||0
3190197|NCT02049814|3918253|FG000|STARTED|Overall Study||248
3190198|NCT02049814|3918254|FG001|STARTED|Overall Study||246
3190199|NCT02049814|3918253|FG000|Safety Set|Overall Study||248
3190200|NCT02049814|3918254|FG001|Safety Set|Overall Study||245
3190201|NCT02049814|3918253|FG000|COMPLETED|Overall Study||219
3190202|NCT02049814|3918254|FG001|COMPLETED|Overall Study||219
3190203|NCT02049814|3918253|FG000|NOT COMPLETED|Overall Study||29
3190204|NCT02049814|3918254|FG001|NOT COMPLETED|Overall Study||27
3190205|NCT02049866|3918260|FG000|STARTED|Overall Study||33
3190206|NCT02049866|3918260|FG000|COMPLETED|Overall Study||32
3190207|NCT02049866|3918260|FG000|NOT COMPLETED|Overall Study||1
3190208|NCT02049931|3918267|FG000|STARTED|Overall Study||20
3190209|NCT02049931|3918268|FG001|STARTED|Overall Study||20
3190210|NCT02049931|3918269|FG002|STARTED|Overall Study||20
3190211|NCT02049931|3918267|FG000|COMPLETED|Overall Study||17
3190212|NCT02049931|3918268|FG001|COMPLETED|Overall Study||15
3190213|NCT02049931|3918269|FG002|COMPLETED|Overall Study||17
3190214|NCT02049931|3918267|FG000|NOT COMPLETED|Overall Study||3
3190215|NCT02049931|3918268|FG001|NOT COMPLETED|Overall Study||5
3190216|NCT02049931|3918269|FG002|NOT COMPLETED|Overall Study||3
3190217|NCT02049944|3918277|FG000|STARTED|Overall Study||30
3190218|NCT02049944|3918277|FG000|Obese (BMI 30-40kg/m^2)|Overall Study||14
3190219|NCT02049944|3918277|FG000|Extremely Obese (BMI >40kg/m^2)|Overall Study||14
3190220|NCT02049944|3918277|FG000|COMPLETED|Overall Study||28
3190221|NCT02049944|3918277|FG000|NOT COMPLETED|Overall Study||2
3190222|NCT02049957|3918290|FG000|STARTED|Overall Study||6
3190223|NCT02049957|3918291|FG001|STARTED|Overall Study||6
3190224|NCT02049957|3918292|FG002|STARTED|Overall Study||3
3190225|NCT02049957|3918293|FG003|STARTED|Overall Study||3
3190226|NCT02049957|3918294|FG004|STARTED|Overall Study||6
3190227|NCT02049957|3918295|FG005|STARTED|Overall Study||43
3190228|NCT02049957|3918296|FG006|STARTED|Overall Study||8
3190229|NCT02049957|3918297|FG007|STARTED|Overall Study||35
3190230|NCT02049957|3918298|FG008|STARTED|Overall Study||8
3190231|NCT02049957|3918290|FG000|COMPLETED|Overall Study||0
3190232|NCT02049957|3918291|FG001|COMPLETED|Overall Study||0
3190233|NCT02049957|3918292|FG002|COMPLETED|Overall Study||0
3190234|NCT02049957|3918293|FG003|COMPLETED|Overall Study||0
3190235|NCT02049957|3918294|FG004|COMPLETED|Overall Study||0
3190236|NCT02049957|3918295|FG005|COMPLETED|Overall Study||0
3190237|NCT02049957|3918296|FG006|COMPLETED|Overall Study||0
3190238|NCT02049957|3918297|FG007|COMPLETED|Overall Study||0
3190239|NCT02049957|3918298|FG008|COMPLETED|Overall Study||0
3190240|NCT02049957|3918290|FG000|NOT COMPLETED|Overall Study||6
3190241|NCT02049957|3918291|FG001|NOT COMPLETED|Overall Study||6
3190242|NCT02049957|3918292|FG002|NOT COMPLETED|Overall Study||3
3190243|NCT02049957|3918293|FG003|NOT COMPLETED|Overall Study||3
3190244|NCT02049957|3918294|FG004|NOT COMPLETED|Overall Study||6
3190245|NCT02049957|3918295|FG005|NOT COMPLETED|Overall Study||43
3190246|NCT02049957|3918296|FG006|NOT COMPLETED|Overall Study||8
3190247|NCT02049957|3918297|FG007|NOT COMPLETED|Overall Study||35
3190248|NCT02049957|3918298|FG008|NOT COMPLETED|Overall Study||8
3190249|NCT02050048|3918320|FG000|STARTED|Overall Study||14
3190250|NCT02050048|3918321|FG001|STARTED|Overall Study||12
3190251|NCT02050048|3918320|FG000|COMPLETED|Overall Study||9
3190252|NCT02050048|3918321|FG001|COMPLETED|Overall Study||10
3190253|NCT02050048|3918320|FG000|NOT COMPLETED|Overall Study||5
3190254|NCT02050048|3918321|FG001|NOT COMPLETED|Overall Study||2
3190255|NCT02050321|3918327|FG000|STARTED|Overall Study||2
3190256|NCT02050321|3918327|FG000|COMPLETED|Overall Study||0
3190257|NCT02050321|3918327|FG000|NOT COMPLETED|Overall Study||2
3190258|NCT02050334|3918333|FG000|STARTED|Overall Study||9
3190259|NCT02050334|3918334|FG001|STARTED|Overall Study||9
3190260|NCT02050334|3918333|FG000|COMPLETED|Overall Study||9
3190261|NCT02050334|3918334|FG001|COMPLETED|Overall Study||9
3190262|NCT02050334|3918333|FG000|NOT COMPLETED|Overall Study||0
3190263|NCT02050334|3918334|FG001|NOT COMPLETED|Overall Study||0
3190264|NCT02050373|3918343|FG000|STARTED|Overall Study||34
3190265|NCT02050373|3918344|FG001|STARTED|Overall Study||34
3190266|NCT02050373|3918343|FG000|COMPLETED|Overall Study||27
3190267|NCT02050373|3918344|FG001|COMPLETED|Overall Study||24
3190268|NCT02050373|3918343|FG000|NOT COMPLETED|Overall Study||7
3190269|NCT02050373|3918344|FG001|NOT COMPLETED|Overall Study||10
3190270|NCT02050841|3918351|FG000|STARTED|Overall Study||50
3190271|NCT02050841|3918351|FG000|COMPLETED|Overall Study||49
3190272|NCT02050841|3918351|FG000|NOT COMPLETED|Overall Study||1
3190273|NCT02050919|3918361|FG000|STARTED|Overall Study||20
3190274|NCT02050919|3918361|FG000|COMPLETED|Overall Study||20
3190275|NCT02050919|3918361|FG000|NOT COMPLETED|Overall Study||0
3190276|NCT02051296|3918367|FG000|STARTED|Overall Study||66
3190277|NCT02051296|3918368|FG001|STARTED|Overall Study||65
3190278|NCT02051296|3918367|FG000|Received Allocated Intervention|Overall Study||59
3190279|NCT02051296|3918368|FG001|Received Allocated Intervention|Overall Study||58
3190280|NCT02051296|3918367|FG000|COMPLETED|Overall Study||58
3190281|NCT02051296|3918368|FG001|COMPLETED|Overall Study||56
3190282|NCT02051296|3918367|FG000|NOT COMPLETED|Overall Study||8
3190283|NCT02051296|3918368|FG001|NOT COMPLETED|Overall Study||9
3190284|NCT02051335|3918378|FG000|STARTED|Period 1||7
3190285|NCT02051335|3918379|FG001|STARTED|Period 1||7
3190286|NCT02051335|3918380|FG002|STARTED|Period 1||7
3190287|NCT02051335|3918381|FG003|STARTED|Period 1||6
3190288|NCT02051335|3918378|FG000|COMPLETED|Period 1||7
3190289|NCT02051335|3918379|FG001|COMPLETED|Period 1||7
3190290|NCT02051335|3918380|FG002|COMPLETED|Period 1||7
3190291|NCT02051335|3918381|FG003|COMPLETED|Period 1||6
3190292|NCT02051335|3918378|FG000|NOT COMPLETED|Period 1||0
3190293|NCT02051335|3918379|FG001|NOT COMPLETED|Period 1||0
3190294|NCT02051335|3918380|FG002|NOT COMPLETED|Period 1||0
3190295|NCT02051335|3918381|FG003|NOT COMPLETED|Period 1||0
3190296|NCT02051335|3918378|FG000|STARTED|Period 2||7
3190297|NCT02051335|3918379|FG001|STARTED|Period 2||7
3190298|NCT02051335|3918380|FG002|STARTED|Period 2||7
3190299|NCT02051335|3918381|FG003|STARTED|Period 2|2 Participants received treatment in Period 1 but discontinued prior to Period 2.|4
3190300|NCT02051335|3918378|FG000|COMPLETED|Period 2||7
3190301|NCT02051335|3918379|FG001|COMPLETED|Period 2||7
3190302|NCT02051335|3918380|FG002|COMPLETED|Period 2||7
3190303|NCT02051335|3918381|FG003|COMPLETED|Period 2||4
3190304|NCT02051335|3918378|FG000|NOT COMPLETED|Period 2||0
3190305|NCT02051335|3918379|FG001|NOT COMPLETED|Period 2||0
3190306|NCT02051335|3918380|FG002|NOT COMPLETED|Period 2||0
3190307|NCT02051335|3918381|FG003|NOT COMPLETED|Period 2||0
3190308|NCT02051335|3918378|FG000|STARTED|Period 3||7
3190309|NCT02051335|3918379|FG001|STARTED|Period 3||7
3190310|NCT02051335|3918380|FG002|STARTED|Period 3|2 Participants received treatment in Period 2 but discontinued prior to Period 3.|5
3190311|NCT02051335|3918381|FG003|STARTED|Period 3||4
3190312|NCT02051335|3918378|FG000|COMPLETED|Period 3||7
3190313|NCT02051335|3918379|FG001|COMPLETED|Period 3||7
3190314|NCT02051335|3918380|FG002|COMPLETED|Period 3||5
3190315|NCT02051335|3918381|FG003|COMPLETED|Period 3||4
3190316|NCT02051335|3918378|FG000|NOT COMPLETED|Period 3||0
3190317|NCT02051335|3918379|FG001|NOT COMPLETED|Period 3||0
3190318|NCT02051335|3918380|FG002|NOT COMPLETED|Period 3||0
3190319|NCT02051335|3918381|FG003|NOT COMPLETED|Period 3||0
3190320|NCT02051335|3918378|FG000|STARTED|Period 4||7
3190321|NCT02051335|3918379|FG001|STARTED|Period 4||7
3190322|NCT02051335|3918380|FG002|STARTED|Period 4||5
3190323|NCT02051335|3918381|FG003|STARTED|Period 4||4
3190324|NCT02051335|3918378|FG000|COMPLETED|Period 4||7
3190325|NCT02051335|3918379|FG001|COMPLETED|Period 4||7
3190326|NCT02051335|3918380|FG002|COMPLETED|Period 4||5
3190327|NCT02051335|3918381|FG003|COMPLETED|Period 4||4
3190328|NCT02051335|3918378|FG000|NOT COMPLETED|Period 4||0
3190329|NCT02051335|3918379|FG001|NOT COMPLETED|Period 4||0
3190330|NCT02051335|3918380|FG002|NOT COMPLETED|Period 4||0
3190331|NCT02051335|3918381|FG003|NOT COMPLETED|Period 4||0
3190332|NCT02051426|3918393|FG000|STARTED|First Intervention||16
3190333|NCT02051426|3918394|FG001|STARTED|First Intervention||19
3190334|NCT02051426|3918393|FG000|COMPLETED|First Intervention||16
3190335|NCT02051426|3918394|FG001|COMPLETED|First Intervention||19
3190336|NCT02051426|3918393|FG000|NOT COMPLETED|First Intervention||0
3190337|NCT02051426|3918394|FG001|NOT COMPLETED|First Intervention||0
3190338|NCT02051426|3918393|FG000|STARTED|Washout Period of 1 Month||16
3190339|NCT02051426|3918394|FG001|STARTED|Washout Period of 1 Month||19
3190340|NCT02051426|3918393|FG000|COMPLETED|Washout Period of 1 Month||16
3190341|NCT02051426|3918394|FG001|COMPLETED|Washout Period of 1 Month||19
3190342|NCT02051426|3918393|FG000|NOT COMPLETED|Washout Period of 1 Month||0
3190343|NCT02051426|3918394|FG001|NOT COMPLETED|Washout Period of 1 Month||0
3190344|NCT02051426|3918393|FG000|STARTED|Second Intervention||16
3190345|NCT02051426|3918394|FG001|STARTED|Second Intervention||19
3190346|NCT02051426|3918393|FG000|COMPLETED|Second Intervention||16
3190347|NCT02051426|3918394|FG001|COMPLETED|Second Intervention||19
3190348|NCT02051426|3918393|FG000|NOT COMPLETED|Second Intervention||0
3190349|NCT02051426|3918394|FG001|NOT COMPLETED|Second Intervention||0
3190350|NCT02051452|3918402|FG000|STARTED|Overall Study||16
3190351|NCT02051452|3918403|FG001|STARTED|Overall Study||16
3190352|NCT02051452|3918402|FG000|COMPLETED|Overall Study||16
3190353|NCT02051452|3918403|FG001|COMPLETED|Overall Study||16
3190354|NCT02051452|3918402|FG000|NOT COMPLETED|Overall Study||0
3190355|NCT02051452|3918403|FG001|NOT COMPLETED|Overall Study||0
3190356|NCT02051595|3918409|FG000|STARTED|Overall Study||25
3190357|NCT02051595|3918409|FG000|COMPLETED|Overall Study||25
3190358|NCT02051595|3918409|FG000|NOT COMPLETED|Overall Study||0
3190359|NCT02051686|3918415|FG000|STARTED|Overall Study||42
3190360|NCT02051686|3918416|FG001|STARTED|Overall Study||46
3190361|NCT02051686|3918415|FG000|COMPLETED|Overall Study||42
3190362|NCT02051686|3918416|FG001|COMPLETED|Overall Study||46
3190363|NCT02051686|3918415|FG000|NOT COMPLETED|Overall Study||0
3190364|NCT02051686|3918416|FG001|NOT COMPLETED|Overall Study||0
3190365|NCT02051764|3918424|FG000|STARTED|Overall Study||16
3190366|NCT02051764|3918425|FG001|STARTED|Overall Study||28
3190367|NCT02051764|3918424|FG000|COMPLETED|Overall Study||16
3190368|NCT02051764|3918425|FG001|COMPLETED|Overall Study||21
3190369|NCT02051764|3918424|FG000|NOT COMPLETED|Overall Study||0
3190370|NCT02051764|3918425|FG001|NOT COMPLETED|Overall Study||7
3190371|NCT02051790|3918431|FG000|STARTED|Overall Study||241
3190372|NCT02051790|3918431|FG000|COMPLETED|Overall Study||241
3190373|NCT02051790|3918431|FG000|NOT COMPLETED|Overall Study||0
3190374|NCT02051816|3918439|FG000|STARTED|Overall Study||37
3190375|NCT02051816|3918440|FG001|STARTED|Overall Study||40
3190376|NCT02051816|3918441|FG002|STARTED|Overall Study||37
3190377|NCT02051816|3918442|FG003|STARTED|Overall Study||36
3190378|NCT02051816|3918439|FG000|COMPLETED|Overall Study||37
3190379|NCT02051816|3918440|FG001|COMPLETED|Overall Study||40
3190380|NCT02051816|3918441|FG002|COMPLETED|Overall Study||37
3190381|NCT02051816|3918442|FG003|COMPLETED|Overall Study||36
3190382|NCT02051816|3918439|FG000|NOT COMPLETED|Overall Study||0
3190383|NCT02051816|3918440|FG001|NOT COMPLETED|Overall Study||0
3190384|NCT02051816|3918441|FG002|NOT COMPLETED|Overall Study||0
3190385|NCT02051816|3918442|FG003|NOT COMPLETED|Overall Study||0
3190386|NCT02052011|3918458|FG000|STARTED|Overall Study||21
3190387|NCT02052011|3918459|FG001|STARTED|Overall Study||10
3190388|NCT02052011|3918458|FG000|COMPLETED|Overall Study||17
3190389|NCT02052011|3918459|FG001|COMPLETED|Overall Study||8
3190390|NCT02052011|3918458|FG000|NOT COMPLETED|Overall Study||4
3190391|NCT02052011|3918459|FG001|NOT COMPLETED|Overall Study||2
3190392|NCT02052141|3918467|FG000|STARTED|Intervention Period 1||5
3190393|NCT02052141|3918468|FG001|STARTED|Intervention Period 1||7
3190394|NCT02052141|3918467|FG000|COMPLETED|Intervention Period 1||5
3190395|NCT02052141|3918468|FG001|COMPLETED|Intervention Period 1||7
3190396|NCT02052141|3918467|FG000|NOT COMPLETED|Intervention Period 1||0
3190397|NCT02052141|3918468|FG001|NOT COMPLETED|Intervention Period 1||0
3190398|NCT02052141|3918467|FG000|STARTED|Intervention Period 2||5
3190399|NCT02052141|3918468|FG001|STARTED|Intervention Period 2||7
3190400|NCT02052141|3918467|FG000|COMPLETED|Intervention Period 2||5
3190401|NCT02052141|3918468|FG001|COMPLETED|Intervention Period 2||7
3190402|NCT02052141|3918467|FG000|NOT COMPLETED|Intervention Period 2||0
3190403|NCT02052141|3918468|FG001|NOT COMPLETED|Intervention Period 2||0
3190404|NCT02052310|3918476|FG000|STARTED|Overall Study||522
3190405|NCT02052310|3918477|FG001|STARTED|Overall Study||521
3190406|NCT02052310|3918476|FG000|Received at Least 1 Dose of Study Drug|Overall Study||522
3190407|NCT02052310|3918477|FG001|Received at Least 1 Dose of Study Drug|Overall Study||517
3190408|NCT02052310|3918476|FG000|COMPLETED|Overall Study||307
3190409|NCT02052310|3918477|FG001|COMPLETED|Overall Study||309
3190410|NCT02052310|3918476|FG000|NOT COMPLETED|Overall Study||215
3190411|NCT02052310|3918477|FG001|NOT COMPLETED|Overall Study||212
3190412|NCT02052414|3918483|FG000|STARTED|Overall Study||34
3190413|NCT02052414|3918483|FG000|COMPLETED|Overall Study||17
3190414|NCT02052414|3918483|FG000|NOT COMPLETED|Overall Study||17
3190415|NCT02052440|3918490|FG000|STARTED|Overall Study||50
3190416|NCT02052440|3918491|FG001|STARTED|Overall Study||52
3190417|NCT02052440|3918490|FG000|COMPLETED|Overall Study||50
3190418|NCT02052440|3918491|FG001|COMPLETED|Overall Study||51
3190419|NCT02052440|3918490|FG000|NOT COMPLETED|Overall Study||0
3190420|NCT02052440|3918491|FG001|NOT COMPLETED|Overall Study||1
3190421|NCT02052466|3918497|FG000|STARTED|Overall Study||32
3190422|NCT02052466|3918497|FG000|COMPLETED|Overall Study||30
3190423|NCT02052466|3918497|FG000|NOT COMPLETED|Overall Study||2
3190424|NCT02052544|3918501|FG000|STARTED|Overall Study|First Subject In|123
3190425|NCT02052544|3918501|FG000|COMPLETED|Overall Study|Last Subject Out|123
3190426|NCT02052544|3918501|FG000|NOT COMPLETED|Overall Study||0
3190427|NCT02052557|3918508|FG000|STARTED|Overall Study||26
3190428|NCT02052557|3918509|FG001|STARTED|Overall Study||25
3190429|NCT02052557|3918508|FG000|COMPLETED|Overall Study||26
3190430|NCT02052557|3918509|FG001|COMPLETED|Overall Study||25
3190431|NCT02052557|3918508|FG000|NOT COMPLETED|Overall Study||0
3190432|NCT02052557|3918509|FG001|NOT COMPLETED|Overall Study||0
3190433|NCT02052596|3918519|FG000|STARTED|Active Phase||412
3190434|NCT02052596|3918520|FG001|STARTED|Active Phase||418
3190435|NCT02052596|3918519|FG000|COMPLETED|Active Phase||396
3190436|NCT02052596|3918520|FG001|COMPLETED|Active Phase||398
3190437|NCT02052596|3918519|FG000|NOT COMPLETED|Active Phase||16
3190438|NCT02052596|3918520|FG001|NOT COMPLETED|Active Phase||20
3190439|NCT02052596|3918519|FG000|STARTED|Safety Phase||412
3190440|NCT02052596|3918520|FG001|STARTED|Safety Phase||418
3190441|NCT02052596|3918519|FG000|COMPLETED|Safety Phase||385
3190442|NCT02052596|3918520|FG001|COMPLETED|Safety Phase||383
3190443|NCT02052596|3918519|FG000|NOT COMPLETED|Safety Phase||27
3190444|NCT02052596|3918520|FG001|NOT COMPLETED|Safety Phase||35
3190445|NCT02052635|3918528|FG000|STARTED|Overall Study||7
3190446|NCT02052635|3918529|FG001|STARTED|Overall Study||6
3190447|NCT02052635|3918528|FG000|COMPLETED|Overall Study||7
3190448|NCT02052635|3918529|FG001|COMPLETED|Overall Study||6
3190449|NCT02052635|3918528|FG000|NOT COMPLETED|Overall Study||0
3190450|NCT02052635|3918529|FG001|NOT COMPLETED|Overall Study||0
3190451|NCT02052661|3918535|FG000|STARTED|Overall Study||300
3190452|NCT02052661|3918535|FG000|COMPLETED|Overall Study||300
3190453|NCT02052661|3918535|FG000|NOT COMPLETED|Overall Study||0
3190454|NCT02052752|3918542|FG000|STARTED|Overall Study||30
3190455|NCT02052752|3918543|FG001|STARTED|Overall Study||30
3190456|NCT02052752|3918544|FG002|STARTED|Overall Study||30
3190457|NCT02052752|3918542|FG000|COMPLETED|Overall Study||30
3190458|NCT02052752|3918543|FG001|COMPLETED|Overall Study||30
3190459|NCT02052752|3918544|FG002|COMPLETED|Overall Study||30
3190460|NCT02052752|3918542|FG000|NOT COMPLETED|Overall Study||0
3190461|NCT02052752|3918543|FG001|NOT COMPLETED|Overall Study||0
3190462|NCT02052752|3918544|FG002|NOT COMPLETED|Overall Study||0
3190463|NCT02052895|3918556|FG000|STARTED|Overall Study||196
3190464|NCT02052895|3918557|FG001|STARTED|Overall Study||15
3190465|NCT02052895|3918558|FG002|STARTED|Overall Study||15
3190466|NCT02052895|3918556|FG000|COMPLETED|Overall Study||196
3190467|NCT02052895|3918557|FG001|COMPLETED|Overall Study||15
3190468|NCT02052895|3918558|FG002|COMPLETED|Overall Study||15
3190469|NCT02052895|3918556|FG000|NOT COMPLETED|Overall Study||0
3190470|NCT02052895|3918557|FG001|NOT COMPLETED|Overall Study||0
3190471|NCT02052895|3918558|FG002|NOT COMPLETED|Overall Study||0
3190472|NCT02052960|3918567|FG000|STARTED|Overall Study||117
3190473|NCT02052960|3918568|FG001|STARTED|Overall Study||123
3190474|NCT02052960|3918567|FG000|Treated Patients|Overall Study||115
3190475|NCT02052960|3918568|FG001|Treated Patients|Overall Study||122
3190476|NCT02052960|3918567|FG000|COMPLETED|Overall Study||63
3190477|NCT02052960|3918568|FG001|COMPLETED|Overall Study||77
3190478|NCT02052960|3918567|FG000|NOT COMPLETED|Overall Study||54
3190479|NCT02052960|3918568|FG001|NOT COMPLETED|Overall Study||46
3190480|NCT02053077|3918577|FG000|STARTED|Overall Study||150
3190481|NCT02053077|3918577|FG000|COMPLETED|Overall Study||150
3190482|NCT02053077|3918577|FG000|NOT COMPLETED|Overall Study||0
3190483|NCT02053168|3918581|FG000|STARTED|Overall Study||25
3190484|NCT02053168|3918581|FG000|COMPLETED|Overall Study||22
3190485|NCT02053168|3918581|FG000|NOT COMPLETED|Overall Study||3
3190486|NCT02053259|3918589|FG000|STARTED|Overall Study||25
3190487|NCT02053259|3918590|FG001|STARTED|Overall Study||24
3190488|NCT02053259|3918591|FG002|STARTED|Overall Study||24
3190489|NCT02053259|3918592|FG003|STARTED|Overall Study||23
3190490|NCT02053259|3918589|FG000|COMPLETED|Overall Study||25
3190491|NCT02053259|3918590|FG001|COMPLETED|Overall Study||24
3190492|NCT02053259|3918591|FG002|COMPLETED|Overall Study||24
3190493|NCT02053259|3918592|FG003|COMPLETED|Overall Study||23
3190494|NCT02053259|3918589|FG000|NOT COMPLETED|Overall Study||0
3190495|NCT02053259|3918590|FG001|NOT COMPLETED|Overall Study||0
3190496|NCT02053259|3918591|FG002|NOT COMPLETED|Overall Study||0
3190497|NCT02053259|3918592|FG003|NOT COMPLETED|Overall Study||0
3190498|NCT02053376|3918602|FG000|STARTED|Overall Study||43
3190499|NCT02053376|3918602|FG000|COMPLETED|Overall Study||43
3190500|NCT02053376|3918602|FG000|NOT COMPLETED|Overall Study||0
3190501|NCT02053493|3918608|FG000|STARTED|Overall Study||51
3190502|NCT02053493|3918609|FG001|STARTED|Overall Study||59
3190503|NCT02053493|3918608|FG000|COMPLETED|Overall Study||50
3190504|NCT02053493|3918609|FG001|COMPLETED|Overall Study||58
3190505|NCT02053493|3918608|FG000|NOT COMPLETED|Overall Study||1
3190506|NCT02053493|3918609|FG001|NOT COMPLETED|Overall Study||1
3190507|NCT02053610|3918617|FG000|STARTED|Overall Study||330
3190508|NCT02053610|3918618|FG001|STARTED|Overall Study||333
3190509|NCT02053610|3918617|FG000|Received Study Drug|Overall Study||326
3190510|NCT02053610|3918618|FG001|Received Study Drug|Overall Study||331
3190511|NCT02053610|3918617|FG000|COMPLETED|Overall Study|Completed=Completed Treatment|288
3190512|NCT02053610|3918618|FG001|COMPLETED|Overall Study|Completed=Completed Treatment|266
3190513|NCT02053610|3918617|FG000|NOT COMPLETED|Overall Study||42
3190514|NCT02053610|3918618|FG001|NOT COMPLETED|Overall Study||67
3190515|NCT02053753|3918626|FG000|STARTED|Overall Study||72
3190516|NCT02053753|3918627|FG001|STARTED|Overall Study||74
3190517|NCT02053753|3918626|FG000|Received Treatment|Overall Study||71
3190518|NCT02053753|3918627|FG001|Received Treatment|Overall Study||71
3190519|NCT02053753|3918626|FG000|COMPLETED|Overall Study||65
3190520|NCT02053753|3918627|FG001|COMPLETED|Overall Study||66
3190521|NCT02053753|3918626|FG000|NOT COMPLETED|Overall Study||7
3190522|NCT02053753|3918627|FG001|NOT COMPLETED|Overall Study||8
3190523|NCT02054130|3918637|FG000|STARTED|Overall Study||138
3190524|NCT02054130|3918638|FG001|STARTED|Overall Study||138
3190525|NCT02054130|3918639|FG002|STARTED|Overall Study||137
3190526|NCT02054130|3918640|FG003|STARTED|Overall Study||137
3190527|NCT02054130|3918637|FG000|COMPLETED|Overall Study||130
3190528|NCT02054130|3918638|FG001|COMPLETED|Overall Study||127
3190529|NCT02054130|3918639|FG002|COMPLETED|Overall Study||122
3190530|NCT02054130|3918640|FG003|COMPLETED|Overall Study||115
3190531|NCT02054130|3918637|FG000|NOT COMPLETED|Overall Study||8
3190532|NCT02054130|3918638|FG001|NOT COMPLETED|Overall Study||11
3190533|NCT02054130|3918639|FG002|NOT COMPLETED|Overall Study||15
3190534|NCT02054130|3918640|FG003|NOT COMPLETED|Overall Study||22
3190535|NCT02054156|3918655|FG000|STARTED|Overall Study||110
3190536|NCT02054156|3918656|FG001|STARTED|Overall Study||111
3190537|NCT02054156|3918655|FG000|COMPLETED|Overall Study||35
3190538|NCT02054156|3918656|FG001|COMPLETED|Overall Study||30
3190539|NCT02054156|3918655|FG000|NOT COMPLETED|Overall Study||75
3190540|NCT02054156|3918656|FG001|NOT COMPLETED|Overall Study||81
3190541|NCT02054325|3918664|FG000|STARTED|Overall Study||51
3190542|NCT02054325|3918665|FG001|STARTED|Overall Study||55
3190543|NCT02054325|3918664|FG000|COMPLETED|Overall Study||43
3190544|NCT02054325|3918665|FG001|COMPLETED|Overall Study||50
3190545|NCT02054325|3918664|FG000|NOT COMPLETED|Overall Study||8
3190546|NCT02054325|3918665|FG001|NOT COMPLETED|Overall Study||5
3190547|NCT02054338|3918673|FG000|STARTED|Overall Study||503
3190548|NCT02054338|3918674|FG001|STARTED|Overall Study||501
3190549|NCT02054338|3918673|FG000|COMPLETED|Overall Study||0
3190550|NCT02054338|3918674|FG001|COMPLETED|Overall Study||0
3190551|NCT02054338|3918673|FG000|NOT COMPLETED|Overall Study||503
3190552|NCT02054338|3918674|FG001|NOT COMPLETED|Overall Study||501
3190553|NCT02054481|3918684|FG000|STARTED|Overall Study||43
3190554|NCT02054481|3918685|FG001|STARTED|Overall Study||41
3190555|NCT02054481|3918686|FG002|STARTED|Overall Study||42
3190556|NCT02054481|3918687|FG003|STARTED|Overall Study||40
3190557|NCT02054481|3918684|FG000|COMPLETED|Overall Study||39
3190558|NCT02054481|3918685|FG001|COMPLETED|Overall Study||39
3190559|NCT02054481|3918686|FG002|COMPLETED|Overall Study||40
3190560|NCT02054481|3918687|FG003|COMPLETED|Overall Study||39
3190561|NCT02054481|3918684|FG000|NOT COMPLETED|Overall Study||4
3190562|NCT02054481|3918685|FG001|NOT COMPLETED|Overall Study||2
3190563|NCT02054481|3918686|FG002|NOT COMPLETED|Overall Study||2
3190564|NCT02054481|3918687|FG003|NOT COMPLETED|Overall Study||1
3364256|NCT04016259|4095460|FG001|STARTED|Overall Study||15
3364257|NCT04016259|4095459|FG000|COMPLETED|Overall Study||15
3364258|NCT04016259|4095460|FG001|COMPLETED|Overall Study||15
3364259|NCT04016259|4095459|FG000|NOT COMPLETED|Overall Study||0
3364260|NCT04016259|4095460|FG001|NOT COMPLETED|Overall Study||0
3190565|NCT02054520|3918704|FG000|STARTED|Overall Study||11
3190566|NCT02054520|3918705|FG001|STARTED|Overall Study||16
3190567|NCT02054520|3918706|FG002|STARTED|Overall Study||6
3190568|NCT02054520|3918707|FG003|STARTED|Overall Study||6
3190569|NCT02054520|3918708|FG004|STARTED|Overall Study||5
3190570|NCT02054520|3918709|FG005|STARTED|Overall Study||3
3190571|NCT02054520|3918704|FG000|COMPLETED|Overall Study||2
3190572|NCT02054520|3918705|FG001|COMPLETED|Overall Study||11
3190573|NCT02054520|3918706|FG002|COMPLETED|Overall Study||0
3190574|NCT02054520|3918707|FG003|COMPLETED|Overall Study||0
3190575|NCT02054520|3918708|FG004|COMPLETED|Overall Study||0
3190576|NCT02054520|3918709|FG005|COMPLETED|Overall Study||0
3190577|NCT02054520|3918704|FG000|NOT COMPLETED|Overall Study||9
3190578|NCT02054520|3918705|FG001|NOT COMPLETED|Overall Study||5
3190579|NCT02054520|3918706|FG002|NOT COMPLETED|Overall Study||6
3190580|NCT02054520|3918707|FG003|NOT COMPLETED|Overall Study||6
3190581|NCT02054520|3918708|FG004|NOT COMPLETED|Overall Study||5
3190582|NCT02054520|3918709|FG005|NOT COMPLETED|Overall Study||3
3190583|NCT02054572|3918723|FG000|STARTED|Overall Study||6
3190584|NCT02054572|3918723|FG000|COMPLETED|Overall Study||6
3190585|NCT02054572|3918723|FG000|NOT COMPLETED|Overall Study||0
3190586|NCT02054702|3918729|FG000|STARTED|Overall Study||64
3190587|NCT02054702|3918730|FG001|STARTED|Overall Study||33
3190588|NCT02054702|3918729|FG000|COMPLETED|Overall Study||40
3190589|NCT02054702|3918730|FG001|COMPLETED|Overall Study||21
3190590|NCT02054702|3918729|FG000|NOT COMPLETED|Overall Study||24
3190591|NCT02054702|3918730|FG001|NOT COMPLETED|Overall Study||12
3190592|NCT02054715|3918738|FG000|STARTED|Baseline/Follow-up 1||219
3190593|NCT02054715|3918739|FG001|STARTED|Baseline/Follow-up 1||199
3190594|NCT02054715|3918738|FG000|COMPLETED|Baseline/Follow-up 1||211
3190595|NCT02054715|3918739|FG001|COMPLETED|Baseline/Follow-up 1||192
3190596|NCT02054715|3918738|FG000|NOT COMPLETED|Baseline/Follow-up 1||8
3190597|NCT02054715|3918739|FG001|NOT COMPLETED|Baseline/Follow-up 1||7
3190598|NCT02054715|3918738|FG000|STARTED|Follow-up 2||211
3190599|NCT02054715|3918739|FG001|STARTED|Follow-up 2||192
3190600|NCT02054715|3918738|FG000|COMPLETED|Follow-up 2||192
3190601|NCT02054715|3918739|FG001|COMPLETED|Follow-up 2||173
3190602|NCT02054715|3918738|FG000|NOT COMPLETED|Follow-up 2||19
3190603|NCT02054715|3918739|FG001|NOT COMPLETED|Follow-up 2||19
3190604|NCT02054754|3918747|FG000|STARTED|Overall Study||6
3190605|NCT02054754|3918748|FG001|STARTED|Overall Study||6
3190606|NCT02054754|3918749|FG002|STARTED|Overall Study||6
3190607|NCT02054754|3918750|FG003|STARTED|Overall Study||6
3190608|NCT02054754|3918751|FG004|STARTED|Overall Study||6
3190609|NCT02054754|3918752|FG005|STARTED|Overall Study||10
3190610|NCT02054754|3918747|FG000|COMPLETED|Overall Study||6
3190611|NCT02054754|3918748|FG001|COMPLETED|Overall Study||6
3190612|NCT02054754|3918749|FG002|COMPLETED|Overall Study||6
3190613|NCT02054754|3918750|FG003|COMPLETED|Overall Study||6
3190614|NCT02054754|3918751|FG004|COMPLETED|Overall Study||6
3190615|NCT02054754|3918752|FG005|COMPLETED|Overall Study||10
3190616|NCT02054754|3918747|FG000|NOT COMPLETED|Overall Study||0
3190617|NCT02054754|3918748|FG001|NOT COMPLETED|Overall Study||0
3190618|NCT02054754|3918749|FG002|NOT COMPLETED|Overall Study||0
3190619|NCT02054754|3918750|FG003|NOT COMPLETED|Overall Study||0
3190620|NCT02054754|3918751|FG004|NOT COMPLETED|Overall Study||0
3190621|NCT02054754|3918752|FG005|NOT COMPLETED|Overall Study||0
3190622|NCT02054897|3918770|FG000|STARTED|Overall Study||129
3190623|NCT02054897|3918771|FG001|STARTED|Overall Study||130
3190624|NCT02054897|3918772|FG002|STARTED|Overall Study||129
3364261|NCT04016077|4095468|FG000|STARTED|Overall Study||10
3364262|NCT04016077|4095469|FG001|STARTED|Overall Study||8
3364263|NCT04016077|4095468|FG000|COMPLETED|Overall Study||10
3364264|NCT04016077|4095469|FG001|COMPLETED|Overall Study||8
3364265|NCT04016077|4095468|FG000|NOT COMPLETED|Overall Study||0
3364266|NCT04016077|4095469|FG001|NOT COMPLETED|Overall Study||0
3364267|NCT04027803|4095477|FG000|STARTED|Overall Study||39
3364268|NCT04027803|4095478|FG001|STARTED|Overall Study||39
3364269|NCT04027803|4095477|FG000|COMPLETED|Overall Study||39
3364270|NCT04027803|4095478|FG001|COMPLETED|Overall Study||39
3364271|NCT04027803|4095477|FG000|NOT COMPLETED|Overall Study||0
3364272|NCT04027803|4095478|FG001|NOT COMPLETED|Overall Study||0
3364273|NCT04016311|4095486|FG000|STARTED|Overall Study||18
3364274|NCT04016311|4095487|FG001|STARTED|Overall Study||20
3364275|NCT04016311|4095486|FG000|COMPLETED|Overall Study||17
3364276|NCT04016311|4095487|FG001|COMPLETED|Overall Study||20
3364277|NCT04016311|4095486|FG000|NOT COMPLETED|Overall Study||1
3190625|NCT02054897|3918770|FG000|Exposed|Overall Study||128
3190626|NCT02054897|3918771|FG001|Exposed|Overall Study||130
3190627|NCT02054897|3918772|FG002|Exposed|Overall Study||129
3190628|NCT02054897|3918770|FG000|COMPLETED|Overall Study||119
3190629|NCT02054897|3918771|FG001|COMPLETED|Overall Study||123
3190630|NCT02054897|3918772|FG002|COMPLETED|Overall Study||117
3190631|NCT02054897|3918770|FG000|NOT COMPLETED|Overall Study||10
3190632|NCT02054897|3918771|FG001|NOT COMPLETED|Overall Study||7
3190633|NCT02054897|3918772|FG002|NOT COMPLETED|Overall Study||12
3364278|NCT04016311|4095487|FG001|NOT COMPLETED|Overall Study||0
3190634|NCT02055118|3918783|FG000|STARTED|Overall Study||15
3190635|NCT02055118|3918784|FG001|STARTED|Overall Study||34
3190636|NCT02055118|3918785|FG002|STARTED|Overall Study||9
3190637|NCT02055118|3918783|FG000|COMPLETED|Overall Study||15
3190638|NCT02055118|3918784|FG001|COMPLETED|Overall Study||32
3190639|NCT02055118|3918785|FG002|COMPLETED|Overall Study||9
3190640|NCT02055118|3918783|FG000|NOT COMPLETED|Overall Study||0
3190641|NCT02055118|3918784|FG001|NOT COMPLETED|Overall Study||2
3190642|NCT02055118|3918785|FG002|NOT COMPLETED|Overall Study||0
3190643|NCT02055157|3918798|FG000|STARTED|Initial 6 Months||8
3190644|NCT02055157|3918799|FG001|STARTED|Initial 6 Months||8
3190645|NCT02055157|3918800|FG002|STARTED|Initial 6 Months||10
3190646|NCT02055157|3918801|FG003|STARTED|Initial 6 Months||9
3190647|NCT02055157|3918798|FG000|COMPLETED|Initial 6 Months||7
3190648|NCT02055157|3918799|FG001|COMPLETED|Initial 6 Months||7
3190649|NCT02055157|3918800|FG002|COMPLETED|Initial 6 Months||10
3190650|NCT02055157|3918801|FG003|COMPLETED|Initial 6 Months||8
3190651|NCT02055157|3918798|FG000|NOT COMPLETED|Initial 6 Months||1
3190652|NCT02055157|3918799|FG001|NOT COMPLETED|Initial 6 Months||1
3190653|NCT02055157|3918800|FG002|NOT COMPLETED|Initial 6 Months||0
3190654|NCT02055157|3918801|FG003|NOT COMPLETED|Initial 6 Months||1
3190655|NCT02055157|3918798|FG000|STARTED|18-month Extension||7
3190656|NCT02055157|3918799|FG001|STARTED|18-month Extension||7
3190657|NCT02055157|3918800|FG002|STARTED|18-month Extension||10
3190658|NCT02055157|3918801|FG003|STARTED|18-month Extension||8
3190659|NCT02055157|3918798|FG000|COMPLETED|18-month Extension||6
3190660|NCT02055157|3918799|FG001|COMPLETED|18-month Extension||6
3190661|NCT02055157|3918800|FG002|COMPLETED|18-month Extension||10
3190662|NCT02055157|3918801|FG003|COMPLETED|18-month Extension||8
3190663|NCT02055157|3918798|FG000|NOT COMPLETED|18-month Extension||1
3190664|NCT02055157|3918799|FG001|NOT COMPLETED|18-month Extension||1
3190665|NCT02055157|3918800|FG002|NOT COMPLETED|18-month Extension||0
3190666|NCT02055157|3918801|FG003|NOT COMPLETED|18-month Extension||0
3190667|NCT02055352|3918824|FG000|STARTED|Overall Study||109
3190668|NCT02055352|3918825|FG001|STARTED|Overall Study||113
3190669|NCT02055352|3918824|FG000|Per-Protocol Set (PPS)|Overall Study||108
3190670|NCT02055352|3918825|FG001|Per-Protocol Set (PPS)|Overall Study||111
3190671|NCT02055352|3918824|FG000|COMPLETED|Overall Study||103
3190672|NCT02055352|3918825|FG001|COMPLETED|Overall Study||96
3190673|NCT02055352|3918824|FG000|NOT COMPLETED|Overall Study||6
3190674|NCT02055352|3918825|FG001|NOT COMPLETED|Overall Study||17
3190675|NCT02055365|3918831|FG000|STARTED|Overall Study||10
3190676|NCT02055365|3918831|FG000|COMPLETED|Overall Study||9
3190677|NCT02055365|3918831|FG000|NOT COMPLETED|Overall Study||1
3190678|NCT02055404|3918842|FG000|STARTED|Overall Study||3
3190679|NCT02055404|3918842|FG000|COMPLETED|Overall Study||3
3190680|NCT02055404|3918842|FG000|NOT COMPLETED|Overall Study||0
3190681|NCT02055430|3918857|FG000|STARTED|Overall Study||45
3190682|NCT02055430|3918858|FG001|STARTED|Overall Study||45
3190683|NCT02055430|3918857|FG000|COMPLETED|Overall Study||45
3190684|NCT02055430|3918858|FG001|COMPLETED|Overall Study||45
3190685|NCT02055430|3918857|FG000|NOT COMPLETED|Overall Study||0
3190686|NCT02055430|3918858|FG001|NOT COMPLETED|Overall Study||0
3190687|NCT02055638|3918866|FG000|STARTED|Overall Study||49
3190688|NCT02055638|3918867|FG001|STARTED|Overall Study||48
3190689|NCT02055638|3918866|FG000|COMPLETED|Overall Study||39
3190690|NCT02055638|3918867|FG001|COMPLETED|Overall Study||40
3190691|NCT02055638|3918866|FG000|NOT COMPLETED|Overall Study||10
3190692|NCT02055638|3918867|FG001|NOT COMPLETED|Overall Study||8
3190693|NCT02055781|3918876|FG000|STARTED|Overall Study||104
3190694|NCT02055781|3918877|FG001|STARTED|Overall Study||107
3190695|NCT02055781|3918878|FG002|STARTED|Overall Study||100
3190696|NCT02055781|3918876|FG000|COMPLETED|Overall Study||62
3190697|NCT02055781|3918877|FG001|COMPLETED|Overall Study||79
3190698|NCT02055781|3918878|FG002|COMPLETED|Overall Study||63
3190699|NCT02055781|3918876|FG000|NOT COMPLETED|Overall Study||42
3190700|NCT02055781|3918877|FG001|NOT COMPLETED|Overall Study||28
3190701|NCT02055781|3918878|FG002|NOT COMPLETED|Overall Study||37
3190702|NCT02055820|3918896|FG000|STARTED|Phase I: Dose-Finding||7
3190703|NCT02055820|3918897|FG001|STARTED|Phase I: Dose-Finding||3
3190704|NCT02055820|3918898|FG002|STARTED|Phase I: Dose-Finding||8
3190705|NCT02055820|3918899|FG003|STARTED|Phase I: Dose-Finding||6
3190706|NCT02055820|3918900|FG004|STARTED|Phase I: Dose-Finding||0
3190707|NCT02055820|3918901|FG005|STARTED|Phase I: Dose-Finding||7
3190708|NCT02055820|3918902|FG006|STARTED|Phase I: Dose-Finding||7
3190709|NCT02055820|3918903|FG007|STARTED|Phase I: Dose-Finding||6
3190710|NCT02055820|3918904|FG008|STARTED|Phase I: Dose-Finding||6
3190711|NCT02055820|3918905|FG009|STARTED|Phase I: Dose-Finding||6
3190712|NCT02055820|3918896|FG000|COMPLETED|Phase I: Dose-Finding||6
3190713|NCT02055820|3918897|FG001|COMPLETED|Phase I: Dose-Finding||3
3190714|NCT02055820|3918898|FG002|COMPLETED|Phase I: Dose-Finding||7
3190715|NCT02055820|3918899|FG003|COMPLETED|Phase I: Dose-Finding||3
3190716|NCT02055820|3918900|FG004|COMPLETED|Phase I: Dose-Finding||0
3190717|NCT02055820|3918901|FG005|COMPLETED|Phase I: Dose-Finding||5
3190718|NCT02055820|3918902|FG006|COMPLETED|Phase I: Dose-Finding||5
3190719|NCT02055820|3918903|FG007|COMPLETED|Phase I: Dose-Finding||6
3190720|NCT02055820|3918904|FG008|COMPLETED|Phase I: Dose-Finding||6
3190721|NCT02055820|3918905|FG009|COMPLETED|Phase I: Dose-Finding||6
3190722|NCT02055820|3918896|FG000|NOT COMPLETED|Phase I: Dose-Finding||1
3190723|NCT02055820|3918897|FG001|NOT COMPLETED|Phase I: Dose-Finding||0
3190724|NCT02055820|3918898|FG002|NOT COMPLETED|Phase I: Dose-Finding||1
3190725|NCT02055820|3918899|FG003|NOT COMPLETED|Phase I: Dose-Finding||3
3190726|NCT02055820|3918900|FG004|NOT COMPLETED|Phase I: Dose-Finding||0
3190727|NCT02055820|3918901|FG005|NOT COMPLETED|Phase I: Dose-Finding||2
3190728|NCT02055820|3918902|FG006|NOT COMPLETED|Phase I: Dose-Finding||2
3190729|NCT02055820|3918903|FG007|NOT COMPLETED|Phase I: Dose-Finding||0
3190730|NCT02055820|3918904|FG008|NOT COMPLETED|Phase I: Dose-Finding||0
3190731|NCT02055820|3918905|FG009|NOT COMPLETED|Phase I: Dose-Finding||0
3190732|NCT02055820|3918896|FG000|STARTED|Phase II: Expansion||0
3190733|NCT02055820|3918897|FG001|STARTED|Phase II: Expansion||0
3190734|NCT02055820|3918898|FG002|STARTED|Phase II: Expansion||0
3190735|NCT02055820|3918899|FG003|STARTED|Phase II: Expansion||0
3190736|NCT02055820|3918900|FG004|STARTED|Phase II: Expansion||208
3190737|NCT02055820|3918901|FG005|STARTED|Phase II: Expansion||0
3190738|NCT02055820|3918902|FG006|STARTED|Phase II: Expansion||0
3190739|NCT02055820|3918903|FG007|STARTED|Phase II: Expansion||0
3190740|NCT02055820|3918904|FG008|STARTED|Phase II: Expansion||0
3190741|NCT02055820|3918905|FG009|STARTED|Phase II: Expansion||0
3190742|NCT02055820|3918896|FG000|COMPLETED|Phase II: Expansion||0
3190743|NCT02055820|3918897|FG001|COMPLETED|Phase II: Expansion||0
3190744|NCT02055820|3918898|FG002|COMPLETED|Phase II: Expansion||0
3190745|NCT02055820|3918899|FG003|COMPLETED|Phase II: Expansion||0
3190746|NCT02055820|3918900|FG004|COMPLETED|Phase II: Expansion||159
3190747|NCT02055820|3918901|FG005|COMPLETED|Phase II: Expansion||0
3190748|NCT02055820|3918902|FG006|COMPLETED|Phase II: Expansion||0
3190749|NCT02055820|3918903|FG007|COMPLETED|Phase II: Expansion||0
3190750|NCT02055820|3918904|FG008|COMPLETED|Phase II: Expansion||0
3190751|NCT02055820|3918905|FG009|COMPLETED|Phase II: Expansion||0
3190752|NCT02055820|3918896|FG000|NOT COMPLETED|Phase II: Expansion||0
3190753|NCT02055820|3918897|FG001|NOT COMPLETED|Phase II: Expansion||0
3190754|NCT02055820|3918898|FG002|NOT COMPLETED|Phase II: Expansion||0
3190755|NCT02055820|3918899|FG003|NOT COMPLETED|Phase II: Expansion||0
3190756|NCT02055820|3918900|FG004|NOT COMPLETED|Phase II: Expansion||49
3190757|NCT02055820|3918901|FG005|NOT COMPLETED|Phase II: Expansion||0
3190758|NCT02055820|3918902|FG006|NOT COMPLETED|Phase II: Expansion||0
3190759|NCT02055820|3918903|FG007|NOT COMPLETED|Phase II: Expansion||0
3190760|NCT02055820|3918904|FG008|NOT COMPLETED|Phase II: Expansion||0
3190761|NCT02055820|3918905|FG009|NOT COMPLETED|Phase II: Expansion||0
3190762|NCT02055898|3918949|FG000|STARTED|First Intervention (5 Days)||7
3190763|NCT02055898|3918950|FG001|STARTED|First Intervention (5 Days)||6
3190764|NCT02055898|3918949|FG000|COMPLETED|First Intervention (5 Days)||5
3190765|NCT02055898|3918950|FG001|COMPLETED|First Intervention (5 Days)||5
3190766|NCT02055898|3918949|FG000|NOT COMPLETED|First Intervention (5 Days)||2
3190767|NCT02055898|3918950|FG001|NOT COMPLETED|First Intervention (5 Days)||1
3190768|NCT02055898|3918949|FG000|STARTED|Washout (at Least 14 Days)||5
3190769|NCT02055898|3918950|FG001|STARTED|Washout (at Least 14 Days)||5
3190770|NCT02055898|3918949|FG000|COMPLETED|Washout (at Least 14 Days)||5
3190771|NCT02055898|3918950|FG001|COMPLETED|Washout (at Least 14 Days)||5
3190772|NCT02055898|3918949|FG000|NOT COMPLETED|Washout (at Least 14 Days)||0
3190773|NCT02055898|3918950|FG001|NOT COMPLETED|Washout (at Least 14 Days)||0
3190774|NCT02055898|3918949|FG000|STARTED|Second Intervention (5 Days)||5
3190775|NCT02055898|3918950|FG001|STARTED|Second Intervention (5 Days)||5
3190776|NCT02055898|3918949|FG000|COMPLETED|Second Intervention (5 Days)||5
3190777|NCT02055898|3918950|FG001|COMPLETED|Second Intervention (5 Days)||5
3190778|NCT02055898|3918949|FG000|NOT COMPLETED|Second Intervention (5 Days)||0
3190779|NCT02055898|3918950|FG001|NOT COMPLETED|Second Intervention (5 Days)||0
3190780|NCT02055976|3918965|FG000|STARTED|Overall Study||25
3190781|NCT02055976|3918966|FG001|STARTED|Overall Study||24
3190782|NCT02055976|3918967|FG002|STARTED|Overall Study||24
3190783|NCT02055976|3918968|FG003|STARTED|Overall Study||26
3190784|NCT02055976|3918969|FG004|STARTED|Overall Study||22
3190785|NCT02055976|3918970|FG005|STARTED|Overall Study||25
3190786|NCT02055976|3918971|FG006|STARTED|Overall Study||25
3190787|NCT02055976|3918972|FG007|STARTED|Overall Study||24
3190788|NCT02055976|3918973|FG008|STARTED|Overall Study||23
3190789|NCT02055976|3918965|FG000|COMPLETED|Overall Study||25
3190790|NCT02055976|3918966|FG001|COMPLETED|Overall Study||24
3190791|NCT02055976|3918967|FG002|COMPLETED|Overall Study||23
3190792|NCT02055976|3918968|FG003|COMPLETED|Overall Study||25
3190793|NCT02055976|3918969|FG004|COMPLETED|Overall Study||22
3190794|NCT02055976|3918970|FG005|COMPLETED|Overall Study||24
3190795|NCT02055976|3918971|FG006|COMPLETED|Overall Study||23
3190796|NCT02055976|3918972|FG007|COMPLETED|Overall Study||24
3190797|NCT02055976|3918973|FG008|COMPLETED|Overall Study||23
3190798|NCT02055976|3918965|FG000|NOT COMPLETED|Overall Study||0
3190799|NCT02055976|3918966|FG001|NOT COMPLETED|Overall Study||0
3190800|NCT02055976|3918967|FG002|NOT COMPLETED|Overall Study||1
3190801|NCT02055976|3918968|FG003|NOT COMPLETED|Overall Study||1
3190802|NCT02055976|3918969|FG004|NOT COMPLETED|Overall Study||0
3190803|NCT02055976|3918970|FG005|NOT COMPLETED|Overall Study||1
3190804|NCT02055976|3918971|FG006|NOT COMPLETED|Overall Study||2
3190805|NCT02055976|3918972|FG007|NOT COMPLETED|Overall Study||0
3190806|NCT02055976|3918973|FG008|NOT COMPLETED|Overall Study||0
3190807|NCT02056171|3919002|FG000|STARTED|Overall Study||3
3190808|NCT02056171|3919003|FG001|STARTED|Overall Study||3
3190809|NCT02056171|3919002|FG000|COMPLETED|Overall Study||3
3190810|NCT02056171|3919003|FG001|COMPLETED|Overall Study||3
3190811|NCT02056171|3919002|FG000|NOT COMPLETED|Overall Study||0
3190812|NCT02056171|3919003|FG001|NOT COMPLETED|Overall Study||0
3190813|NCT02056288|3919011|FG000|STARTED|In-Hospital Data||40
3190814|NCT02056288|3919012|FG001|STARTED|In-Hospital Data||38
3190815|NCT02056288|3919011|FG000|COMPLETED|In-Hospital Data||35
3190816|NCT02056288|3919012|FG001|COMPLETED|In-Hospital Data||38
3190817|NCT02056288|3919011|FG000|NOT COMPLETED|In-Hospital Data||5
3190818|NCT02056288|3919012|FG001|NOT COMPLETED|In-Hospital Data||0
3190819|NCT02056288|3919011|FG000|STARTED|48-Hour Post-Discharge Data||35
3190820|NCT02056288|3919012|FG001|STARTED|48-Hour Post-Discharge Data||38
3190821|NCT02056288|3919011|FG000|COMPLETED|48-Hour Post-Discharge Data||21
3190822|NCT02056288|3919012|FG001|COMPLETED|48-Hour Post-Discharge Data||18
3190823|NCT02056288|3919011|FG000|NOT COMPLETED|48-Hour Post-Discharge Data||14
3190824|NCT02056288|3919012|FG001|NOT COMPLETED|48-Hour Post-Discharge Data||20
3190825|NCT02056301|3919020|FG000|STARTED|Overall Study||33
3190826|NCT02056301|3919021|FG001|STARTED|Overall Study||29
3190827|NCT02056301|3919020|FG000|COMPLETED|Overall Study||31
3190828|NCT02056301|3919021|FG001|COMPLETED|Overall Study||23
3190829|NCT02056301|3919020|FG000|NOT COMPLETED|Overall Study||2
3190830|NCT02056301|3919021|FG001|NOT COMPLETED|Overall Study||6
3190831|NCT02056340|3919029|FG000|STARTED|Overall Study||59
3190832|NCT02056340|3919030|FG001|STARTED|Overall Study||57
3190833|NCT02056340|3919029|FG000|COMPLETED|Overall Study||52
3190834|NCT02056340|3919030|FG001|COMPLETED|Overall Study||46
3190835|NCT02056340|3919029|FG000|NOT COMPLETED|Overall Study||7
3190836|NCT02056340|3919030|FG001|NOT COMPLETED|Overall Study||11
3190837|NCT02056392|3919042|FG000|STARTED|Overall Study||10
3190838|NCT02056392|3919043|FG001|STARTED|Overall Study||9
3190839|NCT02056392|3919044|FG002|STARTED|Overall Study||9
3190840|NCT02056392|3919045|FG003|STARTED|Overall Study||9
3190841|NCT02056392|3919046|FG004|STARTED|Overall Study||8
3190842|NCT02056392|3919047|FG005|STARTED|Overall Study||9
3190843|NCT02056392|3919042|FG000|COMPLETED|Overall Study||8
3190844|NCT02056392|3919043|FG001|COMPLETED|Overall Study||8
3190845|NCT02056392|3919044|FG002|COMPLETED|Overall Study||6
3190846|NCT02056392|3919045|FG003|COMPLETED|Overall Study||9
3190847|NCT02056392|3919046|FG004|COMPLETED|Overall Study||7
3190848|NCT02056392|3919047|FG005|COMPLETED|Overall Study||9
3190849|NCT02056392|3919042|FG000|NOT COMPLETED|Overall Study||2
3190850|NCT02056392|3919043|FG001|NOT COMPLETED|Overall Study||1
3190851|NCT02056392|3919044|FG002|NOT COMPLETED|Overall Study||3
3190852|NCT02056392|3919045|FG003|NOT COMPLETED|Overall Study||0
3190853|NCT02056392|3919046|FG004|NOT COMPLETED|Overall Study||1
3190854|NCT02056392|3919047|FG005|NOT COMPLETED|Overall Study||0
3190855|NCT02056431|3919057|FG000|STARTED|Overall Study||604
3190856|NCT02056431|3919058|FG001|STARTED|Overall Study||666
3190857|NCT02056431|3919057|FG000|COMPLETED|Overall Study||560
3190858|NCT02056431|3919058|FG001|COMPLETED|Overall Study||619
3190859|NCT02056431|3919057|FG000|NOT COMPLETED|Overall Study||44
3190860|NCT02056431|3919058|FG001|NOT COMPLETED|Overall Study||47
3190861|NCT02056626|3919070|FG000|STARTED|Overall Study||13
3190862|NCT02056626|3919071|FG001|STARTED|Overall Study||13
3190863|NCT02056626|3919072|FG002|STARTED|Overall Study||4
3190864|NCT02056626|3919073|FG003|STARTED|Overall Study||14
3190865|NCT02056626|3919070|FG000|COMPLETED|Overall Study||10
3190866|NCT02056626|3919071|FG001|COMPLETED|Overall Study||12
3190867|NCT02056626|3919072|FG002|COMPLETED|Overall Study||4
3190868|NCT02056626|3919073|FG003|COMPLETED|Overall Study||14
3190869|NCT02056626|3919070|FG000|NOT COMPLETED|Overall Study||3
3190870|NCT02056626|3919071|FG001|NOT COMPLETED|Overall Study||1
3190871|NCT02056626|3919072|FG002|NOT COMPLETED|Overall Study||0
3190872|NCT02056626|3919073|FG003|NOT COMPLETED|Overall Study||0
3190873|NCT02056639|3919085|FG000|STARTED|Overall Study||23
3190874|NCT02056639|3919086|FG001|STARTED|Overall Study||23
3190875|NCT02056639|3919085|FG000|COMPLETED|Overall Study||23
3190876|NCT02056639|3919086|FG001|COMPLETED|Overall Study||23
3190877|NCT02056639|3919085|FG000|NOT COMPLETED|Overall Study||0
3190878|NCT02056639|3919086|FG001|NOT COMPLETED|Overall Study||0
3190879|NCT02056652|3919096|FG000|STARTED|Overall Study||61
3190880|NCT02056652|3919097|FG001|STARTED|Overall Study||61
3190881|NCT02056652|3919096|FG000|COMPLETED|Overall Study||60
3190882|NCT02056652|3919097|FG001|COMPLETED|Overall Study||58
3190883|NCT02056652|3919096|FG000|NOT COMPLETED|Overall Study||1
3190884|NCT02056652|3919097|FG001|NOT COMPLETED|Overall Study||3
3190885|NCT02056834|3919103|FG000|STARTED|Overall Study||36
3190886|NCT02056834|3919103|FG000|6 Weeks|Overall Study||34
3190887|NCT02056834|3919103|FG000|6 Months|Overall Study||31
3190888|NCT02056834|3919103|FG000|COMPLETED|Overall Study||29
3190889|NCT02056834|3919103|FG000|NOT COMPLETED|Overall Study||7
3190890|NCT02057042|3919110|FG000|STARTED|Overall Study||163
3190891|NCT02057042|3919111|FG001|STARTED|Overall Study||167
3190892|NCT02057042|3919110|FG000|COMPLETED|Overall Study||118
3190893|NCT02057042|3919111|FG001|COMPLETED|Overall Study||101
3190894|NCT02057042|3919110|FG000|NOT COMPLETED|Overall Study||45
3190895|NCT02057042|3919111|FG001|NOT COMPLETED|Overall Study||66
3190896|NCT02057068|3919119|FG000|STARTED|Overall Study||60
3190897|NCT02057068|3919120|FG001|STARTED|Overall Study||36
3190898|NCT02057068|3919119|FG000|COMPLETED|Overall Study||52
3190899|NCT02057068|3919120|FG001|COMPLETED|Overall Study||28
3190900|NCT02057068|3919119|FG000|NOT COMPLETED|Overall Study||8
3190901|NCT02057068|3919120|FG001|NOT COMPLETED|Overall Study||8
3190902|NCT02057081|3919130|FG000|STARTED|Overall Study||136
3190903|NCT02057081|3919131|FG001|STARTED|Overall Study||112
3190904|NCT02057081|3919130|FG000|Completed Baseline|Overall Study||88
3190905|NCT02057081|3919131|FG001|Completed Baseline|Overall Study||80
3190906|NCT02057081|3919130|FG000|Post-Treatment Assessment|Overall Study||58
3190907|NCT02057081|3919131|FG001|Post-Treatment Assessment|Overall Study||52
3190908|NCT02057081|3919130|FG000|COMPLETED|Overall Study||46
3190909|NCT02057081|3919131|FG001|COMPLETED|Overall Study||44
3190910|NCT02057081|3919130|FG000|NOT COMPLETED|Overall Study||90
3190911|NCT02057081|3919131|FG001|NOT COMPLETED|Overall Study||68
3190912|NCT02057198|3919140|FG000|STARTED|Overall Study||11
3190913|NCT02057198|3919141|FG001|STARTED|Overall Study||11
3190914|NCT02057198|3919142|FG002|STARTED|Overall Study||11
3190915|NCT02057198|3919140|FG000|COMPLETED|Overall Study||11
3190916|NCT02057198|3919141|FG001|COMPLETED|Overall Study||10
3190917|NCT02057198|3919142|FG002|COMPLETED|Overall Study||10
3190918|NCT02057198|3919140|FG000|NOT COMPLETED|Overall Study||0
3190919|NCT02057198|3919141|FG001|NOT COMPLETED|Overall Study||1
3190920|NCT02057198|3919142|FG002|NOT COMPLETED|Overall Study||1
3190921|NCT02057250|3919154|FG000|STARTED|AID Assessment Phase||56
3190922|NCT02057250|3919155|FG001|STARTED|AID Assessment Phase||53
3190923|NCT02057250|3919156|FG002|STARTED|AID Assessment Phase||52
3190924|NCT02057250|3919157|FG003|STARTED|AID Assessment Phase||56
3190925|NCT02057250|3919158|FG004|STARTED|AID Assessment Phase||0
3190926|NCT02057250|3919154|FG000|COMPLETED|AID Assessment Phase||52
3190927|NCT02057250|3919155|FG001|COMPLETED|AID Assessment Phase||50
3190928|NCT02057250|3919156|FG002|COMPLETED|AID Assessment Phase||45
3190929|NCT02057250|3919157|FG003|COMPLETED|AID Assessment Phase||54
3190930|NCT02057250|3919158|FG004|COMPLETED|AID Assessment Phase||0
3190931|NCT02057250|3919154|FG000|NOT COMPLETED|AID Assessment Phase||4
3190932|NCT02057250|3919155|FG001|NOT COMPLETED|AID Assessment Phase||3
3190933|NCT02057250|3919156|FG002|NOT COMPLETED|AID Assessment Phase||7
3190934|NCT02057250|3919157|FG003|NOT COMPLETED|AID Assessment Phase||2
3190935|NCT02057250|3919158|FG004|NOT COMPLETED|AID Assessment Phase||0
3190936|NCT02057250|3919154|FG000|STARTED|Extension Phase||0
3190937|NCT02057250|3919155|FG001|STARTED|Extension Phase||0
3190938|NCT02057250|3919156|FG002|STARTED|Extension Phase||0
3190939|NCT02057250|3919157|FG003|STARTED|Extension Phase||0
3190940|NCT02057250|3919158|FG004|STARTED|Extension Phase|9 participants who completed AID Assessment phase did not enter extension phase.|192
3190941|NCT02057250|3919154|FG000|Treated|Extension Phase||0
3190942|NCT02057250|3919155|FG001|Treated|Extension Phase||0
3190943|NCT02057250|3919156|FG002|Treated|Extension Phase||0
3190944|NCT02057250|3919157|FG003|Treated|Extension Phase||0
3190945|NCT02057250|3919158|FG004|Treated|Extension Phase||188
3190946|NCT02057250|3919154|FG000|COMPLETED|Extension Phase||0
3190947|NCT02057250|3919155|FG001|COMPLETED|Extension Phase||0
3190948|NCT02057250|3919156|FG002|COMPLETED|Extension Phase||0
3190949|NCT02057250|3919157|FG003|COMPLETED|Extension Phase||0
3190950|NCT02057250|3919158|FG004|COMPLETED|Extension Phase||156
3190951|NCT02057250|3919154|FG000|NOT COMPLETED|Extension Phase||0
3190952|NCT02057250|3919155|FG001|NOT COMPLETED|Extension Phase||0
3190953|NCT02057250|3919156|FG002|NOT COMPLETED|Extension Phase||0
3190954|NCT02057250|3919157|FG003|NOT COMPLETED|Extension Phase||0
3190955|NCT02057250|3919158|FG004|NOT COMPLETED|Extension Phase||36
3190956|NCT02057393|3919170|FG000|STARTED|Overall Study||89
3190957|NCT02057393|3919170|FG000|COMPLETED|Overall Study||87
3190958|NCT02057393|3919170|FG000|NOT COMPLETED|Overall Study||2
3190959|NCT02057406|3919177|FG000|STARTED|Overall Study||36
3190960|NCT02057406|3919178|FG001|STARTED|Overall Study||36
3190961|NCT02057406|3919179|FG002|STARTED|Overall Study||36
3190962|NCT02057406|3919177|FG000|COMPLETED|Overall Study||35
3190963|NCT02057406|3919178|FG001|COMPLETED|Overall Study||33
3190964|NCT02057406|3919179|FG002|COMPLETED|Overall Study||32
3190965|NCT02057406|3919177|FG000|NOT COMPLETED|Overall Study||1
3190966|NCT02057406|3919178|FG001|NOT COMPLETED|Overall Study||3
3190967|NCT02057406|3919179|FG002|NOT COMPLETED|Overall Study||4
3190968|NCT02057458|3919187|FG000|STARTED|Recruited for Participation||8
3190969|NCT02057458|3919188|FG001|STARTED|Recruited for Participation||8
3190970|NCT02057458|3919189|FG002|STARTED|Recruited for Participation||3
3190971|NCT02057458|3919187|FG000|COMPLETED|Recruited for Participation||8
3190972|NCT02057458|3919188|FG001|COMPLETED|Recruited for Participation||8
3190973|NCT02057458|3919189|FG002|COMPLETED|Recruited for Participation||3
3190974|NCT02057458|3919187|FG000|NOT COMPLETED|Recruited for Participation||0
3190975|NCT02057458|3919188|FG001|NOT COMPLETED|Recruited for Participation||0
3190976|NCT02057458|3919189|FG002|NOT COMPLETED|Recruited for Participation||0
3190977|NCT02057458|3919187|FG000|STARTED|Met Inclusion Criteria||8
3190978|NCT02057458|3919188|FG001|STARTED|Met Inclusion Criteria||8
3190979|NCT02057458|3919189|FG002|STARTED|Met Inclusion Criteria||3
3190980|NCT02057458|3919187|FG000|COMPLETED|Met Inclusion Criteria||8
3190981|NCT02057458|3919188|FG001|COMPLETED|Met Inclusion Criteria||7
3190982|NCT02057458|3919189|FG002|COMPLETED|Met Inclusion Criteria||3
3190983|NCT02057458|3919187|FG000|NOT COMPLETED|Met Inclusion Criteria||0
3190984|NCT02057458|3919188|FG001|NOT COMPLETED|Met Inclusion Criteria||1
3190985|NCT02057458|3919189|FG002|NOT COMPLETED|Met Inclusion Criteria||0
3190986|NCT02057458|3919187|FG000|STARTED|Acute Study (1 Hour): First Intervention||8
3190987|NCT02057458|3919188|FG001|STARTED|Acute Study (1 Hour): First Intervention||7
3190988|NCT02057458|3919189|FG002|STARTED|Acute Study (1 Hour): First Intervention||0
3190989|NCT02057458|3919187|FG000|COMPLETED|Acute Study (1 Hour): First Intervention||6
3190990|NCT02057458|3919188|FG001|COMPLETED|Acute Study (1 Hour): First Intervention||7
3190991|NCT02057458|3919189|FG002|COMPLETED|Acute Study (1 Hour): First Intervention||0
3190992|NCT02057458|3919187|FG000|NOT COMPLETED|Acute Study (1 Hour): First Intervention||2
3190993|NCT02057458|3919188|FG001|NOT COMPLETED|Acute Study (1 Hour): First Intervention||0
3190994|NCT02057458|3919189|FG002|NOT COMPLETED|Acute Study (1 Hour): First Intervention||0
3190995|NCT02057458|3919187|FG000|STARTED|Acute Study (1 Hour): Second Int.||6
3190996|NCT02057458|3919188|FG001|STARTED|Acute Study (1 Hour): Second Int.||7
3190997|NCT02057458|3919189|FG002|STARTED|Acute Study (1 Hour): Second Int.||0
3190998|NCT02057458|3919187|FG000|COMPLETED|Acute Study (1 Hour): Second Int.||6
3190999|NCT02057458|3919188|FG001|COMPLETED|Acute Study (1 Hour): Second Int.||7
3191000|NCT02057458|3919189|FG002|COMPLETED|Acute Study (1 Hour): Second Int.||0
3191001|NCT02057458|3919187|FG000|NOT COMPLETED|Acute Study (1 Hour): Second Int.||0
3191002|NCT02057458|3919188|FG001|NOT COMPLETED|Acute Study (1 Hour): Second Int.||0
3191003|NCT02057458|3919189|FG002|NOT COMPLETED|Acute Study (1 Hour): Second Int.||0
3191004|NCT02057458|3919187|FG000|STARTED|Sub-Chronic Study (4 Weeks)||6
3191005|NCT02057458|3919188|FG001|STARTED|Sub-Chronic Study (4 Weeks)||7
3191006|NCT02057458|3919189|FG002|STARTED|Sub-Chronic Study (4 Weeks)||3
3191007|NCT02057458|3919187|FG000|COMPLETED|Sub-Chronic Study (4 Weeks)||5
3191008|NCT02057458|3919188|FG001|COMPLETED|Sub-Chronic Study (4 Weeks)||7
3191009|NCT02057458|3919189|FG002|COMPLETED|Sub-Chronic Study (4 Weeks)||3
3191010|NCT02057458|3919187|FG000|NOT COMPLETED|Sub-Chronic Study (4 Weeks)||1
3191011|NCT02057458|3919188|FG001|NOT COMPLETED|Sub-Chronic Study (4 Weeks)||0
3191012|NCT02057458|3919189|FG002|NOT COMPLETED|Sub-Chronic Study (4 Weeks)||0
3191013|NCT02057523|3919219|FG000|STARTED|Overall Study||2
3191014|NCT02057523|3919219|FG000|COMPLETED|Overall Study||0
3191015|NCT02057523|3919219|FG000|NOT COMPLETED|Overall Study||2
3191016|NCT02057549|3919225|FG000|STARTED|Overall Study||18
3191017|NCT02057549|3919226|FG001|STARTED|Overall Study||18
3191018|NCT02057549|3919225|FG000|COMPLETED|Overall Study||15
3191019|NCT02057549|3919226|FG001|COMPLETED|Overall Study||18
3191020|NCT02057549|3919225|FG000|NOT COMPLETED|Overall Study||3
3191021|NCT02057549|3919226|FG001|NOT COMPLETED|Overall Study||0
3191022|NCT02057575|3919236|FG000|STARTED|Overall Study||74
3191023|NCT02057575|3919237|FG001|STARTED|Overall Study||73
3191024|NCT02057575|3919238|FG002|STARTED|Overall Study||78
3191025|NCT02057575|3919239|FG003|STARTED|Overall Study||73
3191026|NCT02057575|3919236|FG000|COMPLETED|Overall Study||73
3191027|NCT02057575|3919237|FG001|COMPLETED|Overall Study||69
3191028|NCT02057575|3919238|FG002|COMPLETED|Overall Study||78
3191029|NCT02057575|3919239|FG003|COMPLETED|Overall Study||72
3191030|NCT02057575|3919236|FG000|NOT COMPLETED|Overall Study||1
3191031|NCT02057575|3919237|FG001|NOT COMPLETED|Overall Study||4
3191032|NCT02057575|3919238|FG002|NOT COMPLETED|Overall Study||0
3191033|NCT02057575|3919239|FG003|NOT COMPLETED|Overall Study||1
3191034|NCT02057640|3919251|FG000|STARTED|Weeks 1-4|1 extra participant accidentally treated at DL1 (in addition to initial 3).|4
3191035|NCT02057640|3919252|FG001|STARTED|Weeks 1-4||3
3191036|NCT02057640|3919251|FG000|COMPLETED|Weeks 1-4||4
3191037|NCT02057640|3919252|FG001|COMPLETED|Weeks 1-4||3
3191038|NCT02057640|3919251|FG000|NOT COMPLETED|Weeks 1-4||0
3191039|NCT02057640|3919252|FG001|NOT COMPLETED|Weeks 1-4||0
3191040|NCT02057640|3919251|FG000|STARTED|Phase II Portion of Study at DL2||0
3191041|NCT02057640|3919252|FG001|STARTED|Phase II Portion of Study at DL2||9
3191042|NCT02057640|3919251|FG000|COMPLETED|Phase II Portion of Study at DL2||0
3191043|NCT02057640|3919252|FG001|COMPLETED|Phase II Portion of Study at DL2||9
3191044|NCT02057640|3919251|FG000|NOT COMPLETED|Phase II Portion of Study at DL2||0
3191045|NCT02057640|3919252|FG001|NOT COMPLETED|Phase II Portion of Study at DL2||0
3191046|NCT02057666|3919261|FG000|STARTED|Double Blind Treatment Period||96
3191047|NCT02057666|3919262|FG001|STARTED|Double Blind Treatment Period||50
3191048|NCT02057666|3919261|FG000|COMPLETED|Double Blind Treatment Period|Number of patients who continued into the open-label treatment period.|0
3191049|NCT02057666|3919262|FG001|COMPLETED|Double Blind Treatment Period|Number of patients who continued into the open-label treatment period.|6
3191050|NCT02057666|3919261|FG000|NOT COMPLETED|Double Blind Treatment Period||96
3191051|NCT02057666|3919262|FG001|NOT COMPLETED|Double Blind Treatment Period||44
3191052|NCT02057666|3919261|FG000|STARTED|Open-Label Treatment Period||0
3191053|NCT02057666|3919262|FG001|STARTED|Open-Label Treatment Period||6
3191054|NCT02057666|3919261|FG000|COMPLETED|Open-Label Treatment Period||0
3191055|NCT02057666|3919262|FG001|COMPLETED|Open-Label Treatment Period||0
3191056|NCT02057666|3919261|FG000|NOT COMPLETED|Open-Label Treatment Period||0
3191057|NCT02057666|3919262|FG001|NOT COMPLETED|Open-Label Treatment Period||6
3191058|NCT02057692|3919272|FG000|STARTED|Overall Study||8
3191059|NCT02057692|3919273|FG001|STARTED|Overall Study||11
3191060|NCT02057692|3919274|FG002|STARTED|Overall Study||6
3191061|NCT02057692|3919275|FG003|STARTED|Overall Study||12
3191062|NCT02057692|3919272|FG000|COMPLETED|Overall Study||7
3191063|NCT02057692|3919273|FG001|COMPLETED|Overall Study||11
3191064|NCT02057692|3919274|FG002|COMPLETED|Overall Study||6
3191065|NCT02057692|3919275|FG003|COMPLETED|Overall Study||11
3191066|NCT02057692|3919272|FG000|NOT COMPLETED|Overall Study||1
3191067|NCT02057692|3919273|FG001|NOT COMPLETED|Overall Study||0
3191068|NCT02057692|3919274|FG002|NOT COMPLETED|Overall Study||0
3191069|NCT02057692|3919275|FG003|NOT COMPLETED|Overall Study||1
3191070|NCT02057718|3919293|FG000|STARTED|Completed Study Treatment Through Wk. 72||8
3191071|NCT02057718|3919294|FG001|STARTED|Completed Study Treatment Through Wk. 72||25
3191072|NCT02057718|3919293|FG000|Completed Study Treatment Through Week 72|Completed Study Treatment Through Wk. 72||6
3191073|NCT02057718|3919294|FG001|Completed Study Treatment Through Week 72|Completed Study Treatment Through Wk. 72||16
3191074|NCT02057718|3919293|FG000|COMPLETED|Completed Study Treatment Through Wk. 72||6
3191075|NCT02057718|3919294|FG001|COMPLETED|Completed Study Treatment Through Wk. 72||16
3191076|NCT02057718|3919293|FG000|NOT COMPLETED|Completed Study Treatment Through Wk. 72||2
3191077|NCT02057718|3919294|FG001|NOT COMPLETED|Completed Study Treatment Through Wk. 72||9
3191078|NCT02057718|3919293|FG000|STARTED|Optional Follow-up Treatment Period||6
3191079|NCT02057718|3919294|FG001|STARTED|Optional Follow-up Treatment Period||16
3191080|NCT02057718|3919293|FG000|COMPLETED|Optional Follow-up Treatment Period||4
3191081|NCT02057718|3919294|FG001|COMPLETED|Optional Follow-up Treatment Period||8
3191082|NCT02057718|3919293|FG000|NOT COMPLETED|Optional Follow-up Treatment Period||2
3191083|NCT02057718|3919294|FG001|NOT COMPLETED|Optional Follow-up Treatment Period||8
3191084|NCT02057757|3919302|FG000|STARTED|Overall Study||131
3191085|NCT02057757|3919303|FG001|STARTED|Overall Study||129
3191086|NCT02057757|3919302|FG000|Intent to Treat|Overall Study||130
3191087|NCT02057757|3919303|FG001|Intent to Treat|Overall Study||127
3191088|NCT02057757|3919302|FG000|COMPLETED|Overall Study||117
3191089|NCT02057757|3919303|FG001|COMPLETED|Overall Study||121
3191090|NCT02057757|3919302|FG000|NOT COMPLETED|Overall Study||14
3191091|NCT02057757|3919303|FG001|NOT COMPLETED|Overall Study||8
3191092|NCT02057835|3919323|FG000|STARTED|Overall Study||8
3191093|NCT02057835|3919324|FG001|STARTED|Overall Study||6
3191094|NCT02057835|3919325|FG002|STARTED|Overall Study||6
3191095|NCT02057835|3919326|FG003|STARTED|Overall Study||6
3191096|NCT02057835|3919327|FG004|STARTED|Overall Study||6
3191097|NCT02057835|3919328|FG005|STARTED|Overall Study||8
3191098|NCT02057835|3919329|FG006|STARTED|Overall Study||6
3191099|NCT02057835|3919330|FG007|STARTED|Overall Study||6
3191100|NCT02057835|3919331|FG008|STARTED|Overall Study||6
3191101|NCT02057835|3919332|FG009|STARTED|Overall Study||6
3191102|NCT02057835|3919323|FG000|COMPLETED|Overall Study||8
3191103|NCT02057835|3919324|FG001|COMPLETED|Overall Study||4
3191104|NCT02057835|3919325|FG002|COMPLETED|Overall Study||6
3191105|NCT02057835|3919326|FG003|COMPLETED|Overall Study||6
3191106|NCT02057835|3919327|FG004|COMPLETED|Overall Study||6
3191107|NCT02057835|3919328|FG005|COMPLETED|Overall Study||8
3191108|NCT02057835|3919329|FG006|COMPLETED|Overall Study||6
3191109|NCT02057835|3919330|FG007|COMPLETED|Overall Study||6
3191110|NCT02057835|3919331|FG008|COMPLETED|Overall Study||6
3191111|NCT02057835|3919332|FG009|COMPLETED|Overall Study||6
3191112|NCT02057835|3919323|FG000|NOT COMPLETED|Overall Study||0
3191113|NCT02057835|3919324|FG001|NOT COMPLETED|Overall Study||2
3191114|NCT02057835|3919325|FG002|NOT COMPLETED|Overall Study||0
3191115|NCT02057835|3919326|FG003|NOT COMPLETED|Overall Study||0
3191116|NCT02057835|3919327|FG004|NOT COMPLETED|Overall Study||0
3191117|NCT02057835|3919328|FG005|NOT COMPLETED|Overall Study||0
3191118|NCT02057835|3919329|FG006|NOT COMPLETED|Overall Study||0
3191119|NCT02057835|3919330|FG007|NOT COMPLETED|Overall Study||0
3191120|NCT02057835|3919331|FG008|NOT COMPLETED|Overall Study||0
3191121|NCT02057835|3919332|FG009|NOT COMPLETED|Overall Study||0
3191122|NCT02057939|3919361|FG000|STARTED|Overall Study||38
3191123|NCT02057939|3919361|FG000|COMPLETED|Overall Study||37
3191124|NCT02057939|3919361|FG000|NOT COMPLETED|Overall Study||1
3191125|NCT02057952|3919368|FG000|STARTED|Overall Study||51
3191126|NCT02057952|3919369|FG001|STARTED|Overall Study||49
3191127|NCT02057952|3919370|FG002|STARTED|Overall Study||50
3191128|NCT02057952|3919368|FG000|COMPLETED|Overall Study||43
3191129|NCT02057952|3919369|FG001|COMPLETED|Overall Study||39
3191130|NCT02057952|3919370|FG002|COMPLETED|Overall Study||28
3191131|NCT02057952|3919368|FG000|NOT COMPLETED|Overall Study||8
3191132|NCT02057952|3919369|FG001|NOT COMPLETED|Overall Study||10
3191133|NCT02057952|3919370|FG002|NOT COMPLETED|Overall Study||22
3191134|NCT02058069|3919378|FG000|STARTED|Overall Study||100
3191135|NCT02058069|3919378|FG000|COMPLETED|Overall Study||89
3191136|NCT02058069|3919378|FG000|NOT COMPLETED|Overall Study||11
3191137|NCT02058095|3919384|FG000|STARTED|Overall Study||15
3191138|NCT02058095|3919385|FG001|STARTED|Overall Study||7
3191139|NCT02058095|3919384|FG000|COMPLETED|Overall Study||14
3191140|NCT02058095|3919385|FG001|COMPLETED|Overall Study||7
3191141|NCT02058095|3919384|FG000|NOT COMPLETED|Overall Study||1
3191142|NCT02058095|3919385|FG001|NOT COMPLETED|Overall Study||0
3191143|NCT02058108|3919393|FG000|STARTED|Overall Study||43
3191144|NCT02058108|3919394|FG001|STARTED|Overall Study||10
3191145|NCT02058108|3919393|FG000|Switched to Telbivudine After Week 24|Overall Study||0
3191146|NCT02058108|3919394|FG001|Switched to Telbivudine After Week 24|Overall Study||5
3191147|NCT02058108|3919393|FG000|COMPLETED|Overall Study||2
3191148|NCT02058108|3919394|FG001|COMPLETED|Overall Study||0
3191149|NCT02058108|3919393|FG000|NOT COMPLETED|Overall Study||41
3191150|NCT02058108|3919394|FG001|NOT COMPLETED|Overall Study||10
3191151|NCT02058147|3919405|FG000|STARTED|Overall Study||469
3191152|NCT02058147|3919406|FG001|STARTED|Overall Study||467
3191153|NCT02058147|3919407|FG002|STARTED|Overall Study||234
3191154|NCT02058147|3919405|FG000|Treated|Overall Study||469
3191155|NCT02058147|3919406|FG001|Treated|Overall Study||467
3191156|NCT02058147|3919407|FG002|Treated|Overall Study||233
3191157|NCT02058147|3919405|FG000|COMPLETED|Overall Study||440
3191158|NCT02058147|3919406|FG001|COMPLETED|Overall Study||440
3191159|NCT02058147|3919407|FG002|COMPLETED|Overall Study||205
3191160|NCT02058147|3919405|FG000|NOT COMPLETED|Overall Study||29
3191161|NCT02058147|3919406|FG001|NOT COMPLETED|Overall Study||27
3191162|NCT02058147|3919407|FG002|NOT COMPLETED|Overall Study||29
3191163|NCT02058160|3919417|FG000|STARTED|Overall Study||367
3191164|NCT02058160|3919418|FG001|STARTED|Overall Study||369
3191165|NCT02058160|3919417|FG000|Treated|Overall Study||365
3191166|NCT02058160|3919418|FG001|Treated|Overall Study||365
3191167|NCT02058160|3919417|FG000|COMPLETED|Overall Study||336
3191168|NCT02058160|3919418|FG001|COMPLETED|Overall Study||355
3191169|NCT02058160|3919417|FG000|NOT COMPLETED|Overall Study||31
3191170|NCT02058160|3919418|FG001|NOT COMPLETED|Overall Study||14
3191171|NCT02058251|3919426|FG000|STARTED|Overall Study||35
3191172|NCT02058251|3919427|FG001|STARTED|Overall Study||38
3191173|NCT02058251|3919426|FG000|COMPLETED|Overall Study||35
3191174|NCT02058251|3919427|FG001|COMPLETED|Overall Study||38
3191175|NCT02058251|3919426|FG000|NOT COMPLETED|Overall Study||0
3191176|NCT02058251|3919427|FG001|NOT COMPLETED|Overall Study||0
3191177|NCT02058290|3919435|FG000|STARTED|Overall Study||77
3191178|NCT02058290|3919436|FG001|STARTED|Overall Study||45
3191179|NCT02058290|3919435|FG000|COMPLETED|Overall Study||66
3191180|NCT02058290|3919436|FG001|COMPLETED|Overall Study||36
3191181|NCT02058290|3919435|FG000|NOT COMPLETED|Overall Study||11
3191182|NCT02058290|3919436|FG001|NOT COMPLETED|Overall Study||9
3191183|NCT02058368|3919444|FG000|STARTED|Overall Study||302
3191184|NCT02058368|3919445|FG001|STARTED|Overall Study||305
3191185|NCT02058368|3919444|FG000|COMPLETED|Overall Study||261
3191186|NCT02058368|3919445|FG001|COMPLETED|Overall Study||251
3191187|NCT02058368|3919444|FG000|NOT COMPLETED|Overall Study||41
3191188|NCT02058368|3919445|FG001|NOT COMPLETED|Overall Study||54
3191189|NCT02058498|3919451|FG000|STARTED|Overall Study||12
3191190|NCT02058498|3919451|FG000|6 Weeks|Overall Study||8
3191191|NCT02058498|3919451|FG000|COMPLETED|Overall Study||8
3191192|NCT02058498|3919451|FG000|NOT COMPLETED|Overall Study||4
3191193|NCT02058511|3919455|FG000|STARTED|Overall Study||24
3191194|NCT02058511|3919455|FG000|COMPLETED|Overall Study||24
3191195|NCT02058511|3919455|FG000|NOT COMPLETED|Overall Study||0
3191196|NCT02058563|3919461|FG000|STARTED|Overall Study||454
3191197|NCT02058563|3919462|FG001|STARTED|Overall Study||457
3191198|NCT02058563|3919461|FG000|COMPLETED|Overall Study||426
3191199|NCT02058563|3919462|FG001|COMPLETED|Overall Study||433
3191200|NCT02058563|3919461|FG000|NOT COMPLETED|Overall Study||28
3191201|NCT02058563|3919462|FG001|NOT COMPLETED|Overall Study||24
3191202|NCT02058589|3919470|FG000|STARTED|Overall Study||132
3191203|NCT02058589|3919471|FG001|STARTED|Overall Study||132
3191204|NCT02058589|3919470|FG000|COMPLETED|Overall Study||130
3191205|NCT02058589|3919471|FG001|COMPLETED|Overall Study||130
3191206|NCT02058589|3919470|FG000|NOT COMPLETED|Overall Study||2
3191207|NCT02058589|3919471|FG001|NOT COMPLETED|Overall Study||2
3191208|NCT02058628|3919481|FG000|STARTED|Overall Study||111
3191209|NCT02058628|3919482|FG001|STARTED|Overall Study||110
3191210|NCT02058628|3919481|FG000|COMPLETED|Overall Study||104
3191211|NCT02058628|3919482|FG001|COMPLETED|Overall Study||102
3191212|NCT02058628|3919481|FG000|NOT COMPLETED|Overall Study||7
3191213|NCT02058628|3919482|FG001|NOT COMPLETED|Overall Study||8
3191214|NCT02058836|3919493|FG000|STARTED|Overall Study||4
3191215|NCT02058836|3919494|FG001|STARTED|Overall Study||4
3191216|NCT02058836|3919493|FG000|COMPLETED|Overall Study||3
3191217|NCT02058836|3919494|FG001|COMPLETED|Overall Study||3
3191218|NCT02058836|3919493|FG000|NOT COMPLETED|Overall Study||1
3191219|NCT02058836|3919494|FG001|NOT COMPLETED|Overall Study||1
3191220|NCT02058849|3919502|FG000|STARTED|Overall Study||11
3191221|NCT02058849|3919503|FG001|STARTED|Overall Study||2
3191222|NCT02058849|3919502|FG000|COMPLETED|Overall Study||4
3191223|NCT02058849|3919503|FG001|COMPLETED|Overall Study||1
3191224|NCT02058849|3919502|FG000|NOT COMPLETED|Overall Study||7
3191225|NCT02058849|3919503|FG001|NOT COMPLETED|Overall Study||1
3364279|NCT04027439|4095501|FG000|STARTED|Part A (R, PC, PG) Single Dose||6
3364280|NCT04027439|4095502|FG001|STARTED|Part A (R, PC, PG) Single Dose||6
3364281|NCT04027439|4095503|FG002|STARTED|Part A (R, PC, PG) Single Dose||7
3364282|NCT04027439|4095504|FG003|STARTED|Part A (R, PC, PG) Single Dose||6
3364283|NCT04027439|4095505|FG004|STARTED|Part A (R, PC, PG) Single Dose||6
3364284|NCT04027439|4095506|FG005|STARTED|Part A (R, PC, PG) Single Dose||6
3364285|NCT04027439|4095507|FG006|STARTED|Part A (R, PC, PG) Single Dose||0
3364286|NCT04027439|4095508|FG007|STARTED|Part A (R, PC, PG) Single Dose||0
3364287|NCT04027439|4095509|FG008|STARTED|Part A (R, PC, PG) Single Dose||0
3364288|NCT04027439|4095510|FG009|STARTED|Part A (R, PC, PG) Single Dose||0
3364289|NCT04027439|4095511|FG010|STARTED|Part A (R, PC, PG) Single Dose||0
3364290|NCT04027439|4095512|FG011|STARTED|Part A (R, PC, PG) Single Dose||0
3364291|NCT04027439|4095513|FG012|STARTED|Part A (R, PC, PG) Single Dose||0
3364292|NCT04027439|4095514|FG013|STARTED|Part A (R, PC, PG) Single Dose||0
3364293|NCT04027439|4095515|FG014|STARTED|Part A (R, PC, PG) Single Dose||0
3364294|NCT04027439|4095516|FG015|STARTED|Part A (R, PC, PG) Single Dose||0
3364295|NCT04027439|4095501|FG000|COMPLETED|Part A (R, PC, PG) Single Dose||6
3364296|NCT04027439|4095502|FG001|COMPLETED|Part A (R, PC, PG) Single Dose||6
3364297|NCT04027439|4095503|FG002|COMPLETED|Part A (R, PC, PG) Single Dose||7
3364298|NCT04027439|4095504|FG003|COMPLETED|Part A (R, PC, PG) Single Dose||6
3364299|NCT04027439|4095505|FG004|COMPLETED|Part A (R, PC, PG) Single Dose||6
3364300|NCT04027439|4095506|FG005|COMPLETED|Part A (R, PC, PG) Single Dose||6
3364301|NCT04027439|4095507|FG006|COMPLETED|Part A (R, PC, PG) Single Dose||0
3364302|NCT04027439|4095508|FG007|COMPLETED|Part A (R, PC, PG) Single Dose||0
3364303|NCT04027439|4095509|FG008|COMPLETED|Part A (R, PC, PG) Single Dose||0
3364304|NCT04027439|4095510|FG009|COMPLETED|Part A (R, PC, PG) Single Dose||0
3364305|NCT04027439|4095511|FG010|COMPLETED|Part A (R, PC, PG) Single Dose||0
3364306|NCT04027439|4095512|FG011|COMPLETED|Part A (R, PC, PG) Single Dose||0
3191226|NCT02058940|3919509|FG000|STARTED|Overall Study||8
3191227|NCT02058940|3919509|FG000|COMPLETED|Overall Study||7
3191228|NCT02058940|3919509|FG000|NOT COMPLETED|Overall Study||1
3191229|NCT02058966|3919513|FG000|STARTED|Open-Label Methamphetamine||19
3191230|NCT02058966|3919513|FG000|Received Methamphetamine|Open-Label Methamphetamine||18
3191231|NCT02058966|3919513|FG000|COMPLETED|Open-Label Methamphetamine||18
3191232|NCT02058966|3919513|FG000|NOT COMPLETED|Open-Label Methamphetamine||1
3191233|NCT02058966|3919513|FG000|STARTED|First Intervention||15
3191234|NCT02058966|3919513|FG000|Received Placebo-Placebo|First Intervention||3
3191235|NCT02058966|3919513|FG000|Received Placebo-Meth|First Intervention||4
3191236|NCT02058966|3919513|FG000|Received Entacapone-Placebo|First Intervention||2
3191237|NCT02058966|3919513|FG000|Received Entacapone-Meth|First Intervention||5
3191238|NCT02058966|3919513|FG000|COMPLETED|First Intervention||14
3191239|NCT02058966|3919513|FG000|NOT COMPLETED|First Intervention||1
3191240|NCT02058966|3919513|FG000|STARTED|Second Intervention||13
3191241|NCT02058966|3919513|FG000|Received Placebo-Placebo|Second Intervention||2
3191242|NCT02058966|3919513|FG000|Received Placebo-Meth|Second Intervention||2
3191243|NCT02058966|3919513|FG000|Received Entacapone-Placebo|Second Intervention||6
3191244|NCT02058966|3919513|FG000|Received Entacapone-Meth|Second Intervention||3
3191245|NCT02058966|3919513|FG000|COMPLETED|Second Intervention||13
3191246|NCT02058966|3919513|FG000|NOT COMPLETED|Second Intervention||0
3191247|NCT02058966|3919513|FG000|STARTED|Third Intervention||12
3191248|NCT02058966|3919513|FG000|Received Placebo-Placebo|Third Intervention||4
3191249|NCT02058966|3919513|FG000|Received Placebo-Meth|Third Intervention||4
3191250|NCT02058966|3919513|FG000|Received Entacapone-Placebo|Third Intervention||1
3191251|NCT02058966|3919513|FG000|Received Entacapone-Meth|Third Intervention||3
3191252|NCT02058966|3919513|FG000|COMPLETED|Third Intervention||12
3191253|NCT02058966|3919513|FG000|NOT COMPLETED|Third Intervention||0
3191254|NCT02058966|3919513|FG000|STARTED|Fourth Intervention||12
3191255|NCT02058966|3919513|FG000|Received Placebo-Placebo|Fourth Intervention||4
3191256|NCT02058966|3919513|FG000|Received Placebo-Meth|Fourth Intervention||3
3191257|NCT02058966|3919513|FG000|Received Entacapone-Placebo|Fourth Intervention||3
3191258|NCT02058966|3919513|FG000|Received Entacapone-Meth|Fourth Intervention||2
3191259|NCT02058966|3919513|FG000|COMPLETED|Fourth Intervention||12
3191260|NCT02058966|3919513|FG000|NOT COMPLETED|Fourth Intervention||0
3191261|NCT02058992|3919525|FG000|STARTED|Overall Study||3339
3191262|NCT02058992|3919525|FG000|COMPLETED|Overall Study||3223
3191263|NCT02058992|3919525|FG000|NOT COMPLETED|Overall Study||116
3191264|NCT02059005|3919531|FG000|STARTED|Overall Study||49
3191265|NCT02059005|3919532|FG001|STARTED|Overall Study||48
3191266|NCT02059005|3919531|FG000|3 Month Assessment|Overall Study||37
3191267|NCT02059005|3919532|FG001|3 Month Assessment|Overall Study||33
3191268|NCT02059005|3919531|FG000|6 Month Assessment|Overall Study||29
3191269|NCT02059005|3919532|FG001|6 Month Assessment|Overall Study||24
3191270|NCT02059005|3919531|FG000|COMPLETED|Overall Study||29
3191271|NCT02059005|3919532|FG001|COMPLETED|Overall Study||24
3191272|NCT02059005|3919531|FG000|NOT COMPLETED|Overall Study||20
3191273|NCT02059005|3919532|FG001|NOT COMPLETED|Overall Study||24
3191274|NCT02059057|3919540|FG000|STARTED|Overall Study||102
3191275|NCT02059057|3919540|FG000|COMPLETED|Overall Study||87
3191276|NCT02059057|3919540|FG000|NOT COMPLETED|Overall Study||15
3191277|NCT02059070|3919547|FG000|STARTED|Overall Study||19
3191278|NCT02059070|3919548|FG001|STARTED|Overall Study||20
3191279|NCT02059070|3919547|FG000|COMPLETED|Overall Study||14
3191280|NCT02059070|3919548|FG001|COMPLETED|Overall Study||16
3191281|NCT02059070|3919547|FG000|NOT COMPLETED|Overall Study||5
3191282|NCT02059070|3919548|FG001|NOT COMPLETED|Overall Study||4
3191283|NCT02059135|3919556|FG000|STARTED|Maternal Follow-up (ITT Population)||62
3191284|NCT02059135|3919557|FG001|STARTED|Maternal Follow-up (ITT Population)||58
3191285|NCT02059135|3919556|FG000|COMPLETED|Maternal Follow-up (ITT Population)||59
3191286|NCT02059135|3919557|FG001|COMPLETED|Maternal Follow-up (ITT Population)||51
3191287|NCT02059135|3919556|FG000|NOT COMPLETED|Maternal Follow-up (ITT Population)||3
3191288|NCT02059135|3919557|FG001|NOT COMPLETED|Maternal Follow-up (ITT Population)||7
3191289|NCT02059135|3919556|FG000|STARTED|Neonatal Follow-up (Safety Population)||60
3191290|NCT02059135|3919557|FG001|STARTED|Neonatal Follow-up (Safety Population)||54
3191291|NCT02059135|3919556|FG000|COMPLETED|Neonatal Follow-up (Safety Population)||56
3191292|NCT02059135|3919557|FG001|COMPLETED|Neonatal Follow-up (Safety Population)||50
3191293|NCT02059135|3919556|FG000|NOT COMPLETED|Neonatal Follow-up (Safety Population)||4
3191294|NCT02059135|3919557|FG001|NOT COMPLETED|Neonatal Follow-up (Safety Population)||4
3191295|NCT02059148|3919565|FG000|STARTED|Treatment 1||4
3191296|NCT02059148|3919566|FG001|STARTED|Treatment 1||4
3191297|NCT02059148|3919567|FG002|STARTED|Treatment 1||4
3191298|NCT02059148|3919568|FG003|STARTED|Treatment 1||4
3191299|NCT02059148|3919569|FG004|STARTED|Treatment 1||4
3191300|NCT02059148|3919570|FG005|STARTED|Treatment 1||4
3191301|NCT02059148|3919565|FG000|COMPLETED|Treatment 1||4
3191302|NCT02059148|3919566|FG001|COMPLETED|Treatment 1||4
3191303|NCT02059148|3919567|FG002|COMPLETED|Treatment 1||4
3191304|NCT02059148|3919568|FG003|COMPLETED|Treatment 1||4
3191305|NCT02059148|3919569|FG004|COMPLETED|Treatment 1||4
3191306|NCT02059148|3919570|FG005|COMPLETED|Treatment 1||3
3191307|NCT02059148|3919565|FG000|NOT COMPLETED|Treatment 1||0
3191308|NCT02059148|3919566|FG001|NOT COMPLETED|Treatment 1||0
3191309|NCT02059148|3919567|FG002|NOT COMPLETED|Treatment 1||0
3191310|NCT02059148|3919568|FG003|NOT COMPLETED|Treatment 1||0
3191311|NCT02059148|3919569|FG004|NOT COMPLETED|Treatment 1||0
3191312|NCT02059148|3919570|FG005|NOT COMPLETED|Treatment 1||1
3191313|NCT02059148|3919565|FG000|STARTED|Treatment 2||4
3191314|NCT02059148|3919566|FG001|STARTED|Treatment 2||4
3191315|NCT02059148|3919567|FG002|STARTED|Treatment 2||4
3191316|NCT02059148|3919568|FG003|STARTED|Treatment 2||4
3191317|NCT02059148|3919569|FG004|STARTED|Treatment 2||4
3191318|NCT02059148|3919570|FG005|STARTED|Treatment 2||3
3191319|NCT02059148|3919565|FG000|COMPLETED|Treatment 2||4
3191320|NCT02059148|3919566|FG001|COMPLETED|Treatment 2||4
3191321|NCT02059148|3919567|FG002|COMPLETED|Treatment 2||4
3191322|NCT02059148|3919568|FG003|COMPLETED|Treatment 2||4
3191323|NCT02059148|3919569|FG004|COMPLETED|Treatment 2||4
3191324|NCT02059148|3919570|FG005|COMPLETED|Treatment 2||3
3191325|NCT02059148|3919565|FG000|NOT COMPLETED|Treatment 2||0
3191326|NCT02059148|3919566|FG001|NOT COMPLETED|Treatment 2||0
3191327|NCT02059148|3919567|FG002|NOT COMPLETED|Treatment 2||0
3191328|NCT02059148|3919568|FG003|NOT COMPLETED|Treatment 2||0
3191329|NCT02059148|3919569|FG004|NOT COMPLETED|Treatment 2||0
3191330|NCT02059148|3919570|FG005|NOT COMPLETED|Treatment 2||0
3191331|NCT02059148|3919565|FG000|STARTED|Treatment 3||4
3191332|NCT02059148|3919566|FG001|STARTED|Treatment 3||4
3191333|NCT02059148|3919567|FG002|STARTED|Treatment 3||4
3191334|NCT02059148|3919568|FG003|STARTED|Treatment 3||4
3191335|NCT02059148|3919569|FG004|STARTED|Treatment 3||4
3191336|NCT02059148|3919570|FG005|STARTED|Treatment 3||3
3191337|NCT02059148|3919565|FG000|COMPLETED|Treatment 3||4
3191338|NCT02059148|3919566|FG001|COMPLETED|Treatment 3||4
3191339|NCT02059148|3919567|FG002|COMPLETED|Treatment 3||4
3191340|NCT02059148|3919568|FG003|COMPLETED|Treatment 3||4
3191341|NCT02059148|3919569|FG004|COMPLETED|Treatment 3||4
3191342|NCT02059148|3919570|FG005|COMPLETED|Treatment 3||3
3191343|NCT02059148|3919565|FG000|NOT COMPLETED|Treatment 3||0
3191344|NCT02059148|3919566|FG001|NOT COMPLETED|Treatment 3||0
3191345|NCT02059148|3919567|FG002|NOT COMPLETED|Treatment 3||0
3191346|NCT02059148|3919568|FG003|NOT COMPLETED|Treatment 3||0
3191347|NCT02059148|3919569|FG004|NOT COMPLETED|Treatment 3||0
3191348|NCT02059148|3919570|FG005|NOT COMPLETED|Treatment 3||0
3191349|NCT02059161|3919583|FG000|STARTED|Overall Study||245
3191350|NCT02059161|3919584|FG001|STARTED|Overall Study||263
3191351|NCT02059161|3919583|FG000|Treated|Overall Study||241
3191352|NCT02059161|3919584|FG001|Treated|Overall Study||258
3191353|NCT02059161|3919583|FG000|COMPLETED|Overall Study||196
3191354|NCT02059161|3919584|FG001|COMPLETED|Overall Study||222
3191355|NCT02059161|3919583|FG000|NOT COMPLETED|Overall Study||49
3191356|NCT02059161|3919584|FG001|NOT COMPLETED|Overall Study||41
3191357|NCT02059174|3919590|FG000|STARTED|Period 1||37
3191358|NCT02059174|3919591|FG001|STARTED|Period 1||39
3191359|NCT02059174|3919590|FG000|COMPLETED|Period 1||37
3191360|NCT02059174|3919591|FG001|COMPLETED|Period 1||37
3191361|NCT02059174|3919590|FG000|NOT COMPLETED|Period 1||0
3191362|NCT02059174|3919591|FG001|NOT COMPLETED|Period 1||2
3191363|NCT02059174|3919590|FG000|STARTED|Period 2||37
3191364|NCT02059174|3919591|FG001|STARTED|Period 2||37
3191365|NCT02059174|3919590|FG000|COMPLETED|Period 2||36
3191366|NCT02059174|3919591|FG001|COMPLETED|Period 2||35
3191367|NCT02059174|3919590|FG000|NOT COMPLETED|Period 2||1
3191368|NCT02059174|3919591|FG001|NOT COMPLETED|Period 2||2
3191369|NCT02059174|3919590|FG000|STARTED|Period 3||36
3191370|NCT02059174|3919591|FG001|STARTED|Period 3||35
3191371|NCT02059174|3919590|FG000|COMPLETED|Period 3||35
3191372|NCT02059174|3919591|FG001|COMPLETED|Period 3||35
3191373|NCT02059174|3919590|FG000|NOT COMPLETED|Period 3||1
3191374|NCT02059174|3919591|FG001|NOT COMPLETED|Period 3||0
3191375|NCT02059174|3919590|FG000|STARTED|Period 4||35
3191376|NCT02059174|3919591|FG001|STARTED|Period 4||35
3191377|NCT02059174|3919590|FG000|COMPLETED|Period 4||35
3191378|NCT02059174|3919591|FG001|COMPLETED|Period 4||35
3191379|NCT02059174|3919590|FG000|NOT COMPLETED|Period 4||0
3191380|NCT02059174|3919591|FG001|NOT COMPLETED|Period 4||0
3191381|NCT02059187|3919599|FG000|STARTED|Overall Study||265
3191382|NCT02059187|3919600|FG001|STARTED|Overall Study||266
3191383|NCT02059187|3919599|FG000|COMPLETED|Overall Study||240
3191384|NCT02059187|3919600|FG001|COMPLETED|Overall Study||244
3191385|NCT02059187|3919599|FG000|NOT COMPLETED|Overall Study||25
3191386|NCT02059187|3919600|FG001|NOT COMPLETED|Overall Study||22
3191387|NCT02059213|3919608|FG000|STARTED|Overall Study||20
3191388|NCT02059213|3919609|FG001|STARTED|Overall Study||42
3191389|NCT02059213|3919608|FG000|Initiated Treatment|Overall Study||20
3191390|NCT02059213|3919609|FG001|Initiated Treatment|Overall Study||40
3191391|NCT02059213|3919608|FG000|COMPLETED|Overall Study||20
3191392|NCT02059213|3919609|FG001|COMPLETED|Overall Study||40
3191393|NCT02059213|3919608|FG000|NOT COMPLETED|Overall Study||0
3191394|NCT02059213|3919609|FG001|NOT COMPLETED|Overall Study||2
3191395|NCT02059239|3919620|FG000|STARTED|Overall Study||18
3191396|NCT02059239|3919621|FG001|STARTED|Overall Study||16
3191397|NCT02059239|3919620|FG000|COMPLETED|Overall Study||16
3191398|NCT02059239|3919621|FG001|COMPLETED|Overall Study||13
3191399|NCT02059239|3919620|FG000|NOT COMPLETED|Overall Study||2
3191400|NCT02059239|3919621|FG001|NOT COMPLETED|Overall Study||3
3191401|NCT02059278|3919630|FG000|STARTED|Overall Study||165
3191402|NCT02059278|3919631|FG001|STARTED|Overall Study||170
3191403|NCT02059278|3919630|FG000|COMPLETED|Overall Study||162
3191404|NCT02059278|3919631|FG001|COMPLETED|Overall Study||166
3191405|NCT02059278|3919630|FG000|NOT COMPLETED|Overall Study||3
3191406|NCT02059278|3919631|FG001|NOT COMPLETED|Overall Study||4
3191407|NCT02059291|3919646|FG000|STARTED|Epoch 2||31
3191408|NCT02059291|3919647|FG001|STARTED|Epoch 2||32
3191409|NCT02059291|3919648|FG002|STARTED|Epoch 2||37
3191410|NCT02059291|3919649|FG003|STARTED|Epoch 2||35
3191411|NCT02059291|3919650|FG004|STARTED|Epoch 2||22
3191412|NCT02059291|3919651|FG005|STARTED|Epoch 2||24
3191413|NCT02059291|3919652|FG006|STARTED|Epoch 2||2
3191414|NCT02059291|3919653|FG007|STARTED|Epoch 2||2
3191415|NCT02059291|3919654|FG008|STARTED|Epoch 2|This Epoch 3 group is shown in Epoch 2 to account for the 203 patients enrolled in the study.|18
3191416|NCT02059291|3919655|FG009|STARTED|Epoch 2||0
3191417|NCT02059291|3919656|FG010|STARTED|Epoch 2||0
3191418|NCT02059291|3919657|FG011|STARTED|Epoch 2||0
3191419|NCT02059291|3919658|FG012|STARTED|Epoch 2||0
3191420|NCT02059291|3919659|FG013|STARTED|Epoch 2||0
3191421|NCT02059291|3919660|FG014|STARTED|Epoch 2||0
3191422|NCT02059291|3919661|FG015|STARTED|Epoch 2||0
3191423|NCT02059291|3919662|FG016|STARTED|Epoch 2||0
3191424|NCT02059291|3919663|FG017|STARTED|Epoch 2||0
3191425|NCT02059291|3919664|FG018|STARTED|Epoch 2||0
3191426|NCT02059291|3919665|FG019|STARTED|Epoch 2||0
3191427|NCT02059291|3919666|FG020|STARTED|Epoch 2||0
3191428|NCT02059291|3919667|FG021|STARTED|Epoch 2||0
3191429|NCT02059291|3919668|FG022|STARTED|Epoch 2||0
3191430|NCT02059291|3919669|FG023|STARTED|Epoch 2||0
3191431|NCT02059291|3919670|FG024|STARTED|Epoch 2||0
3191432|NCT02059291|3919646|FG000|COMPLETED|Epoch 2||31
3191433|NCT02059291|3919647|FG001|COMPLETED|Epoch 2||31
3191434|NCT02059291|3919648|FG002|COMPLETED|Epoch 2||36
3191435|NCT02059291|3919649|FG003|COMPLETED|Epoch 2||33
3191436|NCT02059291|3919650|FG004|COMPLETED|Epoch 2||22
3191437|NCT02059291|3919651|FG005|COMPLETED|Epoch 2||22
3191438|NCT02059291|3919652|FG006|COMPLETED|Epoch 2||2
3191439|NCT02059291|3919653|FG007|COMPLETED|Epoch 2||1
3191440|NCT02059291|3919654|FG008|COMPLETED|Epoch 2||16
3191441|NCT02059291|3919655|FG009|COMPLETED|Epoch 2||0
3191442|NCT02059291|3919656|FG010|COMPLETED|Epoch 2||0
3191443|NCT02059291|3919657|FG011|COMPLETED|Epoch 2||0
3191444|NCT02059291|3919658|FG012|COMPLETED|Epoch 2||0
3191445|NCT02059291|3919659|FG013|COMPLETED|Epoch 2||0
3191446|NCT02059291|3919660|FG014|COMPLETED|Epoch 2||0
3191447|NCT02059291|3919661|FG015|COMPLETED|Epoch 2||0
3191448|NCT02059291|3919662|FG016|COMPLETED|Epoch 2||0
3191449|NCT02059291|3919663|FG017|COMPLETED|Epoch 2||0
3191450|NCT02059291|3919664|FG018|COMPLETED|Epoch 2||0
3191451|NCT02059291|3919665|FG019|COMPLETED|Epoch 2||0
3191452|NCT02059291|3919666|FG020|COMPLETED|Epoch 2||0
3191453|NCT02059291|3919667|FG021|COMPLETED|Epoch 2||0
3191454|NCT02059291|3919668|FG022|COMPLETED|Epoch 2||0
3191455|NCT02059291|3919669|FG023|COMPLETED|Epoch 2||0
3191456|NCT02059291|3919670|FG024|COMPLETED|Epoch 2||0
3191457|NCT02059291|3919646|FG000|NOT COMPLETED|Epoch 2||0
3191458|NCT02059291|3919647|FG001|NOT COMPLETED|Epoch 2||1
3191459|NCT02059291|3919648|FG002|NOT COMPLETED|Epoch 2||1
3191460|NCT02059291|3919649|FG003|NOT COMPLETED|Epoch 2||2
3191461|NCT02059291|3919650|FG004|NOT COMPLETED|Epoch 2||0
3191462|NCT02059291|3919651|FG005|NOT COMPLETED|Epoch 2||2
3191463|NCT02059291|3919652|FG006|NOT COMPLETED|Epoch 2||0
3191464|NCT02059291|3919653|FG007|NOT COMPLETED|Epoch 2||1
3191465|NCT02059291|3919654|FG008|NOT COMPLETED|Epoch 2||2
3191466|NCT02059291|3919655|FG009|NOT COMPLETED|Epoch 2||0
3191467|NCT02059291|3919656|FG010|NOT COMPLETED|Epoch 2||0
3191468|NCT02059291|3919657|FG011|NOT COMPLETED|Epoch 2||0
3191469|NCT02059291|3919658|FG012|NOT COMPLETED|Epoch 2||0
3191470|NCT02059291|3919659|FG013|NOT COMPLETED|Epoch 2||0
3191471|NCT02059291|3919660|FG014|NOT COMPLETED|Epoch 2||0
3191472|NCT02059291|3919661|FG015|NOT COMPLETED|Epoch 2||0
3191473|NCT02059291|3919662|FG016|NOT COMPLETED|Epoch 2||0
3191474|NCT02059291|3919663|FG017|NOT COMPLETED|Epoch 2||0
3191475|NCT02059291|3919664|FG018|NOT COMPLETED|Epoch 2||0
3191476|NCT02059291|3919665|FG019|NOT COMPLETED|Epoch 2||0
3191477|NCT02059291|3919666|FG020|NOT COMPLETED|Epoch 2||0
3191478|NCT02059291|3919667|FG021|NOT COMPLETED|Epoch 2||0
3191479|NCT02059291|3919668|FG022|NOT COMPLETED|Epoch 2||0
3191480|NCT02059291|3919669|FG023|NOT COMPLETED|Epoch 2||0
3191481|NCT02059291|3919670|FG024|NOT COMPLETED|Epoch 2||0
3191482|NCT02059291|3919646|FG000|STARTED|Epoch 3||0
3191483|NCT02059291|3919647|FG001|STARTED|Epoch 3||0
3191484|NCT02059291|3919648|FG002|STARTED|Epoch 3||0
3191485|NCT02059291|3919649|FG003|STARTED|Epoch 3||0
3191486|NCT02059291|3919650|FG004|STARTED|Epoch 3||0
3191487|NCT02059291|3919651|FG005|STARTED|Epoch 3||0
3191488|NCT02059291|3919652|FG006|STARTED|Epoch 3||2
3191489|NCT02059291|3919653|FG007|STARTED|Epoch 3||1
3191490|NCT02059291|3919654|FG008|STARTED|Epoch 3|Presented in Epoch 2.|0
3191491|NCT02059291|3919655|FG009|STARTED|Epoch 3||9
3191492|NCT02059291|3919656|FG010|STARTED|Epoch 3||10
3191493|NCT02059291|3919657|FG011|STARTED|Epoch 3||6
3191494|NCT02059291|3919658|FG012|STARTED|Epoch 3||7
3191495|NCT02059291|3919659|FG013|STARTED|Epoch 3||4
3191496|NCT02059291|3919660|FG014|STARTED|Epoch 3||5
3191497|NCT02059291|3919661|FG015|STARTED|Epoch 3||126
3191498|NCT02059291|3919662|FG016|STARTED|Epoch 3||0
3191499|NCT02059291|3919663|FG017|STARTED|Epoch 3||0
3191500|NCT02059291|3919664|FG018|STARTED|Epoch 3||0
3191501|NCT02059291|3919665|FG019|STARTED|Epoch 3||0
3191502|NCT02059291|3919666|FG020|STARTED|Epoch 3||0
3191503|NCT02059291|3919667|FG021|STARTED|Epoch 3||0
3191504|NCT02059291|3919668|FG022|STARTED|Epoch 3||0
3191505|NCT02059291|3919669|FG023|STARTED|Epoch 3||0
3191506|NCT02059291|3919670|FG024|STARTED|Epoch 3||0
3191507|NCT02059291|3919646|FG000|COMPLETED|Epoch 3||0
3191508|NCT02059291|3919647|FG001|COMPLETED|Epoch 3||0
3191509|NCT02059291|3919648|FG002|COMPLETED|Epoch 3||0
3191510|NCT02059291|3919649|FG003|COMPLETED|Epoch 3||0
3191511|NCT02059291|3919650|FG004|COMPLETED|Epoch 3||0
3191512|NCT02059291|3919651|FG005|COMPLETED|Epoch 3||0
3191513|NCT02059291|3919652|FG006|COMPLETED|Epoch 3||2
3191514|NCT02059291|3919653|FG007|COMPLETED|Epoch 3||1
3191515|NCT02059291|3919654|FG008|COMPLETED|Epoch 3||0
3191516|NCT02059291|3919655|FG009|COMPLETED|Epoch 3||9
3191517|NCT02059291|3919656|FG010|COMPLETED|Epoch 3||10
3191518|NCT02059291|3919657|FG011|COMPLETED|Epoch 3||6
3191519|NCT02059291|3919658|FG012|COMPLETED|Epoch 3||7
3191520|NCT02059291|3919659|FG013|COMPLETED|Epoch 3||3
3191521|NCT02059291|3919660|FG014|COMPLETED|Epoch 3||5
3191522|NCT02059291|3919661|FG015|COMPLETED|Epoch 3||120
3191523|NCT02059291|3919662|FG016|COMPLETED|Epoch 3||0
3191524|NCT02059291|3919663|FG017|COMPLETED|Epoch 3||0
3191525|NCT02059291|3919664|FG018|COMPLETED|Epoch 3||0
3191526|NCT02059291|3919665|FG019|COMPLETED|Epoch 3||0
3191527|NCT02059291|3919666|FG020|COMPLETED|Epoch 3||0
3191528|NCT02059291|3919667|FG021|COMPLETED|Epoch 3||0
3191529|NCT02059291|3919668|FG022|COMPLETED|Epoch 3||0
3191530|NCT02059291|3919669|FG023|COMPLETED|Epoch 3||0
3191531|NCT02059291|3919670|FG024|COMPLETED|Epoch 3||0
3191532|NCT02059291|3919646|FG000|NOT COMPLETED|Epoch 3||0
3191533|NCT02059291|3919647|FG001|NOT COMPLETED|Epoch 3||0
3191534|NCT02059291|3919648|FG002|NOT COMPLETED|Epoch 3||0
3191535|NCT02059291|3919649|FG003|NOT COMPLETED|Epoch 3||0
3191536|NCT02059291|3919650|FG004|NOT COMPLETED|Epoch 3||0
3191537|NCT02059291|3919651|FG005|NOT COMPLETED|Epoch 3||0
3191538|NCT02059291|3919652|FG006|NOT COMPLETED|Epoch 3||0
3191539|NCT02059291|3919653|FG007|NOT COMPLETED|Epoch 3||0
3191540|NCT02059291|3919654|FG008|NOT COMPLETED|Epoch 3||0
3191541|NCT02059291|3919655|FG009|NOT COMPLETED|Epoch 3||0
3191542|NCT02059291|3919656|FG010|NOT COMPLETED|Epoch 3||0
3191543|NCT02059291|3919657|FG011|NOT COMPLETED|Epoch 3||0
3191544|NCT02059291|3919658|FG012|NOT COMPLETED|Epoch 3||0
3191545|NCT02059291|3919659|FG013|NOT COMPLETED|Epoch 3||1
3191546|NCT02059291|3919660|FG014|NOT COMPLETED|Epoch 3||0
3191547|NCT02059291|3919661|FG015|NOT COMPLETED|Epoch 3||6
3191548|NCT02059291|3919662|FG016|NOT COMPLETED|Epoch 3||0
3191549|NCT02059291|3919663|FG017|NOT COMPLETED|Epoch 3||0
3191550|NCT02059291|3919664|FG018|NOT COMPLETED|Epoch 3||0
3191551|NCT02059291|3919665|FG019|NOT COMPLETED|Epoch 3||0
3191552|NCT02059291|3919666|FG020|NOT COMPLETED|Epoch 3||0
3191553|NCT02059291|3919667|FG021|NOT COMPLETED|Epoch 3||0
3191554|NCT02059291|3919668|FG022|NOT COMPLETED|Epoch 3||0
3191555|NCT02059291|3919669|FG023|NOT COMPLETED|Epoch 3||0
3191556|NCT02059291|3919670|FG024|NOT COMPLETED|Epoch 3||0
3191557|NCT02059291|3919646|FG000|STARTED|Epoch 4||0
3191558|NCT02059291|3919647|FG001|STARTED|Epoch 4||0
3191559|NCT02059291|3919648|FG002|STARTED|Epoch 4||0
3191560|NCT02059291|3919649|FG003|STARTED|Epoch 4||0
3191561|NCT02059291|3919650|FG004|STARTED|Epoch 4||0
3191562|NCT02059291|3919651|FG005|STARTED|Epoch 4||0
3191563|NCT02059291|3919652|FG006|STARTED|Epoch 4||0
3191564|NCT02059291|3919653|FG007|STARTED|Epoch 4||0
3191565|NCT02059291|3919654|FG008|STARTED|Epoch 4||0
3191566|NCT02059291|3919655|FG009|STARTED|Epoch 4||0
3191567|NCT02059291|3919656|FG010|STARTED|Epoch 4||0
3191568|NCT02059291|3919657|FG011|STARTED|Epoch 4||0
3191569|NCT02059291|3919658|FG012|STARTED|Epoch 4||0
3191570|NCT02059291|3919659|FG013|STARTED|Epoch 4||0
3191571|NCT02059291|3919660|FG014|STARTED|Epoch 4||0
3191572|NCT02059291|3919661|FG015|STARTED|Epoch 4||0
3191573|NCT02059291|3919662|FG016|STARTED|Epoch 4||43
3191574|NCT02059291|3919663|FG017|STARTED|Epoch 4||14
3191575|NCT02059291|3919664|FG018|STARTED|Epoch 4||2
3191576|NCT02059291|3919665|FG019|STARTED|Epoch 4||18
3191577|NCT02059291|3919666|FG020|STARTED|Epoch 4||34
3191578|NCT02059291|3919667|FG021|STARTED|Epoch 4||14
3191579|NCT02059291|3919668|FG022|STARTED|Epoch 4||31
3191580|NCT02059291|3919669|FG023|STARTED|Epoch 4||22
3191581|NCT02059291|3919670|FG024|STARTED|Epoch 4||0
3191582|NCT02059291|3919646|FG000|COMPLETED|Epoch 4||0
3191583|NCT02059291|3919647|FG001|COMPLETED|Epoch 4||0
3191584|NCT02059291|3919648|FG002|COMPLETED|Epoch 4||0
3191585|NCT02059291|3919649|FG003|COMPLETED|Epoch 4||0
3191586|NCT02059291|3919650|FG004|COMPLETED|Epoch 4||0
3191587|NCT02059291|3919651|FG005|COMPLETED|Epoch 4||0
3191588|NCT02059291|3919652|FG006|COMPLETED|Epoch 4||0
3191589|NCT02059291|3919653|FG007|COMPLETED|Epoch 4||0
3191590|NCT02059291|3919654|FG008|COMPLETED|Epoch 4||0
3191591|NCT02059291|3919655|FG009|COMPLETED|Epoch 4||0
3191592|NCT02059291|3919656|FG010|COMPLETED|Epoch 4||0
3191593|NCT02059291|3919657|FG011|COMPLETED|Epoch 4||0
3191594|NCT02059291|3919658|FG012|COMPLETED|Epoch 4||0
3191595|NCT02059291|3919659|FG013|COMPLETED|Epoch 4||0
3191596|NCT02059291|3919660|FG014|COMPLETED|Epoch 4||0
3191597|NCT02059291|3919661|FG015|COMPLETED|Epoch 4||0
3191598|NCT02059291|3919662|FG016|COMPLETED|Epoch 4||41
3191599|NCT02059291|3919663|FG017|COMPLETED|Epoch 4||14
3191600|NCT02059291|3919664|FG018|COMPLETED|Epoch 4||2
3191601|NCT02059291|3919665|FG019|COMPLETED|Epoch 4||18
3191602|NCT02059291|3919666|FG020|COMPLETED|Epoch 4||33
3191603|NCT02059291|3919667|FG021|COMPLETED|Epoch 4||14
3191604|NCT02059291|3919668|FG022|COMPLETED|Epoch 4||30
3191605|NCT02059291|3919669|FG023|COMPLETED|Epoch 4||21
3191606|NCT02059291|3919670|FG024|COMPLETED|Epoch 4||0
3191607|NCT02059291|3919646|FG000|NOT COMPLETED|Epoch 4||0
3191608|NCT02059291|3919647|FG001|NOT COMPLETED|Epoch 4||0
3191609|NCT02059291|3919648|FG002|NOT COMPLETED|Epoch 4||0
3191610|NCT02059291|3919649|FG003|NOT COMPLETED|Epoch 4||0
3191611|NCT02059291|3919650|FG004|NOT COMPLETED|Epoch 4||0
3191612|NCT02059291|3919651|FG005|NOT COMPLETED|Epoch 4||0
3191613|NCT02059291|3919652|FG006|NOT COMPLETED|Epoch 4||0
3191614|NCT02059291|3919653|FG007|NOT COMPLETED|Epoch 4||0
3191615|NCT02059291|3919654|FG008|NOT COMPLETED|Epoch 4||0
3191616|NCT02059291|3919655|FG009|NOT COMPLETED|Epoch 4||0
3191617|NCT02059291|3919656|FG010|NOT COMPLETED|Epoch 4||0
3191618|NCT02059291|3919657|FG011|NOT COMPLETED|Epoch 4||0
3191619|NCT02059291|3919658|FG012|NOT COMPLETED|Epoch 4||0
3191620|NCT02059291|3919659|FG013|NOT COMPLETED|Epoch 4||0
3191621|NCT02059291|3919660|FG014|NOT COMPLETED|Epoch 4||0
3191622|NCT02059291|3919661|FG015|NOT COMPLETED|Epoch 4||0
3191623|NCT02059291|3919662|FG016|NOT COMPLETED|Epoch 4||2
3191624|NCT02059291|3919663|FG017|NOT COMPLETED|Epoch 4||0
3191625|NCT02059291|3919664|FG018|NOT COMPLETED|Epoch 4||0
3191626|NCT02059291|3919665|FG019|NOT COMPLETED|Epoch 4||0
3191627|NCT02059291|3919666|FG020|NOT COMPLETED|Epoch 4||1
3191628|NCT02059291|3919667|FG021|NOT COMPLETED|Epoch 4||0
3191629|NCT02059291|3919668|FG022|NOT COMPLETED|Epoch 4||1
3191630|NCT02059291|3919669|FG023|NOT COMPLETED|Epoch 4||1
3191631|NCT02059291|3919670|FG024|NOT COMPLETED|Epoch 4||0
3191632|NCT02059395|3919700|FG000|STARTED|Overall Study||22
3191633|NCT02059395|3919701|FG001|STARTED|Overall Study||27
3191634|NCT02059395|3919700|FG000|COMPLETED|Overall Study||20
3191635|NCT02059395|3919701|FG001|COMPLETED|Overall Study||23
3191636|NCT02059395|3919700|FG000|NOT COMPLETED|Overall Study||2
3191637|NCT02059395|3919701|FG001|NOT COMPLETED|Overall Study||4
3191638|NCT02059408|3919710|FG000|STARTED|Overall Study||604
3191639|NCT02059408|3919711|FG001|STARTED|Overall Study||599
3191640|NCT02059408|3919712|FG002|STARTED|Overall Study||616
3191641|NCT02059408|3919710|FG000|COMPLETED|Overall Study||604
3191642|NCT02059408|3919711|FG001|COMPLETED|Overall Study||269
3191643|NCT02059408|3919712|FG002|COMPLETED|Overall Study||258
3191644|NCT02059408|3919710|FG000|NOT COMPLETED|Overall Study||0
3191645|NCT02059408|3919711|FG001|NOT COMPLETED|Overall Study||330
3191646|NCT02059408|3919712|FG002|NOT COMPLETED|Overall Study||358
3191647|NCT02059434|3919731|FG000|STARTED|Period 1 (After Screening/run-in Period)||2
3191648|NCT02059434|3919732|FG001|STARTED|Period 1 (After Screening/run-in Period)||2
3191649|NCT02059434|3919733|FG002|STARTED|Period 1 (After Screening/run-in Period)||2
3191650|NCT02059434|3919734|FG003|STARTED|Period 1 (After Screening/run-in Period)||2
3191651|NCT02059434|3919735|FG004|STARTED|Period 1 (After Screening/run-in Period)||2
3191652|NCT02059434|3919736|FG005|STARTED|Period 1 (After Screening/run-in Period)||2
3191653|NCT02059434|3919737|FG006|STARTED|Period 1 (After Screening/run-in Period)||2
3191654|NCT02059434|3919738|FG007|STARTED|Period 1 (After Screening/run-in Period)||3
3191655|NCT02059434|3919739|FG008|STARTED|Period 1 (After Screening/run-in Period)|Part 2 followed Part 1, and comprised 5 treatment periods|0
3191656|NCT02059434|3919731|FG000|COMPLETED|Period 1 (After Screening/run-in Period)||2
3191657|NCT02059434|3919732|FG001|COMPLETED|Period 1 (After Screening/run-in Period)||2
3191658|NCT02059434|3919733|FG002|COMPLETED|Period 1 (After Screening/run-in Period)||2
3191659|NCT02059434|3919734|FG003|COMPLETED|Period 1 (After Screening/run-in Period)||2
3191660|NCT02059434|3919735|FG004|COMPLETED|Period 1 (After Screening/run-in Period)||2
3191661|NCT02059434|3919736|FG005|COMPLETED|Period 1 (After Screening/run-in Period)||2
3191662|NCT02059434|3919737|FG006|COMPLETED|Period 1 (After Screening/run-in Period)||2
3191663|NCT02059434|3919738|FG007|COMPLETED|Period 1 (After Screening/run-in Period)||3
3191664|NCT02059434|3919739|FG008|COMPLETED|Period 1 (After Screening/run-in Period)|Part 2 followed Part 1, and comprised 5 treatment periods|0
3191665|NCT02059434|3919731|FG000|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
3191666|NCT02059434|3919732|FG001|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
3191667|NCT02059434|3919733|FG002|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
3191668|NCT02059434|3919734|FG003|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
3191669|NCT02059434|3919735|FG004|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
3191670|NCT02059434|3919736|FG005|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
3191671|NCT02059434|3919737|FG006|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
3191672|NCT02059434|3919738|FG007|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
3191673|NCT02059434|3919739|FG008|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
3191674|NCT02059434|3919731|FG000|STARTED|Washout Between Periods 1 and 2||2
3191675|NCT02059434|3919732|FG001|STARTED|Washout Between Periods 1 and 2||2
3191676|NCT02059434|3919733|FG002|STARTED|Washout Between Periods 1 and 2||2
3191677|NCT02059434|3919734|FG003|STARTED|Washout Between Periods 1 and 2||2
3191678|NCT02059434|3919735|FG004|STARTED|Washout Between Periods 1 and 2||2
3191679|NCT02059434|3919736|FG005|STARTED|Washout Between Periods 1 and 2||2
3191680|NCT02059434|3919737|FG006|STARTED|Washout Between Periods 1 and 2||2
3191681|NCT02059434|3919738|FG007|STARTED|Washout Between Periods 1 and 2||3
3191682|NCT02059434|3919739|FG008|STARTED|Washout Between Periods 1 and 2|Part 2 followed Part 1, and comprised 5 treatment periods|0
3191683|NCT02059434|3919731|FG000|COMPLETED|Washout Between Periods 1 and 2||2
3191684|NCT02059434|3919732|FG001|COMPLETED|Washout Between Periods 1 and 2||2
3191685|NCT02059434|3919733|FG002|COMPLETED|Washout Between Periods 1 and 2||2
3191686|NCT02059434|3919734|FG003|COMPLETED|Washout Between Periods 1 and 2||2
3191687|NCT02059434|3919735|FG004|COMPLETED|Washout Between Periods 1 and 2||2
3191688|NCT02059434|3919736|FG005|COMPLETED|Washout Between Periods 1 and 2||2
3191689|NCT02059434|3919737|FG006|COMPLETED|Washout Between Periods 1 and 2||2
3191690|NCT02059434|3919738|FG007|COMPLETED|Washout Between Periods 1 and 2||2
3191691|NCT02059434|3919739|FG008|COMPLETED|Washout Between Periods 1 and 2|Part 2 followed Part 1, and comprised 5 treatment periods|0
3191692|NCT02059434|3919731|FG000|NOT COMPLETED|Washout Between Periods 1 and 2||0
3191693|NCT02059434|3919732|FG001|NOT COMPLETED|Washout Between Periods 1 and 2||0
3191694|NCT02059434|3919733|FG002|NOT COMPLETED|Washout Between Periods 1 and 2||0
3191695|NCT02059434|3919734|FG003|NOT COMPLETED|Washout Between Periods 1 and 2||0
3191696|NCT02059434|3919735|FG004|NOT COMPLETED|Washout Between Periods 1 and 2||0
3191697|NCT02059434|3919736|FG005|NOT COMPLETED|Washout Between Periods 1 and 2||0
3191698|NCT02059434|3919737|FG006|NOT COMPLETED|Washout Between Periods 1 and 2||0
3191699|NCT02059434|3919738|FG007|NOT COMPLETED|Washout Between Periods 1 and 2||1
3191700|NCT02059434|3919739|FG008|NOT COMPLETED|Washout Between Periods 1 and 2||0
3191701|NCT02059434|3919731|FG000|STARTED|Period 2||2
3191702|NCT02059434|3919732|FG001|STARTED|Period 2||2
3191703|NCT02059434|3919733|FG002|STARTED|Period 2||2
3191704|NCT02059434|3919734|FG003|STARTED|Period 2||2
3191705|NCT02059434|3919735|FG004|STARTED|Period 2||2
3191706|NCT02059434|3919736|FG005|STARTED|Period 2||2
3191707|NCT02059434|3919737|FG006|STARTED|Period 2||2
3191708|NCT02059434|3919738|FG007|STARTED|Period 2||2
3191709|NCT02059434|3919739|FG008|STARTED|Period 2|Part 2 followed Part 1, and comprised 5 treatment periods|0
3191710|NCT02059434|3919731|FG000|COMPLETED|Period 2||2
3191711|NCT02059434|3919732|FG001|COMPLETED|Period 2||2
3191712|NCT02059434|3919733|FG002|COMPLETED|Period 2||2
3191713|NCT02059434|3919734|FG003|COMPLETED|Period 2||2
3191714|NCT02059434|3919735|FG004|COMPLETED|Period 2||2
3191715|NCT02059434|3919736|FG005|COMPLETED|Period 2||2
3191716|NCT02059434|3919737|FG006|COMPLETED|Period 2||2
3191717|NCT02059434|3919738|FG007|COMPLETED|Period 2||2
3191718|NCT02059434|3919739|FG008|COMPLETED|Period 2|Part 2 followed Part 1, and comprised 5 treatment periods|0
3191719|NCT02059434|3919731|FG000|NOT COMPLETED|Period 2||0
3191720|NCT02059434|3919732|FG001|NOT COMPLETED|Period 2||0
3191721|NCT02059434|3919733|FG002|NOT COMPLETED|Period 2||0
3191722|NCT02059434|3919734|FG003|NOT COMPLETED|Period 2||0
3191723|NCT02059434|3919735|FG004|NOT COMPLETED|Period 2||0
3191724|NCT02059434|3919736|FG005|NOT COMPLETED|Period 2||0
3191725|NCT02059434|3919737|FG006|NOT COMPLETED|Period 2||0
3191726|NCT02059434|3919738|FG007|NOT COMPLETED|Period 2||0
3191727|NCT02059434|3919739|FG008|NOT COMPLETED|Period 2||0
3191728|NCT02059434|3919731|FG000|STARTED|Washout Between Periods 2 and 3||2
3191729|NCT02059434|3919732|FG001|STARTED|Washout Between Periods 2 and 3||2
3191730|NCT02059434|3919733|FG002|STARTED|Washout Between Periods 2 and 3||2
3191731|NCT02059434|3919734|FG003|STARTED|Washout Between Periods 2 and 3||2
3191732|NCT02059434|3919735|FG004|STARTED|Washout Between Periods 2 and 3||2
3191733|NCT02059434|3919736|FG005|STARTED|Washout Between Periods 2 and 3||2
3191734|NCT02059434|3919737|FG006|STARTED|Washout Between Periods 2 and 3||2
3191735|NCT02059434|3919738|FG007|STARTED|Washout Between Periods 2 and 3||2
3191736|NCT02059434|3919739|FG008|STARTED|Washout Between Periods 2 and 3|Part 2 followed Part 1, and comprised 5 treatment periods|0
3191737|NCT02059434|3919731|FG000|COMPLETED|Washout Between Periods 2 and 3||2
3191738|NCT02059434|3919732|FG001|COMPLETED|Washout Between Periods 2 and 3||2
3191739|NCT02059434|3919733|FG002|COMPLETED|Washout Between Periods 2 and 3||2
3191740|NCT02059434|3919734|FG003|COMPLETED|Washout Between Periods 2 and 3||2
3191741|NCT02059434|3919735|FG004|COMPLETED|Washout Between Periods 2 and 3||2
3191742|NCT02059434|3919736|FG005|COMPLETED|Washout Between Periods 2 and 3||2
3191743|NCT02059434|3919737|FG006|COMPLETED|Washout Between Periods 2 and 3||2
3191744|NCT02059434|3919738|FG007|COMPLETED|Washout Between Periods 2 and 3||2
3191745|NCT02059434|3919739|FG008|COMPLETED|Washout Between Periods 2 and 3|Part 2 followed Part 1, and comprised 5 treatment periods|0
3191746|NCT02059434|3919731|FG000|NOT COMPLETED|Washout Between Periods 2 and 3||0
3191747|NCT02059434|3919732|FG001|NOT COMPLETED|Washout Between Periods 2 and 3||0
3191748|NCT02059434|3919733|FG002|NOT COMPLETED|Washout Between Periods 2 and 3||0
3191749|NCT02059434|3919734|FG003|NOT COMPLETED|Washout Between Periods 2 and 3||0
3191750|NCT02059434|3919735|FG004|NOT COMPLETED|Washout Between Periods 2 and 3||0
3191751|NCT02059434|3919736|FG005|NOT COMPLETED|Washout Between Periods 2 and 3||0
3191752|NCT02059434|3919737|FG006|NOT COMPLETED|Washout Between Periods 2 and 3||0
3191753|NCT02059434|3919738|FG007|NOT COMPLETED|Washout Between Periods 2 and 3||0
3191754|NCT02059434|3919739|FG008|NOT COMPLETED|Washout Between Periods 2 and 3||0
3191755|NCT02059434|3919731|FG000|STARTED|Period 3||2
3191756|NCT02059434|3919732|FG001|STARTED|Period 3||2
3191757|NCT02059434|3919733|FG002|STARTED|Period 3||2
3191758|NCT02059434|3919734|FG003|STARTED|Period 3||2
3191759|NCT02059434|3919735|FG004|STARTED|Period 3||2
3191760|NCT02059434|3919736|FG005|STARTED|Period 3||2
3191761|NCT02059434|3919737|FG006|STARTED|Period 3||2
3191762|NCT02059434|3919738|FG007|STARTED|Period 3||2
3191763|NCT02059434|3919739|FG008|STARTED|Period 3|Part 2 followed Part 1, and comprised 5 treatment periods|0
3191764|NCT02059434|3919731|FG000|COMPLETED|Period 3||2
3191765|NCT02059434|3919732|FG001|COMPLETED|Period 3||2
3191766|NCT02059434|3919733|FG002|COMPLETED|Period 3||2
3191767|NCT02059434|3919734|FG003|COMPLETED|Period 3||2
3191768|NCT02059434|3919735|FG004|COMPLETED|Period 3||2
3191769|NCT02059434|3919736|FG005|COMPLETED|Period 3||2
3191770|NCT02059434|3919737|FG006|COMPLETED|Period 3||2
3191771|NCT02059434|3919738|FG007|COMPLETED|Period 3||2
3191772|NCT02059434|3919739|FG008|COMPLETED|Period 3|Part 2 followed Part 1, and comprised 5 treatment periods|0
3191773|NCT02059434|3919731|FG000|NOT COMPLETED|Period 3||0
3191774|NCT02059434|3919732|FG001|NOT COMPLETED|Period 3||0
3191775|NCT02059434|3919733|FG002|NOT COMPLETED|Period 3||0
3191776|NCT02059434|3919734|FG003|NOT COMPLETED|Period 3||0
3191777|NCT02059434|3919735|FG004|NOT COMPLETED|Period 3||0
3191778|NCT02059434|3919736|FG005|NOT COMPLETED|Period 3||0
3191779|NCT02059434|3919737|FG006|NOT COMPLETED|Period 3||0
3191780|NCT02059434|3919738|FG007|NOT COMPLETED|Period 3||0
3191781|NCT02059434|3919739|FG008|NOT COMPLETED|Period 3||0
3191782|NCT02059434|3919731|FG000|STARTED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
3191783|NCT02059434|3919732|FG001|STARTED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
3191784|NCT02059434|3919733|FG002|STARTED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
3191785|NCT02059434|3919734|FG003|STARTED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
3191786|NCT02059434|3919735|FG004|STARTED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
3191787|NCT02059434|3919736|FG005|STARTED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
3191788|NCT02059434|3919737|FG006|STARTED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
3191789|NCT02059434|3919738|FG007|STARTED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
3191790|NCT02059434|3919739|FG008|STARTED|Period 4 (After Screening/run-in Period)||38
3191791|NCT02059434|3919731|FG000|COMPLETED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
3191792|NCT02059434|3919732|FG001|COMPLETED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
3191793|NCT02059434|3919733|FG002|COMPLETED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
3191794|NCT02059434|3919734|FG003|COMPLETED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
3191795|NCT02059434|3919735|FG004|COMPLETED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
3191796|NCT02059434|3919736|FG005|COMPLETED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
3191797|NCT02059434|3919737|FG006|COMPLETED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
3191798|NCT02059434|3919738|FG007|COMPLETED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
3191799|NCT02059434|3919739|FG008|COMPLETED|Period 4 (After Screening/run-in Period)||38
3191800|NCT02059434|3919731|FG000|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
3191801|NCT02059434|3919732|FG001|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
3191802|NCT02059434|3919733|FG002|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
3191803|NCT02059434|3919734|FG003|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
3191804|NCT02059434|3919735|FG004|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
3191805|NCT02059434|3919736|FG005|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
3191806|NCT02059434|3919737|FG006|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
3191807|NCT02059434|3919738|FG007|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
3191808|NCT02059434|3919739|FG008|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
3191809|NCT02059434|3919731|FG000|STARTED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
3191810|NCT02059434|3919732|FG001|STARTED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
3191811|NCT02059434|3919733|FG002|STARTED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
3191812|NCT02059434|3919734|FG003|STARTED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
3191813|NCT02059434|3919735|FG004|STARTED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
3191814|NCT02059434|3919736|FG005|STARTED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
3191815|NCT02059434|3919737|FG006|STARTED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
3191816|NCT02059434|3919738|FG007|STARTED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
3191817|NCT02059434|3919739|FG008|STARTED|Washout Between Periods 4 and 5||38
3191818|NCT02059434|3919731|FG000|COMPLETED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
3191819|NCT02059434|3919732|FG001|COMPLETED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
3191820|NCT02059434|3919733|FG002|COMPLETED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
3191821|NCT02059434|3919734|FG003|COMPLETED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
3191822|NCT02059434|3919735|FG004|COMPLETED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
3191823|NCT02059434|3919736|FG005|COMPLETED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
3191824|NCT02059434|3919737|FG006|COMPLETED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
3191825|NCT02059434|3919738|FG007|COMPLETED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
3191826|NCT02059434|3919739|FG008|COMPLETED|Washout Between Periods 4 and 5||37
3191827|NCT02059434|3919731|FG000|NOT COMPLETED|Washout Between Periods 4 and 5||0
3191828|NCT02059434|3919732|FG001|NOT COMPLETED|Washout Between Periods 4 and 5||0
3191829|NCT02059434|3919733|FG002|NOT COMPLETED|Washout Between Periods 4 and 5||0
3191830|NCT02059434|3919734|FG003|NOT COMPLETED|Washout Between Periods 4 and 5||0
3191831|NCT02059434|3919735|FG004|NOT COMPLETED|Washout Between Periods 4 and 5||0
3191832|NCT02059434|3919736|FG005|NOT COMPLETED|Washout Between Periods 4 and 5||0
3191833|NCT02059434|3919737|FG006|NOT COMPLETED|Washout Between Periods 4 and 5||0
3191834|NCT02059434|3919738|FG007|NOT COMPLETED|Washout Between Periods 4 and 5||0
3191835|NCT02059434|3919739|FG008|NOT COMPLETED|Washout Between Periods 4 and 5||1
3191836|NCT02059434|3919731|FG000|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
3191837|NCT02059434|3919732|FG001|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
3191838|NCT02059434|3919733|FG002|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
3191839|NCT02059434|3919734|FG003|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
3364307|NCT04027439|4095513|FG012|COMPLETED|Part A (R, PC, PG) Single Dose||0
3191840|NCT02059434|3919735|FG004|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
3191841|NCT02059434|3919736|FG005|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
3191842|NCT02059434|3919737|FG006|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
3191843|NCT02059434|3919738|FG007|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
3191844|NCT02059434|3919739|FG008|STARTED|Period 5||37
3191845|NCT02059434|3919731|FG000|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
3191846|NCT02059434|3919732|FG001|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
3191847|NCT02059434|3919733|FG002|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
3191848|NCT02059434|3919734|FG003|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
3191849|NCT02059434|3919735|FG004|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
3191850|NCT02059434|3919736|FG005|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
3191851|NCT02059434|3919737|FG006|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
3191852|NCT02059434|3919738|FG007|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
3191853|NCT02059434|3919739|FG008|COMPLETED|Period 5||37
3191854|NCT02059434|3919731|FG000|NOT COMPLETED|Period 5||0
3191855|NCT02059434|3919732|FG001|NOT COMPLETED|Period 5||0
3191856|NCT02059434|3919733|FG002|NOT COMPLETED|Period 5||0
3191857|NCT02059434|3919734|FG003|NOT COMPLETED|Period 5||0
3191858|NCT02059434|3919735|FG004|NOT COMPLETED|Period 5||0
3191859|NCT02059434|3919736|FG005|NOT COMPLETED|Period 5||0
3191860|NCT02059434|3919737|FG006|NOT COMPLETED|Period 5||0
3191861|NCT02059434|3919738|FG007|NOT COMPLETED|Period 5||0
3191862|NCT02059434|3919739|FG008|NOT COMPLETED|Period 5||0
3191863|NCT02059434|3919731|FG000|STARTED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
3191864|NCT02059434|3919732|FG001|STARTED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
3191865|NCT02059434|3919733|FG002|STARTED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
3191866|NCT02059434|3919734|FG003|STARTED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
3191867|NCT02059434|3919735|FG004|STARTED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
3191868|NCT02059434|3919736|FG005|STARTED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
3191869|NCT02059434|3919737|FG006|STARTED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
3191870|NCT02059434|3919738|FG007|STARTED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
3191871|NCT02059434|3919739|FG008|STARTED|Washout Between Periods 5 and 6||37
3191872|NCT02059434|3919731|FG000|COMPLETED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
3191873|NCT02059434|3919732|FG001|COMPLETED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
3191874|NCT02059434|3919733|FG002|COMPLETED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
3191875|NCT02059434|3919734|FG003|COMPLETED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
3191876|NCT02059434|3919735|FG004|COMPLETED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
3191877|NCT02059434|3919736|FG005|COMPLETED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
3191878|NCT02059434|3919737|FG006|COMPLETED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
3191879|NCT02059434|3919738|FG007|COMPLETED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
3191880|NCT02059434|3919739|FG008|COMPLETED|Washout Between Periods 5 and 6||37
3191881|NCT02059434|3919731|FG000|NOT COMPLETED|Washout Between Periods 5 and 6||0
3191882|NCT02059434|3919732|FG001|NOT COMPLETED|Washout Between Periods 5 and 6||0
3191883|NCT02059434|3919733|FG002|NOT COMPLETED|Washout Between Periods 5 and 6||0
3191884|NCT02059434|3919734|FG003|NOT COMPLETED|Washout Between Periods 5 and 6||0
3191885|NCT02059434|3919735|FG004|NOT COMPLETED|Washout Between Periods 5 and 6||0
3191886|NCT02059434|3919736|FG005|NOT COMPLETED|Washout Between Periods 5 and 6||0
3191887|NCT02059434|3919737|FG006|NOT COMPLETED|Washout Between Periods 5 and 6||0
3191888|NCT02059434|3919738|FG007|NOT COMPLETED|Washout Between Periods 5 and 6||0
3191889|NCT02059434|3919739|FG008|NOT COMPLETED|Washout Between Periods 5 and 6||0
3191890|NCT02059434|3919731|FG000|STARTED|Period 6|Part 1 comprised 3 treatment periods only|0
3191891|NCT02059434|3919732|FG001|STARTED|Period 6|Part 1 comprised 3 treatment periods only|0
3191892|NCT02059434|3919733|FG002|STARTED|Period 6|Part 1 comprised 3 treatment periods only|0
3191893|NCT02059434|3919734|FG003|STARTED|Period 6|Part 1 comprised 3 treatment periods only|0
3191894|NCT02059434|3919735|FG004|STARTED|Period 6|Part 1 comprised 3 treatment periods only|0
3191895|NCT02059434|3919736|FG005|STARTED|Period 6|Part 1 comprised 3 treatment periods only|0
3191896|NCT02059434|3919737|FG006|STARTED|Period 6|Part 1 comprised 3 treatment periods only|0
3191897|NCT02059434|3919738|FG007|STARTED|Period 6|Part 1 comprised 3 treatment periods only|0
3191898|NCT02059434|3919739|FG008|STARTED|Period 6||37
3191899|NCT02059434|3919731|FG000|COMPLETED|Period 6|Part 1 comprised 3 treatment periods only|0
3191900|NCT02059434|3919732|FG001|COMPLETED|Period 6|Part 1 comprised 3 treatment periods only|0
3191901|NCT02059434|3919733|FG002|COMPLETED|Period 6|Part 1 comprised 3 treatment periods only|0
3191902|NCT02059434|3919734|FG003|COMPLETED|Period 6|Part 1 comprised 3 treatment periods only|0
3191903|NCT02059434|3919735|FG004|COMPLETED|Period 6|Part 1 comprised 3 treatment periods only|0
3191904|NCT02059434|3919736|FG005|COMPLETED|Period 6|Part 1 comprised 3 treatment periods only|0
3191905|NCT02059434|3919737|FG006|COMPLETED|Period 6|Part 1 comprised 3 treatment periods only|0
3191906|NCT02059434|3919738|FG007|COMPLETED|Period 6|Part 1 comprised 3 treatment periods only|0
3191907|NCT02059434|3919739|FG008|COMPLETED|Period 6||37
3191908|NCT02059434|3919731|FG000|NOT COMPLETED|Period 6||0
3191909|NCT02059434|3919732|FG001|NOT COMPLETED|Period 6||0
3191910|NCT02059434|3919733|FG002|NOT COMPLETED|Period 6||0
3191911|NCT02059434|3919734|FG003|NOT COMPLETED|Period 6||0
3191912|NCT02059434|3919735|FG004|NOT COMPLETED|Period 6||0
3191913|NCT02059434|3919736|FG005|NOT COMPLETED|Period 6||0
3191914|NCT02059434|3919737|FG006|NOT COMPLETED|Period 6||0
3191915|NCT02059434|3919738|FG007|NOT COMPLETED|Period 6||0
3191916|NCT02059434|3919739|FG008|NOT COMPLETED|Period 6||0
3191917|NCT02059434|3919731|FG000|STARTED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
3191918|NCT02059434|3919732|FG001|STARTED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
3191919|NCT02059434|3919733|FG002|STARTED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
3191920|NCT02059434|3919734|FG003|STARTED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
3191921|NCT02059434|3919735|FG004|STARTED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
3191922|NCT02059434|3919736|FG005|STARTED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
3191923|NCT02059434|3919737|FG006|STARTED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
3191924|NCT02059434|3919738|FG007|STARTED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
3191925|NCT02059434|3919739|FG008|STARTED|Washout Between Periods 6 and 7||37
3191926|NCT02059434|3919731|FG000|COMPLETED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
3191927|NCT02059434|3919732|FG001|COMPLETED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
3191928|NCT02059434|3919733|FG002|COMPLETED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
3191929|NCT02059434|3919734|FG003|COMPLETED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
3191930|NCT02059434|3919735|FG004|COMPLETED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
3191931|NCT02059434|3919736|FG005|COMPLETED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
3191932|NCT02059434|3919737|FG006|COMPLETED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
3191933|NCT02059434|3919738|FG007|COMPLETED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
3191934|NCT02059434|3919739|FG008|COMPLETED|Washout Between Periods 6 and 7||36
3191935|NCT02059434|3919731|FG000|NOT COMPLETED|Washout Between Periods 6 and 7||0
3191936|NCT02059434|3919732|FG001|NOT COMPLETED|Washout Between Periods 6 and 7||0
3191937|NCT02059434|3919733|FG002|NOT COMPLETED|Washout Between Periods 6 and 7||0
3191938|NCT02059434|3919734|FG003|NOT COMPLETED|Washout Between Periods 6 and 7||0
3191939|NCT02059434|3919735|FG004|NOT COMPLETED|Washout Between Periods 6 and 7||0
3191940|NCT02059434|3919736|FG005|NOT COMPLETED|Washout Between Periods 6 and 7||0
3191941|NCT02059434|3919737|FG006|NOT COMPLETED|Washout Between Periods 6 and 7||0
3191942|NCT02059434|3919738|FG007|NOT COMPLETED|Washout Between Periods 6 and 7||0
3191943|NCT02059434|3919739|FG008|NOT COMPLETED|Washout Between Periods 6 and 7||1
3191944|NCT02059434|3919731|FG000|STARTED|Period 7|Part 1 comprised 3 treatment periods only|0
3191945|NCT02059434|3919732|FG001|STARTED|Period 7|Part 1 comprised 3 treatment periods only|0
3191946|NCT02059434|3919733|FG002|STARTED|Period 7|Part 1 comprised 3 treatment periods only|0
3191947|NCT02059434|3919734|FG003|STARTED|Period 7|Part 1 comprised 3 treatment periods only|0
3191948|NCT02059434|3919735|FG004|STARTED|Period 7|Part 1 comprised 3 treatment periods only|0
3191949|NCT02059434|3919736|FG005|STARTED|Period 7|Part 1 comprised 3 treatment periods only|0
3191950|NCT02059434|3919737|FG006|STARTED|Period 7|Part 1 comprised 3 treatment periods only|0
3191951|NCT02059434|3919738|FG007|STARTED|Period 7|Part 1 comprised 3 treatment periods only|0
3191952|NCT02059434|3919739|FG008|STARTED|Period 7||36
3191953|NCT02059434|3919731|FG000|COMPLETED|Period 7|Part 1 comprised 3 treatment periods only|0
3191954|NCT02059434|3919732|FG001|COMPLETED|Period 7|Part 1 comprised 3 treatment periods only|0
3191955|NCT02059434|3919733|FG002|COMPLETED|Period 7|Part 1 comprised 3 treatment periods only|0
3191956|NCT02059434|3919734|FG003|COMPLETED|Period 7|Part 1 comprised 3 treatment periods only|0
3191957|NCT02059434|3919735|FG004|COMPLETED|Period 7|Part 1 comprised 3 treatment periods only|0
3191958|NCT02059434|3919736|FG005|COMPLETED|Period 7|Part 1 comprised 3 treatment periods only|0
3191959|NCT02059434|3919737|FG006|COMPLETED|Period 7|Part 1 comprised 3 treatment periods only|0
3191960|NCT02059434|3919738|FG007|COMPLETED|Period 7|Part 1 comprised 3 treatment periods only|0
3191961|NCT02059434|3919739|FG008|COMPLETED|Period 7||36
3191962|NCT02059434|3919731|FG000|NOT COMPLETED|Period 7||0
3191963|NCT02059434|3919732|FG001|NOT COMPLETED|Period 7||0
3191964|NCT02059434|3919733|FG002|NOT COMPLETED|Period 7||0
3191965|NCT02059434|3919734|FG003|NOT COMPLETED|Period 7||0
3191966|NCT02059434|3919735|FG004|NOT COMPLETED|Period 7||0
3191967|NCT02059434|3919736|FG005|NOT COMPLETED|Period 7||0
3191968|NCT02059434|3919737|FG006|NOT COMPLETED|Period 7||0
3191969|NCT02059434|3919738|FG007|NOT COMPLETED|Period 7||0
3191970|NCT02059434|3919739|FG008|NOT COMPLETED|Period 7||0
3191971|NCT02059434|3919731|FG000|STARTED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
3191972|NCT02059434|3919732|FG001|STARTED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
3191973|NCT02059434|3919733|FG002|STARTED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
3191974|NCT02059434|3919734|FG003|STARTED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
3191975|NCT02059434|3919735|FG004|STARTED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
3191976|NCT02059434|3919736|FG005|STARTED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
3191977|NCT02059434|3919737|FG006|STARTED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
3191978|NCT02059434|3919738|FG007|STARTED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
3191979|NCT02059434|3919739|FG008|STARTED|Washout Between Periods 7 and 8||36
3191980|NCT02059434|3919731|FG000|COMPLETED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
3191981|NCT02059434|3919732|FG001|COMPLETED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
3191982|NCT02059434|3919733|FG002|COMPLETED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
3191983|NCT02059434|3919734|FG003|COMPLETED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
3191984|NCT02059434|3919735|FG004|COMPLETED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
3191985|NCT02059434|3919736|FG005|COMPLETED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
3191986|NCT02059434|3919737|FG006|COMPLETED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
3191987|NCT02059434|3919738|FG007|COMPLETED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
3191988|NCT02059434|3919739|FG008|COMPLETED|Washout Between Periods 7 and 8||34
3191989|NCT02059434|3919731|FG000|NOT COMPLETED|Washout Between Periods 7 and 8||0
3191990|NCT02059434|3919732|FG001|NOT COMPLETED|Washout Between Periods 7 and 8||0
3191991|NCT02059434|3919733|FG002|NOT COMPLETED|Washout Between Periods 7 and 8||0
3191992|NCT02059434|3919734|FG003|NOT COMPLETED|Washout Between Periods 7 and 8||0
3191993|NCT02059434|3919735|FG004|NOT COMPLETED|Washout Between Periods 7 and 8||0
3191994|NCT02059434|3919736|FG005|NOT COMPLETED|Washout Between Periods 7 and 8||0
3191995|NCT02059434|3919737|FG006|NOT COMPLETED|Washout Between Periods 7 and 8||0
3191996|NCT02059434|3919738|FG007|NOT COMPLETED|Washout Between Periods 7 and 8||0
3191997|NCT02059434|3919739|FG008|NOT COMPLETED|Washout Between Periods 7 and 8||2
3191998|NCT02059434|3919731|FG000|STARTED|Period 8|Part 1 comprised 3 treatment periods only|0
3191999|NCT02059434|3919732|FG001|STARTED|Period 8|Part 1 comprised 3 treatment periods only|0
3192000|NCT02059434|3919733|FG002|STARTED|Period 8|Part 1 comprised 3 treatment periods only|0
3192001|NCT02059434|3919734|FG003|STARTED|Period 8|Part 1 comprised 3 treatment periods only|0
3192002|NCT02059434|3919735|FG004|STARTED|Period 8|Part 1 comprised 3 treatment periods only|0
3192003|NCT02059434|3919736|FG005|STARTED|Period 8|Part 1 comprised 3 treatment periods only|0
3192004|NCT02059434|3919737|FG006|STARTED|Period 8|Part 1 comprised 3 treatment periods only|0
3192005|NCT02059434|3919738|FG007|STARTED|Period 8|Part 1 comprised 3 treatment periods only|0
3192006|NCT02059434|3919739|FG008|STARTED|Period 8||34
3192007|NCT02059434|3919731|FG000|COMPLETED|Period 8|Part 1 comprised 3 treatment periods only|0
3192008|NCT02059434|3919732|FG001|COMPLETED|Period 8|Part 1 comprised 3 treatment periods only|0
3192009|NCT02059434|3919733|FG002|COMPLETED|Period 8|Part 1 comprised 3 treatment periods only|0
3192010|NCT02059434|3919734|FG003|COMPLETED|Period 8|Part 1 comprised 3 treatment periods only|0
3192011|NCT02059434|3919735|FG004|COMPLETED|Period 8|Part 1 comprised 3 treatment periods only|0
3192012|NCT02059434|3919736|FG005|COMPLETED|Period 8|Part 1 comprised 3 treatment periods only|0
3192013|NCT02059434|3919737|FG006|COMPLETED|Period 8|Part 1 comprised 3 treatment periods only|0
3192014|NCT02059434|3919738|FG007|COMPLETED|Period 8|Part 1 comprised 3 treatment periods only|0
3192015|NCT02059434|3919739|FG008|COMPLETED|Period 8||34
3192016|NCT02059434|3919731|FG000|NOT COMPLETED|Period 8||0
3192017|NCT02059434|3919732|FG001|NOT COMPLETED|Period 8||0
3192018|NCT02059434|3919733|FG002|NOT COMPLETED|Period 8||0
3192019|NCT02059434|3919734|FG003|NOT COMPLETED|Period 8||0
3192020|NCT02059434|3919735|FG004|NOT COMPLETED|Period 8||0
3192021|NCT02059434|3919736|FG005|NOT COMPLETED|Period 8||0
3192022|NCT02059434|3919737|FG006|NOT COMPLETED|Period 8||0
3192023|NCT02059434|3919738|FG007|NOT COMPLETED|Period 8||0
3192024|NCT02059434|3919739|FG008|NOT COMPLETED|Period 8||0
3192025|NCT02059512|3919770|FG000|STARTED|Overall Study||46
3192026|NCT02059512|3919771|FG001|STARTED|Overall Study||34
3192027|NCT02059512|3919772|FG002|STARTED|Overall Study||37
3192028|NCT02059512|3919770|FG000|COMPLETED|Overall Study||37
3192029|NCT02059512|3919771|FG001|COMPLETED|Overall Study||25
3192030|NCT02059512|3919772|FG002|COMPLETED|Overall Study||23
3192031|NCT02059512|3919770|FG000|NOT COMPLETED|Overall Study||9
3192032|NCT02059512|3919771|FG001|NOT COMPLETED|Overall Study||9
3192033|NCT02059512|3919772|FG002|NOT COMPLETED|Overall Study||14
3192034|NCT02059642|3919798|FG000|STARTED|Overall Study||148
3192035|NCT02059642|3919799|FG001|STARTED|Overall Study||152
3192036|NCT02059642|3919798|FG000|COMPLETED|Overall Study||121
3192037|NCT02059642|3919799|FG001|COMPLETED|Overall Study||128
3192038|NCT02059642|3919798|FG000|NOT COMPLETED|Overall Study||27
3192039|NCT02059642|3919799|FG001|NOT COMPLETED|Overall Study||24
3192040|NCT02059902|3919807|FG000|STARTED|Overall Study||18
3192041|NCT02059902|3919808|FG001|STARTED|Overall Study||18
3192042|NCT02059902|3919807|FG000|COMPLETED|Overall Study||14
3192043|NCT02059902|3919808|FG001|COMPLETED|Overall Study||14
3192044|NCT02059902|3919807|FG000|NOT COMPLETED|Overall Study||4
3192045|NCT02059902|3919808|FG001|NOT COMPLETED|Overall Study||4
3192046|NCT02059928|3919814|FG000|STARTED|Overall Study||20
3192047|NCT02059928|3919814|FG000|COMPLETED|Overall Study||20
3192048|NCT02059928|3919814|FG000|NOT COMPLETED|Overall Study||0
3192049|NCT02059980|3919820|FG000|STARTED|Overall Study||18
3192050|NCT02059980|3919821|FG001|STARTED|Overall Study||15
3192051|NCT02059980|3919820|FG000|COMPLETED|Overall Study||16
3192052|NCT02059980|3919821|FG001|COMPLETED|Overall Study||14
3192053|NCT02059980|3919820|FG000|NOT COMPLETED|Overall Study||2
3192054|NCT02059980|3919821|FG001|NOT COMPLETED|Overall Study||1
3192055|NCT02059993|3919829|FG000|STARTED|Overall Study||42
3192056|NCT02059993|3919830|FG001|STARTED|Overall Study||41
3192057|NCT02059993|3919829|FG000|COMPLETED|Overall Study||40
3192058|NCT02059993|3919830|FG001|COMPLETED|Overall Study||37
3192059|NCT02059993|3919829|FG000|NOT COMPLETED|Overall Study||2
3192060|NCT02059993|3919830|FG001|NOT COMPLETED|Overall Study||4
3192061|NCT02060058|3919839|FG000|STARTED|Overall Study||4
3192062|NCT02060058|3919840|FG001|STARTED|Overall Study||0
3192063|NCT02060058|3919841|FG002|STARTED|Overall Study||8
3192064|NCT02060058|3919839|FG000|COMPLETED|Overall Study||4
3192065|NCT02060058|3919840|FG001|COMPLETED|Overall Study||0
3192066|NCT02060058|3919841|FG002|COMPLETED|Overall Study||8
3192067|NCT02060058|3919839|FG000|NOT COMPLETED|Overall Study||0
3192068|NCT02060058|3919840|FG001|NOT COMPLETED|Overall Study||0
3192069|NCT02060058|3919841|FG002|NOT COMPLETED|Overall Study||0
3192070|NCT02060370|3919850|FG000|STARTED|Overall Study||60
3192071|NCT02060370|3919850|FG000|COMPLETED|Overall Study||59
3192072|NCT02060370|3919850|FG000|NOT COMPLETED|Overall Study||1
3192073|NCT02060383|3919859|FG000|STARTED|Core Phase||38
3192074|NCT02060383|3919860|FG001|STARTED|Core Phase||43
3192075|NCT02060383|3919861|FG002|STARTED|Core Phase||19
3192076|NCT02060383|3919862|FG003|STARTED|Core Phase||46
3192077|NCT02060383|3919863|FG004|STARTED|Core Phase||103
3192078|NCT02060383|3919859|FG000|Completed Core/Entered Extension|Core Phase||17
3192079|NCT02060383|3919860|FG001|Completed Core/Entered Extension|Core Phase||17
3192080|NCT02060383|3919861|FG002|Completed Core/Entered Extension|Core Phase||10
3192081|NCT02060383|3919862|FG003|Completed Core/Entered Extension|Core Phase||21
3192082|NCT02060383|3919863|FG004|Completed Core/Entered Extension|Core Phase||53
3192083|NCT02060383|3919859|FG000|Completed Core/Did Not Enter Extension|Core Phase||18
3192084|NCT02060383|3919860|FG001|Completed Core/Did Not Enter Extension|Core Phase||20
3192085|NCT02060383|3919861|FG002|Completed Core/Did Not Enter Extension|Core Phase||9
3192086|NCT02060383|3919862|FG003|Completed Core/Did Not Enter Extension|Core Phase||18
3192087|NCT02060383|3919863|FG004|Completed Core/Did Not Enter Extension|Core Phase||42
3192088|NCT02060383|3919859|FG000|COMPLETED|Core Phase||35
3192089|NCT02060383|3919860|FG001|COMPLETED|Core Phase||37
3192090|NCT02060383|3919861|FG002|COMPLETED|Core Phase||19
3192091|NCT02060383|3919862|FG003|COMPLETED|Core Phase||39
3192092|NCT02060383|3919863|FG004|COMPLETED|Core Phase||95
3192093|NCT02060383|3919859|FG000|NOT COMPLETED|Core Phase||3
3192094|NCT02060383|3919860|FG001|NOT COMPLETED|Core Phase||6
3192095|NCT02060383|3919861|FG002|NOT COMPLETED|Core Phase||0
3192096|NCT02060383|3919862|FG003|NOT COMPLETED|Core Phase||7
3192097|NCT02060383|3919863|FG004|NOT COMPLETED|Core Phase||8
3192098|NCT02060383|3919859|FG000|STARTED|Extension Phase||17
3192099|NCT02060383|3919860|FG001|STARTED|Extension Phase||17
3192100|NCT02060383|3919861|FG002|STARTED|Extension Phase||10
3192101|NCT02060383|3919862|FG003|STARTED|Extension Phase||21
3192102|NCT02060383|3919863|FG004|STARTED|Extension Phase||53
3192103|NCT02060383|3919859|FG000|COMPLETED|Extension Phase||14
3192104|NCT02060383|3919860|FG001|COMPLETED|Extension Phase||14
3192105|NCT02060383|3919861|FG002|COMPLETED|Extension Phase||7
3192106|NCT02060383|3919862|FG003|COMPLETED|Extension Phase||19
3192107|NCT02060383|3919863|FG004|COMPLETED|Extension Phase||46
3192108|NCT02060383|3919859|FG000|NOT COMPLETED|Extension Phase||3
3192109|NCT02060383|3919860|FG001|NOT COMPLETED|Extension Phase||3
3192110|NCT02060383|3919861|FG002|NOT COMPLETED|Extension Phase||3
3192111|NCT02060383|3919862|FG003|NOT COMPLETED|Extension Phase||2
3192112|NCT02060383|3919863|FG004|NOT COMPLETED|Extension Phase||7
3192113|NCT02060461|3919875|FG000|STARTED|Overall Study||33
3192114|NCT02060461|3919875|FG000|COMPLETED|Overall Study||33
3192115|NCT02060461|3919875|FG000|NOT COMPLETED|Overall Study||0
3192116|NCT02060526|3919884|FG000|STARTED|Overall Study||7
3192117|NCT02060526|3919885|FG001|STARTED|Overall Study||7
3192118|NCT02060526|3919886|FG002|STARTED|Overall Study||7
3192119|NCT02060526|3919884|FG000|COMPLETED|Overall Study||7
3192120|NCT02060526|3919885|FG001|COMPLETED|Overall Study||7
3192121|NCT02060526|3919886|FG002|COMPLETED|Overall Study||7
3192122|NCT02060526|3919884|FG000|NOT COMPLETED|Overall Study||0
3192123|NCT02060526|3919885|FG001|NOT COMPLETED|Overall Study||0
3192124|NCT02060526|3919886|FG002|NOT COMPLETED|Overall Study||0
3192125|NCT02060539|3919896|FG000|STARTED|Overall Study||19
3192126|NCT02060539|3919896|FG000|COMPLETED|Overall Study||19
3192127|NCT02060539|3919896|FG000|NOT COMPLETED|Overall Study||0
3192128|NCT02060838|3919902|FG000|STARTED|Overall Study||28
3192129|NCT02060838|3919903|FG001|STARTED|Overall Study||22
3192130|NCT02060838|3919902|FG000|COMPLETED|Overall Study||28
3192131|NCT02060838|3919903|FG001|COMPLETED|Overall Study||22
3192132|NCT02060838|3919902|FG000|NOT COMPLETED|Overall Study||0
3192133|NCT02060838|3919903|FG001|NOT COMPLETED|Overall Study||0
3192134|NCT02060890|3919909|FG000|STARTED|Overall Study||20
3192135|NCT02060890|3919909|FG000|COMPLETED|Overall Study||16
3192136|NCT02060890|3919909|FG000|NOT COMPLETED|Overall Study||4
3192137|NCT02060903|3919916|FG000|STARTED|Overall Study||187
3192138|NCT02060903|3919917|FG001|STARTED|Overall Study||192
3192139|NCT02060903|3919916|FG000|COMPLETED|Overall Study||183
3192140|NCT02060903|3919917|FG001|COMPLETED|Overall Study||185
3192141|NCT02060903|3919916|FG000|NOT COMPLETED|Overall Study||4
3192142|NCT02060903|3919917|FG001|NOT COMPLETED|Overall Study||7
3192143|NCT02061202|3919925|FG000|STARTED|Overall Study||36
3192144|NCT02061202|3919926|FG001|STARTED|Overall Study||18
3192145|NCT02061202|3919925|FG000|COMPLETED|Overall Study||35
3192146|NCT02061202|3919926|FG001|COMPLETED|Overall Study||17
3192147|NCT02061202|3919925|FG000|NOT COMPLETED|Overall Study||1
3192148|NCT02061202|3919926|FG001|NOT COMPLETED|Overall Study||1
3192149|NCT02061280|3919934|FG000|STARTED|Overall Study||71
3192150|NCT02061280|3919935|FG001|STARTED|Overall Study||37
3192151|NCT02061280|3919934|FG000|Randomized to Treatment|Overall Study||54
3192152|NCT02061280|3919935|FG001|Randomized to Treatment|Overall Study||25
3192153|NCT02061280|3919934|FG000|COMPLETED|Overall Study||53
3192154|NCT02061280|3919935|FG001|COMPLETED|Overall Study||25
3192155|NCT02061280|3919934|FG000|NOT COMPLETED|Overall Study||18
3192156|NCT02061280|3919935|FG001|NOT COMPLETED|Overall Study||12
3192157|NCT02061358|3919953|FG000|STARTED|Overall Study||6
3192158|NCT02061358|3919954|FG001|STARTED|Overall Study||6
3192159|NCT02061358|3919955|FG002|STARTED|Overall Study||6
3192160|NCT02061358|3919956|FG003|STARTED|Overall Study||6
3192161|NCT02061358|3919957|FG004|STARTED|Overall Study||6
3192162|NCT02061358|3919958|FG005|STARTED|Overall Study||6
3192163|NCT02061358|3919959|FG006|STARTED|Overall Study||6
3192164|NCT02061358|3919960|FG007|STARTED|Overall Study||6
3192165|NCT02061358|3919961|FG008|STARTED|Overall Study||16
3192166|NCT02061358|3919953|FG000|COMPLETED|Overall Study||6
3192167|NCT02061358|3919954|FG001|COMPLETED|Overall Study||6
3192168|NCT02061358|3919955|FG002|COMPLETED|Overall Study||6
3192169|NCT02061358|3919956|FG003|COMPLETED|Overall Study||6
3192170|NCT02061358|3919957|FG004|COMPLETED|Overall Study||6
3192171|NCT02061358|3919958|FG005|COMPLETED|Overall Study||6
3192172|NCT02061358|3919959|FG006|COMPLETED|Overall Study||6
3192173|NCT02061358|3919960|FG007|COMPLETED|Overall Study||6
3192174|NCT02061358|3919961|FG008|COMPLETED|Overall Study||16
3192175|NCT02061358|3919953|FG000|NOT COMPLETED|Overall Study||0
3192176|NCT02061358|3919954|FG001|NOT COMPLETED|Overall Study||0
3192177|NCT02061358|3919955|FG002|NOT COMPLETED|Overall Study||0
3192178|NCT02061358|3919956|FG003|NOT COMPLETED|Overall Study||0
3192179|NCT02061358|3919957|FG004|NOT COMPLETED|Overall Study||0
3192180|NCT02061358|3919958|FG005|NOT COMPLETED|Overall Study||0
3192181|NCT02061358|3919959|FG006|NOT COMPLETED|Overall Study||0
3192182|NCT02061358|3919960|FG007|NOT COMPLETED|Overall Study||0
3192183|NCT02061358|3919961|FG008|NOT COMPLETED|Overall Study||0
3192184|NCT02061384|3919983|FG000|STARTED|Overall Study||10
3192185|NCT02061384|3919984|FG001|STARTED|Overall Study||10
3192186|NCT02061384|3919983|FG000|COMPLETED|Overall Study||10
3192187|NCT02061384|3919984|FG001|COMPLETED|Overall Study||10
3192188|NCT02061384|3919983|FG000|NOT COMPLETED|Overall Study||0
3192189|NCT02061384|3919984|FG001|NOT COMPLETED|Overall Study||0
3192190|NCT02061397|3919990|FG000|STARTED|Simvastatin 20 mg Oral Daily for 2 Month||10
3192191|NCT02061397|3919990|FG000|COMPLETED|Simvastatin 20 mg Oral Daily for 2 Month||10
3192192|NCT02061397|3919990|FG000|NOT COMPLETED|Simvastatin 20 mg Oral Daily for 2 Month||0
3192193|NCT02061397|3919990|FG000|STARTED|Simvastatin 40 mg Oral Daily for 2 Month||10
3192194|NCT02061397|3919990|FG000|COMPLETED|Simvastatin 40 mg Oral Daily for 2 Month||10
3192195|NCT02061397|3919990|FG000|NOT COMPLETED|Simvastatin 40 mg Oral Daily for 2 Month||0
3192196|NCT02061540|3919994|FG000|STARTED|Overall Study||27
3192197|NCT02061540|3919994|FG000|Down-Titrated on LUM001 During the Study|Overall Study||5
3192198|NCT02061540|3919994|FG000|COMPLETED|Overall Study||23
3192199|NCT02061540|3919994|FG000|NOT COMPLETED|Overall Study||4
3364308|NCT04027439|4095514|FG013|COMPLETED|Part A (R, PC, PG) Single Dose||0
3364309|NCT04027439|4095515|FG014|COMPLETED|Part A (R, PC, PG) Single Dose||0
3364310|NCT04027439|4095516|FG015|COMPLETED|Part A (R, PC, PG) Single Dose||0
3364311|NCT04027439|4095501|FG000|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
3364312|NCT04027439|4095502|FG001|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
3364313|NCT04027439|4095503|FG002|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
3364314|NCT04027439|4095504|FG003|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
3364315|NCT04027439|4095505|FG004|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
3364316|NCT04027439|4095506|FG005|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
3364317|NCT04027439|4095507|FG006|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
3364318|NCT04027439|4095508|FG007|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
3364319|NCT04027439|4095509|FG008|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
3364320|NCT04027439|4095510|FG009|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
3364321|NCT04027439|4095511|FG010|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
3364322|NCT04027439|4095512|FG011|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
3364323|NCT04027439|4095513|FG012|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
3364324|NCT04027439|4095514|FG013|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
3364325|NCT04027439|4095515|FG014|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
3364326|NCT04027439|4095516|FG015|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
3364327|NCT04027439|4095501|FG000|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||0
3364328|NCT04027439|4095502|FG001|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||0
3364329|NCT04027439|4095503|FG002|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||0
3364330|NCT04027439|4095504|FG003|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||0
3364331|NCT04027439|4095505|FG004|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||0
3364332|NCT04027439|4095506|FG005|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||0
3364333|NCT04027439|4095507|FG006|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||4
3364334|NCT04027439|4095508|FG007|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||3
3192200|NCT02061592|3920005|FG000|STARTED|Period 1||66
3192201|NCT02061592|3920006|FG001|STARTED|Period 1||62
3192202|NCT02061592|3920005|FG000|COMPLETED|Period 1||64
3192203|NCT02061592|3920006|FG001|COMPLETED|Period 1||62
3192204|NCT02061592|3920005|FG000|NOT COMPLETED|Period 1||2
3192205|NCT02061592|3920006|FG001|NOT COMPLETED|Period 1||0
3192206|NCT02061592|3920005|FG000|STARTED|Period 2||64
3192207|NCT02061592|3920006|FG001|STARTED|Period 2||62
3192208|NCT02061592|3920005|FG000|COMPLETED|Period 2||64
3192209|NCT02061592|3920006|FG001|COMPLETED|Period 2||61
3192210|NCT02061592|3920005|FG000|NOT COMPLETED|Period 2||0
3192211|NCT02061592|3920006|FG001|NOT COMPLETED|Period 2||1
3192212|NCT02061683|3920014|FG000|STARTED|Overall Study||263
3192213|NCT02061683|3920014|FG000|COMPLETED|Overall Study||203
3192214|NCT02061683|3920014|FG000|NOT COMPLETED|Overall Study||60
3192215|NCT02061696|3920020|FG000|STARTED|Overall Study||17
3192216|NCT02061696|3920021|FG001|STARTED|Overall Study||22
3192217|NCT02061696|3920020|FG000|COMPLETED|Overall Study||17
3192218|NCT02061696|3920021|FG001|COMPLETED|Overall Study||22
3192219|NCT02061696|3920020|FG000|NOT COMPLETED|Overall Study||0
3192220|NCT02061696|3920021|FG001|NOT COMPLETED|Overall Study||0
3192221|NCT02061748|3920029|FG000|STARTED|Overall Study||7646
3192222|NCT02061748|3920030|FG001|STARTED|Overall Study||30853
3192223|NCT02061748|3920029|FG000|COMPLETED|Overall Study||7646
3192224|NCT02061748|3920030|FG001|COMPLETED|Overall Study||30853
3192225|NCT02061748|3920029|FG000|NOT COMPLETED|Overall Study||0
3192226|NCT02061748|3920030|FG001|NOT COMPLETED|Overall Study||0
3192227|NCT02061774|3920038|FG000|STARTED|Overall Study||10
3192228|NCT02061774|3920039|FG001|STARTED|Overall Study||11
3192229|NCT02061774|3920038|FG000|COMPLETED|Overall Study||10
3192230|NCT02061774|3920039|FG001|COMPLETED|Overall Study||11
3192231|NCT02061774|3920038|FG000|NOT COMPLETED|Overall Study||0
3192232|NCT02061774|3920039|FG001|NOT COMPLETED|Overall Study||0
3192233|NCT02061813|3920045|FG000|STARTED|Overall Study||40
3192234|NCT02061813|3920045|FG000|Abametapir Lotion|Overall Study||40
3192235|NCT02061813|3920045|FG000|Vehicle Lotion|Overall Study||40
3192236|NCT02061813|3920045|FG000|Saline 0.9%|Overall Study||40
3192237|NCT02061813|3920045|FG000|SLS 0.2%|Overall Study||40
3192238|NCT02061813|3920045|FG000|COMPLETED|Overall Study||37
3192239|NCT02061813|3920045|FG000|NOT COMPLETED|Overall Study||3
3192240|NCT02061969|3920054|FG000|STARTED|Overall Study||73
3192241|NCT02061969|3920055|FG001|STARTED|Overall Study||67
3192242|NCT02061969|3920054|FG000|COMPLETED|Overall Study||73
3192243|NCT02061969|3920055|FG001|COMPLETED|Overall Study||67
3192244|NCT02061969|3920054|FG000|NOT COMPLETED|Overall Study||0
3192245|NCT02061969|3920055|FG001|NOT COMPLETED|Overall Study||0
3192246|NCT02062008|3920061|FG000|STARTED|Overall Study||2
3192247|NCT02062008|3920061|FG000|COMPLETED|Overall Study||2
3192248|NCT02062008|3920061|FG000|NOT COMPLETED|Overall Study||0
3192249|NCT02062151|3920065|FG000|STARTED|Overall Study||21
3192250|NCT02062151|3920065|FG000|COMPLETED|Overall Study||20
3192251|NCT02062151|3920065|FG000|NOT COMPLETED|Overall Study||1
3192252|NCT02062177|3920071|FG000|STARTED|Overall Study||70
3192253|NCT02062177|3920072|FG001|STARTED|Overall Study||70
3192254|NCT02062177|3920071|FG000|COMPLETED|Overall Study||70
3192255|NCT02062177|3920072|FG001|COMPLETED|Overall Study||70
3192256|NCT02062177|3920071|FG000|NOT COMPLETED|Overall Study||0
3192257|NCT02062177|3920072|FG001|NOT COMPLETED|Overall Study||0
3192258|NCT02062294|3920078|FG000|STARTED|Overall Study||14
3192259|NCT02062294|3920078|FG000|COMPLETED|Overall Study||14
3192260|NCT02062294|3920078|FG000|NOT COMPLETED|Overall Study||0
3192261|NCT02062359|3920082|FG000|STARTED|Overall Study||2
3192262|NCT02062359|3920082|FG000|COMPLETED|Overall Study||2
3192263|NCT02062359|3920082|FG000|NOT COMPLETED|Overall Study||0
3192264|NCT02062385|3920090|FG000|STARTED|Overall Study||1620
3192265|NCT02062385|3920091|FG001|STARTED|Overall Study||1620
3192266|NCT02062385|3920092|FG002|STARTED|Overall Study||400
3192267|NCT02062385|3920093|FG003|STARTED|Overall Study||400
3192268|NCT02062385|3920090|FG000|Received Vaccination 1|Overall Study||1618
3192269|NCT02062385|3920091|FG001|Received Vaccination 1|Overall Study||1619
3192270|NCT02062385|3920092|FG002|Received Vaccination 1|Overall Study||400
3192271|NCT02062385|3920093|FG003|Received Vaccination 1|Overall Study||400
3192272|NCT02062385|3920090|FG000|Received Vaccination 2|Overall Study||1554
3192273|NCT02062385|3920091|FG001|Received Vaccination 2|Overall Study||1566
3192274|NCT02062385|3920092|FG002|Received Vaccination 2|Overall Study||392
3192275|NCT02062385|3920093|FG003|Received Vaccination 2|Overall Study||393
3192276|NCT02062385|3920090|FG000|Received Vaccination 3|Overall Study||1543
3192277|NCT02062385|3920091|FG001|Received Vaccination 3|Overall Study||1554
3192278|NCT02062385|3920092|FG002|Received Vaccination 3|Overall Study||389
3192279|NCT02062385|3920093|FG003|Received Vaccination 3|Overall Study||392
3192280|NCT02062385|3920090|FG000|COMPLETED|Overall Study||1542
3192281|NCT02062385|3920091|FG001|COMPLETED|Overall Study||1555
3192282|NCT02062385|3920092|FG002|COMPLETED|Overall Study||388
3192283|NCT02062385|3920093|FG003|COMPLETED|Overall Study||391
3192284|NCT02062385|3920090|FG000|NOT COMPLETED|Overall Study||78
3192285|NCT02062385|3920091|FG001|NOT COMPLETED|Overall Study||65
3192286|NCT02062385|3920092|FG002|NOT COMPLETED|Overall Study||12
3192287|NCT02062385|3920093|FG003|NOT COMPLETED|Overall Study||9
3192288|NCT02062398|3920101|FG000|STARTED|Overall Study||13
3192289|NCT02062398|3920101|FG000|COMPLETED|Overall Study||12
3192290|NCT02062398|3920101|FG000|NOT COMPLETED|Overall Study||1
3364335|NCT04027439|4095509|FG008|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||4
3192291|NCT02062437|3920105|FG000|STARTED|Overall Study|132 patients who undergone THR (July-Oct 2010), complying with in/exclusion criteria were identified|132
3192292|NCT02062437|3920105|FG000|COMPLETED|Overall Study|80 patients were effectively enrolled, when coming back for their 2-year follow-up visit.|80
3192293|NCT02062437|3920105|FG000|NOT COMPLETED|Overall Study||52
3192294|NCT02062450|3920111|FG000|STARTED|Overall Study|379 patients were successfully reached by phone and convoked for the 2-year follow-up visit.|379
3192295|NCT02062450|3920111|FG000|Per Protocol Cohort|Overall Study|255 patients attended their 2-year follow-up visit.|255
3192296|NCT02062450|3920111|FG000|COMPLETED|Overall Study||255
3192297|NCT02062450|3920111|FG000|NOT COMPLETED|Overall Study||124
3192298|NCT02062502|3920121|FG000|STARTED|Overall Study||306
3192299|NCT02062502|3920122|FG001|STARTED|Overall Study||305
3192300|NCT02062502|3920121|FG000|Vaccinated Dose 1|Overall Study||306
3192301|NCT02062502|3920122|FG001|Vaccinated Dose 1|Overall Study||305
3192302|NCT02062502|3920121|FG000|COMPLETED|Overall Study||263
3192303|NCT02062502|3920122|FG001|COMPLETED|Overall Study||270
3192304|NCT02062502|3920121|FG000|NOT COMPLETED|Overall Study||43
3192305|NCT02062502|3920122|FG001|NOT COMPLETED|Overall Study||35
3192306|NCT02062580|3920130|FG000|STARTED|Overall Study||71
3192307|NCT02062580|3920131|FG001|STARTED|Overall Study||78
3192308|NCT02062580|3920130|FG000|COMPLETED|Overall Study||59
3192309|NCT02062580|3920131|FG001|COMPLETED|Overall Study||65
3192310|NCT02062580|3920130|FG000|NOT COMPLETED|Overall Study||12
3192311|NCT02062580|3920131|FG001|NOT COMPLETED|Overall Study||13
3192312|NCT02062593|3920139|FG000|STARTED|Overall Study||105
3192313|NCT02062593|3920140|FG001|STARTED|Overall Study||95
3192314|NCT02062593|3920139|FG000|COMPLETED|Overall Study||105
3192315|NCT02062593|3920140|FG001|COMPLETED|Overall Study||91
3192316|NCT02062593|3920139|FG000|NOT COMPLETED|Overall Study||0
3192317|NCT02062593|3920140|FG001|NOT COMPLETED|Overall Study||4
3192318|NCT02062606|3920146|FG000|STARTED|Overall Study||188
3192319|NCT02062606|3920146|FG000|COMPLETED|Overall Study||99
3192320|NCT02062606|3920146|FG000|NOT COMPLETED|Overall Study||89
3192321|NCT02062632|3920179|FG000|STARTED|Overall Study||3
3192322|NCT02062632|3920179|FG000|COMPLETED|Overall Study||2
3192323|NCT02062632|3920179|FG000|NOT COMPLETED|Overall Study||1
3192324|NCT02062645|3920183|FG000|STARTED|Overall Study||115
3192325|NCT02062645|3920183|FG000|COMPLETED|Overall Study||100
3192326|NCT02062645|3920183|FG000|NOT COMPLETED|Overall Study||15
3192327|NCT02062658|3920187|FG000|STARTED|Overall Study||10
3192328|NCT02062658|3920187|FG000|COMPLETED|Overall Study||8
3192329|NCT02062658|3920187|FG000|NOT COMPLETED|Overall Study||2
3192330|NCT02062710|3920191|FG000|STARTED|Overall Study|3 of total 22 subjects randomized to receive the 3 study drugs in this particular sequence|3
3192331|NCT02062710|3920192|FG001|STARTED|Overall Study|4 of the total 22 subjects randomized to receive the 3 study drugs in this particular sequence|4
3192332|NCT02062710|3920193|FG002|STARTED|Overall Study|5 of total of 22 subjects randomized to receive the 3 study drugs in this particular sequence|5
3192333|NCT02062710|3920194|FG003|STARTED|Overall Study|3 of 22 subjects randomized to receive the 3 study drugs in this particular sequence|3
3192334|NCT02062710|3920195|FG004|STARTED|Overall Study|3 of 22 subjects randomized to receive the 3 study drugs in this aprticular sequence|3
3192335|NCT02062710|3920196|FG005|STARTED|Overall Study|4 of 22 subjects randomized to receive the 3 study drugs in this particular sequence|4
3192336|NCT02062710|3920191|FG000|COMPLETED|Overall Study||3
3192337|NCT02062710|3920192|FG001|COMPLETED|Overall Study||4
3192338|NCT02062710|3920193|FG002|COMPLETED|Overall Study||5
3192339|NCT02062710|3920194|FG003|COMPLETED|Overall Study||3
3192340|NCT02062710|3920195|FG004|COMPLETED|Overall Study||3
3192341|NCT02062710|3920196|FG005|COMPLETED|Overall Study||4
3192342|NCT02062710|3920191|FG000|NOT COMPLETED|Overall Study||0
3192343|NCT02062710|3920192|FG001|NOT COMPLETED|Overall Study||0
3192344|NCT02062710|3920193|FG002|NOT COMPLETED|Overall Study||0
3192345|NCT02062710|3920194|FG003|NOT COMPLETED|Overall Study||0
3192346|NCT02062710|3920195|FG004|NOT COMPLETED|Overall Study||0
3192347|NCT02062710|3920196|FG005|NOT COMPLETED|Overall Study||0
3192348|NCT02062801|3920206|FG000|STARTED|Overall Study||301
3192349|NCT02062801|3920207|FG001|STARTED|Overall Study||301
3192350|NCT02062801|3920206|FG000|COMPLETED|Overall Study||299
3192351|NCT02062801|3920207|FG001|COMPLETED|Overall Study||297
3192352|NCT02062801|3920206|FG000|NOT COMPLETED|Overall Study||2
3192353|NCT02062801|3920207|FG001|NOT COMPLETED|Overall Study||4
3192354|NCT02062879|3920215|FG000|STARTED|Overall Study||10
3192355|NCT02062879|3920216|FG001|STARTED|Overall Study||10
3192356|NCT02062879|3920215|FG000|COMPLETED|Overall Study||6
3192357|NCT02062879|3920216|FG001|COMPLETED|Overall Study||9
3192358|NCT02062879|3920215|FG000|NOT COMPLETED|Overall Study||4
3192359|NCT02062879|3920216|FG001|NOT COMPLETED|Overall Study||1
3192360|NCT02062905|3920224|FG000|STARTED|Overall Study||35
3192361|NCT02062905|3920225|FG001|STARTED|Overall Study||33
3192362|NCT02062905|3920224|FG000|COMPLETED|Overall Study||28
3192363|NCT02062905|3920225|FG001|COMPLETED|Overall Study||31
3192364|NCT02062905|3920224|FG000|NOT COMPLETED|Overall Study||7
3192365|NCT02062905|3920225|FG001|NOT COMPLETED|Overall Study||2
3192366|NCT02063035|3920233|FG000|STARTED|Overall Study||12
3192367|NCT02063035|3920234|FG001|STARTED|Overall Study||17
3192368|NCT02063035|3920233|FG000|COMPLETED|Overall Study||12
3192369|NCT02063035|3920234|FG001|COMPLETED|Overall Study||17
3192370|NCT02063035|3920233|FG000|NOT COMPLETED|Overall Study||0
3192371|NCT02063035|3920234|FG001|NOT COMPLETED|Overall Study||0
3192372|NCT02063087|3920242|FG000|STARTED|Emergency Department Intervention||493
3192373|NCT02063087|3920243|FG001|STARTED|Emergency Department Intervention||478
3192374|NCT02063087|3920242|FG000|COMPLETED|Emergency Department Intervention||493
3192375|NCT02063087|3920243|FG001|COMPLETED|Emergency Department Intervention||478
3192376|NCT02063087|3920242|FG000|NOT COMPLETED|Emergency Department Intervention||0
3192377|NCT02063087|3920243|FG001|NOT COMPLETED|Emergency Department Intervention||0
3192378|NCT02063087|3920242|FG000|STARTED|7 Day Follow-up||493
3192379|NCT02063087|3920243|FG001|STARTED|7 Day Follow-up||478
3192380|NCT02063087|3920242|FG000|COMPLETED|7 Day Follow-up||493
3192381|NCT02063087|3920243|FG001|COMPLETED|7 Day Follow-up||478
3192382|NCT02063087|3920242|FG000|NOT COMPLETED|7 Day Follow-up||0
3192383|NCT02063087|3920243|FG001|NOT COMPLETED|7 Day Follow-up||0
3192384|NCT02063178|3920251|FG000|STARTED|Overall Study||124
3192385|NCT02063178|3920252|FG001|STARTED|Overall Study||124
3192386|NCT02063178|3920251|FG000|COMPLETED|Overall Study||95
3192387|NCT02063178|3920252|FG001|COMPLETED|Overall Study||77
3192388|NCT02063178|3920251|FG000|NOT COMPLETED|Overall Study||29
3192389|NCT02063178|3920252|FG001|NOT COMPLETED|Overall Study||47
3192390|NCT02063217|3920265|FG000|STARTED|Overall Study||12
3192391|NCT02063217|3920266|FG001|STARTED|Overall Study||12
3192392|NCT02063217|3920267|FG002|STARTED|Overall Study||12
3192393|NCT02063217|3920265|FG000|COMPLETED|Overall Study||11
3192394|NCT02063217|3920266|FG001|COMPLETED|Overall Study||12
3192395|NCT02063217|3920267|FG002|COMPLETED|Overall Study||12
3192396|NCT02063217|3920265|FG000|NOT COMPLETED|Overall Study||1
3192397|NCT02063217|3920266|FG001|NOT COMPLETED|Overall Study||0
3192398|NCT02063217|3920267|FG002|NOT COMPLETED|Overall Study||0
3192399|NCT02063230|3920279|FG000|STARTED|Overall Study||8
3192400|NCT02063230|3920280|FG001|STARTED|Overall Study||8
3192401|NCT02063230|3920281|FG002|STARTED|Overall Study||8
3192402|NCT02063230|3920282|FG003|STARTED|Overall Study||8
3192403|NCT02063230|3920279|FG000|Received Treatment|Overall Study||8
3192404|NCT02063230|3920280|FG001|Received Treatment|Overall Study||8
3192405|NCT02063230|3920281|FG002|Received Treatment|Overall Study||8
3192406|NCT02063230|3920282|FG003|Received Treatment|Overall Study||8
3192407|NCT02063230|3920279|FG000|COMPLETED|Overall Study||8
3192408|NCT02063230|3920280|FG001|COMPLETED|Overall Study||8
3192409|NCT02063230|3920281|FG002|COMPLETED|Overall Study||8
3192410|NCT02063230|3920282|FG003|COMPLETED|Overall Study||8
3192411|NCT02063230|3920279|FG000|NOT COMPLETED|Overall Study||0
3192412|NCT02063230|3920280|FG001|NOT COMPLETED|Overall Study||0
3192413|NCT02063230|3920281|FG002|NOT COMPLETED|Overall Study||0
3192414|NCT02063230|3920282|FG003|NOT COMPLETED|Overall Study||0
3192415|NCT02063516|3920294|FG000|STARTED|Overall Study||40
3192416|NCT02063516|3920295|FG001|STARTED|Overall Study||40
3192417|NCT02063516|3920294|FG000|COMPLETED|Overall Study||40
3192418|NCT02063516|3920295|FG001|COMPLETED|Overall Study||40
3192419|NCT02063516|3920294|FG000|NOT COMPLETED|Overall Study||0
3192420|NCT02063516|3920295|FG001|NOT COMPLETED|Overall Study||0
3192421|NCT02063659|3920304|FG000|STARTED|Double-Blind Treatment Period||26
3192422|NCT02063659|3920305|FG001|STARTED|Double-Blind Treatment Period||25
3192423|NCT02063659|3920306|FG002|STARTED|Double-Blind Treatment Period||25
3192424|NCT02063659|3920307|FG003|STARTED|Double-Blind Treatment Period||0
3192425|NCT02063659|3920304|FG000|COMPLETED|Double-Blind Treatment Period||24
3192426|NCT02063659|3920305|FG001|COMPLETED|Double-Blind Treatment Period||22
3192427|NCT02063659|3920306|FG002|COMPLETED|Double-Blind Treatment Period||22
3192428|NCT02063659|3920307|FG003|COMPLETED|Double-Blind Treatment Period||0
3192429|NCT02063659|3920304|FG000|NOT COMPLETED|Double-Blind Treatment Period||2
3192430|NCT02063659|3920305|FG001|NOT COMPLETED|Double-Blind Treatment Period||3
3192431|NCT02063659|3920306|FG002|NOT COMPLETED|Double-Blind Treatment Period||3
3192432|NCT02063659|3920307|FG003|NOT COMPLETED|Double-Blind Treatment Period||0
3192433|NCT02063659|3920304|FG000|STARTED|Open-Label Extension Period (OLE)||0
3192434|NCT02063659|3920305|FG001|STARTED|Open-Label Extension Period (OLE)||0
3192435|NCT02063659|3920306|FG002|STARTED|Open-Label Extension Period (OLE)||0
3192436|NCT02063659|3920307|FG003|STARTED|Open-Label Extension Period (OLE)||67
3364336|NCT04027439|4095510|FG009|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||3
3364337|NCT04027439|4095511|FG010|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||4
3364338|NCT04027439|4095512|FG011|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||3
3364339|NCT04027439|4095513|FG012|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||3
3364340|NCT04027439|4095514|FG013|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||4
3364341|NCT04027439|4095515|FG014|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||4
3364342|NCT04027439|4095516|FG015|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||3
3364343|NCT04027439|4095501|FG000|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
3364344|NCT04027439|4095502|FG001|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
3364345|NCT04027439|4095503|FG002|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
3364346|NCT04027439|4095504|FG003|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
3364347|NCT04027439|4095505|FG004|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
3364348|NCT04027439|4095506|FG005|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
3364349|NCT04027439|4095507|FG006|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||4
3364350|NCT04027439|4095508|FG007|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day|1 patient discontinued in part b/period 2 and another in part b/period 3.|1
3364351|NCT04027439|4095509|FG008|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||4
3364352|NCT04027439|4095510|FG009|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||3
3364353|NCT04027439|4095511|FG010|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||4
3192437|NCT02063659|3920304|FG000|COMPLETED|Open-Label Extension Period (OLE)||0
3192438|NCT02063659|3920305|FG001|COMPLETED|Open-Label Extension Period (OLE)||0
3192439|NCT02063659|3920306|FG002|COMPLETED|Open-Label Extension Period (OLE)||0
3192440|NCT02063659|3920307|FG003|COMPLETED|Open-Label Extension Period (OLE)||47
3192441|NCT02063659|3920304|FG000|NOT COMPLETED|Open-Label Extension Period (OLE)||0
3192442|NCT02063659|3920305|FG001|NOT COMPLETED|Open-Label Extension Period (OLE)||0
3192443|NCT02063659|3920306|FG002|NOT COMPLETED|Open-Label Extension Period (OLE)||0
3192444|NCT02063659|3920307|FG003|NOT COMPLETED|Open-Label Extension Period (OLE)||20
3192445|NCT02063672|3920323|FG000|STARTED|Overall Study||53
3192446|NCT02063672|3920324|FG001|STARTED|Overall Study||29
3192447|NCT02063672|3920323|FG000|COMPLETED|Overall Study||18
3192448|NCT02063672|3920324|FG001|COMPLETED|Overall Study||7
3192449|NCT02063672|3920323|FG000|NOT COMPLETED|Overall Study||35
3192450|NCT02063672|3920324|FG001|NOT COMPLETED|Overall Study||22
3192451|NCT02063698|3920332|FG000|STARTED|Overall Study||15
3192452|NCT02063698|3920333|FG001|STARTED|Overall Study||15
3192453|NCT02063698|3920332|FG000|COMPLETED|Overall Study||14
3192454|NCT02063698|3920333|FG001|COMPLETED|Overall Study||13
3192455|NCT02063698|3920332|FG000|NOT COMPLETED|Overall Study||1
3192456|NCT02063698|3920333|FG001|NOT COMPLETED|Overall Study||2
3192457|NCT02063737|3920341|FG000|STARTED|Overall Study||52
3192458|NCT02063737|3920342|FG001|STARTED|Overall Study||48
3192459|NCT02063737|3920341|FG000|COMPLETED|Overall Study||41
3192460|NCT02063737|3920342|FG001|COMPLETED|Overall Study||44
3192461|NCT02063737|3920341|FG000|NOT COMPLETED|Overall Study||11
3192462|NCT02063737|3920342|FG001|NOT COMPLETED|Overall Study||4
3192463|NCT02063828|3920351|FG000|STARTED|Overall Study||14
3192464|NCT02063828|3920352|FG001|STARTED|Overall Study||14
3192465|NCT02063828|3920353|FG002|STARTED|Overall Study||18
3192466|NCT02063828|3920351|FG000|Week 6|Overall Study||11
3192467|NCT02063828|3920352|FG001|Week 6|Overall Study||9
3192468|NCT02063828|3920353|FG002|Week 6|Overall Study||14
3192469|NCT02063828|3920351|FG000|COMPLETED|Overall Study||10
3192470|NCT02063828|3920352|FG001|COMPLETED|Overall Study||8
3192471|NCT02063828|3920353|FG002|COMPLETED|Overall Study||14
3192472|NCT02063828|3920351|FG000|NOT COMPLETED|Overall Study||4
3192473|NCT02063828|3920352|FG001|NOT COMPLETED|Overall Study||6
3192474|NCT02063828|3920353|FG002|NOT COMPLETED|Overall Study||4
3192475|NCT02063854|3920368|FG000|STARTED|Overall Study||199
3192476|NCT02063854|3920369|FG001|STARTED|Overall Study||66
3192477|NCT02063854|3920370|FG002|STARTED|Overall Study||206
3192478|NCT02063854|3920371|FG003|STARTED|Overall Study||68
3192479|NCT02063854|3920372|FG004|STARTED|Overall Study||65
3192480|NCT02063854|3920373|FG005|STARTED|Overall Study||201
3192481|NCT02063854|3920374|FG006|STARTED|Overall Study||66
3192482|NCT02063854|3920368|FG000|Full Analysis Set: Received Study Drug|Overall Study||199
3192483|NCT02063854|3920369|FG001|Full Analysis Set: Received Study Drug|Overall Study||66
3192484|NCT02063854|3920370|FG002|Full Analysis Set: Received Study Drug|Overall Study||206
3192485|NCT02063854|3920371|FG003|Full Analysis Set: Received Study Drug|Overall Study||68
3192486|NCT02063854|3920372|FG004|Full Analysis Set: Received Study Drug|Overall Study||65
3192487|NCT02063854|3920373|FG005|Full Analysis Set: Received Study Drug|Overall Study||200
3192488|NCT02063854|3920374|FG006|Full Analysis Set: Received Study Drug|Overall Study||66
3192489|NCT02063854|3920368|FG000|COMPLETED|Overall Study||178
3192490|NCT02063854|3920369|FG001|COMPLETED|Overall Study||54
3192491|NCT02063854|3920370|FG002|COMPLETED|Overall Study||176
3192492|NCT02063854|3920371|FG003|COMPLETED|Overall Study||58
3192493|NCT02063854|3920372|FG004|COMPLETED|Overall Study||54
3192494|NCT02063854|3920373|FG005|COMPLETED|Overall Study||170
3364354|NCT04027439|4095512|FG011|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||3
3364355|NCT04027439|4095513|FG012|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||3
3364356|NCT04027439|4095514|FG013|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||4
3364357|NCT04027439|4095515|FG014|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||4
3364358|NCT04027439|4095516|FG015|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||3
3364359|NCT04027439|4095501|FG000|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
3364360|NCT04027439|4095502|FG001|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
3364361|NCT04027439|4095503|FG002|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
3364362|NCT04027439|4095504|FG003|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
3364363|NCT04027439|4095505|FG004|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
3364364|NCT04027439|4095506|FG005|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
3364365|NCT04027439|4095507|FG006|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
3364366|NCT04027439|4095508|FG007|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||2
3364367|NCT04027439|4095509|FG008|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
3364368|NCT04027439|4095510|FG009|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
3364369|NCT04027439|4095511|FG010|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
3364370|NCT04027439|4095512|FG011|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
3364371|NCT04027439|4095513|FG012|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
3364372|NCT04027439|4095514|FG013|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
3364373|NCT04027439|4095515|FG014|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
3364374|NCT04027439|4095516|FG015|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
3364375|NCT04027218|4095546|FG000|STARTED|Overall Study||10
3192495|NCT02063854|3920374|FG006|COMPLETED|Overall Study||60
3192496|NCT02063854|3920368|FG000|NOT COMPLETED|Overall Study||21
3192497|NCT02063854|3920369|FG001|NOT COMPLETED|Overall Study||12
3192498|NCT02063854|3920370|FG002|NOT COMPLETED|Overall Study||30
3192499|NCT02063854|3920371|FG003|NOT COMPLETED|Overall Study||10
3192500|NCT02063854|3920372|FG004|NOT COMPLETED|Overall Study||11
3192501|NCT02063854|3920373|FG005|NOT COMPLETED|Overall Study||31
3192502|NCT02063854|3920374|FG006|NOT COMPLETED|Overall Study||6
3192503|NCT02063867|3920394|FG000|STARTED|Overall Study||156889
3192504|NCT02063867|3920395|FG001|STARTED|Overall Study||183013
3192505|NCT02063867|3920394|FG000|COMPLETED|Overall Study||152598
3192506|NCT02063867|3920395|FG001|COMPLETED|Overall Study||180048
3192507|NCT02063867|3920394|FG000|NOT COMPLETED|Overall Study||4291
3192508|NCT02063867|3920395|FG001|NOT COMPLETED|Overall Study||2965
3192509|NCT02063880|3920403|FG000|STARTED|Overall Study||90
3192510|NCT02063880|3920404|FG001|STARTED|Overall Study||93
3192511|NCT02063880|3920403|FG000|COMPLETED|Overall Study||62
3192512|NCT02063880|3920404|FG001|COMPLETED|Overall Study||66
3192513|NCT02063880|3920403|FG000|NOT COMPLETED|Overall Study||28
3192514|NCT02063880|3920404|FG001|NOT COMPLETED|Overall Study||27
3192515|NCT02063984|3920412|FG000|STARTED|Overall Study||29
3192516|NCT02063984|3920413|FG001|STARTED|Overall Study||30
3192517|NCT02063984|3920412|FG000|COMPLETED|Overall Study||23
3192518|NCT02063984|3920413|FG001|COMPLETED|Overall Study||25
3192519|NCT02063984|3920412|FG000|NOT COMPLETED|Overall Study||6
3192520|NCT02063984|3920413|FG001|NOT COMPLETED|Overall Study||5
3192521|NCT02064166|3920425|FG000|STARTED|Overall Study||9
3192522|NCT02064166|3920426|FG001|STARTED|Overall Study||6
3192523|NCT02064166|3920425|FG000|COMPLETED|Overall Study||8
3192524|NCT02064166|3920426|FG001|COMPLETED|Overall Study||6
3192525|NCT02064166|3920425|FG000|NOT COMPLETED|Overall Study||1
3192526|NCT02064166|3920426|FG001|NOT COMPLETED|Overall Study||0
3192527|NCT02064205|3920454|FG000|STARTED|Overall Study||32
3192528|NCT02064205|3920454|FG000|Condition A|Overall Study||32
3192529|NCT02064205|3920454|FG000|Condition B|Overall Study||32
3192530|NCT02064205|3920454|FG000|Condition C|Overall Study||31
3192531|NCT02064205|3920454|FG000|Condition D|Overall Study||32
3192532|NCT02064205|3920454|FG000|COMPLETED|Overall Study||31
3192533|NCT02064205|3920454|FG000|NOT COMPLETED|Overall Study||1
3192534|NCT02064231|3920470|FG000|STARTED|First Test Period (Test A or Test C)||14
3192535|NCT02064231|3920471|FG001|STARTED|First Test Period (Test A or Test C)||12
3192536|NCT02064231|3920472|FG002|STARTED|First Test Period (Test A or Test C)||1
3192537|NCT02064231|3920473|FG003|STARTED|First Test Period (Test A or Test C)||1
3192538|NCT02064231|3920470|FG000|COMPLETED|First Test Period (Test A or Test C)||7
3192539|NCT02064231|3920471|FG001|COMPLETED|First Test Period (Test A or Test C)||8
3192540|NCT02064231|3920472|FG002|COMPLETED|First Test Period (Test A or Test C)||0
3192541|NCT02064231|3920473|FG003|COMPLETED|First Test Period (Test A or Test C)||1
3192542|NCT02064231|3920470|FG000|NOT COMPLETED|First Test Period (Test A or Test C)||7
3192543|NCT02064231|3920471|FG001|NOT COMPLETED|First Test Period (Test A or Test C)||4
3192544|NCT02064231|3920472|FG002|NOT COMPLETED|First Test Period (Test A or Test C)||1
3192545|NCT02064231|3920473|FG003|NOT COMPLETED|First Test Period (Test A or Test C)||0
3192546|NCT02064231|3920470|FG000|STARTED|Second Test Period (Test B or Test D)||7
3192547|NCT02064231|3920471|FG001|STARTED|Second Test Period (Test B or Test D)||8
3192548|NCT02064231|3920472|FG002|STARTED|Second Test Period (Test B or Test D)||0
3192549|NCT02064231|3920473|FG003|STARTED|Second Test Period (Test B or Test D)||1
3192550|NCT02064231|3920470|FG000|COMPLETED|Second Test Period (Test B or Test D)||6
3192551|NCT02064231|3920471|FG001|COMPLETED|Second Test Period (Test B or Test D)||7
3192552|NCT02064231|3920472|FG002|COMPLETED|Second Test Period (Test B or Test D)||0
3192553|NCT02064231|3920473|FG003|COMPLETED|Second Test Period (Test B or Test D)||1
3192554|NCT02064231|3920470|FG000|NOT COMPLETED|Second Test Period (Test B or Test D)||1
3192555|NCT02064231|3920471|FG001|NOT COMPLETED|Second Test Period (Test B or Test D)||1
3192556|NCT02064231|3920472|FG002|NOT COMPLETED|Second Test Period (Test B or Test D)||0
3192557|NCT02064231|3920473|FG003|NOT COMPLETED|Second Test Period (Test B or Test D)||0
3192558|NCT02064231|3920470|FG000|STARTED|Third Test Period (Own Product)|One subject who discontinued testing Test A proceeded to test Own product afterwards.|8
3192559|NCT02064231|3920471|FG001|STARTED|Third Test Period (Own Product)|One subject who discontinued testing Test C proceeded to test Own product afterwards|8
3192560|NCT02064231|3920472|FG002|STARTED|Third Test Period (Own Product)||0
3192561|NCT02064231|3920473|FG003|STARTED|Third Test Period (Own Product)||1
3192562|NCT02064231|3920470|FG000|COMPLETED|Third Test Period (Own Product)||8
3192563|NCT02064231|3920471|FG001|COMPLETED|Third Test Period (Own Product)||8
3192564|NCT02064231|3920472|FG002|COMPLETED|Third Test Period (Own Product)||0
3192565|NCT02064231|3920473|FG003|COMPLETED|Third Test Period (Own Product)||1
3192566|NCT02064231|3920470|FG000|NOT COMPLETED|Third Test Period (Own Product)||0
3192567|NCT02064231|3920471|FG001|NOT COMPLETED|Third Test Period (Own Product)||0
3192568|NCT02064231|3920472|FG002|NOT COMPLETED|Third Test Period (Own Product)||0
3192569|NCT02064231|3920473|FG003|NOT COMPLETED|Third Test Period (Own Product)||0
3192570|NCT02064270|3920487|FG000|STARTED|Overall Study||263
3192571|NCT02064270|3920488|FG001|STARTED|Overall Study||263
3192572|NCT02064270|3920487|FG000|COMPLETED|Overall Study||201
3192573|NCT02064270|3920488|FG001|COMPLETED|Overall Study||231
3192574|NCT02064270|3920487|FG000|NOT COMPLETED|Overall Study||62
3192575|NCT02064270|3920488|FG001|NOT COMPLETED|Overall Study||32
3192576|NCT02064439|3920497|FG000|STARTED|Overall Study|Full Analysis Set (FAS), randomized and received study medication|1127
3192577|NCT02064439|3920498|FG001|STARTED|Overall Study|FAS, randomized and received study medication|1107
3192578|NCT02064439|3920499|FG002|STARTED|Overall Study|FAS, randomized and received study medication|1131
3192579|NCT02064439|3920497|FG000|COMPLETED|Overall Study||984
3192580|NCT02064439|3920498|FG001|COMPLETED|Overall Study||969
3192581|NCT02064439|3920499|FG002|COMPLETED|Overall Study||949
3192582|NCT02064439|3920497|FG000|NOT COMPLETED|Overall Study||143
3192583|NCT02064439|3920498|FG001|NOT COMPLETED|Overall Study||138
3192584|NCT02064439|3920499|FG002|NOT COMPLETED|Overall Study||182
3192585|NCT02064582|3920507|FG000|STARTED|Overall Study||7
3192586|NCT02064582|3920507|FG000|COMPLETED|Overall Study||7
3192587|NCT02064582|3920507|FG000|NOT COMPLETED|Overall Study||0
3192588|NCT02064816|3920513|FG000|STARTED|Overall Study||104
3192589|NCT02064816|3920514|FG001|STARTED|Overall Study||96
3192590|NCT02064816|3920513|FG000|COMPLETED|Overall Study||96
3192591|NCT02064816|3920514|FG001|COMPLETED|Overall Study||88
3192592|NCT02064816|3920513|FG000|NOT COMPLETED|Overall Study||8
3192593|NCT02064816|3920514|FG001|NOT COMPLETED|Overall Study||8
3192594|NCT02064855|3920520|FG000|STARTED|Overall Study||108
3192595|NCT02064855|3920520|FG000|COMPLETED|Overall Study||53
3192596|NCT02064855|3920520|FG000|NOT COMPLETED|Overall Study||55
3192597|NCT02064868|3920569|FG000|STARTED|Overall Study||1756
3192598|NCT02064868|3920570|FG001|STARTED|Overall Study||894
3192599|NCT02064868|3920569|FG000|Full Analysis Set|Overall Study||1756
3192600|NCT02064868|3920570|FG001|Full Analysis Set|Overall Study||894
3192601|NCT02064868|3920569|FG000|Safety Set|Overall Study|The Safety Set includes one patient not randomized but treated with serelaxin|1729
3192602|NCT02064868|3920570|FG001|Safety Set|Overall Study||894
3192603|NCT02064868|3920569|FG000|Per Protocol Set|Overall Study||1155
3192604|NCT02064868|3920570|FG001|Per Protocol Set|Overall Study||627
3192605|NCT02064868|3920569|FG000|COMPLETED|Overall Study||1722
3192606|NCT02064868|3920570|FG001|COMPLETED|Overall Study||881
3192607|NCT02064868|3920569|FG000|NOT COMPLETED|Overall Study||34
3192608|NCT02064868|3920570|FG001|NOT COMPLETED|Overall Study||13
3192609|NCT02064894|3920579|FG000|STARTED|Overall Study|"Received allocated intervention (n=98)~Did not receive intervention (n=1)"|99
3192610|NCT02064894|3920580|FG001|STARTED|Overall Study|"Received allocated intervention (n=198)~Did not receive allocated intervention (n=3)"|201
3192611|NCT02064894|3920581|FG002|STARTED|Overall Study|"Received allocated intervention (n=199)~Did not receive allocated intervention (n=2)"|201
3192612|NCT02064894|3920579|FG000|Available at T-60|Overall Study||91
3192613|NCT02064894|3920580|FG001|Available at T-60|Overall Study||188
3192614|NCT02064894|3920581|FG002|Available at T-60|Overall Study||177
3192615|NCT02064894|3920579|FG000|Avalaible at T-90|Overall Study||74
3192616|NCT02064894|3920580|FG001|Avalaible at T-90|Overall Study||134
3192617|NCT02064894|3920581|FG002|Avalaible at T-90|Overall Study||129
3192618|NCT02064894|3920579|FG000|COMPLETED|Overall Study||56
3192619|NCT02064894|3920580|FG001|COMPLETED|Overall Study||99
3192620|NCT02064894|3920581|FG002|COMPLETED|Overall Study||86
3192621|NCT02064894|3920579|FG000|NOT COMPLETED|Overall Study||43
3192622|NCT02064894|3920580|FG001|NOT COMPLETED|Overall Study||102
3192623|NCT02064894|3920581|FG002|NOT COMPLETED|Overall Study||115
3192624|NCT02064907|3920591|FG000|STARTED|Period 1||26
3192625|NCT02064907|3920592|FG001|STARTED|Period 1||26
3192626|NCT02064907|3920591|FG000|COMPLETED|Period 1||26
3192627|NCT02064907|3920592|FG001|COMPLETED|Period 1||26
3192628|NCT02064907|3920591|FG000|NOT COMPLETED|Period 1||0
3192629|NCT02064907|3920592|FG001|NOT COMPLETED|Period 1||0
3192630|NCT02064907|3920591|FG000|STARTED|Period 2||26
3192631|NCT02064907|3920592|FG001|STARTED|Period 2||26
3192632|NCT02064907|3920591|FG000|COMPLETED|Period 2||26
3192633|NCT02064907|3920592|FG001|COMPLETED|Period 2||26
3192634|NCT02064907|3920591|FG000|NOT COMPLETED|Period 2||0
3192635|NCT02064907|3920592|FG001|NOT COMPLETED|Period 2||0
3192636|NCT02064920|3920600|FG000|STARTED|Overall Study||6
3192637|NCT02064920|3920601|FG001|STARTED|Overall Study||30
3192638|NCT02064920|3920600|FG000|Treated|Overall Study||6
3192639|NCT02064920|3920601|FG001|Treated|Overall Study|Two participants discontinued from study prior to treatment|28
3192640|NCT02064920|3920600|FG000|COMPLETED|Overall Study||5
3192641|NCT02064920|3920601|FG001|COMPLETED|Overall Study||21
3192642|NCT02064920|3920600|FG000|NOT COMPLETED|Overall Study||1
3192643|NCT02064920|3920601|FG001|NOT COMPLETED|Overall Study||9
3192644|NCT02064959|3920609|FG000|STARTED|Overall Study||16
3192645|NCT02064959|3920610|FG001|STARTED|Overall Study||16
3192646|NCT02064959|3920609|FG000|COMPLETED|Overall Study||16
3192647|NCT02064959|3920610|FG001|COMPLETED|Overall Study||16
3192648|NCT02064959|3920609|FG000|NOT COMPLETED|Overall Study||0
3192649|NCT02064959|3920610|FG001|NOT COMPLETED|Overall Study||0
3192650|NCT02064985|3920619|FG000|STARTED|Overall Study||12
3192651|NCT02064985|3920620|FG001|STARTED|Overall Study||12
3192652|NCT02064985|3920621|FG002|STARTED|Overall Study||12
3192653|NCT02064985|3920619|FG000|COMPLETED|Overall Study||12
3192654|NCT02064985|3920620|FG001|COMPLETED|Overall Study||12
3192655|NCT02064985|3920621|FG002|COMPLETED|Overall Study||12
3192656|NCT02064985|3920619|FG000|NOT COMPLETED|Overall Study||0
3192657|NCT02064985|3920620|FG001|NOT COMPLETED|Overall Study||0
3192658|NCT02064985|3920621|FG002|NOT COMPLETED|Overall Study||0
3192659|NCT02065245|3920636|FG000|STARTED|Infusion 1||5
3192660|NCT02065245|3920637|FG001|STARTED|Infusion 1||5
3192661|NCT02065245|3920638|FG002|STARTED|Infusion 1||5
3192662|NCT02065245|3920639|FG003|STARTED|Infusion 1||10
3192663|NCT02065245|3920640|FG004|STARTED|Infusion 1||10
3192664|NCT02065245|3920641|FG005|STARTED|Infusion 1||10
3192665|NCT02065245|3920642|FG006|STARTED|Infusion 1||20
3192666|NCT02065245|3920636|FG000|COMPLETED|Infusion 1||5
3192667|NCT02065245|3920637|FG001|COMPLETED|Infusion 1||5
3192668|NCT02065245|3920638|FG002|COMPLETED|Infusion 1||4
3192669|NCT02065245|3920639|FG003|COMPLETED|Infusion 1||10
3192670|NCT02065245|3920640|FG004|COMPLETED|Infusion 1||9
3192671|NCT02065245|3920641|FG005|COMPLETED|Infusion 1||10
3192672|NCT02065245|3920642|FG006|COMPLETED|Infusion 1||19
3192673|NCT02065245|3920636|FG000|NOT COMPLETED|Infusion 1||0
3192674|NCT02065245|3920637|FG001|NOT COMPLETED|Infusion 1||0
3192675|NCT02065245|3920638|FG002|NOT COMPLETED|Infusion 1||1
3192676|NCT02065245|3920639|FG003|NOT COMPLETED|Infusion 1||0
3192677|NCT02065245|3920640|FG004|NOT COMPLETED|Infusion 1||1
3192678|NCT02065245|3920641|FG005|NOT COMPLETED|Infusion 1||0
3192679|NCT02065245|3920642|FG006|NOT COMPLETED|Infusion 1||1
3192680|NCT02065245|3920636|FG000|STARTED|Infusion 2||5
3192681|NCT02065245|3920637|FG001|STARTED|Infusion 2||5
3192682|NCT02065245|3920638|FG002|STARTED|Infusion 2||2
3192683|NCT02065245|3920639|FG003|STARTED|Infusion 2||0
3192684|NCT02065245|3920640|FG004|STARTED|Infusion 2||0
3192685|NCT02065245|3920641|FG005|STARTED|Infusion 2||6
3192686|NCT02065245|3920642|FG006|STARTED|Infusion 2||12
3192687|NCT02065245|3920636|FG000|COMPLETED|Infusion 2||5
3192688|NCT02065245|3920637|FG001|COMPLETED|Infusion 2||5
3192689|NCT02065245|3920638|FG002|COMPLETED|Infusion 2||2
3192690|NCT02065245|3920639|FG003|COMPLETED|Infusion 2||0
3192691|NCT02065245|3920640|FG004|COMPLETED|Infusion 2||0
3192692|NCT02065245|3920641|FG005|COMPLETED|Infusion 2||6
3192693|NCT02065245|3920642|FG006|COMPLETED|Infusion 2||11
3192694|NCT02065245|3920636|FG000|NOT COMPLETED|Infusion 2||0
3192695|NCT02065245|3920637|FG001|NOT COMPLETED|Infusion 2||0
3192696|NCT02065245|3920638|FG002|NOT COMPLETED|Infusion 2||0
3192697|NCT02065245|3920639|FG003|NOT COMPLETED|Infusion 2||0
3192698|NCT02065245|3920640|FG004|NOT COMPLETED|Infusion 2||0
3192699|NCT02065245|3920641|FG005|NOT COMPLETED|Infusion 2||0
3192700|NCT02065245|3920642|FG006|NOT COMPLETED|Infusion 2||1
3192701|NCT02065245|3920636|FG000|STARTED|Infusion 3||3
3192702|NCT02065245|3920637|FG001|STARTED|Infusion 3||5
3192703|NCT02065245|3920638|FG002|STARTED|Infusion 3||1
3192704|NCT02065245|3920639|FG003|STARTED|Infusion 3||0
3192705|NCT02065245|3920640|FG004|STARTED|Infusion 3||0
3192706|NCT02065245|3920641|FG005|STARTED|Infusion 3||0
3192707|NCT02065245|3920642|FG006|STARTED|Infusion 3||0
3192708|NCT02065245|3920636|FG000|COMPLETED|Infusion 3||2
3192709|NCT02065245|3920637|FG001|COMPLETED|Infusion 3||4
3192710|NCT02065245|3920638|FG002|COMPLETED|Infusion 3||1
3192711|NCT02065245|3920639|FG003|COMPLETED|Infusion 3||0
3192712|NCT02065245|3920640|FG004|COMPLETED|Infusion 3||0
3192713|NCT02065245|3920641|FG005|COMPLETED|Infusion 3||0
3192714|NCT02065245|3920642|FG006|COMPLETED|Infusion 3||0
3192715|NCT02065245|3920636|FG000|NOT COMPLETED|Infusion 3||1
3192716|NCT02065245|3920637|FG001|NOT COMPLETED|Infusion 3||1
3192717|NCT02065245|3920638|FG002|NOT COMPLETED|Infusion 3||0
3192718|NCT02065245|3920639|FG003|NOT COMPLETED|Infusion 3||0
3192719|NCT02065245|3920640|FG004|NOT COMPLETED|Infusion 3||0
3192720|NCT02065245|3920641|FG005|NOT COMPLETED|Infusion 3||0
3192721|NCT02065245|3920642|FG006|NOT COMPLETED|Infusion 3||0
3192722|NCT02065245|3920636|FG000|STARTED|Infusion 4||1
3192723|NCT02065245|3920637|FG001|STARTED|Infusion 4||2
3192724|NCT02065245|3920638|FG002|STARTED|Infusion 4||1
3192725|NCT02065245|3920639|FG003|STARTED|Infusion 4||0
3192726|NCT02065245|3920640|FG004|STARTED|Infusion 4||0
3192727|NCT02065245|3920641|FG005|STARTED|Infusion 4||0
3192728|NCT02065245|3920642|FG006|STARTED|Infusion 4||0
3192729|NCT02065245|3920636|FG000|COMPLETED|Infusion 4||1
3192730|NCT02065245|3920637|FG001|COMPLETED|Infusion 4||2
3192731|NCT02065245|3920638|FG002|COMPLETED|Infusion 4||1
3192732|NCT02065245|3920639|FG003|COMPLETED|Infusion 4||0
3192733|NCT02065245|3920640|FG004|COMPLETED|Infusion 4||0
3192734|NCT02065245|3920641|FG005|COMPLETED|Infusion 4||0
3192735|NCT02065245|3920642|FG006|COMPLETED|Infusion 4||0
3192736|NCT02065245|3920636|FG000|NOT COMPLETED|Infusion 4||0
3192737|NCT02065245|3920637|FG001|NOT COMPLETED|Infusion 4||0
3192738|NCT02065245|3920638|FG002|NOT COMPLETED|Infusion 4||0
3192739|NCT02065245|3920639|FG003|NOT COMPLETED|Infusion 4||0
3192740|NCT02065245|3920640|FG004|NOT COMPLETED|Infusion 4||0
3192741|NCT02065245|3920641|FG005|NOT COMPLETED|Infusion 4||0
3192742|NCT02065245|3920642|FG006|NOT COMPLETED|Infusion 4||0
3192743|NCT02065336|3920666|FG000|STARTED|Main Study||6
3192744|NCT02065336|3920667|FG001|STARTED|Main Study||6
3192745|NCT02065336|3920668|FG002|STARTED|Main Study||6
3192746|NCT02065336|3920669|FG003|STARTED|Main Study||6
3192747|NCT02065336|3920670|FG004|STARTED|Main Study||6
3192748|NCT02065336|3920671|FG005|STARTED|Main Study||6
3192749|NCT02065336|3920672|FG006|STARTED|Main Study||12
3192750|NCT02065336|3920673|FG007|STARTED|Main Study||10
3192751|NCT02065336|3920674|FG008|STARTED|Main Study||0
3192752|NCT02065336|3920675|FG009|STARTED|Main Study||0
3192753|NCT02065336|3920666|FG000|COMPLETED|Main Study||6
3192754|NCT02065336|3920667|FG001|COMPLETED|Main Study||6
3192755|NCT02065336|3920668|FG002|COMPLETED|Main Study||6
3192756|NCT02065336|3920669|FG003|COMPLETED|Main Study||6
3192757|NCT02065336|3920670|FG004|COMPLETED|Main Study||6
3192758|NCT02065336|3920671|FG005|COMPLETED|Main Study||6
3192759|NCT02065336|3920672|FG006|COMPLETED|Main Study||12
3192760|NCT02065336|3920673|FG007|COMPLETED|Main Study||10
3192761|NCT02065336|3920674|FG008|COMPLETED|Main Study||0
3192762|NCT02065336|3920675|FG009|COMPLETED|Main Study||0
3192763|NCT02065336|3920666|FG000|NOT COMPLETED|Main Study||0
3192764|NCT02065336|3920667|FG001|NOT COMPLETED|Main Study||0
3192765|NCT02065336|3920668|FG002|NOT COMPLETED|Main Study||0
3192766|NCT02065336|3920669|FG003|NOT COMPLETED|Main Study||0
3192767|NCT02065336|3920670|FG004|NOT COMPLETED|Main Study||0
3192768|NCT02065336|3920671|FG005|NOT COMPLETED|Main Study||0
3192769|NCT02065336|3920672|FG006|NOT COMPLETED|Main Study||0
3192770|NCT02065336|3920673|FG007|NOT COMPLETED|Main Study||0
3192771|NCT02065336|3920674|FG008|NOT COMPLETED|Main Study||0
3192772|NCT02065336|3920675|FG009|NOT COMPLETED|Main Study||0
3192773|NCT02065336|3920666|FG000|STARTED|Extension Phase||0
3192774|NCT02065336|3920667|FG001|STARTED|Extension Phase||0
3192775|NCT02065336|3920668|FG002|STARTED|Extension Phase||0
3192776|NCT02065336|3920669|FG003|STARTED|Extension Phase||0
3192777|NCT02065336|3920670|FG004|STARTED|Extension Phase||0
3192778|NCT02065336|3920671|FG005|STARTED|Extension Phase||0
3192779|NCT02065336|3920672|FG006|STARTED|Extension Phase||0
3192780|NCT02065336|3920673|FG007|STARTED|Extension Phase||0
3192781|NCT02065336|3920674|FG008|STARTED|Extension Phase||2
3192782|NCT02065336|3920675|FG009|STARTED|Extension Phase||8
3192783|NCT02065336|3920666|FG000|COMPLETED|Extension Phase||0
3192784|NCT02065336|3920667|FG001|COMPLETED|Extension Phase||0
3192785|NCT02065336|3920668|FG002|COMPLETED|Extension Phase||0
3192786|NCT02065336|3920669|FG003|COMPLETED|Extension Phase||0
3192787|NCT02065336|3920670|FG004|COMPLETED|Extension Phase||0
3192788|NCT02065336|3920671|FG005|COMPLETED|Extension Phase||0
3192789|NCT02065336|3920672|FG006|COMPLETED|Extension Phase||0
3192790|NCT02065336|3920673|FG007|COMPLETED|Extension Phase||0
3192791|NCT02065336|3920674|FG008|COMPLETED|Extension Phase||0
3192792|NCT02065336|3920675|FG009|COMPLETED|Extension Phase||0
3192793|NCT02065336|3920666|FG000|NOT COMPLETED|Extension Phase||0
3192794|NCT02065336|3920667|FG001|NOT COMPLETED|Extension Phase||0
3192795|NCT02065336|3920668|FG002|NOT COMPLETED|Extension Phase||0
3192796|NCT02065336|3920669|FG003|NOT COMPLETED|Extension Phase||0
3192797|NCT02065336|3920670|FG004|NOT COMPLETED|Extension Phase||0
3192798|NCT02065336|3920671|FG005|NOT COMPLETED|Extension Phase||0
3192799|NCT02065336|3920672|FG006|NOT COMPLETED|Extension Phase||0
3192800|NCT02065336|3920673|FG007|NOT COMPLETED|Extension Phase||0
3192801|NCT02065336|3920674|FG008|NOT COMPLETED|Extension Phase||2
3192802|NCT02065336|3920675|FG009|NOT COMPLETED|Extension Phase||8
3192803|NCT02065453|3920708|FG000|STARTED|Overall Study||27
3192804|NCT02065453|3920709|FG001|STARTED|Overall Study||25
3192805|NCT02065453|3920708|FG000|COMPLETED|Overall Study||24
3192806|NCT02065453|3920709|FG001|COMPLETED|Overall Study||21
3192807|NCT02065453|3920708|FG000|NOT COMPLETED|Overall Study||3
3192808|NCT02065453|3920709|FG001|NOT COMPLETED|Overall Study||4
3192809|NCT02065479|3920716|FG000|STARTED|Overall Study||33
3192810|NCT02065479|3920717|FG001|STARTED|Overall Study||32
3192811|NCT02065479|3920716|FG000|COMPLETED|Overall Study||33
3192812|NCT02065479|3920717|FG001|COMPLETED|Overall Study||32
3192813|NCT02065479|3920716|FG000|NOT COMPLETED|Overall Study||0
3192814|NCT02065479|3920717|FG001|NOT COMPLETED|Overall Study||0
3192815|NCT02065518|3920727|FG000|STARTED|Overall Study||19
3192816|NCT02065518|3920728|FG001|STARTED|Overall Study||19
3192817|NCT02065518|3920729|FG002|STARTED|Overall Study||20
3192818|NCT02065518|3920730|FG003|STARTED|Overall Study||20
3192819|NCT02065518|3920727|FG000|COMPLETED|Overall Study||13
3192820|NCT02065518|3920728|FG001|COMPLETED|Overall Study||11
3192821|NCT02065518|3920729|FG002|COMPLETED|Overall Study||11
3192822|NCT02065518|3920730|FG003|COMPLETED|Overall Study||15
3192823|NCT02065518|3920727|FG000|NOT COMPLETED|Overall Study||6
3192824|NCT02065518|3920728|FG001|NOT COMPLETED|Overall Study||8
3192825|NCT02065518|3920729|FG002|NOT COMPLETED|Overall Study||9
3192826|NCT02065518|3920730|FG003|NOT COMPLETED|Overall Study||5
3192827|NCT02065557|3920743|FG000|STARTED|Induction Period||32
3192828|NCT02065557|3920744|FG001|STARTED|Induction Period||51
3192829|NCT02065557|3920745|FG002|STARTED|Induction Period||18
3192830|NCT02065557|3920746|FG003|STARTED|Induction Period||0
3192831|NCT02065557|3920747|FG004|STARTED|Induction Period||0
3192832|NCT02065557|3920748|FG005|STARTED|Induction Period||0
3192833|NCT02065557|3920743|FG000|Enrolled in Main Study|Induction Period||30
3192834|NCT02065557|3920744|FG001|Enrolled in Main Study|Induction Period||47
3192835|NCT02065557|3920745|FG002|Enrolled in Main Study|Induction Period||16
3192836|NCT02065557|3920746|FG003|Enrolled in Main Study|Induction Period||0
3192837|NCT02065557|3920747|FG004|Enrolled in Main Study|Induction Period||0
3192838|NCT02065557|3920748|FG005|Enrolled in Main Study|Induction Period||0
3192839|NCT02065557|3920743|FG000|Enrolled in Japan Sub-study|Induction Period||2
3192840|NCT02065557|3920744|FG001|Enrolled in Japan Sub-study|Induction Period||4
3192841|NCT02065557|3920745|FG002|Enrolled in Japan Sub-study|Induction Period||2
3192842|NCT02065557|3920746|FG003|Enrolled in Japan Sub-study|Induction Period||0
3192843|NCT02065557|3920747|FG004|Enrolled in Japan Sub-study|Induction Period||0
3192844|NCT02065557|3920748|FG005|Enrolled in Japan Sub-study|Induction Period||0
3192845|NCT02065557|3920743|FG000|COMPLETED|Induction Period||22
3192846|NCT02065557|3920744|FG001|COMPLETED|Induction Period||43
3192847|NCT02065557|3920745|FG002|COMPLETED|Induction Period||16
3192848|NCT02065557|3920746|FG003|COMPLETED|Induction Period||0
3192849|NCT02065557|3920747|FG004|COMPLETED|Induction Period||0
3192850|NCT02065557|3920748|FG005|COMPLETED|Induction Period||0
3192851|NCT02065557|3920743|FG000|NOT COMPLETED|Induction Period||10
3192852|NCT02065557|3920744|FG001|NOT COMPLETED|Induction Period||8
3192853|NCT02065557|3920745|FG002|NOT COMPLETED|Induction Period||2
3192854|NCT02065557|3920746|FG003|NOT COMPLETED|Induction Period||0
3192855|NCT02065557|3920747|FG004|NOT COMPLETED|Induction Period||0
3192856|NCT02065557|3920748|FG005|NOT COMPLETED|Induction Period||0
3192857|NCT02065557|3920743|FG000|STARTED|Maintenance Period||0
3192858|NCT02065557|3920744|FG001|STARTED|Maintenance Period||0
3192859|NCT02065557|3920745|FG002|STARTED|Maintenance Period||0
3192860|NCT02065557|3920746|FG003|STARTED|Maintenance Period||12
3192861|NCT02065557|3920747|FG004|STARTED|Maintenance Period||33
3192862|NCT02065557|3920748|FG005|STARTED|Maintenance Period||36
3192863|NCT02065557|3920743|FG000|COMPLETED|Maintenance Period||0
3192864|NCT02065557|3920744|FG001|COMPLETED|Maintenance Period||0
3192865|NCT02065557|3920745|FG002|COMPLETED|Maintenance Period||0
3192866|NCT02065557|3920746|FG003|COMPLETED|Maintenance Period||11
3192867|NCT02065557|3920747|FG004|COMPLETED|Maintenance Period||25
3192868|NCT02065557|3920748|FG005|COMPLETED|Maintenance Period||32
3192869|NCT02065557|3920743|FG000|NOT COMPLETED|Maintenance Period||0
3192870|NCT02065557|3920744|FG001|NOT COMPLETED|Maintenance Period||0
3192871|NCT02065557|3920745|FG002|NOT COMPLETED|Maintenance Period||0
3192872|NCT02065557|3920746|FG003|NOT COMPLETED|Maintenance Period||1
3192873|NCT02065557|3920747|FG004|NOT COMPLETED|Maintenance Period||8
3192874|NCT02065557|3920748|FG005|NOT COMPLETED|Maintenance Period||4
3192875|NCT02065570|3920775|FG000|STARTED|Induction Study||206
3192876|NCT02065570|3920776|FG001|STARTED|Induction Study||308
3192877|NCT02065570|3920777|FG002|STARTED|Induction Study||0
3192878|NCT02065570|3920778|FG003|STARTED|Induction Study||0
3192879|NCT02065570|3920775|FG000|COMPLETED|Induction Study||192
3192880|NCT02065570|3920776|FG001|COMPLETED|Induction Study||287
3192881|NCT02065570|3920777|FG002|COMPLETED|Induction Study||0
3192882|NCT02065570|3920778|FG003|COMPLETED|Induction Study||0
3192883|NCT02065570|3920775|FG000|NOT COMPLETED|Induction Study||14
3192884|NCT02065570|3920776|FG001|NOT COMPLETED|Induction Study||21
3192885|NCT02065570|3920777|FG002|NOT COMPLETED|Induction Study||0
3192886|NCT02065570|3920778|FG003|NOT COMPLETED|Induction Study||0
3192887|NCT02065570|3920775|FG000|STARTED|Maintenance Study||0
3192888|NCT02065570|3920776|FG001|STARTED|Maintenance Study||0
3192889|NCT02065570|3920777|FG002|STARTED|Maintenance Study||109
3192890|NCT02065570|3920778|FG003|STARTED|Maintenance Study||109
3192891|NCT02065570|3920775|FG000|COMPLETED|Maintenance Study||0
3192892|NCT02065570|3920776|FG001|COMPLETED|Maintenance Study||0
3192893|NCT02065570|3920777|FG002|COMPLETED|Maintenance Study||87
3192894|NCT02065570|3920778|FG003|COMPLETED|Maintenance Study||90
3192895|NCT02065570|3920775|FG000|NOT COMPLETED|Maintenance Study||0
3192896|NCT02065570|3920776|FG001|NOT COMPLETED|Maintenance Study||0
3192897|NCT02065570|3920777|FG002|NOT COMPLETED|Maintenance Study||22
3192898|NCT02065570|3920778|FG003|NOT COMPLETED|Maintenance Study||19
3192899|NCT02065622|3920791|FG000|STARTED|Induction Study||379
3192900|NCT02065622|3920792|FG001|STARTED|Induction Study||573
3192901|NCT02065622|3920793|FG002|STARTED|Induction Study||0
3192902|NCT02065622|3920794|FG003|STARTED|Induction Study||0
3192903|NCT02065622|3920795|FG004|STARTED|Induction Study||0
3192904|NCT02065622|3920791|FG000|Enrolled in Main Study|Induction Study||340
3192905|NCT02065622|3920792|FG001|Enrolled in Main Study|Induction Study||512
3192906|NCT02065622|3920793|FG002|Enrolled in Main Study|Induction Study||0
3192907|NCT02065622|3920794|FG003|Enrolled in Main Study|Induction Study||0
3192908|NCT02065622|3920795|FG004|Enrolled in Main Study|Induction Study||0
3192909|NCT02065622|3920791|FG000|Enrolled in Japan Sub-Study|Induction Study||39
3192910|NCT02065622|3920792|FG001|Enrolled in Japan Sub-Study|Induction Study||61
3192911|NCT02065622|3920793|FG002|Enrolled in Japan Sub-Study|Induction Study||0
3192912|NCT02065622|3920794|FG003|Enrolled in Japan Sub-Study|Induction Study||0
3192913|NCT02065622|3920795|FG004|Enrolled in Japan Sub-Study|Induction Study||0
3192914|NCT02065622|3920791|FG000|COMPLETED|Induction Study||332
3192915|NCT02065622|3920792|FG001|COMPLETED|Induction Study||514
3192916|NCT02065622|3920793|FG002|COMPLETED|Induction Study||0
3192917|NCT02065622|3920794|FG003|COMPLETED|Induction Study||0
3192918|NCT02065622|3920795|FG004|COMPLETED|Induction Study||0
3192919|NCT02065622|3920791|FG000|NOT COMPLETED|Induction Study||47
3192920|NCT02065622|3920792|FG001|NOT COMPLETED|Induction Study||59
3192921|NCT02065622|3920793|FG002|NOT COMPLETED|Induction Study||0
3192922|NCT02065622|3920794|FG003|NOT COMPLETED|Induction Study||0
3192923|NCT02065622|3920795|FG004|NOT COMPLETED|Induction Study||0
3192924|NCT02065622|3920791|FG000|STARTED|Maintenance Study||0
3192925|NCT02065622|3920792|FG001|STARTED|Maintenance Study||0
3192926|NCT02065622|3920793|FG002|STARTED|Maintenance Study||345
3192927|NCT02065622|3920794|FG003|STARTED|Maintenance Study||350
3192928|NCT02065622|3920795|FG004|STARTED|Maintenance Study||151
3192929|NCT02065622|3920791|FG000|COMPLETED|Maintenance Study||0
3192930|NCT02065622|3920792|FG001|COMPLETED|Maintenance Study||0
3192931|NCT02065622|3920793|FG002|COMPLETED|Maintenance Study||221
3192932|NCT02065622|3920794|FG003|COMPLETED|Maintenance Study||246
3192933|NCT02065622|3920795|FG004|COMPLETED|Maintenance Study||105
3192934|NCT02065622|3920791|FG000|NOT COMPLETED|Maintenance Study||0
3192935|NCT02065622|3920792|FG001|NOT COMPLETED|Maintenance Study||0
3192936|NCT02065622|3920793|FG002|NOT COMPLETED|Maintenance Study||124
3192937|NCT02065622|3920794|FG003|NOT COMPLETED|Maintenance Study||104
3192938|NCT02065622|3920795|FG004|NOT COMPLETED|Maintenance Study||46
3192939|NCT02065687|3920812|FG000|STARTED|Overall Study||234
3192940|NCT02065687|3920813|FG001|STARTED|Overall Study||235
3192941|NCT02065687|3920812|FG000|COMPLETED|Overall Study||234
3192942|NCT02065687|3920813|FG001|COMPLETED|Overall Study||235
3192943|NCT02065687|3920812|FG000|NOT COMPLETED|Overall Study||0
3192944|NCT02065687|3920813|FG001|NOT COMPLETED|Overall Study||0
3192945|NCT02065713|3920821|FG000|STARTED|Overall Study||23
3192946|NCT02065713|3920822|FG001|STARTED|Overall Study||21
3192947|NCT02065713|3920821|FG000|COMPLETED|Overall Study||22
3192948|NCT02065713|3920822|FG001|COMPLETED|Overall Study||20
3192949|NCT02065713|3920821|FG000|NOT COMPLETED|Overall Study||1
3192950|NCT02065713|3920822|FG001|NOT COMPLETED|Overall Study||1
3192951|NCT02065791|3920830|FG000|STARTED|Overall Study||2199
3192952|NCT02065791|3920831|FG001|STARTED|Overall Study||2202
3192953|NCT02065791|3920830|FG000|Treated|Overall Study||2197
3192954|NCT02065791|3920831|FG001|Treated|Overall Study||2200
3192955|NCT02065791|3920830|FG000|COMPLETED|Overall Study||2174
3192956|NCT02065791|3920831|FG001|COMPLETED|Overall Study||2187
3192957|NCT02065791|3920830|FG000|NOT COMPLETED|Overall Study||25
3192958|NCT02065791|3920831|FG001|NOT COMPLETED|Overall Study||15
3192959|NCT02065895|3920837|FG000|STARTED|Overall Study||1
3192960|NCT02065895|3920838|FG001|STARTED|Overall Study||3
3192961|NCT02065895|3920839|FG002|STARTED|Overall Study||1
3192962|NCT02065895|3920840|FG003|STARTED|Overall Study||1
3192963|NCT02065895|3920841|FG004|STARTED|Overall Study||1
3192964|NCT02065895|3920842|FG005|STARTED|Overall Study||1
3192965|NCT02065895|3920837|FG000|COMPLETED|Overall Study||0
3192966|NCT02065895|3920838|FG001|COMPLETED|Overall Study||2
3192967|NCT02065895|3920839|FG002|COMPLETED|Overall Study||1
3192968|NCT02065895|3920840|FG003|COMPLETED|Overall Study||0
3192969|NCT02065895|3920841|FG004|COMPLETED|Overall Study||1
3192970|NCT02065895|3920842|FG005|COMPLETED|Overall Study||1
3192971|NCT02065895|3920837|FG000|NOT COMPLETED|Overall Study||1
3192972|NCT02065895|3920838|FG001|NOT COMPLETED|Overall Study||1
3192973|NCT02065895|3920839|FG002|NOT COMPLETED|Overall Study||0
3192974|NCT02065895|3920840|FG003|NOT COMPLETED|Overall Study||1
3192975|NCT02065895|3920841|FG004|NOT COMPLETED|Overall Study||0
3192976|NCT02065895|3920842|FG005|NOT COMPLETED|Overall Study||0
3192977|NCT02066051|3920859|FG000|STARTED|Overall Study||8
3192978|NCT02066051|3920859|FG000|COMPLETED|Overall Study||7
3192979|NCT02066051|3920859|FG000|NOT COMPLETED|Overall Study||1
3192980|NCT02066129|3920865|FG000|STARTED|Overall Study||127
3192981|NCT02066129|3920866|FG001|STARTED|Overall Study||127
3192982|NCT02066129|3920865|FG000|COMPLETED|Overall Study||98
3192983|NCT02066129|3920866|FG001|COMPLETED|Overall Study||94
3192984|NCT02066129|3920865|FG000|NOT COMPLETED|Overall Study||29
3192985|NCT02066129|3920866|FG001|NOT COMPLETED|Overall Study||33
3192986|NCT02066233|3920874|FG000|STARTED|EG Scan II (Day 1)||50
3192987|NCT02066233|3920875|FG001|STARTED|EG Scan II (Day 1)||50
3192988|NCT02066233|3920874|FG000|COMPLETED|EG Scan II (Day 1)||44
3192989|NCT02066233|3920875|FG001|COMPLETED|EG Scan II (Day 1)||44
3192990|NCT02066233|3920874|FG000|NOT COMPLETED|EG Scan II (Day 1)||6
3192991|NCT02066233|3920875|FG001|NOT COMPLETED|EG Scan II (Day 1)||6
3192992|NCT02066233|3920874|FG000|STARTED|Standard Endoscopy (Day 2)||44
3192993|NCT02066233|3920875|FG001|STARTED|Standard Endoscopy (Day 2)||44
3192994|NCT02066233|3920874|FG000|COMPLETED|Standard Endoscopy (Day 2)||44
3192995|NCT02066233|3920875|FG001|COMPLETED|Standard Endoscopy (Day 2)||44
3192996|NCT02066233|3920874|FG000|NOT COMPLETED|Standard Endoscopy (Day 2)||0
3192997|NCT02066233|3920875|FG001|NOT COMPLETED|Standard Endoscopy (Day 2)||0
3192998|NCT02066298|3920887|FG000|STARTED|Overall Study||49
3192999|NCT02066298|3920888|FG001|STARTED|Overall Study||48
3193000|NCT02066298|3920889|FG002|STARTED|Overall Study||50
3193001|NCT02066298|3920890|FG003|STARTED|Overall Study||51
3193002|NCT02066298|3920891|FG004|STARTED|Overall Study||47
3193003|NCT02066298|3920892|FG005|STARTED|Overall Study||50
3193004|NCT02066298|3920887|FG000|Completed 1st Period|Overall Study||44
3193005|NCT02066298|3920888|FG001|Completed 1st Period|Overall Study||47
3193006|NCT02066298|3920889|FG002|Completed 1st Period|Overall Study||45
3193007|NCT02066298|3920890|FG003|Completed 1st Period|Overall Study||48
3193008|NCT02066298|3920891|FG004|Completed 1st Period|Overall Study||46
3193009|NCT02066298|3920892|FG005|Completed 1st Period|Overall Study||45
3193010|NCT02066298|3920887|FG000|Completed 2nd Period|Overall Study||41
3193011|NCT02066298|3920888|FG001|Completed 2nd Period|Overall Study||41
3193012|NCT02066298|3920889|FG002|Completed 2nd Period|Overall Study||41
3193013|NCT02066298|3920890|FG003|Completed 2nd Period|Overall Study||46
3193014|NCT02066298|3920891|FG004|Completed 2nd Period|Overall Study||42
3193015|NCT02066298|3920892|FG005|Completed 2nd Period|Overall Study||41
3193016|NCT02066298|3920887|FG000|Completed 3rd Period|Overall Study||40
3193017|NCT02066298|3920888|FG001|Completed 3rd Period|Overall Study||40
3193018|NCT02066298|3920889|FG002|Completed 3rd Period|Overall Study||40
3193019|NCT02066298|3920890|FG003|Completed 3rd Period|Overall Study||45
3193020|NCT02066298|3920891|FG004|Completed 3rd Period|Overall Study||38
3193021|NCT02066298|3920892|FG005|Completed 3rd Period|Overall Study||38
3193022|NCT02066298|3920887|FG000|COMPLETED|Overall Study||40
3193023|NCT02066298|3920888|FG001|COMPLETED|Overall Study||40
3193024|NCT02066298|3920889|FG002|COMPLETED|Overall Study||40
3193025|NCT02066298|3920890|FG003|COMPLETED|Overall Study||45
3193026|NCT02066298|3920891|FG004|COMPLETED|Overall Study||38
3193027|NCT02066298|3920892|FG005|COMPLETED|Overall Study||38
3193028|NCT02066298|3920887|FG000|NOT COMPLETED|Overall Study||9
3193029|NCT02066298|3920888|FG001|NOT COMPLETED|Overall Study||8
3193030|NCT02066298|3920889|FG002|NOT COMPLETED|Overall Study||10
3193031|NCT02066298|3920890|FG003|NOT COMPLETED|Overall Study||6
3193032|NCT02066298|3920891|FG004|NOT COMPLETED|Overall Study||9
3193033|NCT02066298|3920892|FG005|NOT COMPLETED|Overall Study||12
3193034|NCT02066311|3920904|FG000|STARTED|Overall Study||15
3193035|NCT02066311|3920904|FG000|COMPLETED|Overall Study|Stage 1 terminated 6/1/18 prior to completion of Stage 1 due to low enrollment and efficacy.|10
3193036|NCT02066311|3920904|FG000|NOT COMPLETED|Overall Study||5
3193037|NCT02066389|3920914|FG000|STARTED|Overall Study||50
3193038|NCT02066389|3920915|FG001|STARTED|Overall Study||50
3193039|NCT02066389|3920916|FG002|STARTED|Overall Study||50
3193040|NCT02066389|3920917|FG003|STARTED|Overall Study||50
3193041|NCT02066389|3920918|FG004|STARTED|Overall Study||50
3193042|NCT02066389|3920919|FG005|STARTED|Overall Study||50
3193043|NCT02066389|3920914|FG000|Received Study Drug|Overall Study||50
3193044|NCT02066389|3920915|FG001|Received Study Drug|Overall Study||50
3193045|NCT02066389|3920916|FG002|Received Study Drug|Overall Study||50
3193046|NCT02066389|3920917|FG003|Received Study Drug|Overall Study||50
3193047|NCT02066389|3920918|FG004|Received Study Drug|Overall Study||50
3193048|NCT02066389|3920919|FG005|Received Study Drug|Overall Study||49
3193049|NCT02066389|3920914|FG000|COMPLETED|Overall Study||45
3193050|NCT02066389|3920915|FG001|COMPLETED|Overall Study||49
3193051|NCT02066389|3920916|FG002|COMPLETED|Overall Study||44
3193052|NCT02066389|3920917|FG003|COMPLETED|Overall Study||47
3193053|NCT02066389|3920918|FG004|COMPLETED|Overall Study||43
3193054|NCT02066389|3920919|FG005|COMPLETED|Overall Study||45
3193055|NCT02066389|3920914|FG000|NOT COMPLETED|Overall Study||5
3193056|NCT02066389|3920915|FG001|NOT COMPLETED|Overall Study||1
3193057|NCT02066389|3920916|FG002|NOT COMPLETED|Overall Study||6
3193058|NCT02066389|3920917|FG003|NOT COMPLETED|Overall Study||3
3193059|NCT02066389|3920918|FG004|NOT COMPLETED|Overall Study||7
3193060|NCT02066389|3920919|FG005|NOT COMPLETED|Overall Study||5
3193061|NCT02066402|3920935|FG000|STARTED|Overall Study||300
3193062|NCT02066402|3920936|FG001|STARTED|Overall Study||298
3193063|NCT02066402|3920935|FG000|Participants Received Treatment|Overall Study||292
3193064|NCT02066402|3920936|FG001|Participants Received Treatment|Overall Study||297
3193065|NCT02066402|3920935|FG000|Completed Study Treatment Period|Overall Study||261
3193066|NCT02066402|3920936|FG001|Completed Study Treatment Period|Overall Study||256
3193067|NCT02066402|3920935|FG000|COMPLETED|Overall Study||274
3193068|NCT02066402|3920936|FG001|COMPLETED|Overall Study||275
3193069|NCT02066402|3920935|FG000|NOT COMPLETED|Overall Study||26
3193070|NCT02066402|3920936|FG001|NOT COMPLETED|Overall Study||23
3193071|NCT02066415|3920945|FG000|STARTED|Overall Study||286
3193072|NCT02066415|3920946|FG001|STARTED|Overall Study||191
3193073|NCT02066415|3920947|FG002|STARTED|Overall Study||190
3193074|NCT02066415|3920945|FG000|Received Study Drug|Overall Study||282
3193075|NCT02066415|3920946|FG001|Received Study Drug|Overall Study||190
3193076|NCT02066415|3920947|FG002|Received Study Drug|Overall Study||188
3193077|NCT02066415|3920945|FG000|COMPLETED|Overall Study||265
3193078|NCT02066415|3920946|FG001|COMPLETED|Overall Study||184
3193079|NCT02066415|3920947|FG002|COMPLETED|Overall Study||182
3193080|NCT02066415|3920945|FG000|NOT COMPLETED|Overall Study||21
3193081|NCT02066415|3920946|FG001|NOT COMPLETED|Overall Study||7
3193082|NCT02066415|3920947|FG002|NOT COMPLETED|Overall Study||8
3193083|NCT02066467|3920955|FG000|STARTED|Overall Study||863
3193084|NCT02066467|3920955|FG000|COMPLETED|Overall Study||648
3193085|NCT02066467|3920955|FG000|NOT COMPLETED|Overall Study||215
3193086|NCT02066727|3920961|FG000|STARTED|Overall Study||30
3193087|NCT02066727|3920962|FG001|STARTED|Overall Study||30
3193088|NCT02066727|3920961|FG000|COMPLETED|Overall Study||30
3193089|NCT02066727|3920962|FG001|COMPLETED|Overall Study||30
3193090|NCT02066727|3920961|FG000|NOT COMPLETED|Overall Study||0
3193091|NCT02066727|3920962|FG001|NOT COMPLETED|Overall Study||0
3193092|NCT02066740|3920968|FG000|STARTED|Overall Study||34
3193093|NCT02066740|3920968|FG000|COMPLETED|Overall Study||32
3193094|NCT02066740|3920968|FG000|NOT COMPLETED|Overall Study||2
3193095|NCT02066792|3920976|FG000|STARTED|Overall Study||40
3193096|NCT02066792|3920977|FG001|STARTED|Overall Study||38
3193097|NCT02066792|3920978|FG002|STARTED|Overall Study||38
3193098|NCT02066792|3920979|FG003|STARTED|Overall Study||36
3193099|NCT02066792|3920976|FG000|COMPLETED|Overall Study||33
3193100|NCT02066792|3920977|FG001|COMPLETED|Overall Study||33
3193101|NCT02066792|3920978|FG002|COMPLETED|Overall Study||30
3193102|NCT02066792|3920979|FG003|COMPLETED|Overall Study||27
3193103|NCT02066792|3920976|FG000|NOT COMPLETED|Overall Study||7
3193104|NCT02066792|3920977|FG001|NOT COMPLETED|Overall Study||5
3193105|NCT02066792|3920978|FG002|NOT COMPLETED|Overall Study||8
3193106|NCT02066792|3920979|FG003|NOT COMPLETED|Overall Study||9
3193107|NCT02066857|3920991|FG000|STARTED|Overall Study||1
3193108|NCT02066857|3920992|FG001|STARTED|Overall Study||4
3193109|NCT02066857|3920991|FG000|COMPLETED|Overall Study||0
3193110|NCT02066857|3920992|FG001|COMPLETED|Overall Study||3
3193111|NCT02066857|3920991|FG000|NOT COMPLETED|Overall Study||1
3193112|NCT02066857|3920992|FG001|NOT COMPLETED|Overall Study||1
3193113|NCT02066896|3921001|FG000|STARTED|Overall Study||33
3193114|NCT02066896|3921002|FG001|STARTED|Overall Study||33
3193115|NCT02066896|3921001|FG000|COMPLETED|Overall Study||33
3193116|NCT02066896|3921002|FG001|COMPLETED|Overall Study||33
3193117|NCT02066896|3921001|FG000|NOT COMPLETED|Overall Study||0
3193118|NCT02066896|3921002|FG001|NOT COMPLETED|Overall Study||0
3193119|NCT02066922|3921008|FG000|STARTED|Overall Study||15
3193120|NCT02066922|3921008|FG000|COMPLETED|Overall Study||14
3193121|NCT02066922|3921008|FG000|NOT COMPLETED|Overall Study||1
3193122|NCT02067000|3921015|FG000|STARTED|Overall Study||217
3193123|NCT02067000|3921015|FG000|COMPLETED|Overall Study||167
3193124|NCT02067000|3921015|FG000|NOT COMPLETED|Overall Study||50
3193125|NCT02067039|3921021|FG000|STARTED|Overall Study||1325
3193126|NCT02067039|3921022|FG001|STARTED|Overall Study||1340
3193127|NCT02067039|3921021|FG000|3 Month Survey|Overall Study||824
3193128|NCT02067039|3921022|FG001|3 Month Survey|Overall Study||766
3193129|NCT02067039|3921021|FG000|6 Month Survey|Overall Study||735
3193130|NCT02067039|3921022|FG001|6 Month Survey|Overall Study||756
3193131|NCT02067039|3921021|FG000|9 Month Survey|Overall Study||748
3193132|NCT02067039|3921022|FG001|9 Month Survey|Overall Study||838
3193133|NCT02067039|3921021|FG000|COMPLETED|Overall Study||752
3193134|NCT02067039|3921022|FG001|COMPLETED|Overall Study||832
3193135|NCT02067039|3921021|FG000|NOT COMPLETED|Overall Study||573
3193136|NCT02067039|3921022|FG001|NOT COMPLETED|Overall Study||508
3193137|NCT02067273|3921032|FG000|STARTED|Overall Study||5
3193138|NCT02067273|3921033|FG001|STARTED|Overall Study||15
3193139|NCT02067273|3921032|FG000|COMPLETED|Overall Study||5
3193140|NCT02067273|3921033|FG001|COMPLETED|Overall Study||12
3193141|NCT02067273|3921032|FG000|NOT COMPLETED|Overall Study||0
3193142|NCT02067273|3921033|FG001|NOT COMPLETED|Overall Study||3
3193143|NCT02067468|3921042|FG000|STARTED|Overall Study||882
3193144|NCT02067468|3921043|FG001|STARTED|Overall Study||890
3193145|NCT02067468|3921044|FG002|STARTED|Overall Study||889
3193146|NCT02067468|3921042|FG000|Followed-up Through Medical Records|Overall Study||882
3193147|NCT02067468|3921043|FG001|Followed-up Through Medical Records|Overall Study||890
3193148|NCT02067468|3921044|FG002|Followed-up Through Medical Records|Overall Study||889
3193149|NCT02067468|3921042|FG000|Had at Least One Routine Colposcopy|Overall Study||772
3193150|NCT02067468|3921043|FG001|Had at Least One Routine Colposcopy|Overall Study||372
3193151|NCT02067468|3921044|FG002|Had at Least One Routine Colposcopy|Overall Study||462
3193152|NCT02067468|3921042|FG000|COMPLETED|Overall Study||882
3193153|NCT02067468|3921043|FG001|COMPLETED|Overall Study||890
3193154|NCT02067468|3921044|FG002|COMPLETED|Overall Study||889
3193155|NCT02067468|3921042|FG000|NOT COMPLETED|Overall Study||0
3193156|NCT02067468|3921043|FG001|NOT COMPLETED|Overall Study||0
3193157|NCT02067468|3921044|FG002|NOT COMPLETED|Overall Study||0
3193158|NCT02067533|3921054|FG000|STARTED|Overall Study||45
3193159|NCT02067533|3921055|FG001|STARTED|Overall Study||46
3193160|NCT02067533|3921054|FG000|COMPLETED|Overall Study||41
3193161|NCT02067533|3921055|FG001|COMPLETED|Overall Study||44
3193162|NCT02067533|3921054|FG000|NOT COMPLETED|Overall Study||4
3193163|NCT02067533|3921055|FG001|NOT COMPLETED|Overall Study||2
3193164|NCT02067585|3921064|FG000|STARTED|Overall Study||16
3193165|NCT02067585|3921065|FG001|STARTED|Overall Study||16
3193166|NCT02067585|3921066|FG002|STARTED|Overall Study||16
3193167|NCT02067585|3921064|FG000|COMPLETED|Overall Study||16
3193168|NCT02067585|3921065|FG001|COMPLETED|Overall Study||16
3193169|NCT02067585|3921066|FG002|COMPLETED|Overall Study||16
3193170|NCT02067585|3921064|FG000|NOT COMPLETED|Overall Study||0
3193171|NCT02067585|3921065|FG001|NOT COMPLETED|Overall Study||0
3193172|NCT02067585|3921066|FG002|NOT COMPLETED|Overall Study||0
3193173|NCT02067663|3921076|FG000|STARTED|Overall Study||68
3193174|NCT02067663|3921077|FG001|STARTED|Overall Study||55
3193175|NCT02067663|3921076|FG000|COMPLETED|Overall Study||55
3193176|NCT02067663|3921077|FG001|COMPLETED|Overall Study||41
3193177|NCT02067663|3921076|FG000|NOT COMPLETED|Overall Study||13
3193178|NCT02067663|3921077|FG001|NOT COMPLETED|Overall Study||14
3193179|NCT02067676|3921089|FG000|STARTED|Overall Study||8
3193180|NCT02067676|3921090|FG001|STARTED|Overall Study||8
3193181|NCT02067676|3921091|FG002|STARTED|Overall Study||8
3193182|NCT02067676|3921092|FG003|STARTED|Overall Study||8
3193183|NCT02067676|3921093|FG004|STARTED|Overall Study||8
3193184|NCT02067676|3921094|FG005|STARTED|Overall Study||8
3193185|NCT02067676|3921089|FG000|COMPLETED|Overall Study||7
3193186|NCT02067676|3921090|FG001|COMPLETED|Overall Study||8
3193187|NCT02067676|3921091|FG002|COMPLETED|Overall Study||8
3193188|NCT02067676|3921092|FG003|COMPLETED|Overall Study||8
3193189|NCT02067676|3921093|FG004|COMPLETED|Overall Study||8
3193190|NCT02067676|3921094|FG005|COMPLETED|Overall Study||8
3193191|NCT02067676|3921089|FG000|NOT COMPLETED|Overall Study||1
3193192|NCT02067676|3921090|FG001|NOT COMPLETED|Overall Study||0
3193193|NCT02067676|3921091|FG002|NOT COMPLETED|Overall Study||0
3193194|NCT02067676|3921092|FG003|NOT COMPLETED|Overall Study||0
3193195|NCT02067676|3921093|FG004|NOT COMPLETED|Overall Study||0
3193196|NCT02067676|3921094|FG005|NOT COMPLETED|Overall Study||0
3193197|NCT02067728|3921115|FG000|STARTED|Baseline - 1 Month Follow up Survey||220
3193198|NCT02067728|3921116|FG001|STARTED|Baseline - 1 Month Follow up Survey||210
3193199|NCT02067728|3921115|FG000|COMPLETED|Baseline - 1 Month Follow up Survey|213 parents/guardians completed the surveys, along with 82 teens.|213
3193200|NCT02067728|3921116|FG001|COMPLETED|Baseline - 1 Month Follow up Survey|182 parent/guardians completed the surveys, along with 75 teens.|182
3193201|NCT02067728|3921115|FG000|NOT COMPLETED|Baseline - 1 Month Follow up Survey||7
3193202|NCT02067728|3921116|FG001|NOT COMPLETED|Baseline - 1 Month Follow up Survey||28
3193203|NCT02067728|3921115|FG000|STARTED|6 Month Follow up Survey|Participants completed the 6 month follow up even if 1 month data wasn't able to be collected.|220
3193204|NCT02067728|3921116|FG001|STARTED|6 Month Follow up Survey|Participants completed the 6 month follow up even if 1 month data wasn't able to be collected.|210
3193205|NCT02067728|3921115|FG000|COMPLETED|6 Month Follow up Survey|172 parent/guardians completed surveys at this time point, along with 71 teens.|172
3193206|NCT02067728|3921116|FG001|COMPLETED|6 Month Follow up Survey|150 parent/guardians completed surveys at this time point, along with 69 teens.|150
3193207|NCT02067728|3921115|FG000|NOT COMPLETED|6 Month Follow up Survey||48
3193208|NCT02067728|3921116|FG001|NOT COMPLETED|6 Month Follow up Survey||60
3193209|NCT02067728|3921115|FG000|STARTED|6 Month Measurements||220
3193210|NCT02067728|3921116|FG001|STARTED|6 Month Measurements||210
3193211|NCT02067728|3921115|FG000|COMPLETED|6 Month Measurements|Number includes 6 month measurements & chart review for visits at 6 months +/- 2 months from initial|106
3193212|NCT02067728|3921116|FG001|COMPLETED|6 Month Measurements|Number includes 6 month measurements & chart review for visits at 6 months +/- 2 months from initial|113
3193213|NCT02067728|3921115|FG000|NOT COMPLETED|6 Month Measurements||114
3193214|NCT02067728|3921116|FG001|NOT COMPLETED|6 Month Measurements||97
3193215|NCT02067806|3921122|FG000|STARTED|Overall Study||394
3193216|NCT02067806|3921122|FG000|COMPLETED|Overall Study||387
3193217|NCT02067806|3921122|FG000|NOT COMPLETED|Overall Study||7
3193218|NCT02067858|3921127|FG000|STARTED|Overall Study||6
3193219|NCT02067858|3921127|FG000|COMPLETED|Overall Study||6
3193220|NCT02067858|3921127|FG000|NOT COMPLETED|Overall Study||0
3193221|NCT02068027|3921133|FG000|STARTED|Overall Study||130
3193222|NCT02068027|3921134|FG001|STARTED|Overall Study||130
3193223|NCT02068027|3921133|FG000|COMPLETED|Overall Study||117
3193224|NCT02068027|3921134|FG001|COMPLETED|Overall Study||114
3193225|NCT02068027|3921133|FG000|NOT COMPLETED|Overall Study||13
3193226|NCT02068027|3921134|FG001|NOT COMPLETED|Overall Study||16
3193227|NCT02068118|3921142|FG000|STARTED|18-month Comparative Study Period||455
3193228|NCT02068118|3921143|FG001|STARTED|18-month Comparative Study Period||482
3193229|NCT02068118|3921142|FG000|COMPLETED|18-month Comparative Study Period||327
3193230|NCT02068118|3921143|FG001|COMPLETED|18-month Comparative Study Period||305
3193231|NCT02068118|3921142|FG000|NOT COMPLETED|18-month Comparative Study Period||128
3193232|NCT02068118|3921143|FG001|NOT COMPLETED|18-month Comparative Study Period||177
3193233|NCT02068118|3921142|FG000|STARTED|Extension Period|Standard Care/Tele-cardiology : Patients entered Period 2 if they wished and consented|7
3193234|NCT02068118|3921143|FG001|STARTED|Extension Period|Tele-cardiology/Tele-cardiology : Patients entered Period 2 if they wished and consented|13
3193235|NCT02068118|3921142|FG000|COMPLETED|Extension Period||5
3193236|NCT02068118|3921143|FG001|COMPLETED|Extension Period||10
3193237|NCT02068118|3921142|FG000|NOT COMPLETED|Extension Period||2
3193238|NCT02068118|3921143|FG001|NOT COMPLETED|Extension Period||3
3193239|NCT02068157|3921151|FG000|STARTED|Overall Study||3
3193240|NCT02068157|3921151|FG000|COMPLETED|Overall Study||3
3193241|NCT02068157|3921151|FG000|NOT COMPLETED|Overall Study||0
3193242|NCT02068222|3921155|FG000|STARTED|Overall Study||10
3193243|NCT02068222|3921155|FG000|COMPLETED|Overall Study||9
3193244|NCT02068222|3921155|FG000|NOT COMPLETED|Overall Study||1
3193245|NCT02068352|3921162|FG000|STARTED|Overall Study||41
3193246|NCT02068352|3921163|FG001|STARTED|Overall Study||43
3193247|NCT02068352|3921164|FG002|STARTED|Overall Study||37
3193248|NCT02068352|3921162|FG000|COMPLETED|Overall Study||31
3193249|NCT02068352|3921163|FG001|COMPLETED|Overall Study||35
3193250|NCT02068352|3921164|FG002|COMPLETED|Overall Study||28
3193251|NCT02068352|3921162|FG000|NOT COMPLETED|Overall Study||10
3193252|NCT02068352|3921163|FG001|NOT COMPLETED|Overall Study||8
3193253|NCT02068352|3921164|FG002|NOT COMPLETED|Overall Study||9
3193254|NCT02068443|3921175|FG000|STARTED|Overall Study||71
3193255|NCT02068443|3921176|FG001|STARTED|Overall Study||152
3193256|NCT02068443|3921177|FG002|STARTED|Overall Study||151
3193257|NCT02068443|3921175|FG000|COMPLETED|Overall Study||64
3193258|NCT02068443|3921176|FG001|COMPLETED|Overall Study||146
3193259|NCT02068443|3921177|FG002|COMPLETED|Overall Study||148
3193260|NCT02068443|3921175|FG000|NOT COMPLETED|Overall Study||7
3193261|NCT02068443|3921176|FG001|NOT COMPLETED|Overall Study||6
3193262|NCT02068443|3921177|FG002|NOT COMPLETED|Overall Study||3
3364376|NCT04027218|4095547|FG001|STARTED|Overall Study||11
3364377|NCT04027218|4095548|FG002|STARTED|Overall Study||9
3364378|NCT04027218|4095549|FG003|STARTED|Overall Study||11
3364379|NCT04027218|4095550|FG004|STARTED|Overall Study||10
3364380|NCT04027218|4095551|FG005|STARTED|Overall Study||11
3364381|NCT04027218|4095546|FG000|COMPLETED|Overall Study||10
3364382|NCT04027218|4095547|FG001|COMPLETED|Overall Study||8
3364383|NCT04027218|4095548|FG002|COMPLETED|Overall Study||9
3364384|NCT04027218|4095549|FG003|COMPLETED|Overall Study||11
3364385|NCT04027218|4095550|FG004|COMPLETED|Overall Study||10
3364386|NCT04027218|4095551|FG005|COMPLETED|Overall Study||11
3364387|NCT04027218|4095546|FG000|NOT COMPLETED|Overall Study||0
3364388|NCT04027218|4095547|FG001|NOT COMPLETED|Overall Study||3
3364389|NCT04027218|4095548|FG002|NOT COMPLETED|Overall Study||0
3364390|NCT04027218|4095549|FG003|NOT COMPLETED|Overall Study||0
3364391|NCT04027218|4095550|FG004|NOT COMPLETED|Overall Study||0
3364392|NCT04027218|4095551|FG005|NOT COMPLETED|Overall Study||0
3364393|NCT04026750|4095563|FG000|STARTED|Overall Study||3
3364394|NCT04026750|4095564|FG001|STARTED|Overall Study||2
3364395|NCT04026750|4095563|FG000|COMPLETED|Overall Study||3
3364396|NCT04026750|4095564|FG001|COMPLETED|Overall Study||2
3364397|NCT04026750|4095563|FG000|NOT COMPLETED|Overall Study||0
3364398|NCT04026750|4095564|FG001|NOT COMPLETED|Overall Study||0
3364399|NCT04026308|4095573|FG000|STARTED|Overall Study||14
3364400|NCT04026308|4095574|FG001|STARTED|Overall Study||16
3364401|NCT04026308|4095573|FG000|COMPLETED|Overall Study||14
3364402|NCT04026308|4095574|FG001|COMPLETED|Overall Study||16
3364403|NCT04026308|4095573|FG000|NOT COMPLETED|Overall Study||0
3364404|NCT04026308|4095574|FG001|NOT COMPLETED|Overall Study||0
3364405|NCT04023682|4095580|FG000|STARTED|Overall Study||31
3364406|NCT04023682|4095580|FG000|COMPLETED|Overall Study||25
3364407|NCT04023682|4095580|FG000|NOT COMPLETED|Overall Study||6
3364408|NCT04021771|4095590|FG000|STARTED|Overall Study||55
3193263|NCT02068495|3921185|FG000|STARTED|Overall Study||3409
3193264|NCT02068495|3921185|FG000|COMPLETED|Overall Study||3300
3193265|NCT02068495|3921185|FG000|NOT COMPLETED|Overall Study||109
3193266|NCT02068508|3921189|FG000|STARTED|Overall Study||1067
3193267|NCT02068508|3921189|FG000|COMPLETED|Overall Study||1035
3193268|NCT02068508|3921189|FG000|NOT COMPLETED|Overall Study||32
3193269|NCT02068599|3921196|FG000|STARTED|Overall Study||130
3193270|NCT02068599|3921197|FG001|STARTED|Overall Study||129
3193271|NCT02068599|3921198|FG002|STARTED|Overall Study||130
3193272|NCT02068599|3921196|FG000|Safety Analysis Set|Overall Study|One participant withdrew before taking any study drug.|129
3193273|NCT02068599|3921197|FG001|Safety Analysis Set|Overall Study|One participant withdrew before taking any study drug.|128
3193274|NCT02068599|3921198|FG002|Safety Analysis Set|Overall Study||130
3193275|NCT02068599|3921196|FG000|Full Analysis Set|Overall Study||129
3193276|NCT02068599|3921197|FG001|Full Analysis Set|Overall Study||128
3193277|NCT02068599|3921198|FG002|Full Analysis Set|Overall Study||130
3193278|NCT02068599|3921196|FG000|COMPLETED|Overall Study||119
3193279|NCT02068599|3921197|FG001|COMPLETED|Overall Study||119
3193280|NCT02068599|3921198|FG002|COMPLETED|Overall Study||117
3193281|NCT02068599|3921196|FG000|NOT COMPLETED|Overall Study||11
3193282|NCT02068599|3921197|FG001|NOT COMPLETED|Overall Study||10
3193283|NCT02068599|3921198|FG002|NOT COMPLETED|Overall Study||13
3193284|NCT02068729|3921206|FG000|STARTED|Overall Study||131
3193285|NCT02068729|3921206|FG000|COMPLETED|Overall Study||56
3193286|NCT02068729|3921206|FG000|NOT COMPLETED|Overall Study||75
3193287|NCT02068768|3921265|FG000|STARTED|Overall Study||13
3193288|NCT02068768|3921265|FG000|COMPLETED|Overall Study||6
3193289|NCT02068768|3921265|FG000|NOT COMPLETED|Overall Study||7
3193290|NCT02068820|3921271|FG000|STARTED|Overall Study||20
3193291|NCT02068820|3921272|FG001|STARTED|Overall Study||180
3193292|NCT02068820|3921271|FG000|COMPLETED|Overall Study||20
3193293|NCT02068820|3921272|FG001|COMPLETED|Overall Study||180
3193294|NCT02068820|3921271|FG000|NOT COMPLETED|Overall Study||0
3193295|NCT02068820|3921272|FG001|NOT COMPLETED|Overall Study||0
3193296|NCT02068846|3921285|FG000|STARTED|Overall Study||9
3193297|NCT02068846|3921286|FG001|STARTED|Overall Study||8
3193298|NCT02068846|3921285|FG000|COMPLETED|Overall Study||8
3193299|NCT02068846|3921286|FG001|COMPLETED|Overall Study||7
3193300|NCT02068846|3921285|FG000|NOT COMPLETED|Overall Study||1
3193301|NCT02068846|3921286|FG001|NOT COMPLETED|Overall Study||1
3193302|NCT02068885|3921295|FG000|STARTED|Overall Study||57
3193303|NCT02068885|3921296|FG001|STARTED|Overall Study||53
3193304|NCT02068885|3921297|FG002|STARTED|Overall Study||54
3193305|NCT02068885|3921295|FG000|Provided Data at Midpoint Test Phase|Overall Study||56
3193306|NCT02068885|3921296|FG001|Provided Data at Midpoint Test Phase|Overall Study||50
3193307|NCT02068885|3921297|FG002|Provided Data at Midpoint Test Phase|Overall Study||48
3193308|NCT02068885|3921295|FG000|Provided Data at End of Test Phase|Overall Study||54
3193309|NCT02068885|3921296|FG001|Provided Data at End of Test Phase|Overall Study||48
3193310|NCT02068885|3921297|FG002|Provided Data at End of Test Phase|Overall Study||46
3193311|NCT02068885|3921295|FG000|Included in Intention-to-treat Analysis|Overall Study||56
3193312|NCT02068885|3921296|FG001|Included in Intention-to-treat Analysis|Overall Study||52
3193313|NCT02068885|3921297|FG002|Included in Intention-to-treat Analysis|Overall Study||54
3193314|NCT02068885|3921295|FG000|COMPLETED|Overall Study||54
3193315|NCT02068885|3921296|FG001|COMPLETED|Overall Study||48
3193316|NCT02068885|3921297|FG002|COMPLETED|Overall Study||46
3193317|NCT02068885|3921295|FG000|NOT COMPLETED|Overall Study||3
3193318|NCT02068885|3921296|FG001|NOT COMPLETED|Overall Study||5
3193319|NCT02068885|3921297|FG002|NOT COMPLETED|Overall Study||8
3193320|NCT02069015|3921308|FG000|STARTED|Overall Study|Baseline and enrollment at Emergency Department (ED)|71
3193321|NCT02069015|3921309|FG001|STARTED|Overall Study||68
3193322|NCT02069015|3921308|FG000|7 Day|Overall Study|7 day post ED discharge at Clinical Research Center (CRC)|44
3193323|NCT02069015|3921309|FG001|7 Day|Overall Study|7 day post ED discharge at CRC|45
3193324|NCT02069015|3921308|FG000|30 Day|Overall Study|30 day post-discharge at CRC|38
3193325|NCT02069015|3921309|FG001|30 Day|Overall Study|30 day post-discharge at CRC|43
3193326|NCT02069015|3921308|FG000|90 Day|Overall Study|90 day post ED discharge at CRC|32
3193327|NCT02069015|3921309|FG001|90 Day|Overall Study|90 day post ED discharge|35
3193328|NCT02069015|3921308|FG000|COMPLETED|Overall Study|180 post ED discharge at CRC|31
3193329|NCT02069015|3921309|FG001|COMPLETED|Overall Study|180 day post ED discharge at CRC|35
3193330|NCT02069015|3921308|FG000|NOT COMPLETED|Overall Study||40
3193331|NCT02069015|3921309|FG001|NOT COMPLETED|Overall Study||33
3193332|NCT02069041|3921316|FG000|STARTED|Overall Study||8
3193333|NCT02069041|3921316|FG000|Received at Least One Dose of Study Drug|Overall Study||8
3193334|NCT02069041|3921316|FG000|COMPLETED|Overall Study||8
3193335|NCT02069041|3921316|FG000|NOT COMPLETED|Overall Study||0
3193336|NCT02069093|3921320|FG000|STARTED|Overall Study||86
3193337|NCT02069093|3921320|FG000|Pharmacokinetic Analysis Set|Overall Study||50
3193338|NCT02069093|3921320|FG000|COMPLETED|Overall Study||56
3193339|NCT02069093|3921320|FG000|NOT COMPLETED|Overall Study||30
3193340|NCT02069119|3921328|FG000|STARTED|Overall Study||20
3193341|NCT02069119|3921329|FG001|STARTED|Overall Study||4
3193342|NCT02069119|3921330|FG002|STARTED|Overall Study||20
3193343|NCT02069119|3921331|FG003|STARTED|Overall Study||4
3193344|NCT02069119|3921328|FG000|COMPLETED|Overall Study||20
3193345|NCT02069119|3921329|FG001|COMPLETED|Overall Study||4
3193346|NCT02069119|3921330|FG002|COMPLETED|Overall Study||20
3193347|NCT02069119|3921331|FG003|COMPLETED|Overall Study||4
3193348|NCT02069119|3921328|FG000|NOT COMPLETED|Overall Study||0
3193349|NCT02069119|3921329|FG001|NOT COMPLETED|Overall Study||0
3193350|NCT02069119|3921330|FG002|NOT COMPLETED|Overall Study||0
3193351|NCT02069119|3921331|FG003|NOT COMPLETED|Overall Study||0
3193352|NCT02069184|3921345|FG000|STARTED|Overall Study||33
3193353|NCT02069184|3921346|FG001|STARTED|Overall Study||33
3193354|NCT02069184|3921345|FG000|COMPLETED|Overall Study||27
3193355|NCT02069184|3921346|FG001|COMPLETED|Overall Study||31
3193356|NCT02069184|3921345|FG000|NOT COMPLETED|Overall Study||6
3193357|NCT02069184|3921346|FG001|NOT COMPLETED|Overall Study||2
3193358|NCT02069353|3921352|FG000|STARTED|Overall Study||4
3193359|NCT02069353|3921352|FG000|COMPLETED|Overall Study||4
3193360|NCT02069353|3921352|FG000|NOT COMPLETED|Overall Study||0
3193361|NCT02069379|3921358|FG000|STARTED|Baseline Measurements||30
3193362|NCT02069379|3921359|FG001|STARTED|Baseline Measurements||4
3193363|NCT02069379|3921360|FG002|STARTED|Baseline Measurements||2
3193364|NCT02069379|3921361|FG003|STARTED|Baseline Measurements||6
3193365|NCT02069379|3921358|FG000|Baseline Measurements Taken|Baseline Measurements||30
3193366|NCT02069379|3921359|FG001|Baseline Measurements Taken|Baseline Measurements||4
3193367|NCT02069379|3921360|FG002|Baseline Measurements Taken|Baseline Measurements||2
3193368|NCT02069379|3921361|FG003|Baseline Measurements Taken|Baseline Measurements||6
3193369|NCT02069379|3921358|FG000|COMPLETED|Baseline Measurements||27
3193370|NCT02069379|3921359|FG001|COMPLETED|Baseline Measurements||4
3193371|NCT02069379|3921360|FG002|COMPLETED|Baseline Measurements||2
3193372|NCT02069379|3921361|FG003|COMPLETED|Baseline Measurements||4
3193373|NCT02069379|3921358|FG000|NOT COMPLETED|Baseline Measurements||3
3193374|NCT02069379|3921359|FG001|NOT COMPLETED|Baseline Measurements||0
3193375|NCT02069379|3921360|FG002|NOT COMPLETED|Baseline Measurements||0
3193376|NCT02069379|3921361|FG003|NOT COMPLETED|Baseline Measurements||2
3193377|NCT02069379|3921358|FG000|STARTED|First Treatment Arm|Controls are not involved after initial baseline collection|0
3193378|NCT02069379|3921359|FG001|STARTED|First Treatment Arm||4
3193379|NCT02069379|3921360|FG002|STARTED|First Treatment Arm||2
3193380|NCT02069379|3921361|FG003|STARTED|First Treatment Arm|Insulin resistant woman not randomized are not involved after initial baseline collection|0
3193381|NCT02069379|3921358|FG000|COMPLETED|First Treatment Arm||0
3193382|NCT02069379|3921359|FG001|COMPLETED|First Treatment Arm||3
3193383|NCT02069379|3921360|FG002|COMPLETED|First Treatment Arm||1
3193384|NCT02069379|3921361|FG003|COMPLETED|First Treatment Arm||0
3193385|NCT02069379|3921358|FG000|NOT COMPLETED|First Treatment Arm||0
3193386|NCT02069379|3921359|FG001|NOT COMPLETED|First Treatment Arm||1
3193387|NCT02069379|3921360|FG002|NOT COMPLETED|First Treatment Arm||1
3193388|NCT02069379|3921361|FG003|NOT COMPLETED|First Treatment Arm||0
3193389|NCT02069379|3921358|FG000|STARTED|Washout Period (4 Weeks)|Controls are not involved after initial baseline collection|0
3193390|NCT02069379|3921359|FG001|STARTED|Washout Period (4 Weeks)||3
3193391|NCT02069379|3921360|FG002|STARTED|Washout Period (4 Weeks)||1
3193392|NCT02069379|3921361|FG003|STARTED|Washout Period (4 Weeks)|Insulin resistant woman who were not randomized are not involved after initial baseline collection|0
3193393|NCT02069379|3921358|FG000|COMPLETED|Washout Period (4 Weeks)||0
3193394|NCT02069379|3921359|FG001|COMPLETED|Washout Period (4 Weeks)||1
3193395|NCT02069379|3921360|FG002|COMPLETED|Washout Period (4 Weeks)||1
3193396|NCT02069379|3921361|FG003|COMPLETED|Washout Period (4 Weeks)||0
3193397|NCT02069379|3921358|FG000|NOT COMPLETED|Washout Period (4 Weeks)||0
3193398|NCT02069379|3921359|FG001|NOT COMPLETED|Washout Period (4 Weeks)||2
3193399|NCT02069379|3921360|FG002|NOT COMPLETED|Washout Period (4 Weeks)||0
3193400|NCT02069379|3921361|FG003|NOT COMPLETED|Washout Period (4 Weeks)||0
3193401|NCT02069379|3921358|FG000|STARTED|Second Treatment Arm|Controls are not involved after initial baseline collection|0
3193402|NCT02069379|3921359|FG001|STARTED|Second Treatment Arm||1
3193403|NCT02069379|3921360|FG002|STARTED|Second Treatment Arm||1
3193404|NCT02069379|3921361|FG003|STARTED|Second Treatment Arm|Insulin resistant women who are not randomized are not involved after initial baseline collection|0
3193405|NCT02069379|3921358|FG000|COMPLETED|Second Treatment Arm||0
3193406|NCT02069379|3921359|FG001|COMPLETED|Second Treatment Arm||1
3193407|NCT02069379|3921360|FG002|COMPLETED|Second Treatment Arm||0
3193408|NCT02069379|3921361|FG003|COMPLETED|Second Treatment Arm||0
3193409|NCT02069379|3921358|FG000|NOT COMPLETED|Second Treatment Arm||0
3193410|NCT02069379|3921359|FG001|NOT COMPLETED|Second Treatment Arm||0
3193411|NCT02069379|3921360|FG002|NOT COMPLETED|Second Treatment Arm||1
3193412|NCT02069379|3921361|FG003|NOT COMPLETED|Second Treatment Arm||0
3193413|NCT02069392|3921373|FG000|STARTED|Overall Study||14
3193414|NCT02069392|3921374|FG001|STARTED|Overall Study||17
3193415|NCT02069392|3921373|FG000|COMPLETED|Overall Study||10
3193416|NCT02069392|3921374|FG001|COMPLETED|Overall Study||15
3193417|NCT02069392|3921373|FG000|NOT COMPLETED|Overall Study||4
3193418|NCT02069392|3921374|FG001|NOT COMPLETED|Overall Study||2
3193419|NCT02069704|3921384|FG000|STARTED|Overall Study|Two patients were randomized but they did not received study treatment|69
3193420|NCT02069704|3921385|FG001|STARTED|Overall Study||71
3193421|NCT02069704|3921384|FG000|COMPLETED|Overall Study||69
3193422|NCT02069704|3921385|FG001|COMPLETED|Overall Study||71
3193423|NCT02069704|3921384|FG000|NOT COMPLETED|Overall Study||0
3193424|NCT02069704|3921385|FG001|NOT COMPLETED|Overall Study||0
3193425|NCT02069847|3921400|FG000|STARTED|Overall Study||22
3193426|NCT02069847|3921401|FG001|STARTED|Overall Study||68
3193427|NCT02069847|3921400|FG000|COMPLETED|Overall Study||22
3193428|NCT02069847|3921401|FG001|COMPLETED|Overall Study||68
3193429|NCT02069847|3921400|FG000|NOT COMPLETED|Overall Study||0
3193430|NCT02069847|3921401|FG001|NOT COMPLETED|Overall Study||0
3193431|NCT02070237|3921408|FG000|STARTED|Overall Study||45
3193432|NCT02070237|3921409|FG001|STARTED|Overall Study||45
3193433|NCT02070237|3921408|FG000|COMPLETED|Overall Study||42
3193434|NCT02070237|3921409|FG001|COMPLETED|Overall Study||42
3193435|NCT02070237|3921408|FG000|NOT COMPLETED|Overall Study||3
3193436|NCT02070237|3921409|FG001|NOT COMPLETED|Overall Study||3
3193437|NCT02070276|3921418|FG000|STARTED|Overall Study||149
3193438|NCT02070276|3921419|FG001|STARTED|Overall Study||132
3193439|NCT02070276|3921420|FG002|STARTED|Overall Study||148
3193440|NCT02070276|3921418|FG000|COMPLETED|Overall Study||149
3193441|NCT02070276|3921419|FG001|COMPLETED|Overall Study||132
3193442|NCT02070276|3921420|FG002|COMPLETED|Overall Study||148
3193443|NCT02070276|3921418|FG000|NOT COMPLETED|Overall Study||0
3193444|NCT02070276|3921419|FG001|NOT COMPLETED|Overall Study||0
3193445|NCT02070276|3921420|FG002|NOT COMPLETED|Overall Study||0
3193446|NCT02070302|3921430|FG000|STARTED|Overall Study||5
3193447|NCT02070302|3921431|FG001|STARTED|Overall Study||5
3193448|NCT02070302|3921430|FG000|COMPLETED|Overall Study||5
3193449|NCT02070302|3921431|FG001|COMPLETED|Overall Study||5
3193450|NCT02070302|3921430|FG000|NOT COMPLETED|Overall Study||0
3193451|NCT02070302|3921431|FG001|NOT COMPLETED|Overall Study||0
3193452|NCT02070380|3921441|FG000|STARTED|First Injection||31
3193453|NCT02070380|3921442|FG001|STARTED|First Injection||39
3193454|NCT02070380|3921443|FG002|STARTED|First Injection||53
3193455|NCT02070380|3921444|FG003|STARTED|First Injection||54
3193456|NCT02070380|3921441|FG000|COMPLETED|First Injection||31
3193457|NCT02070380|3921442|FG001|COMPLETED|First Injection||39
3193458|NCT02070380|3921443|FG002|COMPLETED|First Injection||53
3193459|NCT02070380|3921444|FG003|COMPLETED|First Injection||54
3193460|NCT02070380|3921441|FG000|NOT COMPLETED|First Injection||0
3193461|NCT02070380|3921442|FG001|NOT COMPLETED|First Injection||0
3193462|NCT02070380|3921443|FG002|NOT COMPLETED|First Injection||0
3364409|NCT04021771|4095591|FG001|STARTED|Overall Study||54
3364410|NCT04021771|4095590|FG000|COMPLETED|Overall Study||55
3364411|NCT04021771|4095591|FG001|COMPLETED|Overall Study||54
3364412|NCT04021771|4095590|FG000|NOT COMPLETED|Overall Study||0
3364413|NCT04021771|4095591|FG001|NOT COMPLETED|Overall Study||0
3364414|NCT04019626|4095602|FG000|STARTED|Overall Study||42
3364415|NCT04019626|4095603|FG001|STARTED|Overall Study||42
3364416|NCT04019626|4095604|FG002|STARTED|Overall Study||45
3364417|NCT04019626|4095605|FG003|STARTED|Overall Study||46
3364418|NCT04019626|4095606|FG004|STARTED|Overall Study||44
3364419|NCT04019626|4095607|FG005|STARTED|Overall Study||21
3364420|NCT04019626|4095602|FG000|COMPLETED|Overall Study||36
3364421|NCT04019626|4095603|FG001|COMPLETED|Overall Study||32
3364422|NCT04019626|4095604|FG002|COMPLETED|Overall Study||37
3364423|NCT04019626|4095605|FG003|COMPLETED|Overall Study||39
3364424|NCT04019626|4095606|FG004|COMPLETED|Overall Study||38
3364425|NCT04019626|4095607|FG005|COMPLETED|Overall Study||20
3364426|NCT04019626|4095602|FG000|NOT COMPLETED|Overall Study||6
3364427|NCT04019626|4095603|FG001|NOT COMPLETED|Overall Study||10
3364428|NCT04019626|4095604|FG002|NOT COMPLETED|Overall Study||8
3364429|NCT04019626|4095605|FG003|NOT COMPLETED|Overall Study||7
3364430|NCT04019626|4095606|FG004|NOT COMPLETED|Overall Study||6
3364431|NCT04019626|4095607|FG005|NOT COMPLETED|Overall Study||1
3364432|NCT04023994|4095627|FG000|STARTED|Overall Study||10
3364433|NCT04023994|4095628|FG001|STARTED|Overall Study||4
3364434|NCT04023994|4095629|FG002|STARTED|Overall Study||4
3364435|NCT04023994|4095630|FG003|STARTED|Overall Study||6
3364436|NCT04023994|4095631|FG004|STARTED|Overall Study||6
3364437|NCT04023994|4095632|FG005|STARTED|Overall Study||6
3364438|NCT04023994|4095627|FG000|COMPLETED|Overall Study||10
3364439|NCT04023994|4095628|FG001|COMPLETED|Overall Study||3
3364440|NCT04023994|4095629|FG002|COMPLETED|Overall Study||2
3364441|NCT04023994|4095630|FG003|COMPLETED|Overall Study||5
3364442|NCT04023994|4095631|FG004|COMPLETED|Overall Study||6
3364443|NCT04023994|4095632|FG005|COMPLETED|Overall Study||6
3364444|NCT04023994|4095627|FG000|NOT COMPLETED|Overall Study||0
3364445|NCT04023994|4095628|FG001|NOT COMPLETED|Overall Study||1
3364446|NCT04023994|4095629|FG002|NOT COMPLETED|Overall Study||2
3364447|NCT04023994|4095630|FG003|NOT COMPLETED|Overall Study||1
3364448|NCT04023994|4095631|FG004|NOT COMPLETED|Overall Study||0
3364449|NCT04023994|4095632|FG005|NOT COMPLETED|Overall Study||0
3364450|NCT04022668|4095654|FG000|STARTED|Overall Study||1000
3364451|NCT04022668|4095655|FG001|STARTED|Overall Study||1000
3364452|NCT04022668|4095656|FG002|STARTED|Overall Study||1000
3364453|NCT04022668|4095654|FG000|COMPLETED|Overall Study||986
3364454|NCT04022668|4095655|FG001|COMPLETED|Overall Study||973
3364455|NCT04022668|4095656|FG002|COMPLETED|Overall Study||1000
3364456|NCT04022668|4095654|FG000|NOT COMPLETED|Overall Study||14
3364457|NCT04022668|4095655|FG001|NOT COMPLETED|Overall Study||27
3364458|NCT04022668|4095656|FG002|NOT COMPLETED|Overall Study||0
3364459|NCT04020822|4095664|FG000|STARTED|Overall Study||19
3364460|NCT04020822|4095664|FG000|COMPLETED|Overall Study||19
3364461|NCT04020822|4095664|FG000|NOT COMPLETED|Overall Study||0
3364462|NCT04019990|4095668|FG000|STARTED|Overall Study||13
3364463|NCT04019990|4095669|FG001|STARTED|Overall Study||15
3364464|NCT04019990|4095668|FG000|COMPLETED|Overall Study||12
3364465|NCT04019990|4095669|FG001|COMPLETED|Overall Study||12
3364466|NCT04019990|4095668|FG000|NOT COMPLETED|Overall Study||1
3364467|NCT04019990|4095669|FG001|NOT COMPLETED|Overall Study||3
3364468|NCT04017611|4095675|FG000|STARTED|Overall Study||13
3193463|NCT02070380|3921444|FG003|NOT COMPLETED|First Injection||0
3193464|NCT02070380|3921441|FG000|STARTED|Washout (no Second Injection/MRI)||31
3193465|NCT02070380|3921442|FG001|STARTED|Washout (no Second Injection/MRI)||39
3193466|NCT02070380|3921443|FG002|STARTED|Washout (no Second Injection/MRI)||53
3193467|NCT02070380|3921444|FG003|STARTED|Washout (no Second Injection/MRI)||54
3193468|NCT02070380|3921441|FG000|COMPLETED|Washout (no Second Injection/MRI)||31
3193469|NCT02070380|3921442|FG001|COMPLETED|Washout (no Second Injection/MRI)||34
3193470|NCT02070380|3921443|FG002|COMPLETED|Washout (no Second Injection/MRI)||51
3193471|NCT02070380|3921444|FG003|COMPLETED|Washout (no Second Injection/MRI)||51
3193472|NCT02070380|3921441|FG000|NOT COMPLETED|Washout (no Second Injection/MRI)||0
3193473|NCT02070380|3921442|FG001|NOT COMPLETED|Washout (no Second Injection/MRI)||5
3193474|NCT02070380|3921443|FG002|NOT COMPLETED|Washout (no Second Injection/MRI)||2
3193475|NCT02070380|3921444|FG003|NOT COMPLETED|Washout (no Second Injection/MRI)||3
3193476|NCT02070380|3921441|FG000|STARTED|Second Injection||31
3193477|NCT02070380|3921442|FG001|STARTED|Second Injection||34
3193478|NCT02070380|3921443|FG002|STARTED|Second Injection||51
3193479|NCT02070380|3921444|FG003|STARTED|Second Injection||51
3193480|NCT02070380|3921441|FG000|COMPLETED|Second Injection||31
3193481|NCT02070380|3921442|FG001|COMPLETED|Second Injection||32
3193482|NCT02070380|3921443|FG002|COMPLETED|Second Injection||50
3193483|NCT02070380|3921444|FG003|COMPLETED|Second Injection||46
3193484|NCT02070380|3921441|FG000|NOT COMPLETED|Second Injection||0
3193485|NCT02070380|3921442|FG001|NOT COMPLETED|Second Injection||2
3193486|NCT02070380|3921443|FG002|NOT COMPLETED|Second Injection||1
3193487|NCT02070380|3921444|FG003|NOT COMPLETED|Second Injection||5
3193488|NCT02070484|3921458|FG000|STARTED|Overall Study||3
3193489|NCT02070484|3921459|FG001|STARTED|Overall Study||3
3193490|NCT02070484|3921458|FG000|COMPLETED|Overall Study||2
3193491|NCT02070484|3921459|FG001|COMPLETED|Overall Study||3
3193492|NCT02070484|3921458|FG000|NOT COMPLETED|Overall Study||1
3193493|NCT02070484|3921459|FG001|NOT COMPLETED|Overall Study||0
3193494|NCT02070588|3921468|FG000|STARTED|Overall Study||86
3193495|NCT02070588|3921469|FG001|STARTED|Overall Study||26
3193496|NCT02070588|3921470|FG002|STARTED|Overall Study||0
3193497|NCT02070588|3921468|FG000|COMPLETED|Overall Study||47
3193498|NCT02070588|3921469|FG001|COMPLETED|Overall Study||25
3193499|NCT02070588|3921470|FG002|COMPLETED|Overall Study||0
3193500|NCT02070588|3921468|FG000|NOT COMPLETED|Overall Study||39
3193501|NCT02070588|3921469|FG001|NOT COMPLETED|Overall Study||1
3193502|NCT02070588|3921470|FG002|NOT COMPLETED|Overall Study||0
3193503|NCT02070640|3921480|FG000|STARTED|Overall Study||93
3193504|NCT02070640|3921481|FG001|STARTED|Overall Study||6
3193505|NCT02070640|3921480|FG000|COMPLETED|Overall Study||82
3193506|NCT02070640|3921481|FG001|COMPLETED|Overall Study||6
3193507|NCT02070640|3921480|FG000|NOT COMPLETED|Overall Study||11
3193508|NCT02070640|3921481|FG001|NOT COMPLETED|Overall Study||0
3193509|NCT02070692|3921490|FG000|STARTED|Overall Study||28
3193510|NCT02070692|3921491|FG001|STARTED|Overall Study||28
3193511|NCT02070692|3921490|FG000|COMPLETED|Overall Study||18
3193512|NCT02070692|3921491|FG001|COMPLETED|Overall Study||16
3193513|NCT02070692|3921490|FG000|NOT COMPLETED|Overall Study||10
3193514|NCT02070692|3921491|FG001|NOT COMPLETED|Overall Study||12
3193515|NCT02070744|3921501|FG000|STARTED|PC Phase (12 Weeks)||6
3193516|NCT02070744|3921502|FG001|STARTED|PC Phase (12 Weeks)||5
3193517|NCT02070744|3921503|FG002|STARTED|PC Phase (12 Weeks)||15
3193518|NCT02070744|3921504|FG003|STARTED|PC Phase (12 Weeks)||14
3193519|NCT02070744|3921505|FG004|STARTED|PC Phase (12 Weeks)||0
3193520|NCT02070744|3921501|FG000|Treated|PC Phase (12 Weeks)||6
3193521|NCT02070744|3921502|FG001|Treated|PC Phase (12 Weeks)||5
3193522|NCT02070744|3921503|FG002|Treated|PC Phase (12 Weeks)||15
3193523|NCT02070744|3921504|FG003|Treated|PC Phase (12 Weeks)||13
3193524|NCT02070744|3921505|FG004|Treated|PC Phase (12 Weeks)||0
3193525|NCT02070744|3921501|FG000|COMPLETED|PC Phase (12 Weeks)||6
3193526|NCT02070744|3921502|FG001|COMPLETED|PC Phase (12 Weeks)||5
3193527|NCT02070744|3921503|FG002|COMPLETED|PC Phase (12 Weeks)||15
3193528|NCT02070744|3921504|FG003|COMPLETED|PC Phase (12 Weeks)||13
3193529|NCT02070744|3921505|FG004|COMPLETED|PC Phase (12 Weeks)||0
3193530|NCT02070744|3921501|FG000|NOT COMPLETED|PC Phase (12 Weeks)||0
3193531|NCT02070744|3921502|FG001|NOT COMPLETED|PC Phase (12 Weeks)||0
3193532|NCT02070744|3921503|FG002|NOT COMPLETED|PC Phase (12 Weeks)||0
3193533|NCT02070744|3921504|FG003|NOT COMPLETED|PC Phase (12 Weeks)||1
3193534|NCT02070744|3921505|FG004|NOT COMPLETED|PC Phase (12 Weeks)||0
3193535|NCT02070744|3921501|FG000|STARTED|OLE Phase (48 Weeks)||0
3193536|NCT02070744|3921502|FG001|STARTED|OLE Phase (48 Weeks)||0
3193537|NCT02070744|3921503|FG002|STARTED|OLE Phase (48 Weeks)||0
3193538|NCT02070744|3921504|FG003|STARTED|OLE Phase (48 Weeks)||0
3193539|NCT02070744|3921505|FG004|STARTED|OLE Phase (48 Weeks)|12 participants completed PC phase, but did not enter OLE phase.|27
3193540|NCT02070744|3921501|FG000|COMPLETED|OLE Phase (48 Weeks)||0
3193541|NCT02070744|3921502|FG001|COMPLETED|OLE Phase (48 Weeks)||0
3193542|NCT02070744|3921503|FG002|COMPLETED|OLE Phase (48 Weeks)||0
3193543|NCT02070744|3921504|FG003|COMPLETED|OLE Phase (48 Weeks)||0
3193544|NCT02070744|3921505|FG004|COMPLETED|OLE Phase (48 Weeks)||24
3193545|NCT02070744|3921501|FG000|NOT COMPLETED|OLE Phase (48 Weeks)||0
3193546|NCT02070744|3921502|FG001|NOT COMPLETED|OLE Phase (48 Weeks)||0
3193547|NCT02070744|3921503|FG002|NOT COMPLETED|OLE Phase (48 Weeks)||0
3193548|NCT02070744|3921504|FG003|NOT COMPLETED|OLE Phase (48 Weeks)||0
3193549|NCT02070744|3921505|FG004|NOT COMPLETED|OLE Phase (48 Weeks)||3
3193550|NCT02070757|3921522|FG000|STARTED|Overall Study||362
3193551|NCT02070757|3921523|FG001|STARTED|Overall Study||364
3193552|NCT02070757|3921522|FG000|Treated Participants|Overall Study||361
3193553|NCT02070757|3921523|FG001|Treated Participants|Overall Study||359
3193554|NCT02070757|3921522|FG000|COMPLETED|Overall Study||245
3193555|NCT02070757|3921523|FG001|COMPLETED|Overall Study||250
3193556|NCT02070757|3921522|FG000|NOT COMPLETED|Overall Study||117
3193557|NCT02070757|3921523|FG001|NOT COMPLETED|Overall Study||114
3193558|NCT02070965|3921532|FG000|STARTED|Overall Study||27
3193559|NCT02070965|3921533|FG001|STARTED|Overall Study||23
3193560|NCT02070965|3921534|FG002|STARTED|Overall Study||25
3193561|NCT02070965|3921532|FG000|COMPLETED|Overall Study||25
3193562|NCT02070965|3921533|FG001|COMPLETED|Overall Study||21
3193563|NCT02070965|3921534|FG002|COMPLETED|Overall Study||24
3193564|NCT02070965|3921532|FG000|NOT COMPLETED|Overall Study||2
3193565|NCT02070965|3921533|FG001|NOT COMPLETED|Overall Study||2
3193566|NCT02070965|3921534|FG002|NOT COMPLETED|Overall Study||1
3193567|NCT02070978|3921545|FG000|STARTED|Overall Study||83
3193568|NCT02070978|3921546|FG001|STARTED|Overall Study||82
3193569|NCT02070978|3921547|FG002|STARTED|Overall Study||88
3193570|NCT02070978|3921545|FG000|COMPLETED|Overall Study||36
3193571|NCT02070978|3921546|FG001|COMPLETED|Overall Study||29
3193572|NCT02070978|3921547|FG002|COMPLETED|Overall Study||35
3193573|NCT02070978|3921545|FG000|NOT COMPLETED|Overall Study||47
3193574|NCT02070978|3921546|FG001|NOT COMPLETED|Overall Study||53
3193575|NCT02070978|3921547|FG002|NOT COMPLETED|Overall Study||53
3193576|NCT02070991|3921557|FG000|STARTED|Overall Study||31
3193577|NCT02070991|3921558|FG001|STARTED|Overall Study||32
3193578|NCT02070991|3921557|FG000|COMPLETED|Overall Study||28
3193579|NCT02070991|3921558|FG001|COMPLETED|Overall Study||32
3193580|NCT02070991|3921557|FG000|NOT COMPLETED|Overall Study||3
3193581|NCT02070991|3921558|FG001|NOT COMPLETED|Overall Study||0
3193582|NCT02071082|3921566|FG000|STARTED|Overall Study||4
3193583|NCT02071082|3921567|FG001|STARTED|Overall Study||75
3193584|NCT02071082|3921566|FG000|COMPLETED|Overall Study||2
3193585|NCT02071082|3921567|FG001|COMPLETED|Overall Study||68
3193586|NCT02071082|3921566|FG000|NOT COMPLETED|Overall Study||2
3193587|NCT02071082|3921567|FG001|NOT COMPLETED|Overall Study||7
3193588|NCT02071095|3921575|FG000|STARTED|Overall Study||12
3193589|NCT02071095|3921576|FG001|STARTED|Overall Study||3
3193590|NCT02071095|3921575|FG000|COMPLETED|Overall Study||12
3193591|NCT02071095|3921576|FG001|COMPLETED|Overall Study||3
3193592|NCT02071095|3921575|FG000|NOT COMPLETED|Overall Study||0
3193593|NCT02071095|3921576|FG001|NOT COMPLETED|Overall Study||0
3193594|NCT02071108|3921582|FG000|STARTED|Overall Study||35
3193595|NCT02071108|3921582|FG000|COMPLETED|Overall Study||35
3193596|NCT02071108|3921582|FG000|NOT COMPLETED|Overall Study||0
3193597|NCT02071173|3921586|FG000|STARTED|Overall Study||2244
3193598|NCT02071173|3921586|FG000|Implanted/Attempted With a Study Device|Overall Study||2200
3193599|NCT02071173|3921586|FG000|RELIANCE 4-FRONT Endpoint Population|Overall Study|1507 with active fixation 4-FRONT lead, 37 with passive fixation 4-FRONT lead|1544
3193600|NCT02071173|3921586|FG000|ACUITY X4 Endpoint Population|Overall Study|536 with ACUITY X4 Spiral lead, 228 with ACUITY X4 Straight lead|764
3193601|NCT02071173|3921586|FG000|COMPLETED|Overall Study|Follow-up is ongoing. Data as of 5-Feb-2020.|409
3193602|NCT02071173|3921586|FG000|NOT COMPLETED|Overall Study||1835
3193603|NCT02071225|3921591|FG000|STARTED|Overall Study||72
3193604|NCT02071225|3921591|FG000|COMPLETED|Overall Study||42
3193605|NCT02071225|3921591|FG000|NOT COMPLETED|Overall Study||30
3193606|NCT02071290|3921597|FG000|STARTED|Overall Study||25
3193607|NCT02071290|3921598|FG001|STARTED|Overall Study||25
3193608|NCT02071290|3921597|FG000|COMPLETED|Overall Study||21
3193609|NCT02071290|3921598|FG001|COMPLETED|Overall Study||18
3193610|NCT02071290|3921597|FG000|NOT COMPLETED|Overall Study||4
3193611|NCT02071290|3921598|FG001|NOT COMPLETED|Overall Study||7
3193612|NCT02071420|3921606|FG000|STARTED|Overall Study||30
3193613|NCT02071420|3921607|FG001|STARTED|Overall Study||30
3193614|NCT02071420|3921606|FG000|COMPLETED|Overall Study||27
3193615|NCT02071420|3921607|FG001|COMPLETED|Overall Study||27
3193616|NCT02071420|3921606|FG000|NOT COMPLETED|Overall Study||3
3193617|NCT02071420|3921607|FG001|NOT COMPLETED|Overall Study||3
3193618|NCT02071706|3921613|FG000|STARTED|Overall Study||62
3193619|NCT02071706|3921613|FG000|COMPLETED|Overall Study||59
3193620|NCT02071706|3921613|FG000|NOT COMPLETED|Overall Study||3
3193621|NCT02071771|3921617|FG000|STARTED|Period 1: First 10 Days||41
3193622|NCT02071771|3921618|FG001|STARTED|Period 1: First 10 Days||39
3193623|NCT02071771|3921617|FG000|Dispensed|Period 1: First 10 Days||39
3193624|NCT02071771|3921618|FG001|Dispensed|Period 1: First 10 Days||39
3193625|NCT02071771|3921617|FG000|COMPLETED|Period 1: First 10 Days||39
3193626|NCT02071771|3921618|FG001|COMPLETED|Period 1: First 10 Days||39
3193627|NCT02071771|3921617|FG000|NOT COMPLETED|Period 1: First 10 Days||2
3193628|NCT02071771|3921618|FG001|NOT COMPLETED|Period 1: First 10 Days||0
3193629|NCT02071771|3921617|FG000|STARTED|Period 2: Second 10 Days||39
3193630|NCT02071771|3921618|FG001|STARTED|Period 2: Second 10 Days|One participant completed Period 1 but did not start Period 2 due to unacceptable fit with DACP T.|38
3193631|NCT02071771|3921617|FG000|COMPLETED|Period 2: Second 10 Days||39
3193632|NCT02071771|3921618|FG001|COMPLETED|Period 2: Second 10 Days||38
3193633|NCT02071771|3921617|FG000|NOT COMPLETED|Period 2: Second 10 Days||0
3193634|NCT02071771|3921618|FG001|NOT COMPLETED|Period 2: Second 10 Days||0
3193635|NCT02071810|3921629|FG000|STARTED|Overall Study||6
3193636|NCT02071810|3921630|FG001|STARTED|Overall Study||6
3193637|NCT02071810|3921631|FG002|STARTED|Overall Study||6
3193638|NCT02071810|3921632|FG003|STARTED|Overall Study||7
3193639|NCT02071810|3921633|FG004|STARTED|Overall Study||9
3193640|NCT02071810|3921629|FG000|COMPLETED|Overall Study||6
3193641|NCT02071810|3921630|FG001|COMPLETED|Overall Study||6
3193642|NCT02071810|3921631|FG002|COMPLETED|Overall Study||6
3193643|NCT02071810|3921632|FG003|COMPLETED|Overall Study||6
3193644|NCT02071810|3921633|FG004|COMPLETED|Overall Study||8
3193645|NCT02071810|3921629|FG000|NOT COMPLETED|Overall Study||0
3193646|NCT02071810|3921630|FG001|NOT COMPLETED|Overall Study||0
3193647|NCT02071810|3921631|FG002|NOT COMPLETED|Overall Study||0
3193648|NCT02071810|3921632|FG003|NOT COMPLETED|Overall Study||1
3193649|NCT02071810|3921633|FG004|NOT COMPLETED|Overall Study||1
3193650|NCT02071823|3921647|FG000|STARTED|Overall Study||6
3193651|NCT02071823|3921648|FG001|STARTED|Overall Study||6
3193652|NCT02071823|3921647|FG000|COMPLETED|Overall Study||5
3193653|NCT02071823|3921648|FG001|COMPLETED|Overall Study||6
3193654|NCT02071823|3921647|FG000|NOT COMPLETED|Overall Study||1
3193655|NCT02071823|3921648|FG001|NOT COMPLETED|Overall Study||0
3193656|NCT02071849|3921656|FG000|STARTED|6-month Primary Endpoint||20
3193657|NCT02071849|3921656|FG000|COMPLETED|6-month Primary Endpoint||15
3193658|NCT02071849|3921656|FG000|NOT COMPLETED|6-month Primary Endpoint||5
3193659|NCT02071849|3921656|FG000|STARTED|2-year Extended Follow-up||15
3193660|NCT02071849|3921656|FG000|COMPLETED|2-year Extended Follow-up||14
3193661|NCT02071849|3921656|FG000|NOT COMPLETED|2-year Extended Follow-up||1
3193662|NCT02071914|3921663|FG000|STARTED|Overall Study||27
3193663|NCT02071914|3921664|FG001|STARTED|Overall Study||27
3193664|NCT02071914|3921665|FG002|STARTED|Overall Study||27
3193665|NCT02071914|3921663|FG000|COMPLETED|Overall Study||27
3193666|NCT02071914|3921664|FG001|COMPLETED|Overall Study||27
3193667|NCT02071914|3921665|FG002|COMPLETED|Overall Study||27
3193668|NCT02071914|3921663|FG000|NOT COMPLETED|Overall Study||0
3193669|NCT02071914|3921664|FG001|NOT COMPLETED|Overall Study||0
3193670|NCT02071914|3921665|FG002|NOT COMPLETED|Overall Study||0
3193671|NCT02072096|3921675|FG000|STARTED|Overall Study||99
3193672|NCT02072096|3921676|FG001|STARTED|Overall Study||93
3193673|NCT02072096|3921675|FG000|Received at Least One Dose of Study Drug|Overall Study||98
3193674|NCT02072096|3921676|FG001|Received at Least One Dose of Study Drug|Overall Study||93
3193675|NCT02072096|3921675|FG000|COMPLETED|Overall Study||14
3193676|NCT02072096|3921676|FG001|COMPLETED|Overall Study||15
3193677|NCT02072096|3921675|FG000|NOT COMPLETED|Overall Study||85
3193678|NCT02072096|3921676|FG001|NOT COMPLETED|Overall Study||78
3193679|NCT02072174|3921685|FG000|STARTED|Overall Study||290
3193680|NCT02072174|3921686|FG001|STARTED|Overall Study||279
3193681|NCT02072174|3921685|FG000|COMPLETED|Overall Study||258
3193682|NCT02072174|3921686|FG001|COMPLETED|Overall Study||240
3193683|NCT02072174|3921685|FG000|NOT COMPLETED|Overall Study||32
3193684|NCT02072174|3921686|FG001|NOT COMPLETED|Overall Study||39
3193685|NCT02072200|3921694|FG000|STARTED|Overall Study||147
3193686|NCT02072200|3921694|FG000|COMPLETED|Overall Study||145
3193687|NCT02072200|3921694|FG000|NOT COMPLETED|Overall Study||2
3193688|NCT02072226|3921700|FG000|STARTED|Overall Study||156
3193689|NCT02072226|3921701|FG001|STARTED|Overall Study||157
3193690|NCT02072226|3921700|FG000|COMPLETED|Overall Study||141
3193691|NCT02072226|3921701|FG001|COMPLETED|Overall Study||147
3193692|NCT02072226|3921700|FG000|NOT COMPLETED|Overall Study||15
3193693|NCT02072226|3921701|FG001|NOT COMPLETED|Overall Study||10
3193694|NCT02072421|3921707|FG000|STARTED|Overall Study||2879
3193695|NCT02072421|3921707|FG000|COMPLETED|Overall Study||2489
3193696|NCT02072421|3921707|FG000|NOT COMPLETED|Overall Study||390
3193697|NCT02072434|3921714|FG000|STARTED|Overall Study||1095
3193698|NCT02072434|3921715|FG001|STARTED|Overall Study||1104
3193699|NCT02072434|3921714|FG000|Intent to Treat Analysis Set|Overall Study||1095
3193700|NCT02072434|3921715|FG001|Intent to Treat Analysis Set|Overall Study||1104
3193701|NCT02072434|3921714|FG000|Received Study Drug|Overall Study||1067
3193702|NCT02072434|3921715|FG001|Received Study Drug|Overall Study||1082
3193703|NCT02072434|3921714|FG000|Safety Analysis Set|Overall Study||1067
3193704|NCT02072434|3921715|FG001|Safety Analysis Set|Overall Study||1082
3193705|NCT02072434|3921714|FG000|COMPLETED|Overall Study||1041
3193706|NCT02072434|3921715|FG001|COMPLETED|Overall Study||1014
3193707|NCT02072434|3921714|FG000|NOT COMPLETED|Overall Study||54
3193708|NCT02072434|3921715|FG001|NOT COMPLETED|Overall Study||90
3193709|NCT02072668|3921721|FG000|STARTED|First Intervention||7
3193710|NCT02072668|3921722|FG001|STARTED|First Intervention||7
3193711|NCT02072668|3921721|FG000|COMPLETED|First Intervention||7
3193712|NCT02072668|3921722|FG001|COMPLETED|First Intervention||7
3193713|NCT02072668|3921721|FG000|NOT COMPLETED|First Intervention||0
3193714|NCT02072668|3921722|FG001|NOT COMPLETED|First Intervention||0
3193715|NCT02072668|3921721|FG000|STARTED|Washout (2 Weeks)||7
3193716|NCT02072668|3921722|FG001|STARTED|Washout (2 Weeks)||7
3193717|NCT02072668|3921721|FG000|COMPLETED|Washout (2 Weeks)||7
3193718|NCT02072668|3921722|FG001|COMPLETED|Washout (2 Weeks)||7
3193719|NCT02072668|3921721|FG000|NOT COMPLETED|Washout (2 Weeks)||0
3193720|NCT02072668|3921722|FG001|NOT COMPLETED|Washout (2 Weeks)||0
3193721|NCT02072668|3921721|FG000|STARTED|Second Intervention||7
3193722|NCT02072668|3921722|FG001|STARTED|Second Intervention||7
3193723|NCT02072668|3921721|FG000|COMPLETED|Second Intervention||6
3193724|NCT02072668|3921722|FG001|COMPLETED|Second Intervention||7
3193725|NCT02072668|3921721|FG000|NOT COMPLETED|Second Intervention||1
3193726|NCT02072668|3921722|FG001|NOT COMPLETED|Second Intervention||0
3193727|NCT02072824|3921733|FG000|STARTED|Overall Study||71
3193728|NCT02072824|3921734|FG001|STARTED|Overall Study||34
3193729|NCT02072824|3921735|FG002|STARTED|Overall Study||70
3193730|NCT02072824|3921733|FG000|COMPLETED|Overall Study||69
3193731|NCT02072824|3921734|FG001|COMPLETED|Overall Study||33
3193732|NCT02072824|3921735|FG002|COMPLETED|Overall Study||67
3193733|NCT02072824|3921733|FG000|NOT COMPLETED|Overall Study||2
3193734|NCT02072824|3921734|FG001|NOT COMPLETED|Overall Study||1
3193735|NCT02072824|3921735|FG002|NOT COMPLETED|Overall Study||3
3193736|NCT02072928|3921743|FG000|STARTED|Overall Study||55
3193737|NCT02072928|3921743|FG000|COMPLETED|Overall Study||55
3193738|NCT02072928|3921743|FG000|NOT COMPLETED|Overall Study||0
3193739|NCT02072941|3921749|FG000|STARTED|Overall Study||219
3193740|NCT02072941|3921750|FG001|STARTED|Overall Study||226
3193741|NCT02072941|3921749|FG000|COMPLETED|Overall Study||181
3193742|NCT02072941|3921750|FG001|COMPLETED|Overall Study||197
3193743|NCT02072941|3921749|FG000|NOT COMPLETED|Overall Study||38
3193744|NCT02072941|3921750|FG001|NOT COMPLETED|Overall Study||29
3193745|NCT02072980|3921756|FG000|STARTED|Period 1, First Wear||7
3193746|NCT02072980|3921757|FG001|STARTED|Period 1, First Wear||8
3193747|NCT02072980|3921756|FG000|COMPLETED|Period 1, First Wear||7
3193748|NCT02072980|3921757|FG001|COMPLETED|Period 1, First Wear||8
3193749|NCT02072980|3921756|FG000|NOT COMPLETED|Period 1, First Wear||0
3193750|NCT02072980|3921757|FG001|NOT COMPLETED|Period 1, First Wear||0
3193751|NCT02072980|3921756|FG000|STARTED|Period 2, Second Wear||7
3193752|NCT02072980|3921757|FG001|STARTED|Period 2, Second Wear||8
3193753|NCT02072980|3921756|FG000|COMPLETED|Period 2, Second Wear||7
3193754|NCT02072980|3921757|FG001|COMPLETED|Period 2, Second Wear||7
3193755|NCT02072980|3921756|FG000|NOT COMPLETED|Period 2, Second Wear||0
3193756|NCT02072980|3921757|FG001|NOT COMPLETED|Period 2, Second Wear||1
3193757|NCT02073162|3921765|FG000|STARTED|Overall Study||1499
3193758|NCT02073162|3921766|FG001|STARTED|Overall Study||1501
3193759|NCT02073162|3921765|FG000|COMPLETED|Overall Study||1493
3193760|NCT02073162|3921766|FG001|COMPLETED|Overall Study||1490
3193761|NCT02073162|3921765|FG000|NOT COMPLETED|Overall Study||6
3193762|NCT02073162|3921766|FG001|NOT COMPLETED|Overall Study||11
3193763|NCT02073331|3921772|FG000|STARTED|Overall Study||1420
3193764|NCT02073331|3921772|FG000|COMPLETED|Overall Study||1420
3193765|NCT02073331|3921772|FG000|NOT COMPLETED|Overall Study||0
3193766|NCT02073435|3921778|FG000|STARTED|Overall Study||81
3193767|NCT02073435|3921779|FG001|STARTED|Overall Study||96
3193768|NCT02073435|3921778|FG000|COMPLETED|Overall Study||81
3193769|NCT02073435|3921779|FG001|COMPLETED|Overall Study||96
3193770|NCT02073435|3921778|FG000|NOT COMPLETED|Overall Study||0
3193771|NCT02073435|3921779|FG001|NOT COMPLETED|Overall Study||0
3193772|NCT02073448|3921788|FG000|STARTED|Overall Study||101
3193773|NCT02073448|3921789|FG001|STARTED|Overall Study||212
3193774|NCT02073448|3921790|FG002|STARTED|Overall Study||104
3193775|NCT02073448|3921788|FG000|COMPLETED|Overall Study||99
3193776|NCT02073448|3921789|FG001|COMPLETED|Overall Study||200
3193777|NCT02073448|3921790|FG002|COMPLETED|Overall Study||99
3193778|NCT02073448|3921788|FG000|NOT COMPLETED|Overall Study||2
3193779|NCT02073448|3921789|FG001|NOT COMPLETED|Overall Study||12
3193780|NCT02073448|3921790|FG002|NOT COMPLETED|Overall Study||5
3193781|NCT02073461|3921803|FG000|STARTED|Overall Study||79
3193782|NCT02073461|3921804|FG001|STARTED|Overall Study||78
3193783|NCT02073461|3921805|FG002|STARTED|Overall Study||79
3193784|NCT02073461|3921803|FG000|COMPLETED|Overall Study||75
3193785|NCT02073461|3921804|FG001|COMPLETED|Overall Study||77
3193786|NCT02073461|3921805|FG002|COMPLETED|Overall Study||78
3193787|NCT02073461|3921803|FG000|NOT COMPLETED|Overall Study||4
3193788|NCT02073461|3921804|FG001|NOT COMPLETED|Overall Study||1
3193789|NCT02073461|3921805|FG002|NOT COMPLETED|Overall Study||1
3193790|NCT02073487|3921815|FG000|STARTED|Overall Study||16
3193791|NCT02073487|3921816|FG001|STARTED|Overall Study||16
3193792|NCT02073487|3921815|FG000|COMPLETED|Overall Study||14
3193793|NCT02073487|3921816|FG001|COMPLETED|Overall Study||16
3193794|NCT02073487|3921815|FG000|NOT COMPLETED|Overall Study||2
3193795|NCT02073487|3921816|FG001|NOT COMPLETED|Overall Study||0
3193796|NCT02073565|3921825|FG000|STARTED|Intention-To-Treat Subjects-Cohorts AB&C||287
3193797|NCT02073565|3921826|FG001|STARTED|Intention-To-Treat Subjects-Cohorts AB&C||285
3193798|NCT02073565|3921825|FG000|COMPLETED|Intention-To-Treat Subjects-Cohorts AB&C||285
3193799|NCT02073565|3921826|FG001|COMPLETED|Intention-To-Treat Subjects-Cohorts AB&C||279
3193800|NCT02073565|3921825|FG000|NOT COMPLETED|Intention-To-Treat Subjects-Cohorts AB&C||2
3193801|NCT02073565|3921826|FG001|NOT COMPLETED|Intention-To-Treat Subjects-Cohorts AB&C||6
3193802|NCT02073565|3921825|FG000|STARTED|Cohort A||16
3193803|NCT02073565|3921826|FG001|STARTED|Cohort A||14
3193804|NCT02073565|3921825|FG000|COMPLETED|Cohort A||15
3193805|NCT02073565|3921826|FG001|COMPLETED|Cohort A||14
3193806|NCT02073565|3921825|FG000|NOT COMPLETED|Cohort A||1
3193807|NCT02073565|3921826|FG001|NOT COMPLETED|Cohort A||0
3193808|NCT02073565|3921825|FG000|STARTED|Cohort B||54
3193809|NCT02073565|3921826|FG001|STARTED|Cohort B||56
3193810|NCT02073565|3921825|FG000|COMPLETED|Cohort B||53
3193811|NCT02073565|3921826|FG001|COMPLETED|Cohort B||54
3193812|NCT02073565|3921825|FG000|NOT COMPLETED|Cohort B||1
3193813|NCT02073565|3921826|FG001|NOT COMPLETED|Cohort B||2
3193814|NCT02073565|3921825|FG000|STARTED|Cohort C||217
3193815|NCT02073565|3921826|FG001|STARTED|Cohort C||215
3193816|NCT02073565|3921825|FG000|COMPLETED|Cohort C||217
3193817|NCT02073565|3921826|FG001|COMPLETED|Cohort C||211
3193818|NCT02073565|3921825|FG000|NOT COMPLETED|Cohort C||0
3193819|NCT02073565|3921826|FG001|NOT COMPLETED|Cohort C||4
3193820|NCT02073643|3921832|FG000|STARTED|Overall Study||204
3193821|NCT02073643|3921832|FG000|COMPLETED|Overall Study||180
3193822|NCT02073643|3921832|FG000|NOT COMPLETED|Overall Study||24
3193823|NCT02073656|3921836|FG000|STARTED|Primary Study||335
3193824|NCT02073656|3921836|FG000|COMPLETED|Primary Study||327
3193825|NCT02073656|3921836|FG000|NOT COMPLETED|Primary Study||8
3193826|NCT02073656|3921836|FG000|STARTED|Retreatment Substudy|Only participants experiencing virologic relapse in the Primary Study were eligible for retreatment.|9
3193827|NCT02073656|3921836|FG000|COMPLETED|Retreatment Substudy||9
3193828|NCT02073656|3921836|FG000|NOT COMPLETED|Retreatment Substudy||0
3193829|NCT02073682|3921844|FG000|STARTED|Overall Study||522
3193830|NCT02073682|3921845|FG001|STARTED|Overall Study||524
3193831|NCT02073682|3921844|FG000|COMPLETED|Overall Study||200
3193832|NCT02073682|3921845|FG001|COMPLETED|Overall Study||154
3193833|NCT02073682|3921844|FG000|NOT COMPLETED|Overall Study||322
3193834|NCT02073682|3921845|FG001|NOT COMPLETED|Overall Study||370
3193835|NCT02073747|3921853|FG000|STARTED|Overall Study||15
3193836|NCT02073747|3921854|FG001|STARTED|Overall Study||15
3193837|NCT02073747|3921853|FG000|COMPLETED|Overall Study||14
3193838|NCT02073747|3921854|FG001|COMPLETED|Overall Study||14
3193839|NCT02073747|3921853|FG000|NOT COMPLETED|Overall Study||1
3193840|NCT02073747|3921854|FG001|NOT COMPLETED|Overall Study||1
3193841|NCT02073929|3921862|FG000|STARTED|Overall Study||48
3193842|NCT02073929|3921863|FG001|STARTED|Overall Study||24
3193843|NCT02073929|3921862|FG000|COMPLETED|Overall Study||44
3193844|NCT02073929|3921863|FG001|COMPLETED|Overall Study||21
3193845|NCT02073929|3921862|FG000|NOT COMPLETED|Overall Study||4
3193846|NCT02073929|3921863|FG001|NOT COMPLETED|Overall Study||3
3193847|NCT02074059|3921875|FG000|STARTED|Overall Study||8
3193848|NCT02074059|3921876|FG001|STARTED|Overall Study||8
3193849|NCT02074059|3921877|FG002|STARTED|Overall Study||8
3193850|NCT02074059|3921878|FG003|STARTED|Overall Study||8
3193851|NCT02074059|3921879|FG004|STARTED|Overall Study||8
3193852|NCT02074059|3921880|FG005|STARTED|Overall Study||40
3193853|NCT02074059|3921875|FG000|COMPLETED|Overall Study||8
3193854|NCT02074059|3921876|FG001|COMPLETED|Overall Study||8
3193855|NCT02074059|3921877|FG002|COMPLETED|Overall Study||8
3193856|NCT02074059|3921878|FG003|COMPLETED|Overall Study||8
3193857|NCT02074059|3921879|FG004|COMPLETED|Overall Study||7
3193858|NCT02074059|3921880|FG005|COMPLETED|Overall Study||39
3193859|NCT02074059|3921875|FG000|NOT COMPLETED|Overall Study||0
3193860|NCT02074059|3921876|FG001|NOT COMPLETED|Overall Study||0
3193861|NCT02074059|3921877|FG002|NOT COMPLETED|Overall Study||0
3193862|NCT02074059|3921878|FG003|NOT COMPLETED|Overall Study||0
3193863|NCT02074059|3921879|FG004|NOT COMPLETED|Overall Study||1
3193864|NCT02074059|3921880|FG005|NOT COMPLETED|Overall Study||1
3193865|NCT02074345|3921895|FG000|STARTED|Overall Study||31
3193866|NCT02074345|3921895|FG000|COMPLETED|Overall Study||31
3193867|NCT02074345|3921895|FG000|NOT COMPLETED|Overall Study||0
3193868|NCT02074358|3921899|FG000|STARTED|Overall Study||3
3193869|NCT02074358|3921900|FG001|STARTED|Overall Study||3
3193870|NCT02074358|3921901|FG002|STARTED|Overall Study||2
3193871|NCT02074358|3921902|FG003|STARTED|Overall Study||2
3193872|NCT02074358|3921903|FG004|STARTED|Overall Study||3
3193873|NCT02074358|3921904|FG005|STARTED|Overall Study||2
3193874|NCT02074358|3921899|FG000|COMPLETED|Overall Study||3
3193875|NCT02074358|3921900|FG001|COMPLETED|Overall Study||3
3193876|NCT02074358|3921901|FG002|COMPLETED|Overall Study||2
3193877|NCT02074358|3921902|FG003|COMPLETED|Overall Study||2
3193878|NCT02074358|3921903|FG004|COMPLETED|Overall Study||3
3193879|NCT02074358|3921904|FG005|COMPLETED|Overall Study||2
3193880|NCT02074358|3921899|FG000|NOT COMPLETED|Overall Study||0
3193881|NCT02074358|3921900|FG001|NOT COMPLETED|Overall Study||0
3193882|NCT02074358|3921901|FG002|NOT COMPLETED|Overall Study||0
3193883|NCT02074358|3921902|FG003|NOT COMPLETED|Overall Study||0
3193884|NCT02074358|3921903|FG004|NOT COMPLETED|Overall Study||0
3193885|NCT02074358|3921904|FG005|NOT COMPLETED|Overall Study||0
3193886|NCT02074384|3921915|FG000|STARTED|Overall Study||74
3193887|NCT02074384|3921916|FG001|STARTED|Overall Study||70
3193888|NCT02074384|3921917|FG002|STARTED|Overall Study||17
3193889|NCT02074384|3921915|FG000|COMPLETED|Overall Study||74
3193890|NCT02074384|3921916|FG001|COMPLETED|Overall Study||70
3193891|NCT02074384|3921917|FG002|COMPLETED|Overall Study||17
3193892|NCT02074384|3921915|FG000|NOT COMPLETED|Overall Study||0
3193893|NCT02074384|3921916|FG001|NOT COMPLETED|Overall Study||0
3193894|NCT02074384|3921917|FG002|NOT COMPLETED|Overall Study||0
3193895|NCT02074514|3921929|FG000|STARTED|Overall Study||59
3193896|NCT02074514|3921930|FG001|STARTED|Overall Study||58
3193897|NCT02074514|3921929|FG000|COMPLETED|Overall Study||56
3193898|NCT02074514|3921930|FG001|COMPLETED|Overall Study||54
3193899|NCT02074514|3921929|FG000|NOT COMPLETED|Overall Study||3
3193900|NCT02074514|3921930|FG001|NOT COMPLETED|Overall Study||4
3193901|NCT02074553|3921942|FG000|STARTED|Intervention Period 1||12
3193902|NCT02074553|3921943|FG001|STARTED|Intervention Period 1||12
3193903|NCT02074553|3921944|FG002|STARTED|Intervention Period 1||12
3193904|NCT02074553|3921945|FG003|STARTED|Intervention Period 1||13
3193905|NCT02074553|3921946|FG004|STARTED|Intervention Period 1||12
3193906|NCT02074553|3921947|FG005|STARTED|Intervention Period 1||12
3193907|NCT02074553|3921948|FG006|STARTED|Intervention Period 1||12
3193908|NCT02074553|3921949|FG007|STARTED|Intervention Period 1||12
3193909|NCT02074553|3921942|FG000|COMPLETED|Intervention Period 1||12
3193910|NCT02074553|3921943|FG001|COMPLETED|Intervention Period 1||12
3193911|NCT02074553|3921944|FG002|COMPLETED|Intervention Period 1||12
3193912|NCT02074553|3921945|FG003|COMPLETED|Intervention Period 1||12
3193913|NCT02074553|3921946|FG004|COMPLETED|Intervention Period 1||12
3193914|NCT02074553|3921947|FG005|COMPLETED|Intervention Period 1||12
3193915|NCT02074553|3921948|FG006|COMPLETED|Intervention Period 1||12
3193916|NCT02074553|3921949|FG007|COMPLETED|Intervention Period 1||12
3193917|NCT02074553|3921942|FG000|NOT COMPLETED|Intervention Period 1||0
3193918|NCT02074553|3921943|FG001|NOT COMPLETED|Intervention Period 1||0
3193919|NCT02074553|3921944|FG002|NOT COMPLETED|Intervention Period 1||0
3193920|NCT02074553|3921945|FG003|NOT COMPLETED|Intervention Period 1||1
3193921|NCT02074553|3921946|FG004|NOT COMPLETED|Intervention Period 1||0
3193922|NCT02074553|3921947|FG005|NOT COMPLETED|Intervention Period 1||0
3193923|NCT02074553|3921948|FG006|NOT COMPLETED|Intervention Period 1||0
3193924|NCT02074553|3921949|FG007|NOT COMPLETED|Intervention Period 1||0
3193925|NCT02074553|3921942|FG000|STARTED|Washout Period 1||12
3193926|NCT02074553|3921943|FG001|STARTED|Washout Period 1||12
3193927|NCT02074553|3921944|FG002|STARTED|Washout Period 1||12
3193928|NCT02074553|3921945|FG003|STARTED|Washout Period 1||12
3193929|NCT02074553|3921946|FG004|STARTED|Washout Period 1||12
3193930|NCT02074553|3921947|FG005|STARTED|Washout Period 1||12
3193931|NCT02074553|3921948|FG006|STARTED|Washout Period 1||12
3193932|NCT02074553|3921949|FG007|STARTED|Washout Period 1||12
3193933|NCT02074553|3921942|FG000|COMPLETED|Washout Period 1||11
3193934|NCT02074553|3921943|FG001|COMPLETED|Washout Period 1||12
3193935|NCT02074553|3921944|FG002|COMPLETED|Washout Period 1||12
3193936|NCT02074553|3921945|FG003|COMPLETED|Washout Period 1||11
3193937|NCT02074553|3921946|FG004|COMPLETED|Washout Period 1||12
3193938|NCT02074553|3921947|FG005|COMPLETED|Washout Period 1||11
3193939|NCT02074553|3921948|FG006|COMPLETED|Washout Period 1||12
3193940|NCT02074553|3921949|FG007|COMPLETED|Washout Period 1||12
3193941|NCT02074553|3921942|FG000|NOT COMPLETED|Washout Period 1||1
3193942|NCT02074553|3921943|FG001|NOT COMPLETED|Washout Period 1||0
3193943|NCT02074553|3921944|FG002|NOT COMPLETED|Washout Period 1||0
3193944|NCT02074553|3921945|FG003|NOT COMPLETED|Washout Period 1||1
3193945|NCT02074553|3921946|FG004|NOT COMPLETED|Washout Period 1||0
3193946|NCT02074553|3921947|FG005|NOT COMPLETED|Washout Period 1||1
3193947|NCT02074553|3921948|FG006|NOT COMPLETED|Washout Period 1||0
3193948|NCT02074553|3921949|FG007|NOT COMPLETED|Washout Period 1||0
3193949|NCT02074553|3921942|FG000|STARTED|Intervention Period 2||11
3193950|NCT02074553|3921943|FG001|STARTED|Intervention Period 2||12
3193951|NCT02074553|3921944|FG002|STARTED|Intervention Period 2||12
3193952|NCT02074553|3921945|FG003|STARTED|Intervention Period 2||11
3193953|NCT02074553|3921946|FG004|STARTED|Intervention Period 2||12
3193954|NCT02074553|3921947|FG005|STARTED|Intervention Period 2||11
3193955|NCT02074553|3921948|FG006|STARTED|Intervention Period 2||12
3193956|NCT02074553|3921949|FG007|STARTED|Intervention Period 2||12
3193957|NCT02074553|3921942|FG000|COMPLETED|Intervention Period 2||11
3193958|NCT02074553|3921943|FG001|COMPLETED|Intervention Period 2||12
3193959|NCT02074553|3921944|FG002|COMPLETED|Intervention Period 2||12
3193960|NCT02074553|3921945|FG003|COMPLETED|Intervention Period 2||11
3193961|NCT02074553|3921946|FG004|COMPLETED|Intervention Period 2||12
3193962|NCT02074553|3921947|FG005|COMPLETED|Intervention Period 2||11
3193963|NCT02074553|3921948|FG006|COMPLETED|Intervention Period 2||12
3193964|NCT02074553|3921949|FG007|COMPLETED|Intervention Period 2||12
3193965|NCT02074553|3921942|FG000|NOT COMPLETED|Intervention Period 2||0
3193966|NCT02074553|3921943|FG001|NOT COMPLETED|Intervention Period 2||0
3193967|NCT02074553|3921944|FG002|NOT COMPLETED|Intervention Period 2||0
3193968|NCT02074553|3921945|FG003|NOT COMPLETED|Intervention Period 2||0
3193969|NCT02074553|3921946|FG004|NOT COMPLETED|Intervention Period 2||0
3193970|NCT02074553|3921947|FG005|NOT COMPLETED|Intervention Period 2||0
3193971|NCT02074553|3921948|FG006|NOT COMPLETED|Intervention Period 2||0
3193972|NCT02074553|3921949|FG007|NOT COMPLETED|Intervention Period 2||0
3193973|NCT02074553|3921942|FG000|STARTED|Washout Period 2||11
3193974|NCT02074553|3921943|FG001|STARTED|Washout Period 2||12
3193975|NCT02074553|3921944|FG002|STARTED|Washout Period 2||12
3193976|NCT02074553|3921945|FG003|STARTED|Washout Period 2||11
3193977|NCT02074553|3921946|FG004|STARTED|Washout Period 2||12
3193978|NCT02074553|3921947|FG005|STARTED|Washout Period 2||11
3193979|NCT02074553|3921948|FG006|STARTED|Washout Period 2||12
3193980|NCT02074553|3921949|FG007|STARTED|Washout Period 2||12
3193981|NCT02074553|3921942|FG000|COMPLETED|Washout Period 2||11
3193982|NCT02074553|3921943|FG001|COMPLETED|Washout Period 2||12
3193983|NCT02074553|3921944|FG002|COMPLETED|Washout Period 2||11
3193984|NCT02074553|3921945|FG003|COMPLETED|Washout Period 2||11
3193985|NCT02074553|3921946|FG004|COMPLETED|Washout Period 2||12
3193986|NCT02074553|3921947|FG005|COMPLETED|Washout Period 2||10
3193987|NCT02074553|3921948|FG006|COMPLETED|Washout Period 2||11
3193988|NCT02074553|3921949|FG007|COMPLETED|Washout Period 2||12
3193989|NCT02074553|3921942|FG000|NOT COMPLETED|Washout Period 2||0
3193990|NCT02074553|3921943|FG001|NOT COMPLETED|Washout Period 2||0
3193991|NCT02074553|3921944|FG002|NOT COMPLETED|Washout Period 2||1
3193992|NCT02074553|3921945|FG003|NOT COMPLETED|Washout Period 2||0
3193993|NCT02074553|3921946|FG004|NOT COMPLETED|Washout Period 2||0
3193994|NCT02074553|3921947|FG005|NOT COMPLETED|Washout Period 2||1
3193995|NCT02074553|3921948|FG006|NOT COMPLETED|Washout Period 2||1
3193996|NCT02074553|3921949|FG007|NOT COMPLETED|Washout Period 2||0
3193997|NCT02074553|3921942|FG000|STARTED|Intervention Period 3||11
3193998|NCT02074553|3921943|FG001|STARTED|Intervention Period 3||12
3193999|NCT02074553|3921944|FG002|STARTED|Intervention Period 3||11
3194000|NCT02074553|3921945|FG003|STARTED|Intervention Period 3||11
3194001|NCT02074553|3921946|FG004|STARTED|Intervention Period 3||12
3194002|NCT02074553|3921947|FG005|STARTED|Intervention Period 3||10
3194003|NCT02074553|3921948|FG006|STARTED|Intervention Period 3||11
3194004|NCT02074553|3921949|FG007|STARTED|Intervention Period 3||12
3194005|NCT02074553|3921942|FG000|COMPLETED|Intervention Period 3||11
3194006|NCT02074553|3921943|FG001|COMPLETED|Intervention Period 3||12
3194007|NCT02074553|3921944|FG002|COMPLETED|Intervention Period 3||11
3194008|NCT02074553|3921945|FG003|COMPLETED|Intervention Period 3||11
3194009|NCT02074553|3921946|FG004|COMPLETED|Intervention Period 3||12
3194010|NCT02074553|3921947|FG005|COMPLETED|Intervention Period 3||10
3194011|NCT02074553|3921948|FG006|COMPLETED|Intervention Period 3||11
3194012|NCT02074553|3921949|FG007|COMPLETED|Intervention Period 3||12
3194013|NCT02074553|3921942|FG000|NOT COMPLETED|Intervention Period 3||0
3194014|NCT02074553|3921943|FG001|NOT COMPLETED|Intervention Period 3||0
3194015|NCT02074553|3921944|FG002|NOT COMPLETED|Intervention Period 3||0
3194016|NCT02074553|3921945|FG003|NOT COMPLETED|Intervention Period 3||0
3194017|NCT02074553|3921946|FG004|NOT COMPLETED|Intervention Period 3||0
3194018|NCT02074553|3921947|FG005|NOT COMPLETED|Intervention Period 3||0
3194019|NCT02074553|3921948|FG006|NOT COMPLETED|Intervention Period 3||0
3194020|NCT02074553|3921949|FG007|NOT COMPLETED|Intervention Period 3||0
3194021|NCT02074553|3921942|FG000|STARTED|Washout Period 3||11
3194022|NCT02074553|3921943|FG001|STARTED|Washout Period 3||12
3194023|NCT02074553|3921944|FG002|STARTED|Washout Period 3||11
3194024|NCT02074553|3921945|FG003|STARTED|Washout Period 3||11
3194025|NCT02074553|3921946|FG004|STARTED|Washout Period 3||12
3194026|NCT02074553|3921947|FG005|STARTED|Washout Period 3||10
3194027|NCT02074553|3921948|FG006|STARTED|Washout Period 3||11
3194028|NCT02074553|3921949|FG007|STARTED|Washout Period 3||12
3194029|NCT02074553|3921942|FG000|COMPLETED|Washout Period 3||11
3194030|NCT02074553|3921943|FG001|COMPLETED|Washout Period 3||12
3194031|NCT02074553|3921944|FG002|COMPLETED|Washout Period 3||11
3194032|NCT02074553|3921945|FG003|COMPLETED|Washout Period 3||11
3194033|NCT02074553|3921946|FG004|COMPLETED|Washout Period 3||12
3194034|NCT02074553|3921947|FG005|COMPLETED|Washout Period 3||10
3194035|NCT02074553|3921948|FG006|COMPLETED|Washout Period 3||11
3194036|NCT02074553|3921949|FG007|COMPLETED|Washout Period 3||11
3194037|NCT02074553|3921942|FG000|NOT COMPLETED|Washout Period 3||0
3194038|NCT02074553|3921943|FG001|NOT COMPLETED|Washout Period 3||0
3194039|NCT02074553|3921944|FG002|NOT COMPLETED|Washout Period 3||0
3194040|NCT02074553|3921945|FG003|NOT COMPLETED|Washout Period 3||0
3194041|NCT02074553|3921946|FG004|NOT COMPLETED|Washout Period 3||0
3194042|NCT02074553|3921947|FG005|NOT COMPLETED|Washout Period 3||0
3194043|NCT02074553|3921948|FG006|NOT COMPLETED|Washout Period 3||0
3194044|NCT02074553|3921949|FG007|NOT COMPLETED|Washout Period 3||1
3194045|NCT02074553|3921942|FG000|STARTED|Intervention Period 4||11
3194046|NCT02074553|3921943|FG001|STARTED|Intervention Period 4||12
3194047|NCT02074553|3921944|FG002|STARTED|Intervention Period 4||11
3194048|NCT02074553|3921945|FG003|STARTED|Intervention Period 4||11
3194049|NCT02074553|3921946|FG004|STARTED|Intervention Period 4||12
3194050|NCT02074553|3921947|FG005|STARTED|Intervention Period 4||10
3194051|NCT02074553|3921948|FG006|STARTED|Intervention Period 4||11
3194052|NCT02074553|3921949|FG007|STARTED|Intervention Period 4||11
3194053|NCT02074553|3921942|FG000|COMPLETED|Intervention Period 4||11
3194054|NCT02074553|3921943|FG001|COMPLETED|Intervention Period 4||12
3194055|NCT02074553|3921944|FG002|COMPLETED|Intervention Period 4||11
3194056|NCT02074553|3921945|FG003|COMPLETED|Intervention Period 4||11
3194057|NCT02074553|3921946|FG004|COMPLETED|Intervention Period 4||12
3194058|NCT02074553|3921947|FG005|COMPLETED|Intervention Period 4||10
3194059|NCT02074553|3921948|FG006|COMPLETED|Intervention Period 4||11
3194060|NCT02074553|3921949|FG007|COMPLETED|Intervention Period 4||11
3194061|NCT02074553|3921942|FG000|NOT COMPLETED|Intervention Period 4||0
3194062|NCT02074553|3921943|FG001|NOT COMPLETED|Intervention Period 4||0
3194063|NCT02074553|3921944|FG002|NOT COMPLETED|Intervention Period 4||0
3194064|NCT02074553|3921945|FG003|NOT COMPLETED|Intervention Period 4||0
3194065|NCT02074553|3921946|FG004|NOT COMPLETED|Intervention Period 4||0
3194066|NCT02074553|3921947|FG005|NOT COMPLETED|Intervention Period 4||0
3194067|NCT02074553|3921948|FG006|NOT COMPLETED|Intervention Period 4||0
3194068|NCT02074553|3921949|FG007|NOT COMPLETED|Intervention Period 4||0
3194069|NCT02074709|3921969|FG000|STARTED|Overall Study||30
3194070|NCT02074709|3921970|FG001|STARTED|Overall Study||30
3194071|NCT02074709|3921969|FG000|COMPLETED|Overall Study||29
3194072|NCT02074709|3921970|FG001|COMPLETED|Overall Study||29
3194073|NCT02074709|3921969|FG000|NOT COMPLETED|Overall Study||1
3194074|NCT02074709|3921970|FG001|NOT COMPLETED|Overall Study||1
3194075|NCT02074735|3921978|FG000|STARTED|Overall Study||29
3194076|NCT02074735|3921979|FG001|STARTED|Overall Study||33
3194077|NCT02074735|3921978|FG000|COMPLETED|Overall Study||26
3194078|NCT02074735|3921979|FG001|COMPLETED|Overall Study||29
3194079|NCT02074735|3921978|FG000|NOT COMPLETED|Overall Study||3
3194080|NCT02074735|3921979|FG001|NOT COMPLETED|Overall Study||4
3194081|NCT02074982|3921987|FG000|STARTED|Overall Study||337
3194082|NCT02074982|3921988|FG001|STARTED|Overall Study||339
3194083|NCT02074982|3921987|FG000|Full Analysis Set (FAS)|Overall Study||336
3194084|NCT02074982|3921988|FG001|Full Analysis Set (FAS)|Overall Study||339
3194085|NCT02074982|3921987|FG000|Safety Set (SF)|Overall Study||335
3194086|NCT02074982|3921988|FG001|Safety Set (SF)|Overall Study||336
3194087|NCT02074982|3921987|FG000|COMPLETED|Overall Study||286
3194088|NCT02074982|3921988|FG001|COMPLETED|Overall Study||285
3194089|NCT02074982|3921987|FG000|NOT COMPLETED|Overall Study||51
3194090|NCT02074982|3921988|FG001|NOT COMPLETED|Overall Study||54
3194091|NCT02074995|3921994|FG000|STARTED|Overall Study||1
3194092|NCT02074995|3921995|FG001|STARTED|Overall Study||0
3194093|NCT02074995|3921996|FG002|STARTED|Overall Study||0
3194094|NCT02074995|3921994|FG000|COMPLETED|Overall Study||1
3194095|NCT02074995|3921995|FG001|COMPLETED|Overall Study||0
3194096|NCT02074995|3921996|FG002|COMPLETED|Overall Study||0
3194097|NCT02074995|3921994|FG000|NOT COMPLETED|Overall Study||0
3194098|NCT02074995|3921995|FG001|NOT COMPLETED|Overall Study||0
3194099|NCT02074995|3921996|FG002|NOT COMPLETED|Overall Study||0
3194100|NCT02075008|3922000|FG000|STARTED|Overall Study||270
3194101|NCT02075008|3922000|FG000|COMPLETED|Overall Study||94
3194102|NCT02075008|3922000|FG000|NOT COMPLETED|Overall Study||176
3194103|NCT02075047|3922006|FG000|STARTED|Treatment Phase (4 Weeks)||86
3194104|NCT02075047|3922007|FG001|STARTED|Treatment Phase (4 Weeks)||85
3194105|NCT02075047|3922006|FG000|COMPLETED|Treatment Phase (4 Weeks)||63
3194106|NCT02075047|3922007|FG001|COMPLETED|Treatment Phase (4 Weeks)||75
3194107|NCT02075047|3922006|FG000|NOT COMPLETED|Treatment Phase (4 Weeks)||23
3194108|NCT02075047|3922007|FG001|NOT COMPLETED|Treatment Phase (4 Weeks)||10
3194109|NCT02075047|3922006|FG000|STARTED|Follow up Phase (5 Weeks)|Participants were followed up after completion or discontinuation of treatment.|86
3194110|NCT02075047|3922007|FG001|STARTED|Follow up Phase (5 Weeks)|Participants were followed up after completion or discontinuation of treatment.|85
3194111|NCT02075047|3922006|FG000|COMPLETED|Follow up Phase (5 Weeks)||60
3194112|NCT02075047|3922007|FG001|COMPLETED|Follow up Phase (5 Weeks)||72
3194113|NCT02075047|3922006|FG000|NOT COMPLETED|Follow up Phase (5 Weeks)||26
3194114|NCT02075047|3922007|FG001|NOT COMPLETED|Follow up Phase (5 Weeks)||13
3194115|NCT02075073|3922016|FG000|STARTED|Overall Study||36
3194116|NCT02075073|3922017|FG001|STARTED|Overall Study||37
3194117|NCT02075073|3922018|FG002|STARTED|Overall Study||36
3194118|NCT02075073|3922016|FG000|COMPLETED|Overall Study||36
3194119|NCT02075073|3922017|FG001|COMPLETED|Overall Study||36
3194120|NCT02075073|3922018|FG002|COMPLETED|Overall Study||36
3194121|NCT02075073|3922016|FG000|NOT COMPLETED|Overall Study||0
3194122|NCT02075073|3922017|FG001|NOT COMPLETED|Overall Study||1
3194123|NCT02075073|3922018|FG002|NOT COMPLETED|Overall Study||0
3194124|NCT02075125|3922028|FG000|STARTED|Overall Study||19
3194125|NCT02075125|3922029|FG001|STARTED|Overall Study||20
3194126|NCT02075125|3922028|FG000|COMPLETED|Overall Study||19
3194127|NCT02075125|3922029|FG001|COMPLETED|Overall Study|One patient switched to clopidogrel treatment after 18 days of ticagrelor treatment.|19
3194128|NCT02075125|3922028|FG000|NOT COMPLETED|Overall Study||0
3194129|NCT02075125|3922029|FG001|NOT COMPLETED|Overall Study||1
3194130|NCT02075203|3922038|FG000|STARTED|Overall Study||330
3194131|NCT02075203|3922039|FG001|STARTED|Overall Study||330
3194132|NCT02075203|3922040|FG002|STARTED|Overall Study||329
3194133|NCT02075203|3922038|FG000|COMPLETED|Overall Study||327
3194134|NCT02075203|3922039|FG001|COMPLETED|Overall Study||330
3194135|NCT02075203|3922040|FG002|COMPLETED|Overall Study||328
3194136|NCT02075203|3922038|FG000|NOT COMPLETED|Overall Study||3
3194137|NCT02075203|3922039|FG001|NOT COMPLETED|Overall Study||0
3194138|NCT02075203|3922040|FG002|NOT COMPLETED|Overall Study||1
3194139|NCT02075255|3922051|FG000|STARTED|Overall Study||72
3194140|NCT02075255|3922052|FG001|STARTED|Overall Study||73
3194141|NCT02075255|3922053|FG002|STARTED|Overall Study||75
3194142|NCT02075255|3922051|FG000|COMPLETED|Overall Study||68
3194143|NCT02075255|3922052|FG001|COMPLETED|Overall Study||69
3194144|NCT02075255|3922053|FG002|COMPLETED|Overall Study||72
3194145|NCT02075255|3922051|FG000|NOT COMPLETED|Overall Study||4
3194146|NCT02075255|3922052|FG001|NOT COMPLETED|Overall Study||4
3194147|NCT02075255|3922053|FG002|NOT COMPLETED|Overall Study||3
3194148|NCT02075320|3922061|FG000|STARTED|Overall Study||50
3194149|NCT02075320|3922061|FG000|COMPLETED|Overall Study||48
3194150|NCT02075320|3922061|FG000|NOT COMPLETED|Overall Study||2
3194151|NCT02075463|3922065|FG000|STARTED|Overall Study||15
3194152|NCT02075463|3922065|FG000|COMPLETED|Overall Study||7
3194153|NCT02075463|3922065|FG000|NOT COMPLETED|Overall Study||8
3194154|NCT02075476|3922072|FG000|STARTED|Overall Study||20
3194155|NCT02075476|3922073|FG001|STARTED|Overall Study||20
3194156|NCT02075476|3922072|FG000|COMPLETED|Overall Study||17
3194157|NCT02075476|3922073|FG001|COMPLETED|Overall Study||15
3194158|NCT02075476|3922072|FG000|NOT COMPLETED|Overall Study||3
3194159|NCT02075476|3922073|FG001|NOT COMPLETED|Overall Study||5
3194160|NCT02075515|3922082|FG000|STARTED|Overall Study||218
3194161|NCT02075515|3922083|FG001|STARTED|Overall Study||217
3194162|NCT02075515|3922084|FG002|STARTED|Overall Study||216
3194163|NCT02075515|3922082|FG000|COMPLETED|Overall Study||214
3194164|NCT02075515|3922083|FG001|COMPLETED|Overall Study||212
3194165|NCT02075515|3922084|FG002|COMPLETED|Overall Study||208
3194166|NCT02075515|3922082|FG000|NOT COMPLETED|Overall Study||4
3194167|NCT02075515|3922083|FG001|NOT COMPLETED|Overall Study||5
3194168|NCT02075515|3922084|FG002|NOT COMPLETED|Overall Study||8
3194169|NCT02075541|3922095|FG000|STARTED|Overall Study||73
3194170|NCT02075541|3922096|FG001|STARTED|Overall Study||72
3194171|NCT02075541|3922095|FG000|COMPLETED|Overall Study||69
3194172|NCT02075541|3922096|FG001|COMPLETED|Overall Study||64
3194173|NCT02075541|3922095|FG000|NOT COMPLETED|Overall Study||4
3194174|NCT02075541|3922096|FG001|NOT COMPLETED|Overall Study||8
3194175|NCT02075554|3922102|FG000|STARTED|Overall Study||58
3194176|NCT02075554|3922102|FG000|COMPLETED|Overall Study||43
3194177|NCT02075554|3922102|FG000|NOT COMPLETED|Overall Study||15
3194178|NCT02075606|3922106|FG000|STARTED|Overall Study||50
3194179|NCT02075606|3922106|FG000|COMPLETED|Overall Study||40
3194180|NCT02075606|3922106|FG000|NOT COMPLETED|Overall Study||10
3194181|NCT02075632|3922117|FG000|STARTED|Overall Study||162
3194182|NCT02075632|3922118|FG001|STARTED|Overall Study||148
3194183|NCT02075632|3922117|FG000|COMPLETED|Overall Study||161
3194184|NCT02075632|3922118|FG001|COMPLETED|Overall Study||143
3194185|NCT02075632|3922117|FG000|NOT COMPLETED|Overall Study||1
3194186|NCT02075632|3922118|FG001|NOT COMPLETED|Overall Study||5
3194187|NCT02075658|3922126|FG000|STARTED|Overall Study||30
3194188|NCT02075658|3922127|FG001|STARTED|Overall Study||30
3194189|NCT02075658|3922126|FG000|COMPLETED|Overall Study||28
3194190|NCT02075658|3922127|FG001|COMPLETED|Overall Study||28
3194191|NCT02075658|3922126|FG000|NOT COMPLETED|Overall Study||2
3194192|NCT02075658|3922127|FG001|NOT COMPLETED|Overall Study||2
3194193|NCT02076022|3922135|FG000|STARTED|Overall Study||7
3194194|NCT02076022|3922136|FG001|STARTED|Overall Study||3
3194195|NCT02076022|3922135|FG000|COMPLETED|Overall Study||5
3194196|NCT02076022|3922136|FG001|COMPLETED|Overall Study||3
3194197|NCT02076022|3922135|FG000|NOT COMPLETED|Overall Study||2
3194198|NCT02076022|3922136|FG001|NOT COMPLETED|Overall Study||0
3194199|NCT02076100|3922149|FG000|STARTED|Overall Study||3
3194200|NCT02076100|3922150|FG001|STARTED|Overall Study||3
3194201|NCT02076100|3922151|FG002|STARTED|Overall Study||3
3194202|NCT02076100|3922152|FG003|STARTED|Overall Study||3
3194203|NCT02076100|3922153|FG004|STARTED|Overall Study||3
3194204|NCT02076100|3922154|FG005|STARTED|Overall Study||3
3194205|NCT02076100|3922155|FG006|STARTED|Overall Study||4
3194206|NCT02076100|3922149|FG000|COMPLETED|Overall Study||3
3194207|NCT02076100|3922150|FG001|COMPLETED|Overall Study||3
3194208|NCT02076100|3922151|FG002|COMPLETED|Overall Study||3
3194209|NCT02076100|3922152|FG003|COMPLETED|Overall Study||3
3194210|NCT02076100|3922153|FG004|COMPLETED|Overall Study||3
3194211|NCT02076100|3922154|FG005|COMPLETED|Overall Study||3
3194212|NCT02076100|3922155|FG006|COMPLETED|Overall Study||4
3194213|NCT02076100|3922149|FG000|NOT COMPLETED|Overall Study||0
3194214|NCT02076100|3922150|FG001|NOT COMPLETED|Overall Study||0
3194215|NCT02076100|3922151|FG002|NOT COMPLETED|Overall Study||0
3194216|NCT02076100|3922152|FG003|NOT COMPLETED|Overall Study||0
3194217|NCT02076100|3922153|FG004|NOT COMPLETED|Overall Study||0
3194218|NCT02076100|3922154|FG005|NOT COMPLETED|Overall Study||0
3194219|NCT02076100|3922155|FG006|NOT COMPLETED|Overall Study||0
3194220|NCT02076113|3922177|FG000|STARTED|Overall Study||63
3194221|NCT02076113|3922178|FG001|STARTED|Overall Study||100
3194222|NCT02076113|3922177|FG000|Surgery as Randomized|Overall Study|1 patient underwent dorsal fusion surgery|62
3194223|NCT02076113|3922178|FG001|Surgery as Randomized|Overall Study|4 patients underwent ventral fusion surgery|96
3194224|NCT02076113|3922177|FG000|3-Month Follow-up|Overall Study|5 missed follow-up visit; 2 lost to follow-up|56
3194225|NCT02076113|3922178|FG001|3-Month Follow-up|Overall Study|9 missed follow-up appointment; 1 lost to follow-up|90
3194226|NCT02076113|3922177|FG000|6-Month Follow-up|Overall Study|7 missed follow-up visit; 3 lost to follow-up|53
3194227|NCT02076113|3922178|FG001|6-Month Follow-up|Overall Study|7 missed follow-up visit; 1 lost to follow-up; 1 deceased|91
3194228|NCT02076113|3922177|FG000|1-Year Follow-up|Overall Study|3 lost to follow-up|60
3194229|NCT02076113|3922178|FG001|1-Year Follow-up|Overall Study|2 missed follow-up visit; 1 lost to follow-up; 2 deceased|95
3194230|NCT02076113|3922177|FG000|2-Year Follow-up|Overall Study|5 missed follow-up visit; 4 lost to follow-up; 2 withdrew consent; 1 deceased|51
3194231|NCT02076113|3922178|FG001|2-Year Follow-up|Overall Study|14 missed follow-up visit; 1 lost to follow-up; 3 withdrew consent; 3 deceased|79
3194232|NCT02076113|3922177|FG000|COMPLETED|Overall Study||56
3194233|NCT02076113|3922178|FG001|COMPLETED|Overall Study||93
3194234|NCT02076113|3922177|FG000|NOT COMPLETED|Overall Study||7
3194235|NCT02076113|3922178|FG001|NOT COMPLETED|Overall Study||7
3194236|NCT02076152|3922189|FG000|STARTED|Overall Study||2
3194237|NCT02076152|3922190|FG001|STARTED|Overall Study||9
3194238|NCT02076152|3922189|FG000|COMPLETED|Overall Study||2
3194239|NCT02076152|3922190|FG001|COMPLETED|Overall Study||9
3194240|NCT02076152|3922189|FG000|NOT COMPLETED|Overall Study||0
3194241|NCT02076152|3922190|FG001|NOT COMPLETED|Overall Study||0
3194242|NCT02076165|3922197|FG000|STARTED|Overall Study||74
3194243|NCT02076165|3922198|FG001|STARTED|Overall Study||75
3194244|NCT02076165|3922197|FG000|COMPLETED|Overall Study||66
3194245|NCT02076165|3922198|FG001|COMPLETED|Overall Study||69
3194246|NCT02076165|3922197|FG000|NOT COMPLETED|Overall Study||8
3194247|NCT02076165|3922198|FG001|NOT COMPLETED|Overall Study||6
3194248|NCT02076243|3922204|FG000|STARTED|Overall Study||2
3194249|NCT02076243|3922204|FG000|COMPLETED|Overall Study||0
3194250|NCT02076243|3922204|FG000|NOT COMPLETED|Overall Study||2
3194251|NCT02076321|3922210|FG000|STARTED|Overall Study||51
3194252|NCT02076321|3922211|FG001|STARTED|Overall Study||51
3194253|NCT02076321|3922210|FG000|COMPLETED|Overall Study||46
3194254|NCT02076321|3922211|FG001|COMPLETED|Overall Study||49
3194255|NCT02076321|3922210|FG000|NOT COMPLETED|Overall Study||5
3194256|NCT02076321|3922211|FG001|NOT COMPLETED|Overall Study||2
3194257|NCT02076334|3922221|FG000|STARTED|Overall Study||21
3194258|NCT02076334|3922222|FG001|STARTED|Overall Study||21
3194259|NCT02076334|3922223|FG002|STARTED|Overall Study||21
3194260|NCT02076334|3922224|FG003|STARTED|Overall Study||21
3194261|NCT02076334|3922221|FG000|COMPLETED|Overall Study||20
3194262|NCT02076334|3922222|FG001|COMPLETED|Overall Study||20
3194263|NCT02076334|3922223|FG002|COMPLETED|Overall Study||20
3194264|NCT02076334|3922224|FG003|COMPLETED|Overall Study||20
3194265|NCT02076334|3922221|FG000|NOT COMPLETED|Overall Study||1
3194266|NCT02076334|3922222|FG001|NOT COMPLETED|Overall Study||1
3194267|NCT02076334|3922223|FG002|NOT COMPLETED|Overall Study||1
3194268|NCT02076334|3922224|FG003|NOT COMPLETED|Overall Study||1
3364469|NCT04017611|4095675|FG000|COMPLETED|Overall Study||12
3364470|NCT04017611|4095675|FG000|NOT COMPLETED|Overall Study||1
3364471|NCT04015232|4095681|FG000|STARTED|Overall Study||100
3364472|NCT04015232|4095682|FG001|STARTED|Overall Study||100
3364473|NCT04015232|4095681|FG000|COMPLETED|Overall Study||89
3364474|NCT04015232|4095682|FG001|COMPLETED|Overall Study||93
3364475|NCT04015232|4095681|FG000|NOT COMPLETED|Overall Study||11
3364476|NCT04015232|4095682|FG001|NOT COMPLETED|Overall Study||7
3364477|NCT04016623|4095692|FG000|STARTED|Pair 1 Test / Control Dispense||10
3364478|NCT04016623|4095692|FG000|COMPLETED|Pair 1 Test / Control Dispense||10
3364479|NCT04016623|4095692|FG000|NOT COMPLETED|Pair 1 Test / Control Dispense||0
3364480|NCT04016623|4095692|FG000|STARTED|Pair 1 Test /Control Follow up||10
3364481|NCT04016623|4095692|FG000|COMPLETED|Pair 1 Test /Control Follow up||10
3364482|NCT04016623|4095692|FG000|NOT COMPLETED|Pair 1 Test /Control Follow up||0
3364483|NCT04016623|4095692|FG000|STARTED|Pair 2 Test / Control Dispense||10
3364484|NCT04016623|4095692|FG000|COMPLETED|Pair 2 Test / Control Dispense||10
3364485|NCT04016623|4095692|FG000|NOT COMPLETED|Pair 2 Test / Control Dispense||0
3364486|NCT04016623|4095692|FG000|STARTED|Pair 2 Test /Control Follow up||10
3364487|NCT04016623|4095692|FG000|COMPLETED|Pair 2 Test /Control Follow up||10
3364488|NCT04016623|4095692|FG000|NOT COMPLETED|Pair 2 Test /Control Follow up||0
3364489|NCT04016623|4095692|FG000|STARTED|Pair 3 Test / Control Dispense||10
3364490|NCT04016623|4095692|FG000|COMPLETED|Pair 3 Test / Control Dispense||10
3364491|NCT04016623|4095692|FG000|NOT COMPLETED|Pair 3 Test / Control Dispense||0
3364492|NCT04016623|4095692|FG000|STARTED|Pair 3 Test /Control Follow up||10
3364493|NCT04016623|4095692|FG000|COMPLETED|Pair 3 Test /Control Follow up||10
3364494|NCT04016623|4095692|FG000|NOT COMPLETED|Pair 3 Test /Control Follow up||0
3364495|NCT04016623|4095692|FG000|STARTED|Pair 4 Test / Control Dispense||10
3364496|NCT04016623|4095692|FG000|COMPLETED|Pair 4 Test / Control Dispense||10
3364497|NCT04016623|4095692|FG000|NOT COMPLETED|Pair 4 Test / Control Dispense||0
3364498|NCT04016623|4095692|FG000|STARTED|Pair 4 Test /Control Follow up||10
3364499|NCT04016623|4095692|FG000|COMPLETED|Pair 4 Test /Control Follow up||10
3364500|NCT04016623|4095692|FG000|NOT COMPLETED|Pair 4 Test /Control Follow up||0
3364501|NCT04013737|4095714|FG000|STARTED|Overall Study||18
3364502|NCT04013737|4095715|FG001|STARTED|Overall Study||15
3364503|NCT04013737|4095714|FG000|COMPLETED|Overall Study|12 participants declined to participate in the study|18
3364504|NCT04013737|4095715|FG001|COMPLETED|Overall Study||15
3364505|NCT04013737|4095714|FG000|NOT COMPLETED|Overall Study||0
3364506|NCT04013737|4095715|FG001|NOT COMPLETED|Overall Study||0
3364507|NCT04014062|4095722|FG000|STARTED|Period I: Dosing||71
3364508|NCT04014062|4095723|FG001|STARTED|Period I: Dosing||71
3364509|NCT04014062|4095722|FG000|COMPLETED|Period I: Dosing|Period I: Dosing, includes a washout period of 42 days before starting Period II: Crossover Dosing|64
3364510|NCT04014062|4095723|FG001|COMPLETED|Period I: Dosing|Period I: Dosing, includes a washout period of 42 days before starting Period II: Crossover Dosing|65
3364511|NCT04014062|4095722|FG000|NOT COMPLETED|Period I: Dosing||7
3364512|NCT04014062|4095723|FG001|NOT COMPLETED|Period I: Dosing||6
3364513|NCT04014062|4095722|FG000|STARTED|Period II: Crossover Dosing||64
3364514|NCT04014062|4095723|FG001|STARTED|Period II: Crossover Dosing||65
3364515|NCT04014062|4095722|FG000|COMPLETED|Period II: Crossover Dosing||64
3364516|NCT04014062|4095723|FG001|COMPLETED|Period II: Crossover Dosing||65
3364517|NCT04014062|4095722|FG000|NOT COMPLETED|Period II: Crossover Dosing||0
3364518|NCT04014062|4095723|FG001|NOT COMPLETED|Period II: Crossover Dosing||0
3364519|NCT04013789|4095734|FG000|STARTED|First Wear Period (1 Week)||33
3364520|NCT04013789|4095735|FG001|STARTED|First Wear Period (1 Week)||34
3364521|NCT04013789|4095734|FG000|COMPLETED|First Wear Period (1 Week)||33
3364522|NCT04013789|4095735|FG001|COMPLETED|First Wear Period (1 Week)||34
3364523|NCT04013789|4095734|FG000|NOT COMPLETED|First Wear Period (1 Week)||0
3364524|NCT04013789|4095735|FG001|NOT COMPLETED|First Wear Period (1 Week)||0
3364525|NCT04013789|4095734|FG000|STARTED|Second Wear Period (1 Week)|One subject withdrew from the study between the first wear period and the second wear period.|32
3364526|NCT04013789|4095735|FG001|STARTED|Second Wear Period (1 Week)||34
3364527|NCT04013789|4095734|FG000|COMPLETED|Second Wear Period (1 Week)||32
3364528|NCT04013789|4095735|FG001|COMPLETED|Second Wear Period (1 Week)||34
3364529|NCT04013789|4095734|FG000|NOT COMPLETED|Second Wear Period (1 Week)||0
3364530|NCT04013789|4095735|FG001|NOT COMPLETED|Second Wear Period (1 Week)||0
3364531|NCT04012970|4095745|FG000|STARTED|Intervention Session, 30 Minutes||26
3364532|NCT04012970|4095746|FG001|STARTED|Intervention Session, 30 Minutes||14
3364533|NCT04012970|4095745|FG000|COMPLETED|Intervention Session, 30 Minutes||26
3364534|NCT04012970|4095746|FG001|COMPLETED|Intervention Session, 30 Minutes||14
3364535|NCT04012970|4095745|FG000|NOT COMPLETED|Intervention Session, 30 Minutes||0
3364536|NCT04012970|4095746|FG001|NOT COMPLETED|Intervention Session, 30 Minutes||0
3194269|NCT02076399|3922236|FG000|STARTED|Overall Study||51
3194270|NCT02076399|3922237|FG001|STARTED|Overall Study||25
3194271|NCT02076399|3922236|FG000|COMPLETED|Overall Study||12
3194272|NCT02076399|3922237|FG001|COMPLETED|Overall Study||1
3194273|NCT02076399|3922236|FG000|NOT COMPLETED|Overall Study||39
3194274|NCT02076399|3922237|FG001|NOT COMPLETED|Overall Study||24
3194275|NCT02076412|3922245|FG000|STARTED|Overall Study||50
3194276|NCT02076412|3922246|FG001|STARTED|Overall Study||24
3194277|NCT02076412|3922245|FG000|COMPLETED|Overall Study||13
3194278|NCT02076412|3922246|FG001|COMPLETED|Overall Study||2
3194279|NCT02076412|3922245|FG000|NOT COMPLETED|Overall Study||37
3194280|NCT02076412|3922246|FG001|NOT COMPLETED|Overall Study||22
3194281|NCT02076425|3922254|FG000|STARTED|Overall Study||114
3194282|NCT02076425|3922255|FG001|STARTED|Overall Study||115
3194283|NCT02076425|3922254|FG000|COMPLETED|Overall Study||100
3194284|NCT02076425|3922255|FG001|COMPLETED|Overall Study||91
3194285|NCT02076425|3922254|FG000|NOT COMPLETED|Overall Study||14
3194286|NCT02076425|3922255|FG001|NOT COMPLETED|Overall Study||24
3194287|NCT02076776|3922264|FG000|STARTED|Overall Study||6
3194288|NCT02076776|3922265|FG001|STARTED|Overall Study||8
3194289|NCT02076776|3922266|FG002|STARTED|Overall Study||6
3194290|NCT02076776|3922264|FG000|COMPLETED|Overall Study||5
3194291|NCT02076776|3922265|FG001|COMPLETED|Overall Study||6
3194292|NCT02076776|3922266|FG002|COMPLETED|Overall Study||6
3194293|NCT02076776|3922264|FG000|NOT COMPLETED|Overall Study||1
3194294|NCT02076776|3922265|FG001|NOT COMPLETED|Overall Study||2
3194295|NCT02076776|3922266|FG002|NOT COMPLETED|Overall Study||0
3194296|NCT02076919|3922286|FG000|STARTED|Overall Study||24
3194297|NCT02076919|3922287|FG001|STARTED|Overall Study||8
3194298|NCT02076919|3922288|FG002|STARTED|Overall Study||36
3194299|NCT02076919|3922289|FG003|STARTED|Overall Study||12
3194300|NCT02076919|3922286|FG000|COMPLETED|Overall Study||24
3194301|NCT02076919|3922287|FG001|COMPLETED|Overall Study||8
3194302|NCT02076919|3922288|FG002|COMPLETED|Overall Study||36
3194303|NCT02076919|3922289|FG003|COMPLETED|Overall Study||12
3194304|NCT02076919|3922286|FG000|NOT COMPLETED|Overall Study||0
3194305|NCT02076919|3922287|FG001|NOT COMPLETED|Overall Study||0
3194306|NCT02076919|3922288|FG002|NOT COMPLETED|Overall Study||0
3194307|NCT02076919|3922289|FG003|NOT COMPLETED|Overall Study||0
3194308|NCT02076997|3922316|FG000|STARTED|Overall Study||23
3194309|NCT02076997|3922316|FG000|COMPLETED|Overall Study||22
3194310|NCT02076997|3922316|FG000|NOT COMPLETED|Overall Study||1
3194311|NCT02077140|3922325|FG000|STARTED|Overall Study||36
3194312|NCT02077140|3922326|FG001|STARTED|Overall Study||36
3194313|NCT02077140|3922327|FG002|STARTED|Overall Study||36
3194314|NCT02077140|3922328|FG003|STARTED|Overall Study||36
3194315|NCT02077140|3922329|FG004|STARTED|Overall Study||48
3194316|NCT02077140|3922325|FG000|COMPLETED|Overall Study||32
3194317|NCT02077140|3922326|FG001|COMPLETED|Overall Study||34
3194318|NCT02077140|3922327|FG002|COMPLETED|Overall Study||34
3194319|NCT02077140|3922328|FG003|COMPLETED|Overall Study||32
3194320|NCT02077140|3922329|FG004|COMPLETED|Overall Study||43
3194321|NCT02077140|3922325|FG000|NOT COMPLETED|Overall Study||4
3194322|NCT02077140|3922326|FG001|NOT COMPLETED|Overall Study||2
3194323|NCT02077140|3922327|FG002|NOT COMPLETED|Overall Study||2
3194324|NCT02077140|3922328|FG003|NOT COMPLETED|Overall Study||4
3194325|NCT02077140|3922329|FG004|NOT COMPLETED|Overall Study||5
3194326|NCT02077374|3922346|FG000|STARTED|Overall Study||19
3194327|NCT02077374|3922347|FG001|STARTED|Overall Study||19
3194328|NCT02077374|3922346|FG000|COMPLETED|Overall Study||19
3194329|NCT02077374|3922347|FG001|COMPLETED|Overall Study||17
3194330|NCT02077374|3922346|FG000|NOT COMPLETED|Overall Study||0
3194331|NCT02077374|3922347|FG001|NOT COMPLETED|Overall Study||2
3194332|NCT02077465|3922358|FG000|STARTED|Overall Study||8
3194333|NCT02077465|3922359|FG001|STARTED|Overall Study||3
3194334|NCT02077465|3922358|FG000|COMPLETED|Overall Study||7
3194335|NCT02077465|3922359|FG001|COMPLETED|Overall Study||2
3194336|NCT02077465|3922358|FG000|NOT COMPLETED|Overall Study||1
3194337|NCT02077465|3922359|FG001|NOT COMPLETED|Overall Study||1
3194338|NCT02078102|3922367|FG000|STARTED|Overall Study||25
3194339|NCT02078102|3922368|FG001|STARTED|Overall Study||13
3194340|NCT02078102|3922367|FG000|COMPLETED|Overall Study||23
3194341|NCT02078102|3922368|FG001|COMPLETED|Overall Study||12
3194342|NCT02078102|3922367|FG000|NOT COMPLETED|Overall Study||2
3194343|NCT02078102|3922368|FG001|NOT COMPLETED|Overall Study||1
3194344|NCT02078180|3922375|FG000|STARTED|Overall Study||34
3194345|NCT02078180|3922375|FG000|IR75|Overall Study||30
3194346|NCT02078180|3922375|FG000|IR100|Overall Study||31
3194347|NCT02078180|3922375|FG000|SR100|Overall Study||31
3194348|NCT02078180|3922375|FG000|SR150|Overall Study||32
3194349|NCT02078180|3922375|FG000|XL 150|Overall Study||31
3194350|NCT02078180|3922375|FG000|XL 300|Overall Study||32
3194351|NCT02078180|3922375|FG000|COMPLETED|Overall Study||29
3194352|NCT02078180|3922375|FG000|NOT COMPLETED|Overall Study||5
3194353|NCT02078193|3922384|FG000|STARTED|Overall Study||3
3194354|NCT02078193|3922384|FG000|COMPLETED|Overall Study||3
3194355|NCT02078193|3922384|FG000|NOT COMPLETED|Overall Study||0
3194356|NCT02078219|3922394|FG000|STARTED|Overall Study||41
3194357|NCT02078219|3922395|FG001|STARTED|Overall Study||40
3194358|NCT02078219|3922396|FG002|STARTED|Overall Study||41
3194359|NCT02078219|3922397|FG003|STARTED|Overall Study||41
3194360|NCT02078219|3922398|FG004|STARTED|Overall Study||41
3194361|NCT02078219|3922394|FG000|COMPLETED|Overall Study||38
3194362|NCT02078219|3922395|FG001|COMPLETED|Overall Study||36
3194363|NCT02078219|3922396|FG002|COMPLETED|Overall Study||35
3194364|NCT02078219|3922397|FG003|COMPLETED|Overall Study||37
3194365|NCT02078219|3922398|FG004|COMPLETED|Overall Study||39
3194366|NCT02078219|3922394|FG000|NOT COMPLETED|Overall Study||3
3194367|NCT02078219|3922395|FG001|NOT COMPLETED|Overall Study||4
3194368|NCT02078219|3922396|FG002|NOT COMPLETED|Overall Study||6
3194369|NCT02078219|3922397|FG003|NOT COMPLETED|Overall Study||4
3194370|NCT02078219|3922398|FG004|NOT COMPLETED|Overall Study||2
3194371|NCT02078284|3922415|FG000|STARTED|Overall Study||5
3194372|NCT02078284|3922416|FG001|STARTED|Overall Study||7
3194373|NCT02078284|3922417|FG002|STARTED|Overall Study||6
3194374|NCT02078284|3922418|FG003|STARTED|Overall Study||6
3194375|NCT02078284|3922419|FG004|STARTED|Overall Study||4
3194376|NCT02078284|3922415|FG000|COMPLETED|Overall Study||5
3194377|NCT02078284|3922416|FG001|COMPLETED|Overall Study||7
3194378|NCT02078284|3922417|FG002|COMPLETED|Overall Study||6
3194379|NCT02078284|3922418|FG003|COMPLETED|Overall Study||6
3194380|NCT02078284|3922419|FG004|COMPLETED|Overall Study||4
3194381|NCT02078284|3922415|FG000|NOT COMPLETED|Overall Study||0
3194382|NCT02078284|3922416|FG001|NOT COMPLETED|Overall Study||0
3194383|NCT02078284|3922417|FG002|NOT COMPLETED|Overall Study||0
3194384|NCT02078284|3922418|FG003|NOT COMPLETED|Overall Study||0
3194385|NCT02078284|3922419|FG004|NOT COMPLETED|Overall Study||0
3194386|NCT02078492|3922434|FG000|STARTED|Overall Study||80
3194387|NCT02078492|3922435|FG001|STARTED|Overall Study||80
3194388|NCT02078492|3922436|FG002|STARTED|Overall Study||80
3194389|NCT02078492|3922434|FG000|COMPLETED|Overall Study||80
3194390|NCT02078492|3922435|FG001|COMPLETED|Overall Study||80
3194391|NCT02078492|3922436|FG002|COMPLETED|Overall Study||80
3194392|NCT02078492|3922434|FG000|NOT COMPLETED|Overall Study||0
3194393|NCT02078492|3922435|FG001|NOT COMPLETED|Overall Study||0
3194394|NCT02078492|3922436|FG002|NOT COMPLETED|Overall Study||0
3194395|NCT02078557|3922444|FG000|STARTED|Overall Study||4
3194396|NCT02078557|3922444|FG000|COMPLETED|Overall Study||4
3194397|NCT02078557|3922444|FG000|NOT COMPLETED|Overall Study||0
3194398|NCT02078713|3922452|FG000|STARTED|Overall Study||407
3194399|NCT02078713|3922453|FG001|STARTED|Overall Study||351
3194400|NCT02078713|3922454|FG002|STARTED|Overall Study||15
3194401|NCT02078713|3922455|FG003|STARTED|Overall Study||13
3194402|NCT02078713|3922452|FG000|COMPLETED|Overall Study||355
3194403|NCT02078713|3922453|FG001|COMPLETED|Overall Study||290
3194404|NCT02078713|3922454|FG002|COMPLETED|Overall Study||15
3194405|NCT02078713|3922455|FG003|COMPLETED|Overall Study||13
3194406|NCT02078713|3922452|FG000|NOT COMPLETED|Overall Study||52
3194407|NCT02078713|3922453|FG001|NOT COMPLETED|Overall Study||61
3194408|NCT02078713|3922454|FG002|NOT COMPLETED|Overall Study||0
3194409|NCT02078713|3922455|FG003|NOT COMPLETED|Overall Study||0
3194410|NCT02078726|3922469|FG000|STARTED|Overall Study||64
3194411|NCT02078726|3922470|FG001|STARTED|Overall Study||36
3194412|NCT02078726|3922469|FG000|COMPLETED|Overall Study||64
3194413|NCT02078726|3922470|FG001|COMPLETED|Overall Study||36
3194414|NCT02078726|3922469|FG000|NOT COMPLETED|Overall Study||0
3194415|NCT02078726|3922470|FG001|NOT COMPLETED|Overall Study||0
3194416|NCT02078752|3922486|FG000|STARTED|Overall Study||3
3194417|NCT02078752|3922487|FG001|STARTED|Overall Study||13
3194418|NCT02078752|3922488|FG002|STARTED|Overall Study||2
3194419|NCT02078752|3922489|FG003|STARTED|Overall Study||7
3194420|NCT02078752|3922490|FG004|STARTED|Overall Study||3
3194421|NCT02078752|3922491|FG005|STARTED|Overall Study||9
3194422|NCT02078752|3922492|FG006|STARTED|Overall Study||3
3194423|NCT02078752|3922493|FG007|STARTED|Overall Study||6
3194424|NCT02078752|3922494|FG008|STARTED|Overall Study||2
3194425|NCT02078752|3922495|FG009|STARTED|Overall Study||12
3194426|NCT02078752|3922486|FG000|COMPLETED|Overall Study||1
3194427|NCT02078752|3922487|FG001|COMPLETED|Overall Study||6
3194428|NCT02078752|3922488|FG002|COMPLETED|Overall Study||1
3194429|NCT02078752|3922489|FG003|COMPLETED|Overall Study||5
3194430|NCT02078752|3922490|FG004|COMPLETED|Overall Study||2
3194431|NCT02078752|3922491|FG005|COMPLETED|Overall Study||5
3194432|NCT02078752|3922492|FG006|COMPLETED|Overall Study||1
3194433|NCT02078752|3922493|FG007|COMPLETED|Overall Study||3
3194434|NCT02078752|3922494|FG008|COMPLETED|Overall Study||2
3194435|NCT02078752|3922495|FG009|COMPLETED|Overall Study||2
3194436|NCT02078752|3922486|FG000|NOT COMPLETED|Overall Study||2
3194437|NCT02078752|3922487|FG001|NOT COMPLETED|Overall Study||7
3194438|NCT02078752|3922488|FG002|NOT COMPLETED|Overall Study||1
3194439|NCT02078752|3922489|FG003|NOT COMPLETED|Overall Study||2
3194440|NCT02078752|3922490|FG004|NOT COMPLETED|Overall Study||1
3194441|NCT02078752|3922491|FG005|NOT COMPLETED|Overall Study||4
3194442|NCT02078752|3922492|FG006|NOT COMPLETED|Overall Study||2
3194443|NCT02078752|3922493|FG007|NOT COMPLETED|Overall Study||3
3194444|NCT02078752|3922494|FG008|NOT COMPLETED|Overall Study||0
3194445|NCT02078752|3922495|FG009|NOT COMPLETED|Overall Study||10
3194446|NCT02078817|3922526|FG000|STARTED|Overall Study||14
3194447|NCT02078817|3922526|FG000|COMPLETED|Overall Study||13
3194448|NCT02078817|3922526|FG000|NOT COMPLETED|Overall Study||1
3194449|NCT02078882|3922530|FG000|STARTED|Overall Study||16
3194450|NCT02078882|3922530|FG000|COMPLETED|Overall Study||16
3194451|NCT02078882|3922530|FG000|NOT COMPLETED|Overall Study||0
3194452|NCT02078960|3922537|FG000|STARTED|Treatment Period||2
3194453|NCT02078960|3922538|FG001|STARTED|Treatment Period||4
3194454|NCT02078960|3922539|FG002|STARTED|Treatment Period||4
3194455|NCT02078960|3922537|FG000|COMPLETED|Treatment Period||0
3194456|NCT02078960|3922538|FG001|COMPLETED|Treatment Period||1
3194457|NCT02078960|3922539|FG002|COMPLETED|Treatment Period||1
3194458|NCT02078960|3922537|FG000|NOT COMPLETED|Treatment Period||2
3194459|NCT02078960|3922538|FG001|NOT COMPLETED|Treatment Period||3
3194460|NCT02078960|3922539|FG002|NOT COMPLETED|Treatment Period||3
3194461|NCT02078960|3922537|FG000|STARTED|Follow-up Period||2
3194462|NCT02078960|3922538|FG001|STARTED|Follow-up Period||2
3194463|NCT02078960|3922539|FG002|STARTED|Follow-up Period||1
3194464|NCT02078960|3922537|FG000|COMPLETED|Follow-up Period||0
3194465|NCT02078960|3922538|FG001|COMPLETED|Follow-up Period||1
3194466|NCT02078960|3922539|FG002|COMPLETED|Follow-up Period||1
3194467|NCT02078960|3922537|FG000|NOT COMPLETED|Follow-up Period||2
3194468|NCT02078960|3922538|FG001|NOT COMPLETED|Follow-up Period||1
3194469|NCT02078960|3922539|FG002|NOT COMPLETED|Follow-up Period||0
3194470|NCT02079025|3922551|FG000|STARTED|Overall Study||839
3194471|NCT02079025|3922552|FG001|STARTED|Overall Study||837
3194472|NCT02079025|3922551|FG000|COMPLETED|Overall Study||839
3194473|NCT02079025|3922552|FG001|COMPLETED|Overall Study||837
3194474|NCT02079025|3922551|FG000|NOT COMPLETED|Overall Study||0
3194475|NCT02079025|3922552|FG001|NOT COMPLETED|Overall Study||0
3194476|NCT02079038|3922561|FG000|STARTED|Modified Intent to Treat Population||112
3194477|NCT02079038|3922562|FG001|STARTED|Modified Intent to Treat Population||56
3194478|NCT02079038|3922561|FG000|COMPLETED|Modified Intent to Treat Population||105
3194479|NCT02079038|3922562|FG001|COMPLETED|Modified Intent to Treat Population||51
3194480|NCT02079038|3922561|FG000|NOT COMPLETED|Modified Intent to Treat Population||7
3194481|NCT02079038|3922562|FG001|NOT COMPLETED|Modified Intent to Treat Population||5
3194482|NCT02079038|3922561|FG000|STARTED|Completed 6 Months||105
3194483|NCT02079038|3922562|FG001|STARTED|Completed 6 Months||51
3194484|NCT02079038|3922561|FG000|COMPLETED|Completed 6 Months||103
3194485|NCT02079038|3922562|FG001|COMPLETED|Completed 6 Months||50
3194486|NCT02079038|3922561|FG000|NOT COMPLETED|Completed 6 Months||2
3194487|NCT02079038|3922562|FG001|NOT COMPLETED|Completed 6 Months||1
3194488|NCT02079077|3922570|FG000|STARTED|Overall Study||43
3194489|NCT02079077|3922571|FG001|STARTED|Overall Study||48
3194490|NCT02079077|3922570|FG000|COMPLETED|Overall Study||37
3194491|NCT02079077|3922571|FG001|COMPLETED|Overall Study||39
3194492|NCT02079077|3922570|FG000|NOT COMPLETED|Overall Study||6
3194493|NCT02079077|3922571|FG001|NOT COMPLETED|Overall Study||9
3194494|NCT02079246|3922577|FG000|STARTED|OLEX||1463
3194495|NCT02079246|3922578|FG001|STARTED|OLEX||0
3194496|NCT02079246|3922577|FG000|COMPLETED|OLEX||1235
3194497|NCT02079246|3922578|FG001|COMPLETED|OLEX||0
3194498|NCT02079246|3922577|FG000|NOT COMPLETED|OLEX||228
3194499|NCT02079246|3922578|FG001|NOT COMPLETED|OLEX||0
3194500|NCT02079246|3922577|FG000|STARTED|OLEX-MEM||0
3194501|NCT02079246|3922578|FG001|STARTED|OLEX-MEM||101
3194502|NCT02079246|3922577|FG000|COMPLETED|OLEX-MEM||0
3194503|NCT02079246|3922578|FG001|COMPLETED|OLEX-MEM||82
3194504|NCT02079246|3922577|FG000|NOT COMPLETED|OLEX-MEM||0
3194505|NCT02079246|3922578|FG001|NOT COMPLETED|OLEX-MEM||19
3194506|NCT02079311|3922589|FG000|STARTED|Overall Study||28
3194507|NCT02079311|3922590|FG001|STARTED|Overall Study||27
3194508|NCT02079311|3922589|FG000|COMPLETED|Overall Study||28
3194509|NCT02079311|3922590|FG001|COMPLETED|Overall Study||26
3194510|NCT02079311|3922589|FG000|NOT COMPLETED|Overall Study||0
3194511|NCT02079311|3922590|FG001|NOT COMPLETED|Overall Study||1
3194512|NCT02079519|3922596|FG000|STARTED|Overall Study||10
3194513|NCT02079519|3922596|FG000|COMPLETED|Overall Study||0
3194514|NCT02079519|3922596|FG000|NOT COMPLETED|Overall Study||10
3194515|NCT02079532|3922600|FG000|STARTED|Overall Study||302
3194516|NCT02079532|3922600|FG000|COMPLETED|Overall Study||273
3194517|NCT02079532|3922600|FG000|NOT COMPLETED|Overall Study||29
3194518|NCT02079610|3922606|FG000|STARTED|Overall Study||19
3194519|NCT02079610|3922607|FG001|STARTED|Overall Study||17
3194520|NCT02079610|3922606|FG000|COMPLETED|Overall Study||18
3194521|NCT02079610|3922607|FG001|COMPLETED|Overall Study||16
3194522|NCT02079610|3922606|FG000|NOT COMPLETED|Overall Study||1
3194523|NCT02079610|3922607|FG001|NOT COMPLETED|Overall Study||1
3194524|NCT02079636|3922628|FG000|STARTED|Overall Study||8
3194525|NCT02079636|3922629|FG001|STARTED|Overall Study||15
3194526|NCT02079636|3922630|FG002|STARTED|Overall Study||3
3194527|NCT02079636|3922631|FG003|STARTED|Overall Study||21
3194528|NCT02079636|3922632|FG004|STARTED|Overall Study||4
3194529|NCT02079636|3922633|FG005|STARTED|Overall Study||19
3194530|NCT02079636|3922634|FG006|STARTED|Overall Study||12
3194531|NCT02079636|3922635|FG007|STARTED|Overall Study||4
3194532|NCT02079636|3922636|FG008|STARTED|Overall Study||3
3194533|NCT02079636|3922637|FG009|STARTED|Overall Study||9
3194534|NCT02079636|3922638|FG010|STARTED|Overall Study||10
3194535|NCT02079636|3922639|FG011|STARTED|Overall Study||6
3194536|NCT02079636|3922640|FG012|STARTED|Overall Study||8
3194537|NCT02079636|3922641|FG013|STARTED|Overall Study||3
3194538|NCT02079636|3922642|FG014|STARTED|Overall Study||17
3194539|NCT02079636|3922628|FG000|Received at Least One Dose of Study Drug|Overall Study||8
3194540|NCT02079636|3922629|FG001|Received at Least One Dose of Study Drug|Overall Study||15
3194541|NCT02079636|3922630|FG002|Received at Least One Dose of Study Drug|Overall Study||3
3194542|NCT02079636|3922631|FG003|Received at Least One Dose of Study Drug|Overall Study||21
3194543|NCT02079636|3922632|FG004|Received at Least One Dose of Study Drug|Overall Study||4
3194544|NCT02079636|3922633|FG005|Received at Least One Dose of Study Drug|Overall Study||19
3194545|NCT02079636|3922634|FG006|Received at Least One Dose of Study Drug|Overall Study||12
3194546|NCT02079636|3922635|FG007|Received at Least One Dose of Study Drug|Overall Study||4
3194547|NCT02079636|3922636|FG008|Received at Least One Dose of Study Drug|Overall Study||3
3194548|NCT02079636|3922637|FG009|Received at Least One Dose of Study Drug|Overall Study||9
3194549|NCT02079636|3922638|FG010|Received at Least One Dose of Study Drug|Overall Study||10
3194550|NCT02079636|3922639|FG011|Received at Least One Dose of Study Drug|Overall Study||6
3194551|NCT02079636|3922640|FG012|Received at Least One Dose of Study Drug|Overall Study||8
3194552|NCT02079636|3922641|FG013|Received at Least One Dose of Study Drug|Overall Study||3
3194553|NCT02079636|3922642|FG014|Received at Least One Dose of Study Drug|Overall Study||17
3194554|NCT02079636|3922628|FG000|COMPLETED|Overall Study||5
3194555|NCT02079636|3922629|FG001|COMPLETED|Overall Study||13
3194556|NCT02079636|3922630|FG002|COMPLETED|Overall Study||3
3194557|NCT02079636|3922631|FG003|COMPLETED|Overall Study||9
3194558|NCT02079636|3922632|FG004|COMPLETED|Overall Study||2
3194559|NCT02079636|3922633|FG005|COMPLETED|Overall Study||13
3194560|NCT02079636|3922634|FG006|COMPLETED|Overall Study||11
3194561|NCT02079636|3922635|FG007|COMPLETED|Overall Study||3
3194562|NCT02079636|3922636|FG008|COMPLETED|Overall Study||3
3194563|NCT02079636|3922637|FG009|COMPLETED|Overall Study||6
3194564|NCT02079636|3922638|FG010|COMPLETED|Overall Study||8
3194565|NCT02079636|3922639|FG011|COMPLETED|Overall Study||4
3194566|NCT02079636|3922640|FG012|COMPLETED|Overall Study||5
3194567|NCT02079636|3922641|FG013|COMPLETED|Overall Study||3
3194568|NCT02079636|3922642|FG014|COMPLETED|Overall Study||12
3194569|NCT02079636|3922628|FG000|NOT COMPLETED|Overall Study||3
3194570|NCT02079636|3922629|FG001|NOT COMPLETED|Overall Study||2
3194571|NCT02079636|3922630|FG002|NOT COMPLETED|Overall Study||0
3194572|NCT02079636|3922631|FG003|NOT COMPLETED|Overall Study||12
3194573|NCT02079636|3922632|FG004|NOT COMPLETED|Overall Study||2
3194574|NCT02079636|3922633|FG005|NOT COMPLETED|Overall Study||6
3194575|NCT02079636|3922634|FG006|NOT COMPLETED|Overall Study||1
3194576|NCT02079636|3922635|FG007|NOT COMPLETED|Overall Study||1
3194577|NCT02079636|3922636|FG008|NOT COMPLETED|Overall Study||0
3194578|NCT02079636|3922637|FG009|NOT COMPLETED|Overall Study||3
3194579|NCT02079636|3922638|FG010|NOT COMPLETED|Overall Study||2
3194580|NCT02079636|3922639|FG011|NOT COMPLETED|Overall Study||2
3194581|NCT02079636|3922640|FG012|NOT COMPLETED|Overall Study||3
3194582|NCT02079636|3922641|FG013|NOT COMPLETED|Overall Study||0
3194583|NCT02079636|3922642|FG014|NOT COMPLETED|Overall Study||5
3194584|NCT02079649|3922710|FG000|STARTED|Overall Study||42
3194585|NCT02079649|3922711|FG001|STARTED|Overall Study||41
3194586|NCT02079649|3922712|FG002|STARTED|Overall Study||41
3194587|NCT02079649|3922713|FG003|STARTED|Overall Study||40
3194588|NCT02079649|3922710|FG000|Treated|Overall Study||41
3194589|NCT02079649|3922711|FG001|Treated|Overall Study||41
3194590|NCT02079649|3922712|FG002|Treated|Overall Study||40
3194591|NCT02079649|3922713|FG003|Treated|Overall Study||40
3194592|NCT02079649|3922710|FG000|COMPLETED|Overall Study||41
3194593|NCT02079649|3922711|FG001|COMPLETED|Overall Study||41
3194594|NCT02079649|3922712|FG002|COMPLETED|Overall Study||40
3194595|NCT02079649|3922713|FG003|COMPLETED|Overall Study||38
3194596|NCT02079649|3922710|FG000|NOT COMPLETED|Overall Study||1
3194597|NCT02079649|3922711|FG001|NOT COMPLETED|Overall Study||0
3194598|NCT02079649|3922712|FG002|NOT COMPLETED|Overall Study||1
3194599|NCT02079649|3922713|FG003|NOT COMPLETED|Overall Study||2
3194600|NCT02079805|3922726|FG000|STARTED|Overall Study||16
3194601|NCT02079805|3922727|FG001|STARTED|Overall Study||17
3194602|NCT02079805|3922726|FG000|COMPLETED|Overall Study||16
3194603|NCT02079805|3922727|FG001|COMPLETED|Overall Study||15
3194604|NCT02079805|3922726|FG000|NOT COMPLETED|Overall Study||0
3194605|NCT02079805|3922727|FG001|NOT COMPLETED|Overall Study||2
3194606|NCT02079844|3922736|FG000|STARTED|Treatment Period 1||6
3194607|NCT02079844|3922737|FG001|STARTED|Treatment Period 1||7
3194608|NCT02079844|3922738|FG002|STARTED|Treatment Period 1||7
3194609|NCT02079844|3922736|FG000|COMPLETED|Treatment Period 1||6
3194610|NCT02079844|3922737|FG001|COMPLETED|Treatment Period 1||7
3194611|NCT02079844|3922738|FG002|COMPLETED|Treatment Period 1||5
3194612|NCT02079844|3922736|FG000|NOT COMPLETED|Treatment Period 1||0
3194613|NCT02079844|3922737|FG001|NOT COMPLETED|Treatment Period 1||0
3194614|NCT02079844|3922738|FG002|NOT COMPLETED|Treatment Period 1||2
3194615|NCT02079844|3922736|FG000|STARTED|Treatment Period 2|1 Participant was withdrawn due to an Adverse Event after completing Period 1.|5
3194616|NCT02079844|3922737|FG001|STARTED|Treatment Period 2||7
3194617|NCT02079844|3922738|FG002|STARTED|Treatment Period 2||5
3194618|NCT02079844|3922736|FG000|COMPLETED|Treatment Period 2||5
3194619|NCT02079844|3922737|FG001|COMPLETED|Treatment Period 2||6
3194620|NCT02079844|3922738|FG002|COMPLETED|Treatment Period 2||5
3194621|NCT02079844|3922736|FG000|NOT COMPLETED|Treatment Period 2||0
3194622|NCT02079844|3922737|FG001|NOT COMPLETED|Treatment Period 2||1
3194623|NCT02079844|3922738|FG002|NOT COMPLETED|Treatment Period 2||0
3194624|NCT02079844|3922736|FG000|STARTED|Treatment Period 3||5
3364537|NCT04012970|4095745|FG000|STARTED|Control Session, 30 Minutes||26
3194625|NCT02079844|3922737|FG001|STARTED|Treatment Period 3|1 Participant Voluntarily Withdrew after completing Period 2.|5
3194626|NCT02079844|3922738|FG002|STARTED|Treatment Period 3||5
3194627|NCT02079844|3922736|FG000|COMPLETED|Treatment Period 3||5
3194628|NCT02079844|3922737|FG001|COMPLETED|Treatment Period 3||5
3194629|NCT02079844|3922738|FG002|COMPLETED|Treatment Period 3||5
3194630|NCT02079844|3922736|FG000|NOT COMPLETED|Treatment Period 3||0
3194631|NCT02079844|3922737|FG001|NOT COMPLETED|Treatment Period 3||0
3194632|NCT02079844|3922738|FG002|NOT COMPLETED|Treatment Period 3||0
3194633|NCT02079909|3922752|FG000|STARTED|Overall Study||158
3194634|NCT02079909|3922753|FG001|STARTED|Overall Study||166
3194635|NCT02079909|3922754|FG002|STARTED|Overall Study||158
3194636|NCT02079909|3922752|FG000|COMPLETED|Overall Study||120
3194637|NCT02079909|3922753|FG001|COMPLETED|Overall Study||117
3194638|NCT02079909|3922754|FG002|COMPLETED|Overall Study||140
3194639|NCT02079909|3922752|FG000|NOT COMPLETED|Overall Study||38
3194640|NCT02079909|3922753|FG001|NOT COMPLETED|Overall Study||49
3194641|NCT02079909|3922754|FG002|NOT COMPLETED|Overall Study||18
3194642|NCT02079987|3922764|FG000|STARTED|Overall Study||557
3194643|NCT02079987|3922765|FG001|STARTED|Overall Study||544
3194644|NCT02079987|3922764|FG000|COMPLETED|Overall Study||557
3194645|NCT02079987|3922765|FG001|COMPLETED|Overall Study||544
3194646|NCT02079987|3922764|FG000|NOT COMPLETED|Overall Study||0
3194647|NCT02079987|3922765|FG001|NOT COMPLETED|Overall Study||0
3194648|NCT02080091|3922772|FG000|STARTED|Overall Study||25
3194649|NCT02080091|3922772|FG000|COMPLETED|Overall Study||0
3194650|NCT02080091|3922772|FG000|NOT COMPLETED|Overall Study||25
3194651|NCT02080195|3922776|FG000|STARTED|Overall Study||1
3194652|NCT02080195|3922776|FG000|COMPLETED|Overall Study||1
3194653|NCT02080195|3922776|FG000|NOT COMPLETED|Overall Study||0
3194654|NCT02080221|3922780|FG000|STARTED|Overall Study||50
3194655|NCT02080221|3922780|FG000|COMPLETED|Overall Study||48
3194656|NCT02080221|3922780|FG000|NOT COMPLETED|Overall Study||2
3194657|NCT02080260|3922784|FG000|STARTED|Overall Study||20
3194658|NCT02080260|3922784|FG000|COMPLETED|Overall Study|Defined as still alive in follow-up when the study was terminated and the database was locked.|1
3194659|NCT02080260|3922784|FG000|NOT COMPLETED|Overall Study||19
3194660|NCT02080273|3922791|FG000|STARTED|Overall Study||45
3194661|NCT02080273|3922792|FG001|STARTED|Overall Study||45
3194662|NCT02080273|3922793|FG002|STARTED|Overall Study||45
3194663|NCT02080273|3922791|FG000|COMPLETED|Overall Study||45
3194664|NCT02080273|3922792|FG001|COMPLETED|Overall Study||45
3194665|NCT02080273|3922793|FG002|COMPLETED|Overall Study||45
3194666|NCT02080273|3922791|FG000|NOT COMPLETED|Overall Study||0
3194667|NCT02080273|3922792|FG001|NOT COMPLETED|Overall Study||0
3194668|NCT02080273|3922793|FG002|NOT COMPLETED|Overall Study||0
3194669|NCT02080312|3922801|FG000|STARTED|Overall Study||6
3194670|NCT02080312|3922801|FG000|COMPLETED|Overall Study||6
3194671|NCT02080312|3922801|FG000|NOT COMPLETED|Overall Study||0
3194672|NCT02080364|3922810|FG000|STARTED|Baseline Period||197
3194673|NCT02080364|3922811|FG001|STARTED|Baseline Period||208
3194674|NCT02080364|3922812|FG002|STARTED|Baseline Period||247
3194675|NCT02080364|3922813|FG003|STARTED|Baseline Period||228
3194676|NCT02080364|3922810|FG000|COMPLETED|Baseline Period||195
3194677|NCT02080364|3922811|FG001|COMPLETED|Baseline Period||206
3194678|NCT02080364|3922812|FG002|COMPLETED|Baseline Period||246
3194679|NCT02080364|3922813|FG003|COMPLETED|Baseline Period||228
3194680|NCT02080364|3922810|FG000|NOT COMPLETED|Baseline Period||2
3194681|NCT02080364|3922811|FG001|NOT COMPLETED|Baseline Period||2
3194682|NCT02080364|3922812|FG002|NOT COMPLETED|Baseline Period||1
3194683|NCT02080364|3922813|FG003|NOT COMPLETED|Baseline Period||0
3194684|NCT02080364|3922810|FG000|STARTED|Treatment Period||195
3194685|NCT02080364|3922811|FG001|STARTED|Treatment Period||206
3194686|NCT02080364|3922812|FG002|STARTED|Treatment Period||246
3194687|NCT02080364|3922813|FG003|STARTED|Treatment Period||228
3194688|NCT02080364|3922810|FG000|COMPLETED|Treatment Period||148
3194689|NCT02080364|3922811|FG001|COMPLETED|Treatment Period||157
3194690|NCT02080364|3922812|FG002|COMPLETED|Treatment Period||9
3194691|NCT02080364|3922813|FG003|COMPLETED|Treatment Period||4
3194692|NCT02080364|3922810|FG000|NOT COMPLETED|Treatment Period||47
3364538|NCT04012970|4095746|FG001|STARTED|Control Session, 30 Minutes||14
3194693|NCT02080364|3922811|FG001|NOT COMPLETED|Treatment Period||49
3194694|NCT02080364|3922812|FG002|NOT COMPLETED|Treatment Period||237
3194695|NCT02080364|3922813|FG003|NOT COMPLETED|Treatment Period||224
3194696|NCT02080403|3922825|FG000|STARTED|Overall Study||146
3194697|NCT02080403|3922826|FG001|STARTED|Overall Study||144
3194698|NCT02080403|3922825|FG000|COMPLETED|Overall Study||131
3194699|NCT02080403|3922826|FG001|COMPLETED|Overall Study||132
3194700|NCT02080403|3922825|FG000|NOT COMPLETED|Overall Study||15
3194701|NCT02080403|3922826|FG001|NOT COMPLETED|Overall Study||12
3194702|NCT02080455|3922834|FG000|STARTED|Overall Study||16
3194703|NCT02080455|3922835|FG001|STARTED|Overall Study||16
3194704|NCT02080455|3922834|FG000|COMPLETED|Overall Study||16
3194705|NCT02080455|3922835|FG001|COMPLETED|Overall Study||16
3194706|NCT02080455|3922834|FG000|NOT COMPLETED|Overall Study||0
3194707|NCT02080455|3922835|FG001|NOT COMPLETED|Overall Study||0
3194708|NCT02080468|3922851|FG000|STARTED|Overall Study||16
3194709|NCT02080468|3922852|FG001|STARTED|Overall Study||16
3194710|NCT02080468|3922851|FG000|COMPLETED|Overall Study||14
3194711|NCT02080468|3922852|FG001|COMPLETED|Overall Study||14
3194712|NCT02080468|3922851|FG000|NOT COMPLETED|Overall Study||2
3194713|NCT02080468|3922852|FG001|NOT COMPLETED|Overall Study||2
3194714|NCT02080481|3922867|FG000|STARTED|Overall Study||68
3194715|NCT02080481|3922868|FG001|STARTED|Overall Study||67
3194716|NCT02080481|3922867|FG000|COMPLETED|Overall Study||67
3194717|NCT02080481|3922868|FG001|COMPLETED|Overall Study||67
3194718|NCT02080481|3922867|FG000|NOT COMPLETED|Overall Study||1
3194719|NCT02080481|3922868|FG001|NOT COMPLETED|Overall Study||0
3194720|NCT02080507|3922876|FG000|STARTED|Overall Study||5
3194721|NCT02080507|3922877|FG001|STARTED|Overall Study||7
3194722|NCT02080507|3922876|FG000|COMPLETED|Overall Study||5
3194723|NCT02080507|3922877|FG001|COMPLETED|Overall Study||7
3194724|NCT02080507|3922876|FG000|NOT COMPLETED|Overall Study||0
3194725|NCT02080507|3922877|FG001|NOT COMPLETED|Overall Study||0
3194726|NCT02080546|3922885|FG000|STARTED|Overall Study||57
3194727|NCT02080546|3922886|FG001|STARTED|Overall Study||63
3194728|NCT02080546|3922885|FG000|COMPLETED|Overall Study||49
3194729|NCT02080546|3922886|FG001|COMPLETED|Overall Study||52
3194730|NCT02080546|3922885|FG000|NOT COMPLETED|Overall Study||8
3194731|NCT02080546|3922886|FG001|NOT COMPLETED|Overall Study||11
3194732|NCT02080637|3922894|FG000|STARTED|Overall Study||13
3194733|NCT02080637|3922895|FG001|STARTED|Overall Study||3
3194734|NCT02080637|3922894|FG000|COMPLETED|Overall Study||13
3194735|NCT02080637|3922895|FG001|COMPLETED|Overall Study||3
3194736|NCT02080637|3922894|FG000|NOT COMPLETED|Overall Study||0
3194737|NCT02080637|3922895|FG001|NOT COMPLETED|Overall Study||0
3194738|NCT02080780|3922901|FG000|STARTED|Overall Study||24
3194739|NCT02080780|3922901|FG000|COMPLETED|Overall Study||24
3194740|NCT02080780|3922901|FG000|NOT COMPLETED|Overall Study||0
3194741|NCT02080819|3922911|FG000|STARTED|Overall Study||63
3194742|NCT02080819|3922912|FG001|STARTED|Overall Study||35
3194743|NCT02080819|3922913|FG002|STARTED|Overall Study||33
3194744|NCT02080819|3922911|FG000|COMPLETED|Overall Study||38
3194745|NCT02080819|3922912|FG001|COMPLETED|Overall Study||9
3194746|NCT02080819|3922913|FG002|COMPLETED|Overall Study||11
3194747|NCT02080819|3922911|FG000|NOT COMPLETED|Overall Study||25
3194748|NCT02080819|3922912|FG001|NOT COMPLETED|Overall Study||26
3194749|NCT02080819|3922913|FG002|NOT COMPLETED|Overall Study||22
3194750|NCT02080832|3922924|FG000|STARTED|Overall Study||15
3194751|NCT02080832|3922925|FG001|STARTED|Overall Study||17
3194752|NCT02080832|3922926|FG002|STARTED|Overall Study||22
3194753|NCT02080832|3922924|FG000|COMPLETED|Overall Study||6
3194754|NCT02080832|3922925|FG001|COMPLETED|Overall Study||5
3194755|NCT02080832|3922926|FG002|COMPLETED|Overall Study||6
3194756|NCT02080832|3922924|FG000|NOT COMPLETED|Overall Study||9
3194757|NCT02080832|3922925|FG001|NOT COMPLETED|Overall Study||12
3194758|NCT02080832|3922926|FG002|NOT COMPLETED|Overall Study||16
3194759|NCT02080871|3922936|FG000|STARTED|Overall Study||134
3194760|NCT02080871|3922936|FG000|COMPLETED|Overall Study||132
3194761|NCT02080871|3922936|FG000|NOT COMPLETED|Overall Study||2
3194762|NCT02081001|3922942|FG000|STARTED|Overall Study||2
3194763|NCT02081001|3922943|FG001|STARTED|Overall Study||1
3194764|NCT02081001|3922944|FG002|STARTED|Overall Study||2
3194765|NCT02081001|3922945|FG003|STARTED|Overall Study||1
3194766|NCT02081001|3922946|FG004|STARTED|Overall Study||3
3194767|NCT02081001|3922947|FG005|STARTED|Overall Study||1
3364539|NCT04012970|4095745|FG000|COMPLETED|Control Session, 30 Minutes||26
3364540|NCT04012970|4095746|FG001|COMPLETED|Control Session, 30 Minutes||14
3364541|NCT04012970|4095745|FG000|NOT COMPLETED|Control Session, 30 Minutes||0
3364542|NCT04012970|4095746|FG001|NOT COMPLETED|Control Session, 30 Minutes||0
3364543|NCT04013191|4095760|FG000|STARTED|Overall Study||10
3364544|NCT04013191|4095761|FG001|STARTED|Overall Study||18
3364545|NCT04013191|4095760|FG000|Completed Period 1A (Single Dose)|Overall Study||10
3364546|NCT04013191|4095761|FG001|Completed Period 1A (Single Dose)|Overall Study||18
3364547|NCT04013191|4095760|FG000|Completed Period 1B (Multiple Dose)|Overall Study||9
3364548|NCT04013191|4095761|FG001|Completed Period 1B (Multiple Dose)|Overall Study||18
3364549|NCT04013191|4095760|FG000|COMPLETED|Overall Study||9
3364550|NCT04013191|4095761|FG001|COMPLETED|Overall Study||18
3364551|NCT04013191|4095760|FG000|NOT COMPLETED|Overall Study||1
3364552|NCT04013191|4095761|FG001|NOT COMPLETED|Overall Study||0
3364553|NCT04011631|4095771|FG000|STARTED|Overall Study||100
3364554|NCT04011631|4095771|FG000|COMPLETED|Overall Study||100
3364555|NCT04011631|4095771|FG000|NOT COMPLETED|Overall Study||0
3364556|NCT04011735|4095778|FG000|STARTED|Overall Study||133
3364557|NCT04011735|4095779|FG001|STARTED|Overall Study||71
3364558|NCT04011735|4095780|FG002|STARTED|Overall Study||56
3364559|NCT04011735|4095778|FG000|COMPLETED|Overall Study||132
3364560|NCT04011735|4095779|FG001|COMPLETED|Overall Study||70
3364561|NCT04011735|4095780|FG002|COMPLETED|Overall Study||55
3364562|NCT04011735|4095778|FG000|NOT COMPLETED|Overall Study||1
3364563|NCT04011735|4095779|FG001|NOT COMPLETED|Overall Study||1
3364564|NCT04011735|4095780|FG002|NOT COMPLETED|Overall Study||1
3364565|NCT04010695|4095790|FG000|STARTED|Overall Study||250
3364566|NCT04010695|4095790|FG000|COMPLETED|Overall Study||250
3364567|NCT04010695|4095790|FG000|NOT COMPLETED|Overall Study||0
3364568|NCT04009577|4095799|FG000|STARTED|Core Study||7
3364569|NCT04009577|4095800|FG001|STARTED|Core Study||3
3364570|NCT04009577|4095801|FG002|STARTED|Core Study||21
3364571|NCT04009577|4095802|FG003|STARTED|Core Study||22
3364572|NCT04009577|4095799|FG000|LEM5|Core Study||7
3364573|NCT04009577|4095800|FG001|LEM5|Core Study||3
3364574|NCT04009577|4095801|FG002|LEM5|Core Study||21
3194768|NCT02081001|3922948|FG006|STARTED|Overall Study||2
3194769|NCT02081001|3922949|FG007|STARTED|Overall Study||1
3194770|NCT02081001|3922950|FG008|STARTED|Overall Study||2
3194771|NCT02081001|3922951|FG009|STARTED|Overall Study||1
3194772|NCT02081001|3922952|FG010|STARTED|Overall Study||2
3194773|NCT02081001|3922953|FG011|STARTED|Overall Study||1
3194774|NCT02081001|3922942|FG000|COMPLETED|Overall Study||2
3194775|NCT02081001|3922943|FG001|COMPLETED|Overall Study||1
3194776|NCT02081001|3922944|FG002|COMPLETED|Overall Study||2
3194777|NCT02081001|3922945|FG003|COMPLETED|Overall Study||1
3194778|NCT02081001|3922946|FG004|COMPLETED|Overall Study||2
3194779|NCT02081001|3922947|FG005|COMPLETED|Overall Study||1
3364575|NCT04009577|4095802|FG003|LEM5|Core Study||5
3194780|NCT02081001|3922948|FG006|COMPLETED|Overall Study||2
3194781|NCT02081001|3922949|FG007|COMPLETED|Overall Study||1
3194782|NCT02081001|3922950|FG008|COMPLETED|Overall Study||2
3194783|NCT02081001|3922951|FG009|COMPLETED|Overall Study||1
3194784|NCT02081001|3922952|FG010|COMPLETED|Overall Study||2
3194785|NCT02081001|3922953|FG011|COMPLETED|Overall Study||1
3194786|NCT02081001|3922942|FG000|NOT COMPLETED|Overall Study||0
3194787|NCT02081001|3922943|FG001|NOT COMPLETED|Overall Study||0
3194788|NCT02081001|3922944|FG002|NOT COMPLETED|Overall Study||0
3194789|NCT02081001|3922945|FG003|NOT COMPLETED|Overall Study||0
3194790|NCT02081001|3922946|FG004|NOT COMPLETED|Overall Study||1
3194791|NCT02081001|3922947|FG005|NOT COMPLETED|Overall Study||0
3194792|NCT02081001|3922948|FG006|NOT COMPLETED|Overall Study||0
3194793|NCT02081001|3922949|FG007|NOT COMPLETED|Overall Study||0
3194794|NCT02081001|3922950|FG008|NOT COMPLETED|Overall Study||0
3194795|NCT02081001|3922951|FG009|NOT COMPLETED|Overall Study||0
3194796|NCT02081001|3922952|FG010|NOT COMPLETED|Overall Study||0
3194797|NCT02081001|3922953|FG011|NOT COMPLETED|Overall Study||0
3194798|NCT02081014|3922964|FG000|STARTED|Overall Study||2
3194799|NCT02081014|3922965|FG001|STARTED|Overall Study||2
3194800|NCT02081014|3922966|FG002|STARTED|Overall Study||2
3194801|NCT02081014|3922967|FG003|STARTED|Overall Study||2
3194802|NCT02081014|3922968|FG004|STARTED|Overall Study||2
3194803|NCT02081014|3922969|FG005|STARTED|Overall Study||2
3194804|NCT02081014|3922964|FG000|COMPLETED|Overall Study||2
3194805|NCT02081014|3922965|FG001|COMPLETED|Overall Study||2
3194806|NCT02081014|3922966|FG002|COMPLETED|Overall Study||2
3194807|NCT02081014|3922967|FG003|COMPLETED|Overall Study||2
3194808|NCT02081014|3922968|FG004|COMPLETED|Overall Study||2
3194809|NCT02081014|3922969|FG005|COMPLETED|Overall Study||2
3194810|NCT02081014|3922964|FG000|NOT COMPLETED|Overall Study||0
3194811|NCT02081014|3922965|FG001|NOT COMPLETED|Overall Study||0
3194812|NCT02081014|3922966|FG002|NOT COMPLETED|Overall Study||0
3194813|NCT02081014|3922967|FG003|NOT COMPLETED|Overall Study||0
3194814|NCT02081014|3922968|FG004|NOT COMPLETED|Overall Study||0
3194815|NCT02081014|3922969|FG005|NOT COMPLETED|Overall Study||0
3194816|NCT02081079|3922990|FG000|STARTED|Overall Study||44
3194817|NCT02081079|3922991|FG001|STARTED|Overall Study||41
3194818|NCT02081079|3922990|FG000|COMPLETED|Overall Study||40
3194819|NCT02081079|3922991|FG001|COMPLETED|Overall Study||39
3194820|NCT02081079|3922990|FG000|NOT COMPLETED|Overall Study||4
3194821|NCT02081079|3922991|FG001|NOT COMPLETED|Overall Study||2
3194822|NCT02081196|3923001|FG000|STARTED|Overall Study|Treatment on one flank. Contralateral flank was untreated control.|45
3194823|NCT02081196|3923001|FG000|Untreated Control Flank|Overall Study||45
3194824|NCT02081196|3923001|FG000|COMPLETED|Overall Study|One (1) subject was lost to FU.|44
3194825|NCT02081196|3923001|FG000|NOT COMPLETED|Overall Study||1
3194826|NCT02081248|3923009|FG000|STARTED|Overall Study||98
3194827|NCT02081248|3923010|FG001|STARTED|Overall Study||100
3194828|NCT02081248|3923009|FG000|COMPLETED|Overall Study||76
3194829|NCT02081248|3923010|FG001|COMPLETED|Overall Study||87
3194830|NCT02081248|3923009|FG000|NOT COMPLETED|Overall Study||22
3194831|NCT02081248|3923010|FG001|NOT COMPLETED|Overall Study||13
3194832|NCT02081365|3923018|FG000|STARTED|Overall Study||74
3194833|NCT02081365|3923019|FG001|STARTED|Overall Study||77
3194834|NCT02081365|3923018|FG000|Received Allocated Intervention|Overall Study||46
3194835|NCT02081365|3923019|FG001|Received Allocated Intervention|Overall Study||59
3194836|NCT02081365|3923018|FG000|COMPLETED|Overall Study||44
3194837|NCT02081365|3923019|FG001|COMPLETED|Overall Study||54
3194838|NCT02081365|3923018|FG000|NOT COMPLETED|Overall Study||30
3194839|NCT02081365|3923019|FG001|NOT COMPLETED|Overall Study||23
3194840|NCT02081417|3923027|FG000|STARTED|Overall Study|Randomized to intervention|163
3194841|NCT02081417|3923028|FG001|STARTED|Overall Study||166
3194842|NCT02081417|3923027|FG000|1st Interview Completed|Overall Study||146
3194843|NCT02081417|3923028|FG001|1st Interview Completed|Overall Study||145
3194844|NCT02081417|3923027|FG000|3-Month Follow-Up|Overall Study||94
3194845|NCT02081417|3923028|FG001|3-Month Follow-Up|Overall Study||95
3194846|NCT02081417|3923027|FG000|6-Month Follow-Up|Overall Study||82
3194847|NCT02081417|3923028|FG001|6-Month Follow-Up|Overall Study||92
3194848|NCT02081417|3923027|FG000|COMPLETED|Overall Study||107
3194849|NCT02081417|3923028|FG001|COMPLETED|Overall Study||115
3194850|NCT02081417|3923027|FG000|NOT COMPLETED|Overall Study||56
3194851|NCT02081417|3923028|FG001|NOT COMPLETED|Overall Study||51
3194852|NCT02081443|3923036|FG000|STARTED|Overall Study||30
3194853|NCT02081443|3923037|FG001|STARTED|Overall Study||30
3194854|NCT02081443|3923036|FG000|COMPLETED|Overall Study||30
3194855|NCT02081443|3923037|FG001|COMPLETED|Overall Study||30
3194856|NCT02081443|3923036|FG000|NOT COMPLETED|Overall Study||0
3194857|NCT02081443|3923037|FG001|NOT COMPLETED|Overall Study||0
3194858|NCT02081456|3923045|FG000|STARTED|Overall Study||11
3194859|NCT02081456|3923046|FG001|STARTED|Overall Study||12
3194860|NCT02081456|3923045|FG000|COMPLETED|Overall Study||11
3194861|NCT02081456|3923046|FG001|COMPLETED|Overall Study||12
3194862|NCT02081456|3923045|FG000|NOT COMPLETED|Overall Study||0
3194863|NCT02081456|3923046|FG001|NOT COMPLETED|Overall Study||0
3194864|NCT02081534|3923059|FG000|STARTED|Overall Study||23
3194865|NCT02081534|3923060|FG001|STARTED|Overall Study||21
3194866|NCT02081534|3923061|FG002|STARTED|Overall Study||23
3194867|NCT02081534|3923062|FG003|STARTED|Overall Study||26
3194868|NCT02081534|3923063|FG004|STARTED|Overall Study||22
3194869|NCT02081534|3923064|FG005|STARTED|Overall Study||21
3194870|NCT02081534|3923065|FG006|STARTED|Overall Study||26
3194871|NCT02081534|3923059|FG000|COMPLETED|Overall Study||18
3194872|NCT02081534|3923060|FG001|COMPLETED|Overall Study||13
3194873|NCT02081534|3923061|FG002|COMPLETED|Overall Study||19
3194874|NCT02081534|3923062|FG003|COMPLETED|Overall Study||13
3194875|NCT02081534|3923063|FG004|COMPLETED|Overall Study||18
3194876|NCT02081534|3923064|FG005|COMPLETED|Overall Study||12
3194877|NCT02081534|3923065|FG006|COMPLETED|Overall Study||22
3194878|NCT02081534|3923059|FG000|NOT COMPLETED|Overall Study||5
3194879|NCT02081534|3923060|FG001|NOT COMPLETED|Overall Study||8
3194880|NCT02081534|3923061|FG002|NOT COMPLETED|Overall Study||4
3194881|NCT02081534|3923062|FG003|NOT COMPLETED|Overall Study||13
3194882|NCT02081534|3923063|FG004|NOT COMPLETED|Overall Study||4
3194883|NCT02081534|3923064|FG005|NOT COMPLETED|Overall Study||9
3194884|NCT02081534|3923065|FG006|NOT COMPLETED|Overall Study||4
3194885|NCT02081573|3923081|FG000|STARTED|Overall Study||10
3194886|NCT02081573|3923081|FG000|COMPLETED|Overall Study||10
3194887|NCT02081573|3923081|FG000|NOT COMPLETED|Overall Study||0
3194888|NCT02081586|3923089|FG000|STARTED|Overall Study||3
3194889|NCT02081586|3923090|FG001|STARTED|Overall Study||3
3194890|NCT02081586|3923091|FG002|STARTED|Overall Study||4
3194891|NCT02081586|3923092|FG003|STARTED|Overall Study||3
3194892|NCT02081586|3923089|FG000|COMPLETED|Overall Study||3
3194893|NCT02081586|3923090|FG001|COMPLETED|Overall Study||2
3194894|NCT02081586|3923091|FG002|COMPLETED|Overall Study||3
3194895|NCT02081586|3923092|FG003|COMPLETED|Overall Study||2
3194896|NCT02081586|3923089|FG000|NOT COMPLETED|Overall Study||0
3194897|NCT02081586|3923090|FG001|NOT COMPLETED|Overall Study||1
3194898|NCT02081586|3923091|FG002|NOT COMPLETED|Overall Study||1
3194899|NCT02081586|3923092|FG003|NOT COMPLETED|Overall Study||1
3194900|NCT02081599|3923106|FG000|STARTED|Period 1：Double-blind Period||71
3194901|NCT02081599|3923107|FG001|STARTED|Period 1：Double-blind Period||77
3194902|NCT02081599|3923106|FG000|COMPLETED|Period 1：Double-blind Period||63
3194903|NCT02081599|3923107|FG001|COMPLETED|Period 1：Double-blind Period||75
3194904|NCT02081599|3923106|FG000|NOT COMPLETED|Period 1：Double-blind Period||8
3194905|NCT02081599|3923107|FG001|NOT COMPLETED|Period 1：Double-blind Period||2
3194906|NCT02081599|3923106|FG000|STARTED|Period 2：Open-label Period||63
3194907|NCT02081599|3923107|FG001|STARTED|Period 2：Open-label Period||75
3194908|NCT02081599|3923106|FG000|COMPLETED|Period 2：Open-label Period||57
3194909|NCT02081599|3923107|FG001|COMPLETED|Period 2：Open-label Period||71
3194910|NCT02081599|3923106|FG000|NOT COMPLETED|Period 2：Open-label Period||6
3194911|NCT02081599|3923107|FG001|NOT COMPLETED|Period 2：Open-label Period||4
3194912|NCT02081638|3923117|FG000|STARTED|Overall Study||26
3194913|NCT02081638|3923118|FG001|STARTED|Overall Study||27
3194914|NCT02081638|3923117|FG000|COMPLETED|Overall Study||24
3194915|NCT02081638|3923118|FG001|COMPLETED|Overall Study||20
3194916|NCT02081638|3923117|FG000|NOT COMPLETED|Overall Study||2
3194917|NCT02081638|3923118|FG001|NOT COMPLETED|Overall Study||7
3194918|NCT02081677|3923132|FG000|STARTED|Overall Study||19
3194919|NCT02081677|3923133|FG001|STARTED|Overall Study||19
3194920|NCT02081677|3923134|FG002|STARTED|Overall Study||19
3194921|NCT02081677|3923135|FG003|STARTED|Overall Study||19
3194922|NCT02081677|3923132|FG000|COMPLETED|Overall Study||18
3194923|NCT02081677|3923133|FG001|COMPLETED|Overall Study||18
3194924|NCT02081677|3923134|FG002|COMPLETED|Overall Study||17
3194925|NCT02081677|3923135|FG003|COMPLETED|Overall Study||19
3194926|NCT02081677|3923132|FG000|NOT COMPLETED|Overall Study||1
3194927|NCT02081677|3923133|FG001|NOT COMPLETED|Overall Study||1
3194928|NCT02081677|3923134|FG002|NOT COMPLETED|Overall Study||2
3194929|NCT02081677|3923135|FG003|NOT COMPLETED|Overall Study||0
3194930|NCT02081690|3923145|FG000|STARTED|Overall Study||88
3194931|NCT02081690|3923145|FG000|COMPLETED|Overall Study||81
3194932|NCT02081690|3923145|FG000|NOT COMPLETED|Overall Study||7
3194933|NCT02081807|3923157|FG000|STARTED|Overall Study||7668
3194934|NCT02081807|3923158|FG001|STARTED|Overall Study||26149
3194935|NCT02081807|3923159|FG002|STARTED|Overall Study||14852
3194936|NCT02081807|3923160|FG003|STARTED|Overall Study||9112
3194937|NCT02081807|3923161|FG004|STARTED|Overall Study||27456
3194938|NCT02081807|3923162|FG005|STARTED|Overall Study||76055
3194939|NCT02081807|3923163|FG006|STARTED|Overall Study||40207
3194940|NCT02081807|3923164|FG007|STARTED|Overall Study||19729
3194941|NCT02081807|3923157|FG000|COMPLETED|Overall Study||7668
3194942|NCT02081807|3923158|FG001|COMPLETED|Overall Study||26149
3194943|NCT02081807|3923159|FG002|COMPLETED|Overall Study||14852
3194944|NCT02081807|3923160|FG003|COMPLETED|Overall Study||9112
3194945|NCT02081807|3923161|FG004|COMPLETED|Overall Study||27456
3194946|NCT02081807|3923162|FG005|COMPLETED|Overall Study||76055
3194947|NCT02081807|3923163|FG006|COMPLETED|Overall Study||40207
3194948|NCT02081807|3923164|FG007|COMPLETED|Overall Study||19729
3194949|NCT02081807|3923157|FG000|NOT COMPLETED|Overall Study||0
3194950|NCT02081807|3923158|FG001|NOT COMPLETED|Overall Study||0
3194951|NCT02081807|3923159|FG002|NOT COMPLETED|Overall Study||0
3194952|NCT02081807|3923160|FG003|NOT COMPLETED|Overall Study||0
3194953|NCT02081807|3923161|FG004|NOT COMPLETED|Overall Study||0
3194954|NCT02081807|3923162|FG005|NOT COMPLETED|Overall Study||0
3194955|NCT02081807|3923163|FG006|NOT COMPLETED|Overall Study||0
3194956|NCT02081807|3923164|FG007|NOT COMPLETED|Overall Study||0
3194957|NCT02081846|3923194|FG000|STARTED|Overall Study||751
3194958|NCT02081846|3923195|FG001|STARTED|Overall Study||749
3194959|NCT02081846|3923194|FG000|COMPLETED|Overall Study||749
3194960|NCT02081846|3923195|FG001|COMPLETED|Overall Study||749
3194961|NCT02081846|3923194|FG000|NOT COMPLETED|Overall Study||2
3194962|NCT02081846|3923195|FG001|NOT COMPLETED|Overall Study||0
3194963|NCT02081859|3923203|FG000|STARTED|Overall Study||150
3194964|NCT02081859|3923204|FG001|STARTED|Overall Study||150
3194965|NCT02081859|3923203|FG000|COMPLETED|Overall Study||116
3194966|NCT02081859|3923204|FG001|COMPLETED|Overall Study||119
3194967|NCT02081859|3923203|FG000|NOT COMPLETED|Overall Study||34
3194968|NCT02081859|3923204|FG001|NOT COMPLETED|Overall Study||31
3194969|NCT02081950|3923210|FG000|STARTED|Treatment Period 1||14
3194970|NCT02081950|3923210|FG000|COMPLETED|Treatment Period 1||14
3194971|NCT02081950|3923210|FG000|NOT COMPLETED|Treatment Period 1||0
3194972|NCT02081950|3923210|FG000|STARTED|Treatment Period 2||14
3194973|NCT02081950|3923210|FG000|COMPLETED|Treatment Period 2||14
3194974|NCT02081950|3923210|FG000|NOT COMPLETED|Treatment Period 2||0
3194975|NCT02081963|3923218|FG000|STARTED|Overall Study||79
3194976|NCT02081963|3923219|FG001|STARTED|Overall Study||73
3194977|NCT02081963|3923218|FG000|COMPLETED|Overall Study||74
3194978|NCT02081963|3923219|FG001|COMPLETED|Overall Study||69
3194979|NCT02081963|3923218|FG000|NOT COMPLETED|Overall Study||5
3194980|NCT02081963|3923219|FG001|NOT COMPLETED|Overall Study||4
3194981|NCT02082119|3923225|FG000|STARTED|Overall Study||82
3194982|NCT02082119|3923225|FG000|COMPLETED|Overall Study||82
3194983|NCT02082119|3923225|FG000|NOT COMPLETED|Overall Study||0
3194984|NCT02082145|3923231|FG000|STARTED|Overall Study||5
3194985|NCT02082145|3923232|FG001|STARTED|Overall Study||9
3194986|NCT02082145|3923231|FG000|COMPLETED|Overall Study||5
3194987|NCT02082145|3923232|FG001|COMPLETED|Overall Study||9
3194988|NCT02082145|3923231|FG000|NOT COMPLETED|Overall Study||0
3194989|NCT02082145|3923232|FG001|NOT COMPLETED|Overall Study||0
3194990|NCT02082158|3923246|FG000|STARTED|Overall Study||66
3194991|NCT02082158|3923247|FG001|STARTED|Overall Study||61
3194992|NCT02082158|3923248|FG002|STARTED|Overall Study||52
3194993|NCT02082158|3923249|FG003|STARTED|Overall Study||72
3194994|NCT02082158|3923250|FG004|STARTED|Overall Study||68
3194995|NCT02082158|3923251|FG005|STARTED|Overall Study||63
3194996|NCT02082158|3923246|FG000|COMPLETED|Overall Study||58
3194997|NCT02082158|3923247|FG001|COMPLETED|Overall Study||53
3194998|NCT02082158|3923248|FG002|COMPLETED|Overall Study||38
3194999|NCT02082158|3923249|FG003|COMPLETED|Overall Study|Includes completion with respirator from secondary randomization after fit-test failure of 1st model|68
3195000|NCT02082158|3923250|FG004|COMPLETED|Overall Study||64
3195001|NCT02082158|3923251|FG005|COMPLETED|Overall Study||56
3195002|NCT02082158|3923246|FG000|NOT COMPLETED|Overall Study||8
3195003|NCT02082158|3923247|FG001|NOT COMPLETED|Overall Study||8
3195004|NCT02082158|3923248|FG002|NOT COMPLETED|Overall Study||14
3195005|NCT02082158|3923249|FG003|NOT COMPLETED|Overall Study||4
3195006|NCT02082158|3923250|FG004|NOT COMPLETED|Overall Study||4
3195007|NCT02082158|3923251|FG005|NOT COMPLETED|Overall Study||7
3195008|NCT02082184|3923273|FG000|STARTED|Overall Study||149
3195009|NCT02082184|3923274|FG001|STARTED|Overall Study||75
3195010|NCT02082184|3923273|FG000|COMPLETED|Overall Study||139
3195011|NCT02082184|3923274|FG001|COMPLETED|Overall Study||62
3195012|NCT02082184|3923273|FG000|NOT COMPLETED|Overall Study||10
3195013|NCT02082184|3923274|FG001|NOT COMPLETED|Overall Study||13
3195014|NCT02082210|3923286|FG000|STARTED|Overall Study||3
3195015|NCT02082210|3923287|FG001|STARTED|Overall Study||3
3195016|NCT02082210|3923288|FG002|STARTED|Overall Study||16
3195017|NCT02082210|3923289|FG003|STARTED|Overall Study||45
3195018|NCT02082210|3923290|FG004|STARTED|Overall Study||15
3195019|NCT02082210|3923291|FG005|STARTED|Overall Study||15
3195020|NCT02082210|3923286|FG000|Received at Least One Dose of Study Drug|Overall Study||3
3195021|NCT02082210|3923287|FG001|Received at Least One Dose of Study Drug|Overall Study||3
3195022|NCT02082210|3923288|FG002|Received at Least One Dose of Study Drug|Overall Study||16
3195023|NCT02082210|3923289|FG003|Received at Least One Dose of Study Drug|Overall Study||45
3195024|NCT02082210|3923290|FG004|Received at Least One Dose of Study Drug|Overall Study||15
3195025|NCT02082210|3923291|FG005|Received at Least One Dose of Study Drug|Overall Study||15
3195026|NCT02082210|3923286|FG000|COMPLETED|Overall Study||3
3195027|NCT02082210|3923287|FG001|COMPLETED|Overall Study||3
3195028|NCT02082210|3923288|FG002|COMPLETED|Overall Study||13
3195029|NCT02082210|3923289|FG003|COMPLETED|Overall Study||39
3195030|NCT02082210|3923290|FG004|COMPLETED|Overall Study||12
3195031|NCT02082210|3923291|FG005|COMPLETED|Overall Study||13
3195032|NCT02082210|3923286|FG000|NOT COMPLETED|Overall Study||0
3195033|NCT02082210|3923287|FG001|NOT COMPLETED|Overall Study||0
3195034|NCT02082210|3923288|FG002|NOT COMPLETED|Overall Study||3
3195035|NCT02082210|3923289|FG003|NOT COMPLETED|Overall Study||6
3195036|NCT02082210|3923290|FG004|NOT COMPLETED|Overall Study||3
3195037|NCT02082210|3923291|FG005|NOT COMPLETED|Overall Study||2
3195038|NCT02082262|3923317|FG000|STARTED|Overall Study||140
3195039|NCT02082262|3923317|FG000|COMPLETED|Overall Study||89
3195040|NCT02082262|3923317|FG000|NOT COMPLETED|Overall Study||51
3195041|NCT02082288|3923321|FG000|STARTED|Overall Study||243
3195042|NCT02082288|3923321|FG000|COMPLETED|Overall Study||243
3195043|NCT02082288|3923321|FG000|NOT COMPLETED|Overall Study||0
3195044|NCT02082340|3923327|FG000|STARTED|Overall Study||194
3195045|NCT02082340|3923328|FG001|STARTED|Overall Study||198
3195046|NCT02082340|3923327|FG000|COMPLETED|Overall Study||193
3195047|NCT02082340|3923328|FG001|COMPLETED|Overall Study||197
3195048|NCT02082340|3923327|FG000|NOT COMPLETED|Overall Study||1
3195049|NCT02082340|3923328|FG001|NOT COMPLETED|Overall Study||1
3195050|NCT02082392|3923336|FG000|STARTED|Overall Study||2
3195051|NCT02082392|3923337|FG001|STARTED|Overall Study||1
3195052|NCT02082392|3923336|FG000|COMPLETED|Overall Study||2
3195053|NCT02082392|3923337|FG001|COMPLETED|Overall Study||1
3195054|NCT02082392|3923336|FG000|NOT COMPLETED|Overall Study||0
3195055|NCT02082392|3923337|FG001|NOT COMPLETED|Overall Study||0
3195056|NCT02082483|3923345|FG000|STARTED|Overall Study||71
3195057|NCT02082483|3923346|FG001|STARTED|Overall Study||73
3195058|NCT02082483|3923345|FG000|COMPLETED|Overall Study||65
3195059|NCT02082483|3923346|FG001|COMPLETED|Overall Study||67
3195060|NCT02082483|3923345|FG000|NOT COMPLETED|Overall Study||6
3195061|NCT02082483|3923346|FG001|NOT COMPLETED|Overall Study||6
3195062|NCT02082522|3923355|FG000|STARTED|Overall Study||15
3195063|NCT02082522|3923356|FG001|STARTED|Overall Study||13
3195064|NCT02082522|3923355|FG000|COMPLETED|Overall Study||0
3195065|NCT02082522|3923356|FG001|COMPLETED|Overall Study||0
3195066|NCT02082522|3923355|FG000|NOT COMPLETED|Overall Study||15
3195067|NCT02082522|3923356|FG001|NOT COMPLETED|Overall Study||13
3195068|NCT02082678|3923364|FG000|STARTED|Overall Study||35
3195069|NCT02082678|3923365|FG001|STARTED|Overall Study||35
3195070|NCT02082678|3923364|FG000|COMPLETED|Overall Study||23
3195071|NCT02082678|3923365|FG001|COMPLETED|Overall Study||21
3195072|NCT02082678|3923364|FG000|NOT COMPLETED|Overall Study||12
3195073|NCT02082678|3923365|FG001|NOT COMPLETED|Overall Study||14
3195074|NCT02082717|3923373|FG000|STARTED|Overall Study||8
3195075|NCT02082717|3923374|FG001|STARTED|Overall Study||9
3195076|NCT02082717|3923373|FG000|COMPLETED|Overall Study||8
3195077|NCT02082717|3923374|FG001|COMPLETED|Overall Study||9
3195078|NCT02082717|3923373|FG000|NOT COMPLETED|Overall Study||0
3195079|NCT02082717|3923374|FG001|NOT COMPLETED|Overall Study||0
3195080|NCT02082769|3923387|FG000|STARTED|Overall Study||168
3195081|NCT02082769|3923388|FG001|STARTED|Overall Study||168
3195082|NCT02082769|3923389|FG002|STARTED|Overall Study||168
3195083|NCT02082769|3923387|FG000|COMPLETED|Overall Study||144
3195084|NCT02082769|3923388|FG001|COMPLETED|Overall Study||141
3195085|NCT02082769|3923389|FG002|COMPLETED|Overall Study||132
3195086|NCT02082769|3923387|FG000|NOT COMPLETED|Overall Study||24
3195087|NCT02082769|3923388|FG001|NOT COMPLETED|Overall Study||27
3195088|NCT02082769|3923389|FG002|NOT COMPLETED|Overall Study||36
3195089|NCT02082912|3923399|FG000|STARTED|Overall Study||7
3195090|NCT02082912|3923400|FG001|STARTED|Overall Study||7
3195091|NCT02082912|3923399|FG000|COMPLETED|Overall Study||7
3195092|NCT02082912|3923400|FG001|COMPLETED|Overall Study||6
3195093|NCT02082912|3923399|FG000|NOT COMPLETED|Overall Study||0
3195094|NCT02082912|3923400|FG001|NOT COMPLETED|Overall Study||1
3195095|NCT02082977|3923416|FG000|STARTED|Part 1 (Up to 3.2 Years)||2
3195096|NCT02082977|3923417|FG001|STARTED|Part 1 (Up to 3.2 Years)||1
3195097|NCT02082977|3923418|FG002|STARTED|Part 1 (Up to 3.2 Years)||1
3195098|NCT02082977|3923419|FG003|STARTED|Part 1 (Up to 3.2 Years)||1
3195099|NCT02082977|3923420|FG004|STARTED|Part 1 (Up to 3.2 Years)||3
3195100|NCT02082977|3923421|FG005|STARTED|Part 1 (Up to 3.2 Years)||4
3195101|NCT02082977|3923422|FG006|STARTED|Part 1 (Up to 3.2 Years)||10
3195102|NCT02082977|3923423|FG007|STARTED|Part 1 (Up to 3.2 Years)||12
3195103|NCT02082977|3923424|FG008|STARTED|Part 1 (Up to 3.2 Years)||7
3195104|NCT02082977|3923425|FG009|STARTED|Part 1 (Up to 3.2 Years)||0
3195105|NCT02082977|3923416|FG000|COMPLETED|Part 1 (Up to 3.2 Years)||1
3195106|NCT02082977|3923417|FG001|COMPLETED|Part 1 (Up to 3.2 Years)||1
3195107|NCT02082977|3923418|FG002|COMPLETED|Part 1 (Up to 3.2 Years)||1
3195108|NCT02082977|3923419|FG003|COMPLETED|Part 1 (Up to 3.2 Years)||1
3195109|NCT02082977|3923420|FG004|COMPLETED|Part 1 (Up to 3.2 Years)||2
3195110|NCT02082977|3923421|FG005|COMPLETED|Part 1 (Up to 3.2 Years)||1
3195111|NCT02082977|3923422|FG006|COMPLETED|Part 1 (Up to 3.2 Years)||4
3195112|NCT02082977|3923423|FG007|COMPLETED|Part 1 (Up to 3.2 Years)||7
3195113|NCT02082977|3923424|FG008|COMPLETED|Part 1 (Up to 3.2 Years)||4
3195114|NCT02082977|3923425|FG009|COMPLETED|Part 1 (Up to 3.2 Years)||0
3195115|NCT02082977|3923416|FG000|NOT COMPLETED|Part 1 (Up to 3.2 Years)||1
3195116|NCT02082977|3923417|FG001|NOT COMPLETED|Part 1 (Up to 3.2 Years)||0
3195117|NCT02082977|3923418|FG002|NOT COMPLETED|Part 1 (Up to 3.2 Years)||0
3195118|NCT02082977|3923419|FG003|NOT COMPLETED|Part 1 (Up to 3.2 Years)||0
3195119|NCT02082977|3923420|FG004|NOT COMPLETED|Part 1 (Up to 3.2 Years)||1
3195120|NCT02082977|3923421|FG005|NOT COMPLETED|Part 1 (Up to 3.2 Years)||3
3195121|NCT02082977|3923422|FG006|NOT COMPLETED|Part 1 (Up to 3.2 Years)||6
3195122|NCT02082977|3923423|FG007|NOT COMPLETED|Part 1 (Up to 3.2 Years)||5
3195123|NCT02082977|3923424|FG008|NOT COMPLETED|Part 1 (Up to 3.2 Years)||3
3195124|NCT02082977|3923425|FG009|NOT COMPLETED|Part 1 (Up to 3.2 Years)||0
3195125|NCT02082977|3923416|FG000|STARTED|Part 2 (Up to 3.2 Years)||0
3195126|NCT02082977|3923417|FG001|STARTED|Part 2 (Up to 3.2 Years)||0
3195127|NCT02082977|3923418|FG002|STARTED|Part 2 (Up to 3.2 Years)||0
3195128|NCT02082977|3923419|FG003|STARTED|Part 2 (Up to 3.2 Years)||0
3195129|NCT02082977|3923420|FG004|STARTED|Part 2 (Up to 3.2 Years)||0
3195130|NCT02082977|3923421|FG005|STARTED|Part 2 (Up to 3.2 Years)||0
3195131|NCT02082977|3923422|FG006|STARTED|Part 2 (Up to 3.2 Years)||0
3195132|NCT02082977|3923423|FG007|STARTED|Part 2 (Up to 3.2 Years)||0
3195133|NCT02082977|3923424|FG008|STARTED|Part 2 (Up to 3.2 Years)||0
3195134|NCT02082977|3923425|FG009|STARTED|Part 2 (Up to 3.2 Years)||0
3195135|NCT02082977|3923416|FG000|COMPLETED|Part 2 (Up to 3.2 Years)||0
3195136|NCT02082977|3923417|FG001|COMPLETED|Part 2 (Up to 3.2 Years)||0
3195137|NCT02082977|3923418|FG002|COMPLETED|Part 2 (Up to 3.2 Years)||0
3195138|NCT02082977|3923419|FG003|COMPLETED|Part 2 (Up to 3.2 Years)||0
3195139|NCT02082977|3923420|FG004|COMPLETED|Part 2 (Up to 3.2 Years)||0
3195140|NCT02082977|3923421|FG005|COMPLETED|Part 2 (Up to 3.2 Years)||0
3195141|NCT02082977|3923422|FG006|COMPLETED|Part 2 (Up to 3.2 Years)||0
3195142|NCT02082977|3923423|FG007|COMPLETED|Part 2 (Up to 3.2 Years)||0
3195143|NCT02082977|3923424|FG008|COMPLETED|Part 2 (Up to 3.2 Years)||0
3195144|NCT02082977|3923425|FG009|COMPLETED|Part 2 (Up to 3.2 Years)||0
3195145|NCT02082977|3923416|FG000|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
3195146|NCT02082977|3923417|FG001|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
3195147|NCT02082977|3923418|FG002|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
3195148|NCT02082977|3923419|FG003|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
3195149|NCT02082977|3923420|FG004|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
3195150|NCT02082977|3923421|FG005|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
3195151|NCT02082977|3923422|FG006|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
3195152|NCT02082977|3923423|FG007|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
3195153|NCT02082977|3923424|FG008|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
3195154|NCT02082977|3923425|FG009|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
3195155|NCT02083107|3923460|FG000|STARTED|Overall Study|212 women received 2 tablets of Misotac® sublingually and 2 placebo tablets rectally.|212
3195156|NCT02083107|3923461|FG001|STARTED|Overall Study|212 women received 2 tablets of placebo sublingually and 2 placebo tablets rectally.|212
3195157|NCT02083107|3923462|FG002|STARTED|Overall Study|212 women received 2 tablets of Misotac® rectally and 2 placebo tablets sublingually.|212
3195158|NCT02083107|3923460|FG000|COMPLETED|Overall Study|212 women received 2 tablets of Misotac® sublingually and 2 placebo tablets rectally.|212
3195159|NCT02083107|3923461|FG001|COMPLETED|Overall Study|212 women received 2 tablets of placebo sublingually and 2 placebo tablets rectally.|212
3195160|NCT02083107|3923462|FG002|COMPLETED|Overall Study|212 women received 2 tablets of Misotac® rectally and 2 placebo tablets sublingually.|212
3195161|NCT02083107|3923460|FG000|NOT COMPLETED|Overall Study||0
3195162|NCT02083107|3923461|FG001|NOT COMPLETED|Overall Study||0
3195163|NCT02083107|3923462|FG002|NOT COMPLETED|Overall Study||0
3195164|NCT02083185|3923473|FG000|STARTED|Overall Study||56
3195165|NCT02083185|3923474|FG001|STARTED|Overall Study||56
3195166|NCT02083185|3923475|FG002|STARTED|Overall Study||24
3195167|NCT02083185|3923473|FG000|Safety Population|Overall Study||56
3195168|NCT02083185|3923474|FG001|Safety Population|Overall Study||54
3195169|NCT02083185|3923475|FG002|Safety Population|Overall Study||24
3195170|NCT02083185|3923473|FG000|COMPLETED|Overall Study||36
3195171|NCT02083185|3923474|FG001|COMPLETED|Overall Study||27
3195172|NCT02083185|3923475|FG002|COMPLETED|Overall Study||17
3195173|NCT02083185|3923473|FG000|NOT COMPLETED|Overall Study||20
3195174|NCT02083185|3923474|FG001|NOT COMPLETED|Overall Study||29
3195175|NCT02083185|3923475|FG002|NOT COMPLETED|Overall Study||7
3195176|NCT02083263|3923485|FG000|STARTED|Overall Study||16
3195177|NCT02083263|3923486|FG001|STARTED|Overall Study||16
3195178|NCT02083263|3923485|FG000|COMPLETED|Overall Study||16
3195179|NCT02083263|3923486|FG001|COMPLETED|Overall Study||16
3195180|NCT02083263|3923485|FG000|NOT COMPLETED|Overall Study||0
3195181|NCT02083263|3923486|FG001|NOT COMPLETED|Overall Study||0
3195182|NCT02083380|3923495|FG000|STARTED|Overall Study|5 subjects excluded from safety / ITT population - no drug administered|148
3195183|NCT02083380|3923496|FG001|STARTED|Overall Study|3 subjects excluded from safety / ITT population - no drug administered|151
3195184|NCT02083380|3923497|FG002|STARTED|Overall Study|3 subjects excluded from safety / ITT population - no drug administered|149
3195185|NCT02083380|3923495|FG000|COMPLETED|Overall Study||57
3195186|NCT02083380|3923496|FG001|COMPLETED|Overall Study||56
3195187|NCT02083380|3923497|FG002|COMPLETED|Overall Study||65
3195188|NCT02083380|3923495|FG000|NOT COMPLETED|Overall Study||91
3195189|NCT02083380|3923496|FG001|NOT COMPLETED|Overall Study||95
3195190|NCT02083380|3923497|FG002|NOT COMPLETED|Overall Study||84
3195191|NCT02083406|3923513|FG000|STARTED|Overall Study||7
3195192|NCT02083406|3923514|FG001|STARTED|Overall Study||8
3195193|NCT02083406|3923515|FG002|STARTED|Overall Study||7
3195194|NCT02083406|3923513|FG000|COMPLETED|Overall Study||7
3195195|NCT02083406|3923514|FG001|COMPLETED|Overall Study||8
3195196|NCT02083406|3923515|FG002|COMPLETED|Overall Study||7
3195197|NCT02083406|3923513|FG000|NOT COMPLETED|Overall Study||0
3195198|NCT02083406|3923514|FG001|NOT COMPLETED|Overall Study||0
3195199|NCT02083406|3923515|FG002|NOT COMPLETED|Overall Study||0
3195200|NCT02083653|3923526|FG000|STARTED|Overall Study||83
3195201|NCT02083653|3923527|FG001|STARTED|Overall Study||86
3195202|NCT02083653|3923528|FG002|STARTED|Overall Study||85
3195203|NCT02083653|3923526|FG000|COMPLETED|Overall Study||1
3195204|NCT02083653|3923527|FG001|COMPLETED|Overall Study||1
3195205|NCT02083653|3923528|FG002|COMPLETED|Overall Study||1
3195206|NCT02083653|3923526|FG000|NOT COMPLETED|Overall Study||82
3195207|NCT02083653|3923527|FG001|NOT COMPLETED|Overall Study||85
3195208|NCT02083653|3923528|FG002|NOT COMPLETED|Overall Study||84
3195209|NCT02083679|3923540|FG000|STARTED|Overall Study||3
3195210|NCT02083679|3923541|FG001|STARTED|Overall Study||6
3195211|NCT02083679|3923542|FG002|STARTED|Overall Study||3
3195212|NCT02083679|3923543|FG003|STARTED|Overall Study||3
3195213|NCT02083679|3923540|FG000|COMPLETED|Overall Study||3
3195214|NCT02083679|3923541|FG001|COMPLETED|Overall Study||6
3195215|NCT02083679|3923542|FG002|COMPLETED|Overall Study||3
3195216|NCT02083679|3923543|FG003|COMPLETED|Overall Study||3
3195217|NCT02083679|3923540|FG000|NOT COMPLETED|Overall Study||0
3195218|NCT02083679|3923541|FG001|NOT COMPLETED|Overall Study||0
3195219|NCT02083679|3923542|FG002|NOT COMPLETED|Overall Study||0
3195220|NCT02083679|3923543|FG003|NOT COMPLETED|Overall Study||0
3195221|NCT02083783|3923555|FG000|STARTED|Overall Study||52
3195222|NCT02083783|3923556|FG001|STARTED|Overall Study||48
3195223|NCT02083783|3923555|FG000|COMPLETED|Overall Study||51
3195224|NCT02083783|3923556|FG001|COMPLETED|Overall Study||48
3195225|NCT02083783|3923555|FG000|NOT COMPLETED|Overall Study||1
3195226|NCT02083783|3923556|FG001|NOT COMPLETED|Overall Study||0
3195227|NCT02083809|3923566|FG000|STARTED|Overall Study||82
3195228|NCT02083809|3923567|FG001|STARTED|Overall Study||84
3195229|NCT02083809|3923566|FG000|COMPLETED|Overall Study||78
3195230|NCT02083809|3923567|FG001|COMPLETED|Overall Study||82
3195231|NCT02083809|3923566|FG000|NOT COMPLETED|Overall Study||4
3195232|NCT02083809|3923567|FG001|NOT COMPLETED|Overall Study||2
3364576|NCT04009577|4095799|FG000|LEM10|Core Study||3
3364577|NCT04009577|4095800|FG001|LEM10|Core Study||2
3364578|NCT04009577|4095801|FG002|LEM10|Core Study||10
3364579|NCT04009577|4095802|FG003|LEM10|Core Study||22
3364580|NCT04009577|4095799|FG000|COMPLETED|Core Study||6
3364581|NCT04009577|4095800|FG001|COMPLETED|Core Study||3
3364582|NCT04009577|4095801|FG002|COMPLETED|Core Study||17
3364583|NCT04009577|4095802|FG003|COMPLETED|Core Study||17
3364584|NCT04009577|4095799|FG000|NOT COMPLETED|Core Study||1
3364585|NCT04009577|4095800|FG001|NOT COMPLETED|Core Study||0
3364586|NCT04009577|4095801|FG002|NOT COMPLETED|Core Study||4
3364587|NCT04009577|4095802|FG003|NOT COMPLETED|Core Study||5
3364588|NCT04009577|4095799|FG000|STARTED|Extension Phase||6
3364589|NCT04009577|4095800|FG001|STARTED|Extension Phase||3
3364590|NCT04009577|4095801|FG002|STARTED|Extension Phase||17
3364591|NCT04009577|4095802|FG003|STARTED|Extension Phase||17
3364592|NCT04009577|4095799|FG000|Treated|Extension Phase||6
3364593|NCT04009577|4095800|FG001|Treated|Extension Phase||3
3364594|NCT04009577|4095801|FG002|Treated|Extension Phase||15
3364595|NCT04009577|4095802|FG003|Treated|Extension Phase||17
3364596|NCT04009577|4095799|FG000|LEM5|Extension Phase||6
3364597|NCT04009577|4095800|FG001|LEM5|Extension Phase||3
3364598|NCT04009577|4095801|FG002|LEM5|Extension Phase||15
3364599|NCT04009577|4095802|FG003|LEM5|Extension Phase||8
3364600|NCT04009577|4095799|FG000|LEM10|Extension Phase||5
3364601|NCT04009577|4095800|FG001|LEM10|Extension Phase||3
3364602|NCT04009577|4095801|FG002|LEM10|Extension Phase||12
3364603|NCT04009577|4095802|FG003|LEM10|Extension Phase||17
3364604|NCT04009577|4095799|FG000|COMPLETED|Extension Phase||6
3364605|NCT04009577|4095800|FG001|COMPLETED|Extension Phase||3
3364606|NCT04009577|4095801|FG002|COMPLETED|Extension Phase||13
3364607|NCT04009577|4095802|FG003|COMPLETED|Extension Phase||16
3364608|NCT04009577|4095799|FG000|NOT COMPLETED|Extension Phase||0
3364609|NCT04009577|4095800|FG001|NOT COMPLETED|Extension Phase||0
3364610|NCT04009577|4095801|FG002|NOT COMPLETED|Extension Phase||4
3364611|NCT04009577|4095802|FG003|NOT COMPLETED|Extension Phase||1
3364612|NCT04007159|4095828|FG000|STARTED|Induction Phase||280
3364613|NCT04007159|4095828|FG000|COMPLETED|Induction Phase||258
3364614|NCT04007159|4095828|FG000|NOT COMPLETED|Induction Phase||22
3364615|NCT04007159|4095828|FG000|STARTED|Rest Phase||258
3364616|NCT04007159|4095828|FG000|COMPLETED|Rest Phase||258
3364617|NCT04007159|4095828|FG000|NOT COMPLETED|Rest Phase||0
3364618|NCT04007159|4095828|FG000|STARTED|Challenge Phase||258
3364619|NCT04007159|4095828|FG000|COMPLETED|Challenge Phase||255
3364620|NCT04007159|4095828|FG000|NOT COMPLETED|Challenge Phase||3
3364621|NCT04007107|4095839|FG000|STARTED|Treatment Period 1 (Day 1)||26
3364622|NCT04007107|4095840|FG001|STARTED|Treatment Period 1 (Day 1)||26
3364623|NCT04007107|4095841|FG002|STARTED|Treatment Period 1 (Day 1)||25
3364624|NCT04007107|4095842|FG003|STARTED|Treatment Period 1 (Day 1)||26
3364625|NCT04007107|4095839|FG000|Full Analysis Set (FAS)|Treatment Period 1 (Day 1)||26
3364626|NCT04007107|4095840|FG001|Full Analysis Set (FAS)|Treatment Period 1 (Day 1)||26
3364627|NCT04007107|4095841|FG002|Full Analysis Set (FAS)|Treatment Period 1 (Day 1)||25
3364628|NCT04007107|4095842|FG003|Full Analysis Set (FAS)|Treatment Period 1 (Day 1)||26
3364629|NCT04007107|4095839|FG000|Safety Analysis Set (SAS)|Treatment Period 1 (Day 1)||26
3364630|NCT04007107|4095840|FG001|Safety Analysis Set (SAS)|Treatment Period 1 (Day 1)||26
3364631|NCT04007107|4095841|FG002|Safety Analysis Set (SAS)|Treatment Period 1 (Day 1)||25
3364632|NCT04007107|4095842|FG003|Safety Analysis Set (SAS)|Treatment Period 1 (Day 1)||26
3364633|NCT04007107|4095839|FG000|Per Protocol (PP) Set|Treatment Period 1 (Day 1)||26
3364634|NCT04007107|4095840|FG001|Per Protocol (PP) Set|Treatment Period 1 (Day 1)||25
3364635|NCT04007107|4095841|FG002|Per Protocol (PP) Set|Treatment Period 1 (Day 1)||25
3364636|NCT04007107|4095842|FG003|Per Protocol (PP) Set|Treatment Period 1 (Day 1)||26
3364637|NCT04007107|4095839|FG000|COMPLETED|Treatment Period 1 (Day 1)||26
3364638|NCT04007107|4095840|FG001|COMPLETED|Treatment Period 1 (Day 1)||26
3364639|NCT04007107|4095841|FG002|COMPLETED|Treatment Period 1 (Day 1)||25
3364640|NCT04007107|4095842|FG003|COMPLETED|Treatment Period 1 (Day 1)||26
3364641|NCT04007107|4095839|FG000|NOT COMPLETED|Treatment Period 1 (Day 1)||0
3364642|NCT04007107|4095840|FG001|NOT COMPLETED|Treatment Period 1 (Day 1)||0
3364643|NCT04007107|4095841|FG002|NOT COMPLETED|Treatment Period 1 (Day 1)||0
3364644|NCT04007107|4095842|FG003|NOT COMPLETED|Treatment Period 1 (Day 1)||0
3364645|NCT04007107|4095839|FG000|STARTED|Treatment Period 2 (Day 1)||26
3364646|NCT04007107|4095840|FG001|STARTED|Treatment Period 2 (Day 1)||26
3364647|NCT04007107|4095841|FG002|STARTED|Treatment Period 2 (Day 1)||25
3364648|NCT04007107|4095842|FG003|STARTED|Treatment Period 2 (Day 1)||26
3364649|NCT04007107|4095839|FG000|COMPLETED|Treatment Period 2 (Day 1)||26
3364650|NCT04007107|4095840|FG001|COMPLETED|Treatment Period 2 (Day 1)||25
3364651|NCT04007107|4095841|FG002|COMPLETED|Treatment Period 2 (Day 1)||25
3364652|NCT04007107|4095842|FG003|COMPLETED|Treatment Period 2 (Day 1)||26
3195233|NCT02083861|3923575|FG000|STARTED|Overall Study||57
3195234|NCT02083861|3923576|FG001|STARTED|Overall Study||36
3195235|NCT02083861|3923575|FG000|Treated|Overall Study||55
3195236|NCT02083861|3923576|FG001|Treated|Overall Study||35
3195237|NCT02083861|3923575|FG000|COMPLETED|Overall Study||51
3195238|NCT02083861|3923576|FG001|COMPLETED|Overall Study||33
3195239|NCT02083861|3923575|FG000|NOT COMPLETED|Overall Study||6
3195240|NCT02083861|3923576|FG001|NOT COMPLETED|Overall Study||3
3195241|NCT02083926|3923586|FG000|STARTED|Overall Study||9
3195242|NCT02083926|3923587|FG001|STARTED|Overall Study||9
3195243|NCT02083926|3923586|FG000|COMPLETED|Overall Study||8
3195244|NCT02083926|3923587|FG001|COMPLETED|Overall Study||9
3195245|NCT02083926|3923586|FG000|NOT COMPLETED|Overall Study||1
3195246|NCT02083926|3923587|FG001|NOT COMPLETED|Overall Study||0
3195247|NCT02083965|3923596|FG000|STARTED|PK Period 1||10
3195248|NCT02083965|3923597|FG001|STARTED|PK Period 1||9
3195249|NCT02083965|3923596|FG000|COMPLETED|PK Period 1||10
3195250|NCT02083965|3923597|FG001|COMPLETED|PK Period 1||9
3195251|NCT02083965|3923596|FG000|NOT COMPLETED|PK Period 1||0
3195252|NCT02083965|3923597|FG001|NOT COMPLETED|PK Period 1||0
3195253|NCT02083965|3923596|FG000|STARTED|Washout Period||10
3195254|NCT02083965|3923597|FG001|STARTED|Washout Period||9
3195255|NCT02083965|3923596|FG000|COMPLETED|Washout Period||10
3195256|NCT02083965|3923597|FG001|COMPLETED|Washout Period||9
3195257|NCT02083965|3923596|FG000|NOT COMPLETED|Washout Period||0
3195258|NCT02083965|3923597|FG001|NOT COMPLETED|Washout Period||0
3195259|NCT02083965|3923596|FG000|STARTED|PK Period 2||10
3195260|NCT02083965|3923597|FG001|STARTED|PK Period 2||9
3195261|NCT02083965|3923596|FG000|COMPLETED|PK Period 2||10
3195262|NCT02083965|3923597|FG001|COMPLETED|PK Period 2||9
3195263|NCT02083965|3923596|FG000|NOT COMPLETED|PK Period 2||0
3195264|NCT02083965|3923597|FG001|NOT COMPLETED|PK Period 2||0
3195265|NCT02083965|3923596|FG000|STARTED|Treatment Period||10
3195266|NCT02083965|3923597|FG001|STARTED|Treatment Period|1 participant completed PK period 1 and 2, then chose to withdraw and did not enter treatment period|8
3195267|NCT02083965|3923596|FG000|COMPLETED|Treatment Period||9
3195268|NCT02083965|3923597|FG001|COMPLETED|Treatment Period||8
3195269|NCT02083965|3923596|FG000|NOT COMPLETED|Treatment Period||1
3195270|NCT02083965|3923597|FG001|NOT COMPLETED|Treatment Period||0
3195271|NCT02084056|3923607|FG000|STARTED|Treatment Period 1 (4 Days)||28
3364653|NCT04007107|4095839|FG000|NOT COMPLETED|Treatment Period 2 (Day 1)||0
3364654|NCT04007107|4095840|FG001|NOT COMPLETED|Treatment Period 2 (Day 1)||1
3364655|NCT04007107|4095841|FG002|NOT COMPLETED|Treatment Period 2 (Day 1)||0
3364656|NCT04007107|4095842|FG003|NOT COMPLETED|Treatment Period 2 (Day 1)||0
3364657|NCT04006795|4095847|FG000|STARTED|Induction Phase||37
3364658|NCT04006795|4095847|FG000|COMPLETED|Induction Phase||37
3364659|NCT04006795|4095847|FG000|NOT COMPLETED|Induction Phase||0
3364660|NCT04006795|4095847|FG000|STARTED|Rest Phase||37
3364661|NCT04006795|4095847|FG000|COMPLETED|Rest Phase||37
3364662|NCT04006795|4095847|FG000|NOT COMPLETED|Rest Phase||0
3364663|NCT04006795|4095847|FG000|STARTED|Challenge Phase||37
3364664|NCT04006795|4095847|FG000|COMPLETED|Challenge Phase||37
3364665|NCT04006795|4095847|FG000|NOT COMPLETED|Challenge Phase||0
3364666|NCT04005885|4095858|FG000|STARTED|First Intervention||26
3364667|NCT04005885|4095859|FG001|STARTED|First Intervention||29
3364668|NCT04005885|4095858|FG000|COMPLETED|First Intervention||25
3364669|NCT04005885|4095859|FG001|COMPLETED|First Intervention||28
3364670|NCT04005885|4095858|FG000|NOT COMPLETED|First Intervention||1
3364671|NCT04005885|4095859|FG001|NOT COMPLETED|First Intervention||1
3364672|NCT04005885|4095858|FG000|STARTED|Second Intervention||25
3364673|NCT04005885|4095859|FG001|STARTED|Second Intervention||28
3364674|NCT04005885|4095858|FG000|COMPLETED|Second Intervention||25
3364675|NCT04005885|4095859|FG001|COMPLETED|Second Intervention||26
3364676|NCT04005885|4095858|FG000|NOT COMPLETED|Second Intervention||0
3364677|NCT04005885|4095859|FG001|NOT COMPLETED|Second Intervention||2
3364678|NCT04005885|4095858|FG000|STARTED|Third Intervention||25
3195272|NCT02084056|3923608|FG001|STARTED|Treatment Period 1 (4 Days)||30
3195273|NCT02084056|3923609|FG002|STARTED|Treatment Period 1 (4 Days)||8
3195274|NCT02084056|3923610|FG003|STARTED|Treatment Period 1 (4 Days)||8
3195275|NCT02084056|3923607|FG000|COMPLETED|Treatment Period 1 (4 Days)||27
3195276|NCT02084056|3923608|FG001|COMPLETED|Treatment Period 1 (4 Days)||30
3195277|NCT02084056|3923609|FG002|COMPLETED|Treatment Period 1 (4 Days)||8
3195278|NCT02084056|3923610|FG003|COMPLETED|Treatment Period 1 (4 Days)||8
3195279|NCT02084056|3923607|FG000|NOT COMPLETED|Treatment Period 1 (4 Days)||1
3364679|NCT04005885|4095859|FG001|STARTED|Third Intervention||26
3364680|NCT04005885|4095858|FG000|COMPLETED|Third Intervention||25
3364681|NCT04005885|4095859|FG001|COMPLETED|Third Intervention||26
3364682|NCT04005885|4095858|FG000|NOT COMPLETED|Third Intervention||0
3364683|NCT04005885|4095859|FG001|NOT COMPLETED|Third Intervention||0
3364684|NCT04000815|4095873|FG000|STARTED|Overall Study||29
3364685|NCT04000815|4095874|FG001|STARTED|Overall Study||20
3364686|NCT04000815|4095875|FG002|STARTED|Overall Study||22
3364687|NCT04000815|4095873|FG000|COMPLETED|Overall Study||15
3364688|NCT04000815|4095874|FG001|COMPLETED|Overall Study||15
3364689|NCT04000815|4095875|FG002|COMPLETED|Overall Study||15
3364690|NCT04000815|4095873|FG000|NOT COMPLETED|Overall Study||14
3364691|NCT04000815|4095874|FG001|NOT COMPLETED|Overall Study||5
3364692|NCT04000815|4095875|FG002|NOT COMPLETED|Overall Study||7
3364693|NCT03999944|4095883|FG000|STARTED|First Sleep Night||26
3364694|NCT03999944|4095884|FG001|STARTED|First Sleep Night||26
3195280|NCT02084056|3923608|FG001|NOT COMPLETED|Treatment Period 1 (4 Days)||0
3195281|NCT02084056|3923609|FG002|NOT COMPLETED|Treatment Period 1 (4 Days)||0
3195282|NCT02084056|3923610|FG003|NOT COMPLETED|Treatment Period 1 (4 Days)||0
3195283|NCT02084056|3923607|FG000|STARTED|Washout Period 1 (35 Days)||27
3195284|NCT02084056|3923608|FG001|STARTED|Washout Period 1 (35 Days)||30
3195285|NCT02084056|3923609|FG002|STARTED|Washout Period 1 (35 Days)||8
3195286|NCT02084056|3923610|FG003|STARTED|Washout Period 1 (35 Days)||8
3195287|NCT02084056|3923607|FG000|COMPLETED|Washout Period 1 (35 Days)||26
3195288|NCT02084056|3923608|FG001|COMPLETED|Washout Period 1 (35 Days)||30
3195289|NCT02084056|3923609|FG002|COMPLETED|Washout Period 1 (35 Days)||8
3195290|NCT02084056|3923610|FG003|COMPLETED|Washout Period 1 (35 Days)||8
3195291|NCT02084056|3923607|FG000|NOT COMPLETED|Washout Period 1 (35 Days)||1
3195292|NCT02084056|3923608|FG001|NOT COMPLETED|Washout Period 1 (35 Days)||0
3195293|NCT02084056|3923609|FG002|NOT COMPLETED|Washout Period 1 (35 Days)||0
3195294|NCT02084056|3923610|FG003|NOT COMPLETED|Washout Period 1 (35 Days)||0
3195295|NCT02084056|3923607|FG000|STARTED|Treatment Period 2 (4 Days)||26
3195296|NCT02084056|3923608|FG001|STARTED|Treatment Period 2 (4 Days)||30
3195297|NCT02084056|3923609|FG002|STARTED|Treatment Period 2 (4 Days)||8
3195298|NCT02084056|3923610|FG003|STARTED|Treatment Period 2 (4 Days)||8
3195299|NCT02084056|3923607|FG000|COMPLETED|Treatment Period 2 (4 Days)||26
3195300|NCT02084056|3923608|FG001|COMPLETED|Treatment Period 2 (4 Days)||30
3195301|NCT02084056|3923609|FG002|COMPLETED|Treatment Period 2 (4 Days)||8
3195302|NCT02084056|3923610|FG003|COMPLETED|Treatment Period 2 (4 Days)||8
3195303|NCT02084056|3923607|FG000|NOT COMPLETED|Treatment Period 2 (4 Days)||0
3195304|NCT02084056|3923608|FG001|NOT COMPLETED|Treatment Period 2 (4 Days)||0
3195305|NCT02084056|3923609|FG002|NOT COMPLETED|Treatment Period 2 (4 Days)||0
3195306|NCT02084056|3923610|FG003|NOT COMPLETED|Treatment Period 2 (4 Days)||0
3195307|NCT02084069|3923622|FG000|STARTED|Overall Study||29
3195308|NCT02084069|3923623|FG001|STARTED|Overall Study||29
3195309|NCT02084069|3923622|FG000|COMPLETED|Overall Study||29
3195310|NCT02084069|3923623|FG001|COMPLETED|Overall Study||29
3195311|NCT02084069|3923622|FG000|NOT COMPLETED|Overall Study||0
3195312|NCT02084069|3923623|FG001|NOT COMPLETED|Overall Study||0
3195313|NCT02084082|3923631|FG000|STARTED|Treatment Period 1 (4 Days)||26
3195314|NCT02084082|3923632|FG001|STARTED|Treatment Period 1 (4 Days)||26
3195315|NCT02084082|3923633|FG002|STARTED|Treatment Period 1 (4 Days)||8
3195316|NCT02084082|3923634|FG003|STARTED|Treatment Period 1 (4 Days)||8
3195317|NCT02084082|3923631|FG000|COMPLETED|Treatment Period 1 (4 Days)||26
3195318|NCT02084082|3923632|FG001|COMPLETED|Treatment Period 1 (4 Days)||26
3195319|NCT02084082|3923633|FG002|COMPLETED|Treatment Period 1 (4 Days)||8
3195320|NCT02084082|3923634|FG003|COMPLETED|Treatment Period 1 (4 Days)||8
3195321|NCT02084082|3923631|FG000|NOT COMPLETED|Treatment Period 1 (4 Days)||0
3195322|NCT02084082|3923632|FG001|NOT COMPLETED|Treatment Period 1 (4 Days)||0
3195323|NCT02084082|3923633|FG002|NOT COMPLETED|Treatment Period 1 (4 Days)||0
3195324|NCT02084082|3923634|FG003|NOT COMPLETED|Treatment Period 1 (4 Days)||0
3195325|NCT02084082|3923631|FG000|STARTED|Washout Period 1 (35 Days)||26
3195326|NCT02084082|3923632|FG001|STARTED|Washout Period 1 (35 Days)||26
3195327|NCT02084082|3923633|FG002|STARTED|Washout Period 1 (35 Days)||8
3195328|NCT02084082|3923634|FG003|STARTED|Washout Period 1 (35 Days)||8
3195329|NCT02084082|3923631|FG000|COMPLETED|Washout Period 1 (35 Days)||26
3195330|NCT02084082|3923632|FG001|COMPLETED|Washout Period 1 (35 Days)||26
3195331|NCT02084082|3923633|FG002|COMPLETED|Washout Period 1 (35 Days)||7
3195332|NCT02084082|3923634|FG003|COMPLETED|Washout Period 1 (35 Days)||6
3195333|NCT02084082|3923631|FG000|NOT COMPLETED|Washout Period 1 (35 Days)||0
3195334|NCT02084082|3923632|FG001|NOT COMPLETED|Washout Period 1 (35 Days)||0
3195335|NCT02084082|3923633|FG002|NOT COMPLETED|Washout Period 1 (35 Days)||1
3195336|NCT02084082|3923634|FG003|NOT COMPLETED|Washout Period 1 (35 Days)||2
3195337|NCT02084082|3923631|FG000|STARTED|Treatment Period 2 (4 Days)||26
3195338|NCT02084082|3923632|FG001|STARTED|Treatment Period 2 (4 Days)||26
3195339|NCT02084082|3923633|FG002|STARTED|Treatment Period 2 (4 Days)||7
3195340|NCT02084082|3923634|FG003|STARTED|Treatment Period 2 (4 Days)||6
3195341|NCT02084082|3923631|FG000|COMPLETED|Treatment Period 2 (4 Days)||26
3195342|NCT02084082|3923632|FG001|COMPLETED|Treatment Period 2 (4 Days)||26
3195343|NCT02084082|3923633|FG002|COMPLETED|Treatment Period 2 (4 Days)||7
3195344|NCT02084082|3923634|FG003|COMPLETED|Treatment Period 2 (4 Days)||6
3195345|NCT02084082|3923631|FG000|NOT COMPLETED|Treatment Period 2 (4 Days)||0
3195346|NCT02084082|3923632|FG001|NOT COMPLETED|Treatment Period 2 (4 Days)||0
3195347|NCT02084082|3923633|FG002|NOT COMPLETED|Treatment Period 2 (4 Days)||0
3195348|NCT02084082|3923634|FG003|NOT COMPLETED|Treatment Period 2 (4 Days)||0
3195349|NCT02084134|3923646|FG000|STARTED|Overall Study||23
3195350|NCT02084134|3923647|FG001|STARTED|Overall Study||20
3195351|NCT02084134|3923646|FG000|COMPLETED|Overall Study||19
3195352|NCT02084134|3923647|FG001|COMPLETED|Overall Study||17
3195353|NCT02084134|3923646|FG000|NOT COMPLETED|Overall Study||4
3195354|NCT02084134|3923647|FG001|NOT COMPLETED|Overall Study||3
3195355|NCT02084160|3923653|FG000|STARTED|Overall Study||579
3195356|NCT02084160|3923653|FG000|COMPLETED|Overall Study||579
3195357|NCT02084160|3923653|FG000|NOT COMPLETED|Overall Study||0
3195358|NCT02084238|3923657|FG000|STARTED|Overall Study||40
3195359|NCT02084238|3923657|FG000|COMPLETED|Overall Study||38
3195360|NCT02084238|3923657|FG000|NOT COMPLETED|Overall Study||2
3195361|NCT02084511|3923672|FG000|STARTED|Overall Study||20
3195362|NCT02084511|3923673|FG001|STARTED|Overall Study||20
3195363|NCT02084511|3923674|FG002|STARTED|Overall Study||20
3195364|NCT02084511|3923675|FG003|STARTED|Overall Study||20
3195365|NCT02084511|3923672|FG000|COMPLETED|Overall Study||20
3195366|NCT02084511|3923673|FG001|COMPLETED|Overall Study||20
3195367|NCT02084511|3923674|FG002|COMPLETED|Overall Study||20
3195368|NCT02084511|3923675|FG003|COMPLETED|Overall Study||20
3195369|NCT02084511|3923672|FG000|NOT COMPLETED|Overall Study||0
3195370|NCT02084511|3923673|FG001|NOT COMPLETED|Overall Study||0
3195371|NCT02084511|3923674|FG002|NOT COMPLETED|Overall Study||0
3195372|NCT02084511|3923675|FG003|NOT COMPLETED|Overall Study||0
3195373|NCT02084628|3923685|FG000|STARTED|Overall Study||1
3195374|NCT02084628|3923685|FG000|COMPLETED|Overall Study||1
3195375|NCT02084628|3923685|FG000|NOT COMPLETED|Overall Study||0
3195376|NCT02084706|3923691|FG000|STARTED|Overall Study||29
3195377|NCT02084706|3923692|FG001|STARTED|Overall Study||31
3195378|NCT02084706|3923691|FG000|COMPLETED|Overall Study||29
3195379|NCT02084706|3923692|FG001|COMPLETED|Overall Study||31
3195380|NCT02084706|3923691|FG000|NOT COMPLETED|Overall Study||0
3195381|NCT02084706|3923692|FG001|NOT COMPLETED|Overall Study||0
3195382|NCT02084797|3923698|FG000|STARTED|Overall Study||10
3195383|NCT02084797|3923698|FG000|COMPLETED|Overall Study||10
3195384|NCT02084797|3923698|FG000|NOT COMPLETED|Overall Study||0
3195385|NCT02085070|3923704|FG000|STARTED|Overall Study||23
3195386|NCT02085070|3923705|FG001|STARTED|Overall Study||42
3195387|NCT02085070|3923704|FG000|COMPLETED|Overall Study||23
3195388|NCT02085070|3923705|FG001|COMPLETED|Overall Study||42
3195389|NCT02085070|3923704|FG000|NOT COMPLETED|Overall Study||0
3195390|NCT02085070|3923705|FG001|NOT COMPLETED|Overall Study||0
3195391|NCT02085135|3923713|FG000|STARTED|Overall Study||34
3195392|NCT02085135|3923714|FG001|STARTED|Overall Study||32
3195393|NCT02085135|3923713|FG000|COMPLETED|Overall Study||23
3195394|NCT02085135|3923714|FG001|COMPLETED|Overall Study||23
3195395|NCT02085135|3923713|FG000|NOT COMPLETED|Overall Study||11
3195396|NCT02085135|3923714|FG001|NOT COMPLETED|Overall Study||9
3195397|NCT02085161|3923724|FG000|STARTED|Overall Study||76
3195398|NCT02085161|3923725|FG001|STARTED|Overall Study||76
3195399|NCT02085161|3923726|FG002|STARTED|Overall Study||76
3195400|NCT02085161|3923727|FG003|STARTED|Overall Study||76
3195401|NCT02085161|3923724|FG000|COMPLETED|Overall Study||64
3195402|NCT02085161|3923725|FG001|COMPLETED|Overall Study||66
3195403|NCT02085161|3923726|FG002|COMPLETED|Overall Study||71
3195404|NCT02085161|3923727|FG003|COMPLETED|Overall Study||66
3195405|NCT02085161|3923724|FG000|NOT COMPLETED|Overall Study||12
3195406|NCT02085161|3923725|FG001|NOT COMPLETED|Overall Study||10
3195407|NCT02085161|3923726|FG002|NOT COMPLETED|Overall Study||5
3195408|NCT02085161|3923727|FG003|NOT COMPLETED|Overall Study||10
3195409|NCT02085252|3923740|FG000|STARTED|Overall Study||58
3195410|NCT02085252|3923741|FG001|STARTED|Overall Study||57
3195411|NCT02085252|3923740|FG000|COMPLETED|Overall Study||57
3195412|NCT02085252|3923741|FG001|COMPLETED|Overall Study||53
3195413|NCT02085252|3923740|FG000|NOT COMPLETED|Overall Study||1
3195414|NCT02085252|3923741|FG001|NOT COMPLETED|Overall Study||4
3195415|NCT02085356|3923751|FG000|STARTED|Overall Study||577
3195416|NCT02085356|3923752|FG001|STARTED|Overall Study||348
3195417|NCT02085356|3923753|FG002|STARTED|Overall Study||681
3195418|NCT02085356|3923754|FG003|STARTED|Overall Study||361
3195419|NCT02085356|3923751|FG000|COMPLETED|Overall Study||577
3195420|NCT02085356|3923752|FG001|COMPLETED|Overall Study||348
3195421|NCT02085356|3923753|FG002|COMPLETED|Overall Study||681
3195422|NCT02085356|3923754|FG003|COMPLETED|Overall Study||361
3195423|NCT02085356|3923751|FG000|NOT COMPLETED|Overall Study||0
3195424|NCT02085356|3923752|FG001|NOT COMPLETED|Overall Study||0
3195425|NCT02085356|3923753|FG002|NOT COMPLETED|Overall Study||0
3195426|NCT02085356|3923754|FG003|NOT COMPLETED|Overall Study||0
3195427|NCT02085447|3923764|FG000|STARTED|Overall Study||30
3195428|NCT02085447|3923764|FG000|COMPLETED|Overall Study||26
3195429|NCT02085447|3923764|FG000|NOT COMPLETED|Overall Study||4
3195430|NCT02085460|3923772|FG000|STARTED|Overall Study||31
3195431|NCT02085460|3923773|FG001|STARTED|Overall Study||32
3195432|NCT02085460|3923774|FG002|STARTED|Overall Study||31
3195433|NCT02085460|3923772|FG000|COMPLETED|Overall Study||17
3195434|NCT02085460|3923773|FG001|COMPLETED|Overall Study||24
3195435|NCT02085460|3923774|FG002|COMPLETED|Overall Study||21
3195436|NCT02085460|3923772|FG000|NOT COMPLETED|Overall Study||14
3195437|NCT02085460|3923773|FG001|NOT COMPLETED|Overall Study||8
3195438|NCT02085460|3923774|FG002|NOT COMPLETED|Overall Study||10
3195439|NCT02085473|3923786|FG000|STARTED|Overall Study||15
3195440|NCT02085473|3923787|FG001|STARTED|Overall Study||15
3195441|NCT02085473|3923788|FG002|STARTED|Overall Study||15
3195442|NCT02085473|3923789|FG003|STARTED|Overall Study||15
3195443|NCT02085473|3923786|FG000|COMPLETED|Overall Study||15
3195444|NCT02085473|3923787|FG001|COMPLETED|Overall Study||15
3195445|NCT02085473|3923788|FG002|COMPLETED|Overall Study||15
3195446|NCT02085473|3923789|FG003|COMPLETED|Overall Study||15
3195447|NCT02085473|3923786|FG000|NOT COMPLETED|Overall Study||0
3195448|NCT02085473|3923787|FG001|NOT COMPLETED|Overall Study||0
3195449|NCT02085473|3923788|FG002|NOT COMPLETED|Overall Study||0
3195450|NCT02085473|3923789|FG003|NOT COMPLETED|Overall Study||0
3195451|NCT02085551|3923799|FG000|STARTED|Overall Study||85
3195452|NCT02085551|3923799|FG000|COMPLETED|Overall Study||85
3195453|NCT02085551|3923799|FG000|NOT COMPLETED|Overall Study||0
3195454|NCT02085720|3923803|FG000|STARTED|Overall Study||819
3195455|NCT02085720|3923803|FG000|COMPLETED|Overall Study||819
3195456|NCT02085720|3923803|FG000|NOT COMPLETED|Overall Study||0
3195457|NCT02085785|3923813|FG000|STARTED|Overall Study||7
3195458|NCT02085785|3923814|FG001|STARTED|Overall Study||8
3195459|NCT02085785|3923813|FG000|COMPLETED|Overall Study||5
3195460|NCT02085785|3923814|FG001|COMPLETED|Overall Study||6
3195461|NCT02085785|3923813|FG000|NOT COMPLETED|Overall Study||2
3195462|NCT02085785|3923814|FG001|NOT COMPLETED|Overall Study||2
3195463|NCT02085980|3923822|FG000|STARTED|Overall Study||30
3195464|NCT02085980|3923822|FG000|COMPLETED|Overall Study||27
3195465|NCT02085980|3923822|FG000|NOT COMPLETED|Overall Study||3
3195466|NCT02086110|3923828|FG000|STARTED|Overall Study||5
3195467|NCT02086110|3923829|FG001|STARTED|Overall Study||6
3195468|NCT02086110|3923828|FG000|COMPLETED|Overall Study||4
3195469|NCT02086110|3923829|FG001|COMPLETED|Overall Study||5
3195470|NCT02086110|3923828|FG000|NOT COMPLETED|Overall Study||1
3195471|NCT02086110|3923829|FG001|NOT COMPLETED|Overall Study||1
3195472|NCT02086162|3923838|FG000|STARTED|Overall Study||78
3195473|NCT02086162|3923839|FG001|STARTED|Overall Study||84
3195474|NCT02086162|3923838|FG000|COMPLETED|Overall Study||68
3195475|NCT02086162|3923839|FG001|COMPLETED|Overall Study||77
3195476|NCT02086162|3923838|FG000|NOT COMPLETED|Overall Study||10
3195477|NCT02086162|3923839|FG001|NOT COMPLETED|Overall Study||7
3195478|NCT02086175|3923849|FG000|STARTED|Overall Study||25
3195479|NCT02086175|3923849|FG000|COMPLETED|Overall Study||25
3195480|NCT02086175|3923849|FG000|NOT COMPLETED|Overall Study||0
3195481|NCT02086331|3923853|FG000|STARTED|Overall Study||5
3195482|NCT02086331|3923853|FG000|COMPLETED|Overall Study||5
3195483|NCT02086331|3923853|FG000|NOT COMPLETED|Overall Study||0
3195484|NCT02086500|3923868|FG000|STARTED|Overall Study||447
3195485|NCT02086500|3923869|FG001|STARTED|Overall Study||456
3195486|NCT02086500|3923868|FG000|COMPLETED|Overall Study||447
3195487|NCT02086500|3923869|FG001|COMPLETED|Overall Study||456
3195488|NCT02086500|3923868|FG000|NOT COMPLETED|Overall Study||0
3195489|NCT02086500|3923869|FG001|NOT COMPLETED|Overall Study||0
3195490|NCT02086565|3923877|FG000|STARTED|Overall Study||151
3195491|NCT02086565|3923878|FG001|STARTED|Overall Study||150
3195492|NCT02086565|3923877|FG000|COMPLETED|Overall Study||135
3195493|NCT02086565|3923878|FG001|COMPLETED|Overall Study||138
3195494|NCT02086565|3923877|FG000|NOT COMPLETED|Overall Study||16
3195495|NCT02086565|3923878|FG001|NOT COMPLETED|Overall Study||12
3195496|NCT02086591|3923884|FG000|STARTED|Overall Study||7
3195497|NCT02086591|3923884|FG000|COMPLETED|Overall Study||2
3195498|NCT02086591|3923884|FG000|NOT COMPLETED|Overall Study||5
3195499|NCT02086682|3923890|FG000|STARTED|Overall Study||156
3195500|NCT02086682|3923891|FG001|STARTED|Overall Study||182
3195501|NCT02086682|3923890|FG000|COMPLETED|Overall Study||156
3195502|NCT02086682|3923891|FG001|COMPLETED|Overall Study||182
3195503|NCT02086682|3923890|FG000|NOT COMPLETED|Overall Study||0
3195504|NCT02086682|3923891|FG001|NOT COMPLETED|Overall Study||0
3195505|NCT02086708|3923897|FG000|STARTED|Overall Study||24
3195506|NCT02086708|3923897|FG000|COMPLETED|Overall Study||24
3195507|NCT02086708|3923897|FG000|NOT COMPLETED|Overall Study||0
3195508|NCT02086786|3923911|FG000|STARTED|Overall Study||35
3195509|NCT02086786|3923912|FG001|STARTED|Overall Study||35
3195510|NCT02086786|3923911|FG000|COMPLETED|Overall Study||17
3195511|NCT02086786|3923912|FG001|COMPLETED|Overall Study||19
3195512|NCT02086786|3923911|FG000|NOT COMPLETED|Overall Study||18
3195513|NCT02086786|3923912|FG001|NOT COMPLETED|Overall Study||16
3195514|NCT02086968|3923922|FG000|STARTED|Overall Study||100
3195515|NCT02086968|3923923|FG001|STARTED|Overall Study||98
3195516|NCT02086968|3923922|FG000|COMPLETED|Overall Study||92
3195517|NCT02086968|3923923|FG001|COMPLETED|Overall Study||85
3195518|NCT02086968|3923922|FG000|NOT COMPLETED|Overall Study||8
3195519|NCT02086968|3923923|FG001|NOT COMPLETED|Overall Study||13
3195520|NCT02087046|3923929|FG000|STARTED|Overall Study||127
3195521|NCT02087046|3923929|FG000|Primary Endpoint|Overall Study||121
3195522|NCT02087046|3923929|FG000|COMPLETED|Overall Study||116
3195523|NCT02087046|3923929|FG000|NOT COMPLETED|Overall Study||11
3195524|NCT02087059|3923934|FG000|STARTED|Overall Study||51
3195525|NCT02087059|3923934|FG000|COMPLETED|Overall Study||44
3195526|NCT02087059|3923934|FG000|NOT COMPLETED|Overall Study||7
3195527|NCT02087085|3923940|FG000|STARTED|Overall Study||154
3195528|NCT02087085|3923941|FG001|STARTED|Overall Study||156
3195529|NCT02087085|3923940|FG000|COMPLETED|Overall Study||34
3195530|NCT02087085|3923941|FG001|COMPLETED|Overall Study||40
3195531|NCT02087085|3923940|FG000|NOT COMPLETED|Overall Study||120
3195532|NCT02087085|3923941|FG001|NOT COMPLETED|Overall Study||116
3195533|NCT02087150|3923950|FG000|STARTED|Overall Study||81
3195534|NCT02087150|3923951|FG001|STARTED|Overall Study||162
3195535|NCT02087150|3923952|FG002|STARTED|Overall Study||80
3195536|NCT02087150|3923950|FG000|Had a Lead-in or Randomized ETBC Proc|Overall Study||80
3195537|NCT02087150|3923951|FG001|Had a Lead-in or Randomized ETBC Proc|Overall Study||149
3195538|NCT02087150|3923952|FG002|Had a Lead-in or Randomized ETBC Proc|Overall Study||0
3195539|NCT02087150|3923950|FG000|Received a Crossover MM ETBC Procedure|Overall Study||0
3195540|NCT02087150|3923951|FG001|Received a Crossover MM ETBC Procedure|Overall Study||0
3195541|NCT02087150|3923952|FG002|Received a Crossover MM ETBC Procedure|Overall Study||70
3195542|NCT02087150|3923950|FG000|COMPLETED|Overall Study||71
3195543|NCT02087150|3923951|FG001|COMPLETED|Overall Study||128
3195544|NCT02087150|3923952|FG002|COMPLETED|Overall Study||69
3195545|NCT02087150|3923950|FG000|NOT COMPLETED|Overall Study||10
3195546|NCT02087150|3923951|FG001|NOT COMPLETED|Overall Study||34
3195547|NCT02087150|3923952|FG002|NOT COMPLETED|Overall Study||11
3195548|NCT02087163|3923961|FG000|STARTED|Overall Study||90
3195549|NCT02087163|3923961|FG000|COMPLETED|Overall Study||73
3195550|NCT02087163|3923961|FG000|NOT COMPLETED|Overall Study||17
3195551|NCT02087176|3923965|FG000|STARTED|Overall Study||32
3195552|NCT02087176|3923965|FG000|COMPLETED|Overall Study|The sponsor terminated the study early.|0
3195553|NCT02087176|3923965|FG000|NOT COMPLETED|Overall Study||32
3195554|NCT02087241|3923973|FG000|STARTED|Overall Study||3
3195555|NCT02087241|3923974|FG001|STARTED|Overall Study||3
3195556|NCT02087241|3923975|FG002|STARTED|Overall Study||1
3195557|NCT02087241|3923976|FG003|STARTED|Overall Study||7
3195558|NCT02087241|3923973|FG000|COMPLETED|Overall Study||0
3195559|NCT02087241|3923974|FG001|COMPLETED|Overall Study||0
3195560|NCT02087241|3923975|FG002|COMPLETED|Overall Study||0
3195561|NCT02087241|3923976|FG003|COMPLETED|Overall Study||0
3195562|NCT02087241|3923973|FG000|NOT COMPLETED|Overall Study||3
3195563|NCT02087241|3923974|FG001|NOT COMPLETED|Overall Study||3
3195564|NCT02087241|3923975|FG002|NOT COMPLETED|Overall Study||1
3195565|NCT02087241|3923976|FG003|NOT COMPLETED|Overall Study||7
3195566|NCT02087306|3923993|FG000|STARTED|Overall Study||65
3195567|NCT02087306|3923994|FG001|STARTED|Overall Study||93
3195568|NCT02087306|3923995|FG002|STARTED|Overall Study||43
3195569|NCT02087306|3923993|FG000|COMPLETED|Overall Study||29
3195570|NCT02087306|3923994|FG001|COMPLETED|Overall Study||29
3195571|NCT02087306|3923995|FG002|COMPLETED|Overall Study||16
3195572|NCT02087306|3923993|FG000|NOT COMPLETED|Overall Study||36
3195573|NCT02087306|3923994|FG001|NOT COMPLETED|Overall Study||64
3195574|NCT02087306|3923995|FG002|NOT COMPLETED|Overall Study||27
3195575|NCT02087423|3924005|FG000|STARTED|Overall Study|Treated|111
3195576|NCT02087423|3924006|FG001|STARTED|Overall Study|Treated|265
3195577|NCT02087423|3924007|FG002|STARTED|Overall Study|Treated|68
3195578|NCT02087423|3924005|FG000|Completed 12 Months of Treatment|Overall Study||18
3195579|NCT02087423|3924006|FG001|Completed 12 Months of Treatment|Overall Study||60
3195580|NCT02087423|3924007|FG002|Completed 12 Months of Treatment|Overall Study||26
3195581|NCT02087423|3924005|FG000|COMPLETED|Overall Study||0
3195582|NCT02087423|3924006|FG001|COMPLETED|Overall Study||0
3195583|NCT02087423|3924007|FG002|COMPLETED|Overall Study||0
3195584|NCT02087423|3924005|FG000|NOT COMPLETED|Overall Study||111
3195585|NCT02087423|3924006|FG001|NOT COMPLETED|Overall Study||265
3195586|NCT02087423|3924007|FG002|NOT COMPLETED|Overall Study||68
3195587|NCT02087514|3924023|FG000|STARTED|Overall Study||10
3195588|NCT02087514|3924024|FG001|STARTED|Overall Study||10
3195589|NCT02087514|3924025|FG002|STARTED|Overall Study||10
3195590|NCT02087514|3924026|FG003|STARTED|Overall Study||10
3195591|NCT02087514|3924027|FG004|STARTED|Overall Study||10
3195592|NCT02087514|3924028|FG005|STARTED|Overall Study||10
3195593|NCT02087514|3924023|FG000|COMPLETED|Overall Study||8
3195594|NCT02087514|3924024|FG001|COMPLETED|Overall Study||10
3195595|NCT02087514|3924025|FG002|COMPLETED|Overall Study||7
3195596|NCT02087514|3924026|FG003|COMPLETED|Overall Study||8
3195597|NCT02087514|3924027|FG004|COMPLETED|Overall Study||10
3195598|NCT02087514|3924028|FG005|COMPLETED|Overall Study||9
3195599|NCT02087514|3924023|FG000|NOT COMPLETED|Overall Study||2
3195600|NCT02087514|3924024|FG001|NOT COMPLETED|Overall Study||0
3195601|NCT02087514|3924025|FG002|NOT COMPLETED|Overall Study||3
3195602|NCT02087514|3924026|FG003|NOT COMPLETED|Overall Study||2
3195603|NCT02087514|3924027|FG004|NOT COMPLETED|Overall Study||0
3195604|NCT02087514|3924028|FG005|NOT COMPLETED|Overall Study||1
3195605|NCT02087670|3924044|FG000|STARTED|Overall Study||20
3195606|NCT02087670|3924045|FG001|STARTED|Overall Study||22
3195607|NCT02087670|3924044|FG000|COMPLETED|Overall Study||17
3195608|NCT02087670|3924045|FG001|COMPLETED|Overall Study||20
3195609|NCT02087670|3924044|FG000|NOT COMPLETED|Overall Study||3
3195610|NCT02087670|3924045|FG001|NOT COMPLETED|Overall Study||2
3195611|NCT02087748|3924051|FG000|STARTED|Overall Study||24
3195612|NCT02087748|3924051|FG000|COMPLETED|Overall Study||24
3195613|NCT02087748|3924051|FG000|NOT COMPLETED|Overall Study||0
3195614|NCT02087774|3924061|FG000|STARTED|Overall Study||150
3195615|NCT02087774|3924062|FG001|STARTED|Overall Study||150
3195616|NCT02087774|3924061|FG000|COMPLETED|Overall Study||142
3195617|NCT02087774|3924062|FG001|COMPLETED|Overall Study||130
3195618|NCT02087774|3924061|FG000|NOT COMPLETED|Overall Study||8
3195619|NCT02087774|3924062|FG001|NOT COMPLETED|Overall Study||20
3195620|NCT02087904|3924072|FG000|STARTED|Overall Study||85
3195621|NCT02087904|3924073|FG001|STARTED|Overall Study||89
3195622|NCT02087904|3924074|FG002|STARTED|Overall Study||87
3195623|NCT02087904|3924075|FG003|STARTED|Overall Study||89
3195624|NCT02087904|3924072|FG000|COMPLETED|Overall Study||60
3195625|NCT02087904|3924073|FG001|COMPLETED|Overall Study||70
3195626|NCT02087904|3924074|FG002|COMPLETED|Overall Study||65
3195627|NCT02087904|3924075|FG003|COMPLETED|Overall Study||64
3195628|NCT02087904|3924072|FG000|NOT COMPLETED|Overall Study||25
3195629|NCT02087904|3924073|FG001|NOT COMPLETED|Overall Study||19
3195630|NCT02087904|3924074|FG002|NOT COMPLETED|Overall Study||22
3195631|NCT02087904|3924075|FG003|NOT COMPLETED|Overall Study||25
3195632|NCT02087943|3924088|FG000|STARTED|Placebo-Controlled Phase Week 0-12||64
3195633|NCT02087943|3924089|FG001|STARTED|Placebo-Controlled Phase Week 0-12||58
3195634|NCT02087943|3924090|FG002|STARTED|Placebo-Controlled Phase Week 0-12||63
3195635|NCT02087943|3924091|FG003|STARTED|Placebo-Controlled Phase Week 0-12||0
3195636|NCT02087943|3924092|FG004|STARTED|Placebo-Controlled Phase Week 0-12||0
3195637|NCT02087943|3924088|FG000|Safety Population|Placebo-Controlled Phase Week 0-12|Includes all participants who received at least one dose of study drug.|64
3195638|NCT02087943|3924089|FG001|Safety Population|Placebo-Controlled Phase Week 0-12|Includes all participants who received at least one dose of study drug.|58
3195639|NCT02087943|3924090|FG002|Safety Population|Placebo-Controlled Phase Week 0-12|Includes all participants who received at least one dose of study drug.|63
3195640|NCT02087943|3924091|FG003|Safety Population|Placebo-Controlled Phase Week 0-12||0
3195641|NCT02087943|3924092|FG004|Safety Population|Placebo-Controlled Phase Week 0-12||0
3195642|NCT02087943|3924088|FG000|COMPLETED|Placebo-Controlled Phase Week 0-12|3 participants who completed week 12 did not enter the active treatment phase.|50
3195643|NCT02087943|3924089|FG001|COMPLETED|Placebo-Controlled Phase Week 0-12||46
3195644|NCT02087943|3924090|FG002|COMPLETED|Placebo-Controlled Phase Week 0-12|1 participant who completed week 12 did not enter the active treatment phase.|50
3195645|NCT02087943|3924091|FG003|COMPLETED|Placebo-Controlled Phase Week 0-12||0
3195646|NCT02087943|3924092|FG004|COMPLETED|Placebo-Controlled Phase Week 0-12||0
3195647|NCT02087943|3924088|FG000|NOT COMPLETED|Placebo-Controlled Phase Week 0-12||14
3195648|NCT02087943|3924089|FG001|NOT COMPLETED|Placebo-Controlled Phase Week 0-12||12
3195649|NCT02087943|3924090|FG002|NOT COMPLETED|Placebo-Controlled Phase Week 0-12||13
3195650|NCT02087943|3924091|FG003|NOT COMPLETED|Placebo-Controlled Phase Week 0-12||0
3195651|NCT02087943|3924092|FG004|NOT COMPLETED|Placebo-Controlled Phase Week 0-12||0
3195652|NCT02087943|3924088|FG000|STARTED|Active Treatment Phase Week 12-24||0
3195653|NCT02087943|3924089|FG001|STARTED|Active Treatment Phase Week 12-24||46
3195654|NCT02087943|3924090|FG002|STARTED|Active Treatment Phase Week 12-24||49
3195655|NCT02087943|3924091|FG003|STARTED|Active Treatment Phase Week 12-24||24
3195656|NCT02087943|3924092|FG004|STARTED|Active Treatment Phase Week 12-24||23
3195657|NCT02087943|3924088|FG000|COMPLETED|Active Treatment Phase Week 12-24||0
3195658|NCT02087943|3924089|FG001|COMPLETED|Active Treatment Phase Week 12-24||42
3195659|NCT02087943|3924090|FG002|COMPLETED|Active Treatment Phase Week 12-24||44
3195660|NCT02087943|3924091|FG003|COMPLETED|Active Treatment Phase Week 12-24||22
3195661|NCT02087943|3924092|FG004|COMPLETED|Active Treatment Phase Week 12-24||21
3195662|NCT02087943|3924088|FG000|NOT COMPLETED|Active Treatment Phase Week 12-24||0
3195663|NCT02087943|3924089|FG001|NOT COMPLETED|Active Treatment Phase Week 12-24||4
3195664|NCT02087943|3924090|FG002|NOT COMPLETED|Active Treatment Phase Week 12-24||5
3195665|NCT02087943|3924091|FG003|NOT COMPLETED|Active Treatment Phase Week 12-24||2
3195666|NCT02087943|3924092|FG004|NOT COMPLETED|Active Treatment Phase Week 12-24||2
3195667|NCT02087943|3924088|FG000|STARTED|Observational Follow-up Phase Week 24-30||0
3195668|NCT02087943|3924089|FG001|STARTED|Observational Follow-up Phase Week 24-30||46
3195669|NCT02087943|3924090|FG002|STARTED|Observational Follow-up Phase Week 24-30||48
3195670|NCT02087943|3924091|FG003|STARTED|Observational Follow-up Phase Week 24-30||24
3195671|NCT02087943|3924092|FG004|STARTED|Observational Follow-up Phase Week 24-30||23
3195672|NCT02087943|3924088|FG000|COMPLETED|Observational Follow-up Phase Week 24-30||0
3195673|NCT02087943|3924089|FG001|COMPLETED|Observational Follow-up Phase Week 24-30||46
3195674|NCT02087943|3924090|FG002|COMPLETED|Observational Follow-up Phase Week 24-30||45
3195675|NCT02087943|3924091|FG003|COMPLETED|Observational Follow-up Phase Week 24-30||23
3195676|NCT02087943|3924092|FG004|COMPLETED|Observational Follow-up Phase Week 24-30||22
3195677|NCT02087943|3924088|FG000|NOT COMPLETED|Observational Follow-up Phase Week 24-30||0
3195678|NCT02087943|3924089|FG001|NOT COMPLETED|Observational Follow-up Phase Week 24-30||0
3195679|NCT02087943|3924090|FG002|NOT COMPLETED|Observational Follow-up Phase Week 24-30||3
3195680|NCT02087943|3924091|FG003|NOT COMPLETED|Observational Follow-up Phase Week 24-30||1
3195681|NCT02087943|3924092|FG004|NOT COMPLETED|Observational Follow-up Phase Week 24-30||1
3195682|NCT02087956|3924106|FG000|STARTED|Overall Study||111
3195683|NCT02087956|3924107|FG001|STARTED|Overall Study||112
3195684|NCT02087956|3924106|FG000|COMPLETED|Overall Study||105
3195685|NCT02087956|3924107|FG001|COMPLETED|Overall Study||107
3195686|NCT02087956|3924106|FG000|NOT COMPLETED|Overall Study||6
3195687|NCT02087956|3924107|FG001|NOT COMPLETED|Overall Study||5
3195688|NCT02087995|3924115|FG000|STARTED|Overall Study||51
3195689|NCT02087995|3924115|FG000|COMPLETED|Overall Study||51
3195690|NCT02087995|3924115|FG000|NOT COMPLETED|Overall Study||0
3195691|NCT02088034|3924122|FG000|STARTED|Overall Study||33
3195692|NCT02088034|3924123|FG001|STARTED|Overall Study||30
3195693|NCT02088034|3924124|FG002|STARTED|Overall Study||29
3195694|NCT02088034|3924122|FG000|COMPLETED|Overall Study||30
3195695|NCT02088034|3924123|FG001|COMPLETED|Overall Study||28
3195696|NCT02088034|3924124|FG002|COMPLETED|Overall Study||27
3195697|NCT02088034|3924122|FG000|NOT COMPLETED|Overall Study||3
3195698|NCT02088034|3924123|FG001|NOT COMPLETED|Overall Study||2
3195699|NCT02088034|3924124|FG002|NOT COMPLETED|Overall Study||2
3195700|NCT02088047|3924134|FG000|STARTED|Overall Study||3
3195701|NCT02088047|3924135|FG001|STARTED|Overall Study||1
3195702|NCT02088047|3924134|FG000|COMPLETED|Overall Study||2
3195703|NCT02088047|3924135|FG001|COMPLETED|Overall Study||1
3195704|NCT02088047|3924134|FG000|NOT COMPLETED|Overall Study||1
3195705|NCT02088047|3924135|FG001|NOT COMPLETED|Overall Study||0
3195706|NCT02088073|3924146|FG000|STARTED|Acute Phase||258
3364695|NCT03999944|4095883|FG000|COMPLETED|First Sleep Night||22
3364696|NCT03999944|4095884|FG001|COMPLETED|First Sleep Night||24
3364697|NCT03999944|4095883|FG000|NOT COMPLETED|First Sleep Night||4
3364698|NCT03999944|4095884|FG001|NOT COMPLETED|First Sleep Night||2
3364699|NCT03999944|4095883|FG000|STARTED|Second Sleep Night||22
3364700|NCT03999944|4095884|FG001|STARTED|Second Sleep Night||24
3364701|NCT03999944|4095883|FG000|COMPLETED|Second Sleep Night||22
3195707|NCT02088073|3924147|FG001|STARTED|Acute Phase||0
3195708|NCT02088073|3924148|FG002|STARTED|Acute Phase||0
3364702|NCT03999944|4095884|FG001|COMPLETED|Second Sleep Night||20
3195709|NCT02088073|3924149|FG003|STARTED|Acute Phase||0
3195710|NCT02088073|3924150|FG004|STARTED|Acute Phase||0
3195711|NCT02088073|3924146|FG000|COMPLETED|Acute Phase||251
3195712|NCT02088073|3924147|FG001|COMPLETED|Acute Phase||0
3195713|NCT02088073|3924148|FG002|COMPLETED|Acute Phase||0
3195714|NCT02088073|3924149|FG003|COMPLETED|Acute Phase||0
3195715|NCT02088073|3924150|FG004|COMPLETED|Acute Phase||0
3195716|NCT02088073|3924146|FG000|NOT COMPLETED|Acute Phase||7
3195717|NCT02088073|3924147|FG001|NOT COMPLETED|Acute Phase||0
3195718|NCT02088073|3924148|FG002|NOT COMPLETED|Acute Phase||0
3195719|NCT02088073|3924149|FG003|NOT COMPLETED|Acute Phase||0
3195720|NCT02088073|3924150|FG004|NOT COMPLETED|Acute Phase||0
3195721|NCT02088073|3924146|FG000|STARTED|Maintanance Phase||0
3195722|NCT02088073|3924147|FG001|STARTED|Maintanance Phase||85
3195723|NCT02088073|3924148|FG002|STARTED|Maintanance Phase||45
3195724|NCT02088073|3924149|FG003|STARTED|Maintanance Phase||51
3195725|NCT02088073|3924150|FG004|STARTED|Maintanance Phase||56
3195726|NCT02088073|3924146|FG000|COMPLETED|Maintanance Phase|251 subjects completed the AP; 240 were eligible to enter the MP. 237 entered the MP.|0
3195727|NCT02088073|3924147|FG001|COMPLETED|Maintanance Phase||75
3195728|NCT02088073|3924148|FG002|COMPLETED|Maintanance Phase||40
3195729|NCT02088073|3924149|FG003|COMPLETED|Maintanance Phase||44
3195730|NCT02088073|3924150|FG004|COMPLETED|Maintanance Phase||49
3195731|NCT02088073|3924146|FG000|NOT COMPLETED|Maintanance Phase||0
3195732|NCT02088073|3924147|FG001|NOT COMPLETED|Maintanance Phase||10
3195733|NCT02088073|3924148|FG002|NOT COMPLETED|Maintanance Phase||5
3195734|NCT02088073|3924149|FG003|NOT COMPLETED|Maintanance Phase||7
3195735|NCT02088073|3924150|FG004|NOT COMPLETED|Maintanance Phase||7
3195736|NCT02088177|3924163|FG000|STARTED|Overall Study||12
3195737|NCT02088177|3924163|FG000|COMPLETED|Overall Study||9
3195738|NCT02088177|3924163|FG000|NOT COMPLETED|Overall Study||3
3195739|NCT02088216|3924169|FG000|STARTED|Overall Study||81
3195740|NCT02088216|3924170|FG001|STARTED|Overall Study||80
3195741|NCT02088216|3924169|FG000|COMPLETED|Overall Study||69
3195742|NCT02088216|3924170|FG001|COMPLETED|Overall Study||70
3195743|NCT02088216|3924169|FG000|NOT COMPLETED|Overall Study||12
3195744|NCT02088216|3924170|FG001|NOT COMPLETED|Overall Study||10
3195745|NCT02088385|3924178|FG000|STARTED|Overall Study||10
3195746|NCT02088385|3924179|FG001|STARTED|Overall Study||10
3195747|NCT02088385|3924178|FG000|COMPLETED|Overall Study||10
3195748|NCT02088385|3924179|FG001|COMPLETED|Overall Study||10
3195749|NCT02088385|3924178|FG000|NOT COMPLETED|Overall Study||0
3195750|NCT02088385|3924179|FG001|NOT COMPLETED|Overall Study||0
3195751|NCT02088541|3924190|FG000|STARTED|Overall Study||71
3195752|NCT02088541|3924191|FG001|STARTED|Overall Study||27
3195753|NCT02088541|3924192|FG002|STARTED|Overall Study||117
3195754|NCT02088541|3924193|FG003|STARTED|Overall Study||44
3195755|NCT02088541|3924194|FG004|STARTED|Overall Study||58
3195756|NCT02088541|3924190|FG000|Safety Population|Overall Study||71
3195757|NCT02088541|3924191|FG001|Safety Population|Overall Study||27
3195758|NCT02088541|3924192|FG002|Safety Population|Overall Study||115
3195759|NCT02088541|3924193|FG003|Safety Population|Overall Study||39
3195760|NCT02088541|3924194|FG004|Safety Population|Overall Study||45
3195761|NCT02088541|3924190|FG000|Intent-to-treat (ITT) Population|Overall Study||0
3195762|NCT02088541|3924191|FG001|Intent-to-treat (ITT) Population|Overall Study||0
3195763|NCT02088541|3924192|FG002|Intent-to-treat (ITT) Population|Overall Study|1 randomized to Selinexor 60mg (PV>=5) but treated with physician choice 2, counted under this arm.|118
3195764|NCT02088541|3924193|FG003|Intent-to-treat (ITT) Population|Overall Study||0
3195765|NCT02088541|3924194|FG004|Intent-to-treat (ITT) Population|Overall Study||57
3195766|NCT02088541|3924190|FG000|COMPLETED|Overall Study||0
3195767|NCT02088541|3924191|FG001|COMPLETED|Overall Study||0
3195768|NCT02088541|3924192|FG002|COMPLETED|Overall Study||0
3195769|NCT02088541|3924193|FG003|COMPLETED|Overall Study||0
3195770|NCT02088541|3924194|FG004|COMPLETED|Overall Study||0
3195771|NCT02088541|3924190|FG000|NOT COMPLETED|Overall Study||71
3195772|NCT02088541|3924191|FG001|NOT COMPLETED|Overall Study||27
3195773|NCT02088541|3924192|FG002|NOT COMPLETED|Overall Study||117
3195774|NCT02088541|3924193|FG003|NOT COMPLETED|Overall Study||44
3195775|NCT02088541|3924194|FG004|NOT COMPLETED|Overall Study||58
3195776|NCT02088697|3924206|FG000|STARTED|Period I||25
3195777|NCT02088697|3924207|FG001|STARTED|Period I||25
3195778|NCT02088697|3924206|FG000|COMPLETED|Period I||24
3195779|NCT02088697|3924207|FG001|COMPLETED|Period I||21
3195780|NCT02088697|3924206|FG000|NOT COMPLETED|Period I||1
3195781|NCT02088697|3924207|FG001|NOT COMPLETED|Period I||4
3195782|NCT02088697|3924206|FG000|STARTED|Wash-out Period (at Least 10 Days)||24
3195783|NCT02088697|3924207|FG001|STARTED|Wash-out Period (at Least 10 Days)||21
3195784|NCT02088697|3924206|FG000|COMPLETED|Wash-out Period (at Least 10 Days)||23
3195785|NCT02088697|3924207|FG001|COMPLETED|Wash-out Period (at Least 10 Days)||21
3195786|NCT02088697|3924206|FG000|NOT COMPLETED|Wash-out Period (at Least 10 Days)||1
3195787|NCT02088697|3924207|FG001|NOT COMPLETED|Wash-out Period (at Least 10 Days)||0
3195788|NCT02088697|3924206|FG000|STARTED|Period II||23
3195789|NCT02088697|3924207|FG001|STARTED|Period II||21
3195790|NCT02088697|3924206|FG000|COMPLETED|Period II||23
3195791|NCT02088697|3924207|FG001|COMPLETED|Period II||21
3195792|NCT02088697|3924206|FG000|NOT COMPLETED|Period II||0
3195793|NCT02088697|3924207|FG001|NOT COMPLETED|Period II||0
3195794|NCT02088788|3924215|FG000|STARTED|Overall Study||135
3195795|NCT02088788|3924216|FG001|STARTED|Overall Study||130
3195796|NCT02088788|3924215|FG000|COMPLETED|Overall Study||105
3195797|NCT02088788|3924216|FG001|COMPLETED|Overall Study||89
3195798|NCT02088788|3924215|FG000|NOT COMPLETED|Overall Study||30
3195799|NCT02088788|3924216|FG001|NOT COMPLETED|Overall Study||41
3195800|NCT02088905|3924224|FG000|STARTED|Overall Study||13
3195801|NCT02088905|3924225|FG001|STARTED|Overall Study||10
3195802|NCT02088905|3924224|FG000|Week 9|Overall Study||10
3195803|NCT02088905|3924225|FG001|Week 9|Overall Study||9
3195804|NCT02088905|3924224|FG000|COMPLETED|Overall Study||8
3195805|NCT02088905|3924225|FG001|COMPLETED|Overall Study||9
3195806|NCT02088905|3924224|FG000|NOT COMPLETED|Overall Study||5
3195807|NCT02088905|3924225|FG001|NOT COMPLETED|Overall Study||1
3195808|NCT02089113|3924233|FG000|STARTED|Overall Study||161
3195809|NCT02089113|3924234|FG001|STARTED|Overall Study||80
3195810|NCT02089113|3924233|FG000|COMPLETED|Overall Study||160
3195811|NCT02089113|3924234|FG001|COMPLETED|Overall Study||80
3195812|NCT02089113|3924233|FG000|NOT COMPLETED|Overall Study||1
3195813|NCT02089113|3924234|FG001|NOT COMPLETED|Overall Study||0
3195814|NCT02089191|3924240|FG000|STARTED|Period 1, First 12 Hours||16
3195815|NCT02089191|3924241|FG001|STARTED|Period 1, First 12 Hours||15
3195816|NCT02089191|3924240|FG000|COMPLETED|Period 1, First 12 Hours||16
3195817|NCT02089191|3924241|FG001|COMPLETED|Period 1, First 12 Hours||15
3195818|NCT02089191|3924240|FG000|NOT COMPLETED|Period 1, First 12 Hours||0
3195819|NCT02089191|3924241|FG001|NOT COMPLETED|Period 1, First 12 Hours||0
3195820|NCT02089191|3924240|FG000|STARTED|Period 2, Second 12 Hours|One participant discontinued between Period 1 and Period 2 due to availability|15
3195821|NCT02089191|3924241|FG001|STARTED|Period 2, Second 12 Hours||15
3195822|NCT02089191|3924240|FG000|COMPLETED|Period 2, Second 12 Hours||15
3195823|NCT02089191|3924241|FG001|COMPLETED|Period 2, Second 12 Hours||15
3195824|NCT02089191|3924240|FG000|NOT COMPLETED|Period 2, Second 12 Hours||0
3195825|NCT02089191|3924241|FG001|NOT COMPLETED|Period 2, Second 12 Hours||0
3195826|NCT02089230|3924250|FG000|STARTED|Overall Study||3
3195827|NCT02089230|3924251|FG001|STARTED|Overall Study||4
3195828|NCT02089230|3924252|FG002|STARTED|Overall Study||12
3195829|NCT02089230|3924250|FG000|COMPLETED|Overall Study||3
3195830|NCT02089230|3924251|FG001|COMPLETED|Overall Study||4
3195831|NCT02089230|3924252|FG002|COMPLETED|Overall Study||6
3195832|NCT02089230|3924250|FG000|NOT COMPLETED|Overall Study||0
3195833|NCT02089230|3924251|FG001|NOT COMPLETED|Overall Study||0
3195834|NCT02089230|3924252|FG002|NOT COMPLETED|Overall Study||6
3195835|NCT02089334|3924264|FG000|STARTED|Overall Study||3
3195836|NCT02089334|3924265|FG001|STARTED|Overall Study||4
3195837|NCT02089334|3924266|FG002|STARTED|Overall Study||4
3195838|NCT02089334|3924267|FG003|STARTED|Overall Study||13
3195839|NCT02089334|3924264|FG000|Received Study Drug|Overall Study||3
3195840|NCT02089334|3924265|FG001|Received Study Drug|Overall Study||4
3195841|NCT02089334|3924266|FG002|Received Study Drug|Overall Study||3
3195842|NCT02089334|3924267|FG003|Received Study Drug|Overall Study||11
3195843|NCT02089334|3924264|FG000|COMPLETED|Overall Study||3
3195844|NCT02089334|3924265|FG001|COMPLETED|Overall Study||4
3195845|NCT02089334|3924266|FG002|COMPLETED|Overall Study||3
3195846|NCT02089334|3924267|FG003|COMPLETED|Overall Study||6
3195847|NCT02089334|3924264|FG000|NOT COMPLETED|Overall Study||0
3195848|NCT02089334|3924265|FG001|NOT COMPLETED|Overall Study||0
3195849|NCT02089334|3924266|FG002|NOT COMPLETED|Overall Study||1
3195850|NCT02089334|3924267|FG003|NOT COMPLETED|Overall Study||7
3195851|NCT02089347|3924282|FG000|STARTED|Overall Study||356
3195852|NCT02089347|3924283|FG001|STARTED|Overall Study||178
3195853|NCT02089347|3924282|FG000|COMPLETED|Overall Study||355
3195854|NCT02089347|3924283|FG001|COMPLETED|Overall Study||178
3195855|NCT02089347|3924282|FG000|NOT COMPLETED|Overall Study||1
3195856|NCT02089347|3924283|FG001|NOT COMPLETED|Overall Study||0
3195857|NCT02089464|3924291|FG000|STARTED|Overall Study||132
3195858|NCT02089464|3924292|FG001|STARTED|Overall Study||67
3195859|NCT02089464|3924291|FG000|COMPLETED|Overall Study||104
3195860|NCT02089464|3924292|FG001|COMPLETED|Overall Study||51
3195861|NCT02089464|3924291|FG000|NOT COMPLETED|Overall Study||28
3195862|NCT02089464|3924292|FG001|NOT COMPLETED|Overall Study||16
3195863|NCT02089659|3924300|FG000|STARTED|Overall Study||8
3195864|NCT02089659|3924301|FG001|STARTED|Overall Study||8
3195865|NCT02089659|3924302|FG002|STARTED|Overall Study||0
3195866|NCT02089659|3924300|FG000|COMPLETED|Overall Study||8
3195867|NCT02089659|3924301|FG001|COMPLETED|Overall Study||8
3195868|NCT02089659|3924302|FG002|COMPLETED|Overall Study||0
3195869|NCT02089659|3924300|FG000|NOT COMPLETED|Overall Study||0
3195870|NCT02089659|3924301|FG001|NOT COMPLETED|Overall Study||0
3195871|NCT02089659|3924302|FG002|NOT COMPLETED|Overall Study||0
3195872|NCT02089737|3924308|FG000|STARTED|Overall Study||3091
3195873|NCT02089737|3924308|FG000|COMPLETED|Overall Study||3085
3195874|NCT02089737|3924308|FG000|NOT COMPLETED|Overall Study||6
3195875|NCT02089997|3924313|FG000|STARTED|Overall Study||3304
3195876|NCT02089997|3924313|FG000|COMPLETED|Overall Study||3058
3195877|NCT02089997|3924313|FG000|NOT COMPLETED|Overall Study||246
3195878|NCT02090075|3924319|FG000|STARTED|Overall Study||33
3195879|NCT02090075|3924320|FG001|STARTED|Overall Study||33
3195880|NCT02090075|3924319|FG000|COMPLETED|Overall Study||26
3195881|NCT02090075|3924320|FG001|COMPLETED|Overall Study||30
3195882|NCT02090075|3924319|FG000|NOT COMPLETED|Overall Study||7
3195883|NCT02090075|3924320|FG001|NOT COMPLETED|Overall Study||3
3195884|NCT02090088|3924326|FG000|STARTED|Overall Study||4
3195885|NCT02090088|3924326|FG000|Gave Birth|Overall Study||4
3195886|NCT02090088|3924326|FG000|COMPLETED|Overall Study||4
3195887|NCT02090088|3924326|FG000|NOT COMPLETED|Overall Study||0
3195888|NCT02090283|3924334|FG000|STARTED|Overall Study||17
3195889|NCT02090283|3924335|FG001|STARTED|Overall Study||15
3195890|NCT02090283|3924336|FG002|STARTED|Overall Study||10
3195891|NCT02090283|3924334|FG000|Received At Least 1 Dose Of Study Drug|Overall Study||17
3195892|NCT02090283|3924335|FG001|Received At Least 1 Dose Of Study Drug|Overall Study||15
3195893|NCT02090283|3924336|FG002|Received At Least 1 Dose Of Study Drug|Overall Study||10
3195894|NCT02090283|3924334|FG000|COMPLETED|Overall Study||0
3195895|NCT02090283|3924335|FG001|COMPLETED|Overall Study||0
3195896|NCT02090283|3924336|FG002|COMPLETED|Overall Study||0
3195897|NCT02090283|3924334|FG000|NOT COMPLETED|Overall Study||17
3195898|NCT02090283|3924335|FG001|NOT COMPLETED|Overall Study||15
3195899|NCT02090283|3924336|FG002|NOT COMPLETED|Overall Study||10
3195900|NCT02090374|3924352|FG000|STARTED|Overall Study||8
3195901|NCT02090374|3924353|FG001|STARTED|Overall Study||4
3195902|NCT02090374|3924354|FG002|STARTED|Overall Study||4
3195903|NCT02090374|3924355|FG003|STARTED|Overall Study||9
3195904|NCT02090374|3924356|FG004|STARTED|Overall Study||35
3195905|NCT02090374|3924357|FG005|STARTED|Overall Study||15
3195906|NCT02090374|3924358|FG006|STARTED|Overall Study||16
3195907|NCT02090374|3924359|FG007|STARTED|Overall Study||2
3195908|NCT02090374|3924352|FG000|COMPLETED|Overall Study||8
3195909|NCT02090374|3924353|FG001|COMPLETED|Overall Study||4
3195910|NCT02090374|3924354|FG002|COMPLETED|Overall Study||4
3195911|NCT02090374|3924355|FG003|COMPLETED|Overall Study||9
3195912|NCT02090374|3924356|FG004|COMPLETED|Overall Study||35
3195913|NCT02090374|3924357|FG005|COMPLETED|Overall Study||15
3195914|NCT02090374|3924358|FG006|COMPLETED|Overall Study||16
3195915|NCT02090374|3924359|FG007|COMPLETED|Overall Study||2
3195916|NCT02090374|3924352|FG000|NOT COMPLETED|Overall Study||0
3195917|NCT02090374|3924353|FG001|NOT COMPLETED|Overall Study||0
3195918|NCT02090374|3924354|FG002|NOT COMPLETED|Overall Study||0
3195919|NCT02090374|3924355|FG003|NOT COMPLETED|Overall Study||0
3195920|NCT02090374|3924356|FG004|NOT COMPLETED|Overall Study||0
3195921|NCT02090374|3924357|FG005|NOT COMPLETED|Overall Study||0
3195922|NCT02090374|3924358|FG006|NOT COMPLETED|Overall Study||0
3195923|NCT02090374|3924359|FG007|NOT COMPLETED|Overall Study||0
3195924|NCT02090413|3924380|FG000|STARTED|Overall Study||81
3195925|NCT02090413|3924381|FG001|STARTED|Overall Study||80
3195926|NCT02090413|3924382|FG002|STARTED|Overall Study||80
3195927|NCT02090413|3924380|FG000|COMPLETED|Overall Study||62
3195928|NCT02090413|3924381|FG001|COMPLETED|Overall Study||60
3195929|NCT02090413|3924382|FG002|COMPLETED|Overall Study||57
3195930|NCT02090413|3924380|FG000|NOT COMPLETED|Overall Study||19
3195931|NCT02090413|3924381|FG001|NOT COMPLETED|Overall Study||20
3195932|NCT02090413|3924382|FG002|NOT COMPLETED|Overall Study||23
3195933|NCT02090426|3924393|FG000|STARTED|Overall Study||401
3195934|NCT02090426|3924394|FG001|STARTED|Overall Study||399
3195935|NCT02090426|3924393|FG000|Analysis Population|Overall Study||389
3195936|NCT02090426|3924394|FG001|Analysis Population|Overall Study||393
3195937|NCT02090426|3924393|FG000|COMPLETED|Overall Study||389
3195938|NCT02090426|3924394|FG001|COMPLETED|Overall Study||393
3195939|NCT02090426|3924393|FG000|NOT COMPLETED|Overall Study||12
3195940|NCT02090426|3924394|FG001|NOT COMPLETED|Overall Study||6
3195941|NCT02090634|3924402|FG000|STARTED|Overall Study||30
3195942|NCT02090634|3924403|FG001|STARTED|Overall Study||28
3195943|NCT02090634|3924402|FG000|COMPLETED|Overall Study||25
3195944|NCT02090634|3924403|FG001|COMPLETED|Overall Study||25
3195945|NCT02090634|3924402|FG000|NOT COMPLETED|Overall Study||5
3195946|NCT02090634|3924403|FG001|NOT COMPLETED|Overall Study||3
3195947|NCT02090725|3924409|FG000|STARTED|Overall Study||4
3195948|NCT02090725|3924409|FG000|COMPLETED|Overall Study||0
3195949|NCT02090725|3924409|FG000|NOT COMPLETED|Overall Study||4
3195950|NCT02090764|3924415|FG000|STARTED|Overall Study||206
3195951|NCT02090764|3924416|FG001|STARTED|Overall Study||206
3195952|NCT02090764|3924415|FG000|COMPLETED|Overall Study||200
3195953|NCT02090764|3924416|FG001|COMPLETED|Overall Study||186
3195954|NCT02090764|3924415|FG000|NOT COMPLETED|Overall Study||6
3195955|NCT02090764|3924416|FG001|NOT COMPLETED|Overall Study||20
3195956|NCT02090777|3924422|FG000|STARTED|Overall Study||4
3195957|NCT02090777|3924422|FG000|COMPLETED|Overall Study||4
3195958|NCT02090777|3924422|FG000|NOT COMPLETED|Overall Study||0
3195959|NCT02090855|3924426|FG000|STARTED|Overall Study||108
3195960|NCT02090855|3924426|FG000|COMPLETED|Overall Study||106
3195961|NCT02090855|3924426|FG000|NOT COMPLETED|Overall Study||2
3195962|NCT02090894|3924433|FG000|STARTED|Overall Study||11
3195963|NCT02090894|3924433|FG000|COMPLETED|Overall Study||11
3195964|NCT02090894|3924433|FG000|NOT COMPLETED|Overall Study||0
3195965|NCT02090959|3924437|FG000|STARTED|Overall Study||219
3195966|NCT02090959|3924437|FG000|As-treated Population|Overall Study||218
3195967|NCT02090959|3924437|FG000|COMPLETED|Overall Study||68
3195968|NCT02090959|3924437|FG000|NOT COMPLETED|Overall Study||151
3195969|NCT02091089|3924441|FG000|STARTED|Overall Study||20
3195970|NCT02091089|3924441|FG000|COMPLETED|Overall Study||18
3195971|NCT02091089|3924441|FG000|NOT COMPLETED|Overall Study||2
3195972|NCT02091102|3924445|FG000|STARTED|Overall Study||20
3195973|NCT02091102|3924445|FG000|COMPLETED|Overall Study||20
3195974|NCT02091102|3924445|FG000|NOT COMPLETED|Overall Study||0
3195975|NCT02091167|3924451|FG000|STARTED|Overall Study||19
3195976|NCT02091167|3924452|FG001|STARTED|Overall Study||16
3195977|NCT02091167|3924451|FG000|COMPLETED|Overall Study||19
3195978|NCT02091167|3924452|FG001|COMPLETED|Overall Study||14
3195979|NCT02091167|3924451|FG000|NOT COMPLETED|Overall Study||0
3195980|NCT02091167|3924452|FG001|NOT COMPLETED|Overall Study||2
3195981|NCT02091206|3924462|FG000|STARTED|Treatment Period||10
3195982|NCT02091206|3924463|FG001|STARTED|Treatment Period||8
3195983|NCT02091206|3924464|FG002|STARTED|Treatment Period||9
3195984|NCT02091206|3924465|FG003|STARTED|Treatment Period||7
3195985|NCT02091206|3924462|FG000|Safety Analysis Set|Treatment Period||10
3195986|NCT02091206|3924463|FG001|Safety Analysis Set|Treatment Period||8
3195987|NCT02091206|3924464|FG002|Safety Analysis Set|Treatment Period||9
3195988|NCT02091206|3924465|FG003|Safety Analysis Set|Treatment Period||7
3195989|NCT02091206|3924462|FG000|COMPLETED|Treatment Period||10
3195990|NCT02091206|3924463|FG001|COMPLETED|Treatment Period||7
3195991|NCT02091206|3924464|FG002|COMPLETED|Treatment Period||8
3195992|NCT02091206|3924465|FG003|COMPLETED|Treatment Period||7
3195993|NCT02091206|3924462|FG000|NOT COMPLETED|Treatment Period||0
3195994|NCT02091206|3924463|FG001|NOT COMPLETED|Treatment Period||1
3195995|NCT02091206|3924464|FG002|NOT COMPLETED|Treatment Period||1
3195996|NCT02091206|3924465|FG003|NOT COMPLETED|Treatment Period||0
3195997|NCT02091206|3924462|FG000|STARTED|Taper Period||10
3195998|NCT02091206|3924463|FG001|STARTED|Taper Period||7
3195999|NCT02091206|3924464|FG002|STARTED|Taper Period||8
3196000|NCT02091206|3924465|FG003|STARTED|Taper Period||7
3196001|NCT02091206|3924462|FG000|COMPLETED|Taper Period||9
3196002|NCT02091206|3924463|FG001|COMPLETED|Taper Period||7
3196003|NCT02091206|3924464|FG002|COMPLETED|Taper Period||8
3196004|NCT02091206|3924465|FG003|COMPLETED|Taper Period||5
3196005|NCT02091206|3924462|FG000|NOT COMPLETED|Taper Period||1
3196006|NCT02091206|3924463|FG001|NOT COMPLETED|Taper Period||0
3196007|NCT02091206|3924464|FG002|NOT COMPLETED|Taper Period||0
3196008|NCT02091206|3924465|FG003|NOT COMPLETED|Taper Period||2
3196009|NCT02091284|3924477|FG000|STARTED|Overall Study|Two subjects from this group discontinued the protocol, data from one subject could not be included.|26
3196010|NCT02091284|3924478|FG001|STARTED|Overall Study|One subject from this group discontinued the protocol|23
3196011|NCT02091284|3924477|FG000|COMPLETED|Overall Study||23
3196012|NCT02091284|3924478|FG001|COMPLETED|Overall Study||22
3196013|NCT02091284|3924477|FG000|NOT COMPLETED|Overall Study||3
3196014|NCT02091284|3924478|FG001|NOT COMPLETED|Overall Study||1
3196015|NCT02091362|3924488|FG000|STARTED|Period 1||133
3196016|NCT02091362|3924489|FG001|STARTED|Period 1||137
3196017|NCT02091362|3924488|FG000|COMPLETED|Period 1||128
3196018|NCT02091362|3924489|FG001|COMPLETED|Period 1||133
3196019|NCT02091362|3924488|FG000|NOT COMPLETED|Period 1||5
3196020|NCT02091362|3924489|FG001|NOT COMPLETED|Period 1||4
3196021|NCT02091362|3924488|FG000|STARTED|Wash-out||128
3196022|NCT02091362|3924489|FG001|STARTED|Wash-out||133
3196023|NCT02091362|3924488|FG000|COMPLETED|Wash-out||127
3196024|NCT02091362|3924489|FG001|COMPLETED|Wash-out||130
3196025|NCT02091362|3924488|FG000|NOT COMPLETED|Wash-out||1
3196026|NCT02091362|3924489|FG001|NOT COMPLETED|Wash-out||3
3196027|NCT02091362|3924488|FG000|STARTED|Period 2||127
3196028|NCT02091362|3924489|FG001|STARTED|Period 2||130
3196029|NCT02091362|3924488|FG000|COMPLETED|Period 2||125
3196030|NCT02091362|3924489|FG001|COMPLETED|Period 2||128
3196031|NCT02091362|3924488|FG000|NOT COMPLETED|Period 2||2
3196032|NCT02091362|3924489|FG001|NOT COMPLETED|Period 2||2
3196033|NCT02091375|3924501|FG000|STARTED|Overall Study||61
3196034|NCT02091375|3924502|FG001|STARTED|Overall Study||59
3196035|NCT02091375|3924501|FG000|Safety Analysis Set|Overall Study||61
3196036|NCT02091375|3924502|FG001|Safety Analysis Set|Overall Study||59
3196037|NCT02091375|3924501|FG000|Intention to Treat (ITT) Analysis Set|Overall Study||61
3196038|NCT02091375|3924502|FG001|Intention to Treat (ITT) Analysis Set|Overall Study||59
3196039|NCT02091375|3924501|FG000|COMPLETED|Overall Study||52
3196040|NCT02091375|3924502|FG001|COMPLETED|Overall Study||56
3196041|NCT02091375|3924501|FG000|NOT COMPLETED|Overall Study||9
3196042|NCT02091375|3924502|FG001|NOT COMPLETED|Overall Study||3
3196043|NCT02091414|3924508|FG000|STARTED|Overall Study||36
3196044|NCT02091414|3924508|FG000|COMPLETED|Overall Study||32
3196045|NCT02091414|3924508|FG000|NOT COMPLETED|Overall Study||4
3196046|NCT02091440|3924512|FG000|STARTED|Overall Study||6
3196047|NCT02091440|3924512|FG000|Primary Endpoint (Success at 180 Days)|Overall Study||6
3196048|NCT02091440|3924512|FG000|Overall Survival at 180 Days|Overall Study||6
3196049|NCT02091440|3924512|FG000|COMPLETED|Overall Study||4
3196050|NCT02091440|3924512|FG000|NOT COMPLETED|Overall Study||2
3196051|NCT02091466|3924518|FG000|STARTED|Overall Study||20
3196052|NCT02091466|3924519|FG001|STARTED|Overall Study||20
3196053|NCT02091466|3924518|FG000|COMPLETED|Overall Study||20
3196054|NCT02091466|3924519|FG001|COMPLETED|Overall Study||20
3196055|NCT02091466|3924518|FG000|NOT COMPLETED|Overall Study||0
3196056|NCT02091466|3924519|FG001|NOT COMPLETED|Overall Study||0
3196057|NCT02091531|3924525|FG000|STARTED|Overall Study||9
3196058|NCT02091531|3924525|FG000|COMPLETED|Overall Study||9
3196059|NCT02091531|3924525|FG000|NOT COMPLETED|Overall Study||0
3196060|NCT02091726|3924529|FG000|STARTED|Overall Study||110
3196061|NCT02091726|3924529|FG000|1 Week Followup|Overall Study||110
3196062|NCT02091726|3924529|FG000|4 Week Followup|Overall Study||104
3196063|NCT02091726|3924529|FG000|COMPLETED|Overall Study||104
3196064|NCT02091726|3924529|FG000|NOT COMPLETED|Overall Study||6
3196065|NCT02091739|3924536|FG000|STARTED|MP: 16 Weeks||36
3196066|NCT02091739|3924537|FG001|STARTED|MP: 16 Weeks||74
3196067|NCT02091739|3924538|FG002|STARTED|MP: 16 Weeks||74
3196068|NCT02091739|3924539|FG003|STARTED|MP: 16 Weeks||0
3196069|NCT02091739|3924540|FG004|STARTED|MP: 16 Weeks||0
3196070|NCT02091739|3924536|FG000|COMPLETED|MP: 16 Weeks||32
3196071|NCT02091739|3924537|FG001|COMPLETED|MP: 16 Weeks||69
3196072|NCT02091739|3924538|FG002|COMPLETED|MP: 16 Weeks||72
3196073|NCT02091739|3924539|FG003|COMPLETED|MP: 16 Weeks||0
3196074|NCT02091739|3924540|FG004|COMPLETED|MP: 16 Weeks||0
3196075|NCT02091739|3924536|FG000|NOT COMPLETED|MP: 16 Weeks||4
3196076|NCT02091739|3924537|FG001|NOT COMPLETED|MP: 16 Weeks||5
3196077|NCT02091739|3924538|FG002|NOT COMPLETED|MP: 16 Weeks||2
3196078|NCT02091739|3924539|FG003|NOT COMPLETED|MP: 16 Weeks||0
3196079|NCT02091739|3924540|FG004|NOT COMPLETED|MP: 16 Weeks||0
3196080|NCT02091739|3924536|FG000|STARTED|EP: 48 Weeks||0
3196081|NCT02091739|3924537|FG001|STARTED|EP: 48 Weeks||0
3196082|NCT02091739|3924538|FG002|STARTED|EP: 48 Weeks||0
3196083|NCT02091739|3924539|FG003|STARTED|EP: 48 Weeks||84
3196084|NCT02091739|3924540|FG004|STARTED|EP: 48 Weeks||89
3196085|NCT02091739|3924536|FG000|COMPLETED|EP: 48 Weeks||0
3196086|NCT02091739|3924537|FG001|COMPLETED|EP: 48 Weeks||0
3196087|NCT02091739|3924538|FG002|COMPLETED|EP: 48 Weeks||0
3196088|NCT02091739|3924539|FG003|COMPLETED|EP: 48 Weeks||76
3196089|NCT02091739|3924540|FG004|COMPLETED|EP: 48 Weeks||75
3196090|NCT02091739|3924536|FG000|NOT COMPLETED|EP: 48 Weeks||0
3196091|NCT02091739|3924537|FG001|NOT COMPLETED|EP: 48 Weeks||0
3196092|NCT02091739|3924538|FG002|NOT COMPLETED|EP: 48 Weeks||0
3196093|NCT02091739|3924539|FG003|NOT COMPLETED|EP: 48 Weeks||8
3196094|NCT02091739|3924540|FG004|NOT COMPLETED|EP: 48 Weeks||14
3196095|NCT02091778|3924550|FG000|STARTED|Overall Study||21
3196096|NCT02091778|3924550|FG000|COMPLETED|Overall Study||20
3196097|NCT02091778|3924550|FG000|NOT COMPLETED|Overall Study||1
3196098|NCT02091856|3924557|FG000|STARTED|Active Intervention Interval||34
3196099|NCT02091856|3924558|FG001|STARTED|Active Intervention Interval||19
3196100|NCT02091856|3924559|FG002|STARTED|Active Intervention Interval||26
3196101|NCT02091856|3924557|FG000|COMPLETED|Active Intervention Interval||15
3196102|NCT02091856|3924558|FG001|COMPLETED|Active Intervention Interval||12
3196103|NCT02091856|3924559|FG002|COMPLETED|Active Intervention Interval||19
3196104|NCT02091856|3924557|FG000|NOT COMPLETED|Active Intervention Interval||19
3196105|NCT02091856|3924558|FG001|NOT COMPLETED|Active Intervention Interval||7
3196106|NCT02091856|3924559|FG002|NOT COMPLETED|Active Intervention Interval||7
3196107|NCT02091856|3924557|FG000|STARTED|Follow-up Assessment|Only a subset of C-CBT participants responded to our request to complete the follow-up assessment.|15
3196108|NCT02091856|3924558|FG001|STARTED|Follow-up Assessment|Only a subset of R-CBT participants responded to our request to complete the follow-up assessment.|12
3196109|NCT02091856|3924559|FG002|STARTED|Follow-up Assessment|WLCG participants were lost at follow-up.|0
3196110|NCT02091856|3924557|FG000|COMPLETED|Follow-up Assessment||10
3196111|NCT02091856|3924558|FG001|COMPLETED|Follow-up Assessment||9
3196112|NCT02091856|3924559|FG002|COMPLETED|Follow-up Assessment||0
3196113|NCT02091856|3924557|FG000|NOT COMPLETED|Follow-up Assessment||5
3196114|NCT02091856|3924558|FG001|NOT COMPLETED|Follow-up Assessment||3
3196115|NCT02091856|3924559|FG002|NOT COMPLETED|Follow-up Assessment||0
3364703|NCT03999944|4095883|FG000|NOT COMPLETED|Second Sleep Night||0
3364704|NCT03999944|4095884|FG001|NOT COMPLETED|Second Sleep Night||4
3364705|NCT03995680|4095893|FG000|STARTED|Overall Study||199
3364706|NCT03995680|4095894|FG001|STARTED|Overall Study||198
3364707|NCT03995680|4095893|FG000|COMPLETED|Overall Study||197
3364708|NCT03995680|4095894|FG001|COMPLETED|Overall Study||196
3364709|NCT03995680|4095893|FG000|NOT COMPLETED|Overall Study||2
3364710|NCT03995680|4095894|FG001|NOT COMPLETED|Overall Study||2
3364711|NCT04006366|4095900|FG000|STARTED|Overall Study||6
3364712|NCT04006366|4095900|FG000|COMPLETED|Overall Study||5
3364713|NCT04006366|4095900|FG000|NOT COMPLETED|Overall Study||1
3364714|NCT04006145|4095906|FG000|STARTED|Overall Study||23
3364715|NCT04006145|4095907|FG001|STARTED|Overall Study||24
3364716|NCT04006145|4095906|FG000|Received Treatment|Overall Study||23
3364717|NCT04006145|4095907|FG001|Received Treatment|Overall Study||24
3364718|NCT04006145|4095906|FG000|COMPLETED|Overall Study||22
3364719|NCT04006145|4095907|FG001|COMPLETED|Overall Study||21
3364720|NCT04006145|4095906|FG000|NOT COMPLETED|Overall Study||1
3364721|NCT04006145|4095907|FG001|NOT COMPLETED|Overall Study||3
3364722|NCT04005755|4095913|FG000|STARTED|Overall Study||232
3364723|NCT04005755|4095913|FG000|COMPLETED|Overall Study||215
3364724|NCT04005755|4095913|FG000|NOT COMPLETED|Overall Study||17
3364725|NCT04005586|4095917|FG000|STARTED|Overall Study||25
3364726|NCT04005586|4095917|FG000|COMPLETED|Overall Study||25
3364727|NCT04005586|4095917|FG000|NOT COMPLETED|Overall Study||0
3364728|NCT04005404|4095924|FG000|STARTED|Overall Study||43
3364729|NCT04005404|4095925|FG001|STARTED|Overall Study||34
3364730|NCT04005404|4095926|FG002|STARTED|Overall Study||3
3364731|NCT04005404|4095924|FG000|COMPLETED|Overall Study||42
3364732|NCT04005404|4095925|FG001|COMPLETED|Overall Study||33
3364733|NCT04005404|4095926|FG002|COMPLETED|Overall Study||3
3364734|NCT04005404|4095924|FG000|NOT COMPLETED|Overall Study||1
3364735|NCT04005404|4095925|FG001|NOT COMPLETED|Overall Study||1
3364736|NCT04005404|4095926|FG002|NOT COMPLETED|Overall Study||0
3364737|NCT03993288|4095936|FG000|STARTED|Overall Study||133
3364738|NCT03993288|4095937|FG001|STARTED|Overall Study||134
3364739|NCT03993288|4095936|FG000|Intention-to-treat (ITT) Population|Overall Study||123
3364740|NCT03993288|4095937|FG001|Intention-to-treat (ITT) Population|Overall Study||129
3364741|NCT03993288|4095936|FG000|Safety Analysis Set|Overall Study||133
3364742|NCT03993288|4095937|FG001|Safety Analysis Set|Overall Study||134
3364743|NCT03993288|4095936|FG000|COMPLETED|Overall Study||123
3364744|NCT03993288|4095937|FG001|COMPLETED|Overall Study||129
3364745|NCT03993288|4095936|FG000|NOT COMPLETED|Overall Study||10
3196116|NCT02091869|3924569|FG000|STARTED|Overall Study||17
3196117|NCT02091869|3924570|FG001|STARTED|Overall Study||17
3196118|NCT02091869|3924569|FG000|COMPLETED|Overall Study||17
3196119|NCT02091869|3924570|FG001|COMPLETED|Overall Study||14
3196120|NCT02091869|3924569|FG000|NOT COMPLETED|Overall Study||0
3196121|NCT02091869|3924570|FG001|NOT COMPLETED|Overall Study||3
3196122|NCT02091882|3924576|FG000|STARTED|Overall Study||30
3196123|NCT02091882|3924576|FG000|COMPLETED|Overall Study||30
3196124|NCT02091882|3924576|FG000|NOT COMPLETED|Overall Study||0
3196125|NCT02091921|3924580|FG000|STARTED|Overall Study||53
3196126|NCT02091921|3924580|FG000|COMPLETED|Overall Study||50
3196127|NCT02091921|3924580|FG000|NOT COMPLETED|Overall Study||3
3196128|NCT02091986|3924590|FG000|STARTED|Overall Study||92
3196129|NCT02091986|3924591|FG001|STARTED|Overall Study||95
3196130|NCT02091986|3924592|FG002|STARTED|Overall Study||92
3196131|NCT02091986|3924590|FG000|COMPLETED|Overall Study||85
3196132|NCT02091986|3924591|FG001|COMPLETED|Overall Study||84
3196133|NCT02091986|3924592|FG002|COMPLETED|Overall Study||84
3196134|NCT02091986|3924590|FG000|NOT COMPLETED|Overall Study||7
3196135|NCT02091986|3924591|FG001|NOT COMPLETED|Overall Study||11
3196136|NCT02091986|3924592|FG002|NOT COMPLETED|Overall Study||8
3196137|NCT02092025|3924600|FG000|STARTED|Overall Study||3437
3196138|NCT02092025|3924600|FG000|COMPLETED|Overall Study||3369
3196139|NCT02092025|3924600|FG000|NOT COMPLETED|Overall Study||68
3196140|NCT02092116|3924606|FG000|STARTED|Overall Study||6
3196141|NCT02092116|3924607|FG001|STARTED|Overall Study||20
3196142|NCT02092116|3924606|FG000|COMPLETED|Overall Study||6
3196143|NCT02092116|3924607|FG001|COMPLETED|Overall Study||16
3196144|NCT02092116|3924606|FG000|NOT COMPLETED|Overall Study||0
3196145|NCT02092116|3924607|FG001|NOT COMPLETED|Overall Study||4
3196146|NCT02092168|3924615|FG000|STARTED|Overall Study||12
3196147|NCT02092168|3924616|FG001|STARTED|Overall Study||12
3196148|NCT02092168|3924615|FG000|COMPLETED|Overall Study||12
3196149|NCT02092168|3924616|FG001|COMPLETED|Overall Study||12
3196150|NCT02092168|3924615|FG000|NOT COMPLETED|Overall Study||0
3196151|NCT02092168|3924616|FG001|NOT COMPLETED|Overall Study||0
3196152|NCT02092181|3924624|FG000|STARTED|Overall Study||15
3196153|NCT02092181|3924625|FG001|STARTED|Overall Study||15
3196154|NCT02092181|3924624|FG000|COMPLETED|Overall Study||12
3196155|NCT02092181|3924625|FG001|COMPLETED|Overall Study||14
3196156|NCT02092181|3924624|FG000|NOT COMPLETED|Overall Study||3
3196157|NCT02092181|3924625|FG001|NOT COMPLETED|Overall Study||1
3196158|NCT02092220|3924631|FG000|STARTED|Period 1||21
3196159|NCT02092220|3924632|FG001|STARTED|Period 1||22
3196160|NCT02092220|3924631|FG000|COMPLETED|Period 1||21
3196161|NCT02092220|3924632|FG001|COMPLETED|Period 1||20
3196162|NCT02092220|3924631|FG000|NOT COMPLETED|Period 1||0
3196163|NCT02092220|3924632|FG001|NOT COMPLETED|Period 1||2
3196164|NCT02092220|3924631|FG000|STARTED|Period 2||21
3196165|NCT02092220|3924632|FG001|STARTED|Period 2||20
3196166|NCT02092220|3924631|FG000|COMPLETED|Period 2||20
3196167|NCT02092220|3924632|FG001|COMPLETED|Period 2||19
3196168|NCT02092220|3924631|FG000|NOT COMPLETED|Period 2||1
3196169|NCT02092220|3924632|FG001|NOT COMPLETED|Period 2||1
3196170|NCT02092285|3924640|FG000|STARTED|Induction Phase||205
3196171|NCT02092285|3924640|FG000|COMPLETED|Induction Phase||170
3196172|NCT02092285|3924640|FG000|NOT COMPLETED|Induction Phase||35
3196173|NCT02092285|3924640|FG000|STARTED|Maintenance Phase & Follow-up||170
3196174|NCT02092285|3924640|FG000|COMPLETED|Maintenance Phase & Follow-up||60
3196175|NCT02092285|3924640|FG000|NOT COMPLETED|Maintenance Phase & Follow-up||110
3196176|NCT02092298|3924644|FG000|STARTED|Overall Study||19
3196177|NCT02092298|3924644|FG000|COMPLETED|Overall Study||19
3196178|NCT02092298|3924644|FG000|NOT COMPLETED|Overall Study||0
3196179|NCT02092311|3924650|FG000|STARTED|Overall Study||285
3196180|NCT02092311|3924651|FG001|STARTED|Overall Study||285
3196181|NCT02092311|3924650|FG000|COMPLETED|Overall Study||285
3196182|NCT02092311|3924651|FG001|COMPLETED|Overall Study||285
3196183|NCT02092311|3924650|FG000|NOT COMPLETED|Overall Study||0
3196184|NCT02092311|3924651|FG001|NOT COMPLETED|Overall Study||0
3196185|NCT02092324|3924659|FG000|STARTED|Overall Study||51
3196186|NCT02092324|3924659|FG000|End of Cycle 6|Overall Study|This study has an accrual goal of 25 evaluable subjects who reach cycle 7, week 1.|25
3196187|NCT02092324|3924659|FG000|Wildtype CSF3R|Overall Study||23
3196188|NCT02092324|3924659|FG000|Mutant CSF3R|Overall Study||26
3196189|NCT02092324|3924659|FG000|COMPLETED|Overall Study||32
3196190|NCT02092324|3924659|FG000|NOT COMPLETED|Overall Study||19
3196191|NCT02092350|3924668|FG000|STARTED|Overall Study||123
3196192|NCT02092350|3924669|FG001|STARTED|Overall Study||114
3196193|NCT02092350|3924668|FG000|COMPLETED|Overall Study||113
3196194|NCT02092350|3924669|FG001|COMPLETED|Overall Study||102
3196195|NCT02092350|3924668|FG000|NOT COMPLETED|Overall Study||10
3196196|NCT02092350|3924669|FG001|NOT COMPLETED|Overall Study||12
3196197|NCT02092389|3924677|FG000|STARTED|Overall Study||10
3196198|NCT02092389|3924677|FG000|COMPLETED|Overall Study||4
3196199|NCT02092389|3924677|FG000|NOT COMPLETED|Overall Study||6
3196200|NCT02092415|3924681|FG000|STARTED|Overall Study||10
3196201|NCT02092415|3924681|FG000|COMPLETED|Overall Study||10
3196202|NCT02092415|3924681|FG000|NOT COMPLETED|Overall Study||0
3196203|NCT02092441|3924688|FG000|STARTED|Overall Study||37
3196204|NCT02092441|3924689|FG001|STARTED|Overall Study||43
3196205|NCT02092441|3924688|FG000|COMPLETED|Overall Study||37
3196206|NCT02092441|3924689|FG001|COMPLETED|Overall Study||43
3196207|NCT02092441|3924688|FG000|NOT COMPLETED|Overall Study||0
3196208|NCT02092441|3924689|FG001|NOT COMPLETED|Overall Study||0
3196209|NCT02092467|3924698|FG000|STARTED|Overall Study||1457
3196210|NCT02092467|3924699|FG001|STARTED|Overall Study||1457
3196211|NCT02092467|3924700|FG002|STARTED|Overall Study||1458
3196212|NCT02092467|3924698|FG000|Treated|Overall Study||1455
3196213|NCT02092467|3924699|FG001|Treated|Overall Study||1456
3196214|NCT02092467|3924700|FG002|Treated|Overall Study||1451
3196215|NCT02092467|3924698|FG000|COMPLETED|Overall Study||1053
3196216|NCT02092467|3924699|FG001|COMPLETED|Overall Study||998
3196217|NCT02092467|3924700|FG002|COMPLETED|Overall Study||1060
3196218|NCT02092467|3924698|FG000|NOT COMPLETED|Overall Study||404
3196219|NCT02092467|3924699|FG001|NOT COMPLETED|Overall Study||459
3196220|NCT02092467|3924700|FG002|NOT COMPLETED|Overall Study||398
3196221|NCT02092610|3924712|FG000|STARTED|Overall Study||25
3196222|NCT02092610|3924713|FG001|STARTED|Overall Study||52
3196223|NCT02092610|3924712|FG000|COMPLETED|Overall Study||17
3196224|NCT02092610|3924713|FG001|COMPLETED|Overall Study||40
3196225|NCT02092610|3924712|FG000|NOT COMPLETED|Overall Study||8
3196226|NCT02092610|3924713|FG001|NOT COMPLETED|Overall Study||12
3196227|NCT02092649|3924721|FG000|STARTED|Overall Study|13 participants recruited|13
3196228|NCT02092649|3924722|FG001|STARTED|Overall Study|13 participants recruited|13
3196229|NCT02092649|3924721|FG000|COMPLETED|Overall Study|13 participants finished study|13
3196230|NCT02092649|3924722|FG001|COMPLETED|Overall Study|13 participants finished study|13
3196231|NCT02092649|3924721|FG000|NOT COMPLETED|Overall Study||0
3196232|NCT02092649|3924722|FG001|NOT COMPLETED|Overall Study||0
3196233|NCT02092662|3924730|FG000|STARTED|Overall Study||38
3196234|NCT02092662|3924731|FG001|STARTED|Overall Study||19
3196235|NCT02092662|3924730|FG000|Recruited|Overall Study||38
3196236|NCT02092662|3924731|FG001|Recruited|Overall Study||19
3196237|NCT02092662|3924730|FG000|COMPLETED|Overall Study||25
3196238|NCT02092662|3924731|FG001|COMPLETED|Overall Study||19
3196239|NCT02092662|3924730|FG000|NOT COMPLETED|Overall Study||13
3196240|NCT02092662|3924731|FG001|NOT COMPLETED|Overall Study||0
3196241|NCT02092857|3924741|FG000|STARTED|Overall Study||30
3196242|NCT02092857|3924742|FG001|STARTED|Overall Study||30
3196243|NCT02092857|3924743|FG002|STARTED|Overall Study||29
3196244|NCT02092857|3924741|FG000|COMPLETED|Overall Study||20
3196245|NCT02092857|3924742|FG001|COMPLETED|Overall Study||18
3196246|NCT02092857|3924743|FG002|COMPLETED|Overall Study||16
3196247|NCT02092857|3924741|FG000|NOT COMPLETED|Overall Study||10
3196248|NCT02092857|3924742|FG001|NOT COMPLETED|Overall Study||12
3196249|NCT02092857|3924743|FG002|NOT COMPLETED|Overall Study||13
3196250|NCT02092909|3924755|FG000|STARTED|Overall Study||6
3196251|NCT02092909|3924756|FG001|STARTED|Overall Study||5
3196252|NCT02092909|3924757|FG002|STARTED|Overall Study||14
3196253|NCT02092909|3924758|FG003|STARTED|Overall Study||6
3196254|NCT02092909|3924755|FG000|COMPLETED|Overall Study||5
3196255|NCT02092909|3924756|FG001|COMPLETED|Overall Study||2
3196256|NCT02092909|3924757|FG002|COMPLETED|Overall Study||5
3196257|NCT02092909|3924758|FG003|COMPLETED|Overall Study||0
3196258|NCT02092909|3924755|FG000|NOT COMPLETED|Overall Study||1
3196259|NCT02092909|3924756|FG001|NOT COMPLETED|Overall Study||3
3196260|NCT02092909|3924757|FG002|NOT COMPLETED|Overall Study||9
3196261|NCT02092909|3924758|FG003|NOT COMPLETED|Overall Study||6
3196262|NCT02092961|3924771|FG000|STARTED|Overall Study|Patients who received treatment|33
3196263|NCT02092961|3924772|FG001|STARTED|Overall Study|Patients who received treatment|28
3196264|NCT02092961|3924773|FG002|STARTED|Overall Study|Patients who received treatment|29
3196265|NCT02092961|3924771|FG000|Randomised But Did Not Receive Treatment|Overall Study|Study stopped|1
3196266|NCT02092961|3924772|FG001|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/study stopped|5
3196267|NCT02092961|3924773|FG002|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled|1
3196268|NCT02092961|3924771|FG000|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|12
3196269|NCT02092961|3924772|FG001|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|14
3196270|NCT02092961|3924773|FG002|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|13
3196271|NCT02092961|3924771|FG000|NOT COMPLETED|Overall Study||21
3196272|NCT02092961|3924772|FG001|NOT COMPLETED|Overall Study||14
3196273|NCT02092961|3924773|FG002|NOT COMPLETED|Overall Study||16
3196274|NCT02092987|3924784|FG000|STARTED|Overall Study||110
3196275|NCT02092987|3924785|FG001|STARTED|Overall Study||111
3196276|NCT02092987|3924784|FG000|COMPLETED|Overall Study||106
3196277|NCT02092987|3924785|FG001|COMPLETED|Overall Study||103
3196278|NCT02092987|3924784|FG000|NOT COMPLETED|Overall Study||4
3196279|NCT02092987|3924785|FG001|NOT COMPLETED|Overall Study||8
3196280|NCT02093026|3924794|FG000|STARTED|Overall Study||465
3196281|NCT02093026|3924794|FG000|COMPLETED|Overall Study|At predefined end-of-treatment date, 272 ongoing participants were designated as completed study.|272
3196282|NCT02093026|3924794|FG000|NOT COMPLETED|Overall Study||193
3196283|NCT02093221|3924804|FG000|STARTED|Overall Study||15
3196284|NCT02093221|3924805|FG001|STARTED|Overall Study||16
3196285|NCT02093221|3924806|FG002|STARTED|Overall Study||15
3196286|NCT02093221|3924807|FG003|STARTED|Overall Study||15
3196287|NCT02093221|3924808|FG004|STARTED|Overall Study||15
3196288|NCT02093221|3924804|FG000|COMPLETED|Overall Study||5
3196289|NCT02093221|3924805|FG001|COMPLETED|Overall Study||8
3196290|NCT02093221|3924806|FG002|COMPLETED|Overall Study||6
3196291|NCT02093221|3924807|FG003|COMPLETED|Overall Study||7
3196292|NCT02093221|3924808|FG004|COMPLETED|Overall Study||7
3196293|NCT02093221|3924804|FG000|NOT COMPLETED|Overall Study||10
3196294|NCT02093221|3924805|FG001|NOT COMPLETED|Overall Study||8
3196295|NCT02093221|3924806|FG002|NOT COMPLETED|Overall Study||9
3196296|NCT02093221|3924807|FG003|NOT COMPLETED|Overall Study||8
3196297|NCT02093221|3924808|FG004|NOT COMPLETED|Overall Study||8
3196298|NCT02093234|3924823|FG000|STARTED|Overall Study||56
3196299|NCT02093234|3924824|FG001|STARTED|Overall Study||56
3196300|NCT02093234|3924825|FG002|STARTED|Overall Study||54
3196301|NCT02093234|3924823|FG000|COMPLETED|Overall Study||53
3196302|NCT02093234|3924824|FG001|COMPLETED|Overall Study||52
3196303|NCT02093234|3924825|FG002|COMPLETED|Overall Study||50
3196304|NCT02093234|3924823|FG000|NOT COMPLETED|Overall Study||3
3196305|NCT02093234|3924824|FG001|NOT COMPLETED|Overall Study||4
3196306|NCT02093234|3924825|FG002|NOT COMPLETED|Overall Study||4
3196307|NCT02093351|3924836|FG000|STARTED|Part A||30
3196308|NCT02093351|3924837|FG001|STARTED|Part A||23
3196309|NCT02093351|3924838|FG002|STARTED|Part A||26
3196310|NCT02093351|3924839|FG003|STARTED|Part A||0
3196311|NCT02093351|3924836|FG000|Completing Treatment Period 1|Part A||29
3196312|NCT02093351|3924837|FG001|Completing Treatment Period 1|Part A||22
3196313|NCT02093351|3924838|FG002|Completing Treatment Period 1|Part A||23
3196314|NCT02093351|3924839|FG003|Completing Treatment Period 1|Part A||0
3196315|NCT02093351|3924836|FG000|Completing Treatment Period 2|Part A||29
3196316|NCT02093351|3924837|FG001|Completing Treatment Period 2|Part A||21
3196317|NCT02093351|3924838|FG002|Completing Treatment Period 2|Part A||23
3196318|NCT02093351|3924839|FG003|Completing Treatment Period 2|Part A||0
3196319|NCT02093351|3924836|FG000|Completing Treatment Period 3|Part A||28
3196320|NCT02093351|3924837|FG001|Completing Treatment Period 3|Part A||21
3196321|NCT02093351|3924838|FG002|Completing Treatment Period 3|Part A||23
3196322|NCT02093351|3924839|FG003|Completing Treatment Period 3|Part A||0
3196323|NCT02093351|3924836|FG000|COMPLETED|Part A||28
3196324|NCT02093351|3924837|FG001|COMPLETED|Part A||21
3196325|NCT02093351|3924838|FG002|COMPLETED|Part A||23
3196326|NCT02093351|3924839|FG003|COMPLETED|Part A||0
3196327|NCT02093351|3924836|FG000|NOT COMPLETED|Part A||2
3196328|NCT02093351|3924837|FG001|NOT COMPLETED|Part A||2
3196329|NCT02093351|3924838|FG002|NOT COMPLETED|Part A||3
3196330|NCT02093351|3924839|FG003|NOT COMPLETED|Part A||0
3196331|NCT02093351|3924836|FG000|STARTED|Part B|Only the Olaparib (Part B) arm is applicable for this period.|0
3196332|NCT02093351|3924837|FG001|STARTED|Part B|Only the Olaparib (Part B) arm is applicable for this period.|0
3196333|NCT02093351|3924838|FG002|STARTED|Part B|Only the Olaparib (Part B) arm is applicable for this period.|0
3196334|NCT02093351|3924839|FG003|STARTED|Part B|Eligible patients completing Part A entered Part B for continued access to olaparib.|69
3196335|NCT02093351|3924836|FG000|COMPLETED|Part B||0
3196336|NCT02093351|3924837|FG001|COMPLETED|Part B||0
3196337|NCT02093351|3924838|FG002|COMPLETED|Part B||0
3196338|NCT02093351|3924839|FG003|COMPLETED|Part B||6
3196339|NCT02093351|3924836|FG000|NOT COMPLETED|Part B||0
3196340|NCT02093351|3924837|FG001|NOT COMPLETED|Part B||0
3196341|NCT02093351|3924838|FG002|NOT COMPLETED|Part B||0
3196342|NCT02093351|3924839|FG003|NOT COMPLETED|Part B||63
3196343|NCT02093390|3924856|FG000|STARTED|Overall Study||20
3196344|NCT02093390|3924857|FG001|STARTED|Overall Study||20
3196345|NCT02093390|3924856|FG000|COMPLETED|Overall Study||20
3196346|NCT02093390|3924857|FG001|COMPLETED|Overall Study||19
3196347|NCT02093390|3924856|FG000|NOT COMPLETED|Overall Study||0
3196348|NCT02093390|3924857|FG001|NOT COMPLETED|Overall Study||1
3196349|NCT02093520|3924866|FG000|STARTED|Overall Study||149
3196350|NCT02093520|3924867|FG001|STARTED|Overall Study||153
3196351|NCT02093520|3924866|FG000|COMPLETED|Overall Study||143
3196352|NCT02093520|3924867|FG001|COMPLETED|Overall Study||131
3196353|NCT02093520|3924866|FG000|NOT COMPLETED|Overall Study||6
3196354|NCT02093520|3924867|FG001|NOT COMPLETED|Overall Study||22
3196355|NCT02093663|3924873|FG000|STARTED|Double Blind Acute Phase (8 Weeks)||27
3196356|NCT02093663|3924874|FG001|STARTED|Double Blind Acute Phase (8 Weeks)||26
3196357|NCT02093663|3924875|FG002|STARTED|Double Blind Acute Phase (8 Weeks)||0
3196358|NCT02093663|3924876|FG003|STARTED|Double Blind Acute Phase (8 Weeks)||0
3196359|NCT02093663|3924877|FG004|STARTED|Double Blind Acute Phase (8 Weeks)||0
3196360|NCT02093663|3924873|FG000|COMPLETED|Double Blind Acute Phase (8 Weeks)||19
3196361|NCT02093663|3924874|FG001|COMPLETED|Double Blind Acute Phase (8 Weeks)||22
3196362|NCT02093663|3924875|FG002|COMPLETED|Double Blind Acute Phase (8 Weeks)||0
3196363|NCT02093663|3924876|FG003|COMPLETED|Double Blind Acute Phase (8 Weeks)||0
3196364|NCT02093663|3924877|FG004|COMPLETED|Double Blind Acute Phase (8 Weeks)||0
3196365|NCT02093663|3924873|FG000|NOT COMPLETED|Double Blind Acute Phase (8 Weeks)||8
3196366|NCT02093663|3924874|FG001|NOT COMPLETED|Double Blind Acute Phase (8 Weeks)||4
3196367|NCT02093663|3924875|FG002|NOT COMPLETED|Double Blind Acute Phase (8 Weeks)||0
3196368|NCT02093663|3924876|FG003|NOT COMPLETED|Double Blind Acute Phase (8 Weeks)||0
3196369|NCT02093663|3924877|FG004|NOT COMPLETED|Double Blind Acute Phase (8 Weeks)||0
3196370|NCT02093663|3924873|FG000|STARTED|Open Label Acute Phase (8 Weeks)||0
3196371|NCT02093663|3924874|FG001|STARTED|Open Label Acute Phase (8 Weeks)||0
3196372|NCT02093663|3924875|FG002|STARTED|Open Label Acute Phase (8 Weeks)||18
3196373|NCT02093663|3924876|FG003|STARTED|Open Label Acute Phase (8 Weeks)||0
3196374|NCT02093663|3924877|FG004|STARTED|Open Label Acute Phase (8 Weeks)||0
3196375|NCT02093663|3924873|FG000|Participants Entered OLA Via DBA|Open Label Acute Phase (8 Weeks)||0
3196376|NCT02093663|3924874|FG001|Participants Entered OLA Via DBA|Open Label Acute Phase (8 Weeks)||0
3196377|NCT02093663|3924875|FG002|Participants Entered OLA Via DBA|Open Label Acute Phase (8 Weeks)||18
3196378|NCT02093663|3924876|FG003|Participants Entered OLA Via DBA|Open Label Acute Phase (8 Weeks)||0
3196379|NCT02093663|3924877|FG004|Participants Entered OLA Via DBA|Open Label Acute Phase (8 Weeks)||0
3196380|NCT02093663|3924873|FG000|COMPLETED|Open Label Acute Phase (8 Weeks)||0
3196381|NCT02093663|3924874|FG001|COMPLETED|Open Label Acute Phase (8 Weeks)||0
3196382|NCT02093663|3924875|FG002|COMPLETED|Open Label Acute Phase (8 Weeks)||12
3196383|NCT02093663|3924876|FG003|COMPLETED|Open Label Acute Phase (8 Weeks)||0
3196384|NCT02093663|3924877|FG004|COMPLETED|Open Label Acute Phase (8 Weeks)||0
3196385|NCT02093663|3924873|FG000|NOT COMPLETED|Open Label Acute Phase (8 Weeks)||0
3196386|NCT02093663|3924874|FG001|NOT COMPLETED|Open Label Acute Phase (8 Weeks)||0
3196387|NCT02093663|3924875|FG002|NOT COMPLETED|Open Label Acute Phase (8 Weeks)||6
3196388|NCT02093663|3924876|FG003|NOT COMPLETED|Open Label Acute Phase (8 Weeks)||0
3196389|NCT02093663|3924877|FG004|NOT COMPLETED|Open Label Acute Phase (8 Weeks)||0
3196390|NCT02093663|3924873|FG000|STARTED|Double Blind Maintenance Phase(26 Weeks)||0
3196391|NCT02093663|3924874|FG001|STARTED|Double Blind Maintenance Phase(26 Weeks)||0
3196392|NCT02093663|3924875|FG002|STARTED|Double Blind Maintenance Phase(26 Weeks)||0
3196393|NCT02093663|3924876|FG003|STARTED|Double Blind Maintenance Phase(26 Weeks)||42
3196394|NCT02093663|3924877|FG004|STARTED|Double Blind Maintenance Phase(26 Weeks)||45
3196395|NCT02093663|3924873|FG000|Participants Entered Directly to DBM|Double Blind Maintenance Phase(26 Weeks)||0
3196396|NCT02093663|3924874|FG001|Participants Entered Directly to DBM|Double Blind Maintenance Phase(26 Weeks)||0
3196397|NCT02093663|3924875|FG002|Participants Entered Directly to DBM|Double Blind Maintenance Phase(26 Weeks)||0
3196398|NCT02093663|3924876|FG003|Participants Entered Directly to DBM|Double Blind Maintenance Phase(26 Weeks)||26
3196399|NCT02093663|3924877|FG004|Participants Entered Directly to DBM|Double Blind Maintenance Phase(26 Weeks)||26
3196400|NCT02093663|3924873|FG000|Participants Entered DBM Via DBA|Double Blind Maintenance Phase(26 Weeks)||0
3196401|NCT02093663|3924874|FG001|Participants Entered DBM Via DBA|Double Blind Maintenance Phase(26 Weeks)||0
3196402|NCT02093663|3924875|FG002|Participants Entered DBM Via DBA|Double Blind Maintenance Phase(26 Weeks)||0
3196403|NCT02093663|3924876|FG003|Participants Entered DBM Via DBA|Double Blind Maintenance Phase(26 Weeks)||12
3196404|NCT02093663|3924877|FG004|Participants Entered DBM Via DBA|Double Blind Maintenance Phase(26 Weeks)||15
3196405|NCT02093663|3924873|FG000|Participants Entered DBM Via OLA|Double Blind Maintenance Phase(26 Weeks)||0
3196406|NCT02093663|3924874|FG001|Participants Entered DBM Via OLA|Double Blind Maintenance Phase(26 Weeks)||0
3196407|NCT02093663|3924875|FG002|Participants Entered DBM Via OLA|Double Blind Maintenance Phase(26 Weeks)||0
3196408|NCT02093663|3924876|FG003|Participants Entered DBM Via OLA|Double Blind Maintenance Phase(26 Weeks)||4
3196409|NCT02093663|3924877|FG004|Participants Entered DBM Via OLA|Double Blind Maintenance Phase(26 Weeks)||4
3196410|NCT02093663|3924873|FG000|COMPLETED|Double Blind Maintenance Phase(26 Weeks)||0
3196411|NCT02093663|3924874|FG001|COMPLETED|Double Blind Maintenance Phase(26 Weeks)||0
3196412|NCT02093663|3924875|FG002|COMPLETED|Double Blind Maintenance Phase(26 Weeks)||0
3196413|NCT02093663|3924876|FG003|COMPLETED|Double Blind Maintenance Phase(26 Weeks)||32
3196414|NCT02093663|3924877|FG004|COMPLETED|Double Blind Maintenance Phase(26 Weeks)||34
3196415|NCT02093663|3924873|FG000|NOT COMPLETED|Double Blind Maintenance Phase(26 Weeks)||0
3196416|NCT02093663|3924874|FG001|NOT COMPLETED|Double Blind Maintenance Phase(26 Weeks)||0
3196417|NCT02093663|3924875|FG002|NOT COMPLETED|Double Blind Maintenance Phase(26 Weeks)||0
3196418|NCT02093663|3924876|FG003|NOT COMPLETED|Double Blind Maintenance Phase(26 Weeks)||10
3196419|NCT02093663|3924877|FG004|NOT COMPLETED|Double Blind Maintenance Phase(26 Weeks)||11
3196420|NCT02093702|3924896|FG000|STARTED|Overall Study||2
3196421|NCT02093702|3924897|FG001|STARTED|Overall Study||3
3196422|NCT02093702|3924896|FG000|COMPLETED|Overall Study||2
3196423|NCT02093702|3924897|FG001|COMPLETED|Overall Study||3
3196424|NCT02093702|3924896|FG000|NOT COMPLETED|Overall Study||0
3196425|NCT02093702|3924897|FG001|NOT COMPLETED|Overall Study||0
3196426|NCT02093793|3924907|FG000|STARTED|Overall Study||98
3196427|NCT02093793|3924908|FG001|STARTED|Overall Study||90
3196428|NCT02093793|3924909|FG002|STARTED|Overall Study||68
3196429|NCT02093793|3924907|FG000|COMPLETED|Overall Study||91
3196430|NCT02093793|3924908|FG001|COMPLETED|Overall Study||80
3196431|NCT02093793|3924909|FG002|COMPLETED|Overall Study||65
3196432|NCT02093793|3924907|FG000|NOT COMPLETED|Overall Study||7
3196433|NCT02093793|3924908|FG001|NOT COMPLETED|Overall Study||10
3196434|NCT02093793|3924909|FG002|NOT COMPLETED|Overall Study||3
3196435|NCT02093819|3924925|FG000|STARTED|Overall Study||15
3196436|NCT02093819|3924926|FG001|STARTED|Overall Study||6
3196437|NCT02093819|3924927|FG002|STARTED|Overall Study||10
3196438|NCT02093819|3924928|FG003|STARTED|Overall Study||6
3196439|NCT02093819|3924929|FG004|STARTED|Overall Study||6
3196440|NCT02093819|3924930|FG005|STARTED|Overall Study||6
3196441|NCT02093819|3924931|FG006|STARTED|Overall Study||5
3196442|NCT02093819|3924932|FG007|STARTED|Overall Study||6
3196443|NCT02093819|3924925|FG000|COMPLETED|Overall Study||15
3196444|NCT02093819|3924926|FG001|COMPLETED|Overall Study||6
3196445|NCT02093819|3924927|FG002|COMPLETED|Overall Study||10
3196446|NCT02093819|3924928|FG003|COMPLETED|Overall Study||6
3196447|NCT02093819|3924929|FG004|COMPLETED|Overall Study||6
3196448|NCT02093819|3924930|FG005|COMPLETED|Overall Study||6
3196449|NCT02093819|3924931|FG006|COMPLETED|Overall Study||5
3196450|NCT02093819|3924932|FG007|COMPLETED|Overall Study||6
3196451|NCT02093819|3924925|FG000|NOT COMPLETED|Overall Study||0
3196452|NCT02093819|3924926|FG001|NOT COMPLETED|Overall Study||0
3196453|NCT02093819|3924927|FG002|NOT COMPLETED|Overall Study||0
3196454|NCT02093819|3924928|FG003|NOT COMPLETED|Overall Study||0
3196455|NCT02093819|3924929|FG004|NOT COMPLETED|Overall Study||0
3196456|NCT02093819|3924930|FG005|NOT COMPLETED|Overall Study||0
3196457|NCT02093819|3924931|FG006|NOT COMPLETED|Overall Study||0
3196458|NCT02093819|3924932|FG007|NOT COMPLETED|Overall Study||0
3196459|NCT02093897|3924959|FG000|STARTED|Overall Study||84
3196460|NCT02093897|3924959|FG000|COMPLETED|Overall Study||65
3196461|NCT02093897|3924959|FG000|NOT COMPLETED|Overall Study||19
3196462|NCT02093923|3924975|FG000|STARTED|Overall Study||4
3196463|NCT02093923|3924976|FG001|STARTED|Overall Study||4
3196464|NCT02093923|3924977|FG002|STARTED|Overall Study||5
3196465|NCT02093923|3924978|FG003|STARTED|Overall Study||12
3196466|NCT02093923|3924979|FG004|STARTED|Overall Study||13
3196467|NCT02093923|3924975|FG000|Total Treated|Overall Study||4
3196468|NCT02093923|3924976|FG001|Total Treated|Overall Study||4
3196469|NCT02093923|3924977|FG002|Total Treated|Overall Study||5
3196470|NCT02093923|3924978|FG003|Total Treated|Overall Study||11
3196471|NCT02093923|3924979|FG004|Total Treated|Overall Study||13
3196472|NCT02093923|3924975|FG000|Treated - 1 Dose Only:|Overall Study||0
3196473|NCT02093923|3924976|FG001|Treated - 1 Dose Only:|Overall Study||0
3196474|NCT02093923|3924977|FG002|Treated - 1 Dose Only:|Overall Study||0
3196475|NCT02093923|3924978|FG003|Treated - 1 Dose Only:|Overall Study||1
3196476|NCT02093923|3924979|FG004|Treated - 1 Dose Only:|Overall Study||0
3196477|NCT02093923|3924975|FG000|Treated - 2 Doses:|Overall Study||4
3196478|NCT02093923|3924976|FG001|Treated - 2 Doses:|Overall Study||4
3196479|NCT02093923|3924977|FG002|Treated - 2 Doses:|Overall Study||5
3196480|NCT02093923|3924978|FG003|Treated - 2 Doses:|Overall Study||10
3196481|NCT02093923|3924979|FG004|Treated - 2 Doses:|Overall Study||13
3196482|NCT02093923|3924975|FG000|COMPLETED|Overall Study||4
3196483|NCT02093923|3924976|FG001|COMPLETED|Overall Study||4
3196484|NCT02093923|3924977|FG002|COMPLETED|Overall Study||5
3196485|NCT02093923|3924978|FG003|COMPLETED|Overall Study||10
3196486|NCT02093923|3924979|FG004|COMPLETED|Overall Study||13
3196487|NCT02093923|3924975|FG000|NOT COMPLETED|Overall Study||0
3196488|NCT02093923|3924976|FG001|NOT COMPLETED|Overall Study||0
3196489|NCT02093923|3924977|FG002|NOT COMPLETED|Overall Study||0
3196490|NCT02093923|3924978|FG003|NOT COMPLETED|Overall Study||2
3196491|NCT02093923|3924979|FG004|NOT COMPLETED|Overall Study||0
3196492|NCT02093949|3924997|FG000|STARTED|Overall Study||105
3196493|NCT02093949|3924998|FG001|STARTED|Overall Study||47
3196494|NCT02093949|3924997|FG000|COMPLETED|Overall Study||105
3196495|NCT02093949|3924998|FG001|COMPLETED|Overall Study||47
3196496|NCT02093949|3924997|FG000|NOT COMPLETED|Overall Study||0
3196497|NCT02093949|3924998|FG001|NOT COMPLETED|Overall Study||0
3196498|NCT02093962|3925014|FG000|STARTED|Overall Study||134
3196499|NCT02093962|3925015|FG001|STARTED|Overall Study||131
3196500|NCT02093962|3925014|FG000|Received Treatment|Overall Study||130
3196501|NCT02093962|3925015|FG001|Received Treatment|Overall Study||130
3196502|NCT02093962|3925014|FG000|COMPLETED|Overall Study||0
3196503|NCT02093962|3925015|FG001|COMPLETED|Overall Study||0
3196504|NCT02093962|3925014|FG000|NOT COMPLETED|Overall Study||134
3196505|NCT02093962|3925015|FG001|NOT COMPLETED|Overall Study||131
3196506|NCT02094118|3925023|FG000|STARTED|Overall Study||85
3196507|NCT02094118|3925024|FG001|STARTED|Overall Study||86
3196508|NCT02094118|3925023|FG000|COMPLETED|Overall Study||73
3196509|NCT02094118|3925024|FG001|COMPLETED|Overall Study||81
3196510|NCT02094118|3925023|FG000|NOT COMPLETED|Overall Study||12
3196511|NCT02094118|3925024|FG001|NOT COMPLETED|Overall Study||5
3196512|NCT02094300|3925034|FG000|STARTED|Overall Study||26
3196513|NCT02094300|3925034|FG000|30 Days|Overall Study||24
3196514|NCT02094300|3925034|FG000|COMPLETED|Overall Study||6
3196515|NCT02094300|3925034|FG000|NOT COMPLETED|Overall Study||20
3196516|NCT02094326|3925038|FG000|STARTED|Overall Study||301
3196517|NCT02094326|3925038|FG000|COMPLETED|Overall Study||301
3196518|NCT02094326|3925038|FG000|NOT COMPLETED|Overall Study||0
3196519|NCT02094417|3925047|FG000|STARTED|Overall Study||7
3196520|NCT02094417|3925048|FG001|STARTED|Overall Study||9
3196521|NCT02094417|3925049|FG002|STARTED|Overall Study||9
3196522|NCT02094417|3925050|FG003|STARTED|Overall Study||10
3196523|NCT02094417|3925047|FG000|COMPLETED|Overall Study||2
3196524|NCT02094417|3925048|FG001|COMPLETED|Overall Study||1
3196525|NCT02094417|3925049|FG002|COMPLETED|Overall Study||4
3196526|NCT02094417|3925050|FG003|COMPLETED|Overall Study||3
3196527|NCT02094417|3925047|FG000|NOT COMPLETED|Overall Study||5
3196528|NCT02094417|3925048|FG001|NOT COMPLETED|Overall Study||8
3196529|NCT02094417|3925049|FG002|NOT COMPLETED|Overall Study||5
3196530|NCT02094417|3925050|FG003|NOT COMPLETED|Overall Study||7
3196531|NCT02094443|3925062|FG000|STARTED|Overall Study||26
3196532|NCT02094443|3925063|FG001|STARTED|Overall Study||26
3196533|NCT02094443|3925062|FG000|Completed at Week 12|Overall Study||0
3196534|NCT02094443|3925063|FG001|Completed at Week 12|Overall Study||1
3196535|NCT02094443|3925062|FG000|Completed at Week 24|Overall Study||11
3196536|NCT02094443|3925063|FG001|Completed at Week 24|Overall Study||8
3196537|NCT02094443|3925062|FG000|COMPLETED|Overall Study||11
3196538|NCT02094443|3925063|FG001|COMPLETED|Overall Study||9
3196539|NCT02094443|3925062|FG000|NOT COMPLETED|Overall Study||15
3196540|NCT02094443|3925063|FG001|NOT COMPLETED|Overall Study||17
3196541|NCT02094534|3925071|FG000|STARTED|Overall Study||15
3196542|NCT02094534|3925072|FG001|STARTED|Overall Study||10
3196543|NCT02094534|3925071|FG000|COMPLETED|Overall Study||15
3196544|NCT02094534|3925072|FG001|COMPLETED|Overall Study||10
3196545|NCT02094534|3925071|FG000|NOT COMPLETED|Overall Study||0
3196546|NCT02094534|3925072|FG001|NOT COMPLETED|Overall Study||0
3196547|NCT02094573|3925080|FG000|STARTED|Overall Study||112
3196548|NCT02094573|3925081|FG001|STARTED|Overall Study||110
3196549|NCT02094573|3925080|FG000|Treated|Overall Study||109
3196550|NCT02094573|3925081|FG001|Treated|Overall Study||110
3196551|NCT02094573|3925080|FG000|COMPLETED|Overall Study||0
3196552|NCT02094573|3925081|FG001|COMPLETED|Overall Study||0
3196553|NCT02094573|3925080|FG000|NOT COMPLETED|Overall Study||112
3196554|NCT02094573|3925081|FG001|NOT COMPLETED|Overall Study||110
3196555|NCT02094586|3925091|FG000|STARTED|Overall Study||927
3196556|NCT02094586|3925092|FG001|STARTED|Overall Study||933
3196557|NCT02094586|3925093|FG002|STARTED|Overall Study||935
3196558|NCT02094586|3925094|FG003|STARTED|Overall Study||351
3196559|NCT02094586|3925091|FG000|COMPLETED|Overall Study||848
3196560|NCT02094586|3925092|FG001|COMPLETED|Overall Study||866
3196561|NCT02094586|3925093|FG002|COMPLETED|Overall Study||876
3196562|NCT02094586|3925094|FG003|COMPLETED|Overall Study||331
3196563|NCT02094586|3925091|FG000|NOT COMPLETED|Overall Study||79
3196564|NCT02094586|3925092|FG001|NOT COMPLETED|Overall Study||67
3196565|NCT02094586|3925093|FG002|NOT COMPLETED|Overall Study||59
3196566|NCT02094586|3925094|FG003|NOT COMPLETED|Overall Study||20
3196567|NCT02094612|3925118|FG000|STARTED|Overall Study||112
3196568|NCT02094612|3925119|FG001|STARTED|Overall Study||95
3196569|NCT02094612|3925118|FG000|1 Month Follow up|Overall Study||67
3196570|NCT02094612|3925119|FG001|1 Month Follow up|Overall Study||50
3196571|NCT02094612|3925118|FG000|3 Month Follow up|Overall Study||50
3196572|NCT02094612|3925119|FG001|3 Month Follow up|Overall Study||43
3196573|NCT02094612|3925118|FG000|6 Month Follow up|Overall Study||33
3196574|NCT02094612|3925119|FG001|6 Month Follow up|Overall Study||25
3196575|NCT02094612|3925118|FG000|COMPLETED|Overall Study||33
3196576|NCT02094612|3925119|FG001|COMPLETED|Overall Study||25
3196577|NCT02094612|3925118|FG000|NOT COMPLETED|Overall Study||79
3196578|NCT02094612|3925119|FG001|NOT COMPLETED|Overall Study||70
3196579|NCT02094664|3925127|FG000|STARTED|Overall Study||16
3196580|NCT02094664|3925128|FG001|STARTED|Overall Study||16
3196581|NCT02094664|3925127|FG000|COMPLETED|Overall Study||16
3196582|NCT02094664|3925128|FG001|COMPLETED|Overall Study||16
3196583|NCT02094664|3925127|FG000|NOT COMPLETED|Overall Study||0
3196584|NCT02094664|3925128|FG001|NOT COMPLETED|Overall Study||0
3196585|NCT02094677|3925136|FG000|STARTED|Overall Study||43
3196586|NCT02094677|3925137|FG001|STARTED|Overall Study||31
3196587|NCT02094677|3925136|FG000|COMPLETED|Overall Study||40
3196588|NCT02094677|3925137|FG001|COMPLETED|Overall Study||30
3196589|NCT02094677|3925136|FG000|NOT COMPLETED|Overall Study||3
3196590|NCT02094677|3925137|FG001|NOT COMPLETED|Overall Study||1
3196591|NCT02094716|3925153|FG000|STARTED|Overall Study||43
3196592|NCT02094716|3925154|FG001|STARTED|Overall Study||43
3196593|NCT02094716|3925155|FG002|STARTED|Overall Study||44
3196594|NCT02094716|3925153|FG000|Received Second Dose at Day 14|Overall Study||15
3196595|NCT02094716|3925154|FG001|Received Second Dose at Day 14|Overall Study||10
3196596|NCT02094716|3925155|FG002|Received Second Dose at Day 14|Overall Study||17
3196597|NCT02094716|3925153|FG000|COMPLETED|Overall Study||41
3196598|NCT02094716|3925154|FG001|COMPLETED|Overall Study||36
3196599|NCT02094716|3925155|FG002|COMPLETED|Overall Study||40
3196600|NCT02094716|3925153|FG000|NOT COMPLETED|Overall Study||2
3196601|NCT02094716|3925154|FG001|NOT COMPLETED|Overall Study||7
3196602|NCT02094716|3925155|FG002|NOT COMPLETED|Overall Study||4
3196603|NCT02094755|3925175|FG000|STARTED|Overall Study||100
3196604|NCT02094755|3925175|FG000|COMPLETED|Overall Study||100
3196605|NCT02094755|3925175|FG000|NOT COMPLETED|Overall Study||0
3196606|NCT02094872|3925179|FG000|STARTED|Overall Study||49
3196607|NCT02094872|3925179|FG000|Received Biopsy|Overall Study||37
3196608|NCT02094872|3925179|FG000|Received Tumor-board Recommendation|Overall Study|1 individual withdrew consent after biopsy.|36
3196609|NCT02094872|3925179|FG000|Received Targeted Therapy|Overall Study||20
3196610|NCT02094872|3925179|FG000|Received Standard of Care|Overall Study|7 standard-of-care patients crossed-over and received targeted therapy.|9
3196611|NCT02094872|3925179|FG000|Patients Treated With MEK162|Overall Study||20
3196612|NCT02094872|3925179|FG000|COMPLETED|Overall Study||20
3196613|NCT02094872|3925179|FG000|NOT COMPLETED|Overall Study||29
3196614|NCT02094885|3925185|FG000|STARTED|Overall Study||125
3196615|NCT02094885|3925186|FG001|STARTED|Overall Study||127
3196616|NCT02094885|3925185|FG000|COMPLETED|Overall Study||123
3196617|NCT02094885|3925186|FG001|COMPLETED|Overall Study||122
3196618|NCT02094885|3925185|FG000|NOT COMPLETED|Overall Study||2
3196619|NCT02094885|3925186|FG001|NOT COMPLETED|Overall Study||5
3196620|NCT02094898|3925192|FG000|STARTED|Overall Study||12
3196621|NCT02094898|3925192|FG000|COMPLETED|Overall Study||7
3196622|NCT02094898|3925192|FG000|NOT COMPLETED|Overall Study||5
3196623|NCT02094937|3925198|FG000|STARTED|8 Weeks in Period 1||430
3196624|NCT02094937|3925199|FG001|STARTED|8 Weeks in Period 1||0
3196625|NCT02094937|3925200|FG002|STARTED|8 Weeks in Period 1||0
3196626|NCT02094937|3925201|FG003|STARTED|8 Weeks in Period 1||0
3196627|NCT02094937|3925198|FG000|COMPLETED|8 Weeks in Period 1||370
3196628|NCT02094937|3925199|FG001|COMPLETED|8 Weeks in Period 1||0
3196629|NCT02094937|3925200|FG002|COMPLETED|8 Weeks in Period 1||0
3196630|NCT02094937|3925201|FG003|COMPLETED|8 Weeks in Period 1||0
3196631|NCT02094937|3925198|FG000|NOT COMPLETED|8 Weeks in Period 1||60
3196632|NCT02094937|3925199|FG001|NOT COMPLETED|8 Weeks in Period 1||0
3196633|NCT02094937|3925200|FG002|NOT COMPLETED|8 Weeks in Period 1||0
3196634|NCT02094937|3925201|FG003|NOT COMPLETED|8 Weeks in Period 1||0
3196635|NCT02094937|3925198|FG000|STARTED|12 Weeks in Period 2||0
3196636|NCT02094937|3925199|FG001|STARTED|12 Weeks in Period 2||123
3196637|NCT02094937|3925200|FG002|STARTED|12 Weeks in Period 2||124
3196638|NCT02094937|3925201|FG003|STARTED|12 Weeks in Period 2||124
3196639|NCT02094937|3925198|FG000|COMPLETED|12 Weeks in Period 2||0
3196640|NCT02094937|3925199|FG001|COMPLETED|12 Weeks in Period 2||112
3196641|NCT02094937|3925200|FG002|COMPLETED|12 Weeks in Period 2||112
3196642|NCT02094937|3925201|FG003|COMPLETED|12 Weeks in Period 2||112
3196643|NCT02094937|3925198|FG000|NOT COMPLETED|12 Weeks in Period 2||0
3196644|NCT02094937|3925199|FG001|NOT COMPLETED|12 Weeks in Period 2||11
3196645|NCT02094937|3925200|FG002|NOT COMPLETED|12 Weeks in Period 2||12
3196646|NCT02094937|3925201|FG003|NOT COMPLETED|12 Weeks in Period 2||12
3196647|NCT02095106|3925212|FG000|STARTED|First Intervention (14 Days)||14
3196648|NCT02095106|3925213|FG001|STARTED|First Intervention (14 Days)||13
3196649|NCT02095106|3925212|FG000|COMPLETED|First Intervention (14 Days)||14
3196650|NCT02095106|3925213|FG001|COMPLETED|First Intervention (14 Days)||13
3196651|NCT02095106|3925212|FG000|NOT COMPLETED|First Intervention (14 Days)||0
3196652|NCT02095106|3925213|FG001|NOT COMPLETED|First Intervention (14 Days)||0
3196653|NCT02095106|3925212|FG000|STARTED|Second Intervention (14 Days)||14
3196654|NCT02095106|3925213|FG001|STARTED|Second Intervention (14 Days)||13
3196655|NCT02095106|3925212|FG000|COMPLETED|Second Intervention (14 Days)||14
3196656|NCT02095106|3925213|FG001|COMPLETED|Second Intervention (14 Days)||12
3196657|NCT02095106|3925212|FG000|NOT COMPLETED|Second Intervention (14 Days)||0
3196658|NCT02095106|3925213|FG001|NOT COMPLETED|Second Intervention (14 Days)||1
3196659|NCT02095145|3925225|FG000|STARTED|Overall Study||15
3196660|NCT02095145|3925226|FG001|STARTED|Overall Study||15
3196661|NCT02095145|3925225|FG000|COMPLETED|Overall Study||14
3196662|NCT02095145|3925226|FG001|COMPLETED|Overall Study||15
3196663|NCT02095145|3925225|FG000|NOT COMPLETED|Overall Study||1
3196664|NCT02095145|3925226|FG001|NOT COMPLETED|Overall Study||0
3196665|NCT02095158|3925234|FG000|STARTED|Overall Study||440
3196666|NCT02095158|3925234|FG000|COMPLETED|Overall Study||365
3196667|NCT02095158|3925234|FG000|NOT COMPLETED|Overall Study||75
3196668|NCT02095197|3925240|FG000|STARTED|Overall Study||40
3196669|NCT02095197|3925241|FG001|STARTED|Overall Study||39
3196670|NCT02095197|3925240|FG000|COMPLETED|Overall Study||40
3196671|NCT02095197|3925241|FG001|COMPLETED|Overall Study||36
3196672|NCT02095197|3925240|FG000|NOT COMPLETED|Overall Study||0
3196673|NCT02095197|3925241|FG001|NOT COMPLETED|Overall Study||3
3196674|NCT02095223|3925249|FG000|STARTED|Overall Study||2
3196675|NCT02095223|3925250|FG001|STARTED|Overall Study||2
3196676|NCT02095223|3925249|FG000|COMPLETED|Overall Study|1 participant dropped out of this study due to the time commitment associated with participation.|1
3196677|NCT02095223|3925250|FG001|COMPLETED|Overall Study||2
3196678|NCT02095223|3925249|FG000|NOT COMPLETED|Overall Study||1
3196679|NCT02095223|3925250|FG001|NOT COMPLETED|Overall Study||0
3196680|NCT02095340|3925259|FG000|STARTED|Overall Study|Mother (not the child) received the training.|51
3196681|NCT02095340|3925260|FG001|STARTED|Overall Study|Mother (not the child) received the training.|54
3196682|NCT02095340|3925261|FG002|STARTED|Overall Study||105
3196683|NCT02095340|3925259|FG000|COMPLETED|Overall Study||51
3196684|NCT02095340|3925260|FG001|COMPLETED|Overall Study||54
3196685|NCT02095340|3925261|FG002|COMPLETED|Overall Study||105
3196686|NCT02095340|3925259|FG000|NOT COMPLETED|Overall Study||0
3196687|NCT02095340|3925260|FG001|NOT COMPLETED|Overall Study||0
3196688|NCT02095340|3925261|FG002|NOT COMPLETED|Overall Study||0
3196689|NCT02095535|3925270|FG000|STARTED|Recruitment||20
3196690|NCT02095535|3925270|FG000|COMPLETED|Recruitment||18
3196691|NCT02095535|3925270|FG000|NOT COMPLETED|Recruitment||2
3196692|NCT02095535|3925270|FG000|STARTED|Analysis||18
3196693|NCT02095535|3925270|FG000|COMPLETED|Analysis||18
3196694|NCT02095535|3925270|FG000|NOT COMPLETED|Analysis||0
3196695|NCT02095561|3925276|FG000|STARTED|Overall Study||3049
3196696|NCT02095561|3925277|FG001|STARTED|Overall Study||2964
3196697|NCT02095561|3925276|FG000|Self-testing Acceptability|Overall Study||2616
3196698|NCT02095561|3925277|FG001|Self-testing Acceptability|Overall Study|Acceptablity only applies to the group of women being offered self-testing.|0
3196699|NCT02095561|3925276|FG000|HPV Self-tested Women|Overall Study||2519
3196700|NCT02095561|3925277|FG001|HPV Self-tested Women|Overall Study|HPV self-testing only applies to the HPV self-testing arm|0
3196701|NCT02095561|3925276|FG000|HPV Tested at Health Centers|Overall Study||99
3196702|NCT02095561|3925277|FG001|HPV Tested at Health Centers|Overall Study||599
3196703|NCT02095561|3925276|FG000|COMPLETED|Overall Study|All women are part of the study, independently of whether they were tested or not.|3049
3196704|NCT02095561|3925277|FG001|COMPLETED|Overall Study|All women are part of the study, independently of whether they were tested or not.|2964
3196705|NCT02095561|3925276|FG000|NOT COMPLETED|Overall Study||0
3196706|NCT02095561|3925277|FG001|NOT COMPLETED|Overall Study||0
3196707|NCT02095678|3925285|FG000|STARTED|Overall Study||34
3196708|NCT02095678|3925286|FG001|STARTED|Overall Study||18
3196709|NCT02095678|3925285|FG000|COMPLETED|Overall Study||17
3196710|NCT02095678|3925286|FG001|COMPLETED|Overall Study||0
3196711|NCT02095678|3925285|FG000|NOT COMPLETED|Overall Study||17
3196712|NCT02095678|3925286|FG001|NOT COMPLETED|Overall Study||18
3196713|NCT02095691|3925295|FG000|STARTED|Overall Study|Subjects who were consented and treated with study ablation catheter.|19
3196714|NCT02095691|3925295|FG000|COMPLETED|Overall Study|Subjects with follow up available at 12 months.|18
3196715|NCT02095691|3925295|FG000|NOT COMPLETED|Overall Study||1
3196716|NCT02095873|3925313|FG000|STARTED|First Intervention (8 Weeks)||16
3196717|NCT02095873|3925314|FG001|STARTED|First Intervention (8 Weeks)||16
3196718|NCT02095873|3925313|FG000|COMPLETED|First Intervention (8 Weeks)||15
3196719|NCT02095873|3925314|FG001|COMPLETED|First Intervention (8 Weeks)||16
3196720|NCT02095873|3925313|FG000|NOT COMPLETED|First Intervention (8 Weeks)||1
3196721|NCT02095873|3925314|FG001|NOT COMPLETED|First Intervention (8 Weeks)||0
3196722|NCT02095873|3925313|FG000|STARTED|Second Intervention (8 Weeks)||15
3196723|NCT02095873|3925314|FG001|STARTED|Second Intervention (8 Weeks)||16
3196724|NCT02095873|3925313|FG000|COMPLETED|Second Intervention (8 Weeks)||13
3196725|NCT02095873|3925314|FG001|COMPLETED|Second Intervention (8 Weeks)||16
3196726|NCT02095873|3925313|FG000|NOT COMPLETED|Second Intervention (8 Weeks)||2
3196727|NCT02095873|3925314|FG001|NOT COMPLETED|Second Intervention (8 Weeks)||0
3196728|NCT02095951|3925324|FG000|STARTED|Overall Study|2 participants with 4 episodes of catheter infection was enrolled twice in this group.|13
3196729|NCT02095951|3925325|FG001|STARTED|Overall Study|1 participant with 2 episodes of catheter infection was enrolled twice in this group.|14
3196730|NCT02095951|3925324|FG000|COMPLETED|Overall Study||4
3196731|NCT02095951|3925325|FG001|COMPLETED|Overall Study||8
3196732|NCT02095951|3925324|FG000|NOT COMPLETED|Overall Study||9
3196733|NCT02095951|3925325|FG001|NOT COMPLETED|Overall Study||6
3196734|NCT02096003|3925337|FG000|STARTED|Overall Study||40
3196735|NCT02096003|3925338|FG001|STARTED|Overall Study||40
3196736|NCT02096003|3925337|FG000|COMPLETED|Overall Study||38
3196737|NCT02096003|3925338|FG001|COMPLETED|Overall Study||37
3196738|NCT02096003|3925337|FG000|NOT COMPLETED|Overall Study||2
3196739|NCT02096003|3925338|FG001|NOT COMPLETED|Overall Study||3
3196740|NCT02096029|3925346|FG000|STARTED|Overall Study||652
3196741|NCT02096029|3925347|FG001|STARTED|Overall Study||593
3196742|NCT02096029|3925346|FG000|COMPLETED|Overall Study||652
3196743|NCT02096029|3925347|FG001|COMPLETED|Overall Study||593
3196744|NCT02096029|3925346|FG000|NOT COMPLETED|Overall Study||0
3196745|NCT02096029|3925347|FG001|NOT COMPLETED|Overall Study||0
3196746|NCT02096081|3925355|FG000|STARTED|Overall Study||122
3196747|NCT02096081|3925356|FG001|STARTED|Overall Study||128
3196748|NCT02096081|3925355|FG000|COMPLETED|Overall Study||119
3196749|NCT02096081|3925356|FG001|COMPLETED|Overall Study||124
3196750|NCT02096081|3925355|FG000|NOT COMPLETED|Overall Study||3
3196751|NCT02096081|3925356|FG001|NOT COMPLETED|Overall Study||4
3196752|NCT02096107|3925364|FG000|STARTED|Overall Study||30
3196753|NCT02096107|3925365|FG001|STARTED|Overall Study||30
3196754|NCT02096107|3925364|FG000|COMPLETED|Overall Study||30
3196755|NCT02096107|3925365|FG001|COMPLETED|Overall Study||30
3196756|NCT02096107|3925364|FG000|NOT COMPLETED|Overall Study||0
3196757|NCT02096107|3925365|FG001|NOT COMPLETED|Overall Study||0
3196758|NCT02096263|3925374|FG000|STARTED|Overall Study||195
3196759|NCT02096263|3925375|FG001|STARTED|Overall Study||194
3196760|NCT02096263|3925376|FG002|STARTED|Overall Study||196
3196761|NCT02096263|3925374|FG000|COMPLETED|Overall Study||161
3196762|NCT02096263|3925375|FG001|COMPLETED|Overall Study||158
3196763|NCT02096263|3925376|FG002|COMPLETED|Overall Study||157
3196764|NCT02096263|3925374|FG000|NOT COMPLETED|Overall Study||34
3196765|NCT02096263|3925375|FG001|NOT COMPLETED|Overall Study||36
3196766|NCT02096263|3925376|FG002|NOT COMPLETED|Overall Study||39
3196767|NCT02096276|3925386|FG000|STARTED|Overall Study||250
3196768|NCT02096276|3925387|FG001|STARTED|Overall Study||55
3196769|NCT02096276|3925386|FG000|COMPLETED|Overall Study||250
3196770|NCT02096276|3925387|FG001|COMPLETED|Overall Study||55
3196771|NCT02096276|3925386|FG000|NOT COMPLETED|Overall Study||0
3196772|NCT02096276|3925387|FG001|NOT COMPLETED|Overall Study||0
3196773|NCT02096458|3925393|FG000|STARTED|Overall Study||8
3196774|NCT02096458|3925393|FG000|COMPLETED|Overall Study||8
3196775|NCT02096458|3925393|FG000|NOT COMPLETED|Overall Study||0
3196776|NCT02096471|3925397|FG000|STARTED|Overall Study||19
3196777|NCT02096471|3925397|FG000|COMPLETED|Overall Study|Participants terminated the study if a partial response was not achieved and/or maintained.|6
3196778|NCT02096471|3925397|FG000|NOT COMPLETED|Overall Study||13
3196779|NCT02096575|3925403|FG000|STARTED|Overall Study||68
3196780|NCT02096575|3925404|FG001|STARTED|Overall Study||67
3196781|NCT02096575|3925405|FG002|STARTED|Overall Study||5
3196782|NCT02096575|3925403|FG000|COMPLETED|Overall Study||68
3196783|NCT02096575|3925404|FG001|COMPLETED|Overall Study||67
3196784|NCT02096575|3925405|FG002|COMPLETED|Overall Study||0
3196785|NCT02096575|3925403|FG000|NOT COMPLETED|Overall Study||0
3196786|NCT02096575|3925404|FG001|NOT COMPLETED|Overall Study||0
3196787|NCT02096575|3925405|FG002|NOT COMPLETED|Overall Study||5
3196788|NCT02096588|3925414|FG000|STARTED|Overall Study||15
3196789|NCT02096588|3925415|FG001|STARTED|Overall Study||16
3364746|NCT03993288|4095937|FG001|NOT COMPLETED|Overall Study||5
3364747|NCT03990298|4095943|FG000|STARTED|Overall Study||16
3364748|NCT03990298|4095943|FG000|COMPLETED|Overall Study||16
3364749|NCT03990298|4095943|FG000|NOT COMPLETED|Overall Study||0
3364750|NCT03988647|4095947|FG000|STARTED|Overall Study||1
3364751|NCT03988647|4095947|FG000|COMPLETED|Overall Study||1
3364752|NCT03988647|4095947|FG000|NOT COMPLETED|Overall Study||0
3364753|NCT03979872|4095955|FG000|STARTED|Overall Study||22
3364754|NCT03979872|4095956|FG001|STARTED|Overall Study||23
3364755|NCT03979872|4095957|FG002|STARTED|Overall Study||24
3364756|NCT03979872|4095958|FG003|STARTED|Overall Study||23
3364757|NCT03979872|4095955|FG000|COMPLETED|Overall Study||19
3364758|NCT03979872|4095956|FG001|COMPLETED|Overall Study||15
3364759|NCT03979872|4095957|FG002|COMPLETED|Overall Study||18
3364760|NCT03979872|4095958|FG003|COMPLETED|Overall Study||19
3196790|NCT02096588|3925414|FG000|COMPLETED|Overall Study||13
3196791|NCT02096588|3925415|FG001|COMPLETED|Overall Study||15
3196792|NCT02096588|3925414|FG000|NOT COMPLETED|Overall Study||2
3196793|NCT02096588|3925415|FG001|NOT COMPLETED|Overall Study||1
3196794|NCT02096679|3925421|FG000|STARTED|Overall Study||8
3196795|NCT02096679|3925421|FG000|COMPLETED|Overall Study||8
3196796|NCT02096679|3925421|FG000|NOT COMPLETED|Overall Study||0
3196797|NCT02096692|3925425|FG000|STARTED|Overall Study||154
3196798|NCT02096692|3925425|FG000|COMPLETED|Overall Study||150
3196799|NCT02096692|3925425|FG000|NOT COMPLETED|Overall Study||4
3196800|NCT02096705|3925431|FG000|STARTED|Treatment||133
3196801|NCT02096705|3925432|FG001|STARTED|Treatment||139
3196802|NCT02096705|3925431|FG000|COMPLETED|Treatment||124
3196803|NCT02096705|3925432|FG001|COMPLETED|Treatment||134
3196804|NCT02096705|3925431|FG000|NOT COMPLETED|Treatment||9
3196805|NCT02096705|3925432|FG001|NOT COMPLETED|Treatment||5
3196806|NCT02096705|3925431|FG000|STARTED|Follow-up|5 participants in this arm did not complete the treatment period and rejoined for follow-up|129
3196807|NCT02096705|3925432|FG001|STARTED|Follow-up|5 participants in this arm did not complete the treatment period and rejoined for follow-up|139
3196808|NCT02096705|3925431|FG000|COMPLETED|Follow-up||125
3196809|NCT02096705|3925432|FG001|COMPLETED|Follow-up||135
3196810|NCT02096705|3925431|FG000|NOT COMPLETED|Follow-up||4
3196811|NCT02096705|3925432|FG001|NOT COMPLETED|Follow-up||4
3196812|NCT02096718|3925441|FG000|STARTED|Overall Study||8
3196813|NCT02096718|3925442|FG001|STARTED|Overall Study||8
3196814|NCT02096718|3925443|FG002|STARTED|Overall Study||14
3196815|NCT02096718|3925441|FG000|COMPLETED|Overall Study||8
3196816|NCT02096718|3925442|FG001|COMPLETED|Overall Study||8
3196817|NCT02096718|3925443|FG002|COMPLETED|Overall Study||14
3196818|NCT02096718|3925441|FG000|NOT COMPLETED|Overall Study||0
3196819|NCT02096718|3925442|FG001|NOT COMPLETED|Overall Study||0
3196820|NCT02096718|3925443|FG002|NOT COMPLETED|Overall Study||0
3196821|NCT02096731|3925454|FG000|STARTED|Overall Study||26442
3196822|NCT02096731|3925455|FG001|STARTED|Overall Study||88955
3196823|NCT02096731|3925454|FG000|COMPLETED|Overall Study||26442
3196824|NCT02096731|3925455|FG001|COMPLETED|Overall Study||88955
3196825|NCT02096731|3925454|FG000|NOT COMPLETED|Overall Study||0
3196826|NCT02096731|3925455|FG001|NOT COMPLETED|Overall Study||0
3196827|NCT02096744|3925464|FG000|STARTED|Treatment Period 1(7 Days)||29
3196828|NCT02096744|3925465|FG001|STARTED|Treatment Period 1(7 Days)||29
3196829|NCT02096744|3925464|FG000|COMPLETED|Treatment Period 1(7 Days)||28
3196830|NCT02096744|3925465|FG001|COMPLETED|Treatment Period 1(7 Days)||28
3196831|NCT02096744|3925464|FG000|NOT COMPLETED|Treatment Period 1(7 Days)||1
3196832|NCT02096744|3925465|FG001|NOT COMPLETED|Treatment Period 1(7 Days)||1
3196833|NCT02096744|3925464|FG000|STARTED|Washout Period 1(7 Days)||28
3196834|NCT02096744|3925465|FG001|STARTED|Washout Period 1(7 Days)||28
3196835|NCT02096744|3925464|FG000|COMPLETED|Washout Period 1(7 Days)||28
3196836|NCT02096744|3925465|FG001|COMPLETED|Washout Period 1(7 Days)||28
3196837|NCT02096744|3925464|FG000|NOT COMPLETED|Washout Period 1(7 Days)||0
3196838|NCT02096744|3925465|FG001|NOT COMPLETED|Washout Period 1(7 Days)||0
3196839|NCT02096744|3925464|FG000|STARTED|Treatment Period 2 (7 Days)||28
3196840|NCT02096744|3925465|FG001|STARTED|Treatment Period 2 (7 Days)||28
3196841|NCT02096744|3925464|FG000|COMPLETED|Treatment Period 2 (7 Days)||28
3196842|NCT02096744|3925465|FG001|COMPLETED|Treatment Period 2 (7 Days)||28
3196843|NCT02096744|3925464|FG000|NOT COMPLETED|Treatment Period 2 (7 Days)||0
3196844|NCT02096744|3925465|FG001|NOT COMPLETED|Treatment Period 2 (7 Days)||0
3196845|NCT02096744|3925464|FG000|STARTED|Washout Period 2 (3 Days)||28
3196846|NCT02096744|3925465|FG001|STARTED|Washout Period 2 (3 Days)||28
3196847|NCT02096744|3925464|FG000|COMPLETED|Washout Period 2 (3 Days)||28
3196848|NCT02096744|3925465|FG001|COMPLETED|Washout Period 2 (3 Days)||28
3196849|NCT02096744|3925464|FG000|NOT COMPLETED|Washout Period 2 (3 Days)||0
3196850|NCT02096744|3925465|FG001|NOT COMPLETED|Washout Period 2 (3 Days)||0
3196851|NCT02096744|3925464|FG000|STARTED|Treatment Period 3 (7 Days)||28
3196852|NCT02096744|3925465|FG001|STARTED|Treatment Period 3 (7 Days)||28
3196853|NCT02096744|3925464|FG000|COMPLETED|Treatment Period 3 (7 Days)||28
3196854|NCT02096744|3925465|FG001|COMPLETED|Treatment Period 3 (7 Days)||27
3196855|NCT02096744|3925464|FG000|NOT COMPLETED|Treatment Period 3 (7 Days)||0
3196856|NCT02096744|3925465|FG001|NOT COMPLETED|Treatment Period 3 (7 Days)||1
3196857|NCT02096835|3925476|FG000|STARTED|Overall Study||53
3196858|NCT02096835|3925477|FG001|STARTED|Overall Study||53
3196859|NCT02096835|3925478|FG002|STARTED|Overall Study||51
3196860|NCT02096835|3925476|FG000|COMPLETED|Overall Study||50
3196861|NCT02096835|3925477|FG001|COMPLETED|Overall Study||53
3196862|NCT02096835|3925478|FG002|COMPLETED|Overall Study||50
3196863|NCT02096835|3925476|FG000|NOT COMPLETED|Overall Study||3
3196864|NCT02096835|3925477|FG001|NOT COMPLETED|Overall Study||0
3196865|NCT02096835|3925478|FG002|NOT COMPLETED|Overall Study||1
3196866|NCT02096861|3925490|FG000|STARTED|Overall Study|CT-P13 followed by CT-P13 from Week 30|56
3196867|NCT02096861|3925491|FG001|STARTED|Overall Study|CT-P13 followed by Remicade from Week 30|55
3196868|NCT02096861|3925492|FG002|STARTED|Overall Study|Remicade followed by Remicade from Week 30|54
3196869|NCT02096861|3925493|FG003|STARTED|Overall Study|Remicade followed by CT-P13 from Week 30|55
3196870|NCT02096861|3925490|FG000|Drug Switching at Week 30|Overall Study||48
3196871|NCT02096861|3925491|FG001|Drug Switching at Week 30|Overall Study||44
3196872|NCT02096861|3925492|FG002|Drug Switching at Week 30|Overall Study||41
3196873|NCT02096861|3925493|FG003|Drug Switching at Week 30|Overall Study||47
3196874|NCT02096861|3925490|FG000|COMPLETED|Overall Study||44
3196875|NCT02096861|3925491|FG001|COMPLETED|Overall Study||40
3196876|NCT02096861|3925492|FG002|COMPLETED|Overall Study||37
3196877|NCT02096861|3925493|FG003|COMPLETED|Overall Study||45
3196878|NCT02096861|3925490|FG000|NOT COMPLETED|Overall Study||12
3196879|NCT02096861|3925491|FG001|NOT COMPLETED|Overall Study||15
3196880|NCT02096861|3925492|FG002|NOT COMPLETED|Overall Study||17
3196881|NCT02096861|3925493|FG003|NOT COMPLETED|Overall Study||10
3196882|NCT02096900|3925507|FG000|STARTED|Overall Study|Allocated to Midazolam|42
3196883|NCT02096900|3925508|FG001|STARTED|Overall Study|Allocated to Zolpidem|44
3196884|NCT02096900|3925507|FG000|COMPLETED|Overall Study||38
3196885|NCT02096900|3925508|FG001|COMPLETED|Overall Study||42
3196886|NCT02096900|3925507|FG000|NOT COMPLETED|Overall Study||4
3196887|NCT02096900|3925508|FG001|NOT COMPLETED|Overall Study||2
3196888|NCT02096952|3925514|FG000|STARTED|Overall Study||15
3196889|NCT02096952|3925514|FG000|COMPLETED|Overall Study||14
3196890|NCT02096952|3925514|FG000|NOT COMPLETED|Overall Study||1
3196891|NCT02097030|3925520|FG000|STARTED|First Intervention (3 Days)||15
3196892|NCT02097030|3925521|FG001|STARTED|First Intervention (3 Days)||17
3196893|NCT02097030|3925520|FG000|COMPLETED|First Intervention (3 Days)||14
3196894|NCT02097030|3925521|FG001|COMPLETED|First Intervention (3 Days)||16
3196895|NCT02097030|3925520|FG000|NOT COMPLETED|First Intervention (3 Days)||1
3196896|NCT02097030|3925521|FG001|NOT COMPLETED|First Intervention (3 Days)||1
3196897|NCT02097030|3925520|FG000|STARTED|Second Intervention (3 Days)||14
3196898|NCT02097030|3925521|FG001|STARTED|Second Intervention (3 Days)||16
3196899|NCT02097030|3925520|FG000|COMPLETED|Second Intervention (3 Days)||14
3196900|NCT02097030|3925521|FG001|COMPLETED|Second Intervention (3 Days)||16
3196901|NCT02097030|3925520|FG000|NOT COMPLETED|Second Intervention (3 Days)||0
3196902|NCT02097030|3925521|FG001|NOT COMPLETED|Second Intervention (3 Days)||0
3196903|NCT02097056|3925531|FG000|STARTED|Overall Study||171
3196904|NCT02097056|3925531|FG000|ParticipantsTreated|Overall Study||170
3196905|NCT02097056|3925531|FG000|COMPLETED|Overall Study||113
3196906|NCT02097056|3925531|FG000|NOT COMPLETED|Overall Study||58
3196907|NCT02097108|3925535|FG000|STARTED|Overall Study||11
3196908|NCT02097108|3925535|FG000|COMPLETED|Overall Study||9
3196909|NCT02097108|3925535|FG000|NOT COMPLETED|Overall Study||2
3196910|NCT02097238|3925539|FG000|STARTED|Overall Study||19
3196911|NCT02097238|3925539|FG000|COMPLETED|Overall Study||0
3196912|NCT02097238|3925539|FG000|NOT COMPLETED|Overall Study||19
3196913|NCT02097277|3925549|FG000|STARTED|Overall Study||24
3196914|NCT02097277|3925550|FG001|STARTED|Overall Study||24
3196915|NCT02097277|3925551|FG002|STARTED|Overall Study||24
3196916|NCT02097277|3925552|FG003|STARTED|Overall Study||24
3196917|NCT02097277|3925553|FG004|STARTED|Overall Study||24
3196918|NCT02097277|3925549|FG000|COMPLETED|Overall Study||22
3196919|NCT02097277|3925550|FG001|COMPLETED|Overall Study||21
3196920|NCT02097277|3925551|FG002|COMPLETED|Overall Study||22
3196921|NCT02097277|3925552|FG003|COMPLETED|Overall Study||20
3196922|NCT02097277|3925553|FG004|COMPLETED|Overall Study||23
3196923|NCT02097277|3925549|FG000|NOT COMPLETED|Overall Study||2
3196924|NCT02097277|3925550|FG001|NOT COMPLETED|Overall Study||3
3196925|NCT02097277|3925551|FG002|NOT COMPLETED|Overall Study||2
3196926|NCT02097277|3925552|FG003|NOT COMPLETED|Overall Study||4
3196927|NCT02097277|3925553|FG004|NOT COMPLETED|Overall Study||1
3196928|NCT02097290|3925569|FG000|STARTED|Overall Study||210
3196929|NCT02097290|3925569|FG000|COMPLETED|Overall Study|Active subjects at the end of 3 month follow up visit for primary end point data collection|193
3196930|NCT02097290|3925569|FG000|NOT COMPLETED|Overall Study||17
3196931|NCT02097303|3925573|FG000|STARTED|Overall Study||36
3196932|NCT02097303|3925573|FG000|COMPLETED|Overall Study||31
3196933|NCT02097303|3925573|FG000|NOT COMPLETED|Overall Study||5
3196934|NCT02097472|3925585|FG000|STARTED|Received Vaccination 1||18
3196935|NCT02097472|3925586|FG001|STARTED|Received Vaccination 1||18
3196936|NCT02097472|3925587|FG002|STARTED|Received Vaccination 1||18
3196937|NCT02097472|3925588|FG003|STARTED|Received Vaccination 1||50
3196938|NCT02097472|3925589|FG004|STARTED|Received Vaccination 1||50
3196939|NCT02097472|3925590|FG005|STARTED|Received Vaccination 1||50
3196940|NCT02097472|3925591|FG006|STARTED|Received Vaccination 1||50
3196941|NCT02097472|3925592|FG007|STARTED|Received Vaccination 1||50
3196942|NCT02097472|3925585|FG000|COMPLETED|Received Vaccination 1||18
3196943|NCT02097472|3925586|FG001|COMPLETED|Received Vaccination 1||18
3196944|NCT02097472|3925587|FG002|COMPLETED|Received Vaccination 1||18
3196945|NCT02097472|3925588|FG003|COMPLETED|Received Vaccination 1||50
3196946|NCT02097472|3925589|FG004|COMPLETED|Received Vaccination 1||50
3196947|NCT02097472|3925590|FG005|COMPLETED|Received Vaccination 1||50
3196948|NCT02097472|3925591|FG006|COMPLETED|Received Vaccination 1||50
3196949|NCT02097472|3925592|FG007|COMPLETED|Received Vaccination 1||50
3196950|NCT02097472|3925585|FG000|NOT COMPLETED|Received Vaccination 1||0
3196951|NCT02097472|3925586|FG001|NOT COMPLETED|Received Vaccination 1||0
3196952|NCT02097472|3925587|FG002|NOT COMPLETED|Received Vaccination 1||0
3196953|NCT02097472|3925588|FG003|NOT COMPLETED|Received Vaccination 1||0
3196954|NCT02097472|3925589|FG004|NOT COMPLETED|Received Vaccination 1||0
3196955|NCT02097472|3925590|FG005|NOT COMPLETED|Received Vaccination 1||0
3196956|NCT02097472|3925591|FG006|NOT COMPLETED|Received Vaccination 1||0
3196957|NCT02097472|3925592|FG007|NOT COMPLETED|Received Vaccination 1||0
3196958|NCT02097472|3925585|FG000|STARTED|Received Vaccination 2||18
3196959|NCT02097472|3925586|FG001|STARTED|Received Vaccination 2||18
3196960|NCT02097472|3925587|FG002|STARTED|Received Vaccination 2||18
3196961|NCT02097472|3925588|FG003|STARTED|Received Vaccination 2||50
3196962|NCT02097472|3925589|FG004|STARTED|Received Vaccination 2||50
3196963|NCT02097472|3925590|FG005|STARTED|Received Vaccination 2||50
3196964|NCT02097472|3925591|FG006|STARTED|Received Vaccination 2||50
3196965|NCT02097472|3925592|FG007|STARTED|Received Vaccination 2||50
3196966|NCT02097472|3925585|FG000|COMPLETED|Received Vaccination 2||18
3196967|NCT02097472|3925586|FG001|COMPLETED|Received Vaccination 2||18
3196968|NCT02097472|3925587|FG002|COMPLETED|Received Vaccination 2||18
3196969|NCT02097472|3925588|FG003|COMPLETED|Received Vaccination 2||50
3196970|NCT02097472|3925589|FG004|COMPLETED|Received Vaccination 2||50
3196971|NCT02097472|3925590|FG005|COMPLETED|Received Vaccination 2||50
3196972|NCT02097472|3925591|FG006|COMPLETED|Received Vaccination 2||49
3196973|NCT02097472|3925592|FG007|COMPLETED|Received Vaccination 2||50
3196974|NCT02097472|3925585|FG000|NOT COMPLETED|Received Vaccination 2||0
3196975|NCT02097472|3925586|FG001|NOT COMPLETED|Received Vaccination 2||0
3196976|NCT02097472|3925587|FG002|NOT COMPLETED|Received Vaccination 2||0
3196977|NCT02097472|3925588|FG003|NOT COMPLETED|Received Vaccination 2||0
3196978|NCT02097472|3925589|FG004|NOT COMPLETED|Received Vaccination 2||0
3196979|NCT02097472|3925590|FG005|NOT COMPLETED|Received Vaccination 2||0
3196980|NCT02097472|3925591|FG006|NOT COMPLETED|Received Vaccination 2||1
3196981|NCT02097472|3925592|FG007|NOT COMPLETED|Received Vaccination 2||0
3196982|NCT02097472|3925585|FG000|STARTED|Assessed for Immunogenicity||18
3196983|NCT02097472|3925586|FG001|STARTED|Assessed for Immunogenicity||18
3196984|NCT02097472|3925587|FG002|STARTED|Assessed for Immunogenicity||18
3196985|NCT02097472|3925588|FG003|STARTED|Assessed for Immunogenicity||50
3196986|NCT02097472|3925589|FG004|STARTED|Assessed for Immunogenicity||50
3196987|NCT02097472|3925590|FG005|STARTED|Assessed for Immunogenicity||50
3196988|NCT02097472|3925591|FG006|STARTED|Assessed for Immunogenicity||49
3196989|NCT02097472|3925592|FG007|STARTED|Assessed for Immunogenicity||50
3196990|NCT02097472|3925585|FG000|COMPLETED|Assessed for Immunogenicity||18
3196991|NCT02097472|3925586|FG001|COMPLETED|Assessed for Immunogenicity||18
3196992|NCT02097472|3925587|FG002|COMPLETED|Assessed for Immunogenicity||17
3196993|NCT02097472|3925588|FG003|COMPLETED|Assessed for Immunogenicity||48
3196994|NCT02097472|3925589|FG004|COMPLETED|Assessed for Immunogenicity||50
3196995|NCT02097472|3925590|FG005|COMPLETED|Assessed for Immunogenicity||48
3196996|NCT02097472|3925591|FG006|COMPLETED|Assessed for Immunogenicity||47
3196997|NCT02097472|3925592|FG007|COMPLETED|Assessed for Immunogenicity||49
3196998|NCT02097472|3925585|FG000|NOT COMPLETED|Assessed for Immunogenicity||0
3196999|NCT02097472|3925586|FG001|NOT COMPLETED|Assessed for Immunogenicity||0
3197000|NCT02097472|3925587|FG002|NOT COMPLETED|Assessed for Immunogenicity||1
3197001|NCT02097472|3925588|FG003|NOT COMPLETED|Assessed for Immunogenicity||2
3197002|NCT02097472|3925589|FG004|NOT COMPLETED|Assessed for Immunogenicity||0
3197003|NCT02097472|3925590|FG005|NOT COMPLETED|Assessed for Immunogenicity||2
3197004|NCT02097472|3925591|FG006|NOT COMPLETED|Assessed for Immunogenicity||2
3197005|NCT02097472|3925592|FG007|NOT COMPLETED|Assessed for Immunogenicity||1
3197006|NCT02097485|3925678|FG000|STARTED|Overall Study||25
3197007|NCT02097485|3925679|FG001|STARTED|Overall Study||25
3197008|NCT02097485|3925678|FG000|COMPLETED|Overall Study||25
3197009|NCT02097485|3925679|FG001|COMPLETED|Overall Study||25
3197010|NCT02097485|3925678|FG000|NOT COMPLETED|Overall Study||0
3197011|NCT02097485|3925679|FG001|NOT COMPLETED|Overall Study||0
3197012|NCT02097537|3925685|FG000|STARTED|Overall Study||10
3197013|NCT02097537|3925685|FG000|Enrollment|Overall Study|Inhalation of Methacholine Chloride|10
3197014|NCT02097537|3925685|FG000|Follow-Up|Overall Study||10
3197015|NCT02097537|3925685|FG000|COMPLETED|Overall Study||10
3197016|NCT02097537|3925685|FG000|NOT COMPLETED|Overall Study||0
3197017|NCT02097641|3925691|FG000|STARTED|Overall Study||40
3197018|NCT02097641|3925692|FG001|STARTED|Overall Study||20
3197019|NCT02097641|3925691|FG000|COMPLETED|Overall Study||40
3197020|NCT02097641|3925692|FG001|COMPLETED|Overall Study||20
3197021|NCT02097641|3925691|FG000|NOT COMPLETED|Overall Study||0
3197022|NCT02097641|3925692|FG001|NOT COMPLETED|Overall Study||0
3197023|NCT02097719|3925702|FG000|STARTED|Overall Study||49
3197024|NCT02097719|3925703|FG001|STARTED|Overall Study||51
3197025|NCT02097719|3925702|FG000|COMPLETED|Overall Study||46
3197026|NCT02097719|3925703|FG001|COMPLETED|Overall Study||50
3197027|NCT02097719|3925702|FG000|NOT COMPLETED|Overall Study||3
3197028|NCT02097719|3925703|FG001|NOT COMPLETED|Overall Study||1
3364761|NCT03979872|4095955|FG000|NOT COMPLETED|Overall Study||3
3364762|NCT03979872|4095956|FG001|NOT COMPLETED|Overall Study||8
3364763|NCT03979872|4095957|FG002|NOT COMPLETED|Overall Study||6
3364764|NCT03979872|4095958|FG003|NOT COMPLETED|Overall Study||4
3364765|NCT03978832|4095968|FG000|STARTED|Overall Study|69 participants signed the ICF and entered screening; 25 met eligibility criteria and were enrolled.|69
3364766|NCT03978832|4095968|FG000|Stabilization Period|Overall Study||25
3364767|NCT03978832|4095968|FG000|Treatment Period|Overall Study||23
3364768|NCT03978832|4095968|FG000|COMPLETED|Overall Study||15
3364769|NCT03978832|4095968|FG000|NOT COMPLETED|Overall Study||54
3364770|NCT04005391|4095974|FG000|STARTED|Overall Study|10/23/18|108
3364771|NCT04005391|4095975|FG001|STARTED|Overall Study|10/23/18|100
3364772|NCT04005391|4095974|FG000|COMPLETED|Overall Study||101
3364773|NCT04005391|4095975|FG001|COMPLETED|Overall Study||100
3364774|NCT04005391|4095974|FG000|NOT COMPLETED|Overall Study||7
3364775|NCT04005391|4095975|FG001|NOT COMPLETED|Overall Study||0
3364776|NCT04004481|4095985|FG000|STARTED|Overall Study||50
3364777|NCT04004481|4095985|FG000|COMPLETED|Overall Study||47
3364778|NCT04004481|4095985|FG000|NOT COMPLETED|Overall Study||3
3364779|NCT04004260|4096009|FG000|STARTED|Overall Study||79
3197029|NCT02097732|3925711|FG000|STARTED|Overall Study||1
3197030|NCT02097732|3925712|FG001|STARTED|Overall Study||3
3197031|NCT02097732|3925711|FG000|COMPLETED|Overall Study||1
3197032|NCT02097732|3925712|FG001|COMPLETED|Overall Study||3
3197033|NCT02097732|3925711|FG000|NOT COMPLETED|Overall Study||0
3197034|NCT02097732|3925712|FG001|NOT COMPLETED|Overall Study||0
3197035|NCT02097745|3925719|FG000|STARTED|Overall Study|Six participants did not receive any treatment and were not included in any analyses.|335
3197036|NCT02097745|3925719|FG000|COMPLETED|Overall Study||157
3197037|NCT02097745|3925719|FG000|NOT COMPLETED|Overall Study||178
3197038|NCT02097823|3925728|FG000|STARTED|Overall Study||11
3197039|NCT02097823|3925729|FG001|STARTED|Overall Study||4
3197040|NCT02097823|3925728|FG000|COMPLETED|Overall Study||10
3197041|NCT02097823|3925729|FG001|COMPLETED|Overall Study||3
3197042|NCT02097823|3925728|FG000|NOT COMPLETED|Overall Study||1
3197043|NCT02097823|3925729|FG001|NOT COMPLETED|Overall Study||1
3197044|NCT02097849|3925738|FG000|STARTED|Overall Study||33
3197045|NCT02097849|3925739|FG001|STARTED|Overall Study||38
3197046|NCT02097849|3925738|FG000|COMPLETED|Overall Study||33
3197047|NCT02097849|3925739|FG001|COMPLETED|Overall Study||38
3197048|NCT02097849|3925738|FG000|NOT COMPLETED|Overall Study||0
3197049|NCT02097849|3925739|FG001|NOT COMPLETED|Overall Study||0
3197050|NCT02097992|3925749|FG000|STARTED|Treatment 1 (1 Day)||2
3197051|NCT02097992|3925750|FG001|STARTED|Treatment 1 (1 Day)||3
3197052|NCT02097992|3925751|FG002|STARTED|Treatment 1 (1 Day)||4
3197053|NCT02097992|3925752|FG003|STARTED|Treatment 1 (1 Day)||2
3197054|NCT02097992|3925749|FG000|COMPLETED|Treatment 1 (1 Day)||2
3197055|NCT02097992|3925750|FG001|COMPLETED|Treatment 1 (1 Day)||3
3197056|NCT02097992|3925751|FG002|COMPLETED|Treatment 1 (1 Day)||4
3197057|NCT02097992|3925752|FG003|COMPLETED|Treatment 1 (1 Day)||2
3197058|NCT02097992|3925749|FG000|NOT COMPLETED|Treatment 1 (1 Day)||0
3197059|NCT02097992|3925750|FG001|NOT COMPLETED|Treatment 1 (1 Day)||0
3197060|NCT02097992|3925751|FG002|NOT COMPLETED|Treatment 1 (1 Day)||0
3197061|NCT02097992|3925752|FG003|NOT COMPLETED|Treatment 1 (1 Day)||0
3197062|NCT02097992|3925749|FG000|STARTED|Treatment 2 (4 Weeks)||2
3197063|NCT02097992|3925750|FG001|STARTED|Treatment 2 (4 Weeks)||3
3197064|NCT02097992|3925751|FG002|STARTED|Treatment 2 (4 Weeks)||4
3197065|NCT02097992|3925752|FG003|STARTED|Treatment 2 (4 Weeks)||2
3197066|NCT02097992|3925749|FG000|COMPLETED|Treatment 2 (4 Weeks)||2
3197067|NCT02097992|3925750|FG001|COMPLETED|Treatment 2 (4 Weeks)||3
3197068|NCT02097992|3925751|FG002|COMPLETED|Treatment 2 (4 Weeks)||4
3197069|NCT02097992|3925752|FG003|COMPLETED|Treatment 2 (4 Weeks)||2
3197070|NCT02097992|3925749|FG000|NOT COMPLETED|Treatment 2 (4 Weeks)||0
3197071|NCT02097992|3925750|FG001|NOT COMPLETED|Treatment 2 (4 Weeks)||0
3197072|NCT02097992|3925751|FG002|NOT COMPLETED|Treatment 2 (4 Weeks)||0
3197073|NCT02097992|3925752|FG003|NOT COMPLETED|Treatment 2 (4 Weeks)||0
3197074|NCT02097992|3925749|FG000|STARTED|Washout (4 Weeks)||2
3197075|NCT02097992|3925750|FG001|STARTED|Washout (4 Weeks)||3
3197076|NCT02097992|3925751|FG002|STARTED|Washout (4 Weeks)||4
3197077|NCT02097992|3925752|FG003|STARTED|Washout (4 Weeks)||2
3197078|NCT02097992|3925749|FG000|COMPLETED|Washout (4 Weeks)||2
3197079|NCT02097992|3925750|FG001|COMPLETED|Washout (4 Weeks)||3
3197080|NCT02097992|3925751|FG002|COMPLETED|Washout (4 Weeks)||4
3197081|NCT02097992|3925752|FG003|COMPLETED|Washout (4 Weeks)||2
3197082|NCT02097992|3925749|FG000|NOT COMPLETED|Washout (4 Weeks)||0
3197083|NCT02097992|3925750|FG001|NOT COMPLETED|Washout (4 Weeks)||0
3197084|NCT02097992|3925751|FG002|NOT COMPLETED|Washout (4 Weeks)||0
3197085|NCT02097992|3925752|FG003|NOT COMPLETED|Washout (4 Weeks)||0
3197086|NCT02097992|3925749|FG000|STARTED|Treatment 3 (4 Weeks)||2
3197087|NCT02097992|3925750|FG001|STARTED|Treatment 3 (4 Weeks)||3
3197088|NCT02097992|3925751|FG002|STARTED|Treatment 3 (4 Weeks)||4
3197089|NCT02097992|3925752|FG003|STARTED|Treatment 3 (4 Weeks)||2
3197090|NCT02097992|3925749|FG000|COMPLETED|Treatment 3 (4 Weeks)||2
3197091|NCT02097992|3925750|FG001|COMPLETED|Treatment 3 (4 Weeks)||3
3197092|NCT02097992|3925751|FG002|COMPLETED|Treatment 3 (4 Weeks)||4
3197093|NCT02097992|3925752|FG003|COMPLETED|Treatment 3 (4 Weeks)||2
3197094|NCT02097992|3925749|FG000|NOT COMPLETED|Treatment 3 (4 Weeks)||0
3197095|NCT02097992|3925750|FG001|NOT COMPLETED|Treatment 3 (4 Weeks)||0
3197096|NCT02097992|3925751|FG002|NOT COMPLETED|Treatment 3 (4 Weeks)||0
3197097|NCT02097992|3925752|FG003|NOT COMPLETED|Treatment 3 (4 Weeks)||0
3197098|NCT02098109|3925762|FG000|STARTED|Overall Study||49
3197099|NCT02098109|3925763|FG001|STARTED|Overall Study||51
3197100|NCT02098109|3925762|FG000|COMPLETED|Overall Study||46
3197101|NCT02098109|3925763|FG001|COMPLETED|Overall Study||51
3197102|NCT02098109|3925762|FG000|NOT COMPLETED|Overall Study||3
3197103|NCT02098109|3925763|FG001|NOT COMPLETED|Overall Study||0
3197104|NCT02098304|3925769|FG000|STARTED|Overall Study||42
3197105|NCT02098304|3925769|FG000|COMPLETED|Overall Study||42
3197106|NCT02098304|3925769|FG000|NOT COMPLETED|Overall Study||0
3197107|NCT02098369|3925778|FG000|STARTED|Overall Study||142
3197108|NCT02098369|3925779|FG001|STARTED|Overall Study||154
3197109|NCT02098369|3925780|FG002|STARTED|Overall Study||148
3197110|NCT02098369|3925778|FG000|COMPLETED|Overall Study||135
3197111|NCT02098369|3925779|FG001|COMPLETED|Overall Study||145
3197112|NCT02098369|3925780|FG002|COMPLETED|Overall Study||143
3197113|NCT02098369|3925778|FG000|NOT COMPLETED|Overall Study||7
3197114|NCT02098369|3925779|FG001|NOT COMPLETED|Overall Study||9
3197115|NCT02098369|3925780|FG002|NOT COMPLETED|Overall Study||5
3197116|NCT02098395|3925792|FG000|STARTED|Overall Study||212
3197117|NCT02098395|3925793|FG001|STARTED|Overall Study||209
3197118|NCT02098395|3925794|FG002|STARTED|Overall Study||207
3197119|NCT02098395|3925795|FG003|STARTED|Overall Study||207
3197120|NCT02098395|3925792|FG000|Exposed|Overall Study||211
3197121|NCT02098395|3925793|FG001|Exposed|Overall Study||209
3197122|NCT02098395|3925794|FG002|Exposed|Overall Study||206
3197123|NCT02098395|3925795|FG003|Exposed|Overall Study||206
3197124|NCT02098395|3925792|FG000|COMPLETED|Overall Study||186
3197125|NCT02098395|3925793|FG001|COMPLETED|Overall Study||177
3197126|NCT02098395|3925794|FG002|COMPLETED|Overall Study||165
3197127|NCT02098395|3925795|FG003|COMPLETED|Overall Study||180
3197128|NCT02098395|3925792|FG000|NOT COMPLETED|Overall Study||26
3197129|NCT02098395|3925793|FG001|NOT COMPLETED|Overall Study||32
3197130|NCT02098395|3925794|FG002|NOT COMPLETED|Overall Study||42
3197131|NCT02098395|3925795|FG003|NOT COMPLETED|Overall Study||27
3197132|NCT02098733|3925805|FG000|STARTED|Overall Study||1168
3197133|NCT02098733|3925805|FG000|COMPLETED|Overall Study||1158
3197134|NCT02098733|3925805|FG000|NOT COMPLETED|Overall Study||10
3197135|NCT02098746|3925809|FG000|STARTED|Overall Study||294
3197136|NCT02098746|3925809|FG000|COMPLETED|Overall Study||289
3197137|NCT02098746|3925809|FG000|NOT COMPLETED|Overall Study||5
3197138|NCT02098993|3925815|FG000|STARTED|Overall Study||4
3197139|NCT02098993|3925816|FG001|STARTED|Overall Study||3
3197140|NCT02098993|3925815|FG000|COMPLETED|Overall Study||4
3197141|NCT02098993|3925816|FG001|COMPLETED|Overall Study||3
3197142|NCT02098993|3925815|FG000|NOT COMPLETED|Overall Study||0
3197143|NCT02098993|3925816|FG001|NOT COMPLETED|Overall Study||0
3197144|NCT02099006|3925822|FG000|STARTED|Overall Study||9
3197145|NCT02099006|3925822|FG000|Received Placebo|Overall Study||9
3197146|NCT02099006|3925822|FG000|Received Amitriptyline/ Baclofen|Overall Study||7
3197147|NCT02099006|3925822|FG000|Received Ketoprofen|Overall Study||3
3197148|NCT02099006|3925822|FG000|Received Loperamide|Overall Study||7
3197149|NCT02099006|3925822|FG000|Received Ketamine|Overall Study||6
3197150|NCT02099006|3925822|FG000|Received Gabapentin|Overall Study||8
3197151|NCT02099006|3925822|FG000|COMPLETED|Overall Study||8
3197152|NCT02099006|3925822|FG000|NOT COMPLETED|Overall Study||1
3197153|NCT02099084|3925828|FG000|STARTED|First Intervention||4
3197154|NCT02099084|3925829|FG001|STARTED|First Intervention||4
3197155|NCT02099084|3925828|FG000|COMPLETED|First Intervention||4
3197156|NCT02099084|3925829|FG001|COMPLETED|First Intervention||4
3197157|NCT02099084|3925828|FG000|NOT COMPLETED|First Intervention||0
3197158|NCT02099084|3925829|FG001|NOT COMPLETED|First Intervention||0
3197159|NCT02099084|3925828|FG000|STARTED|Washout Period of 14 Days||4
3197160|NCT02099084|3925829|FG001|STARTED|Washout Period of 14 Days||4
3197161|NCT02099084|3925828|FG000|COMPLETED|Washout Period of 14 Days||4
3197162|NCT02099084|3925829|FG001|COMPLETED|Washout Period of 14 Days||4
3197163|NCT02099084|3925828|FG000|NOT COMPLETED|Washout Period of 14 Days||0
3197164|NCT02099084|3925829|FG001|NOT COMPLETED|Washout Period of 14 Days||0
3197165|NCT02099084|3925828|FG000|STARTED|Second Intervention||4
3197166|NCT02099084|3925829|FG001|STARTED|Second Intervention||4
3197167|NCT02099084|3925828|FG000|COMPLETED|Second Intervention||4
3197168|NCT02099084|3925829|FG001|COMPLETED|Second Intervention||4
3197169|NCT02099084|3925828|FG000|NOT COMPLETED|Second Intervention||0
3197170|NCT02099084|3925829|FG001|NOT COMPLETED|Second Intervention||0
3197171|NCT02099110|3925840|FG000|STARTED|Overall Study||250
3197172|NCT02099110|3925841|FG001|STARTED|Overall Study||248
3197173|NCT02099110|3925842|FG002|STARTED|Overall Study||247
3197174|NCT02099110|3925843|FG003|STARTED|Overall Study||243
3197175|NCT02099110|3925844|FG004|STARTED|Overall Study||245
3197176|NCT02099110|3925840|FG000|Treated|Overall Study||250
3197177|NCT02099110|3925841|FG001|Treated|Overall Study||248
3197178|NCT02099110|3925842|FG002|Treated|Overall Study||247
3197179|NCT02099110|3925843|FG003|Treated|Overall Study||243
3197180|NCT02099110|3925844|FG004|Treated|Overall Study||244
3197181|NCT02099110|3925840|FG000|COMPLETED|Overall Study||226
3197182|NCT02099110|3925841|FG001|COMPLETED|Overall Study||217
3197183|NCT02099110|3925842|FG002|COMPLETED|Overall Study||219
3197184|NCT02099110|3925843|FG003|COMPLETED|Overall Study||221
3197185|NCT02099110|3925844|FG004|COMPLETED|Overall Study||218
3197186|NCT02099110|3925840|FG000|NOT COMPLETED|Overall Study||24
3197187|NCT02099110|3925841|FG001|NOT COMPLETED|Overall Study||31
3197188|NCT02099110|3925842|FG002|NOT COMPLETED|Overall Study||28
3197189|NCT02099110|3925843|FG003|NOT COMPLETED|Overall Study||22
3197190|NCT02099110|3925844|FG004|NOT COMPLETED|Overall Study||27
3197191|NCT02099266|3925856|FG000|STARTED|Overall Study||15
3197192|NCT02099266|3925856|FG000|COMPLETED|Overall Study||15
3197193|NCT02099266|3925856|FG000|NOT COMPLETED|Overall Study||0
3197194|NCT02099461|3925866|FG000|STARTED|Overall Study||27
3197195|NCT02099461|3925867|FG001|STARTED|Overall Study||27
3197196|NCT02099461|3925868|FG002|STARTED|Overall Study||28
3197197|NCT02099461|3925866|FG000|COMPLETED|Overall Study||27
3197198|NCT02099461|3925867|FG001|COMPLETED|Overall Study||27
3197199|NCT02099461|3925868|FG002|COMPLETED|Overall Study||28
3197200|NCT02099461|3925866|FG000|NOT COMPLETED|Overall Study||0
3197201|NCT02099461|3925867|FG001|NOT COMPLETED|Overall Study||0
3197202|NCT02099461|3925868|FG002|NOT COMPLETED|Overall Study||0
3197203|NCT02099682|3925876|FG000|STARTED|Overall Study|Number of cases.|3366
3197204|NCT02099682|3925876|FG000|Safety Analysis Set (SAS)|Overall Study|All participants who took the study drug at least once.|3255
3197205|NCT02099682|3925876|FG000|COMPLETED|Overall Study||3255
3197206|NCT02099682|3925876|FG000|NOT COMPLETED|Overall Study||111
3197207|NCT02099708|3925880|FG000|STARTED|Overall Study|Number of cases.|3502
3364780|NCT04004260|4096010|FG001|STARTED|Overall Study||79
3197208|NCT02099708|3925880|FG000|Safety Analysis Set (SAS)|Overall Study|All participants who took the study drug at least once.|3302
3197209|NCT02099708|3925880|FG000|COMPLETED|Overall Study||3302
3197210|NCT02099708|3925880|FG000|NOT COMPLETED|Overall Study||200
3197211|NCT02099721|3925890|FG000|STARTED|Overall Study||1066
3197212|NCT02099721|3925891|FG001|STARTED|Overall Study||127
3197213|NCT02099721|3925892|FG002|STARTED|Overall Study||1068
3197214|NCT02099721|3925893|FG003|STARTED|Overall Study||845
3197215|NCT02099721|3925894|FG004|STARTED|Overall Study||331
3197216|NCT02099721|3925895|FG005|STARTED|Overall Study||452
3197217|NCT02099721|3925890|FG000|COMPLETED|Overall Study||990
3197218|NCT02099721|3925891|FG001|COMPLETED|Overall Study|Not implanted secondary patients were automatically exited.|0
3197219|NCT02099721|3925892|FG002|COMPLETED|Overall Study||983
3197220|NCT02099721|3925893|FG003|COMPLETED|Overall Study||774
3197221|NCT02099721|3925894|FG004|COMPLETED|Overall Study||304
3197222|NCT02099721|3925895|FG005|COMPLETED|Overall Study||432
3197223|NCT02099721|3925890|FG000|NOT COMPLETED|Overall Study||76
3197224|NCT02099721|3925891|FG001|NOT COMPLETED|Overall Study||127
3197225|NCT02099721|3925892|FG002|NOT COMPLETED|Overall Study||85
3197226|NCT02099721|3925893|FG003|NOT COMPLETED|Overall Study||71
3197227|NCT02099721|3925894|FG004|NOT COMPLETED|Overall Study||27
3197228|NCT02099721|3925895|FG005|NOT COMPLETED|Overall Study||20
3197229|NCT02099786|3925909|FG000|STARTED|Overall Study||24
3197230|NCT02099786|3925910|FG001|STARTED|Overall Study||23
3197231|NCT02099786|3925909|FG000|Program Eval 1|Overall Study|Baseline (prior to randomization and first cisplatin dose)|24
3197232|NCT02099786|3925910|FG001|Program Eval 1|Overall Study|Baseline (prior to randomization and first cisplatin dose)|23
3197233|NCT02099786|3925909|FG000|Program Eval 2|Overall Study|One month post randomization|23
3197234|NCT02099786|3925910|FG001|Program Eval 2|Overall Study|One month post randomization|19
3197235|NCT02099786|3925909|FG000|Program Eval 3|Overall Study|One year post randomization|21
3197236|NCT02099786|3925910|FG001|Program Eval 3|Overall Study|One year post randomization|15
3197237|NCT02099786|3925909|FG000|COMPLETED|Overall Study||21
3197238|NCT02099786|3925910|FG001|COMPLETED|Overall Study||15
3197239|NCT02099786|3925909|FG000|NOT COMPLETED|Overall Study||3
3197240|NCT02099786|3925910|FG001|NOT COMPLETED|Overall Study||8
3197241|NCT02099799|3925919|FG000|STARTED|Overall Study||75
3197242|NCT02099799|3925920|FG001|STARTED|Overall Study||78
3197243|NCT02099799|3925919|FG000|COMPLETED|Overall Study||60
3197244|NCT02099799|3925920|FG001|COMPLETED|Overall Study||54
3197245|NCT02099799|3925919|FG000|NOT COMPLETED|Overall Study||15
3197246|NCT02099799|3925920|FG001|NOT COMPLETED|Overall Study||24
3197247|NCT02099838|3925930|FG000|STARTED|Overall Study||47
3197248|NCT02099838|3925931|FG001|STARTED|Overall Study||51
3197249|NCT02099838|3925930|FG000|COMPLETED|Overall Study||43
3197250|NCT02099838|3925931|FG001|COMPLETED|Overall Study||49
3197251|NCT02099838|3925930|FG000|NOT COMPLETED|Overall Study||4
3197252|NCT02099838|3925931|FG001|NOT COMPLETED|Overall Study||2
3197253|NCT02099864|3925937|FG000|STARTED|Overall Study||36
3197254|NCT02099864|3925937|FG000|COMPLETED|Overall Study||36
3197255|NCT02099864|3925937|FG000|NOT COMPLETED|Overall Study||0
3197256|NCT02100007|3925945|FG000|STARTED|Overall Study||46
3197257|NCT02100007|3925945|FG000|COMPLETED|Overall Study||46
3197258|NCT02100007|3925945|FG000|NOT COMPLETED|Overall Study||0
3197259|NCT02100072|3925950|FG000|STARTED|Overall Study||5
3197260|NCT02100072|3925950|FG000|COMPLETED|Overall Study||5
3197261|NCT02100072|3925950|FG000|NOT COMPLETED|Overall Study||0
3197262|NCT02100124|3925957|FG000|STARTED|Overall Study||329
3197263|NCT02100124|3925958|FG001|STARTED|Overall Study||329
3197264|NCT02100124|3925959|FG002|STARTED|Overall Study||326
3197265|NCT02100124|3925957|FG000|COMPLETED|Overall Study||323
3197266|NCT02100124|3925958|FG001|COMPLETED|Overall Study||318
3197267|NCT02100124|3925959|FG002|COMPLETED|Overall Study||323
3197268|NCT02100124|3925957|FG000|NOT COMPLETED|Overall Study||6
3197269|NCT02100124|3925958|FG001|NOT COMPLETED|Overall Study||11
3197270|NCT02100124|3925959|FG002|NOT COMPLETED|Overall Study||3
3197271|NCT02100189|3925967|FG000|STARTED|Overall Study||50
3197272|NCT02100189|3925967|FG000|COMPLETED|Overall Study||50
3197273|NCT02100189|3925967|FG000|NOT COMPLETED|Overall Study||0
3197274|NCT02100228|3925973|FG000|STARTED|Overall Study|735 treated with Apixaban|753
3197275|NCT02100228|3925974|FG001|STARTED|Overall Study|721 treated with Usual Care|747
3197276|NCT02100228|3925973|FG000|COMPLETED|Overall Study||678
3197277|NCT02100228|3925974|FG001|COMPLETED|Overall Study||657
3197278|NCT02100228|3925973|FG000|NOT COMPLETED|Overall Study||75
3197279|NCT02100228|3925974|FG001|NOT COMPLETED|Overall Study||90
3197280|NCT02100280|3925982|FG000|STARTED|Overall Study||48
3197281|NCT02100280|3925983|FG001|STARTED|Overall Study||48
3197282|NCT02100280|3925982|FG000|COMPLETED|Overall Study||44
3197283|NCT02100280|3925983|FG001|COMPLETED|Overall Study||44
3197284|NCT02100280|3925982|FG000|NOT COMPLETED|Overall Study||4
3197285|NCT02100280|3925983|FG001|NOT COMPLETED|Overall Study||4
3197286|NCT02100319|3925991|FG000|STARTED|Overall Study||387
3197287|NCT02100319|3925991|FG000|COMPLETED|Overall Study||371
3197288|NCT02100319|3925991|FG000|NOT COMPLETED|Overall Study||16
3197289|NCT02100410|3925995|FG000|STARTED|Exposure Pair 1, 30 Minutes||8
3197290|NCT02100410|3925996|FG001|STARTED|Exposure Pair 1, 30 Minutes||8
3197291|NCT02100410|3925997|FG002|STARTED|Exposure Pair 1, 30 Minutes||8
3197292|NCT02100410|3925998|FG003|STARTED|Exposure Pair 1, 30 Minutes||8
3197293|NCT02100410|3925999|FG004|STARTED|Exposure Pair 1, 30 Minutes||8
3197294|NCT02100410|3926000|FG005|STARTED|Exposure Pair 1, 30 Minutes||9
3197295|NCT02100410|3925995|FG000|COMPLETED|Exposure Pair 1, 30 Minutes||8
3197296|NCT02100410|3925996|FG001|COMPLETED|Exposure Pair 1, 30 Minutes||8
3197297|NCT02100410|3925997|FG002|COMPLETED|Exposure Pair 1, 30 Minutes||8
3197298|NCT02100410|3925998|FG003|COMPLETED|Exposure Pair 1, 30 Minutes||8
3197299|NCT02100410|3925999|FG004|COMPLETED|Exposure Pair 1, 30 Minutes||8
3197300|NCT02100410|3926000|FG005|COMPLETED|Exposure Pair 1, 30 Minutes||9
3197301|NCT02100410|3925995|FG000|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
3197302|NCT02100410|3925996|FG001|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
3197303|NCT02100410|3925997|FG002|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
3197304|NCT02100410|3925998|FG003|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
3197305|NCT02100410|3925999|FG004|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
3197306|NCT02100410|3926000|FG005|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
3197307|NCT02100410|3925995|FG000|STARTED|Exposure Pair 2, 30 Minutes||8
3197308|NCT02100410|3925996|FG001|STARTED|Exposure Pair 2, 30 Minutes||8
3197309|NCT02100410|3925997|FG002|STARTED|Exposure Pair 2, 30 Minutes||8
3197310|NCT02100410|3925998|FG003|STARTED|Exposure Pair 2, 30 Minutes||8
3197311|NCT02100410|3925999|FG004|STARTED|Exposure Pair 2, 30 Minutes||8
3197312|NCT02100410|3926000|FG005|STARTED|Exposure Pair 2, 30 Minutes||9
3197313|NCT02100410|3925995|FG000|COMPLETED|Exposure Pair 2, 30 Minutes||8
3197314|NCT02100410|3925996|FG001|COMPLETED|Exposure Pair 2, 30 Minutes||8
3197315|NCT02100410|3925997|FG002|COMPLETED|Exposure Pair 2, 30 Minutes||8
3197316|NCT02100410|3925998|FG003|COMPLETED|Exposure Pair 2, 30 Minutes||8
3197317|NCT02100410|3925999|FG004|COMPLETED|Exposure Pair 2, 30 Minutes||8
3197318|NCT02100410|3926000|FG005|COMPLETED|Exposure Pair 2, 30 Minutes||9
3197319|NCT02100410|3925995|FG000|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
3197320|NCT02100410|3925996|FG001|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
3197321|NCT02100410|3925997|FG002|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
3197322|NCT02100410|3925998|FG003|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
3197323|NCT02100410|3925999|FG004|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
3197324|NCT02100410|3926000|FG005|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
3197325|NCT02100410|3925995|FG000|STARTED|Exposure Pair 3, 30 Minutes||8
3197326|NCT02100410|3925996|FG001|STARTED|Exposure Pair 3, 30 Minutes||8
3197327|NCT02100410|3925997|FG002|STARTED|Exposure Pair 3, 30 Minutes||8
3197328|NCT02100410|3925998|FG003|STARTED|Exposure Pair 3, 30 Minutes||8
3197329|NCT02100410|3925999|FG004|STARTED|Exposure Pair 3, 30 Minutes||8
3197330|NCT02100410|3926000|FG005|STARTED|Exposure Pair 3, 30 Minutes||9
3197331|NCT02100410|3925995|FG000|COMPLETED|Exposure Pair 3, 30 Minutes||8
3197332|NCT02100410|3925996|FG001|COMPLETED|Exposure Pair 3, 30 Minutes||8
3197333|NCT02100410|3925997|FG002|COMPLETED|Exposure Pair 3, 30 Minutes||8
3197334|NCT02100410|3925998|FG003|COMPLETED|Exposure Pair 3, 30 Minutes||8
3197335|NCT02100410|3925999|FG004|COMPLETED|Exposure Pair 3, 30 Minutes||8
3197336|NCT02100410|3926000|FG005|COMPLETED|Exposure Pair 3, 30 Minutes||9
3197337|NCT02100410|3925995|FG000|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
3197338|NCT02100410|3925996|FG001|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
3197339|NCT02100410|3925997|FG002|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
3197340|NCT02100410|3925998|FG003|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
3197341|NCT02100410|3925999|FG004|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
3197342|NCT02100410|3926000|FG005|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
3197343|NCT02100475|3926014|FG000|STARTED|Overall Study||16
3197344|NCT02100475|3926015|FG001|STARTED|Overall Study||15
3197345|NCT02100475|3926014|FG000|COMPLETED|Overall Study||14
3197346|NCT02100475|3926015|FG001|COMPLETED|Overall Study||13
3197347|NCT02100475|3926014|FG000|NOT COMPLETED|Overall Study||2
3197348|NCT02100475|3926015|FG001|NOT COMPLETED|Overall Study||2
3197349|NCT02100514|3926023|FG000|STARTED|Treatment Period||247
3197350|NCT02100514|3926024|FG001|STARTED|Treatment Period||499
3197351|NCT02100514|3926025|FG002|STARTED|Treatment Period||0
3197352|NCT02100514|3926026|FG003|STARTED|Treatment Period||0
3197353|NCT02100514|3926027|FG004|STARTED|Treatment Period||0
3197354|NCT02100514|3926023|FG000|COMPLETED|Treatment Period||218
3197355|NCT02100514|3926024|FG001|COMPLETED|Treatment Period||425
3197356|NCT02100514|3926025|FG002|COMPLETED|Treatment Period||0
3197357|NCT02100514|3926026|FG003|COMPLETED|Treatment Period||0
3197358|NCT02100514|3926027|FG004|COMPLETED|Treatment Period||0
3197359|NCT02100514|3926023|FG000|NOT COMPLETED|Treatment Period||29
3197360|NCT02100514|3926024|FG001|NOT COMPLETED|Treatment Period||74
3197361|NCT02100514|3926025|FG002|NOT COMPLETED|Treatment Period||0
3197362|NCT02100514|3926026|FG003|NOT COMPLETED|Treatment Period||0
3197363|NCT02100514|3926027|FG004|NOT COMPLETED|Treatment Period||0
3197364|NCT02100514|3926023|FG000|STARTED|Extension Period||0
3197365|NCT02100514|3926024|FG001|STARTED|Extension Period||0
3197366|NCT02100514|3926025|FG002|STARTED|Extension Period||44
3197367|NCT02100514|3926026|FG003|STARTED|Extension Period||33
3197368|NCT02100514|3926027|FG004|STARTED|Extension Period||56
3197369|NCT02100514|3926023|FG000|COMPLETED|Extension Period||0
3197370|NCT02100514|3926024|FG001|COMPLETED|Extension Period||0
3197371|NCT02100514|3926025|FG002|COMPLETED|Extension Period||42
3197372|NCT02100514|3926026|FG003|COMPLETED|Extension Period||33
3197373|NCT02100514|3926027|FG004|COMPLETED|Extension Period||56
3197374|NCT02100514|3926023|FG000|NOT COMPLETED|Extension Period||0
3197375|NCT02100514|3926024|FG001|NOT COMPLETED|Extension Period||0
3197376|NCT02100514|3926025|FG002|NOT COMPLETED|Extension Period||2
3197377|NCT02100514|3926026|FG003|NOT COMPLETED|Extension Period||0
3197378|NCT02100514|3926027|FG004|NOT COMPLETED|Extension Period||0
3197379|NCT02100579|3926043|FG000|STARTED|Overall Study||20
3197380|NCT02100579|3926044|FG001|STARTED|Overall Study||20
3197381|NCT02100579|3926043|FG000|COMPLETED|Overall Study||20
3197382|NCT02100579|3926044|FG001|COMPLETED|Overall Study||20
3197383|NCT02100579|3926043|FG000|NOT COMPLETED|Overall Study||0
3197384|NCT02100579|3926044|FG001|NOT COMPLETED|Overall Study||0
3197385|NCT02100631|3926053|FG000|STARTED|Overall Study||299
3197386|NCT02100631|3926054|FG001|STARTED|Overall Study||99
3197387|NCT02100631|3926055|FG002|STARTED|Overall Study||2688
3197388|NCT02100631|3926053|FG000|COMPLETED|Overall Study||292
3197389|NCT02100631|3926054|FG001|COMPLETED|Overall Study||95
3197390|NCT02100631|3926055|FG002|COMPLETED|Overall Study||2688
3197391|NCT02100631|3926053|FG000|NOT COMPLETED|Overall Study||7
3197392|NCT02100631|3926054|FG001|NOT COMPLETED|Overall Study||4
3197393|NCT02100631|3926055|FG002|NOT COMPLETED|Overall Study||0
3197394|NCT02100644|3926063|FG000|STARTED|LTG Escalation Phase||33
3197395|NCT02100644|3926064|FG001|STARTED|LTG Escalation Phase||0
3197396|NCT02100644|3926065|FG002|STARTED|LTG Escalation Phase||0
3197397|NCT02100644|3926063|FG000|COMPLETED|LTG Escalation Phase||20
3197398|NCT02100644|3926064|FG001|COMPLETED|LTG Escalation Phase||0
3197399|NCT02100644|3926065|FG002|COMPLETED|LTG Escalation Phase||0
3197400|NCT02100644|3926063|FG000|NOT COMPLETED|LTG Escalation Phase||13
3197401|NCT02100644|3926064|FG001|NOT COMPLETED|LTG Escalation Phase||0
3197402|NCT02100644|3926065|FG002|NOT COMPLETED|LTG Escalation Phase||0
3197403|NCT02100644|3926063|FG000|STARTED|VPA Reduction Phase||0
3197404|NCT02100644|3926064|FG001|STARTED|VPA Reduction Phase||20
3197405|NCT02100644|3926065|FG002|STARTED|VPA Reduction Phase||0
3197406|NCT02100644|3926063|FG000|COMPLETED|VPA Reduction Phase||0
3197407|NCT02100644|3926064|FG001|COMPLETED|VPA Reduction Phase||20
3197408|NCT02100644|3926065|FG002|COMPLETED|VPA Reduction Phase||0
3197409|NCT02100644|3926063|FG000|NOT COMPLETED|VPA Reduction Phase||0
3197410|NCT02100644|3926064|FG001|NOT COMPLETED|VPA Reduction Phase||0
3197411|NCT02100644|3926065|FG002|NOT COMPLETED|VPA Reduction Phase||0
3197412|NCT02100644|3926063|FG000|STARTED|LTG and VPA Maintenance Phase||0
3197413|NCT02100644|3926064|FG001|STARTED|LTG and VPA Maintenance Phase||0
3197414|NCT02100644|3926065|FG002|STARTED|LTG and VPA Maintenance Phase||20
3197415|NCT02100644|3926063|FG000|COMPLETED|LTG and VPA Maintenance Phase||0
3197416|NCT02100644|3926064|FG001|COMPLETED|LTG and VPA Maintenance Phase||0
3197417|NCT02100644|3926065|FG002|COMPLETED|LTG and VPA Maintenance Phase||20
3197418|NCT02100644|3926063|FG000|NOT COMPLETED|LTG and VPA Maintenance Phase||0
3197419|NCT02100644|3926064|FG001|NOT COMPLETED|LTG and VPA Maintenance Phase||0
3197420|NCT02100644|3926065|FG002|NOT COMPLETED|LTG and VPA Maintenance Phase||0
3197421|NCT02100657|3926072|FG000|STARTED|Cohort 1: Dose Level 1||8
3197422|NCT02100657|3926073|FG001|STARTED|Cohort 1: Dose Level 1||0
3197423|NCT02100657|3926074|FG002|STARTED|Cohort 1: Dose Level 1||0
3197424|NCT02100657|3926072|FG000|COMPLETED|Cohort 1: Dose Level 1||0
3197425|NCT02100657|3926073|FG001|COMPLETED|Cohort 1: Dose Level 1||0
3197426|NCT02100657|3926074|FG002|COMPLETED|Cohort 1: Dose Level 1||0
3197427|NCT02100657|3926072|FG000|NOT COMPLETED|Cohort 1: Dose Level 1||8
3197428|NCT02100657|3926073|FG001|NOT COMPLETED|Cohort 1: Dose Level 1||0
3197429|NCT02100657|3926074|FG002|NOT COMPLETED|Cohort 1: Dose Level 1||0
3197430|NCT02100657|3926072|FG000|STARTED|Cohort 2: Dose Level 2||0
3197431|NCT02100657|3926073|FG001|STARTED|Cohort 2: Dose Level 2||4
3197432|NCT02100657|3926074|FG002|STARTED|Cohort 2: Dose Level 2||0
3197433|NCT02100657|3926072|FG000|COMPLETED|Cohort 2: Dose Level 2||0
3197434|NCT02100657|3926073|FG001|COMPLETED|Cohort 2: Dose Level 2||0
3197435|NCT02100657|3926074|FG002|COMPLETED|Cohort 2: Dose Level 2||0
3197436|NCT02100657|3926072|FG000|NOT COMPLETED|Cohort 2: Dose Level 2||0
3197437|NCT02100657|3926073|FG001|NOT COMPLETED|Cohort 2: Dose Level 2||4
3197438|NCT02100657|3926074|FG002|NOT COMPLETED|Cohort 2: Dose Level 2||0
3197439|NCT02100657|3926072|FG000|STARTED|Cohort 3: Dose Level 3||0
3197440|NCT02100657|3926073|FG001|STARTED|Cohort 3: Dose Level 3||0
3197441|NCT02100657|3926074|FG002|STARTED|Cohort 3: Dose Level 3||27
3197442|NCT02100657|3926072|FG000|COMPLETED|Cohort 3: Dose Level 3||0
3197443|NCT02100657|3926073|FG001|COMPLETED|Cohort 3: Dose Level 3||0
3197444|NCT02100657|3926074|FG002|COMPLETED|Cohort 3: Dose Level 3||0
3197445|NCT02100657|3926072|FG000|NOT COMPLETED|Cohort 3: Dose Level 3||0
3197446|NCT02100657|3926073|FG001|NOT COMPLETED|Cohort 3: Dose Level 3||0
3197447|NCT02100657|3926074|FG002|NOT COMPLETED|Cohort 3: Dose Level 3||27
3197448|NCT02100670|3926087|FG000|STARTED|Overall Study||118
3197449|NCT02100670|3926088|FG001|STARTED|Overall Study||113
3197450|NCT02100670|3926089|FG002|STARTED|Overall Study||78
3197451|NCT02100670|3926090|FG003|STARTED|Overall Study||76
3197452|NCT02100670|3926087|FG000|COMPLETED|Overall Study||105
3197453|NCT02100670|3926088|FG001|COMPLETED|Overall Study||106
3197454|NCT02100670|3926089|FG002|COMPLETED|Overall Study||74
3197455|NCT02100670|3926090|FG003|COMPLETED|Overall Study||75
3197456|NCT02100670|3926087|FG000|NOT COMPLETED|Overall Study||13
3197457|NCT02100670|3926088|FG001|NOT COMPLETED|Overall Study||7
3197458|NCT02100670|3926089|FG002|NOT COMPLETED|Overall Study||4
3197459|NCT02100670|3926090|FG003|NOT COMPLETED|Overall Study||1
3197460|NCT02100696|3926113|FG000|STARTED|Induction Phase||130
3197461|NCT02100696|3926114|FG001|STARTED|Induction Phase||95
3197462|NCT02100696|3926115|FG002|STARTED|Induction Phase||384
3197463|NCT02100696|3926116|FG003|STARTED|Induction Phase||0
3197464|NCT02100696|3926117|FG004|STARTED|Induction Phase||0
3197465|NCT02100696|3926118|FG005|STARTED|Induction Phase||0
3197466|NCT02100696|3926113|FG000|COMPLETED|Induction Phase||115
3197467|NCT02100696|3926114|FG001|COMPLETED|Induction Phase||90
3197468|NCT02100696|3926115|FG002|COMPLETED|Induction Phase||358
3197469|NCT02100696|3926116|FG003|COMPLETED|Induction Phase||0
3197470|NCT02100696|3926117|FG004|COMPLETED|Induction Phase||0
3197471|NCT02100696|3926118|FG005|COMPLETED|Induction Phase||0
3197472|NCT02100696|3926113|FG000|NOT COMPLETED|Induction Phase||15
3197473|NCT02100696|3926114|FG001|NOT COMPLETED|Induction Phase||5
3197474|NCT02100696|3926115|FG002|NOT COMPLETED|Induction Phase||26
3197475|NCT02100696|3926116|FG003|NOT COMPLETED|Induction Phase||0
3197476|NCT02100696|3926117|FG004|NOT COMPLETED|Induction Phase||0
3197477|NCT02100696|3926118|FG005|NOT COMPLETED|Induction Phase||0
3197478|NCT02100696|3926113|FG000|STARTED|Maintenance Phase||0
3197479|NCT02100696|3926114|FG001|STARTED|Maintenance Phase||0
3197480|NCT02100696|3926115|FG002|STARTED|Maintenance Phase||0
3197481|NCT02100696|3926116|FG003|STARTED|Maintenance Phase||27
3197482|NCT02100696|3926117|FG004|STARTED|Maintenance Phase||115
3197483|NCT02100696|3926118|FG005|STARTED|Maintenance Phase||117
3197484|NCT02100696|3926113|FG000|COMPLETED|Maintenance Phase||0
3197485|NCT02100696|3926114|FG001|COMPLETED|Maintenance Phase||0
3197486|NCT02100696|3926115|FG002|COMPLETED|Maintenance Phase||0
3197487|NCT02100696|3926116|FG003|COMPLETED|Maintenance Phase||26
3197488|NCT02100696|3926117|FG004|COMPLETED|Maintenance Phase||106
3197489|NCT02100696|3926118|FG005|COMPLETED|Maintenance Phase||112
3197490|NCT02100696|3926113|FG000|NOT COMPLETED|Maintenance Phase||0
3197491|NCT02100696|3926114|FG001|NOT COMPLETED|Maintenance Phase||0
3197492|NCT02100696|3926115|FG002|NOT COMPLETED|Maintenance Phase||0
3197493|NCT02100696|3926116|FG003|NOT COMPLETED|Maintenance Phase||1
3197494|NCT02100696|3926117|FG004|NOT COMPLETED|Maintenance Phase||9
3197495|NCT02100696|3926118|FG005|NOT COMPLETED|Maintenance Phase||5
3197496|NCT02100748|3926151|FG000|STARTED|Overall Study||25
3197497|NCT02100748|3926152|FG001|STARTED|Overall Study||24
3197498|NCT02100748|3926153|FG002|STARTED|Overall Study||22
3197499|NCT02100748|3926154|FG003|STARTED|Overall Study||22
3197500|NCT02100748|3926155|FG004|STARTED|Overall Study||25
3197501|NCT02100748|3926156|FG005|STARTED|Overall Study||23
3197502|NCT02100748|3926157|FG006|STARTED|Overall Study||20
3197503|NCT02100748|3926158|FG007|STARTED|Overall Study||38
3197504|NCT02100748|3926159|FG008|STARTED|Overall Study||36
3197505|NCT02100748|3926160|FG009|STARTED|Overall Study||31
3197506|NCT02100748|3926161|FG010|STARTED|Overall Study||28
3197507|NCT02100748|3926162|FG011|STARTED|Overall Study||39
3197508|NCT02100748|3926151|FG000|COMPLETED|Overall Study||23
3197509|NCT02100748|3926152|FG001|COMPLETED|Overall Study||23
3197510|NCT02100748|3926153|FG002|COMPLETED|Overall Study||21
3197511|NCT02100748|3926154|FG003|COMPLETED|Overall Study||21
3197512|NCT02100748|3926155|FG004|COMPLETED|Overall Study||23
3197513|NCT02100748|3926156|FG005|COMPLETED|Overall Study||23
3197514|NCT02100748|3926157|FG006|COMPLETED|Overall Study||18
3197515|NCT02100748|3926158|FG007|COMPLETED|Overall Study||34
3197516|NCT02100748|3926159|FG008|COMPLETED|Overall Study||33
3197517|NCT02100748|3926160|FG009|COMPLETED|Overall Study||29
3197518|NCT02100748|3926161|FG010|COMPLETED|Overall Study||26
3197519|NCT02100748|3926162|FG011|COMPLETED|Overall Study||39
3197520|NCT02100748|3926151|FG000|NOT COMPLETED|Overall Study||2
3197521|NCT02100748|3926152|FG001|NOT COMPLETED|Overall Study||1
3197522|NCT02100748|3926153|FG002|NOT COMPLETED|Overall Study||1
3197523|NCT02100748|3926154|FG003|NOT COMPLETED|Overall Study||1
3197524|NCT02100748|3926155|FG004|NOT COMPLETED|Overall Study||2
3197525|NCT02100748|3926156|FG005|NOT COMPLETED|Overall Study||0
3197526|NCT02100748|3926157|FG006|NOT COMPLETED|Overall Study||2
3197527|NCT02100748|3926158|FG007|NOT COMPLETED|Overall Study||4
3197528|NCT02100748|3926159|FG008|NOT COMPLETED|Overall Study||3
3197529|NCT02100748|3926160|FG009|NOT COMPLETED|Overall Study||2
3197530|NCT02100748|3926161|FG010|NOT COMPLETED|Overall Study||2
3197531|NCT02100748|3926162|FG011|NOT COMPLETED|Overall Study||0
3197532|NCT02100813|3926196|FG000|STARTED|Overall Study||10
3197533|NCT02100813|3926197|FG001|STARTED|Overall Study||11
3197534|NCT02100813|3926198|FG002|STARTED|Overall Study||12
3197535|NCT02100813|3926199|FG003|STARTED|Overall Study||12
3197536|NCT02100813|3926200|FG004|STARTED|Overall Study||12
3197537|NCT02100813|3926201|FG005|STARTED|Overall Study||32
3197538|NCT02100813|3926202|FG006|STARTED|Overall Study||64
3197539|NCT02100813|3926203|FG007|STARTED|Overall Study||67
3197540|NCT02100813|3926196|FG000|COMPLETED|Overall Study||10
3197541|NCT02100813|3926197|FG001|COMPLETED|Overall Study||11
3197542|NCT02100813|3926198|FG002|COMPLETED|Overall Study||12
3197543|NCT02100813|3926199|FG003|COMPLETED|Overall Study||12
3197544|NCT02100813|3926200|FG004|COMPLETED|Overall Study||12
3197545|NCT02100813|3926201|FG005|COMPLETED|Overall Study||32
3197546|NCT02100813|3926202|FG006|COMPLETED|Overall Study||64
3197547|NCT02100813|3926203|FG007|COMPLETED|Overall Study||66
3197548|NCT02100813|3926196|FG000|NOT COMPLETED|Overall Study||0
3197549|NCT02100813|3926197|FG001|NOT COMPLETED|Overall Study||0
3197550|NCT02100813|3926198|FG002|NOT COMPLETED|Overall Study||0
3197551|NCT02100813|3926199|FG003|NOT COMPLETED|Overall Study||0
3197552|NCT02100813|3926200|FG004|NOT COMPLETED|Overall Study||0
3197553|NCT02100813|3926201|FG005|NOT COMPLETED|Overall Study||0
3197554|NCT02100813|3926202|FG006|NOT COMPLETED|Overall Study||0
3197555|NCT02100813|3926203|FG007|NOT COMPLETED|Overall Study||1
3197556|NCT02100826|3926221|FG000|STARTED|Period 1 (7 Days)||14
3197557|NCT02100826|3926222|FG001|STARTED|Period 1 (7 Days)||14
3197558|NCT02100826|3926221|FG000|COMPLETED|Period 1 (7 Days)||14
3197559|NCT02100826|3926222|FG001|COMPLETED|Period 1 (7 Days)||14
3197560|NCT02100826|3926221|FG000|NOT COMPLETED|Period 1 (7 Days)||0
3197561|NCT02100826|3926222|FG001|NOT COMPLETED|Period 1 (7 Days)||0
3197562|NCT02100826|3926221|FG000|STARTED|Washout Period (1 Day)||14
3197563|NCT02100826|3926222|FG001|STARTED|Washout Period (1 Day)||14
3197564|NCT02100826|3926221|FG000|COMPLETED|Washout Period (1 Day)||14
3197565|NCT02100826|3926222|FG001|COMPLETED|Washout Period (1 Day)||14
3197566|NCT02100826|3926221|FG000|NOT COMPLETED|Washout Period (1 Day)||0
3197567|NCT02100826|3926222|FG001|NOT COMPLETED|Washout Period (1 Day)||0
3197568|NCT02100826|3926221|FG000|STARTED|Period 2 (7 Days)||14
3197569|NCT02100826|3926222|FG001|STARTED|Period 2 (7 Days)||14
3197570|NCT02100826|3926221|FG000|COMPLETED|Period 2 (7 Days)||14
3197571|NCT02100826|3926222|FG001|COMPLETED|Period 2 (7 Days)||14
3197572|NCT02100826|3926221|FG000|NOT COMPLETED|Period 2 (7 Days)||0
3197573|NCT02100826|3926222|FG001|NOT COMPLETED|Period 2 (7 Days)||0
3197574|NCT02100839|3926230|FG000|STARTED|Single Ascending Dose||24
3197575|NCT02100839|3926231|FG001|STARTED|Single Ascending Dose||12
3197576|NCT02100839|3926230|FG000|COMPLETED|Single Ascending Dose||24
3197577|NCT02100839|3926231|FG001|COMPLETED|Single Ascending Dose||12
3197578|NCT02100839|3926230|FG000|NOT COMPLETED|Single Ascending Dose||0
3197579|NCT02100839|3926231|FG001|NOT COMPLETED|Single Ascending Dose||0
3197580|NCT02100839|3926230|FG000|STARTED|Multiple Ascending Dose||13
3197581|NCT02100839|3926231|FG001|STARTED|Multiple Ascending Dose||3
3197582|NCT02100839|3926230|FG000|COMPLETED|Multiple Ascending Dose||9
3197583|NCT02100839|3926231|FG001|COMPLETED|Multiple Ascending Dose||3
3197584|NCT02100839|3926230|FG000|NOT COMPLETED|Multiple Ascending Dose||4
3197585|NCT02100839|3926231|FG001|NOT COMPLETED|Multiple Ascending Dose||0
3197586|NCT02100930|3926237|FG000|STARTED|Overall Study||69
3197587|NCT02100930|3926237|FG000|COMPLETED|Overall Study||69
3197588|NCT02100930|3926237|FG000|NOT COMPLETED|Overall Study||0
3197589|NCT02100969|3926241|FG000|STARTED|Overall Study||23
3197590|NCT02100969|3926241|FG000|COMPLETED|Overall Study||22
3197591|NCT02100969|3926241|FG000|NOT COMPLETED|Overall Study||1
3197592|NCT02101008|3926246|FG000|STARTED|Overall Study||12
3197593|NCT02101008|3926246|FG000|COMPLETED|Overall Study||12
3197594|NCT02101008|3926246|FG000|NOT COMPLETED|Overall Study||0
3197595|NCT02101021|3926255|FG000|STARTED|Overall Study||7
3197596|NCT02101021|3926256|FG001|STARTED|Overall Study||4
3197597|NCT02101021|3926257|FG002|STARTED|Overall Study||7
3197598|NCT02101021|3926258|FG003|STARTED|Overall Study||3
3197599|NCT02101021|3926259|FG004|STARTED|Overall Study||4
3197600|NCT02101021|3926255|FG000|COMPLETED|Overall Study||0
3197601|NCT02101021|3926256|FG001|COMPLETED|Overall Study||0
3197602|NCT02101021|3926257|FG002|COMPLETED|Overall Study||0
3197603|NCT02101021|3926258|FG003|COMPLETED|Overall Study||0
3197604|NCT02101021|3926259|FG004|COMPLETED|Overall Study||0
3197605|NCT02101021|3926255|FG000|NOT COMPLETED|Overall Study||7
3197606|NCT02101021|3926256|FG001|NOT COMPLETED|Overall Study||4
3197607|NCT02101021|3926257|FG002|NOT COMPLETED|Overall Study||7
3197608|NCT02101021|3926258|FG003|NOT COMPLETED|Overall Study||3
3197609|NCT02101021|3926259|FG004|NOT COMPLETED|Overall Study||4
3197610|NCT02101034|3926276|FG000|STARTED|Overall Study||3
3197611|NCT02101034|3926277|FG001|STARTED|Overall Study||6
3197612|NCT02101034|3926278|FG002|STARTED|Overall Study||31
3197613|NCT02101034|3926279|FG003|STARTED|Overall Study||32
3197614|NCT02101034|3926280|FG004|STARTED|Overall Study||24
3197615|NCT02101034|3926276|FG000|COMPLETED|Overall Study||3
3197616|NCT02101034|3926277|FG001|COMPLETED|Overall Study||6
3197617|NCT02101034|3926278|FG002|COMPLETED|Overall Study||30
3197618|NCT02101034|3926279|FG003|COMPLETED|Overall Study||32
3197619|NCT02101034|3926280|FG004|COMPLETED|Overall Study||24
3197620|NCT02101034|3926276|FG000|NOT COMPLETED|Overall Study||0
3197621|NCT02101034|3926277|FG001|NOT COMPLETED|Overall Study||0
3197622|NCT02101034|3926278|FG002|NOT COMPLETED|Overall Study||1
3197623|NCT02101034|3926279|FG003|NOT COMPLETED|Overall Study||0
3197624|NCT02101034|3926280|FG004|NOT COMPLETED|Overall Study||0
3197625|NCT02101060|3926300|FG000|STARTED|Overall Study||17
3197626|NCT02101060|3926301|FG001|STARTED|Overall Study||16
3197627|NCT02101060|3926300|FG000|COMPLETED|Overall Study||12
3197628|NCT02101060|3926301|FG001|COMPLETED|Overall Study||12
3197629|NCT02101060|3926300|FG000|NOT COMPLETED|Overall Study||5
3197630|NCT02101060|3926301|FG001|NOT COMPLETED|Overall Study||4
3197631|NCT02101112|3926307|FG000|STARTED|Overall Study||6
3197632|NCT02101112|3926308|FG001|STARTED|Overall Study||5
3197633|NCT02101112|3926309|FG002|STARTED|Overall Study||6
3197634|NCT02101112|3926310|FG003|STARTED|Overall Study||5
3197635|NCT02101112|3926311|FG004|STARTED|Overall Study||6
3197636|NCT02101112|3926312|FG005|STARTED|Overall Study||5
3197637|NCT02101112|3926307|FG000|COMPLETED|Overall Study||6
3197638|NCT02101112|3926308|FG001|COMPLETED|Overall Study||5
3197639|NCT02101112|3926309|FG002|COMPLETED|Overall Study||5
3197640|NCT02101112|3926310|FG003|COMPLETED|Overall Study||5
3197641|NCT02101112|3926311|FG004|COMPLETED|Overall Study||5
3197642|NCT02101112|3926312|FG005|COMPLETED|Overall Study||5
3197643|NCT02101112|3926307|FG000|NOT COMPLETED|Overall Study||0
3197644|NCT02101112|3926308|FG001|NOT COMPLETED|Overall Study||0
3197645|NCT02101112|3926309|FG002|NOT COMPLETED|Overall Study||1
3197646|NCT02101112|3926310|FG003|NOT COMPLETED|Overall Study||0
3197647|NCT02101112|3926311|FG004|NOT COMPLETED|Overall Study||1
3197648|NCT02101112|3926312|FG005|NOT COMPLETED|Overall Study||0
3197649|NCT02101190|3926324|FG000|STARTED|Overall Study||8
3197650|NCT02101190|3926325|FG001|STARTED|Overall Study||8
3197651|NCT02101190|3926324|FG000|COMPLETED|Overall Study||8
3197652|NCT02101190|3926325|FG001|COMPLETED|Overall Study||8
3197653|NCT02101190|3926324|FG000|NOT COMPLETED|Overall Study||0
3197654|NCT02101190|3926325|FG001|NOT COMPLETED|Overall Study||0
3197655|NCT02101281|3926333|FG000|STARTED|Overall Study||20
3197656|NCT02101281|3926334|FG001|STARTED|Overall Study||20
3197657|NCT02101281|3926333|FG000|COMPLETED|Overall Study||20
3197658|NCT02101281|3926334|FG001|COMPLETED|Overall Study||19
3197659|NCT02101281|3926333|FG000|NOT COMPLETED|Overall Study||0
3197660|NCT02101281|3926334|FG001|NOT COMPLETED|Overall Study||1
3197661|NCT02101294|3926346|FG000|STARTED|Overall Study||31
3197662|NCT02101294|3926346|FG000|COMPLETED|Overall Study||20
3197663|NCT02101294|3926346|FG000|NOT COMPLETED|Overall Study||11
3197664|NCT02101359|3926355|FG000|STARTED|Overall Study||295
3197665|NCT02101359|3926356|FG001|STARTED|Overall Study||296
3197666|NCT02101359|3926355|FG000|COMPLETED|Overall Study||266
3197667|NCT02101359|3926356|FG001|COMPLETED|Overall Study||277
3197668|NCT02101359|3926355|FG000|NOT COMPLETED|Overall Study||29
3197669|NCT02101359|3926356|FG001|NOT COMPLETED|Overall Study||19
3197670|NCT02101411|3926365|FG000|STARTED|Overall Study||111
3197671|NCT02101411|3926366|FG001|STARTED|Overall Study||109
3197672|NCT02101411|3926367|FG002|STARTED|Overall Study||114
3197673|NCT02101411|3926365|FG000|COMPLETED|Overall Study||107
3197674|NCT02101411|3926366|FG001|COMPLETED|Overall Study||102
3197675|NCT02101411|3926367|FG002|COMPLETED|Overall Study||104
3197676|NCT02101411|3926365|FG000|NOT COMPLETED|Overall Study||4
3197677|NCT02101411|3926366|FG001|NOT COMPLETED|Overall Study||7
3197678|NCT02101411|3926367|FG002|NOT COMPLETED|Overall Study||10
3197679|NCT02101437|3926379|FG000|STARTED|Overall Study||20
3197680|NCT02101437|3926380|FG001|STARTED|Overall Study||54
3197681|NCT02101437|3926381|FG002|STARTED|Overall Study||52
3197682|NCT02101437|3926382|FG003|STARTED|Overall Study||49
3197683|NCT02101437|3926379|FG000|COMPLETED|Overall Study||20
3364781|NCT04004260|4096009|FG000|COMPLETED|Overall Study||37
3364782|NCT04004260|4096010|FG001|COMPLETED|Overall Study||47
3364783|NCT04004260|4096009|FG000|NOT COMPLETED|Overall Study||42
3364784|NCT04004260|4096010|FG001|NOT COMPLETED|Overall Study||32
3364785|NCT03997851|4096016|FG000|STARTED|Overall Study||17
3364786|NCT03997851|4096016|FG000|COMPLETED|Overall Study||17
3364787|NCT03997851|4096016|FG000|NOT COMPLETED|Overall Study||0
3364788|NCT03991715|4096026|FG000|STARTED|Overall Study||5
3364789|NCT03991715|4096026|FG000|COMPLETED|Overall Study||5
3364790|NCT03991715|4096026|FG000|NOT COMPLETED|Overall Study||0
3364791|NCT03990415|4096033|FG000|STARTED|Overall Study||19
3364792|NCT03990415|4096034|FG001|STARTED|Overall Study||19
3364793|NCT03990415|4096035|FG002|STARTED|Overall Study||14
3364794|NCT03990415|4096033|FG000|COMPLETED|Overall Study||15
3364795|NCT03990415|4096034|FG001|COMPLETED|Overall Study||17
3364796|NCT03990415|4096035|FG002|COMPLETED|Overall Study||14
3364797|NCT03990415|4096033|FG000|NOT COMPLETED|Overall Study||4
3364798|NCT03990415|4096034|FG001|NOT COMPLETED|Overall Study||2
3364799|NCT03990415|4096035|FG002|NOT COMPLETED|Overall Study||0
3364800|NCT04002960|4096043|FG000|STARTED|Overall Study||23
3364801|NCT04002960|4096043|FG000|COMPLETED|Overall Study||21
3364802|NCT04002960|4096043|FG000|NOT COMPLETED|Overall Study||2
3364803|NCT04002973|4096047|FG000|STARTED|Overall Study||11
3364804|NCT04002973|4096047|FG000|COMPLETED|Overall Study||11
3364805|NCT04002973|4096047|FG000|NOT COMPLETED|Overall Study||0
3364806|NCT04002648|4096053|FG000|STARTED|Overall Study||104
3364807|NCT04002648|4096054|FG001|STARTED|Overall Study||104
3364808|NCT04002648|4096053|FG000|COMPLETED|Overall Study||102
3364809|NCT04002648|4096054|FG001|COMPLETED|Overall Study||104
3364810|NCT04002648|4096053|FG000|NOT COMPLETED|Overall Study||2
3364811|NCT04002648|4096054|FG001|NOT COMPLETED|Overall Study||0
3364812|NCT03993210|4096062|FG000|STARTED|Overall Study||1
3364813|NCT03993210|4096063|FG001|STARTED|Overall Study||0
3364814|NCT03993210|4096062|FG000|COMPLETED|Overall Study||1
3364815|NCT03993210|4096063|FG001|COMPLETED|Overall Study||0
3364816|NCT03993210|4096062|FG000|NOT COMPLETED|Overall Study||0
3364817|NCT03993210|4096063|FG001|NOT COMPLETED|Overall Study||0
3364818|NCT03992014|4096073|FG000|STARTED|Treatment Period 1 (8 Days)||6
3364819|NCT03992014|4096073|FG000|COMPLETED|Treatment Period 1 (8 Days)||6
3364820|NCT03992014|4096073|FG000|NOT COMPLETED|Treatment Period 1 (8 Days)||0
3364821|NCT03992014|4096073|FG000|STARTED|Washout Period (7 Days)||6
3364822|NCT03992014|4096073|FG000|COMPLETED|Washout Period (7 Days)||6
3364823|NCT03992014|4096073|FG000|NOT COMPLETED|Washout Period (7 Days)||0
3364824|NCT03992014|4096073|FG000|STARTED|Treatment Period 2 (8 Days)||6
3364825|NCT03992014|4096073|FG000|COMPLETED|Treatment Period 2 (8 Days)||6
3364826|NCT03992014|4096073|FG000|NOT COMPLETED|Treatment Period 2 (8 Days)||0
3364827|NCT03990649|4096083|FG000|STARTED|Part A: DB Treatment Period (15 Weeks)||9
3364828|NCT03990649|4096084|FG001|STARTED|Part A: DB Treatment Period (15 Weeks)||15
3197684|NCT02101437|3926380|FG001|COMPLETED|Overall Study||54
3197685|NCT02101437|3926381|FG002|COMPLETED|Overall Study||52
3197686|NCT02101437|3926382|FG003|COMPLETED|Overall Study||49
3197687|NCT02101437|3926379|FG000|NOT COMPLETED|Overall Study||0
3197688|NCT02101437|3926380|FG001|NOT COMPLETED|Overall Study||0
3197689|NCT02101437|3926381|FG002|NOT COMPLETED|Overall Study||0
3197690|NCT02101437|3926382|FG003|NOT COMPLETED|Overall Study||0
3197691|NCT02101515|3926394|FG000|STARTED|Overall Study||37
3197692|NCT02101515|3926395|FG001|STARTED|Overall Study||41
3197693|NCT02101515|3926394|FG000|COMPLETED|Overall Study||37
3197694|NCT02101515|3926395|FG001|COMPLETED|Overall Study||41
3197695|NCT02101515|3926394|FG000|NOT COMPLETED|Overall Study||0
3197696|NCT02101515|3926395|FG001|NOT COMPLETED|Overall Study||0
3197697|NCT02101554|3926404|FG000|STARTED|Overall Study||6
3197698|NCT02101554|3926405|FG001|STARTED|Overall Study||10
3197699|NCT02101554|3926406|FG002|STARTED|Overall Study||3
3197700|NCT02101554|3926404|FG000|COMPLETED|Overall Study||3
3197701|NCT02101554|3926405|FG001|COMPLETED|Overall Study||5
3197702|NCT02101554|3926406|FG002|COMPLETED|Overall Study||2
3197703|NCT02101554|3926404|FG000|NOT COMPLETED|Overall Study||3
3197704|NCT02101554|3926405|FG001|NOT COMPLETED|Overall Study||5
3197705|NCT02101554|3926406|FG002|NOT COMPLETED|Overall Study||1
3197706|NCT02101918|3926414|FG000|STARTED|Overall Study||22
3197707|NCT02101918|3926414|FG000|COMPLETED|Overall Study||22
3197708|NCT02101918|3926414|FG000|NOT COMPLETED|Overall Study||0
3197709|NCT02101983|3926420|FG000|STARTED|Overall Study||5
3197710|NCT02101983|3926421|FG001|STARTED|Overall Study||6
3197711|NCT02101983|3926420|FG000|COMPLETED|Overall Study||4
3197712|NCT02101983|3926421|FG001|COMPLETED|Overall Study||6
3197713|NCT02101983|3926420|FG000|NOT COMPLETED|Overall Study||1
3197714|NCT02101983|3926421|FG001|NOT COMPLETED|Overall Study||0
3197715|NCT02102100|3926429|FG000|STARTED|Overall Study||32
3197716|NCT02102100|3926430|FG001|STARTED|Overall Study||25
3197717|NCT02102100|3926429|FG000|COMPLETED|Overall Study||23
3197718|NCT02102100|3926430|FG001|COMPLETED|Overall Study||18
3197719|NCT02102100|3926429|FG000|NOT COMPLETED|Overall Study||9
3197720|NCT02102100|3926430|FG001|NOT COMPLETED|Overall Study||7
3197721|NCT02102204|3926436|FG000|STARTED|Overall Study||902
3197722|NCT02102204|3926436|FG000|Received Etelcalcetide|Overall Study||884
3197723|NCT02102204|3926436|FG000|COMPLETED|Overall Study||598
3197724|NCT02102204|3926436|FG000|NOT COMPLETED|Overall Study||304
3197725|NCT02102230|3926443|FG000|STARTED|Overall Study||42
3197726|NCT02102230|3926444|FG001|STARTED|Overall Study||28
3197727|NCT02102230|3926445|FG002|STARTED|Overall Study||41
3197728|NCT02102230|3926443|FG000|COMPLETED|Overall Study||25
3197729|NCT02102230|3926444|FG001|COMPLETED|Overall Study||11
3197730|NCT02102230|3926445|FG002|COMPLETED|Overall Study||24
3197731|NCT02102230|3926443|FG000|NOT COMPLETED|Overall Study||17
3197732|NCT02102230|3926444|FG001|NOT COMPLETED|Overall Study||17
3197733|NCT02102230|3926445|FG002|NOT COMPLETED|Overall Study||17
3197734|NCT02102399|3926456|FG000|STARTED|Overall Study||20
3197735|NCT02102399|3926457|FG001|STARTED|Overall Study||21
3197736|NCT02102399|3926456|FG000|COMPLETED|Overall Study||14
3197737|NCT02102399|3926457|FG001|COMPLETED|Overall Study||17
3197738|NCT02102399|3926456|FG000|NOT COMPLETED|Overall Study||6
3197739|NCT02102399|3926457|FG001|NOT COMPLETED|Overall Study||4
3197740|NCT02102464|3926470|FG000|STARTED|Randomized Study||29
3197741|NCT02102464|3926471|FG001|STARTED|Randomized Study||26
3197742|NCT02102464|3926472|FG002|STARTED|Randomized Study||0
3197743|NCT02102464|3926470|FG000|COMPLETED|Randomized Study||29
3197744|NCT02102464|3926471|FG001|COMPLETED|Randomized Study||25
3197745|NCT02102464|3926472|FG002|COMPLETED|Randomized Study||0
3197746|NCT02102464|3926470|FG000|NOT COMPLETED|Randomized Study||0
3197747|NCT02102464|3926471|FG001|NOT COMPLETED|Randomized Study||1
3197748|NCT02102464|3926472|FG002|NOT COMPLETED|Randomized Study||0
3197749|NCT02102464|3926470|FG000|STARTED|Crossover LipiFlow Treatment of Control||0
3197750|NCT02102464|3926471|FG001|STARTED|Crossover LipiFlow Treatment of Control||0
3197751|NCT02102464|3926472|FG002|STARTED|Crossover LipiFlow Treatment of Control||25
3197752|NCT02102464|3926470|FG000|COMPLETED|Crossover LipiFlow Treatment of Control||0
3197753|NCT02102464|3926471|FG001|COMPLETED|Crossover LipiFlow Treatment of Control||0
3197754|NCT02102464|3926472|FG002|COMPLETED|Crossover LipiFlow Treatment of Control||25
3197755|NCT02102464|3926470|FG000|NOT COMPLETED|Crossover LipiFlow Treatment of Control||0
3197756|NCT02102464|3926471|FG001|NOT COMPLETED|Crossover LipiFlow Treatment of Control||0
3197757|NCT02102464|3926472|FG002|NOT COMPLETED|Crossover LipiFlow Treatment of Control||0
3197758|NCT02102490|3926481|FG000|STARTED|Overall Study||132
3197759|NCT02102490|3926481|FG000|Received at Least 1 Dose of Study Drug|Overall Study||132
3197760|NCT02102490|3926481|FG000|COMPLETED|Overall Study||125
3197761|NCT02102490|3926481|FG000|NOT COMPLETED|Overall Study||7
3197762|NCT02102724|3926487|FG000|STARTED|Overall Study||18
3197763|NCT02102724|3926488|FG001|STARTED|Overall Study||19
3197764|NCT02102724|3926487|FG000|COMPLETED|Overall Study||16
3197765|NCT02102724|3926488|FG001|COMPLETED|Overall Study||18
3197766|NCT02102724|3926487|FG000|NOT COMPLETED|Overall Study||2
3197767|NCT02102724|3926488|FG001|NOT COMPLETED|Overall Study||1
3197768|NCT02102932|3926502|FG000|STARTED|Overall Study||12
3197769|NCT02102932|3926503|FG001|STARTED|Overall Study||12
3197770|NCT02102932|3926504|FG002|STARTED|Overall Study||12
3197771|NCT02102932|3926505|FG003|STARTED|Overall Study||12
3197772|NCT02102932|3926506|FG004|STARTED|Overall Study||12
3197773|NCT02102932|3926507|FG005|STARTED|Overall Study||12
3197774|NCT02102932|3926508|FG006|STARTED|Overall Study||12
3197775|NCT02102932|3926509|FG007|STARTED|Overall Study||12
3197776|NCT02102932|3926502|FG000|COMPLETED|Overall Study||12
3197777|NCT02102932|3926503|FG001|COMPLETED|Overall Study||12
3197778|NCT02102932|3926504|FG002|COMPLETED|Overall Study||12
3197779|NCT02102932|3926505|FG003|COMPLETED|Overall Study||12
3197780|NCT02102932|3926506|FG004|COMPLETED|Overall Study||12
3197781|NCT02102932|3926507|FG005|COMPLETED|Overall Study||12
3197782|NCT02102932|3926508|FG006|COMPLETED|Overall Study||12
3197783|NCT02102932|3926509|FG007|COMPLETED|Overall Study||12
3197784|NCT02102932|3926502|FG000|NOT COMPLETED|Overall Study||0
3197785|NCT02102932|3926503|FG001|NOT COMPLETED|Overall Study||0
3197786|NCT02102932|3926504|FG002|NOT COMPLETED|Overall Study||0
3197787|NCT02102932|3926505|FG003|NOT COMPLETED|Overall Study||0
3197788|NCT02102932|3926506|FG004|NOT COMPLETED|Overall Study||0
3197789|NCT02102932|3926507|FG005|NOT COMPLETED|Overall Study||0
3197790|NCT02102932|3926508|FG006|NOT COMPLETED|Overall Study||0
3197791|NCT02102932|3926509|FG007|NOT COMPLETED|Overall Study||0
3197792|NCT02103062|3926529|FG000|STARTED|Overall Study||18
3197793|NCT02103062|3926530|FG001|STARTED|Overall Study||23
3197794|NCT02103062|3926529|FG000|Safety Population|Overall Study|Includes participants who received at least one dose of study drug.|18
3197795|NCT02103062|3926530|FG001|Safety Population|Overall Study|Includes participants who received at least one dose of study drug.|23
3197796|NCT02103062|3926529|FG000|Intent to Treat Population|Overall Study|Includes participants who met all eligibility criteria and received at least one dose of study drug.|17
3197797|NCT02103062|3926530|FG001|Intent to Treat Population|Overall Study|Includes participants who met all eligibility criteria and received at least one dose of study drug.|20
3197798|NCT02103062|3926529|FG000|COMPLETED|Overall Study||0
3197799|NCT02103062|3926530|FG001|COMPLETED|Overall Study||0
3197800|NCT02103062|3926529|FG000|NOT COMPLETED|Overall Study||18
3197801|NCT02103062|3926530|FG001|NOT COMPLETED|Overall Study||23
3197802|NCT02103114|3926540|FG000|STARTED|Overall Study||20
3197803|NCT02103114|3926541|FG001|STARTED|Overall Study||20
3197804|NCT02103114|3926540|FG000|COMPLETED|Overall Study||20
3197805|NCT02103114|3926541|FG001|COMPLETED|Overall Study||19
3197806|NCT02103114|3926540|FG000|NOT COMPLETED|Overall Study||0
3197807|NCT02103114|3926541|FG001|NOT COMPLETED|Overall Study||1
3197808|NCT02103127|3926548|FG000|STARTED|Overall Study||20
3197809|NCT02103127|3926548|FG000|COMPLETED|Overall Study||17
3197810|NCT02103127|3926548|FG000|NOT COMPLETED|Overall Study||3
3197811|NCT02103153|3926552|FG000|STARTED|Overall Study||44
3197812|NCT02103153|3926552|FG000|COMPLETED|Overall Study||27
3197813|NCT02103153|3926552|FG000|NOT COMPLETED|Overall Study||17
3197814|NCT02103218|3926563|FG000|STARTED|Overall Study||51
3197815|NCT02103218|3926564|FG001|STARTED|Overall Study||59
3197816|NCT02103218|3926565|FG002|STARTED|Overall Study||48
3197817|NCT02103218|3926566|FG003|STARTED|Overall Study||54
3197818|NCT02103218|3926563|FG000|COMPLETED|Overall Study||46
3197819|NCT02103218|3926564|FG001|COMPLETED|Overall Study||51
3197820|NCT02103218|3926565|FG002|COMPLETED|Overall Study||44
3197821|NCT02103218|3926566|FG003|COMPLETED|Overall Study||47
3197822|NCT02103218|3926563|FG000|NOT COMPLETED|Overall Study||5
3197823|NCT02103218|3926564|FG001|NOT COMPLETED|Overall Study||8
3197824|NCT02103218|3926565|FG002|NOT COMPLETED|Overall Study||4
3197825|NCT02103218|3926566|FG003|NOT COMPLETED|Overall Study||7
3197826|NCT02103270|3926577|FG000|STARTED|Overall Study||60
3197827|NCT02103270|3926578|FG001|STARTED|Overall Study||35
3197828|NCT02103270|3926579|FG002|STARTED|Overall Study||25
3197829|NCT02103270|3926577|FG000|COMPLETED|Overall Study||51
3197830|NCT02103270|3926578|FG001|COMPLETED|Overall Study||29
3197831|NCT02103270|3926579|FG002|COMPLETED|Overall Study||1
3197832|NCT02103270|3926577|FG000|NOT COMPLETED|Overall Study||9
3197833|NCT02103270|3926578|FG001|NOT COMPLETED|Overall Study||6
3197834|NCT02103270|3926579|FG002|NOT COMPLETED|Overall Study||24
3197835|NCT02103309|3926590|FG000|STARTED|Overall Study||20
3197836|NCT02103309|3926591|FG001|STARTED|Overall Study||22
3197837|NCT02103309|3926590|FG000|COMPLETED|Overall Study||20
3197838|NCT02103309|3926591|FG001|COMPLETED|Overall Study||22
3197839|NCT02103309|3926590|FG000|NOT COMPLETED|Overall Study||0
3197840|NCT02103309|3926591|FG001|NOT COMPLETED|Overall Study||0
3197841|NCT02103439|3926599|FG000|STARTED|Overall Study||70
3197842|NCT02103439|3926600|FG001|STARTED|Overall Study||70
3197843|NCT02103439|3926599|FG000|COMPLETED|Overall Study||67
3197844|NCT02103439|3926600|FG001|COMPLETED|Overall Study||67
3197845|NCT02103439|3926599|FG000|NOT COMPLETED|Overall Study||3
3197846|NCT02103439|3926600|FG001|NOT COMPLETED|Overall Study||3
3197847|NCT02103478|3926617|FG000|STARTED|Overall Study||7
3197848|NCT02103478|3926618|FG001|STARTED|Overall Study||6
3197849|NCT02103478|3926619|FG002|STARTED|Overall Study||6
3197850|NCT02103478|3926620|FG003|STARTED|Overall Study||6
3197851|NCT02103478|3926621|FG004|STARTED|Overall Study||19
3197852|NCT02103478|3926622|FG005|STARTED|Overall Study||25
3197853|NCT02103478|3926623|FG006|STARTED|Overall Study||25
3197854|NCT02103478|3926624|FG007|STARTED|Overall Study||16
3197855|NCT02103478|3926625|FG008|STARTED|Overall Study||14
3197856|NCT02103478|3926617|FG000|COMPLETED|Overall Study||0
3197857|NCT02103478|3926618|FG001|COMPLETED|Overall Study||0
3197858|NCT02103478|3926619|FG002|COMPLETED|Overall Study||0
3197859|NCT02103478|3926620|FG003|COMPLETED|Overall Study||0
3197860|NCT02103478|3926621|FG004|COMPLETED|Overall Study||0
3197861|NCT02103478|3926622|FG005|COMPLETED|Overall Study||0
3197862|NCT02103478|3926623|FG006|COMPLETED|Overall Study||0
3197863|NCT02103478|3926624|FG007|COMPLETED|Overall Study||0
3197864|NCT02103478|3926625|FG008|COMPLETED|Overall Study||0
3197865|NCT02103478|3926617|FG000|NOT COMPLETED|Overall Study||7
3197866|NCT02103478|3926618|FG001|NOT COMPLETED|Overall Study||6
3197867|NCT02103478|3926619|FG002|NOT COMPLETED|Overall Study||6
3197868|NCT02103478|3926620|FG003|NOT COMPLETED|Overall Study||6
3197869|NCT02103478|3926621|FG004|NOT COMPLETED|Overall Study||19
3197870|NCT02103478|3926622|FG005|NOT COMPLETED|Overall Study||25
3197871|NCT02103478|3926623|FG006|NOT COMPLETED|Overall Study||25
3197872|NCT02103478|3926624|FG007|NOT COMPLETED|Overall Study||16
3197873|NCT02103478|3926625|FG008|NOT COMPLETED|Overall Study||14
3197874|NCT02103608|3926655|FG000|STARTED|Overall Study||17
3197875|NCT02103608|3926655|FG000|COMPLETED|Overall Study||15
3197876|NCT02103608|3926655|FG000|NOT COMPLETED|Overall Study||2
3197877|NCT02103816|3926659|FG000|STARTED|Overall Study||21
3197878|NCT02103816|3926659|FG000|COMPLETED|Overall Study||13
3197879|NCT02103816|3926659|FG000|NOT COMPLETED|Overall Study||8
3197880|NCT02103855|3926663|FG000|STARTED|Overall Study||6
3197881|NCT02103855|3926663|FG000|COMPLETED|Overall Study||4
3197882|NCT02103855|3926663|FG000|NOT COMPLETED|Overall Study||2
3197883|NCT02104141|3926667|FG000|STARTED|Overall Study||51
3197884|NCT02104141|3926667|FG000|COMPLETED|Overall Study||51
3197885|NCT02104141|3926667|FG000|NOT COMPLETED|Overall Study||0
3197886|NCT02104167|3926671|FG000|STARTED|Overall Study||110
3197887|NCT02104167|3926671|FG000|COMPLETED|Overall Study||110
3197888|NCT02104167|3926671|FG000|NOT COMPLETED|Overall Study||0
3197889|NCT02104180|3926677|FG000|STARTED|Overall Study||31
3197890|NCT02104180|3926678|FG001|STARTED|Overall Study||31
3197891|NCT02104180|3926677|FG000|COMPLETED|Overall Study||30
3197892|NCT02104180|3926678|FG001|COMPLETED|Overall Study||31
3197893|NCT02104180|3926677|FG000|NOT COMPLETED|Overall Study||1
3197894|NCT02104180|3926678|FG001|NOT COMPLETED|Overall Study||0
3197895|NCT02104219|3926684|FG000|STARTED|Overall Study||32
3197896|NCT02104219|3926684|FG000|COMPLETED|Overall Study||32
3197897|NCT02104219|3926684|FG000|NOT COMPLETED|Overall Study||0
3197898|NCT02104414|3926691|FG000|STARTED|Overall Study||5
3197899|NCT02104414|3926692|FG001|STARTED|Overall Study||4
3197900|NCT02104414|3926693|FG002|STARTED|Overall Study||2
3197901|NCT02104414|3926691|FG000|COMPLETED|Overall Study||5
3197902|NCT02104414|3926692|FG001|COMPLETED|Overall Study||4
3197903|NCT02104414|3926693|FG002|COMPLETED|Overall Study||2
3197904|NCT02104414|3926691|FG000|NOT COMPLETED|Overall Study||0
3197905|NCT02104414|3926692|FG001|NOT COMPLETED|Overall Study||0
3197906|NCT02104414|3926693|FG002|NOT COMPLETED|Overall Study||0
3197907|NCT02104427|3926701|FG000|STARTED|Overall Study||12
3197908|NCT02104427|3926701|FG000|COMPLETED|Overall Study||12
3197909|NCT02104427|3926701|FG000|NOT COMPLETED|Overall Study||0
3197910|NCT02104505|3926725|FG000|STARTED|First Intervention (14 Days)||12
3197911|NCT02104505|3926726|FG001|STARTED|First Intervention (14 Days)|one participant withdrew prior to receiving study drug|11
3197912|NCT02104505|3926725|FG000|COMPLETED|First Intervention (14 Days)||10
3197913|NCT02104505|3926726|FG001|COMPLETED|First Intervention (14 Days)||8
3197914|NCT02104505|3926725|FG000|NOT COMPLETED|First Intervention (14 Days)||2
3197915|NCT02104505|3926726|FG001|NOT COMPLETED|First Intervention (14 Days)||3
3197916|NCT02104505|3926725|FG000|STARTED|Washout (Minimum 3 Weeks)||10
3197917|NCT02104505|3926726|FG001|STARTED|Washout (Minimum 3 Weeks)||8
3197918|NCT02104505|3926725|FG000|COMPLETED|Washout (Minimum 3 Weeks)||10
3197919|NCT02104505|3926726|FG001|COMPLETED|Washout (Minimum 3 Weeks)||8
3197920|NCT02104505|3926725|FG000|NOT COMPLETED|Washout (Minimum 3 Weeks)||0
3197921|NCT02104505|3926726|FG001|NOT COMPLETED|Washout (Minimum 3 Weeks)||0
3197922|NCT02104505|3926725|FG000|STARTED|Second Intervention (14 Days)||10
3197923|NCT02104505|3926726|FG001|STARTED|Second Intervention (14 Days)||8
3197924|NCT02104505|3926725|FG000|COMPLETED|Second Intervention (14 Days)||8
3197925|NCT02104505|3926726|FG001|COMPLETED|Second Intervention (14 Days)||7
3197926|NCT02104505|3926725|FG000|NOT COMPLETED|Second Intervention (14 Days)||2
3197927|NCT02104505|3926726|FG001|NOT COMPLETED|Second Intervention (14 Days)||1
3197928|NCT02104557|3926733|FG000|STARTED|Overall Study||362
3197929|NCT02104557|3926733|FG000|Safety Population|Overall Study||337
3197930|NCT02104557|3926733|FG000|COMPLETED|Overall Study||185
3197931|NCT02104557|3926733|FG000|NOT COMPLETED|Overall Study||177
3197932|NCT02104583|3926742|FG000|STARTED|Overall Study||48
3197933|NCT02104583|3926743|FG001|STARTED|Overall Study||46
3197934|NCT02104583|3926744|FG002|STARTED|Overall Study||70
3197935|NCT02104583|3926745|FG003|STARTED|Overall Study||74
3197936|NCT02104583|3926746|FG004|STARTED|Overall Study||75
3197937|NCT02104583|3926742|FG000|COMPLETED|Overall Study||30
3197938|NCT02104583|3926743|FG001|COMPLETED|Overall Study||35
3197939|NCT02104583|3926744|FG002|COMPLETED|Overall Study||54
3197940|NCT02104583|3926745|FG003|COMPLETED|Overall Study||57
3197941|NCT02104583|3926746|FG004|COMPLETED|Overall Study||63
3197942|NCT02104583|3926742|FG000|NOT COMPLETED|Overall Study||18
3197943|NCT02104583|3926743|FG001|NOT COMPLETED|Overall Study||11
3197944|NCT02104583|3926744|FG002|NOT COMPLETED|Overall Study||16
3197945|NCT02104583|3926745|FG003|NOT COMPLETED|Overall Study||17
3197946|NCT02104583|3926746|FG004|NOT COMPLETED|Overall Study||12
3197947|NCT02104739|3926767|FG000|STARTED|First Intervention (1 Day)||2
3197948|NCT02104739|3926768|FG001|STARTED|First Intervention (1 Day)||5
3197949|NCT02104739|3926769|FG002|STARTED|First Intervention (1 Day)||2
3197950|NCT02104739|3926770|FG003|STARTED|First Intervention (1 Day)||8
3197951|NCT02104739|3926771|FG004|STARTED|First Intervention (1 Day)||0
3197952|NCT02104739|3926772|FG005|STARTED|First Intervention (1 Day)||3
3197953|NCT02104739|3926773|FG006|STARTED|First Intervention (1 Day)||0
3197954|NCT02104739|3926767|FG000|COMPLETED|First Intervention (1 Day)||2
3197955|NCT02104739|3926768|FG001|COMPLETED|First Intervention (1 Day)||4
3197956|NCT02104739|3926769|FG002|COMPLETED|First Intervention (1 Day)||2
3197957|NCT02104739|3926770|FG003|COMPLETED|First Intervention (1 Day)||7
3197958|NCT02104739|3926771|FG004|COMPLETED|First Intervention (1 Day)||0
3197959|NCT02104739|3926772|FG005|COMPLETED|First Intervention (1 Day)||3
3197960|NCT02104739|3926773|FG006|COMPLETED|First Intervention (1 Day)||0
3197961|NCT02104739|3926767|FG000|NOT COMPLETED|First Intervention (1 Day)||0
3197962|NCT02104739|3926768|FG001|NOT COMPLETED|First Intervention (1 Day)||1
3197963|NCT02104739|3926769|FG002|NOT COMPLETED|First Intervention (1 Day)||0
3197964|NCT02104739|3926770|FG003|NOT COMPLETED|First Intervention (1 Day)||1
3197965|NCT02104739|3926771|FG004|NOT COMPLETED|First Intervention (1 Day)||0
3197966|NCT02104739|3926772|FG005|NOT COMPLETED|First Intervention (1 Day)||0
3197967|NCT02104739|3926773|FG006|NOT COMPLETED|First Intervention (1 Day)||0
3197968|NCT02104739|3926767|FG000|STARTED|Washout (Min of 10 and Max of 107 Days)||1
3197969|NCT02104739|3926768|FG001|STARTED|Washout (Min of 10 and Max of 107 Days)||4
3197970|NCT02104739|3926769|FG002|STARTED|Washout (Min of 10 and Max of 107 Days)||2
3197971|NCT02104739|3926770|FG003|STARTED|Washout (Min of 10 and Max of 107 Days)||7
3197972|NCT02104739|3926771|FG004|STARTED|Washout (Min of 10 and Max of 107 Days)||0
3197973|NCT02104739|3926772|FG005|STARTED|Washout (Min of 10 and Max of 107 Days)||2
3197974|NCT02104739|3926773|FG006|STARTED|Washout (Min of 10 and Max of 107 Days)||0
3197975|NCT02104739|3926767|FG000|COMPLETED|Washout (Min of 10 and Max of 107 Days)||1
3197976|NCT02104739|3926768|FG001|COMPLETED|Washout (Min of 10 and Max of 107 Days)||4
3197977|NCT02104739|3926769|FG002|COMPLETED|Washout (Min of 10 and Max of 107 Days)||2
3197978|NCT02104739|3926770|FG003|COMPLETED|Washout (Min of 10 and Max of 107 Days)||7
3197979|NCT02104739|3926771|FG004|COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
3197980|NCT02104739|3926772|FG005|COMPLETED|Washout (Min of 10 and Max of 107 Days)||2
3197981|NCT02104739|3926773|FG006|COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
3197982|NCT02104739|3926767|FG000|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
3197983|NCT02104739|3926768|FG001|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
3197984|NCT02104739|3926769|FG002|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
3197985|NCT02104739|3926770|FG003|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
3197986|NCT02104739|3926771|FG004|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
3197987|NCT02104739|3926772|FG005|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
3197988|NCT02104739|3926773|FG006|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
3197989|NCT02104739|3926767|FG000|STARTED|Second Intervention (1 Day)||1
3197990|NCT02104739|3926768|FG001|STARTED|Second Intervention (1 Day)||4
3197991|NCT02104739|3926769|FG002|STARTED|Second Intervention (1 Day)||2
3197992|NCT02104739|3926770|FG003|STARTED|Second Intervention (1 Day)||7
3197993|NCT02104739|3926771|FG004|STARTED|Second Intervention (1 Day)||0
3197994|NCT02104739|3926772|FG005|STARTED|Second Intervention (1 Day)||2
3197995|NCT02104739|3926773|FG006|STARTED|Second Intervention (1 Day)||0
3197996|NCT02104739|3926767|FG000|COMPLETED|Second Intervention (1 Day)||1
3197997|NCT02104739|3926768|FG001|COMPLETED|Second Intervention (1 Day)||4
3197998|NCT02104739|3926769|FG002|COMPLETED|Second Intervention (1 Day)||2
3197999|NCT02104739|3926770|FG003|COMPLETED|Second Intervention (1 Day)||7
3198000|NCT02104739|3926771|FG004|COMPLETED|Second Intervention (1 Day)||0
3198001|NCT02104739|3926772|FG005|COMPLETED|Second Intervention (1 Day)||2
3198002|NCT02104739|3926773|FG006|COMPLETED|Second Intervention (1 Day)||0
3198003|NCT02104739|3926767|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
3198004|NCT02104739|3926768|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
3198005|NCT02104739|3926769|FG002|NOT COMPLETED|Second Intervention (1 Day)||0
3198006|NCT02104739|3926770|FG003|NOT COMPLETED|Second Intervention (1 Day)||0
3198007|NCT02104739|3926771|FG004|NOT COMPLETED|Second Intervention (1 Day)||0
3198008|NCT02104739|3926772|FG005|NOT COMPLETED|Second Intervention (1 Day)||0
3198009|NCT02104739|3926773|FG006|NOT COMPLETED|Second Intervention (1 Day)||0
3198010|NCT02104739|3926767|FG000|STARTED|Washout (Min of 10 and Max of 107 Days)||1
3198011|NCT02104739|3926768|FG001|STARTED|Washout (Min of 10 and Max of 107 Days)||4
3198012|NCT02104739|3926769|FG002|STARTED|Washout (Min of 10 and Max of 107 Days)||2
3198013|NCT02104739|3926770|FG003|STARTED|Washout (Min of 10 and Max of 107 Days)||7
3198014|NCT02104739|3926771|FG004|STARTED|Washout (Min of 10 and Max of 107 Days)||0
3198015|NCT02104739|3926772|FG005|STARTED|Washout (Min of 10 and Max of 107 Days)||2
3198016|NCT02104739|3926773|FG006|STARTED|Washout (Min of 10 and Max of 107 Days)||0
3198017|NCT02104739|3926767|FG000|COMPLETED|Washout (Min of 10 and Max of 107 Days)||1
3198018|NCT02104739|3926768|FG001|COMPLETED|Washout (Min of 10 and Max of 107 Days)||4
3198019|NCT02104739|3926769|FG002|COMPLETED|Washout (Min of 10 and Max of 107 Days)||2
3198020|NCT02104739|3926770|FG003|COMPLETED|Washout (Min of 10 and Max of 107 Days)||7
3198021|NCT02104739|3926771|FG004|COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
3198022|NCT02104739|3926772|FG005|COMPLETED|Washout (Min of 10 and Max of 107 Days)||2
3198023|NCT02104739|3926773|FG006|COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
3198024|NCT02104739|3926767|FG000|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
3198025|NCT02104739|3926768|FG001|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
3198026|NCT02104739|3926769|FG002|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
3198027|NCT02104739|3926770|FG003|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
3198028|NCT02104739|3926771|FG004|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
3198029|NCT02104739|3926772|FG005|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
3198030|NCT02104739|3926773|FG006|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
3198031|NCT02104739|3926767|FG000|STARTED|Third Intervention (1 Day)||1
3198032|NCT02104739|3926768|FG001|STARTED|Third Intervention (1 Day)||4
3198033|NCT02104739|3926769|FG002|STARTED|Third Intervention (1 Day)||2
3198034|NCT02104739|3926770|FG003|STARTED|Third Intervention (1 Day)||7
3198035|NCT02104739|3926771|FG004|STARTED|Third Intervention (1 Day)||0
3198036|NCT02104739|3926772|FG005|STARTED|Third Intervention (1 Day)||2
3198037|NCT02104739|3926773|FG006|STARTED|Third Intervention (1 Day)||0
3198038|NCT02104739|3926767|FG000|COMPLETED|Third Intervention (1 Day)||1
3198039|NCT02104739|3926768|FG001|COMPLETED|Third Intervention (1 Day)||4
3198040|NCT02104739|3926769|FG002|COMPLETED|Third Intervention (1 Day)||2
3198041|NCT02104739|3926770|FG003|COMPLETED|Third Intervention (1 Day)||7
3198042|NCT02104739|3926771|FG004|COMPLETED|Third Intervention (1 Day)||0
3198043|NCT02104739|3926772|FG005|COMPLETED|Third Intervention (1 Day)||2
3198044|NCT02104739|3926773|FG006|COMPLETED|Third Intervention (1 Day)||0
3198045|NCT02104739|3926767|FG000|NOT COMPLETED|Third Intervention (1 Day)||0
3198046|NCT02104739|3926768|FG001|NOT COMPLETED|Third Intervention (1 Day)||0
3198047|NCT02104739|3926769|FG002|NOT COMPLETED|Third Intervention (1 Day)||0
3198048|NCT02104739|3926770|FG003|NOT COMPLETED|Third Intervention (1 Day)||0
3198049|NCT02104739|3926771|FG004|NOT COMPLETED|Third Intervention (1 Day)||0
3198050|NCT02104739|3926772|FG005|NOT COMPLETED|Third Intervention (1 Day)||0
3198051|NCT02104739|3926773|FG006|NOT COMPLETED|Third Intervention (1 Day)||0
3198052|NCT02104739|3926767|FG000|STARTED|Washout (Min of 10 and Max of 323 Days)||0
3198053|NCT02104739|3926768|FG001|STARTED|Washout (Min of 10 and Max of 323 Days)||0
3198054|NCT02104739|3926769|FG002|STARTED|Washout (Min of 10 and Max of 323 Days)||0
3198055|NCT02104739|3926770|FG003|STARTED|Washout (Min of 10 and Max of 323 Days)||0
3198056|NCT02104739|3926771|FG004|STARTED|Washout (Min of 10 and Max of 323 Days)||0
3198057|NCT02104739|3926772|FG005|STARTED|Washout (Min of 10 and Max of 323 Days)||0
3198058|NCT02104739|3926773|FG006|STARTED|Washout (Min of 10 and Max of 323 Days)||8
3198059|NCT02104739|3926767|FG000|COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
3198060|NCT02104739|3926768|FG001|COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
3198061|NCT02104739|3926769|FG002|COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
3198062|NCT02104739|3926770|FG003|COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
3198063|NCT02104739|3926771|FG004|COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
3198064|NCT02104739|3926772|FG005|COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
3198065|NCT02104739|3926773|FG006|COMPLETED|Washout (Min of 10 and Max of 323 Days)||7
3198066|NCT02104739|3926767|FG000|NOT COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
3198067|NCT02104739|3926768|FG001|NOT COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
3198068|NCT02104739|3926769|FG002|NOT COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
3198069|NCT02104739|3926770|FG003|NOT COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
3198070|NCT02104739|3926771|FG004|NOT COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
3198071|NCT02104739|3926772|FG005|NOT COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
3198072|NCT02104739|3926773|FG006|NOT COMPLETED|Washout (Min of 10 and Max of 323 Days)||1
3198073|NCT02104739|3926767|FG000|STARTED|Extension Phase (6 Weeks)||0
3198074|NCT02104739|3926768|FG001|STARTED|Extension Phase (6 Weeks)||0
3198075|NCT02104739|3926769|FG002|STARTED|Extension Phase (6 Weeks)||0
3198076|NCT02104739|3926770|FG003|STARTED|Extension Phase (6 Weeks)||0
3198077|NCT02104739|3926771|FG004|STARTED|Extension Phase (6 Weeks)||0
3198078|NCT02104739|3926772|FG005|STARTED|Extension Phase (6 Weeks)||0
3198079|NCT02104739|3926773|FG006|STARTED|Extension Phase (6 Weeks)||8
3198080|NCT02104739|3926767|FG000|COMPLETED|Extension Phase (6 Weeks)||0
3198081|NCT02104739|3926768|FG001|COMPLETED|Extension Phase (6 Weeks)||0
3198082|NCT02104739|3926769|FG002|COMPLETED|Extension Phase (6 Weeks)||0
3198083|NCT02104739|3926770|FG003|COMPLETED|Extension Phase (6 Weeks)||0
3198084|NCT02104739|3926771|FG004|COMPLETED|Extension Phase (6 Weeks)||0
3198085|NCT02104739|3926772|FG005|COMPLETED|Extension Phase (6 Weeks)||0
3198086|NCT02104739|3926773|FG006|COMPLETED|Extension Phase (6 Weeks)||7
3198087|NCT02104739|3926767|FG000|NOT COMPLETED|Extension Phase (6 Weeks)||0
3198088|NCT02104739|3926768|FG001|NOT COMPLETED|Extension Phase (6 Weeks)||0
3198089|NCT02104739|3926769|FG002|NOT COMPLETED|Extension Phase (6 Weeks)||0
3198090|NCT02104739|3926770|FG003|NOT COMPLETED|Extension Phase (6 Weeks)||0
3198091|NCT02104739|3926771|FG004|NOT COMPLETED|Extension Phase (6 Weeks)||0
3198092|NCT02104739|3926772|FG005|NOT COMPLETED|Extension Phase (6 Weeks)||0
3198093|NCT02104739|3926773|FG006|NOT COMPLETED|Extension Phase (6 Weeks)||1
3198094|NCT02104752|3926785|FG000|STARTED|Overall Study||18
3198095|NCT02104752|3926786|FG001|STARTED|Overall Study||21
3198096|NCT02104752|3926785|FG000|COMPLETED|Overall Study||17
3198097|NCT02104752|3926786|FG001|COMPLETED|Overall Study||19
3198098|NCT02104752|3926785|FG000|NOT COMPLETED|Overall Study||1
3198099|NCT02104752|3926786|FG001|NOT COMPLETED|Overall Study||2
3198100|NCT02104765|3926799|FG000|STARTED|Overall Study||8
3198101|NCT02104765|3926800|FG001|STARTED|Overall Study||6
3198102|NCT02104765|3926801|FG002|STARTED|Overall Study||6
3198103|NCT02104765|3926802|FG003|STARTED|Overall Study||7
3198104|NCT02104765|3926803|FG004|STARTED|Overall Study||8
3198105|NCT02104765|3926804|FG005|STARTED|Overall Study||2
3198106|NCT02104765|3926805|FG006|STARTED|Overall Study||8
3198107|NCT02104765|3926799|FG000|Received at Least 1 Dose of Study Drug|Overall Study||8
3198108|NCT02104765|3926800|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6
3198109|NCT02104765|3926801|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
3198110|NCT02104765|3926802|FG003|Received at Least 1 Dose of Study Drug|Overall Study||7
3198111|NCT02104765|3926803|FG004|Received at Least 1 Dose of Study Drug|Overall Study||8
3198112|NCT02104765|3926804|FG005|Received at Least 1 Dose of Study Drug|Overall Study||2
3198113|NCT02104765|3926805|FG006|Received at Least 1 Dose of Study Drug|Overall Study||8
3198114|NCT02104765|3926799|FG000|COMPLETED|Overall Study||8
3198115|NCT02104765|3926800|FG001|COMPLETED|Overall Study||6
3198116|NCT02104765|3926801|FG002|COMPLETED|Overall Study||5
3198117|NCT02104765|3926802|FG003|COMPLETED|Overall Study||6
3198118|NCT02104765|3926803|FG004|COMPLETED|Overall Study||7
3198119|NCT02104765|3926804|FG005|COMPLETED|Overall Study||2
3198120|NCT02104765|3926805|FG006|COMPLETED|Overall Study||7
3198121|NCT02104765|3926799|FG000|NOT COMPLETED|Overall Study||0
3198122|NCT02104765|3926800|FG001|NOT COMPLETED|Overall Study||0
3198123|NCT02104765|3926801|FG002|NOT COMPLETED|Overall Study||1
3198124|NCT02104765|3926802|FG003|NOT COMPLETED|Overall Study||1
3198125|NCT02104765|3926803|FG004|NOT COMPLETED|Overall Study||1
3198126|NCT02104765|3926804|FG005|NOT COMPLETED|Overall Study||0
3198127|NCT02104765|3926805|FG006|NOT COMPLETED|Overall Study||1
3198128|NCT02104804|3926829|FG000|STARTED|Overall Study|Number of patients who were randomized|234
3198129|NCT02104804|3926830|FG001|STARTED|Overall Study|Number of patients who were randomized|232
3198130|NCT02104804|3926829|FG000|COMPLETED|Overall Study|Number of patients who completed 24 weeks of treatment|218
3198131|NCT02104804|3926830|FG001|COMPLETED|Overall Study|Of the 19 who did not complete, 1 did not take study medication after randomization.|213
3198132|NCT02104804|3926829|FG000|NOT COMPLETED|Overall Study||16
3198133|NCT02104804|3926830|FG001|NOT COMPLETED|Overall Study||19
3198134|NCT02104817|3926838|FG000|STARTED|Overall Study||6539
3198135|NCT02104817|3926839|FG001|STARTED|Overall Study||6539
3198136|NCT02104817|3926838|FG000|COMPLETED|Overall Study||80
3198137|NCT02104817|3926839|FG001|COMPLETED|Overall Study||92
3198138|NCT02104817|3926838|FG000|NOT COMPLETED|Overall Study||6459
3198139|NCT02104817|3926839|FG001|NOT COMPLETED|Overall Study||6447
3198140|NCT02104830|3926848|FG000|STARTED|Overall Study||42
3198141|NCT02104830|3926849|FG001|STARTED|Overall Study||43
3198142|NCT02104830|3926850|FG002|STARTED|Overall Study||43
3198143|NCT02104830|3926848|FG000|COMPLETED|Overall Study||38
3198144|NCT02104830|3926849|FG001|COMPLETED|Overall Study||36
3198145|NCT02104830|3926850|FG002|COMPLETED|Overall Study||36
3198146|NCT02104830|3926848|FG000|NOT COMPLETED|Overall Study||4
3198147|NCT02104830|3926849|FG001|NOT COMPLETED|Overall Study||7
3198148|NCT02104830|3926850|FG002|NOT COMPLETED|Overall Study||7
3198149|NCT02104895|3926860|FG000|STARTED|Overall Study||260
3198150|NCT02104895|3926861|FG001|STARTED|Overall Study||260
3198151|NCT02104895|3926860|FG000|COMPLETED|Overall Study||260
3198152|NCT02104895|3926861|FG001|COMPLETED|Overall Study||246
3198153|NCT02104895|3926860|FG000|NOT COMPLETED|Overall Study||0
3198154|NCT02104895|3926861|FG001|NOT COMPLETED|Overall Study||14
3198155|NCT02104947|3926869|FG000|STARTED|Overall Study||301
3198156|NCT02104947|3926870|FG001|STARTED|Overall Study||202
3198157|NCT02104947|3926869|FG000|COMPLETED|Overall Study||222
3198158|NCT02104947|3926870|FG001|COMPLETED|Overall Study||146
3198159|NCT02104947|3926869|FG000|NOT COMPLETED|Overall Study||79
3198160|NCT02104947|3926870|FG001|NOT COMPLETED|Overall Study||56
3198161|NCT02105012|3926880|FG000|STARTED|Overall Study||147
3198162|NCT02105012|3926880|FG000|BD MDI 320 µg|Overall Study||124
3198163|NCT02105012|3926880|FG000|BD MDI 160 µg|Overall Study||132
3198164|NCT02105012|3926880|FG000|BD MDI 80 µg|Overall Study||64
3198165|NCT02105012|3926880|FG000|BD MDI 40 µg|Overall Study||63
3198166|NCT02105012|3926880|FG000|Placebo MDI|Overall Study||127
3198167|NCT02105012|3926880|FG000|COMPLETED|Overall Study||114
3198168|NCT02105012|3926880|FG000|NOT COMPLETED|Overall Study||33
3198169|NCT02105246|3926894|FG000|STARTED|Overall Study||557
3198170|NCT02105246|3926895|FG001|STARTED|Overall Study||597
3198171|NCT02105246|3926894|FG000|COMPLETED|Overall Study||557
3198172|NCT02105246|3926895|FG001|COMPLETED|Overall Study||597
3198173|NCT02105246|3926894|FG000|NOT COMPLETED|Overall Study||0
3198174|NCT02105246|3926895|FG001|NOT COMPLETED|Overall Study||0
3364829|NCT03990649|4096085|FG002|STARTED|Part A: DB Treatment Period (15 Weeks)||0
3364830|NCT03990649|4096083|FG000|COMPLETED|Part A: DB Treatment Period (15 Weeks)||6
3364831|NCT03990649|4096084|FG001|COMPLETED|Part A: DB Treatment Period (15 Weeks)||12
3364832|NCT03990649|4096085|FG002|COMPLETED|Part A: DB Treatment Period (15 Weeks)||0
3364833|NCT03990649|4096083|FG000|NOT COMPLETED|Part A: DB Treatment Period (15 Weeks)||3
3364834|NCT03990649|4096084|FG001|NOT COMPLETED|Part A: DB Treatment Period (15 Weeks)||3
3364835|NCT03990649|4096085|FG002|NOT COMPLETED|Part A: DB Treatment Period (15 Weeks)||0
3364836|NCT03990649|4096083|FG000|STARTED|Part B: OL Extension Period (14 Weeks)||0
3364837|NCT03990649|4096084|FG001|STARTED|Part B: OL Extension Period (14 Weeks)||0
3364838|NCT03990649|4096085|FG002|STARTED|Part B: OL Extension Period (14 Weeks)||18
3364839|NCT03990649|4096083|FG000|COMPLETED|Part B: OL Extension Period (14 Weeks)||0
3364840|NCT03990649|4096084|FG001|COMPLETED|Part B: OL Extension Period (14 Weeks)||0
3364841|NCT03990649|4096085|FG002|COMPLETED|Part B: OL Extension Period (14 Weeks)||14
3364842|NCT03990649|4096083|FG000|NOT COMPLETED|Part B: OL Extension Period (14 Weeks)||0
3364843|NCT03990649|4096084|FG001|NOT COMPLETED|Part B: OL Extension Period (14 Weeks)||0
3364844|NCT03990649|4096085|FG002|NOT COMPLETED|Part B: OL Extension Period (14 Weeks)||4
3364845|NCT04002791|4096094|FG000|STARTED|Overall Study||127
3364846|NCT04002791|4096095|FG001|STARTED|Overall Study||126
3198175|NCT02105272|3926907|FG000|STARTED|Overall Study||118
3198176|NCT02105272|3926908|FG001|STARTED|Overall Study||119
3198177|NCT02105272|3926907|FG000|COMPLETED|Overall Study||113
3198178|NCT02105272|3926908|FG001|COMPLETED|Overall Study||116
3198179|NCT02105272|3926907|FG000|NOT COMPLETED|Overall Study||5
3198180|NCT02105272|3926908|FG001|NOT COMPLETED|Overall Study||3
3198181|NCT02105285|3926917|FG000|STARTED|Overall Study||78
3198182|NCT02105285|3926918|FG001|STARTED|Overall Study||78
3198183|NCT02105285|3926919|FG002|STARTED|Overall Study||37
3198184|NCT02105285|3926917|FG000|COMPLETED|Overall Study||76
3198185|NCT02105285|3926918|FG001|COMPLETED|Overall Study||76
3198186|NCT02105285|3926919|FG002|COMPLETED|Overall Study||37
3198187|NCT02105285|3926917|FG000|NOT COMPLETED|Overall Study||2
3198188|NCT02105285|3926918|FG001|NOT COMPLETED|Overall Study||2
3198189|NCT02105285|3926919|FG002|NOT COMPLETED|Overall Study||0
3198190|NCT02105324|3926926|FG000|STARTED|Period 1||9
3198191|NCT02105324|3926927|FG001|STARTED|Period 1||10
3198192|NCT02105324|3926926|FG000|COMPLETED|Period 1||9
3198193|NCT02105324|3926927|FG001|COMPLETED|Period 1||10
3198194|NCT02105324|3926926|FG000|NOT COMPLETED|Period 1||0
3198195|NCT02105324|3926927|FG001|NOT COMPLETED|Period 1||0
3198196|NCT02105324|3926926|FG000|STARTED|Period 2||9
3198197|NCT02105324|3926927|FG001|STARTED|Period 2||10
3198198|NCT02105324|3926926|FG000|COMPLETED|Period 2||9
3198199|NCT02105324|3926927|FG001|COMPLETED|Period 2||10
3198200|NCT02105324|3926926|FG000|NOT COMPLETED|Period 2||0
3198201|NCT02105324|3926927|FG001|NOT COMPLETED|Period 2||0
3198202|NCT02105415|3926938|FG000|STARTED|Overall Study||76
3198203|NCT02105415|3926939|FG001|STARTED|Overall Study||84
3198204|NCT02105415|3926938|FG000|COMPLETED|Overall Study||73
3198205|NCT02105415|3926939|FG001|COMPLETED|Overall Study||79
3198206|NCT02105415|3926938|FG000|NOT COMPLETED|Overall Study||3
3198207|NCT02105415|3926939|FG001|NOT COMPLETED|Overall Study||5
3198208|NCT02105454|3926950|FG000|STARTED|Overall Study||79
3198209|NCT02105454|3926950|FG000|COMPLETED|Overall Study||78
3198210|NCT02105454|3926950|FG000|NOT COMPLETED|Overall Study||1
3198211|NCT02105467|3926956|FG000|STARTED|Period 1||316
3198212|NCT02105467|3926957|FG001|STARTED|Period 1||105
3198213|NCT02105467|3926956|FG000|COMPLETED|Period 1||314
3198214|NCT02105467|3926957|FG001|COMPLETED|Period 1||105
3198215|NCT02105467|3926956|FG000|NOT COMPLETED|Period 1||2
3198216|NCT02105467|3926957|FG001|NOT COMPLETED|Period 1||0
3198217|NCT02105467|3926956|FG000|STARTED|Period 2||314
3198218|NCT02105467|3926957|FG001|STARTED|Period 2|One participant did not receive deferred treatment (Period 2) but proceeded directly to Period 3|104
3198219|NCT02105467|3926956|FG000|COMPLETED|Period 2||312
3198220|NCT02105467|3926957|FG001|COMPLETED|Period 2||102
3198221|NCT02105467|3926956|FG000|NOT COMPLETED|Period 2||2
3198222|NCT02105467|3926957|FG001|NOT COMPLETED|Period 2||2
3198223|NCT02105467|3926956|FG000|STARTED|Period 3|The Immediate Treatment Group completed the study with Period 2|0
3198224|NCT02105467|3926957|FG001|STARTED|Period 3|One participant did not receive deferred treatment (Period 2) but proceeded directly to Period 3|103
3198225|NCT02105467|3926956|FG000|COMPLETED|Period 3||0
3198226|NCT02105467|3926957|FG001|COMPLETED|Period 3||102
3198227|NCT02105467|3926956|FG000|NOT COMPLETED|Period 3||0
3198228|NCT02105467|3926957|FG001|NOT COMPLETED|Period 3||1
3198229|NCT02105558|3926966|FG000|STARTED|Overall Study||15
3198230|NCT02105558|3926967|FG001|STARTED|Overall Study||28
3198231|NCT02105558|3926966|FG000|COMPLETED|Overall Study||15
3198232|NCT02105558|3926967|FG001|COMPLETED|Overall Study||28
3198233|NCT02105558|3926966|FG000|NOT COMPLETED|Overall Study||0
3198234|NCT02105558|3926967|FG001|NOT COMPLETED|Overall Study||0
3198235|NCT02105662|3926973|FG000|STARTED|Overall Study||218
3198236|NCT02105662|3926973|FG000|COMPLETED|Overall Study||212
3198237|NCT02105662|3926973|FG000|NOT COMPLETED|Overall Study||6
3198238|NCT02105688|3926979|FG000|STARTED|Part A: Double-Blind||201
3198239|NCT02105688|3926980|FG001|STARTED|Part A: Double-Blind||100
3198240|NCT02105688|3926979|FG000|COMPLETED|Part A: Double-Blind|Completed Part A|181
3198241|NCT02105688|3926980|FG001|COMPLETED|Part A: Double-Blind|Completed Part A|83
3198242|NCT02105688|3926979|FG000|NOT COMPLETED|Part A: Double-Blind||20
3198243|NCT02105688|3926980|FG001|NOT COMPLETED|Part A: Double-Blind||17
3198244|NCT02105688|3926979|FG000|STARTED|Part B: Observational Follow-up|Completed Part A and met Part B Extension criteria|131
3198245|NCT02105688|3926980|FG001|STARTED|Part B: Observational Follow-up|Completed Part A and met Part B Extension criteria|68
3198246|NCT02105688|3926979|FG000|COMPLETED|Part B: Observational Follow-up|Completed Part B extension|94
3198247|NCT02105688|3926980|FG001|COMPLETED|Part B: Observational Follow-up|Completed Part B extension|48
3198248|NCT02105688|3926979|FG000|NOT COMPLETED|Part B: Observational Follow-up||37
3198249|NCT02105688|3926980|FG001|NOT COMPLETED|Part B: Observational Follow-up||20
3198250|NCT02105701|3926991|FG000|STARTED|Overall Study||105
3198251|NCT02105701|3926992|FG001|STARTED|Overall Study||104
3198252|NCT02105701|3926993|FG002|STARTED|Overall Study||105
3198253|NCT02105701|3926994|FG003|STARTED|Overall Study||106
3198254|NCT02105701|3926991|FG000|COMPLETED|Overall Study||101
3198255|NCT02105701|3926992|FG001|COMPLETED|Overall Study||103
3198256|NCT02105701|3926993|FG002|COMPLETED|Overall Study||102
3198257|NCT02105701|3926994|FG003|COMPLETED|Overall Study||104
3198258|NCT02105701|3926991|FG000|NOT COMPLETED|Overall Study||4
3198259|NCT02105701|3926992|FG001|NOT COMPLETED|Overall Study||1
3198260|NCT02105701|3926993|FG002|NOT COMPLETED|Overall Study||3
3198261|NCT02105701|3926994|FG003|NOT COMPLETED|Overall Study||2
3364847|NCT04002791|4096094|FG000|COMPLETED|Overall Study||127
3198262|NCT02105740|3927006|FG000|STARTED|Overall Study|Application of EVA and HADS scales and after that application of hypnosis intervention|12
3198263|NCT02105740|3927007|FG001|STARTED|Overall Study|Application of EVA and HADS scales|12
3198264|NCT02105740|3927006|FG000|Second|Overall Study|Intervention with hypnosis and application of EVA scales and HADS (n = 12)|12
3198265|NCT02105740|3927007|FG001|Second|Overall Study|Application of EVA and HADS scales. One accompanying lost|11
3198266|NCT02105740|3927006|FG000|COMPLETED|Overall Study|Application of EVA and HADS scales and data analysis|12
3198267|NCT02105740|3927007|FG001|COMPLETED|Overall Study|Application of EVA and HADS scales and data analysis|11
3198268|NCT02105740|3927006|FG000|NOT COMPLETED|Overall Study||0
3198269|NCT02105740|3927007|FG001|NOT COMPLETED|Overall Study||1
3198270|NCT02105948|3927019|FG000|STARTED|Overall Study||229
3198271|NCT02105948|3927020|FG001|STARTED|Overall Study||233
3198272|NCT02105948|3927021|FG002|STARTED|Overall Study||190
3198273|NCT02105948|3927022|FG003|STARTED|Overall Study||184
3198274|NCT02105948|3927019|FG000|Completed Investigational Product (IP)|Overall Study||185
3198275|NCT02105948|3927020|FG001|Completed Investigational Product (IP)|Overall Study||203
3198276|NCT02105948|3927021|FG002|Completed Investigational Product (IP)|Overall Study||148
3198277|NCT02105948|3927022|FG003|Completed Investigational Product (IP)|Overall Study||149
3198278|NCT02105948|3927019|FG000|Not Completed IP|Overall Study||44
3198279|NCT02105948|3927020|FG001|Not Completed IP|Overall Study||30
3198280|NCT02105948|3927021|FG002|Not Completed IP|Overall Study||42
3198281|NCT02105948|3927022|FG003|Not Completed IP|Overall Study||35
3198282|NCT02105948|3927019|FG000|Withdrew IP Due to: Adverse Event|Overall Study||20
3198283|NCT02105948|3927020|FG001|Withdrew IP Due to: Adverse Event|Overall Study||16
3198284|NCT02105948|3927021|FG002|Withdrew IP Due to: Adverse Event|Overall Study||15
3198285|NCT02105948|3927022|FG003|Withdrew IP Due to: Adverse Event|Overall Study||13
3198286|NCT02105948|3927019|FG000|Withdrew IP Due to: Lack of Efficacy|Overall Study||5
3198287|NCT02105948|3927020|FG001|Withdrew IP Due to: Lack of Efficacy|Overall Study||2
3198288|NCT02105948|3927021|FG002|Withdrew IP Due to: Lack of Efficacy|Overall Study||8
3198289|NCT02105948|3927022|FG003|Withdrew IP Due to: Lack of Efficacy|Overall Study||2
3198290|NCT02105948|3927019|FG000|Withdrew IP Due to: Protocol Deviation|Overall Study||1
3198291|NCT02105948|3927020|FG001|Withdrew IP Due to: Protocol Deviation|Overall Study||3
3198292|NCT02105948|3927021|FG002|Withdrew IP Due to: Protocol Deviation|Overall Study||3
3198293|NCT02105948|3927022|FG003|Withdrew IP Due to: Protocol Deviation|Overall Study||0
3198294|NCT02105948|3927019|FG000|Withdrew IP Due to: Lost to Follow-up|Overall Study||0
3198295|NCT02105948|3927020|FG001|Withdrew IP Due to: Lost to Follow-up|Overall Study||0
3198296|NCT02105948|3927021|FG002|Withdrew IP Due to: Lost to Follow-up|Overall Study||1
3198297|NCT02105948|3927022|FG003|Withdrew IP Due to: Lost to Follow-up|Overall Study||2
3198298|NCT02105948|3927019|FG000|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||16
3198299|NCT02105948|3927020|FG001|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||8
3198300|NCT02105948|3927021|FG002|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||11
3198301|NCT02105948|3927022|FG003|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||15
3198302|NCT02105948|3927019|FG000|Withdrew IP Due to: Physician Decision|Overall Study||2
3198303|NCT02105948|3927020|FG001|Withdrew IP Due to: Physician Decision|Overall Study||1
3198304|NCT02105948|3927021|FG002|Withdrew IP Due to: Physician Decision|Overall Study||4
3198305|NCT02105948|3927022|FG003|Withdrew IP Due to: Physician Decision|Overall Study||2
3198306|NCT02105948|3927019|FG000|Withdrew IP Due to: Stopping Criteria|Overall Study||0
3198307|NCT02105948|3927020|FG001|Withdrew IP Due to: Stopping Criteria|Overall Study||0
3198308|NCT02105948|3927021|FG002|Withdrew IP Due to: Stopping Criteria|Overall Study||0
3198309|NCT02105948|3927022|FG003|Withdrew IP Due to: Stopping Criteria|Overall Study||1
3198310|NCT02105948|3927019|FG000|COMPLETED|Overall Study||202
3198311|NCT02105948|3927020|FG001|COMPLETED|Overall Study||213
3198312|NCT02105948|3927021|FG002|COMPLETED|Overall Study||162
3198313|NCT02105948|3927022|FG003|COMPLETED|Overall Study||157
3198314|NCT02105948|3927019|FG000|NOT COMPLETED|Overall Study||27
3198315|NCT02105948|3927020|FG001|NOT COMPLETED|Overall Study||20
3198316|NCT02105948|3927021|FG002|NOT COMPLETED|Overall Study||28
3198317|NCT02105948|3927022|FG003|NOT COMPLETED|Overall Study||27
3198318|NCT02105961|3927036|FG000|STARTED|Overall Study||226
3198319|NCT02105961|3927037|FG001|STARTED|Overall Study||223
3198320|NCT02105961|3927038|FG002|STARTED|Overall Study||225
3198321|NCT02105961|3927036|FG000|Completed Investigational Product (IP)|Overall Study||170
3198322|NCT02105961|3927037|FG001|Completed Investigational Product (IP)|Overall Study||196
3198323|NCT02105961|3927038|FG002|Completed Investigational Product (IP)|Overall Study||183
3198324|NCT02105961|3927036|FG000|Not Completed IP|Overall Study||56
3198325|NCT02105961|3927037|FG001|Not Completed IP|Overall Study||27
3198326|NCT02105961|3927038|FG002|Not Completed IP|Overall Study||42
3198327|NCT02105961|3927036|FG000|Withdrew IP Due to: Adverse Event|Overall Study||27
3198328|NCT02105961|3927037|FG001|Withdrew IP Due to: Adverse Event|Overall Study||9
3198329|NCT02105961|3927038|FG002|Withdrew IP Due to: Adverse Event|Overall Study||25
3198330|NCT02105961|3927036|FG000|Withdrew IP Due to: Stopping Criteria|Overall Study||1
3198331|NCT02105961|3927037|FG001|Withdrew IP Due to: Stopping Criteria|Overall Study||1
3198332|NCT02105961|3927038|FG002|Withdrew IP Due to: Stopping Criteria|Overall Study||0
3198333|NCT02105961|3927036|FG000|Withdrew IP Due to: Lack of Efficacy|Overall Study||6
3198334|NCT02105961|3927037|FG001|Withdrew IP Due to: Lack of Efficacy|Overall Study||2
3198335|NCT02105961|3927038|FG002|Withdrew IP Due to: Lack of Efficacy|Overall Study||2
3198336|NCT02105961|3927036|FG000|Withdrew IP Due to: Protocol Deviation|Overall Study||2
3198337|NCT02105961|3927037|FG001|Withdrew IP Due to: Protocol Deviation|Overall Study||0
3198338|NCT02105961|3927038|FG002|Withdrew IP Due to: Protocol Deviation|Overall Study||1
3198339|NCT02105961|3927036|FG000|Withdrew IP Due to: Lost to Follow-up|Overall Study||1
3198340|NCT02105961|3927037|FG001|Withdrew IP Due to: Lost to Follow-up|Overall Study||1
3198341|NCT02105961|3927038|FG002|Withdrew IP Due to: Lost to Follow-up|Overall Study||1
3198342|NCT02105961|3927036|FG000|Withdrew IP Due to: Physician Decision|Overall Study||2
3198343|NCT02105961|3927037|FG001|Withdrew IP Due to: Physician Decision|Overall Study||3
3198344|NCT02105961|3927038|FG002|Withdrew IP Due to: Physician Decision|Overall Study||1
3198345|NCT02105961|3927036|FG000|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||16
3198346|NCT02105961|3927037|FG001|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||11
3198347|NCT02105961|3927038|FG002|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||11
3198348|NCT02105961|3927036|FG000|Withdrew IP Due to: Site Closed|Overall Study||1
3198349|NCT02105961|3927037|FG001|Withdrew IP Due to: Site Closed|Overall Study||0
3198350|NCT02105961|3927038|FG002|Withdrew IP Due to: Site Closed|Overall Study||1
3198351|NCT02105961|3927036|FG000|COMPLETED|Overall Study||185
3198352|NCT02105961|3927037|FG001|COMPLETED|Overall Study||206
3198353|NCT02105961|3927038|FG002|COMPLETED|Overall Study||195
3198354|NCT02105961|3927036|FG000|NOT COMPLETED|Overall Study||41
3198355|NCT02105961|3927037|FG001|NOT COMPLETED|Overall Study||17
3198356|NCT02105961|3927038|FG002|NOT COMPLETED|Overall Study||30
3198357|NCT02105974|3927049|FG000|STARTED|2 Week Run-in Period||2423
3198358|NCT02105974|3927050|FG001|STARTED|2 Week Run-in Period||0
3198359|NCT02105974|3927051|FG002|STARTED|2 Week Run-in Period||0
3198360|NCT02105974|3927049|FG000|COMPLETED|2 Week Run-in Period||1622
3198361|NCT02105974|3927050|FG001|COMPLETED|2 Week Run-in Period||0
3198362|NCT02105974|3927051|FG002|COMPLETED|2 Week Run-in Period||0
3198363|NCT02105974|3927049|FG000|NOT COMPLETED|2 Week Run-in Period||801
3198364|NCT02105974|3927050|FG001|NOT COMPLETED|2 Week Run-in Period||0
3198365|NCT02105974|3927051|FG002|NOT COMPLETED|2 Week Run-in Period||0
3198366|NCT02105974|3927049|FG000|STARTED|12 Week (Wk) Treatment Period (TP)||0
3198367|NCT02105974|3927050|FG001|STARTED|12 Week (Wk) Treatment Period (TP)||806
3198368|NCT02105974|3927051|FG002|STARTED|12 Week (Wk) Treatment Period (TP)||814
3198369|NCT02105974|3927049|FG000|Completed the Treatment(Trt) Period|12 Week (Wk) Treatment Period (TP)||0
3198370|NCT02105974|3927050|FG001|Completed the Treatment(Trt) Period|12 Week (Wk) Treatment Period (TP)|Par completed TP if attended Visit (V7, Wk12), did not withdraw at V7 and did not stop trt before V7|764
3198371|NCT02105974|3927051|FG002|Completed the Treatment(Trt) Period|12 Week (Wk) Treatment Period (TP)|Par completed TP if attended Visit (V7, Wk12), did not withdraw at V7 and did not stop trt before V7|754
3198372|NCT02105974|3927049|FG000|COMPLETED|12 Week (Wk) Treatment Period (TP)||0
3198373|NCT02105974|3927050|FG001|COMPLETED|12 Week (Wk) Treatment Period (TP)|Par. completed study if attended visit 7, had follow-up contact and no early withdrawal|764
3198374|NCT02105974|3927051|FG002|COMPLETED|12 Week (Wk) Treatment Period (TP)|Par. completed study if attended visit 7, had follow-up contact and no early withdrawal|756
3198375|NCT02105974|3927049|FG000|NOT COMPLETED|12 Week (Wk) Treatment Period (TP)||0
3198376|NCT02105974|3927050|FG001|NOT COMPLETED|12 Week (Wk) Treatment Period (TP)||42
3198377|NCT02105974|3927051|FG002|NOT COMPLETED|12 Week (Wk) Treatment Period (TP)||58
3198378|NCT02105987|3927059|FG000|STARTED|Early Switch Phase (24 Weeks)|Number Started represents the number of par. in the Intent-To-Treat Exposed (ITT-E) Population.|275
3198379|NCT02105987|3927060|FG001|STARTED|Early Switch Phase (24 Weeks)|Number Started represents the number of par. in the Intent-To-Treat Exposed (ITT-E) Population.|278
3198380|NCT02105987|3927061|FG002|STARTED|Early Switch Phase (24 Weeks)||0
3198381|NCT02105987|3927062|FG003|STARTED|Early Switch Phase (24 Weeks)||0
3198382|NCT02105987|3927063|FG004|STARTED|Early Switch Phase (24 Weeks)||0
3198383|NCT02105987|3927064|FG005|STARTED|Early Switch Phase (24 Weeks)||0
3198384|NCT02105987|3927059|FG000|COMPLETED|Early Switch Phase (24 Weeks)||239
3198385|NCT02105987|3927060|FG001|COMPLETED|Early Switch Phase (24 Weeks)||244
3198386|NCT02105987|3927061|FG002|COMPLETED|Early Switch Phase (24 Weeks)||0
3198387|NCT02105987|3927062|FG003|COMPLETED|Early Switch Phase (24 Weeks)||0
3198388|NCT02105987|3927063|FG004|COMPLETED|Early Switch Phase (24 Weeks)||0
3198389|NCT02105987|3927064|FG005|COMPLETED|Early Switch Phase (24 Weeks)||0
3198390|NCT02105987|3927059|FG000|NOT COMPLETED|Early Switch Phase (24 Weeks)||36
3198391|NCT02105987|3927060|FG001|NOT COMPLETED|Early Switch Phase (24 Weeks)||34
3198392|NCT02105987|3927061|FG002|NOT COMPLETED|Early Switch Phase (24 Weeks)||0
3198393|NCT02105987|3927062|FG003|NOT COMPLETED|Early Switch Phase (24 Weeks)||0
3198394|NCT02105987|3927063|FG004|NOT COMPLETED|Early Switch Phase (24 Weeks)||0
3198395|NCT02105987|3927064|FG005|NOT COMPLETED|Early Switch Phase (24 Weeks)||0
3198396|NCT02105987|3927059|FG000|STARTED|Late Switch Phase (24 Weeks)||0
3198397|NCT02105987|3927060|FG001|STARTED|Late Switch Phase (24 Weeks)||0
3198398|NCT02105987|3927061|FG002|STARTED|Late Switch Phase (24 Weeks)||275
3198399|NCT02105987|3927062|FG003|STARTED|Late Switch Phase (24 Weeks)||244
3198400|NCT02105987|3927063|FG004|STARTED|Late Switch Phase (24 Weeks)||0
3198401|NCT02105987|3927064|FG005|STARTED|Late Switch Phase (24 Weeks)||0
3198402|NCT02105987|3927059|FG000|COMPLETED|Late Switch Phase (24 Weeks)||0
3198403|NCT02105987|3927060|FG001|COMPLETED|Late Switch Phase (24 Weeks)||0
3198404|NCT02105987|3927061|FG002|COMPLETED|Late Switch Phase (24 Weeks)||230
3198405|NCT02105987|3927062|FG003|COMPLETED|Late Switch Phase (24 Weeks)||230
3198406|NCT02105987|3927063|FG004|COMPLETED|Late Switch Phase (24 Weeks)||0
3198407|NCT02105987|3927064|FG005|COMPLETED|Late Switch Phase (24 Weeks)||0
3198408|NCT02105987|3927059|FG000|NOT COMPLETED|Late Switch Phase (24 Weeks)||0
3198409|NCT02105987|3927060|FG001|NOT COMPLETED|Late Switch Phase (24 Weeks)||0
3198410|NCT02105987|3927061|FG002|NOT COMPLETED|Late Switch Phase (24 Weeks)||45
3198411|NCT02105987|3927062|FG003|NOT COMPLETED|Late Switch Phase (24 Weeks)||14
3198412|NCT02105987|3927063|FG004|NOT COMPLETED|Late Switch Phase (24 Weeks)||0
3198413|NCT02105987|3927064|FG005|NOT COMPLETED|Late Switch Phase (24 Weeks)||0
3198414|NCT02105987|3927059|FG000|STARTED|Continuation Phase||0
3198415|NCT02105987|3927060|FG001|STARTED|Continuation Phase||0
3198416|NCT02105987|3927061|FG002|STARTED|Continuation Phase||0
3198417|NCT02105987|3927062|FG003|STARTED|Continuation Phase||0
3198418|NCT02105987|3927063|FG004|STARTED|Continuation Phase||14
3198419|NCT02105987|3927064|FG005|STARTED|Continuation Phase||23
3198420|NCT02105987|3927059|FG000|COMPLETED|Continuation Phase||0
3198421|NCT02105987|3927060|FG001|COMPLETED|Continuation Phase||0
3198422|NCT02105987|3927061|FG002|COMPLETED|Continuation Phase||0
3198423|NCT02105987|3927062|FG003|COMPLETED|Continuation Phase||0
3198424|NCT02105987|3927063|FG004|COMPLETED|Continuation Phase||13
3198425|NCT02105987|3927064|FG005|COMPLETED|Continuation Phase||23
3198426|NCT02105987|3927059|FG000|NOT COMPLETED|Continuation Phase||0
3198427|NCT02105987|3927060|FG001|NOT COMPLETED|Continuation Phase||0
3198428|NCT02105987|3927061|FG002|NOT COMPLETED|Continuation Phase||0
3198429|NCT02105987|3927062|FG003|NOT COMPLETED|Continuation Phase||0
3198430|NCT02105987|3927063|FG004|NOT COMPLETED|Continuation Phase||1
3198431|NCT02105987|3927064|FG005|NOT COMPLETED|Continuation Phase||0
3198432|NCT02106065|3927073|FG000|STARTED|Overall Study||6
3198433|NCT02106065|3927074|FG001|STARTED|Overall Study||11
3198434|NCT02106065|3927075|FG002|STARTED|Overall Study||15
3198435|NCT02106065|3927073|FG000|6 Month Completion|Overall Study||3
3198436|NCT02106065|3927074|FG001|6 Month Completion|Overall Study||8
3198437|NCT02106065|3927075|FG002|6 Month Completion|Overall Study||5
3198438|NCT02106065|3927073|FG000|COMPLETED|Overall Study||3
3198439|NCT02106065|3927074|FG001|COMPLETED|Overall Study||8
3198440|NCT02106065|3927075|FG002|COMPLETED|Overall Study||5
3198441|NCT02106065|3927073|FG000|NOT COMPLETED|Overall Study||3
3198442|NCT02106065|3927074|FG001|NOT COMPLETED|Overall Study||3
3198443|NCT02106065|3927075|FG002|NOT COMPLETED|Overall Study||10
3198444|NCT02106156|3927086|FG000|STARTED|Overall Study||9620
3198445|NCT02106156|3927087|FG001|STARTED|Overall Study||90
3198446|NCT02106156|3927088|FG002|STARTED|Overall Study||518
3198447|NCT02106156|3927086|FG000|COMPLETED|Overall Study||7071
3198448|NCT02106156|3927087|FG001|COMPLETED|Overall Study||50
3198449|NCT02106156|3927088|FG002|COMPLETED|Overall Study||518
3198450|NCT02106156|3927086|FG000|NOT COMPLETED|Overall Study||2549
3198451|NCT02106156|3927087|FG001|NOT COMPLETED|Overall Study||40
3198452|NCT02106156|3927088|FG002|NOT COMPLETED|Overall Study||0
3198453|NCT02106325|3927097|FG000|STARTED|Phase 1||5
3198454|NCT02106325|3927098|FG001|STARTED|Phase 1||3
3198455|NCT02106325|3927097|FG000|COMPLETED|Phase 1||3
3198456|NCT02106325|3927098|FG001|COMPLETED|Phase 1||1
3198457|NCT02106325|3927097|FG000|NOT COMPLETED|Phase 1||2
3198458|NCT02106325|3927098|FG001|NOT COMPLETED|Phase 1||2
3198459|NCT02106325|3927097|FG000|STARTED|Phase 2||4
3198460|NCT02106325|3927098|FG001|STARTED|Phase 2||4
3198461|NCT02106325|3927097|FG000|COMPLETED|Phase 2||2
3198462|NCT02106325|3927098|FG001|COMPLETED|Phase 2||1
3198463|NCT02106325|3927097|FG000|NOT COMPLETED|Phase 2||2
3198464|NCT02106325|3927098|FG001|NOT COMPLETED|Phase 2||3
3198465|NCT02106325|3927097|FG000|STARTED|Phase 3||2
3198466|NCT02106325|3927098|FG001|STARTED|Phase 3||3
3198467|NCT02106325|3927097|FG000|COMPLETED|Phase 3||0
3198468|NCT02106325|3927098|FG001|COMPLETED|Phase 3||2
3198469|NCT02106325|3927097|FG000|NOT COMPLETED|Phase 3||2
3198470|NCT02106325|3927098|FG001|NOT COMPLETED|Phase 3||1
3198471|NCT02106351|3927107|FG000|STARTED|Treatment Cycle 1||71
3198472|NCT02106351|3927108|FG001|STARTED|Treatment Cycle 1||70
3198473|NCT02106351|3927109|FG002|STARTED|Treatment Cycle 1||71
3198474|NCT02106351|3927107|FG000|Received Treatment in TC 1|Treatment Cycle 1||70
3198475|NCT02106351|3927108|FG001|Received Treatment in TC 1|Treatment Cycle 1||70
3198476|NCT02106351|3927109|FG002|Received Treatment in TC 1|Treatment Cycle 1||70
3198477|NCT02106351|3927107|FG000|COMPLETED|Treatment Cycle 1||66
3198478|NCT02106351|3927108|FG001|COMPLETED|Treatment Cycle 1||67
3198479|NCT02106351|3927109|FG002|COMPLETED|Treatment Cycle 1||67
3198480|NCT02106351|3927107|FG000|NOT COMPLETED|Treatment Cycle 1||5
3198481|NCT02106351|3927108|FG001|NOT COMPLETED|Treatment Cycle 1||3
3198482|NCT02106351|3927109|FG002|NOT COMPLETED|Treatment Cycle 1||4
3198483|NCT02106351|3927107|FG000|STARTED|Treatment Cycle 2|Subjects who received Dysport 2 U/kg in TC 1 were randomised to receive 8 or 16 U/kg in TCs 2-4.|0
3198484|NCT02106351|3927108|FG001|STARTED|Treatment Cycle 2|Not all subjects who completed TC 1 required retreatment in TC 2.|88
3198485|NCT02106351|3927109|FG002|STARTED|Treatment Cycle 2|Not all subjects who completed TC 1 required retreatment in TC 2.|90
3198486|NCT02106351|3927107|FG000|COMPLETED|Treatment Cycle 2||0
3198487|NCT02106351|3927108|FG001|COMPLETED|Treatment Cycle 2||83
3198488|NCT02106351|3927109|FG002|COMPLETED|Treatment Cycle 2||87
3198489|NCT02106351|3927107|FG000|NOT COMPLETED|Treatment Cycle 2||0
3198490|NCT02106351|3927108|FG001|NOT COMPLETED|Treatment Cycle 2||5
3198491|NCT02106351|3927109|FG002|NOT COMPLETED|Treatment Cycle 2||3
3198492|NCT02106351|3927107|FG000|STARTED|Treatment Cycle 3||0
3198493|NCT02106351|3927108|FG001|STARTED|Treatment Cycle 3|Not all subjects who completed TC 2 required retreatment in TC 3.|49
3198494|NCT02106351|3927109|FG002|STARTED|Treatment Cycle 3|Not all subjects who completed TC 2 required retreatment in TC 3.|58
3198495|NCT02106351|3927107|FG000|COMPLETED|Treatment Cycle 3||0
3198496|NCT02106351|3927108|FG001|COMPLETED|Treatment Cycle 3||45
3198497|NCT02106351|3927109|FG002|COMPLETED|Treatment Cycle 3||53
3198498|NCT02106351|3927107|FG000|NOT COMPLETED|Treatment Cycle 3||0
3198499|NCT02106351|3927108|FG001|NOT COMPLETED|Treatment Cycle 3||4
3198500|NCT02106351|3927109|FG002|NOT COMPLETED|Treatment Cycle 3||5
3198501|NCT02106351|3927107|FG000|STARTED|Treatment Cycle 4||0
3198502|NCT02106351|3927108|FG001|STARTED|Treatment Cycle 4|Not all subjects who completed TC 3 required retreatment in TC 4.|22
3198503|NCT02106351|3927109|FG002|STARTED|Treatment Cycle 4|Not all subjects who completed TC 3 required retreatment in TC 4.|33
3198504|NCT02106351|3927107|FG000|COMPLETED|Treatment Cycle 4||0
3198505|NCT02106351|3927108|FG001|COMPLETED|Treatment Cycle 4||21
3198506|NCT02106351|3927109|FG002|COMPLETED|Treatment Cycle 4||31
3198507|NCT02106351|3927107|FG000|NOT COMPLETED|Treatment Cycle 4||0
3198508|NCT02106351|3927108|FG001|NOT COMPLETED|Treatment Cycle 4||1
3198509|NCT02106351|3927109|FG002|NOT COMPLETED|Treatment Cycle 4||2
3198510|NCT02106390|3927126|FG000|STARTED|Overall Study||252
3198511|NCT02106390|3927127|FG001|STARTED|Overall Study||250
3198512|NCT02106390|3927128|FG002|STARTED|Overall Study||248
3198513|NCT02106390|3927126|FG000|COMPLETED|Overall Study||203
3198514|NCT02106390|3927127|FG001|COMPLETED|Overall Study||202
3198515|NCT02106390|3927128|FG002|COMPLETED|Overall Study||205
3198516|NCT02106390|3927126|FG000|NOT COMPLETED|Overall Study||49
3198517|NCT02106390|3927127|FG001|NOT COMPLETED|Overall Study||48
3198518|NCT02106390|3927128|FG002|NOT COMPLETED|Overall Study||43
3198519|NCT02106403|3927139|FG000|STARTED|Visit 1, Treatment Period 1||8
3198520|NCT02106403|3927140|FG001|STARTED|Visit 1, Treatment Period 1||8
3198521|NCT02106403|3927141|FG002|STARTED|Visit 1, Treatment Period 1||9
3198522|NCT02106403|3927142|FG003|STARTED|Visit 1, Treatment Period 1||8
3198523|NCT02106403|3927143|FG004|STARTED|Visit 1, Treatment Period 1||8
3198524|NCT02106403|3927144|FG005|STARTED|Visit 1, Treatment Period 1||9
3198525|NCT02106403|3927139|FG000|COMPLETED|Visit 1, Treatment Period 1||8
3198526|NCT02106403|3927140|FG001|COMPLETED|Visit 1, Treatment Period 1||8
3198527|NCT02106403|3927141|FG002|COMPLETED|Visit 1, Treatment Period 1||9
3198528|NCT02106403|3927142|FG003|COMPLETED|Visit 1, Treatment Period 1||8
3198529|NCT02106403|3927143|FG004|COMPLETED|Visit 1, Treatment Period 1||8
3198530|NCT02106403|3927144|FG005|COMPLETED|Visit 1, Treatment Period 1||9
3198531|NCT02106403|3927139|FG000|NOT COMPLETED|Visit 1, Treatment Period 1||0
3198532|NCT02106403|3927140|FG001|NOT COMPLETED|Visit 1, Treatment Period 1||0
3198533|NCT02106403|3927141|FG002|NOT COMPLETED|Visit 1, Treatment Period 1||0
3198534|NCT02106403|3927142|FG003|NOT COMPLETED|Visit 1, Treatment Period 1||0
3198535|NCT02106403|3927143|FG004|NOT COMPLETED|Visit 1, Treatment Period 1||0
3198536|NCT02106403|3927144|FG005|NOT COMPLETED|Visit 1, Treatment Period 1||0
3198537|NCT02106403|3927139|FG000|STARTED|Visit 1, Treatment Period 2||8
3198538|NCT02106403|3927140|FG001|STARTED|Visit 1, Treatment Period 2||8
3198539|NCT02106403|3927141|FG002|STARTED|Visit 1, Treatment Period 2||9
3198540|NCT02106403|3927142|FG003|STARTED|Visit 1, Treatment Period 2||8
3198541|NCT02106403|3927143|FG004|STARTED|Visit 1, Treatment Period 2||8
3198542|NCT02106403|3927144|FG005|STARTED|Visit 1, Treatment Period 2||9
3198543|NCT02106403|3927139|FG000|COMPLETED|Visit 1, Treatment Period 2||8
3198544|NCT02106403|3927140|FG001|COMPLETED|Visit 1, Treatment Period 2||8
3198545|NCT02106403|3927141|FG002|COMPLETED|Visit 1, Treatment Period 2||9
3198546|NCT02106403|3927142|FG003|COMPLETED|Visit 1, Treatment Period 2||8
3198547|NCT02106403|3927143|FG004|COMPLETED|Visit 1, Treatment Period 2||8
3198548|NCT02106403|3927144|FG005|COMPLETED|Visit 1, Treatment Period 2||9
3198549|NCT02106403|3927139|FG000|NOT COMPLETED|Visit 1, Treatment Period 2||0
3198550|NCT02106403|3927140|FG001|NOT COMPLETED|Visit 1, Treatment Period 2||0
3198551|NCT02106403|3927141|FG002|NOT COMPLETED|Visit 1, Treatment Period 2||0
3198552|NCT02106403|3927142|FG003|NOT COMPLETED|Visit 1, Treatment Period 2||0
3198553|NCT02106403|3927143|FG004|NOT COMPLETED|Visit 1, Treatment Period 2||0
3198554|NCT02106403|3927144|FG005|NOT COMPLETED|Visit 1, Treatment Period 2||0
3198555|NCT02106403|3927139|FG000|STARTED|Visit 1, Treatment Period 3||8
3198556|NCT02106403|3927140|FG001|STARTED|Visit 1, Treatment Period 3||8
3198557|NCT02106403|3927141|FG002|STARTED|Visit 1, Treatment Period 3||9
3198558|NCT02106403|3927142|FG003|STARTED|Visit 1, Treatment Period 3||8
3198559|NCT02106403|3927143|FG004|STARTED|Visit 1, Treatment Period 3||8
3198560|NCT02106403|3927144|FG005|STARTED|Visit 1, Treatment Period 3||9
3198561|NCT02106403|3927139|FG000|COMPLETED|Visit 1, Treatment Period 3||8
3198562|NCT02106403|3927140|FG001|COMPLETED|Visit 1, Treatment Period 3||8
3198563|NCT02106403|3927141|FG002|COMPLETED|Visit 1, Treatment Period 3||9
3198564|NCT02106403|3927142|FG003|COMPLETED|Visit 1, Treatment Period 3||8
3198565|NCT02106403|3927143|FG004|COMPLETED|Visit 1, Treatment Period 3||8
3198566|NCT02106403|3927144|FG005|COMPLETED|Visit 1, Treatment Period 3||9
3198567|NCT02106403|3927139|FG000|NOT COMPLETED|Visit 1, Treatment Period 3||0
3198568|NCT02106403|3927140|FG001|NOT COMPLETED|Visit 1, Treatment Period 3||0
3198569|NCT02106403|3927141|FG002|NOT COMPLETED|Visit 1, Treatment Period 3||0
3198570|NCT02106403|3927142|FG003|NOT COMPLETED|Visit 1, Treatment Period 3||0
3198571|NCT02106403|3927143|FG004|NOT COMPLETED|Visit 1, Treatment Period 3||0
3198572|NCT02106403|3927144|FG005|NOT COMPLETED|Visit 1, Treatment Period 3||0
3198573|NCT02106403|3927139|FG000|STARTED|Follow-Up Visit 2||8
3198574|NCT02106403|3927140|FG001|STARTED|Follow-Up Visit 2||8
3198575|NCT02106403|3927141|FG002|STARTED|Follow-Up Visit 2||9
3198576|NCT02106403|3927142|FG003|STARTED|Follow-Up Visit 2||8
3198577|NCT02106403|3927143|FG004|STARTED|Follow-Up Visit 2||8
3198578|NCT02106403|3927144|FG005|STARTED|Follow-Up Visit 2||9
3198579|NCT02106403|3927139|FG000|COMPLETED|Follow-Up Visit 2||8
3198580|NCT02106403|3927140|FG001|COMPLETED|Follow-Up Visit 2||8
3198581|NCT02106403|3927141|FG002|COMPLETED|Follow-Up Visit 2||9
3198582|NCT02106403|3927142|FG003|COMPLETED|Follow-Up Visit 2||8
3198583|NCT02106403|3927143|FG004|COMPLETED|Follow-Up Visit 2||8
3198584|NCT02106403|3927144|FG005|COMPLETED|Follow-Up Visit 2||9
3198585|NCT02106403|3927139|FG000|NOT COMPLETED|Follow-Up Visit 2||0
3198586|NCT02106403|3927140|FG001|NOT COMPLETED|Follow-Up Visit 2||0
3198587|NCT02106403|3927141|FG002|NOT COMPLETED|Follow-Up Visit 2||0
3198588|NCT02106403|3927142|FG003|NOT COMPLETED|Follow-Up Visit 2||0
3198589|NCT02106403|3927143|FG004|NOT COMPLETED|Follow-Up Visit 2||0
3198590|NCT02106403|3927144|FG005|NOT COMPLETED|Follow-Up Visit 2||0
3198591|NCT02106403|3927139|FG000|STARTED|Follow-Up Visit 3||8
3198592|NCT02106403|3927140|FG001|STARTED|Follow-Up Visit 3||8
3198593|NCT02106403|3927141|FG002|STARTED|Follow-Up Visit 3||9
3198594|NCT02106403|3927142|FG003|STARTED|Follow-Up Visit 3||8
3198595|NCT02106403|3927143|FG004|STARTED|Follow-Up Visit 3||8
3198596|NCT02106403|3927144|FG005|STARTED|Follow-Up Visit 3||9
3198597|NCT02106403|3927139|FG000|COMPLETED|Follow-Up Visit 3||8
3198598|NCT02106403|3927140|FG001|COMPLETED|Follow-Up Visit 3||8
3198599|NCT02106403|3927141|FG002|COMPLETED|Follow-Up Visit 3||9
3198600|NCT02106403|3927142|FG003|COMPLETED|Follow-Up Visit 3||8
3198601|NCT02106403|3927143|FG004|COMPLETED|Follow-Up Visit 3||8
3198602|NCT02106403|3927144|FG005|COMPLETED|Follow-Up Visit 3||8
3198603|NCT02106403|3927139|FG000|NOT COMPLETED|Follow-Up Visit 3||0
3198604|NCT02106403|3927140|FG001|NOT COMPLETED|Follow-Up Visit 3||0
3198605|NCT02106403|3927141|FG002|NOT COMPLETED|Follow-Up Visit 3||0
3198606|NCT02106403|3927142|FG003|NOT COMPLETED|Follow-Up Visit 3||0
3198607|NCT02106403|3927143|FG004|NOT COMPLETED|Follow-Up Visit 3||0
3198608|NCT02106403|3927144|FG005|NOT COMPLETED|Follow-Up Visit 3||1
3198609|NCT02106442|3927154|FG000|STARTED|Overall Study||579
3198610|NCT02106442|3927154|FG000|COMPLETED|Overall Study||542
3198611|NCT02106442|3927154|FG000|NOT COMPLETED|Overall Study||37
3198612|NCT02106455|3927158|FG000|STARTED|Overall Study||315
3198613|NCT02106455|3927158|FG000|COMPLETED|Overall Study||307
3198614|NCT02106455|3927158|FG000|NOT COMPLETED|Overall Study||8
3198615|NCT02106494|3927164|FG000|STARTED|Overall Study||471
3198616|NCT02106494|3927165|FG001|STARTED|Overall Study||471
3198617|NCT02106494|3927164|FG000|Safety Population|Overall Study||456
3198618|NCT02106494|3927165|FG001|Safety Population|Overall Study||459
3198619|NCT02106494|3927164|FG000|Efficacy Population|Overall Study||450
3198620|NCT02106494|3927165|FG001|Efficacy Population|Overall Study||452
3198621|NCT02106494|3927164|FG000|COMPLETED|Overall Study||445
3198622|NCT02106494|3927165|FG001|COMPLETED|Overall Study||446
3198623|NCT02106494|3927164|FG000|NOT COMPLETED|Overall Study||26
3198624|NCT02106494|3927165|FG001|NOT COMPLETED|Overall Study||25
3198625|NCT02106728|3927175|FG000|STARTED|Overall Study||70
3198626|NCT02106728|3927176|FG001|STARTED|Overall Study||47
3198627|NCT02106728|3927175|FG000|COMPLETED|Overall Study||70
3198628|NCT02106728|3927176|FG001|COMPLETED|Overall Study||47
3198629|NCT02106728|3927175|FG000|NOT COMPLETED|Overall Study||0
3198630|NCT02106728|3927176|FG001|NOT COMPLETED|Overall Study||0
3198631|NCT02106832|3927192|FG000|STARTED|Overall Study||171
3198632|NCT02106832|3927193|FG001|STARTED|Overall Study||176
3198633|NCT02106832|3927194|FG002|STARTED|Overall Study||86
3198634|NCT02106832|3927195|FG003|STARTED|Overall Study||88
3198635|NCT02106832|3927192|FG000|Participants Received Treatment|Overall Study||171
3198636|NCT02106832|3927193|FG001|Participants Received Treatment|Overall Study||174
3198637|NCT02106832|3927194|FG002|Participants Received Treatment|Overall Study||86
3198638|NCT02106832|3927195|FG003|Participants Received Treatment|Overall Study||88
3198639|NCT02106832|3927192|FG000|COMPLETED|Overall Study||148
3198640|NCT02106832|3927193|FG001|COMPLETED|Overall Study||151
3198641|NCT02106832|3927194|FG002|COMPLETED|Overall Study||70
3198642|NCT02106832|3927195|FG003|COMPLETED|Overall Study||73
3198643|NCT02106832|3927192|FG000|NOT COMPLETED|Overall Study||23
3198644|NCT02106832|3927193|FG001|NOT COMPLETED|Overall Study||25
3198645|NCT02106832|3927194|FG002|NOT COMPLETED|Overall Study||16
3198646|NCT02106832|3927195|FG003|NOT COMPLETED|Overall Study||15
3198647|NCT02106884|3927209|FG000|STARTED|Overall Study||72
3198648|NCT02106884|3927210|FG001|STARTED|Overall Study||74
3198649|NCT02106884|3927209|FG000|COMPLETED|Overall Study||72
3198650|NCT02106884|3927210|FG001|COMPLETED|Overall Study|ITT analysis based on treatment assigned at baseline.|73
3198651|NCT02106884|3927209|FG000|NOT COMPLETED|Overall Study||0
3198652|NCT02106884|3927210|FG001|NOT COMPLETED|Overall Study||1
3198653|NCT02106910|3927221|FG000|STARTED|Overall Study||49
3198654|NCT02106910|3927222|FG001|STARTED|Overall Study||89
3198655|NCT02106910|3927221|FG000|COMPLETED|Overall Study||48
3198656|NCT02106910|3927222|FG001|COMPLETED|Overall Study||88
3198657|NCT02106910|3927221|FG000|NOT COMPLETED|Overall Study||1
3198658|NCT02106910|3927222|FG001|NOT COMPLETED|Overall Study||1
3198659|NCT02106923|3927232|FG000|STARTED|Overall Study||12
3198660|NCT02106923|3927233|FG001|STARTED|Overall Study||12
3198661|NCT02106923|3927234|FG002|STARTED|Overall Study||12
3198662|NCT02106923|3927235|FG003|STARTED|Overall Study||12
3198663|NCT02106923|3927236|FG004|STARTED|Overall Study||12
3198664|NCT02106923|3927237|FG005|STARTED|Overall Study||12
3198665|NCT02106923|3927232|FG000|COMPLETED|Overall Study||12
3198666|NCT02106923|3927233|FG001|COMPLETED|Overall Study||12
3198667|NCT02106923|3927234|FG002|COMPLETED|Overall Study||12
3198668|NCT02106923|3927235|FG003|COMPLETED|Overall Study||12
3198669|NCT02106923|3927236|FG004|COMPLETED|Overall Study||12
3198670|NCT02106923|3927237|FG005|COMPLETED|Overall Study||11
3198671|NCT02106923|3927232|FG000|NOT COMPLETED|Overall Study||0
3198672|NCT02106923|3927233|FG001|NOT COMPLETED|Overall Study||0
3198673|NCT02106923|3927234|FG002|NOT COMPLETED|Overall Study||0
3198674|NCT02106923|3927235|FG003|NOT COMPLETED|Overall Study||0
3198675|NCT02106923|3927236|FG004|NOT COMPLETED|Overall Study||0
3198676|NCT02106923|3927237|FG005|NOT COMPLETED|Overall Study||1
3198677|NCT02106962|3927253|FG000|STARTED|Overall Study||8
3198678|NCT02106962|3927254|FG001|STARTED|Overall Study||9
3198679|NCT02106962|3927253|FG000|COMPLETED|Overall Study||8
3198680|NCT02106962|3927254|FG001|COMPLETED|Overall Study||9
3364848|NCT04002791|4096095|FG001|COMPLETED|Overall Study||126
3364849|NCT04002791|4096094|FG000|NOT COMPLETED|Overall Study||0
3364850|NCT04002791|4096095|FG001|NOT COMPLETED|Overall Study||0
3364851|NCT04000581|4096103|FG000|STARTED|Overall Study||5
3364852|NCT04000581|4096104|FG001|STARTED|Overall Study||12
3364853|NCT04000581|4096103|FG000|COMPLETED|Overall Study||5
3364854|NCT04000581|4096104|FG001|COMPLETED|Overall Study||11
3364855|NCT04000581|4096103|FG000|NOT COMPLETED|Overall Study||0
3364856|NCT04000581|4096104|FG001|NOT COMPLETED|Overall Study||1
3364857|NCT03996694|4096110|FG000|STARTED|First Intervention (1 Day)||3
3364858|NCT03996694|4096111|FG001|STARTED|First Intervention (1 Day)||3
3364859|NCT03996694|4096112|FG002|STARTED|First Intervention (1 Day)||4
3364860|NCT03996694|4096113|FG003|STARTED|First Intervention (1 Day)||3
3364861|NCT03996694|4096114|FG004|STARTED|First Intervention (1 Day)||3
3364862|NCT03996694|4096115|FG005|STARTED|First Intervention (1 Day)||3
3364863|NCT03996694|4096110|FG000|COMPLETED|First Intervention (1 Day)||3
3364864|NCT03996694|4096111|FG001|COMPLETED|First Intervention (1 Day)||3
3364865|NCT03996694|4096112|FG002|COMPLETED|First Intervention (1 Day)||4
3364866|NCT03996694|4096113|FG003|COMPLETED|First Intervention (1 Day)||3
3364867|NCT03996694|4096114|FG004|COMPLETED|First Intervention (1 Day)||3
3364868|NCT03996694|4096115|FG005|COMPLETED|First Intervention (1 Day)||3
3364869|NCT03996694|4096110|FG000|NOT COMPLETED|First Intervention (1 Day)||0
3364870|NCT03996694|4096111|FG001|NOT COMPLETED|First Intervention (1 Day)||0
3364871|NCT03996694|4096112|FG002|NOT COMPLETED|First Intervention (1 Day)||0
3364872|NCT03996694|4096113|FG003|NOT COMPLETED|First Intervention (1 Day)||0
3364873|NCT03996694|4096114|FG004|NOT COMPLETED|First Intervention (1 Day)||0
3364874|NCT03996694|4096115|FG005|NOT COMPLETED|First Intervention (1 Day)||0
3364875|NCT03996694|4096110|FG000|STARTED|First Washout (7 Days)||3
3364876|NCT03996694|4096111|FG001|STARTED|First Washout (7 Days)||3
3364877|NCT03996694|4096112|FG002|STARTED|First Washout (7 Days)||4
3364878|NCT03996694|4096113|FG003|STARTED|First Washout (7 Days)||3
3364879|NCT03996694|4096114|FG004|STARTED|First Washout (7 Days)||3
3364880|NCT03996694|4096115|FG005|STARTED|First Washout (7 Days)||3
3364881|NCT03996694|4096110|FG000|COMPLETED|First Washout (7 Days)||3
3364882|NCT03996694|4096111|FG001|COMPLETED|First Washout (7 Days)||2
3364883|NCT03996694|4096112|FG002|COMPLETED|First Washout (7 Days)||2
3364884|NCT03996694|4096113|FG003|COMPLETED|First Washout (7 Days)||3
3364885|NCT03996694|4096114|FG004|COMPLETED|First Washout (7 Days)||3
3364886|NCT03996694|4096115|FG005|COMPLETED|First Washout (7 Days)||3
3364887|NCT03996694|4096110|FG000|NOT COMPLETED|First Washout (7 Days)||0
3364888|NCT03996694|4096111|FG001|NOT COMPLETED|First Washout (7 Days)||1
3364889|NCT03996694|4096112|FG002|NOT COMPLETED|First Washout (7 Days)||2
3364890|NCT03996694|4096113|FG003|NOT COMPLETED|First Washout (7 Days)||0
3364891|NCT03996694|4096114|FG004|NOT COMPLETED|First Washout (7 Days)||0
3364892|NCT03996694|4096115|FG005|NOT COMPLETED|First Washout (7 Days)||0
3364893|NCT03996694|4096110|FG000|STARTED|Second Intervention (1 Day)||3
3364894|NCT03996694|4096111|FG001|STARTED|Second Intervention (1 Day)||2
3364895|NCT03996694|4096112|FG002|STARTED|Second Intervention (1 Day)||2
3364896|NCT03996694|4096113|FG003|STARTED|Second Intervention (1 Day)||3
3364897|NCT03996694|4096114|FG004|STARTED|Second Intervention (1 Day)||3
3364898|NCT03996694|4096115|FG005|STARTED|Second Intervention (1 Day)||3
3364899|NCT03996694|4096110|FG000|COMPLETED|Second Intervention (1 Day)||3
3364900|NCT03996694|4096111|FG001|COMPLETED|Second Intervention (1 Day)||2
3364901|NCT03996694|4096112|FG002|COMPLETED|Second Intervention (1 Day)||2
3364902|NCT03996694|4096113|FG003|COMPLETED|Second Intervention (1 Day)||3
3364903|NCT03996694|4096114|FG004|COMPLETED|Second Intervention (1 Day)||3
3364904|NCT03996694|4096115|FG005|COMPLETED|Second Intervention (1 Day)||3
3364905|NCT03996694|4096110|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
3364906|NCT03996694|4096111|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
3364907|NCT03996694|4096112|FG002|NOT COMPLETED|Second Intervention (1 Day)||0
3364908|NCT03996694|4096113|FG003|NOT COMPLETED|Second Intervention (1 Day)||0
3364909|NCT03996694|4096114|FG004|NOT COMPLETED|Second Intervention (1 Day)||0
3364910|NCT03996694|4096115|FG005|NOT COMPLETED|Second Intervention (1 Day)||0
3364911|NCT03996694|4096110|FG000|STARTED|Second Washout (7 Days)||3
3364912|NCT03996694|4096111|FG001|STARTED|Second Washout (7 Days)||2
3364913|NCT03996694|4096112|FG002|STARTED|Second Washout (7 Days)||2
3364914|NCT03996694|4096113|FG003|STARTED|Second Washout (7 Days)||3
3364915|NCT03996694|4096114|FG004|STARTED|Second Washout (7 Days)||3
3364916|NCT03996694|4096115|FG005|STARTED|Second Washout (7 Days)||3
3364917|NCT03996694|4096110|FG000|COMPLETED|Second Washout (7 Days)||3
3364918|NCT03996694|4096111|FG001|COMPLETED|Second Washout (7 Days)||2
3364919|NCT03996694|4096112|FG002|COMPLETED|Second Washout (7 Days)||2
3198681|NCT02106962|3927253|FG000|NOT COMPLETED|Overall Study||0
3198682|NCT02106962|3927254|FG001|NOT COMPLETED|Overall Study||0
3198683|NCT02106975|3927264|FG000|STARTED|Overall Study||84
3198684|NCT02106975|3927265|FG001|STARTED|Overall Study||83
3198685|NCT02106975|3927264|FG000|COMPLETED|Overall Study||59
3198686|NCT02106975|3927265|FG001|COMPLETED|Overall Study||44
3198687|NCT02106975|3927264|FG000|NOT COMPLETED|Overall Study||25
3198688|NCT02106975|3927265|FG001|NOT COMPLETED|Overall Study||39
3198689|NCT02107014|3927271|FG000|STARTED|Overall Study||9
3198690|NCT02107014|3927271|FG000|COMPLETED|Overall Study||8
3198691|NCT02107014|3927271|FG000|NOT COMPLETED|Overall Study||1
3198692|NCT02107092|3927275|FG000|STARTED|Overall Study||123
3198693|NCT02107092|3927275|FG000|COMPLETED|Overall Study||79
3198694|NCT02107092|3927275|FG000|NOT COMPLETED|Overall Study||44
3198695|NCT02107131|3927281|FG000|STARTED|Overall Study||20
3198696|NCT02107131|3927282|FG001|STARTED|Overall Study||20
3198697|NCT02107131|3927281|FG000|COMPLETED|Overall Study||12
3198698|NCT02107131|3927282|FG001|COMPLETED|Overall Study||11
3198699|NCT02107131|3927281|FG000|NOT COMPLETED|Overall Study||8
3198700|NCT02107131|3927282|FG001|NOT COMPLETED|Overall Study||9
3198701|NCT02107157|3927293|FG000|STARTED|Overall Study||11
3198702|NCT02107157|3927294|FG001|STARTED|Overall Study||12
3198703|NCT02107157|3927295|FG002|STARTED|Overall Study||4
3198704|NCT02107157|3927293|FG000|COMPLETED|Overall Study||6
3198705|NCT02107157|3927294|FG001|COMPLETED|Overall Study||11
3198706|NCT02107157|3927295|FG002|COMPLETED|Overall Study||4
3198707|NCT02107157|3927293|FG000|NOT COMPLETED|Overall Study||5
3198708|NCT02107157|3927294|FG001|NOT COMPLETED|Overall Study||1
3198709|NCT02107157|3927295|FG002|NOT COMPLETED|Overall Study||0
3198710|NCT02107196|3927305|FG000|STARTED|12-week Treatment Period|Safety population, all enrolled patients who received at least one dose of study drug|271
3198711|NCT02107196|3927306|FG001|STARTED|12-week Treatment Period|Safety population, all enrolled patients who received at least one dose of study drug|264
3198712|NCT02107196|3927305|FG000|Intention To Treat (ITT)|12-week Treatment Period|All randomised patients who took at least one dose of study drug during 12-week treatment period|271
3198713|NCT02107196|3927306|FG001|Intention To Treat (ITT)|12-week Treatment Period|All randomised patients who took at least one dose of study drug during 12-week treatment period|264
3198714|NCT02107196|3927305|FG000|Modified ITT|12-week Treatment Period|All ITT patients, excluding patients of two sites (serious breach of GCP, disqualified Investigator)|221
3198715|NCT02107196|3927306|FG001|Modified ITT|12-week Treatment Period|All ITT patients, excluding patients of two sites (serious breach of GCP, disqualified Investigator)|216
3198716|NCT02107196|3927305|FG000|COMPLETED|12-week Treatment Period||227
3198717|NCT02107196|3927306|FG001|COMPLETED|12-week Treatment Period||225
3198718|NCT02107196|3927305|FG000|NOT COMPLETED|12-week Treatment Period||44
3198719|NCT02107196|3927306|FG001|NOT COMPLETED|12-week Treatment Period||39
3198720|NCT02107196|3927305|FG000|STARTED|4-week Randomized Withdrawal (RW) Period|all re-randomized patients at Visit 6 [Day85]|338
3198721|NCT02107196|3927306|FG001|STARTED|4-week Randomized Withdrawal (RW) Period|all re-randomized patients at Visit 6 [Day85]|114
3198722|NCT02107196|3927305|FG000|RW Population|4-week Randomized Withdrawal (RW) Period|All re-randomized ITT patients,who received at least 1 dose of ibodutant during RW period|338
3198723|NCT02107196|3927306|FG001|RW Population|4-week Randomized Withdrawal (RW) Period|All re-randomized ITT patients,who received at least 1 dose of placebo during RW period|114
3198724|NCT02107196|3927305|FG000|Modified RW Population|4-week Randomized Withdrawal (RW) Period|all RW patients, excluding patients of two sites (serious breach of GCP, disqualified Investigator)|272
3198725|NCT02107196|3927306|FG001|Modified RW Population|4-week Randomized Withdrawal (RW) Period|all RW patients, excluding patients of two sites (serious breach of GCP, disqualified Investigator)|90
3198726|NCT02107196|3927305|FG000|COMPLETED|4-week Randomized Withdrawal (RW) Period||315
3198727|NCT02107196|3927306|FG001|COMPLETED|4-week Randomized Withdrawal (RW) Period||109
3198728|NCT02107196|3927305|FG000|NOT COMPLETED|4-week Randomized Withdrawal (RW) Period||23
3198729|NCT02107196|3927306|FG001|NOT COMPLETED|4-week Randomized Withdrawal (RW) Period||5
3198730|NCT02107274|3927314|FG000|STARTED|Treatment vs. Placebo||39
3198731|NCT02107274|3927315|FG001|STARTED|Treatment vs. Placebo||39
3198732|NCT02107274|3927314|FG000|COMPLETED|Treatment vs. Placebo||36
3198733|NCT02107274|3927315|FG001|COMPLETED|Treatment vs. Placebo||37
3198734|NCT02107274|3927314|FG000|NOT COMPLETED|Treatment vs. Placebo||3
3198735|NCT02107274|3927315|FG001|NOT COMPLETED|Treatment vs. Placebo||2
3198736|NCT02107274|3927314|FG000|STARTED|Control Phase||36
3198737|NCT02107274|3927315|FG001|STARTED|Control Phase||37
3198738|NCT02107274|3927314|FG000|COMPLETED|Control Phase||33
3198739|NCT02107274|3927315|FG001|COMPLETED|Control Phase||35
3198740|NCT02107274|3927314|FG000|NOT COMPLETED|Control Phase||3
3198741|NCT02107274|3927315|FG001|NOT COMPLETED|Control Phase||2
3198742|NCT02107300|3927323|FG000|STARTED|Overall Study||16
3198743|NCT02107300|3927324|FG001|STARTED|Overall Study||15
3198744|NCT02107300|3927323|FG000|COMPLETED|Overall Study||16
3198745|NCT02107300|3927324|FG001|COMPLETED|Overall Study||15
3198746|NCT02107300|3927323|FG000|NOT COMPLETED|Overall Study||0
3198747|NCT02107300|3927324|FG001|NOT COMPLETED|Overall Study||0
3198748|NCT02107313|3927330|FG000|STARTED|Overall Study||9
3198749|NCT02107313|3927331|FG001|STARTED|Overall Study|One participant from the study did not cross over and participate in the FED cohort|9
3198750|NCT02107313|3927330|FG000|COMPLETED|Overall Study||9
3198751|NCT02107313|3927331|FG001|COMPLETED|Overall Study||8
3198752|NCT02107313|3927330|FG000|NOT COMPLETED|Overall Study||0
3198753|NCT02107313|3927331|FG001|NOT COMPLETED|Overall Study||1
3198754|NCT02107339|3927339|FG000|STARTED|Overall Study||63
3198755|NCT02107339|3927340|FG001|STARTED|Overall Study||57
3198756|NCT02107339|3927339|FG000|COMPLETED|Overall Study||62
3198757|NCT02107339|3927340|FG001|COMPLETED|Overall Study||53
3198758|NCT02107339|3927339|FG000|NOT COMPLETED|Overall Study||1
3198759|NCT02107339|3927340|FG001|NOT COMPLETED|Overall Study||4
3198760|NCT02107443|3927348|FG000|STARTED|Overall Study||296
3198761|NCT02107443|3927349|FG001|STARTED|Overall Study||250
3198762|NCT02107443|3927348|FG000|COMPLETED|Overall Study||198
3198763|NCT02107443|3927349|FG001|COMPLETED|Overall Study||167
3198764|NCT02107443|3927348|FG000|NOT COMPLETED|Overall Study||98
3198765|NCT02107443|3927349|FG001|NOT COMPLETED|Overall Study||83
3198766|NCT02107482|3927356|FG000|STARTED|Overall Study|21 participants enrolled. Total of 21 participants recvd both active and sham|21
3198767|NCT02107482|3927356|FG000|COMPLETED|Overall Study||17
3198768|NCT02107482|3927356|FG000|NOT COMPLETED|Overall Study||4
3198769|NCT02107599|3927360|FG000|STARTED|Overall Study||96
3198770|NCT02107599|3927360|FG000|COMPLETED|Overall Study||96
3198771|NCT02107599|3927360|FG000|NOT COMPLETED|Overall Study||0
3198772|NCT02107703|3927369|FG000|STARTED|Overall Study||446
3198773|NCT02107703|3927370|FG001|STARTED|Overall Study||223
3198774|NCT02107703|3927369|FG000|Received at Least 1 Dose of Study Drug|Overall Study||441
3198775|NCT02107703|3927370|FG001|Received at Least 1 Dose of Study Drug|Overall Study||223
3198776|NCT02107703|3927369|FG000|COMPLETED|Overall Study||85
3198777|NCT02107703|3927370|FG001|COMPLETED|Overall Study||48
3198778|NCT02107703|3927369|FG000|NOT COMPLETED|Overall Study||361
3198779|NCT02107703|3927370|FG001|NOT COMPLETED|Overall Study||175
3198780|NCT02107859|3927379|FG000|STARTED|Overall Study||61
3198781|NCT02107859|3927379|FG000|As-treated Population|Overall Study||61
3198782|NCT02107859|3927379|FG000|Intent-to-treat (ITT) Population|Overall Study||60
3198783|NCT02107859|3927379|FG000|COMPLETED|Overall Study||0
3198784|NCT02107859|3927379|FG000|NOT COMPLETED|Overall Study||61
3198785|NCT02107898|3927385|FG000|STARTED|Overall Study|Randomized|72
3198786|NCT02107898|3927386|FG001|STARTED|Overall Study|Randomized|144
3198787|NCT02107898|3927385|FG000|Treated|Overall Study||72
3198788|NCT02107898|3927386|FG001|Treated|Overall Study||143
3198789|NCT02107898|3927385|FG000|COMPLETED|Overall Study||66
3198790|NCT02107898|3927386|FG001|COMPLETED|Overall Study||132
3198791|NCT02107898|3927385|FG000|NOT COMPLETED|Overall Study||6
3198792|NCT02107898|3927386|FG001|NOT COMPLETED|Overall Study||12
3198793|NCT02108171|3927394|FG000|STARTED|Overall Study||40
3198794|NCT02108171|3927395|FG001|STARTED|Overall Study||41
3198795|NCT02108171|3927394|FG000|COMPLETED|Overall Study||40
3198796|NCT02108171|3927395|FG001|COMPLETED|Overall Study||41
3198797|NCT02108171|3927394|FG000|NOT COMPLETED|Overall Study||0
3198798|NCT02108171|3927395|FG001|NOT COMPLETED|Overall Study||0
3198799|NCT02108223|3927405|FG000|STARTED|Overall Study||52
3198800|NCT02108223|3927406|FG001|STARTED|Overall Study||50
3198801|NCT02108223|3927407|FG002|STARTED|Overall Study||35
3198802|NCT02108223|3927405|FG000|COMPLETED|Overall Study||52
3198803|NCT02108223|3927406|FG001|COMPLETED|Overall Study||50
3198804|NCT02108223|3927407|FG002|COMPLETED|Overall Study||35
3198805|NCT02108223|3927405|FG000|NOT COMPLETED|Overall Study||0
3198806|NCT02108223|3927406|FG001|NOT COMPLETED|Overall Study||0
3198807|NCT02108223|3927407|FG002|NOT COMPLETED|Overall Study||0
3198808|NCT02108262|3927422|FG000|STARTED|Overall Study||9
3198809|NCT02108262|3927423|FG001|STARTED|Overall Study||419
3198810|NCT02108262|3927424|FG002|STARTED|Overall Study||421
3198811|NCT02108262|3927425|FG003|STARTED|Overall Study||418
3198812|NCT02108262|3927422|FG000|COMPLETED|Overall Study||9
3198813|NCT02108262|3927423|FG001|COMPLETED|Overall Study||375
3198814|NCT02108262|3927424|FG002|COMPLETED|Overall Study||379
3198815|NCT02108262|3927425|FG003|COMPLETED|Overall Study||376
3198816|NCT02108262|3927422|FG000|NOT COMPLETED|Overall Study||0
3198817|NCT02108262|3927423|FG001|NOT COMPLETED|Overall Study||44
3198818|NCT02108262|3927424|FG002|NOT COMPLETED|Overall Study||42
3198819|NCT02108262|3927425|FG003|NOT COMPLETED|Overall Study||42
3198820|NCT02108288|3927437|FG000|STARTED|Overall Study||10
3198821|NCT02108288|3927438|FG001|STARTED|Overall Study||10
3198822|NCT02108288|3927439|FG002|STARTED|Overall Study||10
3198823|NCT02108288|3927437|FG000|COMPLETED|Overall Study||10
3198824|NCT02108288|3927438|FG001|COMPLETED|Overall Study||10
3198825|NCT02108288|3927439|FG002|COMPLETED|Overall Study||10
3198826|NCT02108288|3927437|FG000|NOT COMPLETED|Overall Study||0
3198827|NCT02108288|3927438|FG001|NOT COMPLETED|Overall Study||0
3198828|NCT02108288|3927439|FG002|NOT COMPLETED|Overall Study||0
3198829|NCT02108457|3927449|FG000|STARTED|Overall Study||3
3198830|NCT02108457|3927450|FG001|STARTED|Overall Study||12
3198831|NCT02108457|3927449|FG000|COMPLETED|Overall Study||3
3198832|NCT02108457|3927450|FG001|COMPLETED|Overall Study||10
3198833|NCT02108457|3927449|FG000|NOT COMPLETED|Overall Study||0
3198834|NCT02108457|3927450|FG001|NOT COMPLETED|Overall Study||2
3198835|NCT02108522|3927456|FG000|STARTED|Screening Period||82
3198836|NCT02108522|3927456|FG000|COMPLETED|Screening Period||58
3198837|NCT02108522|3927456|FG000|NOT COMPLETED|Screening Period||24
3198838|NCT02108522|3927456|FG000|STARTED|Period 1: Initial Cohort||50
3198839|NCT02108522|3927456|FG000|COMPLETED|Period 1: Initial Cohort||28
3198840|NCT02108522|3927456|FG000|NOT COMPLETED|Period 1: Initial Cohort||22
3198841|NCT02108522|3927456|FG000|STARTED|Period 2: Expansion Cohort||8
3198842|NCT02108522|3927456|FG000|COMPLETED|Period 2: Expansion Cohort||2
3198843|NCT02108522|3927456|FG000|NOT COMPLETED|Period 2: Expansion Cohort||6
3198844|NCT02108600|3927462|FG000|STARTED|Overall Study||17
3198845|NCT02108600|3927463|FG001|STARTED|Overall Study||16
3198846|NCT02108600|3927462|FG000|COMPLETED|Overall Study||14
3198847|NCT02108600|3927463|FG001|COMPLETED|Overall Study|1 patient lost to follow up after the primary endpoint biopsy|15
3198848|NCT02108600|3927462|FG000|NOT COMPLETED|Overall Study||3
3198849|NCT02108600|3927463|FG001|NOT COMPLETED|Overall Study||1
3198850|NCT02108691|3927471|FG000|STARTED|Overall Study||40
3198851|NCT02108691|3927472|FG001|STARTED|Overall Study||40
3198852|NCT02108691|3927471|FG000|COMPLETED|Overall Study||32
3198853|NCT02108691|3927472|FG001|COMPLETED|Overall Study||31
3198854|NCT02108691|3927471|FG000|NOT COMPLETED|Overall Study||8
3198855|NCT02108691|3927472|FG001|NOT COMPLETED|Overall Study||9
3198856|NCT02108821|3927478|FG000|STARTED|Overall Study||23
3198857|NCT02108821|3927478|FG000|COMPLETED|Overall Study||23
3198858|NCT02108821|3927478|FG000|NOT COMPLETED|Overall Study||0
3198859|NCT02108912|3927486|FG000|STARTED|Overall Study||9
3198860|NCT02108912|3927487|FG001|STARTED|Overall Study||7
3198861|NCT02108912|3927486|FG000|COMPLETED|Overall Study||6
3198862|NCT02108912|3927487|FG001|COMPLETED|Overall Study||6
3198863|NCT02108912|3927486|FG000|NOT COMPLETED|Overall Study||3
3198864|NCT02108912|3927487|FG001|NOT COMPLETED|Overall Study||1
3198865|NCT02108951|3927493|FG000|STARTED|Overall Study|Indicates patients in enrolled, full analysis and safety set|20
3198866|NCT02108951|3927493|FG000|COMPLETED|Overall Study||4
3198867|NCT02108951|3927493|FG000|NOT COMPLETED|Overall Study||16
3198868|NCT02108977|3927499|FG000|STARTED|Overall Study||18
3198869|NCT02108977|3927500|FG001|STARTED|Overall Study||20
3198870|NCT02108977|3927499|FG000|COMPLETED|Overall Study||8
3198871|NCT02108977|3927500|FG001|COMPLETED|Overall Study||19
3198872|NCT02108977|3927499|FG000|NOT COMPLETED|Overall Study||10
3198873|NCT02108977|3927500|FG001|NOT COMPLETED|Overall Study||1
3198874|NCT02109029|3927511|FG000|STARTED|Part A||2
3198875|NCT02109029|3927512|FG001|STARTED|Part A||2
3198876|NCT02109029|3927513|FG002|STARTED|Part A||4
3198877|NCT02109029|3927514|FG003|STARTED|Part A||4
3198878|NCT02109029|3927515|FG004|STARTED|Part A||0
3198879|NCT02109029|3927516|FG005|STARTED|Part A||0
3198880|NCT02109029|3927511|FG000|Received One Dose of Study Drug|Part A||2
3198881|NCT02109029|3927512|FG001|Received One Dose of Study Drug|Part A||2
3198882|NCT02109029|3927513|FG002|Received One Dose of Study Drug|Part A||4
3198883|NCT02109029|3927514|FG003|Received One Dose of Study Drug|Part A||4
3198884|NCT02109029|3927515|FG004|Received One Dose of Study Drug|Part A||0
3198885|NCT02109029|3927516|FG005|Received One Dose of Study Drug|Part A||0
3198886|NCT02109029|3927511|FG000|COMPLETED|Part A|Participants from Part A did not move on to Part B.|2
3198887|NCT02109029|3927512|FG001|COMPLETED|Part A|Participants from Part A did not move on to Part B.|2
3198888|NCT02109029|3927513|FG002|COMPLETED|Part A|Participants from Part A did not move on to Part B.|4
3198889|NCT02109029|3927514|FG003|COMPLETED|Part A|Participants from Part A did not move on to Part B.|4
3198890|NCT02109029|3927515|FG004|COMPLETED|Part A||0
3198891|NCT02109029|3927516|FG005|COMPLETED|Part A||0
3198892|NCT02109029|3927511|FG000|NOT COMPLETED|Part A||0
3198893|NCT02109029|3927512|FG001|NOT COMPLETED|Part A||0
3198894|NCT02109029|3927513|FG002|NOT COMPLETED|Part A||0
3198895|NCT02109029|3927514|FG003|NOT COMPLETED|Part A||0
3198896|NCT02109029|3927515|FG004|NOT COMPLETED|Part A||0
3198897|NCT02109029|3927516|FG005|NOT COMPLETED|Part A||0
3198898|NCT02109029|3927511|FG000|STARTED|Part B||0
3198899|NCT02109029|3927512|FG001|STARTED|Part B||0
3198900|NCT02109029|3927513|FG002|STARTED|Part B||0
3198901|NCT02109029|3927514|FG003|STARTED|Part B||0
3198902|NCT02109029|3927515|FG004|STARTED|Part B|New participants entered Part B.|6
3198903|NCT02109029|3927516|FG005|STARTED|Part B|New participants entered Part B.|6
3198904|NCT02109029|3927511|FG000|Received at Least One Dose of Study Drug|Part B||0
3198905|NCT02109029|3927512|FG001|Received at Least One Dose of Study Drug|Part B||0
3198906|NCT02109029|3927513|FG002|Received at Least One Dose of Study Drug|Part B||0
3198907|NCT02109029|3927514|FG003|Received at Least One Dose of Study Drug|Part B||0
3198908|NCT02109029|3927515|FG004|Received at Least One Dose of Study Drug|Part B||6
3198909|NCT02109029|3927516|FG005|Received at Least One Dose of Study Drug|Part B||6
3198910|NCT02109029|3927511|FG000|COMPLETED|Part B||0
3198911|NCT02109029|3927512|FG001|COMPLETED|Part B||0
3198912|NCT02109029|3927513|FG002|COMPLETED|Part B||0
3198913|NCT02109029|3927514|FG003|COMPLETED|Part B||0
3198914|NCT02109029|3927515|FG004|COMPLETED|Part B||5
3198915|NCT02109029|3927516|FG005|COMPLETED|Part B||5
3198916|NCT02109029|3927511|FG000|NOT COMPLETED|Part B||0
3198917|NCT02109029|3927512|FG001|NOT COMPLETED|Part B||0
3198918|NCT02109029|3927513|FG002|NOT COMPLETED|Part B||0
3198919|NCT02109029|3927514|FG003|NOT COMPLETED|Part B||0
3198920|NCT02109029|3927515|FG004|NOT COMPLETED|Part B||1
3198921|NCT02109029|3927516|FG005|NOT COMPLETED|Part B||1
3198922|NCT02109042|3927527|FG000|STARTED|Overall Study||15
3198923|NCT02109042|3927527|FG000|Received at Least 1 Dose of Study Drug|Overall Study||15
3198924|NCT02109042|3927527|FG000|Received 180 mg Loading Dose|Overall Study||15
3198925|NCT02109042|3927527|FG000|Receive at Least 1 Subsequent 90 mg Dose|Overall Study||15
3198926|NCT02109042|3927527|FG000|COMPLETED|Overall Study||0
3198927|NCT02109042|3927527|FG000|NOT COMPLETED|Overall Study||15
3198928|NCT02109107|3927532|FG000|STARTED|Overall Study||54
3198929|NCT02109107|3927532|FG000|COMPLETED|Overall Study||52
3198930|NCT02109107|3927532|FG000|NOT COMPLETED|Overall Study||2
3198931|NCT02109133|3927538|FG000|STARTED|Overall Study||33
3198932|NCT02109133|3927539|FG001|STARTED|Overall Study||34
3198933|NCT02109133|3927538|FG000|COMPLETED|Overall Study||32
3198934|NCT02109133|3927539|FG001|COMPLETED|Overall Study||34
3198935|NCT02109133|3927538|FG000|NOT COMPLETED|Overall Study||1
3198936|NCT02109133|3927539|FG001|NOT COMPLETED|Overall Study||0
3198937|NCT02109159|3927549|FG000|STARTED|Overall Study||4178
3198938|NCT02109159|3927550|FG001|STARTED|Overall Study||4175
3198939|NCT02109159|3927549|FG000|COMPLETED|Overall Study||4178
3198940|NCT02109159|3927550|FG001|COMPLETED|Overall Study||4175
3198941|NCT02109159|3927549|FG000|NOT COMPLETED|Overall Study||0
3198942|NCT02109159|3927550|FG001|NOT COMPLETED|Overall Study||0
3198943|NCT02109419|3927556|FG000|STARTED|Overall Study||57
3198944|NCT02109419|3927556|FG000|COMPLETED|Overall Study||57
3198945|NCT02109419|3927556|FG000|NOT COMPLETED|Overall Study||0
3198946|NCT02109432|3927562|FG000|STARTED|Overall Study||7
3198947|NCT02109432|3927562|FG000|COMPLETED|Overall Study||6
3198948|NCT02109432|3927562|FG000|NOT COMPLETED|Overall Study||1
3198949|NCT02109445|3927566|FG000|STARTED|Overall Study||3
3198950|NCT02109445|3927566|FG000|COMPLETED|Overall Study||0
3198951|NCT02109445|3927566|FG000|NOT COMPLETED|Overall Study||3
3198952|NCT02109458|3927570|FG000|STARTED|Overall Study||24
3198953|NCT02109458|3927570|FG000|COMPLETED|Overall Study||24
3198954|NCT02109458|3927570|FG000|NOT COMPLETED|Overall Study||0
3198955|NCT02109484|3927582|FG000|STARTED|Overall Study||5
3198956|NCT02109484|3927583|FG001|STARTED|Overall Study||13
3198957|NCT02109484|3927584|FG002|STARTED|Overall Study||12
3198958|NCT02109484|3927585|FG003|STARTED|Overall Study||12
3198959|NCT02109484|3927586|FG004|STARTED|Overall Study||50
3198960|NCT02109484|3927587|FG005|STARTED|Overall Study||12
3198961|NCT02109484|3927588|FG006|STARTED|Overall Study||50
3198962|NCT02109484|3927589|FG007|STARTED|Overall Study||50
3198963|NCT02109484|3927582|FG000|COMPLETED|Overall Study||5
3198964|NCT02109484|3927583|FG001|COMPLETED|Overall Study||13
3198965|NCT02109484|3927584|FG002|COMPLETED|Overall Study||12
3198966|NCT02109484|3927585|FG003|COMPLETED|Overall Study||11
3198967|NCT02109484|3927586|FG004|COMPLETED|Overall Study||46
3198968|NCT02109484|3927587|FG005|COMPLETED|Overall Study||11
3198969|NCT02109484|3927588|FG006|COMPLETED|Overall Study||47
3198970|NCT02109484|3927589|FG007|COMPLETED|Overall Study||47
3198971|NCT02109484|3927582|FG000|NOT COMPLETED|Overall Study||0
3198972|NCT02109484|3927583|FG001|NOT COMPLETED|Overall Study||0
3198973|NCT02109484|3927584|FG002|NOT COMPLETED|Overall Study||0
3198974|NCT02109484|3927585|FG003|NOT COMPLETED|Overall Study||1
3198975|NCT02109484|3927586|FG004|NOT COMPLETED|Overall Study||4
3198976|NCT02109484|3927587|FG005|NOT COMPLETED|Overall Study||1
3198977|NCT02109484|3927588|FG006|NOT COMPLETED|Overall Study||3
3198978|NCT02109484|3927589|FG007|NOT COMPLETED|Overall Study||3
3198979|NCT02109497|3927624|FG000|STARTED|Overall Study||18
3198980|NCT02109497|3927624|FG000|COMPLETED|Overall Study|One participant completed the safety assessments but did not complete all doses of the study drugs.|17
3198981|NCT02109497|3927624|FG000|NOT COMPLETED|Overall Study||1
3198982|NCT02109562|3927631|FG000|STARTED|Overall Study||116
3198983|NCT02109562|3927632|FG001|STARTED|Overall Study||119
3198984|NCT02109562|3927633|FG002|STARTED|Overall Study||119
3198985|NCT02109562|3927631|FG000|Safety|Overall Study||115
3198986|NCT02109562|3927632|FG001|Safety|Overall Study||117
3198987|NCT02109562|3927633|FG002|Safety|Overall Study||118
3198988|NCT02109562|3927631|FG000|Intent to Treat (ITT)|Overall Study||111
3198989|NCT02109562|3927632|FG001|Intent to Treat (ITT)|Overall Study||114
3198990|NCT02109562|3927633|FG002|Intent to Treat (ITT)|Overall Study||112
3198991|NCT02109562|3927631|FG000|COMPLETED|Overall Study||90
3198992|NCT02109562|3927632|FG001|COMPLETED|Overall Study||85
3198993|NCT02109562|3927633|FG002|COMPLETED|Overall Study||84
3198994|NCT02109562|3927631|FG000|NOT COMPLETED|Overall Study||26
3198995|NCT02109562|3927632|FG001|NOT COMPLETED|Overall Study||34
3198996|NCT02109562|3927633|FG002|NOT COMPLETED|Overall Study||35
3198997|NCT02109640|3927643|FG000|STARTED|Overall Study||27
3198998|NCT02109640|3927644|FG001|STARTED|Overall Study||23
3198999|NCT02109640|3927643|FG000|COMPLETED|Overall Study||27
3199000|NCT02109640|3927644|FG001|COMPLETED|Overall Study||23
3199001|NCT02109640|3927643|FG000|NOT COMPLETED|Overall Study||0
3199002|NCT02109640|3927644|FG001|NOT COMPLETED|Overall Study||0
3199003|NCT02109731|3927650|FG000|STARTED|Overall Study||15
3199004|NCT02109731|3927650|FG000|COMPLETED|Overall Study||15
3199005|NCT02109731|3927650|FG000|NOT COMPLETED|Overall Study||0
3199006|NCT02109939|3927656|FG000|STARTED|Overall Study||681
3199007|NCT02109939|3927657|FG001|STARTED|Overall Study||717
3199008|NCT02109939|3927656|FG000|COMPLETED|Overall Study||560
3199009|NCT02109939|3927657|FG001|COMPLETED|Overall Study||607
3199010|NCT02109939|3927656|FG000|NOT COMPLETED|Overall Study||121
3199011|NCT02109939|3927657|FG001|NOT COMPLETED|Overall Study||110
3199012|NCT02110095|3927667|FG000|STARTED|Overall Study||15
3199013|NCT02110095|3927667|FG000|COMPLETED|Overall Study||8
3199014|NCT02110095|3927667|FG000|NOT COMPLETED|Overall Study||7
3199015|NCT02110108|3927671|FG000|STARTED|Overall Study||10
3199016|NCT02110108|3927671|FG000|RevLite Single Wavelength|Overall Study||10
3199017|NCT02110108|3927671|FG000|RevLite Combo Wavelength|Overall Study||10
3199018|NCT02110108|3927671|FG000|COMPLETED|Overall Study||7
3199019|NCT02110108|3927671|FG000|NOT COMPLETED|Overall Study||3
3199020|NCT02110121|3927681|FG000|STARTED|Overall Study||58
3199021|NCT02110121|3927682|FG001|STARTED|Overall Study||5
3199022|NCT02110121|3927681|FG000|COMPLETED|Overall Study||42
3199023|NCT02110121|3927682|FG001|COMPLETED|Overall Study||5
3199024|NCT02110121|3927681|FG000|NOT COMPLETED|Overall Study||16
3199025|NCT02110121|3927682|FG001|NOT COMPLETED|Overall Study||0
3199026|NCT02110147|3927688|FG000|STARTED|Overall Study||4
3199027|NCT02110147|3927688|FG000|COMPLETED|Overall Study||4
3199028|NCT02110147|3927688|FG000|NOT COMPLETED|Overall Study||0
3199029|NCT02110225|3927695|FG000|STARTED|Overall Study||20
3199030|NCT02110225|3927696|FG001|STARTED|Overall Study||20
3199031|NCT02110225|3927697|FG002|STARTED|Overall Study||10
3199032|NCT02110225|3927695|FG000|COMPLETED|Overall Study||20
3199033|NCT02110225|3927696|FG001|COMPLETED|Overall Study||19
3199034|NCT02110225|3927697|FG002|COMPLETED|Overall Study||10
3199035|NCT02110225|3927695|FG000|NOT COMPLETED|Overall Study||0
3199036|NCT02110225|3927696|FG001|NOT COMPLETED|Overall Study||1
3199037|NCT02110225|3927697|FG002|NOT COMPLETED|Overall Study||0
3199038|NCT02110238|3927708|FG000|STARTED|12 Week Pivotal Phase|One subject was randomized but not treated. As a result there were 211 safety subjects|212
3199039|NCT02110238|3927709|FG001|STARTED|12 Week Pivotal Phase||209
3199040|NCT02110238|3927708|FG000|COMPLETED|12 Week Pivotal Phase||202
3199041|NCT02110238|3927709|FG001|COMPLETED|12 Week Pivotal Phase||200
3199042|NCT02110238|3927708|FG000|NOT COMPLETED|12 Week Pivotal Phase||10
3199043|NCT02110238|3927709|FG001|NOT COMPLETED|12 Week Pivotal Phase||9
3199044|NCT02110238|3927708|FG000|STARTED|14 Week Blinded Extension Phase||202
3199045|NCT02110238|3927709|FG001|STARTED|14 Week Blinded Extension Phase||200
3199046|NCT02110238|3927708|FG000|COMPLETED|14 Week Blinded Extension Phase||190
3199047|NCT02110238|3927709|FG001|COMPLETED|14 Week Blinded Extension Phase||188
3199048|NCT02110238|3927708|FG000|NOT COMPLETED|14 Week Blinded Extension Phase||12
3199049|NCT02110238|3927709|FG001|NOT COMPLETED|14 Week Blinded Extension Phase||12
3199050|NCT02110264|3927718|FG000|STARTED|Overall Study||53
3199051|NCT02110264|3927719|FG001|STARTED|Overall Study||50
3199052|NCT02110264|3927720|FG002|STARTED|Overall Study||48
3199053|NCT02110264|3927718|FG000|COMPLETED|Overall Study||35
3199054|NCT02110264|3927719|FG001|COMPLETED|Overall Study||38
3199055|NCT02110264|3927720|FG002|COMPLETED|Overall Study||39
3199056|NCT02110264|3927718|FG000|NOT COMPLETED|Overall Study||18
3199057|NCT02110264|3927719|FG001|NOT COMPLETED|Overall Study||12
3199058|NCT02110264|3927720|FG002|NOT COMPLETED|Overall Study||9
3199059|NCT02110381|3927730|FG000|STARTED|Single Modality||9
3199060|NCT02110381|3927731|FG001|STARTED|Single Modality||9
3199061|NCT02110381|3927730|FG000|COMPLETED|Single Modality||7
3199062|NCT02110381|3927731|FG001|COMPLETED|Single Modality||8
3199063|NCT02110381|3927730|FG000|NOT COMPLETED|Single Modality||2
3199064|NCT02110381|3927731|FG001|NOT COMPLETED|Single Modality||1
3199065|NCT02110381|3927730|FG000|STARTED|Dual Modality||7
3199066|NCT02110381|3927731|FG001|STARTED|Dual Modality||8
3199067|NCT02110381|3927730|FG000|Began Active Treatment|Dual Modality||7
3199068|NCT02110381|3927731|FG001|Began Active Treatment|Dual Modality||7
3199069|NCT02110381|3927730|FG000|COMPLETED|Dual Modality||5
3199070|NCT02110381|3927731|FG001|COMPLETED|Dual Modality||7
3199071|NCT02110381|3927730|FG000|NOT COMPLETED|Dual Modality||2
3199072|NCT02110381|3927731|FG001|NOT COMPLETED|Dual Modality||1
3199073|NCT02110485|3927740|FG000|STARTED|Overall Study||98
3199074|NCT02110485|3927741|FG001|STARTED|Overall Study||102
3199075|NCT02110485|3927740|FG000|COMPLETED|Overall Study||91
3199076|NCT02110485|3927741|FG001|COMPLETED|Overall Study||83
3199077|NCT02110485|3927740|FG000|NOT COMPLETED|Overall Study||7
3199078|NCT02110485|3927741|FG001|NOT COMPLETED|Overall Study||19
3199079|NCT02110693|3927747|FG000|STARTED|Overall Study||1026
3199080|NCT02110693|3927748|FG001|STARTED|Overall Study||1031
3199081|NCT02110693|3927747|FG000|COMPLETED|Overall Study||998
3199082|NCT02110693|3927748|FG001|COMPLETED|Overall Study||1002
3199083|NCT02110693|3927747|FG000|NOT COMPLETED|Overall Study||28
3199084|NCT02110693|3927748|FG001|NOT COMPLETED|Overall Study||29
3199085|NCT02110706|3927770|FG000|STARTED|Overall Study||25
3199086|NCT02110706|3927771|FG001|STARTED|Overall Study||27
3199087|NCT02110706|3927770|FG000|No. Completing Study Through Week 52|Overall Study||23
3199088|NCT02110706|3927771|FG001|No. Completing Study Through Week 52|Overall Study||24
3199089|NCT02110706|3927770|FG000|COMPLETED|Overall Study||20
3199090|NCT02110706|3927771|FG001|COMPLETED|Overall Study||23
3199091|NCT02110706|3927770|FG000|NOT COMPLETED|Overall Study||5
3199092|NCT02110706|3927771|FG001|NOT COMPLETED|Overall Study||4
3199093|NCT02110732|3927781|FG000|STARTED|Overall Study||20
3199094|NCT02110732|3927782|FG001|STARTED|Overall Study||20
3199095|NCT02110732|3927781|FG000|COMPLETED|Overall Study||14
3199096|NCT02110732|3927782|FG001|COMPLETED|Overall Study||17
3199097|NCT02110732|3927781|FG000|NOT COMPLETED|Overall Study||6
3199098|NCT02110732|3927782|FG001|NOT COMPLETED|Overall Study||3
3199099|NCT02110758|3927793|FG000|STARTED|Baseline: August 2011-July 2013||0
3199100|NCT02110758|3927794|FG001|STARTED|Baseline: August 2011-July 2013||0
3199101|NCT02110758|3927795|FG002|STARTED|Baseline: August 2011-July 2013||9832
3199102|NCT02110758|3927796|FG003|STARTED|Baseline: August 2011-July 2013||18994
3199103|NCT02110758|3927797|FG004|STARTED|Baseline: August 2011-July 2013||308
3199104|NCT02110758|3927793|FG000|COMPLETED|Baseline: August 2011-July 2013||0
3199105|NCT02110758|3927794|FG001|COMPLETED|Baseline: August 2011-July 2013||0
3199106|NCT02110758|3927795|FG002|COMPLETED|Baseline: August 2011-July 2013||9832
3199107|NCT02110758|3927796|FG003|COMPLETED|Baseline: August 2011-July 2013||18994
3199108|NCT02110758|3927797|FG004|COMPLETED|Baseline: August 2011-July 2013||308
3199109|NCT02110758|3927793|FG000|NOT COMPLETED|Baseline: August 2011-July 2013||0
3199110|NCT02110758|3927794|FG001|NOT COMPLETED|Baseline: August 2011-July 2013||0
3199111|NCT02110758|3927795|FG002|NOT COMPLETED|Baseline: August 2011-July 2013||0
3199112|NCT02110758|3927796|FG003|NOT COMPLETED|Baseline: August 2011-July 2013||0
3199113|NCT02110758|3927797|FG004|NOT COMPLETED|Baseline: August 2011-July 2013||0
3199114|NCT02110758|3927793|FG000|STARTED|Start-Up: August 2013-June 2014||175
3199115|NCT02110758|3927794|FG001|STARTED|Start-Up: August 2013-June 2014||431
3199116|NCT02110758|3927795|FG002|STARTED|Start-Up: August 2013-June 2014||8057
3199117|NCT02110758|3927796|FG003|STARTED|Start-Up: August 2013-June 2014||12883
3199118|NCT02110758|3927797|FG004|STARTED|Start-Up: August 2013-June 2014||0
3199119|NCT02110758|3927793|FG000|COMPLETED|Start-Up: August 2013-June 2014||175
3199120|NCT02110758|3927794|FG001|COMPLETED|Start-Up: August 2013-June 2014||431
3199121|NCT02110758|3927795|FG002|COMPLETED|Start-Up: August 2013-June 2014||8057
3199122|NCT02110758|3927796|FG003|COMPLETED|Start-Up: August 2013-June 2014||12883
3199123|NCT02110758|3927797|FG004|COMPLETED|Start-Up: August 2013-June 2014||0
3199124|NCT02110758|3927793|FG000|NOT COMPLETED|Start-Up: August 2013-June 2014||0
3199125|NCT02110758|3927794|FG001|NOT COMPLETED|Start-Up: August 2013-June 2014||0
3199126|NCT02110758|3927795|FG002|NOT COMPLETED|Start-Up: August 2013-June 2014||0
3199127|NCT02110758|3927796|FG003|NOT COMPLETED|Start-Up: August 2013-June 2014||0
3199128|NCT02110758|3927797|FG004|NOT COMPLETED|Start-Up: August 2013-June 2014||0
3199129|NCT02110758|3927793|FG000|STARTED|Intervention: July 2014-December 2015||0
3199130|NCT02110758|3927794|FG001|STARTED|Intervention: July 2014-December 2015||0
3199131|NCT02110758|3927795|FG002|STARTED|Intervention: July 2014-December 2015||10106
3199132|NCT02110758|3927796|FG003|STARTED|Intervention: July 2014-December 2015||33012
3199133|NCT02110758|3927797|FG004|STARTED|Intervention: July 2014-December 2015||0
3199134|NCT02110758|3927793|FG000|COMPLETED|Intervention: July 2014-December 2015||0
3199135|NCT02110758|3927794|FG001|COMPLETED|Intervention: July 2014-December 2015||0
3199136|NCT02110758|3927795|FG002|COMPLETED|Intervention: July 2014-December 2015||10106
3199137|NCT02110758|3927796|FG003|COMPLETED|Intervention: July 2014-December 2015||33012
3199138|NCT02110758|3927797|FG004|COMPLETED|Intervention: July 2014-December 2015||0
3199139|NCT02110758|3927793|FG000|NOT COMPLETED|Intervention: July 2014-December 2015||0
3199140|NCT02110758|3927794|FG001|NOT COMPLETED|Intervention: July 2014-December 2015||0
3199141|NCT02110758|3927795|FG002|NOT COMPLETED|Intervention: July 2014-December 2015||0
3199142|NCT02110758|3927796|FG003|NOT COMPLETED|Intervention: July 2014-December 2015||0
3199143|NCT02110758|3927797|FG004|NOT COMPLETED|Intervention: July 2014-December 2015||0
3364920|NCT03996694|4096113|FG003|COMPLETED|Second Washout (7 Days)||3
3364921|NCT03996694|4096114|FG004|COMPLETED|Second Washout (7 Days)||3
3364922|NCT03996694|4096115|FG005|COMPLETED|Second Washout (7 Days)||3
3364923|NCT03996694|4096110|FG000|NOT COMPLETED|Second Washout (7 Days)||0
3364924|NCT03996694|4096111|FG001|NOT COMPLETED|Second Washout (7 Days)||0
3364925|NCT03996694|4096112|FG002|NOT COMPLETED|Second Washout (7 Days)||0
3364926|NCT03996694|4096113|FG003|NOT COMPLETED|Second Washout (7 Days)||0
3364927|NCT03996694|4096114|FG004|NOT COMPLETED|Second Washout (7 Days)||0
3364928|NCT03996694|4096115|FG005|NOT COMPLETED|Second Washout (7 Days)||0
3364929|NCT03996694|4096110|FG000|STARTED|Third Intervention (1 Day)||3
3364930|NCT03996694|4096111|FG001|STARTED|Third Intervention (1 Day)||2
3364931|NCT03996694|4096112|FG002|STARTED|Third Intervention (1 Day)||2
3364932|NCT03996694|4096113|FG003|STARTED|Third Intervention (1 Day)||3
3364933|NCT03996694|4096114|FG004|STARTED|Third Intervention (1 Day)||3
3364934|NCT03996694|4096115|FG005|STARTED|Third Intervention (1 Day)||3
3364935|NCT03996694|4096110|FG000|COMPLETED|Third Intervention (1 Day)||3
3364936|NCT03996694|4096111|FG001|COMPLETED|Third Intervention (1 Day)||2
3364937|NCT03996694|4096112|FG002|COMPLETED|Third Intervention (1 Day)||2
3364938|NCT03996694|4096113|FG003|COMPLETED|Third Intervention (1 Day)||3
3364939|NCT03996694|4096114|FG004|COMPLETED|Third Intervention (1 Day)||3
3364940|NCT03996694|4096115|FG005|COMPLETED|Third Intervention (1 Day)||3
3364941|NCT03996694|4096110|FG000|NOT COMPLETED|Third Intervention (1 Day)||0
3364942|NCT03996694|4096111|FG001|NOT COMPLETED|Third Intervention (1 Day)||0
3364943|NCT03996694|4096112|FG002|NOT COMPLETED|Third Intervention (1 Day)||0
3364944|NCT03996694|4096113|FG003|NOT COMPLETED|Third Intervention (1 Day)||0
3364945|NCT03996694|4096114|FG004|NOT COMPLETED|Third Intervention (1 Day)||0
3364946|NCT03996694|4096115|FG005|NOT COMPLETED|Third Intervention (1 Day)||0
3364947|NCT03996694|4096110|FG000|STARTED|Third Washout (7 Days)||3
3364948|NCT03996694|4096111|FG001|STARTED|Third Washout (7 Days)||2
3364949|NCT03996694|4096112|FG002|STARTED|Third Washout (7 Days)||2
3364950|NCT03996694|4096113|FG003|STARTED|Third Washout (7 Days)||3
3364951|NCT03996694|4096114|FG004|STARTED|Third Washout (7 Days)||3
3364952|NCT03996694|4096115|FG005|STARTED|Third Washout (7 Days)||3
3364953|NCT03996694|4096110|FG000|COMPLETED|Third Washout (7 Days)||3
3364954|NCT03996694|4096111|FG001|COMPLETED|Third Washout (7 Days)||2
3364955|NCT03996694|4096112|FG002|COMPLETED|Third Washout (7 Days)||2
3364956|NCT03996694|4096113|FG003|COMPLETED|Third Washout (7 Days)||3
3364957|NCT03996694|4096114|FG004|COMPLETED|Third Washout (7 Days)||2
3364958|NCT03996694|4096115|FG005|COMPLETED|Third Washout (7 Days)||3
3364959|NCT03996694|4096110|FG000|NOT COMPLETED|Third Washout (7 Days)||0
3364960|NCT03996694|4096111|FG001|NOT COMPLETED|Third Washout (7 Days)||0
3364961|NCT03996694|4096112|FG002|NOT COMPLETED|Third Washout (7 Days)||0
3364962|NCT03996694|4096113|FG003|NOT COMPLETED|Third Washout (7 Days)||0
3364963|NCT03996694|4096114|FG004|NOT COMPLETED|Third Washout (7 Days)||1
3364964|NCT03996694|4096115|FG005|NOT COMPLETED|Third Washout (7 Days)||0
3364965|NCT03996694|4096110|FG000|STARTED|Fourth Intervention (1 Day)||3
3364966|NCT03996694|4096111|FG001|STARTED|Fourth Intervention (1 Day)||2
3364967|NCT03996694|4096112|FG002|STARTED|Fourth Intervention (1 Day)||2
3364968|NCT03996694|4096113|FG003|STARTED|Fourth Intervention (1 Day)||3
3199144|NCT02110758|3927793|FG000|STARTED|Follow-Up: January-July 2016||81
3199145|NCT02110758|3927794|FG001|STARTED|Follow-Up: January-July 2016||179
3199146|NCT02110758|3927795|FG002|STARTED|Follow-Up: January-July 2016||6451
3199147|NCT02110758|3927796|FG003|STARTED|Follow-Up: January-July 2016||24392
3199148|NCT02110758|3927797|FG004|STARTED|Follow-Up: January-July 2016||349
3199149|NCT02110758|3927793|FG000|COMPLETED|Follow-Up: January-July 2016||81
3199150|NCT02110758|3927794|FG001|COMPLETED|Follow-Up: January-July 2016||179
3199151|NCT02110758|3927795|FG002|COMPLETED|Follow-Up: January-July 2016||6451
3199152|NCT02110758|3927796|FG003|COMPLETED|Follow-Up: January-July 2016||24392
3199153|NCT02110758|3927797|FG004|COMPLETED|Follow-Up: January-July 2016||349
3199154|NCT02110758|3927793|FG000|NOT COMPLETED|Follow-Up: January-July 2016||0
3199155|NCT02110758|3927794|FG001|NOT COMPLETED|Follow-Up: January-July 2016||0
3199156|NCT02110758|3927795|FG002|NOT COMPLETED|Follow-Up: January-July 2016||0
3199157|NCT02110758|3927796|FG003|NOT COMPLETED|Follow-Up: January-July 2016||0
3199158|NCT02110758|3927797|FG004|NOT COMPLETED|Follow-Up: January-July 2016||0
3199159|NCT02110901|3927811|FG000|STARTED|Overall Study||209
3199160|NCT02110901|3927812|FG001|STARTED|Overall Study||102
3199161|NCT02110901|3927811|FG000|COMPLETED|Overall Study||179
3199162|NCT02110901|3927812|FG001|COMPLETED|Overall Study||88
3199163|NCT02110901|3927811|FG000|NOT COMPLETED|Overall Study||30
3199164|NCT02110901|3927812|FG001|NOT COMPLETED|Overall Study||14
3199165|NCT02111083|3927821|FG000|STARTED|First Intervention (1 Day)||19
3199166|NCT02111083|3927822|FG001|STARTED|First Intervention (1 Day)||19
3199167|NCT02111083|3927821|FG000|COMPLETED|First Intervention (1 Day)||19
3199168|NCT02111083|3927822|FG001|COMPLETED|First Intervention (1 Day)||19
3199169|NCT02111083|3927821|FG000|NOT COMPLETED|First Intervention (1 Day)||0
3199170|NCT02111083|3927822|FG001|NOT COMPLETED|First Intervention (1 Day)||0
3199171|NCT02111083|3927821|FG000|STARTED|Interval Between Dosing (7-8 Days)||19
3199172|NCT02111083|3927822|FG001|STARTED|Interval Between Dosing (7-8 Days)||19
3199173|NCT02111083|3927821|FG000|COMPLETED|Interval Between Dosing (7-8 Days)||19
3199174|NCT02111083|3927822|FG001|COMPLETED|Interval Between Dosing (7-8 Days)||19
3199175|NCT02111083|3927821|FG000|NOT COMPLETED|Interval Between Dosing (7-8 Days)||0
3199176|NCT02111083|3927822|FG001|NOT COMPLETED|Interval Between Dosing (7-8 Days)||0
3199177|NCT02111083|3927821|FG000|STARTED|Second Intervention (1 Day)||19
3199178|NCT02111083|3927822|FG001|STARTED|Second Intervention (1 Day)||19
3199179|NCT02111083|3927821|FG000|COMPLETED|Second Intervention (1 Day)||19
3199180|NCT02111083|3927822|FG001|COMPLETED|Second Intervention (1 Day)||19
3199181|NCT02111083|3927821|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
3199182|NCT02111083|3927822|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
3199183|NCT02111083|3927821|FG000|STARTED|Interval Between Dosing (7-8 Days)||19
3199184|NCT02111083|3927822|FG001|STARTED|Interval Between Dosing (7-8 Days)||19
3199185|NCT02111083|3927821|FG000|COMPLETED|Interval Between Dosing (7-8 Days)||19
3199186|NCT02111083|3927822|FG001|COMPLETED|Interval Between Dosing (7-8 Days)||19
3199187|NCT02111083|3927821|FG000|NOT COMPLETED|Interval Between Dosing (7-8 Days)||0
3199188|NCT02111083|3927822|FG001|NOT COMPLETED|Interval Between Dosing (7-8 Days)||0
3199189|NCT02111083|3927821|FG000|STARTED|Third Intervention (1 Day)||19
3199190|NCT02111083|3927822|FG001|STARTED|Third Intervention (1 Day)||19
3199191|NCT02111083|3927821|FG000|COMPLETED|Third Intervention (1 Day)||19
3199192|NCT02111083|3927822|FG001|COMPLETED|Third Intervention (1 Day)||19
3199193|NCT02111083|3927821|FG000|NOT COMPLETED|Third Intervention (1 Day)||0
3199194|NCT02111083|3927822|FG001|NOT COMPLETED|Third Intervention (1 Day)||0
3199195|NCT02111083|3927821|FG000|STARTED|Interval Between Dosing (7-8 Days)||19
3199196|NCT02111083|3927822|FG001|STARTED|Interval Between Dosing (7-8 Days)||19
3199197|NCT02111083|3927821|FG000|COMPLETED|Interval Between Dosing (7-8 Days)||18
3199198|NCT02111083|3927822|FG001|COMPLETED|Interval Between Dosing (7-8 Days)||18
3199199|NCT02111083|3927821|FG000|NOT COMPLETED|Interval Between Dosing (7-8 Days)||1
3199200|NCT02111083|3927822|FG001|NOT COMPLETED|Interval Between Dosing (7-8 Days)||1
3199201|NCT02111083|3927821|FG000|STARTED|Fourth Intervention (1 Day)||18
3199202|NCT02111083|3927822|FG001|STARTED|Fourth Intervention (1 Day)||18
3199203|NCT02111083|3927821|FG000|COMPLETED|Fourth Intervention (1 Day)||18
3199204|NCT02111083|3927822|FG001|COMPLETED|Fourth Intervention (1 Day)||18
3199205|NCT02111083|3927821|FG000|NOT COMPLETED|Fourth Intervention (1 Day)||0
3199206|NCT02111083|3927822|FG001|NOT COMPLETED|Fourth Intervention (1 Day)||0
3199207|NCT02111096|3927831|FG000|STARTED|Overall Study||65
3199208|NCT02111096|3927832|FG001|STARTED|Overall Study||41
3199209|NCT02111096|3927833|FG002|STARTED|Overall Study||68
3199210|NCT02111096|3927831|FG000|Received at Least 1 Dose of Study Drug|Overall Study||65
3199211|NCT02111096|3927832|FG001|Received at Least 1 Dose of Study Drug|Overall Study||41
3199212|NCT02111096|3927833|FG002|Received at Least 1 Dose of Study Drug|Overall Study||68
3199213|NCT02111096|3927831|FG000|COMPLETED|Overall Study||1
3199214|NCT02111096|3927832|FG001|COMPLETED|Overall Study||0
3199215|NCT02111096|3927833|FG002|COMPLETED|Overall Study||2
3199216|NCT02111096|3927831|FG000|NOT COMPLETED|Overall Study||64
3199217|NCT02111096|3927832|FG001|NOT COMPLETED|Overall Study||41
3199218|NCT02111096|3927833|FG002|NOT COMPLETED|Overall Study||66
3199219|NCT02111174|3927846|FG000|STARTED|Treatment and Primary Outcome||18
3199220|NCT02111174|3927847|FG001|STARTED|Treatment and Primary Outcome||18
3199221|NCT02111174|3927846|FG000|COMPLETED|Treatment and Primary Outcome||15
3199222|NCT02111174|3927847|FG001|COMPLETED|Treatment and Primary Outcome||16
3199223|NCT02111174|3927846|FG000|NOT COMPLETED|Treatment and Primary Outcome||3
3199224|NCT02111174|3927847|FG001|NOT COMPLETED|Treatment and Primary Outcome||2
3199225|NCT02111174|3927846|FG000|STARTED|Secondary Outcomes (2 and 3 Month f/u)||15
3199226|NCT02111174|3927847|FG001|STARTED|Secondary Outcomes (2 and 3 Month f/u)||16
3199227|NCT02111174|3927846|FG000|2 Month Follow up Complete|Secondary Outcomes (2 and 3 Month f/u)||8
3199228|NCT02111174|3927847|FG001|2 Month Follow up Complete|Secondary Outcomes (2 and 3 Month f/u)||11
3199229|NCT02111174|3927846|FG000|COMPLETED|Secondary Outcomes (2 and 3 Month f/u)||7
3199230|NCT02111174|3927847|FG001|COMPLETED|Secondary Outcomes (2 and 3 Month f/u)||9
3199231|NCT02111174|3927846|FG000|NOT COMPLETED|Secondary Outcomes (2 and 3 Month f/u)||8
3199232|NCT02111174|3927847|FG001|NOT COMPLETED|Secondary Outcomes (2 and 3 Month f/u)||7
3199233|NCT02111187|3927855|FG000|STARTED|Overall Study||7
3199234|NCT02111187|3927856|FG001|STARTED|Overall Study||7
3199235|NCT02111187|3927855|FG000|COMPLETED|Overall Study||7
3199236|NCT02111187|3927856|FG001|COMPLETED|Overall Study||7
3199237|NCT02111187|3927855|FG000|NOT COMPLETED|Overall Study||0
3199238|NCT02111187|3927856|FG001|NOT COMPLETED|Overall Study||0
3199239|NCT02111200|3927866|FG000|STARTED|Overall Study||3
3199240|NCT02111200|3927867|FG001|STARTED|Overall Study||2
3199241|NCT02111200|3927868|FG002|STARTED|Overall Study||1
3199242|NCT02111200|3927869|FG003|STARTED|Overall Study||1
3199243|NCT02111200|3927866|FG000|COMPLETED|Overall Study||3
3199244|NCT02111200|3927867|FG001|COMPLETED|Overall Study||2
3199245|NCT02111200|3927868|FG002|COMPLETED|Overall Study||1
3199246|NCT02111200|3927869|FG003|COMPLETED|Overall Study||1
3199247|NCT02111200|3927866|FG000|NOT COMPLETED|Overall Study||0
3199248|NCT02111200|3927867|FG001|NOT COMPLETED|Overall Study||0
3199249|NCT02111200|3927868|FG002|NOT COMPLETED|Overall Study||0
3199250|NCT02111200|3927869|FG003|NOT COMPLETED|Overall Study||0
3199251|NCT02111213|3927879|FG000|STARTED|Overall Study||122
3199252|NCT02111213|3927880|FG001|STARTED|Overall Study||123
3199253|NCT02111213|3927879|FG000|COMPLETED|Overall Study||116
3199254|NCT02111213|3927880|FG001|COMPLETED|Overall Study||117
3199255|NCT02111213|3927879|FG000|NOT COMPLETED|Overall Study||6
3199256|NCT02111213|3927880|FG001|NOT COMPLETED|Overall Study||6
3199257|NCT02111252|3927886|FG000|STARTED|Overall Study||55
3199258|NCT02111252|3927886|FG000|COMPLETED|Overall Study||55
3199259|NCT02111252|3927886|FG000|NOT COMPLETED|Overall Study||0
3199260|NCT02111369|3927890|FG000|STARTED|Overall Study||18
3199261|NCT02111369|3927890|FG000|COMPLETED|Overall Study||15
3199262|NCT02111369|3927890|FG000|NOT COMPLETED|Overall Study||3
3199263|NCT02111447|3927898|FG000|STARTED|Overall Study||0
3199264|NCT02111447|3927899|FG001|STARTED|Overall Study||5
3199265|NCT02111447|3927900|FG002|STARTED|Overall Study||1
3199266|NCT02111447|3927901|FG003|STARTED|Overall Study||0
3199267|NCT02111447|3927898|FG000|COMPLETED|Overall Study||0
3199268|NCT02111447|3927899|FG001|COMPLETED|Overall Study||5
3199269|NCT02111447|3927900|FG002|COMPLETED|Overall Study||1
3199270|NCT02111447|3927901|FG003|COMPLETED|Overall Study||0
3199271|NCT02111447|3927898|FG000|NOT COMPLETED|Overall Study||0
3199272|NCT02111447|3927899|FG001|NOT COMPLETED|Overall Study||0
3199273|NCT02111447|3927900|FG002|NOT COMPLETED|Overall Study||0
3199274|NCT02111447|3927901|FG003|NOT COMPLETED|Overall Study||0
3199275|NCT02111564|3927913|FG000|STARTED|Overall Study||6007
3199276|NCT02111564|3927914|FG001|STARTED|Overall Study||6012
3199277|NCT02111564|3927913|FG000|Treated|Overall Study||5982
3199278|NCT02111564|3927914|FG001|Treated|Overall Study||5980
3199279|NCT02111564|3927913|FG000|COMPLETED|Overall Study||5876
3199280|NCT02111564|3927914|FG001|COMPLETED|Overall Study||5869
3199281|NCT02111564|3927913|FG000|NOT COMPLETED|Overall Study||131
3199282|NCT02111564|3927914|FG001|NOT COMPLETED|Overall Study||143
3199283|NCT02111577|3927922|FG000|STARTED|Overall Study||787
3199284|NCT02111577|3927923|FG001|STARTED|Overall Study||395
3199285|NCT02111577|3927922|FG000|COMPLETED|Overall Study||188
3199286|NCT02111577|3927923|FG001|COMPLETED|Overall Study||106
3199287|NCT02111577|3927922|FG000|NOT COMPLETED|Overall Study||599
3199288|NCT02111577|3927923|FG001|NOT COMPLETED|Overall Study||289
3199289|NCT02111603|3927931|FG000|STARTED|Overall Study||13
3199290|NCT02111603|3927931|FG000|COMPLETED|Overall Study||12
3199291|NCT02111603|3927931|FG000|NOT COMPLETED|Overall Study||1
3199292|NCT02111746|3927937|FG000|STARTED|Overall Study||172
3199293|NCT02111746|3927938|FG001|STARTED|Overall Study||171
3199294|NCT02111746|3927937|FG000|COMPLETED|Overall Study||169
3199295|NCT02111746|3927938|FG001|COMPLETED|Overall Study||169
3199296|NCT02111746|3927937|FG000|NOT COMPLETED|Overall Study||3
3199297|NCT02111746|3927938|FG001|NOT COMPLETED|Overall Study||2
3364969|NCT03996694|4096114|FG004|STARTED|Fourth Intervention (1 Day)||2
3364970|NCT03996694|4096115|FG005|STARTED|Fourth Intervention (1 Day)||3
3364971|NCT03996694|4096110|FG000|COMPLETED|Fourth Intervention (1 Day)||3
3364972|NCT03996694|4096111|FG001|COMPLETED|Fourth Intervention (1 Day)||2
3364973|NCT03996694|4096112|FG002|COMPLETED|Fourth Intervention (1 Day)||2
3364974|NCT03996694|4096113|FG003|COMPLETED|Fourth Intervention (1 Day)||3
3364975|NCT03996694|4096114|FG004|COMPLETED|Fourth Intervention (1 Day)||2
3364976|NCT03996694|4096115|FG005|COMPLETED|Fourth Intervention (1 Day)||3
3364977|NCT03996694|4096110|FG000|NOT COMPLETED|Fourth Intervention (1 Day)||0
3364978|NCT03996694|4096111|FG001|NOT COMPLETED|Fourth Intervention (1 Day)||0
3364979|NCT03996694|4096112|FG002|NOT COMPLETED|Fourth Intervention (1 Day)||0
3364980|NCT03996694|4096113|FG003|NOT COMPLETED|Fourth Intervention (1 Day)||0
3364981|NCT03996694|4096114|FG004|NOT COMPLETED|Fourth Intervention (1 Day)||0
3364982|NCT03996694|4096115|FG005|NOT COMPLETED|Fourth Intervention (1 Day)||0
3199298|NCT02111772|3927946|FG000|STARTED|Overall Study||12
3199299|NCT02111772|3927947|FG001|STARTED|Overall Study||14
3199300|NCT02111772|3927946|FG000|COMPLETED|Overall Study||12
3199301|NCT02111772|3927947|FG001|COMPLETED|Overall Study||14
3199302|NCT02111772|3927946|FG000|NOT COMPLETED|Overall Study||0
3199303|NCT02111772|3927947|FG001|NOT COMPLETED|Overall Study||0
3199304|NCT02111785|3927957|FG000|STARTED|Overall Study||3
3199305|NCT02111785|3927958|FG001|STARTED|Overall Study||5
3199306|NCT02111785|3927959|FG002|STARTED|Overall Study||1
3199307|NCT02111785|3927960|FG003|STARTED|Overall Study||1
3199308|NCT02111785|3927957|FG000|COMPLETED|Overall Study||3
3199309|NCT02111785|3927958|FG001|COMPLETED|Overall Study||4
3199310|NCT02111785|3927959|FG002|COMPLETED|Overall Study||1
3199311|NCT02111785|3927960|FG003|COMPLETED|Overall Study||1
3199312|NCT02111785|3927957|FG000|NOT COMPLETED|Overall Study||0
3199313|NCT02111785|3927958|FG001|NOT COMPLETED|Overall Study||1
3199314|NCT02111785|3927959|FG002|NOT COMPLETED|Overall Study||0
3199315|NCT02111785|3927960|FG003|NOT COMPLETED|Overall Study||0
3199316|NCT02111798|3927978|FG000|STARTED|Overall Study||31
3199317|NCT02111798|3927979|FG001|STARTED|Overall Study||32
3199318|NCT02111798|3927980|FG002|STARTED|Overall Study||10
3199319|NCT02111798|3927981|FG003|STARTED|Overall Study||10
3199320|NCT02111798|3927978|FG000|COMPLETED|Overall Study||20
3199321|NCT02111798|3927979|FG001|COMPLETED|Overall Study||16
3199322|NCT02111798|3927980|FG002|COMPLETED|Overall Study||10
3199323|NCT02111798|3927981|FG003|COMPLETED|Overall Study||7
3199324|NCT02111798|3927978|FG000|NOT COMPLETED|Overall Study||11
3199325|NCT02111798|3927979|FG001|NOT COMPLETED|Overall Study||16
3199326|NCT02111798|3927980|FG002|NOT COMPLETED|Overall Study||0
3199327|NCT02111798|3927981|FG003|NOT COMPLETED|Overall Study||3
3199328|NCT02111811|3927994|FG000|STARTED|Treatment Phase||139
3199329|NCT02111811|3927995|FG001|STARTED|Treatment Phase||114
3199330|NCT02111811|3927994|FG000|COMPLETED|Treatment Phase||115
3199331|NCT02111811|3927995|FG001|COMPLETED|Treatment Phase||96
3199332|NCT02111811|3927994|FG000|NOT COMPLETED|Treatment Phase||24
3199333|NCT02111811|3927995|FG001|NOT COMPLETED|Treatment Phase||18
3199334|NCT02111811|3927994|FG000|STARTED|Follow up Period (Aim 2)||139
3199335|NCT02111811|3927995|FG001|STARTED|Follow up Period (Aim 2)|All subjects were approached for followup, 1 patient completed the 2nd followup and not the first.|114
3199336|NCT02111811|3927994|FG000|COMPLETED|Follow up Period (Aim 2)||111
3199337|NCT02111811|3927995|FG001|COMPLETED|Follow up Period (Aim 2)||97
3199338|NCT02111811|3927994|FG000|NOT COMPLETED|Follow up Period (Aim 2)||28
3199339|NCT02111811|3927995|FG001|NOT COMPLETED|Follow up Period (Aim 2)||17
3199340|NCT02111863|3928001|FG000|STARTED|Overall Study||6
3199341|NCT02111863|3928001|FG000|COMPLETED|Overall Study||6
3199342|NCT02111863|3928001|FG000|NOT COMPLETED|Overall Study||0
3199343|NCT02111980|3928005|FG000|STARTED|Overall Study||50
3199344|NCT02111980|3928005|FG000|COMPLETED|Overall Study||50
3199345|NCT02111980|3928005|FG000|NOT COMPLETED|Overall Study||0
3199346|NCT02111993|3928014|FG000|STARTED|Overall Study||30
3199347|NCT02111993|3928015|FG001|STARTED|Overall Study||30
3199348|NCT02111993|3928014|FG000|COMPLETED|Overall Study||25
3199349|NCT02111993|3928015|FG001|COMPLETED|Overall Study||26
3199350|NCT02111993|3928014|FG000|NOT COMPLETED|Overall Study||5
3199351|NCT02111993|3928015|FG001|NOT COMPLETED|Overall Study||4
3199352|NCT02112045|3928025|FG000|STARTED|Overall Study||45
3199353|NCT02112045|3928026|FG001|STARTED|Overall Study||45
3199354|NCT02112045|3928025|FG000|COMPLETED|Overall Study||44
3199355|NCT02112045|3928026|FG001|COMPLETED|Overall Study||45
3199356|NCT02112045|3928025|FG000|NOT COMPLETED|Overall Study||1
3199357|NCT02112045|3928026|FG001|NOT COMPLETED|Overall Study||0
3199358|NCT02112370|3928034|FG000|STARTED|Overall Study||74
3199359|NCT02112370|3928035|FG001|STARTED|Overall Study||74
3199360|NCT02112370|3928034|FG000|COMPLETED|Overall Study||74
3199361|NCT02112370|3928035|FG001|COMPLETED|Overall Study||74
3199362|NCT02112370|3928034|FG000|NOT COMPLETED|Overall Study||0
3199363|NCT02112370|3928035|FG001|NOT COMPLETED|Overall Study||0
3199364|NCT02112448|3928043|FG000|STARTED|Overall Study||38
3199365|NCT02112448|3928044|FG001|STARTED|Overall Study||40
3199366|NCT02112448|3928043|FG000|COMPLETED|Overall Study||30
3199367|NCT02112448|3928044|FG001|COMPLETED|Overall Study||30
3199368|NCT02112448|3928043|FG000|NOT COMPLETED|Overall Study||8
3199369|NCT02112448|3928044|FG001|NOT COMPLETED|Overall Study||10
3199370|NCT02112838|3928055|FG000|STARTED|Overall Study||25
3199371|NCT02112838|3928056|FG001|STARTED|Overall Study||26
3199372|NCT02112838|3928057|FG002|STARTED|Overall Study||25
3199373|NCT02112838|3928055|FG000|COMPLETED|Overall Study||20
3199374|NCT02112838|3928056|FG001|COMPLETED|Overall Study||24
3199375|NCT02112838|3928057|FG002|COMPLETED|Overall Study||24
3199376|NCT02112838|3928055|FG000|NOT COMPLETED|Overall Study||5
3199377|NCT02112838|3928056|FG001|NOT COMPLETED|Overall Study||2
3199378|NCT02112838|3928057|FG002|NOT COMPLETED|Overall Study||1
3199379|NCT02112877|3928067|FG000|STARTED|Overall Study||30
3199380|NCT02112877|3928068|FG001|STARTED|Overall Study||170
3199381|NCT02112877|3928067|FG000|COMPLETED|Overall Study||28
3199382|NCT02112877|3928068|FG001|COMPLETED|Overall Study||157
3199383|NCT02112877|3928067|FG000|NOT COMPLETED|Overall Study||2
3199384|NCT02112877|3928068|FG001|NOT COMPLETED|Overall Study||13
3199385|NCT02112994|3928076|FG000|STARTED|Overall Study||6
3199386|NCT02112994|3928077|FG001|STARTED|Overall Study||16
3199387|NCT02112994|3928078|FG002|STARTED|Overall Study||9
3199388|NCT02112994|3928076|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6
3199389|NCT02112994|3928077|FG001|Received at Least 1 Dose of Study Drug|Overall Study||16
3199390|NCT02112994|3928078|FG002|Received at Least 1 Dose of Study Drug|Overall Study||9
3199391|NCT02112994|3928076|FG000|Received 0.35 mg/kg QOW|Overall Study||0
3199392|NCT02112994|3928077|FG001|Received 0.35 mg/kg QOW|Overall Study||0
3199393|NCT02112994|3928078|FG002|Received 0.35 mg/kg QOW|Overall Study||1
3199394|NCT02112994|3928076|FG000|Received 1 mg/kg QOW|Overall Study||6
3199395|NCT02112994|3928077|FG001|Received 1 mg/kg QOW|Overall Study||16
3199396|NCT02112994|3928078|FG002|Received 1 mg/kg QOW|Overall Study||9
3199397|NCT02112994|3928076|FG000|Received 1 mg/kg QW|Overall Study||1
3199398|NCT02112994|3928077|FG001|Received 1 mg/kg QW|Overall Study||1
3199399|NCT02112994|3928078|FG002|Received 1 mg/kg QW|Overall Study||0
3199400|NCT02112994|3928076|FG000|Received 3 mg/kg QOW|Overall Study||3
3199401|NCT02112994|3928077|FG001|Received 3 mg/kg QOW|Overall Study||5
3199402|NCT02112994|3928078|FG002|Received 3 mg/kg QOW|Overall Study||3
3199403|NCT02112994|3928076|FG000|Received 3 mg/kg QW|Overall Study||2
3199404|NCT02112994|3928077|FG001|Received 3 mg/kg QW|Overall Study||1
3199405|NCT02112994|3928078|FG002|Received 3 mg/kg QW|Overall Study||1
3199406|NCT02112994|3928076|FG000|Completed 96-week Treatment Period|Overall Study||6
3199407|NCT02112994|3928077|FG001|Completed 96-week Treatment Period|Overall Study||14
3199408|NCT02112994|3928078|FG002|Completed 96-week Treatment Period|Overall Study||8
3199409|NCT02112994|3928076|FG000|COMPLETED|Overall Study||6
3199410|NCT02112994|3928077|FG001|COMPLETED|Overall Study||14
3199411|NCT02112994|3928078|FG002|COMPLETED|Overall Study||6
3199412|NCT02112994|3928076|FG000|NOT COMPLETED|Overall Study||0
3199413|NCT02112994|3928077|FG001|NOT COMPLETED|Overall Study||2
3199414|NCT02112994|3928078|FG002|NOT COMPLETED|Overall Study||3
3199415|NCT02113007|3928090|FG000|STARTED|Overall Study||2
3199416|NCT02113007|3928090|FG000|COMPLETED|Overall Study||0
3199417|NCT02113007|3928090|FG000|NOT COMPLETED|Overall Study||2
3199418|NCT02113124|3928096|FG000|STARTED|Overall Study||18
3199419|NCT02113124|3928097|FG001|STARTED|Overall Study||25
3199420|NCT02113124|3928096|FG000|COMPLETED|Overall Study||17
3199421|NCT02113124|3928097|FG001|COMPLETED|Overall Study||24
3199422|NCT02113124|3928096|FG000|NOT COMPLETED|Overall Study||1
3199423|NCT02113124|3928097|FG001|NOT COMPLETED|Overall Study||1
3199424|NCT02113189|3928106|FG000|STARTED|Overall Study||4
3199425|NCT02113189|3928107|FG001|STARTED|Overall Study||4
3199426|NCT02113189|3928108|FG002|STARTED|Overall Study||5
3199427|NCT02113189|3928106|FG000|COMPLETED|Overall Study||2
3199428|NCT02113189|3928107|FG001|COMPLETED|Overall Study||3
3199429|NCT02113189|3928108|FG002|COMPLETED|Overall Study||2
3199430|NCT02113189|3928106|FG000|NOT COMPLETED|Overall Study||2
3199431|NCT02113189|3928107|FG001|NOT COMPLETED|Overall Study||1
3199432|NCT02113189|3928108|FG002|NOT COMPLETED|Overall Study||3
3199433|NCT02113241|3928121|FG000|STARTED|Overall Study||12
3199434|NCT02113241|3928122|FG001|STARTED|Overall Study||12
3199435|NCT02113241|3928121|FG000|COMPLETED|Overall Study||12
3199436|NCT02113241|3928122|FG001|COMPLETED|Overall Study||11
3199437|NCT02113241|3928121|FG000|NOT COMPLETED|Overall Study||0
3199438|NCT02113241|3928122|FG001|NOT COMPLETED|Overall Study||1
3199439|NCT02113410|3928130|FG000|STARTED|Overall Study||65
3199440|NCT02113410|3928131|FG001|STARTED|Overall Study||66
3199441|NCT02113410|3928130|FG000|COMPLETED|Overall Study||49
3199442|NCT02113410|3928131|FG001|COMPLETED|Overall Study||63
3199443|NCT02113410|3928130|FG000|NOT COMPLETED|Overall Study||16
3199444|NCT02113410|3928131|FG001|NOT COMPLETED|Overall Study||3
3199445|NCT02113436|3928141|FG000|STARTED|Period 1: 8 Weeks||150
3199446|NCT02113436|3928142|FG001|STARTED|Period 1: 8 Weeks||150
3199447|NCT02113436|3928143|FG002|STARTED|Period 1: 8 Weeks||0
3199448|NCT02113436|3928144|FG003|STARTED|Period 1: 8 Weeks||0
3199449|NCT02113436|3928141|FG000|COMPLETED|Period 1: 8 Weeks||142
3199450|NCT02113436|3928142|FG001|COMPLETED|Period 1: 8 Weeks||148
3199451|NCT02113436|3928143|FG002|COMPLETED|Period 1: 8 Weeks||0
3199452|NCT02113436|3928144|FG003|COMPLETED|Period 1: 8 Weeks||0
3199453|NCT02113436|3928141|FG000|NOT COMPLETED|Period 1: 8 Weeks||8
3199454|NCT02113436|3928142|FG001|NOT COMPLETED|Period 1: 8 Weeks||2
3199455|NCT02113436|3928143|FG002|NOT COMPLETED|Period 1: 8 Weeks||0
3199456|NCT02113436|3928144|FG003|NOT COMPLETED|Period 1: 8 Weeks||0
3199457|NCT02113436|3928141|FG000|STARTED|Period 2: 16 Weeks||0
3199458|NCT02113436|3928142|FG001|STARTED|Period 2: 16 Weeks||0
3199459|NCT02113436|3928143|FG002|STARTED|Period 2: 16 Weeks|Par. started TP2 are not equal to that completed TP1 as 1 par. in each arm didn't transfer to TP2.|141
3199460|NCT02113436|3928144|FG003|STARTED|Period 2: 16 Weeks|Par. started TP2 are not equal to that completed TP1 as 1 par. in each arm didn't transfer to TP2.|147
3199461|NCT02113436|3928141|FG000|COMPLETED|Period 2: 16 Weeks||0
3199462|NCT02113436|3928142|FG001|COMPLETED|Period 2: 16 Weeks||0
3199463|NCT02113436|3928143|FG002|COMPLETED|Period 2: 16 Weeks||132
3199464|NCT02113436|3928144|FG003|COMPLETED|Period 2: 16 Weeks||136
3199465|NCT02113436|3928141|FG000|NOT COMPLETED|Period 2: 16 Weeks||0
3199466|NCT02113436|3928142|FG001|NOT COMPLETED|Period 2: 16 Weeks||0
3199467|NCT02113436|3928143|FG002|NOT COMPLETED|Period 2: 16 Weeks||9
3199468|NCT02113436|3928144|FG003|NOT COMPLETED|Period 2: 16 Weeks||11
3199469|NCT02113449|3928153|FG000|STARTED|Overall Study||147
3199470|NCT02113449|3928153|FG000|COMPLETED|Overall Study||143
3199471|NCT02113449|3928153|FG000|NOT COMPLETED|Overall Study||4
3199472|NCT02113579|3928163|FG000|STARTED|Overall Study||186
3199473|NCT02113579|3928164|FG001|STARTED|Overall Study||189
3199474|NCT02113579|3928163|FG000|COMPLETED|Overall Study||176
3199475|NCT02113579|3928164|FG001|COMPLETED|Overall Study||185
3199476|NCT02113579|3928163|FG000|NOT COMPLETED|Overall Study||10
3199477|NCT02113579|3928164|FG001|NOT COMPLETED|Overall Study||4
3199478|NCT02113956|3928172|FG000|STARTED|Intervention End (5 Weeks Post Baseline)||150
3199479|NCT02113956|3928173|FG001|STARTED|Intervention End (5 Weeks Post Baseline)||152
3199480|NCT02113956|3928172|FG000|COMPLETED|Intervention End (5 Weeks Post Baseline)||141
3199481|NCT02113956|3928173|FG001|COMPLETED|Intervention End (5 Weeks Post Baseline)||148
3199482|NCT02113956|3928172|FG000|NOT COMPLETED|Intervention End (5 Weeks Post Baseline)||9
3199483|NCT02113956|3928173|FG001|NOT COMPLETED|Intervention End (5 Weeks Post Baseline)||4
3199484|NCT02113956|3928172|FG000|STARTED|3 Month Post-intervention||141
3199485|NCT02113956|3928173|FG001|STARTED|3 Month Post-intervention||148
3199486|NCT02113956|3928172|FG000|COMPLETED|3 Month Post-intervention||137
3199487|NCT02113956|3928173|FG001|COMPLETED|3 Month Post-intervention||146
3199488|NCT02113956|3928172|FG000|NOT COMPLETED|3 Month Post-intervention||4
3199489|NCT02113956|3928173|FG001|NOT COMPLETED|3 Month Post-intervention||2
3199490|NCT02114151|3928179|FG000|STARTED|Overall Study||103
3199491|NCT02114151|3928179|FG000|COMPLETED|Overall Study||96
3199492|NCT02114151|3928179|FG000|NOT COMPLETED|Overall Study||7
3199493|NCT02114164|3928185|FG000|STARTED|Overall Study||50
3199494|NCT02114164|3928186|FG001|STARTED|Overall Study||50
3199495|NCT02114164|3928185|FG000|COMPLETED|Overall Study||50
3199496|NCT02114164|3928186|FG001|COMPLETED|Overall Study||50
3199497|NCT02114164|3928185|FG000|NOT COMPLETED|Overall Study||0
3199498|NCT02114164|3928186|FG001|NOT COMPLETED|Overall Study||0
3199499|NCT02114177|3928194|FG000|STARTED|Overall Study||155
3199500|NCT02114177|3928195|FG001|STARTED|Overall Study||155
3199501|NCT02114177|3928194|FG000|COMPLETED|Overall Study||146
3199502|NCT02114177|3928195|FG001|COMPLETED|Overall Study||151
3199503|NCT02114177|3928194|FG000|NOT COMPLETED|Overall Study||9
3199504|NCT02114177|3928195|FG001|NOT COMPLETED|Overall Study||4
3199505|NCT02114203|3928204|FG000|STARTED|Overall Study||7
3199506|NCT02114203|3928205|FG001|STARTED|Overall Study||16
3199507|NCT02114203|3928206|FG002|STARTED|Overall Study||7
3199508|NCT02114203|3928204|FG000|COMPLETED|Overall Study||7
3199509|NCT02114203|3928205|FG001|COMPLETED|Overall Study||14
3199510|NCT02114203|3928206|FG002|COMPLETED|Overall Study||7
3199511|NCT02114203|3928204|FG000|NOT COMPLETED|Overall Study||0
3199512|NCT02114203|3928205|FG001|NOT COMPLETED|Overall Study||2
3199513|NCT02114203|3928206|FG002|NOT COMPLETED|Overall Study||0
3199514|NCT02114216|3928217|FG000|STARTED|Overall Study||16
3199515|NCT02114216|3928218|FG001|STARTED|Overall Study||45
3199516|NCT02114216|3928219|FG002|STARTED|Overall Study||14
3199517|NCT02114216|3928217|FG000|COMPLETED|Overall Study||16
3199518|NCT02114216|3928218|FG001|COMPLETED|Overall Study||45
3199519|NCT02114216|3928219|FG002|COMPLETED|Overall Study||14
3199520|NCT02114216|3928217|FG000|NOT COMPLETED|Overall Study||0
3199521|NCT02114216|3928218|FG001|NOT COMPLETED|Overall Study||0
3199522|NCT02114216|3928219|FG002|NOT COMPLETED|Overall Study||0
3199523|NCT02114268|3928236|FG000|STARTED|Overall Study||34
3199524|NCT02114268|3928237|FG001|STARTED|Overall Study||6
3199525|NCT02114268|3928238|FG002|STARTED|Overall Study||6
3199526|NCT02114268|3928239|FG003|STARTED|Overall Study||6
3199527|NCT02114268|3928240|FG004|STARTED|Overall Study||6
3199528|NCT02114268|3928241|FG005|STARTED|Overall Study||78
3199529|NCT02114268|3928236|FG000|COMPLETED|Overall Study||28
3199530|NCT02114268|3928237|FG001|COMPLETED|Overall Study||5
3199531|NCT02114268|3928238|FG002|COMPLETED|Overall Study||5
3199532|NCT02114268|3928239|FG003|COMPLETED|Overall Study||6
3199533|NCT02114268|3928240|FG004|COMPLETED|Overall Study||6
3199534|NCT02114268|3928241|FG005|COMPLETED|Overall Study||75
3199535|NCT02114268|3928236|FG000|NOT COMPLETED|Overall Study||6
3199536|NCT02114268|3928237|FG001|NOT COMPLETED|Overall Study||1
3199537|NCT02114268|3928238|FG002|NOT COMPLETED|Overall Study||1
3199538|NCT02114268|3928239|FG003|NOT COMPLETED|Overall Study||0
3199539|NCT02114268|3928240|FG004|NOT COMPLETED|Overall Study||0
3199540|NCT02114268|3928241|FG005|NOT COMPLETED|Overall Study||3
3199541|NCT02114307|3928262|FG000|STARTED|Overall Study||11
3199542|NCT02114307|3928263|FG001|STARTED|Overall Study||11
3199543|NCT02114307|3928262|FG000|COMPLETED|Overall Study||10
3199544|NCT02114307|3928263|FG001|COMPLETED|Overall Study||11
3199545|NCT02114307|3928262|FG000|NOT COMPLETED|Overall Study||1
3199546|NCT02114307|3928263|FG001|NOT COMPLETED|Overall Study||0
3199547|NCT02114385|3928273|FG000|STARTED|Overall Study||249
3199548|NCT02114385|3928274|FG001|STARTED|Overall Study||251
3199549|NCT02114385|3928273|FG000|Vaccinated|Overall Study||249
3199550|NCT02114385|3928274|FG001|Vaccinated|Overall Study||251
3199551|NCT02114385|3928273|FG000|COMPLETED|Overall Study||246
3199552|NCT02114385|3928274|FG001|COMPLETED|Overall Study||243
3199553|NCT02114385|3928273|FG000|NOT COMPLETED|Overall Study||3
3199554|NCT02114385|3928274|FG001|NOT COMPLETED|Overall Study||8
3199555|NCT02114515|3928282|FG000|STARTED|Overall Study||511
3199556|NCT02114515|3928283|FG001|STARTED|Overall Study||518
3199557|NCT02114515|3928282|FG000|COMPLETED|Overall Study||378
3199558|NCT02114515|3928283|FG001|COMPLETED|Overall Study||368
3199559|NCT02114515|3928282|FG000|NOT COMPLETED|Overall Study||133
3199560|NCT02114515|3928283|FG001|NOT COMPLETED|Overall Study||150
3199561|NCT02114606|3928289|FG000|STARTED|Overall Study||86
3199562|NCT02114606|3928289|FG000|COMPLETED|Overall Study||80
3199563|NCT02114606|3928289|FG000|NOT COMPLETED|Overall Study||6
3199564|NCT02114684|3928295|FG000|STARTED|Overall Study||98
3199565|NCT02114684|3928296|FG001|STARTED|Overall Study||98
3199566|NCT02114684|3928295|FG000|COMPLETED|Overall Study||86
3199567|NCT02114684|3928296|FG001|COMPLETED|Overall Study||88
3199568|NCT02114684|3928295|FG000|NOT COMPLETED|Overall Study||12
3199569|NCT02114684|3928296|FG001|NOT COMPLETED|Overall Study||10
3199570|NCT02114814|3928308|FG000|STARTED|Overall Study||103
3199571|NCT02114814|3928309|FG001|STARTED|Overall Study||83
3199572|NCT02114814|3928308|FG000|COMPLETED|Overall Study||88
3199573|NCT02114814|3928309|FG001|COMPLETED|Overall Study||74
3199574|NCT02114814|3928308|FG000|NOT COMPLETED|Overall Study||15
3199575|NCT02114814|3928309|FG001|NOT COMPLETED|Overall Study||9
3199576|NCT02114879|3928321|FG000|STARTED|Overall Study||115
3199577|NCT02114879|3928322|FG001|STARTED|Overall Study||114
3199578|NCT02114879|3928321|FG000|COMPLETED|Overall Study||96
3199579|NCT02114879|3928322|FG001|COMPLETED|Overall Study||90
3199580|NCT02114879|3928321|FG000|NOT COMPLETED|Overall Study||19
3199581|NCT02114879|3928322|FG001|NOT COMPLETED|Overall Study||24
3199582|NCT02114892|3928330|FG000|STARTED|Overall Study||12
3199583|NCT02114892|3928331|FG001|STARTED|Overall Study||12
3199584|NCT02114892|3928330|FG000|COMPLETED|Overall Study|One patient did not complete the study due to early withdrawl|11
3199585|NCT02114892|3928331|FG001|COMPLETED|Overall Study|Two patients did not complete the study due to early withdrawl|10
3199586|NCT02114892|3928330|FG000|NOT COMPLETED|Overall Study||1
3199587|NCT02114892|3928331|FG001|NOT COMPLETED|Overall Study||2
3199588|NCT02114931|3928339|FG000|STARTED|Overall Study||230
3199589|NCT02114931|3928340|FG001|STARTED|Overall Study||237
3199590|NCT02114931|3928339|FG000|Received Treatment|Overall Study|One participant was enrolled in error and did not receive treatment in the extension study|229
3199591|NCT02114931|3928340|FG001|Received Treatment|Overall Study||237
3199592|NCT02114931|3928339|FG000|COMPLETED|Overall Study||205
3199593|NCT02114931|3928340|FG001|COMPLETED|Overall Study||207
3199594|NCT02114931|3928339|FG000|NOT COMPLETED|Overall Study||25
3199595|NCT02114931|3928340|FG001|NOT COMPLETED|Overall Study||30
3199596|NCT02115048|3928348|FG000|STARTED|Overall Study||23
3199597|NCT02115048|3928349|FG001|STARTED|Overall Study||21
3199598|NCT02115048|3928348|FG000|COMPLETED|Overall Study||23
3199599|NCT02115048|3928349|FG001|COMPLETED|Overall Study||21
3199600|NCT02115048|3928348|FG000|NOT COMPLETED|Overall Study||0
3199601|NCT02115048|3928349|FG001|NOT COMPLETED|Overall Study||0
3199602|NCT02115113|3928355|FG000|STARTED|Participants in Run-in Period||0
3199603|NCT02115113|3928356|FG001|STARTED|Participants in Run-in Period||0
3199604|NCT02115113|3928357|FG002|STARTED|Participants in Run-in Period||78
3199605|NCT02115113|3928355|FG000|COMPLETED|Participants in Run-in Period||0
3199606|NCT02115113|3928356|FG001|COMPLETED|Participants in Run-in Period||0
3199607|NCT02115113|3928357|FG002|COMPLETED|Participants in Run-in Period||68
3199608|NCT02115113|3928355|FG000|NOT COMPLETED|Participants in Run-in Period||0
3199609|NCT02115113|3928356|FG001|NOT COMPLETED|Participants in Run-in Period||0
3199610|NCT02115113|3928357|FG002|NOT COMPLETED|Participants in Run-in Period||10
3199611|NCT02115113|3928355|FG000|STARTED|Participants Randomized||24
3199612|NCT02115113|3928356|FG001|STARTED|Participants Randomized||26
3199613|NCT02115113|3928357|FG002|STARTED|Participants Randomized||0
3199614|NCT02115113|3928355|FG000|COMPLETED|Participants Randomized||22
3199615|NCT02115113|3928356|FG001|COMPLETED|Participants Randomized||26
3199616|NCT02115113|3928357|FG002|COMPLETED|Participants Randomized||0
3199617|NCT02115113|3928355|FG000|NOT COMPLETED|Participants Randomized||2
3199618|NCT02115113|3928356|FG001|NOT COMPLETED|Participants Randomized||0
3199619|NCT02115113|3928357|FG002|NOT COMPLETED|Participants Randomized||0
3199620|NCT02115139|3928366|FG000|STARTED|Overall Study||58
3199621|NCT02115139|3928366|FG000|COMPLETED|Overall Study||51
3199622|NCT02115139|3928366|FG000|NOT COMPLETED|Overall Study||7
3199623|NCT02115256|3928372|FG000|STARTED|Overall Study||3
3199624|NCT02115256|3928373|FG001|STARTED|Overall Study||3
3199625|NCT02115256|3928372|FG000|COMPLETED|Overall Study||3
3199626|NCT02115256|3928373|FG001|COMPLETED|Overall Study||2
3199627|NCT02115256|3928372|FG000|NOT COMPLETED|Overall Study||0
3199628|NCT02115256|3928373|FG001|NOT COMPLETED|Overall Study||1
3199629|NCT02115269|3928379|FG000|STARTED|Overall Study||759
3199630|NCT02115269|3928379|FG000|COMPLETED|Overall Study||702
3199631|NCT02115269|3928379|FG000|NOT COMPLETED|Overall Study||57
3199632|NCT02115282|3928396|FG000|STARTED|Overall Study||305
3199633|NCT02115282|3928397|FG001|STARTED|Overall Study||303
3199634|NCT02115282|3928396|FG000|Eligible|Overall Study||265
3199635|NCT02115282|3928397|FG001|Eligible|Overall Study||257
3199636|NCT02115282|3928396|FG000|Treated|Overall Study||296
3199637|NCT02115282|3928397|FG001|Treated|Overall Study||293
3199638|NCT02115282|3928396|FG000|COMPLETED|Overall Study||0
3199639|NCT02115282|3928397|FG001|COMPLETED|Overall Study||0
3199640|NCT02115282|3928396|FG000|NOT COMPLETED|Overall Study||305
3199641|NCT02115282|3928397|FG001|NOT COMPLETED|Overall Study||303
3199642|NCT02115308|3928407|FG000|STARTED|Overall Study|Number of subjects recruited for the CONTROL group.|15
3199643|NCT02115308|3928408|FG001|STARTED|Overall Study|Number of subjects recruited for the CAD group.|25
3199644|NCT02115308|3928407|FG000|COMPLETED|Overall Study|Number of subjects recruited to the Control group meeting all inclusion criteria.|13
3199645|NCT02115308|3928408|FG001|COMPLETED|Overall Study|Number of subjects recruited to the CAD group meeting all inclusion criteria.|23
3199646|NCT02115308|3928407|FG000|NOT COMPLETED|Overall Study||2
3199647|NCT02115308|3928408|FG001|NOT COMPLETED|Overall Study||2
3199648|NCT02115321|3928420|FG000|STARTED|Overall Study||30
3199649|NCT02115321|3928421|FG001|STARTED|Overall Study||10
3199650|NCT02115321|3928420|FG000|COMPLETED|Overall Study||29
3199651|NCT02115321|3928421|FG001|COMPLETED|Overall Study||10
3199652|NCT02115321|3928420|FG000|NOT COMPLETED|Overall Study||1
3199653|NCT02115321|3928421|FG001|NOT COMPLETED|Overall Study||0
3199654|NCT02115347|3928429|FG000|STARTED|Overall Study||8
3199655|NCT02115347|3928430|FG001|STARTED|Overall Study||8
3199656|NCT02115347|3928431|FG002|STARTED|Overall Study||0
3199657|NCT02115347|3928429|FG000|COMPLETED|Overall Study||8
3199658|NCT02115347|3928430|FG001|COMPLETED|Overall Study||8
3199659|NCT02115347|3928431|FG002|COMPLETED|Overall Study||0
3199660|NCT02115347|3928429|FG000|NOT COMPLETED|Overall Study||0
3199661|NCT02115347|3928430|FG001|NOT COMPLETED|Overall Study||0
3199662|NCT02115347|3928431|FG002|NOT COMPLETED|Overall Study||0
3199663|NCT02115373|3928440|FG000|STARTED|Overall Study||4
3199664|NCT02115373|3928441|FG001|STARTED|Overall Study||13
3199665|NCT02115373|3928442|FG002|STARTED|Overall Study||49
3199666|NCT02115373|3928440|FG000|COMPLETED|Overall Study||4
3199667|NCT02115373|3928441|FG001|COMPLETED|Overall Study||13
3199668|NCT02115373|3928442|FG002|COMPLETED|Overall Study||49
3199669|NCT02115373|3928440|FG000|NOT COMPLETED|Overall Study||0
3199670|NCT02115373|3928441|FG001|NOT COMPLETED|Overall Study||0
3199671|NCT02115373|3928442|FG002|NOT COMPLETED|Overall Study||0
3199672|NCT02115386|3928457|FG000|STARTED|Overall Study||7
3199673|NCT02115386|3928457|FG000|COMPLETED|Overall Study||0
3199674|NCT02115386|3928457|FG000|NOT COMPLETED|Overall Study||7
3199675|NCT02115542|3928461|FG000|STARTED|Overall Study||39
3199676|NCT02115542|3928461|FG000|COMPLETED|Overall Study||39
3199677|NCT02115542|3928461|FG000|NOT COMPLETED|Overall Study||0
3199678|NCT02115581|3928467|FG000|STARTED|Overall Study||17
3199679|NCT02115581|3928468|FG001|STARTED|Overall Study||21
3199680|NCT02115581|3928467|FG000|COMPLETED|Overall Study||17
3199681|NCT02115581|3928468|FG001|COMPLETED|Overall Study||21
3199682|NCT02115581|3928467|FG000|NOT COMPLETED|Overall Study||0
3199683|NCT02115581|3928468|FG001|NOT COMPLETED|Overall Study||0
3199684|NCT02115607|3928474|FG000|STARTED|Overall Study||17
3199685|NCT02115607|3928474|FG000|COMPLETED|Overall Study||16
3199686|NCT02115607|3928474|FG000|NOT COMPLETED|Overall Study||1
3199687|NCT02115633|3928480|FG000|STARTED|Overall Study||15
3199688|NCT02115633|3928481|FG001|STARTED|Overall Study||16
3199689|NCT02115633|3928480|FG000|COMPLETED|Overall Study||15
3199690|NCT02115633|3928481|FG001|COMPLETED|Overall Study||16
3199691|NCT02115633|3928480|FG000|NOT COMPLETED|Overall Study||0
3199692|NCT02115633|3928481|FG001|NOT COMPLETED|Overall Study||0
3199693|NCT02115646|3928490|FG000|STARTED|Overall Study||29
3199694|NCT02115646|3928490|FG000|COMPLETED|Overall Study||22
3199695|NCT02115646|3928490|FG000|NOT COMPLETED|Overall Study||7
3364983|NCT03996694|4096110|FG000|STARTED|Fourth Washout (7 Days)||3
3364984|NCT03996694|4096111|FG001|STARTED|Fourth Washout (7 Days)||2
3364985|NCT03996694|4096112|FG002|STARTED|Fourth Washout (7 Days)||2
3364986|NCT03996694|4096113|FG003|STARTED|Fourth Washout (7 Days)||3
3364987|NCT03996694|4096114|FG004|STARTED|Fourth Washout (7 Days)||2
3364988|NCT03996694|4096115|FG005|STARTED|Fourth Washout (7 Days)||3
3364989|NCT03996694|4096110|FG000|COMPLETED|Fourth Washout (7 Days)||3
3364990|NCT03996694|4096111|FG001|COMPLETED|Fourth Washout (7 Days)||2
3364991|NCT03996694|4096112|FG002|COMPLETED|Fourth Washout (7 Days)||2
3364992|NCT03996694|4096113|FG003|COMPLETED|Fourth Washout (7 Days)||3
3364993|NCT03996694|4096114|FG004|COMPLETED|Fourth Washout (7 Days)||2
3364994|NCT03996694|4096115|FG005|COMPLETED|Fourth Washout (7 Days)||3
3364995|NCT03996694|4096110|FG000|NOT COMPLETED|Fourth Washout (7 Days)||0
3364996|NCT03996694|4096111|FG001|NOT COMPLETED|Fourth Washout (7 Days)||0
3364997|NCT03996694|4096112|FG002|NOT COMPLETED|Fourth Washout (7 Days)||0
3364998|NCT03996694|4096113|FG003|NOT COMPLETED|Fourth Washout (7 Days)||0
3364999|NCT03996694|4096114|FG004|NOT COMPLETED|Fourth Washout (7 Days)||0
3365000|NCT03996694|4096115|FG005|NOT COMPLETED|Fourth Washout (7 Days)||0
3365001|NCT03996694|4096110|FG000|STARTED|Fifth Intervention (1 Day)||3
3365002|NCT03996694|4096111|FG001|STARTED|Fifth Intervention (1 Day)||2
3365003|NCT03996694|4096112|FG002|STARTED|Fifth Intervention (1 Day)||2
3365004|NCT03996694|4096113|FG003|STARTED|Fifth Intervention (1 Day)||3
3365005|NCT03996694|4096114|FG004|STARTED|Fifth Intervention (1 Day)||2
3365006|NCT03996694|4096115|FG005|STARTED|Fifth Intervention (1 Day)||3
3365007|NCT03996694|4096110|FG000|COMPLETED|Fifth Intervention (1 Day)||3
3365008|NCT03996694|4096111|FG001|COMPLETED|Fifth Intervention (1 Day)||2
3365009|NCT03996694|4096112|FG002|COMPLETED|Fifth Intervention (1 Day)||2
3365010|NCT03996694|4096113|FG003|COMPLETED|Fifth Intervention (1 Day)||3
3365011|NCT03996694|4096114|FG004|COMPLETED|Fifth Intervention (1 Day)||2
3365012|NCT03996694|4096115|FG005|COMPLETED|Fifth Intervention (1 Day)||3
3365013|NCT03996694|4096110|FG000|NOT COMPLETED|Fifth Intervention (1 Day)||0
3365014|NCT03996694|4096111|FG001|NOT COMPLETED|Fifth Intervention (1 Day)||0
3365015|NCT03996694|4096112|FG002|NOT COMPLETED|Fifth Intervention (1 Day)||0
3365016|NCT03996694|4096113|FG003|NOT COMPLETED|Fifth Intervention (1 Day)||0
3365017|NCT03996694|4096114|FG004|NOT COMPLETED|Fifth Intervention (1 Day)||0
3365018|NCT03996694|4096115|FG005|NOT COMPLETED|Fifth Intervention (1 Day)||0
3365019|NCT03996694|4096110|FG000|STARTED|Fifth Washout (7 Days)||3
3365020|NCT03996694|4096111|FG001|STARTED|Fifth Washout (7 Days)||2
3365021|NCT03996694|4096112|FG002|STARTED|Fifth Washout (7 Days)||2
3365022|NCT03996694|4096113|FG003|STARTED|Fifth Washout (7 Days)||3
3365023|NCT03996694|4096114|FG004|STARTED|Fifth Washout (7 Days)||2
3365024|NCT03996694|4096115|FG005|STARTED|Fifth Washout (7 Days)||3
3199696|NCT02115750|3928501|FG000|STARTED|Part 1||323
3199697|NCT02115750|3928502|FG001|STARTED|Part 1||324
3199698|NCT02115750|3928501|FG000|COMPLETED|Part 1||301
3199699|NCT02115750|3928502|FG001|COMPLETED|Part 1||312
3199700|NCT02115750|3928501|FG000|NOT COMPLETED|Part 1||22
3199701|NCT02115750|3928502|FG001|NOT COMPLETED|Part 1||12
3199702|NCT02115750|3928501|FG000|STARTED|Part 2: All Subjects Receive CHS-0214||280
3199703|NCT02115750|3928502|FG001|STARTED|Part 2: All Subjects Receive CHS-0214||284
3199704|NCT02115750|3928501|FG000|COMPLETED|Part 2: All Subjects Receive CHS-0214||269
3199705|NCT02115750|3928502|FG001|COMPLETED|Part 2: All Subjects Receive CHS-0214||272
3199706|NCT02115750|3928501|FG000|NOT COMPLETED|Part 2: All Subjects Receive CHS-0214||11
3199707|NCT02115750|3928502|FG001|NOT COMPLETED|Part 2: All Subjects Receive CHS-0214||12
3199708|NCT02115815|3928517|FG000|STARTED|Overall Study||24
3199709|NCT02115815|3928518|FG001|STARTED|Overall Study||20
3199710|NCT02115815|3928519|FG002|STARTED|Overall Study||20
3199711|NCT02115815|3928520|FG003|STARTED|Overall Study||20
3199712|NCT02115815|3928521|FG004|STARTED|Overall Study||20
3199713|NCT02115815|3928522|FG005|STARTED|Overall Study||22
3199714|NCT02115815|3928523|FG006|STARTED|Overall Study||20
3199715|NCT02115815|3928517|FG000|COMPLETED|Overall Study||22
3199716|NCT02115815|3928518|FG001|COMPLETED|Overall Study||20
3199717|NCT02115815|3928519|FG002|COMPLETED|Overall Study||20
3199718|NCT02115815|3928520|FG003|COMPLETED|Overall Study||20
3199719|NCT02115815|3928521|FG004|COMPLETED|Overall Study||20
3199720|NCT02115815|3928522|FG005|COMPLETED|Overall Study||20
3199721|NCT02115815|3928523|FG006|COMPLETED|Overall Study||20
3199722|NCT02115815|3928517|FG000|NOT COMPLETED|Overall Study||2
3199723|NCT02115815|3928518|FG001|NOT COMPLETED|Overall Study||0
3199724|NCT02115815|3928519|FG002|NOT COMPLETED|Overall Study||0
3199725|NCT02115815|3928520|FG003|NOT COMPLETED|Overall Study||0
3199726|NCT02115815|3928521|FG004|NOT COMPLETED|Overall Study||0
3199727|NCT02115815|3928522|FG005|NOT COMPLETED|Overall Study||2
3199728|NCT02115815|3928523|FG006|NOT COMPLETED|Overall Study||0
3199729|NCT02115828|3928539|FG000|STARTED|Overall Study||9
3199730|NCT02115828|3928539|FG000|COMPLETED|Overall Study||9
3199731|NCT02115828|3928539|FG000|NOT COMPLETED|Overall Study||0
3199732|NCT02115984|3928545|FG000|STARTED|Overall Study||57
3199733|NCT02115984|3928546|FG001|STARTED|Overall Study||23
3199734|NCT02115984|3928545|FG000|COMPLETED|Overall Study||51
3199735|NCT02115984|3928546|FG001|COMPLETED|Overall Study||16
3199736|NCT02115984|3928545|FG000|NOT COMPLETED|Overall Study||6
3199737|NCT02115984|3928546|FG001|NOT COMPLETED|Overall Study||7
3199738|NCT02116205|3928556|FG000|STARTED|Overall Study||31
3199739|NCT02116205|3928557|FG001|STARTED|Overall Study||33
3199740|NCT02116205|3928558|FG002|STARTED|Overall Study||33
3199741|NCT02116205|3928559|FG003|STARTED|Overall Study||33
3199742|NCT02116205|3928556|FG000|COMPLETED|Overall Study||29
3199743|NCT02116205|3928557|FG001|COMPLETED|Overall Study||26
3199744|NCT02116205|3928558|FG002|COMPLETED|Overall Study||29
3199745|NCT02116205|3928559|FG003|COMPLETED|Overall Study||27
3199746|NCT02116205|3928556|FG000|NOT COMPLETED|Overall Study||2
3199747|NCT02116205|3928557|FG001|NOT COMPLETED|Overall Study||7
3199748|NCT02116205|3928558|FG002|NOT COMPLETED|Overall Study||4
3199749|NCT02116205|3928559|FG003|NOT COMPLETED|Overall Study||6
3199750|NCT02116309|3928571|FG000|STARTED|Overall Study||482
3199751|NCT02116309|3928572|FG001|STARTED|Overall Study||478
3199752|NCT02116309|3928571|FG000|COMPLETED|Overall Study||482
3199753|NCT02116309|3928572|FG001|COMPLETED|Overall Study||477
3199754|NCT02116309|3928571|FG000|NOT COMPLETED|Overall Study||0
3199755|NCT02116309|3928572|FG001|NOT COMPLETED|Overall Study||1
3199756|NCT02116322|3928578|FG000|STARTED|Overall Study||1
3199757|NCT02116322|3928578|FG000|COMPLETED|Overall Study||1
3199758|NCT02116322|3928578|FG000|NOT COMPLETED|Overall Study||0
3199759|NCT02116361|3928586|FG000|STARTED|Overall Study||69
3199760|NCT02116361|3928587|FG001|STARTED|Overall Study||65
3199761|NCT02116361|3928588|FG002|STARTED|Overall Study||59
3199762|NCT02116361|3928589|FG003|STARTED|Overall Study||65
3199763|NCT02116361|3928586|FG000|COMPLETED|Overall Study||38
3199764|NCT02116361|3928587|FG001|COMPLETED|Overall Study||34
3199765|NCT02116361|3928588|FG002|COMPLETED|Overall Study||33
3199766|NCT02116361|3928589|FG003|COMPLETED|Overall Study||34
3199767|NCT02116361|3928586|FG000|NOT COMPLETED|Overall Study||31
3199768|NCT02116361|3928587|FG001|NOT COMPLETED|Overall Study||31
3199769|NCT02116361|3928588|FG002|NOT COMPLETED|Overall Study||26
3199770|NCT02116361|3928589|FG003|NOT COMPLETED|Overall Study||31
3199771|NCT02116530|3928601|FG000|STARTED|Overall Study||192
3199772|NCT02116530|3928602|FG001|STARTED|Overall Study||188
3199773|NCT02116530|3928601|FG000|COMPLETED|Overall Study||183
3199774|NCT02116530|3928602|FG001|COMPLETED|Overall Study||184
3199775|NCT02116530|3928601|FG000|NOT COMPLETED|Overall Study||9
3199776|NCT02116530|3928602|FG001|NOT COMPLETED|Overall Study||4
3199777|NCT02116582|3928608|FG000|STARTED|Overall Study||215
3199778|NCT02116582|3928608|FG000|Treated|Overall Study||214
3199779|NCT02116582|3928608|FG000|COMPLETED|Overall Study||0
3199780|NCT02116582|3928608|FG000|NOT COMPLETED|Overall Study||215
3199781|NCT02116608|3928615|FG000|STARTED|Overall Study||9
3199782|NCT02116608|3928616|FG001|STARTED|Overall Study||9
3199783|NCT02116608|3928617|FG002|STARTED|Overall Study||8
3199784|NCT02116608|3928615|FG000|COMPLETED|Overall Study||9
3199785|NCT02116608|3928616|FG001|COMPLETED|Overall Study||7
3199786|NCT02116608|3928617|FG002|COMPLETED|Overall Study||7
3199787|NCT02116608|3928615|FG000|NOT COMPLETED|Overall Study||0
3199788|NCT02116608|3928616|FG001|NOT COMPLETED|Overall Study||2
3199789|NCT02116608|3928617|FG002|NOT COMPLETED|Overall Study||1
3199790|NCT02116621|3928627|FG000|STARTED|Baseline||108
3199791|NCT02116621|3928628|FG001|STARTED|Baseline||107
3199792|NCT02116621|3928627|FG000|Completed Baseline Visit|Baseline||108
3199793|NCT02116621|3928628|FG001|Completed Baseline Visit|Baseline||103
3199794|NCT02116621|3928627|FG000|Completed Intervention Period|Baseline||95
3199795|NCT02116621|3928628|FG001|Completed Intervention Period|Baseline||103
3199796|NCT02116621|3928627|FG000|COMPLETED|Baseline||108
3199797|NCT02116621|3928628|FG001|COMPLETED|Baseline||103
3199798|NCT02116621|3928627|FG000|NOT COMPLETED|Baseline||0
3199799|NCT02116621|3928628|FG001|NOT COMPLETED|Baseline||4
3199800|NCT02116621|3928627|FG000|STARTED|Three Month Follow-up||108
3199801|NCT02116621|3928628|FG001|STARTED|Three Month Follow-up||103
3199802|NCT02116621|3928627|FG000|COMPLETED|Three Month Follow-up||89
3199803|NCT02116621|3928628|FG001|COMPLETED|Three Month Follow-up||96
3199804|NCT02116621|3928627|FG000|NOT COMPLETED|Three Month Follow-up||19
3199805|NCT02116621|3928628|FG001|NOT COMPLETED|Three Month Follow-up||7
3199806|NCT02116621|3928627|FG000|STARTED|Six Month Follow-up|Patients who didn't complete 3mo survey but didn't drop from study were contacted for 6mo follow-up.|103
3199807|NCT02116621|3928628|FG001|STARTED|Six Month Follow-up|Patients who didn't complete 3mo survey but didn't drop from study were contacted for 6mo follow-up|100
3199808|NCT02116621|3928627|FG000|COMPLETED|Six Month Follow-up||99
3199809|NCT02116621|3928628|FG001|COMPLETED|Six Month Follow-up||97
3199810|NCT02116621|3928627|FG000|NOT COMPLETED|Six Month Follow-up||4
3199811|NCT02116621|3928628|FG001|NOT COMPLETED|Six Month Follow-up||3
3199812|NCT02116621|3928627|FG000|STARTED|Twelve Month Follow-up|Patients who didn't complete 6mo survey but didn't drop from study were contacted for 12mo follow-up|100
3199813|NCT02116621|3928628|FG001|STARTED|Twelve Month Follow-up|Patients who didn't complete 6mo survey but didn't drop from study were contacted for 12mo follow-up|98
3199814|NCT02116621|3928627|FG000|COMPLETED|Twelve Month Follow-up||84
3199815|NCT02116621|3928628|FG001|COMPLETED|Twelve Month Follow-up||86
3199816|NCT02116621|3928627|FG000|NOT COMPLETED|Twelve Month Follow-up||16
3199817|NCT02116621|3928628|FG001|NOT COMPLETED|Twelve Month Follow-up||12
3199818|NCT02116660|3928636|FG000|STARTED|Overall Study||6
3199819|NCT02116660|3928637|FG001|STARTED|Overall Study||5
3199820|NCT02116660|3928636|FG000|COMPLETED|Overall Study||4
3199821|NCT02116660|3928637|FG001|COMPLETED|Overall Study||1
3199822|NCT02116660|3928636|FG000|NOT COMPLETED|Overall Study||2
3199823|NCT02116660|3928637|FG001|NOT COMPLETED|Overall Study||4
3199824|NCT02116777|3928652|FG000|STARTED|Overall Study||3
3199825|NCT02116777|3928653|FG001|STARTED|Overall Study||3
3199826|NCT02116777|3928654|FG002|STARTED|Overall Study||3
3199827|NCT02116777|3928655|FG003|STARTED|Overall Study||13
3199828|NCT02116777|3928656|FG004|STARTED|Overall Study||6
3199829|NCT02116777|3928657|FG005|STARTED|Overall Study||3
3199830|NCT02116777|3928658|FG006|STARTED|Overall Study||9
3199831|NCT02116777|3928652|FG000|COMPLETED|Overall Study||0
3199832|NCT02116777|3928653|FG001|COMPLETED|Overall Study||0
3199833|NCT02116777|3928654|FG002|COMPLETED|Overall Study||0
3199834|NCT02116777|3928655|FG003|COMPLETED|Overall Study||0
3199835|NCT02116777|3928656|FG004|COMPLETED|Overall Study||0
3199836|NCT02116777|3928657|FG005|COMPLETED|Overall Study||0
3199837|NCT02116777|3928658|FG006|COMPLETED|Overall Study||0
3199838|NCT02116777|3928652|FG000|NOT COMPLETED|Overall Study||3
3199839|NCT02116777|3928653|FG001|NOT COMPLETED|Overall Study||3
3199840|NCT02116777|3928654|FG002|NOT COMPLETED|Overall Study||3
3199841|NCT02116777|3928655|FG003|NOT COMPLETED|Overall Study||13
3199842|NCT02116777|3928656|FG004|NOT COMPLETED|Overall Study||6
3199843|NCT02116777|3928657|FG005|NOT COMPLETED|Overall Study||3
3199844|NCT02116777|3928658|FG006|NOT COMPLETED|Overall Study||9
3199845|NCT02116803|3928679|FG000|STARTED|Overall Study||10
3199846|NCT02116803|3928680|FG001|STARTED|Overall Study||2
3199847|NCT02116803|3928679|FG000|COMPLETED|Overall Study||0
3199848|NCT02116803|3928680|FG001|COMPLETED|Overall Study||0
3199849|NCT02116803|3928679|FG000|NOT COMPLETED|Overall Study||10
3199850|NCT02116803|3928680|FG001|NOT COMPLETED|Overall Study||2
3199851|NCT02116972|3928689|FG000|STARTED|Overall Study||102
3199852|NCT02116972|3928690|FG001|STARTED|Overall Study||104
3199853|NCT02116972|3928691|FG002|STARTED|Overall Study||104
3199854|NCT02116972|3928689|FG000|COMPLETED|Overall Study||83
3199855|NCT02116972|3928690|FG001|COMPLETED|Overall Study||87
3199856|NCT02116972|3928691|FG002|COMPLETED|Overall Study||85
3199857|NCT02116972|3928689|FG000|NOT COMPLETED|Overall Study||19
3199858|NCT02116972|3928690|FG001|NOT COMPLETED|Overall Study||17
3199859|NCT02116972|3928691|FG002|NOT COMPLETED|Overall Study||19
3199860|NCT02117024|3928703|FG000|STARTED|Overall Study||45
3199861|NCT02117024|3928704|FG001|STARTED|Overall Study||21
3199862|NCT02117024|3928703|FG000|COMPLETED|Overall Study||1
3199863|NCT02117024|3928704|FG001|COMPLETED|Overall Study||1
3199864|NCT02117024|3928703|FG000|NOT COMPLETED|Overall Study||44
3199865|NCT02117024|3928704|FG001|NOT COMPLETED|Overall Study||20
3199866|NCT02117193|3928710|FG000|STARTED|Overall Study||10
3199867|NCT02117193|3928710|FG000|Alcohol Intake + Normal Sleep|Overall Study||10
3199868|NCT02117193|3928710|FG000|Placebo Intake + Normal Sleep|Overall Study||10
3199869|NCT02117193|3928710|FG000|Alcohol Intake + Sleep Deprivation|Overall Study||10
3199870|NCT02117193|3928710|FG000|Placebo Intake + Sleep Deprivation|Overall Study||10
3199871|NCT02117193|3928710|FG000|COMPLETED|Overall Study||10
3199872|NCT02117193|3928710|FG000|NOT COMPLETED|Overall Study||0
3199873|NCT02117310|3928729|FG000|STARTED|Overall Study||5
3199874|NCT02117310|3928729|FG000|COMPLETED|Overall Study||5
3199875|NCT02117310|3928729|FG000|NOT COMPLETED|Overall Study||0
3199876|NCT02117349|3928735|FG000|STARTED|Overall Study||37
3199877|NCT02117349|3928736|FG001|STARTED|Overall Study||18
3199878|NCT02117349|3928735|FG000|Intent-to-treat Population|Overall Study||37
3199879|NCT02117349|3928736|FG001|Intent-to-treat Population|Overall Study||18
3199880|NCT02117349|3928735|FG000|Safety Population|Overall Study||36
3199881|NCT02117349|3928736|FG001|Safety Population|Overall Study||18
3199882|NCT02117349|3928735|FG000|Modified Intent-to-treat (mITT)|Overall Study||36
3199883|NCT02117349|3928736|FG001|Modified Intent-to-treat (mITT)|Overall Study||18
3199884|NCT02117349|3928735|FG000|COMPLETED|Overall Study||34
3199885|NCT02117349|3928736|FG001|COMPLETED|Overall Study||17
3199886|NCT02117349|3928735|FG000|NOT COMPLETED|Overall Study||3
3199887|NCT02117349|3928736|FG001|NOT COMPLETED|Overall Study||1
3199888|NCT02117414|3928744|FG000|STARTED|Overall Study|Subjects randomized to the MRI group.|175
3199889|NCT02117414|3928745|FG001|STARTED|Overall Study|Subjects randomized to the Control group.|88
3199890|NCT02117414|3928744|FG000|COMPLETED|Overall Study|Subject followed up at least to the one-month post MRI/Waiting period visit in the MRI group.|160
3199891|NCT02117414|3928745|FG001|COMPLETED|Overall Study|Subject followed up at least to the one-month post MRI/Waiting period visit in the Control group.|82
3199892|NCT02117414|3928744|FG000|NOT COMPLETED|Overall Study||15
3199893|NCT02117414|3928745|FG001|NOT COMPLETED|Overall Study||6
3199894|NCT02117427|3928756|FG000|STARTED|Overall Study||6
3199895|NCT02117427|3928757|FG001|STARTED|Overall Study||5
3199896|NCT02117427|3928758|FG002|STARTED|Overall Study||0
3199897|NCT02117427|3928756|FG000|Run in Phase & Harvest|Overall Study||6
3199898|NCT02117427|3928757|FG001|Run in Phase & Harvest|Overall Study||4
3199899|NCT02117427|3928758|FG002|Run in Phase & Harvest|Overall Study||0
3199900|NCT02117427|3928756|FG000|Implantation & Efficacy|Overall Study||6
3199901|NCT02117427|3928757|FG001|Implantation & Efficacy|Overall Study||4
3199902|NCT02117427|3928758|FG002|Implantation & Efficacy|Overall Study||0
3199903|NCT02117427|3928756|FG000|Safety Follow-up|Overall Study||1
3199904|NCT02117427|3928757|FG001|Safety Follow-up|Overall Study||0
3199905|NCT02117427|3928758|FG002|Safety Follow-up|Overall Study||0
3199906|NCT02117427|3928756|FG000|Long Term Safety Follow-up|Overall Study||1
3199907|NCT02117427|3928757|FG001|Long Term Safety Follow-up|Overall Study||0
3199908|NCT02117427|3928758|FG002|Long Term Safety Follow-up|Overall Study||0
3199909|NCT02117427|3928756|FG000|COMPLETED|Overall Study||1
3199910|NCT02117427|3928757|FG001|COMPLETED|Overall Study||0
3199911|NCT02117427|3928758|FG002|COMPLETED|Overall Study||0
3199912|NCT02117427|3928756|FG000|NOT COMPLETED|Overall Study||5
3199913|NCT02117427|3928757|FG001|NOT COMPLETED|Overall Study||5
3199914|NCT02117427|3928758|FG002|NOT COMPLETED|Overall Study||0
3199915|NCT02117479|3928766|FG000|STARTED|Overall Study||161
3199916|NCT02117479|3928767|FG001|STARTED|Overall Study||160
3199917|NCT02117479|3928766|FG000|COMPLETED|Overall Study|Treatment ongoing as of 20APR2016 for remaining participants in the study.|5
3199918|NCT02117479|3928767|FG001|COMPLETED|Overall Study|Treatment ongoing as of 20APR2016 for remaining participants in the study.|4
3199919|NCT02117479|3928766|FG000|NOT COMPLETED|Overall Study||156
3199920|NCT02117479|3928767|FG001|NOT COMPLETED|Overall Study||156
3199921|NCT02117544|3928773|FG000|STARTED|Period 1||54
3199922|NCT02117544|3928774|FG001|STARTED|Period 1||55
3199923|NCT02117544|3928773|FG000|Treated|Period 1||52
3199924|NCT02117544|3928774|FG001|Treated|Period 1||55
3199925|NCT02117544|3928773|FG000|COMPLETED|Period 1||52
3199926|NCT02117544|3928774|FG001|COMPLETED|Period 1||55
3199927|NCT02117544|3928773|FG000|NOT COMPLETED|Period 1||2
3199928|NCT02117544|3928774|FG001|NOT COMPLETED|Period 1||0
3199929|NCT02117544|3928773|FG000|STARTED|Period 2||52
3199930|NCT02117544|3928774|FG001|STARTED|Period 2||55
3199931|NCT02117544|3928773|FG000|COMPLETED|Period 2||52
3199932|NCT02117544|3928774|FG001|COMPLETED|Period 2||55
3199933|NCT02117544|3928773|FG000|NOT COMPLETED|Period 2||0
3199934|NCT02117544|3928774|FG001|NOT COMPLETED|Period 2||0
3199935|NCT02117570|3928784|FG000|STARTED|Stage 1 Participants Aged 50 to 64 Years|Randomized|6
3199936|NCT02117570|3928785|FG001|STARTED|Stage 1 Participants Aged 50 to 64 Years|Randomized|18
3199937|NCT02117570|3928786|FG002|STARTED|Stage 1 Participants Aged 50 to 64 Years|Randomized|18
3199938|NCT02117570|3928784|FG000|Vaccine: Dose 1|Stage 1 Participants Aged 50 to 64 Years||6
3199939|NCT02117570|3928785|FG001|Vaccine: Dose 1|Stage 1 Participants Aged 50 to 64 Years||18
3199940|NCT02117570|3928786|FG002|Vaccine: Dose 1|Stage 1 Participants Aged 50 to 64 Years||18
3199941|NCT02117570|3928784|FG000|Vaccine: Dose 2|Stage 1 Participants Aged 50 to 64 Years||6
3199942|NCT02117570|3928785|FG001|Vaccine: Dose 2|Stage 1 Participants Aged 50 to 64 Years||18
3199943|NCT02117570|3928786|FG002|Vaccine: Dose 2|Stage 1 Participants Aged 50 to 64 Years||18
3199944|NCT02117570|3928784|FG000|Vaccine: Dose 3|Stage 1 Participants Aged 50 to 64 Years||6
3199945|NCT02117570|3928785|FG001|Vaccine: Dose 3|Stage 1 Participants Aged 50 to 64 Years||17
3199946|NCT02117570|3928786|FG002|Vaccine: Dose 3|Stage 1 Participants Aged 50 to 64 Years||18
3199947|NCT02117570|3928784|FG000|COMPLETED|Stage 1 Participants Aged 50 to 64 Years||5
3199948|NCT02117570|3928785|FG001|COMPLETED|Stage 1 Participants Aged 50 to 64 Years||15
3199949|NCT02117570|3928786|FG002|COMPLETED|Stage 1 Participants Aged 50 to 64 Years||17
3199950|NCT02117570|3928784|FG000|NOT COMPLETED|Stage 1 Participants Aged 50 to 64 Years||1
3199951|NCT02117570|3928785|FG001|NOT COMPLETED|Stage 1 Participants Aged 50 to 64 Years||3
3199952|NCT02117570|3928786|FG002|NOT COMPLETED|Stage 1 Participants Aged 50 to 64 Years||1
3199953|NCT02117570|3928784|FG000|STARTED|Stage 2 Participants Aged 65 to 85 Years|Randomized|21
3199954|NCT02117570|3928785|FG001|STARTED|Stage 2 Participants Aged 65 to 85 Years|Randomized|62
3199955|NCT02117570|3928786|FG002|STARTED|Stage 2 Participants Aged 65 to 85 Years|Randomized|60
3365025|NCT03996694|4096110|FG000|COMPLETED|Fifth Washout (7 Days)||3
3199956|NCT02117570|3928784|FG000|Vaccine: Dose 1|Stage 2 Participants Aged 65 to 85 Years||21
3199957|NCT02117570|3928785|FG001|Vaccine: Dose 1|Stage 2 Participants Aged 65 to 85 Years||61
3199958|NCT02117570|3928786|FG002|Vaccine: Dose 1|Stage 2 Participants Aged 65 to 85 Years||60
3199959|NCT02117570|3928784|FG000|Vaccine: Dose 2|Stage 2 Participants Aged 65 to 85 Years||17
3199960|NCT02117570|3928785|FG001|Vaccine: Dose 2|Stage 2 Participants Aged 65 to 85 Years||53
3199961|NCT02117570|3928786|FG002|Vaccine: Dose 2|Stage 2 Participants Aged 65 to 85 Years||50
3199962|NCT02117570|3928784|FG000|Vaccine: Dose 3|Stage 2 Participants Aged 65 to 85 Years||4
3199963|NCT02117570|3928785|FG001|Vaccine: Dose 3|Stage 2 Participants Aged 65 to 85 Years||12
3199964|NCT02117570|3928786|FG002|Vaccine: Dose 3|Stage 2 Participants Aged 65 to 85 Years||12
3199965|NCT02117570|3928784|FG000|COMPLETED|Stage 2 Participants Aged 65 to 85 Years||20
3199966|NCT02117570|3928785|FG001|COMPLETED|Stage 2 Participants Aged 65 to 85 Years||59
3199967|NCT02117570|3928786|FG002|COMPLETED|Stage 2 Participants Aged 65 to 85 Years||54
3199968|NCT02117570|3928784|FG000|NOT COMPLETED|Stage 2 Participants Aged 65 to 85 Years||1
3199969|NCT02117570|3928785|FG001|NOT COMPLETED|Stage 2 Participants Aged 65 to 85 Years||3
3199970|NCT02117570|3928786|FG002|NOT COMPLETED|Stage 2 Participants Aged 65 to 85 Years||6
3199971|NCT02117648|3928797|FG000|STARTED|Abemaciclib Alone Period 1||26
3199972|NCT02117648|3928797|FG000|Received at Least 1 Dose of Study Drug|Abemaciclib Alone Period 1||26
3199973|NCT02117648|3928797|FG000|COMPLETED|Abemaciclib Alone Period 1||24
3199974|NCT02117648|3928797|FG000|NOT COMPLETED|Abemaciclib Alone Period 1||2
3199975|NCT02117648|3928797|FG000|STARTED|Abemaciclib + Clarithromycin Period 2||24
3199976|NCT02117648|3928797|FG000|Received at Least 1 Dose of Study Drug|Abemaciclib + Clarithromycin Period 2||21
3199977|NCT02117648|3928797|FG000|COMPLETED|Abemaciclib + Clarithromycin Period 2||20
3199978|NCT02117648|3928797|FG000|NOT COMPLETED|Abemaciclib + Clarithromycin Period 2||4
3199979|NCT02117648|3928797|FG000|STARTED|Abemaciclib Safety-Extension Phase||20
3199980|NCT02117648|3928797|FG000|COMPLETED|Abemaciclib Safety-Extension Phase||0
3199981|NCT02117648|3928797|FG000|NOT COMPLETED|Abemaciclib Safety-Extension Phase||20
3199982|NCT02117687|3928807|FG000|STARTED|Overall Study||40
3199983|NCT02117687|3928808|FG001|STARTED|Overall Study||40
3199984|NCT02117687|3928807|FG000|COMPLETED|Overall Study||39
3199985|NCT02117687|3928808|FG001|COMPLETED|Overall Study||36
3199986|NCT02117687|3928807|FG000|NOT COMPLETED|Overall Study||1
3199987|NCT02117687|3928808|FG001|NOT COMPLETED|Overall Study||4
3199988|NCT02117713|3928814|FG000|STARTED|Week 48||34
3199989|NCT02117713|3928814|FG000|COMPLETED|Week 48||26
3199990|NCT02117713|3928814|FG000|NOT COMPLETED|Week 48||8
3199991|NCT02117713|3928814|FG000|STARTED|Long Term Follow-up Treatment||26
3199992|NCT02117713|3928814|FG000|COMPLETED|Long Term Follow-up Treatment||20
3199993|NCT02117713|3928814|FG000|NOT COMPLETED|Long Term Follow-up Treatment||6
3365026|NCT03996694|4096111|FG001|COMPLETED|Fifth Washout (7 Days)||2
3365027|NCT03996694|4096112|FG002|COMPLETED|Fifth Washout (7 Days)||2
3365028|NCT03996694|4096113|FG003|COMPLETED|Fifth Washout (7 Days)||3
3365029|NCT03996694|4096114|FG004|COMPLETED|Fifth Washout (7 Days)||2
3365030|NCT03996694|4096115|FG005|COMPLETED|Fifth Washout (7 Days)||3
3365031|NCT03996694|4096110|FG000|NOT COMPLETED|Fifth Washout (7 Days)||0
3365032|NCT03996694|4096111|FG001|NOT COMPLETED|Fifth Washout (7 Days)||0
3365033|NCT03996694|4096112|FG002|NOT COMPLETED|Fifth Washout (7 Days)||0
3365034|NCT03996694|4096113|FG003|NOT COMPLETED|Fifth Washout (7 Days)||0
3365035|NCT03996694|4096114|FG004|NOT COMPLETED|Fifth Washout (7 Days)||0
3365036|NCT03996694|4096115|FG005|NOT COMPLETED|Fifth Washout (7 Days)||0
3365037|NCT03996694|4096110|FG000|STARTED|Sixth Intervention (1 Day)||3
3365038|NCT03996694|4096111|FG001|STARTED|Sixth Intervention (1 Day)||2
3365039|NCT03996694|4096112|FG002|STARTED|Sixth Intervention (1 Day)||2
3365040|NCT03996694|4096113|FG003|STARTED|Sixth Intervention (1 Day)||3
3365041|NCT03996694|4096114|FG004|STARTED|Sixth Intervention (1 Day)||2
3365042|NCT03996694|4096115|FG005|STARTED|Sixth Intervention (1 Day)||3
3365043|NCT03996694|4096110|FG000|COMPLETED|Sixth Intervention (1 Day)||3
3365044|NCT03996694|4096111|FG001|COMPLETED|Sixth Intervention (1 Day)||2
3365045|NCT03996694|4096112|FG002|COMPLETED|Sixth Intervention (1 Day)||2
3365046|NCT03996694|4096113|FG003|COMPLETED|Sixth Intervention (1 Day)||3
3365047|NCT03996694|4096114|FG004|COMPLETED|Sixth Intervention (1 Day)||2
3365048|NCT03996694|4096115|FG005|COMPLETED|Sixth Intervention (1 Day)||3
3365049|NCT03996694|4096110|FG000|NOT COMPLETED|Sixth Intervention (1 Day)||0
3365050|NCT03996694|4096111|FG001|NOT COMPLETED|Sixth Intervention (1 Day)||0
3365051|NCT03996694|4096112|FG002|NOT COMPLETED|Sixth Intervention (1 Day)||0
3365052|NCT03996694|4096113|FG003|NOT COMPLETED|Sixth Intervention (1 Day)||0
3365053|NCT03996694|4096114|FG004|NOT COMPLETED|Sixth Intervention (1 Day)||0
3365054|NCT03996694|4096115|FG005|NOT COMPLETED|Sixth Intervention (1 Day)||0
3365055|NCT03988907|4096131|FG000|STARTED|Overall Study||8
3365056|NCT03988907|4096132|FG001|STARTED|Overall Study||27
3365057|NCT03988907|4096131|FG000|COMPLETED|Overall Study||8
3199994|NCT02117934|3928828|FG000|STARTED|Overall Study||5592
3199995|NCT02117934|3928829|FG001|STARTED|Overall Study||2782
3199996|NCT02117934|3928828|FG000|COMPLETED|Overall Study||5092
3199997|NCT02117934|3928829|FG001|COMPLETED|Overall Study||2567
3199998|NCT02117934|3928828|FG000|NOT COMPLETED|Overall Study||500
3199999|NCT02117934|3928829|FG001|NOT COMPLETED|Overall Study||215
3200000|NCT02117999|3928837|FG000|STARTED|Overall Study||20
3200001|NCT02117999|3928838|FG001|STARTED|Overall Study||10
3200002|NCT02117999|3928837|FG000|Mean Kmax Change in Corneal Topography|Overall Study||20
3200003|NCT02117999|3928838|FG001|Mean Kmax Change in Corneal Topography|Overall Study||10
3200004|NCT02117999|3928837|FG000|COMPLETED|Overall Study||20
3200005|NCT02117999|3928838|FG001|COMPLETED|Overall Study||10
3200006|NCT02117999|3928837|FG000|NOT COMPLETED|Overall Study||0
3200007|NCT02117999|3928838|FG001|NOT COMPLETED|Overall Study||0
3200008|NCT02118012|3928848|FG000|STARTED|Overall Study||12
3200009|NCT02118012|3928849|FG001|STARTED|Overall Study||12
3200010|NCT02118012|3928848|FG000|Day 5|Overall Study||12
3200011|NCT02118012|3928849|FG001|Day 5|Overall Study||11
3200012|NCT02118012|3928848|FG000|Day 14|Overall Study||12
3200013|NCT02118012|3928849|FG001|Day 14|Overall Study||10
3200014|NCT02118012|3928848|FG000|COMPLETED|Overall Study||12
3200015|NCT02118012|3928849|FG001|COMPLETED|Overall Study||10
3200016|NCT02118012|3928848|FG000|NOT COMPLETED|Overall Study||0
3200017|NCT02118012|3928849|FG001|NOT COMPLETED|Overall Study||2
3200018|NCT02118337|3928864|FG000|STARTED|Overall Study||4
3200019|NCT02118337|3928865|FG001|STARTED|Overall Study||5
3200020|NCT02118337|3928866|FG002|STARTED|Overall Study||3
3200021|NCT02118337|3928867|FG003|STARTED|Overall Study||3
3200022|NCT02118337|3928868|FG004|STARTED|Overall Study||9
3200023|NCT02118337|3928869|FG005|STARTED|Overall Study||6
3200024|NCT02118337|3928870|FG006|STARTED|Overall Study||4
3200025|NCT02118337|3928871|FG007|STARTED|Overall Study||42
3200026|NCT02118337|3928872|FG008|STARTED|Overall Study||21
3200027|NCT02118337|3928864|FG000|COMPLETED|Overall Study||0
3200028|NCT02118337|3928865|FG001|COMPLETED|Overall Study||0
3200029|NCT02118337|3928866|FG002|COMPLETED|Overall Study||0
3200030|NCT02118337|3928867|FG003|COMPLETED|Overall Study||0
3200031|NCT02118337|3928868|FG004|COMPLETED|Overall Study||0
3200032|NCT02118337|3928869|FG005|COMPLETED|Overall Study||0
3200033|NCT02118337|3928870|FG006|COMPLETED|Overall Study||0
3200034|NCT02118337|3928871|FG007|COMPLETED|Overall Study||0
3200035|NCT02118337|3928872|FG008|COMPLETED|Overall Study||0
3200036|NCT02118337|3928864|FG000|NOT COMPLETED|Overall Study||4
3200037|NCT02118337|3928865|FG001|NOT COMPLETED|Overall Study||5
3200038|NCT02118337|3928866|FG002|NOT COMPLETED|Overall Study||3
3200039|NCT02118337|3928867|FG003|NOT COMPLETED|Overall Study||3
3200040|NCT02118337|3928868|FG004|NOT COMPLETED|Overall Study||9
3200041|NCT02118337|3928869|FG005|NOT COMPLETED|Overall Study||6
3200042|NCT02118337|3928870|FG006|NOT COMPLETED|Overall Study||4
3200043|NCT02118337|3928871|FG007|NOT COMPLETED|Overall Study||42
3200044|NCT02118337|3928872|FG008|NOT COMPLETED|Overall Study||21
3200045|NCT02118428|3928898|FG000|STARTED|Overall Study||113
3200046|NCT02118428|3928899|FG001|STARTED|Overall Study||113
3200047|NCT02118428|3928900|FG002|STARTED|Overall Study||1
3200048|NCT02118428|3928898|FG000|Received Study Transfusion|Overall Study||111
3200049|NCT02118428|3928899|FG001|Received Study Transfusion|Overall Study||112
3200050|NCT02118428|3928900|FG002|Received Study Transfusion|Overall Study||0
3200051|NCT02118428|3928898|FG000|COMPLETED|Overall Study||100
3200052|NCT02118428|3928899|FG001|COMPLETED|Overall Study||104
3200053|NCT02118428|3928900|FG002|COMPLETED|Overall Study||0
3200054|NCT02118428|3928898|FG000|NOT COMPLETED|Overall Study||13
3200055|NCT02118428|3928899|FG001|NOT COMPLETED|Overall Study||9
3200056|NCT02118428|3928900|FG002|NOT COMPLETED|Overall Study||1
3200057|NCT02118441|3928908|FG000|STARTED|Overall Study||65
3200058|NCT02118441|3928909|FG001|STARTED|Overall Study||64
3200059|NCT02118441|3928908|FG000|COMPLETED|Overall Study||62
3200060|NCT02118441|3928909|FG001|COMPLETED|Overall Study||63
3200061|NCT02118441|3928908|FG000|NOT COMPLETED|Overall Study||3
3200062|NCT02118441|3928909|FG001|NOT COMPLETED|Overall Study||1
3200063|NCT02118597|3928916|FG000|STARTED|Overall Study||19
3200064|NCT02118597|3928916|FG000|COMPLETED|Overall Study||3
3200065|NCT02118597|3928916|FG000|NOT COMPLETED|Overall Study||16
3200066|NCT02118714|3928920|FG000|STARTED|Overall Study||20
3200067|NCT02118714|3928920|FG000|COMPLETED|Overall Study||17
3200068|NCT02118714|3928920|FG000|NOT COMPLETED|Overall Study||3
3200069|NCT02118766|3928926|FG000|STARTED|Overall Study||507
3200070|NCT02118766|3928927|FG001|STARTED|Overall Study||256
3200071|NCT02118766|3928926|FG000|Treated|Overall Study||503
3200072|NCT02118766|3928927|FG001|Treated|Overall Study||256
3200073|NCT02118766|3928926|FG000|COMPLETED|Overall Study||477
3200074|NCT02118766|3928927|FG001|COMPLETED|Overall Study||225
3200075|NCT02118766|3928926|FG000|NOT COMPLETED|Overall Study||30
3200076|NCT02118766|3928927|FG001|NOT COMPLETED|Overall Study||31
3200077|NCT02118792|3928935|FG000|STARTED|Overall Study||514
3200078|NCT02118792|3928936|FG001|STARTED|Overall Study||250
3200079|NCT02118792|3928935|FG000|Treated|Overall Study||513
3200080|NCT02118792|3928936|FG001|Treated|Overall Study||250
3200081|NCT02118792|3928935|FG000|COMPLETED|Overall Study||483
3200082|NCT02118792|3928936|FG001|COMPLETED|Overall Study||213
3200083|NCT02118792|3928935|FG000|NOT COMPLETED|Overall Study||31
3200084|NCT02118792|3928936|FG001|NOT COMPLETED|Overall Study||37
3200085|NCT02118831|3928947|FG000|STARTED|Overall Study||21
3200086|NCT02118831|3928948|FG001|STARTED|Overall Study||15
3200087|NCT02118831|3928949|FG002|STARTED|Overall Study||20
3200088|NCT02118831|3928947|FG000|COMPLETED|Overall Study||21
3200089|NCT02118831|3928948|FG001|COMPLETED|Overall Study||15
3200090|NCT02118831|3928949|FG002|COMPLETED|Overall Study||20
3200091|NCT02118831|3928947|FG000|NOT COMPLETED|Overall Study||0
3200092|NCT02118831|3928948|FG001|NOT COMPLETED|Overall Study||0
3200093|NCT02118831|3928949|FG002|NOT COMPLETED|Overall Study||0
3200094|NCT02118896|3928967|FG000|STARTED|Overall Study||47
3200095|NCT02118896|3928968|FG001|STARTED|Overall Study||47
3200096|NCT02118896|3928969|FG002|STARTED|Overall Study||67
3200097|NCT02118896|3928970|FG003|STARTED|Overall Study||79
3200098|NCT02118896|3928971|FG004|STARTED|Overall Study||130
3200099|NCT02118896|3928972|FG005|STARTED|Overall Study||191
3200100|NCT02118896|3928973|FG006|STARTED|Overall Study||85
3200101|NCT02118896|3928974|FG007|STARTED|Overall Study||107
3200102|NCT02118896|3928975|FG008|STARTED|Overall Study||88
3200103|NCT02118896|3928976|FG009|STARTED|Overall Study||9
3200104|NCT02118896|3928967|FG000|COMPLETED|Overall Study||30
3200105|NCT02118896|3928968|FG001|COMPLETED|Overall Study||32
3200106|NCT02118896|3928969|FG002|COMPLETED|Overall Study||53
3200107|NCT02118896|3928970|FG003|COMPLETED|Overall Study||55
3200108|NCT02118896|3928971|FG004|COMPLETED|Overall Study||113
3200109|NCT02118896|3928972|FG005|COMPLETED|Overall Study||163
3200110|NCT02118896|3928973|FG006|COMPLETED|Overall Study||83
3200111|NCT02118896|3928974|FG007|COMPLETED|Overall Study||105
3200112|NCT02118896|3928975|FG008|COMPLETED|Overall Study||84
3200113|NCT02118896|3928976|FG009|COMPLETED|Overall Study||7
3200114|NCT02118896|3928967|FG000|NOT COMPLETED|Overall Study||17
3200115|NCT02118896|3928968|FG001|NOT COMPLETED|Overall Study||15
3200116|NCT02118896|3928969|FG002|NOT COMPLETED|Overall Study||14
3200117|NCT02118896|3928970|FG003|NOT COMPLETED|Overall Study||24
3200118|NCT02118896|3928971|FG004|NOT COMPLETED|Overall Study||17
3200119|NCT02118896|3928972|FG005|NOT COMPLETED|Overall Study||28
3200120|NCT02118896|3928973|FG006|NOT COMPLETED|Overall Study||2
3200121|NCT02118896|3928974|FG007|NOT COMPLETED|Overall Study||2
3200122|NCT02118896|3928975|FG008|NOT COMPLETED|Overall Study||4
3200123|NCT02118896|3928976|FG009|NOT COMPLETED|Overall Study||2
3200124|NCT02118961|3929001|FG000|STARTED|Overall Study||224
3200125|NCT02118961|3929002|FG001|STARTED|Overall Study||222
3200126|NCT02118961|3929001|FG000|COMPLETED|Overall Study||223
3200127|NCT02118961|3929002|FG001|COMPLETED|Overall Study||222
3200128|NCT02118961|3929001|FG000|NOT COMPLETED|Overall Study||1
3200129|NCT02118961|3929002|FG001|NOT COMPLETED|Overall Study||0
3200130|NCT02119026|3929010|FG000|STARTED|1st-line Treatment||58
3200131|NCT02119026|3929011|FG001|STARTED|1st-line Treatment||62
3200132|NCT02119026|3929010|FG000|COMPLETED|1st-line Treatment||32
3200133|NCT02119026|3929011|FG001|COMPLETED|1st-line Treatment||24
3200134|NCT02119026|3929010|FG000|NOT COMPLETED|1st-line Treatment||26
3200135|NCT02119026|3929011|FG001|NOT COMPLETED|1st-line Treatment||38
3200136|NCT02119026|3929010|FG000|STARTED|2nd-line Treatment||32
3200137|NCT02119026|3929011|FG001|STARTED|2nd-line Treatment||24
3200138|NCT02119026|3929010|FG000|COMPLETED|2nd-line Treatment||23
3200139|NCT02119026|3929011|FG001|COMPLETED|2nd-line Treatment||22
3200140|NCT02119026|3929010|FG000|NOT COMPLETED|2nd-line Treatment||9
3200141|NCT02119026|3929011|FG001|NOT COMPLETED|2nd-line Treatment||2
3200142|NCT02119104|3929017|FG000|STARTED|Overall Study||1087
3200143|NCT02119104|3929017|FG000|COMPLETED|Overall Study||1071
3200144|NCT02119104|3929017|FG000|NOT COMPLETED|Overall Study||16
3200145|NCT02119156|3929024|FG000|STARTED|Treatment Phase (Up to 52 Weeks)||39
3200146|NCT02119156|3929025|FG001|STARTED|Treatment Phase (Up to 52 Weeks)||29
3200147|NCT02119156|3929026|FG002|STARTED|Treatment Phase (Up to 52 Weeks)||12
3200148|NCT02119156|3929024|FG000|COMPLETED|Treatment Phase (Up to 52 Weeks)||33
3200149|NCT02119156|3929025|FG001|COMPLETED|Treatment Phase (Up to 52 Weeks)||27
3200150|NCT02119156|3929026|FG002|COMPLETED|Treatment Phase (Up to 52 Weeks)||11
3200151|NCT02119156|3929024|FG000|NOT COMPLETED|Treatment Phase (Up to 52 Weeks)||6
3200152|NCT02119156|3929025|FG001|NOT COMPLETED|Treatment Phase (Up to 52 Weeks)||2
3200153|NCT02119156|3929026|FG002|NOT COMPLETED|Treatment Phase (Up to 52 Weeks)||1
3200154|NCT02119156|3929024|FG000|STARTED|Maintenance (Up to 48 Weeks of Year 2-4)|Long-term discontinuation participants were not allowed in Maintenance period|0
3200155|NCT02119156|3929025|FG001|STARTED|Maintenance (Up to 48 Weeks of Year 2-4)|Eligible participants of Treatment control and holiday group on completion of 52-weeks were included|16
3200156|NCT02119156|3929026|FG002|STARTED|Maintenance (Up to 48 Weeks of Year 2-4)|Eligible participants of Treatment control and holiday group on completion of 52-weeks were included|10
3200157|NCT02119156|3929024|FG000|COMPLETED|Maintenance (Up to 48 Weeks of Year 2-4)||0
3200158|NCT02119156|3929025|FG001|COMPLETED|Maintenance (Up to 48 Weeks of Year 2-4)||6
3200159|NCT02119156|3929026|FG002|COMPLETED|Maintenance (Up to 48 Weeks of Year 2-4)||3
3200160|NCT02119156|3929024|FG000|NOT COMPLETED|Maintenance (Up to 48 Weeks of Year 2-4)||0
3200161|NCT02119156|3929025|FG001|NOT COMPLETED|Maintenance (Up to 48 Weeks of Year 2-4)||10
3200162|NCT02119156|3929026|FG002|NOT COMPLETED|Maintenance (Up to 48 Weeks of Year 2-4)||7
3200163|NCT02119260|3929048|FG000|STARTED|Overall Study||9
3200164|NCT02119260|3929049|FG001|STARTED|Overall Study||12
3200165|NCT02119260|3929050|FG002|STARTED|Overall Study||8
3200166|NCT02119260|3929051|FG003|STARTED|Overall Study||10
3200167|NCT02119260|3929052|FG004|STARTED|Overall Study||13
3200168|NCT02119260|3929053|FG005|STARTED|Overall Study||6
3200169|NCT02119260|3929054|FG006|STARTED|Overall Study||2
3200170|NCT02119260|3929048|FG000|COMPLETED|Overall Study||8
3200171|NCT02119260|3929049|FG001|COMPLETED|Overall Study||11
3200172|NCT02119260|3929050|FG002|COMPLETED|Overall Study||7
3200173|NCT02119260|3929051|FG003|COMPLETED|Overall Study||10
3200174|NCT02119260|3929052|FG004|COMPLETED|Overall Study||13
3200175|NCT02119260|3929053|FG005|COMPLETED|Overall Study||6
3200176|NCT02119260|3929054|FG006|COMPLETED|Overall Study||2
3200177|NCT02119260|3929048|FG000|NOT COMPLETED|Overall Study||1
3200178|NCT02119260|3929049|FG001|NOT COMPLETED|Overall Study||1
3200179|NCT02119260|3929050|FG002|NOT COMPLETED|Overall Study||1
3200180|NCT02119260|3929051|FG003|NOT COMPLETED|Overall Study||0
3200181|NCT02119260|3929052|FG004|NOT COMPLETED|Overall Study||0
3200182|NCT02119260|3929053|FG005|NOT COMPLETED|Overall Study||0
3200183|NCT02119260|3929054|FG006|NOT COMPLETED|Overall Study||0
3200184|NCT02119286|3929082|FG000|STARTED|Overall Study||206
3200185|NCT02119286|3929083|FG001|STARTED|Overall Study||206
3200186|NCT02119286|3929084|FG002|STARTED|Overall Study||207
3200187|NCT02119286|3929082|FG000|COMPLETED|Overall Study||180
3200188|NCT02119286|3929083|FG001|COMPLETED|Overall Study||195
3200189|NCT02119286|3929084|FG002|COMPLETED|Overall Study||200
3200190|NCT02119286|3929082|FG000|NOT COMPLETED|Overall Study||26
3200191|NCT02119286|3929083|FG001|NOT COMPLETED|Overall Study||11
3200192|NCT02119286|3929084|FG002|NOT COMPLETED|Overall Study||7
3200193|NCT02119299|3929092|FG000|STARTED|Overall Study||76
3200194|NCT02119299|3929092|FG000|COMPLETED|Overall Study||67
3200195|NCT02119299|3929092|FG000|NOT COMPLETED|Overall Study||9
3365058|NCT03988907|4096132|FG001|COMPLETED|Overall Study||26
3365059|NCT03988907|4096131|FG000|NOT COMPLETED|Overall Study||0
3365060|NCT03988907|4096132|FG001|NOT COMPLETED|Overall Study||1
3365061|NCT03988088|4096146|FG000|STARTED|Single-Dose Pharmacokinetic Study||11
3365062|NCT03988088|4096147|FG001|STARTED|Single-Dose Pharmacokinetic Study||7
3365063|NCT03988088|4096148|FG002|STARTED|Single-Dose Pharmacokinetic Study||0
3365064|NCT03988088|4096149|FG003|STARTED|Single-Dose Pharmacokinetic Study||0
3365065|NCT03988088|4096146|FG000|COMPLETED|Single-Dose Pharmacokinetic Study||11
3365066|NCT03988088|4096147|FG001|COMPLETED|Single-Dose Pharmacokinetic Study||6
3365067|NCT03988088|4096148|FG002|COMPLETED|Single-Dose Pharmacokinetic Study||0
3365068|NCT03988088|4096149|FG003|COMPLETED|Single-Dose Pharmacokinetic Study||0
3365069|NCT03988088|4096146|FG000|NOT COMPLETED|Single-Dose Pharmacokinetic Study||0
3365070|NCT03988088|4096147|FG001|NOT COMPLETED|Single-Dose Pharmacokinetic Study||1
3365071|NCT03988088|4096148|FG002|NOT COMPLETED|Single-Dose Pharmacokinetic Study||0
3365072|NCT03988088|4096149|FG003|NOT COMPLETED|Single-Dose Pharmacokinetic Study||0
3365073|NCT03988088|4096146|FG000|STARTED|Open-Label Addendum||0
3365074|NCT03988088|4096147|FG001|STARTED|Open-Label Addendum||0
3365075|NCT03988088|4096148|FG002|STARTED|Open-Label Addendum|The US participants had the option to enter this optional 3-month open-label extension addendum.|2
3365076|NCT03988088|4096149|FG003|STARTED|Open-Label Addendum|The US participants had the option to enter this optional 3-month open-label extension addendum.|2
3365077|NCT03988088|4096146|FG000|COMPLETED|Open-Label Addendum||0
3365078|NCT03988088|4096147|FG001|COMPLETED|Open-Label Addendum||0
3365079|NCT03988088|4096148|FG002|COMPLETED|Open-Label Addendum||1
3365080|NCT03988088|4096149|FG003|COMPLETED|Open-Label Addendum||2
3365081|NCT03988088|4096146|FG000|NOT COMPLETED|Open-Label Addendum||0
3365082|NCT03988088|4096147|FG001|NOT COMPLETED|Open-Label Addendum||0
3365083|NCT03988088|4096148|FG002|NOT COMPLETED|Open-Label Addendum||1
3365084|NCT03988088|4096149|FG003|NOT COMPLETED|Open-Label Addendum||0
3365085|NCT03980522|4096162|FG000|STARTED|Treatment Period||13
3365086|NCT03980522|4096163|FG001|STARTED|Treatment Period||3
3365087|NCT03980522|4096164|FG002|STARTED|Treatment Period||6
3365088|NCT03980522|4096165|FG003|STARTED|Treatment Period||1
3365089|NCT03980522|4096166|FG004|STARTED|Treatment Period||3
3365090|NCT03980522|4096162|FG000|COMPLETED|Treatment Period||12
3365091|NCT03980522|4096163|FG001|COMPLETED|Treatment Period||3
3365092|NCT03980522|4096164|FG002|COMPLETED|Treatment Period||6
3365093|NCT03980522|4096165|FG003|COMPLETED|Treatment Period||1
3365094|NCT03980522|4096166|FG004|COMPLETED|Treatment Period||3
3365095|NCT03980522|4096162|FG000|NOT COMPLETED|Treatment Period||1
3365096|NCT03980522|4096163|FG001|NOT COMPLETED|Treatment Period||0
3365097|NCT03980522|4096164|FG002|NOT COMPLETED|Treatment Period||0
3365098|NCT03980522|4096165|FG003|NOT COMPLETED|Treatment Period||0
3365099|NCT03980522|4096166|FG004|NOT COMPLETED|Treatment Period||0
3365100|NCT03980522|4096162|FG000|STARTED|Extension Period||12
3365101|NCT03980522|4096163|FG001|STARTED|Extension Period||3
3365102|NCT03980522|4096164|FG002|STARTED|Extension Period|1 participant did not sign the optional Extension Period consent form.|5
3365103|NCT03980522|4096165|FG003|STARTED|Extension Period||1
3365104|NCT03980522|4096166|FG004|STARTED|Extension Period||3
3365105|NCT03980522|4096162|FG000|COMPLETED|Extension Period||12
3365106|NCT03980522|4096163|FG001|COMPLETED|Extension Period||3
3365107|NCT03980522|4096164|FG002|COMPLETED|Extension Period||5
3365108|NCT03980522|4096165|FG003|COMPLETED|Extension Period||1
3365109|NCT03980522|4096166|FG004|COMPLETED|Extension Period||3
3365110|NCT03980522|4096162|FG000|NOT COMPLETED|Extension Period||0
3365111|NCT03980522|4096163|FG001|NOT COMPLETED|Extension Period||0
3365112|NCT03980522|4096164|FG002|NOT COMPLETED|Extension Period||0
3365113|NCT03980522|4096165|FG003|NOT COMPLETED|Extension Period||0
3365114|NCT03980522|4096166|FG004|NOT COMPLETED|Extension Period||0
3365115|NCT03999684|4096178|FG000|STARTED|Overall Study||18
3365116|NCT03999684|4096178|FG000|COMPLETED|Overall Study||18
3365117|NCT03999684|4096178|FG000|NOT COMPLETED|Overall Study||0
3365118|NCT03995784|4096182|FG000|STARTED|Overall Study||6
3365119|NCT03995784|4096182|FG000|COMPLETED|Overall Study||5
3200196|NCT02119325|3929096|FG000|STARTED|Period 1||48
3200197|NCT02119325|3929097|FG001|STARTED|Period 1||48
3200198|NCT02119325|3929096|FG000|COMPLETED|Period 1||48
3200199|NCT02119325|3929097|FG001|COMPLETED|Period 1||48
3200200|NCT02119325|3929096|FG000|NOT COMPLETED|Period 1||0
3200201|NCT02119325|3929097|FG001|NOT COMPLETED|Period 1||0
3200202|NCT02119325|3929096|FG000|STARTED|Washout Period 1||48
3200203|NCT02119325|3929097|FG001|STARTED|Washout Period 1||48
3200204|NCT02119325|3929096|FG000|COMPLETED|Washout Period 1||48
3200205|NCT02119325|3929097|FG001|COMPLETED|Washout Period 1||47
3200206|NCT02119325|3929096|FG000|NOT COMPLETED|Washout Period 1||0
3200207|NCT02119325|3929097|FG001|NOT COMPLETED|Washout Period 1||1
3200208|NCT02119325|3929096|FG000|STARTED|Period 2||48
3200209|NCT02119325|3929097|FG001|STARTED|Period 2||47
3200210|NCT02119325|3929096|FG000|COMPLETED|Period 2||48
3200211|NCT02119325|3929097|FG001|COMPLETED|Period 2||47
3200212|NCT02119325|3929096|FG000|NOT COMPLETED|Period 2||0
3200213|NCT02119325|3929097|FG001|NOT COMPLETED|Period 2||0
3200214|NCT02119442|3929105|FG000|STARTED|Overall Study||90
3200215|NCT02119442|3929105|FG000|COMPLETED|Overall Study||90
3200216|NCT02119442|3929105|FG000|NOT COMPLETED|Overall Study||0
3200217|NCT02119455|3929111|FG000|STARTED|Overall Study||20
3200218|NCT02119455|3929112|FG001|STARTED|Overall Study||20
3200219|NCT02119455|3929111|FG000|COMPLETED|Overall Study||20
3200220|NCT02119455|3929112|FG001|COMPLETED|Overall Study||17
3200221|NCT02119455|3929111|FG000|NOT COMPLETED|Overall Study||0
3200222|NCT02119455|3929112|FG001|NOT COMPLETED|Overall Study||3
3200223|NCT02119468|3929120|FG000|STARTED|Overall Study||7
3200224|NCT02119468|3929121|FG001|STARTED|Overall Study||25
3200225|NCT02119468|3929120|FG000|COMPLETED|Overall Study||7
3200226|NCT02119468|3929121|FG001|COMPLETED|Overall Study||25
3200227|NCT02119468|3929120|FG000|NOT COMPLETED|Overall Study||0
3200228|NCT02119468|3929121|FG001|NOT COMPLETED|Overall Study||0
3200229|NCT02119650|3929130|FG000|STARTED|Overall Study||39
3200230|NCT02119650|3929131|FG001|STARTED|Overall Study||37
3200231|NCT02119650|3929130|FG000|COMPLETED|Overall Study|Participants with treatment ongoing when the study was terminated.|14
3200232|NCT02119650|3929131|FG001|COMPLETED|Overall Study|Participants with treatment ongoing when the study was terminated.|11
3200233|NCT02119650|3929130|FG000|NOT COMPLETED|Overall Study||25
3200234|NCT02119650|3929131|FG001|NOT COMPLETED|Overall Study||26
3200235|NCT02119663|3929139|FG000|STARTED|Overall Study||43
3200236|NCT02119663|3929140|FG001|STARTED|Overall Study||43
3200237|NCT02119663|3929139|FG000|COMPLETED|Overall Study|Treatment ongoing as of 13APR2016 for remaining participants in the study.|3
3200238|NCT02119663|3929140|FG001|COMPLETED|Overall Study|Treatment ongoing as of 13APR2016 for remaining participants in the study.|2
3200239|NCT02119663|3929139|FG000|NOT COMPLETED|Overall Study||40
3200240|NCT02119663|3929140|FG001|NOT COMPLETED|Overall Study||41
3200241|NCT02119676|3929150|FG000|STARTED|Overall Study||87
3200242|NCT02119676|3929151|FG001|STARTED|Overall Study||88
3200243|NCT02119676|3929152|FG002|STARTED|Overall Study||110
3200244|NCT02119676|3929153|FG003|STARTED|Overall Study||111
3200245|NCT02119676|3929150|FG000|Treated Patients|Overall Study||85
3200246|NCT02119676|3929151|FG001|Treated Patients|Overall Study||86
3200247|NCT02119676|3929152|FG002|Treated Patients|Overall Study||106
3200248|NCT02119676|3929153|FG003|Treated Patients|Overall Study||106
3200249|NCT02119676|3929150|FG000|COMPLETED|Overall Study||4
3200250|NCT02119676|3929151|FG001|COMPLETED|Overall Study||2
3200251|NCT02119676|3929152|FG002|COMPLETED|Overall Study||13
3200252|NCT02119676|3929153|FG003|COMPLETED|Overall Study||10
3200253|NCT02119676|3929150|FG000|NOT COMPLETED|Overall Study||83
3200254|NCT02119676|3929151|FG001|NOT COMPLETED|Overall Study||86
3200255|NCT02119676|3929152|FG002|NOT COMPLETED|Overall Study||97
3200256|NCT02119676|3929153|FG003|NOT COMPLETED|Overall Study||101
3200257|NCT02119819|3929169|FG000|STARTED|Overall Study||66
3200258|NCT02119819|3929170|FG001|STARTED|Overall Study||71
3200259|NCT02119819|3929171|FG002|STARTED|Overall Study||73
3200260|NCT02119819|3929172|FG003|STARTED|Overall Study||70
3200261|NCT02119819|3929173|FG004|STARTED|Overall Study||69
3200262|NCT02119819|3929174|FG005|STARTED|Overall Study||71
3200263|NCT02119819|3929169|FG000|COMPLETED|Overall Study||57
3200264|NCT02119819|3929170|FG001|COMPLETED|Overall Study||66
3200265|NCT02119819|3929171|FG002|COMPLETED|Overall Study||69
3200266|NCT02119819|3929172|FG003|COMPLETED|Overall Study||63
3200267|NCT02119819|3929173|FG004|COMPLETED|Overall Study||62
3200268|NCT02119819|3929174|FG005|COMPLETED|Overall Study||56
3200269|NCT02119819|3929169|FG000|NOT COMPLETED|Overall Study||9
3200270|NCT02119819|3929170|FG001|NOT COMPLETED|Overall Study||5
3200271|NCT02119819|3929171|FG002|NOT COMPLETED|Overall Study||4
3200272|NCT02119819|3929172|FG003|NOT COMPLETED|Overall Study||7
3200273|NCT02119819|3929173|FG004|NOT COMPLETED|Overall Study||7
3200274|NCT02119819|3929174|FG005|NOT COMPLETED|Overall Study||15
3200275|NCT02119871|3929190|FG000|STARTED|Overall Study||10
3200276|NCT02119871|3929191|FG001|STARTED|Overall Study||10
3200277|NCT02119871|3929190|FG000|COMPLETED|Overall Study||10
3200278|NCT02119871|3929191|FG001|COMPLETED|Overall Study||10
3200279|NCT02119871|3929190|FG000|NOT COMPLETED|Overall Study||0
3200280|NCT02119871|3929191|FG001|NOT COMPLETED|Overall Study||0
3200281|NCT02119936|3929197|FG000|STARTED|Overall Study||10
3200282|NCT02119936|3929197|FG000|COMPLETED|Overall Study||0
3200283|NCT02119936|3929197|FG000|NOT COMPLETED|Overall Study||10
3200284|NCT02120001|3929203|FG000|STARTED|Overall Study||17
3200285|NCT02120001|3929204|FG001|STARTED|Overall Study||19
3200286|NCT02120001|3929203|FG000|COMPLETED|Overall Study||17
3200287|NCT02120001|3929204|FG001|COMPLETED|Overall Study||19
3200288|NCT02120001|3929203|FG000|NOT COMPLETED|Overall Study||0
3200289|NCT02120001|3929204|FG001|NOT COMPLETED|Overall Study||0
3200290|NCT02120027|3929212|FG000|STARTED|Overall Study||277
3200291|NCT02120027|3929213|FG001|STARTED|Overall Study||279
3200292|NCT02120027|3929212|FG000|COMPLETED|Overall Study||161
3200293|NCT02120027|3929213|FG001|COMPLETED|Overall Study||160
3200294|NCT02120027|3929212|FG000|NOT COMPLETED|Overall Study||116
3200295|NCT02120027|3929213|FG001|NOT COMPLETED|Overall Study||119
3200296|NCT02120157|3929219|FG000|STARTED|Overall Study||32
3200297|NCT02120157|3929219|FG000|Completed 180 Days|Overall Study||30
3200298|NCT02120157|3929219|FG000|COMPLETED|Overall Study||24
3200299|NCT02120157|3929219|FG000|NOT COMPLETED|Overall Study||8
3200300|NCT02120261|3929227|FG000|STARTED|Overall Study||23
3200301|NCT02120261|3929228|FG001|STARTED|Overall Study||25
3200302|NCT02120261|3929227|FG000|COMPLETED|Overall Study||23
3200303|NCT02120261|3929228|FG001|COMPLETED|Overall Study||25
3200304|NCT02120261|3929227|FG000|NOT COMPLETED|Overall Study||0
3200305|NCT02120261|3929228|FG001|NOT COMPLETED|Overall Study||0
3200306|NCT02120287|3929234|FG000|STARTED|Overall Study||16
3200307|NCT02120287|3929234|FG000|COMPLETED|Overall Study||16
3200308|NCT02120287|3929234|FG000|NOT COMPLETED|Overall Study||0
3200309|NCT02120300|3929242|FG000|STARTED|Overall Study||101
3200310|NCT02120300|3929243|FG001|STARTED|Overall Study||5
3200311|NCT02120300|3929244|FG002|STARTED|Overall Study||10
3200312|NCT02120300|3929245|FG003|STARTED|Overall Study||6
3200313|NCT02120300|3929242|FG000|COMPLETED|Overall Study||98
3200314|NCT02120300|3929243|FG001|COMPLETED|Overall Study||5
3200315|NCT02120300|3929244|FG002|COMPLETED|Overall Study||10
3200316|NCT02120300|3929245|FG003|COMPLETED|Overall Study||5
3200317|NCT02120300|3929242|FG000|NOT COMPLETED|Overall Study||3
3200318|NCT02120300|3929243|FG001|NOT COMPLETED|Overall Study||0
3200319|NCT02120300|3929244|FG002|NOT COMPLETED|Overall Study||0
3200320|NCT02120300|3929245|FG003|NOT COMPLETED|Overall Study||1
3200321|NCT02120352|3929257|FG000|STARTED|Induction Period (20 Weeks)||309
3200322|NCT02120352|3929258|FG001|STARTED|Induction Period (20 Weeks)||0
3200323|NCT02120352|3929259|FG002|STARTED|Induction Period (20 Weeks)||0
3200324|NCT02120352|3929260|FG003|STARTED|Induction Period (20 Weeks)||0
3200325|NCT02120352|3929257|FG000|COMPLETED|Induction Period (20 Weeks)||288
3200326|NCT02120352|3929258|FG001|COMPLETED|Induction Period (20 Weeks)||0
3200327|NCT02120352|3929259|FG002|COMPLETED|Induction Period (20 Weeks)||0
3200328|NCT02120352|3929260|FG003|COMPLETED|Induction Period (20 Weeks)||0
3200329|NCT02120352|3929257|FG000|NOT COMPLETED|Induction Period (20 Weeks)||21
3200330|NCT02120352|3929258|FG001|NOT COMPLETED|Induction Period (20 Weeks)||0
3200331|NCT02120352|3929259|FG002|NOT COMPLETED|Induction Period (20 Weeks)||0
3200332|NCT02120352|3929260|FG003|NOT COMPLETED|Induction Period (20 Weeks)||0
3200333|NCT02120352|3929257|FG000|STARTED|Maintenance Period (32 Weeks)||0
3200334|NCT02120352|3929258|FG001|STARTED|Maintenance Period (32 Weeks)||115
3200335|NCT02120352|3929259|FG002|STARTED|Maintenance Period (32 Weeks)||115
3200336|NCT02120352|3929260|FG003|STARTED|Maintenance Period (32 Weeks)||56
3200337|NCT02120352|3929257|FG000|COMPLETED|Maintenance Period (32 Weeks)||0
3200338|NCT02120352|3929258|FG001|COMPLETED|Maintenance Period (32 Weeks)||0
3200339|NCT02120352|3929259|FG002|COMPLETED|Maintenance Period (32 Weeks)||0
3200340|NCT02120352|3929260|FG003|COMPLETED|Maintenance Period (32 Weeks)||0
3200341|NCT02120352|3929257|FG000|NOT COMPLETED|Maintenance Period (32 Weeks)||0
3200342|NCT02120352|3929258|FG001|NOT COMPLETED|Maintenance Period (32 Weeks)||115
3200343|NCT02120352|3929259|FG002|NOT COMPLETED|Maintenance Period (32 Weeks)||115
3200344|NCT02120352|3929260|FG003|NOT COMPLETED|Maintenance Period (32 Weeks)||56
3200345|NCT02120417|3929276|FG000|STARTED|Overall Study||76
3200346|NCT02120417|3929277|FG001|STARTED|Overall Study||73
3200347|NCT02120417|3929276|FG000|COMPLETED|Overall Study||16
3200348|NCT02120417|3929277|FG001|COMPLETED|Overall Study||5
3200349|NCT02120417|3929276|FG000|NOT COMPLETED|Overall Study||60
3200350|NCT02120417|3929277|FG001|NOT COMPLETED|Overall Study||68
3200351|NCT02120443|3929283|FG000|STARTED|Overall Study||43
3200352|NCT02120443|3929283|FG000|COMPLETED|Overall Study||43
3200353|NCT02120443|3929283|FG000|NOT COMPLETED|Overall Study||0
3200354|NCT02120456|3929296|FG000|STARTED|Part 1 Open-label, Dose-escalation Phase||12
3200355|NCT02120456|3929297|FG001|STARTED|Part 1 Open-label, Dose-escalation Phase||12
3200356|NCT02120456|3929298|FG002|STARTED|Part 1 Open-label, Dose-escalation Phase||12
3200357|NCT02120456|3929299|FG003|STARTED|Part 1 Open-label, Dose-escalation Phase||12
3200358|NCT02120456|3929300|FG004|STARTED|Part 1 Open-label, Dose-escalation Phase||12
3200359|NCT02120456|3929301|FG005|STARTED|Part 1 Open-label, Dose-escalation Phase||9
3200360|NCT02120456|3929302|FG006|STARTED|Part 1 Open-label, Dose-escalation Phase||0
3200361|NCT02120456|3929303|FG007|STARTED|Part 1 Open-label, Dose-escalation Phase||0
3200362|NCT02120456|3929304|FG008|STARTED|Part 1 Open-label, Dose-escalation Phase||0
3200363|NCT02120456|3929296|FG000|COMPLETED|Part 1 Open-label, Dose-escalation Phase||12
3200364|NCT02120456|3929297|FG001|COMPLETED|Part 1 Open-label, Dose-escalation Phase||12
3200365|NCT02120456|3929298|FG002|COMPLETED|Part 1 Open-label, Dose-escalation Phase||12
3200366|NCT02120456|3929299|FG003|COMPLETED|Part 1 Open-label, Dose-escalation Phase||12
3200367|NCT02120456|3929300|FG004|COMPLETED|Part 1 Open-label, Dose-escalation Phase||12
3200368|NCT02120456|3929301|FG005|COMPLETED|Part 1 Open-label, Dose-escalation Phase||9
3200369|NCT02120456|3929302|FG006|COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
3200370|NCT02120456|3929303|FG007|COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
3200371|NCT02120456|3929304|FG008|COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
3200372|NCT02120456|3929296|FG000|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
3200373|NCT02120456|3929297|FG001|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
3200374|NCT02120456|3929298|FG002|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
3200375|NCT02120456|3929299|FG003|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
3200376|NCT02120456|3929300|FG004|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
3200377|NCT02120456|3929301|FG005|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
3200378|NCT02120456|3929302|FG006|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
3200379|NCT02120456|3929303|FG007|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
3200380|NCT02120456|3929304|FG008|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
3200381|NCT02120456|3929296|FG000|STARTED|Part 2 Double-blind Phase||0
3200382|NCT02120456|3929297|FG001|STARTED|Part 2 Double-blind Phase||0
3200383|NCT02120456|3929298|FG002|STARTED|Part 2 Double-blind Phase||0
3200384|NCT02120456|3929299|FG003|STARTED|Part 2 Double-blind Phase||0
3200385|NCT02120456|3929300|FG004|STARTED|Part 2 Double-blind Phase||0
3200386|NCT02120456|3929301|FG005|STARTED|Part 2 Double-blind Phase||0
3200387|NCT02120456|3929302|FG006|STARTED|Part 2 Double-blind Phase||32
3200388|NCT02120456|3929303|FG007|STARTED|Part 2 Double-blind Phase||60
3200389|NCT02120456|3929304|FG008|STARTED|Part 2 Double-blind Phase||63
3200390|NCT02120456|3929296|FG000|COMPLETED|Part 2 Double-blind Phase||0
3200391|NCT02120456|3929297|FG001|COMPLETED|Part 2 Double-blind Phase||0
3200392|NCT02120456|3929298|FG002|COMPLETED|Part 2 Double-blind Phase||0
3200393|NCT02120456|3929299|FG003|COMPLETED|Part 2 Double-blind Phase||0
3200394|NCT02120456|3929300|FG004|COMPLETED|Part 2 Double-blind Phase||0
3200395|NCT02120456|3929301|FG005|COMPLETED|Part 2 Double-blind Phase||0
3200396|NCT02120456|3929302|FG006|COMPLETED|Part 2 Double-blind Phase||30
3200397|NCT02120456|3929303|FG007|COMPLETED|Part 2 Double-blind Phase||60
3200398|NCT02120456|3929304|FG008|COMPLETED|Part 2 Double-blind Phase||62
3200399|NCT02120456|3929296|FG000|NOT COMPLETED|Part 2 Double-blind Phase||0
3200400|NCT02120456|3929297|FG001|NOT COMPLETED|Part 2 Double-blind Phase||0
3200401|NCT02120456|3929298|FG002|NOT COMPLETED|Part 2 Double-blind Phase||0
3200402|NCT02120456|3929299|FG003|NOT COMPLETED|Part 2 Double-blind Phase||0
3200403|NCT02120456|3929300|FG004|NOT COMPLETED|Part 2 Double-blind Phase||0
3200404|NCT02120456|3929301|FG005|NOT COMPLETED|Part 2 Double-blind Phase||0
3200405|NCT02120456|3929302|FG006|NOT COMPLETED|Part 2 Double-blind Phase||2
3200406|NCT02120456|3929303|FG007|NOT COMPLETED|Part 2 Double-blind Phase||0
3200407|NCT02120456|3929304|FG008|NOT COMPLETED|Part 2 Double-blind Phase||1
3200408|NCT02120625|3929324|FG000|STARTED|Overall Study||8
3200409|NCT02120625|3929324|FG000|COMPLETED|Overall Study||6
3200410|NCT02120625|3929324|FG000|NOT COMPLETED|Overall Study||2
3200411|NCT02120664|3929333|FG000|STARTED|Overall Study||10
3200412|NCT02120664|3929334|FG001|STARTED|Overall Study||4
3200413|NCT02120664|3929335|FG002|STARTED|Overall Study||7
3200414|NCT02120664|3929336|FG003|STARTED|Overall Study||4
3200415|NCT02120664|3929337|FG004|STARTED|Overall Study||10
3200416|NCT02120664|3929333|FG000|COMPLETED|Overall Study||10
3200417|NCT02120664|3929334|FG001|COMPLETED|Overall Study||4
3200418|NCT02120664|3929335|FG002|COMPLETED|Overall Study||7
3200419|NCT02120664|3929336|FG003|COMPLETED|Overall Study||3
3200420|NCT02120664|3929337|FG004|COMPLETED|Overall Study||10
3200421|NCT02120664|3929333|FG000|NOT COMPLETED|Overall Study||0
3200422|NCT02120664|3929334|FG001|NOT COMPLETED|Overall Study||0
3200423|NCT02120664|3929335|FG002|NOT COMPLETED|Overall Study||0
3200424|NCT02120664|3929336|FG003|NOT COMPLETED|Overall Study||1
3200425|NCT02120664|3929337|FG004|NOT COMPLETED|Overall Study||0
3200426|NCT02120716|3929352|FG000|STARTED|Overall Study||31
3200427|NCT02120716|3929353|FG001|STARTED|Overall Study||19
3200428|NCT02120716|3929352|FG000|COMPLETED|Overall Study||30
3200429|NCT02120716|3929353|FG001|COMPLETED|Overall Study||19
3200430|NCT02120716|3929352|FG000|NOT COMPLETED|Overall Study||1
3200431|NCT02120716|3929353|FG001|NOT COMPLETED|Overall Study||0
3200432|NCT02120781|3929361|FG000|STARTED|Overall Study||15
3200433|NCT02120781|3929362|FG001|STARTED|Overall Study||6
3200434|NCT02120781|3929361|FG000|COMPLETED|Overall Study||11
3200435|NCT02120781|3929362|FG001|COMPLETED|Overall Study||5
3200436|NCT02120781|3929361|FG000|NOT COMPLETED|Overall Study||4
3200437|NCT02120781|3929362|FG001|NOT COMPLETED|Overall Study||1
3200438|NCT02120794|3929368|FG000|STARTED|Overall Study||194
3200439|NCT02120794|3929368|FG000|COMPLETED|Overall Study||136
3200440|NCT02120794|3929368|FG000|NOT COMPLETED|Overall Study||58
3200441|NCT02120833|3929374|FG000|STARTED|Overall Study||39
3200442|NCT02120833|3929375|FG001|STARTED|Overall Study||12
3200443|NCT02120833|3929374|FG000|COMPLETED|Overall Study||35
3200444|NCT02120833|3929375|FG001|COMPLETED|Overall Study||11
3200445|NCT02120833|3929374|FG000|NOT COMPLETED|Overall Study||4
3200446|NCT02120833|3929375|FG001|NOT COMPLETED|Overall Study||1
3200447|NCT02120898|3929384|FG000|STARTED|Overall Study||187
3200448|NCT02120898|3929385|FG001|STARTED|Overall Study||187
3200449|NCT02120898|3929386|FG002|STARTED|Overall Study||93
3200450|NCT02120898|3929384|FG000|Safety Population|Overall Study||187
3200451|NCT02120898|3929385|FG001|Safety Population|Overall Study||187
3200452|NCT02120898|3929386|FG002|Safety Population|Overall Study||93
3200453|NCT02120898|3929384|FG000|Intent-to-Treat (ITT) Population|Overall Study||183
3200454|NCT02120898|3929385|FG001|Intent-to-Treat (ITT) Population|Overall Study||185
3200455|NCT02120898|3929386|FG002|Intent-to-Treat (ITT) Population|Overall Study||93
3200456|NCT02120898|3929384|FG000|COMPLETED|Overall Study||178
3200457|NCT02120898|3929385|FG001|COMPLETED|Overall Study||181
3200458|NCT02120898|3929386|FG002|COMPLETED|Overall Study||89
3200459|NCT02120898|3929384|FG000|NOT COMPLETED|Overall Study||9
3200460|NCT02120898|3929385|FG001|NOT COMPLETED|Overall Study||6
3200461|NCT02120898|3929386|FG002|NOT COMPLETED|Overall Study||4
3200462|NCT02120924|3929397|FG000|STARTED|Overall Study||404
3200463|NCT02120924|3929398|FG001|STARTED|Overall Study||403
3200464|NCT02120924|3929399|FG002|STARTED|Overall Study||202
3200465|NCT02120924|3929397|FG000|COMPLETED|Overall Study||362
3200466|NCT02120924|3929398|FG001|COMPLETED|Overall Study||357
3200467|NCT02120924|3929399|FG002|COMPLETED|Overall Study||173
3200468|NCT02120924|3929397|FG000|NOT COMPLETED|Overall Study||42
3200469|NCT02120924|3929398|FG001|NOT COMPLETED|Overall Study||46
3200470|NCT02120924|3929399|FG002|NOT COMPLETED|Overall Study||29
3200471|NCT02120950|3929410|FG000|STARTED|Overall Study||157
3200472|NCT02120950|3929411|FG001|STARTED|Overall Study||161
3200473|NCT02120950|3929412|FG002|STARTED|Overall Study||15
3200474|NCT02120950|3929410|FG000|COMPLETED|Overall Study|Completed Treatment (Week 96)|137
3200475|NCT02120950|3929411|FG001|COMPLETED|Overall Study|Completed Treatment (Week 96)|147
3200476|NCT02120950|3929412|FG002|COMPLETED|Overall Study||0
3200477|NCT02120950|3929410|FG000|NOT COMPLETED|Overall Study||20
3200478|NCT02120950|3929411|FG001|NOT COMPLETED|Overall Study||14
3200479|NCT02120950|3929412|FG002|NOT COMPLETED|Overall Study||15
3200480|NCT02121002|3929422|FG000|STARTED|Overall Study||392
3200481|NCT02121002|3929423|FG001|STARTED|Overall Study||393
3200482|NCT02121002|3929424|FG002|STARTED|Overall Study||391
3200483|NCT02121002|3929422|FG000|COMPLETED|Overall Study||385
3200484|NCT02121002|3929423|FG001|COMPLETED|Overall Study||389
3200485|NCT02121002|3929424|FG002|COMPLETED|Overall Study||381
3200486|NCT02121002|3929422|FG000|NOT COMPLETED|Overall Study||7
3200487|NCT02121002|3929423|FG001|NOT COMPLETED|Overall Study||4
3200488|NCT02121002|3929424|FG002|NOT COMPLETED|Overall Study||10
3200489|NCT02121041|3929434|FG000|STARTED|Overall Study||14
3200490|NCT02121041|3929435|FG001|STARTED|Overall Study||14
3200491|NCT02121041|3929434|FG000|COMPLETED|Overall Study||13
3200492|NCT02121041|3929435|FG001|COMPLETED|Overall Study||8
3200493|NCT02121041|3929434|FG000|NOT COMPLETED|Overall Study||1
3200494|NCT02121041|3929435|FG001|NOT COMPLETED|Overall Study||6
3200495|NCT02121067|3929441|FG000|STARTED|Overall Study||50
3200496|NCT02121067|3929441|FG000|COMPLETED|Overall Study||50
3200497|NCT02121067|3929441|FG000|NOT COMPLETED|Overall Study||0
3200498|NCT02121210|3929448|FG000|STARTED|Overall Study||65
3200499|NCT02121210|3929449|FG001|STARTED|Overall Study||67
3200500|NCT02121210|3929448|FG000|COMPLETED|Overall Study||58
3200501|NCT02121210|3929449|FG001|COMPLETED|Overall Study||58
3200502|NCT02121210|3929448|FG000|NOT COMPLETED|Overall Study||7
3200503|NCT02121210|3929449|FG001|NOT COMPLETED|Overall Study||9
3200504|NCT02121262|3929457|FG000|STARTED|Overall Study||139
3200505|NCT02121262|3929458|FG001|STARTED|Overall Study||145
3200506|NCT02121262|3929457|FG000|Treated|Overall Study||129
3200507|NCT02121262|3929458|FG001|Treated|Overall Study||145
3200508|NCT02121262|3929457|FG000|Modified Intent-to-treat Population|Overall Study||127
3200509|NCT02121262|3929458|FG001|Modified Intent-to-treat Population|Overall Study||145
3200510|NCT02121262|3929457|FG000|COMPLETED|Overall Study||108
3200511|NCT02121262|3929458|FG001|COMPLETED|Overall Study||135
3200512|NCT02121262|3929457|FG000|NOT COMPLETED|Overall Study||31
3200513|NCT02121262|3929458|FG001|NOT COMPLETED|Overall Study||10
3200514|NCT02121301|3929467|FG000|STARTED|Overall Study||30
3200515|NCT02121301|3929468|FG001|STARTED|Overall Study||30
3200516|NCT02121301|3929469|FG002|STARTED|Overall Study||31
3200517|NCT02121301|3929467|FG000|COMPLETED|Overall Study||29
3200518|NCT02121301|3929468|FG001|COMPLETED|Overall Study||26
3200519|NCT02121301|3929469|FG002|COMPLETED|Overall Study||30
3200520|NCT02121301|3929467|FG000|NOT COMPLETED|Overall Study||1
3200521|NCT02121301|3929468|FG001|NOT COMPLETED|Overall Study||4
3200522|NCT02121301|3929469|FG002|NOT COMPLETED|Overall Study||1
3200523|NCT02121392|3929479|FG000|STARTED|Prior to Intervention||83
3200524|NCT02121392|3929480|FG001|STARTED|Prior to Intervention||82
3200525|NCT02121392|3929479|FG000|COMPLETED|Prior to Intervention||35
3200526|NCT02121392|3929480|FG001|COMPLETED|Prior to Intervention||41
3200527|NCT02121392|3929479|FG000|NOT COMPLETED|Prior to Intervention||48
3200528|NCT02121392|3929480|FG001|NOT COMPLETED|Prior to Intervention||41
3200529|NCT02121392|3929479|FG000|STARTED|After Placement of AC Block vs Sham||35
3200530|NCT02121392|3929480|FG001|STARTED|After Placement of AC Block vs Sham||41
3200531|NCT02121392|3929479|FG000|COMPLETED|After Placement of AC Block vs Sham||32
3200532|NCT02121392|3929480|FG001|COMPLETED|After Placement of AC Block vs Sham||38
3200533|NCT02121392|3929479|FG000|NOT COMPLETED|After Placement of AC Block vs Sham||3
3200534|NCT02121392|3929480|FG001|NOT COMPLETED|After Placement of AC Block vs Sham||3
3200535|NCT02121418|3929486|FG000|STARTED|Overall Study||12
3200536|NCT02121418|3929486|FG000|COMPLETED|Overall Study||12
3200537|NCT02121418|3929486|FG000|NOT COMPLETED|Overall Study||0
3200538|NCT02121483|3929493|FG000|STARTED|Overall Study||9
3200539|NCT02121483|3929494|FG001|STARTED|Overall Study||8
3200540|NCT02121483|3929495|FG002|STARTED|Overall Study||10
3200541|NCT02121483|3929493|FG000|COMPLETED|Overall Study||9
3200542|NCT02121483|3929494|FG001|COMPLETED|Overall Study||8
3200543|NCT02121483|3929495|FG002|COMPLETED|Overall Study||10
3200544|NCT02121483|3929493|FG000|NOT COMPLETED|Overall Study||0
3200545|NCT02121483|3929494|FG001|NOT COMPLETED|Overall Study||0
3200546|NCT02121483|3929495|FG002|NOT COMPLETED|Overall Study||0
3200547|NCT02121509|3929505|FG000|STARTED|Treatment Period-1 (4 Days)||30
3200548|NCT02121509|3929506|FG001|STARTED|Treatment Period-1 (4 Days)||28
3200549|NCT02121509|3929507|FG002|STARTED|Treatment Period-1 (4 Days)||8
3200550|NCT02121509|3929508|FG003|STARTED|Treatment Period-1 (4 Days)||8
3200551|NCT02121509|3929505|FG000|COMPLETED|Treatment Period-1 (4 Days)||30
3200552|NCT02121509|3929506|FG001|COMPLETED|Treatment Period-1 (4 Days)||28
3200553|NCT02121509|3929507|FG002|COMPLETED|Treatment Period-1 (4 Days)||8
3200554|NCT02121509|3929508|FG003|COMPLETED|Treatment Period-1 (4 Days)||8
3200555|NCT02121509|3929505|FG000|NOT COMPLETED|Treatment Period-1 (4 Days)||0
3200556|NCT02121509|3929506|FG001|NOT COMPLETED|Treatment Period-1 (4 Days)||0
3200557|NCT02121509|3929507|FG002|NOT COMPLETED|Treatment Period-1 (4 Days)||0
3200558|NCT02121509|3929508|FG003|NOT COMPLETED|Treatment Period-1 (4 Days)||0
3200559|NCT02121509|3929505|FG000|STARTED|Washout Period (35 Days)||30
3200560|NCT02121509|3929506|FG001|STARTED|Washout Period (35 Days)||28
3200561|NCT02121509|3929507|FG002|STARTED|Washout Period (35 Days)||8
3200562|NCT02121509|3929508|FG003|STARTED|Washout Period (35 Days)||8
3200563|NCT02121509|3929505|FG000|COMPLETED|Washout Period (35 Days)||28
3200564|NCT02121509|3929506|FG001|COMPLETED|Washout Period (35 Days)||24
3200565|NCT02121509|3929507|FG002|COMPLETED|Washout Period (35 Days)||8
3200566|NCT02121509|3929508|FG003|COMPLETED|Washout Period (35 Days)||8
3200567|NCT02121509|3929505|FG000|NOT COMPLETED|Washout Period (35 Days)||2
3200568|NCT02121509|3929506|FG001|NOT COMPLETED|Washout Period (35 Days)||4
3200569|NCT02121509|3929507|FG002|NOT COMPLETED|Washout Period (35 Days)||0
3200570|NCT02121509|3929508|FG003|NOT COMPLETED|Washout Period (35 Days)||0
3200571|NCT02121509|3929505|FG000|STARTED|Treatment Period-2 (4 Days)||28
3200572|NCT02121509|3929506|FG001|STARTED|Treatment Period-2 (4 Days)||24
3200573|NCT02121509|3929507|FG002|STARTED|Treatment Period-2 (4 Days)||8
3200574|NCT02121509|3929508|FG003|STARTED|Treatment Period-2 (4 Days)||8
3200575|NCT02121509|3929505|FG000|COMPLETED|Treatment Period-2 (4 Days)||28
3200576|NCT02121509|3929506|FG001|COMPLETED|Treatment Period-2 (4 Days)||24
3200577|NCT02121509|3929507|FG002|COMPLETED|Treatment Period-2 (4 Days)||8
3200578|NCT02121509|3929508|FG003|COMPLETED|Treatment Period-2 (4 Days)||8
3200579|NCT02121509|3929505|FG000|NOT COMPLETED|Treatment Period-2 (4 Days)||0
3200580|NCT02121509|3929506|FG001|NOT COMPLETED|Treatment Period-2 (4 Days)||0
3200581|NCT02121509|3929507|FG002|NOT COMPLETED|Treatment Period-2 (4 Days)||0
3200582|NCT02121509|3929508|FG003|NOT COMPLETED|Treatment Period-2 (4 Days)||0
3200583|NCT02121522|3929518|FG000|STARTED|Overall Study||14
3200584|NCT02121522|3929518|FG000|COMPLETED|Overall Study||13
3200585|NCT02121522|3929518|FG000|NOT COMPLETED|Overall Study||1
3200586|NCT02121535|3929524|FG000|STARTED|Period 1 (8 Trial Days)||36
3200587|NCT02121535|3929525|FG001|STARTED|Period 1 (8 Trial Days)||36
3200588|NCT02121535|3929524|FG000|COMPLETED|Period 1 (8 Trial Days)||36
3200589|NCT02121535|3929525|FG001|COMPLETED|Period 1 (8 Trial Days)|1 subject withdrew his consent during the washout period between Period 1 and 2.|35
3200590|NCT02121535|3929524|FG000|NOT COMPLETED|Period 1 (8 Trial Days)||0
3200591|NCT02121535|3929525|FG001|NOT COMPLETED|Period 1 (8 Trial Days)||1
3200592|NCT02121535|3929524|FG000|STARTED|Period 2 (8 Trial Days)||36
3200593|NCT02121535|3929525|FG001|STARTED|Period 2 (8 Trial Days)||35
3200594|NCT02121535|3929524|FG000|COMPLETED|Period 2 (8 Trial Days)||36
3200595|NCT02121535|3929525|FG001|COMPLETED|Period 2 (8 Trial Days)||35
3200596|NCT02121535|3929524|FG000|NOT COMPLETED|Period 2 (8 Trial Days)||0
3200597|NCT02121535|3929525|FG001|NOT COMPLETED|Period 2 (8 Trial Days)||0
3200598|NCT02121535|3929524|FG000|STARTED|Period 3 (8 Trial Days)||36
3200599|NCT02121535|3929525|FG001|STARTED|Period 3 (8 Trial Days)||35
3200600|NCT02121535|3929524|FG000|COMPLETED|Period 3 (8 Trial Days)|1 subject withdrew consent during the washout period between Period 3 and 4.|35
3200601|NCT02121535|3929525|FG001|COMPLETED|Period 3 (8 Trial Days)||35
3200602|NCT02121535|3929524|FG000|NOT COMPLETED|Period 3 (8 Trial Days)||1
3200603|NCT02121535|3929525|FG001|NOT COMPLETED|Period 3 (8 Trial Days)||0
3200604|NCT02121535|3929524|FG000|STARTED|Period 4 (8 Trial Days)||35
3200605|NCT02121535|3929525|FG001|STARTED|Period 4 (8 Trial Days)||35
3200606|NCT02121535|3929524|FG000|COMPLETED|Period 4 (8 Trial Days)||35
3200607|NCT02121535|3929525|FG001|COMPLETED|Period 4 (8 Trial Days)||35
3200608|NCT02121535|3929524|FG000|NOT COMPLETED|Period 4 (8 Trial Days)||0
3200609|NCT02121535|3929525|FG001|NOT COMPLETED|Period 4 (8 Trial Days)||0
3200610|NCT02121756|3929534|FG000|STARTED|Overall Study||21
3200611|NCT02121756|3929535|FG001|STARTED|Overall Study||19
3200612|NCT02121756|3929534|FG000|COMPLETED|Overall Study||15
3200613|NCT02121756|3929535|FG001|COMPLETED|Overall Study||17
3200614|NCT02121756|3929534|FG000|NOT COMPLETED|Overall Study||6
3200615|NCT02121756|3929535|FG001|NOT COMPLETED|Overall Study||2
3200616|NCT02121795|3929546|FG000|STARTED|Double-Blind Phase||334
3200617|NCT02121795|3929547|FG001|STARTED|Double-Blind Phase||334
3200618|NCT02121795|3929546|FG000|Safety Analysis Set|Double-Blind Phase||333
3200619|NCT02121795|3929547|FG001|Safety Analysis Set|Double-Blind Phase||330
3200620|NCT02121795|3929546|FG000|COMPLETED|Double-Blind Phase||296
3200621|NCT02121795|3929547|FG001|COMPLETED|Double-Blind Phase||300
3200622|NCT02121795|3929546|FG000|NOT COMPLETED|Double-Blind Phase||38
3200623|NCT02121795|3929547|FG001|NOT COMPLETED|Double-Blind Phase||34
3200624|NCT02121795|3929546|FG000|STARTED|Open-Label Phase|Not all participants entered the Open-Label Phase.|33
3200625|NCT02121795|3929547|FG001|STARTED|Open-Label Phase|Not all participants entered the Open-Label Phase.|31
3200626|NCT02121795|3929546|FG000|COMPLETED|Open-Label Phase||21
3200627|NCT02121795|3929547|FG001|COMPLETED|Open-Label Phase||21
3200628|NCT02121795|3929546|FG000|NOT COMPLETED|Open-Label Phase||12
3200629|NCT02121795|3929547|FG001|NOT COMPLETED|Open-Label Phase||10
3200630|NCT02121808|3929555|FG000|STARTED|Overall Study||20
3200631|NCT02121808|3929555|FG000|COMPLETED|Overall Study||17
3200632|NCT02121808|3929555|FG000|NOT COMPLETED|Overall Study||3
3200633|NCT02121834|3929571|FG000|STARTED|Overall Study||12
3200634|NCT02121834|3929572|FG001|STARTED|Overall Study||11
3200635|NCT02121834|3929573|FG002|STARTED|Overall Study||9
3200636|NCT02121834|3929574|FG003|STARTED|Overall Study||10
3200637|NCT02121834|3929575|FG004|STARTED|Overall Study||9
3200638|NCT02121834|3929576|FG005|STARTED|Overall Study||9
3200639|NCT02121834|3929577|FG006|STARTED|Overall Study||3
3200640|NCT02121834|3929571|FG000|Received at Least One Dose of Study Drug|Overall Study||12
3200641|NCT02121834|3929572|FG001|Received at Least One Dose of Study Drug|Overall Study||11
3200642|NCT02121834|3929573|FG002|Received at Least One Dose of Study Drug|Overall Study||9
3200643|NCT02121834|3929574|FG003|Received at Least One Dose of Study Drug|Overall Study||10
3200644|NCT02121834|3929575|FG004|Received at Least One Dose of Study Drug|Overall Study||9
3200645|NCT02121834|3929576|FG005|Received at Least One Dose of Study Drug|Overall Study||9
3200646|NCT02121834|3929577|FG006|Received at Least One Dose of Study Drug|Overall Study||3
3200647|NCT02121834|3929571|FG000|COMPLETED|Overall Study||12
3200648|NCT02121834|3929572|FG001|COMPLETED|Overall Study||9
3200649|NCT02121834|3929573|FG002|COMPLETED|Overall Study||7
3200650|NCT02121834|3929574|FG003|COMPLETED|Overall Study||10
3200651|NCT02121834|3929575|FG004|COMPLETED|Overall Study||9
3200652|NCT02121834|3929576|FG005|COMPLETED|Overall Study||9
3200653|NCT02121834|3929577|FG006|COMPLETED|Overall Study||3
3200654|NCT02121834|3929571|FG000|NOT COMPLETED|Overall Study||0
3200655|NCT02121834|3929572|FG001|NOT COMPLETED|Overall Study||2
3200656|NCT02121834|3929573|FG002|NOT COMPLETED|Overall Study||2
3200657|NCT02121834|3929574|FG003|NOT COMPLETED|Overall Study||0
3200658|NCT02121834|3929575|FG004|NOT COMPLETED|Overall Study||0
3200659|NCT02121834|3929576|FG005|NOT COMPLETED|Overall Study||0
3200660|NCT02121834|3929577|FG006|NOT COMPLETED|Overall Study||0
3200661|NCT02121847|3929603|FG000|STARTED|Overall Study||40
3200662|NCT02121847|3929603|FG000|COMPLETED|Overall Study||37
3200663|NCT02121847|3929603|FG000|NOT COMPLETED|Overall Study||3
3200664|NCT02121860|3929611|FG000|STARTED|Overall Study||8
3200665|NCT02121860|3929612|FG001|STARTED|Overall Study||12
3200666|NCT02121860|3929613|FG002|STARTED|Overall Study||8
3200667|NCT02121860|3929614|FG003|STARTED|Overall Study||8
3200668|NCT02121860|3929611|FG000|COMPLETED|Overall Study||8
3200669|NCT02121860|3929612|FG001|COMPLETED|Overall Study||12
3200670|NCT02121860|3929613|FG002|COMPLETED|Overall Study||8
3200671|NCT02121860|3929614|FG003|COMPLETED|Overall Study||8
3200672|NCT02121860|3929611|FG000|NOT COMPLETED|Overall Study||0
3200673|NCT02121860|3929612|FG001|NOT COMPLETED|Overall Study||0
3200674|NCT02121860|3929613|FG002|NOT COMPLETED|Overall Study||0
3200675|NCT02121860|3929614|FG003|NOT COMPLETED|Overall Study||0
3200676|NCT02121912|3929623|FG000|STARTED|Overall Study||25
3200677|NCT02121912|3929624|FG001|STARTED|Overall Study||25
3200678|NCT02121912|3929623|FG000|COMPLETED|Overall Study||21
3200679|NCT02121912|3929624|FG001|COMPLETED|Overall Study||25
3200680|NCT02121912|3929623|FG000|NOT COMPLETED|Overall Study||4
3200681|NCT02121912|3929624|FG001|NOT COMPLETED|Overall Study||0
3200682|NCT02122146|3929638|FG000|STARTED|Part 1: Dose Escalation||2
3200683|NCT02122146|3929639|FG001|STARTED|Part 1: Dose Escalation||2
3200684|NCT02122146|3929640|FG002|STARTED|Part 1: Dose Escalation||4
3200685|NCT02122146|3929641|FG003|STARTED|Part 1: Dose Escalation||4
3200686|NCT02122146|3929642|FG004|STARTED|Part 1: Dose Escalation||4
3200687|NCT02122146|3929643|FG005|STARTED|Part 1: Dose Escalation||6
3200688|NCT02122146|3929644|FG006|STARTED|Part 1: Dose Escalation||1
3200689|NCT02122146|3929645|FG007|STARTED|Part 1: Dose Escalation||8
3200690|NCT02122146|3929638|FG000|COMPLETED|Part 1: Dose Escalation||1
3200691|NCT02122146|3929639|FG001|COMPLETED|Part 1: Dose Escalation||1
3200692|NCT02122146|3929640|FG002|COMPLETED|Part 1: Dose Escalation||2
3200693|NCT02122146|3929641|FG003|COMPLETED|Part 1: Dose Escalation||3
3200694|NCT02122146|3929642|FG004|COMPLETED|Part 1: Dose Escalation||3
3200695|NCT02122146|3929643|FG005|COMPLETED|Part 1: Dose Escalation||5
3200696|NCT02122146|3929644|FG006|COMPLETED|Part 1: Dose Escalation||0
3200697|NCT02122146|3929645|FG007|COMPLETED|Part 1: Dose Escalation||6
3200698|NCT02122146|3929638|FG000|NOT COMPLETED|Part 1: Dose Escalation||1
3200699|NCT02122146|3929639|FG001|NOT COMPLETED|Part 1: Dose Escalation||1
3200700|NCT02122146|3929640|FG002|NOT COMPLETED|Part 1: Dose Escalation||2
3200701|NCT02122146|3929641|FG003|NOT COMPLETED|Part 1: Dose Escalation||1
3200702|NCT02122146|3929642|FG004|NOT COMPLETED|Part 1: Dose Escalation||1
3200703|NCT02122146|3929643|FG005|NOT COMPLETED|Part 1: Dose Escalation||1
3200704|NCT02122146|3929644|FG006|NOT COMPLETED|Part 1: Dose Escalation||1
3200705|NCT02122146|3929645|FG007|NOT COMPLETED|Part 1: Dose Escalation||2
3200706|NCT02122146|3929638|FG000|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
3200707|NCT02122146|3929639|FG001|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
3200708|NCT02122146|3929640|FG002|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
3200709|NCT02122146|3929641|FG003|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
3200710|NCT02122146|3929642|FG004|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
3200711|NCT02122146|3929643|FG005|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
3365120|NCT03995784|4096182|FG000|NOT COMPLETED|Overall Study||1
3200712|NCT02122146|3929644|FG006|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
3200713|NCT02122146|3929645|FG007|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
3200714|NCT02122146|3929638|FG000|COMPLETED|Part 2: Maximum Tolerated Dose||0
3200715|NCT02122146|3929639|FG001|COMPLETED|Part 2: Maximum Tolerated Dose||0
3200716|NCT02122146|3929640|FG002|COMPLETED|Part 2: Maximum Tolerated Dose||0
3200717|NCT02122146|3929641|FG003|COMPLETED|Part 2: Maximum Tolerated Dose||0
3200718|NCT02122146|3929642|FG004|COMPLETED|Part 2: Maximum Tolerated Dose||0
3200719|NCT02122146|3929643|FG005|COMPLETED|Part 2: Maximum Tolerated Dose||0
3200720|NCT02122146|3929644|FG006|COMPLETED|Part 2: Maximum Tolerated Dose||0
3200721|NCT02122146|3929645|FG007|COMPLETED|Part 2: Maximum Tolerated Dose||0
3200722|NCT02122146|3929638|FG000|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
3200723|NCT02122146|3929639|FG001|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
3200724|NCT02122146|3929640|FG002|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
3200725|NCT02122146|3929641|FG003|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
3200726|NCT02122146|3929642|FG004|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
3200727|NCT02122146|3929643|FG005|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
3200728|NCT02122146|3929644|FG006|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
3200729|NCT02122146|3929645|FG007|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
3200730|NCT02122146|3929638|FG000|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
3200731|NCT02122146|3929639|FG001|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
3200732|NCT02122146|3929640|FG002|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
3200733|NCT02122146|3929641|FG003|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
3200734|NCT02122146|3929642|FG004|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
3200735|NCT02122146|3929643|FG005|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
3200736|NCT02122146|3929644|FG006|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
3200737|NCT02122146|3929645|FG007|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
3200738|NCT02122146|3929638|FG000|COMPLETED|Part 3: Expansion||0
3200739|NCT02122146|3929639|FG001|COMPLETED|Part 3: Expansion||0
3200740|NCT02122146|3929640|FG002|COMPLETED|Part 3: Expansion||0
3200741|NCT02122146|3929641|FG003|COMPLETED|Part 3: Expansion||0
3200742|NCT02122146|3929642|FG004|COMPLETED|Part 3: Expansion||0
3200743|NCT02122146|3929643|FG005|COMPLETED|Part 3: Expansion||0
3200744|NCT02122146|3929644|FG006|COMPLETED|Part 3: Expansion||0
3200745|NCT02122146|3929645|FG007|COMPLETED|Part 3: Expansion||0
3200746|NCT02122146|3929638|FG000|NOT COMPLETED|Part 3: Expansion||0
3200747|NCT02122146|3929639|FG001|NOT COMPLETED|Part 3: Expansion||0
3200748|NCT02122146|3929640|FG002|NOT COMPLETED|Part 3: Expansion||0
3200749|NCT02122146|3929641|FG003|NOT COMPLETED|Part 3: Expansion||0
3200750|NCT02122146|3929642|FG004|NOT COMPLETED|Part 3: Expansion||0
3200751|NCT02122146|3929643|FG005|NOT COMPLETED|Part 3: Expansion||0
3200752|NCT02122146|3929644|FG006|NOT COMPLETED|Part 3: Expansion||0
3200753|NCT02122146|3929645|FG007|NOT COMPLETED|Part 3: Expansion||0
3200754|NCT02122341|3929666|FG000|STARTED|Overall Study||17
3200755|NCT02122341|3929667|FG001|STARTED|Overall Study||18
3200756|NCT02122341|3929666|FG000|COMPLETED|Overall Study||17
3200757|NCT02122341|3929667|FG001|COMPLETED|Overall Study||18
3200758|NCT02122341|3929666|FG000|NOT COMPLETED|Overall Study||0
3200759|NCT02122341|3929667|FG001|NOT COMPLETED|Overall Study||0
3200760|NCT02122380|3929675|FG000|STARTED|First Intervention (30 Days)||11
3200761|NCT02122380|3929676|FG001|STARTED|First Intervention (30 Days)||12
3200762|NCT02122380|3929675|FG000|COMPLETED|First Intervention (30 Days)||10
3200763|NCT02122380|3929676|FG001|COMPLETED|First Intervention (30 Days)||11
3200764|NCT02122380|3929675|FG000|NOT COMPLETED|First Intervention (30 Days)||1
3200765|NCT02122380|3929676|FG001|NOT COMPLETED|First Intervention (30 Days)||1
3200766|NCT02122380|3929675|FG000|STARTED|Washout (8 Weeks)||10
3200767|NCT02122380|3929676|FG001|STARTED|Washout (8 Weeks)||11
3200768|NCT02122380|3929675|FG000|COMPLETED|Washout (8 Weeks)||9
3200769|NCT02122380|3929676|FG001|COMPLETED|Washout (8 Weeks)||9
3200770|NCT02122380|3929675|FG000|NOT COMPLETED|Washout (8 Weeks)||1
3200771|NCT02122380|3929676|FG001|NOT COMPLETED|Washout (8 Weeks)||2
3200772|NCT02122380|3929675|FG000|STARTED|Second Intervention (30 Days)||9
3200773|NCT02122380|3929676|FG001|STARTED|Second Intervention (30 Days)||9
3200774|NCT02122380|3929675|FG000|COMPLETED|Second Intervention (30 Days)||9
3200775|NCT02122380|3929676|FG001|COMPLETED|Second Intervention (30 Days)||7
3200776|NCT02122380|3929675|FG000|NOT COMPLETED|Second Intervention (30 Days)||0
3200777|NCT02122380|3929676|FG001|NOT COMPLETED|Second Intervention (30 Days)||2
3200778|NCT02122406|3929683|FG000|STARTED|Overall Study||200
3200779|NCT02122406|3929683|FG000|COMPLETED|Overall Study||200
3200780|NCT02122406|3929683|FG000|NOT COMPLETED|Overall Study||0
3200781|NCT02122445|3929687|FG000|STARTED|Overall Study||20
3200782|NCT02122445|3929687|FG000|COMPLETED|Overall Study||20
3200783|NCT02122445|3929687|FG000|NOT COMPLETED|Overall Study||0
3200784|NCT02122471|3929694|FG000|STARTED|Overall Study||445
3200785|NCT02122471|3929695|FG001|STARTED|Overall Study||443
3200786|NCT02122471|3929696|FG002|STARTED|Overall Study||449
3200787|NCT02122471|3929694|FG000|COMPLETED|Overall Study||406
3200788|NCT02122471|3929695|FG001|COMPLETED|Overall Study||392
3200789|NCT02122471|3929696|FG002|COMPLETED|Overall Study||405
3200790|NCT02122471|3929694|FG000|NOT COMPLETED|Overall Study||39
3200791|NCT02122471|3929695|FG001|NOT COMPLETED|Overall Study||51
3200792|NCT02122471|3929696|FG002|NOT COMPLETED|Overall Study||44
3200793|NCT02122549|3929705|FG000|STARTED|Overall Study||59
3200794|NCT02122549|3929705|FG000|COMPLETED|Overall Study||59
3200795|NCT02122549|3929705|FG000|NOT COMPLETED|Overall Study||0
3200796|NCT02122770|3929713|FG000|STARTED|Part A: Drug-drug Interaction 2||13
3200797|NCT02122770|3929714|FG001|STARTED|Part A: Drug-drug Interaction 2||13
3200798|NCT02122770|3929715|FG002|STARTED|Part A: Drug-drug Interaction 2||6
3200799|NCT02122770|3929716|FG003|STARTED|Part A: Drug-drug Interaction 2||19
3200800|NCT02122770|3929717|FG004|STARTED|Part A: Drug-drug Interaction 2||0
3200801|NCT02122770|3929718|FG005|STARTED|Part A: Drug-drug Interaction 2||0
3200802|NCT02122770|3929713|FG000|COMPLETED|Part A: Drug-drug Interaction 2||9
3200803|NCT02122770|3929714|FG001|COMPLETED|Part A: Drug-drug Interaction 2||7
3200804|NCT02122770|3929715|FG002|COMPLETED|Part A: Drug-drug Interaction 2||4
3200805|NCT02122770|3929716|FG003|COMPLETED|Part A: Drug-drug Interaction 2||16
3200806|NCT02122770|3929717|FG004|COMPLETED|Part A: Drug-drug Interaction 2||0
3200807|NCT02122770|3929718|FG005|COMPLETED|Part A: Drug-drug Interaction 2||0
3200808|NCT02122770|3929713|FG000|NOT COMPLETED|Part A: Drug-drug Interaction 2||4
3200809|NCT02122770|3929714|FG001|NOT COMPLETED|Part A: Drug-drug Interaction 2||6
3200810|NCT02122770|3929715|FG002|NOT COMPLETED|Part A: Drug-drug Interaction 2||2
3200811|NCT02122770|3929716|FG003|NOT COMPLETED|Part A: Drug-drug Interaction 2||3
3200812|NCT02122770|3929717|FG004|NOT COMPLETED|Part A: Drug-drug Interaction 2||0
3200813|NCT02122770|3929718|FG005|NOT COMPLETED|Part A: Drug-drug Interaction 2||0
3200814|NCT02122770|3929713|FG000|STARTED|Part B: Standard of Care||0
3200815|NCT02122770|3929714|FG001|STARTED|Part B: Standard of Care||0
3200816|NCT02122770|3929715|FG002|STARTED|Part B: Standard of Care||0
3200817|NCT02122770|3929716|FG003|STARTED|Part B: Standard of Care||0
3200818|NCT02122770|3929717|FG004|STARTED|Part B: Standard of Care||23
3200819|NCT02122770|3929718|FG005|STARTED|Part B: Standard of Care||13
3200820|NCT02122770|3929713|FG000|COMPLETED|Part B: Standard of Care||0
3200821|NCT02122770|3929714|FG001|COMPLETED|Part B: Standard of Care||0
3200822|NCT02122770|3929715|FG002|COMPLETED|Part B: Standard of Care||0
3200823|NCT02122770|3929716|FG003|COMPLETED|Part B: Standard of Care||0
3200824|NCT02122770|3929717|FG004|COMPLETED|Part B: Standard of Care||0
3200825|NCT02122770|3929718|FG005|COMPLETED|Part B: Standard of Care||0
3200826|NCT02122770|3929713|FG000|NOT COMPLETED|Part B: Standard of Care||0
3200827|NCT02122770|3929714|FG001|NOT COMPLETED|Part B: Standard of Care||0
3200828|NCT02122770|3929715|FG002|NOT COMPLETED|Part B: Standard of Care||0
3200829|NCT02122770|3929716|FG003|NOT COMPLETED|Part B: Standard of Care||0
3200830|NCT02122770|3929717|FG004|NOT COMPLETED|Part B: Standard of Care||23
3200831|NCT02122770|3929718|FG005|NOT COMPLETED|Part B: Standard of Care||13
3200832|NCT02122783|3929743|FG000|STARTED|Overall Study||2
3200833|NCT02122783|3929744|FG001|STARTED|Overall Study||3
3200834|NCT02122783|3929743|FG000|COMPLETED|Overall Study||2
3200835|NCT02122783|3929744|FG001|COMPLETED|Overall Study||2
3200836|NCT02122783|3929743|FG000|NOT COMPLETED|Overall Study||0
3200837|NCT02122783|3929744|FG001|NOT COMPLETED|Overall Study||1
3200838|NCT02122796|3929755|FG000|STARTED|Visit 1||15
3200839|NCT02122796|3929756|FG001|STARTED|Visit 1||15
3200840|NCT02122796|3929755|FG000|COMPLETED|Visit 1||15
3200841|NCT02122796|3929756|FG001|COMPLETED|Visit 1||15
3200842|NCT02122796|3929755|FG000|NOT COMPLETED|Visit 1||0
3200843|NCT02122796|3929756|FG001|NOT COMPLETED|Visit 1||0
3200844|NCT02122796|3929755|FG000|STARTED|Visit 2||15
3200845|NCT02122796|3929756|FG001|STARTED|Visit 2||15
3200846|NCT02122796|3929755|FG000|COMPLETED|Visit 2||12
3200847|NCT02122796|3929756|FG001|COMPLETED|Visit 2||14
3200848|NCT02122796|3929755|FG000|NOT COMPLETED|Visit 2||3
3200849|NCT02122796|3929756|FG001|NOT COMPLETED|Visit 2||1
3200850|NCT02122887|3929765|FG000|STARTED|Overall Study||60
3200851|NCT02122887|3929766|FG001|STARTED|Overall Study||41
3200852|NCT02122887|3929765|FG000|COMPLETED|Overall Study||40
3200853|NCT02122887|3929766|FG001|COMPLETED|Overall Study||39
3200854|NCT02122887|3929765|FG000|NOT COMPLETED|Overall Study||20
3200855|NCT02122887|3929766|FG001|NOT COMPLETED|Overall Study||2
3200856|NCT02122952|3929774|FG000|STARTED|Overall Study||3
3200857|NCT02122952|3929775|FG001|STARTED|Overall Study||12
3200858|NCT02122952|3929774|FG000|COMPLETED|Overall Study||3
3200859|NCT02122952|3929775|FG001|COMPLETED|Overall Study||12
3200860|NCT02122952|3929774|FG000|NOT COMPLETED|Overall Study||0
3200861|NCT02122952|3929775|FG001|NOT COMPLETED|Overall Study||0
3200862|NCT02123017|3929784|FG000|STARTED|Overall Study||8
3200863|NCT02123017|3929785|FG001|STARTED|Overall Study||12
3200864|NCT02123017|3929786|FG002|STARTED|Overall Study||12
3200865|NCT02123017|3929784|FG000|COMPLETED|Overall Study||8
3200866|NCT02123017|3929785|FG001|COMPLETED|Overall Study||12
3200867|NCT02123017|3929786|FG002|COMPLETED|Overall Study||12
3200868|NCT02123017|3929784|FG000|NOT COMPLETED|Overall Study||0
3200869|NCT02123017|3929785|FG001|NOT COMPLETED|Overall Study||0
3200870|NCT02123017|3929786|FG002|NOT COMPLETED|Overall Study||0
3200871|NCT02123134|3929796|FG000|STARTED|Overall Study||28
3200872|NCT02123134|3929797|FG001|STARTED|Overall Study||27
3200873|NCT02123134|3929796|FG000|COMPLETED|Overall Study||25
3200874|NCT02123134|3929797|FG001|COMPLETED|Overall Study||24
3200875|NCT02123134|3929796|FG000|NOT COMPLETED|Overall Study||3
3200876|NCT02123134|3929797|FG001|NOT COMPLETED|Overall Study||3
3200877|NCT02123251|3929805|FG000|STARTED|Overall Study||159
3200878|NCT02123251|3929806|FG001|STARTED|Overall Study||161
3200879|NCT02123251|3929805|FG000|COMPLETED|Overall Study||125
3200880|NCT02123251|3929806|FG001|COMPLETED|Overall Study||131
3200881|NCT02123251|3929805|FG000|NOT COMPLETED|Overall Study||34
3200882|NCT02123251|3929806|FG001|NOT COMPLETED|Overall Study||30
3200883|NCT02123329|3929815|FG000|STARTED|3 Month Outcome Measure||147
3200884|NCT02123329|3929816|FG001|STARTED|3 Month Outcome Measure||167
3200885|NCT02123329|3929815|FG000|COMPLETED|3 Month Outcome Measure||98
3200886|NCT02123329|3929816|FG001|COMPLETED|3 Month Outcome Measure||101
3200887|NCT02123329|3929815|FG000|NOT COMPLETED|3 Month Outcome Measure||49
3200888|NCT02123329|3929816|FG001|NOT COMPLETED|3 Month Outcome Measure||66
3200889|NCT02123329|3929815|FG000|STARTED|6 Month Outcome Measure||147
3200890|NCT02123329|3929816|FG001|STARTED|6 Month Outcome Measure||167
3200891|NCT02123329|3929815|FG000|COMPLETED|6 Month Outcome Measure||99
3200892|NCT02123329|3929816|FG001|COMPLETED|6 Month Outcome Measure||100
3200893|NCT02123329|3929815|FG000|NOT COMPLETED|6 Month Outcome Measure||48
3200894|NCT02123329|3929816|FG001|NOT COMPLETED|6 Month Outcome Measure||67
3200895|NCT02123329|3929815|FG000|STARTED|12 Month Outcome Measure||147
3200896|NCT02123329|3929816|FG001|STARTED|12 Month Outcome Measure||167
3200897|NCT02123329|3929815|FG000|COMPLETED|12 Month Outcome Measure||83
3200898|NCT02123329|3929816|FG001|COMPLETED|12 Month Outcome Measure||88
3200899|NCT02123329|3929815|FG000|NOT COMPLETED|12 Month Outcome Measure||64
3200900|NCT02123329|3929816|FG001|NOT COMPLETED|12 Month Outcome Measure||79
3200901|NCT02123446|3929822|FG000|STARTED|Period 1 (7 Days)||14
3200902|NCT02123446|3929823|FG001|STARTED|Period 1 (7 Days)||14
3200903|NCT02123446|3929822|FG000|COMPLETED|Period 1 (7 Days)||14
3200904|NCT02123446|3929823|FG001|COMPLETED|Period 1 (7 Days)||14
3365121|NCT03993392|4096193|FG000|STARTED|Overall Study||26
3365122|NCT03993392|4096193|FG000|Treated With SUBLOCADE|Overall Study||24
3365123|NCT03993392|4096193|FG000|COMPLETED|Overall Study||20
3365124|NCT03993392|4096193|FG000|NOT COMPLETED|Overall Study||6
3365125|NCT03989427|4096200|FG000|STARTED|First Intervention (2 Weeks)||15
3365126|NCT03989427|4096201|FG001|STARTED|First Intervention (2 Weeks)||15
3365127|NCT03989427|4096200|FG000|COMPLETED|First Intervention (2 Weeks)||15
3365128|NCT03989427|4096201|FG001|COMPLETED|First Intervention (2 Weeks)||15
3365129|NCT03989427|4096200|FG000|NOT COMPLETED|First Intervention (2 Weeks)||0
3365130|NCT03989427|4096201|FG001|NOT COMPLETED|First Intervention (2 Weeks)||0
3365131|NCT03989427|4096200|FG000|STARTED|Washout (1 Week)||15
3365132|NCT03989427|4096201|FG001|STARTED|Washout (1 Week)||15
3365133|NCT03989427|4096200|FG000|COMPLETED|Washout (1 Week)||15
3365134|NCT03989427|4096201|FG001|COMPLETED|Washout (1 Week)||15
3365135|NCT03989427|4096200|FG000|NOT COMPLETED|Washout (1 Week)||0
3365136|NCT03989427|4096201|FG001|NOT COMPLETED|Washout (1 Week)||0
3365137|NCT03989427|4096200|FG000|STARTED|Second Intervention (2 Weeks)||15
3365138|NCT03989427|4096201|FG001|STARTED|Second Intervention (2 Weeks)||15
3365139|NCT03989427|4096200|FG000|COMPLETED|Second Intervention (2 Weeks)||15
3365140|NCT03989427|4096201|FG001|COMPLETED|Second Intervention (2 Weeks)||15
3365141|NCT03989427|4096200|FG000|NOT COMPLETED|Second Intervention (2 Weeks)||0
3365142|NCT03989427|4096201|FG001|NOT COMPLETED|Second Intervention (2 Weeks)||0
3365143|NCT03981822|4096216|FG000|STARTED|Overall Study||5
3365144|NCT03981822|4096217|FG001|STARTED|Overall Study||5
3365145|NCT03981822|4096218|FG002|STARTED|Overall Study||5
3365146|NCT03981822|4096219|FG003|STARTED|Overall Study||3
3365147|NCT03981822|4096220|FG004|STARTED|Overall Study||25
3365148|NCT03981822|4096221|FG005|STARTED|Overall Study||23
3365149|NCT03981822|4096222|FG006|STARTED|Overall Study||22
3365150|NCT03981822|4096223|FG007|STARTED|Overall Study||17
3365151|NCT03981822|4096216|FG000|COMPLETED|Overall Study||5
3365152|NCT03981822|4096217|FG001|COMPLETED|Overall Study||3
3365153|NCT03981822|4096218|FG002|COMPLETED|Overall Study||4
3365154|NCT03981822|4096219|FG003|COMPLETED|Overall Study||3
3365155|NCT03981822|4096220|FG004|COMPLETED|Overall Study||17
3365156|NCT03981822|4096221|FG005|COMPLETED|Overall Study||17
3365157|NCT03981822|4096222|FG006|COMPLETED|Overall Study||16
3365158|NCT03981822|4096223|FG007|COMPLETED|Overall Study||12
3365159|NCT03981822|4096216|FG000|NOT COMPLETED|Overall Study||0
3365160|NCT03981822|4096217|FG001|NOT COMPLETED|Overall Study||2
3365161|NCT03981822|4096218|FG002|NOT COMPLETED|Overall Study||1
3365162|NCT03981822|4096219|FG003|NOT COMPLETED|Overall Study||0
3365163|NCT03981822|4096220|FG004|NOT COMPLETED|Overall Study||8
3365164|NCT03981822|4096221|FG005|NOT COMPLETED|Overall Study||6
3365165|NCT03981822|4096222|FG006|NOT COMPLETED|Overall Study||6
3365166|NCT03981822|4096223|FG007|NOT COMPLETED|Overall Study||5
3365167|NCT03992482|4096237|FG000|STARTED|Overall Study||13
3365168|NCT03992482|4096238|FG001|STARTED|Overall Study||14
3365169|NCT03992482|4096237|FG000|COMPLETED|Overall Study||13
3365170|NCT03992482|4096238|FG001|COMPLETED|Overall Study||14
3365171|NCT03992482|4096237|FG000|NOT COMPLETED|Overall Study||0
3365172|NCT03992482|4096238|FG001|NOT COMPLETED|Overall Study||0
3365173|NCT03993119|4096248|FG000|STARTED|Overall Study||192
3365174|NCT03993119|4096249|FG001|STARTED|Overall Study||76
3365175|NCT03993119|4096250|FG002|STARTED|Overall Study||166
3365176|NCT03993119|4096251|FG003|STARTED|Overall Study||66
3365177|NCT03993119|4096248|FG000|COMPLETED|Overall Study||192
3365178|NCT03993119|4096249|FG001|COMPLETED|Overall Study||76
3365179|NCT03993119|4096250|FG002|COMPLETED|Overall Study||166
3365180|NCT03993119|4096251|FG003|COMPLETED|Overall Study||66
3365181|NCT03993119|4096248|FG000|NOT COMPLETED|Overall Study||0
3365182|NCT03993119|4096249|FG001|NOT COMPLETED|Overall Study||0
3365183|NCT03993119|4096250|FG002|NOT COMPLETED|Overall Study||0
3365184|NCT03993119|4096251|FG003|NOT COMPLETED|Overall Study||0
3365185|NCT03991494|4096276|FG000|STARTED|Overall Study||4
3200905|NCT02123446|3929822|FG000|NOT COMPLETED|Period 1 (7 Days)||0
3200906|NCT02123446|3929823|FG001|NOT COMPLETED|Period 1 (7 Days)||0
3200907|NCT02123446|3929822|FG000|STARTED|Washout Period (1 Day)||14
3200908|NCT02123446|3929823|FG001|STARTED|Washout Period (1 Day)||14
3200909|NCT02123446|3929822|FG000|COMPLETED|Washout Period (1 Day)||13
3200910|NCT02123446|3929823|FG001|COMPLETED|Washout Period (1 Day)||14
3200911|NCT02123446|3929822|FG000|NOT COMPLETED|Washout Period (1 Day)||1
3200912|NCT02123446|3929823|FG001|NOT COMPLETED|Washout Period (1 Day)||0
3200913|NCT02123446|3929822|FG000|STARTED|Period 2 (7 Days)||13
3200914|NCT02123446|3929823|FG001|STARTED|Period 2 (7 Days)||14
3200915|NCT02123446|3929822|FG000|COMPLETED|Period 2 (7 Days)||13
3200916|NCT02123446|3929823|FG001|COMPLETED|Period 2 (7 Days)||14
3200917|NCT02123446|3929822|FG000|NOT COMPLETED|Period 2 (7 Days)||0
3200918|NCT02123446|3929823|FG001|NOT COMPLETED|Period 2 (7 Days)||0
3200919|NCT02123459|3929829|FG000|STARTED|Period 1 (7 Days)||14
3200920|NCT02123459|3929830|FG001|STARTED|Period 1 (7 Days)||14
3200921|NCT02123459|3929829|FG000|COMPLETED|Period 1 (7 Days)||14
3200922|NCT02123459|3929830|FG001|COMPLETED|Period 1 (7 Days)||14
3200923|NCT02123459|3929829|FG000|NOT COMPLETED|Period 1 (7 Days)||0
3200924|NCT02123459|3929830|FG001|NOT COMPLETED|Period 1 (7 Days)||0
3200925|NCT02123459|3929829|FG000|STARTED|Washout Period (1 Day)||14
3200926|NCT02123459|3929830|FG001|STARTED|Washout Period (1 Day)||14
3200927|NCT02123459|3929829|FG000|COMPLETED|Washout Period (1 Day)||13
3200928|NCT02123459|3929830|FG001|COMPLETED|Washout Period (1 Day)||14
3200929|NCT02123459|3929829|FG000|NOT COMPLETED|Washout Period (1 Day)||1
3200930|NCT02123459|3929830|FG001|NOT COMPLETED|Washout Period (1 Day)||0
3200931|NCT02123459|3929829|FG000|STARTED|Period 2 (7 Days)||13
3200932|NCT02123459|3929830|FG001|STARTED|Period 2 (7 Days)||14
3200933|NCT02123459|3929829|FG000|COMPLETED|Period 2 (7 Days)||13
3200934|NCT02123459|3929830|FG001|COMPLETED|Period 2 (7 Days)||14
3200935|NCT02123459|3929829|FG000|NOT COMPLETED|Period 2 (7 Days)||0
3200936|NCT02123459|3929830|FG001|NOT COMPLETED|Period 2 (7 Days)||0
3200937|NCT02123472|3929836|FG000|STARTED|Period 1 (7 Days)||14
3200938|NCT02123472|3929837|FG001|STARTED|Period 1 (7 Days)||14
3200939|NCT02123472|3929836|FG000|COMPLETED|Period 1 (7 Days)||14
3200940|NCT02123472|3929837|FG001|COMPLETED|Period 1 (7 Days)||14
3200941|NCT02123472|3929836|FG000|NOT COMPLETED|Period 1 (7 Days)||0
3200942|NCT02123472|3929837|FG001|NOT COMPLETED|Period 1 (7 Days)||0
3200943|NCT02123472|3929836|FG000|STARTED|Washout Period (1 Day)||14
3200944|NCT02123472|3929837|FG001|STARTED|Washout Period (1 Day)||14
3200945|NCT02123472|3929836|FG000|COMPLETED|Washout Period (1 Day)||14
3200946|NCT02123472|3929837|FG001|COMPLETED|Washout Period (1 Day)||14
3200947|NCT02123472|3929836|FG000|NOT COMPLETED|Washout Period (1 Day)||0
3200948|NCT02123472|3929837|FG001|NOT COMPLETED|Washout Period (1 Day)||0
3200949|NCT02123472|3929836|FG000|STARTED|Period 2 (7 Days)||14
3200950|NCT02123472|3929837|FG001|STARTED|Period 2 (7 Days)||14
3200951|NCT02123472|3929836|FG000|COMPLETED|Period 2 (7 Days)||14
3200952|NCT02123472|3929837|FG001|COMPLETED|Period 2 (7 Days)||13
3200953|NCT02123472|3929836|FG000|NOT COMPLETED|Period 2 (7 Days)||0
3200954|NCT02123472|3929837|FG001|NOT COMPLETED|Period 2 (7 Days)||1
3200955|NCT02123485|3929845|FG000|STARTED|Overall Study||18
3200956|NCT02123485|3929846|FG001|STARTED|Overall Study||17
3200957|NCT02123485|3929845|FG000|COMPLETED|Overall Study||17
3200958|NCT02123485|3929846|FG001|COMPLETED|Overall Study||17
3200959|NCT02123485|3929845|FG000|NOT COMPLETED|Overall Study||1
3200960|NCT02123485|3929846|FG001|NOT COMPLETED|Overall Study||0
3200961|NCT02123511|3929854|FG000|STARTED|Overall Study||18
3200962|NCT02123511|3929855|FG001|STARTED|Overall Study||16
3200963|NCT02123511|3929854|FG000|Eligible Patients|Overall Study||17
3200964|NCT02123511|3929855|FG001|Eligible Patients|Overall Study||15
3200965|NCT02123511|3929854|FG000|COMPLETED|Overall Study||16
3200966|NCT02123511|3929855|FG001|COMPLETED|Overall Study||12
3200967|NCT02123511|3929854|FG000|NOT COMPLETED|Overall Study||2
3200968|NCT02123511|3929855|FG001|NOT COMPLETED|Overall Study||4
3200969|NCT02123576|3929863|FG000|STARTED|Overall Study||6
3200970|NCT02123576|3929864|FG001|STARTED|Overall Study||6
3200971|NCT02123576|3929863|FG000|COMPLETED|Overall Study||5
3200972|NCT02123576|3929864|FG001|COMPLETED|Overall Study||6
3200973|NCT02123576|3929863|FG000|NOT COMPLETED|Overall Study||1
3200974|NCT02123576|3929864|FG001|NOT COMPLETED|Overall Study||0
3200975|NCT02123745|3929870|FG000|STARTED|Overall Study||71
3200976|NCT02123745|3929870|FG000|COMPLETED|Overall Study||71
3200977|NCT02123745|3929870|FG000|NOT COMPLETED|Overall Study||0
3200978|NCT02123797|3929876|FG000|STARTED|Baseline Intervention||178
3200979|NCT02123797|3929877|FG001|STARTED|Baseline Intervention||348
3200980|NCT02123797|3929878|FG002|STARTED|Baseline Intervention||100
3200981|NCT02123797|3929879|FG003|STARTED|Baseline Intervention||144
3200982|NCT02123797|3929880|FG004|STARTED|Baseline Intervention||11
3200983|NCT02123797|3929876|FG000|COMPLETED|Baseline Intervention||156
3200984|NCT02123797|3929877|FG001|COMPLETED|Baseline Intervention||306
3200985|NCT02123797|3929878|FG002|COMPLETED|Baseline Intervention||100
3200986|NCT02123797|3929879|FG003|COMPLETED|Baseline Intervention||144
3200987|NCT02123797|3929880|FG004|COMPLETED|Baseline Intervention||11
3200988|NCT02123797|3929876|FG000|NOT COMPLETED|Baseline Intervention||22
3200989|NCT02123797|3929877|FG001|NOT COMPLETED|Baseline Intervention||42
3200990|NCT02123797|3929878|FG002|NOT COMPLETED|Baseline Intervention||0
3200991|NCT02123797|3929879|FG003|NOT COMPLETED|Baseline Intervention||0
3200992|NCT02123797|3929880|FG004|NOT COMPLETED|Baseline Intervention||0
3200993|NCT02123797|3929876|FG000|STARTED|3-month Follow up (Cumulative Counts)||156
3200994|NCT02123797|3929877|FG001|STARTED|3-month Follow up (Cumulative Counts)||306
3200995|NCT02123797|3929878|FG002|STARTED|3-month Follow up (Cumulative Counts)||100
3200996|NCT02123797|3929879|FG003|STARTED|3-month Follow up (Cumulative Counts)||144
3200997|NCT02123797|3929880|FG004|STARTED|3-month Follow up (Cumulative Counts)|Clinical providers received 6 month follow-up rather than 3 month follow-up at this stage.|11
3200998|NCT02123797|3929876|FG000|COMPLETED|3-month Follow up (Cumulative Counts)||99
3200999|NCT02123797|3929877|FG001|COMPLETED|3-month Follow up (Cumulative Counts)||189
3201000|NCT02123797|3929878|FG002|COMPLETED|3-month Follow up (Cumulative Counts)||50
3201001|NCT02123797|3929879|FG003|COMPLETED|3-month Follow up (Cumulative Counts)||62
3201002|NCT02123797|3929880|FG004|COMPLETED|3-month Follow up (Cumulative Counts)||8
3201003|NCT02123797|3929876|FG000|NOT COMPLETED|3-month Follow up (Cumulative Counts)||57
3201004|NCT02123797|3929877|FG001|NOT COMPLETED|3-month Follow up (Cumulative Counts)||117
3201005|NCT02123797|3929878|FG002|NOT COMPLETED|3-month Follow up (Cumulative Counts)||50
3201006|NCT02123797|3929879|FG003|NOT COMPLETED|3-month Follow up (Cumulative Counts)||82
3201007|NCT02123797|3929880|FG004|NOT COMPLETED|3-month Follow up (Cumulative Counts)||3
3201008|NCT02123797|3929876|FG000|STARTED|6-month Follow up (Cumulative Counts)||156
3201009|NCT02123797|3929877|FG001|STARTED|6-month Follow up (Cumulative Counts)||306
3201010|NCT02123797|3929878|FG002|STARTED|6-month Follow up (Cumulative Counts)||100
3201011|NCT02123797|3929879|FG003|STARTED|6-month Follow up (Cumulative Counts)||144
3201012|NCT02123797|3929880|FG004|STARTED|6-month Follow up (Cumulative Counts)|Clinical providers received 12 month follow-up rather than 6-month follow-up at this stage.|8
3201013|NCT02123797|3929876|FG000|COMPLETED|6-month Follow up (Cumulative Counts)||101
3201014|NCT02123797|3929877|FG001|COMPLETED|6-month Follow up (Cumulative Counts)||178
3201015|NCT02123797|3929878|FG002|COMPLETED|6-month Follow up (Cumulative Counts)||34
3201016|NCT02123797|3929879|FG003|COMPLETED|6-month Follow up (Cumulative Counts)||31
3201017|NCT02123797|3929880|FG004|COMPLETED|6-month Follow up (Cumulative Counts)||5
3201018|NCT02123797|3929876|FG000|NOT COMPLETED|6-month Follow up (Cumulative Counts)||55
3201019|NCT02123797|3929877|FG001|NOT COMPLETED|6-month Follow up (Cumulative Counts)||128
3201020|NCT02123797|3929878|FG002|NOT COMPLETED|6-month Follow up (Cumulative Counts)||66
3201021|NCT02123797|3929879|FG003|NOT COMPLETED|6-month Follow up (Cumulative Counts)||113
3201022|NCT02123797|3929880|FG004|NOT COMPLETED|6-month Follow up (Cumulative Counts)||3
3201023|NCT02123849|3929902|FG000|STARTED|Overall Study||27
3201024|NCT02123849|3929903|FG001|STARTED|Overall Study||27
3201025|NCT02123849|3929902|FG000|COMPLETED|Overall Study||23
3201026|NCT02123849|3929903|FG001|COMPLETED|Overall Study||18
3201027|NCT02123849|3929902|FG000|NOT COMPLETED|Overall Study||4
3201028|NCT02123849|3929903|FG001|NOT COMPLETED|Overall Study||9
3201029|NCT02123966|3929911|FG000|STARTED|Overall Study||10
3201030|NCT02123966|3929911|FG000|COMPLETED|Overall Study||9
3201031|NCT02123966|3929911|FG000|NOT COMPLETED|Overall Study||1
3201032|NCT02124018|3929918|FG000|STARTED|Overall Study||371
3201033|NCT02124018|3929919|FG001|STARTED|Overall Study||111
3201034|NCT02124018|3929920|FG002|STARTED|Overall Study||41
3201035|NCT02124018|3929918|FG000|COMPLETED|Overall Study||371
3201036|NCT02124018|3929919|FG001|COMPLETED|Overall Study||111
3201037|NCT02124018|3929920|FG002|COMPLETED|Overall Study|Numbers do not add up to 575 (enrolled) due to refusals of programmed ventricular stimulation|41
3201038|NCT02124018|3929918|FG000|NOT COMPLETED|Overall Study||0
3201039|NCT02124018|3929919|FG001|NOT COMPLETED|Overall Study||0
3201040|NCT02124018|3929920|FG002|NOT COMPLETED|Overall Study||0
3201041|NCT02124044|3929933|FG000|STARTED|Overall Study||20
3201042|NCT02124044|3929934|FG001|STARTED|Overall Study||10
3201043|NCT02124044|3929933|FG000|COMPLETED|Overall Study||20
3201044|NCT02124044|3929934|FG001|COMPLETED|Overall Study||9
3201045|NCT02124044|3929933|FG000|NOT COMPLETED|Overall Study||0
3201046|NCT02124044|3929934|FG001|NOT COMPLETED|Overall Study||1
3201047|NCT02124083|3929940|FG000|STARTED|Overall Study||12
3201048|NCT02124083|3929940|FG000|COMPLETED|Overall Study||11
3201049|NCT02124083|3929940|FG000|NOT COMPLETED|Overall Study||1
3201050|NCT02124122|3929946|FG000|STARTED|Overall Study||41
3201051|NCT02124122|3929947|FG001|STARTED|Overall Study||19
3201052|NCT02124122|3929946|FG000|COMPLETED|Overall Study||41
3201053|NCT02124122|3929947|FG001|COMPLETED|Overall Study||19
3201054|NCT02124122|3929946|FG000|NOT COMPLETED|Overall Study||0
3201055|NCT02124122|3929947|FG001|NOT COMPLETED|Overall Study||0
3201056|NCT02124161|3929955|FG000|STARTED|Overall Study||441
3201057|NCT02124161|3929956|FG001|STARTED|Overall Study||441
3201058|NCT02124161|3929955|FG000|Vaccination 1|Overall Study||439
3201059|NCT02124161|3929956|FG001|Vaccination 1|Overall Study||437
3201060|NCT02124161|3929955|FG000|Vaccination 2|Overall Study||431
3201061|NCT02124161|3929956|FG001|Vaccination 2|Overall Study||432
3201062|NCT02124161|3929955|FG000|COMPLETED|Overall Study||425
3201063|NCT02124161|3929956|FG001|COMPLETED|Overall Study||426
3201064|NCT02124161|3929955|FG000|NOT COMPLETED|Overall Study||16
3201065|NCT02124161|3929956|FG001|NOT COMPLETED|Overall Study||15
3201066|NCT02124265|3929969|FG000|STARTED|Overall Study||3
3201067|NCT02124265|3929969|FG000|COMPLETED|Overall Study||2
3201068|NCT02124265|3929969|FG000|NOT COMPLETED|Overall Study||1
3201069|NCT02124304|3929975|FG000|STARTED|Overall Study||15
3201070|NCT02124304|3929976|FG001|STARTED|Overall Study||15
3201071|NCT02124304|3929975|FG000|COMPLETED|Overall Study||15
3201072|NCT02124304|3929976|FG001|COMPLETED|Overall Study||15
3201073|NCT02124304|3929975|FG000|NOT COMPLETED|Overall Study||0
3201074|NCT02124304|3929976|FG001|NOT COMPLETED|Overall Study||0
3201075|NCT02124460|3929984|FG000|STARTED|Overall Study||361
3201076|NCT02124460|3929985|FG001|STARTED|Overall Study||360
3201077|NCT02124460|3929984|FG000|COMPLETED|Overall Study||328
3201078|NCT02124460|3929985|FG001|COMPLETED|Overall Study||336
3201079|NCT02124460|3929984|FG000|NOT COMPLETED|Overall Study||33
3201080|NCT02124460|3929985|FG001|NOT COMPLETED|Overall Study||24
3201081|NCT02124512|3929994|FG000|STARTED|Overall Study||6
3201082|NCT02124512|3929995|FG001|STARTED|Overall Study||6
3201083|NCT02124512|3929994|FG000|COMPLETED|Overall Study||6
3201084|NCT02124512|3929995|FG001|COMPLETED|Overall Study||6
3201085|NCT02124512|3929994|FG000|NOT COMPLETED|Overall Study||0
3201086|NCT02124512|3929995|FG001|NOT COMPLETED|Overall Study||0
3201087|NCT02124564|3930001|FG000|STARTED|Treatment Period||19
3201088|NCT02124564|3930001|FG000|Started Treatment Period|Treatment Period||19
3201089|NCT02124564|3930001|FG000|Started Titration Period|Treatment Period||19
3201090|NCT02124564|3930001|FG000|Started AED Withdrawal Period|Treatment Period||19
3201091|NCT02124564|3930001|FG000|Started Monotherapy Period|Treatment Period||17
3201092|NCT02124564|3930001|FG000|Started Evaluation Period|Treatment Period||17
3201093|NCT02124564|3930001|FG000|Started Follow-Up Period|Treatment Period||13
3201094|NCT02124564|3930001|FG000|COMPLETED|Treatment Period||12
3201095|NCT02124564|3930001|FG000|NOT COMPLETED|Treatment Period||7
3201096|NCT02124564|3930001|FG000|STARTED|Taper Period||2
3201097|NCT02124564|3930001|FG000|COMPLETED|Taper Period||2
3201098|NCT02124564|3930001|FG000|NOT COMPLETED|Taper Period||0
3201099|NCT02124603|3930006|FG000|STARTED|Overall Study||120
3201100|NCT02124603|3930006|FG000|COMPLETED|Overall Study||120
3201101|NCT02124603|3930006|FG000|NOT COMPLETED|Overall Study||0
3201102|NCT02124707|3930011|FG000|STARTED|Overall Study||14
3201103|NCT02124707|3930011|FG000|COMPLETED|Overall Study||7
3201104|NCT02124707|3930011|FG000|NOT COMPLETED|Overall Study||7
3201105|NCT02124746|3930019|FG000|STARTED|Overall Study||30
3201106|NCT02124746|3930020|FG001|STARTED|Overall Study||22
3201107|NCT02124746|3930021|FG002|STARTED|Overall Study||22
3201108|NCT02124746|3930019|FG000|COMPLETED|Overall Study||11
3201109|NCT02124746|3930020|FG001|COMPLETED|Overall Study||4
3201110|NCT02124746|3930021|FG002|COMPLETED|Overall Study||0
3201111|NCT02124746|3930019|FG000|NOT COMPLETED|Overall Study||19
3201112|NCT02124746|3930020|FG001|NOT COMPLETED|Overall Study||18
3201113|NCT02124746|3930021|FG002|NOT COMPLETED|Overall Study||22
3201114|NCT02124759|3930032|FG000|STARTED|Overall Study||6
3201115|NCT02124759|3930033|FG001|STARTED|Overall Study||7
3201116|NCT02124759|3930034|FG002|STARTED|Overall Study||7
3201117|NCT02124759|3930032|FG000|Subjects Randomized to Intervention|Overall Study||4
3201118|NCT02124759|3930033|FG001|Subjects Randomized to Intervention|Overall Study||5
3201119|NCT02124759|3930034|FG002|Subjects Randomized to Intervention|Overall Study||4
3201120|NCT02124759|3930032|FG000|Low Fat Diet|Overall Study|2 subjects did not complete and were withdrawn|4
3201121|NCT02124759|3930033|FG001|Low Fat Diet|Overall Study||4
3201122|NCT02124759|3930034|FG002|Low Fat Diet|Overall Study||4
3201123|NCT02124759|3930032|FG000|High Fat Diet|Overall Study|1 subject did not complete|2
3201124|NCT02124759|3930033|FG001|High Fat Diet|Overall Study|One subject withdrew (low fat diet had already been completed)|5
3201125|NCT02124759|3930034|FG002|High Fat Diet|Overall Study|One subject withdrew and did not complete the low fat diet|4
3201126|NCT02124759|3930032|FG000|COMPLETED|Overall Study||1
3201127|NCT02124759|3930033|FG001|COMPLETED|Overall Study||4
3201128|NCT02124759|3930034|FG002|COMPLETED|Overall Study||3
3201129|NCT02124759|3930032|FG000|NOT COMPLETED|Overall Study||5
3201130|NCT02124759|3930033|FG001|NOT COMPLETED|Overall Study||3
3201131|NCT02124759|3930034|FG002|NOT COMPLETED|Overall Study||4
3201132|NCT02124772|3930060|FG000|STARTED|Overall Study||3
3201133|NCT02124772|3930061|FG001|STARTED|Overall Study||19
3201134|NCT02124772|3930062|FG002|STARTED|Overall Study||12
3201135|NCT02124772|3930063|FG003|STARTED|Overall Study||16
3201136|NCT02124772|3930064|FG004|STARTED|Overall Study||11
3201137|NCT02124772|3930065|FG005|STARTED|Overall Study||10
3201138|NCT02124772|3930066|FG006|STARTED|Overall Study||10
3201139|NCT02124772|3930067|FG007|STARTED|Overall Study||10
3201140|NCT02124772|3930068|FG008|STARTED|Overall Study||3
3201141|NCT02124772|3930069|FG009|STARTED|Overall Study||9
3201142|NCT02124772|3930070|FG010|STARTED|Overall Study||6
3201143|NCT02124772|3930071|FG011|STARTED|Overall Study||20
3201144|NCT02124772|3930072|FG012|STARTED|Overall Study||10
3201145|NCT02124772|3930060|FG000|COMPLETED|Overall Study||0
3201146|NCT02124772|3930061|FG001|COMPLETED|Overall Study||5
3201147|NCT02124772|3930062|FG002|COMPLETED|Overall Study||6
3201148|NCT02124772|3930063|FG003|COMPLETED|Overall Study||3
3201149|NCT02124772|3930064|FG004|COMPLETED|Overall Study||2
3201150|NCT02124772|3930065|FG005|COMPLETED|Overall Study||2
3201151|NCT02124772|3930066|FG006|COMPLETED|Overall Study||2
3201152|NCT02124772|3930067|FG007|COMPLETED|Overall Study||1
3201153|NCT02124772|3930068|FG008|COMPLETED|Overall Study||2
3201154|NCT02124772|3930069|FG009|COMPLETED|Overall Study||2
3201155|NCT02124772|3930070|FG010|COMPLETED|Overall Study||4
3201156|NCT02124772|3930071|FG011|COMPLETED|Overall Study||14
3201157|NCT02124772|3930072|FG012|COMPLETED|Overall Study||8
3201158|NCT02124772|3930060|FG000|NOT COMPLETED|Overall Study||3
3201159|NCT02124772|3930061|FG001|NOT COMPLETED|Overall Study||14
3201160|NCT02124772|3930062|FG002|NOT COMPLETED|Overall Study||6
3201161|NCT02124772|3930063|FG003|NOT COMPLETED|Overall Study||13
3201162|NCT02124772|3930064|FG004|NOT COMPLETED|Overall Study||9
3201163|NCT02124772|3930065|FG005|NOT COMPLETED|Overall Study||8
3201164|NCT02124772|3930066|FG006|NOT COMPLETED|Overall Study||8
3201165|NCT02124772|3930067|FG007|NOT COMPLETED|Overall Study||9
3201166|NCT02124772|3930068|FG008|NOT COMPLETED|Overall Study||1
3201167|NCT02124772|3930069|FG009|NOT COMPLETED|Overall Study||7
3201168|NCT02124772|3930070|FG010|NOT COMPLETED|Overall Study||2
3201169|NCT02124772|3930071|FG011|NOT COMPLETED|Overall Study||6
3201170|NCT02124772|3930072|FG012|NOT COMPLETED|Overall Study||2
3201171|NCT02124798|3930124|FG000|STARTED|Overall Study||95
3201172|NCT02124798|3930124|FG000|COMPLETED|Overall Study||91
3201173|NCT02124798|3930124|FG000|NOT COMPLETED|Overall Study||4
3201174|NCT02124811|3930130|FG000|STARTED|Overall Study||5
3201175|NCT02124811|3930131|FG001|STARTED|Overall Study||5
3201176|NCT02124811|3930130|FG000|COMPLETED|Overall Study||2
3201177|NCT02124811|3930131|FG001|COMPLETED|Overall Study||3
3201178|NCT02124811|3930130|FG000|NOT COMPLETED|Overall Study||3
3201179|NCT02124811|3930131|FG001|NOT COMPLETED|Overall Study||2
3201180|NCT02124863|3930137|FG000|STARTED|Overall Study||67
3201181|NCT02124863|3930137|FG000|COMPLETED|Overall Study||50
3201182|NCT02124863|3930137|FG000|NOT COMPLETED|Overall Study||17
3201183|NCT02124889|3930145|FG000|STARTED|Overall Study||12
3201184|NCT02124889|3930146|FG001|STARTED|Overall Study||12
3201185|NCT02124889|3930145|FG000|COMPLETED|Overall Study||12
3201186|NCT02124889|3930146|FG001|COMPLETED|Overall Study||12
3201187|NCT02124889|3930145|FG000|NOT COMPLETED|Overall Study||0
3201188|NCT02124889|3930146|FG001|NOT COMPLETED|Overall Study||0
3201189|NCT02125279|3930152|FG000|STARTED|Overall Study||54
3201190|NCT02125279|3930152|FG000|COMPLETED|Overall Study||41
3201191|NCT02125279|3930152|FG000|NOT COMPLETED|Overall Study||13
3201192|NCT02125292|3930158|FG000|STARTED|First Intervention (1 Hour)||3
3201193|NCT02125292|3930159|FG001|STARTED|First Intervention (1 Hour)||3
3201194|NCT02125292|3930160|FG002|STARTED|First Intervention (1 Hour)||3
3201195|NCT02125292|3930161|FG003|STARTED|First Intervention (1 Hour)||3
3201196|NCT02125292|3930162|FG004|STARTED|First Intervention (1 Hour)||3
3201197|NCT02125292|3930163|FG005|STARTED|First Intervention (1 Hour)||3
3201198|NCT02125292|3930158|FG000|COMPLETED|First Intervention (1 Hour)||3
3201199|NCT02125292|3930159|FG001|COMPLETED|First Intervention (1 Hour)||3
3201200|NCT02125292|3930160|FG002|COMPLETED|First Intervention (1 Hour)||3
3201201|NCT02125292|3930161|FG003|COMPLETED|First Intervention (1 Hour)||3
3201202|NCT02125292|3930162|FG004|COMPLETED|First Intervention (1 Hour)||3
3201203|NCT02125292|3930163|FG005|COMPLETED|First Intervention (1 Hour)||3
3201204|NCT02125292|3930158|FG000|NOT COMPLETED|First Intervention (1 Hour)||0
3201205|NCT02125292|3930159|FG001|NOT COMPLETED|First Intervention (1 Hour)||0
3201206|NCT02125292|3930160|FG002|NOT COMPLETED|First Intervention (1 Hour)||0
3201207|NCT02125292|3930161|FG003|NOT COMPLETED|First Intervention (1 Hour)||0
3201208|NCT02125292|3930162|FG004|NOT COMPLETED|First Intervention (1 Hour)||0
3201209|NCT02125292|3930163|FG005|NOT COMPLETED|First Intervention (1 Hour)||0
3201210|NCT02125292|3930158|FG000|STARTED|Washout (2 Hours)||3
3201211|NCT02125292|3930159|FG001|STARTED|Washout (2 Hours)||3
3201212|NCT02125292|3930160|FG002|STARTED|Washout (2 Hours)||3
3201213|NCT02125292|3930161|FG003|STARTED|Washout (2 Hours)||3
3201214|NCT02125292|3930162|FG004|STARTED|Washout (2 Hours)||3
3201215|NCT02125292|3930163|FG005|STARTED|Washout (2 Hours)||3
3201216|NCT02125292|3930158|FG000|COMPLETED|Washout (2 Hours)||3
3201217|NCT02125292|3930159|FG001|COMPLETED|Washout (2 Hours)||3
3201218|NCT02125292|3930160|FG002|COMPLETED|Washout (2 Hours)||3
3201219|NCT02125292|3930161|FG003|COMPLETED|Washout (2 Hours)||3
3201220|NCT02125292|3930162|FG004|COMPLETED|Washout (2 Hours)||3
3201221|NCT02125292|3930163|FG005|COMPLETED|Washout (2 Hours)||3
3201222|NCT02125292|3930158|FG000|NOT COMPLETED|Washout (2 Hours)||0
3201223|NCT02125292|3930159|FG001|NOT COMPLETED|Washout (2 Hours)||0
3201224|NCT02125292|3930160|FG002|NOT COMPLETED|Washout (2 Hours)||0
3201225|NCT02125292|3930161|FG003|NOT COMPLETED|Washout (2 Hours)||0
3201226|NCT02125292|3930162|FG004|NOT COMPLETED|Washout (2 Hours)||0
3201227|NCT02125292|3930163|FG005|NOT COMPLETED|Washout (2 Hours)||0
3201228|NCT02125292|3930158|FG000|STARTED|Second Intervention (1 Hour)||3
3201229|NCT02125292|3930159|FG001|STARTED|Second Intervention (1 Hour)||3
3201230|NCT02125292|3930160|FG002|STARTED|Second Intervention (1 Hour)||3
3201231|NCT02125292|3930161|FG003|STARTED|Second Intervention (1 Hour)||3
3201232|NCT02125292|3930162|FG004|STARTED|Second Intervention (1 Hour)||3
3201233|NCT02125292|3930163|FG005|STARTED|Second Intervention (1 Hour)||3
3201234|NCT02125292|3930158|FG000|COMPLETED|Second Intervention (1 Hour)||3
3201235|NCT02125292|3930159|FG001|COMPLETED|Second Intervention (1 Hour)||3
3201236|NCT02125292|3930160|FG002|COMPLETED|Second Intervention (1 Hour)||3
3201237|NCT02125292|3930161|FG003|COMPLETED|Second Intervention (1 Hour)||3
3201238|NCT02125292|3930162|FG004|COMPLETED|Second Intervention (1 Hour)||3
3201239|NCT02125292|3930163|FG005|COMPLETED|Second Intervention (1 Hour)||3
3201240|NCT02125292|3930158|FG000|NOT COMPLETED|Second Intervention (1 Hour)||0
3201241|NCT02125292|3930159|FG001|NOT COMPLETED|Second Intervention (1 Hour)||0
3201242|NCT02125292|3930160|FG002|NOT COMPLETED|Second Intervention (1 Hour)||0
3201243|NCT02125292|3930161|FG003|NOT COMPLETED|Second Intervention (1 Hour)||0
3201244|NCT02125292|3930162|FG004|NOT COMPLETED|Second Intervention (1 Hour)||0
3201245|NCT02125292|3930163|FG005|NOT COMPLETED|Second Intervention (1 Hour)||0
3201246|NCT02125292|3930158|FG000|STARTED|Washout (2 Hours)||3
3201247|NCT02125292|3930159|FG001|STARTED|Washout (2 Hours)||3
3201248|NCT02125292|3930160|FG002|STARTED|Washout (2 Hours)||3
3201249|NCT02125292|3930161|FG003|STARTED|Washout (2 Hours)||3
3201250|NCT02125292|3930162|FG004|STARTED|Washout (2 Hours)||3
3201251|NCT02125292|3930163|FG005|STARTED|Washout (2 Hours)||3
3201252|NCT02125292|3930158|FG000|COMPLETED|Washout (2 Hours)||3
3201253|NCT02125292|3930159|FG001|COMPLETED|Washout (2 Hours)||3
3201254|NCT02125292|3930160|FG002|COMPLETED|Washout (2 Hours)||3
3201255|NCT02125292|3930161|FG003|COMPLETED|Washout (2 Hours)||3
3201256|NCT02125292|3930162|FG004|COMPLETED|Washout (2 Hours)||3
3201257|NCT02125292|3930163|FG005|COMPLETED|Washout (2 Hours)||3
3201258|NCT02125292|3930158|FG000|NOT COMPLETED|Washout (2 Hours)||0
3201259|NCT02125292|3930159|FG001|NOT COMPLETED|Washout (2 Hours)||0
3201260|NCT02125292|3930160|FG002|NOT COMPLETED|Washout (2 Hours)||0
3201261|NCT02125292|3930161|FG003|NOT COMPLETED|Washout (2 Hours)||0
3201262|NCT02125292|3930162|FG004|NOT COMPLETED|Washout (2 Hours)||0
3201263|NCT02125292|3930163|FG005|NOT COMPLETED|Washout (2 Hours)||0
3201264|NCT02125292|3930158|FG000|STARTED|Third Intervention (1 Hour)||3
3201265|NCT02125292|3930159|FG001|STARTED|Third Intervention (1 Hour)||3
3201266|NCT02125292|3930160|FG002|STARTED|Third Intervention (1 Hour)||3
3201267|NCT02125292|3930161|FG003|STARTED|Third Intervention (1 Hour)||3
3201268|NCT02125292|3930162|FG004|STARTED|Third Intervention (1 Hour)||3
3201269|NCT02125292|3930163|FG005|STARTED|Third Intervention (1 Hour)||3
3201270|NCT02125292|3930158|FG000|COMPLETED|Third Intervention (1 Hour)||3
3201271|NCT02125292|3930159|FG001|COMPLETED|Third Intervention (1 Hour)||3
3201272|NCT02125292|3930160|FG002|COMPLETED|Third Intervention (1 Hour)||3
3201273|NCT02125292|3930161|FG003|COMPLETED|Third Intervention (1 Hour)||3
3201274|NCT02125292|3930162|FG004|COMPLETED|Third Intervention (1 Hour)||3
3201275|NCT02125292|3930163|FG005|COMPLETED|Third Intervention (1 Hour)||3
3201276|NCT02125292|3930158|FG000|NOT COMPLETED|Third Intervention (1 Hour)||0
3201277|NCT02125292|3930159|FG001|NOT COMPLETED|Third Intervention (1 Hour)||0
3201278|NCT02125292|3930160|FG002|NOT COMPLETED|Third Intervention (1 Hour)||0
3201279|NCT02125292|3930161|FG003|NOT COMPLETED|Third Intervention (1 Hour)||0
3201280|NCT02125292|3930162|FG004|NOT COMPLETED|Third Intervention (1 Hour)||0
3201281|NCT02125292|3930163|FG005|NOT COMPLETED|Third Intervention (1 Hour)||0
3201282|NCT02125331|3930174|FG000|STARTED|Overall Study||58
3201283|NCT02125331|3930175|FG001|STARTED|Overall Study||25
3201284|NCT02125331|3930174|FG000|COMPLETED|Overall Study||53
3201285|NCT02125331|3930175|FG001|COMPLETED|Overall Study||25
3201286|NCT02125331|3930174|FG000|NOT COMPLETED|Overall Study||5
3201287|NCT02125331|3930175|FG001|NOT COMPLETED|Overall Study||0
3201288|NCT02125604|3930181|FG000|STARTED|Overall Study|enrolled and received at least 1 dose of study drug|211
3201289|NCT02125604|3930181|FG000|COMPLETED|Overall Study||180
3201290|NCT02125604|3930181|FG000|NOT COMPLETED|Overall Study||31
3201291|NCT02125721|3930185|FG000|STARTED|Overall Study||10
3201292|NCT02125721|3930185|FG000|COMPLETED|Overall Study||10
3201293|NCT02125721|3930185|FG000|NOT COMPLETED|Overall Study||0
3201294|NCT02125734|3930191|FG000|STARTED|Period 1||40
3201295|NCT02125734|3930192|FG001|STARTED|Period 1||48
3201296|NCT02125734|3930191|FG000|COMPLETED|Period 1||40
3201297|NCT02125734|3930192|FG001|COMPLETED|Period 1||48
3201298|NCT02125734|3930191|FG000|NOT COMPLETED|Period 1||0
3201299|NCT02125734|3930192|FG001|NOT COMPLETED|Period 1||0
3201300|NCT02125734|3930191|FG000|STARTED|Period 2||40
3201301|NCT02125734|3930192|FG001|STARTED|Period 2||48
3201302|NCT02125734|3930191|FG000|COMPLETED|Period 2||40
3201303|NCT02125734|3930192|FG001|COMPLETED|Period 2||47
3201304|NCT02125734|3930191|FG000|NOT COMPLETED|Period 2||0
3201305|NCT02125734|3930192|FG001|NOT COMPLETED|Period 2||1
3201306|NCT02125838|3930200|FG000|STARTED|Overall Study|Lost to follow-up (n= 4 ) Turned to laparotomy (Adhesions)(n= 2) NBA used (n= 2)|54
3201307|NCT02125838|3930201|FG001|STARTED|Overall Study|Lost to follow-up (n= 4 ) Turned to laparotomy (Adhesions) (n= 2) NBA used (n= 2)|54
3201308|NCT02125838|3930200|FG000|COMPLETED|Overall Study|Analysed (n=50 )|50
3201309|NCT02125838|3930201|FG001|COMPLETED|Overall Study|Analysed (n=50 )|50
3201310|NCT02125838|3930200|FG000|NOT COMPLETED|Overall Study||4
3201311|NCT02125838|3930201|FG001|NOT COMPLETED|Overall Study||4
3365186|NCT03991494|4096276|FG000|COMPLETED|Overall Study||0
3365187|NCT03991494|4096276|FG000|NOT COMPLETED|Overall Study||4
3365188|NCT03989570|4096285|FG000|STARTED|Overall Study||31
3365189|NCT03989570|4096286|FG001|STARTED|Overall Study||31
3365190|NCT03989570|4096287|FG002|STARTED|Overall Study||31
3365191|NCT03989570|4096285|FG000|COMPLETED|Overall Study||31
3365192|NCT03989570|4096286|FG001|COMPLETED|Overall Study||31
3365193|NCT03989570|4096287|FG002|COMPLETED|Overall Study||31
3365194|NCT03989570|4096285|FG000|NOT COMPLETED|Overall Study||0
3365195|NCT03989570|4096286|FG001|NOT COMPLETED|Overall Study||0
3365196|NCT03989570|4096287|FG002|NOT COMPLETED|Overall Study||0
3365197|NCT03988803|4096295|FG000|STARTED|Screening||16
3365198|NCT03988803|4096295|FG000|COMPLETED|Screening||16
3365199|NCT03988803|4096295|FG000|NOT COMPLETED|Screening||0
3365200|NCT03988803|4096295|FG000|STARTED|Period 1||16
3365201|NCT03988803|4096295|FG000|COMPLETED|Period 1||16
3365202|NCT03988803|4096295|FG000|NOT COMPLETED|Period 1||0
3365203|NCT03988803|4096295|FG000|STARTED|Period 2||16
3365204|NCT03988803|4096295|FG000|Treated|Period 2||15
3365205|NCT03988803|4096295|FG000|Started Days 1 - 7: Multiple Doses of 5 mg Memantine qd|Period 2||15
3365206|NCT03988803|4096295|FG000|Started Days 8 - 14: Multiple Doses of 10 mg Memantine qd|Period 2||14
3365207|NCT03988803|4096295|FG000|Started Days 15 - 21: Multiple Doses of 15 mg Memantine qd|Period 2||13
3365208|NCT03988803|4096295|FG000|Started Days 22 - 35: Multiple Doses of 20 mg Memantine qd|Period 2||13
3365209|NCT03988803|4096295|FG000|COMPLETED|Period 2||13
3365210|NCT03988803|4096295|FG000|NOT COMPLETED|Period 2||3
3365211|NCT03988803|4096295|FG000|STARTED|Period 3||13
3365212|NCT03988803|4096295|FG000|COMPLETED|Period 3||13
3365213|NCT03988803|4096295|FG000|NOT COMPLETED|Period 3||0
3201312|NCT02125877|3930209|FG000|STARTED|Overall Study||86
3201313|NCT02125877|3930210|FG001|STARTED|Overall Study||87
3201314|NCT02125877|3930209|FG000|Pharmacokinetic Analysis Set|Overall Study||83
3201315|NCT02125877|3930210|FG001|Pharmacokinetic Analysis Set|Overall Study||83
3201316|NCT02125877|3930209|FG000|Pharmacokinetic Subset A|Overall Study||16
3201317|NCT02125877|3930210|FG001|Pharmacokinetic Subset A|Overall Study||15
3201318|NCT02125877|3930209|FG000|Safety Set|Overall Study||86
3201319|NCT02125877|3930210|FG001|Safety Set|Overall Study||87
3201320|NCT02125877|3930209|FG000|COMPLETED|Overall Study||73
3201321|NCT02125877|3930210|FG001|COMPLETED|Overall Study||77
3201322|NCT02125877|3930209|FG000|NOT COMPLETED|Overall Study||13
3201323|NCT02125877|3930210|FG001|NOT COMPLETED|Overall Study||10
3201324|NCT02126306|3930218|FG000|STARTED|Overall Study||10
3201325|NCT02126306|3930219|FG001|STARTED|Overall Study||13
3201326|NCT02126306|3930218|FG000|COMPLETED|Overall Study||10
3201327|NCT02126306|3930219|FG001|COMPLETED|Overall Study||13
3201328|NCT02126306|3930218|FG000|NOT COMPLETED|Overall Study||0
3201329|NCT02126306|3930219|FG001|NOT COMPLETED|Overall Study||0
3201330|NCT02126319|3930227|FG000|STARTED|Overall Study||61
3201331|NCT02126319|3930228|FG001|STARTED|Overall Study||67
3201332|NCT02126319|3930227|FG000|COMPLETED|Overall Study||40
3201333|NCT02126319|3930228|FG001|COMPLETED|Overall Study||43
3201334|NCT02126319|3930227|FG000|NOT COMPLETED|Overall Study||21
3201335|NCT02126319|3930228|FG001|NOT COMPLETED|Overall Study||24
3201336|NCT02126670|3930240|FG000|STARTED|Overall Study||26
3201337|NCT02126670|3930241|FG001|STARTED|Overall Study||24
3201338|NCT02126670|3930242|FG002|STARTED|Overall Study||25
3201339|NCT02126670|3930243|FG003|STARTED|Overall Study||25
3201340|NCT02126670|3930240|FG000|COMPLETED|Overall Study||25
3201341|NCT02126670|3930241|FG001|COMPLETED|Overall Study||24
3201342|NCT02126670|3930242|FG002|COMPLETED|Overall Study||25
3201343|NCT02126670|3930243|FG003|COMPLETED|Overall Study||24
3201344|NCT02126670|3930240|FG000|NOT COMPLETED|Overall Study||1
3201345|NCT02126670|3930241|FG001|NOT COMPLETED|Overall Study||0
3201346|NCT02126670|3930242|FG002|NOT COMPLETED|Overall Study||0
3201347|NCT02126670|3930243|FG003|NOT COMPLETED|Overall Study||1
3201348|NCT02126748|3930256|FG000|STARTED|Overall Study||33
3201349|NCT02126748|3930257|FG001|STARTED|Overall Study||34
3201350|NCT02126748|3930258|FG002|STARTED|Overall Study||36
3201351|NCT02126748|3930256|FG000|COMPLETED|Overall Study||31
3201352|NCT02126748|3930257|FG001|COMPLETED|Overall Study||31
3201353|NCT02126748|3930258|FG002|COMPLETED|Overall Study||31
3201354|NCT02126748|3930256|FG000|NOT COMPLETED|Overall Study||2
3201355|NCT02126748|3930257|FG001|NOT COMPLETED|Overall Study||3
3201356|NCT02126748|3930258|FG002|NOT COMPLETED|Overall Study||5
3201357|NCT02126826|3930273|FG000|STARTED|Overall Study||9
3201358|NCT02126826|3930274|FG001|STARTED|Overall Study||9
3201359|NCT02126826|3930275|FG002|STARTED|Overall Study||9
3201360|NCT02126826|3930276|FG003|STARTED|Overall Study||9
3201361|NCT02126826|3930277|FG004|STARTED|Overall Study||5
3201362|NCT02126826|3930278|FG005|STARTED|Overall Study||9
3201363|NCT02126826|3930279|FG006|STARTED|Overall Study||8
3201364|NCT02126826|3930273|FG000|COMPLETED|Overall Study||9
3201365|NCT02126826|3930274|FG001|COMPLETED|Overall Study||9
3201366|NCT02126826|3930275|FG002|COMPLETED|Overall Study||9
3201367|NCT02126826|3930276|FG003|COMPLETED|Overall Study||8
3201368|NCT02126826|3930277|FG004|COMPLETED|Overall Study||5
3201369|NCT02126826|3930278|FG005|COMPLETED|Overall Study||9
3201370|NCT02126826|3930279|FG006|COMPLETED|Overall Study||8
3201371|NCT02126826|3930273|FG000|NOT COMPLETED|Overall Study||0
3201372|NCT02126826|3930274|FG001|NOT COMPLETED|Overall Study||0
3201373|NCT02126826|3930275|FG002|NOT COMPLETED|Overall Study||0
3201374|NCT02126826|3930276|FG003|NOT COMPLETED|Overall Study||1
3201375|NCT02126826|3930277|FG004|NOT COMPLETED|Overall Study||0
3201376|NCT02126826|3930278|FG005|NOT COMPLETED|Overall Study||0
3201377|NCT02126826|3930279|FG006|NOT COMPLETED|Overall Study||0
3201378|NCT02126839|3930302|FG000|STARTED|Overall Study||92
3201379|NCT02126839|3930303|FG001|STARTED|Overall Study||94
3201380|NCT02126839|3930302|FG000|Safety Population|Overall Study||92
3201381|NCT02126839|3930303|FG001|Safety Population|Overall Study||93
3201382|NCT02126839|3930302|FG000|Full Analysis Set|Overall Study||92
3201383|NCT02126839|3930303|FG001|Full Analysis Set|Overall Study||92
3201384|NCT02126839|3930302|FG000|COMPLETED|Overall Study||82
3201385|NCT02126839|3930303|FG001|COMPLETED|Overall Study||80
3201386|NCT02126839|3930302|FG000|NOT COMPLETED|Overall Study||10
3201387|NCT02126839|3930303|FG001|NOT COMPLETED|Overall Study||14
3201388|NCT02126969|3930311|FG000|STARTED|Overall Study||23
3201389|NCT02126969|3930312|FG001|STARTED|Overall Study||22
3201390|NCT02126969|3930311|FG000|COMPLETED|Overall Study||22
3201391|NCT02126969|3930312|FG001|COMPLETED|Overall Study||20
3201392|NCT02126969|3930311|FG000|NOT COMPLETED|Overall Study||1
3201393|NCT02126969|3930312|FG001|NOT COMPLETED|Overall Study||2
3201394|NCT02127125|3930327|FG000|STARTED|Overall Study||6
3201395|NCT02127125|3930328|FG001|STARTED|Overall Study||8
3201396|NCT02127125|3930329|FG002|STARTED|Overall Study||9
3201397|NCT02127125|3930330|FG003|STARTED|Overall Study||11
3201398|NCT02127125|3930331|FG004|STARTED|Overall Study||12
3201399|NCT02127125|3930332|FG005|STARTED|Overall Study||12
3201400|NCT02127125|3930333|FG006|STARTED|Overall Study||2
3201401|NCT02127125|3930334|FG007|STARTED|Overall Study||0
3201402|NCT02127125|3930335|FG008|STARTED|Overall Study||1
3201403|NCT02127125|3930327|FG000|COMPLETED|Overall Study||6
3201404|NCT02127125|3930328|FG001|COMPLETED|Overall Study||8
3201405|NCT02127125|3930329|FG002|COMPLETED|Overall Study||8
3201406|NCT02127125|3930330|FG003|COMPLETED|Overall Study||10
3201407|NCT02127125|3930331|FG004|COMPLETED|Overall Study||9
3201408|NCT02127125|3930332|FG005|COMPLETED|Overall Study||9
3201409|NCT02127125|3930333|FG006|COMPLETED|Overall Study||2
3201410|NCT02127125|3930334|FG007|COMPLETED|Overall Study||0
3201411|NCT02127125|3930335|FG008|COMPLETED|Overall Study||1
3201412|NCT02127125|3930327|FG000|NOT COMPLETED|Overall Study||0
3201413|NCT02127125|3930328|FG001|NOT COMPLETED|Overall Study||0
3201414|NCT02127125|3930329|FG002|NOT COMPLETED|Overall Study||1
3201415|NCT02127125|3930330|FG003|NOT COMPLETED|Overall Study||1
3201416|NCT02127125|3930331|FG004|NOT COMPLETED|Overall Study||3
3201417|NCT02127125|3930332|FG005|NOT COMPLETED|Overall Study||3
3201418|NCT02127125|3930333|FG006|NOT COMPLETED|Overall Study||0
3201419|NCT02127125|3930334|FG007|NOT COMPLETED|Overall Study||0
3201420|NCT02127125|3930335|FG008|NOT COMPLETED|Overall Study||0
3201421|NCT02127281|3930357|FG000|STARTED|Overall Study||80
3201422|NCT02127281|3930358|FG001|STARTED|Overall Study||80
3201423|NCT02127281|3930357|FG000|COMPLETED|Overall Study||79
3201424|NCT02127281|3930358|FG001|COMPLETED|Overall Study||80
3201425|NCT02127281|3930357|FG000|NOT COMPLETED|Overall Study||1
3201426|NCT02127281|3930358|FG001|NOT COMPLETED|Overall Study||0
3201427|NCT02127307|3930364|FG000|STARTED|Overall Study||964
3201428|NCT02127307|3930364|FG000|COMPLETED|Overall Study||656
3201429|NCT02127307|3930364|FG000|NOT COMPLETED|Overall Study||308
3201430|NCT02127372|3930370|FG000|STARTED|Overall Study|Signed Consent|15
3201431|NCT02127372|3930371|FG001|STARTED|Overall Study|Signed Consent|28
3201432|NCT02127372|3930370|FG000|Started Study Treatment|Overall Study||15
3201433|NCT02127372|3930371|FG001|Started Study Treatment|Overall Study||28
3201434|NCT02127372|3930370|FG000|COMPLETED|Overall Study|Completed at least one cycle and were available for dose limiting toxicity (DLT) evaluation.|14
3201435|NCT02127372|3930371|FG001|COMPLETED|Overall Study||28
3201436|NCT02127372|3930370|FG000|NOT COMPLETED|Overall Study||1
3201437|NCT02127372|3930371|FG001|NOT COMPLETED|Overall Study||0
3201438|NCT02127567|3930378|FG000|STARTED|Overall Study|41 participants completed 123 domains, 3 domains were completed with the tool per participant|41
3201439|NCT02127567|3930378|FG000|COMPLETED|Overall Study||41
3201440|NCT02127567|3930378|FG000|NOT COMPLETED|Overall Study||0
3201441|NCT02127632|3930388|FG000|STARTED|Overall Study||50
3201442|NCT02127632|3930389|FG001|STARTED|Overall Study||50
3201443|NCT02127632|3930388|FG000|COMPLETED|Overall Study||50
3201444|NCT02127632|3930389|FG001|COMPLETED|Overall Study||50
3201445|NCT02127632|3930388|FG000|NOT COMPLETED|Overall Study||0
3201446|NCT02127632|3930389|FG001|NOT COMPLETED|Overall Study||0
3201447|NCT02127710|3930398|FG000|STARTED|Overall Study||46
3201448|NCT02127710|3930399|FG001|STARTED|Overall Study||47
3201449|NCT02127710|3930400|FG002|STARTED|Overall Study||16
3201450|NCT02127710|3930398|FG000|COMPLETED|Overall Study||46
3201451|NCT02127710|3930399|FG001|COMPLETED|Overall Study||47
3201452|NCT02127710|3930400|FG002|COMPLETED|Overall Study||16
3201453|NCT02127710|3930398|FG000|NOT COMPLETED|Overall Study||0
3365214|NCT03987932|4096306|FG000|STARTED|Overall Study||4
3365215|NCT03987932|4096307|FG001|STARTED|Overall Study||3
3365216|NCT03987932|4096308|FG002|STARTED|Overall Study||4
3365217|NCT03987932|4096306|FG000|1 Month|Overall Study||4
3365218|NCT03987932|4096307|FG001|1 Month|Overall Study||2
3365219|NCT03987932|4096308|FG002|1 Month|Overall Study||3
3365220|NCT03987932|4096306|FG000|3 Months|Overall Study||4
3365221|NCT03987932|4096307|FG001|3 Months|Overall Study||2
3365222|NCT03987932|4096308|FG002|3 Months|Overall Study||3
3365223|NCT03987932|4096306|FG000|6 Months|Overall Study||2
3365224|NCT03987932|4096307|FG001|6 Months|Overall Study||2
3365225|NCT03987932|4096308|FG002|6 Months|Overall Study||2
3365226|NCT03987932|4096306|FG000|COMPLETED|Overall Study||2
3365227|NCT03987932|4096307|FG001|COMPLETED|Overall Study||2
3365228|NCT03987932|4096308|FG002|COMPLETED|Overall Study||2
3365229|NCT03987932|4096306|FG000|NOT COMPLETED|Overall Study||2
3365230|NCT03987932|4096307|FG001|NOT COMPLETED|Overall Study||1
3365231|NCT03987932|4096308|FG002|NOT COMPLETED|Overall Study||2
3365232|NCT03987191|4096318|FG000|STARTED|Overall Study||17
3365233|NCT03987191|4096319|FG001|STARTED|Overall Study||15
3365234|NCT03987191|4096318|FG000|Data Collected|Overall Study||17
3365235|NCT03987191|4096319|FG001|Data Collected|Overall Study||13
3365236|NCT03987191|4096318|FG000|COMPLETED|Overall Study||17
3365237|NCT03987191|4096319|FG001|COMPLETED|Overall Study||13
3365238|NCT03987191|4096318|FG000|NOT COMPLETED|Overall Study||0
3365239|NCT03987191|4096319|FG001|NOT COMPLETED|Overall Study||2
3365240|NCT03988842|4096325|FG000|STARTED|Overall Study||4
3365241|NCT03988842|4096325|FG000|COMPLETED|Overall Study||3
3365242|NCT03988842|4096325|FG000|NOT COMPLETED|Overall Study||1
3365243|NCT03981861|4096330|FG000|STARTED|Overall Study||12
3365244|NCT03981861|4096330|FG000|COMPLETED|Overall Study||9
3365245|NCT03981861|4096330|FG000|NOT COMPLETED|Overall Study||3
3365246|NCT03974334|4096334|FG000|STARTED|Overall Study||25
3365247|NCT03974334|4096334|FG000|COMPLETED|Overall Study||24
3365248|NCT03974334|4096334|FG000|NOT COMPLETED|Overall Study||1
3365249|NCT03988426|4096338|FG000|STARTED|Overall Study||25
3365250|NCT03988426|4096338|FG000|COMPLETED|Overall Study||24
3365251|NCT03988426|4096338|FG000|NOT COMPLETED|Overall Study||1
3365252|NCT03988374|4096347|FG000|STARTED|Overall Study||104
3201454|NCT02127710|3930399|FG001|NOT COMPLETED|Overall Study||0
3201455|NCT02127710|3930400|FG002|NOT COMPLETED|Overall Study||0
3365253|NCT03988374|4096348|FG001|STARTED|Overall Study||107
3201456|NCT02127723|3930411|FG000|STARTED|Overall Study||20
3201457|NCT02127723|3930411|FG000|COMPLETED|Overall Study||19
3201458|NCT02127723|3930411|FG000|NOT COMPLETED|Overall Study||1
3201459|NCT02127892|3930419|FG000|STARTED|Overall Study||7
3201460|NCT02127892|3930420|FG001|STARTED|Overall Study||2
3201461|NCT02127892|3930421|FG002|STARTED|Overall Study||0
3201462|NCT02127892|3930422|FG003|STARTED|Overall Study||0
3201463|NCT02127892|3930419|FG000|COMPLETED|Overall Study||6
3201464|NCT02127892|3930420|FG001|COMPLETED|Overall Study||1
3201465|NCT02127892|3930421|FG002|COMPLETED|Overall Study||0
3201466|NCT02127892|3930422|FG003|COMPLETED|Overall Study||0
3201467|NCT02127892|3930419|FG000|NOT COMPLETED|Overall Study||1
3201468|NCT02127892|3930420|FG001|NOT COMPLETED|Overall Study||1
3201469|NCT02127892|3930421|FG002|NOT COMPLETED|Overall Study||0
3201470|NCT02127892|3930422|FG003|NOT COMPLETED|Overall Study||0
3201471|NCT02127931|3930432|FG000|STARTED|Overall Study||18
3201472|NCT02127931|3930432|FG000|COMPLETED|Overall Study||17
3201473|NCT02127931|3930432|FG000|NOT COMPLETED|Overall Study||1
3201474|NCT02127970|3930439|FG000|STARTED|Overall Study||349
3201475|NCT02127970|3930440|FG001|STARTED|Overall Study||349
3201476|NCT02127970|3930439|FG000|COMPLETED|Overall Study||323
3201477|NCT02127970|3930440|FG001|COMPLETED|Overall Study||322
3201478|NCT02127970|3930439|FG000|NOT COMPLETED|Overall Study||26
3201479|NCT02127970|3930440|FG001|NOT COMPLETED|Overall Study||27
3201480|NCT02128074|3930446|FG000|STARTED|Overall Study||32
3201481|NCT02128074|3930446|FG000|COMPLETED|Overall Study||26
3201482|NCT02128074|3930446|FG000|NOT COMPLETED|Overall Study||6
3201483|NCT02128217|3930452|FG000|STARTED|Overall Study||17
3201484|NCT02128217|3930453|FG001|STARTED|Overall Study||27
3201485|NCT02128217|3930452|FG000|COMPLETED|Overall Study||17
3201486|NCT02128217|3930453|FG001|COMPLETED|Overall Study||26
3201487|NCT02128217|3930452|FG000|NOT COMPLETED|Overall Study||0
3201488|NCT02128217|3930453|FG001|NOT COMPLETED|Overall Study||1
3201489|NCT02128230|3930464|FG000|STARTED|Overall Study||20
3201490|NCT02128230|3930464|FG000|COMPLETED|Overall Study||1
3201491|NCT02128230|3930464|FG000|NOT COMPLETED|Overall Study||19
3201492|NCT02128269|3930468|FG000|STARTED|Treatment Period||9
3201493|NCT02128269|3930468|FG000|COMPLETED|Treatment Period||7
3201494|NCT02128269|3930468|FG000|NOT COMPLETED|Treatment Period||2
3201495|NCT02128269|3930468|FG000|STARTED|Follow-up|All enrolled patients were followed for 12 weeks after their last infusion of ALXN1007.|9
3201496|NCT02128269|3930468|FG000|COMPLETED|Follow-up||9
3201497|NCT02128269|3930468|FG000|NOT COMPLETED|Follow-up||0
3201498|NCT02128490|3930477|FG000|STARTED|Overall Study||38
3201499|NCT02128490|3930478|FG001|STARTED|Overall Study||37
3201500|NCT02128490|3930479|FG002|STARTED|Overall Study||39
3201501|NCT02128490|3930480|FG003|STARTED|Overall Study||37
3201502|NCT02128490|3930481|FG004|STARTED|Overall Study||38
3201503|NCT02128490|3930477|FG000|COMPLETED|Overall Study||33
3201504|NCT02128490|3930478|FG001|COMPLETED|Overall Study||31
3201505|NCT02128490|3930479|FG002|COMPLETED|Overall Study||34
3201506|NCT02128490|3930480|FG003|COMPLETED|Overall Study||31
3201507|NCT02128490|3930481|FG004|COMPLETED|Overall Study||31
3201508|NCT02128490|3930477|FG000|NOT COMPLETED|Overall Study||5
3201509|NCT02128490|3930478|FG001|NOT COMPLETED|Overall Study||6
3201510|NCT02128490|3930479|FG002|NOT COMPLETED|Overall Study||5
3201511|NCT02128490|3930480|FG003|NOT COMPLETED|Overall Study||6
3201512|NCT02128490|3930481|FG004|NOT COMPLETED|Overall Study||7
3201513|NCT02128542|3930495|FG000|STARTED|Overall Study||47
3201514|NCT02128542|3930496|FG001|STARTED|Overall Study||19
3201515|NCT02128542|3930495|FG000|COMPLETED|Overall Study||43
3201516|NCT02128542|3930496|FG001|COMPLETED|Overall Study||19
3201517|NCT02128542|3930495|FG000|NOT COMPLETED|Overall Study||4
3201518|NCT02128542|3930496|FG001|NOT COMPLETED|Overall Study||0
3201519|NCT02128724|3930508|FG000|STARTED|Overall Study||4
3201520|NCT02128724|3930509|FG001|STARTED|Overall Study||4
3201521|NCT02128724|3930510|FG002|STARTED|Overall Study||3
3201522|NCT02128724|3930511|FG003|STARTED|Overall Study||10
3201523|NCT02128724|3930508|FG000|COMPLETED|Overall Study||3
3201524|NCT02128724|3930509|FG001|COMPLETED|Overall Study||3
3201525|NCT02128724|3930510|FG002|COMPLETED|Overall Study||3
3201526|NCT02128724|3930511|FG003|COMPLETED|Overall Study||7
3201527|NCT02128724|3930508|FG000|NOT COMPLETED|Overall Study||1
3201528|NCT02128724|3930509|FG001|NOT COMPLETED|Overall Study||1
3201529|NCT02128724|3930510|FG002|NOT COMPLETED|Overall Study||0
3201530|NCT02128724|3930511|FG003|NOT COMPLETED|Overall Study||3
3201531|NCT02128763|3930522|FG000|STARTED|Overall Study||349
3201532|NCT02128763|3930523|FG001|STARTED|Overall Study||186
3201533|NCT02128763|3930522|FG000|COMPLETED|Overall Study||329
3201534|NCT02128763|3930523|FG001|COMPLETED|Overall Study||170
3201535|NCT02128763|3930522|FG000|NOT COMPLETED|Overall Study||20
3201536|NCT02128763|3930523|FG001|NOT COMPLETED|Overall Study||16
3201537|NCT02128828|3930532|FG000|STARTED|Overall Study||20
3201538|NCT02128828|3930532|FG000|COMPLETED|Overall Study||17
3201539|NCT02128828|3930532|FG000|NOT COMPLETED|Overall Study||3
3201540|NCT02128867|3930539|FG000|STARTED|Overall Study||53
3201541|NCT02128867|3930540|FG001|STARTED|Overall Study||52
3201542|NCT02128867|3930541|FG002|STARTED|Overall Study||54
3201543|NCT02128867|3930539|FG000|COMPLETED|Overall Study||50
3201544|NCT02128867|3930540|FG001|COMPLETED|Overall Study||50
3201545|NCT02128867|3930541|FG002|COMPLETED|Overall Study||50
3201546|NCT02128867|3930539|FG000|NOT COMPLETED|Overall Study||3
3201547|NCT02128867|3930540|FG001|NOT COMPLETED|Overall Study||2
3201548|NCT02128867|3930541|FG002|NOT COMPLETED|Overall Study||4
3201549|NCT02128919|3930551|FG000|STARTED|Overall Study||17
3201550|NCT02128919|3930552|FG001|STARTED|Overall Study||16
3201551|NCT02128919|3930551|FG000|COMPLETED|Overall Study||14
3201552|NCT02128919|3930552|FG001|COMPLETED|Overall Study||15
3201553|NCT02128919|3930551|FG000|NOT COMPLETED|Overall Study||3
3201554|NCT02128919|3930552|FG001|NOT COMPLETED|Overall Study||1
3201555|NCT02128932|3930562|FG000|STARTED|Overall Study||362
3201556|NCT02128932|3930563|FG001|STARTED|Overall Study||360
3201557|NCT02128932|3930564|FG002|STARTED|Overall Study||360
3201558|NCT02128932|3930562|FG000|COMPLETED|Overall Study||335
3201559|NCT02128932|3930563|FG001|COMPLETED|Overall Study||341
3201560|NCT02128932|3930564|FG002|COMPLETED|Overall Study||342
3201561|NCT02128932|3930562|FG000|NOT COMPLETED|Overall Study||27
3201562|NCT02128932|3930563|FG001|NOT COMPLETED|Overall Study||19
3201563|NCT02128932|3930564|FG002|NOT COMPLETED|Overall Study||18
3201564|NCT02128997|3930574|FG000|STARTED|Overall Study||67
3201565|NCT02128997|3930575|FG001|STARTED|Overall Study||69
3201566|NCT02128997|3930574|FG000|COMPLETED|Overall Study||61
3201567|NCT02128997|3930575|FG001|COMPLETED|Overall Study||58
3201568|NCT02128997|3930574|FG000|NOT COMPLETED|Overall Study||6
3201569|NCT02128997|3930575|FG001|NOT COMPLETED|Overall Study||11
3201570|NCT02129062|3930581|FG000|STARTED|Overall Study||3
3201571|NCT02129062|3930581|FG000|COMPLETED|Overall Study||0
3201572|NCT02129062|3930581|FG000|NOT COMPLETED|Overall Study||3
3201573|NCT02129075|3930587|FG000|STARTED|Overall Study||30
3201574|NCT02129075|3930588|FG001|STARTED|Overall Study||30
3201575|NCT02129075|3930587|FG000|COMPLETED|Overall Study||30
3201576|NCT02129075|3930588|FG001|COMPLETED|Overall Study||30
3201577|NCT02129075|3930587|FG000|NOT COMPLETED|Overall Study||0
3201578|NCT02129075|3930588|FG001|NOT COMPLETED|Overall Study||0
3201579|NCT02129192|3930598|FG000|STARTED|Period 1 Including Washout Period||36
3201580|NCT02129192|3930599|FG001|STARTED|Period 1 Including Washout Period||36
3201581|NCT02129192|3930598|FG000|COMPLETED|Period 1 Including Washout Period||36
3201582|NCT02129192|3930599|FG001|COMPLETED|Period 1 Including Washout Period|Withdrawal by one subject in washout period|35
3201583|NCT02129192|3930598|FG000|NOT COMPLETED|Period 1 Including Washout Period||0
3201584|NCT02129192|3930599|FG001|NOT COMPLETED|Period 1 Including Washout Period||1
3201585|NCT02129192|3930598|FG000|STARTED|Period 2 Including Washout Period||36
3201586|NCT02129192|3930599|FG001|STARTED|Period 2 Including Washout Period||35
3201587|NCT02129192|3930598|FG000|COMPLETED|Period 2 Including Washout Period||36
3201588|NCT02129192|3930599|FG001|COMPLETED|Period 2 Including Washout Period||35
3201589|NCT02129192|3930598|FG000|NOT COMPLETED|Period 2 Including Washout Period||0
3201590|NCT02129192|3930599|FG001|NOT COMPLETED|Period 2 Including Washout Period||0
3201591|NCT02129192|3930598|FG000|STARTED|Period 3 Including Washout Period||36
3201592|NCT02129192|3930599|FG001|STARTED|Period 3 Including Washout Period||35
3201593|NCT02129192|3930598|FG000|COMPLETED|Period 3 Including Washout Period||36
3201594|NCT02129192|3930599|FG001|COMPLETED|Period 3 Including Washout Period||35
3201595|NCT02129192|3930598|FG000|NOT COMPLETED|Period 3 Including Washout Period||0
3201596|NCT02129192|3930599|FG001|NOT COMPLETED|Period 3 Including Washout Period||0
3201597|NCT02129192|3930598|FG000|STARTED|Period 4 Including Washout Period||36
3201598|NCT02129192|3930599|FG001|STARTED|Period 4 Including Washout Period||35
3201599|NCT02129192|3930598|FG000|COMPLETED|Period 4 Including Washout Period||36
3201600|NCT02129192|3930599|FG001|COMPLETED|Period 4 Including Washout Period||35
3201601|NCT02129192|3930598|FG000|NOT COMPLETED|Period 4 Including Washout Period||0
3201602|NCT02129192|3930599|FG001|NOT COMPLETED|Period 4 Including Washout Period||0
3201603|NCT02129192|3930598|FG000|STARTED|Period 5||36
3201604|NCT02129192|3930599|FG001|STARTED|Period 5|This sequence consists of only 4 periods.|0
3201605|NCT02129192|3930598|FG000|COMPLETED|Period 5||36
3201606|NCT02129192|3930599|FG001|COMPLETED|Period 5||0
3201607|NCT02129192|3930598|FG000|NOT COMPLETED|Period 5||0
3201608|NCT02129192|3930599|FG001|NOT COMPLETED|Period 5||0
3201609|NCT02129205|3930618|FG000|STARTED|Overall Study||2
3201610|NCT02129205|3930619|FG001|STARTED|Overall Study||2
3201611|NCT02129205|3930620|FG002|STARTED|Overall Study||2
3201612|NCT02129205|3930621|FG003|STARTED|Overall Study||2
3201613|NCT02129205|3930622|FG004|STARTED|Overall Study||7
3201614|NCT02129205|3930623|FG005|STARTED|Overall Study||11
3201615|NCT02129205|3930624|FG006|STARTED|Overall Study||6
3201616|NCT02129205|3930625|FG007|STARTED|Overall Study||6
3201617|NCT02129205|3930626|FG008|STARTED|Overall Study||2
3201618|NCT02129205|3930627|FG009|STARTED|Overall Study||0
3201619|NCT02129205|3930618|FG000|COMPLETED|Overall Study||1
3201620|NCT02129205|3930619|FG001|COMPLETED|Overall Study||2
3201621|NCT02129205|3930620|FG002|COMPLETED|Overall Study||2
3201622|NCT02129205|3930621|FG003|COMPLETED|Overall Study||2
3201623|NCT02129205|3930622|FG004|COMPLETED|Overall Study||4
3201624|NCT02129205|3930623|FG005|COMPLETED|Overall Study||7
3201625|NCT02129205|3930624|FG006|COMPLETED|Overall Study||2
3201626|NCT02129205|3930625|FG007|COMPLETED|Overall Study||4
3201627|NCT02129205|3930626|FG008|COMPLETED|Overall Study||0
3201628|NCT02129205|3930627|FG009|COMPLETED|Overall Study||0
3201629|NCT02129205|3930618|FG000|NOT COMPLETED|Overall Study||1
3201630|NCT02129205|3930619|FG001|NOT COMPLETED|Overall Study||0
3201631|NCT02129205|3930620|FG002|NOT COMPLETED|Overall Study||0
3201632|NCT02129205|3930621|FG003|NOT COMPLETED|Overall Study||0
3201633|NCT02129205|3930622|FG004|NOT COMPLETED|Overall Study||3
3201634|NCT02129205|3930623|FG005|NOT COMPLETED|Overall Study||4
3201635|NCT02129205|3930624|FG006|NOT COMPLETED|Overall Study||4
3201636|NCT02129205|3930625|FG007|NOT COMPLETED|Overall Study||2
3201637|NCT02129205|3930626|FG008|NOT COMPLETED|Overall Study||2
3201638|NCT02129205|3930627|FG009|NOT COMPLETED|Overall Study||0
3201639|NCT02129348|3930653|FG000|STARTED|Overall Study||38
3201640|NCT02129348|3930654|FG001|STARTED|Overall Study||39
3201641|NCT02129348|3930653|FG000|COMPLETED|Overall Study||29
3201642|NCT02129348|3930654|FG001|COMPLETED|Overall Study||29
3201643|NCT02129348|3930653|FG000|NOT COMPLETED|Overall Study||9
3201644|NCT02129348|3930654|FG001|NOT COMPLETED|Overall Study||10
3201645|NCT02129426|3930662|FG000|STARTED|Overall Study||7
3201646|NCT02129426|3930663|FG001|STARTED|Overall Study||13
3201647|NCT02129426|3930662|FG000|COMPLETED|Overall Study||0
3201648|NCT02129426|3930663|FG001|COMPLETED|Overall Study||0
3201649|NCT02129426|3930662|FG000|NOT COMPLETED|Overall Study||7
3201650|NCT02129426|3930663|FG001|NOT COMPLETED|Overall Study||13
3201651|NCT02129478|3930669|FG000|STARTED|Overall Study||15
3201652|NCT02129478|3930669|FG000|COMPLETED|Overall Study||15
3201653|NCT02129478|3930669|FG000|NOT COMPLETED|Overall Study||0
3201654|NCT02129556|3930676|FG000|STARTED|Overall Study||3
3201655|NCT02129556|3930677|FG001|STARTED|Overall Study||3
3201656|NCT02129556|3930678|FG002|STARTED|Overall Study||40
3201657|NCT02129556|3930679|FG003|STARTED|Overall Study||12
3201658|NCT02129556|3930676|FG000|COMPLETED|Overall Study||3
3201659|NCT02129556|3930677|FG001|COMPLETED|Overall Study||3
3201660|NCT02129556|3930678|FG002|COMPLETED|Overall Study||37
3201661|NCT02129556|3930679|FG003|COMPLETED|Overall Study||12
3201662|NCT02129556|3930676|FG000|NOT COMPLETED|Overall Study||0
3201663|NCT02129556|3930677|FG001|NOT COMPLETED|Overall Study||0
3201664|NCT02129556|3930678|FG002|NOT COMPLETED|Overall Study||3
3201665|NCT02129556|3930679|FG003|NOT COMPLETED|Overall Study||0
3201666|NCT02129608|3930691|FG000|STARTED|Overall Study||15
3201667|NCT02129608|3930692|FG001|STARTED|Overall Study||14
3201668|NCT02129608|3930693|FG002|STARTED|Overall Study||15
3201669|NCT02129608|3930691|FG000|End of Treatment|Overall Study||15
3201670|NCT02129608|3930692|FG001|End of Treatment|Overall Study||13
3201671|NCT02129608|3930693|FG002|End of Treatment|Overall Study||12
3201672|NCT02129608|3930691|FG000|COMPLETED|Overall Study||15
3201673|NCT02129608|3930692|FG001|COMPLETED|Overall Study||13
3201674|NCT02129608|3930693|FG002|COMPLETED|Overall Study||12
3201675|NCT02129608|3930691|FG000|NOT COMPLETED|Overall Study||0
3201676|NCT02129608|3930692|FG001|NOT COMPLETED|Overall Study||1
3201677|NCT02129608|3930693|FG002|NOT COMPLETED|Overall Study||3
3201678|NCT02129660|3930706|FG000|STARTED|Overall Study||21
3201679|NCT02129660|3930707|FG001|STARTED|Overall Study||20
3201680|NCT02129660|3930708|FG002|STARTED|Overall Study||22
3201681|NCT02129660|3930709|FG003|STARTED|Overall Study||20
3201682|NCT02129660|3930710|FG004|STARTED|Overall Study||22
3201683|NCT02129660|3930706|FG000|COMPLETED|Overall Study||19
3201684|NCT02129660|3930707|FG001|COMPLETED|Overall Study||20
3201685|NCT02129660|3930708|FG002|COMPLETED|Overall Study||21
3201686|NCT02129660|3930709|FG003|COMPLETED|Overall Study||20
3201687|NCT02129660|3930710|FG004|COMPLETED|Overall Study||20
3201688|NCT02129660|3930706|FG000|NOT COMPLETED|Overall Study||2
3201689|NCT02129660|3930707|FG001|NOT COMPLETED|Overall Study||0
3201690|NCT02129660|3930708|FG002|NOT COMPLETED|Overall Study||1
3201691|NCT02129660|3930709|FG003|NOT COMPLETED|Overall Study||0
3201692|NCT02129660|3930710|FG004|NOT COMPLETED|Overall Study||2
3201693|NCT02129725|3930725|FG000|STARTED|Overall Study||8
3201694|NCT02129725|3930726|FG001|STARTED|Overall Study||7
3201695|NCT02129725|3930725|FG000|COMPLETED|Overall Study||6
3201696|NCT02129725|3930726|FG001|COMPLETED|Overall Study||4
3201697|NCT02129725|3930725|FG000|NOT COMPLETED|Overall Study||2
3201698|NCT02129725|3930726|FG001|NOT COMPLETED|Overall Study||3
3201699|NCT02129777|3930737|FG000|STARTED|Double-Blind Period||24
3201700|NCT02129777|3930738|FG001|STARTED|Double-Blind Period||24
3201701|NCT02129777|3930739|FG002|STARTED|Double-Blind Period||24
3201702|NCT02129777|3930740|FG003|STARTED|Double-Blind Period||25
3201703|NCT02129777|3930741|FG004|STARTED|Double-Blind Period||25
3201704|NCT02129777|3930742|FG005|STARTED|Double-Blind Period||0
3201705|NCT02129777|3930743|FG006|STARTED|Double-Blind Period||0
3201706|NCT02129777|3930737|FG000|COMPLETED|Double-Blind Period||17
3201707|NCT02129777|3930738|FG001|COMPLETED|Double-Blind Period||16
3201708|NCT02129777|3930739|FG002|COMPLETED|Double-Blind Period||20
3201709|NCT02129777|3930740|FG003|COMPLETED|Double-Blind Period||18
3201710|NCT02129777|3930741|FG004|COMPLETED|Double-Blind Period||18
3201711|NCT02129777|3930742|FG005|COMPLETED|Double-Blind Period||0
3201712|NCT02129777|3930743|FG006|COMPLETED|Double-Blind Period||0
3365254|NCT03988374|4096349|FG002|STARTED|Overall Study||108
3365255|NCT03988374|4096347|FG000|COMPLETED|Overall Study||103
3365256|NCT03988374|4096348|FG001|COMPLETED|Overall Study||105
3365257|NCT03988374|4096349|FG002|COMPLETED|Overall Study||107
3365258|NCT03988374|4096347|FG000|NOT COMPLETED|Overall Study||1
3365259|NCT03988374|4096348|FG001|NOT COMPLETED|Overall Study||2
3365260|NCT03988374|4096349|FG002|NOT COMPLETED|Overall Study||1
3365261|NCT03987074|4096362|FG000|STARTED|Overall Study||21
3365262|NCT03987074|4096363|FG001|STARTED|Overall Study||22
3365263|NCT03987074|4096364|FG002|STARTED|Overall Study||22
3365264|NCT03987074|4096365|FG003|STARTED|Overall Study||22
3201713|NCT02129777|3930737|FG000|NOT COMPLETED|Double-Blind Period||7
3201714|NCT02129777|3930738|FG001|NOT COMPLETED|Double-Blind Period||8
3201715|NCT02129777|3930739|FG002|NOT COMPLETED|Double-Blind Period||4
3201716|NCT02129777|3930740|FG003|NOT COMPLETED|Double-Blind Period||7
3201717|NCT02129777|3930741|FG004|NOT COMPLETED|Double-Blind Period||7
3201718|NCT02129777|3930742|FG005|NOT COMPLETED|Double-Blind Period||0
3201719|NCT02129777|3930743|FG006|NOT COMPLETED|Double-Blind Period||0
3201720|NCT02129777|3930737|FG000|STARTED|Open-Label Period||0
3201721|NCT02129777|3930738|FG001|STARTED|Open-Label Period||0
3201722|NCT02129777|3930739|FG002|STARTED|Open-Label Period||0
3201723|NCT02129777|3930740|FG003|STARTED|Open-Label Period||0
3201724|NCT02129777|3930741|FG004|STARTED|Open-Label Period||0
3201725|NCT02129777|3930742|FG005|STARTED|Open-Label Period||12
3201726|NCT02129777|3930743|FG006|STARTED|Open-Label Period||48
3201727|NCT02129777|3930737|FG000|COMPLETED|Open-Label Period||0
3201728|NCT02129777|3930738|FG001|COMPLETED|Open-Label Period||0
3201729|NCT02129777|3930739|FG002|COMPLETED|Open-Label Period||0
3201730|NCT02129777|3930740|FG003|COMPLETED|Open-Label Period||0
3201731|NCT02129777|3930741|FG004|COMPLETED|Open-Label Period||0
3201732|NCT02129777|3930742|FG005|COMPLETED|Open-Label Period||0
3201733|NCT02129777|3930743|FG006|COMPLETED|Open-Label Period||0
3201734|NCT02129777|3930737|FG000|NOT COMPLETED|Open-Label Period||0
3201735|NCT02129777|3930738|FG001|NOT COMPLETED|Open-Label Period||0
3201736|NCT02129777|3930739|FG002|NOT COMPLETED|Open-Label Period||0
3201737|NCT02129777|3930740|FG003|NOT COMPLETED|Open-Label Period||0
3201738|NCT02129777|3930741|FG004|NOT COMPLETED|Open-Label Period||0
3201739|NCT02129777|3930742|FG005|NOT COMPLETED|Open-Label Period||12
3201740|NCT02129777|3930743|FG006|NOT COMPLETED|Open-Label Period||48
3201741|NCT02129803|3930764|FG000|STARTED|Overall Study||12
3201742|NCT02129803|3930765|FG001|STARTED|Overall Study||12
3201743|NCT02129803|3930764|FG000|COMPLETED|Overall Study||6
3201744|NCT02129803|3930765|FG001|COMPLETED|Overall Study||9
3201745|NCT02129803|3930764|FG000|NOT COMPLETED|Overall Study||6
3201746|NCT02129803|3930765|FG001|NOT COMPLETED|Overall Study||3
3201747|NCT02130024|3930773|FG000|STARTED|Overall Study||142
3201748|NCT02130024|3930774|FG001|STARTED|Overall Study||139
3201749|NCT02130024|3930773|FG000|Safety Set|Overall Study|One randomized patient did not receive treatment|141
3201750|NCT02130024|3930774|FG001|Safety Set|Overall Study||139
3201751|NCT02130024|3930773|FG000|Full Analysis Set (FAS)|Overall Study||141
3201752|NCT02130024|3930774|FG001|Full Analysis Set (FAS)|Overall Study|2 patients had no post Baseline geographic atrophy (GA) data|137
3201753|NCT02130024|3930773|FG000|COMPLETED|Overall Study||117
3201754|NCT02130024|3930774|FG001|COMPLETED|Overall Study||108
3201755|NCT02130024|3930773|FG000|NOT COMPLETED|Overall Study||25
3201756|NCT02130024|3930774|FG001|NOT COMPLETED|Overall Study||31
3201757|NCT02130063|3930782|FG000|STARTED|Overall Study||342
3201758|NCT02130063|3930783|FG001|STARTED|Overall Study||169
3201759|NCT02130063|3930782|FG000|COMPLETED|Overall Study||317
3201760|NCT02130063|3930783|FG001|COMPLETED|Overall Study||152
3201761|NCT02130063|3930782|FG000|NOT COMPLETED|Overall Study||25
3201762|NCT02130063|3930783|FG001|NOT COMPLETED|Overall Study||17
3201763|NCT02130193|3930791|FG000|STARTED|Part A: 4-week Open-label Period||9
3201764|NCT02130193|3930792|FG001|STARTED|Part A: 4-week Open-label Period||0
3201765|NCT02130193|3930793|FG002|STARTED|Part A: 4-week Open-label Period||0
3201766|NCT02130193|3930791|FG000|COMPLETED|Part A: 4-week Open-label Period||9
3201767|NCT02130193|3930792|FG001|COMPLETED|Part A: 4-week Open-label Period||0
3201768|NCT02130193|3930793|FG002|COMPLETED|Part A: 4-week Open-label Period||0
3201769|NCT02130193|3930791|FG000|NOT COMPLETED|Part A: 4-week Open-label Period||0
3201770|NCT02130193|3930792|FG001|NOT COMPLETED|Part A: 4-week Open-label Period||0
3201771|NCT02130193|3930793|FG002|NOT COMPLETED|Part A: 4-week Open-label Period||0
3201772|NCT02130193|3930791|FG000|STARTED|Part B: 52-week Double-blind Period||0
3201773|NCT02130193|3930792|FG001|STARTED|Part B: 52-week Double-blind Period||48
3201774|NCT02130193|3930793|FG002|STARTED|Part B: 52-week Double-blind Period||45
3201775|NCT02130193|3930791|FG000|COMPLETED|Part B: 52-week Double-blind Period||0
3201776|NCT02130193|3930792|FG001|COMPLETED|Part B: 52-week Double-blind Period||38
3201777|NCT02130193|3930793|FG002|COMPLETED|Part B: 52-week Double-blind Period||37
3201778|NCT02130193|3930791|FG000|NOT COMPLETED|Part B: 52-week Double-blind Period||0
3201779|NCT02130193|3930792|FG001|NOT COMPLETED|Part B: 52-week Double-blind Period||10
3201780|NCT02130193|3930793|FG002|NOT COMPLETED|Part B: 52-week Double-blind Period||8
3201781|NCT02130258|3930804|FG000|STARTED|Overall Study||9
3201782|NCT02130258|3930805|FG001|STARTED|Overall Study||11
3201783|NCT02130258|3930804|FG000|COMPLETED|Overall Study||9
3201784|NCT02130258|3930805|FG001|COMPLETED|Overall Study||11
3201785|NCT02130258|3930804|FG000|NOT COMPLETED|Overall Study||0
3201786|NCT02130258|3930805|FG001|NOT COMPLETED|Overall Study||0
3365265|NCT03987074|4096366|FG004|STARTED|Overall Study||21
3365266|NCT03987074|4096362|FG000|COMPLETED|Overall Study||18
3365267|NCT03987074|4096363|FG001|COMPLETED|Overall Study||20
3365268|NCT03987074|4096364|FG002|COMPLETED|Overall Study||21
3365269|NCT03987074|4096365|FG003|COMPLETED|Overall Study||18
3365270|NCT03987074|4096366|FG004|COMPLETED|Overall Study||19
3365271|NCT03987074|4096362|FG000|NOT COMPLETED|Overall Study||3
3365272|NCT03987074|4096363|FG001|NOT COMPLETED|Overall Study||2
3365273|NCT03987074|4096364|FG002|NOT COMPLETED|Overall Study||1
3365274|NCT03987074|4096365|FG003|NOT COMPLETED|Overall Study||4
3365275|NCT03987074|4096366|FG004|NOT COMPLETED|Overall Study||2
3365276|NCT03977935|4096380|FG000|STARTED|Overall Study||40
3365277|NCT03977935|4096381|FG001|STARTED|Overall Study||40
3365278|NCT03977935|4096380|FG000|COMPLETED|Overall Study||40
3365279|NCT03977935|4096381|FG001|COMPLETED|Overall Study||40
3365280|NCT03977935|4096380|FG000|NOT COMPLETED|Overall Study||0
3365281|NCT03977935|4096381|FG001|NOT COMPLETED|Overall Study||0
3365282|NCT03988049|4096389|FG000|STARTED|Overall Study||22
3201787|NCT02130284|3930811|FG000|STARTED|Overall Study||80
3201788|NCT02130284|3930811|FG000|COMPLETED|Overall Study||71
3201789|NCT02130284|3930811|FG000|NOT COMPLETED|Overall Study||9
3201790|NCT02130297|3930815|FG000|STARTED|Overall Study||30
3201791|NCT02130297|3930815|FG000|COMPLETED|Overall Study||26
3201792|NCT02130297|3930815|FG000|NOT COMPLETED|Overall Study||4
3201793|NCT02130427|3930819|FG000|STARTED|Overall Study||74
3201794|NCT02130427|3930819|FG000|COMPLETED|Overall Study||44
3201795|NCT02130427|3930819|FG000|NOT COMPLETED|Overall Study||30
3201796|NCT02130557|3930825|FG000|STARTED|Overall Study||268
3201797|NCT02130557|3930826|FG001|STARTED|Overall Study||268
3201798|NCT02130557|3930825|FG000|Treated|Overall Study||268
3201799|NCT02130557|3930826|FG001|Treated|Overall Study||265
3201800|NCT02130557|3930825|FG000|mITT Population|Overall Study||246
3201801|NCT02130557|3930826|FG001|mITT Population|Overall Study||241
3201802|NCT02130557|3930825|FG000|COMPLETED|Overall Study||232
3201803|NCT02130557|3930826|FG001|COMPLETED|Overall Study||231
3201804|NCT02130557|3930825|FG000|NOT COMPLETED|Overall Study||36
3201805|NCT02130557|3930826|FG001|NOT COMPLETED|Overall Study||37
3201806|NCT02130570|3930834|FG000|STARTED|Overall Study||987
3201807|NCT02130570|3930835|FG001|STARTED|Overall Study||692
3201808|NCT02130570|3930834|FG000|COMPLETED|Overall Study|Participants enrolled, did not die during index admission, did not withdraw consent|978
3201809|NCT02130570|3930835|FG001|COMPLETED|Overall Study|Participants enrolled, did not die during index admission, did not withdraw consent|679
3201810|NCT02130570|3930834|FG000|NOT COMPLETED|Overall Study||9
3201811|NCT02130570|3930835|FG001|NOT COMPLETED|Overall Study||13
3201812|NCT02130583|3930844|FG000|STARTED|Overall Study||26
3201813|NCT02130583|3930845|FG001|STARTED|Overall Study||26
3201814|NCT02130583|3930844|FG000|COMPLETED|Overall Study||17
3201815|NCT02130583|3930845|FG001|COMPLETED|Overall Study||19
3201816|NCT02130583|3930844|FG000|NOT COMPLETED|Overall Study||9
3201817|NCT02130583|3930845|FG001|NOT COMPLETED|Overall Study||7
3201818|NCT02130635|3930860|FG000|STARTED|Part A-Safety and Tolerability||7
3201819|NCT02130635|3930861|FG001|STARTED|Part A-Safety and Tolerability||21
3201820|NCT02130635|3930862|FG002|STARTED|Part A-Safety and Tolerability||0
3201821|NCT02130635|3930863|FG003|STARTED|Part A-Safety and Tolerability||0
3201822|NCT02130635|3930864|FG004|STARTED|Part A-Safety and Tolerability||0
3201823|NCT02130635|3930865|FG005|STARTED|Part A-Safety and Tolerability||0
3201824|NCT02130635|3930866|FG006|STARTED|Part A-Safety and Tolerability||0
3201825|NCT02130635|3930867|FG007|STARTED|Part A-Safety and Tolerability||0
3201826|NCT02130635|3930868|FG008|STARTED|Part A-Safety and Tolerability||0
3201827|NCT02130635|3930860|FG000|COMPLETED|Part A-Safety and Tolerability||7
3201828|NCT02130635|3930861|FG001|COMPLETED|Part A-Safety and Tolerability||21
3201829|NCT02130635|3930862|FG002|COMPLETED|Part A-Safety and Tolerability||0
3201830|NCT02130635|3930863|FG003|COMPLETED|Part A-Safety and Tolerability||0
3201831|NCT02130635|3930864|FG004|COMPLETED|Part A-Safety and Tolerability||0
3201832|NCT02130635|3930865|FG005|COMPLETED|Part A-Safety and Tolerability||0
3201833|NCT02130635|3930866|FG006|COMPLETED|Part A-Safety and Tolerability||0
3201834|NCT02130635|3930867|FG007|COMPLETED|Part A-Safety and Tolerability||0
3201835|NCT02130635|3930868|FG008|COMPLETED|Part A-Safety and Tolerability||0
3201836|NCT02130635|3930860|FG000|NOT COMPLETED|Part A-Safety and Tolerability||0
3201837|NCT02130635|3930861|FG001|NOT COMPLETED|Part A-Safety and Tolerability||0
3201838|NCT02130635|3930862|FG002|NOT COMPLETED|Part A-Safety and Tolerability||0
3201839|NCT02130635|3930863|FG003|NOT COMPLETED|Part A-Safety and Tolerability||0
3201840|NCT02130635|3930864|FG004|NOT COMPLETED|Part A-Safety and Tolerability||0
3201841|NCT02130635|3930865|FG005|NOT COMPLETED|Part A-Safety and Tolerability||0
3201842|NCT02130635|3930866|FG006|NOT COMPLETED|Part A-Safety and Tolerability||0
3201843|NCT02130635|3930867|FG007|NOT COMPLETED|Part A-Safety and Tolerability||0
3201844|NCT02130635|3930868|FG008|NOT COMPLETED|Part A-Safety and Tolerability||0
3201845|NCT02130635|3930860|FG000|STARTED|Part B-Dose-Response Relationship||0
3201846|NCT02130635|3930861|FG001|STARTED|Part B-Dose-Response Relationship||0
3201847|NCT02130635|3930862|FG002|STARTED|Part B-Dose-Response Relationship||5
3201848|NCT02130635|3930863|FG003|STARTED|Part B-Dose-Response Relationship||5
3201849|NCT02130635|3930864|FG004|STARTED|Part B-Dose-Response Relationship||5
3201850|NCT02130635|3930865|FG005|STARTED|Part B-Dose-Response Relationship||5
3201851|NCT02130635|3930866|FG006|STARTED|Part B-Dose-Response Relationship||6
3201852|NCT02130635|3930867|FG007|STARTED|Part B-Dose-Response Relationship||5
3201853|NCT02130635|3930868|FG008|STARTED|Part B-Dose-Response Relationship||5
3201854|NCT02130635|3930860|FG000|COMPLETED|Part B-Dose-Response Relationship||0
3201855|NCT02130635|3930861|FG001|COMPLETED|Part B-Dose-Response Relationship||0
3201856|NCT02130635|3930862|FG002|COMPLETED|Part B-Dose-Response Relationship||5
3201857|NCT02130635|3930863|FG003|COMPLETED|Part B-Dose-Response Relationship||5
3201858|NCT02130635|3930864|FG004|COMPLETED|Part B-Dose-Response Relationship||5
3201859|NCT02130635|3930865|FG005|COMPLETED|Part B-Dose-Response Relationship||5
3201860|NCT02130635|3930866|FG006|COMPLETED|Part B-Dose-Response Relationship||6
3201861|NCT02130635|3930867|FG007|COMPLETED|Part B-Dose-Response Relationship||5
3201862|NCT02130635|3930868|FG008|COMPLETED|Part B-Dose-Response Relationship||5
3201863|NCT02130635|3930860|FG000|NOT COMPLETED|Part B-Dose-Response Relationship||0
3201864|NCT02130635|3930861|FG001|NOT COMPLETED|Part B-Dose-Response Relationship||0
3201865|NCT02130635|3930862|FG002|NOT COMPLETED|Part B-Dose-Response Relationship||0
3201866|NCT02130635|3930863|FG003|NOT COMPLETED|Part B-Dose-Response Relationship||0
3201867|NCT02130635|3930864|FG004|NOT COMPLETED|Part B-Dose-Response Relationship||0
3201868|NCT02130635|3930865|FG005|NOT COMPLETED|Part B-Dose-Response Relationship||0
3201869|NCT02130635|3930866|FG006|NOT COMPLETED|Part B-Dose-Response Relationship||0
3201870|NCT02130635|3930867|FG007|NOT COMPLETED|Part B-Dose-Response Relationship||0
3201871|NCT02130635|3930868|FG008|NOT COMPLETED|Part B-Dose-Response Relationship||0
3201872|NCT02130687|3930898|FG000|STARTED|Washout||36
3201873|NCT02130687|3930899|FG001|STARTED|Washout||35
3201874|NCT02130687|3930900|FG002|STARTED|Washout||35
3201875|NCT02130687|3930898|FG000|COMPLETED|Washout||36
3201876|NCT02130687|3930899|FG001|COMPLETED|Washout||33
3201877|NCT02130687|3930900|FG002|COMPLETED|Washout||31
3201878|NCT02130687|3930898|FG000|NOT COMPLETED|Washout||0
3201879|NCT02130687|3930899|FG001|NOT COMPLETED|Washout||2
3201880|NCT02130687|3930900|FG002|NOT COMPLETED|Washout||4
3201881|NCT02130687|3930898|FG000|STARTED|Drug 1 Only||36
3201882|NCT02130687|3930899|FG001|STARTED|Drug 1 Only||33
3201883|NCT02130687|3930900|FG002|STARTED|Drug 1 Only||31
3201884|NCT02130687|3930898|FG000|COMPLETED|Drug 1 Only||33
3201885|NCT02130687|3930899|FG001|COMPLETED|Drug 1 Only||30
3201886|NCT02130687|3930900|FG002|COMPLETED|Drug 1 Only||30
3201887|NCT02130687|3930898|FG000|NOT COMPLETED|Drug 1 Only||3
3201888|NCT02130687|3930899|FG001|NOT COMPLETED|Drug 1 Only||3
3201889|NCT02130687|3930900|FG002|NOT COMPLETED|Drug 1 Only||1
3201890|NCT02130687|3930898|FG000|STARTED|Crossover Period 1||33
3201891|NCT02130687|3930899|FG001|STARTED|Crossover Period 1||30
3201892|NCT02130687|3930900|FG002|STARTED|Crossover Period 1||30
3201893|NCT02130687|3930898|FG000|COMPLETED|Crossover Period 1||33
3201894|NCT02130687|3930899|FG001|COMPLETED|Crossover Period 1||30
3201895|NCT02130687|3930900|FG002|COMPLETED|Crossover Period 1||30
3201896|NCT02130687|3930898|FG000|NOT COMPLETED|Crossover Period 1||0
3201897|NCT02130687|3930899|FG001|NOT COMPLETED|Crossover Period 1||0
3201898|NCT02130687|3930900|FG002|NOT COMPLETED|Crossover Period 1||0
3201899|NCT02130687|3930898|FG000|STARTED|Drug 1 Only Between Periods 1 and 2||33
3201900|NCT02130687|3930899|FG001|STARTED|Drug 1 Only Between Periods 1 and 2||30
3201901|NCT02130687|3930900|FG002|STARTED|Drug 1 Only Between Periods 1 and 2||30
3201902|NCT02130687|3930898|FG000|COMPLETED|Drug 1 Only Between Periods 1 and 2||33
3201903|NCT02130687|3930899|FG001|COMPLETED|Drug 1 Only Between Periods 1 and 2||26
3201904|NCT02130687|3930900|FG002|COMPLETED|Drug 1 Only Between Periods 1 and 2||29
3201905|NCT02130687|3930898|FG000|NOT COMPLETED|Drug 1 Only Between Periods 1 and 2||0
3201906|NCT02130687|3930899|FG001|NOT COMPLETED|Drug 1 Only Between Periods 1 and 2||4
3201907|NCT02130687|3930900|FG002|NOT COMPLETED|Drug 1 Only Between Periods 1 and 2||1
3201908|NCT02130687|3930898|FG000|STARTED|Crossover Period 2||33
3201909|NCT02130687|3930899|FG001|STARTED|Crossover Period 2||26
3201910|NCT02130687|3930900|FG002|STARTED|Crossover Period 2||29
3201911|NCT02130687|3930898|FG000|COMPLETED|Crossover Period 2||33
3201912|NCT02130687|3930899|FG001|COMPLETED|Crossover Period 2||26
3201913|NCT02130687|3930900|FG002|COMPLETED|Crossover Period 2||29
3201914|NCT02130687|3930898|FG000|NOT COMPLETED|Crossover Period 2||0
3201915|NCT02130687|3930899|FG001|NOT COMPLETED|Crossover Period 2||0
3201916|NCT02130687|3930900|FG002|NOT COMPLETED|Crossover Period 2||0
3201917|NCT02130687|3930898|FG000|STARTED|Drug 1 Only Between Periods 2 and 3||33
3201918|NCT02130687|3930899|FG001|STARTED|Drug 1 Only Between Periods 2 and 3||26
3201919|NCT02130687|3930900|FG002|STARTED|Drug 1 Only Between Periods 2 and 3||29
3201920|NCT02130687|3930898|FG000|COMPLETED|Drug 1 Only Between Periods 2 and 3||33
3201921|NCT02130687|3930899|FG001|COMPLETED|Drug 1 Only Between Periods 2 and 3||25
3201922|NCT02130687|3930900|FG002|COMPLETED|Drug 1 Only Between Periods 2 and 3||27
3201923|NCT02130687|3930898|FG000|NOT COMPLETED|Drug 1 Only Between Periods 2 and 3||0
3201924|NCT02130687|3930899|FG001|NOT COMPLETED|Drug 1 Only Between Periods 2 and 3||1
3201925|NCT02130687|3930900|FG002|NOT COMPLETED|Drug 1 Only Between Periods 2 and 3||2
3201926|NCT02130687|3930898|FG000|STARTED|Crossover Period 3||33
3201927|NCT02130687|3930899|FG001|STARTED|Crossover Period 3||25
3201928|NCT02130687|3930900|FG002|STARTED|Crossover Period 3||27
3201929|NCT02130687|3930898|FG000|COMPLETED|Crossover Period 3||33
3201930|NCT02130687|3930899|FG001|COMPLETED|Crossover Period 3||25
3201931|NCT02130687|3930900|FG002|COMPLETED|Crossover Period 3||27
3201932|NCT02130687|3930898|FG000|NOT COMPLETED|Crossover Period 3||0
3201933|NCT02130687|3930899|FG001|NOT COMPLETED|Crossover Period 3||0
3201934|NCT02130687|3930900|FG002|NOT COMPLETED|Crossover Period 3||0
3201935|NCT02130765|3930930|FG000|STARTED|Overall Study||11
3201936|NCT02130765|3930931|FG001|STARTED|Overall Study||8
3201937|NCT02130765|3930932|FG002|STARTED|Overall Study||26
3201938|NCT02130765|3930933|FG003|STARTED|Overall Study||19
3201939|NCT02130765|3930930|FG000|COMPLETED|Overall Study||7
3201940|NCT02130765|3930931|FG001|COMPLETED|Overall Study||8
3201941|NCT02130765|3930932|FG002|COMPLETED|Overall Study||26
3201942|NCT02130765|3930933|FG003|COMPLETED|Overall Study||19
3201943|NCT02130765|3930930|FG000|NOT COMPLETED|Overall Study||4
3201944|NCT02130765|3930931|FG001|NOT COMPLETED|Overall Study||0
3201945|NCT02130765|3930932|FG002|NOT COMPLETED|Overall Study||0
3201946|NCT02130765|3930933|FG003|NOT COMPLETED|Overall Study||0
3201947|NCT02130986|3930947|FG000|STARTED|Overall Study||830
3201948|NCT02130986|3930948|FG001|STARTED|Overall Study||834
3201949|NCT02130986|3930947|FG000|COMPLETED|Overall Study||675
3201950|NCT02130986|3930948|FG001|COMPLETED|Overall Study||670
3201951|NCT02130986|3930947|FG000|NOT COMPLETED|Overall Study||155
3201952|NCT02130986|3930948|FG001|NOT COMPLETED|Overall Study||164
3201953|NCT02130999|3930956|FG000|STARTED|Overall Study||6
3201954|NCT02130999|3930957|FG001|STARTED|Overall Study||8
3201955|NCT02130999|3930956|FG000|COMPLETED|Overall Study||6
3201956|NCT02130999|3930957|FG001|COMPLETED|Overall Study||8
3201957|NCT02130999|3930956|FG000|NOT COMPLETED|Overall Study||0
3201958|NCT02130999|3930957|FG001|NOT COMPLETED|Overall Study||0
3201959|NCT02131064|3930970|FG000|STARTED|Overall Study||221
3201960|NCT02131064|3930971|FG001|STARTED|Overall Study||223
3201961|NCT02131064|3930970|FG000|COMPLETED|Overall Study||196
3201962|NCT02131064|3930971|FG001|COMPLETED|Overall Study||189
3201963|NCT02131064|3930970|FG000|NOT COMPLETED|Overall Study||25
3201964|NCT02131064|3930971|FG001|NOT COMPLETED|Overall Study||34
3201965|NCT02131129|3930980|FG000|STARTED|Overall Study||10
3201966|NCT02131129|3930981|FG001|STARTED|Overall Study||10
3201967|NCT02131129|3930980|FG000|COMPLETED|Overall Study||9
3201968|NCT02131129|3930981|FG001|COMPLETED|Overall Study||10
3201969|NCT02131129|3930980|FG000|NOT COMPLETED|Overall Study||1
3201970|NCT02131129|3930981|FG001|NOT COMPLETED|Overall Study||0
3201971|NCT02131233|3930989|FG000|STARTED|Overall Study|Enrolled participants|533
3201972|NCT02131233|3930990|FG001|STARTED|Overall Study|Enrolled participants|269
3201973|NCT02131233|3930989|FG000|Treated|Overall Study||531
3201974|NCT02131233|3930990|FG001|Treated|Overall Study||266
3201975|NCT02131233|3930989|FG000|COMPLETED|Overall Study|Completed to Week 96|467
3201976|NCT02131233|3930990|FG001|COMPLETED|Overall Study|Completed to Week 96|227
3201977|NCT02131233|3930989|FG000|NOT COMPLETED|Overall Study||66
3201978|NCT02131233|3930990|FG001|NOT COMPLETED|Overall Study||42
3201979|NCT02131259|3930996|FG000|STARTED|Overall Study|Patients received treatment of GIOTRIF® Tablets|1602
3201980|NCT02131259|3930996|FG000|COMPLETED|Overall Study|Completed is defined as 52 weeks follow-up after starting administration of GIOTRIF® tablets.|377
3201981|NCT02131259|3930996|FG000|NOT COMPLETED|Overall Study||1225
3201982|NCT02131272|3931002|FG000|STARTED|Overall Study||20
3201983|NCT02131272|3931003|FG001|STARTED|Overall Study||22
3201984|NCT02131272|3931002|FG000|COMPLETED|Overall Study||19
3201985|NCT02131272|3931003|FG001|COMPLETED|Overall Study||20
3201986|NCT02131272|3931002|FG000|NOT COMPLETED|Overall Study||1
3201987|NCT02131272|3931003|FG001|NOT COMPLETED|Overall Study||2
3201988|NCT02131311|3931009|FG000|STARTED|Overall Study||90
3201989|NCT02131311|3931009|FG000|COMPLETED|Overall Study||86
3201990|NCT02131311|3931009|FG000|NOT COMPLETED|Overall Study||4
3201991|NCT02131324|3931016|FG000|STARTED|Overall Study|2 subjects randomized into Comp01 not included in analysis as there was no post-baseline information|24
3201992|NCT02131324|3931017|FG001|STARTED|Overall Study|2 subjects randomized into DFD-06 not included in analysis as there was no post-baseline information|26
3201993|NCT02131324|3931016|FG000|Analyzed|Overall Study||22
3201994|NCT02131324|3931017|FG001|Analyzed|Overall Study||24
3201995|NCT02131324|3931016|FG000|COMPLETED|Overall Study||22
3201996|NCT02131324|3931017|FG001|COMPLETED|Overall Study||23
3201997|NCT02131324|3931016|FG000|NOT COMPLETED|Overall Study||2
3201998|NCT02131324|3931017|FG001|NOT COMPLETED|Overall Study||3
3201999|NCT02131402|3931023|FG000|STARTED|Overall Study||60
3202000|NCT02131402|3931023|FG000|COMPLETED|Overall Study||60
3202001|NCT02131402|3931023|FG000|NOT COMPLETED|Overall Study||0
3202002|NCT02131532|3931086|FG000|STARTED|Overall Study||12
3202003|NCT02131532|3931086|FG000|COMPLETED|Overall Study||8
3202004|NCT02131532|3931086|FG000|NOT COMPLETED|Overall Study||4
3202005|NCT02131636|3931093|FG000|STARTED|Overall Study||222
3202006|NCT02131636|3931094|FG001|STARTED|Overall Study||218
3202007|NCT02131636|3931093|FG000|COMPLETED|Overall Study||210
3202008|NCT02131636|3931094|FG001|COMPLETED|Overall Study||213
3202009|NCT02131636|3931093|FG000|NOT COMPLETED|Overall Study||12
3202010|NCT02131636|3931094|FG001|NOT COMPLETED|Overall Study||5
3202011|NCT02131662|3931105|FG000|STARTED|Overall Study||62
3202012|NCT02131662|3931106|FG001|STARTED|Overall Study||61
3202013|NCT02131662|3931107|FG002|STARTED|Overall Study||63
3202014|NCT02131662|3931108|FG003|STARTED|Overall Study||62
3202015|NCT02131662|3931109|FG004|STARTED|Overall Study||61
3202016|NCT02131662|3931105|FG000|Treated|Overall Study||60
3202017|NCT02131662|3931106|FG001|Treated|Overall Study||61
3202018|NCT02131662|3931107|FG002|Treated|Overall Study||61
3202019|NCT02131662|3931108|FG003|Treated|Overall Study||60
3202020|NCT02131662|3931109|FG004|Treated|Overall Study||58
3202021|NCT02131662|3931105|FG000|Completed Treatment|Overall Study||57
3202022|NCT02131662|3931106|FG001|Completed Treatment|Overall Study||60
3202023|NCT02131662|3931107|FG002|Completed Treatment|Overall Study||61
3202024|NCT02131662|3931108|FG003|Completed Treatment|Overall Study||56
3202025|NCT02131662|3931109|FG004|Completed Treatment|Overall Study||52
3202026|NCT02131662|3931105|FG000|Completed Follow-up|Overall Study||54
3202027|NCT02131662|3931106|FG001|Completed Follow-up|Overall Study||47
3202028|NCT02131662|3931107|FG002|Completed Follow-up|Overall Study||56
3202029|NCT02131662|3931108|FG003|Completed Follow-up|Overall Study||42
3202030|NCT02131662|3931109|FG004|Completed Follow-up|Overall Study||44
3202031|NCT02131662|3931105|FG000|COMPLETED|Overall Study||54
3202032|NCT02131662|3931106|FG001|COMPLETED|Overall Study||47
3202033|NCT02131662|3931107|FG002|COMPLETED|Overall Study||56
3202034|NCT02131662|3931108|FG003|COMPLETED|Overall Study||41
3202035|NCT02131662|3931109|FG004|COMPLETED|Overall Study||43
3202036|NCT02131662|3931105|FG000|NOT COMPLETED|Overall Study||8
3202037|NCT02131662|3931106|FG001|NOT COMPLETED|Overall Study||14
3202038|NCT02131662|3931107|FG002|NOT COMPLETED|Overall Study||7
3202039|NCT02131662|3931108|FG003|NOT COMPLETED|Overall Study||21
3202040|NCT02131662|3931109|FG004|NOT COMPLETED|Overall Study||18
3202041|NCT02131766|3931125|FG000|STARTED|Overall Study||44
3202042|NCT02131766|3931125|FG000|COMPLETED|Overall Study||40
3202043|NCT02131766|3931125|FG000|NOT COMPLETED|Overall Study||4
3202044|NCT02132117|3931134|FG000|STARTED|Overall Study||224
3202045|NCT02132117|3931135|FG001|STARTED|Overall Study||221
3202046|NCT02132117|3931134|FG000|COMPLETED|Overall Study||213
3202047|NCT02132117|3931135|FG001|COMPLETED|Overall Study||216
3202048|NCT02132117|3931134|FG000|NOT COMPLETED|Overall Study||11
3202049|NCT02132117|3931135|FG001|NOT COMPLETED|Overall Study||5
3202050|NCT02132130|3931145|FG000|STARTED|Overall Study||3
3202051|NCT02132130|3931146|FG001|STARTED|Overall Study||12
3202052|NCT02132130|3931147|FG002|STARTED|Overall Study||4
3202053|NCT02132130|3931148|FG003|STARTED|Overall Study||3
3202054|NCT02132130|3931145|FG000|COMPLETED|Overall Study||3
3202055|NCT02132130|3931146|FG001|COMPLETED|Overall Study||10
3202056|NCT02132130|3931147|FG002|COMPLETED|Overall Study||4
3202057|NCT02132130|3931148|FG003|COMPLETED|Overall Study||2
3202058|NCT02132130|3931145|FG000|NOT COMPLETED|Overall Study||0
3202059|NCT02132130|3931146|FG001|NOT COMPLETED|Overall Study||2
3202060|NCT02132130|3931147|FG002|NOT COMPLETED|Overall Study||0
3202061|NCT02132130|3931148|FG003|NOT COMPLETED|Overall Study||1
3202062|NCT02132169|3931164|FG000|STARTED|Overall Study||341
3202063|NCT02132169|3931165|FG001|STARTED|Overall Study||171
3202064|NCT02132169|3931164|FG000|COMPLETED|Overall Study||326
3202065|NCT02132169|3931165|FG001|COMPLETED|Overall Study||162
3202066|NCT02132169|3931164|FG000|NOT COMPLETED|Overall Study||15
3202067|NCT02132169|3931165|FG001|NOT COMPLETED|Overall Study||9
3202068|NCT02132195|3931174|FG000|STARTED|Initial Assignment||15
3202069|NCT02132195|3931175|FG001|STARTED|Initial Assignment||16
3202070|NCT02132195|3931176|FG002|STARTED|Initial Assignment||0
3202071|NCT02132195|3931174|FG000|COMPLETED|Initial Assignment||1
3202072|NCT02132195|3931175|FG001|COMPLETED|Initial Assignment||16
3202073|NCT02132195|3931176|FG002|COMPLETED|Initial Assignment||0
3202074|NCT02132195|3931174|FG000|NOT COMPLETED|Initial Assignment||14
3202075|NCT02132195|3931175|FG001|NOT COMPLETED|Initial Assignment||0
3202076|NCT02132195|3931176|FG002|NOT COMPLETED|Initial Assignment||0
3202077|NCT02132195|3931174|FG000|STARTED|Rescue Therapy||0
3202078|NCT02132195|3931175|FG001|STARTED|Rescue Therapy||0
3202079|NCT02132195|3931176|FG002|STARTED|Rescue Therapy||13
3202080|NCT02132195|3931174|FG000|COMPLETED|Rescue Therapy||0
3202081|NCT02132195|3931175|FG001|COMPLETED|Rescue Therapy||0
3202082|NCT02132195|3931176|FG002|COMPLETED|Rescue Therapy||2
3202083|NCT02132195|3931174|FG000|NOT COMPLETED|Rescue Therapy||0
3202084|NCT02132195|3931175|FG001|NOT COMPLETED|Rescue Therapy||0
3202085|NCT02132195|3931176|FG002|NOT COMPLETED|Rescue Therapy||11
3202086|NCT02132247|3931186|FG000|STARTED|Overall Study||52
3202087|NCT02132247|3931187|FG001|STARTED|Overall Study||52
3202088|NCT02132247|3931186|FG000|COMPLETED|Overall Study||51
3202089|NCT02132247|3931187|FG001|COMPLETED|Overall Study||52
3202090|NCT02132247|3931186|FG000|NOT COMPLETED|Overall Study||1
3202091|NCT02132247|3931187|FG001|NOT COMPLETED|Overall Study||0
3202092|NCT02132312|3931195|FG000|STARTED|Overall Study||37
3202093|NCT02132312|3931196|FG001|STARTED|Overall Study||41
3202094|NCT02132312|3931195|FG000|COMPLETED|Overall Study||31
3202095|NCT02132312|3931196|FG001|COMPLETED|Overall Study||38
3202096|NCT02132312|3931195|FG000|NOT COMPLETED|Overall Study||6
3202097|NCT02132312|3931196|FG001|NOT COMPLETED|Overall Study||3
3202098|NCT02132468|3931202|FG000|STARTED|Overall Study||18
3202099|NCT02132468|3931202|FG000|COMPLETED|Overall Study||11
3202100|NCT02132468|3931202|FG000|NOT COMPLETED|Overall Study||7
3202101|NCT02132520|3931209|FG000|STARTED|Overall Study||0
3202102|NCT02132520|3931210|FG001|STARTED|Overall Study||1
3202103|NCT02132520|3931211|FG002|STARTED|Overall Study||2
3202104|NCT02132520|3931209|FG000|COMPLETED|Overall Study||0
3202105|NCT02132520|3931210|FG001|COMPLETED|Overall Study||1
3202106|NCT02132520|3931211|FG002|COMPLETED|Overall Study||2
3202107|NCT02132520|3931209|FG000|NOT COMPLETED|Overall Study||0
3202108|NCT02132520|3931210|FG001|NOT COMPLETED|Overall Study||0
3202109|NCT02132520|3931211|FG002|NOT COMPLETED|Overall Study||0
3202110|NCT02132533|3931220|FG000|STARTED|Overall Study||46
3202111|NCT02132533|3931221|FG001|STARTED|Overall Study||42
3202112|NCT02132533|3931220|FG000|COMPLETED|Overall Study||46
3202113|NCT02132533|3931221|FG001|COMPLETED|Overall Study||42
3202114|NCT02132533|3931220|FG000|NOT COMPLETED|Overall Study||0
3202115|NCT02132533|3931221|FG001|NOT COMPLETED|Overall Study||0
3202116|NCT02132572|3931227|FG000|STARTED|Overall Study||201
3202117|NCT02132572|3931227|FG000|COMPLETED|Overall Study||201
3202118|NCT02132572|3931227|FG000|NOT COMPLETED|Overall Study||0
3202119|NCT02132598|3931231|FG000|STARTED|Overall Study||5
3202120|NCT02132598|3931231|FG000|COMPLETED|Overall Study||5
3202121|NCT02132598|3931231|FG000|NOT COMPLETED|Overall Study||0
3202122|NCT02132637|3931237|FG000|STARTED|Study Period 1||34
3202123|NCT02132637|3931238|FG001|STARTED|Study Period 1||34
3202124|NCT02132637|3931237|FG000|Received at Least One Dose of Study Drug|Study Period 1||34
3202125|NCT02132637|3931238|FG001|Received at Least One Dose of Study Drug|Study Period 1||34
3202126|NCT02132637|3931237|FG000|COMPLETED|Study Period 1||33
3202127|NCT02132637|3931238|FG001|COMPLETED|Study Period 1||30
3202128|NCT02132637|3931237|FG000|NOT COMPLETED|Study Period 1||1
3202129|NCT02132637|3931238|FG001|NOT COMPLETED|Study Period 1||4
3202130|NCT02132637|3931237|FG000|STARTED|Study Period 2 (Crossover)||33
3202131|NCT02132637|3931238|FG001|STARTED|Study Period 2 (Crossover)||30
3202132|NCT02132637|3931237|FG000|COMPLETED|Study Period 2 (Crossover)||31
3202133|NCT02132637|3931238|FG001|COMPLETED|Study Period 2 (Crossover)||29
3202134|NCT02132637|3931237|FG000|NOT COMPLETED|Study Period 2 (Crossover)||2
3202135|NCT02132637|3931238|FG001|NOT COMPLETED|Study Period 2 (Crossover)||1
3202136|NCT02132650|3931246|FG000|STARTED|Overall Study||20
3202137|NCT02132650|3931247|FG001|STARTED|Overall Study||18
3202138|NCT02132650|3931246|FG000|Post-Intervention Assessment|Overall Study||19
3202139|NCT02132650|3931247|FG001|Post-Intervention Assessment|Overall Study||17
3202140|NCT02132650|3931246|FG000|COMPLETED|Overall Study||17
3202141|NCT02132650|3931247|FG001|COMPLETED|Overall Study||14
3202142|NCT02132650|3931246|FG000|NOT COMPLETED|Overall Study||3
3202143|NCT02132650|3931247|FG001|NOT COMPLETED|Overall Study||4
3202144|NCT02132676|3931255|FG000|STARTED|Overall Study||727
3202145|NCT02132676|3931256|FG001|STARTED|Overall Study||809
3202146|NCT02132676|3931255|FG000|COMPLETED|Overall Study||727
3202147|NCT02132676|3931256|FG001|COMPLETED|Overall Study||809
3202148|NCT02132676|3931255|FG000|NOT COMPLETED|Overall Study||0
3202149|NCT02132676|3931256|FG001|NOT COMPLETED|Overall Study||0
3202150|NCT02132754|3931297|FG000|STARTED|Overall Study||1
3202151|NCT02132754|3931298|FG001|STARTED|Overall Study||1
3202152|NCT02132754|3931299|FG002|STARTED|Overall Study||1
3202153|NCT02132754|3931300|FG003|STARTED|Overall Study||1
3202154|NCT02132754|3931301|FG004|STARTED|Overall Study||1
3202155|NCT02132754|3931302|FG005|STARTED|Overall Study||1
3202156|NCT02132754|3931303|FG006|STARTED|Overall Study||1
3202157|NCT02132754|3931304|FG007|STARTED|Overall Study||1
3202158|NCT02132754|3931305|FG008|STARTED|Overall Study||1
3202159|NCT02132754|3931306|FG009|STARTED|Overall Study||6
3202160|NCT02132754|3931307|FG010|STARTED|Overall Study||3
3202161|NCT02132754|3931308|FG011|STARTED|Overall Study||3
3202162|NCT02132754|3931309|FG012|STARTED|Overall Study||4
3202163|NCT02132754|3931310|FG013|STARTED|Overall Study||3
3202164|NCT02132754|3931311|FG014|STARTED|Overall Study||3
3202165|NCT02132754|3931312|FG015|STARTED|Overall Study||5
3202166|NCT02132754|3931313|FG016|STARTED|Overall Study||4
3202167|NCT02132754|3931314|FG017|STARTED|Overall Study||3
3202168|NCT02132754|3931315|FG018|STARTED|Overall Study||3
3202169|NCT02132754|3931316|FG019|STARTED|Overall Study||4
3202170|NCT02132754|3931317|FG020|STARTED|Overall Study||3
3202171|NCT02132754|3931318|FG021|STARTED|Overall Study||5
3202172|NCT02132754|3931319|FG022|STARTED|Overall Study||3
3202173|NCT02132754|3931320|FG023|STARTED|Overall Study||3
3202174|NCT02132754|3931321|FG024|STARTED|Overall Study||3
3202175|NCT02132754|3931322|FG025|STARTED|Overall Study||3
3202176|NCT02132754|3931323|FG026|STARTED|Overall Study||4
3202177|NCT02132754|3931324|FG027|STARTED|Overall Study||3
3202178|NCT02132754|3931325|FG028|STARTED|Overall Study||3
3202179|NCT02132754|3931326|FG029|STARTED|Overall Study||3
3202180|NCT02132754|3931327|FG030|STARTED|Overall Study||3
3202181|NCT02132754|3931328|FG031|STARTED|Overall Study||3
3202182|NCT02132754|3931329|FG032|STARTED|Overall Study||4
3202183|NCT02132754|3931330|FG033|STARTED|Overall Study||23
3202184|NCT02132754|3931297|FG000|Treated|Overall Study||1
3202185|NCT02132754|3931298|FG001|Treated|Overall Study||1
3202186|NCT02132754|3931299|FG002|Treated|Overall Study||1
3202187|NCT02132754|3931300|FG003|Treated|Overall Study||1
3202188|NCT02132754|3931301|FG004|Treated|Overall Study||1
3202189|NCT02132754|3931302|FG005|Treated|Overall Study||1
3202190|NCT02132754|3931303|FG006|Treated|Overall Study||1
3202191|NCT02132754|3931304|FG007|Treated|Overall Study||1
3202192|NCT02132754|3931305|FG008|Treated|Overall Study||1
3202193|NCT02132754|3931306|FG009|Treated|Overall Study||6
3202194|NCT02132754|3931307|FG010|Treated|Overall Study||3
3202195|NCT02132754|3931308|FG011|Treated|Overall Study||3
3202196|NCT02132754|3931309|FG012|Treated|Overall Study||3
3202197|NCT02132754|3931310|FG013|Treated|Overall Study||3
3202198|NCT02132754|3931311|FG014|Treated|Overall Study||3
3202199|NCT02132754|3931312|FG015|Treated|Overall Study||5
3202200|NCT02132754|3931313|FG016|Treated|Overall Study||4
3202201|NCT02132754|3931314|FG017|Treated|Overall Study||3
3202202|NCT02132754|3931315|FG018|Treated|Overall Study||3
3202203|NCT02132754|3931316|FG019|Treated|Overall Study||3
3202204|NCT02132754|3931317|FG020|Treated|Overall Study||3
3202205|NCT02132754|3931318|FG021|Treated|Overall Study||4
3202206|NCT02132754|3931319|FG022|Treated|Overall Study||3
3202207|NCT02132754|3931320|FG023|Treated|Overall Study||3
3202208|NCT02132754|3931321|FG024|Treated|Overall Study||3
3202209|NCT02132754|3931322|FG025|Treated|Overall Study||3
3202210|NCT02132754|3931323|FG026|Treated|Overall Study||4
3202211|NCT02132754|3931324|FG027|Treated|Overall Study||3
3202212|NCT02132754|3931325|FG028|Treated|Overall Study||3
3202213|NCT02132754|3931326|FG029|Treated|Overall Study||3
3202214|NCT02132754|3931327|FG030|Treated|Overall Study||3
3202215|NCT02132754|3931328|FG031|Treated|Overall Study||3
3202216|NCT02132754|3931329|FG032|Treated|Overall Study||4
3202217|NCT02132754|3931330|FG033|Treated|Overall Study||23
3202218|NCT02132754|3931297|FG000|COMPLETED|Overall Study||0
3202219|NCT02132754|3931298|FG001|COMPLETED|Overall Study||0
3202220|NCT02132754|3931299|FG002|COMPLETED|Overall Study||0
3202221|NCT02132754|3931300|FG003|COMPLETED|Overall Study||0
3202222|NCT02132754|3931301|FG004|COMPLETED|Overall Study||0
3202223|NCT02132754|3931302|FG005|COMPLETED|Overall Study||0
3202224|NCT02132754|3931303|FG006|COMPLETED|Overall Study||0
3202225|NCT02132754|3931304|FG007|COMPLETED|Overall Study||0
3202226|NCT02132754|3931305|FG008|COMPLETED|Overall Study||0
3202227|NCT02132754|3931306|FG009|COMPLETED|Overall Study||0
3202228|NCT02132754|3931307|FG010|COMPLETED|Overall Study||0
3202229|NCT02132754|3931308|FG011|COMPLETED|Overall Study||0
3202230|NCT02132754|3931309|FG012|COMPLETED|Overall Study||0
3202231|NCT02132754|3931310|FG013|COMPLETED|Overall Study||0
3202232|NCT02132754|3931311|FG014|COMPLETED|Overall Study||0
3202233|NCT02132754|3931312|FG015|COMPLETED|Overall Study||0
3202234|NCT02132754|3931313|FG016|COMPLETED|Overall Study||0
3202235|NCT02132754|3931314|FG017|COMPLETED|Overall Study||0
3202236|NCT02132754|3931315|FG018|COMPLETED|Overall Study||0
3202237|NCT02132754|3931316|FG019|COMPLETED|Overall Study||0
3202238|NCT02132754|3931317|FG020|COMPLETED|Overall Study||0
3202239|NCT02132754|3931318|FG021|COMPLETED|Overall Study||0
3202240|NCT02132754|3931319|FG022|COMPLETED|Overall Study||0
3202241|NCT02132754|3931320|FG023|COMPLETED|Overall Study||0
3202242|NCT02132754|3931321|FG024|COMPLETED|Overall Study||0
3202243|NCT02132754|3931322|FG025|COMPLETED|Overall Study||0
3202244|NCT02132754|3931323|FG026|COMPLETED|Overall Study||0
3202245|NCT02132754|3931324|FG027|COMPLETED|Overall Study||0
3202246|NCT02132754|3931325|FG028|COMPLETED|Overall Study||0
3202247|NCT02132754|3931326|FG029|COMPLETED|Overall Study||0
3202248|NCT02132754|3931327|FG030|COMPLETED|Overall Study||0
3202249|NCT02132754|3931328|FG031|COMPLETED|Overall Study||0
3202250|NCT02132754|3931329|FG032|COMPLETED|Overall Study||0
3202251|NCT02132754|3931330|FG033|COMPLETED|Overall Study||0
3202252|NCT02132754|3931297|FG000|NOT COMPLETED|Overall Study||1
3202253|NCT02132754|3931298|FG001|NOT COMPLETED|Overall Study||1
3202254|NCT02132754|3931299|FG002|NOT COMPLETED|Overall Study||1
3202255|NCT02132754|3931300|FG003|NOT COMPLETED|Overall Study||1
3202256|NCT02132754|3931301|FG004|NOT COMPLETED|Overall Study||1
3202257|NCT02132754|3931302|FG005|NOT COMPLETED|Overall Study||1
3202258|NCT02132754|3931303|FG006|NOT COMPLETED|Overall Study||1
3202259|NCT02132754|3931304|FG007|NOT COMPLETED|Overall Study||1
3202260|NCT02132754|3931305|FG008|NOT COMPLETED|Overall Study||1
3202261|NCT02132754|3931306|FG009|NOT COMPLETED|Overall Study||6
3202262|NCT02132754|3931307|FG010|NOT COMPLETED|Overall Study||3
3202263|NCT02132754|3931308|FG011|NOT COMPLETED|Overall Study||3
3202264|NCT02132754|3931309|FG012|NOT COMPLETED|Overall Study||4
3202265|NCT02132754|3931310|FG013|NOT COMPLETED|Overall Study||3
3202266|NCT02132754|3931311|FG014|NOT COMPLETED|Overall Study||3
3202267|NCT02132754|3931312|FG015|NOT COMPLETED|Overall Study||5
3202268|NCT02132754|3931313|FG016|NOT COMPLETED|Overall Study||4
3202269|NCT02132754|3931314|FG017|NOT COMPLETED|Overall Study||3
3202270|NCT02132754|3931315|FG018|NOT COMPLETED|Overall Study||3
3202271|NCT02132754|3931316|FG019|NOT COMPLETED|Overall Study||4
3202272|NCT02132754|3931317|FG020|NOT COMPLETED|Overall Study||3
3202273|NCT02132754|3931318|FG021|NOT COMPLETED|Overall Study||5
3202274|NCT02132754|3931319|FG022|NOT COMPLETED|Overall Study||3
3202275|NCT02132754|3931320|FG023|NOT COMPLETED|Overall Study||3
3202276|NCT02132754|3931321|FG024|NOT COMPLETED|Overall Study||3
3202277|NCT02132754|3931322|FG025|NOT COMPLETED|Overall Study||3
3202278|NCT02132754|3931323|FG026|NOT COMPLETED|Overall Study||4
3202279|NCT02132754|3931324|FG027|NOT COMPLETED|Overall Study||3
3202280|NCT02132754|3931325|FG028|NOT COMPLETED|Overall Study||3
3202281|NCT02132754|3931326|FG029|NOT COMPLETED|Overall Study||3
3202282|NCT02132754|3931327|FG030|NOT COMPLETED|Overall Study||3
3202283|NCT02132754|3931328|FG031|NOT COMPLETED|Overall Study||3
3202284|NCT02132754|3931329|FG032|NOT COMPLETED|Overall Study||4
3202285|NCT02132754|3931330|FG033|NOT COMPLETED|Overall Study||23
3202286|NCT02132767|3931442|FG000|STARTED|Overall Study||262
3202287|NCT02132767|3931443|FG001|STARTED|Overall Study||261
3202288|NCT02132767|3931442|FG000|COMPLETED|Overall Study||245
3202289|NCT02132767|3931443|FG001|COMPLETED|Overall Study||246
3202290|NCT02132767|3931442|FG000|NOT COMPLETED|Overall Study||17
3202291|NCT02132767|3931443|FG001|NOT COMPLETED|Overall Study||15
3202292|NCT02132832|3931451|FG000|STARTED|Overall Study||19
3202293|NCT02132832|3931452|FG001|STARTED|Overall Study||23
3202294|NCT02132832|3931451|FG000|COMPLETED|Overall Study||16
3202295|NCT02132832|3931452|FG001|COMPLETED|Overall Study||16
3202296|NCT02132832|3931451|FG000|NOT COMPLETED|Overall Study||3
3202297|NCT02132832|3931452|FG001|NOT COMPLETED|Overall Study||7
3202298|NCT02132910|3931460|FG000|STARTED|Overall Study||34
3202299|NCT02132910|3931461|FG001|STARTED|Overall Study||34
3202300|NCT02132910|3931460|FG000|COMPLETED|Overall Study||34
3202301|NCT02132910|3931461|FG001|COMPLETED|Overall Study||34
3202302|NCT02132910|3931460|FG000|NOT COMPLETED|Overall Study||0
3202303|NCT02132910|3931461|FG001|NOT COMPLETED|Overall Study||0
3202304|NCT02132936|3931471|FG000|STARTED|Overall Study||185
3202305|NCT02132936|3931472|FG001|STARTED|Overall Study||47
3202306|NCT02132936|3931473|FG002|STARTED|Overall Study||188
3202307|NCT02132936|3931474|FG003|STARTED|Overall Study||43
3202308|NCT02132936|3931471|FG000|COMPLETED|Overall Study||175
3202309|NCT02132936|3931472|FG001|COMPLETED|Overall Study||38
3202310|NCT02132936|3931473|FG002|COMPLETED|Overall Study||174
3202311|NCT02132936|3931474|FG003|COMPLETED|Overall Study||29
3202312|NCT02132936|3931471|FG000|NOT COMPLETED|Overall Study||10
3202313|NCT02132936|3931472|FG001|NOT COMPLETED|Overall Study||9
3202314|NCT02132936|3931473|FG002|NOT COMPLETED|Overall Study||14
3202315|NCT02132936|3931474|FG003|NOT COMPLETED|Overall Study||14
3202316|NCT02132949|3931487|FG000|STARTED|Overall Study||199
3202317|NCT02132949|3931488|FG001|STARTED|Overall Study|1 participant enrolled in Cohort B received Cohort A treatment (and was counted as part of Cohort B for efficacy).|201
3202318|NCT02132949|3931487|FG000|Received Any Cohort A Study Treatment|Overall Study|1 participant withdrew prior to receiving any study drug.|198
3202319|NCT02132949|3931488|FG001|Received Any Cohort A Study Treatment|Overall Study|1 participant enrolled in Cohort B received Cohort A treatment (and was counted as part of Cohort A for safety).|1
3202320|NCT02132949|3931487|FG000|Received Any Cohort B Study Treatment|Overall Study||0
3202321|NCT02132949|3931488|FG001|Received Any Cohort B Study Treatment|Overall Study|2 participants withdrew prior to receiving any study drug.|198
3202322|NCT02132949|3931487|FG000|Underwent Surgery|Overall Study||187
3202323|NCT02132949|3931488|FG001|Underwent Surgery|Overall Study||194
3202324|NCT02132949|3931487|FG000|Completed Neoadjuvant Treatment (25 Weeks)|Overall Study||182
3202325|NCT02132949|3931488|FG001|Completed Neoadjuvant Treatment (25 Weeks)|Overall Study||189
3202326|NCT02132949|3931487|FG000|Started Adjuvant Treatment|Overall Study||181
3202327|NCT02132949|3931488|FG001|Started Adjuvant Treatment|Overall Study|1 participant did not complete neoadjuvant treatment but started adjuvant treatment.|190
3202328|NCT02132949|3931487|FG000|Completed Adjuvant Treatment (Up to 39 Weeks)|Overall Study||163
3202329|NCT02132949|3931488|FG001|Completed Adjuvant Treatment (Up to 39 Weeks)|Overall Study||176
3202330|NCT02132949|3931487|FG000|Started Treatment-Free Follow-Up (Up to 5 Years)|Overall Study||195
3202331|NCT02132949|3931488|FG001|Started Treatment-Free Follow-Up (Up to 5 Years)|Overall Study||195
3202332|NCT02132949|3931487|FG000|COMPLETED|Overall Study||158
3202333|NCT02132949|3931488|FG001|COMPLETED|Overall Study||173
3202334|NCT02132949|3931487|FG000|NOT COMPLETED|Overall Study||41
3202335|NCT02132949|3931488|FG001|NOT COMPLETED|Overall Study||28
3202336|NCT02133001|3931496|FG000|STARTED|Double Blind (Day 1-25)||32
3202337|NCT02133001|3931497|FG001|STARTED|Double Blind (Day 1-25)||36
3202338|NCT02133001|3931496|FG000|Safety|Double Blind (Day 1-25)||31
3202339|NCT02133001|3931497|FG001|Safety|Double Blind (Day 1-25)||35
3202340|NCT02133001|3931496|FG000|COMPLETED|Double Blind (Day 1-25)|Participants who completed continued to follow-up phase.|22
3202341|NCT02133001|3931497|FG001|COMPLETED|Double Blind (Day 1-25)|Participants who completed continued to follow-up phase.|27
3202342|NCT02133001|3931496|FG000|NOT COMPLETED|Double Blind (Day 1-25)||10
3202343|NCT02133001|3931497|FG001|NOT COMPLETED|Double Blind (Day 1-25)||9
3202344|NCT02133001|3931496|FG000|STARTED|Follow-Up Phase (Day 26-81)||22
3202345|NCT02133001|3931497|FG001|STARTED|Follow-Up Phase (Day 26-81)||27
3202346|NCT02133001|3931496|FG000|COMPLETED|Follow-Up Phase (Day 26-81)||20
3202347|NCT02133001|3931497|FG001|COMPLETED|Follow-Up Phase (Day 26-81)||24
3202348|NCT02133001|3931496|FG000|NOT COMPLETED|Follow-Up Phase (Day 26-81)||2
3202349|NCT02133001|3931497|FG001|NOT COMPLETED|Follow-Up Phase (Day 26-81)||3
3202350|NCT02133066|3931507|FG000|STARTED|Overall Study||64
3202351|NCT02133066|3931508|FG001|STARTED|Overall Study||64
3202352|NCT02133066|3931507|FG000|COMPLETED|Overall Study||64
3202353|NCT02133066|3931508|FG001|COMPLETED|Overall Study||64
3202354|NCT02133066|3931507|FG000|NOT COMPLETED|Overall Study||0
3202355|NCT02133066|3931508|FG001|NOT COMPLETED|Overall Study||0
3202356|NCT02133131|3931521|FG000|STARTED|Overall Study||31
3202357|NCT02133131|3931522|FG001|STARTED|Overall Study||30
3202358|NCT02133131|3931523|FG002|STARTED|Overall Study||20
3202359|NCT02133131|3931524|FG003|STARTED|Overall Study||21
3202360|NCT02133131|3931525|FG004|STARTED|Overall Study||15
3202361|NCT02133131|3931526|FG005|STARTED|Overall Study||14
3202362|NCT02133131|3931527|FG006|STARTED|Overall Study||12
3202363|NCT02133131|3931521|FG000|COMPLETED|Overall Study||26
3202364|NCT02133131|3931522|FG001|COMPLETED|Overall Study||25
3202365|NCT02133131|3931523|FG002|COMPLETED|Overall Study||19
3202366|NCT02133131|3931524|FG003|COMPLETED|Overall Study||15
3202367|NCT02133131|3931525|FG004|COMPLETED|Overall Study||0
3202368|NCT02133131|3931526|FG005|COMPLETED|Overall Study||0
3202369|NCT02133131|3931527|FG006|COMPLETED|Overall Study||0
3202370|NCT02133131|3931521|FG000|NOT COMPLETED|Overall Study||5
3202371|NCT02133131|3931522|FG001|NOT COMPLETED|Overall Study||5
3202372|NCT02133131|3931523|FG002|NOT COMPLETED|Overall Study||1
3202373|NCT02133131|3931524|FG003|NOT COMPLETED|Overall Study||6
3202374|NCT02133131|3931525|FG004|NOT COMPLETED|Overall Study||15
3202375|NCT02133131|3931526|FG005|NOT COMPLETED|Overall Study||14
3202376|NCT02133131|3931527|FG006|NOT COMPLETED|Overall Study||12
3202377|NCT02133235|3931545|FG000|STARTED|Overall Study||55
3202378|NCT02133235|3931546|FG001|STARTED|Overall Study||57
3202379|NCT02133235|3931545|FG000|COMPLETED|Overall Study||55
3202380|NCT02133235|3931546|FG001|COMPLETED|Overall Study||57
3202381|NCT02133235|3931545|FG000|NOT COMPLETED|Overall Study||0
3202382|NCT02133235|3931546|FG001|NOT COMPLETED|Overall Study||0
3202383|NCT02133352|3931558|FG000|STARTED|Main Study (180 Day)||10
3202384|NCT02133352|3931558|FG000|COMPLETED|Main Study (180 Day)||10
3202385|NCT02133352|3931558|FG000|NOT COMPLETED|Main Study (180 Day)||0
3202386|NCT02133352|3931558|FG000|STARTED|Longer Term Extension||10
3202387|NCT02133352|3931558|FG000|COMPLETED|Longer Term Extension||4
3202388|NCT02133352|3931558|FG000|NOT COMPLETED|Longer Term Extension||6
3202389|NCT02133508|3931562|FG000|STARTED|Overall Study||156
3202390|NCT02133508|3931562|FG000|COMPLETED|Overall Study||141
3202391|NCT02133508|3931562|FG000|NOT COMPLETED|Overall Study||15
3202392|NCT02133664|3931568|FG000|STARTED|Overall Study||26
3202393|NCT02133664|3931569|FG001|STARTED|Overall Study||28
3202394|NCT02133664|3931568|FG000|COMPLETED|Overall Study||21
3202395|NCT02133664|3931569|FG001|COMPLETED|Overall Study||21
3202396|NCT02133664|3931568|FG000|NOT COMPLETED|Overall Study||5
3202397|NCT02133664|3931569|FG001|NOT COMPLETED|Overall Study||7
3202398|NCT02133742|3931575|FG000|STARTED|Period 1: Dose Finding Phase (6 Months)||11
3202399|NCT02133742|3931575|FG000|COMPLETED|Period 1: Dose Finding Phase (6 Months)||11
3202400|NCT02133742|3931575|FG000|NOT COMPLETED|Period 1: Dose Finding Phase (6 Months)||0
3202401|NCT02133742|3931575|FG000|STARTED|Period 2:Dose Expansion Phase (1344days)|Participants participated in dose finding phase continued treatment in dose expansion phase.|52
3202402|NCT02133742|3931575|FG000|COMPLETED|Period 2:Dose Expansion Phase (1344days)||0
3202403|NCT02133742|3931575|FG000|NOT COMPLETED|Period 2:Dose Expansion Phase (1344days)||52
3365283|NCT03988049|4096390|FG001|STARTED|Overall Study||22
3365284|NCT03988049|4096389|FG000|COMPLETED|Overall Study||22
3365285|NCT03988049|4096390|FG001|COMPLETED|Overall Study||22
3365286|NCT03988049|4096389|FG000|NOT COMPLETED|Overall Study||0
3365287|NCT03988049|4096390|FG001|NOT COMPLETED|Overall Study||0
3365288|NCT03979820|4096400|FG000|STARTED|Overall Study||13
3365289|NCT03979820|4096401|FG001|STARTED|Overall Study||14
3365290|NCT03979820|4096402|FG002|STARTED|Overall Study||16
3365291|NCT03979820|4096403|FG003|STARTED|Overall Study||10
3365292|NCT03979820|4096400|FG000|COMPLETED|Overall Study||7
3365293|NCT03979820|4096401|FG001|COMPLETED|Overall Study||14
3365294|NCT03979820|4096402|FG002|COMPLETED|Overall Study||15
3365295|NCT03979820|4096403|FG003|COMPLETED|Overall Study||0
3365296|NCT03979820|4096400|FG000|NOT COMPLETED|Overall Study||6
3365297|NCT03979820|4096401|FG001|NOT COMPLETED|Overall Study||0
3365298|NCT03979820|4096402|FG002|NOT COMPLETED|Overall Study||1
3365299|NCT03979820|4096403|FG003|NOT COMPLETED|Overall Study||10
3365300|NCT03972137|4096417|FG000|STARTED|Overall Study||10
3365301|NCT03972137|4096417|FG000|Enrolled|Overall Study||10
3365302|NCT03972137|4096417|FG000|Treatment Completed|Overall Study||6
3365303|NCT03972137|4096417|FG000|Follow-up Completed|Overall Study||4
3365304|NCT03972137|4096417|FG000|COMPLETED|Overall Study||4
3365305|NCT03972137|4096417|FG000|NOT COMPLETED|Overall Study||6
3365306|NCT03970395|4096435|FG000|STARTED|Overall Study||48
3365307|NCT03970395|4096436|FG001|STARTED|Overall Study||48
3365308|NCT03970395|4096435|FG000|COMPLETED|Overall Study||41
3365309|NCT03970395|4096436|FG001|COMPLETED|Overall Study||36
3365310|NCT03970395|4096435|FG000|NOT COMPLETED|Overall Study||7
3365311|NCT03970395|4096436|FG001|NOT COMPLETED|Overall Study||12
3365312|NCT03987620|4096448|FG000|STARTED|Overall Study||303
3365313|NCT03987620|4096449|FG001|STARTED|Overall Study||152
3365314|NCT03987620|4096448|FG000|Withdrawn Before Treatment|Overall Study||5
3365315|NCT03987620|4096449|FG001|Withdrawn Before Treatment|Overall Study||1
3365316|NCT03987620|4096448|FG000|Withdrawn Before TOC|Overall Study||48
3365317|NCT03987620|4096449|FG001|Withdrawn Before TOC|Overall Study||45
3365318|NCT03987620|4096448|FG000|Completed the TOC Visit|Overall Study||250
3365319|NCT03987620|4096449|FG001|Completed the TOC Visit|Overall Study||106
3365320|NCT03987620|4096448|FG000|Withdrawn At or After the TOC Visit|Overall Study||4
3365321|NCT03987620|4096449|FG001|Withdrawn At or After the TOC Visit|Overall Study||4
3365322|NCT03987620|4096448|FG000|COMPLETED|Overall Study||246
3365323|NCT03987620|4096449|FG001|COMPLETED|Overall Study||102
3365324|NCT03987620|4096448|FG000|NOT COMPLETED|Overall Study||57
3365325|NCT03987620|4096449|FG001|NOT COMPLETED|Overall Study||50
3365326|NCT03983317|4096455|FG000|STARTED|Overall Study||25
3365327|NCT03983317|4096455|FG000|COMPLETED|Overall Study||20
3365328|NCT03983317|4096455|FG000|NOT COMPLETED|Overall Study||5
3365329|NCT03985657|4096459|FG000|STARTED|Intervention 1 (One Night)||20
3365330|NCT03985657|4096460|FG001|STARTED|Intervention 1 (One Night)||11
3365331|NCT03985657|4096459|FG000|COMPLETED|Intervention 1 (One Night)||20
3365332|NCT03985657|4096460|FG001|COMPLETED|Intervention 1 (One Night)||10
3365333|NCT03985657|4096459|FG000|NOT COMPLETED|Intervention 1 (One Night)||0
3365334|NCT03985657|4096460|FG001|NOT COMPLETED|Intervention 1 (One Night)||1
3365335|NCT03985657|4096459|FG000|STARTED|Washout (Up to 1 Week)||20
3365336|NCT03985657|4096460|FG001|STARTED|Washout (Up to 1 Week)||10
3365337|NCT03985657|4096459|FG000|COMPLETED|Washout (Up to 1 Week)||20
3365338|NCT03985657|4096460|FG001|COMPLETED|Washout (Up to 1 Week)||10
3365339|NCT03985657|4096459|FG000|NOT COMPLETED|Washout (Up to 1 Week)||0
3365340|NCT03985657|4096460|FG001|NOT COMPLETED|Washout (Up to 1 Week)||0
3365341|NCT03985657|4096459|FG000|STARTED|Intervention 2 (One Night)||20
3365342|NCT03985657|4096460|FG001|STARTED|Intervention 2 (One Night)||10
3365343|NCT03985657|4096459|FG000|COMPLETED|Intervention 2 (One Night)||20
3365344|NCT03985657|4096460|FG001|COMPLETED|Intervention 2 (One Night)||10
3365345|NCT03985657|4096459|FG000|NOT COMPLETED|Intervention 2 (One Night)||0
3365346|NCT03985657|4096460|FG001|NOT COMPLETED|Intervention 2 (One Night)||0
3365347|NCT03981939|4096469|FG000|STARTED|Overall Study||549
3365348|NCT03981939|4096470|FG001|STARTED|Overall Study||1902
3365349|NCT03981939|4096471|FG002|STARTED|Overall Study||581
3365350|NCT03981939|4096469|FG000|COMPLETED|Overall Study||549
3365351|NCT03981939|4096470|FG001|COMPLETED|Overall Study||1902
3365352|NCT03981939|4096471|FG002|COMPLETED|Overall Study||581
3365353|NCT03981939|4096469|FG000|NOT COMPLETED|Overall Study||0
3365354|NCT03981939|4096470|FG001|NOT COMPLETED|Overall Study||0
3365355|NCT03981939|4096471|FG002|NOT COMPLETED|Overall Study||0
3365356|NCT03973905|4096484|FG000|STARTED|Overall Study||107
3365357|NCT03973905|4096485|FG001|STARTED|Overall Study||183
3365358|NCT03973905|4096484|FG000|COMPLETED|Overall Study||107
3202404|NCT02133781|3931584|FG000|STARTED|Overall Study||6
3202405|NCT02133781|3931585|FG001|STARTED|Overall Study||24
3202406|NCT02133781|3931586|FG002|STARTED|Overall Study||21
3202407|NCT02133781|3931584|FG000|COMPLETED|Overall Study||6
3202408|NCT02133781|3931585|FG001|COMPLETED|Overall Study||24
3202409|NCT02133781|3931586|FG002|COMPLETED|Overall Study||21
3202410|NCT02133781|3931584|FG000|NOT COMPLETED|Overall Study||0
3202411|NCT02133781|3931585|FG001|NOT COMPLETED|Overall Study||0
3202412|NCT02133781|3931586|FG002|NOT COMPLETED|Overall Study||0
3202413|NCT02134015|3931596|FG000|STARTED|Overall Study||71
3202414|NCT02134015|3931597|FG001|STARTED|Overall Study||74
3202415|NCT02134015|3931596|FG000|COMPLETED|Overall Study||0
3202416|NCT02134015|3931597|FG001|COMPLETED|Overall Study||0
3202417|NCT02134015|3931596|FG000|NOT COMPLETED|Overall Study||71
3202418|NCT02134015|3931597|FG001|NOT COMPLETED|Overall Study||74
3202419|NCT02134028|3931611|FG000|STARTED|Overall Study||111
3202420|NCT02134028|3931612|FG001|STARTED|Overall Study||421
3202421|NCT02134028|3931613|FG002|STARTED|Overall Study||517
3202422|NCT02134028|3931614|FG003|STARTED|Overall Study||1013
3202423|NCT02134028|3931615|FG004|STARTED|Overall Study||97
3202424|NCT02134028|3931616|FG005|STARTED|Overall Study||90
3202425|NCT02134028|3931617|FG006|STARTED|Overall Study||19
3202426|NCT02134028|3931618|FG007|STARTED|Overall Study||14
3202427|NCT02134028|3931611|FG000|COMPLETED|Overall Study||102
3202428|NCT02134028|3931612|FG001|COMPLETED|Overall Study||379
3202429|NCT02134028|3931613|FG002|COMPLETED|Overall Study||465
3202430|NCT02134028|3931614|FG003|COMPLETED|Overall Study||908
3202431|NCT02134028|3931615|FG004|COMPLETED|Overall Study||83
3202432|NCT02134028|3931616|FG005|COMPLETED|Overall Study||76
3202433|NCT02134028|3931617|FG006|COMPLETED|Overall Study||15
3202434|NCT02134028|3931618|FG007|COMPLETED|Overall Study||11
3202435|NCT02134028|3931611|FG000|NOT COMPLETED|Overall Study||9
3202436|NCT02134028|3931612|FG001|NOT COMPLETED|Overall Study||42
3202437|NCT02134028|3931613|FG002|NOT COMPLETED|Overall Study||52
3202438|NCT02134028|3931614|FG003|NOT COMPLETED|Overall Study||105
3202439|NCT02134028|3931615|FG004|NOT COMPLETED|Overall Study||14
3202440|NCT02134028|3931616|FG005|NOT COMPLETED|Overall Study||14
3202441|NCT02134028|3931617|FG006|NOT COMPLETED|Overall Study||4
3202442|NCT02134028|3931618|FG007|NOT COMPLETED|Overall Study||3
3202443|NCT02134119|3931640|FG000|STARTED|Overall Study||30
3202444|NCT02134119|3931641|FG001|STARTED|Overall Study||15
3202445|NCT02134119|3931640|FG000|COMPLETED|Overall Study||30
3202446|NCT02134119|3931641|FG001|COMPLETED|Overall Study||15
3202447|NCT02134119|3931640|FG000|NOT COMPLETED|Overall Study||0
3202448|NCT02134119|3931641|FG001|NOT COMPLETED|Overall Study||0
3202449|NCT02134184|3931650|FG000|STARTED|Overall Study||33
3202450|NCT02134184|3931651|FG001|STARTED|Overall Study||37
3202451|NCT02134184|3931652|FG002|STARTED|Overall Study||8
3202452|NCT02134184|3931650|FG000|COMPLETED|Overall Study||33
3202453|NCT02134184|3931651|FG001|COMPLETED|Overall Study||37
3202454|NCT02134184|3931652|FG002|COMPLETED|Overall Study||8
3202455|NCT02134184|3931650|FG000|NOT COMPLETED|Overall Study||0
3202456|NCT02134184|3931651|FG001|NOT COMPLETED|Overall Study||0
3202457|NCT02134184|3931652|FG002|NOT COMPLETED|Overall Study||0
3202458|NCT02134210|3931662|FG000|STARTED|Part One: Weeks 0-12||260
3202459|NCT02134210|3931663|FG001|STARTED|Part One: Weeks 0-12||261
3202460|NCT02134210|3931662|FG000|COMPLETED|Part One: Weeks 0-12||241
3202461|NCT02134210|3931663|FG001|COMPLETED|Part One: Weeks 0-12||255
3202462|NCT02134210|3931662|FG000|NOT COMPLETED|Part One: Weeks 0-12||19
3202463|NCT02134210|3931663|FG001|NOT COMPLETED|Part One: Weeks 0-12||6
3202464|NCT02134210|3931662|FG000|STARTED|Part Two: Weeks 13-48||241
3202465|NCT02134210|3931663|FG001|STARTED|Part Two: Weeks 13-48||255
3202466|NCT02134210|3931662|FG000|COMPLETED|Part Two: Weeks 13-48||211
3202467|NCT02134210|3931663|FG001|COMPLETED|Part Two: Weeks 13-48||227
3202468|NCT02134210|3931662|FG000|NOT COMPLETED|Part Two: Weeks 13-48||30
3202469|NCT02134210|3931663|FG001|NOT COMPLETED|Part Two: Weeks 13-48||28
3202470|NCT02134314|3931671|FG000|STARTED|Overall Study||35
3202471|NCT02134314|3931672|FG001|STARTED|Overall Study||35
3202472|NCT02134314|3931671|FG000|COMPLETED|Overall Study||34
3202473|NCT02134314|3931672|FG001|COMPLETED|Overall Study||34
3202474|NCT02134314|3931671|FG000|NOT COMPLETED|Overall Study||1
3202475|NCT02134314|3931672|FG001|NOT COMPLETED|Overall Study||1
3202476|NCT02134353|3931681|FG000|STARTED|Overall Study||209
3202477|NCT02134353|3931682|FG001|STARTED|Overall Study||214
3202478|NCT02134353|3931681|FG000|COMPLETED|Overall Study||183
3202479|NCT02134353|3931682|FG001|COMPLETED|Overall Study||190
3202480|NCT02134353|3931681|FG000|NOT COMPLETED|Overall Study||26
3202481|NCT02134353|3931682|FG001|NOT COMPLETED|Overall Study||24
3202482|NCT02134522|3931688|FG000|STARTED|Overall Study||1
3202483|NCT02134522|3931688|FG000|COMPLETED|Overall Study||1
3202484|NCT02134522|3931688|FG000|NOT COMPLETED|Overall Study||0
3202485|NCT02134587|3931692|FG000|STARTED|Overall Study||203
3202486|NCT02134587|3931692|FG000|COMPLETED|Overall Study||173
3202487|NCT02134587|3931692|FG000|NOT COMPLETED|Overall Study||30
3202488|NCT02134756|3931703|FG000|STARTED|Overall Study||15
3202489|NCT02134756|3931704|FG001|STARTED|Overall Study||15
3202490|NCT02134756|3931703|FG000|COMPLETED|Overall Study||14
3202491|NCT02134756|3931704|FG001|COMPLETED|Overall Study||13
3202492|NCT02134756|3931703|FG000|NOT COMPLETED|Overall Study||1
3202493|NCT02134756|3931704|FG001|NOT COMPLETED|Overall Study||2
3202494|NCT02134951|3931712|FG000|STARTED|Overall Study||39
3202495|NCT02134951|3931713|FG001|STARTED|Overall Study||20
3365359|NCT03973905|4096485|FG001|COMPLETED|Overall Study||183
3202496|NCT02134951|3931712|FG000|COMPLETED|Overall Study|number of subjects with at least one valid scan|39
3202497|NCT02134951|3931713|FG001|COMPLETED|Overall Study|number of subjects with at least one valid scan|20
3202498|NCT02134951|3931712|FG000|NOT COMPLETED|Overall Study||0
3202499|NCT02134951|3931713|FG001|NOT COMPLETED|Overall Study||0
3202500|NCT02134977|3931719|FG000|STARTED|Overall Study||2816
3202501|NCT02134977|3931719|FG000|COMPLETED|Overall Study||2714
3202502|NCT02134977|3931719|FG000|NOT COMPLETED|Overall Study||102
3202503|NCT02135016|3931726|FG000|STARTED|Overall Study||15
3202504|NCT02135016|3931727|FG001|STARTED|Overall Study||15
3202505|NCT02135016|3931728|FG002|STARTED|Overall Study||15
3202506|NCT02135016|3931726|FG000|COMPLETED|Overall Study||15
3202507|NCT02135016|3931727|FG001|COMPLETED|Overall Study||15
3202508|NCT02135016|3931728|FG002|COMPLETED|Overall Study||15
3202509|NCT02135016|3931726|FG000|NOT COMPLETED|Overall Study||0
3202510|NCT02135016|3931727|FG001|NOT COMPLETED|Overall Study||0
3202511|NCT02135016|3931728|FG002|NOT COMPLETED|Overall Study||0
3202512|NCT02135094|3931738|FG000|STARTED|Overall Study||25
3202513|NCT02135094|3931739|FG001|STARTED|Overall Study||8
3202514|NCT02135094|3931738|FG000|Week 2|Overall Study||25
3202515|NCT02135094|3931739|FG001|Week 2|Overall Study||8
3202516|NCT02135094|3931738|FG000|Week 3|Overall Study||25
3202517|NCT02135094|3931739|FG001|Week 3|Overall Study||8
3202518|NCT02135094|3931738|FG000|Week 4|Overall Study||25
3202519|NCT02135094|3931739|FG001|Week 4|Overall Study||8
3202520|NCT02135094|3931738|FG000|COMPLETED|Overall Study||25
3202521|NCT02135094|3931739|FG001|COMPLETED|Overall Study||8
3202522|NCT02135094|3931738|FG000|NOT COMPLETED|Overall Study||0
3202523|NCT02135094|3931739|FG001|NOT COMPLETED|Overall Study||0
3202524|NCT02135107|3931747|FG000|STARTED|Treatment Period||437
3202525|NCT02135107|3931748|FG001|STARTED|Treatment Period||80
3202526|NCT02135107|3931749|FG002|STARTED|Treatment Period||0
3202527|NCT02135107|3931750|FG003|STARTED|Treatment Period||0
3202528|NCT02135107|3931747|FG000|COMPLETED|Treatment Period||305
3202529|NCT02135107|3931748|FG001|COMPLETED|Treatment Period||54
3202530|NCT02135107|3931749|FG002|COMPLETED|Treatment Period||0
3202531|NCT02135107|3931750|FG003|COMPLETED|Treatment Period||0
3202532|NCT02135107|3931747|FG000|NOT COMPLETED|Treatment Period||132
3202533|NCT02135107|3931748|FG001|NOT COMPLETED|Treatment Period||26
3202534|NCT02135107|3931749|FG002|NOT COMPLETED|Treatment Period||0
3202535|NCT02135107|3931750|FG003|NOT COMPLETED|Treatment Period||0
3202536|NCT02135107|3931747|FG000|STARTED|Maintenance Therapy Period|Treatment Phase only|0
3202537|NCT02135107|3931748|FG001|STARTED|Maintenance Therapy Period|Treatment Phase only|0
3202538|NCT02135107|3931749|FG002|STARTED|Maintenance Therapy Period|Only eligible participants entered into the Maintenance Therapy Period|178
3202539|NCT02135107|3931750|FG003|STARTED|Maintenance Therapy Period|Only eligible participants entered into the Maintenance Therapy Period|181
3202540|NCT02135107|3931747|FG000|COMPLETED|Maintenance Therapy Period||0
3202541|NCT02135107|3931748|FG001|COMPLETED|Maintenance Therapy Period||0
3202542|NCT02135107|3931749|FG002|COMPLETED|Maintenance Therapy Period||163
3202543|NCT02135107|3931750|FG003|COMPLETED|Maintenance Therapy Period||161
3202544|NCT02135107|3931747|FG000|NOT COMPLETED|Maintenance Therapy Period||0
3202545|NCT02135107|3931748|FG001|NOT COMPLETED|Maintenance Therapy Period||0
3202546|NCT02135107|3931749|FG002|NOT COMPLETED|Maintenance Therapy Period||15
3202547|NCT02135107|3931750|FG003|NOT COMPLETED|Maintenance Therapy Period||20
3202548|NCT02135146|3931764|FG000|STARTED|Overall Study||20
3202549|NCT02135146|3931765|FG001|STARTED|Overall Study||20
3202550|NCT02135146|3931764|FG000|COMPLETED|Overall Study||20
3202551|NCT02135146|3931765|FG001|COMPLETED|Overall Study||20
3202552|NCT02135146|3931764|FG000|NOT COMPLETED|Overall Study||0
3202553|NCT02135146|3931765|FG001|NOT COMPLETED|Overall Study||0
3202554|NCT02135432|3931773|FG000|STARTED|Overall Study||8
3202555|NCT02135432|3931774|FG001|STARTED|Overall Study||4
3202556|NCT02135432|3931773|FG000|COMPLETED|Overall Study||8
3202557|NCT02135432|3931774|FG001|COMPLETED|Overall Study||4
3202558|NCT02135432|3931773|FG000|NOT COMPLETED|Overall Study||0
3202559|NCT02135432|3931774|FG001|NOT COMPLETED|Overall Study||0
3202560|NCT02135445|3931783|FG000|STARTED|Overall Study||65
3202561|NCT02135445|3931784|FG001|STARTED|Overall Study||38
3202562|NCT02135445|3931783|FG000|COMPLETED|Overall Study||63
3202563|NCT02135445|3931784|FG001|COMPLETED|Overall Study||38
3202564|NCT02135445|3931783|FG000|NOT COMPLETED|Overall Study||2
3202565|NCT02135445|3931784|FG001|NOT COMPLETED|Overall Study||0
3202566|NCT02135614|3931792|FG000|STARTED|Overall Study||94
3202567|NCT02135614|3931793|FG001|STARTED|Overall Study||95
3202568|NCT02135614|3931792|FG000|COMPLETED|Overall Study||86
3202569|NCT02135614|3931793|FG001|COMPLETED|Overall Study||90
3202570|NCT02135614|3931792|FG000|NOT COMPLETED|Overall Study||8
3202571|NCT02135614|3931793|FG001|NOT COMPLETED|Overall Study||5
3202572|NCT02135653|3931801|FG000|STARTED|Overall Study||35
3202573|NCT02135653|3931802|FG001|STARTED|Overall Study||33
3202574|NCT02135653|3931801|FG000|COMPLETED|Overall Study||22
3202575|NCT02135653|3931802|FG001|COMPLETED|Overall Study||28
3202576|NCT02135653|3931801|FG000|NOT COMPLETED|Overall Study||13
3202577|NCT02135653|3931802|FG001|NOT COMPLETED|Overall Study||5
3202578|NCT02135692|3931810|FG000|STARTED|Overall Study||339
3202579|NCT02135692|3931810|FG000|COMPLETED|Overall Study||0
3202580|NCT02135692|3931810|FG000|NOT COMPLETED|Overall Study||339
3202581|NCT02135848|3931816|FG000|STARTED|Overall Study||26
3202582|NCT02135848|3931817|FG001|STARTED|Overall Study||20
3202583|NCT02135848|3931816|FG000|COMPLETED|Overall Study||23
3202584|NCT02135848|3931817|FG001|COMPLETED|Overall Study||19
3202585|NCT02135848|3931816|FG000|NOT COMPLETED|Overall Study||3
3202586|NCT02135848|3931817|FG001|NOT COMPLETED|Overall Study||1
3202587|NCT02135861|3931833|FG000|STARTED|Overall Study||21
3202588|NCT02135861|3931834|FG001|STARTED|Overall Study||12
3202589|NCT02135861|3931835|FG002|STARTED|Overall Study||3
3202590|NCT02135861|3931833|FG000|COMPLETED|Overall Study||21
3202591|NCT02135861|3931834|FG001|COMPLETED|Overall Study||12
3202592|NCT02135861|3931835|FG002|COMPLETED|Overall Study||3
3202593|NCT02135861|3931833|FG000|NOT COMPLETED|Overall Study||0
3202594|NCT02135861|3931834|FG001|NOT COMPLETED|Overall Study||0
3202595|NCT02135861|3931835|FG002|NOT COMPLETED|Overall Study||0
3202596|NCT02135900|3931845|FG000|STARTED|Overall Study|32 subjects started the study. 50 subjects were screened.|32
3202597|NCT02135900|3931845|FG000|COMPLETED|Overall Study||32
3202598|NCT02135900|3931845|FG000|NOT COMPLETED|Overall Study||0
3202599|NCT02136004|3931851|FG000|STARTED|Overall Study|Enrollment commenced on May 20, 2014 and the last subject completed follow-up on February 28, 2015|220
3202600|NCT02136004|3931851|FG000|COMPLETED|Overall Study||219
3202601|NCT02136004|3931851|FG000|NOT COMPLETED|Overall Study||1
3202602|NCT02136238|3931857|FG000|STARTED|Overall Study||4
3202603|NCT02136238|3931858|FG001|STARTED|Overall Study||4
3202604|NCT02136238|3931859|FG002|STARTED|Overall Study||10
3202605|NCT02136238|3931857|FG000|COMPLETED|Overall Study||4
3202606|NCT02136238|3931858|FG001|COMPLETED|Overall Study||4
3202607|NCT02136238|3931859|FG002|COMPLETED|Overall Study||10
3202608|NCT02136238|3931857|FG000|NOT COMPLETED|Overall Study||0
3202609|NCT02136238|3931858|FG001|NOT COMPLETED|Overall Study||0
3202610|NCT02136238|3931859|FG002|NOT COMPLETED|Overall Study||0
3202611|NCT02136420|3931874|FG000|STARTED|Overall Study||10
3202612|NCT02136420|3931875|FG001|STARTED|Overall Study||0
3202613|NCT02136420|3931876|FG002|STARTED|Overall Study||0
3202614|NCT02136420|3931877|FG003|STARTED|Overall Study||0
3202615|NCT02136420|3931878|FG004|STARTED|Overall Study||10
3202616|NCT02136420|3931879|FG005|STARTED|Overall Study||0
3202617|NCT02136420|3931880|FG006|STARTED|Overall Study||0
3202618|NCT02136420|3931881|FG007|STARTED|Overall Study||0
3202619|NCT02136420|3931882|FG008|STARTED|Overall Study||5
3202620|NCT02136420|3931883|FG009|STARTED|Overall Study||5
3202621|NCT02136420|3931874|FG000|COMPLETED|Overall Study||9
3202622|NCT02136420|3931875|FG001|COMPLETED|Overall Study||0
3202623|NCT02136420|3931876|FG002|COMPLETED|Overall Study||0
3202624|NCT02136420|3931877|FG003|COMPLETED|Overall Study||0
3202625|NCT02136420|3931878|FG004|COMPLETED|Overall Study||10
3202626|NCT02136420|3931879|FG005|COMPLETED|Overall Study||0
3202627|NCT02136420|3931880|FG006|COMPLETED|Overall Study||0
3202628|NCT02136420|3931881|FG007|COMPLETED|Overall Study||0
3202629|NCT02136420|3931882|FG008|COMPLETED|Overall Study||5
3202630|NCT02136420|3931883|FG009|COMPLETED|Overall Study||5
3202631|NCT02136420|3931874|FG000|NOT COMPLETED|Overall Study||1
3202632|NCT02136420|3931875|FG001|NOT COMPLETED|Overall Study||0
3202633|NCT02136420|3931876|FG002|NOT COMPLETED|Overall Study||0
3202634|NCT02136420|3931877|FG003|NOT COMPLETED|Overall Study||0
3202635|NCT02136420|3931878|FG004|NOT COMPLETED|Overall Study||0
3202636|NCT02136420|3931879|FG005|NOT COMPLETED|Overall Study||0
3202637|NCT02136420|3931880|FG006|NOT COMPLETED|Overall Study||0
3202638|NCT02136420|3931881|FG007|NOT COMPLETED|Overall Study||0
3202639|NCT02136420|3931882|FG008|NOT COMPLETED|Overall Study||0
3202640|NCT02136420|3931883|FG009|NOT COMPLETED|Overall Study||0
3202641|NCT02136498|3931900|FG000|STARTED|Overall Study||33
3202642|NCT02136498|3931901|FG001|STARTED|Overall Study||33
3202643|NCT02136498|3931900|FG000|COMPLETED|Overall Study||33
3202644|NCT02136498|3931901|FG001|COMPLETED|Overall Study||33
3202645|NCT02136498|3931900|FG000|NOT COMPLETED|Overall Study||0
3202646|NCT02136498|3931901|FG001|NOT COMPLETED|Overall Study||0
3202647|NCT02136576|3931910|FG000|STARTED|Overall Study||13
3202648|NCT02136576|3931911|FG001|STARTED|Overall Study||13
3202649|NCT02136576|3931912|FG002|STARTED|Overall Study||13
3202650|NCT02136576|3931910|FG000|COMPLETED|Overall Study||11
3202651|NCT02136576|3931911|FG001|COMPLETED|Overall Study||13
3202652|NCT02136576|3931912|FG002|COMPLETED|Overall Study||13
3202653|NCT02136576|3931910|FG000|NOT COMPLETED|Overall Study||2
3202654|NCT02136576|3931911|FG001|NOT COMPLETED|Overall Study||0
3202655|NCT02136576|3931912|FG002|NOT COMPLETED|Overall Study||0
3202656|NCT02136680|3931922|FG000|STARTED|Overall Study||112
3202657|NCT02136680|3931923|FG001|STARTED|Overall Study||85
3202658|NCT02136680|3931922|FG000|Interview 1|Overall Study||112
3202659|NCT02136680|3931923|FG001|Interview 1|Overall Study||85
3202660|NCT02136680|3931922|FG000|Interview 2|Overall Study||97
3202661|NCT02136680|3931923|FG001|Interview 2|Overall Study||70
3202662|NCT02136680|3931922|FG000|Interview 3|Overall Study||80
3202663|NCT02136680|3931923|FG001|Interview 3|Overall Study||56
3202664|NCT02136680|3931922|FG000|COMPLETED|Overall Study||80
3202665|NCT02136680|3931923|FG001|COMPLETED|Overall Study||56
3202666|NCT02136680|3931922|FG000|NOT COMPLETED|Overall Study||32
3202667|NCT02136680|3931923|FG001|NOT COMPLETED|Overall Study||29
3202668|NCT02136810|3931929|FG000|STARTED|Overall Study||200
3202669|NCT02136810|3931929|FG000|COMPLETED|Overall Study||200
3202670|NCT02136810|3931929|FG000|NOT COMPLETED|Overall Study||0
3202671|NCT02136914|3931935|FG000|STARTED|Overall Study||63
3202672|NCT02136914|3931936|FG001|STARTED|Overall Study||63
3202673|NCT02136914|3931935|FG000|Received Study Drug|Overall Study||60
3202674|NCT02136914|3931936|FG001|Received Study Drug|Overall Study||63
3202675|NCT02136914|3931935|FG000|COMPLETED|Overall Study||42
3202676|NCT02136914|3931936|FG001|COMPLETED|Overall Study||42
3202677|NCT02136914|3931935|FG000|NOT COMPLETED|Overall Study||21
3202678|NCT02136914|3931936|FG001|NOT COMPLETED|Overall Study||21
3202679|NCT02137226|3931944|FG000|STARTED|Period 1 (Initial Randomization)||324
3202680|NCT02137226|3931945|FG001|STARTED|Period 1 (Initial Randomization)||321
3202681|NCT02137226|3931946|FG002|STARTED|Period 1 (Initial Randomization)||0
3202682|NCT02137226|3931947|FG003|STARTED|Period 1 (Initial Randomization)||0
3202683|NCT02137226|3931948|FG004|STARTED|Period 1 (Initial Randomization)||0
3202684|NCT02137226|3931944|FG000|COMPLETED|Period 1 (Initial Randomization)|Not completed are discontinued from study|304
3202685|NCT02137226|3931945|FG001|COMPLETED|Period 1 (Initial Randomization)|Not completed are discontinued from study|305
3202686|NCT02137226|3931946|FG002|COMPLETED|Period 1 (Initial Randomization)||0
3202687|NCT02137226|3931947|FG003|COMPLETED|Period 1 (Initial Randomization)||0
3202688|NCT02137226|3931948|FG004|COMPLETED|Period 1 (Initial Randomization)||0
3202689|NCT02137226|3931944|FG000|NOT COMPLETED|Period 1 (Initial Randomization)||20
3202690|NCT02137226|3931945|FG001|NOT COMPLETED|Period 1 (Initial Randomization)||16
3202691|NCT02137226|3931946|FG002|NOT COMPLETED|Period 1 (Initial Randomization)||0
3202692|NCT02137226|3931947|FG003|NOT COMPLETED|Period 1 (Initial Randomization)||0
3202693|NCT02137226|3931948|FG004|NOT COMPLETED|Period 1 (Initial Randomization)||0
3202694|NCT02137226|3931944|FG000|STARTED|Period 2 (Re - Randomization)||0
3202695|NCT02137226|3931945|FG001|STARTED|Period 2 (Re - Randomization)||0
3202696|NCT02137226|3931946|FG002|STARTED|Period 2 (Re - Randomization)||298
3202697|NCT02137226|3931947|FG003|STARTED|Period 2 (Re - Randomization)||148
3202698|NCT02137226|3931948|FG004|STARTED|Period 2 (Re - Randomization)||147
3202699|NCT02137226|3931944|FG000|COMPLETED|Period 2 (Re - Randomization)||0
3202700|NCT02137226|3931945|FG001|COMPLETED|Period 2 (Re - Randomization)||0
3202701|NCT02137226|3931946|FG002|COMPLETED|Period 2 (Re - Randomization)|Not completed are discontinued from study|281
3202702|NCT02137226|3931947|FG003|COMPLETED|Period 2 (Re - Randomization)|Not completed are discontinued from study|140
3202703|NCT02137226|3931948|FG004|COMPLETED|Period 2 (Re - Randomization)|Not completed are discontinued from study|138
3202704|NCT02137226|3931944|FG000|NOT COMPLETED|Period 2 (Re - Randomization)||0
3202705|NCT02137226|3931945|FG001|NOT COMPLETED|Period 2 (Re - Randomization)||0
3202706|NCT02137226|3931946|FG002|NOT COMPLETED|Period 2 (Re - Randomization)||17
3202707|NCT02137226|3931947|FG003|NOT COMPLETED|Period 2 (Re - Randomization)||8
3202708|NCT02137226|3931948|FG004|NOT COMPLETED|Period 2 (Re - Randomization)||9
3202709|NCT02137369|3931958|FG000|STARTED|Overall Study||49
3202710|NCT02137369|3931959|FG001|STARTED|Overall Study||11
3202711|NCT02137369|3931958|FG000|COMPLETED|Overall Study||41
3202712|NCT02137369|3931959|FG001|COMPLETED|Overall Study||9
3202713|NCT02137369|3931958|FG000|NOT COMPLETED|Overall Study||8
3202714|NCT02137369|3931959|FG001|NOT COMPLETED|Overall Study||2
3202715|NCT02137382|3931966|FG000|STARTED|Cross-over Period 1||20
3202716|NCT02137382|3931967|FG001|STARTED|Cross-over Period 1||21
3202717|NCT02137382|3931966|FG000|COMPLETED|Cross-over Period 1||18
3202718|NCT02137382|3931967|FG001|COMPLETED|Cross-over Period 1||21
3202719|NCT02137382|3931966|FG000|NOT COMPLETED|Cross-over Period 1||2
3202720|NCT02137382|3931967|FG001|NOT COMPLETED|Cross-over Period 1||0
3202721|NCT02137382|3931966|FG000|STARTED|Wash Out||18
3202722|NCT02137382|3931967|FG001|STARTED|Wash Out||21
3202723|NCT02137382|3931966|FG000|COMPLETED|Wash Out||18
3202724|NCT02137382|3931967|FG001|COMPLETED|Wash Out||21
3202725|NCT02137382|3931966|FG000|NOT COMPLETED|Wash Out||0
3202726|NCT02137382|3931967|FG001|NOT COMPLETED|Wash Out||0
3202727|NCT02137382|3931966|FG000|STARTED|Cross-over Period 2||18
3202728|NCT02137382|3931967|FG001|STARTED|Cross-over Period 2||21
3202729|NCT02137382|3931966|FG000|COMPLETED|Cross-over Period 2||18
3202730|NCT02137382|3931967|FG001|COMPLETED|Cross-over Period 2||21
3202731|NCT02137382|3931966|FG000|NOT COMPLETED|Cross-over Period 2||0
3202732|NCT02137382|3931967|FG001|NOT COMPLETED|Cross-over Period 2||0
3202733|NCT02137447|3931974|FG000|STARTED|Overall Study||10
3202734|NCT02137447|3931974|FG000|COMPLETED|Overall Study||10
3202735|NCT02137447|3931974|FG000|NOT COMPLETED|Overall Study||0
3202736|NCT02137486|3931980|FG000|STARTED|Overall Study||112
3202737|NCT02137486|3931981|FG001|STARTED|Overall Study||102
3202738|NCT02137486|3931980|FG000|COMPLETED|Overall Study||112
3202739|NCT02137486|3931981|FG001|COMPLETED|Overall Study||102
3202740|NCT02137486|3931980|FG000|NOT COMPLETED|Overall Study||0
3202741|NCT02137486|3931981|FG001|NOT COMPLETED|Overall Study||0
3202742|NCT02137499|3931995|FG000|STARTED|Overall Study||10
3202743|NCT02137499|3931996|FG001|STARTED|Overall Study||10
3202744|NCT02137499|3931997|FG002|STARTED|Overall Study||10
3202745|NCT02137499|3931998|FG003|STARTED|Overall Study||10
3202746|NCT02137499|3931995|FG000|COMPLETED|Overall Study||10
3202747|NCT02137499|3931996|FG001|COMPLETED|Overall Study||10
3202748|NCT02137499|3931997|FG002|COMPLETED|Overall Study||10
3202749|NCT02137499|3931998|FG003|COMPLETED|Overall Study||10
3202750|NCT02137499|3931995|FG000|NOT COMPLETED|Overall Study||0
3202751|NCT02137499|3931996|FG001|NOT COMPLETED|Overall Study||0
3202752|NCT02137499|3931997|FG002|NOT COMPLETED|Overall Study||0
3202753|NCT02137499|3931998|FG003|NOT COMPLETED|Overall Study||0
3202754|NCT02137512|3932008|FG000|STARTED|2-Week Baseline Sensor-Augmented Pump||30
3202755|NCT02137512|3932008|FG000|COMPLETED|2-Week Baseline Sensor-Augmented Pump||30
3202756|NCT02137512|3932008|FG000|NOT COMPLETED|2-Week Baseline Sensor-Augmented Pump||0
3202757|NCT02137512|3932008|FG000|STARTED|2-Week Overnight-Only Closed-Loop||30
3202758|NCT02137512|3932008|FG000|COMPLETED|2-Week Overnight-Only Closed-Loop||30
3202759|NCT02137512|3932008|FG000|NOT COMPLETED|2-Week Overnight-Only Closed-Loop||0
3202760|NCT02137512|3932008|FG000|STARTED|2-Week 24/7 Closed-Loop||30
3202761|NCT02137512|3932008|FG000|COMPLETED|2-Week 24/7 Closed-Loop||30
3202762|NCT02137512|3932008|FG000|NOT COMPLETED|2-Week 24/7 Closed-Loop||0
3202763|NCT02137512|3932008|FG000|STARTED|5-Month 24/7 Closed-Loop||14
3202764|NCT02137512|3932008|FG000|COMPLETED|5-Month 24/7 Closed-Loop||14
3202765|NCT02137512|3932008|FG000|NOT COMPLETED|5-Month 24/7 Closed-Loop||0
3202766|NCT02137538|3932018|FG000|STARTED|Overall Study||39
3202767|NCT02137538|3932019|FG001|STARTED|Overall Study||40
3202768|NCT02137538|3932018|FG000|COMPLETED|Overall Study||23
3202769|NCT02137538|3932019|FG001|COMPLETED|Overall Study||26
3202770|NCT02137538|3932018|FG000|NOT COMPLETED|Overall Study||16
3202771|NCT02137538|3932019|FG001|NOT COMPLETED|Overall Study||14
3202772|NCT02137603|3932027|FG000|STARTED|Overall Study||18
3202773|NCT02137603|3932028|FG001|STARTED|Overall Study||18
3202774|NCT02137603|3932027|FG000|COMPLETED|Overall Study||16
3202775|NCT02137603|3932028|FG001|COMPLETED|Overall Study||18
3202776|NCT02137603|3932027|FG000|NOT COMPLETED|Overall Study||2
3202777|NCT02137603|3932028|FG001|NOT COMPLETED|Overall Study||0
3202778|NCT02137772|3932036|FG000|STARTED|Overall Study|Randomized participants|376
3202779|NCT02137772|3932037|FG001|STARTED|Overall Study|Randomized participants|194
3202780|NCT02137772|3932036|FG000|Treated Participants|Overall Study||373
3202781|NCT02137772|3932037|FG001|Treated Participants|Overall Study||192
3202782|NCT02137772|3932036|FG000|COMPLETED|Overall Study||244
3202783|NCT02137772|3932037|FG001|COMPLETED|Overall Study||119
3202784|NCT02137772|3932036|FG000|NOT COMPLETED|Overall Study||132
3202785|NCT02137772|3932037|FG001|NOT COMPLETED|Overall Study||75
3202786|NCT02137785|3932045|FG000|STARTED|Overall Study||135
3202787|NCT02137785|3932046|FG001|STARTED|Overall Study||134
3202788|NCT02137785|3932045|FG000|COMPLETED|Overall Study||132
3202789|NCT02137785|3932046|FG001|COMPLETED|Overall Study||130
3365360|NCT03973905|4096484|FG000|NOT COMPLETED|Overall Study||0
3365361|NCT03973905|4096485|FG001|NOT COMPLETED|Overall Study||0
3365362|NCT03984838|4096491|FG000|STARTED|Overall Study||16
3365363|NCT03984838|4096491|FG000|COMPLETED|Overall Study||16
3365364|NCT03984838|4096491|FG000|NOT COMPLETED|Overall Study||0
3365365|NCT03983941|4096497|FG000|STARTED|Overall Study||2
3365366|NCT03983941|4096498|FG001|STARTED|Overall Study||5
3365367|NCT03983941|4096497|FG000|COMPLETED|Overall Study||2
3365368|NCT03983941|4096498|FG001|COMPLETED|Overall Study||5
3365369|NCT03983941|4096497|FG000|NOT COMPLETED|Overall Study||0
3365370|NCT03983941|4096498|FG001|NOT COMPLETED|Overall Study||0
3365371|NCT03976752|4096506|FG000|STARTED|Overall Study||4
3365372|NCT03976752|4096507|FG001|STARTED|Overall Study||37
3365373|NCT03976752|4096506|FG000|Started Study Arm A|Overall Study||0
3365374|NCT03976752|4096507|FG001|Started Study Arm A|Overall Study||14
3365375|NCT03976752|4096506|FG000|Completed Study Arm A|Overall Study||0
3365376|NCT03976752|4096507|FG001|Completed Study Arm A|Overall Study||8
3365377|NCT03976752|4096506|FG000|Started Study Arm B|Overall Study||0
3365378|NCT03976752|4096507|FG001|Started Study Arm B|Overall Study||8
3365379|NCT03976752|4096506|FG000|Completed Study Arm B|Overall Study||0
3365380|NCT03976752|4096507|FG001|Completed Study Arm B|Overall Study||8
3365381|NCT03976752|4096506|FG000|Started Study Arm C|Overall Study||0
3365382|NCT03976752|4096507|FG001|Started Study Arm C|Overall Study||11
3365383|NCT03976752|4096506|FG000|Completed Study Arm C|Overall Study||0
3365384|NCT03976752|4096507|FG001|Completed Study Arm C|Overall Study||8
3365385|NCT03976752|4096506|FG000|Started Study Arm D|Overall Study||0
3365386|NCT03976752|4096507|FG001|Started Study Arm D|Overall Study||6
3365387|NCT03976752|4096506|FG000|Completed Study Arm D|Overall Study||0
3365388|NCT03976752|4096507|FG001|Completed Study Arm D|Overall Study||4
3365389|NCT03976752|4096506|FG000|COMPLETED|Overall Study||3
3365390|NCT03976752|4096507|FG001|COMPLETED|Overall Study||28
3365391|NCT03976752|4096506|FG000|NOT COMPLETED|Overall Study||1
3365392|NCT03976752|4096507|FG001|NOT COMPLETED|Overall Study||9
3365393|NCT03984825|4096518|FG000|STARTED|Run-in Period (Day -3 to -1)||23
3365394|NCT03984825|4096518|FG000|COMPLETED|Run-in Period (Day -3 to -1)||23
3365395|NCT03984825|4096518|FG000|NOT COMPLETED|Run-in Period (Day -3 to -1)||0
3365396|NCT03984825|4096518|FG000|STARTED|Treatment Period 1 (Day 1 to 10)||23
3365397|NCT03984825|4096518|FG000|COMPLETED|Treatment Period 1 (Day 1 to 10)||21
3365398|NCT03984825|4096518|FG000|NOT COMPLETED|Treatment Period 1 (Day 1 to 10)||2
3365399|NCT03984825|4096518|FG000|STARTED|Treatment Period 2 (Day 11 to 21)||21
3365400|NCT03984825|4096518|FG000|COMPLETED|Treatment Period 2 (Day 11 to 21)||17
3365401|NCT03984825|4096518|FG000|NOT COMPLETED|Treatment Period 2 (Day 11 to 21)||4
3365402|NCT03971721|4096527|FG000|STARTED|Overall Study||3
3365403|NCT03971721|4096527|FG000|COMPLETED|Overall Study||3
3202790|NCT02137785|3932045|FG000|NOT COMPLETED|Overall Study||3
3202791|NCT02137785|3932046|FG001|NOT COMPLETED|Overall Study||4
3202792|NCT02137837|3932055|FG000|STARTED|Overall Study||13
3365404|NCT03971721|4096527|FG000|NOT COMPLETED|Overall Study||0
3202793|NCT02137837|3932056|FG001|STARTED|Overall Study||12
3202794|NCT02137837|3932057|FG002|STARTED|Overall Study||12
3202795|NCT02137837|3932055|FG000|Received Protocol Therapy|Overall Study||13
3202796|NCT02137837|3932056|FG001|Received Protocol Therapy|Overall Study||11
3202797|NCT02137837|3932057|FG002|Received Protocol Therapy|Overall Study||12
3202798|NCT02137837|3932055|FG000|COMPLETED|Overall Study||0
3202799|NCT02137837|3932056|FG001|COMPLETED|Overall Study||0
3202800|NCT02137837|3932057|FG002|COMPLETED|Overall Study||0
3202801|NCT02137837|3932055|FG000|NOT COMPLETED|Overall Study||13
3202802|NCT02137837|3932056|FG001|NOT COMPLETED|Overall Study||12
3202803|NCT02137837|3932057|FG002|NOT COMPLETED|Overall Study||12
3202804|NCT02138006|3932072|FG000|STARTED|Overall Study||48
3202805|NCT02138006|3932073|FG001|STARTED|Overall Study||54
3202806|NCT02138006|3932072|FG000|COMPLETED|Overall Study||48
3202807|NCT02138006|3932073|FG001|COMPLETED|Overall Study||54
3202808|NCT02138006|3932072|FG000|NOT COMPLETED|Overall Study||0
3202809|NCT02138006|3932073|FG001|NOT COMPLETED|Overall Study||0
3202810|NCT02138097|3932097|FG000|STARTED|Overall Study||155345
3202811|NCT02138097|3932098|FG001|STARTED|Overall Study||459722
3202812|NCT02138097|3932097|FG000|COMPLETED|Overall Study||155345
3202813|NCT02138097|3932098|FG001|COMPLETED|Overall Study||459722
3202814|NCT02138097|3932097|FG000|NOT COMPLETED|Overall Study||0
3202815|NCT02138097|3932098|FG001|NOT COMPLETED|Overall Study||0
3202816|NCT02138110|3932122|FG000|STARTED|Enrolled in Study||20
3202817|NCT02138110|3932122|FG000|COMPLETED|Enrolled in Study||20
3202818|NCT02138110|3932122|FG000|NOT COMPLETED|Enrolled in Study||0
3202819|NCT02138110|3932122|FG000|STARTED|Enrolled for Scaffold Implantation||20
3202820|NCT02138110|3932122|FG000|COMPLETED|Enrolled for Scaffold Implantation||19
3202821|NCT02138110|3932122|FG000|NOT COMPLETED|Enrolled for Scaffold Implantation||1
3202822|NCT02138110|3932122|FG000|STARTED|Overall Scaffold Implantation||19
3202823|NCT02138110|3932122|FG000|6-month Follow-Up|Overall Scaffold Implantation||16
3202824|NCT02138110|3932122|FG000|COMPLETED|Overall Scaffold Implantation||16
3202825|NCT02138110|3932122|FG000|NOT COMPLETED|Overall Scaffold Implantation||3
3202826|NCT02138136|3932126|FG000|STARTED|Overall Study||419
3202827|NCT02138136|3932126|FG000|Safety Analysis Set|Overall Study||419
3202828|NCT02138136|3932126|FG000|Modified Intent to Treat (mITT)|Overall Study||418
3202829|NCT02138136|3932126|FG000|COMPLETED|Overall Study||280
3202830|NCT02138136|3932126|FG000|NOT COMPLETED|Overall Study||139
3202831|NCT02138214|3932134|FG000|STARTED|Overall Study||30
3202832|NCT02138214|3932135|FG001|STARTED|Overall Study||30
3202833|NCT02138214|3932136|FG002|STARTED|Overall Study||30
3202834|NCT02138214|3932134|FG000|Analyzed for Baseline Measures|Overall Study||30
3202835|NCT02138214|3932135|FG001|Analyzed for Baseline Measures|Overall Study||29
3202836|NCT02138214|3932136|FG002|Analyzed for Baseline Measures|Overall Study||30
3202837|NCT02138214|3932134|FG000|COMPLETED|Overall Study||30
3202838|NCT02138214|3932135|FG001|COMPLETED|Overall Study||26
3202839|NCT02138214|3932136|FG002|COMPLETED|Overall Study||26
3202840|NCT02138214|3932134|FG000|NOT COMPLETED|Overall Study||0
3202841|NCT02138214|3932135|FG001|NOT COMPLETED|Overall Study||4
3202842|NCT02138214|3932136|FG002|NOT COMPLETED|Overall Study||4
3202843|NCT02138227|3932145|FG000|STARTED|Overall Study||55
3202844|NCT02138227|3932146|FG001|STARTED|Overall Study||218
3202845|NCT02138227|3932145|FG000|COMPLETED|Overall Study||55
3202846|NCT02138227|3932146|FG001|COMPLETED|Overall Study||218
3202847|NCT02138227|3932145|FG000|NOT COMPLETED|Overall Study||0
3202848|NCT02138227|3932146|FG001|NOT COMPLETED|Overall Study||0
3202849|NCT02138240|3932177|FG000|STARTED|Overall Study||34
3202850|NCT02138240|3932177|FG000|COMPLETED|Overall Study||34
3202851|NCT02138240|3932177|FG000|NOT COMPLETED|Overall Study||0
3202852|NCT02138253|3932183|FG000|STARTED|Overall Study||41
3202853|NCT02138253|3932184|FG001|STARTED|Overall Study||23
3202854|NCT02138253|3932183|FG000|COMPLETED|Overall Study||32
3202855|NCT02138253|3932184|FG001|COMPLETED|Overall Study||19
3202856|NCT02138253|3932183|FG000|NOT COMPLETED|Overall Study||9
3202857|NCT02138253|3932184|FG001|NOT COMPLETED|Overall Study||4
3202858|NCT02138461|3932192|FG000|STARTED|Overall Study||101
3202859|NCT02138461|3932193|FG001|STARTED|Overall Study||110
3202860|NCT02138461|3932192|FG000|COMPLETED|Overall Study||101
3202861|NCT02138461|3932193|FG001|COMPLETED|Overall Study||110
3202862|NCT02138461|3932192|FG000|NOT COMPLETED|Overall Study||0
3202863|NCT02138461|3932193|FG001|NOT COMPLETED|Overall Study||0
3202864|NCT02138578|3932202|FG000|STARTED|Overall Study||1
3202865|NCT02138578|3932203|FG001|STARTED|Overall Study||0
3202866|NCT02138578|3932204|FG002|STARTED|Overall Study||3
3202867|NCT02138578|3932202|FG000|COMPLETED|Overall Study||1
3202868|NCT02138578|3932203|FG001|COMPLETED|Overall Study||0
3202869|NCT02138578|3932204|FG002|COMPLETED|Overall Study||3
3202870|NCT02138578|3932202|FG000|NOT COMPLETED|Overall Study||0
3202871|NCT02138578|3932203|FG001|NOT COMPLETED|Overall Study||0
3202872|NCT02138578|3932204|FG002|NOT COMPLETED|Overall Study||0
3365405|NCT03982433|4096531|FG000|STARTED|Overall Study||8
3202873|NCT02138747|3932216|FG000|STARTED|Treatment Period 1||156
3202874|NCT02138747|3932217|FG001|STARTED|Treatment Period 1||157
3202875|NCT02138747|3932218|FG002|STARTED|Treatment Period 1||31
3202876|NCT02138747|3932219|FG003|STARTED|Treatment Period 1||32
3202877|NCT02138747|3932216|FG000|COMPLETED|Treatment Period 1||136
3202878|NCT02138747|3932217|FG001|COMPLETED|Treatment Period 1||132
3202879|NCT02138747|3932218|FG002|COMPLETED|Treatment Period 1||27
3202880|NCT02138747|3932219|FG003|COMPLETED|Treatment Period 1||28
3202881|NCT02138747|3932216|FG000|NOT COMPLETED|Treatment Period 1||20
3202882|NCT02138747|3932217|FG001|NOT COMPLETED|Treatment Period 1||25
3202883|NCT02138747|3932218|FG002|NOT COMPLETED|Treatment Period 1||4
3202884|NCT02138747|3932219|FG003|NOT COMPLETED|Treatment Period 1||4
3202885|NCT02138747|3932216|FG000|STARTED|Treatment Period 2|Two participants who discontinued treatment in period 1 entered period 2.|138
3202886|NCT02138747|3932217|FG001|STARTED|Treatment Period 2||132
3202887|NCT02138747|3932218|FG002|STARTED|Treatment Period 2|One participant completed treatment in period 1.|26
3202888|NCT02138747|3932219|FG003|STARTED|Treatment Period 2|One participant completed treatment in period 1.|27
3202889|NCT02138747|3932216|FG000|COMPLETED|Treatment Period 2||121
3202890|NCT02138747|3932217|FG001|COMPLETED|Treatment Period 2||125
3202891|NCT02138747|3932218|FG002|COMPLETED|Treatment Period 2||24
3202892|NCT02138747|3932219|FG003|COMPLETED|Treatment Period 2||24
3202893|NCT02138747|3932216|FG000|NOT COMPLETED|Treatment Period 2||17
3202894|NCT02138747|3932217|FG001|NOT COMPLETED|Treatment Period 2||7
3202895|NCT02138747|3932218|FG002|NOT COMPLETED|Treatment Period 2||2
3202896|NCT02138747|3932219|FG003|NOT COMPLETED|Treatment Period 2||3
3202897|NCT02138786|3932232|FG000|STARTED|Overall Study||3
3202898|NCT02138786|3932233|FG001|STARTED|Overall Study||15
3202899|NCT02138786|3932234|FG002|STARTED|Overall Study||8
3202900|NCT02138786|3932232|FG000|COMPLETED|Overall Study||0
3202901|NCT02138786|3932233|FG001|COMPLETED|Overall Study||0
3202902|NCT02138786|3932234|FG002|COMPLETED|Overall Study||0
3202903|NCT02138786|3932232|FG000|NOT COMPLETED|Overall Study||3
3202904|NCT02138786|3932233|FG001|NOT COMPLETED|Overall Study||15
3202905|NCT02138786|3932234|FG002|NOT COMPLETED|Overall Study||8
3202906|NCT02138825|3932242|FG000|STARTED|Main Study Treatment|safety population|73
3202907|NCT02138825|3932243|FG001|STARTED|Main Study Treatment|safety population|74
3202908|NCT02138825|3932242|FG000|COMPLETED|Main Study Treatment||33
3202909|NCT02138825|3932243|FG001|COMPLETED|Main Study Treatment||39
3202910|NCT02138825|3932242|FG000|NOT COMPLETED|Main Study Treatment||40
3202911|NCT02138825|3932243|FG001|NOT COMPLETED|Main Study Treatment||35
3202912|NCT02138825|3932242|FG000|STARTED|Long-term Extension||32
3202913|NCT02138825|3932243|FG001|STARTED|Long-term Extension||38
3202914|NCT02138825|3932242|FG000|COMPLETED|Long-term Extension|no participants were considered as completed LTE phase at time of study termination|0
3202915|NCT02138825|3932243|FG001|COMPLETED|Long-term Extension|no participants were considered as completed LTE phase at time of study termination|0
3202916|NCT02138825|3932242|FG000|NOT COMPLETED|Long-term Extension||32
3202917|NCT02138825|3932243|FG001|NOT COMPLETED|Long-term Extension||38
3202918|NCT02138825|3932242|FG000|STARTED|Safety Follow-up|Participants from main study treatment and LTE phase entered safety follow-up|72
3202919|NCT02138825|3932243|FG001|STARTED|Safety Follow-up|Participants from main study treatment and LTE phase entered safety follow-up|64
3202920|NCT02138825|3932242|FG000|COMPLETED|Safety Follow-up||50
3202921|NCT02138825|3932243|FG001|COMPLETED|Safety Follow-up||47
3202922|NCT02138825|3932242|FG000|NOT COMPLETED|Safety Follow-up||22
3202923|NCT02138825|3932243|FG001|NOT COMPLETED|Safety Follow-up||17
3202924|NCT02138838|3932256|FG000|STARTED|Overall Study||28
3202925|NCT02138838|3932257|FG001|STARTED|Overall Study||27
3202926|NCT02138838|3932256|FG000|Received Study Drug|Overall Study||28
3202927|NCT02138838|3932257|FG001|Received Study Drug|Overall Study||25
3202928|NCT02138838|3932256|FG000|COMPLETED|Overall Study||20
3202929|NCT02138838|3932257|FG001|COMPLETED|Overall Study||16
3202930|NCT02138838|3932256|FG000|NOT COMPLETED|Overall Study||8
3202931|NCT02138838|3932257|FG001|NOT COMPLETED|Overall Study||11
3202932|NCT02138890|3932265|FG000|STARTED|Overall Study||31
3202933|NCT02138890|3932266|FG001|STARTED|Overall Study||15
3202934|NCT02138890|3932265|FG000|COMPLETED|Overall Study||30
3202935|NCT02138890|3932266|FG001|COMPLETED|Overall Study||15
3202936|NCT02138890|3932265|FG000|NOT COMPLETED|Overall Study||1
3202937|NCT02138890|3932266|FG001|NOT COMPLETED|Overall Study||0
3202938|NCT02138916|3932276|FG000|STARTED|Overall Study||554
3202939|NCT02138916|3932277|FG001|STARTED|Overall Study||552
3202940|NCT02138916|3932278|FG002|STARTED|Overall Study||550
3202941|NCT02138916|3932276|FG000|COMPLETED|Overall Study||497
3202942|NCT02138916|3932277|FG001|COMPLETED|Overall Study||492
3202943|NCT02138916|3932278|FG002|COMPLETED|Overall Study||491
3202944|NCT02138916|3932276|FG000|NOT COMPLETED|Overall Study||57
3202945|NCT02138916|3932277|FG001|NOT COMPLETED|Overall Study||60
3202946|NCT02138916|3932278|FG002|NOT COMPLETED|Overall Study||59
3202947|NCT02139007|3932288|FG000|STARTED|Study Site Recruitment||4
3202948|NCT02139007|3932289|FG001|STARTED|Study Site Recruitment||5
3202949|NCT02139007|3932288|FG000|COMPLETED|Study Site Recruitment||1
3202950|NCT02139007|3932289|FG001|COMPLETED|Study Site Recruitment||1
3202951|NCT02139007|3932288|FG000|NOT COMPLETED|Study Site Recruitment||3
3202952|NCT02139007|3932289|FG001|NOT COMPLETED|Study Site Recruitment||4
3202953|NCT02139007|3932288|FG000|STARTED|Patient Participant Recruitment||13
3202954|NCT02139007|3932289|FG001|STARTED|Patient Participant Recruitment||14
3202955|NCT02139007|3932288|FG000|COMPLETED|Patient Participant Recruitment||11
3202956|NCT02139007|3932289|FG001|COMPLETED|Patient Participant Recruitment||13
3202957|NCT02139007|3932288|FG000|NOT COMPLETED|Patient Participant Recruitment||2
3202958|NCT02139007|3932289|FG001|NOT COMPLETED|Patient Participant Recruitment||1
3202959|NCT02139046|3932303|FG000|STARTED|Overall Study||358
3202960|NCT02139046|3932304|FG001|STARTED|Overall Study||359
3202961|NCT02139046|3932305|FG002|STARTED|Overall Study||357
3202962|NCT02139046|3932306|FG003|STARTED|Overall Study||358
3202963|NCT02139046|3932307|FG004|STARTED|Overall Study||358
3202964|NCT02139046|3932303|FG000|Safety Analysis Set|Overall Study||356
3202965|NCT02139046|3932304|FG001|Safety Analysis Set|Overall Study||358
3202966|NCT02139046|3932305|FG002|Safety Analysis Set|Overall Study||355
3202967|NCT02139046|3932306|FG003|Safety Analysis Set|Overall Study||357
3202968|NCT02139046|3932307|FG004|Safety Analysis Set|Overall Study||357
3202969|NCT02139046|3932303|FG000|Full Analysis Set|Overall Study||357
3202970|NCT02139046|3932304|FG001|Full Analysis Set|Overall Study||357
3202971|NCT02139046|3932305|FG002|Full Analysis Set|Overall Study||355
3202972|NCT02139046|3932306|FG003|Full Analysis Set|Overall Study||357
3202973|NCT02139046|3932307|FG004|Full Analysis Set|Overall Study||357
3202974|NCT02139046|3932303|FG000|COMPLETED|Overall Study|Completed=Completed Study Drug|296
3202975|NCT02139046|3932304|FG001|COMPLETED|Overall Study||305
3202976|NCT02139046|3932305|FG002|COMPLETED|Overall Study||298
3202977|NCT02139046|3932306|FG003|COMPLETED|Overall Study||290
3202978|NCT02139046|3932307|FG004|COMPLETED|Overall Study||301
3202979|NCT02139046|3932303|FG000|NOT COMPLETED|Overall Study||62
3202980|NCT02139046|3932304|FG001|NOT COMPLETED|Overall Study||54
3202981|NCT02139046|3932305|FG002|NOT COMPLETED|Overall Study||59
3202982|NCT02139046|3932306|FG003|NOT COMPLETED|Overall Study||68
3202983|NCT02139046|3932307|FG004|NOT COMPLETED|Overall Study||57
3202984|NCT02139124|3932324|FG000|STARTED|Overall Study||78
3202985|NCT02139124|3932325|FG001|STARTED|Overall Study||77
3202986|NCT02139124|3932326|FG002|STARTED|Overall Study||73
3202987|NCT02139124|3932327|FG003|STARTED|Overall Study||73
3202988|NCT02139124|3932328|FG004|STARTED|Overall Study||74
3202989|NCT02139124|3932324|FG000|COMPLETED|Overall Study||69
3202990|NCT02139124|3932325|FG001|COMPLETED|Overall Study||73
3202991|NCT02139124|3932326|FG002|COMPLETED|Overall Study||69
3202992|NCT02139124|3932327|FG003|COMPLETED|Overall Study||61
3202993|NCT02139124|3932328|FG004|COMPLETED|Overall Study||61
3202994|NCT02139124|3932324|FG000|NOT COMPLETED|Overall Study||9
3202995|NCT02139124|3932325|FG001|NOT COMPLETED|Overall Study||4
3202996|NCT02139124|3932326|FG002|NOT COMPLETED|Overall Study||4
3202997|NCT02139124|3932327|FG003|NOT COMPLETED|Overall Study||12
3202998|NCT02139124|3932328|FG004|NOT COMPLETED|Overall Study||13
3202999|NCT02139137|3932342|FG000|STARTED|Overall Study||22
3203000|NCT02139137|3932343|FG001|STARTED|Overall Study||20
3203001|NCT02139137|3932342|FG000|COMPLETED|Overall Study||15
3203002|NCT02139137|3932343|FG001|COMPLETED|Overall Study||10
3203003|NCT02139137|3932342|FG000|NOT COMPLETED|Overall Study||7
3203004|NCT02139137|3932343|FG001|NOT COMPLETED|Overall Study||10
3203005|NCT02139176|3932351|FG000|STARTED|Overall Study||100
3203006|NCT02139176|3932352|FG001|STARTED|Overall Study||100
3203007|NCT02139176|3932351|FG000|COMPLETED|Overall Study||100
3203008|NCT02139176|3932352|FG001|COMPLETED|Overall Study||100
3203009|NCT02139176|3932351|FG000|NOT COMPLETED|Overall Study||0
3203010|NCT02139176|3932352|FG001|NOT COMPLETED|Overall Study||0
3203011|NCT02139228|3932361|FG000|STARTED|Overall Study||215
3203012|NCT02139228|3932362|FG001|STARTED|Overall Study||211
3203013|NCT02139228|3932361|FG000|COMPLETED|Overall Study||215
3203014|NCT02139228|3932362|FG001|COMPLETED|Overall Study||211
3203015|NCT02139228|3932361|FG000|NOT COMPLETED|Overall Study||0
3203016|NCT02139228|3932362|FG001|NOT COMPLETED|Overall Study||0
3203017|NCT02139280|3932370|FG000|STARTED|Overall Study||34
3203018|NCT02139280|3932371|FG001|STARTED|Overall Study||20
3203019|NCT02139280|3932370|FG000|COMPLETED|Overall Study||32
3203020|NCT02139280|3932371|FG001|COMPLETED|Overall Study||20
3203021|NCT02139280|3932370|FG000|NOT COMPLETED|Overall Study||2
3203022|NCT02139280|3932371|FG001|NOT COMPLETED|Overall Study||0
3203023|NCT02139306|3932379|FG000|STARTED|Overall Study||140
3203024|NCT02139306|3932380|FG001|STARTED|Overall Study||139
3203025|NCT02139306|3932379|FG000|COMPLETED|Overall Study||127
3203026|NCT02139306|3932380|FG001|COMPLETED|Overall Study||125
3203027|NCT02139306|3932379|FG000|NOT COMPLETED|Overall Study||13
3203028|NCT02139306|3932380|FG001|NOT COMPLETED|Overall Study||14
3203029|NCT02139358|3932387|FG000|STARTED|Overall Study||15
3203030|NCT02139358|3932387|FG000|COMPLETED|Overall Study||15
3203031|NCT02139358|3932387|FG000|NOT COMPLETED|Overall Study||0
3203032|NCT02139540|3932393|FG000|STARTED|Overall Study||11
3203033|NCT02139540|3932394|FG001|STARTED|Overall Study||10
3203034|NCT02139540|3932393|FG000|COMPLETED|Overall Study||10
3203035|NCT02139540|3932394|FG001|COMPLETED|Overall Study||10
3203036|NCT02139540|3932393|FG000|NOT COMPLETED|Overall Study||1
3203037|NCT02139540|3932394|FG001|NOT COMPLETED|Overall Study||0
3203038|NCT02139592|3932400|FG000|STARTED|Overall Study||292
3203039|NCT02139592|3932400|FG000|COMPLETED|Overall Study||284
3203040|NCT02139592|3932400|FG000|NOT COMPLETED|Overall Study||8
3203041|NCT02139644|3932409|FG000|STARTED|Run-In Period (Pre-assignment)|Enrolled|787
3203042|NCT02139644|3932410|FG001|STARTED|Run-In Period (Pre-assignment)||0
3203043|NCT02139644|3932411|FG002|STARTED|Run-In Period (Pre-assignment)||0
3203044|NCT02139644|3932412|FG003|STARTED|Run-In Period (Pre-assignment)||0
3203045|NCT02139644|3932413|FG004|STARTED|Run-In Period (Pre-assignment)||0
3203046|NCT02139644|3932414|FG005|STARTED|Run-In Period (Pre-assignment)||0
3203047|NCT02139644|3932409|FG000|COMPLETED|Run-In Period (Pre-assignment)||647
3203048|NCT02139644|3932410|FG001|COMPLETED|Run-In Period (Pre-assignment)||0
3203049|NCT02139644|3932411|FG002|COMPLETED|Run-In Period (Pre-assignment)||0
3203050|NCT02139644|3932412|FG003|COMPLETED|Run-In Period (Pre-assignment)||0
3203051|NCT02139644|3932413|FG004|COMPLETED|Run-In Period (Pre-assignment)||0
3203052|NCT02139644|3932414|FG005|COMPLETED|Run-In Period (Pre-assignment)||0
3203053|NCT02139644|3932409|FG000|NOT COMPLETED|Run-In Period (Pre-assignment)||140
3203054|NCT02139644|3932410|FG001|NOT COMPLETED|Run-In Period (Pre-assignment)||0
3203055|NCT02139644|3932411|FG002|NOT COMPLETED|Run-In Period (Pre-assignment)||0
3203056|NCT02139644|3932412|FG003|NOT COMPLETED|Run-In Period (Pre-assignment)||0
3203057|NCT02139644|3932413|FG004|NOT COMPLETED|Run-In Period (Pre-assignment)||0
3203058|NCT02139644|3932414|FG005|NOT COMPLETED|Run-In Period (Pre-assignment)||0
3203059|NCT02139644|3932409|FG000|STARTED|Treatment Period||0
3203060|NCT02139644|3932410|FG001|STARTED|Treatment Period|Randomized|129
3203061|NCT02139644|3932411|FG002|STARTED|Treatment Period|Randomized|129
3203062|NCT02139644|3932412|FG003|STARTED|Treatment Period|Randomized|130
3203063|NCT02139644|3932413|FG004|STARTED|Treatment Period|Randomized|129
3203064|NCT02139644|3932414|FG005|STARTED|Treatment Period|Randomized|130
3203065|NCT02139644|3932409|FG000|COMPLETED|Treatment Period||0
3203066|NCT02139644|3932410|FG001|COMPLETED|Treatment Period||126
3203067|NCT02139644|3932411|FG002|COMPLETED|Treatment Period||121
3203068|NCT02139644|3932412|FG003|COMPLETED|Treatment Period||121
3203069|NCT02139644|3932413|FG004|COMPLETED|Treatment Period||121
3203070|NCT02139644|3932414|FG005|COMPLETED|Treatment Period||113
3203071|NCT02139644|3932409|FG000|NOT COMPLETED|Treatment Period||0
3203072|NCT02139644|3932410|FG001|NOT COMPLETED|Treatment Period||3
3203073|NCT02139644|3932411|FG002|NOT COMPLETED|Treatment Period||8
3203074|NCT02139644|3932412|FG003|NOT COMPLETED|Treatment Period||9
3203075|NCT02139644|3932413|FG004|NOT COMPLETED|Treatment Period||8
3203076|NCT02139644|3932414|FG005|NOT COMPLETED|Treatment Period||17
3203077|NCT02139800|3932428|FG000|STARTED|Overall Study||224
3203078|NCT02139800|3932429|FG001|STARTED|Overall Study||236
3203079|NCT02139800|3932428|FG000|COMPLETED|Overall Study||211
3203080|NCT02139800|3932429|FG001|COMPLETED|Overall Study||215
3203081|NCT02139800|3932428|FG000|NOT COMPLETED|Overall Study||13
3203082|NCT02139800|3932429|FG001|NOT COMPLETED|Overall Study||21
3203083|NCT02139826|3932435|FG000|STARTED|Overall Study||12
3203084|NCT02139826|3932435|FG000|COMPLETED|Overall Study||11
3203085|NCT02139826|3932435|FG000|NOT COMPLETED|Overall Study||1
3203086|NCT02139878|3932445|FG000|STARTED|First Intervention (7 Days)||10
3203087|NCT02139878|3932446|FG001|STARTED|First Intervention (7 Days)||10
3203088|NCT02139878|3932445|FG000|COMPLETED|First Intervention (7 Days)||9
3203089|NCT02139878|3932446|FG001|COMPLETED|First Intervention (7 Days)||10
3203090|NCT02139878|3932445|FG000|NOT COMPLETED|First Intervention (7 Days)||1
3203091|NCT02139878|3932446|FG001|NOT COMPLETED|First Intervention (7 Days)||0
3203092|NCT02139878|3932445|FG000|STARTED|Washout Period (8 Days)||9
3203093|NCT02139878|3932446|FG001|STARTED|Washout Period (8 Days)||10
3203094|NCT02139878|3932445|FG000|COMPLETED|Washout Period (8 Days)||9
3203095|NCT02139878|3932446|FG001|COMPLETED|Washout Period (8 Days)||10
3203096|NCT02139878|3932445|FG000|NOT COMPLETED|Washout Period (8 Days)||0
3203097|NCT02139878|3932446|FG001|NOT COMPLETED|Washout Period (8 Days)||0
3203098|NCT02139878|3932445|FG000|STARTED|Second Intervention (7 Days)||9
3203099|NCT02139878|3932446|FG001|STARTED|Second Intervention (7 Days)||10
3203100|NCT02139878|3932445|FG000|COMPLETED|Second Intervention (7 Days)||9
3203101|NCT02139878|3932446|FG001|COMPLETED|Second Intervention (7 Days)||10
3203102|NCT02139878|3932445|FG000|NOT COMPLETED|Second Intervention (7 Days)||0
3203103|NCT02139878|3932446|FG001|NOT COMPLETED|Second Intervention (7 Days)||0
3203104|NCT02139943|3932455|FG000|STARTED|Overall Study||117
3203105|NCT02139943|3932456|FG001|STARTED|Overall Study||117
3203106|NCT02139943|3932457|FG002|STARTED|Overall Study||117
3203107|NCT02139943|3932455|FG000|COMPLETED|Overall Study||107
3203108|NCT02139943|3932456|FG001|COMPLETED|Overall Study||111
3203109|NCT02139943|3932457|FG002|COMPLETED|Overall Study||110
3203110|NCT02139943|3932455|FG000|NOT COMPLETED|Overall Study||10
3203111|NCT02139943|3932456|FG001|NOT COMPLETED|Overall Study||6
3203112|NCT02139943|3932457|FG002|NOT COMPLETED|Overall Study||7
3203113|NCT02139969|3932465|FG000|STARTED|Overall Study||956
3203114|NCT02139969|3932465|FG000|COMPLETED|Overall Study||956
3203115|NCT02139969|3932465|FG000|NOT COMPLETED|Overall Study||0
3203116|NCT02139982|3932479|FG000|STARTED|Overall Study||8
3203117|NCT02139982|3932480|FG001|STARTED|Overall Study||8
3203118|NCT02139982|3932481|FG002|STARTED|Overall Study||8
3203119|NCT02139982|3932482|FG003|STARTED|Overall Study||8
3203120|NCT02139982|3932483|FG004|STARTED|Overall Study||13
3203121|NCT02139982|3932484|FG005|STARTED|Overall Study||13
3203122|NCT02139982|3932485|FG006|STARTED|Overall Study||13
3203123|NCT02139982|3932486|FG007|STARTED|Overall Study||13
3203124|NCT02139982|3932487|FG008|STARTED|Overall Study||13
3203125|NCT02139982|3932488|FG009|STARTED|Overall Study||13
3203126|NCT02139982|3932479|FG000|COMPLETED|Overall Study||8
3203127|NCT02139982|3932480|FG001|COMPLETED|Overall Study||7
3203128|NCT02139982|3932481|FG002|COMPLETED|Overall Study||8
3203129|NCT02139982|3932482|FG003|COMPLETED|Overall Study||7
3203130|NCT02139982|3932483|FG004|COMPLETED|Overall Study||13
3203131|NCT02139982|3932484|FG005|COMPLETED|Overall Study||13
3203132|NCT02139982|3932485|FG006|COMPLETED|Overall Study||13
3203133|NCT02139982|3932486|FG007|COMPLETED|Overall Study||13
3365406|NCT03982433|4096531|FG000|COMPLETED|Overall Study||7
3365407|NCT03982433|4096531|FG000|NOT COMPLETED|Overall Study||1
3365408|NCT03979677|4096535|FG000|STARTED|Overall Study|Participants enrolled|41
3365409|NCT03979677|4096535|FG000|COMPLETED|Overall Study|participants completed|28
3365410|NCT03979677|4096535|FG000|NOT COMPLETED|Overall Study||13
3365411|NCT03976466|4096541|FG000|STARTED|Overall Study||44
3365412|NCT03976466|4096542|FG001|STARTED|Overall Study||43
3365413|NCT03976466|4096541|FG000|COMPLETED|Overall Study||43
3365414|NCT03976466|4096542|FG001|COMPLETED|Overall Study||40
3203134|NCT02139982|3932487|FG008|COMPLETED|Overall Study||13
3203135|NCT02139982|3932488|FG009|COMPLETED|Overall Study||13
3203136|NCT02139982|3932479|FG000|NOT COMPLETED|Overall Study||0
3203137|NCT02139982|3932480|FG001|NOT COMPLETED|Overall Study||1
3203138|NCT02139982|3932481|FG002|NOT COMPLETED|Overall Study||0
3203139|NCT02139982|3932482|FG003|NOT COMPLETED|Overall Study||1
3203140|NCT02139982|3932483|FG004|NOT COMPLETED|Overall Study||0
3203141|NCT02139982|3932484|FG005|NOT COMPLETED|Overall Study||0
3203142|NCT02139982|3932485|FG006|NOT COMPLETED|Overall Study||0
3203143|NCT02139982|3932486|FG007|NOT COMPLETED|Overall Study||0
3203144|NCT02139982|3932487|FG008|NOT COMPLETED|Overall Study||0
3203145|NCT02139982|3932488|FG009|NOT COMPLETED|Overall Study||0
3203146|NCT02140060|3932516|FG000|STARTED|Overall Study||44
3203147|NCT02140060|3932517|FG001|STARTED|Overall Study||44
3203148|NCT02140060|3932518|FG002|STARTED|Overall Study||44
3203149|NCT02140060|3932519|FG003|STARTED|Overall Study||45
3203150|NCT02140060|3932520|FG004|STARTED|Overall Study||45
3203151|NCT02140060|3932521|FG005|STARTED|Overall Study||44
3203152|NCT02140060|3932516|FG000|COMPLETED|Overall Study||44
3203153|NCT02140060|3932517|FG001|COMPLETED|Overall Study||44
3203154|NCT02140060|3932518|FG002|COMPLETED|Overall Study||44
3203155|NCT02140060|3932519|FG003|COMPLETED|Overall Study||43
3203156|NCT02140060|3932520|FG004|COMPLETED|Overall Study||44
3203157|NCT02140060|3932521|FG005|COMPLETED|Overall Study||43
3203158|NCT02140060|3932516|FG000|NOT COMPLETED|Overall Study||0
3203159|NCT02140060|3932517|FG001|NOT COMPLETED|Overall Study||0
3203160|NCT02140060|3932518|FG002|NOT COMPLETED|Overall Study||0
3203161|NCT02140060|3932519|FG003|NOT COMPLETED|Overall Study||2
3203162|NCT02140060|3932520|FG004|NOT COMPLETED|Overall Study||1
3203163|NCT02140060|3932521|FG005|NOT COMPLETED|Overall Study||1
3203164|NCT02140164|3932536|FG000|STARTED|Overall Study||7
3203165|NCT02140164|3932536|FG000|COMPLETED|Overall Study||5
3203166|NCT02140164|3932536|FG000|NOT COMPLETED|Overall Study||2
3203167|NCT02140372|3932540|FG000|STARTED|Overall Study||10
3203168|NCT02140372|3932540|FG000|COMPLETED|Overall Study||10
3203169|NCT02140372|3932540|FG000|NOT COMPLETED|Overall Study||0
3203170|NCT02140411|3932544|FG000|STARTED|Overall Study||21
3203171|NCT02140411|3932544|FG000|COMPLETED|Overall Study||20
3203172|NCT02140411|3932544|FG000|NOT COMPLETED|Overall Study||1
3203173|NCT02140567|3932548|FG000|STARTED|Overall Study||140
3203174|NCT02140567|3932548|FG000|COMPLETED|Overall Study||134
3203175|NCT02140567|3932548|FG000|NOT COMPLETED|Overall Study||6
3203176|NCT02140593|3932555|FG000|STARTED|Overall Study||63
3203177|NCT02140593|3932556|FG001|STARTED|Overall Study||65
3203178|NCT02140593|3932555|FG000|COMPLETED|Overall Study||63
3203179|NCT02140593|3932556|FG001|COMPLETED|Overall Study||65
3203180|NCT02140593|3932555|FG000|NOT COMPLETED|Overall Study||0
3203181|NCT02140593|3932556|FG001|NOT COMPLETED|Overall Study||0
3203182|NCT02140645|3932568|FG000|STARTED|Overall Study||5732
3203183|NCT02140645|3932569|FG001|STARTED|Overall Study||64695
3203184|NCT02140645|3932570|FG002|STARTED|Overall Study||4441
3203185|NCT02140645|3932571|FG003|STARTED|Overall Study||14363
3203186|NCT02140645|3932572|FG004|STARTED|Overall Study||3436
3203187|NCT02140645|3932573|FG005|STARTED|Overall Study||73946
3203188|NCT02140645|3932568|FG000|COMPLETED|Overall Study||243
3203189|NCT02140645|3932569|FG001|COMPLETED|Overall Study||3041
3203190|NCT02140645|3932570|FG002|COMPLETED|Overall Study||205
3203191|NCT02140645|3932571|FG003|COMPLETED|Overall Study||530
3203192|NCT02140645|3932572|FG004|COMPLETED|Overall Study||150
3203193|NCT02140645|3932573|FG005|COMPLETED|Overall Study||3050
3203194|NCT02140645|3932568|FG000|NOT COMPLETED|Overall Study||5489
3203195|NCT02140645|3932569|FG001|NOT COMPLETED|Overall Study||61654
3203196|NCT02140645|3932570|FG002|NOT COMPLETED|Overall Study||4236
3203197|NCT02140645|3932571|FG003|NOT COMPLETED|Overall Study||13833
3203198|NCT02140645|3932572|FG004|NOT COMPLETED|Overall Study||3286
3203199|NCT02140645|3932573|FG005|NOT COMPLETED|Overall Study||70896
3203200|NCT02140762|3932584|FG000|STARTED|Overall Study||154
3203201|NCT02140762|3932585|FG001|STARTED|Overall Study||151
3203202|NCT02140762|3932584|FG000|COMPLETED|Overall Study||137
3203203|NCT02140762|3932585|FG001|COMPLETED|Overall Study||139
3203204|NCT02140762|3932584|FG000|NOT COMPLETED|Overall Study||17
3203205|NCT02140762|3932585|FG001|NOT COMPLETED|Overall Study||12
3203206|NCT02140775|3932598|FG000|STARTED|Overall Study||87
3203207|NCT02140775|3932599|FG001|STARTED|Overall Study||29
3203208|NCT02140775|3932598|FG000|COMPLETED|Overall Study||57
3203209|NCT02140775|3932599|FG001|COMPLETED|Overall Study||22
3203210|NCT02140775|3932598|FG000|NOT COMPLETED|Overall Study||30
3203211|NCT02140775|3932599|FG001|NOT COMPLETED|Overall Study||7
3203212|NCT02140957|3932609|FG000|STARTED|Overall Study||129
3203213|NCT02140957|3932610|FG001|STARTED|Overall Study||122
3203214|NCT02140957|3932609|FG000|COMPLETED|Overall Study||102
3203215|NCT02140957|3932610|FG001|COMPLETED|Overall Study||99
3203216|NCT02140957|3932609|FG000|NOT COMPLETED|Overall Study||27
3203217|NCT02140957|3932610|FG001|NOT COMPLETED|Overall Study||23
3203218|NCT02140970|3932618|FG000|STARTED|Overall Study||24
3203219|NCT02140970|3932619|FG001|STARTED|Overall Study||25
3203220|NCT02140970|3932618|FG000|Received Intervention|Overall Study||23
3203221|NCT02140970|3932619|FG001|Received Intervention|Overall Study||25
3203222|NCT02140970|3932618|FG000|Analyzed|Overall Study||22
3203223|NCT02140970|3932619|FG001|Analyzed|Overall Study||22
3203224|NCT02140970|3932618|FG000|COMPLETED|Overall Study||22
3203225|NCT02140970|3932619|FG001|COMPLETED|Overall Study||22
3203226|NCT02140970|3932618|FG000|NOT COMPLETED|Overall Study||2
3203227|NCT02140970|3932619|FG001|NOT COMPLETED|Overall Study||3
3203228|NCT02141204|3932627|FG000|STARTED|Overall Study||224
3203229|NCT02141204|3932628|FG001|STARTED|Overall Study||225
3203230|NCT02141204|3932627|FG000|COMPLETED|Overall Study||209
3203231|NCT02141204|3932628|FG001|COMPLETED|Overall Study||210
3203232|NCT02141204|3932627|FG000|NOT COMPLETED|Overall Study||15
3203233|NCT02141204|3932628|FG001|NOT COMPLETED|Overall Study||15
3203234|NCT02141217|3932636|FG000|STARTED|Overall Study||234
3203235|NCT02141217|3932637|FG001|STARTED|Overall Study||237
3203236|NCT02141217|3932636|FG000|ITT Population-Randomized Treatment Arm|Overall Study||234
3203237|NCT02141217|3932637|FG001|ITT Population-Randomized Treatment Arm|Overall Study||237
3203238|NCT02141217|3932636|FG000|ITT Population-Actual Treatment Received|Overall Study||236
3203239|NCT02141217|3932637|FG001|ITT Population-Actual Treatment Received|Overall Study||235
3203240|NCT02141217|3932636|FG000|COMPLETED|Overall Study||223
3203241|NCT02141217|3932637|FG001|COMPLETED|Overall Study||229
3203242|NCT02141217|3932636|FG000|NOT COMPLETED|Overall Study||11
3203243|NCT02141217|3932637|FG001|NOT COMPLETED|Overall Study||8
3203244|NCT02141295|3932649|FG000|STARTED|Overall Study||8
3203245|NCT02141295|3932650|FG001|STARTED|Overall Study||94
3203246|NCT02141295|3932651|FG002|STARTED|Overall Study||95
3203247|NCT02141295|3932649|FG000|COMPLETED|Overall Study||2
3203248|NCT02141295|3932650|FG001|COMPLETED|Overall Study||0
3203249|NCT02141295|3932651|FG002|COMPLETED|Overall Study||0
3203250|NCT02141295|3932649|FG000|NOT COMPLETED|Overall Study||6
3203251|NCT02141295|3932650|FG001|NOT COMPLETED|Overall Study||94
3203252|NCT02141295|3932651|FG002|NOT COMPLETED|Overall Study||95
3203253|NCT02141360|3932663|FG000|STARTED|Overall Study||11
3203254|NCT02141360|3932664|FG001|STARTED|Overall Study||6
3203255|NCT02141360|3932665|FG002|STARTED|Overall Study||6
3203256|NCT02141360|3932663|FG000|COMPLETED|Overall Study||4
3203257|NCT02141360|3932664|FG001|COMPLETED|Overall Study||6
3203258|NCT02141360|3932665|FG002|COMPLETED|Overall Study||6
3203259|NCT02141360|3932663|FG000|NOT COMPLETED|Overall Study||7
3203260|NCT02141360|3932664|FG001|NOT COMPLETED|Overall Study||0
3203261|NCT02141360|3932665|FG002|NOT COMPLETED|Overall Study||0
3203262|NCT02141399|3932673|FG000|STARTED|Overall Study||1485
3203263|NCT02141399|3932673|FG000|COMPLETED|Overall Study||741
3203264|NCT02141399|3932673|FG000|NOT COMPLETED|Overall Study||744
3203265|NCT02141451|3932681|FG000|STARTED|Overall Study||3
3203266|NCT02141451|3932682|FG001|STARTED|Overall Study||4
3203267|NCT02141451|3932683|FG002|STARTED|Overall Study||7
3203268|NCT02141451|3932684|FG003|STARTED|Overall Study||16
3203269|NCT02141451|3932681|FG000|COMPLETED|Overall Study||3
3203270|NCT02141451|3932682|FG001|COMPLETED|Overall Study||2
3203271|NCT02141451|3932683|FG002|COMPLETED|Overall Study||2
3203272|NCT02141451|3932684|FG003|COMPLETED|Overall Study||7
3203273|NCT02141451|3932681|FG000|NOT COMPLETED|Overall Study||0
3203274|NCT02141451|3932682|FG001|NOT COMPLETED|Overall Study||2
3203275|NCT02141451|3932683|FG002|NOT COMPLETED|Overall Study||5
3203276|NCT02141451|3932684|FG003|NOT COMPLETED|Overall Study||9
3203277|NCT02141490|3932700|FG000|STARTED|Overall Study||34
3203278|NCT02141490|3932701|FG001|STARTED|Overall Study||6
3203279|NCT02141490|3932702|FG002|STARTED|Overall Study||3
3203280|NCT02141490|3932700|FG000|COMPLETED|Overall Study||30
3203281|NCT02141490|3932701|FG001|COMPLETED|Overall Study||6
3203282|NCT02141490|3932702|FG002|COMPLETED|Overall Study||3
3203283|NCT02141490|3932700|FG000|NOT COMPLETED|Overall Study||4
3203284|NCT02141490|3932701|FG001|NOT COMPLETED|Overall Study||0
3203285|NCT02141490|3932702|FG002|NOT COMPLETED|Overall Study||0
3203286|NCT02141516|3932715|FG000|STARTED|Overall Study||40
3203287|NCT02141516|3932716|FG001|STARTED|Overall Study||112
3203288|NCT02141516|3932717|FG002|STARTED|Overall Study||87
3203289|NCT02141516|3932715|FG000|COMPLETED|Overall Study||40
3203290|NCT02141516|3932716|FG001|COMPLETED|Overall Study||107
3203291|NCT02141516|3932717|FG002|COMPLETED|Overall Study||87
3203292|NCT02141516|3932715|FG000|NOT COMPLETED|Overall Study||0
3203293|NCT02141516|3932716|FG001|NOT COMPLETED|Overall Study||5
3203294|NCT02141516|3932717|FG002|NOT COMPLETED|Overall Study||0
3203295|NCT02141555|3932731|FG000|STARTED|Overall Study||2
3203296|NCT02141555|3932732|FG001|STARTED|Overall Study||2
3203297|NCT02141555|3932731|FG000|COMPLETED|Overall Study||2
3203298|NCT02141555|3932732|FG001|COMPLETED|Overall Study||2
3203299|NCT02141555|3932731|FG000|NOT COMPLETED|Overall Study||0
3203300|NCT02141555|3932732|FG001|NOT COMPLETED|Overall Study||0
3203301|NCT02141581|3932741|FG000|STARTED|Overall Study||42
3203302|NCT02141581|3932742|FG001|STARTED|Overall Study||19
3203303|NCT02141581|3932743|FG002|STARTED|Overall Study||25
3203304|NCT02141581|3932741|FG000|COMPLETED|Overall Study||42
3203305|NCT02141581|3932742|FG001|COMPLETED|Overall Study||19
3203306|NCT02141581|3932743|FG002|COMPLETED|Overall Study||25
3203307|NCT02141581|3932741|FG000|NOT COMPLETED|Overall Study||0
3203308|NCT02141581|3932742|FG001|NOT COMPLETED|Overall Study||0
3203309|NCT02141581|3932743|FG002|NOT COMPLETED|Overall Study||0
3365415|NCT03976466|4096541|FG000|NOT COMPLETED|Overall Study||1
3365416|NCT03976466|4096542|FG001|NOT COMPLETED|Overall Study||3
3365417|NCT03979638|4096552|FG000|STARTED|Period 1||33
3365418|NCT03979638|4096553|FG001|STARTED|Period 1||35
3365419|NCT03979638|4096552|FG000|COMPLETED|Period 1||26
3365420|NCT03979638|4096553|FG001|COMPLETED|Period 1||28
3365421|NCT03979638|4096552|FG000|NOT COMPLETED|Period 1||7
3365422|NCT03979638|4096553|FG001|NOT COMPLETED|Period 1||7
3365423|NCT03979638|4096552|FG000|STARTED|Period 2||26
3365424|NCT03979638|4096553|FG001|STARTED|Period 2||28
3365425|NCT03979638|4096552|FG000|COMPLETED|Period 2||25
3365426|NCT03979638|4096553|FG001|COMPLETED|Period 2||27
3203310|NCT02141620|3932751|FG000|STARTED|Treatment Condition 1 (7 Days)||8
3203311|NCT02141620|3932752|FG001|STARTED|Treatment Condition 1 (7 Days)||7
3203312|NCT02141620|3932751|FG000|COMPLETED|Treatment Condition 1 (7 Days)|7 completing subjects switched to n-acetylcysteine for Condition 2.|7
3203313|NCT02141620|3932752|FG001|COMPLETED|Treatment Condition 1 (7 Days)|7 completing subjects switched to placebo for Condition 2.|7
3203314|NCT02141620|3932751|FG000|NOT COMPLETED|Treatment Condition 1 (7 Days)||1
3203315|NCT02141620|3932752|FG001|NOT COMPLETED|Treatment Condition 1 (7 Days)||0
3203316|NCT02141620|3932751|FG000|STARTED|Treatment Condition 2 (7 Days)||7
3203317|NCT02141620|3932752|FG001|STARTED|Treatment Condition 2 (7 Days)||7
3203318|NCT02141620|3932751|FG000|COMPLETED|Treatment Condition 2 (7 Days)||7
3203319|NCT02141620|3932752|FG001|COMPLETED|Treatment Condition 2 (7 Days)||7
3203320|NCT02141620|3932751|FG000|NOT COMPLETED|Treatment Condition 2 (7 Days)||0
3203321|NCT02141620|3932752|FG001|NOT COMPLETED|Treatment Condition 2 (7 Days)||0
3203322|NCT02141633|3932760|FG000|STARTED|Overall Study||16
3203323|NCT02141633|3932761|FG001|STARTED|Overall Study||15
3203324|NCT02141633|3932760|FG000|COMPLETED|Overall Study||15
3203325|NCT02141633|3932761|FG001|COMPLETED|Overall Study||15
3203326|NCT02141633|3932760|FG000|NOT COMPLETED|Overall Study||1
3203327|NCT02141633|3932761|FG001|NOT COMPLETED|Overall Study||0
3203328|NCT02141659|3932773|FG000|STARTED|Overall Study||3
3203329|NCT02141659|3932774|FG001|STARTED|Overall Study||4
3203330|NCT02141659|3932775|FG002|STARTED|Overall Study||3
3203331|NCT02141659|3932776|FG003|STARTED|Overall Study||3
3203332|NCT02141659|3932777|FG004|STARTED|Overall Study||15
3203333|NCT02141659|3932778|FG005|STARTED|Overall Study||15
3203334|NCT02141659|3932773|FG000|COMPLETED|Overall Study||3
3203335|NCT02141659|3932774|FG001|COMPLETED|Overall Study||3
3203336|NCT02141659|3932775|FG002|COMPLETED|Overall Study||3
3203337|NCT02141659|3932776|FG003|COMPLETED|Overall Study||3
3203338|NCT02141659|3932777|FG004|COMPLETED|Overall Study||13
3203339|NCT02141659|3932778|FG005|COMPLETED|Overall Study||13
3203340|NCT02141659|3932773|FG000|NOT COMPLETED|Overall Study||0
3203341|NCT02141659|3932774|FG001|NOT COMPLETED|Overall Study||1
3203342|NCT02141659|3932775|FG002|NOT COMPLETED|Overall Study||0
3203343|NCT02141659|3932776|FG003|NOT COMPLETED|Overall Study||0
3203344|NCT02141659|3932777|FG004|NOT COMPLETED|Overall Study||2
3203345|NCT02141659|3932778|FG005|NOT COMPLETED|Overall Study||2
3203346|NCT02141672|3932795|FG000|STARTED|Overall Study||89
3203347|NCT02141672|3932796|FG001|STARTED|Overall Study||88
3203348|NCT02141672|3932797|FG002|STARTED|Overall Study||88
3203349|NCT02141672|3932795|FG000|COMPLETED|Overall Study||73
3203350|NCT02141672|3932796|FG001|COMPLETED|Overall Study||80
3203351|NCT02141672|3932797|FG002|COMPLETED|Overall Study||70
3203352|NCT02141672|3932795|FG000|NOT COMPLETED|Overall Study||16
3203353|NCT02141672|3932796|FG001|NOT COMPLETED|Overall Study||8
3203354|NCT02141672|3932797|FG002|NOT COMPLETED|Overall Study||18
3203355|NCT02141854|3932810|FG000|STARTED|Run-In Period (Pre-assignment)||882
3203356|NCT02141854|3932811|FG001|STARTED|Run-In Period (Pre-assignment)||0
3203357|NCT02141854|3932812|FG002|STARTED|Run-In Period (Pre-assignment)||0
3203358|NCT02141854|3932813|FG003|STARTED|Run-In Period (Pre-assignment)||0
3203359|NCT02141854|3932814|FG004|STARTED|Run-In Period (Pre-assignment)||0
3203360|NCT02141854|3932815|FG005|STARTED|Run-In Period (Pre-assignment)||0
3203361|NCT02141854|3932810|FG000|COMPLETED|Run-In Period (Pre-assignment)||728
3203362|NCT02141854|3932811|FG001|COMPLETED|Run-In Period (Pre-assignment)||0
3203363|NCT02141854|3932812|FG002|COMPLETED|Run-In Period (Pre-assignment)||0
3203364|NCT02141854|3932813|FG003|COMPLETED|Run-In Period (Pre-assignment)||0
3203365|NCT02141854|3932814|FG004|COMPLETED|Run-In Period (Pre-assignment)||0
3203366|NCT02141854|3932815|FG005|COMPLETED|Run-In Period (Pre-assignment)||0
3203367|NCT02141854|3932810|FG000|NOT COMPLETED|Run-In Period (Pre-assignment)||154
3203368|NCT02141854|3932811|FG001|NOT COMPLETED|Run-In Period (Pre-assignment)||0
3203369|NCT02141854|3932812|FG002|NOT COMPLETED|Run-In Period (Pre-assignment)||0
3203370|NCT02141854|3932813|FG003|NOT COMPLETED|Run-In Period (Pre-assignment)||0
3203371|NCT02141854|3932814|FG004|NOT COMPLETED|Run-In Period (Pre-assignment)||0
3203372|NCT02141854|3932815|FG005|NOT COMPLETED|Run-In Period (Pre-assignment)||0
3203373|NCT02141854|3932810|FG000|STARTED|Treatment Period||0
3203374|NCT02141854|3932811|FG001|STARTED|Treatment Period||146
3203375|NCT02141854|3932812|FG002|STARTED|Treatment Period||145
3203376|NCT02141854|3932813|FG003|STARTED|Treatment Period||146
3203377|NCT02141854|3932814|FG004|STARTED|Treatment Period||146
3203378|NCT02141854|3932815|FG005|STARTED|Treatment Period||145
3203379|NCT02141854|3932810|FG000|Intent to Treat Population|Treatment Period||0
3203380|NCT02141854|3932811|FG001|Intent to Treat Population|Treatment Period||146
3203381|NCT02141854|3932812|FG002|Intent to Treat Population|Treatment Period||145
3203382|NCT02141854|3932813|FG003|Intent to Treat Population|Treatment Period||146
3203383|NCT02141854|3932814|FG004|Intent to Treat Population|Treatment Period||146
3203384|NCT02141854|3932815|FG005|Intent to Treat Population|Treatment Period||145
3203385|NCT02141854|3932810|FG000|Safety Population|Treatment Period||0
3203386|NCT02141854|3932811|FG001|Safety Population|Treatment Period||145
3203387|NCT02141854|3932812|FG002|Safety Population|Treatment Period||143
3203388|NCT02141854|3932813|FG003|Safety Population|Treatment Period||146
3203389|NCT02141854|3932814|FG004|Safety Population|Treatment Period||145
3203390|NCT02141854|3932815|FG005|Safety Population|Treatment Period||144
3203391|NCT02141854|3932810|FG000|Full Analysis Set|Treatment Period||0
3203392|NCT02141854|3932811|FG001|Full Analysis Set|Treatment Period||145
3203393|NCT02141854|3932812|FG002|Full Analysis Set|Treatment Period||141
3203394|NCT02141854|3932813|FG003|Full Analysis Set|Treatment Period||146
3203395|NCT02141854|3932814|FG004|Full Analysis Set|Treatment Period||145
3203396|NCT02141854|3932815|FG005|Full Analysis Set|Treatment Period||143
3203397|NCT02141854|3932810|FG000|COMPLETED|Treatment Period||0
3203398|NCT02141854|3932811|FG001|COMPLETED|Treatment Period||136
3203399|NCT02141854|3932812|FG002|COMPLETED|Treatment Period||136
3203400|NCT02141854|3932813|FG003|COMPLETED|Treatment Period||135
3203401|NCT02141854|3932814|FG004|COMPLETED|Treatment Period||136
3203402|NCT02141854|3932815|FG005|COMPLETED|Treatment Period||107
3203403|NCT02141854|3932810|FG000|NOT COMPLETED|Treatment Period||0
3203404|NCT02141854|3932811|FG001|NOT COMPLETED|Treatment Period||10
3203405|NCT02141854|3932812|FG002|NOT COMPLETED|Treatment Period||9
3203406|NCT02141854|3932813|FG003|NOT COMPLETED|Treatment Period||11
3203407|NCT02141854|3932814|FG004|NOT COMPLETED|Treatment Period||10
3203408|NCT02141854|3932815|FG005|NOT COMPLETED|Treatment Period||38
3203409|NCT02141867|3932827|FG000|STARTED|Overall Study||4021
3203410|NCT02141867|3932827|FG000|COMPLETED|Overall Study||3927
3203411|NCT02141867|3932827|FG000|NOT COMPLETED|Overall Study||94
3203412|NCT02141984|3932831|FG000|STARTED|Overall Study||28
3203413|NCT02141984|3932831|FG000|COMPLETED|Overall Study||26
3203414|NCT02141984|3932831|FG000|NOT COMPLETED|Overall Study||2
3203415|NCT02141997|3932839|FG000|STARTED|Overall Study||56
3203416|NCT02141997|3932840|FG001|STARTED|Overall Study||55
3203417|NCT02141997|3932841|FG002|STARTED|Overall Study||56
3203418|NCT02141997|3932842|FG003|STARTED|Overall Study||55
3203419|NCT02141997|3932839|FG000|COMPLETED|Overall Study||53
3203420|NCT02141997|3932840|FG001|COMPLETED|Overall Study||49
3203421|NCT02141997|3932841|FG002|COMPLETED|Overall Study||53
3203422|NCT02141997|3932842|FG003|COMPLETED|Overall Study||54
3203423|NCT02141997|3932839|FG000|NOT COMPLETED|Overall Study||3
3203424|NCT02141997|3932840|FG001|NOT COMPLETED|Overall Study||6
3203425|NCT02141997|3932841|FG002|NOT COMPLETED|Overall Study||3
3203426|NCT02141997|3932842|FG003|NOT COMPLETED|Overall Study||1
3203427|NCT02142049|3932857|FG000|STARTED|Overall Study||3
3203428|NCT02142049|3932858|FG001|STARTED|Overall Study||3
3203429|NCT02142049|3932859|FG002|STARTED|Overall Study||3
3203430|NCT02142049|3932860|FG003|STARTED|Overall Study||6
3203431|NCT02142049|3932861|FG004|STARTED|Overall Study||20
3203432|NCT02142049|3932857|FG000|COMPLETED|Overall Study||3
3203433|NCT02142049|3932858|FG001|COMPLETED|Overall Study||3
3203434|NCT02142049|3932859|FG002|COMPLETED|Overall Study||3
3203435|NCT02142049|3932860|FG003|COMPLETED|Overall Study||6
3203436|NCT02142049|3932861|FG004|COMPLETED|Overall Study||20
3203437|NCT02142049|3932857|FG000|NOT COMPLETED|Overall Study||0
3203438|NCT02142049|3932858|FG001|NOT COMPLETED|Overall Study||0
3203439|NCT02142049|3932859|FG002|NOT COMPLETED|Overall Study||0
3203440|NCT02142049|3932860|FG003|NOT COMPLETED|Overall Study||0
3203441|NCT02142049|3932861|FG004|NOT COMPLETED|Overall Study||0
3203442|NCT02142153|3932888|FG000|STARTED|Overall Study||6
3203443|NCT02142153|3932889|FG001|STARTED|Overall Study||2
3203444|NCT02142153|3932890|FG002|STARTED|Overall Study||6
3203445|NCT02142153|3932891|FG003|STARTED|Overall Study||2
3203446|NCT02142153|3932892|FG004|STARTED|Overall Study||6
3203447|NCT02142153|3932893|FG005|STARTED|Overall Study||2
3203448|NCT02142153|3932894|FG006|STARTED|Overall Study||6
3203449|NCT02142153|3932895|FG007|STARTED|Overall Study||2
3203450|NCT02142153|3932896|FG008|STARTED|Overall Study||6
3203451|NCT02142153|3932897|FG009|STARTED|Overall Study||2
3203452|NCT02142153|3932888|FG000|COMPLETED|Overall Study||6
3203453|NCT02142153|3932889|FG001|COMPLETED|Overall Study||2
3203454|NCT02142153|3932890|FG002|COMPLETED|Overall Study||6
3203455|NCT02142153|3932891|FG003|COMPLETED|Overall Study||2
3203456|NCT02142153|3932892|FG004|COMPLETED|Overall Study||6
3203457|NCT02142153|3932893|FG005|COMPLETED|Overall Study||2
3203458|NCT02142153|3932894|FG006|COMPLETED|Overall Study||6
3203459|NCT02142153|3932895|FG007|COMPLETED|Overall Study||2
3203460|NCT02142153|3932896|FG008|COMPLETED|Overall Study||6
3203461|NCT02142153|3932897|FG009|COMPLETED|Overall Study||2
3203462|NCT02142153|3932888|FG000|NOT COMPLETED|Overall Study||0
3203463|NCT02142153|3932889|FG001|NOT COMPLETED|Overall Study||0
3203464|NCT02142153|3932890|FG002|NOT COMPLETED|Overall Study||0
3203465|NCT02142153|3932891|FG003|NOT COMPLETED|Overall Study||0
3203466|NCT02142153|3932892|FG004|NOT COMPLETED|Overall Study||0
3203467|NCT02142153|3932893|FG005|NOT COMPLETED|Overall Study||0
3203468|NCT02142153|3932894|FG006|NOT COMPLETED|Overall Study||0
3203469|NCT02142153|3932895|FG007|NOT COMPLETED|Overall Study||0
3203470|NCT02142153|3932896|FG008|NOT COMPLETED|Overall Study||0
3203471|NCT02142153|3932897|FG009|NOT COMPLETED|Overall Study||0
3203472|NCT02142283|3932931|FG000|STARTED|Overall Study||107
3203473|NCT02142283|3932932|FG001|STARTED|Overall Study||99
3203474|NCT02142283|3932931|FG000|COMPLETED|Overall Study||86
3203475|NCT02142283|3932932|FG001|COMPLETED|Overall Study||78
3203476|NCT02142283|3932931|FG000|NOT COMPLETED|Overall Study||21
3203477|NCT02142283|3932932|FG001|NOT COMPLETED|Overall Study||21
3203478|NCT02142361|3932938|FG000|STARTED|Overall Study||20
3203479|NCT02142361|3932939|FG001|STARTED|Overall Study||20
3203480|NCT02142361|3932940|FG002|STARTED|Overall Study||20
3203481|NCT02142361|3932938|FG000|COMPLETED|Overall Study||20
3203482|NCT02142361|3932939|FG001|COMPLETED|Overall Study||20
3203483|NCT02142361|3932940|FG002|COMPLETED|Overall Study||20
3203484|NCT02142361|3932938|FG000|NOT COMPLETED|Overall Study||0
3203485|NCT02142361|3932939|FG001|NOT COMPLETED|Overall Study||0
3203486|NCT02142361|3932940|FG002|NOT COMPLETED|Overall Study||0
3203487|NCT02142387|3932953|FG000|STARTED|Overall Study|Out-of-hospital cardiac arrest (OHCA) patients with presumed cardiac etiology.|2551
3203488|NCT02142387|3932954|FG001|STARTED|Overall Study||16271
3203489|NCT02142387|3932953|FG000|COMPLETED|Overall Study|Limited to the case where OHCA occurred in the private place.|1486
3203490|NCT02142387|3932954|FG001|COMPLETED|Overall Study||8641
3203491|NCT02142387|3932953|FG000|NOT COMPLETED|Overall Study||1065
3203492|NCT02142387|3932954|FG001|NOT COMPLETED|Overall Study||7630
3203493|NCT02142504|3932963|FG000|STARTED|Overall Study||153
3203494|NCT02142504|3932964|FG001|STARTED|Overall Study||147
3203495|NCT02142504|3932965|FG002|STARTED|Overall Study||154
3203496|NCT02142504|3932963|FG000|Randomized and Received Treatment|Overall Study||153
3203497|NCT02142504|3932964|FG001|Randomized and Received Treatment|Overall Study||145
3203498|NCT02142504|3932965|FG002|Randomized and Received Treatment|Overall Study||154
3203499|NCT02142504|3932963|FG000|Received Booster (Second Vaccination)|Overall Study||126
3203500|NCT02142504|3932964|FG001|Received Booster (Second Vaccination)|Overall Study||109
3203501|NCT02142504|3932965|FG002|Received Booster (Second Vaccination)|Overall Study||116
3203502|NCT02142504|3932963|FG000|COMPLETED|Overall Study||122
3203503|NCT02142504|3932964|FG001|COMPLETED|Overall Study||105
3203504|NCT02142504|3932965|FG002|COMPLETED|Overall Study||111
3203505|NCT02142504|3932963|FG000|NOT COMPLETED|Overall Study||31
3203506|NCT02142504|3932964|FG001|NOT COMPLETED|Overall Study||42
3203507|NCT02142504|3932965|FG002|NOT COMPLETED|Overall Study||43
3203508|NCT02142608|3932973|FG000|STARTED|Overall Study||18
3203509|NCT02142608|3932973|FG000|COMPLETED|Overall Study||18
3203510|NCT02142608|3932973|FG000|NOT COMPLETED|Overall Study||0
3203511|NCT02142712|3932981|FG000|STARTED|Overall Study||1
3203512|NCT02142712|3932982|FG001|STARTED|Overall Study||1
3203513|NCT02142712|3932983|FG002|STARTED|Overall Study||1
3203514|NCT02142712|3932984|FG003|STARTED|Overall Study||0
3203515|NCT02142712|3932981|FG000|COMPLETED|Overall Study||0
3203516|NCT02142712|3932982|FG001|COMPLETED|Overall Study||0
3203517|NCT02142712|3932983|FG002|COMPLETED|Overall Study||0
3203518|NCT02142712|3932984|FG003|COMPLETED|Overall Study||0
3203519|NCT02142712|3932981|FG000|NOT COMPLETED|Overall Study||1
3203520|NCT02142712|3932982|FG001|NOT COMPLETED|Overall Study||1
3203521|NCT02142712|3932983|FG002|NOT COMPLETED|Overall Study||1
3203522|NCT02142712|3932984|FG003|NOT COMPLETED|Overall Study||0
3203523|NCT02142738|3932995|FG000|STARTED|Overall Study||154
3203524|NCT02142738|3932996|FG001|STARTED|Overall Study||151
3203525|NCT02142738|3932995|FG000|Treated|Overall Study||154
3203526|NCT02142738|3932996|FG001|Treated|Overall Study||150
3203527|NCT02142738|3932995|FG000|COMPLETED|Overall Study||0
3203528|NCT02142738|3932996|FG001|COMPLETED|Overall Study||0
3203529|NCT02142738|3932995|FG000|NOT COMPLETED|Overall Study||154
3203530|NCT02142738|3932996|FG001|NOT COMPLETED|Overall Study||151
3203531|NCT02142894|3933002|FG000|STARTED|Overall Study||33
3203532|NCT02142894|3933002|FG000|COMPLETED|Overall Study||25
3203533|NCT02142894|3933002|FG000|NOT COMPLETED|Overall Study||8
3203534|NCT02143024|3933008|FG000|STARTED|Overall Study||15
3203535|NCT02143024|3933009|FG001|STARTED|Overall Study||8
3203536|NCT02143024|3933008|FG000|Received Treatment|Overall Study||13
3203537|NCT02143024|3933009|FG001|Received Treatment|Overall Study||7
3203538|NCT02143024|3933008|FG000|COMPLETED|Overall Study||13
3203539|NCT02143024|3933009|FG001|COMPLETED|Overall Study||7
3203540|NCT02143024|3933008|FG000|NOT COMPLETED|Overall Study||2
3203541|NCT02143024|3933009|FG001|NOT COMPLETED|Overall Study||1
3203542|NCT02143102|3933017|FG000|STARTED|Overall Study||97
3203543|NCT02143102|3933018|FG001|STARTED|Overall Study||28
3203544|NCT02143102|3933017|FG000|COMPLETED|Overall Study||86
3203545|NCT02143102|3933018|FG001|COMPLETED|Overall Study||28
3203546|NCT02143102|3933017|FG000|NOT COMPLETED|Overall Study||11
3203547|NCT02143102|3933018|FG001|NOT COMPLETED|Overall Study||0
3203548|NCT02143141|3933026|FG000|STARTED|Overall Study||7
3203549|NCT02143141|3933027|FG001|STARTED|Overall Study||6
3203550|NCT02143141|3933026|FG000|COMPLETED|Overall Study||6
3203551|NCT02143141|3933027|FG001|COMPLETED|Overall Study||6
3203552|NCT02143141|3933026|FG000|NOT COMPLETED|Overall Study||1
3203553|NCT02143141|3933027|FG001|NOT COMPLETED|Overall Study||0
3203554|NCT02143310|3933033|FG000|STARTED|Overall Study||209
3203555|NCT02143310|3933033|FG000|COMPLETED|Overall Study||102
3203556|NCT02143310|3933033|FG000|NOT COMPLETED|Overall Study||107
3203557|NCT02143583|3933040|FG000|STARTED|Overall Study||62
3203558|NCT02143583|3933041|FG001|STARTED|Overall Study||66
3203559|NCT02143583|3933042|FG002|STARTED|Overall Study||68
3203560|NCT02143583|3933040|FG000|COMPLETED|Overall Study||61
3203561|NCT02143583|3933041|FG001|COMPLETED|Overall Study||66
3203562|NCT02143583|3933042|FG002|COMPLETED|Overall Study||66
3203563|NCT02143583|3933040|FG000|NOT COMPLETED|Overall Study||1
3203564|NCT02143583|3933041|FG001|NOT COMPLETED|Overall Study||0
3203565|NCT02143583|3933042|FG002|NOT COMPLETED|Overall Study||2
3365427|NCT03979638|4096552|FG000|NOT COMPLETED|Period 2||1
3203566|NCT02143648|3933053|FG000|STARTED|Overall Study||128
3203567|NCT02143648|3933054|FG001|STARTED|Overall Study||120
3203568|NCT02143648|3933055|FG002|STARTED|Overall Study||125
3203569|NCT02143648|3933053|FG000|COMPLETED|Overall Study||74
3203570|NCT02143648|3933054|FG001|COMPLETED|Overall Study||78
3203571|NCT02143648|3933055|FG002|COMPLETED|Overall Study||101
3203572|NCT02143648|3933053|FG000|NOT COMPLETED|Overall Study||54
3203573|NCT02143648|3933054|FG001|NOT COMPLETED|Overall Study||42
3203574|NCT02143648|3933055|FG002|NOT COMPLETED|Overall Study||24
3203575|NCT02143713|3933067|FG000|STARTED|Treatment Period (6 Months)||102
3203576|NCT02143713|3933068|FG001|STARTED|Treatment Period (6 Months)||111
3203577|NCT02143713|3933069|FG002|STARTED|Treatment Period (6 Months)||142
3203578|NCT02143713|3933070|FG003|STARTED|Treatment Period (6 Months)||140
3203579|NCT02143713|3933067|FG000|Received Elagolix|Treatment Period (6 Months)||102
3203580|NCT02143713|3933068|FG001|Received Elagolix|Treatment Period (6 Months)||111
3203581|NCT02143713|3933069|FG002|Received Elagolix|Treatment Period (6 Months)||142
3203582|NCT02143713|3933070|FG003|Received Elagolix|Treatment Period (6 Months)||140
3203583|NCT02143713|3933067|FG000|COMPLETED|Treatment Period (6 Months)||82
3203584|NCT02143713|3933068|FG001|COMPLETED|Treatment Period (6 Months)||99
3203585|NCT02143713|3933069|FG002|COMPLETED|Treatment Period (6 Months)||120
3203586|NCT02143713|3933070|FG003|COMPLETED|Treatment Period (6 Months)||112
3203587|NCT02143713|3933067|FG000|NOT COMPLETED|Treatment Period (6 Months)||20
3203588|NCT02143713|3933068|FG001|NOT COMPLETED|Treatment Period (6 Months)||12
3203589|NCT02143713|3933069|FG002|NOT COMPLETED|Treatment Period (6 Months)||22
3203590|NCT02143713|3933070|FG003|NOT COMPLETED|Treatment Period (6 Months)||28
3203591|NCT02143713|3933067|FG000|STARTED|Post-treatment Follow-up (12 Months)||85
3203592|NCT02143713|3933068|FG001|STARTED|Post-treatment Follow-up (12 Months)||105
3203593|NCT02143713|3933069|FG002|STARTED|Post-treatment Follow-up (12 Months)||125
3203594|NCT02143713|3933070|FG003|STARTED|Post-treatment Follow-up (12 Months)||122
3203595|NCT02143713|3933067|FG000|COMPLETED|Post-treatment Follow-up (12 Months)||73
3203596|NCT02143713|3933068|FG001|COMPLETED|Post-treatment Follow-up (12 Months)||81
3203597|NCT02143713|3933069|FG002|COMPLETED|Post-treatment Follow-up (12 Months)||96
3203598|NCT02143713|3933070|FG003|COMPLETED|Post-treatment Follow-up (12 Months)||95
3203599|NCT02143713|3933067|FG000|NOT COMPLETED|Post-treatment Follow-up (12 Months)||12
3203600|NCT02143713|3933068|FG001|NOT COMPLETED|Post-treatment Follow-up (12 Months)||24
3203601|NCT02143713|3933069|FG002|NOT COMPLETED|Post-treatment Follow-up (12 Months)||29
3203602|NCT02143713|3933070|FG003|NOT COMPLETED|Post-treatment Follow-up (12 Months)||27
3203603|NCT02143778|3933081|FG000|STARTED|Overall Study||246
3203604|NCT02143778|3933081|FG000|COMPLETED|Overall Study||243
3203605|NCT02143778|3933081|FG000|NOT COMPLETED|Overall Study||3
3203606|NCT02143843|3933086|FG000|STARTED|Overall Study||75
3203607|NCT02143843|3933086|FG000|COMPLETED|Overall Study||63
3203608|NCT02143843|3933086|FG000|NOT COMPLETED|Overall Study||12
3203609|NCT02143947|3933092|FG000|STARTED|Overall Study||36
3203610|NCT02143947|3933093|FG001|STARTED|Overall Study||44
3203611|NCT02143947|3933092|FG000|COMPLETED|Overall Study||32
3203612|NCT02143947|3933093|FG001|COMPLETED|Overall Study||42
3203613|NCT02143947|3933092|FG000|NOT COMPLETED|Overall Study||4
3203614|NCT02143947|3933093|FG001|NOT COMPLETED|Overall Study||2
3203615|NCT02143973|3933101|FG000|STARTED|Overall Study||167
3203616|NCT02143973|3933101|FG000|COMPLETED|Overall Study||101
3203617|NCT02143973|3933101|FG000|NOT COMPLETED|Overall Study||66
3203618|NCT02144012|3933107|FG000|STARTED|Overall Study||34
3203619|NCT02144012|3933108|FG001|STARTED|Overall Study||15
3203620|NCT02144012|3933107|FG000|COMPLETED|Overall Study||0
3203621|NCT02144012|3933108|FG001|COMPLETED|Overall Study||0
3203622|NCT02144012|3933107|FG000|NOT COMPLETED|Overall Study||34
3203623|NCT02144012|3933108|FG001|NOT COMPLETED|Overall Study||15
3203624|NCT02144077|3933116|FG000|STARTED|Overall Study||138
3203625|NCT02144077|3933117|FG001|STARTED|Overall Study||143
3203626|NCT02144077|3933116|FG000|COMPLETED|Overall Study||128
3203627|NCT02144077|3933117|FG001|COMPLETED|Overall Study||132
3203628|NCT02144077|3933116|FG000|NOT COMPLETED|Overall Study||10
3203629|NCT02144077|3933117|FG001|NOT COMPLETED|Overall Study||11
3203630|NCT02144220|3933123|FG000|STARTED|Overall Study||277
3203631|NCT02144220|3933123|FG000|COMPLETED|Overall Study||258
3203632|NCT02144220|3933123|FG000|NOT COMPLETED|Overall Study||19
3203633|NCT02144233|3933129|FG000|STARTED|Overall Study||39
3203634|NCT02144233|3933130|FG001|STARTED|Overall Study||38
3203635|NCT02144233|3933129|FG000|COMPLETED|Overall Study|The last participant was assessed at month 3 due to early study stop|39
3203636|NCT02144233|3933130|FG001|COMPLETED|Overall Study||38
3203637|NCT02144233|3933129|FG000|NOT COMPLETED|Overall Study||0
3203638|NCT02144233|3933130|FG001|NOT COMPLETED|Overall Study||0
3203639|NCT02144259|3933139|FG000|STARTED|Overall Study||33
3203640|NCT02144259|3933140|FG001|STARTED|Overall Study||33
3203641|NCT02144259|3933141|FG002|STARTED|Overall Study||34
3365428|NCT03979638|4096553|FG001|NOT COMPLETED|Period 2||1
3365429|NCT03979274|4096568|FG000|STARTED|Treatment Period 1||22
3365430|NCT03979274|4096569|FG001|STARTED|Treatment Period 1||22
3365431|NCT03979274|4096568|FG000|COMPLETED|Treatment Period 1||22
3365432|NCT03979274|4096569|FG001|COMPLETED|Treatment Period 1||22
3365433|NCT03979274|4096568|FG000|NOT COMPLETED|Treatment Period 1||0
3365434|NCT03979274|4096569|FG001|NOT COMPLETED|Treatment Period 1||0
3365435|NCT03979274|4096568|FG000|STARTED|Treatment Period 2||22
3365436|NCT03979274|4096569|FG001|STARTED|Treatment Period 2||22
3365437|NCT03979274|4096568|FG000|COMPLETED|Treatment Period 2||22
3365438|NCT03979274|4096569|FG001|COMPLETED|Treatment Period 2||21
3365439|NCT03979274|4096568|FG000|NOT COMPLETED|Treatment Period 2||0
3365440|NCT03979274|4096569|FG001|NOT COMPLETED|Treatment Period 2||1
3365441|NCT03979066|4096577|FG000|STARTED|Overall Study||0
3365442|NCT03979066|4096578|FG001|STARTED|Overall Study||0
3203642|NCT02144259|3933139|FG000|COMPLETED|Overall Study||23
3203643|NCT02144259|3933140|FG001|COMPLETED|Overall Study||28
3203644|NCT02144259|3933141|FG002|COMPLETED|Overall Study||16
3203645|NCT02144259|3933139|FG000|NOT COMPLETED|Overall Study||10
3203646|NCT02144259|3933140|FG001|NOT COMPLETED|Overall Study||5
3203647|NCT02144259|3933141|FG002|NOT COMPLETED|Overall Study||18
3203648|NCT02144285|3933159|FG000|STARTED|Overall Study||14
3203649|NCT02144285|3933160|FG001|STARTED|Overall Study||6
3203650|NCT02144285|3933161|FG002|STARTED|Overall Study||6
3203651|NCT02144285|3933162|FG003|STARTED|Overall Study||6
3203652|NCT02144285|3933163|FG004|STARTED|Overall Study||6
3203653|NCT02144285|3933164|FG005|STARTED|Overall Study||6
3203654|NCT02144285|3933165|FG006|STARTED|Overall Study||6
3203655|NCT02144285|3933166|FG007|STARTED|Overall Study||6
3203656|NCT02144285|3933167|FG008|STARTED|Overall Study||2
3203657|NCT02144285|3933168|FG009|STARTED|Overall Study||6
3203658|NCT02144285|3933159|FG000|Received At Least One Dose of Study Drug|Overall Study||14
3203659|NCT02144285|3933160|FG001|Received At Least One Dose of Study Drug|Overall Study||6
3203660|NCT02144285|3933161|FG002|Received At Least One Dose of Study Drug|Overall Study||6
3203661|NCT02144285|3933162|FG003|Received At Least One Dose of Study Drug|Overall Study||6
3203662|NCT02144285|3933163|FG004|Received At Least One Dose of Study Drug|Overall Study||6
3203663|NCT02144285|3933164|FG005|Received At Least One Dose of Study Drug|Overall Study||6
3203664|NCT02144285|3933165|FG006|Received At Least One Dose of Study Drug|Overall Study||6
3203665|NCT02144285|3933166|FG007|Received At Least One Dose of Study Drug|Overall Study||6
3203666|NCT02144285|3933167|FG008|Received At Least One Dose of Study Drug|Overall Study||2
3203667|NCT02144285|3933168|FG009|Received At Least One Dose of Study Drug|Overall Study||6
3203668|NCT02144285|3933159|FG000|COMPLETED|Overall Study||14
3203669|NCT02144285|3933160|FG001|COMPLETED|Overall Study||6
3203670|NCT02144285|3933161|FG002|COMPLETED|Overall Study||6
3203671|NCT02144285|3933162|FG003|COMPLETED|Overall Study||6
3203672|NCT02144285|3933163|FG004|COMPLETED|Overall Study||5
3203673|NCT02144285|3933164|FG005|COMPLETED|Overall Study||6
3203674|NCT02144285|3933165|FG006|COMPLETED|Overall Study||6
3203675|NCT02144285|3933166|FG007|COMPLETED|Overall Study||6
3203676|NCT02144285|3933167|FG008|COMPLETED|Overall Study||2
3203677|NCT02144285|3933168|FG009|COMPLETED|Overall Study||6
3203678|NCT02144285|3933159|FG000|NOT COMPLETED|Overall Study||0
3203679|NCT02144285|3933160|FG001|NOT COMPLETED|Overall Study||0
3203680|NCT02144285|3933161|FG002|NOT COMPLETED|Overall Study||0
3203681|NCT02144285|3933162|FG003|NOT COMPLETED|Overall Study||0
3203682|NCT02144285|3933163|FG004|NOT COMPLETED|Overall Study||1
3203683|NCT02144285|3933164|FG005|NOT COMPLETED|Overall Study||0
3203684|NCT02144285|3933165|FG006|NOT COMPLETED|Overall Study||0
3203685|NCT02144285|3933166|FG007|NOT COMPLETED|Overall Study||0
3203686|NCT02144285|3933167|FG008|NOT COMPLETED|Overall Study||0
3203687|NCT02144285|3933168|FG009|NOT COMPLETED|Overall Study||0
3203688|NCT02144337|3933206|FG000|STARTED|Baseline 0 Months||8
3203689|NCT02144337|3933207|FG001|STARTED|Baseline 0 Months||5
3203690|NCT02144337|3933206|FG000|COMPLETED|Baseline 0 Months||8
3203691|NCT02144337|3933207|FG001|COMPLETED|Baseline 0 Months||5
3203692|NCT02144337|3933206|FG000|NOT COMPLETED|Baseline 0 Months||0
3203693|NCT02144337|3933207|FG001|NOT COMPLETED|Baseline 0 Months||0
3203694|NCT02144337|3933206|FG000|STARTED|T2 Follow-up (Post-intervention)||8
3203695|NCT02144337|3933207|FG001|STARTED|T2 Follow-up (Post-intervention)||5
3203696|NCT02144337|3933206|FG000|COMPLETED|T2 Follow-up (Post-intervention)||4
3203697|NCT02144337|3933207|FG001|COMPLETED|T2 Follow-up (Post-intervention)||4
3203698|NCT02144337|3933206|FG000|NOT COMPLETED|T2 Follow-up (Post-intervention)||4
3203699|NCT02144337|3933207|FG001|NOT COMPLETED|T2 Follow-up (Post-intervention)||1
3203700|NCT02144337|3933206|FG000|STARTED|T3 Follow-up (3 Month Post-intervention)|Number not the same as number who completed previous period due to absence/loss of data at T2|8
3203701|NCT02144337|3933207|FG001|STARTED|T3 Follow-up (3 Month Post-intervention)|Number not the same as number who completed previous period due to absence/loss of data at T2|5
3203702|NCT02144337|3933206|FG000|COMPLETED|T3 Follow-up (3 Month Post-intervention)||5
3203703|NCT02144337|3933207|FG001|COMPLETED|T3 Follow-up (3 Month Post-intervention)||5
3203704|NCT02144337|3933206|FG000|NOT COMPLETED|T3 Follow-up (3 Month Post-intervention)||3
3203705|NCT02144337|3933207|FG001|NOT COMPLETED|T3 Follow-up (3 Month Post-intervention)||0
3203706|NCT02144519|3933216|FG000|STARTED|Year 1||895
3203707|NCT02144519|3933217|FG001|STARTED|Year 1||870
3203708|NCT02144519|3933216|FG000|COMPLETED|Year 1||895
3203709|NCT02144519|3933217|FG001|COMPLETED|Year 1||870
3203710|NCT02144519|3933216|FG000|NOT COMPLETED|Year 1||0
3203711|NCT02144519|3933217|FG001|NOT COMPLETED|Year 1||0
3203712|NCT02144519|3933216|FG000|STARTED|Year 2||763
3203713|NCT02144519|3933217|FG001|STARTED|Year 2||864
3203714|NCT02144519|3933216|FG000|COMPLETED|Year 2||763
3203715|NCT02144519|3933217|FG001|COMPLETED|Year 2||864
3203716|NCT02144519|3933216|FG000|NOT COMPLETED|Year 2||0
3203717|NCT02144519|3933217|FG001|NOT COMPLETED|Year 2||0
3203718|NCT02144519|3933216|FG000|STARTED|Year 3||894
3203719|NCT02144519|3933217|FG001|STARTED|Year 3||760
3203720|NCT02144519|3933216|FG000|COMPLETED|Year 3||894
3203721|NCT02144519|3933217|FG001|COMPLETED|Year 3||760
3203722|NCT02144519|3933216|FG000|NOT COMPLETED|Year 3||0
3203723|NCT02144519|3933217|FG001|NOT COMPLETED|Year 3||0
3203724|NCT02144597|3933226|FG000|STARTED|Overall Study||10
3203725|NCT02144597|3933227|FG001|STARTED|Overall Study||10
3203726|NCT02144597|3933228|FG002|STARTED|Overall Study||10
3203727|NCT02144597|3933226|FG000|COMPLETED|Overall Study||4
3203728|NCT02144597|3933227|FG001|COMPLETED|Overall Study||6
3203729|NCT02144597|3933228|FG002|COMPLETED|Overall Study||6
3203730|NCT02144597|3933226|FG000|NOT COMPLETED|Overall Study||6
3203731|NCT02144597|3933227|FG001|NOT COMPLETED|Overall Study||4
3203732|NCT02144597|3933228|FG002|NOT COMPLETED|Overall Study||4
3203733|NCT02144610|3933238|FG000|STARTED|Overall Study||23
3203734|NCT02144610|3933239|FG001|STARTED|Overall Study||23
3203735|NCT02144610|3933238|FG000|COMPLETED|Overall Study||0
3203736|NCT02144610|3933239|FG001|COMPLETED|Overall Study||1
3203737|NCT02144610|3933238|FG000|NOT COMPLETED|Overall Study||23
3203738|NCT02144610|3933239|FG001|NOT COMPLETED|Overall Study||22
3203739|NCT02144675|3933247|FG000|STARTED|Overall Study||13
3203740|NCT02144675|3933248|FG001|STARTED|Overall Study||14
3203741|NCT02144675|3933247|FG000|COMPLETED|Overall Study||13
3203742|NCT02144675|3933248|FG001|COMPLETED|Overall Study||14
3203743|NCT02144675|3933247|FG000|NOT COMPLETED|Overall Study||0
3203744|NCT02144675|3933248|FG001|NOT COMPLETED|Overall Study||0
3203745|NCT02144701|3933256|FG000|STARTED|Overall Study||22
3203746|NCT02144701|3933257|FG001|STARTED|Overall Study||11
3203747|NCT02144701|3933256|FG000|COMPLETED|Overall Study||13
3203748|NCT02144701|3933257|FG001|COMPLETED|Overall Study||8
3203749|NCT02144701|3933256|FG000|NOT COMPLETED|Overall Study||9
3203750|NCT02144701|3933257|FG001|NOT COMPLETED|Overall Study||3
3203751|NCT02144714|3933266|FG000|STARTED|Overall Study||63
3203752|NCT02144714|3933267|FG001|STARTED|Overall Study||63
3203753|NCT02144714|3933268|FG002|STARTED|Overall Study||63
3203754|NCT02144714|3933266|FG000|COMPLETED|Overall Study||63
3203755|NCT02144714|3933267|FG001|COMPLETED|Overall Study||63
3203756|NCT02144714|3933268|FG002|COMPLETED|Overall Study||63
3203757|NCT02144714|3933266|FG000|NOT COMPLETED|Overall Study||0
3203758|NCT02144714|3933267|FG001|NOT COMPLETED|Overall Study||0
3203759|NCT02144714|3933268|FG002|NOT COMPLETED|Overall Study||0
3203760|NCT02145026|3933276|FG000|STARTED|Overall Study||100
3203761|NCT02145026|3933276|FG000|COMPLETED|Overall Study||88
3203762|NCT02145026|3933276|FG000|NOT COMPLETED|Overall Study||12
3203763|NCT02145039|3933280|FG000|STARTED|Overall Study||2
3203764|NCT02145039|3933280|FG000|COMPLETED|Overall Study||2
3203765|NCT02145039|3933280|FG000|NOT COMPLETED|Overall Study||0
3203766|NCT02145078|3933284|FG000|STARTED|Overall Study||4
3203767|NCT02145078|3933284|FG000|COMPLETED|Overall Study||0
3203768|NCT02145078|3933284|FG000|NOT COMPLETED|Overall Study||4
3203769|NCT02145156|3933291|FG000|STARTED|Overall Study||430
3203770|NCT02145156|3933292|FG001|STARTED|Overall Study||425
3203771|NCT02145156|3933293|FG002|STARTED|Overall Study||439
3203772|NCT02145156|3933291|FG000|COMPLETED|Overall Study||370
3203773|NCT02145156|3933292|FG001|COMPLETED|Overall Study||373
3203774|NCT02145156|3933293|FG002|COMPLETED|Overall Study||398
3203775|NCT02145156|3933291|FG000|NOT COMPLETED|Overall Study||60
3203776|NCT02145156|3933292|FG001|NOT COMPLETED|Overall Study||52
3203777|NCT02145156|3933293|FG002|NOT COMPLETED|Overall Study||41
3203778|NCT02145182|3933303|FG000|STARTED|Overall Study||142
3203779|NCT02145182|3933304|FG001|STARTED|Overall Study||146
3203780|NCT02145182|3933303|FG000|Received at Least 1 Dose of Study Drug|Overall Study||142
3203781|NCT02145182|3933304|FG001|Received at Least 1 Dose of Study Drug|Overall Study||146
3203782|NCT02145182|3933303|FG000|COMPLETED|Overall Study||124
3203783|NCT02145182|3933304|FG001|COMPLETED|Overall Study||130
3203784|NCT02145182|3933303|FG000|NOT COMPLETED|Overall Study||18
3203785|NCT02145182|3933304|FG001|NOT COMPLETED|Overall Study||16
3203786|NCT02145247|3933312|FG000|STARTED|Overall Study||20
3203787|NCT02145247|3933313|FG001|STARTED|Overall Study||19
3203788|NCT02145247|3933312|FG000|COMPLETED|Overall Study||20
3203789|NCT02145247|3933313|FG001|COMPLETED|Overall Study||19
3203790|NCT02145247|3933312|FG000|NOT COMPLETED|Overall Study||0
3203791|NCT02145247|3933313|FG001|NOT COMPLETED|Overall Study||0
3203792|NCT02145299|3933321|FG000|STARTED|Overall Study||6
3203793|NCT02145299|3933322|FG001|STARTED|Overall Study||2
3203794|NCT02145299|3933321|FG000|COMPLETED|Overall Study||6
3203795|NCT02145299|3933322|FG001|COMPLETED|Overall Study||2
3203796|NCT02145299|3933321|FG000|NOT COMPLETED|Overall Study||0
3203797|NCT02145299|3933322|FG001|NOT COMPLETED|Overall Study||0
3203798|NCT02145429|3933330|FG000|STARTED|Overall Study||91
3203799|NCT02145429|3933331|FG001|STARTED|Overall Study||90
3203800|NCT02145429|3933330|FG000|COMPLETED|Overall Study||75
3203801|NCT02145429|3933331|FG001|COMPLETED|Overall Study||79
3203802|NCT02145429|3933330|FG000|NOT COMPLETED|Overall Study||16
3203803|NCT02145429|3933331|FG001|NOT COMPLETED|Overall Study||11
3203804|NCT02145468|3933339|FG000|STARTED|Overall Study||1758
3203805|NCT02145468|3933340|FG001|STARTED|Overall Study||1731
3203806|NCT02145468|3933339|FG000|COMPLETED|Overall Study||1753
3203807|NCT02145468|3933340|FG001|COMPLETED|Overall Study||1723
3203808|NCT02145468|3933339|FG000|NOT COMPLETED|Overall Study||5
3203809|NCT02145468|3933340|FG001|NOT COMPLETED|Overall Study||8
3203810|NCT02145676|3933349|FG000|STARTED|Overall Study||17
3203811|NCT02145676|3933350|FG001|STARTED|Overall Study||18
3203812|NCT02145676|3933351|FG002|STARTED|Overall Study||18
3203813|NCT02145676|3933349|FG000|COMPLETED|Overall Study||17
3203814|NCT02145676|3933350|FG001|COMPLETED|Overall Study||18
3203815|NCT02145676|3933351|FG002|COMPLETED|Overall Study||18
3203816|NCT02145676|3933349|FG000|NOT COMPLETED|Overall Study||0
3203817|NCT02145676|3933350|FG001|NOT COMPLETED|Overall Study||0
3203818|NCT02145676|3933351|FG002|NOT COMPLETED|Overall Study||0
3203819|NCT02145754|3933359|FG000|STARTED|Overall Study||235
3203820|NCT02145754|3933359|FG000|COMPLETED|Overall Study||235
3203821|NCT02145754|3933359|FG000|NOT COMPLETED|Overall Study||0
3203822|NCT02146001|3933365|FG000|STARTED|Overall Study||19
3203823|NCT02146001|3933366|FG001|STARTED|Overall Study||19
3203824|NCT02146001|3933365|FG000|COMPLETED|Overall Study||19
3203825|NCT02146001|3933366|FG001|COMPLETED|Overall Study||19
3203826|NCT02146001|3933365|FG000|NOT COMPLETED|Overall Study||0
3203827|NCT02146001|3933366|FG001|NOT COMPLETED|Overall Study||0
3203828|NCT02146105|3933372|FG000|STARTED|Overall Study||45
3203829|NCT02146105|3933372|FG000|COMPLETED|Overall Study||39
3203830|NCT02146105|3933372|FG000|NOT COMPLETED|Overall Study||6
3203831|NCT02146131|3933378|FG000|STARTED|Overall Study||170
3203832|NCT02146131|3933379|FG001|STARTED|Overall Study||169
3203833|NCT02146131|3933378|FG000|COMPLETED|Overall Study||109
3203834|NCT02146131|3933379|FG001|COMPLETED|Overall Study||113
3203835|NCT02146131|3933378|FG000|NOT COMPLETED|Overall Study||61
3203836|NCT02146131|3933379|FG001|NOT COMPLETED|Overall Study||56
3203837|NCT02146248|3933385|FG000|STARTED|Overall Study||11
3203838|NCT02146248|3933385|FG000|Enrolled|Overall Study||11
3203839|NCT02146248|3933385|FG000|Uterine Sounding|Overall Study|one subject dropped out after uterine sound before HSG #1|11
3203840|NCT02146248|3933385|FG000|HSG 1|Overall Study||10
3203841|NCT02146248|3933385|FG000|HSG 2|Overall Study||10
3203842|NCT02146248|3933385|FG000|HSG 3|Overall Study||9
3203843|NCT02146248|3933385|FG000|HSG 4|Overall Study||7
3203844|NCT02146248|3933385|FG000|HSG 5|Overall Study||1
3203845|NCT02146248|3933385|FG000|COMPLETED|Overall Study||9
3203846|NCT02146248|3933385|FG000|NOT COMPLETED|Overall Study||2
3203847|NCT02146274|3933393|FG000|STARTED|Overall Study||1877
3203848|NCT02146274|3933393|FG000|COMPLETED|Overall Study||1804
3203849|NCT02146274|3933393|FG000|NOT COMPLETED|Overall Study||73
3203850|NCT02146326|3933404|FG000|STARTED|Overall Study||89
3203851|NCT02146326|3933405|FG001|STARTED|Overall Study||103
3203852|NCT02146326|3933406|FG002|STARTED|Overall Study||211
3203853|NCT02146326|3933407|FG003|STARTED|Overall Study||258
3203854|NCT02146326|3933404|FG000|Baseline|Overall Study||89
3203855|NCT02146326|3933405|FG001|Baseline|Overall Study||103
3203856|NCT02146326|3933406|FG002|Baseline|Overall Study||211
3203857|NCT02146326|3933407|FG003|Baseline|Overall Study||258
3203858|NCT02146326|3933404|FG000|3 Months|Overall Study||71
3203859|NCT02146326|3933405|FG001|3 Months|Overall Study||83
3203860|NCT02146326|3933406|FG002|3 Months|Overall Study||0
3203861|NCT02146326|3933407|FG003|3 Months|Overall Study||0
3203862|NCT02146326|3933404|FG000|6 Months|Overall Study||71
3203863|NCT02146326|3933405|FG001|6 Months|Overall Study||71
3203864|NCT02146326|3933406|FG002|6 Months|Overall Study||186
3203865|NCT02146326|3933407|FG003|6 Months|Overall Study||235
3203866|NCT02146326|3933404|FG000|12 Months|Overall Study||61
3203867|NCT02146326|3933405|FG001|12 Months|Overall Study||66
3203868|NCT02146326|3933406|FG002|12 Months|Overall Study||168
3203869|NCT02146326|3933407|FG003|12 Months|Overall Study||210
3203870|NCT02146326|3933404|FG000|COMPLETED|Overall Study||61
3203871|NCT02146326|3933405|FG001|COMPLETED|Overall Study||66
3203872|NCT02146326|3933406|FG002|COMPLETED|Overall Study||168
3203873|NCT02146326|3933407|FG003|COMPLETED|Overall Study||210
3203874|NCT02146326|3933404|FG000|NOT COMPLETED|Overall Study||28
3203875|NCT02146326|3933405|FG001|NOT COMPLETED|Overall Study||37
3203876|NCT02146326|3933406|FG002|NOT COMPLETED|Overall Study||43
3203877|NCT02146326|3933407|FG003|NOT COMPLETED|Overall Study||48
3203878|NCT02146352|3933423|FG000|STARTED|Overall Study||30
3203879|NCT02146352|3933423|FG000|30 or 60 Days Post-procedure|Overall Study||30
3203880|NCT02146352|3933423|FG000|7 Days Post-stent Removal|Overall Study||28
3203881|NCT02146352|3933423|FG000|COMPLETED|Overall Study||28
3203882|NCT02146352|3933423|FG000|NOT COMPLETED|Overall Study||2
3203883|NCT02146365|3933433|FG000|STARTED|Overall Study||49
3203884|NCT02146365|3933434|FG001|STARTED|Overall Study||49
3203885|NCT02146365|3933435|FG002|STARTED|Overall Study||50
3203886|NCT02146365|3933436|FG003|STARTED|Overall Study||50
3203887|NCT02146365|3933437|FG004|STARTED|Overall Study||24
3203888|NCT02146365|3933438|FG005|STARTED|Overall Study||25
3203889|NCT02146365|3933439|FG006|STARTED|Overall Study||25
3203890|NCT02146365|3933440|FG007|STARTED|Overall Study||25
3203891|NCT02146365|3933433|FG000|COMPLETED|Overall Study||45
3203892|NCT02146365|3933434|FG001|COMPLETED|Overall Study||45
3203893|NCT02146365|3933435|FG002|COMPLETED|Overall Study||43
3203894|NCT02146365|3933436|FG003|COMPLETED|Overall Study||41
3203895|NCT02146365|3933437|FG004|COMPLETED|Overall Study||22
3203896|NCT02146365|3933438|FG005|COMPLETED|Overall Study||24
3203897|NCT02146365|3933439|FG006|COMPLETED|Overall Study||25
3203898|NCT02146365|3933440|FG007|COMPLETED|Overall Study||24
3203899|NCT02146365|3933433|FG000|NOT COMPLETED|Overall Study||4
3203900|NCT02146365|3933434|FG001|NOT COMPLETED|Overall Study||4
3203901|NCT02146365|3933435|FG002|NOT COMPLETED|Overall Study||7
3203902|NCT02146365|3933436|FG003|NOT COMPLETED|Overall Study||9
3203903|NCT02146365|3933437|FG004|NOT COMPLETED|Overall Study||2
3203904|NCT02146365|3933438|FG005|NOT COMPLETED|Overall Study||1
3203905|NCT02146365|3933439|FG006|NOT COMPLETED|Overall Study||0
3203906|NCT02146365|3933440|FG007|NOT COMPLETED|Overall Study||1
3203907|NCT02146430|3933462|FG000|STARTED|Overall Study||323
3203908|NCT02146430|3933463|FG001|STARTED|Overall Study||323
3203909|NCT02146430|3933464|FG002|STARTED|Overall Study||324
3203910|NCT02146430|3933465|FG003|STARTED|Overall Study||323
3203911|NCT02146430|3933462|FG000|Safety Analysis Set|Overall Study||318
3203912|NCT02146430|3933463|FG001|Safety Analysis Set|Overall Study||318
3203913|NCT02146430|3933464|FG002|Safety Analysis Set|Overall Study||320
3203914|NCT02146430|3933465|FG003|Safety Analysis Set|Overall Study||320
3203915|NCT02146430|3933462|FG000|Modified Intent to Treat Set (mITT)|Overall Study||318
3203916|NCT02146430|3933463|FG001|Modified Intent to Treat Set (mITT)|Overall Study||317
3203917|NCT02146430|3933464|FG002|Modified Intent to Treat Set (mITT)|Overall Study||319
3203918|NCT02146430|3933465|FG003|Modified Intent to Treat Set (mITT)|Overall Study||319
3203919|NCT02146430|3933462|FG000|COMPLETED|Overall Study||256
3203920|NCT02146430|3933463|FG001|COMPLETED|Overall Study||236
3203921|NCT02146430|3933464|FG002|COMPLETED|Overall Study||242
3203922|NCT02146430|3933465|FG003|COMPLETED|Overall Study||224
3203923|NCT02146430|3933462|FG000|NOT COMPLETED|Overall Study||67
3203924|NCT02146430|3933463|FG001|NOT COMPLETED|Overall Study||87
3203925|NCT02146430|3933464|FG002|NOT COMPLETED|Overall Study||82
3203926|NCT02146430|3933465|FG003|NOT COMPLETED|Overall Study||99
3203927|NCT02146482|3933481|FG000|STARTED|Overall Study|11 participants total enrolled in study but withdrew prior to randomization|21
3203928|NCT02146482|3933482|FG001|STARTED|Overall Study|11 participants total enrolled in study but withdrew prior to randomization|25
3203929|NCT02146482|3933481|FG000|COMPLETED|Overall Study||21
3203930|NCT02146482|3933482|FG001|COMPLETED|Overall Study||25
3203931|NCT02146482|3933481|FG000|NOT COMPLETED|Overall Study||0
3203932|NCT02146482|3933482|FG001|NOT COMPLETED|Overall Study||0
3203933|NCT02146599|3933488|FG000|STARTED|Overall Study||301
3203934|NCT02146599|3933488|FG000|COMPLETED|Overall Study||296
3203935|NCT02146599|3933488|FG000|NOT COMPLETED|Overall Study||5
3203936|NCT02146833|3933492|FG000|STARTED|Overall Study||20
3203937|NCT02146833|3933492|FG000|COMPLETED|Overall Study||9
3203938|NCT02146833|3933492|FG000|NOT COMPLETED|Overall Study||11
3203939|NCT02147067|3933498|FG000|STARTED|Overall Study||13
3203940|NCT02147067|3933499|FG001|STARTED|Overall Study||13
3203941|NCT02147067|3933498|FG000|COMPLETED|Overall Study||11
3203942|NCT02147067|3933499|FG001|COMPLETED|Overall Study||11
3203943|NCT02147067|3933498|FG000|NOT COMPLETED|Overall Study||2
3203944|NCT02147067|3933499|FG001|NOT COMPLETED|Overall Study||2
3203945|NCT02147093|3933507|FG000|STARTED|Period 1||20
3203946|NCT02147093|3933508|FG001|STARTED|Period 1||20
3203947|NCT02147093|3933507|FG000|COMPLETED|Period 1||20
3203948|NCT02147093|3933508|FG001|COMPLETED|Period 1||19
3203949|NCT02147093|3933507|FG000|NOT COMPLETED|Period 1||0
3203950|NCT02147093|3933508|FG001|NOT COMPLETED|Period 1||1
3203951|NCT02147093|3933507|FG000|STARTED|Period 2||20
3203952|NCT02147093|3933508|FG001|STARTED|Period 2||19
3203953|NCT02147093|3933507|FG000|COMPLETED|Period 2||18
3203954|NCT02147093|3933508|FG001|COMPLETED|Period 2||19
3203955|NCT02147093|3933507|FG000|NOT COMPLETED|Period 2||2
3203956|NCT02147093|3933508|FG001|NOT COMPLETED|Period 2||0
3203957|NCT02147132|3933514|FG000|STARTED|Overall Study||2
3203958|NCT02147132|3933515|FG001|STARTED|Overall Study||2
3203959|NCT02147132|3933516|FG002|STARTED|Overall Study||1
3203960|NCT02147132|3933517|FG003|STARTED|Overall Study||2
3203961|NCT02147132|3933514|FG000|COMPLETED|Overall Study||1
3203962|NCT02147132|3933515|FG001|COMPLETED|Overall Study||2
3203963|NCT02147132|3933516|FG002|COMPLETED|Overall Study||1
3203964|NCT02147132|3933517|FG003|COMPLETED|Overall Study||2
3203965|NCT02147132|3933514|FG000|NOT COMPLETED|Overall Study||1
3203966|NCT02147132|3933515|FG001|NOT COMPLETED|Overall Study||0
3203967|NCT02147132|3933516|FG002|NOT COMPLETED|Overall Study||0
3203968|NCT02147132|3933517|FG003|NOT COMPLETED|Overall Study||0
3203969|NCT02147158|3933533|FG000|STARTED|Treatment Course 1||55
3203970|NCT02147158|3933534|FG001|STARTED|Treatment Course 1||47
3203971|NCT02147158|3933535|FG002|STARTED|Treatment Course 1||107
3203972|NCT02147158|3933536|FG003|STARTED|Treatment Course 1||110
3203973|NCT02147158|3933537|FG004|STARTED|Treatment Course 1||55
3203974|NCT02147158|3933538|FG005|STARTED|Treatment Course 1||58
3203975|NCT02147158|3933533|FG000|COMPLETED|Treatment Course 1||51
3203976|NCT02147158|3933534|FG001|COMPLETED|Treatment Course 1||38
3203977|NCT02147158|3933535|FG002|COMPLETED|Treatment Course 1||99
3203978|NCT02147158|3933536|FG003|COMPLETED|Treatment Course 1||97
3203979|NCT02147158|3933537|FG004|COMPLETED|Treatment Course 1||49
3203980|NCT02147158|3933538|FG005|COMPLETED|Treatment Course 1||50
3203981|NCT02147158|3933533|FG000|NOT COMPLETED|Treatment Course 1||4
3203982|NCT02147158|3933534|FG001|NOT COMPLETED|Treatment Course 1||9
3203983|NCT02147158|3933535|FG002|NOT COMPLETED|Treatment Course 1||8
3203984|NCT02147158|3933536|FG003|NOT COMPLETED|Treatment Course 1||13
3203985|NCT02147158|3933537|FG004|NOT COMPLETED|Treatment Course 1||6
3203986|NCT02147158|3933538|FG005|NOT COMPLETED|Treatment Course 1||8
3203987|NCT02147158|3933533|FG000|STARTED|Off-Treatment Interval 1||51
3203988|NCT02147158|3933534|FG001|STARTED|Off-Treatment Interval 1||38
3203989|NCT02147158|3933535|FG002|STARTED|Off-Treatment Interval 1||99
3203990|NCT02147158|3933536|FG003|STARTED|Off-Treatment Interval 1||97
3203991|NCT02147158|3933537|FG004|STARTED|Off-Treatment Interval 1||49
3203992|NCT02147158|3933538|FG005|STARTED|Off-Treatment Interval 1||50
3203993|NCT02147158|3933533|FG000|COMPLETED|Off-Treatment Interval 1||41
3203994|NCT02147158|3933534|FG001|COMPLETED|Off-Treatment Interval 1||34
3203995|NCT02147158|3933535|FG002|COMPLETED|Off-Treatment Interval 1||84
3203996|NCT02147158|3933536|FG003|COMPLETED|Off-Treatment Interval 1||82
3203997|NCT02147158|3933537|FG004|COMPLETED|Off-Treatment Interval 1||41
3203998|NCT02147158|3933538|FG005|COMPLETED|Off-Treatment Interval 1||45
3365443|NCT03979066|4096577|FG000|COMPLETED|Overall Study||0
3365444|NCT03979066|4096578|FG001|COMPLETED|Overall Study||0
3365445|NCT03979066|4096577|FG000|NOT COMPLETED|Overall Study||0
3365446|NCT03979066|4096578|FG001|NOT COMPLETED|Overall Study||0
3365447|NCT03977727|4096586|FG000|STARTED|First Treatment||20
3365448|NCT03977727|4096587|FG001|STARTED|First Treatment||20
3203999|NCT02147158|3933533|FG000|NOT COMPLETED|Off-Treatment Interval 1||10
3365449|NCT03977727|4096586|FG000|Received Treatment|First Treatment||20
3365450|NCT03977727|4096587|FG001|Received Treatment|First Treatment||20
3204000|NCT02147158|3933534|FG001|NOT COMPLETED|Off-Treatment Interval 1||4
3204001|NCT02147158|3933535|FG002|NOT COMPLETED|Off-Treatment Interval 1||15
3204002|NCT02147158|3933536|FG003|NOT COMPLETED|Off-Treatment Interval 1||15
3204003|NCT02147158|3933537|FG004|NOT COMPLETED|Off-Treatment Interval 1||8
3204004|NCT02147158|3933538|FG005|NOT COMPLETED|Off-Treatment Interval 1||5
3204005|NCT02147158|3933533|FG000|STARTED|Treatment Course 2||41
3204006|NCT02147158|3933534|FG001|STARTED|Treatment Course 2||34
3204007|NCT02147158|3933535|FG002|STARTED|Treatment Course 2||84
3204008|NCT02147158|3933536|FG003|STARTED|Treatment Course 2||82
3204009|NCT02147158|3933537|FG004|STARTED|Treatment Course 2||41
3204010|NCT02147158|3933538|FG005|STARTED|Treatment Course 2||45
3204011|NCT02147158|3933533|FG000|COMPLETED|Treatment Course 2||40
3204012|NCT02147158|3933534|FG001|COMPLETED|Treatment Course 2||29
3204013|NCT02147158|3933535|FG002|COMPLETED|Treatment Course 2||79
3204014|NCT02147158|3933536|FG003|COMPLETED|Treatment Course 2||77
3204015|NCT02147158|3933537|FG004|COMPLETED|Treatment Course 2||41
3204016|NCT02147158|3933538|FG005|COMPLETED|Treatment Course 2||43
3204017|NCT02147158|3933533|FG000|NOT COMPLETED|Treatment Course 2||1
3204018|NCT02147158|3933534|FG001|NOT COMPLETED|Treatment Course 2||5
3204019|NCT02147158|3933535|FG002|NOT COMPLETED|Treatment Course 2||5
3204020|NCT02147158|3933536|FG003|NOT COMPLETED|Treatment Course 2||5
3204021|NCT02147158|3933537|FG004|NOT COMPLETED|Treatment Course 2||0
3204022|NCT02147158|3933538|FG005|NOT COMPLETED|Treatment Course 2||2
3204023|NCT02147158|3933533|FG000|STARTED|Off-Treatment Interval 2||40
3204024|NCT02147158|3933534|FG001|STARTED|Off-Treatment Interval 2||29
3204025|NCT02147158|3933535|FG002|STARTED|Off-Treatment Interval 2||79
3204026|NCT02147158|3933536|FG003|STARTED|Off-Treatment Interval 2||77
3204027|NCT02147158|3933537|FG004|STARTED|Off-Treatment Interval 2||41
3204028|NCT02147158|3933538|FG005|STARTED|Off-Treatment Interval 2||43
3204029|NCT02147158|3933533|FG000|COMPLETED|Off-Treatment Interval 2||36
3204030|NCT02147158|3933534|FG001|COMPLETED|Off-Treatment Interval 2||25
3204031|NCT02147158|3933535|FG002|COMPLETED|Off-Treatment Interval 2||69
3204032|NCT02147158|3933536|FG003|COMPLETED|Off-Treatment Interval 2||66
3204033|NCT02147158|3933537|FG004|COMPLETED|Off-Treatment Interval 2||39
3365451|NCT03977727|4096586|FG000|COMPLETED|First Treatment||20
3365452|NCT03977727|4096587|FG001|COMPLETED|First Treatment||20
3365453|NCT03977727|4096586|FG000|NOT COMPLETED|First Treatment||0
3365454|NCT03977727|4096587|FG001|NOT COMPLETED|First Treatment||0
3365455|NCT03977727|4096586|FG000|STARTED|Second Treatment||20
3365456|NCT03977727|4096587|FG001|STARTED|Second Treatment||20
3365457|NCT03977727|4096586|FG000|COMPLETED|Second Treatment||20
3365458|NCT03977727|4096587|FG001|COMPLETED|Second Treatment||17
3365459|NCT03977727|4096586|FG000|NOT COMPLETED|Second Treatment||0
3365460|NCT03977727|4096587|FG001|NOT COMPLETED|Second Treatment||3
3365461|NCT03977155|4096596|FG000|STARTED|Overall Study||43
3365462|NCT03977155|4096597|FG001|STARTED|Overall Study||48
3365463|NCT03977155|4096598|FG002|STARTED|Overall Study||42
3365464|NCT03977155|4096596|FG000|COMPLETED|Overall Study||38
3365465|NCT03977155|4096597|FG001|COMPLETED|Overall Study||46
3365466|NCT03977155|4096598|FG002|COMPLETED|Overall Study||40
3365467|NCT03977155|4096596|FG000|NOT COMPLETED|Overall Study||5
3365468|NCT03977155|4096597|FG001|NOT COMPLETED|Overall Study||2
3365469|NCT03977155|4096598|FG002|NOT COMPLETED|Overall Study||2
3365470|NCT03974802|4096608|FG000|STARTED|Overall Study||41
3365471|NCT03974802|4096608|FG000|COMPLETED|Overall Study||41
3365472|NCT03974802|4096608|FG000|NOT COMPLETED|Overall Study||0
3365473|NCT03970733|4096620|FG000|STARTED|Overall Study||97
3365474|NCT03970733|4096621|FG001|STARTED|Overall Study||98
3365475|NCT03970733|4096622|FG002|STARTED|Overall Study||51
3365476|NCT03970733|4096620|FG000|COMPLETED|Overall Study||93
3365477|NCT03970733|4096621|FG001|COMPLETED|Overall Study||92
3365478|NCT03970733|4096622|FG002|COMPLETED|Overall Study||49
3365479|NCT03970733|4096620|FG000|NOT COMPLETED|Overall Study||4
3365480|NCT03970733|4096621|FG001|NOT COMPLETED|Overall Study||6
3365481|NCT03970733|4096622|FG002|NOT COMPLETED|Overall Study||2
3365482|NCT03968978|4096632|FG000|STARTED|Overall Study||111
3365483|NCT03968978|4096633|FG001|STARTED|Overall Study||105
3365484|NCT03968978|4096632|FG000|COMPLETED|Overall Study||110
3365485|NCT03968978|4096633|FG001|COMPLETED|Overall Study||105
3365486|NCT03968978|4096632|FG000|NOT COMPLETED|Overall Study||1
3365487|NCT03968978|4096633|FG001|NOT COMPLETED|Overall Study||0
3365488|NCT03968848|4096641|FG000|STARTED|Overall Study||8
3365489|NCT03968848|4096642|FG001|STARTED|Overall Study||8
3365490|NCT03968848|4096641|FG000|COMPLETED|Overall Study||8
3365491|NCT03968848|4096642|FG001|COMPLETED|Overall Study||8
3365492|NCT03968848|4096641|FG000|NOT COMPLETED|Overall Study||0
3365493|NCT03968848|4096642|FG001|NOT COMPLETED|Overall Study||0
3365494|NCT03967444|4096650|FG000|STARTED|Overall Study||19
3365495|NCT03967444|4096651|FG001|STARTED|Overall Study||40
3365496|NCT03967444|4096650|FG000|COMPLETED|Overall Study||18
3365497|NCT03967444|4096651|FG001|COMPLETED|Overall Study||38
3365498|NCT03967444|4096650|FG000|NOT COMPLETED|Overall Study||1
3365499|NCT03967444|4096651|FG001|NOT COMPLETED|Overall Study||2
3365500|NCT03966924|4096657|FG000|STARTED|Overall Study||2
3365501|NCT03966924|4096657|FG000|COMPLETED|Overall Study||2
3365502|NCT03966924|4096657|FG000|NOT COMPLETED|Overall Study||0
3365503|NCT03966911|4096663|FG000|STARTED|Overall Study||169
3365504|NCT03966911|4096664|FG001|STARTED|Overall Study||142
3365505|NCT03966911|4096663|FG000|COMPLETED|Overall Study||160
3365506|NCT03966911|4096664|FG001|COMPLETED|Overall Study||126
3365507|NCT03966911|4096663|FG000|NOT COMPLETED|Overall Study||9
3204034|NCT02147158|3933538|FG005|COMPLETED|Off-Treatment Interval 2||39
3204035|NCT02147158|3933533|FG000|NOT COMPLETED|Off-Treatment Interval 2||4
3204036|NCT02147158|3933534|FG001|NOT COMPLETED|Off-Treatment Interval 2||4
3204037|NCT02147158|3933535|FG002|NOT COMPLETED|Off-Treatment Interval 2||10
3204038|NCT02147158|3933536|FG003|NOT COMPLETED|Off-Treatment Interval 2||11
3204039|NCT02147158|3933537|FG004|NOT COMPLETED|Off-Treatment Interval 2||2
3204040|NCT02147158|3933538|FG005|NOT COMPLETED|Off-Treatment Interval 2||4
3204041|NCT02147197|3933558|FG000|STARTED|Overall Study||56
3204042|NCT02147197|3933559|FG001|STARTED|Overall Study||53
3204043|NCT02147197|3933560|FG002|STARTED|Overall Study||48
3204044|NCT02147197|3933558|FG000|COMPLETED|Overall Study||47
3204045|NCT02147197|3933559|FG001|COMPLETED|Overall Study||47
3204046|NCT02147197|3933560|FG002|COMPLETED|Overall Study||39
3204047|NCT02147197|3933558|FG000|NOT COMPLETED|Overall Study||9
3204048|NCT02147197|3933559|FG001|NOT COMPLETED|Overall Study||6
3204049|NCT02147197|3933560|FG002|NOT COMPLETED|Overall Study||9
3204050|NCT02147288|3933570|FG000|STARTED|Overall Study||22
3204051|NCT02147288|3933571|FG001|STARTED|Overall Study||24
3204052|NCT02147288|3933572|FG002|STARTED|Overall Study||0
3204053|NCT02147288|3933573|FG003|STARTED|Overall Study||0
3204054|NCT02147288|3933574|FG004|STARTED|Overall Study||0
3204055|NCT02147288|3933575|FG005|STARTED|Overall Study||0
3204056|NCT02147288|3933576|FG006|STARTED|Overall Study||0
3204057|NCT02147288|3933577|FG007|STARTED|Overall Study||0
3204058|NCT02147288|3933578|FG008|STARTED|Overall Study||0
3204059|NCT02147288|3933579|FG009|STARTED|Overall Study||0
3204060|NCT02147288|3933570|FG000|COMPLETED|Overall Study||21
3204061|NCT02147288|3933571|FG001|COMPLETED|Overall Study||22
3204062|NCT02147288|3933572|FG002|COMPLETED|Overall Study||0
3204063|NCT02147288|3933573|FG003|COMPLETED|Overall Study||0
3204064|NCT02147288|3933574|FG004|COMPLETED|Overall Study||0
3204065|NCT02147288|3933575|FG005|COMPLETED|Overall Study||0
3204066|NCT02147288|3933576|FG006|COMPLETED|Overall Study||0
3204067|NCT02147288|3933577|FG007|COMPLETED|Overall Study||0
3204068|NCT02147288|3933578|FG008|COMPLETED|Overall Study||0
3204069|NCT02147288|3933579|FG009|COMPLETED|Overall Study||0
3204070|NCT02147288|3933570|FG000|NOT COMPLETED|Overall Study||1
3204071|NCT02147288|3933571|FG001|NOT COMPLETED|Overall Study||2
3204072|NCT02147288|3933572|FG002|NOT COMPLETED|Overall Study||0
3204073|NCT02147288|3933573|FG003|NOT COMPLETED|Overall Study||0
3204074|NCT02147288|3933574|FG004|NOT COMPLETED|Overall Study||0
3204075|NCT02147288|3933575|FG005|NOT COMPLETED|Overall Study||0
3204076|NCT02147288|3933576|FG006|NOT COMPLETED|Overall Study||0
3204077|NCT02147288|3933577|FG007|NOT COMPLETED|Overall Study||0
3204078|NCT02147288|3933578|FG008|NOT COMPLETED|Overall Study||0
3204079|NCT02147288|3933579|FG009|NOT COMPLETED|Overall Study||0
3204080|NCT02147301|3933585|FG000|STARTED|Overall Study||17
3204081|NCT02147301|3933585|FG000|COMPLETED|Overall Study||17
3204082|NCT02147301|3933585|FG000|NOT COMPLETED|Overall Study||0
3204083|NCT02147353|3933591|FG000|STARTED|Overall Study||21
3204084|NCT02147353|3933592|FG001|STARTED|Overall Study||21
3204085|NCT02147353|3933591|FG000|COMPLETED|Overall Study||12
3204086|NCT02147353|3933592|FG001|COMPLETED|Overall Study||21
3204087|NCT02147353|3933591|FG000|NOT COMPLETED|Overall Study||9
3204088|NCT02147353|3933592|FG001|NOT COMPLETED|Overall Study||0
3204089|NCT02147522|3933600|FG000|STARTED|Overall Study||178
3204090|NCT02147522|3933601|FG001|STARTED|Overall Study||170
3204091|NCT02147522|3933600|FG000|COMPLETED|Overall Study||122
3204092|NCT02147522|3933601|FG001|COMPLETED|Overall Study||122
3204093|NCT02147522|3933600|FG000|NOT COMPLETED|Overall Study||56
3204094|NCT02147522|3933601|FG001|NOT COMPLETED|Overall Study||48
3204095|NCT02147561|3933607|FG000|STARTED|Overall Study||280
3204096|NCT02147561|3933607|FG000|COMPLETED|Overall Study||276
3204097|NCT02147561|3933607|FG000|NOT COMPLETED|Overall Study||4
3204098|NCT02147587|3933613|FG000|STARTED|Overall Study||57
3204099|NCT02147587|3933614|FG001|STARTED|Overall Study||55
3204100|NCT02147587|3933613|FG000|COMPLETED|Overall Study||46
3204101|NCT02147587|3933614|FG001|COMPLETED|Overall Study||50
3204102|NCT02147587|3933613|FG000|NOT COMPLETED|Overall Study||11
3204103|NCT02147587|3933614|FG001|NOT COMPLETED|Overall Study||5
3204104|NCT02147613|3933622|FG000|STARTED|Overall Study||10
3204105|NCT02147613|3933623|FG001|STARTED|Overall Study||9
3204106|NCT02147613|3933622|FG000|COMPLETED|Overall Study||9
3204107|NCT02147613|3933623|FG001|COMPLETED|Overall Study||6
3204108|NCT02147613|3933622|FG000|NOT COMPLETED|Overall Study||1
3204109|NCT02147613|3933623|FG001|NOT COMPLETED|Overall Study||3
3204110|NCT02147626|3933631|FG000|STARTED|Overall Study||75
3204111|NCT02147626|3933632|FG001|STARTED|Overall Study||76
3204112|NCT02147626|3933631|FG000|COMPLETED|Overall Study||70
3204113|NCT02147626|3933632|FG001|COMPLETED|Overall Study||69
3204114|NCT02147626|3933631|FG000|NOT COMPLETED|Overall Study||5
3204115|NCT02147626|3933632|FG001|NOT COMPLETED|Overall Study||7
3204116|NCT02147691|3933640|FG000|STARTED|Overall Study||10
3204117|NCT02147691|3933641|FG001|STARTED|Overall Study||12
3204118|NCT02147691|3933640|FG000|COMPLETED|Overall Study||6
3204119|NCT02147691|3933641|FG001|COMPLETED|Overall Study||11
3204120|NCT02147691|3933640|FG000|NOT COMPLETED|Overall Study||4
3204121|NCT02147691|3933641|FG001|NOT COMPLETED|Overall Study||1
3204122|NCT02147769|3933647|FG000|STARTED|Overall Study||111
3204123|NCT02147769|3933647|FG000|COMPLETED|Overall Study||111
3204124|NCT02147769|3933647|FG000|NOT COMPLETED|Overall Study||0
3204125|NCT02147899|3933654|FG000|STARTED|Overall Study||71
3204126|NCT02147899|3933655|FG001|STARTED|Overall Study||72
3204127|NCT02147899|3933656|FG002|STARTED|Overall Study||72
3204128|NCT02147899|3933654|FG000|COMPLETED|Overall Study||71
3204129|NCT02147899|3933655|FG001|COMPLETED|Overall Study||72
3204130|NCT02147899|3933656|FG002|COMPLETED|Overall Study||72
3204131|NCT02147899|3933654|FG000|NOT COMPLETED|Overall Study||0
3204132|NCT02147899|3933655|FG001|NOT COMPLETED|Overall Study||0
3204133|NCT02147899|3933656|FG002|NOT COMPLETED|Overall Study||0
3204134|NCT02147990|3933667|FG000|STARTED|Overall Study||154
3204135|NCT02147990|3933668|FG001|STARTED|Overall Study||100
3204136|NCT02147990|3933669|FG002|STARTED|Overall Study||63
3204137|NCT02147990|3933667|FG000|COMPLETED|Overall Study||154
3204138|NCT02147990|3933668|FG001|COMPLETED|Overall Study||100
3204139|NCT02147990|3933669|FG002|COMPLETED|Overall Study||63
3204140|NCT02147990|3933667|FG000|NOT COMPLETED|Overall Study||0
3204141|NCT02147990|3933668|FG001|NOT COMPLETED|Overall Study||0
3204142|NCT02147990|3933669|FG002|NOT COMPLETED|Overall Study||0
3204143|NCT02148107|3933681|FG000|STARTED|Overall Study||8
3204144|NCT02148107|3933682|FG001|STARTED|Overall Study||7
3204145|NCT02148107|3933683|FG002|STARTED|Overall Study||3
3204146|NCT02148107|3933681|FG000|COMPLETED|Overall Study||8
3204147|NCT02148107|3933682|FG001|COMPLETED|Overall Study||7
3204148|NCT02148107|3933683|FG002|COMPLETED|Overall Study||3
3204149|NCT02148107|3933681|FG000|NOT COMPLETED|Overall Study||0
3204150|NCT02148107|3933682|FG001|NOT COMPLETED|Overall Study||0
3204151|NCT02148107|3933683|FG002|NOT COMPLETED|Overall Study||0
3204152|NCT02148211|3933691|FG000|STARTED|Overall Study||507
3204153|NCT02148211|3933691|FG000|COMPLETED|Overall Study||155
3204154|NCT02148211|3933691|FG000|NOT COMPLETED|Overall Study||352
3204155|NCT02148250|3933695|FG000|STARTED|Screening||17
3204156|NCT02148250|3933696|FG001|STARTED|Screening||0
3204157|NCT02148250|3933695|FG000|COMPLETED|Screening||12
3204158|NCT02148250|3933696|FG001|COMPLETED|Screening||0
3204159|NCT02148250|3933695|FG000|NOT COMPLETED|Screening||5
3204160|NCT02148250|3933696|FG001|NOT COMPLETED|Screening||0
3204161|NCT02148250|3933695|FG000|STARTED|Period 1||6
3204162|NCT02148250|3933696|FG001|STARTED|Period 1||6
3204163|NCT02148250|3933695|FG000|COMPLETED|Period 1||6
3204164|NCT02148250|3933696|FG001|COMPLETED|Period 1||6
3204165|NCT02148250|3933695|FG000|NOT COMPLETED|Period 1||0
3204166|NCT02148250|3933696|FG001|NOT COMPLETED|Period 1||0
3204167|NCT02148250|3933695|FG000|STARTED|Period 2||6
3204168|NCT02148250|3933696|FG001|STARTED|Period 2||6
3204169|NCT02148250|3933695|FG000|COMPLETED|Period 2||6
3204170|NCT02148250|3933696|FG001|COMPLETED|Period 2||6
3204171|NCT02148250|3933695|FG000|NOT COMPLETED|Period 2||0
3204172|NCT02148250|3933696|FG001|NOT COMPLETED|Period 2||0
3204173|NCT02148302|3933705|FG000|STARTED|Overall Study||57
3204174|NCT02148302|3933706|FG001|STARTED|Overall Study||66
3204175|NCT02148302|3933705|FG000|COMPLETED|Overall Study||57
3204176|NCT02148302|3933706|FG001|COMPLETED|Overall Study||66
3204177|NCT02148302|3933705|FG000|NOT COMPLETED|Overall Study||0
3204178|NCT02148302|3933706|FG001|NOT COMPLETED|Overall Study||0
3204179|NCT02148445|3933714|FG000|STARTED|Overall Study||198
3204180|NCT02148445|3933715|FG001|STARTED|Overall Study||200
3204181|NCT02148445|3933714|FG000|COMPLETED|Overall Study||197
3204182|NCT02148445|3933715|FG001|COMPLETED|Overall Study||197
3204183|NCT02148445|3933714|FG000|NOT COMPLETED|Overall Study||1
3204184|NCT02148445|3933715|FG001|NOT COMPLETED|Overall Study||3
3204185|NCT02148523|3933726|FG000|STARTED|Overall Study||67
3204186|NCT02148523|3933727|FG001|STARTED|Overall Study||67
3204187|NCT02148523|3933728|FG002|STARTED|Overall Study||67
3204188|NCT02148523|3933726|FG000|COMPLETED|Overall Study||67
3204189|NCT02148523|3933727|FG001|COMPLETED|Overall Study||67
3204190|NCT02148523|3933728|FG002|COMPLETED|Overall Study||67
3204191|NCT02148523|3933726|FG000|NOT COMPLETED|Overall Study||0
3204192|NCT02148523|3933727|FG001|NOT COMPLETED|Overall Study||0
3204193|NCT02148523|3933728|FG002|NOT COMPLETED|Overall Study||0
3204194|NCT02148588|3933736|FG000|STARTED|Overall Study||8
3204195|NCT02148588|3933736|FG000|COMPLETED|Overall Study||8
3204196|NCT02148588|3933736|FG000|NOT COMPLETED|Overall Study||0
3204197|NCT02148718|3933740|FG000|STARTED|Overall Study||86
3204198|NCT02148718|3933740|FG000|COMPLETED|Overall Study||55
3204199|NCT02148718|3933740|FG000|NOT COMPLETED|Overall Study||31
3204200|NCT02148809|3933744|FG000|STARTED|Overall Study||14
3204201|NCT02148809|3933744|FG000|COMPLETED|Overall Study||14
3204202|NCT02148809|3933744|FG000|NOT COMPLETED|Overall Study||0
3204203|NCT02148835|3933751|FG000|STARTED|Overall Study||22
3204204|NCT02148835|3933752|FG001|STARTED|Overall Study||22
3204205|NCT02148835|3933751|FG000|COMPLETED|Overall Study||22
3204206|NCT02148835|3933752|FG001|COMPLETED|Overall Study||22
3204207|NCT02148835|3933751|FG000|NOT COMPLETED|Overall Study||0
3204208|NCT02148835|3933752|FG001|NOT COMPLETED|Overall Study||0
3204209|NCT02148874|3933760|FG000|STARTED|Overall Study||201
3204210|NCT02148874|3933761|FG001|STARTED|Overall Study||86
3204211|NCT02148874|3933760|FG000|COMPLETED|Overall Study||194
3204212|NCT02148874|3933761|FG001|COMPLETED|Overall Study||84
3204213|NCT02148874|3933760|FG000|NOT COMPLETED|Overall Study||7
3204214|NCT02148874|3933761|FG001|NOT COMPLETED|Overall Study||2
3204215|NCT02148952|3933769|FG000|STARTED|Assessing Eligibility and Consent||83166
3204216|NCT02148952|3933770|FG001|STARTED|Assessing Eligibility and Consent||80773
3204217|NCT02148952|3933769|FG000|COMPLETED|Assessing Eligibility and Consent||80063
3204218|NCT02148952|3933770|FG001|COMPLETED|Assessing Eligibility and Consent||77626
3204219|NCT02148952|3933769|FG000|NOT COMPLETED|Assessing Eligibility and Consent||3103
3204220|NCT02148952|3933770|FG001|NOT COMPLETED|Assessing Eligibility and Consent||3147
3204221|NCT02148952|3933769|FG000|STARTED|Follow-Up||80063
3204222|NCT02148952|3933770|FG001|STARTED|Follow-Up||77626
3204223|NCT02148952|3933769|FG000|COMPLETED|Follow-Up||79798
3204224|NCT02148952|3933770|FG001|COMPLETED|Follow-Up||77347
3204225|NCT02148952|3933769|FG000|NOT COMPLETED|Follow-Up||265
3204226|NCT02148952|3933770|FG001|NOT COMPLETED|Follow-Up||279
3204227|NCT02149108|3933786|FG000|STARTED|Overall Study|Randomised patients.|382
3204228|NCT02149108|3933787|FG001|STARTED|Overall Study|Randomised patients.|386
3204229|NCT02149108|3933786|FG000|COMPLETED|Overall Study|On-treatment at analysis cut-off date (14JUN2016).|2
3204230|NCT02149108|3933787|FG001|COMPLETED|Overall Study|On-treatment at analysis cut-off date (14JUN2016).|3
3204231|NCT02149108|3933786|FG000|NOT COMPLETED|Overall Study||380
3204232|NCT02149108|3933787|FG001|NOT COMPLETED|Overall Study||383
3204233|NCT02149173|3933793|FG000|STARTED|Overall Study||29
3204234|NCT02149173|3933793|FG000|COMPLETED|Overall Study||29
3204235|NCT02149173|3933793|FG000|NOT COMPLETED|Overall Study||0
3204236|NCT02149199|3933806|FG000|STARTED|Overall Study||1277
3204237|NCT02149199|3933807|FG001|STARTED|Overall Study||1277
3204238|NCT02149199|3933808|FG002|STARTED|Overall Study||1282
3204239|NCT02149199|3933806|FG000|COMPLETED|Overall Study||1144
3204240|NCT02149199|3933807|FG001|COMPLETED|Overall Study||1084
3204241|NCT02149199|3933808|FG002|COMPLETED|Overall Study||1135
3204242|NCT02149199|3933806|FG000|NOT COMPLETED|Overall Study||133
3204243|NCT02149199|3933807|FG001|NOT COMPLETED|Overall Study||193
3204244|NCT02149199|3933808|FG002|NOT COMPLETED|Overall Study||147
3204245|NCT02149264|3933816|FG000|STARTED|Overall Study|Of the 160 enrolled subjects, one discontinued before receiving treatment.|159
3204246|NCT02149264|3933816|FG000|COMPLETED|Overall Study||139
3204247|NCT02149264|3933816|FG000|NOT COMPLETED|Overall Study||20
3204248|NCT02149290|3933820|FG000|STARTED|Overall Study||198
3204249|NCT02149290|3933820|FG000|COMPLETED|Overall Study||198
3204250|NCT02149290|3933820|FG000|NOT COMPLETED|Overall Study||0
3204251|NCT02149303|3933826|FG000|STARTED|Overall Study||191
3204252|NCT02149303|3933826|FG000|COMPLETED|Overall Study||191
3204253|NCT02149303|3933826|FG000|NOT COMPLETED|Overall Study||0
3365508|NCT03966911|4096664|FG001|NOT COMPLETED|Overall Study||16
3365509|NCT03966365|4096674|FG000|STARTED|Overall Study||12
3365510|NCT03966365|4096675|FG001|STARTED|Overall Study||12
3365511|NCT03966365|4096674|FG000|COMPLETED|Overall Study||11
3365512|NCT03966365|4096675|FG001|COMPLETED|Overall Study||12
3365513|NCT03966365|4096674|FG000|NOT COMPLETED|Overall Study||1
3365514|NCT03966365|4096675|FG001|NOT COMPLETED|Overall Study||0
3365515|NCT03965403|4096681|FG000|STARTED|Overall Study||7
3365516|NCT03965403|4096681|FG000|COMPLETED|Overall Study||6
3365517|NCT03965403|4096681|FG000|NOT COMPLETED|Overall Study||1
3365518|NCT03965754|4096689|FG000|STARTED|Overall Study||1422
3365519|NCT03965754|4096690|FG001|STARTED|Overall Study||1425
3365520|NCT03965754|4096691|FG002|STARTED|Overall Study||1425
3365521|NCT03965754|4096692|FG003|STARTED|Overall Study||1425
3365522|NCT03965754|4096689|FG000|COMPLETED|Overall Study||1422
3365523|NCT03965754|4096690|FG001|COMPLETED|Overall Study||1425
3365524|NCT03965754|4096691|FG002|COMPLETED|Overall Study||1425
3365525|NCT03965754|4096692|FG003|COMPLETED|Overall Study||1425
3365526|NCT03965754|4096689|FG000|NOT COMPLETED|Overall Study||0
3365527|NCT03965754|4096690|FG001|NOT COMPLETED|Overall Study||0
3365528|NCT03965754|4096691|FG002|NOT COMPLETED|Overall Study||0
3365529|NCT03965754|4096692|FG003|NOT COMPLETED|Overall Study||0
3365530|NCT03965533|4096709|FG000|STARTED|Part A (112 Days)||2
3365531|NCT03965533|4096710|FG001|STARTED|Part A (112 Days)||6
3365532|NCT03965533|4096711|FG002|STARTED|Part A (112 Days)||2
3365533|NCT03965533|4096712|FG003|STARTED|Part A (112 Days)||6
3365534|NCT03965533|4096713|FG004|STARTED|Part A (112 Days)||0
3365535|NCT03965533|4096714|FG005|STARTED|Part A (112 Days)||0
3365536|NCT03965533|4096715|FG006|STARTED|Part A (112 Days)||0
3365537|NCT03965533|4096709|FG000|COMPLETED|Part A (112 Days)||2
3365538|NCT03965533|4096710|FG001|COMPLETED|Part A (112 Days)||6
3365539|NCT03965533|4096711|FG002|COMPLETED|Part A (112 Days)||2
3365540|NCT03965533|4096712|FG003|COMPLETED|Part A (112 Days)||6
3365541|NCT03965533|4096713|FG004|COMPLETED|Part A (112 Days)||0
3365542|NCT03965533|4096714|FG005|COMPLETED|Part A (112 Days)||0
3365543|NCT03965533|4096715|FG006|COMPLETED|Part A (112 Days)||0
3365544|NCT03965533|4096709|FG000|NOT COMPLETED|Part A (112 Days)||0
3365545|NCT03965533|4096710|FG001|NOT COMPLETED|Part A (112 Days)||0
3365546|NCT03965533|4096711|FG002|NOT COMPLETED|Part A (112 Days)||0
3365547|NCT03965533|4096712|FG003|NOT COMPLETED|Part A (112 Days)||0
3365548|NCT03965533|4096713|FG004|NOT COMPLETED|Part A (112 Days)||0
3365549|NCT03965533|4096714|FG005|NOT COMPLETED|Part A (112 Days)||0
3365550|NCT03965533|4096715|FG006|NOT COMPLETED|Part A (112 Days)||0
3365551|NCT03965533|4096709|FG000|STARTED|Part B (112 Days)||0
3365552|NCT03965533|4096710|FG001|STARTED|Part B (112 Days)||0
3365553|NCT03965533|4096711|FG002|STARTED|Part B (112 Days)||0
3365554|NCT03965533|4096712|FG003|STARTED|Part B (112 Days)||0
3365555|NCT03965533|4096713|FG004|STARTED|Part B (112 Days)||4
3365556|NCT03965533|4096714|FG005|STARTED|Part B (112 Days)||8
3365557|NCT03965533|4096715|FG006|STARTED|Part B (112 Days)||8
3365558|NCT03965533|4096709|FG000|COMPLETED|Part B (112 Days)||0
3365559|NCT03965533|4096710|FG001|COMPLETED|Part B (112 Days)||0
3365560|NCT03965533|4096711|FG002|COMPLETED|Part B (112 Days)||0
3365561|NCT03965533|4096712|FG003|COMPLETED|Part B (112 Days)||0
3365562|NCT03965533|4096713|FG004|COMPLETED|Part B (112 Days)||4
3365563|NCT03965533|4096714|FG005|COMPLETED|Part B (112 Days)||8
3365564|NCT03965533|4096715|FG006|COMPLETED|Part B (112 Days)||8
3204254|NCT02149342|3933830|FG000|STARTED|Overall Study|14 patients|14
3204255|NCT02149342|3933830|FG000|COMPLETED|Overall Study|14 patients|14
3204256|NCT02149342|3933830|FG000|NOT COMPLETED|Overall Study||0
3204257|NCT02149420|3933840|FG000|STARTED|Core Study||9
3204258|NCT02149420|3933841|FG001|STARTED|Core Study||6
3204259|NCT02149420|3933842|FG002|STARTED|Core Study||12
3204260|NCT02149420|3933840|FG000|Safety Analysis Set|Core Study||9
3204261|NCT02149420|3933841|FG001|Safety Analysis Set|Core Study||6
3204262|NCT02149420|3933842|FG002|Safety Analysis Set|Core Study||12
3204263|NCT02149420|3933840|FG000|PK Analysis Set|Core Study|for patients entering open label VAY736 10 mg/kg at Week 24|5
3204264|NCT02149420|3933841|FG001|PK Analysis Set|Core Study||6
3204265|NCT02149420|3933842|FG002|PK Analysis Set|Core Study||12
3204266|NCT02149420|3933840|FG000|PD (Pharmacodynamics) Analysis Set|Core Study||9
3204267|NCT02149420|3933841|FG001|PD (Pharmacodynamics) Analysis Set|Core Study||6
3204268|NCT02149420|3933842|FG002|PD (Pharmacodynamics) Analysis Set|Core Study||12
3204269|NCT02149420|3933840|FG000|COMPLETED|Core Study||9
3204270|NCT02149420|3933841|FG001|COMPLETED|Core Study||5
3204271|NCT02149420|3933842|FG002|COMPLETED|Core Study||10
3204272|NCT02149420|3933840|FG000|NOT COMPLETED|Core Study||0
3204273|NCT02149420|3933841|FG001|NOT COMPLETED|Core Study||1
3204274|NCT02149420|3933842|FG002|NOT COMPLETED|Core Study||2
3204275|NCT02149420|3933840|FG000|STARTED|Open Label VAY736 10 mg/kg Extension|Patients received single dose of VAY736 10mg/kg at Week 24.|5
3204276|NCT02149420|3933841|FG001|STARTED|Open Label VAY736 10 mg/kg Extension|Only patients origianally randomized to Placebo were allowed to enter this Period.|0
3204277|NCT02149420|3933842|FG002|STARTED|Open Label VAY736 10 mg/kg Extension|Only patients origianally randomized to Placebo were allowed to enter this Period.|0
3204278|NCT02149420|3933840|FG000|COMPLETED|Open Label VAY736 10 mg/kg Extension||4
3204279|NCT02149420|3933841|FG001|COMPLETED|Open Label VAY736 10 mg/kg Extension||0
3204280|NCT02149420|3933842|FG002|COMPLETED|Open Label VAY736 10 mg/kg Extension||0
3204281|NCT02149420|3933840|FG000|NOT COMPLETED|Open Label VAY736 10 mg/kg Extension||1
3204282|NCT02149420|3933841|FG001|NOT COMPLETED|Open Label VAY736 10 mg/kg Extension||0
3204283|NCT02149420|3933842|FG002|NOT COMPLETED|Open Label VAY736 10 mg/kg Extension||0
3204284|NCT02149524|3933857|FG000|STARTED|Overall Study||438
3204285|NCT02149524|3933858|FG001|STARTED|Overall Study||437
3204286|NCT02149524|3933857|FG000|COMPLETED|Overall Study||384
3204287|NCT02149524|3933858|FG001|COMPLETED|Overall Study||380
3204288|NCT02149524|3933857|FG000|NOT COMPLETED|Overall Study||54
3204289|NCT02149524|3933858|FG001|NOT COMPLETED|Overall Study||57
3204290|NCT02149810|3933866|FG000|STARTED|Overall Study||48
3204291|NCT02149810|3933867|FG001|STARTED|Overall Study||47
3204292|NCT02149810|3933866|FG000|Baseline|Overall Study||47
3204293|NCT02149810|3933867|FG001|Baseline|Overall Study||44
3204294|NCT02149810|3933866|FG000|Week 4|Overall Study||43
3204295|NCT02149810|3933867|FG001|Week 4|Overall Study||42
3204296|NCT02149810|3933866|FG000|Week 8|Overall Study||40
3204297|NCT02149810|3933867|FG001|Week 8|Overall Study||43
3204298|NCT02149810|3933866|FG000|Week 12|Overall Study||40
3204299|NCT02149810|3933867|FG001|Week 12|Overall Study||43
3204300|NCT02149810|3933866|FG000|Week 24|Overall Study||31
3204301|NCT02149810|3933867|FG001|Week 24|Overall Study|Not applicable study was amended such that week 24 data was not collected for TAU participants.|0
3204302|NCT02149810|3933866|FG000|COMPLETED|Overall Study||40
3204303|NCT02149810|3933867|FG001|COMPLETED|Overall Study||43
3204304|NCT02149810|3933866|FG000|NOT COMPLETED|Overall Study||8
3204305|NCT02149810|3933867|FG001|NOT COMPLETED|Overall Study||4
3204306|NCT02149836|3933873|FG000|STARTED|Overall Study||18
3204307|NCT02149836|3933873|FG000|COMPLETED|Overall Study||17
3204308|NCT02149836|3933873|FG000|NOT COMPLETED|Overall Study||1
3204309|NCT02149875|3933880|FG000|STARTED|Overall Study||27
3204310|NCT02149875|3933881|FG001|STARTED|Overall Study||28
3204311|NCT02149875|3933882|FG002|STARTED|Overall Study||29
3204312|NCT02149875|3933880|FG000|COMPLETED|Overall Study||20
3204313|NCT02149875|3933881|FG001|COMPLETED|Overall Study||20
3204314|NCT02149875|3933882|FG002|COMPLETED|Overall Study||20
3204315|NCT02149875|3933880|FG000|NOT COMPLETED|Overall Study||7
3204316|NCT02149875|3933881|FG001|NOT COMPLETED|Overall Study||8
3204317|NCT02149875|3933882|FG002|NOT COMPLETED|Overall Study||9
3204318|NCT02150044|3933890|FG000|STARTED|Overall Study||29
3204319|NCT02150044|3933890|FG000|Lead-In Subjects|Overall Study||16
3204320|NCT02150044|3933890|FG000|Study Cohort|Overall Study||13
3204321|NCT02150044|3933890|FG000|COMPLETED|Overall Study||29
3204322|NCT02150044|3933890|FG000|NOT COMPLETED|Overall Study||0
3204323|NCT02150057|3933896|FG000|STARTED|Overall Study||25
3204324|NCT02150057|3933897|FG001|STARTED|Overall Study||26
3204325|NCT02150057|3933896|FG000|COMPLETED|Overall Study||19
3204326|NCT02150057|3933897|FG001|COMPLETED|Overall Study||22
3204327|NCT02150057|3933896|FG000|NOT COMPLETED|Overall Study||6
3204328|NCT02150057|3933897|FG001|NOT COMPLETED|Overall Study||4
3204329|NCT02150109|3933903|FG000|STARTED|Overall Study||372
3204330|NCT02150109|3933903|FG000|COMPLETED|Overall Study||372
3204331|NCT02150109|3933903|FG000|NOT COMPLETED|Overall Study||0
3204332|NCT02150213|3933913|FG000|STARTED|Overall Study||59
3204333|NCT02150213|3933913|FG000|COMPLETED|Overall Study||57
3204334|NCT02150213|3933913|FG000|NOT COMPLETED|Overall Study||2
3204335|NCT02150343|3933921|FG000|STARTED|Overall Study||180
3204336|NCT02150343|3933922|FG001|STARTED|Overall Study||178
3204337|NCT02150343|3933923|FG002|STARTED|Overall Study||178
3204338|NCT02150343|3933924|FG003|STARTED|Overall Study||178
3204339|NCT02150343|3933921|FG000|COMPLETED|Overall Study||159
3204340|NCT02150343|3933922|FG001|COMPLETED|Overall Study||158
3204341|NCT02150343|3933923|FG002|COMPLETED|Overall Study||166
3204342|NCT02150343|3933924|FG003|COMPLETED|Overall Study||168
3204343|NCT02150343|3933921|FG000|NOT COMPLETED|Overall Study||21
3204344|NCT02150343|3933922|FG001|NOT COMPLETED|Overall Study||20
3204345|NCT02150343|3933923|FG002|NOT COMPLETED|Overall Study||12
3204346|NCT02150343|3933924|FG003|NOT COMPLETED|Overall Study||10
3204347|NCT02150460|3933936|FG000|STARTED|Overall Study||50
3204348|NCT02150460|3933937|FG001|STARTED|Overall Study||50
3204349|NCT02150460|3933936|FG000|COMPLETED|Overall Study||50
3204350|NCT02150460|3933937|FG001|COMPLETED|Overall Study||50
3204351|NCT02150460|3933936|FG000|NOT COMPLETED|Overall Study||0
3204352|NCT02150460|3933937|FG001|NOT COMPLETED|Overall Study||0
3204353|NCT02150499|3933945|FG000|STARTED|Overall Study||9
3204354|NCT02150499|3933946|FG001|STARTED|Overall Study||9
3204355|NCT02150499|3933945|FG000|COMPLETED|Overall Study||9
3204356|NCT02150499|3933946|FG001|COMPLETED|Overall Study||9
3204357|NCT02150499|3933945|FG000|NOT COMPLETED|Overall Study||0
3204358|NCT02150499|3933946|FG001|NOT COMPLETED|Overall Study||0
3204359|NCT02150759|3933954|FG000|STARTED|Overall Study||23
3204360|NCT02150759|3933955|FG001|STARTED|Overall Study||23
3204361|NCT02150759|3933954|FG000|COMPLETED|Overall Study||22
3204362|NCT02150759|3933955|FG001|COMPLETED|Overall Study||21
3204363|NCT02150759|3933954|FG000|NOT COMPLETED|Overall Study||1
3204364|NCT02150759|3933955|FG001|NOT COMPLETED|Overall Study||2
3204365|NCT02150837|3933963|FG000|STARTED|Overall Study|87 Charts were screened with 25 screen failures due to exclusion criteria.|62
3204366|NCT02150837|3933964|FG001|STARTED|Overall Study|478 charts were screened with 168 screen failures due to exclusion criteria.|310
3204367|NCT02150837|3933963|FG000|COMPLETED|Overall Study|There was no predefined study period to complete. 37 remained through the 12 wk primary endpoint.|37
3204368|NCT02150837|3933964|FG001|COMPLETED|Overall Study|There was no predefined study period to complete. 185 remained through the 12 wk primary endpoint.|185
3204369|NCT02150837|3933963|FG000|NOT COMPLETED|Overall Study||25
3204370|NCT02150837|3933964|FG001|NOT COMPLETED|Overall Study||125
3204371|NCT02150954|3933972|FG000|STARTED|Overall Study||58
3204372|NCT02150954|3933973|FG001|STARTED|Overall Study||59
3204373|NCT02150954|3933972|FG000|COMPLETED|Overall Study||57
3204374|NCT02150954|3933973|FG001|COMPLETED|Overall Study||59
3204375|NCT02150954|3933972|FG000|NOT COMPLETED|Overall Study||1
3204376|NCT02150954|3933973|FG001|NOT COMPLETED|Overall Study||0
3204377|NCT02151058|3933982|FG000|STARTED|Overall Study||45
3204378|NCT02151058|3933983|FG001|STARTED|Overall Study||91
3204379|NCT02151058|3933984|FG002|STARTED|Overall Study||91
3204380|NCT02151058|3933982|FG000|COMPLETED|Overall Study||43
3204381|NCT02151058|3933983|FG001|COMPLETED|Overall Study||90
3204382|NCT02151058|3933984|FG002|COMPLETED|Overall Study||86
3204383|NCT02151058|3933982|FG000|NOT COMPLETED|Overall Study||2
3204384|NCT02151058|3933983|FG001|NOT COMPLETED|Overall Study||1
3204385|NCT02151058|3933984|FG002|NOT COMPLETED|Overall Study||5
3204386|NCT02151110|3934000|FG000|STARTED|Overall Study||12
3204387|NCT02151110|3934001|FG001|STARTED|Overall Study||2
3204388|NCT02151110|3934002|FG002|STARTED|Overall Study||2
3204389|NCT02151110|3934003|FG003|STARTED|Overall Study||8
3204390|NCT02151110|3934004|FG004|STARTED|Overall Study||8
3204391|NCT02151110|3934005|FG005|STARTED|Overall Study||8
3204392|NCT02151110|3934006|FG006|STARTED|Overall Study||8
3204393|NCT02151110|3934007|FG007|STARTED|Overall Study||8
3204394|NCT02151110|3934000|FG000|COMPLETED|Overall Study||12
3204395|NCT02151110|3934001|FG001|COMPLETED|Overall Study||2
3204396|NCT02151110|3934002|FG002|COMPLETED|Overall Study||2
3204397|NCT02151110|3934003|FG003|COMPLETED|Overall Study||8
3204398|NCT02151110|3934004|FG004|COMPLETED|Overall Study||8
3204399|NCT02151110|3934005|FG005|COMPLETED|Overall Study||8
3204400|NCT02151110|3934006|FG006|COMPLETED|Overall Study||8
3204401|NCT02151110|3934007|FG007|COMPLETED|Overall Study||5
3204402|NCT02151110|3934000|FG000|NOT COMPLETED|Overall Study||0
3204403|NCT02151110|3934001|FG001|NOT COMPLETED|Overall Study||0
3204404|NCT02151110|3934002|FG002|NOT COMPLETED|Overall Study||0
3204405|NCT02151110|3934003|FG003|NOT COMPLETED|Overall Study||0
3204406|NCT02151110|3934004|FG004|NOT COMPLETED|Overall Study||0
3204407|NCT02151110|3934005|FG005|NOT COMPLETED|Overall Study||0
3204408|NCT02151110|3934006|FG006|NOT COMPLETED|Overall Study||0
3204409|NCT02151110|3934007|FG007|NOT COMPLETED|Overall Study||3
3204410|NCT02151149|3934034|FG000|STARTED|Treatment Period|3 participants did not receive treatment|71
3204411|NCT02151149|3934035|FG001|STARTED|Treatment Period|2 participants did not receive treatment|72
3204412|NCT02151149|3934034|FG000|Treated Population|Treatment Period||68
3204413|NCT02151149|3934035|FG001|Treated Population|Treatment Period||70
3204414|NCT02151149|3934034|FG000|COMPLETED|Treatment Period||1
3204415|NCT02151149|3934035|FG001|COMPLETED|Treatment Period||1
3204416|NCT02151149|3934034|FG000|NOT COMPLETED|Treatment Period||70
3204417|NCT02151149|3934035|FG001|NOT COMPLETED|Treatment Period||71
3204418|NCT02151149|3934034|FG000|STARTED|Follow-Up Period||58
3204419|NCT02151149|3934035|FG001|STARTED|Follow-Up Period||55
3204420|NCT02151149|3934034|FG000|COMPLETED|Follow-Up Period|Completed = participants alive at final data cut-off date|19
3204421|NCT02151149|3934035|FG001|COMPLETED|Follow-Up Period|Completed = participants alive at final data cut-off date|18
3204422|NCT02151149|3934034|FG000|NOT COMPLETED|Follow-Up Period||39
3204423|NCT02151149|3934035|FG001|NOT COMPLETED|Follow-Up Period||37
3204424|NCT02151253|3934041|FG000|STARTED|Overall Study||13
3365565|NCT03965533|4096709|FG000|NOT COMPLETED|Part B (112 Days)||0
3204425|NCT02151253|3934042|FG001|STARTED|Overall Study||15
3204426|NCT02151253|3934041|FG000|COMPLETED|Overall Study||13
3204427|NCT02151253|3934042|FG001|COMPLETED|Overall Study||15
3204428|NCT02151253|3934041|FG000|NOT COMPLETED|Overall Study||0
3204429|NCT02151253|3934042|FG001|NOT COMPLETED|Overall Study||0
3204430|NCT02151266|3934051|FG000|STARTED|Overall Study||19
3204431|NCT02151266|3934052|FG001|STARTED|Overall Study||29
3204432|NCT02151266|3934053|FG002|STARTED|Overall Study||21
3204433|NCT02151266|3934051|FG000|COMPLETED|Overall Study||11
3204434|NCT02151266|3934052|FG001|COMPLETED|Overall Study||14
3204435|NCT02151266|3934053|FG002|COMPLETED|Overall Study||14
3204436|NCT02151266|3934051|FG000|NOT COMPLETED|Overall Study||8
3204437|NCT02151266|3934052|FG001|NOT COMPLETED|Overall Study||15
3204438|NCT02151266|3934053|FG002|NOT COMPLETED|Overall Study||7
3204439|NCT02151331|3934063|FG000|STARTED|Overall Study||77
3204440|NCT02151331|3934064|FG001|STARTED|Overall Study||92
3204441|NCT02151331|3934063|FG000|COMPLETED|Overall Study||45
3204442|NCT02151331|3934064|FG001|COMPLETED|Overall Study||52
3204443|NCT02151331|3934063|FG000|NOT COMPLETED|Overall Study||32
3204444|NCT02151331|3934064|FG001|NOT COMPLETED|Overall Study||40
3204445|NCT02151448|3934070|FG000|STARTED|Phase 1||9
3204446|NCT02151448|3934070|FG000|COMPLETED|Phase 1||9
3204447|NCT02151448|3934070|FG000|NOT COMPLETED|Phase 1||0
3204448|NCT02151448|3934070|FG000|STARTED|Phase 2||55
3204449|NCT02151448|3934070|FG000|COMPLETED|Phase 2||55
3204450|NCT02151448|3934070|FG000|NOT COMPLETED|Phase 2||0
3204451|NCT02151461|3934082|FG000|STARTED|Overall Study||24
3204452|NCT02151461|3934083|FG001|STARTED|Overall Study||25
3204453|NCT02151461|3934084|FG002|STARTED|Overall Study||24
3204454|NCT02151461|3934085|FG003|STARTED|Overall Study||23
3204455|NCT02151461|3934082|FG000|COMPLETED|Overall Study||18
3204456|NCT02151461|3934083|FG001|COMPLETED|Overall Study||24
3204457|NCT02151461|3934084|FG002|COMPLETED|Overall Study||21
3204458|NCT02151461|3934085|FG003|COMPLETED|Overall Study||19
3204459|NCT02151461|3934082|FG000|NOT COMPLETED|Overall Study||6
3204460|NCT02151461|3934083|FG001|NOT COMPLETED|Overall Study||1
3204461|NCT02151461|3934084|FG002|NOT COMPLETED|Overall Study||3
3204462|NCT02151461|3934085|FG003|NOT COMPLETED|Overall Study||4
3204463|NCT02151487|3934099|FG000|STARTED|Overall Study||27
3204464|NCT02151487|3934100|FG001|STARTED|Overall Study||27
3204465|NCT02151487|3934101|FG002|STARTED|Overall Study||20
3204466|NCT02151487|3934102|FG003|STARTED|Overall Study||23
3204467|NCT02151487|3934099|FG000|COMPLETED|Overall Study||25
3204468|NCT02151487|3934100|FG001|COMPLETED|Overall Study||22
3204469|NCT02151487|3934101|FG002|COMPLETED|Overall Study||16
3204470|NCT02151487|3934102|FG003|COMPLETED|Overall Study||20
3204471|NCT02151487|3934099|FG000|NOT COMPLETED|Overall Study||2
3204472|NCT02151487|3934100|FG001|NOT COMPLETED|Overall Study||5
3204473|NCT02151487|3934101|FG002|NOT COMPLETED|Overall Study||4
3204474|NCT02151487|3934102|FG003|NOT COMPLETED|Overall Study||3
3204475|NCT02151526|3934114|FG000|STARTED|Overall Study||3
3365566|NCT03965533|4096710|FG001|NOT COMPLETED|Part B (112 Days)||0
3365567|NCT03965533|4096711|FG002|NOT COMPLETED|Part B (112 Days)||0
3365568|NCT03965533|4096712|FG003|NOT COMPLETED|Part B (112 Days)||0
3365569|NCT03965533|4096713|FG004|NOT COMPLETED|Part B (112 Days)||0
3365570|NCT03965533|4096714|FG005|NOT COMPLETED|Part B (112 Days)||0
3365571|NCT03965533|4096715|FG006|NOT COMPLETED|Part B (112 Days)||0
3365572|NCT03965351|4096738|FG000|STARTED|First Intervention (4 Weeks)||3
3365573|NCT03965351|4096739|FG001|STARTED|First Intervention (4 Weeks)||5
3365574|NCT03965351|4096738|FG000|COMPLETED|First Intervention (4 Weeks)||3
3365575|NCT03965351|4096739|FG001|COMPLETED|First Intervention (4 Weeks)||4
3365576|NCT03965351|4096738|FG000|NOT COMPLETED|First Intervention (4 Weeks)||0
3365577|NCT03965351|4096739|FG001|NOT COMPLETED|First Intervention (4 Weeks)||1
3365578|NCT03965351|4096738|FG000|STARTED|Wash Out Period (4 Weeks)||3
3365579|NCT03965351|4096739|FG001|STARTED|Wash Out Period (4 Weeks)||4
3365580|NCT03965351|4096738|FG000|COMPLETED|Wash Out Period (4 Weeks)||3
3365581|NCT03965351|4096739|FG001|COMPLETED|Wash Out Period (4 Weeks)||4
3365582|NCT03965351|4096738|FG000|NOT COMPLETED|Wash Out Period (4 Weeks)||0
3365583|NCT03965351|4096739|FG001|NOT COMPLETED|Wash Out Period (4 Weeks)||0
3365584|NCT03965351|4096738|FG000|STARTED|Second Intervention (4 Weeks)||3
3365585|NCT03965351|4096739|FG001|STARTED|Second Intervention (4 Weeks)||4
3365586|NCT03965351|4096738|FG000|COMPLETED|Second Intervention (4 Weeks)||3
3365587|NCT03965351|4096739|FG001|COMPLETED|Second Intervention (4 Weeks)||3
3365588|NCT03965351|4096738|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||0
3365589|NCT03965351|4096739|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||1
3365590|NCT03964220|4096747|FG000|STARTED|Overall Study||2619
3365591|NCT03964220|4096748|FG001|STARTED|Overall Study||5238
3365592|NCT03964220|4096747|FG000|COMPLETED|Overall Study||2619
3365593|NCT03964220|4096748|FG001|COMPLETED|Overall Study||5238
3365594|NCT03964220|4096747|FG000|NOT COMPLETED|Overall Study||0
3365595|NCT03964220|4096748|FG001|NOT COMPLETED|Overall Study||0
3365596|NCT03958955|4096754|FG000|STARTED|Overall Study||27
3204476|NCT02151526|3934115|FG001|STARTED|Overall Study||4
3204477|NCT02151526|3934114|FG000|COMPLETED|Overall Study||3
3204478|NCT02151526|3934115|FG001|COMPLETED|Overall Study||4
3204479|NCT02151526|3934114|FG000|NOT COMPLETED|Overall Study||0
3204480|NCT02151526|3934115|FG001|NOT COMPLETED|Overall Study||0
3204481|NCT02151591|3934125|FG000|STARTED|Overall Study||13
3204482|NCT02151591|3934126|FG001|STARTED|Overall Study||13
3204483|NCT02151591|3934125|FG000|COMPLETED|Overall Study||7
3204484|NCT02151591|3934126|FG001|COMPLETED|Overall Study||10
3204485|NCT02151591|3934125|FG000|NOT COMPLETED|Overall Study||6
3204486|NCT02151591|3934126|FG001|NOT COMPLETED|Overall Study||3
3204487|NCT02151643|3934137|FG000|STARTED|Overall Study||26
3204488|NCT02151643|3934138|FG001|STARTED|Overall Study||25
3204489|NCT02151643|3934139|FG002|STARTED|Overall Study||25
3204490|NCT02151643|3934140|FG003|STARTED|Overall Study||39
3204491|NCT02151643|3934141|FG004|STARTED|Overall Study||38
3204492|NCT02151643|3934137|FG000|COMPLETED|Overall Study||20
3204493|NCT02151643|3934138|FG001|COMPLETED|Overall Study||21
3204494|NCT02151643|3934139|FG002|COMPLETED|Overall Study||21
3204495|NCT02151643|3934140|FG003|COMPLETED|Overall Study||32
3204496|NCT02151643|3934141|FG004|COMPLETED|Overall Study||35
3204497|NCT02151643|3934137|FG000|NOT COMPLETED|Overall Study||6
3204498|NCT02151643|3934138|FG001|NOT COMPLETED|Overall Study||4
3204499|NCT02151643|3934139|FG002|NOT COMPLETED|Overall Study||4
3204500|NCT02151643|3934140|FG003|NOT COMPLETED|Overall Study||7
3204501|NCT02151643|3934141|FG004|NOT COMPLETED|Overall Study||3
3204502|NCT02151682|3934155|FG000|STARTED|Part 1: 14 Days Morphine or Tapentadol||24
3204503|NCT02151682|3934156|FG001|STARTED|Part 1: 14 Days Morphine or Tapentadol||45
3204504|NCT02151682|3934157|FG002|STARTED|Part 1: 14 Days Morphine or Tapentadol|Group not defined for Part 1.|0
3204505|NCT02151682|3934158|FG003|STARTED|Part 1: 14 Days Morphine or Tapentadol|Group not defined for Part 1.|0
3204506|NCT02151682|3934159|FG004|STARTED|Part 1: 14 Days Morphine or Tapentadol|Group not defined for Part 1.|0
3204507|NCT02151682|3934160|FG005|STARTED|Part 1: 14 Days Morphine or Tapentadol|Group not defined for Part 1.|0
3204508|NCT02151682|3934155|FG000|COMPLETED|Part 1: 14 Days Morphine or Tapentadol|14-Day treatment and final post-treatment visit completed or tapentadol treatment in Part 2 entered.|22
3204509|NCT02151682|3934156|FG001|COMPLETED|Part 1: 14 Days Morphine or Tapentadol|14-Day treatment and final post-treatment visit completed or tapentadol treatment in Part 2 entered.|40
3204510|NCT02151682|3934157|FG002|COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0
3204511|NCT02151682|3934158|FG003|COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0
3204512|NCT02151682|3934159|FG004|COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0
3204513|NCT02151682|3934160|FG005|COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0
3204514|NCT02151682|3934155|FG000|NOT COMPLETED|Part 1: 14 Days Morphine or Tapentadol||2
3204515|NCT02151682|3934156|FG001|NOT COMPLETED|Part 1: 14 Days Morphine or Tapentadol||5
3204516|NCT02151682|3934157|FG002|NOT COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0
3204517|NCT02151682|3934158|FG003|NOT COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0
3204518|NCT02151682|3934159|FG004|NOT COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0
3204519|NCT02151682|3934160|FG005|NOT COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0
3204520|NCT02151682|3934155|FG000|STARTED|Part 2: Tapent. Extension or Observation|Group not defined for Part 2.|0
3204521|NCT02151682|3934156|FG001|STARTED|Part 2: Tapent. Extension or Observation|Group not defined for Part 2.|0
3204522|NCT02151682|3934157|FG002|STARTED|Part 2: Tapent. Extension or Observation|26 Completers on tapentadol PR and 10 completers on morphine PR from Part 1.|36
3204523|NCT02151682|3934158|FG003|STARTED|Part 2: Tapent. Extension or Observation|14 Completers and 4 of 5 non-completers on tapentadol in Part 1.|18
3204524|NCT02151682|3934159|FG004|STARTED|Part 2: Tapent. Extension or Observation|12 Completers and 2 non-completers from morphine treatment in Part 1.|14
3204525|NCT02151682|3934160|FG005|STARTED|Part 2: Tapent. Extension or Observation||0
3204526|NCT02151682|3934155|FG000|COMPLETED|Part 2: Tapent. Extension or Observation||0
3204527|NCT02151682|3934156|FG001|COMPLETED|Part 2: Tapent. Extension or Observation||0
3204528|NCT02151682|3934157|FG002|COMPLETED|Part 2: Tapent. Extension or Observation|12 Month of tapentadol treatment completed and final visit of Part 2 performed.|8
3204529|NCT02151682|3934158|FG003|COMPLETED|Part 2: Tapent. Extension or Observation||14
3204530|NCT02151682|3934159|FG004|COMPLETED|Part 2: Tapent. Extension or Observation||14
3204531|NCT02151682|3934160|FG005|COMPLETED|Part 2: Tapent. Extension or Observation||0
3204532|NCT02151682|3934155|FG000|NOT COMPLETED|Part 2: Tapent. Extension or Observation||0
3204533|NCT02151682|3934156|FG001|NOT COMPLETED|Part 2: Tapent. Extension or Observation||0
3204534|NCT02151682|3934157|FG002|NOT COMPLETED|Part 2: Tapent. Extension or Observation||28
3204535|NCT02151682|3934158|FG003|NOT COMPLETED|Part 2: Tapent. Extension or Observation||4
3204536|NCT02151682|3934159|FG004|NOT COMPLETED|Part 2: Tapent. Extension or Observation||0
3204537|NCT02151682|3934160|FG005|NOT COMPLETED|Part 2: Tapent. Extension or Observation||0
3204538|NCT02151682|3934155|FG000|STARTED|Part 2: Observ. Aft. Tapent. Extension|Group not defined for Part 2.|0
3204539|NCT02151682|3934156|FG001|STARTED|Part 2: Observ. Aft. Tapent. Extension|Group not defined for Part 2.|0
3204540|NCT02151682|3934157|FG002|STARTED|Part 2: Observ. Aft. Tapent. Extension|Not applicable for this period.|0
3204541|NCT02151682|3934158|FG003|STARTED|Part 2: Observ. Aft. Tapent. Extension|Not applicable for this period.|0
3204542|NCT02151682|3934159|FG004|STARTED|Part 2: Observ. Aft. Tapent. Extension|Not applicable for this period.|0
3204543|NCT02151682|3934160|FG005|STARTED|Part 2: Observ. Aft. Tapent. Extension|19 tapentadol and 7 morphine completers (Part 1) who discontinued from tapentadol treatm. in Part 2.|26
3204544|NCT02151682|3934155|FG000|COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
3204545|NCT02151682|3934156|FG001|COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
3204546|NCT02151682|3934157|FG002|COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
3204547|NCT02151682|3934158|FG003|COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
3204548|NCT02151682|3934159|FG004|COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
3204549|NCT02151682|3934160|FG005|COMPLETED|Part 2: Observ. Aft. Tapent. Extension||19
3204550|NCT02151682|3934155|FG000|NOT COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
3204551|NCT02151682|3934156|FG001|NOT COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
3204552|NCT02151682|3934157|FG002|NOT COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
3204553|NCT02151682|3934158|FG003|NOT COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
3204554|NCT02151682|3934159|FG004|NOT COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
3204555|NCT02151682|3934160|FG005|NOT COMPLETED|Part 2: Observ. Aft. Tapent. Extension||7
3204556|NCT02151773|3934178|FG000|STARTED|Overall Study||3493
3204557|NCT02151773|3934178|FG000|COMPLETED|Overall Study||3429
3204558|NCT02151773|3934178|FG000|NOT COMPLETED|Overall Study||64
3204559|NCT02151786|3934182|FG000|STARTED|Overall Study||1120
3204560|NCT02151786|3934182|FG000|COMPLETED|Overall Study||1084
3204561|NCT02151786|3934182|FG000|NOT COMPLETED|Overall Study||36
3204562|NCT02151851|3934188|FG000|STARTED|Overall Study||114
3204563|NCT02151851|3934189|FG001|STARTED|Overall Study||316
3204564|NCT02151851|3934188|FG000|Included in the Safety Set|Overall Study||113
3204565|NCT02151851|3934189|FG001|Included in the Safety Set|Overall Study||316
3204566|NCT02151851|3934188|FG000|COMPLETED|Overall Study||38
3204567|NCT02151851|3934189|FG001|COMPLETED|Overall Study||186
3204568|NCT02151851|3934188|FG000|NOT COMPLETED|Overall Study||76
3204569|NCT02151851|3934189|FG001|NOT COMPLETED|Overall Study||130
3204570|NCT02151877|3934197|FG000|STARTED|Overall Study||12
3204571|NCT02151877|3934198|FG001|STARTED|Overall Study||12
3204572|NCT02151877|3934197|FG000|COMPLETED|Overall Study||12
3204573|NCT02151877|3934198|FG001|COMPLETED|Overall Study||12
3204574|NCT02151877|3934197|FG000|NOT COMPLETED|Overall Study||0
3204575|NCT02151877|3934198|FG001|NOT COMPLETED|Overall Study||0
3204576|NCT02151903|3934208|FG000|STARTED|Overall Study||3
3204577|NCT02151903|3934209|FG001|STARTED|Overall Study||2
3204578|NCT02151903|3934208|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
3204579|NCT02151903|3934209|FG001|Received at Least 1 Dose of Study Drug|Overall Study||2
3204580|NCT02151903|3934208|FG000|COMPLETED|Overall Study||0
3204581|NCT02151903|3934209|FG001|COMPLETED|Overall Study||1
3204582|NCT02151903|3934208|FG000|NOT COMPLETED|Overall Study||3
3204583|NCT02151903|3934209|FG001|NOT COMPLETED|Overall Study||1
3204584|NCT02151981|3934217|FG000|STARTED|Overall Study||279
3204585|NCT02151981|3934218|FG001|STARTED|Overall Study||140
3204586|NCT02151981|3934217|FG000|Received Randomised Treatment Only|Overall Study||279
3204587|NCT02151981|3934218|FG001|Received Randomised Treatment Only|Overall Study||136
3204588|NCT02151981|3934217|FG000|Did Not Receive Treatment|Overall Study||0
3204589|NCT02151981|3934218|FG001|Did Not Receive Treatment|Overall Study||4
3204590|NCT02151981|3934217|FG000|Crossed Over Osimertinib|Overall Study||0
3204591|NCT02151981|3934218|FG001|Crossed Over Osimertinib|Overall Study|Patients randomised to chemotherapy were allowed to crossover to Osimertinib after progression|99
3204592|NCT02151981|3934217|FG000|COMPLETED|Overall Study||0
3204593|NCT02151981|3934218|FG001|COMPLETED|Overall Study||0
3204594|NCT02151981|3934217|FG000|NOT COMPLETED|Overall Study||279
3204595|NCT02151981|3934218|FG001|NOT COMPLETED|Overall Study||140
3204596|NCT02151994|3934227|FG000|STARTED|Single Ascending Dose (SAD)||18
3204597|NCT02151994|3934228|FG001|STARTED|Single Ascending Dose (SAD)||6
3204598|NCT02151994|3934229|FG002|STARTED|Single Ascending Dose (SAD)||6
3204599|NCT02151994|3934230|FG003|STARTED|Single Ascending Dose (SAD)||6
3204600|NCT02151994|3934231|FG004|STARTED|Single Ascending Dose (SAD)||6
3204601|NCT02151994|3934232|FG005|STARTED|Single Ascending Dose (SAD)||6
3204602|NCT02151994|3934233|FG006|STARTED|Single Ascending Dose (SAD)||6
3204603|NCT02151994|3934234|FG007|STARTED|Single Ascending Dose (SAD)||6
3204604|NCT02151994|3934235|FG008|STARTED|Single Ascending Dose (SAD)||0
3204605|NCT02151994|3934236|FG009|STARTED|Single Ascending Dose (SAD)||6
3204606|NCT02151994|3934237|FG010|STARTED|Single Ascending Dose (SAD)||6
3204607|NCT02151994|3934238|FG011|STARTED|Single Ascending Dose (SAD)||0
3204608|NCT02151994|3934239|FG012|STARTED|Single Ascending Dose (SAD)||0
3204609|NCT02151994|3934227|FG000|COMPLETED|Single Ascending Dose (SAD)||18
3204610|NCT02151994|3934228|FG001|COMPLETED|Single Ascending Dose (SAD)||6
3204611|NCT02151994|3934229|FG002|COMPLETED|Single Ascending Dose (SAD)||6
3204612|NCT02151994|3934230|FG003|COMPLETED|Single Ascending Dose (SAD)||6
3204613|NCT02151994|3934231|FG004|COMPLETED|Single Ascending Dose (SAD)||6
3204614|NCT02151994|3934232|FG005|COMPLETED|Single Ascending Dose (SAD)||6
3204615|NCT02151994|3934233|FG006|COMPLETED|Single Ascending Dose (SAD)||6
3204616|NCT02151994|3934234|FG007|COMPLETED|Single Ascending Dose (SAD)||6
3204617|NCT02151994|3934235|FG008|COMPLETED|Single Ascending Dose (SAD)||0
3204618|NCT02151994|3934236|FG009|COMPLETED|Single Ascending Dose (SAD)||6
3204619|NCT02151994|3934237|FG010|COMPLETED|Single Ascending Dose (SAD)||6
3204620|NCT02151994|3934238|FG011|COMPLETED|Single Ascending Dose (SAD)||0
3204621|NCT02151994|3934239|FG012|COMPLETED|Single Ascending Dose (SAD)||0
3204622|NCT02151994|3934227|FG000|NOT COMPLETED|Single Ascending Dose (SAD)||0
3204623|NCT02151994|3934228|FG001|NOT COMPLETED|Single Ascending Dose (SAD)||0
3204624|NCT02151994|3934229|FG002|NOT COMPLETED|Single Ascending Dose (SAD)||0
3204625|NCT02151994|3934230|FG003|NOT COMPLETED|Single Ascending Dose (SAD)||0
3204626|NCT02151994|3934231|FG004|NOT COMPLETED|Single Ascending Dose (SAD)||0
3204627|NCT02151994|3934232|FG005|NOT COMPLETED|Single Ascending Dose (SAD)||0
3204628|NCT02151994|3934233|FG006|NOT COMPLETED|Single Ascending Dose (SAD)||0
3204629|NCT02151994|3934234|FG007|NOT COMPLETED|Single Ascending Dose (SAD)||0
3204630|NCT02151994|3934235|FG008|NOT COMPLETED|Single Ascending Dose (SAD)||0
3204631|NCT02151994|3934236|FG009|NOT COMPLETED|Single Ascending Dose (SAD)||0
3204632|NCT02151994|3934237|FG010|NOT COMPLETED|Single Ascending Dose (SAD)||0
3204633|NCT02151994|3934238|FG011|NOT COMPLETED|Single Ascending Dose (SAD)||0
3204634|NCT02151994|3934239|FG012|NOT COMPLETED|Single Ascending Dose (SAD)||0
3204635|NCT02151994|3934227|FG000|STARTED|Multiple Ascending Dose (MAD)||10
3204636|NCT02151994|3934228|FG001|STARTED|Multiple Ascending Dose (MAD)||0
3204637|NCT02151994|3934229|FG002|STARTED|Multiple Ascending Dose (MAD)||0
3204638|NCT02151994|3934230|FG003|STARTED|Multiple Ascending Dose (MAD)||6
3204639|NCT02151994|3934231|FG004|STARTED|Multiple Ascending Dose (MAD)||6
3204640|NCT02151994|3934232|FG005|STARTED|Multiple Ascending Dose (MAD)||6
3204641|NCT02151994|3934233|FG006|STARTED|Multiple Ascending Dose (MAD)||6
3204642|NCT02151994|3934234|FG007|STARTED|Multiple Ascending Dose (MAD)||0
3204643|NCT02151994|3934235|FG008|STARTED|Multiple Ascending Dose (MAD)||6
3204644|NCT02151994|3934236|FG009|STARTED|Multiple Ascending Dose (MAD)||0
3204645|NCT02151994|3934237|FG010|STARTED|Multiple Ascending Dose (MAD)||0
3204646|NCT02151994|3934238|FG011|STARTED|Multiple Ascending Dose (MAD)||0
3204647|NCT02151994|3934239|FG012|STARTED|Multiple Ascending Dose (MAD)||0
3204648|NCT02151994|3934227|FG000|COMPLETED|Multiple Ascending Dose (MAD)||10
3204649|NCT02151994|3934228|FG001|COMPLETED|Multiple Ascending Dose (MAD)||0
3204650|NCT02151994|3934229|FG002|COMPLETED|Multiple Ascending Dose (MAD)||0
3204651|NCT02151994|3934230|FG003|COMPLETED|Multiple Ascending Dose (MAD)||6
3204652|NCT02151994|3934231|FG004|COMPLETED|Multiple Ascending Dose (MAD)||6
3204653|NCT02151994|3934232|FG005|COMPLETED|Multiple Ascending Dose (MAD)||6
3204654|NCT02151994|3934233|FG006|COMPLETED|Multiple Ascending Dose (MAD)||6
3204655|NCT02151994|3934234|FG007|COMPLETED|Multiple Ascending Dose (MAD)||0
3204656|NCT02151994|3934235|FG008|COMPLETED|Multiple Ascending Dose (MAD)||6
3204657|NCT02151994|3934236|FG009|COMPLETED|Multiple Ascending Dose (MAD)||0
3204658|NCT02151994|3934237|FG010|COMPLETED|Multiple Ascending Dose (MAD)||0
3204659|NCT02151994|3934238|FG011|COMPLETED|Multiple Ascending Dose (MAD)||0
3204660|NCT02151994|3934239|FG012|COMPLETED|Multiple Ascending Dose (MAD)||0
3204661|NCT02151994|3934227|FG000|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
3204662|NCT02151994|3934228|FG001|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
3204663|NCT02151994|3934229|FG002|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
3204664|NCT02151994|3934230|FG003|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
3204665|NCT02151994|3934231|FG004|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
3204666|NCT02151994|3934232|FG005|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
3204667|NCT02151994|3934233|FG006|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
3204668|NCT02151994|3934234|FG007|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
3204669|NCT02151994|3934235|FG008|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
3204670|NCT02151994|3934236|FG009|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
3204671|NCT02151994|3934237|FG010|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
3204672|NCT02151994|3934238|FG011|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
3204673|NCT02151994|3934239|FG012|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
3204674|NCT02151994|3934227|FG000|STARTED|Food Effect (FE): Fasted||0
3204675|NCT02151994|3934228|FG001|STARTED|Food Effect (FE): Fasted||0
3204676|NCT02151994|3934229|FG002|STARTED|Food Effect (FE): Fasted||0
3204677|NCT02151994|3934230|FG003|STARTED|Food Effect (FE): Fasted||0
3204678|NCT02151994|3934231|FG004|STARTED|Food Effect (FE): Fasted||0
3204679|NCT02151994|3934232|FG005|STARTED|Food Effect (FE): Fasted||0
3204680|NCT02151994|3934233|FG006|STARTED|Food Effect (FE): Fasted||0
3204681|NCT02151994|3934234|FG007|STARTED|Food Effect (FE): Fasted||0
3204682|NCT02151994|3934235|FG008|STARTED|Food Effect (FE): Fasted||0
3204683|NCT02151994|3934236|FG009|STARTED|Food Effect (FE): Fasted||0
3204684|NCT02151994|3934237|FG010|STARTED|Food Effect (FE): Fasted||0
3204685|NCT02151994|3934238|FG011|STARTED|Food Effect (FE): Fasted||12
3204686|NCT02151994|3934239|FG012|STARTED|Food Effect (FE): Fasted||0
3204687|NCT02151994|3934227|FG000|COMPLETED|Food Effect (FE): Fasted||0
3204688|NCT02151994|3934228|FG001|COMPLETED|Food Effect (FE): Fasted||0
3204689|NCT02151994|3934229|FG002|COMPLETED|Food Effect (FE): Fasted||0
3204690|NCT02151994|3934230|FG003|COMPLETED|Food Effect (FE): Fasted||0
3204691|NCT02151994|3934231|FG004|COMPLETED|Food Effect (FE): Fasted||0
3204692|NCT02151994|3934232|FG005|COMPLETED|Food Effect (FE): Fasted||0
3204693|NCT02151994|3934233|FG006|COMPLETED|Food Effect (FE): Fasted||0
3204694|NCT02151994|3934234|FG007|COMPLETED|Food Effect (FE): Fasted||0
3204695|NCT02151994|3934235|FG008|COMPLETED|Food Effect (FE): Fasted||0
3204696|NCT02151994|3934236|FG009|COMPLETED|Food Effect (FE): Fasted||0
3204697|NCT02151994|3934237|FG010|COMPLETED|Food Effect (FE): Fasted||0
3204698|NCT02151994|3934238|FG011|COMPLETED|Food Effect (FE): Fasted||12
3204699|NCT02151994|3934239|FG012|COMPLETED|Food Effect (FE): Fasted||0
3204700|NCT02151994|3934227|FG000|NOT COMPLETED|Food Effect (FE): Fasted||0
3204701|NCT02151994|3934228|FG001|NOT COMPLETED|Food Effect (FE): Fasted||0
3204702|NCT02151994|3934229|FG002|NOT COMPLETED|Food Effect (FE): Fasted||0
3204703|NCT02151994|3934230|FG003|NOT COMPLETED|Food Effect (FE): Fasted||0
3204704|NCT02151994|3934231|FG004|NOT COMPLETED|Food Effect (FE): Fasted||0
3204705|NCT02151994|3934232|FG005|NOT COMPLETED|Food Effect (FE): Fasted||0
3204706|NCT02151994|3934233|FG006|NOT COMPLETED|Food Effect (FE): Fasted||0
3204707|NCT02151994|3934234|FG007|NOT COMPLETED|Food Effect (FE): Fasted||0
3204708|NCT02151994|3934235|FG008|NOT COMPLETED|Food Effect (FE): Fasted||0
3204709|NCT02151994|3934236|FG009|NOT COMPLETED|Food Effect (FE): Fasted||0
3204710|NCT02151994|3934237|FG010|NOT COMPLETED|Food Effect (FE): Fasted||0
3204711|NCT02151994|3934238|FG011|NOT COMPLETED|Food Effect (FE): Fasted||0
3204712|NCT02151994|3934239|FG012|NOT COMPLETED|Food Effect (FE): Fasted||0
3204713|NCT02151994|3934227|FG000|STARTED|Food Effect (FE): Fed||0
3204714|NCT02151994|3934228|FG001|STARTED|Food Effect (FE): Fed||0
3204715|NCT02151994|3934229|FG002|STARTED|Food Effect (FE): Fed||0
3204716|NCT02151994|3934230|FG003|STARTED|Food Effect (FE): Fed||0
3204717|NCT02151994|3934231|FG004|STARTED|Food Effect (FE): Fed||0
3204718|NCT02151994|3934232|FG005|STARTED|Food Effect (FE): Fed||0
3204719|NCT02151994|3934233|FG006|STARTED|Food Effect (FE): Fed||0
3204720|NCT02151994|3934234|FG007|STARTED|Food Effect (FE): Fed||0
3204721|NCT02151994|3934235|FG008|STARTED|Food Effect (FE): Fed||0
3204722|NCT02151994|3934236|FG009|STARTED|Food Effect (FE): Fed||0
3204723|NCT02151994|3934237|FG010|STARTED|Food Effect (FE): Fed||0
3204724|NCT02151994|3934238|FG011|STARTED|Food Effect (FE): Fed||0
3204725|NCT02151994|3934239|FG012|STARTED|Food Effect (FE): Fed||12
3204726|NCT02151994|3934227|FG000|COMPLETED|Food Effect (FE): Fed||0
3204727|NCT02151994|3934228|FG001|COMPLETED|Food Effect (FE): Fed||0
3204728|NCT02151994|3934229|FG002|COMPLETED|Food Effect (FE): Fed||0
3204729|NCT02151994|3934230|FG003|COMPLETED|Food Effect (FE): Fed||0
3204730|NCT02151994|3934231|FG004|COMPLETED|Food Effect (FE): Fed||0
3204731|NCT02151994|3934232|FG005|COMPLETED|Food Effect (FE): Fed||0
3204732|NCT02151994|3934233|FG006|COMPLETED|Food Effect (FE): Fed||0
3204733|NCT02151994|3934234|FG007|COMPLETED|Food Effect (FE): Fed||0
3204734|NCT02151994|3934235|FG008|COMPLETED|Food Effect (FE): Fed||0
3204735|NCT02151994|3934236|FG009|COMPLETED|Food Effect (FE): Fed||0
3204736|NCT02151994|3934237|FG010|COMPLETED|Food Effect (FE): Fed||0
3204737|NCT02151994|3934238|FG011|COMPLETED|Food Effect (FE): Fed||0
3204738|NCT02151994|3934239|FG012|COMPLETED|Food Effect (FE): Fed||12
3204739|NCT02151994|3934227|FG000|NOT COMPLETED|Food Effect (FE): Fed||0
3204740|NCT02151994|3934228|FG001|NOT COMPLETED|Food Effect (FE): Fed||0
3204741|NCT02151994|3934229|FG002|NOT COMPLETED|Food Effect (FE): Fed||0
3204742|NCT02151994|3934230|FG003|NOT COMPLETED|Food Effect (FE): Fed||0
3204743|NCT02151994|3934231|FG004|NOT COMPLETED|Food Effect (FE): Fed||0
3204744|NCT02151994|3934232|FG005|NOT COMPLETED|Food Effect (FE): Fed||0
3204745|NCT02151994|3934233|FG006|NOT COMPLETED|Food Effect (FE): Fed||0
3204746|NCT02151994|3934234|FG007|NOT COMPLETED|Food Effect (FE): Fed||0
3204747|NCT02151994|3934235|FG008|NOT COMPLETED|Food Effect (FE): Fed||0
3204748|NCT02151994|3934236|FG009|NOT COMPLETED|Food Effect (FE): Fed||0
3204749|NCT02151994|3934237|FG010|NOT COMPLETED|Food Effect (FE): Fed||0
3204750|NCT02151994|3934238|FG011|NOT COMPLETED|Food Effect (FE): Fed||0
3204751|NCT02151994|3934239|FG012|NOT COMPLETED|Food Effect (FE): Fed||0
3204752|NCT02152007|3934276|FG000|STARTED|Overall Study||15
3204753|NCT02152007|3934276|FG000|COMPLETED|Overall Study||14
3204754|NCT02152007|3934276|FG000|NOT COMPLETED|Overall Study||1
3204755|NCT02152085|3934283|FG000|STARTED|Overall Study||14
3365597|NCT03958955|4096754|FG000|Lesions Treated With Delgocitinib Cream|Overall Study||27
3365598|NCT03958955|4096754|FG000|Lesions Treated With Delgocitinib Cream Vehicle|Overall Study||27
3365599|NCT03958955|4096754|FG000|COMPLETED|Overall Study||26
3365600|NCT03958955|4096754|FG000|NOT COMPLETED|Overall Study||1
3365601|NCT03965052|4096762|FG000|STARTED|Overall Study||12
3365602|NCT03965052|4096763|FG001|STARTED|Overall Study||12
3365603|NCT03965052|4096762|FG000|COMPLETED|Overall Study||11
3365604|NCT03965052|4096763|FG001|COMPLETED|Overall Study||12
3365605|NCT03965052|4096762|FG000|NOT COMPLETED|Overall Study||1
3365606|NCT03965052|4096763|FG001|NOT COMPLETED|Overall Study||0
3365607|NCT03965039|4096773|FG000|STARTED|Overall Study||30
3365608|NCT03965039|4096774|FG001|STARTED|Overall Study||30
3365609|NCT03965039|4096775|FG002|STARTED|Overall Study||30
3365610|NCT03965039|4096776|FG003|STARTED|Overall Study||30
3365611|NCT03965039|4096773|FG000|COMPLETED|Overall Study||30
3365612|NCT03965039|4096774|FG001|COMPLETED|Overall Study||29
3365613|NCT03965039|4096775|FG002|COMPLETED|Overall Study||30
3365614|NCT03965039|4096776|FG003|COMPLETED|Overall Study||29
3365615|NCT03965039|4096773|FG000|NOT COMPLETED|Overall Study||0
3365616|NCT03965039|4096774|FG001|NOT COMPLETED|Overall Study||1
3365617|NCT03965039|4096775|FG002|NOT COMPLETED|Overall Study||0
3365618|NCT03965039|4096776|FG003|NOT COMPLETED|Overall Study||1
3365619|NCT03963401|4096792|FG000|STARTED|Initial Period (Day 1 - Week 16)||60
3365620|NCT03963401|4096793|FG001|STARTED|Initial Period (Day 1 - Week 16)||61
3365621|NCT03963401|4096794|FG002|STARTED|Initial Period (Day 1 - Week 16)||16
3365622|NCT03963401|4096795|FG003|STARTED|Initial Period (Day 1 - Week 16)||15
3365623|NCT03963401|4096796|FG004|STARTED|Initial Period (Day 1 - Week 16)||34
3365624|NCT03963401|4096797|FG005|STARTED|Initial Period (Day 1 - Week 16)||33
3365625|NCT03963401|4096792|FG000|Treated|Initial Period (Day 1 - Week 16)||60
3365626|NCT03963401|4096793|FG001|Treated|Initial Period (Day 1 - Week 16)||60
3365627|NCT03963401|4096794|FG002|Treated|Initial Period (Day 1 - Week 16)||16
3365628|NCT03963401|4096795|FG003|Treated|Initial Period (Day 1 - Week 16)||15
3365629|NCT03963401|4096796|FG004|Treated|Initial Period (Day 1 - Week 16)||34
3365630|NCT03963401|4096797|FG005|Treated|Initial Period (Day 1 - Week 16)||33
3365631|NCT03963401|4096792|FG000|COMPLETED|Initial Period (Day 1 - Week 16)||57
3365632|NCT03963401|4096793|FG001|COMPLETED|Initial Period (Day 1 - Week 16)||57
3365633|NCT03963401|4096794|FG002|COMPLETED|Initial Period (Day 1 - Week 16)||14
3365634|NCT03963401|4096795|FG003|COMPLETED|Initial Period (Day 1 - Week 16)||13
3365635|NCT03963401|4096796|FG004|COMPLETED|Initial Period (Day 1 - Week 16)||31
3365636|NCT03963401|4096797|FG005|COMPLETED|Initial Period (Day 1 - Week 16)||31
3365637|NCT03963401|4096792|FG000|NOT COMPLETED|Initial Period (Day 1 - Week 16)||3
3365638|NCT03963401|4096793|FG001|NOT COMPLETED|Initial Period (Day 1 - Week 16)||4
3204756|NCT02152085|3934284|FG001|STARTED|Overall Study||15
3204757|NCT02152085|3934283|FG000|COMPLETED|Overall Study||13
3204758|NCT02152085|3934284|FG001|COMPLETED|Overall Study||14
3204759|NCT02152085|3934283|FG000|NOT COMPLETED|Overall Study||1
3204760|NCT02152085|3934284|FG001|NOT COMPLETED|Overall Study||1
3204761|NCT02152137|3934290|FG000|STARTED|Overall Study||19
3204762|NCT02152137|3934290|FG000|Originally Assigned to Arm A|Overall Study||16
3204763|NCT02152137|3934290|FG000|Originally Assigned to Arm B|Overall Study|With update #2, Arm B is closed and all patients should receive paclitaxel and efatutazone.|3
3204764|NCT02152137|3934290|FG000|COMPLETED|Overall Study||15
3204765|NCT02152137|3934290|FG000|NOT COMPLETED|Overall Study||4
3204766|NCT02152163|3934296|FG000|STARTED|Overall Study||51
3204767|NCT02152163|3934297|FG001|STARTED|Overall Study||48
3204768|NCT02152163|3934296|FG000|COMPLETED|Overall Study||39
3204769|NCT02152163|3934297|FG001|COMPLETED|Overall Study||35
3204770|NCT02152163|3934296|FG000|NOT COMPLETED|Overall Study||12
3204771|NCT02152163|3934297|FG001|NOT COMPLETED|Overall Study||13
3204772|NCT02152345|3934305|FG000|STARTED|Overall Study|The first subject randomized to Belatacept was on 15-Sep-2014.|28
3204773|NCT02152345|3934306|FG001|STARTED|Overall Study|The first subject randomized to Standard Immunosuppression was on 14-Jun-2014.|29
3204774|NCT02152345|3934305|FG000|COMPLETED|Overall Study|The last subject randomized to Belatacept was on 29-Dec-2016.|24
3204775|NCT02152345|3934306|FG001|COMPLETED|Overall Study|The last subject randomized to Standard Immunosuppression was on 25-Dec-2016.|24
3204776|NCT02152345|3934305|FG000|NOT COMPLETED|Overall Study||4
3204777|NCT02152345|3934306|FG001|NOT COMPLETED|Overall Study||5
3204778|NCT02152371|3934314|FG000|STARTED|Overall Study||150
3204779|NCT02152371|3934315|FG001|STARTED|Overall Study||150
3204780|NCT02152371|3934314|FG000|Received at Least 1 Dose of Study Drug.|Overall Study||150
3204781|NCT02152371|3934315|FG001|Received at Least 1 Dose of Study Drug.|Overall Study||150
3204782|NCT02152371|3934314|FG000|COMPLETED|Overall Study||138
3204783|NCT02152371|3934315|FG001|COMPLETED|Overall Study||134
3204784|NCT02152371|3934314|FG000|NOT COMPLETED|Overall Study||12
3204785|NCT02152371|3934315|FG001|NOT COMPLETED|Overall Study||16
3204786|NCT02152384|3934321|FG000|STARTED|Run In (1-5 Week Transition)||14
3204787|NCT02152384|3934322|FG001|STARTED|Run In (1-5 Week Transition)||14
3204788|NCT02152384|3934321|FG000|COMPLETED|Run In (1-5 Week Transition)||14
3204789|NCT02152384|3934322|FG001|COMPLETED|Run In (1-5 Week Transition)||14
3204790|NCT02152384|3934321|FG000|NOT COMPLETED|Run In (1-5 Week Transition)||0
3204791|NCT02152384|3934322|FG001|NOT COMPLETED|Run In (1-5 Week Transition)||0
3204792|NCT02152384|3934321|FG000|STARTED|Period 1||14
3204793|NCT02152384|3934322|FG001|STARTED|Period 1||14
3204794|NCT02152384|3934321|FG000|Received at Least 1 Dose of Study Drug|Period 1||14
3204795|NCT02152384|3934322|FG001|Received at Least 1 Dose of Study Drug|Period 1||14
3204796|NCT02152384|3934321|FG000|COMPLETED|Period 1||13
3204797|NCT02152384|3934322|FG001|COMPLETED|Period 1||12
3204798|NCT02152384|3934321|FG000|NOT COMPLETED|Period 1||1
3204799|NCT02152384|3934322|FG001|NOT COMPLETED|Period 1||2
3204800|NCT02152384|3934321|FG000|STARTED|Period 2||13
3204801|NCT02152384|3934322|FG001|STARTED|Period 2||12
3204802|NCT02152384|3934321|FG000|COMPLETED|Period 2||13
3204803|NCT02152384|3934322|FG001|COMPLETED|Period 2||12
3204804|NCT02152384|3934321|FG000|NOT COMPLETED|Period 2||0
3204805|NCT02152384|3934322|FG001|NOT COMPLETED|Period 2||0
3204806|NCT02152540|3934334|FG000|STARTED|Overall Study||17
3204807|NCT02152540|3934335|FG001|STARTED|Overall Study||16
3204808|NCT02152540|3934334|FG000|COMPLETED|Overall Study||17
3204809|NCT02152540|3934335|FG001|COMPLETED|Overall Study||16
3204810|NCT02152540|3934334|FG000|NOT COMPLETED|Overall Study||0
3204811|NCT02152540|3934335|FG001|NOT COMPLETED|Overall Study||0
3204812|NCT02152605|3934350|FG000|STARTED|Overall Study||248
3204813|NCT02152605|3934351|FG001|STARTED|Overall Study||248
3204814|NCT02152605|3934350|FG000|COMPLETED|Overall Study||229
3204815|NCT02152605|3934351|FG001|COMPLETED|Overall Study||230
3204816|NCT02152605|3934350|FG000|NOT COMPLETED|Overall Study||19
3204817|NCT02152605|3934351|FG001|NOT COMPLETED|Overall Study||18
3204818|NCT02152631|3934360|FG000|STARTED|Overall Study||270
3204819|NCT02152631|3934361|FG001|STARTED|Overall Study||183
3204820|NCT02152631|3934360|FG000|Received at Least One Dose of Study Drug|Overall Study||265
3204821|NCT02152631|3934361|FG001|Received at Least One Dose of Study Drug|Overall Study||175
3204822|NCT02152631|3934360|FG000|Off Treatment|Overall Study||246
3204823|NCT02152631|3934361|FG001|Off Treatment|Overall Study||172
3204824|NCT02152631|3934360|FG000|Death Due to Any Cause|Overall Study||30
3204825|NCT02152631|3934361|FG001|Death Due to Any Cause|Overall Study||20
3204826|NCT02152631|3934360|FG000|Progressive Disease|Overall Study||174
3204827|NCT02152631|3934361|FG001|Progressive Disease|Overall Study||137
3204828|NCT02152631|3934360|FG000|COMPLETED|Overall Study||204
3204829|NCT02152631|3934361|FG001|COMPLETED|Overall Study||157
3204830|NCT02152631|3934360|FG000|NOT COMPLETED|Overall Study||66
3204831|NCT02152631|3934361|FG001|NOT COMPLETED|Overall Study||26
3365639|NCT03963401|4096794|FG002|NOT COMPLETED|Initial Period (Day 1 - Week 16)||2
3365640|NCT03963401|4096795|FG003|NOT COMPLETED|Initial Period (Day 1 - Week 16)||2
3365641|NCT03963401|4096796|FG004|NOT COMPLETED|Initial Period (Day 1 - Week 16)||3
3365642|NCT03963401|4096797|FG005|NOT COMPLETED|Initial Period (Day 1 - Week 16)||2
3365643|NCT03963401|4096792|FG000|STARTED|Extension Period (Week 17 - Week 52)||57
3365644|NCT03963401|4096793|FG001|STARTED|Extension Period (Week 17 - Week 52)||57
3365645|NCT03963401|4096794|FG002|STARTED|Extension Period (Week 17 - Week 52)||14
3365646|NCT03963401|4096795|FG003|STARTED|Extension Period (Week 17 - Week 52)||13
3365647|NCT03963401|4096796|FG004|STARTED|Extension Period (Week 17 - Week 52)||31
3365648|NCT03963401|4096797|FG005|STARTED|Extension Period (Week 17 - Week 52)||31
3204832|NCT02152696|3934370|FG000|STARTED|Overall Study||86
3204833|NCT02152696|3934371|FG001|STARTED|Overall Study||87
3204834|NCT02152696|3934372|FG002|STARTED|Overall Study||82
3204835|NCT02152696|3934370|FG000|COMPLETED|Overall Study||86
3204836|NCT02152696|3934371|FG001|COMPLETED|Overall Study||86
3204837|NCT02152696|3934372|FG002|COMPLETED|Overall Study||81
3204838|NCT02152696|3934370|FG000|NOT COMPLETED|Overall Study||0
3204839|NCT02152696|3934371|FG001|NOT COMPLETED|Overall Study||1
3204840|NCT02152696|3934372|FG002|NOT COMPLETED|Overall Study||1
3204841|NCT02152761|3934384|FG000|STARTED|Epoch: Treatment Epoch||75
3204842|NCT02152761|3934385|FG001|STARTED|Epoch: Treatment Epoch||70
3204843|NCT02152761|3934386|FG002|STARTED|Epoch: Treatment Epoch||34
3204844|NCT02152761|3934387|FG003|STARTED|Epoch: Treatment Epoch||72
3204845|NCT02152761|3934384|FG000|COMPLETED|Epoch: Treatment Epoch||64
3204846|NCT02152761|3934385|FG001|COMPLETED|Epoch: Treatment Epoch||50
3204847|NCT02152761|3934386|FG002|COMPLETED|Epoch: Treatment Epoch||29
3204848|NCT02152761|3934387|FG003|COMPLETED|Epoch: Treatment Epoch||64
3204849|NCT02152761|3934384|FG000|NOT COMPLETED|Epoch: Treatment Epoch||11
3204850|NCT02152761|3934385|FG001|NOT COMPLETED|Epoch: Treatment Epoch||20
3204851|NCT02152761|3934386|FG002|NOT COMPLETED|Epoch: Treatment Epoch||5
3204852|NCT02152761|3934387|FG003|NOT COMPLETED|Epoch: Treatment Epoch||8
3204853|NCT02152761|3934384|FG000|STARTED|Epoch: Post-treatment Follow-up Epoch||67
3204854|NCT02152761|3934385|FG001|STARTED|Epoch: Post-treatment Follow-up Epoch||54
3204855|NCT02152761|3934386|FG002|STARTED|Epoch: Post-treatment Follow-up Epoch||30
3204856|NCT02152761|3934387|FG003|STARTED|Epoch: Post-treatment Follow-up Epoch||68
3204857|NCT02152761|3934384|FG000|COMPLETED|Epoch: Post-treatment Follow-up Epoch||63
3204858|NCT02152761|3934385|FG001|COMPLETED|Epoch: Post-treatment Follow-up Epoch||47
3204859|NCT02152761|3934386|FG002|COMPLETED|Epoch: Post-treatment Follow-up Epoch||30
3204860|NCT02152761|3934387|FG003|COMPLETED|Epoch: Post-treatment Follow-up Epoch||66
3204861|NCT02152761|3934384|FG000|NOT COMPLETED|Epoch: Post-treatment Follow-up Epoch||4
3204862|NCT02152761|3934385|FG001|NOT COMPLETED|Epoch: Post-treatment Follow-up Epoch||7
3204863|NCT02152761|3934386|FG002|NOT COMPLETED|Epoch: Post-treatment Follow-up Epoch||0
3204864|NCT02152761|3934387|FG003|NOT COMPLETED|Epoch: Post-treatment Follow-up Epoch||2
3204865|NCT02152826|3934405|FG000|STARTED|Overall Study||45
3204866|NCT02152826|3934406|FG001|STARTED|Overall Study||35
3204867|NCT02152826|3934405|FG000|COMPLETED|Overall Study||44
3204868|NCT02152826|3934406|FG001|COMPLETED|Overall Study||34
3204869|NCT02152826|3934405|FG000|NOT COMPLETED|Overall Study||1
3204870|NCT02152826|3934406|FG001|NOT COMPLETED|Overall Study||1
3204871|NCT02153073|3934412|FG000|STARTED|Overall Study||3084
3204872|NCT02153073|3934412|FG000|COMPLETED|Overall Study||2786
3204873|NCT02153073|3934412|FG000|NOT COMPLETED|Overall Study||298
3204874|NCT02153086|3934416|FG000|STARTED|Overall Study||236
3204875|NCT02153086|3934416|FG000|COMPLETED|Overall Study||232
3204876|NCT02153086|3934416|FG000|NOT COMPLETED|Overall Study||4
3204877|NCT02153099|3934427|FG000|STARTED|Overall Study||6
3204878|NCT02153099|3934428|FG001|STARTED|Overall Study||6
3204879|NCT02153099|3934429|FG002|STARTED|Overall Study||6
3204880|NCT02153099|3934430|FG003|STARTED|Overall Study||6
3204881|NCT02153099|3934431|FG004|STARTED|Overall Study||6
3204882|NCT02153099|3934432|FG005|STARTED|Overall Study||6
3204883|NCT02153099|3934433|FG006|STARTED|Overall Study||12
3204884|NCT02153099|3934427|FG000|COMPLETED|Overall Study||6
3204885|NCT02153099|3934428|FG001|COMPLETED|Overall Study||6
3204886|NCT02153099|3934429|FG002|COMPLETED|Overall Study||6
3204887|NCT02153099|3934430|FG003|COMPLETED|Overall Study||6
3204888|NCT02153099|3934431|FG004|COMPLETED|Overall Study||6
3204889|NCT02153099|3934432|FG005|COMPLETED|Overall Study||6
3204890|NCT02153099|3934433|FG006|COMPLETED|Overall Study||12
3204891|NCT02153099|3934427|FG000|NOT COMPLETED|Overall Study||0
3204892|NCT02153099|3934428|FG001|NOT COMPLETED|Overall Study||0
3204893|NCT02153099|3934429|FG002|NOT COMPLETED|Overall Study||0
3204894|NCT02153099|3934430|FG003|NOT COMPLETED|Overall Study||0
3204895|NCT02153099|3934431|FG004|NOT COMPLETED|Overall Study||0
3204896|NCT02153099|3934432|FG005|NOT COMPLETED|Overall Study||0
3204897|NCT02153099|3934433|FG006|NOT COMPLETED|Overall Study||0
3204898|NCT02153112|3934459|FG000|STARTED|Overall Study||61
3204899|NCT02153112|3934460|FG001|STARTED|Overall Study||59
3204900|NCT02153112|3934461|FG002|STARTED|Overall Study||61
3204901|NCT02153112|3934462|FG003|STARTED|Overall Study||59
3204902|NCT02153112|3934463|FG004|STARTED|Overall Study||60
3204903|NCT02153112|3934464|FG005|STARTED|Overall Study||60
3204904|NCT02153112|3934465|FG006|STARTED|Overall Study||60
3204905|NCT02153112|3934466|FG007|STARTED|Overall Study||60
3204906|NCT02153112|3934467|FG008|STARTED|Overall Study||180
3204907|NCT02153112|3934468|FG009|STARTED|Overall Study||180
3204908|NCT02153112|3934459|FG000|COMPLETED|Overall Study||57
3204909|NCT02153112|3934460|FG001|COMPLETED|Overall Study||57
3204910|NCT02153112|3934461|FG002|COMPLETED|Overall Study||58
3204911|NCT02153112|3934462|FG003|COMPLETED|Overall Study||57
3204912|NCT02153112|3934463|FG004|COMPLETED|Overall Study||57
3204913|NCT02153112|3934464|FG005|COMPLETED|Overall Study||58
3204914|NCT02153112|3934465|FG006|COMPLETED|Overall Study||52
3204915|NCT02153112|3934466|FG007|COMPLETED|Overall Study||58
3204916|NCT02153112|3934467|FG008|COMPLETED|Overall Study||165
3204917|NCT02153112|3934468|FG009|COMPLETED|Overall Study||166
3204918|NCT02153112|3934459|FG000|NOT COMPLETED|Overall Study||4
3204919|NCT02153112|3934460|FG001|NOT COMPLETED|Overall Study||2
3204920|NCT02153112|3934461|FG002|NOT COMPLETED|Overall Study||3
3204921|NCT02153112|3934462|FG003|NOT COMPLETED|Overall Study||2
3204922|NCT02153112|3934463|FG004|NOT COMPLETED|Overall Study||3
3204923|NCT02153112|3934464|FG005|NOT COMPLETED|Overall Study||2
3204924|NCT02153112|3934465|FG006|NOT COMPLETED|Overall Study||8
3204925|NCT02153112|3934466|FG007|NOT COMPLETED|Overall Study||2
3204926|NCT02153112|3934467|FG008|NOT COMPLETED|Overall Study||15
3204927|NCT02153112|3934468|FG009|NOT COMPLETED|Overall Study||14
3204928|NCT02153346|3934492|FG000|STARTED|Overall Study||101
3204929|NCT02153346|3934492|FG000|COMPLETED|Overall Study||90
3204930|NCT02153346|3934492|FG000|NOT COMPLETED|Overall Study||11
3204931|NCT02153359|3934497|FG000|STARTED|Intervention 1 (1 Month)||11
3204932|NCT02153359|3934498|FG001|STARTED|Intervention 1 (1 Month)||12
3204933|NCT02153359|3934497|FG000|COMPLETED|Intervention 1 (1 Month)||11
3204934|NCT02153359|3934498|FG001|COMPLETED|Intervention 1 (1 Month)||12
3204935|NCT02153359|3934497|FG000|NOT COMPLETED|Intervention 1 (1 Month)||0
3204936|NCT02153359|3934498|FG001|NOT COMPLETED|Intervention 1 (1 Month)||0
3204937|NCT02153359|3934497|FG000|STARTED|Washout (at Least 1 Month)||11
3204938|NCT02153359|3934498|FG001|STARTED|Washout (at Least 1 Month)||12
3204939|NCT02153359|3934497|FG000|COMPLETED|Washout (at Least 1 Month)||11
3204940|NCT02153359|3934498|FG001|COMPLETED|Washout (at Least 1 Month)||12
3204941|NCT02153359|3934497|FG000|NOT COMPLETED|Washout (at Least 1 Month)||0
3204942|NCT02153359|3934498|FG001|NOT COMPLETED|Washout (at Least 1 Month)||0
3204943|NCT02153359|3934497|FG000|STARTED|Intervention 2 (1 Month)||11
3204944|NCT02153359|3934498|FG001|STARTED|Intervention 2 (1 Month)||12
3204945|NCT02153359|3934497|FG000|COMPLETED|Intervention 2 (1 Month)||11
3204946|NCT02153359|3934498|FG001|COMPLETED|Intervention 2 (1 Month)||10
3204947|NCT02153359|3934497|FG000|NOT COMPLETED|Intervention 2 (1 Month)||0
3204948|NCT02153359|3934498|FG001|NOT COMPLETED|Intervention 2 (1 Month)||2
3204949|NCT02153398|3934512|FG000|STARTED|Overall Study||10
3204950|NCT02153398|3934513|FG001|STARTED|Overall Study||10
3204951|NCT02153398|3934514|FG002|STARTED|Overall Study||10
3204952|NCT02153398|3934515|FG003|STARTED|Overall Study||10
3204953|NCT02153398|3934516|FG004|STARTED|Overall Study||10
3204954|NCT02153398|3934512|FG000|COMPLETED|Overall Study||9
3204955|NCT02153398|3934513|FG001|COMPLETED|Overall Study||10
3204956|NCT02153398|3934514|FG002|COMPLETED|Overall Study||9
3204957|NCT02153398|3934515|FG003|COMPLETED|Overall Study||9
3204958|NCT02153398|3934516|FG004|COMPLETED|Overall Study||10
3204959|NCT02153398|3934512|FG000|NOT COMPLETED|Overall Study||1
3204960|NCT02153398|3934513|FG001|NOT COMPLETED|Overall Study||0
3204961|NCT02153398|3934514|FG002|NOT COMPLETED|Overall Study||1
3204962|NCT02153398|3934515|FG003|NOT COMPLETED|Overall Study||1
3204963|NCT02153398|3934516|FG004|NOT COMPLETED|Overall Study||0
3204964|NCT02153476|3934530|FG000|STARTED|Overall Study||23
3204965|NCT02153476|3934531|FG001|STARTED|Overall Study||22
3204966|NCT02153476|3934530|FG000|COMPLETED|Overall Study||22
3204967|NCT02153476|3934531|FG001|COMPLETED|Overall Study||22
3204968|NCT02153476|3934530|FG000|NOT COMPLETED|Overall Study||1
3204969|NCT02153476|3934531|FG001|NOT COMPLETED|Overall Study||0
3204970|NCT02153489|3934537|FG000|STARTED|Period 1||15
3204971|NCT02153489|3934538|FG001|STARTED|Period 1||15
3204972|NCT02153489|3934537|FG000|COMPLETED|Period 1||15
3204973|NCT02153489|3934538|FG001|COMPLETED|Period 1||15
3204974|NCT02153489|3934537|FG000|NOT COMPLETED|Period 1||0
3204975|NCT02153489|3934538|FG001|NOT COMPLETED|Period 1||0
3204976|NCT02153489|3934537|FG000|STARTED|Period 2||15
3204977|NCT02153489|3934538|FG001|STARTED|Period 2||15
3204978|NCT02153489|3934537|FG000|COMPLETED|Period 2||15
3204979|NCT02153489|3934538|FG001|COMPLETED|Period 2||15
3204980|NCT02153489|3934537|FG000|NOT COMPLETED|Period 2||0
3204981|NCT02153489|3934538|FG001|NOT COMPLETED|Period 2||0
3204982|NCT02153528|3934546|FG000|STARTED|Overall Study||348
3204983|NCT02153528|3934547|FG001|STARTED|Overall Study||353
3204984|NCT02153528|3934546|FG000|COMPLETED|Overall Study||348
3204985|NCT02153528|3934547|FG001|COMPLETED|Overall Study||353
3204986|NCT02153528|3934546|FG000|NOT COMPLETED|Overall Study||0
3204987|NCT02153528|3934547|FG001|NOT COMPLETED|Overall Study||0
3204988|NCT02153671|3934557|FG000|STARTED|Overall Study||19
3204989|NCT02153671|3934558|FG001|STARTED|Overall Study||24
3204990|NCT02153671|3934557|FG000|COMPLETED|Overall Study||19
3204991|NCT02153671|3934558|FG001|COMPLETED|Overall Study||24
3204992|NCT02153671|3934557|FG000|NOT COMPLETED|Overall Study||0
3204993|NCT02153671|3934558|FG001|NOT COMPLETED|Overall Study||0
3204994|NCT02153710|3934566|FG000|STARTED|Overall Study||28
3204995|NCT02153710|3934567|FG001|STARTED|Overall Study||30
3204996|NCT02153710|3934566|FG000|COMPLETED|Overall Study||28
3204997|NCT02153710|3934567|FG001|COMPLETED|Overall Study||30
3204998|NCT02153710|3934566|FG000|NOT COMPLETED|Overall Study||0
3204999|NCT02153710|3934567|FG001|NOT COMPLETED|Overall Study||0
3205000|NCT02153723|3934573|FG000|STARTED|Overall Study||10
3205001|NCT02153723|3934573|FG000|COMPLETED|Overall Study||10
3205002|NCT02153723|3934573|FG000|NOT COMPLETED|Overall Study||0
3205003|NCT02153736|3934579|FG000|STARTED|Overall Study||7
3205004|NCT02153736|3934580|FG001|STARTED|Overall Study||7
3205005|NCT02153736|3934579|FG000|COMPLETED|Overall Study||5
3205006|NCT02153736|3934580|FG001|COMPLETED|Overall Study||5
3205007|NCT02153736|3934579|FG000|NOT COMPLETED|Overall Study||2
3205008|NCT02153736|3934580|FG001|NOT COMPLETED|Overall Study||2
3205009|NCT02153788|3934588|FG000|STARTED|Overall Study||25
3205010|NCT02153788|3934589|FG001|STARTED|Overall Study||19
3205011|NCT02153788|3934588|FG000|COMPLETED|Overall Study||23
3205012|NCT02153788|3934589|FG001|COMPLETED|Overall Study||18
3205013|NCT02153788|3934588|FG000|NOT COMPLETED|Overall Study||2
3205014|NCT02153788|3934589|FG001|NOT COMPLETED|Overall Study||1
3205015|NCT02153827|3934597|FG000|STARTED|Overall Study||25
3205016|NCT02153827|3934598|FG001|STARTED|Overall Study||23
3205017|NCT02153827|3934597|FG000|COMPLETED|Overall Study||22
3205018|NCT02153827|3934598|FG001|COMPLETED|Overall Study||14
3205019|NCT02153827|3934597|FG000|NOT COMPLETED|Overall Study||3
3205020|NCT02153827|3934598|FG001|NOT COMPLETED|Overall Study||9
3205021|NCT02153905|3934606|FG000|STARTED|Overall Study||1
3205022|NCT02153905|3934607|FG001|STARTED|Overall Study||2
3205023|NCT02153905|3934606|FG000|COMPLETED|Overall Study||0
3205024|NCT02153905|3934607|FG001|COMPLETED|Overall Study||2
3205025|NCT02153905|3934606|FG000|NOT COMPLETED|Overall Study||1
3205026|NCT02153905|3934607|FG001|NOT COMPLETED|Overall Study||0
3205027|NCT02153918|3934613|FG000|STARTED|Overall Study||27
3205028|NCT02153918|3934613|FG000|COMPLETED|Overall Study||26
3205029|NCT02153918|3934613|FG000|NOT COMPLETED|Overall Study||1
3205030|NCT02153983|3934623|FG000|STARTED|Overall Study||19
3205031|NCT02153983|3934624|FG001|STARTED|Overall Study||21
3205032|NCT02153983|3934625|FG002|STARTED|Overall Study||4
3205033|NCT02153983|3934626|FG003|STARTED|Overall Study||13
3205034|NCT02153983|3934627|FG004|STARTED|Overall Study||19
3205035|NCT02153983|3934628|FG005|STARTED|Overall Study||1
3205036|NCT02153983|3934623|FG000|COMPLETED|Overall Study||19
3205037|NCT02153983|3934624|FG001|COMPLETED|Overall Study||18
3205038|NCT02153983|3934625|FG002|COMPLETED|Overall Study||2
3205039|NCT02153983|3934626|FG003|COMPLETED|Overall Study||13
3205040|NCT02153983|3934627|FG004|COMPLETED|Overall Study||19
3205041|NCT02153983|3934628|FG005|COMPLETED|Overall Study||1
3205042|NCT02153983|3934623|FG000|NOT COMPLETED|Overall Study||0
3205043|NCT02153983|3934624|FG001|NOT COMPLETED|Overall Study||3
3205044|NCT02153983|3934625|FG002|NOT COMPLETED|Overall Study||2
3205045|NCT02153983|3934626|FG003|NOT COMPLETED|Overall Study||0
3205046|NCT02153983|3934627|FG004|NOT COMPLETED|Overall Study||0
3205047|NCT02153983|3934628|FG005|NOT COMPLETED|Overall Study||0
3205048|NCT02154048|3934645|FG000|STARTED|Overall Study||2
3205049|NCT02154048|3934646|FG001|STARTED|Overall Study||2
3205050|NCT02154048|3934647|FG002|STARTED|Overall Study||1
3205051|NCT02154048|3934645|FG000|COMPLETED|Overall Study||2
3205052|NCT02154048|3934646|FG001|COMPLETED|Overall Study||2
3205053|NCT02154048|3934647|FG002|COMPLETED|Overall Study||1
3205054|NCT02154048|3934645|FG000|NOT COMPLETED|Overall Study||0
3205055|NCT02154048|3934646|FG001|NOT COMPLETED|Overall Study||0
3205056|NCT02154048|3934647|FG002|NOT COMPLETED|Overall Study||0
3205057|NCT02154061|3934657|FG000|STARTED|Overall Study||16
3205058|NCT02154061|3934658|FG001|STARTED|Overall Study||17
3205059|NCT02154061|3934657|FG000|COMPLETED|Overall Study||14
3205060|NCT02154061|3934658|FG001|COMPLETED|Overall Study||17
3205061|NCT02154061|3934657|FG000|NOT COMPLETED|Overall Study||2
3205062|NCT02154061|3934658|FG001|NOT COMPLETED|Overall Study||0
3205063|NCT02154139|3934664|FG000|STARTED|Overall Study||651
3205064|NCT02154139|3934664|FG000|COMPLETED|Overall Study||644
3205065|NCT02154139|3934664|FG000|NOT COMPLETED|Overall Study||7
3205066|NCT02154243|3934671|FG000|STARTED|Overall Study||5
3205067|NCT02154243|3934672|FG001|STARTED|Overall Study||4
3205068|NCT02154243|3934673|FG002|STARTED|Overall Study||4
3205069|NCT02154243|3934671|FG000|COMPLETED|Overall Study||5
3205070|NCT02154243|3934672|FG001|COMPLETED|Overall Study||4
3205071|NCT02154243|3934673|FG002|COMPLETED|Overall Study||4
3205072|NCT02154243|3934671|FG000|NOT COMPLETED|Overall Study||0
3205073|NCT02154243|3934672|FG001|NOT COMPLETED|Overall Study||0
3205074|NCT02154243|3934673|FG002|NOT COMPLETED|Overall Study||0
3205075|NCT02154347|3934683|FG000|STARTED|Double-blind Period||60
3205076|NCT02154347|3934684|FG001|STARTED|Double-blind Period||118
3205077|NCT02154347|3934683|FG000|COMPLETED|Double-blind Period||57
3205078|NCT02154347|3934684|FG001|COMPLETED|Double-blind Period||114
3205079|NCT02154347|3934683|FG000|NOT COMPLETED|Double-blind Period||3
3205080|NCT02154347|3934684|FG001|NOT COMPLETED|Double-blind Period||4
3205081|NCT02154347|3934683|FG000|STARTED|Open-label Period||57
3205082|NCT02154347|3934684|FG001|STARTED|Open-label Period||113
3205083|NCT02154347|3934683|FG000|COMPLETED|Open-label Period||50
3205084|NCT02154347|3934684|FG001|COMPLETED|Open-label Period||88
3205085|NCT02154347|3934683|FG000|NOT COMPLETED|Open-label Period||7
3205086|NCT02154347|3934684|FG001|NOT COMPLETED|Open-label Period||25
3205087|NCT02154386|3934693|FG000|STARTED|Overall Study||23
3205088|NCT02154386|3934694|FG001|STARTED|Overall Study||23
3205089|NCT02154386|3934693|FG000|COMPLETED|Overall Study||22
3205090|NCT02154386|3934694|FG001|COMPLETED|Overall Study||21
3205091|NCT02154386|3934693|FG000|NOT COMPLETED|Overall Study||1
3205092|NCT02154386|3934694|FG001|NOT COMPLETED|Overall Study||2
3205093|NCT02154425|3934700|FG000|STARTED|Screening Period||18
3205094|NCT02154425|3934700|FG000|COMPLETED|Screening Period||17
3205095|NCT02154425|3934700|FG000|NOT COMPLETED|Screening Period||1
3205096|NCT02154425|3934700|FG000|STARTED|Sampling Period||17
3205097|NCT02154425|3934700|FG000|COMPLETED|Sampling Period||17
3205098|NCT02154425|3934700|FG000|NOT COMPLETED|Sampling Period||0
3205099|NCT02154477|3934710|FG000|STARTED|Overall Study||6
3205100|NCT02154477|3934711|FG001|STARTED|Overall Study||8
3205101|NCT02154477|3934710|FG000|COMPLETED|Overall Study||6
3205102|NCT02154477|3934711|FG001|COMPLETED|Overall Study||8
3205103|NCT02154477|3934710|FG000|NOT COMPLETED|Overall Study||0
3205104|NCT02154477|3934711|FG001|NOT COMPLETED|Overall Study||0
3205105|NCT02154581|3934719|FG000|STARTED|Overall Study||21
3205106|NCT02154581|3934720|FG001|STARTED|Overall Study||20
3205107|NCT02154581|3934719|FG000|COMPLETED|Overall Study||14
3205108|NCT02154581|3934720|FG001|COMPLETED|Overall Study||12
3205109|NCT02154581|3934719|FG000|NOT COMPLETED|Overall Study||7
3205110|NCT02154581|3934720|FG001|NOT COMPLETED|Overall Study||8
3205111|NCT02154672|3934728|FG000|STARTED|Overall Study||1
3205112|NCT02154672|3934728|FG000|COMPLETED|Overall Study||1
3205113|NCT02154672|3934728|FG000|NOT COMPLETED|Overall Study||0
3205114|NCT02154763|3934734|FG000|STARTED|Overall Study||60
3205115|NCT02154763|3934735|FG001|STARTED|Overall Study||60
3205116|NCT02154763|3934734|FG000|COMPLETED|Overall Study||46
3205117|NCT02154763|3934735|FG001|COMPLETED|Overall Study||46
3205118|NCT02154763|3934734|FG000|NOT COMPLETED|Overall Study||14
3205119|NCT02154763|3934735|FG001|NOT COMPLETED|Overall Study||14
3205120|NCT02154906|3934745|FG000|STARTED|Overall Study||21
3205121|NCT02154906|3934746|FG001|STARTED|Overall Study||20
3205122|NCT02154906|3934745|FG000|COMPLETED|Overall Study||19
3205123|NCT02154906|3934746|FG001|COMPLETED|Overall Study||17
3205124|NCT02154906|3934745|FG000|NOT COMPLETED|Overall Study||2
3205125|NCT02154906|3934746|FG001|NOT COMPLETED|Overall Study||3
3205126|NCT02155010|3934754|FG000|STARTED|Overall Study||37
3205127|NCT02155010|3934755|FG001|STARTED|Overall Study||37
3205128|NCT02155010|3934754|FG000|COMPLETED|Overall Study||31
3205129|NCT02155010|3934755|FG001|COMPLETED|Overall Study||31
3205130|NCT02155010|3934754|FG000|NOT COMPLETED|Overall Study||6
3205131|NCT02155010|3934755|FG001|NOT COMPLETED|Overall Study||6
3205132|NCT02155101|3934763|FG000|STARTED|Overall Study||39
3205133|NCT02155101|3934764|FG001|STARTED|Overall Study||81
3205134|NCT02155101|3934763|FG000|COMPLETED|Overall Study||39
3205135|NCT02155101|3934764|FG001|COMPLETED|Overall Study||80
3205136|NCT02155101|3934763|FG000|NOT COMPLETED|Overall Study||0
3205137|NCT02155101|3934764|FG001|NOT COMPLETED|Overall Study||1
3205138|NCT02155257|3934773|FG000|STARTED|Overall Study||10
3205139|NCT02155257|3934774|FG001|STARTED|Overall Study||10
3205140|NCT02155257|3934775|FG002|STARTED|Overall Study||10
3205141|NCT02155257|3934773|FG000|COMPLETED|Overall Study||10
3205142|NCT02155257|3934774|FG001|COMPLETED|Overall Study||10
3205143|NCT02155257|3934775|FG002|COMPLETED|Overall Study||10
3205144|NCT02155257|3934773|FG000|NOT COMPLETED|Overall Study||0
3205145|NCT02155257|3934774|FG001|NOT COMPLETED|Overall Study||0
3205146|NCT02155257|3934775|FG002|NOT COMPLETED|Overall Study||0
3205147|NCT02155283|3934783|FG000|STARTED|Overall Study||16
3205148|NCT02155283|3934783|FG000|COMPLETED|Overall Study||9
3205149|NCT02155283|3934783|FG000|NOT COMPLETED|Overall Study||7
3205150|NCT02155309|3934789|FG000|STARTED|Overall Study||13
3205151|NCT02155309|3934790|FG001|STARTED|Overall Study||10
3205152|NCT02155309|3934791|FG002|STARTED|Overall Study||13
3205153|NCT02155309|3934789|FG000|COMPLETED|Overall Study||13
3205154|NCT02155309|3934790|FG001|COMPLETED|Overall Study||10
3205155|NCT02155309|3934791|FG002|COMPLETED|Overall Study||12
3205156|NCT02155309|3934789|FG000|NOT COMPLETED|Overall Study||0
3205157|NCT02155309|3934790|FG001|NOT COMPLETED|Overall Study||0
3205158|NCT02155309|3934791|FG002|NOT COMPLETED|Overall Study||1
3205159|NCT02155322|3934798|FG000|STARTED|Overall Study||33
3205160|NCT02155322|3934798|FG000|Treated|Overall Study|32 of 33 participants treated. 1 participant not treated at the discretion of the investigator.|32
3205161|NCT02155322|3934798|FG000|COMPLETED|Overall Study||19
3205162|NCT02155322|3934798|FG000|NOT COMPLETED|Overall Study||14
3205163|NCT02155335|3934802|FG000|STARTED|Period 1||50
3205164|NCT02155335|3934803|FG001|STARTED|Period 1||50
3205165|NCT02155335|3934802|FG000|Treated|Period 1||50
3205166|NCT02155335|3934803|FG001|Treated|Period 1||49
3205167|NCT02155335|3934802|FG000|COMPLETED|Period 1||50
3205168|NCT02155335|3934803|FG001|COMPLETED|Period 1||49
3205169|NCT02155335|3934802|FG000|NOT COMPLETED|Period 1||0
3205170|NCT02155335|3934803|FG001|NOT COMPLETED|Period 1||1
3205171|NCT02155335|3934802|FG000|STARTED|Period 2||50
3205172|NCT02155335|3934803|FG001|STARTED|Period 2||49
3205173|NCT02155335|3934802|FG000|COMPLETED|Period 2||50
3205174|NCT02155335|3934803|FG001|COMPLETED|Period 2||49
3205175|NCT02155335|3934802|FG000|NOT COMPLETED|Period 2||0
3205176|NCT02155335|3934803|FG001|NOT COMPLETED|Period 2||0
3205177|NCT02155465|3934814|FG000|STARTED|Overall Study||3
3205178|NCT02155465|3934815|FG001|STARTED|Overall Study||3
3205179|NCT02155465|3934816|FG002|STARTED|Overall Study||6
3205180|NCT02155465|3934817|FG003|STARTED|Overall Study||2
3205181|NCT02155465|3934818|FG004|STARTED|Overall Study||1
3205182|NCT02155465|3934819|FG005|STARTED|Overall Study||2
3205183|NCT02155465|3934820|FG006|STARTED|Overall Study||5
3205184|NCT02155465|3934814|FG000|COMPLETED|Overall Study||3
3205185|NCT02155465|3934815|FG001|COMPLETED|Overall Study||3
3205186|NCT02155465|3934816|FG002|COMPLETED|Overall Study||6
3205187|NCT02155465|3934817|FG003|COMPLETED|Overall Study||2
3205188|NCT02155465|3934818|FG004|COMPLETED|Overall Study||1
3205189|NCT02155465|3934819|FG005|COMPLETED|Overall Study||2
3205190|NCT02155465|3934820|FG006|COMPLETED|Overall Study||5
3205191|NCT02155465|3934814|FG000|NOT COMPLETED|Overall Study||0
3205192|NCT02155465|3934815|FG001|NOT COMPLETED|Overall Study||0
3205193|NCT02155465|3934816|FG002|NOT COMPLETED|Overall Study||0
3205194|NCT02155465|3934817|FG003|NOT COMPLETED|Overall Study||0
3205195|NCT02155465|3934818|FG004|NOT COMPLETED|Overall Study||0
3205196|NCT02155465|3934819|FG005|NOT COMPLETED|Overall Study||0
3205197|NCT02155465|3934820|FG006|NOT COMPLETED|Overall Study||0
3205198|NCT02155543|3934846|FG000|STARTED|Overall Study||9
3205199|NCT02155543|3934847|FG001|STARTED|Overall Study||9
3205200|NCT02155543|3934848|FG002|STARTED|Overall Study||9
3205201|NCT02155543|3934849|FG003|STARTED|Overall Study||9
3205202|NCT02155543|3934850|FG004|STARTED|Overall Study||3
3205203|NCT02155543|3934851|FG005|STARTED|Overall Study||3
3205204|NCT02155543|3934852|FG006|STARTED|Overall Study||9
3205205|NCT02155543|3934846|FG000|COMPLETED|Overall Study||9
3205206|NCT02155543|3934847|FG001|COMPLETED|Overall Study||9
3205207|NCT02155543|3934848|FG002|COMPLETED|Overall Study||9
3205208|NCT02155543|3934849|FG003|COMPLETED|Overall Study||9
3205209|NCT02155543|3934850|FG004|COMPLETED|Overall Study||3
3205210|NCT02155543|3934851|FG005|COMPLETED|Overall Study||3
3205211|NCT02155543|3934852|FG006|COMPLETED|Overall Study||9
3205212|NCT02155543|3934846|FG000|NOT COMPLETED|Overall Study||0
3205213|NCT02155543|3934847|FG001|NOT COMPLETED|Overall Study||0
3205214|NCT02155543|3934848|FG002|NOT COMPLETED|Overall Study||0
3205215|NCT02155543|3934849|FG003|NOT COMPLETED|Overall Study||0
3205216|NCT02155543|3934850|FG004|NOT COMPLETED|Overall Study||0
3205217|NCT02155543|3934851|FG005|NOT COMPLETED|Overall Study||0
3205218|NCT02155543|3934852|FG006|NOT COMPLETED|Overall Study||0
3205219|NCT02155608|3934867|FG000|STARTED|1a: 4 Week Double Blind Sham Controlled||32
3205220|NCT02155608|3934868|FG001|STARTED|1a: 4 Week Double Blind Sham Controlled||30
3205221|NCT02155608|3934867|FG000|COMPLETED|1a: 4 Week Double Blind Sham Controlled||32
3205222|NCT02155608|3934868|FG001|COMPLETED|1a: 4 Week Double Blind Sham Controlled||29
3205223|NCT02155608|3934867|FG000|NOT COMPLETED|1a: 4 Week Double Blind Sham Controlled||0
3205224|NCT02155608|3934868|FG001|NOT COMPLETED|1a: 4 Week Double Blind Sham Controlled||1
3205225|NCT02155608|3934867|FG000|STARTED|1b: 1 Week Blinded Post Treatment||32
3205226|NCT02155608|3934868|FG001|STARTED|1b: 1 Week Blinded Post Treatment||29
3205227|NCT02155608|3934867|FG000|COMPLETED|1b: 1 Week Blinded Post Treatment||31
3205228|NCT02155608|3934868|FG001|COMPLETED|1b: 1 Week Blinded Post Treatment||28
3205229|NCT02155608|3934867|FG000|NOT COMPLETED|1b: 1 Week Blinded Post Treatment||1
3205230|NCT02155608|3934868|FG001|NOT COMPLETED|1b: 1 Week Blinded Post Treatment||1
3205231|NCT02155647|3934882|FG000|STARTED|Overall Study||88
3205232|NCT02155647|3934883|FG001|STARTED|Overall Study||116
3205233|NCT02155647|3934882|FG000|COMPLETED|Overall Study||47
3205234|NCT02155647|3934883|FG001|COMPLETED|Overall Study||64
3205235|NCT02155647|3934882|FG000|NOT COMPLETED|Overall Study||41
3205236|NCT02155647|3934883|FG001|NOT COMPLETED|Overall Study||52
3205237|NCT02155660|3934893|FG000|STARTED|Overall Study||562
3205238|NCT02155660|3934894|FG001|STARTED|Overall Study||562
3205239|NCT02155660|3934895|FG002|STARTED|Overall Study||562
3205240|NCT02155660|3934896|FG003|STARTED|Overall Study||568
3205241|NCT02155660|3934893|FG000|COMPLETED|Overall Study||504
3205242|NCT02155660|3934894|FG001|COMPLETED|Overall Study||489
3205243|NCT02155660|3934895|FG002|COMPLETED|Overall Study||502
3205244|NCT02155660|3934896|FG003|COMPLETED|Overall Study||507
3205245|NCT02155660|3934893|FG000|NOT COMPLETED|Overall Study||58
3205246|NCT02155660|3934894|FG001|NOT COMPLETED|Overall Study||73
3205247|NCT02155660|3934895|FG002|NOT COMPLETED|Overall Study||60
3205248|NCT02155660|3934896|FG003|NOT COMPLETED|Overall Study||61
3205249|NCT02155712|3934908|FG000|STARTED|Primary Objective||319
3205250|NCT02155712|3934909|FG001|STARTED|Primary Objective|Cohort 2 isn't included in primary obj analysis|0
3205251|NCT02155712|3934908|FG000|COMPLETED|Primary Objective||259
3205252|NCT02155712|3934909|FG001|COMPLETED|Primary Objective||0
3205253|NCT02155712|3934908|FG000|NOT COMPLETED|Primary Objective||60
3205254|NCT02155712|3934909|FG001|NOT COMPLETED|Primary Objective||0
3205255|NCT02155712|3934908|FG000|STARTED|Secondary Objectives||319
3205256|NCT02155712|3934909|FG001|STARTED|Secondary Objectives|This period will be updated when posting secondary objective results.|134
3205257|NCT02155712|3934908|FG000|COMPLETED|Secondary Objectives||0
3205258|NCT02155712|3934909|FG001|COMPLETED|Secondary Objectives||0
3205259|NCT02155712|3934908|FG000|NOT COMPLETED|Secondary Objectives||319
3205260|NCT02155712|3934909|FG001|NOT COMPLETED|Secondary Objectives||134
3205261|NCT02155725|3934917|FG000|STARTED|Treatment Period||224
3205262|NCT02155725|3934918|FG001|STARTED|Treatment Period||213
3205263|NCT02155725|3934917|FG000|COMPLETED|Treatment Period||224
3205264|NCT02155725|3934918|FG001|COMPLETED|Treatment Period||213
3205265|NCT02155725|3934917|FG000|NOT COMPLETED|Treatment Period||0
3205266|NCT02155725|3934918|FG001|NOT COMPLETED|Treatment Period||0
3205267|NCT02155725|3934917|FG000|STARTED|Follow-up Period||224
3205268|NCT02155725|3934918|FG001|STARTED|Follow-up Period||213
3205269|NCT02155725|3934917|FG000|COMPLETED|Follow-up Period||207
3205270|NCT02155725|3934918|FG001|COMPLETED|Follow-up Period||202
3205271|NCT02155725|3934917|FG000|NOT COMPLETED|Follow-up Period||17
3205272|NCT02155725|3934918|FG001|NOT COMPLETED|Follow-up Period||11
3205273|NCT02155738|3934934|FG000|STARTED|Overall Study||50
3205274|NCT02155738|3934935|FG001|STARTED|Overall Study||52
3205275|NCT02155738|3934936|FG002|STARTED|Overall Study||51
3205276|NCT02155738|3934937|FG003|STARTED|Overall Study||51
3205277|NCT02155738|3934934|FG000|COMPLETED|Overall Study||49
3205278|NCT02155738|3934935|FG001|COMPLETED|Overall Study||52
3205279|NCT02155738|3934936|FG002|COMPLETED|Overall Study||51
3205280|NCT02155738|3934937|FG003|COMPLETED|Overall Study||50
3205281|NCT02155738|3934934|FG000|NOT COMPLETED|Overall Study||1
3205282|NCT02155738|3934935|FG001|NOT COMPLETED|Overall Study||0
3205283|NCT02155738|3934936|FG002|NOT COMPLETED|Overall Study||0
3205284|NCT02155738|3934937|FG003|NOT COMPLETED|Overall Study||1
3205285|NCT02155829|3934949|FG000|STARTED|Overall Study||37
3205286|NCT02155829|3934950|FG001|STARTED|Overall Study||38
3205287|NCT02155829|3934949|FG000|COMPLETED|Overall Study||31
3205288|NCT02155829|3934950|FG001|COMPLETED|Overall Study||35
3205289|NCT02155829|3934949|FG000|NOT COMPLETED|Overall Study||6
3205290|NCT02155829|3934950|FG001|NOT COMPLETED|Overall Study||3
3205291|NCT02155881|3934959|FG000|STARTED|Overall Study||40
3205292|NCT02155881|3934960|FG001|STARTED|Overall Study||40
3205293|NCT02155881|3934959|FG000|COMPLETED|Overall Study||38
3205294|NCT02155881|3934960|FG001|COMPLETED|Overall Study||36
3205295|NCT02155881|3934959|FG000|NOT COMPLETED|Overall Study||2
3205296|NCT02155881|3934960|FG001|NOT COMPLETED|Overall Study||4
3205297|NCT02155985|3934969|FG000|STARTED|Overall Study||40
3205298|NCT02155985|3934970|FG001|STARTED|Overall Study||41
3205299|NCT02155985|3934971|FG002|STARTED|Overall Study||40
3205300|NCT02155985|3934969|FG000|COMPLETED|Overall Study||39
3205301|NCT02155985|3934970|FG001|COMPLETED|Overall Study||41
3205302|NCT02155985|3934971|FG002|COMPLETED|Overall Study||39
3205303|NCT02155985|3934969|FG000|NOT COMPLETED|Overall Study||1
3205304|NCT02155985|3934970|FG001|NOT COMPLETED|Overall Study||0
3205305|NCT02155985|3934971|FG002|NOT COMPLETED|Overall Study||1
3205306|NCT02156076|3934983|FG000|STARTED|Treatment Period||7
3205307|NCT02156076|3934984|FG001|STARTED|Treatment Period||7
3205308|NCT02156076|3934985|FG002|STARTED|Treatment Period||6
3205309|NCT02156076|3934986|FG003|STARTED|Treatment Period||6
3205310|NCT02156076|3934983|FG000|COMPLETED|Treatment Period||7
3205311|NCT02156076|3934984|FG001|COMPLETED|Treatment Period||5
3205312|NCT02156076|3934985|FG002|COMPLETED|Treatment Period||4
3205313|NCT02156076|3934986|FG003|COMPLETED|Treatment Period||4
3205314|NCT02156076|3934983|FG000|NOT COMPLETED|Treatment Period||0
3205315|NCT02156076|3934984|FG001|NOT COMPLETED|Treatment Period||2
3205316|NCT02156076|3934985|FG002|NOT COMPLETED|Treatment Period||2
3205317|NCT02156076|3934986|FG003|NOT COMPLETED|Treatment Period||2
3205318|NCT02156076|3934983|FG000|STARTED|Follow-up Period||7
3205319|NCT02156076|3934984|FG001|STARTED|Follow-up Period||5
3365649|NCT03963401|4096792|FG000|COMPLETED|Extension Period (Week 17 - Week 52)||43
3365650|NCT03963401|4096793|FG001|COMPLETED|Extension Period (Week 17 - Week 52)||52
3365651|NCT03963401|4096794|FG002|COMPLETED|Extension Period (Week 17 - Week 52)||10
3365652|NCT03963401|4096795|FG003|COMPLETED|Extension Period (Week 17 - Week 52)||12
3365653|NCT03963401|4096796|FG004|COMPLETED|Extension Period (Week 17 - Week 52)||25
3365654|NCT03963401|4096797|FG005|COMPLETED|Extension Period (Week 17 - Week 52)||26
3365655|NCT03963401|4096792|FG000|NOT COMPLETED|Extension Period (Week 17 - Week 52)||14
3365656|NCT03963401|4096793|FG001|NOT COMPLETED|Extension Period (Week 17 - Week 52)||5
3365657|NCT03963401|4096794|FG002|NOT COMPLETED|Extension Period (Week 17 - Week 52)||4
3365658|NCT03963401|4096795|FG003|NOT COMPLETED|Extension Period (Week 17 - Week 52)||1
3365659|NCT03963401|4096796|FG004|NOT COMPLETED|Extension Period (Week 17 - Week 52)||6
3365660|NCT03963401|4096797|FG005|NOT COMPLETED|Extension Period (Week 17 - Week 52)||5
3365661|NCT03962634|4096817|FG000|STARTED|Overall Study||1
3365662|NCT03962634|4096818|FG001|STARTED|Overall Study||2
3365663|NCT03962634|4096817|FG000|COMPLETED|Overall Study||1
3365664|NCT03962634|4096818|FG001|COMPLETED|Overall Study||2
3365665|NCT03962634|4096817|FG000|NOT COMPLETED|Overall Study||0
3365666|NCT03962634|4096818|FG001|NOT COMPLETED|Overall Study||0
3365667|NCT03962790|4096824|FG000|STARTED|Period 1||48
3365668|NCT03962790|4096825|FG001|STARTED|Period 1||46
3365669|NCT03962790|4096824|FG000|COMPLETED|Period 1||45
3365670|NCT03962790|4096825|FG001|COMPLETED|Period 1||44
3365671|NCT03962790|4096824|FG000|NOT COMPLETED|Period 1||3
3365672|NCT03962790|4096825|FG001|NOT COMPLETED|Period 1||2
3365673|NCT03962790|4096824|FG000|STARTED|Period 2||45
3365674|NCT03962790|4096825|FG001|STARTED|Period 2||44
3365675|NCT03962790|4096824|FG000|COMPLETED|Period 2||45
3365676|NCT03962790|4096825|FG001|COMPLETED|Period 2||44
3365677|NCT03962790|4096824|FG000|NOT COMPLETED|Period 2||0
3365678|NCT03962790|4096825|FG001|NOT COMPLETED|Period 2||0
3365679|NCT03956225|4096833|FG000|STARTED|Overall Study||119
3365680|NCT03956225|4096834|FG001|STARTED|Overall Study||117
3365681|NCT03956225|4096833|FG000|COMPLETED|Overall Study||114
3365682|NCT03956225|4096834|FG001|COMPLETED|Overall Study||113
3365683|NCT03956225|4096833|FG000|NOT COMPLETED|Overall Study||5
3365684|NCT03956225|4096834|FG001|NOT COMPLETED|Overall Study||4
3365685|NCT03951610|4096843|FG000|STARTED|First Intervention||27
3365686|NCT03951610|4096844|FG001|STARTED|First Intervention||25
3365687|NCT03951610|4096843|FG000|COMPLETED|First Intervention||27
3365688|NCT03951610|4096844|FG001|COMPLETED|First Intervention||25
3365689|NCT03951610|4096843|FG000|NOT COMPLETED|First Intervention||0
3365690|NCT03951610|4096844|FG001|NOT COMPLETED|First Intervention||0
3365691|NCT03951610|4096843|FG000|STARTED|Second Intervention||27
3365692|NCT03951610|4096844|FG001|STARTED|Second Intervention||25
3365693|NCT03951610|4096843|FG000|COMPLETED|Second Intervention||27
3365694|NCT03951610|4096844|FG001|COMPLETED|Second Intervention||25
3205320|NCT02156076|3934985|FG002|STARTED|Follow-up Period||4
3205321|NCT02156076|3934986|FG003|STARTED|Follow-up Period||4
3205322|NCT02156076|3934983|FG000|COMPLETED|Follow-up Period||6
3205323|NCT02156076|3934984|FG001|COMPLETED|Follow-up Period||5
3205324|NCT02156076|3934985|FG002|COMPLETED|Follow-up Period||4
3205325|NCT02156076|3934986|FG003|COMPLETED|Follow-up Period||4
3205326|NCT02156076|3934983|FG000|NOT COMPLETED|Follow-up Period||1
3205327|NCT02156076|3934984|FG001|NOT COMPLETED|Follow-up Period||0
3205328|NCT02156076|3934985|FG002|NOT COMPLETED|Follow-up Period||0
3365695|NCT03951610|4096843|FG000|NOT COMPLETED|Second Intervention||0
3365696|NCT03951610|4096844|FG001|NOT COMPLETED|Second Intervention||0
3365697|NCT03958149|4096852|FG000|STARTED|Overall Study||20
3365698|NCT03958149|4096853|FG001|STARTED|Overall Study||18
3205329|NCT02156076|3934986|FG003|NOT COMPLETED|Follow-up Period||0
3205330|NCT02156154|3934998|FG000|STARTED|Overall Study||291
3205331|NCT02156154|3934999|FG001|STARTED|Overall Study||289
3205332|NCT02156154|3934998|FG000|COMPLETED|Overall Study||287
3205333|NCT02156154|3934999|FG001|COMPLETED|Overall Study||283
3205334|NCT02156154|3934998|FG000|NOT COMPLETED|Overall Study||4
3205335|NCT02156154|3934999|FG001|NOT COMPLETED|Overall Study||6
3365699|NCT03958149|4096852|FG000|COMPLETED|Overall Study||20
3365700|NCT03958149|4096853|FG001|COMPLETED|Overall Study||17
3365701|NCT03958149|4096852|FG000|NOT COMPLETED|Overall Study||0
3365702|NCT03958149|4096853|FG001|NOT COMPLETED|Overall Study||1
3365703|NCT03953183|4096865|FG000|STARTED|Overall Study||30
3365704|NCT03953183|4096866|FG001|STARTED|Overall Study||30
3365705|NCT03953183|4096865|FG000|COMPLETED|Overall Study||30
3365706|NCT03953183|4096866|FG001|COMPLETED|Overall Study||28
3365707|NCT03953183|4096865|FG000|NOT COMPLETED|Overall Study||0
3365708|NCT03953183|4096866|FG001|NOT COMPLETED|Overall Study||2
3365709|NCT03949335|4096874|FG000|STARTED|Overall Study||135
3365710|NCT03949335|4096875|FG001|STARTED|Overall Study||137
3365711|NCT03949335|4096874|FG000|COMPLETED|Overall Study||132
3365712|NCT03949335|4096875|FG001|COMPLETED|Overall Study||131
3365713|NCT03949335|4096874|FG000|NOT COMPLETED|Overall Study||3
3365714|NCT03949335|4096875|FG001|NOT COMPLETED|Overall Study||6
3365715|NCT03962738|4096887|FG000|STARTED|Overall Study||258
3365716|NCT03962738|4096888|FG001|STARTED|Overall Study||109
3365717|NCT03962738|4096889|FG002|STARTED|Overall Study||261
3365718|NCT03962738|4096890|FG003|STARTED|Overall Study||218
3365719|NCT03962738|4096887|FG000|Received At Least One Dose of Study Drug|Overall Study||214
3365720|NCT03962738|4096888|FG001|Received At Least One Dose of Study Drug|Overall Study||87
3365721|NCT03962738|4096889|FG002|Received At Least One Dose of Study Drug|Overall Study||208
3365722|NCT03962738|4096890|FG003|Received At Least One Dose of Study Drug|Overall Study||182
3365723|NCT03962738|4096887|FG000|COMPLETED|Overall Study||251
3365724|NCT03962738|4096888|FG001|COMPLETED|Overall Study||109
3365725|NCT03962738|4096889|FG002|COMPLETED|Overall Study||259
3365726|NCT03962738|4096890|FG003|COMPLETED|Overall Study||217
3365727|NCT03962738|4096887|FG000|NOT COMPLETED|Overall Study||7
3365728|NCT03962738|4096888|FG001|NOT COMPLETED|Overall Study||0
3365729|NCT03962738|4096889|FG002|NOT COMPLETED|Overall Study||2
3365730|NCT03962738|4096890|FG003|NOT COMPLETED|Overall Study||1
3365731|NCT03962101|4096908|FG000|STARTED|Overall Study||45
3365732|NCT03962101|4096908|FG000|COMPLETED|Overall Study||41
3365733|NCT03962101|4096908|FG000|NOT COMPLETED|Overall Study||4
3365734|NCT03959137|4096913|FG000|STARTED|Overall Study||215
3365735|NCT03959137|4096913|FG000|COMPLETED|Overall Study||209
3365736|NCT03959137|4096913|FG000|NOT COMPLETED|Overall Study||6
3365737|NCT03946124|4096917|FG000|STARTED|Overall Study||74
3365738|NCT03946124|4096917|FG000|COMPLETED|Overall Study||55
3365739|NCT03946124|4096917|FG000|NOT COMPLETED|Overall Study||19
3365740|NCT03961308|4096923|FG000|STARTED|Overall Study||102
3365741|NCT03961308|4096924|FG001|STARTED|Overall Study||102
3365742|NCT03961308|4096923|FG000|COMPLETED|Overall Study||100
3365743|NCT03961308|4096924|FG001|COMPLETED|Overall Study||100
3365744|NCT03961308|4096923|FG000|NOT COMPLETED|Overall Study||2
3365745|NCT03961308|4096924|FG001|NOT COMPLETED|Overall Study||2
3365746|NCT03961295|4096932|FG000|STARTED|Overall Study||12
3365747|NCT03961295|4096933|FG001|STARTED|Overall Study||12
3365748|NCT03961295|4096932|FG000|COMPLETED|Overall Study||12
3365749|NCT03961295|4096933|FG001|COMPLETED|Overall Study||12
3365750|NCT03961295|4096932|FG000|NOT COMPLETED|Overall Study||0
3365751|NCT03961295|4096933|FG001|NOT COMPLETED|Overall Study||0
3365752|NCT03960957|4096941|FG000|STARTED|Overall Study||224
3365753|NCT03960957|4096942|FG001|STARTED|Overall Study||77
3365754|NCT03960957|4096941|FG000|COMPLETED|Overall Study||216
3365755|NCT03960957|4096942|FG001|COMPLETED|Overall Study||71
3365756|NCT03960957|4096941|FG000|NOT COMPLETED|Overall Study||8
3365757|NCT03960957|4096942|FG001|NOT COMPLETED|Overall Study||6
3365758|NCT03956862|4096950|FG000|STARTED|Overall Study||50
3365759|NCT03956862|4096951|FG001|STARTED|Overall Study||47
3365760|NCT03956862|4096950|FG000|COMPLETED|Overall Study||48
3365761|NCT03956862|4096951|FG001|COMPLETED|Overall Study||45
3365762|NCT03956862|4096950|FG000|NOT COMPLETED|Overall Study||2
3365763|NCT03956862|4096951|FG001|NOT COMPLETED|Overall Study||2
3365764|NCT03954444|4096960|FG000|STARTED|Overall Study||379
3365765|NCT03954444|4096961|FG001|STARTED|Overall Study||382
3365766|NCT03954444|4096962|FG002|STARTED|Overall Study||344
3365767|NCT03954444|4096960|FG000|COMPLETED|Overall Study||366
3365768|NCT03954444|4096961|FG001|COMPLETED|Overall Study||366
3365769|NCT03954444|4096962|FG002|COMPLETED|Overall Study||327
3365770|NCT03954444|4096960|FG000|NOT COMPLETED|Overall Study||13
3365771|NCT03954444|4096961|FG001|NOT COMPLETED|Overall Study||16
3365772|NCT03954444|4096962|FG002|NOT COMPLETED|Overall Study||17
3365773|NCT03953820|4096970|FG000|STARTED|Two-Sequence, Two-Way Crossover||15
3365774|NCT03953820|4096971|FG001|STARTED|Two-Sequence, Two-Way Crossover||16
3365775|NCT03953820|4096972|FG002|STARTED|Two-Sequence, Two-Way Crossover||0
3365776|NCT03953820|4096970|FG000|COMPLETED|Two-Sequence, Two-Way Crossover||13
3365777|NCT03953820|4096971|FG001|COMPLETED|Two-Sequence, Two-Way Crossover||16
3365778|NCT03953820|4096972|FG002|COMPLETED|Two-Sequence, Two-Way Crossover||0
3365779|NCT03953820|4096970|FG000|NOT COMPLETED|Two-Sequence, Two-Way Crossover||2
3365780|NCT03953820|4096971|FG001|NOT COMPLETED|Two-Sequence, Two-Way Crossover||0
3365781|NCT03953820|4096972|FG002|NOT COMPLETED|Two-Sequence, Two-Way Crossover||0
3205336|NCT02156167|3935005|FG000|STARTED|Overall Study||15
3205337|NCT02156167|3935005|FG000|COMPLETED|Overall Study||15
3205338|NCT02156167|3935005|FG000|NOT COMPLETED|Overall Study||0
3205339|NCT02156258|3935012|FG000|STARTED|Overall Study||674
3205340|NCT02156258|3935013|FG001|STARTED|Overall Study||203
3205341|NCT02156258|3935014|FG002|STARTED|Overall Study||355
3205342|NCT02156258|3935012|FG000|COMPLETED|Overall Study||642
3205343|NCT02156258|3935013|FG001|COMPLETED|Overall Study||124
3205344|NCT02156258|3935014|FG002|COMPLETED|Overall Study||244
3205345|NCT02156258|3935012|FG000|NOT COMPLETED|Overall Study||32
3205346|NCT02156258|3935013|FG001|NOT COMPLETED|Overall Study||79
3205347|NCT02156258|3935014|FG002|NOT COMPLETED|Overall Study||111
3205348|NCT02156271|3935024|FG000|STARTED|Overall Study||26
3205349|NCT02156271|3935025|FG001|STARTED|Overall Study||13
3205350|NCT02156271|3935024|FG000|COMPLETED|Overall Study||22
3205351|NCT02156271|3935025|FG001|COMPLETED|Overall Study||10
3205352|NCT02156271|3935024|FG000|NOT COMPLETED|Overall Study||4
3205353|NCT02156271|3935025|FG001|NOT COMPLETED|Overall Study||3
3205354|NCT02156466|3935036|FG000|STARTED|Overall Study||8
3205355|NCT02156466|3935037|FG001|STARTED|Overall Study||8
3205356|NCT02156466|3935038|FG002|STARTED|Overall Study||8
3205357|NCT02156466|3935039|FG003|STARTED|Overall Study||9
3205358|NCT02156466|3935040|FG004|STARTED|Overall Study||8
3205359|NCT02156466|3935036|FG000|COMPLETED|Overall Study||8
3205360|NCT02156466|3935037|FG001|COMPLETED|Overall Study||8
3205361|NCT02156466|3935038|FG002|COMPLETED|Overall Study||7
3205362|NCT02156466|3935039|FG003|COMPLETED|Overall Study||7
3205363|NCT02156466|3935040|FG004|COMPLETED|Overall Study||8
3205364|NCT02156466|3935036|FG000|NOT COMPLETED|Overall Study||0
3205365|NCT02156466|3935037|FG001|NOT COMPLETED|Overall Study||0
3205366|NCT02156466|3935038|FG002|NOT COMPLETED|Overall Study||1
3205367|NCT02156466|3935039|FG003|NOT COMPLETED|Overall Study||2
3205368|NCT02156466|3935040|FG004|NOT COMPLETED|Overall Study||0
3205369|NCT02156492|3935064|FG000|STARTED|Period 1||16
3205370|NCT02156492|3935065|FG001|STARTED|Period 1||24
3205371|NCT02156492|3935066|FG002|STARTED|Period 1||22
3205372|NCT02156492|3935064|FG000|Received at Least One Dose of Study Drug|Period 1||16
3205373|NCT02156492|3935065|FG001|Received at Least One Dose of Study Drug|Period 1||24
3205374|NCT02156492|3935066|FG002|Received at Least One Dose of Study Drug|Period 1||22
3205375|NCT02156492|3935064|FG000|COMPLETED|Period 1||16
3205376|NCT02156492|3935065|FG001|COMPLETED|Period 1||23
3205377|NCT02156492|3935066|FG002|COMPLETED|Period 1||22
3205378|NCT02156492|3935064|FG000|NOT COMPLETED|Period 1||0
3205379|NCT02156492|3935065|FG001|NOT COMPLETED|Period 1||1
3205380|NCT02156492|3935066|FG002|NOT COMPLETED|Period 1||0
3205381|NCT02156492|3935064|FG000|STARTED|Period 2||16
3205382|NCT02156492|3935065|FG001|STARTED|Period 2||23
3205383|NCT02156492|3935066|FG002|STARTED|Period 2||22
3205384|NCT02156492|3935064|FG000|COMPLETED|Period 2||16
3205385|NCT02156492|3935065|FG001|COMPLETED|Period 2||23
3205386|NCT02156492|3935066|FG002|COMPLETED|Period 2||22
3205387|NCT02156492|3935064|FG000|NOT COMPLETED|Period 2||0
3205388|NCT02156492|3935065|FG001|NOT COMPLETED|Period 2||0
3205389|NCT02156492|3935066|FG002|NOT COMPLETED|Period 2||0
3205390|NCT02156492|3935064|FG000|STARTED|Period 3|Cohort A participated in Period 1 and Period 2 only.|0
3205391|NCT02156492|3935065|FG001|STARTED|Period 3||23
3205392|NCT02156492|3935066|FG002|STARTED|Period 3||22
3205393|NCT02156492|3935064|FG000|COMPLETED|Period 3||0
3205394|NCT02156492|3935065|FG001|COMPLETED|Period 3||22
3205395|NCT02156492|3935066|FG002|COMPLETED|Period 3||22
3205396|NCT02156492|3935064|FG000|NOT COMPLETED|Period 3||0
3205397|NCT02156492|3935065|FG001|NOT COMPLETED|Period 3||1
3205398|NCT02156492|3935066|FG002|NOT COMPLETED|Period 3||0
3205399|NCT02156674|3935084|FG000|STARTED|Overall Study||1
3205400|NCT02156674|3935084|FG000|COMPLETED|Overall Study||1
3205401|NCT02156674|3935084|FG000|NOT COMPLETED|Overall Study||0
3205402|NCT02156687|3935090|FG000|STARTED|Overall Study||30
3205403|NCT02156687|3935091|FG001|STARTED|Overall Study||29
3205404|NCT02156687|3935090|FG000|COMPLETED|Overall Study||20
3205405|NCT02156687|3935091|FG001|COMPLETED|Overall Study||24
3205406|NCT02156687|3935090|FG000|NOT COMPLETED|Overall Study||10
3205407|NCT02156687|3935091|FG001|NOT COMPLETED|Overall Study||5
3205408|NCT02156804|3935097|FG000|STARTED|Overall Study||1009
3205409|NCT02156804|3935097|FG000|COMPLETED|Overall Study||1008
3205410|NCT02156804|3935097|FG000|NOT COMPLETED|Overall Study||1
3205411|NCT02156908|3935103|FG000|STARTED|Overall Study||5
3205412|NCT02156908|3935104|FG001|STARTED|Overall Study||3
3205413|NCT02156908|3935103|FG000|COMPLETED|Overall Study||5
3205414|NCT02156908|3935104|FG001|COMPLETED|Overall Study||3
3205415|NCT02156908|3935103|FG000|NOT COMPLETED|Overall Study||0
3205416|NCT02156908|3935104|FG001|NOT COMPLETED|Overall Study||0
3205417|NCT02157103|3935111|FG000|STARTED|Overall Study||3
3205418|NCT02157103|3935111|FG000|COMPLETED|Overall Study||3
3205419|NCT02157103|3935111|FG000|NOT COMPLETED|Overall Study||0
3205420|NCT02157168|3935118|FG000|STARTED|Overall Study||746
3205421|NCT02157168|3935119|FG001|STARTED|Overall Study||159
3205422|NCT02157168|3935120|FG002|STARTED|Overall Study||1362
3205423|NCT02157168|3935118|FG000|COMPLETED|Overall Study||746
3205424|NCT02157168|3935119|FG001|COMPLETED|Overall Study||159
3205425|NCT02157168|3935120|FG002|COMPLETED|Overall Study||1362
3205426|NCT02157168|3935118|FG000|NOT COMPLETED|Overall Study||0
3205427|NCT02157168|3935119|FG001|NOT COMPLETED|Overall Study||0
3205428|NCT02157168|3935120|FG002|NOT COMPLETED|Overall Study||0
3205429|NCT02157298|3935133|FG000|STARTED|Overall Study||123
3205430|NCT02157298|3935134|FG001|STARTED|Overall Study||60
3205431|NCT02157298|3935133|FG000|COMPLETED|Overall Study||119
3205432|NCT02157298|3935134|FG001|COMPLETED|Overall Study||58
3205433|NCT02157298|3935133|FG000|NOT COMPLETED|Overall Study||4
3205434|NCT02157298|3935134|FG001|NOT COMPLETED|Overall Study||2
3205435|NCT02157376|3935142|FG000|STARTED|Overall Study||155
3205436|NCT02157376|3935143|FG001|STARTED|Overall Study||156
3205437|NCT02157376|3935142|FG000|COMPLETED|Overall Study||133
3205438|NCT02157376|3935143|FG001|COMPLETED|Overall Study||138
3205439|NCT02157376|3935142|FG000|NOT COMPLETED|Overall Study||22
3205440|NCT02157376|3935143|FG001|NOT COMPLETED|Overall Study||18
3205441|NCT02157506|3935154|FG000|STARTED|Overall Study||12
3205442|NCT02157506|3935155|FG001|STARTED|Overall Study||6
3205443|NCT02157506|3935156|FG002|STARTED|Overall Study||9
3205444|NCT02157506|3935157|FG003|STARTED|Overall Study||12
3205445|NCT02157506|3935158|FG004|STARTED|Overall Study||7
3205446|NCT02157506|3935154|FG000|COMPLETED|Overall Study||12
3205447|NCT02157506|3935155|FG001|COMPLETED|Overall Study||5
3205448|NCT02157506|3935156|FG002|COMPLETED|Overall Study||8
3205449|NCT02157506|3935157|FG003|COMPLETED|Overall Study||12
3205450|NCT02157506|3935158|FG004|COMPLETED|Overall Study||7
3205451|NCT02157506|3935154|FG000|NOT COMPLETED|Overall Study||0
3205452|NCT02157506|3935155|FG001|NOT COMPLETED|Overall Study||1
3205453|NCT02157506|3935156|FG002|NOT COMPLETED|Overall Study||1
3205454|NCT02157506|3935157|FG003|NOT COMPLETED|Overall Study||0
3205455|NCT02157506|3935158|FG004|NOT COMPLETED|Overall Study||0
3205456|NCT02157519|3935172|FG000|STARTED|Overall Study||91
3205457|NCT02157519|3935173|FG001|STARTED|Overall Study||90
3205458|NCT02157519|3935172|FG000|MEMScap Collected|Overall Study||84
3205459|NCT02157519|3935173|FG001|MEMScap Collected|Overall Study||86
3205460|NCT02157519|3935172|FG000|COMPLETED|Overall Study||80
3205461|NCT02157519|3935173|FG001|COMPLETED|Overall Study||89
3205462|NCT02157519|3935172|FG000|NOT COMPLETED|Overall Study||11
3205463|NCT02157519|3935173|FG001|NOT COMPLETED|Overall Study||1
3205464|NCT02157623|3935179|FG000|STARTED|Overall Study|3 patients, each received red light on half of body and blue light on the contralateral side.|3
3205465|NCT02157623|3935179|FG000|COMPLETED|Overall Study||3
3205466|NCT02157623|3935179|FG000|NOT COMPLETED|Overall Study||0
3205467|NCT02157779|3935191|FG000|STARTED|Overall Study||47
3205468|NCT02157779|3935192|FG001|STARTED|Overall Study||45
3205469|NCT02157779|3935191|FG000|COMPLETED|Overall Study||23
3205470|NCT02157779|3935192|FG001|COMPLETED|Overall Study||34
3205471|NCT02157779|3935191|FG000|NOT COMPLETED|Overall Study||24
3205472|NCT02157779|3935192|FG001|NOT COMPLETED|Overall Study||11
3205473|NCT02157909|3935203|FG000|STARTED|Overall Study||66
3205474|NCT02157909|3935204|FG001|STARTED|Overall Study||66
3205475|NCT02157909|3935203|FG000|COMPLETED|Overall Study||66
3205476|NCT02157909|3935204|FG001|COMPLETED|Overall Study||66
3205477|NCT02157909|3935203|FG000|NOT COMPLETED|Overall Study||0
3205478|NCT02157909|3935204|FG001|NOT COMPLETED|Overall Study||0
3205479|NCT02157935|3935213|FG000|STARTED|Overall Study||606
3205480|NCT02157935|3935214|FG001|STARTED|Overall Study||613
3205481|NCT02157935|3935213|FG000|COMPLETED|Overall Study||567
3205482|NCT02157935|3935214|FG001|COMPLETED|Overall Study||548
3205483|NCT02157935|3935213|FG000|NOT COMPLETED|Overall Study||39
3205484|NCT02157935|3935214|FG001|NOT COMPLETED|Overall Study||65
3205485|NCT02157948|3935222|FG000|STARTED|Overall Study||197
3205486|NCT02157948|3935223|FG001|STARTED|Overall Study||197
3205487|NCT02157948|3935222|FG000|Received Treatment|Overall Study||196
3205488|NCT02157948|3935223|FG001|Received Treatment|Overall Study||196
3205489|NCT02157948|3935222|FG000|COMPLETED|Overall Study||188
3205490|NCT02157948|3935223|FG001|COMPLETED|Overall Study||188
3205491|NCT02157948|3935222|FG000|NOT COMPLETED|Overall Study||9
3205492|NCT02157948|3935223|FG001|NOT COMPLETED|Overall Study||9
3205493|NCT02158039|3935229|FG000|STARTED|Overall Study||33
3205494|NCT02158039|3935229|FG000|COMPLETED|Overall Study||23
3205495|NCT02158039|3935229|FG000|NOT COMPLETED|Overall Study||10
3205496|NCT02158091|3935236|FG000|STARTED|Overall Study||6
3205497|NCT02158091|3935237|FG001|STARTED|Overall Study||6
3205498|NCT02158091|3935238|FG002|STARTED|Overall Study||20
3205499|NCT02158091|3935236|FG000|COMPLETED|Overall Study||4
3205500|NCT02158091|3935237|FG001|COMPLETED|Overall Study||5
3205501|NCT02158091|3935238|FG002|COMPLETED|Overall Study||20
3205502|NCT02158091|3935236|FG000|NOT COMPLETED|Overall Study||2
3205503|NCT02158091|3935237|FG001|NOT COMPLETED|Overall Study||1
3205504|NCT02158091|3935238|FG002|NOT COMPLETED|Overall Study||0
3205505|NCT02158247|3935248|FG000|STARTED|Overall Study||181
3205506|NCT02158247|3935248|FG000|COMPLETED|Overall Study||176
3205507|NCT02158247|3935248|FG000|NOT COMPLETED|Overall Study||5
3205508|NCT02158273|3935266|FG000|STARTED|Overall Study||25
3205509|NCT02158273|3935267|FG001|STARTED|Overall Study||25
3205510|NCT02158273|3935266|FG000|COMPLETED|Overall Study||22
3205511|NCT02158273|3935267|FG001|COMPLETED|Overall Study||22
3205512|NCT02158273|3935266|FG000|NOT COMPLETED|Overall Study||3
3205513|NCT02158273|3935267|FG001|NOT COMPLETED|Overall Study||3
3205514|NCT02158364|3935273|FG000|STARTED|Overall Study||3331
3205515|NCT02158364|3935273|FG000|COMPLETED|Overall Study||3271
3205516|NCT02158364|3935273|FG000|NOT COMPLETED|Overall Study||60
3205517|NCT02158442|3935279|FG000|STARTED|Overall Study||8
3205518|NCT02158442|3935280|FG001|STARTED|Overall Study||7
3205519|NCT02158442|3935279|FG000|COMPLETED|Overall Study||6
3205520|NCT02158442|3935280|FG001|COMPLETED|Overall Study||7
3205521|NCT02158442|3935279|FG000|NOT COMPLETED|Overall Study||2
3205522|NCT02158442|3935280|FG001|NOT COMPLETED|Overall Study||0
3205523|NCT02158494|3935288|FG000|STARTED|Overall Study||22
3205524|NCT02158494|3935289|FG001|STARTED|Overall Study||22
3205525|NCT02158494|3935288|FG000|COMPLETED|Overall Study||22
3205526|NCT02158494|3935289|FG001|COMPLETED|Overall Study||21
3205527|NCT02158494|3935288|FG000|NOT COMPLETED|Overall Study||0
3205528|NCT02158494|3935289|FG001|NOT COMPLETED|Overall Study||1
3205529|NCT02158520|3935302|FG000|STARTED|Overall Study||12
3205530|NCT02158520|3935303|FG001|STARTED|Overall Study||12
3205531|NCT02158520|3935302|FG000|AE Evaluated Prior to Crossover|Overall Study||12
3205532|NCT02158520|3935303|FG001|AE Evaluated Prior to Crossover|Overall Study||12
3205533|NCT02158520|3935302|FG000|Eligible for Crossover|Overall Study||8
3205534|NCT02158520|3935303|FG001|Eligible for Crossover|Overall Study||8
3205535|NCT02158520|3935302|FG000|Eligible for Crossover With AE Evaluated|Overall Study||7
3205536|NCT02158520|3935303|FG001|Eligible for Crossover With AE Evaluated|Overall Study||7
3205537|NCT02158520|3935302|FG000|Crossover Cohort|Overall Study||4
3205538|NCT02158520|3935303|FG001|Crossover Cohort|Overall Study||6
3205539|NCT02158520|3935302|FG000|COMPLETED|Overall Study||12
3205540|NCT02158520|3935303|FG001|COMPLETED|Overall Study||12
3205541|NCT02158520|3935302|FG000|NOT COMPLETED|Overall Study||0
3205542|NCT02158520|3935303|FG001|NOT COMPLETED|Overall Study||0
3205543|NCT02158533|3935314|FG000|STARTED|Stage 1||265
3205544|NCT02158533|3935315|FG001|STARTED|Stage 1||59
3205545|NCT02158533|3935316|FG002|STARTED|Stage 1||60
3205546|NCT02158533|3935317|FG003|STARTED|Stage 1||0
3205547|NCT02158533|3935318|FG004|STARTED|Stage 1||0
3205548|NCT02158533|3935319|FG005|STARTED|Stage 1||0
3205549|NCT02158533|3935314|FG000|COMPLETED|Stage 1||251
3205550|NCT02158533|3935315|FG001|COMPLETED|Stage 1||51
3205551|NCT02158533|3935316|FG002|COMPLETED|Stage 1||52
3205552|NCT02158533|3935317|FG003|COMPLETED|Stage 1||0
3205553|NCT02158533|3935318|FG004|COMPLETED|Stage 1||0
3205554|NCT02158533|3935319|FG005|COMPLETED|Stage 1||0
3205555|NCT02158533|3935314|FG000|NOT COMPLETED|Stage 1||14
3205556|NCT02158533|3935315|FG001|NOT COMPLETED|Stage 1||8
3205557|NCT02158533|3935316|FG002|NOT COMPLETED|Stage 1||8
3205558|NCT02158533|3935317|FG003|NOT COMPLETED|Stage 1||0
3205559|NCT02158533|3935318|FG004|NOT COMPLETED|Stage 1||0
3205560|NCT02158533|3935319|FG005|NOT COMPLETED|Stage 1||0
3205561|NCT02158533|3935314|FG000|STARTED|Stage 2||0
3205562|NCT02158533|3935315|FG001|STARTED|Stage 2||0
3205563|NCT02158533|3935316|FG002|STARTED|Stage 2||0
3205564|NCT02158533|3935317|FG003|STARTED|Stage 2||56
3205565|NCT02158533|3935318|FG004|STARTED|Stage 2||56
3205566|NCT02158533|3935319|FG005|STARTED|Stage 2||56
3205567|NCT02158533|3935314|FG000|COMPLETED|Stage 2||0
3205568|NCT02158533|3935315|FG001|COMPLETED|Stage 2||0
3205569|NCT02158533|3935316|FG002|COMPLETED|Stage 2||0
3205570|NCT02158533|3935317|FG003|COMPLETED|Stage 2||53
3205571|NCT02158533|3935318|FG004|COMPLETED|Stage 2||52
3205572|NCT02158533|3935319|FG005|COMPLETED|Stage 2||50
3205573|NCT02158533|3935314|FG000|NOT COMPLETED|Stage 2||0
3205574|NCT02158533|3935315|FG001|NOT COMPLETED|Stage 2||0
3205575|NCT02158533|3935316|FG002|NOT COMPLETED|Stage 2||0
3205576|NCT02158533|3935317|FG003|NOT COMPLETED|Stage 2||3
3205577|NCT02158533|3935318|FG004|NOT COMPLETED|Stage 2||4
3205578|NCT02158533|3935319|FG005|NOT COMPLETED|Stage 2||6
3205579|NCT02158546|3935337|FG000|STARTED|Overall Study||152
3205580|NCT02158546|3935338|FG001|STARTED|Overall Study||153
3205581|NCT02158546|3935339|FG002|STARTED|Overall Study||18
3205582|NCT02158546|3935340|FG003|STARTED|Overall Study||19
3205583|NCT02158546|3935337|FG000|COMPLETED|Overall Study||133
3205584|NCT02158546|3935338|FG001|COMPLETED|Overall Study||136
3205585|NCT02158546|3935339|FG002|COMPLETED|Overall Study||14
3205586|NCT02158546|3935340|FG003|COMPLETED|Overall Study||13
3205587|NCT02158546|3935337|FG000|NOT COMPLETED|Overall Study||19
3205588|NCT02158546|3935338|FG001|NOT COMPLETED|Overall Study||17
3205589|NCT02158546|3935339|FG002|NOT COMPLETED|Overall Study||4
3205590|NCT02158546|3935340|FG003|NOT COMPLETED|Overall Study||6
3205591|NCT02158572|3935350|FG000|STARTED|Overall Study||2032
3205592|NCT02158572|3935350|FG000|COMPLETED|Overall Study||989
3205593|NCT02158572|3935350|FG000|NOT COMPLETED|Overall Study||1043
3205594|NCT02158663|3935356|FG000|STARTED|Overall Study||22
3205595|NCT02158663|3935357|FG001|STARTED|Overall Study||22
3205596|NCT02158663|3935356|FG000|COMPLETED|Overall Study||17
3205597|NCT02158663|3935357|FG001|COMPLETED|Overall Study||18
3205598|NCT02158663|3935356|FG000|NOT COMPLETED|Overall Study||5
3205599|NCT02158663|3935357|FG001|NOT COMPLETED|Overall Study||4
3205600|NCT02158728|3935365|FG000|STARTED|Overall Study||80
3205601|NCT02158728|3935365|FG000|COMPLETED|Overall Study||53
3205602|NCT02158728|3935365|FG000|NOT COMPLETED|Overall Study||27
3365782|NCT03953820|4096970|FG000|STARTED|DBF Following High-Fat Meal|This arm did not continue in Period 2.|0
3365783|NCT03953820|4096971|FG001|STARTED|DBF Following High-Fat Meal|This arm did not continue in Period 2.|0
3365784|NCT03953820|4096972|FG002|STARTED|DBF Following High-Fat Meal|Participants in Period 2 completed 1 of the 2 arms in Period 1 and volunteered to continue.|10
3365785|NCT03953820|4096970|FG000|COMPLETED|DBF Following High-Fat Meal||0
3365786|NCT03953820|4096971|FG001|COMPLETED|DBF Following High-Fat Meal||0
3365787|NCT03953820|4096972|FG002|COMPLETED|DBF Following High-Fat Meal||10
3365788|NCT03953820|4096970|FG000|NOT COMPLETED|DBF Following High-Fat Meal||0
3365789|NCT03953820|4096971|FG001|NOT COMPLETED|DBF Following High-Fat Meal||0
3365790|NCT03953820|4096972|FG002|NOT COMPLETED|DBF Following High-Fat Meal||0
3205603|NCT02158806|3935371|FG000|STARTED|Overall Study||125
3205604|NCT02158806|3935372|FG001|STARTED|Overall Study||126
3205605|NCT02158806|3935371|FG000|COMPLETED|Overall Study|We had information on all participants for the primary outcome (time to complete healing).|121
3205606|NCT02158806|3935372|FG001|COMPLETED|Overall Study|We had information on all participants for the primary outcome (time to complete healing).|121
3205607|NCT02158806|3935371|FG000|NOT COMPLETED|Overall Study||4
3205608|NCT02158806|3935372|FG001|NOT COMPLETED|Overall Study||5
3205609|NCT02158884|3935378|FG000|STARTED|Baseline Assessment||91
3205610|NCT02158884|3935378|FG000|COMPLETED|Baseline Assessment||87
3205611|NCT02158884|3935378|FG000|NOT COMPLETED|Baseline Assessment||4
3205612|NCT02158884|3935378|FG000|STARTED|Intervention: IDEO and PT Program||87
3205613|NCT02158884|3935378|FG000|COMPLETED|Intervention: IDEO and PT Program||81
3205614|NCT02158884|3935378|FG000|NOT COMPLETED|Intervention: IDEO and PT Program||6
3205615|NCT02158884|3935378|FG000|STARTED|Post Intervention (~4 Weeks)||81
3205616|NCT02158884|3935378|FG000|COMPLETED|Post Intervention (~4 Weeks)||71
3205617|NCT02158884|3935378|FG000|NOT COMPLETED|Post Intervention (~4 Weeks)||10
3205618|NCT02158884|3935378|FG000|STARTED|6 Month Assessment||81
3205619|NCT02158884|3935378|FG000|COMPLETED|6 Month Assessment||61
3205620|NCT02158884|3935378|FG000|NOT COMPLETED|6 Month Assessment||20
3205621|NCT02158884|3935378|FG000|STARTED|12 Month Assessment||81
3205622|NCT02158884|3935378|FG000|COMPLETED|12 Month Assessment||64
3205623|NCT02158884|3935378|FG000|NOT COMPLETED|12 Month Assessment||17
3205624|NCT02158936|3935385|FG000|STARTED|Overall Study||179
3205625|NCT02158936|3935386|FG001|STARTED|Overall Study||177
3205626|NCT02158936|3935385|FG000|Treated|Overall Study||177
3205627|NCT02158936|3935386|FG001|Treated|Overall Study||177
3205628|NCT02158936|3935385|FG000|Untreated|Overall Study||2
3205629|NCT02158936|3935386|FG001|Untreated|Overall Study||0
3205630|NCT02158936|3935385|FG000|COMPLETED|Overall Study||0
3205631|NCT02158936|3935386|FG001|COMPLETED|Overall Study||0
3205632|NCT02158936|3935385|FG000|NOT COMPLETED|Overall Study||179
3205633|NCT02158936|3935386|FG001|NOT COMPLETED|Overall Study||177
3205634|NCT02158949|3935394|FG000|STARTED|Overall Study||24
3205635|NCT02158949|3935395|FG001|STARTED|Overall Study||24
3205636|NCT02158949|3935394|FG000|COMPLETED|Overall Study||18
3205637|NCT02158949|3935395|FG001|COMPLETED|Overall Study||13
3205638|NCT02158949|3935394|FG000|NOT COMPLETED|Overall Study||6
3205639|NCT02158949|3935395|FG001|NOT COMPLETED|Overall Study||11
3205640|NCT02158975|3935401|FG000|STARTED|Overall Study||13
3205641|NCT02158975|3935401|FG000|COMPLETED|Overall Study||12
3205642|NCT02158975|3935401|FG000|NOT COMPLETED|Overall Study||1
3205643|NCT02159053|3935409|FG000|STARTED|Overall Study||116
3205644|NCT02159053|3935410|FG001|STARTED|Overall Study||117
3205645|NCT02159053|3935411|FG002|STARTED|Overall Study||117
3205646|NCT02159053|3935409|FG000|Paticipants Week 16 Onwards|Overall Study||116
3205647|NCT02159053|3935410|FG001|Paticipants Week 16 Onwards|Overall Study||117
3205648|NCT02159053|3935411|FG002|Paticipants Week 16 Onwards|Overall Study||113
3205649|NCT02159053|3935409|FG000|COMPLETED|Overall Study||96
3205650|NCT02159053|3935410|FG001|COMPLETED|Overall Study||96
3205651|NCT02159053|3935411|FG002|COMPLETED|Overall Study||97
3205652|NCT02159053|3935409|FG000|NOT COMPLETED|Overall Study||20
3205653|NCT02159053|3935410|FG001|NOT COMPLETED|Overall Study||21
3205654|NCT02159053|3935411|FG002|NOT COMPLETED|Overall Study||20
3205655|NCT02159079|3935423|FG000|STARTED|Overall Study||15
3205656|NCT02159079|3935424|FG001|STARTED|Overall Study||15
3205657|NCT02159079|3935423|FG000|COMPLETED|Overall Study||15
3205658|NCT02159079|3935424|FG001|COMPLETED|Overall Study||15
3205659|NCT02159079|3935423|FG000|NOT COMPLETED|Overall Study||0
3205660|NCT02159079|3935424|FG001|NOT COMPLETED|Overall Study||0
3205661|NCT02159118|3935432|FG000|STARTED|Overall Study||22
3205662|NCT02159118|3935433|FG001|STARTED|Overall Study||22
3205663|NCT02159118|3935432|FG000|COMPLETED|Overall Study||22
3365791|NCT03951766|4096985|FG000|STARTED|Treatment Phase||100
3365792|NCT03951766|4096985|FG000|COMPLETED|Treatment Phase||99
3365793|NCT03951766|4096985|FG000|NOT COMPLETED|Treatment Phase||1
3365794|NCT03951766|4096985|FG000|STARTED|Follow-up Phase||99
3365795|NCT03951766|4096985|FG000|COMPLETED|Follow-up Phase||89
3365796|NCT03951766|4096985|FG000|NOT COMPLETED|Follow-up Phase||10
3365797|NCT03961100|4096995|FG000|STARTED|Part 1||5
3365798|NCT03961100|4096996|FG001|STARTED|Part 1||5
3365799|NCT03961100|4096997|FG002|STARTED|Part 1||5
3365800|NCT03961100|4096998|FG003|STARTED|Part 1||0
3365801|NCT03961100|4096999|FG004|STARTED|Part 1||0
3365802|NCT03961100|4096995|FG000|COMPLETED|Part 1||5
3365803|NCT03961100|4096996|FG001|COMPLETED|Part 1||5
3365804|NCT03961100|4096997|FG002|COMPLETED|Part 1||5
3365805|NCT03961100|4096998|FG003|COMPLETED|Part 1||0
3365806|NCT03961100|4096999|FG004|COMPLETED|Part 1||0
3365807|NCT03961100|4096995|FG000|NOT COMPLETED|Part 1||0
3365808|NCT03961100|4096996|FG001|NOT COMPLETED|Part 1||0
3365809|NCT03961100|4096997|FG002|NOT COMPLETED|Part 1||0
3365810|NCT03961100|4096998|FG003|NOT COMPLETED|Part 1||0
3365811|NCT03961100|4096999|FG004|NOT COMPLETED|Part 1||0
3365812|NCT03961100|4096995|FG000|STARTED|Part 2||0
3365813|NCT03961100|4096996|FG001|STARTED|Part 2||0
3365814|NCT03961100|4096997|FG002|STARTED|Part 2||0
3365815|NCT03961100|4096998|FG003|STARTED|Part 2||8
3365816|NCT03961100|4096999|FG004|STARTED|Part 2||8
3365817|NCT03961100|4096995|FG000|COMPLETED|Part 2||0
3365818|NCT03961100|4096996|FG001|COMPLETED|Part 2||0
3365819|NCT03961100|4096997|FG002|COMPLETED|Part 2||0
3365820|NCT03961100|4096998|FG003|COMPLETED|Part 2||8
3365821|NCT03961100|4096999|FG004|COMPLETED|Part 2||8
3365822|NCT03961100|4096995|FG000|NOT COMPLETED|Part 2||0
3365823|NCT03961100|4096996|FG001|NOT COMPLETED|Part 2||0
3205664|NCT02159118|3935433|FG001|COMPLETED|Overall Study||22
3205665|NCT02159118|3935432|FG000|NOT COMPLETED|Overall Study||0
3205666|NCT02159118|3935433|FG001|NOT COMPLETED|Overall Study||0
3205667|NCT02159183|3935441|FG000|STARTED|Analysis After the 36 Months Follow-up||22
3205668|NCT02159183|3935442|FG001|STARTED|Analysis After the 36 Months Follow-up||21
3205669|NCT02159183|3935441|FG000|COMPLETED|Analysis After the 36 Months Follow-up||19
3205670|NCT02159183|3935442|FG001|COMPLETED|Analysis After the 36 Months Follow-up||19
3205671|NCT02159183|3935441|FG000|NOT COMPLETED|Analysis After the 36 Months Follow-up||3
3205672|NCT02159183|3935442|FG001|NOT COMPLETED|Analysis After the 36 Months Follow-up||2
3205673|NCT02159183|3935441|FG000|STARTED|Analysis of Primary Endpoint (12 Mts)||22
3205674|NCT02159183|3935442|FG001|STARTED|Analysis of Primary Endpoint (12 Mts)||21
3205675|NCT02159183|3935441|FG000|COMPLETED|Analysis of Primary Endpoint (12 Mts)||19
3205676|NCT02159183|3935442|FG001|COMPLETED|Analysis of Primary Endpoint (12 Mts)||20
3205677|NCT02159183|3935441|FG000|NOT COMPLETED|Analysis of Primary Endpoint (12 Mts)||3
3205678|NCT02159183|3935442|FG001|NOT COMPLETED|Analysis of Primary Endpoint (12 Mts)||1
3205679|NCT02159352|3935450|FG000|STARTED|Overall Study||14
3205680|NCT02159352|3935451|FG001|STARTED|Overall Study||14
3205681|NCT02159352|3935450|FG000|Phase 1 (Day 1- 4)|Overall Study||14
3205682|NCT02159352|3935451|FG001|Phase 1 (Day 1- 4)|Overall Study||14
3205683|NCT02159352|3935450|FG000|Phase 2 (Day 5-14)|Overall Study||11
3205684|NCT02159352|3935451|FG001|Phase 2 (Day 5-14)|Overall Study||12
3205685|NCT02159352|3935450|FG000|COMPLETED|Overall Study||11
3205686|NCT02159352|3935451|FG001|COMPLETED|Overall Study||12
3205687|NCT02159352|3935450|FG000|NOT COMPLETED|Overall Study||3
3205688|NCT02159352|3935451|FG001|NOT COMPLETED|Overall Study||2
3205689|NCT02159365|3935476|FG000|STARTED|Overall Study||70
3205690|NCT02159365|3935476|FG000|COMPLETED|Overall Study|Completed = Still on treatment|0
3205691|NCT02159365|3935476|FG000|NOT COMPLETED|Overall Study||70
3205692|NCT02159469|3935480|FG000|STARTED|Overall Study||150
3205693|NCT02159469|3935480|FG000|Completed 12 Week|Overall Study||137
3205694|NCT02159469|3935480|FG000|COMPLETED|Overall Study||97
3205695|NCT02159469|3935480|FG000|NOT COMPLETED|Overall Study||53
3205696|NCT02159482|3935485|FG000|STARTED|Overall Study||11
3205697|NCT02159482|3935485|FG000|COMPLETED|Overall Study||6
3205698|NCT02159482|3935485|FG000|NOT COMPLETED|Overall Study||5
3205699|NCT02159521|3935489|FG000|STARTED|Overall Study|4 participants had both limbs treated.|81
3205700|NCT02159521|3935489|FG000|Received EkoSonic® Treatment|Overall Study||78
3205701|NCT02159521|3935489|FG000|COMPLETED|Overall Study||63
3205702|NCT02159521|3935489|FG000|NOT COMPLETED|Overall Study||18
3205703|NCT02159547|3935495|FG000|STARTED|Overall Study||112
3205704|NCT02159547|3935496|FG001|STARTED|Overall Study||112
3205705|NCT02159547|3935495|FG000|COMPLETED|Overall Study||112
3205706|NCT02159547|3935496|FG001|COMPLETED|Overall Study||112
3205707|NCT02159547|3935495|FG000|NOT COMPLETED|Overall Study||0
3205708|NCT02159547|3935496|FG001|NOT COMPLETED|Overall Study||0
3205709|NCT02159703|3935503|FG000|STARTED|Overall Study||60
3205710|NCT02159703|3935503|FG000|COMPLETED|Overall Study||60
3205711|NCT02159703|3935503|FG000|NOT COMPLETED|Overall Study||0
3205712|NCT02159729|3935509|FG000|STARTED|Overall Study||140
3205713|NCT02159729|3935510|FG001|STARTED|Overall Study||65
3205714|NCT02159729|3935509|FG000|COMPLETED|Overall Study||98
3205715|NCT02159729|3935510|FG001|COMPLETED|Overall Study||44
3205716|NCT02159729|3935509|FG000|NOT COMPLETED|Overall Study||42
3205717|NCT02159729|3935510|FG001|NOT COMPLETED|Overall Study||21
3205718|NCT02159768|3935516|FG000|STARTED|Overall Study|Started 16 July 2014|30
3205719|NCT02159768|3935516|FG000|COMPLETED|Overall Study|Completed 27 July 2015|30
3205720|NCT02159768|3935516|FG000|NOT COMPLETED|Overall Study||0
3205721|NCT02159807|3935523|FG000|STARTED|Overall Study||67
3205722|NCT02159807|3935524|FG001|STARTED|Overall Study||52
3205723|NCT02159807|3935525|FG002|STARTED|Overall Study||51
3205724|NCT02159807|3935523|FG000|COMPLETED|Overall Study||66
3205725|NCT02159807|3935524|FG001|COMPLETED|Overall Study||51
3205726|NCT02159807|3935525|FG002|COMPLETED|Overall Study||48
3205727|NCT02159807|3935523|FG000|NOT COMPLETED|Overall Study||1
3205728|NCT02159807|3935524|FG001|NOT COMPLETED|Overall Study||1
3205729|NCT02159807|3935525|FG002|NOT COMPLETED|Overall Study||3
3205730|NCT02159859|3935533|FG000|STARTED|Overall Study||7
3205731|NCT02159859|3935533|FG000|COMPLETED|Overall Study||7
3205732|NCT02159859|3935533|FG000|NOT COMPLETED|Overall Study||0
3205733|NCT02159872|3935537|FG000|STARTED|Overall Study||48
3205734|NCT02159872|3935537|FG000|COMPLETED|Overall Study||48
3205735|NCT02159872|3935537|FG000|NOT COMPLETED|Overall Study||0
3205736|NCT02159898|3935543|FG000|STARTED|Overall Study||30
3205737|NCT02159898|3935544|FG001|STARTED|Overall Study||30
3205738|NCT02159898|3935543|FG000|COMPLETED|Overall Study||29
3205739|NCT02159898|3935544|FG001|COMPLETED|Overall Study||30
3205740|NCT02159898|3935543|FG000|NOT COMPLETED|Overall Study||1
3205741|NCT02159898|3935544|FG001|NOT COMPLETED|Overall Study||0
3205742|NCT02159950|3935554|FG000|STARTED|Overall Study||0
3205743|NCT02159950|3935555|FG001|STARTED|Overall Study||2
3205744|NCT02159950|3935554|FG000|COMPLETED|Overall Study||0
3205745|NCT02159950|3935555|FG001|COMPLETED|Overall Study||0
3205746|NCT02159950|3935554|FG000|NOT COMPLETED|Overall Study||0
3205747|NCT02159950|3935555|FG001|NOT COMPLETED|Overall Study||2
3205748|NCT02159976|3935563|FG000|STARTED|Overall Study||195
3205749|NCT02159976|3935564|FG001|STARTED|Overall Study||195
3205750|NCT02159976|3935563|FG000|COMPLETED|Overall Study||165
3205751|NCT02159976|3935564|FG001|COMPLETED|Overall Study||170
3205752|NCT02159976|3935563|FG000|NOT COMPLETED|Overall Study||30
3205753|NCT02159976|3935564|FG001|NOT COMPLETED|Overall Study||25
3205754|NCT02160002|3935574|FG000|STARTED|Overall Study||187
3205755|NCT02160002|3935575|FG001|STARTED|Overall Study||179
3205756|NCT02160002|3935574|FG000|Primary Outcome|Overall Study||185
3205757|NCT02160002|3935575|FG001|Primary Outcome|Overall Study||178
3205758|NCT02160002|3935574|FG000|COMPLETED|Overall Study||185
3205759|NCT02160002|3935575|FG001|COMPLETED|Overall Study||178
3205760|NCT02160002|3935574|FG000|NOT COMPLETED|Overall Study||2
3205761|NCT02160002|3935575|FG001|NOT COMPLETED|Overall Study||1
3205762|NCT02160041|3935581|FG000|STARTED|Overall Study||84
3205763|NCT02160041|3935581|FG000|COMPLETED|Overall Study||0
3205764|NCT02160041|3935581|FG000|NOT COMPLETED|Overall Study||84
3205765|NCT02160145|3935587|FG000|STARTED|Prerandomization Single-blind Period||1519
3205766|NCT02160145|3935588|FG001|STARTED|Prerandomization Single-blind Period||0
3205767|NCT02160145|3935589|FG002|STARTED|Prerandomization Single-blind Period||0
3205768|NCT02160145|3935587|FG000|Treated in Placebo Run-in|Prerandomization Single-blind Period||1514
3205769|NCT02160145|3935588|FG001|Treated in Placebo Run-in|Prerandomization Single-blind Period||0
3205770|NCT02160145|3935589|FG002|Treated in Placebo Run-in|Prerandomization Single-blind Period||0
3205771|NCT02160145|3935587|FG000|Treated in Tolvaptan Titration/Run-in|Prerandomization Single-blind Period||1491
3205772|NCT02160145|3935588|FG001|Treated in Tolvaptan Titration/Run-in|Prerandomization Single-blind Period||0
3205773|NCT02160145|3935589|FG002|Treated in Tolvaptan Titration/Run-in|Prerandomization Single-blind Period||0
3205774|NCT02160145|3935587|FG000|Randomized|Prerandomization Single-blind Period||1370
3205775|NCT02160145|3935588|FG001|Randomized|Prerandomization Single-blind Period||0
3205776|NCT02160145|3935589|FG002|Randomized|Prerandomization Single-blind Period||0
3205777|NCT02160145|3935587|FG000|COMPLETED|Prerandomization Single-blind Period||1370
3205778|NCT02160145|3935588|FG001|COMPLETED|Prerandomization Single-blind Period||0
3205779|NCT02160145|3935589|FG002|COMPLETED|Prerandomization Single-blind Period||0
3205780|NCT02160145|3935587|FG000|NOT COMPLETED|Prerandomization Single-blind Period||149
3205781|NCT02160145|3935588|FG001|NOT COMPLETED|Prerandomization Single-blind Period||0
3205782|NCT02160145|3935589|FG002|NOT COMPLETED|Prerandomization Single-blind Period||0
3205783|NCT02160145|3935587|FG000|STARTED|Randomized Double-blind Period|1370 subjects were randomized to receive tolvaptan or placebo in the double-blind period.|0
3205784|NCT02160145|3935588|FG001|STARTED|Randomized Double-blind Period|Subjects completed the single-blind period and were randomized to receive tolvaptan.|683
3205785|NCT02160145|3935589|FG002|STARTED|Randomized Double-blind Period|Subjects completed the single-blind period and were randomized to receive placebo.|687
3205786|NCT02160145|3935587|FG000|On-treatment Completers|Randomized Double-blind Period||0
3205787|NCT02160145|3935588|FG001|On-treatment Completers|Randomized Double-blind Period||578
3205788|NCT02160145|3935589|FG002|On-treatment Completers|Randomized Double-blind Period||637
3205789|NCT02160145|3935587|FG000|Off-treatment Completers|Randomized Double-blind Period||0
3205790|NCT02160145|3935588|FG001|Off-treatment Completers|Randomized Double-blind Period||76
3205791|NCT02160145|3935589|FG002|Off-treatment Completers|Randomized Double-blind Period||22
3205792|NCT02160145|3935587|FG000|COMPLETED|Randomized Double-blind Period||0
3205793|NCT02160145|3935588|FG001|COMPLETED|Randomized Double-blind Period||654
3205794|NCT02160145|3935589|FG002|COMPLETED|Randomized Double-blind Period||659
3205795|NCT02160145|3935587|FG000|NOT COMPLETED|Randomized Double-blind Period||0
3205796|NCT02160145|3935588|FG001|NOT COMPLETED|Randomized Double-blind Period||29
3205797|NCT02160145|3935589|FG002|NOT COMPLETED|Randomized Double-blind Period||28
3205798|NCT02160288|3935598|FG000|STARTED|Overall Study||1
3205799|NCT02160288|3935599|FG001|STARTED|Overall Study||0
3205800|NCT02160288|3935598|FG000|COMPLETED|Overall Study||1
3205801|NCT02160288|3935599|FG001|COMPLETED|Overall Study||0
3205802|NCT02160288|3935598|FG000|NOT COMPLETED|Overall Study||0
3205803|NCT02160288|3935599|FG001|NOT COMPLETED|Overall Study||0
3205804|NCT02160314|3935607|FG000|STARTED|Overall Study||73
3205805|NCT02160314|3935608|FG001|STARTED|Overall Study||72
3205806|NCT02160314|3935607|FG000|COMPLETED|Overall Study||72
3205807|NCT02160314|3935608|FG001|COMPLETED|Overall Study||59
3205808|NCT02160314|3935607|FG000|NOT COMPLETED|Overall Study||1
3205809|NCT02160314|3935608|FG001|NOT COMPLETED|Overall Study||13
3205810|NCT02160535|3935614|FG000|STARTED|Overall Study||13
3205811|NCT02160535|3935614|FG000|COMPLETED|Overall Study||10
3205812|NCT02160535|3935614|FG000|NOT COMPLETED|Overall Study||3
3205813|NCT02160626|3935621|FG000|STARTED|Overall Study||58
3205814|NCT02160626|3935622|FG001|STARTED|Overall Study||57
3205815|NCT02160626|3935623|FG002|STARTED|Overall Study||57
3205816|NCT02160626|3935621|FG000|COMPLETED|Overall Study||57
3205817|NCT02160626|3935622|FG001|COMPLETED|Overall Study||56
3205818|NCT02160626|3935623|FG002|COMPLETED|Overall Study||56
3205819|NCT02160626|3935621|FG000|NOT COMPLETED|Overall Study||1
3205820|NCT02160626|3935622|FG001|NOT COMPLETED|Overall Study||1
3205821|NCT02160626|3935623|FG002|NOT COMPLETED|Overall Study||1
3205822|NCT02160730|3935633|FG000|STARTED|Overall Study||4
3205823|NCT02160730|3935633|FG000|COMPLETED|Overall Study||4
3205824|NCT02160730|3935633|FG000|NOT COMPLETED|Overall Study||0
3205825|NCT02160782|3935638|FG000|STARTED|Open-label Period: Maralixibat||31
3205826|NCT02160782|3935639|FG001|STARTED|Open-label Period: Maralixibat||0
3205827|NCT02160782|3935640|FG002|STARTED|Open-label Period: Maralixibat||0
3205828|NCT02160782|3935641|FG003|STARTED|Open-label Period: Maralixibat||0
3205829|NCT02160782|3935642|FG004|STARTED|Open-label Period: Maralixibat||0
3205830|NCT02160782|3935638|FG000|COMPLETED|Open-label Period: Maralixibat||29
3205831|NCT02160782|3935639|FG001|COMPLETED|Open-label Period: Maralixibat||0
3205832|NCT02160782|3935640|FG002|COMPLETED|Open-label Period: Maralixibat||0
3205833|NCT02160782|3935641|FG003|COMPLETED|Open-label Period: Maralixibat||0
3205834|NCT02160782|3935642|FG004|COMPLETED|Open-label Period: Maralixibat||0
3205835|NCT02160782|3935638|FG000|NOT COMPLETED|Open-label Period: Maralixibat||2
3205836|NCT02160782|3935639|FG001|NOT COMPLETED|Open-label Period: Maralixibat||0
3205837|NCT02160782|3935640|FG002|NOT COMPLETED|Open-label Period: Maralixibat||0
3205838|NCT02160782|3935641|FG003|NOT COMPLETED|Open-label Period: Maralixibat||0
3205839|NCT02160782|3935642|FG004|NOT COMPLETED|Open-label Period: Maralixibat||0
3205840|NCT02160782|3935638|FG000|STARTED|Randomized Withdrawal Period- Pbo vs MRX||0
3205841|NCT02160782|3935639|FG001|STARTED|Randomized Withdrawal Period- Pbo vs MRX||13
3205842|NCT02160782|3935640|FG002|STARTED|Randomized Withdrawal Period- Pbo vs MRX||16
3205843|NCT02160782|3935641|FG003|STARTED|Randomized Withdrawal Period- Pbo vs MRX||0
3205844|NCT02160782|3935642|FG004|STARTED|Randomized Withdrawal Period- Pbo vs MRX||0
3205845|NCT02160782|3935638|FG000|COMPLETED|Randomized Withdrawal Period- Pbo vs MRX||0
3205846|NCT02160782|3935639|FG001|COMPLETED|Randomized Withdrawal Period- Pbo vs MRX||13
3205847|NCT02160782|3935640|FG002|COMPLETED|Randomized Withdrawal Period- Pbo vs MRX||16
3205848|NCT02160782|3935641|FG003|COMPLETED|Randomized Withdrawal Period- Pbo vs MRX||0
3205849|NCT02160782|3935642|FG004|COMPLETED|Randomized Withdrawal Period- Pbo vs MRX||0
3205850|NCT02160782|3935638|FG000|NOT COMPLETED|Randomized Withdrawal Period- Pbo vs MRX||0
3205851|NCT02160782|3935639|FG001|NOT COMPLETED|Randomized Withdrawal Period- Pbo vs MRX||0
3205852|NCT02160782|3935640|FG002|NOT COMPLETED|Randomized Withdrawal Period- Pbo vs MRX||0
3205853|NCT02160782|3935641|FG003|NOT COMPLETED|Randomized Withdrawal Period- Pbo vs MRX||0
3205854|NCT02160782|3935642|FG004|NOT COMPLETED|Randomized Withdrawal Period- Pbo vs MRX||0
3205855|NCT02160782|3935638|FG000|STARTED|After Randomized Withdrawal: Maralixibat||0
3205856|NCT02160782|3935639|FG001|STARTED|After Randomized Withdrawal: Maralixibat||0
3205857|NCT02160782|3935640|FG002|STARTED|After Randomized Withdrawal: Maralixibat||0
3205858|NCT02160782|3935641|FG003|STARTED|After Randomized Withdrawal: Maralixibat||29
3205859|NCT02160782|3935642|FG004|STARTED|After Randomized Withdrawal: Maralixibat||0
3205860|NCT02160782|3935638|FG000|COMPLETED|After Randomized Withdrawal: Maralixibat||0
3205861|NCT02160782|3935639|FG001|COMPLETED|After Randomized Withdrawal: Maralixibat||0
3205862|NCT02160782|3935640|FG002|COMPLETED|After Randomized Withdrawal: Maralixibat||0
3205863|NCT02160782|3935641|FG003|COMPLETED|After Randomized Withdrawal: Maralixibat||23
3205864|NCT02160782|3935642|FG004|COMPLETED|After Randomized Withdrawal: Maralixibat||0
3205865|NCT02160782|3935638|FG000|NOT COMPLETED|After Randomized Withdrawal: Maralixibat||0
3205866|NCT02160782|3935639|FG001|NOT COMPLETED|After Randomized Withdrawal: Maralixibat||0
3205867|NCT02160782|3935640|FG002|NOT COMPLETED|After Randomized Withdrawal: Maralixibat||0
3205868|NCT02160782|3935641|FG003|NOT COMPLETED|After Randomized Withdrawal: Maralixibat||6
3205869|NCT02160782|3935642|FG004|NOT COMPLETED|After Randomized Withdrawal: Maralixibat||0
3205870|NCT02160782|3935638|FG000|STARTED|Long-term Extension Period: Maralixibat||0
3205871|NCT02160782|3935639|FG001|STARTED|Long-term Extension Period: Maralixibat||0
3205872|NCT02160782|3935640|FG002|STARTED|Long-term Extension Period: Maralixibat||0
3205873|NCT02160782|3935641|FG003|STARTED|Long-term Extension Period: Maralixibat||0
3205874|NCT02160782|3935642|FG004|STARTED|Long-term Extension Period: Maralixibat||23
3205875|NCT02160782|3935638|FG000|COMPLETED|Long-term Extension Period: Maralixibat||0
3205876|NCT02160782|3935639|FG001|COMPLETED|Long-term Extension Period: Maralixibat||0
3205877|NCT02160782|3935640|FG002|COMPLETED|Long-term Extension Period: Maralixibat||0
3205878|NCT02160782|3935641|FG003|COMPLETED|Long-term Extension Period: Maralixibat||0
3205879|NCT02160782|3935642|FG004|COMPLETED|Long-term Extension Period: Maralixibat||14
3205880|NCT02160782|3935638|FG000|NOT COMPLETED|Long-term Extension Period: Maralixibat||0
3205881|NCT02160782|3935639|FG001|NOT COMPLETED|Long-term Extension Period: Maralixibat||0
3205882|NCT02160782|3935640|FG002|NOT COMPLETED|Long-term Extension Period: Maralixibat||0
3205883|NCT02160782|3935641|FG003|NOT COMPLETED|Long-term Extension Period: Maralixibat||0
3205884|NCT02160782|3935642|FG004|NOT COMPLETED|Long-term Extension Period: Maralixibat||9
3205885|NCT02160808|3935668|FG000|STARTED|Overall Study||87
3205886|NCT02160808|3935669|FG001|STARTED|Overall Study||83
3205887|NCT02160808|3935668|FG000|COMPLETED|Overall Study||87
3205888|NCT02160808|3935669|FG001|COMPLETED|Overall Study||83
3205889|NCT02160808|3935668|FG000|NOT COMPLETED|Overall Study||0
3205890|NCT02160808|3935669|FG001|NOT COMPLETED|Overall Study||0
3205891|NCT02160847|3935677|FG000|STARTED|Overall Study||16
3205892|NCT02160847|3935678|FG001|STARTED|Overall Study||16
3205893|NCT02160847|3935677|FG000|COMPLETED|Overall Study||16
3205894|NCT02160847|3935678|FG001|COMPLETED|Overall Study||16
3205895|NCT02160847|3935677|FG000|NOT COMPLETED|Overall Study||0
3205896|NCT02160847|3935678|FG001|NOT COMPLETED|Overall Study||0
3205897|NCT02160873|3935686|FG000|STARTED|Overall Study||6
3205898|NCT02160873|3935687|FG001|STARTED|Overall Study||6
3205899|NCT02160873|3935686|FG000|COMPLETED|Overall Study||6
3205900|NCT02160873|3935687|FG001|COMPLETED|Overall Study||6
3205901|NCT02160873|3935686|FG000|NOT COMPLETED|Overall Study||0
3205902|NCT02160873|3935687|FG001|NOT COMPLETED|Overall Study||0
3205903|NCT02160899|3935705|FG000|STARTED|Overall Study||26
3205904|NCT02160899|3935706|FG001|STARTED|Overall Study||4
3205905|NCT02160899|3935707|FG002|STARTED|Overall Study||21
3205906|NCT02160899|3935708|FG003|STARTED|Overall Study||3
3205907|NCT02160899|3935709|FG004|STARTED|Overall Study||2
3205908|NCT02160899|3935710|FG005|STARTED|Overall Study||8
3205909|NCT02160899|3935705|FG000|COMPLETED|Overall Study||26
3205910|NCT02160899|3935706|FG001|COMPLETED|Overall Study||3
3205911|NCT02160899|3935707|FG002|COMPLETED|Overall Study||21
3205912|NCT02160899|3935708|FG003|COMPLETED|Overall Study||2
3205913|NCT02160899|3935709|FG004|COMPLETED|Overall Study||0
3205914|NCT02160899|3935710|FG005|COMPLETED|Overall Study||8
3205915|NCT02160899|3935705|FG000|NOT COMPLETED|Overall Study||0
3205916|NCT02160899|3935706|FG001|NOT COMPLETED|Overall Study||1
3205917|NCT02160899|3935707|FG002|NOT COMPLETED|Overall Study||0
3205918|NCT02160899|3935708|FG003|NOT COMPLETED|Overall Study||1
3205919|NCT02160899|3935709|FG004|NOT COMPLETED|Overall Study||2
3205920|NCT02160899|3935710|FG005|NOT COMPLETED|Overall Study||0
3205921|NCT02160977|3935726|FG000|STARTED|One Week After Surgery||45
3205922|NCT02160977|3935727|FG001|STARTED|One Week After Surgery||45
3205923|NCT02160977|3935726|FG000|COMPLETED|One Week After Surgery||45
3205924|NCT02160977|3935727|FG001|COMPLETED|One Week After Surgery||45
3205925|NCT02160977|3935726|FG000|NOT COMPLETED|One Week After Surgery||0
3205926|NCT02160977|3935727|FG001|NOT COMPLETED|One Week After Surgery||0
3205927|NCT02160977|3935726|FG000|STARTED|Six Weeks After Surgery||45
3205928|NCT02160977|3935727|FG001|STARTED|Six Weeks After Surgery||45
3205929|NCT02160977|3935726|FG000|COMPLETED|Six Weeks After Surgery||44
3205930|NCT02160977|3935727|FG001|COMPLETED|Six Weeks After Surgery||45
3205931|NCT02160977|3935726|FG000|NOT COMPLETED|Six Weeks After Surgery||1
3205932|NCT02160977|3935727|FG001|NOT COMPLETED|Six Weeks After Surgery||0
3365824|NCT03961100|4096997|FG002|NOT COMPLETED|Part 2||0
3365825|NCT03961100|4096998|FG003|NOT COMPLETED|Part 2||0
3365826|NCT03961100|4096999|FG004|NOT COMPLETED|Part 2||0
3365827|NCT03950856|4097015|FG000|STARTED|Overall Study||702
3365828|NCT03950856|4097016|FG001|STARTED|Overall Study||704
3365829|NCT03950856|4097017|FG002|STARTED|Overall Study||701
3365830|NCT03950856|4097018|FG003|STARTED|Overall Study||233
3365831|NCT03950856|4097015|FG000|Vaccinated|Overall Study||698
3365832|NCT03950856|4097016|FG001|Vaccinated|Overall Study||704
3365833|NCT03950856|4097017|FG002|Vaccinated|Overall Study||700
3365834|NCT03950856|4097018|FG003|Vaccinated|Overall Study||231
3365835|NCT03950856|4097015|FG000|COMPLETED|Overall Study||683
3365836|NCT03950856|4097016|FG001|COMPLETED|Overall Study||689
3365837|NCT03950856|4097017|FG002|COMPLETED|Overall Study||683
3365838|NCT03950856|4097018|FG003|COMPLETED|Overall Study||227
3365839|NCT03950856|4097015|FG000|NOT COMPLETED|Overall Study||19
3365840|NCT03950856|4097016|FG001|NOT COMPLETED|Overall Study||15
3365841|NCT03950856|4097017|FG002|NOT COMPLETED|Overall Study||18
3365842|NCT03950856|4097018|FG003|NOT COMPLETED|Overall Study||6
3365843|NCT03947983|4097032|FG000|STARTED|Overall Study||19
3365844|NCT03947983|4097033|FG001|STARTED|Overall Study||19
3365845|NCT03947983|4097032|FG000|12 Weeks|Overall Study||15
3365846|NCT03947983|4097033|FG001|12 Weeks|Overall Study||17
3365847|NCT03947983|4097032|FG000|COMPLETED|Overall Study||14
3365848|NCT03947983|4097033|FG001|COMPLETED|Overall Study||13
3365849|NCT03947983|4097032|FG000|NOT COMPLETED|Overall Study||5
3365850|NCT03947983|4097033|FG001|NOT COMPLETED|Overall Study||6
3365851|NCT03960658|4097039|FG000|STARTED|Overall Study||12
3365852|NCT03960658|4097039|FG000|COMPLETED|Overall Study||10
3365853|NCT03960658|4097039|FG000|NOT COMPLETED|Overall Study||2
3365854|NCT03959332|4097045|FG000|STARTED|Overall Study||16
3365855|NCT03959332|4097046|FG001|STARTED|Overall Study||16
3365856|NCT03959332|4097045|FG000|COMPLETED|Overall Study||16
3365857|NCT03959332|4097046|FG001|COMPLETED|Overall Study||16
3365858|NCT03959332|4097045|FG000|NOT COMPLETED|Overall Study||0
3365859|NCT03959332|4097046|FG001|NOT COMPLETED|Overall Study||0
3365860|NCT03959189|4097054|FG000|STARTED|Overall Study||7
3365861|NCT03959189|4097055|FG001|STARTED|Overall Study||5
3365862|NCT03959189|4097054|FG000|COMPLETED|Overall Study||7
3365863|NCT03959189|4097055|FG001|COMPLETED|Overall Study||5
3365864|NCT03959189|4097054|FG000|NOT COMPLETED|Overall Study||0
3365865|NCT03959189|4097055|FG001|NOT COMPLETED|Overall Study||0
3365866|NCT03956550|4097071|FG000|STARTED|Overall Study||88
3365867|NCT03956550|4097072|FG001|STARTED|Overall Study||86
3365868|NCT03956550|4097073|FG002|STARTED|Overall Study||85
3365869|NCT03956550|4097071|FG000|COMPLETED|Overall Study||18
3365870|NCT03956550|4097072|FG001|COMPLETED|Overall Study||14
3365871|NCT03956550|4097073|FG002|COMPLETED|Overall Study||15
3365872|NCT03956550|4097071|FG000|NOT COMPLETED|Overall Study||70
3365873|NCT03956550|4097072|FG001|NOT COMPLETED|Overall Study||72
3365874|NCT03956550|4097073|FG002|NOT COMPLETED|Overall Study||70
3365875|NCT03954158|4097085|FG000|STARTED|Overall Study||20
3365876|NCT03954158|4097086|FG001|STARTED|Overall Study||21
3365877|NCT03954158|4097087|FG002|STARTED|Overall Study||20
3365878|NCT03954158|4097088|FG003|STARTED|Overall Study||20
3365879|NCT03954158|4097085|FG000|COMPLETED|Overall Study||20
3365880|NCT03954158|4097086|FG001|COMPLETED|Overall Study||21
3365881|NCT03954158|4097087|FG002|COMPLETED|Overall Study||20
3365882|NCT03954158|4097088|FG003|COMPLETED|Overall Study||20
3365883|NCT03954158|4097085|FG000|NOT COMPLETED|Overall Study||0
3365884|NCT03954158|4097086|FG001|NOT COMPLETED|Overall Study||0
3365885|NCT03954158|4097087|FG002|NOT COMPLETED|Overall Study||0
3365886|NCT03954158|4097088|FG003|NOT COMPLETED|Overall Study||0
3365887|NCT03958656|4097125|FG000|STARTED|Overall Study||3
3365888|NCT03958656|4097126|FG001|STARTED|Overall Study||4
3365889|NCT03958656|4097127|FG002|STARTED|Overall Study||5
3365890|NCT03958656|4097128|FG003|STARTED|Overall Study||1
3365891|NCT03958656|4097125|FG000|COMPLETED|Overall Study||3
3365892|NCT03958656|4097126|FG001|COMPLETED|Overall Study||3
3205933|NCT02160977|3935726|FG000|STARTED|Three Months After Surgery||44
3205934|NCT02160977|3935727|FG001|STARTED|Three Months After Surgery||45
3205935|NCT02160977|3935726|FG000|COMPLETED|Three Months After Surgery||44
3205936|NCT02160977|3935727|FG001|COMPLETED|Three Months After Surgery||43
3205937|NCT02160977|3935726|FG000|NOT COMPLETED|Three Months After Surgery||0
3205938|NCT02160977|3935727|FG001|NOT COMPLETED|Three Months After Surgery||2
3205939|NCT02160977|3935726|FG000|STARTED|Six Months After Surgery||44
3205940|NCT02160977|3935727|FG001|STARTED|Six Months After Surgery||43
3205941|NCT02160977|3935726|FG000|COMPLETED|Six Months After Surgery||42
3205942|NCT02160977|3935727|FG001|COMPLETED|Six Months After Surgery||42
3205943|NCT02160977|3935726|FG000|NOT COMPLETED|Six Months After Surgery||2
3205944|NCT02160977|3935727|FG001|NOT COMPLETED|Six Months After Surgery||1
3205945|NCT02160990|3935735|FG000|STARTED|Overall Study||10
3205946|NCT02160990|3935736|FG001|STARTED|Overall Study||10
3205947|NCT02160990|3935735|FG000|COMPLETED|Overall Study||10
3205948|NCT02160990|3935736|FG001|COMPLETED|Overall Study||10
3205949|NCT02160990|3935735|FG000|NOT COMPLETED|Overall Study||0
3205950|NCT02160990|3935736|FG001|NOT COMPLETED|Overall Study||0
3205951|NCT02161133|3935744|FG000|STARTED|Overall Study||135
3205952|NCT02161133|3935745|FG001|STARTED|Overall Study||133
3205953|NCT02161133|3935744|FG000|COMPLETED|Overall Study||116
3205954|NCT02161133|3935745|FG001|COMPLETED|Overall Study||122
3205955|NCT02161133|3935744|FG000|NOT COMPLETED|Overall Study||19
3205956|NCT02161133|3935745|FG001|NOT COMPLETED|Overall Study||11
3205957|NCT02161146|3935756|FG000|STARTED|Overall Study||47
3205958|NCT02161146|3935757|FG001|STARTED|Overall Study||47
3205959|NCT02161146|3935758|FG002|STARTED|Overall Study||49
3205960|NCT02161146|3935759|FG003|STARTED|Overall Study||48
3205961|NCT02161146|3935760|FG004|STARTED|Overall Study||49
3205962|NCT02161146|3935756|FG000|COMPLETED|Overall Study||46
3205963|NCT02161146|3935757|FG001|COMPLETED|Overall Study||43
3205964|NCT02161146|3935758|FG002|COMPLETED|Overall Study||49
3205965|NCT02161146|3935759|FG003|COMPLETED|Overall Study||45
3205966|NCT02161146|3935760|FG004|COMPLETED|Overall Study||48
3205967|NCT02161146|3935756|FG000|NOT COMPLETED|Overall Study||1
3205968|NCT02161146|3935757|FG001|NOT COMPLETED|Overall Study||4
3205969|NCT02161146|3935758|FG002|NOT COMPLETED|Overall Study||0
3205970|NCT02161146|3935759|FG003|NOT COMPLETED|Overall Study||3
3205971|NCT02161146|3935760|FG004|NOT COMPLETED|Overall Study||1
3205972|NCT02161185|3935770|FG000|STARTED|Test Dose Phase||7
3205973|NCT02161185|3935770|FG000|COMPLETED|Test Dose Phase||7
3205974|NCT02161185|3935770|FG000|NOT COMPLETED|Test Dose Phase||0
3205975|NCT02161185|3935770|FG000|STARTED|Treatment Phase||7
3205976|NCT02161185|3935770|FG000|COMPLETED|Treatment Phase||0
3205977|NCT02161185|3935770|FG000|NOT COMPLETED|Treatment Phase||7
3205978|NCT02161406|3935776|FG000|STARTED|Overall Study||44
3205979|NCT02161406|3935777|FG001|STARTED|Overall Study||44
3205980|NCT02161406|3935776|FG000|COMPLETED|Overall Study||34
3205981|NCT02161406|3935777|FG001|COMPLETED|Overall Study||35
3205982|NCT02161406|3935776|FG000|NOT COMPLETED|Overall Study||10
3205983|NCT02161406|3935777|FG001|NOT COMPLETED|Overall Study||9
3205984|NCT02161458|3935787|FG000|STARTED|Overall Study||22
3205985|NCT02161458|3935788|FG001|STARTED|Overall Study||35
3205986|NCT02161458|3935789|FG002|STARTED|Overall Study||33
3205987|NCT02161458|3935790|FG003|STARTED|Overall Study||8
3205988|NCT02161458|3935787|FG000|COMPLETED|Overall Study||22
3205989|NCT02161458|3935788|FG001|COMPLETED|Overall Study||29
3205990|NCT02161458|3935789|FG002|COMPLETED|Overall Study||28
3205991|NCT02161458|3935790|FG003|COMPLETED|Overall Study||8
3205992|NCT02161458|3935787|FG000|NOT COMPLETED|Overall Study||0
3205993|NCT02161458|3935788|FG001|NOT COMPLETED|Overall Study||6
3205994|NCT02161458|3935789|FG002|NOT COMPLETED|Overall Study||5
3205995|NCT02161458|3935790|FG003|NOT COMPLETED|Overall Study||0
3205996|NCT02161484|3935802|FG000|STARTED|Overall Study||5
3205997|NCT02161484|3935803|FG001|STARTED|Overall Study||5
3205998|NCT02161484|3935802|FG000|COMPLETED|Overall Study||1
3205999|NCT02161484|3935803|FG001|COMPLETED|Overall Study||2
3206000|NCT02161484|3935802|FG000|NOT COMPLETED|Overall Study||4
3206001|NCT02161484|3935803|FG001|NOT COMPLETED|Overall Study||3
3206002|NCT02161536|3935812|FG000|STARTED|Overall Study||6
3206003|NCT02161536|3935813|FG001|STARTED|Overall Study||21
3206004|NCT02161536|3935814|FG002|STARTED|Overall Study||20
3206005|NCT02161536|3935812|FG000|COMPLETED|Overall Study||6
3206006|NCT02161536|3935813|FG001|COMPLETED|Overall Study||21
3206007|NCT02161536|3935814|FG002|COMPLETED|Overall Study||20
3206008|NCT02161536|3935812|FG000|NOT COMPLETED|Overall Study||0
3206009|NCT02161536|3935813|FG001|NOT COMPLETED|Overall Study||0
3206010|NCT02161536|3935814|FG002|NOT COMPLETED|Overall Study||0
3206011|NCT02161549|3935824|FG000|STARTED|Overall Study||40
3206012|NCT02161549|3935825|FG001|STARTED|Overall Study||31
3206013|NCT02161549|3935824|FG000|COMPLETED|Overall Study||34
3206014|NCT02161549|3935825|FG001|COMPLETED|Overall Study||29
3206015|NCT02161549|3935824|FG000|NOT COMPLETED|Overall Study||6
3206016|NCT02161549|3935825|FG001|NOT COMPLETED|Overall Study||2
3206017|NCT02161562|3935833|FG000|STARTED|Overall Study||178
3206018|NCT02161562|3935834|FG001|STARTED|Overall Study||136
3206019|NCT02161562|3935833|FG000|COMPLETED|Overall Study||152
3206020|NCT02161562|3935834|FG001|COMPLETED|Overall Study||119
3206021|NCT02161562|3935833|FG000|NOT COMPLETED|Overall Study||26
3206022|NCT02161562|3935834|FG001|NOT COMPLETED|Overall Study||17
3206023|NCT02161575|3935853|FG000|STARTED|Overall Study||103
3206024|NCT02161575|3935853|FG000|Full Analysis Set (FAS) Population|Overall Study||100
3206025|NCT02161575|3935853|FG000|Safety (SAF) Population|Overall Study||100
3206026|NCT02161575|3935853|FG000|COMPLETED|Overall Study||92
3206027|NCT02161575|3935853|FG000|NOT COMPLETED|Overall Study||11
3206028|NCT02161705|3935859|FG000|STARTED|Overall Study||9
3206029|NCT02161705|3935860|FG001|STARTED|Overall Study||9
3206030|NCT02161705|3935859|FG000|COMPLETED|Overall Study||9
3206031|NCT02161705|3935860|FG001|COMPLETED|Overall Study||9
3206032|NCT02161705|3935859|FG000|NOT COMPLETED|Overall Study||0
3206033|NCT02161705|3935860|FG001|NOT COMPLETED|Overall Study||0
3206034|NCT02161718|3935868|FG000|STARTED|Open-Label ALKS 3831 Period||255
3206035|NCT02161718|3935869|FG001|STARTED|Open-Label ALKS 3831 Period||0
3206036|NCT02161718|3935870|FG002|STARTED|Open-Label ALKS 3831 Period||0
3206037|NCT02161718|3935868|FG000|COMPLETED|Open-Label ALKS 3831 Period||234
3206038|NCT02161718|3935869|FG001|COMPLETED|Open-Label ALKS 3831 Period||0
3206039|NCT02161718|3935870|FG002|COMPLETED|Open-Label ALKS 3831 Period||0
3206040|NCT02161718|3935868|FG000|NOT COMPLETED|Open-Label ALKS 3831 Period||21
3206041|NCT02161718|3935869|FG001|NOT COMPLETED|Open-Label ALKS 3831 Period||0
3206042|NCT02161718|3935870|FG002|NOT COMPLETED|Open-Label ALKS 3831 Period||0
3206043|NCT02161718|3935868|FG000|STARTED|Post- Randomization Period||0
3206044|NCT02161718|3935869|FG001|STARTED|Post- Randomization Period||112
3206045|NCT02161718|3935870|FG002|STARTED|Post- Randomization Period||117
3206046|NCT02161718|3935868|FG000|COMPLETED|Post- Randomization Period||0
3206047|NCT02161718|3935869|FG001|COMPLETED|Post- Randomization Period||53
3206048|NCT02161718|3935870|FG002|COMPLETED|Post- Randomization Period||58
3206049|NCT02161718|3935868|FG000|NOT COMPLETED|Post- Randomization Period||0
3206050|NCT02161718|3935869|FG001|NOT COMPLETED|Post- Randomization Period||59
3206051|NCT02161718|3935870|FG002|NOT COMPLETED|Post- Randomization Period||59
3206052|NCT02161731|3935877|FG000|STARTED|Period 1 (Day -1 to Day 7 Predose)||24
3206053|NCT02161731|3935878|FG001|STARTED|Period 1 (Day -1 to Day 7 Predose)||0
3206054|NCT02161731|3935877|FG000|Received 1 Dose of Study Drug|Period 1 (Day -1 to Day 7 Predose)||24
3206055|NCT02161731|3935878|FG001|Received 1 Dose of Study Drug|Period 1 (Day -1 to Day 7 Predose)||0
3206056|NCT02161731|3935877|FG000|COMPLETED|Period 1 (Day -1 to Day 7 Predose)||24
3206057|NCT02161731|3935878|FG001|COMPLETED|Period 1 (Day -1 to Day 7 Predose)||0
3206058|NCT02161731|3935877|FG000|NOT COMPLETED|Period 1 (Day -1 to Day 7 Predose)||0
3206059|NCT02161731|3935878|FG001|NOT COMPLETED|Period 1 (Day -1 to Day 7 Predose)||0
3206060|NCT02161731|3935877|FG000|STARTED|Period 2 (Day 7 Dosing to Day 23)||0
3206061|NCT02161731|3935878|FG001|STARTED|Period 2 (Day 7 Dosing to Day 23)||24
3206062|NCT02161731|3935877|FG000|Received 1 Dose of Study Drug|Period 2 (Day 7 Dosing to Day 23)||0
3206063|NCT02161731|3935878|FG001|Received 1 Dose of Study Drug|Period 2 (Day 7 Dosing to Day 23)||24
3206064|NCT02161731|3935877|FG000|COMPLETED|Period 2 (Day 7 Dosing to Day 23)||0
3206065|NCT02161731|3935878|FG001|COMPLETED|Period 2 (Day 7 Dosing to Day 23)||22
3206066|NCT02161731|3935877|FG000|NOT COMPLETED|Period 2 (Day 7 Dosing to Day 23)||0
3206067|NCT02161731|3935878|FG001|NOT COMPLETED|Period 2 (Day 7 Dosing to Day 23)||2
3206068|NCT02161757|3935888|FG000|STARTED|Randomised Through Start Treatment||401
3206069|NCT02161757|3935889|FG001|STARTED|Randomised Through Start Treatment||406
3206070|NCT02161757|3935890|FG002|STARTED|Randomised Through Start Treatment||400
3206071|NCT02161757|3935888|FG000|COMPLETED|Randomised Through Start Treatment||398
3206072|NCT02161757|3935889|FG001|COMPLETED|Randomised Through Start Treatment||404
3206073|NCT02161757|3935890|FG002|COMPLETED|Randomised Through Start Treatment||400
3206074|NCT02161757|3935888|FG000|NOT COMPLETED|Randomised Through Start Treatment||3
3206075|NCT02161757|3935889|FG001|NOT COMPLETED|Randomised Through Start Treatment||2
3206076|NCT02161757|3935890|FG002|NOT COMPLETED|Randomised Through Start Treatment||0
3206077|NCT02161757|3935888|FG000|STARTED|Treatment Through Study Completion||398
3206078|NCT02161757|3935889|FG001|STARTED|Treatment Through Study Completion||404
3206079|NCT02161757|3935890|FG002|STARTED|Treatment Through Study Completion||400
3206080|NCT02161757|3935888|FG000|Completed Treatment for Week 52 Cut-off|Treatment Through Study Completion||332
3206081|NCT02161757|3935889|FG001|Completed Treatment for Week 52 Cut-off|Treatment Through Study Completion||355
3206082|NCT02161757|3935890|FG002|Completed Treatment for Week 52 Cut-off|Treatment Through Study Completion||360
3206083|NCT02161757|3935888|FG000|COMPLETED|Treatment Through Study Completion||341
3206084|NCT02161757|3935889|FG001|COMPLETED|Treatment Through Study Completion||361
3206085|NCT02161757|3935890|FG002|COMPLETED|Treatment Through Study Completion||361
3206086|NCT02161757|3935888|FG000|NOT COMPLETED|Treatment Through Study Completion||57
3206087|NCT02161757|3935889|FG001|NOT COMPLETED|Treatment Through Study Completion||43
3206088|NCT02161757|3935890|FG002|NOT COMPLETED|Treatment Through Study Completion||39
3206089|NCT02162433|3935902|FG000|STARTED|Overall Study||23
3206090|NCT02162433|3935903|FG001|STARTED|Overall Study||23
3206091|NCT02162433|3935904|FG002|STARTED|Overall Study||23
3206092|NCT02162433|3935905|FG003|STARTED|Overall Study||23
3206093|NCT02162433|3935902|FG000|COMPLETED|Overall Study||22
3206094|NCT02162433|3935903|FG001|COMPLETED|Overall Study||21
3206095|NCT02162433|3935904|FG002|COMPLETED|Overall Study||21
3206096|NCT02162433|3935905|FG003|COMPLETED|Overall Study||22
3206097|NCT02162433|3935902|FG000|NOT COMPLETED|Overall Study||1
3206098|NCT02162433|3935903|FG001|NOT COMPLETED|Overall Study||2
3206099|NCT02162433|3935904|FG002|NOT COMPLETED|Overall Study||2
3206100|NCT02162433|3935905|FG003|NOT COMPLETED|Overall Study||1
3206101|NCT02162446|3935915|FG000|STARTED|Overall Study||12
3206102|NCT02162446|3935915|FG000|COMPLETED|Overall Study||12
3206103|NCT02162446|3935915|FG000|NOT COMPLETED|Overall Study||0
3206104|NCT02162576|3935924|FG000|STARTED|Overall Study||95
3206105|NCT02162576|3935924|FG000|COMPLETED|Overall Study||95
3206106|NCT02162576|3935924|FG000|NOT COMPLETED|Overall Study||0
3206107|NCT02162667|3935931|FG000|STARTED|Neoadjuvant Period||278
3206108|NCT02162667|3935932|FG001|STARTED|Neoadjuvant Period||284
3206109|NCT02162667|3935931|FG000|COMPLETED|Neoadjuvant Period||264
3206110|NCT02162667|3935932|FG001|COMPLETED|Neoadjuvant Period||267
3206111|NCT02162667|3935931|FG000|NOT COMPLETED|Neoadjuvant Period||14
3206112|NCT02162667|3935932|FG001|NOT COMPLETED|Neoadjuvant Period||17
3206113|NCT02162667|3935931|FG000|STARTED|Adjuvant Period||260
3206114|NCT02162667|3935932|FG001|STARTED|Adjuvant Period||268
3206115|NCT02162667|3935931|FG000|COMPLETED|Adjuvant Period||248
3206116|NCT02162667|3935932|FG001|COMPLETED|Adjuvant Period||255
3206117|NCT02162667|3935931|FG000|NOT COMPLETED|Adjuvant Period||12
3206118|NCT02162667|3935932|FG001|NOT COMPLETED|Adjuvant Period||13
3206119|NCT02162680|3935945|FG000|STARTED|Overall Study||33
3206120|NCT02162680|3935946|FG001|STARTED|Overall Study||33
3206121|NCT02162680|3935947|FG002|STARTED|Overall Study||32
3206122|NCT02162680|3935945|FG000|COMPLETED|Overall Study||33
3206123|NCT02162680|3935946|FG001|COMPLETED|Overall Study||33
3206124|NCT02162680|3935947|FG002|COMPLETED|Overall Study||32
3206125|NCT02162680|3935945|FG000|NOT COMPLETED|Overall Study||0
3206126|NCT02162680|3935946|FG001|NOT COMPLETED|Overall Study||0
3206127|NCT02162680|3935947|FG002|NOT COMPLETED|Overall Study||0
3206128|NCT02162719|3935957|FG000|STARTED|Overall Study||62
3206129|NCT02162719|3935958|FG001|STARTED|Overall Study||62
3206130|NCT02162719|3935957|FG000|COMPLETED|Overall Study||0
3206131|NCT02162719|3935958|FG001|COMPLETED|Overall Study||0
3206132|NCT02162719|3935957|FG000|NOT COMPLETED|Overall Study||62
3206133|NCT02162719|3935958|FG001|NOT COMPLETED|Overall Study||62
3206134|NCT02162758|3935966|FG000|STARTED|Overall Study||3
3206135|NCT02162758|3935967|FG001|STARTED|Overall Study||3
3206136|NCT02162758|3935966|FG000|COMPLETED|Overall Study||3
3206137|NCT02162758|3935967|FG001|COMPLETED|Overall Study||2
3206138|NCT02162758|3935966|FG000|NOT COMPLETED|Overall Study||0
3206139|NCT02162758|3935967|FG001|NOT COMPLETED|Overall Study||1
3206140|NCT02162771|3935975|FG000|STARTED|Core Study Period (Part 2)||70
3206141|NCT02162771|3935976|FG001|STARTED|Core Study Period (Part 2)||70
3206142|NCT02162771|3935975|FG000|COMPLETED|Core Study Period (Part 2)||62
3206143|NCT02162771|3935976|FG001|COMPLETED|Core Study Period (Part 2)||62
3206144|NCT02162771|3935975|FG000|NOT COMPLETED|Core Study Period (Part 2)||8
3206145|NCT02162771|3935976|FG001|NOT COMPLETED|Core Study Period (Part 2)||8
3206146|NCT02162771|3935975|FG000|STARTED|Maintenance Study Period (Part 2)||62
3206147|NCT02162771|3935976|FG001|STARTED|Maintenance Study Period (Part 2)|Two subjects did not enter this period due to Withdrawal by subject and Non-responder, 1 for each.|60
3206148|NCT02162771|3935975|FG000|COMPLETED|Maintenance Study Period (Part 2)||46
3206149|NCT02162771|3935976|FG001|COMPLETED|Maintenance Study Period (Part 2)||38
3206150|NCT02162771|3935975|FG000|NOT COMPLETED|Maintenance Study Period (Part 2)||16
3206151|NCT02162771|3935976|FG001|NOT COMPLETED|Maintenance Study Period (Part 2)||22
3206152|NCT02162862|3935985|FG000|STARTED|Overall Study||31
3206153|NCT02162862|3935986|FG001|STARTED|Overall Study||35
3206154|NCT02162862|3935987|FG002|STARTED|Overall Study||33
3206155|NCT02162862|3935985|FG000|COMPLETED|Overall Study||31
3206156|NCT02162862|3935986|FG001|COMPLETED|Overall Study||24
3206157|NCT02162862|3935987|FG002|COMPLETED|Overall Study||29
3206158|NCT02162862|3935985|FG000|NOT COMPLETED|Overall Study||0
3206159|NCT02162862|3935986|FG001|NOT COMPLETED|Overall Study||11
3206160|NCT02162862|3935987|FG002|NOT COMPLETED|Overall Study||4
3206161|NCT02162992|3935999|FG000|STARTED|Overall Study||51
3206162|NCT02162992|3936000|FG001|STARTED|Overall Study||100
3206163|NCT02162992|3935999|FG000|COMPLETED|Overall Study||46
3206164|NCT02162992|3936000|FG001|COMPLETED|Overall Study||99
3206165|NCT02162992|3935999|FG000|NOT COMPLETED|Overall Study||5
3206166|NCT02162992|3936000|FG001|NOT COMPLETED|Overall Study||1
3206167|NCT02163057|3936008|FG000|STARTED|Overall Study||6
3206168|NCT02163057|3936009|FG001|STARTED|Overall Study||16
3206169|NCT02163057|3936008|FG000|COMPLETED|Overall Study||3
3206170|NCT02163057|3936009|FG001|COMPLETED|Overall Study||11
3206171|NCT02163057|3936008|FG000|NOT COMPLETED|Overall Study||3
3206172|NCT02163057|3936009|FG001|NOT COMPLETED|Overall Study||5
3206173|NCT02163226|3936019|FG000|STARTED|Overall Study||79
3206174|NCT02163226|3936020|FG001|STARTED|Overall Study||81
3206175|NCT02163226|3936019|FG000|COMPLETED|Overall Study||63
3206176|NCT02163226|3936020|FG001|COMPLETED|Overall Study||70
3206177|NCT02163226|3936019|FG000|NOT COMPLETED|Overall Study||16
3206178|NCT02163226|3936020|FG001|NOT COMPLETED|Overall Study||11
3206179|NCT02163395|3936026|FG000|STARTED|Overall Study||44
3206180|NCT02163395|3936026|FG000|COMPLETED|Overall Study||39
3206181|NCT02163395|3936026|FG000|NOT COMPLETED|Overall Study||5
3206182|NCT02163421|3936034|FG000|STARTED|Overall Study||12
3206183|NCT02163421|3936035|FG001|STARTED|Overall Study||12
3206184|NCT02163421|3936036|FG002|STARTED|Overall Study||12
3206185|NCT02163421|3936037|FG003|STARTED|Overall Study||12
3206186|NCT02163421|3936034|FG000|COMPLETED|Overall Study||12
3206187|NCT02163421|3936035|FG001|COMPLETED|Overall Study||12
3206188|NCT02163421|3936036|FG002|COMPLETED|Overall Study||12
3206189|NCT02163421|3936037|FG003|COMPLETED|Overall Study||12
3206190|NCT02163421|3936034|FG000|NOT COMPLETED|Overall Study||0
3206191|NCT02163421|3936035|FG001|NOT COMPLETED|Overall Study||0
3206192|NCT02163421|3936036|FG002|NOT COMPLETED|Overall Study||0
3206193|NCT02163421|3936037|FG003|NOT COMPLETED|Overall Study||0
3206194|NCT02163434|3936046|FG000|STARTED|Overall Study||15
3206195|NCT02163434|3936047|FG001|STARTED|Overall Study||16
3206196|NCT02163434|3936046|FG000|COMPLETED|Overall Study||12
3206197|NCT02163434|3936047|FG001|COMPLETED|Overall Study||9
3206198|NCT02163434|3936046|FG000|NOT COMPLETED|Overall Study||3
3206199|NCT02163434|3936047|FG001|NOT COMPLETED|Overall Study||7
3206200|NCT02163447|3936056|FG000|STARTED|Overall Study||106
3206201|NCT02163447|3936057|FG001|STARTED|Overall Study||94
3206202|NCT02163447|3936058|FG002|STARTED|Overall Study||100
3206203|NCT02163447|3936056|FG000|Infants Born|Overall Study||101
3206204|NCT02163447|3936057|FG001|Infants Born|Overall Study||93
3206205|NCT02163447|3936058|FG002|Infants Born|Overall Study||100
3206206|NCT02163447|3936056|FG000|COMPLETED|Overall Study||100
3206207|NCT02163447|3936057|FG001|COMPLETED|Overall Study||88
3206208|NCT02163447|3936058|FG002|COMPLETED|Overall Study||97
3206209|NCT02163447|3936056|FG000|NOT COMPLETED|Overall Study||6
3206210|NCT02163447|3936057|FG001|NOT COMPLETED|Overall Study||6
3206211|NCT02163447|3936058|FG002|NOT COMPLETED|Overall Study||3
3206212|NCT02163486|3936078|FG000|STARTED|Overall Study||51
3206213|NCT02163486|3936079|FG001|STARTED|Overall Study||52
3206214|NCT02163486|3936078|FG000|COMPLETED|Overall Study||50
3206215|NCT02163486|3936079|FG001|COMPLETED|Overall Study||50
3206216|NCT02163486|3936078|FG000|NOT COMPLETED|Overall Study||1
3206217|NCT02163486|3936079|FG001|NOT COMPLETED|Overall Study||2
3206218|NCT02163499|3936085|FG000|STARTED|Acute Phase: ZS 10 g TID||751
3206219|NCT02163499|3936085|FG000|COMPLETED|Acute Phase: ZS 10 g TID||746
3206220|NCT02163499|3936085|FG000|NOT COMPLETED|Acute Phase: ZS 10 g TID||5
3206221|NCT02163499|3936085|FG000|STARTED|Extended Dosing Phase: ZS||746
3206222|NCT02163499|3936085|FG000|COMPLETED|Extended Dosing Phase: ZS||466
3206223|NCT02163499|3936085|FG000|NOT COMPLETED|Extended Dosing Phase: ZS||280
3206224|NCT02163538|3936095|FG000|STARTED|Overall Study||71
3206225|NCT02163538|3936096|FG001|STARTED|Overall Study||71
3206226|NCT02163538|3936095|FG000|COMPLETED|Overall Study||70
3206227|NCT02163538|3936096|FG001|COMPLETED|Overall Study||70
3206228|NCT02163538|3936095|FG000|NOT COMPLETED|Overall Study||1
3206229|NCT02163538|3936096|FG001|NOT COMPLETED|Overall Study||1
3206230|NCT02163577|3936104|FG000|STARTED|Overall Study||26
3206231|NCT02163577|3936105|FG001|STARTED|Overall Study||26
3206232|NCT02163577|3936104|FG000|COMPLETED|Overall Study||26
3206233|NCT02163577|3936105|FG001|COMPLETED|Overall Study||26
3206234|NCT02163577|3936104|FG000|NOT COMPLETED|Overall Study||0
3206235|NCT02163577|3936105|FG001|NOT COMPLETED|Overall Study||0
3206236|NCT02163759|3936114|FG000|STARTED|Overall Study||72
3206237|NCT02163759|3936115|FG001|STARTED|Overall Study||142
3206238|NCT02163759|3936116|FG002|STARTED|Overall Study||144
3206239|NCT02163759|3936114|FG000|Completed Week 10|Overall Study||71
3206240|NCT02163759|3936115|FG001|Completed Week 10|Overall Study||141
3206241|NCT02163759|3936116|FG002|Completed Week 10|Overall Study||143
3206242|NCT02163759|3936114|FG000|COMPLETED|Overall Study||71
3206243|NCT02163759|3936115|FG001|COMPLETED|Overall Study||137
3206244|NCT02163759|3936116|FG002|COMPLETED|Overall Study||141
3206245|NCT02163759|3936114|FG000|NOT COMPLETED|Overall Study||1
3206246|NCT02163759|3936115|FG001|NOT COMPLETED|Overall Study||5
3206247|NCT02163759|3936116|FG002|NOT COMPLETED|Overall Study||3
3206248|NCT02163811|3936129|FG000|STARTED|Overall Study||71
3206249|NCT02163811|3936130|FG001|STARTED|Overall Study||76
3206250|NCT02163811|3936129|FG000|COMPLETED|Overall Study||35
3206251|NCT02163811|3936130|FG001|COMPLETED|Overall Study||60
3206252|NCT02163811|3936129|FG000|NOT COMPLETED|Overall Study||36
3206253|NCT02163811|3936130|FG001|NOT COMPLETED|Overall Study||16
3206254|NCT02163824|3936139|FG000|STARTED|Overall Study||129
3206255|NCT02163824|3936140|FG001|STARTED|Overall Study||125
3206256|NCT02163824|3936141|FG002|STARTED|Overall Study||126
3206257|NCT02163824|3936139|FG000|COMPLETED|Overall Study||127
3206258|NCT02163824|3936140|FG001|COMPLETED|Overall Study||124
3206259|NCT02163824|3936141|FG002|COMPLETED|Overall Study||124
3206260|NCT02163824|3936139|FG000|NOT COMPLETED|Overall Study||2
3206261|NCT02163824|3936140|FG001|NOT COMPLETED|Overall Study||1
3206262|NCT02163824|3936141|FG002|NOT COMPLETED|Overall Study||2
3206263|NCT02163837|3936149|FG000|STARTED|Before Rifaximin||15
3206264|NCT02163837|3936149|FG000|COMPLETED|Before Rifaximin||15
3206265|NCT02163837|3936149|FG000|NOT COMPLETED|Before Rifaximin||0
3206266|NCT02163837|3936149|FG000|STARTED|Day 28 of Rifaximin Treatment||15
3206267|NCT02163837|3936149|FG000|COMPLETED|Day 28 of Rifaximin Treatment||15
3206268|NCT02163837|3936149|FG000|NOT COMPLETED|Day 28 of Rifaximin Treatment||0
3206269|NCT02163902|3936155|FG000|STARTED|Overall Study||113
3206270|NCT02163902|3936156|FG001|STARTED|Overall Study||111
3206271|NCT02163902|3936155|FG000|COMPLETED|Overall Study||102
3206272|NCT02163902|3936156|FG001|COMPLETED|Overall Study||98
3206273|NCT02163902|3936155|FG000|NOT COMPLETED|Overall Study||11
3206274|NCT02163902|3936156|FG001|NOT COMPLETED|Overall Study||13
3206275|NCT02163915|3936167|FG000|STARTED|Overall Study||10
3206276|NCT02163915|3936168|FG001|STARTED|Overall Study||8
3206277|NCT02163915|3936169|FG002|STARTED|Overall Study||10
3206278|NCT02163915|3936170|FG003|STARTED|Overall Study||9
3206279|NCT02163915|3936171|FG004|STARTED|Overall Study||10
3206280|NCT02163915|3936167|FG000|COMPLETED|Overall Study||7
3206281|NCT02163915|3936168|FG001|COMPLETED|Overall Study||8
3206282|NCT02163915|3936169|FG002|COMPLETED|Overall Study||8
3206283|NCT02163915|3936170|FG003|COMPLETED|Overall Study||6
3206284|NCT02163915|3936171|FG004|COMPLETED|Overall Study||6
3206285|NCT02163915|3936167|FG000|NOT COMPLETED|Overall Study||3
3206286|NCT02163915|3936168|FG001|NOT COMPLETED|Overall Study||0
3206287|NCT02163915|3936169|FG002|NOT COMPLETED|Overall Study||2
3206288|NCT02163915|3936170|FG003|NOT COMPLETED|Overall Study||3
3206289|NCT02163915|3936171|FG004|NOT COMPLETED|Overall Study||4
3206290|NCT02163967|3936187|FG000|STARTED|First Intervention/ Day 1||4
3206291|NCT02163967|3936188|FG001|STARTED|First Intervention/ Day 1||4
3206292|NCT02163967|3936189|FG002|STARTED|First Intervention/ Day 1||3
3206293|NCT02163967|3936190|FG003|STARTED|First Intervention/ Day 1||4
3206294|NCT02163967|3936191|FG004|STARTED|First Intervention/ Day 1||3
3206295|NCT02163967|3936192|FG005|STARTED|First Intervention/ Day 1||3
3206296|NCT02163967|3936187|FG000|COMPLETED|First Intervention/ Day 1||4
3206297|NCT02163967|3936188|FG001|COMPLETED|First Intervention/ Day 1||4
3206298|NCT02163967|3936189|FG002|COMPLETED|First Intervention/ Day 1||3
3206299|NCT02163967|3936190|FG003|COMPLETED|First Intervention/ Day 1||4
3206300|NCT02163967|3936191|FG004|COMPLETED|First Intervention/ Day 1||3
3206301|NCT02163967|3936192|FG005|COMPLETED|First Intervention/ Day 1||3
3206302|NCT02163967|3936187|FG000|NOT COMPLETED|First Intervention/ Day 1||0
3206303|NCT02163967|3936188|FG001|NOT COMPLETED|First Intervention/ Day 1||0
3206304|NCT02163967|3936189|FG002|NOT COMPLETED|First Intervention/ Day 1||0
3206305|NCT02163967|3936190|FG003|NOT COMPLETED|First Intervention/ Day 1||0
3206306|NCT02163967|3936191|FG004|NOT COMPLETED|First Intervention/ Day 1||0
3206307|NCT02163967|3936192|FG005|NOT COMPLETED|First Intervention/ Day 1||0
3206308|NCT02163967|3936187|FG000|STARTED|Second Intevention/Day 2||3
3206309|NCT02163967|3936188|FG001|STARTED|Second Intevention/Day 2||4
3206310|NCT02163967|3936189|FG002|STARTED|Second Intevention/Day 2||2
3206311|NCT02163967|3936190|FG003|STARTED|Second Intevention/Day 2||4
3206312|NCT02163967|3936191|FG004|STARTED|Second Intevention/Day 2||3
3206313|NCT02163967|3936192|FG005|STARTED|Second Intevention/Day 2||3
3206314|NCT02163967|3936187|FG000|COMPLETED|Second Intevention/Day 2||3
3206315|NCT02163967|3936188|FG001|COMPLETED|Second Intevention/Day 2||4
3206316|NCT02163967|3936189|FG002|COMPLETED|Second Intevention/Day 2||2
3206317|NCT02163967|3936190|FG003|COMPLETED|Second Intevention/Day 2||4
3206318|NCT02163967|3936191|FG004|COMPLETED|Second Intevention/Day 2||3
3206319|NCT02163967|3936192|FG005|COMPLETED|Second Intevention/Day 2||3
3206320|NCT02163967|3936187|FG000|NOT COMPLETED|Second Intevention/Day 2||0
3206321|NCT02163967|3936188|FG001|NOT COMPLETED|Second Intevention/Day 2||0
3206322|NCT02163967|3936189|FG002|NOT COMPLETED|Second Intevention/Day 2||0
3206323|NCT02163967|3936190|FG003|NOT COMPLETED|Second Intevention/Day 2||0
3206324|NCT02163967|3936191|FG004|NOT COMPLETED|Second Intevention/Day 2||0
3206325|NCT02163967|3936192|FG005|NOT COMPLETED|Second Intevention/Day 2||0
3206326|NCT02163967|3936187|FG000|STARTED|Third Intervention/Day 3||3
3206327|NCT02163967|3936188|FG001|STARTED|Third Intervention/Day 3||3
3206328|NCT02163967|3936189|FG002|STARTED|Third Intervention/Day 3||2
3206329|NCT02163967|3936190|FG003|STARTED|Third Intervention/Day 3||4
3206330|NCT02163967|3936191|FG004|STARTED|Third Intervention/Day 3||3
3206331|NCT02163967|3936192|FG005|STARTED|Third Intervention/Day 3||3
3206332|NCT02163967|3936187|FG000|COMPLETED|Third Intervention/Day 3||3
3206333|NCT02163967|3936188|FG001|COMPLETED|Third Intervention/Day 3||3
3206334|NCT02163967|3936189|FG002|COMPLETED|Third Intervention/Day 3||2
3206335|NCT02163967|3936190|FG003|COMPLETED|Third Intervention/Day 3||4
3206336|NCT02163967|3936191|FG004|COMPLETED|Third Intervention/Day 3||3
3206337|NCT02163967|3936192|FG005|COMPLETED|Third Intervention/Day 3||3
3206338|NCT02163967|3936187|FG000|NOT COMPLETED|Third Intervention/Day 3||0
3206339|NCT02163967|3936188|FG001|NOT COMPLETED|Third Intervention/Day 3||0
3206340|NCT02163967|3936189|FG002|NOT COMPLETED|Third Intervention/Day 3||0
3206341|NCT02163967|3936190|FG003|NOT COMPLETED|Third Intervention/Day 3||0
3206342|NCT02163967|3936191|FG004|NOT COMPLETED|Third Intervention/Day 3||0
3206343|NCT02163967|3936192|FG005|NOT COMPLETED|Third Intervention/Day 3||0
3206344|NCT02163993|3936208|FG000|STARTED|Treatment Period||138
3206345|NCT02163993|3936209|FG001|STARTED|Treatment Period||68
3206346|NCT02163993|3936210|FG002|STARTED|Treatment Period||68
3206347|NCT02163993|3936211|FG003|STARTED|Treatment Period||71
3206348|NCT02163993|3936212|FG004|STARTED|Treatment Period||69
3206349|NCT02163993|3936208|FG000|Received at Least 1 Dose of Study Drug|Treatment Period||137
3206350|NCT02163993|3936209|FG001|Received at Least 1 Dose of Study Drug|Treatment Period||68
3206351|NCT02163993|3936210|FG002|Received at Least 1 Dose of Study Drug|Treatment Period||68
3206352|NCT02163993|3936211|FG003|Received at Least 1 Dose of Study Drug|Treatment Period||70
3206353|NCT02163993|3936212|FG004|Received at Least 1 Dose of Study Drug|Treatment Period||67
3206354|NCT02163993|3936208|FG000|COMPLETED|Treatment Period||126
3206355|NCT02163993|3936209|FG001|COMPLETED|Treatment Period||59
3206356|NCT02163993|3936210|FG002|COMPLETED|Treatment Period||66
3206357|NCT02163993|3936211|FG003|COMPLETED|Treatment Period||62
3206358|NCT02163993|3936212|FG004|COMPLETED|Treatment Period||62
3206359|NCT02163993|3936208|FG000|NOT COMPLETED|Treatment Period||12
3206360|NCT02163993|3936209|FG001|NOT COMPLETED|Treatment Period||9
3206361|NCT02163993|3936210|FG002|NOT COMPLETED|Treatment Period||2
3206362|NCT02163993|3936211|FG003|NOT COMPLETED|Treatment Period||9
3206363|NCT02163993|3936212|FG004|NOT COMPLETED|Treatment Period||7
3206364|NCT02163993|3936208|FG000|STARTED|Post-treatment Period|One participant discontinued after Treatment Period. Did not enter into Post-treatment Period.|125
3206365|NCT02163993|3936209|FG001|STARTED|Post-treatment Period|Participants who discontinued or completed the Treatment Period entered the Post-treatment period.|61
3206366|NCT02163993|3936210|FG002|STARTED|Post-treatment Period||66
3365893|NCT03958656|4097127|FG002|COMPLETED|Overall Study||3
3206367|NCT02163993|3936211|FG003|STARTED|Post-treatment Period|Participants who discontinued or completed the Treatment Period entered the Post-treatment period.|63
3206368|NCT02163993|3936212|FG004|STARTED|Post-treatment Period|Participants who discontinued or completed the Treatment Period entered the Post-treatment period.|65
3206369|NCT02163993|3936208|FG000|COMPLETED|Post-treatment Period||121
3206370|NCT02163993|3936209|FG001|COMPLETED|Post-treatment Period||55
3206371|NCT02163993|3936210|FG002|COMPLETED|Post-treatment Period||62
3206372|NCT02163993|3936211|FG003|COMPLETED|Post-treatment Period||61
3206373|NCT02163993|3936212|FG004|COMPLETED|Post-treatment Period||62
3206374|NCT02163993|3936208|FG000|NOT COMPLETED|Post-treatment Period||4
3206375|NCT02163993|3936209|FG001|NOT COMPLETED|Post-treatment Period||6
3206376|NCT02163993|3936210|FG002|NOT COMPLETED|Post-treatment Period||4
3206377|NCT02163993|3936211|FG003|NOT COMPLETED|Post-treatment Period||2
3206378|NCT02163993|3936212|FG004|NOT COMPLETED|Post-treatment Period||3
3206379|NCT02164240|3936233|FG000|STARTED|Overall Study||4
3206380|NCT02164240|3936234|FG001|STARTED|Overall Study||5
3206381|NCT02164240|3936235|FG002|STARTED|Overall Study||4
3206382|NCT02164240|3936233|FG000|COMPLETED|Overall Study||4
3206383|NCT02164240|3936234|FG001|COMPLETED|Overall Study||5
3206384|NCT02164240|3936235|FG002|COMPLETED|Overall Study||4
3206385|NCT02164240|3936233|FG000|NOT COMPLETED|Overall Study||0
3206386|NCT02164240|3936234|FG001|NOT COMPLETED|Overall Study||0
3206387|NCT02164240|3936235|FG002|NOT COMPLETED|Overall Study||0
3206388|NCT02164318|3936248|FG000|STARTED|Overall Study||4
3206389|NCT02164318|3936249|FG001|STARTED|Overall Study||3
3206390|NCT02164318|3936250|FG002|STARTED|Overall Study||1
3206391|NCT02164318|3936251|FG003|STARTED|Overall Study||3
3206392|NCT02164318|3936248|FG000|COMPLETED|Overall Study||4
3206393|NCT02164318|3936249|FG001|COMPLETED|Overall Study||2
3206394|NCT02164318|3936250|FG002|COMPLETED|Overall Study||1
3206395|NCT02164318|3936251|FG003|COMPLETED|Overall Study||2
3206396|NCT02164318|3936248|FG000|NOT COMPLETED|Overall Study||0
3206397|NCT02164318|3936249|FG001|NOT COMPLETED|Overall Study||1
3206398|NCT02164318|3936250|FG002|NOT COMPLETED|Overall Study||0
3206399|NCT02164318|3936251|FG003|NOT COMPLETED|Overall Study||1
3206400|NCT02164383|3936263|FG000|STARTED|Overall Study||16
3206401|NCT02164383|3936264|FG001|STARTED|Overall Study||14
3206402|NCT02164383|3936263|FG000|COMPLETED|Overall Study||15
3365894|NCT03958656|4097128|FG003|COMPLETED|Overall Study||1
3365895|NCT03958656|4097125|FG000|NOT COMPLETED|Overall Study||0
3365896|NCT03958656|4097126|FG001|NOT COMPLETED|Overall Study||1
3365897|NCT03958656|4097127|FG002|NOT COMPLETED|Overall Study||2
3365898|NCT03958656|4097128|FG003|NOT COMPLETED|Overall Study||0
3365899|NCT03955133|4097138|FG000|STARTED|Overall Study|participants recruited from 3 care homes|19
3365900|NCT03955133|4097138|FG000|COMPLETED|Overall Study|End of study funding|19
3365901|NCT03955133|4097138|FG000|NOT COMPLETED|Overall Study||0
3365902|NCT03954626|4097143|FG000|STARTED|Overall Study||14
3365903|NCT03954626|4097143|FG000|COMPLETED|Overall Study||14
3365904|NCT03954626|4097143|FG000|NOT COMPLETED|Overall Study||0
3365905|NCT03954743|4097149|FG000|STARTED|Overall Study||677
3365906|NCT03954743|4097150|FG001|STARTED|Overall Study||674
3365907|NCT03954743|4097149|FG000|COMPLETED|Overall Study||653
3365908|NCT03954743|4097150|FG001|COMPLETED|Overall Study||657
3365909|NCT03954743|4097149|FG000|NOT COMPLETED|Overall Study||24
3365910|NCT03954743|4097150|FG001|NOT COMPLETED|Overall Study||17
3365911|NCT03951805|4097160|FG000|STARTED|Overall Study||51
3365912|NCT03951805|4097161|FG001|STARTED|Overall Study||51
3365913|NCT03951805|4097162|FG002|STARTED|Overall Study||52
3365914|NCT03951805|4097163|FG003|STARTED|Overall Study||51
3365915|NCT03951805|4097160|FG000|Full Analysis Set (FAS)|Overall Study||51
3365916|NCT03951805|4097161|FG001|Full Analysis Set (FAS)|Overall Study||51
3365917|NCT03951805|4097162|FG002|Full Analysis Set (FAS)|Overall Study||52
3365918|NCT03951805|4097163|FG003|Full Analysis Set (FAS)|Overall Study||51
3365919|NCT03951805|4097160|FG000|Safety Analysis Set (SAS)|Overall Study||51
3365920|NCT03951805|4097161|FG001|Safety Analysis Set (SAS)|Overall Study||51
3365921|NCT03951805|4097162|FG002|Safety Analysis Set (SAS)|Overall Study||52
3365922|NCT03951805|4097163|FG003|Safety Analysis Set (SAS)|Overall Study||51
3365923|NCT03951805|4097160|FG000|COMPLETED|Overall Study||50
3365924|NCT03951805|4097161|FG001|COMPLETED|Overall Study||51
3365925|NCT03951805|4097162|FG002|COMPLETED|Overall Study||52
3365926|NCT03951805|4097163|FG003|COMPLETED|Overall Study||51
3365927|NCT03951805|4097160|FG000|NOT COMPLETED|Overall Study||1
3365928|NCT03951805|4097161|FG001|NOT COMPLETED|Overall Study||0
3365929|NCT03951805|4097162|FG002|NOT COMPLETED|Overall Study||0
3365930|NCT03951805|4097163|FG003|NOT COMPLETED|Overall Study||0
3365931|NCT03944785|4097176|FG000|STARTED|2 Month Study Completion||2
3365932|NCT03944785|4097177|FG001|STARTED|2 Month Study Completion||34
3365933|NCT03944785|4097178|FG002|STARTED|2 Month Study Completion||128
3365934|NCT03944785|4097176|FG000|COMPLETED|2 Month Study Completion||2
3365935|NCT03944785|4097177|FG001|COMPLETED|2 Month Study Completion||30
3365936|NCT03944785|4097178|FG002|COMPLETED|2 Month Study Completion||123
3365937|NCT03944785|4097176|FG000|NOT COMPLETED|2 Month Study Completion||0
3206403|NCT02164383|3936264|FG001|COMPLETED|Overall Study||14
3206404|NCT02164383|3936263|FG000|NOT COMPLETED|Overall Study||1
3206405|NCT02164383|3936264|FG001|NOT COMPLETED|Overall Study||0
3206406|NCT02164396|3936273|FG000|STARTED|Overall Study||10
3206407|NCT02164396|3936274|FG001|STARTED|Overall Study||10
3206408|NCT02164396|3936275|FG002|STARTED|Overall Study||10
3206409|NCT02164396|3936273|FG000|COMPLETED|Overall Study||10
3206410|NCT02164396|3936274|FG001|COMPLETED|Overall Study||10
3206411|NCT02164396|3936275|FG002|COMPLETED|Overall Study||10
3206412|NCT02164396|3936273|FG000|NOT COMPLETED|Overall Study||0
3206413|NCT02164396|3936274|FG001|NOT COMPLETED|Overall Study||0
3206414|NCT02164396|3936275|FG002|NOT COMPLETED|Overall Study||0
3206415|NCT02164422|3936286|FG000|STARTED|Overall Study||25
3206416|NCT02164422|3936287|FG001|STARTED|Overall Study||22
3206417|NCT02164422|3936288|FG002|STARTED|Overall Study||23
3206418|NCT02164422|3936286|FG000|COMPLETED|Overall Study||24
3206419|NCT02164422|3936287|FG001|COMPLETED|Overall Study||20
3206420|NCT02164422|3936288|FG002|COMPLETED|Overall Study||23
3206421|NCT02164422|3936286|FG000|NOT COMPLETED|Overall Study||1
3206422|NCT02164422|3936287|FG001|NOT COMPLETED|Overall Study||2
3206423|NCT02164422|3936288|FG002|NOT COMPLETED|Overall Study||0
3206424|NCT02164513|3936299|FG000|STARTED|Overall Study||4151
3206425|NCT02164513|3936300|FG001|STARTED|Overall Study||4134
3206426|NCT02164513|3936301|FG002|STARTED|Overall Study||2070
3206427|NCT02164513|3936299|FG000|Completed Investigational Product (IP)|Overall Study||3393
3206428|NCT02164513|3936300|FG001|Completed Investigational Product (IP)|Overall Study||3094
3206429|NCT02164513|3936301|FG002|Completed Investigational Product (IP)|Overall Study||1504
3206430|NCT02164513|3936299|FG000|Not Completed IP|Overall Study||758
3206431|NCT02164513|3936300|FG001|Not Completed IP|Overall Study||1040
3206432|NCT02164513|3936301|FG002|Not Completed IP|Overall Study||566
3206433|NCT02164513|3936299|FG000|Withdrew IP (WIP): Adverse Event|Overall Study||249
3206434|NCT02164513|3936300|FG001|Withdrew IP (WIP): Adverse Event|Overall Study||325
3206435|NCT02164513|3936301|FG002|Withdrew IP (WIP): Adverse Event|Overall Study||186
3206436|NCT02164513|3936299|FG000|WIP: Lack of Efficacy|Overall Study||163
3206437|NCT02164513|3936300|FG001|WIP: Lack of Efficacy|Overall Study||313
3206438|NCT02164513|3936301|FG002|WIP: Lack of Efficacy|Overall Study||172
3206439|NCT02164513|3936299|FG000|Withdrew IP: Protocol Deviation|Overall Study||32
3206440|NCT02164513|3936300|FG001|Withdrew IP: Protocol Deviation|Overall Study||41
3206441|NCT02164513|3936301|FG002|Withdrew IP: Protocol Deviation|Overall Study||19
3206442|NCT02164513|3936299|FG000|WIP (Other): Stopping Criteria Reached|Overall Study||4
3206443|NCT02164513|3936300|FG001|WIP (Other): Stopping Criteria Reached|Overall Study||1
3206444|NCT02164513|3936301|FG002|WIP (Other): Stopping Criteria Reached|Overall Study||2
3206445|NCT02164513|3936299|FG000|WIP: Study Closed/Terminated|Overall Study||5
3206446|NCT02164513|3936300|FG001|WIP: Study Closed/Terminated|Overall Study||2
3206447|NCT02164513|3936301|FG002|WIP: Study Closed/Terminated|Overall Study||5
3206448|NCT02164513|3936299|FG000|WIP: Lost to Follow-up|Overall Study||21
3206449|NCT02164513|3936300|FG001|WIP: Lost to Follow-up|Overall Study||25
3206450|NCT02164513|3936301|FG002|WIP: Lost to Follow-up|Overall Study||14
3206451|NCT02164513|3936299|FG000|WIP: Investigator Discretion|Overall Study||33
3206452|NCT02164513|3936300|FG001|WIP: Investigator Discretion|Overall Study||36
3206453|NCT02164513|3936301|FG002|WIP: Investigator Discretion|Overall Study||15
3206454|NCT02164513|3936299|FG000|WIP: Withdrawal by Participant|Overall Study||250
3206455|NCT02164513|3936300|FG001|WIP: Withdrawal by Participant|Overall Study||296
3206456|NCT02164513|3936301|FG002|WIP: Withdrawal by Participant|Overall Study||153
3206457|NCT02164513|3936299|FG000|WIP :Did Not Complete Study Treatment|Overall Study||1
3206458|NCT02164513|3936300|FG001|WIP :Did Not Complete Study Treatment|Overall Study||1
3206459|NCT02164513|3936301|FG002|WIP :Did Not Complete Study Treatment|Overall Study||0
3206460|NCT02164513|3936299|FG000|COMPLETED|Overall Study||3714
3206461|NCT02164513|3936300|FG001|COMPLETED|Overall Study||3598
3206462|NCT02164513|3936301|FG002|COMPLETED|Overall Study||1775
3206463|NCT02164513|3936299|FG000|NOT COMPLETED|Overall Study||437
3206464|NCT02164513|3936300|FG001|NOT COMPLETED|Overall Study||536
3206465|NCT02164513|3936301|FG002|NOT COMPLETED|Overall Study||295
3365938|NCT03944785|4097177|FG001|NOT COMPLETED|2 Month Study Completion||4
3365939|NCT03944785|4097178|FG002|NOT COMPLETED|2 Month Study Completion||5
3365940|NCT03944785|4097176|FG000|STARTED|4 Month Study Optional Extension||1
3365941|NCT03944785|4097177|FG001|STARTED|4 Month Study Optional Extension||10
3365942|NCT03944785|4097178|FG002|STARTED|4 Month Study Optional Extension||64
3365943|NCT03944785|4097176|FG000|COMPLETED|4 Month Study Optional Extension||0
3365944|NCT03944785|4097177|FG001|COMPLETED|4 Month Study Optional Extension||8
3365945|NCT03944785|4097178|FG002|COMPLETED|4 Month Study Optional Extension||41
3365946|NCT03944785|4097176|FG000|NOT COMPLETED|4 Month Study Optional Extension||1
3365947|NCT03944785|4097177|FG001|NOT COMPLETED|4 Month Study Optional Extension||2
3365948|NCT03944785|4097178|FG002|NOT COMPLETED|4 Month Study Optional Extension||23
3365949|NCT03950622|4097188|FG000|STARTED|Overall Study||604
3365950|NCT03950622|4097189|FG001|STARTED|Overall Study||601
3365951|NCT03950622|4097188|FG000|Vaccinated|Overall Study||602
3365952|NCT03950622|4097189|FG001|Vaccinated|Overall Study||600
3365953|NCT03950622|4097188|FG000|COMPLETED|Overall Study||596
3365954|NCT03950622|4097189|FG001|COMPLETED|Overall Study||594
3365955|NCT03950622|4097188|FG000|NOT COMPLETED|Overall Study||8
3365956|NCT03950622|4097189|FG001|NOT COMPLETED|Overall Study||7
3365957|NCT03949621|4097197|FG000|STARTED|Overall Study||12
3206466|NCT02164539|3936316|FG000|STARTED|Treatment Phase A (4 Weeks)||41
3206467|NCT02164539|3936317|FG001|STARTED|Treatment Phase A (4 Weeks)||42
3206468|NCT02164539|3936318|FG002|STARTED|Treatment Phase A (4 Weeks)||40
3206469|NCT02164539|3936319|FG003|STARTED|Treatment Phase A (4 Weeks)||46
3206470|NCT02164539|3936320|FG004|STARTED|Treatment Phase A (4 Weeks)||85
3206471|NCT02164539|3936321|FG005|STARTED|Treatment Phase A (4 Weeks)||84
3206472|NCT02164539|3936322|FG006|STARTED|Treatment Phase A (4 Weeks)||0
3206473|NCT02164539|3936316|FG000|COMPLETED|Treatment Phase A (4 Weeks)||39
3206474|NCT02164539|3936317|FG001|COMPLETED|Treatment Phase A (4 Weeks)||42
3206475|NCT02164539|3936318|FG002|COMPLETED|Treatment Phase A (4 Weeks)||39
3206476|NCT02164539|3936319|FG003|COMPLETED|Treatment Phase A (4 Weeks)||44
3206477|NCT02164539|3936320|FG004|COMPLETED|Treatment Phase A (4 Weeks)||82
3206478|NCT02164539|3936321|FG005|COMPLETED|Treatment Phase A (4 Weeks)||83
3206479|NCT02164539|3936322|FG006|COMPLETED|Treatment Phase A (4 Weeks)||0
3206480|NCT02164539|3936316|FG000|NOT COMPLETED|Treatment Phase A (4 Weeks)||2
3206481|NCT02164539|3936317|FG001|NOT COMPLETED|Treatment Phase A (4 Weeks)||0
3206482|NCT02164539|3936318|FG002|NOT COMPLETED|Treatment Phase A (4 Weeks)||1
3206483|NCT02164539|3936319|FG003|NOT COMPLETED|Treatment Phase A (4 Weeks)||2
3206484|NCT02164539|3936320|FG004|NOT COMPLETED|Treatment Phase A (4 Weeks)||3
3206485|NCT02164539|3936321|FG005|NOT COMPLETED|Treatment Phase A (4 Weeks)||1
3206486|NCT02164539|3936322|FG006|NOT COMPLETED|Treatment Phase A (4 Weeks)||0
3206487|NCT02164539|3936316|FG000|STARTED|Treatment Phase B (1 Week)||0
3206488|NCT02164539|3936317|FG001|STARTED|Treatment Phase B (1 Week)||0
3206489|NCT02164539|3936318|FG002|STARTED|Treatment Phase B (1 Week)||0
3206490|NCT02164539|3936319|FG003|STARTED|Treatment Phase B (1 Week)||0
3206491|NCT02164539|3936320|FG004|STARTED|Treatment Phase B (1 Week)||166
3206492|NCT02164539|3936321|FG005|STARTED|Treatment Phase B (1 Week)||0
3206493|NCT02164539|3936322|FG006|STARTED|Treatment Phase B (1 Week)||163
3206494|NCT02164539|3936316|FG000|COMPLETED|Treatment Phase B (1 Week)||0
3206495|NCT02164539|3936317|FG001|COMPLETED|Treatment Phase B (1 Week)||0
3206496|NCT02164539|3936318|FG002|COMPLETED|Treatment Phase B (1 Week)||0
3206497|NCT02164539|3936319|FG003|COMPLETED|Treatment Phase B (1 Week)||0
3206498|NCT02164539|3936320|FG004|COMPLETED|Treatment Phase B (1 Week)||163
3206499|NCT02164539|3936321|FG005|COMPLETED|Treatment Phase B (1 Week)||0
3206500|NCT02164539|3936322|FG006|COMPLETED|Treatment Phase B (1 Week)||162
3206501|NCT02164539|3936316|FG000|NOT COMPLETED|Treatment Phase B (1 Week)||0
3206502|NCT02164539|3936317|FG001|NOT COMPLETED|Treatment Phase B (1 Week)||0
3206503|NCT02164539|3936318|FG002|NOT COMPLETED|Treatment Phase B (1 Week)||0
3206504|NCT02164539|3936319|FG003|NOT COMPLETED|Treatment Phase B (1 Week)||0
3206505|NCT02164539|3936320|FG004|NOT COMPLETED|Treatment Phase B (1 Week)||3
3206506|NCT02164539|3936321|FG005|NOT COMPLETED|Treatment Phase B (1 Week)||0
3206507|NCT02164539|3936322|FG006|NOT COMPLETED|Treatment Phase B (1 Week)||1
3206508|NCT02164539|3936316|FG000|STARTED|Treatment Phase C (1 Week)||79
3206509|NCT02164539|3936317|FG001|STARTED|Treatment Phase C (1 Week)||0
3206510|NCT02164539|3936318|FG002|STARTED|Treatment Phase C (1 Week)||0
3206511|NCT02164539|3936319|FG003|STARTED|Treatment Phase C (1 Week)||0
3206512|NCT02164539|3936320|FG004|STARTED|Treatment Phase C (1 Week)||84
3206513|NCT02164539|3936321|FG005|STARTED|Treatment Phase C (1 Week)||82
3206514|NCT02164539|3936322|FG006|STARTED|Treatment Phase C (1 Week)||80
3206515|NCT02164539|3936316|FG000|COMPLETED|Treatment Phase C (1 Week)||78
3206516|NCT02164539|3936317|FG001|COMPLETED|Treatment Phase C (1 Week)||0
3206517|NCT02164539|3936318|FG002|COMPLETED|Treatment Phase C (1 Week)||0
3206518|NCT02164539|3936319|FG003|COMPLETED|Treatment Phase C (1 Week)||0
3206519|NCT02164539|3936320|FG004|COMPLETED|Treatment Phase C (1 Week)||84
3206520|NCT02164539|3936321|FG005|COMPLETED|Treatment Phase C (1 Week)||82
3206521|NCT02164539|3936322|FG006|COMPLETED|Treatment Phase C (1 Week)||78
3206522|NCT02164539|3936316|FG000|NOT COMPLETED|Treatment Phase C (1 Week)||1
3206523|NCT02164539|3936317|FG001|NOT COMPLETED|Treatment Phase C (1 Week)||0
3206524|NCT02164539|3936318|FG002|NOT COMPLETED|Treatment Phase C (1 Week)||0
3206525|NCT02164539|3936319|FG003|NOT COMPLETED|Treatment Phase C (1 Week)||0
3206526|NCT02164539|3936320|FG004|NOT COMPLETED|Treatment Phase C (1 Week)||0
3206527|NCT02164539|3936321|FG005|NOT COMPLETED|Treatment Phase C (1 Week)||0
3206528|NCT02164539|3936322|FG006|NOT COMPLETED|Treatment Phase C (1 Week)||2
3206529|NCT02164721|3936337|FG000|STARTED|Overall Study||30
3206530|NCT02164721|3936337|FG000|COMPLETED|Overall Study||30
3206531|NCT02164721|3936337|FG000|NOT COMPLETED|Overall Study||0
3206532|NCT02164864|3936345|FG000|STARTED|Overall Study|Started are the Randomised/entered patients.|981
3206533|NCT02164864|3936346|FG001|STARTED|Overall Study|Started are the Randomised/entered patients.|763
3206534|NCT02164864|3936347|FG002|STARTED|Overall Study|Started are the Randomised/entered patients.|981
3206535|NCT02164864|3936345|FG000|COMPLETED|Overall Study||886
3206536|NCT02164864|3936346|FG001|COMPLETED|Overall Study||703
3206537|NCT02164864|3936347|FG002|COMPLETED|Overall Study||849
3206538|NCT02164864|3936345|FG000|NOT COMPLETED|Overall Study||95
3206539|NCT02164864|3936346|FG001|NOT COMPLETED|Overall Study||60
3206540|NCT02164864|3936347|FG002|NOT COMPLETED|Overall Study||132
3206541|NCT02164916|3936360|FG000|STARTED|Overall Study||52
3206542|NCT02164916|3936361|FG001|STARTED|Overall Study||54
3206543|NCT02164916|3936360|FG000|Eligible|Overall Study||50
3206544|NCT02164916|3936361|FG001|Eligible|Overall Study||49
3206545|NCT02164916|3936360|FG000|Cross-over to Arm II|Overall Study|Following disease progression on Arm 1. Note: these patients are also counted in 'Not Completed'.|24
3206546|NCT02164916|3936361|FG001|Cross-over to Arm II|Overall Study||0
3206547|NCT02164916|3936360|FG000|COMPLETED|Overall Study||0
3206548|NCT02164916|3936361|FG001|COMPLETED|Overall Study||0
3206549|NCT02164916|3936360|FG000|NOT COMPLETED|Overall Study||52
3206550|NCT02164916|3936361|FG001|NOT COMPLETED|Overall Study||54
3206551|NCT02164929|3936376|FG000|STARTED|Overall Study||4
3206552|NCT02164929|3936377|FG001|STARTED|Overall Study||3
3206553|NCT02164929|3936378|FG002|STARTED|Overall Study||5
3206554|NCT02164929|3936379|FG003|STARTED|Overall Study||4
3206555|NCT02164929|3936376|FG000|COMPLETED|Overall Study||3
3206556|NCT02164929|3936377|FG001|COMPLETED|Overall Study||3
3206557|NCT02164929|3936378|FG002|COMPLETED|Overall Study||4
3206558|NCT02164929|3936379|FG003|COMPLETED|Overall Study||2
3206559|NCT02164929|3936376|FG000|NOT COMPLETED|Overall Study||1
3206560|NCT02164929|3936377|FG001|NOT COMPLETED|Overall Study||0
3206561|NCT02164929|3936378|FG002|NOT COMPLETED|Overall Study||1
3206562|NCT02164929|3936379|FG003|NOT COMPLETED|Overall Study||2
3206563|NCT02164981|3936392|FG000|STARTED|Started||23
3206564|NCT02164981|3936393|FG001|STARTED|Started||19
3206565|NCT02164981|3936394|FG002|STARTED|Started||18
3206566|NCT02164981|3936392|FG000|COMPLETED|Started||18
3206567|NCT02164981|3936393|FG001|COMPLETED|Started||16
3206568|NCT02164981|3936394|FG002|COMPLETED|Started||18
3206569|NCT02164981|3936392|FG000|NOT COMPLETED|Started||5
3206570|NCT02164981|3936393|FG001|NOT COMPLETED|Started||3
3206571|NCT02164981|3936394|FG002|NOT COMPLETED|Started||0
3206572|NCT02164981|3936392|FG000|STARTED|Phase 1 (Day 0 - Day 14)||18
3206573|NCT02164981|3936393|FG001|STARTED|Phase 1 (Day 0 - Day 14)||16
3206574|NCT02164981|3936394|FG002|STARTED|Phase 1 (Day 0 - Day 14)||18
3206575|NCT02164981|3936392|FG000|COMPLETED|Phase 1 (Day 0 - Day 14)||18
3206576|NCT02164981|3936393|FG001|COMPLETED|Phase 1 (Day 0 - Day 14)||14
3206577|NCT02164981|3936394|FG002|COMPLETED|Phase 1 (Day 0 - Day 14)||18
3206578|NCT02164981|3936392|FG000|NOT COMPLETED|Phase 1 (Day 0 - Day 14)||0
3206579|NCT02164981|3936393|FG001|NOT COMPLETED|Phase 1 (Day 0 - Day 14)||2
3206580|NCT02164981|3936394|FG002|NOT COMPLETED|Phase 1 (Day 0 - Day 14)||0
3206581|NCT02164981|3936392|FG000|STARTED|Phase 2 (Day 14 - Day 28)||18
3206582|NCT02164981|3936393|FG001|STARTED|Phase 2 (Day 14 - Day 28)||14
3206583|NCT02164981|3936394|FG002|STARTED|Phase 2 (Day 14 - Day 28)||18
3206584|NCT02164981|3936392|FG000|COMPLETED|Phase 2 (Day 14 - Day 28)||16
3206585|NCT02164981|3936393|FG001|COMPLETED|Phase 2 (Day 14 - Day 28)||12
3206586|NCT02164981|3936394|FG002|COMPLETED|Phase 2 (Day 14 - Day 28)||18
3206587|NCT02164981|3936392|FG000|NOT COMPLETED|Phase 2 (Day 14 - Day 28)||2
3206588|NCT02164981|3936393|FG001|NOT COMPLETED|Phase 2 (Day 14 - Day 28)||2
3206589|NCT02164981|3936394|FG002|NOT COMPLETED|Phase 2 (Day 14 - Day 28)||0
3206590|NCT02165072|3936415|FG000|STARTED|Overall Study||30
3206591|NCT02165072|3936415|FG000|COMPLETED|Overall Study||30
3206592|NCT02165072|3936415|FG000|NOT COMPLETED|Overall Study||0
3206593|NCT02165111|3936421|FG000|STARTED|Overall Study||40
3206594|NCT02165111|3936422|FG001|STARTED|Overall Study||40
3206595|NCT02165111|3936421|FG000|COMPLETED|Overall Study||40
3206596|NCT02165111|3936422|FG001|COMPLETED|Overall Study||40
3206597|NCT02165111|3936421|FG000|NOT COMPLETED|Overall Study||0
3206598|NCT02165111|3936422|FG001|NOT COMPLETED|Overall Study||0
3206599|NCT02165124|3936430|FG000|STARTED|Overall Study||20
3206600|NCT02165124|3936430|FG000|COMPLETED|Overall Study||15
3206601|NCT02165124|3936430|FG000|NOT COMPLETED|Overall Study||5
3206602|NCT02165202|3936436|FG000|STARTED|Oral Phase|Participants Enrolled in the study|91
3206603|NCT02165202|3936437|FG001|STARTED|Oral Phase|Participants Enrolled in the study|45
3206604|NCT02165202|3936436|FG000|COMPLETED|Oral Phase||80
3206605|NCT02165202|3936437|FG001|COMPLETED|Oral Phase||42
3206606|NCT02165202|3936436|FG000|NOT COMPLETED|Oral Phase||11
3206607|NCT02165202|3936437|FG001|NOT COMPLETED|Oral Phase||3
3206608|NCT02165202|3936436|FG000|STARTED|Injection Phase|Participants who received at least one injection.|80
3206609|NCT02165202|3936437|FG001|STARTED|Injection Phase|Participants who received at least one injection.|42
3206610|NCT02165202|3936436|FG000|COMPLETED|Injection Phase||70
3206611|NCT02165202|3936437|FG001|COMPLETED|Injection Phase||36
3206612|NCT02165202|3936436|FG000|NOT COMPLETED|Injection Phase||10
3206613|NCT02165202|3936437|FG001|NOT COMPLETED|Injection Phase||6
3365958|NCT03949621|4097198|FG001|STARTED|Overall Study||12
3206614|NCT02165384|3936443|FG000|STARTED|Overall Study||199
3206615|NCT02165384|3936443|FG000|COMPLETED|Overall Study||199
3206616|NCT02165384|3936443|FG000|NOT COMPLETED|Overall Study||0
3206617|NCT02165397|3936450|FG000|STARTED|Overall Study||75
3206618|NCT02165397|3936451|FG001|STARTED|Overall Study||75
3206619|NCT02165397|3936452|FG002|STARTED|Overall Study||31
3206620|NCT02165397|3936450|FG000|COMPLETED|Overall Study||61
3206621|NCT02165397|3936451|FG001|COMPLETED|Overall Study||56
3206622|NCT02165397|3936452|FG002|COMPLETED|Overall Study||21
3206623|NCT02165397|3936450|FG000|NOT COMPLETED|Overall Study||14
3206624|NCT02165397|3936451|FG001|NOT COMPLETED|Overall Study||19
3206625|NCT02165397|3936452|FG002|NOT COMPLETED|Overall Study||10
3206626|NCT02165462|3936462|FG000|STARTED|Overall Study||17
3206627|NCT02165462|3936462|FG000|COMPLETED|Overall Study||17
3206628|NCT02165462|3936462|FG000|NOT COMPLETED|Overall Study||0
3206629|NCT02165605|3936466|FG000|STARTED|Overall Study||28
3206630|NCT02165605|3936466|FG000|COMPLETED|Overall Study||28
3206631|NCT02165605|3936466|FG000|NOT COMPLETED|Overall Study||0
3206632|NCT02165722|3936475|FG000|STARTED|Overall Study||1971
3206633|NCT02165722|3936476|FG001|STARTED|Overall Study||2202
3206634|NCT02165722|3936475|FG000|COMPLETED|Overall Study|Started and completed participants reflect the longitudinal analytic data set of patients used|1971
3365959|NCT03949621|4097197|FG000|COMPLETED|Overall Study||12
3206635|NCT02165722|3936476|FG001|COMPLETED|Overall Study|Started and completed participants reflect the longitudinal analytic data set of patients used|2202
3206636|NCT02165722|3936475|FG000|NOT COMPLETED|Overall Study||0
3206637|NCT02165722|3936476|FG001|NOT COMPLETED|Overall Study||0
3206638|NCT02165735|3936490|FG000|STARTED|Overall Study||180
3206639|NCT02165735|3936491|FG001|STARTED|Overall Study||180
3206640|NCT02165735|3936490|FG000|COMPLETED|Overall Study||164
3206641|NCT02165735|3936491|FG001|COMPLETED|Overall Study||166
3206642|NCT02165735|3936490|FG000|NOT COMPLETED|Overall Study||16
3206643|NCT02165735|3936491|FG001|NOT COMPLETED|Overall Study||14
3206644|NCT02165761|3936499|FG000|STARTED|Overall Study||23
3206645|NCT02165761|3936500|FG001|STARTED|Overall Study||19
3206646|NCT02165761|3936499|FG000|COMPLETED|Overall Study||4
3206647|NCT02165761|3936500|FG001|COMPLETED|Overall Study||5
3206648|NCT02165761|3936499|FG000|NOT COMPLETED|Overall Study||19
3206649|NCT02165761|3936500|FG001|NOT COMPLETED|Overall Study||14
3206650|NCT02165826|3936509|FG000|STARTED|Main Treatment Period||441
3206651|NCT02165826|3936510|FG001|STARTED|Main Treatment Period||439
3206652|NCT02165826|3936511|FG002|STARTED|Main Treatment Period||443
3206653|NCT02165826|3936509|FG000|Safety Analysis Set: Received Study Drug|Main Treatment Period||441
3206654|NCT02165826|3936510|FG001|Safety Analysis Set: Received Study Drug|Main Treatment Period||437
3206655|NCT02165826|3936511|FG002|Safety Analysis Set: Received Study Drug|Main Treatment Period||443
3206656|NCT02165826|3936509|FG000|COMPLETED|Main Treatment Period||360
3206657|NCT02165826|3936510|FG001|COMPLETED|Main Treatment Period||349
3206658|NCT02165826|3936511|FG002|COMPLETED|Main Treatment Period||334
3206659|NCT02165826|3936509|FG000|NOT COMPLETED|Main Treatment Period||81
3206660|NCT02165826|3936510|FG001|NOT COMPLETED|Main Treatment Period||90
3206661|NCT02165826|3936511|FG002|NOT COMPLETED|Main Treatment Period||109
3206662|NCT02165826|3936509|FG000|STARTED|Down-Titration Period||27
3206663|NCT02165826|3936510|FG001|STARTED|Down-Titration Period||39
3206664|NCT02165826|3936511|FG002|STARTED|Down-Titration Period||38
3206665|NCT02165826|3936509|FG000|Safety Analysis Set: Received Study Drug|Down-Titration Period||27
3206666|NCT02165826|3936510|FG001|Safety Analysis Set: Received Study Drug|Down-Titration Period||39
3206667|NCT02165826|3936511|FG002|Safety Analysis Set: Received Study Drug|Down-Titration Period||38
3206668|NCT02165826|3936509|FG000|COMPLETED|Down-Titration Period||20
3206669|NCT02165826|3936510|FG001|COMPLETED|Down-Titration Period||28
3206670|NCT02165826|3936511|FG002|COMPLETED|Down-Titration Period||31
3206671|NCT02165826|3936509|FG000|NOT COMPLETED|Down-Titration Period||7
3206672|NCT02165826|3936510|FG001|NOT COMPLETED|Down-Titration Period||11
3206673|NCT02165826|3936511|FG002|NOT COMPLETED|Down-Titration Period||7
3206674|NCT02165839|3936538|FG000|STARTED|Overall Study||66
3206675|NCT02165839|3936539|FG001|STARTED|Overall Study||73
3206676|NCT02165839|3936538|FG000|COMPLETED|Overall Study||66
3206677|NCT02165839|3936539|FG001|COMPLETED|Overall Study||73
3206678|NCT02165839|3936538|FG000|NOT COMPLETED|Overall Study||0
3206679|NCT02165839|3936539|FG001|NOT COMPLETED|Overall Study||0
3206680|NCT02165904|3936546|FG000|STARTED|Overall Study||10
3206681|NCT02165904|3936546|FG000|COMPLETED|Overall Study||10
3206682|NCT02165904|3936546|FG000|NOT COMPLETED|Overall Study||0
3206683|NCT02166047|3936562|FG000|STARTED|Overall Study||16
3206684|NCT02166047|3936563|FG001|STARTED|Overall Study||15
3206685|NCT02166047|3936564|FG002|STARTED|Overall Study||16
3206686|NCT02166047|3936565|FG003|STARTED|Overall Study||5
3206687|NCT02166047|3936566|FG004|STARTED|Overall Study||18
3206688|NCT02166047|3936567|FG005|STARTED|Overall Study||17
3206689|NCT02166047|3936568|FG006|STARTED|Overall Study||17
3206690|NCT02166047|3936569|FG007|STARTED|Overall Study||5
3206691|NCT02166047|3936570|FG008|STARTED|Overall Study||16
3206692|NCT02166047|3936571|FG009|STARTED|Overall Study||17
3206693|NCT02166047|3936572|FG010|STARTED|Overall Study||14
3206694|NCT02166047|3936573|FG011|STARTED|Overall Study||6
3206695|NCT02166047|3936562|FG000|COMPLETED|Overall Study||16
3206696|NCT02166047|3936563|FG001|COMPLETED|Overall Study||14
3206697|NCT02166047|3936564|FG002|COMPLETED|Overall Study||14
3206698|NCT02166047|3936565|FG003|COMPLETED|Overall Study||5
3206699|NCT02166047|3936566|FG004|COMPLETED|Overall Study||17
3206700|NCT02166047|3936567|FG005|COMPLETED|Overall Study||17
3206701|NCT02166047|3936568|FG006|COMPLETED|Overall Study||15
3206702|NCT02166047|3936569|FG007|COMPLETED|Overall Study||5
3206703|NCT02166047|3936570|FG008|COMPLETED|Overall Study||16
3206704|NCT02166047|3936571|FG009|COMPLETED|Overall Study||17
3365960|NCT03949621|4097198|FG001|COMPLETED|Overall Study||12
3365961|NCT03949621|4097197|FG000|NOT COMPLETED|Overall Study||0
3365962|NCT03949621|4097198|FG001|NOT COMPLETED|Overall Study||0
3206705|NCT02166047|3936572|FG010|COMPLETED|Overall Study||12
3206706|NCT02166047|3936573|FG011|COMPLETED|Overall Study||6
3206707|NCT02166047|3936562|FG000|NOT COMPLETED|Overall Study||0
3206708|NCT02166047|3936563|FG001|NOT COMPLETED|Overall Study||1
3206709|NCT02166047|3936564|FG002|NOT COMPLETED|Overall Study||2
3206710|NCT02166047|3936565|FG003|NOT COMPLETED|Overall Study||0
3206711|NCT02166047|3936566|FG004|NOT COMPLETED|Overall Study||1
3206712|NCT02166047|3936567|FG005|NOT COMPLETED|Overall Study||0
3206713|NCT02166047|3936568|FG006|NOT COMPLETED|Overall Study||2
3206714|NCT02166047|3936569|FG007|NOT COMPLETED|Overall Study||0
3206715|NCT02166047|3936570|FG008|NOT COMPLETED|Overall Study||0
3206716|NCT02166047|3936571|FG009|NOT COMPLETED|Overall Study||0
3206717|NCT02166047|3936572|FG010|NOT COMPLETED|Overall Study||2
3206718|NCT02166047|3936573|FG011|NOT COMPLETED|Overall Study||0
3206719|NCT02166333|3936603|FG000|STARTED|Stage 1||262
3206720|NCT02166333|3936604|FG001|STARTED|Stage 1||0
3206721|NCT02166333|3936605|FG002|STARTED|Stage 1||130
3206722|NCT02166333|3936606|FG003|STARTED|Stage 1||0
3206723|NCT02166333|3936607|FG004|STARTED|Stage 1|Randomization to 2000 IU/d was stopped in February 2018 as part of planned dose-finding|68
3206724|NCT02166333|3936608|FG005|STARTED|Stage 1|Randomization to 4000 IU/d was stopped in March 2018 as part of planned dose-finding|69
3206725|NCT02166333|3936603|FG000|COMPLETED|Stage 1||242
3206726|NCT02166333|3936604|FG001|COMPLETED|Stage 1||0
3206727|NCT02166333|3936605|FG002|COMPLETED|Stage 1||122
3206728|NCT02166333|3936606|FG003|COMPLETED|Stage 1||0
3206729|NCT02166333|3936607|FG004|COMPLETED|Stage 1||59
3206730|NCT02166333|3936608|FG005|COMPLETED|Stage 1||63
3206731|NCT02166333|3936603|FG000|NOT COMPLETED|Stage 1||20
3206732|NCT02166333|3936604|FG001|NOT COMPLETED|Stage 1||0
3206733|NCT02166333|3936605|FG002|NOT COMPLETED|Stage 1||8
3206734|NCT02166333|3936606|FG003|NOT COMPLETED|Stage 1||0
3206735|NCT02166333|3936607|FG004|NOT COMPLETED|Stage 1||9
3206736|NCT02166333|3936608|FG005|NOT COMPLETED|Stage 1||6
3206737|NCT02166333|3936603|FG000|STARTED|Stage 2||242
3206738|NCT02166333|3936604|FG001|STARTED|Stage 2||77
3206739|NCT02166333|3936605|FG002|STARTED|Stage 2||122
3206740|NCT02166333|3936606|FG003|STARTED|Stage 2||82
3206741|NCT02166333|3936607|FG004|STARTED|Stage 2||59
3206742|NCT02166333|3936608|FG005|STARTED|Stage 2||63
3206743|NCT02166333|3936603|FG000|COMPLETED|Stage 2||35
3206744|NCT02166333|3936604|FG001|COMPLETED|Stage 2||71
3206745|NCT02166333|3936605|FG002|COMPLETED|Stage 2||47
3206746|NCT02166333|3936606|FG003|COMPLETED|Stage 2||73
3206747|NCT02166333|3936607|FG004|COMPLETED|Stage 2||2
3206748|NCT02166333|3936608|FG005|COMPLETED|Stage 2||4
3206749|NCT02166333|3936603|FG000|NOT COMPLETED|Stage 2||207
3206750|NCT02166333|3936604|FG001|NOT COMPLETED|Stage 2||6
3206751|NCT02166333|3936605|FG002|NOT COMPLETED|Stage 2||75
3206752|NCT02166333|3936606|FG003|NOT COMPLETED|Stage 2||9
3206753|NCT02166333|3936607|FG004|NOT COMPLETED|Stage 2||57
3206754|NCT02166333|3936608|FG005|NOT COMPLETED|Stage 2||59
3206755|NCT02166346|3936620|FG000|STARTED|Screening and Randomization||12
3206756|NCT02166346|3936621|FG001|STARTED|Screening and Randomization||12
3206757|NCT02166346|3936620|FG000|COMPLETED|Screening and Randomization||8
3206758|NCT02166346|3936621|FG001|COMPLETED|Screening and Randomization||8
3206759|NCT02166346|3936620|FG000|NOT COMPLETED|Screening and Randomization||4
3206760|NCT02166346|3936621|FG001|NOT COMPLETED|Screening and Randomization||4
3206761|NCT02166346|3936620|FG000|STARTED|Intervention - Phase 1||8
3206762|NCT02166346|3936621|FG001|STARTED|Intervention - Phase 1||8
3206763|NCT02166346|3936620|FG000|COMPLETED|Intervention - Phase 1||8
3206764|NCT02166346|3936621|FG001|COMPLETED|Intervention - Phase 1||6
3206765|NCT02166346|3936620|FG000|NOT COMPLETED|Intervention - Phase 1||0
3206766|NCT02166346|3936621|FG001|NOT COMPLETED|Intervention - Phase 1||2
3206767|NCT02166346|3936620|FG000|STARTED|Intervention - Phase 2 (After Crossover)||8
3206768|NCT02166346|3936621|FG001|STARTED|Intervention - Phase 2 (After Crossover)||6
3206769|NCT02166346|3936620|FG000|COMPLETED|Intervention - Phase 2 (After Crossover)||7
3206770|NCT02166346|3936621|FG001|COMPLETED|Intervention - Phase 2 (After Crossover)||6
3206771|NCT02166346|3936620|FG000|NOT COMPLETED|Intervention - Phase 2 (After Crossover)||1
3206772|NCT02166346|3936621|FG001|NOT COMPLETED|Intervention - Phase 2 (After Crossover)||0
3206773|NCT02166476|3936629|FG000|STARTED|Overall Study||272
3206774|NCT02166476|3936630|FG001|STARTED|Overall Study||273
3206775|NCT02166476|3936629|FG000|Received at Least 1 Dose of Study Drug|Overall Study||272
3206776|NCT02166476|3936630|FG001|Received at Least 1 Dose of Study Drug|Overall Study||273
3206777|NCT02166476|3936629|FG000|COMPLETED|Overall Study||258
3206778|NCT02166476|3936630|FG001|COMPLETED|Overall Study||250
3206779|NCT02166476|3936629|FG000|NOT COMPLETED|Overall Study||14
3206780|NCT02166476|3936630|FG001|NOT COMPLETED|Overall Study||23
3206781|NCT02166606|3936639|FG000|STARTED|Overall Study||1184
3206782|NCT02166606|3936639|FG000|Actively Enrolled|Overall Study||1180
3206783|NCT02166606|3936639|FG000|Consent Eligible|Overall Study||1174
3206784|NCT02166606|3936639|FG000|COMPLETED|Overall Study||1106
3206785|NCT02166606|3936639|FG000|NOT COMPLETED|Overall Study||78
3206786|NCT02166697|3936643|FG000|STARTED|Overall Study||14151
3206787|NCT02166697|3936643|FG000|COMPLETED|Overall Study||13804
3206788|NCT02166697|3936643|FG000|NOT COMPLETED|Overall Study||347
3206789|NCT02167035|3936649|FG000|STARTED|Overall Study||21
3206790|NCT02167035|3936650|FG001|STARTED|Overall Study||22
3206791|NCT02167035|3936649|FG000|COMPLETED|Overall Study||16
3206792|NCT02167035|3936650|FG001|COMPLETED|Overall Study||16
3206793|NCT02167035|3936649|FG000|NOT COMPLETED|Overall Study||5
3206794|NCT02167035|3936650|FG001|NOT COMPLETED|Overall Study||6
3206795|NCT02167074|3936660|FG000|STARTED|Overall Study||306
3206796|NCT02167074|3936661|FG001|STARTED|Overall Study||302
3206797|NCT02167074|3936660|FG000|COMPLETED|Overall Study||306
3206798|NCT02167074|3936661|FG001|COMPLETED|Overall Study||302
3206799|NCT02167074|3936660|FG000|NOT COMPLETED|Overall Study||0
3206800|NCT02167074|3936661|FG001|NOT COMPLETED|Overall Study||0
3206801|NCT02167139|3936669|FG000|STARTED|Randomised, Double-blind||271
3206802|NCT02167139|3936670|FG001|STARTED|Randomised, Double-blind||273
3365963|NCT03949244|4097207|FG000|STARTED|Overall Study||12
3206803|NCT02167139|3936671|FG002|STARTED|Randomised, Double-blind||0
3206804|NCT02167139|3936672|FG003|STARTED|Randomised, Double-blind||0
3206805|NCT02167139|3936669|FG000|COMPLETED|Randomised, Double-blind||254
3206806|NCT02167139|3936670|FG001|COMPLETED|Randomised, Double-blind||254
3206807|NCT02167139|3936671|FG002|COMPLETED|Randomised, Double-blind||0
3206808|NCT02167139|3936672|FG003|COMPLETED|Randomised, Double-blind||0
3206809|NCT02167139|3936669|FG000|NOT COMPLETED|Randomised, Double-blind||17
3206810|NCT02167139|3936670|FG001|NOT COMPLETED|Randomised, Double-blind||19
3206811|NCT02167139|3936671|FG002|NOT COMPLETED|Randomised, Double-blind||0
3206812|NCT02167139|3936672|FG003|NOT COMPLETED|Randomised, Double-blind||0
3206813|NCT02167139|3936669|FG000|STARTED|Transition-extension||254
3206814|NCT02167139|3936670|FG001|STARTED|Transition-extension||0
3206815|NCT02167139|3936671|FG002|STARTED|Transition-extension||125
3206816|NCT02167139|3936672|FG003|STARTED|Transition-extension||129
3206817|NCT02167139|3936669|FG000|COMPLETED|Transition-extension||248
3206818|NCT02167139|3936670|FG001|COMPLETED|Transition-extension||0
3206819|NCT02167139|3936671|FG002|COMPLETED|Transition-extension||117
3206820|NCT02167139|3936672|FG003|COMPLETED|Transition-extension||124
3206821|NCT02167139|3936669|FG000|NOT COMPLETED|Transition-extension||6
3206822|NCT02167139|3936670|FG001|NOT COMPLETED|Transition-extension||0
3206823|NCT02167139|3936671|FG002|NOT COMPLETED|Transition-extension||8
3206824|NCT02167139|3936672|FG003|NOT COMPLETED|Transition-extension||5
3206825|NCT02167204|3936686|FG000|STARTED|Overall Study||9
3206826|NCT02167204|3936686|FG000|COMPLETED|Overall Study||9
3206827|NCT02167204|3936686|FG000|NOT COMPLETED|Overall Study||0
3206828|NCT02167217|3936696|FG000|STARTED|Overall Study||25
3206829|NCT02167217|3936696|FG000|COMPLETED|Overall Study||23
3206830|NCT02167217|3936696|FG000|NOT COMPLETED|Overall Study||2
3206831|NCT02167256|3936702|FG000|STARTED|Overall Study||79
3206832|NCT02167256|3936703|FG001|STARTED|Overall Study||80
3206833|NCT02167256|3936702|FG000|COMPLETED|Overall Study||58
3206834|NCT02167256|3936703|FG001|COMPLETED|Overall Study||70
3206835|NCT02167256|3936702|FG000|NOT COMPLETED|Overall Study||21
3206836|NCT02167256|3936703|FG001|NOT COMPLETED|Overall Study||10
3206837|NCT02167451|3936709|FG000|STARTED|Overall Study||31
3206838|NCT02167451|3936709|FG000|COMPLETED|Overall Study||30
3206839|NCT02167451|3936709|FG000|NOT COMPLETED|Overall Study||1
3206840|NCT02167594|3936716|FG000|STARTED|Overall Study||20
3206841|NCT02167594|3936717|FG001|STARTED|Overall Study||6
3206842|NCT02167594|3936718|FG002|STARTED|Overall Study||3
3206843|NCT02167594|3936716|FG000|COMPLETED|Overall Study||18
3206844|NCT02167594|3936717|FG001|COMPLETED|Overall Study||5
3206845|NCT02167594|3936718|FG002|COMPLETED|Overall Study||3
3206846|NCT02167594|3936716|FG000|NOT COMPLETED|Overall Study||2
3206847|NCT02167594|3936717|FG001|NOT COMPLETED|Overall Study||1
3206848|NCT02167594|3936718|FG002|NOT COMPLETED|Overall Study||0
3206849|NCT02167815|3936729|FG000|STARTED|Overall Study||9
3206850|NCT02167815|3936730|FG001|STARTED|Overall Study||21
3206851|NCT02167815|3936729|FG000|COMPLETED|Overall Study||9
3206852|NCT02167815|3936730|FG001|COMPLETED|Overall Study||21
3206853|NCT02167815|3936729|FG000|NOT COMPLETED|Overall Study||0
3206854|NCT02167815|3936730|FG001|NOT COMPLETED|Overall Study||0
3206855|NCT02167867|3936740|FG000|STARTED|Overall Study||22
3206856|NCT02167867|3936741|FG001|STARTED|Overall Study||22
3206857|NCT02167867|3936740|FG000|COMPLETED|Overall Study||22
3206858|NCT02167867|3936741|FG001|COMPLETED|Overall Study||22
3206859|NCT02167867|3936740|FG000|NOT COMPLETED|Overall Study||0
3206860|NCT02167867|3936741|FG001|NOT COMPLETED|Overall Study||0
3206861|NCT02167893|3936746|FG000|STARTED|Overall Study||11288
3206862|NCT02167893|3936746|FG000|COMPLETED|Overall Study||11125
3206863|NCT02167893|3936746|FG000|NOT COMPLETED|Overall Study||163
3206864|NCT02168062|3936753|FG000|STARTED|Overall Study||23
3206865|NCT02168062|3936754|FG001|STARTED|Overall Study||26
3206866|NCT02168062|3936755|FG002|STARTED|Overall Study||8
3206867|NCT02168062|3936753|FG000|COMPLETED|Overall Study||23
3206868|NCT02168062|3936754|FG001|COMPLETED|Overall Study||26
3206869|NCT02168062|3936755|FG002|COMPLETED|Overall Study||8
3206870|NCT02168062|3936753|FG000|NOT COMPLETED|Overall Study||0
3206871|NCT02168062|3936754|FG001|NOT COMPLETED|Overall Study||0
3206872|NCT02168062|3936755|FG002|NOT COMPLETED|Overall Study||0
3206873|NCT02168101|3936768|FG000|STARTED|Overall Study||3
3206874|NCT02168101|3936769|FG001|STARTED|Overall Study||3
3206875|NCT02168101|3936770|FG002|STARTED|Overall Study||3
3206876|NCT02168101|3936768|FG000|COMPLETED|Overall Study||1
3206877|NCT02168101|3936769|FG001|COMPLETED|Overall Study||1
3206878|NCT02168101|3936770|FG002|COMPLETED|Overall Study||2
3206879|NCT02168101|3936768|FG000|NOT COMPLETED|Overall Study||2
3206880|NCT02168101|3936769|FG001|NOT COMPLETED|Overall Study||2
3206881|NCT02168101|3936770|FG002|NOT COMPLETED|Overall Study||1
3206882|NCT02168153|3936781|FG000|STARTED|Overall Study||60
3206883|NCT02168153|3936782|FG001|STARTED|Overall Study||60
3206884|NCT02168153|3936781|FG000|COMPLETED|Overall Study||57
3206885|NCT02168153|3936782|FG001|COMPLETED|Overall Study||60
3206886|NCT02168153|3936781|FG000|NOT COMPLETED|Overall Study||3
3206887|NCT02168153|3936782|FG001|NOT COMPLETED|Overall Study||0
3206888|NCT02168309|3936790|FG000|STARTED|Overall Study||25
3206889|NCT02168309|3936791|FG001|STARTED|Overall Study||25
3206890|NCT02168309|3936790|FG000|COMPLETED|Overall Study||25
3206891|NCT02168309|3936791|FG001|COMPLETED|Overall Study||25
3206892|NCT02168309|3936790|FG000|NOT COMPLETED|Overall Study||0
3206893|NCT02168309|3936791|FG001|NOT COMPLETED|Overall Study||0
3206894|NCT02168361|3936799|FG000|STARTED|Overall Study||62
3206895|NCT02168361|3936800|FG001|STARTED|Overall Study||31
3206896|NCT02168361|3936799|FG000|COMPLETED|Overall Study||57
3206897|NCT02168361|3936800|FG001|COMPLETED|Overall Study||21
3206898|NCT02168361|3936799|FG000|NOT COMPLETED|Overall Study||5
3206899|NCT02168361|3936800|FG001|NOT COMPLETED|Overall Study||10
3206900|NCT02168387|3936808|FG000|STARTED|Overall Study||20
3206901|NCT02168387|3936809|FG001|STARTED|Overall Study||19
3206902|NCT02168387|3936808|FG000|COMPLETED|Overall Study||13
3206903|NCT02168387|3936809|FG001|COMPLETED|Overall Study||16
3206904|NCT02168387|3936808|FG000|NOT COMPLETED|Overall Study||7
3206905|NCT02168387|3936809|FG001|NOT COMPLETED|Overall Study||3
3206906|NCT02168439|3936817|FG000|STARTED|Overall Study||20
3206907|NCT02168439|3936818|FG001|STARTED|Overall Study||20
3206908|NCT02168439|3936817|FG000|COMPLETED|Overall Study||20
3206909|NCT02168439|3936818|FG001|COMPLETED|Overall Study||18
3206910|NCT02168439|3936817|FG000|NOT COMPLETED|Overall Study||0
3206911|NCT02168439|3936818|FG001|NOT COMPLETED|Overall Study||2
3206912|NCT02168478|3936824|FG000|STARTED|Overall Study||206
3206913|NCT02168478|3936824|FG000|COMPLETED|Overall Study||202
3206914|NCT02168478|3936824|FG000|NOT COMPLETED|Overall Study||4
3206915|NCT02168491|3936828|FG000|STARTED|Overall Study||9
3206916|NCT02168491|3936828|FG000|COMPLETED|Overall Study||8
3206917|NCT02168491|3936828|FG000|NOT COMPLETED|Overall Study||1
3206918|NCT02168660|3936835|FG000|STARTED|Overall Study||38
3206919|NCT02168660|3936836|FG001|STARTED|Overall Study||35
3206920|NCT02168660|3936837|FG002|STARTED|Overall Study||36
3206921|NCT02168660|3936835|FG000|COMPLETED|Overall Study||22
3206922|NCT02168660|3936836|FG001|COMPLETED|Overall Study||18
3206923|NCT02168660|3936837|FG002|COMPLETED|Overall Study||21
3206924|NCT02168660|3936835|FG000|NOT COMPLETED|Overall Study||16
3206925|NCT02168660|3936836|FG001|NOT COMPLETED|Overall Study||17
3206926|NCT02168660|3936837|FG002|NOT COMPLETED|Overall Study||15
3206927|NCT02168777|3936851|FG000|STARTED|Overall Study||2
3206928|NCT02168777|3936852|FG001|STARTED|Overall Study||7
3206929|NCT02168777|3936853|FG002|STARTED|Overall Study||11
3206930|NCT02168777|3936851|FG000|COMPLETED|Overall Study||0
3206931|NCT02168777|3936852|FG001|COMPLETED|Overall Study||0
3206932|NCT02168777|3936853|FG002|COMPLETED|Overall Study||0
3206933|NCT02168777|3936851|FG000|NOT COMPLETED|Overall Study||2
3206934|NCT02168777|3936852|FG001|NOT COMPLETED|Overall Study||7
3206935|NCT02168777|3936853|FG002|NOT COMPLETED|Overall Study||11
3206936|NCT02168803|3936867|FG000|STARTED|Overall Study||30
3206937|NCT02168803|3936868|FG001|STARTED|Overall Study||32
3206938|NCT02168803|3936869|FG002|STARTED|Overall Study||39
3206939|NCT02168803|3936867|FG000|Received at Least 1 Dose of Study Drug|Overall Study||30
3206940|NCT02168803|3936868|FG001|Received at Least 1 Dose of Study Drug|Overall Study||32
3206941|NCT02168803|3936869|FG002|Received at Least 1 Dose of Study Drug|Overall Study||39
3206942|NCT02168803|3936867|FG000|COMPLETED|Overall Study||28
3206943|NCT02168803|3936868|FG001|COMPLETED|Overall Study||29
3206944|NCT02168803|3936869|FG002|COMPLETED|Overall Study||33
3206945|NCT02168803|3936867|FG000|NOT COMPLETED|Overall Study||2
3206946|NCT02168803|3936868|FG001|NOT COMPLETED|Overall Study||3
3206947|NCT02168803|3936869|FG002|NOT COMPLETED|Overall Study||6
3206948|NCT02168816|3936886|FG000|STARTED|Overall Study||5
3206949|NCT02168816|3936887|FG001|STARTED|Overall Study||7
3206950|NCT02168816|3936886|FG000|COMPLETED|Overall Study||3
3206951|NCT02168816|3936887|FG001|COMPLETED|Overall Study||5
3206952|NCT02168816|3936886|FG000|NOT COMPLETED|Overall Study||2
3206953|NCT02168816|3936887|FG001|NOT COMPLETED|Overall Study||2
3206954|NCT02168842|3936895|FG000|STARTED|Overall Study||170
3206955|NCT02168842|3936896|FG001|STARTED|Overall Study||166
3206956|NCT02168842|3936895|FG000|COMPLETED|Overall Study||162
3206957|NCT02168842|3936896|FG001|COMPLETED|Overall Study||158
3206958|NCT02168842|3936895|FG000|NOT COMPLETED|Overall Study||8
3206959|NCT02168842|3936896|FG001|NOT COMPLETED|Overall Study||8
3206960|NCT02168855|3936906|FG000|STARTED|Overall Study||181
3206961|NCT02168855|3936907|FG001|STARTED|Overall Study||188
3206962|NCT02168855|3936906|FG000|COMPLETED|Overall Study||169
3206963|NCT02168855|3936907|FG001|COMPLETED|Overall Study||177
3206964|NCT02168855|3936906|FG000|NOT COMPLETED|Overall Study||12
3206965|NCT02168855|3936907|FG001|NOT COMPLETED|Overall Study||11
3206966|NCT02168933|3936915|FG000|STARTED|Overall Study||8
3206967|NCT02168933|3936915|FG000|COMPLETED|Overall Study||7
3206968|NCT02168933|3936915|FG000|NOT COMPLETED|Overall Study||1
3206969|NCT02168946|3936925|FG000|STARTED|Overall Study|2 additional subjects were randomized to Vabomere but did not receive study drug|50
3206970|NCT02168946|3936926|FG001|STARTED|Overall Study||25
3206971|NCT02168946|3936925|FG000|COMPLETED|Overall Study||38
3206972|NCT02168946|3936926|FG001|COMPLETED|Overall Study||20
3206973|NCT02168946|3936925|FG000|NOT COMPLETED|Overall Study||12
3206974|NCT02168946|3936926|FG001|NOT COMPLETED|Overall Study||5
3206975|NCT02169115|3936935|FG000|STARTED|Overall Study||19
3206976|NCT02169115|3936936|FG001|STARTED|Overall Study||21
3206977|NCT02169115|3936937|FG002|STARTED|Overall Study||21
3206978|NCT02169115|3936935|FG000|COMPLETED|Overall Study||19
3206979|NCT02169115|3936936|FG001|COMPLETED|Overall Study||21
3206980|NCT02169115|3936937|FG002|COMPLETED|Overall Study||21
3206981|NCT02169115|3936935|FG000|NOT COMPLETED|Overall Study||0
3206982|NCT02169115|3936936|FG001|NOT COMPLETED|Overall Study||0
3206983|NCT02169115|3936937|FG002|NOT COMPLETED|Overall Study||0
3206984|NCT02169219|3936946|FG000|STARTED|Overall Study||20
3206985|NCT02169219|3936946|FG000|COMPLETED|Overall Study||14
3206986|NCT02169219|3936946|FG000|NOT COMPLETED|Overall Study||6
3206987|NCT02169271|3936957|FG000|STARTED|Overall Study||49
3206988|NCT02169271|3936958|FG001|STARTED|Overall Study||49
3206989|NCT02169271|3936957|FG000|COMPLETED|Overall Study||48
3206990|NCT02169271|3936958|FG001|COMPLETED|Overall Study||47
3206991|NCT02169271|3936957|FG000|NOT COMPLETED|Overall Study||1
3206992|NCT02169271|3936958|FG001|NOT COMPLETED|Overall Study||2
3206993|NCT02169284|3936966|FG000|STARTED|Overall Study||24
3206994|NCT02169284|3936967|FG001|STARTED|Overall Study||13
3206995|NCT02169284|3936966|FG000|COMPLETED|Overall Study||24
3206996|NCT02169284|3936967|FG001|COMPLETED|Overall Study||12
3206997|NCT02169284|3936966|FG000|NOT COMPLETED|Overall Study||0
3206998|NCT02169284|3936967|FG001|NOT COMPLETED|Overall Study||1
3206999|NCT02169336|3936978|FG000|STARTED|Overall Study||31
3207000|NCT02169336|3936979|FG001|STARTED|Overall Study||32
3207001|NCT02169336|3936980|FG002|STARTED|Overall Study||32
3207002|NCT02169336|3936978|FG000|COMPLETED|Overall Study||27
3207003|NCT02169336|3936979|FG001|COMPLETED|Overall Study||28
3207004|NCT02169336|3936980|FG002|COMPLETED|Overall Study||29
3207005|NCT02169336|3936978|FG000|NOT COMPLETED|Overall Study||4
3207006|NCT02169336|3936979|FG001|NOT COMPLETED|Overall Study||4
3207007|NCT02169336|3936980|FG002|NOT COMPLETED|Overall Study||3
3207008|NCT02169414|3936992|FG000|STARTED|Overall Study||19
3207009|NCT02169414|3936993|FG001|STARTED|Overall Study||19
3207010|NCT02169414|3936994|FG002|STARTED|Overall Study||18
3207011|NCT02169414|3936995|FG003|STARTED|Overall Study||18
3207012|NCT02169414|3936992|FG000|BIA 9-1067 + Levodopa/Carbidopa|Overall Study||18
3207013|NCT02169414|3936993|FG001|BIA 9-1067 + Levodopa/Carbidopa|Overall Study||19
3207014|NCT02169414|3936994|FG002|BIA 9-1067 + Levodopa/Carbidopa|Overall Study||18
3207015|NCT02169414|3936995|FG003|BIA 9-1067 + Levodopa/Carbidopa|Overall Study||18
3207016|NCT02169414|3936992|FG000|BIA 9-1067 + Levodopa/Benserazide|Overall Study||18
3207017|NCT02169414|3936993|FG001|BIA 9-1067 + Levodopa/Benserazide|Overall Study||18
3207018|NCT02169414|3936994|FG002|BIA 9-1067 + Levodopa/Benserazide|Overall Study||18
3207019|NCT02169414|3936995|FG003|BIA 9-1067 + Levodopa/Benserazide|Overall Study||18
3207020|NCT02169414|3936992|FG000|COMPLETED|Overall Study||18
3207021|NCT02169414|3936993|FG001|COMPLETED|Overall Study||18
3207022|NCT02169414|3936994|FG002|COMPLETED|Overall Study||18
3207023|NCT02169414|3936995|FG003|COMPLETED|Overall Study||18
3207024|NCT02169414|3936992|FG000|NOT COMPLETED|Overall Study||1
3207025|NCT02169414|3936993|FG001|NOT COMPLETED|Overall Study||1
3207026|NCT02169414|3936994|FG002|NOT COMPLETED|Overall Study||0
3207027|NCT02169414|3936995|FG003|NOT COMPLETED|Overall Study||0
3207028|NCT02169427|3937009|FG000|STARTED|Overall Study||6
3207029|NCT02169427|3937009|FG000|COMPLETED|Overall Study||6
3207030|NCT02169427|3937009|FG000|NOT COMPLETED|Overall Study||0
3207031|NCT02169440|3937015|FG000|STARTED|Overall Study||10
3207032|NCT02169440|3937016|FG001|STARTED|Overall Study||10
3207033|NCT02169440|3937015|FG000|COMPLETED|Overall Study||10
3207034|NCT02169440|3937016|FG001|COMPLETED|Overall Study||10
3207035|NCT02169440|3937015|FG000|NOT COMPLETED|Overall Study||0
3207036|NCT02169440|3937016|FG001|NOT COMPLETED|Overall Study||0
3207037|NCT02169453|3937027|FG000|STARTED|Overall Study||3
3207038|NCT02169453|3937028|FG001|STARTED|Overall Study||3
3207039|NCT02169453|3937029|FG002|STARTED|Overall Study||3
3207040|NCT02169453|3937030|FG003|STARTED|Overall Study||3
3207041|NCT02169453|3937027|FG000|25 mg BIA 9-1067|Overall Study||3
3207042|NCT02169453|3937028|FG001|25 mg BIA 9-1067|Overall Study||3
3207043|NCT02169453|3937029|FG002|25 mg BIA 9-1067|Overall Study||3
3207044|NCT02169453|3937030|FG003|25 mg BIA 9-1067|Overall Study||3
3207045|NCT02169453|3937027|FG000|50 mg BIA 9-1067|Overall Study||3
3207046|NCT02169453|3937028|FG001|50 mg BIA 9-1067|Overall Study||3
3207047|NCT02169453|3937029|FG002|50 mg BIA 9-1067|Overall Study||2
3207048|NCT02169453|3937030|FG003|50 mg BIA 9-1067|Overall Study||3
3207049|NCT02169453|3937027|FG000|100 mg BIA 9-1067|Overall Study||3
3207050|NCT02169453|3937028|FG001|100 mg BIA 9-1067|Overall Study||3
3207051|NCT02169453|3937029|FG002|100 mg BIA 9-1067|Overall Study||3
3207052|NCT02169453|3937030|FG003|100 mg BIA 9-1067|Overall Study||3
3207053|NCT02169453|3937027|FG000|Placebo|Overall Study||3
3207054|NCT02169453|3937028|FG001|Placebo|Overall Study||3
3207055|NCT02169453|3937029|FG002|Placebo|Overall Study||3
3207056|NCT02169453|3937030|FG003|Placebo|Overall Study||3
3207057|NCT02169453|3937027|FG000|COMPLETED|Overall Study||3
3207058|NCT02169453|3937028|FG001|COMPLETED|Overall Study||3
3207059|NCT02169453|3937029|FG002|COMPLETED|Overall Study||2
3207060|NCT02169453|3937030|FG003|COMPLETED|Overall Study||3
3207061|NCT02169453|3937027|FG000|NOT COMPLETED|Overall Study||0
3207062|NCT02169453|3937028|FG001|NOT COMPLETED|Overall Study||0
3207063|NCT02169453|3937029|FG002|NOT COMPLETED|Overall Study||1
3207064|NCT02169453|3937030|FG003|NOT COMPLETED|Overall Study||0
3207065|NCT02169466|3937044|FG000|STARTED|Overall Study||6
3207066|NCT02169466|3937045|FG001|STARTED|Overall Study||6
3207067|NCT02169466|3937046|FG002|STARTED|Overall Study||5
3207068|NCT02169466|3937047|FG003|STARTED|Overall Study||5
3207069|NCT02169466|3937044|FG000|25 mg BIA 9-1067|Overall Study||6
3207070|NCT02169466|3937045|FG001|25 mg BIA 9-1067|Overall Study||5
3207071|NCT02169466|3937046|FG002|25 mg BIA 9-1067|Overall Study||5
3207072|NCT02169466|3937047|FG003|25 mg BIA 9-1067|Overall Study||5
3207073|NCT02169466|3937044|FG000|50 mg BIA 9-1067|Overall Study||6
3207074|NCT02169466|3937045|FG001|50 mg BIA 9-1067|Overall Study||6
3207075|NCT02169466|3937046|FG002|50 mg BIA 9-1067|Overall Study||5
3207076|NCT02169466|3937047|FG003|50 mg BIA 9-1067|Overall Study||5
3207077|NCT02169466|3937044|FG000|100 mg BIA 9-1067|Overall Study||6
3207078|NCT02169466|3937045|FG001|100 mg BIA 9-1067|Overall Study||6
3207079|NCT02169466|3937046|FG002|100 mg BIA 9-1067|Overall Study||5
3207080|NCT02169466|3937047|FG003|100 mg BIA 9-1067|Overall Study||5
3207081|NCT02169466|3937044|FG000|Placebo|Overall Study||5
3207082|NCT02169466|3937045|FG001|Placebo|Overall Study||6
3207083|NCT02169466|3937046|FG002|Placebo|Overall Study||5
3207084|NCT02169466|3937047|FG003|Placebo|Overall Study||5
3207085|NCT02169466|3937044|FG000|COMPLETED|Overall Study||5
3207086|NCT02169466|3937045|FG001|COMPLETED|Overall Study||5
3207087|NCT02169466|3937046|FG002|COMPLETED|Overall Study||5
3207088|NCT02169466|3937047|FG003|COMPLETED|Overall Study||5
3207089|NCT02169466|3937044|FG000|NOT COMPLETED|Overall Study||1
3207090|NCT02169466|3937045|FG001|NOT COMPLETED|Overall Study||1
3207091|NCT02169466|3937046|FG002|NOT COMPLETED|Overall Study||0
3207092|NCT02169466|3937047|FG003|NOT COMPLETED|Overall Study||0
3207093|NCT02169479|3937065|FG000|STARTED|Overall Study||4
3207094|NCT02169479|3937066|FG001|STARTED|Overall Study||4
3207095|NCT02169479|3937067|FG002|STARTED|Overall Study||4
3207096|NCT02169479|3937068|FG003|STARTED|Overall Study||4
3207097|NCT02169479|3937065|FG000|25 mg BIA 9-1067|Overall Study||4
3207098|NCT02169479|3937066|FG001|25 mg BIA 9-1067|Overall Study||3
3207099|NCT02169479|3937067|FG002|25 mg BIA 9-1067|Overall Study||4
3207100|NCT02169479|3937068|FG003|25 mg BIA 9-1067|Overall Study||4
3207101|NCT02169479|3937065|FG000|50 mg BIA 9-1067|Overall Study||4
3207102|NCT02169479|3937066|FG001|50 mg BIA 9-1067|Overall Study||4
3207103|NCT02169479|3937067|FG002|50 mg BIA 9-1067|Overall Study||4
3207104|NCT02169479|3937068|FG003|50 mg BIA 9-1067|Overall Study||4
3207105|NCT02169479|3937065|FG000|100 mg BIA 9-1067|Overall Study||3
3207106|NCT02169479|3937066|FG001|100 mg BIA 9-1067|Overall Study||4
3207107|NCT02169479|3937067|FG002|100 mg BIA 9-1067|Overall Study||4
3207108|NCT02169479|3937068|FG003|100 mg BIA 9-1067|Overall Study||4
3207109|NCT02169479|3937065|FG000|Placebo|Overall Study||3
3207110|NCT02169479|3937066|FG001|Placebo|Overall Study||3
3207111|NCT02169479|3937067|FG002|Placebo|Overall Study||4
3207112|NCT02169479|3937068|FG003|Placebo|Overall Study||4
3207113|NCT02169479|3937065|FG000|COMPLETED|Overall Study||3
3207114|NCT02169479|3937066|FG001|COMPLETED|Overall Study||3
3207115|NCT02169479|3937067|FG002|COMPLETED|Overall Study||4
3207116|NCT02169479|3937068|FG003|COMPLETED|Overall Study||4
3207117|NCT02169479|3937065|FG000|NOT COMPLETED|Overall Study||1
3207118|NCT02169479|3937066|FG001|NOT COMPLETED|Overall Study||1
3207119|NCT02169479|3937067|FG002|NOT COMPLETED|Overall Study||0
3207120|NCT02169479|3937068|FG003|NOT COMPLETED|Overall Study||0
3207121|NCT02169505|3937078|FG000|STARTED|Overall Study||2
3207122|NCT02169505|3937078|FG000|COMPLETED|Overall Study||1
3207123|NCT02169505|3937078|FG000|NOT COMPLETED|Overall Study||1
3207124|NCT02169674|3937084|FG000|STARTED|Overall Study||137
3207125|NCT02169674|3937085|FG001|STARTED|Overall Study||213
3207126|NCT02169674|3937084|FG000|COMPLETED|Overall Study||105
3207127|NCT02169674|3937085|FG001|COMPLETED|Overall Study||135
3207128|NCT02169674|3937084|FG000|NOT COMPLETED|Overall Study||32
3207129|NCT02169674|3937085|FG001|NOT COMPLETED|Overall Study||78
3207130|NCT02169739|3937093|FG000|STARTED|Overall Study||2
3207131|NCT02169739|3937094|FG001|STARTED|Overall Study||4
3207132|NCT02169739|3937093|FG000|COMPLETED|Overall Study||2
3207133|NCT02169739|3937094|FG001|COMPLETED|Overall Study||0
3207134|NCT02169739|3937093|FG000|NOT COMPLETED|Overall Study||0
3207135|NCT02169739|3937094|FG001|NOT COMPLETED|Overall Study||4
3207136|NCT02169791|3937101|FG000|STARTED|Overall Study||25
3207137|NCT02169791|3937101|FG000|COMPLETED|Overall Study||18
3207138|NCT02169791|3937101|FG000|NOT COMPLETED|Overall Study||7
3207139|NCT02169869|3937107|FG000|STARTED|Overall Study||17
3207140|NCT02169869|3937108|FG001|STARTED|Overall Study||16
3207141|NCT02169869|3937107|FG000|COMPLETED|Overall Study||17
3207142|NCT02169869|3937108|FG001|COMPLETED|Overall Study||16
3207143|NCT02169869|3937107|FG000|NOT COMPLETED|Overall Study||0
3207144|NCT02169869|3937108|FG001|NOT COMPLETED|Overall Study||0
3207145|NCT02169895|3937118|FG000|STARTED|Overall Study||4
3207146|NCT02169895|3937119|FG001|STARTED|Overall Study||4
3207147|NCT02169895|3937120|FG002|STARTED|Overall Study||4
3207148|NCT02169895|3937121|FG003|STARTED|Overall Study||4
3207149|NCT02169895|3937118|FG000|25 mg BIA 9-1067|Overall Study||4
3207150|NCT02169895|3937119|FG001|25 mg BIA 9-1067|Overall Study||4
3207151|NCT02169895|3937120|FG002|25 mg BIA 9-1067|Overall Study||4
3207152|NCT02169895|3937121|FG003|25 mg BIA 9-1067|Overall Study||4
3207153|NCT02169895|3937118|FG000|50 mg BIA 9-1067|Overall Study||4
3207154|NCT02169895|3937119|FG001|50 mg BIA 9-1067|Overall Study||4
3207155|NCT02169895|3937120|FG002|50 mg BIA 9-1067|Overall Study||4
3207156|NCT02169895|3937121|FG003|50 mg BIA 9-1067|Overall Study||4
3207157|NCT02169895|3937118|FG000|100 mg BIA 9-1067|Overall Study||4
3207158|NCT02169895|3937119|FG001|100 mg BIA 9-1067|Overall Study||4
3207159|NCT02169895|3937120|FG002|100 mg BIA 9-1067|Overall Study||4
3207160|NCT02169895|3937121|FG003|100 mg BIA 9-1067|Overall Study||2
3207161|NCT02169895|3937118|FG000|Placebo|Overall Study||4
3207162|NCT02169895|3937119|FG001|Placebo|Overall Study||4
3207163|NCT02169895|3937120|FG002|Placebo|Overall Study||4
3207164|NCT02169895|3937121|FG003|Placebo|Overall Study||4
3207165|NCT02169895|3937118|FG000|COMPLETED|Overall Study||4
3207166|NCT02169895|3937119|FG001|COMPLETED|Overall Study||4
3207167|NCT02169895|3937120|FG002|COMPLETED|Overall Study||4
3207168|NCT02169895|3937121|FG003|COMPLETED|Overall Study||2
3207169|NCT02169895|3937118|FG000|NOT COMPLETED|Overall Study||0
3207170|NCT02169895|3937119|FG001|NOT COMPLETED|Overall Study||0
3207171|NCT02169895|3937120|FG002|NOT COMPLETED|Overall Study||0
3207172|NCT02169895|3937121|FG003|NOT COMPLETED|Overall Study||2
3207173|NCT02170025|3937133|FG000|STARTED|Overall Study||14
3207174|NCT02170025|3937134|FG001|STARTED|Overall Study||7
3207175|NCT02170025|3937133|FG000|COMPLETED|Overall Study||12
3207176|NCT02170025|3937134|FG001|COMPLETED|Overall Study||7
3207177|NCT02170025|3937133|FG000|NOT COMPLETED|Overall Study||2
3207178|NCT02170025|3937134|FG001|NOT COMPLETED|Overall Study||0
3207179|NCT02170051|3937142|FG000|STARTED|Overall Study||26
3207180|NCT02170051|3937143|FG001|STARTED|Overall Study||29
3207181|NCT02170051|3937142|FG000|Tested at Mid-point|Overall Study||13
3207182|NCT02170051|3937143|FG001|Tested at Mid-point|Overall Study||18
3207183|NCT02170051|3937142|FG000|Tested at Post-treatment|Overall Study||15
3207184|NCT02170051|3937143|FG001|Tested at Post-treatment|Overall Study||16
3207185|NCT02170051|3937142|FG000|COMPLETED|Overall Study||15
3207186|NCT02170051|3937143|FG001|COMPLETED|Overall Study||16
3207187|NCT02170051|3937142|FG000|NOT COMPLETED|Overall Study||11
3207188|NCT02170051|3937143|FG001|NOT COMPLETED|Overall Study||13
3207189|NCT02170064|3937152|FG000|STARTED|Overall Study||15
3207190|NCT02170064|3937153|FG001|STARTED|Overall Study||9
3207191|NCT02170064|3937154|FG002|STARTED|Overall Study||11
3207192|NCT02170064|3937152|FG000|Safety Population (SP)|Overall Study||12
3207193|NCT02170064|3937153|FG001|Safety Population (SP)|Overall Study||8
3207194|NCT02170064|3937154|FG002|Safety Population (SP)|Overall Study||11
3207195|NCT02170064|3937152|FG000|Pharmacokinetic Population (PKP)|Overall Study||11
3207196|NCT02170064|3937153|FG001|Pharmacokinetic Population (PKP)|Overall Study||8
3207197|NCT02170064|3937154|FG002|Pharmacokinetic Population (PKP)|Overall Study||10
3207198|NCT02170064|3937152|FG000|Efficacy Population (EP)|Overall Study||11
3207199|NCT02170064|3937153|FG001|Efficacy Population (EP)|Overall Study||8
3207200|NCT02170064|3937154|FG002|Efficacy Population (EP)|Overall Study||10
3207201|NCT02170064|3937152|FG000|COMPLETED|Overall Study||9
3207202|NCT02170064|3937153|FG001|COMPLETED|Overall Study||7
3207203|NCT02170064|3937154|FG002|COMPLETED|Overall Study||10
3207204|NCT02170064|3937152|FG000|NOT COMPLETED|Overall Study||6
3207205|NCT02170064|3937153|FG001|NOT COMPLETED|Overall Study||2
3207206|NCT02170064|3937154|FG002|NOT COMPLETED|Overall Study||1
3207207|NCT02170077|3937165|FG000|STARTED|Overall Study||50
3207208|NCT02170077|3937166|FG001|STARTED|Overall Study||47
3207209|NCT02170077|3937167|FG002|STARTED|Overall Study||47
3207210|NCT02170077|3937165|FG000|Intent to Treat (ITT) Population|Overall Study||50
3207211|NCT02170077|3937166|FG001|Intent to Treat (ITT) Population|Overall Study||46
3207212|NCT02170077|3937167|FG002|Intent to Treat (ITT) Population|Overall Study||47
3207213|NCT02170077|3937165|FG000|COMPLETED|Overall Study||41
3207214|NCT02170077|3937166|FG001|COMPLETED|Overall Study||34
3207215|NCT02170077|3937167|FG002|COMPLETED|Overall Study||35
3207216|NCT02170077|3937165|FG000|NOT COMPLETED|Overall Study||9
3207217|NCT02170077|3937166|FG001|NOT COMPLETED|Overall Study||13
3207218|NCT02170077|3937167|FG002|NOT COMPLETED|Overall Study||12
3207219|NCT02170207|3937175|FG000|STARTED|Overall Study||63
3207220|NCT02170207|3937175|FG000|COMPLETED|Overall Study||58
3207221|NCT02170207|3937175|FG000|NOT COMPLETED|Overall Study||5
3207222|NCT02170220|3937181|FG000|STARTED|Overall Study||6
3207223|NCT02170220|3937182|FG001|STARTED|Overall Study||6
3207224|NCT02170220|3937181|FG000|COMPLETED|Overall Study||6
3207225|NCT02170220|3937182|FG001|COMPLETED|Overall Study||6
3207226|NCT02170220|3937181|FG000|NOT COMPLETED|Overall Study||0
3207227|NCT02170220|3937182|FG001|NOT COMPLETED|Overall Study||0
3207228|NCT02170363|3937188|FG000|STARTED|Overall Study||50
3207229|NCT02170363|3937188|FG000|COMPLETED|Overall Study|Followed to the 6-Month Primary Endpoint|50
3207230|NCT02170363|3937188|FG000|NOT COMPLETED|Overall Study||0
3207231|NCT02170376|3937199|FG000|STARTED|Overall Study||16
3207232|NCT02170376|3937200|FG001|STARTED|Overall Study||16
3207233|NCT02170376|3937201|FG002|STARTED|Overall Study||16
3207234|NCT02170376|3937202|FG003|STARTED|Overall Study||16
3207235|NCT02170376|3937203|FG004|STARTED|Overall Study||16
3207236|NCT02170376|3937199|FG000|Pharmacokinetic Population|Overall Study||16
3207237|NCT02170376|3937200|FG001|Pharmacokinetic Population|Overall Study||15
3207238|NCT02170376|3937201|FG002|Pharmacokinetic Population|Overall Study||16
3207239|NCT02170376|3937202|FG003|Pharmacokinetic Population|Overall Study||16
3207240|NCT02170376|3937203|FG004|Pharmacokinetic Population|Overall Study||16
3207241|NCT02170376|3937199|FG000|COMPLETED|Overall Study||16
3207242|NCT02170376|3937200|FG001|COMPLETED|Overall Study||15
3207243|NCT02170376|3937201|FG002|COMPLETED|Overall Study||16
3207244|NCT02170376|3937202|FG003|COMPLETED|Overall Study||16
3207245|NCT02170376|3937203|FG004|COMPLETED|Overall Study||16
3207246|NCT02170376|3937199|FG000|NOT COMPLETED|Overall Study||0
3207247|NCT02170376|3937200|FG001|NOT COMPLETED|Overall Study||1
3207248|NCT02170376|3937201|FG002|NOT COMPLETED|Overall Study||0
3207249|NCT02170376|3937202|FG003|NOT COMPLETED|Overall Study||0
3207250|NCT02170376|3937203|FG004|NOT COMPLETED|Overall Study||0
3207251|NCT02170389|3937215|FG000|STARTED|Overall Study||5
3207252|NCT02170389|3937215|FG000|COMPLETED|Overall Study||4
3207253|NCT02170389|3937215|FG000|NOT COMPLETED|Overall Study||1
3365964|NCT03949244|4097208|FG001|STARTED|Overall Study||21
3365965|NCT03949244|4097209|FG002|STARTED|Overall Study||14
3365966|NCT03949244|4097207|FG000|COMPLETED|Overall Study||12
3365967|NCT03949244|4097208|FG001|COMPLETED|Overall Study||21
3365968|NCT03949244|4097209|FG002|COMPLETED|Overall Study||14
3365969|NCT03949244|4097207|FG000|NOT COMPLETED|Overall Study||0
3365970|NCT03949244|4097208|FG001|NOT COMPLETED|Overall Study||0
3365971|NCT03949244|4097209|FG002|NOT COMPLETED|Overall Study||0
3365972|NCT03948581|4097219|FG000|STARTED|Overall Study||51
3365973|NCT03948581|4097220|FG001|STARTED|Overall Study||51
3365974|NCT03948581|4097219|FG000|COMPLETED|Overall Study||51
3365975|NCT03948581|4097220|FG001|COMPLETED|Overall Study||50
3207254|NCT02170519|3937221|FG000|STARTED|Overall Study||22
3207255|NCT02170519|3937222|FG001|STARTED|Overall Study||5
3207256|NCT02170519|3937221|FG000|COMPLETED|Overall Study||22
3207257|NCT02170519|3937222|FG001|COMPLETED|Overall Study||5
3207258|NCT02170519|3937221|FG000|NOT COMPLETED|Overall Study||0
3207259|NCT02170519|3937222|FG001|NOT COMPLETED|Overall Study||0
3207260|NCT02170532|3937229|FG000|STARTED|Overall Study||10
3207261|NCT02170532|3937229|FG000|COMPLETED|Overall Study||10
3207262|NCT02170532|3937229|FG000|NOT COMPLETED|Overall Study||0
3207263|NCT02170649|3937240|FG000|STARTED|Fasting Period||12
3207264|NCT02170649|3937240|FG000|COMPLETED|Fasting Period||12
3207265|NCT02170649|3937240|FG000|NOT COMPLETED|Fasting Period||0
3207266|NCT02170649|3937240|FG000|STARTED|Fed Period||12
3207267|NCT02170649|3937240|FG000|COMPLETED|Fed Period||12
3207268|NCT02170649|3937240|FG000|NOT COMPLETED|Fed Period||0
3207269|NCT02170662|3937246|FG000|STARTED|Overall Study||3
3207270|NCT02170662|3937247|FG001|STARTED|Overall Study||6
3207271|NCT02170662|3937246|FG000|COMPLETED|Overall Study||3
3207272|NCT02170662|3937247|FG001|COMPLETED|Overall Study||6
3207273|NCT02170662|3937246|FG000|NOT COMPLETED|Overall Study||0
3207274|NCT02170662|3937247|FG001|NOT COMPLETED|Overall Study||0
3207275|NCT02170688|3937258|FG000|STARTED|Overall Study||29
3207276|NCT02170688|3937259|FG001|STARTED|Overall Study||29
3207277|NCT02170688|3937260|FG002|STARTED|Overall Study||29
3207278|NCT02170688|3937261|FG003|STARTED|Overall Study||27
3207279|NCT02170688|3937262|FG004|STARTED|Overall Study||25
3207280|NCT02170688|3937258|FG000|COMPLETED|Overall Study||25
3207281|NCT02170688|3937259|FG001|COMPLETED|Overall Study||26
3207282|NCT02170688|3937260|FG002|COMPLETED|Overall Study||25
3207283|NCT02170688|3937261|FG003|COMPLETED|Overall Study||25
3207284|NCT02170688|3937262|FG004|COMPLETED|Overall Study||25
3207285|NCT02170688|3937258|FG000|NOT COMPLETED|Overall Study||4
3207286|NCT02170688|3937259|FG001|NOT COMPLETED|Overall Study||3
3207287|NCT02170688|3937260|FG002|NOT COMPLETED|Overall Study||4
3207288|NCT02170688|3937261|FG003|NOT COMPLETED|Overall Study||2
3207289|NCT02170688|3937262|FG004|NOT COMPLETED|Overall Study||0
3207290|NCT02170727|3937276|FG000|STARTED|Overall Study||138
3207291|NCT02170727|3937277|FG001|STARTED|Overall Study||31
3207292|NCT02170727|3937276|FG000|COMPLETED|Overall Study||135
3207293|NCT02170727|3937277|FG001|COMPLETED|Overall Study||31
3207294|NCT02170727|3937276|FG000|NOT COMPLETED|Overall Study||3
3207295|NCT02170727|3937277|FG001|NOT COMPLETED|Overall Study||0
3207296|NCT02170779|3937288|FG000|STARTED|Overall Study||20
3207297|NCT02170779|3937289|FG001|STARTED|Overall Study||20
3207298|NCT02170779|3937288|FG000|COMPLETED|Overall Study||19
3207299|NCT02170779|3937289|FG001|COMPLETED|Overall Study||19
3207300|NCT02170779|3937288|FG000|NOT COMPLETED|Overall Study||1
3207301|NCT02170779|3937289|FG001|NOT COMPLETED|Overall Study||1
3207302|NCT02170870|3937301|FG000|STARTED|Overall Study||13
3207303|NCT02170870|3937302|FG001|STARTED|Overall Study||11
3207304|NCT02170870|3937303|FG002|STARTED|Overall Study||20
3207305|NCT02170870|3937304|FG003|STARTED|Overall Study||20
3207306|NCT02170870|3937305|FG004|STARTED|Overall Study||20
3207307|NCT02170870|3937306|FG005|STARTED|Overall Study||20
3207308|NCT02170870|3937301|FG000|COMPLETED|Overall Study||13
3207309|NCT02170870|3937302|FG001|COMPLETED|Overall Study||11
3207310|NCT02170870|3937303|FG002|COMPLETED|Overall Study||20
3207311|NCT02170870|3937304|FG003|COMPLETED|Overall Study||20
3207312|NCT02170870|3937305|FG004|COMPLETED|Overall Study||20
3207313|NCT02170870|3937306|FG005|COMPLETED|Overall Study||20
3207314|NCT02170870|3937301|FG000|NOT COMPLETED|Overall Study||0
3207315|NCT02170870|3937302|FG001|NOT COMPLETED|Overall Study||0
3207316|NCT02170870|3937303|FG002|NOT COMPLETED|Overall Study||0
3207317|NCT02170870|3937304|FG003|NOT COMPLETED|Overall Study||0
3207318|NCT02170870|3937305|FG004|NOT COMPLETED|Overall Study||0
3207319|NCT02170870|3937306|FG005|NOT COMPLETED|Overall Study||0
3207320|NCT02171065|3937326|FG000|STARTED|Overall Study||89
3207321|NCT02171065|3937327|FG001|STARTED|Overall Study||93
3207322|NCT02171065|3937328|FG002|STARTED|Overall Study||716
3207323|NCT02171065|3937326|FG000|COMPLETED|Overall Study||88
3207324|NCT02171065|3937327|FG001|COMPLETED|Overall Study||93
3207325|NCT02171065|3937328|FG002|COMPLETED|Overall Study||715
3207326|NCT02171065|3937326|FG000|NOT COMPLETED|Overall Study||1
3207327|NCT02171065|3937327|FG001|NOT COMPLETED|Overall Study||0
3207328|NCT02171065|3937328|FG002|NOT COMPLETED|Overall Study||1
3207329|NCT02171130|3937338|FG000|STARTED|Overall Study||129
3207330|NCT02171130|3937338|FG000|Received at Least One Dose of Study Drug|Overall Study||87
3207331|NCT02171130|3937338|FG000|Experienced Hypoglycemic Event|Overall Study|Experienced at least one hypoglycemic event and received at least one dose of study drug.|87
3207332|NCT02171130|3937338|FG000|COMPLETED|Overall Study|Including participants who completed the 6-month study but did not experience any hypoglycemia event|101
3207333|NCT02171130|3937338|FG000|NOT COMPLETED|Overall Study||28
3207334|NCT02171195|3937351|FG000|STARTED|Overall Study||16
3207335|NCT02171195|3937352|FG001|STARTED|Overall Study||6
3207336|NCT02171195|3937353|FG002|STARTED|Overall Study||6
3207337|NCT02171195|3937354|FG003|STARTED|Overall Study||6
3207338|NCT02171195|3937355|FG004|STARTED|Overall Study||6
3207339|NCT02171195|3937356|FG005|STARTED|Overall Study||6
3207340|NCT02171195|3937357|FG006|STARTED|Overall Study||6
3207341|NCT02171195|3937358|FG007|STARTED|Overall Study||6
3207342|NCT02171195|3937359|FG008|STARTED|Overall Study||6
3207343|NCT02171195|3937351|FG000|COMPLETED|Overall Study||16
3207344|NCT02171195|3937352|FG001|COMPLETED|Overall Study||6
3207345|NCT02171195|3937353|FG002|COMPLETED|Overall Study||6
3207346|NCT02171195|3937354|FG003|COMPLETED|Overall Study||6
3207347|NCT02171195|3937355|FG004|COMPLETED|Overall Study||6
3207348|NCT02171195|3937356|FG005|COMPLETED|Overall Study||6
3207349|NCT02171195|3937357|FG006|COMPLETED|Overall Study||6
3207350|NCT02171195|3937358|FG007|COMPLETED|Overall Study||6
3207351|NCT02171195|3937359|FG008|COMPLETED|Overall Study||6
3207352|NCT02171195|3937351|FG000|NOT COMPLETED|Overall Study||0
3207353|NCT02171195|3937352|FG001|NOT COMPLETED|Overall Study||0
3207354|NCT02171195|3937353|FG002|NOT COMPLETED|Overall Study||0
3207355|NCT02171195|3937354|FG003|NOT COMPLETED|Overall Study||0
3207356|NCT02171195|3937355|FG004|NOT COMPLETED|Overall Study||0
3207357|NCT02171195|3937356|FG005|NOT COMPLETED|Overall Study||0
3207358|NCT02171195|3937357|FG006|NOT COMPLETED|Overall Study||0
3207359|NCT02171195|3937358|FG007|NOT COMPLETED|Overall Study||0
3207360|NCT02171195|3937359|FG008|NOT COMPLETED|Overall Study||0
3207361|NCT02171234|3937384|FG000|STARTED|Overall Study||8
3207362|NCT02171234|3937385|FG001|STARTED|Overall Study||6
3207363|NCT02171234|3937386|FG002|STARTED|Overall Study||6
3207364|NCT02171234|3937387|FG003|STARTED|Overall Study||6
3207365|NCT02171234|3937388|FG004|STARTED|Overall Study||6
3207366|NCT02171234|3937384|FG000|COMPLETED|Overall Study||8
3207367|NCT02171234|3937385|FG001|COMPLETED|Overall Study||6
3207368|NCT02171234|3937386|FG002|COMPLETED|Overall Study||6
3207369|NCT02171234|3937387|FG003|COMPLETED|Overall Study||6
3207370|NCT02171234|3937388|FG004|COMPLETED|Overall Study||6
3207371|NCT02171234|3937384|FG000|NOT COMPLETED|Overall Study||0
3207372|NCT02171234|3937385|FG001|NOT COMPLETED|Overall Study||0
3207373|NCT02171234|3937386|FG002|NOT COMPLETED|Overall Study||0
3207374|NCT02171234|3937387|FG003|NOT COMPLETED|Overall Study||0
3207375|NCT02171234|3937388|FG004|NOT COMPLETED|Overall Study||0
3207376|NCT02171247|3937402|FG000|STARTED|Overall Study||16
3207377|NCT02171247|3937403|FG001|STARTED|Overall Study||17
3207378|NCT02171247|3937402|FG000|COMPLETED|Overall Study||16
3207379|NCT02171247|3937403|FG001|COMPLETED|Overall Study||17
3207380|NCT02171247|3937402|FG000|NOT COMPLETED|Overall Study||0
3207381|NCT02171247|3937403|FG001|NOT COMPLETED|Overall Study||0
3207382|NCT02171260|3937413|FG000|STARTED|Overall Study||6
3207383|NCT02171260|3937414|FG001|STARTED|Overall Study||6
3207384|NCT02171260|3937415|FG002|STARTED|Overall Study||5
3207385|NCT02171260|3937416|FG003|STARTED|Overall Study||5
3207386|NCT02171260|3937413|FG000|COMPLETED|Overall Study||0
3207387|NCT02171260|3937414|FG001|COMPLETED|Overall Study||0
3207388|NCT02171260|3937415|FG002|COMPLETED|Overall Study||0
3207389|NCT02171260|3937416|FG003|COMPLETED|Overall Study||0
3207390|NCT02171260|3937413|FG000|NOT COMPLETED|Overall Study||6
3207391|NCT02171260|3937414|FG001|NOT COMPLETED|Overall Study||6
3207392|NCT02171260|3937415|FG002|NOT COMPLETED|Overall Study||5
3207393|NCT02171260|3937416|FG003|NOT COMPLETED|Overall Study||5
3207394|NCT02171429|3937435|FG000|STARTED|Overall Study||72
3207395|NCT02171429|3937436|FG001|STARTED|Overall Study||143
3207396|NCT02171429|3937437|FG002|STARTED|Overall Study||143
3207397|NCT02171429|3937435|FG000|Completed Week 10 Visit|Overall Study||70
3207398|NCT02171429|3937436|FG001|Completed Week 10 Visit|Overall Study||141
3207399|NCT02171429|3937437|FG002|Completed Week 10 Visit|Overall Study||141
3207400|NCT02171429|3937435|FG000|COMPLETED|Overall Study||71
3207401|NCT02171429|3937436|FG001|COMPLETED|Overall Study||140
3207402|NCT02171429|3937437|FG002|COMPLETED|Overall Study||138
3207403|NCT02171429|3937435|FG000|NOT COMPLETED|Overall Study||1
3207404|NCT02171429|3937436|FG001|NOT COMPLETED|Overall Study||3
3207405|NCT02171429|3937437|FG002|NOT COMPLETED|Overall Study||5
3207406|NCT02171611|3937448|FG000|STARTED|Overall Study||5
3207407|NCT02171611|3937449|FG001|STARTED|Overall Study||5
3207408|NCT02171611|3937450|FG002|STARTED|Overall Study||5
3207409|NCT02171611|3937451|FG003|STARTED|Overall Study||5
3207410|NCT02171611|3937452|FG004|STARTED|Overall Study||5
3207411|NCT02171611|3937453|FG005|STARTED|Overall Study||5
3207412|NCT02171611|3937448|FG000|COMPLETED|Overall Study||5
3207413|NCT02171611|3937449|FG001|COMPLETED|Overall Study||5
3207414|NCT02171611|3937450|FG002|COMPLETED|Overall Study||5
3207415|NCT02171611|3937451|FG003|COMPLETED|Overall Study||5
3207416|NCT02171611|3937452|FG004|COMPLETED|Overall Study||5
3207417|NCT02171611|3937453|FG005|COMPLETED|Overall Study||5
3207418|NCT02171611|3937448|FG000|NOT COMPLETED|Overall Study||0
3207419|NCT02171611|3937449|FG001|NOT COMPLETED|Overall Study||0
3207420|NCT02171611|3937450|FG002|NOT COMPLETED|Overall Study||0
3207421|NCT02171611|3937451|FG003|NOT COMPLETED|Overall Study||0
3207422|NCT02171611|3937452|FG004|NOT COMPLETED|Overall Study||0
3207423|NCT02171611|3937453|FG005|NOT COMPLETED|Overall Study||0
3207424|NCT02171819|3937464|FG000|STARTED|Overall Study||31
3207425|NCT02171819|3937465|FG001|STARTED|Overall Study||32
3207426|NCT02171819|3937466|FG002|STARTED|Overall Study||12
3207427|NCT02171819|3937464|FG000|COMPLETED|Overall Study||31
3207428|NCT02171819|3937465|FG001|COMPLETED|Overall Study||32
3207429|NCT02171819|3937466|FG002|COMPLETED|Overall Study||12
3207430|NCT02171819|3937464|FG000|NOT COMPLETED|Overall Study||0
3207431|NCT02171819|3937465|FG001|NOT COMPLETED|Overall Study||0
3207432|NCT02171819|3937466|FG002|NOT COMPLETED|Overall Study||0
3207433|NCT02172040|3937482|FG000|STARTED|Overall Study||49
3207434|NCT02172040|3937483|FG001|STARTED|Overall Study||45
3207435|NCT02172040|3937484|FG002|STARTED|Overall Study||31
3207436|NCT02172040|3937485|FG003|STARTED|Overall Study||27
3207437|NCT02172040|3937482|FG000|COMPLETED|Overall Study||49
3207438|NCT02172040|3937483|FG001|COMPLETED|Overall Study||42
3207439|NCT02172040|3937484|FG002|COMPLETED|Overall Study||29
3207440|NCT02172040|3937485|FG003|COMPLETED|Overall Study||26
3207441|NCT02172040|3937482|FG000|NOT COMPLETED|Overall Study||0
3207442|NCT02172040|3937483|FG001|NOT COMPLETED|Overall Study||3
3207443|NCT02172040|3937484|FG002|NOT COMPLETED|Overall Study||2
3207444|NCT02172040|3937485|FG003|NOT COMPLETED|Overall Study||1
3207445|NCT02172625|3937498|FG000|STARTED|Overall Study||19
3207446|NCT02172625|3937499|FG001|STARTED|Overall Study||19
3207447|NCT02172625|3937498|FG000|COMPLETED|Overall Study||19
3207448|NCT02172625|3937499|FG001|COMPLETED|Overall Study||16
3207449|NCT02172625|3937498|FG000|NOT COMPLETED|Overall Study||0
3207450|NCT02172625|3937499|FG001|NOT COMPLETED|Overall Study||3
3207451|NCT02172664|3937509|FG000|STARTED|Overall Study||33
3207452|NCT02172664|3937510|FG001|STARTED|Overall Study||33
3207453|NCT02172664|3937509|FG000|COMPLETED|Overall Study||27
3207454|NCT02172664|3937510|FG001|COMPLETED|Overall Study||27
3207455|NCT02172664|3937509|FG000|NOT COMPLETED|Overall Study||6
3207456|NCT02172664|3937510|FG001|NOT COMPLETED|Overall Study||6
3207457|NCT02172742|3937517|FG000|STARTED|Overall Study||7
3207458|NCT02172742|3937518|FG001|STARTED|Overall Study||6
3207459|NCT02172742|3937517|FG000|COMPLETED|Overall Study||6
3207460|NCT02172742|3937518|FG001|COMPLETED|Overall Study||6
3207461|NCT02172742|3937517|FG000|NOT COMPLETED|Overall Study||1
3207462|NCT02172742|3937518|FG001|NOT COMPLETED|Overall Study||0
3207463|NCT02172755|3937525|FG000|STARTED|Overall Study||14
3207464|NCT02172755|3937526|FG001|STARTED|Overall Study||16
3207465|NCT02172755|3937525|FG000|COMPLETED|Overall Study||12
3207466|NCT02172755|3937526|FG001|COMPLETED|Overall Study||12
3207467|NCT02172755|3937525|FG000|NOT COMPLETED|Overall Study||2
3207468|NCT02172755|3937526|FG001|NOT COMPLETED|Overall Study||4
3207469|NCT02172820|3937534|FG000|STARTED|Overall Study||65
3207470|NCT02172820|3937535|FG001|STARTED|Overall Study||65
3207471|NCT02172820|3937534|FG000|COMPLETED|Overall Study||65
3207472|NCT02172820|3937535|FG001|COMPLETED|Overall Study||65
3207473|NCT02172820|3937534|FG000|NOT COMPLETED|Overall Study||0
3207474|NCT02172820|3937535|FG001|NOT COMPLETED|Overall Study||0
3207475|NCT02172911|3937543|FG000|STARTED|Overall Study||7
3207476|NCT02172911|3937544|FG001|STARTED|Overall Study||3
3207477|NCT02172911|3937543|FG000|COMPLETED|Overall Study||6
3207478|NCT02172911|3937544|FG001|COMPLETED|Overall Study||1
3207479|NCT02172911|3937543|FG000|NOT COMPLETED|Overall Study||1
3207480|NCT02172911|3937544|FG001|NOT COMPLETED|Overall Study||2
3207481|NCT02172950|3937552|FG000|STARTED|Overall Study||222
3207482|NCT02172950|3937553|FG001|STARTED|Overall Study||24
3207483|NCT02172950|3937552|FG000|COMPLETED|Overall Study||197
3207484|NCT02172950|3937553|FG001|COMPLETED|Overall Study||19
3207485|NCT02172950|3937552|FG000|NOT COMPLETED|Overall Study||25
3207486|NCT02172950|3937553|FG001|NOT COMPLETED|Overall Study||5
3207487|NCT02173054|3937563|FG000|STARTED|Overall Study||40
3207488|NCT02173054|3937564|FG001|STARTED|Overall Study||40
3207489|NCT02173054|3937565|FG002|STARTED|Overall Study||40
3207490|NCT02173054|3937563|FG000|COMPLETED|Overall Study||39
3207491|NCT02173054|3937564|FG001|COMPLETED|Overall Study||40
3207492|NCT02173054|3937565|FG002|COMPLETED|Overall Study||39
3207493|NCT02173054|3937563|FG000|NOT COMPLETED|Overall Study||1
3207494|NCT02173054|3937564|FG001|NOT COMPLETED|Overall Study||0
3207495|NCT02173054|3937565|FG002|NOT COMPLETED|Overall Study||1
3207496|NCT02173158|3937573|FG000|STARTED|Efficacy Phase||9
3207497|NCT02173158|3937573|FG000|COMPLETED|Efficacy Phase||8
3207498|NCT02173158|3937573|FG000|NOT COMPLETED|Efficacy Phase||1
3207499|NCT02173158|3937573|FG000|STARTED|Safety Phase||8
3207500|NCT02173158|3937573|FG000|COMPLETED|Safety Phase||8
3207501|NCT02173158|3937573|FG000|NOT COMPLETED|Safety Phase||0
3207502|NCT02173379|3937580|FG000|STARTED|Overall Study||1296
3207503|NCT02173379|3937581|FG001|STARTED|Overall Study||1308
3207504|NCT02173379|3937580|FG000|COMPLETED|Overall Study||1205
3207505|NCT02173379|3937581|FG001|COMPLETED|Overall Study||1231
3207506|NCT02173379|3937580|FG000|NOT COMPLETED|Overall Study||91
3207507|NCT02173379|3937581|FG001|NOT COMPLETED|Overall Study||77
3207508|NCT02173392|3937590|FG000|STARTED|Overall Study||73
3207509|NCT02173392|3937591|FG001|STARTED|Overall Study||72
3207510|NCT02173392|3937590|FG000|COMPLETED|Overall Study||59
3207511|NCT02173392|3937591|FG001|COMPLETED|Overall Study||68
3207512|NCT02173392|3937590|FG000|NOT COMPLETED|Overall Study||14
3207513|NCT02173392|3937591|FG001|NOT COMPLETED|Overall Study||4
3207514|NCT02173522|3937601|FG000|STARTED|Overall Study||4
3207515|NCT02173522|3937602|FG001|STARTED|Overall Study||0
3207516|NCT02173522|3937601|FG000|COMPLETED|Overall Study||4
3207517|NCT02173522|3937602|FG001|COMPLETED|Overall Study||0
3207518|NCT02173522|3937601|FG000|NOT COMPLETED|Overall Study||0
3207519|NCT02173522|3937602|FG001|NOT COMPLETED|Overall Study||0
3207520|NCT02173535|3937626|FG000|STARTED|Period 1||12
3207521|NCT02173535|3937627|FG001|STARTED|Period 1||12
3207522|NCT02173535|3937628|FG002|STARTED|Period 1||12
3207523|NCT02173535|3937629|FG003|STARTED|Period 1||12
3207524|NCT02173535|3937630|FG004|STARTED|Period 1||12
3207525|NCT02173535|3937631|FG005|STARTED|Period 1||12
3207526|NCT02173535|3937632|FG006|STARTED|Period 1||12
3207527|NCT02173535|3937633|FG007|STARTED|Period 1||12
3207528|NCT02173535|3937634|FG008|STARTED|Period 1||12
3207529|NCT02173535|3937635|FG009|STARTED|Period 1||12
3207530|NCT02173535|3937636|FG010|STARTED|Period 1||12
3207531|NCT02173535|3937637|FG011|STARTED|Period 1||12
3207532|NCT02173535|3937638|FG012|STARTED|Period 1||12
3207533|NCT02173535|3937639|FG013|STARTED|Period 1||12
3207534|NCT02173535|3937640|FG014|STARTED|Period 1||12
3207535|NCT02173535|3937641|FG015|STARTED|Period 1||12
3207536|NCT02173535|3937642|FG016|STARTED|Period 1||12
3207537|NCT02173535|3937643|FG017|STARTED|Period 1||12
3207538|NCT02173535|3937644|FG018|STARTED|Period 1||12
3207539|NCT02173535|3937645|FG019|STARTED|Period 1||12
3207540|NCT02173535|3937626|FG000|COMPLETED|Period 1||12
3207541|NCT02173535|3937627|FG001|COMPLETED|Period 1||12
3207542|NCT02173535|3937628|FG002|COMPLETED|Period 1||12
3207543|NCT02173535|3937629|FG003|COMPLETED|Period 1||12
3207544|NCT02173535|3937630|FG004|COMPLETED|Period 1||12
3207545|NCT02173535|3937631|FG005|COMPLETED|Period 1||12
3207546|NCT02173535|3937632|FG006|COMPLETED|Period 1||12
3207547|NCT02173535|3937633|FG007|COMPLETED|Period 1||12
3207548|NCT02173535|3937634|FG008|COMPLETED|Period 1||12
3207549|NCT02173535|3937635|FG009|COMPLETED|Period 1||12
3207550|NCT02173535|3937636|FG010|COMPLETED|Period 1||12
3207551|NCT02173535|3937637|FG011|COMPLETED|Period 1||12
3207552|NCT02173535|3937638|FG012|COMPLETED|Period 1||12
3207553|NCT02173535|3937639|FG013|COMPLETED|Period 1||12
3207554|NCT02173535|3937640|FG014|COMPLETED|Period 1||12
3207555|NCT02173535|3937641|FG015|COMPLETED|Period 1||12
3207556|NCT02173535|3937642|FG016|COMPLETED|Period 1||12
3207557|NCT02173535|3937643|FG017|COMPLETED|Period 1||12
3207558|NCT02173535|3937644|FG018|COMPLETED|Period 1||12
3207559|NCT02173535|3937645|FG019|COMPLETED|Period 1||12
3207560|NCT02173535|3937626|FG000|NOT COMPLETED|Period 1||0
3207561|NCT02173535|3937627|FG001|NOT COMPLETED|Period 1||0
3207562|NCT02173535|3937628|FG002|NOT COMPLETED|Period 1||0
3207563|NCT02173535|3937629|FG003|NOT COMPLETED|Period 1||0
3207564|NCT02173535|3937630|FG004|NOT COMPLETED|Period 1||0
3207565|NCT02173535|3937631|FG005|NOT COMPLETED|Period 1||0
3207566|NCT02173535|3937632|FG006|NOT COMPLETED|Period 1||0
3207567|NCT02173535|3937633|FG007|NOT COMPLETED|Period 1||0
3207568|NCT02173535|3937634|FG008|NOT COMPLETED|Period 1||0
3207569|NCT02173535|3937635|FG009|NOT COMPLETED|Period 1||0
3207570|NCT02173535|3937636|FG010|NOT COMPLETED|Period 1||0
3207571|NCT02173535|3937637|FG011|NOT COMPLETED|Period 1||0
3207572|NCT02173535|3937638|FG012|NOT COMPLETED|Period 1||0
3365976|NCT03948581|4097219|FG000|NOT COMPLETED|Overall Study||0
3365977|NCT03948581|4097220|FG001|NOT COMPLETED|Overall Study||1
3365978|NCT03948386|4097229|FG000|STARTED|Overall Study||52
3365979|NCT03948386|4097230|FG001|STARTED|Overall Study||54
3365980|NCT03948386|4097231|FG002|STARTED|Overall Study||53
3365981|NCT03948386|4097229|FG000|COMPLETED|Overall Study||51
3365982|NCT03948386|4097230|FG001|COMPLETED|Overall Study||53
3365983|NCT03948386|4097231|FG002|COMPLETED|Overall Study||50
3365984|NCT03948386|4097229|FG000|NOT COMPLETED|Overall Study||1
3365985|NCT03948386|4097230|FG001|NOT COMPLETED|Overall Study||1
3365986|NCT03948386|4097231|FG002|NOT COMPLETED|Overall Study||3
3365987|NCT03948334|4097241|FG000|STARTED|Overall Study||60
3207573|NCT02173535|3937639|FG013|NOT COMPLETED|Period 1||0
3207574|NCT02173535|3937640|FG014|NOT COMPLETED|Period 1||0
3207575|NCT02173535|3937641|FG015|NOT COMPLETED|Period 1||0
3207576|NCT02173535|3937642|FG016|NOT COMPLETED|Period 1||0
3207577|NCT02173535|3937643|FG017|NOT COMPLETED|Period 1||0
3207578|NCT02173535|3937644|FG018|NOT COMPLETED|Period 1||0
3207579|NCT02173535|3937645|FG019|NOT COMPLETED|Period 1||0
3207580|NCT02173535|3937626|FG000|STARTED|Period 2||12
3207581|NCT02173535|3937627|FG001|STARTED|Period 2||12
3207582|NCT02173535|3937628|FG002|STARTED|Period 2||12
3207583|NCT02173535|3937629|FG003|STARTED|Period 2||12
3207584|NCT02173535|3937630|FG004|STARTED|Period 2||12
3207585|NCT02173535|3937631|FG005|STARTED|Period 2||12
3207586|NCT02173535|3937632|FG006|STARTED|Period 2||12
3207587|NCT02173535|3937633|FG007|STARTED|Period 2||12
3365988|NCT03948334|4097242|FG001|STARTED|Overall Study||63
3365989|NCT03948334|4097241|FG000|COMPLETED|Overall Study||0
3365990|NCT03948334|4097242|FG001|COMPLETED|Overall Study||0
3365991|NCT03948334|4097241|FG000|NOT COMPLETED|Overall Study||60
3365992|NCT03948334|4097242|FG001|NOT COMPLETED|Overall Study||63
3365993|NCT03946059|4097258|FG000|STARTED|Overall Study||13
3365994|NCT03946059|4097259|FG001|STARTED|Overall Study||12
3365995|NCT03946059|4097258|FG000|COMPLETED|Overall Study||13
3365996|NCT03946059|4097259|FG001|COMPLETED|Overall Study||11
3365997|NCT03946059|4097258|FG000|NOT COMPLETED|Overall Study||0
3365998|NCT03946059|4097259|FG001|NOT COMPLETED|Overall Study||1
3365999|NCT03944707|4097269|FG000|STARTED|Overall Study||47
3366000|NCT03944707|4097270|FG001|STARTED|Overall Study||29
3366001|NCT03944707|4097269|FG000|PK Analysis Set|Overall Study||33
3366002|NCT03944707|4097270|FG001|PK Analysis Set|Overall Study||0
3366003|NCT03944707|4097269|FG000|PD Analysis Set|Overall Study||47
3366004|NCT03944707|4097270|FG001|PD Analysis Set|Overall Study||29
3366005|NCT03944707|4097269|FG000|COMPLETED|Overall Study||35
3366006|NCT03944707|4097270|FG001|COMPLETED|Overall Study||19
3366007|NCT03944707|4097269|FG000|NOT COMPLETED|Overall Study||12
3366008|NCT03944707|4097270|FG001|NOT COMPLETED|Overall Study||10
3366009|NCT03944668|4097276|FG000|STARTED|Overall Study|Enrolled in Study|17
3207588|NCT02173535|3937634|FG008|STARTED|Period 2||12
3207589|NCT02173535|3937635|FG009|STARTED|Period 2||12
3207590|NCT02173535|3937636|FG010|STARTED|Period 2||12
3207591|NCT02173535|3937637|FG011|STARTED|Period 2||12
3207592|NCT02173535|3937638|FG012|STARTED|Period 2||12
3207593|NCT02173535|3937639|FG013|STARTED|Period 2||12
3207594|NCT02173535|3937640|FG014|STARTED|Period 2||12
3207595|NCT02173535|3937641|FG015|STARTED|Period 2||12
3207596|NCT02173535|3937642|FG016|STARTED|Period 2||12
3207597|NCT02173535|3937643|FG017|STARTED|Period 2||12
3207598|NCT02173535|3937644|FG018|STARTED|Period 2||12
3207599|NCT02173535|3937645|FG019|STARTED|Period 2||12
3207600|NCT02173535|3937626|FG000|COMPLETED|Period 2||12
3207601|NCT02173535|3937627|FG001|COMPLETED|Period 2||12
3207602|NCT02173535|3937628|FG002|COMPLETED|Period 2||12
3207603|NCT02173535|3937629|FG003|COMPLETED|Period 2||12
3207604|NCT02173535|3937630|FG004|COMPLETED|Period 2||12
3207605|NCT02173535|3937631|FG005|COMPLETED|Period 2||12
3207606|NCT02173535|3937632|FG006|COMPLETED|Period 2||12
3207607|NCT02173535|3937633|FG007|COMPLETED|Period 2||12
3207608|NCT02173535|3937634|FG008|COMPLETED|Period 2||12
3207609|NCT02173535|3937635|FG009|COMPLETED|Period 2||12
3207610|NCT02173535|3937636|FG010|COMPLETED|Period 2||12
3207611|NCT02173535|3937637|FG011|COMPLETED|Period 2||12
3207612|NCT02173535|3937638|FG012|COMPLETED|Period 2||12
3207613|NCT02173535|3937639|FG013|COMPLETED|Period 2||12
3207614|NCT02173535|3937640|FG014|COMPLETED|Period 2||12
3207615|NCT02173535|3937641|FG015|COMPLETED|Period 2||12
3207616|NCT02173535|3937642|FG016|COMPLETED|Period 2||12
3207617|NCT02173535|3937643|FG017|COMPLETED|Period 2||12
3207618|NCT02173535|3937644|FG018|COMPLETED|Period 2||12
3207619|NCT02173535|3937645|FG019|COMPLETED|Period 2||12
3207620|NCT02173535|3937626|FG000|NOT COMPLETED|Period 2||0
3207621|NCT02173535|3937627|FG001|NOT COMPLETED|Period 2||0
3207622|NCT02173535|3937628|FG002|NOT COMPLETED|Period 2||0
3207623|NCT02173535|3937629|FG003|NOT COMPLETED|Period 2||0
3207624|NCT02173535|3937630|FG004|NOT COMPLETED|Period 2||0
3207625|NCT02173535|3937631|FG005|NOT COMPLETED|Period 2||0
3207626|NCT02173535|3937632|FG006|NOT COMPLETED|Period 2||0
3207627|NCT02173535|3937633|FG007|NOT COMPLETED|Period 2||0
3207628|NCT02173535|3937634|FG008|NOT COMPLETED|Period 2||0
3207629|NCT02173535|3937635|FG009|NOT COMPLETED|Period 2||0
3207630|NCT02173535|3937636|FG010|NOT COMPLETED|Period 2||0
3207631|NCT02173535|3937637|FG011|NOT COMPLETED|Period 2||0
3207632|NCT02173535|3937638|FG012|NOT COMPLETED|Period 2||0
3207633|NCT02173535|3937639|FG013|NOT COMPLETED|Period 2||0
3207634|NCT02173535|3937640|FG014|NOT COMPLETED|Period 2||0
3207635|NCT02173535|3937641|FG015|NOT COMPLETED|Period 2||0
3207636|NCT02173535|3937642|FG016|NOT COMPLETED|Period 2||0
3207637|NCT02173535|3937643|FG017|NOT COMPLETED|Period 2||0
3207638|NCT02173535|3937644|FG018|NOT COMPLETED|Period 2||0
3207639|NCT02173535|3937645|FG019|NOT COMPLETED|Period 2||0
3207640|NCT02173535|3937626|FG000|STARTED|Period 3||12
3207641|NCT02173535|3937627|FG001|STARTED|Period 3||12
3207642|NCT02173535|3937628|FG002|STARTED|Period 3||12
3207643|NCT02173535|3937629|FG003|STARTED|Period 3||12
3207644|NCT02173535|3937630|FG004|STARTED|Period 3||12
3207645|NCT02173535|3937631|FG005|STARTED|Period 3||12
3207646|NCT02173535|3937632|FG006|STARTED|Period 3||12
3207647|NCT02173535|3937633|FG007|STARTED|Period 3||12
3207648|NCT02173535|3937634|FG008|STARTED|Period 3||12
3207649|NCT02173535|3937635|FG009|STARTED|Period 3||12
3207650|NCT02173535|3937636|FG010|STARTED|Period 3||12
3207651|NCT02173535|3937637|FG011|STARTED|Period 3||12
3207652|NCT02173535|3937638|FG012|STARTED|Period 3||12
3207653|NCT02173535|3937639|FG013|STARTED|Period 3||12
3207654|NCT02173535|3937640|FG014|STARTED|Period 3||12
3207655|NCT02173535|3937641|FG015|STARTED|Period 3||12
3207656|NCT02173535|3937642|FG016|STARTED|Period 3||12
3207657|NCT02173535|3937643|FG017|STARTED|Period 3||12
3207658|NCT02173535|3937644|FG018|STARTED|Period 3||12
3207659|NCT02173535|3937645|FG019|STARTED|Period 3||12
3207660|NCT02173535|3937626|FG000|COMPLETED|Period 3||12
3207661|NCT02173535|3937627|FG001|COMPLETED|Period 3||12
3207662|NCT02173535|3937628|FG002|COMPLETED|Period 3||12
3207663|NCT02173535|3937629|FG003|COMPLETED|Period 3||12
3207664|NCT02173535|3937630|FG004|COMPLETED|Period 3||12
3207665|NCT02173535|3937631|FG005|COMPLETED|Period 3||12
3207666|NCT02173535|3937632|FG006|COMPLETED|Period 3||12
3207667|NCT02173535|3937633|FG007|COMPLETED|Period 3||12
3207668|NCT02173535|3937634|FG008|COMPLETED|Period 3||12
3207669|NCT02173535|3937635|FG009|COMPLETED|Period 3||12
3207670|NCT02173535|3937636|FG010|COMPLETED|Period 3||12
3207671|NCT02173535|3937637|FG011|COMPLETED|Period 3||12
3207672|NCT02173535|3937638|FG012|COMPLETED|Period 3||12
3207673|NCT02173535|3937639|FG013|COMPLETED|Period 3||12
3207674|NCT02173535|3937640|FG014|COMPLETED|Period 3||12
3207675|NCT02173535|3937641|FG015|COMPLETED|Period 3||12
3207676|NCT02173535|3937642|FG016|COMPLETED|Period 3||12
3207677|NCT02173535|3937643|FG017|COMPLETED|Period 3||12
3207678|NCT02173535|3937644|FG018|COMPLETED|Period 3||12
3207679|NCT02173535|3937645|FG019|COMPLETED|Period 3||12
3207680|NCT02173535|3937626|FG000|NOT COMPLETED|Period 3||0
3207681|NCT02173535|3937627|FG001|NOT COMPLETED|Period 3||0
3207682|NCT02173535|3937628|FG002|NOT COMPLETED|Period 3||0
3207683|NCT02173535|3937629|FG003|NOT COMPLETED|Period 3||0
3207684|NCT02173535|3937630|FG004|NOT COMPLETED|Period 3||0
3207685|NCT02173535|3937631|FG005|NOT COMPLETED|Period 3||0
3207686|NCT02173535|3937632|FG006|NOT COMPLETED|Period 3||0
3207687|NCT02173535|3937633|FG007|NOT COMPLETED|Period 3||0
3207688|NCT02173535|3937634|FG008|NOT COMPLETED|Period 3||0
3207689|NCT02173535|3937635|FG009|NOT COMPLETED|Period 3||0
3207690|NCT02173535|3937636|FG010|NOT COMPLETED|Period 3||0
3207691|NCT02173535|3937637|FG011|NOT COMPLETED|Period 3||0
3207692|NCT02173535|3937638|FG012|NOT COMPLETED|Period 3||0
3207693|NCT02173535|3937639|FG013|NOT COMPLETED|Period 3||0
3207694|NCT02173535|3937640|FG014|NOT COMPLETED|Period 3||0
3207695|NCT02173535|3937641|FG015|NOT COMPLETED|Period 3||0
3207696|NCT02173535|3937642|FG016|NOT COMPLETED|Period 3||0
3207697|NCT02173535|3937643|FG017|NOT COMPLETED|Period 3||0
3207698|NCT02173535|3937644|FG018|NOT COMPLETED|Period 3||0
3207699|NCT02173535|3937645|FG019|NOT COMPLETED|Period 3||0
3207700|NCT02173535|3937626|FG000|STARTED|Period 4||12
3207701|NCT02173535|3937627|FG001|STARTED|Period 4||12
3207702|NCT02173535|3937628|FG002|STARTED|Period 4||12
3207703|NCT02173535|3937629|FG003|STARTED|Period 4||12
3207704|NCT02173535|3937630|FG004|STARTED|Period 4||12
3207705|NCT02173535|3937631|FG005|STARTED|Period 4||12
3207706|NCT02173535|3937632|FG006|STARTED|Period 4||12
3207707|NCT02173535|3937633|FG007|STARTED|Period 4||12
3207708|NCT02173535|3937634|FG008|STARTED|Period 4||12
3207709|NCT02173535|3937635|FG009|STARTED|Period 4||12
3207710|NCT02173535|3937636|FG010|STARTED|Period 4||12
3207711|NCT02173535|3937637|FG011|STARTED|Period 4||12
3207712|NCT02173535|3937638|FG012|STARTED|Period 4||12
3207713|NCT02173535|3937639|FG013|STARTED|Period 4||12
3207714|NCT02173535|3937640|FG014|STARTED|Period 4||12
3207715|NCT02173535|3937641|FG015|STARTED|Period 4||12
3207716|NCT02173535|3937642|FG016|STARTED|Period 4||12
3207717|NCT02173535|3937643|FG017|STARTED|Period 4||12
3207718|NCT02173535|3937644|FG018|STARTED|Period 4||12
3207719|NCT02173535|3937645|FG019|STARTED|Period 4||12
3207720|NCT02173535|3937626|FG000|COMPLETED|Period 4||12
3207721|NCT02173535|3937627|FG001|COMPLETED|Period 4||12
3207722|NCT02173535|3937628|FG002|COMPLETED|Period 4||12
3207723|NCT02173535|3937629|FG003|COMPLETED|Period 4||12
3207724|NCT02173535|3937630|FG004|COMPLETED|Period 4||12
3207725|NCT02173535|3937631|FG005|COMPLETED|Period 4||12
3207726|NCT02173535|3937632|FG006|COMPLETED|Period 4||12
3207727|NCT02173535|3937633|FG007|COMPLETED|Period 4||12
3207728|NCT02173535|3937634|FG008|COMPLETED|Period 4||12
3207729|NCT02173535|3937635|FG009|COMPLETED|Period 4||12
3207730|NCT02173535|3937636|FG010|COMPLETED|Period 4||12
3207731|NCT02173535|3937637|FG011|COMPLETED|Period 4||12
3207732|NCT02173535|3937638|FG012|COMPLETED|Period 4||12
3207733|NCT02173535|3937639|FG013|COMPLETED|Period 4||12
3207734|NCT02173535|3937640|FG014|COMPLETED|Period 4||12
3207735|NCT02173535|3937641|FG015|COMPLETED|Period 4||12
3207736|NCT02173535|3937642|FG016|COMPLETED|Period 4||12
3207737|NCT02173535|3937643|FG017|COMPLETED|Period 4||12
3207738|NCT02173535|3937644|FG018|COMPLETED|Period 4||12
3207739|NCT02173535|3937645|FG019|COMPLETED|Period 4||12
3207740|NCT02173535|3937626|FG000|NOT COMPLETED|Period 4||0
3207741|NCT02173535|3937627|FG001|NOT COMPLETED|Period 4||0
3207742|NCT02173535|3937628|FG002|NOT COMPLETED|Period 4||0
3207743|NCT02173535|3937629|FG003|NOT COMPLETED|Period 4||0
3207744|NCT02173535|3937630|FG004|NOT COMPLETED|Period 4||0
3207745|NCT02173535|3937631|FG005|NOT COMPLETED|Period 4||0
3207746|NCT02173535|3937632|FG006|NOT COMPLETED|Period 4||0
3207747|NCT02173535|3937633|FG007|NOT COMPLETED|Period 4||0
3207748|NCT02173535|3937634|FG008|NOT COMPLETED|Period 4||0
3207749|NCT02173535|3937635|FG009|NOT COMPLETED|Period 4||0
3207750|NCT02173535|3937636|FG010|NOT COMPLETED|Period 4||0
3207751|NCT02173535|3937637|FG011|NOT COMPLETED|Period 4||0
3207752|NCT02173535|3937638|FG012|NOT COMPLETED|Period 4||0
3207753|NCT02173535|3937639|FG013|NOT COMPLETED|Period 4||0
3207754|NCT02173535|3937640|FG014|NOT COMPLETED|Period 4||0
3207755|NCT02173535|3937641|FG015|NOT COMPLETED|Period 4||0
3207756|NCT02173535|3937642|FG016|NOT COMPLETED|Period 4||0
3207757|NCT02173535|3937643|FG017|NOT COMPLETED|Period 4||0
3207758|NCT02173535|3937644|FG018|NOT COMPLETED|Period 4||0
3207759|NCT02173535|3937645|FG019|NOT COMPLETED|Period 4||0
3207760|NCT02173535|3937626|FG000|STARTED|Period 5||12
3207761|NCT02173535|3937627|FG001|STARTED|Period 5||12
3207762|NCT02173535|3937628|FG002|STARTED|Period 5||12
3207763|NCT02173535|3937629|FG003|STARTED|Period 5||12
3207764|NCT02173535|3937630|FG004|STARTED|Period 5||12
3207765|NCT02173535|3937631|FG005|STARTED|Period 5||12
3207766|NCT02173535|3937632|FG006|STARTED|Period 5||12
3207767|NCT02173535|3937633|FG007|STARTED|Period 5||12
3207768|NCT02173535|3937634|FG008|STARTED|Period 5||12
3207769|NCT02173535|3937635|FG009|STARTED|Period 5||12
3207770|NCT02173535|3937636|FG010|STARTED|Period 5||12
3207771|NCT02173535|3937637|FG011|STARTED|Period 5||12
3207772|NCT02173535|3937638|FG012|STARTED|Period 5||12
3207773|NCT02173535|3937639|FG013|STARTED|Period 5||12
3207774|NCT02173535|3937640|FG014|STARTED|Period 5||12
3207775|NCT02173535|3937641|FG015|STARTED|Period 5||12
3207776|NCT02173535|3937642|FG016|STARTED|Period 5||12
3207777|NCT02173535|3937643|FG017|STARTED|Period 5||12
3207778|NCT02173535|3937644|FG018|STARTED|Period 5||12
3207779|NCT02173535|3937645|FG019|STARTED|Period 5||12
3207780|NCT02173535|3937626|FG000|COMPLETED|Period 5||12
3207781|NCT02173535|3937627|FG001|COMPLETED|Period 5||12
3207782|NCT02173535|3937628|FG002|COMPLETED|Period 5||12
3207783|NCT02173535|3937629|FG003|COMPLETED|Period 5||12
3207784|NCT02173535|3937630|FG004|COMPLETED|Period 5||12
3207785|NCT02173535|3937631|FG005|COMPLETED|Period 5||12
3207786|NCT02173535|3937632|FG006|COMPLETED|Period 5||12
3207787|NCT02173535|3937633|FG007|COMPLETED|Period 5||12
3207788|NCT02173535|3937634|FG008|COMPLETED|Period 5||12
3207789|NCT02173535|3937635|FG009|COMPLETED|Period 5||12
3207790|NCT02173535|3937636|FG010|COMPLETED|Period 5||12
3207791|NCT02173535|3937637|FG011|COMPLETED|Period 5||12
3207792|NCT02173535|3937638|FG012|COMPLETED|Period 5||12
3207793|NCT02173535|3937639|FG013|COMPLETED|Period 5||12
3207794|NCT02173535|3937640|FG014|COMPLETED|Period 5||12
3207795|NCT02173535|3937641|FG015|COMPLETED|Period 5||12
3207796|NCT02173535|3937642|FG016|COMPLETED|Period 5||12
3207797|NCT02173535|3937643|FG017|COMPLETED|Period 5||12
3207798|NCT02173535|3937644|FG018|COMPLETED|Period 5||12
3207799|NCT02173535|3937645|FG019|COMPLETED|Period 5||12
3207800|NCT02173535|3937626|FG000|NOT COMPLETED|Period 5||0
3207801|NCT02173535|3937627|FG001|NOT COMPLETED|Period 5||0
3207802|NCT02173535|3937628|FG002|NOT COMPLETED|Period 5||0
3207803|NCT02173535|3937629|FG003|NOT COMPLETED|Period 5||0
3207804|NCT02173535|3937630|FG004|NOT COMPLETED|Period 5||0
3207805|NCT02173535|3937631|FG005|NOT COMPLETED|Period 5||0
3207806|NCT02173535|3937632|FG006|NOT COMPLETED|Period 5||0
3366010|NCT03944668|4097276|FG000|Able to Use Patient Data|Overall Study|3 Patient's Data Unusable|14
3366011|NCT03944668|4097276|FG000|Participated in Intervention|Overall Study|Started Cardiac Rehabilitation|10
3366012|NCT03944668|4097276|FG000|COMPLETED|Overall Study|Completed 75% of Comprehensive Cardiac Rehabilitation Sessions|8
3366013|NCT03944668|4097276|FG000|NOT COMPLETED|Overall Study||9
3366014|NCT03943160|4097281|FG000|STARTED|Overall Study||50
3366015|NCT03943160|4097281|FG000|COMPLETED|Overall Study||50
3366016|NCT03943160|4097281|FG000|NOT COMPLETED|Overall Study||0
3366017|NCT03943095|4097287|FG000|STARTED|Overall Study||52
3366018|NCT03943095|4097288|FG001|STARTED|Overall Study||52
3366019|NCT03943095|4097287|FG000|COMPLETED|Overall Study||51
3366020|NCT03943095|4097288|FG001|COMPLETED|Overall Study||51
3366021|NCT03943095|4097287|FG000|NOT COMPLETED|Overall Study||1
3366022|NCT03943095|4097288|FG001|NOT COMPLETED|Overall Study||1
3366023|NCT03943290|4097304|FG000|STARTED|Overall Study||7
3366024|NCT03943290|4097305|FG001|STARTED|Overall Study||1
3366025|NCT03943290|4097306|FG002|STARTED|Overall Study||13
3366026|NCT03943290|4097307|FG003|STARTED|Overall Study||6
3366027|NCT03943290|4097308|FG004|STARTED|Overall Study||7
3366028|NCT03943290|4097309|FG005|STARTED|Overall Study||6
3366029|NCT03943290|4097310|FG006|STARTED|Overall Study||6
3366030|NCT03943290|4097311|FG007|STARTED|Overall Study||8
3366031|NCT03943290|4097312|FG008|STARTED|Overall Study||8
3366032|NCT03943290|4097304|FG000|COMPLETED|Overall Study||0
3366033|NCT03943290|4097305|FG001|COMPLETED|Overall Study||0
3366034|NCT03943290|4097306|FG002|COMPLETED|Overall Study||0
3366035|NCT03943290|4097307|FG003|COMPLETED|Overall Study||0
3366036|NCT03943290|4097308|FG004|COMPLETED|Overall Study||0
3366037|NCT03943290|4097309|FG005|COMPLETED|Overall Study||0
3366038|NCT03943290|4097310|FG006|COMPLETED|Overall Study||0
3366039|NCT03943290|4097311|FG007|COMPLETED|Overall Study||0
3366040|NCT03943290|4097312|FG008|COMPLETED|Overall Study||0
3366041|NCT03943290|4097304|FG000|NOT COMPLETED|Overall Study||7
3366042|NCT03943290|4097305|FG001|NOT COMPLETED|Overall Study||1
3366043|NCT03943290|4097306|FG002|NOT COMPLETED|Overall Study||13
3366044|NCT03943290|4097307|FG003|NOT COMPLETED|Overall Study||6
3366045|NCT03943290|4097308|FG004|NOT COMPLETED|Overall Study||7
3366046|NCT03943290|4097309|FG005|NOT COMPLETED|Overall Study||6
3366047|NCT03943290|4097310|FG006|NOT COMPLETED|Overall Study||6
3366048|NCT03943290|4097311|FG007|NOT COMPLETED|Overall Study||8
3366049|NCT03943290|4097312|FG008|NOT COMPLETED|Overall Study||8
3366050|NCT03942042|4097347|FG000|STARTED|Induction Dosing Period (12 Weeks)||7
3366051|NCT03942042|4097348|FG001|STARTED|Induction Dosing Period (12 Weeks)||5
3366052|NCT03942042|4097347|FG000|Received at Least One Dose of Study Drug|Induction Dosing Period (12 Weeks)||7
3366053|NCT03942042|4097348|FG001|Received at Least One Dose of Study Drug|Induction Dosing Period (12 Weeks)||5
3366054|NCT03942042|4097347|FG000|Participants With GIS=1 at Week 12|Induction Dosing Period (12 Weeks)||4
3366055|NCT03942042|4097348|FG001|Participants With GIS=1 at Week 12|Induction Dosing Period (12 Weeks)||0
3366056|NCT03942042|4097347|FG000|Participants Who Completed Week 12 With GIS >= 2|Induction Dosing Period (12 Weeks)||2
3366057|NCT03942042|4097348|FG001|Participants Who Completed Week 12 With GIS >= 2|Induction Dosing Period (12 Weeks)||4
3366058|NCT03942042|4097347|FG000|COMPLETED|Induction Dosing Period (12 Weeks)||6
3366059|NCT03942042|4097348|FG001|COMPLETED|Induction Dosing Period (12 Weeks)||4
3366060|NCT03942042|4097347|FG000|NOT COMPLETED|Induction Dosing Period (12 Weeks)||1
3366061|NCT03942042|4097348|FG001|NOT COMPLETED|Induction Dosing Period (12 Weeks)||1
3366062|NCT03942042|4097347|FG000|STARTED|Maintenance Dosing Period (8 Weeks)|Only participants with GIS ≥2 at Week 12 and based on investigators' discretion continued to maintenance dosing period.|2
3366063|NCT03942042|4097348|FG001|STARTED|Maintenance Dosing Period (8 Weeks)||4
3366064|NCT03942042|4097347|FG000|COMPLETED|Maintenance Dosing Period (8 Weeks)||2
3366065|NCT03942042|4097348|FG001|COMPLETED|Maintenance Dosing Period (8 Weeks)||4
3366066|NCT03942042|4097347|FG000|NOT COMPLETED|Maintenance Dosing Period (8 Weeks)||0
3366067|NCT03942042|4097348|FG001|NOT COMPLETED|Maintenance Dosing Period (8 Weeks)||0
3366068|NCT03938337|4097360|FG000|STARTED|Overall Study||1
3366069|NCT03938337|4097361|FG001|STARTED|Overall Study||0
3366070|NCT03938337|4097360|FG000|COMPLETED|Overall Study||1
3366071|NCT03938337|4097361|FG001|COMPLETED|Overall Study||0
3366072|NCT03938337|4097360|FG000|NOT COMPLETED|Overall Study||0
3366073|NCT03938337|4097361|FG001|NOT COMPLETED|Overall Study||0
3366074|NCT03923530|4097367|FG000|STARTED|Overall Study||12
3366075|NCT03923530|4097367|FG000|COMPLETED|Overall Study||8
3366076|NCT03923530|4097367|FG000|NOT COMPLETED|Overall Study||4
3366077|NCT03914417|4097371|FG000|STARTED|Overall Study||21
3366078|NCT03914417|4097371|FG000|COMPLETED|Overall Study||19
3366079|NCT03914417|4097371|FG000|NOT COMPLETED|Overall Study||2
3366080|NCT03913377|4097377|FG000|STARTED|Period 1||21
3366081|NCT03913377|4097378|FG001|STARTED|Period 1||22
3366082|NCT03913377|4097379|FG002|STARTED|Period 1||22
3207807|NCT02173535|3937633|FG007|NOT COMPLETED|Period 5||0
3207808|NCT02173535|3937634|FG008|NOT COMPLETED|Period 5||0
3207809|NCT02173535|3937635|FG009|NOT COMPLETED|Period 5||0
3207810|NCT02173535|3937636|FG010|NOT COMPLETED|Period 5||0
3207811|NCT02173535|3937637|FG011|NOT COMPLETED|Period 5||0
3207812|NCT02173535|3937638|FG012|NOT COMPLETED|Period 5||0
3207813|NCT02173535|3937639|FG013|NOT COMPLETED|Period 5||0
3207814|NCT02173535|3937640|FG014|NOT COMPLETED|Period 5||0
3207815|NCT02173535|3937641|FG015|NOT COMPLETED|Period 5||0
3207816|NCT02173535|3937642|FG016|NOT COMPLETED|Period 5||0
3207817|NCT02173535|3937643|FG017|NOT COMPLETED|Period 5||0
3207818|NCT02173535|3937644|FG018|NOT COMPLETED|Period 5||0
3207819|NCT02173535|3937645|FG019|NOT COMPLETED|Period 5||0
3207820|NCT02173548|3937674|FG000|STARTED|Overall Study||21
3207821|NCT02173548|3937675|FG001|STARTED|Overall Study||10
3207822|NCT02173548|3937674|FG000|COMPLETED|Overall Study||20
3207823|NCT02173548|3937675|FG001|COMPLETED|Overall Study||8
3207824|NCT02173548|3937674|FG000|NOT COMPLETED|Overall Study||1
3207825|NCT02173548|3937675|FG001|NOT COMPLETED|Overall Study||2
3207826|NCT02173704|3937683|FG000|STARTED|Overall Study||150
3207827|NCT02173704|3937684|FG001|STARTED|Overall Study||75
3207828|NCT02173704|3937683|FG000|COMPLETED|Overall Study||137
3207829|NCT02173704|3937684|FG001|COMPLETED|Overall Study||71
3207830|NCT02173704|3937683|FG000|NOT COMPLETED|Overall Study||13
3207831|NCT02173704|3937684|FG001|NOT COMPLETED|Overall Study||4
3207832|NCT02173769|3937690|FG000|STARTED|Overall Study||1858
3207833|NCT02173769|3937690|FG000|COMPLETED|Overall Study||1854
3207834|NCT02173769|3937690|FG000|NOT COMPLETED|Overall Study||4
3207835|NCT02174198|3937697|FG000|STARTED|Overall Study||16
3207836|NCT02174198|3937698|FG001|STARTED|Overall Study||16
3207837|NCT02174198|3937697|FG000|COMPLETED|Overall Study||16
3207838|NCT02174198|3937698|FG001|COMPLETED|Overall Study||16
3207839|NCT02174198|3937697|FG000|NOT COMPLETED|Overall Study||0
3207840|NCT02174198|3937698|FG001|NOT COMPLETED|Overall Study||0
3207841|NCT02174276|3937708|FG000|STARTED|Study Treatment Phase (Weeks 1 to 48)||27
3207842|NCT02174276|3937709|FG001|STARTED|Study Treatment Phase (Weeks 1 to 48)||57
3207843|NCT02174276|3937710|FG002|STARTED|Study Treatment Phase (Weeks 1 to 48)||56
3207844|NCT02174276|3937711|FG003|STARTED|Study Treatment Phase (Weeks 1 to 48)||55
3207845|NCT02174276|3937708|FG000|COMPLETED|Study Treatment Phase (Weeks 1 to 48)||26
3207846|NCT02174276|3937709|FG001|COMPLETED|Study Treatment Phase (Weeks 1 to 48)||56
3207847|NCT02174276|3937710|FG002|COMPLETED|Study Treatment Phase (Weeks 1 to 48)||53
3207848|NCT02174276|3937711|FG003|COMPLETED|Study Treatment Phase (Weeks 1 to 48)||55
3207849|NCT02174276|3937708|FG000|NOT COMPLETED|Study Treatment Phase (Weeks 1 to 48)||1
3207850|NCT02174276|3937709|FG001|NOT COMPLETED|Study Treatment Phase (Weeks 1 to 48)||1
3207851|NCT02174276|3937710|FG002|NOT COMPLETED|Study Treatment Phase (Weeks 1 to 48)||3
3207852|NCT02174276|3937711|FG003|NOT COMPLETED|Study Treatment Phase (Weeks 1 to 48)||0
3207853|NCT02174276|3937708|FG000|STARTED|OTEP (Weeks 48 to 144)||26
3207854|NCT02174276|3937709|FG001|STARTED|OTEP (Weeks 48 to 144)|2 Participants completed the study treatment phase but did not continue in OTEP.|54
3207855|NCT02174276|3937710|FG002|STARTED|OTEP (Weeks 48 to 144)|2 Participants completed the study treatment phase but did not continue in OTEP.|51
3207856|NCT02174276|3937711|FG003|STARTED|OTEP (Weeks 48 to 144)|3 Participants completed the study treatment phase but did not continue in OTEP.|52
3207857|NCT02174276|3937708|FG000|COMPLETED|OTEP (Weeks 48 to 144)||25
3207858|NCT02174276|3937709|FG001|COMPLETED|OTEP (Weeks 48 to 144)||54
3207859|NCT02174276|3937710|FG002|COMPLETED|OTEP (Weeks 48 to 144)||48
3207860|NCT02174276|3937711|FG003|COMPLETED|OTEP (Weeks 48 to 144)||50
3207861|NCT02174276|3937708|FG000|NOT COMPLETED|OTEP (Weeks 48 to 144)||1
3207862|NCT02174276|3937709|FG001|NOT COMPLETED|OTEP (Weeks 48 to 144)||0
3207863|NCT02174276|3937710|FG002|NOT COMPLETED|OTEP (Weeks 48 to 144)||3
3207864|NCT02174276|3937711|FG003|NOT COMPLETED|OTEP (Weeks 48 to 144)||2
3207865|NCT02174419|3937724|FG000|STARTED|Overall Study||22
3207866|NCT02174419|3937725|FG001|STARTED|Overall Study||18
3207867|NCT02174419|3937726|FG002|STARTED|Overall Study||22
3207868|NCT02174419|3937724|FG000|COMPLETED|Overall Study||18
3207869|NCT02174419|3937725|FG001|COMPLETED|Overall Study||12
3207870|NCT02174419|3937726|FG002|COMPLETED|Overall Study||20
3207871|NCT02174419|3937724|FG000|NOT COMPLETED|Overall Study||4
3207872|NCT02174419|3937725|FG001|NOT COMPLETED|Overall Study||6
3207873|NCT02174419|3937726|FG002|NOT COMPLETED|Overall Study||2
3207874|NCT02174432|3937734|FG000|STARTED|Overall Study||36
3207875|NCT02174432|3937734|FG000|COMPLETED|Overall Study||16
3207876|NCT02174432|3937734|FG000|NOT COMPLETED|Overall Study||20
3207877|NCT02174510|3937742|FG000|STARTED|Overall Study||8
3207878|NCT02174510|3937743|FG001|STARTED|Overall Study||8
3207879|NCT02174510|3937744|FG002|STARTED|Overall Study||12
3207880|NCT02174510|3937745|FG003|STARTED|Overall Study||9
3207881|NCT02174510|3937742|FG000|COMPLETED|Overall Study||8
3207882|NCT02174510|3937743|FG001|COMPLETED|Overall Study||8
3207883|NCT02174510|3937744|FG002|COMPLETED|Overall Study||12
3207884|NCT02174510|3937745|FG003|COMPLETED|Overall Study||9
3207885|NCT02174510|3937742|FG000|NOT COMPLETED|Overall Study||0
3207886|NCT02174510|3937743|FG001|NOT COMPLETED|Overall Study||0
3207887|NCT02174510|3937744|FG002|NOT COMPLETED|Overall Study||0
3207888|NCT02174510|3937745|FG003|NOT COMPLETED|Overall Study||0
3207889|NCT02174523|3937756|FG000|STARTED|Overall Study||10
3207890|NCT02174523|3937757|FG001|STARTED|Overall Study||4
3207891|NCT02174523|3937756|FG000|COMPLETED|Overall Study||9
3207892|NCT02174523|3937757|FG001|COMPLETED|Overall Study||4
3207893|NCT02174523|3937756|FG000|NOT COMPLETED|Overall Study||1
3207894|NCT02174523|3937757|FG001|NOT COMPLETED|Overall Study||0
3207895|NCT02174562|3937764|FG000|STARTED|Overall Study||50
3207896|NCT02174562|3937765|FG001|STARTED|Overall Study||51
3207897|NCT02174562|3937764|FG000|COMPLETED|Overall Study||41
3207898|NCT02174562|3937765|FG001|COMPLETED|Overall Study||46
3207899|NCT02174562|3937764|FG000|NOT COMPLETED|Overall Study||9
3207900|NCT02174562|3937765|FG001|NOT COMPLETED|Overall Study||5
3207901|NCT02174627|3937773|FG000|STARTED|Overall Study||1384
3207902|NCT02174627|3937774|FG001|STARTED|Overall Study||1377
3207903|NCT02174627|3937773|FG000|Received Treatment|Overall Study||1384
3207904|NCT02174627|3937774|FG001|Received Treatment|Overall Study||1376
3207905|NCT02174627|3937773|FG000|Discontinued Treatment|Overall Study||499
3207906|NCT02174627|3937774|FG001|Discontinued Treatment|Overall Study||801
3207907|NCT02174627|3937773|FG000|COMPLETED|Overall Study||1300
3207908|NCT02174627|3937774|FG001|COMPLETED|Overall Study||1247
3207909|NCT02174627|3937773|FG000|NOT COMPLETED|Overall Study||84
3207910|NCT02174627|3937774|FG001|NOT COMPLETED|Overall Study||130
3207911|NCT02174731|3937782|FG000|STARTED|Overall Study||1051
3207912|NCT02174731|3937783|FG001|STARTED|Overall Study||1055
3207913|NCT02174731|3937782|FG000|Received Treatment|Overall Study||1048
3207914|NCT02174731|3937783|FG001|Received Treatment|Overall Study||1053
3207915|NCT02174731|3937782|FG000|COMPLETED|Overall Study||982
3207916|NCT02174731|3937783|FG001|COMPLETED|Overall Study||990
3207917|NCT02174731|3937782|FG000|NOT COMPLETED|Overall Study||69
3207918|NCT02174731|3937783|FG001|NOT COMPLETED|Overall Study||65
3207919|NCT02174848|3937791|FG000|STARTED|Overall Study||24
3207920|NCT02174848|3937792|FG001|STARTED|Overall Study||44
3207921|NCT02174848|3937791|FG000|Provided Post-baseline Efficacy Data|Overall Study||19
3207922|NCT02174848|3937792|FG001|Provided Post-baseline Efficacy Data|Overall Study||43
3207923|NCT02174848|3937791|FG000|COMPLETED|Overall Study||17
3207924|NCT02174848|3937792|FG001|COMPLETED|Overall Study||38
3207925|NCT02174848|3937791|FG000|NOT COMPLETED|Overall Study||7
3207926|NCT02174848|3937792|FG001|NOT COMPLETED|Overall Study||6
3207927|NCT02174861|3937803|FG000|STARTED|Overall Study||609
3207928|NCT02174861|3937803|FG000|Enrolled in CHU Substudy|Overall Study||53
3207929|NCT02174861|3937803|FG000|COMPLETED|Overall Study||451
3207930|NCT02174861|3937803|FG000|NOT COMPLETED|Overall Study||158
3207931|NCT02174913|3937811|FG000|STARTED|Overall Study||17
3207932|NCT02174913|3937812|FG001|STARTED|Overall Study||17
3207933|NCT02174913|3937811|FG000|COMPLETED|Overall Study||17
3207934|NCT02174913|3937812|FG001|COMPLETED|Overall Study||17
3207935|NCT02174913|3937811|FG000|NOT COMPLETED|Overall Study||0
3207936|NCT02174913|3937812|FG001|NOT COMPLETED|Overall Study||0
3207937|NCT02175121|3937823|FG000|STARTED|Overall Study||34
3207938|NCT02175121|3937824|FG001|STARTED|Overall Study||35
3207939|NCT02175121|3937825|FG002|STARTED|Overall Study||34
3207940|NCT02175121|3937826|FG003|STARTED|Overall Study||35
3207941|NCT02175121|3937827|FG004|STARTED|Overall Study||34
3207942|NCT02175121|3937823|FG000|COMPLETED|Overall Study||33
3207943|NCT02175121|3937824|FG001|COMPLETED|Overall Study||34
3207944|NCT02175121|3937825|FG002|COMPLETED|Overall Study||32
3207945|NCT02175121|3937826|FG003|COMPLETED|Overall Study||34
3207946|NCT02175121|3937827|FG004|COMPLETED|Overall Study||33
3207947|NCT02175121|3937823|FG000|NOT COMPLETED|Overall Study||1
3207948|NCT02175121|3937824|FG001|NOT COMPLETED|Overall Study||1
3207949|NCT02175121|3937825|FG002|NOT COMPLETED|Overall Study||2
3207950|NCT02175121|3937826|FG003|NOT COMPLETED|Overall Study||1
3207951|NCT02175121|3937827|FG004|NOT COMPLETED|Overall Study||1
3207952|NCT02175199|3937845|FG000|STARTED|Overall Study||74
3207953|NCT02175199|3937846|FG001|STARTED|Overall Study||76
3207954|NCT02175199|3937845|FG000|Dispensed|Overall Study|Two subjects were randomized but never dispensed study lenses.|72
3207955|NCT02175199|3937846|FG001|Dispensed|Overall Study|Two subjects were randomized but never dispensed study lenses.|74
3207956|NCT02175199|3937845|FG000|COMPLETED|Overall Study||71
3207957|NCT02175199|3937846|FG001|COMPLETED|Overall Study||71
3207958|NCT02175199|3937845|FG000|NOT COMPLETED|Overall Study||3
3207959|NCT02175199|3937846|FG001|NOT COMPLETED|Overall Study||5
3207960|NCT02175212|3937855|FG000|STARTED|Overall Study||177
3207961|NCT02175212|3937856|FG001|STARTED|Overall Study||178
3207962|NCT02175212|3937855|FG000|COMPLETED|Overall Study||14
3207963|NCT02175212|3937856|FG001|COMPLETED|Overall Study||31
3207964|NCT02175212|3937855|FG000|NOT COMPLETED|Overall Study||163
3207965|NCT02175212|3937856|FG001|NOT COMPLETED|Overall Study||147
3207966|NCT02175225|3937864|FG000|STARTED|Overall Study||145
3207967|NCT02175225|3937865|FG001|STARTED|Overall Study||149
3207968|NCT02175225|3937864|FG000|Initiated Study Drug|Overall Study|Subjects in whom study drug was not initiated are not subsequently followed per the protocol.|144
3207969|NCT02175225|3937865|FG001|Initiated Study Drug|Overall Study|Subjects in whom study drug was not initiated are not subsequently followed per the protocol.|147
3207970|NCT02175225|3937864|FG000|90 Day Outcome Obtained|Overall Study||140
3207971|NCT02175225|3937865|FG001|90 Day Outcome Obtained|Overall Study||143
3207972|NCT02175225|3937864|FG000|180 Day Outcome Obtained|Overall Study||135
3207973|NCT02175225|3937865|FG001|180 Day Outcome Obtained|Overall Study||135
3207974|NCT02175225|3937864|FG000|COMPLETED|Overall Study||137
3207975|NCT02175225|3937865|FG001|COMPLETED|Overall Study||138
3207976|NCT02175225|3937864|FG000|NOT COMPLETED|Overall Study||8
3207977|NCT02175225|3937865|FG001|NOT COMPLETED|Overall Study||11
3207978|NCT02175277|3937871|FG000|STARTED|Overall Study||9
3207979|NCT02175277|3937871|FG000|COMPLETED|Overall Study||8
3207980|NCT02175277|3937871|FG000|NOT COMPLETED|Overall Study||1
3207981|NCT02175368|3937875|FG000|STARTED|Overall Study||28
3207982|NCT02175368|3937875|FG000|COMPLETED|Overall Study||27
3207983|NCT02175368|3937875|FG000|NOT COMPLETED|Overall Study||1
3207984|NCT02175472|3937881|FG000|STARTED|Overall Study||45
3207985|NCT02175472|3937882|FG001|STARTED|Overall Study||47
3207986|NCT02175472|3937881|FG000|COMPLETED|Overall Study||38
3207987|NCT02175472|3937882|FG001|COMPLETED|Overall Study||45
3207988|NCT02175472|3937881|FG000|NOT COMPLETED|Overall Study||7
3207989|NCT02175472|3937882|FG001|NOT COMPLETED|Overall Study||2
3207990|NCT02175641|3937890|FG000|STARTED|Overall Study||157
3207991|NCT02175641|3937891|FG001|STARTED|Overall Study||157
3207992|NCT02175641|3937890|FG000|6-month Follow up|Overall Study||144
3207993|NCT02175641|3937891|FG001|6-month Follow up|Overall Study||149
3207994|NCT02175641|3937890|FG000|12-month Follow up|Overall Study||129
3207995|NCT02175641|3937891|FG001|12-month Follow up|Overall Study||136
3207996|NCT02175641|3937890|FG000|18-month Follow up|Overall Study||122
3207997|NCT02175641|3937891|FG001|18-month Follow up|Overall Study||130
3207998|NCT02175641|3937890|FG000|COMPLETED|Overall Study||122
3207999|NCT02175641|3937891|FG001|COMPLETED|Overall Study||130
3208000|NCT02175641|3937890|FG000|NOT COMPLETED|Overall Study||35
3208001|NCT02175641|3937891|FG001|NOT COMPLETED|Overall Study||27
3208002|NCT02175745|3937897|FG000|STARTED|Overall Study||2
3208003|NCT02175745|3937897|FG000|COMPLETED|Overall Study||1
3208004|NCT02175745|3937897|FG000|NOT COMPLETED|Overall Study||1
3208005|NCT02175758|3937907|FG000|STARTED|PK Lead-in Phase||4
3208006|NCT02175758|3937908|FG001|STARTED|PK Lead-in Phase||6
3208007|NCT02175758|3937909|FG002|STARTED|PK Lead-in Phase||2
3208008|NCT02175758|3937910|FG003|STARTED|PK Lead-in Phase||10
3208009|NCT02175758|3937911|FG004|STARTED|PK Lead-in Phase||4
3208010|NCT02175758|3937912|FG005|STARTED|PK Lead-in Phase||8
3208011|NCT02175758|3937907|FG000|COMPLETED|PK Lead-in Phase||4
3208012|NCT02175758|3937908|FG001|COMPLETED|PK Lead-in Phase||6
3208013|NCT02175758|3937909|FG002|COMPLETED|PK Lead-in Phase||2
3208014|NCT02175758|3937910|FG003|COMPLETED|PK Lead-in Phase||10
3208015|NCT02175758|3937911|FG004|COMPLETED|PK Lead-in Phase||4
3208016|NCT02175758|3937912|FG005|COMPLETED|PK Lead-in Phase||8
3208017|NCT02175758|3937907|FG000|NOT COMPLETED|PK Lead-in Phase||0
3208018|NCT02175758|3937908|FG001|NOT COMPLETED|PK Lead-in Phase||0
3208019|NCT02175758|3937909|FG002|NOT COMPLETED|PK Lead-in Phase||0
3208020|NCT02175758|3937910|FG003|NOT COMPLETED|PK Lead-in Phase||0
3208021|NCT02175758|3937911|FG004|NOT COMPLETED|PK Lead-in Phase||0
3208022|NCT02175758|3937912|FG005|NOT COMPLETED|PK Lead-in Phase||0
3208023|NCT02175758|3937907|FG000|STARTED|Treatment Phase|9 participants enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|13
3208024|NCT02175758|3937908|FG001|STARTED|Treatment Phase|33 participants enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|39
3208025|NCT02175758|3937909|FG002|STARTED|Treatment Phase|11 participants enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|13
3208026|NCT02175758|3937910|FG003|STARTED|Treatment Phase|18 participants enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|28
3208027|NCT02175758|3937911|FG004|STARTED|Treatment Phase|1 participant enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|5
3208028|NCT02175758|3937912|FG005|STARTED|Treatment Phase||8
3208029|NCT02175758|3937907|FG000|COMPLETED|Treatment Phase||13
3208030|NCT02175758|3937908|FG001|COMPLETED|Treatment Phase||38
3208031|NCT02175758|3937909|FG002|COMPLETED|Treatment Phase||13
3208032|NCT02175758|3937910|FG003|COMPLETED|Treatment Phase||28
3208033|NCT02175758|3937911|FG004|COMPLETED|Treatment Phase||4
3208034|NCT02175758|3937912|FG005|COMPLETED|Treatment Phase||8
3208035|NCT02175758|3937907|FG000|NOT COMPLETED|Treatment Phase||0
3208036|NCT02175758|3937908|FG001|NOT COMPLETED|Treatment Phase||1
3208037|NCT02175758|3937909|FG002|NOT COMPLETED|Treatment Phase||0
3208038|NCT02175758|3937910|FG003|NOT COMPLETED|Treatment Phase||0
3208039|NCT02175758|3937911|FG004|NOT COMPLETED|Treatment Phase||1
3208040|NCT02175758|3937912|FG005|NOT COMPLETED|Treatment Phase||0
3208041|NCT02175771|3937960|FG000|STARTED|Run-In Period (Pre-assignment)|Enrolled; two participants were enrolled but had no enrollment date in their records.|758
3208042|NCT02175771|3937961|FG001|STARTED|Run-In Period (Pre-assignment)||0
3208043|NCT02175771|3937962|FG002|STARTED|Run-In Period (Pre-assignment)||0
3208044|NCT02175771|3937963|FG003|STARTED|Run-In Period (Pre-assignment)||0
3208045|NCT02175771|3937964|FG004|STARTED|Run-In Period (Pre-assignment)||0
3208046|NCT02175771|3937965|FG005|STARTED|Run-In Period (Pre-assignment)||0
3208047|NCT02175771|3937966|FG006|STARTED|Run-In Period (Pre-assignment)||0
3208048|NCT02175771|3937967|FG007|STARTED|Run-In Period (Pre-assignment)||0
3208049|NCT02175771|3937968|FG008|STARTED|Run-In Period (Pre-assignment)||0
3208050|NCT02175771|3937960|FG000|COMPLETED|Run-In Period (Pre-assignment)||674
3208051|NCT02175771|3937961|FG001|COMPLETED|Run-In Period (Pre-assignment)||0
3208052|NCT02175771|3937962|FG002|COMPLETED|Run-In Period (Pre-assignment)||0
3208053|NCT02175771|3937963|FG003|COMPLETED|Run-In Period (Pre-assignment)||0
3208054|NCT02175771|3937964|FG004|COMPLETED|Run-In Period (Pre-assignment)||0
3208055|NCT02175771|3937965|FG005|COMPLETED|Run-In Period (Pre-assignment)||0
3208056|NCT02175771|3937966|FG006|COMPLETED|Run-In Period (Pre-assignment)||0
3208057|NCT02175771|3937967|FG007|COMPLETED|Run-In Period (Pre-assignment)||0
3208058|NCT02175771|3937968|FG008|COMPLETED|Run-In Period (Pre-assignment)||0
3208059|NCT02175771|3937960|FG000|NOT COMPLETED|Run-In Period (Pre-assignment)||84
3208060|NCT02175771|3937961|FG001|NOT COMPLETED|Run-In Period (Pre-assignment)||0
3208061|NCT02175771|3937962|FG002|NOT COMPLETED|Run-In Period (Pre-assignment)||0
3208062|NCT02175771|3937963|FG003|NOT COMPLETED|Run-In Period (Pre-assignment)||0
3366083|NCT03913377|4097377|FG000|COMPLETED|Period 1||21
3208063|NCT02175771|3937964|FG004|NOT COMPLETED|Run-In Period (Pre-assignment)||0
3208064|NCT02175771|3937965|FG005|NOT COMPLETED|Run-In Period (Pre-assignment)||0
3208065|NCT02175771|3937966|FG006|NOT COMPLETED|Run-In Period (Pre-assignment)||0
3208066|NCT02175771|3937967|FG007|NOT COMPLETED|Run-In Period (Pre-assignment)||0
3208067|NCT02175771|3937968|FG008|NOT COMPLETED|Run-In Period (Pre-assignment)||0
3208068|NCT02175771|3937960|FG000|STARTED|Treatment Period||0
3208069|NCT02175771|3937961|FG001|STARTED|Treatment Period||127
3208070|NCT02175771|3937962|FG002|STARTED|Treatment Period||42
3208071|NCT02175771|3937963|FG003|STARTED|Treatment Period||126
3208072|NCT02175771|3937964|FG004|STARTED|Treatment Period||41
3208073|NCT02175771|3937965|FG005|STARTED|Treatment Period||120
3208074|NCT02175771|3937966|FG006|STARTED|Treatment Period||41
3208075|NCT02175771|3937967|FG007|STARTED|Treatment Period||133
3208076|NCT02175771|3937968|FG008|STARTED|Treatment Period||44
3208077|NCT02175771|3937960|FG000|COMPLETED|Treatment Period||0
3208078|NCT02175771|3937961|FG001|COMPLETED|Treatment Period||111
3208079|NCT02175771|3937962|FG002|COMPLETED|Treatment Period||35
3208080|NCT02175771|3937963|FG003|COMPLETED|Treatment Period||113
3208081|NCT02175771|3937964|FG004|COMPLETED|Treatment Period||36
3208082|NCT02175771|3937965|FG005|COMPLETED|Treatment Period||110
3208083|NCT02175771|3937966|FG006|COMPLETED|Treatment Period||36
3208084|NCT02175771|3937967|FG007|COMPLETED|Treatment Period||116
3208085|NCT02175771|3937968|FG008|COMPLETED|Treatment Period||38
3208086|NCT02175771|3937960|FG000|NOT COMPLETED|Treatment Period||0
3208087|NCT02175771|3937961|FG001|NOT COMPLETED|Treatment Period||16
3208088|NCT02175771|3937962|FG002|NOT COMPLETED|Treatment Period||7
3208089|NCT02175771|3937963|FG003|NOT COMPLETED|Treatment Period||13
3208090|NCT02175771|3937964|FG004|NOT COMPLETED|Treatment Period||5
3208091|NCT02175771|3937965|FG005|NOT COMPLETED|Treatment Period||10
3208092|NCT02175771|3937966|FG006|NOT COMPLETED|Treatment Period||5
3208093|NCT02175771|3937967|FG007|NOT COMPLETED|Treatment Period||17
3208094|NCT02175771|3937968|FG008|NOT COMPLETED|Treatment Period||6
3208095|NCT02175966|3937988|FG000|STARTED|Treatment Period||14
3208096|NCT02175966|3937989|FG001|STARTED|Treatment Period||14
3208097|NCT02175966|3937988|FG000|COMPLETED|Treatment Period||14
3208098|NCT02175966|3937989|FG001|COMPLETED|Treatment Period||14
3208099|NCT02175966|3937988|FG000|NOT COMPLETED|Treatment Period||0
3208100|NCT02175966|3937989|FG001|NOT COMPLETED|Treatment Period||0
3208101|NCT02175966|3937988|FG000|STARTED|Follow-up Period||14
3208102|NCT02175966|3937989|FG001|STARTED|Follow-up Period||14
3208103|NCT02175966|3937988|FG000|COMPLETED|Follow-up Period||4
3208104|NCT02175966|3937989|FG001|COMPLETED|Follow-up Period||8
3208105|NCT02175966|3937988|FG000|NOT COMPLETED|Follow-up Period||10
3208106|NCT02175966|3937989|FG001|NOT COMPLETED|Follow-up Period||6
3208107|NCT02175979|3937997|FG000|STARTED|Overall Study||140
3208108|NCT02175979|3937998|FG001|STARTED|Overall Study||140
3208109|NCT02175979|3937997|FG000|COMPLETED|Overall Study||133
3208110|NCT02175979|3937998|FG001|COMPLETED|Overall Study||132
3208111|NCT02175979|3937997|FG000|NOT COMPLETED|Overall Study||7
3208112|NCT02175979|3937998|FG001|NOT COMPLETED|Overall Study||8
3208113|NCT02176005|3938008|FG000|STARTED|Overall Study||14
3208114|NCT02176005|3938009|FG001|STARTED|Overall Study||14
3208115|NCT02176005|3938010|FG002|STARTED|Overall Study||8
3208116|NCT02176005|3938011|FG003|STARTED|Overall Study||8
3208117|NCT02176005|3938008|FG000|COMPLETED|Overall Study||14
3208118|NCT02176005|3938009|FG001|COMPLETED|Overall Study||14
3208119|NCT02176005|3938010|FG002|COMPLETED|Overall Study||8
3208120|NCT02176005|3938011|FG003|COMPLETED|Overall Study||8
3208121|NCT02176005|3938008|FG000|NOT COMPLETED|Overall Study||0
3208122|NCT02176005|3938009|FG001|NOT COMPLETED|Overall Study||0
3208123|NCT02176005|3938010|FG002|NOT COMPLETED|Overall Study||0
3208124|NCT02176005|3938011|FG003|NOT COMPLETED|Overall Study||0
3208125|NCT02176018|3938023|FG000|STARTED|Overall Study||22
3208126|NCT02176018|3938024|FG001|STARTED|Overall Study||23
3208127|NCT02176018|3938023|FG000|COMPLETED|Overall Study||17
3208128|NCT02176018|3938024|FG001|COMPLETED|Overall Study||17
3208129|NCT02176018|3938023|FG000|NOT COMPLETED|Overall Study||5
3208130|NCT02176018|3938024|FG001|NOT COMPLETED|Overall Study||6
3208131|NCT02176031|3938030|FG000|STARTED|Overall Study||21
3208132|NCT02176031|3938030|FG000|COMPLETED|Overall Study||9
3208133|NCT02176031|3938030|FG000|NOT COMPLETED|Overall Study||12
3208134|NCT02176083|3938037|FG000|STARTED|Overall Study||11
3208135|NCT02176083|3938038|FG001|STARTED|Overall Study||27
3208136|NCT02176083|3938037|FG000|COMPLETED|Overall Study||11
3366084|NCT03913377|4097378|FG001|COMPLETED|Period 1||21
3366085|NCT03913377|4097379|FG002|COMPLETED|Period 1||21
3208137|NCT02176083|3938038|FG001|COMPLETED|Overall Study||27
3208138|NCT02176083|3938037|FG000|NOT COMPLETED|Overall Study||0
3208139|NCT02176083|3938038|FG001|NOT COMPLETED|Overall Study||0
3208140|NCT02176226|3938044|FG000|STARTED|Overall Study||105
3208141|NCT02176226|3938044|FG000|COMPLETED|Overall Study||96
3208142|NCT02176226|3938044|FG000|NOT COMPLETED|Overall Study||9
3208143|NCT02176291|3938050|FG000|STARTED|Overall Study||20
3208144|NCT02176291|3938051|FG001|STARTED|Overall Study||11
3208145|NCT02176291|3938050|FG000|COMPLETED|Overall Study||15
3208146|NCT02176291|3938051|FG001|COMPLETED|Overall Study||11
3208147|NCT02176291|3938050|FG000|NOT COMPLETED|Overall Study||5
3208148|NCT02176291|3938051|FG001|NOT COMPLETED|Overall Study||0
3208149|NCT02176343|3938057|FG000|STARTED|Overall Study||31
3208150|NCT02176343|3938057|FG000|COMPLETED|Overall Study||31
3208151|NCT02176343|3938057|FG000|NOT COMPLETED|Overall Study||0
3208152|NCT02176356|3938061|FG000|STARTED|Overall Study||116
3208153|NCT02176356|3938061|FG000|Eligible and Received Treatment|Overall Study||100
3208154|NCT02176356|3938061|FG000|COMPLETED|Overall Study||93
3208155|NCT02176356|3938061|FG000|NOT COMPLETED|Overall Study||23
3208156|NCT02176382|3938067|FG000|STARTED|DATA-HD Study||39
3208157|NCT02176382|3938068|FG001|STARTED|DATA-HD Study||37
3208158|NCT02176382|3938067|FG000|COMPLETED|DATA-HD Study||31
3208159|NCT02176382|3938068|FG001|COMPLETED|DATA-HD Study||29
3208160|NCT02176382|3938067|FG000|NOT COMPLETED|DATA-HD Study||8
3208161|NCT02176382|3938068|FG001|NOT COMPLETED|DATA-HD Study||8
3208162|NCT02176382|3938067|FG000|STARTED|DATA-HD Extension||27
3208163|NCT02176382|3938068|FG001|STARTED|DATA-HD Extension||26
3208164|NCT02176382|3938067|FG000|COMPLETED|DATA-HD Extension||26
3208165|NCT02176382|3938068|FG001|COMPLETED|DATA-HD Extension||26
3208166|NCT02176382|3938067|FG000|NOT COMPLETED|DATA-HD Extension||1
3208167|NCT02176382|3938068|FG001|NOT COMPLETED|DATA-HD Extension||0
3208168|NCT02176408|3938076|FG000|STARTED|Overall Study||15
3208169|NCT02176408|3938077|FG001|STARTED|Overall Study||16
3208170|NCT02176408|3938076|FG000|COMPLETED|Overall Study||9
3208171|NCT02176408|3938077|FG001|COMPLETED|Overall Study||12
3208172|NCT02176408|3938076|FG000|NOT COMPLETED|Overall Study||6
3208173|NCT02176408|3938077|FG001|NOT COMPLETED|Overall Study||4
3208174|NCT02176421|3938083|FG000|STARTED|Overall Study||80
3208175|NCT02176421|3938083|FG000|COMPLETED|Overall Study||75
3208176|NCT02176421|3938083|FG000|NOT COMPLETED|Overall Study||5
3208177|NCT02176486|3938090|FG000|STARTED|Overall Study||3
3208178|NCT02176486|3938091|FG001|STARTED|Overall Study||5
3208179|NCT02176486|3938092|FG002|STARTED|Overall Study||4
3208180|NCT02176486|3938090|FG000|COMPLETED|Overall Study||3
3208181|NCT02176486|3938091|FG001|COMPLETED|Overall Study||5
3208182|NCT02176486|3938092|FG002|COMPLETED|Overall Study||4
3208183|NCT02176486|3938090|FG000|NOT COMPLETED|Overall Study||0
3208184|NCT02176486|3938091|FG001|NOT COMPLETED|Overall Study||0
3208185|NCT02176486|3938092|FG002|NOT COMPLETED|Overall Study||0
3208186|NCT02176525|3938110|FG000|STARTED|Overall Study|15 subjects randomized, 14 subjects treated with at least one dose, 1 subject was not treated|15
3208187|NCT02176525|3938111|FG001|STARTED|Overall Study||9
3208188|NCT02176525|3938112|FG002|STARTED|Overall Study||9
3208189|NCT02176525|3938113|FG003|STARTED|Overall Study||9
3208190|NCT02176525|3938114|FG004|STARTED|Overall Study||8
3208191|NCT02176525|3938115|FG005|STARTED|Overall Study|6 subjects randomized, 5 subjects treated with at least one dose, 1 subject was not treated|6
3208192|NCT02176525|3938116|FG006|STARTED|Overall Study||9
3208193|NCT02176525|3938117|FG007|STARTED|Overall Study||10
3208194|NCT02176525|3938110|FG000|COMPLETED|Overall Study||14
3208195|NCT02176525|3938111|FG001|COMPLETED|Overall Study||9
3208196|NCT02176525|3938112|FG002|COMPLETED|Overall Study||9
3208197|NCT02176525|3938113|FG003|COMPLETED|Overall Study||8
3208198|NCT02176525|3938114|FG004|COMPLETED|Overall Study||7
3208199|NCT02176525|3938115|FG005|COMPLETED|Overall Study||5
3208200|NCT02176525|3938116|FG006|COMPLETED|Overall Study||8
3208201|NCT02176525|3938117|FG007|COMPLETED|Overall Study||10
3208202|NCT02176525|3938110|FG000|NOT COMPLETED|Overall Study||1
3208203|NCT02176525|3938111|FG001|NOT COMPLETED|Overall Study||0
3208204|NCT02176525|3938112|FG002|NOT COMPLETED|Overall Study||0
3208205|NCT02176525|3938113|FG003|NOT COMPLETED|Overall Study||1
3208206|NCT02176525|3938114|FG004|NOT COMPLETED|Overall Study||1
3208207|NCT02176525|3938115|FG005|NOT COMPLETED|Overall Study||1
3208208|NCT02176525|3938116|FG006|NOT COMPLETED|Overall Study||1
3208209|NCT02176525|3938117|FG007|NOT COMPLETED|Overall Study||0
3208210|NCT02176642|3938145|FG000|STARTED|Overall Study||18
3208211|NCT02176642|3938146|FG001|STARTED|Overall Study||17
3208212|NCT02176642|3938145|FG000|COMPLETED|Overall Study||18
3208213|NCT02176642|3938146|FG001|COMPLETED|Overall Study||16
3208214|NCT02176642|3938145|FG000|NOT COMPLETED|Overall Study||0
3208215|NCT02176642|3938146|FG001|NOT COMPLETED|Overall Study||1
3208216|NCT02176655|3938152|FG000|STARTED|Overall Study||31
3208217|NCT02176655|3938152|FG000|COMPLETED|Overall Study||25
3208218|NCT02176655|3938152|FG000|NOT COMPLETED|Overall Study||6
3208219|NCT02176837|3938157|FG000|STARTED|Overall Study||6
3208220|NCT02176837|3938157|FG000|COMPLETED|Overall Study||0
3208221|NCT02176837|3938157|FG000|NOT COMPLETED|Overall Study||6
3208222|NCT02176928|3938163|FG000|STARTED|Overall Study||21
3208223|NCT02176928|3938164|FG001|STARTED|Overall Study||21
3208224|NCT02176928|3938163|FG000|COMPLETED|Overall Study||19
3208225|NCT02176928|3938164|FG001|COMPLETED|Overall Study||17
3208226|NCT02176928|3938163|FG000|NOT COMPLETED|Overall Study||2
3208227|NCT02176928|3938164|FG001|NOT COMPLETED|Overall Study||4
3208228|NCT02177032|3938174|FG000|STARTED|Overall Study||355
3208229|NCT02177032|3938175|FG001|STARTED|Overall Study||88
3208230|NCT02177032|3938176|FG002|STARTED|Overall Study||354
3208231|NCT02177032|3938177|FG003|STARTED|Overall Study||88
3208232|NCT02177032|3938174|FG000|COMPLETED|Overall Study||350
3208233|NCT02177032|3938175|FG001|COMPLETED|Overall Study||86
3208234|NCT02177032|3938176|FG002|COMPLETED|Overall Study||351
3208235|NCT02177032|3938177|FG003|COMPLETED|Overall Study||88
3208236|NCT02177032|3938174|FG000|NOT COMPLETED|Overall Study||5
3208237|NCT02177032|3938175|FG001|NOT COMPLETED|Overall Study||2
3208238|NCT02177032|3938176|FG002|NOT COMPLETED|Overall Study||3
3208239|NCT02177032|3938177|FG003|NOT COMPLETED|Overall Study||0
3208240|NCT02177123|3938198|FG000|STARTED|Overall Study||107
3208241|NCT02177123|3938198|FG000|COMPLETED|Overall Study||83
3208242|NCT02177123|3938198|FG000|NOT COMPLETED|Overall Study||24
3208243|NCT02177136|3938208|FG000|STARTED|DB Phase||26
3208244|NCT02177136|3938209|FG001|STARTED|DB Phase||26
3208245|NCT02177136|3938210|FG002|STARTED|DB Phase||25
3208246|NCT02177136|3938211|FG003|STARTED|DB Phase||0
3208247|NCT02177136|3938208|FG000|Received At Least 1 Dose Of Study Drug|DB Phase|One participant randomized to receive 1.5 mg OCA titrating to 3 mg OCA withdrew prior to dosing.|25
3208248|NCT02177136|3938209|FG001|Received At Least 1 Dose Of Study Drug|DB Phase||26
3208249|NCT02177136|3938210|FG002|Received At Least 1 Dose Of Study Drug|DB Phase||25
3208250|NCT02177136|3938211|FG003|Received At Least 1 Dose Of Study Drug|DB Phase||0
3208251|NCT02177136|3938208|FG000|COMPLETED|DB Phase||19
3208252|NCT02177136|3938209|FG001|COMPLETED|DB Phase||21
3208253|NCT02177136|3938210|FG002|COMPLETED|DB Phase||21
3208254|NCT02177136|3938211|FG003|COMPLETED|DB Phase||0
3208255|NCT02177136|3938208|FG000|NOT COMPLETED|DB Phase||7
3208256|NCT02177136|3938209|FG001|NOT COMPLETED|DB Phase||5
3208257|NCT02177136|3938210|FG002|NOT COMPLETED|DB Phase||4
3208258|NCT02177136|3938211|FG003|NOT COMPLETED|DB Phase||0
3208259|NCT02177136|3938208|FG000|STARTED|LTSE Phase|Eligible participants who completed the DB phase could enroll in the LTSE phase.|0
3208260|NCT02177136|3938209|FG001|STARTED|LTSE Phase|Eligible participants who completed the DB phase could enroll in the LTSE phase.|0
3208261|NCT02177136|3938210|FG002|STARTED|LTSE Phase|Eligible participants who completed the DB phase could enroll in the LTSE phase.|0
3208262|NCT02177136|3938211|FG003|STARTED|LTSE Phase|Eligible participants who completed the DB phase could enroll in the LTSE phase.|59
3208263|NCT02177136|3938208|FG000|Received At Least 1 Dose Of Study Drug|LTSE Phase||0
3208264|NCT02177136|3938209|FG001|Received At Least 1 Dose Of Study Drug|LTSE Phase||0
3208265|NCT02177136|3938210|FG002|Received At Least 1 Dose Of Study Drug|LTSE Phase||0
3208266|NCT02177136|3938211|FG003|Received At Least 1 Dose Of Study Drug|LTSE Phase||59
3208267|NCT02177136|3938208|FG000|COMPLETED|LTSE Phase||0
3208268|NCT02177136|3938209|FG001|COMPLETED|LTSE Phase||0
3208269|NCT02177136|3938210|FG002|COMPLETED|LTSE Phase||0
3208270|NCT02177136|3938211|FG003|COMPLETED|LTSE Phase||35
3208271|NCT02177136|3938208|FG000|NOT COMPLETED|LTSE Phase||0
3208272|NCT02177136|3938209|FG001|NOT COMPLETED|LTSE Phase||0
3208273|NCT02177136|3938210|FG002|NOT COMPLETED|LTSE Phase||0
3208274|NCT02177136|3938211|FG003|NOT COMPLETED|LTSE Phase||24
3208275|NCT02177201|3938224|FG000|STARTED|Overall Study||80
3208276|NCT02177201|3938225|FG001|STARTED|Overall Study||80
3208277|NCT02177201|3938224|FG000|COMPLETED|Overall Study||77
3208278|NCT02177201|3938225|FG001|COMPLETED|Overall Study||77
3208279|NCT02177201|3938224|FG000|NOT COMPLETED|Overall Study||3
3208280|NCT02177201|3938225|FG001|NOT COMPLETED|Overall Study||3
3208281|NCT02177786|3938235|FG000|STARTED|Overall Study||81
3208282|NCT02177786|3938236|FG001|STARTED|Overall Study||84
3208283|NCT02177786|3938237|FG002|STARTED|Overall Study||84
3208284|NCT02177786|3938238|FG003|STARTED|Overall Study||85
3208285|NCT02177786|3938235|FG000|Randomized and Treated|Overall Study||81
3208286|NCT02177786|3938236|FG001|Randomized and Treated|Overall Study||84
3208287|NCT02177786|3938237|FG002|Randomized and Treated|Overall Study||83
3208288|NCT02177786|3938238|FG003|Randomized and Treated|Overall Study||85
3208289|NCT02177786|3938235|FG000|COMPLETED|Overall Study||75
3208290|NCT02177786|3938236|FG001|COMPLETED|Overall Study||70
3208291|NCT02177786|3938237|FG002|COMPLETED|Overall Study||66
3208292|NCT02177786|3938238|FG003|COMPLETED|Overall Study||72
3208293|NCT02177786|3938235|FG000|NOT COMPLETED|Overall Study||6
3208294|NCT02177786|3938236|FG001|NOT COMPLETED|Overall Study||14
3208295|NCT02177786|3938237|FG002|NOT COMPLETED|Overall Study||18
3208296|NCT02177786|3938238|FG003|NOT COMPLETED|Overall Study||13
3208297|NCT02177812|3938257|FG000|STARTED|Part 1 (Median of 4 Weeks)||1
3208298|NCT02177812|3938258|FG001|STARTED|Part 1 (Median of 4 Weeks)||2
3208299|NCT02177812|3938259|FG002|STARTED|Part 1 (Median of 4 Weeks)||7
3208300|NCT02177812|3938260|FG003|STARTED|Part 1 (Median of 4 Weeks)||5
3208301|NCT02177812|3938261|FG004|STARTED|Part 1 (Median of 4 Weeks)||6
3208302|NCT02177812|3938262|FG005|STARTED|Part 1 (Median of 4 Weeks)||4
3208303|NCT02177812|3938263|FG006|STARTED|Part 1 (Median of 4 Weeks)||10
3208304|NCT02177812|3938264|FG007|STARTED|Part 1 (Median of 4 Weeks)||6
3208305|NCT02177812|3938265|FG008|STARTED|Part 1 (Median of 4 Weeks)||0
3208306|NCT02177812|3938257|FG000|COMPLETED|Part 1 (Median of 4 Weeks)||1
3208307|NCT02177812|3938258|FG001|COMPLETED|Part 1 (Median of 4 Weeks)||2
3208308|NCT02177812|3938259|FG002|COMPLETED|Part 1 (Median of 4 Weeks)||7
3208309|NCT02177812|3938260|FG003|COMPLETED|Part 1 (Median of 4 Weeks)||4
3208310|NCT02177812|3938261|FG004|COMPLETED|Part 1 (Median of 4 Weeks)||5
3208311|NCT02177812|3938262|FG005|COMPLETED|Part 1 (Median of 4 Weeks)||1
3208312|NCT02177812|3938263|FG006|COMPLETED|Part 1 (Median of 4 Weeks)||1
3208313|NCT02177812|3938264|FG007|COMPLETED|Part 1 (Median of 4 Weeks)||4
3208314|NCT02177812|3938265|FG008|COMPLETED|Part 1 (Median of 4 Weeks)||0
3208315|NCT02177812|3938257|FG000|NOT COMPLETED|Part 1 (Median of 4 Weeks)||0
3208316|NCT02177812|3938258|FG001|NOT COMPLETED|Part 1 (Median of 4 Weeks)||0
3208317|NCT02177812|3938259|FG002|NOT COMPLETED|Part 1 (Median of 4 Weeks)||0
3208318|NCT02177812|3938260|FG003|NOT COMPLETED|Part 1 (Median of 4 Weeks)||1
3208319|NCT02177812|3938261|FG004|NOT COMPLETED|Part 1 (Median of 4 Weeks)||1
3208320|NCT02177812|3938262|FG005|NOT COMPLETED|Part 1 (Median of 4 Weeks)||3
3208321|NCT02177812|3938263|FG006|NOT COMPLETED|Part 1 (Median of 4 Weeks)||9
3208322|NCT02177812|3938264|FG007|NOT COMPLETED|Part 1 (Median of 4 Weeks)||2
3208323|NCT02177812|3938265|FG008|NOT COMPLETED|Part 1 (Median of 4 Weeks)||0
3208324|NCT02177812|3938257|FG000|STARTED|Part 2 (Up to 14 Months)||0
3208325|NCT02177812|3938258|FG001|STARTED|Part 2 (Up to 14 Months)||0
3208326|NCT02177812|3938259|FG002|STARTED|Part 2 (Up to 14 Months)||0
3208327|NCT02177812|3938260|FG003|STARTED|Part 2 (Up to 14 Months)||0
3208328|NCT02177812|3938261|FG004|STARTED|Part 2 (Up to 14 Months)||0
3208329|NCT02177812|3938262|FG005|STARTED|Part 2 (Up to 14 Months)||0
3208330|NCT02177812|3938263|FG006|STARTED|Part 2 (Up to 14 Months)||0
3208331|NCT02177812|3938264|FG007|STARTED|Part 2 (Up to 14 Months)||0
3208332|NCT02177812|3938265|FG008|STARTED|Part 2 (Up to 14 Months)||0
3208333|NCT02177812|3938257|FG000|COMPLETED|Part 2 (Up to 14 Months)||0
3208334|NCT02177812|3938258|FG001|COMPLETED|Part 2 (Up to 14 Months)||0
3208335|NCT02177812|3938259|FG002|COMPLETED|Part 2 (Up to 14 Months)||0
3208336|NCT02177812|3938260|FG003|COMPLETED|Part 2 (Up to 14 Months)||0
3208337|NCT02177812|3938261|FG004|COMPLETED|Part 2 (Up to 14 Months)||0
3208338|NCT02177812|3938262|FG005|COMPLETED|Part 2 (Up to 14 Months)||0
3208339|NCT02177812|3938263|FG006|COMPLETED|Part 2 (Up to 14 Months)||0
3208340|NCT02177812|3938264|FG007|COMPLETED|Part 2 (Up to 14 Months)||0
3208341|NCT02177812|3938265|FG008|COMPLETED|Part 2 (Up to 14 Months)||0
3208342|NCT02177812|3938257|FG000|NOT COMPLETED|Part 2 (Up to 14 Months)||0
3208343|NCT02177812|3938258|FG001|NOT COMPLETED|Part 2 (Up to 14 Months)||0
3208344|NCT02177812|3938259|FG002|NOT COMPLETED|Part 2 (Up to 14 Months)||0
3208345|NCT02177812|3938260|FG003|NOT COMPLETED|Part 2 (Up to 14 Months)||0
3208346|NCT02177812|3938261|FG004|NOT COMPLETED|Part 2 (Up to 14 Months)||0
3208347|NCT02177812|3938262|FG005|NOT COMPLETED|Part 2 (Up to 14 Months)||0
3208348|NCT02177812|3938263|FG006|NOT COMPLETED|Part 2 (Up to 14 Months)||0
3208349|NCT02177812|3938264|FG007|NOT COMPLETED|Part 2 (Up to 14 Months)||0
3208350|NCT02177812|3938265|FG008|NOT COMPLETED|Part 2 (Up to 14 Months)||0
3208351|NCT02177838|3938294|FG000|STARTED|Overall Study||8
3208352|NCT02177838|3938294|FG000|COMPLETED|Overall Study||5
3208353|NCT02177838|3938294|FG000|NOT COMPLETED|Overall Study||3
3208354|NCT02177942|3938300|FG000|STARTED|Overall Study||262
3208355|NCT02177942|3938301|FG001|STARTED|Overall Study||266
3208356|NCT02177942|3938300|FG000|COMPLETED|Overall Study||185
3208357|NCT02177942|3938301|FG001|COMPLETED|Overall Study||178
3208358|NCT02177942|3938300|FG000|NOT COMPLETED|Overall Study||77
3208359|NCT02177942|3938301|FG001|NOT COMPLETED|Overall Study||88
3208360|NCT02178059|3938311|FG000|STARTED|First Intervention||17
3208361|NCT02178059|3938312|FG001|STARTED|First Intervention||17
3208362|NCT02178059|3938311|FG000|COMPLETED|First Intervention||17
3208363|NCT02178059|3938312|FG001|COMPLETED|First Intervention||17
3208364|NCT02178059|3938311|FG000|NOT COMPLETED|First Intervention||0
3208365|NCT02178059|3938312|FG001|NOT COMPLETED|First Intervention||0
3208366|NCT02178059|3938311|FG000|STARTED|Washout||17
3208367|NCT02178059|3938312|FG001|STARTED|Washout||17
3208368|NCT02178059|3938311|FG000|COMPLETED|Washout||16
3208369|NCT02178059|3938312|FG001|COMPLETED|Washout||17
3208370|NCT02178059|3938311|FG000|NOT COMPLETED|Washout||1
3208371|NCT02178059|3938312|FG001|NOT COMPLETED|Washout||0
3208372|NCT02178059|3938311|FG000|STARTED|Second Intervention||16
3208373|NCT02178059|3938312|FG001|STARTED|Second Intervention||17
3208374|NCT02178059|3938311|FG000|COMPLETED|Second Intervention||16
3208375|NCT02178059|3938312|FG001|COMPLETED|Second Intervention||17
3208376|NCT02178059|3938311|FG000|NOT COMPLETED|Second Intervention||0
3208377|NCT02178059|3938312|FG001|NOT COMPLETED|Second Intervention||0
3208378|NCT02178241|3938318|FG000|STARTED|Overall Study||24
3208379|NCT02178241|3938318|FG000|COMPLETED|Overall Study||24
3208380|NCT02178241|3938318|FG000|NOT COMPLETED|Overall Study||0
3208381|NCT02178475|3938322|FG000|STARTED|Overall Study||943
3208382|NCT02178475|3938322|FG000|Primary Analysis Set|Overall Study|All enrolled participants who met eligibility criteria|844
3208383|NCT02178475|3938322|FG000|COMPLETED|Overall Study||814
3208384|NCT02178475|3938322|FG000|NOT COMPLETED|Overall Study||129
3208385|NCT02178540|3938326|FG000|STARTED|Overall Study||45
3208386|NCT02178540|3938326|FG000|COMPLETED|Overall Study||45
3208387|NCT02178540|3938326|FG000|NOT COMPLETED|Overall Study||0
3208388|NCT02178553|3938335|FG000|STARTED|Overall Study||53
3208389|NCT02178553|3938336|FG001|STARTED|Overall Study||49
3208390|NCT02178553|3938335|FG000|COMPLETED|Overall Study||45
3208391|NCT02178553|3938336|FG001|COMPLETED|Overall Study||39
3208392|NCT02178553|3938335|FG000|NOT COMPLETED|Overall Study||8
3208393|NCT02178553|3938336|FG001|NOT COMPLETED|Overall Study||10
3208394|NCT02178592|3938344|FG000|STARTED|Randomized Phase (Up to Week 52)||69
3208395|NCT02178592|3938345|FG001|STARTED|Randomized Phase (Up to Week 52)||44
3208396|NCT02178592|3938344|FG000|COMPLETED|Randomized Phase (Up to Week 52)||50
3208397|NCT02178592|3938345|FG001|COMPLETED|Randomized Phase (Up to Week 52)||35
3208398|NCT02178592|3938344|FG000|NOT COMPLETED|Randomized Phase (Up to Week 52)||19
3208399|NCT02178592|3938345|FG001|NOT COMPLETED|Randomized Phase (Up to Week 52)||9
3208400|NCT02178592|3938344|FG000|STARTED|OLE Phase (Week 52 to Week 252)|As OLE phase was optional, 3 participants from DTG arm did not enter OLE from Randomized Phase.|47
3208401|NCT02178592|3938345|FG001|STARTED|OLE Phase (Week 52 to Week 252)|As OLE phase was optional, 16 participants from EFV arm did not enter OLE from Randomized Phase.|19
3208402|NCT02178592|3938344|FG000|COMPLETED|OLE Phase (Week 52 to Week 252)||35
3208403|NCT02178592|3938345|FG001|COMPLETED|OLE Phase (Week 52 to Week 252)||16
3208404|NCT02178592|3938344|FG000|NOT COMPLETED|OLE Phase (Week 52 to Week 252)||12
3208405|NCT02178592|3938345|FG001|NOT COMPLETED|OLE Phase (Week 52 to Week 252)||3
3208406|NCT02178696|3938354|FG000|STARTED|First Assignment and Washout||20
3208407|NCT02178696|3938355|FG001|STARTED|First Assignment and Washout||20
3208408|NCT02178696|3938354|FG000|COMPLETED|First Assignment and Washout||20
3208409|NCT02178696|3938355|FG001|COMPLETED|First Assignment and Washout||20
3208410|NCT02178696|3938354|FG000|NOT COMPLETED|First Assignment and Washout||0
3208411|NCT02178696|3938355|FG001|NOT COMPLETED|First Assignment and Washout||0
3208412|NCT02178696|3938354|FG000|STARTED|Second Assignment After Crossover||20
3208413|NCT02178696|3938355|FG001|STARTED|Second Assignment After Crossover||20
3208414|NCT02178696|3938354|FG000|COMPLETED|Second Assignment After Crossover||20
3208415|NCT02178696|3938355|FG001|COMPLETED|Second Assignment After Crossover||20
3208416|NCT02178696|3938354|FG000|NOT COMPLETED|Second Assignment After Crossover||0
3208417|NCT02178696|3938355|FG001|NOT COMPLETED|Second Assignment After Crossover||0
3208418|NCT02178696|3938354|FG000|STARTED|Open-label Antidepressant||20
3208419|NCT02178696|3938355|FG001|STARTED|Open-label Antidepressant||20
3208420|NCT02178696|3938354|FG000|COMPLETED|Open-label Antidepressant||14
3208421|NCT02178696|3938355|FG001|COMPLETED|Open-label Antidepressant||13
3208422|NCT02178696|3938354|FG000|NOT COMPLETED|Open-label Antidepressant||6
3208423|NCT02178696|3938355|FG001|NOT COMPLETED|Open-label Antidepressant||7
3208424|NCT02178787|3938368|FG000|STARTED|Overall Study||35
3208425|NCT02178787|3938369|FG001|STARTED|Overall Study||39
3208426|NCT02178787|3938368|FG000|COMPLETED|Overall Study||30
3208427|NCT02178787|3938369|FG001|COMPLETED|Overall Study||30
3208428|NCT02178787|3938368|FG000|NOT COMPLETED|Overall Study||5
3208429|NCT02178787|3938369|FG001|NOT COMPLETED|Overall Study||9
3208430|NCT02178800|3938379|FG000|STARTED|Overall Study||151
3208431|NCT02178800|3938380|FG001|STARTED|Overall Study||48
3208432|NCT02178800|3938379|FG000|COMPLETED|Overall Study|Number of participants who weren't terminated at week 41|131
3208433|NCT02178800|3938380|FG001|COMPLETED|Overall Study|Number of participants who weren't terminated at week 41|42
3208434|NCT02178800|3938379|FG000|NOT COMPLETED|Overall Study||20
3208435|NCT02178800|3938380|FG001|NOT COMPLETED|Overall Study||6
3208436|NCT02178956|3938396|FG000|STARTED|Overall Study||357
3208437|NCT02178956|3938397|FG001|STARTED|Overall Study||357
3208438|NCT02178956|3938396|FG000|COMPLETED|Overall Study||286
3208439|NCT02178956|3938397|FG001|COMPLETED|Overall Study||279
3208440|NCT02178956|3938396|FG000|NOT COMPLETED|Overall Study||71
3208441|NCT02178956|3938397|FG001|NOT COMPLETED|Overall Study||78
3208442|NCT02178995|3938409|FG000|STARTED|Double Blind||0
3208443|NCT02178995|3938410|FG001|STARTED|Double Blind||16
3208444|NCT02178995|3938411|FG002|STARTED|Double Blind||5
3208445|NCT02178995|3938412|FG003|STARTED|Double Blind||6
3208446|NCT02178995|3938413|FG004|STARTED|Double Blind||6
3208447|NCT02178995|3938414|FG005|STARTED|Double Blind||6
3208448|NCT02178995|3938415|FG006|STARTED|Double Blind||5
3208449|NCT02178995|3938416|FG007|STARTED|Double Blind||6
3208450|NCT02178995|3938417|FG008|STARTED|Double Blind||1
3208451|NCT02178995|3938409|FG000|COMPLETED|Double Blind||0
3208452|NCT02178995|3938410|FG001|COMPLETED|Double Blind||15
3208453|NCT02178995|3938411|FG002|COMPLETED|Double Blind||5
3208454|NCT02178995|3938412|FG003|COMPLETED|Double Blind||6
3208455|NCT02178995|3938413|FG004|COMPLETED|Double Blind||6
3208456|NCT02178995|3938414|FG005|COMPLETED|Double Blind||5
3208457|NCT02178995|3938415|FG006|COMPLETED|Double Blind||5
3208458|NCT02178995|3938416|FG007|COMPLETED|Double Blind||4
3208459|NCT02178995|3938417|FG008|COMPLETED|Double Blind||0
3208460|NCT02178995|3938409|FG000|NOT COMPLETED|Double Blind||0
3208461|NCT02178995|3938410|FG001|NOT COMPLETED|Double Blind||1
3208462|NCT02178995|3938411|FG002|NOT COMPLETED|Double Blind||0
3208463|NCT02178995|3938412|FG003|NOT COMPLETED|Double Blind||0
3208464|NCT02178995|3938413|FG004|NOT COMPLETED|Double Blind||0
3208465|NCT02178995|3938414|FG005|NOT COMPLETED|Double Blind||1
3208466|NCT02178995|3938415|FG006|NOT COMPLETED|Double Blind||0
3208467|NCT02178995|3938416|FG007|NOT COMPLETED|Double Blind||2
3208468|NCT02178995|3938417|FG008|NOT COMPLETED|Double Blind||1
3208469|NCT02178995|3938409|FG000|STARTED|Open Label|2 declined to join open-label. 1 withdrew from double-blind but rejoined open-label due to benefit.|30
3208470|NCT02178995|3938410|FG001|STARTED|Open Label|One was lost to follow-up after completion of visit 4.|14
3208471|NCT02178995|3938411|FG002|STARTED|Open Label||0
3208472|NCT02178995|3938412|FG003|STARTED|Open Label||0
3208473|NCT02178995|3938413|FG004|STARTED|Open Label||0
3208474|NCT02178995|3938414|FG005|STARTED|Open Label||0
3208475|NCT02178995|3938415|FG006|STARTED|Open Label||0
3208476|NCT02178995|3938416|FG007|STARTED|Open Label||0
3208477|NCT02178995|3938417|FG008|STARTED|Open Label||0
3208478|NCT02178995|3938409|FG000|COMPLETED|Open Label||28
3208479|NCT02178995|3938410|FG001|COMPLETED|Open Label||14
3208480|NCT02178995|3938411|FG002|COMPLETED|Open Label||0
3208481|NCT02178995|3938412|FG003|COMPLETED|Open Label||0
3208482|NCT02178995|3938413|FG004|COMPLETED|Open Label||0
3208483|NCT02178995|3938414|FG005|COMPLETED|Open Label||0
3208484|NCT02178995|3938415|FG006|COMPLETED|Open Label||0
3208485|NCT02178995|3938416|FG007|COMPLETED|Open Label||0
3208486|NCT02178995|3938417|FG008|COMPLETED|Open Label||0
3208487|NCT02178995|3938409|FG000|NOT COMPLETED|Open Label||2
3208488|NCT02178995|3938410|FG001|NOT COMPLETED|Open Label||0
3208489|NCT02178995|3938411|FG002|NOT COMPLETED|Open Label||0
3208490|NCT02178995|3938412|FG003|NOT COMPLETED|Open Label||0
3208491|NCT02178995|3938413|FG004|NOT COMPLETED|Open Label||0
3208492|NCT02178995|3938414|FG005|NOT COMPLETED|Open Label||0
3208493|NCT02178995|3938415|FG006|NOT COMPLETED|Open Label||0
3208494|NCT02178995|3938416|FG007|NOT COMPLETED|Open Label||0
3208495|NCT02178995|3938417|FG008|NOT COMPLETED|Open Label||0
3208496|NCT02179047|3938443|FG000|STARTED|Overall Study||194
3208497|NCT02179047|3938444|FG001|STARTED|Overall Study||20
3208498|NCT02179047|3938443|FG000|COMPLETED|Overall Study||187
3208499|NCT02179047|3938444|FG001|COMPLETED|Overall Study||20
3208500|NCT02179047|3938443|FG000|NOT COMPLETED|Overall Study||7
3208501|NCT02179047|3938444|FG001|NOT COMPLETED|Overall Study||0
3208502|NCT02179177|3938463|FG000|STARTED|Overall Study||8
3208503|NCT02179177|3938464|FG001|STARTED|Overall Study||8
3208504|NCT02179177|3938463|FG000|COMPLETED|Overall Study||6
3208505|NCT02179177|3938464|FG001|COMPLETED|Overall Study||6
3208506|NCT02179177|3938463|FG000|NOT COMPLETED|Overall Study||2
3208507|NCT02179177|3938464|FG001|NOT COMPLETED|Overall Study||2
3208508|NCT02179190|3938470|FG000|STARTED|Enrollment||138
3208509|NCT02179190|3938470|FG000|COMPLETED|Enrollment||127
3208510|NCT02179190|3938470|FG000|NOT COMPLETED|Enrollment||11
3208511|NCT02179190|3938470|FG000|STARTED|Index Procedure With Barrel VRD Attempt||127
3208512|NCT02179190|3938470|FG000|COMPLETED|Index Procedure With Barrel VRD Attempt||120
3208513|NCT02179190|3938470|FG000|NOT COMPLETED|Index Procedure With Barrel VRD Attempt||7
3208514|NCT02179190|3938470|FG000|STARTED|Follow-Up Post Barrel VRD Implanted||120
3208515|NCT02179190|3938470|FG000|COMPLETED|Follow-Up Post Barrel VRD Implanted||111
3208516|NCT02179190|3938470|FG000|NOT COMPLETED|Follow-Up Post Barrel VRD Implanted||9
3208517|NCT02179398|3938476|FG000|STARTED|Overall Study||134
3208518|NCT02179398|3938477|FG001|STARTED|Overall Study||144
3208519|NCT02179398|3938476|FG000|COMPLETED|Overall Study||131
3208520|NCT02179398|3938477|FG001|COMPLETED|Overall Study||140
3208521|NCT02179398|3938476|FG000|NOT COMPLETED|Overall Study||3
3208522|NCT02179398|3938477|FG001|NOT COMPLETED|Overall Study||4
3208523|NCT02179424|3938491|FG000|STARTED|Overall Study||76
3208524|NCT02179424|3938492|FG001|STARTED|Overall Study||11
3208525|NCT02179424|3938493|FG002|STARTED|Overall Study||516
3208526|NCT02179424|3938494|FG003|STARTED|Overall Study||39
3208527|NCT02179424|3938491|FG000|COMPLETED|Overall Study||76
3208528|NCT02179424|3938492|FG001|COMPLETED|Overall Study||11
3208529|NCT02179424|3938493|FG002|COMPLETED|Overall Study||516
3208530|NCT02179424|3938494|FG003|COMPLETED|Overall Study||39
3208531|NCT02179424|3938491|FG000|NOT COMPLETED|Overall Study||0
3208532|NCT02179424|3938492|FG001|NOT COMPLETED|Overall Study||0
3208533|NCT02179424|3938493|FG002|NOT COMPLETED|Overall Study||0
3208534|NCT02179424|3938494|FG003|NOT COMPLETED|Overall Study||0
3366086|NCT03913377|4097377|FG000|NOT COMPLETED|Period 1||0
3366087|NCT03913377|4097378|FG001|NOT COMPLETED|Period 1||1
3366088|NCT03913377|4097379|FG002|NOT COMPLETED|Period 1||1
3366089|NCT03913377|4097377|FG000|STARTED|Period 2||0
3366090|NCT03913377|4097378|FG001|STARTED|Period 2||21
3366091|NCT03913377|4097379|FG002|STARTED|Period 2||21
3366092|NCT03913377|4097377|FG000|COMPLETED|Period 2||0
3366093|NCT03913377|4097378|FG001|COMPLETED|Period 2||21
3366094|NCT03913377|4097379|FG002|COMPLETED|Period 2||21
3366095|NCT03913377|4097377|FG000|NOT COMPLETED|Period 2||0
3366096|NCT03913377|4097378|FG001|NOT COMPLETED|Period 2||0
3366097|NCT03913377|4097379|FG002|NOT COMPLETED|Period 2||0
3366098|NCT03937791|4097386|FG000|STARTED|Overall Study||1
3366099|NCT03937791|4097386|FG000|COMPLETED|Overall Study||1
3366100|NCT03937791|4097386|FG000|NOT COMPLETED|Overall Study||0
3366101|NCT03937778|4097390|FG000|STARTED|Overall Study||7
3366102|NCT03937778|4097390|FG000|COMPLETED|Overall Study||5
3366103|NCT03937778|4097390|FG000|NOT COMPLETED|Overall Study||2
3366104|NCT03937479|4097399|FG000|STARTED|Overall Study||83
3366105|NCT03937479|4097400|FG001|STARTED|Overall Study||85
3366106|NCT03937479|4097401|FG002|STARTED|Overall Study||82
3366107|NCT03937479|4097402|FG003|STARTED|Overall Study||82
3366108|NCT03937479|4097403|FG004|STARTED|Overall Study||84
3366109|NCT03937479|4097399|FG000|Received Treatment|Overall Study||83
3366110|NCT03937479|4097400|FG001|Received Treatment|Overall Study||83
3366111|NCT03937479|4097401|FG002|Received Treatment|Overall Study||81
3366112|NCT03937479|4097402|FG003|Received Treatment|Overall Study||82
3366113|NCT03937479|4097403|FG004|Received Treatment|Overall Study||84
3366114|NCT03937479|4097399|FG000|COMPLETED|Overall Study||73
3366115|NCT03937479|4097400|FG001|COMPLETED|Overall Study||70
3366116|NCT03937479|4097401|FG002|COMPLETED|Overall Study||75
3366117|NCT03937479|4097402|FG003|COMPLETED|Overall Study||76
3366118|NCT03937479|4097403|FG004|COMPLETED|Overall Study||79
3366119|NCT03937479|4097399|FG000|NOT COMPLETED|Overall Study||10
3366120|NCT03937479|4097400|FG001|NOT COMPLETED|Overall Study||15
3366121|NCT03937479|4097401|FG002|NOT COMPLETED|Overall Study||7
3366122|NCT03937479|4097402|FG003|NOT COMPLETED|Overall Study||6
3366123|NCT03937479|4097403|FG004|NOT COMPLETED|Overall Study||5
3366124|NCT03936387|4097415|FG000|STARTED|Overall Study||10
3366125|NCT03936387|4097415|FG000|COMPLETED|Overall Study||10
3366126|NCT03936387|4097415|FG000|NOT COMPLETED|Overall Study||0
3366127|NCT03935399|4097421|FG000|STARTED|First Study Day||5
3366128|NCT03935399|4097422|FG001|STARTED|First Study Day||5
3366129|NCT03935399|4097421|FG000|COMPLETED|First Study Day||5
3366130|NCT03935399|4097422|FG001|COMPLETED|First Study Day||5
3366131|NCT03935399|4097421|FG000|NOT COMPLETED|First Study Day||0
3366132|NCT03935399|4097422|FG001|NOT COMPLETED|First Study Day||0
3366133|NCT03935399|4097421|FG000|STARTED|Second Study Day||5
3366134|NCT03935399|4097422|FG001|STARTED|Second Study Day||5
3366135|NCT03935399|4097421|FG000|COMPLETED|Second Study Day||5
3366136|NCT03935399|4097422|FG001|COMPLETED|Second Study Day||5
3366137|NCT03935399|4097421|FG000|NOT COMPLETED|Second Study Day||0
3366138|NCT03935399|4097422|FG001|NOT COMPLETED|Second Study Day||0
3366139|NCT03936608|4097430|FG000|STARTED|Overall Study||2
3366140|NCT03936608|4097431|FG001|STARTED|Overall Study||2
3366141|NCT03936608|4097430|FG000|COMPLETED|Overall Study||0
3208535|NCT02179515|3938508|FG000|STARTED|Overall Study||3
3208536|NCT02179515|3938509|FG001|STARTED|Overall Study||17
3208537|NCT02179515|3938510|FG002|STARTED|Overall Study||18
3208538|NCT02179515|3938508|FG000|COMPLETED|Overall Study||1
3208539|NCT02179515|3938509|FG001|COMPLETED|Overall Study||1
3208540|NCT02179515|3938510|FG002|COMPLETED|Overall Study||4
3208541|NCT02179515|3938508|FG000|NOT COMPLETED|Overall Study||2
3208542|NCT02179515|3938509|FG001|NOT COMPLETED|Overall Study||16
3208543|NCT02179515|3938510|FG002|NOT COMPLETED|Overall Study||14
3208544|NCT02179671|3938527|FG000|STARTED|Overall Study||1
3208545|NCT02179671|3938528|FG001|STARTED|Overall Study||1
3208546|NCT02179671|3938529|FG002|STARTED|Overall Study||2
3208547|NCT02179671|3938530|FG003|STARTED|Overall Study||14
3208548|NCT02179671|3938531|FG004|STARTED|Overall Study||14
3208549|NCT02179671|3938527|FG000|COMPLETED|Overall Study||0
3208550|NCT02179671|3938528|FG001|COMPLETED|Overall Study||0
3208551|NCT02179671|3938529|FG002|COMPLETED|Overall Study||1
3208552|NCT02179671|3938530|FG003|COMPLETED|Overall Study||1
3208553|NCT02179671|3938531|FG004|COMPLETED|Overall Study||1
3208554|NCT02179671|3938527|FG000|NOT COMPLETED|Overall Study||1
3208555|NCT02179671|3938528|FG001|NOT COMPLETED|Overall Study||1
3208556|NCT02179671|3938529|FG002|NOT COMPLETED|Overall Study||1
3208557|NCT02179671|3938530|FG003|NOT COMPLETED|Overall Study||13
3208558|NCT02179671|3938531|FG004|NOT COMPLETED|Overall Study||13
3208559|NCT02179788|3938545|FG000|STARTED|Overall Study||10
3208560|NCT02179788|3938546|FG001|STARTED|Overall Study||5
3208561|NCT02179788|3938545|FG000|COMPLETED|Overall Study||10
3208562|NCT02179788|3938546|FG001|COMPLETED|Overall Study||5
3208563|NCT02179788|3938545|FG000|NOT COMPLETED|Overall Study||0
3208564|NCT02179788|3938546|FG001|NOT COMPLETED|Overall Study||0
3208565|NCT02179892|3938554|FG000|STARTED|Overall Study||5
3208566|NCT02179892|3938555|FG001|STARTED|Overall Study||4
3208567|NCT02179892|3938554|FG000|COMPLETED|Overall Study||5
3208568|NCT02179892|3938555|FG001|COMPLETED|Overall Study||4
3208569|NCT02179892|3938554|FG000|NOT COMPLETED|Overall Study||0
3208570|NCT02179892|3938555|FG001|NOT COMPLETED|Overall Study||0
3208571|NCT02179918|3938566|FG000|STARTED|Overall Study||5
3208572|NCT02179918|3938567|FG001|STARTED|Overall Study||3
3208573|NCT02179918|3938568|FG002|STARTED|Overall Study||3
3208574|NCT02179918|3938569|FG003|STARTED|Overall Study||3
3208575|NCT02179918|3938570|FG004|STARTED|Overall Study||9
3208576|NCT02179918|3938566|FG000|COMPLETED|Overall Study||1
3208577|NCT02179918|3938567|FG001|COMPLETED|Overall Study||0
3208578|NCT02179918|3938568|FG002|COMPLETED|Overall Study||1
3208579|NCT02179918|3938569|FG003|COMPLETED|Overall Study||0
3208580|NCT02179918|3938570|FG004|COMPLETED|Overall Study||1
3208581|NCT02179918|3938566|FG000|NOT COMPLETED|Overall Study||4
3208582|NCT02179918|3938567|FG001|NOT COMPLETED|Overall Study||3
3208583|NCT02179918|3938568|FG002|NOT COMPLETED|Overall Study||2
3208584|NCT02179918|3938569|FG003|NOT COMPLETED|Overall Study||3
3208585|NCT02179918|3938570|FG004|NOT COMPLETED|Overall Study||8
3208586|NCT02180061|3938585|FG000|STARTED|Overall Study||34
3208587|NCT02180061|3938586|FG001|STARTED|Overall Study||8
3208588|NCT02180061|3938585|FG000|COMPLETED|Overall Study||9
3208589|NCT02180061|3938586|FG001|COMPLETED|Overall Study||0
3208590|NCT02180061|3938585|FG000|NOT COMPLETED|Overall Study||25
3208591|NCT02180061|3938586|FG001|NOT COMPLETED|Overall Study||8
3208592|NCT02180100|3938594|FG000|STARTED|Overall Study||70
3208593|NCT02180100|3938595|FG001|STARTED|Overall Study||70
3208594|NCT02180100|3938594|FG000|COMPLETED|Overall Study||58
3208595|NCT02180100|3938595|FG001|COMPLETED|Overall Study||66
3208596|NCT02180100|3938594|FG000|NOT COMPLETED|Overall Study||12
3208597|NCT02180100|3938595|FG001|NOT COMPLETED|Overall Study||4
3208598|NCT02180165|3938605|FG000|STARTED|Overall Study||15
3208599|NCT02180165|3938606|FG001|STARTED|Overall Study||7
3208600|NCT02180165|3938607|FG002|STARTED|Overall Study||63
3208601|NCT02180165|3938608|FG003|STARTED|Overall Study||31
3208602|NCT02180165|3938605|FG000|Treated Participants|Overall Study||15
3208603|NCT02180165|3938606|FG001|Treated Participants|Overall Study||7
3208604|NCT02180165|3938607|FG002|Treated Participants|Overall Study||62
3208605|NCT02180165|3938608|FG003|Treated Participants|Overall Study||31
3208606|NCT02180165|3938605|FG000|Type of Aspergillosis|Overall Study|Chronic Pulmonary Aspergillosis|15
3208607|NCT02180165|3938606|FG001|Type of Aspergillosis|Overall Study|Chronic Pulmonary Aspergillosis|7
3208608|NCT02180165|3938607|FG002|Type of Aspergillosis|Overall Study|Invasive Aspergillosis and Chronic Pulmonary Aspergillosis|57
3208609|NCT02180165|3938608|FG003|Type of Aspergillosis|Overall Study|Invasive Aspergillosis and Chronic Pulmonary Aspergillosis|27
3208610|NCT02180165|3938605|FG000|COMPLETED|Overall Study||4
3208611|NCT02180165|3938606|FG001|COMPLETED|Overall Study||6
3208612|NCT02180165|3938607|FG002|COMPLETED|Overall Study||34
3208613|NCT02180165|3938608|FG003|COMPLETED|Overall Study||25
3208614|NCT02180165|3938605|FG000|NOT COMPLETED|Overall Study||11
3208615|NCT02180165|3938606|FG001|NOT COMPLETED|Overall Study||1
3208616|NCT02180165|3938607|FG002|NOT COMPLETED|Overall Study||29
3208617|NCT02180165|3938608|FG003|NOT COMPLETED|Overall Study||6
3208618|NCT02180230|3938620|FG000|STARTED|Overall Study||38
3208619|NCT02180230|3938620|FG000|COMPLETED|Overall Study||31
3208620|NCT02180230|3938620|FG000|NOT COMPLETED|Overall Study||7
3208621|NCT02180438|3938624|FG000|STARTED|Overall Study||30
3208622|NCT02180438|3938624|FG000|COMPLETED|Overall Study||29
3208623|NCT02180438|3938624|FG000|NOT COMPLETED|Overall Study||1
3208624|NCT02180646|3938630|FG000|STARTED|First Intervention (7 Days)||6
3208625|NCT02180646|3938631|FG001|STARTED|First Intervention (7 Days)||6
3208626|NCT02180646|3938630|FG000|COMPLETED|First Intervention (7 Days)||6
3208627|NCT02180646|3938631|FG001|COMPLETED|First Intervention (7 Days)||6
3208628|NCT02180646|3938630|FG000|NOT COMPLETED|First Intervention (7 Days)||0
3208629|NCT02180646|3938631|FG001|NOT COMPLETED|First Intervention (7 Days)||0
3208630|NCT02180646|3938630|FG000|STARTED|Washout (7 Days)||6
3208631|NCT02180646|3938631|FG001|STARTED|Washout (7 Days)||6
3208632|NCT02180646|3938630|FG000|COMPLETED|Washout (7 Days)||6
3208633|NCT02180646|3938631|FG001|COMPLETED|Washout (7 Days)||6
3208634|NCT02180646|3938630|FG000|NOT COMPLETED|Washout (7 Days)||0
3208635|NCT02180646|3938631|FG001|NOT COMPLETED|Washout (7 Days)||0
3208636|NCT02180646|3938630|FG000|STARTED|Second Intervention (7 Days)||6
3208637|NCT02180646|3938631|FG001|STARTED|Second Intervention (7 Days)||6
3208638|NCT02180646|3938630|FG000|COMPLETED|Second Intervention (7 Days)||6
3208639|NCT02180646|3938631|FG001|COMPLETED|Second Intervention (7 Days)||6
3208640|NCT02180646|3938630|FG000|NOT COMPLETED|Second Intervention (7 Days)||0
3208641|NCT02180646|3938631|FG001|NOT COMPLETED|Second Intervention (7 Days)||0
3208642|NCT02180659|3938641|FG000|STARTED|Overall Study||87
3208643|NCT02180659|3938642|FG001|STARTED|Overall Study|N=90 randomized, however N=89 received study medication|89
3208644|NCT02180659|3938641|FG000|COMPLETED|Overall Study||81
3208645|NCT02180659|3938642|FG001|COMPLETED|Overall Study||84
3208646|NCT02180659|3938641|FG000|NOT COMPLETED|Overall Study||6
3208647|NCT02180659|3938642|FG001|NOT COMPLETED|Overall Study||5
3208648|NCT02180672|3938650|FG000|STARTED|Overall Study||91
3208649|NCT02180672|3938651|FG001|STARTED|Overall Study||43
3208650|NCT02180672|3938650|FG000|COMPLETED|Overall Study||86
3208651|NCT02180672|3938651|FG001|COMPLETED|Overall Study||36
3208652|NCT02180672|3938650|FG000|NOT COMPLETED|Overall Study||5
3208653|NCT02180672|3938651|FG001|NOT COMPLETED|Overall Study||7
3208654|NCT02180828|3938659|FG000|STARTED|Overall Study||120
3208655|NCT02180828|3938660|FG001|STARTED|Overall Study||120
3208656|NCT02180828|3938659|FG000|COMPLETED|Overall Study||115
3208657|NCT02180828|3938660|FG001|COMPLETED|Overall Study||113
3208658|NCT02180828|3938659|FG000|NOT COMPLETED|Overall Study||5
3208659|NCT02180828|3938660|FG001|NOT COMPLETED|Overall Study||7
3208660|NCT02180867|3938673|FG000|STARTED|Overall Study||10
3208661|NCT02180867|3938674|FG001|STARTED|Overall Study||11
3208662|NCT02180867|3938675|FG002|STARTED|Overall Study||10
3208663|NCT02180867|3938676|FG003|STARTED|Overall Study||49
3208664|NCT02180867|3938677|FG004|STARTED|Overall Study||48
3208665|NCT02180867|3938678|FG005|STARTED|Overall Study||6
3208666|NCT02180867|3938679|FG006|STARTED|Overall Study||6
3208667|NCT02180867|3938673|FG000|Pediatric Patients|Overall Study||6
3208668|NCT02180867|3938674|FG001|Pediatric Patients|Overall Study||4
3208669|NCT02180867|3938675|FG002|Pediatric Patients|Overall Study||3
3208670|NCT02180867|3938676|FG003|Pediatric Patients|Overall Study||18
3208671|NCT02180867|3938677|FG004|Pediatric Patients|Overall Study||19
3208672|NCT02180867|3938678|FG005|Pediatric Patients|Overall Study||1
3208673|NCT02180867|3938679|FG006|Pediatric Patients|Overall Study||0
3208674|NCT02180867|3938673|FG000|Adult Patients|Overall Study||4
3208675|NCT02180867|3938674|FG001|Adult Patients|Overall Study||7
3208676|NCT02180867|3938675|FG002|Adult Patients|Overall Study||7
3208677|NCT02180867|3938676|FG003|Adult Patients|Overall Study||31
3208678|NCT02180867|3938677|FG004|Adult Patients|Overall Study||29
3208679|NCT02180867|3938678|FG005|Adult Patients|Overall Study||5
3208680|NCT02180867|3938679|FG006|Adult Patients|Overall Study||6
3208681|NCT02180867|3938673|FG000|COMPLETED|Overall Study||4
3208682|NCT02180867|3938674|FG001|COMPLETED|Overall Study||0
3208683|NCT02180867|3938675|FG002|COMPLETED|Overall Study||6
3208684|NCT02180867|3938676|FG003|COMPLETED|Overall Study||23
3208685|NCT02180867|3938677|FG004|COMPLETED|Overall Study||21
3208686|NCT02180867|3938678|FG005|COMPLETED|Overall Study||3
3208687|NCT02180867|3938679|FG006|COMPLETED|Overall Study||1
3208688|NCT02180867|3938673|FG000|NOT COMPLETED|Overall Study||6
3208689|NCT02180867|3938674|FG001|NOT COMPLETED|Overall Study||11
3208690|NCT02180867|3938675|FG002|NOT COMPLETED|Overall Study||4
3208691|NCT02180867|3938676|FG003|NOT COMPLETED|Overall Study||26
3208692|NCT02180867|3938677|FG004|NOT COMPLETED|Overall Study||27
3208693|NCT02180867|3938678|FG005|NOT COMPLETED|Overall Study||3
3208694|NCT02180867|3938679|FG006|NOT COMPLETED|Overall Study||5
3208695|NCT02180893|3938709|FG000|STARTED|Overall Study||30
3208696|NCT02180893|3938710|FG001|STARTED|Overall Study||30
3208697|NCT02180893|3938709|FG000|COMPLETED|Overall Study||27
3208698|NCT02180893|3938710|FG001|COMPLETED|Overall Study||23
3208699|NCT02180893|3938709|FG000|NOT COMPLETED|Overall Study||3
3208700|NCT02180893|3938710|FG001|NOT COMPLETED|Overall Study||7
3208701|NCT02181075|3938718|FG000|STARTED|Overall Study||6
3208702|NCT02181075|3938719|FG001|STARTED|Overall Study||4
3208703|NCT02181075|3938718|FG000|COMPLETED|Overall Study||6
3208704|NCT02181075|3938719|FG001|COMPLETED|Overall Study||4
3208705|NCT02181075|3938718|FG000|NOT COMPLETED|Overall Study||0
3208706|NCT02181075|3938719|FG001|NOT COMPLETED|Overall Study||0
3208707|NCT02181127|3938729|FG000|STARTED|Overall Study||22
3208708|NCT02181127|3938729|FG000|COMPLETED|Overall Study||22
3208709|NCT02181127|3938729|FG000|NOT COMPLETED|Overall Study||0
3208710|NCT02181140|3938736|FG000|STARTED|Overall Study||56
3208711|NCT02181140|3938736|FG000|COMPLETED|Overall Study||56
3208712|NCT02181140|3938736|FG000|NOT COMPLETED|Overall Study||0
3208713|NCT02181231|3938744|FG000|STARTED|Overall Study||12
3208714|NCT02181231|3938745|FG001|STARTED|Overall Study||6
3208715|NCT02181231|3938744|FG000|COMPLETED|Overall Study||10
3208716|NCT02181231|3938745|FG001|COMPLETED|Overall Study||6
3208717|NCT02181231|3938744|FG000|NOT COMPLETED|Overall Study||2
3208718|NCT02181231|3938745|FG001|NOT COMPLETED|Overall Study||0
3208719|NCT02181296|3938753|FG000|STARTED|Overall Study||25
3208720|NCT02181296|3938754|FG001|STARTED|Overall Study||25
3208721|NCT02181296|3938753|FG000|COMPLETED|Overall Study||18
3208722|NCT02181296|3938754|FG001|COMPLETED|Overall Study||19
3208723|NCT02181296|3938753|FG000|NOT COMPLETED|Overall Study||7
3208724|NCT02181296|3938754|FG001|NOT COMPLETED|Overall Study||6
3208725|NCT02181387|3938762|FG000|STARTED|Overall Study||14
3208726|NCT02181387|3938763|FG001|STARTED|Overall Study||19
3208727|NCT02181387|3938762|FG000|COMPLETED|Overall Study||12
3208728|NCT02181387|3938763|FG001|COMPLETED|Overall Study||15
3208729|NCT02181387|3938762|FG000|NOT COMPLETED|Overall Study||2
3208730|NCT02181387|3938763|FG001|NOT COMPLETED|Overall Study||4
3208731|NCT02181400|3938772|FG000|STARTED|Overall Study||7
3208732|NCT02181400|3938773|FG001|STARTED|Overall Study||7
3208733|NCT02181400|3938774|FG002|STARTED|Overall Study||7
3208734|NCT02181400|3938772|FG000|COMPLETED|Overall Study||7
3208735|NCT02181400|3938773|FG001|COMPLETED|Overall Study||7
3208736|NCT02181400|3938774|FG002|COMPLETED|Overall Study||7
3208737|NCT02181400|3938772|FG000|NOT COMPLETED|Overall Study||0
3208738|NCT02181400|3938773|FG001|NOT COMPLETED|Overall Study||0
3208739|NCT02181400|3938774|FG002|NOT COMPLETED|Overall Study||0
3208740|NCT02181413|3938784|FG000|STARTED|Overall Study||261
3208741|NCT02181413|3938785|FG001|STARTED|Overall Study||395
3208742|NCT02181413|3938784|FG000|Intent-to-Treat (ITT) Population|Overall Study||261
3208743|NCT02181413|3938785|FG001|Intent-to-Treat (ITT) Population|Overall Study||395
3208744|NCT02181413|3938784|FG000|Safety Population|Overall Study||259
3208745|NCT02181413|3938785|FG001|Safety Population|Overall Study||394
3208746|NCT02181413|3938784|FG000|Per Protocol (PP) Population|Overall Study||256
3208747|NCT02181413|3938785|FG001|Per Protocol (PP) Population|Overall Study||387
3208748|NCT02181413|3938784|FG000|COMPLETED|Overall Study||109
3208749|NCT02181413|3938785|FG001|COMPLETED|Overall Study||198
3208750|NCT02181413|3938784|FG000|NOT COMPLETED|Overall Study||152
3208751|NCT02181413|3938785|FG001|NOT COMPLETED|Overall Study||197
3208752|NCT02181426|3938795|FG000|STARTED|Overall Study||28
3208753|NCT02181426|3938796|FG001|STARTED|Overall Study||28
3208754|NCT02181426|3938797|FG002|STARTED|Overall Study||28
3208755|NCT02181426|3938798|FG003|STARTED|Overall Study||28
3208756|NCT02181426|3938795|FG000|COMPLETED|Overall Study||28
3208757|NCT02181426|3938796|FG001|COMPLETED|Overall Study||28
3208758|NCT02181426|3938797|FG002|COMPLETED|Overall Study||28
3208759|NCT02181426|3938798|FG003|COMPLETED|Overall Study||28
3208760|NCT02181426|3938795|FG000|NOT COMPLETED|Overall Study||0
3208761|NCT02181426|3938796|FG001|NOT COMPLETED|Overall Study||0
3208762|NCT02181426|3938797|FG002|NOT COMPLETED|Overall Study||0
3208763|NCT02181426|3938798|FG003|NOT COMPLETED|Overall Study||0
3208764|NCT02181504|3938811|FG000|STARTED|Overall Study||10
3208765|NCT02181504|3938812|FG001|STARTED|Overall Study||10
3208766|NCT02181504|3938813|FG002|STARTED|Overall Study||5
3208767|NCT02181504|3938811|FG000|COMPLETED|Overall Study||9
3208768|NCT02181504|3938812|FG001|COMPLETED|Overall Study||9
3208769|NCT02181504|3938813|FG002|COMPLETED|Overall Study||4
3208770|NCT02181504|3938811|FG000|NOT COMPLETED|Overall Study||1
3208771|NCT02181504|3938812|FG001|NOT COMPLETED|Overall Study||1
3208772|NCT02181504|3938813|FG002|NOT COMPLETED|Overall Study||1
3208773|NCT02181517|3938825|FG000|STARTED|Overall Study||10
3208774|NCT02181517|3938826|FG001|STARTED|Overall Study||10
3208775|NCT02181517|3938827|FG002|STARTED|Overall Study||5
3208776|NCT02181517|3938825|FG000|COMPLETED|Overall Study||10
3208777|NCT02181517|3938826|FG001|COMPLETED|Overall Study||10
3208778|NCT02181517|3938827|FG002|COMPLETED|Overall Study||5
3208779|NCT02181517|3938825|FG000|NOT COMPLETED|Overall Study||0
3208780|NCT02181517|3938826|FG001|NOT COMPLETED|Overall Study||0
3208781|NCT02181517|3938827|FG002|NOT COMPLETED|Overall Study||0
3208782|NCT02181530|3938835|FG000|STARTED|Overall Study||43
3208783|NCT02181530|3938835|FG000|COMPLETED|Overall Study||43
3208784|NCT02181530|3938835|FG000|NOT COMPLETED|Overall Study||0
3208785|NCT02181556|3938839|FG000|STARTED|Overall Study||41
3366142|NCT03936608|4097431|FG001|COMPLETED|Overall Study||0
3208786|NCT02181556|3938839|FG000|COMPLETED|Overall Study||40
3208787|NCT02181556|3938839|FG000|NOT COMPLETED|Overall Study||1
3208788|NCT02181634|3938843|FG000|STARTED|Overall Study||74
3208789|NCT02181634|3938843|FG000|Eligible and Treated|Overall Study||73
3208790|NCT02181634|3938843|FG000|COMPLETED|Overall Study||2
3208791|NCT02181634|3938843|FG000|NOT COMPLETED|Overall Study||72
3208792|NCT02181673|3938849|FG000|STARTED|Up to Week 24||239
3208793|NCT02181673|3938850|FG001|STARTED|Up to Week 24||0
3208794|NCT02181673|3938851|FG002|STARTED|Up to Week 24||241
3208795|NCT02181673|3938849|FG000|Treated|Up to Week 24||239
3208796|NCT02181673|3938850|FG001|Treated|Up to Week 24||0
3208797|NCT02181673|3938851|FG002|Treated|Up to Week 24||240
3208798|NCT02181673|3938849|FG000|COMPLETED|Up to Week 24||222
3208799|NCT02181673|3938850|FG001|COMPLETED|Up to Week 24||0
3208800|NCT02181673|3938851|FG002|COMPLETED|Up to Week 24||230
3208801|NCT02181673|3938849|FG000|NOT COMPLETED|Up to Week 24||17
3208802|NCT02181673|3938850|FG001|NOT COMPLETED|Up to Week 24||0
3208803|NCT02181673|3938851|FG002|NOT COMPLETED|Up to Week 24||11
3208804|NCT02181673|3938849|FG000|STARTED|Week 24-Week 60||0
3208805|NCT02181673|3938850|FG001|STARTED|Week 24-Week 60||222
3208806|NCT02181673|3938851|FG002|STARTED|Week 24-Week 60||230
3208807|NCT02181673|3938849|FG000|Treated|Week 24-Week 60||0
3208808|NCT02181673|3938850|FG001|Treated|Week 24-Week 60||220
3208809|NCT02181673|3938851|FG002|Treated|Week 24-Week 60||230
3208810|NCT02181673|3938849|FG000|COMPLETED|Week 24-Week 60||0
3208811|NCT02181673|3938850|FG001|COMPLETED|Week 24-Week 60||214
3208812|NCT02181673|3938851|FG002|COMPLETED|Week 24-Week 60||213
3208813|NCT02181673|3938849|FG000|NOT COMPLETED|Week 24-Week 60||0
3208814|NCT02181673|3938850|FG001|NOT COMPLETED|Week 24-Week 60||8
3208815|NCT02181673|3938851|FG002|NOT COMPLETED|Week 24-Week 60||17
3208816|NCT02181738|3938862|FG000|STARTED|Overall Study||63
3208817|NCT02181738|3938863|FG001|STARTED|Overall Study||80
3208818|NCT02181738|3938864|FG002|STARTED|Overall Study||100
3208819|NCT02181738|3938865|FG003|STARTED|Overall Study||51
3208820|NCT02181738|3938862|FG000|COMPLETED|Overall Study||61
3208821|NCT02181738|3938863|FG001|COMPLETED|Overall Study||71
3208822|NCT02181738|3938864|FG002|COMPLETED|Overall Study||90
3208823|NCT02181738|3938865|FG003|COMPLETED|Overall Study||49
3208824|NCT02181738|3938862|FG000|NOT COMPLETED|Overall Study||2
3208825|NCT02181738|3938863|FG001|NOT COMPLETED|Overall Study||9
3208826|NCT02181738|3938864|FG002|NOT COMPLETED|Overall Study||10
3208827|NCT02181738|3938865|FG003|NOT COMPLETED|Overall Study||2
3208828|NCT02181803|3938884|FG000|STARTED|Overall Study||1
3208829|NCT02181803|3938885|FG001|STARTED|Overall Study||13
3208830|NCT02181803|3938886|FG002|STARTED|Overall Study||4
3208831|NCT02181803|3938887|FG003|STARTED|Overall Study||13
3208832|NCT02181803|3938888|FG004|STARTED|Overall Study||6
3208833|NCT02181803|3938889|FG005|STARTED|Overall Study||6
3208834|NCT02181803|3938890|FG006|STARTED|Overall Study||9
3208835|NCT02181803|3938891|FG007|STARTED|Overall Study||1
3208836|NCT02181803|3938892|FG008|STARTED|Overall Study||2
3208837|NCT02181803|3938884|FG000|COMPLETED|Overall Study||1
3208838|NCT02181803|3938885|FG001|COMPLETED|Overall Study||9
3208839|NCT02181803|3938886|FG002|COMPLETED|Overall Study||4
3208840|NCT02181803|3938887|FG003|COMPLETED|Overall Study||11
3208841|NCT02181803|3938888|FG004|COMPLETED|Overall Study||6
3208842|NCT02181803|3938889|FG005|COMPLETED|Overall Study||6
3208843|NCT02181803|3938890|FG006|COMPLETED|Overall Study||8
3208844|NCT02181803|3938891|FG007|COMPLETED|Overall Study||0
3208845|NCT02181803|3938892|FG008|COMPLETED|Overall Study||2
3208846|NCT02181803|3938884|FG000|NOT COMPLETED|Overall Study||0
3208847|NCT02181803|3938885|FG001|NOT COMPLETED|Overall Study||4
3208848|NCT02181803|3938886|FG002|NOT COMPLETED|Overall Study||0
3208849|NCT02181803|3938887|FG003|NOT COMPLETED|Overall Study||2
3208850|NCT02181803|3938888|FG004|NOT COMPLETED|Overall Study||0
3208851|NCT02181803|3938889|FG005|NOT COMPLETED|Overall Study||0
3208852|NCT02181803|3938890|FG006|NOT COMPLETED|Overall Study||1
3208853|NCT02181803|3938891|FG007|NOT COMPLETED|Overall Study||1
3208854|NCT02181803|3938892|FG008|NOT COMPLETED|Overall Study||0
3208855|NCT02181816|3938937|FG000|STARTED|Overall Study||1090
3208856|NCT02181816|3938937|FG000|COMPLETED|Overall Study||1031
3208857|NCT02181816|3938937|FG000|NOT COMPLETED|Overall Study||59
3208858|NCT02181829|3938941|FG000|STARTED|Overall Study||10
3208859|NCT02181829|3938941|FG000|COMPLETED|Overall Study||10
3208860|NCT02181829|3938941|FG000|NOT COMPLETED|Overall Study||0
3208861|NCT02181842|3938945|FG000|STARTED|Overall Study||246
3208862|NCT02181842|3938945|FG000|COMPLETED|Overall Study||244
3208863|NCT02181842|3938945|FG000|NOT COMPLETED|Overall Study||2
3208864|NCT02182115|3938951|FG000|STARTED|Overall Study||53
3208865|NCT02182115|3938952|FG001|STARTED|Overall Study||57
3208866|NCT02182115|3938951|FG000|COMPLETED|Overall Study||53
3208867|NCT02182115|3938952|FG001|COMPLETED|Overall Study||57
3208868|NCT02182115|3938951|FG000|NOT COMPLETED|Overall Study||0
3208869|NCT02182115|3938952|FG001|NOT COMPLETED|Overall Study||0
3208870|NCT02182440|3938962|FG000|STARTED|Overall Study||116
3208871|NCT02182440|3938963|FG001|STARTED|Overall Study||39
3208872|NCT02182440|3938964|FG002|STARTED|Overall Study||35
3208873|NCT02182440|3938965|FG003|STARTED|Overall Study||111
3208874|NCT02182440|3938962|FG000|ITTcombined|Overall Study||116
3208875|NCT02182440|3938963|FG001|ITTcombined|Overall Study||31
3208876|NCT02182440|3938964|FG002|ITTcombined|Overall Study||32
3208877|NCT02182440|3938965|FG003|ITTcombined|Overall Study||111
3208878|NCT02182440|3938962|FG000|ITTinterim|Overall Study||30
3208879|NCT02182440|3938963|FG001|ITTinterim|Overall Study||31
3208880|NCT02182440|3938964|FG002|ITTinterim|Overall Study||32
3208881|NCT02182440|3938965|FG003|ITTinterim|Overall Study||29
3208882|NCT02182440|3938962|FG000|Safety Population|Overall Study||112
3208883|NCT02182440|3938963|FG001|Safety Population|Overall Study||38
3208884|NCT02182440|3938964|FG002|Safety Population|Overall Study||35
3208885|NCT02182440|3938965|FG003|Safety Population|Overall Study||109
3208886|NCT02182440|3938962|FG000|COMPLETED|Overall Study||71
3208887|NCT02182440|3938963|FG001|COMPLETED|Overall Study||25
3208888|NCT02182440|3938964|FG002|COMPLETED|Overall Study||24
3208889|NCT02182440|3938965|FG003|COMPLETED|Overall Study||81
3208890|NCT02182440|3938962|FG000|NOT COMPLETED|Overall Study||45
3208891|NCT02182440|3938963|FG001|NOT COMPLETED|Overall Study||14
3208892|NCT02182440|3938964|FG002|NOT COMPLETED|Overall Study||11
3208893|NCT02182440|3938965|FG003|NOT COMPLETED|Overall Study||30
3208894|NCT02182492|3938979|FG000|STARTED|Overall Study|CRSsNP: 28; Non-Eos CRSwNP: 34; Eos CRSwNP: 31|93
3208895|NCT02182492|3938980|FG001|STARTED|Overall Study|CRSsNP: 30; Non-Eos CRSwNP: 32; Eos CRSwNP: 32|94
3208896|NCT02182492|3938979|FG000|COMPLETED|Overall Study|CRSsNP: 27; Non-Eos CRSwNP: 31; Eos CRSwNP: 28|86
3208897|NCT02182492|3938980|FG001|COMPLETED|Overall Study|CRSsNP: 29; Non-Eos CRSwNP: 28; Eos CRSwNP: 29|86
3208898|NCT02182492|3938979|FG000|NOT COMPLETED|Overall Study||7
3208899|NCT02182492|3938980|FG001|NOT COMPLETED|Overall Study||8
3208900|NCT02182804|3938986|FG000|STARTED|Overall Study||44
3208901|NCT02182804|3938986|FG000|COMPLETED|Overall Study||44
3208902|NCT02182804|3938986|FG000|NOT COMPLETED|Overall Study||0
3208903|NCT02182830|3938992|FG000|STARTED|Overall Study||83
3208904|NCT02182830|3938993|FG001|STARTED|Overall Study||83
3208905|NCT02182830|3938992|FG000|Randomised Set (RS)|Overall Study|From started, 2 duplicate patients and 2 patients from one site were removed|79
3208906|NCT02182830|3938993|FG001|Randomised Set (RS)|Overall Study|From started, 1 patient from one site was removed|82
3208907|NCT02182830|3938992|FG000|Treated Set (TS)|Overall Study|From RS, 1 duplicate patient and 1 non treated patient was removed|77
3208908|NCT02182830|3938993|FG001|Treated Set (TS)|Overall Study|From RS, 1 duplicate patient and 1 non treated patient was removed|80
3208909|NCT02182830|3938992|FG000|COMPLETED|Overall Study||68
3208910|NCT02182830|3938993|FG001|COMPLETED|Overall Study||68
3208911|NCT02182830|3938992|FG000|NOT COMPLETED|Overall Study||15
3208912|NCT02182830|3938993|FG001|NOT COMPLETED|Overall Study||15
3208913|NCT02182843|3938999|FG000|STARTED|Overall Study||81
3208914|NCT02182843|3938999|FG000|COMPLETED|Overall Study||71
3208915|NCT02182843|3938999|FG000|NOT COMPLETED|Overall Study||10
3208916|NCT02182895|3939005|FG000|STARTED|Overall Study||35
3208917|NCT02182895|3939006|FG001|STARTED|Overall Study||37
3208918|NCT02182895|3939005|FG000|COMPLETED|Overall Study||33
3208919|NCT02182895|3939006|FG001|COMPLETED|Overall Study||33
3208920|NCT02182895|3939005|FG000|NOT COMPLETED|Overall Study||2
3208921|NCT02182895|3939006|FG001|NOT COMPLETED|Overall Study||4
3366143|NCT03936608|4097430|FG000|NOT COMPLETED|Overall Study||2
3366144|NCT03936608|4097431|FG001|NOT COMPLETED|Overall Study||2
3366145|NCT03936244|4097439|FG000|STARTED|Overall Study||57
3366146|NCT03936244|4097440|FG001|STARTED|Overall Study||43
3366147|NCT03936244|4097439|FG000|COMPLETED|Overall Study||45
3366148|NCT03936244|4097440|FG001|COMPLETED|Overall Study||39
3366149|NCT03936244|4097439|FG000|NOT COMPLETED|Overall Study||12
3366150|NCT03936244|4097440|FG001|NOT COMPLETED|Overall Study||4
3366151|NCT03935126|4097447|FG000|STARTED|Overall Study||3
3366152|NCT03935126|4097447|FG000|COMPLETED|Overall Study||0
3366153|NCT03935126|4097447|FG000|NOT COMPLETED|Overall Study||3
3366154|NCT03928327|4097453|FG000|STARTED|Period 1||12
3366155|NCT03928327|4097454|FG001|STARTED|Period 1||12
3366156|NCT03928327|4097453|FG000|COMPLETED|Period 1||12
3366157|NCT03928327|4097454|FG001|COMPLETED|Period 1||12
3366158|NCT03928327|4097453|FG000|NOT COMPLETED|Period 1||0
3366159|NCT03928327|4097454|FG001|NOT COMPLETED|Period 1||0
3366160|NCT03928327|4097453|FG000|STARTED|Washout Period||12
3366161|NCT03928327|4097454|FG001|STARTED|Washout Period||12
3366162|NCT03928327|4097453|FG000|COMPLETED|Washout Period||12
3366163|NCT03928327|4097454|FG001|COMPLETED|Washout Period||12
3366164|NCT03928327|4097453|FG000|NOT COMPLETED|Washout Period||0
3366165|NCT03928327|4097454|FG001|NOT COMPLETED|Washout Period||0
3366166|NCT03928327|4097453|FG000|STARTED|Period 2||12
3366167|NCT03928327|4097454|FG001|STARTED|Period 2||12
3366168|NCT03928327|4097453|FG000|COMPLETED|Period 2||12
3366169|NCT03928327|4097454|FG001|COMPLETED|Period 2||12
3366170|NCT03928327|4097453|FG000|NOT COMPLETED|Period 2||0
3366171|NCT03928327|4097454|FG001|NOT COMPLETED|Period 2||0
3366172|NCT03933462|4097466|FG000|STARTED|Overall Study||10
3366173|NCT03933462|4097467|FG001|STARTED|Overall Study||10
3366174|NCT03933462|4097466|FG000|Crossover|Overall Study||8
3366175|NCT03933462|4097467|FG001|Crossover|Overall Study||10
3366176|NCT03933462|4097466|FG000|COMPLETED|Overall Study||8
3366177|NCT03933462|4097467|FG001|COMPLETED|Overall Study||10
3366178|NCT03933462|4097466|FG000|NOT COMPLETED|Overall Study||2
3366179|NCT03933462|4097467|FG001|NOT COMPLETED|Overall Study||0
3366180|NCT03933774|4097475|FG000|STARTED|Overall Study||12
3366181|NCT03933774|4097476|FG001|STARTED|Overall Study||13
3366182|NCT03933774|4097475|FG000|COMPLETED|Overall Study||10
3366183|NCT03933774|4097476|FG001|COMPLETED|Overall Study||11
3366184|NCT03933774|4097475|FG000|NOT COMPLETED|Overall Study||2
3366185|NCT03933774|4097476|FG001|NOT COMPLETED|Overall Study||2
3366186|NCT03931330|4097482|FG000|STARTED|Overall Study||8
3366187|NCT03931330|4097482|FG000|4 Weeks of Neuromodulation|Overall Study|at 4 weeks of neuromodulation|7
3366188|NCT03931330|4097482|FG000|COMPLETED|Overall Study||7
3366189|NCT03931330|4097482|FG000|NOT COMPLETED|Overall Study||1
3366190|NCT03918811|4097489|FG000|STARTED|Overall Study||367
3366191|NCT03918811|4097490|FG001|STARTED|Overall Study||358
3366192|NCT03918811|4097489|FG000|COMPLETED|Overall Study||363
3366193|NCT03918811|4097490|FG001|COMPLETED|Overall Study||345
3366194|NCT03918811|4097489|FG000|NOT COMPLETED|Overall Study||4
3366195|NCT03918811|4097490|FG001|NOT COMPLETED|Overall Study||13
3366196|NCT03912259|4097498|FG000|STARTED|Overall Study||83
3366197|NCT03912259|4097499|FG001|STARTED|Overall Study||82
3366198|NCT03912259|4097498|FG000|COMPLETED|Overall Study||66
3366199|NCT03912259|4097499|FG001|COMPLETED|Overall Study||76
3366200|NCT03912259|4097498|FG000|NOT COMPLETED|Overall Study||17
3366201|NCT03912259|4097499|FG001|NOT COMPLETED|Overall Study||6
3366202|NCT03933618|4097512|FG000|STARTED|Baseline||4
3366203|NCT03933618|4097513|FG001|STARTED|Baseline||4
3366204|NCT03933618|4097514|FG002|STARTED|Baseline||4
3366205|NCT03933618|4097515|FG003|STARTED|Baseline||4
3366206|NCT03933618|4097516|FG004|STARTED|Baseline||4
3366207|NCT03933618|4097517|FG005|STARTED|Baseline||4
3366208|NCT03933618|4097512|FG000|COMPLETED|Baseline||4
3208922|NCT02182947|3939012|FG000|STARTED|Overall Study||45
3208923|NCT02182947|3939012|FG000|COMPLETED|Overall Study||27
3208924|NCT02182947|3939012|FG000|NOT COMPLETED|Overall Study||18
3208925|NCT02182973|3939018|FG000|STARTED|Overall Study||12
3208926|NCT02182973|3939019|FG001|STARTED|Overall Study||9
3208927|NCT02182973|3939018|FG000|COMPLETED|Overall Study||9
3208928|NCT02182973|3939019|FG001|COMPLETED|Overall Study||9
3208929|NCT02182973|3939018|FG000|NOT COMPLETED|Overall Study||3
3208930|NCT02182973|3939019|FG001|NOT COMPLETED|Overall Study||0
3208931|NCT02182999|3939028|FG000|STARTED|Overall Study||25
3208932|NCT02182999|3939029|FG001|STARTED|Overall Study||25
3208933|NCT02182999|3939028|FG000|COMPLETED|Overall Study||20
3208934|NCT02182999|3939029|FG001|COMPLETED|Overall Study||22
3208935|NCT02182999|3939028|FG000|NOT COMPLETED|Overall Study||5
3208936|NCT02182999|3939029|FG001|NOT COMPLETED|Overall Study||3
3208937|NCT02183519|3939037|FG000|STARTED|Overall Study||28
3208938|NCT02183519|3939038|FG001|STARTED|Overall Study||16
3208939|NCT02183519|3939037|FG000|COMPLETED|Overall Study||25
3208940|NCT02183519|3939038|FG001|COMPLETED|Overall Study||13
3208941|NCT02183519|3939037|FG000|NOT COMPLETED|Overall Study||3
3208942|NCT02183519|3939038|FG001|NOT COMPLETED|Overall Study||3
3208943|NCT02183675|3939050|FG000|STARTED|Treatment Period 1 (10 Days)||6
3208944|NCT02183675|3939051|FG001|STARTED|Treatment Period 1 (10 Days)||6
3208945|NCT02183675|3939052|FG002|STARTED|Treatment Period 1 (10 Days)||6
3208946|NCT02183675|3939053|FG003|STARTED|Treatment Period 1 (10 Days)||6
3208947|NCT02183675|3939054|FG004|STARTED|Treatment Period 1 (10 Days)||6
3208948|NCT02183675|3939055|FG005|STARTED|Treatment Period 1 (10 Days)||6
3208949|NCT02183675|3939050|FG000|COMPLETED|Treatment Period 1 (10 Days)||6
3208950|NCT02183675|3939051|FG001|COMPLETED|Treatment Period 1 (10 Days)||6
3208951|NCT02183675|3939052|FG002|COMPLETED|Treatment Period 1 (10 Days)||6
3208952|NCT02183675|3939053|FG003|COMPLETED|Treatment Period 1 (10 Days)||6
3208953|NCT02183675|3939054|FG004|COMPLETED|Treatment Period 1 (10 Days)||6
3208954|NCT02183675|3939055|FG005|COMPLETED|Treatment Period 1 (10 Days)||6
3208955|NCT02183675|3939050|FG000|NOT COMPLETED|Treatment Period 1 (10 Days)||0
3208956|NCT02183675|3939051|FG001|NOT COMPLETED|Treatment Period 1 (10 Days)||0
3208957|NCT02183675|3939052|FG002|NOT COMPLETED|Treatment Period 1 (10 Days)||0
3208958|NCT02183675|3939053|FG003|NOT COMPLETED|Treatment Period 1 (10 Days)||0
3208959|NCT02183675|3939054|FG004|NOT COMPLETED|Treatment Period 1 (10 Days)||0
3208960|NCT02183675|3939055|FG005|NOT COMPLETED|Treatment Period 1 (10 Days)||0
3208961|NCT02183675|3939050|FG000|STARTED|Treatment Period 2 (10 Days)||6
3208962|NCT02183675|3939051|FG001|STARTED|Treatment Period 2 (10 Days)||6
3208963|NCT02183675|3939052|FG002|STARTED|Treatment Period 2 (10 Days)||6
3208964|NCT02183675|3939053|FG003|STARTED|Treatment Period 2 (10 Days)||6
3208965|NCT02183675|3939054|FG004|STARTED|Treatment Period 2 (10 Days)||6
3208966|NCT02183675|3939055|FG005|STARTED|Treatment Period 2 (10 Days)||6
3208967|NCT02183675|3939050|FG000|COMPLETED|Treatment Period 2 (10 Days)||6
3208968|NCT02183675|3939051|FG001|COMPLETED|Treatment Period 2 (10 Days)||6
3208969|NCT02183675|3939052|FG002|COMPLETED|Treatment Period 2 (10 Days)||6
3208970|NCT02183675|3939053|FG003|COMPLETED|Treatment Period 2 (10 Days)||6
3208971|NCT02183675|3939054|FG004|COMPLETED|Treatment Period 2 (10 Days)||6
3208972|NCT02183675|3939055|FG005|COMPLETED|Treatment Period 2 (10 Days)|Patients withdrew after completion of treatment period 2 but before beginning of treatment period 3|4
3208973|NCT02183675|3939050|FG000|NOT COMPLETED|Treatment Period 2 (10 Days)||0
3208974|NCT02183675|3939051|FG001|NOT COMPLETED|Treatment Period 2 (10 Days)||0
3208975|NCT02183675|3939052|FG002|NOT COMPLETED|Treatment Period 2 (10 Days)||0
3208976|NCT02183675|3939053|FG003|NOT COMPLETED|Treatment Period 2 (10 Days)||0
3208977|NCT02183675|3939054|FG004|NOT COMPLETED|Treatment Period 2 (10 Days)||0
3208978|NCT02183675|3939055|FG005|NOT COMPLETED|Treatment Period 2 (10 Days)||2
3208979|NCT02183675|3939050|FG000|STARTED|Treatment Period 3 (10 Days)||6
3208980|NCT02183675|3939051|FG001|STARTED|Treatment Period 3 (10 Days)||6
3208981|NCT02183675|3939052|FG002|STARTED|Treatment Period 3 (10 Days)||6
3208982|NCT02183675|3939053|FG003|STARTED|Treatment Period 3 (10 Days)||6
3208983|NCT02183675|3939054|FG004|STARTED|Treatment Period 3 (10 Days)||6
3208984|NCT02183675|3939055|FG005|STARTED|Treatment Period 3 (10 Days)||4
3208985|NCT02183675|3939050|FG000|COMPLETED|Treatment Period 3 (10 Days)||6
3208986|NCT02183675|3939051|FG001|COMPLETED|Treatment Period 3 (10 Days)||6
3208987|NCT02183675|3939052|FG002|COMPLETED|Treatment Period 3 (10 Days)||6
3208988|NCT02183675|3939053|FG003|COMPLETED|Treatment Period 3 (10 Days)||6
3208989|NCT02183675|3939054|FG004|COMPLETED|Treatment Period 3 (10 Days)||6
3208990|NCT02183675|3939055|FG005|COMPLETED|Treatment Period 3 (10 Days)||4
3208991|NCT02183675|3939050|FG000|NOT COMPLETED|Treatment Period 3 (10 Days)||0
3208992|NCT02183675|3939051|FG001|NOT COMPLETED|Treatment Period 3 (10 Days)||0
3208993|NCT02183675|3939052|FG002|NOT COMPLETED|Treatment Period 3 (10 Days)||0
3208994|NCT02183675|3939053|FG003|NOT COMPLETED|Treatment Period 3 (10 Days)||0
3208995|NCT02183675|3939054|FG004|NOT COMPLETED|Treatment Period 3 (10 Days)||0
3208996|NCT02183675|3939055|FG005|NOT COMPLETED|Treatment Period 3 (10 Days)||0
3208997|NCT02183792|3939067|FG000|STARTED|Overall Study||18
3208998|NCT02183792|3939068|FG001|STARTED|Overall Study||15
3208999|NCT02183792|3939067|FG000|COMPLETED|Overall Study||18
3209000|NCT02183792|3939068|FG001|COMPLETED|Overall Study||15
3209001|NCT02183792|3939067|FG000|NOT COMPLETED|Overall Study||0
3209002|NCT02183792|3939068|FG001|NOT COMPLETED|Overall Study||0
3366209|NCT03933618|4097513|FG001|COMPLETED|Baseline||4
3209003|NCT02184143|3939076|FG000|STARTED|Overall Study|124 participants randomized; 118 participant received intervention|124
3209004|NCT02184143|3939077|FG001|STARTED|Overall Study|124 participants randomized; 121 received intervention|124
3209005|NCT02184143|3939076|FG000|COMPLETED|Overall Study|114 patients completed PROs. 98 actigraph valid wear time.|114
3209006|NCT02184143|3939077|FG001|COMPLETED|Overall Study|117 patients completed PROs. 100 actigraph valid wear time.|117
3209007|NCT02184143|3939076|FG000|NOT COMPLETED|Overall Study||10
3209008|NCT02184143|3939077|FG001|NOT COMPLETED|Overall Study||7
3209009|NCT02184169|3939087|FG000|STARTED|Overall Study||21
3209010|NCT02184169|3939088|FG001|STARTED|Overall Study||6
3209011|NCT02184169|3939087|FG000|COMPLETED|Overall Study||21
3209012|NCT02184169|3939088|FG001|COMPLETED|Overall Study||6
3209013|NCT02184169|3939087|FG000|NOT COMPLETED|Overall Study||0
3209014|NCT02184169|3939088|FG001|NOT COMPLETED|Overall Study||0
3209015|NCT02184195|3939098|FG000|STARTED|Overall Study||92
3209016|NCT02184195|3939099|FG001|STARTED|Overall Study||62
3209017|NCT02184195|3939098|FG000|COMPLETED|Overall Study||49
3366210|NCT03933618|4097514|FG002|COMPLETED|Baseline||4
3366211|NCT03933618|4097515|FG003|COMPLETED|Baseline||4
3366212|NCT03933618|4097516|FG004|COMPLETED|Baseline||4
3366213|NCT03933618|4097517|FG005|COMPLETED|Baseline||4
3366214|NCT03933618|4097512|FG000|NOT COMPLETED|Baseline||0
3366215|NCT03933618|4097513|FG001|NOT COMPLETED|Baseline||0
3366216|NCT03933618|4097514|FG002|NOT COMPLETED|Baseline||0
3366217|NCT03933618|4097515|FG003|NOT COMPLETED|Baseline||0
3366218|NCT03933618|4097516|FG004|NOT COMPLETED|Baseline||0
3366219|NCT03933618|4097517|FG005|NOT COMPLETED|Baseline||0
3366220|NCT03933618|4097512|FG000|STARTED|Baseline to Week 8||4
3366221|NCT03933618|4097513|FG001|STARTED|Baseline to Week 8||4
3366222|NCT03933618|4097514|FG002|STARTED|Baseline to Week 8||4
3366223|NCT03933618|4097515|FG003|STARTED|Baseline to Week 8||4
3366224|NCT03933618|4097516|FG004|STARTED|Baseline to Week 8||4
3366225|NCT03933618|4097517|FG005|STARTED|Baseline to Week 8||4
3366226|NCT03933618|4097512|FG000|COMPLETED|Baseline to Week 8||4
3366227|NCT03933618|4097513|FG001|COMPLETED|Baseline to Week 8||4
3366228|NCT03933618|4097514|FG002|COMPLETED|Baseline to Week 8||4
3366229|NCT03933618|4097515|FG003|COMPLETED|Baseline to Week 8||4
3366230|NCT03933618|4097516|FG004|COMPLETED|Baseline to Week 8||4
3366231|NCT03933618|4097517|FG005|COMPLETED|Baseline to Week 8||4
3366232|NCT03933618|4097512|FG000|NOT COMPLETED|Baseline to Week 8||0
3366233|NCT03933618|4097513|FG001|NOT COMPLETED|Baseline to Week 8||0
3366234|NCT03933618|4097514|FG002|NOT COMPLETED|Baseline to Week 8||0
3366235|NCT03933618|4097515|FG003|NOT COMPLETED|Baseline to Week 8||0
3366236|NCT03933618|4097516|FG004|NOT COMPLETED|Baseline to Week 8||0
3366237|NCT03933618|4097517|FG005|NOT COMPLETED|Baseline to Week 8||0
3366238|NCT03933618|4097512|FG000|STARTED|Week 8 to Week 16||4
3366239|NCT03933618|4097513|FG001|STARTED|Week 8 to Week 16||4
3366240|NCT03933618|4097514|FG002|STARTED|Week 8 to Week 16||4
3366241|NCT03933618|4097515|FG003|STARTED|Week 8 to Week 16||4
3366242|NCT03933618|4097516|FG004|STARTED|Week 8 to Week 16||4
3366243|NCT03933618|4097517|FG005|STARTED|Week 8 to Week 16||4
3366244|NCT03933618|4097512|FG000|COMPLETED|Week 8 to Week 16||4
3366245|NCT03933618|4097513|FG001|COMPLETED|Week 8 to Week 16||4
3366246|NCT03933618|4097514|FG002|COMPLETED|Week 8 to Week 16||4
3366247|NCT03933618|4097515|FG003|COMPLETED|Week 8 to Week 16||4
3366248|NCT03933618|4097516|FG004|COMPLETED|Week 8 to Week 16||4
3366249|NCT03933618|4097517|FG005|COMPLETED|Week 8 to Week 16||4
3366250|NCT03933618|4097512|FG000|NOT COMPLETED|Week 8 to Week 16||0
3366251|NCT03933618|4097513|FG001|NOT COMPLETED|Week 8 to Week 16||0
3366252|NCT03933618|4097514|FG002|NOT COMPLETED|Week 8 to Week 16||0
3366253|NCT03933618|4097515|FG003|NOT COMPLETED|Week 8 to Week 16||0
3366254|NCT03933618|4097516|FG004|NOT COMPLETED|Week 8 to Week 16||0
3366255|NCT03933618|4097517|FG005|NOT COMPLETED|Week 8 to Week 16||0
3366256|NCT03933618|4097512|FG000|STARTED|Week 16 to Week 24||4
3366257|NCT03933618|4097513|FG001|STARTED|Week 16 to Week 24||4
3366258|NCT03933618|4097514|FG002|STARTED|Week 16 to Week 24||4
3366259|NCT03933618|4097515|FG003|STARTED|Week 16 to Week 24||4
3366260|NCT03933618|4097516|FG004|STARTED|Week 16 to Week 24||4
3366261|NCT03933618|4097517|FG005|STARTED|Week 16 to Week 24||4
3366262|NCT03933618|4097512|FG000|COMPLETED|Week 16 to Week 24||4
3366263|NCT03933618|4097513|FG001|COMPLETED|Week 16 to Week 24||4
3366264|NCT03933618|4097514|FG002|COMPLETED|Week 16 to Week 24||4
3366265|NCT03933618|4097515|FG003|COMPLETED|Week 16 to Week 24||4
3366266|NCT03933618|4097516|FG004|COMPLETED|Week 16 to Week 24||4
3366267|NCT03933618|4097517|FG005|COMPLETED|Week 16 to Week 24||4
3366268|NCT03933618|4097512|FG000|NOT COMPLETED|Week 16 to Week 24||0
3366269|NCT03933618|4097513|FG001|NOT COMPLETED|Week 16 to Week 24||0
3366270|NCT03933618|4097514|FG002|NOT COMPLETED|Week 16 to Week 24||0
3366271|NCT03933618|4097515|FG003|NOT COMPLETED|Week 16 to Week 24||0
3366272|NCT03933618|4097516|FG004|NOT COMPLETED|Week 16 to Week 24||0
3366273|NCT03933618|4097517|FG005|NOT COMPLETED|Week 16 to Week 24||0
3366274|NCT03931785|4097535|FG000|STARTED|Overall Study||97
3366275|NCT03931785|4097536|FG001|STARTED|Overall Study||97
3366276|NCT03931785|4097537|FG002|STARTED|Overall Study||97
3366277|NCT03931785|4097538|FG003|STARTED|Overall Study||97
3366278|NCT03931785|4097535|FG000|COMPLETED|Overall Study||92
3366279|NCT03931785|4097536|FG001|COMPLETED|Overall Study||90
3366280|NCT03931785|4097537|FG002|COMPLETED|Overall Study||84
3366281|NCT03931785|4097538|FG003|COMPLETED|Overall Study||86
3366282|NCT03931785|4097535|FG000|NOT COMPLETED|Overall Study||5
3209018|NCT02184195|3939099|FG001|COMPLETED|Overall Study||27
3209019|NCT02184195|3939098|FG000|NOT COMPLETED|Overall Study||43
3209020|NCT02184195|3939099|FG001|NOT COMPLETED|Overall Study||35
3209021|NCT02184208|3939105|FG000|STARTED|Overall Study||278
3209022|NCT02184208|3939105|FG000|COMPLETED|Overall Study||222
3209023|NCT02184208|3939105|FG000|NOT COMPLETED|Overall Study||56
3209024|NCT02184442|3939113|FG000|STARTED|Overall Study||284
3209025|NCT02184442|3939114|FG001|STARTED|Overall Study||276
3209026|NCT02184442|3939113|FG000|As-Treated|Overall Study||282
3209027|NCT02184442|3939114|FG001|As-Treated|Overall Study||271
3209028|NCT02184442|3939113|FG000|Valve-Implant|Overall Study||280
3209029|NCT02184442|3939114|FG001|Valve-Implant|Overall Study||263
3209030|NCT02184442|3939113|FG000|COMPLETED|Overall Study||220
3209031|NCT02184442|3939114|FG001|COMPLETED|Overall Study||200
3209032|NCT02184442|3939113|FG000|NOT COMPLETED|Overall Study||64
3209033|NCT02184442|3939114|FG001|NOT COMPLETED|Overall Study||76
3209034|NCT02184455|3939120|FG000|STARTED|Overall Study||11
3209035|NCT02184455|3939120|FG000|COMPLETED|Overall Study||10
3209036|NCT02184455|3939120|FG000|NOT COMPLETED|Overall Study||1
3209037|NCT02184494|3939127|FG000|STARTED|Overall Study||13
3209038|NCT02184494|3939128|FG001|STARTED|Overall Study||13
3209039|NCT02184494|3939129|FG002|STARTED|Overall Study||8
3209040|NCT02184494|3939127|FG000|COMPLETED|Overall Study||12
3209041|NCT02184494|3939128|FG001|COMPLETED|Overall Study||11
3209042|NCT02184494|3939129|FG002|COMPLETED|Overall Study||8
3209043|NCT02184494|3939127|FG000|NOT COMPLETED|Overall Study||1
3209044|NCT02184494|3939128|FG001|NOT COMPLETED|Overall Study||2
3209045|NCT02184494|3939129|FG002|NOT COMPLETED|Overall Study||0
3209046|NCT02184572|3939139|FG000|STARTED|Overall Study||1164
3209047|NCT02184572|3939140|FG001|STARTED|Overall Study||572
3209048|NCT02184572|3939139|FG000|COMPLETED|Overall Study||1117
3209049|NCT02184572|3939140|FG001|COMPLETED|Overall Study||542
3209050|NCT02184572|3939139|FG000|NOT COMPLETED|Overall Study||47
3209051|NCT02184572|3939140|FG001|NOT COMPLETED|Overall Study||30
3209052|NCT02184611|3939150|FG000|STARTED|Overall Study||101
3209053|NCT02184611|3939151|FG001|STARTED|Overall Study||205
3209054|NCT02184611|3939150|FG000|COMPLETED|Overall Study||80
3209055|NCT02184611|3939151|FG001|COMPLETED|Overall Study||177
3209056|NCT02184611|3939150|FG000|NOT COMPLETED|Overall Study||21
3209057|NCT02184611|3939151|FG001|NOT COMPLETED|Overall Study||28
3209058|NCT02184624|3939162|FG000|STARTED|Overall Study||171
3209059|NCT02184624|3939163|FG001|STARTED|Overall Study||80
3209060|NCT02184624|3939164|FG002|STARTED|Overall Study||100
3209061|NCT02184624|3939165|FG003|STARTED|Overall Study||118
3209062|NCT02184624|3939166|FG004|STARTED|Overall Study||98
3209063|NCT02184624|3939162|FG000|COMPLETED|Overall Study||171
3209064|NCT02184624|3939163|FG001|COMPLETED|Overall Study||80
3209065|NCT02184624|3939164|FG002|COMPLETED|Overall Study||100
3209066|NCT02184624|3939165|FG003|COMPLETED|Overall Study||118
3209067|NCT02184624|3939166|FG004|COMPLETED|Overall Study||98
3209068|NCT02184624|3939162|FG000|NOT COMPLETED|Overall Study||0
3209069|NCT02184624|3939163|FG001|NOT COMPLETED|Overall Study||0
3209070|NCT02184624|3939164|FG002|NOT COMPLETED|Overall Study||0
3209071|NCT02184624|3939165|FG003|NOT COMPLETED|Overall Study||0
3209072|NCT02184624|3939166|FG004|NOT COMPLETED|Overall Study||0
3209073|NCT02184988|3939178|FG000|STARTED|Overall Study||352
3209074|NCT02184988|3939178|FG000|COMPLETED|Overall Study||297
3209075|NCT02184988|3939178|FG000|NOT COMPLETED|Overall Study||55
3209076|NCT02185014|3939182|FG000|STARTED|Overall Study||252
3209077|NCT02185014|3939182|FG000|COMPLETED|Overall Study||198
3209078|NCT02185014|3939182|FG000|NOT COMPLETED|Overall Study||54
3209079|NCT02185040|3939191|FG000|STARTED|Part 1 Treatment Phase||8
3209080|NCT02185040|3939192|FG001|STARTED|Part 1 Treatment Phase||8
3209081|NCT02185040|3939193|FG002|STARTED|Part 1 Treatment Phase||8
3209082|NCT02185040|3939194|FG003|STARTED|Part 1 Treatment Phase||9
3209083|NCT02185040|3939195|FG004|STARTED|Part 1 Treatment Phase||9
3209084|NCT02185040|3939196|FG005|STARTED|Part 1 Treatment Phase||0
3209085|NCT02185040|3939197|FG006|STARTED|Part 1 Treatment Phase||0
3209086|NCT02185040|3939191|FG000|COMPLETED|Part 1 Treatment Phase||7
3209087|NCT02185040|3939192|FG001|COMPLETED|Part 1 Treatment Phase||6
3209088|NCT02185040|3939193|FG002|COMPLETED|Part 1 Treatment Phase||7
3209089|NCT02185040|3939194|FG003|COMPLETED|Part 1 Treatment Phase||7
3209090|NCT02185040|3939195|FG004|COMPLETED|Part 1 Treatment Phase||6
3209091|NCT02185040|3939196|FG005|COMPLETED|Part 1 Treatment Phase||0
3209092|NCT02185040|3939197|FG006|COMPLETED|Part 1 Treatment Phase||0
3209093|NCT02185040|3939191|FG000|NOT COMPLETED|Part 1 Treatment Phase||1
3209094|NCT02185040|3939192|FG001|NOT COMPLETED|Part 1 Treatment Phase||2
3209095|NCT02185040|3939193|FG002|NOT COMPLETED|Part 1 Treatment Phase||1
3209096|NCT02185040|3939194|FG003|NOT COMPLETED|Part 1 Treatment Phase||2
3209097|NCT02185040|3939195|FG004|NOT COMPLETED|Part 1 Treatment Phase||3
3209098|NCT02185040|3939196|FG005|NOT COMPLETED|Part 1 Treatment Phase||0
3209099|NCT02185040|3939197|FG006|NOT COMPLETED|Part 1 Treatment Phase||0
3209100|NCT02185040|3939191|FG000|STARTED|Active Treatment Extension Phase||0
3209101|NCT02185040|3939192|FG001|STARTED|Active Treatment Extension Phase||0
3209102|NCT02185040|3939193|FG002|STARTED|Active Treatment Extension Phase||0
3209103|NCT02185040|3939194|FG003|STARTED|Active Treatment Extension Phase||0
3209104|NCT02185040|3939195|FG004|STARTED|Active Treatment Extension Phase||0
3209105|NCT02185040|3939196|FG005|STARTED|Active Treatment Extension Phase||9
3209106|NCT02185040|3939197|FG006|STARTED|Active Treatment Extension Phase||8
3209107|NCT02185040|3939191|FG000|COMPLETED|Active Treatment Extension Phase||0
3209108|NCT02185040|3939192|FG001|COMPLETED|Active Treatment Extension Phase||0
3209109|NCT02185040|3939193|FG002|COMPLETED|Active Treatment Extension Phase||0
3209110|NCT02185040|3939194|FG003|COMPLETED|Active Treatment Extension Phase||0
3209111|NCT02185040|3939195|FG004|COMPLETED|Active Treatment Extension Phase||0
3209112|NCT02185040|3939196|FG005|COMPLETED|Active Treatment Extension Phase||6
3209113|NCT02185040|3939197|FG006|COMPLETED|Active Treatment Extension Phase||1
3209114|NCT02185040|3939191|FG000|NOT COMPLETED|Active Treatment Extension Phase||0
3209115|NCT02185040|3939192|FG001|NOT COMPLETED|Active Treatment Extension Phase||0
3209116|NCT02185040|3939193|FG002|NOT COMPLETED|Active Treatment Extension Phase||0
3209117|NCT02185040|3939194|FG003|NOT COMPLETED|Active Treatment Extension Phase||0
3209118|NCT02185040|3939195|FG004|NOT COMPLETED|Active Treatment Extension Phase||0
3209119|NCT02185040|3939196|FG005|NOT COMPLETED|Active Treatment Extension Phase||3
3209120|NCT02185040|3939197|FG006|NOT COMPLETED|Active Treatment Extension Phase||7
3209121|NCT02185053|3939217|FG000|STARTED|Solifenacin Dose Escalation Phase||41
3209122|NCT02185053|3939218|FG001|STARTED|Solifenacin Dose Escalation Phase||0
3209123|NCT02185053|3939219|FG002|STARTED|Solifenacin Dose Escalation Phase||0
3209124|NCT02185053|3939217|FG000|COMPLETED|Solifenacin Dose Escalation Phase||38
3209125|NCT02185053|3939218|FG001|COMPLETED|Solifenacin Dose Escalation Phase||0
3209126|NCT02185053|3939219|FG002|COMPLETED|Solifenacin Dose Escalation Phase||0
3209127|NCT02185053|3939217|FG000|NOT COMPLETED|Solifenacin Dose Escalation Phase||3
3209128|NCT02185053|3939218|FG001|NOT COMPLETED|Solifenacin Dose Escalation Phase||0
3209129|NCT02185053|3939219|FG002|NOT COMPLETED|Solifenacin Dose Escalation Phase||0
3209130|NCT02185053|3939217|FG000|STARTED|Donepezil Dose Escalation Phase||0
3209131|NCT02185053|3939218|FG001|STARTED|Donepezil Dose Escalation Phase||38
3209132|NCT02185053|3939219|FG002|STARTED|Donepezil Dose Escalation Phase||0
3209133|NCT02185053|3939217|FG000|COMPLETED|Donepezil Dose Escalation Phase||0
3209134|NCT02185053|3939218|FG001|COMPLETED|Donepezil Dose Escalation Phase||33
3209135|NCT02185053|3939219|FG002|COMPLETED|Donepezil Dose Escalation Phase||0
3209136|NCT02185053|3939217|FG000|NOT COMPLETED|Donepezil Dose Escalation Phase||0
3209137|NCT02185053|3939218|FG001|NOT COMPLETED|Donepezil Dose Escalation Phase||5
3209138|NCT02185053|3939219|FG002|NOT COMPLETED|Donepezil Dose Escalation Phase||0
3209139|NCT02185053|3939217|FG000|STARTED|Donepezil Dose Maintenance Phase||0
3209140|NCT02185053|3939218|FG001|STARTED|Donepezil Dose Maintenance Phase||0
3209141|NCT02185053|3939219|FG002|STARTED|Donepezil Dose Maintenance Phase||33
3209142|NCT02185053|3939217|FG000|COMPLETED|Donepezil Dose Maintenance Phase||0
3209143|NCT02185053|3939218|FG001|COMPLETED|Donepezil Dose Maintenance Phase||0
3209144|NCT02185053|3939219|FG002|COMPLETED|Donepezil Dose Maintenance Phase||30
3209145|NCT02185053|3939217|FG000|NOT COMPLETED|Donepezil Dose Maintenance Phase||0
3209146|NCT02185053|3939218|FG001|NOT COMPLETED|Donepezil Dose Maintenance Phase||0
3209147|NCT02185053|3939219|FG002|NOT COMPLETED|Donepezil Dose Maintenance Phase||3
3209148|NCT02185105|3939228|FG000|STARTED|Overall Study||30
3209149|NCT02185105|3939228|FG000|COMPLETED|Overall Study||30
3209150|NCT02185105|3939228|FG000|NOT COMPLETED|Overall Study||0
3209151|NCT02185131|3939241|FG000|STARTED|Overall Study||7
3209152|NCT02185131|3939242|FG001|STARTED|Overall Study||9
3209153|NCT02185131|3939241|FG000|COMPLETED|Overall Study||6
3209154|NCT02185131|3939242|FG001|COMPLETED|Overall Study||8
3209155|NCT02185131|3939241|FG000|NOT COMPLETED|Overall Study||1
3209156|NCT02185131|3939242|FG001|NOT COMPLETED|Overall Study||1
3209157|NCT02185183|3939248|FG000|STARTED|Overall Study||14
3209158|NCT02185183|3939248|FG000|COMPLETED|Overall Study||14
3209159|NCT02185183|3939248|FG000|NOT COMPLETED|Overall Study||0
3209160|NCT02185339|3939254|FG000|STARTED|Overall Study||30
3209161|NCT02185339|3939255|FG001|STARTED|Overall Study||31
3209162|NCT02185339|3939254|FG000|COMPLETED|Overall Study||30
3209163|NCT02185339|3939255|FG001|COMPLETED|Overall Study||30
3209164|NCT02185339|3939254|FG000|NOT COMPLETED|Overall Study||0
3209165|NCT02185339|3939255|FG001|NOT COMPLETED|Overall Study||1
3209166|NCT02185404|3939261|FG000|STARTED|Overall Study||6
3209167|NCT02185404|3939261|FG000|COMPLETED|Overall Study||6
3209168|NCT02185404|3939261|FG000|NOT COMPLETED|Overall Study||0
3209169|NCT02185521|3939265|FG000|STARTED|Overall Study||127
3209170|NCT02185521|3939265|FG000|COMPLETED|Overall Study||125
3209171|NCT02185521|3939265|FG000|NOT COMPLETED|Overall Study||2
3209172|NCT02185534|3939276|FG000|STARTED|First Period||14
3209173|NCT02185534|3939277|FG001|STARTED|First Period||14
3209174|NCT02185534|3939278|FG002|STARTED|First Period||14
3209175|NCT02185534|3939279|FG003|STARTED|First Period||14
3209176|NCT02185534|3939280|FG004|STARTED|First Period||14
3209177|NCT02185534|3939281|FG005|STARTED|First Period||14
3209178|NCT02185534|3939276|FG000|COMPLETED|First Period||14
3209179|NCT02185534|3939277|FG001|COMPLETED|First Period||14
3209180|NCT02185534|3939278|FG002|COMPLETED|First Period||14
3209181|NCT02185534|3939279|FG003|COMPLETED|First Period||13
3209182|NCT02185534|3939280|FG004|COMPLETED|First Period||14
3209183|NCT02185534|3939281|FG005|COMPLETED|First Period||14
3209184|NCT02185534|3939276|FG000|NOT COMPLETED|First Period||0
3209185|NCT02185534|3939277|FG001|NOT COMPLETED|First Period||0
3209186|NCT02185534|3939278|FG002|NOT COMPLETED|First Period||0
3209187|NCT02185534|3939279|FG003|NOT COMPLETED|First Period||1
3209188|NCT02185534|3939280|FG004|NOT COMPLETED|First Period||0
3209189|NCT02185534|3939281|FG005|NOT COMPLETED|First Period||0
3209190|NCT02185534|3939276|FG000|STARTED|First Washout Period||14
3209191|NCT02185534|3939277|FG001|STARTED|First Washout Period||14
3209192|NCT02185534|3939278|FG002|STARTED|First Washout Period||14
3209193|NCT02185534|3939279|FG003|STARTED|First Washout Period||13
3209194|NCT02185534|3939280|FG004|STARTED|First Washout Period||14
3209195|NCT02185534|3939281|FG005|STARTED|First Washout Period||14
3209196|NCT02185534|3939276|FG000|COMPLETED|First Washout Period||13
3209197|NCT02185534|3939277|FG001|COMPLETED|First Washout Period||14
3209198|NCT02185534|3939278|FG002|COMPLETED|First Washout Period||14
3209199|NCT02185534|3939279|FG003|COMPLETED|First Washout Period||13
3209200|NCT02185534|3939280|FG004|COMPLETED|First Washout Period||13
3209201|NCT02185534|3939281|FG005|COMPLETED|First Washout Period||13
3209202|NCT02185534|3939276|FG000|NOT COMPLETED|First Washout Period||1
3209203|NCT02185534|3939277|FG001|NOT COMPLETED|First Washout Period||0
3209204|NCT02185534|3939278|FG002|NOT COMPLETED|First Washout Period||0
3209205|NCT02185534|3939279|FG003|NOT COMPLETED|First Washout Period||0
3209206|NCT02185534|3939280|FG004|NOT COMPLETED|First Washout Period||1
3209207|NCT02185534|3939281|FG005|NOT COMPLETED|First Washout Period||1
3209208|NCT02185534|3939276|FG000|STARTED|Second Period||13
3209209|NCT02185534|3939277|FG001|STARTED|Second Period||14
3209210|NCT02185534|3939278|FG002|STARTED|Second Period||14
3209211|NCT02185534|3939279|FG003|STARTED|Second Period||13
3209212|NCT02185534|3939280|FG004|STARTED|Second Period||13
3209213|NCT02185534|3939281|FG005|STARTED|Second Period||13
3209214|NCT02185534|3939276|FG000|COMPLETED|Second Period||13
3209215|NCT02185534|3939277|FG001|COMPLETED|Second Period||14
3209216|NCT02185534|3939278|FG002|COMPLETED|Second Period||14
3209217|NCT02185534|3939279|FG003|COMPLETED|Second Period||13
3209218|NCT02185534|3939280|FG004|COMPLETED|Second Period||13
3209219|NCT02185534|3939281|FG005|COMPLETED|Second Period||13
3209220|NCT02185534|3939276|FG000|NOT COMPLETED|Second Period||0
3209221|NCT02185534|3939277|FG001|NOT COMPLETED|Second Period||0
3209222|NCT02185534|3939278|FG002|NOT COMPLETED|Second Period||0
3209223|NCT02185534|3939279|FG003|NOT COMPLETED|Second Period||0
3209224|NCT02185534|3939280|FG004|NOT COMPLETED|Second Period||0
3209225|NCT02185534|3939281|FG005|NOT COMPLETED|Second Period||0
3209226|NCT02185534|3939276|FG000|STARTED|Second Washout Period||13
3209227|NCT02185534|3939277|FG001|STARTED|Second Washout Period||14
3209228|NCT02185534|3939278|FG002|STARTED|Second Washout Period||14
3209229|NCT02185534|3939279|FG003|STARTED|Second Washout Period||13
3209230|NCT02185534|3939280|FG004|STARTED|Second Washout Period||13
3209231|NCT02185534|3939281|FG005|STARTED|Second Washout Period||13
3209232|NCT02185534|3939276|FG000|COMPLETED|Second Washout Period||13
3209233|NCT02185534|3939277|FG001|COMPLETED|Second Washout Period||14
3209234|NCT02185534|3939278|FG002|COMPLETED|Second Washout Period||14
3209235|NCT02185534|3939279|FG003|COMPLETED|Second Washout Period||13
3209236|NCT02185534|3939280|FG004|COMPLETED|Second Washout Period||13
3209237|NCT02185534|3939281|FG005|COMPLETED|Second Washout Period||13
3209238|NCT02185534|3939276|FG000|NOT COMPLETED|Second Washout Period||0
3209239|NCT02185534|3939277|FG001|NOT COMPLETED|Second Washout Period||0
3209240|NCT02185534|3939278|FG002|NOT COMPLETED|Second Washout Period||0
3209241|NCT02185534|3939279|FG003|NOT COMPLETED|Second Washout Period||0
3209242|NCT02185534|3939280|FG004|NOT COMPLETED|Second Washout Period||0
3209243|NCT02185534|3939281|FG005|NOT COMPLETED|Second Washout Period||0
3209244|NCT02185534|3939276|FG000|STARTED|Third Period||13
3209245|NCT02185534|3939277|FG001|STARTED|Third Period||14
3209246|NCT02185534|3939278|FG002|STARTED|Third Period||14
3209247|NCT02185534|3939279|FG003|STARTED|Third Period||13
3209248|NCT02185534|3939280|FG004|STARTED|Third Period||13
3209249|NCT02185534|3939281|FG005|STARTED|Third Period||13
3209250|NCT02185534|3939276|FG000|COMPLETED|Third Period||13
3209251|NCT02185534|3939277|FG001|COMPLETED|Third Period||14
3209252|NCT02185534|3939278|FG002|COMPLETED|Third Period||14
3209253|NCT02185534|3939279|FG003|COMPLETED|Third Period||13
3209254|NCT02185534|3939280|FG004|COMPLETED|Third Period||13
3209255|NCT02185534|3939281|FG005|COMPLETED|Third Period||13
3209256|NCT02185534|3939276|FG000|NOT COMPLETED|Third Period||0
3209257|NCT02185534|3939277|FG001|NOT COMPLETED|Third Period||0
3209258|NCT02185534|3939278|FG002|NOT COMPLETED|Third Period||0
3209259|NCT02185534|3939279|FG003|NOT COMPLETED|Third Period||0
3209260|NCT02185534|3939280|FG004|NOT COMPLETED|Third Period||0
3209261|NCT02185534|3939281|FG005|NOT COMPLETED|Third Period||0
3209262|NCT02185729|3939290|FG000|STARTED|0 Hour (Baseline) of Saline Infusion||12
3209263|NCT02185729|3939290|FG000|COMPLETED|0 Hour (Baseline) of Saline Infusion||12
3209264|NCT02185729|3939290|FG000|NOT COMPLETED|0 Hour (Baseline) of Saline Infusion||0
3209265|NCT02185729|3939290|FG000|STARTED|4 Hours Into Saline Infusion||12
3209266|NCT02185729|3939290|FG000|COMPLETED|4 Hours Into Saline Infusion||12
3209267|NCT02185729|3939290|FG000|NOT COMPLETED|4 Hours Into Saline Infusion||0
3209268|NCT02185729|3939290|FG000|STARTED|24 Hours Into Saline Infusion||12
3209269|NCT02185729|3939290|FG000|COMPLETED|24 Hours Into Saline Infusion||12
3209270|NCT02185729|3939290|FG000|NOT COMPLETED|24 Hours Into Saline Infusion||0
3209271|NCT02185729|3939290|FG000|STARTED|0 Hour (Baseline) of Intralipid Infusion||12
3209272|NCT02185729|3939290|FG000|COMPLETED|0 Hour (Baseline) of Intralipid Infusion||12
3209273|NCT02185729|3939290|FG000|NOT COMPLETED|0 Hour (Baseline) of Intralipid Infusion||0
3209274|NCT02185729|3939290|FG000|STARTED|4 Hours Into Intralipid Infusion||12
3209275|NCT02185729|3939290|FG000|COMPLETED|4 Hours Into Intralipid Infusion||12
3209276|NCT02185729|3939290|FG000|NOT COMPLETED|4 Hours Into Intralipid Infusion||0
3209277|NCT02185729|3939290|FG000|STARTED|24 Hours Into Intralipid Infusion||12
3209278|NCT02185729|3939290|FG000|COMPLETED|24 Hours Into Intralipid Infusion||12
3209279|NCT02185729|3939290|FG000|NOT COMPLETED|24 Hours Into Intralipid Infusion||0
3209280|NCT02185729|3939290|FG000|STARTED|0 Hour (Baseline) of ClinOleic Infusion||12
3209281|NCT02185729|3939290|FG000|COMPLETED|0 Hour (Baseline) of ClinOleic Infusion||12
3209282|NCT02185729|3939290|FG000|NOT COMPLETED|0 Hour (Baseline) of ClinOleic Infusion||0
3209283|NCT02185729|3939290|FG000|STARTED|4 Hours Into ClinOleic Infusion||12
3209284|NCT02185729|3939290|FG000|COMPLETED|4 Hours Into ClinOleic Infusion||12
3209285|NCT02185729|3939290|FG000|NOT COMPLETED|4 Hours Into ClinOleic Infusion||0
3209286|NCT02185729|3939290|FG000|STARTED|24 Hours Into ClinOleic Infusion||12
3209287|NCT02185729|3939290|FG000|COMPLETED|24 Hours Into ClinOleic Infusion||12
3209288|NCT02185729|3939290|FG000|NOT COMPLETED|24 Hours Into ClinOleic Infusion||0
3209289|NCT02185729|3939290|FG000|STARTED|0 Hour (Baseline) of Dextrose Infusion||12
3209290|NCT02185729|3939290|FG000|COMPLETED|0 Hour (Baseline) of Dextrose Infusion||12
3209291|NCT02185729|3939290|FG000|NOT COMPLETED|0 Hour (Baseline) of Dextrose Infusion||0
3209292|NCT02185729|3939290|FG000|STARTED|4 Hours Into Dextrose Infusion||12
3209293|NCT02185729|3939290|FG000|COMPLETED|4 Hours Into Dextrose Infusion||12
3209294|NCT02185729|3939290|FG000|NOT COMPLETED|4 Hours Into Dextrose Infusion||0
3209295|NCT02185729|3939290|FG000|STARTED|24 Hours Into Dextrose Infusion||12
3209296|NCT02185729|3939290|FG000|COMPLETED|24 Hours Into Dextrose Infusion||12
3209297|NCT02185729|3939290|FG000|NOT COMPLETED|24 Hours Into Dextrose Infusion||0
3209298|NCT02185794|3939303|FG000|STARTED|Overall Study||9
3209299|NCT02185794|3939304|FG001|STARTED|Overall Study||20
3209300|NCT02185794|3939305|FG002|STARTED|Overall Study||33
3209301|NCT02185794|3939306|FG003|STARTED|Overall Study||16
3209302|NCT02185794|3939307|FG004|STARTED|Overall Study||7
3209303|NCT02185794|3939308|FG005|STARTED|Overall Study||16
3209304|NCT02185794|3939303|FG000|COMPLETED|Overall Study||4
3209305|NCT02185794|3939304|FG001|COMPLETED|Overall Study||7
3209306|NCT02185794|3939305|FG002|COMPLETED|Overall Study||17
3209307|NCT02185794|3939306|FG003|COMPLETED|Overall Study||8
3209308|NCT02185794|3939307|FG004|COMPLETED|Overall Study||4
3209309|NCT02185794|3939308|FG005|COMPLETED|Overall Study||0
3209310|NCT02185794|3939303|FG000|NOT COMPLETED|Overall Study||5
3209311|NCT02185794|3939304|FG001|NOT COMPLETED|Overall Study||13
3209312|NCT02185794|3939305|FG002|NOT COMPLETED|Overall Study||16
3209313|NCT02185794|3939306|FG003|NOT COMPLETED|Overall Study||8
3209314|NCT02185794|3939307|FG004|NOT COMPLETED|Overall Study||3
3209315|NCT02185794|3939308|FG005|NOT COMPLETED|Overall Study||16
3209316|NCT02186015|3939338|FG000|STARTED|Overall Study||11
3209317|NCT02186015|3939339|FG001|STARTED|Overall Study||31
3209318|NCT02186015|3939338|FG000|COMPLETED|Overall Study||10
3209319|NCT02186015|3939339|FG001|COMPLETED|Overall Study||31
3209320|NCT02186015|3939338|FG000|NOT COMPLETED|Overall Study||1
3209321|NCT02186015|3939339|FG001|NOT COMPLETED|Overall Study||0
3209322|NCT02186171|3939348|FG000|STARTED|Overall Study||82
3209323|NCT02186171|3939349|FG001|STARTED|Overall Study||163
3209324|NCT02186171|3939348|FG000|Received Treatment|Overall Study||81
3209325|NCT02186171|3939349|FG001|Received Treatment|Overall Study||163
3209326|NCT02186171|3939348|FG000|COMPLETED|Overall Study||78
3209327|NCT02186171|3939349|FG001|COMPLETED|Overall Study||148
3209328|NCT02186171|3939348|FG000|NOT COMPLETED|Overall Study||4
3209329|NCT02186171|3939349|FG001|NOT COMPLETED|Overall Study||15
3209330|NCT02186210|3939357|FG000|STARTED|Overall Study||20
3209331|NCT02186210|3939358|FG001|STARTED|Overall Study||20
3209332|NCT02186210|3939357|FG000|COMPLETED|Overall Study||20
3209333|NCT02186210|3939358|FG001|COMPLETED|Overall Study||20
3209334|NCT02186210|3939357|FG000|NOT COMPLETED|Overall Study||0
3209335|NCT02186210|3939358|FG001|NOT COMPLETED|Overall Study||0
3209336|NCT02186223|3939366|FG000|STARTED|Overall Study||172
3209337|NCT02186223|3939366|FG000|Device Placed|Overall Study||163
3209338|NCT02186223|3939366|FG000|COMPLETED|Overall Study||151
3209339|NCT02186223|3939366|FG000|NOT COMPLETED|Overall Study||21
3209340|NCT02186301|3939374|FG000|STARTED|Overall Study||20
3209341|NCT02186301|3939375|FG001|STARTED|Overall Study||30
3209342|NCT02186301|3939376|FG002|STARTED|Overall Study||50
3209343|NCT02186301|3939374|FG000|COMPLETED|Overall Study|Patients who are off study for any reason.|0
3209344|NCT02186301|3939375|FG001|COMPLETED|Overall Study|Patients who are off study for any reason.|0
3209345|NCT02186301|3939376|FG002|COMPLETED|Overall Study|Patients who are off study for any reason.|0
3209346|NCT02186301|3939374|FG000|NOT COMPLETED|Overall Study||20
3209347|NCT02186301|3939375|FG001|NOT COMPLETED|Overall Study||30
3209348|NCT02186301|3939376|FG002|NOT COMPLETED|Overall Study||50
3209349|NCT02186509|3939386|FG000|STARTED|Overall Study||17
3209350|NCT02186509|3939386|FG000|COMPLETED|Overall Study||17
3209351|NCT02186509|3939386|FG000|NOT COMPLETED|Overall Study||0
3209352|NCT02186561|3939390|FG000|STARTED|Enrollment||197
3209353|NCT02186561|3939390|FG000|COMPLETED|Enrollment||141
3209354|NCT02186561|3939390|FG000|NOT COMPLETED|Enrollment||56
3209355|NCT02186561|3939390|FG000|STARTED|Subjects Implanted With Device||141
3209356|NCT02186561|3939390|FG000|COMPLETED|Subjects Implanted With Device||141
3209357|NCT02186561|3939390|FG000|NOT COMPLETED|Subjects Implanted With Device||0
3209358|NCT02186561|3939390|FG000|STARTED|30-Day Post Index Procedure Visit||141
3209359|NCT02186561|3939390|FG000|COMPLETED|30-Day Post Index Procedure Visit||140
3209360|NCT02186561|3939390|FG000|NOT COMPLETED|30-Day Post Index Procedure Visit||1
3209361|NCT02186561|3939390|FG000|STARTED|180- Day Post Index Procedure Visit||141
3209362|NCT02186561|3939390|FG000|COMPLETED|180- Day Post Index Procedure Visit||134
3209363|NCT02186561|3939390|FG000|NOT COMPLETED|180- Day Post Index Procedure Visit||7
3209364|NCT02186561|3939390|FG000|STARTED|1- Year Post Index Procedure Visit||141
3209365|NCT02186561|3939390|FG000|COMPLETED|1- Year Post Index Procedure Visit||139
3209366|NCT02186561|3939390|FG000|NOT COMPLETED|1- Year Post Index Procedure Visit||2
3209367|NCT02186561|3939390|FG000|STARTED|2 - Year Post Index Procedure Visit||141
3209368|NCT02186561|3939390|FG000|COMPLETED|2 - Year Post Index Procedure Visit||134
3209369|NCT02186561|3939390|FG000|NOT COMPLETED|2 - Year Post Index Procedure Visit||7
3209370|NCT02186561|3939390|FG000|STARTED|3 - Year Post Index Procedure Visit||141
3209371|NCT02186561|3939390|FG000|COMPLETED|3 - Year Post Index Procedure Visit||128
3209372|NCT02186561|3939390|FG000|NOT COMPLETED|3 - Year Post Index Procedure Visit||13
3209373|NCT02186587|3939398|FG000|STARTED|Overall Study||28
3209374|NCT02186587|3939399|FG001|STARTED|Overall Study||0
3209375|NCT02186587|3939398|FG000|COMPLETED|Overall Study||23
3209376|NCT02186587|3939399|FG001|COMPLETED|Overall Study||0
3209377|NCT02186587|3939398|FG000|NOT COMPLETED|Overall Study||5
3209378|NCT02186587|3939399|FG001|NOT COMPLETED|Overall Study||0
3209379|NCT02186652|3939406|FG000|STARTED|Overall Study||19
3209380|NCT02186652|3939407|FG001|STARTED|Overall Study||22
3209381|NCT02186652|3939406|FG000|COMPLETED|Overall Study||17
3209382|NCT02186652|3939407|FG001|COMPLETED|Overall Study||22
3209383|NCT02186652|3939406|FG000|NOT COMPLETED|Overall Study||2
3209384|NCT02186652|3939407|FG001|NOT COMPLETED|Overall Study||0
3209385|NCT02186665|3939422|FG000|STARTED|Overall Study||8
3209386|NCT02186665|3939423|FG001|STARTED|Overall Study||11
3209387|NCT02186665|3939422|FG000|COMPLETED|Overall Study||8
3209388|NCT02186665|3939423|FG001|COMPLETED|Overall Study||10
3209389|NCT02186665|3939422|FG000|NOT COMPLETED|Overall Study||0
3209390|NCT02186665|3939423|FG001|NOT COMPLETED|Overall Study||1
3209391|NCT02186795|3939431|FG000|STARTED|Overall Study||24
3209392|NCT02186795|3939432|FG001|STARTED|Overall Study||24
3209393|NCT02186795|3939431|FG000|COMPLETED|Overall Study||24
3209394|NCT02186795|3939432|FG001|COMPLETED|Overall Study||24
3209395|NCT02186795|3939431|FG000|NOT COMPLETED|Overall Study||0
3209396|NCT02186795|3939432|FG001|NOT COMPLETED|Overall Study||0
3209397|NCT02186808|3939438|FG000|STARTED|Overall Study||80
3209398|NCT02186808|3939438|FG000|COMPLETED|Overall Study||67
3209399|NCT02186808|3939438|FG000|NOT COMPLETED|Overall Study||13
3209400|NCT02186821|3939442|FG000|STARTED|Overall Study||47
3209401|NCT02186821|3939442|FG000|COMPLETED|Overall Study||0
3209402|NCT02186821|3939442|FG000|NOT COMPLETED|Overall Study||47
3209403|NCT02186847|3939448|FG000|STARTED|Overall Study||84
3209404|NCT02186847|3939449|FG001|STARTED|Overall Study||86
3209405|NCT02186847|3939448|FG000|Eligible Population|Overall Study||81
3209406|NCT02186847|3939449|FG001|Eligible Population|Overall Study||86
3209407|NCT02186847|3939448|FG000|Eligible and Started Protocol Treatment|Overall Study||76
3209408|NCT02186847|3939449|FG001|Eligible and Started Protocol Treatment|Overall Study||82
3209409|NCT02186847|3939448|FG000|COMPLETED|Overall Study||81
3209410|NCT02186847|3939449|FG001|COMPLETED|Overall Study||86
3209411|NCT02186847|3939448|FG000|NOT COMPLETED|Overall Study||3
3209412|NCT02186847|3939449|FG001|NOT COMPLETED|Overall Study||0
3209413|NCT02186873|3939457|FG000|STARTED|Overall Study||103
3209414|NCT02186873|3939458|FG001|STARTED|Overall Study||105
3209415|NCT02186873|3939457|FG000|End of Control Period|Overall Study|Participants taking placebo crossed over to golimumab|99
3209416|NCT02186873|3939458|FG001|End of Control Period|Overall Study|Participants continued to receive golimumab|105
3209417|NCT02186873|3939457|FG000|COMPLETED|Overall Study||94
3209418|NCT02186873|3939458|FG001|COMPLETED|Overall Study||97
3209419|NCT02186873|3939457|FG000|NOT COMPLETED|Overall Study||9
3209420|NCT02186873|3939458|FG001|NOT COMPLETED|Overall Study||8
3209421|NCT02186938|3939467|FG000|STARTED|Overall Study|2012|47
3209422|NCT02186938|3939468|FG001|STARTED|Overall Study||47
3209423|NCT02186938|3939467|FG000|COMPLETED|Overall Study||38
3209424|NCT02186938|3939468|FG001|COMPLETED|Overall Study||44
3209425|NCT02186938|3939467|FG000|NOT COMPLETED|Overall Study||9
3209426|NCT02186938|3939468|FG001|NOT COMPLETED|Overall Study||3
3209427|NCT02187016|3939478|FG000|STARTED|Overall Study||80
3209428|NCT02187016|3939479|FG001|STARTED|Overall Study||80
3209429|NCT02187016|3939480|FG002|STARTED|Overall Study||79
3209430|NCT02187016|3939481|FG003|STARTED|Overall Study||51
3209431|NCT02187016|3939478|FG000|COMPLETED|Overall Study||79
3209432|NCT02187016|3939479|FG001|COMPLETED|Overall Study||78
3209433|NCT02187016|3939480|FG002|COMPLETED|Overall Study||78
3209434|NCT02187016|3939481|FG003|COMPLETED|Overall Study||51
3209435|NCT02187016|3939478|FG000|NOT COMPLETED|Overall Study||1
3209436|NCT02187016|3939479|FG001|NOT COMPLETED|Overall Study||2
3209437|NCT02187016|3939480|FG002|NOT COMPLETED|Overall Study||1
3209438|NCT02187016|3939481|FG003|NOT COMPLETED|Overall Study||0
3209439|NCT02187029|3939495|FG000|STARTED|Overall Study||7
3209440|NCT02187029|3939496|FG001|STARTED|Overall Study||3
3209441|NCT02187029|3939497|FG002|STARTED|Overall Study||11
3209442|NCT02187029|3939498|FG003|STARTED|Overall Study||9
3209443|NCT02187029|3939495|FG000|COMPLETED|Overall Study||6
3209444|NCT02187029|3939496|FG001|COMPLETED|Overall Study||2
3209445|NCT02187029|3939497|FG002|COMPLETED|Overall Study||0
3209446|NCT02187029|3939498|FG003|COMPLETED|Overall Study||6
3209447|NCT02187029|3939495|FG000|NOT COMPLETED|Overall Study||1
3209448|NCT02187029|3939496|FG001|NOT COMPLETED|Overall Study||1
3209449|NCT02187029|3939497|FG002|NOT COMPLETED|Overall Study||11
3209450|NCT02187029|3939498|FG003|NOT COMPLETED|Overall Study||3
3209451|NCT02187042|3939510|FG000|STARTED|Overall Study||42
3209452|NCT02187042|3939511|FG001|STARTED|Overall Study||27
3209453|NCT02187042|3939510|FG000|COMPLETED|Overall Study||29
3209454|NCT02187042|3939511|FG001|COMPLETED|Overall Study||13
3209455|NCT02187042|3939510|FG000|NOT COMPLETED|Overall Study||13
3209456|NCT02187042|3939511|FG001|NOT COMPLETED|Overall Study||14
3209457|NCT02187055|3939521|FG000|STARTED|Overall Study|Treated|384
3209458|NCT02187055|3939522|FG001|STARTED|Overall Study|Treated|376
3209459|NCT02187055|3939523|FG002|STARTED|Overall Study|Treated|386
3209460|NCT02187055|3939521|FG000|COMPLETED|Overall Study||315
3209461|NCT02187055|3939522|FG001|COMPLETED|Overall Study||303
3209462|NCT02187055|3939523|FG002|COMPLETED|Overall Study||312
3209463|NCT02187055|3939521|FG000|NOT COMPLETED|Overall Study||69
3209464|NCT02187055|3939522|FG001|NOT COMPLETED|Overall Study||73
3209465|NCT02187055|3939523|FG002|NOT COMPLETED|Overall Study||74
3209466|NCT02187159|3939535|FG000|STARTED|Overall Study||318
3209467|NCT02187159|3939536|FG001|STARTED|Overall Study||317
3209468|NCT02187159|3939537|FG002|STARTED|Overall Study||318
3209469|NCT02187159|3939538|FG003|STARTED|Overall Study||317
3209470|NCT02187159|3939535|FG000|COMPLETED|Overall Study||249
3209471|NCT02187159|3939536|FG001|COMPLETED|Overall Study||238
3209472|NCT02187159|3939537|FG002|COMPLETED|Overall Study||241
3209473|NCT02187159|3939538|FG003|COMPLETED|Overall Study||221
3209474|NCT02187159|3939535|FG000|NOT COMPLETED|Overall Study||69
3209475|NCT02187159|3939536|FG001|NOT COMPLETED|Overall Study||79
3209476|NCT02187159|3939537|FG002|NOT COMPLETED|Overall Study||77
3209477|NCT02187159|3939538|FG003|NOT COMPLETED|Overall Study||96
3209478|NCT02187172|3939550|FG000|STARTED|Overall Study||22
3209479|NCT02187172|3939551|FG001|STARTED|Overall Study||21
3209480|NCT02187172|3939550|FG000|RCT Phase Completed|Overall Study||22
3209481|NCT02187172|3939551|FG001|RCT Phase Completed|Overall Study||19
3209482|NCT02187172|3939550|FG000|COMPLETED|Overall Study||19
3209483|NCT02187172|3939551|FG001|COMPLETED|Overall Study||15
3209484|NCT02187172|3939550|FG000|NOT COMPLETED|Overall Study||3
3209485|NCT02187172|3939551|FG001|NOT COMPLETED|Overall Study||6
3209486|NCT02187471|3939563|FG000|STARTED|Overall Study||325
3209487|NCT02187471|3939564|FG001|STARTED|Overall Study||324
3209488|NCT02187471|3939565|FG002|STARTED|Overall Study||326
3209489|NCT02187471|3939566|FG003|STARTED|Overall Study||326
3209490|NCT02187471|3939563|FG000|COMPLETED|Overall Study||249
3209491|NCT02187471|3939564|FG001|COMPLETED|Overall Study||242
3209492|NCT02187471|3939565|FG002|COMPLETED|Overall Study||240
3209493|NCT02187471|3939566|FG003|COMPLETED|Overall Study||246
3209494|NCT02187471|3939563|FG000|NOT COMPLETED|Overall Study||76
3209495|NCT02187471|3939564|FG001|NOT COMPLETED|Overall Study||82
3209496|NCT02187471|3939565|FG002|NOT COMPLETED|Overall Study||86
3209497|NCT02187471|3939566|FG003|NOT COMPLETED|Overall Study||80
3209498|NCT02187744|3939579|FG000|STARTED|Study|Received treatment|113
3209499|NCT02187744|3939580|FG001|STARTED|Study|Received treatment|112
3209500|NCT02187744|3939579|FG000|COMPLETED|Study||109
3209501|NCT02187744|3939580|FG001|COMPLETED|Study||106
3209502|NCT02187744|3939579|FG000|NOT COMPLETED|Study||4
3209503|NCT02187744|3939580|FG001|NOT COMPLETED|Study||6
3209504|NCT02187744|3939579|FG000|STARTED|Treatment||113
3209505|NCT02187744|3939580|FG001|STARTED|Treatment||112
3209506|NCT02187744|3939579|FG000|COMPLETED|Treatment||109
3209507|NCT02187744|3939580|FG001|COMPLETED|Treatment||107
3209508|NCT02187744|3939579|FG000|NOT COMPLETED|Treatment||4
3209509|NCT02187744|3939580|FG001|NOT COMPLETED|Treatment||5
3209510|NCT02187783|3939586|FG000|STARTED|Overall Study||106
3209511|NCT02187783|3939586|FG000|Patients With Solid Tumors|Overall Study||105
3209512|NCT02187783|3939586|FG000|COMPLETED|Overall Study||0
3209513|NCT02187783|3939586|FG000|NOT COMPLETED|Overall Study||106
3209514|NCT02187809|3939590|FG000|STARTED|Overall Study||3
3209515|NCT02187809|3939590|FG000|Treated|Overall Study||1
3209516|NCT02187809|3939590|FG000|COMPLETED|Overall Study||0
3209517|NCT02187809|3939590|FG000|NOT COMPLETED|Overall Study||3
3209518|NCT02187861|3939598|FG000|STARTED|Overall Study||9
3209519|NCT02187861|3939599|FG001|STARTED|Overall Study||52
3209520|NCT02187861|3939600|FG002|STARTED|Overall Study||51
3209521|NCT02187861|3939601|FG003|STARTED|Overall Study||51
3209522|NCT02187861|3939598|FG000|Treated|Overall Study||9
3209523|NCT02187861|3939599|FG001|Treated|Overall Study||52
3209524|NCT02187861|3939600|FG002|Treated|Overall Study||49
3209525|NCT02187861|3939601|FG003|Treated|Overall Study||50
3209526|NCT02187861|3939598|FG000|COMPLETED|Overall Study||3
3209527|NCT02187861|3939599|FG001|COMPLETED|Overall Study||4
3209528|NCT02187861|3939600|FG002|COMPLETED|Overall Study||19
3209529|NCT02187861|3939601|FG003|COMPLETED|Overall Study||19
3209530|NCT02187861|3939598|FG000|NOT COMPLETED|Overall Study||6
3209531|NCT02187861|3939599|FG001|NOT COMPLETED|Overall Study||48
3209532|NCT02187861|3939600|FG002|NOT COMPLETED|Overall Study||32
3209533|NCT02187861|3939601|FG003|NOT COMPLETED|Overall Study||32
3209534|NCT02187887|3939613|FG000|STARTED|Overall Study||393
3209535|NCT02187887|3939614|FG001|STARTED|Overall Study||400
3209536|NCT02187887|3939613|FG000|COMPLETED|Overall Study||388
3209537|NCT02187887|3939614|FG001|COMPLETED|Overall Study||396
3209538|NCT02187887|3939613|FG000|NOT COMPLETED|Overall Study||5
3209539|NCT02187887|3939614|FG001|NOT COMPLETED|Overall Study||4
3366283|NCT03931785|4097536|FG001|NOT COMPLETED|Overall Study||7
3366284|NCT03931785|4097537|FG002|NOT COMPLETED|Overall Study||13
3366285|NCT03931785|4097538|FG003|NOT COMPLETED|Overall Study||11
3366286|NCT03930641|4097548|FG000|STARTED|Overall Study||34
3366287|NCT03930641|4097548|FG000|COMPLETED|Overall Study||34
3366288|NCT03930641|4097548|FG000|NOT COMPLETED|Overall Study||0
3366289|NCT03927846|4097554|FG000|STARTED|Overall Study||30
3209540|NCT02188160|3939622|FG000|STARTED|Overall Study||73
3209541|NCT02188160|3939623|FG001|STARTED|Overall Study||77
3209542|NCT02188160|3939622|FG000|COMPLETED|Overall Study||72
3209543|NCT02188160|3939623|FG001|COMPLETED|Overall Study||76
3209544|NCT02188160|3939622|FG000|NOT COMPLETED|Overall Study||1
3209545|NCT02188160|3939623|FG001|NOT COMPLETED|Overall Study||1
3209546|NCT02188303|3939637|FG000|STARTED|Overall Study||6
3209547|NCT02188303|3939638|FG001|STARTED|Overall Study||6
3209548|NCT02188303|3939639|FG002|STARTED|Overall Study||6
3209549|NCT02188303|3939640|FG003|STARTED|Overall Study||6
3209550|NCT02188303|3939641|FG004|STARTED|Overall Study||4
3209551|NCT02188303|3939642|FG005|STARTED|Overall Study||12
3209552|NCT02188303|3939643|FG006|STARTED|Overall Study||2
3209553|NCT02188303|3939644|FG007|STARTED|Overall Study||6
3209554|NCT02188303|3939637|FG000|COMPLETED|Overall Study||6
3209555|NCT02188303|3939638|FG001|COMPLETED|Overall Study||6
3209556|NCT02188303|3939639|FG002|COMPLETED|Overall Study||6
3209557|NCT02188303|3939640|FG003|COMPLETED|Overall Study||6
3209558|NCT02188303|3939641|FG004|COMPLETED|Overall Study||4
3209559|NCT02188303|3939642|FG005|COMPLETED|Overall Study||10
3209560|NCT02188303|3939643|FG006|COMPLETED|Overall Study|Protocol-defined dose termination criteria met, dosing stopped on Day 5 and study was terminated.|0
3209561|NCT02188303|3939644|FG007|COMPLETED|Overall Study|Protocol-defined dose termination criteria met, dosing stopped on Day 5 and study was terminated.|0
3209562|NCT02188303|3939637|FG000|NOT COMPLETED|Overall Study||0
3209563|NCT02188303|3939638|FG001|NOT COMPLETED|Overall Study||0
3209564|NCT02188303|3939639|FG002|NOT COMPLETED|Overall Study||0
3209565|NCT02188303|3939640|FG003|NOT COMPLETED|Overall Study||0
3209566|NCT02188303|3939641|FG004|NOT COMPLETED|Overall Study||0
3209567|NCT02188303|3939642|FG005|NOT COMPLETED|Overall Study||2
3209568|NCT02188303|3939643|FG006|NOT COMPLETED|Overall Study||2
3209569|NCT02188303|3939644|FG007|NOT COMPLETED|Overall Study||6
3209570|NCT02188459|3939670|FG000|STARTED|Overall Study||64
3209571|NCT02188459|3939671|FG001|STARTED|Overall Study||65
3209572|NCT02188459|3939670|FG000|COMPLETED|Overall Study||61
3209573|NCT02188459|3939671|FG001|COMPLETED|Overall Study||58
3209574|NCT02188459|3939670|FG000|NOT COMPLETED|Overall Study||3
3209575|NCT02188459|3939671|FG001|NOT COMPLETED|Overall Study||7
3209576|NCT02188485|3939683|FG000|STARTED|Overall Study||32
3209577|NCT02188485|3939684|FG001|STARTED|Overall Study||30
3209578|NCT02188485|3939683|FG000|COMPLETED|Overall Study||30
3209579|NCT02188485|3939684|FG001|COMPLETED|Overall Study||27
3209580|NCT02188485|3939683|FG000|NOT COMPLETED|Overall Study||2
3209581|NCT02188485|3939684|FG001|NOT COMPLETED|Overall Study||3
3209582|NCT02188576|3939692|FG000|STARTED|Overall Study||32
3209583|NCT02188576|3939693|FG001|STARTED|Overall Study||34
3209584|NCT02188576|3939692|FG000|COMPLETED|Overall Study||32
3209585|NCT02188576|3939693|FG001|COMPLETED|Overall Study||34
3209586|NCT02188576|3939692|FG000|NOT COMPLETED|Overall Study||0
3209587|NCT02188576|3939693|FG001|NOT COMPLETED|Overall Study||0
3209588|NCT02188589|3939699|FG000|STARTED|Overall Study||30
3209589|NCT02188589|3939699|FG000|6 Months|Overall Study||30
3209590|NCT02188589|3939699|FG000|12 Months|Overall Study||30
3209591|NCT02188589|3939699|FG000|24 Months|Overall Study||25
3209592|NCT02188589|3939699|FG000|COMPLETED|Overall Study||25
3209593|NCT02188589|3939699|FG000|NOT COMPLETED|Overall Study||5
3209594|NCT02188719|3939708|FG000|STARTED|Overall Study||6
3209595|NCT02188719|3939709|FG001|STARTED|Overall Study||9
3209596|NCT02188719|3939710|FG002|STARTED|Overall Study||0
3209597|NCT02188719|3939711|FG003|STARTED|Overall Study||0
3209598|NCT02188719|3939708|FG000|COMPLETED|Overall Study||6
3209599|NCT02188719|3939709|FG001|COMPLETED|Overall Study||8
3209600|NCT02188719|3939710|FG002|COMPLETED|Overall Study||0
3209601|NCT02188719|3939711|FG003|COMPLETED|Overall Study||0
3209602|NCT02188719|3939708|FG000|NOT COMPLETED|Overall Study||0
3209603|NCT02188719|3939709|FG001|NOT COMPLETED|Overall Study||1
3209604|NCT02188719|3939710|FG002|NOT COMPLETED|Overall Study||0
3209605|NCT02188719|3939711|FG003|NOT COMPLETED|Overall Study||0
3209606|NCT02188784|3939721|FG000|STARTED|Overall Study||111
3209607|NCT02188784|3939722|FG001|STARTED|Overall Study||114
3209608|NCT02188784|3939721|FG000|COMPLETED|Overall Study|Patients completing the protocol excluding death, lost to follow-up and withdrawn consent.|102
3209609|NCT02188784|3939722|FG001|COMPLETED|Overall Study|Patients completing the protocol excluding death, lost to follow-up and withdrawn consent.|101
3209610|NCT02188784|3939721|FG000|NOT COMPLETED|Overall Study||9
3209611|NCT02188784|3939722|FG001|NOT COMPLETED|Overall Study||13
3209612|NCT02188849|3939730|FG000|STARTED|Overall Study||25
3209613|NCT02188849|3939731|FG001|STARTED|Overall Study||25
3209614|NCT02188849|3939730|FG000|COMPLETED|Overall Study||22
3209615|NCT02188849|3939731|FG001|COMPLETED|Overall Study||17
3209616|NCT02188849|3939730|FG000|NOT COMPLETED|Overall Study||3
3209617|NCT02188849|3939731|FG001|NOT COMPLETED|Overall Study||8
3209618|NCT02189122|3939739|FG000|STARTED|Overall Study||18
3209619|NCT02189122|3939740|FG001|STARTED|Overall Study||18
3209620|NCT02189122|3939739|FG000|COMPLETED|Overall Study||18
3209621|NCT02189122|3939740|FG001|COMPLETED|Overall Study||18
3209622|NCT02189122|3939739|FG000|NOT COMPLETED|Overall Study||0
3209623|NCT02189122|3939740|FG001|NOT COMPLETED|Overall Study||0
3209624|NCT02189161|3939748|FG000|STARTED|Overall Study||10
3209625|NCT02189161|3939748|FG000|COMPLETED|Overall Study||10
3209626|NCT02189161|3939748|FG000|NOT COMPLETED|Overall Study||0
3209627|NCT02189213|3939754|FG000|STARTED|Overall Study||13
3209628|NCT02189213|3939755|FG001|STARTED|Overall Study||1
3209629|NCT02189213|3939754|FG000|COMPLETED|Overall Study||7
3209630|NCT02189213|3939755|FG001|COMPLETED|Overall Study||1
3209631|NCT02189213|3939754|FG000|NOT COMPLETED|Overall Study||6
3209632|NCT02189213|3939755|FG001|NOT COMPLETED|Overall Study||0
3209633|NCT02189252|3939765|FG000|STARTED|Period 1 (Visit 4b, Week 4)||4
3209634|NCT02189252|3939766|FG001|STARTED|Period 1 (Visit 4b, Week 4)||4
3209635|NCT02189252|3939767|FG002|STARTED|Period 1 (Visit 4b, Week 4)||3
3209636|NCT02189252|3939768|FG003|STARTED|Period 1 (Visit 4b, Week 4)||4
3209637|NCT02189252|3939765|FG000|COMPLETED|Period 1 (Visit 4b, Week 4)||4
3209638|NCT02189252|3939766|FG001|COMPLETED|Period 1 (Visit 4b, Week 4)||2
3209639|NCT02189252|3939767|FG002|COMPLETED|Period 1 (Visit 4b, Week 4)||3
3209640|NCT02189252|3939768|FG003|COMPLETED|Period 1 (Visit 4b, Week 4)||4
3209641|NCT02189252|3939765|FG000|NOT COMPLETED|Period 1 (Visit 4b, Week 4)||0
3209642|NCT02189252|3939766|FG001|NOT COMPLETED|Period 1 (Visit 4b, Week 4)||2
3209643|NCT02189252|3939767|FG002|NOT COMPLETED|Period 1 (Visit 4b, Week 4)||0
3209644|NCT02189252|3939768|FG003|NOT COMPLETED|Period 1 (Visit 4b, Week 4)||0
3209645|NCT02189252|3939765|FG000|STARTED|Period 2 (Visit6b, Week 12)||4
3209646|NCT02189252|3939766|FG001|STARTED|Period 2 (Visit6b, Week 12)||2
3209647|NCT02189252|3939767|FG002|STARTED|Period 2 (Visit6b, Week 12)||3
3209648|NCT02189252|3939768|FG003|STARTED|Period 2 (Visit6b, Week 12)||4
3209649|NCT02189252|3939765|FG000|COMPLETED|Period 2 (Visit6b, Week 12)||4
3209650|NCT02189252|3939766|FG001|COMPLETED|Period 2 (Visit6b, Week 12)||2
3209651|NCT02189252|3939767|FG002|COMPLETED|Period 2 (Visit6b, Week 12)||3
3209652|NCT02189252|3939768|FG003|COMPLETED|Period 2 (Visit6b, Week 12)||4
3209653|NCT02189252|3939765|FG000|NOT COMPLETED|Period 2 (Visit6b, Week 12)||0
3209654|NCT02189252|3939766|FG001|NOT COMPLETED|Period 2 (Visit6b, Week 12)||0
3209655|NCT02189252|3939767|FG002|NOT COMPLETED|Period 2 (Visit6b, Week 12)||0
3209656|NCT02189252|3939768|FG003|NOT COMPLETED|Period 2 (Visit6b, Week 12)||0
3209657|NCT02189317|3939781|FG000|STARTED|Overall Study||16
3209658|NCT02189317|3939782|FG001|STARTED|Overall Study||16
3209659|NCT02189317|3939781|FG000|COMPLETED|Overall Study||16
3209660|NCT02189317|3939782|FG001|COMPLETED|Overall Study||16
3209661|NCT02189317|3939781|FG000|NOT COMPLETED|Overall Study||0
3209662|NCT02189317|3939782|FG001|NOT COMPLETED|Overall Study||0
3209663|NCT02189382|3939790|FG000|STARTED|Overall Study||35
3209664|NCT02189382|3939791|FG001|STARTED|Overall Study||35
3209665|NCT02189382|3939790|FG000|COMPLETED|Overall Study||35
3209666|NCT02189382|3939791|FG001|COMPLETED|Overall Study||35
3209667|NCT02189382|3939790|FG000|NOT COMPLETED|Overall Study||0
3209668|NCT02189382|3939791|FG001|NOT COMPLETED|Overall Study||0
3209669|NCT02189473|3939799|FG000|STARTED|Overall Study||101
3209670|NCT02189473|3939800|FG001|STARTED|Overall Study||102
3209671|NCT02189473|3939799|FG000|COMPLETED|Overall Study||78
3209672|NCT02189473|3939800|FG001|COMPLETED|Overall Study||77
3209673|NCT02189473|3939799|FG000|NOT COMPLETED|Overall Study||23
3209674|NCT02189473|3939800|FG001|NOT COMPLETED|Overall Study||25
3209675|NCT02189629|3939806|FG000|STARTED|Overall Study||453
3209676|NCT02189629|3939806|FG000|COMPLETED|Overall Study||348
3209677|NCT02189629|3939806|FG000|NOT COMPLETED|Overall Study||105
3209678|NCT02189668|3939812|FG000|STARTED|Overall Study||5
3209679|NCT02189668|3939813|FG001|STARTED|Overall Study||9
3209680|NCT02189668|3939812|FG000|COMPLETED|Overall Study||5
3209681|NCT02189668|3939813|FG001|COMPLETED|Overall Study||9
3209682|NCT02189668|3939812|FG000|NOT COMPLETED|Overall Study||0
3209683|NCT02189668|3939813|FG001|NOT COMPLETED|Overall Study||0
3209684|NCT02189759|3939823|FG000|STARTED|Overall Study||102
3209685|NCT02189759|3939824|FG001|STARTED|Overall Study||101
3209686|NCT02189759|3939825|FG002|STARTED|Overall Study||83
3209687|NCT02189759|3939826|FG003|STARTED|Overall Study||89
3209688|NCT02189759|3939823|FG000|COMPLETED|Overall Study||102
3209689|NCT02189759|3939824|FG001|COMPLETED|Overall Study||101
3209690|NCT02189759|3939825|FG002|COMPLETED|Overall Study||81
3209691|NCT02189759|3939826|FG003|COMPLETED|Overall Study||84
3209692|NCT02189759|3939823|FG000|NOT COMPLETED|Overall Study||0
3209693|NCT02189759|3939824|FG001|NOT COMPLETED|Overall Study||0
3209694|NCT02189759|3939825|FG002|NOT COMPLETED|Overall Study||2
3209695|NCT02189759|3939826|FG003|NOT COMPLETED|Overall Study||5
3209696|NCT02189837|3939842|FG000|STARTED|Overall Study||22
3209697|NCT02189837|3939843|FG001|STARTED|Overall Study||23
3209698|NCT02189837|3939844|FG002|STARTED|Overall Study||23
3209699|NCT02189837|3939845|FG003|STARTED|Overall Study||21
3209700|NCT02189837|3939842|FG000|Received Treatment|Overall Study||21
3209701|NCT02189837|3939843|FG001|Received Treatment|Overall Study||22
3209702|NCT02189837|3939844|FG002|Received Treatment|Overall Study||22
3209703|NCT02189837|3939845|FG003|Received Treatment|Overall Study||20
3209704|NCT02189837|3939842|FG000|COMPLETED|Overall Study||20
3209705|NCT02189837|3939843|FG001|COMPLETED|Overall Study||22
3209706|NCT02189837|3939844|FG002|COMPLETED|Overall Study||20
3209707|NCT02189837|3939845|FG003|COMPLETED|Overall Study||19
3209708|NCT02189837|3939842|FG000|NOT COMPLETED|Overall Study||2
3209709|NCT02189837|3939843|FG001|NOT COMPLETED|Overall Study||1
3209710|NCT02189837|3939844|FG002|NOT COMPLETED|Overall Study||3
3209711|NCT02189837|3939845|FG003|NOT COMPLETED|Overall Study||2
3209712|NCT02189850|3939857|FG000|STARTED|Overall Study||16
3209713|NCT02189850|3939858|FG001|STARTED|Overall Study||13
3209714|NCT02189850|3939857|FG000|COMPLETED|Overall Study||14
3209715|NCT02189850|3939858|FG001|COMPLETED|Overall Study||11
3209716|NCT02189850|3939857|FG000|NOT COMPLETED|Overall Study||2
3209717|NCT02189850|3939858|FG001|NOT COMPLETED|Overall Study||2
3209718|NCT02189863|3939864|FG000|STARTED|First 2 Weeks||12
3209719|NCT02189863|3939865|FG001|STARTED|First 2 Weeks||15
3209720|NCT02189863|3939864|FG000|COMPLETED|First 2 Weeks||8
3209721|NCT02189863|3939865|FG001|COMPLETED|First 2 Weeks||13
3209722|NCT02189863|3939864|FG000|NOT COMPLETED|First 2 Weeks||4
3209723|NCT02189863|3939865|FG001|NOT COMPLETED|First 2 Weeks||2
3209724|NCT02189863|3939864|FG000|STARTED|Second 2 Weeks||8
3209725|NCT02189863|3939865|FG001|STARTED|Second 2 Weeks||13
3209726|NCT02189863|3939864|FG000|COMPLETED|Second 2 Weeks||8
3209727|NCT02189863|3939865|FG001|COMPLETED|Second 2 Weeks||13
3209728|NCT02189863|3939864|FG000|NOT COMPLETED|Second 2 Weeks||0
3209729|NCT02189863|3939865|FG001|NOT COMPLETED|Second 2 Weeks||0
3209730|NCT02189889|3939876|FG000|STARTED|Overall Study||2
3209731|NCT02189889|3939877|FG001|STARTED|Overall Study||3
3209732|NCT02189889|3939876|FG000|COMPLETED|Overall Study||2
3209733|NCT02189889|3939877|FG001|COMPLETED|Overall Study||3
3209734|NCT02189889|3939876|FG000|NOT COMPLETED|Overall Study||0
3209735|NCT02189889|3939877|FG001|NOT COMPLETED|Overall Study||0
3209736|NCT02189915|3939883|FG000|STARTED|Overall Study||14
3209737|NCT02189915|3939883|FG000|COMPLETED|Overall Study||11
3209738|NCT02189915|3939883|FG000|NOT COMPLETED|Overall Study||3
3209739|NCT02189941|3939887|FG000|STARTED|Overall Study||4
3209740|NCT02189941|3939888|FG001|STARTED|Overall Study||4
3209741|NCT02189941|3939889|FG002|STARTED|Overall Study||3
3209742|NCT02189941|3939887|FG000|COMPLETED|Overall Study||4
3209743|NCT02189941|3939888|FG001|COMPLETED|Overall Study||4
3209744|NCT02189941|3939889|FG002|COMPLETED|Overall Study||2
3209745|NCT02189941|3939887|FG000|NOT COMPLETED|Overall Study||0
3209746|NCT02189941|3939888|FG001|NOT COMPLETED|Overall Study||0
3209747|NCT02189941|3939889|FG002|NOT COMPLETED|Overall Study||1
3209748|NCT02189954|3939899|FG000|STARTED|Overall Study||45
3209749|NCT02189954|3939900|FG001|STARTED|Overall Study||45
3209750|NCT02189954|3939899|FG000|COMPLETED|Overall Study||45
3209751|NCT02189954|3939900|FG001|COMPLETED|Overall Study||45
3209752|NCT02189954|3939899|FG000|NOT COMPLETED|Overall Study||0
3209753|NCT02189954|3939900|FG001|NOT COMPLETED|Overall Study||0
3209754|NCT02190045|3939908|FG000|STARTED|Overall Study||15
3209755|NCT02190045|3939909|FG001|STARTED|Overall Study||15
3209756|NCT02190045|3939908|FG000|COMPLETED|Overall Study||12
3209757|NCT02190045|3939909|FG001|COMPLETED|Overall Study||15
3209758|NCT02190045|3939908|FG000|NOT COMPLETED|Overall Study||3
3209759|NCT02190045|3939909|FG001|NOT COMPLETED|Overall Study||0
3209760|NCT02190279|3939918|FG000|STARTED|Overall Study||16
3209761|NCT02190279|3939919|FG001|STARTED|Overall Study||69
3209762|NCT02190279|3939920|FG002|STARTED|Overall Study||31
3209763|NCT02190279|3939918|FG000|COMPLETED|Overall Study||13
3209764|NCT02190279|3939919|FG001|COMPLETED|Overall Study||69
3209765|NCT02190279|3939920|FG002|COMPLETED|Overall Study||28
3209766|NCT02190279|3939918|FG000|NOT COMPLETED|Overall Study||3
3209767|NCT02190279|3939919|FG001|NOT COMPLETED|Overall Study||0
3209768|NCT02190279|3939920|FG002|NOT COMPLETED|Overall Study||3
3209769|NCT02190435|3939932|FG000|STARTED|Overall Study||41
3209770|NCT02190435|3939933|FG001|STARTED|Overall Study||24
3209771|NCT02190435|3939932|FG000|COMPLETED|Overall Study||26
3209772|NCT02190435|3939933|FG001|COMPLETED|Overall Study||24
3209773|NCT02190435|3939932|FG000|NOT COMPLETED|Overall Study||15
3209774|NCT02190435|3939933|FG001|NOT COMPLETED|Overall Study||0
3209775|NCT02190552|3939939|FG000|STARTED|Overall Study||40
3209776|NCT02190552|3939939|FG000|COMPLETED|Overall Study||36
3209777|NCT02190552|3939939|FG000|NOT COMPLETED|Overall Study||4
3209778|NCT02190591|3939946|FG000|STARTED|Overall Study||102
3209779|NCT02190591|3939947|FG001|STARTED|Overall Study||102
3209780|NCT02190591|3939946|FG000|COMPLETED|Overall Study||100
3209781|NCT02190591|3939947|FG001|COMPLETED|Overall Study||91
3209782|NCT02190591|3939946|FG000|NOT COMPLETED|Overall Study||2
3209783|NCT02190591|3939947|FG001|NOT COMPLETED|Overall Study||11
3209784|NCT02190604|3939972|FG000|STARTED|Part 1 and 2 (Healthy Volunteers)||6
3366290|NCT03927846|4097555|FG001|STARTED|Overall Study||30
3366291|NCT03927846|4097554|FG000|COMPLETED|Overall Study||20
3366292|NCT03927846|4097555|FG001|COMPLETED|Overall Study||19
3366293|NCT03927846|4097554|FG000|NOT COMPLETED|Overall Study||10
3366294|NCT03927846|4097555|FG001|NOT COMPLETED|Overall Study||11
3366295|NCT03927105|4097561|FG000|STARTED|Overall Study||4
3366296|NCT03927105|4097561|FG000|Began Treatment|Overall Study||3
3366297|NCT03927105|4097561|FG000|Follow-up|Overall Study||3
3366298|NCT03927105|4097561|FG000|COMPLETED|Overall Study||0
3366299|NCT03927105|4097561|FG000|NOT COMPLETED|Overall Study||4
3366300|NCT03923933|4097567|FG000|STARTED|Overall Study||17
3366301|NCT03923933|4097568|FG001|STARTED|Overall Study||17
3366302|NCT03923933|4097567|FG000|COMPLETED|Overall Study||16
3366303|NCT03923933|4097568|FG001|COMPLETED|Overall Study||16
3366304|NCT03923933|4097567|FG000|NOT COMPLETED|Overall Study||1
3209785|NCT02190604|3939973|FG001|STARTED|Part 1 and 2 (Healthy Volunteers)||6
3209786|NCT02190604|3939974|FG002|STARTED|Part 1 and 2 (Healthy Volunteers)||6
3209787|NCT02190604|3939975|FG003|STARTED|Part 1 and 2 (Healthy Volunteers)||6
3209788|NCT02190604|3939976|FG004|STARTED|Part 1 and 2 (Healthy Volunteers)||6
3209789|NCT02190604|3939977|FG005|STARTED|Part 1 and 2 (Healthy Volunteers)||6
3209790|NCT02190604|3939978|FG006|STARTED|Part 1 and 2 (Healthy Volunteers)||6
3366305|NCT03923933|4097568|FG001|NOT COMPLETED|Overall Study||1
3366306|NCT03909295|4097574|FG000|STARTED|Overall Study||52
3366307|NCT03909295|4097574|FG000|Safety Set (SAF)|Overall Study||52
3366308|NCT03909295|4097574|FG000|COMPLETED|Overall Study||0
3209791|NCT02190604|3939979|FG007|STARTED|Part 1 and 2 (Healthy Volunteers)||6
3209792|NCT02190604|3939980|FG008|STARTED|Part 1 and 2 (Healthy Volunteers)||16
3209793|NCT02190604|3939981|FG009|STARTED|Part 1 and 2 (Healthy Volunteers)||6
3209794|NCT02190604|3939982|FG010|STARTED|Part 1 and 2 (Healthy Volunteers)||6
3209795|NCT02190604|3939983|FG011|STARTED|Part 1 and 2 (Healthy Volunteers)||6
3209796|NCT02190604|3939984|FG012|STARTED|Part 1 and 2 (Healthy Volunteers)||6
3209797|NCT02190604|3939985|FG013|STARTED|Part 1 and 2 (Healthy Volunteers)||6
3209798|NCT02190604|3939986|FG014|STARTED|Part 1 and 2 (Healthy Volunteers)||10
3209799|NCT02190604|3939987|FG015|STARTED|Part 1 and 2 (Healthy Volunteers)||0
3209800|NCT02190604|3939988|FG016|STARTED|Part 1 and 2 (Healthy Volunteers)||0
3209801|NCT02190604|3939989|FG017|STARTED|Part 1 and 2 (Healthy Volunteers)||0
3209802|NCT02190604|3939990|FG018|STARTED|Part 1 and 2 (Healthy Volunteers)||0
3209803|NCT02190604|3939972|FG000|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
3209804|NCT02190604|3939973|FG001|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
3209805|NCT02190604|3939974|FG002|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
3209806|NCT02190604|3939975|FG003|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
3209807|NCT02190604|3939976|FG004|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
3209808|NCT02190604|3939977|FG005|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
3209809|NCT02190604|3939978|FG006|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
3209810|NCT02190604|3939979|FG007|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
3209811|NCT02190604|3939980|FG008|COMPLETED|Part 1 and 2 (Healthy Volunteers)||16
3209812|NCT02190604|3939981|FG009|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
3209813|NCT02190604|3939982|FG010|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
3209814|NCT02190604|3939983|FG011|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
3209815|NCT02190604|3939984|FG012|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
3209816|NCT02190604|3939985|FG013|COMPLETED|Part 1 and 2 (Healthy Volunteers)||5
3209817|NCT02190604|3939986|FG014|COMPLETED|Part 1 and 2 (Healthy Volunteers)||8
3209818|NCT02190604|3939987|FG015|COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
3209819|NCT02190604|3939988|FG016|COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
3209820|NCT02190604|3939989|FG017|COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
3209821|NCT02190604|3939990|FG018|COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
3209822|NCT02190604|3939972|FG000|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
3209823|NCT02190604|3939973|FG001|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
3209824|NCT02190604|3939974|FG002|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
3209825|NCT02190604|3939975|FG003|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
3209826|NCT02190604|3939976|FG004|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
3209827|NCT02190604|3939977|FG005|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
3209828|NCT02190604|3939978|FG006|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
3209829|NCT02190604|3939979|FG007|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
3209830|NCT02190604|3939980|FG008|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
3209831|NCT02190604|3939981|FG009|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
3209832|NCT02190604|3939982|FG010|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
3209833|NCT02190604|3939983|FG011|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
3209834|NCT02190604|3939984|FG012|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
3209835|NCT02190604|3939985|FG013|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||1
3209836|NCT02190604|3939986|FG014|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||2
3209837|NCT02190604|3939987|FG015|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
3209838|NCT02190604|3939988|FG016|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
3209839|NCT02190604|3939989|FG017|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
3209840|NCT02190604|3939990|FG018|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
3209841|NCT02190604|3939972|FG000|STARTED|Part 3 (Patients)||0
3209842|NCT02190604|3939973|FG001|STARTED|Part 3 (Patients)||0
3209843|NCT02190604|3939974|FG002|STARTED|Part 3 (Patients)||0
3209844|NCT02190604|3939975|FG003|STARTED|Part 3 (Patients)||0
3209845|NCT02190604|3939976|FG004|STARTED|Part 3 (Patients)||0
3209846|NCT02190604|3939977|FG005|STARTED|Part 3 (Patients)||0
3209847|NCT02190604|3939978|FG006|STARTED|Part 3 (Patients)||0
3209848|NCT02190604|3939979|FG007|STARTED|Part 3 (Patients)||0
3209849|NCT02190604|3939980|FG008|STARTED|Part 3 (Patients)||0
3209850|NCT02190604|3939981|FG009|STARTED|Part 3 (Patients)||0
3209851|NCT02190604|3939982|FG010|STARTED|Part 3 (Patients)||0
3209852|NCT02190604|3939983|FG011|STARTED|Part 3 (Patients)||0
3209853|NCT02190604|3939984|FG012|STARTED|Part 3 (Patients)||0
3209854|NCT02190604|3939985|FG013|STARTED|Part 3 (Patients)||0
3209855|NCT02190604|3939986|FG014|STARTED|Part 3 (Patients)||0
3209856|NCT02190604|3939987|FG015|STARTED|Part 3 (Patients)||6
3209857|NCT02190604|3939988|FG016|STARTED|Part 3 (Patients)||12
3209858|NCT02190604|3939989|FG017|STARTED|Part 3 (Patients)||19
3209859|NCT02190604|3939990|FG018|STARTED|Part 3 (Patients)||12
3209860|NCT02190604|3939972|FG000|COMPLETED|Part 3 (Patients)||0
3209861|NCT02190604|3939973|FG001|COMPLETED|Part 3 (Patients)||0
3209862|NCT02190604|3939974|FG002|COMPLETED|Part 3 (Patients)||0
3209863|NCT02190604|3939975|FG003|COMPLETED|Part 3 (Patients)||0
3209864|NCT02190604|3939976|FG004|COMPLETED|Part 3 (Patients)||0
3209865|NCT02190604|3939977|FG005|COMPLETED|Part 3 (Patients)||0
3209866|NCT02190604|3939978|FG006|COMPLETED|Part 3 (Patients)||0
3209867|NCT02190604|3939979|FG007|COMPLETED|Part 3 (Patients)||0
3209868|NCT02190604|3939980|FG008|COMPLETED|Part 3 (Patients)||0
3209869|NCT02190604|3939981|FG009|COMPLETED|Part 3 (Patients)||0
3209870|NCT02190604|3939982|FG010|COMPLETED|Part 3 (Patients)||0
3209871|NCT02190604|3939983|FG011|COMPLETED|Part 3 (Patients)||0
3209872|NCT02190604|3939984|FG012|COMPLETED|Part 3 (Patients)||0
3209873|NCT02190604|3939985|FG013|COMPLETED|Part 3 (Patients)||0
3209874|NCT02190604|3939986|FG014|COMPLETED|Part 3 (Patients)||0
3209875|NCT02190604|3939987|FG015|COMPLETED|Part 3 (Patients)||6
3209876|NCT02190604|3939988|FG016|COMPLETED|Part 3 (Patients)||12
3209877|NCT02190604|3939989|FG017|COMPLETED|Part 3 (Patients)||19
3209878|NCT02190604|3939990|FG018|COMPLETED|Part 3 (Patients)||12
3209879|NCT02190604|3939972|FG000|NOT COMPLETED|Part 3 (Patients)||0
3209880|NCT02190604|3939973|FG001|NOT COMPLETED|Part 3 (Patients)||0
3209881|NCT02190604|3939974|FG002|NOT COMPLETED|Part 3 (Patients)||0
3209882|NCT02190604|3939975|FG003|NOT COMPLETED|Part 3 (Patients)||0
3209883|NCT02190604|3939976|FG004|NOT COMPLETED|Part 3 (Patients)||0
3209884|NCT02190604|3939977|FG005|NOT COMPLETED|Part 3 (Patients)||0
3209885|NCT02190604|3939978|FG006|NOT COMPLETED|Part 3 (Patients)||0
3209886|NCT02190604|3939979|FG007|NOT COMPLETED|Part 3 (Patients)||0
3209887|NCT02190604|3939980|FG008|NOT COMPLETED|Part 3 (Patients)||0
3209888|NCT02190604|3939981|FG009|NOT COMPLETED|Part 3 (Patients)||0
3209889|NCT02190604|3939982|FG010|NOT COMPLETED|Part 3 (Patients)||0
3209890|NCT02190604|3939983|FG011|NOT COMPLETED|Part 3 (Patients)||0
3209891|NCT02190604|3939984|FG012|NOT COMPLETED|Part 3 (Patients)||0
3209892|NCT02190604|3939985|FG013|NOT COMPLETED|Part 3 (Patients)||0
3209893|NCT02190604|3939986|FG014|NOT COMPLETED|Part 3 (Patients)||0
3209894|NCT02190604|3939987|FG015|NOT COMPLETED|Part 3 (Patients)||0
3209895|NCT02190604|3939988|FG016|NOT COMPLETED|Part 3 (Patients)||0
3209896|NCT02190604|3939989|FG017|NOT COMPLETED|Part 3 (Patients)||0
3209897|NCT02190604|3939990|FG018|NOT COMPLETED|Part 3 (Patients)||0
3209898|NCT02190747|3940050|FG000|STARTED|Overall Study||21
3209899|NCT02190747|3940051|FG001|STARTED|Overall Study||9
3209900|NCT02190747|3940052|FG002|STARTED|Overall Study||10
3209901|NCT02190747|3940050|FG000|COMPLETED|Overall Study||21
3209902|NCT02190747|3940051|FG001|COMPLETED|Overall Study||9
3209903|NCT02190747|3940052|FG002|COMPLETED|Overall Study||10
3209904|NCT02190747|3940050|FG000|NOT COMPLETED|Overall Study||0
3209905|NCT02190747|3940051|FG001|NOT COMPLETED|Overall Study||0
3209906|NCT02190747|3940052|FG002|NOT COMPLETED|Overall Study||0
3209907|NCT02190903|3940062|FG000|STARTED|Overall Study||6
3209908|NCT02190903|3940063|FG001|STARTED|Overall Study||6
3209909|NCT02190903|3940062|FG000|COMPLETED|Overall Study||6
3209910|NCT02190903|3940063|FG001|COMPLETED|Overall Study||6
3209911|NCT02190903|3940062|FG000|NOT COMPLETED|Overall Study||0
3209912|NCT02190903|3940063|FG001|NOT COMPLETED|Overall Study||0
3366309|NCT03909295|4097574|FG000|NOT COMPLETED|Overall Study||52
3366310|NCT03908970|4097580|FG000|STARTED|Overall Study||182
3366311|NCT03908970|4097581|FG001|STARTED|Overall Study||182
3366312|NCT03908970|4097580|FG000|COMPLETED|Overall Study||165
3366313|NCT03908970|4097581|FG001|COMPLETED|Overall Study||135
3366314|NCT03908970|4097580|FG000|NOT COMPLETED|Overall Study||17
3366315|NCT03908970|4097581|FG001|NOT COMPLETED|Overall Study||47
3366316|NCT03897179|4097587|FG000|STARTED|Overall Study||27
3366317|NCT03897179|4097587|FG000|COMPLETED|Overall Study||26
3366318|NCT03897179|4097587|FG000|NOT COMPLETED|Overall Study||1
3366319|NCT03930264|4097593|FG000|STARTED|Overall Study||15
3366320|NCT03930264|4097594|FG001|STARTED|Overall Study||15
3366321|NCT03930264|4097593|FG000|COMPLETED|Overall Study||15
3366322|NCT03930264|4097594|FG001|COMPLETED|Overall Study||14
3366323|NCT03930264|4097593|FG000|NOT COMPLETED|Overall Study||0
3366324|NCT03930264|4097594|FG001|NOT COMPLETED|Overall Study||1
3366325|NCT03929367|4097600|FG000|STARTED|Overall Study||11
3366326|NCT03929367|4097600|FG000|COMPLETED|Overall Study||11
3366327|NCT03929367|4097600|FG000|NOT COMPLETED|Overall Study||0
3366328|NCT03928522|4097609|FG000|STARTED|Overall Study||12
3366329|NCT03928522|4097610|FG001|STARTED|Overall Study||12
3366330|NCT03928522|4097611|FG002|STARTED|Overall Study||12
3366331|NCT03928522|4097612|FG003|STARTED|Overall Study||12
3366332|NCT03928522|4097613|FG004|STARTED|Overall Study||12
3366333|NCT03928522|4097609|FG000|COMPLETED|Overall Study||12
3366334|NCT03928522|4097610|FG001|COMPLETED|Overall Study||12
3366335|NCT03928522|4097611|FG002|COMPLETED|Overall Study||12
3366336|NCT03928522|4097612|FG003|COMPLETED|Overall Study||12
3366337|NCT03928522|4097613|FG004|COMPLETED|Overall Study||12
3366338|NCT03928522|4097609|FG000|NOT COMPLETED|Overall Study||0
3366339|NCT03928522|4097610|FG001|NOT COMPLETED|Overall Study||0
3366340|NCT03928522|4097611|FG002|NOT COMPLETED|Overall Study||0
3366341|NCT03928522|4097612|FG003|NOT COMPLETED|Overall Study||0
3366342|NCT03928522|4097613|FG004|NOT COMPLETED|Overall Study||0
3209913|NCT02191033|3940071|FG000|STARTED|Overall Study||20
3209914|NCT02191033|3940072|FG001|STARTED|Overall Study||20
3209915|NCT02191033|3940071|FG000|COMPLETED|Overall Study||18
3209916|NCT02191033|3940072|FG001|COMPLETED|Overall Study||19
3209917|NCT02191033|3940071|FG000|NOT COMPLETED|Overall Study||2
3209918|NCT02191033|3940072|FG001|NOT COMPLETED|Overall Study||1
3209919|NCT02191046|3940080|FG000|STARTED|Overall Study||41
3209920|NCT02191046|3940081|FG001|STARTED|Overall Study||39
3209921|NCT02191046|3940080|FG000|COMPLETED|Overall Study|exclude 5 patients because low compliance|36
3209922|NCT02191046|3940081|FG001|COMPLETED|Overall Study|exclude 1 patient because low compliance|38
3209923|NCT02191046|3940080|FG000|NOT COMPLETED|Overall Study||5
3209924|NCT02191046|3940081|FG001|NOT COMPLETED|Overall Study||1
3209925|NCT02191137|3940087|FG000|STARTED|Treatment||75
3209926|NCT02191137|3940087|FG000|COMPLETED|Treatment||65
3209927|NCT02191137|3940087|FG000|NOT COMPLETED|Treatment||10
3209928|NCT02191137|3940087|FG000|STARTED|Follow-up||65
3209929|NCT02191137|3940087|FG000|COMPLETED|Follow-up||60
3209930|NCT02191137|3940087|FG000|NOT COMPLETED|Follow-up||5
3209931|NCT02191267|3940094|FG000|STARTED|Overall Study||20
3209932|NCT02191267|3940095|FG001|STARTED|Overall Study||6
3209933|NCT02191267|3940096|FG002|STARTED|Overall Study||4
3209934|NCT02191267|3940094|FG000|COMPLETED|Overall Study||19
3209935|NCT02191267|3940095|FG001|COMPLETED|Overall Study||6
3209936|NCT02191267|3940096|FG002|COMPLETED|Overall Study||4
3209937|NCT02191267|3940094|FG000|NOT COMPLETED|Overall Study||1
3209938|NCT02191267|3940095|FG001|NOT COMPLETED|Overall Study||0
3209939|NCT02191267|3940096|FG002|NOT COMPLETED|Overall Study||0
3209940|NCT02191397|3940106|FG000|STARTED|Overall Study||266
3209941|NCT02191397|3940107|FG001|STARTED|Overall Study||268
3209942|NCT02191397|3940106|FG000|COMPLETED|Overall Study||183
3209943|NCT02191397|3940107|FG001|COMPLETED|Overall Study||198
3209944|NCT02191397|3940106|FG000|NOT COMPLETED|Overall Study||83
3209945|NCT02191397|3940107|FG001|NOT COMPLETED|Overall Study||70
3209946|NCT02191579|3940115|FG000|STARTED|Treatment 1||140
3209947|NCT02191579|3940116|FG001|STARTED|Treatment 1||142
3209948|NCT02191579|3940115|FG000|COMPLETED|Treatment 1||113
3209949|NCT02191579|3940116|FG001|COMPLETED|Treatment 1||84
3209950|NCT02191579|3940115|FG000|NOT COMPLETED|Treatment 1||27
3209951|NCT02191579|3940116|FG001|NOT COMPLETED|Treatment 1||58
3209952|NCT02191579|3940115|FG000|STARTED|Treatment 2||0
3209953|NCT02191579|3940116|FG001|STARTED|Treatment 2||80
3209954|NCT02191579|3940115|FG000|COMPLETED|Treatment 2||0
3209955|NCT02191579|3940116|FG001|COMPLETED|Treatment 2||55
3209956|NCT02191579|3940115|FG000|NOT COMPLETED|Treatment 2||0
3209957|NCT02191579|3940116|FG001|NOT COMPLETED|Treatment 2||25
3209958|NCT02191605|3940127|FG000|STARTED|Overall Study||15
3209959|NCT02191605|3940128|FG001|STARTED|Overall Study||15
3209960|NCT02191605|3940129|FG002|STARTED|Overall Study||15
3209961|NCT02191605|3940130|FG003|STARTED|Overall Study||8
3209962|NCT02191605|3940131|FG004|STARTED|Overall Study||7
3209963|NCT02191605|3940127|FG000|Completed Intervention Portion|Overall Study||15
3209964|NCT02191605|3940128|FG001|Completed Intervention Portion|Overall Study||15
3209965|NCT02191605|3940129|FG002|Completed Intervention Portion|Overall Study||15
3209966|NCT02191605|3940130|FG003|Completed Intervention Portion|Overall Study||8
3209967|NCT02191605|3940131|FG004|Completed Intervention Portion|Overall Study||7
3209968|NCT02191605|3940127|FG000|COMPLETED|Overall Study||6
3209969|NCT02191605|3940128|FG001|COMPLETED|Overall Study||11
3209970|NCT02191605|3940129|FG002|COMPLETED|Overall Study||8
3209971|NCT02191605|3940130|FG003|COMPLETED|Overall Study||5
3209972|NCT02191605|3940131|FG004|COMPLETED|Overall Study||3
3209973|NCT02191605|3940127|FG000|NOT COMPLETED|Overall Study||9
3209974|NCT02191605|3940128|FG001|NOT COMPLETED|Overall Study||4
3209975|NCT02191605|3940129|FG002|NOT COMPLETED|Overall Study||7
3209976|NCT02191605|3940130|FG003|NOT COMPLETED|Overall Study||3
3209977|NCT02191605|3940131|FG004|NOT COMPLETED|Overall Study||4
3209978|NCT02191618|3940143|FG000|STARTED|Overall Study||150
3209979|NCT02191618|3940143|FG000|COMPLETED|Overall Study||143
3209980|NCT02191618|3940143|FG000|NOT COMPLETED|Overall Study||7
3209981|NCT02191865|3940150|FG000|STARTED|Overall Study||8
3209982|NCT02191865|3940151|FG001|STARTED|Overall Study||8
3209983|NCT02191865|3940152|FG002|STARTED|Overall Study||17
3209984|NCT02191865|3940150|FG000|COMPLETED|Overall Study||8
3209985|NCT02191865|3940151|FG001|COMPLETED|Overall Study||8
3209986|NCT02191865|3940152|FG002|COMPLETED|Overall Study||17
3209987|NCT02191865|3940150|FG000|NOT COMPLETED|Overall Study||0
3209988|NCT02191865|3940151|FG001|NOT COMPLETED|Overall Study||0
3209989|NCT02191865|3940152|FG002|NOT COMPLETED|Overall Study||0
3209990|NCT02192099|3940163|FG000|STARTED|Overall Study||61
3209991|NCT02192099|3940163|FG000|COMPLETED|Overall Study||0
3209992|NCT02192099|3940163|FG000|NOT COMPLETED|Overall Study||61
3209993|NCT02192164|3940167|FG000|STARTED|Overall Study||126
3209994|NCT02192164|3940167|FG000|Etanercept Treated Population|Overall Study||112
3209995|NCT02192164|3940167|FG000|COMPLETED|Overall Study||112
3209996|NCT02192164|3940167|FG000|NOT COMPLETED|Overall Study||14
3209997|NCT02192190|3940180|FG000|STARTED|Overall Study||76
3209998|NCT02192190|3940181|FG001|STARTED|Overall Study||39
3209999|NCT02192190|3940182|FG002|STARTED|Overall Study||38
3210000|NCT02192190|3940183|FG003|STARTED|Overall Study||38
3210001|NCT02192190|3940184|FG004|STARTED|Overall Study||39
3210002|NCT02192190|3940185|FG005|STARTED|Overall Study||38
3210003|NCT02192190|3940180|FG000|Received at Least 1 Dose of Study Drug|Overall Study||76
3210004|NCT02192190|3940181|FG001|Received at Least 1 Dose of Study Drug|Overall Study||39
3210005|NCT02192190|3940182|FG002|Received at Least 1 Dose of Study Drug|Overall Study||38
3210006|NCT02192190|3940183|FG003|Received at Least 1 Dose of Study Drug|Overall Study||38
3210007|NCT02192190|3940184|FG004|Received at Least 1 Dose of Study Drug|Overall Study||38
3210008|NCT02192190|3940185|FG005|Received at Least 1 Dose of Study Drug|Overall Study||37
3210009|NCT02192190|3940180|FG000|COMPLETED|Overall Study||22
3210010|NCT02192190|3940181|FG001|COMPLETED|Overall Study||10
3210011|NCT02192190|3940182|FG002|COMPLETED|Overall Study||13
3210012|NCT02192190|3940183|FG003|COMPLETED|Overall Study||12
3210013|NCT02192190|3940184|FG004|COMPLETED|Overall Study||9
3210014|NCT02192190|3940185|FG005|COMPLETED|Overall Study||9
3210015|NCT02192190|3940180|FG000|NOT COMPLETED|Overall Study||54
3210016|NCT02192190|3940181|FG001|NOT COMPLETED|Overall Study||29
3210017|NCT02192190|3940182|FG002|NOT COMPLETED|Overall Study||25
3210018|NCT02192190|3940183|FG003|NOT COMPLETED|Overall Study||26
3210019|NCT02192190|3940184|FG004|NOT COMPLETED|Overall Study||30
3210020|NCT02192190|3940185|FG005|NOT COMPLETED|Overall Study||29
3210021|NCT02192307|3940202|FG000|STARTED|Overall Study||30
3210022|NCT02192307|3940203|FG001|STARTED|Overall Study||30
3210023|NCT02192307|3940202|FG000|COMPLETED|Overall Study||30
3210024|NCT02192307|3940203|FG001|COMPLETED|Overall Study||30
3210025|NCT02192307|3940202|FG000|NOT COMPLETED|Overall Study||0
3210026|NCT02192307|3940203|FG001|NOT COMPLETED|Overall Study||0
3210027|NCT02192541|3940211|FG000|STARTED|Overall Study||2
3210028|NCT02192541|3940212|FG001|STARTED|Overall Study||3
3210029|NCT02192541|3940211|FG000|Treated|Overall Study||2
3210030|NCT02192541|3940212|FG001|Treated|Overall Study||3
3210031|NCT02192541|3940211|FG000|Evaluable for Response|Overall Study||1
3210032|NCT02192541|3940212|FG001|Evaluable for Response|Overall Study||3
3210033|NCT02192541|3940211|FG000|COMPLETED|Overall Study||2
3210034|NCT02192541|3940212|FG001|COMPLETED|Overall Study||3
3210035|NCT02192541|3940211|FG000|NOT COMPLETED|Overall Study||0
3210036|NCT02192541|3940212|FG001|NOT COMPLETED|Overall Study||0
3210037|NCT02192606|3940221|FG000|STARTED|Overall Study||29
3210038|NCT02192606|3940222|FG001|STARTED|Overall Study||28
3210039|NCT02192606|3940221|FG000|COMPLETED|Overall Study||27
3210040|NCT02192606|3940222|FG001|COMPLETED|Overall Study||24
3210041|NCT02192606|3940221|FG000|NOT COMPLETED|Overall Study||2
3210042|NCT02192606|3940222|FG001|NOT COMPLETED|Overall Study||4
3210043|NCT02192684|3940230|FG000|STARTED|Overall Study||30
3210044|NCT02192684|3940231|FG001|STARTED|Overall Study||15
3210045|NCT02192684|3940230|FG000|COMPLETED|Overall Study||30
3210046|NCT02192684|3940231|FG001|COMPLETED|Overall Study||15
3210047|NCT02192684|3940230|FG000|NOT COMPLETED|Overall Study||0
3210048|NCT02192684|3940231|FG001|NOT COMPLETED|Overall Study||0
3210049|NCT02192814|3940237|FG000|STARTED|Overall Study||9
3210050|NCT02192814|3940237|FG000|COMPLETED|Overall Study||9
3210051|NCT02192814|3940237|FG000|NOT COMPLETED|Overall Study||0
3210052|NCT02192879|3940244|FG000|STARTED|Overall Study||3
3210053|NCT02192879|3940245|FG001|STARTED|Overall Study||4
3210054|NCT02192879|3940246|FG002|STARTED|Overall Study||3
3210055|NCT02192879|3940244|FG000|COMPLETED|Overall Study||3
3210056|NCT02192879|3940245|FG001|COMPLETED|Overall Study||4
3210057|NCT02192879|3940246|FG002|COMPLETED|Overall Study||3
3210058|NCT02192879|3940244|FG000|NOT COMPLETED|Overall Study||0
3210059|NCT02192879|3940245|FG001|NOT COMPLETED|Overall Study||0
3210060|NCT02192879|3940246|FG002|NOT COMPLETED|Overall Study||0
3210061|NCT02192905|3940254|FG000|STARTED|Overall Study||43
3210062|NCT02192905|3940254|FG000|COMPLETED|Overall Study|Reporting a minimum of current weight at 16-week follow-up|42
3210063|NCT02192905|3940254|FG000|NOT COMPLETED|Overall Study||1
3210064|NCT02192970|3940261|FG000|STARTED|Overall Study||101
3210065|NCT02192970|3940262|FG001|STARTED|Overall Study||195
3210066|NCT02192970|3940261|FG000|COMPLETED|Overall Study||95
3210067|NCT02192970|3940262|FG001|COMPLETED|Overall Study||195
3210068|NCT02192970|3940261|FG000|NOT COMPLETED|Overall Study||6
3210069|NCT02192970|3940262|FG001|NOT COMPLETED|Overall Study||0
3210070|NCT02193074|3940270|FG000|STARTED|Overall Study|Randomized and received double-blind treatment.|41
3210071|NCT02193074|3940271|FG001|STARTED|Overall Study|Randomized and received double-blind treatment.|80
3210072|NCT02193074|3940270|FG000|Completed During Follow-Up Period|Overall Study||11
3210073|NCT02193074|3940271|FG001|Completed During Follow-Up Period|Overall Study||26
3210074|NCT02193074|3940270|FG000|Completed Due to Early Study Termination|Overall Study||13
3210075|NCT02193074|3940271|FG001|Completed Due to Early Study Termination|Overall Study||39
3210076|NCT02193074|3940270|FG000|COMPLETED|Overall Study||24
3210077|NCT02193074|3940271|FG001|COMPLETED|Overall Study||65
3210078|NCT02193074|3940270|FG000|NOT COMPLETED|Overall Study||17
3210079|NCT02193074|3940271|FG001|NOT COMPLETED|Overall Study||15
3210080|NCT02193087|3940281|FG000|STARTED|Overall Study||199
3210081|NCT02193087|3940282|FG001|STARTED|Overall Study||100
3210082|NCT02193087|3940283|FG002|STARTED|Overall Study||100
3210083|NCT02193087|3940284|FG003|STARTED|Overall Study||603
3210084|NCT02193087|3940281|FG000|Received Vaccination|Overall Study||197
3210085|NCT02193087|3940282|FG001|Received Vaccination|Overall Study||97
3210086|NCT02193087|3940283|FG002|Received Vaccination|Overall Study||100
3210087|NCT02193087|3940284|FG003|Received Vaccination|Overall Study||602
3210088|NCT02193087|3940281|FG000|COMPLETED|Overall Study||162
3210089|NCT02193087|3940282|FG001|COMPLETED|Overall Study||86
3210090|NCT02193087|3940283|FG002|COMPLETED|Overall Study||93
3210091|NCT02193087|3940284|FG003|COMPLETED|Overall Study||524
3210092|NCT02193087|3940281|FG000|NOT COMPLETED|Overall Study||37
3210093|NCT02193087|3940282|FG001|NOT COMPLETED|Overall Study||14
3210094|NCT02193087|3940283|FG002|NOT COMPLETED|Overall Study||7
3210095|NCT02193087|3940284|FG003|NOT COMPLETED|Overall Study||79
3210096|NCT02193152|3940301|FG000|STARTED|Overall Study||16
3210097|NCT02193152|3940301|FG000|COMPLETED|Overall Study||16
3210098|NCT02193152|3940301|FG000|NOT COMPLETED|Overall Study||0
3210099|NCT02193165|3940308|FG000|STARTED|4 Week Product Use||40
3210100|NCT02193165|3940309|FG001|STARTED|4 Week Product Use||40
3210101|NCT02193165|3940310|FG002|STARTED|4 Week Product Use||40
3210102|NCT02193165|3940308|FG000|COMPLETED|4 Week Product Use|1 subject failed to keep appointments and didn't return to clinical site|39
3210103|NCT02193165|3940309|FG001|COMPLETED|4 Week Product Use|1 subject failed to keep appointments and didn't return to clinical site|39
3210104|NCT02193165|3940310|FG002|COMPLETED|4 Week Product Use|1 subject failed to keep appointments and didn't return to clinical site|39
3210105|NCT02193165|3940308|FG000|NOT COMPLETED|4 Week Product Use||1
3210106|NCT02193165|3940309|FG001|NOT COMPLETED|4 Week Product Use||1
3210107|NCT02193165|3940310|FG002|NOT COMPLETED|4 Week Product Use||1
3210108|NCT02193165|3940308|FG000|STARTED|6 Week Product Use||39
3210109|NCT02193165|3940309|FG001|STARTED|6 Week Product Use||39
3210110|NCT02193165|3940310|FG002|STARTED|6 Week Product Use||39
3210111|NCT02193165|3940308|FG000|COMPLETED|6 Week Product Use||39
3210112|NCT02193165|3940309|FG001|COMPLETED|6 Week Product Use|1 subject failed to keep appointment time and didn't return to clinical site.|38
3210113|NCT02193165|3940310|FG002|COMPLETED|6 Week Product Use||39
3210114|NCT02193165|3940308|FG000|NOT COMPLETED|6 Week Product Use||0
3210115|NCT02193165|3940309|FG001|NOT COMPLETED|6 Week Product Use||1
3210116|NCT02193165|3940310|FG002|NOT COMPLETED|6 Week Product Use||0
3210117|NCT02193178|3940318|FG000|STARTED|Overall Study||15
3210118|NCT02193178|3940318|FG000|COMPLETED|Overall Study||13
3210119|NCT02193178|3940318|FG000|NOT COMPLETED|Overall Study||2
3210120|NCT02193347|3940336|FG000|STARTED|Overall Study||24
3210121|NCT02193347|3940336|FG000|COMPLETED|Overall Study||24
3210122|NCT02193347|3940336|FG000|NOT COMPLETED|Overall Study||0
3210123|NCT02193490|3940342|FG000|STARTED|Overall Study||25
3210124|NCT02193490|3940343|FG001|STARTED|Overall Study||22
3210125|NCT02193490|3940342|FG000|COMPLETED|Overall Study||21
3210126|NCT02193490|3940343|FG001|COMPLETED|Overall Study||20
3210127|NCT02193490|3940342|FG000|NOT COMPLETED|Overall Study||4
3210128|NCT02193490|3940343|FG001|NOT COMPLETED|Overall Study||2
3210129|NCT02193776|3940353|FG000|STARTED|Overall Study||59
3210130|NCT02193776|3940354|FG001|STARTED|Overall Study||60
3210131|NCT02193776|3940355|FG002|STARTED|Overall Study||61
3210132|NCT02193776|3940356|FG003|STARTED|Overall Study||60
3210133|NCT02193776|3940353|FG000|Completed Day 70 Follow-up|Overall Study||54
3210134|NCT02193776|3940354|FG001|Completed Day 70 Follow-up|Overall Study||56
3210135|NCT02193776|3940355|FG002|Completed Day 70 Follow-up|Overall Study||60
3210136|NCT02193776|3940356|FG003|Completed Day 70 Follow-up|Overall Study||60
3210137|NCT02193776|3940353|FG000|Completed Day 140 Follow-up|Overall Study||52
3210138|NCT02193776|3940354|FG001|Completed Day 140 Follow-up|Overall Study||52
3210139|NCT02193776|3940355|FG002|Completed Day 140 Follow-up|Overall Study||58
3210140|NCT02193776|3940356|FG003|Completed Day 140 Follow-up|Overall Study||58
3210141|NCT02193776|3940353|FG000|COMPLETED|Overall Study||51
3210142|NCT02193776|3940354|FG001|COMPLETED|Overall Study||53
3210143|NCT02193776|3940355|FG002|COMPLETED|Overall Study||59
3210144|NCT02193776|3940356|FG003|COMPLETED|Overall Study||58
3210145|NCT02193776|3940353|FG000|NOT COMPLETED|Overall Study||8
3210146|NCT02193776|3940354|FG001|NOT COMPLETED|Overall Study||7
3210147|NCT02193776|3940355|FG002|NOT COMPLETED|Overall Study||2
3210148|NCT02193776|3940356|FG003|NOT COMPLETED|Overall Study||2
3210149|NCT02193815|3940366|FG000|STARTED|Overall Study||15
3210150|NCT02193815|3940366|FG000|COMPLETED|Overall Study||15
3210151|NCT02193815|3940366|FG000|NOT COMPLETED|Overall Study||0
3210152|NCT02193828|3940384|FG000|STARTED|Overall Study||18
3210153|NCT02193828|3940385|FG001|STARTED|Overall Study||18
3210154|NCT02193828|3940386|FG002|STARTED|Overall Study||23
3210155|NCT02193828|3940387|FG003|STARTED|Overall Study||17
3210156|NCT02193828|3940384|FG000|COMPLETED|Overall Study||18
3210157|NCT02193828|3940385|FG001|COMPLETED|Overall Study||18
3210158|NCT02193828|3940386|FG002|COMPLETED|Overall Study||22
3210159|NCT02193828|3940387|FG003|COMPLETED|Overall Study||16
3210160|NCT02193828|3940384|FG000|NOT COMPLETED|Overall Study||0
3210161|NCT02193828|3940385|FG001|NOT COMPLETED|Overall Study||0
3210162|NCT02193828|3940386|FG002|NOT COMPLETED|Overall Study||1
3210163|NCT02193828|3940387|FG003|NOT COMPLETED|Overall Study||1
3210164|NCT02193880|3940397|FG000|STARTED|Overall Study||7
3210165|NCT02193880|3940397|FG000|COMPLETED|Overall Study||4
3210166|NCT02193880|3940397|FG000|NOT COMPLETED|Overall Study||3
3210167|NCT02194062|3940404|FG000|STARTED|Overall Study||10
3210168|NCT02194062|3940405|FG001|STARTED|Overall Study||10
3210169|NCT02194062|3940406|FG002|STARTED|Overall Study||12
3210170|NCT02194062|3940404|FG000|COMPLETED|Overall Study||8
3210171|NCT02194062|3940405|FG001|COMPLETED|Overall Study||8
3210172|NCT02194062|3940406|FG002|COMPLETED|Overall Study||7
3210173|NCT02194062|3940404|FG000|NOT COMPLETED|Overall Study||2
3210174|NCT02194062|3940405|FG001|NOT COMPLETED|Overall Study||2
3210175|NCT02194062|3940406|FG002|NOT COMPLETED|Overall Study||5
3210176|NCT02194088|3940416|FG000|STARTED|Overall Study||75
3210177|NCT02194088|3940417|FG001|STARTED|Overall Study||25
3210178|NCT02194088|3940416|FG000|COMPLETED|Overall Study||75
3210179|NCT02194088|3940417|FG001|COMPLETED|Overall Study||25
3210180|NCT02194088|3940416|FG000|NOT COMPLETED|Overall Study||0
3210181|NCT02194088|3940417|FG001|NOT COMPLETED|Overall Study||0
3210182|NCT02194439|3940425|FG000|STARTED|Overall Study||415
3210183|NCT02194439|3940425|FG000|COMPLETED|Overall Study||415
3210184|NCT02194439|3940425|FG000|NOT COMPLETED|Overall Study||0
3210185|NCT02194465|3940436|FG000|STARTED|Overall Study||51
3210186|NCT02194465|3940437|FG001|STARTED|Overall Study||50
3210187|NCT02194465|3940438|FG002|STARTED|Overall Study||52
3210188|NCT02194465|3940439|FG003|STARTED|Overall Study||49
3210189|NCT02194465|3940440|FG004|STARTED|Overall Study||51
3210190|NCT02194465|3940441|FG005|STARTED|Overall Study||25
3210191|NCT02194465|3940442|FG006|STARTED|Overall Study||26
3210192|NCT02194465|3940436|FG000|Received at Least 1 Dose of Study Drug|Overall Study||51
3210193|NCT02194465|3940437|FG001|Received at Least 1 Dose of Study Drug|Overall Study||50
3210194|NCT02194465|3940438|FG002|Received at Least 1 Dose of Study Drug|Overall Study||51
3210195|NCT02194465|3940439|FG003|Received at Least 1 Dose of Study Drug|Overall Study||49
3210196|NCT02194465|3940440|FG004|Received at Least 1 Dose of Study Drug|Overall Study||51
3210197|NCT02194465|3940441|FG005|Received at Least 1 Dose of Study Drug|Overall Study||25
3210198|NCT02194465|3940442|FG006|Received at Least 1 Dose of Study Drug|Overall Study||26
3210199|NCT02194465|3940436|FG000|COMPLETED|Overall Study||42
3210200|NCT02194465|3940437|FG001|COMPLETED|Overall Study||43
3210201|NCT02194465|3940438|FG002|COMPLETED|Overall Study||44
3210202|NCT02194465|3940439|FG003|COMPLETED|Overall Study||41
3210203|NCT02194465|3940440|FG004|COMPLETED|Overall Study||42
3210204|NCT02194465|3940441|FG005|COMPLETED|Overall Study||21
3210205|NCT02194465|3940442|FG006|COMPLETED|Overall Study||24
3210206|NCT02194465|3940436|FG000|NOT COMPLETED|Overall Study||9
3210207|NCT02194465|3940437|FG001|NOT COMPLETED|Overall Study||7
3210208|NCT02194465|3940438|FG002|NOT COMPLETED|Overall Study||8
3210209|NCT02194465|3940439|FG003|NOT COMPLETED|Overall Study||8
3210210|NCT02194465|3940440|FG004|NOT COMPLETED|Overall Study||9
3210211|NCT02194465|3940441|FG005|NOT COMPLETED|Overall Study||4
3210212|NCT02194465|3940442|FG006|NOT COMPLETED|Overall Study||2
3210213|NCT02194621|3940465|FG000|STARTED|Overall Study||43
3210214|NCT02194621|3940466|FG001|STARTED|Overall Study||42
3210215|NCT02194621|3940467|FG002|STARTED|Overall Study||43
3210216|NCT02194621|3940465|FG000|COMPLETED|Overall Study||37
3210217|NCT02194621|3940466|FG001|COMPLETED|Overall Study||36
3210218|NCT02194621|3940467|FG002|COMPLETED|Overall Study||34
3210219|NCT02194621|3940465|FG000|NOT COMPLETED|Overall Study||6
3210220|NCT02194621|3940466|FG001|NOT COMPLETED|Overall Study||6
3210221|NCT02194621|3940467|FG002|NOT COMPLETED|Overall Study||9
3210222|NCT02194699|3940477|FG000|STARTED|Randomised||428
3210223|NCT02194699|3940478|FG001|STARTED|Randomised||428
3210224|NCT02194699|3940477|FG000|COMPLETED|Randomised||420
3210225|NCT02194699|3940478|FG001|COMPLETED|Randomised||417
3210226|NCT02194699|3940477|FG000|NOT COMPLETED|Randomised||8
3210227|NCT02194699|3940478|FG001|NOT COMPLETED|Randomised||11
3210228|NCT02194699|3940477|FG000|STARTED|With Potential to Receive 52 Weeks of IP|Includes all patients randomised with the potential to receive 52 weeks of IP and receiving any IP.|420
3210229|NCT02194699|3940478|FG001|STARTED|With Potential to Receive 52 Weeks of IP|Includes all patients randomised with the potential to receive 52 weeks of IP and receiving any IP.|417
3210230|NCT02194699|3940477|FG000|COMPLETED|With Potential to Receive 52 Weeks of IP||370
3210231|NCT02194699|3940478|FG001|COMPLETED|With Potential to Receive 52 Weeks of IP||365
3210232|NCT02194699|3940477|FG000|NOT COMPLETED|With Potential to Receive 52 Weeks of IP||50
3210233|NCT02194699|3940478|FG001|NOT COMPLETED|With Potential to Receive 52 Weeks of IP||52
3210234|NCT02194933|3940494|FG000|STARTED|Overall Study||19
3210235|NCT02194933|3940495|FG001|STARTED|Overall Study||19
3210236|NCT02194933|3940494|FG000|COMPLETED|Overall Study||16
3210237|NCT02194933|3940495|FG001|COMPLETED|Overall Study||10
3210238|NCT02194933|3940494|FG000|NOT COMPLETED|Overall Study||3
3210239|NCT02194933|3940495|FG001|NOT COMPLETED|Overall Study||9
3210240|NCT02194985|3940503|FG000|STARTED|Overall Study||84
3210241|NCT02194985|3940503|FG000|Received at Least 1 Dose of Study Drug|Overall Study||84
3210242|NCT02194985|3940503|FG000|COMPLETED|Overall Study||73
3210243|NCT02194985|3940503|FG000|NOT COMPLETED|Overall Study||11
3210244|NCT02194998|3940511|FG000|STARTED|On-HCV Treatment||21
3210245|NCT02194998|3940512|FG001|STARTED|On-HCV Treatment||6
3210246|NCT02194998|3940513|FG002|STARTED|On-HCV Treatment||15
3210247|NCT02194998|3940514|FG003|STARTED|On-HCV Treatment||4
3210248|NCT02194998|3940511|FG000|COMPLETED|On-HCV Treatment||21
3210249|NCT02194998|3940512|FG001|COMPLETED|On-HCV Treatment||5
3210250|NCT02194998|3940513|FG002|COMPLETED|On-HCV Treatment||15
3210251|NCT02194998|3940514|FG003|COMPLETED|On-HCV Treatment||4
3210252|NCT02194998|3940511|FG000|NOT COMPLETED|On-HCV Treatment||0
3210253|NCT02194998|3940512|FG001|NOT COMPLETED|On-HCV Treatment||1
3210254|NCT02194998|3940513|FG002|NOT COMPLETED|On-HCV Treatment||0
3210255|NCT02194998|3940514|FG003|NOT COMPLETED|On-HCV Treatment||0
3210256|NCT02194998|3940511|FG000|STARTED|Post-HCV Treatment Follow-Up||21
3210257|NCT02194998|3940512|FG001|STARTED|Post-HCV Treatment Follow-Up||5
3210258|NCT02194998|3940513|FG002|STARTED|Post-HCV Treatment Follow-Up||15
3210259|NCT02194998|3940514|FG003|STARTED|Post-HCV Treatment Follow-Up||4
3210260|NCT02194998|3940511|FG000|COMPLETED|Post-HCV Treatment Follow-Up||20
3210261|NCT02194998|3940512|FG001|COMPLETED|Post-HCV Treatment Follow-Up||5
3210262|NCT02194998|3940513|FG002|COMPLETED|Post-HCV Treatment Follow-Up||14
3210263|NCT02194998|3940514|FG003|COMPLETED|Post-HCV Treatment Follow-Up||4
3210264|NCT02194998|3940511|FG000|NOT COMPLETED|Post-HCV Treatment Follow-Up||1
3210265|NCT02194998|3940512|FG001|NOT COMPLETED|Post-HCV Treatment Follow-Up||0
3210266|NCT02194998|3940513|FG002|NOT COMPLETED|Post-HCV Treatment Follow-Up||1
3210267|NCT02194998|3940514|FG003|NOT COMPLETED|Post-HCV Treatment Follow-Up||0
3210268|NCT02195011|3940526|FG000|STARTED|Overall Study||25
3210269|NCT02195011|3940527|FG001|STARTED|Overall Study||1
3210270|NCT02195011|3940526|FG000|COMPLETED|Overall Study||0
3210271|NCT02195011|3940527|FG001|COMPLETED|Overall Study||0
3210272|NCT02195011|3940526|FG000|NOT COMPLETED|Overall Study||25
3210273|NCT02195011|3940527|FG001|NOT COMPLETED|Overall Study||1
3210274|NCT02195232|3940535|FG000|STARTED|Overall Study|patients consented|32
3210275|NCT02195232|3940536|FG001|STARTED|Overall Study|patients consented|32
3210276|NCT02195232|3940535|FG000|COMPLETED|Overall Study|Evaluated for VTE and safety|28
3210277|NCT02195232|3940536|FG001|COMPLETED|Overall Study|Evaluated for VTE and safety|29
3210278|NCT02195232|3940535|FG000|NOT COMPLETED|Overall Study||4
3210279|NCT02195232|3940536|FG001|NOT COMPLETED|Overall Study||3
3210280|NCT02195310|3940548|FG000|STARTED|Overall Study||173
3210281|NCT02195310|3940549|FG001|STARTED|Overall Study||169
3210282|NCT02195310|3940548|FG000|COMPLETED|Overall Study||153
3210283|NCT02195310|3940549|FG001|COMPLETED|Overall Study||153
3210284|NCT02195310|3940548|FG000|NOT COMPLETED|Overall Study||20
3210285|NCT02195310|3940549|FG001|NOT COMPLETED|Overall Study||16
3210286|NCT02195349|3940566|FG000|STARTED|Overall Study||14
3210287|NCT02195349|3940567|FG001|STARTED|Overall Study||1
3210288|NCT02195349|3940568|FG002|STARTED|Overall Study||1
3210289|NCT02195349|3940569|FG003|STARTED|Overall Study||6
3210290|NCT02195349|3940570|FG004|STARTED|Overall Study||6
3210291|NCT02195349|3940571|FG005|STARTED|Overall Study||6
3210292|NCT02195349|3940572|FG006|STARTED|Overall Study||6
3210293|NCT02195349|3940573|FG007|STARTED|Overall Study||9
3210294|NCT02195349|3940574|FG008|STARTED|Overall Study||6
3210295|NCT02195349|3940575|FG009|STARTED|Overall Study||6
3210296|NCT02195349|3940576|FG010|STARTED|Overall Study||6
3210297|NCT02195349|3940566|FG000|COMPLETED|Overall Study||14
3210298|NCT02195349|3940567|FG001|COMPLETED|Overall Study||1
3210299|NCT02195349|3940568|FG002|COMPLETED|Overall Study||1
3210300|NCT02195349|3940569|FG003|COMPLETED|Overall Study||6
3210301|NCT02195349|3940570|FG004|COMPLETED|Overall Study||6
3210302|NCT02195349|3940571|FG005|COMPLETED|Overall Study||6
3210303|NCT02195349|3940572|FG006|COMPLETED|Overall Study||6
3210304|NCT02195349|3940573|FG007|COMPLETED|Overall Study||9
3210305|NCT02195349|3940574|FG008|COMPLETED|Overall Study||6
3210306|NCT02195349|3940575|FG009|COMPLETED|Overall Study||6
3210307|NCT02195349|3940576|FG010|COMPLETED|Overall Study||6
3210308|NCT02195349|3940566|FG000|NOT COMPLETED|Overall Study||0
3210309|NCT02195349|3940567|FG001|NOT COMPLETED|Overall Study||0
3210310|NCT02195349|3940568|FG002|NOT COMPLETED|Overall Study||0
3210311|NCT02195349|3940569|FG003|NOT COMPLETED|Overall Study||0
3210312|NCT02195349|3940570|FG004|NOT COMPLETED|Overall Study||0
3210313|NCT02195349|3940571|FG005|NOT COMPLETED|Overall Study||0
3210314|NCT02195349|3940572|FG006|NOT COMPLETED|Overall Study||0
3210315|NCT02195349|3940573|FG007|NOT COMPLETED|Overall Study||0
3210316|NCT02195349|3940574|FG008|NOT COMPLETED|Overall Study||0
3210317|NCT02195349|3940575|FG009|NOT COMPLETED|Overall Study||0
3210318|NCT02195349|3940576|FG010|NOT COMPLETED|Overall Study||0
3210319|NCT02195414|3940616|FG000|STARTED|Overall Study||31
3210320|NCT02195414|3940616|FG000|Primary Endpoint|Overall Study||31
3210321|NCT02195414|3940616|FG000|COMPLETED|Overall Study||31
3210322|NCT02195414|3940616|FG000|NOT COMPLETED|Overall Study||0
3210323|NCT02195427|3940622|FG000|STARTED|Overall Study||73
3210324|NCT02195427|3940623|FG001|STARTED|Overall Study||74
3210325|NCT02195427|3940622|FG000|N Patients at W24 (Primary Outcome)|Overall Study||67
3210326|NCT02195427|3940623|FG001|N Patients at W24 (Primary Outcome)|Overall Study||62
3210327|NCT02195427|3940622|FG000|N Patients at W36|Overall Study||65
3210328|NCT02195427|3940623|FG001|N Patients at W36|Overall Study||59
3210329|NCT02195427|3940622|FG000|N Patients at W52|Overall Study||63
3210330|NCT02195427|3940623|FG001|N Patients at W52|Overall Study||56
3210331|NCT02195427|3940622|FG000|COMPLETED|Overall Study||47
3210332|NCT02195427|3940623|FG001|COMPLETED|Overall Study||47
3210333|NCT02195427|3940622|FG000|NOT COMPLETED|Overall Study||26
3210334|NCT02195427|3940623|FG001|NOT COMPLETED|Overall Study||27
3210335|NCT02195518|3940633|FG000|STARTED|Overall Study||213
3210336|NCT02195518|3940633|FG000|COMPLETED|Overall Study||204
3210337|NCT02195518|3940633|FG000|NOT COMPLETED|Overall Study||9
3210338|NCT02195531|3940640|FG000|STARTED|Overall Study||64
3210339|NCT02195531|3940641|FG001|STARTED|Overall Study||49
3210340|NCT02195531|3940642|FG002|STARTED|Overall Study||56
3210341|NCT02195531|3940640|FG000|COMPLETED|Overall Study||63
3210342|NCT02195531|3940641|FG001|COMPLETED|Overall Study||48
3210343|NCT02195531|3940642|FG002|COMPLETED|Overall Study||55
3210344|NCT02195531|3940640|FG000|NOT COMPLETED|Overall Study||1
3210345|NCT02195531|3940641|FG001|NOT COMPLETED|Overall Study||1
3210346|NCT02195531|3940642|FG002|NOT COMPLETED|Overall Study||1
3366343|NCT03910439|4097625|FG000|STARTED|Overall Study||4
3366344|NCT03910439|4097625|FG000|COMPLETED|Overall Study||4
3366345|NCT03910439|4097625|FG000|NOT COMPLETED|Overall Study||0
3366346|NCT03907241|4097636|FG000|STARTED|Overall Study||27
3210347|NCT02195583|3940650|FG000|STARTED|Overall Study||62
3210348|NCT02195583|3940650|FG000|Sodium Fluoride (1150 Ppm)|Overall Study|Discontinuations: 1 due to other reason in Period 5|57
3366347|NCT03907241|4097636|FG000|COMPLETED|Overall Study||23
3210349|NCT02195583|3940650|FG000|Sodium Fluoride (0 Ppm)|Overall Study||59
3210350|NCT02195583|3940650|FG000|Sodium Fluoride (1426 Ppm) + Zinc Base A|Overall Study|Discontinuations: 1 withdrawal of consent in Period 3 and 1 withdrawal of consent in Period 4|58
3210351|NCT02195583|3940650|FG000|Sodium Fluoride (250 Ppm)|Overall Study||55
3210352|NCT02195583|3940650|FG000|Sodium Fluoride (1426 Ppm)|Overall Study|Discontinuation:1 lost to follow up, 1 withdrawal of consent in Period 2, 1 other reason in Period 5|59
3210353|NCT02195583|3940650|FG000|Sodium Fluoride (1426 Ppm) + Zinc Base B|Overall Study|Discontinuations: 1 withdrawal of consent in Period 2;1 adverse event each in Period 3 and Period 4|60
3210354|NCT02195583|3940650|FG000|COMPLETED|Overall Study||53
3210355|NCT02195583|3940650|FG000|NOT COMPLETED|Overall Study||9
3210356|NCT02195622|3940667|FG000|STARTED|Overall Study||37
3210357|NCT02195622|3940668|FG001|STARTED|Overall Study||37
3210358|NCT02195622|3940667|FG000|COMPLETED|Overall Study||37
3210359|NCT02195622|3940668|FG001|COMPLETED|Overall Study||37
3210360|NCT02195622|3940667|FG000|NOT COMPLETED|Overall Study||0
3210361|NCT02195622|3940668|FG001|NOT COMPLETED|Overall Study||0
3210362|NCT02195687|3940676|FG000|STARTED|Overall Study||316
3210363|NCT02195687|3940677|FG001|STARTED|Overall Study||101
3210364|NCT02195687|3940676|FG000|COMPLETED|Overall Study||311
3210365|NCT02195687|3940677|FG001|COMPLETED|Overall Study||99
3210366|NCT02195687|3940676|FG000|NOT COMPLETED|Overall Study||5
3210367|NCT02195687|3940677|FG001|NOT COMPLETED|Overall Study||2
3210368|NCT02195700|3940685|FG000|STARTED|Overall Study||58
3210369|NCT02195700|3940686|FG001|STARTED|Overall Study||59
3210370|NCT02195700|3940685|FG000|Safety and ITT Populations|Overall Study||58
3210371|NCT02195700|3940686|FG001|Safety and ITT Populations|Overall Study||59
3210372|NCT02195700|3940685|FG000|Modified ITT Population|Overall Study|ITT who received study drug and >=1 centrally read post-baseline AIMS from weeks 2, 4, 6, 9, or 12|56
3210373|NCT02195700|3940686|FG001|Modified ITT Population|Overall Study|ITT who received study drug and >=1 centrally read post-baseline AIMS from weeks 2, 4, 6, 9, or 12|57
3210374|NCT02195700|3940685|FG000|Maintenance Period|Overall Study||53
3210375|NCT02195700|3940686|FG001|Maintenance Period|Overall Study||54
3210376|NCT02195700|3940685|FG000|COMPLETED|Overall Study||52
3210377|NCT02195700|3940686|FG001|COMPLETED|Overall Study||52
3210378|NCT02195700|3940685|FG000|NOT COMPLETED|Overall Study||6
3210379|NCT02195700|3940686|FG001|NOT COMPLETED|Overall Study||7
3210380|NCT02195713|3940694|FG000|STARTED|Overall Study||10
3210381|NCT02195713|3940695|FG001|STARTED|Overall Study||10
3210382|NCT02195713|3940694|FG000|COMPLETED|Overall Study||10
3210383|NCT02195713|3940695|FG001|COMPLETED|Overall Study||10
3210384|NCT02195713|3940694|FG000|NOT COMPLETED|Overall Study||0
3210385|NCT02195713|3940695|FG001|NOT COMPLETED|Overall Study||0
3210386|NCT02195869|3940701|FG000|STARTED|Overall Study|Phase 1b: 6 patients, 420 mg, no DLT observed. Phase 2: 42 patients, 420 mg|42
3210387|NCT02195869|3940701|FG000|All-Treated Population|Overall Study||42
3210388|NCT02195869|3940701|FG000|COMPLETED|Overall Study||0
3210389|NCT02195869|3940701|FG000|NOT COMPLETED|Overall Study||42
3210390|NCT02195895|3940708|FG000|STARTED|Overall Study||17
3210391|NCT02195895|3940708|FG000|COMPLETED|Overall Study||17
3210392|NCT02195895|3940708|FG000|NOT COMPLETED|Overall Study||0
3210393|NCT02195921|3940716|FG000|STARTED|Overall Study||40
3210394|NCT02195921|3940717|FG001|STARTED|Overall Study||40
3210395|NCT02195921|3940718|FG002|STARTED|Overall Study||40
3210396|NCT02195921|3940719|FG003|STARTED|Overall Study||40
3210397|NCT02195921|3940716|FG000|COMPLETED|Overall Study||39
3210398|NCT02195921|3940717|FG001|COMPLETED|Overall Study||39
3210399|NCT02195921|3940718|FG002|COMPLETED|Overall Study||39
3210400|NCT02195921|3940719|FG003|COMPLETED|Overall Study||40
3210401|NCT02195921|3940716|FG000|NOT COMPLETED|Overall Study||1
3210402|NCT02195921|3940717|FG001|NOT COMPLETED|Overall Study||1
3366348|NCT03907241|4097636|FG000|NOT COMPLETED|Overall Study||4
3366349|NCT03927950|4097651|FG000|STARTED|Overall Study||135
3366350|NCT03927950|4097651|FG000|COMPLETED|Overall Study||126
3366351|NCT03927950|4097651|FG000|NOT COMPLETED|Overall Study||9
3366352|NCT03927781|4097656|FG000|STARTED|Overall Study||10
3366353|NCT03927781|4097656|FG000|COMPLETED|Overall Study||10
3366354|NCT03927781|4097656|FG000|NOT COMPLETED|Overall Study||0
3366355|NCT03927209|4097662|FG000|STARTED|Overall Study||5
3366356|NCT03927209|4097663|FG001|STARTED|Overall Study||5
3366357|NCT03927209|4097662|FG000|COMPLETED|Overall Study||5
3366358|NCT03927209|4097663|FG001|COMPLETED|Overall Study||5
3366359|NCT03927209|4097662|FG000|NOT COMPLETED|Overall Study||0
3366360|NCT03927209|4097663|FG001|NOT COMPLETED|Overall Study||0
3366361|NCT03920670|4097673|FG000|STARTED|Overall Study||60
3366362|NCT03920670|4097674|FG001|STARTED|Overall Study||60
3366363|NCT03920670|4097673|FG000|COMPLETED|Overall Study||57
3366364|NCT03920670|4097674|FG001|COMPLETED|Overall Study||58
3366365|NCT03920670|4097673|FG000|NOT COMPLETED|Overall Study||3
3366366|NCT03920670|4097674|FG001|NOT COMPLETED|Overall Study||2
3366367|NCT03919422|4097682|FG000|STARTED|Overall Study||40
3366368|NCT03919422|4097683|FG001|STARTED|Overall Study||40
3366369|NCT03919422|4097682|FG000|COMPLETED|Overall Study||40
3366370|NCT03919422|4097683|FG001|COMPLETED|Overall Study||40
3366371|NCT03919422|4097682|FG000|NOT COMPLETED|Overall Study||0
3366372|NCT03919422|4097683|FG001|NOT COMPLETED|Overall Study||0
3366373|NCT03907579|4097689|FG000|STARTED|Overall Study||100
3366374|NCT03907579|4097689|FG000|COMPLETED|Overall Study||100
3366375|NCT03907579|4097689|FG000|NOT COMPLETED|Overall Study||0
3366376|NCT03905811|4097695|FG000|STARTED|Overall Study||8
3366377|NCT03905811|4097696|FG001|STARTED|Overall Study||5
3366378|NCT03905811|4097695|FG000|COMPLETED|Overall Study||6
3210403|NCT02195921|3940718|FG002|NOT COMPLETED|Overall Study||1
3210404|NCT02195921|3940719|FG003|NOT COMPLETED|Overall Study||0
3210405|NCT02195986|3940737|FG000|STARTED|Overall Study||146
3210406|NCT02195986|3940738|FG001|STARTED|Overall Study||147
3210407|NCT02195986|3940739|FG002|STARTED|Overall Study||73
3210408|NCT02195986|3940737|FG000|COMPLETED|Overall Study||143
3210409|NCT02195986|3940738|FG001|COMPLETED|Overall Study||142
3210410|NCT02195986|3940739|FG002|COMPLETED|Overall Study||71
3210411|NCT02195986|3940737|FG000|NOT COMPLETED|Overall Study||3
3210412|NCT02195986|3940738|FG001|NOT COMPLETED|Overall Study||5
3210413|NCT02195986|3940739|FG002|NOT COMPLETED|Overall Study||2
3210414|NCT02196038|3940749|FG000|STARTED|Overall Study||174
3210415|NCT02196038|3940750|FG001|STARTED|Overall Study||175
3210416|NCT02196038|3940749|FG000|COMPLETED|Overall Study||157
3210417|NCT02196038|3940750|FG001|COMPLETED|Overall Study||153
3210418|NCT02196038|3940749|FG000|NOT COMPLETED|Overall Study||17
3210419|NCT02196038|3940750|FG001|NOT COMPLETED|Overall Study||22
3210420|NCT02196077|3940756|FG000|STARTED|Overall Study||180
3210421|NCT02196077|3940756|FG000|BFF MDI 320/9.6 μg|Overall Study||155
3210422|NCT02196077|3940756|FG000|BFF MDI 160/9.6 μg|Overall Study||106
3210423|NCT02196077|3940756|FG000|BFF MDI 80/9.6 μg|Overall Study||103
3210424|NCT02196077|3940756|FG000|BD MDI 320 μg|Overall Study||108
3210425|NCT02196077|3940756|FG000|FF MDI 9.6 μg|Overall Study||157
3210426|NCT02196077|3940756|FG000|COMPLETED|Overall Study||133
3210427|NCT02196077|3940756|FG000|NOT COMPLETED|Overall Study||47
3210428|NCT02196168|3940770|FG000|STARTED|Overall Study||6
3210429|NCT02196168|3940771|FG001|STARTED|Overall Study||0
3210430|NCT02196168|3940770|FG000|COMPLETED|Overall Study||6
3210431|NCT02196168|3940771|FG001|COMPLETED|Overall Study||0
3210432|NCT02196168|3940770|FG000|NOT COMPLETED|Overall Study||0
3210433|NCT02196168|3940771|FG001|NOT COMPLETED|Overall Study||0
3210434|NCT02196259|3940780|FG000|STARTED|Overall Study||3
3210435|NCT02196259|3940781|FG001|STARTED|Overall Study||7
3210436|NCT02196259|3940782|FG002|STARTED|Overall Study||3
3210437|NCT02196259|3940780|FG000|COMPLETED|Overall Study||3
3210438|NCT02196259|3940781|FG001|COMPLETED|Overall Study||4
3210439|NCT02196259|3940782|FG002|COMPLETED|Overall Study||2
3210440|NCT02196259|3940780|FG000|NOT COMPLETED|Overall Study||0
3210441|NCT02196259|3940781|FG001|NOT COMPLETED|Overall Study||3
3210442|NCT02196259|3940782|FG002|NOT COMPLETED|Overall Study||1
3210443|NCT02196324|3940791|FG000|STARTED|Overall Study||63
3210444|NCT02196324|3940792|FG001|STARTED|Overall Study||65
3210445|NCT02196324|3940791|FG000|COMPLETED|Overall Study||48
3210446|NCT02196324|3940792|FG001|COMPLETED|Overall Study||57
3210447|NCT02196324|3940791|FG000|NOT COMPLETED|Overall Study||15
3210448|NCT02196324|3940792|FG001|NOT COMPLETED|Overall Study||8
3210449|NCT02196506|3940800|FG000|STARTED|Phase A||837
3210450|NCT02196506|3940801|FG001|STARTED|Phase A||0
3210451|NCT02196506|3940802|FG002|STARTED|Phase A||0
3210452|NCT02196506|3940803|FG003|STARTED|Phase A||0
3210453|NCT02196506|3940800|FG000|COMPLETED|Phase A||716
3210454|NCT02196506|3940801|FG001|COMPLETED|Phase A||0
3210455|NCT02196506|3940802|FG002|COMPLETED|Phase A||0
3210456|NCT02196506|3940803|FG003|COMPLETED|Phase A||0
3210457|NCT02196506|3940800|FG000|NOT COMPLETED|Phase A||121
3210458|NCT02196506|3940801|FG001|NOT COMPLETED|Phase A||0
3210459|NCT02196506|3940802|FG002|NOT COMPLETED|Phase A||0
3210460|NCT02196506|3940803|FG003|NOT COMPLETED|Phase A||0
3210461|NCT02196506|3940800|FG000|STARTED|Phase B||0
3210462|NCT02196506|3940801|FG001|STARTED|Phase B||192
3210463|NCT02196506|3940802|FG002|STARTED|Phase B||202
3210464|NCT02196506|3940803|FG003|STARTED|Phase B||0
3210465|NCT02196506|3940800|FG000|COMPLETED|Phase B||0
3210466|NCT02196506|3940801|FG001|COMPLETED|Phase B||177
3210467|NCT02196506|3940802|FG002|COMPLETED|Phase B||196
3210468|NCT02196506|3940803|FG003|COMPLETED|Phase B||0
3210469|NCT02196506|3940800|FG000|NOT COMPLETED|Phase B||0
3210470|NCT02196506|3940801|FG001|NOT COMPLETED|Phase B||15
3210471|NCT02196506|3940802|FG002|NOT COMPLETED|Phase B||6
3210472|NCT02196506|3940803|FG003|NOT COMPLETED|Phase B||0
3210473|NCT02196506|3940800|FG000|STARTED|Phase A+||0
3210474|NCT02196506|3940801|FG001|STARTED|Phase A+||0
3210475|NCT02196506|3940802|FG002|STARTED|Phase A+||0
3210476|NCT02196506|3940803|FG003|STARTED|Phase A+||322
3210477|NCT02196506|3940800|FG000|COMPLETED|Phase A+||0
3210478|NCT02196506|3940801|FG001|COMPLETED|Phase A+||0
3210479|NCT02196506|3940802|FG002|COMPLETED|Phase A+||0
3210480|NCT02196506|3940803|FG003|COMPLETED|Phase A+||308
3210481|NCT02196506|3940800|FG000|NOT COMPLETED|Phase A+||0
3210482|NCT02196506|3940801|FG001|NOT COMPLETED|Phase A+||0
3210483|NCT02196506|3940802|FG002|NOT COMPLETED|Phase A+||0
3210484|NCT02196506|3940803|FG003|NOT COMPLETED|Phase A+||14
3210485|NCT02196558|3940812|FG000|STARTED|Treatment Phase (12 Weeks)||12
3210486|NCT02196558|3940813|FG001|STARTED|Treatment Phase (12 Weeks)||15
3210487|NCT02196558|3940814|FG002|STARTED|Treatment Phase (12 Weeks)||10
3210488|NCT02196558|3940812|FG000|COMPLETED|Treatment Phase (12 Weeks)||12
3210489|NCT02196558|3940813|FG001|COMPLETED|Treatment Phase (12 Weeks)||12
3210490|NCT02196558|3940814|FG002|COMPLETED|Treatment Phase (12 Weeks)||8
3210491|NCT02196558|3940812|FG000|NOT COMPLETED|Treatment Phase (12 Weeks)||0
3210492|NCT02196558|3940813|FG001|NOT COMPLETED|Treatment Phase (12 Weeks)||3
3210493|NCT02196558|3940814|FG002|NOT COMPLETED|Treatment Phase (12 Weeks)||2
3210494|NCT02196558|3940812|FG000|STARTED|Extension Phase (40 Weeks)|Participants who wished to continue, had no safety issues, and had>=20% improvement in joint counts.|11
3366379|NCT03905811|4097696|FG001|COMPLETED|Overall Study||5
3366380|NCT03905811|4097695|FG000|NOT COMPLETED|Overall Study||2
3210495|NCT02196558|3940813|FG001|STARTED|Extension Phase (40 Weeks)|Participants who wished to continue, had no safety issues, and had>=20% improvement in joint counts.|11
3210496|NCT02196558|3940814|FG002|STARTED|Extension Phase (40 Weeks)|Participants who wished to continue, had no safety issues, and had>=20% improvement in joint counts.|6
3210497|NCT02196558|3940812|FG000|COMPLETED|Extension Phase (40 Weeks)||9
3210498|NCT02196558|3940813|FG001|COMPLETED|Extension Phase (40 Weeks)||8
3210499|NCT02196558|3940814|FG002|COMPLETED|Extension Phase (40 Weeks)||5
3210500|NCT02196558|3940812|FG000|NOT COMPLETED|Extension Phase (40 Weeks)||2
3210501|NCT02196558|3940813|FG001|NOT COMPLETED|Extension Phase (40 Weeks)||3
3210502|NCT02196558|3940814|FG002|NOT COMPLETED|Extension Phase (40 Weeks)||1
3210503|NCT02196675|3940825|FG000|STARTED|Overall Study||27
3210504|NCT02196675|3940826|FG001|STARTED|Overall Study||70
3210505|NCT02196675|3940827|FG002|STARTED|Overall Study||8
3210506|NCT02196675|3940825|FG000|COMPLETED|Overall Study||25
3210507|NCT02196675|3940826|FG001|COMPLETED|Overall Study||68
3210508|NCT02196675|3940827|FG002|COMPLETED|Overall Study||7
3210509|NCT02196675|3940825|FG000|NOT COMPLETED|Overall Study||2
3210510|NCT02196675|3940826|FG001|NOT COMPLETED|Overall Study||2
3210511|NCT02196675|3940827|FG002|NOT COMPLETED|Overall Study||1
3210512|NCT02196688|3940837|FG000|STARTED|Overall Study||47
3210513|NCT02196688|3940838|FG001|STARTED|Overall Study||24
3210514|NCT02196688|3940837|FG000|COMPLETED|Overall Study||40
3210515|NCT02196688|3940838|FG001|COMPLETED|Overall Study||23
3210516|NCT02196688|3940837|FG000|NOT COMPLETED|Overall Study||7
3210517|NCT02196688|3940838|FG001|NOT COMPLETED|Overall Study||1
3366381|NCT03905811|4097696|FG001|NOT COMPLETED|Overall Study||0
3366382|NCT03898063|4097704|FG000|STARTED|Overall Study||74
3366383|NCT03898063|4097705|FG001|STARTED|Overall Study||74
3366384|NCT03898063|4097704|FG000|COMPLETED|Overall Study||64
3366385|NCT03898063|4097705|FG001|COMPLETED|Overall Study||66
3366386|NCT03898063|4097704|FG000|NOT COMPLETED|Overall Study||10
3366387|NCT03898063|4097705|FG001|NOT COMPLETED|Overall Study||8
3366388|NCT03895307|4097715|FG000|STARTED|Overall Study||21
3366389|NCT03895307|4097716|FG001|STARTED|Overall Study||20
3366390|NCT03895307|4097717|FG002|STARTED|Overall Study||22
3366391|NCT03895307|4097718|FG003|STARTED|Overall Study||21
3366392|NCT03895307|4097715|FG000|COMPLETED|Overall Study||19
3366393|NCT03895307|4097716|FG001|COMPLETED|Overall Study||20
3366394|NCT03895307|4097717|FG002|COMPLETED|Overall Study||20
3366395|NCT03895307|4097718|FG003|COMPLETED|Overall Study||21
3366396|NCT03895307|4097715|FG000|NOT COMPLETED|Overall Study||2
3366397|NCT03895307|4097716|FG001|NOT COMPLETED|Overall Study||0
3366398|NCT03895307|4097717|FG002|NOT COMPLETED|Overall Study||2
3366399|NCT03895307|4097718|FG003|NOT COMPLETED|Overall Study||0
3366400|NCT03926208|4097730|FG000|STARTED|Overall Study||119
3366401|NCT03926208|4097731|FG001|STARTED|Overall Study||123
3366402|NCT03926208|4097730|FG000|COMPLETED|Overall Study||119
3366403|NCT03926208|4097731|FG001|COMPLETED|Overall Study||123
3366404|NCT03926208|4097730|FG000|NOT COMPLETED|Overall Study||0
3366405|NCT03926208|4097731|FG001|NOT COMPLETED|Overall Study||0
3366406|NCT03926065|4097737|FG000|STARTED|Study Week 1||11
3366407|NCT03926065|4097738|FG001|STARTED|Study Week 1||9
3366408|NCT03926065|4097739|FG002|STARTED|Study Week 1||14
3366409|NCT03926065|4097740|FG003|STARTED|Study Week 1||18
3366410|NCT03926065|4097741|FG004|STARTED|Study Week 1||15
3366411|NCT03926065|4097737|FG000|COMPLETED|Study Week 1||11
3366412|NCT03926065|4097738|FG001|COMPLETED|Study Week 1||9
3366413|NCT03926065|4097739|FG002|COMPLETED|Study Week 1||14
3366414|NCT03926065|4097740|FG003|COMPLETED|Study Week 1||18
3366415|NCT03926065|4097741|FG004|COMPLETED|Study Week 1||15
3366416|NCT03926065|4097737|FG000|NOT COMPLETED|Study Week 1||0
3366417|NCT03926065|4097738|FG001|NOT COMPLETED|Study Week 1||0
3366418|NCT03926065|4097739|FG002|NOT COMPLETED|Study Week 1||0
3366419|NCT03926065|4097740|FG003|NOT COMPLETED|Study Week 1||0
3366420|NCT03926065|4097741|FG004|NOT COMPLETED|Study Week 1||0
3366421|NCT03926065|4097737|FG000|STARTED|Study Week 2||11
3366422|NCT03926065|4097738|FG001|STARTED|Study Week 2||9
3366423|NCT03926065|4097739|FG002|STARTED|Study Week 2||14
3366424|NCT03926065|4097740|FG003|STARTED|Study Week 2||18
3366425|NCT03926065|4097741|FG004|STARTED|Study Week 2||15
3366426|NCT03926065|4097737|FG000|COMPLETED|Study Week 2||11
3366427|NCT03926065|4097738|FG001|COMPLETED|Study Week 2||9
3366428|NCT03926065|4097739|FG002|COMPLETED|Study Week 2||14
3366429|NCT03926065|4097740|FG003|COMPLETED|Study Week 2||18
3366430|NCT03926065|4097741|FG004|COMPLETED|Study Week 2||15
3366431|NCT03926065|4097737|FG000|NOT COMPLETED|Study Week 2||0
3366432|NCT03926065|4097738|FG001|NOT COMPLETED|Study Week 2||0
3366433|NCT03926065|4097739|FG002|NOT COMPLETED|Study Week 2||0
3366434|NCT03926065|4097740|FG003|NOT COMPLETED|Study Week 2||0
3366435|NCT03926065|4097741|FG004|NOT COMPLETED|Study Week 2||0
3366436|NCT03926065|4097737|FG000|STARTED|Study Week 3||11
3366437|NCT03926065|4097738|FG001|STARTED|Study Week 3||9
3366438|NCT03926065|4097739|FG002|STARTED|Study Week 3||14
3366439|NCT03926065|4097740|FG003|STARTED|Study Week 3||18
3366440|NCT03926065|4097741|FG004|STARTED|Study Week 3||15
3366441|NCT03926065|4097737|FG000|COMPLETED|Study Week 3||11
3366442|NCT03926065|4097738|FG001|COMPLETED|Study Week 3||9
3366443|NCT03926065|4097739|FG002|COMPLETED|Study Week 3||14
3366444|NCT03926065|4097740|FG003|COMPLETED|Study Week 3||18
3366445|NCT03926065|4097741|FG004|COMPLETED|Study Week 3||15
3366446|NCT03926065|4097737|FG000|NOT COMPLETED|Study Week 3||0
3366447|NCT03926065|4097738|FG001|NOT COMPLETED|Study Week 3||0
3210518|NCT02196701|3940846|FG000|STARTED|Overall Study||46
3210519|NCT02196701|3940846|FG000|COMPLETED|Overall Study||43
3210520|NCT02196701|3940846|FG000|NOT COMPLETED|Overall Study||3
3210521|NCT02196714|3940853|FG000|STARTED|Overall Study||24
3210522|NCT02196714|3940854|FG001|STARTED|Overall Study||23
3210523|NCT02196714|3940855|FG002|STARTED|Overall Study||24
3210524|NCT02196714|3940856|FG003|STARTED|Overall Study||24
3210525|NCT02196714|3940853|FG000|COMPLETED|Overall Study||24
3210526|NCT02196714|3940854|FG001|COMPLETED|Overall Study||23
3210527|NCT02196714|3940855|FG002|COMPLETED|Overall Study||23
3210528|NCT02196714|3940856|FG003|COMPLETED|Overall Study||24
3210529|NCT02196714|3940853|FG000|NOT COMPLETED|Overall Study||0
3210530|NCT02196714|3940854|FG001|NOT COMPLETED|Overall Study||0
3210531|NCT02196714|3940855|FG002|NOT COMPLETED|Overall Study||1
3210532|NCT02196714|3940856|FG003|NOT COMPLETED|Overall Study||0
3210533|NCT02196766|3940868|FG000|STARTED|First Intervention (7 Days)||15
3210534|NCT02196766|3940869|FG001|STARTED|First Intervention (7 Days)||15
3210535|NCT02196766|3940868|FG000|COMPLETED|First Intervention (7 Days)||15
3210536|NCT02196766|3940869|FG001|COMPLETED|First Intervention (7 Days)||15
3210537|NCT02196766|3940868|FG000|NOT COMPLETED|First Intervention (7 Days)||0
3210538|NCT02196766|3940869|FG001|NOT COMPLETED|First Intervention (7 Days)||0
3210539|NCT02196766|3940868|FG000|STARTED|Second Intervention (7 Days)||15
3210540|NCT02196766|3940869|FG001|STARTED|Second Intervention (7 Days)||15
3210541|NCT02196766|3940868|FG000|COMPLETED|Second Intervention (7 Days)||15
3210542|NCT02196766|3940869|FG001|COMPLETED|Second Intervention (7 Days)||15
3210543|NCT02196766|3940868|FG000|NOT COMPLETED|Second Intervention (7 Days)||0
3210544|NCT02196766|3940869|FG001|NOT COMPLETED|Second Intervention (7 Days)||0
3210545|NCT02196831|3940877|FG000|STARTED|Overall Study||30
3210546|NCT02196831|3940878|FG001|STARTED|Overall Study||30
3210547|NCT02196831|3940877|FG000|Received Follow-up Imaging|Overall Study||26
3210548|NCT02196831|3940878|FG001|Received Follow-up Imaging|Overall Study||28
3210549|NCT02196831|3940877|FG000|COMPLETED|Overall Study||21
3210550|NCT02196831|3940878|FG001|COMPLETED|Overall Study||26
3210551|NCT02196831|3940877|FG000|NOT COMPLETED|Overall Study||9
3210552|NCT02196831|3940878|FG001|NOT COMPLETED|Overall Study||4
3210553|NCT02196857|3940885|FG000|STARTED|Overall Study||16
3210554|NCT02196857|3940885|FG000|COMPLETED|Overall Study||16
3210555|NCT02196857|3940885|FG000|NOT COMPLETED|Overall Study||0
3210556|NCT02196922|3940891|FG000|STARTED|Overall Study||58
3210557|NCT02196922|3940892|FG001|STARTED|Overall Study||46
3210558|NCT02196922|3940891|FG000|COMPLETED|Overall Study||58
3210559|NCT02196922|3940892|FG001|COMPLETED|Overall Study||46
3210560|NCT02196922|3940891|FG000|NOT COMPLETED|Overall Study||0
3210561|NCT02196922|3940892|FG001|NOT COMPLETED|Overall Study||0
3210562|NCT02197065|3940902|FG000|STARTED|Overall Study||10
3210563|NCT02197065|3940903|FG001|STARTED|Overall Study||10
3210564|NCT02197065|3940902|FG000|COMPLETED|Overall Study||10
3210565|NCT02197065|3940903|FG001|COMPLETED|Overall Study||10
3210566|NCT02197065|3940902|FG000|NOT COMPLETED|Overall Study||0
3210567|NCT02197065|3940903|FG001|NOT COMPLETED|Overall Study||0
3210568|NCT02197078|3940924|FG000|STARTED|Overall Study||14688
3210569|NCT02197078|3940925|FG001|STARTED|Overall Study||14688
3210570|NCT02197078|3940926|FG002|STARTED|Overall Study||10614
3210571|NCT02197078|3940927|FG003|STARTED|Overall Study||10614
3210572|NCT02197078|3940928|FG004|STARTED|Overall Study||9538
3210573|NCT02197078|3940929|FG005|STARTED|Overall Study||9538
3210574|NCT02197078|3940930|FG006|STARTED|Overall Study||25135
3210575|NCT02197078|3940931|FG007|STARTED|Overall Study||25135
3210576|NCT02197078|3940932|FG008|STARTED|Overall Study||18996
3210577|NCT02197078|3940933|FG009|STARTED|Overall Study||18996
3210578|NCT02197078|3940934|FG010|STARTED|Overall Study||15742
3210579|NCT02197078|3940935|FG011|STARTED|Overall Study||15742
3210580|NCT02197078|3940924|FG000|COMPLETED|Overall Study||14688
3210581|NCT02197078|3940925|FG001|COMPLETED|Overall Study||14688
3210582|NCT02197078|3940926|FG002|COMPLETED|Overall Study||10614
3210583|NCT02197078|3940927|FG003|COMPLETED|Overall Study||10614
3210584|NCT02197078|3940928|FG004|COMPLETED|Overall Study||9538
3210585|NCT02197078|3940929|FG005|COMPLETED|Overall Study||9538
3210586|NCT02197078|3940930|FG006|COMPLETED|Overall Study||25135
3210587|NCT02197078|3940931|FG007|COMPLETED|Overall Study||25135
3210588|NCT02197078|3940932|FG008|COMPLETED|Overall Study||18996
3210589|NCT02197078|3940933|FG009|COMPLETED|Overall Study||18996
3210590|NCT02197078|3940934|FG010|COMPLETED|Overall Study||15742
3210591|NCT02197078|3940935|FG011|COMPLETED|Overall Study||15742
3210592|NCT02197078|3940924|FG000|NOT COMPLETED|Overall Study||0
3210593|NCT02197078|3940925|FG001|NOT COMPLETED|Overall Study||0
3210594|NCT02197078|3940926|FG002|NOT COMPLETED|Overall Study||0
3210595|NCT02197078|3940927|FG003|NOT COMPLETED|Overall Study||0
3210596|NCT02197078|3940928|FG004|NOT COMPLETED|Overall Study||0
3210597|NCT02197078|3940929|FG005|NOT COMPLETED|Overall Study||0
3210598|NCT02197078|3940930|FG006|NOT COMPLETED|Overall Study||0
3210599|NCT02197078|3940931|FG007|NOT COMPLETED|Overall Study||0
3210600|NCT02197078|3940932|FG008|NOT COMPLETED|Overall Study||0
3210601|NCT02197078|3940933|FG009|NOT COMPLETED|Overall Study||0
3210602|NCT02197078|3940934|FG010|NOT COMPLETED|Overall Study||0
3210603|NCT02197078|3940935|FG011|NOT COMPLETED|Overall Study||0
3210604|NCT02197130|3940964|FG000|STARTED|Overall Study||95
3210605|NCT02197130|3940965|FG001|STARTED|Overall Study||89
3210606|NCT02197130|3940966|FG002|STARTED|Overall Study||88
3210607|NCT02197130|3940964|FG000|Received Treatment|Overall Study||95
3210608|NCT02197130|3940965|FG001|Received Treatment|Overall Study||88
3210609|NCT02197130|3940966|FG002|Received Treatment|Overall Study||87
3210610|NCT02197130|3940964|FG000|COMPLETED|Overall Study||79
3210611|NCT02197130|3940965|FG001|COMPLETED|Overall Study||81
3210612|NCT02197130|3940966|FG002|COMPLETED|Overall Study||56
3210613|NCT02197130|3940964|FG000|NOT COMPLETED|Overall Study||16
3210614|NCT02197130|3940965|FG001|NOT COMPLETED|Overall Study||8
3210615|NCT02197130|3940966|FG002|NOT COMPLETED|Overall Study||32
3210616|NCT02197247|3940974|FG000|STARTED|Part A: Day 1-28 (AZD9291 Alone)||41
3210617|NCT02197247|3940974|FG000|COMPLETED|Part A: Day 1-28 (AZD9291 Alone)||41
3210618|NCT02197247|3940974|FG000|NOT COMPLETED|Part A: Day 1-28 (AZD9291 Alone)||0
3210619|NCT02197247|3940974|FG000|STARTED|Part A: Day 29-49 (AZD9291+Rifampicin)||41
3210620|NCT02197247|3940974|FG000|COMPLETED|Part A: Day 29-49 (AZD9291+Rifampicin)||37
3210621|NCT02197247|3940974|FG000|NOT COMPLETED|Part A: Day 29-49 (AZD9291+Rifampicin)||4
3210622|NCT02197247|3940974|FG000|STARTED|Part A: Day 50-77 (AZD9291 Alone)||37
3210623|NCT02197247|3940974|FG000|COMPLETED|Part A: Day 50-77 (AZD9291 Alone)||32
3210624|NCT02197247|3940974|FG000|NOT COMPLETED|Part A: Day 50-77 (AZD9291 Alone)||5
3210625|NCT02197247|3940974|FG000|STARTED|Part B: Day 78 to End Part B (AZD9291)|32 completed Part A + 2 entered Part B without completing Part A (both due to AE) =34 started Part B|34
3210626|NCT02197247|3940974|FG000|COMPLETED|Part B: Day 78 to End Part B (AZD9291)||19
3210627|NCT02197247|3940974|FG000|NOT COMPLETED|Part B: Day 78 to End Part B (AZD9291)||15
3210628|NCT02197273|3940986|FG000|STARTED|Overall Study||107
3210629|NCT02197273|3940987|FG001|STARTED|Overall Study||104
3210630|NCT02197273|3940986|FG000|COMPLETED|Overall Study||107
3210631|NCT02197273|3940987|FG001|COMPLETED|Overall Study||104
3210632|NCT02197273|3940986|FG000|NOT COMPLETED|Overall Study||0
3210633|NCT02197273|3940987|FG001|NOT COMPLETED|Overall Study||0
3210634|NCT02197377|3940995|FG000|STARTED|Overall Study||30
3210635|NCT02197377|3940996|FG001|STARTED|Overall Study||30
3210636|NCT02197377|3940995|FG000|COMPLETED|Overall Study||30
3210637|NCT02197377|3940996|FG001|COMPLETED|Overall Study||27
3210638|NCT02197377|3940995|FG000|NOT COMPLETED|Overall Study||0
3210639|NCT02197377|3940996|FG001|NOT COMPLETED|Overall Study||3
3210640|NCT02197416|3941005|FG000|STARTED|Overall Study||9
3210641|NCT02197416|3941006|FG001|STARTED|Overall Study||43
3210642|NCT02197416|3941007|FG002|STARTED|Overall Study||161
3210643|NCT02197416|3941005|FG000|COMPLETED|Overall Study||8
3210644|NCT02197416|3941006|FG001|COMPLETED|Overall Study||39
3210645|NCT02197416|3941007|FG002|COMPLETED|Overall Study||153
3210646|NCT02197416|3941005|FG000|NOT COMPLETED|Overall Study||1
3210647|NCT02197416|3941006|FG001|NOT COMPLETED|Overall Study||4
3210648|NCT02197416|3941007|FG002|NOT COMPLETED|Overall Study||8
3210649|NCT02197455|3941013|FG000|STARTED|Overall Study||30
3210650|NCT02197455|3941013|FG000|COMPLETED|Overall Study||30
3210651|NCT02197455|3941013|FG000|NOT COMPLETED|Overall Study||0
3210652|NCT02197481|3941019|FG000|STARTED|Overall Study|October 2014|43
3210653|NCT02197481|3941020|FG001|STARTED|Overall Study||43
3210654|NCT02197481|3941019|FG000|COMPLETED|Overall Study|February 2016|43
3210655|NCT02197481|3941020|FG001|COMPLETED|Overall Study||43
3210656|NCT02197481|3941019|FG000|NOT COMPLETED|Overall Study||0
3210657|NCT02197481|3941020|FG001|NOT COMPLETED|Overall Study||0
3210658|NCT02197520|3941026|FG000|STARTED|Period 1||12
3210659|NCT02197520|3941027|FG001|STARTED|Period 1||12
3210660|NCT02197520|3941026|FG000|COMPLETED|Period 1||11
3210661|NCT02197520|3941027|FG001|COMPLETED|Period 1||12
3210662|NCT02197520|3941026|FG000|NOT COMPLETED|Period 1||1
3210663|NCT02197520|3941027|FG001|NOT COMPLETED|Period 1||0
3210664|NCT02197520|3941026|FG000|STARTED|Period 2||11
3210665|NCT02197520|3941027|FG001|STARTED|Period 2||12
3210666|NCT02197520|3941026|FG000|COMPLETED|Period 2||10
3210667|NCT02197520|3941027|FG001|COMPLETED|Period 2||10
3210668|NCT02197520|3941026|FG000|NOT COMPLETED|Period 2||1
3210669|NCT02197520|3941027|FG001|NOT COMPLETED|Period 2||2
3210670|NCT02197572|3941035|FG000|STARTED|Overall Study||44
3210671|NCT02197572|3941035|FG000|COMPLETED|Overall Study||0
3210672|NCT02197572|3941035|FG000|NOT COMPLETED|Overall Study||44
3210673|NCT02197767|3941039|FG000|STARTED|Overall Study||11
3210674|NCT02197767|3941039|FG000|COMPLETED|Overall Study||11
3210675|NCT02197767|3941039|FG000|NOT COMPLETED|Overall Study||0
3210676|NCT02197806|3941047|FG000|STARTED|Overall Study||15
3210677|NCT02197806|3941048|FG001|STARTED|Overall Study||17
3210678|NCT02197806|3941049|FG002|STARTED|Overall Study||16
3210679|NCT02197806|3941050|FG003|STARTED|Overall Study||17
3210680|NCT02197806|3941047|FG000|COMPLETED|Overall Study||15
3210681|NCT02197806|3941048|FG001|COMPLETED|Overall Study||16
3210682|NCT02197806|3941049|FG002|COMPLETED|Overall Study||16
3210683|NCT02197806|3941050|FG003|COMPLETED|Overall Study||16
3210684|NCT02197806|3941047|FG000|NOT COMPLETED|Overall Study||0
3210685|NCT02197806|3941048|FG001|NOT COMPLETED|Overall Study||1
3210686|NCT02197806|3941049|FG002|NOT COMPLETED|Overall Study||0
3210687|NCT02197806|3941050|FG003|NOT COMPLETED|Overall Study||1
3210688|NCT02197897|3941060|FG000|STARTED|Overall Study||15
3210689|NCT02197897|3941060|FG000|COMPLETED|Overall Study||14
3210690|NCT02197897|3941060|FG000|NOT COMPLETED|Overall Study||1
3210691|NCT02198040|3941067|FG000|STARTED|Overall Study||9
3210692|NCT02198040|3941068|FG001|STARTED|Overall Study||9
3210693|NCT02198040|3941069|FG002|STARTED|Overall Study||9
3210694|NCT02198040|3941067|FG000|COMPLETED|Overall Study||9
3210695|NCT02198040|3941068|FG001|COMPLETED|Overall Study||8
3210696|NCT02198040|3941069|FG002|COMPLETED|Overall Study||8
3210697|NCT02198040|3941067|FG000|NOT COMPLETED|Overall Study||0
3210698|NCT02198040|3941068|FG001|NOT COMPLETED|Overall Study||1
3210699|NCT02198040|3941069|FG002|NOT COMPLETED|Overall Study||1
3210700|NCT02198235|3941082|FG000|STARTED|Overall Study||30
3210701|NCT02198235|3941083|FG001|STARTED|Overall Study||30
3210702|NCT02198235|3941084|FG002|STARTED|Overall Study||30
3210703|NCT02198235|3941082|FG000|COMPLETED|Overall Study||27
3210704|NCT02198235|3941083|FG001|COMPLETED|Overall Study||28
3210705|NCT02198235|3941084|FG002|COMPLETED|Overall Study||28
3210706|NCT02198235|3941082|FG000|NOT COMPLETED|Overall Study||3
3210707|NCT02198235|3941083|FG001|NOT COMPLETED|Overall Study||2
3210708|NCT02198235|3941084|FG002|NOT COMPLETED|Overall Study||2
3210709|NCT02198430|3941094|FG000|STARTED|Overall Study||53
3210710|NCT02198430|3941095|FG001|STARTED|Overall Study||51
3210711|NCT02198430|3941094|FG000|COMPLETED|Overall Study||53
3210712|NCT02198430|3941095|FG001|COMPLETED|Overall Study||51
3210713|NCT02198430|3941094|FG000|NOT COMPLETED|Overall Study||0
3210714|NCT02198430|3941095|FG001|NOT COMPLETED|Overall Study||0
3210715|NCT02198651|3941101|FG000|STARTED|Lead-in Period||149
3210716|NCT02198651|3941102|FG001|STARTED|Lead-in Period||0
3210717|NCT02198651|3941103|FG002|STARTED|Lead-in Period||0
3210718|NCT02198651|3941104|FG003|STARTED|Lead-in Period||0
3210719|NCT02198651|3941105|FG004|STARTED|Lead-in Period||0
3210720|NCT02198651|3941101|FG000|Participants Treated in Lead-In Period|Lead-in Period||146
3210721|NCT02198651|3941102|FG001|Participants Treated in Lead-In Period|Lead-in Period||0
3210722|NCT02198651|3941103|FG002|Participants Treated in Lead-In Period|Lead-in Period||0
3210723|NCT02198651|3941104|FG003|Participants Treated in Lead-In Period|Lead-in Period||0
3210724|NCT02198651|3941105|FG004|Participants Treated in Lead-In Period|Lead-in Period||0
3210725|NCT02198651|3941101|FG000|COMPLETED|Lead-in Period||112
3210726|NCT02198651|3941102|FG001|COMPLETED|Lead-in Period||0
3210727|NCT02198651|3941103|FG002|COMPLETED|Lead-in Period||0
3210728|NCT02198651|3941104|FG003|COMPLETED|Lead-in Period||0
3210729|NCT02198651|3941105|FG004|COMPLETED|Lead-in Period||0
3210730|NCT02198651|3941101|FG000|NOT COMPLETED|Lead-in Period||37
3210731|NCT02198651|3941102|FG001|NOT COMPLETED|Lead-in Period||0
3210732|NCT02198651|3941103|FG002|NOT COMPLETED|Lead-in Period||0
3210733|NCT02198651|3941104|FG003|NOT COMPLETED|Lead-in Period||0
3210734|NCT02198651|3941105|FG004|NOT COMPLETED|Lead-in Period||0
3210735|NCT02198651|3941101|FG000|STARTED|Double-blind Period||0
3210736|NCT02198651|3941102|FG001|STARTED|Double-blind Period||102
3210737|NCT02198651|3941103|FG002|STARTED|Double-blind Period||20
3210738|NCT02198651|3941104|FG003|STARTED|Double-blind Period||0
3210739|NCT02198651|3941105|FG004|STARTED|Double-blind Period||0
3210740|NCT02198651|3941101|FG000|COMPLETED|Double-blind Period||0
3210741|NCT02198651|3941102|FG001|COMPLETED|Double-blind Period||93
3210742|NCT02198651|3941103|FG002|COMPLETED|Double-blind Period||19
3210743|NCT02198651|3941104|FG003|COMPLETED|Double-blind Period||0
3210744|NCT02198651|3941105|FG004|COMPLETED|Double-blind Period||0
3210745|NCT02198651|3941101|FG000|NOT COMPLETED|Double-blind Period||0
3210746|NCT02198651|3941102|FG001|NOT COMPLETED|Double-blind Period||9
3210747|NCT02198651|3941103|FG002|NOT COMPLETED|Double-blind Period||1
3210748|NCT02198651|3941104|FG003|NOT COMPLETED|Double-blind Period||0
3210749|NCT02198651|3941105|FG004|NOT COMPLETED|Double-blind Period||0
3210750|NCT02198651|3941101|FG000|STARTED|Open-label Rescue Period||0
3210751|NCT02198651|3941102|FG001|STARTED|Open-label Rescue Period||0
3210752|NCT02198651|3941103|FG002|STARTED|Open-label Rescue Period||0
3210753|NCT02198651|3941104|FG003|STARTED|Open-label Rescue Period||31
3210754|NCT02198651|3941105|FG004|STARTED|Open-label Rescue Period||8
3210755|NCT02198651|3941101|FG000|Correctly Entered Open-label Rescue|Open-label Rescue Period||0
3210756|NCT02198651|3941102|FG001|Correctly Entered Open-label Rescue|Open-label Rescue Period||0
3210757|NCT02198651|3941103|FG002|Correctly Entered Open-label Rescue|Open-label Rescue Period||0
3210758|NCT02198651|3941104|FG003|Correctly Entered Open-label Rescue|Open-label Rescue Period||30
3210759|NCT02198651|3941105|FG004|Correctly Entered Open-label Rescue|Open-label Rescue Period||8
3210760|NCT02198651|3941101|FG000|COMPLETED|Open-label Rescue Period||0
3210761|NCT02198651|3941102|FG001|COMPLETED|Open-label Rescue Period||0
3210762|NCT02198651|3941103|FG002|COMPLETED|Open-label Rescue Period||0
3210763|NCT02198651|3941104|FG003|COMPLETED|Open-label Rescue Period||28
3210764|NCT02198651|3941105|FG004|COMPLETED|Open-label Rescue Period||8
3210765|NCT02198651|3941101|FG000|NOT COMPLETED|Open-label Rescue Period||0
3210766|NCT02198651|3941102|FG001|NOT COMPLETED|Open-label Rescue Period||0
3210767|NCT02198651|3941103|FG002|NOT COMPLETED|Open-label Rescue Period||0
3210768|NCT02198651|3941104|FG003|NOT COMPLETED|Open-label Rescue Period||3
3210769|NCT02198651|3941105|FG004|NOT COMPLETED|Open-label Rescue Period||0
3210770|NCT02198664|3941120|FG000|STARTED|Overall Study||26
3210771|NCT02198664|3941121|FG001|STARTED|Overall Study||21
3210772|NCT02198664|3941120|FG000|COMPLETED|Overall Study||10
3210773|NCT02198664|3941121|FG001|COMPLETED|Overall Study||13
3210774|NCT02198664|3941120|FG000|NOT COMPLETED|Overall Study||16
3210775|NCT02198664|3941121|FG001|NOT COMPLETED|Overall Study||8
3210776|NCT02198963|3941129|FG000|STARTED|Overall Study||43
3210777|NCT02198963|3941129|FG000|COMPLETED|Overall Study||36
3210778|NCT02198963|3941129|FG000|NOT COMPLETED|Overall Study||7
3210779|NCT02199028|3941140|FG000|STARTED|Week 1||15
3210780|NCT02199028|3941141|FG001|STARTED|Week 1||15
3210781|NCT02199028|3941140|FG000|COMPLETED|Week 1||14
3210782|NCT02199028|3941141|FG001|COMPLETED|Week 1||15
3210783|NCT02199028|3941140|FG000|NOT COMPLETED|Week 1||1
3210784|NCT02199028|3941141|FG001|NOT COMPLETED|Week 1||0
3210785|NCT02199028|3941140|FG000|STARTED|Week 2||14
3210786|NCT02199028|3941141|FG001|STARTED|Week 2||15
3210787|NCT02199028|3941140|FG000|COMPLETED|Week 2||14
3210788|NCT02199028|3941141|FG001|COMPLETED|Week 2||15
3210789|NCT02199028|3941140|FG000|NOT COMPLETED|Week 2||0
3210790|NCT02199028|3941141|FG001|NOT COMPLETED|Week 2||0
3210791|NCT02199028|3941140|FG000|STARTED|Week 3||14
3210792|NCT02199028|3941141|FG001|STARTED|Week 3||15
3210793|NCT02199028|3941140|FG000|COMPLETED|Week 3||13
3210794|NCT02199028|3941141|FG001|COMPLETED|Week 3||15
3210795|NCT02199028|3941140|FG000|NOT COMPLETED|Week 3||1
3210796|NCT02199028|3941141|FG001|NOT COMPLETED|Week 3||0
3210797|NCT02199028|3941140|FG000|STARTED|Week 4||13
3210798|NCT02199028|3941141|FG001|STARTED|Week 4||15
3210799|NCT02199028|3941140|FG000|COMPLETED|Week 4||13
3210800|NCT02199028|3941141|FG001|COMPLETED|Week 4||15
3210801|NCT02199028|3941140|FG000|NOT COMPLETED|Week 4||0
3210802|NCT02199028|3941141|FG001|NOT COMPLETED|Week 4||0
3210803|NCT02199041|3941148|FG000|STARTED|Overall Study||12
3210804|NCT02199041|3941148|FG000|COMPLETED|Overall Study||12
3210805|NCT02199041|3941148|FG000|NOT COMPLETED|Overall Study||0
3210806|NCT02199080|3941153|FG000|STARTED|Overall Study||2506
3210807|NCT02199080|3941153|FG000|COMPLETED|Overall Study||2494
3210808|NCT02199080|3941153|FG000|NOT COMPLETED|Overall Study||12
3210809|NCT02199197|3941161|FG000|STARTED|Overall Study||35
3210810|NCT02199197|3941162|FG001|STARTED|Overall Study||14
3210811|NCT02199197|3941161|FG000|COMPLETED|Overall Study||35
3210812|NCT02199197|3941162|FG001|COMPLETED|Overall Study||12
3210813|NCT02199197|3941161|FG000|NOT COMPLETED|Overall Study||0
3210814|NCT02199197|3941162|FG001|NOT COMPLETED|Overall Study||2
3210815|NCT02199314|3941169|FG000|STARTED|Overall Study||30
3210816|NCT02199314|3941169|FG000|COMPLETED|Overall Study||14
3210817|NCT02199314|3941169|FG000|NOT COMPLETED|Overall Study||16
3210818|NCT02199496|3941175|FG000|STARTED|Ustekinumab-Single Dose||3
3210819|NCT02199496|3941176|FG001|STARTED|Ustekinumab-Single Dose||0
3210820|NCT02199496|3941175|FG000|COMPLETED|Ustekinumab-Single Dose||3
3210821|NCT02199496|3941176|FG001|COMPLETED|Ustekinumab-Single Dose||0
3210822|NCT02199496|3941175|FG000|NOT COMPLETED|Ustekinumab-Single Dose||0
3210823|NCT02199496|3941176|FG001|NOT COMPLETED|Ustekinumab-Single Dose||0
3210824|NCT02199496|3941175|FG000|STARTED|Ustekinumab-Multi-dose||3
3210825|NCT02199496|3941176|FG001|STARTED|Ustekinumab-Multi-dose|Cohort 2 only participated in multi-dose phase 2|2
3210826|NCT02199496|3941175|FG000|COMPLETED|Ustekinumab-Multi-dose||3
3210827|NCT02199496|3941176|FG001|COMPLETED|Ustekinumab-Multi-dose||2
3210828|NCT02199496|3941175|FG000|NOT COMPLETED|Ustekinumab-Multi-dose||0
3210829|NCT02199496|3941176|FG001|NOT COMPLETED|Ustekinumab-Multi-dose||0
3210830|NCT02199509|3941184|FG000|STARTED|Overall Study||3
3210831|NCT02199509|3941185|FG001|STARTED|Overall Study||4
3210832|NCT02199509|3941184|FG000|COMPLETED|Overall Study||2
3210833|NCT02199509|3941185|FG001|COMPLETED|Overall Study||3
3210834|NCT02199509|3941184|FG000|NOT COMPLETED|Overall Study||1
3210835|NCT02199509|3941185|FG001|NOT COMPLETED|Overall Study||1
3210836|NCT02199574|3941195|FG000|STARTED|Overall Study||12
3210837|NCT02199574|3941195|FG000|COMPLETED|Overall Study||12
3210838|NCT02199574|3941195|FG000|NOT COMPLETED|Overall Study||0
3210839|NCT02199652|3941203|FG000|STARTED|Overall Study||10
3210840|NCT02199652|3941204|FG001|STARTED|Overall Study||10
3210841|NCT02199652|3941203|FG000|COMPLETED|Overall Study||3
3210842|NCT02199652|3941204|FG001|COMPLETED|Overall Study||3
3210843|NCT02199652|3941203|FG000|NOT COMPLETED|Overall Study||7
3210844|NCT02199652|3941204|FG001|NOT COMPLETED|Overall Study||7
3210845|NCT02199691|3941214|FG000|STARTED|Overall Study||505
3210846|NCT02199691|3941215|FG001|STARTED|Overall Study||507
3210847|NCT02199691|3941216|FG002|STARTED|Overall Study||403
3210848|NCT02199691|3941217|FG003|STARTED|Overall Study||300
3210849|NCT02199691|3941214|FG000|Safety Analysis Set (SafAS)|Overall Study||503
3210850|NCT02199691|3941215|FG001|Safety Analysis Set (SafAS)|Overall Study||501
3210851|NCT02199691|3941216|FG002|Safety Analysis Set (SafAS)|Overall Study||392
3210852|NCT02199691|3941217|FG003|Safety Analysis Set (SafAS)|Overall Study||296
3210853|NCT02199691|3941214|FG000|COMPLETED|Overall Study||495
3210854|NCT02199691|3941215|FG001|COMPLETED|Overall Study||500
3210855|NCT02199691|3941216|FG002|COMPLETED|Overall Study||376
3210856|NCT02199691|3941217|FG003|COMPLETED|Overall Study||270
3210857|NCT02199691|3941214|FG000|NOT COMPLETED|Overall Study||10
3210858|NCT02199691|3941215|FG001|NOT COMPLETED|Overall Study||7
3210859|NCT02199691|3941216|FG002|NOT COMPLETED|Overall Study||27
3210860|NCT02199691|3941217|FG003|NOT COMPLETED|Overall Study||30
3210861|NCT02199717|3941229|FG000|STARTED|Overall Study||66
3210862|NCT02199717|3941229|FG000|COMPLETED|Overall Study||66
3210863|NCT02199717|3941229|FG000|NOT COMPLETED|Overall Study||0
3210864|NCT02199743|3941236|FG000|STARTED|Overall Study||14
3210865|NCT02199743|3941237|FG001|STARTED|Overall Study||10
3210866|NCT02199743|3941236|FG000|COMPLETED|Overall Study||14
3210867|NCT02199743|3941237|FG001|COMPLETED|Overall Study||8
3210868|NCT02199743|3941236|FG000|NOT COMPLETED|Overall Study||0
3210869|NCT02199743|3941237|FG001|NOT COMPLETED|Overall Study||2
3210870|NCT02199795|3941247|FG000|STARTED|Overall Study||4
3366448|NCT03926065|4097739|FG002|NOT COMPLETED|Study Week 3||0
3366449|NCT03926065|4097740|FG003|NOT COMPLETED|Study Week 3||0
3366450|NCT03926065|4097741|FG004|NOT COMPLETED|Study Week 3||0
3366451|NCT03926065|4097737|FG000|STARTED|Study Week 4||11
3366452|NCT03926065|4097738|FG001|STARTED|Study Week 4||9
3210871|NCT02199795|3941248|FG001|STARTED|Overall Study||3
3210872|NCT02199795|3941247|FG000|COMPLETED|Overall Study||2
3210873|NCT02199795|3941248|FG001|COMPLETED|Overall Study||3
3210874|NCT02199795|3941247|FG000|NOT COMPLETED|Overall Study||2
3210875|NCT02199795|3941248|FG001|NOT COMPLETED|Overall Study||0
3210876|NCT02199964|3941256|FG000|STARTED|Overall Study||2
3210877|NCT02199964|3941257|FG001|STARTED|Overall Study||2
3210878|NCT02199964|3941256|FG000|COMPLETED|Overall Study||2
3210879|NCT02199964|3941257|FG001|COMPLETED|Overall Study||2
3210880|NCT02199964|3941256|FG000|NOT COMPLETED|Overall Study||0
3210881|NCT02199964|3941257|FG001|NOT COMPLETED|Overall Study||0
3210882|NCT02200055|3941263|FG000|STARTED|Overall Study||86
3210883|NCT02200055|3941263|FG000|COMPLETED|Overall Study||86
3210884|NCT02200055|3941263|FG000|NOT COMPLETED|Overall Study||0
3210885|NCT02200211|3941273|FG000|STARTED|Overall Study||190
3210886|NCT02200211|3941274|FG001|STARTED|Overall Study||195
3210887|NCT02200211|3941275|FG002|STARTED|Overall Study||40
3210888|NCT02200211|3941276|FG003|STARTED|Overall Study||60
3210889|NCT02200211|3941273|FG000|Included in 16-week Primary Analysis|Overall Study||177
3210890|NCT02200211|3941274|FG001|Included in 16-week Primary Analysis|Overall Study||186
3210891|NCT02200211|3941275|FG002|Included in 16-week Primary Analysis|Overall Study||39
3210892|NCT02200211|3941276|FG003|Included in 16-week Primary Analysis|Overall Study||56
3210893|NCT02200211|3941273|FG000|COMPLETED|Overall Study||182
3210894|NCT02200211|3941274|FG001|COMPLETED|Overall Study||188
3210895|NCT02200211|3941275|FG002|COMPLETED|Overall Study||39
3210896|NCT02200211|3941276|FG003|COMPLETED|Overall Study||58
3210897|NCT02200211|3941273|FG000|NOT COMPLETED|Overall Study||8
3210898|NCT02200211|3941274|FG001|NOT COMPLETED|Overall Study||7
3210899|NCT02200211|3941275|FG002|NOT COMPLETED|Overall Study||1
3210900|NCT02200211|3941276|FG003|NOT COMPLETED|Overall Study||2
3210901|NCT02200445|3941297|FG000|STARTED|Overall Study||4
3210902|NCT02200445|3941298|FG001|STARTED|Overall Study||17
3210903|NCT02200445|3941299|FG002|STARTED|Overall Study||5
3210904|NCT02200445|3941297|FG000|COMPLETED|Overall Study||3
3210905|NCT02200445|3941298|FG001|COMPLETED|Overall Study||13
3210906|NCT02200445|3941299|FG002|COMPLETED|Overall Study||3
3210907|NCT02200445|3941297|FG000|NOT COMPLETED|Overall Study||1
3210908|NCT02200445|3941298|FG001|NOT COMPLETED|Overall Study||4
3210909|NCT02200445|3941299|FG002|NOT COMPLETED|Overall Study||2
3210910|NCT02200458|3941307|FG000|STARTED|Overall Study||62
3210911|NCT02200458|3941307|FG000|COMPLETED|Overall Study||62
3210912|NCT02200458|3941307|FG000|NOT COMPLETED|Overall Study||0
3210913|NCT02200510|3941313|FG000|STARTED|Overall Study|Number who only completed self-management or completed it before portal (could do 6 months later).|31
3210914|NCT02200510|3941314|FG001|STARTED|Overall Study|Number who only completed portal or completed it before self-management (could do 6 months later).|47
3210915|NCT02200510|3941313|FG000|COMPLETED|Overall Study|This is the number of participants with baseline and post data.|22
3210916|NCT02200510|3941314|FG001|COMPLETED|Overall Study|This number is the number of participants with both baseline and post data.|44
3210917|NCT02200510|3941313|FG000|NOT COMPLETED|Overall Study||9
3210918|NCT02200510|3941314|FG001|NOT COMPLETED|Overall Study||3
3210919|NCT02200523|3941322|FG000|STARTED|Overall Study||20
3210920|NCT02200523|3941323|FG001|STARTED|Overall Study||20
3210921|NCT02200523|3941322|FG000|COMPLETED|Overall Study||20
3210922|NCT02200523|3941323|FG001|COMPLETED|Overall Study||20
3210923|NCT02200523|3941322|FG000|NOT COMPLETED|Overall Study||0
3210924|NCT02200523|3941323|FG001|NOT COMPLETED|Overall Study||0
3210925|NCT02200536|3941332|FG000|STARTED|Overall Study||32
3210926|NCT02200536|3941333|FG001|STARTED|Overall Study||30
3210927|NCT02200536|3941334|FG002|STARTED|Overall Study||30
3210928|NCT02200536|3941332|FG000|COMPLETED|Overall Study||32
3210929|NCT02200536|3941333|FG001|COMPLETED|Overall Study||30
3210930|NCT02200536|3941334|FG002|COMPLETED|Overall Study||30
3210931|NCT02200536|3941332|FG000|NOT COMPLETED|Overall Study||0
3210932|NCT02200536|3941333|FG001|NOT COMPLETED|Overall Study||0
3210933|NCT02200536|3941334|FG002|NOT COMPLETED|Overall Study||0
3210934|NCT02200614|3941344|FG000|STARTED|Double Blind Treatment||955
3210935|NCT02200614|3941345|FG001|STARTED|Double Blind Treatment||554
3210936|NCT02200614|3941344|FG000|COMPLETED|Double Blind Treatment||591
3210937|NCT02200614|3941345|FG001|COMPLETED|Double Blind Treatment||170
3210938|NCT02200614|3941344|FG000|NOT COMPLETED|Double Blind Treatment||364
3210939|NCT02200614|3941345|FG001|NOT COMPLETED|Double Blind Treatment||384
3210940|NCT02200614|3941344|FG000|STARTED|Open Label|Not all participants from treatment period entered follow-up|591
3210941|NCT02200614|3941345|FG001|STARTED|Open Label|Not all participants from treatment period entered follow-up|170
3210942|NCT02200614|3941344|FG000|COMPLETED|Open Label||466
3210943|NCT02200614|3941345|FG001|COMPLETED|Open Label||147
3210944|NCT02200614|3941344|FG000|NOT COMPLETED|Open Label||125
3210945|NCT02200614|3941345|FG001|NOT COMPLETED|Open Label||23
3210946|NCT02201056|3941360|FG000|STARTED|Overall Study||12
3210947|NCT02201056|3941361|FG001|STARTED|Overall Study||6
3210948|NCT02201056|3941362|FG002|STARTED|Overall Study||6
3210949|NCT02201056|3941363|FG003|STARTED|Overall Study||6
3210950|NCT02201056|3941364|FG004|STARTED|Overall Study||6
3210951|NCT02201056|3941365|FG005|STARTED|Overall Study||6
3210952|NCT02201056|3941366|FG006|STARTED|Overall Study||6
3210953|NCT02201056|3941360|FG000|COMPLETED|Overall Study||12
3210954|NCT02201056|3941361|FG001|COMPLETED|Overall Study||6
3210955|NCT02201056|3941362|FG002|COMPLETED|Overall Study||6
3210956|NCT02201056|3941363|FG003|COMPLETED|Overall Study||6
3210957|NCT02201056|3941364|FG004|COMPLETED|Overall Study||6
3210958|NCT02201056|3941365|FG005|COMPLETED|Overall Study||6
3210959|NCT02201056|3941366|FG006|COMPLETED|Overall Study||6
3210960|NCT02201056|3941360|FG000|NOT COMPLETED|Overall Study||0
3210961|NCT02201056|3941361|FG001|NOT COMPLETED|Overall Study||0
3210962|NCT02201056|3941362|FG002|NOT COMPLETED|Overall Study||0
3210963|NCT02201056|3941363|FG003|NOT COMPLETED|Overall Study||0
3210964|NCT02201056|3941364|FG004|NOT COMPLETED|Overall Study||0
3210965|NCT02201056|3941365|FG005|NOT COMPLETED|Overall Study||0
3210966|NCT02201056|3941366|FG006|NOT COMPLETED|Overall Study||0
3210967|NCT02201108|3941390|FG000|STARTED|Overall Study||57
3210968|NCT02201108|3941391|FG001|STARTED|Overall Study||109
3210969|NCT02201108|3941390|FG000|On-going Participants|Overall Study||0
3210970|NCT02201108|3941391|FG001|On-going Participants|Overall Study||58
3210971|NCT02201108|3941390|FG000|COMPLETED|Overall Study||53
3210972|NCT02201108|3941391|FG001|COMPLETED|Overall Study||102
3210973|NCT02201108|3941390|FG000|NOT COMPLETED|Overall Study||4
3210974|NCT02201108|3941391|FG001|NOT COMPLETED|Overall Study||7
3366453|NCT03926065|4097739|FG002|STARTED|Study Week 4||14
3366454|NCT03926065|4097740|FG003|STARTED|Study Week 4||18
3366455|NCT03926065|4097741|FG004|STARTED|Study Week 4||15
3366456|NCT03926065|4097737|FG000|COMPLETED|Study Week 4||11
3366457|NCT03926065|4097738|FG001|COMPLETED|Study Week 4||9
3366458|NCT03926065|4097739|FG002|COMPLETED|Study Week 4||14
3366459|NCT03926065|4097740|FG003|COMPLETED|Study Week 4||18
3366460|NCT03926065|4097741|FG004|COMPLETED|Study Week 4||15
3366461|NCT03926065|4097737|FG000|NOT COMPLETED|Study Week 4||0
3366462|NCT03926065|4097738|FG001|NOT COMPLETED|Study Week 4||0
3366463|NCT03926065|4097739|FG002|NOT COMPLETED|Study Week 4||0
3366464|NCT03926065|4097740|FG003|NOT COMPLETED|Study Week 4||0
3366465|NCT03926065|4097741|FG004|NOT COMPLETED|Study Week 4||0
3366466|NCT03909100|4097751|FG000|STARTED|Overall Study||120
3366467|NCT03909100|4097751|FG000|Safety Population|Overall Study||112
3366468|NCT03909100|4097751|FG000|Received Treatment in Session 2|Overall Study||107
3366469|NCT03909100|4097751|FG000|Evaluable Population|Overall Study||106
3366470|NCT03909100|4097751|FG000|COMPLETED|Overall Study||105
3366471|NCT03909100|4097751|FG000|NOT COMPLETED|Overall Study||15
3366472|NCT03905642|4097758|FG000|STARTED|Overall Study||49
3366473|NCT03905642|4097758|FG000|COMPLETED|Overall Study||41
3366474|NCT03905642|4097758|FG000|NOT COMPLETED|Overall Study||8
3366475|NCT03892889|4097762|FG000|STARTED|Overall Study||277
3366476|NCT03892889|4097762|FG000|COMPLETED|Overall Study||73
3366477|NCT03892889|4097762|FG000|NOT COMPLETED|Overall Study||204
3366478|NCT03921723|4097766|FG000|STARTED|Period 1 (4 Days)||22
3366479|NCT03921723|4097766|FG000|COMPLETED|Period 1 (4 Days)||22
3366480|NCT03921723|4097766|FG000|NOT COMPLETED|Period 1 (4 Days)||0
3366481|NCT03921723|4097766|FG000|STARTED|Period 2 (4 Days)||22
3366482|NCT03921723|4097766|FG000|COMPLETED|Period 2 (4 Days)||19
3366483|NCT03921723|4097766|FG000|NOT COMPLETED|Period 2 (4 Days)||3
3366484|NCT03921723|4097766|FG000|STARTED|Period 3 (4 Days)||19
3366485|NCT03921723|4097766|FG000|COMPLETED|Period 3 (4 Days)||18
3366486|NCT03921723|4097766|FG000|NOT COMPLETED|Period 3 (4 Days)||1
3366487|NCT03921190|4097776|FG000|STARTED|Overall Study||56
3366488|NCT03921190|4097777|FG001|STARTED|Overall Study||64
3366489|NCT03921190|4097776|FG000|COMPLETED|Overall Study||56
3366490|NCT03921190|4097777|FG001|COMPLETED|Overall Study||64
3366491|NCT03921190|4097776|FG000|NOT COMPLETED|Overall Study||0
3366492|NCT03921190|4097777|FG001|NOT COMPLETED|Overall Study||0
3366493|NCT03920865|4097788|FG000|STARTED|Overall Study||8
3366494|NCT03920865|4097789|FG001|STARTED|Overall Study||8
3366495|NCT03920865|4097790|FG002|STARTED|Overall Study||10
3366496|NCT03920865|4097788|FG000|COMPLETED|Overall Study||8
3366497|NCT03920865|4097789|FG001|COMPLETED|Overall Study||8
3366498|NCT03920865|4097790|FG002|COMPLETED|Overall Study||10
3366499|NCT03920865|4097788|FG000|NOT COMPLETED|Overall Study||0
3366500|NCT03920865|4097789|FG001|NOT COMPLETED|Overall Study||0
3366501|NCT03920865|4097790|FG002|NOT COMPLETED|Overall Study||0
3366502|NCT03918239|4097810|FG000|STARTED|Overall Study||94
3366503|NCT03918239|4097811|FG001|STARTED|Overall Study||96
3366504|NCT03918239|4097810|FG000|COMPLETED|Overall Study||84
3366505|NCT03918239|4097811|FG001|COMPLETED|Overall Study||89
3366506|NCT03918239|4097810|FG000|NOT COMPLETED|Overall Study||10
3366507|NCT03918239|4097811|FG001|NOT COMPLETED|Overall Study||7
3366508|NCT03917823|4097819|FG000|STARTED|Overall Study||2
3366509|NCT03917823|4097820|FG001|STARTED|Overall Study||2
3366510|NCT03917823|4097819|FG000|COMPLETED|Overall Study||1
3366511|NCT03917823|4097820|FG001|COMPLETED|Overall Study||0
3366512|NCT03917823|4097819|FG000|NOT COMPLETED|Overall Study||1
3366513|NCT03917823|4097820|FG001|NOT COMPLETED|Overall Study||2
3366514|NCT03911752|4097829|FG000|STARTED|Overall Study||8
3366515|NCT03911752|4097830|FG001|STARTED|Overall Study||2
3366516|NCT03911752|4097831|FG002|STARTED|Overall Study||2
3366517|NCT03911752|4097829|FG000|COMPLETED|Overall Study||8
3366518|NCT03911752|4097830|FG001|COMPLETED|Overall Study||2
3366519|NCT03911752|4097831|FG002|COMPLETED|Overall Study||2
3366520|NCT03911752|4097829|FG000|NOT COMPLETED|Overall Study||0
3366521|NCT03911752|4097830|FG001|NOT COMPLETED|Overall Study||0
3366522|NCT03911752|4097831|FG002|NOT COMPLETED|Overall Study||0
3366523|NCT03902613|4097841|FG000|STARTED|Overall Study||1
3366524|NCT03902613|4097841|FG000|COMPLETED|Overall Study||0
3366525|NCT03902613|4097841|FG000|NOT COMPLETED|Overall Study||1
3366526|NCT03902574|4097848|FG000|STARTED|Overall Study||7
3210975|NCT02201212|3941400|FG000|STARTED|Overall Study||30
3210976|NCT02201212|3941400|FG000|COMPLETED|Overall Study||30
3210977|NCT02201212|3941400|FG000|NOT COMPLETED|Overall Study||0
3210978|NCT02201251|3941406|FG000|STARTED|Overall Study||28
3210979|NCT02201251|3941407|FG001|STARTED|Overall Study||35
3210980|NCT02201251|3941406|FG000|COMPLETED|Overall Study||24
3210981|NCT02201251|3941407|FG001|COMPLETED|Overall Study||32
3210982|NCT02201251|3941406|FG000|NOT COMPLETED|Overall Study||4
3210983|NCT02201251|3941407|FG001|NOT COMPLETED|Overall Study||3
3210984|NCT02201277|3941415|FG000|STARTED|Overall Study|24 patients were consented but 1 patient had denali filter placed twice.|24
3210985|NCT02201277|3941416|FG001|STARTED|Overall Study|1 patient was withdrawn after signing consent due to physician preference for the option filter.|21
3210986|NCT02201277|3941415|FG000|Filter Retrieval|Overall Study||17
3210987|NCT02201277|3941416|FG001|Filter Retrieval|Overall Study||16
3210988|NCT02201277|3941415|FG000|Signed ICF But Did Not Enroll|Overall Study|Physician had preference for a specific filter so patient not randomized.|0
3210989|NCT02201277|3941416|FG001|Signed ICF But Did Not Enroll|Overall Study||1
3210990|NCT02201277|3941415|FG000|Filter Ruled to be Permanent|Overall Study||2
3210991|NCT02201277|3941416|FG001|Filter Ruled to be Permanent|Overall Study||2
3210992|NCT02201277|3941415|FG000|Lost to Follow up|Overall Study||2
3210993|NCT02201277|3941416|FG001|Lost to Follow up|Overall Study||1
3210994|NCT02201277|3941415|FG000|Death (Before Removal)|Overall Study||3
3210995|NCT02201277|3941416|FG001|Death (Before Removal)|Overall Study||4
3210996|NCT02201277|3941415|FG000|Complicated Retrieval|Overall Study||2
3210997|NCT02201277|3941416|FG001|Complicated Retrieval|Overall Study||0
3210998|NCT02201277|3941415|FG000|Failed Retrieval (Referred Elsewhere)|Overall Study||1
3210999|NCT02201277|3941416|FG001|Failed Retrieval (Referred Elsewhere)|Overall Study||0
3211000|NCT02201277|3941415|FG000|COMPLETED|Overall Study||17
3211001|NCT02201277|3941416|FG001|COMPLETED|Overall Study||16
3211002|NCT02201277|3941415|FG000|NOT COMPLETED|Overall Study||7
3211003|NCT02201277|3941416|FG001|NOT COMPLETED|Overall Study||5
3211004|NCT02201290|3941426|FG000|STARTED|Overall Study||9
3211005|NCT02201290|3941426|FG000|COMPLETED|Overall Study||4
3211006|NCT02201290|3941426|FG000|NOT COMPLETED|Overall Study||5
3211007|NCT02201329|3941430|FG000|STARTED|Overall Study||5
3211008|NCT02201329|3941430|FG000|COMPLETED|Overall Study||0
3211009|NCT02201329|3941430|FG000|NOT COMPLETED|Overall Study||5
3211010|NCT02201394|3941434|FG000|STARTED|Loading Dose||20
3211011|NCT02201394|3941434|FG000|COMPLETED|Loading Dose||20
3211012|NCT02201394|3941434|FG000|NOT COMPLETED|Loading Dose||0
3211013|NCT02201394|3941434|FG000|STARTED|Maintenance Dose||20
3211014|NCT02201394|3941434|FG000|COMPLETED|Maintenance Dose||20
3211015|NCT02201394|3941434|FG000|NOT COMPLETED|Maintenance Dose||0
3211016|NCT02201420|3941439|FG000|STARTED|Overall Study||5
3211017|NCT02201420|3941439|FG000|COMPLETED|Overall Study||5
3211018|NCT02201420|3941439|FG000|NOT COMPLETED|Overall Study||0
3211019|NCT02201446|3941445|FG000|STARTED|Overall Study||81
3211020|NCT02201446|3941446|FG001|STARTED|Overall Study||58
3211021|NCT02201446|3941445|FG000|COMPLETED|Overall Study||81
3211022|NCT02201446|3941446|FG001|COMPLETED|Overall Study||58
3211023|NCT02201446|3941445|FG000|NOT COMPLETED|Overall Study||0
3211024|NCT02201446|3941446|FG001|NOT COMPLETED|Overall Study||0
3211025|NCT02201524|3941456|FG000|STARTED|Overall Study||14
3211026|NCT02201524|3941457|FG001|STARTED|Overall Study||15
3211027|NCT02201524|3941458|FG002|STARTED|Overall Study||16
3211028|NCT02201524|3941459|FG003|STARTED|Overall Study||14
3211029|NCT02201524|3941456|FG000|COMPLETED|Overall Study||12
3211030|NCT02201524|3941457|FG001|COMPLETED|Overall Study||12
3211031|NCT02201524|3941458|FG002|COMPLETED|Overall Study||12
3211032|NCT02201524|3941459|FG003|COMPLETED|Overall Study||10
3211033|NCT02201524|3941456|FG000|NOT COMPLETED|Overall Study||2
3211034|NCT02201524|3941457|FG001|NOT COMPLETED|Overall Study||3
3211035|NCT02201524|3941458|FG002|NOT COMPLETED|Overall Study||4
3211036|NCT02201524|3941459|FG003|NOT COMPLETED|Overall Study||4
3211037|NCT02201771|3941472|FG000|STARTED|Overall Study||166
3211038|NCT02201771|3941473|FG001|STARTED|Overall Study||168
3211039|NCT02201771|3941474|FG002|STARTED|Overall Study||166
3211040|NCT02201771|3941472|FG000|COMPLETED|Overall Study||153
3211041|NCT02201771|3941473|FG001|COMPLETED|Overall Study||158
3211042|NCT02201771|3941474|FG002|COMPLETED|Overall Study||156
3211043|NCT02201771|3941472|FG000|NOT COMPLETED|Overall Study||13
3211044|NCT02201771|3941473|FG001|NOT COMPLETED|Overall Study||10
3211045|NCT02201771|3941474|FG002|NOT COMPLETED|Overall Study||10
3211046|NCT02201784|3941484|FG000|STARTED|Overall Study||30
3211047|NCT02201784|3941485|FG001|STARTED|Overall Study||30
3211048|NCT02201784|3941484|FG000|COMPLETED|Overall Study||28
3211049|NCT02201784|3941485|FG001|COMPLETED|Overall Study||30
3211050|NCT02201784|3941484|FG000|NOT COMPLETED|Overall Study||2
3211051|NCT02201784|3941485|FG001|NOT COMPLETED|Overall Study||0
3211052|NCT02201901|3941494|FG000|STARTED|Overall Study||90
3211053|NCT02201901|3941495|FG001|STARTED|Overall Study||88
3211054|NCT02201901|3941496|FG002|STARTED|Overall Study||90
3211055|NCT02201901|3941494|FG000|COMPLETED|Overall Study||75
3211056|NCT02201901|3941495|FG001|COMPLETED|Overall Study||79
3211057|NCT02201901|3941496|FG002|COMPLETED|Overall Study||77
3211058|NCT02201901|3941494|FG000|NOT COMPLETED|Overall Study||15
3211059|NCT02201901|3941495|FG001|NOT COMPLETED|Overall Study||9
3211060|NCT02201901|3941496|FG002|NOT COMPLETED|Overall Study||13
3211061|NCT02201940|3941507|FG000|STARTED|Overall Study||625
3211062|NCT02201940|3941508|FG001|STARTED|Overall Study||116
3211063|NCT02201940|3941507|FG000|COMPLETED|Overall Study||613
3211064|NCT02201940|3941508|FG001|COMPLETED|Overall Study||0
3211065|NCT02201940|3941507|FG000|NOT COMPLETED|Overall Study||12
3211066|NCT02201940|3941508|FG001|NOT COMPLETED|Overall Study||116
3211067|NCT02201953|3941516|FG000|STARTED|Overall Study||278
3211068|NCT02201953|3941517|FG001|STARTED|Overall Study||280
3211069|NCT02201953|3941516|FG000|COMPLETED|Overall Study||258
3211070|NCT02201953|3941517|FG001|COMPLETED|Overall Study||224
3211071|NCT02201953|3941516|FG000|NOT COMPLETED|Overall Study||20
3211072|NCT02201953|3941517|FG001|NOT COMPLETED|Overall Study||56
3211073|NCT02202031|3941525|FG000|STARTED|Overall Study||82
3211074|NCT02202031|3941526|FG001|STARTED|Overall Study||79
3211075|NCT02202031|3941525|FG000|COMPLETED|Overall Study||77
3211076|NCT02202031|3941526|FG001|COMPLETED|Overall Study||74
3211077|NCT02202031|3941525|FG000|NOT COMPLETED|Overall Study||5
3211078|NCT02202031|3941526|FG001|NOT COMPLETED|Overall Study||5
3211079|NCT02202109|3941534|FG000|STARTED|Overall Study||302
3211080|NCT02202109|3941535|FG001|STARTED|Overall Study||300
3211081|NCT02202109|3941534|FG000|COMPLETED|Overall Study||212
3211082|NCT02202109|3941535|FG001|COMPLETED|Overall Study||213
3211083|NCT02202109|3941534|FG000|NOT COMPLETED|Overall Study||90
3211084|NCT02202109|3941535|FG001|NOT COMPLETED|Overall Study||87
3211085|NCT02202135|3941541|FG000|STARTED|Overall Study||4
3211086|NCT02202135|3941541|FG000|COMPLETED|Overall Study||4
3211087|NCT02202135|3941541|FG000|NOT COMPLETED|Overall Study||0
3211088|NCT02202161|3941553|FG000|STARTED|Overall Study||13
3211089|NCT02202161|3941554|FG001|STARTED|Overall Study||5
3211090|NCT02202161|3941555|FG002|STARTED|Overall Study||5
3211091|NCT02202161|3941556|FG003|STARTED|Overall Study||9
3211092|NCT02202161|3941557|FG004|STARTED|Overall Study||9
3211093|NCT02202161|3941558|FG005|STARTED|Overall Study||10
3211094|NCT02202161|3941559|FG006|STARTED|Overall Study||13
3211095|NCT02202161|3941560|FG007|STARTED|Overall Study||6
3211096|NCT02202161|3941553|FG000|COMPLETED|Overall Study||12
3211097|NCT02202161|3941554|FG001|COMPLETED|Overall Study||4
3211098|NCT02202161|3941555|FG002|COMPLETED|Overall Study||5
3211099|NCT02202161|3941556|FG003|COMPLETED|Overall Study||9
3211100|NCT02202161|3941557|FG004|COMPLETED|Overall Study||8
3211101|NCT02202161|3941558|FG005|COMPLETED|Overall Study||9
3211102|NCT02202161|3941559|FG006|COMPLETED|Overall Study||13
3211103|NCT02202161|3941560|FG007|COMPLETED|Overall Study||0
3211104|NCT02202161|3941553|FG000|NOT COMPLETED|Overall Study||1
3211105|NCT02202161|3941554|FG001|NOT COMPLETED|Overall Study||1
3211106|NCT02202161|3941555|FG002|NOT COMPLETED|Overall Study||0
3211107|NCT02202161|3941556|FG003|NOT COMPLETED|Overall Study||0
3211108|NCT02202161|3941557|FG004|NOT COMPLETED|Overall Study||1
3211109|NCT02202161|3941558|FG005|NOT COMPLETED|Overall Study||1
3211110|NCT02202161|3941559|FG006|NOT COMPLETED|Overall Study||0
3211111|NCT02202161|3941560|FG007|NOT COMPLETED|Overall Study||6
3211112|NCT02202252|3941581|FG000|STARTED|Overall Study||30
3211113|NCT02202252|3941582|FG001|STARTED|Overall Study||30
3211114|NCT02202252|3941581|FG000|COMPLETED|Overall Study||30
3211115|NCT02202252|3941582|FG001|COMPLETED|Overall Study||30
3211116|NCT02202252|3941581|FG000|NOT COMPLETED|Overall Study||0
3211117|NCT02202252|3941582|FG001|NOT COMPLETED|Overall Study||0
3211118|NCT02202317|3941588|FG000|STARTED|Overall Study||9
3211119|NCT02202317|3941588|FG000|COMPLETED|Overall Study||8
3211120|NCT02202317|3941588|FG000|NOT COMPLETED|Overall Study||1
3211121|NCT02202499|3941595|FG000|STARTED|Overall Study||21
3211122|NCT02202499|3941596|FG001|STARTED|Overall Study||20
3211123|NCT02202499|3941597|FG002|STARTED|Overall Study||21
3211124|NCT02202499|3941595|FG000|COMPLETED|Overall Study||19
3211125|NCT02202499|3941596|FG001|COMPLETED|Overall Study||20
3211126|NCT02202499|3941597|FG002|COMPLETED|Overall Study||19
3211127|NCT02202499|3941595|FG000|NOT COMPLETED|Overall Study||2
3211128|NCT02202499|3941596|FG001|NOT COMPLETED|Overall Study||0
3211129|NCT02202499|3941597|FG002|NOT COMPLETED|Overall Study||2
3211130|NCT02202538|3941610|FG000|STARTED|Overall Study||53
3211131|NCT02202538|3941610|FG000|Screen Failure|Overall Study||2
3211132|NCT02202538|3941610|FG000|COMPLETED|Overall Study||45
3211133|NCT02202538|3941610|FG000|NOT COMPLETED|Overall Study||8
3211134|NCT02202551|3941618|FG000|STARTED|Overall Study||60
3211135|NCT02202551|3941619|FG001|STARTED|Overall Study||78
3211136|NCT02202551|3941620|FG002|STARTED|Overall Study||24
3211137|NCT02202551|3941621|FG003|STARTED|Overall Study||61
3211138|NCT02202551|3941618|FG000|COMPLETED|Overall Study||35
3211139|NCT02202551|3941619|FG001|COMPLETED|Overall Study||41
3211140|NCT02202551|3941620|FG002|COMPLETED|Overall Study||14
3211141|NCT02202551|3941621|FG003|COMPLETED|Overall Study||39
3211142|NCT02202551|3941618|FG000|NOT COMPLETED|Overall Study||25
3211143|NCT02202551|3941619|FG001|NOT COMPLETED|Overall Study||37
3211144|NCT02202551|3941620|FG002|NOT COMPLETED|Overall Study||10
3211145|NCT02202551|3941621|FG003|NOT COMPLETED|Overall Study||22
3211146|NCT02202616|3941635|FG000|STARTED|Overall Study||401
3211147|NCT02202616|3941635|FG000|Intent to Treat Set (ITT)|Overall Study||338
3211148|NCT02202616|3941635|FG000|COMPLETED|Overall Study||301
3211149|NCT02202616|3941635|FG000|NOT COMPLETED|Overall Study||100
3211150|NCT02202746|3941642|FG000|STARTED|Overall Study||109
3211151|NCT02202746|3941643|FG001|STARTED|Overall Study||69
3211152|NCT02202746|3941642|FG000|COMPLETED|Overall Study||109
3211153|NCT02202746|3941643|FG001|COMPLETED|Overall Study||69
3211154|NCT02202746|3941642|FG000|NOT COMPLETED|Overall Study||0
3211155|NCT02202746|3941643|FG001|NOT COMPLETED|Overall Study||0
3211156|NCT02202759|3941655|FG000|STARTED|Overall Study||9
3211157|NCT02202759|3941656|FG001|STARTED|Overall Study||15
3211158|NCT02202759|3941657|FG002|STARTED|Overall Study||14
3211159|NCT02202759|3941655|FG000|COMPLETED|Overall Study||0
3211160|NCT02202759|3941656|FG001|COMPLETED|Overall Study||0
3211161|NCT02202759|3941657|FG002|COMPLETED|Overall Study||0
3211162|NCT02202759|3941655|FG000|NOT COMPLETED|Overall Study||9
3211163|NCT02202759|3941656|FG001|NOT COMPLETED|Overall Study||15
3211164|NCT02202759|3941657|FG002|NOT COMPLETED|Overall Study||14
3211165|NCT02202785|3941667|FG000|STARTED|Overall Study||11
3211166|NCT02202785|3941668|FG001|STARTED|Overall Study||15
3211167|NCT02202785|3941669|FG002|STARTED|Overall Study||17
3211168|NCT02202785|3941667|FG000|COMPLETED|Overall Study||0
3211169|NCT02202785|3941668|FG001|COMPLETED|Overall Study||0
3211170|NCT02202785|3941669|FG002|COMPLETED|Overall Study||0
3211171|NCT02202785|3941667|FG000|NOT COMPLETED|Overall Study||11
3211172|NCT02202785|3941668|FG001|NOT COMPLETED|Overall Study||15
3211173|NCT02202785|3941669|FG002|NOT COMPLETED|Overall Study||17
3211174|NCT02202837|3941679|FG000|STARTED|Overall Study||140
3211175|NCT02202837|3941680|FG001|STARTED|Overall Study||17
3211176|NCT02202837|3941679|FG000|COMPLETED|Overall Study||87
3211177|NCT02202837|3941680|FG001|COMPLETED|Overall Study||12
3211178|NCT02202837|3941679|FG000|NOT COMPLETED|Overall Study||53
3211179|NCT02202837|3941680|FG001|NOT COMPLETED|Overall Study||5
3211180|NCT02202850|3941688|FG000|STARTED|Overall Study||70
3211181|NCT02202850|3941689|FG001|STARTED|Overall Study||14
3211182|NCT02202850|3941688|FG000|COMPLETED|Overall Study||46
3211183|NCT02202850|3941689|FG001|COMPLETED|Overall Study||8
3211184|NCT02202850|3941688|FG000|NOT COMPLETED|Overall Study||24
3211185|NCT02202850|3941689|FG001|NOT COMPLETED|Overall Study||6
3211186|NCT02202980|3941709|FG000|STARTED|Overall Study||14
3211187|NCT02202980|3941710|FG001|STARTED|Overall Study||26
3211188|NCT02202980|3941711|FG002|STARTED|Overall Study||27
3211189|NCT02202980|3941712|FG003|STARTED|Overall Study||32
3211190|NCT02202980|3941713|FG004|STARTED|Overall Study||13
3211191|NCT02202980|3941714|FG005|STARTED|Overall Study||15
3211192|NCT02202980|3941715|FG006|STARTED|Overall Study||15
3211193|NCT02202980|3941716|FG007|STARTED|Overall Study||15
3211194|NCT02202980|3941717|FG008|STARTED|Overall Study||18
3211195|NCT02202980|3941718|FG009|STARTED|Overall Study||17
3211196|NCT02202980|3941719|FG010|STARTED|Overall Study||19
3211197|NCT02202980|3941720|FG011|STARTED|Overall Study||28
3211198|NCT02202980|3941721|FG012|STARTED|Overall Study||30
3211199|NCT02202980|3941722|FG013|STARTED|Overall Study||4
3211200|NCT02202980|3941709|FG000|COMPLETED|Overall Study||13
3211201|NCT02202980|3941710|FG001|COMPLETED|Overall Study||24
3211202|NCT02202980|3941711|FG002|COMPLETED|Overall Study||17
3211203|NCT02202980|3941712|FG003|COMPLETED|Overall Study||28
3211204|NCT02202980|3941713|FG004|COMPLETED|Overall Study||7
3211205|NCT02202980|3941714|FG005|COMPLETED|Overall Study||14
3211206|NCT02202980|3941715|FG006|COMPLETED|Overall Study||4
3211207|NCT02202980|3941716|FG007|COMPLETED|Overall Study||12
3211208|NCT02202980|3941717|FG008|COMPLETED|Overall Study||14
3211209|NCT02202980|3941718|FG009|COMPLETED|Overall Study||17
3211210|NCT02202980|3941719|FG010|COMPLETED|Overall Study||19
3211211|NCT02202980|3941720|FG011|COMPLETED|Overall Study||25
3211212|NCT02202980|3941721|FG012|COMPLETED|Overall Study||19
3211213|NCT02202980|3941722|FG013|COMPLETED|Overall Study||4
3211214|NCT02202980|3941709|FG000|NOT COMPLETED|Overall Study||1
3211215|NCT02202980|3941710|FG001|NOT COMPLETED|Overall Study||2
3211216|NCT02202980|3941711|FG002|NOT COMPLETED|Overall Study||10
3211217|NCT02202980|3941712|FG003|NOT COMPLETED|Overall Study||4
3211218|NCT02202980|3941713|FG004|NOT COMPLETED|Overall Study||6
3211219|NCT02202980|3941714|FG005|NOT COMPLETED|Overall Study||1
3211220|NCT02202980|3941715|FG006|NOT COMPLETED|Overall Study||11
3211221|NCT02202980|3941716|FG007|NOT COMPLETED|Overall Study||3
3211222|NCT02202980|3941717|FG008|NOT COMPLETED|Overall Study||4
3211223|NCT02202980|3941718|FG009|NOT COMPLETED|Overall Study||0
3211224|NCT02202980|3941719|FG010|NOT COMPLETED|Overall Study||0
3211225|NCT02202980|3941720|FG011|NOT COMPLETED|Overall Study||3
3211226|NCT02202980|3941721|FG012|NOT COMPLETED|Overall Study||11
3211227|NCT02202980|3941722|FG013|NOT COMPLETED|Overall Study||0
3211228|NCT02203019|3941754|FG000|STARTED|Overall Study||19
3211229|NCT02203019|3941755|FG001|STARTED|Overall Study||17
3211230|NCT02203019|3941754|FG000|COMPLETED|Overall Study||19
3211231|NCT02203019|3941755|FG001|COMPLETED|Overall Study||17
3211232|NCT02203019|3941754|FG000|NOT COMPLETED|Overall Study||0
3211233|NCT02203019|3941755|FG001|NOT COMPLETED|Overall Study||0
3211234|NCT02203032|3941761|FG000|STARTED|Open Label Run-in (Week 0 to Week 16)||872
3211235|NCT02203032|3941762|FG001|STARTED|Open Label Run-in (Week 0 to Week 16)||0
3211236|NCT02203032|3941763|FG002|STARTED|Open Label Run-in (Week 0 to Week 16)||0
3211237|NCT02203032|3941764|FG003|STARTED|Open Label Run-in (Week 0 to Week 16)||0
3211238|NCT02203032|3941761|FG000|Treated|Open Label Run-in (Week 0 to Week 16)||871
3211239|NCT02203032|3941762|FG001|Treated|Open Label Run-in (Week 0 to Week 16)||0
3211240|NCT02203032|3941763|FG002|Treated|Open Label Run-in (Week 0 to Week 16)||0
3211241|NCT02203032|3941764|FG003|Treated|Open Label Run-in (Week 0 to Week 16)||0
3211242|NCT02203032|3941761|FG000|COMPLETED|Open Label Run-in (Week 0 to Week 16)||853
3211243|NCT02203032|3941762|FG001|COMPLETED|Open Label Run-in (Week 0 to Week 16)||0
3211244|NCT02203032|3941763|FG002|COMPLETED|Open Label Run-in (Week 0 to Week 16)||0
3211245|NCT02203032|3941764|FG003|COMPLETED|Open Label Run-in (Week 0 to Week 16)||0
3211246|NCT02203032|3941761|FG000|NOT COMPLETED|Open Label Run-in (Week 0 to Week 16)||19
3211247|NCT02203032|3941762|FG001|NOT COMPLETED|Open Label Run-in (Week 0 to Week 16)||0
3211248|NCT02203032|3941763|FG002|NOT COMPLETED|Open Label Run-in (Week 0 to Week 16)||0
3211249|NCT02203032|3941764|FG003|NOT COMPLETED|Open Label Run-in (Week 0 to Week 16)||0
3211250|NCT02203032|3941761|FG000|STARTED|Blinded Phase (Week 16 to Week 44)||0
3211251|NCT02203032|3941762|FG001|STARTED|Blinded Phase (Week 16 to Week 44)||135
3211252|NCT02203032|3941763|FG002|STARTED|Blinded Phase (Week 16 to Week 44)||133
3211253|NCT02203032|3941764|FG003|STARTED|Blinded Phase (Week 16 to Week 44)||585
3211254|NCT02203032|3941761|FG000|COMPLETED|Blinded Phase (Week 16 to Week 44)||0
3211255|NCT02203032|3941762|FG001|COMPLETED|Blinded Phase (Week 16 to Week 44)||120
3211256|NCT02203032|3941763|FG002|COMPLETED|Blinded Phase (Week 16 to Week 44)||107
3211257|NCT02203032|3941764|FG003|COMPLETED|Blinded Phase (Week 16 to Week 44)||539
3211258|NCT02203032|3941761|FG000|NOT COMPLETED|Blinded Phase (Week 16 to Week 44)||0
3211259|NCT02203032|3941762|FG001|NOT COMPLETED|Blinded Phase (Week 16 to Week 44)||15
3211260|NCT02203032|3941763|FG002|NOT COMPLETED|Blinded Phase (Week 16 to Week 44)||26
3211261|NCT02203032|3941764|FG003|NOT COMPLETED|Blinded Phase (Week 16 to Week 44)||46
3211262|NCT02203071|3941774|FG000|STARTED|Overall Study||13
3211263|NCT02203071|3941775|FG001|STARTED|Overall Study||6
3211264|NCT02203071|3941774|FG000|COMPLETED|Overall Study||10
3211265|NCT02203071|3941775|FG001|COMPLETED|Overall Study||5
3211266|NCT02203071|3941774|FG000|NOT COMPLETED|Overall Study||3
3211267|NCT02203071|3941775|FG001|NOT COMPLETED|Overall Study||1
3211268|NCT02203149|3941786|FG000|STARTED|Part 1||31
3211269|NCT02203149|3941787|FG001|STARTED|Part 1||32
3211270|NCT02203149|3941788|FG002|STARTED|Part 1||0
3211271|NCT02203149|3941789|FG003|STARTED|Part 1||0
3211272|NCT02203149|3941790|FG004|STARTED|Part 1||0
3211273|NCT02203149|3941786|FG000|COMPLETED|Part 1||31
3211274|NCT02203149|3941787|FG001|COMPLETED|Part 1||31
3211275|NCT02203149|3941788|FG002|COMPLETED|Part 1||0
3211276|NCT02203149|3941789|FG003|COMPLETED|Part 1||0
3211277|NCT02203149|3941790|FG004|COMPLETED|Part 1||0
3211278|NCT02203149|3941786|FG000|NOT COMPLETED|Part 1||0
3211279|NCT02203149|3941787|FG001|NOT COMPLETED|Part 1||1
3211280|NCT02203149|3941788|FG002|NOT COMPLETED|Part 1||0
3211281|NCT02203149|3941789|FG003|NOT COMPLETED|Part 1||0
3211282|NCT02203149|3941790|FG004|NOT COMPLETED|Part 1||0
3211283|NCT02203149|3941786|FG000|STARTED|Part 2|Participants of Part 1 did not enter Part 2|0
3211284|NCT02203149|3941787|FG001|STARTED|Part 2|Participants of Part 1 did not enter Part 2|0
3211285|NCT02203149|3941788|FG002|STARTED|Part 2||227
3211286|NCT02203149|3941789|FG003|STARTED|Part 2||74
3211287|NCT02203149|3941790|FG004|STARTED|Part 2||35
3211288|NCT02203149|3941786|FG000|Started Deferred Active Treatment|Part 2||0
3211289|NCT02203149|3941787|FG001|Started Deferred Active Treatment|Part 2||0
3211290|NCT02203149|3941788|FG002|Started Deferred Active Treatment|Part 2||0
3211291|NCT02203149|3941789|FG003|Started Deferred Active Treatment|Part 2|1 participant in Deferred Treatment Arm receiving Placebo did not receive Deferred Active Treatment.|73
3211292|NCT02203149|3941790|FG004|Started Deferred Active Treatment|Part 2||0
3211293|NCT02203149|3941786|FG000|COMPLETED|Part 2||0
3211294|NCT02203149|3941787|FG001|COMPLETED|Part 2||0
3211295|NCT02203149|3941788|FG002|COMPLETED|Part 2||226
3211296|NCT02203149|3941789|FG003|COMPLETED|Part 2||71
3211297|NCT02203149|3941790|FG004|COMPLETED|Part 2||34
3211298|NCT02203149|3941786|FG000|NOT COMPLETED|Part 2||0
3211299|NCT02203149|3941787|FG001|NOT COMPLETED|Part 2||0
3211300|NCT02203149|3941788|FG002|NOT COMPLETED|Part 2||1
3211301|NCT02203149|3941789|FG003|NOT COMPLETED|Part 2||3
3211302|NCT02203149|3941790|FG004|NOT COMPLETED|Part 2||1
3211303|NCT02203162|3941812|FG000|STARTED|Overall Study||30
3211304|NCT02203162|3941812|FG000|COMPLETED|Overall Study||30
3211305|NCT02203162|3941812|FG000|NOT COMPLETED|Overall Study||0
3211306|NCT02203331|3941822|FG000|STARTED|Overall Study||52
3211307|NCT02203331|3941823|FG001|STARTED|Overall Study||53
3211308|NCT02203331|3941824|FG002|STARTED|Overall Study||55
3211309|NCT02203331|3941825|FG003|STARTED|Overall Study||53
3211310|NCT02203331|3941826|FG004|STARTED|Overall Study||53
3211311|NCT02203331|3941827|FG005|STARTED|Overall Study||53
3211312|NCT02203331|3941822|FG000|Treated|Overall Study||49
3211313|NCT02203331|3941823|FG001|Treated|Overall Study||50
3211314|NCT02203331|3941824|FG002|Treated|Overall Study||54
3211315|NCT02203331|3941825|FG003|Treated|Overall Study||49
3211316|NCT02203331|3941826|FG004|Treated|Overall Study||50
3211317|NCT02203331|3941827|FG005|Treated|Overall Study||53
3211318|NCT02203331|3941822|FG000|COMPLETED|Overall Study||45
3211319|NCT02203331|3941823|FG001|COMPLETED|Overall Study||39
3211320|NCT02203331|3941824|FG002|COMPLETED|Overall Study||50
3211321|NCT02203331|3941825|FG003|COMPLETED|Overall Study||46
3211322|NCT02203331|3941826|FG004|COMPLETED|Overall Study||46
3211323|NCT02203331|3941827|FG005|COMPLETED|Overall Study||46
3211324|NCT02203331|3941822|FG000|NOT COMPLETED|Overall Study||7
3211325|NCT02203331|3941823|FG001|NOT COMPLETED|Overall Study||14
3211326|NCT02203331|3941824|FG002|NOT COMPLETED|Overall Study||5
3211327|NCT02203331|3941825|FG003|NOT COMPLETED|Overall Study||7
3211328|NCT02203331|3941826|FG004|NOT COMPLETED|Overall Study||7
3211329|NCT02203331|3941827|FG005|NOT COMPLETED|Overall Study||7
3211330|NCT02203357|3941844|FG000|STARTED|Overall Study||117
3211331|NCT02203357|3941845|FG001|STARTED|Overall Study||111
3211332|NCT02203357|3941846|FG002|STARTED|Overall Study||125
3211333|NCT02203357|3941844|FG000|mon7/2/3|Overall Study||114
3211334|NCT02203357|3941845|FG001|mon7/2/3|Overall Study||110
3211335|NCT02203357|3941846|FG002|mon7/2/3|Overall Study||124
3211336|NCT02203357|3941844|FG000|mon12|Overall Study||113
3211337|NCT02203357|3941845|FG001|mon12|Overall Study||101
3211338|NCT02203357|3941846|FG002|mon12|Overall Study||122
3211339|NCT02203357|3941844|FG000|mon24|Overall Study||59
3211340|NCT02203357|3941845|FG001|mon24|Overall Study||45
3211341|NCT02203357|3941846|FG002|mon24|Overall Study||55
3211342|NCT02203357|3941844|FG000|COMPLETED|Overall Study||59
3211343|NCT02203357|3941845|FG001|COMPLETED|Overall Study||45
3211344|NCT02203357|3941846|FG002|COMPLETED|Overall Study||55
3211345|NCT02203357|3941844|FG000|NOT COMPLETED|Overall Study||58
3211346|NCT02203357|3941845|FG001|NOT COMPLETED|Overall Study||66
3211347|NCT02203357|3941846|FG002|NOT COMPLETED|Overall Study||70
3211348|NCT02203565|3941857|FG000|STARTED|Overall Study||20
3211349|NCT02203565|3941857|FG000|COMPLETED|Overall Study||19
3211350|NCT02203565|3941857|FG000|NOT COMPLETED|Overall Study||1
3211351|NCT02203578|3941861|FG000|STARTED|Overall Study||1
3211352|NCT02203578|3941861|FG000|COMPLETED|Overall Study||1
3211353|NCT02203578|3941861|FG000|NOT COMPLETED|Overall Study||0
3211354|NCT02203591|3941873|FG000|STARTED|Overall Study||343
3211355|NCT02203591|3941874|FG001|STARTED|Overall Study||344
3211356|NCT02203591|3941875|FG002|STARTED|Overall Study||347
3211357|NCT02203591|3941876|FG003|STARTED|Overall Study||104
3211358|NCT02203591|3941877|FG004|STARTED|Overall Study||242
3211359|NCT02203591|3941878|FG005|STARTED|Overall Study||244
3211360|NCT02203591|3941879|FG006|STARTED|Overall Study||248
3211361|NCT02203591|3941880|FG007|STARTED|Overall Study||74
3211362|NCT02203591|3941873|FG000|COMPLETED|Overall Study||196
3211363|NCT02203591|3941874|FG001|COMPLETED|Overall Study||202
3211364|NCT02203591|3941875|FG002|COMPLETED|Overall Study||196
3211365|NCT02203591|3941876|FG003|COMPLETED|Overall Study||59
3211366|NCT02203591|3941877|FG004|COMPLETED|Overall Study||208
3211367|NCT02203591|3941878|FG005|COMPLETED|Overall Study||209
3211368|NCT02203591|3941879|FG006|COMPLETED|Overall Study||219
3211369|NCT02203591|3941880|FG007|COMPLETED|Overall Study||61
3211370|NCT02203591|3941873|FG000|NOT COMPLETED|Overall Study||147
3211371|NCT02203591|3941874|FG001|NOT COMPLETED|Overall Study||142
3211372|NCT02203591|3941875|FG002|NOT COMPLETED|Overall Study||151
3211373|NCT02203591|3941876|FG003|NOT COMPLETED|Overall Study||45
3211374|NCT02203591|3941877|FG004|NOT COMPLETED|Overall Study||34
3211375|NCT02203591|3941878|FG005|NOT COMPLETED|Overall Study||35
3211376|NCT02203591|3941879|FG006|NOT COMPLETED|Overall Study||29
3211377|NCT02203591|3941880|FG007|NOT COMPLETED|Overall Study||13
3211378|NCT02203630|3941904|FG000|STARTED|Overall Study||8
3211379|NCT02203630|3941905|FG001|STARTED|Overall Study||9
3211380|NCT02203630|3941904|FG000|COMPLETED|Overall Study||8
3211381|NCT02203630|3941905|FG001|COMPLETED|Overall Study||9
3211382|NCT02203630|3941904|FG000|NOT COMPLETED|Overall Study||0
3211383|NCT02203630|3941905|FG001|NOT COMPLETED|Overall Study||0
3211384|NCT02203721|3941913|FG000|STARTED|Overall Study||148
3211385|NCT02203721|3941914|FG001|STARTED|Overall Study||151
3211386|NCT02203721|3941913|FG000|COMPLETED|Overall Study||147
3211387|NCT02203721|3941914|FG001|COMPLETED|Overall Study||148
3211388|NCT02203721|3941913|FG000|NOT COMPLETED|Overall Study||1
3211389|NCT02203721|3941914|FG001|NOT COMPLETED|Overall Study||3
3211390|NCT02203747|3941922|FG000|STARTED|Overall Study||45
3211391|NCT02203747|3941923|FG001|STARTED|Overall Study||34
3211392|NCT02203747|3941922|FG000|COMPLETED|Overall Study||45
3211393|NCT02203747|3941923|FG001|COMPLETED|Overall Study||34
3211394|NCT02203747|3941922|FG000|NOT COMPLETED|Overall Study||0
3211395|NCT02203747|3941923|FG001|NOT COMPLETED|Overall Study||0
3211396|NCT02203786|3941933|FG000|STARTED|Overall Study||15
3211397|NCT02203786|3941934|FG001|STARTED|Overall Study||15
3211398|NCT02203786|3941935|FG002|STARTED|Overall Study||17
3211399|NCT02203786|3941936|FG003|STARTED|Overall Study||15
3211400|NCT02203786|3941933|FG000|COMPLETED|Overall Study||15
3211401|NCT02203786|3941934|FG001|COMPLETED|Overall Study||15
3211402|NCT02203786|3941935|FG002|COMPLETED|Overall Study||15
3211403|NCT02203786|3941936|FG003|COMPLETED|Overall Study||15
3211404|NCT02203786|3941933|FG000|NOT COMPLETED|Overall Study||0
3211405|NCT02203786|3941934|FG001|NOT COMPLETED|Overall Study||0
3211406|NCT02203786|3941935|FG002|NOT COMPLETED|Overall Study||2
3211407|NCT02203786|3941936|FG003|NOT COMPLETED|Overall Study||0
3211408|NCT02203838|3941952|FG000|STARTED|Overall Study||408
3211409|NCT02203838|3941953|FG001|STARTED|Overall Study||28
3211410|NCT02203838|3941954|FG002|STARTED|Overall Study||31
3211411|NCT02203838|3941955|FG003|STARTED|Overall Study||33
3211412|NCT02203838|3941952|FG000|COMPLETED|Overall Study||198
3366527|NCT03902574|4097849|FG001|STARTED|Overall Study||7
3366528|NCT03902574|4097850|FG002|STARTED|Overall Study||7
3211413|NCT02203838|3941953|FG001|COMPLETED|Overall Study||6
3211414|NCT02203838|3941954|FG002|COMPLETED|Overall Study||15
3211415|NCT02203838|3941955|FG003|COMPLETED|Overall Study||15
3211416|NCT02203838|3941952|FG000|NOT COMPLETED|Overall Study||210
3211417|NCT02203838|3941953|FG001|NOT COMPLETED|Overall Study||22
3211418|NCT02203838|3941954|FG002|NOT COMPLETED|Overall Study||16
3211419|NCT02203838|3941955|FG003|NOT COMPLETED|Overall Study||18
3211420|NCT02203851|3941965|FG000|STARTED|Overall Study||110
3211421|NCT02203851|3941965|FG000|COMPLETED|Overall Study||99
3211422|NCT02203851|3941965|FG000|NOT COMPLETED|Overall Study||11
3211423|NCT02203916|3941979|FG000|STARTED|Overall Study||65
3211424|NCT02203916|3941980|FG001|STARTED|Overall Study||132
3211425|NCT02203916|3941981|FG002|STARTED|Overall Study|1 participant was randomized twice and counted only once.|131
3211426|NCT02203916|3941979|FG000|Full Analysis Set (FAS)|Overall Study||65
3211427|NCT02203916|3941980|FG001|Full Analysis Set (FAS)|Overall Study||132
3211428|NCT02203916|3941981|FG002|Full Analysis Set (FAS)|Overall Study|1 participant was randomized twice, counted once in randomized set, and excluded from the FAS.|130
3211429|NCT02203916|3941979|FG000|Safety Analysis Set (SAS)|Overall Study||65
3211430|NCT02203916|3941980|FG001|Safety Analysis Set (SAS)|Overall Study||132
3211431|NCT02203916|3941981|FG002|Safety Analysis Set (SAS)|Overall Study|1 participant was randomized twice, counted once in randomized set, and excluded from the SAS.|130
3211432|NCT02203916|3941979|FG000|COMPLETED|Overall Study||57
3211433|NCT02203916|3941980|FG001|COMPLETED|Overall Study||122
3211434|NCT02203916|3941981|FG002|COMPLETED|Overall Study||120
3211435|NCT02203916|3941979|FG000|NOT COMPLETED|Overall Study||8
3211436|NCT02203916|3941980|FG001|NOT COMPLETED|Overall Study||10
3211437|NCT02203916|3941981|FG002|NOT COMPLETED|Overall Study||11
3211438|NCT02204007|3941991|FG000|STARTED|Overall Study||18
3211439|NCT02204007|3941992|FG001|STARTED|Overall Study||18
3211440|NCT02204007|3941991|FG000|COMPLETED|Overall Study||17
3211441|NCT02204007|3941992|FG001|COMPLETED|Overall Study||17
3211442|NCT02204007|3941991|FG000|NOT COMPLETED|Overall Study||1
3211443|NCT02204007|3941992|FG001|NOT COMPLETED|Overall Study||1
3211444|NCT02204124|3942000|FG000|STARTED|Overall Study||13
3211445|NCT02204124|3942001|FG001|STARTED|Overall Study||19
3211446|NCT02204124|3942000|FG000|COMPLETED|Overall Study||13
3211447|NCT02204124|3942001|FG001|COMPLETED|Overall Study||19
3211448|NCT02204124|3942000|FG000|NOT COMPLETED|Overall Study||0
3211449|NCT02204124|3942001|FG001|NOT COMPLETED|Overall Study||0
3211450|NCT02204150|3942007|FG000|STARTED|Overall Study||56
3211451|NCT02204150|3942007|FG000|COMPLETED|Overall Study||56
3211452|NCT02204150|3942007|FG000|NOT COMPLETED|Overall Study||0
3366529|NCT03902574|4097848|FG000|COMPLETED|Overall Study||7
3366530|NCT03902574|4097849|FG001|COMPLETED|Overall Study||7
3366531|NCT03902574|4097850|FG002|COMPLETED|Overall Study||6
3366532|NCT03902574|4097848|FG000|NOT COMPLETED|Overall Study||0
3366533|NCT03902574|4097849|FG001|NOT COMPLETED|Overall Study||0
3366534|NCT03902574|4097850|FG002|NOT COMPLETED|Overall Study||1
3366535|NCT03914950|4097858|FG000|STARTED|Overall Study||174
3366536|NCT03914950|4097858|FG000|COMPLETED|Overall Study||120
3366537|NCT03914950|4097858|FG000|NOT COMPLETED|Overall Study||54
3366538|NCT03911843|4097870|FG000|STARTED|Overall Study||26
3366539|NCT03911843|4097871|FG001|STARTED|Overall Study||38
3366540|NCT03911843|4097870|FG000|COMPLETED|Overall Study||22
3366541|NCT03911843|4097871|FG001|COMPLETED|Overall Study||37
3366542|NCT03911843|4097870|FG000|NOT COMPLETED|Overall Study||4
3366543|NCT03911843|4097871|FG001|NOT COMPLETED|Overall Study||1
3366544|NCT03896633|4097879|FG000|STARTED|Overall Study||321
3366545|NCT03896633|4097880|FG001|STARTED|Overall Study||316
3366546|NCT03896633|4097879|FG000|COMPLETED|Overall Study||312
3366547|NCT03896633|4097880|FG001|COMPLETED|Overall Study||306
3366548|NCT03896633|4097879|FG000|NOT COMPLETED|Overall Study||9
3366549|NCT03896633|4097880|FG001|NOT COMPLETED|Overall Study||10
3366550|NCT03894813|4097888|FG000|STARTED|Overall Study||63
3366551|NCT03894813|4097889|FG001|STARTED|Overall Study||63
3366552|NCT03894813|4097888|FG000|COMPLETED|Overall Study||52
3366553|NCT03894813|4097889|FG001|COMPLETED|Overall Study||47
3366554|NCT03894813|4097888|FG000|NOT COMPLETED|Overall Study||11
3366555|NCT03894813|4097889|FG001|NOT COMPLETED|Overall Study||16
3366556|NCT03911960|4097897|FG000|STARTED|Overall Study||9
3366557|NCT03911960|4097898|FG001|STARTED|Overall Study||5
3366558|NCT03911960|4097897|FG000|COMPLETED|Overall Study||4
3366559|NCT03911960|4097898|FG001|COMPLETED|Overall Study||2
3366560|NCT03911960|4097897|FG000|NOT COMPLETED|Overall Study||5
3366561|NCT03911960|4097898|FG001|NOT COMPLETED|Overall Study||3
3366562|NCT03907072|4097908|FG000|STARTED|Overall Study||2
3366563|NCT03907072|4097909|FG001|STARTED|Overall Study||2
3366564|NCT03907072|4097910|FG002|STARTED|Overall Study||2
3366565|NCT03907072|4097908|FG000|COMPLETED|Overall Study||0
3366566|NCT03907072|4097909|FG001|COMPLETED|Overall Study||0
3366567|NCT03907072|4097910|FG002|COMPLETED|Overall Study||0
3366568|NCT03907072|4097908|FG000|NOT COMPLETED|Overall Study||2
3366569|NCT03907072|4097909|FG001|NOT COMPLETED|Overall Study||2
3366570|NCT03907072|4097910|FG002|NOT COMPLETED|Overall Study||2
3366571|NCT03906448|4097920|FG000|STARTED|Overall Study||1
3366572|NCT03906448|4097921|FG001|STARTED|Overall Study||0
3366573|NCT03906448|4097920|FG000|COMPLETED|Overall Study||1
3366574|NCT03906448|4097921|FG001|COMPLETED|Overall Study||0
3366575|NCT03906448|4097920|FG000|NOT COMPLETED|Overall Study||0
3366576|NCT03906448|4097921|FG001|NOT COMPLETED|Overall Study||0
3366577|NCT03911401|4097930|FG000|STARTED|Overall Study||83
3366578|NCT03911401|4097931|FG001|STARTED|Overall Study||85
3366579|NCT03911401|4097932|FG002|STARTED|Overall Study||83
3366580|NCT03911401|4097930|FG000|COMPLETED|Overall Study||76
3366581|NCT03911401|4097931|FG001|COMPLETED|Overall Study||76
3366582|NCT03911401|4097932|FG002|COMPLETED|Overall Study||58
3366583|NCT03911401|4097930|FG000|NOT COMPLETED|Overall Study||7
3366584|NCT03911401|4097931|FG001|NOT COMPLETED|Overall Study||9
3366585|NCT03911401|4097932|FG002|NOT COMPLETED|Overall Study||25
3366586|NCT03909763|4097940|FG000|STARTED|Overall Study||55
3366587|NCT03909763|4097940|FG000|COMPLETED|Overall Study||45
3366588|NCT03909763|4097940|FG000|NOT COMPLETED|Overall Study||10
3366589|NCT03909009|4097946|FG000|STARTED|Overall Study||10
3366590|NCT03909009|4097947|FG001|STARTED|Overall Study||10
3366591|NCT03909009|4097946|FG000|COMPLETED|Overall Study||10
3366592|NCT03909009|4097947|FG001|COMPLETED|Overall Study||10
3366593|NCT03909009|4097946|FG000|NOT COMPLETED|Overall Study||0
3366594|NCT03909009|4097947|FG001|NOT COMPLETED|Overall Study||0
3211453|NCT02204176|3942014|FG000|STARTED|Overall Study||74
3211454|NCT02204176|3942015|FG001|STARTED|Overall Study||73
3211455|NCT02204176|3942016|FG002|STARTED|Overall Study||74
3211456|NCT02204176|3942014|FG000|COMPLETED|Overall Study||64
3211457|NCT02204176|3942015|FG001|COMPLETED|Overall Study||61
3211458|NCT02204176|3942016|FG002|COMPLETED|Overall Study||58
3211459|NCT02204176|3942014|FG000|NOT COMPLETED|Overall Study||10
3211460|NCT02204176|3942015|FG001|NOT COMPLETED|Overall Study||12
3211461|NCT02204176|3942016|FG002|NOT COMPLETED|Overall Study||16
3211462|NCT02204293|3942026|FG000|STARTED|Core Study Part I||19
3211463|NCT02204293|3942027|FG001|STARTED|Core Study Part I||17
3211464|NCT02204293|3942028|FG002|STARTED|Core Study Part I||0
3211465|NCT02204293|3942029|FG003|STARTED|Core Study Part I||0
3211466|NCT02204293|3942030|FG004|STARTED|Core Study Part I||0
3211467|NCT02204293|3942031|FG005|STARTED|Core Study Part I||0
3211468|NCT02204293|3942026|FG000|Intention-to-treat Population|Core Study Part I|One participant left the study before treatment was started.|18
3211469|NCT02204293|3942027|FG001|Intention-to-treat Population|Core Study Part I||17
3211470|NCT02204293|3942028|FG002|Intention-to-treat Population|Core Study Part I||0
3211471|NCT02204293|3942029|FG003|Intention-to-treat Population|Core Study Part I||0
3211472|NCT02204293|3942030|FG004|Intention-to-treat Population|Core Study Part I||0
3211473|NCT02204293|3942031|FG005|Intention-to-treat Population|Core Study Part I||0
3211474|NCT02204293|3942026|FG000|Safety Population|Core Study Part I|2 participants from placebo arm received canakinumab at Week 4, included in Safety population.|20
3211475|NCT02204293|3942027|FG001|Safety Population|Core Study Part I||15
3211476|NCT02204293|3942028|FG002|Safety Population|Core Study Part I||0
3211477|NCT02204293|3942029|FG003|Safety Population|Core Study Part I||0
3211478|NCT02204293|3942030|FG004|Safety Population|Core Study Part I||0
3211479|NCT02204293|3942031|FG005|Safety Population|Core Study Part I||0
3211480|NCT02204293|3942026|FG000|COMPLETED|Core Study Part I||17
3211481|NCT02204293|3942027|FG001|COMPLETED|Core Study Part I||14
3211482|NCT02204293|3942028|FG002|COMPLETED|Core Study Part I||0
3211483|NCT02204293|3942029|FG003|COMPLETED|Core Study Part I||0
3211484|NCT02204293|3942030|FG004|COMPLETED|Core Study Part I||0
3211485|NCT02204293|3942031|FG005|COMPLETED|Core Study Part I||0
3211486|NCT02204293|3942026|FG000|NOT COMPLETED|Core Study Part I||2
3211487|NCT02204293|3942027|FG001|NOT COMPLETED|Core Study Part I||3
3211488|NCT02204293|3942028|FG002|NOT COMPLETED|Core Study Part I||0
3211489|NCT02204293|3942029|FG003|NOT COMPLETED|Core Study Part I||0
3211490|NCT02204293|3942030|FG004|NOT COMPLETED|Core Study Part I||0
3211491|NCT02204293|3942031|FG005|NOT COMPLETED|Core Study Part I||0
3211492|NCT02204293|3942026|FG000|STARTED|Core Study Part 2|Participants who achieved response at Week 12, entered Part II.|0
3211493|NCT02204293|3942027|FG001|STARTED|Core Study Part 2||0
3211494|NCT02204293|3942028|FG002|STARTED|Core Study Part 2|Participants who achieved response at Week 12, entered Part II.|12
3211495|NCT02204293|3942029|FG003|STARTED|Core Study Part 2||4
3211496|NCT02204293|3942030|FG004|STARTED|Core Study Part 2||7
3211497|NCT02204293|3942031|FG005|STARTED|Core Study Part 2||0
3211498|NCT02204293|3942026|FG000|Safety Population|Core Study Part 2||0
3211499|NCT02204293|3942027|FG001|Safety Population|Core Study Part 2||0
3211500|NCT02204293|3942028|FG002|Safety Population|Core Study Part 2|Included 2 participants from placebo arm who received canakinumab at Week 4.|14
3211501|NCT02204293|3942029|FG003|Safety Population|Core Study Part 2||2
3211502|NCT02204293|3942030|FG004|Safety Population|Core Study Part 2||7
3211503|NCT02204293|3942031|FG005|Safety Population|Core Study Part 2||0
3211504|NCT02204293|3942026|FG000|COMPLETED|Core Study Part 2||0
3211505|NCT02204293|3942027|FG001|COMPLETED|Core Study Part 2||0
3211506|NCT02204293|3942028|FG002|COMPLETED|Core Study Part 2||12
3211507|NCT02204293|3942029|FG003|COMPLETED|Core Study Part 2||4
3211508|NCT02204293|3942030|FG004|COMPLETED|Core Study Part 2||7
3211509|NCT02204293|3942031|FG005|COMPLETED|Core Study Part 2||0
3211510|NCT02204293|3942026|FG000|NOT COMPLETED|Core Study Part 2||0
3211511|NCT02204293|3942027|FG001|NOT COMPLETED|Core Study Part 2||0
3211512|NCT02204293|3942028|FG002|NOT COMPLETED|Core Study Part 2||0
3211513|NCT02204293|3942029|FG003|NOT COMPLETED|Core Study Part 2||0
3211514|NCT02204293|3942030|FG004|NOT COMPLETED|Core Study Part 2||0
3211515|NCT02204293|3942031|FG005|NOT COMPLETED|Core Study Part 2||0
3211516|NCT02204293|3942026|FG000|STARTED|LTE Phase||0
3211517|NCT02204293|3942027|FG001|STARTED|LTE Phase||0
3211518|NCT02204293|3942028|FG002|STARTED|LTE Phase||0
3211519|NCT02204293|3942029|FG003|STARTED|LTE Phase||0
3211520|NCT02204293|3942030|FG004|STARTED|LTE Phase||0
3211521|NCT02204293|3942031|FG005|STARTED|LTE Phase||7
3211522|NCT02204293|3942026|FG000|COMPLETED|LTE Phase||0
3211523|NCT02204293|3942027|FG001|COMPLETED|LTE Phase||0
3211524|NCT02204293|3942028|FG002|COMPLETED|LTE Phase||0
3211525|NCT02204293|3942029|FG003|COMPLETED|LTE Phase||0
3211526|NCT02204293|3942030|FG004|COMPLETED|LTE Phase||0
3211527|NCT02204293|3942031|FG005|COMPLETED|LTE Phase||0
3211528|NCT02204293|3942026|FG000|NOT COMPLETED|LTE Phase||0
3211529|NCT02204293|3942027|FG001|NOT COMPLETED|LTE Phase||0
3211530|NCT02204293|3942028|FG002|NOT COMPLETED|LTE Phase||0
3211531|NCT02204293|3942029|FG003|NOT COMPLETED|LTE Phase||0
3211532|NCT02204293|3942030|FG004|NOT COMPLETED|LTE Phase||0
3211533|NCT02204293|3942031|FG005|NOT COMPLETED|LTE Phase||7
3211534|NCT02204319|3942045|FG000|STARTED|Overall Study||10
3211535|NCT02204319|3942045|FG000|COMPLETED|Overall Study|3 did not complete study.|7
3211536|NCT02204319|3942045|FG000|NOT COMPLETED|Overall Study||3
3211537|NCT02204371|3942050|FG000|STARTED|Overall Study||7
3211538|NCT02204371|3942050|FG000|COMPLETED|Overall Study||6
3211539|NCT02204371|3942050|FG000|NOT COMPLETED|Overall Study||1
3211540|NCT02204410|3942054|FG000|STARTED|Overall Study||21
3211541|NCT02204410|3942054|FG000|COMPLETED|Overall Study||10
3211542|NCT02204410|3942054|FG000|NOT COMPLETED|Overall Study||11
3211543|NCT02204449|3942060|FG000|STARTED|Overall Study||46
3211544|NCT02204449|3942061|FG001|STARTED|Overall Study||48
3211545|NCT02204449|3942060|FG000|COMPLETED|Overall Study||39
3211546|NCT02204449|3942061|FG001|COMPLETED|Overall Study||37
3211547|NCT02204449|3942060|FG000|NOT COMPLETED|Overall Study||7
3211548|NCT02204449|3942061|FG001|NOT COMPLETED|Overall Study||11
3211549|NCT02204566|3942067|FG000|STARTED|Overall Study||5
3211550|NCT02204566|3942067|FG000|COMPLETED|Overall Study||1
3211551|NCT02204566|3942067|FG000|NOT COMPLETED|Overall Study||4
3211552|NCT02204579|3942071|FG000|STARTED|Overall Study||7
3211553|NCT02204579|3942071|FG000|Participants Started in Pre-Amendment|Overall Study|Two participants completed treatment in pre-amendment and were re-enrolled in post-amendment.|2
3211554|NCT02204579|3942071|FG000|Participants Started in Post-Amendment|Overall Study|Two participants from pre-amendment were re-enrolled with different identification numbers.|5
3211555|NCT02204579|3942071|FG000|Treated|Overall Study||5
3211556|NCT02204579|3942071|FG000|COMPLETED|Overall Study||5
3211557|NCT02204579|3942071|FG000|NOT COMPLETED|Overall Study||2
3211558|NCT02204657|3942082|FG000|STARTED|Overall Study||32
3211559|NCT02204657|3942083|FG001|STARTED|Overall Study||25
3211560|NCT02204657|3942082|FG000|COMPLETED|Overall Study||25
3211561|NCT02204657|3942083|FG001|COMPLETED|Overall Study||25
3211562|NCT02204657|3942082|FG000|NOT COMPLETED|Overall Study||7
3211563|NCT02204657|3942083|FG001|NOT COMPLETED|Overall Study||0
3211564|NCT02204748|3942089|FG000|STARTED|Overall Study||5
3211565|NCT02204748|3942089|FG000|COMPLETED|Overall Study||5
3211566|NCT02204748|3942089|FG000|NOT COMPLETED|Overall Study||0
3211567|NCT02204761|3942093|FG000|STARTED|Overall Study||6
3211568|NCT02204761|3942093|FG000|COMPLETED|Overall Study||6
3211569|NCT02204761|3942093|FG000|NOT COMPLETED|Overall Study||0
3211570|NCT02204917|3942097|FG000|STARTED|Overall Study||31
3211571|NCT02204917|3942097|FG000|COMPLETED|Overall Study||30
3211572|NCT02204917|3942097|FG000|NOT COMPLETED|Overall Study||1
3211573|NCT02204982|3942106|FG000|STARTED|Overall Study||6
3211574|NCT02204982|3942107|FG001|STARTED|Overall Study||7
3211575|NCT02204982|3942106|FG000|COMPLETED|Overall Study||2
3211576|NCT02204982|3942107|FG001|COMPLETED|Overall Study||0
3211577|NCT02204982|3942106|FG000|NOT COMPLETED|Overall Study||4
3211578|NCT02204982|3942107|FG001|NOT COMPLETED|Overall Study||7
3211579|NCT02205177|3942115|FG000|STARTED|Overall Study||8
3211580|NCT02205177|3942116|FG001|STARTED|Overall Study||2
3211581|NCT02205177|3942115|FG000|COMPLETED|Overall Study||6
3211582|NCT02205177|3942116|FG001|COMPLETED|Overall Study||2
3211583|NCT02205177|3942115|FG000|NOT COMPLETED|Overall Study||2
3211584|NCT02205177|3942116|FG001|NOT COMPLETED|Overall Study||0
3211585|NCT02205307|3942124|FG000|STARTED|Overall Study||178
3211586|NCT02205307|3942125|FG001|STARTED|Overall Study||169
3211587|NCT02205307|3942124|FG000|COMPLETED|Overall Study||161
3211588|NCT02205307|3942125|FG001|COMPLETED|Overall Study||163
3211589|NCT02205307|3942124|FG000|NOT COMPLETED|Overall Study||17
3211590|NCT02205307|3942125|FG001|NOT COMPLETED|Overall Study||6
3211591|NCT02205333|3942141|FG000|STARTED|Overall Study||8
3211592|NCT02205333|3942142|FG001|STARTED|Overall Study||6
3211593|NCT02205333|3942143|FG002|STARTED|Overall Study||3
3211594|NCT02205333|3942144|FG003|STARTED|Overall Study||7
3211595|NCT02205333|3942145|FG004|STARTED|Overall Study||6
3211596|NCT02205333|3942146|FG005|STARTED|Overall Study||7
3211597|NCT02205333|3942147|FG006|STARTED|Overall Study||7
3211598|NCT02205333|3942148|FG007|STARTED|Overall Study||3
3211599|NCT02205333|3942149|FG008|STARTED|Overall Study||1
3211600|NCT02205333|3942141|FG000|COMPLETED|Overall Study||2
3211601|NCT02205333|3942142|FG001|COMPLETED|Overall Study||0
3211602|NCT02205333|3942143|FG002|COMPLETED|Overall Study||1
3211603|NCT02205333|3942144|FG003|COMPLETED|Overall Study||0
3211604|NCT02205333|3942145|FG004|COMPLETED|Overall Study||1
3211605|NCT02205333|3942146|FG005|COMPLETED|Overall Study||4
3211606|NCT02205333|3942147|FG006|COMPLETED|Overall Study||2
3211607|NCT02205333|3942148|FG007|COMPLETED|Overall Study||1
3211608|NCT02205333|3942149|FG008|COMPLETED|Overall Study||1
3211609|NCT02205333|3942141|FG000|NOT COMPLETED|Overall Study||6
3211610|NCT02205333|3942142|FG001|NOT COMPLETED|Overall Study||6
3211611|NCT02205333|3942143|FG002|NOT COMPLETED|Overall Study||2
3211612|NCT02205333|3942144|FG003|NOT COMPLETED|Overall Study||7
3211613|NCT02205333|3942145|FG004|NOT COMPLETED|Overall Study||5
3211614|NCT02205333|3942146|FG005|NOT COMPLETED|Overall Study||3
3211615|NCT02205333|3942147|FG006|NOT COMPLETED|Overall Study||5
3211616|NCT02205333|3942148|FG007|NOT COMPLETED|Overall Study||2
3211617|NCT02205333|3942149|FG008|NOT COMPLETED|Overall Study||0
3211618|NCT02205476|3942171|FG000|STARTED|Overall Study||7
3211619|NCT02205476|3942172|FG001|STARTED|Overall Study||3
3211620|NCT02205476|3942171|FG000|COMPLETED|Overall Study||0
3211621|NCT02205476|3942172|FG001|COMPLETED|Overall Study||0
3211622|NCT02205476|3942171|FG000|NOT COMPLETED|Overall Study||7
3211623|NCT02205476|3942172|FG001|NOT COMPLETED|Overall Study||3
3211624|NCT02205801|3942188|FG000|STARTED|Overall Study||11
3211625|NCT02205801|3942189|FG001|STARTED|Overall Study||8
3211626|NCT02205801|3942190|FG002|STARTED|Overall Study||9
3211627|NCT02205801|3942191|FG003|STARTED|Overall Study||8
3211628|NCT02205801|3942188|FG000|COMPLETED|Overall Study||11
3211629|NCT02205801|3942189|FG001|COMPLETED|Overall Study||8
3211630|NCT02205801|3942190|FG002|COMPLETED|Overall Study||9
3211631|NCT02205801|3942191|FG003|COMPLETED|Overall Study||8
3211632|NCT02205801|3942188|FG000|NOT COMPLETED|Overall Study||0
3211633|NCT02205801|3942189|FG001|NOT COMPLETED|Overall Study||0
3211634|NCT02205801|3942190|FG002|NOT COMPLETED|Overall Study||0
3211635|NCT02205801|3942191|FG003|NOT COMPLETED|Overall Study||0
3211636|NCT02205814|3942205|FG000|STARTED|Overall Study||110
3211637|NCT02205814|3942206|FG001|STARTED|Overall Study||110
3211638|NCT02205814|3942207|FG002|STARTED|Overall Study||108
3211639|NCT02205814|3942208|FG003|STARTED|Overall Study||108
3211640|NCT02205814|3942205|FG000|COMPLETED|Overall Study||108
3211641|NCT02205814|3942206|FG001|COMPLETED|Overall Study||109
3211642|NCT02205814|3942207|FG002|COMPLETED|Overall Study||103
3211643|NCT02205814|3942208|FG003|COMPLETED|Overall Study||104
3211644|NCT02205814|3942205|FG000|NOT COMPLETED|Overall Study||2
3211645|NCT02205814|3942206|FG001|NOT COMPLETED|Overall Study||1
3211646|NCT02205814|3942207|FG002|NOT COMPLETED|Overall Study||5
3211647|NCT02205814|3942208|FG003|NOT COMPLETED|Overall Study||4
3211648|NCT02205983|3942222|FG000|STARTED|Overall Study||12
3211649|NCT02205983|3942223|FG001|STARTED|Overall Study||12
3211650|NCT02205983|3942224|FG002|STARTED|Overall Study||13
3211651|NCT02205983|3942225|FG003|STARTED|Overall Study||13
3211652|NCT02205983|3942222|FG000|COMPLETED|Overall Study||12
3211653|NCT02205983|3942223|FG001|COMPLETED|Overall Study||12
3211654|NCT02205983|3942224|FG002|COMPLETED|Overall Study||13
3211655|NCT02205983|3942225|FG003|COMPLETED|Overall Study||13
3211656|NCT02205983|3942222|FG000|NOT COMPLETED|Overall Study||0
3211657|NCT02205983|3942223|FG001|NOT COMPLETED|Overall Study||0
3211658|NCT02205983|3942224|FG002|NOT COMPLETED|Overall Study||0
3211659|NCT02205983|3942225|FG003|NOT COMPLETED|Overall Study||0
3211660|NCT02206061|3942238|FG000|STARTED|Overall Study||149
3211661|NCT02206061|3942239|FG001|STARTED|Overall Study||142
3211662|NCT02206061|3942240|FG002|STARTED|Overall Study||139
3211663|NCT02206061|3942238|FG000|COMPLETED|Overall Study||131
3211664|NCT02206061|3942239|FG001|COMPLETED|Overall Study||128
3211665|NCT02206061|3942240|FG002|COMPLETED|Overall Study||118
3211666|NCT02206061|3942238|FG000|NOT COMPLETED|Overall Study||18
3211667|NCT02206061|3942239|FG001|NOT COMPLETED|Overall Study||14
3211668|NCT02206061|3942240|FG002|NOT COMPLETED|Overall Study||21
3211669|NCT02206152|3942248|FG000|STARTED|Pre-Randomization||22
3211670|NCT02206152|3942248|FG000|COMPLETED|Pre-Randomization||20
3211671|NCT02206152|3942248|FG000|NOT COMPLETED|Pre-Randomization||2
3211672|NCT02206152|3942248|FG000|STARTED|Placebo, Then NAC||10
3211673|NCT02206152|3942248|FG000|COMPLETED|Placebo, Then NAC||10
3211674|NCT02206152|3942248|FG000|NOT COMPLETED|Placebo, Then NAC||0
3211675|NCT02206152|3942248|FG000|STARTED|NAC, Then Placebo||10
3211676|NCT02206152|3942248|FG000|COMPLETED|NAC, Then Placebo||10
3211677|NCT02206152|3942248|FG000|NOT COMPLETED|NAC, Then Placebo||0
3211678|NCT02206217|3942256|FG000|STARTED|Overall Study||90
3211679|NCT02206217|3942257|FG001|STARTED|Overall Study||93
3211680|NCT02206217|3942256|FG000|COMPLETED|Overall Study||81
3211681|NCT02206217|3942257|FG001|COMPLETED|Overall Study||79
3211682|NCT02206217|3942256|FG000|NOT COMPLETED|Overall Study||9
3211683|NCT02206217|3942257|FG001|NOT COMPLETED|Overall Study||14
3211684|NCT02206607|3942263|FG000|STARTED|Open-Label Run-In||42
3211685|NCT02206607|3942264|FG001|STARTED|Open-Label Run-In||0
3211686|NCT02206607|3942265|FG002|STARTED|Open-Label Run-In||0
3211687|NCT02206607|3942266|FG003|STARTED|Open-Label Run-In||0
3211688|NCT02206607|3942267|FG004|STARTED|Open-Label Run-In||0
3211689|NCT02206607|3942263|FG000|COMPLETED|Open-Label Run-In||39
3211690|NCT02206607|3942264|FG001|COMPLETED|Open-Label Run-In||0
3211691|NCT02206607|3942265|FG002|COMPLETED|Open-Label Run-In||0
3211692|NCT02206607|3942266|FG003|COMPLETED|Open-Label Run-In||0
3211693|NCT02206607|3942267|FG004|COMPLETED|Open-Label Run-In||0
3211694|NCT02206607|3942263|FG000|NOT COMPLETED|Open-Label Run-In||3
3211695|NCT02206607|3942264|FG001|NOT COMPLETED|Open-Label Run-In||0
3211696|NCT02206607|3942265|FG002|NOT COMPLETED|Open-Label Run-In||0
3211697|NCT02206607|3942266|FG003|NOT COMPLETED|Open-Label Run-In||0
3211698|NCT02206607|3942267|FG004|NOT COMPLETED|Open-Label Run-In||0
3211699|NCT02206607|3942263|FG000|STARTED|First Intervention Period||0
3211700|NCT02206607|3942264|FG001|STARTED|First Intervention Period||9
3211701|NCT02206607|3942265|FG002|STARTED|First Intervention Period||9
3211702|NCT02206607|3942266|FG003|STARTED|First Intervention Period||11
3211703|NCT02206607|3942267|FG004|STARTED|First Intervention Period||10
3211704|NCT02206607|3942263|FG000|COMPLETED|First Intervention Period||0
3211705|NCT02206607|3942264|FG001|COMPLETED|First Intervention Period||9
3211706|NCT02206607|3942265|FG002|COMPLETED|First Intervention Period||9
3211707|NCT02206607|3942266|FG003|COMPLETED|First Intervention Period||11
3211708|NCT02206607|3942267|FG004|COMPLETED|First Intervention Period||10
3211709|NCT02206607|3942263|FG000|NOT COMPLETED|First Intervention Period||0
3211710|NCT02206607|3942264|FG001|NOT COMPLETED|First Intervention Period||0
3211711|NCT02206607|3942265|FG002|NOT COMPLETED|First Intervention Period||0
3211712|NCT02206607|3942266|FG003|NOT COMPLETED|First Intervention Period||0
3211713|NCT02206607|3942267|FG004|NOT COMPLETED|First Intervention Period||0
3211714|NCT02206607|3942263|FG000|STARTED|First Washout Period 5 to 10 Days||0
3211715|NCT02206607|3942264|FG001|STARTED|First Washout Period 5 to 10 Days||9
3211716|NCT02206607|3942265|FG002|STARTED|First Washout Period 5 to 10 Days||9
3211717|NCT02206607|3942266|FG003|STARTED|First Washout Period 5 to 10 Days||11
3211718|NCT02206607|3942267|FG004|STARTED|First Washout Period 5 to 10 Days||10
3211719|NCT02206607|3942263|FG000|COMPLETED|First Washout Period 5 to 10 Days||0
3211720|NCT02206607|3942264|FG001|COMPLETED|First Washout Period 5 to 10 Days||9
3211721|NCT02206607|3942265|FG002|COMPLETED|First Washout Period 5 to 10 Days||9
3211722|NCT02206607|3942266|FG003|COMPLETED|First Washout Period 5 to 10 Days||11
3211723|NCT02206607|3942267|FG004|COMPLETED|First Washout Period 5 to 10 Days||10
3211724|NCT02206607|3942263|FG000|NOT COMPLETED|First Washout Period 5 to 10 Days||0
3211725|NCT02206607|3942264|FG001|NOT COMPLETED|First Washout Period 5 to 10 Days||0
3211726|NCT02206607|3942265|FG002|NOT COMPLETED|First Washout Period 5 to 10 Days||0
3211727|NCT02206607|3942266|FG003|NOT COMPLETED|First Washout Period 5 to 10 Days||0
3211728|NCT02206607|3942267|FG004|NOT COMPLETED|First Washout Period 5 to 10 Days||0
3211729|NCT02206607|3942263|FG000|STARTED|Second Intervention Period||0
3211730|NCT02206607|3942264|FG001|STARTED|Second Intervention Period||9
3211731|NCT02206607|3942265|FG002|STARTED|Second Intervention Period||9
3211732|NCT02206607|3942266|FG003|STARTED|Second Intervention Period||11
3211733|NCT02206607|3942267|FG004|STARTED|Second Intervention Period||10
3211734|NCT02206607|3942263|FG000|COMPLETED|Second Intervention Period||0
3211735|NCT02206607|3942264|FG001|COMPLETED|Second Intervention Period||9
3211736|NCT02206607|3942265|FG002|COMPLETED|Second Intervention Period||9
3211737|NCT02206607|3942266|FG003|COMPLETED|Second Intervention Period||10
3211738|NCT02206607|3942267|FG004|COMPLETED|Second Intervention Period||10
3211739|NCT02206607|3942263|FG000|NOT COMPLETED|Second Intervention Period||0
3211740|NCT02206607|3942264|FG001|NOT COMPLETED|Second Intervention Period||0
3211741|NCT02206607|3942265|FG002|NOT COMPLETED|Second Intervention Period||0
3211742|NCT02206607|3942266|FG003|NOT COMPLETED|Second Intervention Period||1
3211743|NCT02206607|3942267|FG004|NOT COMPLETED|Second Intervention Period||0
3211744|NCT02206607|3942263|FG000|STARTED|Second Washout Period 5 to 10 Days||0
3211745|NCT02206607|3942264|FG001|STARTED|Second Washout Period 5 to 10 Days||9
3211746|NCT02206607|3942265|FG002|STARTED|Second Washout Period 5 to 10 Days||9
3211747|NCT02206607|3942266|FG003|STARTED|Second Washout Period 5 to 10 Days||10
3211748|NCT02206607|3942267|FG004|STARTED|Second Washout Period 5 to 10 Days||10
3211749|NCT02206607|3942263|FG000|COMPLETED|Second Washout Period 5 to 10 Days||0
3211750|NCT02206607|3942264|FG001|COMPLETED|Second Washout Period 5 to 10 Days||9
3211751|NCT02206607|3942265|FG002|COMPLETED|Second Washout Period 5 to 10 Days||9
3211752|NCT02206607|3942266|FG003|COMPLETED|Second Washout Period 5 to 10 Days||10
3211753|NCT02206607|3942267|FG004|COMPLETED|Second Washout Period 5 to 10 Days||10
3211754|NCT02206607|3942263|FG000|NOT COMPLETED|Second Washout Period 5 to 10 Days||0
3211755|NCT02206607|3942264|FG001|NOT COMPLETED|Second Washout Period 5 to 10 Days||0
3211756|NCT02206607|3942265|FG002|NOT COMPLETED|Second Washout Period 5 to 10 Days||0
3211757|NCT02206607|3942266|FG003|NOT COMPLETED|Second Washout Period 5 to 10 Days||0
3211758|NCT02206607|3942267|FG004|NOT COMPLETED|Second Washout Period 5 to 10 Days||0
3211759|NCT02206607|3942263|FG000|STARTED|Third Intervention Period||0
3211760|NCT02206607|3942264|FG001|STARTED|Third Intervention Period||9
3211761|NCT02206607|3942265|FG002|STARTED|Third Intervention Period||9
3211762|NCT02206607|3942266|FG003|STARTED|Third Intervention Period||10
3211763|NCT02206607|3942267|FG004|STARTED|Third Intervention Period||10
3211764|NCT02206607|3942263|FG000|COMPLETED|Third Intervention Period||0
3211765|NCT02206607|3942264|FG001|COMPLETED|Third Intervention Period||9
3211766|NCT02206607|3942265|FG002|COMPLETED|Third Intervention Period||9
3211767|NCT02206607|3942266|FG003|COMPLETED|Third Intervention Period||10
3211768|NCT02206607|3942267|FG004|COMPLETED|Third Intervention Period||10
3211769|NCT02206607|3942263|FG000|NOT COMPLETED|Third Intervention Period||0
3211770|NCT02206607|3942264|FG001|NOT COMPLETED|Third Intervention Period||0
3211771|NCT02206607|3942265|FG002|NOT COMPLETED|Third Intervention Period||0
3211772|NCT02206607|3942266|FG003|NOT COMPLETED|Third Intervention Period||0
3211773|NCT02206607|3942267|FG004|NOT COMPLETED|Third Intervention Period||0
3211774|NCT02206607|3942263|FG000|STARTED|Third Washout Period 5 to 10 Days||0
3211775|NCT02206607|3942264|FG001|STARTED|Third Washout Period 5 to 10 Days||9
3211776|NCT02206607|3942265|FG002|STARTED|Third Washout Period 5 to 10 Days||9
3211777|NCT02206607|3942266|FG003|STARTED|Third Washout Period 5 to 10 Days||10
3211778|NCT02206607|3942267|FG004|STARTED|Third Washout Period 5 to 10 Days||10
3211779|NCT02206607|3942263|FG000|COMPLETED|Third Washout Period 5 to 10 Days||0
3211780|NCT02206607|3942264|FG001|COMPLETED|Third Washout Period 5 to 10 Days||9
3211781|NCT02206607|3942265|FG002|COMPLETED|Third Washout Period 5 to 10 Days||9
3211782|NCT02206607|3942266|FG003|COMPLETED|Third Washout Period 5 to 10 Days||10
3211783|NCT02206607|3942267|FG004|COMPLETED|Third Washout Period 5 to 10 Days||10
3211784|NCT02206607|3942263|FG000|NOT COMPLETED|Third Washout Period 5 to 10 Days||0
3211785|NCT02206607|3942264|FG001|NOT COMPLETED|Third Washout Period 5 to 10 Days||0
3211786|NCT02206607|3942265|FG002|NOT COMPLETED|Third Washout Period 5 to 10 Days||0
3211787|NCT02206607|3942266|FG003|NOT COMPLETED|Third Washout Period 5 to 10 Days||0
3211788|NCT02206607|3942267|FG004|NOT COMPLETED|Third Washout Period 5 to 10 Days||0
3211789|NCT02206607|3942263|FG000|STARTED|Fourth Intervention Period||0
3211790|NCT02206607|3942264|FG001|STARTED|Fourth Intervention Period||9
3211791|NCT02206607|3942265|FG002|STARTED|Fourth Intervention Period||9
3211792|NCT02206607|3942266|FG003|STARTED|Fourth Intervention Period||10
3211793|NCT02206607|3942267|FG004|STARTED|Fourth Intervention Period||10
3211794|NCT02206607|3942263|FG000|COMPLETED|Fourth Intervention Period||0
3211795|NCT02206607|3942264|FG001|COMPLETED|Fourth Intervention Period||9
3211796|NCT02206607|3942265|FG002|COMPLETED|Fourth Intervention Period||9
3211797|NCT02206607|3942266|FG003|COMPLETED|Fourth Intervention Period||10
3211798|NCT02206607|3942267|FG004|COMPLETED|Fourth Intervention Period||10
3211799|NCT02206607|3942263|FG000|NOT COMPLETED|Fourth Intervention Period||0
3211800|NCT02206607|3942264|FG001|NOT COMPLETED|Fourth Intervention Period||0
3211801|NCT02206607|3942265|FG002|NOT COMPLETED|Fourth Intervention Period||0
3211802|NCT02206607|3942266|FG003|NOT COMPLETED|Fourth Intervention Period||0
3211803|NCT02206607|3942267|FG004|NOT COMPLETED|Fourth Intervention Period||0
3211804|NCT02206620|3942283|FG000|STARTED|Phase I - First Intervention (6 Weeks)||22
3211805|NCT02206620|3942284|FG001|STARTED|Phase I - First Intervention (6 Weeks)||27
3211806|NCT02206620|3942283|FG000|COMPLETED|Phase I - First Intervention (6 Weeks)||21
3211807|NCT02206620|3942284|FG001|COMPLETED|Phase I - First Intervention (6 Weeks)||26
3211808|NCT02206620|3942283|FG000|NOT COMPLETED|Phase I - First Intervention (6 Weeks)||1
3211809|NCT02206620|3942284|FG001|NOT COMPLETED|Phase I - First Intervention (6 Weeks)||1
3211810|NCT02206620|3942283|FG000|STARTED|Washout (6 Weeks)||21
3211811|NCT02206620|3942284|FG001|STARTED|Washout (6 Weeks)||26
3211812|NCT02206620|3942283|FG000|COMPLETED|Washout (6 Weeks)||21
3211813|NCT02206620|3942284|FG001|COMPLETED|Washout (6 Weeks)||26
3211814|NCT02206620|3942283|FG000|NOT COMPLETED|Washout (6 Weeks)||0
3211815|NCT02206620|3942284|FG001|NOT COMPLETED|Washout (6 Weeks)||0
3211816|NCT02206620|3942283|FG000|STARTED|Phase II - Second Intervention (6 Weeks)||21
3211817|NCT02206620|3942284|FG001|STARTED|Phase II - Second Intervention (6 Weeks)||26
3211818|NCT02206620|3942283|FG000|COMPLETED|Phase II - Second Intervention (6 Weeks)||21
3211819|NCT02206620|3942284|FG001|COMPLETED|Phase II - Second Intervention (6 Weeks)||24
3211820|NCT02206620|3942283|FG000|NOT COMPLETED|Phase II - Second Intervention (6 Weeks)||0
3211821|NCT02206620|3942284|FG001|NOT COMPLETED|Phase II - Second Intervention (6 Weeks)||2
3211822|NCT02206685|3942298|FG000|STARTED|Overall Study||37
3211823|NCT02206685|3942299|FG001|STARTED|Overall Study||37
3211824|NCT02206685|3942298|FG000|COMPLETED|Overall Study||32
3211825|NCT02206685|3942299|FG001|COMPLETED|Overall Study||30
3211826|NCT02206685|3942298|FG000|NOT COMPLETED|Overall Study||5
3211827|NCT02206685|3942299|FG001|NOT COMPLETED|Overall Study||7
3211828|NCT02206776|3942307|FG000|STARTED|Overall Study||1
3211829|NCT02206776|3942308|FG001|STARTED|Overall Study||1
3211830|NCT02206776|3942307|FG000|COMPLETED|Overall Study||1
3211831|NCT02206776|3942308|FG001|COMPLETED|Overall Study||1
3211832|NCT02206776|3942307|FG000|NOT COMPLETED|Overall Study||0
3211833|NCT02206776|3942308|FG001|NOT COMPLETED|Overall Study||0
3211834|NCT02206828|3942314|FG000|STARTED|Overall Study||100
3211835|NCT02206828|3942314|FG000|COMPLETED|Overall Study||93
3211836|NCT02206828|3942314|FG000|NOT COMPLETED|Overall Study||7
3211837|NCT02207088|3942341|FG000|STARTED|Overall Study||68
3211838|NCT02207088|3942341|FG000|COMPLETED|Overall Study||66
3211839|NCT02207088|3942341|FG000|NOT COMPLETED|Overall Study||2
3211840|NCT02207231|3942348|FG000|STARTED|Placebo Controlled Period: Week 0 - 16||174
3211841|NCT02207231|3942349|FG001|STARTED|Placebo Controlled Period: Week 0 - 16||329
3211842|NCT02207231|3942350|FG002|STARTED|Placebo Controlled Period: Week 0 - 16||334
3211843|NCT02207231|3942351|FG003|STARTED|Placebo Controlled Period: Week 0 - 16||0
3211844|NCT02207231|3942348|FG000|Treated|Placebo Controlled Period: Week 0 - 16||174
3211845|NCT02207231|3942349|FG001|Treated|Placebo Controlled Period: Week 0 - 16||329
3211846|NCT02207231|3942350|FG002|Treated|Placebo Controlled Period: Week 0 - 16||333
3211847|NCT02207231|3942351|FG003|Treated|Placebo Controlled Period: Week 0 - 16||0
3211848|NCT02207231|3942348|FG000|COMPLETED|Placebo Controlled Period: Week 0 - 16||167
3211849|NCT02207231|3942349|FG001|COMPLETED|Placebo Controlled Period: Week 0 - 16||322
3211850|NCT02207231|3942350|FG002|COMPLETED|Placebo Controlled Period: Week 0 - 16||324
3211851|NCT02207231|3942351|FG003|COMPLETED|Placebo Controlled Period: Week 0 - 16||0
3211852|NCT02207231|3942348|FG000|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||7
3211853|NCT02207231|3942349|FG001|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||7
3211854|NCT02207231|3942350|FG002|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||10
3211855|NCT02207231|3942351|FG003|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||0
3211856|NCT02207231|3942348|FG000|STARTED|Active Controlled Period: Week 16 - 48|2 participants did not cross-over.|165
3211857|NCT02207231|3942349|FG001|STARTED|Active Controlled Period: Week 16 - 48||322
3211858|NCT02207231|3942350|FG002|STARTED|Active Controlled Period: Week 16 - 48||324
3211859|NCT02207231|3942351|FG003|STARTED|Active Controlled Period: Week 16 - 48||0
3211860|NCT02207231|3942348|FG000|COMPLETED|Active Controlled Period: Week 16 - 48||162
3211861|NCT02207231|3942349|FG001|COMPLETED|Active Controlled Period: Week 16 - 48||301
3211862|NCT02207231|3942350|FG002|COMPLETED|Active Controlled Period: Week 16 - 48||281
3211863|NCT02207231|3942351|FG003|COMPLETED|Active Controlled Period: Week 16 - 48||0
3211864|NCT02207231|3942348|FG000|NOT COMPLETED|Active Controlled Period: Week 16 - 48||3
3211865|NCT02207231|3942349|FG001|NOT COMPLETED|Active Controlled Period: Week 16 - 48||21
3211866|NCT02207231|3942350|FG002|NOT COMPLETED|Active Controlled Period: Week 16 - 48||43
3211867|NCT02207231|3942351|FG003|NOT COMPLETED|Active Controlled Period: Week 16 - 48||0
3211868|NCT02207231|3942348|FG000|STARTED|Open-label Guselkumab: Week 48 - 264||0
3211869|NCT02207231|3942349|FG001|STARTED|Open-label Guselkumab: Week 48 - 264||0
3211870|NCT02207231|3942350|FG002|STARTED|Open-label Guselkumab: Week 48 - 264|One participant did not crossover at Week 52 due to adverse event.|280
3211871|NCT02207231|3942351|FG003|STARTED|Open-label Guselkumab: Week 48 - 264|162 + 301= 463|463
3211872|NCT02207231|3942348|FG000|COMPLETED|Open-label Guselkumab: Week 48 - 264||0
3211873|NCT02207231|3942349|FG001|COMPLETED|Open-label Guselkumab: Week 48 - 264||0
3211874|NCT02207231|3942350|FG002|COMPLETED|Open-label Guselkumab: Week 48 - 264||242
3211875|NCT02207231|3942351|FG003|COMPLETED|Open-label Guselkumab: Week 48 - 264||380
3366595|NCT03906968|4097953|FG000|STARTED|Overall Study||40
3211876|NCT02207231|3942348|FG000|NOT COMPLETED|Open-label Guselkumab: Week 48 - 264||0
3211877|NCT02207231|3942349|FG001|NOT COMPLETED|Open-label Guselkumab: Week 48 - 264||0
3211878|NCT02207231|3942350|FG002|NOT COMPLETED|Open-label Guselkumab: Week 48 - 264||38
3211879|NCT02207231|3942351|FG003|NOT COMPLETED|Open-label Guselkumab: Week 48 - 264||83
3211880|NCT02207244|3942372|FG000|STARTED|Placebo Controlled Period: Week 0-16||248
3211881|NCT02207244|3942373|FG001|STARTED|Placebo Controlled Period: Week 0-16||496
3211882|NCT02207244|3942374|FG002|STARTED|Placebo Controlled Period: Week 0-16||248
3211883|NCT02207244|3942375|FG003|STARTED|Placebo Controlled Period: Week 0-16||0
3211884|NCT02207244|3942376|FG004|STARTED|Placebo Controlled Period: Week 0-16||0
3211885|NCT02207244|3942377|FG005|STARTED|Placebo Controlled Period: Week 0-16||0
3211886|NCT02207244|3942378|FG006|STARTED|Placebo Controlled Period: Week 0-16||0
3211887|NCT02207244|3942379|FG007|STARTED|Placebo Controlled Period: Week 0-16||0
3211888|NCT02207244|3942380|FG008|STARTED|Placebo Controlled Period: Week 0-16||0
3211889|NCT02207244|3942381|FG009|STARTED|Placebo Controlled Period: Week 0-16||0
3211890|NCT02207244|3942382|FG010|STARTED|Placebo Controlled Period: Week 0-16||0
3211891|NCT02207244|3942372|FG000|Treated|Placebo Controlled Period: Week 0-16||248
3211892|NCT02207244|3942373|FG001|Treated|Placebo Controlled Period: Week 0-16||494
3211893|NCT02207244|3942374|FG002|Treated|Placebo Controlled Period: Week 0-16||248
3211894|NCT02207244|3942375|FG003|Treated|Placebo Controlled Period: Week 0-16||0
3211895|NCT02207244|3942376|FG004|Treated|Placebo Controlled Period: Week 0-16||0
3211896|NCT02207244|3942377|FG005|Treated|Placebo Controlled Period: Week 0-16||0
3211897|NCT02207244|3942378|FG006|Treated|Placebo Controlled Period: Week 0-16||0
3211898|NCT02207244|3942379|FG007|Treated|Placebo Controlled Period: Week 0-16||0
3211899|NCT02207244|3942380|FG008|Treated|Placebo Controlled Period: Week 0-16||0
3211900|NCT02207244|3942381|FG009|Treated|Placebo Controlled Period: Week 0-16||0
3211901|NCT02207244|3942382|FG010|Treated|Placebo Controlled Period: Week 0-16||0
3211902|NCT02207244|3942372|FG000|COMPLETED|Placebo Controlled Period: Week 0-16||233
3211903|NCT02207244|3942373|FG001|COMPLETED|Placebo Controlled Period: Week 0-16||478
3211904|NCT02207244|3942374|FG002|COMPLETED|Placebo Controlled Period: Week 0-16||237
3211905|NCT02207244|3942375|FG003|COMPLETED|Placebo Controlled Period: Week 0-16||0
3211906|NCT02207244|3942376|FG004|COMPLETED|Placebo Controlled Period: Week 0-16||0
3211907|NCT02207244|3942377|FG005|COMPLETED|Placebo Controlled Period: Week 0-16||0
3211908|NCT02207244|3942378|FG006|COMPLETED|Placebo Controlled Period: Week 0-16||0
3211909|NCT02207244|3942379|FG007|COMPLETED|Placebo Controlled Period: Week 0-16||0
3211910|NCT02207244|3942380|FG008|COMPLETED|Placebo Controlled Period: Week 0-16||0
3211911|NCT02207244|3942381|FG009|COMPLETED|Placebo Controlled Period: Week 0-16||0
3211912|NCT02207244|3942382|FG010|COMPLETED|Placebo Controlled Period: Week 0-16||0
3211913|NCT02207244|3942372|FG000|NOT COMPLETED|Placebo Controlled Period: Week 0-16||15
3211914|NCT02207244|3942373|FG001|NOT COMPLETED|Placebo Controlled Period: Week 0-16||18
3211915|NCT02207244|3942374|FG002|NOT COMPLETED|Placebo Controlled Period: Week 0-16||11
3211916|NCT02207244|3942375|FG003|NOT COMPLETED|Placebo Controlled Period: Week 0-16||0
3211917|NCT02207244|3942376|FG004|NOT COMPLETED|Placebo Controlled Period: Week 0-16||0
3211918|NCT02207244|3942377|FG005|NOT COMPLETED|Placebo Controlled Period: Week 0-16||0
3211919|NCT02207244|3942378|FG006|NOT COMPLETED|Placebo Controlled Period: Week 0-16||0
3211920|NCT02207244|3942379|FG007|NOT COMPLETED|Placebo Controlled Period: Week 0-16||0
3211921|NCT02207244|3942380|FG008|NOT COMPLETED|Placebo Controlled Period: Week 0-16||0
3211922|NCT02207244|3942381|FG009|NOT COMPLETED|Placebo Controlled Period: Week 0-16||0
3211923|NCT02207244|3942382|FG010|NOT COMPLETED|Placebo Controlled Period: Week 0-16||0
3211924|NCT02207244|3942372|FG000|STARTED|Placebo Crossover and ACP: Week 16-28||0
3211925|NCT02207244|3942373|FG001|STARTED|Placebo Crossover and ACP: Week 16-28||0
3211926|NCT02207244|3942374|FG002|STARTED|Placebo Crossover and ACP: Week 16-28||0
3211927|NCT02207244|3942375|FG003|STARTED|Placebo Crossover and ACP: Week 16-28||233
3211928|NCT02207244|3942376|FG004|STARTED|Placebo Crossover and ACP: Week 16-28||478
3211929|NCT02207244|3942377|FG005|STARTED|Placebo Crossover and ACP: Week 16-28||237
3211930|NCT02207244|3942378|FG006|STARTED|Placebo Crossover and ACP: Week 16-28||0
3211931|NCT02207244|3942379|FG007|STARTED|Placebo Crossover and ACP: Week 16-28||0
3211932|NCT02207244|3942380|FG008|STARTED|Placebo Crossover and ACP: Week 16-28||0
3211933|NCT02207244|3942381|FG009|STARTED|Placebo Crossover and ACP: Week 16-28||0
3211934|NCT02207244|3942382|FG010|STARTED|Placebo Crossover and ACP: Week 16-28||0
3211935|NCT02207244|3942372|FG000|COMPLETED|Placebo Crossover and ACP: Week 16-28||0
3211936|NCT02207244|3942373|FG001|COMPLETED|Placebo Crossover and ACP: Week 16-28||0
3211937|NCT02207244|3942374|FG002|COMPLETED|Placebo Crossover and ACP: Week 16-28||0
3211938|NCT02207244|3942375|FG003|COMPLETED|Placebo Crossover and ACP: Week 16-28||227
3211939|NCT02207244|3942376|FG004|COMPLETED|Placebo Crossover and ACP: Week 16-28||470
3211940|NCT02207244|3942377|FG005|COMPLETED|Placebo Crossover and ACP: Week 16-28||228
3211941|NCT02207244|3942378|FG006|COMPLETED|Placebo Crossover and ACP: Week 16-28||0
3211942|NCT02207244|3942379|FG007|COMPLETED|Placebo Crossover and ACP: Week 16-28||0
3211943|NCT02207244|3942380|FG008|COMPLETED|Placebo Crossover and ACP: Week 16-28||0
3211944|NCT02207244|3942381|FG009|COMPLETED|Placebo Crossover and ACP: Week 16-28||0
3211945|NCT02207244|3942382|FG010|COMPLETED|Placebo Crossover and ACP: Week 16-28||0
3211946|NCT02207244|3942372|FG000|NOT COMPLETED|Placebo Crossover and ACP: Week 16-28||0
3211947|NCT02207244|3942373|FG001|NOT COMPLETED|Placebo Crossover and ACP: Week 16-28||0
3211948|NCT02207244|3942374|FG002|NOT COMPLETED|Placebo Crossover and ACP: Week 16-28||0
3211949|NCT02207244|3942375|FG003|NOT COMPLETED|Placebo Crossover and ACP: Week 16-28||6
3211950|NCT02207244|3942376|FG004|NOT COMPLETED|Placebo Crossover and ACP: Week 16-28||8
3211951|NCT02207244|3942377|FG005|NOT COMPLETED|Placebo Crossover and ACP: Week 16-28||9
3211952|NCT02207244|3942378|FG006|NOT COMPLETED|Placebo Crossover and ACP: Week 16-28||0
3211953|NCT02207244|3942379|FG007|NOT COMPLETED|Placebo Crossover and ACP: Week 16-28||0
3211954|NCT02207244|3942380|FG008|NOT COMPLETED|Placebo Crossover and ACP: Week 16-28||0
3211955|NCT02207244|3942381|FG009|NOT COMPLETED|Placebo Crossover and ACP: Week 16-28||0
3211956|NCT02207244|3942382|FG010|NOT COMPLETED|Placebo Crossover and ACP: Week 16-28||0
3211957|NCT02207244|3942372|FG000|STARTED|Withdrawal and Re-treatment: Week 28-72||0
3211958|NCT02207244|3942373|FG001|STARTED|Withdrawal and Re-treatment: Week 28-72||0
3211959|NCT02207244|3942374|FG002|STARTED|Withdrawal and Re-treatment: Week 28-72||0
3211960|NCT02207244|3942375|FG003|STARTED|Withdrawal and Re-treatment: Week 28-72||0
3211961|NCT02207244|3942376|FG004|STARTED|Withdrawal and Re-treatment: Week 28-72||0
3211962|NCT02207244|3942377|FG005|STARTED|Withdrawal and Re-treatment: Week 28-72||0
3211963|NCT02207244|3942378|FG006|STARTED|Withdrawal and Re-treatment: Week 28-72||227
3211964|NCT02207244|3942379|FG007|STARTED|Withdrawal and Re-treatment: Week 28-72||470
3211965|NCT02207244|3942380|FG008|STARTED|Withdrawal and Re-treatment: Week 28-72||220
3211966|NCT02207244|3942381|FG009|STARTED|Withdrawal and Re-treatment: Week 28-72||8
3211967|NCT02207244|3942382|FG010|STARTED|Withdrawal and Re-treatment: Week 28-72||0
3211968|NCT02207244|3942372|FG000|Nonresponders|Withdrawal and Re-treatment: Week 28-72||0
3211969|NCT02207244|3942373|FG001|Nonresponders|Withdrawal and Re-treatment: Week 28-72||0
3211970|NCT02207244|3942374|FG002|Nonresponders|Withdrawal and Re-treatment: Week 28-72||0
3211971|NCT02207244|3942375|FG003|Nonresponders|Withdrawal and Re-treatment: Week 28-72||0
3211972|NCT02207244|3942376|FG004|Nonresponders|Withdrawal and Re-treatment: Week 28-72||0
3211973|NCT02207244|3942377|FG005|Nonresponders|Withdrawal and Re-treatment: Week 28-72||0
3211974|NCT02207244|3942378|FG006|Nonresponders|Withdrawal and Re-treatment: Week 28-72||80
3211975|NCT02207244|3942379|FG007|Nonresponders|Withdrawal and Re-treatment: Week 28-72||95
3211976|NCT02207244|3942380|FG008|Nonresponders|Withdrawal and Re-treatment: Week 28-72||112
3211977|NCT02207244|3942381|FG009|Nonresponders|Withdrawal and Re-treatment: Week 28-72||0
3211978|NCT02207244|3942382|FG010|Nonresponders|Withdrawal and Re-treatment: Week 28-72||0
3211979|NCT02207244|3942372|FG000|Responders at Week 28|Withdrawal and Re-treatment: Week 28-72||0
3211980|NCT02207244|3942373|FG001|Responders at Week 28|Withdrawal and Re-treatment: Week 28-72||0
3211981|NCT02207244|3942374|FG002|Responders at Week 28|Withdrawal and Re-treatment: Week 28-72||0
3211982|NCT02207244|3942375|FG003|Responders at Week 28|Withdrawal and Re-treatment: Week 28-72||0
3211983|NCT02207244|3942376|FG004|Responders at Week 28|Withdrawal and Re-treatment: Week 28-72||0
3211984|NCT02207244|3942377|FG005|Responders at Week 28|Withdrawal and Re-treatment: Week 28-72||0
3211985|NCT02207244|3942378|FG006|Responders at Week 28|Withdrawal and Re-treatment: Week 28-72||0
3211986|NCT02207244|3942379|FG007|Responders at Week 28|Withdrawal and Re-treatment: Week 28-72|Participants randomized to withdrawal=182 and maintenance= 193|375
3211987|NCT02207244|3942380|FG008|Responders at Week 28|Withdrawal and Re-treatment: Week 28-72||0
3211988|NCT02207244|3942381|FG009|Responders at Week 28|Withdrawal and Re-treatment: Week 28-72||0
3211989|NCT02207244|3942382|FG010|Responders at Week 28|Withdrawal and Re-treatment: Week 28-72||0
3211990|NCT02207244|3942372|FG000|Responders at Week 28 and Withdrawn From Treatment|Withdrawal and Re-treatment: Week 28-72||0
3211991|NCT02207244|3942373|FG001|Responders at Week 28 and Withdrawn From Treatment|Withdrawal and Re-treatment: Week 28-72||0
3211992|NCT02207244|3942374|FG002|Responders at Week 28 and Withdrawn From Treatment|Withdrawal and Re-treatment: Week 28-72||0
3211993|NCT02207244|3942375|FG003|Responders at Week 28 and Withdrawn From Treatment|Withdrawal and Re-treatment: Week 28-72||0
3211994|NCT02207244|3942376|FG004|Responders at Week 28 and Withdrawn From Treatment|Withdrawal and Re-treatment: Week 28-72||0
3211995|NCT02207244|3942377|FG005|Responders at Week 28 and Withdrawn From Treatment|Withdrawal and Re-treatment: Week 28-72||0
3211996|NCT02207244|3942378|FG006|Responders at Week 28 and Withdrawn From Treatment|Withdrawal and Re-treatment: Week 28-72||147
3211997|NCT02207244|3942379|FG007|Responders at Week 28 and Withdrawn From Treatment|Withdrawal and Re-treatment: Week 28-72||0
3211998|NCT02207244|3942380|FG008|Responders at Week 28 and Withdrawn From Treatment|Withdrawal and Re-treatment: Week 28-72||108
3211999|NCT02207244|3942381|FG009|Responders at Week 28 and Withdrawn From Treatment|Withdrawal and Re-treatment: Week 28-72||0
3212000|NCT02207244|3942382|FG010|Responders at Week 28 and Withdrawn From Treatment|Withdrawal and Re-treatment: Week 28-72||0
3212001|NCT02207244|3942372|FG000|COMPLETED|Withdrawal and Re-treatment: Week 28-72||0
3212002|NCT02207244|3942373|FG001|COMPLETED|Withdrawal and Re-treatment: Week 28-72||0
3212003|NCT02207244|3942374|FG002|COMPLETED|Withdrawal and Re-treatment: Week 28-72||0
3212004|NCT02207244|3942375|FG003|COMPLETED|Withdrawal and Re-treatment: Week 28-72||0
3212005|NCT02207244|3942376|FG004|COMPLETED|Withdrawal and Re-treatment: Week 28-72||0
3212006|NCT02207244|3942377|FG005|COMPLETED|Withdrawal and Re-treatment: Week 28-72||0
3212007|NCT02207244|3942378|FG006|COMPLETED|Withdrawal and Re-treatment: Week 28-72||213
3212008|NCT02207244|3942379|FG007|COMPLETED|Withdrawal and Re-treatment: Week 28-72||443
3212009|NCT02207244|3942380|FG008|COMPLETED|Withdrawal and Re-treatment: Week 28-72||211
3212010|NCT02207244|3942381|FG009|COMPLETED|Withdrawal and Re-treatment: Week 28-72||0
3212011|NCT02207244|3942382|FG010|COMPLETED|Withdrawal and Re-treatment: Week 28-72||0
3212012|NCT02207244|3942372|FG000|NOT COMPLETED|Withdrawal and Re-treatment: Week 28-72||0
3212013|NCT02207244|3942373|FG001|NOT COMPLETED|Withdrawal and Re-treatment: Week 28-72||0
3212014|NCT02207244|3942374|FG002|NOT COMPLETED|Withdrawal and Re-treatment: Week 28-72||0
3212015|NCT02207244|3942375|FG003|NOT COMPLETED|Withdrawal and Re-treatment: Week 28-72||0
3212016|NCT02207244|3942376|FG004|NOT COMPLETED|Withdrawal and Re-treatment: Week 28-72||0
3212017|NCT02207244|3942377|FG005|NOT COMPLETED|Withdrawal and Re-treatment: Week 28-72||0
3212018|NCT02207244|3942378|FG006|NOT COMPLETED|Withdrawal and Re-treatment: Week 28-72||14
3212019|NCT02207244|3942379|FG007|NOT COMPLETED|Withdrawal and Re-treatment: Week 28-72||27
3212020|NCT02207244|3942380|FG008|NOT COMPLETED|Withdrawal and Re-treatment: Week 28-72||9
3212021|NCT02207244|3942381|FG009|NOT COMPLETED|Withdrawal and Re-treatment: Week 28-72||8
3212022|NCT02207244|3942382|FG010|NOT COMPLETED|Withdrawal and Re-treatment: Week 28-72||0
3212023|NCT02207244|3942372|FG000|STARTED|Open-label Guselkumab: Week 72-264||0
3212024|NCT02207244|3942373|FG001|STARTED|Open-label Guselkumab: Week 72-264||0
3212025|NCT02207244|3942374|FG002|STARTED|Open-label Guselkumab: Week 72-264||0
3212026|NCT02207244|3942375|FG003|STARTED|Open-label Guselkumab: Week 72-264||0
3212027|NCT02207244|3942376|FG004|STARTED|Open-label Guselkumab: Week 72-264||0
3212028|NCT02207244|3942377|FG005|STARTED|Open-label Guselkumab: Week 72-264||0
3212029|NCT02207244|3942378|FG006|STARTED|Open-label Guselkumab: Week 72-264||0
3212030|NCT02207244|3942379|FG007|STARTED|Open-label Guselkumab: Week 72-264||0
3212031|NCT02207244|3942380|FG008|STARTED|Open-label Guselkumab: Week 72-264||211
3212032|NCT02207244|3942381|FG009|STARTED|Open-label Guselkumab: Week 72-264||0
3212033|NCT02207244|3942382|FG010|STARTED|Open-label Guselkumab: Week 72-264||656
3212034|NCT02207244|3942372|FG000|COMPLETED|Open-label Guselkumab: Week 72-264||0
3212035|NCT02207244|3942373|FG001|COMPLETED|Open-label Guselkumab: Week 72-264||0
3212036|NCT02207244|3942374|FG002|COMPLETED|Open-label Guselkumab: Week 72-264||0
3212037|NCT02207244|3942375|FG003|COMPLETED|Open-label Guselkumab: Week 72-264||0
3366596|NCT03906968|4097953|FG000|COMPLETED|Overall Study||40
3366597|NCT03906968|4097953|FG000|NOT COMPLETED|Overall Study||0
3366598|NCT03904420|4097959|FG000|STARTED|Overall Study||2
3366599|NCT03904420|4097960|FG001|STARTED|Overall Study||2
3366600|NCT03904420|4097959|FG000|COMPLETED|Overall Study||0
3366601|NCT03904420|4097960|FG001|COMPLETED|Overall Study||0
3366602|NCT03904420|4097959|FG000|NOT COMPLETED|Overall Study||2
3366603|NCT03904420|4097960|FG001|NOT COMPLETED|Overall Study||2
3366604|NCT03903822|4097974|FG000|STARTED|Treatment Phase (6 Weeks)||37
3366605|NCT03903822|4097975|FG001|STARTED|Treatment Phase (6 Weeks)||37
3366606|NCT03903822|4097976|FG002|STARTED|Treatment Phase (6 Weeks)||36
3366607|NCT03903822|4097977|FG003|STARTED|Treatment Phase (6 Weeks)||37
3366608|NCT03903822|4097978|FG004|STARTED|Treatment Phase (6 Weeks)||36
3366609|NCT03903822|4097979|FG005|STARTED|Treatment Phase (6 Weeks)||36
3366610|NCT03903822|4097980|FG006|STARTED|Treatment Phase (6 Weeks)||36
3366611|NCT03903822|4097981|FG007|STARTED|Treatment Phase (6 Weeks)||37
3366612|NCT03903822|4097974|FG000|COMPLETED|Treatment Phase (6 Weeks)||28
3366613|NCT03903822|4097975|FG001|COMPLETED|Treatment Phase (6 Weeks)||27
3366614|NCT03903822|4097976|FG002|COMPLETED|Treatment Phase (6 Weeks)||33
3366615|NCT03903822|4097977|FG003|COMPLETED|Treatment Phase (6 Weeks)||32
3366616|NCT03903822|4097978|FG004|COMPLETED|Treatment Phase (6 Weeks)||31
3366617|NCT03903822|4097979|FG005|COMPLETED|Treatment Phase (6 Weeks)||25
3366618|NCT03903822|4097980|FG006|COMPLETED|Treatment Phase (6 Weeks)||31
3366619|NCT03903822|4097981|FG007|COMPLETED|Treatment Phase (6 Weeks)||33
3366620|NCT03903822|4097974|FG000|NOT COMPLETED|Treatment Phase (6 Weeks)||9
3366621|NCT03903822|4097975|FG001|NOT COMPLETED|Treatment Phase (6 Weeks)||10
3366622|NCT03903822|4097976|FG002|NOT COMPLETED|Treatment Phase (6 Weeks)||3
3366623|NCT03903822|4097977|FG003|NOT COMPLETED|Treatment Phase (6 Weeks)||5
3366624|NCT03903822|4097978|FG004|NOT COMPLETED|Treatment Phase (6 Weeks)||5
3366625|NCT03903822|4097979|FG005|NOT COMPLETED|Treatment Phase (6 Weeks)||11
3366626|NCT03903822|4097980|FG006|NOT COMPLETED|Treatment Phase (6 Weeks)||5
3366627|NCT03903822|4097981|FG007|NOT COMPLETED|Treatment Phase (6 Weeks)||4
3366628|NCT03903822|4097974|FG000|STARTED|Follow up Phase (4 Weeks)|Participants not completing treatment phase could also start this phase.|37
3366629|NCT03903822|4097975|FG001|STARTED|Follow up Phase (4 Weeks)|Participants not completing treatment phase could also start this phase.|37
3366630|NCT03903822|4097976|FG002|STARTED|Follow up Phase (4 Weeks)|Participants not completing treatment phase could also start this phase.|36
3366631|NCT03903822|4097977|FG003|STARTED|Follow up Phase (4 Weeks)|Participants not completing treatment phase could also start this phase.|37
3366632|NCT03903822|4097978|FG004|STARTED|Follow up Phase (4 Weeks)|Participants not completing treatment phase could also start this phase.|36
3366633|NCT03903822|4097979|FG005|STARTED|Follow up Phase (4 Weeks)|Participants not completing treatment phase could also start this phase.|36
3366634|NCT03903822|4097980|FG006|STARTED|Follow up Phase (4 Weeks)|Participants not completing treatment phase could also start this phase.|36
3366635|NCT03903822|4097981|FG007|STARTED|Follow up Phase (4 Weeks)|Participants not completing treatment phase could also start this phase.|37
3366636|NCT03903822|4097974|FG000|COMPLETED|Follow up Phase (4 Weeks)||29
3366637|NCT03903822|4097975|FG001|COMPLETED|Follow up Phase (4 Weeks)||29
3366638|NCT03903822|4097976|FG002|COMPLETED|Follow up Phase (4 Weeks)||32
3366639|NCT03903822|4097977|FG003|COMPLETED|Follow up Phase (4 Weeks)||33
3366640|NCT03903822|4097978|FG004|COMPLETED|Follow up Phase (4 Weeks)||32
3366641|NCT03903822|4097979|FG005|COMPLETED|Follow up Phase (4 Weeks)||28
3366642|NCT03903822|4097980|FG006|COMPLETED|Follow up Phase (4 Weeks)||31
3366643|NCT03903822|4097981|FG007|COMPLETED|Follow up Phase (4 Weeks)||31
3366644|NCT03903822|4097974|FG000|NOT COMPLETED|Follow up Phase (4 Weeks)||8
3366645|NCT03903822|4097975|FG001|NOT COMPLETED|Follow up Phase (4 Weeks)||8
3366646|NCT03903822|4097976|FG002|NOT COMPLETED|Follow up Phase (4 Weeks)||4
3212038|NCT02207244|3942376|FG004|COMPLETED|Open-label Guselkumab: Week 72-264||0
3212039|NCT02207244|3942377|FG005|COMPLETED|Open-label Guselkumab: Week 72-264||0
3212040|NCT02207244|3942378|FG006|COMPLETED|Open-label Guselkumab: Week 72-264||0
3212041|NCT02207244|3942379|FG007|COMPLETED|Open-label Guselkumab: Week 72-264||0
3212042|NCT02207244|3942380|FG008|COMPLETED|Open-label Guselkumab: Week 72-264||173
3212043|NCT02207244|3942381|FG009|COMPLETED|Open-label Guselkumab: Week 72-264||0
3212044|NCT02207244|3942382|FG010|COMPLETED|Open-label Guselkumab: Week 72-264||554
3212045|NCT02207244|3942372|FG000|NOT COMPLETED|Open-label Guselkumab: Week 72-264||0
3212046|NCT02207244|3942373|FG001|NOT COMPLETED|Open-label Guselkumab: Week 72-264||0
3212047|NCT02207244|3942374|FG002|NOT COMPLETED|Open-label Guselkumab: Week 72-264||0
3212048|NCT02207244|3942375|FG003|NOT COMPLETED|Open-label Guselkumab: Week 72-264||0
3212049|NCT02207244|3942376|FG004|NOT COMPLETED|Open-label Guselkumab: Week 72-264||0
3212050|NCT02207244|3942377|FG005|NOT COMPLETED|Open-label Guselkumab: Week 72-264||0
3212051|NCT02207244|3942378|FG006|NOT COMPLETED|Open-label Guselkumab: Week 72-264||0
3212052|NCT02207244|3942379|FG007|NOT COMPLETED|Open-label Guselkumab: Week 72-264||0
3212053|NCT02207244|3942380|FG008|NOT COMPLETED|Open-label Guselkumab: Week 72-264||38
3212054|NCT02207244|3942381|FG009|NOT COMPLETED|Open-label Guselkumab: Week 72-264||0
3212055|NCT02207244|3942382|FG010|NOT COMPLETED|Open-label Guselkumab: Week 72-264||102
3212056|NCT02207322|3942413|FG000|STARTED|Overall Study||79
3212057|NCT02207322|3942414|FG001|STARTED|Overall Study||81
3212058|NCT02207322|3942413|FG000|Week-2|Overall Study||77
3212059|NCT02207322|3942414|FG001|Week-2|Overall Study||80
3212060|NCT02207322|3942413|FG000|3-month|Overall Study||74
3212061|NCT02207322|3942414|FG001|3-month|Overall Study||75
3212062|NCT02207322|3942413|FG000|COMPLETED|Overall Study|6-month|70
3212063|NCT02207322|3942414|FG001|COMPLETED|Overall Study|6-month|71
3212064|NCT02207322|3942413|FG000|NOT COMPLETED|Overall Study||9
3212065|NCT02207322|3942414|FG001|NOT COMPLETED|Overall Study||10
3212066|NCT02207374|3942423|FG000|STARTED|Overall Study||239
3212067|NCT02207374|3942424|FG001|STARTED|Overall Study||241
3212068|NCT02207374|3942425|FG002|STARTED|Overall Study||121
3212069|NCT02207374|3942423|FG000|Exposed|Overall Study||239
3212070|NCT02207374|3942424|FG001|Exposed|Overall Study||241
3212071|NCT02207374|3942425|FG002|Exposed|Overall Study||120
3212072|NCT02207374|3942423|FG000|COMPLETED|Overall Study||233
3212073|NCT02207374|3942424|FG001|COMPLETED|Overall Study||231
3212074|NCT02207374|3942425|FG002|COMPLETED|Overall Study||115
3212075|NCT02207374|3942423|FG000|NOT COMPLETED|Overall Study||6
3212076|NCT02207374|3942424|FG001|NOT COMPLETED|Overall Study||10
3212077|NCT02207374|3942425|FG002|NOT COMPLETED|Overall Study||6
3212078|NCT02207400|3942435|FG000|STARTED|Overall Study||123
3212079|NCT02207400|3942436|FG001|STARTED|Overall Study||123
3212080|NCT02207400|3942435|FG000|COMPLETED|Overall Study||107
3212081|NCT02207400|3942436|FG001|COMPLETED|Overall Study||109
3212082|NCT02207400|3942435|FG000|NOT COMPLETED|Overall Study||16
3212083|NCT02207400|3942436|FG001|NOT COMPLETED|Overall Study||14
3212084|NCT02207413|3942451|FG000|STARTED|Overall Study||60
3212085|NCT02207413|3942452|FG001|STARTED|Overall Study||60
3212086|NCT02207413|3942453|FG002|STARTED|Overall Study||410
3212087|NCT02207413|3942454|FG003|STARTED|Overall Study||411
3212088|NCT02207413|3942455|FG004|STARTED|Overall Study||466
3212089|NCT02207413|3942456|FG005|STARTED|Overall Study||474
3212090|NCT02207413|3942451|FG000|COMPLETED|Overall Study||59
3212091|NCT02207413|3942452|FG001|COMPLETED|Overall Study||60
3212092|NCT02207413|3942453|FG002|COMPLETED|Overall Study|Primed subjects: 309; Unprimed subjects: 101|410
3212093|NCT02207413|3942454|FG003|COMPLETED|Overall Study|Primed subjects: 312; Unprimed subjects: 98|410
3212094|NCT02207413|3942455|FG004|COMPLETED|Overall Study|Primed subjects: 40; Unprimed subjects: 419|459
3212095|NCT02207413|3942456|FG005|COMPLETED|Overall Study|Primed subjects: 41; Unprimed subjects: 420|461
3212096|NCT02207413|3942451|FG000|NOT COMPLETED|Overall Study||1
3212097|NCT02207413|3942452|FG001|NOT COMPLETED|Overall Study||0
3212098|NCT02207413|3942453|FG002|NOT COMPLETED|Overall Study||0
3212099|NCT02207413|3942454|FG003|NOT COMPLETED|Overall Study||1
3212100|NCT02207413|3942455|FG004|NOT COMPLETED|Overall Study||7
3212101|NCT02207413|3942456|FG005|NOT COMPLETED|Overall Study||13
3212102|NCT02207478|3942478|FG000|STARTED|Overall Study||40
3212103|NCT02207478|3942479|FG001|STARTED|Overall Study||46
3212104|NCT02207478|3942478|FG000|COMPLETED|Overall Study||40
3212105|NCT02207478|3942479|FG001|COMPLETED|Overall Study||46
3212106|NCT02207478|3942478|FG000|NOT COMPLETED|Overall Study||0
3212107|NCT02207478|3942479|FG001|NOT COMPLETED|Overall Study||0
3212108|NCT02207491|3942487|FG000|STARTED|Overall Study||202
3212109|NCT02207491|3942488|FG001|STARTED|Overall Study||209
3212110|NCT02207491|3942487|FG000|COMPLETED|Overall Study||171
3212111|NCT02207491|3942488|FG001|COMPLETED|Overall Study||196
3212112|NCT02207491|3942487|FG000|NOT COMPLETED|Overall Study||31
3212113|NCT02207491|3942488|FG001|NOT COMPLETED|Overall Study||13
3212114|NCT02207530|3942494|FG000|STARTED|Overall Study||112
3212115|NCT02207530|3942494|FG000|COMPLETED|Overall Study||21
3212116|NCT02207530|3942494|FG000|NOT COMPLETED|Overall Study||91
3212117|NCT02207556|3942500|FG000|STARTED|Overall Study||7
3212118|NCT02207556|3942501|FG001|STARTED|Overall Study||25
3212119|NCT02207556|3942500|FG000|COMPLETED|Overall Study||5
3212120|NCT02207556|3942501|FG001|COMPLETED|Overall Study||20
3212121|NCT02207556|3942500|FG000|NOT COMPLETED|Overall Study||2
3212122|NCT02207556|3942501|FG001|NOT COMPLETED|Overall Study||5
3212123|NCT02207569|3942510|FG000|STARTED|Enrolled to Implant|241 Attempted Implant|241
3212124|NCT02207569|3942510|FG000|COMPLETED|Enrolled to Implant|237 Implanted|237
3212125|NCT02207569|3942510|FG000|NOT COMPLETED|Enrolled to Implant||4
3212126|NCT02207569|3942510|FG000|STARTED|Implant to 1-Month|241 Attempted Implant|241
3212127|NCT02207569|3942510|FG000|COMPLETED|Implant to 1-Month||232
3212128|NCT02207569|3942510|FG000|NOT COMPLETED|Implant to 1-Month||9
3212129|NCT02207569|3942510|FG000|STARTED|1-Month to 6-Month||232
3212130|NCT02207569|3942510|FG000|COMPLETED|1-Month to 6-Month||222
3212131|NCT02207569|3942510|FG000|NOT COMPLETED|1-Month to 6-Month||10
3212132|NCT02207569|3942510|FG000|STARTED|12-Month||222
3212133|NCT02207569|3942510|FG000|COMPLETED|12-Month||213
3212134|NCT02207569|3942510|FG000|NOT COMPLETED|12-Month||9
3212135|NCT02207569|3942510|FG000|STARTED|6-Month to 12-Month||213
3212136|NCT02207569|3942510|FG000|COMPLETED|6-Month to 12-Month||197
3212137|NCT02207569|3942510|FG000|NOT COMPLETED|6-Month to 12-Month||16
3212138|NCT02207569|3942510|FG000|STARTED|12-Month to 24 Month||197
3212139|NCT02207569|3942510|FG000|COMPLETED|12-Month to 24 Month||171
3212140|NCT02207569|3942510|FG000|NOT COMPLETED|12-Month to 24 Month||26
3212141|NCT02207569|3942510|FG000|STARTED|24-Month to 36-Month||171
3212142|NCT02207569|3942510|FG000|COMPLETED|24-Month to 36-Month||144
3212143|NCT02207569|3942510|FG000|NOT COMPLETED|24-Month to 36-Month||27
3212144|NCT02207569|3942510|FG000|STARTED|36-Month to 48-Month||144
3212145|NCT02207569|3942510|FG000|COMPLETED|36-Month to 48-Month||113
3212146|NCT02207569|3942510|FG000|NOT COMPLETED|36-Month to 48-Month||31
3212147|NCT02207569|3942510|FG000|STARTED|48-Month to 60-Month||113
3212148|NCT02207569|3942510|FG000|COMPLETED|48-Month to 60-Month||109
3212149|NCT02207569|3942510|FG000|NOT COMPLETED|48-Month to 60-Month||4
3212150|NCT02207608|3942516|FG000|STARTED|Overall Study||15
3212151|NCT02207608|3942517|FG001|STARTED|Overall Study||15
3212152|NCT02207608|3942516|FG000|COMPLETED|Overall Study||14
3212153|NCT02207608|3942517|FG001|COMPLETED|Overall Study||15
3212154|NCT02207608|3942516|FG000|NOT COMPLETED|Overall Study||1
3212155|NCT02207608|3942517|FG001|NOT COMPLETED|Overall Study||0
3212156|NCT02207621|3942526|FG000|STARTED|Overall Study||251
3212157|NCT02207621|3942527|FG001|STARTED|Overall Study||251
3212158|NCT02207621|3942528|FG002|STARTED|Overall Study||254
3212159|NCT02207621|3942526|FG000|COMPLETED|Overall Study||146
3212160|NCT02207621|3942527|FG001|COMPLETED|Overall Study||204
3212161|NCT02207621|3942528|FG002|COMPLETED|Overall Study||86
3212162|NCT02207621|3942526|FG000|NOT COMPLETED|Overall Study||105
3212163|NCT02207621|3942527|FG001|NOT COMPLETED|Overall Study||47
3212164|NCT02207621|3942528|FG002|NOT COMPLETED|Overall Study||168
3212165|NCT02207634|3942539|FG000|STARTED|Overall Study||990
3212166|NCT02207634|3942540|FG001|STARTED|Overall Study||984
3212167|NCT02207634|3942539|FG000|Received Treatment|Overall Study||990
3212168|NCT02207634|3942540|FG001|Received Treatment|Overall Study||983
3212169|NCT02207634|3942539|FG000|COMPLETED|Overall Study||968
3212170|NCT02207634|3942540|FG001|COMPLETED|Overall Study||953
3212171|NCT02207634|3942539|FG000|NOT COMPLETED|Overall Study||22
3212172|NCT02207634|3942540|FG001|NOT COMPLETED|Overall Study||31
3212173|NCT02207725|3942550|FG000|STARTED|Overall Study||9
3212174|NCT02207725|3942551|FG001|STARTED|Overall Study||25
3212175|NCT02207725|3942552|FG002|STARTED|Overall Study||9
3212176|NCT02207725|3942553|FG003|STARTED|Overall Study||25
3212177|NCT02207725|3942550|FG000|COMPLETED|Overall Study||9
3212178|NCT02207725|3942551|FG001|COMPLETED|Overall Study||24
3212179|NCT02207725|3942552|FG002|COMPLETED|Overall Study||8
3212180|NCT02207725|3942553|FG003|COMPLETED|Overall Study||24
3212181|NCT02207725|3942550|FG000|NOT COMPLETED|Overall Study||0
3212182|NCT02207725|3942551|FG001|NOT COMPLETED|Overall Study||1
3212183|NCT02207725|3942552|FG002|NOT COMPLETED|Overall Study||1
3212184|NCT02207725|3942553|FG003|NOT COMPLETED|Overall Study||1
3212185|NCT02207803|3942567|FG000|STARTED|Overall Study||125
3212186|NCT02207803|3942568|FG001|STARTED|Overall Study||125
3212187|NCT02207803|3942567|FG000|COMPLETED|Overall Study||110
3212188|NCT02207803|3942568|FG001|COMPLETED|Overall Study||108
3212189|NCT02207803|3942567|FG000|NOT COMPLETED|Overall Study||15
3212190|NCT02207803|3942568|FG001|NOT COMPLETED|Overall Study||17
3212191|NCT02207816|3942577|FG000|STARTED|Overall Study||1046
3212192|NCT02207816|3942578|FG001|STARTED|Overall Study||1010
3212193|NCT02207816|3942579|FG002|STARTED|Overall Study||1028
3212194|NCT02207816|3942577|FG000|COMPLETED|Overall Study||995
3212195|NCT02207816|3942578|FG001|COMPLETED|Overall Study||924
3212196|NCT02207816|3942579|FG002|COMPLETED|Overall Study||961
3212197|NCT02207816|3942577|FG000|NOT COMPLETED|Overall Study||51
3212198|NCT02207816|3942578|FG001|NOT COMPLETED|Overall Study||86
3212199|NCT02207816|3942579|FG002|NOT COMPLETED|Overall Study||67
3212200|NCT02207829|3942592|FG000|STARTED|Overall Study||509
3212201|NCT02207829|3942593|FG001|STARTED|Overall Study||508
3212202|NCT02207829|3942592|FG000|COMPLETED|Overall Study||467
3212203|NCT02207829|3942593|FG001|COMPLETED|Overall Study||474
3212204|NCT02207829|3942592|FG000|NOT COMPLETED|Overall Study||42
3212205|NCT02207829|3942593|FG001|NOT COMPLETED|Overall Study||34
3212206|NCT02207907|3942601|FG000|STARTED|Overall Study||124
3212207|NCT02207907|3942602|FG001|STARTED|Overall Study||123
3212208|NCT02207907|3942601|FG000|COMPLETED|Overall Study||113
3212209|NCT02207907|3942602|FG001|COMPLETED|Overall Study||115
3212210|NCT02207907|3942601|FG000|NOT COMPLETED|Overall Study||11
3212211|NCT02207907|3942602|FG001|NOT COMPLETED|Overall Study||8
3212212|NCT02207946|3942611|FG000|STARTED|Overall Study||19
3212213|NCT02207946|3942612|FG001|STARTED|Overall Study||11
3212214|NCT02207946|3942611|FG000|COMPLETED|Overall Study||18
3212215|NCT02207946|3942612|FG001|COMPLETED|Overall Study||10
3212216|NCT02207946|3942611|FG000|NOT COMPLETED|Overall Study||1
3212217|NCT02207946|3942612|FG001|NOT COMPLETED|Overall Study||1
3212218|NCT02207972|3942621|FG000|STARTED|Overall Study||22
3212219|NCT02207972|3942622|FG001|STARTED|Overall Study||24
3212220|NCT02207972|3942621|FG000|COMPLETED|Overall Study||22
3212221|NCT02207972|3942622|FG001|COMPLETED|Overall Study||24
3212222|NCT02207972|3942621|FG000|NOT COMPLETED|Overall Study||0
3212223|NCT02207972|3942622|FG001|NOT COMPLETED|Overall Study||0
3212224|NCT02208037|3942632|FG000|STARTED|Overall Study||93
3212225|NCT02208037|3942633|FG001|STARTED|Overall Study||93
3212226|NCT02208037|3942634|FG002|STARTED|Overall Study||93
3212227|NCT02208037|3942632|FG000|COMPLETED|Overall Study||89
3212228|NCT02208037|3942633|FG001|COMPLETED|Overall Study||92
3212229|NCT02208037|3942634|FG002|COMPLETED|Overall Study||92
3212230|NCT02208037|3942632|FG000|NOT COMPLETED|Overall Study||4
3212231|NCT02208037|3942633|FG001|NOT COMPLETED|Overall Study||1
3212232|NCT02208037|3942634|FG002|NOT COMPLETED|Overall Study||1
3212233|NCT02208050|3942644|FG000|STARTED|Baseline Assessment Period: 2 Weeks||36
3212234|NCT02208050|3942645|FG001|STARTED|Baseline Assessment Period: 2 Weeks||28
3212235|NCT02208050|3942644|FG000|COMPLETED|Baseline Assessment Period: 2 Weeks||36
3212236|NCT02208050|3942645|FG001|COMPLETED|Baseline Assessment Period: 2 Weeks||28
3212237|NCT02208050|3942644|FG000|NOT COMPLETED|Baseline Assessment Period: 2 Weeks||0
3212238|NCT02208050|3942645|FG001|NOT COMPLETED|Baseline Assessment Period: 2 Weeks||0
3212239|NCT02208050|3942644|FG000|STARTED|Treatment Period 1: 8 Weeks Treatment||36
3212240|NCT02208050|3942645|FG001|STARTED|Treatment Period 1: 8 Weeks Treatment||28
3212241|NCT02208050|3942644|FG000|COMPLETED|Treatment Period 1: 8 Weeks Treatment||36
3212242|NCT02208050|3942645|FG001|COMPLETED|Treatment Period 1: 8 Weeks Treatment||28
3212243|NCT02208050|3942644|FG000|NOT COMPLETED|Treatment Period 1: 8 Weeks Treatment||0
3212244|NCT02208050|3942645|FG001|NOT COMPLETED|Treatment Period 1: 8 Weeks Treatment||0
3212245|NCT02208050|3942644|FG000|STARTED|Washout Period 1: 2 Weeks||36
3212246|NCT02208050|3942645|FG001|STARTED|Washout Period 1: 2 Weeks||28
3212247|NCT02208050|3942644|FG000|COMPLETED|Washout Period 1: 2 Weeks||35
3212248|NCT02208050|3942645|FG001|COMPLETED|Washout Period 1: 2 Weeks||28
3212249|NCT02208050|3942644|FG000|NOT COMPLETED|Washout Period 1: 2 Weeks||1
3212250|NCT02208050|3942645|FG001|NOT COMPLETED|Washout Period 1: 2 Weeks||0
3212251|NCT02208050|3942644|FG000|STARTED|Treatment Period 2: 8 Weeks Treatment||35
3212252|NCT02208050|3942645|FG001|STARTED|Treatment Period 2: 8 Weeks Treatment||28
3212253|NCT02208050|3942644|FG000|COMPLETED|Treatment Period 2: 8 Weeks Treatment||33
3212254|NCT02208050|3942645|FG001|COMPLETED|Treatment Period 2: 8 Weeks Treatment||28
3212255|NCT02208050|3942644|FG000|NOT COMPLETED|Treatment Period 2: 8 Weeks Treatment||2
3212256|NCT02208050|3942645|FG001|NOT COMPLETED|Treatment Period 2: 8 Weeks Treatment||0
3212257|NCT02208050|3942644|FG000|STARTED|Washout Period 2: 2 Weeks Washout.||33
3212258|NCT02208050|3942645|FG001|STARTED|Washout Period 2: 2 Weeks Washout.||28
3212259|NCT02208050|3942644|FG000|COMPLETED|Washout Period 2: 2 Weeks Washout.||33
3212260|NCT02208050|3942645|FG001|COMPLETED|Washout Period 2: 2 Weeks Washout.||28
3212261|NCT02208050|3942644|FG000|NOT COMPLETED|Washout Period 2: 2 Weeks Washout.||0
3212262|NCT02208050|3942645|FG001|NOT COMPLETED|Washout Period 2: 2 Weeks Washout.||0
3212263|NCT02208063|3942667|FG000|STARTED|Overall Study||60
3212264|NCT02208063|3942668|FG001|STARTED|Overall Study||61
3212265|NCT02208063|3942667|FG000|Randomized and Treated|Overall Study||58
3212266|NCT02208063|3942668|FG001|Randomized and Treated|Overall Study||60
3212267|NCT02208063|3942667|FG000|Microbiological All Treated|Overall Study||47
3212268|NCT02208063|3942668|FG001|Microbiological All Treated|Overall Study||52
3212269|NCT02208063|3942667|FG000|COMPLETED|Overall Study||48
3212270|NCT02208063|3942668|FG001|COMPLETED|Overall Study||50
3212271|NCT02208063|3942667|FG000|NOT COMPLETED|Overall Study||12
3212272|NCT02208063|3942668|FG001|NOT COMPLETED|Overall Study||11
3212273|NCT02208089|3942676|FG000|STARTED|Overall Study||47
3212274|NCT02208089|3942677|FG001|STARTED|Overall Study||47
3212275|NCT02208089|3942676|FG000|COMPLETED|Overall Study||40
3212276|NCT02208089|3942677|FG001|COMPLETED|Overall Study||47
3212277|NCT02208089|3942676|FG000|NOT COMPLETED|Overall Study||7
3212278|NCT02208089|3942677|FG001|NOT COMPLETED|Overall Study||0
3212279|NCT02208297|3942686|FG000|STARTED|Overall Study||163
3212280|NCT02208297|3942687|FG001|STARTED|Overall Study||163
3212281|NCT02208297|3942686|FG000|COMPLETED|Overall Study||141
3212282|NCT02208297|3942687|FG001|COMPLETED|Overall Study||107
3212283|NCT02208297|3942686|FG000|NOT COMPLETED|Overall Study||22
3212284|NCT02208297|3942687|FG001|NOT COMPLETED|Overall Study||56
3212285|NCT02208310|3942695|FG000|STARTED|Overall Study||6
3212286|NCT02208310|3942696|FG001|STARTED|Overall Study||5
3212287|NCT02208310|3942695|FG000|Day 180|Overall Study||0
3212288|NCT02208310|3942696|FG001|Day 180|Overall Study||1
3212289|NCT02208310|3942695|FG000|COMPLETED|Overall Study||0
3212290|NCT02208310|3942696|FG001|COMPLETED|Overall Study||0
3212291|NCT02208310|3942695|FG000|NOT COMPLETED|Overall Study||6
3212292|NCT02208310|3942696|FG001|NOT COMPLETED|Overall Study||5
3212293|NCT02208349|3942704|FG000|STARTED|Initial 6 Months||16
3212294|NCT02208349|3942705|FG001|STARTED|Initial 6 Months||9
3212295|NCT02208349|3942704|FG000|COMPLETED|Initial 6 Months||16
3212296|NCT02208349|3942705|FG001|COMPLETED|Initial 6 Months||9
3212297|NCT02208349|3942704|FG000|NOT COMPLETED|Initial 6 Months||0
3212298|NCT02208349|3942705|FG001|NOT COMPLETED|Initial 6 Months||0
3212299|NCT02208349|3942704|FG000|STARTED|Second 6 Months||11
3212300|NCT02208349|3942705|FG001|STARTED|Second 6 Months||7
3212301|NCT02208349|3942704|FG000|COMPLETED|Second 6 Months||11
3212302|NCT02208349|3942705|FG001|COMPLETED|Second 6 Months||7
3212303|NCT02208349|3942704|FG000|NOT COMPLETED|Second 6 Months||0
3212304|NCT02208349|3942705|FG001|NOT COMPLETED|Second 6 Months||0
3212305|NCT02208349|3942704|FG000|STARTED|Third 6 Month||6
3212306|NCT02208349|3942705|FG001|STARTED|Third 6 Month||3
3212307|NCT02208349|3942704|FG000|COMPLETED|Third 6 Month||6
3212308|NCT02208349|3942705|FG001|COMPLETED|Third 6 Month||3
3212309|NCT02208349|3942704|FG000|NOT COMPLETED|Third 6 Month||0
3212310|NCT02208349|3942705|FG001|NOT COMPLETED|Third 6 Month||0
3212311|NCT02208349|3942704|FG000|STARTED|Fourth 6 Month||14
3212312|NCT02208349|3942705|FG001|STARTED|Fourth 6 Month||2
3212313|NCT02208349|3942704|FG000|COMPLETED|Fourth 6 Month||14
3212314|NCT02208349|3942705|FG001|COMPLETED|Fourth 6 Month||2
3212315|NCT02208349|3942704|FG000|NOT COMPLETED|Fourth 6 Month||0
3212316|NCT02208349|3942705|FG001|NOT COMPLETED|Fourth 6 Month||0
3212317|NCT02208349|3942704|FG000|STARTED|Fifth 6 Month||7
3212318|NCT02208349|3942705|FG001|STARTED|Fifth 6 Month||2
3212319|NCT02208349|3942704|FG000|COMPLETED|Fifth 6 Month||7
3212320|NCT02208349|3942705|FG001|COMPLETED|Fifth 6 Month||2
3212321|NCT02208349|3942704|FG000|NOT COMPLETED|Fifth 6 Month||0
3212322|NCT02208349|3942705|FG001|NOT COMPLETED|Fifth 6 Month||0
3212323|NCT02208349|3942704|FG000|STARTED|Sixth 6 Month||3
3212324|NCT02208349|3942705|FG001|STARTED|Sixth 6 Month||2
3212325|NCT02208349|3942704|FG000|COMPLETED|Sixth 6 Month||3
3212326|NCT02208349|3942705|FG001|COMPLETED|Sixth 6 Month||2
3212327|NCT02208349|3942704|FG000|NOT COMPLETED|Sixth 6 Month||0
3212328|NCT02208349|3942705|FG001|NOT COMPLETED|Sixth 6 Month||0
3212329|NCT02208466|3942716|FG000|STARTED|Overall Study||9
3212330|NCT02208466|3942717|FG001|STARTED|Overall Study||10
3212331|NCT02208466|3942718|FG002|STARTED|Overall Study||8
3212332|NCT02208466|3942716|FG000|COMPLETED|Overall Study||9
3212333|NCT02208466|3942717|FG001|COMPLETED|Overall Study||10
3212334|NCT02208466|3942718|FG002|COMPLETED|Overall Study||8
3212335|NCT02208466|3942716|FG000|NOT COMPLETED|Overall Study||0
3212336|NCT02208466|3942717|FG001|NOT COMPLETED|Overall Study||0
3212337|NCT02208466|3942718|FG002|NOT COMPLETED|Overall Study||0
3212338|NCT02208843|3942726|FG000|STARTED|Overall Study||60
3212339|NCT02208843|3942726|FG000|COMPLETED|Overall Study||0
3212340|NCT02208843|3942726|FG000|NOT COMPLETED|Overall Study||60
3212341|NCT02208999|3942732|FG000|STARTED|Overall Study||106
3212342|NCT02208999|3942732|FG000|COMPLETED|Overall Study||105
3212343|NCT02208999|3942732|FG000|NOT COMPLETED|Overall Study||1
3212344|NCT02209064|3942751|FG000|STARTED|Overall Study||25
3212345|NCT02209064|3942751|FG000|COMPLETED|Overall Study||25
3212346|NCT02209064|3942751|FG000|NOT COMPLETED|Overall Study||0
3212347|NCT02209181|3942760|FG000|STARTED|Overall Study||67
3212348|NCT02209181|3942761|FG001|STARTED|Overall Study||67
3212349|NCT02209181|3942762|FG002|STARTED|Overall Study||69
3212350|NCT02209181|3942763|FG003|STARTED|Overall Study||66
3212351|NCT02209181|3942760|FG000|COMPLETED|Overall Study||66
3212352|NCT02209181|3942761|FG001|COMPLETED|Overall Study||66
3212353|NCT02209181|3942762|FG002|COMPLETED|Overall Study||68
3212354|NCT02209181|3942763|FG003|COMPLETED|Overall Study||66
3212355|NCT02209181|3942760|FG000|NOT COMPLETED|Overall Study||1
3212356|NCT02209181|3942761|FG001|NOT COMPLETED|Overall Study||1
3212357|NCT02209181|3942762|FG002|NOT COMPLETED|Overall Study||1
3212358|NCT02209181|3942763|FG003|NOT COMPLETED|Overall Study||0
3212359|NCT02209259|3942776|FG000|STARTED|Overall Study||56
3212360|NCT02209259|3942777|FG001|STARTED|Overall Study||56
3212361|NCT02209259|3942778|FG002|STARTED|Overall Study||56
3212362|NCT02209259|3942776|FG000|COMPLETED|Overall Study||56
3212363|NCT02209259|3942777|FG001|COMPLETED|Overall Study||56
3212364|NCT02209259|3942778|FG002|COMPLETED|Overall Study||56
3212365|NCT02209259|3942776|FG000|NOT COMPLETED|Overall Study||0
3212366|NCT02209259|3942777|FG001|NOT COMPLETED|Overall Study||0
3212367|NCT02209259|3942778|FG002|NOT COMPLETED|Overall Study||0
3212368|NCT02209272|3942788|FG000|STARTED|Overall Study||32
3212369|NCT02209272|3942789|FG001|STARTED|Overall Study||36
3212370|NCT02209272|3942788|FG000|COMPLETED|Overall Study||32
3212371|NCT02209272|3942789|FG001|COMPLETED|Overall Study||36
3212372|NCT02209272|3942788|FG000|NOT COMPLETED|Overall Study||0
3212373|NCT02209272|3942789|FG001|NOT COMPLETED|Overall Study||0
3212374|NCT02209454|3942795|FG000|STARTED|First Period||13
3212375|NCT02209454|3942796|FG001|STARTED|First Period||13
3212376|NCT02209454|3942795|FG000|COMPLETED|First Period||13
3212377|NCT02209454|3942796|FG001|COMPLETED|First Period||13
3212378|NCT02209454|3942795|FG000|NOT COMPLETED|First Period||0
3212379|NCT02209454|3942796|FG001|NOT COMPLETED|First Period||0
3212380|NCT02209454|3942795|FG000|STARTED|Washout Period a Minimum of a 7 Day||13
3212381|NCT02209454|3942796|FG001|STARTED|Washout Period a Minimum of a 7 Day||13
3212382|NCT02209454|3942795|FG000|COMPLETED|Washout Period a Minimum of a 7 Day||13
3212383|NCT02209454|3942796|FG001|COMPLETED|Washout Period a Minimum of a 7 Day||13
3212384|NCT02209454|3942795|FG000|NOT COMPLETED|Washout Period a Minimum of a 7 Day||0
3212385|NCT02209454|3942796|FG001|NOT COMPLETED|Washout Period a Minimum of a 7 Day||0
3212386|NCT02209454|3942795|FG000|STARTED|Second Period||13
3212387|NCT02209454|3942796|FG001|STARTED|Second Period||13
3212388|NCT02209454|3942795|FG000|COMPLETED|Second Period||12
3212389|NCT02209454|3942796|FG001|COMPLETED|Second Period||13
3212390|NCT02209454|3942795|FG000|NOT COMPLETED|Second Period||1
3212391|NCT02209454|3942796|FG001|NOT COMPLETED|Second Period||0
3212392|NCT02209506|3942807|FG000|STARTED|Overall Study||3
3212393|NCT02209506|3942808|FG001|STARTED|Overall Study||6
3212394|NCT02209506|3942809|FG002|STARTED|Overall Study||6
3212395|NCT02209506|3942810|FG003|STARTED|Overall Study||2
3212396|NCT02209506|3942811|FG004|STARTED|Overall Study||6
3212397|NCT02209506|3942807|FG000|COMPLETED|Overall Study||3
3212398|NCT02209506|3942808|FG001|COMPLETED|Overall Study||6
3212399|NCT02209506|3942809|FG002|COMPLETED|Overall Study||6
3212400|NCT02209506|3942810|FG003|COMPLETED|Overall Study||2
3212401|NCT02209506|3942811|FG004|COMPLETED|Overall Study||5
3212402|NCT02209506|3942807|FG000|NOT COMPLETED|Overall Study||0
3212403|NCT02209506|3942808|FG001|NOT COMPLETED|Overall Study||0
3212404|NCT02209506|3942809|FG002|NOT COMPLETED|Overall Study||0
3212405|NCT02209506|3942810|FG003|NOT COMPLETED|Overall Study||0
3212406|NCT02209506|3942811|FG004|NOT COMPLETED|Overall Study||1
3212407|NCT02209519|3942828|FG000|STARTED|Overall Study||107
3212408|NCT02209519|3942829|FG001|STARTED|Overall Study||107
3212409|NCT02209519|3942828|FG000|COMPLETED|Overall Study||107
3212410|NCT02209519|3942829|FG001|COMPLETED|Overall Study||107
3212411|NCT02209519|3942828|FG000|NOT COMPLETED|Overall Study||0
3212412|NCT02209519|3942829|FG001|NOT COMPLETED|Overall Study||0
3212413|NCT02209532|3942838|FG000|STARTED|Overall Study||90
3212414|NCT02209532|3942839|FG001|STARTED|Overall Study||90
3212415|NCT02209532|3942838|FG000|COMPLETED|Overall Study||87
3212416|NCT02209532|3942839|FG001|COMPLETED|Overall Study||89
3212417|NCT02209532|3942838|FG000|NOT COMPLETED|Overall Study||3
3212418|NCT02209532|3942839|FG001|NOT COMPLETED|Overall Study||1
3212419|NCT02209597|3942846|FG000|STARTED|Phase 1 Current Tx (Non-randomized)||74
3212420|NCT02209597|3942846|FG000|COMPLETED|Phase 1 Current Tx (Non-randomized)||71
3212421|NCT02209597|3942846|FG000|NOT COMPLETED|Phase 1 Current Tx (Non-randomized)||3
3212422|NCT02209597|3942846|FG000|STARTED|Phase 2 (Randomized: 1 Brand, 3 Generic)||71
3212423|NCT02209597|3942846|FG000|COMPLETED|Phase 2 (Randomized: 1 Brand, 3 Generic)||67
3212424|NCT02209597|3942846|FG000|NOT COMPLETED|Phase 2 (Randomized: 1 Brand, 3 Generic)||4
3212425|NCT02209597|3942846|FG000|STARTED|Phase 3 (Randomized: 1 Brand, 3 Generic)||67
3212426|NCT02209597|3942846|FG000|COMPLETED|Phase 3 (Randomized: 1 Brand, 3 Generic)||67
3212427|NCT02209597|3942846|FG000|NOT COMPLETED|Phase 3 (Randomized: 1 Brand, 3 Generic)||0
3212428|NCT02209597|3942846|FG000|STARTED|Phase 4 (Randomized: 1 Brand, 3 Generic)||67
3212429|NCT02209597|3942846|FG000|COMPLETED|Phase 4 (Randomized: 1 Brand, 3 Generic)||67
3212430|NCT02209597|3942846|FG000|NOT COMPLETED|Phase 4 (Randomized: 1 Brand, 3 Generic)||0
3212431|NCT02209610|3942858|FG000|STARTED|Overall Study||16
3212432|NCT02209610|3942859|FG001|STARTED|Overall Study||16
3212433|NCT02209610|3942858|FG000|COMPLETED|Overall Study||16
3212434|NCT02209610|3942859|FG001|COMPLETED|Overall Study||16
3212435|NCT02209610|3942858|FG000|NOT COMPLETED|Overall Study||0
3212436|NCT02209610|3942859|FG001|NOT COMPLETED|Overall Study||0
3212437|NCT02209766|3942870|FG000|STARTED|Overall Study||6
3212438|NCT02209766|3942871|FG001|STARTED|Overall Study||3
3212439|NCT02209766|3942872|FG002|STARTED|Overall Study||6
3212440|NCT02209766|3942873|FG003|STARTED|Overall Study||3
3212441|NCT02209766|3942874|FG004|STARTED|Overall Study||6
3212442|NCT02209766|3942870|FG000|COMPLETED|Overall Study||6
3212443|NCT02209766|3942871|FG001|COMPLETED|Overall Study||3
3212444|NCT02209766|3942872|FG002|COMPLETED|Overall Study||6
3212445|NCT02209766|3942873|FG003|COMPLETED|Overall Study||2
3212446|NCT02209766|3942874|FG004|COMPLETED|Overall Study||6
3212447|NCT02209766|3942870|FG000|NOT COMPLETED|Overall Study||0
3212448|NCT02209766|3942871|FG001|NOT COMPLETED|Overall Study||0
3212449|NCT02209766|3942872|FG002|NOT COMPLETED|Overall Study||0
3212450|NCT02209766|3942873|FG003|NOT COMPLETED|Overall Study||1
3212451|NCT02209766|3942874|FG004|NOT COMPLETED|Overall Study||0
3212452|NCT02209948|3942886|FG000|STARTED|Overall Study||80
3212453|NCT02209948|3942887|FG001|STARTED|Overall Study||79
3212454|NCT02209948|3942886|FG000|Recieved Alocated Intervention|Overall Study||80
3212455|NCT02209948|3942887|FG001|Recieved Alocated Intervention|Overall Study||79
3212456|NCT02209948|3942886|FG000|Lost to Follow up|Overall Study||0
3212457|NCT02209948|3942887|FG001|Lost to Follow up|Overall Study||1
3212458|NCT02209948|3942886|FG000|Discontinued Due to Progression|Overall Study||31
3212459|NCT02209948|3942887|FG001|Discontinued Due to Progression|Overall Study||39
3212460|NCT02209948|3942886|FG000|COMPLETED|Overall Study||80
3212461|NCT02209948|3942887|FG001|COMPLETED|Overall Study||79
3212462|NCT02209948|3942886|FG000|NOT COMPLETED|Overall Study||0
3212463|NCT02209948|3942887|FG001|NOT COMPLETED|Overall Study||0
3212464|NCT02210000|3942895|FG000|STARTED|Overall Study||57
3212465|NCT02210000|3942896|FG001|STARTED|Overall Study||57
3212466|NCT02210000|3942895|FG000|COMPLETED|Overall Study||38
3212467|NCT02210000|3942896|FG001|COMPLETED|Overall Study||36
3212468|NCT02210000|3942895|FG000|NOT COMPLETED|Overall Study||19
3212469|NCT02210000|3942896|FG001|NOT COMPLETED|Overall Study||21
3212470|NCT02210039|3942902|FG000|STARTED|Overall Study||6
3212471|NCT02210039|3942902|FG000|COMPLETED|Overall Study||6
3212472|NCT02210039|3942902|FG000|NOT COMPLETED|Overall Study||0
3212473|NCT02210052|3942906|FG000|STARTED|Overall Study||6
3212474|NCT02210052|3942906|FG000|COMPLETED|Overall Study||6
3212475|NCT02210052|3942906|FG000|NOT COMPLETED|Overall Study||0
3212476|NCT02210065|3942910|FG000|STARTED|Overall Study||1
3212477|NCT02210065|3942910|FG000|COMPLETED|Overall Study||1
3212478|NCT02210065|3942910|FG000|NOT COMPLETED|Overall Study||0
3212479|NCT02210091|3942916|FG000|STARTED|Overall Study||32
3212480|NCT02210091|3942917|FG001|STARTED|Overall Study||34
3212481|NCT02210091|3942916|FG000|COMPLETED|Overall Study||32
3212482|NCT02210091|3942917|FG001|COMPLETED|Overall Study||32
3212483|NCT02210091|3942916|FG000|NOT COMPLETED|Overall Study||0
3212484|NCT02210091|3942917|FG001|NOT COMPLETED|Overall Study||2
3212485|NCT02210195|3942941|FG000|STARTED|Overall Study||10
3212486|NCT02210195|3942942|FG001|STARTED|Overall Study||10
3212487|NCT02210195|3942941|FG000|COMPLETED|Overall Study||6
3212488|NCT02210195|3942942|FG001|COMPLETED|Overall Study||10
3212489|NCT02210195|3942941|FG000|NOT COMPLETED|Overall Study||4
3212490|NCT02210195|3942942|FG001|NOT COMPLETED|Overall Study||0
3212491|NCT02210208|3942948|FG000|STARTED|Period A (Graft Site)||25
3212492|NCT02210208|3942948|FG000|COMPLETED|Period A (Graft Site)||23
3212493|NCT02210208|3942948|FG000|NOT COMPLETED|Period A (Graft Site)||2
3212494|NCT02210208|3942948|FG000|STARTED|Period B (Donor Site)|6 subjects was decided by the Physician not to be included in the Part B.|19
3212495|NCT02210208|3942948|FG000|COMPLETED|Period B (Donor Site)||12
3212496|NCT02210208|3942948|FG000|NOT COMPLETED|Period B (Donor Site)||7
3212497|NCT02210221|3942954|FG000|STARTED|Overall Study||4559
3212498|NCT02210221|3942954|FG000|COMPLETED|Overall Study||4509
3212499|NCT02210221|3942954|FG000|NOT COMPLETED|Overall Study||50
3212500|NCT02210247|3942968|FG000|STARTED|Overall Study||12
3212501|NCT02210247|3942969|FG001|STARTED|Overall Study||12
3212502|NCT02210247|3942970|FG002|STARTED|Overall Study||12
3212503|NCT02210247|3942971|FG003|STARTED|Overall Study||12
3212504|NCT02210247|3942972|FG004|STARTED|Overall Study||12
3212505|NCT02210247|3942968|FG000|COMPLETED|Overall Study||12
3212506|NCT02210247|3942969|FG001|COMPLETED|Overall Study||12
3212507|NCT02210247|3942970|FG002|COMPLETED|Overall Study||12
3212508|NCT02210247|3942971|FG003|COMPLETED|Overall Study||12
3212509|NCT02210247|3942972|FG004|COMPLETED|Overall Study||12
3212510|NCT02210247|3942968|FG000|NOT COMPLETED|Overall Study||0
3212511|NCT02210247|3942969|FG001|NOT COMPLETED|Overall Study||0
3212512|NCT02210247|3942970|FG002|NOT COMPLETED|Overall Study||0
3212513|NCT02210247|3942971|FG003|NOT COMPLETED|Overall Study||0
3212514|NCT02210247|3942972|FG004|NOT COMPLETED|Overall Study||0
3212515|NCT02210286|3942989|FG000|STARTED|Overall Study||17
3212516|NCT02210286|3942989|FG000|COMPLETED|Overall Study||15
3212517|NCT02210286|3942989|FG000|NOT COMPLETED|Overall Study||2
3212518|NCT02210689|3943000|FG000|STARTED|Overall Study||242
3212519|NCT02210689|3943001|FG001|STARTED|Overall Study||240
3212520|NCT02210689|3943002|FG002|STARTED|Overall Study||122
3212521|NCT02210689|3943000|FG000|Safety Population|Overall Study||233
3212522|NCT02210689|3943001|FG001|Safety Population|Overall Study||236
3212523|NCT02210689|3943002|FG002|Safety Population|Overall Study||122
3212524|NCT02210689|3943000|FG000|mITT Population|Overall Study||199
3212525|NCT02210689|3943001|FG001|mITT Population|Overall Study||207
3212526|NCT02210689|3943002|FG002|mITT Population|Overall Study||107
3212527|NCT02210689|3943000|FG000|PP Population|Overall Study||164
3212528|NCT02210689|3943001|FG001|PP Population|Overall Study||169
3212529|NCT02210689|3943002|FG002|PP Population|Overall Study||84
3212530|NCT02210689|3943000|FG000|COMPLETED|Overall Study||190
3212531|NCT02210689|3943001|FG001|COMPLETED|Overall Study||193
3212532|NCT02210689|3943002|FG002|COMPLETED|Overall Study||99
3212533|NCT02210689|3943000|FG000|NOT COMPLETED|Overall Study||52
3212534|NCT02210689|3943001|FG001|NOT COMPLETED|Overall Study||47
3212535|NCT02210689|3943002|FG002|NOT COMPLETED|Overall Study||23
3212536|NCT02210780|3943012|FG000|STARTED|Overall Study||97
3212537|NCT02210780|3943013|FG001|STARTED|Overall Study||97
3212538|NCT02210780|3943012|FG000|COMPLETED|Overall Study||92
3212539|NCT02210780|3943013|FG001|COMPLETED|Overall Study||89
3212540|NCT02210780|3943012|FG000|NOT COMPLETED|Overall Study||5
3212541|NCT02210780|3943013|FG001|NOT COMPLETED|Overall Study||8
3212542|NCT02211014|3943021|FG000|STARTED|Overall Study||13
3212543|NCT02211014|3943022|FG001|STARTED|Overall Study||14
3212544|NCT02211014|3943021|FG000|COMPLETED|Overall Study||11
3212545|NCT02211014|3943022|FG001|COMPLETED|Overall Study||8
3212546|NCT02211014|3943021|FG000|NOT COMPLETED|Overall Study||2
3212547|NCT02211014|3943022|FG001|NOT COMPLETED|Overall Study||6
3212548|NCT02211261|3943055|FG000|STARTED|Overall Study||9
3212549|NCT02211261|3943056|FG001|STARTED|Overall Study||6
3212550|NCT02211261|3943057|FG002|STARTED|Overall Study||6
3212551|NCT02211261|3943058|FG003|STARTED|Overall Study||6
3212552|NCT02211261|3943059|FG004|STARTED|Overall Study||9
3212553|NCT02211261|3943060|FG005|STARTED|Overall Study||2
3212554|NCT02211261|3943061|FG006|STARTED|Overall Study||6
3212555|NCT02211261|3943062|FG007|STARTED|Overall Study||8
3212556|NCT02211261|3943063|FG008|STARTED|Overall Study||8
3212557|NCT02211261|3943064|FG009|STARTED|Overall Study||16
3212558|NCT02211261|3943065|FG010|STARTED|Overall Study||8
3212559|NCT02211261|3943055|FG000|COMPLETED|Overall Study||9
3212560|NCT02211261|3943056|FG001|COMPLETED|Overall Study||6
3212561|NCT02211261|3943057|FG002|COMPLETED|Overall Study||5
3212562|NCT02211261|3943058|FG003|COMPLETED|Overall Study||6
3212563|NCT02211261|3943059|FG004|COMPLETED|Overall Study||7
3212564|NCT02211261|3943060|FG005|COMPLETED|Overall Study||1
3212565|NCT02211261|3943061|FG006|COMPLETED|Overall Study||6
3212566|NCT02211261|3943062|FG007|COMPLETED|Overall Study||7
3212567|NCT02211261|3943063|FG008|COMPLETED|Overall Study||8
3212568|NCT02211261|3943064|FG009|COMPLETED|Overall Study||14
3212569|NCT02211261|3943065|FG010|COMPLETED|Overall Study||8
3212570|NCT02211261|3943055|FG000|NOT COMPLETED|Overall Study||0
3212571|NCT02211261|3943056|FG001|NOT COMPLETED|Overall Study||0
3212572|NCT02211261|3943057|FG002|NOT COMPLETED|Overall Study||1
3212573|NCT02211261|3943058|FG003|NOT COMPLETED|Overall Study||0
3212574|NCT02211261|3943059|FG004|NOT COMPLETED|Overall Study||2
3212575|NCT02211261|3943060|FG005|NOT COMPLETED|Overall Study||1
3212576|NCT02211261|3943061|FG006|NOT COMPLETED|Overall Study||0
3212577|NCT02211261|3943062|FG007|NOT COMPLETED|Overall Study||1
3212578|NCT02211261|3943063|FG008|NOT COMPLETED|Overall Study||0
3212579|NCT02211261|3943064|FG009|NOT COMPLETED|Overall Study||2
3212580|NCT02211261|3943065|FG010|NOT COMPLETED|Overall Study||0
3212581|NCT02211313|3943100|FG000|STARTED|Overall Study||18
3212582|NCT02211313|3943101|FG001|STARTED|Overall Study||23
3212583|NCT02211313|3943100|FG000|COMPLETED|Overall Study||12
3212584|NCT02211313|3943101|FG001|COMPLETED|Overall Study||20
3212585|NCT02211313|3943100|FG000|NOT COMPLETED|Overall Study||6
3212586|NCT02211313|3943101|FG001|NOT COMPLETED|Overall Study||3
3212587|NCT02211456|3943107|FG000|STARTED|Overall Study||15
3212588|NCT02211456|3943107|FG000|COMPLETED|Overall Study||15
3212589|NCT02211456|3943107|FG000|NOT COMPLETED|Overall Study||0
3212590|NCT02211495|3943113|FG000|STARTED|Overall Study||4
3212591|NCT02211495|3943114|FG001|STARTED|Overall Study||4
3212592|NCT02211495|3943113|FG000|COMPLETED|Overall Study||4
3212593|NCT02211495|3943114|FG001|COMPLETED|Overall Study||4
3366647|NCT03903822|4097977|FG003|NOT COMPLETED|Follow up Phase (4 Weeks)||4
3366648|NCT03903822|4097978|FG004|NOT COMPLETED|Follow up Phase (4 Weeks)||4
3366649|NCT03903822|4097979|FG005|NOT COMPLETED|Follow up Phase (4 Weeks)||8
3366650|NCT03903822|4097980|FG006|NOT COMPLETED|Follow up Phase (4 Weeks)||5
3366651|NCT03903822|4097981|FG007|NOT COMPLETED|Follow up Phase (4 Weeks)||6
3366652|NCT03905096|4098001|FG000|STARTED|Period 1 for Trial Part 1 and 2||18
3366653|NCT03905096|4098002|FG001|STARTED|Period 1 for Trial Part 1 and 2||14
3366654|NCT03905096|4098001|FG000|COMPLETED|Period 1 for Trial Part 1 and 2||18
3366655|NCT03905096|4098002|FG001|COMPLETED|Period 1 for Trial Part 1 and 2||14
3366656|NCT03905096|4098001|FG000|NOT COMPLETED|Period 1 for Trial Part 1 and 2||0
3366657|NCT03905096|4098002|FG001|NOT COMPLETED|Period 1 for Trial Part 1 and 2||0
3366658|NCT03905096|4098001|FG000|STARTED|Period 2 for Trial Part 1 and 2||18
3366659|NCT03905096|4098002|FG001|STARTED|Period 2 for Trial Part 1 and 2||14
3366660|NCT03905096|4098001|FG000|COMPLETED|Period 2 for Trial Part 1 and 2||17
3366661|NCT03905096|4098002|FG001|COMPLETED|Period 2 for Trial Part 1 and 2||14
3366662|NCT03905096|4098001|FG000|NOT COMPLETED|Period 2 for Trial Part 1 and 2||1
3366663|NCT03905096|4098002|FG001|NOT COMPLETED|Period 2 for Trial Part 1 and 2||0
3366664|NCT03899064|4098015|FG000|STARTED|Overall Study||58
3366665|NCT03899064|4098015|FG000|MC2-01 Cream, Irradiation|Overall Study||58
3366666|NCT03899064|4098015|FG000|MC2-01 Cream, No Irradiation|Overall Study||58
3366667|NCT03899064|4098015|FG000|MC2-01 Vehicle, Irradiation|Overall Study||58
3366668|NCT03899064|4098015|FG000|MC2-01 Vehicle, no Irradiation|Overall Study||58
3366669|NCT03899064|4098015|FG000|Control, Irradiation|Overall Study||58
3366670|NCT03899064|4098015|FG000|COMPLETED|Overall Study||51
3366671|NCT03899064|4098015|FG000|NOT COMPLETED|Overall Study||7
3366672|NCT03894969|4098024|FG000|STARTED|Overall Study||134
3366673|NCT03894969|4098025|FG001|STARTED|Overall Study||134
3366674|NCT03894969|4098026|FG002|STARTED|Overall Study||122
3366675|NCT03894969|4098027|FG003|STARTED|Overall Study||135
3366676|NCT03894969|4098028|FG004|STARTED|Overall Study||16
3366677|NCT03894969|4098024|FG000|COMPLETED|Overall Study||132
3366678|NCT03894969|4098025|FG001|COMPLETED|Overall Study||131
3366679|NCT03894969|4098026|FG002|COMPLETED|Overall Study||120
3366680|NCT03894969|4098027|FG003|COMPLETED|Overall Study||129
3366681|NCT03894969|4098028|FG004|COMPLETED|Overall Study||2
3366682|NCT03894969|4098024|FG000|NOT COMPLETED|Overall Study||2
3366683|NCT03894969|4098025|FG001|NOT COMPLETED|Overall Study||3
3366684|NCT03894969|4098026|FG002|NOT COMPLETED|Overall Study||2
3366685|NCT03894969|4098027|FG003|NOT COMPLETED|Overall Study||6
3366686|NCT03894969|4098028|FG004|NOT COMPLETED|Overall Study||14
3366687|NCT03903159|4098041|FG000|STARTED|Overall Study||15
3366688|NCT03903159|4098041|FG000|COMPLETED|Overall Study||10
3366689|NCT03903159|4098041|FG000|NOT COMPLETED|Overall Study||5
3366690|NCT03902392|4098047|FG000|STARTED|Overall Study||25
3366691|NCT03902392|4098048|FG001|STARTED|Overall Study||25
3366692|NCT03902392|4098047|FG000|COMPLETED|Overall Study||18
3366693|NCT03902392|4098048|FG001|COMPLETED|Overall Study||18
3366694|NCT03902392|4098047|FG000|NOT COMPLETED|Overall Study||7
3366695|NCT03902392|4098048|FG001|NOT COMPLETED|Overall Study||7
3366696|NCT03901105|4098054|FG000|STARTED|Overall Study||205
3366697|NCT03901105|4098054|FG000|COMPLETED|Overall Study||205
3366698|NCT03901105|4098054|FG000|NOT COMPLETED|Overall Study||0
3366699|NCT03895853|4098066|FG000|STARTED|Overall Study||0
3366700|NCT03895853|4098067|FG001|STARTED|Overall Study||2
3366701|NCT03895853|4098066|FG000|COMPLETED|Overall Study||0
3366702|NCT03895853|4098067|FG001|COMPLETED|Overall Study||2
3366703|NCT03895853|4098066|FG000|NOT COMPLETED|Overall Study||0
3366704|NCT03895853|4098067|FG001|NOT COMPLETED|Overall Study||0
3366705|NCT03901313|4098073|FG000|STARTED|Overall Study||4
3366706|NCT03901313|4098074|FG001|STARTED|Overall Study||4
3366707|NCT03901313|4098075|FG002|STARTED|Overall Study||4
3366708|NCT03901313|4098076|FG003|STARTED|Overall Study||4
3366709|NCT03901313|4098077|FG004|STARTED|Overall Study||4
3366710|NCT03901313|4098078|FG005|STARTED|Overall Study||4
3212594|NCT02211495|3943113|FG000|NOT COMPLETED|Overall Study||0
3212595|NCT02211495|3943114|FG001|NOT COMPLETED|Overall Study||0
3212596|NCT02211534|3943126|FG000|STARTED|Overall Study||24
3212597|NCT02211534|3943127|FG001|STARTED|Overall Study||11
3212598|NCT02211534|3943126|FG000|COMPLETED|Overall Study||11
3366711|NCT03901313|4098073|FG000|COMPLETED|Overall Study||4
3366712|NCT03901313|4098074|FG001|COMPLETED|Overall Study||4
3212599|NCT02211534|3943127|FG001|COMPLETED|Overall Study||6
3212600|NCT02211534|3943126|FG000|NOT COMPLETED|Overall Study||13
3212601|NCT02211534|3943127|FG001|NOT COMPLETED|Overall Study||5
3212602|NCT02211638|3943133|FG000|STARTED|Overall Study||18113
3212603|NCT02211638|3943133|FG000|COMPLETED|Overall Study||17130
3212604|NCT02211638|3943133|FG000|NOT COMPLETED|Overall Study||983
3212605|NCT02212028|3943139|FG000|STARTED|Overall Study||26
3212606|NCT02212028|3943140|FG001|STARTED|Overall Study||26
3212607|NCT02212028|3943139|FG000|COMPLETED|Overall Study||26
3212608|NCT02212028|3943140|FG001|COMPLETED|Overall Study||26
3212609|NCT02212028|3943139|FG000|NOT COMPLETED|Overall Study||0
3212610|NCT02212028|3943140|FG001|NOT COMPLETED|Overall Study||0
3212611|NCT02212106|3943148|FG000|STARTED|Overall Study||302
3212612|NCT02212106|3943149|FG001|STARTED|Overall Study||100
3212613|NCT02212106|3943148|FG000|COMPLETED|Overall Study||292
3212614|NCT02212106|3943149|FG001|COMPLETED|Overall Study||96
3212615|NCT02212106|3943148|FG000|NOT COMPLETED|Overall Study||10
3212616|NCT02212106|3943149|FG001|NOT COMPLETED|Overall Study||4
3212617|NCT02212197|3943159|FG000|STARTED|Overall Study||19
3212618|NCT02212197|3943160|FG001|STARTED|Overall Study||15
3212619|NCT02212197|3943161|FG002|STARTED|Overall Study||17
3212620|NCT02212197|3943159|FG000|COMPLETED|Overall Study||18
3212621|NCT02212197|3943160|FG001|COMPLETED|Overall Study||15
3212622|NCT02212197|3943161|FG002|COMPLETED|Overall Study||17
3212623|NCT02212197|3943159|FG000|NOT COMPLETED|Overall Study||1
3212624|NCT02212197|3943160|FG001|NOT COMPLETED|Overall Study||0
3212625|NCT02212197|3943161|FG002|NOT COMPLETED|Overall Study||0
3212626|NCT02212301|3943169|FG000|STARTED|Period 1||21
3212627|NCT02212301|3943170|FG001|STARTED|Period 1||22
3212628|NCT02212301|3943169|FG000|COMPLETED|Period 1||21
3212629|NCT02212301|3943170|FG001|COMPLETED|Period 1||21
3212630|NCT02212301|3943169|FG000|NOT COMPLETED|Period 1||0
3212631|NCT02212301|3943170|FG001|NOT COMPLETED|Period 1||1
3212632|NCT02212301|3943169|FG000|STARTED|Period 2||21
3212633|NCT02212301|3943170|FG001|STARTED|Period 2||21
3212634|NCT02212301|3943169|FG000|COMPLETED|Period 2||21
3212635|NCT02212301|3943170|FG001|COMPLETED|Period 2||21
3212636|NCT02212301|3943169|FG000|NOT COMPLETED|Period 2||0
3212637|NCT02212301|3943170|FG001|NOT COMPLETED|Period 2||0
3212638|NCT02212379|3943177|FG000|STARTED|From Baseline to Week 48||165
3212639|NCT02212379|3943177|FG000|COMPLETED|From Baseline to Week 48||156
3212640|NCT02212379|3943177|FG000|NOT COMPLETED|From Baseline to Week 48||9
3212641|NCT02212379|3943177|FG000|STARTED|From Week 48 to Week 96||156
3212642|NCT02212379|3943177|FG000|COMPLETED|From Week 48 to Week 96||152
3212643|NCT02212379|3943177|FG000|NOT COMPLETED|From Week 48 to Week 96||4
3212644|NCT02212457|3943190|FG000|STARTED|Overall Study||228
3212645|NCT02212457|3943191|FG001|STARTED|Overall Study||232
3212646|NCT02212457|3943192|FG002|STARTED|Overall Study||157
3212647|NCT02212457|3943193|FG003|STARTED|Overall Study||134
3212648|NCT02212457|3943194|FG004|STARTED|Overall Study||152
3212649|NCT02212457|3943195|FG005|STARTED|Overall Study||160
3212650|NCT02212457|3943190|FG000|COMPLETED|Overall Study||209
3212651|NCT02212457|3943191|FG001|COMPLETED|Overall Study||211
3212652|NCT02212457|3943192|FG002|COMPLETED|Overall Study||141
3212653|NCT02212457|3943193|FG003|COMPLETED|Overall Study||123
3212654|NCT02212457|3943194|FG004|COMPLETED|Overall Study||137
3212655|NCT02212457|3943195|FG005|COMPLETED|Overall Study||147
3212656|NCT02212457|3943190|FG000|NOT COMPLETED|Overall Study||19
3212657|NCT02212457|3943191|FG001|NOT COMPLETED|Overall Study||21
3212658|NCT02212457|3943192|FG002|NOT COMPLETED|Overall Study||16
3212659|NCT02212457|3943193|FG003|NOT COMPLETED|Overall Study||11
3212660|NCT02212457|3943194|FG004|NOT COMPLETED|Overall Study||15
3212661|NCT02212457|3943195|FG005|NOT COMPLETED|Overall Study||13
3212662|NCT02212587|3943216|FG000|STARTED|Overall Study||10
3212663|NCT02212587|3943216|FG000|COMPLETED|Overall Study||9
3212664|NCT02212587|3943216|FG000|NOT COMPLETED|Overall Study||1
3212665|NCT02212678|3943220|FG000|STARTED|Overall Study||8
3212666|NCT02212678|3943220|FG000|COMPLETED|Overall Study||7
3212667|NCT02212678|3943220|FG000|NOT COMPLETED|Overall Study||1
3212668|NCT02212730|3943226|FG000|STARTED|Overall Study||6
3212669|NCT02212730|3943227|FG001|STARTED|Overall Study||4
3212670|NCT02212730|3943226|FG000|Received Neoadjuvant Pembrolizumab|Overall Study||4
3212671|NCT02212730|3943227|FG001|Received Neoadjuvant Pembrolizumab|Overall Study||0
3212672|NCT02212730|3943226|FG000|Underwent RCC|Overall Study||4
3212673|NCT02212730|3943227|FG001|Underwent RCC|Overall Study||3
3212674|NCT02212730|3943226|FG000|Received Post-RCC Pembrolizumab|Overall Study||1
3212675|NCT02212730|3943227|FG001|Received Post-RCC Pembrolizumab|Overall Study||1
3212676|NCT02212730|3943226|FG000|COMPLETED|Overall Study||4
3212677|NCT02212730|3943227|FG001|COMPLETED|Overall Study||3
3212678|NCT02212730|3943226|FG000|NOT COMPLETED|Overall Study||2
3212679|NCT02212730|3943227|FG001|NOT COMPLETED|Overall Study||1
3366713|NCT03901313|4098075|FG002|COMPLETED|Overall Study||4
3366714|NCT03901313|4098076|FG003|COMPLETED|Overall Study||4
3366715|NCT03901313|4098077|FG004|COMPLETED|Overall Study||4
3366716|NCT03901313|4098078|FG005|COMPLETED|Overall Study||4
3366717|NCT03901313|4098073|FG000|NOT COMPLETED|Overall Study||0
3366718|NCT03901313|4098074|FG001|NOT COMPLETED|Overall Study||0
3366719|NCT03901313|4098075|FG002|NOT COMPLETED|Overall Study||0
3366720|NCT03901313|4098076|FG003|NOT COMPLETED|Overall Study||0
3366721|NCT03901313|4098077|FG004|NOT COMPLETED|Overall Study||0
3366722|NCT03901313|4098078|FG005|NOT COMPLETED|Overall Study||0
3366723|NCT03901092|4098086|FG000|STARTED|Overall Study||83
3212680|NCT02212834|3943237|FG000|STARTED|Overall Study||33938
3212681|NCT02212834|3943238|FG001|STARTED|Overall Study||2506
3212682|NCT02212834|3943237|FG000|COMPLETED|Overall Study||33938
3212683|NCT02212834|3943238|FG001|COMPLETED|Overall Study||2506
3212684|NCT02212834|3943237|FG000|NOT COMPLETED|Overall Study||0
3212685|NCT02212834|3943238|FG001|NOT COMPLETED|Overall Study||0
3212686|NCT02212977|3943246|FG000|STARTED|Overall Study||55
3212687|NCT02212977|3943247|FG001|STARTED|Overall Study||54
3212688|NCT02212977|3943246|FG000|COMPLETED|Overall Study||50
3212689|NCT02212977|3943247|FG001|COMPLETED|Overall Study||48
3212690|NCT02212977|3943246|FG000|NOT COMPLETED|Overall Study||5
3212691|NCT02212977|3943247|FG001|NOT COMPLETED|Overall Study||6
3212692|NCT02213042|3943256|FG000|STARTED|Overall Study||17
3212693|NCT02213042|3943257|FG001|STARTED|Overall Study||15
3212694|NCT02213042|3943258|FG002|STARTED|Overall Study||10
3212695|NCT02213042|3943256|FG000|Total Deaths|Overall Study||11
3212696|NCT02213042|3943257|FG001|Total Deaths|Overall Study||9
3212697|NCT02213042|3943258|FG002|Total Deaths|Overall Study||6
3212698|NCT02213042|3943256|FG000|COMPLETED|Overall Study||0
3212699|NCT02213042|3943257|FG001|COMPLETED|Overall Study||0
3212700|NCT02213042|3943258|FG002|COMPLETED|Overall Study||0
3212701|NCT02213042|3943256|FG000|NOT COMPLETED|Overall Study||17
3212702|NCT02213042|3943257|FG001|NOT COMPLETED|Overall Study||15
3212703|NCT02213042|3943258|FG002|NOT COMPLETED|Overall Study||10
3212704|NCT02213055|3943270|FG000|STARTED|Overall Study||97
3212705|NCT02213055|3943271|FG001|STARTED|Overall Study||0
3212706|NCT02213055|3943270|FG000|COMPLETED|Overall Study||58
3212707|NCT02213055|3943271|FG001|COMPLETED|Overall Study||0
3212708|NCT02213055|3943270|FG000|NOT COMPLETED|Overall Study||39
3212709|NCT02213055|3943271|FG001|NOT COMPLETED|Overall Study||0
3212710|NCT02213068|3943280|FG000|STARTED|Overall Study||9
3212711|NCT02213068|3943281|FG001|STARTED|Overall Study||8
3212712|NCT02213068|3943282|FG002|STARTED|Overall Study||10
3212713|NCT02213068|3943280|FG000|COMPLETED|Overall Study||9
3212714|NCT02213068|3943281|FG001|COMPLETED|Overall Study||8
3212715|NCT02213068|3943282|FG002|COMPLETED|Overall Study||10
3212716|NCT02213068|3943280|FG000|NOT COMPLETED|Overall Study||0
3212717|NCT02213068|3943281|FG001|NOT COMPLETED|Overall Study||0
3212718|NCT02213068|3943282|FG002|NOT COMPLETED|Overall Study||0
3212719|NCT02213094|3943292|FG000|STARTED|Overall Study||5
3212720|NCT02213094|3943293|FG001|STARTED|Overall Study||5
3212721|NCT02213094|3943292|FG000|COMPLETED|Overall Study|One subject stopped study agent early because of elevation in LFTs > 3x ULN|4
3212722|NCT02213094|3943293|FG001|COMPLETED|Overall Study||5
3212723|NCT02213094|3943292|FG000|NOT COMPLETED|Overall Study||1
3212724|NCT02213094|3943293|FG001|NOT COMPLETED|Overall Study||0
3212725|NCT02213133|3943302|FG000|STARTED|Overall Study||37
3212726|NCT02213133|3943303|FG001|STARTED|Overall Study||5
3212727|NCT02213133|3943304|FG002|STARTED|Overall Study||3
3212728|NCT02213133|3943302|FG000|Treated|Overall Study||33
3212729|NCT02213133|3943303|FG001|Treated|Overall Study||4
3212730|NCT02213133|3943304|FG002|Treated|Overall Study||1
3212731|NCT02213133|3943302|FG000|COMPLETED|Overall Study||0
3212732|NCT02213133|3943303|FG001|COMPLETED|Overall Study||0
3212733|NCT02213133|3943304|FG002|COMPLETED|Overall Study||0
3212734|NCT02213133|3943302|FG000|NOT COMPLETED|Overall Study||37
3212735|NCT02213133|3943303|FG001|NOT COMPLETED|Overall Study||5
3212736|NCT02213133|3943304|FG002|NOT COMPLETED|Overall Study||3
3212737|NCT02213198|3943315|FG000|STARTED|Baseline||306
3212738|NCT02213198|3943316|FG001|STARTED|Baseline||159
3212739|NCT02213198|3943315|FG000|COMPLETED|Baseline||218
3212740|NCT02213198|3943316|FG001|COMPLETED|Baseline||108
3212741|NCT02213198|3943315|FG000|NOT COMPLETED|Baseline||88
3212742|NCT02213198|3943316|FG001|NOT COMPLETED|Baseline||51
3212743|NCT02213198|3943315|FG000|STARTED|Follow up 1 3 Mos Post BL End of TCC tx||218
3212744|NCT02213198|3943316|FG001|STARTED|Follow up 1 3 Mos Post BL End of TCC tx||108
3212745|NCT02213198|3943315|FG000|COMPLETED|Follow up 1 3 Mos Post BL End of TCC tx||125
3212746|NCT02213198|3943316|FG001|COMPLETED|Follow up 1 3 Mos Post BL End of TCC tx||67
3212747|NCT02213198|3943315|FG000|NOT COMPLETED|Follow up 1 3 Mos Post BL End of TCC tx||93
3212748|NCT02213198|3943316|FG001|NOT COMPLETED|Follow up 1 3 Mos Post BL End of TCC tx||41
3212749|NCT02213198|3943315|FG000|STARTED|Follow up 2 6 Months Post TCC Treatment||125
3212750|NCT02213198|3943316|FG001|STARTED|Follow up 2 6 Months Post TCC Treatment||67
3212751|NCT02213198|3943315|FG000|COMPLETED|Follow up 2 6 Months Post TCC Treatment||102
3212752|NCT02213198|3943316|FG001|COMPLETED|Follow up 2 6 Months Post TCC Treatment||60
3212753|NCT02213198|3943315|FG000|NOT COMPLETED|Follow up 2 6 Months Post TCC Treatment||23
3212754|NCT02213198|3943316|FG001|NOT COMPLETED|Follow up 2 6 Months Post TCC Treatment||7
3212755|NCT02213250|3943322|FG000|STARTED|Overall Study||4
3212756|NCT02213250|3943323|FG001|STARTED|Overall Study||8
3212757|NCT02213250|3943322|FG000|COMPLETED|Overall Study||4
3212758|NCT02213250|3943323|FG001|COMPLETED|Overall Study||8
3212759|NCT02213250|3943322|FG000|NOT COMPLETED|Overall Study||0
3212760|NCT02213250|3943323|FG001|NOT COMPLETED|Overall Study||0
3212761|NCT02213263|3943332|FG000|STARTED|Overall Study||198
3212762|NCT02213263|3943333|FG001|STARTED|Overall Study||196
3212763|NCT02213263|3943332|FG000|Treated|Overall Study||197
3212764|NCT02213263|3943333|FG001|Treated|Overall Study||196
3212765|NCT02213263|3943332|FG000|COMPLETED|Overall Study||170
3212766|NCT02213263|3943333|FG001|COMPLETED|Overall Study||170
3212767|NCT02213263|3943332|FG000|NOT COMPLETED|Overall Study||28
3212768|NCT02213263|3943333|FG001|NOT COMPLETED|Overall Study||26
3212769|NCT02213289|3943341|FG000|STARTED|Overall Study||68
3212770|NCT02213289|3943342|FG001|STARTED|Overall Study||12
3212771|NCT02213289|3943341|FG000|Immuno-oncology|Overall Study||5
3212772|NCT02213289|3943342|FG001|Immuno-oncology|Overall Study||0
3212773|NCT02213289|3943341|FG000|HER2 Amplified|Overall Study||16
3212774|NCT02213289|3943342|FG001|HER2 Amplified|Overall Study||0
3212775|NCT02213289|3943341|FG000|EGFR Amplified|Overall Study||8
3212776|NCT02213289|3943342|FG001|EGFR Amplified|Overall Study||0
3212777|NCT02213289|3943341|FG000|FGFR2 Amplified|Overall Study||1
3212778|NCT02213289|3943342|FG001|FGFR2 Amplified|Overall Study||0
3212779|NCT02213289|3943341|FG000|MAPK/PIK3CA Aberrant|Overall Study||20
3212780|NCT02213289|3943342|FG001|MAPK/PIK3CA Aberrant|Overall Study||0
3212781|NCT02213289|3943341|FG000|EGFR Expressing|Overall Study||9
3212782|NCT02213289|3943342|FG001|EGFR Expressing|Overall Study||0
3212783|NCT02213289|3943341|FG000|All Negative|Overall Study||9
3212784|NCT02213289|3943342|FG001|All Negative|Overall Study||0
3212785|NCT02213289|3943341|FG000|Other (Non-ITT)|Overall Study||0
3212786|NCT02213289|3943342|FG001|Other (Non-ITT)|Overall Study||12
3212787|NCT02213289|3943341|FG000|COMPLETED|Overall Study||68
3212788|NCT02213289|3943342|FG001|COMPLETED|Overall Study||12
3212789|NCT02213289|3943341|FG000|NOT COMPLETED|Overall Study||0
3212790|NCT02213289|3943342|FG001|NOT COMPLETED|Overall Study||0
3212791|NCT02213380|3943354|FG000|STARTED|Underwent Randomization||476
3212792|NCT02213380|3943355|FG001|STARTED|Underwent Randomization||474
3212793|NCT02213380|3943354|FG000|COMPLETED|Underwent Randomization||471
3212794|NCT02213380|3943355|FG001|COMPLETED|Underwent Randomization||471
3212795|NCT02213380|3943354|FG000|NOT COMPLETED|Underwent Randomization||5
3212796|NCT02213380|3943355|FG001|NOT COMPLETED|Underwent Randomization||3
3212797|NCT02213380|3943354|FG000|STARTED|Per-protocol Analysis||471
3212798|NCT02213380|3943355|FG001|STARTED|Per-protocol Analysis||471
3212799|NCT02213380|3943354|FG000|COMPLETED|Per-protocol Analysis||439
3212800|NCT02213380|3943355|FG001|COMPLETED|Per-protocol Analysis||435
3212801|NCT02213380|3943354|FG000|NOT COMPLETED|Per-protocol Analysis||32
3212802|NCT02213380|3943355|FG001|NOT COMPLETED|Per-protocol Analysis||36
3212803|NCT02213458|3943363|FG000|STARTED|Overall Study||1024
3212804|NCT02213458|3943364|FG001|STARTED|Overall Study||536
3212805|NCT02213458|3943363|FG000|COMPLETED|Overall Study||970
3212806|NCT02213458|3943364|FG001|COMPLETED|Overall Study||526
3212807|NCT02213458|3943363|FG000|NOT COMPLETED|Overall Study||54
3212808|NCT02213458|3943364|FG001|NOT COMPLETED|Overall Study||10
3212809|NCT02213510|3943372|FG000|STARTED|Overall Study||21
3212810|NCT02213510|3943373|FG001|STARTED|Overall Study||19
3212811|NCT02213510|3943372|FG000|COMPLETED|Overall Study||20
3212812|NCT02213510|3943373|FG001|COMPLETED|Overall Study||18
3212813|NCT02213510|3943372|FG000|NOT COMPLETED|Overall Study||1
3212814|NCT02213510|3943373|FG001|NOT COMPLETED|Overall Study||1
3212815|NCT02213666|3943379|FG000|STARTED|Overall Study||72
3212816|NCT02213666|3943379|FG000|COMPLETED|Overall Study||71
3212817|NCT02213666|3943379|FG000|NOT COMPLETED|Overall Study||1
3212818|NCT02213900|3943385|FG000|STARTED|Overall Study||68
3212819|NCT02213900|3943386|FG001|STARTED|Overall Study||67
3212820|NCT02213900|3943385|FG000|COMPLETED|Overall Study||68
3212821|NCT02213900|3943386|FG001|COMPLETED|Overall Study||67
3212822|NCT02213900|3943385|FG000|NOT COMPLETED|Overall Study||0
3212823|NCT02213900|3943386|FG001|NOT COMPLETED|Overall Study||0
3212824|NCT02214017|3943394|FG000|STARTED|Overall Study||22
3212825|NCT02214017|3943395|FG001|STARTED|Overall Study||18
3212826|NCT02214017|3943394|FG000|COMPLETED|Overall Study||22
3212827|NCT02214017|3943395|FG001|COMPLETED|Overall Study||18
3212828|NCT02214017|3943394|FG000|NOT COMPLETED|Overall Study||0
3212829|NCT02214017|3943395|FG001|NOT COMPLETED|Overall Study||0
3212830|NCT02214121|3943404|FG000|STARTED|Part A||46
3212831|NCT02214121|3943405|FG001|STARTED|Part A||0
3212832|NCT02214121|3943406|FG002|STARTED|Part A||0
3212833|NCT02214121|3943404|FG000|COMPLETED|Part A||39
3212834|NCT02214121|3943405|FG001|COMPLETED|Part A||0
3212835|NCT02214121|3943406|FG002|COMPLETED|Part A||0
3212836|NCT02214121|3943404|FG000|NOT COMPLETED|Part A||7
3212837|NCT02214121|3943405|FG001|NOT COMPLETED|Part A||0
3212838|NCT02214121|3943406|FG002|NOT COMPLETED|Part A||0
3212839|NCT02214121|3943404|FG000|STARTED|Part B||0
3212840|NCT02214121|3943405|FG001|STARTED|Part B||17
3212841|NCT02214121|3943406|FG002|STARTED|Part B||8
3212842|NCT02214121|3943404|FG000|COMPLETED|Part B||0
3212843|NCT02214121|3943405|FG001|COMPLETED|Part B||14
3212844|NCT02214121|3943406|FG002|COMPLETED|Part B||7
3212845|NCT02214121|3943404|FG000|NOT COMPLETED|Part B||0
3212846|NCT02214121|3943405|FG001|NOT COMPLETED|Part B||3
3212847|NCT02214121|3943406|FG002|NOT COMPLETED|Part B||1
3212848|NCT02214147|3943429|FG000|STARTED|Overall Study||16
3212849|NCT02214147|3943430|FG001|STARTED|Overall Study||12
3212850|NCT02214147|3943431|FG002|STARTED|Overall Study||8
3212851|NCT02214147|3943429|FG000|COMPLETED|Overall Study||16
3212852|NCT02214147|3943430|FG001|COMPLETED|Overall Study||12
3212853|NCT02214147|3943431|FG002|COMPLETED|Overall Study||8
3212854|NCT02214147|3943429|FG000|NOT COMPLETED|Overall Study||0
3212855|NCT02214147|3943430|FG001|NOT COMPLETED|Overall Study||0
3212856|NCT02214147|3943431|FG002|NOT COMPLETED|Overall Study||0
3212857|NCT02214186|3943441|FG000|STARTED|Overall Study||23
3212858|NCT02214186|3943442|FG001|STARTED|Overall Study||23
3212859|NCT02214186|3943441|FG000|COMPLETED|Overall Study||21
3212860|NCT02214186|3943442|FG001|COMPLETED|Overall Study||21
3212861|NCT02214186|3943441|FG000|NOT COMPLETED|Overall Study||2
3212862|NCT02214186|3943442|FG001|NOT COMPLETED|Overall Study||2
3212863|NCT02214212|3943450|FG000|STARTED|Overall Study||66
3212864|NCT02214212|3943451|FG001|STARTED|Overall Study||65
3212865|NCT02214212|3943450|FG000|COMPLETED|Overall Study||57
3212866|NCT02214212|3943451|FG001|COMPLETED|Overall Study||59
3212867|NCT02214212|3943450|FG000|NOT COMPLETED|Overall Study||9
3212868|NCT02214212|3943451|FG001|NOT COMPLETED|Overall Study||6
3212869|NCT02214225|3943465|FG000|STARTED|Overall Study||1741
3212870|NCT02214225|3943466|FG001|STARTED|Overall Study||871
3212871|NCT02214225|3943467|FG002|STARTED|Overall Study||872
3212872|NCT02214225|3943465|FG000|COMPLETED|Overall Study||1686
3212873|NCT02214225|3943466|FG001|COMPLETED|Overall Study||852
3212874|NCT02214225|3943467|FG002|COMPLETED|Overall Study||850
3212875|NCT02214225|3943465|FG000|NOT COMPLETED|Overall Study||55
3212876|NCT02214225|3943466|FG001|NOT COMPLETED|Overall Study||19
3212877|NCT02214225|3943467|FG002|NOT COMPLETED|Overall Study||22
3212878|NCT02214238|3943500|FG000|STARTED|Overall Study||26
3212879|NCT02214238|3943501|FG001|STARTED|Overall Study||23
3212880|NCT02214238|3943500|FG000|COMPLETED|Overall Study||20
3212881|NCT02214238|3943501|FG001|COMPLETED|Overall Study||17
3212882|NCT02214238|3943500|FG000|NOT COMPLETED|Overall Study||6
3212883|NCT02214238|3943501|FG001|NOT COMPLETED|Overall Study||6
3212884|NCT02214277|3943510|FG000|STARTED|Overall Study||123
3212885|NCT02214277|3943511|FG001|STARTED|Overall Study||121
3212886|NCT02214277|3943512|FG002|STARTED|Overall Study||119
3212887|NCT02214277|3943510|FG000|COMPLETED|Overall Study||104
3212888|NCT02214277|3943511|FG001|COMPLETED|Overall Study||96
3212889|NCT02214277|3943512|FG002|COMPLETED|Overall Study||85
3212890|NCT02214277|3943510|FG000|NOT COMPLETED|Overall Study||19
3212891|NCT02214277|3943511|FG001|NOT COMPLETED|Overall Study||25
3212892|NCT02214277|3943512|FG002|NOT COMPLETED|Overall Study||34
3212893|NCT02214290|3943519|FG000|STARTED|First Intervention (7 Days)||8
3212894|NCT02214290|3943520|FG001|STARTED|First Intervention (7 Days)||8
3212895|NCT02214290|3943519|FG000|COMPLETED|First Intervention (7 Days)||8
3212896|NCT02214290|3943520|FG001|COMPLETED|First Intervention (7 Days)||8
3212897|NCT02214290|3943519|FG000|NOT COMPLETED|First Intervention (7 Days)||0
3212898|NCT02214290|3943520|FG001|NOT COMPLETED|First Intervention (7 Days)||0
3212899|NCT02214290|3943519|FG000|STARTED|Washout (14 Days)||8
3212900|NCT02214290|3943520|FG001|STARTED|Washout (14 Days)||8
3212901|NCT02214290|3943519|FG000|COMPLETED|Washout (14 Days)||8
3212902|NCT02214290|3943520|FG001|COMPLETED|Washout (14 Days)||8
3212903|NCT02214290|3943519|FG000|NOT COMPLETED|Washout (14 Days)||0
3212904|NCT02214290|3943520|FG001|NOT COMPLETED|Washout (14 Days)||0
3212905|NCT02214290|3943519|FG000|STARTED|Second Intervention (7 Days)||8
3212906|NCT02214290|3943520|FG001|STARTED|Second Intervention (7 Days)||8
3212907|NCT02214290|3943519|FG000|COMPLETED|Second Intervention (7 Days)||8
3212908|NCT02214290|3943520|FG001|COMPLETED|Second Intervention (7 Days)||8
3212909|NCT02214290|3943519|FG000|NOT COMPLETED|Second Intervention (7 Days)||0
3212910|NCT02214290|3943520|FG001|NOT COMPLETED|Second Intervention (7 Days)||0
3212911|NCT02214420|3943531|FG000|STARTED|Overall Study||14
3212912|NCT02214420|3943532|FG001|STARTED|Overall Study||10
3212913|NCT02214420|3943531|FG000|COMPLETED|Overall Study||13
3212914|NCT02214420|3943532|FG001|COMPLETED|Overall Study||10
3212915|NCT02214420|3943531|FG000|NOT COMPLETED|Overall Study||1
3212916|NCT02214420|3943532|FG001|NOT COMPLETED|Overall Study||0
3212917|NCT02214615|3943540|FG000|STARTED|First Intervention||1
3212918|NCT02214615|3943541|FG001|STARTED|First Intervention||1
3212919|NCT02214615|3943540|FG000|COMPLETED|First Intervention||1
3212920|NCT02214615|3943541|FG001|COMPLETED|First Intervention||1
3212921|NCT02214615|3943540|FG000|NOT COMPLETED|First Intervention||0
3212922|NCT02214615|3943541|FG001|NOT COMPLETED|First Intervention||0
3212923|NCT02214615|3943540|FG000|STARTED|Washout||1
3212924|NCT02214615|3943541|FG001|STARTED|Washout||1
3212925|NCT02214615|3943540|FG000|COMPLETED|Washout||1
3212926|NCT02214615|3943541|FG001|COMPLETED|Washout||1
3212927|NCT02214615|3943540|FG000|NOT COMPLETED|Washout||0
3212928|NCT02214615|3943541|FG001|NOT COMPLETED|Washout||0
3212929|NCT02214615|3943540|FG000|STARTED|Second Intervention||1
3212930|NCT02214615|3943541|FG001|STARTED|Second Intervention||1
3212931|NCT02214615|3943540|FG000|COMPLETED|Second Intervention||1
3212932|NCT02214615|3943541|FG001|COMPLETED|Second Intervention||1
3212933|NCT02214615|3943540|FG000|NOT COMPLETED|Second Intervention||0
3212934|NCT02214615|3943541|FG001|NOT COMPLETED|Second Intervention||0
3212935|NCT02214628|3943549|FG000|STARTED|Overall Study||63
3212936|NCT02214628|3943550|FG001|STARTED|Overall Study||38
3212937|NCT02214628|3943549|FG000|COMPLETED|Overall Study||36
3212938|NCT02214628|3943550|FG001|COMPLETED|Overall Study||9
3212939|NCT02214628|3943549|FG000|NOT COMPLETED|Overall Study||27
3212940|NCT02214628|3943550|FG001|NOT COMPLETED|Overall Study||29
3212941|NCT02215070|3943560|FG000|STARTED|Overall Study||26
3212942|NCT02215070|3943561|FG001|STARTED|Overall Study||52
3212943|NCT02215070|3943560|FG000|COMPLETED|Overall Study||20
3212944|NCT02215070|3943561|FG001|COMPLETED|Overall Study||52
3212945|NCT02215070|3943560|FG000|NOT COMPLETED|Overall Study||6
3212946|NCT02215070|3943561|FG001|NOT COMPLETED|Overall Study||0
3212947|NCT02215161|3943567|FG000|STARTED|Overall Study||14
3212948|NCT02215161|3943567|FG000|COMPLETED|Overall Study||14
3212949|NCT02215161|3943567|FG000|NOT COMPLETED|Overall Study||0
3212950|NCT02215200|3943582|FG000|STARTED|Overall Study||29
3212951|NCT02215200|3943583|FG001|STARTED|Overall Study||29
3212952|NCT02215200|3943584|FG002|STARTED|Overall Study||31
3212953|NCT02215200|3943582|FG000|COMPLETED|Overall Study||29
3212954|NCT02215200|3943583|FG001|COMPLETED|Overall Study||28
3212955|NCT02215200|3943584|FG002|COMPLETED|Overall Study||30
3212956|NCT02215200|3943582|FG000|NOT COMPLETED|Overall Study||0
3212957|NCT02215200|3943583|FG001|NOT COMPLETED|Overall Study||1
3212958|NCT02215200|3943584|FG002|NOT COMPLETED|Overall Study||1
3212959|NCT02215252|3943595|FG000|STARTED|Overall Study||44
3212960|NCT02215252|3943596|FG001|STARTED|Overall Study||46
3212961|NCT02215252|3943597|FG002|STARTED|Overall Study||45
3212962|NCT02215252|3943595|FG000|COMPLETED|Overall Study||42
3212963|NCT02215252|3943596|FG001|COMPLETED|Overall Study||38
3212964|NCT02215252|3943597|FG002|COMPLETED|Overall Study||41
3212965|NCT02215252|3943595|FG000|NOT COMPLETED|Overall Study||2
3212966|NCT02215252|3943596|FG001|NOT COMPLETED|Overall Study||8
3212967|NCT02215252|3943597|FG002|NOT COMPLETED|Overall Study||4
3212968|NCT02215369|3943605|FG000|STARTED|Overall Study||112
3212969|NCT02215369|3943605|FG000|COMPLETED|Overall Study||70
3212970|NCT02215369|3943605|FG000|NOT COMPLETED|Overall Study||42
3212971|NCT02215616|3943613|FG000|STARTED|Overall Study||108
3212972|NCT02215616|3943614|FG001|STARTED|Overall Study||107
3212973|NCT02215616|3943615|FG002|STARTED|Overall Study||107
3212974|NCT02215616|3943616|FG003|STARTED|Overall Study||30
3212975|NCT02215616|3943613|FG000|Received at Least 1 Dose of Study Drug|Overall Study||108
3212976|NCT02215616|3943614|FG001|Received at Least 1 Dose of Study Drug|Overall Study||107
3212977|NCT02215616|3943615|FG002|Received at Least 1 Dose of Study Drug|Overall Study||106
3212978|NCT02215616|3943616|FG003|Received at Least 1 Dose of Study Drug|Overall Study||29
3212979|NCT02215616|3943613|FG000|COMPLETED|Overall Study||97
3212980|NCT02215616|3943614|FG001|COMPLETED|Overall Study||90
3212981|NCT02215616|3943615|FG002|COMPLETED|Overall Study||93
3212982|NCT02215616|3943616|FG003|COMPLETED|Overall Study||17
3212983|NCT02215616|3943613|FG000|NOT COMPLETED|Overall Study||11
3212984|NCT02215616|3943614|FG001|NOT COMPLETED|Overall Study||17
3212985|NCT02215616|3943615|FG002|NOT COMPLETED|Overall Study||14
3212986|NCT02215616|3943616|FG003|NOT COMPLETED|Overall Study||13
3212987|NCT02215954|3943629|FG000|STARTED|Overall Study||214
3212988|NCT02215954|3943630|FG001|STARTED|Overall Study||212
3212989|NCT02215954|3943631|FG002|STARTED|Overall Study||211
3212990|NCT02215954|3943629|FG000|Intention-To-Treat (ITT) Analysis Set|Overall Study||214
3212991|NCT02215954|3943630|FG001|Intention-To-Treat (ITT) Analysis Set|Overall Study||212
3212992|NCT02215954|3943631|FG002|Intention-To-Treat (ITT) Analysis Set|Overall Study||211
3212993|NCT02215954|3943629|FG000|Per Protocol (PP) Analysis Set|Overall Study||212
3212994|NCT02215954|3943630|FG001|Per Protocol (PP) Analysis Set|Overall Study||208
3212995|NCT02215954|3943631|FG002|Per Protocol (PP) Analysis Set|Overall Study||205
3212996|NCT02215954|3943629|FG000|Safety Analysis Set|Overall Study||213
3212997|NCT02215954|3943630|FG001|Safety Analysis Set|Overall Study||211
3212998|NCT02215954|3943631|FG002|Safety Analysis Set|Overall Study||208
3212999|NCT02215954|3943629|FG000|COMPLETED|Overall Study||213
3213000|NCT02215954|3943630|FG001|COMPLETED|Overall Study||211
3213001|NCT02215954|3943631|FG002|COMPLETED|Overall Study||205
3213002|NCT02215954|3943629|FG000|NOT COMPLETED|Overall Study||1
3213003|NCT02215954|3943630|FG001|NOT COMPLETED|Overall Study||1
3213004|NCT02215954|3943631|FG002|NOT COMPLETED|Overall Study||6
3213005|NCT02215967|3943644|FG000|STARTED|Overall Study||3
3213006|NCT02215967|3943645|FG001|STARTED|Overall Study||3
3213007|NCT02215967|3943646|FG002|STARTED|Overall Study||5
3213008|NCT02215967|3943647|FG003|STARTED|Overall Study||19
3213009|NCT02215967|3943644|FG000|COMPLETED|Overall Study||3
3213010|NCT02215967|3943645|FG001|COMPLETED|Overall Study||3
3213011|NCT02215967|3943646|FG002|COMPLETED|Overall Study||4
3213012|NCT02215967|3943647|FG003|COMPLETED|Overall Study||16
3213013|NCT02215967|3943644|FG000|NOT COMPLETED|Overall Study||0
3213014|NCT02215967|3943645|FG001|NOT COMPLETED|Overall Study||0
3213015|NCT02215967|3943646|FG002|NOT COMPLETED|Overall Study||1
3213016|NCT02215967|3943647|FG003|NOT COMPLETED|Overall Study||3
3213017|NCT02216071|3943659|FG000|STARTED|Overall Study||254
3213018|NCT02216071|3943660|FG001|STARTED|Overall Study||245
3213019|NCT02216071|3943659|FG000|COMPLETED|Overall Study||239
3213020|NCT02216071|3943660|FG001|COMPLETED|Overall Study||233
3213021|NCT02216071|3943659|FG000|NOT COMPLETED|Overall Study||15
3213022|NCT02216071|3943660|FG001|NOT COMPLETED|Overall Study||12
3213023|NCT02216097|3943668|FG000|STARTED|Overall Study||8
3213024|NCT02216097|3943669|FG001|STARTED|Overall Study||6
3213025|NCT02216097|3943668|FG000|COMPLETED|Overall Study||8
3213026|NCT02216097|3943669|FG001|COMPLETED|Overall Study||6
3213027|NCT02216097|3943668|FG000|NOT COMPLETED|Overall Study||0
3213028|NCT02216097|3943669|FG001|NOT COMPLETED|Overall Study||0
3213029|NCT02216123|3943677|FG000|STARTED|Overall Study||166
3213030|NCT02216123|3943678|FG001|STARTED|Overall Study||85
3213031|NCT02216123|3943677|FG000|COMPLETED|Overall Study||160
3213032|NCT02216123|3943678|FG001|COMPLETED|Overall Study||83
3213033|NCT02216123|3943677|FG000|NOT COMPLETED|Overall Study||6
3213034|NCT02216123|3943678|FG001|NOT COMPLETED|Overall Study||2
3213035|NCT02216136|3943691|FG000|STARTED|Overall Study||72
3213036|NCT02216136|3943692|FG001|STARTED|Overall Study||90
3213037|NCT02216136|3943693|FG002|STARTED|Overall Study||0
3213038|NCT02216136|3943691|FG000|COMPLETED|Overall Study||72
3213039|NCT02216136|3943692|FG001|COMPLETED|Overall Study||90
3213040|NCT02216136|3943693|FG002|COMPLETED|Overall Study||0
3213041|NCT02216136|3943691|FG000|NOT COMPLETED|Overall Study||0
3213042|NCT02216136|3943692|FG001|NOT COMPLETED|Overall Study||0
3213043|NCT02216136|3943693|FG002|NOT COMPLETED|Overall Study||0
3213044|NCT02216214|3943703|FG000|STARTED|Overall Study||443
3213045|NCT02216214|3943704|FG001|STARTED|Overall Study||445
3213046|NCT02216214|3943703|FG000|Treated|Overall Study||442
3213047|NCT02216214|3943704|FG001|Treated|Overall Study||445
3213048|NCT02216214|3943703|FG000|COMPLETED|Overall Study||400
3213049|NCT02216214|3943704|FG001|COMPLETED|Overall Study||409
3213050|NCT02216214|3943703|FG000|NOT COMPLETED|Overall Study||43
3213051|NCT02216214|3943704|FG001|NOT COMPLETED|Overall Study||36
3213052|NCT02216357|3943712|FG000|STARTED|Overall Study||14
3213053|NCT02216357|3943713|FG001|STARTED|Overall Study||5
3213054|NCT02216357|3943712|FG000|COMPLETED|Overall Study||12
3213055|NCT02216357|3943713|FG001|COMPLETED|Overall Study||4
3213056|NCT02216357|3943712|FG000|NOT COMPLETED|Overall Study||2
3213057|NCT02216357|3943713|FG001|NOT COMPLETED|Overall Study||1
3213058|NCT02216422|3943719|FG000|STARTED|Overall Study||36
3213059|NCT02216422|3943719|FG000|COMPLETED|Overall Study||36
3213060|NCT02216422|3943719|FG000|NOT COMPLETED|Overall Study||0
3213061|NCT02216526|3943726|FG000|STARTED|Overall Study||45
3213062|NCT02216526|3943727|FG001|STARTED|Overall Study||44
3213063|NCT02216526|3943728|FG002|STARTED|Overall Study||44
3213064|NCT02216526|3943726|FG000|COMPLETED|Overall Study||40
3213065|NCT02216526|3943727|FG001|COMPLETED|Overall Study||41
3213066|NCT02216526|3943728|FG002|COMPLETED|Overall Study||36
3213067|NCT02216526|3943726|FG000|NOT COMPLETED|Overall Study||5
3213068|NCT02216526|3943727|FG001|NOT COMPLETED|Overall Study||3
3213069|NCT02216526|3943728|FG002|NOT COMPLETED|Overall Study||8
3213070|NCT02216591|3943738|FG000|STARTED|Overall Study||11
3213071|NCT02216591|3943739|FG001|STARTED|Overall Study||10
3213072|NCT02216591|3943738|FG000|COMPLETED|Overall Study||11
3213073|NCT02216591|3943739|FG001|COMPLETED|Overall Study||9
3213074|NCT02216591|3943738|FG000|NOT COMPLETED|Overall Study||0
3213075|NCT02216591|3943739|FG001|NOT COMPLETED|Overall Study||1
3213076|NCT02216695|3943745|FG000|STARTED|Overall Study||64882
3213077|NCT02216695|3943745|FG000|COMPLETED|Overall Study|This is a database study and hence, 64882 patients were finally included|64882
3213078|NCT02216695|3943745|FG000|NOT COMPLETED|Overall Study||0
3213079|NCT02216773|3943756|FG000|STARTED|Overall Study||28
3213080|NCT02216773|3943757|FG001|STARTED|Overall Study||29
3213081|NCT02216773|3943756|FG000|Underwent Procedure (PVE/RALPPS)|Overall Study||24
3213082|NCT02216773|3943757|FG001|Underwent Procedure (PVE/RALPPS)|Overall Study||26
3213083|NCT02216773|3943756|FG000|COMPLETED|Overall Study||16
3213084|NCT02216773|3943757|FG001|COMPLETED|Overall Study||24
3213085|NCT02216773|3943756|FG000|NOT COMPLETED|Overall Study||12
3213086|NCT02216773|3943757|FG001|NOT COMPLETED|Overall Study||5
3213087|NCT02216812|3943765|FG000|STARTED|Overall Study||67
3213088|NCT02216812|3943766|FG001|STARTED|Overall Study||67
3213089|NCT02216812|3943765|FG000|COMPLETED|Overall Study||57
3213090|NCT02216812|3943766|FG001|COMPLETED|Overall Study||62
3213091|NCT02216812|3943765|FG000|NOT COMPLETED|Overall Study||10
3213092|NCT02216812|3943766|FG001|NOT COMPLETED|Overall Study||5
3213093|NCT02216851|3943774|FG000|STARTED|Overall Study||98
3213094|NCT02216851|3943775|FG001|STARTED|Overall Study||33
3213095|NCT02216851|3943774|FG000|COMPLETED|Overall Study||96
3213096|NCT02216851|3943775|FG001|COMPLETED|Overall Study||32
3213097|NCT02216851|3943774|FG000|NOT COMPLETED|Overall Study||2
3213098|NCT02216851|3943775|FG001|NOT COMPLETED|Overall Study||1
3213099|NCT02217280|3943781|FG000|STARTED|Overall Study||20
3213100|NCT02217280|3943781|FG000|COMPLETED|Overall Study||16
3213101|NCT02217280|3943781|FG000|NOT COMPLETED|Overall Study||4
3213102|NCT02217332|3943786|FG000|STARTED|Overall Study|Safety Population|20
3213103|NCT02217332|3943786|FG000|COMPLETED|Overall Study|Subjects who continued to optional open-label treatment|13
3213104|NCT02217332|3943786|FG000|NOT COMPLETED|Overall Study||7
3213105|NCT02217410|3943793|FG000|STARTED|Overall Study||7
3213106|NCT02217410|3943794|FG001|STARTED|Overall Study||34
3213107|NCT02217410|3943795|FG002|STARTED|Overall Study||18
3213108|NCT02217410|3943793|FG000|COMPLETED|Overall Study||6
3213109|NCT02217410|3943794|FG001|COMPLETED|Overall Study||30
3213110|NCT02217410|3943795|FG002|COMPLETED|Overall Study||13
3213111|NCT02217410|3943793|FG000|NOT COMPLETED|Overall Study||1
3213112|NCT02217410|3943794|FG001|NOT COMPLETED|Overall Study||4
3213113|NCT02217410|3943795|FG002|NOT COMPLETED|Overall Study||5
3213114|NCT02217436|3943810|FG000|STARTED|Overall Study||40
3213115|NCT02217436|3943811|FG001|STARTED|Overall Study||40
3213116|NCT02217436|3943810|FG000|COMPLETED|Overall Study||39
3213117|NCT02217436|3943811|FG001|COMPLETED|Overall Study||38
3213118|NCT02217436|3943810|FG000|NOT COMPLETED|Overall Study||1
3213119|NCT02217436|3943811|FG001|NOT COMPLETED|Overall Study||2
3213120|NCT02217475|3943820|FG000|STARTED|Treatment Period 1 (Year 1)||72
3213121|NCT02217475|3943821|FG001|STARTED|Treatment Period 1 (Year 1)||72
3213122|NCT02217475|3943822|FG002|STARTED|Treatment Period 1 (Year 1)||145
3213123|NCT02217475|3943820|FG000|Safety Analysis Set|Treatment Period 1 (Year 1)||72
3213124|NCT02217475|3943821|FG001|Safety Analysis Set|Treatment Period 1 (Year 1)||72
3213125|NCT02217475|3943822|FG002|Safety Analysis Set|Treatment Period 1 (Year 1)||144
3213126|NCT02217475|3943820|FG000|COMPLETED|Treatment Period 1 (Year 1)||62
3213127|NCT02217475|3943821|FG001|COMPLETED|Treatment Period 1 (Year 1)||64
3213128|NCT02217475|3943822|FG002|COMPLETED|Treatment Period 1 (Year 1)||124
3213129|NCT02217475|3943820|FG000|NOT COMPLETED|Treatment Period 1 (Year 1)||10
3213130|NCT02217475|3943821|FG001|NOT COMPLETED|Treatment Period 1 (Year 1)||8
3213131|NCT02217475|3943822|FG002|NOT COMPLETED|Treatment Period 1 (Year 1)||21
3213132|NCT02217475|3943820|FG000|STARTED|Discontinued After Period 1||62
3213133|NCT02217475|3943821|FG001|STARTED|Discontinued After Period 1||64
3213134|NCT02217475|3943822|FG002|STARTED|Discontinued After Period 1||124
3213135|NCT02217475|3943820|FG000|COMPLETED|Discontinued After Period 1||60
3213136|NCT02217475|3943821|FG001|COMPLETED|Discontinued After Period 1||61
3213137|NCT02217475|3943822|FG002|COMPLETED|Discontinued After Period 1||121
3213138|NCT02217475|3943820|FG000|NOT COMPLETED|Discontinued After Period 1||2
3213139|NCT02217475|3943821|FG001|NOT COMPLETED|Discontinued After Period 1||3
3213140|NCT02217475|3943822|FG002|NOT COMPLETED|Discontinued After Period 1||3
3213141|NCT02217475|3943820|FG000|STARTED|Treatment Period 2 (Year 2)||60
3213142|NCT02217475|3943821|FG001|STARTED|Treatment Period 2 (Year 2)||61
3213143|NCT02217475|3943822|FG002|STARTED|Treatment Period 2 (Year 2)||121
3213144|NCT02217475|3943820|FG000|COMPLETED|Treatment Period 2 (Year 2)||58
3213145|NCT02217475|3943821|FG001|COMPLETED|Treatment Period 2 (Year 2)||59
3213146|NCT02217475|3943822|FG002|COMPLETED|Treatment Period 2 (Year 2)||109
3213147|NCT02217475|3943820|FG000|NOT COMPLETED|Treatment Period 2 (Year 2)||2
3213148|NCT02217475|3943821|FG001|NOT COMPLETED|Treatment Period 2 (Year 2)||2
3213149|NCT02217475|3943822|FG002|NOT COMPLETED|Treatment Period 2 (Year 2)||12
3213150|NCT02217501|3943841|FG000|STARTED|Overall Study||77
3213151|NCT02217501|3943842|FG001|STARTED|Overall Study||82
3213152|NCT02217501|3943841|FG000|COMPLETED|Overall Study||74
3213153|NCT02217501|3943842|FG001|COMPLETED|Overall Study||78
3213154|NCT02217501|3943841|FG000|NOT COMPLETED|Overall Study||3
3213155|NCT02217501|3943842|FG001|NOT COMPLETED|Overall Study||4
3213156|NCT02217527|3943850|FG000|STARTED|Drug Condition 1: First Study Phase||18
3213157|NCT02217527|3943851|FG001|STARTED|Drug Condition 1: First Study Phase||18
3213158|NCT02217527|3943850|FG000|COMPLETED|Drug Condition 1: First Study Phase||17
3213159|NCT02217527|3943851|FG001|COMPLETED|Drug Condition 1: First Study Phase||15
3213160|NCT02217527|3943850|FG000|NOT COMPLETED|Drug Condition 1: First Study Phase||1
3213161|NCT02217527|3943851|FG001|NOT COMPLETED|Drug Condition 1: First Study Phase||3
3213162|NCT02217527|3943850|FG000|STARTED|Drug Condition 2: Second Study Phase||17
3213163|NCT02217527|3943851|FG001|STARTED|Drug Condition 2: Second Study Phase||15
3213164|NCT02217527|3943850|FG000|COMPLETED|Drug Condition 2: Second Study Phase||17
3213165|NCT02217527|3943851|FG001|COMPLETED|Drug Condition 2: Second Study Phase||14
3213166|NCT02217527|3943850|FG000|NOT COMPLETED|Drug Condition 2: Second Study Phase||0
3213167|NCT02217527|3943851|FG001|NOT COMPLETED|Drug Condition 2: Second Study Phase||1
3213168|NCT02217566|3943857|FG000|STARTED|Overall Study||46
3213169|NCT02217566|3943857|FG000|COMPLETED|Overall Study||35
3213170|NCT02217566|3943857|FG000|NOT COMPLETED|Overall Study||11
3213171|NCT02217618|3943861|FG000|STARTED|Overall Study||16
3213172|NCT02217618|3943861|FG000|Received Study Drug|Overall Study||16
3366724|NCT03901092|4098087|FG001|STARTED|Overall Study||159
3366725|NCT03901092|4098086|FG000|COMPLETED|Overall Study||83
3366726|NCT03901092|4098087|FG001|COMPLETED|Overall Study||159
3366727|NCT03901092|4098086|FG000|NOT COMPLETED|Overall Study||0
3366728|NCT03901092|4098087|FG001|NOT COMPLETED|Overall Study||0
3366729|NCT03895034|4098101|FG000|STARTED|Overall Study||66
3366730|NCT03895034|4098101|FG000|COMPLETED|Overall Study||64
3366731|NCT03895034|4098101|FG000|NOT COMPLETED|Overall Study||2
3366732|NCT03900728|4098108|FG000|STARTED|Overall Study||40
3366733|NCT03900728|4098109|FG001|STARTED|Overall Study||57
3366734|NCT03900728|4098110|FG002|STARTED|Overall Study||39
3366735|NCT03900728|4098108|FG000|COMPLETED|Overall Study||40
3366736|NCT03900728|4098109|FG001|COMPLETED|Overall Study||57
3366737|NCT03900728|4098110|FG002|COMPLETED|Overall Study||35
3366738|NCT03900728|4098108|FG000|NOT COMPLETED|Overall Study||0
3366739|NCT03900728|4098109|FG001|NOT COMPLETED|Overall Study||0
3366740|NCT03900728|4098110|FG002|NOT COMPLETED|Overall Study||4
3366741|NCT03900299|4098120|FG000|STARTED|Overall Study||56
3366742|NCT03900299|4098121|FG001|STARTED|Overall Study||58
3366743|NCT03900299|4098120|FG000|COMPLETED|Overall Study||56
3366744|NCT03900299|4098121|FG001|COMPLETED|Overall Study||58
3366745|NCT03900299|4098120|FG000|NOT COMPLETED|Overall Study||0
3366746|NCT03900299|4098121|FG001|NOT COMPLETED|Overall Study||0
3366747|NCT03898349|4098130|FG000|STARTED|Overall Study||125
3366748|NCT03898349|4098131|FG001|STARTED|Overall Study||625
3366749|NCT03898349|4098130|FG000|COMPLETED|Overall Study||15
3366750|NCT03898349|4098131|FG001|COMPLETED|Overall Study||15
3366751|NCT03898349|4098130|FG000|NOT COMPLETED|Overall Study||110
3366752|NCT03898349|4098131|FG001|NOT COMPLETED|Overall Study||610
3366753|NCT03897634|4098137|FG000|STARTED|Overall Study||22
3366754|NCT03897634|4098137|FG000|COMPLETED|Overall Study||22
3366755|NCT03897634|4098137|FG000|NOT COMPLETED|Overall Study||0
3366756|NCT03895372|4098149|FG000|STARTED|Investigational Treatment Period||23
3366757|NCT03895372|4098150|FG001|STARTED|Investigational Treatment Period||22
3366758|NCT03895372|4098151|FG002|STARTED|Investigational Treatment Period||11
3366759|NCT03895372|4098152|FG003|STARTED|Investigational Treatment Period||11
3213173|NCT02217618|3943861|FG000|COMPLETED|Overall Study||16
3213174|NCT02217618|3943861|FG000|NOT COMPLETED|Overall Study||0
3213175|NCT02217800|3943865|FG000|STARTED|Overall Study||8
3213176|NCT02217800|3943865|FG000|COMPLETED|Overall Study||8
3366760|NCT03895372|4098153|FG004|STARTED|Investigational Treatment Period||12
3366761|NCT03895372|4098154|FG005|STARTED|Investigational Treatment Period||11
3366762|NCT03895372|4098155|FG006|STARTED|Investigational Treatment Period||45
3366763|NCT03895372|4098156|FG007|STARTED|Investigational Treatment Period||43
3366764|NCT03895372|4098149|FG000|COMPLETED|Investigational Treatment Period||19
3366765|NCT03895372|4098150|FG001|COMPLETED|Investigational Treatment Period||19
3213177|NCT02217800|3943865|FG000|NOT COMPLETED|Overall Study||0
3213178|NCT02217878|3943879|FG000|STARTED|Overall Study||37
3213179|NCT02217878|3943880|FG001|STARTED|Overall Study||37
3213180|NCT02217878|3943879|FG000|COMPLETED|Overall Study||35
3213181|NCT02217878|3943880|FG001|COMPLETED|Overall Study||35
3213182|NCT02217878|3943879|FG000|NOT COMPLETED|Overall Study||2
3213183|NCT02217878|3943880|FG001|NOT COMPLETED|Overall Study||2
3213184|NCT02217904|3943891|FG000|STARTED|Overall Study||6
3213185|NCT02217904|3943892|FG001|STARTED|Overall Study||6
3213186|NCT02217904|3943893|FG002|STARTED|Overall Study||6
3213187|NCT02217904|3943894|FG003|STARTED|Overall Study||6
3213188|NCT02217904|3943895|FG004|STARTED|Overall Study||6
3213189|NCT02217904|3943896|FG005|STARTED|Overall Study||0
3213190|NCT02217904|3943897|FG006|STARTED|Overall Study||0
3213191|NCT02217904|3943891|FG000|COMPLETED|Overall Study||6
3213192|NCT02217904|3943892|FG001|COMPLETED|Overall Study||6
3213193|NCT02217904|3943893|FG002|COMPLETED|Overall Study||6
3213194|NCT02217904|3943894|FG003|COMPLETED|Overall Study||6
3213195|NCT02217904|3943895|FG004|COMPLETED|Overall Study||6
3213196|NCT02217904|3943896|FG005|COMPLETED|Overall Study||0
3213197|NCT02217904|3943897|FG006|COMPLETED|Overall Study||0
3213198|NCT02217904|3943891|FG000|NOT COMPLETED|Overall Study||0
3213199|NCT02217904|3943892|FG001|NOT COMPLETED|Overall Study||0
3213200|NCT02217904|3943893|FG002|NOT COMPLETED|Overall Study||0
3213201|NCT02217904|3943894|FG003|NOT COMPLETED|Overall Study||0
3213202|NCT02217904|3943895|FG004|NOT COMPLETED|Overall Study||0
3213203|NCT02217904|3943896|FG005|NOT COMPLETED|Overall Study||0
3213204|NCT02217904|3943897|FG006|NOT COMPLETED|Overall Study||0
3213205|NCT02217982|3943911|FG000|STARTED|Overall Study||1
3213206|NCT02217982|3943912|FG001|STARTED|Overall Study||4
3213207|NCT02217982|3943911|FG000|COMPLETED|Overall Study|Trial closed before patient finished|0
3213208|NCT02217982|3943912|FG001|COMPLETED|Overall Study||3
3213209|NCT02217982|3943911|FG000|NOT COMPLETED|Overall Study||1
3213210|NCT02217982|3943912|FG001|NOT COMPLETED|Overall Study||1
3213211|NCT02218008|3943921|FG000|STARTED|Stage 1 (S1)||280
3213212|NCT02218008|3943922|FG001|STARTED|Stage 1 (S1)||63
3213213|NCT02218008|3943923|FG002|STARTED|Stage 1 (S1)||63
3213214|NCT02218008|3943924|FG003|STARTED|Stage 1 (S1)||0
3213215|NCT02218008|3943925|FG004|STARTED|Stage 1 (S1)||0
3213216|NCT02218008|3943926|FG005|STARTED|Stage 1 (S1)||0
3213217|NCT02218008|3943921|FG000|COMPLETED|Stage 1 (S1)||258
3213218|NCT02218008|3943922|FG001|COMPLETED|Stage 1 (S1)||56
3213219|NCT02218008|3943923|FG002|COMPLETED|Stage 1 (S1)||48
3213220|NCT02218008|3943924|FG003|COMPLETED|Stage 1 (S1)||0
3213221|NCT02218008|3943925|FG004|COMPLETED|Stage 1 (S1)||0
3213222|NCT02218008|3943926|FG005|COMPLETED|Stage 1 (S1)||0
3213223|NCT02218008|3943921|FG000|NOT COMPLETED|Stage 1 (S1)||22
3213224|NCT02218008|3943922|FG001|NOT COMPLETED|Stage 1 (S1)||7
3213225|NCT02218008|3943923|FG002|NOT COMPLETED|Stage 1 (S1)||15
3213226|NCT02218008|3943924|FG003|NOT COMPLETED|Stage 1 (S1)||0
3213227|NCT02218008|3943925|FG004|NOT COMPLETED|Stage 1 (S1)||0
3213228|NCT02218008|3943926|FG005|NOT COMPLETED|Stage 1 (S1)||0
3213229|NCT02218008|3943921|FG000|STARTED|Stage 2 (S2)||0
3213230|NCT02218008|3943922|FG001|STARTED|Stage 2 (S2)||0
3213231|NCT02218008|3943923|FG002|STARTED|Stage 2 (S2)||0
3213232|NCT02218008|3943924|FG003|STARTED|Stage 2 (S2)||62
3213233|NCT02218008|3943925|FG004|STARTED|Stage 2 (S2)||62
3213234|NCT02218008|3943926|FG005|STARTED|Stage 2 (S2)||63
3213235|NCT02218008|3943921|FG000|COMPLETED|Stage 2 (S2)||0
3213236|NCT02218008|3943922|FG001|COMPLETED|Stage 2 (S2)||0
3213237|NCT02218008|3943923|FG002|COMPLETED|Stage 2 (S2)||0
3213238|NCT02218008|3943924|FG003|COMPLETED|Stage 2 (S2)||58
3213239|NCT02218008|3943925|FG004|COMPLETED|Stage 2 (S2)||58
3213240|NCT02218008|3943926|FG005|COMPLETED|Stage 2 (S2)||57
3213241|NCT02218008|3943921|FG000|NOT COMPLETED|Stage 2 (S2)||0
3213242|NCT02218008|3943922|FG001|NOT COMPLETED|Stage 2 (S2)||0
3213243|NCT02218008|3943923|FG002|NOT COMPLETED|Stage 2 (S2)||0
3213244|NCT02218008|3943924|FG003|NOT COMPLETED|Stage 2 (S2)||4
3213245|NCT02218008|3943925|FG004|NOT COMPLETED|Stage 2 (S2)||4
3213246|NCT02218008|3943926|FG005|NOT COMPLETED|Stage 2 (S2)||6
3213247|NCT02218164|3943940|FG000|STARTED|Overall Study||8
3213248|NCT02218164|3943940|FG000|COMPLETED|Overall Study||8
3213249|NCT02218164|3943940|FG000|NOT COMPLETED|Overall Study||0
3213250|NCT02218190|3943946|FG000|STARTED|Overall Study||13
3213251|NCT02218190|3943947|FG001|STARTED|Overall Study||13
3213252|NCT02218190|3943946|FG000|COMPLETED|Overall Study||13
3213253|NCT02218190|3943947|FG001|COMPLETED|Overall Study||13
3213254|NCT02218190|3943946|FG000|NOT COMPLETED|Overall Study||0
3213255|NCT02218190|3943947|FG001|NOT COMPLETED|Overall Study||0
3213256|NCT02218203|3943953|FG000|STARTED|Overall Study||26
3213257|NCT02218203|3943953|FG000|Placebo Dex v. 0mg/km LBM Lidocaine|Overall Study||24
3213258|NCT02218203|3943953|FG000|Placebo Dex v. 1mg/km LBM Lidocaine|Overall Study||24
3213259|NCT02218203|3943953|FG000|Placebo Dex v. 2mg/km LBM Lidocaine|Overall Study||24
3213260|NCT02218203|3943953|FG000|Placebo Dex v. 4mg/km LBM Lidocaine|Overall Study||24
3213261|NCT02218203|3943953|FG000|Low Dose Dex v. 0mg/km LBM Lidocaine|Overall Study||26
3213262|NCT02218203|3943953|FG000|Low Dose Dex v. 1mg/km LBM Lidocaine|Overall Study||26
3213263|NCT02218203|3943953|FG000|Low Dose Dex v. 2mg/km LBM Lidocaine|Overall Study||26
3213264|NCT02218203|3943953|FG000|Low Dose Dex v. 4mg/km LBM Lidocaine|Overall Study||26
3213265|NCT02218203|3943953|FG000|Medium Dose Dex v. 0mg/km LBM Lidocaine|Overall Study||24
3213266|NCT02218203|3943953|FG000|Medium Dose Dex v. 1mg/km LBM Lidocaine|Overall Study||24
3213267|NCT02218203|3943953|FG000|Medium Dose Dex v. 2mg/km LBM Lidocaine|Overall Study||24
3213268|NCT02218203|3943953|FG000|Medium Dose Dex v. 4mg/km LBM Lidocaine|Overall Study||24
3213269|NCT02218203|3943953|FG000|High Dose Dex v. 0mg/km LBM Lidocaine|Overall Study||24
3213270|NCT02218203|3943953|FG000|High Dose Dex v. 1mg/km LBM Lidocaine|Overall Study||24
3213271|NCT02218203|3943953|FG000|High Dose Dex v. 2mg/km LBM Lidocaine|Overall Study||24
3213272|NCT02218203|3943953|FG000|High Dose Dex v. 4mg/km LBM Lidocaine|Overall Study||24
3213273|NCT02218203|3943953|FG000|COMPLETED|Overall Study|2 subjects did not complete the placebo, medium dose, and high dose dex/lido combination arms.|26
3213274|NCT02218203|3943953|FG000|NOT COMPLETED|Overall Study||0
3213275|NCT02218216|3943977|FG000|STARTED|Overall Study||14
3213276|NCT02218216|3943978|FG001|STARTED|Overall Study||2
3213277|NCT02218216|3943979|FG002|STARTED|Overall Study||3
3213278|NCT02218216|3943977|FG000|COMPLETED|Overall Study||8
3213279|NCT02218216|3943978|FG001|COMPLETED|Overall Study||2
3213280|NCT02218216|3943979|FG002|COMPLETED|Overall Study||3
3213281|NCT02218216|3943977|FG000|NOT COMPLETED|Overall Study||6
3213282|NCT02218216|3943978|FG001|NOT COMPLETED|Overall Study||0
3213283|NCT02218216|3943979|FG002|NOT COMPLETED|Overall Study||0
3213284|NCT02218242|3943987|FG000|STARTED|Overall Study||9
3213285|NCT02218242|3943987|FG000|COMPLETED|Overall Study||9
3213286|NCT02218242|3943987|FG000|NOT COMPLETED|Overall Study||0
3213287|NCT02218268|3943991|FG000|STARTED|First Phase (2 Hours)||30
3213288|NCT02218268|3943992|FG001|STARTED|First Phase (2 Hours)||30
3213289|NCT02218268|3943991|FG000|COMPLETED|First Phase (2 Hours)||30
3213290|NCT02218268|3943992|FG001|COMPLETED|First Phase (2 Hours)||30
3213291|NCT02218268|3943991|FG000|NOT COMPLETED|First Phase (2 Hours)||0
3213292|NCT02218268|3943992|FG001|NOT COMPLETED|First Phase (2 Hours)||0
3213293|NCT02218268|3943991|FG000|STARTED|24 Hour Washout||30
3213294|NCT02218268|3943992|FG001|STARTED|24 Hour Washout||30
3213295|NCT02218268|3943991|FG000|COMPLETED|24 Hour Washout||19
3213296|NCT02218268|3943992|FG001|COMPLETED|24 Hour Washout||21
3213297|NCT02218268|3943991|FG000|NOT COMPLETED|24 Hour Washout||11
3213298|NCT02218268|3943992|FG001|NOT COMPLETED|24 Hour Washout||9
3213299|NCT02218268|3943991|FG000|STARTED|Final Phase (2 Hours)||19
3213300|NCT02218268|3943992|FG001|STARTED|Final Phase (2 Hours)||21
3213301|NCT02218268|3943991|FG000|COMPLETED|Final Phase (2 Hours)||19
3213302|NCT02218268|3943992|FG001|COMPLETED|Final Phase (2 Hours)||21
3213303|NCT02218268|3943991|FG000|NOT COMPLETED|Final Phase (2 Hours)||0
3213304|NCT02218268|3943992|FG001|NOT COMPLETED|Final Phase (2 Hours)||0
3213305|NCT02218307|3944000|FG000|STARTED|Overall Study||34
3213306|NCT02218307|3944001|FG001|STARTED|Overall Study||34
3213307|NCT02218307|3944000|FG000|COMPLETED|Overall Study||25
3213308|NCT02218307|3944001|FG001|COMPLETED|Overall Study||33
3213309|NCT02218307|3944000|FG000|NOT COMPLETED|Overall Study||9
3213310|NCT02218307|3944001|FG001|NOT COMPLETED|Overall Study||1
3213311|NCT02218320|3944009|FG000|STARTED|Overall Study|First participant visit on this arm Dec 2014|10
3213312|NCT02218320|3944010|FG001|STARTED|Overall Study|First participant contact on this arm was December 2014|10
3213313|NCT02218320|3944009|FG000|COMPLETED|Overall Study|Last participant contact on this arm was June 2015|10
3213314|NCT02218320|3944010|FG001|COMPLETED|Overall Study|Last participant contact on this arm was October 2015|10
3213315|NCT02218320|3944009|FG000|NOT COMPLETED|Overall Study||0
3213316|NCT02218320|3944010|FG001|NOT COMPLETED|Overall Study||0
3213317|NCT02218372|3944018|FG000|STARTED|Overall Study||100
3213318|NCT02218372|3944019|FG001|STARTED|Overall Study||48
3213319|NCT02218372|3944018|FG000|Treated|Overall Study||98
3213320|NCT02218372|3944019|FG001|Treated|Overall Study||44
3213321|NCT02218372|3944018|FG000|COMPLETED|Overall Study||95
3213322|NCT02218372|3944019|FG001|COMPLETED|Overall Study||42
3213323|NCT02218372|3944018|FG000|NOT COMPLETED|Overall Study||5
3213324|NCT02218372|3944019|FG001|NOT COMPLETED|Overall Study||6
3213325|NCT02218424|3944032|FG000|STARTED|Overall Study||30
3213326|NCT02218424|3944033|FG001|STARTED|Overall Study||30
3213327|NCT02218424|3944032|FG000|COMPLETED|Overall Study||30
3213328|NCT02218424|3944033|FG001|COMPLETED|Overall Study||30
3213329|NCT02218424|3944032|FG000|NOT COMPLETED|Overall Study||0
3213330|NCT02218424|3944033|FG001|NOT COMPLETED|Overall Study||0
3213331|NCT02218463|3944041|FG000|STARTED|Overall Study||21
3213332|NCT02218463|3944042|FG001|STARTED|Overall Study||22
3213333|NCT02218463|3944041|FG000|COMPLETED|Overall Study||18
3213334|NCT02218463|3944042|FG001|COMPLETED|Overall Study||19
3213335|NCT02218463|3944041|FG000|NOT COMPLETED|Overall Study||3
3213336|NCT02218463|3944042|FG001|NOT COMPLETED|Overall Study||3
3213337|NCT02218489|3944050|FG000|STARTED|Overall Study||101
3213338|NCT02218489|3944051|FG001|STARTED|Overall Study||104
3213339|NCT02218489|3944050|FG000|COMPLETED|Overall Study||96
3213340|NCT02218489|3944051|FG001|COMPLETED|Overall Study||101
3213341|NCT02218489|3944050|FG000|NOT COMPLETED|Overall Study||5
3213342|NCT02218489|3944051|FG001|NOT COMPLETED|Overall Study||3
3213343|NCT02218541|3944060|FG000|STARTED|Overall Study||11
3213344|NCT02218541|3944061|FG001|STARTED|Overall Study||11
3213345|NCT02218541|3944060|FG000|COMPLETED|Overall Study||5
3213346|NCT02218541|3944061|FG001|COMPLETED|Overall Study||9
3213347|NCT02218541|3944060|FG000|NOT COMPLETED|Overall Study||6
3213348|NCT02218541|3944061|FG001|NOT COMPLETED|Overall Study||2
3213349|NCT02218736|3944070|FG000|STARTED|Overall Study||45
3213350|NCT02218736|3944071|FG001|STARTED|Overall Study||44
3213351|NCT02218736|3944070|FG000|COMPLETED|Overall Study||33
3213352|NCT02218736|3944071|FG001|COMPLETED|Overall Study||35
3213353|NCT02218736|3944070|FG000|NOT COMPLETED|Overall Study||12
3213354|NCT02218736|3944071|FG001|NOT COMPLETED|Overall Study||9
3213355|NCT02219009|3944079|FG000|STARTED|Overall Study||37
3213356|NCT02219009|3944080|FG001|STARTED|Overall Study||30
3213357|NCT02219009|3944079|FG000|COMPLETED|Overall Study||27
3213358|NCT02219009|3944080|FG001|COMPLETED|Overall Study||22
3213359|NCT02219009|3944079|FG000|NOT COMPLETED|Overall Study||10
3213360|NCT02219009|3944080|FG001|NOT COMPLETED|Overall Study||8
3213361|NCT02219048|3944088|FG000|STARTED|Overall Study||26
3213362|NCT02219048|3944089|FG001|STARTED|Overall Study||25
3213363|NCT02219048|3944088|FG000|COMPLETED|Overall Study||5
3213364|NCT02219048|3944089|FG001|COMPLETED|Overall Study||4
3213365|NCT02219048|3944088|FG000|NOT COMPLETED|Overall Study||21
3213366|NCT02219048|3944089|FG001|NOT COMPLETED|Overall Study||21
3213367|NCT02219087|3944097|FG000|STARTED|Overall Study||30
3213368|NCT02219087|3944098|FG001|STARTED|Overall Study||30
3213369|NCT02219087|3944097|FG000|COMPLETED|Overall Study||30
3213370|NCT02219087|3944098|FG001|COMPLETED|Overall Study|Randomization envelope pulled out of sequence for consented patient. Excluded by request of IRB|29
3213371|NCT02219087|3944097|FG000|NOT COMPLETED|Overall Study||0
3213372|NCT02219087|3944098|FG001|NOT COMPLETED|Overall Study||1
3213373|NCT02219256|3944116|FG000|STARTED|Overall Study||12
3213374|NCT02219256|3944117|FG001|STARTED|Overall Study||4
3213375|NCT02219256|3944118|FG002|STARTED|Overall Study||4
3213376|NCT02219256|3944119|FG003|STARTED|Overall Study||4
3213377|NCT02219256|3944120|FG004|STARTED|Overall Study||6
3213378|NCT02219256|3944121|FG005|STARTED|Overall Study||6
3213379|NCT02219256|3944122|FG006|STARTED|Overall Study||6
3213380|NCT02219256|3944123|FG007|STARTED|Overall Study||8
3213381|NCT02219256|3944124|FG008|STARTED|Overall Study||6
3213382|NCT02219256|3944125|FG009|STARTED|Overall Study||6
3213383|NCT02219256|3944126|FG010|STARTED|Overall Study||6
3213384|NCT02219256|3944127|FG011|STARTED|Overall Study||6
3213385|NCT02219256|3944116|FG000|COMPLETED|Overall Study||12
3213386|NCT02219256|3944117|FG001|COMPLETED|Overall Study||4
3213387|NCT02219256|3944118|FG002|COMPLETED|Overall Study||4
3213388|NCT02219256|3944119|FG003|COMPLETED|Overall Study||4
3213389|NCT02219256|3944120|FG004|COMPLETED|Overall Study||6
3213390|NCT02219256|3944121|FG005|COMPLETED|Overall Study||6
3213391|NCT02219256|3944122|FG006|COMPLETED|Overall Study||6
3213392|NCT02219256|3944123|FG007|COMPLETED|Overall Study||8
3213393|NCT02219256|3944124|FG008|COMPLETED|Overall Study||6
3213394|NCT02219256|3944125|FG009|COMPLETED|Overall Study||6
3213395|NCT02219256|3944126|FG010|COMPLETED|Overall Study||6
3213396|NCT02219256|3944127|FG011|COMPLETED|Overall Study||6
3213397|NCT02219256|3944116|FG000|NOT COMPLETED|Overall Study||0
3213398|NCT02219256|3944117|FG001|NOT COMPLETED|Overall Study||0
3213399|NCT02219256|3944118|FG002|NOT COMPLETED|Overall Study||0
3213400|NCT02219256|3944119|FG003|NOT COMPLETED|Overall Study||0
3213401|NCT02219256|3944120|FG004|NOT COMPLETED|Overall Study||0
3213402|NCT02219256|3944121|FG005|NOT COMPLETED|Overall Study||0
3213403|NCT02219256|3944122|FG006|NOT COMPLETED|Overall Study||0
3213404|NCT02219256|3944123|FG007|NOT COMPLETED|Overall Study||0
3213405|NCT02219256|3944124|FG008|NOT COMPLETED|Overall Study||0
3213406|NCT02219256|3944125|FG009|NOT COMPLETED|Overall Study||0
3213407|NCT02219256|3944126|FG010|NOT COMPLETED|Overall Study||0
3213408|NCT02219256|3944127|FG011|NOT COMPLETED|Overall Study||0
3213409|NCT02219282|3944155|FG000|STARTED|Overall Study||33
3213410|NCT02219282|3944156|FG001|STARTED|Overall Study||33
3213411|NCT02219282|3944155|FG000|COMPLETED|Overall Study||32
3213412|NCT02219282|3944156|FG001|COMPLETED|Overall Study||32
3213413|NCT02219282|3944155|FG000|NOT COMPLETED|Overall Study||1
3213414|NCT02219282|3944156|FG001|NOT COMPLETED|Overall Study||1
3213415|NCT02219308|3944168|FG000|STARTED|Overall Study||32
3213416|NCT02219308|3944169|FG001|STARTED|Overall Study||35
3213417|NCT02219308|3944168|FG000|COMPLETED|Overall Study||31
3213418|NCT02219308|3944169|FG001|COMPLETED|Overall Study||33
3213419|NCT02219308|3944168|FG000|NOT COMPLETED|Overall Study||1
3213420|NCT02219308|3944169|FG001|NOT COMPLETED|Overall Study||2
3213421|NCT02219321|3944177|FG000|STARTED|Overall Study||1
3213422|NCT02219321|3944178|FG001|STARTED|Overall Study||2
3213423|NCT02219321|3944177|FG000|COMPLETED|Overall Study||1
3213424|NCT02219321|3944178|FG001|COMPLETED|Overall Study||2
3213425|NCT02219321|3944177|FG000|NOT COMPLETED|Overall Study||0
3213426|NCT02219321|3944178|FG001|NOT COMPLETED|Overall Study||0
3213427|NCT02219334|3944186|FG000|STARTED|Overall Study||32
3213428|NCT02219334|3944187|FG001|STARTED|Overall Study||23
3213429|NCT02219334|3944186|FG000|COMPLETED|Overall Study||24
3213430|NCT02219334|3944187|FG001|COMPLETED|Overall Study||20
3213431|NCT02219334|3944186|FG000|NOT COMPLETED|Overall Study||8
3213432|NCT02219334|3944187|FG001|NOT COMPLETED|Overall Study||3
3213433|NCT02219438|3944195|FG000|STARTED|Overall Study||13
3213434|NCT02219438|3944196|FG001|STARTED|Overall Study||11
3213435|NCT02219438|3944195|FG000|COMPLETED|Overall Study||13
3213436|NCT02219438|3944196|FG001|COMPLETED|Overall Study||11
3213437|NCT02219438|3944195|FG000|NOT COMPLETED|Overall Study||0
3213438|NCT02219438|3944196|FG001|NOT COMPLETED|Overall Study||0
3213439|NCT02219464|3944206|FG000|STARTED|Overall Study||30
3213440|NCT02219464|3944207|FG001|STARTED|Overall Study||30
3213441|NCT02219464|3944206|FG000|COMPLETED|Overall Study||27
3213442|NCT02219464|3944207|FG001|COMPLETED|Overall Study||30
3213443|NCT02219464|3944206|FG000|NOT COMPLETED|Overall Study||3
3213444|NCT02219464|3944207|FG001|NOT COMPLETED|Overall Study||0
3213445|NCT02219477|3944216|FG000|STARTED|Overall Study||9
3213446|NCT02219477|3944217|FG001|STARTED|Overall Study||24
3213447|NCT02219477|3944218|FG002|STARTED|Overall Study||3
3213448|NCT02219477|3944216|FG000|COMPLETED|Overall Study||9
3213449|NCT02219477|3944217|FG001|COMPLETED|Overall Study||22
3213450|NCT02219477|3944218|FG002|COMPLETED|Overall Study||2
3213451|NCT02219477|3944216|FG000|NOT COMPLETED|Overall Study||0
3213452|NCT02219477|3944217|FG001|NOT COMPLETED|Overall Study||2
3213453|NCT02219477|3944218|FG002|NOT COMPLETED|Overall Study||1
3213454|NCT02219503|3944227|FG000|STARTED|Overall Study||60
3213455|NCT02219503|3944227|FG000|COMPLETED|Overall Study||60
3213456|NCT02219503|3944227|FG000|NOT COMPLETED|Overall Study||0
3213457|NCT02219516|3944235|FG000|STARTED|Overall Study||8
3213458|NCT02219516|3944236|FG001|STARTED|Overall Study||8
3213459|NCT02219516|3944237|FG002|STARTED|Overall Study||7
3213460|NCT02219516|3944238|FG003|STARTED|Overall Study||8
3213461|NCT02219516|3944235|FG000|COMPLETED|Overall Study||8
3213462|NCT02219516|3944236|FG001|COMPLETED|Overall Study||8
3213463|NCT02219516|3944237|FG002|COMPLETED|Overall Study||7
3213464|NCT02219516|3944238|FG003|COMPLETED|Overall Study||8
3213465|NCT02219516|3944235|FG000|NOT COMPLETED|Overall Study||0
3213466|NCT02219516|3944236|FG001|NOT COMPLETED|Overall Study||0
3213467|NCT02219516|3944237|FG002|NOT COMPLETED|Overall Study||0
3213468|NCT02219516|3944238|FG003|NOT COMPLETED|Overall Study||0
3213469|NCT02219685|3944250|FG000|STARTED|Blinded Treatment Phase||26
3213470|NCT02219685|3944251|FG001|STARTED|Blinded Treatment Phase||14
3213471|NCT02219685|3944250|FG000|COMPLETED|Blinded Treatment Phase||24
3213472|NCT02219685|3944251|FG001|COMPLETED|Blinded Treatment Phase||14
3213473|NCT02219685|3944250|FG000|NOT COMPLETED|Blinded Treatment Phase||2
3213474|NCT02219685|3944251|FG001|NOT COMPLETED|Blinded Treatment Phase||0
3213475|NCT02219685|3944250|FG000|STARTED|Open-Label (After Posttreatment Week 4)|Only participants from the Placebo arm were eligible to enroll in the Open-Label Phase.|0
3213476|NCT02219685|3944251|FG001|STARTED|Open-Label (After Posttreatment Week 4)||14
3213477|NCT02219685|3944250|FG000|COMPLETED|Open-Label (After Posttreatment Week 4)||0
3213478|NCT02219685|3944251|FG001|COMPLETED|Open-Label (After Posttreatment Week 4)||14
3213479|NCT02219685|3944250|FG000|NOT COMPLETED|Open-Label (After Posttreatment Week 4)||0
3213480|NCT02219685|3944251|FG001|NOT COMPLETED|Open-Label (After Posttreatment Week 4)||0
3213481|NCT02219815|3944261|FG000|STARTED|Overall Study||44
3213482|NCT02219815|3944262|FG001|STARTED|Overall Study||45
3213483|NCT02219815|3944261|FG000|Post Hospital Discharge Analysis|Overall Study||42
3213484|NCT02219815|3944262|FG001|Post Hospital Discharge Analysis|Overall Study||39
3213485|NCT02219815|3944261|FG000|3 Month Post Surgery|Overall Study||34
3213486|NCT02219815|3944262|FG001|3 Month Post Surgery|Overall Study||31
3213487|NCT02219815|3944261|FG000|COMPLETED|Overall Study||22
3213488|NCT02219815|3944262|FG001|COMPLETED|Overall Study||21
3213489|NCT02219815|3944261|FG000|NOT COMPLETED|Overall Study||22
3213490|NCT02219815|3944262|FG001|NOT COMPLETED|Overall Study||24
3213491|NCT02219932|3944270|FG000|STARTED|Overall Study||319
3213492|NCT02219932|3944271|FG001|STARTED|Overall Study||317
3213493|NCT02219932|3944270|FG000|Randomized, Not Treated|Overall Study||0
3213494|NCT02219932|3944271|FG001|Randomized, Not Treated|Overall Study||1
3213495|NCT02219932|3944270|FG000|COMPLETED|Overall Study||254
3213496|NCT02219932|3944271|FG001|COMPLETED|Overall Study||266
3213497|NCT02219932|3944270|FG000|NOT COMPLETED|Overall Study||65
3213498|NCT02219932|3944271|FG001|NOT COMPLETED|Overall Study||51
3213499|NCT02219997|3944279|FG000|STARTED|First Filter||33
3213500|NCT02219997|3944280|FG001|STARTED|First Filter||17
3213501|NCT02219997|3944281|FG002|STARTED|First Filter||18
3213502|NCT02219997|3944279|FG000|COMPLETED|First Filter||33
3213503|NCT02219997|3944280|FG001|COMPLETED|First Filter||17
3213504|NCT02219997|3944281|FG002|COMPLETED|First Filter||18
3213505|NCT02219997|3944279|FG000|NOT COMPLETED|First Filter||0
3213506|NCT02219997|3944280|FG001|NOT COMPLETED|First Filter||0
3213507|NCT02219997|3944281|FG002|NOT COMPLETED|First Filter||0
3213508|NCT02219997|3944279|FG000|STARTED|Second Filter||0
3213509|NCT02219997|3944280|FG001|STARTED|Second Filter||17
3213510|NCT02219997|3944281|FG002|STARTED|Second Filter||18
3213511|NCT02219997|3944279|FG000|COMPLETED|Second Filter||0
3213512|NCT02219997|3944280|FG001|COMPLETED|Second Filter||17
3213513|NCT02219997|3944281|FG002|COMPLETED|Second Filter||18
3213514|NCT02219997|3944279|FG000|NOT COMPLETED|Second Filter||0
3213515|NCT02219997|3944280|FG001|NOT COMPLETED|Second Filter||0
3213516|NCT02219997|3944281|FG002|NOT COMPLETED|Second Filter||0
3213517|NCT02220205|3944294|FG000|STARTED|Overall Study||30
3213518|NCT02220205|3944295|FG001|STARTED|Overall Study||30
3213519|NCT02220205|3944294|FG000|COMPLETED|Overall Study||29
3213520|NCT02220205|3944295|FG001|COMPLETED|Overall Study||30
3213521|NCT02220205|3944294|FG000|NOT COMPLETED|Overall Study||1
3213522|NCT02220205|3944295|FG001|NOT COMPLETED|Overall Study||0
3213523|NCT02220712|3944301|FG000|STARTED|Overall Study||17
3213524|NCT02220712|3944301|FG000|COMPLETED|Overall Study||13
3213525|NCT02220712|3944301|FG000|NOT COMPLETED|Overall Study||4
3213526|NCT02220725|3944313|FG000|STARTED|Overall Study||14
3213527|NCT02220725|3944314|FG001|STARTED|Overall Study||27
3213528|NCT02220725|3944315|FG002|STARTED|Overall Study||13
3213529|NCT02220725|3944316|FG003|STARTED|Overall Study||26
3213530|NCT02220725|3944313|FG000|COMPLETED|Overall Study||14
3213531|NCT02220725|3944314|FG001|COMPLETED|Overall Study||27
3213532|NCT02220725|3944315|FG002|COMPLETED|Overall Study||13
3213533|NCT02220725|3944316|FG003|COMPLETED|Overall Study||24
3213534|NCT02220725|3944313|FG000|NOT COMPLETED|Overall Study||0
3213535|NCT02220725|3944314|FG001|NOT COMPLETED|Overall Study||0
3213536|NCT02220725|3944315|FG002|NOT COMPLETED|Overall Study||0
3213537|NCT02220725|3944316|FG003|NOT COMPLETED|Overall Study||2
3213538|NCT02220764|3944331|FG000|STARTED|Overall Study||24
3213539|NCT02220764|3944332|FG001|STARTED|Overall Study||8
3213540|NCT02220764|3944331|FG000|COMPLETED|Overall Study||20
3213541|NCT02220764|3944332|FG001|COMPLETED|Overall Study||7
3213542|NCT02220764|3944331|FG000|NOT COMPLETED|Overall Study||4
3213543|NCT02220764|3944332|FG001|NOT COMPLETED|Overall Study||1
3213544|NCT02220855|3944338|FG000|STARTED|Overall Study||14
3213545|NCT02220855|3944338|FG000|COMPLETED|Overall Study||0
3213546|NCT02220855|3944338|FG000|NOT COMPLETED|Overall Study||14
3213547|NCT02220907|3944342|FG000|STARTED|Overall Study||153
3213548|NCT02220907|3944342|FG000|COMPLETED|Overall Study||142
3213549|NCT02220907|3944342|FG000|NOT COMPLETED|Overall Study||11
3366766|NCT03895372|4098151|FG002|COMPLETED|Investigational Treatment Period||10
3366767|NCT03895372|4098152|FG003|COMPLETED|Investigational Treatment Period||9
3366768|NCT03895372|4098153|FG004|COMPLETED|Investigational Treatment Period||12
3366769|NCT03895372|4098154|FG005|COMPLETED|Investigational Treatment Period||9
3366770|NCT03895372|4098155|FG006|COMPLETED|Investigational Treatment Period||37
3366771|NCT03895372|4098156|FG007|COMPLETED|Investigational Treatment Period||38
3366772|NCT03895372|4098149|FG000|NOT COMPLETED|Investigational Treatment Period||4
3366773|NCT03895372|4098150|FG001|NOT COMPLETED|Investigational Treatment Period||3
3366774|NCT03895372|4098151|FG002|NOT COMPLETED|Investigational Treatment Period||1
3366775|NCT03895372|4098152|FG003|NOT COMPLETED|Investigational Treatment Period||2
3366776|NCT03895372|4098153|FG004|NOT COMPLETED|Investigational Treatment Period||0
3366777|NCT03895372|4098154|FG005|NOT COMPLETED|Investigational Treatment Period||2
3366778|NCT03895372|4098155|FG006|NOT COMPLETED|Investigational Treatment Period||8
3366779|NCT03895372|4098156|FG007|NOT COMPLETED|Investigational Treatment Period||5
3366780|NCT03895372|4098149|FG000|STARTED|Extension Treatment Period||19
3366781|NCT03895372|4098150|FG001|STARTED|Extension Treatment Period||19
3366782|NCT03895372|4098151|FG002|STARTED|Extension Treatment Period||10
3366783|NCT03895372|4098152|FG003|STARTED|Extension Treatment Period||9
3366784|NCT03895372|4098153|FG004|STARTED|Extension Treatment Period||12
3366785|NCT03895372|4098154|FG005|STARTED|Extension Treatment Period||9
3366786|NCT03895372|4098155|FG006|STARTED|Extension Treatment Period||37
3366787|NCT03895372|4098156|FG007|STARTED|Extension Treatment Period||38
3366788|NCT03895372|4098149|FG000|COMPLETED|Extension Treatment Period||16
3366789|NCT03895372|4098150|FG001|COMPLETED|Extension Treatment Period||14
3366790|NCT03895372|4098151|FG002|COMPLETED|Extension Treatment Period||10
3366791|NCT03895372|4098152|FG003|COMPLETED|Extension Treatment Period||8
3366792|NCT03895372|4098153|FG004|COMPLETED|Extension Treatment Period||9
3366793|NCT03895372|4098154|FG005|COMPLETED|Extension Treatment Period||8
3366794|NCT03895372|4098155|FG006|COMPLETED|Extension Treatment Period||33
3366795|NCT03895372|4098156|FG007|COMPLETED|Extension Treatment Period||32
3366796|NCT03895372|4098149|FG000|NOT COMPLETED|Extension Treatment Period||3
3366797|NCT03895372|4098150|FG001|NOT COMPLETED|Extension Treatment Period||5
3366798|NCT03895372|4098151|FG002|NOT COMPLETED|Extension Treatment Period||0
3366799|NCT03895372|4098152|FG003|NOT COMPLETED|Extension Treatment Period||1
3366800|NCT03895372|4098153|FG004|NOT COMPLETED|Extension Treatment Period||3
3366801|NCT03895372|4098154|FG005|NOT COMPLETED|Extension Treatment Period||1
3366802|NCT03895372|4098155|FG006|NOT COMPLETED|Extension Treatment Period||4
3366803|NCT03895372|4098156|FG007|NOT COMPLETED|Extension Treatment Period||6
3366804|NCT03896022|4098182|FG000|STARTED|Overall Study||74
3366805|NCT03896022|4098183|FG001|STARTED|Overall Study||51
3366806|NCT03896022|4098184|FG002|STARTED|Overall Study||52
3366807|NCT03896022|4098182|FG000|COMPLETED|Overall Study||70
3366808|NCT03896022|4098183|FG001|COMPLETED|Overall Study||51
3366809|NCT03896022|4098184|FG002|COMPLETED|Overall Study||52
3366810|NCT03896022|4098182|FG000|NOT COMPLETED|Overall Study||4
3366811|NCT03896022|4098183|FG001|NOT COMPLETED|Overall Study||0
3366812|NCT03896022|4098184|FG002|NOT COMPLETED|Overall Study||0
3366813|NCT03891862|4098196|FG000|STARTED|Open-label Period||135
3366814|NCT03891862|4098197|FG001|STARTED|Open-label Period||0
3366815|NCT03891862|4098198|FG002|STARTED|Open-label Period||0
3366816|NCT03891862|4098196|FG000|Safety Analysis Set|Open-label Period||132
3366817|NCT03891862|4098197|FG001|Safety Analysis Set|Open-label Period||0
3366818|NCT03891862|4098198|FG002|Safety Analysis Set|Open-label Period||0
3366819|NCT03891862|4098196|FG000|COMPLETED|Open-label Period||119
3366820|NCT03891862|4098197|FG001|COMPLETED|Open-label Period||0
3366821|NCT03891862|4098198|FG002|COMPLETED|Open-label Period||0
3366822|NCT03891862|4098196|FG000|NOT COMPLETED|Open-label Period||16
3366823|NCT03891862|4098197|FG001|NOT COMPLETED|Open-label Period||0
3366824|NCT03891862|4098198|FG002|NOT COMPLETED|Open-label Period||0
3366825|NCT03891862|4098196|FG000|STARTED|Placebo-controlled Period and Follow-up||0
3366826|NCT03891862|4098197|FG001|STARTED|Placebo-controlled Period and Follow-up||59
3366827|NCT03891862|4098198|FG002|STARTED|Placebo-controlled Period and Follow-up||59
3366828|NCT03891862|4098196|FG000|Persistence of Effect Analysis Set|Placebo-controlled Period and Follow-up||0
3366829|NCT03891862|4098197|FG001|Persistence of Effect Analysis Set|Placebo-controlled Period and Follow-up||58
3366830|NCT03891862|4098198|FG002|Persistence of Effect Analysis Set|Placebo-controlled Period and Follow-up||59
3366831|NCT03891862|4098196|FG000|Completed Placebo-controlled Period|Placebo-controlled Period and Follow-up||0
3366832|NCT03891862|4098197|FG001|Completed Placebo-controlled Period|Placebo-controlled Period and Follow-up||53
3213550|NCT02220920|3944348|FG000|STARTED|Overall Study||76
3213551|NCT02220920|3944349|FG001|STARTED|Overall Study||70
3213552|NCT02220920|3944348|FG000|COMPLETED|Overall Study||73
3213553|NCT02220920|3944349|FG001|COMPLETED|Overall Study||67
3213554|NCT02220920|3944348|FG000|NOT COMPLETED|Overall Study||3
3213555|NCT02220920|3944349|FG001|NOT COMPLETED|Overall Study||3
3213556|NCT02220998|3944357|FG000|STARTED|Overall Study||135
3213557|NCT02220998|3944358|FG001|STARTED|Overall Study||134
3213558|NCT02220998|3944357|FG000|COMPLETED|Overall Study||128
3213559|NCT02220998|3944358|FG001|COMPLETED|Overall Study||123
3213560|NCT02220998|3944357|FG000|NOT COMPLETED|Overall Study||7
3213561|NCT02220998|3944358|FG001|NOT COMPLETED|Overall Study||11
3213562|NCT02221219|3944368|FG000|STARTED|Overall Study||36
3213563|NCT02221219|3944369|FG001|STARTED|Overall Study||87
3213564|NCT02221219|3944370|FG002|STARTED|Overall Study||41
3213565|NCT02221219|3944371|FG003|STARTED|Overall Study||92
3213566|NCT02221219|3944368|FG000|COMPLETED|Overall Study||36
3213567|NCT02221219|3944369|FG001|COMPLETED|Overall Study||87
3213568|NCT02221219|3944370|FG002|COMPLETED|Overall Study||41
3213569|NCT02221219|3944371|FG003|COMPLETED|Overall Study||92
3213570|NCT02221219|3944368|FG000|NOT COMPLETED|Overall Study||0
3213571|NCT02221219|3944369|FG001|NOT COMPLETED|Overall Study||0
3213572|NCT02221219|3944370|FG002|NOT COMPLETED|Overall Study||0
3213573|NCT02221219|3944371|FG003|NOT COMPLETED|Overall Study||0
3213574|NCT02221284|3944385|FG000|STARTED|Overall Study||964
3213575|NCT02221284|3944385|FG000|COMPLETED|Overall Study||903
3213576|NCT02221284|3944385|FG000|NOT COMPLETED|Overall Study||61
3213577|NCT02221349|3944397|FG000|STARTED|Overall Study||15
3213578|NCT02221349|3944398|FG001|STARTED|Overall Study||15
3213579|NCT02221349|3944397|FG000|COMPLETED|Overall Study||14
3213580|NCT02221349|3944398|FG001|COMPLETED|Overall Study||15
3213581|NCT02221349|3944397|FG000|NOT COMPLETED|Overall Study||1
3213582|NCT02221349|3944398|FG001|NOT COMPLETED|Overall Study||0
3213583|NCT02221557|3944404|FG000|STARTED|Overall Study||8
3213584|NCT02221557|3944404|FG000|COMPLETED|Overall Study||5
3213585|NCT02221557|3944404|FG000|NOT COMPLETED|Overall Study||3
3213586|NCT02221648|3944410|FG000|STARTED|Overall Study||22
3213587|NCT02221648|3944411|FG001|STARTED|Overall Study||21
3213588|NCT02221648|3944410|FG000|COMPLETED|Overall Study||19
3213589|NCT02221648|3944411|FG001|COMPLETED|Overall Study||18
3213590|NCT02221648|3944410|FG000|NOT COMPLETED|Overall Study||3
3213591|NCT02221648|3944411|FG001|NOT COMPLETED|Overall Study||3
3213592|NCT02221674|3944424|FG000|STARTED|Overall Study||8
3213593|NCT02221674|3944425|FG001|STARTED|Overall Study||6
3213594|NCT02221674|3944426|FG002|STARTED|Overall Study||5
3213595|NCT02221674|3944424|FG000|COMPLETED|Overall Study||7
3213596|NCT02221674|3944425|FG001|COMPLETED|Overall Study||6
3213597|NCT02221674|3944426|FG002|COMPLETED|Overall Study||5
3213598|NCT02221674|3944424|FG000|NOT COMPLETED|Overall Study||1
3213599|NCT02221674|3944425|FG001|NOT COMPLETED|Overall Study||0
3213600|NCT02221674|3944426|FG002|NOT COMPLETED|Overall Study||0
3213601|NCT02221739|3944437|FG000|STARTED|Overall Study||39
3213602|NCT02221739|3944437|FG000|COMPLETED|Overall Study||21
3213603|NCT02221739|3944437|FG000|NOT COMPLETED|Overall Study||18
3213604|NCT02221869|3944444|FG000|STARTED|Overall Study||31
3213605|NCT02221869|3944445|FG001|STARTED|Overall Study||32
3213606|NCT02221869|3944446|FG002|STARTED|Overall Study||43
3213607|NCT02221869|3944444|FG000|COMPLETED|Overall Study||30
3213608|NCT02221869|3944445|FG001|COMPLETED|Overall Study||32
3213609|NCT02221869|3944446|FG002|COMPLETED|Overall Study||33
3213610|NCT02221869|3944444|FG000|NOT COMPLETED|Overall Study||1
3213611|NCT02221869|3944445|FG001|NOT COMPLETED|Overall Study||0
3213612|NCT02221869|3944446|FG002|NOT COMPLETED|Overall Study||10
3213613|NCT02221882|3944458|FG000|STARTED|Overall Study||3
3213614|NCT02221882|3944459|FG001|STARTED|Overall Study||3
3213615|NCT02221882|3944460|FG002|STARTED|Overall Study||11
3213616|NCT02221882|3944461|FG003|STARTED|Overall Study||3
3213617|NCT02221882|3944462|FG004|STARTED|Overall Study||5
3366833|NCT03891862|4098198|FG002|Completed Placebo-controlled Period|Placebo-controlled Period and Follow-up||56
3366834|NCT03891862|4098196|FG000|COMPLETED|Placebo-controlled Period and Follow-up||0
3366835|NCT03891862|4098197|FG001|COMPLETED|Placebo-controlled Period and Follow-up||53
3366836|NCT03891862|4098198|FG002|COMPLETED|Placebo-controlled Period and Follow-up||55
3366837|NCT03891862|4098196|FG000|NOT COMPLETED|Placebo-controlled Period and Follow-up||0
3366838|NCT03891862|4098197|FG001|NOT COMPLETED|Placebo-controlled Period and Follow-up||6
3366839|NCT03891862|4098198|FG002|NOT COMPLETED|Placebo-controlled Period and Follow-up||4
3366840|NCT03894449|4098210|FG000|STARTED|Overall Study||15
3213618|NCT02221882|3944463|FG005|STARTED|Overall Study||4
3213619|NCT02221882|3944458|FG000|Received at Least One Dose of Study Drug|Overall Study||3
3213620|NCT02221882|3944459|FG001|Received at Least One Dose of Study Drug|Overall Study||3
3213621|NCT02221882|3944460|FG002|Received at Least One Dose of Study Drug|Overall Study||11
3213622|NCT02221882|3944461|FG003|Received at Least One Dose of Study Drug|Overall Study||3
3213623|NCT02221882|3944462|FG004|Received at Least One Dose of Study Drug|Overall Study||5
3366841|NCT03894449|4098211|FG001|STARTED|Overall Study||15
3366842|NCT03894449|4098212|FG002|STARTED|Overall Study||15
3213624|NCT02221882|3944463|FG005|Received at Least One Dose of Study Drug|Overall Study||4
3213625|NCT02221882|3944458|FG000|COMPLETED|Overall Study||3
3213626|NCT02221882|3944459|FG001|COMPLETED|Overall Study||2
3213627|NCT02221882|3944460|FG002|COMPLETED|Overall Study||7
3213628|NCT02221882|3944461|FG003|COMPLETED|Overall Study||1
3213629|NCT02221882|3944462|FG004|COMPLETED|Overall Study||3
3213630|NCT02221882|3944463|FG005|COMPLETED|Overall Study||2
3213631|NCT02221882|3944458|FG000|NOT COMPLETED|Overall Study||0
3213632|NCT02221882|3944459|FG001|NOT COMPLETED|Overall Study||1
3213633|NCT02221882|3944460|FG002|NOT COMPLETED|Overall Study||4
3213634|NCT02221882|3944461|FG003|NOT COMPLETED|Overall Study||2
3213635|NCT02221882|3944462|FG004|NOT COMPLETED|Overall Study||2
3213636|NCT02221882|3944463|FG005|NOT COMPLETED|Overall Study||2
3213637|NCT02221947|3944484|FG000|STARTED|Overall Study||6
3213638|NCT02221947|3944485|FG001|STARTED|Overall Study||3
3213639|NCT02221947|3944484|FG000|COMPLETED|Overall Study||6
3213640|NCT02221947|3944485|FG001|COMPLETED|Overall Study||3
3213641|NCT02221947|3944484|FG000|NOT COMPLETED|Overall Study||0
3213642|NCT02221947|3944485|FG001|NOT COMPLETED|Overall Study||0
3213643|NCT02222129|3944496|FG000|STARTED|Overall Study||100
3213644|NCT02222129|3944497|FG001|STARTED|Overall Study||106
3213645|NCT02222129|3944496|FG000|COMPLETED|Overall Study||100
3213646|NCT02222129|3944497|FG001|COMPLETED|Overall Study||106
3213647|NCT02222129|3944496|FG000|NOT COMPLETED|Overall Study||0
3213648|NCT02222129|3944497|FG001|NOT COMPLETED|Overall Study||0
3213649|NCT02222181|3944503|FG000|STARTED|Overall Study||163
3213650|NCT02222181|3944503|FG000|COMPLETED|Overall Study||55
3213651|NCT02222181|3944503|FG000|NOT COMPLETED|Overall Study||108
3213652|NCT02222207|3944507|FG000|STARTED|Overall Study||52
3213653|NCT02222207|3944507|FG000|Treated and Valid for Full Analysis Set|Overall Study||51
3213654|NCT02222207|3944507|FG000|COMPLETED|Overall Study||48
3213655|NCT02222207|3944507|FG000|NOT COMPLETED|Overall Study||4
3213656|NCT02222246|3944513|FG000|STARTED|Overall Study||53
3213657|NCT02222246|3944514|FG001|STARTED|Overall Study||53
3213658|NCT02222246|3944513|FG000|COMPLETED|Overall Study||26
3213659|NCT02222246|3944514|FG001|COMPLETED|Overall Study||26
3213660|NCT02222246|3944513|FG000|NOT COMPLETED|Overall Study||27
3213661|NCT02222246|3944514|FG001|NOT COMPLETED|Overall Study||27
3213662|NCT02222337|3944524|FG000|STARTED|Overall Study||140
3213663|NCT02222337|3944525|FG001|STARTED|Overall Study|132 participants were enrolled but 2 withdrew and never provided any data.|132
3213664|NCT02222337|3944524|FG000|COMPLETED|Overall Study||114
3213665|NCT02222337|3944525|FG001|COMPLETED|Overall Study||108
3213666|NCT02222337|3944524|FG000|NOT COMPLETED|Overall Study||26
3213667|NCT02222337|3944525|FG001|NOT COMPLETED|Overall Study||24
3213668|NCT02222493|3944537|FG000|STARTED|Period 1: First Dose-Week 30 (Pre-dose)||324
3213669|NCT02222493|3944538|FG001|STARTED|Period 1: First Dose-Week 30 (Pre-dose)||326
3213670|NCT02222493|3944537|FG000|Received Treatment|Period 1: First Dose-Week 30 (Pre-dose)||323
3213671|NCT02222493|3944538|FG001|Received Treatment|Period 1: First Dose-Week 30 (Pre-dose)||326
3213672|NCT02222493|3944537|FG000|COMPLETED|Period 1: First Dose-Week 30 (Pre-dose)||280
3213673|NCT02222493|3944538|FG001|COMPLETED|Period 1: First Dose-Week 30 (Pre-dose)||286
3213674|NCT02222493|3944537|FG000|NOT COMPLETED|Period 1: First Dose-Week 30 (Pre-dose)||44
3213675|NCT02222493|3944538|FG001|NOT COMPLETED|Period 1: First Dose-Week 30 (Pre-dose)||40
3213676|NCT02222493|3944537|FG000|STARTED|Period 2: Week30 Dosing-Week54(Pre-dose)||423
3213677|NCT02222493|3944538|FG001|STARTED|Period 2: Week30 Dosing-Week54(Pre-dose)||143
3213678|NCT02222493|3944537|FG000|COMPLETED|Period 2: Week30 Dosing-Week54(Pre-dose)||380
3213679|NCT02222493|3944538|FG001|COMPLETED|Period 2: Week30 Dosing-Week54(Pre-dose)||126
3213680|NCT02222493|3944537|FG000|NOT COMPLETED|Period 2: Week30 Dosing-Week54(Pre-dose)||43
3213681|NCT02222493|3944538|FG001|NOT COMPLETED|Period 2: Week30 Dosing-Week54(Pre-dose)||17
3213682|NCT02222493|3944537|FG000|STARTED|Period 3: Week 54 Dosing-Week 78 Visit||505
3213683|NCT02222493|3944538|FG001|STARTED|Period 3: Week 54 Dosing-Week 78 Visit||0
3213684|NCT02222493|3944537|FG000|COMPLETED|Period 3: Week 54 Dosing-Week 78 Visit||474
3213685|NCT02222493|3944538|FG001|COMPLETED|Period 3: Week 54 Dosing-Week 78 Visit||0
3213686|NCT02222493|3944537|FG000|NOT COMPLETED|Period 3: Week 54 Dosing-Week 78 Visit||31
3213687|NCT02222493|3944538|FG001|NOT COMPLETED|Period 3: Week 54 Dosing-Week 78 Visit||0
3213688|NCT02222558|3944557|FG000|STARTED|Period 1: Single Dose||25
3213689|NCT02222558|3944558|FG001|STARTED|Period 1: Single Dose||0
3213690|NCT02222558|3944559|FG002|STARTED|Period 1: Single Dose||0
3213691|NCT02222558|3944560|FG003|STARTED|Period 1: Single Dose||0
3213692|NCT02222558|3944561|FG004|STARTED|Period 1: Single Dose||0
3213693|NCT02222558|3944562|FG005|STARTED|Period 1: Single Dose||0
3213694|NCT02222558|3944557|FG000|COMPLETED|Period 1: Single Dose||21
3213695|NCT02222558|3944558|FG001|COMPLETED|Period 1: Single Dose||0
3213696|NCT02222558|3944559|FG002|COMPLETED|Period 1: Single Dose||0
3213697|NCT02222558|3944560|FG003|COMPLETED|Period 1: Single Dose||0
3213698|NCT02222558|3944561|FG004|COMPLETED|Period 1: Single Dose||0
3213699|NCT02222558|3944562|FG005|COMPLETED|Period 1: Single Dose||0
3213700|NCT02222558|3944557|FG000|NOT COMPLETED|Period 1: Single Dose||4
3213701|NCT02222558|3944558|FG001|NOT COMPLETED|Period 1: Single Dose||0
3213702|NCT02222558|3944559|FG002|NOT COMPLETED|Period 1: Single Dose||0
3213703|NCT02222558|3944560|FG003|NOT COMPLETED|Period 1: Single Dose||0
3213704|NCT02222558|3944561|FG004|NOT COMPLETED|Period 1: Single Dose||0
3213705|NCT02222558|3944562|FG005|NOT COMPLETED|Period 1: Single Dose||0
3213706|NCT02222558|3944557|FG000|STARTED|Period 2: Two Times Daily Dosing 90 mg||0
3213707|NCT02222558|3944558|FG001|STARTED|Period 2: Two Times Daily Dosing 90 mg||21
3213708|NCT02222558|3944559|FG002|STARTED|Period 2: Two Times Daily Dosing 90 mg||0
3213709|NCT02222558|3944560|FG003|STARTED|Period 2: Two Times Daily Dosing 90 mg||0
3213710|NCT02222558|3944561|FG004|STARTED|Period 2: Two Times Daily Dosing 90 mg||0
3213711|NCT02222558|3944562|FG005|STARTED|Period 2: Two Times Daily Dosing 90 mg||0
3213712|NCT02222558|3944557|FG000|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
3213713|NCT02222558|3944558|FG001|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||21
3213714|NCT02222558|3944559|FG002|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
3213715|NCT02222558|3944560|FG003|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
3213716|NCT02222558|3944561|FG004|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
3213717|NCT02222558|3944562|FG005|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
3213718|NCT02222558|3944557|FG000|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
3213719|NCT02222558|3944558|FG001|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
3213720|NCT02222558|3944559|FG002|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
3213721|NCT02222558|3944560|FG003|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
3213722|NCT02222558|3944561|FG004|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
3213723|NCT02222558|3944562|FG005|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
3213724|NCT02222558|3944557|FG000|STARTED|Period 3||0
3213725|NCT02222558|3944558|FG001|STARTED|Period 3||0
3213726|NCT02222558|3944559|FG002|STARTED|Period 3||4
3213727|NCT02222558|3944560|FG003|STARTED|Period 3||1
3213728|NCT02222558|3944561|FG004|STARTED|Period 3||8
3213729|NCT02222558|3944562|FG005|STARTED|Period 3||8
3213730|NCT02222558|3944557|FG000|COMPLETED|Period 3||0
3213731|NCT02222558|3944558|FG001|COMPLETED|Period 3||0
3213732|NCT02222558|3944559|FG002|COMPLETED|Period 3||4
3213733|NCT02222558|3944560|FG003|COMPLETED|Period 3||1
3213734|NCT02222558|3944561|FG004|COMPLETED|Period 3||8
3213735|NCT02222558|3944562|FG005|COMPLETED|Period 3||7
3213736|NCT02222558|3944557|FG000|NOT COMPLETED|Period 3||0
3213737|NCT02222558|3944558|FG001|NOT COMPLETED|Period 3||0
3213738|NCT02222558|3944559|FG002|NOT COMPLETED|Period 3||0
3213739|NCT02222558|3944560|FG003|NOT COMPLETED|Period 3||0
3213740|NCT02222558|3944561|FG004|NOT COMPLETED|Period 3||0
3213741|NCT02222558|3944562|FG005|NOT COMPLETED|Period 3||1
3213742|NCT02222610|3944579|FG000|STARTED|Baseline to W48||8
3213743|NCT02222610|3944580|FG001|STARTED|Baseline to W48||16
3213744|NCT02222610|3944581|FG002|STARTED|Baseline to W48||16
3213745|NCT02222610|3944579|FG000|COMPLETED|Baseline to W48||8
3213746|NCT02222610|3944580|FG001|COMPLETED|Baseline to W48||14
3213747|NCT02222610|3944581|FG002|COMPLETED|Baseline to W48||15
3213748|NCT02222610|3944579|FG000|NOT COMPLETED|Baseline to W48||0
3213749|NCT02222610|3944580|FG001|NOT COMPLETED|Baseline to W48||2
3213750|NCT02222610|3944581|FG002|NOT COMPLETED|Baseline to W48||1
3213751|NCT02222610|3944579|FG000|STARTED|Baseline to W104||8
3213752|NCT02222610|3944580|FG001|STARTED|Baseline to W104||16
3213753|NCT02222610|3944581|FG002|STARTED|Baseline to W104||16
3213754|NCT02222610|3944579|FG000|COMPLETED|Baseline to W104||8
3213755|NCT02222610|3944580|FG001|COMPLETED|Baseline to W104||11
3213756|NCT02222610|3944581|FG002|COMPLETED|Baseline to W104||10
3213757|NCT02222610|3944579|FG000|NOT COMPLETED|Baseline to W104||0
3213758|NCT02222610|3944580|FG001|NOT COMPLETED|Baseline to W104||5
3213759|NCT02222610|3944581|FG002|NOT COMPLETED|Baseline to W104||6
3213760|NCT02222688|3944596|FG000|STARTED|Overall Study||4
3213761|NCT02222688|3944597|FG001|STARTED|Overall Study||3
3213762|NCT02222688|3944598|FG002|STARTED|Overall Study||3
3213763|NCT02222688|3944599|FG003|STARTED|Overall Study||5
3213764|NCT02222688|3944600|FG004|STARTED|Overall Study||3
3213765|NCT02222688|3944601|FG005|STARTED|Overall Study||3
3213766|NCT02222688|3944602|FG006|STARTED|Overall Study||6
3213767|NCT02222688|3944596|FG000|COMPLETED|Overall Study||3
3213768|NCT02222688|3944597|FG001|COMPLETED|Overall Study||3
3213769|NCT02222688|3944598|FG002|COMPLETED|Overall Study||3
3213770|NCT02222688|3944599|FG003|COMPLETED|Overall Study||3
3213771|NCT02222688|3944600|FG004|COMPLETED|Overall Study||2
3213772|NCT02222688|3944601|FG005|COMPLETED|Overall Study||3
3213773|NCT02222688|3944602|FG006|COMPLETED|Overall Study||5
3213774|NCT02222688|3944596|FG000|NOT COMPLETED|Overall Study||1
3213775|NCT02222688|3944597|FG001|NOT COMPLETED|Overall Study||0
3213776|NCT02222688|3944598|FG002|NOT COMPLETED|Overall Study||0
3213777|NCT02222688|3944599|FG003|NOT COMPLETED|Overall Study||2
3213778|NCT02222688|3944600|FG004|NOT COMPLETED|Overall Study||1
3213779|NCT02222688|3944601|FG005|NOT COMPLETED|Overall Study||0
3213780|NCT02222688|3944602|FG006|NOT COMPLETED|Overall Study||1
3213781|NCT02222714|3944625|FG000|STARTED|Overall Study||15
3213782|NCT02222714|3944626|FG001|STARTED|Overall Study||24
3213783|NCT02222714|3944627|FG002|STARTED|Overall Study||12
3213784|NCT02222714|3944628|FG003|STARTED|Overall Study||15
3213785|NCT02222714|3944629|FG004|STARTED|Overall Study||44
3213786|NCT02222714|3944625|FG000|COMPLETED|Overall Study||15
3213787|NCT02222714|3944626|FG001|COMPLETED|Overall Study||22
3213788|NCT02222714|3944627|FG002|COMPLETED|Overall Study||8
3213789|NCT02222714|3944628|FG003|COMPLETED|Overall Study||11
3213790|NCT02222714|3944629|FG004|COMPLETED|Overall Study||37
3213791|NCT02222714|3944625|FG000|NOT COMPLETED|Overall Study||0
3213792|NCT02222714|3944626|FG001|NOT COMPLETED|Overall Study||2
3213793|NCT02222714|3944627|FG002|NOT COMPLETED|Overall Study||4
3213794|NCT02222714|3944628|FG003|NOT COMPLETED|Overall Study||4
3213795|NCT02222714|3944629|FG004|NOT COMPLETED|Overall Study||7
3213796|NCT02222818|3944646|FG000|STARTED|Period 1|Start of CAFR evaluation period|33
3366843|NCT03894449|4098213|FG003|STARTED|Overall Study||15
3213797|NCT02222818|3944647|FG001|STARTED|Period 1|Start of CAFRPlus evaluation period|33
3213798|NCT02222818|3944646|FG000|COMPLETED|Period 1|End of CAFR evaluation period|33
3213799|NCT02222818|3944647|FG001|COMPLETED|Period 1|End of CAFRPlus evaluation period|30
3213800|NCT02222818|3944646|FG000|NOT COMPLETED|Period 1||0
3213801|NCT02222818|3944647|FG001|NOT COMPLETED|Period 1||3
3213802|NCT02222818|3944646|FG000|STARTED|Period 2|Start of CAFRPlus evaluation period|33
3213803|NCT02222818|3944647|FG001|STARTED|Period 2|Start of CAFR evaluation period|30
3213804|NCT02222818|3944646|FG000|COMPLETED|Period 2|End of CAFRPlus evaluation period|33
3213805|NCT02222818|3944647|FG001|COMPLETED|Period 2|End of CAFR evaluation period|30
3213806|NCT02222818|3944646|FG000|NOT COMPLETED|Period 2||0
3213807|NCT02222818|3944647|FG001|NOT COMPLETED|Period 2||0
3213808|NCT02222870|3944654|FG000|STARTED|Overall Study||30
3213809|NCT02222870|3944655|FG001|STARTED|Overall Study||30
3213810|NCT02222870|3944654|FG000|COMPLETED|Overall Study||30
3213811|NCT02222870|3944655|FG001|COMPLETED|Overall Study||30
3213812|NCT02222870|3944654|FG000|NOT COMPLETED|Overall Study||0
3213813|NCT02222870|3944655|FG001|NOT COMPLETED|Overall Study||0
3213814|NCT02222896|3944661|FG000|STARTED|Abdomen||253
3213815|NCT02222896|3944662|FG001|STARTED|Abdomen||48
3213816|NCT02222896|3944663|FG002|STARTED|Abdomen||253
3213817|NCT02222896|3944661|FG000|COMPLETED|Abdomen||219
3213818|NCT02222896|3944662|FG001|COMPLETED|Abdomen||38
3213819|NCT02222896|3944663|FG002|COMPLETED|Abdomen||221
3213820|NCT02222896|3944661|FG000|NOT COMPLETED|Abdomen||34
3213821|NCT02222896|3944662|FG001|NOT COMPLETED|Abdomen||10
3213822|NCT02222896|3944663|FG002|NOT COMPLETED|Abdomen||32
3213823|NCT02222896|3944661|FG000|STARTED|Groin||254
3213824|NCT02222896|3944662|FG001|STARTED|Groin||48
3213825|NCT02222896|3944663|FG002|STARTED|Groin||250
3213826|NCT02222896|3944661|FG000|COMPLETED|Groin||211
3213827|NCT02222896|3944662|FG001|COMPLETED|Groin||39
3213828|NCT02222896|3944663|FG002|COMPLETED|Groin||210
3213829|NCT02222896|3944661|FG000|NOT COMPLETED|Groin||43
3213830|NCT02222896|3944662|FG001|NOT COMPLETED|Groin||9
3213831|NCT02222896|3944663|FG002|NOT COMPLETED|Groin||40
3213832|NCT02222922|3944683|FG000|STARTED|Overall Study||2
3213833|NCT02222922|3944684|FG001|STARTED|Overall Study||2
3213834|NCT02222922|3944685|FG002|STARTED|Overall Study||2
3213835|NCT02222922|3944686|FG003|STARTED|Overall Study||5
3213836|NCT02222922|3944687|FG004|STARTED|Overall Study||96
3213837|NCT02222922|3944688|FG005|STARTED|Overall Study||6
3213838|NCT02222922|3944689|FG006|STARTED|Overall Study||3
3213839|NCT02222922|3944690|FG007|STARTED|Overall Study||10
3213840|NCT02222922|3944691|FG008|STARTED|Overall Study||12
3213841|NCT02222922|3944683|FG000|Received Treatment|Overall Study||2
3213842|NCT02222922|3944684|FG001|Received Treatment|Overall Study||2
3213843|NCT02222922|3944685|FG002|Received Treatment|Overall Study||2
3213844|NCT02222922|3944686|FG003|Received Treatment|Overall Study||4
3213845|NCT02222922|3944687|FG004|Received Treatment|Overall Study||96
3213846|NCT02222922|3944688|FG005|Received Treatment|Overall Study||6
3213847|NCT02222922|3944689|FG006|Received Treatment|Overall Study||3
3213848|NCT02222922|3944690|FG007|Received Treatment|Overall Study||10
3213849|NCT02222922|3944691|FG008|Received Treatment|Overall Study||12
3213850|NCT02222922|3944683|FG000|COMPLETED|Overall Study||1
3213851|NCT02222922|3944684|FG001|COMPLETED|Overall Study||2
3213852|NCT02222922|3944685|FG002|COMPLETED|Overall Study||1
3213853|NCT02222922|3944686|FG003|COMPLETED|Overall Study||2
3213854|NCT02222922|3944687|FG004|COMPLETED|Overall Study||58
3213855|NCT02222922|3944688|FG005|COMPLETED|Overall Study||3
3213856|NCT02222922|3944689|FG006|COMPLETED|Overall Study||1
3213857|NCT02222922|3944690|FG007|COMPLETED|Overall Study||6
3213858|NCT02222922|3944691|FG008|COMPLETED|Overall Study||6
3213859|NCT02222922|3944683|FG000|NOT COMPLETED|Overall Study||1
3213860|NCT02222922|3944684|FG001|NOT COMPLETED|Overall Study||0
3213861|NCT02222922|3944685|FG002|NOT COMPLETED|Overall Study||1
3213862|NCT02222922|3944686|FG003|NOT COMPLETED|Overall Study||3
3213863|NCT02222922|3944687|FG004|NOT COMPLETED|Overall Study||38
3213864|NCT02222922|3944688|FG005|NOT COMPLETED|Overall Study||3
3213865|NCT02222922|3944689|FG006|NOT COMPLETED|Overall Study||2
3213866|NCT02222922|3944690|FG007|NOT COMPLETED|Overall Study||4
3213867|NCT02222922|3944691|FG008|NOT COMPLETED|Overall Study||6
3213868|NCT02223065|3944727|FG000|STARTED|Overall Study||18
3213869|NCT02223065|3944728|FG001|STARTED|Overall Study||18
3213870|NCT02223065|3944727|FG000|COMPLETED|Overall Study||18
3213871|NCT02223065|3944728|FG001|COMPLETED|Overall Study||18
3213872|NCT02223065|3944727|FG000|NOT COMPLETED|Overall Study||0
3213873|NCT02223065|3944728|FG001|NOT COMPLETED|Overall Study||0
3213874|NCT02223260|3944734|FG000|STARTED|Overall Study||8
3213875|NCT02223260|3944734|FG000|COMPLETED|Overall Study||8
3213876|NCT02223260|3944734|FG000|NOT COMPLETED|Overall Study||0
3213877|NCT02223338|3944740|FG000|STARTED|Overall Study||60
3213878|NCT02223338|3944741|FG001|STARTED|Overall Study||60
3213879|NCT02223338|3944740|FG000|COMPLETED|Overall Study||60
3213880|NCT02223338|3944741|FG001|COMPLETED|Overall Study||60
3213881|NCT02223338|3944740|FG000|NOT COMPLETED|Overall Study||0
3213882|NCT02223338|3944741|FG001|NOT COMPLETED|Overall Study||0
3213883|NCT02223351|3944749|FG000|STARTED|Overall Study||24
3213884|NCT02223351|3944750|FG001|STARTED|Overall Study||24
3213885|NCT02223351|3944749|FG000|First Intervention (8 Days)|Overall Study||24
3213886|NCT02223351|3944750|FG001|First Intervention (8 Days)|Overall Study||24
3213887|NCT02223351|3944749|FG000|Wasout (2weeks)|Overall Study||24
3213888|NCT02223351|3944750|FG001|Wasout (2weeks)|Overall Study||24
3213889|NCT02223351|3944749|FG000|Second Intervention (8 Days)|Overall Study||24
3213890|NCT02223351|3944750|FG001|Second Intervention (8 Days)|Overall Study||24
3213891|NCT02223351|3944749|FG000|COMPLETED|Overall Study||24
3213892|NCT02223351|3944750|FG001|COMPLETED|Overall Study||24
3213893|NCT02223351|3944749|FG000|NOT COMPLETED|Overall Study||0
3213894|NCT02223351|3944750|FG001|NOT COMPLETED|Overall Study||0
3213895|NCT02223364|3944767|FG000|STARTED|Overall Study||55
3213896|NCT02223364|3944768|FG001|STARTED|Overall Study||55
3213897|NCT02223364|3944769|FG002|STARTED|Overall Study||55
3213898|NCT02223364|3944767|FG000|COMPLETED|Overall Study||50
3213899|NCT02223364|3944768|FG001|COMPLETED|Overall Study||55
3213900|NCT02223364|3944769|FG002|COMPLETED|Overall Study||52
3213901|NCT02223364|3944767|FG000|NOT COMPLETED|Overall Study||5
3213902|NCT02223364|3944768|FG001|NOT COMPLETED|Overall Study||0
3213903|NCT02223364|3944769|FG002|NOT COMPLETED|Overall Study||3
3213904|NCT02223390|3944779|FG000|STARTED|Overall Study||32
3213905|NCT02223390|3944780|FG001|STARTED|Overall Study||32
3213906|NCT02223390|3944779|FG000|COMPLETED|Overall Study||23
3213907|NCT02223390|3944780|FG001|COMPLETED|Overall Study||28
3213908|NCT02223390|3944779|FG000|NOT COMPLETED|Overall Study||9
3213909|NCT02223390|3944780|FG001|NOT COMPLETED|Overall Study||4
3213910|NCT02223429|3944790|FG000|STARTED|Overall Study||8
3213911|NCT02223429|3944791|FG001|STARTED|Overall Study||8
3213912|NCT02223429|3944792|FG002|STARTED|Overall Study||8
3213913|NCT02223429|3944793|FG003|STARTED|Overall Study||8
3213914|NCT02223429|3944790|FG000|COMPLETED|Overall Study||7
3213915|NCT02223429|3944791|FG001|COMPLETED|Overall Study||8
3213916|NCT02223429|3944792|FG002|COMPLETED|Overall Study||8
3213917|NCT02223429|3944793|FG003|COMPLETED|Overall Study||8
3213918|NCT02223429|3944790|FG000|NOT COMPLETED|Overall Study||1
3213919|NCT02223429|3944791|FG001|NOT COMPLETED|Overall Study||0
3213920|NCT02223429|3944792|FG002|NOT COMPLETED|Overall Study||0
3213921|NCT02223429|3944793|FG003|NOT COMPLETED|Overall Study||0
3213922|NCT02223455|3944811|FG000|STARTED|Overall Study|Participant level data not collected.|
3213923|NCT02223455|3944812|FG001|STARTED|Overall Study|Participant level data not collected.|
3213924|NCT02223455|3944813|FG002|STARTED|Overall Study|Participant level data not collected.|
3213925|NCT02223455|3944811|FG000|COMPLETED|Overall Study|Participant level data not collected.|
3213926|NCT02223455|3944812|FG001|COMPLETED|Overall Study|Participant level data not collected.|
3213927|NCT02223455|3944813|FG002|COMPLETED|Overall Study|Participant level data not collected.|
3213928|NCT02223455|3944811|FG000|NOT COMPLETED|Overall Study||
3213929|NCT02223455|3944812|FG001|NOT COMPLETED|Overall Study||
3213930|NCT02223455|3944813|FG002|NOT COMPLETED|Overall Study||
3213931|NCT02223546|3944821|FG000|STARTED|Overall Study||15
3213932|NCT02223546|3944821|FG000|COMPLETED|Overall Study||15
3213933|NCT02223546|3944821|FG000|NOT COMPLETED|Overall Study||0
3213934|NCT02223637|3944825|FG000|STARTED|Overall Study||82
3213935|NCT02223637|3944825|FG000|COMPLETED|Overall Study||82
3213936|NCT02223637|3944825|FG000|NOT COMPLETED|Overall Study||0
3213937|NCT02223650|3944832|FG000|STARTED|Overall Study||27
3213938|NCT02223650|3944833|FG001|STARTED|Overall Study||31
3213939|NCT02223650|3944832|FG000|COMPLETED|Overall Study||27
3213940|NCT02223650|3944833|FG001|COMPLETED|Overall Study||31
3213941|NCT02223650|3944832|FG000|NOT COMPLETED|Overall Study||0
3213942|NCT02223650|3944833|FG001|NOT COMPLETED|Overall Study||0
3213943|NCT02223689|3944841|FG000|STARTED|Overall Study||35
3213944|NCT02223689|3944841|FG000|COMPLETED|Overall Study||35
3213945|NCT02223689|3944841|FG000|NOT COMPLETED|Overall Study||0
3213946|NCT02223702|3944848|FG000|STARTED|Overall Study||20
3213947|NCT02223702|3944849|FG001|STARTED|Overall Study||19
3213948|NCT02223702|3944848|FG000|COMPLETED|Overall Study||19
3213949|NCT02223702|3944849|FG001|COMPLETED|Overall Study||15
3213950|NCT02223702|3944848|FG000|NOT COMPLETED|Overall Study||1
3213951|NCT02223702|3944849|FG001|NOT COMPLETED|Overall Study||4
3213952|NCT02223715|3944855|FG000|STARTED|Overall Study||600
3213953|NCT02223715|3944855|FG000|COMPLETED|Overall Study||496
3213954|NCT02223715|3944855|FG000|NOT COMPLETED|Overall Study||104
3213955|NCT02223754|3944864|FG000|STARTED|Period 1||163
3213956|NCT02223754|3944865|FG001|STARTED|Period 1||159
3213957|NCT02223754|3944864|FG000|COMPLETED|Period 1||159
3213958|NCT02223754|3944865|FG001|COMPLETED|Period 1||144
3366844|NCT03894449|4098214|FG004|STARTED|Overall Study||15
3213959|NCT02223754|3944864|FG000|NOT COMPLETED|Period 1||4
3213960|NCT02223754|3944865|FG001|NOT COMPLETED|Period 1||15
3213961|NCT02223754|3944864|FG000|STARTED|Period 2||159
3213962|NCT02223754|3944865|FG001|STARTED|Period 2||144
3213963|NCT02223754|3944864|FG000|COMPLETED|Period 2||156
3213964|NCT02223754|3944865|FG001|COMPLETED|Period 2||141
3213965|NCT02223754|3944864|FG000|NOT COMPLETED|Period 2||3
3213966|NCT02223754|3944865|FG001|NOT COMPLETED|Period 2||3
3213967|NCT02223793|3944875|FG000|STARTED|Overall Study||185
3213968|NCT02223793|3944876|FG001|STARTED|Overall Study||199
3213969|NCT02223793|3944877|FG002|STARTED|Overall Study||198
3213970|NCT02223793|3944875|FG000|COMPLETED|Overall Study||168
3213971|NCT02223793|3944876|FG001|COMPLETED|Overall Study||190
3213972|NCT02223793|3944877|FG002|COMPLETED|Overall Study||185
3213973|NCT02223793|3944875|FG000|NOT COMPLETED|Overall Study||17
3213974|NCT02223793|3944876|FG001|NOT COMPLETED|Overall Study||9
3213975|NCT02223793|3944877|FG002|NOT COMPLETED|Overall Study||13
3213976|NCT02223858|3944887|FG000|STARTED|Overall Study||180
3213977|NCT02223858|3944888|FG001|STARTED|Overall Study||180
3213978|NCT02223858|3944887|FG000|1-month Follow-up|Overall Study||156
3213979|NCT02223858|3944888|FG001|1-month Follow-up|Overall Study||150
3213980|NCT02223858|3944887|FG000|3-month Follow-up|Overall Study||155
3213981|NCT02223858|3944888|FG001|3-month Follow-up|Overall Study||154
3213982|NCT02223858|3944887|FG000|6-month Follow-up|Overall Study||156
3213983|NCT02223858|3944888|FG001|6-month Follow-up|Overall Study||154
3213984|NCT02223858|3944887|FG000|COMPLETED|Overall Study||156
3213985|NCT02223858|3944888|FG001|COMPLETED|Overall Study||154
3213986|NCT02223858|3944887|FG000|NOT COMPLETED|Overall Study||24
3213987|NCT02223858|3944888|FG001|NOT COMPLETED|Overall Study||26
3213988|NCT02223871|3944894|FG000|STARTED|Overall Study||8
3213989|NCT02223871|3944894|FG000|COMPLETED|Overall Study||8
3213990|NCT02223871|3944894|FG000|NOT COMPLETED|Overall Study||0
3213991|NCT02224053|3944898|FG000|STARTED|AZD9291 and Omeprazole Co-administration||68
3213992|NCT02224053|3944898|FG000|COMPLETED|AZD9291 and Omeprazole Co-administration||47
3213993|NCT02224053|3944898|FG000|NOT COMPLETED|AZD9291 and Omeprazole Co-administration||21
3213994|NCT02224053|3944898|FG000|STARTED|AZD9291 Alone||47
3213995|NCT02224053|3944898|FG000|COMPLETED|AZD9291 Alone||47
3213996|NCT02224053|3944898|FG000|NOT COMPLETED|AZD9291 Alone||0
3213997|NCT02224157|3944906|FG000|STARTED|Overall Study||2095
3213998|NCT02224157|3944907|FG001|STARTED|Overall Study||2094
3213999|NCT02224157|3944906|FG000|Patients Who Completed Treatment|Overall Study||1924
3214000|NCT02224157|3944907|FG001|Patients Who Completed Treatment|Overall Study||1903
3214001|NCT02224157|3944906|FG000|COMPLETED|Overall Study||1985
3214002|NCT02224157|3944907|FG001|COMPLETED|Overall Study||1983
3214003|NCT02224157|3944906|FG000|NOT COMPLETED|Overall Study||110
3214004|NCT02224157|3944907|FG001|NOT COMPLETED|Overall Study||111
3214005|NCT02224274|3944915|FG000|STARTED|Overall Study||17
3214006|NCT02224274|3944916|FG001|STARTED|Overall Study||20
3214007|NCT02224274|3944915|FG000|COMPLETED|Overall Study||16
3214008|NCT02224274|3944916|FG001|COMPLETED|Overall Study||20
3214009|NCT02224274|3944915|FG000|NOT COMPLETED|Overall Study||1
3214010|NCT02224274|3944916|FG001|NOT COMPLETED|Overall Study||0
3214011|NCT02224313|3944924|FG000|STARTED|Overall Study||10
3214012|NCT02224313|3944925|FG001|STARTED|Overall Study||10
3214013|NCT02224313|3944924|FG000|COMPLETED|Overall Study||7
3214014|NCT02224313|3944925|FG001|COMPLETED|Overall Study||9
3214015|NCT02224313|3944924|FG000|NOT COMPLETED|Overall Study||3
3214016|NCT02224313|3944925|FG001|NOT COMPLETED|Overall Study||1
3214017|NCT02224404|3944931|FG000|STARTED|Overall Study||21
3214018|NCT02224404|3944931|FG000|COMPLETED|Overall Study||21
3214019|NCT02224404|3944931|FG000|NOT COMPLETED|Overall Study||0
3214020|NCT02224482|3944937|FG000|STARTED|Overall Study||214
3214021|NCT02224482|3944938|FG001|STARTED|Overall Study||217
3214022|NCT02224482|3944937|FG000|COMPLETED|Overall Study||63
3214023|NCT02224482|3944938|FG001|COMPLETED|Overall Study||57
3214024|NCT02224482|3944937|FG000|NOT COMPLETED|Overall Study||151
3214025|NCT02224482|3944938|FG001|NOT COMPLETED|Overall Study||160
3214026|NCT02224508|3944946|FG000|STARTED|Overall Study|Number of patients surveyed in intervention segment of the health plan (group practice).|935
3214027|NCT02224508|3944947|FG001|STARTED|Overall Study|Number of patients surveyed in the control segment of the health plan (contracted care).|653
3214028|NCT02224508|3944946|FG000|COMPLETED|Overall Study||935
3214029|NCT02224508|3944947|FG001|COMPLETED|Overall Study||653
3214030|NCT02224508|3944946|FG000|NOT COMPLETED|Overall Study||0
3214031|NCT02224508|3944947|FG001|NOT COMPLETED|Overall Study||0
3214032|NCT02224560|3944957|FG000|STARTED|Overall Study||76
3214033|NCT02224560|3944958|FG001|STARTED|Overall Study||73
3214034|NCT02224560|3944959|FG002|STARTED|Overall Study||76
3214035|NCT02224560|3944957|FG000|Safety Analysis Set|Overall Study|Six participants assigned to the 10 mg/kg/day dose were included in the 20 mg/kg/day group.|82
3214036|NCT02224560|3944958|FG001|Safety Analysis Set|Overall Study|Six participants assigned to the 10 mg/kg/day dose were included in the 20 mg/kg/day group.|67
3214037|NCT02224560|3944959|FG002|Safety Analysis Set|Overall Study||76
3214038|NCT02224560|3944957|FG000|Intent to Treat (ITT) Analysis Set|Overall Study||76
3214039|NCT02224560|3944958|FG001|Intent to Treat (ITT) Analysis Set|Overall Study||73
3214040|NCT02224560|3944959|FG002|Intent to Treat (ITT) Analysis Set|Overall Study||76
3214041|NCT02224560|3944957|FG000|COMPLETED|Overall Study||67
3214042|NCT02224560|3944958|FG001|COMPLETED|Overall Study||71
3214043|NCT02224560|3944959|FG002|COMPLETED|Overall Study||74
3214044|NCT02224560|3944957|FG000|NOT COMPLETED|Overall Study||9
3214045|NCT02224560|3944958|FG001|NOT COMPLETED|Overall Study||2
3214046|NCT02224560|3944959|FG002|NOT COMPLETED|Overall Study||2
3214047|NCT02224612|3944967|FG000|STARTED|Overall Study||48
3214048|NCT02224612|3944968|FG001|STARTED|Overall Study||48
3214049|NCT02224612|3944967|FG000|COMPLETED|Overall Study||48
3214050|NCT02224612|3944968|FG001|COMPLETED|Overall Study||48
3214051|NCT02224612|3944967|FG000|NOT COMPLETED|Overall Study||0
3214052|NCT02224612|3944968|FG001|NOT COMPLETED|Overall Study||0
3214053|NCT02224625|3944976|FG000|STARTED|Irritation||39
3214054|NCT02224625|3944976|FG000|COMPLETED|Irritation||33
3214055|NCT02224625|3944976|FG000|NOT COMPLETED|Irritation||6
3214056|NCT02224625|3944976|FG000|STARTED|Sensitization|Subjects from Irritation study also participated in Sensitization Study|249
3214057|NCT02224625|3944976|FG000|COMPLETED|Sensitization||194
3214058|NCT02224625|3944976|FG000|NOT COMPLETED|Sensitization||55
3214059|NCT02224638|3944990|FG000|STARTED|Overall Study||11
3214060|NCT02224638|3944991|FG001|STARTED|Overall Study||10
3214061|NCT02224638|3944990|FG000|COMPLETED|Overall Study||10
3214062|NCT02224638|3944991|FG001|COMPLETED|Overall Study||9
3214063|NCT02224638|3944990|FG000|NOT COMPLETED|Overall Study||1
3214064|NCT02224638|3944991|FG001|NOT COMPLETED|Overall Study||1
3214065|NCT02224664|3944999|FG000|STARTED|Lead-in Period (3 Days)||50
3214066|NCT02224664|3945000|FG001|STARTED|Lead-in Period (3 Days)||0
3214067|NCT02224664|3945001|FG002|STARTED|Lead-in Period (3 Days)||0
3214068|NCT02224664|3945002|FG003|STARTED|Lead-in Period (3 Days)||0
3214069|NCT02224664|3945003|FG004|STARTED|Lead-in Period (3 Days)||0
3214070|NCT02224664|3944999|FG000|COMPLETED|Lead-in Period (3 Days)||45
3214071|NCT02224664|3945000|FG001|COMPLETED|Lead-in Period (3 Days)||0
3214072|NCT02224664|3945001|FG002|COMPLETED|Lead-in Period (3 Days)||0
3214073|NCT02224664|3945002|FG003|COMPLETED|Lead-in Period (3 Days)||0
3214074|NCT02224664|3945003|FG004|COMPLETED|Lead-in Period (3 Days)||0
3214075|NCT02224664|3944999|FG000|NOT COMPLETED|Lead-in Period (3 Days)||5
3214076|NCT02224664|3945000|FG001|NOT COMPLETED|Lead-in Period (3 Days)||0
3214077|NCT02224664|3945001|FG002|NOT COMPLETED|Lead-in Period (3 Days)||0
3214078|NCT02224664|3945002|FG003|NOT COMPLETED|Lead-in Period (3 Days)||0
3214079|NCT02224664|3945003|FG004|NOT COMPLETED|Lead-in Period (3 Days)||0
3214080|NCT02224664|3944999|FG000|STARTED|Dose Escalation Period (21 Days)||0
3214081|NCT02224664|3945000|FG001|STARTED|Dose Escalation Period (21 Days)||9
3214082|NCT02224664|3945001|FG002|STARTED|Dose Escalation Period (21 Days)||11
3214083|NCT02224664|3945002|FG003|STARTED|Dose Escalation Period (21 Days)||6
3214084|NCT02224664|3945003|FG004|STARTED|Dose Escalation Period (21 Days)||19
3214085|NCT02224664|3944999|FG000|COMPLETED|Dose Escalation Period (21 Days)||0
3214086|NCT02224664|3945000|FG001|COMPLETED|Dose Escalation Period (21 Days)||9
3214087|NCT02224664|3945001|FG002|COMPLETED|Dose Escalation Period (21 Days)||9
3214088|NCT02224664|3945002|FG003|COMPLETED|Dose Escalation Period (21 Days)||3
3214089|NCT02224664|3945003|FG004|COMPLETED|Dose Escalation Period (21 Days)||8
3214090|NCT02224664|3944999|FG000|NOT COMPLETED|Dose Escalation Period (21 Days)||0
3214091|NCT02224664|3945000|FG001|NOT COMPLETED|Dose Escalation Period (21 Days)||0
3214092|NCT02224664|3945001|FG002|NOT COMPLETED|Dose Escalation Period (21 Days)||2
3214093|NCT02224664|3945002|FG003|NOT COMPLETED|Dose Escalation Period (21 Days)||3
3214094|NCT02224664|3945003|FG004|NOT COMPLETED|Dose Escalation Period (21 Days)||11
3214095|NCT02224690|3945021|FG000|STARTED|Overall Study||86
3214096|NCT02224690|3945022|FG001|STARTED|Overall Study||85
3214097|NCT02224690|3945021|FG000|Safety Analysis Set|Overall Study||86
3214098|NCT02224690|3945022|FG001|Safety Analysis Set|Overall Study||85
3214099|NCT02224690|3945021|FG000|Intent to Treat (ITT) Analysis Set|Overall Study||86
3214100|NCT02224690|3945022|FG001|Intent to Treat (ITT) Analysis Set|Overall Study||85
3214101|NCT02224690|3945021|FG000|COMPLETED|Overall Study||72
3214102|NCT02224690|3945022|FG001|COMPLETED|Overall Study||84
3214103|NCT02224690|3945021|FG000|NOT COMPLETED|Overall Study||14
3214104|NCT02224690|3945022|FG001|NOT COMPLETED|Overall Study||1
3214105|NCT02224703|3945031|FG000|STARTED|Overall Study||67
3214106|NCT02224703|3945032|FG001|STARTED|Overall Study||67
3214107|NCT02224703|3945033|FG002|STARTED|Overall Study||65
3214108|NCT02224703|3945031|FG000|Received at Least 1 Dose of Study Drug|Overall Study||66
3214109|NCT02224703|3945032|FG001|Received at Least 1 Dose of Study Drug|Overall Study||67
3214110|NCT02224703|3945033|FG002|Received at Least 1 Dose of Study Drug|Overall Study||65
3214111|NCT02224703|3945031|FG000|Safety Analysis Set|Overall Study|Two participants assigned to the 10 mg/kg/day dose were included in the 20 mg/kg/day group|64
3214112|NCT02224703|3945032|FG001|Safety Analysis Set|Overall Study|Two participants assigned to the 10 mg/kg/day dose were included in the 20 mg/kg/day group|69
3214113|NCT02224703|3945033|FG002|Safety Analysis Set|Overall Study||65
3214114|NCT02224703|3945031|FG000|Intent to Treat (ITT) Analysis Set|Overall Study||66
3214115|NCT02224703|3945032|FG001|Intent to Treat (ITT) Analysis Set|Overall Study||67
3214116|NCT02224703|3945033|FG002|Intent to Treat (ITT) Analysis Set|Overall Study||65
3214117|NCT02224703|3945031|FG000|COMPLETED|Overall Study||64
3214118|NCT02224703|3945032|FG001|COMPLETED|Overall Study||61
3214119|NCT02224703|3945033|FG002|COMPLETED|Overall Study||65
3214120|NCT02224703|3945031|FG000|NOT COMPLETED|Overall Study||3
3214121|NCT02224703|3945032|FG001|NOT COMPLETED|Overall Study||6
3214122|NCT02224703|3945033|FG002|NOT COMPLETED|Overall Study||0
3214123|NCT02224729|3945042|FG000|STARTED|Overall Study||24
3214124|NCT02224729|3945042|FG000|COMPLETED|Overall Study||24
3214125|NCT02224729|3945042|FG000|NOT COMPLETED|Overall Study||0
3214126|NCT02224755|3945048|FG000|STARTED|Randomization to Device Implant|Patients in the Full Study Cohort (n=1028) who were randomized to HeartMate II|512
3214127|NCT02224755|3945049|FG001|STARTED|Randomization to Device Implant|Patients in the Full Study Cohort (n=1028) who were randomized to HeartMate 3|516
3214128|NCT02224755|3945048|FG000|COMPLETED|Randomization to Device Implant|Patients who underwent HeartMate II LVAS implant|505
3214129|NCT02224755|3945049|FG001|COMPLETED|Randomization to Device Implant|Patients who underwent HeartMate 3 LVAS implant|515
3214130|NCT02224755|3945048|FG000|NOT COMPLETED|Randomization to Device Implant||7
3214131|NCT02224755|3945049|FG001|NOT COMPLETED|Randomization to Device Implant||1
3214132|NCT02224755|3945048|FG000|STARTED|Two Year Follow up Post-implant||505
3214133|NCT02224755|3945049|FG001|STARTED|Two Year Follow up Post-implant||515
3214134|NCT02224755|3945048|FG000|COMPLETED|Two Year Follow up Post-implant||247
3214135|NCT02224755|3945049|FG001|COMPLETED|Two Year Follow up Post-implant||289
3214136|NCT02224755|3945048|FG000|NOT COMPLETED|Two Year Follow up Post-implant||258
3214137|NCT02224755|3945049|FG001|NOT COMPLETED|Two Year Follow up Post-implant||226
3214138|NCT02224820|3945059|FG000|STARTED|Overall Study||8
3214139|NCT02224820|3945059|FG000|COMPLETED|Overall Study|One patient did not receive full dose|8
3214140|NCT02224820|3945059|FG000|NOT COMPLETED|Overall Study||0
3214141|NCT02224846|3945065|FG000|STARTED|Period 1 (Month 3)||211
3214142|NCT02224846|3945066|FG001|STARTED|Period 1 (Month 3)||424
3214143|NCT02224846|3945065|FG000|Received at Least One Dose of Study Drug|Period 1 (Month 3)||210
3214144|NCT02224846|3945066|FG001|Received at Least One Dose of Study Drug|Period 1 (Month 3)||421
3214145|NCT02224846|3945065|FG000|COMPLETED|Period 1 (Month 3)||192
3214146|NCT02224846|3945066|FG001|COMPLETED|Period 1 (Month 3)||388
3214147|NCT02224846|3945065|FG000|NOT COMPLETED|Period 1 (Month 3)||19
3214148|NCT02224846|3945066|FG001|NOT COMPLETED|Period 1 (Month 3)||36
3214149|NCT02224846|3945065|FG000|STARTED|Period 2 (Month 3 to Month 12)||192
3214150|NCT02224846|3945066|FG001|STARTED|Period 2 (Month 3 to Month 12)||388
3214151|NCT02224846|3945065|FG000|COMPLETED|Period 2 (Month 3 to Month 12)||173
3214152|NCT02224846|3945066|FG001|COMPLETED|Period 2 (Month 3 to Month 12)||357
3214153|NCT02224846|3945065|FG000|NOT COMPLETED|Period 2 (Month 3 to Month 12)||19
3214154|NCT02224846|3945066|FG001|NOT COMPLETED|Period 2 (Month 3 to Month 12)||31
3214155|NCT02224846|3945065|FG000|STARTED|Period 2 (Month 12 to Month 24)||173
3214156|NCT02224846|3945066|FG001|STARTED|Period 2 (Month 12 to Month 24)||357
3214157|NCT02224846|3945065|FG000|COMPLETED|Period 2 (Month 12 to Month 24)||131
3214158|NCT02224846|3945066|FG001|COMPLETED|Period 2 (Month 12 to Month 24)||283
3214159|NCT02224846|3945065|FG000|NOT COMPLETED|Period 2 (Month 12 to Month 24)||42
3214160|NCT02224846|3945066|FG001|NOT COMPLETED|Period 2 (Month 12 to Month 24)||74
3214161|NCT02225080|3945072|FG000|STARTED|Overall Study||100
3214162|NCT02225080|3945072|FG000|COMPLETED|Overall Study||100
3214163|NCT02225080|3945072|FG000|NOT COMPLETED|Overall Study||0
3214164|NCT02225106|3945076|FG000|STARTED|Overall Study||11
3214165|NCT02225106|3945076|FG000|COMPLETED|Overall Study||11
3214166|NCT02225106|3945076|FG000|NOT COMPLETED|Overall Study||0
3214167|NCT02225132|3945080|FG000|STARTED|Overall Study||10
3214168|NCT02225132|3945080|FG000|COMPLETED|Overall Study||10
3214169|NCT02225132|3945080|FG000|NOT COMPLETED|Overall Study||0
3214170|NCT02225223|3945086|FG000|STARTED|Overall Study||27
3214171|NCT02225223|3945087|FG001|STARTED|Overall Study||8
3214172|NCT02225223|3945086|FG000|COMPLETED|Overall Study||8
3214173|NCT02225223|3945087|FG001|COMPLETED|Overall Study||3
3214174|NCT02225223|3945086|FG000|NOT COMPLETED|Overall Study||19
3214175|NCT02225223|3945087|FG001|NOT COMPLETED|Overall Study||5
3214176|NCT02225353|3945096|FG000|STARTED|Overall Study||91
3214177|NCT02225353|3945097|FG001|STARTED|Overall Study||90
3214178|NCT02225353|3945098|FG002|STARTED|Overall Study||90
3214179|NCT02225353|3945096|FG000|COMPLETED|Overall Study||87
3214180|NCT02225353|3945097|FG001|COMPLETED|Overall Study||84
3214181|NCT02225353|3945098|FG002|COMPLETED|Overall Study||75
3214182|NCT02225353|3945096|FG000|NOT COMPLETED|Overall Study||4
3214183|NCT02225353|3945097|FG001|NOT COMPLETED|Overall Study||6
3214184|NCT02225353|3945098|FG002|NOT COMPLETED|Overall Study||15
3214185|NCT02225587|3945111|FG000|STARTED|Overall Study||200
3214186|NCT02225587|3945112|FG001|STARTED|Overall Study||200
3214187|NCT02225587|3945111|FG000|Vaccination 2|Overall Study||188
3214188|NCT02225587|3945112|FG001|Vaccination 2|Overall Study||185
3214189|NCT02225587|3945111|FG000|Vaccination 3|Overall Study||172
3214190|NCT02225587|3945112|FG001|Vaccination 3|Overall Study||164
3214191|NCT02225587|3945111|FG000|COMPLETED|Overall Study||172
3214192|NCT02225587|3945112|FG001|COMPLETED|Overall Study||162
3214193|NCT02225587|3945111|FG000|NOT COMPLETED|Overall Study||28
3214194|NCT02225587|3945112|FG001|NOT COMPLETED|Overall Study||38
3214195|NCT02225665|3945120|FG000|STARTED|Overall Study||3
3214196|NCT02225665|3945121|FG001|STARTED|Overall Study||5
3214197|NCT02225665|3945120|FG000|COMPLETED|Overall Study||2
3214198|NCT02225665|3945121|FG001|COMPLETED|Overall Study||4
3214199|NCT02225665|3945120|FG000|NOT COMPLETED|Overall Study||1
3214200|NCT02225665|3945121|FG001|NOT COMPLETED|Overall Study||1
3214201|NCT02225743|3945127|FG000|STARTED|Overall Study||120
3214202|NCT02225743|3945127|FG000|COMPLETED|Overall Study|18 patients chose not to participate on the day of surgery.|102
3214203|NCT02225743|3945127|FG000|NOT COMPLETED|Overall Study||18
3214204|NCT02225860|3945133|FG000|STARTED|Overall Study||17
3214205|NCT02225860|3945134|FG001|STARTED|Overall Study||17
3214206|NCT02225860|3945133|FG000|COMPLETED|Overall Study||16
3214207|NCT02225860|3945134|FG001|COMPLETED|Overall Study||17
3214208|NCT02225860|3945133|FG000|NOT COMPLETED|Overall Study||1
3214209|NCT02225860|3945134|FG001|NOT COMPLETED|Overall Study||0
3214210|NCT02225925|3945141|FG000|STARTED|Overall Study||45
3214211|NCT02225925|3945141|FG000|COMPLETED|Overall Study||45
3214212|NCT02225925|3945141|FG000|NOT COMPLETED|Overall Study||0
3214213|NCT02226003|3945148|FG000|STARTED|Overall Study||98
3214214|NCT02226003|3945149|FG001|STARTED|Overall Study||96
3214215|NCT02226003|3945150|FG002|STARTED|Overall Study||97
3214216|NCT02226003|3945148|FG000|COMPLETED|Overall Study||96
3214217|NCT02226003|3945149|FG001|COMPLETED|Overall Study||95
3214218|NCT02226003|3945150|FG002|COMPLETED|Overall Study||91
3214219|NCT02226003|3945148|FG000|NOT COMPLETED|Overall Study||2
3214220|NCT02226003|3945149|FG001|NOT COMPLETED|Overall Study||1
3214221|NCT02226003|3945150|FG002|NOT COMPLETED|Overall Study||6
3214222|NCT02226120|3945158|FG000|STARTED|Overall Study||1980
3214223|NCT02226120|3945158|FG000|COMPLETED|Overall Study||1660
3214224|NCT02226120|3945158|FG000|NOT COMPLETED|Overall Study||320
3214225|NCT02226159|3945164|FG000|STARTED|Overall Study||33
3214226|NCT02226159|3945165|FG001|STARTED|Overall Study||32
3214227|NCT02226159|3945164|FG000|COMPLETED|Overall Study||27
3214228|NCT02226159|3945165|FG001|COMPLETED|Overall Study||26
3214229|NCT02226159|3945164|FG000|NOT COMPLETED|Overall Study||6
3214230|NCT02226159|3945165|FG001|NOT COMPLETED|Overall Study||6
3214231|NCT02226172|3945171|FG000|STARTED|Overall Study||21
3214232|NCT02226172|3945171|FG000|COMPLETED|Overall Study||4
3214233|NCT02226172|3945171|FG000|NOT COMPLETED|Overall Study||17
3214234|NCT02226198|3945175|FG000|STARTED|Lead-in Phase||11
3214235|NCT02226198|3945176|FG001|STARTED|Lead-in Phase||0
3214236|NCT02226198|3945177|FG002|STARTED|Lead-in Phase||0
3214237|NCT02226198|3945175|FG000|COMPLETED|Lead-in Phase||10
3214238|NCT02226198|3945176|FG001|COMPLETED|Lead-in Phase||0
3214239|NCT02226198|3945177|FG002|COMPLETED|Lead-in Phase||0
3214240|NCT02226198|3945175|FG000|NOT COMPLETED|Lead-in Phase||1
3214241|NCT02226198|3945176|FG001|NOT COMPLETED|Lead-in Phase||0
3214242|NCT02226198|3945177|FG002|NOT COMPLETED|Lead-in Phase||0
3214243|NCT02226198|3945175|FG000|STARTED|Cross-Over: First Intervention (6 Weeks)||0
3214244|NCT02226198|3945176|FG001|STARTED|Cross-Over: First Intervention (6 Weeks)||7
3214245|NCT02226198|3945177|FG002|STARTED|Cross-Over: First Intervention (6 Weeks)||7
3214246|NCT02226198|3945175|FG000|COMPLETED|Cross-Over: First Intervention (6 Weeks)||0
3214247|NCT02226198|3945176|FG001|COMPLETED|Cross-Over: First Intervention (6 Weeks)||6
3214248|NCT02226198|3945177|FG002|COMPLETED|Cross-Over: First Intervention (6 Weeks)||7
3214249|NCT02226198|3945175|FG000|NOT COMPLETED|Cross-Over: First Intervention (6 Weeks)||0
3214250|NCT02226198|3945176|FG001|NOT COMPLETED|Cross-Over: First Intervention (6 Weeks)||1
3214251|NCT02226198|3945177|FG002|NOT COMPLETED|Cross-Over: First Intervention (6 Weeks)||0
3214252|NCT02226198|3945175|FG000|STARTED|Cross-Over: Second Interv. (6 Weeks)||0
3214253|NCT02226198|3945176|FG001|STARTED|Cross-Over: Second Interv. (6 Weeks)||6
3214254|NCT02226198|3945177|FG002|STARTED|Cross-Over: Second Interv. (6 Weeks)||7
3214255|NCT02226198|3945175|FG000|COMPLETED|Cross-Over: Second Interv. (6 Weeks)||0
3214256|NCT02226198|3945176|FG001|COMPLETED|Cross-Over: Second Interv. (6 Weeks)||6
3214257|NCT02226198|3945177|FG002|COMPLETED|Cross-Over: Second Interv. (6 Weeks)||7
3214258|NCT02226198|3945175|FG000|NOT COMPLETED|Cross-Over: Second Interv. (6 Weeks)||0
3214259|NCT02226198|3945176|FG001|NOT COMPLETED|Cross-Over: Second Interv. (6 Weeks)||0
3214260|NCT02226198|3945177|FG002|NOT COMPLETED|Cross-Over: Second Interv. (6 Weeks)||0
3214261|NCT02226198|3945175|FG000|STARTED|Maintenance Phase (12 Weeks)||13
3214262|NCT02226198|3945176|FG001|STARTED|Maintenance Phase (12 Weeks)||0
3214263|NCT02226198|3945177|FG002|STARTED|Maintenance Phase (12 Weeks)||0
3214264|NCT02226198|3945175|FG000|COMPLETED|Maintenance Phase (12 Weeks)||13
3214265|NCT02226198|3945176|FG001|COMPLETED|Maintenance Phase (12 Weeks)||0
3214266|NCT02226198|3945177|FG002|COMPLETED|Maintenance Phase (12 Weeks)||0
3214267|NCT02226198|3945175|FG000|NOT COMPLETED|Maintenance Phase (12 Weeks)||0
3214268|NCT02226198|3945176|FG001|NOT COMPLETED|Maintenance Phase (12 Weeks)||0
3214269|NCT02226198|3945177|FG002|NOT COMPLETED|Maintenance Phase (12 Weeks)||0
3214270|NCT02226549|3945205|FG000|STARTED|Overall Study||23
3214271|NCT02226549|3945206|FG001|STARTED|Overall Study||24
3214272|NCT02226549|3945205|FG000|COMPLETED|Overall Study||22
3214273|NCT02226549|3945206|FG001|COMPLETED|Overall Study||23
3214274|NCT02226549|3945205|FG000|NOT COMPLETED|Overall Study||1
3214275|NCT02226549|3945206|FG001|NOT COMPLETED|Overall Study||1
3214276|NCT02226562|3945214|FG000|STARTED|Overall Study||95
3214277|NCT02226562|3945215|FG001|STARTED|Overall Study||96
3214278|NCT02226562|3945214|FG000|COMPLETED|Overall Study||95
3214279|NCT02226562|3945215|FG001|COMPLETED|Overall Study|Lost to follow up|95
3214280|NCT02226562|3945214|FG000|NOT COMPLETED|Overall Study||0
3214281|NCT02226562|3945215|FG001|NOT COMPLETED|Overall Study||1
3214282|NCT02226653|3945223|FG000|STARTED|Treatment Period 1 Fasted State||24
3214283|NCT02226653|3945224|FG001|STARTED|Treatment Period 1 Fasted State||24
3214284|NCT02226653|3945223|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 1 Fasted State||24
3214285|NCT02226653|3945224|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 1 Fasted State||24
3214286|NCT02226653|3945223|FG000|COMPLETED|Treatment Period 1 Fasted State||24
3214287|NCT02226653|3945224|FG001|COMPLETED|Treatment Period 1 Fasted State||24
3214288|NCT02226653|3945223|FG000|NOT COMPLETED|Treatment Period 1 Fasted State||0
3214289|NCT02226653|3945224|FG001|NOT COMPLETED|Treatment Period 1 Fasted State||0
3214290|NCT02226653|3945223|FG000|STARTED|Washout Period 1 (at Least 21 Days)||24
3214291|NCT02226653|3945224|FG001|STARTED|Washout Period 1 (at Least 21 Days)||24
3214292|NCT02226653|3945223|FG000|COMPLETED|Washout Period 1 (at Least 21 Days)||24
3214293|NCT02226653|3945224|FG001|COMPLETED|Washout Period 1 (at Least 21 Days)||24
3214294|NCT02226653|3945223|FG000|NOT COMPLETED|Washout Period 1 (at Least 21 Days)||0
3214295|NCT02226653|3945224|FG001|NOT COMPLETED|Washout Period 1 (at Least 21 Days)||0
3214296|NCT02226653|3945223|FG000|STARTED|Treatment Period 2 Fasted State||24
3366845|NCT03894449|4098210|FG000|COMPLETED|Overall Study||15
3366846|NCT03894449|4098211|FG001|COMPLETED|Overall Study||15
3366847|NCT03894449|4098212|FG002|COMPLETED|Overall Study||15
3366848|NCT03894449|4098213|FG003|COMPLETED|Overall Study||15
3366849|NCT03894449|4098214|FG004|COMPLETED|Overall Study||15
3366850|NCT03894449|4098210|FG000|NOT COMPLETED|Overall Study||0
3366851|NCT03894449|4098211|FG001|NOT COMPLETED|Overall Study||0
3366852|NCT03894449|4098212|FG002|NOT COMPLETED|Overall Study||0
3366853|NCT03894449|4098213|FG003|NOT COMPLETED|Overall Study||0
3366854|NCT03894449|4098214|FG004|NOT COMPLETED|Overall Study||0
3366855|NCT03892564|4098226|FG000|STARTED|Overall Study||35
3366856|NCT03892564|4098226|FG000|MC2-01 Cream + Irridiation|Overall Study||35
3366857|NCT03892564|4098226|FG000|MC2-01 Cream + Non-irridiation|Overall Study||35
3366858|NCT03892564|4098226|FG000|MC2-01 Vehicle + Irridiation|Overall Study||35
3366859|NCT03892564|4098226|FG000|MC2-01 Vehicle + Non-irridiation|Overall Study||35
3366860|NCT03892564|4098226|FG000|Control Site|Overall Study||35
3366861|NCT03892564|4098226|FG000|COMPLETED|Overall Study||33
3366862|NCT03892564|4098226|FG000|NOT COMPLETED|Overall Study||2
3214297|NCT02226653|3945224|FG001|STARTED|Treatment Period 2 Fasted State||24
3214298|NCT02226653|3945223|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 2 Fasted State||24
3214299|NCT02226653|3945224|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 2 Fasted State||24
3214300|NCT02226653|3945223|FG000|COMPLETED|Treatment Period 2 Fasted State||23
3214301|NCT02226653|3945224|FG001|COMPLETED|Treatment Period 2 Fasted State||24
3214302|NCT02226653|3945223|FG000|NOT COMPLETED|Treatment Period 2 Fasted State||1
3214303|NCT02226653|3945224|FG001|NOT COMPLETED|Treatment Period 2 Fasted State||0
3214304|NCT02226653|3945223|FG000|STARTED|Washout Period 2 (at Least 21 Days)||23
3214305|NCT02226653|3945224|FG001|STARTED|Washout Period 2 (at Least 21 Days)||24
3214306|NCT02226653|3945223|FG000|COMPLETED|Washout Period 2 (at Least 21 Days)||23
3214307|NCT02226653|3945224|FG001|COMPLETED|Washout Period 2 (at Least 21 Days)||24
3214308|NCT02226653|3945223|FG000|NOT COMPLETED|Washout Period 2 (at Least 21 Days)||0
3214309|NCT02226653|3945224|FG001|NOT COMPLETED|Washout Period 2 (at Least 21 Days)||0
3214310|NCT02226653|3945223|FG000|STARTED|Treatment Period 3 Fasted State||23
3214311|NCT02226653|3945224|FG001|STARTED|Treatment Period 3 Fasted State||24
3214312|NCT02226653|3945223|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 3 Fasted State||23
3214313|NCT02226653|3945224|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 3 Fasted State||24
3214314|NCT02226653|3945223|FG000|COMPLETED|Treatment Period 3 Fasted State||23
3214315|NCT02226653|3945224|FG001|COMPLETED|Treatment Period 3 Fasted State||24
3214316|NCT02226653|3945223|FG000|NOT COMPLETED|Treatment Period 3 Fasted State||0
3214317|NCT02226653|3945224|FG001|NOT COMPLETED|Treatment Period 3 Fasted State||0
3214318|NCT02226653|3945223|FG000|STARTED|Washout Period 3 (at Least 21 Days)||23
3214319|NCT02226653|3945224|FG001|STARTED|Washout Period 3 (at Least 21 Days)||24
3214320|NCT02226653|3945223|FG000|COMPLETED|Washout Period 3 (at Least 21 Days)||23
3214321|NCT02226653|3945224|FG001|COMPLETED|Washout Period 3 (at Least 21 Days)||24
3214322|NCT02226653|3945223|FG000|NOT COMPLETED|Washout Period 3 (at Least 21 Days)||0
3214323|NCT02226653|3945224|FG001|NOT COMPLETED|Washout Period 3 (at Least 21 Days)||0
3214324|NCT02226653|3945223|FG000|STARTED|Treatment Period 4 Fasted State||23
3214325|NCT02226653|3945224|FG001|STARTED|Treatment Period 4 Fasted State||24
3214326|NCT02226653|3945223|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 4 Fasted State||23
3214327|NCT02226653|3945224|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 4 Fasted State||24
3214328|NCT02226653|3945223|FG000|COMPLETED|Treatment Period 4 Fasted State||23
3214329|NCT02226653|3945224|FG001|COMPLETED|Treatment Period 4 Fasted State||24
3214330|NCT02226653|3945223|FG000|NOT COMPLETED|Treatment Period 4 Fasted State||0
3214331|NCT02226653|3945224|FG001|NOT COMPLETED|Treatment Period 4 Fasted State||0
3214332|NCT02226653|3945223|FG000|STARTED|Washout Period 4 (at Least 21 Days)||23
3214333|NCT02226653|3945224|FG001|STARTED|Washout Period 4 (at Least 21 Days)||24
3214334|NCT02226653|3945223|FG000|COMPLETED|Washout Period 4 (at Least 21 Days)||23
3214335|NCT02226653|3945224|FG001|COMPLETED|Washout Period 4 (at Least 21 Days)||24
3214336|NCT02226653|3945223|FG000|NOT COMPLETED|Washout Period 4 (at Least 21 Days)||0
3214337|NCT02226653|3945224|FG001|NOT COMPLETED|Washout Period 4 (at Least 21 Days)||0
3214338|NCT02226653|3945223|FG000|STARTED|Treatment Period 5 Fed State||23
3214339|NCT02226653|3945224|FG001|STARTED|Treatment Period 5 Fed State||24
3214340|NCT02226653|3945223|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 5 Fed State||23
3214341|NCT02226653|3945224|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 5 Fed State||24
3214342|NCT02226653|3945223|FG000|COMPLETED|Treatment Period 5 Fed State||23
3214343|NCT02226653|3945224|FG001|COMPLETED|Treatment Period 5 Fed State||23
3214344|NCT02226653|3945223|FG000|NOT COMPLETED|Treatment Period 5 Fed State||0
3214345|NCT02226653|3945224|FG001|NOT COMPLETED|Treatment Period 5 Fed State||1
3214346|NCT02226653|3945223|FG000|STARTED|Washout Period 5 (at Least 21 Days)||23
3214347|NCT02226653|3945224|FG001|STARTED|Washout Period 5 (at Least 21 Days)||23
3214348|NCT02226653|3945223|FG000|COMPLETED|Washout Period 5 (at Least 21 Days)||23
3214349|NCT02226653|3945224|FG001|COMPLETED|Washout Period 5 (at Least 21 Days)||23
3214350|NCT02226653|3945223|FG000|NOT COMPLETED|Washout Period 5 (at Least 21 Days)||0
3214351|NCT02226653|3945224|FG001|NOT COMPLETED|Washout Period 5 (at Least 21 Days)||0
3214352|NCT02226796|3945237|FG000|STARTED|First Intervention Phase (Week 1)||2
3214353|NCT02226796|3945238|FG001|STARTED|First Intervention Phase (Week 1)||1
3214354|NCT02226796|3945237|FG000|Baseline Assessment|First Intervention Phase (Week 1)||2
3214355|NCT02226796|3945238|FG001|Baseline Assessment|First Intervention Phase (Week 1)||1
3214356|NCT02226796|3945237|FG000|Follow Up Assessment|First Intervention Phase (Week 1)||2
3214357|NCT02226796|3945238|FG001|Follow Up Assessment|First Intervention Phase (Week 1)||1
3214358|NCT02226796|3945237|FG000|COMPLETED|First Intervention Phase (Week 1)||2
3214359|NCT02226796|3945238|FG001|COMPLETED|First Intervention Phase (Week 1)||1
3214360|NCT02226796|3945237|FG000|NOT COMPLETED|First Intervention Phase (Week 1)||0
3214361|NCT02226796|3945238|FG001|NOT COMPLETED|First Intervention Phase (Week 1)||0
3214362|NCT02226796|3945237|FG000|STARTED|Washout (Weeks 2-5)||2
3214363|NCT02226796|3945238|FG001|STARTED|Washout (Weeks 2-5)||1
3214364|NCT02226796|3945237|FG000|COMPLETED|Washout (Weeks 2-5)||2
3214365|NCT02226796|3945238|FG001|COMPLETED|Washout (Weeks 2-5)||1
3214366|NCT02226796|3945237|FG000|NOT COMPLETED|Washout (Weeks 2-5)||0
3214367|NCT02226796|3945238|FG001|NOT COMPLETED|Washout (Weeks 2-5)||0
3214368|NCT02226796|3945237|FG000|STARTED|Second Intervention Phase (Week 6)||2
3214369|NCT02226796|3945238|FG001|STARTED|Second Intervention Phase (Week 6)||1
3214370|NCT02226796|3945237|FG000|Baseline Assessment|Second Intervention Phase (Week 6)||2
3214371|NCT02226796|3945238|FG001|Baseline Assessment|Second Intervention Phase (Week 6)||1
3214372|NCT02226796|3945237|FG000|Follow Up Assessment|Second Intervention Phase (Week 6)||2
3214373|NCT02226796|3945238|FG001|Follow Up Assessment|Second Intervention Phase (Week 6)||1
3214374|NCT02226796|3945237|FG000|COMPLETED|Second Intervention Phase (Week 6)||2
3214375|NCT02226796|3945238|FG001|COMPLETED|Second Intervention Phase (Week 6)||1
3214376|NCT02226796|3945237|FG000|NOT COMPLETED|Second Intervention Phase (Week 6)||0
3214377|NCT02226796|3945238|FG001|NOT COMPLETED|Second Intervention Phase (Week 6)||0
3214378|NCT02226965|3945244|FG000|STARTED|Overall Study||45
3214379|NCT02226965|3945244|FG000|COMPLETED|Overall Study||4
3214380|NCT02226965|3945244|FG000|NOT COMPLETED|Overall Study||41
3214381|NCT02227108|3945248|FG000|STARTED|Overall Study||32
3214382|NCT02227108|3945248|FG000|Treated|Overall Study||30
3214383|NCT02227108|3945248|FG000|COMPLETED|Overall Study||1
3214384|NCT02227108|3945248|FG000|NOT COMPLETED|Overall Study||31
3214385|NCT02227121|3945252|FG000|STARTED|Overall Study||16
3214386|NCT02227121|3945252|FG000|COMPLETED|Overall Study||16
3214387|NCT02227121|3945252|FG000|NOT COMPLETED|Overall Study||0
3214388|NCT02227147|3945258|FG000|STARTED|Controlled Treatment Period||24
3214389|NCT02227147|3945259|FG001|STARTED|Controlled Treatment Period||24
3214390|NCT02227147|3945258|FG000|COMPLETED|Controlled Treatment Period||18
3214391|NCT02227147|3945259|FG001|COMPLETED|Controlled Treatment Period||21
3214392|NCT02227147|3945258|FG000|NOT COMPLETED|Controlled Treatment Period||6
3214393|NCT02227147|3945259|FG001|NOT COMPLETED|Controlled Treatment Period||3
3214394|NCT02227147|3945258|FG000|STARTED|Follow-up Period||18
3214395|NCT02227147|3945259|FG001|STARTED|Follow-up Period||21
3214396|NCT02227147|3945258|FG000|COMPLETED|Follow-up Period||15
3214397|NCT02227147|3945259|FG001|COMPLETED|Follow-up Period||16
3214398|NCT02227147|3945258|FG000|NOT COMPLETED|Follow-up Period||3
3214399|NCT02227147|3945259|FG001|NOT COMPLETED|Follow-up Period||5
3214400|NCT02227316|3945273|FG000|STARTED|Overall Study||4
3214401|NCT02227316|3945274|FG001|STARTED|Overall Study||4
3214402|NCT02227316|3945275|FG002|STARTED|Overall Study||16
3214403|NCT02227316|3945276|FG003|STARTED|Overall Study||16
3214404|NCT02227316|3945273|FG000|COMPLETED|Overall Study||4
3214405|NCT02227316|3945274|FG001|COMPLETED|Overall Study||4
3214406|NCT02227316|3945275|FG002|COMPLETED|Overall Study||16
3214407|NCT02227316|3945276|FG003|COMPLETED|Overall Study||16
3214408|NCT02227316|3945273|FG000|NOT COMPLETED|Overall Study||0
3214409|NCT02227316|3945274|FG001|NOT COMPLETED|Overall Study||0
3214410|NCT02227316|3945275|FG002|NOT COMPLETED|Overall Study||0
3214411|NCT02227316|3945276|FG003|NOT COMPLETED|Overall Study||0
3214412|NCT02227329|3945288|FG000|STARTED|Overall Study||18
3214413|NCT02227329|3945289|FG001|STARTED|Overall Study||20
3214414|NCT02227329|3945288|FG000|COMPLETED|Overall Study||18
3214415|NCT02227329|3945289|FG001|COMPLETED|Overall Study||20
3214416|NCT02227329|3945288|FG000|NOT COMPLETED|Overall Study||0
3214417|NCT02227329|3945289|FG001|NOT COMPLETED|Overall Study||0
3214418|NCT02227368|3945297|FG000|STARTED|Overall Study||16
3214419|NCT02227368|3945298|FG001|STARTED|Overall Study||24
3214420|NCT02227368|3945297|FG000|Sujects Who Received Treatment|Overall Study||16
3214421|NCT02227368|3945298|FG001|Sujects Who Received Treatment|Overall Study||24
3214422|NCT02227368|3945297|FG000|Sujects Who Completed Treatment|Overall Study||10
3214423|NCT02227368|3945298|FG001|Sujects Who Completed Treatment|Overall Study||17
3214424|NCT02227368|3945297|FG000|COMPLETED|Overall Study|Subjects who discontinued treatment were encouraged to remain in the study.|14
3214425|NCT02227368|3945298|FG001|COMPLETED|Overall Study|Subjects who discontinued treatment were encouraged to remain in the study.|20
3214426|NCT02227368|3945297|FG000|NOT COMPLETED|Overall Study||2
3214427|NCT02227368|3945298|FG001|NOT COMPLETED|Overall Study||4
3214428|NCT02227446|3945306|FG000|STARTED|Overall Study||521
3214429|NCT02227446|3945307|FG001|STARTED|Overall Study||515
3214430|NCT02227446|3945306|FG000|COMPLETED|Overall Study||499
3214431|NCT02227446|3945307|FG001|COMPLETED|Overall Study||481
3214432|NCT02227446|3945306|FG000|NOT COMPLETED|Overall Study||22
3214433|NCT02227446|3945307|FG001|NOT COMPLETED|Overall Study||34
3366863|NCT03892707|4098233|FG000|STARTED|Overall Study||250
3366864|NCT03892707|4098234|FG001|STARTED|Overall Study||250
3366865|NCT03892707|4098233|FG000|Started Study Treatment at Baseline|Overall Study||244
3366866|NCT03892707|4098234|FG001|Started Study Treatment at Baseline|Overall Study||250
3366867|NCT03892707|4098233|FG000|COMPLETED|Overall Study||244
3366868|NCT03892707|4098234|FG001|COMPLETED|Overall Study||244
3366869|NCT03892707|4098233|FG000|NOT COMPLETED|Overall Study||6
3366870|NCT03892707|4098234|FG001|NOT COMPLETED|Overall Study||6
3366871|NCT03892460|4098243|FG000|STARTED|Overall Study||30
3366872|NCT03892460|4098244|FG001|STARTED|Overall Study||24
3366873|NCT03892460|4098243|FG000|Randomization|Overall Study||25
3366874|NCT03892460|4098244|FG001|Randomization|Overall Study||20
3366875|NCT03892460|4098243|FG000|COMPLETED|Overall Study||18
3366876|NCT03892460|4098244|FG001|COMPLETED|Overall Study||19
3366877|NCT03892460|4098243|FG000|NOT COMPLETED|Overall Study||12
3366878|NCT03892460|4098244|FG001|NOT COMPLETED|Overall Study||5
3366879|NCT03891641|4098253|FG000|STARTED|Overall Study||10
3366880|NCT03891641|4098254|FG001|STARTED|Overall Study||7
3366881|NCT03891641|4098253|FG000|COMPLETED|Overall Study||8
3214434|NCT02227485|3945315|FG000|STARTED|First Follow-up||40
3214435|NCT02227485|3945316|FG001|STARTED|First Follow-up||40
3214436|NCT02227485|3945315|FG000|COMPLETED|First Follow-up|At the first follow-up we lost 4 patients.|36
3214437|NCT02227485|3945316|FG001|COMPLETED|First Follow-up|After 2 weeks, 2 patients had withdrew the study.|38
3214438|NCT02227485|3945315|FG000|NOT COMPLETED|First Follow-up||4
3214439|NCT02227485|3945316|FG001|NOT COMPLETED|First Follow-up||2
3214440|NCT02227485|3945315|FG000|STARTED|Second Follow-up||36
3214441|NCT02227485|3945316|FG001|STARTED|Second Follow-up||38
3214442|NCT02227485|3945315|FG000|COMPLETED|Second Follow-up|At the second follow-up we lost 2 patients.|34
3214443|NCT02227485|3945316|FG001|COMPLETED|Second Follow-up|At the second follow-up we lost 2 patients.|36
3214444|NCT02227485|3945315|FG000|NOT COMPLETED|Second Follow-up||2
3214445|NCT02227485|3945316|FG001|NOT COMPLETED|Second Follow-up||2
3214446|NCT02227667|3945323|FG000|STARTED|Overall Study||16
3214447|NCT02227667|3945323|FG000|COMPLETED|Overall Study||16
3214448|NCT02227667|3945323|FG000|NOT COMPLETED|Overall Study||0
3214449|NCT02227693|3945331|FG000|STARTED|Overall Study||11
3214450|NCT02227693|3945332|FG001|STARTED|Overall Study||7
3214451|NCT02227693|3945333|FG002|STARTED|Overall Study||11
3214452|NCT02227693|3945334|FG003|STARTED|Overall Study||10
3214453|NCT02227693|3945331|FG000|COMPLETED|Overall Study||11
3214454|NCT02227693|3945332|FG001|COMPLETED|Overall Study||7
3214455|NCT02227693|3945333|FG002|COMPLETED|Overall Study||11
3214456|NCT02227693|3945334|FG003|COMPLETED|Overall Study||10
3214457|NCT02227693|3945331|FG000|NOT COMPLETED|Overall Study||0
3214458|NCT02227693|3945332|FG001|NOT COMPLETED|Overall Study||0
3214459|NCT02227693|3945333|FG002|NOT COMPLETED|Overall Study||0
3214460|NCT02227693|3945334|FG003|NOT COMPLETED|Overall Study||0
3214461|NCT02227706|3945350|FG000|STARTED|Overall Study||20
3214462|NCT02227706|3945351|FG001|STARTED|Overall Study||20
3214463|NCT02227706|3945350|FG000|COMPLETED|Overall Study||20
3214464|NCT02227706|3945351|FG001|COMPLETED|Overall Study||20
3214465|NCT02227706|3945350|FG000|NOT COMPLETED|Overall Study||0
3214466|NCT02227706|3945351|FG001|NOT COMPLETED|Overall Study||0
3214467|NCT02227758|3945357|FG000|STARTED|Overall Study||112
3214468|NCT02227758|3945357|FG000|COMPLETED|Overall Study||45
3214469|NCT02227758|3945357|FG000|NOT COMPLETED|Overall Study||67
3214470|NCT02227784|3945367|FG000|STARTED|Double-Blind Phase||123
3214471|NCT02227784|3945368|FG001|STARTED|Double-Blind Phase||54
3214472|NCT02227784|3945369|FG002|STARTED|Double-Blind Phase||62
3214473|NCT02227784|3945370|FG003|STARTED|Double-Blind Phase||127
3214474|NCT02227784|3945371|FG004|STARTED|Double-Blind Phase||0
3214475|NCT02227784|3945367|FG000|COMPLETED|Double-Blind Phase||83
3214476|NCT02227784|3945368|FG001|COMPLETED|Double-Blind Phase||36
3214477|NCT02227784|3945369|FG002|COMPLETED|Double-Blind Phase||41
3214478|NCT02227784|3945370|FG003|COMPLETED|Double-Blind Phase||88
3214479|NCT02227784|3945371|FG004|COMPLETED|Double-Blind Phase||0
3214480|NCT02227784|3945367|FG000|NOT COMPLETED|Double-Blind Phase||40
3214481|NCT02227784|3945368|FG001|NOT COMPLETED|Double-Blind Phase||18
3214482|NCT02227784|3945369|FG002|NOT COMPLETED|Double-Blind Phase||21
3214483|NCT02227784|3945370|FG003|NOT COMPLETED|Double-Blind Phase||39
3214484|NCT02227784|3945371|FG004|NOT COMPLETED|Double-Blind Phase||0
3214485|NCT02227784|3945367|FG000|STARTED|Open-Label Extension Phase (OLE)|After the double-blind treatment phase, participants entered an OLE phase.|0
3214486|NCT02227784|3945368|FG001|STARTED|Open-Label Extension Phase (OLE)|After the double-blind treatment phase, participants entered an OLE phase.|0
3214487|NCT02227784|3945369|FG002|STARTED|Open-Label Extension Phase (OLE)|After the double-blind treatment phase, participants entered an OLE phase.|0
3214488|NCT02227784|3945370|FG003|STARTED|Open-Label Extension Phase (OLE)|After the double-blind treatment phase, participants entered an OLE phase.|0
3214489|NCT02227784|3945371|FG004|STARTED|Open-Label Extension Phase (OLE)|After the double-blind treatment phase, participants entered an OLE phase.|248
3214490|NCT02227784|3945367|FG000|Received at Least 1 Dose of Study Drug|Open-Label Extension Phase (OLE)||0
3214491|NCT02227784|3945368|FG001|Received at Least 1 Dose of Study Drug|Open-Label Extension Phase (OLE)||0
3214492|NCT02227784|3945369|FG002|Received at Least 1 Dose of Study Drug|Open-Label Extension Phase (OLE)||0
3214493|NCT02227784|3945370|FG003|Received at Least 1 Dose of Study Drug|Open-Label Extension Phase (OLE)||0
3214494|NCT02227784|3945371|FG004|Received at Least 1 Dose of Study Drug|Open-Label Extension Phase (OLE)||247
3214495|NCT02227784|3945367|FG000|COMPLETED|Open-Label Extension Phase (OLE)||0
3214496|NCT02227784|3945368|FG001|COMPLETED|Open-Label Extension Phase (OLE)||0
3214497|NCT02227784|3945369|FG002|COMPLETED|Open-Label Extension Phase (OLE)||0
3214498|NCT02227784|3945370|FG003|COMPLETED|Open-Label Extension Phase (OLE)||0
3214499|NCT02227784|3945371|FG004|COMPLETED|Open-Label Extension Phase (OLE)||0
3214500|NCT02227784|3945367|FG000|NOT COMPLETED|Open-Label Extension Phase (OLE)||0
3214501|NCT02227784|3945368|FG001|NOT COMPLETED|Open-Label Extension Phase (OLE)||0
3214502|NCT02227784|3945369|FG002|NOT COMPLETED|Open-Label Extension Phase (OLE)||0
3214503|NCT02227784|3945370|FG003|NOT COMPLETED|Open-Label Extension Phase (OLE)||0
3214504|NCT02227784|3945371|FG004|NOT COMPLETED|Open-Label Extension Phase (OLE)||248
3214505|NCT02227810|3945386|FG000|STARTED|Overall Study||19
3214506|NCT02227810|3945387|FG001|STARTED|Overall Study||34
3214507|NCT02227810|3945386|FG000|COMPLETED|Overall Study||17
3214508|NCT02227810|3945387|FG001|COMPLETED|Overall Study||29
3214509|NCT02227810|3945386|FG000|NOT COMPLETED|Overall Study||2
3214510|NCT02227810|3945387|FG001|NOT COMPLETED|Overall Study||5
3214511|NCT02227836|3945395|FG000|STARTED|Overall Study||8
3214512|NCT02227836|3945395|FG000|COMPLETED|Overall Study||8
3214513|NCT02227836|3945395|FG000|NOT COMPLETED|Overall Study||0
3214514|NCT02227849|3945399|FG000|STARTED|Overall Study||71
3214515|NCT02227849|3945399|FG000|COMPLETED|Overall Study||63
3214516|NCT02227849|3945399|FG000|NOT COMPLETED|Overall Study||8
3214517|NCT02227862|3945405|FG000|STARTED|Overall Study||280
3214518|NCT02227862|3945406|FG001|STARTED|Overall Study||278
3214519|NCT02227862|3945405|FG000|Week 24|Overall Study||269
3214520|NCT02227862|3945406|FG001|Week 24|Overall Study||263
3214521|NCT02227862|3945405|FG000|COMPLETED|Overall Study||261
3214522|NCT02227862|3945406|FG001|COMPLETED|Overall Study||256
3214523|NCT02227862|3945405|FG000|NOT COMPLETED|Overall Study||19
3214524|NCT02227862|3945406|FG001|NOT COMPLETED|Overall Study||22
3214525|NCT02227875|3945414|FG000|STARTED|Overall Study||277
3214526|NCT02227875|3945415|FG001|STARTED|Overall Study||283
3214527|NCT02227875|3945414|FG000|COMPLETED|Overall Study||240
3214528|NCT02227875|3945415|FG001|COMPLETED|Overall Study||250
3214529|NCT02227875|3945414|FG000|NOT COMPLETED|Overall Study||37
3214530|NCT02227875|3945415|FG001|NOT COMPLETED|Overall Study||33
3366882|NCT03891641|4098254|FG001|COMPLETED|Overall Study||5
3366883|NCT03891641|4098253|FG000|NOT COMPLETED|Overall Study||2
3366884|NCT03891641|4098254|FG001|NOT COMPLETED|Overall Study||2
3366885|NCT03890367|4098263|FG000|STARTED|Overall Study||232
3366886|NCT03890367|4098264|FG001|STARTED|Overall Study||235
3366887|NCT03890367|4098265|FG002|STARTED|Overall Study||240
3366888|NCT03890367|4098263|FG000|Safety Analysis Set|Overall Study||230
3366889|NCT03890367|4098264|FG001|Safety Analysis Set|Overall Study||232
3366890|NCT03890367|4098265|FG002|Safety Analysis Set|Overall Study||239
3366891|NCT03890367|4098263|FG000|COMPLETED|Overall Study||228
3366892|NCT03890367|4098264|FG001|COMPLETED|Overall Study||229
3366893|NCT03890367|4098265|FG002|COMPLETED|Overall Study||239
3366894|NCT03890367|4098263|FG000|NOT COMPLETED|Overall Study||4
3366895|NCT03890367|4098264|FG001|NOT COMPLETED|Overall Study||6
3366896|NCT03890367|4098265|FG002|NOT COMPLETED|Overall Study||1
3366897|NCT03889704|4098273|FG000|STARTED|Overall Study||2
3366898|NCT03889704|4098273|FG000|COMPLETED|Overall Study||1
3366899|NCT03889704|4098273|FG000|NOT COMPLETED|Overall Study||1
3366900|NCT03889444|4098277|FG000|STARTED|Overall Study||141
3366901|NCT03889444|4098277|FG000|COMPLETED|Overall Study||141
3366902|NCT03889444|4098277|FG000|NOT COMPLETED|Overall Study||0
3366903|NCT03888755|4098281|FG000|STARTED|Overall Study||8
3366904|NCT03888755|4098281|FG000|COMPLETED|Overall Study||8
3366905|NCT03888755|4098281|FG000|NOT COMPLETED|Overall Study||0
3366906|NCT03888391|4098287|FG000|STARTED|Overall Study||18
3366907|NCT03888391|4098287|FG000|COMPLETED|Overall Study||3
3366908|NCT03888391|4098287|FG000|NOT COMPLETED|Overall Study||15
3366909|NCT03888482|4098293|FG000|STARTED|First Wear Period (8 -1/+2 Days)||76
3366910|NCT03888482|4098294|FG001|STARTED|First Wear Period (8 -1/+2 Days)||75
3366911|NCT03888482|4098293|FG000|COMPLETED|First Wear Period (8 -1/+2 Days)||76
3366912|NCT03888482|4098294|FG001|COMPLETED|First Wear Period (8 -1/+2 Days)||75
3366913|NCT03888482|4098293|FG000|NOT COMPLETED|First Wear Period (8 -1/+2 Days)||0
3366914|NCT03888482|4098294|FG001|NOT COMPLETED|First Wear Period (8 -1/+2 Days)||0
3366915|NCT03888482|4098293|FG000|STARTED|Second Wear (8 -1/+2 Days)|2 subjects were discontinued between Treatment 1 and Treatment 2.|74
3366916|NCT03888482|4098294|FG001|STARTED|Second Wear (8 -1/+2 Days)||75
3366917|NCT03888482|4098293|FG000|COMPLETED|Second Wear (8 -1/+2 Days)||73
3366918|NCT03888482|4098294|FG001|COMPLETED|Second Wear (8 -1/+2 Days)||74
3366919|NCT03888482|4098293|FG000|NOT COMPLETED|Second Wear (8 -1/+2 Days)||1
3366920|NCT03888482|4098294|FG001|NOT COMPLETED|Second Wear (8 -1/+2 Days)||1
3366921|NCT03888274|4098302|FG000|STARTED|Overall Study||30
3366922|NCT03888274|4098302|FG000|COMPLETED|Overall Study||30
3366923|NCT03888274|4098302|FG000|NOT COMPLETED|Overall Study||0
3366924|NCT03888365|4098308|FG000|STARTED|Cohort A Peak Level/Cohort B Period 1||20
3366925|NCT03888365|4098309|FG001|STARTED|Cohort A Peak Level/Cohort B Period 1||23
3366926|NCT03888365|4098308|FG000|Safety Population|Cohort A Peak Level/Cohort B Period 1||20
3366927|NCT03888365|4098309|FG001|Safety Population|Cohort A Peak Level/Cohort B Period 1||23
3366928|NCT03888365|4098308|FG000|COMPLETED|Cohort A Peak Level/Cohort B Period 1||20
3366929|NCT03888365|4098309|FG001|COMPLETED|Cohort A Peak Level/Cohort B Period 1||23
3366930|NCT03888365|4098308|FG000|NOT COMPLETED|Cohort A Peak Level/Cohort B Period 1||0
3366931|NCT03888365|4098309|FG001|NOT COMPLETED|Cohort A Peak Level/Cohort B Period 1||0
3366932|NCT03888365|4098308|FG000|STARTED|Rest - At Least 1 h||20
3366933|NCT03888365|4098309|FG001|STARTED|Rest - At Least 1 h||23
3366934|NCT03888365|4098308|FG000|COMPLETED|Rest - At Least 1 h||20
3366935|NCT03888365|4098309|FG001|COMPLETED|Rest - At Least 1 h||23
3366936|NCT03888365|4098308|FG000|NOT COMPLETED|Rest - At Least 1 h||0
3366937|NCT03888365|4098309|FG001|NOT COMPLETED|Rest - At Least 1 h||0
3366938|NCT03888365|4098308|FG000|STARTED|Cohort A Trough Level/Cohort B Period 2||20
3366939|NCT03888365|4098309|FG001|STARTED|Cohort A Trough Level/Cohort B Period 2||23
3366940|NCT03888365|4098308|FG000|COMPLETED|Cohort A Trough Level/Cohort B Period 2||20
3366941|NCT03888365|4098309|FG001|COMPLETED|Cohort A Trough Level/Cohort B Period 2||23
3366942|NCT03888365|4098308|FG000|NOT COMPLETED|Cohort A Trough Level/Cohort B Period 2||0
3366943|NCT03888365|4098309|FG001|NOT COMPLETED|Cohort A Trough Level/Cohort B Period 2||0
3366944|NCT03888469|4098318|FG000|STARTED|First Wear Period (8 -1/+2 Days)||46
3366945|NCT03888469|4098319|FG001|STARTED|First Wear Period (8 -1/+2 Days)||46
3366946|NCT03888469|4098318|FG000|COMPLETED|First Wear Period (8 -1/+2 Days)||46
3366947|NCT03888469|4098319|FG001|COMPLETED|First Wear Period (8 -1/+2 Days)||46
3366948|NCT03888469|4098318|FG000|NOT COMPLETED|First Wear Period (8 -1/+2 Days)||0
3366949|NCT03888469|4098319|FG001|NOT COMPLETED|First Wear Period (8 -1/+2 Days)||0
3366950|NCT03888469|4098318|FG000|STARTED|Second Wear Period (8 -1/+2 Days)||46
3366951|NCT03888469|4098319|FG001|STARTED|Second Wear Period (8 -1/+2 Days)||46
3366952|NCT03888469|4098318|FG000|COMPLETED|Second Wear Period (8 -1/+2 Days)||46
3366953|NCT03888469|4098319|FG001|COMPLETED|Second Wear Period (8 -1/+2 Days)||46
3214531|NCT02228096|3945423|FG000|STARTED|Overall Study||75
3214532|NCT02228096|3945423|FG000|Enrolled Into Long-term f/u Protocol|Overall Study||31
3214533|NCT02228096|3945423|FG000|Enrolled But Not Infused|Overall Study||11
3214534|NCT02228096|3945423|FG000|Enrolled and Infused|Overall Study||64
3214535|NCT02228096|3945423|FG000|COMPLETED|Overall Study|Completed = study follow-up completed|4
3214536|NCT02228096|3945423|FG000|NOT COMPLETED|Overall Study||71
3214537|NCT02228174|3945441|FG000|STARTED|Overall Study||147
3214538|NCT02228174|3945441|FG000|Full Analysis Population|Overall Study|Subjects who didn't become pregnant or diagnosed with an interfering medical condition at 12-months|143
3214539|NCT02228174|3945441|FG000|COMPLETED|Overall Study||142
3214540|NCT02228174|3945441|FG000|NOT COMPLETED|Overall Study||5
3214541|NCT02228395|3945445|FG000|STARTED|First Intervention Period||3
3214542|NCT02228395|3945446|FG001|STARTED|First Intervention Period||3
3214543|NCT02228395|3945447|FG002|STARTED|First Intervention Period||3
3214544|NCT02228395|3945445|FG000|COMPLETED|First Intervention Period||2
3214545|NCT02228395|3945446|FG001|COMPLETED|First Intervention Period||2
3214546|NCT02228395|3945447|FG002|COMPLETED|First Intervention Period||2
3214547|NCT02228395|3945445|FG000|NOT COMPLETED|First Intervention Period||1
3214548|NCT02228395|3945446|FG001|NOT COMPLETED|First Intervention Period||1
3214549|NCT02228395|3945447|FG002|NOT COMPLETED|First Intervention Period||1
3214550|NCT02228395|3945445|FG000|STARTED|Washout Period (at Least 10 Days)|One participant discontinued in the First Intervention Period and was replaced.|3
3214551|NCT02228395|3945446|FG001|STARTED|Washout Period (at Least 10 Days)|One participant discontinued in the First Intervention Period and was replaced.|3
3214552|NCT02228395|3945447|FG002|STARTED|Washout Period (at Least 10 Days)|One participant discontinued in the First Intervention Period and was replaced.|3
3214553|NCT02228395|3945445|FG000|COMPLETED|Washout Period (at Least 10 Days)||3
3214554|NCT02228395|3945446|FG001|COMPLETED|Washout Period (at Least 10 Days)||3
3214555|NCT02228395|3945447|FG002|COMPLETED|Washout Period (at Least 10 Days)||3
3214556|NCT02228395|3945445|FG000|NOT COMPLETED|Washout Period (at Least 10 Days)||0
3214557|NCT02228395|3945446|FG001|NOT COMPLETED|Washout Period (at Least 10 Days)||0
3214558|NCT02228395|3945447|FG002|NOT COMPLETED|Washout Period (at Least 10 Days)||0
3214559|NCT02228395|3945445|FG000|STARTED|Second Intervention Period||3
3214560|NCT02228395|3945446|FG001|STARTED|Second Intervention Period||3
3214561|NCT02228395|3945447|FG002|STARTED|Second Intervention Period||3
3214562|NCT02228395|3945445|FG000|COMPLETED|Second Intervention Period||3
3214563|NCT02228395|3945446|FG001|COMPLETED|Second Intervention Period||3
3214564|NCT02228395|3945447|FG002|COMPLETED|Second Intervention Period||3
3214565|NCT02228395|3945445|FG000|NOT COMPLETED|Second Intervention Period||0
3214566|NCT02228395|3945446|FG001|NOT COMPLETED|Second Intervention Period||0
3214567|NCT02228395|3945447|FG002|NOT COMPLETED|Second Intervention Period||0
3214568|NCT02228395|3945445|FG000|STARTED|Washout Period (at Least 10 Days)||3
3214569|NCT02228395|3945446|FG001|STARTED|Washout Period (at Least 10 Days)||3
3214570|NCT02228395|3945447|FG002|STARTED|Washout Period (at Least 10 Days)||3
3214571|NCT02228395|3945445|FG000|COMPLETED|Washout Period (at Least 10 Days)||3
3214572|NCT02228395|3945446|FG001|COMPLETED|Washout Period (at Least 10 Days)||3
3214573|NCT02228395|3945447|FG002|COMPLETED|Washout Period (at Least 10 Days)||3
3214574|NCT02228395|3945445|FG000|NOT COMPLETED|Washout Period (at Least 10 Days)||0
3214575|NCT02228395|3945446|FG001|NOT COMPLETED|Washout Period (at Least 10 Days)||0
3214576|NCT02228395|3945447|FG002|NOT COMPLETED|Washout Period (at Least 10 Days)||0
3214577|NCT02228395|3945445|FG000|STARTED|Third Intervention Period||3
3214578|NCT02228395|3945446|FG001|STARTED|Third Intervention Period||3
3214579|NCT02228395|3945447|FG002|STARTED|Third Intervention Period||3
3214580|NCT02228395|3945445|FG000|COMPLETED|Third Intervention Period||3
3214581|NCT02228395|3945446|FG001|COMPLETED|Third Intervention Period||3
3214582|NCT02228395|3945447|FG002|COMPLETED|Third Intervention Period||3
3214583|NCT02228395|3945445|FG000|NOT COMPLETED|Third Intervention Period||0
3214584|NCT02228395|3945446|FG001|NOT COMPLETED|Third Intervention Period||0
3214585|NCT02228395|3945447|FG002|NOT COMPLETED|Third Intervention Period||0
3214586|NCT02228408|3945459|FG000|STARTED|Overall Study||7
3214587|NCT02228408|3945460|FG001|STARTED|Overall Study||10
3214588|NCT02228408|3945459|FG000|COMPLETED|Overall Study||7
3366954|NCT03888469|4098318|FG000|NOT COMPLETED|Second Wear Period (8 -1/+2 Days)||0
3366955|NCT03888469|4098319|FG001|NOT COMPLETED|Second Wear Period (8 -1/+2 Days)||0
3366956|NCT03887442|4098329|FG000|STARTED|Overall Study||9
3366957|NCT03887442|4098330|FG001|STARTED|Overall Study||8
3366958|NCT03887442|4098329|FG000|COMPLETED|Overall Study||8
3366959|NCT03887442|4098330|FG001|COMPLETED|Overall Study||8
3366960|NCT03887442|4098329|FG000|NOT COMPLETED|Overall Study||1
3366961|NCT03887442|4098330|FG001|NOT COMPLETED|Overall Study||0
3366962|NCT03887286|4098338|FG000|STARTED|Overall Study||47
3366963|NCT03887286|4098338|FG000|COMPLETED|Overall Study||47
3366964|NCT03887286|4098338|FG000|NOT COMPLETED|Overall Study||0
3366965|NCT03881007|4098345|FG000|STARTED|First 3 Months||172
3366966|NCT03881007|4098346|FG001|STARTED|First 3 Months||171
3366967|NCT03881007|4098345|FG000|COMPLETED|First 3 Months||121
3366968|NCT03881007|4098346|FG001|COMPLETED|First 3 Months||119
3366969|NCT03881007|4098345|FG000|NOT COMPLETED|First 3 Months||51
3366970|NCT03881007|4098346|FG001|NOT COMPLETED|First 3 Months||52
3366971|NCT03881007|4098345|FG000|STARTED|Last 3 Months||121
3366972|NCT03881007|4098346|FG001|STARTED|Last 3 Months||119
3366973|NCT03881007|4098345|FG000|COMPLETED|Last 3 Months||77
3366974|NCT03881007|4098346|FG001|COMPLETED|Last 3 Months||74
3366975|NCT03881007|4098345|FG000|NOT COMPLETED|Last 3 Months||44
3214589|NCT02228408|3945460|FG001|COMPLETED|Overall Study||10
3214590|NCT02228408|3945459|FG000|NOT COMPLETED|Overall Study||0
3214591|NCT02228408|3945460|FG001|NOT COMPLETED|Overall Study||0
3214592|NCT02228460|3945466|FG000|STARTED|Overall Study||11
3214593|NCT02228460|3945466|FG000|COMPLETED|Overall Study||9
3214594|NCT02228460|3945466|FG000|NOT COMPLETED|Overall Study||2
3214595|NCT02228499|3945473|FG000|STARTED|Overall Study||30
3214596|NCT02228499|3945474|FG001|STARTED|Overall Study||36
3214597|NCT02228499|3945473|FG000|COMPLETED|Overall Study||7
3214598|NCT02228499|3945474|FG001|COMPLETED|Overall Study||10
3214599|NCT02228499|3945473|FG000|NOT COMPLETED|Overall Study||23
3214600|NCT02228499|3945474|FG001|NOT COMPLETED|Overall Study||26
3214601|NCT02228564|3945480|FG000|STARTED|Overall Study||155
3214602|NCT02228564|3945480|FG000|COMPLETED|Overall Study||106
3214603|NCT02228564|3945480|FG000|NOT COMPLETED|Overall Study||49
3214604|NCT02228590|3945484|FG000|STARTED|Overall Study||20
3214605|NCT02228590|3945484|FG000|COMPLETED|Overall Study||19
3214606|NCT02228590|3945484|FG000|NOT COMPLETED|Overall Study||1
3214607|NCT02228681|3945491|FG000|STARTED|Overall Study||37
3214608|NCT02228681|3945492|FG001|STARTED|Overall Study||37
3214609|NCT02228681|3945491|FG000|COMPLETED|Overall Study||37
3214610|NCT02228681|3945492|FG001|COMPLETED|Overall Study||37
3214611|NCT02228681|3945491|FG000|NOT COMPLETED|Overall Study||0
3214612|NCT02228681|3945492|FG001|NOT COMPLETED|Overall Study||0
3214613|NCT02228720|3945498|FG000|STARTED|Open Label - Baseline||15
3214614|NCT02228720|3945498|FG000|COMPLETED|Open Label - Baseline||15
3214615|NCT02228720|3945498|FG000|NOT COMPLETED|Open Label - Baseline||0
3214616|NCT02228720|3945498|FG000|STARTED|Open Label - Day 30||15
3214617|NCT02228720|3945498|FG000|COMPLETED|Open Label - Day 30||14
3214618|NCT02228720|3945498|FG000|NOT COMPLETED|Open Label - Day 30||1
3214619|NCT02228720|3945498|FG000|STARTED|Open Label - Day 90||14
3214620|NCT02228720|3945498|FG000|COMPLETED|Open Label - Day 90||14
3214621|NCT02228720|3945498|FG000|NOT COMPLETED|Open Label - Day 90||0
3214622|NCT02228824|3945504|FG000|STARTED|Overall Study||118
3214623|NCT02228824|3945505|FG001|STARTED|Overall Study||120
3214624|NCT02228824|3945504|FG000|COMPLETED|Overall Study||89
3214625|NCT02228824|3945505|FG001|COMPLETED|Overall Study||98
3214626|NCT02228824|3945504|FG000|NOT COMPLETED|Overall Study||29
3214627|NCT02228824|3945505|FG001|NOT COMPLETED|Overall Study||22
3214628|NCT02228967|3945513|FG000|STARTED|Overall Study||403
3214629|NCT02228967|3945514|FG001|STARTED|Overall Study||388
3214630|NCT02228967|3945513|FG000|COMPLETED|Overall Study||244
3214631|NCT02228967|3945514|FG001|COMPLETED|Overall Study||228
3214632|NCT02228967|3945513|FG000|NOT COMPLETED|Overall Study||159
3214633|NCT02228967|3945514|FG001|NOT COMPLETED|Overall Study||160
3214634|NCT02228980|3945524|FG000|STARTED|Overall Study||150
3214635|NCT02228980|3945525|FG001|STARTED|Overall Study||150
3214636|NCT02228980|3945526|FG002|STARTED|Overall Study||151
3214637|NCT02228980|3945527|FG003|STARTED|Overall Study||151
3214638|NCT02228980|3945524|FG000|COMPLETED|Overall Study||126
3214639|NCT02228980|3945525|FG001|COMPLETED|Overall Study||147
3214640|NCT02228980|3945526|FG002|COMPLETED|Overall Study||149
3214641|NCT02228980|3945527|FG003|COMPLETED|Overall Study||148
3214642|NCT02228980|3945524|FG000|NOT COMPLETED|Overall Study||24
3214643|NCT02228980|3945525|FG001|NOT COMPLETED|Overall Study||3
3214644|NCT02228980|3945526|FG002|NOT COMPLETED|Overall Study||2
3214645|NCT02228980|3945527|FG003|NOT COMPLETED|Overall Study||3
3214646|NCT02229214|3945543|FG000|STARTED|Overall Study||41
3214647|NCT02229214|3945544|FG001|STARTED|Overall Study||10
3214648|NCT02229214|3945543|FG000|COMPLETED|Overall Study||35
3214649|NCT02229214|3945544|FG001|COMPLETED|Overall Study||10
3214650|NCT02229214|3945543|FG000|NOT COMPLETED|Overall Study||6
3214651|NCT02229214|3945544|FG001|NOT COMPLETED|Overall Study||0
3214652|NCT02229227|3945554|FG000|STARTED|Overall Study||402
3214653|NCT02229227|3945555|FG001|STARTED|Overall Study||412
3214654|NCT02229227|3945554|FG000|COMPLETED|Overall Study||351
3214655|NCT02229227|3945555|FG001|COMPLETED|Overall Study||350
3214656|NCT02229227|3945554|FG000|NOT COMPLETED|Overall Study||51
3214657|NCT02229227|3945555|FG001|NOT COMPLETED|Overall Study||62
3214658|NCT02229318|3945561|FG000|STARTED|Overall Study|September 6th 2014 11 enrolled|11
3214659|NCT02229318|3945561|FG000|COMPLETED|Overall Study|September 15th 2014 11 completed|11
3214660|NCT02229318|3945561|FG000|NOT COMPLETED|Overall Study||0
3214661|NCT02229383|3945568|FG000|STARTED|Overall Study||232
3214662|NCT02229383|3945569|FG001|STARTED|Overall Study||229
3214663|NCT02229383|3945568|FG000|Received Treatment|Overall Study||231
3214664|NCT02229383|3945569|FG001|Received Treatment|Overall Study||229
3214665|NCT02229383|3945568|FG000|Safety Analysis Set|Overall Study||231
3214666|NCT02229383|3945569|FG001|Safety Analysis Set|Overall Study||229
3214667|NCT02229383|3945568|FG000|Intent-to-treat (ITT) Analysis Set|Overall Study||230
3214668|NCT02229383|3945569|FG001|Intent-to-treat (ITT) Analysis Set|Overall Study||228
3214669|NCT02229383|3945568|FG000|COMPLETED|Overall Study||212
3214670|NCT02229383|3945569|FG001|COMPLETED|Overall Study||207
3214671|NCT02229383|3945568|FG000|NOT COMPLETED|Overall Study||20
3214672|NCT02229383|3945569|FG001|NOT COMPLETED|Overall Study||22
3214673|NCT02229396|3945578|FG000|STARTED|Overall Study||233
3214674|NCT02229396|3945579|FG001|STARTED|Overall Study||231
3214675|NCT02229396|3945580|FG002|STARTED|Overall Study||231
3214676|NCT02229396|3945578|FG000|Randomization Code Allocated|Overall Study||233
3214677|NCT02229396|3945579|FG001|Randomization Code Allocated|Overall Study||231
3214678|NCT02229396|3945580|FG002|Randomization Code Allocated|Overall Study||231
3214679|NCT02229396|3945578|FG000|Safety Analysis Set|Overall Study||233
3214680|NCT02229396|3945579|FG001|Safety Analysis Set|Overall Study||231
3214681|NCT02229396|3945580|FG002|Safety Analysis Set|Overall Study||230
3214682|NCT02229396|3945578|FG000|Intent-to-Treat (ITT) Analysis Set|Overall Study||230
3214683|NCT02229396|3945579|FG001|Intent-to-Treat (ITT) Analysis Set|Overall Study||228
3214684|NCT02229396|3945580|FG002|Intent-to-Treat (ITT) Analysis Set|Overall Study||227
3214685|NCT02229396|3945578|FG000|Completed 28-Week Study Period|Overall Study||208
3214686|NCT02229396|3945579|FG001|Completed 28-Week Study Period|Overall Study||202
3214687|NCT02229396|3945580|FG002|Completed 28-Week Study Period|Overall Study||193
3214688|NCT02229396|3945578|FG000|Completed 52-Week Study Period|Overall Study||194
3214689|NCT02229396|3945579|FG001|Completed 52-Week Study Period|Overall Study||193
3214690|NCT02229396|3945580|FG002|Completed 52-Week Study Period|Overall Study||177
3214691|NCT02229396|3945578|FG000|COMPLETED|Overall Study||155
3214692|NCT02229396|3945579|FG001|COMPLETED|Overall Study||154
3214693|NCT02229396|3945580|FG002|COMPLETED|Overall Study||136
3214694|NCT02229396|3945578|FG000|NOT COMPLETED|Overall Study||78
3214695|NCT02229396|3945579|FG001|NOT COMPLETED|Overall Study||77
3214696|NCT02229396|3945580|FG002|NOT COMPLETED|Overall Study||95
3214697|NCT02229461|3945595|FG000|STARTED|Overall Study|Randomized and received treatment|17
3214698|NCT02229461|3945596|FG001|STARTED|Overall Study|Randomized and received treatment|17
3214699|NCT02229461|3945597|FG002|STARTED|Overall Study|Randomized and received treatment|17
3214700|NCT02229461|3945598|FG003|STARTED|Overall Study|Randomized and received treatment|17
3214701|NCT02229461|3945599|FG004|STARTED|Overall Study|Randomized and received treatment|17
3214702|NCT02229461|3945600|FG005|STARTED|Overall Study|Randomized and received treatment|17
3214703|NCT02229461|3945595|FG000|COMPLETED|Overall Study||17
3214704|NCT02229461|3945596|FG001|COMPLETED|Overall Study||17
3214705|NCT02229461|3945597|FG002|COMPLETED|Overall Study||17
3214706|NCT02229461|3945598|FG003|COMPLETED|Overall Study||17
3214707|NCT02229461|3945599|FG004|COMPLETED|Overall Study||17
3214708|NCT02229461|3945600|FG005|COMPLETED|Overall Study||17
3214709|NCT02229461|3945595|FG000|NOT COMPLETED|Overall Study||0
3214710|NCT02229461|3945596|FG001|NOT COMPLETED|Overall Study||0
3214711|NCT02229461|3945597|FG002|NOT COMPLETED|Overall Study||0
3214712|NCT02229461|3945598|FG003|NOT COMPLETED|Overall Study||0
3214713|NCT02229461|3945599|FG004|NOT COMPLETED|Overall Study||0
3214714|NCT02229461|3945600|FG005|NOT COMPLETED|Overall Study||0
3214715|NCT02229474|3945617|FG000|STARTED|Overall Study||16
3214716|NCT02229474|3945618|FG001|STARTED|Overall Study||18
3214717|NCT02229474|3945617|FG000|COMPLETED|Overall Study||16
3214718|NCT02229474|3945618|FG001|COMPLETED|Overall Study||15
3214719|NCT02229474|3945617|FG000|NOT COMPLETED|Overall Study||0
3214720|NCT02229474|3945618|FG001|NOT COMPLETED|Overall Study||3
3214721|NCT02229487|3945627|FG000|STARTED|Overall Study||24
3214722|NCT02229487|3945628|FG001|STARTED|Overall Study||27
3214723|NCT02229487|3945627|FG000|COMPLETED|Overall Study||24
3214724|NCT02229487|3945628|FG001|COMPLETED|Overall Study||27
3214725|NCT02229487|3945627|FG000|NOT COMPLETED|Overall Study||0
3214726|NCT02229487|3945628|FG001|NOT COMPLETED|Overall Study||0
3214727|NCT02229513|3945636|FG000|STARTED|Overall Study||100
3214728|NCT02229513|3945637|FG001|STARTED|Overall Study||100
3214729|NCT02229513|3945636|FG000|COMPLETED|Overall Study||100
3214730|NCT02229513|3945637|FG001|COMPLETED|Overall Study||100
3214731|NCT02229513|3945636|FG000|NOT COMPLETED|Overall Study||0
3214732|NCT02229513|3945637|FG001|NOT COMPLETED|Overall Study||0
3214733|NCT02229539|3945646|FG000|STARTED|Cycle 1 (Treatment Per Protocol)||77
3214734|NCT02229539|3945647|FG001|STARTED|Cycle 1 (Treatment Per Protocol)||76
3214735|NCT02229539|3945648|FG002|STARTED|Cycle 1 (Treatment Per Protocol)||75
3214736|NCT02229539|3945646|FG000|COMPLETED|Cycle 1 (Treatment Per Protocol)||74
3214737|NCT02229539|3945647|FG001|COMPLETED|Cycle 1 (Treatment Per Protocol)||71
3214738|NCT02229539|3945648|FG002|COMPLETED|Cycle 1 (Treatment Per Protocol)||72
3214739|NCT02229539|3945646|FG000|NOT COMPLETED|Cycle 1 (Treatment Per Protocol)||3
3214740|NCT02229539|3945647|FG001|NOT COMPLETED|Cycle 1 (Treatment Per Protocol)||5
3214741|NCT02229539|3945648|FG002|NOT COMPLETED|Cycle 1 (Treatment Per Protocol)||3
3214742|NCT02229539|3945646|FG000|STARTED|Cycle 2 (Optional Continuation Phase)||35
3214743|NCT02229539|3945647|FG001|STARTED|Cycle 2 (Optional Continuation Phase)||36
3214744|NCT02229539|3945648|FG002|STARTED|Cycle 2 (Optional Continuation Phase)||32
3214745|NCT02229539|3945646|FG000|COMPLETED|Cycle 2 (Optional Continuation Phase)||26
3214746|NCT02229539|3945647|FG001|COMPLETED|Cycle 2 (Optional Continuation Phase)||29
3214747|NCT02229539|3945648|FG002|COMPLETED|Cycle 2 (Optional Continuation Phase)||22
3214748|NCT02229539|3945646|FG000|NOT COMPLETED|Cycle 2 (Optional Continuation Phase)||9
3214749|NCT02229539|3945647|FG001|NOT COMPLETED|Cycle 2 (Optional Continuation Phase)||7
3214750|NCT02229539|3945648|FG002|NOT COMPLETED|Cycle 2 (Optional Continuation Phase)||10
3214751|NCT02229552|3945656|FG000|STARTED|Baseline||237
3214752|NCT02229552|3945656|FG000|COMPLETED|Baseline||231
3214753|NCT02229552|3945656|FG000|NOT COMPLETED|Baseline||6
3214754|NCT02229552|3945656|FG000|STARTED|1-year Follow up||231
3214755|NCT02229552|3945656|FG000|COMPLETED|1-year Follow up||206
3214756|NCT02229552|3945656|FG000|NOT COMPLETED|1-year Follow up||25
3214757|NCT02229552|3945656|FG000|STARTED|2-Year Follow up|All baseline participants were eligible for year 2 follow up, regardless of completion of year 1.|231
3214758|NCT02229552|3945656|FG000|COMPLETED|2-Year Follow up||205
3214759|NCT02229552|3945656|FG000|NOT COMPLETED|2-Year Follow up||26
3214760|NCT02229851|3945663|FG000|STARTED|Main Phase (Double-blind Phase)||61
3214761|NCT02229851|3945664|FG001|STARTED|Main Phase (Double-blind Phase)||119
3214762|NCT02229851|3945665|FG002|STARTED|Main Phase (Double-blind Phase)||120
3214763|NCT02229851|3945666|FG003|STARTED|Main Phase (Double-blind Phase)|This arm is not applicable for the Main phase.|0
3214764|NCT02229851|3945667|FG004|STARTED|Main Phase (Double-blind Phase)|This arm is not applicable for the Main phase.|0
3214765|NCT02229851|3945668|FG005|STARTED|Main Phase (Double-blind Phase)|This arm is not applicable for the Main phase.|0
3214766|NCT02229851|3945669|FG006|STARTED|Main Phase (Double-blind Phase)|This arm is not applicable for the Main phase.|0
3214767|NCT02229851|3945663|FG000|Full Analysis Set|Main Phase (Double-blind Phase)||61
3214768|NCT02229851|3945664|FG001|Full Analysis Set|Main Phase (Double-blind Phase)||119
3214769|NCT02229851|3945665|FG002|Full Analysis Set|Main Phase (Double-blind Phase)||120
3214770|NCT02229851|3945666|FG003|Full Analysis Set|Main Phase (Double-blind Phase)||0
3214771|NCT02229851|3945667|FG004|Full Analysis Set|Main Phase (Double-blind Phase)||0
3214772|NCT02229851|3945668|FG005|Full Analysis Set|Main Phase (Double-blind Phase)||0
3214773|NCT02229851|3945669|FG006|Full Analysis Set|Main Phase (Double-blind Phase)||0
3214774|NCT02229851|3945663|FG000|Safety Analysis Set|Main Phase (Double-blind Phase)||61
3214775|NCT02229851|3945664|FG001|Safety Analysis Set|Main Phase (Double-blind Phase)||119
3214776|NCT02229851|3945665|FG002|Safety Analysis Set|Main Phase (Double-blind Phase)||120
3214777|NCT02229851|3945666|FG003|Safety Analysis Set|Main Phase (Double-blind Phase)||0
3214778|NCT02229851|3945667|FG004|Safety Analysis Set|Main Phase (Double-blind Phase)||0
3214779|NCT02229851|3945668|FG005|Safety Analysis Set|Main Phase (Double-blind Phase)||0
3214780|NCT02229851|3945669|FG006|Safety Analysis Set|Main Phase (Double-blind Phase)||0
3214781|NCT02229851|3945663|FG000|COMPLETED|Main Phase (Double-blind Phase)||55
3214782|NCT02229851|3945664|FG001|COMPLETED|Main Phase (Double-blind Phase)||103
3214783|NCT02229851|3945665|FG002|COMPLETED|Main Phase (Double-blind Phase)||114
3214784|NCT02229851|3945666|FG003|COMPLETED|Main Phase (Double-blind Phase)||0
3214785|NCT02229851|3945667|FG004|COMPLETED|Main Phase (Double-blind Phase)||0
3214786|NCT02229851|3945668|FG005|COMPLETED|Main Phase (Double-blind Phase)||0
3214787|NCT02229851|3945669|FG006|COMPLETED|Main Phase (Double-blind Phase)||0
3214788|NCT02229851|3945663|FG000|NOT COMPLETED|Main Phase (Double-blind Phase)||6
3214789|NCT02229851|3945664|FG001|NOT COMPLETED|Main Phase (Double-blind Phase)||16
3214790|NCT02229851|3945665|FG002|NOT COMPLETED|Main Phase (Double-blind Phase)||6
3214791|NCT02229851|3945666|FG003|NOT COMPLETED|Main Phase (Double-blind Phase)||0
3214792|NCT02229851|3945667|FG004|NOT COMPLETED|Main Phase (Double-blind Phase)||0
3214793|NCT02229851|3945668|FG005|NOT COMPLETED|Main Phase (Double-blind Phase)||0
3214794|NCT02229851|3945669|FG006|NOT COMPLETED|Main Phase (Double-blind Phase)||0
3214795|NCT02229851|3945663|FG000|STARTED|Extension Phase (Open-label Phase)|This arm is not applicable for the Extension phase.|0
3214796|NCT02229851|3945664|FG001|STARTED|Extension Phase (Open-label Phase)|This arm is not applicable for the Extension phase.|0
3214797|NCT02229851|3945665|FG002|STARTED|Extension Phase (Open-label Phase)|This arm is not applicable for the Extension phase.|0
3214798|NCT02229851|3945666|FG003|STARTED|Extension Phase (Open-label Phase)||55
3214799|NCT02229851|3945667|FG004|STARTED|Extension Phase (Open-label Phase)||114
3214800|NCT02229851|3945668|FG005|STARTED|Extension Phase (Open-label Phase)||52
3214801|NCT02229851|3945669|FG006|STARTED|Extension Phase (Open-label Phase)||51
3214802|NCT02229851|3945663|FG000|COMPLETED|Extension Phase (Open-label Phase)||0
3214803|NCT02229851|3945664|FG001|COMPLETED|Extension Phase (Open-label Phase)||0
3214804|NCT02229851|3945665|FG002|COMPLETED|Extension Phase (Open-label Phase)||0
3214805|NCT02229851|3945666|FG003|COMPLETED|Extension Phase (Open-label Phase)||53
3214806|NCT02229851|3945667|FG004|COMPLETED|Extension Phase (Open-label Phase)||109
3214807|NCT02229851|3945668|FG005|COMPLETED|Extension Phase (Open-label Phase)||47
3214808|NCT02229851|3945669|FG006|COMPLETED|Extension Phase (Open-label Phase)||48
3214809|NCT02229851|3945663|FG000|NOT COMPLETED|Extension Phase (Open-label Phase)||0
3214810|NCT02229851|3945664|FG001|NOT COMPLETED|Extension Phase (Open-label Phase)||0
3214811|NCT02229851|3945665|FG002|NOT COMPLETED|Extension Phase (Open-label Phase)||0
3214812|NCT02229851|3945666|FG003|NOT COMPLETED|Extension Phase (Open-label Phase)||2
3214813|NCT02229851|3945667|FG004|NOT COMPLETED|Extension Phase (Open-label Phase)||5
3214814|NCT02229851|3945668|FG005|NOT COMPLETED|Extension Phase (Open-label Phase)||5
3214815|NCT02229851|3945669|FG006|NOT COMPLETED|Extension Phase (Open-label Phase)||3
3214816|NCT02229864|3945684|FG000|STARTED|Overall Study||12
3214817|NCT02229864|3945684|FG000|COMPLETED|Overall Study||9
3214818|NCT02229864|3945684|FG000|NOT COMPLETED|Overall Study||3
3214819|NCT02230085|3945688|FG000|STARTED|Overall Study||110
3214820|NCT02230085|3945688|FG000|COMPLETED|Overall Study||106
3214821|NCT02230085|3945688|FG000|NOT COMPLETED|Overall Study||4
3214822|NCT02230306|3945692|FG000|STARTED|Overall Study||5
3214823|NCT02230306|3945692|FG000|COMPLETED|Overall Study||4
3214824|NCT02230306|3945692|FG000|NOT COMPLETED|Overall Study||1
3214825|NCT02230332|3945698|FG000|STARTED|Overall Study||38
3214826|NCT02230332|3945699|FG001|STARTED|Overall Study||40
3214827|NCT02230332|3945698|FG000|COMPLETED|Overall Study||34
3214828|NCT02230332|3945699|FG001|COMPLETED|Overall Study||39
3214829|NCT02230332|3945698|FG000|NOT COMPLETED|Overall Study||4
3214830|NCT02230332|3945699|FG001|NOT COMPLETED|Overall Study||1
3214831|NCT02230384|3945707|FG000|STARTED|Phase 1||30
3214832|NCT02230384|3945708|FG001|STARTED|Phase 1||32
3214833|NCT02230384|3945707|FG000|COMPLETED|Phase 1||29
3214834|NCT02230384|3945708|FG001|COMPLETED|Phase 1||31
3214835|NCT02230384|3945707|FG000|NOT COMPLETED|Phase 1||1
3214836|NCT02230384|3945708|FG001|NOT COMPLETED|Phase 1||1
3214837|NCT02230384|3945707|FG000|STARTED|Phase 1 Wash Out||29
3214838|NCT02230384|3945708|FG001|STARTED|Phase 1 Wash Out||31
3214839|NCT02230384|3945707|FG000|COMPLETED|Phase 1 Wash Out||29
3214840|NCT02230384|3945708|FG001|COMPLETED|Phase 1 Wash Out||31
3214841|NCT02230384|3945707|FG000|NOT COMPLETED|Phase 1 Wash Out||0
3214842|NCT02230384|3945708|FG001|NOT COMPLETED|Phase 1 Wash Out||0
3214843|NCT02230384|3945707|FG000|STARTED|Phase 2 - Switch||29
3214844|NCT02230384|3945708|FG001|STARTED|Phase 2 - Switch||31
3214845|NCT02230384|3945707|FG000|COMPLETED|Phase 2 - Switch||26
3214846|NCT02230384|3945708|FG001|COMPLETED|Phase 2 - Switch||30
3214847|NCT02230384|3945707|FG000|NOT COMPLETED|Phase 2 - Switch||3
3214848|NCT02230384|3945708|FG001|NOT COMPLETED|Phase 2 - Switch||1
3214849|NCT02230384|3945707|FG000|STARTED|Phase 2 Wash Out||26
3214850|NCT02230384|3945708|FG001|STARTED|Phase 2 Wash Out||30
3214851|NCT02230384|3945707|FG000|COMPLETED|Phase 2 Wash Out||26
3214852|NCT02230384|3945708|FG001|COMPLETED|Phase 2 Wash Out||30
3214853|NCT02230384|3945707|FG000|NOT COMPLETED|Phase 2 Wash Out||0
3214854|NCT02230384|3945708|FG001|NOT COMPLETED|Phase 2 Wash Out||0
3214855|NCT02230527|3945724|FG000|STARTED|Overall Study||23
3214856|NCT02230527|3945725|FG001|STARTED|Overall Study||23
3214857|NCT02230527|3945724|FG000|COMPLETED|Overall Study||18
3214858|NCT02230527|3945725|FG001|COMPLETED|Overall Study||21
3214859|NCT02230527|3945724|FG000|NOT COMPLETED|Overall Study||5
3214860|NCT02230527|3945725|FG001|NOT COMPLETED|Overall Study||2
3214861|NCT02230540|3945731|FG000|STARTED|Overall Study||8
3214862|NCT02230540|3945732|FG001|STARTED|Overall Study|The study was terminated before initiation of sequence B. Sequence B was therefore not initiated.|0
3214863|NCT02230540|3945731|FG000|COMPLETED|Overall Study||8
3214864|NCT02230540|3945732|FG001|COMPLETED|Overall Study||0
3214865|NCT02230540|3945731|FG000|NOT COMPLETED|Overall Study||0
3214866|NCT02230540|3945732|FG001|NOT COMPLETED|Overall Study||0
3214867|NCT02230566|3945740|FG000|STARTED|Overall Study||3
3214868|NCT02230566|3945741|FG001|STARTED|Overall Study||3
3214869|NCT02230566|3945742|FG002|STARTED|Overall Study||3
3214870|NCT02230566|3945743|FG003|STARTED|Overall Study||3
3214871|NCT02230566|3945740|FG000|COMPLETED|Overall Study||3
3214872|NCT02230566|3945741|FG001|COMPLETED|Overall Study||3
3214873|NCT02230566|3945742|FG002|COMPLETED|Overall Study||3
3214874|NCT02230566|3945743|FG003|COMPLETED|Overall Study||3
3214875|NCT02230566|3945740|FG000|NOT COMPLETED|Overall Study||0
3214876|NCT02230566|3945741|FG001|NOT COMPLETED|Overall Study||0
3214877|NCT02230566|3945742|FG002|NOT COMPLETED|Overall Study||0
3214878|NCT02230566|3945743|FG003|NOT COMPLETED|Overall Study||0
3214879|NCT02230579|3945755|FG000|STARTED|Overall Study||6
3214880|NCT02230579|3945756|FG001|STARTED|Overall Study||6
3214881|NCT02230579|3945757|FG002|STARTED|Overall Study||6
3214882|NCT02230579|3945758|FG003|STARTED|Overall Study||6
3214883|NCT02230579|3945759|FG004|STARTED|Overall Study||6
3214884|NCT02230579|3945760|FG005|STARTED|Overall Study||6
3214885|NCT02230579|3945761|FG006|STARTED|Overall Study||12
3214886|NCT02230579|3945755|FG000|COMPLETED|Overall Study||6
3214887|NCT02230579|3945756|FG001|COMPLETED|Overall Study||6
3214888|NCT02230579|3945757|FG002|COMPLETED|Overall Study||6
3214889|NCT02230579|3945758|FG003|COMPLETED|Overall Study||6
3214890|NCT02230579|3945759|FG004|COMPLETED|Overall Study||6
3214891|NCT02230579|3945760|FG005|COMPLETED|Overall Study||6
3214892|NCT02230579|3945761|FG006|COMPLETED|Overall Study||12
3214893|NCT02230579|3945755|FG000|NOT COMPLETED|Overall Study||0
3214894|NCT02230579|3945756|FG001|NOT COMPLETED|Overall Study||0
3214895|NCT02230579|3945757|FG002|NOT COMPLETED|Overall Study||0
3214896|NCT02230579|3945758|FG003|NOT COMPLETED|Overall Study||0
3214897|NCT02230579|3945759|FG004|NOT COMPLETED|Overall Study||0
3214898|NCT02230579|3945760|FG005|NOT COMPLETED|Overall Study||0
3214899|NCT02230579|3945761|FG006|NOT COMPLETED|Overall Study||0
3214900|NCT02230670|3945779|FG000|STARTED|Overall Study||44
3214901|NCT02230670|3945780|FG001|STARTED|Overall Study|One subject randomized to placebo withdrew from the study before receiving any study treatment.|42
3214902|NCT02230670|3945779|FG000|COMPLETED|Overall Study||40
3214903|NCT02230670|3945780|FG001|COMPLETED|Overall Study||34
3214904|NCT02230670|3945779|FG000|NOT COMPLETED|Overall Study||4
3214905|NCT02230670|3945780|FG001|NOT COMPLETED|Overall Study||8
3214906|NCT02230683|3945786|FG000|STARTED|Overall Study||23
3214907|NCT02230683|3945786|FG000|COMPLETED|Overall Study||22
3214908|NCT02230683|3945786|FG000|NOT COMPLETED|Overall Study||1
3214909|NCT02230696|3945799|FG000|STARTED|Overall Study||381
3214910|NCT02230696|3945800|FG001|STARTED|Overall Study||376
3214911|NCT02230696|3945801|FG002|STARTED|Overall Study||194
3214912|NCT02230696|3945799|FG000|COMPLETED|Overall Study||366
3214913|NCT02230696|3945800|FG001|COMPLETED|Overall Study||365
3214914|NCT02230696|3945801|FG002|COMPLETED|Overall Study||190
3214915|NCT02230696|3945799|FG000|NOT COMPLETED|Overall Study||15
3214916|NCT02230696|3945800|FG001|NOT COMPLETED|Overall Study||11
3214917|NCT02230696|3945801|FG002|NOT COMPLETED|Overall Study||4
3214918|NCT02230761|3945811|FG000|STARTED|Overall Study||60
3214919|NCT02230761|3945812|FG001|STARTED|Overall Study||30
3214920|NCT02230761|3945811|FG000|COMPLETED|Overall Study||60
3214921|NCT02230761|3945812|FG001|COMPLETED|Overall Study||29
3214922|NCT02230761|3945811|FG000|NOT COMPLETED|Overall Study||0
3214923|NCT02230761|3945812|FG001|NOT COMPLETED|Overall Study||1
3214924|NCT02230904|3945820|FG000|STARTED|Overall Study||29
3214925|NCT02230904|3945821|FG001|STARTED|Overall Study||28
3214926|NCT02230904|3945820|FG000|COMPLETED|Overall Study||29
3214927|NCT02230904|3945821|FG001|COMPLETED|Overall Study||27
3214928|NCT02230904|3945820|FG000|NOT COMPLETED|Overall Study||0
3214929|NCT02230904|3945821|FG001|NOT COMPLETED|Overall Study||1
3214930|NCT02230956|3945832|FG000|STARTED|Overall Study||44
3214931|NCT02230956|3945833|FG001|STARTED|Overall Study||43
3214932|NCT02230956|3945834|FG002|STARTED|Overall Study||89
3214933|NCT02230956|3945832|FG000|COMPLETED|Overall Study||39
3214934|NCT02230956|3945833|FG001|COMPLETED|Overall Study||37
3214935|NCT02230956|3945834|FG002|COMPLETED|Overall Study||82
3214936|NCT02230956|3945832|FG000|NOT COMPLETED|Overall Study||5
3214937|NCT02230956|3945833|FG001|NOT COMPLETED|Overall Study||6
3214938|NCT02230956|3945834|FG002|NOT COMPLETED|Overall Study||7
3214939|NCT02230995|3945844|FG000|STARTED|Period 1 + Washout||15
3214940|NCT02230995|3945845|FG001|STARTED|Period 1 + Washout||15
3214941|NCT02230995|3945844|FG000|COMPLETED|Period 1 + Washout||15
3214942|NCT02230995|3945845|FG001|COMPLETED|Period 1 + Washout||15
3214943|NCT02230995|3945844|FG000|NOT COMPLETED|Period 1 + Washout||0
3214944|NCT02230995|3945845|FG001|NOT COMPLETED|Period 1 + Washout||0
3214945|NCT02230995|3945844|FG000|STARTED|Period 2 + Washout||15
3214946|NCT02230995|3945845|FG001|STARTED|Period 2 + Washout||15
3214947|NCT02230995|3945844|FG000|COMPLETED|Period 2 + Washout||15
3214948|NCT02230995|3945845|FG001|COMPLETED|Period 2 + Washout||15
3214949|NCT02230995|3945844|FG000|NOT COMPLETED|Period 2 + Washout||0
3214950|NCT02230995|3945845|FG001|NOT COMPLETED|Period 2 + Washout||0
3214951|NCT02231086|3945853|FG000|STARTED|Overall Study||102
3214952|NCT02231086|3945854|FG001|STARTED|Overall Study||102
3214953|NCT02231086|3945853|FG000|COMPLETED|Overall Study||63
3214954|NCT02231086|3945854|FG001|COMPLETED|Overall Study||65
3214955|NCT02231086|3945853|FG000|NOT COMPLETED|Overall Study||39
3214956|NCT02231086|3945854|FG001|NOT COMPLETED|Overall Study||37
3214957|NCT02231164|3945862|FG000|STARTED|Overall Study||6
3214958|NCT02231164|3945863|FG001|STARTED|Overall Study||6
3214959|NCT02231164|3945862|FG000|COMPLETED|Overall Study||0
3214960|NCT02231164|3945863|FG001|COMPLETED|Overall Study||0
3214961|NCT02231164|3945862|FG000|NOT COMPLETED|Overall Study||6
3214962|NCT02231164|3945863|FG001|NOT COMPLETED|Overall Study||6
3214963|NCT02231177|3945869|FG000|STARTED|Treatment Period 1 (21 Days)||8
3214964|NCT02231177|3945870|FG001|STARTED|Treatment Period 1 (21 Days)||7
3214965|NCT02231177|3945871|FG002|STARTED|Treatment Period 1 (21 Days)||8
3214966|NCT02231177|3945872|FG003|STARTED|Treatment Period 1 (21 Days)||7
3214967|NCT02231177|3945873|FG004|STARTED|Treatment Period 1 (21 Days)||8
3214968|NCT02231177|3945874|FG005|STARTED|Treatment Period 1 (21 Days)||9
3214969|NCT02231177|3945869|FG000|COMPLETED|Treatment Period 1 (21 Days)||8
3214970|NCT02231177|3945870|FG001|COMPLETED|Treatment Period 1 (21 Days)||7
3214971|NCT02231177|3945871|FG002|COMPLETED|Treatment Period 1 (21 Days)||8
3214972|NCT02231177|3945872|FG003|COMPLETED|Treatment Period 1 (21 Days)||7
3214973|NCT02231177|3945873|FG004|COMPLETED|Treatment Period 1 (21 Days)||8
3214974|NCT02231177|3945874|FG005|COMPLETED|Treatment Period 1 (21 Days)||9
3214975|NCT02231177|3945869|FG000|NOT COMPLETED|Treatment Period 1 (21 Days)||0
3214976|NCT02231177|3945870|FG001|NOT COMPLETED|Treatment Period 1 (21 Days)||0
3214977|NCT02231177|3945871|FG002|NOT COMPLETED|Treatment Period 1 (21 Days)||0
3214978|NCT02231177|3945872|FG003|NOT COMPLETED|Treatment Period 1 (21 Days)||0
3214979|NCT02231177|3945873|FG004|NOT COMPLETED|Treatment Period 1 (21 Days)||0
3214980|NCT02231177|3945874|FG005|NOT COMPLETED|Treatment Period 1 (21 Days)||0
3214981|NCT02231177|3945869|FG000|STARTED|Treatment Period 2 (21 Days)||8
3214982|NCT02231177|3945870|FG001|STARTED|Treatment Period 2 (21 Days)||7
3214983|NCT02231177|3945871|FG002|STARTED|Treatment Period 2 (21 Days)||8
3214984|NCT02231177|3945872|FG003|STARTED|Treatment Period 2 (21 Days)||7
3214985|NCT02231177|3945873|FG004|STARTED|Treatment Period 2 (21 Days)||8
3214986|NCT02231177|3945874|FG005|STARTED|Treatment Period 2 (21 Days)||9
3214987|NCT02231177|3945869|FG000|COMPLETED|Treatment Period 2 (21 Days)||8
3214988|NCT02231177|3945870|FG001|COMPLETED|Treatment Period 2 (21 Days)||7
3214989|NCT02231177|3945871|FG002|COMPLETED|Treatment Period 2 (21 Days)||8
3214990|NCT02231177|3945872|FG003|COMPLETED|Treatment Period 2 (21 Days)||7
3214991|NCT02231177|3945873|FG004|COMPLETED|Treatment Period 2 (21 Days)||8
3214992|NCT02231177|3945874|FG005|COMPLETED|Treatment Period 2 (21 Days)||9
3214993|NCT02231177|3945869|FG000|NOT COMPLETED|Treatment Period 2 (21 Days)||0
3214994|NCT02231177|3945870|FG001|NOT COMPLETED|Treatment Period 2 (21 Days)||0
3214995|NCT02231177|3945871|FG002|NOT COMPLETED|Treatment Period 2 (21 Days)||0
3214996|NCT02231177|3945872|FG003|NOT COMPLETED|Treatment Period 2 (21 Days)||0
3214997|NCT02231177|3945873|FG004|NOT COMPLETED|Treatment Period 2 (21 Days)||0
3214998|NCT02231177|3945874|FG005|NOT COMPLETED|Treatment Period 2 (21 Days)||0
3214999|NCT02231177|3945869|FG000|STARTED|Treatment Period 3 (21 Days)||8
3215000|NCT02231177|3945870|FG001|STARTED|Treatment Period 3 (21 Days)||7
3215001|NCT02231177|3945871|FG002|STARTED|Treatment Period 3 (21 Days)||8
3215002|NCT02231177|3945872|FG003|STARTED|Treatment Period 3 (21 Days)||7
3215003|NCT02231177|3945873|FG004|STARTED|Treatment Period 3 (21 Days)||8
3215004|NCT02231177|3945874|FG005|STARTED|Treatment Period 3 (21 Days)||9
3215005|NCT02231177|3945869|FG000|COMPLETED|Treatment Period 3 (21 Days)||8
3366976|NCT03881007|4098346|FG001|NOT COMPLETED|Last 3 Months||45
3366977|NCT03878602|4098354|FG000|STARTED|Overall Study||75
3366978|NCT03878602|4098355|FG001|STARTED|Overall Study||67
3366979|NCT03878602|4098354|FG000|COMPLETED|Overall Study||66
3366980|NCT03878602|4098355|FG001|COMPLETED|Overall Study||66
3366981|NCT03878602|4098354|FG000|NOT COMPLETED|Overall Study||9
3366982|NCT03878602|4098355|FG001|NOT COMPLETED|Overall Study||1
3366983|NCT03875118|4098365|FG000|STARTED|Overall Study||34
3366984|NCT03875118|4098366|FG001|STARTED|Overall Study||34
3366985|NCT03875118|4098365|FG000|COMPLETED|Overall Study||30
3215006|NCT02231177|3945870|FG001|COMPLETED|Treatment Period 3 (21 Days)||7
3215007|NCT02231177|3945871|FG002|COMPLETED|Treatment Period 3 (21 Days)||8
3215008|NCT02231177|3945872|FG003|COMPLETED|Treatment Period 3 (21 Days)||7
3215009|NCT02231177|3945873|FG004|COMPLETED|Treatment Period 3 (21 Days)||8
3215010|NCT02231177|3945874|FG005|COMPLETED|Treatment Period 3 (21 Days)||9
3215011|NCT02231177|3945869|FG000|NOT COMPLETED|Treatment Period 3 (21 Days)||0
3215012|NCT02231177|3945870|FG001|NOT COMPLETED|Treatment Period 3 (21 Days)||0
3215013|NCT02231177|3945871|FG002|NOT COMPLETED|Treatment Period 3 (21 Days)||0
3215014|NCT02231177|3945872|FG003|NOT COMPLETED|Treatment Period 3 (21 Days)||0
3215015|NCT02231177|3945873|FG004|NOT COMPLETED|Treatment Period 3 (21 Days)||0
3215016|NCT02231177|3945874|FG005|NOT COMPLETED|Treatment Period 3 (21 Days)||0
3215017|NCT02231580|3945885|FG000|STARTED|Overall Study||14
3215018|NCT02231580|3945886|FG001|STARTED|Overall Study||3
3215019|NCT02231580|3945885|FG000|Cohort 1|Overall Study||8
3215020|NCT02231580|3945886|FG001|Cohort 1|Overall Study||2
3215021|NCT02231580|3945885|FG000|Cohort 2|Overall Study||6
3215022|NCT02231580|3945886|FG001|Cohort 2|Overall Study||1
3215023|NCT02231580|3945885|FG000|COMPLETED|Overall Study||9
3215024|NCT02231580|3945886|FG001|COMPLETED|Overall Study||3
3215025|NCT02231580|3945885|FG000|NOT COMPLETED|Overall Study||5
3215026|NCT02231580|3945886|FG001|NOT COMPLETED|Overall Study||0
3215027|NCT02231749|3945896|FG000|STARTED|Overall Study||550
3215028|NCT02231749|3945897|FG001|STARTED|Overall Study||546
3215029|NCT02231749|3945896|FG000|Received Treatment|Overall Study||547
3215030|NCT02231749|3945897|FG001|Received Treatment|Overall Study||535
3215031|NCT02231749|3945896|FG000|COMPLETED|Overall Study||128
3215032|NCT02231749|3945897|FG001|COMPLETED|Overall Study||97
3215033|NCT02231749|3945896|FG000|NOT COMPLETED|Overall Study||422
3215034|NCT02231749|3945897|FG001|NOT COMPLETED|Overall Study||449
3215035|NCT02231918|3945906|FG000|STARTED|Overall Study||9
3215036|NCT02231918|3945907|FG001|STARTED|Overall Study||15
3215037|NCT02231918|3945908|FG002|STARTED|Overall Study||2
3215038|NCT02231918|3945906|FG000|COMPLETED|Overall Study||9
3215039|NCT02231918|3945907|FG001|COMPLETED|Overall Study||14
3215040|NCT02231918|3945908|FG002|COMPLETED|Overall Study||1
3215041|NCT02231918|3945906|FG000|NOT COMPLETED|Overall Study||0
3215042|NCT02231918|3945907|FG001|NOT COMPLETED|Overall Study||1
3215043|NCT02231918|3945908|FG002|NOT COMPLETED|Overall Study||1
3215044|NCT02232009|3945916|FG000|STARTED|Overall Study||9
3215045|NCT02232009|3945916|FG000|COMPLETED|Overall Study||9
3215046|NCT02232009|3945916|FG000|NOT COMPLETED|Overall Study||0
3215047|NCT02232022|3945920|FG000|STARTED|Overall Study||53
3215048|NCT02232022|3945920|FG000|COMPLETED|Overall Study||51
3215049|NCT02232022|3945920|FG000|NOT COMPLETED|Overall Study||2
3215050|NCT02232061|3945926|FG000|STARTED|Overall Study||6
3215051|NCT02232061|3945926|FG000|COMPLETED|Overall Study||4
3215052|NCT02232061|3945926|FG000|NOT COMPLETED|Overall Study||2
3215053|NCT02232074|3945932|FG000|STARTED|Overall Study||154
3215054|NCT02232074|3945933|FG001|STARTED|Overall Study||152
3215055|NCT02232074|3945932|FG000|COMPLETED|Overall Study||113
3215056|NCT02232074|3945933|FG001|COMPLETED|Overall Study||107
3215057|NCT02232074|3945932|FG000|NOT COMPLETED|Overall Study||41
3215058|NCT02232074|3945933|FG001|NOT COMPLETED|Overall Study||45
3215059|NCT02232087|3945945|FG000|STARTED|Overall Study||9
3215060|NCT02232087|3945946|FG001|STARTED|Overall Study||10
3215061|NCT02232087|3945947|FG002|STARTED|Overall Study||8
3215062|NCT02232087|3945948|FG003|STARTED|Overall Study||8
3215063|NCT02232087|3945949|FG004|STARTED|Overall Study||8
3215064|NCT02232087|3945950|FG005|STARTED|Overall Study||9
3215065|NCT02232087|3945945|FG000|COMPLETED|Overall Study||7
3215066|NCT02232087|3945946|FG001|COMPLETED|Overall Study||8
3215067|NCT02232087|3945947|FG002|COMPLETED|Overall Study||8
3215068|NCT02232087|3945948|FG003|COMPLETED|Overall Study||7
3215069|NCT02232087|3945949|FG004|COMPLETED|Overall Study||7
3215070|NCT02232087|3945950|FG005|COMPLETED|Overall Study||6
3215071|NCT02232087|3945945|FG000|NOT COMPLETED|Overall Study||2
3215072|NCT02232087|3945946|FG001|NOT COMPLETED|Overall Study||2
3215073|NCT02232087|3945947|FG002|NOT COMPLETED|Overall Study||0
3215074|NCT02232087|3945948|FG003|NOT COMPLETED|Overall Study||1
3215075|NCT02232087|3945949|FG004|NOT COMPLETED|Overall Study||1
3215076|NCT02232087|3945950|FG005|NOT COMPLETED|Overall Study||3
3215077|NCT02232126|3945971|FG000|STARTED|Overall Study||91
3215078|NCT02232126|3945972|FG001|STARTED|Overall Study||90
3215079|NCT02232126|3945971|FG000|COMPLETED|Overall Study||91
3215080|NCT02232126|3945972|FG001|COMPLETED|Overall Study||90
3215081|NCT02232126|3945971|FG000|NOT COMPLETED|Overall Study||0
3215082|NCT02232126|3945972|FG001|NOT COMPLETED|Overall Study||0
3215083|NCT02232178|3945983|FG000|STARTED|Overall Study||26
3215084|NCT02232178|3945984|FG001|STARTED|Overall Study||25
3215085|NCT02232178|3945985|FG002|STARTED|Overall Study||13
3215086|NCT02232178|3945983|FG000|Per Protocol PK Population|Overall Study||26
3215087|NCT02232178|3945984|FG001|Per Protocol PK Population|Overall Study||24
3215088|NCT02232178|3945985|FG002|Per Protocol PK Population|Overall Study||11
3215089|NCT02232178|3945983|FG000|Safety Population|Overall Study||26
3215090|NCT02232178|3945984|FG001|Safety Population|Overall Study||24
3215091|NCT02232178|3945985|FG002|Safety Population|Overall Study||12
3215092|NCT02232178|3945983|FG000|COMPLETED|Overall Study||25
3215093|NCT02232178|3945984|FG001|COMPLETED|Overall Study||24
3215094|NCT02232178|3945985|FG002|COMPLETED|Overall Study||12
3215095|NCT02232178|3945983|FG000|NOT COMPLETED|Overall Study||1
3215096|NCT02232178|3945984|FG001|NOT COMPLETED|Overall Study||1
3215097|NCT02232178|3945985|FG002|NOT COMPLETED|Overall Study||1
3215098|NCT02232243|3945996|FG000|STARTED|First Dose (200mg HCQ Twice Daily)||3
3215099|NCT02232243|3945997|FG001|STARTED|First Dose (200mg HCQ Twice Daily)||0
3215100|NCT02232243|3945998|FG002|STARTED|First Dose (200mg HCQ Twice Daily)||0
3215101|NCT02232243|3945996|FG000|COMPLETED|First Dose (200mg HCQ Twice Daily)||3
3215102|NCT02232243|3945997|FG001|COMPLETED|First Dose (200mg HCQ Twice Daily)||0
3215103|NCT02232243|3945998|FG002|COMPLETED|First Dose (200mg HCQ Twice Daily)||0
3215104|NCT02232243|3945996|FG000|NOT COMPLETED|First Dose (200mg HCQ Twice Daily)||0
3215105|NCT02232243|3945997|FG001|NOT COMPLETED|First Dose (200mg HCQ Twice Daily)||0
3215106|NCT02232243|3945998|FG002|NOT COMPLETED|First Dose (200mg HCQ Twice Daily)||0
3215107|NCT02232243|3945996|FG000|STARTED|Second Dose (400mg HCQ Twice Daily)||0
3215108|NCT02232243|3945997|FG001|STARTED|Second Dose (400mg HCQ Twice Daily)||4
3215109|NCT02232243|3945998|FG002|STARTED|Second Dose (400mg HCQ Twice Daily)||0
3215110|NCT02232243|3945996|FG000|COMPLETED|Second Dose (400mg HCQ Twice Daily)||0
3215111|NCT02232243|3945997|FG001|COMPLETED|Second Dose (400mg HCQ Twice Daily)||3
3215112|NCT02232243|3945998|FG002|COMPLETED|Second Dose (400mg HCQ Twice Daily)||0
3215113|NCT02232243|3945996|FG000|NOT COMPLETED|Second Dose (400mg HCQ Twice Daily)||0
3215114|NCT02232243|3945997|FG001|NOT COMPLETED|Second Dose (400mg HCQ Twice Daily)||1
3215115|NCT02232243|3945998|FG002|NOT COMPLETED|Second Dose (400mg HCQ Twice Daily)||0
3215116|NCT02232243|3945996|FG000|STARTED|Third Dose(200mg HCQ Twice Daily)||0
3215117|NCT02232243|3945997|FG001|STARTED|Third Dose(200mg HCQ Twice Daily)||0
3215118|NCT02232243|3945998|FG002|STARTED|Third Dose(200mg HCQ Twice Daily)||3
3215119|NCT02232243|3945996|FG000|COMPLETED|Third Dose(200mg HCQ Twice Daily)||0
3215120|NCT02232243|3945997|FG001|COMPLETED|Third Dose(200mg HCQ Twice Daily)||0
3215121|NCT02232243|3945998|FG002|COMPLETED|Third Dose(200mg HCQ Twice Daily)||3
3215122|NCT02232243|3945996|FG000|NOT COMPLETED|Third Dose(200mg HCQ Twice Daily)||0
3215123|NCT02232243|3945997|FG001|NOT COMPLETED|Third Dose(200mg HCQ Twice Daily)||0
3215124|NCT02232243|3945998|FG002|NOT COMPLETED|Third Dose(200mg HCQ Twice Daily)||0
3215125|NCT02232282|3946009|FG000|STARTED|Overall Study||10
3215126|NCT02232282|3946010|FG001|STARTED|Overall Study||11
3215127|NCT02232282|3946009|FG000|COMPLETED|Overall Study||10
3215128|NCT02232282|3946010|FG001|COMPLETED|Overall Study||11
3215129|NCT02232282|3946009|FG000|NOT COMPLETED|Overall Study||0
3215130|NCT02232282|3946010|FG001|NOT COMPLETED|Overall Study||0
3215131|NCT02232425|3946022|FG000|STARTED|Overall Study||58
3215132|NCT02232425|3946023|FG001|STARTED|Overall Study||30
3215133|NCT02232425|3946022|FG000|COMPLETED|Overall Study||44
3215134|NCT02232425|3946023|FG001|COMPLETED|Overall Study||22
3215135|NCT02232425|3946022|FG000|NOT COMPLETED|Overall Study||14
3215136|NCT02232425|3946023|FG001|NOT COMPLETED|Overall Study||8
3215137|NCT02232698|3946031|FG000|STARTED|Overall Study||120
3215138|NCT02232698|3946032|FG001|STARTED|Overall Study||121
3215139|NCT02232698|3946031|FG000|COMPLETED|Overall Study||110
3215140|NCT02232698|3946032|FG001|COMPLETED|Overall Study||101
3215141|NCT02232698|3946031|FG000|NOT COMPLETED|Overall Study||10
3215142|NCT02232698|3946032|FG001|NOT COMPLETED|Overall Study||20
3215143|NCT02232802|3946040|FG000|STARTED|Period 1||24
3215144|NCT02232802|3946041|FG001|STARTED|Period 1||23
3215145|NCT02232802|3946040|FG000|COMPLETED|Period 1||22
3215146|NCT02232802|3946041|FG001|COMPLETED|Period 1||22
3215147|NCT02232802|3946040|FG000|NOT COMPLETED|Period 1||2
3215148|NCT02232802|3946041|FG001|NOT COMPLETED|Period 1||1
3215149|NCT02232802|3946040|FG000|STARTED|Washout||22
3215150|NCT02232802|3946041|FG001|STARTED|Washout||22
3215151|NCT02232802|3946040|FG000|COMPLETED|Washout||22
3215152|NCT02232802|3946041|FG001|COMPLETED|Washout||22
3215153|NCT02232802|3946040|FG000|NOT COMPLETED|Washout||0
3215154|NCT02232802|3946041|FG001|NOT COMPLETED|Washout||0
3215155|NCT02232802|3946040|FG000|STARTED|Period 2||22
3215156|NCT02232802|3946041|FG001|STARTED|Period 2||22
3215157|NCT02232802|3946040|FG000|COMPLETED|Period 2||22
3215158|NCT02232802|3946041|FG001|COMPLETED|Period 2||22
3215159|NCT02232802|3946040|FG000|NOT COMPLETED|Period 2||0
3215160|NCT02232802|3946041|FG001|NOT COMPLETED|Period 2||0
3215161|NCT02232802|3946040|FG000|STARTED|Washout||22
3215162|NCT02232802|3946041|FG001|STARTED|Washout||22
3215163|NCT02232802|3946040|FG000|COMPLETED|Washout||22
3215164|NCT02232802|3946041|FG001|COMPLETED|Washout||22
3215165|NCT02232802|3946040|FG000|NOT COMPLETED|Washout||0
3215166|NCT02232802|3946041|FG001|NOT COMPLETED|Washout||0
3366986|NCT03875118|4098366|FG001|COMPLETED|Overall Study||30
3366987|NCT03875118|4098365|FG000|NOT COMPLETED|Overall Study||4
3366988|NCT03875118|4098366|FG001|NOT COMPLETED|Overall Study||4
3366989|NCT03873987|4098374|FG000|STARTED|Overall Study||52
3366990|NCT03873987|4098375|FG001|STARTED|Overall Study||50
3366991|NCT03873987|4098374|FG000|COMPLETED|Overall Study||50
3366992|NCT03873987|4098375|FG001|COMPLETED|Overall Study||49
3366993|NCT03873987|4098374|FG000|NOT COMPLETED|Overall Study||2
3366994|NCT03873987|4098375|FG001|NOT COMPLETED|Overall Study||1
3366995|NCT03870893|4098384|FG000|STARTED|Overall Study||23
3215167|NCT02232893|3946049|FG000|STARTED|Overall Study||35
3215168|NCT02232893|3946050|FG001|STARTED|Overall Study||34
3215169|NCT02232893|3946049|FG000|Safety Population|Overall Study|Pts who rec'd at least 1 dose of study drug. All safety analyses performed using this population.|34
3215170|NCT02232893|3946050|FG001|Safety Population|Overall Study|Pts who rec'd at least 1 dose of study drug. All safety analyses performed using this population.|32
3215171|NCT02232893|3946049|FG000|Primary Endpoint Population|Overall Study|Patients who provided GIQLI scores both at baseline and Visit 4 were analyzed for primary endpoint|24
3215172|NCT02232893|3946050|FG001|Primary Endpoint Population|Overall Study|Patients who provided GIQLI scores both at baseline and Visit 4 were analyzed for primary endpoint|19
3215173|NCT02232893|3946049|FG000|COMPLETED|Overall Study||31
3215174|NCT02232893|3946050|FG001|COMPLETED|Overall Study||27
3215175|NCT02232893|3946049|FG000|NOT COMPLETED|Overall Study||4
3215176|NCT02232893|3946050|FG001|NOT COMPLETED|Overall Study||7
3215177|NCT02232984|3946056|FG000|STARTED|Overall Study|Enrolled subjects|749
3215178|NCT02232984|3946056|FG000|Successfully Implanted|Overall Study|Successfully implanted subjects|675
3215179|NCT02232984|3946056|FG000|COMPLETED|Overall Study|Total number of subjects who completed study|672
3215180|NCT02232984|3946056|FG000|NOT COMPLETED|Overall Study||77
3215181|NCT02233101|3946065|FG000|STARTED|Overall Study||86
3215182|NCT02233101|3946066|FG001|STARTED|Overall Study||81
3215183|NCT02233101|3946065|FG000|COMPLETED|Overall Study||74
3215184|NCT02233101|3946066|FG001|COMPLETED|Overall Study||80
3215185|NCT02233101|3946065|FG000|NOT COMPLETED|Overall Study||12
3215186|NCT02233101|3946066|FG001|NOT COMPLETED|Overall Study||1
3215187|NCT02233296|3946074|FG000|STARTED|Overall Study||16
3215188|NCT02233296|3946075|FG001|STARTED|Overall Study||14
3215189|NCT02233296|3946074|FG000|COMPLETED|Overall Study||16
3215190|NCT02233296|3946075|FG001|COMPLETED|Overall Study||14
3215191|NCT02233296|3946074|FG000|NOT COMPLETED|Overall Study||0
3215192|NCT02233296|3946075|FG001|NOT COMPLETED|Overall Study||0
3215193|NCT02233309|3946085|FG000|STARTED|Overall Study||36
3215194|NCT02233309|3946085|FG000|COMPLETED|Overall Study||31
3215195|NCT02233309|3946085|FG000|NOT COMPLETED|Overall Study||5
3215196|NCT02233413|3946091|FG000|STARTED|Overall Study||35
3215197|NCT02233413|3946092|FG001|STARTED|Overall Study||33
3215198|NCT02233413|3946091|FG000|COMPLETED|Overall Study||24
3215199|NCT02233413|3946092|FG001|COMPLETED|Overall Study||19
3215200|NCT02233413|3946091|FG000|NOT COMPLETED|Overall Study||11
3215201|NCT02233413|3946092|FG001|NOT COMPLETED|Overall Study||14
3215202|NCT02233478|3946098|FG000|STARTED|First Intervention (1 Day)||3
3215203|NCT02233478|3946099|FG001|STARTED|First Intervention (1 Day)||3
3215204|NCT02233478|3946100|FG002|STARTED|First Intervention (1 Day)||3
3215205|NCT02233478|3946101|FG003|STARTED|First Intervention (1 Day)||3
3215206|NCT02233478|3946102|FG004|STARTED|First Intervention (1 Day)||3
3215207|NCT02233478|3946103|FG005|STARTED|First Intervention (1 Day)||3
3215208|NCT02233478|3946098|FG000|COMPLETED|First Intervention (1 Day)||3
3215209|NCT02233478|3946099|FG001|COMPLETED|First Intervention (1 Day)||3
3215210|NCT02233478|3946100|FG002|COMPLETED|First Intervention (1 Day)||3
3215211|NCT02233478|3946101|FG003|COMPLETED|First Intervention (1 Day)||3
3215212|NCT02233478|3946102|FG004|COMPLETED|First Intervention (1 Day)||3
3215213|NCT02233478|3946103|FG005|COMPLETED|First Intervention (1 Day)||3
3215214|NCT02233478|3946098|FG000|NOT COMPLETED|First Intervention (1 Day)||0
3215215|NCT02233478|3946099|FG001|NOT COMPLETED|First Intervention (1 Day)||0
3215216|NCT02233478|3946100|FG002|NOT COMPLETED|First Intervention (1 Day)||0
3215217|NCT02233478|3946101|FG003|NOT COMPLETED|First Intervention (1 Day)||0
3215218|NCT02233478|3946102|FG004|NOT COMPLETED|First Intervention (1 Day)||0
3215219|NCT02233478|3946103|FG005|NOT COMPLETED|First Intervention (1 Day)||0
3215220|NCT02233478|3946098|FG000|STARTED|Washout (7 Days)||3
3215221|NCT02233478|3946099|FG001|STARTED|Washout (7 Days)||3
3215222|NCT02233478|3946100|FG002|STARTED|Washout (7 Days)||3
3215223|NCT02233478|3946101|FG003|STARTED|Washout (7 Days)||3
3215224|NCT02233478|3946102|FG004|STARTED|Washout (7 Days)||3
3215225|NCT02233478|3946103|FG005|STARTED|Washout (7 Days)||3
3215226|NCT02233478|3946098|FG000|COMPLETED|Washout (7 Days)||3
3215227|NCT02233478|3946099|FG001|COMPLETED|Washout (7 Days)||3
3215228|NCT02233478|3946100|FG002|COMPLETED|Washout (7 Days)||3
3215229|NCT02233478|3946101|FG003|COMPLETED|Washout (7 Days)||3
3215230|NCT02233478|3946102|FG004|COMPLETED|Washout (7 Days)||3
3215231|NCT02233478|3946103|FG005|COMPLETED|Washout (7 Days)||3
3215232|NCT02233478|3946098|FG000|NOT COMPLETED|Washout (7 Days)||0
3215233|NCT02233478|3946099|FG001|NOT COMPLETED|Washout (7 Days)||0
3215234|NCT02233478|3946100|FG002|NOT COMPLETED|Washout (7 Days)||0
3215235|NCT02233478|3946101|FG003|NOT COMPLETED|Washout (7 Days)||0
3215236|NCT02233478|3946102|FG004|NOT COMPLETED|Washout (7 Days)||0
3215237|NCT02233478|3946103|FG005|NOT COMPLETED|Washout (7 Days)||0
3215238|NCT02233478|3946098|FG000|STARTED|Second Intervention (1 Day)||3
3215239|NCT02233478|3946099|FG001|STARTED|Second Intervention (1 Day)||3
3215240|NCT02233478|3946100|FG002|STARTED|Second Intervention (1 Day)||3
3215241|NCT02233478|3946101|FG003|STARTED|Second Intervention (1 Day)||3
3215242|NCT02233478|3946102|FG004|STARTED|Second Intervention (1 Day)||3
3215243|NCT02233478|3946103|FG005|STARTED|Second Intervention (1 Day)||3
3215244|NCT02233478|3946098|FG000|COMPLETED|Second Intervention (1 Day)||3
3215245|NCT02233478|3946099|FG001|COMPLETED|Second Intervention (1 Day)||3
3215246|NCT02233478|3946100|FG002|COMPLETED|Second Intervention (1 Day)||3
3215247|NCT02233478|3946101|FG003|COMPLETED|Second Intervention (1 Day)||3
3215248|NCT02233478|3946102|FG004|COMPLETED|Second Intervention (1 Day)||3
3215249|NCT02233478|3946103|FG005|COMPLETED|Second Intervention (1 Day)||3
3215250|NCT02233478|3946098|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
3215251|NCT02233478|3946099|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
3215252|NCT02233478|3946100|FG002|NOT COMPLETED|Second Intervention (1 Day)||0
3215253|NCT02233478|3946101|FG003|NOT COMPLETED|Second Intervention (1 Day)||0
3215254|NCT02233478|3946102|FG004|NOT COMPLETED|Second Intervention (1 Day)||0
3215255|NCT02233478|3946103|FG005|NOT COMPLETED|Second Intervention (1 Day)||0
3215256|NCT02233478|3946098|FG000|STARTED|Washout (7 Days)||3
3215257|NCT02233478|3946099|FG001|STARTED|Washout (7 Days)||3
3215258|NCT02233478|3946100|FG002|STARTED|Washout (7 Days)||3
3215259|NCT02233478|3946101|FG003|STARTED|Washout (7 Days)||3
3215260|NCT02233478|3946102|FG004|STARTED|Washout (7 Days)||3
3215261|NCT02233478|3946103|FG005|STARTED|Washout (7 Days)||3
3215262|NCT02233478|3946098|FG000|COMPLETED|Washout (7 Days)||3
3215263|NCT02233478|3946099|FG001|COMPLETED|Washout (7 Days)||3
3215264|NCT02233478|3946100|FG002|COMPLETED|Washout (7 Days)||3
3215265|NCT02233478|3946101|FG003|COMPLETED|Washout (7 Days)||3
3215266|NCT02233478|3946102|FG004|COMPLETED|Washout (7 Days)||3
3215267|NCT02233478|3946103|FG005|COMPLETED|Washout (7 Days)||3
3215268|NCT02233478|3946098|FG000|NOT COMPLETED|Washout (7 Days)||0
3215269|NCT02233478|3946099|FG001|NOT COMPLETED|Washout (7 Days)||0
3215270|NCT02233478|3946100|FG002|NOT COMPLETED|Washout (7 Days)||0
3215271|NCT02233478|3946101|FG003|NOT COMPLETED|Washout (7 Days)||0
3215272|NCT02233478|3946102|FG004|NOT COMPLETED|Washout (7 Days)||0
3215273|NCT02233478|3946103|FG005|NOT COMPLETED|Washout (7 Days)||0
3215274|NCT02233478|3946098|FG000|STARTED|Third Intervention (1 Day)||3
3215275|NCT02233478|3946099|FG001|STARTED|Third Intervention (1 Day)||3
3215276|NCT02233478|3946100|FG002|STARTED|Third Intervention (1 Day)||3
3215277|NCT02233478|3946101|FG003|STARTED|Third Intervention (1 Day)||3
3215278|NCT02233478|3946102|FG004|STARTED|Third Intervention (1 Day)||3
3215279|NCT02233478|3946103|FG005|STARTED|Third Intervention (1 Day)||3
3215280|NCT02233478|3946098|FG000|COMPLETED|Third Intervention (1 Day)||3
3215281|NCT02233478|3946099|FG001|COMPLETED|Third Intervention (1 Day)||3
3215282|NCT02233478|3946100|FG002|COMPLETED|Third Intervention (1 Day)||3
3215283|NCT02233478|3946101|FG003|COMPLETED|Third Intervention (1 Day)||3
3215284|NCT02233478|3946102|FG004|COMPLETED|Third Intervention (1 Day)||3
3215285|NCT02233478|3946103|FG005|COMPLETED|Third Intervention (1 Day)||3
3215286|NCT02233478|3946098|FG000|NOT COMPLETED|Third Intervention (1 Day)||0
3215287|NCT02233478|3946099|FG001|NOT COMPLETED|Third Intervention (1 Day)||0
3215288|NCT02233478|3946100|FG002|NOT COMPLETED|Third Intervention (1 Day)||0
3215289|NCT02233478|3946101|FG003|NOT COMPLETED|Third Intervention (1 Day)||0
3215290|NCT02233478|3946102|FG004|NOT COMPLETED|Third Intervention (1 Day)||0
3215291|NCT02233478|3946103|FG005|NOT COMPLETED|Third Intervention (1 Day)||0
3215292|NCT02233517|3946113|FG000|STARTED|Overall Study||19
3215293|NCT02233517|3946114|FG001|STARTED|Overall Study||17
3215294|NCT02233517|3946113|FG000|COMPLETED|Overall Study||12
3215295|NCT02233517|3946114|FG001|COMPLETED|Overall Study||13
3215296|NCT02233517|3946113|FG000|NOT COMPLETED|Overall Study||7
3215297|NCT02233517|3946114|FG001|NOT COMPLETED|Overall Study||4
3215298|NCT02233530|3946120|FG000|STARTED|Overall Study||8
3215299|NCT02233530|3946120|FG000|COMPLETED|Overall Study||8
3215300|NCT02233530|3946120|FG000|NOT COMPLETED|Overall Study||0
3215301|NCT02233543|3946124|FG000|STARTED|Period 1||22
3215302|NCT02233543|3946125|FG001|STARTED|Period 1||16
3215303|NCT02233543|3946124|FG000|COMPLETED|Period 1||19
3215304|NCT02233543|3946125|FG001|COMPLETED|Period 1||13
3215305|NCT02233543|3946124|FG000|NOT COMPLETED|Period 1||3
3215306|NCT02233543|3946125|FG001|NOT COMPLETED|Period 1||3
3215307|NCT02233543|3946124|FG000|STARTED|Period 2||19
3215308|NCT02233543|3946125|FG001|STARTED|Period 2||13
3215309|NCT02233543|3946124|FG000|COMPLETED|Period 2|1 participant erroneously received QVA149 during both periods.|17
3215310|NCT02233543|3946125|FG001|COMPLETED|Period 2||12
3215311|NCT02233543|3946124|FG000|NOT COMPLETED|Period 2||2
3215312|NCT02233543|3946125|FG001|NOT COMPLETED|Period 2||1
3215313|NCT02233647|3946131|FG000|STARTED|Overall Study||11
3215314|NCT02233647|3946131|FG000|0 mg Cocaine With 0 mg Phendimetrazine|Overall Study||11
3215315|NCT02233647|3946131|FG000|10 mg Cocaine With 0 mg Phendimetrazine|Overall Study||11
3215316|NCT02233647|3946131|FG000|20 mg Cocaine With 0 mg Phendimetrazine|Overall Study||10
3215317|NCT02233647|3946131|FG000|40 mg Cocaine With 0 mg Phendimetrazine|Overall Study||10
3215318|NCT02233647|3946131|FG000|80 mg Cocaine With 0 mg Phendimetrazine|Overall Study||10
3215319|NCT02233647|3946131|FG000|0 mg Cocaine With 70 mg Phendimetrazine|Overall Study||10
3215320|NCT02233647|3946131|FG000|10 mg Cocaine With 70 mg Phendimetrazine|Overall Study||10
3215321|NCT02233647|3946131|FG000|20 mg Cocaine With 70 mg Phendimetrazine|Overall Study||10
3215322|NCT02233647|3946131|FG000|40 mg Cocaine With 70 mg Phendimetrazine|Overall Study||10
3215323|NCT02233647|3946131|FG000|80 mg Cocaine With 70 mg Phendimetrazine|Overall Study||10
3366996|NCT03870893|4098385|FG001|STARTED|Overall Study||24
3215324|NCT02233647|3946131|FG000|0 mg Cocaine With 140 mg Phendimetrazine|Overall Study||10
3215325|NCT02233647|3946131|FG000|10 mg Cocaine with140 mg Phendimetrazine|Overall Study||10
3215326|NCT02233647|3946131|FG000|20 mg Cocaine with140 mg Phendimetrazine|Overall Study||10
3215327|NCT02233647|3946131|FG000|40 mg Cocaine with140 mg Phendimetrazine|Overall Study||10
3215328|NCT02233647|3946131|FG000|80 mg Cocaine with140 mg Phendimetrazine|Overall Study||10
3215329|NCT02233647|3946131|FG000|0 mg Cocaine With 210 mg Phendimetrazine|Overall Study||10
3215330|NCT02233647|3946131|FG000|10 mg Cocaine with210 mg Phendimetrazine|Overall Study||10
3366997|NCT03870893|4098384|FG000|COMPLETED|Overall Study||23
3215331|NCT02233647|3946131|FG000|20 mg Cocaine with210 mg Phendimetrazine|Overall Study||10
3215332|NCT02233647|3946131|FG000|40 mg Cocaine with210 mg Phendimetrazine|Overall Study||10
3215333|NCT02233647|3946131|FG000|80 mg Cocaine with210 mg Phendimetrazine|Overall Study||10
3215334|NCT02233647|3946131|FG000|COMPLETED|Overall Study||10
3215335|NCT02233647|3946131|FG000|NOT COMPLETED|Overall Study||1
3215336|NCT02233738|3946137|FG000|STARTED|Overall Study||93
3215337|NCT02233738|3946138|FG001|STARTED|Overall Study||91
3215338|NCT02233738|3946137|FG000|1 Month Follow-Up|Overall Study||89
3215339|NCT02233738|3946138|FG001|1 Month Follow-Up|Overall Study||82
3215340|NCT02233738|3946137|FG000|3 Month Follow-Up|Overall Study||87
3215341|NCT02233738|3946138|FG001|3 Month Follow-Up|Overall Study||77
3215342|NCT02233738|3946137|FG000|6 Month Follow-Up|Overall Study||85
3215343|NCT02233738|3946138|FG001|6 Month Follow-Up|Overall Study||75
3215344|NCT02233738|3946137|FG000|COMPLETED|Overall Study||85
3215345|NCT02233738|3946138|FG001|COMPLETED|Overall Study||75
3215346|NCT02233738|3946137|FG000|NOT COMPLETED|Overall Study||8
3215347|NCT02233738|3946138|FG001|NOT COMPLETED|Overall Study||16
3215348|NCT02233751|3946308|FG000|STARTED|Overall Study||6
3215349|NCT02233751|3946309|FG001|STARTED|Overall Study||6
3215350|NCT02233751|3946308|FG000|COMPLETED|Overall Study||6
3215351|NCT02233751|3946309|FG001|COMPLETED|Overall Study||6
3215352|NCT02233751|3946308|FG000|NOT COMPLETED|Overall Study||0
3215353|NCT02233751|3946309|FG001|NOT COMPLETED|Overall Study||0
3215354|NCT02233803|3946315|FG000|STARTED|Treatment Period 1 (4-Wks)||100
3215355|NCT02233803|3946316|FG001|STARTED|Treatment Period 1 (4-Wks)||99
3215356|NCT02233803|3946315|FG000|COMPLETED|Treatment Period 1 (4-Wks)||97
3215357|NCT02233803|3946316|FG001|COMPLETED|Treatment Period 1 (4-Wks)||95
3215358|NCT02233803|3946315|FG000|NOT COMPLETED|Treatment Period 1 (4-Wks)||3
3215359|NCT02233803|3946316|FG001|NOT COMPLETED|Treatment Period 1 (4-Wks)||4
3215360|NCT02233803|3946315|FG000|STARTED|Washout Period (4-Wks)||97
3215361|NCT02233803|3946316|FG001|STARTED|Washout Period (4-Wks)||95
3215362|NCT02233803|3946315|FG000|COMPLETED|Washout Period (4-Wks)||95
3215363|NCT02233803|3946316|FG001|COMPLETED|Washout Period (4-Wks)||93
3215364|NCT02233803|3946315|FG000|NOT COMPLETED|Washout Period (4-Wks)||2
3215365|NCT02233803|3946316|FG001|NOT COMPLETED|Washout Period (4-Wks)||2
3215366|NCT02233803|3946315|FG000|STARTED|Treatment Period 2 (4-Wks)||95
3215367|NCT02233803|3946316|FG001|STARTED|Treatment Period 2 (4-Wks)||93
3215368|NCT02233803|3946315|FG000|COMPLETED|Treatment Period 2 (4-Wks)||93
3215369|NCT02233803|3946316|FG001|COMPLETED|Treatment Period 2 (4-Wks)||91
3215370|NCT02233803|3946315|FG000|NOT COMPLETED|Treatment Period 2 (4-Wks)||2
3215371|NCT02233803|3946316|FG001|NOT COMPLETED|Treatment Period 2 (4-Wks)||2
3215372|NCT02233842|3946324|FG000|STARTED|Questionnaire 1 Version 1||5
3215373|NCT02233842|3946324|FG000|COMPLETED|Questionnaire 1 Version 1||5
3215374|NCT02233842|3946324|FG000|NOT COMPLETED|Questionnaire 1 Version 1||0
3215375|NCT02233842|3946324|FG000|STARTED|Questionnaire 1 Version 2||5
3215376|NCT02233842|3946324|FG000|COMPLETED|Questionnaire 1 Version 2||5
3215377|NCT02233842|3946324|FG000|NOT COMPLETED|Questionnaire 1 Version 2||0
3215378|NCT02233842|3946324|FG000|STARTED|Questionnaire 2 Version 1||5
3215379|NCT02233842|3946324|FG000|COMPLETED|Questionnaire 2 Version 1||5
3215380|NCT02233842|3946324|FG000|NOT COMPLETED|Questionnaire 2 Version 1||0
3215381|NCT02233842|3946324|FG000|STARTED|Questionnaire 2 Version 2||5
3215382|NCT02233842|3946324|FG000|COMPLETED|Questionnaire 2 Version 2||5
3215383|NCT02233842|3946324|FG000|NOT COMPLETED|Questionnaire 2 Version 2||0
3215384|NCT02233842|3946324|FG000|STARTED|Questionnaire 3 Version 1||5
3215385|NCT02233842|3946324|FG000|COMPLETED|Questionnaire 3 Version 1||5
3215386|NCT02233842|3946324|FG000|NOT COMPLETED|Questionnaire 3 Version 1||0
3215387|NCT02233842|3946324|FG000|STARTED|Questionnaire 3 Version 2||5
3215388|NCT02233842|3946324|FG000|COMPLETED|Questionnaire 3 Version 2||5
3215389|NCT02233842|3946324|FG000|NOT COMPLETED|Questionnaire 3 Version 2||0
3215390|NCT02233946|3946331|FG000|STARTED|Baseline|Allocated to and received the intervention|628
3215391|NCT02233946|3946332|FG001|STARTED|Baseline|Allocated to and received usual care|243
3215392|NCT02233946|3946331|FG000|COMPLETED|Baseline|Completed baseline assessment|626
3215393|NCT02233946|3946332|FG001|COMPLETED|Baseline|Completed baseline assessment|243
3215394|NCT02233946|3946331|FG000|NOT COMPLETED|Baseline||2
3215395|NCT02233946|3946332|FG001|NOT COMPLETED|Baseline||0
3215396|NCT02233946|3946331|FG000|STARTED|Immediate Post-visit Questionnaire||626
3215397|NCT02233946|3946332|FG001|STARTED|Immediate Post-visit Questionnaire||243
3215398|NCT02233946|3946331|FG000|COMPLETED|Immediate Post-visit Questionnaire||624
3215399|NCT02233946|3946332|FG001|COMPLETED|Immediate Post-visit Questionnaire||243
3215400|NCT02233946|3946331|FG000|NOT COMPLETED|Immediate Post-visit Questionnaire||2
3215401|NCT02233946|3946332|FG001|NOT COMPLETED|Immediate Post-visit Questionnaire||0
3215402|NCT02233946|3946331|FG000|STARTED|3-months Follow-up||624
3215403|NCT02233946|3946332|FG001|STARTED|3-months Follow-up||243
3215404|NCT02233946|3946331|FG000|COMPLETED|3-months Follow-up||571
3215405|NCT02233946|3946332|FG001|COMPLETED|3-months Follow-up||214
3215406|NCT02233946|3946331|FG000|NOT COMPLETED|3-months Follow-up||53
3215407|NCT02233946|3946332|FG001|NOT COMPLETED|3-months Follow-up||29
3215408|NCT02233946|3946331|FG000|STARTED|6-months Follow-up||571
3215409|NCT02233946|3946332|FG001|STARTED|6-months Follow-up||214
3215410|NCT02233946|3946331|FG000|COMPLETED|6-months Follow-up||550
3215411|NCT02233946|3946332|FG001|COMPLETED|6-months Follow-up||212
3215412|NCT02233946|3946331|FG000|NOT COMPLETED|6-months Follow-up||21
3215413|NCT02233946|3946332|FG001|NOT COMPLETED|6-months Follow-up||2
3215414|NCT02233946|3946331|FG000|STARTED|9-month Follow-up||550
3215415|NCT02233946|3946332|FG001|STARTED|9-month Follow-up||212
3215416|NCT02233946|3946331|FG000|COMPLETED|9-month Follow-up||530
3215417|NCT02233946|3946332|FG001|COMPLETED|9-month Follow-up||201
3215418|NCT02233946|3946331|FG000|NOT COMPLETED|9-month Follow-up||20
3215419|NCT02233946|3946332|FG001|NOT COMPLETED|9-month Follow-up||11
3215420|NCT02233946|3946331|FG000|STARTED|12-month Follow-up||530
3215421|NCT02233946|3946332|FG001|STARTED|12-month Follow-up||201
3215422|NCT02233946|3946331|FG000|COMPLETED|12-month Follow-up||502
3215423|NCT02233946|3946332|FG001|COMPLETED|12-month Follow-up||190
3215424|NCT02233946|3946331|FG000|NOT COMPLETED|12-month Follow-up||28
3215425|NCT02233946|3946332|FG001|NOT COMPLETED|12-month Follow-up||11
3215426|NCT02233985|3946340|FG000|STARTED|Overall Study||33
3215427|NCT02233985|3946341|FG001|STARTED|Overall Study||31
3215428|NCT02233985|3946340|FG000|COMPLETED|Overall Study||33
3215429|NCT02233985|3946341|FG001|COMPLETED|Overall Study||31
3215430|NCT02233985|3946340|FG000|NOT COMPLETED|Overall Study||0
3215431|NCT02233985|3946341|FG001|NOT COMPLETED|Overall Study||0
3215432|NCT02233998|3946352|FG000|STARTED|Overall Study||53
3215433|NCT02233998|3946353|FG001|STARTED|Overall Study||52
3215434|NCT02233998|3946354|FG002|STARTED|Overall Study||53
3215435|NCT02233998|3946352|FG000|COMPLETED|Overall Study||53
3215436|NCT02233998|3946353|FG001|COMPLETED|Overall Study||52
3215437|NCT02233998|3946354|FG002|COMPLETED|Overall Study||53
3215438|NCT02233998|3946352|FG000|NOT COMPLETED|Overall Study||0
3215439|NCT02233998|3946353|FG001|NOT COMPLETED|Overall Study||0
3215440|NCT02233998|3946354|FG002|NOT COMPLETED|Overall Study||0
3215441|NCT02234063|3946364|FG000|STARTED|Overall Study||1795
3215442|NCT02234063|3946365|FG001|STARTED|Overall Study||255
3215443|NCT02234063|3946364|FG000|COMPLETED|Overall Study||1540
3215444|NCT02234063|3946365|FG001|COMPLETED|Overall Study||212
3215445|NCT02234063|3946364|FG000|NOT COMPLETED|Overall Study||255
3215446|NCT02234063|3946365|FG001|NOT COMPLETED|Overall Study||43
3215447|NCT02234115|3946376|FG000|STARTED|Overall Study||137
3215448|NCT02234115|3946376|FG000|ITT|Overall Study||137
3215449|NCT02234115|3946376|FG000|PP|Overall Study||124
3215450|NCT02234115|3946376|FG000|PK Subgroup|Overall Study||31
3215451|NCT02234115|3946376|FG000|COMPLETED|Overall Study||122
3215452|NCT02234115|3946376|FG000|NOT COMPLETED|Overall Study||15
3215453|NCT02234128|3946383|FG000|STARTED|Overall Study||35
3215454|NCT02234128|3946384|FG001|STARTED|Overall Study||31
3215455|NCT02234128|3946385|FG002|STARTED|Overall Study||52
3215456|NCT02234128|3946383|FG000|COMPLETED|Overall Study||30
3215457|NCT02234128|3946384|FG001|COMPLETED|Overall Study||29
3215458|NCT02234128|3946385|FG002|COMPLETED|Overall Study||48
3215459|NCT02234128|3946383|FG000|NOT COMPLETED|Overall Study||5
3215460|NCT02234128|3946384|FG001|NOT COMPLETED|Overall Study||2
3215461|NCT02234128|3946385|FG002|NOT COMPLETED|Overall Study||4
3215462|NCT02234141|3946397|FG000|STARTED|Treatment Period (24 Weeks)||39
3215463|NCT02234141|3946398|FG001|STARTED|Treatment Period (24 Weeks)||38
3215464|NCT02234141|3946399|FG002|STARTED|Treatment Period (24 Weeks)||37
3215465|NCT02234141|3946400|FG003|STARTED|Treatment Period (24 Weeks)||37
3215466|NCT02234141|3946401|FG004|STARTED|Treatment Period (24 Weeks)||0
3215467|NCT02234141|3946402|FG005|STARTED|Treatment Period (24 Weeks)||0
3215468|NCT02234141|3946403|FG006|STARTED|Treatment Period (24 Weeks)||0
3215469|NCT02234141|3946397|FG000|COMPLETED|Treatment Period (24 Weeks)||35
3215470|NCT02234141|3946398|FG001|COMPLETED|Treatment Period (24 Weeks)||32
3215471|NCT02234141|3946399|FG002|COMPLETED|Treatment Period (24 Weeks)||35
3215472|NCT02234141|3946400|FG003|COMPLETED|Treatment Period (24 Weeks)||32
3215473|NCT02234141|3946401|FG004|COMPLETED|Treatment Period (24 Weeks)||0
3215474|NCT02234141|3946402|FG005|COMPLETED|Treatment Period (24 Weeks)||0
3215475|NCT02234141|3946403|FG006|COMPLETED|Treatment Period (24 Weeks)||0
3215476|NCT02234141|3946397|FG000|NOT COMPLETED|Treatment Period (24 Weeks)||4
3215477|NCT02234141|3946398|FG001|NOT COMPLETED|Treatment Period (24 Weeks)||6
3215478|NCT02234141|3946399|FG002|NOT COMPLETED|Treatment Period (24 Weeks)||2
3215479|NCT02234141|3946400|FG003|NOT COMPLETED|Treatment Period (24 Weeks)||5
3215480|NCT02234141|3946401|FG004|NOT COMPLETED|Treatment Period (24 Weeks)||0
3215481|NCT02234141|3946402|FG005|NOT COMPLETED|Treatment Period (24 Weeks)||0
3215482|NCT02234141|3946403|FG006|NOT COMPLETED|Treatment Period (24 Weeks)||0
3215483|NCT02234141|3946397|FG000|STARTED|Long-Term Treatment Period|2 participants who completed Period 1 did not continue into the Long-Term Treatment Phase.|33
3215484|NCT02234141|3946398|FG001|STARTED|Long-Term Treatment Period|1 participant who completed the Period 1 did not continue into the Long-Term Treatment Phase.|31
3215485|NCT02234141|3946399|FG002|STARTED|Long-Term Treatment Period|2 participants who completed Period 1 did not continue into the Long-Term Treatment Phase.|33
3215486|NCT02234141|3946400|FG003|STARTED|Long-Term Treatment Period|Participants were rerandomized to receive selonsertib during the Long-Term Treatment Phase.|0
3215487|NCT02234141|3946401|FG004|STARTED|Long-Term Treatment Period|The Placebo group was rerandomized to receive selonsertib during the Long-Term Treatment Phase.|10
3215488|NCT02234141|3946402|FG005|STARTED|Long-Term Treatment Period|The Placebo group was rerandomized to receive selonsertib during the Long-Term Treatment Phase.|12
3215489|NCT02234141|3946403|FG006|STARTED|Long-Term Treatment Period|The Placebo group was rerandomized to receive selonsertib during the Long-Term Treatment Phase.|10
3215490|NCT02234141|3946397|FG000|COMPLETED|Long-Term Treatment Period||0
3215491|NCT02234141|3946398|FG001|COMPLETED|Long-Term Treatment Period||0
3215492|NCT02234141|3946399|FG002|COMPLETED|Long-Term Treatment Period||0
3215493|NCT02234141|3946400|FG003|COMPLETED|Long-Term Treatment Period||0
3215494|NCT02234141|3946401|FG004|COMPLETED|Long-Term Treatment Period||0
3215495|NCT02234141|3946402|FG005|COMPLETED|Long-Term Treatment Period||0
3215496|NCT02234141|3946403|FG006|COMPLETED|Long-Term Treatment Period||0
3215497|NCT02234141|3946397|FG000|NOT COMPLETED|Long-Term Treatment Period||33
3215498|NCT02234141|3946398|FG001|NOT COMPLETED|Long-Term Treatment Period||31
3215499|NCT02234141|3946399|FG002|NOT COMPLETED|Long-Term Treatment Period||33
3215500|NCT02234141|3946400|FG003|NOT COMPLETED|Long-Term Treatment Period||0
3215501|NCT02234141|3946401|FG004|NOT COMPLETED|Long-Term Treatment Period||10
3215502|NCT02234141|3946402|FG005|NOT COMPLETED|Long-Term Treatment Period||12
3215503|NCT02234141|3946403|FG006|NOT COMPLETED|Long-Term Treatment Period||10
3215504|NCT02234180|3946414|FG000|STARTED|Overall Study||2
3215505|NCT02234180|3946415|FG001|STARTED|Overall Study||1
3215506|NCT02234180|3946414|FG000|COMPLETED|Overall Study||2
3215507|NCT02234180|3946415|FG001|COMPLETED|Overall Study||1
3215508|NCT02234180|3946414|FG000|NOT COMPLETED|Overall Study||0
3215509|NCT02234180|3946415|FG001|NOT COMPLETED|Overall Study||0
3215510|NCT02234284|3946421|FG000|STARTED|Overall Study||100
3215511|NCT02234284|3946422|FG001|STARTED|Overall Study||92
3215512|NCT02234284|3946421|FG000|COMPLETED|Overall Study||75
3215513|NCT02234284|3946422|FG001|COMPLETED|Overall Study||83
3215514|NCT02234284|3946421|FG000|NOT COMPLETED|Overall Study||25
3215515|NCT02234284|3946422|FG001|NOT COMPLETED|Overall Study||9
3215516|NCT02234310|3946432|FG000|STARTED|Overall Study||33
3215517|NCT02234310|3946432|FG000|Episodic Treatment Regimen|Overall Study|Participants were treated in more than one regimen and counted in all categories wherever applicable|22
3215518|NCT02234310|3946432|FG000|Prophylactic Treatment Regimen|Overall Study|17 participants among the 22 who started in episodic regimen, switched to the prophylactic regimen.|28
3215519|NCT02234310|3946432|FG000|COMPLETED|Overall Study||27
3215520|NCT02234310|3946432|FG000|NOT COMPLETED|Overall Study||6
3215521|NCT02234323|3946436|FG000|STARTED|All Enrolled||108
3215522|NCT02234323|3946436|FG000|COMPLETED|All Enrolled|These participants received at least one dose of study drug.|103
3215523|NCT02234323|3946436|FG000|NOT COMPLETED|All Enrolled||5
3215524|NCT02234323|3946436|FG000|STARTED|All Treated||103
3215525|NCT02234323|3946436|FG000|Episodic Treatment Regimen|All Treated|Participants were treated in more than one regimen and counted in all categories wherever applicable|81
3215526|NCT02234323|3946436|FG000|Prophylactic Treatment Regimen|All Treated|69 participants among the 81 who started in episodic regimen, switched to the prophylactic regimen.|89
3215527|NCT02234323|3946436|FG000|Immune Tolerance Induction (ITI)|All Treated|1/81 on episodic and 14/89 on prophylactic regimen had inhibitors and were switched directly to ITI.|15
3215528|NCT02234323|3946436|FG000|COMPLETED|All Treated||85
3215529|NCT02234323|3946436|FG000|NOT COMPLETED|All Treated||18
3215530|NCT02234362|3946442|FG000|STARTED|Overall Study||47
3215531|NCT02234362|3946442|FG000|Received at Least One Dose of Medication|Overall Study||27
3215532|NCT02234362|3946442|FG000|COMPLETED|Overall Study||21
3215533|NCT02234362|3946442|FG000|NOT COMPLETED|Overall Study||26
3215534|NCT02234427|3946446|FG000|STARTED|Overall Study||34
3215535|NCT02234427|3946446|FG000|COMPLETED|Overall Study|One individual withdrew after first visit|33
3215536|NCT02234427|3946446|FG000|NOT COMPLETED|Overall Study||1
3215537|NCT02234479|3946452|FG000|STARTED|Overall Study||16
3215538|NCT02234479|3946453|FG001|STARTED|Overall Study||18
3215539|NCT02234479|3946452|FG000|COMPLETED|Overall Study||15
3215540|NCT02234479|3946453|FG001|COMPLETED|Overall Study||15
3215541|NCT02234479|3946452|FG000|NOT COMPLETED|Overall Study||1
3215542|NCT02234479|3946453|FG001|NOT COMPLETED|Overall Study||3
3215543|NCT02234570|3946467|FG000|STARTED|Overall Study||8
3215544|NCT02234570|3946468|FG001|STARTED|Overall Study||8
3215545|NCT02234570|3946469|FG002|STARTED|Overall Study||8
3215546|NCT02234570|3946470|FG003|STARTED|Overall Study||8
3215547|NCT02234570|3946471|FG004|STARTED|Overall Study||8
3215548|NCT02234570|3946472|FG005|STARTED|Overall Study||8
3215549|NCT02234570|3946473|FG006|STARTED|Overall Study||8
3215550|NCT02234570|3946474|FG007|STARTED|Overall Study||14
3215551|NCT02234570|3946467|FG000|COMPLETED|Overall Study||8
3215552|NCT02234570|3946468|FG001|COMPLETED|Overall Study||8
3215553|NCT02234570|3946469|FG002|COMPLETED|Overall Study||8
3215554|NCT02234570|3946470|FG003|COMPLETED|Overall Study||8
3215555|NCT02234570|3946471|FG004|COMPLETED|Overall Study||8
3215556|NCT02234570|3946472|FG005|COMPLETED|Overall Study||8
3215557|NCT02234570|3946473|FG006|COMPLETED|Overall Study||8
3215558|NCT02234570|3946474|FG007|COMPLETED|Overall Study||14
3215559|NCT02234570|3946467|FG000|NOT COMPLETED|Overall Study||0
3215560|NCT02234570|3946468|FG001|NOT COMPLETED|Overall Study||0
3215561|NCT02234570|3946469|FG002|NOT COMPLETED|Overall Study||0
3215562|NCT02234570|3946470|FG003|NOT COMPLETED|Overall Study||0
3215563|NCT02234570|3946471|FG004|NOT COMPLETED|Overall Study||0
3215564|NCT02234570|3946472|FG005|NOT COMPLETED|Overall Study||0
3215565|NCT02234570|3946473|FG006|NOT COMPLETED|Overall Study||0
3215566|NCT02234570|3946474|FG007|NOT COMPLETED|Overall Study||0
3215567|NCT02234583|3946494|FG000|STARTED|Overall Study||847
3215568|NCT02234583|3946495|FG001|STARTED|Overall Study||1241
3215569|NCT02234583|3946494|FG000|COMPLETED|Overall Study||434
3215570|NCT02234583|3946495|FG001|COMPLETED|Overall Study||685
3215571|NCT02234583|3946494|FG000|NOT COMPLETED|Overall Study||413
3215572|NCT02234583|3946495|FG001|NOT COMPLETED|Overall Study||556
3215573|NCT02234596|3946507|FG000|STARTED|Overall Study||34
3215574|NCT02234596|3946507|FG000|COMPLETED|Overall Study||32
3215575|NCT02234596|3946507|FG000|NOT COMPLETED|Overall Study||2
3215576|NCT02234622|3946513|FG000|STARTED|Overall Study||108
3215577|NCT02234622|3946514|FG001|STARTED|Overall Study||104
3366998|NCT03870893|4098385|FG001|COMPLETED|Overall Study||23
3215578|NCT02234622|3946513|FG000|COMPLETED|Overall Study||65
3215579|NCT02234622|3946514|FG001|COMPLETED|Overall Study||68
3215580|NCT02234622|3946513|FG000|NOT COMPLETED|Overall Study||43
3215581|NCT02234622|3946514|FG001|NOT COMPLETED|Overall Study||36
3215582|NCT02234713|3946524|FG000|STARTED|Overall Study||31
3215583|NCT02234713|3946525|FG001|STARTED|Overall Study||32
3215584|NCT02234713|3946524|FG000|COMPLETED|Overall Study||25
3215585|NCT02234713|3946525|FG001|COMPLETED|Overall Study||27
3215586|NCT02234713|3946524|FG000|NOT COMPLETED|Overall Study||6
3215587|NCT02234713|3946525|FG001|NOT COMPLETED|Overall Study||5
3215588|NCT02234752|3946532|FG000|STARTED|Overall Study||3
3215589|NCT02234752|3946532|FG000|COMPLETED|Overall Study||2
3215590|NCT02234752|3946532|FG000|NOT COMPLETED|Overall Study||1
3215591|NCT02235064|3946539|FG000|STARTED|Overall Study||1
3215592|NCT02235064|3946540|FG001|STARTED|Overall Study||1
3215593|NCT02235064|3946539|FG000|COMPLETED|Overall Study||1
3215594|NCT02235064|3946540|FG001|COMPLETED|Overall Study||1
3215595|NCT02235064|3946539|FG000|NOT COMPLETED|Overall Study||0
3215596|NCT02235064|3946540|FG001|NOT COMPLETED|Overall Study||0
3215597|NCT02235077|3946550|FG000|STARTED|Overall Study||182
3215598|NCT02235077|3946551|FG001|STARTED|Overall Study||178
3215599|NCT02235077|3946550|FG000|COMPLETED|Overall Study||164
3215600|NCT02235077|3946551|FG001|COMPLETED|Overall Study||159
3215601|NCT02235077|3946550|FG000|NOT COMPLETED|Overall Study||18
3215602|NCT02235077|3946551|FG001|NOT COMPLETED|Overall Study||19
3215603|NCT02235285|3946557|FG000|STARTED|Overall Study||162
3215604|NCT02235285|3946557|FG000|COMPLETED|Overall Study||149
3215605|NCT02235285|3946557|FG000|NOT COMPLETED|Overall Study||13
3215606|NCT02235298|3946563|FG000|STARTED|Overall Study||50
3215607|NCT02235298|3946564|FG001|STARTED|Overall Study||50
3215608|NCT02235298|3946563|FG000|COMPLETED|Overall Study||42
3215609|NCT02235298|3946564|FG001|COMPLETED|Overall Study||42
3215610|NCT02235298|3946563|FG000|NOT COMPLETED|Overall Study||8
3215611|NCT02235298|3946564|FG001|NOT COMPLETED|Overall Study||8
3215612|NCT02235311|3946572|FG000|STARTED|Overall Study||1
3215613|NCT02235311|3946573|FG001|STARTED|Overall Study||2
3215614|NCT02235311|3946572|FG000|COMPLETED|Overall Study||1
3215615|NCT02235311|3946573|FG001|COMPLETED|Overall Study||0
3215616|NCT02235311|3946572|FG000|NOT COMPLETED|Overall Study||0
3215617|NCT02235311|3946573|FG001|NOT COMPLETED|Overall Study||2
3215618|NCT02235454|3946579|FG000|STARTED|Overall Study||57
3215619|NCT02235454|3946579|FG000|COMPLETED|Overall Study||55
3215620|NCT02235454|3946579|FG000|NOT COMPLETED|Overall Study||2
3366999|NCT03870893|4098384|FG000|NOT COMPLETED|Overall Study||0
3367000|NCT03870893|4098385|FG001|NOT COMPLETED|Overall Study||1
3367001|NCT03887299|4098394|FG000|STARTED|Overall Study||77
3367002|NCT03887299|4098395|FG001|STARTED|Overall Study||77
3367003|NCT03887299|4098394|FG000|COMPLETED|Overall Study||77
3367004|NCT03887299|4098395|FG001|COMPLETED|Overall Study||77
3367005|NCT03887299|4098394|FG000|NOT COMPLETED|Overall Study||0
3367006|NCT03887299|4098395|FG001|NOT COMPLETED|Overall Study||0
3367007|NCT03878758|4098401|FG000|STARTED|Overall Study||158
3367008|NCT03878758|4098401|FG000|COMPLETED|Overall Study||154
3367009|NCT03878758|4098401|FG000|NOT COMPLETED|Overall Study||4
3367010|NCT03849300|4098418|FG000|STARTED|Overall Study||42
3367011|NCT03849300|4098419|FG001|STARTED|Overall Study||42
3367012|NCT03849300|4098420|FG002|STARTED|Overall Study||32
3367013|NCT03849300|4098421|FG003|STARTED|Overall Study||31
3367014|NCT03849300|4098418|FG000|COMPLETED|Overall Study||37
3367015|NCT03849300|4098419|FG001|COMPLETED|Overall Study||35
3367016|NCT03849300|4098420|FG002|COMPLETED|Overall Study||28
3367017|NCT03849300|4098421|FG003|COMPLETED|Overall Study||25
3367018|NCT03849300|4098418|FG000|NOT COMPLETED|Overall Study||5
3367019|NCT03849300|4098419|FG001|NOT COMPLETED|Overall Study||7
3367020|NCT03849300|4098420|FG002|NOT COMPLETED|Overall Study||4
3367021|NCT03849300|4098421|FG003|NOT COMPLETED|Overall Study||6
3367022|NCT03887429|4098437|FG000|STARTED|Overall Study||8
3367023|NCT03887429|4098438|FG001|STARTED|Overall Study||9
3367024|NCT03887429|4098439|FG002|STARTED|Overall Study||9
3367025|NCT03887429|4098440|FG003|STARTED|Overall Study||8
3367026|NCT03887429|4098437|FG000|Completed First Intervention (5 Days)|Overall Study||7
3367027|NCT03887429|4098438|FG001|Completed First Intervention (5 Days)|Overall Study||8
3367028|NCT03887429|4098439|FG002|Completed First Intervention (5 Days)|Overall Study||7
3367029|NCT03887429|4098440|FG003|Completed First Intervention (5 Days)|Overall Study||7
3367030|NCT03887429|4098437|FG000|Completed Washout (9 Days)|Overall Study||7
3367031|NCT03887429|4098438|FG001|Completed Washout (9 Days)|Overall Study||8
3367032|NCT03887429|4098439|FG002|Completed Washout (9 Days)|Overall Study||7
3367033|NCT03887429|4098440|FG003|Completed Washout (9 Days)|Overall Study||7
3367034|NCT03887429|4098437|FG000|Completed Second Intervention (5 Days)|Overall Study||7
3367035|NCT03887429|4098438|FG001|Completed Second Intervention (5 Days)|Overall Study||8
3367036|NCT03887429|4098439|FG002|Completed Second Intervention (5 Days)|Overall Study||7
3367037|NCT03887429|4098440|FG003|Completed Second Intervention (5 Days)|Overall Study||7
3367038|NCT03887429|4098437|FG000|COMPLETED|Overall Study||7
3367039|NCT03887429|4098438|FG001|COMPLETED|Overall Study||8
3367040|NCT03887429|4098439|FG002|COMPLETED|Overall Study||7
3367041|NCT03887429|4098440|FG003|COMPLETED|Overall Study||7
3367042|NCT03887429|4098437|FG000|NOT COMPLETED|Overall Study||1
3367043|NCT03887429|4098438|FG001|NOT COMPLETED|Overall Study||1
3367044|NCT03887429|4098439|FG002|NOT COMPLETED|Overall Study||2
3367045|NCT03887429|4098440|FG003|NOT COMPLETED|Overall Study||1
3215621|NCT02235493|3946583|FG000|STARTED|Overall Study||6
3215622|NCT02235493|3946583|FG000|COMPLETED|Overall Study||6
3215623|NCT02235493|3946583|FG000|NOT COMPLETED|Overall Study||0
3215624|NCT02235831|3946587|FG000|STARTED|Period 1, First 5 Days of Wear||4
3215625|NCT02235831|3946588|FG001|STARTED|Period 1, First 5 Days of Wear||4
3215626|NCT02235831|3946589|FG002|STARTED|Period 1, First 5 Days of Wear||4
3215627|NCT02235831|3946590|FG003|STARTED|Period 1, First 5 Days of Wear||4
3215628|NCT02235831|3946591|FG004|STARTED|Period 1, First 5 Days of Wear||4
3215629|NCT02235831|3946592|FG005|STARTED|Period 1, First 5 Days of Wear||4
3215630|NCT02235831|3946587|FG000|COMPLETED|Period 1, First 5 Days of Wear||4
3215631|NCT02235831|3946588|FG001|COMPLETED|Period 1, First 5 Days of Wear||4
3215632|NCT02235831|3946589|FG002|COMPLETED|Period 1, First 5 Days of Wear||4
3215633|NCT02235831|3946590|FG003|COMPLETED|Period 1, First 5 Days of Wear||4
3215634|NCT02235831|3946591|FG004|COMPLETED|Period 1, First 5 Days of Wear||4
3215635|NCT02235831|3946592|FG005|COMPLETED|Period 1, First 5 Days of Wear||4
3215636|NCT02235831|3946587|FG000|NOT COMPLETED|Period 1, First 5 Days of Wear||0
3215637|NCT02235831|3946588|FG001|NOT COMPLETED|Period 1, First 5 Days of Wear||0
3215638|NCT02235831|3946589|FG002|NOT COMPLETED|Period 1, First 5 Days of Wear||0
3215639|NCT02235831|3946590|FG003|NOT COMPLETED|Period 1, First 5 Days of Wear||0
3215640|NCT02235831|3946591|FG004|NOT COMPLETED|Period 1, First 5 Days of Wear||0
3215641|NCT02235831|3946592|FG005|NOT COMPLETED|Period 1, First 5 Days of Wear||0
3215642|NCT02235831|3946587|FG000|STARTED|Period 2, Second 5 Days of Wear||4
3215643|NCT02235831|3946588|FG001|STARTED|Period 2, Second 5 Days of Wear||4
3215644|NCT02235831|3946589|FG002|STARTED|Period 2, Second 5 Days of Wear||4
3215645|NCT02235831|3946590|FG003|STARTED|Period 2, Second 5 Days of Wear||4
3215646|NCT02235831|3946591|FG004|STARTED|Period 2, Second 5 Days of Wear||4
3215647|NCT02235831|3946592|FG005|STARTED|Period 2, Second 5 Days of Wear||4
3215648|NCT02235831|3946587|FG000|COMPLETED|Period 2, Second 5 Days of Wear||4
3215649|NCT02235831|3946588|FG001|COMPLETED|Period 2, Second 5 Days of Wear||4
3215650|NCT02235831|3946589|FG002|COMPLETED|Period 2, Second 5 Days of Wear||4
3215651|NCT02235831|3946590|FG003|COMPLETED|Period 2, Second 5 Days of Wear||4
3215652|NCT02235831|3946591|FG004|COMPLETED|Period 2, Second 5 Days of Wear||4
3215653|NCT02235831|3946592|FG005|COMPLETED|Period 2, Second 5 Days of Wear||4
3215654|NCT02235831|3946587|FG000|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
3215655|NCT02235831|3946588|FG001|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
3215656|NCT02235831|3946589|FG002|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
3215657|NCT02235831|3946590|FG003|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
3215658|NCT02235831|3946591|FG004|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
3215659|NCT02235831|3946592|FG005|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
3215660|NCT02235831|3946587|FG000|STARTED|Period 3, Third 5 Days of Wear||4
3215661|NCT02235831|3946588|FG001|STARTED|Period 3, Third 5 Days of Wear||4
3215662|NCT02235831|3946589|FG002|STARTED|Period 3, Third 5 Days of Wear||4
3215663|NCT02235831|3946590|FG003|STARTED|Period 3, Third 5 Days of Wear||4
3215664|NCT02235831|3946591|FG004|STARTED|Period 3, Third 5 Days of Wear||4
3215665|NCT02235831|3946592|FG005|STARTED|Period 3, Third 5 Days of Wear||4
3215666|NCT02235831|3946587|FG000|COMPLETED|Period 3, Third 5 Days of Wear||4
3215667|NCT02235831|3946588|FG001|COMPLETED|Period 3, Third 5 Days of Wear||4
3215668|NCT02235831|3946589|FG002|COMPLETED|Period 3, Third 5 Days of Wear||4
3215669|NCT02235831|3946590|FG003|COMPLETED|Period 3, Third 5 Days of Wear||4
3215670|NCT02235831|3946591|FG004|COMPLETED|Period 3, Third 5 Days of Wear||4
3215671|NCT02235831|3946592|FG005|COMPLETED|Period 3, Third 5 Days of Wear||4
3215672|NCT02235831|3946587|FG000|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
3215673|NCT02235831|3946588|FG001|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
3215674|NCT02235831|3946589|FG002|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
3215675|NCT02235831|3946590|FG003|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
3215676|NCT02235831|3946591|FG004|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
3215677|NCT02235831|3946592|FG005|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
3215678|NCT02235870|3946601|FG000|STARTED|Overall Study||198
3215679|NCT02235870|3946602|FG001|STARTED|Overall Study||189
3215680|NCT02235870|3946601|FG000|Completed Phase I (Week 24)|Overall Study||182
3215681|NCT02235870|3946602|FG001|Completed Phase I (Week 24)|Overall Study||179
3215682|NCT02235870|3946601|FG000|Crossover (Week 24)|Overall Study||170
3215683|NCT02235870|3946602|FG001|Crossover (Week 24)|Overall Study||138
3215684|NCT02235870|3946601|FG000|COMPLETED|Overall Study||160
3215685|NCT02235870|3946602|FG001|COMPLETED|Overall Study||128
3215686|NCT02235870|3946601|FG000|NOT COMPLETED|Overall Study||38
3215687|NCT02235870|3946602|FG001|NOT COMPLETED|Overall Study||61
3215688|NCT02235987|3946609|FG000|STARTED|Overall Study||20
3215689|NCT02235987|3946609|FG000|Received Octreotide|Overall Study||20
3215690|NCT02235987|3946609|FG000|Received 100 µg DG3173|Overall Study||20
3215691|NCT02235987|3946609|FG000|Received 300 µg DG3173|Overall Study||20
3215692|NCT02235987|3946609|FG000|Received 900 µg DG3173|Overall Study||19
3215693|NCT02235987|3946609|FG000|Received 1800 µg DG3173|Overall Study||19
3215694|NCT02235987|3946609|FG000|COMPLETED|Overall Study||19
3215695|NCT02235987|3946609|FG000|NOT COMPLETED|Overall Study||1
3215696|NCT02236130|3946624|FG000|STARTED|Overall Study||22
3215697|NCT02236130|3946625|FG001|STARTED|Overall Study||27
3215698|NCT02236130|3946624|FG000|COMPLETED|Overall Study||15
3215699|NCT02236130|3946625|FG001|COMPLETED|Overall Study||15
3215700|NCT02236130|3946624|FG000|NOT COMPLETED|Overall Study||7
3215701|NCT02236130|3946625|FG001|NOT COMPLETED|Overall Study||12
3215702|NCT02236338|3946633|FG000|STARTED|Overall Study||100
3215703|NCT02236338|3946634|FG001|STARTED|Overall Study||100
3215704|NCT02236338|3946633|FG000|COMPLETED|Overall Study||100
3215705|NCT02236338|3946634|FG001|COMPLETED|Overall Study||100
3215706|NCT02236338|3946633|FG000|NOT COMPLETED|Overall Study||0
3215707|NCT02236338|3946634|FG001|NOT COMPLETED|Overall Study||0
3215708|NCT02236520|3946644|FG000|STARTED|Overall Study||16
3215709|NCT02236520|3946645|FG001|STARTED|Overall Study||13
3215710|NCT02236520|3946646|FG002|STARTED|Overall Study||15
3215711|NCT02236520|3946647|FG003|STARTED|Overall Study||15
3215712|NCT02236520|3946644|FG000|COMPLETED|Overall Study||14
3215713|NCT02236520|3946645|FG001|COMPLETED|Overall Study||8
3215714|NCT02236520|3946646|FG002|COMPLETED|Overall Study||15
3215715|NCT02236520|3946647|FG003|COMPLETED|Overall Study||14
3215716|NCT02236520|3946644|FG000|NOT COMPLETED|Overall Study||2
3215717|NCT02236520|3946645|FG001|NOT COMPLETED|Overall Study||5
3215718|NCT02236520|3946646|FG002|NOT COMPLETED|Overall Study||0
3215719|NCT02236520|3946647|FG003|NOT COMPLETED|Overall Study||1
3215720|NCT02236559|3946659|FG000|STARTED|Overall Study||112
3215721|NCT02236559|3946660|FG001|STARTED|Overall Study||116
3215722|NCT02236559|3946659|FG000|COMPLETED|Overall Study||100
3215723|NCT02236559|3946660|FG001|COMPLETED|Overall Study||104
3215724|NCT02236559|3946659|FG000|NOT COMPLETED|Overall Study||12
3215725|NCT02236559|3946660|FG001|NOT COMPLETED|Overall Study||12
3215726|NCT02236598|3946668|FG000|STARTED|Overall Study||15
3215727|NCT02236598|3946669|FG001|STARTED|Overall Study||14
3215728|NCT02236598|3946668|FG000|COMPLETED|Overall Study||15
3215729|NCT02236598|3946669|FG001|COMPLETED|Overall Study||12
3215730|NCT02236598|3946668|FG000|NOT COMPLETED|Overall Study||0
3215731|NCT02236598|3946669|FG001|NOT COMPLETED|Overall Study||2
3215732|NCT02236611|3946677|FG000|STARTED|Overall Study||516
3215733|NCT02236611|3946678|FG001|STARTED|Overall Study||518
3215734|NCT02236611|3946677|FG000|COMPLETED|Overall Study||490
3215735|NCT02236611|3946678|FG001|COMPLETED|Overall Study||484
3215736|NCT02236611|3946677|FG000|NOT COMPLETED|Overall Study||26
3215737|NCT02236611|3946678|FG001|NOT COMPLETED|Overall Study||34
3215738|NCT02236767|3946684|FG000|STARTED|Overall Study||1
3215739|NCT02236767|3946684|FG000|COMPLETED|Overall Study||1
3215740|NCT02236767|3946684|FG000|NOT COMPLETED|Overall Study||0
3367046|NCT03886701|4098455|FG000|STARTED|Period 1: Study Days 1-4||11
3367047|NCT03886701|4098455|FG000|COMPLETED|Period 1: Study Days 1-4||11
3367048|NCT03886701|4098455|FG000|NOT COMPLETED|Period 1: Study Days 1-4||0
3367049|NCT03886701|4098455|FG000|STARTED|Period 2: Study Days 7-21||11
3367050|NCT03886701|4098455|FG000|COMPLETED|Period 2: Study Days 7-21||11
3367051|NCT03886701|4098455|FG000|NOT COMPLETED|Period 2: Study Days 7-21||0
3367052|NCT03883113|4098463|FG000|STARTED|Overall Study||87
3367053|NCT03883113|4098464|FG001|STARTED|Overall Study||58
3367054|NCT03883113|4098463|FG000|COMPLETED|Overall Study||71
3367055|NCT03883113|4098464|FG001|COMPLETED|Overall Study||46
3367056|NCT03883113|4098463|FG000|NOT COMPLETED|Overall Study||16
3367057|NCT03883113|4098464|FG001|NOT COMPLETED|Overall Study||12
3367058|NCT03880227|4098486|FG000|STARTED|First Visit||20
3367059|NCT03880227|4098487|FG001|STARTED|First Visit||21
3367060|NCT03880227|4098488|FG002|STARTED|First Visit||22
3367061|NCT03880227|4098489|FG003|STARTED|First Visit||18
3367062|NCT03880227|4098486|FG000|COMPLETED|First Visit||19
3367063|NCT03880227|4098487|FG001|COMPLETED|First Visit||21
3367064|NCT03880227|4098488|FG002|COMPLETED|First Visit||22
3367065|NCT03880227|4098489|FG003|COMPLETED|First Visit||18
3367066|NCT03880227|4098486|FG000|NOT COMPLETED|First Visit||1
3367067|NCT03880227|4098487|FG001|NOT COMPLETED|First Visit||0
3367068|NCT03880227|4098488|FG002|NOT COMPLETED|First Visit||0
3367069|NCT03880227|4098489|FG003|NOT COMPLETED|First Visit||0
3367070|NCT03880227|4098486|FG000|STARTED|1 Week Washout/ Delay||19
3367071|NCT03880227|4098487|FG001|STARTED|1 Week Washout/ Delay||21
3367072|NCT03880227|4098488|FG002|STARTED|1 Week Washout/ Delay||22
3367073|NCT03880227|4098489|FG003|STARTED|1 Week Washout/ Delay||18
3367074|NCT03880227|4098486|FG000|COMPLETED|1 Week Washout/ Delay||19
3367075|NCT03880227|4098487|FG001|COMPLETED|1 Week Washout/ Delay||20
3367076|NCT03880227|4098488|FG002|COMPLETED|1 Week Washout/ Delay||19
3367077|NCT03880227|4098489|FG003|COMPLETED|1 Week Washout/ Delay||18
3367078|NCT03880227|4098486|FG000|NOT COMPLETED|1 Week Washout/ Delay||0
3367079|NCT03880227|4098487|FG001|NOT COMPLETED|1 Week Washout/ Delay||1
3367080|NCT03880227|4098488|FG002|NOT COMPLETED|1 Week Washout/ Delay||3
3367081|NCT03880227|4098489|FG003|NOT COMPLETED|1 Week Washout/ Delay||0
3367082|NCT03880227|4098486|FG000|STARTED|Second Visit||19
3367083|NCT03880227|4098487|FG001|STARTED|Second Visit||20
3367084|NCT03880227|4098488|FG002|STARTED|Second Visit||19
3367085|NCT03880227|4098489|FG003|STARTED|Second Visit||18
3367086|NCT03880227|4098486|FG000|COMPLETED|Second Visit||19
3367087|NCT03880227|4098487|FG001|COMPLETED|Second Visit||20
3367088|NCT03880227|4098488|FG002|COMPLETED|Second Visit||19
3367089|NCT03880227|4098489|FG003|COMPLETED|Second Visit||18
3367090|NCT03880227|4098486|FG000|NOT COMPLETED|Second Visit||0
3367091|NCT03880227|4098487|FG001|NOT COMPLETED|Second Visit||0
3367092|NCT03880227|4098488|FG002|NOT COMPLETED|Second Visit||0
3367093|NCT03880227|4098489|FG003|NOT COMPLETED|Second Visit||0
3367094|NCT03876743|4098503|FG000|STARTED|Overall Study||54
3367095|NCT03876743|4098504|FG001|STARTED|Overall Study||51
3367096|NCT03876743|4098505|FG002|STARTED|Overall Study||46
3367097|NCT03876743|4098506|FG003|STARTED|Overall Study||50
3367098|NCT03876743|4098503|FG000|COMPLETED|Overall Study||48
3367099|NCT03876743|4098504|FG001|COMPLETED|Overall Study||47
3215741|NCT02236988|3946692|FG000|STARTED|Overall Study||16
3215742|NCT02236988|3946693|FG001|STARTED|Overall Study||16
3215743|NCT02236988|3946694|FG002|STARTED|Overall Study||18
3215744|NCT02236988|3946695|FG003|STARTED|Overall Study||30
3215745|NCT02236988|3946692|FG000|COMPLETED|Overall Study||16
3215746|NCT02236988|3946693|FG001|COMPLETED|Overall Study||16
3215747|NCT02236988|3946694|FG002|COMPLETED|Overall Study||18
3215748|NCT02236988|3946695|FG003|COMPLETED|Overall Study||27
3215749|NCT02236988|3946692|FG000|NOT COMPLETED|Overall Study||0
3215750|NCT02236988|3946693|FG001|NOT COMPLETED|Overall Study||0
3215751|NCT02236988|3946694|FG002|NOT COMPLETED|Overall Study||0
3215752|NCT02236988|3946695|FG003|NOT COMPLETED|Overall Study||3
3215753|NCT02237001|3946746|FG000|STARTED|Overall Study||30
3215754|NCT02237001|3946746|FG000|6 Month Follow-up|Overall Study||27
3215755|NCT02237001|3946746|FG000|12 Month Follow-up|Overall Study||21
3215756|NCT02237001|3946746|FG000|24 Month Follow-up|Overall Study||19
3215757|NCT02237001|3946746|FG000|COMPLETED|Overall Study||19
3215758|NCT02237001|3946746|FG000|NOT COMPLETED|Overall Study||11
3215759|NCT02237092|3946750|FG000|STARTED|Overall Study||196
3215760|NCT02237092|3946750|FG000|COMPLETED|Overall Study||196
3215761|NCT02237092|3946750|FG000|NOT COMPLETED|Overall Study||0
3215762|NCT02237118|3946767|FG000|STARTED|Overall Study||60
3215763|NCT02237118|3946768|FG001|STARTED|Overall Study||63
3215764|NCT02237118|3946767|FG000|COMPLETED|Overall Study||59
3215765|NCT02237118|3946768|FG001|COMPLETED|Overall Study||62
3215766|NCT02237118|3946767|FG000|NOT COMPLETED|Overall Study||1
3215767|NCT02237118|3946768|FG001|NOT COMPLETED|Overall Study||1
3215768|NCT02237157|3946782|FG000|STARTED|Gemcitabine, Local Delivery (Dose 1)||20
3215769|NCT02237157|3946783|FG001|STARTED|Gemcitabine, Local Delivery (Dose 1)||0
3215770|NCT02237157|3946784|FG002|STARTED|Gemcitabine, Local Delivery (Dose 1)||0
3215771|NCT02237157|3946785|FG003|STARTED|Gemcitabine, Local Delivery (Dose 1)||0
3215772|NCT02237157|3946782|FG000|COMPLETED|Gemcitabine, Local Delivery (Dose 1)||16
3215773|NCT02237157|3946783|FG001|COMPLETED|Gemcitabine, Local Delivery (Dose 1)||0
3215774|NCT02237157|3946784|FG002|COMPLETED|Gemcitabine, Local Delivery (Dose 1)||0
3215775|NCT02237157|3946785|FG003|COMPLETED|Gemcitabine, Local Delivery (Dose 1)||0
3215776|NCT02237157|3946782|FG000|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 1)||4
3215777|NCT02237157|3946783|FG001|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 1)||0
3215778|NCT02237157|3946784|FG002|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 1)||0
3215779|NCT02237157|3946785|FG003|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 1)||0
3215780|NCT02237157|3946782|FG000|STARTED|Gemcitabine, Local Delivery (Dose 2)||0
3215781|NCT02237157|3946783|FG001|STARTED|Gemcitabine, Local Delivery (Dose 2)||15
3215782|NCT02237157|3946784|FG002|STARTED|Gemcitabine, Local Delivery (Dose 2)||0
3215783|NCT02237157|3946785|FG003|STARTED|Gemcitabine, Local Delivery (Dose 2)||0
3215784|NCT02237157|3946782|FG000|COMPLETED|Gemcitabine, Local Delivery (Dose 2)||0
3215785|NCT02237157|3946783|FG001|COMPLETED|Gemcitabine, Local Delivery (Dose 2)||15
3215786|NCT02237157|3946784|FG002|COMPLETED|Gemcitabine, Local Delivery (Dose 2)||0
3215787|NCT02237157|3946785|FG003|COMPLETED|Gemcitabine, Local Delivery (Dose 2)||0
3215788|NCT02237157|3946782|FG000|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 2)||0
3215789|NCT02237157|3946783|FG001|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 2)||0
3215790|NCT02237157|3946784|FG002|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 2)||0
3367100|NCT03876743|4098505|FG002|COMPLETED|Overall Study||42
3367101|NCT03876743|4098506|FG003|COMPLETED|Overall Study||43
3367102|NCT03876743|4098503|FG000|NOT COMPLETED|Overall Study||6
3367103|NCT03876743|4098504|FG001|NOT COMPLETED|Overall Study||4
3367104|NCT03876743|4098505|FG002|NOT COMPLETED|Overall Study||4
3367105|NCT03876743|4098506|FG003|NOT COMPLETED|Overall Study||7
3367106|NCT03885934|4098526|FG000|STARTED|Overall Study||64
3367107|NCT03885934|4098527|FG001|STARTED|Overall Study||64
3367108|NCT03885934|4098528|FG002|STARTED|Overall Study||62
3367109|NCT03885934|4098529|FG003|STARTED|Overall Study||64
3367110|NCT03885934|4098530|FG004|STARTED|Overall Study||177
3367111|NCT03885934|4098531|FG005|STARTED|Overall Study||175
3367112|NCT03885934|4098526|FG000|PCV Dose 1|Overall Study||64
3367113|NCT03885934|4098527|FG001|PCV Dose 1|Overall Study||64
3367114|NCT03885934|4098528|FG002|PCV Dose 1|Overall Study||62
3367115|NCT03885934|4098529|FG003|PCV Dose 1|Overall Study||64
3367116|NCT03885934|4098530|FG004|PCV Dose 1|Overall Study||177
3367117|NCT03885934|4098531|FG005|PCV Dose 1|Overall Study||175
3367118|NCT03885934|4098526|FG000|PCV Dose 2|Overall Study||63
3367119|NCT03885934|4098527|FG001|PCV Dose 2|Overall Study||64
3367120|NCT03885934|4098528|FG002|PCV Dose 2|Overall Study||62
3367121|NCT03885934|4098529|FG003|PCV Dose 2|Overall Study||64
3367122|NCT03885934|4098530|FG004|PCV Dose 2|Overall Study||0
3367123|NCT03885934|4098531|FG005|PCV Dose 2|Overall Study||0
3367124|NCT03885934|4098526|FG000|PCV Dose 3|Overall Study||63
3367125|NCT03885934|4098527|FG001|PCV Dose 3|Overall Study||64
3367126|NCT03885934|4098528|FG002|PCV Dose 3|Overall Study||0
3367127|NCT03885934|4098529|FG003|PCV Dose 3|Overall Study||0
3367128|NCT03885934|4098530|FG004|PCV Dose 3|Overall Study||0
3367129|NCT03885934|4098531|FG005|PCV Dose 3|Overall Study||0
3367130|NCT03885934|4098526|FG000|COMPLETED|Overall Study||63
3367131|NCT03885934|4098527|FG001|COMPLETED|Overall Study||64
3367132|NCT03885934|4098528|FG002|COMPLETED|Overall Study||62
3367133|NCT03885934|4098529|FG003|COMPLETED|Overall Study||64
3367134|NCT03885934|4098530|FG004|COMPLETED|Overall Study||177
3367135|NCT03885934|4098531|FG005|COMPLETED|Overall Study||175
3367136|NCT03885934|4098526|FG000|NOT COMPLETED|Overall Study||1
3367137|NCT03885934|4098527|FG001|NOT COMPLETED|Overall Study||0
3215791|NCT02237157|3946785|FG003|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 2)||0
3215792|NCT02237157|3946782|FG000|STARTED|Gemcitabine, Local Delivery (Dose 3)||0
3215793|NCT02237157|3946783|FG001|STARTED|Gemcitabine, Local Delivery (Dose 3)||0
3215794|NCT02237157|3946784|FG002|STARTED|Gemcitabine, Local Delivery (Dose 3)||11
3215795|NCT02237157|3946785|FG003|STARTED|Gemcitabine, Local Delivery (Dose 3)||0
3215796|NCT02237157|3946782|FG000|COMPLETED|Gemcitabine, Local Delivery (Dose 3)||0
3215797|NCT02237157|3946783|FG001|COMPLETED|Gemcitabine, Local Delivery (Dose 3)||0
3215798|NCT02237157|3946784|FG002|COMPLETED|Gemcitabine, Local Delivery (Dose 3)||11
3215799|NCT02237157|3946785|FG003|COMPLETED|Gemcitabine, Local Delivery (Dose 3)||0
3215800|NCT02237157|3946782|FG000|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 3)||0
3215801|NCT02237157|3946783|FG001|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 3)||0
3215802|NCT02237157|3946784|FG002|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 3)||0
3215803|NCT02237157|3946785|FG003|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 3)||0
3215804|NCT02237157|3946782|FG000|STARTED|Gemcitabine, Local Delivery (Dose 4)||0
3215805|NCT02237157|3946783|FG001|STARTED|Gemcitabine, Local Delivery (Dose 4)||0
3215806|NCT02237157|3946784|FG002|STARTED|Gemcitabine, Local Delivery (Dose 4)||0
3215807|NCT02237157|3946785|FG003|STARTED|Gemcitabine, Local Delivery (Dose 4)||8
3215808|NCT02237157|3946782|FG000|COMPLETED|Gemcitabine, Local Delivery (Dose 4)||0
3215809|NCT02237157|3946783|FG001|COMPLETED|Gemcitabine, Local Delivery (Dose 4)||0
3215810|NCT02237157|3946784|FG002|COMPLETED|Gemcitabine, Local Delivery (Dose 4)||0
3215811|NCT02237157|3946785|FG003|COMPLETED|Gemcitabine, Local Delivery (Dose 4)||8
3215812|NCT02237157|3946782|FG000|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 4)||0
3215813|NCT02237157|3946783|FG001|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 4)||0
3215814|NCT02237157|3946784|FG002|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 4)||0
3215815|NCT02237157|3946785|FG003|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 4)||0
3215816|NCT02237196|3946796|FG000|STARTED|Overall Study||32
3215817|NCT02237196|3946797|FG001|STARTED|Overall Study||31
3215818|NCT02237196|3946798|FG002|STARTED|Overall Study||30
3215819|NCT02237196|3946799|FG003|STARTED|Overall Study||28
3215820|NCT02237196|3946796|FG000|COMPLETED|Overall Study||24
3215821|NCT02237196|3946797|FG001|COMPLETED|Overall Study||25
3215822|NCT02237196|3946798|FG002|COMPLETED|Overall Study||20
3215823|NCT02237196|3946799|FG003|COMPLETED|Overall Study||17
3215824|NCT02237196|3946796|FG000|NOT COMPLETED|Overall Study||8
3215825|NCT02237196|3946797|FG001|NOT COMPLETED|Overall Study||6
3215826|NCT02237196|3946798|FG002|NOT COMPLETED|Overall Study||10
3215827|NCT02237196|3946799|FG003|NOT COMPLETED|Overall Study||11
3215828|NCT02237417|3946812|FG000|STARTED|Overall Study||16
3215829|NCT02237417|3946813|FG001|STARTED|Overall Study||15
3215830|NCT02237417|3946814|FG002|STARTED|Overall Study||16
3215831|NCT02237417|3946812|FG000|COMPLETED|Overall Study||16
3215832|NCT02237417|3946813|FG001|COMPLETED|Overall Study||9
3215833|NCT02237417|3946814|FG002|COMPLETED|Overall Study||7
3215834|NCT02237417|3946812|FG000|NOT COMPLETED|Overall Study||0
3215835|NCT02237417|3946813|FG001|NOT COMPLETED|Overall Study||6
3215836|NCT02237417|3946814|FG002|NOT COMPLETED|Overall Study||9
3215837|NCT02237898|3946824|FG000|STARTED|Overall Study||12
3215838|NCT02237898|3946825|FG001|STARTED|Overall Study||14
3215839|NCT02237898|3946824|FG000|Completed 12 Weeks of CM|Overall Study||7
3215840|NCT02237898|3946825|FG001|Completed 12 Weeks of CM|Overall Study||2
3215841|NCT02237898|3946824|FG000|Completed 3 Month Follow-up|Overall Study||6
3215842|NCT02237898|3946825|FG001|Completed 3 Month Follow-up|Overall Study||6
3215843|NCT02237898|3946824|FG000|Completed 9 Month Follow-up|Overall Study||6
3215844|NCT02237898|3946825|FG001|Completed 9 Month Follow-up|Overall Study||7
3215845|NCT02237898|3946824|FG000|Completed 15 Month Follow-up|Overall Study||8
3215846|NCT02237898|3946825|FG001|Completed 15 Month Follow-up|Overall Study||8
3215847|NCT02237898|3946824|FG000|COMPLETED|Overall Study||5
3215848|NCT02237898|3946825|FG001|COMPLETED|Overall Study||2
3215849|NCT02237898|3946824|FG000|NOT COMPLETED|Overall Study||7
3215850|NCT02237898|3946825|FG001|NOT COMPLETED|Overall Study||12
3215851|NCT02237911|3946836|FG000|STARTED|Overall Study||96
3215852|NCT02237911|3946837|FG001|STARTED|Overall Study||96
3215853|NCT02237911|3946838|FG002|STARTED|Overall Study||48
3215854|NCT02237911|3946836|FG000|3 Months|Overall Study||90
3215855|NCT02237911|3946837|FG001|3 Months|Overall Study||87
3215856|NCT02237911|3946838|FG002|3 Months|Overall Study||44
3215857|NCT02237911|3946836|FG000|6 Months|Overall Study||89
3215858|NCT02237911|3946837|FG001|6 Months|Overall Study||88
3215859|NCT02237911|3946838|FG002|6 Months|Overall Study||45
3215860|NCT02237911|3946836|FG000|COMPLETED|Overall Study||89
3215861|NCT02237911|3946837|FG001|COMPLETED|Overall Study||88
3215862|NCT02237911|3946838|FG002|COMPLETED|Overall Study||45
3215863|NCT02237911|3946836|FG000|NOT COMPLETED|Overall Study||7
3215864|NCT02237911|3946837|FG001|NOT COMPLETED|Overall Study||8
3215865|NCT02237911|3946838|FG002|NOT COMPLETED|Overall Study||3
3215866|NCT02237950|3946848|FG000|STARTED|Overall Study||295
3215867|NCT02237950|3946849|FG001|STARTED|Overall Study||291
3215868|NCT02237950|3946848|FG000|COMPLETED|Overall Study||247
3215869|NCT02237950|3946849|FG001|COMPLETED|Overall Study||243
3215870|NCT02237950|3946848|FG000|NOT COMPLETED|Overall Study||48
3215871|NCT02237950|3946849|FG001|NOT COMPLETED|Overall Study||48
3215872|NCT02237989|3946857|FG000|STARTED|Overall Study||19
3215873|NCT02237989|3946858|FG001|STARTED|Overall Study||20
3215874|NCT02237989|3946857|FG000|COMPLETED|Overall Study||19
3215875|NCT02237989|3946858|FG001|COMPLETED|Overall Study||20
3215876|NCT02237989|3946857|FG000|NOT COMPLETED|Overall Study||0
3215877|NCT02237989|3946858|FG001|NOT COMPLETED|Overall Study||0
3215878|NCT02238028|3946864|FG000|STARTED|Overall Study||14
3215879|NCT02238028|3946865|FG001|STARTED|Overall Study||14
3215880|NCT02238028|3946864|FG000|COMPLETED|Overall Study||12
3215881|NCT02238028|3946865|FG001|COMPLETED|Overall Study||12
3215882|NCT02238028|3946864|FG000|NOT COMPLETED|Overall Study||2
3215883|NCT02238028|3946865|FG001|NOT COMPLETED|Overall Study||2
3215884|NCT02238067|3946876|FG000|STARTED|Overall Study||196
3215885|NCT02238067|3946876|FG000|COMPLETED|Overall Study||151
3215886|NCT02238067|3946876|FG000|NOT COMPLETED|Overall Study||45
3215887|NCT02238080|3946880|FG000|STARTED|Overall Study||197
3215888|NCT02238080|3946880|FG000|COMPLETED|Overall Study||172
3215889|NCT02238080|3946880|FG000|NOT COMPLETED|Overall Study||25
3215890|NCT02238379|3946886|FG000|STARTED|Overall Study||12
3215891|NCT02238379|3946887|FG001|STARTED|Overall Study||14
3215892|NCT02238379|3946886|FG000|COMPLETED|Overall Study||11
3215893|NCT02238379|3946887|FG001|COMPLETED|Overall Study||14
3215894|NCT02238379|3946886|FG000|NOT COMPLETED|Overall Study||1
3215895|NCT02238379|3946887|FG001|NOT COMPLETED|Overall Study||0
3215896|NCT02238483|3946895|FG000|STARTED|Overall Study||108
3215897|NCT02238483|3946896|FG001|STARTED|Overall Study||105
3215898|NCT02238483|3946895|FG000|COMPLETED|Overall Study||93
3215899|NCT02238483|3946896|FG001|COMPLETED|Overall Study||91
3215900|NCT02238483|3946895|FG000|NOT COMPLETED|Overall Study||15
3215901|NCT02238483|3946896|FG001|NOT COMPLETED|Overall Study||14
3215902|NCT02238626|3946906|FG000|STARTED|Overall Study||17
3215903|NCT02238626|3946907|FG001|STARTED|Overall Study||34
3215904|NCT02238626|3946908|FG002|STARTED|Overall Study||8
3215905|NCT02238626|3946909|FG003|STARTED|Overall Study||11
3215906|NCT02238626|3946906|FG000|COMPLETED|Overall Study||12
3215907|NCT02238626|3946907|FG001|COMPLETED|Overall Study||20
3215908|NCT02238626|3946908|FG002|COMPLETED|Overall Study||5
3215909|NCT02238626|3946909|FG003|COMPLETED|Overall Study||4
3215910|NCT02238626|3946906|FG000|NOT COMPLETED|Overall Study||5
3215911|NCT02238626|3946907|FG001|NOT COMPLETED|Overall Study||14
3215912|NCT02238626|3946908|FG002|NOT COMPLETED|Overall Study||3
3215913|NCT02238626|3946909|FG003|NOT COMPLETED|Overall Study||7
3215914|NCT02238782|3946930|FG000|STARTED|Overall Study||12
3215915|NCT02238782|3946930|FG000|Subjects Treated|Overall Study||12
3215916|NCT02238782|3946930|FG000|COMPLETED|Overall Study||12
3215917|NCT02238782|3946930|FG000|NOT COMPLETED|Overall Study||0
3215918|NCT02238847|3946936|FG000|STARTED|Overall Study||59
3215919|NCT02238847|3946937|FG001|STARTED|Overall Study||60
3215920|NCT02238847|3946936|FG000|COMPLETED|Overall Study||37
3215921|NCT02238847|3946937|FG001|COMPLETED|Overall Study||36
3215922|NCT02238847|3946936|FG000|NOT COMPLETED|Overall Study||22
3215923|NCT02238847|3946937|FG001|NOT COMPLETED|Overall Study||24
3215924|NCT02238925|3946943|FG000|STARTED|Overall Study||26
3215925|NCT02238925|3946943|FG000|COMPLETED|Overall Study||1
3215926|NCT02238925|3946943|FG000|NOT COMPLETED|Overall Study||25
3215927|NCT02238977|3946949|FG000|STARTED|Overall Study||0
3215928|NCT02238977|3946950|FG001|STARTED|Overall Study||1
3215929|NCT02238977|3946949|FG000|COMPLETED|Overall Study||0
3215930|NCT02238977|3946950|FG001|COMPLETED|Overall Study||1
3215931|NCT02238977|3946949|FG000|NOT COMPLETED|Overall Study||0
3215932|NCT02238977|3946950|FG001|NOT COMPLETED|Overall Study||0
3215933|NCT02239094|3946956|FG000|STARTED|Overall Study||20
3215934|NCT02239094|3946956|FG000|COMPLETED|Overall Study||18
3215935|NCT02239094|3946956|FG000|NOT COMPLETED|Overall Study||2
3215936|NCT02239120|3946962|FG000|STARTED|Overall Study||2695
3215937|NCT02239120|3946963|FG001|STARTED|Overall Study||2695
3215938|NCT02239120|3946962|FG000|COMPLETED|Overall Study||2620
3215939|NCT02239120|3946963|FG001|COMPLETED|Overall Study||2623
3215940|NCT02239120|3946962|FG000|NOT COMPLETED|Overall Study||75
3215941|NCT02239120|3946963|FG001|NOT COMPLETED|Overall Study||72
3215942|NCT02239224|3946973|FG000|STARTED|Overall Study||3
3215943|NCT02239224|3946974|FG001|STARTED|Overall Study||6
3215944|NCT02239224|3946975|FG002|STARTED|Overall Study||6
3215945|NCT02239224|3946976|FG003|STARTED|Overall Study||5
3215946|NCT02239224|3946973|FG000|Received at Least One Dose of Study Drug|Overall Study||3
3215947|NCT02239224|3946974|FG001|Received at Least One Dose of Study Drug|Overall Study||6
3215948|NCT02239224|3946975|FG002|Received at Least One Dose of Study Drug|Overall Study||6
3215949|NCT02239224|3946976|FG003|Received at Least One Dose of Study Drug|Overall Study||5
3215950|NCT02239224|3946973|FG000|COMPLETED|Overall Study||3
3215951|NCT02239224|3946974|FG001|COMPLETED|Overall Study||6
3215952|NCT02239224|3946975|FG002|COMPLETED|Overall Study||3
3215953|NCT02239224|3946976|FG003|COMPLETED|Overall Study||4
3215954|NCT02239224|3946973|FG000|NOT COMPLETED|Overall Study||0
3215955|NCT02239224|3946974|FG001|NOT COMPLETED|Overall Study||0
3215956|NCT02239224|3946975|FG002|NOT COMPLETED|Overall Study||3
3215957|NCT02239224|3946976|FG003|NOT COMPLETED|Overall Study||1
3215958|NCT02239263|3946986|FG000|STARTED|Overall Study||40
3215959|NCT02239263|3946986|FG000|COMPLETED|Overall Study||34
3215960|NCT02239263|3946986|FG000|NOT COMPLETED|Overall Study||6
3215961|NCT02239289|3946992|FG000|STARTED|Overall Study||21
3215962|NCT02239289|3946992|FG000|COMPLETED|Overall Study||21
3215963|NCT02239289|3946992|FG000|NOT COMPLETED|Overall Study||0
3215964|NCT02239328|3946996|FG000|STARTED|Overall Study||182
3215965|NCT02239328|3946996|FG000|COMPLETED|Overall Study||174
3215966|NCT02239328|3946996|FG000|NOT COMPLETED|Overall Study||8
3215967|NCT02239380|3947000|FG000|STARTED|Overall Study||26
3215968|NCT02239380|3947000|FG000|COMPLETED|Overall Study||26
3215969|NCT02239380|3947000|FG000|NOT COMPLETED|Overall Study||0
3215970|NCT02239510|3947006|FG000|STARTED|Overall Study||5
3215971|NCT02239510|3947007|FG001|STARTED|Overall Study||4
3215972|NCT02239510|3947006|FG000|COMPLETED|Overall Study||3
3215973|NCT02239510|3947007|FG001|COMPLETED|Overall Study||3
3215974|NCT02239510|3947006|FG000|NOT COMPLETED|Overall Study||2
3215975|NCT02239510|3947007|FG001|NOT COMPLETED|Overall Study||1
3215976|NCT02239536|3947015|FG000|STARTED|Overall Study||190
3215977|NCT02239536|3947016|FG001|STARTED|Overall Study||172
3215978|NCT02239536|3947015|FG000|COMPLETED|Overall Study||167
3215979|NCT02239536|3947016|FG001|COMPLETED|Overall Study||155
3215980|NCT02239536|3947015|FG000|NOT COMPLETED|Overall Study||23
3215981|NCT02239536|3947016|FG001|NOT COMPLETED|Overall Study||17
3215982|NCT02239562|3947028|FG000|STARTED|Overall Study||6
3215983|NCT02239562|3947029|FG001|STARTED|Overall Study||6
3215984|NCT02239562|3947030|FG002|STARTED|Overall Study||6
3215985|NCT02239562|3947031|FG003|STARTED|Overall Study||6
3215986|NCT02239562|3947032|FG004|STARTED|Overall Study||6
3215987|NCT02239562|3947033|FG005|STARTED|Overall Study||6
3215988|NCT02239562|3947028|FG000|COMPLETED|Overall Study||6
3215989|NCT02239562|3947029|FG001|COMPLETED|Overall Study||6
3215990|NCT02239562|3947030|FG002|COMPLETED|Overall Study||6
3215991|NCT02239562|3947031|FG003|COMPLETED|Overall Study||6
3215992|NCT02239562|3947032|FG004|COMPLETED|Overall Study||6
3215993|NCT02239562|3947033|FG005|COMPLETED|Overall Study||6
3215994|NCT02239562|3947028|FG000|NOT COMPLETED|Overall Study||0
3215995|NCT02239562|3947029|FG001|NOT COMPLETED|Overall Study||0
3215996|NCT02239562|3947030|FG002|NOT COMPLETED|Overall Study||0
3215997|NCT02239562|3947031|FG003|NOT COMPLETED|Overall Study||0
3215998|NCT02239562|3947032|FG004|NOT COMPLETED|Overall Study||0
3215999|NCT02239562|3947033|FG005|NOT COMPLETED|Overall Study||0
3216000|NCT02239601|3947051|FG000|STARTED|Overall Study||29
3216001|NCT02239601|3947052|FG001|STARTED|Overall Study||32
3216002|NCT02239601|3947051|FG000|COMPLETED|Overall Study||22
3216003|NCT02239601|3947052|FG001|COMPLETED|Overall Study||26
3216004|NCT02239601|3947051|FG000|NOT COMPLETED|Overall Study||7
3216005|NCT02239601|3947052|FG001|NOT COMPLETED|Overall Study||6
3216006|NCT02239640|3947063|FG000|STARTED|Overall Study||984
3216007|NCT02239640|3947063|FG000|COMPLETED|Overall Study||767
3216008|NCT02239640|3947063|FG000|NOT COMPLETED|Overall Study||217
3216009|NCT02239679|3947076|FG000|STARTED|Overall Study||53
3216010|NCT02239679|3947077|FG001|STARTED|Overall Study||59
3216011|NCT02239679|3947078|FG002|STARTED|Overall Study||54
3216012|NCT02239679|3947076|FG000|COMPLETED|Overall Study||50
3216013|NCT02239679|3947077|FG001|COMPLETED|Overall Study||56
3216014|NCT02239679|3947078|FG002|COMPLETED|Overall Study||53
3216015|NCT02239679|3947076|FG000|NOT COMPLETED|Overall Study||3
3216016|NCT02239679|3947077|FG001|NOT COMPLETED|Overall Study||3
3216017|NCT02239679|3947078|FG002|NOT COMPLETED|Overall Study||1
3216018|NCT02239692|3947088|FG000|STARTED|Overall Study||73
3216019|NCT02239692|3947089|FG001|STARTED|Overall Study||131
3216020|NCT02239692|3947088|FG000|Intention-to-treat Analysis Set|Overall Study||73
3216021|NCT02239692|3947089|FG001|Intention-to-treat Analysis Set|Overall Study||131
3216022|NCT02239692|3947088|FG000|Per-protocol Analysis Set|Overall Study||66
3216023|NCT02239692|3947089|FG001|Per-protocol Analysis Set|Overall Study||120
3216024|NCT02239692|3947088|FG000|Safety Analysis Set|Overall Study||70
3216025|NCT02239692|3947089|FG001|Safety Analysis Set|Overall Study||125
3216026|NCT02239692|3947088|FG000|COMPLETED|Overall Study||67
3216027|NCT02239692|3947089|FG001|COMPLETED|Overall Study||118
3216028|NCT02239692|3947088|FG000|NOT COMPLETED|Overall Study||6
3216029|NCT02239692|3947089|FG001|NOT COMPLETED|Overall Study||13
3216030|NCT02239744|3947097|FG000|STARTED|Period 1||17
3216031|NCT02239744|3947098|FG001|STARTED|Period 1||18
3216032|NCT02239744|3947097|FG000|COMPLETED|Period 1||17
3216033|NCT02239744|3947098|FG001|COMPLETED|Period 1||18
3216034|NCT02239744|3947097|FG000|NOT COMPLETED|Period 1||0
3216035|NCT02239744|3947098|FG001|NOT COMPLETED|Period 1||0
3216036|NCT02239744|3947097|FG000|STARTED|Period 2||17
3216037|NCT02239744|3947098|FG001|STARTED|Period 2||18
3216038|NCT02239744|3947097|FG000|COMPLETED|Period 2||17
3216039|NCT02239744|3947098|FG001|COMPLETED|Period 2||18
3216040|NCT02239744|3947097|FG000|NOT COMPLETED|Period 2||0
3216041|NCT02239744|3947098|FG001|NOT COMPLETED|Period 2||0
3216042|NCT02239770|3947111|FG000|STARTED|Part 1||4
3216043|NCT02239770|3947112|FG001|STARTED|Part 1||4
3216044|NCT02239770|3947113|FG002|STARTED|Part 1||4
3216045|NCT02239770|3947114|FG003|STARTED|Part 1||0
3216046|NCT02239770|3947115|FG004|STARTED|Part 1||0
3216047|NCT02239770|3947116|FG005|STARTED|Part 1||0
3216048|NCT02239770|3947111|FG000|COMPLETED|Part 1||4
3216049|NCT02239770|3947112|FG001|COMPLETED|Part 1||4
3216050|NCT02239770|3947113|FG002|COMPLETED|Part 1||4
3216051|NCT02239770|3947114|FG003|COMPLETED|Part 1||0
3216052|NCT02239770|3947115|FG004|COMPLETED|Part 1||0
3216053|NCT02239770|3947116|FG005|COMPLETED|Part 1||0
3216054|NCT02239770|3947111|FG000|NOT COMPLETED|Part 1||0
3216055|NCT02239770|3947112|FG001|NOT COMPLETED|Part 1||0
3216056|NCT02239770|3947113|FG002|NOT COMPLETED|Part 1||0
3216057|NCT02239770|3947114|FG003|NOT COMPLETED|Part 1||0
3216058|NCT02239770|3947115|FG004|NOT COMPLETED|Part 1||0
3216059|NCT02239770|3947116|FG005|NOT COMPLETED|Part 1||0
3216060|NCT02239770|3947111|FG000|STARTED|Part 2||0
3216061|NCT02239770|3947112|FG001|STARTED|Part 2||0
3216062|NCT02239770|3947113|FG002|STARTED|Part 2||0
3216063|NCT02239770|3947114|FG003|STARTED|Part 2||4
3216064|NCT02239770|3947115|FG004|STARTED|Part 2||4
3216065|NCT02239770|3947116|FG005|STARTED|Part 2||4
3216066|NCT02239770|3947111|FG000|COMPLETED|Part 2||0
3216067|NCT02239770|3947112|FG001|COMPLETED|Part 2||0
3216068|NCT02239770|3947113|FG002|COMPLETED|Part 2||0
3216069|NCT02239770|3947114|FG003|COMPLETED|Part 2||4
3216070|NCT02239770|3947115|FG004|COMPLETED|Part 2||4
3216071|NCT02239770|3947116|FG005|COMPLETED|Part 2||4
3216072|NCT02239770|3947111|FG000|NOT COMPLETED|Part 2||0
3216073|NCT02239770|3947112|FG001|NOT COMPLETED|Part 2||0
3216074|NCT02239770|3947113|FG002|NOT COMPLETED|Part 2||0
3216075|NCT02239770|3947114|FG003|NOT COMPLETED|Part 2||0
3216076|NCT02239770|3947115|FG004|NOT COMPLETED|Part 2||0
3216077|NCT02239770|3947116|FG005|NOT COMPLETED|Part 2||0
3216078|NCT02239939|3947140|FG000|STARTED|Overall Study||20
3216079|NCT02239939|3947141|FG001|STARTED|Overall Study||17
3216080|NCT02239939|3947140|FG000|COMPLETED|Overall Study||18
3216081|NCT02239939|3947141|FG001|COMPLETED|Overall Study||15
3216082|NCT02239939|3947140|FG000|NOT COMPLETED|Overall Study||2
3216083|NCT02239939|3947141|FG001|NOT COMPLETED|Overall Study||2
3216084|NCT02239978|3947151|FG000|STARTED|Overall Study||30
3216085|NCT02239978|3947152|FG001|STARTED|Overall Study||12
3216086|NCT02239978|3947151|FG000|COMPLETED|Overall Study||28
3216087|NCT02239978|3947152|FG001|COMPLETED|Overall Study||12
3216088|NCT02239978|3947151|FG000|NOT COMPLETED|Overall Study||2
3216089|NCT02239978|3947152|FG001|NOT COMPLETED|Overall Study||0
3216090|NCT02240030|3947163|FG000|STARTED|Overall Study||113
3216091|NCT02240030|3947164|FG001|STARTED|Overall Study||114
3216092|NCT02240030|3947165|FG002|STARTED|Overall Study||112
3216093|NCT02240030|3947163|FG000|COMPLETED|Overall Study||96
3216094|NCT02240030|3947164|FG001|COMPLETED|Overall Study||97
3216095|NCT02240030|3947165|FG002|COMPLETED|Overall Study||97
3216096|NCT02240030|3947163|FG000|NOT COMPLETED|Overall Study||17
3216097|NCT02240030|3947164|FG001|NOT COMPLETED|Overall Study||17
3216098|NCT02240030|3947165|FG002|NOT COMPLETED|Overall Study||15
3216099|NCT02240108|3947177|FG000|STARTED|Overall Study||35
3216100|NCT02240108|3947178|FG001|STARTED|Overall Study||46
3216101|NCT02240108|3947177|FG000|Intent-to-treat (ITT) Population|Overall Study||35
3216102|NCT02240108|3947178|FG001|Intent-to-treat (ITT) Population|Overall Study||45
3216103|NCT02240108|3947177|FG000|COMPLETED|Overall Study||21
3216104|NCT02240108|3947178|FG001|COMPLETED|Overall Study||21
3216105|NCT02240108|3947177|FG000|NOT COMPLETED|Overall Study||14
3216106|NCT02240108|3947178|FG001|NOT COMPLETED|Overall Study||25
3216107|NCT02240121|3947186|FG000|STARTED|Overall Study||40
3216108|NCT02240121|3947187|FG001|STARTED|Overall Study||40
3216109|NCT02240121|3947186|FG000|COMPLETED|Overall Study||22
3216110|NCT02240121|3947187|FG001|COMPLETED|Overall Study||20
3216111|NCT02240121|3947186|FG000|NOT COMPLETED|Overall Study||18
3216112|NCT02240121|3947187|FG001|NOT COMPLETED|Overall Study||20
3367138|NCT03885934|4098528|FG002|NOT COMPLETED|Overall Study||0
3367139|NCT03885934|4098529|FG003|NOT COMPLETED|Overall Study||0
3367140|NCT03885934|4098530|FG004|NOT COMPLETED|Overall Study||0
3367141|NCT03885934|4098531|FG005|NOT COMPLETED|Overall Study||0
3367142|NCT03885726|4098545|FG000|STARTED|Overall Study||32
3367143|NCT03885726|4098545|FG000|COMPLETED|Overall Study||28
3367144|NCT03885726|4098545|FG000|NOT COMPLETED|Overall Study||4
3367145|NCT03885154|4098557|FG000|STARTED|Overall Study||12
3367146|NCT03885154|4098558|FG001|STARTED|Overall Study||10
3367147|NCT03885154|4098559|FG002|STARTED|Overall Study||0
3367148|NCT03885154|4098560|FG003|STARTED|Overall Study||2
3367149|NCT03885154|4098557|FG000|COMPLETED|Overall Study||12
3367150|NCT03885154|4098558|FG001|COMPLETED|Overall Study||10
3367151|NCT03885154|4098559|FG002|COMPLETED|Overall Study||0
3367152|NCT03885154|4098560|FG003|COMPLETED|Overall Study||2
3367153|NCT03885154|4098557|FG000|NOT COMPLETED|Overall Study||0
3367154|NCT03885154|4098558|FG001|NOT COMPLETED|Overall Study||0
3367155|NCT03885154|4098559|FG002|NOT COMPLETED|Overall Study||0
3367156|NCT03885154|4098560|FG003|NOT COMPLETED|Overall Study||0
3367157|NCT03883386|4098570|FG000|STARTED|First Assignment||2
3367158|NCT03883386|4098571|FG001|STARTED|First Assignment||1
3367159|NCT03883386|4098570|FG000|Surveys Begun|First Assignment||1
3367160|NCT03883386|4098571|FG001|Surveys Begun|First Assignment||1
3367161|NCT03883386|4098570|FG000|COMPLETED|First Assignment||0
3367162|NCT03883386|4098571|FG001|COMPLETED|First Assignment||0
3367163|NCT03883386|4098570|FG000|NOT COMPLETED|First Assignment||2
3367164|NCT03883386|4098571|FG001|NOT COMPLETED|First Assignment||1
3367165|NCT03883386|4098570|FG000|STARTED|Washout and Second Assignment||0
3367166|NCT03883386|4098571|FG001|STARTED|Washout and Second Assignment||0
3367167|NCT03883386|4098570|FG000|COMPLETED|Washout and Second Assignment||0
3367168|NCT03883386|4098571|FG001|COMPLETED|Washout and Second Assignment||0
3367169|NCT03883386|4098570|FG000|NOT COMPLETED|Washout and Second Assignment||0
3367170|NCT03883386|4098571|FG001|NOT COMPLETED|Washout and Second Assignment||0
3216113|NCT02240186|3947193|FG000|STARTED|Overall Study||50
3216114|NCT02240186|3947193|FG000|COMPLETED|Overall Study||23
3216115|NCT02240186|3947193|FG000|NOT COMPLETED|Overall Study||27
3216116|NCT02240329|3947200|FG000|STARTED|Overall Study||4
3216117|NCT02240329|3947200|FG000|Determination of Urge to Cough|Overall Study||4
3216118|NCT02240329|3947200|FG000|COMPLETED|Overall Study||4
3216119|NCT02240329|3947200|FG000|NOT COMPLETED|Overall Study||0
3367171|NCT03882528|4098577|FG000|STARTED|Overall Study||12
3367172|NCT03882528|4098577|FG000|COMPLETED|Overall Study||12
3367173|NCT03882528|4098577|FG000|NOT COMPLETED|Overall Study||0
3367174|NCT03882801|4098583|FG000|STARTED|Period 1||12
3216120|NCT02240368|3947207|FG000|STARTED|Overall Study||9
3216121|NCT02240368|3947208|FG001|STARTED|Overall Study||22
3216122|NCT02240368|3947209|FG002|STARTED|Overall Study||19
3216123|NCT02240368|3947207|FG000|COMPLETED|Overall Study||8
3216124|NCT02240368|3947208|FG001|COMPLETED|Overall Study||22
3216125|NCT02240368|3947209|FG002|COMPLETED|Overall Study||18
3216126|NCT02240368|3947207|FG000|NOT COMPLETED|Overall Study||1
3216127|NCT02240368|3947208|FG001|NOT COMPLETED|Overall Study||0
3216128|NCT02240368|3947209|FG002|NOT COMPLETED|Overall Study||1
3216129|NCT02240589|3947219|FG000|STARTED|Overall Study||5
3216130|NCT02240589|3947220|FG001|STARTED|Overall Study||6
3216131|NCT02240589|3947219|FG000|COMPLETED|Overall Study||3
3216132|NCT02240589|3947220|FG001|COMPLETED|Overall Study||4
3216133|NCT02240589|3947219|FG000|NOT COMPLETED|Overall Study||2
3216134|NCT02240589|3947220|FG001|NOT COMPLETED|Overall Study||2
3216135|NCT02240628|3947228|FG000|STARTED|Overall Study||38
3216136|NCT02240628|3947229|FG001|STARTED|Overall Study||38
3216137|NCT02240628|3947228|FG000|COMPLETED|Overall Study||32
3216138|NCT02240628|3947229|FG001|COMPLETED|Overall Study||33
3216139|NCT02240628|3947228|FG000|NOT COMPLETED|Overall Study||6
3216140|NCT02240628|3947229|FG001|NOT COMPLETED|Overall Study||5
3216141|NCT02240654|3947240|FG000|STARTED|Overall Study||1706
3216142|NCT02240654|3947241|FG001|STARTED|Overall Study||2813
3216143|NCT02240654|3947242|FG002|STARTED|Overall Study||28619
3216144|NCT02240654|3947243|FG003|STARTED|Overall Study||2150
3216145|NCT02240654|3947244|FG004|STARTED|Overall Study||1285
3216146|NCT02240654|3947240|FG000|COMPLETED|Overall Study||1706
3216147|NCT02240654|3947241|FG001|COMPLETED|Overall Study||2813
3216148|NCT02240654|3947242|FG002|COMPLETED|Overall Study||28619
3216149|NCT02240654|3947243|FG003|COMPLETED|Overall Study||2150
3216150|NCT02240654|3947244|FG004|COMPLETED|Overall Study||1285
3216151|NCT02240654|3947240|FG000|NOT COMPLETED|Overall Study||0
3216152|NCT02240654|3947241|FG001|NOT COMPLETED|Overall Study||0
3216153|NCT02240654|3947242|FG002|NOT COMPLETED|Overall Study||0
3216154|NCT02240654|3947243|FG003|NOT COMPLETED|Overall Study||0
3216155|NCT02240654|3947244|FG004|NOT COMPLETED|Overall Study||0
3216156|NCT02240667|3947258|FG000|STARTED|Overall Study||771
3216157|NCT02240667|3947259|FG001|STARTED|Overall Study||650
3216158|NCT02240667|3947258|FG000|COMPLETED|Overall Study||771
3216159|NCT02240667|3947259|FG001|COMPLETED|Overall Study||650
3216160|NCT02240667|3947258|FG000|NOT COMPLETED|Overall Study||0
3216161|NCT02240667|3947259|FG001|NOT COMPLETED|Overall Study||0
3216162|NCT02240680|3947267|FG000|STARTED|Overall Study (Up to 24 Weeks)||151
3216163|NCT02240680|3947268|FG001|STARTED|Overall Study (Up to 24 Weeks)||151
3216164|NCT02240680|3947269|FG002|STARTED|Overall Study (Up to 24 Weeks)||0
3216165|NCT02240680|3947270|FG003|STARTED|Overall Study (Up to 24 Weeks)||0
3216166|NCT02240680|3947267|FG000|COMPLETED|Overall Study (Up to 24 Weeks)||136
3216167|NCT02240680|3947268|FG001|COMPLETED|Overall Study (Up to 24 Weeks)||143
3216168|NCT02240680|3947269|FG002|COMPLETED|Overall Study (Up to 24 Weeks)||0
3216169|NCT02240680|3947270|FG003|COMPLETED|Overall Study (Up to 24 Weeks)||0
3216170|NCT02240680|3947267|FG000|NOT COMPLETED|Overall Study (Up to 24 Weeks)||15
3216171|NCT02240680|3947268|FG001|NOT COMPLETED|Overall Study (Up to 24 Weeks)||8
3216172|NCT02240680|3947269|FG002|NOT COMPLETED|Overall Study (Up to 24 Weeks)||0
3216173|NCT02240680|3947270|FG003|NOT COMPLETED|Overall Study (Up to 24 Weeks)||0
3216174|NCT02240680|3947267|FG000|STARTED|Japanese Patients (Up to 52 Weeks)||0
3216175|NCT02240680|3947268|FG001|STARTED|Japanese Patients (Up to 52 Weeks)||0
3216176|NCT02240680|3947269|FG002|STARTED|Japanese Patients (Up to 52 Weeks)||50
3216177|NCT02240680|3947270|FG003|STARTED|Japanese Patients (Up to 52 Weeks)||52
3216178|NCT02240680|3947267|FG000|COMPLETED|Japanese Patients (Up to 52 Weeks)||0
3216179|NCT02240680|3947268|FG001|COMPLETED|Japanese Patients (Up to 52 Weeks)||0
3216180|NCT02240680|3947269|FG002|COMPLETED|Japanese Patients (Up to 52 Weeks)||42
3216181|NCT02240680|3947270|FG003|COMPLETED|Japanese Patients (Up to 52 Weeks)||45
3216182|NCT02240680|3947267|FG000|NOT COMPLETED|Japanese Patients (Up to 52 Weeks)||0
3216183|NCT02240680|3947268|FG001|NOT COMPLETED|Japanese Patients (Up to 52 Weeks)||0
3216184|NCT02240680|3947269|FG002|NOT COMPLETED|Japanese Patients (Up to 52 Weeks)||8
3216185|NCT02240680|3947270|FG003|NOT COMPLETED|Japanese Patients (Up to 52 Weeks)||7
3216186|NCT02240693|3947283|FG000|STARTED|Overall Study||22
3216187|NCT02240693|3947284|FG001|STARTED|Overall Study||21
3216188|NCT02240693|3947285|FG002|STARTED|Overall Study||21
3216189|NCT02240693|3947286|FG003|STARTED|Overall Study||21
3216190|NCT02240693|3947287|FG004|STARTED|Overall Study||43
3216191|NCT02240693|3947283|FG000|COMPLETED|Overall Study||22
3216192|NCT02240693|3947284|FG001|COMPLETED|Overall Study||21
3216193|NCT02240693|3947285|FG002|COMPLETED|Overall Study||17
3216194|NCT02240693|3947286|FG003|COMPLETED|Overall Study||20
3216195|NCT02240693|3947287|FG004|COMPLETED|Overall Study||42
3216196|NCT02240693|3947283|FG000|NOT COMPLETED|Overall Study||0
3216197|NCT02240693|3947284|FG001|NOT COMPLETED|Overall Study||0
3216198|NCT02240693|3947285|FG002|NOT COMPLETED|Overall Study||4
3216199|NCT02240693|3947286|FG003|NOT COMPLETED|Overall Study||1
3216200|NCT02240693|3947287|FG004|NOT COMPLETED|Overall Study||1
3216201|NCT02240706|3947306|FG000|STARTED|Overall Study||3
3216202|NCT02240706|3947307|FG001|STARTED|Overall Study||3
3216203|NCT02240706|3947308|FG002|STARTED|Overall Study||6
3216204|NCT02240706|3947309|FG003|STARTED|Overall Study||4
3216205|NCT02240706|3947310|FG004|STARTED|Overall Study||11
3216206|NCT02240706|3947311|FG005|STARTED|Overall Study|No patients were enrolled in the Phase II part due to strategic reasons.|0
3367175|NCT03882801|4098584|FG001|STARTED|Period 1||12
3216207|NCT02240706|3947312|FG006|STARTED|Overall Study|No patients were enrolled in the Phase II part due to strategic reasons.|0
3216208|NCT02240706|3947306|FG000|COMPLETED|Overall Study||0
3216209|NCT02240706|3947307|FG001|COMPLETED|Overall Study||0
3216210|NCT02240706|3947308|FG002|COMPLETED|Overall Study||0
3216211|NCT02240706|3947309|FG003|COMPLETED|Overall Study||0
3216212|NCT02240706|3947310|FG004|COMPLETED|Overall Study||0
3216213|NCT02240706|3947311|FG005|COMPLETED|Overall Study||0
3216214|NCT02240706|3947312|FG006|COMPLETED|Overall Study||0
3216215|NCT02240706|3947306|FG000|NOT COMPLETED|Overall Study||3
3216216|NCT02240706|3947307|FG001|NOT COMPLETED|Overall Study||3
3216217|NCT02240706|3947308|FG002|NOT COMPLETED|Overall Study||6
3216218|NCT02240706|3947309|FG003|NOT COMPLETED|Overall Study||4
3216219|NCT02240706|3947310|FG004|NOT COMPLETED|Overall Study||11
3216220|NCT02240706|3947311|FG005|NOT COMPLETED|Overall Study||0
3216221|NCT02240706|3947312|FG006|NOT COMPLETED|Overall Study||0
3216222|NCT02240810|3947329|FG000|STARTED|Overall Study||1501
3216223|NCT02240810|3947330|FG001|STARTED|Overall Study|correct typo|2681
3216224|NCT02240810|3947329|FG000|COMPLETED|Overall Study||1441
3216225|NCT02240810|3947330|FG001|COMPLETED|Overall Study||2621
3216226|NCT02240810|3947329|FG000|NOT COMPLETED|Overall Study||60
3216227|NCT02240810|3947330|FG001|NOT COMPLETED|Overall Study||60
3216228|NCT02241486|3947337|FG000|STARTED|Overall Study||2
3216229|NCT02241486|3947337|FG000|COMPLETED|Overall Study||2
3216230|NCT02241486|3947337|FG000|NOT COMPLETED|Overall Study||0
3216231|NCT02241512|3947343|FG000|STARTED|Overall Study||30
3216232|NCT02241512|3947344|FG001|STARTED|Overall Study||29
3216233|NCT02241512|3947343|FG000|COMPLETED|Overall Study||29
3216234|NCT02241512|3947344|FG001|COMPLETED|Overall Study||29
3216235|NCT02241512|3947343|FG000|NOT COMPLETED|Overall Study||1
3216236|NCT02241512|3947344|FG001|NOT COMPLETED|Overall Study||0
3216237|NCT02241655|3947352|FG000|STARTED|Overall Study||614
3216238|NCT02241655|3947353|FG001|STARTED|Overall Study||618
3216239|NCT02241655|3947352|FG000|COMPLETED|Overall Study||614
3216240|NCT02241655|3947353|FG001|COMPLETED|Overall Study||618
3216241|NCT02241655|3947352|FG000|NOT COMPLETED|Overall Study||0
3216242|NCT02241655|3947353|FG001|NOT COMPLETED|Overall Study||0
3216243|NCT02241720|3947364|FG000|STARTED|Overall Study||5
3216244|NCT02241720|3947364|FG000|COMPLETED|Overall Study||1
3216245|NCT02241720|3947364|FG000|NOT COMPLETED|Overall Study||4
3216246|NCT02241733|3947370|FG000|STARTED|Overall Study||40
3216247|NCT02241733|3947371|FG001|STARTED|Overall Study||40
3216248|NCT02241733|3947370|FG000|COMPLETED|Overall Study||25
3216249|NCT02241733|3947371|FG001|COMPLETED|Overall Study||30
3216250|NCT02241733|3947370|FG000|NOT COMPLETED|Overall Study||15
3216251|NCT02241733|3947371|FG001|NOT COMPLETED|Overall Study||10
3216252|NCT02241785|3947377|FG000|STARTED|Overall Study||47
3216253|NCT02241785|3947377|FG000|COMPLETED|Overall Study||0
3216254|NCT02241785|3947377|FG000|NOT COMPLETED|Overall Study||47
3216255|NCT02241889|3947381|FG000|STARTED|Overall Study||4
3216256|NCT02241889|3947382|FG001|STARTED|Overall Study||4
3216257|NCT02241889|3947383|FG002|STARTED|Overall Study||3
3216258|NCT02241889|3947384|FG003|STARTED|Overall Study||3
3216259|NCT02241889|3947385|FG004|STARTED|Overall Study||5
3216260|NCT02241889|3947386|FG005|STARTED|Overall Study||4
3216261|NCT02241889|3947381|FG000|COMPLETED|Overall Study||4
3216262|NCT02241889|3947382|FG001|COMPLETED|Overall Study||4
3216263|NCT02241889|3947383|FG002|COMPLETED|Overall Study||2
3216264|NCT02241889|3947384|FG003|COMPLETED|Overall Study||3
3216265|NCT02241889|3947385|FG004|COMPLETED|Overall Study||5
3216266|NCT02241889|3947386|FG005|COMPLETED|Overall Study||3
3216267|NCT02241889|3947381|FG000|NOT COMPLETED|Overall Study||0
3216268|NCT02241889|3947382|FG001|NOT COMPLETED|Overall Study||0
3216269|NCT02241889|3947383|FG002|NOT COMPLETED|Overall Study||1
3216270|NCT02241889|3947384|FG003|NOT COMPLETED|Overall Study||0
3216271|NCT02241889|3947385|FG004|NOT COMPLETED|Overall Study||0
3216272|NCT02241889|3947386|FG005|NOT COMPLETED|Overall Study||1
3216273|NCT02241967|3947398|FG000|STARTED|Overall Study||30
3216274|NCT02241967|3947399|FG001|STARTED|Overall Study||30
3216275|NCT02241967|3947400|FG002|STARTED|Overall Study||30
3216276|NCT02241967|3947401|FG003|STARTED|Overall Study||29
3216277|NCT02241967|3947398|FG000|COMPLETED|Overall Study||30
3216278|NCT02241967|3947399|FG001|COMPLETED|Overall Study||30
3216279|NCT02241967|3947400|FG002|COMPLETED|Overall Study||30
3216280|NCT02241967|3947401|FG003|COMPLETED|Overall Study||29
3216281|NCT02241967|3947398|FG000|NOT COMPLETED|Overall Study||0
3216282|NCT02241967|3947399|FG001|NOT COMPLETED|Overall Study||0
3216283|NCT02241967|3947400|FG002|NOT COMPLETED|Overall Study||0
3216284|NCT02241967|3947401|FG003|NOT COMPLETED|Overall Study||0
3216285|NCT02242019|3947411|FG000|STARTED|Overall Study||109
3216286|NCT02242019|3947411|FG000|COMPLETED|Overall Study||109
3216287|NCT02242019|3947411|FG000|NOT COMPLETED|Overall Study||0
3216288|NCT02242045|3947415|FG000|STARTED|Overall Study||6
3216289|NCT02242045|3947415|FG000|COMPLETED|Overall Study||0
3216290|NCT02242045|3947415|FG000|NOT COMPLETED|Overall Study||6
3216291|NCT02242201|3947422|FG000|STARTED|Overall Study||55
3216292|NCT02242201|3947423|FG001|STARTED|Overall Study||55
3216293|NCT02242201|3947424|FG002|STARTED|Overall Study||55
3216294|NCT02242201|3947422|FG000|COMPLETED|Overall Study||51
3216295|NCT02242201|3947423|FG001|COMPLETED|Overall Study||54
3216296|NCT02242201|3947424|FG002|COMPLETED|Overall Study||54
3216297|NCT02242201|3947422|FG000|NOT COMPLETED|Overall Study||4
3216298|NCT02242201|3947423|FG001|NOT COMPLETED|Overall Study||1
3216299|NCT02242201|3947424|FG002|NOT COMPLETED|Overall Study||1
3216300|NCT02242305|3947434|FG000|STARTED|Overall Study||151
3216301|NCT02242305|3947435|FG001|STARTED|Overall Study||151
3216302|NCT02242305|3947434|FG000|COMPLETED|Overall Study||145
3216303|NCT02242305|3947435|FG001|COMPLETED|Overall Study||141
3216304|NCT02242305|3947434|FG000|NOT COMPLETED|Overall Study||6
3216305|NCT02242305|3947435|FG001|NOT COMPLETED|Overall Study||10
3216306|NCT02242487|3947443|FG000|STARTED|Overall Study||161
3216307|NCT02242487|3947444|FG001|STARTED|Overall Study||164
3216308|NCT02242487|3947443|FG000|COMPLETED|Overall Study||99
3216309|NCT02242487|3947444|FG001|COMPLETED|Overall Study||117
3216310|NCT02242487|3947443|FG000|NOT COMPLETED|Overall Study||62
3216311|NCT02242487|3947444|FG001|NOT COMPLETED|Overall Study||47
3216312|NCT02242630|3947456|FG000|STARTED|Overall Study||15
3216313|NCT02242630|3947457|FG001|STARTED|Overall Study||15
3216314|NCT02242630|3947458|FG002|STARTED|Overall Study||15
3216315|NCT02242630|3947459|FG003|STARTED|Overall Study||16
3216316|NCT02242630|3947456|FG000|COMPLETED|Overall Study||15
3216317|NCT02242630|3947457|FG001|COMPLETED|Overall Study||15
3216318|NCT02242630|3947458|FG002|COMPLETED|Overall Study||15
3216319|NCT02242630|3947459|FG003|COMPLETED|Overall Study||16
3216320|NCT02242630|3947456|FG000|NOT COMPLETED|Overall Study||0
3216321|NCT02242630|3947457|FG001|NOT COMPLETED|Overall Study||0
3216322|NCT02242630|3947458|FG002|NOT COMPLETED|Overall Study||0
3216323|NCT02242630|3947459|FG003|NOT COMPLETED|Overall Study||0
3216324|NCT02242643|3947471|FG000|STARTED|Overall Study||1207
3216325|NCT02242643|3947472|FG001|STARTED|Overall Study||1217
3216326|NCT02242643|3947471|FG000|COMPLETED|Overall Study||1132
3216327|NCT02242643|3947472|FG001|COMPLETED|Overall Study||1139
3216328|NCT02242643|3947471|FG000|NOT COMPLETED|Overall Study||75
3216329|NCT02242643|3947472|FG001|NOT COMPLETED|Overall Study||78
3216330|NCT02242903|3947487|FG000|STARTED|Overall Study||12
3216331|NCT02242903|3947488|FG001|STARTED|Overall Study||6
3216332|NCT02242903|3947489|FG002|STARTED|Overall Study||6
3216333|NCT02242903|3947490|FG003|STARTED|Overall Study||6
3216334|NCT02242903|3947491|FG004|STARTED|Overall Study||6
3216335|NCT02242903|3947492|FG005|STARTED|Overall Study||6
3216336|NCT02242903|3947493|FG006|STARTED|Overall Study||6
3216337|NCT02242903|3947487|FG000|Received at Least One Dose of Study Drug|Overall Study||12
3216338|NCT02242903|3947488|FG001|Received at Least One Dose of Study Drug|Overall Study||6
3216339|NCT02242903|3947489|FG002|Received at Least One Dose of Study Drug|Overall Study||6
3216340|NCT02242903|3947490|FG003|Received at Least One Dose of Study Drug|Overall Study||6
3216341|NCT02242903|3947491|FG004|Received at Least One Dose of Study Drug|Overall Study||6
3216342|NCT02242903|3947492|FG005|Received at Least One Dose of Study Drug|Overall Study||6
3216343|NCT02242903|3947493|FG006|Received at Least One Dose of Study Drug|Overall Study||6
3216344|NCT02242903|3947487|FG000|COMPLETED|Overall Study||11
3216345|NCT02242903|3947488|FG001|COMPLETED|Overall Study||6
3216346|NCT02242903|3947489|FG002|COMPLETED|Overall Study||6
3216347|NCT02242903|3947490|FG003|COMPLETED|Overall Study||6
3216348|NCT02242903|3947491|FG004|COMPLETED|Overall Study||6
3216349|NCT02242903|3947492|FG005|COMPLETED|Overall Study||6
3216350|NCT02242903|3947493|FG006|COMPLETED|Overall Study||6
3216351|NCT02242903|3947487|FG000|NOT COMPLETED|Overall Study||1
3216352|NCT02242903|3947488|FG001|NOT COMPLETED|Overall Study||0
3216353|NCT02242903|3947489|FG002|NOT COMPLETED|Overall Study||0
3216354|NCT02242903|3947490|FG003|NOT COMPLETED|Overall Study||0
3216355|NCT02242903|3947491|FG004|NOT COMPLETED|Overall Study||0
3216356|NCT02242903|3947492|FG005|NOT COMPLETED|Overall Study||0
3216357|NCT02242903|3947493|FG006|NOT COMPLETED|Overall Study||0
3216358|NCT02242942|3947518|FG000|STARTED|Overall Study||216
3216359|NCT02242942|3947519|FG001|STARTED|Overall Study||216
3216360|NCT02242942|3947520|FG002|STARTED|Overall Study||13
3216361|NCT02242942|3947518|FG000|Treated|Overall Study||214
3216362|NCT02242942|3947519|FG001|Treated|Overall Study||212
3216363|NCT02242942|3947520|FG002|Treated|Overall Study||13
3216364|NCT02242942|3947518|FG000|COMPLETED|Overall Study||0
3216365|NCT02242942|3947519|FG001|COMPLETED|Overall Study||0
3216366|NCT02242942|3947520|FG002|COMPLETED|Overall Study||0
3216367|NCT02242942|3947518|FG000|NOT COMPLETED|Overall Study||216
3216368|NCT02242942|3947519|FG001|NOT COMPLETED|Overall Study||216
3216369|NCT02242942|3947520|FG002|NOT COMPLETED|Overall Study||13
3216370|NCT02242981|3947530|FG000|STARTED|Overall Study||6
3216371|NCT02242981|3947530|FG000|Received Study Drug|Overall Study||6
3216372|NCT02242981|3947530|FG000|COMPLETED|Overall Study||5
3216373|NCT02242981|3947530|FG000|NOT COMPLETED|Overall Study||1
3216374|NCT02242994|3947534|FG000|STARTED|Overall Study||5
3216375|NCT02242994|3947534|FG000|COMPLETED|Overall Study||5
3216376|NCT02242994|3947534|FG000|NOT COMPLETED|Overall Study||0
3216377|NCT02243007|3947540|FG000|STARTED|Overall Study||4
3216378|NCT02243007|3947541|FG001|STARTED|Overall Study||3
3216379|NCT02243007|3947540|FG000|COMPLETED|Overall Study||4
3216380|NCT02243007|3947541|FG001|COMPLETED|Overall Study||3
3216381|NCT02243007|3947540|FG000|NOT COMPLETED|Overall Study||0
3216382|NCT02243007|3947541|FG001|NOT COMPLETED|Overall Study||0
3216383|NCT02243020|3947549|FG000|STARTED|Overall Study||8
3216384|NCT02243020|3947550|FG001|STARTED|Overall Study||9
3216385|NCT02243020|3947549|FG000|COMPLETED|Overall Study||8
3216386|NCT02243020|3947550|FG001|COMPLETED|Overall Study||9
3216387|NCT02243020|3947549|FG000|NOT COMPLETED|Overall Study||0
3216388|NCT02243020|3947550|FG001|NOT COMPLETED|Overall Study||0
3216389|NCT02243046|3947559|FG000|STARTED|Overall Study||55
3216390|NCT02243046|3947560|FG001|STARTED|Overall Study||54
3216391|NCT02243046|3947561|FG002|STARTED|Overall Study||53
3216392|NCT02243046|3947559|FG000|3 Month|Overall Study|1 subject didn't return for 3 month clinic visit|54
3216393|NCT02243046|3947560|FG001|3 Month|Overall Study|1 subject didn't return for 3 month clinic visit|53
3216394|NCT02243046|3947561|FG002|3 Month|Overall Study|2 subjects didn't return for 3 month clinic visit|51
3216395|NCT02243046|3947559|FG000|6 Month|Overall Study||54
3216396|NCT02243046|3947560|FG001|6 Month|Overall Study||53
3216397|NCT02243046|3947561|FG002|6 Month|Overall Study|2 subjects didn't return for 6 month clinic visit|49
3216398|NCT02243046|3947559|FG000|COMPLETED|Overall Study||54
3216399|NCT02243046|3947560|FG001|COMPLETED|Overall Study||53
3216400|NCT02243046|3947561|FG002|COMPLETED|Overall Study||49
3216401|NCT02243046|3947559|FG000|NOT COMPLETED|Overall Study||1
3216402|NCT02243046|3947560|FG001|NOT COMPLETED|Overall Study||1
3216403|NCT02243046|3947561|FG002|NOT COMPLETED|Overall Study||4
3216404|NCT02243176|3947571|FG000|STARTED|Overall Study|3 of the randomized subjects withdrew before taking any medication|244
3216405|NCT02243176|3947572|FG001|STARTED|Overall Study||244
3216406|NCT02243176|3947571|FG000|COMPLETED|Overall Study||230
3216407|NCT02243176|3947572|FG001|COMPLETED|Overall Study||229
3216408|NCT02243176|3947571|FG000|NOT COMPLETED|Overall Study||14
3216409|NCT02243176|3947572|FG001|NOT COMPLETED|Overall Study||15
3216410|NCT02243202|3947582|FG000|STARTED|Overall Study||82
3216411|NCT02243202|3947583|FG001|STARTED|Overall Study||85
3216412|NCT02243202|3947584|FG002|STARTED|Overall Study||84
3216413|NCT02243202|3947585|FG003|STARTED|Overall Study||84
3216414|NCT02243202|3947582|FG000|Treated|Overall Study||82
3216415|NCT02243202|3947583|FG001|Treated|Overall Study||85
3216416|NCT02243202|3947584|FG002|Treated|Overall Study||84
3216417|NCT02243202|3947585|FG003|Treated|Overall Study||83
3216418|NCT02243202|3947582|FG000|COMPLETED|Overall Study||57
3216419|NCT02243202|3947583|FG001|COMPLETED|Overall Study||60
3216420|NCT02243202|3947584|FG002|COMPLETED|Overall Study||53
3216421|NCT02243202|3947585|FG003|COMPLETED|Overall Study||61
3216422|NCT02243202|3947582|FG000|NOT COMPLETED|Overall Study||25
3216423|NCT02243202|3947583|FG001|NOT COMPLETED|Overall Study||25
3216424|NCT02243202|3947584|FG002|NOT COMPLETED|Overall Study||31
3216425|NCT02243202|3947585|FG003|NOT COMPLETED|Overall Study||23
3216426|NCT02243280|3947606|FG000|STARTED|Enrolled||40
3216427|NCT02243280|3947607|FG001|STARTED|Enrolled||39
3216428|NCT02243280|3947608|FG002|STARTED|Enrolled||0
3216429|NCT02243280|3947609|FG003|STARTED|Enrolled||0
3216430|NCT02243280|3947610|FG004|STARTED|Enrolled||0
3216431|NCT02243280|3947611|FG005|STARTED|Enrolled||27
3216432|NCT02243280|3947612|FG006|STARTED|Enrolled||0
3216433|NCT02243280|3947613|FG007|STARTED|Enrolled||0
3216434|NCT02243280|3947614|FG008|STARTED|Enrolled||34
3216435|NCT02243280|3947615|FG009|STARTED|Enrolled||0
3216436|NCT02243280|3947616|FG010|STARTED|Enrolled||34
3216437|NCT02243280|3947606|FG000|COMPLETED|Enrolled||40
3216438|NCT02243280|3947607|FG001|COMPLETED|Enrolled||39
3216439|NCT02243280|3947608|FG002|COMPLETED|Enrolled||0
3216440|NCT02243280|3947609|FG003|COMPLETED|Enrolled||0
3216441|NCT02243280|3947610|FG004|COMPLETED|Enrolled||0
3216442|NCT02243280|3947611|FG005|COMPLETED|Enrolled||27
3216443|NCT02243280|3947612|FG006|COMPLETED|Enrolled||0
3216444|NCT02243280|3947613|FG007|COMPLETED|Enrolled||0
3216445|NCT02243280|3947614|FG008|COMPLETED|Enrolled||34
3216446|NCT02243280|3947615|FG009|COMPLETED|Enrolled||0
3216447|NCT02243280|3947616|FG010|COMPLETED|Enrolled||34
3216448|NCT02243280|3947606|FG000|NOT COMPLETED|Enrolled||0
3216449|NCT02243280|3947607|FG001|NOT COMPLETED|Enrolled||0
3216450|NCT02243280|3947608|FG002|NOT COMPLETED|Enrolled||0
3216451|NCT02243280|3947609|FG003|NOT COMPLETED|Enrolled||0
3216452|NCT02243280|3947610|FG004|NOT COMPLETED|Enrolled||0
3216453|NCT02243280|3947611|FG005|NOT COMPLETED|Enrolled||0
3216454|NCT02243280|3947612|FG006|NOT COMPLETED|Enrolled||0
3216455|NCT02243280|3947613|FG007|NOT COMPLETED|Enrolled||0
3216456|NCT02243280|3947614|FG008|NOT COMPLETED|Enrolled||0
3216457|NCT02243280|3947615|FG009|NOT COMPLETED|Enrolled||0
3216458|NCT02243280|3947616|FG010|NOT COMPLETED|Enrolled||0
3216459|NCT02243280|3947606|FG000|STARTED|Treated|Two Arm I participants received ABT-493 doses of 200 mg instead of 300 mg and are included in Arm A|42
3216460|NCT02243280|3947607|FG001|STARTED|Treated||39
3216461|NCT02243280|3947608|FG002|STARTED|Treated||0
3216462|NCT02243280|3947609|FG003|STARTED|Treated||0
3216463|NCT02243280|3947610|FG004|STARTED|Treated||0
3216464|NCT02243280|3947611|FG005|STARTED|Treated||27
3216465|NCT02243280|3947612|FG006|STARTED|Treated||0
3216466|NCT02243280|3947613|FG007|STARTED|Treated||0
3216467|NCT02243280|3947614|FG008|STARTED|Treated|Two Arm I participants received ABT-493 doses of 200 mg instead of 300 mg and are included in Arm A|32
3216468|NCT02243280|3947615|FG009|STARTED|Treated||0
3216469|NCT02243280|3947616|FG010|STARTED|Treated||34
3216470|NCT02243280|3947606|FG000|Completed Treatment|Treated||42
3216471|NCT02243280|3947607|FG001|Completed Treatment|Treated||38
3216472|NCT02243280|3947608|FG002|Completed Treatment|Treated||0
3216473|NCT02243280|3947609|FG003|Completed Treatment|Treated||0
3216474|NCT02243280|3947610|FG004|Completed Treatment|Treated||0
3216475|NCT02243280|3947611|FG005|Completed Treatment|Treated||27
3216476|NCT02243280|3947612|FG006|Completed Treatment|Treated||0
3216477|NCT02243280|3947613|FG007|Completed Treatment|Treated||0
3216478|NCT02243280|3947614|FG008|Completed Treatment|Treated||32
3216479|NCT02243280|3947615|FG009|Completed Treatment|Treated||0
3216480|NCT02243280|3947616|FG010|Completed Treatment|Treated||33
3216481|NCT02243280|3947606|FG000|COMPLETED|Treated||41
3216482|NCT02243280|3947607|FG001|COMPLETED|Treated||39
3216483|NCT02243280|3947608|FG002|COMPLETED|Treated||0
3216484|NCT02243280|3947609|FG003|COMPLETED|Treated||0
3216485|NCT02243280|3947610|FG004|COMPLETED|Treated||0
3216486|NCT02243280|3947611|FG005|COMPLETED|Treated||27
3216487|NCT02243280|3947612|FG006|COMPLETED|Treated||0
3216488|NCT02243280|3947613|FG007|COMPLETED|Treated||0
3216489|NCT02243280|3947614|FG008|COMPLETED|Treated||31
3216490|NCT02243280|3947615|FG009|COMPLETED|Treated||0
3216491|NCT02243280|3947616|FG010|COMPLETED|Treated||31
3216492|NCT02243280|3947606|FG000|NOT COMPLETED|Treated||1
3216493|NCT02243280|3947607|FG001|NOT COMPLETED|Treated||0
3216494|NCT02243280|3947608|FG002|NOT COMPLETED|Treated||0
3216495|NCT02243280|3947609|FG003|NOT COMPLETED|Treated||0
3216496|NCT02243280|3947610|FG004|NOT COMPLETED|Treated||0
3216497|NCT02243280|3947611|FG005|NOT COMPLETED|Treated||0
3216498|NCT02243280|3947612|FG006|NOT COMPLETED|Treated||0
3216499|NCT02243280|3947613|FG007|NOT COMPLETED|Treated||0
3216500|NCT02243280|3947614|FG008|NOT COMPLETED|Treated||1
3216501|NCT02243280|3947615|FG009|NOT COMPLETED|Treated||0
3216502|NCT02243280|3947616|FG010|NOT COMPLETED|Treated||3
3216503|NCT02243293|3947651|FG000|STARTED|Overall Study||25
3216504|NCT02243293|3947652|FG001|STARTED|Overall Study||24
3216505|NCT02243293|3947653|FG002|STARTED|Overall Study||25
3216506|NCT02243293|3947654|FG003|STARTED|Overall Study||30
3216507|NCT02243293|3947655|FG004|STARTED|Overall Study||31
3216508|NCT02243293|3947656|FG005|STARTED|Overall Study||31
3216509|NCT02243293|3947657|FG006|STARTED|Overall Study||30
3216510|NCT02243293|3947658|FG007|STARTED|Overall Study||0
3216511|NCT02243293|3947659|FG008|STARTED|Overall Study||0
3216512|NCT02243293|3947660|FG009|STARTED|Overall Study||55
3216513|NCT02243293|3947661|FG010|STARTED|Overall Study||0
3216514|NCT02243293|3947662|FG011|STARTED|Overall Study||53
3216515|NCT02243293|3947663|FG012|STARTED|Overall Study||0
3216516|NCT02243293|3947664|FG013|STARTED|Overall Study||0
3216517|NCT02243293|3947665|FG014|STARTED|Overall Study||28
3216518|NCT02243293|3947666|FG015|STARTED|Overall Study||27
3216519|NCT02243293|3947667|FG016|STARTED|Overall Study||40
3216520|NCT02243293|3947668|FG017|STARTED|Overall Study||22
3216521|NCT02243293|3947669|FG018|STARTED|Overall Study||22
3216522|NCT02243293|3947670|FG019|STARTED|Overall Study||48
3216523|NCT02243293|3947671|FG020|STARTED|Overall Study||145
3216524|NCT02243293|3947672|FG021|STARTED|Overall Study||58
3216525|NCT02243293|3947651|FG000|COMPLETED|Overall Study||23
3216526|NCT02243293|3947652|FG001|COMPLETED|Overall Study||23
3216527|NCT02243293|3947653|FG002|COMPLETED|Overall Study||24
3216528|NCT02243293|3947654|FG003|COMPLETED|Overall Study||29
3216529|NCT02243293|3947655|FG004|COMPLETED|Overall Study||30
3216530|NCT02243293|3947656|FG005|COMPLETED|Overall Study||31
3216531|NCT02243293|3947657|FG006|COMPLETED|Overall Study||27
3216532|NCT02243293|3947658|FG007|COMPLETED|Overall Study||0
3216533|NCT02243293|3947659|FG008|COMPLETED|Overall Study||0
3216534|NCT02243293|3947660|FG009|COMPLETED|Overall Study||53
3216535|NCT02243293|3947661|FG010|COMPLETED|Overall Study||0
3216536|NCT02243293|3947662|FG011|COMPLETED|Overall Study||50
3216537|NCT02243293|3947663|FG012|COMPLETED|Overall Study||0
3216538|NCT02243293|3947664|FG013|COMPLETED|Overall Study||0
3216539|NCT02243293|3947665|FG014|COMPLETED|Overall Study||27
3216540|NCT02243293|3947666|FG015|COMPLETED|Overall Study||26
3216541|NCT02243293|3947667|FG016|COMPLETED|Overall Study||37
3216542|NCT02243293|3947668|FG017|COMPLETED|Overall Study||21
3216543|NCT02243293|3947669|FG018|COMPLETED|Overall Study||22
3216544|NCT02243293|3947670|FG019|COMPLETED|Overall Study||47
3216545|NCT02243293|3947671|FG020|COMPLETED|Overall Study||143
3216546|NCT02243293|3947672|FG021|COMPLETED|Overall Study||55
3216547|NCT02243293|3947651|FG000|NOT COMPLETED|Overall Study||2
3216548|NCT02243293|3947652|FG001|NOT COMPLETED|Overall Study||1
3216549|NCT02243293|3947653|FG002|NOT COMPLETED|Overall Study||1
3216550|NCT02243293|3947654|FG003|NOT COMPLETED|Overall Study||1
3216551|NCT02243293|3947655|FG004|NOT COMPLETED|Overall Study||1
3216552|NCT02243293|3947656|FG005|NOT COMPLETED|Overall Study||0
3216553|NCT02243293|3947657|FG006|NOT COMPLETED|Overall Study||3
3216554|NCT02243293|3947658|FG007|NOT COMPLETED|Overall Study||0
3216555|NCT02243293|3947659|FG008|NOT COMPLETED|Overall Study||0
3216556|NCT02243293|3947660|FG009|NOT COMPLETED|Overall Study||2
3216557|NCT02243293|3947661|FG010|NOT COMPLETED|Overall Study||0
3216558|NCT02243293|3947662|FG011|NOT COMPLETED|Overall Study||3
3216559|NCT02243293|3947663|FG012|NOT COMPLETED|Overall Study||0
3216560|NCT02243293|3947664|FG013|NOT COMPLETED|Overall Study||0
3216561|NCT02243293|3947665|FG014|NOT COMPLETED|Overall Study||1
3216562|NCT02243293|3947666|FG015|NOT COMPLETED|Overall Study||1
3216563|NCT02243293|3947667|FG016|NOT COMPLETED|Overall Study||3
3216564|NCT02243293|3947668|FG017|NOT COMPLETED|Overall Study||1
3216565|NCT02243293|3947669|FG018|NOT COMPLETED|Overall Study||0
3216566|NCT02243293|3947670|FG019|NOT COMPLETED|Overall Study||1
3216567|NCT02243293|3947671|FG020|NOT COMPLETED|Overall Study||2
3216568|NCT02243293|3947672|FG021|NOT COMPLETED|Overall Study||3
3216569|NCT02243371|3947711|FG000|STARTED|Overall Study||51
3216570|NCT02243371|3947712|FG001|STARTED|Overall Study||42
3216571|NCT02243371|3947711|FG000|COMPLETED|Overall Study||14
3216572|NCT02243371|3947712|FG001|COMPLETED|Overall Study||10
3216573|NCT02243371|3947711|FG000|NOT COMPLETED|Overall Study||37
3216574|NCT02243371|3947712|FG001|NOT COMPLETED|Overall Study||32
3216575|NCT02243527|3947720|FG000|STARTED|Overall Study||12
3216576|NCT02243527|3947721|FG001|STARTED|Overall Study||13
3216577|NCT02243527|3947720|FG000|COMPLETED|Overall Study||12
3216578|NCT02243527|3947721|FG001|COMPLETED|Overall Study||13
3216579|NCT02243527|3947720|FG000|NOT COMPLETED|Overall Study||0
3216580|NCT02243527|3947721|FG001|NOT COMPLETED|Overall Study||0
3216581|NCT02243579|3947727|FG000|STARTED|Overall Study||24
3216582|NCT02243579|3947727|FG000|COMPLETED|Overall Study||4
3216583|NCT02243579|3947727|FG000|NOT COMPLETED|Overall Study||20
3216584|NCT02243605|3947733|FG000|STARTED|Stage 1 - Interim Analysis Population||23
3216585|NCT02243605|3947734|FG001|STARTED|Stage 1 - Interim Analysis Population||22
3216586|NCT02243605|3947733|FG000|COMPLETED|Stage 1 - Interim Analysis Population||21
3216587|NCT02243605|3947734|FG001|COMPLETED|Stage 1 - Interim Analysis Population||21
3216588|NCT02243605|3947733|FG000|NOT COMPLETED|Stage 1 - Interim Analysis Population||2
3216589|NCT02243605|3947734|FG001|NOT COMPLETED|Stage 1 - Interim Analysis Population||1
3216590|NCT02243605|3947733|FG000|STARTED|Stage 2 - Final Analysis Population||45
3216591|NCT02243605|3947734|FG001|STARTED|Stage 2 - Final Analysis Population||45
3216592|NCT02243605|3947733|FG000|COMPLETED|Stage 2 - Final Analysis Population||39
3216593|NCT02243605|3947734|FG001|COMPLETED|Stage 2 - Final Analysis Population||42
3216594|NCT02243605|3947733|FG000|NOT COMPLETED|Stage 2 - Final Analysis Population||6
3216595|NCT02243605|3947734|FG001|NOT COMPLETED|Stage 2 - Final Analysis Population||3
3216596|NCT02243696|3947740|FG000|STARTED|Overall Study||1694
3216597|NCT02243696|3947740|FG000|COMPLETED|Overall Study||0
3216598|NCT02243696|3947740|FG000|NOT COMPLETED|Overall Study||1694
3216599|NCT02243865|3947746|FG000|STARTED|Overall Study||44
3216600|NCT02243865|3947747|FG001|STARTED|Overall Study||43
3216601|NCT02243865|3947746|FG000|COMPLETED|Overall Study||40
3216602|NCT02243865|3947747|FG001|COMPLETED|Overall Study||38
3216603|NCT02243865|3947746|FG000|NOT COMPLETED|Overall Study||4
3216604|NCT02243865|3947747|FG001|NOT COMPLETED|Overall Study||5
3216605|NCT02243943|3947757|FG000|STARTED|Overall Study||50
3216606|NCT02243943|3947758|FG001|STARTED|Overall Study||50
3216607|NCT02243943|3947757|FG000|COMPLETED|Overall Study||50
3216608|NCT02243943|3947758|FG001|COMPLETED|Overall Study||50
3216609|NCT02243943|3947757|FG000|NOT COMPLETED|Overall Study||0
3216610|NCT02243943|3947758|FG001|NOT COMPLETED|Overall Study||0
3216611|NCT02244424|3947766|FG000|STARTED|Overall Study|Teens were the participants who received the intervention. Data were collected on the infants.|102
3216612|NCT02244424|3947767|FG001|STARTED|Overall Study|Teen participants received the MIHP standard care. Data were collected on infants.|62
3216613|NCT02244424|3947766|FG000|Infants|Overall Study|Infants of participants included in the study for collection of demographic and weight data.|51
3216614|NCT02244424|3947767|FG001|Infants|Overall Study|Infants of participants included in the study for collection of demographic and weight data.|31
3216615|NCT02244424|3947766|FG000|Mothers|Overall Study||51
3216616|NCT02244424|3947767|FG001|Mothers|Overall Study||31
3216617|NCT02244424|3947766|FG000|COMPLETED|Overall Study|Data were collected on all of the infants of the teen moms (n = 41).|82
3216618|NCT02244424|3947767|FG001|COMPLETED|Overall Study|Data were collected on all of the infants of teen moms (n = 26).|52
3216619|NCT02244424|3947766|FG000|NOT COMPLETED|Overall Study||20
3216620|NCT02244424|3947767|FG001|NOT COMPLETED|Overall Study||10
3216621|NCT02244580|3947773|FG000|STARTED|Overall Study||1010
3216622|NCT02244580|3947773|FG000|COMPLETED|Overall Study|An RT-qPCR assay was performed from breast cancer tissues of 769 out of the 1010 patients.|769
3216623|NCT02244580|3947773|FG000|NOT COMPLETED|Overall Study||241
3216624|NCT02244619|3947783|FG000|STARTED|Overall Study||249
3216625|NCT02244619|3947784|FG001|STARTED|Overall Study||266
3216626|NCT02244619|3947783|FG000|COMPLETED|Overall Study||241
3216627|NCT02244619|3947784|FG001|COMPLETED|Overall Study||245
3216628|NCT02244619|3947783|FG000|NOT COMPLETED|Overall Study||8
3216629|NCT02244619|3947784|FG001|NOT COMPLETED|Overall Study||21
3367176|NCT03882801|4098583|FG000|Treated|Period 1|1 participant did not receive any dose of study drug|11
3367177|NCT03882801|4098584|FG001|Treated|Period 1||12
3367178|NCT03882801|4098583|FG000|COMPLETED|Period 1||10
3367179|NCT03882801|4098584|FG001|COMPLETED|Period 1||10
3367180|NCT03882801|4098583|FG000|NOT COMPLETED|Period 1||2
3367181|NCT03882801|4098584|FG001|NOT COMPLETED|Period 1||2
3367182|NCT03882801|4098583|FG000|STARTED|Washout Period||10
3367183|NCT03882801|4098584|FG001|STARTED|Washout Period||10
3367184|NCT03882801|4098583|FG000|COMPLETED|Washout Period||10
3367185|NCT03882801|4098584|FG001|COMPLETED|Washout Period||9
3367186|NCT03882801|4098583|FG000|NOT COMPLETED|Washout Period||0
3367187|NCT03882801|4098584|FG001|NOT COMPLETED|Washout Period||1
3367188|NCT03882801|4098583|FG000|STARTED|Period 2||10
3367189|NCT03882801|4098584|FG001|STARTED|Period 2||9
3367190|NCT03882801|4098583|FG000|COMPLETED|Period 2||10
3367191|NCT03882801|4098584|FG001|COMPLETED|Period 2||8
3367192|NCT03882801|4098583|FG000|NOT COMPLETED|Period 2||0
3367193|NCT03882801|4098584|FG001|NOT COMPLETED|Period 2||1
3367194|NCT03882424|4098595|FG000|STARTED|Overall Study||38
3367195|NCT03882424|4098596|FG001|STARTED|Overall Study||38
3367196|NCT03882424|4098597|FG002|STARTED|Overall Study||38
3367197|NCT03882424|4098595|FG000|COMPLETED|Overall Study||34
3367198|NCT03882424|4098596|FG001|COMPLETED|Overall Study||38
3367199|NCT03882424|4098597|FG002|COMPLETED|Overall Study||38
3367200|NCT03882424|4098595|FG000|NOT COMPLETED|Overall Study||4
3367201|NCT03882424|4098596|FG001|NOT COMPLETED|Overall Study||0
3367202|NCT03882424|4098597|FG002|NOT COMPLETED|Overall Study||0
3367203|NCT03881163|4098605|FG000|STARTED|Overall Study||24
3367204|NCT03881163|4098605|FG000|COMPLETED|Overall Study||24
3367205|NCT03881163|4098605|FG000|NOT COMPLETED|Overall Study||0
3367206|NCT03881670|4098613|FG000|STARTED|Overall Study||12
3367207|NCT03881670|4098614|FG001|STARTED|Overall Study||12
3216630|NCT02244840|3947790|FG000|STARTED|Overall Study||40
3216631|NCT02244840|3947790|FG000|COMPLETED|Overall Study||40
3216632|NCT02244840|3947790|FG000|NOT COMPLETED|Overall Study||0
3216633|NCT02244918|3947796|FG000|STARTED|Overall Study||185
3216634|NCT02244918|3947797|FG001|STARTED|Overall Study||93
3216635|NCT02244918|3947796|FG000|Week 12|Overall Study||160
3216636|NCT02244918|3947797|FG001|Week 12|Overall Study||83
3216637|NCT02244918|3947796|FG000|COMPLETED|Overall Study||185
3216638|NCT02244918|3947797|FG001|COMPLETED|Overall Study||93
3216639|NCT02244918|3947796|FG000|NOT COMPLETED|Overall Study||0
3216640|NCT02244918|3947797|FG001|NOT COMPLETED|Overall Study||0
3216641|NCT02244957|3947806|FG000|STARTED|Overall Study||7
3216642|NCT02244957|3947807|FG001|STARTED|Overall Study||16
3216643|NCT02244957|3947806|FG000|COMPLETED|Overall Study||6
3216644|NCT02244957|3947807|FG001|COMPLETED|Overall Study||16
3216645|NCT02244957|3947806|FG000|NOT COMPLETED|Overall Study||1
3216646|NCT02244957|3947807|FG001|NOT COMPLETED|Overall Study||0
3216647|NCT02244996|3947817|FG000|STARTED|Overall Study||25
3216648|NCT02244996|3947818|FG001|STARTED|Overall Study||25
3216649|NCT02244996|3947817|FG000|COMPLETED|Overall Study||23
3216650|NCT02244996|3947818|FG001|COMPLETED|Overall Study||19
3216651|NCT02244996|3947817|FG000|NOT COMPLETED|Overall Study||2
3216652|NCT02244996|3947818|FG001|NOT COMPLETED|Overall Study||6
3216653|NCT02245217|3947824|FG000|STARTED|Overall Study||9
3216654|NCT02245217|3947824|FG000|COMPLETED|Overall Study||7
3216655|NCT02245217|3947824|FG000|NOT COMPLETED|Overall Study||2
3216656|NCT02245360|3947830|FG000|STARTED|Overall Study||53
3216657|NCT02245360|3947831|FG001|STARTED|Overall Study||54
3216658|NCT02245360|3947830|FG000|COMPLETED|Overall Study||48
3216659|NCT02245360|3947831|FG001|COMPLETED|Overall Study||52
3216660|NCT02245360|3947830|FG000|NOT COMPLETED|Overall Study||5
3216661|NCT02245360|3947831|FG001|NOT COMPLETED|Overall Study||2
3216662|NCT02245412|3947840|FG000|STARTED|Treatment Period||17
3216663|NCT02245412|3947841|FG001|STARTED|Treatment Period||6
3216664|NCT02245412|3947842|FG002|STARTED|Treatment Period||2
3216665|NCT02245412|3947840|FG000|Received at Least 1 Dose of Study Drug|Treatment Period||17
3216666|NCT02245412|3947841|FG001|Received at Least 1 Dose of Study Drug|Treatment Period||6
3216667|NCT02245412|3947842|FG002|Received at Least 1 Dose of Study Drug|Treatment Period||2
3216668|NCT02245412|3947840|FG000|Modified Full Analysis Set (mFAS)|Treatment Period||16
3216669|NCT02245412|3947841|FG001|Modified Full Analysis Set (mFAS)|Treatment Period||6
3216670|NCT02245412|3947842|FG002|Modified Full Analysis Set (mFAS)|Treatment Period||2
3216671|NCT02245412|3947840|FG000|COMPLETED|Treatment Period||12
3216672|NCT02245412|3947841|FG001|COMPLETED|Treatment Period||3
3216673|NCT02245412|3947842|FG002|COMPLETED|Treatment Period||2
3216674|NCT02245412|3947840|FG000|NOT COMPLETED|Treatment Period||5
3216675|NCT02245412|3947841|FG001|NOT COMPLETED|Treatment Period||3
3216676|NCT02245412|3947842|FG002|NOT COMPLETED|Treatment Period||0
3216677|NCT02245412|3947840|FG000|STARTED|Follow-Up Period|One participant who discontinued Study Drug in Treatment Period continued to Follow-Up Period.|13
3216678|NCT02245412|3947841|FG001|STARTED|Follow-Up Period|One participant who discontinued Study Drug in Treatment Period continued to Follow-Up Period.|4
3216679|NCT02245412|3947842|FG002|STARTED|Follow-Up Period||2
3216680|NCT02245412|3947840|FG000|COMPLETED|Follow-Up Period||8
3216681|NCT02245412|3947841|FG001|COMPLETED|Follow-Up Period||2
3216682|NCT02245412|3947842|FG002|COMPLETED|Follow-Up Period||0
3216683|NCT02245412|3947840|FG000|NOT COMPLETED|Follow-Up Period||5
3216684|NCT02245412|3947841|FG001|NOT COMPLETED|Follow-Up Period||2
3216685|NCT02245412|3947842|FG002|NOT COMPLETED|Follow-Up Period||2
3216686|NCT02245516|3947852|FG000|STARTED|Overall Study||9
3216687|NCT02245516|3947853|FG001|STARTED|Overall Study||7
3216688|NCT02245516|3947852|FG000|COMPLETED|Overall Study||9
3216689|NCT02245516|3947853|FG001|COMPLETED|Overall Study||4
3216690|NCT02245516|3947852|FG000|NOT COMPLETED|Overall Study||0
3216691|NCT02245516|3947853|FG001|NOT COMPLETED|Overall Study||3
3216692|NCT02245568|3947859|FG000|STARTED|Overall Study||913
3216693|NCT02245568|3947859|FG000|COMPLETED|Overall Study||60
3216694|NCT02245568|3947859|FG000|NOT COMPLETED|Overall Study||853
3216695|NCT02245620|3947865|FG000|STARTED|Overall Study||20
3216696|NCT02245620|3947866|FG001|STARTED|Overall Study||21
3216697|NCT02245620|3947865|FG000|COMPLETED|Overall Study||19
3216698|NCT02245620|3947866|FG001|COMPLETED|Overall Study||20
3216699|NCT02245620|3947865|FG000|NOT COMPLETED|Overall Study||1
3216700|NCT02245620|3947866|FG001|NOT COMPLETED|Overall Study||1
3216701|NCT02245737|3947875|FG000|STARTED|Overall Study||740
3216702|NCT02245737|3947876|FG001|STARTED|Overall Study||739
3216703|NCT02245737|3947877|FG002|STARTED|Overall Study||739
3216704|NCT02245737|3947875|FG000|Received at Least 1 Dose of Study Drug|Overall Study||738
3216705|NCT02245737|3947876|FG001|Received at Least 1 Dose of Study Drug|Overall Study||736
3216706|NCT02245737|3947877|FG002|Received at Least 1 Dose of Study Drug|Overall Study||735
3216707|NCT02245737|3947875|FG000|COMPLETED|Overall Study||187
3216708|NCT02245737|3947876|FG001|COMPLETED|Overall Study||184
3216709|NCT02245737|3947877|FG002|COMPLETED|Overall Study||168
3216710|NCT02245737|3947875|FG000|NOT COMPLETED|Overall Study||553
3216711|NCT02245737|3947876|FG001|NOT COMPLETED|Overall Study||555
3216712|NCT02245737|3947877|FG002|NOT COMPLETED|Overall Study||571
3216713|NCT02245815|3947889|FG000|STARTED|Overall Study||45
3216714|NCT02245815|3947890|FG001|STARTED|Overall Study||45
3216715|NCT02245815|3947889|FG000|COMPLETED|Overall Study||45
3216716|NCT02245815|3947890|FG001|COMPLETED|Overall Study||45
3216717|NCT02245815|3947889|FG000|NOT COMPLETED|Overall Study||0
3216718|NCT02245815|3947890|FG001|NOT COMPLETED|Overall Study||0
3216719|NCT02246010|3947900|FG000|STARTED|Overall Study||4
3216720|NCT02246010|3947901|FG001|STARTED|Overall Study||2
3216721|NCT02246010|3947900|FG000|COMPLETED|Overall Study||4
3216722|NCT02246010|3947901|FG001|COMPLETED|Overall Study||2
3216723|NCT02246010|3947900|FG000|NOT COMPLETED|Overall Study||0
3216724|NCT02246010|3947901|FG001|NOT COMPLETED|Overall Study||0
3216725|NCT02246062|3947911|FG000|STARTED|Overall Study||21
3216726|NCT02246062|3947912|FG001|STARTED|Overall Study||21
3216727|NCT02246062|3947913|FG002|STARTED|Overall Study||21
3216728|NCT02246062|3947914|FG003|STARTED|Overall Study||21
3216729|NCT02246062|3947911|FG000|COMPLETED|Overall Study||21
3216730|NCT02246062|3947912|FG001|COMPLETED|Overall Study||21
3216731|NCT02246062|3947913|FG002|COMPLETED|Overall Study||21
3216732|NCT02246062|3947914|FG003|COMPLETED|Overall Study||21
3216733|NCT02246062|3947911|FG000|NOT COMPLETED|Overall Study||0
3216734|NCT02246062|3947912|FG001|NOT COMPLETED|Overall Study||0
3216735|NCT02246062|3947913|FG002|NOT COMPLETED|Overall Study||0
3216736|NCT02246062|3947914|FG003|NOT COMPLETED|Overall Study||0
3216737|NCT02246166|3947926|FG000|STARTED|Overall Study||26
3216738|NCT02246166|3947927|FG001|STARTED|Overall Study||27
3216739|NCT02246166|3947926|FG000|COMPLETED|Overall Study||25
3216740|NCT02246166|3947927|FG001|COMPLETED|Overall Study||27
3216741|NCT02246166|3947926|FG000|NOT COMPLETED|Overall Study||1
3216742|NCT02246166|3947927|FG001|NOT COMPLETED|Overall Study||0
3216743|NCT02246218|3947935|FG000|STARTED|Overall Study||10
3216744|NCT02246218|3947936|FG001|STARTED|Overall Study||16
3216745|NCT02246218|3947935|FG000|COMPLETED|Overall Study||6
3216746|NCT02246218|3947936|FG001|COMPLETED|Overall Study||10
3216747|NCT02246218|3947935|FG000|NOT COMPLETED|Overall Study||4
3216748|NCT02246218|3947936|FG001|NOT COMPLETED|Overall Study||6
3216749|NCT02246309|3947944|FG000|STARTED|Overall Study|16 patients going through Time Lapse System and 15 through Standard Embryo Culture.|16
3216750|NCT02246309|3947945|FG001|STARTED|Overall Study||15
3216751|NCT02246309|3947944|FG000|COMPLETED|Overall Study||16
3216752|NCT02246309|3947945|FG001|COMPLETED|Overall Study||15
3216753|NCT02246309|3947944|FG000|NOT COMPLETED|Overall Study||0
3216754|NCT02246309|3947945|FG001|NOT COMPLETED|Overall Study||0
3216755|NCT02246413|3947953|FG000|STARTED|12-months (Primary Outcome)||204
3216756|NCT02246413|3947954|FG001|STARTED|12-months (Primary Outcome)||205
3216757|NCT02246413|3947953|FG000|COMPLETED|12-months (Primary Outcome)||169
3216758|NCT02246413|3947954|FG001|COMPLETED|12-months (Primary Outcome)||175
3216759|NCT02246413|3947953|FG000|NOT COMPLETED|12-months (Primary Outcome)||35
3216760|NCT02246413|3947954|FG001|NOT COMPLETED|12-months (Primary Outcome)||30
3216761|NCT02246413|3947953|FG000|STARTED|24-months (Secondary Outcome)||204
3216762|NCT02246413|3947954|FG001|STARTED|24-months (Secondary Outcome)||205
3216763|NCT02246413|3947953|FG000|COMPLETED|24-months (Secondary Outcome)||153
3216764|NCT02246413|3947954|FG001|COMPLETED|24-months (Secondary Outcome)||173
3216765|NCT02246413|3947953|FG000|NOT COMPLETED|24-months (Secondary Outcome)||51
3216766|NCT02246413|3947954|FG001|NOT COMPLETED|24-months (Secondary Outcome)||32
3216767|NCT02246439|3947962|FG000|STARTED|Overall Study|6 participants that enrolled in the study did not receive allocated intervention.|192
3216768|NCT02246439|3947963|FG001|STARTED|Overall Study|3 participants that enrolled in the study did not receive allocated intervention.|129
3216769|NCT02246439|3947962|FG000|Randomized|Overall Study||198
3216770|NCT02246439|3947963|FG001|Randomized|Overall Study||132
3216771|NCT02246439|3947962|FG000|COMPLETED|Overall Study||180
3216772|NCT02246439|3947963|FG001|COMPLETED|Overall Study||118
3216773|NCT02246439|3947962|FG000|NOT COMPLETED|Overall Study||12
3216774|NCT02246439|3947963|FG001|NOT COMPLETED|Overall Study||11
3216775|NCT02246478|3947973|FG000|STARTED|Single-dose Phase||6
3216776|NCT02246478|3947974|FG001|STARTED|Single-dose Phase||5
3216777|NCT02246478|3947975|FG002|STARTED|Single-dose Phase||5
3216778|NCT02246478|3947976|FG003|STARTED|Single-dose Phase||5
3216779|NCT02246478|3947973|FG000|COMPLETED|Single-dose Phase||6
3216780|NCT02246478|3947974|FG001|COMPLETED|Single-dose Phase||5
3216781|NCT02246478|3947975|FG002|COMPLETED|Single-dose Phase||5
3216782|NCT02246478|3947976|FG003|COMPLETED|Single-dose Phase||5
3216783|NCT02246478|3947973|FG000|NOT COMPLETED|Single-dose Phase||0
3216784|NCT02246478|3947974|FG001|NOT COMPLETED|Single-dose Phase||0
3216785|NCT02246478|3947975|FG002|NOT COMPLETED|Single-dose Phase||0
3216786|NCT02246478|3947976|FG003|NOT COMPLETED|Single-dose Phase||0
3216787|NCT02246478|3947973|FG000|STARTED|Multiple-dose Phase||6
3216788|NCT02246478|3947974|FG001|STARTED|Multiple-dose Phase||5
3216789|NCT02246478|3947975|FG002|STARTED|Multiple-dose Phase||5
3216790|NCT02246478|3947976|FG003|STARTED|Multiple-dose Phase||5
3216791|NCT02246478|3947973|FG000|COMPLETED|Multiple-dose Phase||5
3216792|NCT02246478|3947974|FG001|COMPLETED|Multiple-dose Phase||5
3216793|NCT02246478|3947975|FG002|COMPLETED|Multiple-dose Phase||5
3216794|NCT02246478|3947976|FG003|COMPLETED|Multiple-dose Phase||4
3216795|NCT02246478|3947973|FG000|NOT COMPLETED|Multiple-dose Phase||1
3216796|NCT02246478|3947974|FG001|NOT COMPLETED|Multiple-dose Phase||0
3216797|NCT02246478|3947975|FG002|NOT COMPLETED|Multiple-dose Phase||0
3216798|NCT02246478|3947976|FG003|NOT COMPLETED|Multiple-dose Phase||1
3367208|NCT03881670|4098613|FG000|Completed First Intervention|Overall Study||12
3216799|NCT02246582|3947993|FG000|STARTED|Overall Study||44
3216800|NCT02246582|3947994|FG001|STARTED|Overall Study||45
3216801|NCT02246582|3947993|FG000|COMPLETED|Overall Study||41
3216802|NCT02246582|3947994|FG001|COMPLETED|Overall Study||41
3216803|NCT02246582|3947993|FG000|NOT COMPLETED|Overall Study||3
3216804|NCT02246582|3947994|FG001|NOT COMPLETED|Overall Study||4
3216805|NCT02246608|3948000|FG000|STARTED|Overall Study||22
3216806|NCT02246608|3948001|FG001|STARTED|Overall Study||21
3216807|NCT02246608|3948000|FG000|COMPLETED|Overall Study||10
3216808|NCT02246608|3948001|FG001|COMPLETED|Overall Study||11
3216809|NCT02246608|3948000|FG000|NOT COMPLETED|Overall Study||12
3216810|NCT02246608|3948001|FG001|NOT COMPLETED|Overall Study||10
3216811|NCT02246647|3948009|FG000|STARTED|Overall Study||19
3216812|NCT02246647|3948010|FG001|STARTED|Overall Study||20
3216813|NCT02246647|3948009|FG000|COMPLETED|Overall Study||18
3216814|NCT02246647|3948010|FG001|COMPLETED|Overall Study||19
3216815|NCT02246647|3948009|FG000|NOT COMPLETED|Overall Study||1
3216816|NCT02246647|3948010|FG001|NOT COMPLETED|Overall Study||1
3216817|NCT02246660|3948033|FG000|STARTED|Overall Study||23
3216818|NCT02246660|3948034|FG001|STARTED|Overall Study||21
3216819|NCT02246660|3948035|FG002|STARTED|Overall Study||22
3216820|NCT02246660|3948033|FG000|COMPLETED|Overall Study||23
3216821|NCT02246660|3948034|FG001|COMPLETED|Overall Study||20
3216822|NCT02246660|3948035|FG002|COMPLETED|Overall Study||21
3216823|NCT02246660|3948033|FG000|NOT COMPLETED|Overall Study||0
3216824|NCT02246660|3948034|FG001|NOT COMPLETED|Overall Study||1
3216825|NCT02246660|3948035|FG002|NOT COMPLETED|Overall Study||1
3216826|NCT02246673|3948048|FG000|STARTED|Overall Study||14
3216827|NCT02246673|3948049|FG001|STARTED|Overall Study||12
3216828|NCT02246673|3948050|FG002|STARTED|Overall Study||12
3216829|NCT02246673|3948051|FG003|STARTED|Overall Study||14
3216830|NCT02246673|3948052|FG004|STARTED|Overall Study||12
3216831|NCT02246673|3948048|FG000|COMPLETED|Overall Study||13
3216832|NCT02246673|3948049|FG001|COMPLETED|Overall Study||12
3216833|NCT02246673|3948050|FG002|COMPLETED|Overall Study||12
3216834|NCT02246673|3948051|FG003|COMPLETED|Overall Study||12
3216835|NCT02246673|3948052|FG004|COMPLETED|Overall Study||11
3216836|NCT02246673|3948048|FG000|NOT COMPLETED|Overall Study||1
3216837|NCT02246673|3948049|FG001|NOT COMPLETED|Overall Study||0
3216838|NCT02246673|3948050|FG002|NOT COMPLETED|Overall Study||0
3216839|NCT02246673|3948051|FG003|NOT COMPLETED|Overall Study||2
3216840|NCT02246673|3948052|FG004|NOT COMPLETED|Overall Study||1
3216841|NCT02246764|3948097|FG000|STARTED|Overall Study||34
3216842|NCT02246764|3948098|FG001|STARTED|Overall Study||36
3216843|NCT02246764|3948099|FG002|STARTED|Overall Study||23
3216844|NCT02246764|3948097|FG000|COMPLETED|Overall Study||16
3216845|NCT02246764|3948098|FG001|COMPLETED|Overall Study||4
3216846|NCT02246764|3948099|FG002|COMPLETED|Overall Study||19
3216847|NCT02246764|3948097|FG000|NOT COMPLETED|Overall Study||18
3216848|NCT02246764|3948098|FG001|NOT COMPLETED|Overall Study||32
3216849|NCT02246764|3948099|FG002|NOT COMPLETED|Overall Study||4
3216850|NCT02246777|3948107|FG000|STARTED|Overall Study||32
3216851|NCT02246777|3948107|FG000|COMPLETED|Overall Study||29
3216852|NCT02246777|3948107|FG000|NOT COMPLETED|Overall Study||3
3216853|NCT02246998|3948120|FG000|STARTED|Overall Study||18
3216854|NCT02246998|3948121|FG001|STARTED|Overall Study||18
3216855|NCT02246998|3948122|FG002|STARTED|Overall Study||18
3216856|NCT02246998|3948123|FG003|STARTED|Overall Study||18
3216857|NCT02246998|3948120|FG000|COMPLETED|Overall Study||16
3216858|NCT02246998|3948121|FG001|COMPLETED|Overall Study||15
3216859|NCT02246998|3948122|FG002|COMPLETED|Overall Study||15
3216860|NCT02246998|3948123|FG003|COMPLETED|Overall Study||16
3216861|NCT02246998|3948120|FG000|NOT COMPLETED|Overall Study||2
3216862|NCT02246998|3948121|FG001|NOT COMPLETED|Overall Study||3
3216863|NCT02246998|3948122|FG002|NOT COMPLETED|Overall Study||3
3216864|NCT02246998|3948123|FG003|NOT COMPLETED|Overall Study||2
3216865|NCT02247011|3948138|FG000|STARTED|Overall Study||1100
3216866|NCT02247011|3948138|FG000|COMPLETED|Overall Study||975
3216867|NCT02247011|3948138|FG000|NOT COMPLETED|Overall Study||125
3216868|NCT02247063|3948147|FG000|STARTED|Overall Study||12
3216869|NCT02247063|3948148|FG001|STARTED|Overall Study||12
3216870|NCT02247063|3948147|FG000|COMPLETED|Overall Study||12
3216871|NCT02247063|3948148|FG001|COMPLETED|Overall Study||12
3216872|NCT02247063|3948147|FG000|NOT COMPLETED|Overall Study||0
3216873|NCT02247063|3948148|FG001|NOT COMPLETED|Overall Study||0
3216874|NCT02247193|3948156|FG000|STARTED|Overall Study||15
3216875|NCT02247193|3948157|FG001|STARTED|Overall Study||15
3216876|NCT02247193|3948156|FG000|Number Who Underwent Cleft Lip Repair Surgery|Overall Study||15
3216877|NCT02247193|3948157|FG001|Number Who Underwent Cleft Lip Repair Surgery|Overall Study||15
3216878|NCT02247193|3948156|FG000|Number Who Received Botox or Placebo|Overall Study||15
3216879|NCT02247193|3948157|FG001|Number Who Received Botox or Placebo|Overall Study||15
3216880|NCT02247193|3948156|FG000|Number Who Completed the 6-month Follow up|Overall Study||15
3216881|NCT02247193|3948157|FG001|Number Who Completed the 6-month Follow up|Overall Study||15
3216882|NCT02247193|3948156|FG000|Number Who Completed the 12-month Follow up|Overall Study||15
3216883|NCT02247193|3948157|FG001|Number Who Completed the 12-month Follow up|Overall Study||15
3216884|NCT02247193|3948156|FG000|COMPLETED|Overall Study||15
3216885|NCT02247193|3948157|FG001|COMPLETED|Overall Study||15
3216886|NCT02247193|3948156|FG000|NOT COMPLETED|Overall Study||0
3216887|NCT02247193|3948157|FG001|NOT COMPLETED|Overall Study||0
3216888|NCT02247245|3948167|FG000|STARTED|Overall Study||13
3216889|NCT02247245|3948168|FG001|STARTED|Overall Study||13
3216890|NCT02247245|3948169|FG002|STARTED|Overall Study||7
3216891|NCT02247245|3948170|FG003|STARTED|Overall Study||7
3216892|NCT02247245|3948167|FG000|COMPLETED|Overall Study||13
3216893|NCT02247245|3948168|FG001|COMPLETED|Overall Study||13
3216894|NCT02247245|3948169|FG002|COMPLETED|Overall Study||7
3216895|NCT02247245|3948170|FG003|COMPLETED|Overall Study||7
3216896|NCT02247245|3948167|FG000|NOT COMPLETED|Overall Study||0
3216897|NCT02247245|3948168|FG001|NOT COMPLETED|Overall Study||0
3216898|NCT02247245|3948169|FG002|NOT COMPLETED|Overall Study||0
3216899|NCT02247245|3948170|FG003|NOT COMPLETED|Overall Study||0
3216900|NCT02247336|3948182|FG000|STARTED|Overall Study||252
3216901|NCT02247336|3948183|FG001|STARTED|Overall Study||253
3216902|NCT02247336|3948182|FG000|COMPLETED|Overall Study||252
3216903|NCT02247336|3948183|FG001|COMPLETED|Overall Study||253
3216904|NCT02247336|3948182|FG000|NOT COMPLETED|Overall Study||0
3216905|NCT02247336|3948183|FG001|NOT COMPLETED|Overall Study||0
3216906|NCT02247401|3948192|FG000|STARTED|Overall Study||100
3216907|NCT02247401|3948193|FG001|STARTED|Overall Study||31
3216908|NCT02247401|3948194|FG002|STARTED|Overall Study||29
3216909|NCT02247401|3948192|FG000|COMPLETED|Overall Study||94
3216910|NCT02247401|3948193|FG001|COMPLETED|Overall Study||29
3216911|NCT02247401|3948194|FG002|COMPLETED|Overall Study||27
3216912|NCT02247401|3948192|FG000|NOT COMPLETED|Overall Study||6
3216913|NCT02247401|3948193|FG001|NOT COMPLETED|Overall Study||2
3216914|NCT02247401|3948194|FG002|NOT COMPLETED|Overall Study||2
3216915|NCT02247440|3948203|FG000|STARTED|Overall Study||18
3216916|NCT02247440|3948203|FG000|COMPLETED|Overall Study||14
3216917|NCT02247440|3948203|FG000|NOT COMPLETED|Overall Study||4
3216918|NCT02247466|3948209|FG000|STARTED|Overall Study||19
3216919|NCT02247466|3948210|FG001|STARTED|Overall Study||18
3216920|NCT02247466|3948209|FG000|COMPLETED|Overall Study||19
3216921|NCT02247466|3948210|FG001|COMPLETED|Overall Study||15
3216922|NCT02247466|3948209|FG000|NOT COMPLETED|Overall Study||0
3216923|NCT02247466|3948210|FG001|NOT COMPLETED|Overall Study||3
3216924|NCT02247479|3948219|FG000|STARTED|Overall Study||305
3216925|NCT02247479|3948220|FG001|STARTED|Overall Study||298
3216926|NCT02247479|3948221|FG002|STARTED|Overall Study||303
3216927|NCT02247479|3948219|FG000|COMPLETED|Overall Study||163
3216928|NCT02247479|3948220|FG001|COMPLETED|Overall Study||160
3216929|NCT02247479|3948221|FG002|COMPLETED|Overall Study||165
3216930|NCT02247479|3948219|FG000|NOT COMPLETED|Overall Study||142
3216931|NCT02247479|3948220|FG001|NOT COMPLETED|Overall Study||138
3216932|NCT02247479|3948221|FG002|NOT COMPLETED|Overall Study||138
3216933|NCT02247531|3948232|FG000|STARTED|Overall Study||321
3216934|NCT02247531|3948233|FG001|STARTED|Overall Study||330
3216935|NCT02247531|3948234|FG002|STARTED|Overall Study||324
3216936|NCT02247531|3948232|FG000|COMPLETED|Overall Study||215
3216937|NCT02247531|3948233|FG001|COMPLETED|Overall Study||205
3216938|NCT02247531|3948234|FG002|COMPLETED|Overall Study||214
3216939|NCT02247531|3948232|FG000|NOT COMPLETED|Overall Study||106
3216940|NCT02247531|3948233|FG001|NOT COMPLETED|Overall Study||125
3216941|NCT02247531|3948234|FG002|NOT COMPLETED|Overall Study||110
3216942|NCT02247739|3948242|FG000|STARTED|Overall Study||5
3216943|NCT02247739|3948243|FG001|STARTED|Overall Study||6
3216944|NCT02247739|3948244|FG002|STARTED|Overall Study||5
3216945|NCT02247739|3948245|FG003|STARTED|Overall Study||5
3216946|NCT02247739|3948246|FG004|STARTED|Overall Study||6
3216947|NCT02247739|3948247|FG005|STARTED|Overall Study||5
3216948|NCT02247739|3948242|FG000|COMPLETED|Overall Study||5
3216949|NCT02247739|3948243|FG001|COMPLETED|Overall Study||3
3216950|NCT02247739|3948244|FG002|COMPLETED|Overall Study||4
3367209|NCT03881670|4098614|FG001|Completed First Intervention|Overall Study||12
3367210|NCT03881670|4098613|FG000|Completed Second Intervetion|Overall Study||12
3367211|NCT03881670|4098614|FG001|Completed Second Intervetion|Overall Study||12
3367212|NCT03881670|4098613|FG000|COMPLETED|Overall Study||12
3367213|NCT03881670|4098614|FG001|COMPLETED|Overall Study||12
3367214|NCT03881670|4098613|FG000|NOT COMPLETED|Overall Study||0
3367215|NCT03881670|4098614|FG001|NOT COMPLETED|Overall Study||0
3367216|NCT03880266|4098630|FG000|STARTED|Overall Study||12
3367217|NCT03880266|4098631|FG001|STARTED|Overall Study||6
3367218|NCT03880266|4098632|FG002|STARTED|Overall Study||12
3367219|NCT03880266|4098633|FG003|STARTED|Overall Study||4
3367220|NCT03880266|4098634|FG004|STARTED|Overall Study||12
3367221|NCT03880266|4098635|FG005|STARTED|Overall Study||6
3367222|NCT03880266|4098636|FG006|STARTED|Overall Study||13
3367223|NCT03880266|4098637|FG007|STARTED|Overall Study||7
3367224|NCT03880266|4098630|FG000|COMPLETED|Overall Study||12
3367225|NCT03880266|4098631|FG001|COMPLETED|Overall Study||5
3367226|NCT03880266|4098632|FG002|COMPLETED|Overall Study||11
3367227|NCT03880266|4098633|FG003|COMPLETED|Overall Study||4
3367228|NCT03880266|4098634|FG004|COMPLETED|Overall Study||12
3367229|NCT03880266|4098635|FG005|COMPLETED|Overall Study||6
3367230|NCT03880266|4098636|FG006|COMPLETED|Overall Study||13
3367231|NCT03880266|4098637|FG007|COMPLETED|Overall Study||7
3367232|NCT03880266|4098630|FG000|NOT COMPLETED|Overall Study||0
3367233|NCT03880266|4098631|FG001|NOT COMPLETED|Overall Study||1
3367234|NCT03880266|4098632|FG002|NOT COMPLETED|Overall Study||1
3216951|NCT02247739|3948245|FG003|COMPLETED|Overall Study||5
3216952|NCT02247739|3948246|FG004|COMPLETED|Overall Study||5
3216953|NCT02247739|3948247|FG005|COMPLETED|Overall Study||4
3216954|NCT02247739|3948242|FG000|NOT COMPLETED|Overall Study||0
3216955|NCT02247739|3948243|FG001|NOT COMPLETED|Overall Study||3
3216956|NCT02247739|3948244|FG002|NOT COMPLETED|Overall Study||1
3216957|NCT02247739|3948245|FG003|NOT COMPLETED|Overall Study||0
3216958|NCT02247739|3948246|FG004|NOT COMPLETED|Overall Study||1
3216959|NCT02247739|3948247|FG005|NOT COMPLETED|Overall Study||1
3367235|NCT03880266|4098633|FG003|NOT COMPLETED|Overall Study||0
3367236|NCT03880266|4098634|FG004|NOT COMPLETED|Overall Study||0
3216960|NCT02247765|3948257|FG000|STARTED|Overall Study||18
3216961|NCT02247765|3948257|FG000|COMPLETED|Overall Study||18
3216962|NCT02247765|3948257|FG000|NOT COMPLETED|Overall Study||0
3216963|NCT02247804|3948264|FG000|STARTED|Treatment Period 1||198
3216964|NCT02247804|3948265|FG001|STARTED|Treatment Period 1||198
3216965|NCT02247804|3948266|FG002|STARTED|Treatment Period 1||198
3216966|NCT02247804|3948264|FG000|Received (Sham or Bimatoprost SR)|Treatment Period 1||193
3216967|NCT02247804|3948265|FG001|Received (Sham or Bimatoprost SR)|Treatment Period 1||197
3216968|NCT02247804|3948266|FG002|Received (Sham or Bimatoprost SR)|Treatment Period 1||197
3216969|NCT02247804|3948264|FG000|COMPLETED|Treatment Period 1||176
3216970|NCT02247804|3948265|FG001|COMPLETED|Treatment Period 1||194
3216971|NCT02247804|3948266|FG002|COMPLETED|Treatment Period 1||190
3216972|NCT02247804|3948264|FG000|NOT COMPLETED|Treatment Period 1||22
3216973|NCT02247804|3948265|FG001|NOT COMPLETED|Treatment Period 1||4
3216974|NCT02247804|3948266|FG002|NOT COMPLETED|Treatment Period 1||8
3216975|NCT02247804|3948264|FG000|STARTED|Treatment Period 2||172
3216976|NCT02247804|3948265|FG001|STARTED|Treatment Period 2||191
3216977|NCT02247804|3948266|FG002|STARTED|Treatment Period 2||187
3216978|NCT02247804|3948264|FG000|COMPLETED|Treatment Period 2||164
3216979|NCT02247804|3948265|FG001|COMPLETED|Treatment Period 2||186
3216980|NCT02247804|3948266|FG002|COMPLETED|Treatment Period 2||179
3216981|NCT02247804|3948264|FG000|NOT COMPLETED|Treatment Period 2||8
3216982|NCT02247804|3948265|FG001|NOT COMPLETED|Treatment Period 2||5
3216983|NCT02247804|3948266|FG002|NOT COMPLETED|Treatment Period 2||8
3216984|NCT02247804|3948264|FG000|STARTED|Treatment Period 3||158
3216985|NCT02247804|3948265|FG001|STARTED|Treatment Period 3||183
3216986|NCT02247804|3948266|FG002|STARTED|Treatment Period 3||177
3216987|NCT02247804|3948264|FG000|COMPLETED|Treatment Period 3||147
3216988|NCT02247804|3948265|FG001|COMPLETED|Treatment Period 3||173
3216989|NCT02247804|3948266|FG002|COMPLETED|Treatment Period 3||167
3216990|NCT02247804|3948264|FG000|NOT COMPLETED|Treatment Period 3||11
3216991|NCT02247804|3948265|FG001|NOT COMPLETED|Treatment Period 3||10
3216992|NCT02247804|3948266|FG002|NOT COMPLETED|Treatment Period 3||10
3216993|NCT02247960|3948276|FG000|STARTED|Patient Consent and Randomization||85
3216994|NCT02247960|3948277|FG001|STARTED|Patient Consent and Randomization||90
3216995|NCT02247960|3948276|FG000|COMPLETED|Patient Consent and Randomization||83
3216996|NCT02247960|3948277|FG001|COMPLETED|Patient Consent and Randomization||84
3216997|NCT02247960|3948276|FG000|NOT COMPLETED|Patient Consent and Randomization||2
3216998|NCT02247960|3948277|FG001|NOT COMPLETED|Patient Consent and Randomization||6
3216999|NCT02247960|3948276|FG000|STARTED|Catheter Removed||83
3217000|NCT02247960|3948277|FG001|STARTED|Catheter Removed||84
3217001|NCT02247960|3948276|FG000|COMPLETED|Catheter Removed||76
3217002|NCT02247960|3948277|FG001|COMPLETED|Catheter Removed||74
3217003|NCT02247960|3948276|FG000|NOT COMPLETED|Catheter Removed||7
3217004|NCT02247960|3948277|FG001|NOT COMPLETED|Catheter Removed||10
3217005|NCT02248103|3948285|FG000|STARTED|Overall Study||10
3217006|NCT02248103|3948286|FG001|STARTED|Overall Study||10
3217007|NCT02248103|3948285|FG000|COMPLETED|Overall Study||10
3217008|NCT02248103|3948286|FG001|COMPLETED|Overall Study||10
3217009|NCT02248103|3948285|FG000|NOT COMPLETED|Overall Study||0
3217010|NCT02248103|3948286|FG001|NOT COMPLETED|Overall Study||0
3217011|NCT02248246|3948292|FG000|STARTED|Overall Study||40
3217012|NCT02248246|3948292|FG000|COMPLETED|Overall Study||40
3217013|NCT02248246|3948292|FG000|NOT COMPLETED|Overall Study||0
3217014|NCT02248285|3948298|FG000|STARTED|Overall Study||687
3217015|NCT02248285|3948299|FG001|STARTED|Overall Study||858
3217016|NCT02248285|3948298|FG000|COMPLETED|Overall Study||586
3217017|NCT02248285|3948299|FG001|COMPLETED|Overall Study||571
3217018|NCT02248285|3948298|FG000|NOT COMPLETED|Overall Study||101
3217019|NCT02248285|3948299|FG001|NOT COMPLETED|Overall Study||287
3217020|NCT02248480|3948307|FG000|STARTED|Overall Study||178
3217021|NCT02248480|3948308|FG001|STARTED|Overall Study||176
3217022|NCT02248480|3948307|FG000|Efficacy Population|Overall Study||177
3217023|NCT02248480|3948308|FG001|Efficacy Population|Overall Study||176
3217024|NCT02248480|3948307|FG000|COMPLETED|Overall Study||161
3217025|NCT02248480|3948308|FG001|COMPLETED|Overall Study||162
3217026|NCT02248480|3948307|FG000|NOT COMPLETED|Overall Study||17
3217027|NCT02248480|3948308|FG001|NOT COMPLETED|Overall Study||14
3217028|NCT02248558|3948317|FG000|STARTED|Overall Study||369
3217029|NCT02248558|3948318|FG001|STARTED|Overall Study||352
3217030|NCT02248558|3948317|FG000|COMPLETED|Overall Study||317
3217031|NCT02248558|3948318|FG001|COMPLETED|Overall Study||307
3217032|NCT02248558|3948317|FG000|NOT COMPLETED|Overall Study||52
3217033|NCT02248558|3948318|FG001|NOT COMPLETED|Overall Study||45
3217034|NCT02248636|3948328|FG000|STARTED|Overall Study||26
3217035|NCT02248636|3948329|FG001|STARTED|Overall Study||35
3217036|NCT02248636|3948328|FG000|COMPLETED|Overall Study||20
3217037|NCT02248636|3948329|FG001|COMPLETED|Overall Study||32
3217038|NCT02248636|3948328|FG000|NOT COMPLETED|Overall Study||6
3217039|NCT02248636|3948329|FG001|NOT COMPLETED|Overall Study||3
3217040|NCT02248649|3948337|FG000|STARTED|Overall Study||80
3217041|NCT02248649|3948338|FG001|STARTED|Overall Study||80
3217042|NCT02248649|3948337|FG000|COMPLETED|Overall Study||59
3217043|NCT02248649|3948338|FG001|COMPLETED|Overall Study||59
3217044|NCT02248649|3948337|FG000|NOT COMPLETED|Overall Study||21
3217045|NCT02248649|3948338|FG001|NOT COMPLETED|Overall Study||21
3217046|NCT02248662|3948346|FG000|STARTED|Overall Study||5320
3217047|NCT02248662|3948347|FG001|STARTED|Overall Study||33194
3217048|NCT02248662|3948346|FG000|COMPLETED|Overall Study||757
3217049|NCT02248662|3948347|FG001|COMPLETED|Overall Study||2679
3217050|NCT02248662|3948346|FG000|NOT COMPLETED|Overall Study||4563
3217051|NCT02248662|3948347|FG001|NOT COMPLETED|Overall Study||30515
3217052|NCT02248675|3948359|FG000|STARTED|Overall Study||26
3217053|NCT02248675|3948360|FG001|STARTED|Overall Study||28
3217054|NCT02248675|3948359|FG000|COMPLETED|Overall Study||23
3217055|NCT02248675|3948360|FG001|COMPLETED|Overall Study||27
3217056|NCT02248675|3948359|FG000|NOT COMPLETED|Overall Study||3
3217057|NCT02248675|3948360|FG001|NOT COMPLETED|Overall Study||1
3217058|NCT02248714|3948368|FG000|STARTED|Overall Study||66
3217059|NCT02248714|3948369|FG001|STARTED|Overall Study||65
3217060|NCT02248714|3948368|FG000|COMPLETED|Overall Study||62
3217061|NCT02248714|3948369|FG001|COMPLETED|Overall Study||61
3217062|NCT02248714|3948368|FG000|NOT COMPLETED|Overall Study||4
3217063|NCT02248714|3948369|FG001|NOT COMPLETED|Overall Study||4
3217064|NCT02248727|3948375|FG000|STARTED|Overall Study||30
3217065|NCT02248727|3948375|FG000|COMPLETED|Overall Study||30
3217066|NCT02248727|3948375|FG000|NOT COMPLETED|Overall Study||0
3217067|NCT02248766|3948382|FG000|STARTED|Overall Study||30
3217068|NCT02248766|3948382|FG000|COMPLETED|Overall Study||30
3217069|NCT02248766|3948382|FG000|NOT COMPLETED|Overall Study||0
3217070|NCT02248818|3948398|FG000|STARTED|Screening||0
3217071|NCT02248818|3948399|FG001|STARTED|Screening||0
3217072|NCT02248818|3948400|FG002|STARTED|Screening||0
3217073|NCT02248818|3948401|FG003|STARTED|Screening||0
3217074|NCT02248818|3948402|FG004|STARTED|Screening||0
3217075|NCT02248818|3948403|FG005|STARTED|Screening||0
3217076|NCT02248818|3948404|FG006|STARTED|Screening||0
3217077|NCT02248818|3948405|FG007|STARTED|Screening||0
3217078|NCT02248818|3948406|FG008|STARTED|Screening||155
3217079|NCT02248818|3948398|FG000|COMPLETED|Screening||0
3217080|NCT02248818|3948399|FG001|COMPLETED|Screening||0
3217081|NCT02248818|3948400|FG002|COMPLETED|Screening||0
3217082|NCT02248818|3948401|FG003|COMPLETED|Screening||0
3217083|NCT02248818|3948402|FG004|COMPLETED|Screening||0
3217084|NCT02248818|3948403|FG005|COMPLETED|Screening||0
3217085|NCT02248818|3948404|FG006|COMPLETED|Screening||0
3217086|NCT02248818|3948405|FG007|COMPLETED|Screening||0
3217087|NCT02248818|3948406|FG008|COMPLETED|Screening||48
3217088|NCT02248818|3948398|FG000|NOT COMPLETED|Screening||0
3217089|NCT02248818|3948399|FG001|NOT COMPLETED|Screening||0
3217090|NCT02248818|3948400|FG002|NOT COMPLETED|Screening||0
3217091|NCT02248818|3948401|FG003|NOT COMPLETED|Screening||0
3217092|NCT02248818|3948402|FG004|NOT COMPLETED|Screening||0
3217093|NCT02248818|3948403|FG005|NOT COMPLETED|Screening||0
3217094|NCT02248818|3948404|FG006|NOT COMPLETED|Screening||0
3217095|NCT02248818|3948405|FG007|NOT COMPLETED|Screening||0
3217096|NCT02248818|3948406|FG008|NOT COMPLETED|Screening||107
3217097|NCT02248818|3948398|FG000|STARTED|Randomised Study||6
3217098|NCT02248818|3948399|FG001|STARTED|Randomised Study||6
3217099|NCT02248818|3948400|FG002|STARTED|Randomised Study||6
3217100|NCT02248818|3948401|FG003|STARTED|Randomised Study||6
3217101|NCT02248818|3948402|FG004|STARTED|Randomised Study||6
3217102|NCT02248818|3948403|FG005|STARTED|Randomised Study||8
3217103|NCT02248818|3948404|FG006|STARTED|Randomised Study||6
3217104|NCT02248818|3948405|FG007|STARTED|Randomised Study||4
3217105|NCT02248818|3948406|FG008|STARTED|Randomised Study||0
3217106|NCT02248818|3948398|FG000|COMPLETED|Randomised Study||6
3217107|NCT02248818|3948399|FG001|COMPLETED|Randomised Study||6
3217108|NCT02248818|3948400|FG002|COMPLETED|Randomised Study||6
3217109|NCT02248818|3948401|FG003|COMPLETED|Randomised Study||6
3217110|NCT02248818|3948402|FG004|COMPLETED|Randomised Study||6
3217111|NCT02248818|3948403|FG005|COMPLETED|Randomised Study||0
3217112|NCT02248818|3948404|FG006|COMPLETED|Randomised Study||6
3217113|NCT02248818|3948405|FG007|COMPLETED|Randomised Study||4
3217114|NCT02248818|3948406|FG008|COMPLETED|Randomised Study||0
3217115|NCT02248818|3948398|FG000|NOT COMPLETED|Randomised Study||0
3217116|NCT02248818|3948399|FG001|NOT COMPLETED|Randomised Study||0
3217117|NCT02248818|3948400|FG002|NOT COMPLETED|Randomised Study||0
3217118|NCT02248818|3948401|FG003|NOT COMPLETED|Randomised Study||0
3217119|NCT02248818|3948402|FG004|NOT COMPLETED|Randomised Study||0
3217120|NCT02248818|3948403|FG005|NOT COMPLETED|Randomised Study||8
3217121|NCT02248818|3948404|FG006|NOT COMPLETED|Randomised Study||0
3217122|NCT02248818|3948405|FG007|NOT COMPLETED|Randomised Study||0
3217123|NCT02248818|3948406|FG008|NOT COMPLETED|Randomised Study||0
3217124|NCT02248857|3948427|FG000|STARTED|Baseline||157
3217125|NCT02248857|3948428|FG001|STARTED|Baseline||168
3217126|NCT02248857|3948429|FG002|STARTED|Baseline||127
3217127|NCT02248857|3948427|FG000|COMPLETED|Baseline||157
3217128|NCT02248857|3948428|FG001|COMPLETED|Baseline||168
3217129|NCT02248857|3948429|FG002|COMPLETED|Baseline||127
3217130|NCT02248857|3948427|FG000|NOT COMPLETED|Baseline||0
3217131|NCT02248857|3948428|FG001|NOT COMPLETED|Baseline||0
3217132|NCT02248857|3948429|FG002|NOT COMPLETED|Baseline||0
3217133|NCT02248857|3948427|FG000|STARTED|3 Month||157
3217134|NCT02248857|3948428|FG001|STARTED|3 Month||168
3217135|NCT02248857|3948429|FG002|STARTED|3 Month||127
3217136|NCT02248857|3948427|FG000|COMPLETED|3 Month||111
3217137|NCT02248857|3948428|FG001|COMPLETED|3 Month||134
3217138|NCT02248857|3948429|FG002|COMPLETED|3 Month||96
3217139|NCT02248857|3948427|FG000|NOT COMPLETED|3 Month||46
3217140|NCT02248857|3948428|FG001|NOT COMPLETED|3 Month||34
3217141|NCT02248857|3948429|FG002|NOT COMPLETED|3 Month||31
3217142|NCT02248857|3948427|FG000|STARTED|6 Month|157 baseline - 9 who withdrew = 148|148
3217143|NCT02248857|3948428|FG001|STARTED|6 Month|168 baseline - 3 who withdrew = 165|165
3217144|NCT02248857|3948429|FG002|STARTED|6 Month|127 baseline - 4 who withdrew = 123|123
3217145|NCT02248857|3948427|FG000|COMPLETED|6 Month||120
3217146|NCT02248857|3948428|FG001|COMPLETED|6 Month||136
3217147|NCT02248857|3948429|FG002|COMPLETED|6 Month||106
3217148|NCT02248857|3948427|FG000|NOT COMPLETED|6 Month||28
3217149|NCT02248857|3948428|FG001|NOT COMPLETED|6 Month||29
3217150|NCT02248857|3948429|FG002|NOT COMPLETED|6 Month||17
3217151|NCT02248922|3948439|FG000|STARTED|Overall Study||5
3217152|NCT02248922|3948440|FG001|STARTED|Overall Study||12
3217153|NCT02248922|3948439|FG000|COMPLETED|Overall Study||5
3217154|NCT02248922|3948440|FG001|COMPLETED|Overall Study||12
3217155|NCT02248922|3948439|FG000|NOT COMPLETED|Overall Study||0
3217156|NCT02248922|3948440|FG001|NOT COMPLETED|Overall Study||0
3217157|NCT02248961|3948447|FG000|STARTED|Overall Study||89
3217158|NCT02248961|3948448|FG001|STARTED|Overall Study||90
3217159|NCT02248961|3948447|FG000|COMPLETED|Overall Study||86
3217160|NCT02248961|3948448|FG001|COMPLETED|Overall Study||88
3217161|NCT02248961|3948447|FG000|NOT COMPLETED|Overall Study||3
3217162|NCT02248961|3948448|FG001|NOT COMPLETED|Overall Study||2
3217163|NCT02248974|3948456|FG000|STARTED|Baseline||47
3217164|NCT02248974|3948457|FG001|STARTED|Baseline||51
3217165|NCT02248974|3948456|FG000|COMPLETED|Baseline||47
3217166|NCT02248974|3948457|FG001|COMPLETED|Baseline||51
3217167|NCT02248974|3948456|FG000|NOT COMPLETED|Baseline||0
3217168|NCT02248974|3948457|FG001|NOT COMPLETED|Baseline||0
3217169|NCT02248974|3948456|FG000|STARTED|1-Day Follow-Up||47
3217170|NCT02248974|3948457|FG001|STARTED|1-Day Follow-Up|"No DA group did not receive 1-Day Follow-up survey."|0
3217171|NCT02248974|3948456|FG000|COMPLETED|1-Day Follow-Up||37
3217172|NCT02248974|3948457|FG001|COMPLETED|1-Day Follow-Up|"No DA group did not receive 1-Day Follow-up survey."|0
3217173|NCT02248974|3948456|FG000|NOT COMPLETED|1-Day Follow-Up||10
3217174|NCT02248974|3948457|FG001|NOT COMPLETED|1-Day Follow-Up||0
3217175|NCT02248974|3948456|FG000|STARTED|1-Week Follow-Up||37
3217176|NCT02248974|3948457|FG001|STARTED|1-Week Follow-Up||51
3217177|NCT02248974|3948456|FG000|COMPLETED|1-Week Follow-Up||29
3217178|NCT02248974|3948457|FG001|COMPLETED|1-Week Follow-Up||34
3217179|NCT02248974|3948456|FG000|NOT COMPLETED|1-Week Follow-Up||8
3217180|NCT02248974|3948457|FG001|NOT COMPLETED|1-Week Follow-Up||17
3217181|NCT02248974|3948456|FG000|STARTED|1-Month Follow-Up||29
3217182|NCT02248974|3948457|FG001|STARTED|1-Month Follow-Up||34
3217183|NCT02248974|3948456|FG000|COMPLETED|1-Month Follow-Up||27
3217184|NCT02248974|3948457|FG001|COMPLETED|1-Month Follow-Up||31
3217185|NCT02248974|3948456|FG000|NOT COMPLETED|1-Month Follow-Up||2
3217186|NCT02248974|3948457|FG001|NOT COMPLETED|1-Month Follow-Up||3
3217187|NCT02249052|3948463|FG000|STARTED|Overall Study||19
3217188|NCT02249052|3948463|FG000|COMPLETED|Overall Study||19
3217189|NCT02249052|3948463|FG000|NOT COMPLETED|Overall Study||0
3217190|NCT02249065|3948471|FG000|STARTED|Overall Study||205
3217191|NCT02249065|3948471|FG000|Treated|Overall Study||181
3217192|NCT02249065|3948471|FG000|COMPLETED|Overall Study||176
3217193|NCT02249065|3948471|FG000|NOT COMPLETED|Overall Study||29
3217194|NCT02249091|3948477|FG000|STARTED|Overall Study||27
3217195|NCT02249091|3948478|FG001|STARTED|Overall Study||15
3217196|NCT02249091|3948477|FG000|COMPLETED|Overall Study||7
3217197|NCT02249091|3948478|FG001|COMPLETED|Overall Study||2
3217198|NCT02249091|3948477|FG000|NOT COMPLETED|Overall Study||20
3217199|NCT02249091|3948478|FG001|NOT COMPLETED|Overall Study||13
3217200|NCT02249104|3948484|FG000|STARTED|Overall Study||28
3217201|NCT02249104|3948484|FG000|COMPLETED|Overall Study||25
3217202|NCT02249104|3948484|FG000|NOT COMPLETED|Overall Study||3
3217203|NCT02249143|3948490|FG000|STARTED|Overall Study||24
3217204|NCT02249143|3948491|FG001|STARTED|Overall Study|randomized|26
3217205|NCT02249143|3948490|FG000|COMPLETED|Overall Study|with technically acceptable pulmonary function tests in the neonatal intensive care unit|22
3217206|NCT02249143|3948491|FG001|COMPLETED|Overall Study|with technically acceptable pulmonary function tests in the neonatal intensive care unit|22
3217207|NCT02249143|3948490|FG000|NOT COMPLETED|Overall Study||2
3217208|NCT02249143|3948491|FG001|NOT COMPLETED|Overall Study||4
3217209|NCT02249182|3948502|FG000|STARTED|PK Lead-In Phase||10
3217210|NCT02249182|3948503|FG001|STARTED|PK Lead-In Phase||12
3217211|NCT02249182|3948504|FG002|STARTED|PK Lead-In Phase||0
3217212|NCT02249182|3948505|FG003|STARTED|PK Lead-In Phase||0
3217213|NCT02249182|3948506|FG004|STARTED|PK Lead-In Phase||17
3217214|NCT02249182|3948502|FG000|COMPLETED|PK Lead-In Phase||10
3217215|NCT02249182|3948503|FG001|COMPLETED|PK Lead-In Phase||12
3217216|NCT02249182|3948504|FG002|COMPLETED|PK Lead-In Phase||0
3217217|NCT02249182|3948505|FG003|COMPLETED|PK Lead-In Phase||0
3217218|NCT02249182|3948506|FG004|COMPLETED|PK Lead-In Phase||17
3217219|NCT02249182|3948502|FG000|NOT COMPLETED|PK Lead-In Phase||0
3217220|NCT02249182|3948503|FG001|NOT COMPLETED|PK Lead-In Phase||0
3217221|NCT02249182|3948504|FG002|NOT COMPLETED|PK Lead-In Phase||0
3217222|NCT02249182|3948505|FG003|NOT COMPLETED|PK Lead-In Phase||0
3217223|NCT02249182|3948506|FG004|NOT COMPLETED|PK Lead-In Phase||0
3217224|NCT02249182|3948502|FG000|STARTED|Treatment Phase|90 participants enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|100
3217225|NCT02249182|3948503|FG001|STARTED|Treatment Phase|77 participants enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|89
3217226|NCT02249182|3948504|FG002|STARTED|Treatment Phase|1 participant enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|1
3217227|NCT02249182|3948505|FG003|STARTED|Treatment Phase|2 participants enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|2
3217228|NCT02249182|3948506|FG004|STARTED|Treatment Phase|17 participants enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|34
3217229|NCT02249182|3948502|FG000|COMPLETED|Treatment Phase||96
3217230|NCT02249182|3948503|FG001|COMPLETED|Treatment Phase||89
3217231|NCT02249182|3948504|FG002|COMPLETED|Treatment Phase||1
3217232|NCT02249182|3948505|FG003|COMPLETED|Treatment Phase||2
3217233|NCT02249182|3948506|FG004|COMPLETED|Treatment Phase||34
3217234|NCT02249182|3948502|FG000|NOT COMPLETED|Treatment Phase||4
3217235|NCT02249182|3948503|FG001|NOT COMPLETED|Treatment Phase||0
3217236|NCT02249182|3948504|FG002|NOT COMPLETED|Treatment Phase||0
3217237|NCT02249182|3948505|FG003|NOT COMPLETED|Treatment Phase||0
3217238|NCT02249182|3948506|FG004|NOT COMPLETED|Treatment Phase||0
3217239|NCT02249585|3948534|FG000|STARTED|Overall Study||43
3217240|NCT02249585|3948535|FG001|STARTED|Overall Study||44
3217241|NCT02249585|3948536|FG002|STARTED|Overall Study||44
3217242|NCT02249585|3948534|FG000|COMPLETED|Overall Study||43
3217243|NCT02249585|3948535|FG001|COMPLETED|Overall Study||44
3217244|NCT02249585|3948536|FG002|COMPLETED|Overall Study||44
3217245|NCT02249585|3948534|FG000|NOT COMPLETED|Overall Study||0
3217246|NCT02249585|3948535|FG001|NOT COMPLETED|Overall Study||0
3217247|NCT02249585|3948536|FG002|NOT COMPLETED|Overall Study||0
3217248|NCT02249728|3948544|FG000|STARTED|Part One (4 Days)||6
3217249|NCT02249728|3948544|FG000|COMPLETED|Part One (4 Days)||6
3217250|NCT02249728|3948544|FG000|NOT COMPLETED|Part One (4 Days)||0
3217251|NCT02249728|3948544|FG000|STARTED|Part Two (up to 6 Days)||6
3217252|NCT02249728|3948544|FG000|COMPLETED|Part Two (up to 6 Days)||6
3217253|NCT02249728|3948544|FG000|NOT COMPLETED|Part Two (up to 6 Days)||0
3217254|NCT02249767|3948554|FG000|STARTED|Overall Study||230
3217255|NCT02249767|3948555|FG001|STARTED|Overall Study||229
3217256|NCT02249767|3948556|FG002|STARTED|Overall Study||115
3217257|NCT02249767|3948554|FG000|COMPLETED|Overall Study||222
3217258|NCT02249767|3948555|FG001|COMPLETED|Overall Study||220
3217259|NCT02249767|3948556|FG002|COMPLETED|Overall Study||107
3217260|NCT02249767|3948554|FG000|NOT COMPLETED|Overall Study||8
3217261|NCT02249767|3948555|FG001|NOT COMPLETED|Overall Study||9
3217262|NCT02249767|3948556|FG002|NOT COMPLETED|Overall Study||8
3217263|NCT02249793|3948564|FG000|STARTED|Session 1, 48-hours Healthy Volunteers||6
3217264|NCT02249793|3948564|FG000|COMPLETED|Session 1, 48-hours Healthy Volunteers||6
3217265|NCT02249793|3948564|FG000|NOT COMPLETED|Session 1, 48-hours Healthy Volunteers||0
3217266|NCT02249793|3948564|FG000|STARTED|Session 2, 48-Hours Healthy Volunteers||6
3217267|NCT02249793|3948564|FG000|COMPLETED|Session 2, 48-Hours Healthy Volunteers||6
3217268|NCT02249793|3948564|FG000|NOT COMPLETED|Session 2, 48-Hours Healthy Volunteers||0
3217269|NCT02249819|3948569|FG000|STARTED|Overall Study||8
3217270|NCT02249819|3948570|FG001|STARTED|Overall Study||7
3217271|NCT02249819|3948569|FG000|COMPLETED|Overall Study||8
3217272|NCT02249819|3948570|FG001|COMPLETED|Overall Study||7
3217273|NCT02249819|3948569|FG000|NOT COMPLETED|Overall Study||0
3217274|NCT02249819|3948570|FG001|NOT COMPLETED|Overall Study||0
3217275|NCT02249832|3948576|FG000|STARTED|Overall Study||55
3217276|NCT02249832|3948576|FG000|COMPLETED|Overall Study||42
3217277|NCT02249832|3948576|FG000|NOT COMPLETED|Overall Study||13
3217278|NCT02249949|3948585|FG000|STARTED|Overall Study||13
3217279|NCT02249949|3948585|FG000|COMPLETED|Overall Study||11
3217280|NCT02249949|3948585|FG000|NOT COMPLETED|Overall Study||2
3217281|NCT02250092|3948591|FG000|STARTED|Overall Study||10
3217282|NCT02250092|3948592|FG001|STARTED|Overall Study||10
3217283|NCT02250092|3948591|FG000|COMPLETED|Overall Study||10
3217284|NCT02250092|3948592|FG001|COMPLETED|Overall Study||10
3217285|NCT02250092|3948591|FG000|NOT COMPLETED|Overall Study||0
3217286|NCT02250092|3948592|FG001|NOT COMPLETED|Overall Study||0
3217287|NCT02250183|3948598|FG000|STARTED|Overall Study||21
3217288|NCT02250183|3948598|FG000|COMPLETED|Overall Study||13
3217289|NCT02250183|3948598|FG000|NOT COMPLETED|Overall Study||8
3217290|NCT02250274|3948607|FG000|STARTED|Overall Study||85
3217291|NCT02250274|3948608|FG001|STARTED|Overall Study||46
3217292|NCT02250274|3948607|FG000|COMPLETED|Overall Study||78
3217293|NCT02250274|3948608|FG001|COMPLETED|Overall Study||40
3217294|NCT02250274|3948607|FG000|NOT COMPLETED|Overall Study||7
3217295|NCT02250274|3948608|FG001|NOT COMPLETED|Overall Study||6
3217296|NCT02250417|3948620|FG000|STARTED|First Intervention (1 Night)||6
3217297|NCT02250417|3948621|FG001|STARTED|First Intervention (1 Night)||6
3217298|NCT02250417|3948620|FG000|COMPLETED|First Intervention (1 Night)||6
3217299|NCT02250417|3948621|FG001|COMPLETED|First Intervention (1 Night)||6
3217300|NCT02250417|3948620|FG000|NOT COMPLETED|First Intervention (1 Night)||0
3217301|NCT02250417|3948621|FG001|NOT COMPLETED|First Intervention (1 Night)||0
3217302|NCT02250417|3948620|FG000|STARTED|Second Intervention (1 Night)||6
3217303|NCT02250417|3948621|FG001|STARTED|Second Intervention (1 Night)||6
3217304|NCT02250417|3948620|FG000|COMPLETED|Second Intervention (1 Night)||6
3217305|NCT02250417|3948621|FG001|COMPLETED|Second Intervention (1 Night)||6
3217306|NCT02250417|3948620|FG000|NOT COMPLETED|Second Intervention (1 Night)||0
3217307|NCT02250417|3948621|FG001|NOT COMPLETED|Second Intervention (1 Night)||0
3217308|NCT02250443|3948630|FG000|STARTED|Overall Study||10
3217309|NCT02250443|3948630|FG000|COMPLETED|Overall Study||0
3217310|NCT02250443|3948630|FG000|NOT COMPLETED|Overall Study||10
3217311|NCT02250521|3948634|FG000|STARTED|Overall Study||100
3217312|NCT02250521|3948634|FG000|COMPLETED|Overall Study||99
3217313|NCT02250521|3948634|FG000|NOT COMPLETED|Overall Study||1
3217314|NCT02250612|3948643|FG000|STARTED|Overall Study||37
3217315|NCT02250612|3948644|FG001|STARTED|Overall Study||40
3217316|NCT02250612|3948645|FG002|STARTED|Overall Study||37
3217317|NCT02250612|3948646|FG003|STARTED|Overall Study||33
3217318|NCT02250612|3948647|FG004|STARTED|Overall Study||37
3217319|NCT02250612|3948643|FG000|COMPLETED|Overall Study||36
3217320|NCT02250612|3948644|FG001|COMPLETED|Overall Study||38
3217321|NCT02250612|3948645|FG002|COMPLETED|Overall Study||35
3217322|NCT02250612|3948646|FG003|COMPLETED|Overall Study||33
3217323|NCT02250612|3948647|FG004|COMPLETED|Overall Study||36
3217324|NCT02250612|3948643|FG000|NOT COMPLETED|Overall Study||1
3217325|NCT02250612|3948644|FG001|NOT COMPLETED|Overall Study||2
3217326|NCT02250612|3948645|FG002|NOT COMPLETED|Overall Study||2
3217327|NCT02250612|3948646|FG003|NOT COMPLETED|Overall Study||0
3217328|NCT02250612|3948647|FG004|NOT COMPLETED|Overall Study||1
3217329|NCT02250651|3948669|FG000|STARTED|Treatment Period 1 (Day 1 to Week 15)||176
3217330|NCT02250651|3948670|FG001|STARTED|Treatment Period 1 (Day 1 to Week 15)||176
3217331|NCT02250651|3948671|FG002|STARTED|Treatment Period 1 (Day 1 to Week 15)||176
3217332|NCT02250651|3948669|FG000|Received Sham or Bimatoprost SR|Treatment Period 1 (Day 1 to Week 15)||176
3217333|NCT02250651|3948670|FG001|Received Sham or Bimatoprost SR|Treatment Period 1 (Day 1 to Week 15)||175
3217334|NCT02250651|3948671|FG002|Received Sham or Bimatoprost SR|Treatment Period 1 (Day 1 to Week 15)||173
3217335|NCT02250651|3948669|FG000|COMPLETED|Treatment Period 1 (Day 1 to Week 15)||172
3217336|NCT02250651|3948670|FG001|COMPLETED|Treatment Period 1 (Day 1 to Week 15)||170
3217337|NCT02250651|3948671|FG002|COMPLETED|Treatment Period 1 (Day 1 to Week 15)||165
3217338|NCT02250651|3948669|FG000|NOT COMPLETED|Treatment Period 1 (Day 1 to Week 15)||4
3217339|NCT02250651|3948670|FG001|NOT COMPLETED|Treatment Period 1 (Day 1 to Week 15)||6
3217340|NCT02250651|3948671|FG002|NOT COMPLETED|Treatment Period 1 (Day 1 to Week 15)||11
3217341|NCT02250651|3948669|FG000|STARTED|Treatment Period 2 (Week 16 to Week 31)||165
3217342|NCT02250651|3948670|FG001|STARTED|Treatment Period 2 (Week 16 to Week 31)||168
3217343|NCT02250651|3948671|FG002|STARTED|Treatment Period 2 (Week 16 to Week 31)||165
3217344|NCT02250651|3948669|FG000|COMPLETED|Treatment Period 2 (Week 16 to Week 31)||159
3217345|NCT02250651|3948670|FG001|COMPLETED|Treatment Period 2 (Week 16 to Week 31)||162
3217346|NCT02250651|3948671|FG002|COMPLETED|Treatment Period 2 (Week 16 to Week 31)||160
3217347|NCT02250651|3948669|FG000|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 31)||6
3217348|NCT02250651|3948670|FG001|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 31)||6
3217349|NCT02250651|3948671|FG002|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 31)||5
3217350|NCT02250651|3948669|FG000|STARTED|Treatment Period 3 (Week 32 to Week 52)||147
3217351|NCT02250651|3948670|FG001|STARTED|Treatment Period 3 (Week 32 to Week 52)||156
3217352|NCT02250651|3948671|FG002|STARTED|Treatment Period 3 (Week 32 to Week 52)||159
3217353|NCT02250651|3948669|FG000|COMPLETED|Treatment Period 3 (Week 32 to Week 52)||138
3217354|NCT02250651|3948670|FG001|COMPLETED|Treatment Period 3 (Week 32 to Week 52)||152
3217355|NCT02250651|3948671|FG002|COMPLETED|Treatment Period 3 (Week 32 to Week 52)||154
3217356|NCT02250651|3948669|FG000|NOT COMPLETED|Treatment Period 3 (Week 32 to Week 52)||9
3217357|NCT02250651|3948670|FG001|NOT COMPLETED|Treatment Period 3 (Week 32 to Week 52)||4
3217358|NCT02250651|3948671|FG002|NOT COMPLETED|Treatment Period 3 (Week 32 to Week 52)||5
3217359|NCT02250703|3948681|FG000|STARTED|Overall Study||38
3217360|NCT02250703|3948682|FG001|STARTED|Overall Study||37
3217361|NCT02250703|3948681|FG000|COMPLETED|Overall Study||37
3217362|NCT02250703|3948682|FG001|COMPLETED|Overall Study||36
3217363|NCT02250703|3948681|FG000|NOT COMPLETED|Overall Study||1
3217364|NCT02250703|3948682|FG001|NOT COMPLETED|Overall Study||1
3217365|NCT02250807|3948688|FG000|STARTED|Overall Study||40
3217366|NCT02250807|3948688|FG000|COMPLETED|Overall Study||40
3217367|NCT02250807|3948688|FG000|NOT COMPLETED|Overall Study||0
3217368|NCT02251236|3948695|FG000|STARTED|Overall Study||9
3217369|NCT02251236|3948696|FG001|STARTED|Overall Study||5
3217370|NCT02251236|3948697|FG002|STARTED|Overall Study||0
3217371|NCT02251236|3948695|FG000|COMPLETED|Overall Study||9
3217372|NCT02251236|3948696|FG001|COMPLETED|Overall Study||5
3217373|NCT02251236|3948697|FG002|COMPLETED|Overall Study||0
3217374|NCT02251236|3948695|FG000|NOT COMPLETED|Overall Study||0
3217375|NCT02251236|3948696|FG001|NOT COMPLETED|Overall Study||0
3217376|NCT02251236|3948697|FG002|NOT COMPLETED|Overall Study||0
3217377|NCT02251275|3948710|FG000|STARTED|Overall Study||506
3217378|NCT02251275|3948711|FG001|STARTED|Overall Study||570
3217379|NCT02251275|3948712|FG002|STARTED|Overall Study||718
3217380|NCT02251275|3948713|FG003|STARTED|Overall Study|From trials 156-04-251 and 156-09-290|6
3217381|NCT02251275|3948714|FG004|STARTED|Overall Study|From trials 156-04-251 and 156-09-290|3
3217382|NCT02251275|3948710|FG000|Received at Least 1 Dose of Study Drug|Overall Study||505
3217383|NCT02251275|3948711|FG001|Received at Least 1 Dose of Study Drug|Overall Study||569
3217384|NCT02251275|3948712|FG002|Received at Least 1 Dose of Study Drug|Overall Study||717
3217385|NCT02251275|3948713|FG003|Received at Least 1 Dose of Study Drug|Overall Study||6
3217386|NCT02251275|3948714|FG004|Received at Least 1 Dose of Study Drug|Overall Study||3
3217387|NCT02251275|3948710|FG000|COMPLETED|Overall Study||434
3217388|NCT02251275|3948711|FG001|COMPLETED|Overall Study||423
3217389|NCT02251275|3948712|FG002|COMPLETED|Overall Study||624
3217390|NCT02251275|3948713|FG003|COMPLETED|Overall Study||5
3217391|NCT02251275|3948714|FG004|COMPLETED|Overall Study||2
3217392|NCT02251275|3948710|FG000|NOT COMPLETED|Overall Study||72
3217393|NCT02251275|3948711|FG001|NOT COMPLETED|Overall Study||147
3217394|NCT02251275|3948712|FG002|NOT COMPLETED|Overall Study||94
3217395|NCT02251275|3948713|FG003|NOT COMPLETED|Overall Study||1
3217396|NCT02251275|3948714|FG004|NOT COMPLETED|Overall Study||1
3217397|NCT02251379|3948728|FG000|STARTED|Overall Study||77
3217398|NCT02251379|3948729|FG001|STARTED|Overall Study||78
3217399|NCT02251379|3948728|FG000|COMPLETED|Overall Study||57
3217400|NCT02251379|3948729|FG001|COMPLETED|Overall Study||58
3217401|NCT02251379|3948728|FG000|NOT COMPLETED|Overall Study||20
3217402|NCT02251379|3948729|FG001|NOT COMPLETED|Overall Study||20
3217403|NCT02251496|3948737|FG000|STARTED|Overall Study||19
3217404|NCT02251496|3948738|FG001|STARTED|Overall Study||15
3217405|NCT02251496|3948737|FG000|COMPLETED|Overall Study||14
3217406|NCT02251496|3948738|FG001|COMPLETED|Overall Study||11
3217407|NCT02251496|3948737|FG000|NOT COMPLETED|Overall Study||5
3217408|NCT02251496|3948738|FG001|NOT COMPLETED|Overall Study||4
3217409|NCT02251548|3948744|FG000|STARTED|Overall Study||85
3217410|NCT02251548|3948744|FG000|COMPLETED|Overall Study||0
3217411|NCT02251548|3948744|FG000|NOT COMPLETED|Overall Study||85
3217412|NCT02251561|3948749|FG000|STARTED|Overall Study||28
3217413|NCT02251561|3948749|FG000|COMPLETED|Overall Study||28
3217414|NCT02251561|3948749|FG000|NOT COMPLETED|Overall Study||0
3217415|NCT02251613|3948755|FG000|STARTED|Overall Study||50
3217416|NCT02251613|3948755|FG000|COMPLETED|Overall Study||50
3217417|NCT02251613|3948755|FG000|NOT COMPLETED|Overall Study||0
3217418|NCT02251652|3948761|FG000|STARTED|Overall Study||17
3217419|NCT02251652|3948761|FG000|COMPLETED|Overall Study||16
3217420|NCT02251652|3948761|FG000|NOT COMPLETED|Overall Study||1
3217421|NCT02251717|3948769|FG000|STARTED|Overall Study||57
3217422|NCT02251717|3948770|FG001|STARTED|Overall Study||57
3217423|NCT02251717|3948769|FG000|COMPLETED|Overall Study||56
3217424|NCT02251717|3948770|FG001|COMPLETED|Overall Study||56
3217425|NCT02251717|3948769|FG000|NOT COMPLETED|Overall Study||1
3217426|NCT02251717|3948770|FG001|NOT COMPLETED|Overall Study||1
3217427|NCT02251743|3948778|FG000|STARTED|Overall Study||85
3217428|NCT02251743|3948779|FG001|STARTED|Overall Study||59
3217429|NCT02251743|3948778|FG000|COMPLETED|Overall Study||84
3217430|NCT02251743|3948779|FG001|COMPLETED|Overall Study||58
3217431|NCT02251743|3948778|FG000|NOT COMPLETED|Overall Study||1
3217432|NCT02251743|3948779|FG001|NOT COMPLETED|Overall Study||1
3217433|NCT02251886|3948789|FG000|STARTED|Overall Study||48
3217434|NCT02251886|3948790|FG001|STARTED|Overall Study||54
3217435|NCT02251886|3948791|FG002|STARTED|Overall Study||44
3217436|NCT02251886|3948792|FG003|STARTED|Overall Study||54
3217437|NCT02251886|3948789|FG000|COMPLETED|Overall Study||48
3217438|NCT02251886|3948790|FG001|COMPLETED|Overall Study||54
3217439|NCT02251886|3948791|FG002|COMPLETED|Overall Study||44
3217440|NCT02251886|3948792|FG003|COMPLETED|Overall Study||54
3217441|NCT02251886|3948789|FG000|NOT COMPLETED|Overall Study||0
3217442|NCT02251886|3948790|FG001|NOT COMPLETED|Overall Study||0
3217443|NCT02251886|3948791|FG002|NOT COMPLETED|Overall Study||0
3217444|NCT02251886|3948792|FG003|NOT COMPLETED|Overall Study||0
3217445|NCT02251912|3948804|FG000|STARTED|Overall Study||12
3217446|NCT02251912|3948805|FG001|STARTED|Overall Study||10
3217447|NCT02251912|3948804|FG000|COMPLETED|Overall Study||10
3217448|NCT02251912|3948805|FG001|COMPLETED|Overall Study||5
3217449|NCT02251912|3948804|FG000|NOT COMPLETED|Overall Study||2
3217450|NCT02251912|3948805|FG001|NOT COMPLETED|Overall Study||5
3217451|NCT02251938|3948811|FG000|STARTED|Overall Study||60
3217452|NCT02251938|3948811|FG000|COMPLETED|Overall Study||43
3217453|NCT02251938|3948811|FG000|NOT COMPLETED|Overall Study||17
3367237|NCT03880266|4098635|FG005|NOT COMPLETED|Overall Study||0
3367238|NCT03880266|4098636|FG006|NOT COMPLETED|Overall Study||0
3367239|NCT03880266|4098637|FG007|NOT COMPLETED|Overall Study||0
3367240|NCT03875664|4098657|FG000|STARTED|Overall Study||37
3367241|NCT03875664|4098658|FG001|STARTED|Overall Study||35
3367242|NCT03875664|4098657|FG000|COMPLETED|Overall Study|vaginal surgery n=18; vaginal + abdominal surgery n=19|37
3367243|NCT03875664|4098658|FG001|COMPLETED|Overall Study|Vaginal surgery n=18; vaginal + abdominal surgery n=17|35
3367244|NCT03875664|4098657|FG000|NOT COMPLETED|Overall Study||0
3367245|NCT03875664|4098658|FG001|NOT COMPLETED|Overall Study||0
3367246|NCT03856320|4098666|FG000|STARTED|Overall Study||20
3367247|NCT03856320|4098667|FG001|STARTED|Overall Study||22
3367248|NCT03856320|4098666|FG000|COMPLETED|Overall Study||20
3367249|NCT03856320|4098667|FG001|COMPLETED|Overall Study||20
3367250|NCT03856320|4098666|FG000|NOT COMPLETED|Overall Study||0
3367251|NCT03856320|4098667|FG001|NOT COMPLETED|Overall Study||2
3367252|NCT03848871|4098673|FG000|STARTED|Overall Study||20
3367253|NCT03848871|4098673|FG000|COMPLETED|Overall Study||20
3367254|NCT03848871|4098673|FG000|NOT COMPLETED|Overall Study||0
3367255|NCT03880474|4098679|FG000|STARTED|Overall Study||1077
3367256|NCT03880474|4098680|FG001|STARTED|Overall Study||1075
3367257|NCT03880474|4098679|FG000|COMPLETED|Overall Study||1054
3367258|NCT03880474|4098680|FG001|COMPLETED|Overall Study||1055
3367259|NCT03880474|4098679|FG000|NOT COMPLETED|Overall Study||23
3367260|NCT03880474|4098680|FG001|NOT COMPLETED|Overall Study||20
3367261|NCT03878160|4098689|FG000|STARTED|Overall Study||7
3367262|NCT03878160|4098690|FG001|STARTED|Overall Study||9
3367263|NCT03878160|4098691|FG002|STARTED|Overall Study||11
3367264|NCT03878160|4098689|FG000|COMPLETED|Overall Study||5
3367265|NCT03878160|4098690|FG001|COMPLETED|Overall Study||8
3367266|NCT03878160|4098691|FG002|COMPLETED|Overall Study||10
3367267|NCT03878160|4098689|FG000|NOT COMPLETED|Overall Study||2
3367268|NCT03878160|4098690|FG001|NOT COMPLETED|Overall Study||1
3367269|NCT03878160|4098691|FG002|NOT COMPLETED|Overall Study||1
3217454|NCT02251990|3948817|FG000|STARTED|Period 1 (Double-blind [DB])||366
3217455|NCT02251990|3948818|FG001|STARTED|Period 1 (Double-blind [DB])||123
3217456|NCT02251990|3948817|FG000|Treated|Period 1 (Double-blind [DB])|Started Grazoprevir/Elbasvir|365
3367270|NCT03864627|4098701|FG000|STARTED|Overall Study||11
3367271|NCT03864627|4098702|FG001|STARTED|Overall Study||22
3217457|NCT02251990|3948818|FG001|Treated|Period 1 (Double-blind [DB])|Started Placebo|123
3217458|NCT02251990|3948817|FG000|COMPLETED|Period 1 (Double-blind [DB])|Completed 12 weeks of Grazoprevir/Elbasvir|358
3217459|NCT02251990|3948818|FG001|COMPLETED|Period 1 (Double-blind [DB])|Completed 12 weeks of Placebo|122
3217460|NCT02251990|3948817|FG000|NOT COMPLETED|Period 1 (Double-blind [DB])||8
3217461|NCT02251990|3948818|FG001|NOT COMPLETED|Period 1 (Double-blind [DB])||1
3217462|NCT02251990|3948817|FG000|STARTED|Period 2 (ITG Follow-up/DTG Open Label)|2 participants that did not complete Period 1 treatment were included in Follow-up.|360
3217463|NCT02251990|3948818|FG001|STARTED|Period 2 (ITG Follow-up/DTG Open Label)|1 participant completing Period 1 was not eligible for Period 2 and was not treated.|121
3217464|NCT02251990|3948817|FG000|COMPLETED|Period 2 (ITG Follow-up/DTG Open Label)|Completed 24 weeks of follow-up|360
3217465|NCT02251990|3948818|FG001|COMPLETED|Period 2 (ITG Follow-up/DTG Open Label)|Completed 12 weeks of Grazoprevir/Elbasvir|118
3217466|NCT02251990|3948817|FG000|NOT COMPLETED|Period 2 (ITG Follow-up/DTG Open Label)||0
3217467|NCT02251990|3948818|FG001|NOT COMPLETED|Period 2 (ITG Follow-up/DTG Open Label)||3
3217468|NCT02251990|3948817|FG000|STARTED|Period 3 (DTG Follow-up)|The ITG completed the study with Period 2|0
3217469|NCT02251990|3948818|FG001|STARTED|Period 3 (DTG Follow-up)|3 participants that discontinued treatment in Period 2 were included in Follow-up.|121
3217470|NCT02251990|3948817|FG000|COMPLETED|Period 3 (DTG Follow-up)||0
3217471|NCT02251990|3948818|FG001|COMPLETED|Period 3 (DTG Follow-up)|Completed 24 weeks of follow-up|121
3217472|NCT02251990|3948817|FG000|NOT COMPLETED|Period 3 (DTG Follow-up)||0
3217473|NCT02251990|3948818|FG001|NOT COMPLETED|Period 3 (DTG Follow-up)||0
3217474|NCT02252016|3948827|FG000|STARTED|Overall Study||107
3217475|NCT02252016|3948828|FG001|STARTED|Overall Study||52
3217476|NCT02252016|3948827|FG000|COMPLETED|Overall Study|Completed = completed 24 weeks of follow-up|104
3217477|NCT02252016|3948828|FG001|COMPLETED|Overall Study|Completed = completed 24 weeks of follow-up|49
3217478|NCT02252016|3948827|FG000|NOT COMPLETED|Overall Study||3
3217479|NCT02252016|3948828|FG001|NOT COMPLETED|Overall Study||3
3217480|NCT02252042|3948836|FG000|STARTED|Overall Study||247
3217481|NCT02252042|3948837|FG001|STARTED|Overall Study||248
3217482|NCT02252042|3948836|FG000|Treated|Overall Study|1 participant was randomized but did not receive study treatment.|246
3217483|NCT02252042|3948837|FG001|Treated|Overall Study|14 participants were randomized but did not receive study treatment.|234
3217484|NCT02252042|3948836|FG000|COMPLETED|Overall Study||0
3217485|NCT02252042|3948837|FG001|COMPLETED|Overall Study||0
3217486|NCT02252042|3948836|FG000|NOT COMPLETED|Overall Study||247
3217487|NCT02252042|3948837|FG001|NOT COMPLETED|Overall Study||248
3217488|NCT02252068|3948846|FG000|STARTED|Overall Study||5
3217489|NCT02252068|3948847|FG001|STARTED|Overall Study||13
3217490|NCT02252068|3948848|FG002|STARTED|Overall Study||13
3217491|NCT02252068|3948846|FG000|COMPLETED|Overall Study||3
3217492|NCT02252068|3948847|FG001|COMPLETED|Overall Study||13
3217493|NCT02252068|3948848|FG002|COMPLETED|Overall Study||13
3217494|NCT02252068|3948846|FG000|NOT COMPLETED|Overall Study||2
3217495|NCT02252068|3948847|FG001|NOT COMPLETED|Overall Study||0
3217496|NCT02252068|3948848|FG002|NOT COMPLETED|Overall Study||0
3217497|NCT02252081|3948858|FG000|STARTED|Overall Study||30
3217498|NCT02252081|3948859|FG001|STARTED|Overall Study||30
3217499|NCT02252081|3948858|FG000|COMPLETED|Overall Study||24
3217500|NCT02252081|3948859|FG001|COMPLETED|Overall Study||26
3217501|NCT02252081|3948858|FG000|NOT COMPLETED|Overall Study||6
3217502|NCT02252081|3948859|FG001|NOT COMPLETED|Overall Study||4
3367272|NCT03864627|4098701|FG000|COMPLETED|Overall Study||7
3367273|NCT03864627|4098702|FG001|COMPLETED|Overall Study||10
3367274|NCT03864627|4098701|FG000|NOT COMPLETED|Overall Study||4
3367275|NCT03864627|4098702|FG001|NOT COMPLETED|Overall Study||12
3367276|NCT03861000|4098711|FG000|STARTED|Overall Study||2
3367277|NCT03861000|4098712|FG001|STARTED|Overall Study||1
3367278|NCT03861000|4098711|FG000|COMPLETED|Overall Study||2
3367279|NCT03861000|4098712|FG001|COMPLETED|Overall Study||1
3367280|NCT03861000|4098711|FG000|NOT COMPLETED|Overall Study||0
3367281|NCT03861000|4098712|FG001|NOT COMPLETED|Overall Study||0
3217503|NCT02252133|3948870|FG000|STARTED|Period 1||23
3217504|NCT02252133|3948871|FG001|STARTED|Period 1||24
3217505|NCT02252133|3948870|FG000|COMPLETED|Period 1||23
3217506|NCT02252133|3948871|FG001|COMPLETED|Period 1||24
3217507|NCT02252133|3948870|FG000|NOT COMPLETED|Period 1||0
3217508|NCT02252133|3948871|FG001|NOT COMPLETED|Period 1||0
3217509|NCT02252133|3948870|FG000|STARTED|Period 2||23
3217510|NCT02252133|3948871|FG001|STARTED|Period 2||24
3217511|NCT02252133|3948870|FG000|COMPLETED|Period 2||23
3217512|NCT02252133|3948871|FG001|COMPLETED|Period 2||24
3217513|NCT02252133|3948870|FG000|NOT COMPLETED|Period 2||0
3217514|NCT02252133|3948871|FG001|NOT COMPLETED|Period 2||0
3217515|NCT02252146|3948877|FG000|STARTED|Overall Study||6
3217516|NCT02252146|3948877|FG000|COMPLETED|Overall Study||0
3217517|NCT02252146|3948877|FG000|NOT COMPLETED|Overall Study||6
3217518|NCT02252211|3948883|FG000|STARTED|Overall Study||5
3217519|NCT02252211|3948884|FG001|STARTED|Overall Study||3
3217520|NCT02252211|3948885|FG002|STARTED|Overall Study||1
3217521|NCT02252211|3948883|FG000|Received Dose 1 (Day 1)|Overall Study||4
3217522|NCT02252211|3948884|FG001|Received Dose 1 (Day 1)|Overall Study||3
3217523|NCT02252211|3948885|FG002|Received Dose 1 (Day 1)|Overall Study||0
3217524|NCT02252211|3948883|FG000|Received Dose 2 (Day 8)|Overall Study||4
3217525|NCT02252211|3948884|FG001|Received Dose 2 (Day 8)|Overall Study||3
3217526|NCT02252211|3948885|FG002|Received Dose 2 (Day 8)|Overall Study||0
3217527|NCT02252211|3948883|FG000|Received Dose 3 (Day 22)|Overall Study||3
3217528|NCT02252211|3948884|FG001|Received Dose 3 (Day 22)|Overall Study||3
3217529|NCT02252211|3948885|FG002|Received Dose 3 (Day 22)|Overall Study||0
3217530|NCT02252211|3948883|FG000|Received Dose 4 (Day 36)|Overall Study||1
3217531|NCT02252211|3948884|FG001|Received Dose 4 (Day 36)|Overall Study||1
3217532|NCT02252211|3948885|FG002|Received Dose 4 (Day 36)|Overall Study||0
3217533|NCT02252211|3948883|FG000|Received Further Doses (Through Dose 24)|Overall Study||1
3217534|NCT02252211|3948884|FG001|Received Further Doses (Through Dose 24)|Overall Study||0
3217535|NCT02252211|3948885|FG002|Received Further Doses (Through Dose 24)|Overall Study||0
3217536|NCT02252211|3948883|FG000|COMPLETED|Overall Study||0
3217537|NCT02252211|3948884|FG001|COMPLETED|Overall Study||0
3217538|NCT02252211|3948885|FG002|COMPLETED|Overall Study||0
3217539|NCT02252211|3948883|FG000|NOT COMPLETED|Overall Study||5
3217540|NCT02252211|3948884|FG001|NOT COMPLETED|Overall Study||3
3217541|NCT02252211|3948885|FG002|NOT COMPLETED|Overall Study||1
3217542|NCT02252354|3948894|FG000|STARTED|Overall Study||6
3217543|NCT02252354|3948895|FG001|STARTED|Overall Study||6
3217544|NCT02252354|3948894|FG000|COMPLETED|Overall Study||6
3217545|NCT02252354|3948895|FG001|COMPLETED|Overall Study||6
3217546|NCT02252354|3948894|FG000|NOT COMPLETED|Overall Study||0
3217547|NCT02252354|3948895|FG001|NOT COMPLETED|Overall Study||0
3217548|NCT02252406|3948903|FG000|STARTED|Starting Dose Ranolazine 500 mg BID||16
3217549|NCT02252406|3948904|FG001|STARTED|Starting Dose Ranolazine 500 mg BID||17
3217550|NCT02252406|3948903|FG000|COMPLETED|Starting Dose Ranolazine 500 mg BID||12
3217551|NCT02252406|3948904|FG001|COMPLETED|Starting Dose Ranolazine 500 mg BID||14
3217552|NCT02252406|3948903|FG000|NOT COMPLETED|Starting Dose Ranolazine 500 mg BID||4
3217553|NCT02252406|3948904|FG001|NOT COMPLETED|Starting Dose Ranolazine 500 mg BID||3
3217554|NCT02252406|3948903|FG000|STARTED|Titrated to Ranolazine 1000mg BID||12
3217555|NCT02252406|3948904|FG001|STARTED|Titrated to Ranolazine 1000mg BID||14
3217556|NCT02252406|3948903|FG000|COMPLETED|Titrated to Ranolazine 1000mg BID||9
3217557|NCT02252406|3948904|FG001|COMPLETED|Titrated to Ranolazine 1000mg BID||13
3217558|NCT02252406|3948903|FG000|NOT COMPLETED|Titrated to Ranolazine 1000mg BID||3
3217559|NCT02252406|3948904|FG001|NOT COMPLETED|Titrated to Ranolazine 1000mg BID||1
3217560|NCT02252445|3948912|FG000|STARTED|Overall Study||41
3217561|NCT02252445|3948913|FG001|STARTED|Overall Study||41
3217562|NCT02252445|3948912|FG000|COMPLETED|Overall Study||41
3217563|NCT02252445|3948913|FG001|COMPLETED|Overall Study||41
3217564|NCT02252445|3948912|FG000|NOT COMPLETED|Overall Study||0
3217565|NCT02252445|3948913|FG001|NOT COMPLETED|Overall Study||0
3217566|NCT02252536|3948921|FG000|STARTED|Overall Study||173
3217567|NCT02252536|3948922|FG001|STARTED|Overall Study||173
3217568|NCT02252536|3948921|FG000|COMPLETED|Overall Study||168
3217569|NCT02252536|3948922|FG001|COMPLETED|Overall Study||170
3217570|NCT02252536|3948921|FG000|NOT COMPLETED|Overall Study||5
3217571|NCT02252536|3948922|FG001|NOT COMPLETED|Overall Study||3
3217572|NCT02252562|3948930|FG000|STARTED|Overall Study||1620
3217573|NCT02252562|3948931|FG001|STARTED|Overall Study||1636
3217574|NCT02252562|3948930|FG000|COMPLETED|Overall Study||1620
3217575|NCT02252562|3948931|FG001|COMPLETED|Overall Study||1636
3217576|NCT02252562|3948930|FG000|NOT COMPLETED|Overall Study||0
3217577|NCT02252562|3948931|FG001|NOT COMPLETED|Overall Study||0
3217578|NCT02252588|3948940|FG000|STARTED|Overall Study||24
3217579|NCT02252588|3948941|FG001|STARTED|Overall Study||20
3217580|NCT02252588|3948940|FG000|COMPLETED|Overall Study||20
3217581|NCT02252588|3948941|FG001|COMPLETED|Overall Study||20
3217582|NCT02252588|3948940|FG000|NOT COMPLETED|Overall Study||4
3217583|NCT02252588|3948941|FG001|NOT COMPLETED|Overall Study||0
3217584|NCT02252666|3948947|FG000|STARTED|Overall Study||6
3217585|NCT02252666|3948947|FG000|COMPLETED|Overall Study||6
3217586|NCT02252666|3948947|FG000|NOT COMPLETED|Overall Study||0
3217587|NCT02252718|3948951|FG000|STARTED|Overall Study||100
3217588|NCT02252718|3948951|FG000|COMPLETED|Overall Study||100
3217589|NCT02252718|3948951|FG000|NOT COMPLETED|Overall Study||0
3217590|NCT02252744|3948955|FG000|STARTED|Overall Study||286
3217591|NCT02252744|3948955|FG000|COMPLETED|Overall Study||286
3217592|NCT02252744|3948955|FG000|NOT COMPLETED|Overall Study||0
3217593|NCT02252939|3948959|FG000|STARTED|Overall Study||62
3217594|NCT02252939|3948959|FG000|COMPLETED|Overall Study||59
3217595|NCT02252939|3948959|FG000|NOT COMPLETED|Overall Study||3
3217596|NCT02252965|3948970|FG000|STARTED|Overall Study||267
3217597|NCT02252965|3948971|FG001|STARTED|Overall Study||265
3217598|NCT02252965|3948970|FG000|Safety Population|Overall Study|Out of 261, 12 subjects intolerant to the Metformin IR switched to Metformin XR group.|261
3217599|NCT02252965|3948971|FG001|Safety Population|Overall Study||264
3217600|NCT02252965|3948970|FG000|COMPLETED|Overall Study||227
3217601|NCT02252965|3948971|FG001|COMPLETED|Overall Study||222
3217602|NCT02252965|3948970|FG000|NOT COMPLETED|Overall Study||40
3217603|NCT02252965|3948971|FG001|NOT COMPLETED|Overall Study||43
3217604|NCT02253147|3948979|FG000|STARTED|Overall Study||118
3217605|NCT02253147|3948979|FG000|N Patients at W24 (Primary Outcome)|Overall Study||88
3217606|NCT02253147|3948979|FG000|N Patients at W36|Overall Study||86
3217607|NCT02253147|3948979|FG000|N Patients at W52|Overall Study||84
3217608|NCT02253147|3948979|FG000|COMPLETED|Overall Study||71
3217609|NCT02253147|3948979|FG000|NOT COMPLETED|Overall Study||47
3217610|NCT02253160|3948988|FG000|STARTED|Overall Study||1
3217611|NCT02253160|3948989|FG001|STARTED|Overall Study||12
3217612|NCT02253160|3948990|FG002|STARTED|Overall Study||10
3217613|NCT02253160|3948988|FG000|COMPLETED|Overall Study||1
3217614|NCT02253160|3948989|FG001|COMPLETED|Overall Study||12
3217615|NCT02253160|3948990|FG002|COMPLETED|Overall Study||10
3217616|NCT02253160|3948988|FG000|NOT COMPLETED|Overall Study||0
3217617|NCT02253160|3948989|FG001|NOT COMPLETED|Overall Study||0
3217618|NCT02253160|3948990|FG002|NOT COMPLETED|Overall Study||0
3217619|NCT02253173|3949004|FG000|STARTED|Overall Study||191
3217620|NCT02253173|3949005|FG001|STARTED|Overall Study||191
3217621|NCT02253173|3949006|FG002|STARTED|Overall Study||190
3217622|NCT02253173|3949007|FG003|STARTED|Overall Study||192
3217623|NCT02253173|3949004|FG000|COMPLETED|Overall Study||175
3217624|NCT02253173|3949005|FG001|COMPLETED|Overall Study||174
3217625|NCT02253173|3949006|FG002|COMPLETED|Overall Study||177
3217626|NCT02253173|3949007|FG003|COMPLETED|Overall Study||178
3217627|NCT02253173|3949004|FG000|NOT COMPLETED|Overall Study||16
3217628|NCT02253173|3949005|FG001|NOT COMPLETED|Overall Study||17
3217629|NCT02253173|3949006|FG002|NOT COMPLETED|Overall Study||13
3217630|NCT02253173|3949007|FG003|NOT COMPLETED|Overall Study||14
3217631|NCT02253433|3949023|FG000|STARTED|Overall Study||130
3217632|NCT02253433|3949024|FG001|STARTED|Overall Study||134
3217633|NCT02253433|3949023|FG000|COMPLETED|Overall Study||114
3217634|NCT02253433|3949024|FG001|COMPLETED|Overall Study||79
3217635|NCT02253433|3949023|FG000|NOT COMPLETED|Overall Study||16
3217636|NCT02253433|3949024|FG001|NOT COMPLETED|Overall Study||55
3217637|NCT02253537|3949031|FG000|STARTED|Overall Study||15
3217638|NCT02253537|3949031|FG000|COMPLETED|Overall Study||15
3217639|NCT02253537|3949031|FG000|NOT COMPLETED|Overall Study||0
3217640|NCT02253654|3949037|FG000|STARTED|Overall Study||108
3217641|NCT02253654|3949038|FG001|STARTED|Overall Study||108
3217642|NCT02253654|3949037|FG000|Received Treatment|Overall Study||104
3217643|NCT02253654|3949038|FG001|Received Treatment|Overall Study||107
3217644|NCT02253654|3949037|FG000|COMPLETED|Overall Study||85
3217645|NCT02253654|3949038|FG001|COMPLETED|Overall Study||90
3217646|NCT02253654|3949037|FG000|NOT COMPLETED|Overall Study||23
3217647|NCT02253654|3949038|FG001|NOT COMPLETED|Overall Study||18
3217648|NCT02253992|3949047|FG000|STARTED|Overall Study||6
3217649|NCT02253992|3949048|FG001|STARTED|Overall Study||4
3217650|NCT02253992|3949049|FG002|STARTED|Overall Study||150
3217651|NCT02253992|3949047|FG000|COMPLETED|Overall Study||0
3217652|NCT02253992|3949048|FG001|COMPLETED|Overall Study||0
3217653|NCT02253992|3949049|FG002|COMPLETED|Overall Study||6
3217654|NCT02253992|3949047|FG000|NOT COMPLETED|Overall Study||6
3217655|NCT02253992|3949048|FG001|NOT COMPLETED|Overall Study||4
3217656|NCT02253992|3949049|FG002|NOT COMPLETED|Overall Study||144
3217657|NCT02254252|3949073|FG000|STARTED|Overall Study||27
3217658|NCT02254252|3949074|FG001|STARTED|Overall Study||27
3217659|NCT02254252|3949073|FG000|COMPLETED|Overall Study||24
3217660|NCT02254252|3949074|FG001|COMPLETED|Overall Study||25
3217661|NCT02254252|3949073|FG000|NOT COMPLETED|Overall Study||3
3217662|NCT02254252|3949074|FG001|NOT COMPLETED|Overall Study||2
3217663|NCT02254265|3949083|FG000|STARTED|Overall Study||151
3217664|NCT02254265|3949084|FG001|STARTED|Overall Study||152
3217665|NCT02254265|3949085|FG002|STARTED|Overall Study||152
3217666|NCT02254265|3949083|FG000|COMPLETED|Overall Study||142
3217667|NCT02254265|3949084|FG001|COMPLETED|Overall Study||140
3217668|NCT02254265|3949085|FG002|COMPLETED|Overall Study||144
3217669|NCT02254265|3949083|FG000|NOT COMPLETED|Overall Study||9
3217670|NCT02254265|3949084|FG001|NOT COMPLETED|Overall Study||12
3217671|NCT02254265|3949085|FG002|NOT COMPLETED|Overall Study||8
3217672|NCT02254278|3949095|FG000|STARTED|Overall Study||158
3217673|NCT02254278|3949096|FG001|STARTED|Overall Study||150
3217674|NCT02254278|3949095|FG000|Eligible|Overall Study||157
3217675|NCT02254278|3949096|FG001|Eligible|Overall Study||149
3217676|NCT02254278|3949095|FG000|Started Study Treatment|Overall Study||152
3217677|NCT02254278|3949096|FG001|Started Study Treatment|Overall Study||147
3217678|NCT02254278|3949095|FG000|Negative Post-treatment PET|Overall Study||58
3217679|NCT02254278|3949096|FG001|Negative Post-treatment PET|Overall Study||57
3217680|NCT02254278|3949095|FG000|COMPLETED|Overall Study||157
3217681|NCT02254278|3949096|FG001|COMPLETED|Overall Study||149
3217682|NCT02254278|3949095|FG000|NOT COMPLETED|Overall Study||1
3217683|NCT02254278|3949096|FG001|NOT COMPLETED|Overall Study||1
3217684|NCT02254291|3949108|FG000|STARTED|Overall Study||103
3217685|NCT02254291|3949109|FG001|STARTED|Overall Study||102
3217686|NCT02254291|3949110|FG002|STARTED|Overall Study||103
3217687|NCT02254291|3949108|FG000|Exposed|Overall Study||103
3217688|NCT02254291|3949109|FG001|Exposed|Overall Study||102
3217689|NCT02254291|3949110|FG002|Exposed|Overall Study||103
3217690|NCT02254291|3949108|FG000|COMPLETED|Overall Study||103
3217691|NCT02254291|3949109|FG001|COMPLETED|Overall Study||99
3217692|NCT02254291|3949110|FG002|COMPLETED|Overall Study||101
3217693|NCT02254291|3949108|FG000|NOT COMPLETED|Overall Study||0
3217694|NCT02254291|3949109|FG001|NOT COMPLETED|Overall Study||3
3217695|NCT02254291|3949110|FG002|NOT COMPLETED|Overall Study||2
3217696|NCT02254304|3949120|FG000|STARTED|Overall Study||89
3217697|NCT02254304|3949121|FG001|STARTED|Overall Study||17
3217698|NCT02254304|3949120|FG000|COMPLETED|Overall Study||75
3217699|NCT02254304|3949121|FG001|COMPLETED|Overall Study||13
3217700|NCT02254304|3949120|FG000|NOT COMPLETED|Overall Study||14
3217701|NCT02254304|3949121|FG001|NOT COMPLETED|Overall Study||4
3217702|NCT02254408|3949131|FG000|STARTED|Overall Study||96
3217703|NCT02254408|3949132|FG001|STARTED|Overall Study||93
3217704|NCT02254408|3949131|FG000|COMPLETED|Overall Study||88
3217705|NCT02254408|3949132|FG001|COMPLETED|Overall Study||83
3217706|NCT02254408|3949131|FG000|NOT COMPLETED|Overall Study||8
3217707|NCT02254408|3949132|FG001|NOT COMPLETED|Overall Study||10
3217708|NCT02254421|3949140|FG000|STARTED|Overall Study||31
3217709|NCT02254421|3949141|FG001|STARTED|Overall Study||29
3217710|NCT02254421|3949140|FG000|COMPLETED|Overall Study||29
3217711|NCT02254421|3949141|FG001|COMPLETED|Overall Study||26
3217712|NCT02254421|3949140|FG000|NOT COMPLETED|Overall Study||2
3217713|NCT02254421|3949141|FG001|NOT COMPLETED|Overall Study||3
3217714|NCT02254460|3949147|FG000|STARTED|Overall Study||13
3217715|NCT02254460|3949148|FG001|STARTED|Overall Study||12
3217716|NCT02254460|3949147|FG000|COMPLETED|Overall Study||12
3217717|NCT02254460|3949148|FG001|COMPLETED|Overall Study||12
3217718|NCT02254460|3949147|FG000|NOT COMPLETED|Overall Study||1
3217719|NCT02254460|3949148|FG001|NOT COMPLETED|Overall Study||0
3217720|NCT02254473|3949156|FG000|STARTED|Overall Study||9
3217721|NCT02254473|3949157|FG001|STARTED|Overall Study||3
3217722|NCT02254473|3949156|FG000|COMPLETED|Overall Study||7
3217723|NCT02254473|3949157|FG001|COMPLETED|Overall Study||2
3217724|NCT02254473|3949156|FG000|NOT COMPLETED|Overall Study||2
3217725|NCT02254473|3949157|FG001|NOT COMPLETED|Overall Study||1
3217726|NCT02254486|3949165|FG000|STARTED|Overall Study||311
3217727|NCT02254486|3949166|FG001|STARTED|Overall Study||310
3217728|NCT02254486|3949165|FG000|COMPLETED|Overall Study||261
3217729|NCT02254486|3949166|FG001|COMPLETED|Overall Study||255
3217730|NCT02254486|3949165|FG000|NOT COMPLETED|Overall Study||50
3217731|NCT02254486|3949166|FG001|NOT COMPLETED|Overall Study||55
3217732|NCT02254551|3949172|FG000|STARTED|Dose Escalation||7
3217733|NCT02254551|3949172|FG000|Cohort 1: LDE225 400mg|Dose Escalation|1 patient was found to be refractory to bortezomib and deemed ineligible.|7
3217734|NCT02254551|3949172|FG000|Cohort 2: LDE225 600mg|Dose Escalation||0
3217735|NCT02254551|3949172|FG000|Cohort 3: LDE225 800mg|Dose Escalation||0
3217736|NCT02254551|3949172|FG000|COMPLETED|Dose Escalation|Due to toxicity and lack of efficacy, no other dose levels were examined.|4
3217737|NCT02254551|3949172|FG000|NOT COMPLETED|Dose Escalation||3
3217738|NCT02254551|3949172|FG000|STARTED|Expansion||0
3217739|NCT02254551|3949172|FG000|COMPLETED|Expansion||0
3217740|NCT02254551|3949172|FG000|NOT COMPLETED|Expansion||0
3217741|NCT02254551|3949172|FG000|STARTED|Maintenance||0
3217742|NCT02254551|3949172|FG000|COMPLETED|Maintenance||0
3217743|NCT02254551|3949172|FG000|NOT COMPLETED|Maintenance||0
3217744|NCT02254681|3949179|FG000|STARTED|Overall Study||6
3217745|NCT02254681|3949179|FG000|COMPLETED|Overall Study||0
3217746|NCT02254681|3949179|FG000|NOT COMPLETED|Overall Study||6
3217747|NCT02254772|3949184|FG000|STARTED|Overall Study||9
3217748|NCT02254772|3949184|FG000|COMPLETED|Overall Study||7
3217749|NCT02254772|3949184|FG000|NOT COMPLETED|Overall Study||2
3217750|NCT02255032|3949190|FG000|STARTED|Overall Study||17
3217751|NCT02255032|3949191|FG001|STARTED|Overall Study||5
3217752|NCT02255032|3949190|FG000|COMPLETED|Overall Study||17
3217753|NCT02255032|3949191|FG001|COMPLETED|Overall Study||5
3217754|NCT02255032|3949190|FG000|NOT COMPLETED|Overall Study||0
3217755|NCT02255032|3949191|FG001|NOT COMPLETED|Overall Study||0
3217756|NCT02255097|3949197|FG000|STARTED|Overall Study||172
3217757|NCT02255097|3949197|FG000|Treated|Overall Study||171
3217758|NCT02255097|3949197|FG000|COMPLETED|Overall Study||0
3217759|NCT02255097|3949197|FG000|NOT COMPLETED|Overall Study||172
3217760|NCT02255110|3949201|FG000|STARTED|Overall Study||6
3217761|NCT02255110|3949201|FG000|COMPLETED|Overall Study||6
3217762|NCT02255110|3949201|FG000|NOT COMPLETED|Overall Study||0
3217763|NCT02255149|3949205|FG000|STARTED|Overall Study||10
3217764|NCT02255149|3949205|FG000|COMPLETED|Overall Study||5
3217765|NCT02255149|3949205|FG000|NOT COMPLETED|Overall Study||5
3217766|NCT02255175|3949211|FG000|STARTED|Overall Study||33
3217767|NCT02255175|3949212|FG001|STARTED|Overall Study||31
3217768|NCT02255175|3949211|FG000|COMPLETED|Overall Study||16
3217769|NCT02255175|3949212|FG001|COMPLETED|Overall Study||19
3217770|NCT02255175|3949211|FG000|NOT COMPLETED|Overall Study||17
3217771|NCT02255175|3949212|FG001|NOT COMPLETED|Overall Study||12
3217772|NCT02255279|3949224|FG000|STARTED|Overall Study||144
3217773|NCT02255279|3949225|FG001|STARTED|Overall Study||143
3217774|NCT02255279|3949224|FG000|COMPLETED|Overall Study||139
3217775|NCT02255279|3949225|FG001|COMPLETED|Overall Study||134
3217776|NCT02255279|3949224|FG000|NOT COMPLETED|Overall Study||5
3217777|NCT02255279|3949225|FG001|NOT COMPLETED|Overall Study||9
3217778|NCT02255357|3949247|FG000|STARTED|Overall Study||11
3217779|NCT02255357|3949248|FG001|STARTED|Overall Study||15
3217780|NCT02255357|3949247|FG000|COMPLETED|Overall Study||4
3217781|NCT02255357|3949248|FG001|COMPLETED|Overall Study||5
3217782|NCT02255357|3949247|FG000|NOT COMPLETED|Overall Study||7
3217783|NCT02255357|3949248|FG001|NOT COMPLETED|Overall Study||10
3217784|NCT02255422|3949261|FG000|STARTED|Overall Study||13
3217785|NCT02255422|3949262|FG001|STARTED|Overall Study||6
3217786|NCT02255422|3949263|FG002|STARTED|Overall Study||6
3217787|NCT02255422|3949264|FG003|STARTED|Overall Study||6
3217788|NCT02255422|3949265|FG004|STARTED|Overall Study||6
3217789|NCT02255422|3949266|FG005|STARTED|Overall Study||6
3217790|NCT02255422|3949267|FG006|STARTED|Overall Study||10
3217791|NCT02255422|3949261|FG000|COMPLETED|Overall Study||13
3217792|NCT02255422|3949262|FG001|COMPLETED|Overall Study||6
3217793|NCT02255422|3949263|FG002|COMPLETED|Overall Study||5
3217794|NCT02255422|3949264|FG003|COMPLETED|Overall Study||6
3217795|NCT02255422|3949265|FG004|COMPLETED|Overall Study||6
3217796|NCT02255422|3949266|FG005|COMPLETED|Overall Study||6
3217797|NCT02255422|3949267|FG006|COMPLETED|Overall Study||8
3217798|NCT02255422|3949261|FG000|NOT COMPLETED|Overall Study||0
3217799|NCT02255422|3949262|FG001|NOT COMPLETED|Overall Study||0
3217800|NCT02255422|3949263|FG002|NOT COMPLETED|Overall Study||1
3217801|NCT02255422|3949264|FG003|NOT COMPLETED|Overall Study||0
3217802|NCT02255422|3949265|FG004|NOT COMPLETED|Overall Study||0
3217803|NCT02255422|3949266|FG005|NOT COMPLETED|Overall Study||0
3217804|NCT02255422|3949267|FG006|NOT COMPLETED|Overall Study||2
3217805|NCT02255461|3949288|FG000|STARTED|Overall Study||3
3217806|NCT02255461|3949289|FG001|STARTED|Overall Study||12
3217807|NCT02255461|3949290|FG002|STARTED|Overall Study||6
3217808|NCT02255461|3949291|FG003|STARTED|Overall Study||4
3217809|NCT02255461|3949292|FG004|STARTED|Overall Study||10
3217810|NCT02255461|3949288|FG000|COMPLETED|Overall Study||3
3217811|NCT02255461|3949289|FG001|COMPLETED|Overall Study||10
3217812|NCT02255461|3949290|FG002|COMPLETED|Overall Study||5
3217813|NCT02255461|3949291|FG003|COMPLETED|Overall Study||4
3217814|NCT02255461|3949292|FG004|COMPLETED|Overall Study||8
3217815|NCT02255461|3949288|FG000|NOT COMPLETED|Overall Study||0
3217816|NCT02255461|3949289|FG001|NOT COMPLETED|Overall Study||2
3217817|NCT02255461|3949290|FG002|NOT COMPLETED|Overall Study||1
3217818|NCT02255461|3949291|FG003|NOT COMPLETED|Overall Study||0
3217819|NCT02255461|3949292|FG004|NOT COMPLETED|Overall Study||2
3217820|NCT02255474|3949312|FG000|STARTED|Overall Study||98
3217821|NCT02255474|3949313|FG001|STARTED|Overall Study||98
3217822|NCT02255474|3949314|FG002|STARTED|Overall Study||98
3217823|NCT02255474|3949312|FG000|COMPLETED|Overall Study||96
3217824|NCT02255474|3949313|FG001|COMPLETED|Overall Study||96
3217825|NCT02255474|3949314|FG002|COMPLETED|Overall Study||95
3217826|NCT02255474|3949312|FG000|NOT COMPLETED|Overall Study||2
3217827|NCT02255474|3949313|FG001|NOT COMPLETED|Overall Study||2
3217828|NCT02255474|3949314|FG002|NOT COMPLETED|Overall Study||3
3217829|NCT02255500|3949325|FG000|STARTED|Overall Study||16
3217830|NCT02255500|3949326|FG001|STARTED|Overall Study||7
3217831|NCT02255500|3949325|FG000|COMPLETED|Overall Study||15
3217832|NCT02255500|3949326|FG001|COMPLETED|Overall Study||7
3217833|NCT02255500|3949325|FG000|NOT COMPLETED|Overall Study||1
3217834|NCT02255500|3949326|FG001|NOT COMPLETED|Overall Study||0
3217835|NCT02255513|3949334|FG000|STARTED|Open-label, Treatment Optimization||43
3217836|NCT02255513|3949335|FG001|STARTED|Open-label, Treatment Optimization||0
3217837|NCT02255513|3949334|FG000|COMPLETED|Open-label, Treatment Optimization||43
3217838|NCT02255513|3949335|FG001|COMPLETED|Open-label, Treatment Optimization||0
3217839|NCT02255513|3949334|FG000|NOT COMPLETED|Open-label, Treatment Optimization||0
3217840|NCT02255513|3949335|FG001|NOT COMPLETED|Open-label, Treatment Optimization||0
3217841|NCT02255513|3949334|FG000|STARTED|Double Blind, Placebo-controlled||22
3217842|NCT02255513|3949335|FG001|STARTED|Double Blind, Placebo-controlled||21
3367282|NCT03848403|4098717|FG000|STARTED|Period 1 (Day 1)||24
3367283|NCT03848403|4098718|FG001|STARTED|Period 1 (Day 1)||24
3367284|NCT03848403|4098719|FG002|STARTED|Period 1 (Day 1)||22
3367285|NCT03848403|4098717|FG000|Received Intervention|Period 1 (Day 1)||24
3367286|NCT03848403|4098718|FG001|Received Intervention|Period 1 (Day 1)||24
3367287|NCT03848403|4098719|FG002|Received Intervention|Period 1 (Day 1)||22
3367288|NCT03848403|4098717|FG000|COMPLETED|Period 1 (Day 1)||24
3367289|NCT03848403|4098718|FG001|COMPLETED|Period 1 (Day 1)||24
3367290|NCT03848403|4098719|FG002|COMPLETED|Period 1 (Day 1)||22
3367291|NCT03848403|4098717|FG000|NOT COMPLETED|Period 1 (Day 1)||0
3367292|NCT03848403|4098718|FG001|NOT COMPLETED|Period 1 (Day 1)||0
3367293|NCT03848403|4098719|FG002|NOT COMPLETED|Period 1 (Day 1)||0
3367294|NCT03848403|4098717|FG000|STARTED|Period 2 (Day 8)||24
3367295|NCT03848403|4098718|FG001|STARTED|Period 2 (Day 8)||24
3367296|NCT03848403|4098719|FG002|STARTED|Period 2 (Day 8)||22
3367297|NCT03848403|4098717|FG000|Received at Least One Dose of Study Drug|Period 2 (Day 8)||24
3367298|NCT03848403|4098718|FG001|Received at Least One Dose of Study Drug|Period 2 (Day 8)||24
3367299|NCT03848403|4098719|FG002|Received at Least One Dose of Study Drug|Period 2 (Day 8)||22
3367300|NCT03848403|4098717|FG000|COMPLETED|Period 2 (Day 8)||15
3367301|NCT03848403|4098718|FG001|COMPLETED|Period 2 (Day 8)||15
3367302|NCT03848403|4098719|FG002|COMPLETED|Period 2 (Day 8)||15
3367303|NCT03848403|4098717|FG000|NOT COMPLETED|Period 2 (Day 8)||9
3217843|NCT02255513|3949334|FG000|COMPLETED|Double Blind, Placebo-controlled||22
3217844|NCT02255513|3949335|FG001|COMPLETED|Double Blind, Placebo-controlled||21
3217845|NCT02255513|3949334|FG000|NOT COMPLETED|Double Blind, Placebo-controlled||0
3217846|NCT02255513|3949335|FG001|NOT COMPLETED|Double Blind, Placebo-controlled||0
3217847|NCT02255552|3949343|FG000|STARTED|Overall Study||79
3217848|NCT02255552|3949344|FG001|STARTED|Overall Study||30
3217849|NCT02255552|3949343|FG000|COMPLETED|Overall Study||78
3217850|NCT02255552|3949344|FG001|COMPLETED|Overall Study||15
3217851|NCT02255552|3949343|FG000|NOT COMPLETED|Overall Study||1
3217852|NCT02255552|3949344|FG001|NOT COMPLETED|Overall Study||15
3217853|NCT02255565|3949353|FG000|STARTED|Overall Study||9
3217854|NCT02255565|3949354|FG001|STARTED|Overall Study||9
3217855|NCT02255565|3949355|FG002|STARTED|Overall Study||9
3217856|NCT02255565|3949353|FG000|COMPLETED|Overall Study||9
3217857|NCT02255565|3949354|FG001|COMPLETED|Overall Study||8
3217858|NCT02255565|3949355|FG002|COMPLETED|Overall Study||9
3217859|NCT02255565|3949353|FG000|NOT COMPLETED|Overall Study||0
3217860|NCT02255565|3949354|FG001|NOT COMPLETED|Overall Study||1
3217861|NCT02255565|3949355|FG002|NOT COMPLETED|Overall Study||0
3217862|NCT02255604|3949399|FG000|STARTED|Overall Study||12
3217863|NCT02255604|3949400|FG001|STARTED|Overall Study||12
3217864|NCT02255604|3949401|FG002|STARTED|Overall Study||12
3217865|NCT02255604|3949399|FG000|COMPLETED|Overall Study||10
3217866|NCT02255604|3949400|FG001|COMPLETED|Overall Study||11
3217867|NCT02255604|3949401|FG002|COMPLETED|Overall Study||9
3217868|NCT02255604|3949399|FG000|NOT COMPLETED|Overall Study||2
3217869|NCT02255604|3949400|FG001|NOT COMPLETED|Overall Study||1
3217870|NCT02255604|3949401|FG002|NOT COMPLETED|Overall Study||3
3217871|NCT02255656|3949409|FG000|STARTED|Overall Study||1062
3217872|NCT02255656|3949409|FG000|COMPLETED|Overall Study||592
3217873|NCT02255656|3949409|FG000|NOT COMPLETED|Overall Study||470
3217874|NCT02255760|3949425|FG000|STARTED|Overall Study||14
3217875|NCT02255760|3949426|FG001|STARTED|Overall Study||3
3217876|NCT02255760|3949427|FG002|STARTED|Overall Study||15
3217877|NCT02255760|3949428|FG003|STARTED|Overall Study||15
3217878|NCT02255760|3949429|FG004|STARTED|Overall Study||9
3217879|NCT02255760|3949425|FG000|COMPLETED|Overall Study||14
3217880|NCT02255760|3949426|FG001|COMPLETED|Overall Study||2
3217881|NCT02255760|3949427|FG002|COMPLETED|Overall Study||15
3217882|NCT02255760|3949428|FG003|COMPLETED|Overall Study||15
3217883|NCT02255760|3949429|FG004|COMPLETED|Overall Study||9
3217884|NCT02255760|3949425|FG000|NOT COMPLETED|Overall Study||0
3217885|NCT02255760|3949426|FG001|NOT COMPLETED|Overall Study||1
3217886|NCT02255760|3949427|FG002|NOT COMPLETED|Overall Study||0
3217887|NCT02255760|3949428|FG003|NOT COMPLETED|Overall Study||0
3217888|NCT02255760|3949429|FG004|NOT COMPLETED|Overall Study||0
3217889|NCT02255981|3949445|FG000|STARTED|Overall Study|Both eyes of each patient were included except 2 that not were treatable|33
3217890|NCT02255981|3949445|FG000|COMPLETED|Overall Study|2 eyes of the final 29 subjects were excluded.|29
3217891|NCT02255981|3949445|FG000|NOT COMPLETED|Overall Study||4
3217892|NCT02256072|3949457|FG000|STARTED|Overall Study||194
3217893|NCT02256072|3949458|FG001|STARTED|Overall Study||191
3217894|NCT02256072|3949457|FG000|Completed 1 Month Follow-Up|Overall Study|Completed the 1-month follow-up|167
3217895|NCT02256072|3949458|FG001|Completed 1 Month Follow-Up|Overall Study||179
3217896|NCT02256072|3949457|FG000|COMPLETED|Overall Study|Completed the 3-month follow-up|152
3217897|NCT02256072|3949458|FG001|COMPLETED|Overall Study||162
3217898|NCT02256072|3949457|FG000|NOT COMPLETED|Overall Study||42
3217899|NCT02256072|3949458|FG001|NOT COMPLETED|Overall Study||29
3217900|NCT02256111|3949467|FG000|STARTED|Overall Study||13
3217901|NCT02256111|3949468|FG001|STARTED|Overall Study||13
3217902|NCT02256111|3949467|FG000|COMPLETED|Overall Study||13
3217903|NCT02256111|3949468|FG001|COMPLETED|Overall Study||13
3217904|NCT02256111|3949467|FG000|NOT COMPLETED|Overall Study||0
3217905|NCT02256111|3949468|FG001|NOT COMPLETED|Overall Study||0
3217906|NCT02256189|3949477|FG000|STARTED|Overall Study||15
3217907|NCT02256189|3949478|FG001|STARTED|Overall Study||13
3217908|NCT02256189|3949477|FG000|COMPLETED|Overall Study||15
3217909|NCT02256189|3949478|FG001|COMPLETED|Overall Study||13
3217910|NCT02256189|3949477|FG000|NOT COMPLETED|Overall Study||0
3217911|NCT02256189|3949478|FG001|NOT COMPLETED|Overall Study||0
3217912|NCT02256267|3949486|FG000|STARTED|Period 1 (Day 1; Day 2 to Day 9 Washout)||24
3217913|NCT02256267|3949486|FG000|Received at Least 1 Dose of LY2835219|Period 1 (Day 1; Day 2 to Day 9 Washout)||24
3217914|NCT02256267|3949486|FG000|COMPLETED|Period 1 (Day 1; Day 2 to Day 9 Washout)||23
3217915|NCT02256267|3949486|FG000|NOT COMPLETED|Period 1 (Day 1; Day 2 to Day 9 Washout)||1
3217916|NCT02256267|3949486|FG000|STARTED|Period 2 (Day 1 to Day 6)||23
3217917|NCT02256267|3949486|FG000|Received at Least 1 Dose of Rifampin|Period 2 (Day 1 to Day 6)||23
3217918|NCT02256267|3949486|FG000|COMPLETED|Period 2 (Day 1 to Day 6)||23
3217919|NCT02256267|3949486|FG000|NOT COMPLETED|Period 2 (Day 1 to Day 6)||0
3217920|NCT02256267|3949486|FG000|STARTED|Period 2 (Day 7 to Day 14)||23
3217921|NCT02256267|3949486|FG000|Received LY2835219 + Rifampin|Period 2 (Day 7 to Day 14)||23
3217922|NCT02256267|3949486|FG000|COMPLETED|Period 2 (Day 7 to Day 14)||22
3217923|NCT02256267|3949486|FG000|NOT COMPLETED|Period 2 (Day 7 to Day 14)||1
3217924|NCT02256345|3949495|FG000|STARTED|Overall Study||9
3217925|NCT02256345|3949496|FG001|STARTED|Overall Study||3
3217926|NCT02256345|3949495|FG000|COMPLETED|Overall Study||9
3217927|NCT02256345|3949496|FG001|COMPLETED|Overall Study||3
3217928|NCT02256345|3949495|FG000|NOT COMPLETED|Overall Study||0
3217929|NCT02256345|3949496|FG001|NOT COMPLETED|Overall Study||0
3217930|NCT02256358|3949504|FG000|STARTED|Overall Study||34
3217931|NCT02256358|3949505|FG001|STARTED|Overall Study||34
3217932|NCT02256358|3949504|FG000|COMPLETED|Overall Study||34
3217933|NCT02256358|3949505|FG001|COMPLETED|Overall Study||33
3217934|NCT02256358|3949504|FG000|NOT COMPLETED|Overall Study||0
3217935|NCT02256358|3949505|FG001|NOT COMPLETED|Overall Study||1
3217936|NCT02256384|3949511|FG000|STARTED|Overall Study||76
3217937|NCT02256384|3949511|FG000|COMPLETED|Overall Study||62
3217938|NCT02256384|3949511|FG000|NOT COMPLETED|Overall Study||14
3217939|NCT02256436|3949521|FG000|STARTED|Overall Study||272
3217940|NCT02256436|3949522|FG001|STARTED|Overall Study||270
3217941|NCT02256436|3949521|FG000|Treated|Overall Study||255
3217942|NCT02256436|3949522|FG001|Treated|Overall Study||266
3217943|NCT02256436|3949521|FG000|Switched Over to Pembrolizumab|Overall Study||13
3217944|NCT02256436|3949522|FG001|Switched Over to Pembrolizumab|Overall Study||0
3217945|NCT02256436|3949521|FG000|COMPLETED|Overall Study||0
3217946|NCT02256436|3949522|FG001|COMPLETED|Overall Study||0
3217947|NCT02256436|3949521|FG000|NOT COMPLETED|Overall Study||272
3217948|NCT02256436|3949522|FG001|NOT COMPLETED|Overall Study||270
3217949|NCT02256488|3949533|FG000|STARTED|Overall Study||387
3217950|NCT02256488|3949534|FG001|STARTED|Overall Study||392
3217951|NCT02256488|3949535|FG002|STARTED|Overall Study||392
3217952|NCT02256488|3949536|FG003|STARTED|Overall Study||390
3217953|NCT02256488|3949533|FG000|COMPLETED|Overall Study||379
3217954|NCT02256488|3949534|FG001|COMPLETED|Overall Study||386
3217955|NCT02256488|3949535|FG002|COMPLETED|Overall Study||382
3217956|NCT02256488|3949536|FG003|COMPLETED|Overall Study||384
3217957|NCT02256488|3949533|FG000|NOT COMPLETED|Overall Study||8
3217958|NCT02256488|3949534|FG001|NOT COMPLETED|Overall Study||6
3217959|NCT02256488|3949535|FG002|NOT COMPLETED|Overall Study||10
3217960|NCT02256488|3949536|FG003|NOT COMPLETED|Overall Study||6
3217961|NCT02256540|3949547|FG000|STARTED|Overall Study||6
3217962|NCT02256540|3949548|FG001|STARTED|Overall Study||6
3217963|NCT02256540|3949549|FG002|STARTED|Overall Study||6
3217964|NCT02256540|3949547|FG000|COMPLETED|Overall Study||6
3217965|NCT02256540|3949548|FG001|COMPLETED|Overall Study||5
3217966|NCT02256540|3949549|FG002|COMPLETED|Overall Study||4
3217967|NCT02256540|3949547|FG000|NOT COMPLETED|Overall Study||0
3217968|NCT02256540|3949548|FG001|NOT COMPLETED|Overall Study||1
3217969|NCT02256540|3949549|FG002|NOT COMPLETED|Overall Study||2
3217970|NCT02256553|3949557|FG000|STARTED|Period I||102
3217971|NCT02256553|3949557|FG000|COMPLETED|Period I||96
3217972|NCT02256553|3949557|FG000|NOT COMPLETED|Period I||6
3217973|NCT02256553|3949557|FG000|STARTED|Period II||96
3217974|NCT02256553|3949557|FG000|COMPLETED|Period II||94
3217975|NCT02256553|3949557|FG000|NOT COMPLETED|Period II||2
3217976|NCT02256553|3949557|FG000|STARTED|Period III||94
3217977|NCT02256553|3949557|FG000|COMPLETED|Period III||91
3217978|NCT02256553|3949557|FG000|NOT COMPLETED|Period III||3
3217979|NCT02256839|3949565|FG000|STARTED|Overall Study||53
3217980|NCT02256839|3949566|FG001|STARTED|Overall Study||215
3217981|NCT02256839|3949565|FG000|COMPLETED|Overall Study||51
3217982|NCT02256839|3949566|FG001|COMPLETED|Overall Study||212
3217983|NCT02256839|3949565|FG000|NOT COMPLETED|Overall Study||2
3217984|NCT02256839|3949566|FG001|NOT COMPLETED|Overall Study||3
3217985|NCT02256891|3949574|FG000|STARTED|Overall Study||55
3217986|NCT02256891|3949575|FG001|STARTED|Overall Study||42
3217987|NCT02256891|3949574|FG000|COMPLETED|Overall Study||43
3217988|NCT02256891|3949575|FG001|COMPLETED|Overall Study||29
3217989|NCT02256891|3949574|FG000|NOT COMPLETED|Overall Study||12
3217990|NCT02256891|3949575|FG001|NOT COMPLETED|Overall Study||13
3217991|NCT02256917|3949583|FG000|STARTED|Pharmacokinetic (PK) Evaluation Phase||58
3217992|NCT02256917|3949583|FG000|COMPLETED|Pharmacokinetic (PK) Evaluation Phase||58
3217993|NCT02256917|3949583|FG000|NOT COMPLETED|Pharmacokinetic (PK) Evaluation Phase||0
3217994|NCT02256917|3949583|FG000|STARTED|Prophylactic Treatment Phase I||57
3217995|NCT02256917|3949583|FG000|COMPLETED|Prophylactic Treatment Phase I||56
3217996|NCT02256917|3949583|FG000|NOT COMPLETED|Prophylactic Treatment Phase I||1
3217997|NCT02256917|3949583|FG000|STARTED|Prophylactic Treatment Phase II||56
3217998|NCT02256917|3949583|FG000|COMPLETED|Prophylactic Treatment Phase II||52
3367304|NCT03848403|4098718|FG001|NOT COMPLETED|Period 2 (Day 8)||9
3367305|NCT03848403|4098719|FG002|NOT COMPLETED|Period 2 (Day 8)||7
3367306|NCT03848403|4098717|FG000|STARTED|Period 3 (Day 15)||15
3367307|NCT03848403|4098718|FG001|STARTED|Period 3 (Day 15)||15
3367308|NCT03848403|4098719|FG002|STARTED|Period 3 (Day 15)||15
3367309|NCT03848403|4098717|FG000|COMPLETED|Period 3 (Day 15)||15
3367310|NCT03848403|4098718|FG001|COMPLETED|Period 3 (Day 15)||15
3367311|NCT03848403|4098719|FG002|COMPLETED|Period 3 (Day 15)||15
3367312|NCT03848403|4098717|FG000|NOT COMPLETED|Period 3 (Day 15)||0
3367313|NCT03848403|4098718|FG001|NOT COMPLETED|Period 3 (Day 15)||0
3367314|NCT03848403|4098719|FG002|NOT COMPLETED|Period 3 (Day 15)||0
3367315|NCT03847233|4098727|FG000|STARTED|Index Procedure||31
3367316|NCT03847233|4098727|FG000|COMPLETED|Index Procedure||31
3367317|NCT03847233|4098727|FG000|NOT COMPLETED|Index Procedure||0
3367318|NCT03847233|4098727|FG000|STARTED|6 Month After Index Procedure||31
3367319|NCT03847233|4098727|FG000|COMPLETED|6 Month After Index Procedure||30
3217999|NCT02256917|3949583|FG000|NOT COMPLETED|Prophylactic Treatment Phase II||4
3218000|NCT02256969|3949597|FG000|STARTED|Overall Study||15
3218001|NCT02256969|3949598|FG001|STARTED|Overall Study||15
3218002|NCT02256969|3949599|FG002|STARTED|Overall Study||15
3367320|NCT03847233|4098727|FG000|NOT COMPLETED|6 Month After Index Procedure||1
3367321|NCT03879603|4098738|FG000|STARTED|Overall Study||5
3218003|NCT02256969|3949597|FG000|COMPLETED|Overall Study||13
3218004|NCT02256969|3949598|FG001|COMPLETED|Overall Study||14
3218005|NCT02256969|3949599|FG002|COMPLETED|Overall Study||14
3218006|NCT02256969|3949597|FG000|NOT COMPLETED|Overall Study||2
3218007|NCT02256969|3949598|FG001|NOT COMPLETED|Overall Study||1
3218008|NCT02256969|3949599|FG002|NOT COMPLETED|Overall Study||1
3218009|NCT02256982|3949609|FG000|STARTED|Overall Study||1
3218010|NCT02256982|3949610|FG001|STARTED|Overall Study||2
3218011|NCT02256982|3949609|FG000|COMPLETED|Overall Study||1
3218012|NCT02256982|3949610|FG001|COMPLETED|Overall Study||1
3218013|NCT02256982|3949609|FG000|NOT COMPLETED|Overall Study||0
3218014|NCT02256982|3949610|FG001|NOT COMPLETED|Overall Study||1
3218015|NCT02257099|3949616|FG000|STARTED|Overall Study||20
3218016|NCT02257099|3949616|FG000|COMPLETED|Overall Study||20
3218017|NCT02257099|3949616|FG000|NOT COMPLETED|Overall Study||0
3218018|NCT02257177|3949633|FG000|STARTED|Overall Study||4
3218019|NCT02257177|3949634|FG001|STARTED|Overall Study||4
3218020|NCT02257177|3949635|FG002|STARTED|Overall Study||4
3218021|NCT02257177|3949636|FG003|STARTED|Overall Study||4
3218022|NCT02257177|3949637|FG004|STARTED|Overall Study||4
3218023|NCT02257177|3949638|FG005|STARTED|Overall Study||4
3218024|NCT02257177|3949639|FG006|STARTED|Overall Study||12
3218025|NCT02257177|3949640|FG007|STARTED|Overall Study||5
3218026|NCT02257177|3949641|FG008|STARTED|Overall Study||5
3218027|NCT02257177|3949642|FG009|STARTED|Overall Study||5
3218028|NCT02257177|3949643|FG010|STARTED|Overall Study||9
3218029|NCT02257177|3949633|FG000|COMPLETED|Overall Study||4
3218030|NCT02257177|3949634|FG001|COMPLETED|Overall Study||4
3218031|NCT02257177|3949635|FG002|COMPLETED|Overall Study||4
3218032|NCT02257177|3949636|FG003|COMPLETED|Overall Study||4
3218033|NCT02257177|3949637|FG004|COMPLETED|Overall Study||4
3218034|NCT02257177|3949638|FG005|COMPLETED|Overall Study||4
3218035|NCT02257177|3949639|FG006|COMPLETED|Overall Study||12
3218036|NCT02257177|3949640|FG007|COMPLETED|Overall Study||5
3218037|NCT02257177|3949641|FG008|COMPLETED|Overall Study||5
3218038|NCT02257177|3949642|FG009|COMPLETED|Overall Study||4
3218039|NCT02257177|3949643|FG010|COMPLETED|Overall Study||9
3218040|NCT02257177|3949633|FG000|NOT COMPLETED|Overall Study||0
3218041|NCT02257177|3949634|FG001|NOT COMPLETED|Overall Study||0
3218042|NCT02257177|3949635|FG002|NOT COMPLETED|Overall Study||0
3218043|NCT02257177|3949636|FG003|NOT COMPLETED|Overall Study||0
3218044|NCT02257177|3949637|FG004|NOT COMPLETED|Overall Study||0
3218045|NCT02257177|3949638|FG005|NOT COMPLETED|Overall Study||0
3218046|NCT02257177|3949639|FG006|NOT COMPLETED|Overall Study||0
3218047|NCT02257177|3949640|FG007|NOT COMPLETED|Overall Study||0
3218048|NCT02257177|3949641|FG008|NOT COMPLETED|Overall Study||0
3218049|NCT02257177|3949642|FG009|NOT COMPLETED|Overall Study||1
3218050|NCT02257177|3949643|FG010|NOT COMPLETED|Overall Study||0
3218051|NCT02257372|3949669|FG000|STARTED|Overall Study||117
3218052|NCT02257372|3949670|FG001|STARTED|Overall Study||119
3218053|NCT02257372|3949669|FG000|COMPLETED|Overall Study||110
3218054|NCT02257372|3949670|FG001|COMPLETED|Overall Study||109
3218055|NCT02257372|3949669|FG000|NOT COMPLETED|Overall Study||7
3218056|NCT02257372|3949670|FG001|NOT COMPLETED|Overall Study||10
3218057|NCT02257385|3949678|FG000|STARTED|Overall Study||482
3218058|NCT02257385|3949679|FG001|STARTED|Overall Study||479
3218059|NCT02257385|3949678|FG000|COMPLETED|Overall Study||460
3218060|NCT02257385|3949679|FG001|COMPLETED|Overall Study||457
3218061|NCT02257385|3949678|FG000|NOT COMPLETED|Overall Study||22
3218062|NCT02257385|3949679|FG001|NOT COMPLETED|Overall Study||22
3218063|NCT02257489|3949694|FG000|STARTED|Overall Study||6
3218064|NCT02257489|3949695|FG001|STARTED|Overall Study||6
3218065|NCT02257489|3949696|FG002|STARTED|Overall Study||6
3218066|NCT02257489|3949697|FG003|STARTED|Overall Study||6
3218067|NCT02257489|3949698|FG004|STARTED|Overall Study||6
3218068|NCT02257489|3949699|FG005|STARTED|Overall Study||6
3218069|NCT02257489|3949700|FG006|STARTED|Overall Study||6
3218070|NCT02257489|3949701|FG007|STARTED|Overall Study||10
3218071|NCT02257489|3949702|FG008|STARTED|Overall Study||6
3218072|NCT02257489|3949694|FG000|COMPLETED|Overall Study||6
3218073|NCT02257489|3949695|FG001|COMPLETED|Overall Study||6
3218074|NCT02257489|3949696|FG002|COMPLETED|Overall Study||6
3218075|NCT02257489|3949697|FG003|COMPLETED|Overall Study||5
3218076|NCT02257489|3949698|FG004|COMPLETED|Overall Study||6
3218077|NCT02257489|3949699|FG005|COMPLETED|Overall Study||6
3218078|NCT02257489|3949700|FG006|COMPLETED|Overall Study||6
3218079|NCT02257489|3949701|FG007|COMPLETED|Overall Study||10
3218080|NCT02257489|3949702|FG008|COMPLETED|Overall Study||6
3218081|NCT02257489|3949694|FG000|NOT COMPLETED|Overall Study||0
3218082|NCT02257489|3949695|FG001|NOT COMPLETED|Overall Study||0
3218083|NCT02257489|3949696|FG002|NOT COMPLETED|Overall Study||0
3218084|NCT02257489|3949697|FG003|NOT COMPLETED|Overall Study||1
3218085|NCT02257489|3949698|FG004|NOT COMPLETED|Overall Study||0
3218086|NCT02257489|3949699|FG005|NOT COMPLETED|Overall Study||0
3218087|NCT02257489|3949700|FG006|NOT COMPLETED|Overall Study||0
3218088|NCT02257489|3949701|FG007|NOT COMPLETED|Overall Study||0
3218089|NCT02257489|3949702|FG008|NOT COMPLETED|Overall Study||0
3218090|NCT02257541|3949727|FG000|STARTED|Overall Study||3
3218091|NCT02257541|3949728|FG001|STARTED|Overall Study||8
3218092|NCT02257541|3949729|FG002|STARTED|Overall Study||1
3218093|NCT02257541|3949730|FG003|STARTED|Overall Study||3
3218094|NCT02257541|3949731|FG004|STARTED|Overall Study||1
3218095|NCT02257541|3949727|FG000|COMPLETED|Overall Study||3
3218096|NCT02257541|3949728|FG001|COMPLETED|Overall Study||8
3218097|NCT02257541|3949729|FG002|COMPLETED|Overall Study||1
3218098|NCT02257541|3949730|FG003|COMPLETED|Overall Study||3
3218099|NCT02257541|3949731|FG004|COMPLETED|Overall Study||1
3218100|NCT02257541|3949727|FG000|NOT COMPLETED|Overall Study||0
3218101|NCT02257541|3949728|FG001|NOT COMPLETED|Overall Study||0
3218102|NCT02257541|3949729|FG002|NOT COMPLETED|Overall Study||0
3218103|NCT02257541|3949730|FG003|NOT COMPLETED|Overall Study||0
3218104|NCT02257541|3949731|FG004|NOT COMPLETED|Overall Study||0
3218105|NCT02257632|3949744|FG000|STARTED|Overall Study||19
3218106|NCT02257632|3949745|FG001|STARTED|Overall Study||22
3218107|NCT02257632|3949744|FG000|Full Analysis Set (FAS)|Overall Study||19
3218108|NCT02257632|3949745|FG001|Full Analysis Set (FAS)|Overall Study||21
3218109|NCT02257632|3949744|FG000|Safety Set (SAF)|Overall Study||19
3218110|NCT02257632|3949745|FG001|Safety Set (SAF)|Overall Study||21
3218111|NCT02257632|3949744|FG000|Per-Protocol Set (PPS)|Overall Study||17
3218112|NCT02257632|3949745|FG001|Per-Protocol Set (PPS)|Overall Study||20
3218113|NCT02257632|3949744|FG000|COMPLETED|Overall Study||18
3218114|NCT02257632|3949745|FG001|COMPLETED|Overall Study||19
3218115|NCT02257632|3949744|FG000|NOT COMPLETED|Overall Study||1
3218116|NCT02257632|3949745|FG001|NOT COMPLETED|Overall Study||3
3218117|NCT02257684|3949753|FG000|STARTED|Overall Study||4
3218118|NCT02257684|3949753|FG000|COMPLETED|Overall Study||0
3218119|NCT02257684|3949753|FG000|NOT COMPLETED|Overall Study||4
3218120|NCT02257957|3949759|FG000|STARTED|Overall Study||15
3218121|NCT02257957|3949760|FG001|STARTED|Overall Study||15
3218122|NCT02257957|3949759|FG000|COMPLETED|Overall Study||15
3218123|NCT02257957|3949760|FG001|COMPLETED|Overall Study||15
3218124|NCT02257957|3949759|FG000|NOT COMPLETED|Overall Study||0
3218125|NCT02257957|3949760|FG001|NOT COMPLETED|Overall Study||0
3218126|NCT02257970|3949770|FG000|STARTED|Part 1||50
3218127|NCT02257970|3949771|FG001|STARTED|Part 1||0
3218128|NCT02257970|3949772|FG002|STARTED|Part 1||0
3218129|NCT02257970|3949773|FG003|STARTED|Part 1||0
3218130|NCT02257970|3949770|FG000|COMPLETED|Part 1||50
3218131|NCT02257970|3949771|FG001|COMPLETED|Part 1||0
3218132|NCT02257970|3949772|FG002|COMPLETED|Part 1||0
3218133|NCT02257970|3949773|FG003|COMPLETED|Part 1||0
3218134|NCT02257970|3949770|FG000|NOT COMPLETED|Part 1||0
3218135|NCT02257970|3949771|FG001|NOT COMPLETED|Part 1||0
3218136|NCT02257970|3949772|FG002|NOT COMPLETED|Part 1||0
3218137|NCT02257970|3949773|FG003|NOT COMPLETED|Part 1||0
3218138|NCT02257970|3949770|FG000|STARTED|Part 2||0
3218139|NCT02257970|3949771|FG001|STARTED|Part 2||23
3218140|NCT02257970|3949772|FG002|STARTED|Part 2||0
3218141|NCT02257970|3949773|FG003|STARTED|Part 2||0
3218142|NCT02257970|3949770|FG000|COMPLETED|Part 2||0
3218143|NCT02257970|3949771|FG001|COMPLETED|Part 2||16
3218144|NCT02257970|3949772|FG002|COMPLETED|Part 2||0
3218145|NCT02257970|3949773|FG003|COMPLETED|Part 2||0
3218146|NCT02257970|3949770|FG000|NOT COMPLETED|Part 2||0
3218147|NCT02257970|3949771|FG001|NOT COMPLETED|Part 2||7
3218148|NCT02257970|3949772|FG002|NOT COMPLETED|Part 2||0
3218149|NCT02257970|3949773|FG003|NOT COMPLETED|Part 2||0
3218150|NCT02257970|3949770|FG000|STARTED|Part 3||0
3218151|NCT02257970|3949771|FG001|STARTED|Part 3||0
3218152|NCT02257970|3949772|FG002|STARTED|Part 3||23
3218153|NCT02257970|3949773|FG003|STARTED|Part 3||21
3218154|NCT02257970|3949770|FG000|COMPLETED|Part 3||0
3218155|NCT02257970|3949771|FG001|COMPLETED|Part 3||0
3218156|NCT02257970|3949772|FG002|COMPLETED|Part 3||16
3218157|NCT02257970|3949773|FG003|COMPLETED|Part 3||14
3218158|NCT02257970|3949770|FG000|NOT COMPLETED|Part 3||0
3218159|NCT02257970|3949771|FG001|NOT COMPLETED|Part 3||0
3218160|NCT02257970|3949772|FG002|NOT COMPLETED|Part 3||7
3218161|NCT02257970|3949773|FG003|NOT COMPLETED|Part 3||7
3218162|NCT02258074|3949796|FG000|STARTED|Overall Study||53
3218163|NCT02258074|3949797|FG001|STARTED|Overall Study||50
3218164|NCT02258074|3949798|FG002|STARTED|Overall Study||51
3218165|NCT02258074|3949799|FG003|STARTED|Overall Study||51
3218166|NCT02258074|3949796|FG000|COMPLETED|Overall Study||52
3218167|NCT02258074|3949797|FG001|COMPLETED|Overall Study||50
3218168|NCT02258074|3949798|FG002|COMPLETED|Overall Study||51
3218169|NCT02258074|3949799|FG003|COMPLETED|Overall Study||51
3218170|NCT02258074|3949796|FG000|NOT COMPLETED|Overall Study||1
3218171|NCT02258074|3949797|FG001|NOT COMPLETED|Overall Study||0
3218172|NCT02258074|3949798|FG002|NOT COMPLETED|Overall Study||0
3218173|NCT02258074|3949799|FG003|NOT COMPLETED|Overall Study||0
3218174|NCT02258139|3949809|FG000|STARTED|Overall Study||38
3218175|NCT02258139|3949809|FG000|COMPLETED|Overall Study||30
3218176|NCT02258139|3949809|FG000|NOT COMPLETED|Overall Study||8
3218177|NCT02258152|3949817|FG000|STARTED|Overall Study||44
3218178|NCT02258152|3949818|FG001|STARTED|Overall Study||38
3218179|NCT02258152|3949817|FG000|COMPLETED|Overall Study||38
3218180|NCT02258152|3949818|FG001|COMPLETED|Overall Study||34
3218181|NCT02258152|3949817|FG000|NOT COMPLETED|Overall Study||6
3218182|NCT02258152|3949818|FG001|NOT COMPLETED|Overall Study||4
3218183|NCT02258217|3949824|FG000|STARTED|Overall Study||30
3367322|NCT03879603|4098739|FG001|STARTED|Overall Study||5
3367323|NCT03879603|4098740|FG002|STARTED|Overall Study||5
3367324|NCT03879603|4098741|FG003|STARTED|Overall Study||5
3218184|NCT02258217|3949824|FG000|COMPLETED|Overall Study||30
3218185|NCT02258217|3949824|FG000|NOT COMPLETED|Overall Study||0
3218186|NCT02258256|3949828|FG000|STARTED|Overall Study||11
3218187|NCT02258256|3949828|FG000|COMPLETED|Overall Study||11
3218188|NCT02258256|3949828|FG000|NOT COMPLETED|Overall Study||0
3218189|NCT02258334|3949836|FG000|STARTED|Overall Study||50
3218190|NCT02258334|3949837|FG001|STARTED|Overall Study||54
3218191|NCT02258334|3949838|FG002|STARTED|Overall Study||52
3218192|NCT02258334|3949839|FG003|STARTED|Overall Study||52
3218193|NCT02258334|3949836|FG000|COMPLETED|Overall Study||49
3218194|NCT02258334|3949837|FG001|COMPLETED|Overall Study||54
3218195|NCT02258334|3949838|FG002|COMPLETED|Overall Study||52
3218196|NCT02258334|3949839|FG003|COMPLETED|Overall Study||52
3218197|NCT02258334|3949836|FG000|NOT COMPLETED|Overall Study||1
3218198|NCT02258334|3949837|FG001|NOT COMPLETED|Overall Study||0
3218199|NCT02258334|3949838|FG002|NOT COMPLETED|Overall Study||0
3218200|NCT02258334|3949839|FG003|NOT COMPLETED|Overall Study||0
3218201|NCT02258373|3949853|FG000|STARTED|Overall Study||149
3218202|NCT02258373|3949854|FG001|STARTED|Overall Study||77
3218203|NCT02258373|3949853|FG000|COMPLETED|Overall Study||142
3218204|NCT02258373|3949854|FG001|COMPLETED|Overall Study||75
3218205|NCT02258373|3949853|FG000|NOT COMPLETED|Overall Study||7
3218206|NCT02258373|3949854|FG001|NOT COMPLETED|Overall Study||2
3218207|NCT02258412|3949863|FG000|STARTED|Overall Study||26
3218208|NCT02258412|3949864|FG001|STARTED|Overall Study||25
3218209|NCT02258412|3949865|FG002|STARTED|Overall Study||61
3218210|NCT02258412|3949863|FG000|COMPLETED|Overall Study||26
3218211|NCT02258412|3949864|FG001|COMPLETED|Overall Study||25
3218212|NCT02258412|3949865|FG002|COMPLETED|Overall Study||61
3218213|NCT02258412|3949863|FG000|NOT COMPLETED|Overall Study||0
3218214|NCT02258412|3949864|FG001|NOT COMPLETED|Overall Study||0
3218215|NCT02258412|3949865|FG002|NOT COMPLETED|Overall Study||0
3218216|NCT02258464|3949874|FG000|STARTED|Overall Study||49
3218217|NCT02258464|3949875|FG001|STARTED|Overall Study||50
3218218|NCT02258464|3949874|FG000|COMPLETED|Overall Study||32
3218219|NCT02258464|3949875|FG001|COMPLETED|Overall Study||25
3218220|NCT02258464|3949874|FG000|NOT COMPLETED|Overall Study||17
3218221|NCT02258464|3949875|FG001|NOT COMPLETED|Overall Study||25
3218222|NCT02258477|3949881|FG000|STARTED|First Intervention (1 Week)||10
3218223|NCT02258477|3949882|FG001|STARTED|First Intervention (1 Week)||9
3218224|NCT02258477|3949883|FG002|STARTED|First Intervention (1 Week)||9
3218225|NCT02258477|3949884|FG003|STARTED|First Intervention (1 Week)||9
3218226|NCT02258477|3949881|FG000|COMPLETED|First Intervention (1 Week)||9
3218227|NCT02258477|3949882|FG001|COMPLETED|First Intervention (1 Week)||8
3218228|NCT02258477|3949883|FG002|COMPLETED|First Intervention (1 Week)||9
3218229|NCT02258477|3949884|FG003|COMPLETED|First Intervention (1 Week)||9
3218230|NCT02258477|3949881|FG000|NOT COMPLETED|First Intervention (1 Week)||1
3218231|NCT02258477|3949882|FG001|NOT COMPLETED|First Intervention (1 Week)||1
3218232|NCT02258477|3949883|FG002|NOT COMPLETED|First Intervention (1 Week)||0
3218233|NCT02258477|3949884|FG003|NOT COMPLETED|First Intervention (1 Week)||0
3218234|NCT02258477|3949881|FG000|STARTED|Second Intervention (1 Week)||9
3218235|NCT02258477|3949882|FG001|STARTED|Second Intervention (1 Week)||8
3218236|NCT02258477|3949883|FG002|STARTED|Second Intervention (1 Week)||9
3218237|NCT02258477|3949884|FG003|STARTED|Second Intervention (1 Week)||9
3218238|NCT02258477|3949881|FG000|COMPLETED|Second Intervention (1 Week)||9
3218239|NCT02258477|3949882|FG001|COMPLETED|Second Intervention (1 Week)||8
3218240|NCT02258477|3949883|FG002|COMPLETED|Second Intervention (1 Week)||8
3218241|NCT02258477|3949884|FG003|COMPLETED|Second Intervention (1 Week)||8
3218242|NCT02258477|3949881|FG000|NOT COMPLETED|Second Intervention (1 Week)||0
3218243|NCT02258477|3949882|FG001|NOT COMPLETED|Second Intervention (1 Week)||0
3218244|NCT02258477|3949883|FG002|NOT COMPLETED|Second Intervention (1 Week)||1
3218245|NCT02258477|3949884|FG003|NOT COMPLETED|Second Intervention (1 Week)||1
3218246|NCT02258477|3949881|FG000|STARTED|Third Intervention (1 Week)||9
3218247|NCT02258477|3949882|FG001|STARTED|Third Intervention (1 Week)||8
3218248|NCT02258477|3949883|FG002|STARTED|Third Intervention (1 Week)||8
3218249|NCT02258477|3949884|FG003|STARTED|Third Intervention (1 Week)||8
3218250|NCT02258477|3949881|FG000|COMPLETED|Third Intervention (1 Week)||9
3218251|NCT02258477|3949882|FG001|COMPLETED|Third Intervention (1 Week)||8
3218252|NCT02258477|3949883|FG002|COMPLETED|Third Intervention (1 Week)||8
3218253|NCT02258477|3949884|FG003|COMPLETED|Third Intervention (1 Week)||8
3218254|NCT02258477|3949881|FG000|NOT COMPLETED|Third Intervention (1 Week)||0
3218255|NCT02258477|3949882|FG001|NOT COMPLETED|Third Intervention (1 Week)||0
3218256|NCT02258477|3949883|FG002|NOT COMPLETED|Third Intervention (1 Week)||0
3218257|NCT02258477|3949884|FG003|NOT COMPLETED|Third Intervention (1 Week)||0
3218258|NCT02258477|3949881|FG000|STARTED|Fourth Intervention (1 Week)||9
3218259|NCT02258477|3949882|FG001|STARTED|Fourth Intervention (1 Week)||8
3218260|NCT02258477|3949883|FG002|STARTED|Fourth Intervention (1 Week)||8
3218261|NCT02258477|3949884|FG003|STARTED|Fourth Intervention (1 Week)||8
3218262|NCT02258477|3949881|FG000|COMPLETED|Fourth Intervention (1 Week)||9
3218263|NCT02258477|3949882|FG001|COMPLETED|Fourth Intervention (1 Week)||8
3218264|NCT02258477|3949883|FG002|COMPLETED|Fourth Intervention (1 Week)||8
3218265|NCT02258477|3949884|FG003|COMPLETED|Fourth Intervention (1 Week)||8
3218266|NCT02258477|3949881|FG000|NOT COMPLETED|Fourth Intervention (1 Week)||0
3218267|NCT02258477|3949882|FG001|NOT COMPLETED|Fourth Intervention (1 Week)||0
3218268|NCT02258477|3949883|FG002|NOT COMPLETED|Fourth Intervention (1 Week)||0
3218269|NCT02258477|3949884|FG003|NOT COMPLETED|Fourth Intervention (1 Week)||0
3218270|NCT02258529|3949893|FG000|STARTED|Overall Study||10
3218271|NCT02258529|3949893|FG000|COMPLETED|Overall Study||0
3218272|NCT02258529|3949893|FG000|NOT COMPLETED|Overall Study||10
3218273|NCT02259010|3949897|FG000|STARTED|Overall Study||24
3218274|NCT02259010|3949897|FG000|COMPLETED|Overall Study|Completed=Completed protocol-specified dosing and PK assessment.|19
3218275|NCT02259010|3949897|FG000|NOT COMPLETED|Overall Study||5
3218276|NCT02259088|3949905|FG000|STARTED|Overall Study||307
3218277|NCT02259088|3949906|FG001|STARTED|Overall Study||77
3218278|NCT02259088|3949905|FG000|Full Analysis Set|Overall Study||307
3218279|NCT02259088|3949906|FG001|Full Analysis Set|Overall Study||77
3218280|NCT02259088|3949905|FG000|Treated (Safety Analysis Set)|Overall Study||307
3218281|NCT02259088|3949906|FG001|Treated (Safety Analysis Set)|Overall Study||75
3218282|NCT02259088|3949905|FG000|COMPLETED|Overall Study||279
3218283|NCT02259088|3949906|FG001|COMPLETED|Overall Study||63
3218284|NCT02259088|3949905|FG000|NOT COMPLETED|Overall Study||28
3218285|NCT02259088|3949906|FG001|NOT COMPLETED|Overall Study||14
3218286|NCT02259114|3949917|FG000|STARTED|Overall Study||21
3218287|NCT02259114|3949918|FG001|STARTED|Overall Study||4
3218288|NCT02259114|3949919|FG002|STARTED|Overall Study||13
3218289|NCT02259114|3949920|FG003|STARTED|Overall Study||3
3218290|NCT02259114|3949921|FG004|STARTED|Overall Study||6
3218291|NCT02259114|3949917|FG000|Treated|Overall Study|One participant was randomized but did not receive treatment due to a protocol violation.|20
3218292|NCT02259114|3949918|FG001|Treated|Overall Study||4
3218293|NCT02259114|3949919|FG002|Treated|Overall Study||13
3218294|NCT02259114|3949920|FG003|Treated|Overall Study||3
3218295|NCT02259114|3949921|FG004|Treated|Overall Study||6
3218296|NCT02259114|3949917|FG000|COMPLETED|Overall Study||0
3218297|NCT02259114|3949918|FG001|COMPLETED|Overall Study||0
3218298|NCT02259114|3949919|FG002|COMPLETED|Overall Study||0
3218299|NCT02259114|3949920|FG003|COMPLETED|Overall Study||0
3218300|NCT02259114|3949921|FG004|COMPLETED|Overall Study||0
3218301|NCT02259114|3949917|FG000|NOT COMPLETED|Overall Study||21
3218302|NCT02259114|3949918|FG001|NOT COMPLETED|Overall Study||4
3218303|NCT02259114|3949919|FG002|NOT COMPLETED|Overall Study||13
3218304|NCT02259114|3949920|FG003|NOT COMPLETED|Overall Study||3
3218305|NCT02259114|3949921|FG004|NOT COMPLETED|Overall Study||6
3218306|NCT02259231|3949940|FG000|STARTED|Overall Study||6
3218307|NCT02259231|3949941|FG001|STARTED|Overall Study||6
3218308|NCT02259231|3949942|FG002|STARTED|Overall Study||6
3218309|NCT02259231|3949943|FG003|STARTED|Overall Study||6
3218310|NCT02259231|3949944|FG004|STARTED|Overall Study||6
3218311|NCT02259231|3949945|FG005|STARTED|Overall Study||6
3218312|NCT02259231|3949946|FG006|STARTED|Overall Study||5
3218313|NCT02259231|3949940|FG000|COMPLETED|Overall Study||0
3218314|NCT02259231|3949941|FG001|COMPLETED|Overall Study||0
3218315|NCT02259231|3949942|FG002|COMPLETED|Overall Study||0
3218316|NCT02259231|3949943|FG003|COMPLETED|Overall Study||0
3218317|NCT02259231|3949944|FG004|COMPLETED|Overall Study||0
3218318|NCT02259231|3949945|FG005|COMPLETED|Overall Study||0
3218319|NCT02259231|3949946|FG006|COMPLETED|Overall Study||0
3218320|NCT02259231|3949940|FG000|NOT COMPLETED|Overall Study||6
3218321|NCT02259231|3949941|FG001|NOT COMPLETED|Overall Study||6
3218322|NCT02259231|3949942|FG002|NOT COMPLETED|Overall Study||6
3218323|NCT02259231|3949943|FG003|NOT COMPLETED|Overall Study||6
3218324|NCT02259231|3949944|FG004|NOT COMPLETED|Overall Study||6
3218325|NCT02259231|3949945|FG005|NOT COMPLETED|Overall Study||6
3218326|NCT02259231|3949946|FG006|NOT COMPLETED|Overall Study||5
3218327|NCT02259348|3949962|FG000|STARTED|Overall Study||12
3218328|NCT02259348|3949962|FG000|One Year Post-transplant|Overall Study||2
3218329|NCT02259348|3949962|FG000|COMPLETED|Overall Study||2
3218330|NCT02259348|3949962|FG000|NOT COMPLETED|Overall Study||10
3218331|NCT02259400|3949968|FG000|STARTED|Overall Study||62
3218332|NCT02259400|3949969|FG001|STARTED|Overall Study||62
3218333|NCT02259400|3949968|FG000|COMPLETED|Overall Study||62
3218334|NCT02259400|3949969|FG001|COMPLETED|Overall Study||60
3218335|NCT02259400|3949968|FG000|NOT COMPLETED|Overall Study||0
3218336|NCT02259400|3949969|FG001|NOT COMPLETED|Overall Study||2
3218337|NCT02259582|3949978|FG000|STARTED|Overall Study||25
3218338|NCT02259582|3949979|FG001|STARTED|Overall Study||28
3218339|NCT02259582|3949980|FG002|STARTED|Overall Study||29
3218340|NCT02259582|3949978|FG000|COMPLETED|Overall Study||9
3218341|NCT02259582|3949979|FG001|COMPLETED|Overall Study||11
3218342|NCT02259582|3949980|FG002|COMPLETED|Overall Study||8
3218343|NCT02259582|3949978|FG000|NOT COMPLETED|Overall Study||16
3218344|NCT02259582|3949979|FG001|NOT COMPLETED|Overall Study||17
3218345|NCT02259582|3949980|FG002|NOT COMPLETED|Overall Study||21
3218346|NCT02259608|3949988|FG000|STARTED|Overall Study||15
3218347|NCT02259608|3949988|FG000|COMPLETED|Overall Study||15
3218348|NCT02259608|3949988|FG000|NOT COMPLETED|Overall Study||0
3218349|NCT02259699|3949994|FG000|STARTED|Overall Study||64
3218350|NCT02259699|3949995|FG001|STARTED|Overall Study||60
3218351|NCT02259699|3949994|FG000|COMPLETED|Overall Study||37
3218352|NCT02259699|3949995|FG001|COMPLETED|Overall Study||40
3218353|NCT02259699|3949994|FG000|NOT COMPLETED|Overall Study||27
3218354|NCT02259699|3949995|FG001|NOT COMPLETED|Overall Study||20
3218355|NCT02260154|3950001|FG000|STARTED|Overall Study||220
3218356|NCT02260154|3950001|FG000|COMPLETED|Overall Study||218
3218357|NCT02260154|3950001|FG000|NOT COMPLETED|Overall Study||2
3218358|NCT02260180|3950009|FG000|STARTED|Overall Study||39
3218359|NCT02260180|3950010|FG001|STARTED|Overall Study||39
3218360|NCT02260180|3950011|FG002|STARTED|Overall Study||41
3218361|NCT02260180|3950009|FG000|COMPLETED|Overall Study||37
3218362|NCT02260180|3950010|FG001|COMPLETED|Overall Study||39
3218363|NCT02260180|3950011|FG002|COMPLETED|Overall Study||40
3218364|NCT02260180|3950009|FG000|NOT COMPLETED|Overall Study||2
3218365|NCT02260180|3950010|FG001|NOT COMPLETED|Overall Study||0
3218366|NCT02260180|3950011|FG002|NOT COMPLETED|Overall Study||1
3218367|NCT02260258|3950021|FG000|STARTED|Overall Study||39
3218368|NCT02260258|3950022|FG001|STARTED|Overall Study||44
3218369|NCT02260258|3950021|FG000|COMPLETED|Overall Study||37
3218370|NCT02260258|3950022|FG001|COMPLETED|Overall Study||43
3218371|NCT02260258|3950021|FG000|NOT COMPLETED|Overall Study||2
3218372|NCT02260258|3950022|FG001|NOT COMPLETED|Overall Study||1
3218373|NCT02260388|3950033|FG000|STARTED|Overall Study||134
3218374|NCT02260388|3950034|FG001|STARTED|Overall Study||126
3218375|NCT02260388|3950035|FG002|STARTED|Overall Study||73
3218376|NCT02260388|3950036|FG003|STARTED|Overall Study||69
3218377|NCT02260388|3950033|FG000|COMPLETED|Overall Study||132
3218378|NCT02260388|3950034|FG001|COMPLETED|Overall Study||118
3218379|NCT02260388|3950035|FG002|COMPLETED|Overall Study||70
3218380|NCT02260388|3950036|FG003|COMPLETED|Overall Study||65
3218381|NCT02260388|3950033|FG000|NOT COMPLETED|Overall Study||2
3218382|NCT02260388|3950034|FG001|NOT COMPLETED|Overall Study||8
3218383|NCT02260388|3950035|FG002|NOT COMPLETED|Overall Study||3
3218384|NCT02260388|3950036|FG003|NOT COMPLETED|Overall Study||4
3218385|NCT02260401|3950048|FG000|STARTED|Overall Study||80
3218386|NCT02260401|3950049|FG001|STARTED|Overall Study||85
3218387|NCT02260401|3950048|FG000|COMPLETED|Overall Study||75
3218388|NCT02260401|3950049|FG001|COMPLETED|Overall Study||73
3218389|NCT02260401|3950048|FG000|NOT COMPLETED|Overall Study||5
3218390|NCT02260401|3950049|FG001|NOT COMPLETED|Overall Study||12
3218391|NCT02260440|3950055|FG000|STARTED|Overall Study||31
3218392|NCT02260440|3950055|FG000|COMPLETED|Overall Study||31
3218393|NCT02260440|3950055|FG000|NOT COMPLETED|Overall Study||0
3218394|NCT02260492|3950062|FG000|STARTED|Overall Study||418
3218395|NCT02260492|3950063|FG001|STARTED|Overall Study||419
3218396|NCT02260492|3950064|FG002|STARTED|Overall Study||42
3218397|NCT02260492|3950062|FG000|Completed Day 1|Overall Study||418
3218398|NCT02260492|3950063|FG001|Completed Day 1|Overall Study||419
3218399|NCT02260492|3950064|FG002|Completed Day 1|Overall Study||42
3218400|NCT02260492|3950062|FG000|COMPLETED|Overall Study||395
3218401|NCT02260492|3950063|FG001|COMPLETED|Overall Study||406
3218402|NCT02260492|3950064|FG002|COMPLETED|Overall Study||37
3218403|NCT02260492|3950062|FG000|NOT COMPLETED|Overall Study||23
3218404|NCT02260492|3950063|FG001|NOT COMPLETED|Overall Study||13
3218405|NCT02260492|3950064|FG002|NOT COMPLETED|Overall Study||5
3218406|NCT02260531|3950075|FG000|STARTED|Overall Study||21
3218407|NCT02260531|3950076|FG001|STARTED|Overall Study||7
3218408|NCT02260531|3950077|FG002|STARTED|Overall Study||8
3218409|NCT02260531|3950075|FG000|COMPLETED|Overall Study||21
3218410|NCT02260531|3950076|FG001|COMPLETED|Overall Study||7
3218411|NCT02260531|3950077|FG002|COMPLETED|Overall Study||8
3218412|NCT02260531|3950075|FG000|NOT COMPLETED|Overall Study||0
3218413|NCT02260531|3950076|FG001|NOT COMPLETED|Overall Study||0
3218414|NCT02260531|3950077|FG002|NOT COMPLETED|Overall Study||0
3218415|NCT02260622|3950094|FG000|STARTED|Overall Study||11
3218416|NCT02260622|3950095|FG001|STARTED|Overall Study||9
3218417|NCT02260622|3950094|FG000|COMPLETED|Overall Study||11
3218418|NCT02260622|3950095|FG001|COMPLETED|Overall Study||9
3218419|NCT02260622|3950094|FG000|NOT COMPLETED|Overall Study||0
3218420|NCT02260622|3950095|FG001|NOT COMPLETED|Overall Study||0
3218421|NCT02260635|3950103|FG000|STARTED|Double-Blind Treatment Period||27
3218422|NCT02260635|3950104|FG001|STARTED|Double-Blind Treatment Period||27
3218423|NCT02260635|3950103|FG000|Received at Least One Dose of Study Drug|Double-Blind Treatment Period||27
3218424|NCT02260635|3950104|FG001|Received at Least One Dose of Study Drug|Double-Blind Treatment Period||26
3218425|NCT02260635|3950103|FG000|COMPLETED|Double-Blind Treatment Period||26
3218426|NCT02260635|3950104|FG001|COMPLETED|Double-Blind Treatment Period||25
3218427|NCT02260635|3950103|FG000|NOT COMPLETED|Double-Blind Treatment Period||1
3218428|NCT02260635|3950104|FG001|NOT COMPLETED|Double-Blind Treatment Period||2
3218429|NCT02260635|3950103|FG000|STARTED|Open-Label Extension||26
3218430|NCT02260635|3950104|FG001|STARTED|Open-Label Extension||25
3218431|NCT02260635|3950103|FG000|Received at Least One Dose of Study Drug|Open-Label Extension||26
3218432|NCT02260635|3950104|FG001|Received at Least One Dose of Study Drug|Open-Label Extension||25
3218433|NCT02260635|3950103|FG000|COMPLETED|Open-Label Extension||0
3218434|NCT02260635|3950104|FG001|COMPLETED|Open-Label Extension||0
3218435|NCT02260635|3950103|FG000|NOT COMPLETED|Open-Label Extension||26
3218436|NCT02260635|3950104|FG001|NOT COMPLETED|Open-Label Extension||25
3218437|NCT02260648|3950115|FG000|STARTED|Overall Study||53
3218438|NCT02260648|3950116|FG001|STARTED|Overall Study||46
3218439|NCT02260648|3950117|FG002|STARTED|Overall Study||50
3218440|NCT02260648|3950115|FG000|Received at Least One Dose of Study Drug|Overall Study||53
3218441|NCT02260648|3950116|FG001|Received at Least One Dose of Study Drug|Overall Study||46
3218442|NCT02260648|3950117|FG002|Received at Least One Dose of Study Drug|Overall Study||50
3218443|NCT02260648|3950115|FG000|COMPLETED|Overall Study||35
3218444|NCT02260648|3950116|FG001|COMPLETED|Overall Study||33
3218445|NCT02260648|3950117|FG002|COMPLETED|Overall Study||42
3218446|NCT02260648|3950115|FG000|NOT COMPLETED|Overall Study||18
3218447|NCT02260648|3950116|FG001|NOT COMPLETED|Overall Study||13
3218448|NCT02260648|3950117|FG002|NOT COMPLETED|Overall Study||8
3218449|NCT02260791|3950127|FG000|STARTED|Overall Study||366
3218450|NCT02260791|3950128|FG001|STARTED|Overall Study||362
3218451|NCT02260791|3950127|FG000|COMPLETED|Overall Study||333
3218452|NCT02260791|3950128|FG001|COMPLETED|Overall Study||328
3218453|NCT02260791|3950127|FG000|NOT COMPLETED|Overall Study||33
3218454|NCT02260791|3950128|FG001|NOT COMPLETED|Overall Study||34
3218455|NCT02260804|3950136|FG000|STARTED|Induction Study Period||130
3218456|NCT02260804|3950137|FG001|STARTED|Induction Study Period||128
3218457|NCT02260804|3950136|FG000|COMPLETED|Induction Study Period||128
3218458|NCT02260804|3950137|FG001|COMPLETED|Induction Study Period||128
3218459|NCT02260804|3950136|FG000|NOT COMPLETED|Induction Study Period||2
3218460|NCT02260804|3950137|FG001|NOT COMPLETED|Induction Study Period||0
3218461|NCT02260804|3950136|FG000|STARTED|1st Year of the Maintenance Period (MP1)|Five subjects completed the induction period but did not initiate this period in the CT-P10 group.|123
3218462|NCT02260804|3950137|FG001|STARTED|1st Year of the Maintenance Period (MP1)|Eight subjects completed the induction period but did not initiate this period in the Rituxan group.|120
3218463|NCT02260804|3950136|FG000|COMPLETED|1st Year of the Maintenance Period (MP1)||111
3218464|NCT02260804|3950137|FG001|COMPLETED|1st Year of the Maintenance Period (MP1)||105
3218465|NCT02260804|3950136|FG000|NOT COMPLETED|1st Year of the Maintenance Period (MP1)||12
3218466|NCT02260804|3950137|FG001|NOT COMPLETED|1st Year of the Maintenance Period (MP1)||15
3218467|NCT02260804|3950136|FG000|STARTED|2nd Year of the Maintenance Period (MP2)|One subject completed the MP1 but did not initiate this period in the CT-P10 group.|110
3218468|NCT02260804|3950137|FG001|STARTED|2nd Year of the Maintenance Period (MP2)|Two subjects completed the MP1 but did not initiate this period in the Rituxan group.|103
3218469|NCT02260804|3950136|FG000|COMPLETED|2nd Year of the Maintenance Period (MP2)||101
3218470|NCT02260804|3950137|FG001|COMPLETED|2nd Year of the Maintenance Period (MP2)||97
3218471|NCT02260804|3950136|FG000|NOT COMPLETED|2nd Year of the Maintenance Period (MP2)||9
3218472|NCT02260804|3950137|FG001|NOT COMPLETED|2nd Year of the Maintenance Period (MP2)||6
3218473|NCT02260817|3950145|FG000|STARTED|Overall Study||14
3218474|NCT02260817|3950146|FG001|STARTED|Overall Study||95
3218475|NCT02260817|3950145|FG000|COMPLETED|Overall Study||14
3218476|NCT02260817|3950146|FG001|COMPLETED|Overall Study||58
3218477|NCT02260817|3950145|FG000|NOT COMPLETED|Overall Study||0
3218478|NCT02260817|3950146|FG001|NOT COMPLETED|Overall Study||37
3218479|NCT02260882|3950154|FG000|STARTED|Overall Study||161
3218480|NCT02260882|3950155|FG001|STARTED|Overall Study||82
3218481|NCT02260882|3950154|FG000|COMPLETED|Overall Study||161
3218482|NCT02260882|3950155|FG001|COMPLETED|Overall Study||81
3218483|NCT02260882|3950154|FG000|NOT COMPLETED|Overall Study||0
3218484|NCT02260882|3950155|FG001|NOT COMPLETED|Overall Study||1
3218485|NCT02260921|3950164|FG000|STARTED|Overall Study||121
3218486|NCT02260921|3950165|FG001|STARTED|Overall Study||59
3218487|NCT02260921|3950164|FG000|Per-Protocol Population|Overall Study||112
3218488|NCT02260921|3950165|FG001|Per-Protocol Population|Overall Study||56
3218489|NCT02260921|3950164|FG000|COMPLETED|Overall Study||107
3218490|NCT02260921|3950165|FG001|COMPLETED|Overall Study||55
3218491|NCT02260921|3950164|FG000|NOT COMPLETED|Overall Study||14
3218492|NCT02260921|3950165|FG001|NOT COMPLETED|Overall Study||4
3218493|NCT02260934|3950173|FG000|STARTED|Overall Study||22
3218494|NCT02260934|3950174|FG001|STARTED|Overall Study||21
3218495|NCT02260934|3950173|FG000|COMPLETED|Overall Study|At primary outcome timepoint: Ten participants engaged in ongoing scheduled study visits.|19
3218496|NCT02260934|3950174|FG001|COMPLETED|Overall Study|At primary outcome timepoint: Eleven participants engaged in ongoing scheduled study visits.|17
3218497|NCT02260934|3950173|FG000|NOT COMPLETED|Overall Study||3
3218498|NCT02260934|3950174|FG001|NOT COMPLETED|Overall Study||4
3218499|NCT02260986|3950190|FG000|STARTED|Overall Study||315
3218500|NCT02260986|3950191|FG001|STARTED|Overall Study||106
3218501|NCT02260986|3950192|FG002|STARTED|Overall Study||319
3218502|NCT02260986|3950190|FG000|Safety Population|Overall Study||315
3218503|NCT02260986|3950191|FG001|Safety Population|Overall Study|4 participants from Dupilumab 300 mg qw arm analyzed in Dupilumab 300 mg q2w arm|110
3218504|NCT02260986|3950192|FG002|Safety Population|Overall Study|4 participants received fewer injections of Dupilumab 300 mg (analyzed in Dupilumab 300 mg q2w arm)|315
3218505|NCT02260986|3950190|FG000|COMPLETED|Overall Study||225
3218506|NCT02260986|3950191|FG001|COMPLETED|Overall Study||93
3218507|NCT02260986|3950192|FG002|COMPLETED|Overall Study||278
3218508|NCT02260986|3950190|FG000|NOT COMPLETED|Overall Study||90
3218509|NCT02260986|3950191|FG001|NOT COMPLETED|Overall Study||13
3218510|NCT02260986|3950192|FG002|NOT COMPLETED|Overall Study||41
3218511|NCT02261428|3950207|FG000|STARTED|Overall Study|Washout (30 minutes)|10
3218512|NCT02261428|3950208|FG001|STARTED|Overall Study|Washout (30 minutes)|10
3367325|NCT03879603|4098742|FG004|STARTED|Overall Study||5
3367326|NCT03879603|4098743|FG005|STARTED|Overall Study||5
3367327|NCT03879603|4098738|FG000|Received First Product Administration|Overall Study||5
3367328|NCT03879603|4098739|FG001|Received First Product Administration|Overall Study||5
3367329|NCT03879603|4098740|FG002|Received First Product Administration|Overall Study||5
3367330|NCT03879603|4098741|FG003|Received First Product Administration|Overall Study||5
3367331|NCT03879603|4098742|FG004|Received First Product Administration|Overall Study||5
3367332|NCT03879603|4098743|FG005|Received First Product Administration|Overall Study||5
3367333|NCT03879603|4098738|FG000|Received All Product Administrations|Overall Study|Second administration not completed due to a grade 3 neutropenia not related to study product.|4
3367334|NCT03879603|4098739|FG001|Received All Product Administrations|Overall Study||5
3367335|NCT03879603|4098740|FG002|Received All Product Administrations|Overall Study||5
3367336|NCT03879603|4098741|FG003|Received All Product Administrations|Overall Study||5
3367337|NCT03879603|4098742|FG004|Received All Product Administrations|Overall Study||5
3367338|NCT03879603|4098743|FG005|Received All Product Administrations|Overall Study||5
3367339|NCT03879603|4098738|FG000|COMPLETED|Overall Study||5
3367340|NCT03879603|4098739|FG001|COMPLETED|Overall Study||5
3367341|NCT03879603|4098740|FG002|COMPLETED|Overall Study||5
3218513|NCT02261428|3950207|FG000|COMPLETED|Overall Study||10
3218514|NCT02261428|3950208|FG001|COMPLETED|Overall Study||10
3218515|NCT02261428|3950207|FG000|NOT COMPLETED|Overall Study||0
3218516|NCT02261428|3950208|FG001|NOT COMPLETED|Overall Study||0
3218517|NCT02261467|3950228|FG000|STARTED|Overall Study||101
3218518|NCT02261467|3950229|FG001|STARTED|Overall Study||290
3218519|NCT02261467|3950228|FG000|COMPLETED|Overall Study||80
3218520|NCT02261467|3950229|FG001|COMPLETED|Overall Study||253
3218521|NCT02261467|3950228|FG000|NOT COMPLETED|Overall Study||21
3218522|NCT02261467|3950229|FG001|NOT COMPLETED|Overall Study||37
3218523|NCT02261493|3950238|FG000|STARTED|Overall Study||156
3218524|NCT02261493|3950239|FG001|STARTED|Overall Study||318
3218525|NCT02261493|3950240|FG002|STARTED|Overall Study||313
3218526|NCT02261493|3950238|FG000|COMPLETED|Overall Study||126
3218527|NCT02261493|3950239|FG001|COMPLETED|Overall Study||271
3218528|NCT02261493|3950240|FG002|COMPLETED|Overall Study||287
3218529|NCT02261493|3950238|FG000|NOT COMPLETED|Overall Study||30
3218530|NCT02261493|3950239|FG001|NOT COMPLETED|Overall Study||47
3218531|NCT02261493|3950240|FG002|NOT COMPLETED|Overall Study||26
3218532|NCT02261597|3950250|FG000|STARTED|Overall Study||22
3218533|NCT02261597|3950251|FG001|STARTED|Overall Study||22
3218534|NCT02261597|3950250|FG000|COMPLETED|Overall Study||22
3218535|NCT02261597|3950251|FG001|COMPLETED|Overall Study||22
3218536|NCT02261597|3950250|FG000|NOT COMPLETED|Overall Study||0
3218537|NCT02261597|3950251|FG001|NOT COMPLETED|Overall Study||0
3218538|NCT02261714|3950257|FG000|STARTED|Overall Study||32
3218539|NCT02261714|3950257|FG000|COMPLETED|Overall Study||4
3218540|NCT02261714|3950257|FG000|NOT COMPLETED|Overall Study||28
3218541|NCT02261727|3950265|FG000|STARTED|Overall Study||568
3218542|NCT02261727|3950266|FG001|STARTED|Overall Study||554
3218543|NCT02261727|3950267|FG002|STARTED|Overall Study||548
3218544|NCT02261727|3950265|FG000|COMPLETED|Overall Study||411
3218545|NCT02261727|3950266|FG001|COMPLETED|Overall Study||408
3218546|NCT02261727|3950267|FG002|COMPLETED|Overall Study||423
3218547|NCT02261727|3950265|FG000|NOT COMPLETED|Overall Study||157
3218548|NCT02261727|3950266|FG001|NOT COMPLETED|Overall Study||146
3218549|NCT02261727|3950267|FG002|NOT COMPLETED|Overall Study||125
3218550|NCT02261805|3950275|FG000|STARTED|Overall Study||3
3218551|NCT02261805|3950276|FG001|STARTED|Overall Study||6
3218552|NCT02261805|3950277|FG002|STARTED|Overall Study||2
3218553|NCT02261805|3950275|FG000|COMPLETED|Overall Study||3
3218554|NCT02261805|3950276|FG001|COMPLETED|Overall Study||6
3218555|NCT02261805|3950277|FG002|COMPLETED|Overall Study||2
3218556|NCT02261805|3950275|FG000|NOT COMPLETED|Overall Study||0
3218557|NCT02261805|3950276|FG001|NOT COMPLETED|Overall Study||0
3218558|NCT02261805|3950277|FG002|NOT COMPLETED|Overall Study||0
3218559|NCT02261818|3950283|FG000|STARTED|Overall Study||30
3218560|NCT02261818|3950283|FG000|COMPLETED|Overall Study||27
3218561|NCT02261818|3950283|FG000|NOT COMPLETED|Overall Study||3
3218562|NCT02261948|3950289|FG000|STARTED|Overall Study||23
3218563|NCT02261948|3950290|FG001|STARTED|Overall Study||19
3218564|NCT02261948|3950289|FG000|COMPLETED|Overall Study||23
3218565|NCT02261948|3950290|FG001|COMPLETED|Overall Study||19
3218566|NCT02261948|3950289|FG000|NOT COMPLETED|Overall Study||0
3218567|NCT02261948|3950290|FG001|NOT COMPLETED|Overall Study||0
3218568|NCT02261961|3950298|FG000|STARTED|Overall Study||22
3218569|NCT02261961|3950299|FG001|STARTED|Overall Study||22
3218570|NCT02261961|3950298|FG000|COMPLETED|Overall Study||13
3218571|NCT02261961|3950299|FG001|COMPLETED|Overall Study|One subject listed as completed who withdrew but finished training phase and has usable data.|20
3218572|NCT02261961|3950298|FG000|NOT COMPLETED|Overall Study||9
3218573|NCT02261961|3950299|FG001|NOT COMPLETED|Overall Study||2
3218574|NCT02261974|3950318|FG000|STARTED|Overall Study||123
3218575|NCT02261974|3950319|FG001|STARTED|Overall Study||63
3218576|NCT02261974|3950318|FG000|Treated|Overall Study||117
3218577|NCT02261974|3950319|FG001|Treated|Overall Study||57
3218578|NCT02261974|3950318|FG000|COMPLETED|Overall Study||108
3218579|NCT02261974|3950319|FG001|COMPLETED|Overall Study||56
3218580|NCT02261974|3950318|FG000|NOT COMPLETED|Overall Study||15
3218581|NCT02261974|3950319|FG001|NOT COMPLETED|Overall Study||7
3218582|NCT02262039|3950327|FG000|STARTED|Overall Study||14
3218583|NCT02262039|3950328|FG001|STARTED|Overall Study||27
3218584|NCT02262039|3950327|FG000|COMPLETED|Overall Study||14
3218585|NCT02262039|3950328|FG001|COMPLETED|Overall Study||27
3218586|NCT02262039|3950327|FG000|NOT COMPLETED|Overall Study||0
3218587|NCT02262039|3950328|FG001|NOT COMPLETED|Overall Study||0
3218588|NCT02262078|3950336|FG000|STARTED|Overall Study||13
3218589|NCT02262078|3950337|FG001|STARTED|Overall Study||13
3218590|NCT02262078|3950336|FG000|COMPLETED|Overall Study||13
3218591|NCT02262078|3950337|FG001|COMPLETED|Overall Study||13
3218592|NCT02262078|3950336|FG000|NOT COMPLETED|Overall Study||0
3218593|NCT02262078|3950337|FG001|NOT COMPLETED|Overall Study||0
3218594|NCT02262130|3950343|FG000|STARTED|Overall Study||10
3218595|NCT02262130|3950343|FG000|COMPLETED|Overall Study||10
3218596|NCT02262130|3950343|FG000|NOT COMPLETED|Overall Study||0
3218597|NCT02262260|3950349|FG000|STARTED|Overall Study||45
3218598|NCT02262260|3950350|FG001|STARTED|Overall Study||42
3218599|NCT02262260|3950349|FG000|COMPLETED|Overall Study||34
3218600|NCT02262260|3950350|FG001|COMPLETED|Overall Study||32
3218601|NCT02262260|3950349|FG000|NOT COMPLETED|Overall Study||11
3218602|NCT02262260|3950350|FG001|NOT COMPLETED|Overall Study||10
3218603|NCT02262364|3950356|FG000|STARTED|Study Enrollment||11
3218604|NCT02262364|3950356|FG000|COMPLETED|Study Enrollment||11
3218605|NCT02262364|3950356|FG000|NOT COMPLETED|Study Enrollment||0
3218606|NCT02262364|3950356|FG000|STARTED|Blood Draw for Device Processing||11
3218607|NCT02262364|3950356|FG000|COMPLETED|Blood Draw for Device Processing||10
3218608|NCT02262364|3950356|FG000|NOT COMPLETED|Blood Draw for Device Processing||1
3218609|NCT02262364|3950356|FG000|STARTED|Injection With APS||10
3218610|NCT02262364|3950356|FG000|COMPLETED|Injection With APS||10
3218611|NCT02262364|3950356|FG000|NOT COMPLETED|Injection With APS||0
3218612|NCT02262364|3950356|FG000|STARTED|Follow-Up Through 12 Months||10
3218613|NCT02262364|3950356|FG000|COMPLETED|Follow-Up Through 12 Months||10
3218614|NCT02262364|3950356|FG000|NOT COMPLETED|Follow-Up Through 12 Months||0
3218615|NCT02262377|3950362|FG000|STARTED|Overall Study||80
3218616|NCT02262377|3950363|FG001|STARTED|Overall Study||79
3218617|NCT02262377|3950362|FG000|COMPLETED|Overall Study||68
3218618|NCT02262377|3950363|FG001|COMPLETED|Overall Study||73
3218619|NCT02262377|3950362|FG000|NOT COMPLETED|Overall Study||12
3218620|NCT02262377|3950363|FG001|NOT COMPLETED|Overall Study||6
3218621|NCT02262507|3950370|FG000|STARTED|Overall Study||410
3218622|NCT02262507|3950370|FG000|COMPLETED|Overall Study||410
3218623|NCT02262507|3950370|FG000|NOT COMPLETED|Overall Study||0
3218624|NCT02262728|3950377|FG000|STARTED|Treatment Period (12 Weeks)||19
3218625|NCT02262728|3950378|FG001|STARTED|Treatment Period (12 Weeks)||21
3218626|NCT02262728|3950377|FG000|COMPLETED|Treatment Period (12 Weeks)|Participants who completed continued follow-up phase.|19
3218627|NCT02262728|3950378|FG001|COMPLETED|Treatment Period (12 Weeks)|Participants who completed continued follow-up phase.|21
3218628|NCT02262728|3950377|FG000|NOT COMPLETED|Treatment Period (12 Weeks)||0
3218629|NCT02262728|3950378|FG001|NOT COMPLETED|Treatment Period (12 Weeks)||0
3218630|NCT02262728|3950377|FG000|STARTED|Follow-up Phase (3 Years)||19
3218631|NCT02262728|3950378|FG001|STARTED|Follow-up Phase (3 Years)||21
3218632|NCT02262728|3950377|FG000|COMPLETED|Follow-up Phase (3 Years)||15
3218633|NCT02262728|3950378|FG001|COMPLETED|Follow-up Phase (3 Years)||18
3218634|NCT02262728|3950377|FG000|NOT COMPLETED|Follow-up Phase (3 Years)||4
3218635|NCT02262728|3950378|FG001|NOT COMPLETED|Follow-up Phase (3 Years)||3
3218636|NCT02262754|3950387|FG000|STARTED|Overall Study||74
3218637|NCT02262754|3950388|FG001|STARTED|Overall Study||74
3218638|NCT02262754|3950389|FG002|STARTED|Overall Study||74
3218639|NCT02262754|3950387|FG000|COMPLETED|Overall Study||58
3218640|NCT02262754|3950388|FG001|COMPLETED|Overall Study||65
3218641|NCT02262754|3950389|FG002|COMPLETED|Overall Study||65
3218642|NCT02262754|3950387|FG000|NOT COMPLETED|Overall Study||16
3218643|NCT02262754|3950388|FG001|NOT COMPLETED|Overall Study||9
3218644|NCT02262754|3950389|FG002|NOT COMPLETED|Overall Study||9
3218645|NCT02263014|3950401|FG000|STARTED|Overall Study||44
3218646|NCT02263014|3950402|FG001|STARTED|Overall Study||208
3218647|NCT02263014|3950401|FG000|COMPLETED|Overall Study||44
3218648|NCT02263014|3950402|FG001|COMPLETED|Overall Study||208
3218649|NCT02263014|3950401|FG000|NOT COMPLETED|Overall Study||0
3218650|NCT02263014|3950402|FG001|NOT COMPLETED|Overall Study||0
3218651|NCT02263040|3950412|FG000|STARTED|Overall Study||87
3218652|NCT02263040|3950413|FG001|STARTED|Overall Study||83
3218653|NCT02263040|3950412|FG000|COMPLETED|Overall Study||87
3218654|NCT02263040|3950413|FG001|COMPLETED|Overall Study||83
3218655|NCT02263040|3950412|FG000|NOT COMPLETED|Overall Study||0
3218656|NCT02263040|3950413|FG001|NOT COMPLETED|Overall Study||0
3218657|NCT02263079|3950426|FG000|STARTED|Overall Study||26
3218658|NCT02263079|3950427|FG001|STARTED|Overall Study||33
3218659|NCT02263079|3950428|FG002|STARTED|Overall Study||3
3218660|NCT02263079|3950426|FG000|COMPLETED|Overall Study||23
3218661|NCT02263079|3950427|FG001|COMPLETED|Overall Study||25
3218662|NCT02263079|3950428|FG002|COMPLETED|Overall Study|Completed study but not included in the analysis|3
3218663|NCT02263079|3950426|FG000|NOT COMPLETED|Overall Study||3
3218664|NCT02263079|3950427|FG001|NOT COMPLETED|Overall Study||8
3218665|NCT02263079|3950428|FG002|NOT COMPLETED|Overall Study||0
3218666|NCT02263118|3950440|FG000|STARTED|Overall Study||24
3218667|NCT02263118|3950441|FG001|STARTED|Overall Study||32
3218668|NCT02263118|3950442|FG002|STARTED|Overall Study||30
3218669|NCT02263118|3950443|FG003|STARTED|Overall Study||14
3218670|NCT02263118|3950440|FG000|COMPLETED|Overall Study||20
3218671|NCT02263118|3950441|FG001|COMPLETED|Overall Study||24
3218672|NCT02263118|3950442|FG002|COMPLETED|Overall Study||22
3218673|NCT02263118|3950443|FG003|COMPLETED|Overall Study||12
3218674|NCT02263118|3950440|FG000|NOT COMPLETED|Overall Study||4
3218675|NCT02263118|3950441|FG001|NOT COMPLETED|Overall Study||8
3218676|NCT02263118|3950442|FG002|NOT COMPLETED|Overall Study||8
3218677|NCT02263118|3950443|FG003|NOT COMPLETED|Overall Study||2
3218678|NCT02263131|3950457|FG000|STARTED|Overall Study||347
3218679|NCT02263131|3950458|FG001|STARTED|Overall Study||69
3218680|NCT02263131|3950457|FG000|COMPLETED|Overall Study||337
3218681|NCT02263131|3950458|FG001|COMPLETED|Overall Study||68
3218682|NCT02263131|3950457|FG000|NOT COMPLETED|Overall Study||10
3218683|NCT02263131|3950458|FG001|NOT COMPLETED|Overall Study||1
3218684|NCT02263326|3950466|FG000|STARTED|Overall Study||44
3218685|NCT02263326|3950467|FG001|STARTED|Overall Study||45
3218686|NCT02263326|3950466|FG000|COMPLETED|Overall Study||43
3218687|NCT02263326|3950467|FG001|COMPLETED|Overall Study||44
3218688|NCT02263326|3950466|FG000|NOT COMPLETED|Overall Study||1
3218689|NCT02263326|3950467|FG001|NOT COMPLETED|Overall Study||1
3218690|NCT02263547|3950473|FG000|STARTED|Overall Study||14
3218691|NCT02263547|3950473|FG000|COMPLETED|Overall Study||11
3218692|NCT02263547|3950473|FG000|NOT COMPLETED|Overall Study||3
3218693|NCT02263833|3950477|FG000|STARTED|Overall Study||742
3218694|NCT02263833|3950477|FG000|COMPLETED|Overall Study||742
3218695|NCT02263833|3950477|FG000|NOT COMPLETED|Overall Study||0
3218696|NCT02263911|3950481|FG000|STARTED|Period 1||4
3218697|NCT02263911|3950482|FG001|STARTED|Period 1||4
3218698|NCT02263911|3950483|FG002|STARTED|Period 1||4
3218699|NCT02263911|3950484|FG003|STARTED|Period 1||4
3218700|NCT02263911|3950481|FG000|COMPLETED|Period 1||4
3218701|NCT02263911|3950482|FG001|COMPLETED|Period 1||4
3218702|NCT02263911|3950483|FG002|COMPLETED|Period 1||4
3218703|NCT02263911|3950484|FG003|COMPLETED|Period 1||4
3218704|NCT02263911|3950481|FG000|NOT COMPLETED|Period 1||0
3218705|NCT02263911|3950482|FG001|NOT COMPLETED|Period 1||0
3218706|NCT02263911|3950483|FG002|NOT COMPLETED|Period 1||0
3218707|NCT02263911|3950484|FG003|NOT COMPLETED|Period 1||0
3218708|NCT02263911|3950481|FG000|STARTED|Period 1 Washout||4
3218709|NCT02263911|3950482|FG001|STARTED|Period 1 Washout||4
3218710|NCT02263911|3950483|FG002|STARTED|Period 1 Washout||4
3218711|NCT02263911|3950484|FG003|STARTED|Period 1 Washout||4
3218712|NCT02263911|3950481|FG000|COMPLETED|Period 1 Washout||4
3218713|NCT02263911|3950482|FG001|COMPLETED|Period 1 Washout||4
3218714|NCT02263911|3950483|FG002|COMPLETED|Period 1 Washout||4
3218715|NCT02263911|3950484|FG003|COMPLETED|Period 1 Washout||4
3218716|NCT02263911|3950481|FG000|NOT COMPLETED|Period 1 Washout||0
3218717|NCT02263911|3950482|FG001|NOT COMPLETED|Period 1 Washout||0
3218718|NCT02263911|3950483|FG002|NOT COMPLETED|Period 1 Washout||0
3218719|NCT02263911|3950484|FG003|NOT COMPLETED|Period 1 Washout||0
3218720|NCT02263911|3950481|FG000|STARTED|Period 2||4
3218721|NCT02263911|3950482|FG001|STARTED|Period 2||4
3218722|NCT02263911|3950483|FG002|STARTED|Period 2||4
3218723|NCT02263911|3950484|FG003|STARTED|Period 2||4
3218724|NCT02263911|3950481|FG000|COMPLETED|Period 2||4
3218725|NCT02263911|3950482|FG001|COMPLETED|Period 2||4
3218726|NCT02263911|3950483|FG002|COMPLETED|Period 2||4
3218727|NCT02263911|3950484|FG003|COMPLETED|Period 2||4
3218728|NCT02263911|3950481|FG000|NOT COMPLETED|Period 2||0
3218729|NCT02263911|3950482|FG001|NOT COMPLETED|Period 2||0
3218730|NCT02263911|3950483|FG002|NOT COMPLETED|Period 2||0
3218731|NCT02263911|3950484|FG003|NOT COMPLETED|Period 2||0
3218732|NCT02263911|3950481|FG000|STARTED|Period 2 Washout||4
3218733|NCT02263911|3950482|FG001|STARTED|Period 2 Washout||4
3218734|NCT02263911|3950483|FG002|STARTED|Period 2 Washout||4
3218735|NCT02263911|3950484|FG003|STARTED|Period 2 Washout||4
3218736|NCT02263911|3950481|FG000|COMPLETED|Period 2 Washout||4
3218737|NCT02263911|3950482|FG001|COMPLETED|Period 2 Washout||4
3218738|NCT02263911|3950483|FG002|COMPLETED|Period 2 Washout||4
3218739|NCT02263911|3950484|FG003|COMPLETED|Period 2 Washout||4
3218740|NCT02263911|3950481|FG000|NOT COMPLETED|Period 2 Washout||0
3218741|NCT02263911|3950482|FG001|NOT COMPLETED|Period 2 Washout||0
3218742|NCT02263911|3950483|FG002|NOT COMPLETED|Period 2 Washout||0
3218743|NCT02263911|3950484|FG003|NOT COMPLETED|Period 2 Washout||0
3218744|NCT02263911|3950481|FG000|STARTED|Period 3||4
3218745|NCT02263911|3950482|FG001|STARTED|Period 3||4
3218746|NCT02263911|3950483|FG002|STARTED|Period 3||4
3218747|NCT02263911|3950484|FG003|STARTED|Period 3||4
3218748|NCT02263911|3950481|FG000|COMPLETED|Period 3||4
3218749|NCT02263911|3950482|FG001|COMPLETED|Period 3||4
3218750|NCT02263911|3950483|FG002|COMPLETED|Period 3||4
3218751|NCT02263911|3950484|FG003|COMPLETED|Period 3||4
3218752|NCT02263911|3950481|FG000|NOT COMPLETED|Period 3||0
3218753|NCT02263911|3950482|FG001|NOT COMPLETED|Period 3||0
3218754|NCT02263911|3950483|FG002|NOT COMPLETED|Period 3||0
3218755|NCT02263911|3950484|FG003|NOT COMPLETED|Period 3||0
3218756|NCT02263911|3950481|FG000|STARTED|Period 3 Washout||4
3218757|NCT02263911|3950482|FG001|STARTED|Period 3 Washout||4
3218758|NCT02263911|3950483|FG002|STARTED|Period 3 Washout||4
3218759|NCT02263911|3950484|FG003|STARTED|Period 3 Washout||4
3218760|NCT02263911|3950481|FG000|COMPLETED|Period 3 Washout||4
3218761|NCT02263911|3950482|FG001|COMPLETED|Period 3 Washout||4
3218762|NCT02263911|3950483|FG002|COMPLETED|Period 3 Washout||4
3218763|NCT02263911|3950484|FG003|COMPLETED|Period 3 Washout||4
3218764|NCT02263911|3950481|FG000|NOT COMPLETED|Period 3 Washout||0
3218765|NCT02263911|3950482|FG001|NOT COMPLETED|Period 3 Washout||0
3218766|NCT02263911|3950483|FG002|NOT COMPLETED|Period 3 Washout||0
3218767|NCT02263911|3950484|FG003|NOT COMPLETED|Period 3 Washout||0
3218768|NCT02263911|3950481|FG000|STARTED|Period 4||4
3218769|NCT02263911|3950482|FG001|STARTED|Period 4||4
3218770|NCT02263911|3950483|FG002|STARTED|Period 4||4
3218771|NCT02263911|3950484|FG003|STARTED|Period 4||4
3218772|NCT02263911|3950481|FG000|COMPLETED|Period 4||4
3218773|NCT02263911|3950482|FG001|COMPLETED|Period 4||4
3218774|NCT02263911|3950483|FG002|COMPLETED|Period 4||4
3218775|NCT02263911|3950484|FG003|COMPLETED|Period 4||4
3218776|NCT02263911|3950481|FG000|NOT COMPLETED|Period 4||0
3218777|NCT02263911|3950482|FG001|NOT COMPLETED|Period 4||0
3218778|NCT02263911|3950483|FG002|NOT COMPLETED|Period 4||0
3218779|NCT02263911|3950484|FG003|NOT COMPLETED|Period 4||0
3218780|NCT02263911|3950481|FG000|STARTED|Period 4 Washout||4
3218781|NCT02263911|3950482|FG001|STARTED|Period 4 Washout||4
3218782|NCT02263911|3950483|FG002|STARTED|Period 4 Washout||4
3218783|NCT02263911|3950484|FG003|STARTED|Period 4 Washout||4
3218784|NCT02263911|3950481|FG000|COMPLETED|Period 4 Washout||4
3218785|NCT02263911|3950482|FG001|COMPLETED|Period 4 Washout||4
3218786|NCT02263911|3950483|FG002|COMPLETED|Period 4 Washout||4
3218787|NCT02263911|3950484|FG003|COMPLETED|Period 4 Washout||4
3218788|NCT02263911|3950481|FG000|NOT COMPLETED|Period 4 Washout||0
3218789|NCT02263911|3950482|FG001|NOT COMPLETED|Period 4 Washout||0
3218790|NCT02263911|3950483|FG002|NOT COMPLETED|Period 4 Washout||0
3218791|NCT02263911|3950484|FG003|NOT COMPLETED|Period 4 Washout||0
3218792|NCT02263911|3950481|FG000|STARTED|Period 5||4
3218793|NCT02263911|3950482|FG001|STARTED|Period 5||4
3218794|NCT02263911|3950483|FG002|STARTED|Period 5||4
3218795|NCT02263911|3950484|FG003|STARTED|Period 5||4
3218796|NCT02263911|3950481|FG000|COMPLETED|Period 5||4
3218797|NCT02263911|3950482|FG001|COMPLETED|Period 5||4
3218798|NCT02263911|3950483|FG002|COMPLETED|Period 5||4
3218799|NCT02263911|3950484|FG003|COMPLETED|Period 5||4
3218800|NCT02263911|3950481|FG000|NOT COMPLETED|Period 5||0
3218801|NCT02263911|3950482|FG001|NOT COMPLETED|Period 5||0
3218802|NCT02263911|3950483|FG002|NOT COMPLETED|Period 5||0
3218803|NCT02263911|3950484|FG003|NOT COMPLETED|Period 5||0
3218804|NCT02264249|3950501|FG000|STARTED|Overall Study||21
3218805|NCT02264249|3950502|FG001|STARTED|Overall Study||187
3218806|NCT02264249|3950503|FG002|STARTED|Overall Study||241
3218807|NCT02264249|3950501|FG000|COMPLETED|Overall Study||21
3367342|NCT03879603|4098741|FG003|COMPLETED|Overall Study||5
3367343|NCT03879603|4098742|FG004|COMPLETED|Overall Study||5
3367344|NCT03879603|4098743|FG005|COMPLETED|Overall Study||5
3367345|NCT03879603|4098738|FG000|NOT COMPLETED|Overall Study||0
3367346|NCT03879603|4098739|FG001|NOT COMPLETED|Overall Study||0
3367347|NCT03879603|4098740|FG002|NOT COMPLETED|Overall Study||0
3367348|NCT03879603|4098741|FG003|NOT COMPLETED|Overall Study||0
3367349|NCT03879603|4098742|FG004|NOT COMPLETED|Overall Study||0
3367350|NCT03879603|4098743|FG005|NOT COMPLETED|Overall Study||0
3367351|NCT03878745|4098759|FG000|STARTED|Overall Study||55
3367352|NCT03878745|4098759|FG000|COMPLETED|Overall Study||55
3367353|NCT03878745|4098759|FG000|NOT COMPLETED|Overall Study||0
3367354|NCT03848221|4098774|FG000|STARTED|Overall Study||25
3367355|NCT03848221|4098775|FG001|STARTED|Overall Study||24
3367356|NCT03848221|4098776|FG002|STARTED|Overall Study||24
3367357|NCT03848221|4098774|FG000|COMPLETED|Overall Study||25
3367358|NCT03848221|4098775|FG001|COMPLETED|Overall Study||24
3367359|NCT03848221|4098776|FG002|COMPLETED|Overall Study||24
3367360|NCT03848221|4098774|FG000|NOT COMPLETED|Overall Study||0
3367361|NCT03848221|4098775|FG001|NOT COMPLETED|Overall Study||0
3367362|NCT03848221|4098776|FG002|NOT COMPLETED|Overall Study||0
3367363|NCT03878108|4098786|FG000|STARTED|Overall Study||11
3367364|NCT03878108|4098787|FG001|STARTED|Overall Study||10
3367365|NCT03878108|4098786|FG000|Completed First Phase|Overall Study||10
3367366|NCT03878108|4098787|FG001|Completed First Phase|Overall Study||10
3367367|NCT03878108|4098786|FG000|COMPLETED|Overall Study||10
3367368|NCT03878108|4098787|FG001|COMPLETED|Overall Study||10
3367369|NCT03878108|4098786|FG000|NOT COMPLETED|Overall Study||1
3367370|NCT03878108|4098787|FG001|NOT COMPLETED|Overall Study||0
3367371|NCT03877432|4098793|FG000|STARTED|Overall Study||10
3367372|NCT03877432|4098793|FG000|COMPLETED|Overall Study||10
3367373|NCT03877432|4098793|FG000|NOT COMPLETED|Overall Study||0
3367374|NCT03877237|4098803|FG000|STARTED|Overall Study||156
3367375|NCT03877237|4098804|FG001|STARTED|Overall Study||157
3367376|NCT03877237|4098803|FG000|Treated|Overall Study||156
3367377|NCT03877237|4098804|FG001|Treated|Overall Study||157
3367378|NCT03877237|4098803|FG000|COMPLETED|Overall Study||151
3367379|NCT03877237|4098804|FG001|COMPLETED|Overall Study||151
3367380|NCT03877237|4098803|FG000|NOT COMPLETED|Overall Study||5
3367381|NCT03877237|4098804|FG001|NOT COMPLETED|Overall Study||6
3367382|NCT03866434|4098810|FG000|STARTED|Overall Study||20
3367383|NCT03866434|4098810|FG000|COMPLETED|Overall Study||20
3367384|NCT03866434|4098810|FG000|NOT COMPLETED|Overall Study||0
3367385|NCT03863210|4098816|FG000|STARTED|Overall Study|March 1st, 2014.|104
3367386|NCT03863210|4098816|FG000|COMPLETED|Overall Study|September 1st, 2014.|102
3367387|NCT03863210|4098816|FG000|NOT COMPLETED|Overall Study||2
3367388|NCT03859323|4098833|FG000|STARTED|Overall Study||5
3367389|NCT03859323|4098834|FG001|STARTED|Overall Study||5
3367390|NCT03859323|4098835|FG002|STARTED|Overall Study||5
3367391|NCT03859323|4098836|FG003|STARTED|Overall Study||5
3367392|NCT03859323|4098837|FG004|STARTED|Overall Study||5
3367393|NCT03859323|4098838|FG005|STARTED|Overall Study||5
3367394|NCT03859323|4098839|FG006|STARTED|Overall Study||12
3367395|NCT03859323|4098840|FG007|STARTED|Overall Study||10
3367396|NCT03859323|4098841|FG008|STARTED|Overall Study||10
3367397|NCT03859323|4098842|FG009|STARTED|Overall Study||10
3367398|NCT03859323|4098843|FG010|STARTED|Overall Study||10
3367399|NCT03859323|4098844|FG011|STARTED|Overall Study||12
3367400|NCT03859323|4098845|FG012|STARTED|Overall Study||10
3367401|NCT03859323|4098833|FG000|COMPLETED|Overall Study||5
3367402|NCT03859323|4098834|FG001|COMPLETED|Overall Study||5
3367403|NCT03859323|4098835|FG002|COMPLETED|Overall Study||4
3367404|NCT03859323|4098836|FG003|COMPLETED|Overall Study||5
3367405|NCT03859323|4098837|FG004|COMPLETED|Overall Study||5
3367406|NCT03859323|4098838|FG005|COMPLETED|Overall Study||4
3367407|NCT03859323|4098839|FG006|COMPLETED|Overall Study||11
3367408|NCT03859323|4098840|FG007|COMPLETED|Overall Study||10
3367409|NCT03859323|4098841|FG008|COMPLETED|Overall Study||10
3367410|NCT03859323|4098842|FG009|COMPLETED|Overall Study||8
3367411|NCT03859323|4098843|FG010|COMPLETED|Overall Study||9
3218808|NCT02264249|3950502|FG001|COMPLETED|Overall Study||187
3367412|NCT03859323|4098844|FG011|COMPLETED|Overall Study||10
3367413|NCT03859323|4098845|FG012|COMPLETED|Overall Study||9
3367414|NCT03859323|4098833|FG000|NOT COMPLETED|Overall Study||0
3367415|NCT03859323|4098834|FG001|NOT COMPLETED|Overall Study||0
3367416|NCT03859323|4098835|FG002|NOT COMPLETED|Overall Study||1
3218809|NCT02264249|3950503|FG002|COMPLETED|Overall Study||241
3218810|NCT02264249|3950501|FG000|NOT COMPLETED|Overall Study||0
3218811|NCT02264249|3950502|FG001|NOT COMPLETED|Overall Study||0
3218812|NCT02264249|3950503|FG002|NOT COMPLETED|Overall Study||0
3218813|NCT02264353|3950511|FG000|STARTED|Overall Study||20
3218814|NCT02264353|3950512|FG001|STARTED|Overall Study||24
3218815|NCT02264353|3950511|FG000|COMPLETED|Overall Study||17
3218816|NCT02264353|3950512|FG001|COMPLETED|Overall Study||24
3218817|NCT02264353|3950511|FG000|NOT COMPLETED|Overall Study||3
3218818|NCT02264353|3950512|FG001|NOT COMPLETED|Overall Study||0
3218819|NCT02264574|3950520|FG000|STARTED|Overall Study||113
3218820|NCT02264574|3950521|FG001|STARTED|Overall Study||116
3218821|NCT02264574|3950520|FG000|COMPLETED|Overall Study||84
3218822|NCT02264574|3950521|FG001|COMPLETED|Overall Study||86
3218823|NCT02264574|3950520|FG000|NOT COMPLETED|Overall Study||29
3218824|NCT02264574|3950521|FG001|NOT COMPLETED|Overall Study||30
3218825|NCT02264639|3950532|FG000|STARTED|Overall Study|Subjects in this arm participated in Cohort 1 only.|2
3218826|NCT02264639|3950533|FG001|STARTED|Overall Study|Subject in this arm participated in Cohort 2 only.|1
3218827|NCT02264639|3950534|FG002|STARTED|Overall Study|Subject in this arm participated in Cohorts 2, 3 and 4.|1
3218828|NCT02264639|3950535|FG003|STARTED|Overall Study|Subject in this arm participated in Cohorts 3 and 4; single-dose phase was not applicable.|1
3218829|NCT02264639|3950536|FG004|STARTED|Overall Study|Subjects in this arm participated in Cohort 4 only; single-dose phase was not applicable.|4
3218830|NCT02264639|3950532|FG000|COMPLETED|Overall Study||0
3218831|NCT02264639|3950533|FG001|COMPLETED|Overall Study||1
3218832|NCT02264639|3950534|FG002|COMPLETED|Overall Study||0
3218833|NCT02264639|3950535|FG003|COMPLETED|Overall Study||1
3218834|NCT02264639|3950536|FG004|COMPLETED|Overall Study||3
3218835|NCT02264639|3950532|FG000|NOT COMPLETED|Overall Study||2
3218836|NCT02264639|3950533|FG001|NOT COMPLETED|Overall Study||0
3218837|NCT02264639|3950534|FG002|NOT COMPLETED|Overall Study||1
3218838|NCT02264639|3950535|FG003|NOT COMPLETED|Overall Study||0
3218839|NCT02264639|3950536|FG004|NOT COMPLETED|Overall Study||1
3218840|NCT02264821|3950554|FG000|STARTED|Overall Study|Double Blind|64
3218841|NCT02264821|3950555|FG001|STARTED|Overall Study|Double Blind|64
3218842|NCT02264821|3950556|FG002|STARTED|Overall Study|Double Blind|64
3218843|NCT02264821|3950554|FG000|COMPLETED|Overall Study||63
3218844|NCT02264821|3950555|FG001|COMPLETED|Overall Study||61
3218845|NCT02264821|3950556|FG002|COMPLETED|Overall Study||58
3218846|NCT02264821|3950554|FG000|NOT COMPLETED|Overall Study||1
3218847|NCT02264821|3950555|FG001|NOT COMPLETED|Overall Study||3
3218848|NCT02264821|3950556|FG002|NOT COMPLETED|Overall Study||6
3218849|NCT02264990|3950566|FG000|STARTED|Overall Study||297
3218850|NCT02264990|3950567|FG001|STARTED|Overall Study||298
3218851|NCT02264990|3950566|FG000|Received Treatment|Overall Study||288
3218852|NCT02264990|3950567|FG001|Received Treatment|Overall Study||293
3218853|NCT02264990|3950566|FG000|Received Maintenance Therapy|Overall Study||148
3218854|NCT02264990|3950567|FG001|Received Maintenance Therapy|Overall Study||123
3218855|NCT02264990|3950566|FG000|COMPLETED|Overall Study||37
3218856|NCT02264990|3950567|FG001|COMPLETED|Overall Study||39
3218857|NCT02264990|3950566|FG000|NOT COMPLETED|Overall Study||260
3218858|NCT02264990|3950567|FG001|NOT COMPLETED|Overall Study||259
3218859|NCT02265224|3950574|FG000|STARTED|Overall Study||48
3218860|NCT02265224|3950574|FG000|COMPLETED|Overall Study||48
3218861|NCT02265224|3950574|FG000|NOT COMPLETED|Overall Study||0
3218862|NCT02265237|3950585|FG000|STARTED|As Enrolled (Overall Study)||59
3218863|NCT02265237|3950586|FG001|STARTED|As Enrolled (Overall Study)||61
3218864|NCT02265237|3950587|FG002|STARTED|As Enrolled (Overall Study)||61
3218865|NCT02265237|3950588|FG003|STARTED|As Enrolled (Overall Study)||3
3218866|NCT02265237|3950585|FG000|COMPLETED|As Enrolled (Overall Study)||54
3218867|NCT02265237|3950586|FG001|COMPLETED|As Enrolled (Overall Study)||58
3218868|NCT02265237|3950587|FG002|COMPLETED|As Enrolled (Overall Study)||51
3218869|NCT02265237|3950588|FG003|COMPLETED|As Enrolled (Overall Study)||2
3218870|NCT02265237|3950585|FG000|NOT COMPLETED|As Enrolled (Overall Study)||5
3218871|NCT02265237|3950586|FG001|NOT COMPLETED|As Enrolled (Overall Study)||3
3218872|NCT02265237|3950587|FG002|NOT COMPLETED|As Enrolled (Overall Study)||10
3218873|NCT02265237|3950588|FG003|NOT COMPLETED|As Enrolled (Overall Study)||1
3218874|NCT02265237|3950585|FG000|STARTED|As Treated (Overall Study)|One arm B subject received the drug for the duration for arm A and was included in arm A for safety.|60
3218875|NCT02265237|3950586|FG001|STARTED|As Treated (Overall Study)|One arm B subject received the drug for the duration for arm A and was included in arm A for safety.|60
3218876|NCT02265237|3950587|FG002|STARTED|As Treated (Overall Study)||61
3218877|NCT02265237|3950588|FG003|STARTED|As Treated (Overall Study)||3
3218878|NCT02265237|3950585|FG000|COMPLETED|As Treated (Overall Study)||55
3218879|NCT02265237|3950586|FG001|COMPLETED|As Treated (Overall Study)||57
3218880|NCT02265237|3950587|FG002|COMPLETED|As Treated (Overall Study)||51
3218881|NCT02265237|3950588|FG003|COMPLETED|As Treated (Overall Study)||2
3218882|NCT02265237|3950585|FG000|NOT COMPLETED|As Treated (Overall Study)||5
3218883|NCT02265237|3950586|FG001|NOT COMPLETED|As Treated (Overall Study)||3
3218884|NCT02265237|3950587|FG002|NOT COMPLETED|As Treated (Overall Study)||10
3218885|NCT02265237|3950588|FG003|NOT COMPLETED|As Treated (Overall Study)||1
3218886|NCT02265341|3950599|FG000|STARTED|Overall Study||12
3218887|NCT02265341|3950599|FG000|COMPLETED|Overall Study||12
3218888|NCT02265341|3950599|FG000|NOT COMPLETED|Overall Study||0
3218889|NCT02265510|3950617|FG000|STARTED|Overall Study||3
3218890|NCT02265510|3950618|FG001|STARTED|Overall Study||3
3218891|NCT02265510|3950619|FG002|STARTED|Overall Study||6
3218892|NCT02265510|3950620|FG003|STARTED|Overall Study||4
3218893|NCT02265510|3950621|FG004|STARTED|Overall Study||3
3218894|NCT02265510|3950622|FG005|STARTED|Overall Study||6
3218895|NCT02265510|3950623|FG006|STARTED|Overall Study||3
3218896|NCT02265510|3950624|FG007|STARTED|Overall Study||4
3218897|NCT02265510|3950625|FG008|STARTED|Overall Study||4
3218898|NCT02265510|3950626|FG009|STARTED|Overall Study||7
3218899|NCT02265510|3950627|FG010|STARTED|Overall Study||5
3218900|NCT02265510|3950628|FG011|STARTED|Overall Study||16
3218901|NCT02265510|3950629|FG012|STARTED|Overall Study||9
3218902|NCT02265510|3950630|FG013|STARTED|Overall Study||10
3218903|NCT02265510|3950617|FG000|COMPLETED|Overall Study||0
3218904|NCT02265510|3950618|FG001|COMPLETED|Overall Study||0
3218905|NCT02265510|3950619|FG002|COMPLETED|Overall Study||0
3218906|NCT02265510|3950620|FG003|COMPLETED|Overall Study||0
3218907|NCT02265510|3950621|FG004|COMPLETED|Overall Study||0
3218908|NCT02265510|3950622|FG005|COMPLETED|Overall Study||0
3218909|NCT02265510|3950623|FG006|COMPLETED|Overall Study||0
3218910|NCT02265510|3950624|FG007|COMPLETED|Overall Study||0
3218911|NCT02265510|3950625|FG008|COMPLETED|Overall Study||0
3218912|NCT02265510|3950626|FG009|COMPLETED|Overall Study||0
3218913|NCT02265510|3950627|FG010|COMPLETED|Overall Study||0
3367417|NCT03859323|4098836|FG003|NOT COMPLETED|Overall Study||0
3367418|NCT03859323|4098837|FG004|NOT COMPLETED|Overall Study||0
3367419|NCT03859323|4098838|FG005|NOT COMPLETED|Overall Study||1
3367420|NCT03859323|4098839|FG006|NOT COMPLETED|Overall Study||1
3367421|NCT03859323|4098840|FG007|NOT COMPLETED|Overall Study||0
3367422|NCT03859323|4098841|FG008|NOT COMPLETED|Overall Study||0
3367423|NCT03859323|4098842|FG009|NOT COMPLETED|Overall Study||2
3367424|NCT03859323|4098843|FG010|NOT COMPLETED|Overall Study||1
3367425|NCT03859323|4098844|FG011|NOT COMPLETED|Overall Study||2
3367426|NCT03859323|4098845|FG012|NOT COMPLETED|Overall Study||1
3367427|NCT03867838|4098884|FG000|STARTED|Overall Study||6
3367428|NCT03867838|4098884|FG000|COMPLETED|Overall Study||6
3367429|NCT03867838|4098884|FG000|NOT COMPLETED|Overall Study||0
3367430|NCT03855059|4098890|FG000|STARTED|Overall Study||25
3367431|NCT03855059|4098891|FG001|STARTED|Overall Study||25
3367432|NCT03855059|4098890|FG000|COMPLETED|Overall Study||23
3367433|NCT03855059|4098891|FG001|COMPLETED|Overall Study||25
3367434|NCT03855059|4098890|FG000|NOT COMPLETED|Overall Study||2
3367435|NCT03855059|4098891|FG001|NOT COMPLETED|Overall Study||0
3367436|NCT03852537|4098899|FG000|STARTED|Overall Study||23
3367437|NCT03852537|4098900|FG001|STARTED|Overall Study||21
3367438|NCT03852537|4098899|FG000|COMPLETED|Overall Study||23
3367439|NCT03852537|4098900|FG001|COMPLETED|Overall Study||21
3367440|NCT03852537|4098899|FG000|NOT COMPLETED|Overall Study||0
3367441|NCT03852537|4098900|FG001|NOT COMPLETED|Overall Study||0
3367442|NCT03875859|4098906|FG000|STARTED|Overall Study||4
3367443|NCT03875859|4098906|FG000|COMPLETED|Overall Study||4
3367444|NCT03875859|4098906|FG000|NOT COMPLETED|Overall Study||0
3367445|NCT03875508|4098910|FG000|STARTED|Overall Study||108
3367446|NCT03875508|4098910|FG000|COMPLETED|Overall Study||96
3367447|NCT03875508|4098910|FG000|NOT COMPLETED|Overall Study||12
3367448|NCT03869333|4098918|FG000|STARTED|Overall Study||14
3367449|NCT03869333|4098919|FG001|STARTED|Overall Study||16
3367450|NCT03869333|4098920|FG002|STARTED|Overall Study||16
3367451|NCT03869333|4098921|FG003|STARTED|Overall Study||12
3367452|NCT03869333|4098918|FG000|Received First Dose|Overall Study||14
3367453|NCT03869333|4098919|FG001|Received First Dose|Overall Study||16
3367454|NCT03869333|4098920|FG002|Received First Dose|Overall Study||16
3367455|NCT03869333|4098921|FG003|Received First Dose|Overall Study||12
3367456|NCT03869333|4098918|FG000|Received Second Dose|Overall Study||13
3367457|NCT03869333|4098919|FG001|Received Second Dose|Overall Study||15
3367458|NCT03869333|4098920|FG002|Received Second Dose|Overall Study||16
3367459|NCT03869333|4098921|FG003|Received Second Dose|Overall Study||12
3367460|NCT03869333|4098918|FG000|Received Third Dose|Overall Study||13
3367461|NCT03869333|4098919|FG001|Received Third Dose|Overall Study||15
3367462|NCT03869333|4098920|FG002|Received Third Dose|Overall Study||16
3218914|NCT02265510|3950628|FG011|COMPLETED|Overall Study||0
3218915|NCT02265510|3950629|FG012|COMPLETED|Overall Study||0
3218916|NCT02265510|3950630|FG013|COMPLETED|Overall Study||0
3218917|NCT02265510|3950617|FG000|NOT COMPLETED|Overall Study||3
3218918|NCT02265510|3950618|FG001|NOT COMPLETED|Overall Study||3
3218919|NCT02265510|3950619|FG002|NOT COMPLETED|Overall Study||6
3218920|NCT02265510|3950620|FG003|NOT COMPLETED|Overall Study||4
3218921|NCT02265510|3950621|FG004|NOT COMPLETED|Overall Study||3
3218922|NCT02265510|3950622|FG005|NOT COMPLETED|Overall Study||6
3218923|NCT02265510|3950623|FG006|NOT COMPLETED|Overall Study||3
3218924|NCT02265510|3950624|FG007|NOT COMPLETED|Overall Study||4
3218925|NCT02265510|3950625|FG008|NOT COMPLETED|Overall Study||4
3367463|NCT03869333|4098921|FG003|Received Third Dose|Overall Study||11
3367464|NCT03869333|4098918|FG000|COMPLETED|Overall Study||12
3367465|NCT03869333|4098919|FG001|COMPLETED|Overall Study||15
3367466|NCT03869333|4098920|FG002|COMPLETED|Overall Study||16
3367467|NCT03869333|4098921|FG003|COMPLETED|Overall Study||12
3367468|NCT03869333|4098918|FG000|NOT COMPLETED|Overall Study||2
3367469|NCT03869333|4098919|FG001|NOT COMPLETED|Overall Study||1
3367470|NCT03869333|4098920|FG002|NOT COMPLETED|Overall Study||0
3367471|NCT03869333|4098921|FG003|NOT COMPLETED|Overall Study||0
3367472|NCT03864900|4098933|FG000|STARTED|Overall Study||36
3367473|NCT03864900|4098934|FG001|STARTED|Overall Study||36
3218926|NCT02265510|3950626|FG009|NOT COMPLETED|Overall Study||7
3218927|NCT02265510|3950627|FG010|NOT COMPLETED|Overall Study||5
3218928|NCT02265510|3950628|FG011|NOT COMPLETED|Overall Study||16
3218929|NCT02265510|3950629|FG012|NOT COMPLETED|Overall Study||9
3218930|NCT02265510|3950630|FG013|NOT COMPLETED|Overall Study||10
3218931|NCT02265705|3950688|FG000|STARTED|Treatment Period Week 0-24||145
3218932|NCT02265705|3950689|FG001|STARTED|Treatment Period Week 0-24||145
3218933|NCT02265705|3950690|FG002|STARTED|Treatment Period Week 0-24||0
3218934|NCT02265705|3950691|FG003|STARTED|Treatment Period Week 0-24||0
3218935|NCT02265705|3950692|FG004|STARTED|Treatment Period Week 0-24||0
3218936|NCT02265705|3950693|FG005|STARTED|Treatment Period Week 0-24||0
3218937|NCT02265705|3950694|FG006|STARTED|Treatment Period Week 0-24||0
3218938|NCT02265705|3950688|FG000|Received at Least One Dose of Study Drug|Treatment Period Week 0-24||145
3218939|NCT02265705|3950689|FG001|Received at Least One Dose of Study Drug|Treatment Period Week 0-24||145
3218940|NCT02265705|3950690|FG002|Received at Least One Dose of Study Drug|Treatment Period Week 0-24||0
3218941|NCT02265705|3950691|FG003|Received at Least One Dose of Study Drug|Treatment Period Week 0-24||0
3218942|NCT02265705|3950692|FG004|Received at Least One Dose of Study Drug|Treatment Period Week 0-24||0
3218943|NCT02265705|3950693|FG005|Received at Least One Dose of Study Drug|Treatment Period Week 0-24||0
3218944|NCT02265705|3950694|FG006|Received at Least One Dose of Study Drug|Treatment Period Week 0-24||0
3218945|NCT02265705|3950688|FG000|Rescued|Treatment Period Week 0-24||59
3218946|NCT02265705|3950689|FG001|Rescued|Treatment Period Week 0-24||17
3218947|NCT02265705|3950690|FG002|Rescued|Treatment Period Week 0-24||0
3218948|NCT02265705|3950691|FG003|Rescued|Treatment Period Week 0-24||0
3218949|NCT02265705|3950692|FG004|Rescued|Treatment Period Week 0-24||0
3218950|NCT02265705|3950693|FG005|Rescued|Treatment Period Week 0-24||0
3218951|NCT02265705|3950694|FG006|Rescued|Treatment Period Week 0-24||0
3218952|NCT02265705|3950688|FG000|COMPLETED|Treatment Period Week 0-24|"Completers include rescued participants."|133
3218953|NCT02265705|3950689|FG001|COMPLETED|Treatment Period Week 0-24|"Completers include rescued participants."|136
3218954|NCT02265705|3950690|FG002|COMPLETED|Treatment Period Week 0-24||0
3218955|NCT02265705|3950691|FG003|COMPLETED|Treatment Period Week 0-24||0
3218956|NCT02265705|3950692|FG004|COMPLETED|Treatment Period Week 0-24||0
3218957|NCT02265705|3950693|FG005|COMPLETED|Treatment Period Week 0-24||0
3218958|NCT02265705|3950694|FG006|COMPLETED|Treatment Period Week 0-24||0
3218959|NCT02265705|3950688|FG000|NOT COMPLETED|Treatment Period Week 0-24||12
3218960|NCT02265705|3950689|FG001|NOT COMPLETED|Treatment Period Week 0-24||9
3218961|NCT02265705|3950690|FG002|NOT COMPLETED|Treatment Period Week 0-24||0
3218962|NCT02265705|3950691|FG003|NOT COMPLETED|Treatment Period Week 0-24||0
3218963|NCT02265705|3950692|FG004|NOT COMPLETED|Treatment Period Week 0-24||0
3218964|NCT02265705|3950693|FG005|NOT COMPLETED|Treatment Period Week 0-24||0
3218965|NCT02265705|3950694|FG006|NOT COMPLETED|Treatment Period Week 0-24||0
3218966|NCT02265705|3950688|FG000|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
3218967|NCT02265705|3950689|FG001|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
3218968|NCT02265705|3950690|FG002|STARTED|Rescue Period|Participants who were determined to be nonresponders based on tender/swollen joint count.|77
3218969|NCT02265705|3950691|FG003|STARTED|Rescue Period||0
3218970|NCT02265705|3950692|FG004|STARTED|Rescue Period||0
3218971|NCT02265705|3950693|FG005|STARTED|Rescue Period||0
3218972|NCT02265705|3950694|FG006|STARTED|Rescue Period||0
3218973|NCT02265705|3950688|FG000|COMPLETED|Rescue Period||0
3218974|NCT02265705|3950689|FG001|COMPLETED|Rescue Period||0
3218975|NCT02265705|3950690|FG002|COMPLETED|Rescue Period||74
3218976|NCT02265705|3950691|FG003|COMPLETED|Rescue Period||0
3218977|NCT02265705|3950692|FG004|COMPLETED|Rescue Period||0
3218978|NCT02265705|3950693|FG005|COMPLETED|Rescue Period||0
3218979|NCT02265705|3950694|FG006|COMPLETED|Rescue Period||0
3218980|NCT02265705|3950688|FG000|NOT COMPLETED|Rescue Period||0
3218981|NCT02265705|3950689|FG001|NOT COMPLETED|Rescue Period||0
3218982|NCT02265705|3950690|FG002|NOT COMPLETED|Rescue Period||3
3218983|NCT02265705|3950691|FG003|NOT COMPLETED|Rescue Period||0
3218984|NCT02265705|3950692|FG004|NOT COMPLETED|Rescue Period||0
3218985|NCT02265705|3950693|FG005|NOT COMPLETED|Rescue Period||0
3218986|NCT02265705|3950694|FG006|NOT COMPLETED|Rescue Period||0
3218987|NCT02265705|3950688|FG000|STARTED|Open Label Period||0
3218988|NCT02265705|3950689|FG001|STARTED|Open Label Period||0
3218989|NCT02265705|3950690|FG002|STARTED|Open Label Period||0
3218990|NCT02265705|3950691|FG003|STARTED|Open Label Period|Completed Wk 24 w/o rescue Tx, switched to or remained on active Tx, and entered Open Label Period.|74
3218991|NCT02265705|3950692|FG004|STARTED|Open Label Period|Completed Wk 24 w/o rescue Tx, switched to or remained on active Tx, and entered Open Label Period.|120
3218992|NCT02265705|3950693|FG005|STARTED|Open Label Period||0
3218993|NCT02265705|3950694|FG006|STARTED|Open Label Period||0
3218994|NCT02265705|3950688|FG000|COMPLETED|Open Label Period||0
3218995|NCT02265705|3950689|FG001|COMPLETED|Open Label Period||0
3218996|NCT02265705|3950690|FG002|COMPLETED|Open Label Period||0
3218997|NCT02265705|3950691|FG003|COMPLETED|Open Label Period||72
3218998|NCT02265705|3950692|FG004|COMPLETED|Open Label Period||115
3218999|NCT02265705|3950693|FG005|COMPLETED|Open Label Period||0
3219000|NCT02265705|3950694|FG006|COMPLETED|Open Label Period||0
3219001|NCT02265705|3950688|FG000|NOT COMPLETED|Open Label Period||0
3219002|NCT02265705|3950689|FG001|NOT COMPLETED|Open Label Period||0
3219003|NCT02265705|3950690|FG002|NOT COMPLETED|Open Label Period||0
3219004|NCT02265705|3950691|FG003|NOT COMPLETED|Open Label Period||2
3219005|NCT02265705|3950692|FG004|NOT COMPLETED|Open Label Period||5
3219006|NCT02265705|3950693|FG005|NOT COMPLETED|Open Label Period||0
3219007|NCT02265705|3950694|FG006|NOT COMPLETED|Open Label Period||0
3219008|NCT02265705|3950688|FG000|STARTED|Follow-up Period||0
3219009|NCT02265705|3950689|FG001|STARTED|Follow-up Period||0
3219010|NCT02265705|3950690|FG002|STARTED|Follow-up Period||0
3219011|NCT02265705|3950691|FG003|STARTED|Follow-up Period||0
3219012|NCT02265705|3950692|FG004|STARTED|Follow-up Period||0
3219013|NCT02265705|3950693|FG005|STARTED|Follow-up Period|Participants from placebo who never rescued or switched and entered post-treatment follow-up period.|2
3219014|NCT02265705|3950694|FG006|STARTED|Follow-up Period|Participants who ever took baricitinib and entered the post-treatment follow-up period.|58
3219015|NCT02265705|3950688|FG000|COMPLETED|Follow-up Period||0
3219016|NCT02265705|3950689|FG001|COMPLETED|Follow-up Period||0
3219017|NCT02265705|3950690|FG002|COMPLETED|Follow-up Period||0
3219018|NCT02265705|3950691|FG003|COMPLETED|Follow-up Period||0
3219019|NCT02265705|3950692|FG004|COMPLETED|Follow-up Period||0
3219020|NCT02265705|3950693|FG005|COMPLETED|Follow-up Period||1
3219021|NCT02265705|3950694|FG006|COMPLETED|Follow-up Period||47
3219022|NCT02265705|3950688|FG000|NOT COMPLETED|Follow-up Period||0
3219023|NCT02265705|3950689|FG001|NOT COMPLETED|Follow-up Period||0
3219024|NCT02265705|3950690|FG002|NOT COMPLETED|Follow-up Period||0
3219025|NCT02265705|3950691|FG003|NOT COMPLETED|Follow-up Period||0
3219026|NCT02265705|3950692|FG004|NOT COMPLETED|Follow-up Period||0
3219027|NCT02265705|3950693|FG005|NOT COMPLETED|Follow-up Period||1
3219028|NCT02265705|3950694|FG006|NOT COMPLETED|Follow-up Period||11
3219029|NCT02265744|3950710|FG000|STARTED|Overall Study||69
3219030|NCT02265744|3950711|FG001|STARTED|Overall Study||68
3219031|NCT02265744|3950712|FG002|STARTED|Overall Study||68
3219032|NCT02265744|3950713|FG003|STARTED|Overall Study||70
3219033|NCT02265744|3950714|FG004|STARTED|Overall Study||71
3219034|NCT02265744|3950710|FG000|COMPLETED|Overall Study||49
3219035|NCT02265744|3950711|FG001|COMPLETED|Overall Study||53
3219036|NCT02265744|3950712|FG002|COMPLETED|Overall Study||51
3219037|NCT02265744|3950713|FG003|COMPLETED|Overall Study||47
3219038|NCT02265744|3950714|FG004|COMPLETED|Overall Study||58
3219039|NCT02265744|3950710|FG000|NOT COMPLETED|Overall Study||20
3219040|NCT02265744|3950711|FG001|NOT COMPLETED|Overall Study||15
3219041|NCT02265744|3950712|FG002|NOT COMPLETED|Overall Study||17
3219042|NCT02265744|3950713|FG003|NOT COMPLETED|Overall Study||23
3219043|NCT02265744|3950714|FG004|NOT COMPLETED|Overall Study||13
3219044|NCT02265783|3950726|FG000|STARTED|Overall Study||20
3219045|NCT02265783|3950726|FG000|COMPLETED|Overall Study|All subjects completed, one excluded from the analysis due to an issue with the data collection|20
3219046|NCT02265783|3950726|FG000|NOT COMPLETED|Overall Study||0
3219047|NCT02265796|3950732|FG000|STARTED|Overall Study||25
3219048|NCT02265796|3950733|FG001|STARTED|Overall Study||25
3219049|NCT02265796|3950732|FG000|COMPLETED|Overall Study||22
3219050|NCT02265796|3950733|FG001|COMPLETED|Overall Study||24
3219051|NCT02265796|3950732|FG000|NOT COMPLETED|Overall Study||3
3219052|NCT02265796|3950733|FG001|NOT COMPLETED|Overall Study||1
3219053|NCT02265848|3950741|FG000|STARTED|Overall Study|First subject for this study was randomized on October 1st 2014|11
3219054|NCT02265848|3950742|FG001|STARTED|Overall Study||11
3219055|NCT02265848|3950741|FG000|COMPLETED|Overall Study||11
3219056|NCT02265848|3950742|FG001|COMPLETED|Overall Study|Last subject for this study completed the visit on December 24, 2014|11
3219057|NCT02265848|3950741|FG000|NOT COMPLETED|Overall Study||0
3219058|NCT02265848|3950742|FG001|NOT COMPLETED|Overall Study||0
3219059|NCT02265913|3950751|FG000|STARTED|Overall Study||1357
3219060|NCT02265913|3950752|FG001|STARTED|Overall Study||1361
3219061|NCT02265913|3950753|FG002|STARTED|Overall Study||1358
3219062|NCT02265913|3950751|FG000|COMPLETED|Overall Study||793
3219063|NCT02265913|3950752|FG001|COMPLETED|Overall Study||810
3219064|NCT02265913|3950753|FG002|COMPLETED|Overall Study||813
3219065|NCT02265913|3950751|FG000|NOT COMPLETED|Overall Study||564
3219066|NCT02265913|3950752|FG001|NOT COMPLETED|Overall Study||551
3219067|NCT02265913|3950753|FG002|NOT COMPLETED|Overall Study||545
3219068|NCT02265952|3950761|FG000|STARTED|Main Study Period||9
3219069|NCT02265952|3950762|FG001|STARTED|Main Study Period||0
3219070|NCT02265952|3950761|FG000|COMPLETED|Main Study Period||9
3219071|NCT02265952|3950762|FG001|COMPLETED|Main Study Period||0
3219072|NCT02265952|3950761|FG000|NOT COMPLETED|Main Study Period||0
3219073|NCT02265952|3950762|FG001|NOT COMPLETED|Main Study Period||0
3219074|NCT02265952|3950761|FG000|STARTED|Open Label Extension (OLE) Period||0
3219075|NCT02265952|3950762|FG001|STARTED|Open Label Extension (OLE) Period||8
3219076|NCT02265952|3950761|FG000|COMPLETED|Open Label Extension (OLE) Period||0
3219077|NCT02265952|3950762|FG001|COMPLETED|Open Label Extension (OLE) Period||0
3219078|NCT02265952|3950761|FG000|NOT COMPLETED|Open Label Extension (OLE) Period||0
3219079|NCT02265952|3950762|FG001|NOT COMPLETED|Open Label Extension (OLE) Period||8
3219080|NCT02265965|3950770|FG000|STARTED|Overall Study||7
3219081|NCT02265965|3950771|FG001|STARTED|Overall Study||11
3219082|NCT02265965|3950770|FG000|COMPLETED|Overall Study||7
3219083|NCT02265965|3950771|FG001|COMPLETED|Overall Study||11
3219084|NCT02265965|3950770|FG000|NOT COMPLETED|Overall Study||0
3219085|NCT02265965|3950771|FG001|NOT COMPLETED|Overall Study||0
3219086|NCT02266004|3950777|FG000|STARTED|Overall Study||9
3219087|NCT02266004|3950777|FG000|COMPLETED|Overall Study||7
3219088|NCT02266004|3950777|FG000|NOT COMPLETED|Overall Study||2
3219089|NCT02266108|3950783|FG000|STARTED|Overall Study||80
3219090|NCT02266108|3950784|FG001|STARTED|Overall Study||71
3219091|NCT02266108|3950783|FG000|COMPLETED|Overall Study||80
3219092|NCT02266108|3950784|FG001|COMPLETED|Overall Study||71
3219093|NCT02266108|3950783|FG000|NOT COMPLETED|Overall Study||0
3219094|NCT02266108|3950784|FG001|NOT COMPLETED|Overall Study||0
3219095|NCT02266147|3950794|FG000|STARTED|PART 1: Dose Escalation||3
3219096|NCT02266147|3950795|FG001|STARTED|PART 1: Dose Escalation||3
3219097|NCT02266147|3950796|FG002|STARTED|PART 1: Dose Escalation||3
3219098|NCT02266147|3950797|FG003|STARTED|PART 1: Dose Escalation||4
3219099|NCT02266147|3950794|FG000|COMPLETED|PART 1: Dose Escalation||2
3219100|NCT02266147|3950795|FG001|COMPLETED|PART 1: Dose Escalation||0
3219101|NCT02266147|3950796|FG002|COMPLETED|PART 1: Dose Escalation||0
3219102|NCT02266147|3950797|FG003|COMPLETED|PART 1: Dose Escalation||0
3219103|NCT02266147|3950794|FG000|NOT COMPLETED|PART 1: Dose Escalation||1
3219104|NCT02266147|3950795|FG001|NOT COMPLETED|PART 1: Dose Escalation||3
3219105|NCT02266147|3950796|FG002|NOT COMPLETED|PART 1: Dose Escalation||3
3219106|NCT02266147|3950797|FG003|NOT COMPLETED|PART 1: Dose Escalation||4
3219107|NCT02266147|3950794|FG000|STARTED|PART 2: Dose Expansion|Participants were enrolled separately from Part 1; sponsor terminated the trial early during Part 2.|7
3219108|NCT02266147|3950795|FG001|STARTED|PART 2: Dose Expansion|No new participants were enrolled and sponsor terminated the trial early during Part 2.|0
3219109|NCT02266147|3950796|FG002|STARTED|PART 2: Dose Expansion|No new participants were enrolled and sponsor terminated the trial early during Part 2.|0
3219110|NCT02266147|3950797|FG003|STARTED|PART 2: Dose Expansion|Participants were enrolled separately from Part 1; sponsor terminated the trial early during Part 2.|9
3219111|NCT02266147|3950794|FG000|COMPLETED|PART 2: Dose Expansion||0
3219112|NCT02266147|3950795|FG001|COMPLETED|PART 2: Dose Expansion||0
3219113|NCT02266147|3950796|FG002|COMPLETED|PART 2: Dose Expansion||0
3219114|NCT02266147|3950797|FG003|COMPLETED|PART 2: Dose Expansion||0
3219115|NCT02266147|3950794|FG000|NOT COMPLETED|PART 2: Dose Expansion||7
3219116|NCT02266147|3950795|FG001|NOT COMPLETED|PART 2: Dose Expansion||0
3219117|NCT02266147|3950796|FG002|NOT COMPLETED|PART 2: Dose Expansion||0
3219118|NCT02266147|3950797|FG003|NOT COMPLETED|PART 2: Dose Expansion||9
3219119|NCT02266225|3950809|FG000|STARTED|Overall Study||48
3219120|NCT02266225|3950809|FG000|Enrolled in Intervention|Overall Study||44
3219121|NCT02266225|3950809|FG000|COMPLETED|Overall Study||32
3219122|NCT02266225|3950809|FG000|NOT COMPLETED|Overall Study||16
3219123|NCT02266277|3950820|FG000|STARTED|Overall Study||5000
3219124|NCT02266277|3950821|FG001|STARTED|Overall Study||5000
3219125|NCT02266277|3950822|FG002|STARTED|Overall Study||5000
3219126|NCT02266277|3950823|FG003|STARTED|Overall Study||5000
3219127|NCT02266277|3950824|FG004|STARTED|Overall Study||5000
3219128|NCT02266277|3950825|FG005|STARTED|Overall Study||5000
3219129|NCT02266277|3950820|FG000|COMPLETED|Overall Study||5000
3219130|NCT02266277|3950821|FG001|COMPLETED|Overall Study||5000
3219131|NCT02266277|3950822|FG002|COMPLETED|Overall Study||5000
3219132|NCT02266277|3950823|FG003|COMPLETED|Overall Study||5000
3219133|NCT02266277|3950824|FG004|COMPLETED|Overall Study||5000
3219134|NCT02266277|3950825|FG005|COMPLETED|Overall Study||5000
3219135|NCT02266277|3950820|FG000|NOT COMPLETED|Overall Study||0
3219136|NCT02266277|3950821|FG001|NOT COMPLETED|Overall Study||0
3219137|NCT02266277|3950822|FG002|NOT COMPLETED|Overall Study||0
3219138|NCT02266277|3950823|FG003|NOT COMPLETED|Overall Study||0
3219139|NCT02266277|3950824|FG004|NOT COMPLETED|Overall Study||0
3219140|NCT02266277|3950825|FG005|NOT COMPLETED|Overall Study||0
3219141|NCT02266381|3950844|FG000|STARTED|Overall Study||150
3219142|NCT02266381|3950845|FG001|STARTED|Overall Study||150
3219143|NCT02266381|3950846|FG002|STARTED|Overall Study||150
3219144|NCT02266381|3950844|FG000|COMPLETED|Overall Study||147
3219145|NCT02266381|3950845|FG001|COMPLETED|Overall Study||145
3219146|NCT02266381|3950846|FG002|COMPLETED|Overall Study||146
3219147|NCT02266381|3950844|FG000|NOT COMPLETED|Overall Study||3
3219148|NCT02266381|3950845|FG001|NOT COMPLETED|Overall Study||5
3219149|NCT02266381|3950846|FG002|NOT COMPLETED|Overall Study||4
3219150|NCT02266433|3950858|FG000|STARTED|Overall Study||127
3219151|NCT02266433|3950859|FG001|STARTED|Overall Study||118
3219152|NCT02266433|3950858|FG000|COMPLETED|Overall Study||68
3219153|NCT02266433|3950859|FG001|COMPLETED|Overall Study||65
3219154|NCT02266433|3950858|FG000|NOT COMPLETED|Overall Study||59
3219155|NCT02266433|3950859|FG001|NOT COMPLETED|Overall Study||53
3219156|NCT02266472|3950868|FG000|STARTED|Period 1+ Washout||15
3219157|NCT02266472|3950869|FG001|STARTED|Period 1+ Washout||15
3219158|NCT02266472|3950868|FG000|COMPLETED|Period 1+ Washout||15
3219159|NCT02266472|3950869|FG001|COMPLETED|Period 1+ Washout||15
3219160|NCT02266472|3950868|FG000|NOT COMPLETED|Period 1+ Washout||0
3219161|NCT02266472|3950869|FG001|NOT COMPLETED|Period 1+ Washout||0
3219162|NCT02266472|3950868|FG000|STARTED|Period 2+ Washout||15
3219163|NCT02266472|3950869|FG001|STARTED|Period 2+ Washout||15
3219164|NCT02266472|3950868|FG000|COMPLETED|Period 2+ Washout||15
3219165|NCT02266472|3950869|FG001|COMPLETED|Period 2+ Washout||15
3219166|NCT02266472|3950868|FG000|NOT COMPLETED|Period 2+ Washout||0
3219167|NCT02266472|3950869|FG001|NOT COMPLETED|Period 2+ Washout||0
3219168|NCT02266576|3950877|FG000|STARTED|Overall Study||102
3219169|NCT02266576|3950878|FG001|STARTED|Overall Study||105
3219170|NCT02266576|3950877|FG000|COMPLETED|Overall Study||85
3219171|NCT02266576|3950878|FG001|COMPLETED|Overall Study||90
3219172|NCT02266576|3950877|FG000|NOT COMPLETED|Overall Study||17
3219173|NCT02266576|3950878|FG001|NOT COMPLETED|Overall Study||15
3219174|NCT02266706|3950893|FG000|STARTED|Overall Study||6
3219175|NCT02266706|3950894|FG001|STARTED|Overall Study||7
3219176|NCT02266706|3950895|FG002|STARTED|Overall Study||4
3219177|NCT02266706|3950896|FG003|STARTED|Overall Study||4
3219178|NCT02266706|3950897|FG004|STARTED|Overall Study||1
3219179|NCT02266706|3950898|FG005|STARTED|Overall Study||7
3219180|NCT02266706|3950899|FG006|STARTED|Overall Study||8
3219181|NCT02266706|3950900|FG007|STARTED|Overall Study||2
3219182|NCT02266706|3950901|FG008|STARTED|Overall Study||4
3219183|NCT02266706|3950893|FG000|Treated|Overall Study||6
3219184|NCT02266706|3950894|FG001|Treated|Overall Study||6
3219185|NCT02266706|3950895|FG002|Treated|Overall Study||3
3219186|NCT02266706|3950896|FG003|Treated|Overall Study||3
3219187|NCT02266706|3950897|FG004|Treated|Overall Study||1
3219188|NCT02266706|3950898|FG005|Treated|Overall Study||5
3219189|NCT02266706|3950899|FG006|Treated|Overall Study||7
3219190|NCT02266706|3950900|FG007|Treated|Overall Study||2
3219191|NCT02266706|3950901|FG008|Treated|Overall Study||4
3219192|NCT02266706|3950893|FG000|COMPLETED|Overall Study||6
3219193|NCT02266706|3950894|FG001|COMPLETED|Overall Study||6
3219194|NCT02266706|3950895|FG002|COMPLETED|Overall Study||3
3219195|NCT02266706|3950896|FG003|COMPLETED|Overall Study||3
3219196|NCT02266706|3950897|FG004|COMPLETED|Overall Study||1
3219197|NCT02266706|3950898|FG005|COMPLETED|Overall Study||5
3219198|NCT02266706|3950899|FG006|COMPLETED|Overall Study||7
3219199|NCT02266706|3950900|FG007|COMPLETED|Overall Study||2
3219200|NCT02266706|3950901|FG008|COMPLETED|Overall Study||4
3219201|NCT02266706|3950893|FG000|NOT COMPLETED|Overall Study||0
3219202|NCT02266706|3950894|FG001|NOT COMPLETED|Overall Study||1
3219203|NCT02266706|3950895|FG002|NOT COMPLETED|Overall Study||1
3219204|NCT02266706|3950896|FG003|NOT COMPLETED|Overall Study||1
3219205|NCT02266706|3950897|FG004|NOT COMPLETED|Overall Study||0
3219206|NCT02266706|3950898|FG005|NOT COMPLETED|Overall Study||2
3219207|NCT02266706|3950899|FG006|NOT COMPLETED|Overall Study||1
3219208|NCT02266706|3950900|FG007|NOT COMPLETED|Overall Study||0
3219209|NCT02266706|3950901|FG008|NOT COMPLETED|Overall Study||0
3219210|NCT02266810|3950923|FG000|STARTED|Overall Study|sinus sides|80
3219211|NCT02266810|3950924|FG001|STARTED|Overall Study|sinus sides|80
3219212|NCT02266810|3950923|FG000|COMPLETED|Overall Study|sinus sides|79
3219213|NCT02266810|3950924|FG001|COMPLETED|Overall Study|sinus sides|79
3219214|NCT02266810|3950923|FG000|NOT COMPLETED|Overall Study||1
3219215|NCT02266810|3950924|FG001|NOT COMPLETED|Overall Study||1
3219216|NCT02266875|3950941|FG000|STARTED|Overall Study||40
3219217|NCT02266875|3950942|FG001|STARTED|Overall Study||30
3219218|NCT02266875|3950941|FG000|COMPLETED|Overall Study||29
3219219|NCT02266875|3950942|FG001|COMPLETED|Overall Study||30
3219220|NCT02266875|3950941|FG000|NOT COMPLETED|Overall Study||11
3219221|NCT02266875|3950942|FG001|NOT COMPLETED|Overall Study||0
3219222|NCT02266888|3950950|FG000|STARTED|Overall Study||15
3219223|NCT02266888|3950951|FG001|STARTED|Overall Study||12
3219224|NCT02266888|3950952|FG002|STARTED|Overall Study||11
3219225|NCT02266888|3950953|FG003|STARTED|Overall Study||7
3219226|NCT02266888|3950950|FG000|COMPLETED|Overall Study||8
3219227|NCT02266888|3950951|FG001|COMPLETED|Overall Study||8
3219228|NCT02266888|3950952|FG002|COMPLETED|Overall Study||0
3219229|NCT02266888|3950953|FG003|COMPLETED|Overall Study||0
3219230|NCT02266888|3950950|FG000|NOT COMPLETED|Overall Study||7
3219231|NCT02266888|3950951|FG001|NOT COMPLETED|Overall Study||4
3219232|NCT02266888|3950952|FG002|NOT COMPLETED|Overall Study||11
3219233|NCT02266888|3950953|FG003|NOT COMPLETED|Overall Study||7
3219234|NCT02267083|3950961|FG000|STARTED|Overall Study||22
3219235|NCT02267083|3950961|FG000|COMPLETED|Overall Study||3
3219236|NCT02267083|3950961|FG000|NOT COMPLETED|Overall Study||19
3219237|NCT02267135|3950967|FG000|STARTED|Period 1 (Randomized Set)||51
3219238|NCT02267135|3950968|FG001|STARTED|Period 1 (Randomized Set)||51
3219239|NCT02267135|3950967|FG000|COMPLETED|Period 1 (Randomized Set)||50
3219240|NCT02267135|3950968|FG001|COMPLETED|Period 1 (Randomized Set)||47
3219241|NCT02267135|3950967|FG000|NOT COMPLETED|Period 1 (Randomized Set)||1
3219242|NCT02267135|3950968|FG001|NOT COMPLETED|Period 1 (Randomized Set)||4
3219243|NCT02267135|3950967|FG000|STARTED|Period 2 (Randomized Set)||50
3219244|NCT02267135|3950968|FG001|STARTED|Period 2 (Randomized Set)||47
3219245|NCT02267135|3950967|FG000|COMPLETED|Period 2 (Randomized Set)||46
3219246|NCT02267135|3950968|FG001|COMPLETED|Period 2 (Randomized Set)||46
3219247|NCT02267135|3950967|FG000|NOT COMPLETED|Period 2 (Randomized Set)||4
3219248|NCT02267135|3950968|FG001|NOT COMPLETED|Period 2 (Randomized Set)||1
3219249|NCT02267187|3950977|FG000|STARTED|Overall Study||15
3219250|NCT02267187|3950977|FG000|COMPLETED|Overall Study||10
3219251|NCT02267187|3950977|FG000|NOT COMPLETED|Overall Study||5
3219252|NCT02267226|3950981|FG000|STARTED|Overall Study||25
3219253|NCT02267226|3950981|FG000|SAFETY Population|Overall Study||25
3219254|NCT02267226|3950981|FG000|FAS-Bleeding Population|Overall Study||24
3219255|NCT02267226|3950981|FG000|Surgical Prophylaxis Population|Overall Study||9
3219256|NCT02267226|3950981|FG000|COMPLETED|Overall Study||18
3219257|NCT02267226|3950981|FG000|NOT COMPLETED|Overall Study||7
3219258|NCT02267278|3951000|FG000|STARTED|Overall Study||25
3219259|NCT02267278|3951000|FG000|COMPLETED|Overall Study||20
3219260|NCT02267278|3951000|FG000|NOT COMPLETED|Overall Study||5
3219261|NCT02267317|3951007|FG000|STARTED|Infusion1||8
3219262|NCT02267317|3951008|FG001|STARTED|Infusion1||3
3219263|NCT02267317|3951009|FG002|STARTED|Infusion1||1
3219264|NCT02267317|3951010|FG003|STARTED|Infusion1||2
3219265|NCT02267317|3951011|FG004|STARTED|Infusion1||0
3219266|NCT02267317|3951012|FG005|STARTED|Infusion1||1
3219267|NCT02267317|3951007|FG000|COMPLETED|Infusion1||8
3219268|NCT02267317|3951008|FG001|COMPLETED|Infusion1||3
3219269|NCT02267317|3951009|FG002|COMPLETED|Infusion1||1
3219270|NCT02267317|3951010|FG003|COMPLETED|Infusion1||2
3219271|NCT02267317|3951011|FG004|COMPLETED|Infusion1||0
3219272|NCT02267317|3951012|FG005|COMPLETED|Infusion1||1
3219273|NCT02267317|3951007|FG000|NOT COMPLETED|Infusion1||0
3219274|NCT02267317|3951008|FG001|NOT COMPLETED|Infusion1||0
3219275|NCT02267317|3951009|FG002|NOT COMPLETED|Infusion1||0
3219276|NCT02267317|3951010|FG003|NOT COMPLETED|Infusion1||0
3219277|NCT02267317|3951011|FG004|NOT COMPLETED|Infusion1||0
3219278|NCT02267317|3951012|FG005|NOT COMPLETED|Infusion1||0
3219279|NCT02267317|3951007|FG000|STARTED|Washout (3-4weeks Between Infusions)||8
3219280|NCT02267317|3951008|FG001|STARTED|Washout (3-4weeks Between Infusions)||3
3219281|NCT02267317|3951009|FG002|STARTED|Washout (3-4weeks Between Infusions)||1
3219282|NCT02267317|3951010|FG003|STARTED|Washout (3-4weeks Between Infusions)||2
3219283|NCT02267317|3951011|FG004|STARTED|Washout (3-4weeks Between Infusions)||0
3219284|NCT02267317|3951012|FG005|STARTED|Washout (3-4weeks Between Infusions)||1
3219285|NCT02267317|3951007|FG000|COMPLETED|Washout (3-4weeks Between Infusions)||6
3219286|NCT02267317|3951008|FG001|COMPLETED|Washout (3-4weeks Between Infusions)||3
3219287|NCT02267317|3951009|FG002|COMPLETED|Washout (3-4weeks Between Infusions)||1
3219288|NCT02267317|3951010|FG003|COMPLETED|Washout (3-4weeks Between Infusions)||2
3219289|NCT02267317|3951011|FG004|COMPLETED|Washout (3-4weeks Between Infusions)||0
3219290|NCT02267317|3951012|FG005|COMPLETED|Washout (3-4weeks Between Infusions)||1
3219291|NCT02267317|3951007|FG000|NOT COMPLETED|Washout (3-4weeks Between Infusions)||2
3219292|NCT02267317|3951008|FG001|NOT COMPLETED|Washout (3-4weeks Between Infusions)||0
3219293|NCT02267317|3951009|FG002|NOT COMPLETED|Washout (3-4weeks Between Infusions)||0
3219294|NCT02267317|3951010|FG003|NOT COMPLETED|Washout (3-4weeks Between Infusions)||0
3219295|NCT02267317|3951011|FG004|NOT COMPLETED|Washout (3-4weeks Between Infusions)||0
3219296|NCT02267317|3951012|FG005|NOT COMPLETED|Washout (3-4weeks Between Infusions)||0
3219297|NCT02267317|3951007|FG000|STARTED|Infusion2||6
3219298|NCT02267317|3951008|FG001|STARTED|Infusion2||3
3219299|NCT02267317|3951009|FG002|STARTED|Infusion2||1
3219300|NCT02267317|3951010|FG003|STARTED|Infusion2||2
3219301|NCT02267317|3951011|FG004|STARTED|Infusion2||0
3219302|NCT02267317|3951012|FG005|STARTED|Infusion2||1
3219303|NCT02267317|3951007|FG000|COMPLETED|Infusion2||6
3219304|NCT02267317|3951008|FG001|COMPLETED|Infusion2||3
3219305|NCT02267317|3951009|FG002|COMPLETED|Infusion2||1
3219306|NCT02267317|3951010|FG003|COMPLETED|Infusion2||2
3219307|NCT02267317|3951011|FG004|COMPLETED|Infusion2||0
3219308|NCT02267317|3951012|FG005|COMPLETED|Infusion2||1
3219309|NCT02267317|3951007|FG000|NOT COMPLETED|Infusion2||0
3219310|NCT02267317|3951008|FG001|NOT COMPLETED|Infusion2||0
3219311|NCT02267317|3951009|FG002|NOT COMPLETED|Infusion2||0
3219312|NCT02267317|3951010|FG003|NOT COMPLETED|Infusion2||0
3219313|NCT02267317|3951011|FG004|NOT COMPLETED|Infusion2||0
3219314|NCT02267317|3951012|FG005|NOT COMPLETED|Infusion2||0
3219315|NCT02267356|3951031|FG000|STARTED|Initial Study||53
3219316|NCT02267356|3951032|FG001|STARTED|Initial Study||53
3219317|NCT02267356|3951033|FG002|STARTED|Initial Study||52
3219318|NCT02267356|3951034|FG003|STARTED|Initial Study||54
3219319|NCT02267356|3951035|FG004|STARTED|Initial Study||47
3219320|NCT02267356|3951031|FG000|COMPLETED|Initial Study||47
3219321|NCT02267356|3951032|FG001|COMPLETED|Initial Study||48
3219322|NCT02267356|3951033|FG002|COMPLETED|Initial Study||42
3219323|NCT02267356|3951034|FG003|COMPLETED|Initial Study||43
3219324|NCT02267356|3951035|FG004|COMPLETED|Initial Study||42
3219325|NCT02267356|3951031|FG000|NOT COMPLETED|Initial Study||6
3219326|NCT02267356|3951032|FG001|NOT COMPLETED|Initial Study||5
3219327|NCT02267356|3951033|FG002|NOT COMPLETED|Initial Study||10
3219328|NCT02267356|3951034|FG003|NOT COMPLETED|Initial Study||11
3219329|NCT02267356|3951035|FG004|NOT COMPLETED|Initial Study||5
3219330|NCT02267356|3951031|FG000|STARTED|Study Extension||33
3219331|NCT02267356|3951032|FG001|STARTED|Study Extension||37
3219332|NCT02267356|3951033|FG002|STARTED|Study Extension||30
3219333|NCT02267356|3951034|FG003|STARTED|Study Extension||32
3219334|NCT02267356|3951035|FG004|STARTED|Study Extension||26
3219335|NCT02267356|3951031|FG000|COMPLETED|Study Extension||32
3219336|NCT02267356|3951032|FG001|COMPLETED|Study Extension||37
3219337|NCT02267356|3951033|FG002|COMPLETED|Study Extension||29
3219338|NCT02267356|3951034|FG003|COMPLETED|Study Extension||30
3219339|NCT02267356|3951035|FG004|COMPLETED|Study Extension||26
3219340|NCT02267356|3951031|FG000|NOT COMPLETED|Study Extension||1
3219341|NCT02267356|3951032|FG001|NOT COMPLETED|Study Extension||0
3219342|NCT02267356|3951033|FG002|NOT COMPLETED|Study Extension||1
3219343|NCT02267356|3951034|FG003|NOT COMPLETED|Study Extension||2
3219344|NCT02267356|3951035|FG004|NOT COMPLETED|Study Extension||0
3219345|NCT02267382|3951052|FG000|STARTED|Overall Study||42
3219346|NCT02267382|3951053|FG001|STARTED|Overall Study||43
3219347|NCT02267382|3951054|FG002|STARTED|Overall Study||43
3219348|NCT02267382|3951055|FG003|STARTED|Overall Study||41
3219349|NCT02267382|3951056|FG004|STARTED|Overall Study||46
3219350|NCT02267382|3951052|FG000|COMPLETED|Overall Study||35
3219351|NCT02267382|3951053|FG001|COMPLETED|Overall Study||33
3219352|NCT02267382|3951054|FG002|COMPLETED|Overall Study||34
3219353|NCT02267382|3951055|FG003|COMPLETED|Overall Study||35
3219354|NCT02267382|3951056|FG004|COMPLETED|Overall Study||39
3219355|NCT02267382|3951052|FG000|NOT COMPLETED|Overall Study||7
3219356|NCT02267382|3951053|FG001|NOT COMPLETED|Overall Study||10
3219357|NCT02267382|3951054|FG002|NOT COMPLETED|Overall Study||9
3219358|NCT02267382|3951055|FG003|NOT COMPLETED|Overall Study||6
3219359|NCT02267382|3951056|FG004|NOT COMPLETED|Overall Study||7
3219360|NCT02267447|3951070|FG000|STARTED|Overall Study||77251
3219361|NCT02267447|3951071|FG001|STARTED|Overall Study||26968
3219362|NCT02267447|3951070|FG000|COMPLETED|Overall Study||77251
3219363|NCT02267447|3951071|FG001|COMPLETED|Overall Study||26968
3219364|NCT02267447|3951070|FG000|NOT COMPLETED|Overall Study||0
3219365|NCT02267447|3951071|FG001|NOT COMPLETED|Overall Study||0
3219366|NCT02267538|3951080|FG000|STARTED|Overall Study||142
3219367|NCT02267538|3951081|FG001|STARTED|Overall Study||143
3219368|NCT02267538|3951080|FG000|COMPLETED|Overall Study||142
3219369|NCT02267538|3951081|FG001|COMPLETED|Overall Study||143
3219370|NCT02267538|3951080|FG000|NOT COMPLETED|Overall Study||0
3219371|NCT02267538|3951081|FG001|NOT COMPLETED|Overall Study||0
3219372|NCT02267577|3951087|FG000|STARTED|Overall Study||85
3219373|NCT02267577|3951087|FG000|COMPLETED|Overall Study||81
3219374|NCT02267577|3951087|FG000|NOT COMPLETED|Overall Study||4
3219375|NCT02267603|3951092|FG000|STARTED|Overall Study||50
3219376|NCT02267603|3951092|FG000|COMPLETED|Overall Study||6
3219377|NCT02267603|3951092|FG000|NOT COMPLETED|Overall Study||44
3219378|NCT02267629|3951096|FG000|STARTED|Overall Study||7
3219379|NCT02267629|3951096|FG000|COMPLETED|Overall Study||7
3219380|NCT02267629|3951096|FG000|NOT COMPLETED|Overall Study||0
3219381|NCT02267746|3951103|FG000|STARTED|Overall Study||298
3219382|NCT02267746|3951104|FG001|STARTED|Overall Study||296
3219383|NCT02267746|3951105|FG002|STARTED|Overall Study||299
3219384|NCT02267746|3951103|FG000|COMPLETED|Overall Study||277
3219385|NCT02267746|3951104|FG001|COMPLETED|Overall Study||274
3219386|NCT02267746|3951105|FG002|COMPLETED|Overall Study||278
3219387|NCT02267746|3951103|FG000|NOT COMPLETED|Overall Study||21
3219388|NCT02267746|3951104|FG001|NOT COMPLETED|Overall Study||22
3219389|NCT02267746|3951105|FG002|NOT COMPLETED|Overall Study||21
3219390|NCT02267772|3951117|FG000|STARTED|Overall Study||50
3219391|NCT02267772|3951118|FG001|STARTED|Overall Study||52
3219392|NCT02267772|3951117|FG000|Randomized|Overall Study||50
3219393|NCT02267772|3951118|FG001|Randomized|Overall Study||52
3219394|NCT02267772|3951117|FG000|Received Study Drug|Overall Study||48
3219395|NCT02267772|3951118|FG001|Received Study Drug|Overall Study||52
3219396|NCT02267772|3951117|FG000|COMPLETED|Overall Study||48
3219397|NCT02267772|3951118|FG001|COMPLETED|Overall Study||52
3219398|NCT02267772|3951117|FG000|NOT COMPLETED|Overall Study||2
3219399|NCT02267772|3951118|FG001|NOT COMPLETED|Overall Study||0
3219400|NCT02267811|3951126|FG000|STARTED|Overall Study||16
3219401|NCT02267811|3951127|FG001|STARTED|Overall Study||17
3219402|NCT02267811|3951126|FG000|COMPLETED|Overall Study||15
3219403|NCT02267811|3951127|FG001|COMPLETED|Overall Study||15
3219404|NCT02267811|3951126|FG000|NOT COMPLETED|Overall Study||1
3219405|NCT02267811|3951127|FG001|NOT COMPLETED|Overall Study||2
3219406|NCT02267824|3951137|FG000|STARTED|Overall Study||83
3219407|NCT02267824|3951138|FG001|STARTED|Overall Study||18
3219408|NCT02267824|3951137|FG000|COMPLETED|Overall Study||73
3219409|NCT02267824|3951138|FG001|COMPLETED|Overall Study||17
3219410|NCT02267824|3951137|FG000|NOT COMPLETED|Overall Study||10
3219411|NCT02267824|3951138|FG001|NOT COMPLETED|Overall Study||1
3219412|NCT02267837|3951146|FG000|STARTED|Overall Study||11
3219413|NCT02267837|3951147|FG001|STARTED|Overall Study||9
3219414|NCT02267837|3951146|FG000|COMPLETED|Overall Study||11
3219415|NCT02267837|3951147|FG001|COMPLETED|Overall Study||9
3219416|NCT02267837|3951146|FG000|NOT COMPLETED|Overall Study||0
3219417|NCT02267837|3951147|FG001|NOT COMPLETED|Overall Study||0
3219418|NCT02267850|3951155|FG000|STARTED|Overall Study||15
3219419|NCT02267850|3951156|FG001|STARTED|Overall Study||14
3219420|NCT02267850|3951155|FG000|COMPLETED|Overall Study||14
3219421|NCT02267850|3951156|FG001|COMPLETED|Overall Study||12
3219422|NCT02267850|3951155|FG000|NOT COMPLETED|Overall Study||1
3219423|NCT02267850|3951156|FG001|NOT COMPLETED|Overall Study||2
3219424|NCT02268045|3951164|FG000|STARTED|Overall Study||136
3219425|NCT02268045|3951165|FG001|STARTED|Overall Study||136
3219426|NCT02268045|3951164|FG000|COMPLETED|Overall Study||120
3219427|NCT02268045|3951165|FG001|COMPLETED|Overall Study||116
3219428|NCT02268045|3951164|FG000|NOT COMPLETED|Overall Study||16
3219429|NCT02268045|3951165|FG001|NOT COMPLETED|Overall Study||20
3219430|NCT02268058|3951177|FG000|STARTED|Overall Study||20
3219431|NCT02268058|3951178|FG001|STARTED|Overall Study||20
3219432|NCT02268058|3951179|FG002|STARTED|Overall Study||20
3219433|NCT02268058|3951180|FG003|STARTED|Overall Study||20
3219434|NCT02268058|3951177|FG000|COMPLETED|Overall Study||19
3219435|NCT02268058|3951178|FG001|COMPLETED|Overall Study||20
3219436|NCT02268058|3951179|FG002|COMPLETED|Overall Study||20
3219437|NCT02268058|3951180|FG003|COMPLETED|Overall Study||20
3219438|NCT02268058|3951177|FG000|NOT COMPLETED|Overall Study||1
3219439|NCT02268058|3951178|FG001|NOT COMPLETED|Overall Study||0
3219440|NCT02268058|3951179|FG002|NOT COMPLETED|Overall Study||0
3219441|NCT02268058|3951180|FG003|NOT COMPLETED|Overall Study||0
3219442|NCT02268084|3951192|FG000|STARTED|Overall Study||49
3219443|NCT02268084|3951193|FG001|STARTED|Overall Study||47
3219444|NCT02268084|3951192|FG000|COMPLETED|Overall Study||40
3219445|NCT02268084|3951193|FG001|COMPLETED|Overall Study||40
3219446|NCT02268084|3951192|FG000|NOT COMPLETED|Overall Study||9
3219447|NCT02268084|3951193|FG001|NOT COMPLETED|Overall Study||7
3219448|NCT02268175|3951207|FG000|STARTED|Overall Study||50
3219449|NCT02268175|3951208|FG001|STARTED|Overall Study||25
3219450|NCT02268175|3951207|FG000|COMPLETED|Overall Study||50
3219451|NCT02268175|3951208|FG001|COMPLETED|Overall Study||25
3219452|NCT02268175|3951207|FG000|NOT COMPLETED|Overall Study||0
3219453|NCT02268175|3951208|FG001|NOT COMPLETED|Overall Study||0
3219454|NCT02268214|3951217|FG000|STARTED|Overall Study||277
3219455|NCT02268214|3951218|FG001|STARTED|Overall Study||296
3219456|NCT02268214|3951219|FG002|STARTED|Overall Study||260
3219457|NCT02268214|3951217|FG000|COMPLETED 24 WEEK PERIOD|Overall Study||252
3219458|NCT02268214|3951218|FG001|COMPLETED 24 WEEK PERIOD|Overall Study||273
3219459|NCT02268214|3951219|FG002|COMPLETED 24 WEEK PERIOD|Overall Study||232
3219460|NCT02268214|3951217|FG000|COMPLETED|Overall Study||235
3219461|NCT02268214|3951218|FG001|COMPLETED|Overall Study||255
3219462|NCT02268214|3951219|FG002|COMPLETED|Overall Study||218
3219463|NCT02268214|3951217|FG000|NOT COMPLETED|Overall Study||42
3219464|NCT02268214|3951218|FG001|NOT COMPLETED|Overall Study||41
3219465|NCT02268214|3951219|FG002|NOT COMPLETED|Overall Study||42
3367474|NCT03864900|4098933|FG000|COMPLETED|Overall Study||33
3367475|NCT03864900|4098934|FG001|COMPLETED|Overall Study||30
3367476|NCT03864900|4098933|FG000|NOT COMPLETED|Overall Study||3
3367477|NCT03864900|4098934|FG001|NOT COMPLETED|Overall Study||6
3367478|NCT03863795|4098944|FG000|STARTED|Overall Study||306
3367479|NCT03863795|4098945|FG001|STARTED|Overall Study||269
3367480|NCT03863795|4098946|FG002|STARTED|Overall Study||244
3367481|NCT03863795|4098947|FG003|STARTED|Overall Study||281
3367482|NCT03863795|4098944|FG000|COMPLETED|Overall Study||306
3367483|NCT03863795|4098945|FG001|COMPLETED|Overall Study||269
3367484|NCT03863795|4098946|FG002|COMPLETED|Overall Study||244
3367485|NCT03863795|4098947|FG003|COMPLETED|Overall Study||281
3367486|NCT03863795|4098944|FG000|NOT COMPLETED|Overall Study||0
3367487|NCT03863795|4098945|FG001|NOT COMPLETED|Overall Study||0
3367488|NCT03863795|4098946|FG002|NOT COMPLETED|Overall Study||0
3367489|NCT03863795|4098947|FG003|NOT COMPLETED|Overall Study||0
3367490|NCT03875482|4098959|FG000|STARTED|Overall Study||105
3367491|NCT03875482|4098960|FG001|STARTED|Overall Study||52
3367492|NCT03875482|4098959|FG000|COMPLETED|Overall Study||92
3367493|NCT03875482|4098960|FG001|COMPLETED|Overall Study||32
3367494|NCT03875482|4098959|FG000|NOT COMPLETED|Overall Study||13
3367495|NCT03875482|4098960|FG001|NOT COMPLETED|Overall Study||20
3367496|NCT03874377|4098966|FG000|STARTED|Overall Study||11
3367497|NCT03874377|4098966|FG000|COMPLETED|Overall Study||8
3367498|NCT03874377|4098966|FG000|NOT COMPLETED|Overall Study||3
3367499|NCT03863496|4098970|FG000|STARTED|Overall Study||71
3367500|NCT03863496|4098970|FG000|COMPLETED|Overall Study||71
3367501|NCT03863496|4098970|FG000|NOT COMPLETED|Overall Study||0
3367502|NCT03874013|4098978|FG000|STARTED|Overall Study||22
3367503|NCT03874013|4098979|FG001|STARTED|Overall Study||22
3367504|NCT03874013|4098978|FG000|COMPLETED|Overall Study||22
3367505|NCT03874013|4098979|FG001|COMPLETED|Overall Study||21
3367506|NCT03874013|4098978|FG000|NOT COMPLETED|Overall Study||0
3367507|NCT03874013|4098979|FG001|NOT COMPLETED|Overall Study||1
3367508|NCT03873116|4098988|FG000|STARTED|Overall Study||6
3367509|NCT03873116|4098989|FG001|STARTED|Overall Study||7
3367510|NCT03873116|4098990|FG002|STARTED|Overall Study||6
3367511|NCT03873116|4098988|FG000|COMPLETED|Overall Study||6
3367512|NCT03873116|4098989|FG001|COMPLETED|Overall Study||7
3367513|NCT03873116|4098990|FG002|COMPLETED|Overall Study||5
3367514|NCT03873116|4098988|FG000|NOT COMPLETED|Overall Study||0
3367515|NCT03873116|4098989|FG001|NOT COMPLETED|Overall Study||0
3367516|NCT03873116|4098990|FG002|NOT COMPLETED|Overall Study||1
3367517|NCT03872843|4099000|FG000|STARTED|Overall Study||12
3367518|NCT03872843|4099001|FG001|STARTED|Overall Study||10
3367519|NCT03872843|4099000|FG000|COMPLETED|Overall Study||7
3367520|NCT03872843|4099001|FG001|COMPLETED|Overall Study||3
3367521|NCT03872843|4099000|FG000|NOT COMPLETED|Overall Study||5
3367522|NCT03872843|4099001|FG001|NOT COMPLETED|Overall Study||7
3367523|NCT03870997|4099013|FG000|STARTED|Overall Study||15702
3367524|NCT03870997|4099014|FG001|STARTED|Overall Study||15702
3367525|NCT03870997|4099015|FG002|STARTED|Overall Study||15756
3367526|NCT03870997|4099016|FG003|STARTED|Overall Study||15757
3367527|NCT03870997|4099017|FG004|STARTED|Overall Study||15702
3367528|NCT03870997|4099018|FG005|STARTED|Overall Study||15702
3367529|NCT03870997|4099013|FG000|COMPLETED|Overall Study||5158
3367530|NCT03870997|4099014|FG001|COMPLETED|Overall Study||5271
3367531|NCT03870997|4099015|FG002|COMPLETED|Overall Study||4778
3367532|NCT03870997|4099016|FG003|COMPLETED|Overall Study||4810
3367533|NCT03870997|4099017|FG004|COMPLETED|Overall Study||5114
3367534|NCT03870997|4099018|FG005|COMPLETED|Overall Study||5171
3367535|NCT03870997|4099013|FG000|NOT COMPLETED|Overall Study||10544
3367536|NCT03870997|4099014|FG001|NOT COMPLETED|Overall Study||10431
3367537|NCT03870997|4099015|FG002|NOT COMPLETED|Overall Study||10978
3367538|NCT03870997|4099016|FG003|NOT COMPLETED|Overall Study||10947
3367539|NCT03870997|4099017|FG004|NOT COMPLETED|Overall Study||10588
3367540|NCT03870997|4099018|FG005|NOT COMPLETED|Overall Study||10531
3367541|NCT03869684|4099030|FG000|STARTED|Overall Study||3
3367542|NCT03869684|4099031|FG001|STARTED|Overall Study||5
3367543|NCT03869684|4099032|FG002|STARTED|Overall Study||5
3367544|NCT03869684|4099030|FG000|COMPLETED|Overall Study||1
3367545|NCT03869684|4099031|FG001|COMPLETED|Overall Study||2
3367546|NCT03869684|4099032|FG002|COMPLETED|Overall Study||2
3367547|NCT03869684|4099030|FG000|NOT COMPLETED|Overall Study||2
3367548|NCT03869684|4099031|FG001|NOT COMPLETED|Overall Study||3
3367549|NCT03869684|4099032|FG002|NOT COMPLETED|Overall Study||3
3367550|NCT03861338|4099040|FG000|STARTED|Overall Study||10
3367551|NCT03861338|4099040|FG000|COMPLETED|Overall Study||8
3367552|NCT03861338|4099040|FG000|NOT COMPLETED|Overall Study||2
3367553|NCT03858335|4099046|FG000|STARTED|Overall Study||16
3219466|NCT02268396|3951227|FG000|STARTED|Overall Study||138
3219467|NCT02268396|3951227|FG000|COMPLETED|Overall Study||126
3219468|NCT02268396|3951227|FG000|NOT COMPLETED|Overall Study||12
3219469|NCT02268500|3951233|FG000|STARTED|Overall Study||24
3219470|NCT02268500|3951234|FG001|STARTED|Overall Study||24
3219471|NCT02268500|3951233|FG000|COMPLETED|Overall Study||24
3219472|NCT02268500|3951234|FG001|COMPLETED|Overall Study||24
3219473|NCT02268500|3951233|FG000|NOT COMPLETED|Overall Study||0
3219474|NCT02268500|3951234|FG001|NOT COMPLETED|Overall Study||0
3219475|NCT02268526|3951243|FG000|STARTED|Overall Study||6
3219476|NCT02268526|3951244|FG001|STARTED|Overall Study||59
3219477|NCT02268526|3951245|FG002|STARTED|Overall Study||21
3219478|NCT02268526|3951243|FG000|PD Analysis Set (Cohort 2)|Overall Study||0
3219479|NCT02268526|3951244|FG001|PD Analysis Set (Cohort 2)|Overall Study||42
3219480|NCT02268526|3951245|FG002|PD Analysis Set (Cohort 2)|Overall Study||17
3219481|NCT02268526|3951243|FG000|COMPLETED|Overall Study||5
3219482|NCT02268526|3951244|FG001|COMPLETED|Overall Study||38
3219483|NCT02268526|3951245|FG002|COMPLETED|Overall Study||16
3219484|NCT02268526|3951243|FG000|NOT COMPLETED|Overall Study||1
3219485|NCT02268526|3951244|FG001|NOT COMPLETED|Overall Study||21
3219486|NCT02268526|3951245|FG002|NOT COMPLETED|Overall Study||5
3219487|NCT02268786|3951257|FG000|STARTED|Overall Study||330
3219488|NCT02268786|3951258|FG001|STARTED|Overall Study||331
3219489|NCT02268786|3951257|FG000|COMPLETED|Overall Study||274
3219490|NCT02268786|3951258|FG001|COMPLETED|Overall Study||313
3219491|NCT02268786|3951257|FG000|NOT COMPLETED|Overall Study||56
3219492|NCT02268786|3951258|FG001|NOT COMPLETED|Overall Study||18
3219493|NCT02268812|3951268|FG000|STARTED|Overall Study||77
3219494|NCT02268812|3951269|FG001|STARTED|Overall Study||72
3219495|NCT02268812|3951270|FG002|STARTED|Overall Study||30
3219496|NCT02268812|3951271|FG003|STARTED|Overall Study||40
3219497|NCT02268812|3951268|FG000|COMPLETED|Overall Study||61
3219498|NCT02268812|3951269|FG001|COMPLETED|Overall Study||40
3219499|NCT02268812|3951270|FG002|COMPLETED|Overall Study||21
3219500|NCT02268812|3951271|FG003|COMPLETED|Overall Study||26
3219501|NCT02268812|3951268|FG000|NOT COMPLETED|Overall Study||16
3219502|NCT02268812|3951269|FG001|NOT COMPLETED|Overall Study||32
3219503|NCT02268812|3951270|FG002|NOT COMPLETED|Overall Study||9
3219504|NCT02268812|3951271|FG003|NOT COMPLETED|Overall Study||14
3219505|NCT02268851|3951287|FG000|STARTED|Overall Study||3
3219506|NCT02268851|3951288|FG001|STARTED|Overall Study||3
3219507|NCT02268851|3951289|FG002|STARTED|Overall Study||4
3219508|NCT02268851|3951290|FG003|STARTED|Overall Study||3
3219509|NCT02268851|3951291|FG004|STARTED|Overall Study||15
3219510|NCT02268851|3951292|FG005|STARTED|Overall Study||15
3219511|NCT02268851|3951287|FG000|COMPLETED|Overall Study||2
3219512|NCT02268851|3951288|FG001|COMPLETED|Overall Study||0
3219513|NCT02268851|3951289|FG002|COMPLETED|Overall Study||3
3219514|NCT02268851|3951290|FG003|COMPLETED|Overall Study||0
3219515|NCT02268851|3951291|FG004|COMPLETED|Overall Study||8
3219516|NCT02268851|3951292|FG005|COMPLETED|Overall Study||4
3219517|NCT02268851|3951287|FG000|NOT COMPLETED|Overall Study||1
3219518|NCT02268851|3951288|FG001|NOT COMPLETED|Overall Study||3
3219519|NCT02268851|3951289|FG002|NOT COMPLETED|Overall Study||1
3219520|NCT02268851|3951290|FG003|NOT COMPLETED|Overall Study||3
3219521|NCT02268851|3951291|FG004|NOT COMPLETED|Overall Study||7
3219522|NCT02268851|3951292|FG005|NOT COMPLETED|Overall Study||11
3367554|NCT03858335|4099047|FG001|STARTED|Overall Study||16
3367555|NCT03858335|4099046|FG000|COMPLETED|Overall Study||12
3367556|NCT03858335|4099047|FG001|COMPLETED|Overall Study||12
3367557|NCT03858335|4099046|FG000|NOT COMPLETED|Overall Study||4
3367558|NCT03858335|4099047|FG001|NOT COMPLETED|Overall Study||4
3367559|NCT03857243|4099055|FG000|STARTED|Overall Study||1
3367560|NCT03857243|4099056|FG001|STARTED|Overall Study||1
3367561|NCT03857243|4099055|FG000|COMPLETED|Overall Study||1
3367562|NCT03857243|4099056|FG001|COMPLETED|Overall Study||1
3367563|NCT03857243|4099055|FG000|NOT COMPLETED|Overall Study||0
3219523|NCT02268864|3951309|FG000|STARTED|Overall Study||17
3219524|NCT02268864|3951310|FG001|STARTED|Overall Study||25
3219525|NCT02268864|3951311|FG002|STARTED|Overall Study||64
3219526|NCT02268864|3951309|FG000|COMPLETED|Overall Study||15
3219527|NCT02268864|3951310|FG001|COMPLETED|Overall Study||24
3219528|NCT02268864|3951311|FG002|COMPLETED|Overall Study||64
3219529|NCT02268864|3951309|FG000|NOT COMPLETED|Overall Study||2
3219530|NCT02268864|3951310|FG001|NOT COMPLETED|Overall Study||1
3219531|NCT02268864|3951311|FG002|NOT COMPLETED|Overall Study||0
3219532|NCT02268877|3951323|FG000|STARTED|Overall Study||122
3219533|NCT02268877|3951324|FG001|STARTED|Overall Study|111 patients were randomized to this arm.|111
3219534|NCT02268877|3951323|FG000|COMPLETED|Overall Study||118
3219535|NCT02268877|3951324|FG001|COMPLETED|Overall Study|106 patients received the intervention.|106
3219536|NCT02268877|3951323|FG000|NOT COMPLETED|Overall Study||4
3219537|NCT02268877|3951324|FG001|NOT COMPLETED|Overall Study||5
3219538|NCT02268942|3951330|FG000|STARTED|Overall Study||144
3219539|NCT02268942|3951330|FG000|COMPLETED|Overall Study||144
3219540|NCT02268942|3951330|FG000|NOT COMPLETED|Overall Study||0
3219541|NCT02268955|3951336|FG000|STARTED|Overall Study||11
3219542|NCT02268955|3951337|FG001|STARTED|Overall Study||11
3219543|NCT02268955|3951336|FG000|COMPLETED|Overall Study||9
3219544|NCT02268955|3951337|FG001|COMPLETED|Overall Study||9
3219545|NCT02268955|3951336|FG000|NOT COMPLETED|Overall Study||2
3219546|NCT02268955|3951337|FG001|NOT COMPLETED|Overall Study||2
3219547|NCT02268994|3951345|FG000|STARTED|Overall Study||117
3219548|NCT02268994|3951346|FG001|STARTED|Overall Study||116
3219549|NCT02268994|3951345|FG000|COMPLETED|Overall Study||86
3219550|NCT02268994|3951346|FG001|COMPLETED|Overall Study||81
3219551|NCT02268994|3951345|FG000|NOT COMPLETED|Overall Study||31
3219552|NCT02268994|3951346|FG001|NOT COMPLETED|Overall Study||35
3219553|NCT02269098|3951357|FG000|STARTED|Overall Study||51
3219554|NCT02269098|3951358|FG001|STARTED|Overall Study||50
3219555|NCT02269098|3951357|FG000|COMPLETED|Overall Study||37
3219556|NCT02269098|3951358|FG001|COMPLETED|Overall Study||41
3219557|NCT02269098|3951357|FG000|NOT COMPLETED|Overall Study||14
3219558|NCT02269098|3951358|FG001|NOT COMPLETED|Overall Study||9
3219559|NCT02269124|3951367|FG000|STARTED|Overall Study||21
3219560|NCT02269124|3951368|FG001|STARTED|Overall Study||16
3219561|NCT02269124|3951367|FG000|Completed Survey Round 1 (Arm 1, 0 Weeks)|Overall Study||20
3219562|NCT02269124|3951368|FG001|Completed Survey Round 1 (Arm 1, 0 Weeks)|Overall Study||14
3219563|NCT02269124|3951367|FG000|Completed Survey Round 2 (Arm 1, 6 Weeks)|Overall Study||17
3219564|NCT02269124|3951368|FG001|Completed Survey Round 2 (Arm 1, 6 Weeks)|Overall Study||13
3219565|NCT02269124|3951367|FG000|Completed Survey Round 3 (Arm 1, 12 Weeks)|Overall Study||17
3219566|NCT02269124|3951368|FG001|Completed Survey Round 3 (Arm 1, 12 Weeks)|Overall Study||11
3219567|NCT02269124|3951367|FG000|Completed Survey Round 4 (Arm 2, 12 Weeks)|Overall Study||11
3219568|NCT02269124|3951368|FG001|Completed Survey Round 4 (Arm 2, 12 Weeks)|Overall Study||8
3219569|NCT02269124|3951367|FG000|Completed Survey Round 5 (Arm 2, 18 Weeks)|Overall Study||16
3219570|NCT02269124|3951368|FG001|Completed Survey Round 5 (Arm 2, 18 Weeks)|Overall Study||10
3219571|NCT02269124|3951367|FG000|Completed Survey Round 6 (Arm 2, 24 Weeks)|Overall Study||14
3219572|NCT02269124|3951368|FG001|Completed Survey Round 6 (Arm 2, 24 Weeks)|Overall Study||10
3219573|NCT02269124|3951367|FG000|COMPLETED|Overall Study|One participant from the Conventional Measures Only First arm did not return any surveys, nor did their parent/guardian or teacher, and were deemed lost to follow-up.|20
3219574|NCT02269124|3951368|FG001|COMPLETED|Overall Study|Two participants from the Conventional measures + Hearing Aid First arm withdrew from the study prior to the second arm because they did not wish to stop using the hearing aid.|14
3219575|NCT02269124|3951367|FG000|NOT COMPLETED|Overall Study||1
3219576|NCT02269124|3951368|FG001|NOT COMPLETED|Overall Study||2
3219577|NCT02269163|3951377|FG000|STARTED|Overall Study||50
3219578|NCT02269163|3951378|FG001|STARTED|Overall Study||25
3219579|NCT02269163|3951377|FG000|COMPLETED|Overall Study||47
3219580|NCT02269163|3951378|FG001|COMPLETED|Overall Study||18
3219581|NCT02269163|3951377|FG000|NOT COMPLETED|Overall Study||3
3219582|NCT02269163|3951378|FG001|NOT COMPLETED|Overall Study||7
3219583|NCT02269241|3951386|FG000|STARTED|Overall Study||1552
3219584|NCT02269241|3951386|FG000|COMPLETED|Overall Study||352
3219585|NCT02269241|3951386|FG000|NOT COMPLETED|Overall Study||1200
3219586|NCT02269423|3951395|FG000|STARTED|Overall Study||10
3219587|NCT02269423|3951396|FG001|STARTED|Overall Study||10
3219588|NCT02269423|3951397|FG002|STARTED|Overall Study||10
3219589|NCT02269423|3951398|FG003|STARTED|Overall Study||9
3219590|NCT02269423|3951395|FG000|COMPLETED|Overall Study||10
3219591|NCT02269423|3951396|FG001|COMPLETED|Overall Study||9
3219592|NCT02269423|3951397|FG002|COMPLETED|Overall Study||10
3219593|NCT02269423|3951398|FG003|COMPLETED|Overall Study||8
3219594|NCT02269423|3951395|FG000|NOT COMPLETED|Overall Study||0
3219595|NCT02269423|3951396|FG001|NOT COMPLETED|Overall Study||1
3219596|NCT02269423|3951397|FG002|NOT COMPLETED|Overall Study||0
3219597|NCT02269423|3951398|FG003|NOT COMPLETED|Overall Study||1
3219598|NCT02269475|3951410|FG000|STARTED|Overall Study||868
3219599|NCT02269475|3951411|FG001|STARTED|Overall Study||433
3219600|NCT02269475|3951410|FG000|Received IP (Safety Population)|Overall Study||868
3219601|NCT02269475|3951411|FG001|Received IP (Safety Population)|Overall Study||433
3219602|NCT02269475|3951410|FG000|Per Protocol Population|Overall Study||849
3219603|NCT02269475|3951411|FG001|Per Protocol Population|Overall Study||430
3219604|NCT02269475|3951410|FG000|COMPLETED|Overall Study||865
3219605|NCT02269475|3951411|FG001|COMPLETED|Overall Study||432
3219606|NCT02269475|3951410|FG000|NOT COMPLETED|Overall Study||3
3219607|NCT02269475|3951411|FG001|NOT COMPLETED|Overall Study||1
3219608|NCT02269488|3951418|FG000|STARTED|Overall Study||100
3219609|NCT02269488|3951418|FG000|COMPLETED|Overall Study||100
3219610|NCT02269488|3951418|FG000|NOT COMPLETED|Overall Study||0
3219611|NCT02269631|3951424|FG000|STARTED|Overall Study||7
3219612|NCT02269631|3951425|FG001|STARTED|Overall Study||5
3219613|NCT02269631|3951424|FG000|COMPLETED|Overall Study||7
3219614|NCT02269631|3951425|FG001|COMPLETED|Overall Study||5
3219615|NCT02269631|3951424|FG000|NOT COMPLETED|Overall Study||0
3219616|NCT02269631|3951425|FG001|NOT COMPLETED|Overall Study||0
3219617|NCT02269657|3951431|FG000|STARTED|Overall Study||40
3219618|NCT02269657|3951431|FG000|COMPLETED|Overall Study||37
3219619|NCT02269657|3951431|FG000|NOT COMPLETED|Overall Study||3
3219620|NCT02269709|3951437|FG000|STARTED|Time of Enrollment||21
3219621|NCT02269709|3951437|FG000|COMPLETED|Time of Enrollment||18
3219622|NCT02269709|3951437|FG000|NOT COMPLETED|Time of Enrollment||3
3219623|NCT02269709|3951437|FG000|STARTED|Follow-up #1 (24-72 Hours Post-surgery)||18
3219624|NCT02269709|3951437|FG000|COMPLETED|Follow-up #1 (24-72 Hours Post-surgery)||17
3219625|NCT02269709|3951437|FG000|NOT COMPLETED|Follow-up #1 (24-72 Hours Post-surgery)||1
3219626|NCT02269709|3951437|FG000|STARTED|Prior to Hospital Discharge||17
3219627|NCT02269709|3951437|FG000|COMPLETED|Prior to Hospital Discharge||17
3219628|NCT02269709|3951437|FG000|NOT COMPLETED|Prior to Hospital Discharge||0
3219629|NCT02269709|3951437|FG000|STARTED|Six Month Follow-up||17
3219630|NCT02269709|3951437|FG000|COMPLETED|Six Month Follow-up||5
3219631|NCT02269709|3951437|FG000|NOT COMPLETED|Six Month Follow-up||12
3219632|NCT02269787|3951444|FG000|STARTED|Overall Study||148
3219633|NCT02269787|3951445|FG001|STARTED|Overall Study||150
3219634|NCT02269787|3951444|FG000|COMPLETED|Overall Study||126
3219635|NCT02269787|3951445|FG001|COMPLETED|Overall Study||140
3219636|NCT02269787|3951444|FG000|NOT COMPLETED|Overall Study||22
3219637|NCT02269787|3951445|FG001|NOT COMPLETED|Overall Study||10
3219638|NCT02269943|3951453|FG000|STARTED|Treatment Period||6
3219639|NCT02269943|3951454|FG001|STARTED|Treatment Period||30
3219640|NCT02269943|3951453|FG000|Investigational Product (IP) Stopped|Treatment Period||6
3219641|NCT02269943|3951454|FG001|Investigational Product (IP) Stopped|Treatment Period||30
3219642|NCT02269943|3951453|FG000|COMPLETED|Treatment Period|Not applicable according to the study design|0
3219643|NCT02269943|3951454|FG001|COMPLETED|Treatment Period|Not applicable according to the study design|0
3219644|NCT02269943|3951453|FG000|NOT COMPLETED|Treatment Period||6
3219645|NCT02269943|3951454|FG001|NOT COMPLETED|Treatment Period||30
3219646|NCT02269943|3951453|FG000|STARTED|Follow-Up Survival Period||5
3219647|NCT02269943|3951454|FG001|STARTED|Follow-Up Survival Period||26
3219648|NCT02269943|3951453|FG000|COMPLETED|Follow-Up Survival Period|Not applicable according to the study design.|0
3219649|NCT02269943|3951454|FG001|COMPLETED|Follow-Up Survival Period|Not applicable according to the study design.|0
3219650|NCT02269943|3951453|FG000|NOT COMPLETED|Follow-Up Survival Period||5
3219651|NCT02269943|3951454|FG001|NOT COMPLETED|Follow-Up Survival Period||26
3219652|NCT02270060|3951463|FG000|STARTED|Overall Study||20
3219653|NCT02270060|3951464|FG001|STARTED|Overall Study||20
3219654|NCT02270060|3951465|FG002|STARTED|Overall Study||20
3219655|NCT02270060|3951463|FG000|COMPLETED|Overall Study||20
3219656|NCT02270060|3951464|FG001|COMPLETED|Overall Study||20
3219657|NCT02270060|3951465|FG002|COMPLETED|Overall Study||20
3219658|NCT02270060|3951463|FG000|NOT COMPLETED|Overall Study||0
3219659|NCT02270060|3951464|FG001|NOT COMPLETED|Overall Study||0
3219660|NCT02270060|3951465|FG002|NOT COMPLETED|Overall Study||0
3219661|NCT02270242|3951475|FG000|STARTED|Overall Study||3555
3219662|NCT02270242|3951476|FG001|STARTED|Overall Study||3564
3219663|NCT02270242|3951475|FG000|COMPLETED|Overall Study||3496
3219664|NCT02270242|3951476|FG001|COMPLETED|Overall Study||3511
3219665|NCT02270242|3951475|FG000|NOT COMPLETED|Overall Study||59
3219666|NCT02270242|3951476|FG001|NOT COMPLETED|Overall Study||53
3219667|NCT02270255|3951484|FG000|STARTED|Overall Study||22
3219668|NCT02270255|3951485|FG001|STARTED|Overall Study||22
3219669|NCT02270255|3951484|FG000|Complete Data at Discharge PACU|Overall Study||22
3219670|NCT02270255|3951485|FG001|Complete Data at Discharge PACU|Overall Study||22
3219671|NCT02270255|3951484|FG000|Complete Data From Home Survey|Overall Study||21
3219672|NCT02270255|3951485|FG001|Complete Data From Home Survey|Overall Study||22
3219673|NCT02270255|3951484|FG000|COMPLETED|Overall Study||21
3219674|NCT02270255|3951485|FG001|COMPLETED|Overall Study||22
3219675|NCT02270255|3951484|FG000|NOT COMPLETED|Overall Study||1
3219676|NCT02270255|3951485|FG001|NOT COMPLETED|Overall Study||0
3219677|NCT02270515|3951491|FG000|STARTED|Intervention Period 1: 0-6 Months||175
3219678|NCT02270515|3951491|FG000|COMPLETED|Intervention Period 1: 0-6 Months||159
3219679|NCT02270515|3951491|FG000|NOT COMPLETED|Intervention Period 1: 0-6 Months||16
3219680|NCT02270515|3951491|FG000|STARTED|Intervention Period 2: 6-12 Months||159
3219681|NCT02270515|3951491|FG000|COMPLETED|Intervention Period 2: 6-12 Months||127
3219682|NCT02270515|3951491|FG000|NOT COMPLETED|Intervention Period 2: 6-12 Months||32
3219683|NCT02270515|3951491|FG000|STARTED|Intervention Period 3: 12-18 Months||127
3219684|NCT02270515|3951491|FG000|COMPLETED|Intervention Period 3: 12-18 Months||103
3219685|NCT02270515|3951491|FG000|NOT COMPLETED|Intervention Period 3: 12-18 Months||24
3219686|NCT02270645|3951504|FG000|STARTED|Overall Study||8
3219687|NCT02270645|3951505|FG001|STARTED|Overall Study||4
3219688|NCT02270645|3951504|FG000|COMPLETED|Overall Study||6
3219689|NCT02270645|3951505|FG001|COMPLETED|Overall Study||4
3219690|NCT02270645|3951504|FG000|NOT COMPLETED|Overall Study||2
3219691|NCT02270645|3951505|FG001|NOT COMPLETED|Overall Study||0
3219692|NCT02270671|3951513|FG000|STARTED|Overall Study||64
3219693|NCT02270671|3951514|FG001|STARTED|Overall Study||66
3219694|NCT02270671|3951513|FG000|COMPLETED|Overall Study||59
3367564|NCT03857243|4099056|FG001|NOT COMPLETED|Overall Study||0
3219695|NCT02270671|3951514|FG001|COMPLETED|Overall Study||61
3219696|NCT02270671|3951513|FG000|NOT COMPLETED|Overall Study||5
3219697|NCT02270671|3951514|FG001|NOT COMPLETED|Overall Study||5
3219698|NCT02270736|3951523|FG000|STARTED|Main Period (MP) (up to 16 Weeks)||72
3219699|NCT02270736|3951524|FG001|STARTED|Main Period (MP) (up to 16 Weeks)||148
3219700|NCT02270736|3951525|FG002|STARTED|Main Period (MP) (up to 16 Weeks)||36
3219701|NCT02270736|3951526|FG003|STARTED|Main Period (MP) (up to 16 Weeks)||0
3219702|NCT02270736|3951527|FG004|STARTED|Main Period (MP) (up to 16 Weeks)||0
3219703|NCT02270736|3951523|FG000|Treated|Main Period (MP) (up to 16 Weeks)||72
3219704|NCT02270736|3951524|FG001|Treated|Main Period (MP) (up to 16 Weeks)||148
3219705|NCT02270736|3951525|FG002|Treated|Main Period (MP) (up to 16 Weeks)||35
3219706|NCT02270736|3951526|FG003|Treated|Main Period (MP) (up to 16 Weeks)||0
3219707|NCT02270736|3951527|FG004|Treated|Main Period (MP) (up to 16 Weeks)||0
3219708|NCT02270736|3951523|FG000|COMPLETED|Main Period (MP) (up to 16 Weeks)||70
3219709|NCT02270736|3951524|FG001|COMPLETED|Main Period (MP) (up to 16 Weeks)||146
3219710|NCT02270736|3951525|FG002|COMPLETED|Main Period (MP) (up to 16 Weeks)||34
3219711|NCT02270736|3951526|FG003|COMPLETED|Main Period (MP) (up to 16 Weeks)||0
3219712|NCT02270736|3951527|FG004|COMPLETED|Main Period (MP) (up to 16 Weeks)||0
3219713|NCT02270736|3951523|FG000|NOT COMPLETED|Main Period (MP) (up to 16 Weeks)||2
3219714|NCT02270736|3951524|FG001|NOT COMPLETED|Main Period (MP) (up to 16 Weeks)||2
3219715|NCT02270736|3951525|FG002|NOT COMPLETED|Main Period (MP) (up to 16 Weeks)||2
3219716|NCT02270736|3951526|FG003|NOT COMPLETED|Main Period (MP) (up to 16 Weeks)||0
3219717|NCT02270736|3951527|FG004|NOT COMPLETED|Main Period (MP) (up to 16 Weeks)||0
3219718|NCT02270736|3951523|FG000|STARTED|OLEX Period (up to 48 Weeks)||0
3219719|NCT02270736|3951524|FG001|STARTED|OLEX Period (up to 48 Weeks)||0
3219720|NCT02270736|3951525|FG002|STARTED|OLEX Period (up to 48 Weeks)||0
3219721|NCT02270736|3951526|FG003|STARTED|OLEX Period (up to 48 Weeks)|2 participants from MP did not enter OLEX due to withdrawal of consent.|214
3219722|NCT02270736|3951527|FG004|STARTED|OLEX Period (up to 48 Weeks)|1 participant from MP did not enter OLEX due to adverse event.|33
3219723|NCT02270736|3951523|FG000|COMPLETED|OLEX Period (up to 48 Weeks)||0
3219724|NCT02270736|3951524|FG001|COMPLETED|OLEX Period (up to 48 Weeks)||0
3219725|NCT02270736|3951525|FG002|COMPLETED|OLEX Period (up to 48 Weeks)||0
3219726|NCT02270736|3951526|FG003|COMPLETED|OLEX Period (up to 48 Weeks)||189
3219727|NCT02270736|3951527|FG004|COMPLETED|OLEX Period (up to 48 Weeks)||33
3219728|NCT02270736|3951523|FG000|NOT COMPLETED|OLEX Period (up to 48 Weeks)||0
3219729|NCT02270736|3951524|FG001|NOT COMPLETED|OLEX Period (up to 48 Weeks)||0
3219730|NCT02270736|3951525|FG002|NOT COMPLETED|OLEX Period (up to 48 Weeks)||0
3219731|NCT02270736|3951526|FG003|NOT COMPLETED|OLEX Period (up to 48 Weeks)||25
3219732|NCT02270736|3951527|FG004|NOT COMPLETED|OLEX Period (up to 48 Weeks)||0
3219733|NCT02270944|3951542|FG000|STARTED|Overall Study||529
3219734|NCT02270944|3951543|FG001|STARTED|Overall Study||521
3219735|NCT02270944|3951542|FG000|COMPLETED|Overall Study||518
3219736|NCT02270944|3951543|FG001|COMPLETED|Overall Study||516
3219737|NCT02270944|3951542|FG000|NOT COMPLETED|Overall Study||11
3219738|NCT02270944|3951543|FG001|NOT COMPLETED|Overall Study||5
3219739|NCT02270983|3951553|FG000|STARTED|Overall Study||79
3219740|NCT02270983|3951554|FG001|STARTED|Overall Study||87
3219741|NCT02270983|3951555|FG002|STARTED|Overall Study||88
3219742|NCT02270983|3951553|FG000|COMPLETED|Overall Study||70
3219743|NCT02270983|3951554|FG001|COMPLETED|Overall Study||80
3219744|NCT02270983|3951555|FG002|COMPLETED|Overall Study||76
3219745|NCT02270983|3951553|FG000|NOT COMPLETED|Overall Study||9
3219746|NCT02270983|3951554|FG001|NOT COMPLETED|Overall Study||7
3219747|NCT02270983|3951555|FG002|NOT COMPLETED|Overall Study||12
3219748|NCT02271217|3951566|FG000|STARTED|Overall Study||126
3219749|NCT02271217|3951567|FG001|STARTED|Overall Study||126
3219750|NCT02271217|3951568|FG002|STARTED|Overall Study||125
3219751|NCT02271217|3951566|FG000|COMPLETED|Overall Study||115
3219752|NCT02271217|3951567|FG001|COMPLETED|Overall Study||113
3219753|NCT02271217|3951568|FG002|COMPLETED|Overall Study||113
3219754|NCT02271217|3951566|FG000|NOT COMPLETED|Overall Study||11
3219755|NCT02271217|3951567|FG001|NOT COMPLETED|Overall Study||13
3219756|NCT02271217|3951568|FG002|NOT COMPLETED|Overall Study||12
3219757|NCT02271386|3951580|FG000|STARTED|Baseline Period- 8 Months||53
3219758|NCT02271386|3951581|FG001|STARTED|Baseline Period- 8 Months||52
3219759|NCT02271386|3951582|FG002|STARTED|Baseline Period- 8 Months||200
3219760|NCT02271386|3951583|FG003|STARTED|Baseline Period- 8 Months||191
3219761|NCT02271386|3951580|FG000|COMPLETED|Baseline Period- 8 Months||53
3219762|NCT02271386|3951581|FG001|COMPLETED|Baseline Period- 8 Months||52
3219763|NCT02271386|3951582|FG002|COMPLETED|Baseline Period- 8 Months||200
3219764|NCT02271386|3951583|FG003|COMPLETED|Baseline Period- 8 Months||191
3219765|NCT02271386|3951580|FG000|NOT COMPLETED|Baseline Period- 8 Months||0
3219766|NCT02271386|3951581|FG001|NOT COMPLETED|Baseline Period- 8 Months||0
3219767|NCT02271386|3951582|FG002|NOT COMPLETED|Baseline Period- 8 Months||0
3219768|NCT02271386|3951583|FG003|NOT COMPLETED|Baseline Period- 8 Months||0
3219769|NCT02271386|3951580|FG000|STARTED|Intervention Period- 8 Months||53
3219770|NCT02271386|3951581|FG001|STARTED|Intervention Period- 8 Months||52
3219771|NCT02271386|3951582|FG002|STARTED|Intervention Period- 8 Months||202
3219772|NCT02271386|3951583|FG003|STARTED|Intervention Period- 8 Months||197
3219773|NCT02271386|3951580|FG000|COMPLETED|Intervention Period- 8 Months||53
3219774|NCT02271386|3951581|FG001|COMPLETED|Intervention Period- 8 Months||52
3219775|NCT02271386|3951582|FG002|COMPLETED|Intervention Period- 8 Months||202
3219776|NCT02271386|3951583|FG003|COMPLETED|Intervention Period- 8 Months||197
3219777|NCT02271386|3951580|FG000|NOT COMPLETED|Intervention Period- 8 Months||0
3219778|NCT02271386|3951581|FG001|NOT COMPLETED|Intervention Period- 8 Months||0
3219779|NCT02271386|3951582|FG002|NOT COMPLETED|Intervention Period- 8 Months||0
3219780|NCT02271386|3951583|FG003|NOT COMPLETED|Intervention Period- 8 Months||0
3219781|NCT02271425|3951597|FG000|STARTED|Overall Study||8
3219782|NCT02271425|3951597|FG000|COMPLETED|Overall Study||8
3219783|NCT02271425|3951597|FG000|NOT COMPLETED|Overall Study||0
3219784|NCT02271451|3951604|FG000|STARTED|Overall Study||7
3219785|NCT02271451|3951605|FG001|STARTED|Overall Study||8
3219786|NCT02271451|3951604|FG000|COMPLETED|Overall Study||7
3219787|NCT02271451|3951605|FG001|COMPLETED|Overall Study|one subject does not have MRI data due to braces|7
3219788|NCT02271451|3951604|FG000|NOT COMPLETED|Overall Study||0
3219789|NCT02271451|3951605|FG001|NOT COMPLETED|Overall Study||1
3219790|NCT02271477|3951613|FG000|STARTED|Overall Study||80
3219791|NCT02271477|3951614|FG001|STARTED|Overall Study||80
3219792|NCT02271477|3951613|FG000|COMPLETED|Overall Study||80
3219793|NCT02271477|3951614|FG001|COMPLETED|Overall Study||80
3219794|NCT02271477|3951613|FG000|NOT COMPLETED|Overall Study||0
3219795|NCT02271477|3951614|FG001|NOT COMPLETED|Overall Study||0
3219796|NCT02271529|3951621|FG000|STARTED|Overall Study||40
3219797|NCT02271529|3951621|FG000|COMPLETED|Overall Study||39
3219798|NCT02271529|3951621|FG000|NOT COMPLETED|Overall Study||1
3219799|NCT02271698|3951629|FG000|STARTED|Overall Study||11
3219800|NCT02271698|3951630|FG001|STARTED|Overall Study||10
3219801|NCT02271698|3951631|FG002|STARTED|Overall Study||10
3219802|NCT02271698|3951632|FG003|STARTED|Overall Study||11
3219803|NCT02271698|3951629|FG000|COMPLETED|Overall Study||11
3219804|NCT02271698|3951630|FG001|COMPLETED|Overall Study||10
3367565|NCT03851744|4099064|FG000|STARTED|Overall Study||4
3367566|NCT03851744|4099065|FG001|STARTED|Overall Study||6
3367567|NCT03851744|4099064|FG000|COMPLETED|Overall Study||4
3367568|NCT03851744|4099065|FG001|COMPLETED|Overall Study||4
3367569|NCT03851744|4099064|FG000|NOT COMPLETED|Overall Study||0
3367570|NCT03851744|4099065|FG001|NOT COMPLETED|Overall Study||2
3367571|NCT03849937|4099071|FG000|STARTED|Overall Study||147
3367572|NCT03849937|4099072|FG001|STARTED|Overall Study||72
3367573|NCT03849937|4099071|FG000|COMPLETED|Overall Study||94
3367574|NCT03849937|4099072|FG001|COMPLETED|Overall Study||35
3367575|NCT03849937|4099071|FG000|NOT COMPLETED|Overall Study||53
3367576|NCT03849937|4099072|FG001|NOT COMPLETED|Overall Study||37
3367577|NCT03848416|4099086|FG000|STARTED|Overall Study||33
3367578|NCT03848416|4099087|FG001|STARTED|Overall Study||33
3367579|NCT03848416|4099088|FG002|STARTED|Overall Study||33
3367580|NCT03848416|4099086|FG000|Received at Least One Dose of Study Drug|Overall Study||33
3367581|NCT03848416|4099087|FG001|Received at Least One Dose of Study Drug|Overall Study||33
3367582|NCT03848416|4099088|FG002|Received at Least One Dose of Study Drug|Overall Study||33
3367583|NCT03848416|4099086|FG000|COMPLETED|Overall Study||32
3367584|NCT03848416|4099087|FG001|COMPLETED|Overall Study||33
3367585|NCT03848416|4099088|FG002|COMPLETED|Overall Study||32
3367586|NCT03848416|4099086|FG000|NOT COMPLETED|Overall Study||1
3367587|NCT03848416|4099087|FG001|NOT COMPLETED|Overall Study||0
3367588|NCT03848416|4099088|FG002|NOT COMPLETED|Overall Study||1
3367589|NCT03847987|4099098|FG000|STARTED|Overall Study||16
3367590|NCT03847987|4099099|FG001|STARTED|Overall Study||8
3367591|NCT03847987|4099098|FG000|COMPLETED|Overall Study||13
3219805|NCT02271698|3951631|FG002|COMPLETED|Overall Study||10
3219806|NCT02271698|3951632|FG003|COMPLETED|Overall Study||11
3219807|NCT02271698|3951629|FG000|NOT COMPLETED|Overall Study||0
3367592|NCT03847987|4099099|FG001|COMPLETED|Overall Study||8
3367593|NCT03847987|4099098|FG000|NOT COMPLETED|Overall Study||3
3367594|NCT03847987|4099099|FG001|NOT COMPLETED|Overall Study||0
3367595|NCT03854253|4099118|FG000|STARTED|Overall Study||50
3219808|NCT02271698|3951630|FG001|NOT COMPLETED|Overall Study||0
3219809|NCT02271698|3951631|FG002|NOT COMPLETED|Overall Study||0
3219810|NCT02271698|3951632|FG003|NOT COMPLETED|Overall Study||0
3219811|NCT02271854|3951642|FG000|STARTED|Overall Study||102
3219812|NCT02271854|3951642|FG000|COMPLETED|Overall Study||98
3219813|NCT02271854|3951642|FG000|NOT COMPLETED|Overall Study||4
3219814|NCT02271880|3951649|FG000|STARTED|Overall Study||3
3219815|NCT02271880|3951650|FG001|STARTED|Overall Study||4
3219816|NCT02271880|3951649|FG000|COMPLETED|Overall Study||0
3219817|NCT02271880|3951650|FG001|COMPLETED|Overall Study||0
3219818|NCT02271880|3951649|FG000|NOT COMPLETED|Overall Study||3
3219819|NCT02271880|3951650|FG001|NOT COMPLETED|Overall Study||4
3219820|NCT02271906|3951658|FG000|STARTED|Overall Study||2
3219821|NCT02271906|3951658|FG000|COMPLETED|Overall Study||2
3219822|NCT02271906|3951658|FG000|NOT COMPLETED|Overall Study||0
3219823|NCT02271945|3951664|FG000|STARTED|Overall Study||5
3219824|NCT02271945|3951665|FG001|STARTED|Overall Study||5
3219825|NCT02271945|3951664|FG000|COMPLETED|Overall Study||0
3219826|NCT02271945|3951665|FG001|COMPLETED|Overall Study||0
3219827|NCT02271945|3951664|FG000|NOT COMPLETED|Overall Study||5
3219828|NCT02271945|3951665|FG001|NOT COMPLETED|Overall Study||5
3219829|NCT02271984|3951671|FG000|STARTED|First Intervention Period (1 Day)||3
3219830|NCT02271984|3951672|FG001|STARTED|First Intervention Period (1 Day)||3
3219831|NCT02271984|3951673|FG002|STARTED|First Intervention Period (1 Day)||3
3219832|NCT02271984|3951674|FG003|STARTED|First Intervention Period (1 Day)||3
3219833|NCT02271984|3951675|FG004|STARTED|First Intervention Period (1 Day)||3
3219834|NCT02271984|3951676|FG005|STARTED|First Intervention Period (1 Day)||3
3219835|NCT02271984|3951677|FG006|STARTED|First Intervention Period (1 Day)||3
3219836|NCT02271984|3951678|FG007|STARTED|First Intervention Period (1 Day)||3
3219837|NCT02271984|3951679|FG008|STARTED|First Intervention Period (1 Day)||3
3219838|NCT02271984|3951680|FG009|STARTED|First Intervention Period (1 Day)||3
3219839|NCT02271984|3951681|FG010|STARTED|First Intervention Period (1 Day)||3
3219840|NCT02271984|3951682|FG011|STARTED|First Intervention Period (1 Day)||3
3219841|NCT02271984|3951671|FG000|COMPLETED|First Intervention Period (1 Day)||3
3219842|NCT02271984|3951672|FG001|COMPLETED|First Intervention Period (1 Day)||3
3219843|NCT02271984|3951673|FG002|COMPLETED|First Intervention Period (1 Day)||3
3219844|NCT02271984|3951674|FG003|COMPLETED|First Intervention Period (1 Day)||3
3219845|NCT02271984|3951675|FG004|COMPLETED|First Intervention Period (1 Day)||3
3219846|NCT02271984|3951676|FG005|COMPLETED|First Intervention Period (1 Day)||3
3219847|NCT02271984|3951677|FG006|COMPLETED|First Intervention Period (1 Day)||3
3219848|NCT02271984|3951678|FG007|COMPLETED|First Intervention Period (1 Day)||3
3219849|NCT02271984|3951679|FG008|COMPLETED|First Intervention Period (1 Day)||3
3219850|NCT02271984|3951680|FG009|COMPLETED|First Intervention Period (1 Day)||3
3219851|NCT02271984|3951681|FG010|COMPLETED|First Intervention Period (1 Day)||3
3219852|NCT02271984|3951682|FG011|COMPLETED|First Intervention Period (1 Day)||3
3219853|NCT02271984|3951671|FG000|NOT COMPLETED|First Intervention Period (1 Day)||0
3219854|NCT02271984|3951672|FG001|NOT COMPLETED|First Intervention Period (1 Day)||0
3219855|NCT02271984|3951673|FG002|NOT COMPLETED|First Intervention Period (1 Day)||0
3219856|NCT02271984|3951674|FG003|NOT COMPLETED|First Intervention Period (1 Day)||0
3219857|NCT02271984|3951675|FG004|NOT COMPLETED|First Intervention Period (1 Day)||0
3219858|NCT02271984|3951676|FG005|NOT COMPLETED|First Intervention Period (1 Day)||0
3219859|NCT02271984|3951677|FG006|NOT COMPLETED|First Intervention Period (1 Day)||0
3219860|NCT02271984|3951678|FG007|NOT COMPLETED|First Intervention Period (1 Day)||0
3219861|NCT02271984|3951679|FG008|NOT COMPLETED|First Intervention Period (1 Day)||0
3219862|NCT02271984|3951680|FG009|NOT COMPLETED|First Intervention Period (1 Day)||0
3219863|NCT02271984|3951681|FG010|NOT COMPLETED|First Intervention Period (1 Day)||0
3219864|NCT02271984|3951682|FG011|NOT COMPLETED|First Intervention Period (1 Day)||0
3219865|NCT02271984|3951671|FG000|STARTED|Washout Period 1 (7 Days)||3
3219866|NCT02271984|3951672|FG001|STARTED|Washout Period 1 (7 Days)||3
3219867|NCT02271984|3951673|FG002|STARTED|Washout Period 1 (7 Days)||3
3367596|NCT03854253|4099119|FG001|STARTED|Overall Study||50
3367597|NCT03854253|4099118|FG000|COMPLETED|Overall Study||49
3367598|NCT03854253|4099119|FG001|COMPLETED|Overall Study||50
3367599|NCT03854253|4099118|FG000|NOT COMPLETED|Overall Study||1
3367600|NCT03854253|4099119|FG001|NOT COMPLETED|Overall Study||0
3367601|NCT03870737|4099125|FG000|STARTED|Overall Study||22
3367602|NCT03870737|4099125|FG000|COMPLETED|Overall Study||20
3367603|NCT03870737|4099125|FG000|NOT COMPLETED|Overall Study||2
3367604|NCT03860181|4099133|FG000|STARTED|Overall Study||21
3367605|NCT03860181|4099134|FG001|STARTED|Overall Study||22
3367606|NCT03860181|4099135|FG002|STARTED|Overall Study||25
3367607|NCT03860181|4099136|FG003|STARTED|Overall Study||21
3367608|NCT03860181|4099133|FG000|COMPLETED|Overall Study||21
3367609|NCT03860181|4099134|FG001|COMPLETED|Overall Study||22
3367610|NCT03860181|4099135|FG002|COMPLETED|Overall Study||25
3367611|NCT03860181|4099136|FG003|COMPLETED|Overall Study||21
3367612|NCT03860181|4099133|FG000|NOT COMPLETED|Overall Study||0
3367613|NCT03860181|4099134|FG001|NOT COMPLETED|Overall Study||0
3367614|NCT03860181|4099135|FG002|NOT COMPLETED|Overall Study||0
3367615|NCT03860181|4099136|FG003|NOT COMPLETED|Overall Study||0
3367616|NCT03856944|4099157|FG000|STARTED|Overall Study||29
3367617|NCT03856944|4099157|FG000|COMPLETED|Overall Study||29
3367618|NCT03856944|4099157|FG000|NOT COMPLETED|Overall Study||0
3367619|NCT03853551|4099161|FG000|STARTED|Overall Study||60
3367620|NCT03853551|4099161|FG000|COMPLETED|Overall Study||51
3219868|NCT02271984|3951674|FG003|STARTED|Washout Period 1 (7 Days)||3
3219869|NCT02271984|3951675|FG004|STARTED|Washout Period 1 (7 Days)||3
3219870|NCT02271984|3951676|FG005|STARTED|Washout Period 1 (7 Days)||3
3219871|NCT02271984|3951677|FG006|STARTED|Washout Period 1 (7 Days)||3
3219872|NCT02271984|3951678|FG007|STARTED|Washout Period 1 (7 Days)||3
3219873|NCT02271984|3951679|FG008|STARTED|Washout Period 1 (7 Days)||3
3219874|NCT02271984|3951680|FG009|STARTED|Washout Period 1 (7 Days)||3
3219875|NCT02271984|3951681|FG010|STARTED|Washout Period 1 (7 Days)||3
3219876|NCT02271984|3951682|FG011|STARTED|Washout Period 1 (7 Days)||3
3219877|NCT02271984|3951671|FG000|COMPLETED|Washout Period 1 (7 Days)||3
3219878|NCT02271984|3951672|FG001|COMPLETED|Washout Period 1 (7 Days)||3
3219879|NCT02271984|3951673|FG002|COMPLETED|Washout Period 1 (7 Days)||3
3219880|NCT02271984|3951674|FG003|COMPLETED|Washout Period 1 (7 Days)||3
3219881|NCT02271984|3951675|FG004|COMPLETED|Washout Period 1 (7 Days)||3
3219882|NCT02271984|3951676|FG005|COMPLETED|Washout Period 1 (7 Days)||3
3219883|NCT02271984|3951677|FG006|COMPLETED|Washout Period 1 (7 Days)||3
3219884|NCT02271984|3951678|FG007|COMPLETED|Washout Period 1 (7 Days)||3
3219885|NCT02271984|3951679|FG008|COMPLETED|Washout Period 1 (7 Days)||3
3219886|NCT02271984|3951680|FG009|COMPLETED|Washout Period 1 (7 Days)||3
3219887|NCT02271984|3951681|FG010|COMPLETED|Washout Period 1 (7 Days)||3
3219888|NCT02271984|3951682|FG011|COMPLETED|Washout Period 1 (7 Days)||3
3219889|NCT02271984|3951671|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0
3219890|NCT02271984|3951672|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0
3219891|NCT02271984|3951673|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||0
3219892|NCT02271984|3951674|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||0
3219893|NCT02271984|3951675|FG004|NOT COMPLETED|Washout Period 1 (7 Days)||0
3219894|NCT02271984|3951676|FG005|NOT COMPLETED|Washout Period 1 (7 Days)||0
3219895|NCT02271984|3951677|FG006|NOT COMPLETED|Washout Period 1 (7 Days)||0
3219896|NCT02271984|3951678|FG007|NOT COMPLETED|Washout Period 1 (7 Days)||0
3219897|NCT02271984|3951679|FG008|NOT COMPLETED|Washout Period 1 (7 Days)||0
3219898|NCT02271984|3951680|FG009|NOT COMPLETED|Washout Period 1 (7 Days)||0
3219899|NCT02271984|3951681|FG010|NOT COMPLETED|Washout Period 1 (7 Days)||0
3219900|NCT02271984|3951682|FG011|NOT COMPLETED|Washout Period 1 (7 Days)||0
3219901|NCT02271984|3951671|FG000|STARTED|Second Intervention Period (1 Day)||3
3219902|NCT02271984|3951672|FG001|STARTED|Second Intervention Period (1 Day)||3
3219903|NCT02271984|3951673|FG002|STARTED|Second Intervention Period (1 Day)||3
3219904|NCT02271984|3951674|FG003|STARTED|Second Intervention Period (1 Day)||3
3219905|NCT02271984|3951675|FG004|STARTED|Second Intervention Period (1 Day)||3
3219906|NCT02271984|3951676|FG005|STARTED|Second Intervention Period (1 Day)||3
3219907|NCT02271984|3951677|FG006|STARTED|Second Intervention Period (1 Day)||3
3219908|NCT02271984|3951678|FG007|STARTED|Second Intervention Period (1 Day)||3
3219909|NCT02271984|3951679|FG008|STARTED|Second Intervention Period (1 Day)||3
3219910|NCT02271984|3951680|FG009|STARTED|Second Intervention Period (1 Day)||3
3219911|NCT02271984|3951681|FG010|STARTED|Second Intervention Period (1 Day)||3
3219912|NCT02271984|3951682|FG011|STARTED|Second Intervention Period (1 Day)||3
3219913|NCT02271984|3951671|FG000|COMPLETED|Second Intervention Period (1 Day)||3
3219914|NCT02271984|3951672|FG001|COMPLETED|Second Intervention Period (1 Day)||3
3219915|NCT02271984|3951673|FG002|COMPLETED|Second Intervention Period (1 Day)||3
3219916|NCT02271984|3951674|FG003|COMPLETED|Second Intervention Period (1 Day)||3
3219917|NCT02271984|3951675|FG004|COMPLETED|Second Intervention Period (1 Day)||3
3219918|NCT02271984|3951676|FG005|COMPLETED|Second Intervention Period (1 Day)||3
3219919|NCT02271984|3951677|FG006|COMPLETED|Second Intervention Period (1 Day)||3
3219920|NCT02271984|3951678|FG007|COMPLETED|Second Intervention Period (1 Day)||3
3219921|NCT02271984|3951679|FG008|COMPLETED|Second Intervention Period (1 Day)||3
3219922|NCT02271984|3951680|FG009|COMPLETED|Second Intervention Period (1 Day)||3
3219923|NCT02271984|3951681|FG010|COMPLETED|Second Intervention Period (1 Day)||3
3219924|NCT02271984|3951682|FG011|COMPLETED|Second Intervention Period (1 Day)||3
3219925|NCT02271984|3951671|FG000|NOT COMPLETED|Second Intervention Period (1 Day)||0
3219926|NCT02271984|3951672|FG001|NOT COMPLETED|Second Intervention Period (1 Day)||0
3219927|NCT02271984|3951673|FG002|NOT COMPLETED|Second Intervention Period (1 Day)||0
3219928|NCT02271984|3951674|FG003|NOT COMPLETED|Second Intervention Period (1 Day)||0
3219929|NCT02271984|3951675|FG004|NOT COMPLETED|Second Intervention Period (1 Day)||0
3219930|NCT02271984|3951676|FG005|NOT COMPLETED|Second Intervention Period (1 Day)||0
3219931|NCT02271984|3951677|FG006|NOT COMPLETED|Second Intervention Period (1 Day)||0
3219932|NCT02271984|3951678|FG007|NOT COMPLETED|Second Intervention Period (1 Day)||0
3219933|NCT02271984|3951679|FG008|NOT COMPLETED|Second Intervention Period (1 Day)||0
3219934|NCT02271984|3951680|FG009|NOT COMPLETED|Second Intervention Period (1 Day)||0
3219935|NCT02271984|3951681|FG010|NOT COMPLETED|Second Intervention Period (1 Day)||0
3219936|NCT02271984|3951682|FG011|NOT COMPLETED|Second Intervention Period (1 Day)||0
3219937|NCT02271984|3951671|FG000|STARTED|Washout Period 2 (7 Days)||3
3219938|NCT02271984|3951672|FG001|STARTED|Washout Period 2 (7 Days)||3
3219939|NCT02271984|3951673|FG002|STARTED|Washout Period 2 (7 Days)||3
3219940|NCT02271984|3951674|FG003|STARTED|Washout Period 2 (7 Days)||3
3219941|NCT02271984|3951675|FG004|STARTED|Washout Period 2 (7 Days)||3
3219942|NCT02271984|3951676|FG005|STARTED|Washout Period 2 (7 Days)||3
3219943|NCT02271984|3951677|FG006|STARTED|Washout Period 2 (7 Days)||3
3367621|NCT03853551|4099161|FG000|NOT COMPLETED|Overall Study||9
3367622|NCT03870555|4099168|FG000|STARTED|Period 1 (2 Days)||2
3367623|NCT03870555|4099169|FG001|STARTED|Period 1 (2 Days)||2
3367624|NCT03870555|4099170|FG002|STARTED|Period 1 (2 Days)||2
3219944|NCT02271984|3951678|FG007|STARTED|Washout Period 2 (7 Days)||3
3219945|NCT02271984|3951679|FG008|STARTED|Washout Period 2 (7 Days)||3
3219946|NCT02271984|3951680|FG009|STARTED|Washout Period 2 (7 Days)||3
3219947|NCT02271984|3951681|FG010|STARTED|Washout Period 2 (7 Days)||3
3219948|NCT02271984|3951682|FG011|STARTED|Washout Period 2 (7 Days)||3
3219949|NCT02271984|3951671|FG000|COMPLETED|Washout Period 2 (7 Days)||3
3219950|NCT02271984|3951672|FG001|COMPLETED|Washout Period 2 (7 Days)||3
3219951|NCT02271984|3951673|FG002|COMPLETED|Washout Period 2 (7 Days)||3
3219952|NCT02271984|3951674|FG003|COMPLETED|Washout Period 2 (7 Days)||3
3219953|NCT02271984|3951675|FG004|COMPLETED|Washout Period 2 (7 Days)||3
3219954|NCT02271984|3951676|FG005|COMPLETED|Washout Period 2 (7 Days)||3
3219955|NCT02271984|3951677|FG006|COMPLETED|Washout Period 2 (7 Days)||3
3219956|NCT02271984|3951678|FG007|COMPLETED|Washout Period 2 (7 Days)||3
3219957|NCT02271984|3951679|FG008|COMPLETED|Washout Period 2 (7 Days)||3
3219958|NCT02271984|3951680|FG009|COMPLETED|Washout Period 2 (7 Days)||3
3219959|NCT02271984|3951681|FG010|COMPLETED|Washout Period 2 (7 Days)||3
3219960|NCT02271984|3951682|FG011|COMPLETED|Washout Period 2 (7 Days)||3
3219961|NCT02271984|3951671|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||0
3219962|NCT02271984|3951672|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0
3219963|NCT02271984|3951673|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0
3219964|NCT02271984|3951674|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||0
3219965|NCT02271984|3951675|FG004|NOT COMPLETED|Washout Period 2 (7 Days)||0
3219966|NCT02271984|3951676|FG005|NOT COMPLETED|Washout Period 2 (7 Days)||0
3219967|NCT02271984|3951677|FG006|NOT COMPLETED|Washout Period 2 (7 Days)||0
3219968|NCT02271984|3951678|FG007|NOT COMPLETED|Washout Period 2 (7 Days)||0
3219969|NCT02271984|3951679|FG008|NOT COMPLETED|Washout Period 2 (7 Days)||0
3219970|NCT02271984|3951680|FG009|NOT COMPLETED|Washout Period 2 (7 Days)||0
3219971|NCT02271984|3951681|FG010|NOT COMPLETED|Washout Period 2 (7 Days)||0
3219972|NCT02271984|3951682|FG011|NOT COMPLETED|Washout Period 2 (7 Days)||0
3219973|NCT02271984|3951671|FG000|STARTED|Third Intervention Period (1 Day)||3
3219974|NCT02271984|3951672|FG001|STARTED|Third Intervention Period (1 Day)||3
3219975|NCT02271984|3951673|FG002|STARTED|Third Intervention Period (1 Day)||3
3219976|NCT02271984|3951674|FG003|STARTED|Third Intervention Period (1 Day)||3
3219977|NCT02271984|3951675|FG004|STARTED|Third Intervention Period (1 Day)||3
3219978|NCT02271984|3951676|FG005|STARTED|Third Intervention Period (1 Day)||3
3219979|NCT02271984|3951677|FG006|STARTED|Third Intervention Period (1 Day)||3
3219980|NCT02271984|3951678|FG007|STARTED|Third Intervention Period (1 Day)||3
3219981|NCT02271984|3951679|FG008|STARTED|Third Intervention Period (1 Day)||3
3219982|NCT02271984|3951680|FG009|STARTED|Third Intervention Period (1 Day)||3
3219983|NCT02271984|3951681|FG010|STARTED|Third Intervention Period (1 Day)||3
3219984|NCT02271984|3951682|FG011|STARTED|Third Intervention Period (1 Day)||3
3219985|NCT02271984|3951671|FG000|COMPLETED|Third Intervention Period (1 Day)||3
3219986|NCT02271984|3951672|FG001|COMPLETED|Third Intervention Period (1 Day)||3
3219987|NCT02271984|3951673|FG002|COMPLETED|Third Intervention Period (1 Day)||3
3219988|NCT02271984|3951674|FG003|COMPLETED|Third Intervention Period (1 Day)||3
3219989|NCT02271984|3951675|FG004|COMPLETED|Third Intervention Period (1 Day)||3
3219990|NCT02271984|3951676|FG005|COMPLETED|Third Intervention Period (1 Day)||3
3219991|NCT02271984|3951677|FG006|COMPLETED|Third Intervention Period (1 Day)||3
3219992|NCT02271984|3951678|FG007|COMPLETED|Third Intervention Period (1 Day)||3
3219993|NCT02271984|3951679|FG008|COMPLETED|Third Intervention Period (1 Day)||3
3219994|NCT02271984|3951680|FG009|COMPLETED|Third Intervention Period (1 Day)||3
3219995|NCT02271984|3951681|FG010|COMPLETED|Third Intervention Period (1 Day)||3
3219996|NCT02271984|3951682|FG011|COMPLETED|Third Intervention Period (1 Day)||3
3219997|NCT02271984|3951671|FG000|NOT COMPLETED|Third Intervention Period (1 Day)||0
3219998|NCT02271984|3951672|FG001|NOT COMPLETED|Third Intervention Period (1 Day)||0
3219999|NCT02271984|3951673|FG002|NOT COMPLETED|Third Intervention Period (1 Day)||0
3220000|NCT02271984|3951674|FG003|NOT COMPLETED|Third Intervention Period (1 Day)||0
3220001|NCT02271984|3951675|FG004|NOT COMPLETED|Third Intervention Period (1 Day)||0
3220002|NCT02271984|3951676|FG005|NOT COMPLETED|Third Intervention Period (1 Day)||0
3220003|NCT02271984|3951677|FG006|NOT COMPLETED|Third Intervention Period (1 Day)||0
3220004|NCT02271984|3951678|FG007|NOT COMPLETED|Third Intervention Period (1 Day)||0
3220005|NCT02271984|3951679|FG008|NOT COMPLETED|Third Intervention Period (1 Day)||0
3220006|NCT02271984|3951680|FG009|NOT COMPLETED|Third Intervention Period (1 Day)||0
3220007|NCT02271984|3951681|FG010|NOT COMPLETED|Third Intervention Period (1 Day)||0
3220008|NCT02271984|3951682|FG011|NOT COMPLETED|Third Intervention Period (1 Day)||0
3220009|NCT02271984|3951671|FG000|STARTED|Washout Period 3 (7 Days)||3
3220010|NCT02271984|3951672|FG001|STARTED|Washout Period 3 (7 Days)||3
3220011|NCT02271984|3951673|FG002|STARTED|Washout Period 3 (7 Days)||3
3220012|NCT02271984|3951674|FG003|STARTED|Washout Period 3 (7 Days)||3
3220013|NCT02271984|3951675|FG004|STARTED|Washout Period 3 (7 Days)||3
3220014|NCT02271984|3951676|FG005|STARTED|Washout Period 3 (7 Days)||3
3220015|NCT02271984|3951677|FG006|STARTED|Washout Period 3 (7 Days)||3
3220016|NCT02271984|3951678|FG007|STARTED|Washout Period 3 (7 Days)||3
3220017|NCT02271984|3951679|FG008|STARTED|Washout Period 3 (7 Days)||3
3220018|NCT02271984|3951680|FG009|STARTED|Washout Period 3 (7 Days)||3
3220019|NCT02271984|3951681|FG010|STARTED|Washout Period 3 (7 Days)||3
3220020|NCT02271984|3951682|FG011|STARTED|Washout Period 3 (7 Days)||3
3220021|NCT02271984|3951671|FG000|COMPLETED|Washout Period 3 (7 Days)||3
3220022|NCT02271984|3951672|FG001|COMPLETED|Washout Period 3 (7 Days)||3
3220023|NCT02271984|3951673|FG002|COMPLETED|Washout Period 3 (7 Days)||3
3220024|NCT02271984|3951674|FG003|COMPLETED|Washout Period 3 (7 Days)||3
3220025|NCT02271984|3951675|FG004|COMPLETED|Washout Period 3 (7 Days)||3
3220026|NCT02271984|3951676|FG005|COMPLETED|Washout Period 3 (7 Days)||3
3220027|NCT02271984|3951677|FG006|COMPLETED|Washout Period 3 (7 Days)||3
3220028|NCT02271984|3951678|FG007|COMPLETED|Washout Period 3 (7 Days)||3
3220029|NCT02271984|3951679|FG008|COMPLETED|Washout Period 3 (7 Days)||3
3220030|NCT02271984|3951680|FG009|COMPLETED|Washout Period 3 (7 Days)||3
3220031|NCT02271984|3951681|FG010|COMPLETED|Washout Period 3 (7 Days)||3
3220032|NCT02271984|3951682|FG011|COMPLETED|Washout Period 3 (7 Days)||3
3220033|NCT02271984|3951671|FG000|NOT COMPLETED|Washout Period 3 (7 Days)||0
3220034|NCT02271984|3951672|FG001|NOT COMPLETED|Washout Period 3 (7 Days)||0
3220035|NCT02271984|3951673|FG002|NOT COMPLETED|Washout Period 3 (7 Days)||0
3220036|NCT02271984|3951674|FG003|NOT COMPLETED|Washout Period 3 (7 Days)||0
3220037|NCT02271984|3951675|FG004|NOT COMPLETED|Washout Period 3 (7 Days)||0
3220038|NCT02271984|3951676|FG005|NOT COMPLETED|Washout Period 3 (7 Days)||0
3220039|NCT02271984|3951677|FG006|NOT COMPLETED|Washout Period 3 (7 Days)||0
3220040|NCT02271984|3951678|FG007|NOT COMPLETED|Washout Period 3 (7 Days)||0
3220041|NCT02271984|3951679|FG008|NOT COMPLETED|Washout Period 3 (7 Days)||0
3220042|NCT02271984|3951680|FG009|NOT COMPLETED|Washout Period 3 (7 Days)||0
3220043|NCT02271984|3951681|FG010|NOT COMPLETED|Washout Period 3 (7 Days)||0
3220044|NCT02271984|3951682|FG011|NOT COMPLETED|Washout Period 3 (7 Days)||0
3220045|NCT02271984|3951671|FG000|STARTED|Fourth Intervention Period (Day 1)||3
3220046|NCT02271984|3951672|FG001|STARTED|Fourth Intervention Period (Day 1)||3
3220047|NCT02271984|3951673|FG002|STARTED|Fourth Intervention Period (Day 1)||3
3220048|NCT02271984|3951674|FG003|STARTED|Fourth Intervention Period (Day 1)||3
3220049|NCT02271984|3951675|FG004|STARTED|Fourth Intervention Period (Day 1)||3
3220050|NCT02271984|3951676|FG005|STARTED|Fourth Intervention Period (Day 1)||3
3220051|NCT02271984|3951677|FG006|STARTED|Fourth Intervention Period (Day 1)||3
3220052|NCT02271984|3951678|FG007|STARTED|Fourth Intervention Period (Day 1)||3
3220053|NCT02271984|3951679|FG008|STARTED|Fourth Intervention Period (Day 1)||3
3220054|NCT02271984|3951680|FG009|STARTED|Fourth Intervention Period (Day 1)||3
3220055|NCT02271984|3951681|FG010|STARTED|Fourth Intervention Period (Day 1)||3
3220056|NCT02271984|3951682|FG011|STARTED|Fourth Intervention Period (Day 1)||3
3220057|NCT02271984|3951671|FG000|COMPLETED|Fourth Intervention Period (Day 1)||3
3220058|NCT02271984|3951672|FG001|COMPLETED|Fourth Intervention Period (Day 1)||3
3220059|NCT02271984|3951673|FG002|COMPLETED|Fourth Intervention Period (Day 1)||3
3220060|NCT02271984|3951674|FG003|COMPLETED|Fourth Intervention Period (Day 1)||3
3220061|NCT02271984|3951675|FG004|COMPLETED|Fourth Intervention Period (Day 1)||3
3220062|NCT02271984|3951676|FG005|COMPLETED|Fourth Intervention Period (Day 1)||3
3220063|NCT02271984|3951677|FG006|COMPLETED|Fourth Intervention Period (Day 1)||3
3220064|NCT02271984|3951678|FG007|COMPLETED|Fourth Intervention Period (Day 1)||3
3220065|NCT02271984|3951679|FG008|COMPLETED|Fourth Intervention Period (Day 1)||3
3220066|NCT02271984|3951680|FG009|COMPLETED|Fourth Intervention Period (Day 1)||3
3220067|NCT02271984|3951681|FG010|COMPLETED|Fourth Intervention Period (Day 1)||3
3220068|NCT02271984|3951682|FG011|COMPLETED|Fourth Intervention Period (Day 1)||3
3220069|NCT02271984|3951671|FG000|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
3220070|NCT02271984|3951672|FG001|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
3220071|NCT02271984|3951673|FG002|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
3220072|NCT02271984|3951674|FG003|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
3220073|NCT02271984|3951675|FG004|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
3220074|NCT02271984|3951676|FG005|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
3220075|NCT02271984|3951677|FG006|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
3220076|NCT02271984|3951678|FG007|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
3220077|NCT02271984|3951679|FG008|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
3220078|NCT02271984|3951680|FG009|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
3220079|NCT02271984|3951681|FG010|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
3220080|NCT02271984|3951682|FG011|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
3220081|NCT02271984|3951671|FG000|STARTED|Washout Period 4 (7 Days)||3
3220082|NCT02271984|3951672|FG001|STARTED|Washout Period 4 (7 Days)||3
3220083|NCT02271984|3951673|FG002|STARTED|Washout Period 4 (7 Days)||3
3220084|NCT02271984|3951674|FG003|STARTED|Washout Period 4 (7 Days)||3
3220085|NCT02271984|3951675|FG004|STARTED|Washout Period 4 (7 Days)||3
3220086|NCT02271984|3951676|FG005|STARTED|Washout Period 4 (7 Days)||3
3220087|NCT02271984|3951677|FG006|STARTED|Washout Period 4 (7 Days)||3
3220088|NCT02271984|3951678|FG007|STARTED|Washout Period 4 (7 Days)||3
3220089|NCT02271984|3951679|FG008|STARTED|Washout Period 4 (7 Days)||3
3220090|NCT02271984|3951680|FG009|STARTED|Washout Period 4 (7 Days)||3
3220091|NCT02271984|3951681|FG010|STARTED|Washout Period 4 (7 Days)||3
3220092|NCT02271984|3951682|FG011|STARTED|Washout Period 4 (7 Days)||3
3220093|NCT02271984|3951671|FG000|COMPLETED|Washout Period 4 (7 Days)||3
3220094|NCT02271984|3951672|FG001|COMPLETED|Washout Period 4 (7 Days)||3
3220095|NCT02271984|3951673|FG002|COMPLETED|Washout Period 4 (7 Days)||3
3220096|NCT02271984|3951674|FG003|COMPLETED|Washout Period 4 (7 Days)||3
3220097|NCT02271984|3951675|FG004|COMPLETED|Washout Period 4 (7 Days)||3
3220098|NCT02271984|3951676|FG005|COMPLETED|Washout Period 4 (7 Days)||2
3220099|NCT02271984|3951677|FG006|COMPLETED|Washout Period 4 (7 Days)||3
3220100|NCT02271984|3951678|FG007|COMPLETED|Washout Period 4 (7 Days)||2
3220101|NCT02271984|3951679|FG008|COMPLETED|Washout Period 4 (7 Days)||3
3220102|NCT02271984|3951680|FG009|COMPLETED|Washout Period 4 (7 Days)||3
3220103|NCT02271984|3951681|FG010|COMPLETED|Washout Period 4 (7 Days)||3
3220104|NCT02271984|3951682|FG011|COMPLETED|Washout Period 4 (7 Days)||3
3220105|NCT02271984|3951671|FG000|NOT COMPLETED|Washout Period 4 (7 Days)||0
3220106|NCT02271984|3951672|FG001|NOT COMPLETED|Washout Period 4 (7 Days)||0
3220107|NCT02271984|3951673|FG002|NOT COMPLETED|Washout Period 4 (7 Days)||0
3220108|NCT02271984|3951674|FG003|NOT COMPLETED|Washout Period 4 (7 Days)||0
3220109|NCT02271984|3951675|FG004|NOT COMPLETED|Washout Period 4 (7 Days)||0
3220110|NCT02271984|3951676|FG005|NOT COMPLETED|Washout Period 4 (7 Days)||1
3220111|NCT02271984|3951677|FG006|NOT COMPLETED|Washout Period 4 (7 Days)||0
3220112|NCT02271984|3951678|FG007|NOT COMPLETED|Washout Period 4 (7 Days)||1
3220113|NCT02271984|3951679|FG008|NOT COMPLETED|Washout Period 4 (7 Days)||0
3220114|NCT02271984|3951680|FG009|NOT COMPLETED|Washout Period 4 (7 Days)||0
3220115|NCT02271984|3951681|FG010|NOT COMPLETED|Washout Period 4 (7 Days)||0
3220116|NCT02271984|3951682|FG011|NOT COMPLETED|Washout Period 4 (7 Days)||0
3220117|NCT02271984|3951671|FG000|STARTED|Fifth Intervention Period (1 Day)||3
3220118|NCT02271984|3951672|FG001|STARTED|Fifth Intervention Period (1 Day)||3
3220119|NCT02271984|3951673|FG002|STARTED|Fifth Intervention Period (1 Day)||3
3220120|NCT02271984|3951674|FG003|STARTED|Fifth Intervention Period (1 Day)||3
3220121|NCT02271984|3951675|FG004|STARTED|Fifth Intervention Period (1 Day)||3
3220122|NCT02271984|3951676|FG005|STARTED|Fifth Intervention Period (1 Day)||2
3220123|NCT02271984|3951677|FG006|STARTED|Fifth Intervention Period (1 Day)||3
3220124|NCT02271984|3951678|FG007|STARTED|Fifth Intervention Period (1 Day)||2
3220125|NCT02271984|3951679|FG008|STARTED|Fifth Intervention Period (1 Day)||3
3220126|NCT02271984|3951680|FG009|STARTED|Fifth Intervention Period (1 Day)||3
3220127|NCT02271984|3951681|FG010|STARTED|Fifth Intervention Period (1 Day)||3
3220128|NCT02271984|3951682|FG011|STARTED|Fifth Intervention Period (1 Day)||3
3220129|NCT02271984|3951671|FG000|COMPLETED|Fifth Intervention Period (1 Day)||3
3220130|NCT02271984|3951672|FG001|COMPLETED|Fifth Intervention Period (1 Day)||3
3220131|NCT02271984|3951673|FG002|COMPLETED|Fifth Intervention Period (1 Day)||3
3220132|NCT02271984|3951674|FG003|COMPLETED|Fifth Intervention Period (1 Day)||3
3220133|NCT02271984|3951675|FG004|COMPLETED|Fifth Intervention Period (1 Day)||3
3220134|NCT02271984|3951676|FG005|COMPLETED|Fifth Intervention Period (1 Day)||2
3220135|NCT02271984|3951677|FG006|COMPLETED|Fifth Intervention Period (1 Day)||3
3220136|NCT02271984|3951678|FG007|COMPLETED|Fifth Intervention Period (1 Day)||2
3220137|NCT02271984|3951679|FG008|COMPLETED|Fifth Intervention Period (1 Day)||3
3220138|NCT02271984|3951680|FG009|COMPLETED|Fifth Intervention Period (1 Day)||3
3220139|NCT02271984|3951681|FG010|COMPLETED|Fifth Intervention Period (1 Day)||3
3220140|NCT02271984|3951682|FG011|COMPLETED|Fifth Intervention Period (1 Day)||3
3220141|NCT02271984|3951671|FG000|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
3220142|NCT02271984|3951672|FG001|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
3220143|NCT02271984|3951673|FG002|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
3220144|NCT02271984|3951674|FG003|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
3220145|NCT02271984|3951675|FG004|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
3220146|NCT02271984|3951676|FG005|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
3220147|NCT02271984|3951677|FG006|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
3220148|NCT02271984|3951678|FG007|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
3220149|NCT02271984|3951679|FG008|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
3220150|NCT02271984|3951680|FG009|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
3220151|NCT02271984|3951681|FG010|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
3220152|NCT02271984|3951682|FG011|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
3220153|NCT02272244|3951699|FG000|STARTED|Overall Study||203
3220154|NCT02272244|3951700|FG001|STARTED|Overall Study||197
3220155|NCT02272244|3951699|FG000|COMPLETED|Overall Study||203
3220156|NCT02272244|3951700|FG001|COMPLETED|Overall Study||197
3220157|NCT02272244|3951699|FG000|NOT COMPLETED|Overall Study||0
3220158|NCT02272244|3951700|FG001|NOT COMPLETED|Overall Study||0
3220159|NCT02272413|3951708|FG000|STARTED|Randomized Through Treatment Start|Started for this period|338
3220160|NCT02272413|3951709|FG001|STARTED|Randomized Through Treatment Start|Started for this period|333
3220161|NCT02272413|3951708|FG000|Treated|Randomized Through Treatment Start||335
3220162|NCT02272413|3951709|FG001|Treated|Randomized Through Treatment Start||328
3220163|NCT02272413|3951708|FG000|COMPLETED|Randomized Through Treatment Start||335
3220164|NCT02272413|3951709|FG001|COMPLETED|Randomized Through Treatment Start||328
3220165|NCT02272413|3951708|FG000|NOT COMPLETED|Randomized Through Treatment Start||3
3220166|NCT02272413|3951709|FG001|NOT COMPLETED|Randomized Through Treatment Start||5
3220167|NCT02272413|3951708|FG000|STARTED|Pre-switch Period|Started for this period|335
3220168|NCT02272413|3951709|FG001|STARTED|Pre-switch Period|Started for this period|328
3220169|NCT02272413|3951708|FG000|COMPLETED|Pre-switch Period||42
3220170|NCT02272413|3951709|FG001|COMPLETED|Pre-switch Period||46
3220171|NCT02272413|3951708|FG000|NOT COMPLETED|Pre-switch Period||293
3367625|NCT03870555|4099168|FG000|COMPLETED|Period 1 (2 Days)||2
3367626|NCT03870555|4099169|FG001|COMPLETED|Period 1 (2 Days)||2
3367627|NCT03870555|4099170|FG002|COMPLETED|Period 1 (2 Days)||2
3367628|NCT03870555|4099168|FG000|NOT COMPLETED|Period 1 (2 Days)||0
3367629|NCT03870555|4099169|FG001|NOT COMPLETED|Period 1 (2 Days)||0
3367630|NCT03870555|4099170|FG002|NOT COMPLETED|Period 1 (2 Days)||0
3367631|NCT03870555|4099168|FG000|STARTED|Washout Period (at Least 16 Days)||2
3367632|NCT03870555|4099169|FG001|STARTED|Washout Period (at Least 16 Days)||2
3367633|NCT03870555|4099170|FG002|STARTED|Washout Period (at Least 16 Days)||2
3367634|NCT03870555|4099168|FG000|COMPLETED|Washout Period (at Least 16 Days)||2
3220172|NCT02272413|3951709|FG001|NOT COMPLETED|Pre-switch Period||282
3220173|NCT02272413|3951708|FG000|STARTED|Post-switch Period|Started for this period|42
3220174|NCT02272413|3951709|FG001|STARTED|Post-switch Period|Started for this period|46
3220175|NCT02272413|3951708|FG000|COMPLETED|Post-switch Period||0
3220176|NCT02272413|3951709|FG001|COMPLETED|Post-switch Period||0
3220177|NCT02272413|3951708|FG000|NOT COMPLETED|Post-switch Period||42
3220178|NCT02272413|3951709|FG001|NOT COMPLETED|Post-switch Period||46
3220179|NCT02272634|3951720|FG000|STARTED|Overall Study||20
3220180|NCT02272634|3951721|FG001|STARTED|Overall Study||21
3220181|NCT02272634|3951722|FG002|STARTED|Overall Study||20
3220182|NCT02272634|3951720|FG000|COMPLETED|Overall Study||19
3220183|NCT02272634|3951721|FG001|COMPLETED|Overall Study||20
3220184|NCT02272634|3951722|FG002|COMPLETED|Overall Study||19
3220185|NCT02272634|3951720|FG000|NOT COMPLETED|Overall Study||1
3220186|NCT02272634|3951721|FG001|NOT COMPLETED|Overall Study||1
3220187|NCT02272634|3951722|FG002|NOT COMPLETED|Overall Study||1
3220188|NCT02272686|3951733|FG000|STARTED|Overall Study||1
3220189|NCT02272686|3951733|FG000|COMPLETED|Overall Study||1
3220190|NCT02272686|3951733|FG000|NOT COMPLETED|Overall Study||0
3220191|NCT02272725|3951739|FG000|STARTED|Overall Study||49
3220192|NCT02272725|3951740|FG001|STARTED|Overall Study||42
3220193|NCT02272725|3951739|FG000|COMPLETED|Overall Study||47
3220194|NCT02272725|3951740|FG001|COMPLETED|Overall Study||42
3220195|NCT02272725|3951739|FG000|NOT COMPLETED|Overall Study||2
3220196|NCT02272725|3951740|FG001|NOT COMPLETED|Overall Study||0
3220197|NCT02272777|3951748|FG000|STARTED|Overall Study||112
3220198|NCT02272777|3951749|FG001|STARTED|Overall Study||113
3220199|NCT02272777|3951748|FG000|COMPLETED|Overall Study||108
3220200|NCT02272777|3951749|FG001|COMPLETED|Overall Study||109
3220201|NCT02272777|3951748|FG000|NOT COMPLETED|Overall Study||4
3220202|NCT02272777|3951749|FG001|NOT COMPLETED|Overall Study||4
3220203|NCT02272790|3951761|FG000|STARTED|Overall Study||9
3220204|NCT02272790|3951762|FG001|STARTED|Overall Study||39
3220205|NCT02272790|3951763|FG002|STARTED|Overall Study||23
3220206|NCT02272790|3951764|FG003|STARTED|Overall Study||12
3220207|NCT02272790|3951765|FG004|STARTED|Overall Study||6
3220208|NCT02272790|3951766|FG005|STARTED|Overall Study||6
3220209|NCT02272790|3951761|FG000|COMPLETED|Overall Study||9
3220210|NCT02272790|3951762|FG001|COMPLETED|Overall Study||38
3220211|NCT02272790|3951763|FG002|COMPLETED|Overall Study||23
3220212|NCT02272790|3951764|FG003|COMPLETED|Overall Study||12
3220213|NCT02272790|3951765|FG004|COMPLETED|Overall Study||6
3220214|NCT02272790|3951766|FG005|COMPLETED|Overall Study||6
3220215|NCT02272790|3951761|FG000|NOT COMPLETED|Overall Study||0
3220216|NCT02272790|3951762|FG001|NOT COMPLETED|Overall Study||1
3220217|NCT02272790|3951763|FG002|NOT COMPLETED|Overall Study||0
3220218|NCT02272790|3951764|FG003|NOT COMPLETED|Overall Study||0
3220219|NCT02272790|3951765|FG004|NOT COMPLETED|Overall Study||0
3220220|NCT02272790|3951766|FG005|NOT COMPLETED|Overall Study||0
3220221|NCT02272816|3951786|FG000|STARTED|Overall Study||48
3220222|NCT02272816|3951786|FG000|COMPLETED|Overall Study||47
3220223|NCT02272816|3951786|FG000|NOT COMPLETED|Overall Study||1
3220224|NCT02272842|3951792|FG000|STARTED|Overall Study||300
3220225|NCT02272842|3951793|FG001|STARTED|Overall Study||300
3220226|NCT02272842|3951792|FG000|COMPLETED|Overall Study||284
3220227|NCT02272842|3951793|FG001|COMPLETED|Overall Study||290
3220228|NCT02272842|3951792|FG000|NOT COMPLETED|Overall Study||16
3220229|NCT02272842|3951793|FG001|NOT COMPLETED|Overall Study||10
3220230|NCT02272985|3951800|FG000|STARTED|Overall Study||15
3220231|NCT02272985|3951800|FG000|COMPLETED|Overall Study||12
3220232|NCT02272985|3951800|FG000|NOT COMPLETED|Overall Study||3
3220233|NCT02273037|3951807|FG000|STARTED|Overall Study||987
3220234|NCT02273037|3951808|FG001|STARTED|Overall Study||1000
3220235|NCT02273037|3951807|FG000|COMPLETED|Overall Study||979
3220236|NCT02273037|3951808|FG001|COMPLETED|Overall Study||992
3220237|NCT02273037|3951807|FG000|NOT COMPLETED|Overall Study||8
3220238|NCT02273037|3951808|FG001|NOT COMPLETED|Overall Study||8
3220239|NCT02273050|3951819|FG000|STARTED|Overall Study||210
3220240|NCT02273050|3951820|FG001|STARTED|Overall Study||216
3220241|NCT02273050|3951821|FG002|STARTED|Overall Study||214
3220242|NCT02273050|3951819|FG000|COMPLETED|Overall Study||186
3220243|NCT02273050|3951820|FG001|COMPLETED|Overall Study||194
3220244|NCT02273050|3951821|FG002|COMPLETED|Overall Study||185
3220245|NCT02273050|3951819|FG000|NOT COMPLETED|Overall Study||24
3220246|NCT02273050|3951820|FG001|NOT COMPLETED|Overall Study||22
3220247|NCT02273050|3951821|FG002|NOT COMPLETED|Overall Study||29
3220248|NCT02273063|3951829|FG000|STARTED|Overall Study||40
3220249|NCT02273063|3951829|FG000|COMPLETED|Overall Study||35
3220250|NCT02273063|3951829|FG000|NOT COMPLETED|Overall Study||5
3220251|NCT02273115|3951838|FG000|STARTED|Overall Study||94
3220252|NCT02273115|3951839|FG001|STARTED|Overall Study||90
3220253|NCT02273115|3951840|FG002|STARTED|Overall Study||67
3220254|NCT02273115|3951841|FG003|STARTED|Overall Study||72
3220255|NCT02273115|3951838|FG000|COMPLETED|Overall Study||94
3220256|NCT02273115|3951839|FG001|COMPLETED|Overall Study||90
3220257|NCT02273115|3951840|FG002|COMPLETED|Overall Study||67
3220258|NCT02273115|3951841|FG003|COMPLETED|Overall Study||71
3220259|NCT02273115|3951838|FG000|NOT COMPLETED|Overall Study||0
3220260|NCT02273115|3951839|FG001|NOT COMPLETED|Overall Study||0
3220261|NCT02273115|3951840|FG002|NOT COMPLETED|Overall Study||0
3220262|NCT02273115|3951841|FG003|NOT COMPLETED|Overall Study||1
3220263|NCT02273141|3951853|FG000|STARTED|Overall Study||257
3220264|NCT02273141|3951854|FG001|STARTED|Overall Study||258
3220265|NCT02273141|3951853|FG000|COMPLETED|Overall Study||240
3220266|NCT02273141|3951854|FG001|COMPLETED|Overall Study||233
3220267|NCT02273141|3951853|FG000|NOT COMPLETED|Overall Study||17
3220268|NCT02273141|3951854|FG001|NOT COMPLETED|Overall Study||25
3220269|NCT02273167|3951863|FG000|STARTED|Overall Study||283
3220270|NCT02273167|3951864|FG001|STARTED|Overall Study||283
3220271|NCT02273167|3951865|FG002|STARTED|Overall Study||283
3220272|NCT02273167|3951863|FG000|COMPLETED|Overall Study||259
3220273|NCT02273167|3951864|FG001|COMPLETED|Overall Study||260
3220274|NCT02273167|3951865|FG002|COMPLETED|Overall Study||262
3220275|NCT02273167|3951863|FG000|NOT COMPLETED|Overall Study||24
3220276|NCT02273167|3951864|FG001|NOT COMPLETED|Overall Study||23
3220277|NCT02273167|3951865|FG002|NOT COMPLETED|Overall Study||21
3220278|NCT02273180|3951876|FG000|STARTED|Overall Study||253
3220279|NCT02273180|3951877|FG001|STARTED|Overall Study||254
3220280|NCT02273180|3951876|FG000|Treated|Overall Study||252
3220281|NCT02273180|3951877|FG001|Treated|Overall Study||254
3220282|NCT02273180|3951876|FG000|COMPLETED|Overall Study||226
3220283|NCT02273180|3951877|FG001|COMPLETED|Overall Study||235
3220284|NCT02273180|3951876|FG000|NOT COMPLETED|Overall Study||27
3220285|NCT02273180|3951877|FG001|NOT COMPLETED|Overall Study||19
3220286|NCT02273206|3951885|FG000|STARTED|Overall Study||378
3220287|NCT02273206|3951886|FG001|STARTED|Overall Study||379
3220288|NCT02273206|3951885|FG000|COMPLETED|Overall Study||353
3220289|NCT02273206|3951886|FG001|COMPLETED|Overall Study||337
3220290|NCT02273206|3951885|FG000|NOT COMPLETED|Overall Study||25
3220291|NCT02273206|3951886|FG001|NOT COMPLETED|Overall Study||42
3220292|NCT02273310|3951894|FG000|STARTED|Overall Study||42
3220293|NCT02273310|3951895|FG001|STARTED|Overall Study||41
3220294|NCT02273310|3951894|FG000|COMPLETED|Overall Study||24
3220295|NCT02273310|3951895|FG001|COMPLETED|Overall Study||38
3220296|NCT02273310|3951894|FG000|NOT COMPLETED|Overall Study||18
3220297|NCT02273310|3951895|FG001|NOT COMPLETED|Overall Study||3
3220298|NCT02273323|3951902|FG000|STARTED|Overall Study||15
3220299|NCT02273323|3951903|FG001|STARTED|Overall Study||15
3220300|NCT02273323|3951902|FG000|COMPLETED|Overall Study||15
3220301|NCT02273323|3951903|FG001|COMPLETED|Overall Study||15
3220302|NCT02273323|3951902|FG000|NOT COMPLETED|Overall Study||0
3220303|NCT02273323|3951903|FG001|NOT COMPLETED|Overall Study||0
3220304|NCT02273596|3951909|FG000|STARTED|24-Week Treatment Period||29
3220305|NCT02273596|3951909|FG000|Received at Least 1 Dose of Study Drug|24-Week Treatment Period||28
3220306|NCT02273596|3951909|FG000|COMPLETED|24-Week Treatment Period||22
3220307|NCT02273596|3951909|FG000|NOT COMPLETED|24-Week Treatment Period||7
3220308|NCT02273596|3951909|FG000|STARTED|Extension Period||22
3220309|NCT02273596|3951909|FG000|Received at Least 1 Dose of Study Drug|Extension Period||22
3220310|NCT02273596|3951909|FG000|COMPLETED|Extension Period||0
3220311|NCT02273596|3951909|FG000|NOT COMPLETED|Extension Period||22
3220312|NCT02273726|3951921|FG000|STARTED|Overall Study||370
3220313|NCT02273726|3951922|FG001|STARTED|Overall Study||371
3220314|NCT02273726|3951921|FG000|Received at Least 1 Dose of Study Drug|Overall Study||370
3220315|NCT02273726|3951922|FG001|Received at Least 1 Dose of Study Drug|Overall Study||370
3220316|NCT02273726|3951921|FG000|COMPLETED|Overall Study||127
3220317|NCT02273726|3951922|FG001|COMPLETED|Overall Study||183
3220318|NCT02273726|3951921|FG000|NOT COMPLETED|Overall Study||243
3220319|NCT02273726|3951922|FG001|NOT COMPLETED|Overall Study||188
3220320|NCT02273739|3951932|FG000|STARTED|Overall Study||3
3220321|NCT02273739|3951933|FG001|STARTED|Overall Study||4
3220322|NCT02273739|3951934|FG002|STARTED|Overall Study||7
3220323|NCT02273739|3951935|FG003|STARTED|Overall Study||7
3220324|NCT02273739|3951932|FG000|COMPLETED|Overall Study||0
3220325|NCT02273739|3951933|FG001|COMPLETED|Overall Study||0
3220326|NCT02273739|3951934|FG002|COMPLETED|Overall Study||0
3220327|NCT02273739|3951935|FG003|COMPLETED|Overall Study||0
3220328|NCT02273739|3951932|FG000|NOT COMPLETED|Overall Study||3
3220329|NCT02273739|3951933|FG001|NOT COMPLETED|Overall Study||4
3220330|NCT02273739|3951934|FG002|NOT COMPLETED|Overall Study||7
3220331|NCT02273739|3951935|FG003|NOT COMPLETED|Overall Study||7
3220332|NCT02273908|3951952|FG000|STARTED|Overall Study||157
3220333|NCT02273908|3951953|FG001|STARTED|Overall Study||174
3220334|NCT02273908|3951952|FG000|COMPLETED|Overall Study||124
3220335|NCT02273908|3951953|FG001|COMPLETED|Overall Study||169
3220336|NCT02273908|3951952|FG000|NOT COMPLETED|Overall Study||33
3220337|NCT02273908|3951953|FG001|NOT COMPLETED|Overall Study||5
3220338|NCT02273960|3951967|FG000|STARTED|Short Term Period||5
3220339|NCT02273960|3951968|FG001|STARTED|Short Term Period||6
3220340|NCT02273960|3951969|FG002|STARTED|Short Term Period||5
3220341|NCT02273960|3951970|FG003|STARTED|Short Term Period||10
3220342|NCT02273960|3951967|FG000|COMPLETED|Short Term Period||0
3220343|NCT02273960|3951968|FG001|COMPLETED|Short Term Period||0
3220344|NCT02273960|3951969|FG002|COMPLETED|Short Term Period||1
3220345|NCT02273960|3951970|FG003|COMPLETED|Short Term Period||4
3220346|NCT02273960|3951967|FG000|NOT COMPLETED|Short Term Period||5
3220347|NCT02273960|3951968|FG001|NOT COMPLETED|Short Term Period||6
3220348|NCT02273960|3951969|FG002|NOT COMPLETED|Short Term Period||4
3220349|NCT02273960|3951970|FG003|NOT COMPLETED|Short Term Period||6
3220350|NCT02273960|3951967|FG000|STARTED|Long Term Extension||0
3220351|NCT02273960|3951968|FG001|STARTED|Long Term Extension||0
3220352|NCT02273960|3951969|FG002|STARTED|Long Term Extension||1
3220353|NCT02273960|3951970|FG003|STARTED|Long Term Extension||4
3220354|NCT02273960|3951967|FG000|COMPLETED|Long Term Extension||0
3220355|NCT02273960|3951968|FG001|COMPLETED|Long Term Extension||0
3220356|NCT02273960|3951969|FG002|COMPLETED|Long Term Extension||1
3220357|NCT02273960|3951970|FG003|COMPLETED|Long Term Extension||3
3220358|NCT02273960|3951967|FG000|NOT COMPLETED|Long Term Extension||0
3220359|NCT02273960|3951968|FG001|NOT COMPLETED|Long Term Extension||0
3220360|NCT02273960|3951969|FG002|NOT COMPLETED|Long Term Extension||0
3220361|NCT02273960|3951970|FG003|NOT COMPLETED|Long Term Extension||1
3220362|NCT02273973|3951982|FG000|STARTED|Overall Study||166
3220363|NCT02273973|3951983|FG001|STARTED|Overall Study||168
3220364|NCT02273973|3951982|FG000|COMPLETED|Overall Study||157
3220365|NCT02273973|3951983|FG001|COMPLETED|Overall Study||160
3220366|NCT02273973|3951982|FG000|NOT COMPLETED|Overall Study||9
3220367|NCT02273973|3951983|FG001|NOT COMPLETED|Overall Study||8
3220368|NCT02274038|3951989|FG000|STARTED|Overall Study||3
3220369|NCT02274038|3951989|FG000|COMPLETED|Overall Study||2
3220370|NCT02274038|3951989|FG000|NOT COMPLETED|Overall Study||1
3220371|NCT02274311|3951995|FG000|STARTED|Three Months of Clomiphene Treatment||16
3220372|NCT02274311|3951995|FG000|COMPLETED|Three Months of Clomiphene Treatment||16
3220373|NCT02274311|3951995|FG000|NOT COMPLETED|Three Months of Clomiphene Treatment||0
3220374|NCT02274311|3951995|FG000|STARTED|Three Months of Clomiphene Wash-out||16
3220375|NCT02274311|3951995|FG000|COMPLETED|Three Months of Clomiphene Wash-out||15
3220376|NCT02274311|3951995|FG000|NOT COMPLETED|Three Months of Clomiphene Wash-out||1
3220377|NCT02274493|3952001|FG000|STARTED|Overall Study||15
3220378|NCT02274493|3952001|FG000|COMPLETED|Overall Study||14
3220379|NCT02274493|3952001|FG000|NOT COMPLETED|Overall Study||1
3220380|NCT02274558|3952008|FG000|STARTED|Overall Study||78
3220381|NCT02274558|3952009|FG001|STARTED|Overall Study||76
3220382|NCT02274558|3952010|FG002|STARTED|Overall Study||80
3220383|NCT02274558|3952008|FG000|Included in the Safety Analysis Set|Overall Study||76
3220384|NCT02274558|3952009|FG001|Included in the Safety Analysis Set|Overall Study||72
3220385|NCT02274558|3952010|FG002|Included in the Safety Analysis Set|Overall Study||79
3220386|NCT02274558|3952008|FG000|COMPLETED|Overall Study||71
3220387|NCT02274558|3952009|FG001|COMPLETED|Overall Study||63
3220388|NCT02274558|3952010|FG002|COMPLETED|Overall Study||71
3220389|NCT02274558|3952008|FG000|NOT COMPLETED|Overall Study||7
3220390|NCT02274558|3952009|FG001|NOT COMPLETED|Overall Study||13
3220391|NCT02274558|3952010|FG002|NOT COMPLETED|Overall Study||9
3220392|NCT02274649|3952022|FG000|STARTED|Overall Study||101
3220393|NCT02274649|3952023|FG001|STARTED|Overall Study||93
3220394|NCT02274649|3952022|FG000|COMPLETED|Overall Study||77
3220395|NCT02274649|3952023|FG001|COMPLETED|Overall Study||81
3220396|NCT02274649|3952022|FG000|NOT COMPLETED|Overall Study||24
3220397|NCT02274649|3952023|FG001|NOT COMPLETED|Overall Study||12
3220398|NCT02274675|3952029|FG000|STARTED|Overall Study||7
3220399|NCT02274675|3952029|FG000|COMPLETED|Overall Study||7
3220400|NCT02274675|3952029|FG000|NOT COMPLETED|Overall Study||0
3220401|NCT02274688|3952035|FG000|STARTED|Overall Study||86
3220402|NCT02274688|3952036|FG001|STARTED|Overall Study||85
3220403|NCT02274688|3952035|FG000|COMPLETED|Overall Study||72
3220404|NCT02274688|3952036|FG001|COMPLETED|Overall Study||72
3220405|NCT02274688|3952035|FG000|NOT COMPLETED|Overall Study||14
3220406|NCT02274688|3952036|FG001|NOT COMPLETED|Overall Study||13
3220407|NCT02274766|3952045|FG000|STARTED|Overall Study||39
3220408|NCT02274766|3952046|FG001|STARTED|Overall Study||38
3220409|NCT02274766|3952045|FG000|Received Study Drug|Overall Study||38
3220410|NCT02274766|3952046|FG001|Received Study Drug|Overall Study||37
3220411|NCT02274766|3952045|FG000|COMPLETED|Overall Study||35
3220412|NCT02274766|3952046|FG001|COMPLETED|Overall Study||29
3220413|NCT02274766|3952045|FG000|NOT COMPLETED|Overall Study||4
3220414|NCT02274766|3952046|FG001|NOT COMPLETED|Overall Study||9
3220415|NCT02274792|3952052|FG000|STARTED|Overall Study||132
3220416|NCT02274792|3952052|FG000|Received Treatment|Overall Study||131
3220417|NCT02274792|3952052|FG000|COMPLETED|Overall Study||107
3220418|NCT02274792|3952052|FG000|NOT COMPLETED|Overall Study||25
3220419|NCT02274844|3952058|FG000|STARTED|Overall Study||203
3220420|NCT02274844|3952059|FG001|STARTED|Overall Study||270
3220421|NCT02274844|3952058|FG000|COMPLETED|Overall Study||165
3220422|NCT02274844|3952059|FG001|COMPLETED|Overall Study||238
3220423|NCT02274844|3952058|FG000|NOT COMPLETED|Overall Study||38
3220424|NCT02274844|3952059|FG001|NOT COMPLETED|Overall Study||32
3220425|NCT02274857|3952067|FG000|STARTED|Overall Study||179
3220426|NCT02274857|3952068|FG001|STARTED|Overall Study||171
3220427|NCT02274857|3952067|FG000|Completed Per Protocol|Overall Study||102
3220428|NCT02274857|3952068|FG001|Completed Per Protocol|Overall Study||114
3220429|NCT02274857|3952067|FG000|COMPLETED|Overall Study||159
3220430|NCT02274857|3952068|FG001|COMPLETED|Overall Study||165
3220431|NCT02274857|3952067|FG000|NOT COMPLETED|Overall Study||20
3220432|NCT02274857|3952068|FG001|NOT COMPLETED|Overall Study||6
3220433|NCT02274870|3952077|FG000|STARTED|Overall Study||32
3220434|NCT02274870|3952078|FG001|STARTED|Overall Study||33
3220435|NCT02274870|3952077|FG000|COMPLETED|Overall Study||32
3220436|NCT02274870|3952078|FG001|COMPLETED|Overall Study||33
3220437|NCT02274870|3952077|FG000|NOT COMPLETED|Overall Study||0
3220438|NCT02274870|3952078|FG001|NOT COMPLETED|Overall Study||0
3220439|NCT02274948|3952089|FG000|STARTED|Overall Study||166
3220440|NCT02274948|3952090|FG001|STARTED|Overall Study||173
3220441|NCT02274948|3952089|FG000|COMPLETED|Overall Study||68
3220442|NCT02274948|3952090|FG001|COMPLETED|Overall Study||82
3220443|NCT02274948|3952089|FG000|NOT COMPLETED|Overall Study||98
3220444|NCT02274948|3952090|FG001|NOT COMPLETED|Overall Study||91
3220445|NCT02275026|3952097|FG000|STARTED|Overall Study||104
3220446|NCT02275026|3952097|FG000|COMPLETED|Overall Study||71
3220447|NCT02275026|3952097|FG000|NOT COMPLETED|Overall Study||33
3220448|NCT02275052|3952104|FG000|STARTED|Period 1: Treatment Period 1 (12 Weeks)||99
3220449|NCT02275052|3952105|FG001|STARTED|Period 1: Treatment Period 1 (12 Weeks)||99
3220450|NCT02275052|3952106|FG002|STARTED|Period 1: Treatment Period 1 (12 Weeks)||0
3220451|NCT02275052|3952107|FG003|STARTED|Period 1: Treatment Period 1 (12 Weeks)||0
3220452|NCT02275052|3952104|FG000|COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||90
3220453|NCT02275052|3952105|FG001|COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||93
3220454|NCT02275052|3952106|FG002|COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||0
3220455|NCT02275052|3952107|FG003|COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||0
3220456|NCT02275052|3952104|FG000|NOT COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||9
3220457|NCT02275052|3952105|FG001|NOT COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||6
3220458|NCT02275052|3952106|FG002|NOT COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||0
3220459|NCT02275052|3952107|FG003|NOT COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||0
3220460|NCT02275052|3952104|FG000|STARTED|Washout Period (12-17 Days)||90
3220461|NCT02275052|3952105|FG001|STARTED|Washout Period (12-17 Days)||93
3220462|NCT02275052|3952106|FG002|STARTED|Washout Period (12-17 Days)||0
3220463|NCT02275052|3952107|FG003|STARTED|Washout Period (12-17 Days)||0
3220464|NCT02275052|3952104|FG000|COMPLETED|Washout Period (12-17 Days)||86
3220465|NCT02275052|3952105|FG001|COMPLETED|Washout Period (12-17 Days)||93
3220466|NCT02275052|3952106|FG002|COMPLETED|Washout Period (12-17 Days)||0
3220467|NCT02275052|3952107|FG003|COMPLETED|Washout Period (12-17 Days)||0
3220468|NCT02275052|3952104|FG000|NOT COMPLETED|Washout Period (12-17 Days)||4
3220469|NCT02275052|3952105|FG001|NOT COMPLETED|Washout Period (12-17 Days)||0
3220470|NCT02275052|3952106|FG002|NOT COMPLETED|Washout Period (12-17 Days)||0
3220471|NCT02275052|3952107|FG003|NOT COMPLETED|Washout Period (12-17 Days)||0
3220472|NCT02275052|3952104|FG000|STARTED|Period 2: Treatment Period 2 (12 Weeks)||0
3220473|NCT02275052|3952105|FG001|STARTED|Period 2: Treatment Period 2 (12 Weeks)||0
3220474|NCT02275052|3952106|FG002|STARTED|Period 2: Treatment Period 2 (12 Weeks)||93
3220475|NCT02275052|3952107|FG003|STARTED|Period 2: Treatment Period 2 (12 Weeks)||86
3220476|NCT02275052|3952104|FG000|COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||0
3220477|NCT02275052|3952105|FG001|COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||0
3220478|NCT02275052|3952106|FG002|COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||88
3220479|NCT02275052|3952107|FG003|COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||72
3220480|NCT02275052|3952104|FG000|NOT COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||0
3220481|NCT02275052|3952105|FG001|NOT COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||0
3220482|NCT02275052|3952106|FG002|NOT COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||5
3220483|NCT02275052|3952107|FG003|NOT COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||14
3220484|NCT02275065|3952118|FG000|STARTED|Overall Study||5
3220485|NCT02275065|3952119|FG001|STARTED|Overall Study||4
3220486|NCT02275065|3952120|FG002|STARTED|Overall Study||5
3220487|NCT02275065|3952121|FG003|STARTED|Overall Study||5
3220488|NCT02275065|3952122|FG004|STARTED|Overall Study||4
3220489|NCT02275065|3952118|FG000|COMPLETED|Overall Study||4
3220490|NCT02275065|3952119|FG001|COMPLETED|Overall Study||4
3220491|NCT02275065|3952120|FG002|COMPLETED|Overall Study||4
3220492|NCT02275065|3952121|FG003|COMPLETED|Overall Study||4
3220493|NCT02275065|3952122|FG004|COMPLETED|Overall Study||4
3220494|NCT02275065|3952118|FG000|NOT COMPLETED|Overall Study||1
3220495|NCT02275065|3952119|FG001|NOT COMPLETED|Overall Study||0
3220496|NCT02275065|3952120|FG002|NOT COMPLETED|Overall Study||1
3220497|NCT02275065|3952121|FG003|NOT COMPLETED|Overall Study||1
3220498|NCT02275065|3952122|FG004|NOT COMPLETED|Overall Study||0
3220499|NCT02275117|3952139|FG000|STARTED|Overall Study||131
3220500|NCT02275117|3952140|FG001|STARTED|Overall Study||133
3220501|NCT02275117|3952141|FG002|STARTED|Overall Study||134
3220502|NCT02275117|3952142|FG003|STARTED|Overall Study||133
3220503|NCT02275117|3952143|FG004|STARTED|Overall Study||134
3220504|NCT02275117|3952139|FG000|Randomized and Treated|Overall Study||120
3220505|NCT02275117|3952140|FG001|Randomized and Treated|Overall Study||123
3220506|NCT02275117|3952141|FG002|Randomized and Treated|Overall Study||122
3220507|NCT02275117|3952142|FG003|Randomized and Treated|Overall Study||130
3220508|NCT02275117|3952143|FG004|Randomized and Treated|Overall Study||121
3220509|NCT02275117|3952139|FG000|COMPLETED|Overall Study||97
3220510|NCT02275117|3952140|FG001|COMPLETED|Overall Study||96
3220511|NCT02275117|3952141|FG002|COMPLETED|Overall Study||92
3220512|NCT02275117|3952142|FG003|COMPLETED|Overall Study||100
3220513|NCT02275117|3952143|FG004|COMPLETED|Overall Study||98
3220514|NCT02275117|3952139|FG000|NOT COMPLETED|Overall Study||34
3220515|NCT02275117|3952140|FG001|NOT COMPLETED|Overall Study||37
3220516|NCT02275117|3952141|FG002|NOT COMPLETED|Overall Study||42
3220517|NCT02275117|3952142|FG003|NOT COMPLETED|Overall Study||33
3220518|NCT02275117|3952143|FG004|NOT COMPLETED|Overall Study||36
3220519|NCT02275156|3952158|FG000|STARTED|Overall Study||6
3220520|NCT02275156|3952159|FG001|STARTED|Overall Study||6
3220521|NCT02275156|3952160|FG002|STARTED|Overall Study||6
3220522|NCT02275156|3952158|FG000|COMPLETED|Overall Study||6
3220523|NCT02275156|3952159|FG001|COMPLETED|Overall Study||6
3220524|NCT02275156|3952160|FG002|COMPLETED|Overall Study||6
3367635|NCT03870555|4099169|FG001|COMPLETED|Washout Period (at Least 16 Days)||2
3220525|NCT02275156|3952158|FG000|NOT COMPLETED|Overall Study||0
3220526|NCT02275156|3952159|FG001|NOT COMPLETED|Overall Study||0
3220527|NCT02275156|3952160|FG002|NOT COMPLETED|Overall Study||0
3220528|NCT02275338|3952169|FG000|STARTED|Overall Study||52
3220529|NCT02275338|3952169|FG000|Completed Phase 1|Overall Study||25
3220530|NCT02275338|3952169|FG000|Started Phase 2|Overall Study||21
3220531|NCT02275338|3952169|FG000|COMPLETED|Overall Study||19
3220532|NCT02275338|3952169|FG000|NOT COMPLETED|Overall Study||33
3220533|NCT02275364|3952174|FG000|STARTED|Period 1||14
3220534|NCT02275364|3952175|FG001|STARTED|Period 1||14
3220535|NCT02275364|3952174|FG000|COMPLETED|Period 1||12
3220536|NCT02275364|3952175|FG001|COMPLETED|Period 1||14
3220537|NCT02275364|3952174|FG000|NOT COMPLETED|Period 1||2
3220538|NCT02275364|3952175|FG001|NOT COMPLETED|Period 1||0
3220539|NCT02275364|3952174|FG000|STARTED|Washout Period 1||12
3220540|NCT02275364|3952175|FG001|STARTED|Washout Period 1||14
3220541|NCT02275364|3952174|FG000|COMPLETED|Washout Period 1||12
3220542|NCT02275364|3952175|FG001|COMPLETED|Washout Period 1||14
3220543|NCT02275364|3952174|FG000|NOT COMPLETED|Washout Period 1||0
3220544|NCT02275364|3952175|FG001|NOT COMPLETED|Washout Period 1||0
3220545|NCT02275364|3952174|FG000|STARTED|Period 2||12
3220546|NCT02275364|3952175|FG001|STARTED|Period 2||14
3220547|NCT02275364|3952174|FG000|COMPLETED|Period 2||12
3220548|NCT02275364|3952175|FG001|COMPLETED|Period 2||14
3220549|NCT02275364|3952174|FG000|NOT COMPLETED|Period 2||0
3220550|NCT02275364|3952175|FG001|NOT COMPLETED|Period 2||0
3220551|NCT02275364|3952174|FG000|STARTED|Washout Period 2||12
3220552|NCT02275364|3952175|FG001|STARTED|Washout Period 2||14
3220553|NCT02275364|3952174|FG000|COMPLETED|Washout Period 2||12
3220554|NCT02275364|3952175|FG001|COMPLETED|Washout Period 2||14
3220555|NCT02275364|3952174|FG000|NOT COMPLETED|Washout Period 2||0
3220556|NCT02275364|3952175|FG001|NOT COMPLETED|Washout Period 2||0
3220557|NCT02275364|3952174|FG000|STARTED|Period 3||12
3220558|NCT02275364|3952175|FG001|STARTED|Period 3||14
3220559|NCT02275364|3952174|FG000|COMPLETED|Period 3||12
3220560|NCT02275364|3952175|FG001|COMPLETED|Period 3||14
3220561|NCT02275364|3952174|FG000|NOT COMPLETED|Period 3||0
3220562|NCT02275364|3952175|FG001|NOT COMPLETED|Period 3||0
3220563|NCT02275364|3952174|FG000|STARTED|Period 4||12
3220564|NCT02275364|3952175|FG001|STARTED|Period 4||14
3220565|NCT02275364|3952174|FG000|COMPLETED|Period 4||12
3220566|NCT02275364|3952175|FG001|COMPLETED|Period 4||14
3220567|NCT02275364|3952174|FG000|NOT COMPLETED|Period 4||0
3220568|NCT02275364|3952175|FG001|NOT COMPLETED|Period 4||0
3220569|NCT02275611|3952196|FG000|STARTED|Inpatient Withdrawal||5
3220570|NCT02275611|3952197|FG001|STARTED|Inpatient Withdrawal||4
3220571|NCT02275611|3952198|FG002|STARTED|Inpatient Withdrawal||0
3220572|NCT02275611|3952199|FG003|STARTED|Inpatient Withdrawal||0
3220573|NCT02275611|3952196|FG000|COMPLETED|Inpatient Withdrawal||4
3220574|NCT02275611|3952197|FG001|COMPLETED|Inpatient Withdrawal||4
3220575|NCT02275611|3952198|FG002|COMPLETED|Inpatient Withdrawal||0
3220576|NCT02275611|3952199|FG003|COMPLETED|Inpatient Withdrawal||0
3220577|NCT02275611|3952196|FG000|NOT COMPLETED|Inpatient Withdrawal||1
3220578|NCT02275611|3952197|FG001|NOT COMPLETED|Inpatient Withdrawal||0
3220579|NCT02275611|3952198|FG002|NOT COMPLETED|Inpatient Withdrawal||0
3220580|NCT02275611|3952199|FG003|NOT COMPLETED|Inpatient Withdrawal||0
3220581|NCT02275611|3952196|FG000|STARTED|Outpatient Drinking||0
3220582|NCT02275611|3952197|FG001|STARTED|Outpatient Drinking||0
3220583|NCT02275611|3952198|FG002|STARTED|Outpatient Drinking||6
3220584|NCT02275611|3952199|FG003|STARTED|Outpatient Drinking||3
3220585|NCT02275611|3952196|FG000|COMPLETED|Outpatient Drinking||0
3220586|NCT02275611|3952197|FG001|COMPLETED|Outpatient Drinking||0
3220587|NCT02275611|3952198|FG002|COMPLETED|Outpatient Drinking||6
3220588|NCT02275611|3952199|FG003|COMPLETED|Outpatient Drinking||3
3220589|NCT02275611|3952196|FG000|NOT COMPLETED|Outpatient Drinking||0
3220590|NCT02275611|3952197|FG001|NOT COMPLETED|Outpatient Drinking||0
3220591|NCT02275611|3952198|FG002|NOT COMPLETED|Outpatient Drinking||0
3220592|NCT02275611|3952199|FG003|NOT COMPLETED|Outpatient Drinking||0
3220593|NCT02275767|3952214|FG000|STARTED|Overall Study||22
3220594|NCT02275767|3952215|FG001|STARTED|Overall Study||22
3220595|NCT02275767|3952216|FG002|STARTED|Overall Study||22
3220596|NCT02275767|3952214|FG000|COMPLETED|Overall Study||20
3220597|NCT02275767|3952215|FG001|COMPLETED|Overall Study||18
3220598|NCT02275767|3952216|FG002|COMPLETED|Overall Study||19
3220599|NCT02275767|3952214|FG000|NOT COMPLETED|Overall Study||2
3220600|NCT02275767|3952215|FG001|NOT COMPLETED|Overall Study||4
3220601|NCT02275767|3952216|FG002|NOT COMPLETED|Overall Study||3
3220602|NCT02275780|3952226|FG000|STARTED|Base Study: 96 Weeks||385
3220603|NCT02275780|3952227|FG001|STARTED|Base Study: 96 Weeks||384
3220604|NCT02275780|3952226|FG000|Treated|Base Study: 96 Weeks||383
3220605|NCT02275780|3952227|FG001|Treated|Base Study: 96 Weeks||383
3220606|NCT02275780|3952226|FG000|COMPLETED|Base Study: 96 Weeks||292
3220607|NCT02275780|3952227|FG001|COMPLETED|Base Study: 96 Weeks||273
3220608|NCT02275780|3952226|FG000|NOT COMPLETED|Base Study: 96 Weeks||93
3220609|NCT02275780|3952227|FG001|NOT COMPLETED|Base Study: 96 Weeks||111
3220610|NCT02275780|3952226|FG000|STARTED|Extension Study: up to 192 Weeks|The extension study is optional; not all eligible participants enrolled|260
3220611|NCT02275780|3952227|FG001|STARTED|Extension Study: up to 192 Weeks|The extension study is optional; not all eligible participants enrolled|233
3220612|NCT02275780|3952226|FG000|COMPLETED|Extension Study: up to 192 Weeks|The extension study is ongoing|0
3220613|NCT02275780|3952227|FG001|COMPLETED|Extension Study: up to 192 Weeks|The extension study is ongoing|0
3220614|NCT02275780|3952226|FG000|NOT COMPLETED|Extension Study: up to 192 Weeks||260
3220615|NCT02275780|3952227|FG001|NOT COMPLETED|Extension Study: up to 192 Weeks||233
3220616|NCT02275819|3952235|FG000|STARTED|Overall Study||5
3220617|NCT02275819|3952236|FG001|STARTED|Overall Study||6
3220618|NCT02275819|3952235|FG000|COMPLETED|Overall Study||5
3220619|NCT02275819|3952236|FG001|COMPLETED|Overall Study||5
3220620|NCT02275819|3952235|FG000|NOT COMPLETED|Overall Study||0
3220621|NCT02275819|3952236|FG001|NOT COMPLETED|Overall Study||1
3220622|NCT02275923|3952242|FG000|STARTED|Overall Study||9
3220623|NCT02275923|3952242|FG000|COMPLETED|Overall Study||7
3220624|NCT02275923|3952242|FG000|NOT COMPLETED|Overall Study||2
3220625|NCT02276027|3952250|FG000|STARTED|Overall Study||2
3220626|NCT02276027|3952251|FG001|STARTED|Overall Study||16
3220627|NCT02276027|3952252|FG002|STARTED|Overall Study||26
3220628|NCT02276027|3952253|FG003|STARTED|Overall Study||22
3220629|NCT02276027|3952250|FG000|COMPLETED|Overall Study||0
3220630|NCT02276027|3952251|FG001|COMPLETED|Overall Study||0
3220631|NCT02276027|3952252|FG002|COMPLETED|Overall Study||6
3220632|NCT02276027|3952253|FG003|COMPLETED|Overall Study||0
3220633|NCT02276027|3952250|FG000|NOT COMPLETED|Overall Study||2
3220634|NCT02276027|3952251|FG001|NOT COMPLETED|Overall Study||16
3220635|NCT02276027|3952252|FG002|NOT COMPLETED|Overall Study||20
3220636|NCT02276027|3952253|FG003|NOT COMPLETED|Overall Study||22
3220637|NCT02276040|3952263|FG000|STARTED|Overall Study||26
3220638|NCT02276040|3952263|FG000|COMPLETED|Overall Study||11
3220639|NCT02276040|3952263|FG000|NOT COMPLETED|Overall Study||15
3220640|NCT02276053|3952267|FG000|STARTED|Overall Study||93
3220641|NCT02276053|3952267|FG000|COMPLETED|Overall Study||79
3220642|NCT02276053|3952267|FG000|NOT COMPLETED|Overall Study||14
3220643|NCT02276222|3952274|FG000|STARTED|Overall Study||621
3220644|NCT02276222|3952275|FG001|STARTED|Overall Study||466
3220645|NCT02276222|3952274|FG000|COMPLETED|Overall Study|one subject withdrew at randomization due to a pre-treatment event prior to being dosed|436
3220646|NCT02276222|3952275|FG001|COMPLETED|Overall Study||402
3220647|NCT02276222|3952274|FG000|NOT COMPLETED|Overall Study||185
3220648|NCT02276222|3952275|FG001|NOT COMPLETED|Overall Study||64
3220649|NCT02276274|3952283|FG000|STARTED|First Intervention Period||6
3220650|NCT02276274|3952284|FG001|STARTED|First Intervention Period||6
3220651|NCT02276274|3952283|FG000|COMPLETED|First Intervention Period||6
3220652|NCT02276274|3952284|FG001|COMPLETED|First Intervention Period||6
3220653|NCT02276274|3952283|FG000|NOT COMPLETED|First Intervention Period||0
3220654|NCT02276274|3952284|FG001|NOT COMPLETED|First Intervention Period||0
3220655|NCT02276274|3952283|FG000|STARTED|Washout Period (at Least 15 Days)||6
3220656|NCT02276274|3952284|FG001|STARTED|Washout Period (at Least 15 Days)||6
3220657|NCT02276274|3952283|FG000|COMPLETED|Washout Period (at Least 15 Days)||6
3220658|NCT02276274|3952284|FG001|COMPLETED|Washout Period (at Least 15 Days)||6
3220659|NCT02276274|3952283|FG000|NOT COMPLETED|Washout Period (at Least 15 Days)||0
3220660|NCT02276274|3952284|FG001|NOT COMPLETED|Washout Period (at Least 15 Days)||0
3220661|NCT02276274|3952283|FG000|STARTED|Second Intervention Period||6
3220662|NCT02276274|3952284|FG001|STARTED|Second Intervention Period||6
3220663|NCT02276274|3952283|FG000|COMPLETED|Second Intervention Period||6
3220664|NCT02276274|3952284|FG001|COMPLETED|Second Intervention Period||6
3220665|NCT02276274|3952283|FG000|NOT COMPLETED|Second Intervention Period||0
3220666|NCT02276274|3952284|FG001|NOT COMPLETED|Second Intervention Period||0
3367636|NCT03870555|4099170|FG002|COMPLETED|Washout Period (at Least 16 Days)||2
3367637|NCT03870555|4099168|FG000|NOT COMPLETED|Washout Period (at Least 16 Days)||0
3367638|NCT03870555|4099169|FG001|NOT COMPLETED|Washout Period (at Least 16 Days)||0
3367639|NCT03870555|4099170|FG002|NOT COMPLETED|Washout Period (at Least 16 Days)||0
3367640|NCT03870555|4099168|FG000|STARTED|Period 2 (2 Days)||2
3367641|NCT03870555|4099169|FG001|STARTED|Period 2 (2 Days)||2
3367642|NCT03870555|4099170|FG002|STARTED|Period 2 (2 Days)||2
3367643|NCT03870555|4099168|FG000|COMPLETED|Period 2 (2 Days)||2
3367644|NCT03870555|4099169|FG001|COMPLETED|Period 2 (2 Days)||2
3367645|NCT03870555|4099170|FG002|COMPLETED|Period 2 (2 Days)||2
3367646|NCT03870555|4099168|FG000|NOT COMPLETED|Period 2 (2 Days)||0
3367647|NCT03870555|4099169|FG001|NOT COMPLETED|Period 2 (2 Days)||0
3367648|NCT03870555|4099170|FG002|NOT COMPLETED|Period 2 (2 Days)||0
3367649|NCT03870555|4099168|FG000|STARTED|Washout Period (at Least 16 Days)||2
3367650|NCT03870555|4099169|FG001|STARTED|Washout Period (at Least 16 Days)||2
3367651|NCT03870555|4099170|FG002|STARTED|Washout Period (at Least 16 Days)||2
3367652|NCT03870555|4099168|FG000|COMPLETED|Washout Period (at Least 16 Days)||2
3367653|NCT03870555|4099169|FG001|COMPLETED|Washout Period (at Least 16 Days)||2
3367654|NCT03870555|4099170|FG002|COMPLETED|Washout Period (at Least 16 Days)||2
3367655|NCT03870555|4099168|FG000|NOT COMPLETED|Washout Period (at Least 16 Days)||0
3367656|NCT03870555|4099169|FG001|NOT COMPLETED|Washout Period (at Least 16 Days)||0
3367657|NCT03870555|4099170|FG002|NOT COMPLETED|Washout Period (at Least 16 Days)||0
3367658|NCT03870555|4099168|FG000|STARTED|Period 3 (2 Days)||2
3367659|NCT03870555|4099169|FG001|STARTED|Period 3 (2 Days)||2
3367660|NCT03870555|4099170|FG002|STARTED|Period 3 (2 Days)||2
3367661|NCT03870555|4099168|FG000|COMPLETED|Period 3 (2 Days)||1
3367662|NCT03870555|4099169|FG001|COMPLETED|Period 3 (2 Days)||2
3367663|NCT03870555|4099170|FG002|COMPLETED|Period 3 (2 Days)||2
3367664|NCT03870555|4099168|FG000|NOT COMPLETED|Period 3 (2 Days)||1
3367665|NCT03870555|4099169|FG001|NOT COMPLETED|Period 3 (2 Days)||0
3367666|NCT03870555|4099170|FG002|NOT COMPLETED|Period 3 (2 Days)||0
3367667|NCT03861845|4099184|FG000|STARTED|Overall Study||6
3367668|NCT03861845|4099185|FG001|STARTED|Overall Study||5
3367669|NCT03861845|4099186|FG002|STARTED|Overall Study||4
3367670|NCT03861845|4099184|FG000|COMPLETED|Overall Study||6
3367671|NCT03861845|4099185|FG001|COMPLETED|Overall Study||5
3367672|NCT03861845|4099186|FG002|COMPLETED|Overall Study||4
3367673|NCT03861845|4099184|FG000|NOT COMPLETED|Overall Study||0
3220667|NCT02276482|3952292|FG000|STARTED|Overall Study||91
3220668|NCT02276482|3952293|FG001|STARTED|Overall Study||29
3220669|NCT02276482|3952292|FG000|COMPLETED|Overall Study||88
3220670|NCT02276482|3952293|FG001|COMPLETED|Overall Study||28
3220671|NCT02276482|3952292|FG000|NOT COMPLETED|Overall Study||3
3220672|NCT02276482|3952293|FG001|NOT COMPLETED|Overall Study||1
3220673|NCT02276612|3952301|FG000|STARTED|Overall Study||50
3220674|NCT02276612|3952302|FG001|STARTED|Overall Study||10
3220675|NCT02276612|3952301|FG000|COMPLETED|Overall Study||46
3220676|NCT02276612|3952302|FG001|COMPLETED|Overall Study||10
3220677|NCT02276612|3952301|FG000|NOT COMPLETED|Overall Study||4
3220678|NCT02276612|3952302|FG001|NOT COMPLETED|Overall Study||0
3220679|NCT02276638|3952311|FG000|STARTED|Overall Study||28
3220680|NCT02276638|3952312|FG001|STARTED|Overall Study||28
3220681|NCT02276638|3952313|FG002|STARTED|Overall Study||23
3220682|NCT02276638|3952311|FG000|COMPLETED|Overall Study||28
3220683|NCT02276638|3952312|FG001|COMPLETED|Overall Study||28
3220684|NCT02276638|3952313|FG002|COMPLETED|Overall Study||23
3220685|NCT02276638|3952311|FG000|NOT COMPLETED|Overall Study||0
3220686|NCT02276638|3952312|FG001|NOT COMPLETED|Overall Study||0
3220687|NCT02276638|3952313|FG002|NOT COMPLETED|Overall Study||0
3220688|NCT02276807|3952323|FG000|STARTED|Overall Study||68
3220689|NCT02276807|3952324|FG001|STARTED|Overall Study||72
3220690|NCT02276807|3952323|FG000|12-week Assessment|Overall Study||57
3220691|NCT02276807|3952324|FG001|12-week Assessment|Overall Study||63
3220692|NCT02276807|3952323|FG000|COMPLETED|Overall Study||50
3220693|NCT02276807|3952324|FG001|COMPLETED|Overall Study||55
3220694|NCT02276807|3952323|FG000|NOT COMPLETED|Overall Study||18
3220695|NCT02276807|3952324|FG001|NOT COMPLETED|Overall Study||17
3220696|NCT02276872|3952333|FG000|STARTED|Overall Study||10
3220697|NCT02276872|3952334|FG001|STARTED|Overall Study||10
3220698|NCT02276872|3952335|FG002|STARTED|Overall Study||12
3220699|NCT02276872|3952333|FG000|COMPLETED|Overall Study||9
3220700|NCT02276872|3952334|FG001|COMPLETED|Overall Study||10
3220701|NCT02276872|3952335|FG002|COMPLETED|Overall Study||12
3220702|NCT02276872|3952333|FG000|NOT COMPLETED|Overall Study||1
3220703|NCT02276872|3952334|FG001|NOT COMPLETED|Overall Study||0
3220704|NCT02276872|3952335|FG002|NOT COMPLETED|Overall Study||0
3220705|NCT02276963|3952348|FG000|STARTED|Overall Study||6
3220706|NCT02276963|3952348|FG000|COMPLETED|Overall Study||3
3220707|NCT02276963|3952348|FG000|NOT COMPLETED|Overall Study||3
3220708|NCT02277054|3952352|FG000|STARTED|Overall Study||5
3220709|NCT02277054|3952352|FG000|COMPLETED|Overall Study||5
3220710|NCT02277054|3952352|FG000|NOT COMPLETED|Overall Study||0
3220711|NCT02277093|3952357|FG000|STARTED|Overall Study||11
3220712|NCT02277093|3952357|FG000|COMPLETED|Overall Study||11
3220713|NCT02277093|3952357|FG000|NOT COMPLETED|Overall Study||0
3220714|NCT02277249|3952363|FG000|STARTED|Overall Study||30
3220715|NCT02277249|3952364|FG001|STARTED|Overall Study||30
3220716|NCT02277249|3952363|FG000|COMPLETED|Overall Study||30
3220717|NCT02277249|3952364|FG001|COMPLETED|Overall Study||30
3220718|NCT02277249|3952363|FG000|NOT COMPLETED|Overall Study||0
3220719|NCT02277249|3952364|FG001|NOT COMPLETED|Overall Study||0
3220720|NCT02277548|3952372|FG000|STARTED|Overall Study||9
3220721|NCT02277548|3952373|FG001|STARTED|Overall Study||11
3220722|NCT02277548|3952372|FG000|COMPLETED|Overall Study||9
3220723|NCT02277548|3952373|FG001|COMPLETED|Overall Study||9
3220724|NCT02277548|3952372|FG000|NOT COMPLETED|Overall Study||0
3220725|NCT02277548|3952373|FG001|NOT COMPLETED|Overall Study||2
3220726|NCT02277626|3952379|FG000|STARTED|Overall Study||6
3220727|NCT02277626|3952380|FG001|STARTED|Overall Study||9
3220728|NCT02277626|3952379|FG000|COMPLETED|Overall Study||6
3220729|NCT02277626|3952380|FG001|COMPLETED|Overall Study||9
3220730|NCT02277626|3952379|FG000|NOT COMPLETED|Overall Study||0
3220731|NCT02277626|3952380|FG001|NOT COMPLETED|Overall Study||0
3220732|NCT02277639|3952393|FG000|STARTED|Overall Study||0
3220733|NCT02277639|3952394|FG001|STARTED|Overall Study||2
3220734|NCT02277639|3952393|FG000|COMPLETED|Overall Study||0
3220735|NCT02277639|3952394|FG001|COMPLETED|Overall Study||2
3220736|NCT02277639|3952393|FG000|NOT COMPLETED|Overall Study||0
3220737|NCT02277639|3952394|FG001|NOT COMPLETED|Overall Study||0
3220738|NCT02277665|3952402|FG000|STARTED|Overall Study||33
3220739|NCT02277665|3952403|FG001|STARTED|Overall Study||34
3220740|NCT02277665|3952402|FG000|COMPLETED|Overall Study||33
3220741|NCT02277665|3952403|FG001|COMPLETED|Overall Study||34
3220742|NCT02277665|3952402|FG000|NOT COMPLETED|Overall Study||0
3220743|NCT02277665|3952403|FG001|NOT COMPLETED|Overall Study||0
3220744|NCT02277691|3952411|FG000|STARTED|Overall Study||341
3220745|NCT02277691|3952411|FG000|COMPLETED|Overall Study||295
3220746|NCT02277691|3952411|FG000|NOT COMPLETED|Overall Study||46
3220747|NCT02277743|3952418|FG000|STARTED|Overall Study||224
3220748|NCT02277743|3952419|FG001|STARTED|Overall Study||224
3220749|NCT02277743|3952420|FG002|STARTED|Overall Study||223
3220750|NCT02277743|3952418|FG000|Treated|Overall Study||223
3220751|NCT02277743|3952419|FG001|Treated|Overall Study||223
3220752|NCT02277743|3952420|FG002|Treated|Overall Study||223
3220753|NCT02277743|3952418|FG000|Safety Population|Overall Study|1 participant received at least 1 injection of Dupilumab 300mg(analyzed in Dupilumab 300 mg q2w arm)|222
3220754|NCT02277743|3952419|FG001|Safety Population|Overall Study|6 participants (1 [placebo] + 5 [Dupilumab 300 mg qw arm]) analyzed in Dupilumab 300 mg q2w arm|229
3220755|NCT02277743|3952420|FG002|Safety Population|Overall Study|5 participants received fewer injections of Dupilumab 300 mg (analyzed in Dupilumab 300 mg q2w arm)|218
3220756|NCT02277743|3952418|FG000|COMPLETED|Overall Study||184
3220757|NCT02277743|3952419|FG001|COMPLETED|Overall Study||208
3220758|NCT02277743|3952420|FG002|COMPLETED|Overall Study||197
3220759|NCT02277743|3952418|FG000|NOT COMPLETED|Overall Study||40
3220760|NCT02277743|3952419|FG001|NOT COMPLETED|Overall Study||16
3220761|NCT02277743|3952420|FG002|NOT COMPLETED|Overall Study||26
3220762|NCT02277769|3952431|FG000|STARTED|Overall Study||236
3220763|NCT02277769|3952432|FG001|STARTED|Overall Study||233
3220764|NCT02277769|3952433|FG002|STARTED|Overall Study||239
3220765|NCT02277769|3952431|FG000|Treated|Overall Study||235
3220766|NCT02277769|3952432|FG001|Treated|Overall Study||233
3220767|NCT02277769|3952433|FG002|Treated|Overall Study||239
3220768|NCT02277769|3952431|FG000|Safety Population|Overall Study|1 participant received at least 1 injection of Dupilumab 300mg(analyzed in Dupilumab 300 mg q2w arm)|234
3220769|NCT02277769|3952432|FG001|Safety Population|Overall Study|3 participants (1 [placebo] + 2 [Dupilumab 300 mg qw arm]) analyzed in Dupilumab 300 mg q2w arm|236
3220770|NCT02277769|3952433|FG002|Safety Population|Overall Study|2 participants received fewer injections of Dupilumab 300 mg (analyzed in Dupilumab 300 mg q2w arm)|237
3220771|NCT02277769|3952431|FG000|COMPLETED|Overall Study||190
3220772|NCT02277769|3952432|FG001|COMPLETED|Overall Study||220
3220773|NCT02277769|3952433|FG002|COMPLETED|Overall Study||221
3220774|NCT02277769|3952431|FG000|NOT COMPLETED|Overall Study||46
3220775|NCT02277769|3952432|FG001|NOT COMPLETED|Overall Study||13
3220776|NCT02277769|3952433|FG002|NOT COMPLETED|Overall Study||18
3220777|NCT02277925|3952443|FG000|STARTED|Overall Study||102
3220778|NCT02277925|3952444|FG001|STARTED|Overall Study||102
3220779|NCT02277925|3952443|FG000|Surgery|Overall Study||99
3220780|NCT02277925|3952444|FG001|Surgery|Overall Study||101
3220781|NCT02277925|3952443|FG000|COMPLETED|Overall Study||95
3220782|NCT02277925|3952444|FG001|COMPLETED|Overall Study||87
3220783|NCT02277925|3952443|FG000|NOT COMPLETED|Overall Study||7
3220784|NCT02277925|3952444|FG001|NOT COMPLETED|Overall Study||15
3220785|NCT02277990|3952454|FG000|STARTED|Overall Study||3495
3220786|NCT02277990|3952455|FG001|STARTED|Overall Study||3488
3220787|NCT02277990|3952454|FG000|COMPLETED|Overall Study||3129
3220788|NCT02277990|3952455|FG001|COMPLETED|Overall Study||3112
3220789|NCT02277990|3952454|FG000|NOT COMPLETED|Overall Study||366
3220790|NCT02277990|3952455|FG001|NOT COMPLETED|Overall Study||376
3220791|NCT02278003|3952463|FG000|STARTED|Overall Study||49
3220792|NCT02278003|3952464|FG001|STARTED|Overall Study||20
3220793|NCT02278003|3952463|FG000|COMPLETED|Overall Study||30
3367674|NCT03861845|4099185|FG001|NOT COMPLETED|Overall Study||0
3367675|NCT03861845|4099186|FG002|NOT COMPLETED|Overall Study||0
3367676|NCT03851094|4099196|FG000|STARTED|Overall Study||111
3367677|NCT03851094|4099197|FG001|STARTED|Overall Study||55
3367678|NCT03851094|4099196|FG000|COMPLETED|Overall Study||111
3367679|NCT03851094|4099197|FG001|COMPLETED|Overall Study||51
3367680|NCT03851094|4099196|FG000|NOT COMPLETED|Overall Study||0
3367681|NCT03851094|4099197|FG001|NOT COMPLETED|Overall Study||4
3367682|NCT03869450|4099208|FG000|STARTED|Overall Study||31
3367683|NCT03869450|4099209|FG001|STARTED|Overall Study||25
3367684|NCT03869450|4099210|FG002|STARTED|Overall Study||34
3367685|NCT03869450|4099208|FG000|COMPLETED|Overall Study||30
3367686|NCT03869450|4099209|FG001|COMPLETED|Overall Study||23
3367687|NCT03869450|4099210|FG002|COMPLETED|Overall Study||34
3367688|NCT03869450|4099208|FG000|NOT COMPLETED|Overall Study||1
3367689|NCT03869450|4099209|FG001|NOT COMPLETED|Overall Study||2
3367690|NCT03869450|4099210|FG002|NOT COMPLETED|Overall Study||0
3367691|NCT03868631|4099220|FG000|STARTED|Baseline to Week 6||30
3367692|NCT03868631|4099221|FG001|STARTED|Baseline to Week 6||31
3367693|NCT03868631|4099220|FG000|COMPLETED|Baseline to Week 6||26
3367694|NCT03868631|4099221|FG001|COMPLETED|Baseline to Week 6||27
3367695|NCT03868631|4099220|FG000|NOT COMPLETED|Baseline to Week 6||4
3367696|NCT03868631|4099221|FG001|NOT COMPLETED|Baseline to Week 6||4
3367697|NCT03868631|4099220|FG000|STARTED|Week 6 to Week 12 (Study Completion)||26
3367698|NCT03868631|4099221|FG001|STARTED|Week 6 to Week 12 (Study Completion)||27
3367699|NCT03868631|4099220|FG000|COMPLETED|Week 6 to Week 12 (Study Completion)||22
3367700|NCT03868631|4099221|FG001|COMPLETED|Week 6 to Week 12 (Study Completion)||26
3367701|NCT03868631|4099220|FG000|NOT COMPLETED|Week 6 to Week 12 (Study Completion)||4
3367702|NCT03868631|4099221|FG001|NOT COMPLETED|Week 6 to Week 12 (Study Completion)||1
3367703|NCT03865953|4099229|FG000|STARTED|First Intervention (4 Weeks)||25
3367704|NCT03865953|4099230|FG001|STARTED|First Intervention (4 Weeks)||28
3367705|NCT03865953|4099229|FG000|COMPLETED|First Intervention (4 Weeks)||23
3367706|NCT03865953|4099230|FG001|COMPLETED|First Intervention (4 Weeks)||27
3367707|NCT03865953|4099229|FG000|NOT COMPLETED|First Intervention (4 Weeks)||2
3367708|NCT03865953|4099230|FG001|NOT COMPLETED|First Intervention (4 Weeks)||1
3367709|NCT03865953|4099229|FG000|STARTED|Washout/Baseline Period (3 Weeks)||23
3367710|NCT03865953|4099230|FG001|STARTED|Washout/Baseline Period (3 Weeks)||27
3367711|NCT03865953|4099229|FG000|COMPLETED|Washout/Baseline Period (3 Weeks)||23
3367712|NCT03865953|4099230|FG001|COMPLETED|Washout/Baseline Period (3 Weeks)||27
3367713|NCT03865953|4099229|FG000|NOT COMPLETED|Washout/Baseline Period (3 Weeks)||0
3367714|NCT03865953|4099230|FG001|NOT COMPLETED|Washout/Baseline Period (3 Weeks)||0
3367715|NCT03865953|4099229|FG000|STARTED|Second Intervention (4 Weeks)||23
3367716|NCT03865953|4099230|FG001|STARTED|Second Intervention (4 Weeks)||27
3367717|NCT03865953|4099229|FG000|COMPLETED|Second Intervention (4 Weeks)||23
3367718|NCT03865953|4099230|FG001|COMPLETED|Second Intervention (4 Weeks)||25
3367719|NCT03865953|4099229|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||0
3367720|NCT03865953|4099230|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||2
3220794|NCT02278003|3952464|FG001|COMPLETED|Overall Study||20
3220795|NCT02278003|3952463|FG000|NOT COMPLETED|Overall Study||19
3220796|NCT02278003|3952464|FG001|NOT COMPLETED|Overall Study||0
3220797|NCT02278146|3952472|FG000|STARTED|Overall Study||6
3220798|NCT02278146|3952473|FG001|STARTED|Overall Study||10
3220799|NCT02278146|3952472|FG000|COMPLETED|Overall Study||6
3220800|NCT02278146|3952473|FG001|COMPLETED|Overall Study||8
3220801|NCT02278146|3952472|FG000|NOT COMPLETED|Overall Study||0
3220802|NCT02278146|3952473|FG001|NOT COMPLETED|Overall Study||2
3220803|NCT02278237|3952479|FG000|STARTED|Overall Study||90
3220804|NCT02278237|3952479|FG000|COMPLETED|Overall Study||83
3220805|NCT02278237|3952479|FG000|NOT COMPLETED|Overall Study||7
3220806|NCT02278263|3952486|FG000|STARTED|Overall Study||30
3220807|NCT02278263|3952487|FG001|STARTED|Overall Study||60
3220808|NCT02278263|3952488|FG002|STARTED|Overall Study||60
3220809|NCT02278263|3952486|FG000|COMPLETED|Overall Study||23
3220810|NCT02278263|3952487|FG001|COMPLETED|Overall Study|Correction|60
3220811|NCT02278263|3952488|FG002|COMPLETED|Overall Study||51
3220812|NCT02278263|3952486|FG000|NOT COMPLETED|Overall Study||7
3220813|NCT02278263|3952487|FG001|NOT COMPLETED|Overall Study||0
3220814|NCT02278263|3952488|FG002|NOT COMPLETED|Overall Study||9
3220815|NCT02278289|3952501|FG000|STARTED|Overall Study||30
3220816|NCT02278289|3952502|FG001|STARTED|Overall Study||30
3220817|NCT02278289|3952501|FG000|COMPLETED|Overall Study||24
3220818|NCT02278289|3952502|FG001|COMPLETED|Overall Study||23
3220819|NCT02278289|3952501|FG000|NOT COMPLETED|Overall Study||6
3220820|NCT02278289|3952502|FG001|NOT COMPLETED|Overall Study||7
3220821|NCT02278328|3952508|FG000|STARTED|Neuropsych Screening||10
3220822|NCT02278328|3952509|FG001|STARTED|Neuropsych Screening||7
3220823|NCT02278328|3952510|FG002|STARTED|Neuropsych Screening||8
3220824|NCT02278328|3952508|FG000|COMPLETED|Neuropsych Screening||9
3220825|NCT02278328|3952509|FG001|COMPLETED|Neuropsych Screening||6
3220826|NCT02278328|3952510|FG002|COMPLETED|Neuropsych Screening||6
3220827|NCT02278328|3952508|FG000|NOT COMPLETED|Neuropsych Screening||1
3220828|NCT02278328|3952509|FG001|NOT COMPLETED|Neuropsych Screening||1
3220829|NCT02278328|3952510|FG002|NOT COMPLETED|Neuropsych Screening||2
3220830|NCT02278328|3952508|FG000|STARTED|First Intervention (1 Day)||9
3220831|NCT02278328|3952509|FG001|STARTED|First Intervention (1 Day)||6
3220832|NCT02278328|3952510|FG002|STARTED|First Intervention (1 Day)||6
3220833|NCT02278328|3952508|FG000|COMPLETED|First Intervention (1 Day)||9
3220834|NCT02278328|3952509|FG001|COMPLETED|First Intervention (1 Day)||6
3220835|NCT02278328|3952510|FG002|COMPLETED|First Intervention (1 Day)||6
3220836|NCT02278328|3952508|FG000|NOT COMPLETED|First Intervention (1 Day)||0
3220837|NCT02278328|3952509|FG001|NOT COMPLETED|First Intervention (1 Day)||0
3220838|NCT02278328|3952510|FG002|NOT COMPLETED|First Intervention (1 Day)||0
3220839|NCT02278328|3952508|FG000|STARTED|Washout (1 Week)||9
3220840|NCT02278328|3952509|FG001|STARTED|Washout (1 Week)||6
3220841|NCT02278328|3952510|FG002|STARTED|Washout (1 Week)||6
3220842|NCT02278328|3952508|FG000|COMPLETED|Washout (1 Week)||9
3220843|NCT02278328|3952509|FG001|COMPLETED|Washout (1 Week)||6
3220844|NCT02278328|3952510|FG002|COMPLETED|Washout (1 Week)||6
3220845|NCT02278328|3952508|FG000|NOT COMPLETED|Washout (1 Week)||0
3220846|NCT02278328|3952509|FG001|NOT COMPLETED|Washout (1 Week)||0
3220847|NCT02278328|3952510|FG002|NOT COMPLETED|Washout (1 Week)||0
3220848|NCT02278328|3952508|FG000|STARTED|Second Intervention (1 Day)||9
3220849|NCT02278328|3952509|FG001|STARTED|Second Intervention (1 Day)||6
3220850|NCT02278328|3952510|FG002|STARTED|Second Intervention (1 Day)||6
3220851|NCT02278328|3952508|FG000|COMPLETED|Second Intervention (1 Day)||9
3220852|NCT02278328|3952509|FG001|COMPLETED|Second Intervention (1 Day)||6
3220853|NCT02278328|3952510|FG002|COMPLETED|Second Intervention (1 Day)||6
3220854|NCT02278328|3952508|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
3220855|NCT02278328|3952509|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
3220856|NCT02278328|3952510|FG002|NOT COMPLETED|Second Intervention (1 Day)||0
3220857|NCT02278328|3952508|FG000|STARTED|Second Washout (1 Week)||9
3220858|NCT02278328|3952509|FG001|STARTED|Second Washout (1 Week)||6
3220859|NCT02278328|3952510|FG002|STARTED|Second Washout (1 Week)||6
3220860|NCT02278328|3952508|FG000|COMPLETED|Second Washout (1 Week)||9
3220861|NCT02278328|3952509|FG001|COMPLETED|Second Washout (1 Week)||6
3220862|NCT02278328|3952510|FG002|COMPLETED|Second Washout (1 Week)||6
3220863|NCT02278328|3952508|FG000|NOT COMPLETED|Second Washout (1 Week)||0
3220864|NCT02278328|3952509|FG001|NOT COMPLETED|Second Washout (1 Week)||0
3220865|NCT02278328|3952510|FG002|NOT COMPLETED|Second Washout (1 Week)||0
3220866|NCT02278328|3952508|FG000|STARTED|Third Intervention (1 Day)||9
3220867|NCT02278328|3952509|FG001|STARTED|Third Intervention (1 Day)||6
3220868|NCT02278328|3952510|FG002|STARTED|Third Intervention (1 Day)||6
3220869|NCT02278328|3952508|FG000|COMPLETED|Third Intervention (1 Day)||9
3220870|NCT02278328|3952509|FG001|COMPLETED|Third Intervention (1 Day)||6
3220871|NCT02278328|3952510|FG002|COMPLETED|Third Intervention (1 Day)||6
3220872|NCT02278328|3952508|FG000|NOT COMPLETED|Third Intervention (1 Day)||0
3220873|NCT02278328|3952509|FG001|NOT COMPLETED|Third Intervention (1 Day)||0
3220874|NCT02278328|3952510|FG002|NOT COMPLETED|Third Intervention (1 Day)||0
3220875|NCT02278328|3952508|FG000|STARTED|Third Washout (1 Week)||9
3220876|NCT02278328|3952509|FG001|STARTED|Third Washout (1 Week)||6
3220877|NCT02278328|3952510|FG002|STARTED|Third Washout (1 Week)||6
3220878|NCT02278328|3952508|FG000|COMPLETED|Third Washout (1 Week)||9
3220879|NCT02278328|3952509|FG001|COMPLETED|Third Washout (1 Week)||6
3220880|NCT02278328|3952510|FG002|COMPLETED|Third Washout (1 Week)||6
3220881|NCT02278328|3952508|FG000|NOT COMPLETED|Third Washout (1 Week)||0
3220882|NCT02278328|3952509|FG001|NOT COMPLETED|Third Washout (1 Week)||0
3220883|NCT02278328|3952510|FG002|NOT COMPLETED|Third Washout (1 Week)||0
3220884|NCT02278341|3952518|FG000|STARTED|Overall Study||415
3220885|NCT02278341|3952519|FG001|STARTED|Overall Study||421
3220886|NCT02278341|3952518|FG000|Received Treatment|Overall Study||414
3220887|NCT02278341|3952519|FG001|Received Treatment|Overall Study||420
3220888|NCT02278341|3952518|FG000|COMPLETED|Overall Study||297
3220889|NCT02278341|3952519|FG001|COMPLETED|Overall Study||329
3220890|NCT02278341|3952518|FG000|NOT COMPLETED|Overall Study||118
3220891|NCT02278341|3952519|FG001|NOT COMPLETED|Overall Study||92
3220892|NCT02278354|3952528|FG000|STARTED|Overall Study||12
3220893|NCT02278354|3952529|FG001|STARTED|Overall Study||23
3220894|NCT02278354|3952528|FG000|Flortaucipir PET Scan|Overall Study||10
3220895|NCT02278354|3952529|FG001|Flortaucipir PET Scan|Overall Study||20
3220896|NCT02278354|3952528|FG000|COMPLETED|Overall Study||8
3220897|NCT02278354|3952529|FG001|COMPLETED|Overall Study||20
3220898|NCT02278354|3952528|FG000|NOT COMPLETED|Overall Study||4
3220899|NCT02278354|3952529|FG001|NOT COMPLETED|Overall Study||3
3220900|NCT02278367|3952539|FG000|STARTED|Overall Study||69
3220901|NCT02278367|3952540|FG001|STARTED|Overall Study||110
3220902|NCT02278367|3952539|FG000|COMPLETED|Overall Study||59
3220903|NCT02278367|3952540|FG001|COMPLETED|Overall Study||110
3220904|NCT02278367|3952539|FG000|NOT COMPLETED|Overall Study||10
3220905|NCT02278367|3952540|FG001|NOT COMPLETED|Overall Study||0
3220906|NCT02278471|3952548|FG000|STARTED|Overall Study||155
3220907|NCT02278471|3952549|FG001|STARTED|Overall Study||148
3220908|NCT02278471|3952548|FG000|COMPLETED|Overall Study||147
3220909|NCT02278471|3952549|FG001|COMPLETED|Overall Study||128
3220910|NCT02278471|3952548|FG000|NOT COMPLETED|Overall Study||8
3220911|NCT02278471|3952549|FG001|NOT COMPLETED|Overall Study||20
3220912|NCT02278484|3952556|FG000|STARTED|Overall Study||50
3220913|NCT02278484|3952556|FG000|COMPLETED|Overall Study||50
3220914|NCT02278484|3952556|FG000|NOT COMPLETED|Overall Study||0
3220915|NCT02278562|3952564|FG000|STARTED|Overall Study||9
3220916|NCT02278562|3952565|FG001|STARTED|Overall Study||7
3220917|NCT02278562|3952566|FG002|STARTED|Overall Study||8
3220918|NCT02278562|3952564|FG000|COMPLETED|Overall Study||9
3220919|NCT02278562|3952565|FG001|COMPLETED|Overall Study||7
3220920|NCT02278562|3952566|FG002|COMPLETED|Overall Study||8
3220921|NCT02278562|3952564|FG000|NOT COMPLETED|Overall Study||0
3220922|NCT02278562|3952565|FG001|NOT COMPLETED|Overall Study||0
3220923|NCT02278562|3952566|FG002|NOT COMPLETED|Overall Study||0
3220924|NCT02278614|3952576|FG000|STARTED|Overall Study||127
3220925|NCT02278614|3952577|FG001|STARTED|Overall Study||115
3220926|NCT02278614|3952576|FG000|COMPLETED|Overall Study||122
3220927|NCT02278614|3952577|FG001|COMPLETED|Overall Study||110
3220928|NCT02278614|3952576|FG000|NOT COMPLETED|Overall Study||5
3220929|NCT02278614|3952577|FG001|NOT COMPLETED|Overall Study||5
3220930|NCT02278640|3952583|FG000|STARTED|Overall Study||40
3220931|NCT02278640|3952583|FG000|COMPLETED|Overall Study||40
3220932|NCT02278640|3952583|FG000|NOT COMPLETED|Overall Study||0
3220933|NCT02278783|3952587|FG000|STARTED|Overall Study||1
3220934|NCT02278783|3952587|FG000|COMPLETED|Overall Study||1
3220935|NCT02278783|3952587|FG000|NOT COMPLETED|Overall Study||0
3220936|NCT02278939|3952593|FG000|STARTED|Overall Study||33
3220937|NCT02278939|3952594|FG001|STARTED|Overall Study||34
3220938|NCT02278939|3952593|FG000|COMPLETED|Overall Study||28
3220939|NCT02278939|3952594|FG001|COMPLETED|Overall Study||33
3220940|NCT02278939|3952593|FG000|NOT COMPLETED|Overall Study||5
3220941|NCT02278939|3952594|FG001|NOT COMPLETED|Overall Study||1
3220942|NCT02278952|3952600|FG000|STARTED|Overall Study|The number of biopsy procedures performed during the time the patient was enrolled in the study.|50
3220943|NCT02278952|3952600|FG000|COMPLETED|Overall Study|The number of biopsy samples assayed during the time the patient was enrolled in the study.|44
3220944|NCT02278952|3952600|FG000|NOT COMPLETED|Overall Study||6
3220945|NCT02279043|3952613|FG000|STARTED|Overall Study||175
3220946|NCT02279043|3952614|FG001|STARTED|Overall Study||315
3220947|NCT02279043|3952615|FG002|STARTED|Overall Study||140
3220948|NCT02279043|3952613|FG000|COMPLETED|Overall Study||128
3220949|NCT02279043|3952614|FG001|COMPLETED|Overall Study||226
3220950|NCT02279043|3952615|FG002|COMPLETED|Overall Study||140
3220951|NCT02279043|3952613|FG000|NOT COMPLETED|Overall Study||47
3220952|NCT02279043|3952614|FG001|NOT COMPLETED|Overall Study||89
3220953|NCT02279043|3952615|FG002|NOT COMPLETED|Overall Study||0
3220954|NCT02279082|3952621|FG000|STARTED|Overall Study|Intentions were to have 173 participants, but only 167 participants received study drug.|167
3220955|NCT02279082|3952621|FG000|COMPLETED|Overall Study||134
3220956|NCT02279082|3952621|FG000|NOT COMPLETED|Overall Study||33
3220957|NCT02279108|3952627|FG000|STARTED|Overall Study||50
3220958|NCT02279108|3952628|FG001|STARTED|Overall Study||50
3367721|NCT03865381|4099236|FG000|STARTED|Overall Study||60
3367722|NCT03865381|4099236|FG000|COMPLETED|Overall Study||55
3367723|NCT03865381|4099236|FG000|NOT COMPLETED|Overall Study||5
3367724|NCT03865446|4099242|FG000|STARTED|Overall Study||8
3367725|NCT03865446|4099243|FG001|STARTED|Overall Study||8
3367726|NCT03865446|4099242|FG000|COMPLETED|Overall Study||8
3367727|NCT03865446|4099243|FG001|COMPLETED|Overall Study||8
3367728|NCT03865446|4099242|FG000|NOT COMPLETED|Overall Study||0
3367729|NCT03865446|4099243|FG001|NOT COMPLETED|Overall Study||0
3367730|NCT03862027|4099249|FG000|STARTED|Overall Study||1
3367731|NCT03862027|4099249|FG000|COMPLETED|Overall Study||1
3367732|NCT03862027|4099249|FG000|NOT COMPLETED|Overall Study||0
3220959|NCT02279108|3952627|FG000|COMPLETED|Overall Study||50
3220960|NCT02279108|3952628|FG001|COMPLETED|Overall Study||49
3220961|NCT02279108|3952627|FG000|NOT COMPLETED|Overall Study||0
3220962|NCT02279108|3952628|FG001|NOT COMPLETED|Overall Study||1
3220963|NCT02279160|3952636|FG000|STARTED|Overall Study||40
3220964|NCT02279160|3952637|FG001|STARTED|Overall Study||21
3220965|NCT02279160|3952636|FG000|COMPLETED|Overall Study||34
3220966|NCT02279160|3952637|FG001|COMPLETED|Overall Study||19
3220967|NCT02279160|3952636|FG000|NOT COMPLETED|Overall Study||6
3220968|NCT02279160|3952637|FG001|NOT COMPLETED|Overall Study||2
3220969|NCT02279173|3952643|FG000|STARTED|Overall Study||203
3220970|NCT02279173|3952643|FG000|Received Treatment|Overall Study||203
3220971|NCT02279173|3952643|FG000|Enrolled Under Protocol Supplement|Overall Study||79
3220972|NCT02279173|3952643|FG000|COMPLETED|Overall Study||109
3220973|NCT02279173|3952643|FG000|NOT COMPLETED|Overall Study||94
3220974|NCT02279407|3952653|FG000|STARTED|Overall Study||22
3220975|NCT02279407|3952654|FG001|STARTED|Overall Study||21
3220976|NCT02279407|3952655|FG002|STARTED|Overall Study||20
3220977|NCT02279407|3952656|FG003|STARTED|Overall Study||21
3220978|NCT02279407|3952653|FG000|COMPLETED|Overall Study||20
3220979|NCT02279407|3952654|FG001|COMPLETED|Overall Study||20
3220980|NCT02279407|3952655|FG002|COMPLETED|Overall Study||15
3220981|NCT02279407|3952656|FG003|COMPLETED|Overall Study||20
3220982|NCT02279407|3952653|FG000|NOT COMPLETED|Overall Study||2
3220983|NCT02279407|3952654|FG001|NOT COMPLETED|Overall Study||1
3220984|NCT02279407|3952655|FG002|NOT COMPLETED|Overall Study||5
3220985|NCT02279407|3952656|FG003|NOT COMPLETED|Overall Study||1
3220986|NCT02279420|3952666|FG000|STARTED|Overall Study||73
3220987|NCT02279420|3952666|FG000|COMPLETED|Overall Study||50
3220988|NCT02279420|3952666|FG000|NOT COMPLETED|Overall Study||23
3220989|NCT02279498|3952672|FG000|STARTED|Overall Study||65
3220990|NCT02279498|3952673|FG001|STARTED|Overall Study||63
3220991|NCT02279498|3952672|FG000|COMPLETED|Overall Study||47
3220992|NCT02279498|3952673|FG001|COMPLETED|Overall Study||59
3220993|NCT02279498|3952672|FG000|NOT COMPLETED|Overall Study||18
3220994|NCT02279498|3952673|FG001|NOT COMPLETED|Overall Study||4
3220995|NCT02279524|3952683|FG000|STARTED|Overall Study||98
3220996|NCT02279524|3952684|FG001|STARTED|Overall Study||101
3220997|NCT02279524|3952685|FG002|STARTED|Overall Study||48
3220998|NCT02279524|3952683|FG000|COMPLETED|Overall Study||88
3220999|NCT02279524|3952684|FG001|COMPLETED|Overall Study||90
3221000|NCT02279524|3952685|FG002|COMPLETED|Overall Study||41
3221001|NCT02279524|3952683|FG000|NOT COMPLETED|Overall Study||10
3221002|NCT02279524|3952684|FG001|NOT COMPLETED|Overall Study||11
3221003|NCT02279524|3952685|FG002|NOT COMPLETED|Overall Study||7
3221004|NCT02279641|3952695|FG000|STARTED|Overall Study||6
3221005|NCT02279641|3952696|FG001|STARTED|Overall Study||6
3221006|NCT02279641|3952695|FG000|COMPLETED|Overall Study||6
3221007|NCT02279641|3952696|FG001|COMPLETED|Overall Study||6
3221008|NCT02279641|3952695|FG000|NOT COMPLETED|Overall Study||0
3221009|NCT02279641|3952696|FG001|NOT COMPLETED|Overall Study||0
3221010|NCT02279667|3952715|FG000|STARTED|Overall Study||6
3221011|NCT02279667|3952716|FG001|STARTED|Overall Study||6
3221012|NCT02279667|3952717|FG002|STARTED|Overall Study||6
3221013|NCT02279667|3952715|FG000|COMPLETED|Overall Study||6
3221014|NCT02279667|3952716|FG001|COMPLETED|Overall Study||6
3221015|NCT02279667|3952717|FG002|COMPLETED|Overall Study||6
3221016|NCT02279667|3952715|FG000|NOT COMPLETED|Overall Study||0
3221017|NCT02279667|3952716|FG001|NOT COMPLETED|Overall Study||0
3221018|NCT02279667|3952717|FG002|NOT COMPLETED|Overall Study||0
3221019|NCT02279719|3952733|FG000|STARTED|Overall Study||5
3221020|NCT02279719|3952734|FG001|STARTED|Overall Study||10
3221021|NCT02279719|3952735|FG002|STARTED|Overall Study||4
3221022|NCT02279719|3952736|FG003|STARTED|Overall Study||9
3221023|NCT02279719|3952737|FG004|STARTED|Overall Study||28
3221024|NCT02279719|3952738|FG005|STARTED|Overall Study||10
3221025|NCT02279719|3952739|FG006|STARTED|Overall Study||31
3221026|NCT02279719|3952733|FG000|COMPLETED|Overall Study||5
3221027|NCT02279719|3952734|FG001|COMPLETED|Overall Study||10
3221028|NCT02279719|3952735|FG002|COMPLETED|Overall Study||4
3221029|NCT02279719|3952736|FG003|COMPLETED|Overall Study||9
3221030|NCT02279719|3952737|FG004|COMPLETED|Overall Study||25
3221031|NCT02279719|3952738|FG005|COMPLETED|Overall Study||10
3221032|NCT02279719|3952739|FG006|COMPLETED|Overall Study||28
3221033|NCT02279719|3952733|FG000|NOT COMPLETED|Overall Study||0
3221034|NCT02279719|3952734|FG001|NOT COMPLETED|Overall Study||0
3367733|NCT03859960|4099255|FG000|STARTED|Overall Study||14
3367734|NCT03859960|4099256|FG001|STARTED|Overall Study||19
3221035|NCT02279719|3952735|FG002|NOT COMPLETED|Overall Study||0
3221036|NCT02279719|3952736|FG003|NOT COMPLETED|Overall Study||0
3221037|NCT02279719|3952737|FG004|NOT COMPLETED|Overall Study||3
3221038|NCT02279719|3952738|FG005|NOT COMPLETED|Overall Study||0
3221039|NCT02279719|3952739|FG006|NOT COMPLETED|Overall Study||3
3221040|NCT02279732|3952774|FG000|STARTED|Overall Study||98
3221041|NCT02279732|3952775|FG001|STARTED|Overall Study||106
3221042|NCT02279732|3952774|FG000|COMPLETED|Overall Study||0
3221043|NCT02279732|3952775|FG001|COMPLETED|Overall Study||0
3221044|NCT02279732|3952774|FG000|NOT COMPLETED|Overall Study||98
3221045|NCT02279732|3952775|FG001|NOT COMPLETED|Overall Study||106
3221046|NCT02279862|3952783|FG000|STARTED|Overall Study||26
3221047|NCT02279862|3952784|FG001|STARTED|Overall Study||27
3221048|NCT02279862|3952783|FG000|Treated|Overall Study||25
3221049|NCT02279862|3952784|FG001|Treated|Overall Study||26
3367735|NCT03859960|4099255|FG000|COMPLETED|Overall Study||14
3221050|NCT02279862|3952783|FG000|COMPLETED|Overall Study|Completed treatment in induction period|0
3221051|NCT02279862|3952784|FG001|COMPLETED|Overall Study|Completed treatment in induction period|2
3221052|NCT02279862|3952783|FG000|NOT COMPLETED|Overall Study||26
3221053|NCT02279862|3952784|FG001|NOT COMPLETED|Overall Study||25
3221054|NCT02280044|3952792|FG000|STARTED|Overall Study||15
3221055|NCT02280044|3952793|FG001|STARTED|Overall Study||15
3221056|NCT02280044|3952792|FG000|COMPLETED|Overall Study||15
3221057|NCT02280044|3952793|FG001|COMPLETED|Overall Study||13
3221058|NCT02280044|3952792|FG000|NOT COMPLETED|Overall Study||0
3221059|NCT02280044|3952793|FG001|NOT COMPLETED|Overall Study||2
3221060|NCT02280096|3952801|FG000|STARTED|Overall Study||13
3221061|NCT02280096|3952802|FG001|STARTED|Overall Study||11
3221062|NCT02280096|3952801|FG000|COMPLETED|Overall Study||11
3221063|NCT02280096|3952802|FG001|COMPLETED|Overall Study||10
3221064|NCT02280096|3952801|FG000|NOT COMPLETED|Overall Study||2
3221065|NCT02280096|3952802|FG001|NOT COMPLETED|Overall Study||1
3221066|NCT02280122|3952819|FG000|STARTED|Overall Study||15
3221067|NCT02280122|3952820|FG001|STARTED|Overall Study||15
3221068|NCT02280122|3952821|FG002|STARTED|Overall Study||30
3221069|NCT02280122|3952819|FG000|COMPLETED|Overall Study||15
3221070|NCT02280122|3952820|FG001|COMPLETED|Overall Study||15
3221071|NCT02280122|3952821|FG002|COMPLETED|Overall Study||30
3221072|NCT02280122|3952819|FG000|NOT COMPLETED|Overall Study||0
3221073|NCT02280122|3952820|FG001|NOT COMPLETED|Overall Study||0
3221074|NCT02280122|3952821|FG002|NOT COMPLETED|Overall Study||0
3221075|NCT02280187|3952827|FG000|STARTED|Overall Study||400
3221076|NCT02280187|3952827|FG000|COMPLETED|Overall Study||182
3221077|NCT02280187|3952827|FG000|NOT COMPLETED|Overall Study||218
3221078|NCT02280200|3952833|FG000|STARTED|Overall Study||15
3221079|NCT02280200|3952834|FG001|STARTED|Overall Study||13
3221080|NCT02280200|3952833|FG000|COMPLETED|Overall Study||12
3221081|NCT02280200|3952834|FG001|COMPLETED|Overall Study||10
3221082|NCT02280200|3952833|FG000|NOT COMPLETED|Overall Study||3
3221083|NCT02280200|3952834|FG001|NOT COMPLETED|Overall Study||3
3221084|NCT02280226|3952840|FG000|STARTED|Overall Study||17
3221085|NCT02280226|3952840|FG000|COMPLETED|Overall Study||17
3221086|NCT02280226|3952840|FG000|NOT COMPLETED|Overall Study||0
3221087|NCT02280291|3952848|FG000|STARTED|Overall Study||25
3221088|NCT02280291|3952849|FG001|STARTED|Overall Study||25
3221089|NCT02280291|3952850|FG002|STARTED|Overall Study||24
3367736|NCT03859960|4099256|FG001|COMPLETED|Overall Study||19
3367737|NCT03859960|4099255|FG000|NOT COMPLETED|Overall Study||0
3367738|NCT03859960|4099256|FG001|NOT COMPLETED|Overall Study||0
3367739|NCT03868059|4099264|FG000|STARTED|Overall Study||138
3367740|NCT03868059|4099264|FG000|COMPLETED|Overall Study||126
3367741|NCT03868059|4099264|FG000|NOT COMPLETED|Overall Study||12
3367742|NCT03850444|4099270|FG000|STARTED|Overall Study||128
3367743|NCT03850444|4099271|FG001|STARTED|Overall Study||134
3367744|NCT03850444|4099270|FG000|COMPLETED|Overall Study||0
3367745|NCT03850444|4099271|FG001|COMPLETED|Overall Study||0
3367746|NCT03850444|4099270|FG000|NOT COMPLETED|Overall Study||128
3367747|NCT03850444|4099271|FG001|NOT COMPLETED|Overall Study||134
3367748|NCT03868254|4099279|FG000|STARTED|Overall Study||98
3367749|NCT03868254|4099280|FG001|STARTED|Overall Study||76
3367750|NCT03868254|4099279|FG000|COMPLETED|Overall Study||98
3367751|NCT03868254|4099280|FG001|COMPLETED|Overall Study||76
3367752|NCT03868254|4099279|FG000|NOT COMPLETED|Overall Study||0
3367753|NCT03868254|4099280|FG001|NOT COMPLETED|Overall Study||0
3367754|NCT03865407|4099288|FG000|STARTED|Overall Study||10
3367755|NCT03865407|4099289|FG001|STARTED|Overall Study||7
3367756|NCT03865407|4099288|FG000|COMPLETED|Overall Study||7
3367757|NCT03865407|4099289|FG001|COMPLETED|Overall Study||7
3367758|NCT03865407|4099288|FG000|NOT COMPLETED|Overall Study||3
3367759|NCT03865407|4099289|FG001|NOT COMPLETED|Overall Study||0
3367760|NCT03857230|4099297|FG000|STARTED|Period 1 (Primapur-Gonal-F)||12
3367761|NCT03857230|4099298|FG001|STARTED|Period 1 (Primapur-Gonal-F)||12
3367762|NCT03857230|4099297|FG000|COMPLETED|Period 1 (Primapur-Gonal-F)||12
3367763|NCT03857230|4099298|FG001|COMPLETED|Period 1 (Primapur-Gonal-F)||12
3367764|NCT03857230|4099297|FG000|NOT COMPLETED|Period 1 (Primapur-Gonal-F)||0
3367765|NCT03857230|4099298|FG001|NOT COMPLETED|Period 1 (Primapur-Gonal-F)||0
3367766|NCT03857230|4099297|FG000|STARTED|Period 2 (Gonal-F-Primapur)||12
3221090|NCT02280291|3952851|FG003|STARTED|Overall Study||26
3221091|NCT02280291|3952848|FG000|COMPLETED|Overall Study||21
3221092|NCT02280291|3952849|FG001|COMPLETED|Overall Study||23
3221093|NCT02280291|3952850|FG002|COMPLETED|Overall Study||21
3221094|NCT02280291|3952851|FG003|COMPLETED|Overall Study||18
3221095|NCT02280291|3952848|FG000|NOT COMPLETED|Overall Study||4
3221096|NCT02280291|3952849|FG001|NOT COMPLETED|Overall Study||2
3221097|NCT02280291|3952850|FG002|NOT COMPLETED|Overall Study||3
3221098|NCT02280291|3952851|FG003|NOT COMPLETED|Overall Study||8
3221099|NCT02280304|3952865|FG000|STARTED|Overall Study||19
3221100|NCT02280304|3952866|FG001|STARTED|Overall Study||18
3221101|NCT02280304|3952865|FG000|COMPLETED|Overall Study||12
3221102|NCT02280304|3952866|FG001|COMPLETED|Overall Study|A non completer received the allocated intervention before being lost to follow-up.|10
3221103|NCT02280304|3952865|FG000|NOT COMPLETED|Overall Study||7
3221104|NCT02280304|3952866|FG001|NOT COMPLETED|Overall Study||8
3221105|NCT02280317|3952884|FG000|STARTED|Overall Study|Patients receiving at least one dose.|1
3221106|NCT02280317|3952885|FG001|STARTED|Overall Study|Patients receiving at least one dose.|1
3221107|NCT02280317|3952886|FG002|STARTED|Overall Study|Patients receiving at least one dose.|3
3221108|NCT02280317|3952887|FG003|STARTED|Overall Study|Patients receiving at least one dose.|5
3221109|NCT02280317|3952888|FG004|STARTED|Overall Study|Patients receiving at least one dose.|2
3221110|NCT02280317|3952884|FG000|COMPLETED|Overall Study|Patients completing six cycles.|1
3221111|NCT02280317|3952885|FG001|COMPLETED|Overall Study|Patients completing six cycles.|1
3221112|NCT02280317|3952886|FG002|COMPLETED|Overall Study|Patients completing six cycles.|0
3221113|NCT02280317|3952887|FG003|COMPLETED|Overall Study|Patients completing six cycles.|2
3221114|NCT02280317|3952888|FG004|COMPLETED|Overall Study|Patients completing six cycles.|0
3221115|NCT02280317|3952884|FG000|NOT COMPLETED|Overall Study||0
3221116|NCT02280317|3952885|FG001|NOT COMPLETED|Overall Study||0
3221117|NCT02280317|3952886|FG002|NOT COMPLETED|Overall Study||3
3221118|NCT02280317|3952887|FG003|NOT COMPLETED|Overall Study||3
3221119|NCT02280317|3952888|FG004|NOT COMPLETED|Overall Study||2
3221120|NCT02280408|3952915|FG000|STARTED|Overall Study||10
3221121|NCT02280408|3952916|FG001|STARTED|Overall Study||10
3221122|NCT02280408|3952917|FG002|STARTED|Overall Study||10
3221123|NCT02280408|3952918|FG003|STARTED|Overall Study||9
3221124|NCT02280408|3952915|FG000|Vaccination 1|Overall Study||10
3221125|NCT02280408|3952916|FG001|Vaccination 1|Overall Study||10
3221126|NCT02280408|3952917|FG002|Vaccination 1|Overall Study||10
3221127|NCT02280408|3952918|FG003|Vaccination 1|Overall Study||9
3221128|NCT02280408|3952915|FG000|Vaccination 2|Overall Study||10
3221129|NCT02280408|3952916|FG001|Vaccination 2|Overall Study||10
3221130|NCT02280408|3952917|FG002|Vaccination 2|Overall Study||10
3221131|NCT02280408|3952918|FG003|Vaccination 2|Overall Study||9
3221132|NCT02280408|3952915|FG000|COMPLETED|Overall Study||10
3221133|NCT02280408|3952916|FG001|COMPLETED|Overall Study||8
3221134|NCT02280408|3952917|FG002|COMPLETED|Overall Study||10
3221135|NCT02280408|3952918|FG003|COMPLETED|Overall Study||9
3221136|NCT02280408|3952915|FG000|NOT COMPLETED|Overall Study||0
3221137|NCT02280408|3952916|FG001|NOT COMPLETED|Overall Study||2
3221138|NCT02280408|3952917|FG002|NOT COMPLETED|Overall Study||0
3221139|NCT02280408|3952918|FG003|NOT COMPLETED|Overall Study||0
3221140|NCT02280421|3952930|FG000|STARTED|First Intervention(2 Weeks)||12
3221141|NCT02280421|3952931|FG001|STARTED|First Intervention(2 Weeks)||12
3221142|NCT02280421|3952930|FG000|Received Intervention|First Intervention(2 Weeks)||12
3221143|NCT02280421|3952931|FG001|Received Intervention|First Intervention(2 Weeks)||12
3221144|NCT02280421|3952930|FG000|COMPLETED|First Intervention(2 Weeks)||12
3221145|NCT02280421|3952931|FG001|COMPLETED|First Intervention(2 Weeks)||12
3221146|NCT02280421|3952930|FG000|NOT COMPLETED|First Intervention(2 Weeks)||0
3221147|NCT02280421|3952931|FG001|NOT COMPLETED|First Intervention(2 Weeks)||0
3221148|NCT02280421|3952930|FG000|STARTED|Washout (2 Weeks)||12
3221149|NCT02280421|3952931|FG001|STARTED|Washout (2 Weeks)||12
3221150|NCT02280421|3952930|FG000|COMPLETED|Washout (2 Weeks)||11
3221151|NCT02280421|3952931|FG001|COMPLETED|Washout (2 Weeks)||11
3221152|NCT02280421|3952930|FG000|NOT COMPLETED|Washout (2 Weeks)||1
3221153|NCT02280421|3952931|FG001|NOT COMPLETED|Washout (2 Weeks)||1
3221154|NCT02280421|3952930|FG000|STARTED|Second Intervention(2 Weeks)||12
3221155|NCT02280421|3952931|FG001|STARTED|Second Intervention(2 Weeks)||12
3221156|NCT02280421|3952930|FG000|Received Intervention|Second Intervention(2 Weeks)||12
3221157|NCT02280421|3952931|FG001|Received Intervention|Second Intervention(2 Weeks)||12
3221158|NCT02280421|3952930|FG000|COMPLETED|Second Intervention(2 Weeks)||12
3221159|NCT02280421|3952931|FG001|COMPLETED|Second Intervention(2 Weeks)||12
3221160|NCT02280421|3952930|FG000|NOT COMPLETED|Second Intervention(2 Weeks)||0
3221161|NCT02280421|3952931|FG001|NOT COMPLETED|Second Intervention(2 Weeks)||0
3221162|NCT02280473|3952951|FG000|STARTED|Overall Study||94
3221163|NCT02280473|3952952|FG001|STARTED|Overall Study||94
3221164|NCT02280473|3952951|FG000|COMPLETED|Overall Study||93
3221165|NCT02280473|3952952|FG001|COMPLETED|Overall Study||91
3221166|NCT02280473|3952951|FG000|NOT COMPLETED|Overall Study||1
3221167|NCT02280473|3952952|FG001|NOT COMPLETED|Overall Study||3
3221168|NCT02280499|3952958|FG000|STARTED|Overall Study||87
3221169|NCT02280499|3952958|FG000|COMPLETED|Overall Study||26
3221170|NCT02280499|3952958|FG000|NOT COMPLETED|Overall Study||61
3221171|NCT02280655|3952964|FG000|STARTED|Overall Study||25
3221172|NCT02280655|3952965|FG001|STARTED|Overall Study||18
3221173|NCT02280655|3952964|FG000|COMPLETED|Overall Study||25
3221174|NCT02280655|3952965|FG001|COMPLETED|Overall Study||18
3221175|NCT02280655|3952964|FG000|NOT COMPLETED|Overall Study||0
3221176|NCT02280655|3952965|FG001|NOT COMPLETED|Overall Study||0
3221177|NCT02280811|3952976|FG000|STARTED|Drug Administration||1
3221178|NCT02280811|3952977|FG001|STARTED|Drug Administration||2
3221179|NCT02280811|3952978|FG002|STARTED|Drug Administration||1
3221180|NCT02280811|3952979|FG003|STARTED|Drug Administration||6
3221181|NCT02280811|3952980|FG004|STARTED|Drug Administration||2
3221182|NCT02280811|3952976|FG000|COMPLETED|Drug Administration||1
3221183|NCT02280811|3952977|FG001|COMPLETED|Drug Administration||2
3221184|NCT02280811|3952978|FG002|COMPLETED|Drug Administration||1
3221185|NCT02280811|3952979|FG003|COMPLETED|Drug Administration||6
3221186|NCT02280811|3952980|FG004|COMPLETED|Drug Administration||2
3221187|NCT02280811|3952976|FG000|NOT COMPLETED|Drug Administration||0
3221188|NCT02280811|3952977|FG001|NOT COMPLETED|Drug Administration||0
3221189|NCT02280811|3952978|FG002|NOT COMPLETED|Drug Administration||0
3221190|NCT02280811|3952979|FG003|NOT COMPLETED|Drug Administration||0
3221191|NCT02280811|3952980|FG004|NOT COMPLETED|Drug Administration||0
3221192|NCT02280811|3952976|FG000|STARTED|Retreated at the MTD||0
3221193|NCT02280811|3952977|FG001|STARTED|Retreated at the MTD||0
3221194|NCT02280811|3952978|FG002|STARTED|Retreated at the MTD||0
3221195|NCT02280811|3952979|FG003|STARTED|Retreated at the MTD||0
3221196|NCT02280811|3952980|FG004|STARTED|Retreated at the MTD|Patient originally started in Grp1(HPV-16 E6mTCR PBL 1x10^9+HD IL-2) and was retreated at the MTD.|1
3221197|NCT02280811|3952976|FG000|COMPLETED|Retreated at the MTD||0
3221198|NCT02280811|3952977|FG001|COMPLETED|Retreated at the MTD||0
3221199|NCT02280811|3952978|FG002|COMPLETED|Retreated at the MTD||0
3221200|NCT02280811|3952979|FG003|COMPLETED|Retreated at the MTD||0
3221201|NCT02280811|3952980|FG004|COMPLETED|Retreated at the MTD||1
3221202|NCT02280811|3952976|FG000|NOT COMPLETED|Retreated at the MTD||0
3221203|NCT02280811|3952977|FG001|NOT COMPLETED|Retreated at the MTD||0
3221204|NCT02280811|3952978|FG002|NOT COMPLETED|Retreated at the MTD||0
3221205|NCT02280811|3952979|FG003|NOT COMPLETED|Retreated at the MTD||0
3221206|NCT02280811|3952980|FG004|NOT COMPLETED|Retreated at the MTD||0
3221207|NCT02280863|3952996|FG000|STARTED|Android Platform||8
3221208|NCT02280863|3952997|FG001|STARTED|Android Platform||0
3221209|NCT02280863|3952996|FG000|COMPLETED|Android Platform||8
3221210|NCT02280863|3952997|FG001|COMPLETED|Android Platform||0
3221211|NCT02280863|3952996|FG000|NOT COMPLETED|Android Platform||0
3221212|NCT02280863|3952997|FG001|NOT COMPLETED|Android Platform||0
3221213|NCT02280863|3952996|FG000|STARTED|Integrated Platform|One additional participant was enrolled for part 2.|9
3221214|NCT02280863|3952997|FG001|STARTED|Integrated Platform||15
3221215|NCT02280863|3952996|FG000|COMPLETED|Integrated Platform||9
3221216|NCT02280863|3952997|FG001|COMPLETED|Integrated Platform||14
3221217|NCT02280863|3952996|FG000|NOT COMPLETED|Integrated Platform||0
3221218|NCT02280863|3952997|FG001|NOT COMPLETED|Integrated Platform||1
3221219|NCT02281136|3953007|FG000|STARTED|Overall Study||29
3221220|NCT02281136|3953007|FG000|COMPLETED|Overall Study||29
3221221|NCT02281136|3953007|FG000|NOT COMPLETED|Overall Study||0
3221222|NCT02281318|3953013|FG000|STARTED|Overall Study||277
3221223|NCT02281318|3953014|FG001|STARTED|Overall Study||274
3221224|NCT02281318|3953013|FG000|COMPLETED|Overall Study||263
3221225|NCT02281318|3953014|FG001|COMPLETED|Overall Study||269
3221226|NCT02281318|3953013|FG000|NOT COMPLETED|Overall Study||14
3221227|NCT02281318|3953014|FG001|NOT COMPLETED|Overall Study||5
3221228|NCT02281344|3953020|FG000|STARTED|Overall Study||6
3221229|NCT02281344|3953020|FG000|COMPLETED|Overall Study||6
3221230|NCT02281344|3953020|FG000|NOT COMPLETED|Overall Study||0
3221231|NCT02281357|3953026|FG000|STARTED|Overall Study||70
3221232|NCT02281357|3953027|FG001|STARTED|Overall Study||70
3221233|NCT02281357|3953026|FG000|COMPLETED|Overall Study||63
3221234|NCT02281357|3953027|FG001|COMPLETED|Overall Study||66
3221235|NCT02281357|3953026|FG000|NOT COMPLETED|Overall Study||7
3221236|NCT02281357|3953027|FG001|NOT COMPLETED|Overall Study||4
3221237|NCT02281409|3953037|FG000|STARTED|Overall Study||3
3221238|NCT02281409|3953038|FG001|STARTED|Overall Study||3
3221239|NCT02281409|3953039|FG002|STARTED|Overall Study||5
3221240|NCT02281409|3953040|FG003|STARTED|Overall Study||6
3221241|NCT02281409|3953037|FG000|COMPLETED|Overall Study||3
3221242|NCT02281409|3953038|FG001|COMPLETED|Overall Study||3
3221243|NCT02281409|3953039|FG002|COMPLETED|Overall Study||5
3221244|NCT02281409|3953040|FG003|COMPLETED|Overall Study||6
3221245|NCT02281409|3953037|FG000|NOT COMPLETED|Overall Study||0
3221246|NCT02281409|3953038|FG001|NOT COMPLETED|Overall Study||0
3221247|NCT02281409|3953039|FG002|NOT COMPLETED|Overall Study||0
3221248|NCT02281409|3953040|FG003|NOT COMPLETED|Overall Study||0
3221249|NCT02281422|3953056|FG000|STARTED|Overall Study||8
3221250|NCT02281422|3953057|FG001|STARTED|Overall Study||8
3221251|NCT02281422|3953058|FG002|STARTED|Overall Study||8
3221252|NCT02281422|3953059|FG003|STARTED|Overall Study||8
3221253|NCT02281422|3953060|FG004|STARTED|Overall Study||8
3221254|NCT02281422|3953056|FG000|COMPLETED|Overall Study||8
3221255|NCT02281422|3953057|FG001|COMPLETED|Overall Study||8
3221256|NCT02281422|3953058|FG002|COMPLETED|Overall Study||8
3221257|NCT02281422|3953059|FG003|COMPLETED|Overall Study||8
3221258|NCT02281422|3953060|FG004|COMPLETED|Overall Study||8
3221259|NCT02281422|3953056|FG000|NOT COMPLETED|Overall Study||0
3221260|NCT02281422|3953057|FG001|NOT COMPLETED|Overall Study||0
3221261|NCT02281422|3953058|FG002|NOT COMPLETED|Overall Study||0
3221262|NCT02281422|3953059|FG003|NOT COMPLETED|Overall Study||0
3221263|NCT02281422|3953060|FG004|NOT COMPLETED|Overall Study||0
3221264|NCT02281448|3953074|FG000|STARTED|Overall Study||10
3221265|NCT02281448|3953075|FG001|STARTED|Overall Study||10
3221266|NCT02281448|3953074|FG000|COMPLETED|Overall Study||8
3221267|NCT02281448|3953075|FG001|COMPLETED|Overall Study||9
3221268|NCT02281448|3953074|FG000|NOT COMPLETED|Overall Study||2
3221269|NCT02281448|3953075|FG001|NOT COMPLETED|Overall Study||1
3221270|NCT02281500|3953081|FG000|STARTED|Overall Study||22
3221271|NCT02281500|3953081|FG000|COMPLETED|Overall Study||22
3221272|NCT02281500|3953081|FG000|NOT COMPLETED|Overall Study||0
3221273|NCT02281526|3953087|FG000|STARTED|Overall Study||9
3221274|NCT02281526|3953088|FG001|STARTED|Overall Study||8
3221275|NCT02281526|3953087|FG000|COMPLETED|Overall Study||8
3221276|NCT02281526|3953088|FG001|COMPLETED|Overall Study||8
3221277|NCT02281526|3953087|FG000|NOT COMPLETED|Overall Study||1
3221278|NCT02281526|3953088|FG001|NOT COMPLETED|Overall Study||0
3221279|NCT02281552|3953096|FG000|STARTED|Overall Study||104
3221280|NCT02281552|3953097|FG001|STARTED|Overall Study||105
3221281|NCT02281552|3953096|FG000|COMPLETED|Overall Study||100
3221282|NCT02281552|3953097|FG001|COMPLETED|Overall Study||95
3221283|NCT02281552|3953096|FG000|NOT COMPLETED|Overall Study||4
3221284|NCT02281552|3953097|FG001|NOT COMPLETED|Overall Study||10
3221285|NCT02281591|3953107|FG000|STARTED|Overall Study||8
3221286|NCT02281591|3953108|FG001|STARTED|Overall Study||8
3221287|NCT02281591|3953109|FG002|STARTED|Overall Study||8
3221288|NCT02281591|3953110|FG003|STARTED|Overall Study||8
3221289|NCT02281591|3953107|FG000|COMPLETED|Overall Study||8
3221290|NCT02281591|3953108|FG001|COMPLETED|Overall Study||8
3221291|NCT02281591|3953109|FG002|COMPLETED|Overall Study||8
3221292|NCT02281591|3953110|FG003|COMPLETED|Overall Study||8
3221293|NCT02281591|3953107|FG000|NOT COMPLETED|Overall Study||0
3221294|NCT02281591|3953108|FG001|NOT COMPLETED|Overall Study||0
3221295|NCT02281591|3953109|FG002|NOT COMPLETED|Overall Study||0
3221296|NCT02281591|3953110|FG003|NOT COMPLETED|Overall Study||0
3221297|NCT02281760|3953120|FG000|STARTED|Overall Study||6
3221298|NCT02281760|3953120|FG000|COMPLETED|Overall Study||5
3221299|NCT02281760|3953120|FG000|NOT COMPLETED|Overall Study||1
3221300|NCT02281773|3953129|FG000|STARTED|Overall Study||87
3221301|NCT02281773|3953130|FG001|STARTED|Overall Study|Started are the treated patients|85
3221302|NCT02281773|3953131|FG002|STARTED|Overall Study||85
3221303|NCT02281773|3953132|FG003|STARTED|Overall Study||86
3221304|NCT02281773|3953133|FG004|STARTED|Overall Study|Started are the treated patients|173
3221305|NCT02281773|3953129|FG000|COMPLETED|Overall Study||76
3221306|NCT02281773|3953130|FG001|COMPLETED|Overall Study||70
3221307|NCT02281773|3953131|FG002|COMPLETED|Overall Study||67
3221308|NCT02281773|3953132|FG003|COMPLETED|Overall Study||65
3221309|NCT02281773|3953133|FG004|COMPLETED|Overall Study||143
3221310|NCT02281773|3953129|FG000|NOT COMPLETED|Overall Study||11
3221311|NCT02281773|3953130|FG001|NOT COMPLETED|Overall Study||15
3221312|NCT02281773|3953131|FG002|NOT COMPLETED|Overall Study||18
3221313|NCT02281773|3953132|FG003|NOT COMPLETED|Overall Study||21
3221314|NCT02281773|3953133|FG004|NOT COMPLETED|Overall Study||30
3221315|NCT02281851|3953147|FG000|STARTED|Overall Study||4
3221316|NCT02281851|3953148|FG001|STARTED|Overall Study||10
3221317|NCT02281851|3953147|FG000|COMPLETED|Overall Study||4
3221318|NCT02281851|3953148|FG001|COMPLETED|Overall Study||10
3221319|NCT02281851|3953147|FG000|NOT COMPLETED|Overall Study||0
3221320|NCT02281851|3953148|FG001|NOT COMPLETED|Overall Study||0
3221321|NCT02282111|3953156|FG000|STARTED|Overall Study||26
3221322|NCT02282111|3953157|FG001|STARTED|Overall Study||30
3221323|NCT02282111|3953156|FG000|COMPLETED|Overall Study||19
3221324|NCT02282111|3953157|FG001|COMPLETED|Overall Study||22
3221325|NCT02282111|3953156|FG000|NOT COMPLETED|Overall Study||7
3221326|NCT02282111|3953157|FG001|NOT COMPLETED|Overall Study||8
3221327|NCT02282163|3953163|FG000|STARTED|Overall Study||13
3221328|NCT02282163|3953163|FG000|COMPLETED|Overall Study||12
3221329|NCT02282163|3953163|FG000|NOT COMPLETED|Overall Study||1
3221330|NCT02282293|3953178|FG000|STARTED|Overall Study||100
3221331|NCT02282293|3953179|FG001|STARTED|Overall Study||100
3221332|NCT02282293|3953178|FG000|COMPLETED|Overall Study||97
3221333|NCT02282293|3953179|FG001|COMPLETED|Overall Study||97
3221334|NCT02282293|3953178|FG000|NOT COMPLETED|Overall Study||3
3221335|NCT02282293|3953179|FG001|NOT COMPLETED|Overall Study||3
3221336|NCT02282514|3953185|FG000|STARTED|Overall Study||23
3221337|NCT02282514|3953185|FG000|COMPLETED|Overall Study||23
3221338|NCT02282514|3953185|FG000|NOT COMPLETED|Overall Study||0
3221339|NCT02282527|3953191|FG000|STARTED|Overall Study||16
3221340|NCT02282527|3953192|FG001|STARTED|Overall Study||16
3221341|NCT02282527|3953191|FG000|COMPLETED|Overall Study||15
3221342|NCT02282527|3953192|FG001|COMPLETED|Overall Study||15
3221343|NCT02282527|3953191|FG000|NOT COMPLETED|Overall Study||1
3221344|NCT02282527|3953192|FG001|NOT COMPLETED|Overall Study||1
3221345|NCT02282605|3953204|FG000|STARTED|Overall Study||27
3221346|NCT02282605|3953205|FG001|STARTED|Overall Study||12
3221347|NCT02282605|3953206|FG002|STARTED|Overall Study||24
3221348|NCT02282605|3953204|FG000|COMPLETED|Overall Study||24
3221349|NCT02282605|3953205|FG001|COMPLETED|Overall Study||12
3221350|NCT02282605|3953206|FG002|COMPLETED|Overall Study||24
3221351|NCT02282605|3953204|FG000|NOT COMPLETED|Overall Study||3
3221352|NCT02282605|3953205|FG001|NOT COMPLETED|Overall Study||0
3221353|NCT02282605|3953206|FG002|NOT COMPLETED|Overall Study||0
3221354|NCT02282631|3953216|FG000|STARTED|Overall Study|The two dropouts happened on the 2nd and 3rd weeks post-baseline, respectively|14
3221355|NCT02282631|3953217|FG001|STARTED|Overall Study||15
3221356|NCT02282631|3953216|FG000|COMPLETED|Overall Study||12
3221357|NCT02282631|3953217|FG001|COMPLETED|Overall Study||15
3221358|NCT02282631|3953216|FG000|NOT COMPLETED|Overall Study||2
3221359|NCT02282631|3953217|FG001|NOT COMPLETED|Overall Study||0
3221360|NCT02282722|3953231|FG000|STARTED|Overall Study||94
3221361|NCT02282722|3953232|FG001|STARTED|Overall Study||92
3221362|NCT02282722|3953231|FG000|2-week Assessment|Overall Study||79
3221363|NCT02282722|3953232|FG001|2-week Assessment|Overall Study||75
3221364|NCT02282722|3953231|FG000|3-month Assessment|Overall Study||71
3221365|NCT02282722|3953232|FG001|3-month Assessment|Overall Study||73
3221366|NCT02282722|3953231|FG000|COMPLETED|Overall Study||71
3221367|NCT02282722|3953232|FG001|COMPLETED|Overall Study||73
3221368|NCT02282722|3953231|FG000|NOT COMPLETED|Overall Study||23
3221369|NCT02282722|3953232|FG001|NOT COMPLETED|Overall Study||19
3221370|NCT02282813|3953241|FG000|STARTED|Overall Study|ITT Population|103
3221371|NCT02282813|3953242|FG001|STARTED|Overall Study|ITT Population - not randomized or randomized to CTAP101 monotherapy|153
3221372|NCT02282813|3953243|FG002|STARTED|Overall Study|Randomization to take adjunctive treatment in addition to CTAP101 capsules began after week 12.|42
3221373|NCT02282813|3953241|FG000|COMPLETED|Overall Study||91
3221374|NCT02282813|3953242|FG001|COMPLETED|Overall Study||130
3221375|NCT02282813|3953243|FG002|COMPLETED|Overall Study||39
3221376|NCT02282813|3953241|FG000|NOT COMPLETED|Overall Study||12
3221377|NCT02282813|3953242|FG001|NOT COMPLETED|Overall Study||23
3221378|NCT02282813|3953243|FG002|NOT COMPLETED|Overall Study||3
3221379|NCT02282904|3953253|FG000|STARTED|Overall Study||7
3221380|NCT02282904|3953253|FG000|COMPLETED|Overall Study|Patient accrual was stopped early, and the protocol closed after completing followup|7
3221381|NCT02282904|3953253|FG000|NOT COMPLETED|Overall Study||0
3221382|NCT02282930|3953257|FG000|STARTED|Overall Study||20
3221383|NCT02282930|3953257|FG000|COMPLETED|Overall Study||19
3221384|NCT02282930|3953257|FG000|NOT COMPLETED|Overall Study||1
3221385|NCT02282982|3953261|FG000|STARTED|Overall Study||359
3221386|NCT02282982|3953261|FG000|Attended Visit 1|Overall Study||359
3221387|NCT02282982|3953261|FG000|Attended Visit 2|Overall Study||341
3221388|NCT02282982|3953261|FG000|Attended Visit 3|Overall Study||298
3221389|NCT02282982|3953261|FG000|Attended Visit 4|Overall Study||194
3221390|NCT02282982|3953261|FG000|Attended Visit 5|Overall Study||83
3221391|NCT02282982|3953261|FG000|Attended Follow-up Visit|Overall Study||349
3221392|NCT02282982|3953261|FG000|COMPLETED|Overall Study||153
3221393|NCT02282982|3953261|FG000|NOT COMPLETED|Overall Study||206
3221394|NCT02283268|3953265|FG000|STARTED|Overall Study||15
3221395|NCT02283268|3953265|FG000|COMPLETED|Overall Study||14
3221396|NCT02283268|3953265|FG000|NOT COMPLETED|Overall Study||1
3221397|NCT02283294|3953279|FG000|STARTED|Overall Study||41
3221398|NCT02283294|3953280|FG001|STARTED|Overall Study||47
3221399|NCT02283294|3953279|FG000|Received Allocated Treatment Intervention|Overall Study||38
3221400|NCT02283294|3953280|FG001|Received Allocated Treatment Intervention|Overall Study||31
3221401|NCT02283294|3953279|FG000|COMPLETED|Overall Study||38
3221402|NCT02283294|3953280|FG001|COMPLETED|Overall Study||39
3221403|NCT02283294|3953279|FG000|NOT COMPLETED|Overall Study||3
3221404|NCT02283294|3953280|FG001|NOT COMPLETED|Overall Study||8
3221405|NCT02283333|3953289|FG000|STARTED|Overall Study||77
3221406|NCT02283333|3953290|FG001|STARTED|Overall Study||78
3221407|NCT02283333|3953289|FG000|COMPLETED|Overall Study||63
3221408|NCT02283333|3953290|FG001|COMPLETED|Overall Study||64
3221409|NCT02283333|3953289|FG000|NOT COMPLETED|Overall Study||14
3221410|NCT02283333|3953290|FG001|NOT COMPLETED|Overall Study||14
3221411|NCT02283411|3953296|FG000|STARTED|Overall Study||156
3221412|NCT02283411|3953296|FG000|COMPLETED|Overall Study||125
3221413|NCT02283411|3953296|FG000|NOT COMPLETED|Overall Study||31
3221414|NCT02283528|3953302|FG000|STARTED|Overall Study||26
3221415|NCT02283528|3953303|FG001|STARTED|Overall Study||24
3221416|NCT02283528|3953302|FG000|COMPLETED|Overall Study||26
3221417|NCT02283528|3953303|FG001|COMPLETED|Overall Study||24
3221418|NCT02283528|3953302|FG000|NOT COMPLETED|Overall Study||0
3221419|NCT02283528|3953303|FG001|NOT COMPLETED|Overall Study||0
3221420|NCT02283658|3953309|FG000|STARTED|Overall Study||20
3221421|NCT02283658|3953309|FG000|COMPLETED|Overall Study||19
3221422|NCT02283658|3953309|FG000|NOT COMPLETED|Overall Study||1
3221423|NCT02283749|3953313|FG000|STARTED|Overall Study||5
3221424|NCT02283749|3953313|FG000|COMPLETED|Overall Study||5
3221425|NCT02283749|3953313|FG000|NOT COMPLETED|Overall Study||0
3221426|NCT02283762|3953319|FG000|STARTED|Main Treatment Phase (MT)||60
3221427|NCT02283762|3953320|FG001|STARTED|Main Treatment Phase (MT)||61
3221428|NCT02283762|3953319|FG000|COMPLETED|Main Treatment Phase (MT)||42
3221429|NCT02283762|3953320|FG001|COMPLETED|Main Treatment Phase (MT)||46
3221430|NCT02283762|3953319|FG000|NOT COMPLETED|Main Treatment Phase (MT)||18
3221431|NCT02283762|3953320|FG001|NOT COMPLETED|Main Treatment Phase (MT)||15
3221432|NCT02283762|3953319|FG000|STARTED|Long-term Extension Phase (LTE)||42
3221433|NCT02283762|3953320|FG001|STARTED|Long-term Extension Phase (LTE)|Of the 46 patients who completed the main treatment phase, 1 patient did not enter the LTE phase|45
3221434|NCT02283762|3953319|FG000|COMPLETED|Long-term Extension Phase (LTE)||32
3221435|NCT02283762|3953320|FG001|COMPLETED|Long-term Extension Phase (LTE)||31
3221436|NCT02283762|3953319|FG000|NOT COMPLETED|Long-term Extension Phase (LTE)||10
3221437|NCT02283762|3953320|FG001|NOT COMPLETED|Long-term Extension Phase (LTE)||14
3221438|NCT02283788|3953332|FG000|STARTED|Overall Study||17
3221439|NCT02283788|3953333|FG001|STARTED|Overall Study||17
3221440|NCT02283788|3953334|FG002|STARTED|Overall Study||17
3221441|NCT02283788|3953335|FG003|STARTED|Overall Study||16
3221442|NCT02283788|3953332|FG000|COMPLETED|Overall Study||16
3367767|NCT03857230|4099298|FG001|STARTED|Period 2 (Gonal-F-Primapur)||12
3367768|NCT03857230|4099297|FG000|COMPLETED|Period 2 (Gonal-F-Primapur)||12
3367769|NCT03857230|4099298|FG001|COMPLETED|Period 2 (Gonal-F-Primapur)||12
3367770|NCT03857230|4099297|FG000|NOT COMPLETED|Period 2 (Gonal-F-Primapur)||0
3367771|NCT03857230|4099298|FG001|NOT COMPLETED|Period 2 (Gonal-F-Primapur)||0
3367772|NCT03865329|4099304|FG000|STARTED|Overall Study||9
3367773|NCT03865329|4099304|FG000|COMPLETED|Overall Study||9
3367774|NCT03865329|4099304|FG000|NOT COMPLETED|Overall Study||0
3367775|NCT03864653|4099308|FG000|STARTED|Overall Study||39
3221443|NCT02283788|3953333|FG001|COMPLETED|Overall Study||13
3221444|NCT02283788|3953334|FG002|COMPLETED|Overall Study||12
3221445|NCT02283788|3953335|FG003|COMPLETED|Overall Study||14
3221446|NCT02283788|3953332|FG000|NOT COMPLETED|Overall Study||1
3221447|NCT02283788|3953333|FG001|NOT COMPLETED|Overall Study||4
3221448|NCT02283788|3953334|FG002|NOT COMPLETED|Overall Study||5
3221449|NCT02283788|3953335|FG003|NOT COMPLETED|Overall Study||2
3367776|NCT03864653|4099308|FG000|COMPLETED|Overall Study||38
3367777|NCT03864653|4099308|FG000|NOT COMPLETED|Overall Study||1
3367778|NCT03862482|4099315|FG000|STARTED|Overall Study|Eight participants (forty implant units) were randomly allocated to Configuration 1 by study coordinator. Each participant was also randomly assigned one of the three implant units (B or SW or SC) on a rotating basis to one of five sites between mental foramen. As a result, an equal number of each implant unit type was placed at each the five sites|8
3367779|NCT03862482|4099316|FG001|STARTED|Overall Study|Eight participants (forty implant units) were randomly allocated to Configuration 2 by study coordinator. Each participant was also randomly assigned one of the three implant units (B or SW or SC) on a rotating basis to one of five sites between mental foramen. As a result, an equal number of each implant unit type was placed at each the five sites|8
3367780|NCT03862482|4099317|FG002|STARTED|Overall Study|Six participants (thirty implant units) were randomly allocated to Configuration 3 by study coordinator. Each participant was also randomly assigned one of the three implant units (B or SW or SC) on a rotating basis to one of five sites between mental foramen. As a result, an equal number of each implant unit type was placed at each the five sites|6
3367781|NCT03862482|4099315|FG000|COMPLETED|Overall Study|Sixteen B, 16 SW, and eight SC implant units were placed on a rotating basis at the five sites for a total of 40 implant units. Of these, one implant unit (SW) had fractured and was subsequently excluded from all future analyses|8
3367782|NCT03862482|4099316|FG001|COMPLETED|Overall Study|Eight B, 16 SW, and 16 SC implant units were placed on a rotating basis at the five sites for a total of 40 implant units. Of these, two implant units (one B, one SW) were removed from all future analyses due to technical issues with radiographs|8
3367783|NCT03862482|4099317|FG002|COMPLETED|Overall Study|Twelve B, six SW, and 12 SC implant units were placed on a rotating basis at the five sites for a total of 30 implant units|6
3367784|NCT03862482|4099315|FG000|NOT COMPLETED|Overall Study||0
3367785|NCT03862482|4099316|FG001|NOT COMPLETED|Overall Study||0
3367786|NCT03862482|4099317|FG002|NOT COMPLETED|Overall Study||0
3367787|NCT03853213|4099325|FG000|STARTED|Overall Study||11
3367788|NCT03853213|4099326|FG001|STARTED|Overall Study||9
3367789|NCT03853213|4099325|FG000|COMPLETED|Overall Study||10
3367790|NCT03853213|4099326|FG001|COMPLETED|Overall Study||7
3367791|NCT03853213|4099325|FG000|NOT COMPLETED|Overall Study||1
3367792|NCT03853213|4099326|FG001|NOT COMPLETED|Overall Study||2
3367793|NCT03847610|4099332|FG000|STARTED|Overall Study||11
3367794|NCT03847610|4099332|FG000|COMPLETED|Overall Study||10
3367795|NCT03847610|4099332|FG000|NOT COMPLETED|Overall Study||1
3367796|NCT03850093|4099339|FG000|STARTED|Overall Study||22
3367797|NCT03850093|4099340|FG001|STARTED|Overall Study||22
3367798|NCT03850093|4099341|FG002|STARTED|Overall Study||19
3367799|NCT03850093|4099339|FG000|COMPLETED|Overall Study||21
3367800|NCT03850093|4099340|FG001|COMPLETED|Overall Study||22
3367801|NCT03850093|4099341|FG002|COMPLETED|Overall Study||17
3367802|NCT03850093|4099339|FG000|NOT COMPLETED|Overall Study||1
3367803|NCT03850093|4099340|FG001|NOT COMPLETED|Overall Study||0
3367804|NCT03850093|4099341|FG002|NOT COMPLETED|Overall Study||2
3367805|NCT03848208|4099359|FG000|STARTED|Overall Study||18
3367806|NCT03848208|4099360|FG001|STARTED|Overall Study||6
3367807|NCT03848208|4099361|FG002|STARTED|Overall Study||6
3367808|NCT03848208|4099362|FG003|STARTED|Overall Study||6
3367809|NCT03848208|4099363|FG004|STARTED|Overall Study||6
3367810|NCT03848208|4099364|FG005|STARTED|Overall Study||6
3367811|NCT03848208|4099365|FG006|STARTED|Overall Study||6
3367812|NCT03848208|4099366|FG007|STARTED|Overall Study||6
3367813|NCT03848208|4099367|FG008|STARTED|Overall Study||6
3367814|NCT03848208|4099368|FG009|STARTED|Overall Study||6
3367815|NCT03848208|4099359|FG000|COMPLETED|Overall Study||18
3367816|NCT03848208|4099360|FG001|COMPLETED|Overall Study||6
3367817|NCT03848208|4099361|FG002|COMPLETED|Overall Study||6
3367818|NCT03848208|4099362|FG003|COMPLETED|Overall Study||6
3367819|NCT03848208|4099363|FG004|COMPLETED|Overall Study||6
3367820|NCT03848208|4099364|FG005|COMPLETED|Overall Study||6
3367821|NCT03848208|4099365|FG006|COMPLETED|Overall Study||6
3367822|NCT03848208|4099366|FG007|COMPLETED|Overall Study||6
3367823|NCT03848208|4099367|FG008|COMPLETED|Overall Study||6
3367824|NCT03848208|4099368|FG009|COMPLETED|Overall Study||6
3367825|NCT03848208|4099359|FG000|NOT COMPLETED|Overall Study||0
3367826|NCT03848208|4099360|FG001|NOT COMPLETED|Overall Study||0
3367827|NCT03848208|4099361|FG002|NOT COMPLETED|Overall Study||0
3367828|NCT03848208|4099362|FG003|NOT COMPLETED|Overall Study||0
3367829|NCT03848208|4099363|FG004|NOT COMPLETED|Overall Study||0
3367830|NCT03848208|4099364|FG005|NOT COMPLETED|Overall Study||0
3367831|NCT03848208|4099365|FG006|NOT COMPLETED|Overall Study||0
3367832|NCT03848208|4099366|FG007|NOT COMPLETED|Overall Study||0
3367833|NCT03848208|4099367|FG008|NOT COMPLETED|Overall Study||0
3367834|NCT03848208|4099368|FG009|NOT COMPLETED|Overall Study||0
3367835|NCT03847389|4099402|FG000|STARTED|Overall Study||8
3367836|NCT03847389|4099403|FG001|STARTED|Overall Study|Start of Cohort 2 can only happen if less than or equal to 40% of subjects in Cohort 1 had HPA axis suppression.|0
3367837|NCT03847389|4099404|FG002|STARTED|Overall Study|Start of Cohort 3 can only happen if less than or equal to 40% of subjects in Cohort 2 had HPA axis suppression.|0
3367838|NCT03847389|4099402|FG000|COMPLETED|Overall Study||8
3367839|NCT03847389|4099403|FG001|COMPLETED|Overall Study||0
3367840|NCT03847389|4099404|FG002|COMPLETED|Overall Study||0
3367841|NCT03847389|4099402|FG000|NOT COMPLETED|Overall Study||0
3221450|NCT02283814|3953347|FG000|STARTED|Overall Study||16
3221451|NCT02283814|3953348|FG001|STARTED|Overall Study||16
3221452|NCT02283814|3953347|FG000|COMPLETED|Overall Study||13
3221453|NCT02283814|3953348|FG001|COMPLETED|Overall Study||14
3221454|NCT02283814|3953347|FG000|NOT COMPLETED|Overall Study||3
3221455|NCT02283814|3953348|FG001|NOT COMPLETED|Overall Study||2
3221456|NCT02283827|3953356|FG000|STARTED|Overall Study||16
3221457|NCT02283827|3953357|FG001|STARTED|Overall Study||16
3221458|NCT02283827|3953356|FG000|COMPLETED|Overall Study||15
3221459|NCT02283827|3953357|FG001|COMPLETED|Overall Study||13
3221460|NCT02283827|3953356|FG000|NOT COMPLETED|Overall Study||1
3221461|NCT02283827|3953357|FG001|NOT COMPLETED|Overall Study||3
3221462|NCT02283840|3953372|FG000|STARTED|Overall Study||20
3221463|NCT02283840|3953373|FG001|STARTED|Overall Study||20
3221464|NCT02283840|3953374|FG002|STARTED|Overall Study||20
3221465|NCT02283840|3953372|FG000|COMPLETED|Overall Study||20
3221466|NCT02283840|3953373|FG001|COMPLETED|Overall Study||19
3221467|NCT02283840|3953374|FG002|COMPLETED|Overall Study||20
3221468|NCT02283840|3953372|FG000|NOT COMPLETED|Overall Study||0
3221469|NCT02283840|3953373|FG001|NOT COMPLETED|Overall Study||1
3221470|NCT02283840|3953374|FG002|NOT COMPLETED|Overall Study||0
3221471|NCT02284009|3953387|FG000|STARTED|Overall Study||17
3221472|NCT02284009|3953388|FG001|STARTED|Overall Study||50
3221473|NCT02284009|3953387|FG000|COMPLETED|Overall Study||11
3221474|NCT02284009|3953388|FG001|COMPLETED|Overall Study||40
3221475|NCT02284009|3953387|FG000|NOT COMPLETED|Overall Study||6
3221476|NCT02284009|3953388|FG001|NOT COMPLETED|Overall Study||10
3221477|NCT02284126|3953398|FG000|STARTED|Overall Study||552
3221478|NCT02284126|3953399|FG001|STARTED|Overall Study||551
3221479|NCT02284126|3953398|FG000|COMPLETED|Overall Study||484
3221480|NCT02284126|3953399|FG001|COMPLETED|Overall Study||489
3221481|NCT02284126|3953398|FG000|NOT COMPLETED|Overall Study||68
3221482|NCT02284126|3953399|FG001|NOT COMPLETED|Overall Study||62
3221483|NCT02284165|3953408|FG000|STARTED|Overall Study||36448
3221484|NCT02284165|3953409|FG001|STARTED|Overall Study||40272
3221485|NCT02284165|3953410|FG002|STARTED|Overall Study||70996
3221486|NCT02284165|3953408|FG000|COMPLETED|Overall Study||36448
3221487|NCT02284165|3953409|FG001|COMPLETED|Overall Study||40272
3221488|NCT02284165|3953410|FG002|COMPLETED|Overall Study||70996
3221489|NCT02284165|3953408|FG000|NOT COMPLETED|Overall Study||0
3221490|NCT02284165|3953409|FG001|NOT COMPLETED|Overall Study||0
3221491|NCT02284165|3953410|FG002|NOT COMPLETED|Overall Study||0
3221492|NCT02284178|3953418|FG000|STARTED|Overall Study||255
3221493|NCT02284178|3953419|FG001|STARTED|Overall Study||258
3221494|NCT02284178|3953418|FG000|COMPLETED|Overall Study||206
3221495|NCT02284178|3953419|FG001|COMPLETED|Overall Study||204
3221496|NCT02284178|3953418|FG000|NOT COMPLETED|Overall Study||49
3221497|NCT02284178|3953419|FG001|NOT COMPLETED|Overall Study||54
3221498|NCT02284243|3953427|FG000|STARTED|Overall Study||84
3221499|NCT02284243|3953428|FG001|STARTED|Overall Study||84
3221500|NCT02284243|3953427|FG000|COMPLETED|Overall Study||80
3221501|NCT02284243|3953428|FG001|COMPLETED|Overall Study||81
3221502|NCT02284243|3953427|FG000|NOT COMPLETED|Overall Study||4
3221503|NCT02284243|3953428|FG001|NOT COMPLETED|Overall Study||3
3221504|NCT02284347|3953434|FG000|STARTED|Overall Study||51
3221505|NCT02284347|3953434|FG000|COMPLETED|Overall Study||48
3221506|NCT02284347|3953434|FG000|NOT COMPLETED|Overall Study||3
3221507|NCT02284386|3953438|FG000|STARTED|Overall Study||15
3221508|NCT02284386|3953438|FG000|COMPLETED|Overall Study||15
3221509|NCT02284386|3953438|FG000|NOT COMPLETED|Overall Study||0
3221510|NCT02284399|3953444|FG000|STARTED|Overall Study||1414
3221511|NCT02284399|3953445|FG001|STARTED|Overall Study||3074
3221512|NCT02284399|3953444|FG000|COMPLETED|Overall Study||1414
3221513|NCT02284399|3953445|FG001|COMPLETED|Overall Study||3074
3221514|NCT02284399|3953444|FG000|NOT COMPLETED|Overall Study||0
3221515|NCT02284399|3953445|FG001|NOT COMPLETED|Overall Study||0
3221516|NCT02284464|3953455|FG000|STARTED|Overall Study||52
3221517|NCT02284464|3953456|FG001|STARTED|Overall Study||53
3221518|NCT02284464|3953455|FG000|COMPLETED|Overall Study||39
3221519|NCT02284464|3953456|FG001|COMPLETED|Overall Study||36
3221520|NCT02284464|3953455|FG000|NOT COMPLETED|Overall Study||13
3221521|NCT02284464|3953456|FG001|NOT COMPLETED|Overall Study||17
3221522|NCT02284516|3953464|FG000|STARTED|Overall Study||356
3221523|NCT02284516|3953465|FG001|STARTED|Overall Study||355
3221524|NCT02284516|3953464|FG000|Safety Population|Overall Study|Two placebo participants were considered for Lifitegrast arm; Placebo safety analysis set (N= 354).|354
3221525|NCT02284516|3953465|FG001|Safety Population|Overall Study|Two placebo participants were included in Lifitegrast arm for safety analysis set (N=357).|357
3221526|NCT02284516|3953464|FG000|COMPLETED|Overall Study||318
3221527|NCT02284516|3953465|FG001|COMPLETED|Overall Study||319
3221528|NCT02284516|3953464|FG000|NOT COMPLETED|Overall Study||38
3221529|NCT02284516|3953465|FG001|NOT COMPLETED|Overall Study||36
3221530|NCT02284555|3953471|FG000|STARTED|Overall Study||12
3221531|NCT02284555|3953471|FG000|COMPLETED|Overall Study||12
3221532|NCT02284555|3953471|FG000|NOT COMPLETED|Overall Study||0
3221533|NCT02284568|3953478|FG000|STARTED|Overall Study|Intent to treat (ITT) population|140
3221534|NCT02284568|3953479|FG001|STARTED|Overall Study|Intent to treat (ITT) population|139
3221535|NCT02284568|3953480|FG002|STARTED|Overall Study|Intent to treat (ITT) population|95
3221536|NCT02284568|3953478|FG000|Safety Population|Overall Study||140
3221537|NCT02284568|3953479|FG001|Safety Population|Overall Study||138
3221538|NCT02284568|3953480|FG002|Safety Population|Overall Study||95
3221539|NCT02284568|3953478|FG000|Completed Week 48 MRI - on Treatment|Overall Study||113
3221540|NCT02284568|3953479|FG001|Completed Week 48 MRI - on Treatment|Overall Study||107
3221541|NCT02284568|3953480|FG002|Completed Week 48 MRI - on Treatment|Overall Study||0
3221542|NCT02284568|3953478|FG000|COMPLETED|Overall Study||109
3221543|NCT02284568|3953479|FG001|COMPLETED|Overall Study||93
3221544|NCT02284568|3953480|FG002|COMPLETED|Overall Study||0
3221545|NCT02284568|3953478|FG000|NOT COMPLETED|Overall Study||31
3221546|NCT02284568|3953479|FG001|NOT COMPLETED|Overall Study||46
3221547|NCT02284568|3953480|FG002|NOT COMPLETED|Overall Study||95
3221548|NCT02284828|3953488|FG000|STARTED|Overall Study||26
3221549|NCT02284828|3953488|FG000|COMPLETED|Overall Study||22
3221550|NCT02284828|3953488|FG000|NOT COMPLETED|Overall Study||4
3221551|NCT02284854|3953497|FG000|STARTED|Overall Study||23
3221552|NCT02284854|3953498|FG001|STARTED|Overall Study||20
3221553|NCT02284854|3953497|FG000|COMPLETED|Overall Study||18
3221554|NCT02284854|3953498|FG001|COMPLETED|Overall Study||20
3221555|NCT02284854|3953497|FG000|NOT COMPLETED|Overall Study||5
3221556|NCT02284854|3953498|FG001|NOT COMPLETED|Overall Study||0
3221557|NCT02284867|3953513|FG000|STARTED|Overall Study||30
3221558|NCT02284867|3953514|FG001|STARTED|Overall Study||30
3221559|NCT02284867|3953513|FG000|COMPLETED|Overall Study||30
3221560|NCT02284867|3953514|FG001|COMPLETED|Overall Study||30
3221561|NCT02284867|3953513|FG000|NOT COMPLETED|Overall Study||0
3221562|NCT02284867|3953514|FG001|NOT COMPLETED|Overall Study||0
3221563|NCT02284880|3953522|FG000|STARTED|Overall Study||11
3221564|NCT02284880|3953523|FG001|STARTED|Overall Study||9
3221565|NCT02284880|3953524|FG002|STARTED|Overall Study||10
3221566|NCT02284880|3953525|FG003|STARTED|Overall Study||10
3221567|NCT02284880|3953522|FG000|First Period (4 Days)|Overall Study||11
3221568|NCT02284880|3953523|FG001|First Period (4 Days)|Overall Study||9
3221569|NCT02284880|3953524|FG002|First Period (4 Days)|Overall Study||10
3221570|NCT02284880|3953525|FG003|First Period (4 Days)|Overall Study||10
3221571|NCT02284880|3953522|FG000|Wash-out Period (7 Days)|Overall Study||11
3221572|NCT02284880|3953523|FG001|Wash-out Period (7 Days)|Overall Study||9
3221573|NCT02284880|3953524|FG002|Wash-out Period (7 Days)|Overall Study||10
3221574|NCT02284880|3953525|FG003|Wash-out Period (7 Days)|Overall Study||10
3221575|NCT02284880|3953522|FG000|Second Period (4 Days)|Overall Study||11
3221576|NCT02284880|3953523|FG001|Second Period (4 Days)|Overall Study||9
3221577|NCT02284880|3953524|FG002|Second Period (4 Days)|Overall Study||8
3221578|NCT02284880|3953525|FG003|Second Period (4 Days)|Overall Study||10
3221579|NCT02284880|3953522|FG000|COMPLETED|Overall Study||11
3221580|NCT02284880|3953523|FG001|COMPLETED|Overall Study||9
3221581|NCT02284880|3953524|FG002|COMPLETED|Overall Study||8
3221582|NCT02284880|3953525|FG003|COMPLETED|Overall Study||10
3221583|NCT02284880|3953522|FG000|NOT COMPLETED|Overall Study||0
3221584|NCT02284880|3953523|FG001|NOT COMPLETED|Overall Study||0
3221585|NCT02284880|3953524|FG002|NOT COMPLETED|Overall Study||2
3221586|NCT02284880|3953525|FG003|NOT COMPLETED|Overall Study||0
3221587|NCT02284893|3953537|FG000|STARTED|26 Week (Short Term)||232
3221588|NCT02284893|3953538|FG001|STARTED|26 Week (Short Term)||229
3221589|NCT02284893|3953537|FG000|COMPLETED|26 Week (Short Term)||213
3221590|NCT02284893|3953538|FG001|COMPLETED|26 Week (Short Term)||198
3221591|NCT02284893|3953537|FG000|NOT COMPLETED|26 Week (Short Term)||19
3221592|NCT02284893|3953538|FG001|NOT COMPLETED|26 Week (Short Term)||31
3221593|NCT02284893|3953537|FG000|STARTED|52 Week (Long Term)||209
3221594|NCT02284893|3953538|FG001|STARTED|52 Week (Long Term)||193
3221595|NCT02284893|3953537|FG000|COMPLETED|52 Week (Long Term)||198
3221596|NCT02284893|3953538|FG001|COMPLETED|52 Week (Long Term)||180
3221597|NCT02284893|3953537|FG000|NOT COMPLETED|52 Week (Long Term)||11
3221598|NCT02284893|3953538|FG001|NOT COMPLETED|52 Week (Long Term)||13
3221599|NCT02285010|3953546|FG000|STARTED|Overall Study||63
3221600|NCT02285010|3953547|FG001|STARTED|Overall Study||62
3221601|NCT02285010|3953546|FG000|COMPLETED|Overall Study||58
3221602|NCT02285010|3953547|FG001|COMPLETED|Overall Study||61
3221603|NCT02285010|3953546|FG000|NOT COMPLETED|Overall Study||5
3221604|NCT02285010|3953547|FG001|NOT COMPLETED|Overall Study||1
3221605|NCT02285023|3953553|FG000|STARTED|Overall Study||166
3221606|NCT02285023|3953553|FG000|COMPLETED|Overall Study||166
3221607|NCT02285023|3953553|FG000|NOT COMPLETED|Overall Study||0
3221608|NCT02285114|3953566|FG000|STARTED|Overall Study||29
3221609|NCT02285114|3953567|FG001|STARTED|Overall Study||9
3221610|NCT02285114|3953568|FG002|STARTED|Overall Study||3
3221611|NCT02285114|3953566|FG000|COMPLETED|Overall Study||7
3221612|NCT02285114|3953567|FG001|COMPLETED|Overall Study||2
3221613|NCT02285114|3953568|FG002|COMPLETED|Overall Study||0
3221614|NCT02285114|3953566|FG000|NOT COMPLETED|Overall Study||22
3221615|NCT02285114|3953567|FG001|NOT COMPLETED|Overall Study||7
3221616|NCT02285114|3953568|FG002|NOT COMPLETED|Overall Study||3
3221617|NCT02285153|3953584|FG000|STARTED|Overall Study||7
3221618|NCT02285153|3953585|FG001|STARTED|Overall Study||8
3221619|NCT02285153|3953584|FG000|COMPLETED|Overall Study||6
3221620|NCT02285153|3953585|FG001|COMPLETED|Overall Study||8
3221621|NCT02285153|3953584|FG000|NOT COMPLETED|Overall Study||1
3221622|NCT02285153|3953585|FG001|NOT COMPLETED|Overall Study||0
3221623|NCT02285283|3953593|FG000|STARTED|Overall Study||29
3221624|NCT02285283|3953594|FG001|STARTED|Overall Study||29
3221625|NCT02285283|3953593|FG000|COMPLETED|Overall Study||25
3221626|NCT02285283|3953594|FG001|COMPLETED|Overall Study||20
3221627|NCT02285283|3953593|FG000|NOT COMPLETED|Overall Study||4
3221628|NCT02285283|3953594|FG001|NOT COMPLETED|Overall Study||9
3221629|NCT02285361|3953600|FG000|STARTED|Overall Study||1272
3221630|NCT02285361|3953600|FG000|COMPLETED|Overall Study||1221
3221631|NCT02285361|3953600|FG000|NOT COMPLETED|Overall Study||51
3221632|NCT02285634|3953608|FG000|STARTED|Overall Study||15
3221633|NCT02285634|3953609|FG001|STARTED|Overall Study||20
3221634|NCT02285634|3953610|FG002|STARTED|Overall Study||15
3221635|NCT02285634|3953611|FG003|STARTED|Overall Study||18
3221636|NCT02285634|3953608|FG000|COMPLETED|Overall Study||15
3221637|NCT02285634|3953609|FG001|COMPLETED|Overall Study||20
3221638|NCT02285634|3953610|FG002|COMPLETED|Overall Study||11
3221639|NCT02285634|3953611|FG003|COMPLETED|Overall Study||17
3221640|NCT02285634|3953608|FG000|NOT COMPLETED|Overall Study||0
3221641|NCT02285634|3953609|FG001|NOT COMPLETED|Overall Study||0
3221642|NCT02285634|3953610|FG002|NOT COMPLETED|Overall Study||4
3221643|NCT02285634|3953611|FG003|NOT COMPLETED|Overall Study||1
3221644|NCT02285777|3953624|FG000|STARTED|Overall Study||95
3221645|NCT02285777|3953625|FG001|STARTED|Overall Study||94
3221646|NCT02285777|3953624|FG000|COMPLETED|Overall Study||90
3221647|NCT02285777|3953625|FG001|COMPLETED|Overall Study||91
3221648|NCT02285777|3953624|FG000|NOT COMPLETED|Overall Study||5
3221649|NCT02285777|3953625|FG001|NOT COMPLETED|Overall Study||3
3221650|NCT02285855|3953633|FG000|STARTED|Overall Study||16
3221651|NCT02285855|3953634|FG001|STARTED|Overall Study||2
3221652|NCT02285855|3953633|FG000|Randomized|Overall Study||16
3221653|NCT02285855|3953634|FG001|Randomized|Overall Study||2
3221654|NCT02285855|3953633|FG000|COMPLETED|Overall Study||14
3221655|NCT02285855|3953634|FG001|COMPLETED|Overall Study||1
3221656|NCT02285855|3953633|FG000|NOT COMPLETED|Overall Study||2
3221657|NCT02285855|3953634|FG001|NOT COMPLETED|Overall Study||1
3221658|NCT02285907|3953640|FG000|STARTED|Overall Study||21
3221659|NCT02285907|3953640|FG000|Began 1st Intervention|Overall Study||21
3221660|NCT02285907|3953640|FG000|Began 2nd Intervention|Overall Study||21
3221661|NCT02285907|3953640|FG000|Began 3rd Intervention|Overall Study||21
3221662|NCT02285907|3953640|FG000|Began 4th Intervention|Overall Study||21
3221663|NCT02285907|3953640|FG000|COMPLETED|Overall Study||21
3221664|NCT02285907|3953640|FG000|NOT COMPLETED|Overall Study||0
3221665|NCT02285920|3953657|FG000|STARTED|Overall Study||51
3221666|NCT02285920|3953658|FG001|STARTED|Overall Study||27
3221667|NCT02285920|3953659|FG002|STARTED|Overall Study||26
3221668|NCT02285920|3953660|FG003|STARTED|Overall Study||25
3221669|NCT02285920|3953657|FG000|COMPLETED|Overall Study||47
3221670|NCT02285920|3953658|FG001|COMPLETED|Overall Study||23
3221671|NCT02285920|3953659|FG002|COMPLETED|Overall Study||21
3221672|NCT02285920|3953660|FG003|COMPLETED|Overall Study||24
3221673|NCT02285920|3953657|FG000|NOT COMPLETED|Overall Study||4
3221674|NCT02285920|3953658|FG001|NOT COMPLETED|Overall Study||4
3221675|NCT02285920|3953659|FG002|NOT COMPLETED|Overall Study||5
3221676|NCT02285920|3953660|FG003|NOT COMPLETED|Overall Study||1
3221677|NCT02285998|3953672|FG000|STARTED|Overall Study||4474
3221678|NCT02285998|3953673|FG001|STARTED|Overall Study||4489
3221679|NCT02285998|3953672|FG000|COMPLETED|Overall Study||4228
3221680|NCT02285998|3953673|FG001|COMPLETED|Overall Study||4236
3221681|NCT02285998|3953672|FG000|NOT COMPLETED|Overall Study||246
3221682|NCT02285998|3953673|FG001|NOT COMPLETED|Overall Study||253
3221683|NCT02286102|3953681|FG000|STARTED|Overall Study||36
3221684|NCT02286102|3953682|FG001|STARTED|Overall Study||34
3221685|NCT02286102|3953681|FG000|COMPLETED|Overall Study||35
3221686|NCT02286102|3953682|FG001|COMPLETED|Overall Study||33
3221687|NCT02286102|3953681|FG000|NOT COMPLETED|Overall Study||1
3221688|NCT02286102|3953682|FG001|NOT COMPLETED|Overall Study||1
3221689|NCT02286193|3953688|FG000|STARTED|Overall Study||622
3221690|NCT02286193|3953688|FG000|COMPLETED|Overall Study||418
3221691|NCT02286193|3953688|FG000|NOT COMPLETED|Overall Study||204
3221692|NCT02286466|3953695|FG000|STARTED|Overall Study||72
3221693|NCT02286466|3953696|FG001|STARTED|Overall Study||73
3221694|NCT02286466|3953695|FG000|Baseline Clinician Assessment|Overall Study||72
3221695|NCT02286466|3953696|FG001|Baseline Clinician Assessment|Overall Study||72
3221696|NCT02286466|3953695|FG000|Post Self-report|Overall Study||67
3221697|NCT02286466|3953696|FG001|Post Self-report|Overall Study||68
3221698|NCT02286466|3953695|FG000|COMPLETED|Overall Study||65
3221699|NCT02286466|3953696|FG001|COMPLETED|Overall Study||63
3221700|NCT02286466|3953695|FG000|NOT COMPLETED|Overall Study||7
3221701|NCT02286466|3953696|FG001|NOT COMPLETED|Overall Study||10
3221702|NCT02286518|3953716|FG000|STARTED|All Parts (16 Days)||6
3221703|NCT02286518|3953717|FG001|STARTED|All Parts (16 Days)||6
3221704|NCT02286518|3953718|FG002|STARTED|All Parts (16 Days)||6
3221705|NCT02286518|3953719|FG003|STARTED|All Parts (16 Days)||6
3221706|NCT02286518|3953720|FG004|STARTED|All Parts (16 Days)||6
3221707|NCT02286518|3953721|FG005|STARTED|All Parts (16 Days)||6
3221708|NCT02286518|3953722|FG006|STARTED|All Parts (16 Days)||6
3221709|NCT02286518|3953723|FG007|STARTED|All Parts (16 Days)||6
3221710|NCT02286518|3953724|FG008|STARTED|All Parts (16 Days)||6
3221711|NCT02286518|3953725|FG009|STARTED|All Parts (16 Days)||4
3221712|NCT02286518|3953726|FG010|STARTED|All Parts (16 Days)||6
3221713|NCT02286518|3953727|FG011|STARTED|All Parts (16 Days)||6
3221714|NCT02286518|3953728|FG012|STARTED|All Parts (16 Days)||6
3221715|NCT02286518|3953729|FG013|STARTED|All Parts (16 Days)||6
3221716|NCT02286518|3953716|FG000|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
3221717|NCT02286518|3953717|FG001|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
3367842|NCT03847389|4099403|FG001|NOT COMPLETED|Overall Study||0
3221718|NCT02286518|3953718|FG002|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
3221719|NCT02286518|3953719|FG003|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
3221720|NCT02286518|3953720|FG004|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
3221721|NCT02286518|3953721|FG005|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
3221722|NCT02286518|3953722|FG006|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
3221723|NCT02286518|3953723|FG007|COMPLETED|All Parts (16 Days)|Only participants of Part 2 continued in next period.|6
3221724|NCT02286518|3953724|FG008|COMPLETED|All Parts (16 Days)|Only participants of Part 2 would continue in next period.|6
3221725|NCT02286518|3953725|FG009|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|4
3221726|NCT02286518|3953726|FG010|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
3221727|NCT02286518|3953727|FG011|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
3221728|NCT02286518|3953728|FG012|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
3221729|NCT02286518|3953729|FG013|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
3221730|NCT02286518|3953716|FG000|NOT COMPLETED|All Parts (16 Days)||0
3221731|NCT02286518|3953717|FG001|NOT COMPLETED|All Parts (16 Days)||0
3221732|NCT02286518|3953718|FG002|NOT COMPLETED|All Parts (16 Days)||0
3221733|NCT02286518|3953719|FG003|NOT COMPLETED|All Parts (16 Days)||0
3221734|NCT02286518|3953720|FG004|NOT COMPLETED|All Parts (16 Days)||0
3221735|NCT02286518|3953721|FG005|NOT COMPLETED|All Parts (16 Days)||0
3221736|NCT02286518|3953722|FG006|NOT COMPLETED|All Parts (16 Days)||0
3221737|NCT02286518|3953723|FG007|NOT COMPLETED|All Parts (16 Days)||0
3221738|NCT02286518|3953724|FG008|NOT COMPLETED|All Parts (16 Days)||0
3221739|NCT02286518|3953725|FG009|NOT COMPLETED|All Parts (16 Days)||0
3221740|NCT02286518|3953726|FG010|NOT COMPLETED|All Parts (16 Days)||0
3221741|NCT02286518|3953727|FG011|NOT COMPLETED|All Parts (16 Days)||0
3221742|NCT02286518|3953728|FG012|NOT COMPLETED|All Parts (16 Days)||0
3221743|NCT02286518|3953729|FG013|NOT COMPLETED|All Parts (16 Days)||0
3221744|NCT02286518|3953716|FG000|STARTED|Washout Crossover Period(Part 2:14 Days)||0
3221745|NCT02286518|3953717|FG001|STARTED|Washout Crossover Period(Part 2:14 Days)||0
3221746|NCT02286518|3953718|FG002|STARTED|Washout Crossover Period(Part 2:14 Days)||0
3221747|NCT02286518|3953719|FG003|STARTED|Washout Crossover Period(Part 2:14 Days)||0
3221748|NCT02286518|3953720|FG004|STARTED|Washout Crossover Period(Part 2:14 Days)||0
3221749|NCT02286518|3953721|FG005|STARTED|Washout Crossover Period(Part 2:14 Days)||0
3221750|NCT02286518|3953722|FG006|STARTED|Washout Crossover Period(Part 2:14 Days)||0
3221751|NCT02286518|3953723|FG007|STARTED|Washout Crossover Period(Part 2:14 Days)||6
3221752|NCT02286518|3953724|FG008|STARTED|Washout Crossover Period(Part 2:14 Days)||6
3221753|NCT02286518|3953725|FG009|STARTED|Washout Crossover Period(Part 2:14 Days)||0
3221754|NCT02286518|3953726|FG010|STARTED|Washout Crossover Period(Part 2:14 Days)||0
3221755|NCT02286518|3953727|FG011|STARTED|Washout Crossover Period(Part 2:14 Days)||0
3221756|NCT02286518|3953728|FG012|STARTED|Washout Crossover Period(Part 2:14 Days)||0
3221757|NCT02286518|3953729|FG013|STARTED|Washout Crossover Period(Part 2:14 Days)||0
3221758|NCT02286518|3953716|FG000|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
3221759|NCT02286518|3953717|FG001|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
3221760|NCT02286518|3953718|FG002|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
3221761|NCT02286518|3953719|FG003|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
3367843|NCT03847389|4099404|FG002|NOT COMPLETED|Overall Study||0
3367844|NCT03862040|4099415|FG000|STARTED|Overall Study||7
3367845|NCT03862040|4099415|FG000|COMPLETED|Overall Study||7
3367846|NCT03862040|4099415|FG000|NOT COMPLETED|Overall Study||0
3367847|NCT03861936|4099422|FG000|STARTED|Overall Study||48
3367848|NCT03861936|4099423|FG001|STARTED|Overall Study||53
3367849|NCT03861936|4099424|FG002|STARTED|Overall Study||49
3367850|NCT03861936|4099422|FG000|COMPLETED|Overall Study||34
3367851|NCT03861936|4099423|FG001|COMPLETED|Overall Study||43
3367852|NCT03861936|4099424|FG002|COMPLETED|Overall Study||39
3367853|NCT03861936|4099422|FG000|NOT COMPLETED|Overall Study||14
3367854|NCT03861936|4099423|FG001|NOT COMPLETED|Overall Study||10
3367855|NCT03861936|4099424|FG002|NOT COMPLETED|Overall Study||10
3367856|NCT03859739|4099436|FG000|STARTED|Overall Study||5
3367857|NCT03859739|4099437|FG001|STARTED|Overall Study||6
3367858|NCT03859739|4099438|FG002|STARTED|Overall Study||6
3367859|NCT03859739|4099439|FG003|STARTED|Overall Study||4
3367860|NCT03859739|4099436|FG000|COMPLETED|Overall Study||5
3367861|NCT03859739|4099437|FG001|COMPLETED|Overall Study||6
3367862|NCT03859739|4099438|FG002|COMPLETED|Overall Study||6
3367863|NCT03859739|4099439|FG003|COMPLETED|Overall Study||4
3367864|NCT03859739|4099436|FG000|NOT COMPLETED|Overall Study||0
3367865|NCT03859739|4099437|FG001|NOT COMPLETED|Overall Study||0
3367866|NCT03859739|4099438|FG002|NOT COMPLETED|Overall Study||0
3367867|NCT03859739|4099439|FG003|NOT COMPLETED|Overall Study||0
3367868|NCT03857750|4099451|FG000|STARTED|Overall Study||16
3367869|NCT03857750|4099452|FG001|STARTED|Overall Study||16
3367870|NCT03857750|4099451|FG000|COMPLETED|Overall Study||16
3367871|NCT03857750|4099452|FG001|COMPLETED|Overall Study||16
3367872|NCT03857750|4099451|FG000|NOT COMPLETED|Overall Study||0
3221762|NCT02286518|3953720|FG004|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
3221763|NCT02286518|3953721|FG005|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
3221764|NCT02286518|3953722|FG006|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
3221765|NCT02286518|3953723|FG007|COMPLETED|Washout Crossover Period(Part 2:14 Days)||6
3221766|NCT02286518|3953724|FG008|COMPLETED|Washout Crossover Period(Part 2:14 Days)||6
3221767|NCT02286518|3953725|FG009|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
3221768|NCT02286518|3953726|FG010|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
3221769|NCT02286518|3953727|FG011|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
3221770|NCT02286518|3953728|FG012|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
3221771|NCT02286518|3953729|FG013|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
3221772|NCT02286518|3953716|FG000|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
3221773|NCT02286518|3953717|FG001|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
3221774|NCT02286518|3953718|FG002|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
3221775|NCT02286518|3953719|FG003|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
3221776|NCT02286518|3953720|FG004|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
3221777|NCT02286518|3953721|FG005|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
3221778|NCT02286518|3953722|FG006|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
3221779|NCT02286518|3953723|FG007|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
3221780|NCT02286518|3953724|FG008|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
3221781|NCT02286518|3953725|FG009|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
3221782|NCT02286518|3953726|FG010|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
3221783|NCT02286518|3953727|FG011|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
3221784|NCT02286518|3953728|FG012|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
3221785|NCT02286518|3953729|FG013|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
3221786|NCT02286518|3953716|FG000|STARTED|Crossover Treatment (Part 2: 3 Days)||0
3221787|NCT02286518|3953717|FG001|STARTED|Crossover Treatment (Part 2: 3 Days)||0
3221788|NCT02286518|3953718|FG002|STARTED|Crossover Treatment (Part 2: 3 Days)||0
3221789|NCT02286518|3953719|FG003|STARTED|Crossover Treatment (Part 2: 3 Days)||0
3221790|NCT02286518|3953720|FG004|STARTED|Crossover Treatment (Part 2: 3 Days)||0
3221791|NCT02286518|3953721|FG005|STARTED|Crossover Treatment (Part 2: 3 Days)||0
3221792|NCT02286518|3953722|FG006|STARTED|Crossover Treatment (Part 2: 3 Days)||0
3221793|NCT02286518|3953723|FG007|STARTED|Crossover Treatment (Part 2: 3 Days)||6
3221794|NCT02286518|3953724|FG008|STARTED|Crossover Treatment (Part 2: 3 Days)||6
3221795|NCT02286518|3953725|FG009|STARTED|Crossover Treatment (Part 2: 3 Days)||0
3221796|NCT02286518|3953726|FG010|STARTED|Crossover Treatment (Part 2: 3 Days)||0
3221797|NCT02286518|3953727|FG011|STARTED|Crossover Treatment (Part 2: 3 Days)||0
3221798|NCT02286518|3953728|FG012|STARTED|Crossover Treatment (Part 2: 3 Days)||0
3221799|NCT02286518|3953729|FG013|STARTED|Crossover Treatment (Part 2: 3 Days)||0
3221800|NCT02286518|3953716|FG000|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
3221801|NCT02286518|3953717|FG001|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
3221802|NCT02286518|3953718|FG002|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
3221803|NCT02286518|3953719|FG003|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
3221804|NCT02286518|3953720|FG004|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
3221805|NCT02286518|3953721|FG005|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
3221806|NCT02286518|3953722|FG006|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
3221807|NCT02286518|3953723|FG007|COMPLETED|Crossover Treatment (Part 2: 3 Days)||6
3221808|NCT02286518|3953724|FG008|COMPLETED|Crossover Treatment (Part 2: 3 Days)||6
3221809|NCT02286518|3953725|FG009|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
3221810|NCT02286518|3953726|FG010|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
3221811|NCT02286518|3953727|FG011|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
3221812|NCT02286518|3953728|FG012|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
3221813|NCT02286518|3953729|FG013|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
3221814|NCT02286518|3953716|FG000|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
3221815|NCT02286518|3953717|FG001|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
3221816|NCT02286518|3953718|FG002|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
3221817|NCT02286518|3953719|FG003|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
3221818|NCT02286518|3953720|FG004|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
3221819|NCT02286518|3953721|FG005|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
3221820|NCT02286518|3953722|FG006|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
3221821|NCT02286518|3953723|FG007|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
3221822|NCT02286518|3953724|FG008|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
3221823|NCT02286518|3953725|FG009|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
3221824|NCT02286518|3953726|FG010|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
3221825|NCT02286518|3953727|FG011|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
3221826|NCT02286518|3953728|FG012|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
3221827|NCT02286518|3953729|FG013|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
3221828|NCT02286713|3953777|FG000|STARTED|One Week Follow-Up||259
3221829|NCT02286713|3953778|FG001|STARTED|One Week Follow-Up||257
3221830|NCT02286713|3953777|FG000|COMPLETED|One Week Follow-Up||235
3221831|NCT02286713|3953778|FG001|COMPLETED|One Week Follow-Up||233
3221832|NCT02286713|3953777|FG000|NOT COMPLETED|One Week Follow-Up||24
3221833|NCT02286713|3953778|FG001|NOT COMPLETED|One Week Follow-Up||24
3221834|NCT02286713|3953777|FG000|STARTED|Three Month Follow-Up||252
3221835|NCT02286713|3953778|FG001|STARTED|Three Month Follow-Up||254
3367873|NCT03857750|4099452|FG001|NOT COMPLETED|Overall Study||0
3367874|NCT03856255|4099458|FG000|STARTED|Overall Study||23
3367875|NCT03856255|4099458|FG000|COMPLETED|Overall Study||23
3367876|NCT03856255|4099458|FG000|NOT COMPLETED|Overall Study||0
3367877|NCT03850509|4099464|FG000|STARTED|Overall Study||2
3367878|NCT03850509|4099465|FG001|STARTED|Overall Study||1
3367879|NCT03850509|4099464|FG000|COMPLETED|Overall Study||0
3367880|NCT03850509|4099465|FG001|COMPLETED|Overall Study||0
3367881|NCT03850509|4099464|FG000|NOT COMPLETED|Overall Study||2
3367882|NCT03850509|4099465|FG001|NOT COMPLETED|Overall Study||1
3367883|NCT03860753|4099473|FG000|STARTED|Overall Study||4
3367884|NCT03860753|4099474|FG001|STARTED|Overall Study||0
3367885|NCT03860753|4099473|FG000|COMPLETED|Overall Study||4
3367886|NCT03860753|4099474|FG001|COMPLETED|Overall Study||0
3367887|NCT03860753|4099473|FG000|NOT COMPLETED|Overall Study||0
3367888|NCT03860753|4099474|FG001|NOT COMPLETED|Overall Study||0
3367889|NCT03848455|4099483|FG000|STARTED|Overall Study||90
3367890|NCT03848455|4099484|FG001|STARTED|Overall Study||125
3367891|NCT03848455|4099485|FG002|STARTED|Overall Study||23
3367892|NCT03848455|4099483|FG000|COMPLETED|Overall Study||90
3367893|NCT03848455|4099484|FG001|COMPLETED|Overall Study||125
3367894|NCT03848455|4099485|FG002|COMPLETED|Overall Study||23
3367895|NCT03848455|4099483|FG000|NOT COMPLETED|Overall Study||0
3367896|NCT03848455|4099484|FG001|NOT COMPLETED|Overall Study||0
3367897|NCT03848455|4099485|FG002|NOT COMPLETED|Overall Study||0
3367898|NCT03858894|4099496|FG000|STARTED|Overall Study||48
3367899|NCT03858894|4099497|FG001|STARTED|Overall Study||50
3367900|NCT03858894|4099496|FG000|COMPLETED|Overall Study||44
3367901|NCT03858894|4099497|FG001|COMPLETED|Overall Study||50
3367902|NCT03858894|4099496|FG000|NOT COMPLETED|Overall Study||4
3367903|NCT03858894|4099497|FG001|NOT COMPLETED|Overall Study||0
3367904|NCT03856164|4099505|FG000|STARTED|Overall Study||55
3367905|NCT03856164|4099506|FG001|STARTED|Overall Study||55
3367906|NCT03856164|4099505|FG000|COMPLETED|Overall Study||55
3367907|NCT03856164|4099506|FG001|COMPLETED|Overall Study||55
3367908|NCT03856164|4099505|FG000|NOT COMPLETED|Overall Study||0
3367909|NCT03856164|4099506|FG001|NOT COMPLETED|Overall Study||0
3367910|NCT03850275|4099520|FG000|STARTED|Overall Study||5
3367911|NCT03850275|4099521|FG001|STARTED|Overall Study||5
3367912|NCT03850275|4099522|FG002|STARTED|Overall Study||5
3367913|NCT03850275|4099523|FG003|STARTED|Overall Study||5
3367914|NCT03850275|4099524|FG004|STARTED|Overall Study||5
3367915|NCT03850275|4099525|FG005|STARTED|Overall Study||5
3367916|NCT03850275|4099520|FG000|COMPLETED|Overall Study||5
3367917|NCT03850275|4099521|FG001|COMPLETED|Overall Study||5
3367918|NCT03850275|4099522|FG002|COMPLETED|Overall Study||5
3367919|NCT03850275|4099523|FG003|COMPLETED|Overall Study||5
3367920|NCT03850275|4099524|FG004|COMPLETED|Overall Study||5
3367921|NCT03850275|4099525|FG005|COMPLETED|Overall Study||5
3367922|NCT03850275|4099520|FG000|NOT COMPLETED|Overall Study||0
3367923|NCT03850275|4099521|FG001|NOT COMPLETED|Overall Study||0
3367924|NCT03850275|4099522|FG002|NOT COMPLETED|Overall Study||0
3367925|NCT03850275|4099523|FG003|NOT COMPLETED|Overall Study||0
3367926|NCT03850275|4099524|FG004|NOT COMPLETED|Overall Study||0
3367927|NCT03850275|4099525|FG005|NOT COMPLETED|Overall Study||0
3367928|NCT03851016|4099550|FG000|STARTED|First Intervention (3 Weeks)||12
3367929|NCT03851016|4099551|FG001|STARTED|First Intervention (3 Weeks)||12
3367930|NCT03851016|4099550|FG000|COMPLETED|First Intervention (3 Weeks)||11
3367931|NCT03851016|4099551|FG001|COMPLETED|First Intervention (3 Weeks)||10
3367932|NCT03851016|4099550|FG000|NOT COMPLETED|First Intervention (3 Weeks)||1
3367933|NCT03851016|4099551|FG001|NOT COMPLETED|First Intervention (3 Weeks)||2
3367934|NCT03851016|4099550|FG000|STARTED|Washout (1 Week)||11
3367935|NCT03851016|4099551|FG001|STARTED|Washout (1 Week)||10
3367936|NCT03851016|4099550|FG000|COMPLETED|Washout (1 Week)||11
3367937|NCT03851016|4099551|FG001|COMPLETED|Washout (1 Week)||10
3367938|NCT03851016|4099550|FG000|NOT COMPLETED|Washout (1 Week)||0
3367939|NCT03851016|4099551|FG001|NOT COMPLETED|Washout (1 Week)||0
3367940|NCT03851016|4099550|FG000|STARTED|Second Intervention (3 Weeks)||11
3367941|NCT03851016|4099551|FG001|STARTED|Second Intervention (3 Weeks)||10
3367942|NCT03851016|4099550|FG000|COMPLETED|Second Intervention (3 Weeks)||11
3367943|NCT03851016|4099551|FG001|COMPLETED|Second Intervention (3 Weeks)||10
3367944|NCT03851016|4099550|FG000|NOT COMPLETED|Second Intervention (3 Weeks)||0
3367945|NCT03851016|4099551|FG001|NOT COMPLETED|Second Intervention (3 Weeks)||0
3367946|NCT03850496|4099560|FG000|STARTED|Overall Study||26
3367947|NCT03850496|4099561|FG001|STARTED|Overall Study||25
3367948|NCT03850496|4099562|FG002|STARTED|Overall Study||25
3367949|NCT03850496|4099560|FG000|COMPLETED|Overall Study||25
3367950|NCT03850496|4099561|FG001|COMPLETED|Overall Study||24
3367951|NCT03850496|4099562|FG002|COMPLETED|Overall Study||21
3367952|NCT03850496|4099560|FG000|NOT COMPLETED|Overall Study||1
3367953|NCT03850496|4099561|FG001|NOT COMPLETED|Overall Study||1
3367954|NCT03850496|4099562|FG002|NOT COMPLETED|Overall Study||4
3367955|NCT03848949|4099572|FG000|STARTED|Overall Study||54
3367956|NCT03848949|4099573|FG001|STARTED|Overall Study||53
3367957|NCT03848949|4099572|FG000|COMPLETED|Overall Study||49
3367958|NCT03848949|4099573|FG001|COMPLETED|Overall Study||46
3367959|NCT03848949|4099572|FG000|NOT COMPLETED|Overall Study||5
3367960|NCT03848949|4099573|FG001|NOT COMPLETED|Overall Study||7
3367961|NCT03849690|4099579|FG000|STARTED|Period 1 (3 Days)||12
3367962|NCT03849690|4099579|FG000|COMPLETED|Period 1 (3 Days)||12
3221836|NCT02286713|3953777|FG000|COMPLETED|Three Month Follow-Up||224
3221837|NCT02286713|3953778|FG001|COMPLETED|Three Month Follow-Up||228
3221838|NCT02286713|3953777|FG000|NOT COMPLETED|Three Month Follow-Up||28
3221839|NCT02286713|3953778|FG001|NOT COMPLETED|Three Month Follow-Up||26
3221840|NCT02286713|3953777|FG000|STARTED|Six Month Follow-Up||250
3221841|NCT02286713|3953778|FG001|STARTED|Six Month Follow-Up||252
3221842|NCT02286713|3953777|FG000|COMPLETED|Six Month Follow-Up||218
3221843|NCT02286713|3953778|FG001|COMPLETED|Six Month Follow-Up||225
3221844|NCT02286713|3953777|FG000|NOT COMPLETED|Six Month Follow-Up||32
3221845|NCT02286713|3953778|FG001|NOT COMPLETED|Six Month Follow-Up||27
3221846|NCT02286726|3953787|FG000|STARTED|Overall Study||16
3221847|NCT02286726|3953788|FG001|STARTED|Overall Study||24
3221848|NCT02286726|3953789|FG002|STARTED|Overall Study||16
3221849|NCT02286726|3953787|FG000|COMPLETED|Overall Study||16
3221850|NCT02286726|3953788|FG001|COMPLETED|Overall Study||24
3221851|NCT02286726|3953789|FG002|COMPLETED|Overall Study||16
3221852|NCT02286726|3953787|FG000|NOT COMPLETED|Overall Study||0
3221853|NCT02286726|3953788|FG001|NOT COMPLETED|Overall Study||0
3221854|NCT02286726|3953789|FG002|NOT COMPLETED|Overall Study||0
3221855|NCT02286843|3953797|FG000|STARTED|Overall Study||49
3221856|NCT02286843|3953797|FG000|COMPLETED|Overall Study||43
3221857|NCT02286843|3953797|FG000|NOT COMPLETED|Overall Study||6
3221858|NCT02286895|3953803|FG000|STARTED|Randomized and Vaccinated||300
3221859|NCT02286895|3953804|FG001|STARTED|Randomized and Vaccinated||300
3221860|NCT02286895|3953803|FG000|COMPLETED|Randomized and Vaccinated||300
3221861|NCT02286895|3953804|FG001|COMPLETED|Randomized and Vaccinated||300
3221862|NCT02286895|3953803|FG000|NOT COMPLETED|Randomized and Vaccinated||0
3221863|NCT02286895|3953804|FG001|NOT COMPLETED|Randomized and Vaccinated||0
3221864|NCT02286895|3953803|FG000|STARTED|Assessed for Measles Seroconversion||300
3221865|NCT02286895|3953804|FG001|STARTED|Assessed for Measles Seroconversion||300
3221866|NCT02286895|3953803|FG000|COMPLETED|Assessed for Measles Seroconversion||252
3221867|NCT02286895|3953804|FG001|COMPLETED|Assessed for Measles Seroconversion||261
3221868|NCT02286895|3953803|FG000|NOT COMPLETED|Assessed for Measles Seroconversion||48
3221869|NCT02286895|3953804|FG001|NOT COMPLETED|Assessed for Measles Seroconversion||39
3221870|NCT02286921|3953812|FG000|STARTED|Overall Study||94
3221871|NCT02286921|3953813|FG001|STARTED|Overall Study||101
3221872|NCT02286921|3953812|FG000|COMPLETED|Overall Study||94
3221873|NCT02286921|3953813|FG001|COMPLETED|Overall Study||101
3221874|NCT02286921|3953812|FG000|NOT COMPLETED|Overall Study||0
3221875|NCT02286921|3953813|FG001|NOT COMPLETED|Overall Study||0
3221876|NCT02286947|3953819|FG000|STARTED|Overall Study||24
3221877|NCT02286947|3953819|FG000|COMPLETED|Overall Study||22
3221878|NCT02286947|3953819|FG000|NOT COMPLETED|Overall Study||2
3221879|NCT02286960|3953827|FG000|STARTED|Overall Study||19
3221880|NCT02286960|3953828|FG001|STARTED|Overall Study||17
3221881|NCT02286960|3953827|FG000|COMPLETED|Overall Study||16
3221882|NCT02286960|3953828|FG001|COMPLETED|Overall Study||14
3221883|NCT02286960|3953827|FG000|NOT COMPLETED|Overall Study||3
3221884|NCT02286960|3953828|FG001|NOT COMPLETED|Overall Study||3
3221885|NCT02287038|3953836|FG000|STARTED|Overall Study||23
3221886|NCT02287038|3953837|FG001|STARTED|Overall Study||21
3221887|NCT02287038|3953836|FG000|COMPLETED|Overall Study||18
3221888|NCT02287038|3953837|FG001|COMPLETED|Overall Study||18
3221889|NCT02287038|3953836|FG000|NOT COMPLETED|Overall Study||5
3221890|NCT02287038|3953837|FG001|NOT COMPLETED|Overall Study||3
3221891|NCT02287350|3953845|FG000|STARTED|Overall Study||51
3221892|NCT02287350|3953845|FG000|COMPLETED|Overall Study||48
3221893|NCT02287350|3953845|FG000|NOT COMPLETED|Overall Study||3
3221894|NCT02287376|3953849|FG000|STARTED|Overall Study||25
3221895|NCT02287376|3953849|FG000|COMPLETED|Overall Study||25
3221896|NCT02287376|3953849|FG000|NOT COMPLETED|Overall Study||0
3221897|NCT02287402|3953853|FG000|STARTED|Treatment Period||197
3221898|NCT02287402|3953853|FG000|COMPLETED|Treatment Period||170
3221899|NCT02287402|3953853|FG000|NOT COMPLETED|Treatment Period||27
3221900|NCT02287402|3953853|FG000|STARTED|Follow-up|64 participants who completed the Treatment Period did not continue to Follow-up.|106
3221901|NCT02287402|3953853|FG000|COMPLETED|Follow-up||103
3221902|NCT02287402|3953853|FG000|NOT COMPLETED|Follow-up||3
3221903|NCT02287415|3953857|FG000|STARTED|Overall Study||13
3221904|NCT02287415|3953857|FG000|COMPLETED|Overall Study||13
3221905|NCT02287415|3953857|FG000|NOT COMPLETED|Overall Study||0
3221906|NCT02287467|3953863|FG000|STARTED|Overall Study||168
3221907|NCT02287467|3953864|FG001|STARTED|Overall Study||161
3221908|NCT02287467|3953863|FG000|COMPLETED|Overall Study||156
3221909|NCT02287467|3953864|FG001|COMPLETED|Overall Study||152
3221910|NCT02287467|3953863|FG000|NOT COMPLETED|Overall Study||12
3221911|NCT02287467|3953864|FG001|NOT COMPLETED|Overall Study||9
3221912|NCT02287584|3953876|FG000|STARTED|the Double-blind Phase||190
3221913|NCT02287584|3953877|FG001|STARTED|the Double-blind Phase||196
3221914|NCT02287584|3953878|FG002|STARTED|the Double-blind Phase||194
3221915|NCT02287584|3953879|FG003|STARTED|the Double-blind Phase||0
3221916|NCT02287584|3953880|FG004|STARTED|the Double-blind Phase||0
3221917|NCT02287584|3953881|FG005|STARTED|the Double-blind Phase||0
3221918|NCT02287584|3953876|FG000|COMPLETED|the Double-blind Phase||138
3221919|NCT02287584|3953877|FG001|COMPLETED|the Double-blind Phase||149
3221920|NCT02287584|3953878|FG002|COMPLETED|the Double-blind Phase||161
3221921|NCT02287584|3953879|FG003|COMPLETED|the Double-blind Phase||0
3221922|NCT02287584|3953880|FG004|COMPLETED|the Double-blind Phase||0
3221923|NCT02287584|3953881|FG005|COMPLETED|the Double-blind Phase||0
3221924|NCT02287584|3953876|FG000|NOT COMPLETED|the Double-blind Phase||52
3221925|NCT02287584|3953877|FG001|NOT COMPLETED|the Double-blind Phase||47
3221926|NCT02287584|3953878|FG002|NOT COMPLETED|the Double-blind Phase||33
3221927|NCT02287584|3953879|FG003|NOT COMPLETED|the Double-blind Phase||0
3221928|NCT02287584|3953880|FG004|NOT COMPLETED|the Double-blind Phase||0
3221929|NCT02287584|3953881|FG005|NOT COMPLETED|the Double-blind Phase||0
3221930|NCT02287584|3953876|FG000|STARTED|the Open-label Phase||0
3221931|NCT02287584|3953877|FG001|STARTED|the Open-label Phase||0
3221932|NCT02287584|3953878|FG002|STARTED|the Open-label Phase||0
3221933|NCT02287584|3953879|FG003|STARTED|the Open-label Phase||138
3221934|NCT02287584|3953880|FG004|STARTED|the Open-label Phase||149
3221935|NCT02287584|3953881|FG005|STARTED|the Open-label Phase||161
3221936|NCT02287584|3953876|FG000|Treated|the Open-label Phase||0
3221937|NCT02287584|3953877|FG001|Treated|the Open-label Phase||0
3221938|NCT02287584|3953878|FG002|Treated|the Open-label Phase||0
3221939|NCT02287584|3953879|FG003|Treated|the Open-label Phase||131
3221940|NCT02287584|3953880|FG004|Treated|the Open-label Phase||143
3221941|NCT02287584|3953881|FG005|Treated|the Open-label Phase||157
3221942|NCT02287584|3953876|FG000|COMPLETED|the Open-label Phase||0
3221943|NCT02287584|3953877|FG001|COMPLETED|the Open-label Phase||0
3221944|NCT02287584|3953878|FG002|COMPLETED|the Open-label Phase||0
3221945|NCT02287584|3953879|FG003|COMPLETED|the Open-label Phase||81
3221946|NCT02287584|3953880|FG004|COMPLETED|the Open-label Phase||87
3221947|NCT02287584|3953881|FG005|COMPLETED|the Open-label Phase||104
3221948|NCT02287584|3953876|FG000|NOT COMPLETED|the Open-label Phase||0
3221949|NCT02287584|3953877|FG001|NOT COMPLETED|the Open-label Phase||0
3221950|NCT02287584|3953878|FG002|NOT COMPLETED|the Open-label Phase||0
3221951|NCT02287584|3953879|FG003|NOT COMPLETED|the Open-label Phase||57
3221952|NCT02287584|3953880|FG004|NOT COMPLETED|the Open-label Phase||62
3221953|NCT02287584|3953881|FG005|NOT COMPLETED|the Open-label Phase||57
3221954|NCT02287610|3953895|FG000|STARTED|Overall Study||64
3221955|NCT02287610|3953895|FG000|Per Protocol Follow-Up|Overall Study||56
3221956|NCT02287610|3953895|FG000|COMPLETED|Overall Study||48
3221957|NCT02287610|3953895|FG000|NOT COMPLETED|Overall Study||16
3221958|NCT02287623|3953901|FG000|STARTED|Overall Study||30
3221959|NCT02287623|3953902|FG001|STARTED|Overall Study||30
3221960|NCT02287623|3953901|FG000|COMPLETED|Overall Study||30
3221961|NCT02287623|3953902|FG001|COMPLETED|Overall Study||29
3221962|NCT02287623|3953901|FG000|NOT COMPLETED|Overall Study||0
3221963|NCT02287623|3953902|FG001|NOT COMPLETED|Overall Study||1
3221964|NCT02287675|3953910|FG000|STARTED|Overall Study||22
3221965|NCT02287675|3953911|FG001|STARTED|Overall Study||18
3221966|NCT02287675|3953910|FG000|COMPLETED|Overall Study||22
3221967|NCT02287675|3953911|FG001|COMPLETED|Overall Study||18
3221968|NCT02287675|3953910|FG000|NOT COMPLETED|Overall Study||0
3221969|NCT02287675|3953911|FG001|NOT COMPLETED|Overall Study||0
3221970|NCT02287688|3953917|FG000|STARTED|Overall Study||138
3221971|NCT02287688|3953917|FG000|COMPLETED|Overall Study||138
3221972|NCT02287688|3953917|FG000|NOT COMPLETED|Overall Study||0
3221973|NCT02287779|3953929|FG000|STARTED|Overall Study||21
3221974|NCT02287779|3953930|FG001|STARTED|Overall Study||9
3221975|NCT02287779|3953931|FG002|STARTED|Overall Study||9
3221976|NCT02287779|3953932|FG003|STARTED|Overall Study||9
3221977|NCT02287779|3953933|FG004|STARTED|Overall Study||9
3221978|NCT02287779|3953934|FG005|STARTED|Overall Study||9
3221979|NCT02287779|3953935|FG006|STARTED|Overall Study||9
3221980|NCT02287779|3953936|FG007|STARTED|Overall Study||9
3221981|NCT02287779|3953929|FG000|COMPLETED|Overall Study||21
3221982|NCT02287779|3953930|FG001|COMPLETED|Overall Study||9
3221983|NCT02287779|3953931|FG002|COMPLETED|Overall Study||9
3221984|NCT02287779|3953932|FG003|COMPLETED|Overall Study||9
3221985|NCT02287779|3953933|FG004|COMPLETED|Overall Study||9
3221986|NCT02287779|3953934|FG005|COMPLETED|Overall Study||9
3221987|NCT02287779|3953935|FG006|COMPLETED|Overall Study||9
3221988|NCT02287779|3953936|FG007|COMPLETED|Overall Study||9
3221989|NCT02287779|3953929|FG000|NOT COMPLETED|Overall Study||0
3221990|NCT02287779|3953930|FG001|NOT COMPLETED|Overall Study||0
3221991|NCT02287779|3953931|FG002|NOT COMPLETED|Overall Study||0
3221992|NCT02287779|3953932|FG003|NOT COMPLETED|Overall Study||0
3221993|NCT02287779|3953933|FG004|NOT COMPLETED|Overall Study||0
3221994|NCT02287779|3953934|FG005|NOT COMPLETED|Overall Study||0
3221995|NCT02287779|3953935|FG006|NOT COMPLETED|Overall Study||0
3221996|NCT02287779|3953936|FG007|NOT COMPLETED|Overall Study||0
3221997|NCT02287818|3953960|FG000|STARTED|Overall Study||60
3221998|NCT02287818|3953961|FG001|STARTED|Overall Study||67
3221999|NCT02287818|3953960|FG000|COMPLETED|Overall Study||53
3222000|NCT02287818|3953961|FG001|COMPLETED|Overall Study||54
3222001|NCT02287818|3953960|FG000|NOT COMPLETED|Overall Study||7
3222002|NCT02287818|3953961|FG001|NOT COMPLETED|Overall Study||13
3222003|NCT02287883|3953969|FG000|STARTED|Overall Study||1081
3222004|NCT02287883|3953970|FG001|STARTED|Overall Study||1095
3222005|NCT02287883|3953969|FG000|One-year Follow-up Survey|Overall Study||622
3222006|NCT02287883|3953970|FG001|One-year Follow-up Survey|Overall Study||669
3222007|NCT02287883|3953969|FG000|COMPLETED|Overall Study||622
3222008|NCT02287883|3953970|FG001|COMPLETED|Overall Study||669
3222009|NCT02287883|3953969|FG000|NOT COMPLETED|Overall Study||459
3222010|NCT02287883|3953970|FG001|NOT COMPLETED|Overall Study||426
3222011|NCT02287896|3953978|FG000|STARTED|Screening Visit V1||36
3222012|NCT02287896|3953979|FG001|STARTED|Screening Visit V1||26
3222013|NCT02287896|3953978|FG000|COMPLETED|Screening Visit V1||36
3222014|NCT02287896|3953979|FG001|COMPLETED|Screening Visit V1||26
3222015|NCT02287896|3953978|FG000|NOT COMPLETED|Screening Visit V1||0
3222016|NCT02287896|3953979|FG001|NOT COMPLETED|Screening Visit V1||0
3222017|NCT02287896|3953978|FG000|STARTED|First Injection Visit||36
3222018|NCT02287896|3953979|FG001|STARTED|First Injection Visit||26
3222019|NCT02287896|3953978|FG000|COMPLETED|First Injection Visit||36
3222020|NCT02287896|3953979|FG001|COMPLETED|First Injection Visit||26
3222021|NCT02287896|3953978|FG000|NOT COMPLETED|First Injection Visit||0
3222022|NCT02287896|3953979|FG001|NOT COMPLETED|First Injection Visit||0
3222023|NCT02287896|3953978|FG000|STARTED|Second Injection Visit||36
3222024|NCT02287896|3953979|FG001|STARTED|Second Injection Visit||26
3222025|NCT02287896|3953978|FG000|COMPLETED|Second Injection Visit||36
3222026|NCT02287896|3953979|FG001|COMPLETED|Second Injection Visit||25
3222027|NCT02287896|3953978|FG000|NOT COMPLETED|Second Injection Visit||0
3222028|NCT02287896|3953979|FG001|NOT COMPLETED|Second Injection Visit||1
3222029|NCT02287909|3953995|FG000|STARTED|Overall Study||20
3222030|NCT02287909|3953996|FG001|STARTED|Overall Study||20
3222031|NCT02287909|3953997|FG002|STARTED|Overall Study||20
3222032|NCT02287909|3953998|FG003|STARTED|Overall Study||20
3222033|NCT02287909|3953995|FG000|COMPLETED|Overall Study||18
3222034|NCT02287909|3953996|FG001|COMPLETED|Overall Study||19
3222035|NCT02287909|3953997|FG002|COMPLETED|Overall Study||20
3222036|NCT02287909|3953998|FG003|COMPLETED|Overall Study||19
3222037|NCT02287909|3953995|FG000|NOT COMPLETED|Overall Study||2
3222038|NCT02287909|3953996|FG001|NOT COMPLETED|Overall Study||1
3222039|NCT02287909|3953997|FG002|NOT COMPLETED|Overall Study||0
3222040|NCT02287909|3953998|FG003|NOT COMPLETED|Overall Study||1
3222041|NCT02287922|3954012|FG000|STARTED|Overall Study||62
3222042|NCT02287922|3954013|FG001|STARTED|Overall Study||62
3222043|NCT02287922|3954014|FG002|STARTED|Overall Study||63
3222044|NCT02287922|3954015|FG003|STARTED|Overall Study||64
3222045|NCT02287922|3954012|FG000|COMPLETED|Overall Study||59
3222046|NCT02287922|3954013|FG001|COMPLETED|Overall Study||60
3222047|NCT02287922|3954014|FG002|COMPLETED|Overall Study||56
3222048|NCT02287922|3954015|FG003|COMPLETED|Overall Study||57
3222049|NCT02287922|3954012|FG000|NOT COMPLETED|Overall Study||3
3222050|NCT02287922|3954013|FG001|NOT COMPLETED|Overall Study||2
3222051|NCT02287922|3954014|FG002|NOT COMPLETED|Overall Study||7
3222052|NCT02287922|3954015|FG003|NOT COMPLETED|Overall Study||7
3222053|NCT02288091|3954026|FG000|STARTED|Overall Study||32
3222054|NCT02288091|3954026|FG000|Randomized/Treated|Overall Study||25
3222055|NCT02288091|3954026|FG000|COMPLETED|Overall Study||24
3222056|NCT02288091|3954026|FG000|NOT COMPLETED|Overall Study||8
3222057|NCT02288156|3954034|FG000|STARTED|Overall Study||20
3222058|NCT02288156|3954035|FG001|STARTED|Overall Study||20
3222059|NCT02288156|3954036|FG002|STARTED|Overall Study||20
3222060|NCT02288156|3954037|FG003|STARTED|Overall Study||20
3222061|NCT02288156|3954034|FG000|COMPLETED|Overall Study||16
3222062|NCT02288156|3954035|FG001|COMPLETED|Overall Study||16
3222063|NCT02288156|3954036|FG002|COMPLETED|Overall Study||18
3222064|NCT02288156|3954037|FG003|COMPLETED|Overall Study||18
3222065|NCT02288156|3954034|FG000|NOT COMPLETED|Overall Study||4
3222066|NCT02288156|3954035|FG001|NOT COMPLETED|Overall Study||4
3222067|NCT02288156|3954036|FG002|NOT COMPLETED|Overall Study||2
3222068|NCT02288156|3954037|FG003|NOT COMPLETED|Overall Study||2
3222069|NCT02288182|3954051|FG000|STARTED|Overall Study||25
3222070|NCT02288182|3954052|FG001|STARTED|Overall Study||27
3222071|NCT02288182|3954051|FG000|COMPLETED|Overall Study||25
3222072|NCT02288182|3954052|FG001|COMPLETED|Overall Study||25
3222073|NCT02288182|3954051|FG000|NOT COMPLETED|Overall Study||0
3222074|NCT02288182|3954052|FG001|NOT COMPLETED|Overall Study||2
3222075|NCT02288273|3954062|FG000|STARTED|Overall Study||61
3222076|NCT02288273|3954063|FG001|STARTED|Overall Study||56
3222077|NCT02288273|3954062|FG000|COMPLETED|Overall Study||53
3222078|NCT02288273|3954063|FG001|COMPLETED|Overall Study||48
3222079|NCT02288273|3954062|FG000|NOT COMPLETED|Overall Study||8
3222080|NCT02288273|3954063|FG001|NOT COMPLETED|Overall Study||8
3222081|NCT02288312|3954072|FG000|STARTED|Overall Study||6
3222082|NCT02288312|3954073|FG001|STARTED|Overall Study||6
3222083|NCT02288312|3954074|FG002|STARTED|Overall Study||6
3222084|NCT02288312|3954072|FG000|COMPLETED|Overall Study||5
3222085|NCT02288312|3954073|FG001|COMPLETED|Overall Study||6
3222086|NCT02288312|3954074|FG002|COMPLETED|Overall Study||6
3222087|NCT02288312|3954072|FG000|NOT COMPLETED|Overall Study||1
3222088|NCT02288312|3954073|FG001|NOT COMPLETED|Overall Study||0
3222089|NCT02288312|3954074|FG002|NOT COMPLETED|Overall Study||0
3222090|NCT02288325|3954082|FG000|STARTED|Run-in Period||644
3222091|NCT02288325|3954083|FG001|STARTED|Run-in Period||0
3222092|NCT02288325|3954084|FG002|STARTED|Run-in Period||0
3222093|NCT02288325|3954082|FG000|COMPLETED|Run-in Period||499
3222094|NCT02288325|3954083|FG001|COMPLETED|Run-in Period||0
3222095|NCT02288325|3954084|FG002|COMPLETED|Run-in Period||0
3222096|NCT02288325|3954082|FG000|NOT COMPLETED|Run-in Period||145
3222097|NCT02288325|3954083|FG001|NOT COMPLETED|Run-in Period||0
3222098|NCT02288325|3954084|FG002|NOT COMPLETED|Run-in Period||0
3222099|NCT02288325|3954082|FG000|STARTED|Stabilization Period|70 participants did not enter Stabilization Period (69 did not meet entry criteria; 1 other reason)|429
3222100|NCT02288325|3954083|FG001|STARTED|Stabilization Period||0
3222101|NCT02288325|3954084|FG002|STARTED|Stabilization Period||0
3222102|NCT02288325|3954082|FG000|COMPLETED|Stabilization Period||331
3222103|NCT02288325|3954083|FG001|COMPLETED|Stabilization Period||0
3222104|NCT02288325|3954084|FG002|COMPLETED|Stabilization Period||0
3222105|NCT02288325|3954082|FG000|NOT COMPLETED|Stabilization Period||98
3222106|NCT02288325|3954083|FG001|NOT COMPLETED|Stabilization Period||0
3222107|NCT02288325|3954084|FG002|NOT COMPLETED|Stabilization Period||0
3222108|NCT02288325|3954082|FG000|STARTED|Double-blind Treatment Period||0
3222109|NCT02288325|3954083|FG001|STARTED|Double-blind Treatment Period|7 participants did not enter Double-Blind Period (2 did not meet entry criteria; 5 other reasons)|159
3222110|NCT02288325|3954084|FG002|STARTED|Double-blind Treatment Period|7 participants did not enter Double-Blind Period (2 did not meet entry criteria; 5 other reasons)|165
3222111|NCT02288325|3954082|FG000|COMPLETED|Double-blind Treatment Period||0
3222112|NCT02288325|3954083|FG001|COMPLETED|Double-blind Treatment Period||135
3222113|NCT02288325|3954084|FG002|COMPLETED|Double-blind Treatment Period||139
3222114|NCT02288325|3954082|FG000|NOT COMPLETED|Double-blind Treatment Period||0
3222115|NCT02288325|3954083|FG001|NOT COMPLETED|Double-blind Treatment Period||24
3222116|NCT02288325|3954084|FG002|NOT COMPLETED|Double-blind Treatment Period||26
3222117|NCT02288364|3954093|FG000|STARTED|Overall Study||42
3222118|NCT02288364|3954094|FG001|STARTED|Overall Study||44
3222119|NCT02288364|3954093|FG000|COMPLETED|Overall Study||42
3222120|NCT02288364|3954094|FG001|COMPLETED|Overall Study||44
3222121|NCT02288364|3954093|FG000|NOT COMPLETED|Overall Study||0
3222122|NCT02288364|3954094|FG001|NOT COMPLETED|Overall Study||0
3222123|NCT02288377|3954102|FG000|STARTED|Overall Study||26
3222124|NCT02288377|3954103|FG001|STARTED|Overall Study||27
3222125|NCT02288377|3954102|FG000|COMPLETED|Overall Study||25
3222126|NCT02288377|3954103|FG001|COMPLETED|Overall Study||27
3222127|NCT02288377|3954102|FG000|NOT COMPLETED|Overall Study||1
3222128|NCT02288377|3954103|FG001|NOT COMPLETED|Overall Study||0
3222129|NCT02288559|3954113|FG000|STARTED|Overall Study||10
3222130|NCT02288559|3954114|FG001|STARTED|Overall Study||11
3222131|NCT02288559|3954115|FG002|STARTED|Overall Study||46
3222132|NCT02288559|3954116|FG003|STARTED|Overall Study||22
3222133|NCT02288559|3954113|FG000|COMPLETED|Overall Study||9
3222134|NCT02288559|3954114|FG001|COMPLETED|Overall Study||10
3222135|NCT02288559|3954115|FG002|COMPLETED|Overall Study||35
3222136|NCT02288559|3954116|FG003|COMPLETED|Overall Study||20
3222137|NCT02288559|3954113|FG000|NOT COMPLETED|Overall Study||1
3222138|NCT02288559|3954114|FG001|NOT COMPLETED|Overall Study||1
3222139|NCT02288559|3954115|FG002|NOT COMPLETED|Overall Study||11
3222140|NCT02288559|3954116|FG003|NOT COMPLETED|Overall Study||2
3222141|NCT02288819|3954128|FG000|STARTED|Overall Study||50
3222142|NCT02288819|3954128|FG000|COMPLETED|Overall Study||50
3222143|NCT02288819|3954128|FG000|NOT COMPLETED|Overall Study||0
3222144|NCT02289079|3954134|FG000|STARTED|Overall Study||30
3222145|NCT02289079|3954135|FG001|STARTED|Overall Study||30
3222146|NCT02289079|3954134|FG000|COMPLETED|Overall Study||28
3222147|NCT02289079|3954135|FG001|COMPLETED|Overall Study||29
3222148|NCT02289079|3954134|FG000|NOT COMPLETED|Overall Study||2
3222149|NCT02289079|3954135|FG001|NOT COMPLETED|Overall Study||1
3222150|NCT02289105|3954143|FG000|STARTED|Overall Study||642
3222151|NCT02289105|3954144|FG001|STARTED|Overall Study||637
3222152|NCT02289105|3954143|FG000|COMPLETED|Overall Study||642
3222153|NCT02289105|3954144|FG001|COMPLETED|Overall Study||637
3222154|NCT02289105|3954143|FG000|NOT COMPLETED|Overall Study||0
3222155|NCT02289105|3954144|FG001|NOT COMPLETED|Overall Study||0
3222156|NCT02289157|3954152|FG000|STARTED|Overall Study||222
3222157|NCT02289157|3954153|FG001|STARTED|Overall Study||219
3222158|NCT02289157|3954152|FG000|No Post op Check or Follow up Phone Call|Overall Study||2
3222159|NCT02289157|3954153|FG001|No Post op Check or Follow up Phone Call|Overall Study||4
3222160|NCT02289157|3954152|FG000|COMPLETED|Overall Study||222
3222161|NCT02289157|3954153|FG001|COMPLETED|Overall Study||219
3222162|NCT02289157|3954152|FG000|NOT COMPLETED|Overall Study||0
3222163|NCT02289157|3954153|FG001|NOT COMPLETED|Overall Study||0
3222164|NCT02289222|3954159|FG000|STARTED|Overall Study||48
3222165|NCT02289222|3954159|FG000|COMPLETED|Overall Study||48
3222166|NCT02289222|3954159|FG000|NOT COMPLETED|Overall Study||0
3222167|NCT02289352|3954166|FG000|STARTED|Overall Study||199
3222168|NCT02289352|3954167|FG001|STARTED|Overall Study||199
3222169|NCT02289352|3954168|FG002|STARTED|Overall Study||64
3222170|NCT02289352|3954166|FG000|Safety Population|Overall Study||199
3222171|NCT02289352|3954167|FG001|Safety Population|Overall Study||199
3222172|NCT02289352|3954168|FG002|Safety Population|Overall Study||64
3222173|NCT02289352|3954166|FG000|mITT Population|Overall Study||191
3222174|NCT02289352|3954167|FG001|mITT Population|Overall Study||193
3222175|NCT02289352|3954168|FG002|mITT Population|Overall Study||58
3222176|NCT02289352|3954166|FG000|PP Population|Overall Study||173
3222177|NCT02289352|3954167|FG001|PP Population|Overall Study||173
3222178|NCT02289352|3954168|FG002|PP Population|Overall Study||54
3222179|NCT02289352|3954166|FG000|COMPLETED|Overall Study||198
3222180|NCT02289352|3954167|FG001|COMPLETED|Overall Study||198
3222181|NCT02289352|3954168|FG002|COMPLETED|Overall Study||64
3222182|NCT02289352|3954166|FG000|NOT COMPLETED|Overall Study||1
3222183|NCT02289352|3954167|FG001|NOT COMPLETED|Overall Study||1
3222184|NCT02289352|3954168|FG002|NOT COMPLETED|Overall Study||0
3222185|NCT02289417|3954180|FG000|STARTED|Placebo-Controlled Phase Weeks 0-12||58
3222186|NCT02289417|3954181|FG001|STARTED|Placebo-Controlled Phase Weeks 0-12||57
3222187|NCT02289417|3954182|FG002|STARTED|Placebo-Controlled Phase Weeks 0-12||55
3222188|NCT02289417|3954183|FG003|STARTED|Placebo-Controlled Phase Weeks 0-12||0
3222189|NCT02289417|3954184|FG004|STARTED|Placebo-Controlled Phase Weeks 0-12||0
3367963|NCT03849690|4099579|FG000|NOT COMPLETED|Period 1 (3 Days)||0
3222190|NCT02289417|3954185|FG005|STARTED|Placebo-Controlled Phase Weeks 0-12||0
3222191|NCT02289417|3954186|FG006|STARTED|Placebo-Controlled Phase Weeks 0-12||0
3222192|NCT02289417|3954187|FG007|STARTED|Placebo-Controlled Phase Weeks 0-12||0
3222193|NCT02289417|3954188|FG008|STARTED|Placebo-Controlled Phase Weeks 0-12||0
3222194|NCT02289417|3954180|FG000|COMPLETED|Placebo-Controlled Phase Weeks 0-12||51
3222195|NCT02289417|3954181|FG001|COMPLETED|Placebo-Controlled Phase Weeks 0-12||53
3222196|NCT02289417|3954182|FG002|COMPLETED|Placebo-Controlled Phase Weeks 0-12||52
3222197|NCT02289417|3954183|FG003|COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
3222198|NCT02289417|3954184|FG004|COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
3222199|NCT02289417|3954185|FG005|COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
3222200|NCT02289417|3954186|FG006|COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
3222201|NCT02289417|3954187|FG007|COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
3222202|NCT02289417|3954188|FG008|COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
3222203|NCT02289417|3954180|FG000|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||7
3222204|NCT02289417|3954181|FG001|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||4
3222205|NCT02289417|3954182|FG002|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||3
3222206|NCT02289417|3954183|FG003|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
3222207|NCT02289417|3954184|FG004|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
3222208|NCT02289417|3954185|FG005|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
3222209|NCT02289417|3954186|FG006|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
3222210|NCT02289417|3954187|FG007|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
3222211|NCT02289417|3954188|FG008|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
3222212|NCT02289417|3954180|FG000|STARTED|Active Treatment Phase Weeks 12-52||0
3222213|NCT02289417|3954181|FG001|STARTED|Active Treatment Phase Weeks 12-52||41
3222214|NCT02289417|3954182|FG002|STARTED|Active Treatment Phase Weeks 12-52||42
3222215|NCT02289417|3954183|FG003|STARTED|Active Treatment Phase Weeks 12-52||26
3222216|NCT02289417|3954184|FG004|STARTED|Active Treatment Phase Weeks 12-52||25
3222217|NCT02289417|3954185|FG005|STARTED|Active Treatment Phase Weeks 12-52|1 participant went only to Week 20|12
3222218|NCT02289417|3954186|FG006|STARTED|Active Treatment Phase Weeks 12-52|Week 12 TMS were missing for 3 participants|7
3222219|NCT02289417|3954187|FG007|STARTED|Active Treatment Phase Weeks 12-52||0
3222220|NCT02289417|3954188|FG008|STARTED|Active Treatment Phase Weeks 12-52||0
3222221|NCT02289417|3954180|FG000|COMPLETED|Active Treatment Phase Weeks 12-52||0
3222222|NCT02289417|3954181|FG001|COMPLETED|Active Treatment Phase Weeks 12-52||39
3222223|NCT02289417|3954182|FG002|COMPLETED|Active Treatment Phase Weeks 12-52||32
3222224|NCT02289417|3954183|FG003|COMPLETED|Active Treatment Phase Weeks 12-52||17
3222225|NCT02289417|3954184|FG004|COMPLETED|Active Treatment Phase Weeks 12-52||20
3222226|NCT02289417|3954185|FG005|COMPLETED|Active Treatment Phase Weeks 12-52||7
3222227|NCT02289417|3954186|FG006|COMPLETED|Active Treatment Phase Weeks 12-52||5
3222228|NCT02289417|3954187|FG007|COMPLETED|Active Treatment Phase Weeks 12-52||0
3222229|NCT02289417|3954188|FG008|COMPLETED|Active Treatment Phase Weeks 12-52||0
3367964|NCT03849690|4099579|FG000|STARTED|Washout Period (at Least 4 Days)||12
3367965|NCT03849690|4099579|FG000|COMPLETED|Washout Period (at Least 4 Days)||12
3367966|NCT03849690|4099579|FG000|NOT COMPLETED|Washout Period (at Least 4 Days)||0
3367967|NCT03849690|4099579|FG000|STARTED|Period 2 (6 Days)||12
3367968|NCT03849690|4099579|FG000|COMPLETED|Period 2 (6 Days)||12
3367969|NCT03849690|4099579|FG000|NOT COMPLETED|Period 2 (6 Days)||0
3367970|NCT03845933|4099590|FG000|STARTED|Overall Study||131
3367971|NCT03845933|4099591|FG001|STARTED|Overall Study||131
3367972|NCT03845933|4099590|FG000|COMPLETED|Overall Study||131
3367973|NCT03845933|4099591|FG001|COMPLETED|Overall Study||131
3367974|NCT03845933|4099590|FG000|NOT COMPLETED|Overall Study||0
3367975|NCT03845933|4099591|FG001|NOT COMPLETED|Overall Study||0
3367976|NCT03844945|4099601|FG000|STARTED|Overall Study||55
3367977|NCT03844945|4099602|FG001|STARTED|Overall Study||54
3367978|NCT03844945|4099603|FG002|STARTED|Overall Study||51
3367979|NCT03844945|4099604|FG003|STARTED|Overall Study||55
3367980|NCT03844945|4099601|FG000|COMPLETED|Overall Study||54
3367981|NCT03844945|4099602|FG001|COMPLETED|Overall Study||53
3367982|NCT03844945|4099603|FG002|COMPLETED|Overall Study||46
3367983|NCT03844945|4099604|FG003|COMPLETED|Overall Study||54
3367984|NCT03844945|4099601|FG000|NOT COMPLETED|Overall Study||1
3367985|NCT03844945|4099602|FG001|NOT COMPLETED|Overall Study||1
3367986|NCT03844945|4099603|FG002|NOT COMPLETED|Overall Study||5
3367987|NCT03844945|4099604|FG003|NOT COMPLETED|Overall Study||1
3367988|NCT03844321|4099616|FG000|STARTED|Overall Study||2220
3367989|NCT03844321|4099617|FG001|STARTED|Overall Study||2192
3367990|NCT03844321|4099616|FG000|COMPLETED|Overall Study||579
3367991|NCT03844321|4099617|FG001|COMPLETED|Overall Study||533
3367992|NCT03844321|4099616|FG000|NOT COMPLETED|Overall Study||1641
3367993|NCT03844321|4099617|FG001|NOT COMPLETED|Overall Study||1659
3367994|NCT03843632|4099627|FG000|STARTED|Overall Study||50
3367995|NCT03843632|4099628|FG001|STARTED|Overall Study||30
3367996|NCT03843632|4099629|FG002|STARTED|Overall Study||33
3367997|NCT03843632|4099630|FG003|STARTED|Overall Study||37
3367998|NCT03843632|4099627|FG000|Vaccination 1|Overall Study||50
3367999|NCT03843632|4099628|FG001|Vaccination 1|Overall Study||30
3222230|NCT02289417|3954180|FG000|NOT COMPLETED|Active Treatment Phase Weeks 12-52||0
3222231|NCT02289417|3954181|FG001|NOT COMPLETED|Active Treatment Phase Weeks 12-52||2
3222232|NCT02289417|3954182|FG002|NOT COMPLETED|Active Treatment Phase Weeks 12-52||10
3222233|NCT02289417|3954183|FG003|NOT COMPLETED|Active Treatment Phase Weeks 12-52||9
3222234|NCT02289417|3954184|FG004|NOT COMPLETED|Active Treatment Phase Weeks 12-52||5
3222235|NCT02289417|3954185|FG005|NOT COMPLETED|Active Treatment Phase Weeks 12-52||5
3222236|NCT02289417|3954186|FG006|NOT COMPLETED|Active Treatment Phase Weeks 12-52||2
3222237|NCT02289417|3954187|FG007|NOT COMPLETED|Active Treatment Phase Weeks 12-52||0
3222238|NCT02289417|3954188|FG008|NOT COMPLETED|Active Treatment Phase Weeks 12-52||0
3222239|NCT02289417|3954180|FG000|STARTED|Extension Phase Weeks 52-104||0
3222240|NCT02289417|3954181|FG001|STARTED|Extension Phase Weeks 52-104||0
3222241|NCT02289417|3954182|FG002|STARTED|Extension Phase Weeks 52-104||0
3222242|NCT02289417|3954183|FG003|STARTED|Extension Phase Weeks 52-104||0
3222243|NCT02289417|3954184|FG004|STARTED|Extension Phase Weeks 52-104||0
3222244|NCT02289417|3954185|FG005|STARTED|Extension Phase Weeks 52-104||0
3222245|NCT02289417|3954186|FG006|STARTED|Extension Phase Weeks 52-104||0
3222246|NCT02289417|3954187|FG007|STARTED|Extension Phase Weeks 52-104||45
3222247|NCT02289417|3954188|FG008|STARTED|Extension Phase Weeks 52-104||54
3222248|NCT02289417|3954180|FG000|COMPLETED|Extension Phase Weeks 52-104||0
3222249|NCT02289417|3954181|FG001|COMPLETED|Extension Phase Weeks 52-104||0
3222250|NCT02289417|3954182|FG002|COMPLETED|Extension Phase Weeks 52-104||0
3222251|NCT02289417|3954183|FG003|COMPLETED|Extension Phase Weeks 52-104||0
3222252|NCT02289417|3954184|FG004|COMPLETED|Extension Phase Weeks 52-104||0
3222253|NCT02289417|3954185|FG005|COMPLETED|Extension Phase Weeks 52-104||0
3222254|NCT02289417|3954186|FG006|COMPLETED|Extension Phase Weeks 52-104||0
3222255|NCT02289417|3954187|FG007|COMPLETED|Extension Phase Weeks 52-104||38
3222256|NCT02289417|3954188|FG008|COMPLETED|Extension Phase Weeks 52-104||48
3222257|NCT02289417|3954180|FG000|NOT COMPLETED|Extension Phase Weeks 52-104||0
3222258|NCT02289417|3954181|FG001|NOT COMPLETED|Extension Phase Weeks 52-104||0
3222259|NCT02289417|3954182|FG002|NOT COMPLETED|Extension Phase Weeks 52-104||0
3222260|NCT02289417|3954183|FG003|NOT COMPLETED|Extension Phase Weeks 52-104||0
3222261|NCT02289417|3954184|FG004|NOT COMPLETED|Extension Phase Weeks 52-104||0
3222262|NCT02289417|3954185|FG005|NOT COMPLETED|Extension Phase Weeks 52-104||0
3222263|NCT02289417|3954186|FG006|NOT COMPLETED|Extension Phase Weeks 52-104||0
3222264|NCT02289417|3954187|FG007|NOT COMPLETED|Extension Phase Weeks 52-104||7
3222265|NCT02289417|3954188|FG008|NOT COMPLETED|Extension Phase Weeks 52-104||6
3222266|NCT02289456|3954204|FG000|STARTED|Induction Period||40
3222267|NCT02289456|3954204|FG000|Treated Population|Induction Period||40
3222268|NCT02289456|3954204|FG000|COMPLETED|Induction Period||16
3222269|NCT02289456|3954204|FG000|NOT COMPLETED|Induction Period||24
3222270|NCT02289456|3954204|FG000|STARTED|Monotherapy Period||16
3222271|NCT02289456|3954204|FG000|COMPLETED|Monotherapy Period||0
3222272|NCT02289456|3954204|FG000|NOT COMPLETED|Monotherapy Period||16
3222273|NCT02289469|3954215|FG000|STARTED|Overall Study||250
3222274|NCT02289469|3954216|FG001|STARTED|Overall Study||244
3222275|NCT02289469|3954215|FG000|COMPLETED|Overall Study||244
3222276|NCT02289469|3954216|FG001|COMPLETED|Overall Study||244
3222277|NCT02289469|3954215|FG000|NOT COMPLETED|Overall Study||6
3222278|NCT02289469|3954216|FG001|NOT COMPLETED|Overall Study||0
3222279|NCT02289690|3954232|FG000|STARTED|Overall Study||4
3222280|NCT02289690|3954233|FG001|STARTED|Overall Study||3
3222281|NCT02289690|3954234|FG002|STARTED|Overall Study||4
3222282|NCT02289690|3954235|FG003|STARTED|Overall Study||3
3222283|NCT02289690|3954236|FG004|STARTED|Overall Study||8
3222284|NCT02289690|3954237|FG005|STARTED|Overall Study||14
3222285|NCT02289690|3954238|FG006|STARTED|Overall Study||4
3222286|NCT02289690|3954239|FG007|STARTED|Overall Study||61
3222287|NCT02289690|3954240|FG008|STARTED|Overall Study||59
3222288|NCT02289690|3954241|FG009|STARTED|Overall Study||61
3222289|NCT02289690|3954232|FG000|Received Study Drug|Overall Study||4
3222290|NCT02289690|3954233|FG001|Received Study Drug|Overall Study||3
3222291|NCT02289690|3954234|FG002|Received Study Drug|Overall Study||4
3222292|NCT02289690|3954235|FG003|Received Study Drug|Overall Study||3
3222293|NCT02289690|3954236|FG004|Received Study Drug|Overall Study||8
3222294|NCT02289690|3954237|FG005|Received Study Drug|Overall Study||14
3222295|NCT02289690|3954238|FG006|Received Study Drug|Overall Study||4
3222296|NCT02289690|3954239|FG007|Received Study Drug|Overall Study||60
3222297|NCT02289690|3954240|FG008|Received Study Drug|Overall Study||58
3222298|NCT02289690|3954241|FG009|Received Study Drug|Overall Study||60
3222299|NCT02289690|3954232|FG000|COMPLETED|Overall Study||0
3222300|NCT02289690|3954233|FG001|COMPLETED|Overall Study||0
3222301|NCT02289690|3954234|FG002|COMPLETED|Overall Study||0
3222302|NCT02289690|3954235|FG003|COMPLETED|Overall Study||0
3222303|NCT02289690|3954236|FG004|COMPLETED|Overall Study||0
3222304|NCT02289690|3954237|FG005|COMPLETED|Overall Study||0
3222305|NCT02289690|3954238|FG006|COMPLETED|Overall Study||0
3222306|NCT02289690|3954239|FG007|COMPLETED|Overall Study||0
3222307|NCT02289690|3954240|FG008|COMPLETED|Overall Study||0
3222308|NCT02289690|3954241|FG009|COMPLETED|Overall Study||0
3222309|NCT02289690|3954232|FG000|NOT COMPLETED|Overall Study||4
3222310|NCT02289690|3954233|FG001|NOT COMPLETED|Overall Study||3
3222311|NCT02289690|3954234|FG002|NOT COMPLETED|Overall Study||4
3222312|NCT02289690|3954235|FG003|NOT COMPLETED|Overall Study||3
3222313|NCT02289690|3954236|FG004|NOT COMPLETED|Overall Study||8
3222314|NCT02289690|3954237|FG005|NOT COMPLETED|Overall Study||14
3222315|NCT02289690|3954238|FG006|NOT COMPLETED|Overall Study||4
3222316|NCT02289690|3954239|FG007|NOT COMPLETED|Overall Study||61
3222317|NCT02289690|3954240|FG008|NOT COMPLETED|Overall Study||59
3222318|NCT02289690|3954241|FG009|NOT COMPLETED|Overall Study||61
3222319|NCT02289729|3954277|FG000|STARTED|Overall Study||59
3222320|NCT02289729|3954277|FG000|COMPLETED|Overall Study||53
3222321|NCT02289729|3954277|FG000|NOT COMPLETED|Overall Study||6
3222322|NCT02289742|3954283|FG000|STARTED|First Wear Period||11
3222323|NCT02289742|3954284|FG001|STARTED|First Wear Period||12
3222324|NCT02289742|3954285|FG002|STARTED|First Wear Period||12
3222325|NCT02289742|3954286|FG003|STARTED|First Wear Period||10
3222326|NCT02289742|3954283|FG000|Treated|First Wear Period||11
3222327|NCT02289742|3954284|FG001|Treated|First Wear Period||11
3222328|NCT02289742|3954285|FG002|Treated|First Wear Period||12
3222329|NCT02289742|3954286|FG003|Treated|First Wear Period||9
3222330|NCT02289742|3954283|FG000|COMPLETED|First Wear Period||11
3222331|NCT02289742|3954284|FG001|COMPLETED|First Wear Period||11
3222332|NCT02289742|3954285|FG002|COMPLETED|First Wear Period||11
3222333|NCT02289742|3954286|FG003|COMPLETED|First Wear Period||9
3222334|NCT02289742|3954283|FG000|NOT COMPLETED|First Wear Period||0
3222335|NCT02289742|3954284|FG001|NOT COMPLETED|First Wear Period||1
3222336|NCT02289742|3954285|FG002|NOT COMPLETED|First Wear Period||1
3222337|NCT02289742|3954286|FG003|NOT COMPLETED|First Wear Period||1
3222338|NCT02289742|3954283|FG000|STARTED|Second Wear Period||11
3222339|NCT02289742|3954284|FG001|STARTED|Second Wear Period||11
3222340|NCT02289742|3954285|FG002|STARTED|Second Wear Period||11
3222341|NCT02289742|3954286|FG003|STARTED|Second Wear Period||9
3222342|NCT02289742|3954283|FG000|COMPLETED|Second Wear Period||11
3222343|NCT02289742|3954284|FG001|COMPLETED|Second Wear Period||11
3222344|NCT02289742|3954285|FG002|COMPLETED|Second Wear Period||11
3222345|NCT02289742|3954286|FG003|COMPLETED|Second Wear Period||9
3222346|NCT02289742|3954283|FG000|NOT COMPLETED|Second Wear Period||0
3222347|NCT02289742|3954284|FG001|NOT COMPLETED|Second Wear Period||0
3222348|NCT02289742|3954285|FG002|NOT COMPLETED|Second Wear Period||0
3222349|NCT02289742|3954286|FG003|NOT COMPLETED|Second Wear Period||0
3222350|NCT02289742|3954283|FG000|STARTED|Third Wear Period||11
3222351|NCT02289742|3954284|FG001|STARTED|Third Wear Period||11
3222352|NCT02289742|3954285|FG002|STARTED|Third Wear Period||11
3222353|NCT02289742|3954286|FG003|STARTED|Third Wear Period||9
3222354|NCT02289742|3954283|FG000|COMPLETED|Third Wear Period||11
3222355|NCT02289742|3954284|FG001|COMPLETED|Third Wear Period||10
3222356|NCT02289742|3954285|FG002|COMPLETED|Third Wear Period||11
3222357|NCT02289742|3954286|FG003|COMPLETED|Third Wear Period||8
3222358|NCT02289742|3954283|FG000|NOT COMPLETED|Third Wear Period||0
3222359|NCT02289742|3954284|FG001|NOT COMPLETED|Third Wear Period||1
3222360|NCT02289742|3954285|FG002|NOT COMPLETED|Third Wear Period||0
3222361|NCT02289742|3954286|FG003|NOT COMPLETED|Third Wear Period||1
3222362|NCT02289755|3954300|FG000|STARTED|Baseline Period [No Treatment, 3 Days]||16
3222363|NCT02289755|3954300|FG000|COMPLETED|Baseline Period [No Treatment, 3 Days]||16
3222364|NCT02289755|3954300|FG000|NOT COMPLETED|Baseline Period [No Treatment, 3 Days]||0
3222365|NCT02289755|3954300|FG000|STARTED|ALLN-177 Treatment Period [4 Days]||16
3222366|NCT02289755|3954300|FG000|COMPLETED|ALLN-177 Treatment Period [4 Days]||16
3222367|NCT02289755|3954300|FG000|NOT COMPLETED|ALLN-177 Treatment Period [4 Days]||0
3222368|NCT02289755|3954300|FG000|STARTED|Follow up Period [4 Days]||16
3222369|NCT02289755|3954300|FG000|COMPLETED|Follow up Period [4 Days]||16
3222370|NCT02289755|3954300|FG000|NOT COMPLETED|Follow up Period [4 Days]||0
3222371|NCT02289820|3954311|FG000|STARTED|Overall Study||39
3222372|NCT02289820|3954312|FG001|STARTED|Overall Study||20
3222373|NCT02289820|3954313|FG002|STARTED|Overall Study||44
3222374|NCT02289820|3954314|FG003|STARTED|Overall Study||39
3222375|NCT02289820|3954315|FG004|STARTED|Overall Study||40
3222376|NCT02289820|3954316|FG005|STARTED|Overall Study||40
3222377|NCT02289820|3954317|FG006|STARTED|Overall Study||39
3222378|NCT02289820|3954311|FG000|COMPLETED|Overall Study||37
3222379|NCT02289820|3954312|FG001|COMPLETED|Overall Study||18
3222380|NCT02289820|3954313|FG002|COMPLETED|Overall Study||38
3222381|NCT02289820|3954314|FG003|COMPLETED|Overall Study||37
3222382|NCT02289820|3954315|FG004|COMPLETED|Overall Study||40
3222383|NCT02289820|3954316|FG005|COMPLETED|Overall Study||39
3222384|NCT02289820|3954317|FG006|COMPLETED|Overall Study||37
3222385|NCT02289820|3954311|FG000|NOT COMPLETED|Overall Study||2
3222386|NCT02289820|3954312|FG001|NOT COMPLETED|Overall Study||2
3222387|NCT02289820|3954313|FG002|NOT COMPLETED|Overall Study||6
3222388|NCT02289820|3954314|FG003|NOT COMPLETED|Overall Study||2
3222389|NCT02289820|3954315|FG004|NOT COMPLETED|Overall Study||0
3222390|NCT02289820|3954316|FG005|NOT COMPLETED|Overall Study||1
3222391|NCT02289820|3954317|FG006|NOT COMPLETED|Overall Study||2
3222392|NCT02289833|3954339|FG000|STARTED|Overall Study||29
3222393|NCT02289833|3954340|FG001|STARTED|Overall Study||20
3222394|NCT02289833|3954339|FG000|COMPLETED|Overall Study||2
3222395|NCT02289833|3954340|FG001|COMPLETED|Overall Study||3
3222396|NCT02289833|3954339|FG000|NOT COMPLETED|Overall Study||27
3222397|NCT02289833|3954340|FG001|NOT COMPLETED|Overall Study||17
3222398|NCT02289898|3954351|FG000|STARTED|Overall Study||68
3222399|NCT02289898|3954352|FG001|STARTED|Overall Study||71
3222400|NCT02289898|3954353|FG002|STARTED|Overall Study||65
3222401|NCT02289898|3954351|FG000|COMPLETED|Overall Study||16
3222402|NCT02289898|3954352|FG001|COMPLETED|Overall Study||18
3222403|NCT02289898|3954353|FG002|COMPLETED|Overall Study||9
3222404|NCT02289898|3954351|FG000|NOT COMPLETED|Overall Study||52
3222405|NCT02289898|3954352|FG001|NOT COMPLETED|Overall Study||53
3222406|NCT02289898|3954353|FG002|NOT COMPLETED|Overall Study||56
3222407|NCT02289950|3954362|FG000|STARTED|Overall Study||142
3222408|NCT02289950|3954363|FG001|STARTED|Overall Study||72
3222409|NCT02289950|3954362|FG000|Treated|Overall Study|1 participant randomized to placebo group but was treated with farletuzumab, and was analyzed in the farletuzumab group in safety analysis set.|140
3222410|NCT02289950|3954363|FG001|Treated|Overall Study||71
3222411|NCT02289950|3954362|FG000|COMPLETED|Overall Study||0
3222412|NCT02289950|3954363|FG001|COMPLETED|Overall Study||0
3222413|NCT02289950|3954362|FG000|NOT COMPLETED|Overall Study||142
3222414|NCT02289950|3954363|FG001|NOT COMPLETED|Overall Study||72
3222415|NCT02289963|3954371|FG000|STARTED|Overall Study|Randomized|102
3222416|NCT02289963|3954372|FG001|STARTED|Overall Study|Randomized|97
3222417|NCT02289963|3954371|FG000|Treated|Overall Study||102
3222418|NCT02289963|3954372|FG001|Treated|Overall Study||97
3222419|NCT02289963|3954371|FG000|COMPLETED|Overall Study||97
3222420|NCT02289963|3954372|FG001|COMPLETED|Overall Study||87
3222421|NCT02289963|3954371|FG000|NOT COMPLETED|Overall Study||5
3222422|NCT02289963|3954372|FG001|NOT COMPLETED|Overall Study||10
3222423|NCT02289989|3954380|FG000|STARTED|Overall Study||0
3222424|NCT02289989|3954381|FG001|STARTED|Overall Study||1
3222425|NCT02289989|3954380|FG000|COMPLETED|Overall Study||0
3222426|NCT02289989|3954381|FG001|COMPLETED|Overall Study||1
3222427|NCT02289989|3954380|FG000|NOT COMPLETED|Overall Study||0
3222428|NCT02289989|3954381|FG001|NOT COMPLETED|Overall Study||0
3222429|NCT02290028|3954387|FG000|STARTED|Overall Study||2226
3222430|NCT02290028|3954387|FG000|COMPLETED|Overall Study||0
3222431|NCT02290028|3954387|FG000|NOT COMPLETED|Overall Study||2226
3222432|NCT02290106|3954396|FG000|STARTED|Overall Study||25
3222433|NCT02290106|3954397|FG001|STARTED|Overall Study||25
3222434|NCT02290106|3954396|FG000|COMPLETED|Overall Study||24
3222435|NCT02290106|3954397|FG001|COMPLETED|Overall Study||23
3222436|NCT02290106|3954396|FG000|NOT COMPLETED|Overall Study||1
3222437|NCT02290106|3954397|FG001|NOT COMPLETED|Overall Study||2
3222438|NCT02290184|3954405|FG000|STARTED|Overall Study||22
3222439|NCT02290184|3954406|FG001|STARTED|Overall Study||23
3222440|NCT02290184|3954405|FG000|3-month Follow-up|Overall Study|Completed initial 3-month intervention and now transition to a 3-month maintenance phase|22
3222441|NCT02290184|3954406|FG001|3-month Follow-up|Overall Study|Completed initial 3-month control period and transition to receive the 3-month intervention|23
3222442|NCT02290184|3954405|FG000|COMPLETED|Overall Study|6-month follow-up visit - completed the 3-month maintenance phase and completed study|22
3222443|NCT02290184|3954406|FG001|COMPLETED|Overall Study|6-month follow up visit - completed 3-month intervention and competed study|23
3222444|NCT02290184|3954405|FG000|NOT COMPLETED|Overall Study||0
3222445|NCT02290184|3954406|FG001|NOT COMPLETED|Overall Study||0
3222446|NCT02290223|3954420|FG000|STARTED|Baseline||189
3222447|NCT02290223|3954421|FG001|STARTED|Baseline||187
3222448|NCT02290223|3954420|FG000|COMPLETED|Baseline||189
3222449|NCT02290223|3954421|FG001|COMPLETED|Baseline||187
3222450|NCT02290223|3954420|FG000|NOT COMPLETED|Baseline||0
3222451|NCT02290223|3954421|FG001|NOT COMPLETED|Baseline||0
3222452|NCT02290223|3954420|FG000|STARTED|6 Months||189
3222453|NCT02290223|3954421|FG001|STARTED|6 Months||187
3222454|NCT02290223|3954420|FG000|COMPLETED|6 Months||173
3222455|NCT02290223|3954421|FG001|COMPLETED|6 Months||181
3222456|NCT02290223|3954420|FG000|NOT COMPLETED|6 Months||16
3222457|NCT02290223|3954421|FG001|NOT COMPLETED|6 Months||6
3222458|NCT02290223|3954420|FG000|STARTED|12 Months|All participants were contacted at 12 mo, unless deceased or withdrawn (n=7).|182
3222459|NCT02290223|3954421|FG001|STARTED|12 Months|All participants were contacted at 12 mo, unless deceased or withdrawn (n=0).|187
3222460|NCT02290223|3954420|FG000|COMPLETED|12 Months||166
3222461|NCT02290223|3954421|FG001|COMPLETED|12 Months||176
3222462|NCT02290223|3954420|FG000|NOT COMPLETED|12 Months||16
3222463|NCT02290223|3954421|FG001|NOT COMPLETED|12 Months||11
3222464|NCT02290340|3954431|FG000|STARTED|Overall Study||18
3222465|NCT02290340|3954432|FG001|STARTED|Overall Study||8
3222466|NCT02290340|3954433|FG002|STARTED|Overall Study||31
3222467|NCT02290340|3954434|FG003|STARTED|Overall Study||32
3222468|NCT02290340|3954431|FG000|COMPLETED|Overall Study||16
3222469|NCT02290340|3954432|FG001|COMPLETED|Overall Study||8
3222470|NCT02290340|3954433|FG002|COMPLETED|Overall Study||31
3222471|NCT02290340|3954434|FG003|COMPLETED|Overall Study||30
3222472|NCT02290340|3954431|FG000|NOT COMPLETED|Overall Study||2
3222473|NCT02290340|3954432|FG001|NOT COMPLETED|Overall Study||0
3222474|NCT02290340|3954433|FG002|NOT COMPLETED|Overall Study||0
3222475|NCT02290340|3954434|FG003|NOT COMPLETED|Overall Study||2
3222476|NCT02290405|3954449|FG000|STARTED|Overall Study||36
3222477|NCT02290405|3954450|FG001|STARTED|Overall Study||53
3222478|NCT02290405|3954449|FG000|COMPLETED|Overall Study||35
3222479|NCT02290405|3954450|FG001|COMPLETED|Overall Study||53
3222480|NCT02290405|3954449|FG000|NOT COMPLETED|Overall Study||1
3222481|NCT02290405|3954450|FG001|NOT COMPLETED|Overall Study||0
3222482|NCT02290444|3954458|FG000|STARTED|Overall Study||30
3222483|NCT02290444|3954459|FG001|STARTED|Overall Study||34
3222484|NCT02290444|3954458|FG000|COMPLETED|Overall Study||29
3222485|NCT02290444|3954459|FG001|COMPLETED|Overall Study||32
3222486|NCT02290444|3954458|FG000|NOT COMPLETED|Overall Study||1
3222487|NCT02290444|3954459|FG001|NOT COMPLETED|Overall Study||2
3222488|NCT02290509|3954467|FG000|STARTED|Overall Study||1011
3222489|NCT02290509|3954468|FG001|STARTED|Overall Study||339
3222490|NCT02290509|3954467|FG000|COMPLETED|Overall Study||962
3222491|NCT02290509|3954468|FG001|COMPLETED|Overall Study||325
3222492|NCT02290509|3954467|FG000|NOT COMPLETED|Overall Study||49
3222493|NCT02290509|3954468|FG001|NOT COMPLETED|Overall Study||14
3222494|NCT02290574|3954474|FG000|STARTED|Overall Study||14
3222495|NCT02290574|3954474|FG000|COMPLETED|Overall Study||13
3222496|NCT02290574|3954474|FG000|NOT COMPLETED|Overall Study||1
3222497|NCT02290613|3954481|FG000|STARTED|Overall Study||19
3222498|NCT02290613|3954482|FG001|STARTED|Overall Study||19
3222499|NCT02290613|3954481|FG000|COMPLETED|Overall Study||17
3222500|NCT02290613|3954482|FG001|COMPLETED|Overall Study||15
3222501|NCT02290613|3954481|FG000|NOT COMPLETED|Overall Study||2
3222502|NCT02290613|3954482|FG001|NOT COMPLETED|Overall Study||4
3222503|NCT02290691|3954490|FG000|STARTED|Overall Study||496
3222504|NCT02290691|3954491|FG001|STARTED|Overall Study||488
3222505|NCT02290691|3954490|FG000|COMPLETED|Overall Study||488
3222506|NCT02290691|3954491|FG001|COMPLETED|Overall Study||479
3222507|NCT02290691|3954490|FG000|NOT COMPLETED|Overall Study||8
3222508|NCT02290691|3954491|FG001|NOT COMPLETED|Overall Study||9
3222509|NCT02290821|3954499|FG000|STARTED|Overall Study||109
3222510|NCT02290821|3954500|FG001|STARTED|Overall Study||106
3222511|NCT02290821|3954499|FG000|COMPLETED|Overall Study||103
3222512|NCT02290821|3954500|FG001|COMPLETED|Overall Study||103
3222513|NCT02290821|3954499|FG000|NOT COMPLETED|Overall Study||6
3222514|NCT02290821|3954500|FG001|NOT COMPLETED|Overall Study||3
3368000|NCT03843632|4099629|FG002|Vaccination 1|Overall Study||33
3368001|NCT03843632|4099630|FG003|Vaccination 1|Overall Study||37
3368002|NCT03843632|4099627|FG000|Vaccination 2|Overall Study||49
3368003|NCT03843632|4099628|FG001|Vaccination 2|Overall Study||30
3368004|NCT03843632|4099629|FG002|Vaccination 2|Overall Study||0
3368005|NCT03843632|4099630|FG003|Vaccination 2|Overall Study||0
3368006|NCT03843632|4099627|FG000|COMPLETED|Overall Study||49
3368007|NCT03843632|4099628|FG001|COMPLETED|Overall Study||30
3368008|NCT03843632|4099629|FG002|COMPLETED|Overall Study||33
3368009|NCT03843632|4099630|FG003|COMPLETED|Overall Study||37
3368010|NCT03843632|4099627|FG000|NOT COMPLETED|Overall Study||1
3368011|NCT03843632|4099628|FG001|NOT COMPLETED|Overall Study||0
3368012|NCT03843632|4099629|FG002|NOT COMPLETED|Overall Study||0
3368013|NCT03843632|4099630|FG003|NOT COMPLETED|Overall Study||0
3368014|NCT03840811|4099643|FG000|STARTED|Overall Study||9
3368015|NCT03840811|4099644|FG001|STARTED|Overall Study||6
3368016|NCT03840811|4099645|FG002|STARTED|Overall Study||12
3368017|NCT03840811|4099643|FG000|COMPLETED|Overall Study||9
3368018|NCT03840811|4099644|FG001|COMPLETED|Overall Study||6
3368019|NCT03840811|4099645|FG002|COMPLETED|Overall Study||11
3368020|NCT03840811|4099643|FG000|NOT COMPLETED|Overall Study||0
3368021|NCT03840811|4099644|FG001|NOT COMPLETED|Overall Study||0
3368022|NCT03840811|4099645|FG002|NOT COMPLETED|Overall Study||1
3368023|NCT03837028|4099657|FG000|STARTED|Overall Study||35
3368024|NCT03837028|4099658|FG001|STARTED|Overall Study||34
3368025|NCT03837028|4099659|FG002|STARTED|Overall Study||33
3368026|NCT03837028|4099660|FG003|STARTED|Overall Study||25
3368027|NCT03837028|4099657|FG000|COMPLETED|Overall Study||19
3368028|NCT03837028|4099658|FG001|COMPLETED|Overall Study||23
3368029|NCT03837028|4099659|FG002|COMPLETED|Overall Study||20
3368030|NCT03837028|4099660|FG003|COMPLETED|Overall Study||18
3368031|NCT03837028|4099657|FG000|NOT COMPLETED|Overall Study||16
3368032|NCT03837028|4099658|FG001|NOT COMPLETED|Overall Study||11
3368033|NCT03837028|4099659|FG002|NOT COMPLETED|Overall Study||13
3368034|NCT03837028|4099660|FG003|NOT COMPLETED|Overall Study||7
3368035|NCT03825939|4099673|FG000|STARTED|Overall Study||18
3368036|NCT03825939|4099674|FG001|STARTED|Overall Study||20
3368037|NCT03825939|4099675|FG002|STARTED|Overall Study||14
3368038|NCT03825939|4099673|FG000|COMPLETED|Overall Study||18
3368039|NCT03825939|4099674|FG001|COMPLETED|Overall Study||20
3368040|NCT03825939|4099675|FG002|COMPLETED|Overall Study||14
3368041|NCT03825939|4099673|FG000|NOT COMPLETED|Overall Study||0
3368042|NCT03825939|4099674|FG001|NOT COMPLETED|Overall Study||0
3368043|NCT03825939|4099675|FG002|NOT COMPLETED|Overall Study||0
3368044|NCT03817775|4099685|FG000|STARTED|Overall Study||22
3368045|NCT03817775|4099686|FG001|STARTED|Overall Study||54
3368046|NCT03817775|4099685|FG000|COMPLETED|Overall Study||22
3368047|NCT03817775|4099686|FG001|COMPLETED|Overall Study||54
3368048|NCT03817775|4099685|FG000|NOT COMPLETED|Overall Study||0
3368049|NCT03817775|4099686|FG001|NOT COMPLETED|Overall Study||0
3368050|NCT03843372|4099694|FG000|STARTED|Overall Study||14
3368051|NCT03843372|4099695|FG001|STARTED|Overall Study||18
3368052|NCT03843372|4099694|FG000|COMPLETED|Overall Study||12
3368053|NCT03843372|4099695|FG001|COMPLETED|Overall Study||16
3368054|NCT03843372|4099694|FG000|NOT COMPLETED|Overall Study||2
3368055|NCT03843372|4099695|FG001|NOT COMPLETED|Overall Study||2
3368056|NCT03841331|4099703|FG000|STARTED|Overall Study||117
3368057|NCT03841331|4099704|FG001|STARTED|Overall Study||116
3368058|NCT03841331|4099703|FG000|COMPLETED|Overall Study||108
3368059|NCT03841331|4099704|FG001|COMPLETED|Overall Study||106
3368060|NCT03841331|4099703|FG000|NOT COMPLETED|Overall Study||9
3368061|NCT03841331|4099704|FG001|NOT COMPLETED|Overall Study||10
3368062|NCT03840278|4099710|FG000|STARTED|Overall Study||5
3368063|NCT03840278|4099711|FG001|STARTED|Overall Study||5
3368064|NCT03840278|4099710|FG000|COMPLETED|Overall Study||5
3368065|NCT03840278|4099711|FG001|COMPLETED|Overall Study||5
3368066|NCT03840278|4099710|FG000|NOT COMPLETED|Overall Study||0
3368067|NCT03840278|4099711|FG001|NOT COMPLETED|Overall Study||0
3368068|NCT03840135|4099719|FG000|STARTED|Overall Study||86
3368069|NCT03840135|4099720|FG001|STARTED|Overall Study||86
3222515|NCT02290873|3954509|FG000|STARTED|Overall Study||298
3222516|NCT02290873|3954510|FG001|STARTED|Overall Study||60
3222517|NCT02290873|3954511|FG002|STARTED|Overall Study||103
3222518|NCT02290873|3954509|FG000|Modified Intention to Treat (mITT)|Overall Study||296
3222519|NCT02290873|3954510|FG001|Modified Intention to Treat (mITT)|Overall Study||60
3222520|NCT02290873|3954511|FG002|Modified Intention to Treat (mITT)|Overall Study||102
3222521|NCT02290873|3954509|FG000|Safety Population|Overall Study||296
3222522|NCT02290873|3954510|FG001|Safety Population|Overall Study||60
3222523|NCT02290873|3954511|FG002|Safety Population|Overall Study||102
3222524|NCT02290873|3954509|FG000|COMPLETED|Overall Study||296
3222525|NCT02290873|3954510|FG001|COMPLETED|Overall Study||59
3222526|NCT02290873|3954511|FG002|COMPLETED|Overall Study||101
3222527|NCT02290873|3954509|FG000|NOT COMPLETED|Overall Study||2
3222528|NCT02290873|3954510|FG001|NOT COMPLETED|Overall Study||1
3222529|NCT02290873|3954511|FG002|NOT COMPLETED|Overall Study||2
3222530|NCT02290925|3954522|FG000|STARTED|First Period of Three Months||62
3222531|NCT02290925|3954523|FG001|STARTED|First Period of Three Months||71
3222532|NCT02290925|3954522|FG000|COMPLETED|First Period of Three Months||58
3222533|NCT02290925|3954523|FG001|COMPLETED|First Period of Three Months||69
3222534|NCT02290925|3954522|FG000|NOT COMPLETED|First Period of Three Months||4
3222535|NCT02290925|3954523|FG001|NOT COMPLETED|First Period of Three Months||2
3222536|NCT02290925|3954522|FG000|STARTED|Second Period of 3 Months||58
3222537|NCT02290925|3954523|FG001|STARTED|Second Period of 3 Months||69
3222538|NCT02290925|3954522|FG000|COMPLETED|Second Period of 3 Months||57
3222539|NCT02290925|3954523|FG001|COMPLETED|Second Period of 3 Months||65
3222540|NCT02290925|3954522|FG000|NOT COMPLETED|Second Period of 3 Months||1
3222541|NCT02290925|3954523|FG001|NOT COMPLETED|Second Period of 3 Months||4
3222542|NCT02291016|3954533|FG000|STARTED|Visit 1||2
3222543|NCT02291016|3954534|FG001|STARTED|Visit 1||5
3222544|NCT02291016|3954533|FG000|COMPLETED|Visit 1||2
3222545|NCT02291016|3954534|FG001|COMPLETED|Visit 1||5
3222546|NCT02291016|3954533|FG000|NOT COMPLETED|Visit 1||0
3222547|NCT02291016|3954534|FG001|NOT COMPLETED|Visit 1||0
3222548|NCT02291016|3954533|FG000|STARTED|Visit 2||2
3222549|NCT02291016|3954534|FG001|STARTED|Visit 2||5
3222550|NCT02291016|3954533|FG000|COMPLETED|Visit 2|Patients did not meet visit 2 FEV1 criteria ( 15% or closer to value at visit 1)|1
3222551|NCT02291016|3954534|FG001|COMPLETED|Visit 2||5
3222552|NCT02291016|3954533|FG000|NOT COMPLETED|Visit 2||1
3222553|NCT02291016|3954534|FG001|NOT COMPLETED|Visit 2||0
3222554|NCT02291029|3954547|FG000|STARTED|Overall Study||8
3222555|NCT02291029|3954548|FG001|STARTED|Overall Study||4
3222556|NCT02291029|3954549|FG002|STARTED|Overall Study||21
3222557|NCT02291029|3954550|FG003|STARTED|Overall Study||11
3222558|NCT02291029|3954551|FG004|STARTED|Overall Study||13
3222559|NCT02291029|3954552|FG005|STARTED|Overall Study||12
3222560|NCT02291029|3954547|FG000|COMPLETED|Overall Study||8
3222561|NCT02291029|3954548|FG001|COMPLETED|Overall Study||3
3222562|NCT02291029|3954549|FG002|COMPLETED|Overall Study||20
3222563|NCT02291029|3954550|FG003|COMPLETED|Overall Study||11
3222564|NCT02291029|3954551|FG004|COMPLETED|Overall Study||13
3222565|NCT02291029|3954552|FG005|COMPLETED|Overall Study||12
3222566|NCT02291029|3954547|FG000|NOT COMPLETED|Overall Study||0
3222567|NCT02291029|3954548|FG001|NOT COMPLETED|Overall Study||1
3222568|NCT02291029|3954549|FG002|NOT COMPLETED|Overall Study||1
3222569|NCT02291029|3954550|FG003|NOT COMPLETED|Overall Study||0
3222570|NCT02291029|3954551|FG004|NOT COMPLETED|Overall Study||0
3222571|NCT02291029|3954552|FG005|NOT COMPLETED|Overall Study||0
3222572|NCT02291133|3954566|FG000|STARTED|Overall Study||25
3222573|NCT02291133|3954566|FG000|COMPLETED|Overall Study||24
3222574|NCT02291133|3954566|FG000|NOT COMPLETED|Overall Study||1
3222575|NCT02291237|3954572|FG000|STARTED|Overall Study||86
3222576|NCT02291237|3954573|FG001|STARTED|Overall Study||86
3222577|NCT02291237|3954572|FG000|COMPLETED|Overall Study||0
3222578|NCT02291237|3954573|FG001|COMPLETED|Overall Study||0
3222579|NCT02291237|3954572|FG000|NOT COMPLETED|Overall Study||86
3222580|NCT02291237|3954573|FG001|NOT COMPLETED|Overall Study||86
3222581|NCT02291289|3954583|FG000|STARTED|Induction Treatment||60
3222582|NCT02291289|3954584|FG001|STARTED|Induction Treatment||0
3222583|NCT02291289|3954585|FG002|STARTED|Induction Treatment||0
3222584|NCT02291289|3954586|FG003|STARTED|Induction Treatment||445
3222585|NCT02291289|3954587|FG004|STARTED|Induction Treatment||0
3222586|NCT02291289|3954588|FG005|STARTED|Induction Treatment||0
3222587|NCT02291289|3954589|FG006|STARTED|Induction Treatment||5
3222588|NCT02291289|3954590|FG007|STARTED|Induction Treatment||0
3222589|NCT02291289|3954591|FG008|STARTED|Induction Treatment||0
3222590|NCT02291289|3954592|FG009|STARTED|Induction Treatment||99
3222591|NCT02291289|3954593|FG010|STARTED|Induction Treatment||0
3222592|NCT02291289|3954594|FG011|STARTED|Induction Treatment||0
3222593|NCT02291289|3954583|FG000|COMPLETED|Induction Treatment||58
3222594|NCT02291289|3954584|FG001|COMPLETED|Induction Treatment||0
3222595|NCT02291289|3954585|FG002|COMPLETED|Induction Treatment||0
3222596|NCT02291289|3954586|FG003|COMPLETED|Induction Treatment||436
3222597|NCT02291289|3954587|FG004|COMPLETED|Induction Treatment||0
3222598|NCT02291289|3954588|FG005|COMPLETED|Induction Treatment||0
3222599|NCT02291289|3954589|FG006|COMPLETED|Induction Treatment||5
3222600|NCT02291289|3954590|FG007|COMPLETED|Induction Treatment||0
3222601|NCT02291289|3954591|FG008|COMPLETED|Induction Treatment||0
3222602|NCT02291289|3954592|FG009|COMPLETED|Induction Treatment||98
3222603|NCT02291289|3954593|FG010|COMPLETED|Induction Treatment||0
3222604|NCT02291289|3954594|FG011|COMPLETED|Induction Treatment||0
3222605|NCT02291289|3954583|FG000|NOT COMPLETED|Induction Treatment||2
3222606|NCT02291289|3954584|FG001|NOT COMPLETED|Induction Treatment||0
3222607|NCT02291289|3954585|FG002|NOT COMPLETED|Induction Treatment||0
3222608|NCT02291289|3954586|FG003|NOT COMPLETED|Induction Treatment||9
3222609|NCT02291289|3954587|FG004|NOT COMPLETED|Induction Treatment||0
3222610|NCT02291289|3954588|FG005|NOT COMPLETED|Induction Treatment||0
3222611|NCT02291289|3954589|FG006|NOT COMPLETED|Induction Treatment||0
3222612|NCT02291289|3954590|FG007|NOT COMPLETED|Induction Treatment||0
3222613|NCT02291289|3954591|FG008|NOT COMPLETED|Induction Treatment||0
3222614|NCT02291289|3954592|FG009|NOT COMPLETED|Induction Treatment||1
3222615|NCT02291289|3954593|FG010|NOT COMPLETED|Induction Treatment||0
3222616|NCT02291289|3954594|FG011|NOT COMPLETED|Induction Treatment||0
3222617|NCT02291289|3954583|FG000|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|0
3222618|NCT02291289|3954584|FG001|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|40
3222619|NCT02291289|3954585|FG002|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|20
3222620|NCT02291289|3954586|FG003|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|0
3222621|NCT02291289|3954587|FG004|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|297
3222622|NCT02291289|3954588|FG005|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|148
3222623|NCT02291289|3954589|FG006|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|0
3222624|NCT02291289|3954590|FG007|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|3
3222625|NCT02291289|3954591|FG008|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|2
3222626|NCT02291289|3954592|FG009|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|0
3222627|NCT02291289|3954593|FG010|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|65
3222628|NCT02291289|3954594|FG011|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|34
3222629|NCT02291289|3954583|FG000|Dosed|Maintenance Treatment Phase||0
3222630|NCT02291289|3954584|FG001|Dosed|Maintenance Treatment Phase||40
3222631|NCT02291289|3954585|FG002|Dosed|Maintenance Treatment Phase||18
3222632|NCT02291289|3954586|FG003|Dosed|Maintenance Treatment Phase||0
3222633|NCT02291289|3954587|FG004|Dosed|Maintenance Treatment Phase||293
3222634|NCT02291289|3954588|FG005|Dosed|Maintenance Treatment Phase||143
3222635|NCT02291289|3954589|FG006|Dosed|Maintenance Treatment Phase||0
3222636|NCT02291289|3954590|FG007|Dosed|Maintenance Treatment Phase||3
3222637|NCT02291289|3954591|FG008|Dosed|Maintenance Treatment Phase||2
3222638|NCT02291289|3954592|FG009|Dosed|Maintenance Treatment Phase||0
3222639|NCT02291289|3954593|FG010|Dosed|Maintenance Treatment Phase||64
3222640|NCT02291289|3954594|FG011|Dosed|Maintenance Treatment Phase||34
3222641|NCT02291289|3954583|FG000|COMPLETED|Maintenance Treatment Phase||0
3222642|NCT02291289|3954584|FG001|COMPLETED|Maintenance Treatment Phase||16
3222643|NCT02291289|3954585|FG002|COMPLETED|Maintenance Treatment Phase||4
3222644|NCT02291289|3954586|FG003|COMPLETED|Maintenance Treatment Phase||0
3222645|NCT02291289|3954587|FG004|COMPLETED|Maintenance Treatment Phase||45
3222646|NCT02291289|3954588|FG005|COMPLETED|Maintenance Treatment Phase||19
3222647|NCT02291289|3954589|FG006|COMPLETED|Maintenance Treatment Phase||0
3222648|NCT02291289|3954590|FG007|COMPLETED|Maintenance Treatment Phase||1
3222649|NCT02291289|3954591|FG008|COMPLETED|Maintenance Treatment Phase||0
3222650|NCT02291289|3954592|FG009|COMPLETED|Maintenance Treatment Phase||0
3222651|NCT02291289|3954593|FG010|COMPLETED|Maintenance Treatment Phase||34
3222652|NCT02291289|3954594|FG011|COMPLETED|Maintenance Treatment Phase||18
3222653|NCT02291289|3954583|FG000|NOT COMPLETED|Maintenance Treatment Phase||0
3222654|NCT02291289|3954584|FG001|NOT COMPLETED|Maintenance Treatment Phase||24
3222655|NCT02291289|3954585|FG002|NOT COMPLETED|Maintenance Treatment Phase||16
3222656|NCT02291289|3954586|FG003|NOT COMPLETED|Maintenance Treatment Phase||0
3222657|NCT02291289|3954587|FG004|NOT COMPLETED|Maintenance Treatment Phase||252
3222658|NCT02291289|3954588|FG005|NOT COMPLETED|Maintenance Treatment Phase||129
3222659|NCT02291289|3954589|FG006|NOT COMPLETED|Maintenance Treatment Phase||0
3222660|NCT02291289|3954590|FG007|NOT COMPLETED|Maintenance Treatment Phase||2
3222661|NCT02291289|3954591|FG008|NOT COMPLETED|Maintenance Treatment Phase||2
3222662|NCT02291289|3954592|FG009|NOT COMPLETED|Maintenance Treatment Phase||0
3222663|NCT02291289|3954593|FG010|NOT COMPLETED|Maintenance Treatment Phase||31
3222664|NCT02291289|3954594|FG011|NOT COMPLETED|Maintenance Treatment Phase||16
3222665|NCT02291302|3954623|FG000|STARTED|Overall Study||59
3222666|NCT02291302|3954624|FG001|STARTED|Overall Study||59
3222667|NCT02291302|3954625|FG002|STARTED|Overall Study||59
3222668|NCT02291302|3954626|FG003|STARTED|Overall Study||59
3222669|NCT02291302|3954623|FG000|COMPLETED|Overall Study||59
3222670|NCT02291302|3954624|FG001|COMPLETED|Overall Study||59
3222671|NCT02291302|3954625|FG002|COMPLETED|Overall Study||59
3222672|NCT02291302|3954626|FG003|COMPLETED|Overall Study||59
3222673|NCT02291302|3954623|FG000|NOT COMPLETED|Overall Study||0
3222674|NCT02291302|3954624|FG001|NOT COMPLETED|Overall Study||0
3222675|NCT02291302|3954625|FG002|NOT COMPLETED|Overall Study||0
3222676|NCT02291302|3954626|FG003|NOT COMPLETED|Overall Study||0
3222677|NCT02291419|3954638|FG000|STARTED|Overall Study||1
3222678|NCT02291419|3954639|FG001|STARTED|Overall Study||5
3222679|NCT02291419|3954638|FG000|COMPLETED|Overall Study||0
3222680|NCT02291419|3954639|FG001|COMPLETED|Overall Study||0
3222681|NCT02291419|3954638|FG000|NOT COMPLETED|Overall Study||1
3222682|NCT02291419|3954639|FG001|NOT COMPLETED|Overall Study||5
3368070|NCT03840135|4099719|FG000|COMPLETED|Overall Study||79
3368071|NCT03840135|4099720|FG001|COMPLETED|Overall Study||85
3368072|NCT03840135|4099719|FG000|NOT COMPLETED|Overall Study||7
3368073|NCT03840135|4099720|FG001|NOT COMPLETED|Overall Study||1
3368074|NCT03839641|4099732|FG000|STARTED|Overall Study||5
3368075|NCT03839641|4099733|FG001|STARTED|Overall Study||5
3368076|NCT03839641|4099732|FG000|COMPLETED|Overall Study||4
3368077|NCT03839641|4099733|FG001|COMPLETED|Overall Study||4
3368078|NCT03839641|4099732|FG000|NOT COMPLETED|Overall Study||1
3368079|NCT03839641|4099733|FG001|NOT COMPLETED|Overall Study||1
3368080|NCT03839212|4099741|FG000|STARTED|Overall Study||18
3368081|NCT03839212|4099741|FG000|COMPLETED|Overall Study||14
3368082|NCT03839212|4099741|FG000|NOT COMPLETED|Overall Study||4
3368083|NCT03839355|4099747|FG000|STARTED|Overall Study||18
3368084|NCT03839355|4099748|FG001|STARTED|Overall Study||16
3368085|NCT03839355|4099747|FG000|COMPLETED|Overall Study||17
3368086|NCT03839355|4099748|FG001|COMPLETED|Overall Study||16
3368087|NCT03839355|4099747|FG000|NOT COMPLETED|Overall Study||1
3368088|NCT03839355|4099748|FG001|NOT COMPLETED|Overall Study||0
3368089|NCT03838874|4099756|FG000|STARTED|Overall Study||80
3368090|NCT03838874|4099757|FG001|STARTED|Overall Study||74
3368091|NCT03838874|4099756|FG000|COMPLETED|Overall Study||80
3368092|NCT03838874|4099757|FG001|COMPLETED|Overall Study||74
3368093|NCT03838874|4099756|FG000|NOT COMPLETED|Overall Study||0
3368094|NCT03838874|4099757|FG001|NOT COMPLETED|Overall Study||0
3368095|NCT03838731|4099765|FG000|STARTED|Overall Study||27
3368096|NCT03838731|4099766|FG001|STARTED|Overall Study||29
3368097|NCT03838731|4099765|FG000|COMPLETED|Overall Study||26
3368098|NCT03838731|4099766|FG001|COMPLETED|Overall Study||28
3368099|NCT03838731|4099765|FG000|NOT COMPLETED|Overall Study||1
3368100|NCT03838731|4099766|FG001|NOT COMPLETED|Overall Study||1
3368101|NCT03838198|4099774|FG000|STARTED|Phase 1: Safety Plan (SP) vs. SP w/Texts|Because it was a SMART trial, no participants were allocated to receive booster calls until Phase 2.|0
3368102|NCT03838198|4099775|FG001|STARTED|Phase 1: Safety Plan (SP) vs. SP w/Texts||40
3368103|NCT03838198|4099776|FG002|STARTED|Phase 1: Safety Plan (SP) vs. SP w/Texts|Because it was a SMART trial, no participants were allocated to receive booster calls until Phase 2.|0
3368104|NCT03838198|4099777|FG003|STARTED|Phase 1: Safety Plan (SP) vs. SP w/Texts||40
3368105|NCT03838198|4099774|FG000|COMPLETED|Phase 1: Safety Plan (SP) vs. SP w/Texts||0
3368106|NCT03838198|4099775|FG001|COMPLETED|Phase 1: Safety Plan (SP) vs. SP w/Texts||40
3368107|NCT03838198|4099776|FG002|COMPLETED|Phase 1: Safety Plan (SP) vs. SP w/Texts||0
3368108|NCT03838198|4099777|FG003|COMPLETED|Phase 1: Safety Plan (SP) vs. SP w/Texts||40
3368109|NCT03838198|4099774|FG000|NOT COMPLETED|Phase 1: Safety Plan (SP) vs. SP w/Texts||0
3368110|NCT03838198|4099775|FG001|NOT COMPLETED|Phase 1: Safety Plan (SP) vs. SP w/Texts||0
3368111|NCT03838198|4099776|FG002|NOT COMPLETED|Phase 1: Safety Plan (SP) vs. SP w/Texts||0
3368112|NCT03838198|4099777|FG003|NOT COMPLETED|Phase 1: Safety Plan (SP) vs. SP w/Texts||0
3368113|NCT03838198|4099774|FG000|STARTED|Phase 2: Added Booster Call or Not|These participants continued with Phase 1 intervention (Safety plan and text) with added booster call.|18
3368114|NCT03838198|4099775|FG001|STARTED|Phase 2: Added Booster Call or Not|These participants continued with Phase 1 intervention (Safety plan and text) with no added booster call.|22
3368115|NCT03838198|4099776|FG002|STARTED|Phase 2: Added Booster Call or Not|These participants continued with Phase 1 intervention (Safety plan only) with added booster call.|18
3368116|NCT03838198|4099777|FG003|STARTED|Phase 2: Added Booster Call or Not|These participants continued with Phase 1 intervention (Safety plan only) with no added booster call in Phase 2|22
3368117|NCT03838198|4099774|FG000|COMPLETED|Phase 2: Added Booster Call or Not|All 18 completed the safety plan; but only 14 had both parent and adolescent completing the call; 1 had parent only; 1 had adolescent only; 2 were unable to be reached.|18
3368118|NCT03838198|4099775|FG001|COMPLETED|Phase 2: Added Booster Call or Not||0
3368119|NCT03838198|4099776|FG002|COMPLETED|Phase 2: Added Booster Call or Not|Of the 17 who completed the safety plan, only 15 had both parent and adolescent completing the call; 1 had parent only; 1 was unable to be reached.|17
3368120|NCT03838198|4099777|FG003|COMPLETED|Phase 2: Added Booster Call or Not||0
3368121|NCT03838198|4099774|FG000|NOT COMPLETED|Phase 2: Added Booster Call or Not||0
3368122|NCT03838198|4099775|FG001|NOT COMPLETED|Phase 2: Added Booster Call or Not||22
3368123|NCT03838198|4099776|FG002|NOT COMPLETED|Phase 2: Added Booster Call or Not||1
3368124|NCT03838198|4099777|FG003|NOT COMPLETED|Phase 2: Added Booster Call or Not||22
3368125|NCT03838198|4099774|FG000|STARTED|1 Month Follow up Period||18
3368126|NCT03838198|4099775|FG001|STARTED|1 Month Follow up Period|All participants from Phase 1 and 2 were followed unless they withdrew.|22
3368127|NCT03838198|4099776|FG002|STARTED|1 Month Follow up Period||17
3368128|NCT03838198|4099777|FG003|STARTED|1 Month Follow up Period|All participants from Phase 1 and 2 were followed unless they withdrew.|22
3368129|NCT03838198|4099774|FG000|Adolescent Surveys Completed|1 Month Follow up Period||16
3368130|NCT03838198|4099775|FG001|Adolescent Surveys Completed|1 Month Follow up Period||22
3368131|NCT03838198|4099776|FG002|Adolescent Surveys Completed|1 Month Follow up Period||16
3368132|NCT03838198|4099777|FG003|Adolescent Surveys Completed|1 Month Follow up Period||22
3368133|NCT03838198|4099774|FG000|COMPLETED|1 Month Follow up Period||16
3368134|NCT03838198|4099775|FG001|COMPLETED|1 Month Follow up Period||22
3368135|NCT03838198|4099776|FG002|COMPLETED|1 Month Follow up Period||16
3222683|NCT02291432|3954645|FG000|STARTED|Overall Study||25
3222684|NCT02291432|3954645|FG000|Muscle Biopsy|Overall Study||25
3222685|NCT02291432|3954645|FG000|AMDC Injection|Overall Study||23
3222686|NCT02291432|3954645|FG000|1-Month Follow Up|Overall Study||23
3222687|NCT02291432|3954645|FG000|3-Month Follow Up|Overall Study||23
3222688|NCT02291432|3954645|FG000|6-Month Follow Up|Overall Study||23
3222689|NCT02291432|3954645|FG000|12-Month Follow Up|Overall Study||23
3222690|NCT02291432|3954645|FG000|COMPLETED|Overall Study||23
3222691|NCT02291432|3954645|FG000|NOT COMPLETED|Overall Study||2
3222692|NCT02291510|3954653|FG000|STARTED|Overall Study||5
3222693|NCT02291510|3954654|FG001|STARTED|Overall Study||5
3222694|NCT02291510|3954655|FG002|STARTED|Overall Study||5
3222695|NCT02291510|3954656|FG003|STARTED|Overall Study||5
3222696|NCT02291510|3954653|FG000|Completed Treatment A|Overall Study||5
3222697|NCT02291510|3954654|FG001|Completed Treatment A|Overall Study||5
3222698|NCT02291510|3954655|FG002|Completed Treatment A|Overall Study||5
3222699|NCT02291510|3954656|FG003|Completed Treatment A|Overall Study||5
3222700|NCT02291510|3954653|FG000|Completed Treatment B|Overall Study||5
3222701|NCT02291510|3954654|FG001|Completed Treatment B|Overall Study||5
3222702|NCT02291510|3954655|FG002|Completed Treatment B|Overall Study||5
3222703|NCT02291510|3954656|FG003|Completed Treatment B|Overall Study||4
3222704|NCT02291510|3954653|FG000|Completed Treatment C|Overall Study||5
3222705|NCT02291510|3954654|FG001|Completed Treatment C|Overall Study||5
3222706|NCT02291510|3954655|FG002|Completed Treatment C|Overall Study||5
3222707|NCT02291510|3954656|FG003|Completed Treatment C|Overall Study||4
3222708|NCT02291510|3954653|FG000|Completed Treatment D|Overall Study||5
3222709|NCT02291510|3954654|FG001|Completed Treatment D|Overall Study||5
3222710|NCT02291510|3954655|FG002|Completed Treatment D|Overall Study||5
3222711|NCT02291510|3954656|FG003|Completed Treatment D|Overall Study||5
3222712|NCT02291510|3954653|FG000|COMPLETED|Overall Study||5
3222713|NCT02291510|3954654|FG001|COMPLETED|Overall Study||5
3222714|NCT02291510|3954655|FG002|COMPLETED|Overall Study||5
3222715|NCT02291510|3954656|FG003|COMPLETED|Overall Study||4
3222716|NCT02291510|3954653|FG000|NOT COMPLETED|Overall Study||0
3222717|NCT02291510|3954654|FG001|NOT COMPLETED|Overall Study||0
3222718|NCT02291510|3954655|FG002|NOT COMPLETED|Overall Study||0
3222719|NCT02291510|3954656|FG003|NOT COMPLETED|Overall Study||1
3222720|NCT02291549|3954668|FG000|STARTED|Overall Study||201
3222721|NCT02291549|3954669|FG001|STARTED|Overall Study||99
3222722|NCT02291549|3954668|FG000|COMPLETED|Overall Study||200
3222723|NCT02291549|3954669|FG001|COMPLETED|Overall Study||98
3222724|NCT02291549|3954668|FG000|NOT COMPLETED|Overall Study||1
3222725|NCT02291549|3954669|FG001|NOT COMPLETED|Overall Study||1
3222726|NCT02291601|3954677|FG000|STARTED|Abdomen||638
3222727|NCT02291601|3954678|FG001|STARTED|Abdomen||108
3222728|NCT02291601|3954679|FG002|STARTED|Abdomen||642
3222729|NCT02291601|3954677|FG000|COMPLETED|Abdomen|638 participants received CHG cloth|305
3222730|NCT02291601|3954678|FG001|COMPLETED|Abdomen|108 participants received vehicle|54
3222731|NCT02291601|3954679|FG002|COMPLETED|Abdomen|642 participants received comparator CHG|303
3222732|NCT02291601|3954677|FG000|NOT COMPLETED|Abdomen||333
3222733|NCT02291601|3954678|FG001|NOT COMPLETED|Abdomen||54
3222734|NCT02291601|3954679|FG002|NOT COMPLETED|Abdomen||339
3222735|NCT02291601|3954677|FG000|STARTED|Groin||520
3222736|NCT02291601|3954678|FG001|STARTED|Groin||93
3222737|NCT02291601|3954679|FG002|STARTED|Groin||515
3222738|NCT02291601|3954677|FG000|COMPLETED|Groin|520 participants received CHG cloth|337
3222739|NCT02291601|3954678|FG001|COMPLETED|Groin|93 participants received vehicle|63
3222740|NCT02291601|3954679|FG002|COMPLETED|Groin|515 participants received Comparator CHG|338
3222741|NCT02291601|3954677|FG000|NOT COMPLETED|Groin||183
3222742|NCT02291601|3954678|FG001|NOT COMPLETED|Groin||30
3222743|NCT02291601|3954679|FG002|NOT COMPLETED|Groin||177
3222744|NCT02291614|3954701|FG000|STARTED|Overall Study||3
3222745|NCT02291614|3954702|FG001|STARTED|Overall Study||3
3222746|NCT02291614|3954703|FG002|STARTED|Overall Study||3
3222747|NCT02291614|3954704|FG003|STARTED|Overall Study||5
3222748|NCT02291614|3954705|FG004|STARTED|Overall Study||3
3222749|NCT02291614|3954706|FG005|STARTED|Overall Study||3
3222750|NCT02291614|3954707|FG006|STARTED|Overall Study||6
3222751|NCT02291614|3954708|FG007|STARTED|Overall Study||3
3222752|NCT02291614|3954709|FG008|STARTED|Overall Study||3
3222753|NCT02291614|3954710|FG009|STARTED|Overall Study||11
3222754|NCT02291614|3954711|FG010|STARTED|Overall Study||2
3222755|NCT02291614|3954701|FG000|Received AMG 211|Overall Study||3
3222756|NCT02291614|3954702|FG001|Received AMG 211|Overall Study||3
3222757|NCT02291614|3954703|FG002|Received AMG 211|Overall Study||3
3222758|NCT02291614|3954704|FG003|Received AMG 211|Overall Study||5
3222759|NCT02291614|3954705|FG004|Received AMG 211|Overall Study||3
3222760|NCT02291614|3954706|FG005|Received AMG 211|Overall Study||3
3222761|NCT02291614|3954707|FG006|Received AMG 211|Overall Study||6
3222762|NCT02291614|3954708|FG007|Received AMG 211|Overall Study||3
3222763|NCT02291614|3954709|FG008|Received AMG 211|Overall Study||3
3222764|NCT02291614|3954710|FG009|Received AMG 211|Overall Study||10
3222765|NCT02291614|3954711|FG010|Received AMG 211|Overall Study||2
3222766|NCT02291614|3954701|FG000|COMPLETED|Overall Study||3
3222767|NCT02291614|3954702|FG001|COMPLETED|Overall Study||2
3222768|NCT02291614|3954703|FG002|COMPLETED|Overall Study||2
3222769|NCT02291614|3954704|FG003|COMPLETED|Overall Study||4
3222770|NCT02291614|3954705|FG004|COMPLETED|Overall Study||2
3222771|NCT02291614|3954706|FG005|COMPLETED|Overall Study||2
3222772|NCT02291614|3954707|FG006|COMPLETED|Overall Study||5
3222773|NCT02291614|3954708|FG007|COMPLETED|Overall Study||2
3222774|NCT02291614|3954709|FG008|COMPLETED|Overall Study||3
3222775|NCT02291614|3954710|FG009|COMPLETED|Overall Study||9
3222776|NCT02291614|3954711|FG010|COMPLETED|Overall Study||0
3222777|NCT02291614|3954701|FG000|NOT COMPLETED|Overall Study||0
3222778|NCT02291614|3954702|FG001|NOT COMPLETED|Overall Study||1
3222779|NCT02291614|3954703|FG002|NOT COMPLETED|Overall Study||1
3222780|NCT02291614|3954704|FG003|NOT COMPLETED|Overall Study||1
3222781|NCT02291614|3954705|FG004|NOT COMPLETED|Overall Study||1
3222782|NCT02291614|3954706|FG005|NOT COMPLETED|Overall Study||1
3222783|NCT02291614|3954707|FG006|NOT COMPLETED|Overall Study||1
3222784|NCT02291614|3954708|FG007|NOT COMPLETED|Overall Study||1
3222785|NCT02291614|3954709|FG008|NOT COMPLETED|Overall Study||0
3222786|NCT02291614|3954710|FG009|NOT COMPLETED|Overall Study||2
3222787|NCT02291614|3954711|FG010|NOT COMPLETED|Overall Study||2
3222788|NCT02291679|3954744|FG000|STARTED|Overall Study||401
3222789|NCT02291679|3954745|FG001|STARTED|Overall Study||411
3222790|NCT02291679|3954746|FG002|STARTED|Overall Study||411
3222791|NCT02291679|3954744|FG000|COMPLETED|Overall Study||357
3222792|NCT02291679|3954745|FG001|COMPLETED|Overall Study||369
3222793|NCT02291679|3954746|FG002|COMPLETED|Overall Study||352
3222794|NCT02291679|3954744|FG000|NOT COMPLETED|Overall Study||44
3222795|NCT02291679|3954745|FG001|NOT COMPLETED|Overall Study||42
3222796|NCT02291679|3954746|FG002|NOT COMPLETED|Overall Study||59
3222797|NCT02291718|3954756|FG000|STARTED|Overall Study||50
3222798|NCT02291718|3954757|FG001|STARTED|Overall Study||50
3222799|NCT02291718|3954758|FG002|STARTED|Overall Study||50
3222800|NCT02291718|3954756|FG000|COMPLETED|Overall Study||50
3222801|NCT02291718|3954757|FG001|COMPLETED|Overall Study||50
3222802|NCT02291718|3954758|FG002|COMPLETED|Overall Study||50
3222803|NCT02291718|3954756|FG000|NOT COMPLETED|Overall Study||0
3222804|NCT02291718|3954757|FG001|NOT COMPLETED|Overall Study||0
3222805|NCT02291718|3954758|FG002|NOT COMPLETED|Overall Study||0
3222806|NCT02291861|3954770|FG000|STARTED|Overall Study||74
3222807|NCT02291861|3954771|FG001|STARTED|Overall Study||75
3222808|NCT02291861|3954772|FG002|STARTED|Overall Study||74
3222809|NCT02291861|3954773|FG003|STARTED|Overall Study||75
3222810|NCT02291861|3954770|FG000|Safety Population|Overall Study||72
3222811|NCT02291861|3954771|FG001|Safety Population|Overall Study||74
3222812|NCT02291861|3954772|FG002|Safety Population|Overall Study||73
3222813|NCT02291861|3954773|FG003|Safety Population|Overall Study||74
3222814|NCT02291861|3954770|FG000|Modified Intent to Treat Pop (mITT)|Overall Study||58
3222815|NCT02291861|3954771|FG001|Modified Intent to Treat Pop (mITT)|Overall Study||60
3222816|NCT02291861|3954772|FG002|Modified Intent to Treat Pop (mITT)|Overall Study||49
3222817|NCT02291861|3954773|FG003|Modified Intent to Treat Pop (mITT)|Overall Study||55
3222818|NCT02291861|3954770|FG000|COMPLETED|Overall Study||67
3222819|NCT02291861|3954771|FG001|COMPLETED|Overall Study||67
3222820|NCT02291861|3954772|FG002|COMPLETED|Overall Study||65
3222821|NCT02291861|3954773|FG003|COMPLETED|Overall Study||65
3222822|NCT02291861|3954770|FG000|NOT COMPLETED|Overall Study||7
3222823|NCT02291861|3954771|FG001|NOT COMPLETED|Overall Study||8
3222824|NCT02291861|3954772|FG002|NOT COMPLETED|Overall Study||9
3222825|NCT02291861|3954773|FG003|NOT COMPLETED|Overall Study||10
3222826|NCT02291913|3954783|FG000|STARTED|Overall Study||48
3222827|NCT02291913|3954783|FG000|COMPLETED|Overall Study||0
3222828|NCT02291913|3954783|FG000|NOT COMPLETED|Overall Study||48
3222829|NCT02292082|3954789|FG000|STARTED|Overall Study||56
3222830|NCT02292082|3954790|FG001|STARTED|Overall Study||55
3222831|NCT02292082|3954789|FG000|COMPLETED|Overall Study||56
3222832|NCT02292082|3954790|FG001|COMPLETED|Overall Study||55
3222833|NCT02292082|3954789|FG000|NOT COMPLETED|Overall Study||0
3222834|NCT02292082|3954790|FG001|NOT COMPLETED|Overall Study||0
3222835|NCT02292186|3954796|FG000|STARTED|Overall Study||25
3222836|NCT02292186|3954796|FG000|COMPLETED|Overall Study||7
3222837|NCT02292186|3954796|FG000|NOT COMPLETED|Overall Study||18
3222838|NCT02292212|3954800|FG000|STARTED|Pre-ViE Phase||17
3222839|NCT02292212|3954800|FG000|COMPLETED|Pre-ViE Phase||17
3222840|NCT02292212|3954800|FG000|NOT COMPLETED|Pre-ViE Phase||0
3222841|NCT02292212|3954800|FG000|STARTED|ViE Phase||17
3222842|NCT02292212|3954800|FG000|COMPLETED|ViE Phase||14
3222843|NCT02292212|3954800|FG000|NOT COMPLETED|ViE Phase||3
3222844|NCT02292212|3954800|FG000|STARTED|Post-ViE Phase||14
3222845|NCT02292212|3954800|FG000|COMPLETED|Post-ViE Phase||14
3222846|NCT02292212|3954800|FG000|NOT COMPLETED|Post-ViE Phase||0
3222847|NCT02292433|3954814|FG000|STARTED|First Intervention Period (7 Days)||4
3222848|NCT02292433|3954815|FG001|STARTED|First Intervention Period (7 Days)||4
3222849|NCT02292433|3954816|FG002|STARTED|First Intervention Period (7 Days)||4
3222850|NCT02292433|3954814|FG000|COMPLETED|First Intervention Period (7 Days)||4
3222851|NCT02292433|3954815|FG001|COMPLETED|First Intervention Period (7 Days)||4
3222852|NCT02292433|3954816|FG002|COMPLETED|First Intervention Period (7 Days)||4
3222853|NCT02292433|3954814|FG000|NOT COMPLETED|First Intervention Period (7 Days)||0
3222854|NCT02292433|3954815|FG001|NOT COMPLETED|First Intervention Period (7 Days)||0
3222855|NCT02292433|3954816|FG002|NOT COMPLETED|First Intervention Period (7 Days)||0
3222856|NCT02292433|3954814|FG000|STARTED|First Washout Period (7 to 14 Days)||4
3222857|NCT02292433|3954815|FG001|STARTED|First Washout Period (7 to 14 Days)||4
3222858|NCT02292433|3954816|FG002|STARTED|First Washout Period (7 to 14 Days)||4
3222859|NCT02292433|3954814|FG000|COMPLETED|First Washout Period (7 to 14 Days)||4
3222860|NCT02292433|3954815|FG001|COMPLETED|First Washout Period (7 to 14 Days)||4
3222861|NCT02292433|3954816|FG002|COMPLETED|First Washout Period (7 to 14 Days)||4
3222862|NCT02292433|3954814|FG000|NOT COMPLETED|First Washout Period (7 to 14 Days)||0
3222863|NCT02292433|3954815|FG001|NOT COMPLETED|First Washout Period (7 to 14 Days)||0
3222864|NCT02292433|3954816|FG002|NOT COMPLETED|First Washout Period (7 to 14 Days)||0
3222865|NCT02292433|3954814|FG000|STARTED|Second Intervention Period (7 Days)||4
3222866|NCT02292433|3954815|FG001|STARTED|Second Intervention Period (7 Days)||4
3222867|NCT02292433|3954816|FG002|STARTED|Second Intervention Period (7 Days)||4
3222868|NCT02292433|3954814|FG000|COMPLETED|Second Intervention Period (7 Days)||4
3222869|NCT02292433|3954815|FG001|COMPLETED|Second Intervention Period (7 Days)||4
3222870|NCT02292433|3954816|FG002|COMPLETED|Second Intervention Period (7 Days)||4
3222871|NCT02292433|3954814|FG000|NOT COMPLETED|Second Intervention Period (7 Days)||0
3222872|NCT02292433|3954815|FG001|NOT COMPLETED|Second Intervention Period (7 Days)||0
3222873|NCT02292433|3954816|FG002|NOT COMPLETED|Second Intervention Period (7 Days)||0
3222874|NCT02292433|3954814|FG000|STARTED|Second Washout Period (7 to 14 Days)||4
3222875|NCT02292433|3954815|FG001|STARTED|Second Washout Period (7 to 14 Days)||4
3222876|NCT02292433|3954816|FG002|STARTED|Second Washout Period (7 to 14 Days)||4
3222877|NCT02292433|3954814|FG000|COMPLETED|Second Washout Period (7 to 14 Days)||4
3222878|NCT02292433|3954815|FG001|COMPLETED|Second Washout Period (7 to 14 Days)||4
3222879|NCT02292433|3954816|FG002|COMPLETED|Second Washout Period (7 to 14 Days)||4
3222880|NCT02292433|3954814|FG000|NOT COMPLETED|Second Washout Period (7 to 14 Days)||0
3222881|NCT02292433|3954815|FG001|NOT COMPLETED|Second Washout Period (7 to 14 Days)||0
3222882|NCT02292433|3954816|FG002|NOT COMPLETED|Second Washout Period (7 to 14 Days)||0
3222883|NCT02292433|3954814|FG000|STARTED|Third Intervention Period (7 Days)||4
3222884|NCT02292433|3954815|FG001|STARTED|Third Intervention Period (7 Days)||4
3222885|NCT02292433|3954816|FG002|STARTED|Third Intervention Period (7 Days)||4
3222886|NCT02292433|3954814|FG000|COMPLETED|Third Intervention Period (7 Days)||4
3222887|NCT02292433|3954815|FG001|COMPLETED|Third Intervention Period (7 Days)||4
3222888|NCT02292433|3954816|FG002|COMPLETED|Third Intervention Period (7 Days)||4
3222889|NCT02292433|3954814|FG000|NOT COMPLETED|Third Intervention Period (7 Days)||0
3222890|NCT02292433|3954815|FG001|NOT COMPLETED|Third Intervention Period (7 Days)||0
3222891|NCT02292433|3954816|FG002|NOT COMPLETED|Third Intervention Period (7 Days)||0
3222892|NCT02292446|3954824|FG000|STARTED|Overall Study||161
3222893|NCT02292446|3954824|FG000|COMPLETED|Overall Study||141
3222894|NCT02292446|3954824|FG000|NOT COMPLETED|Overall Study||20
3222895|NCT02292537|3954833|FG000|STARTED|Overall Study||42
3222896|NCT02292537|3954834|FG001|STARTED|Overall Study||84
3222897|NCT02292537|3954833|FG000|Completed Treatment|Overall Study||42
3222898|NCT02292537|3954834|FG001|Completed Treatment|Overall Study|1 participant completed the study but did not complete treatments due to early study closure|83
3222899|NCT02292537|3954833|FG000|COMPLETED|Overall Study||42
3222900|NCT02292537|3954834|FG001|COMPLETED|Overall Study||84
3222901|NCT02292537|3954833|FG000|NOT COMPLETED|Overall Study||0
3222902|NCT02292537|3954834|FG001|NOT COMPLETED|Overall Study||0
3222903|NCT02292654|3954843|FG000|STARTED|Overall Study||4
3222904|NCT02292654|3954844|FG001|STARTED|Overall Study||9
3222905|NCT02292654|3954845|FG002|STARTED|Overall Study||7
3222906|NCT02292654|3954843|FG000|COMPLETED|Overall Study||4
3222907|NCT02292654|3954844|FG001|COMPLETED|Overall Study||9
3222908|NCT02292654|3954845|FG002|COMPLETED|Overall Study||7
3222909|NCT02292654|3954843|FG000|NOT COMPLETED|Overall Study||0
3222910|NCT02292654|3954844|FG001|NOT COMPLETED|Overall Study||0
3222911|NCT02292654|3954845|FG002|NOT COMPLETED|Overall Study||0
3222912|NCT02292719|3954865|FG000|STARTED|Overall Study||9
3222913|NCT02292719|3954866|FG001|STARTED|Overall Study||11
3222914|NCT02292719|3954867|FG002|STARTED|Overall Study||10
3222915|NCT02292719|3954868|FG003|STARTED|Overall Study||9
3222916|NCT02292719|3954869|FG004|STARTED|Overall Study||21
3222917|NCT02292719|3954870|FG005|STARTED|Overall Study||10
3222918|NCT02292719|3954865|FG000|COMPLETED|Overall Study||9
3222919|NCT02292719|3954866|FG001|COMPLETED|Overall Study||11
3222920|NCT02292719|3954867|FG002|COMPLETED|Overall Study||9
3222921|NCT02292719|3954868|FG003|COMPLETED|Overall Study||8
3222922|NCT02292719|3954869|FG004|COMPLETED|Overall Study||20
3222923|NCT02292719|3954870|FG005|COMPLETED|Overall Study||10
3222924|NCT02292719|3954865|FG000|NOT COMPLETED|Overall Study||0
3222925|NCT02292719|3954866|FG001|NOT COMPLETED|Overall Study||0
3222926|NCT02292719|3954867|FG002|NOT COMPLETED|Overall Study||1
3222927|NCT02292719|3954868|FG003|NOT COMPLETED|Overall Study||1
3222928|NCT02292719|3954869|FG004|NOT COMPLETED|Overall Study||1
3222929|NCT02292719|3954870|FG005|NOT COMPLETED|Overall Study||0
3222930|NCT02292771|3954886|FG000|STARTED|Overall Study||47
3222931|NCT02292771|3954887|FG001|STARTED|Overall Study||50
3222932|NCT02292771|3954886|FG000|COMPLETED|Overall Study||43
3222933|NCT02292771|3954887|FG001|COMPLETED|Overall Study||48
3222934|NCT02292771|3954886|FG000|NOT COMPLETED|Overall Study||4
3222935|NCT02292771|3954887|FG001|NOT COMPLETED|Overall Study||2
3222936|NCT02292784|3954900|FG000|STARTED|Overall Study||5
3222937|NCT02292784|3954901|FG001|STARTED|Overall Study||44
3222938|NCT02292784|3954902|FG002|STARTED|Overall Study||49
3222939|NCT02292784|3954900|FG000|COMPLETED|Overall Study||4
3222940|NCT02292784|3954901|FG001|COMPLETED|Overall Study||24
3222941|NCT02292784|3954902|FG002|COMPLETED|Overall Study||28
3222942|NCT02292784|3954900|FG000|NOT COMPLETED|Overall Study||1
3222943|NCT02292784|3954901|FG001|NOT COMPLETED|Overall Study||20
3222944|NCT02292784|3954902|FG002|NOT COMPLETED|Overall Study||21
3222945|NCT02292849|3954913|FG000|STARTED|Overall Study||11
3222946|NCT02292849|3954914|FG001|STARTED|Overall Study||8
3222947|NCT02292849|3954915|FG002|STARTED|Overall Study||10
3222948|NCT02292849|3954913|FG000|COMPLETED|Overall Study||7
3222949|NCT02292849|3954914|FG001|COMPLETED|Overall Study||6
3222950|NCT02292849|3954915|FG002|COMPLETED|Overall Study||8
3222951|NCT02292849|3954913|FG000|NOT COMPLETED|Overall Study||4
3222952|NCT02292849|3954914|FG001|NOT COMPLETED|Overall Study||2
3222953|NCT02292849|3954915|FG002|NOT COMPLETED|Overall Study||2
3222954|NCT02292927|3954925|FG000|STARTED|Overall Study||13
3222955|NCT02292927|3954926|FG001|STARTED|Overall Study||12
3222956|NCT02292927|3954925|FG000|COMPLETED|Overall Study||0
3222957|NCT02292927|3954926|FG001|COMPLETED|Overall Study||5
3222958|NCT02292927|3954925|FG000|NOT COMPLETED|Overall Study||13
3222959|NCT02292927|3954926|FG001|NOT COMPLETED|Overall Study||7
3222960|NCT02292940|3954937|FG000|STARTED|Overall Study||165477
3222961|NCT02292940|3954938|FG001|STARTED|Overall Study||3000
3222962|NCT02292940|3954937|FG000|COMPLETED|Overall Study||165477
3222963|NCT02292940|3954938|FG001|COMPLETED|Overall Study||1824
3222964|NCT02292940|3954937|FG000|NOT COMPLETED|Overall Study||0
3222965|NCT02292940|3954938|FG001|NOT COMPLETED|Overall Study||1176
3222966|NCT02293044|3954945|FG000|STARTED|Overall Study||15
3222967|NCT02293044|3954945|FG000|COMPLETED|Overall Study||15
3222968|NCT02293044|3954945|FG000|NOT COMPLETED|Overall Study||0
3222969|NCT02293096|3954949|FG000|STARTED|Overall Study||140
3222970|NCT02293096|3954949|FG000|COMPLETED|Overall Study||140
3222971|NCT02293096|3954949|FG000|NOT COMPLETED|Overall Study||0
3222972|NCT02293395|3954955|FG000|STARTED|Overall Study||1519
3222973|NCT02293395|3954956|FG001|STARTED|Overall Study||1518
3222974|NCT02293395|3954955|FG000|Treated|Overall Study||1510
3222975|NCT02293395|3954956|FG001|Treated|Overall Study||1506
3222976|NCT02293395|3954955|FG000|COMPLETED|Overall Study||1510
3222977|NCT02293395|3954956|FG001|COMPLETED|Overall Study||1511
3222978|NCT02293395|3954955|FG000|NOT COMPLETED|Overall Study||9
3222979|NCT02293395|3954956|FG001|NOT COMPLETED|Overall Study||7
3222980|NCT02293460|3954962|FG000|STARTED|Overall Study||43
3222981|NCT02293460|3954962|FG000|COMPLETED|Overall Study||37
3222982|NCT02293460|3954962|FG000|NOT COMPLETED|Overall Study||6
3222983|NCT02293499|3954969|FG000|STARTED|Baseline - Enrollment||152
3222984|NCT02293499|3954970|FG001|STARTED|Baseline - Enrollment||168
3222985|NCT02293499|3954971|FG002|STARTED|Baseline - Enrollment||51
3222986|NCT02293499|3954969|FG000|COMPLETED|Baseline - Enrollment||152
3222987|NCT02293499|3954970|FG001|COMPLETED|Baseline - Enrollment||168
3222988|NCT02293499|3954971|FG002|COMPLETED|Baseline - Enrollment||51
3222989|NCT02293499|3954969|FG000|NOT COMPLETED|Baseline - Enrollment||0
3222990|NCT02293499|3954970|FG001|NOT COMPLETED|Baseline - Enrollment||0
3222991|NCT02293499|3954971|FG002|NOT COMPLETED|Baseline - Enrollment||0
3222992|NCT02293499|3954969|FG000|STARTED|Training - Peer Leaders Only|Participant number carried over from previous time point.|0
3222993|NCT02293499|3954970|FG001|STARTED|Training - Peer Leaders Only|Participant number carried over from previous time point.|0
3222994|NCT02293499|3954971|FG002|STARTED|Training - Peer Leaders Only||51
3222995|NCT02293499|3954969|FG000|COMPLETED|Training - Peer Leaders Only||0
3222996|NCT02293499|3954970|FG001|COMPLETED|Training - Peer Leaders Only||0
3222997|NCT02293499|3954971|FG002|COMPLETED|Training - Peer Leaders Only||41
3222998|NCT02293499|3954969|FG000|NOT COMPLETED|Training - Peer Leaders Only||0
3222999|NCT02293499|3954970|FG001|NOT COMPLETED|Training - Peer Leaders Only||0
3223000|NCT02293499|3954971|FG002|NOT COMPLETED|Training - Peer Leaders Only||10
3223001|NCT02293499|3954969|FG000|STARTED|Intervention - Camp|By design, they did not participate in the previous period.|152
3223002|NCT02293499|3954970|FG001|STARTED|Intervention - Camp|By design, they did not participate in the previous period.|168
3223003|NCT02293499|3954971|FG002|STARTED|Intervention - Camp||41
3223004|NCT02293499|3954969|FG000|COMPLETED|Intervention - Camp||125
3223005|NCT02293499|3954970|FG001|COMPLETED|Intervention - Camp||134
3223006|NCT02293499|3954971|FG002|COMPLETED|Intervention - Camp||35
3223007|NCT02293499|3954969|FG000|NOT COMPLETED|Intervention - Camp||27
3223008|NCT02293499|3954970|FG001|NOT COMPLETED|Intervention - Camp||34
3223009|NCT02293499|3954971|FG002|NOT COMPLETED|Intervention - Camp||6
3223010|NCT02293499|3954969|FG000|STARTED|3 Month Follow Up||149
3223011|NCT02293499|3954970|FG001|STARTED|3 Month Follow Up||162
3223012|NCT02293499|3954971|FG002|STARTED|3 Month Follow Up||39
3223013|NCT02293499|3954969|FG000|COMPLETED|3 Month Follow Up||134
3223014|NCT02293499|3954970|FG001|COMPLETED|3 Month Follow Up||147
3223015|NCT02293499|3954971|FG002|COMPLETED|3 Month Follow Up||29
3223016|NCT02293499|3954969|FG000|NOT COMPLETED|3 Month Follow Up||15
3223017|NCT02293499|3954970|FG001|NOT COMPLETED|3 Month Follow Up||15
3223018|NCT02293499|3954971|FG002|NOT COMPLETED|3 Month Follow Up||10
3223019|NCT02293499|3954969|FG000|STARTED|6 Month Follow Up||148
3223020|NCT02293499|3954970|FG001|STARTED|6 Month Follow Up||162
3223021|NCT02293499|3954971|FG002|STARTED|6 Month Follow Up||35
3223022|NCT02293499|3954969|FG000|COMPLETED|6 Month Follow Up||131
3223023|NCT02293499|3954970|FG001|COMPLETED|6 Month Follow Up||135
3223024|NCT02293499|3954971|FG002|COMPLETED|6 Month Follow Up||28
3223025|NCT02293499|3954969|FG000|NOT COMPLETED|6 Month Follow Up||17
3223026|NCT02293499|3954970|FG001|NOT COMPLETED|6 Month Follow Up||27
3223027|NCT02293499|3954971|FG002|NOT COMPLETED|6 Month Follow Up||7
3223028|NCT02293499|3954969|FG000|STARTED|9 Month Follow Up||148
3223029|NCT02293499|3954970|FG001|STARTED|9 Month Follow Up||162
3223030|NCT02293499|3954971|FG002|STARTED|9 Month Follow Up||34
3223031|NCT02293499|3954969|FG000|COMPLETED|9 Month Follow Up||122
3223032|NCT02293499|3954970|FG001|COMPLETED|9 Month Follow Up||134
3223033|NCT02293499|3954971|FG002|COMPLETED|9 Month Follow Up||30
3223034|NCT02293499|3954969|FG000|NOT COMPLETED|9 Month Follow Up||26
3223035|NCT02293499|3954970|FG001|NOT COMPLETED|9 Month Follow Up||28
3223036|NCT02293499|3954971|FG002|NOT COMPLETED|9 Month Follow Up||4
3223037|NCT02293499|3954969|FG000|STARTED|12 Month Follow Up||146
3223038|NCT02293499|3954970|FG001|STARTED|12 Month Follow Up||162
3223039|NCT02293499|3954971|FG002|STARTED|12 Month Follow Up||34
3223040|NCT02293499|3954969|FG000|COMPLETED|12 Month Follow Up||120
3223041|NCT02293499|3954970|FG001|COMPLETED|12 Month Follow Up||136
3223042|NCT02293499|3954971|FG002|COMPLETED|12 Month Follow Up||28
3223043|NCT02293499|3954969|FG000|NOT COMPLETED|12 Month Follow Up||26
3223044|NCT02293499|3954970|FG001|NOT COMPLETED|12 Month Follow Up||26
3223045|NCT02293499|3954971|FG002|NOT COMPLETED|12 Month Follow Up||6
3223046|NCT02293499|3954969|FG000|STARTED|15 Month Follow Up||146
3223047|NCT02293499|3954970|FG001|STARTED|15 Month Follow Up||161
3223048|NCT02293499|3954971|FG002|STARTED|15 Month Follow Up||34
3223049|NCT02293499|3954969|FG000|COMPLETED|15 Month Follow Up||124
3223050|NCT02293499|3954970|FG001|COMPLETED|15 Month Follow Up||139
3223051|NCT02293499|3954971|FG002|COMPLETED|15 Month Follow Up||27
3223052|NCT02293499|3954969|FG000|NOT COMPLETED|15 Month Follow Up||22
3223053|NCT02293499|3954970|FG001|NOT COMPLETED|15 Month Follow Up||22
3223054|NCT02293499|3954971|FG002|NOT COMPLETED|15 Month Follow Up||7
3223055|NCT02293512|3954984|FG000|STARTED|Overall Study||10
3223056|NCT02293512|3954985|FG001|STARTED|Overall Study||10
3223057|NCT02293512|3954986|FG002|STARTED|Overall Study||10
3223058|NCT02293512|3954987|FG003|STARTED|Overall Study||10
3223059|NCT02293512|3954984|FG000|COMPLETED|Overall Study||6
3223060|NCT02293512|3954985|FG001|COMPLETED|Overall Study||4
3223061|NCT02293512|3954986|FG002|COMPLETED|Overall Study||7
3223062|NCT02293512|3954987|FG003|COMPLETED|Overall Study||8
3223063|NCT02293512|3954984|FG000|NOT COMPLETED|Overall Study||4
3223064|NCT02293512|3954985|FG001|NOT COMPLETED|Overall Study||6
3223065|NCT02293512|3954986|FG002|NOT COMPLETED|Overall Study||3
3223066|NCT02293512|3954987|FG003|NOT COMPLETED|Overall Study||2
3223067|NCT02293538|3954999|FG000|STARTED|Overall Study||73
3223068|NCT02293538|3955000|FG001|STARTED|Overall Study||71
3223069|NCT02293538|3954999|FG000|COMPLETED|Overall Study||72
3223070|NCT02293538|3955000|FG001|COMPLETED|Overall Study||69
3223071|NCT02293538|3954999|FG000|NOT COMPLETED|Overall Study||1
3223072|NCT02293538|3955000|FG001|NOT COMPLETED|Overall Study||2
3223073|NCT02293798|3955007|FG000|STARTED|Overall Study|2 units of SERI Mesh placed in each patient|13
3223074|NCT02293798|3955007|FG000|COMPLETED|Overall Study|2 units of SERI Mesh placed in each patient|13
3223075|NCT02293798|3955007|FG000|NOT COMPLETED|Overall Study||0
3223076|NCT02293837|3955015|FG000|STARTED|Overall Study||54
3223077|NCT02293837|3955016|FG001|STARTED|Overall Study||27
3223078|NCT02293837|3955017|FG002|STARTED|Overall Study|1 randomized adult was never treated|35
3223079|NCT02293837|3955018|FG003|STARTED|Overall Study||20
3223080|NCT02293837|3955015|FG000|COMPLETED|Overall Study||51
3223081|NCT02293837|3955016|FG001|COMPLETED|Overall Study||23
3223082|NCT02293837|3955017|FG002|COMPLETED|Overall Study||31
3223083|NCT02293837|3955018|FG003|COMPLETED|Overall Study||19
3223084|NCT02293837|3955015|FG000|NOT COMPLETED|Overall Study||3
3223085|NCT02293837|3955016|FG001|NOT COMPLETED|Overall Study||4
3223086|NCT02293837|3955017|FG002|NOT COMPLETED|Overall Study||4
3223087|NCT02293837|3955018|FG003|NOT COMPLETED|Overall Study||1
3223088|NCT02293863|3955035|FG000|STARTED|Overall Study||56
3223089|NCT02293863|3955036|FG001|STARTED|Overall Study||55
3223090|NCT02293863|3955037|FG002|STARTED|Overall Study||47
3223091|NCT02293863|3955035|FG000|COMPLETED|Overall Study||47
3223092|NCT02293863|3955036|FG001|COMPLETED|Overall Study||42
3223093|NCT02293863|3955037|FG002|COMPLETED|Overall Study||38
3223094|NCT02293863|3955035|FG000|NOT COMPLETED|Overall Study||9
3223095|NCT02293863|3955036|FG001|NOT COMPLETED|Overall Study||13
3223096|NCT02293863|3955037|FG002|NOT COMPLETED|Overall Study||9
3223097|NCT02293902|3955050|FG000|STARTED|Double-Blind Period (Up to Week 24)||82
3223098|NCT02293902|3955051|FG001|STARTED|Double-Blind Period (Up to Week 24)||81
3223099|NCT02293902|3955052|FG002|STARTED|Double-Blind Period (Up to Week 24)||80
3223100|NCT02293902|3955053|FG003|STARTED|Double-Blind Period (Up to Week 24)||0
3223101|NCT02293902|3955054|FG004|STARTED|Double-Blind Period (Up to Week 24)||0
3223102|NCT02293902|3955050|FG000|Treated|Double-Blind Period (Up to Week 24)||81
3223103|NCT02293902|3955051|FG001|Treated|Double-Blind Period (Up to Week 24)||81
3223104|NCT02293902|3955052|FG002|Treated|Double-Blind Period (Up to Week 24)||80
3223105|NCT02293902|3955053|FG003|Treated|Double-Blind Period (Up to Week 24)||0
3223106|NCT02293902|3955054|FG004|Treated|Double-Blind Period (Up to Week 24)||0
3223107|NCT02293902|3955050|FG000|Rescued|Double-Blind Period (Up to Week 24)||44
3223108|NCT02293902|3955051|FG001|Rescued|Double-Blind Period (Up to Week 24)||6
3223109|NCT02293902|3955052|FG002|Rescued|Double-Blind Period (Up to Week 24)||8
3223110|NCT02293902|3955053|FG003|Rescued|Double-Blind Period (Up to Week 24)||0
3223111|NCT02293902|3955054|FG004|Rescued|Double-Blind Period (Up to Week 24)||0
3223112|NCT02293902|3955050|FG000|COMPLETED|Double-Blind Period (Up to Week 24)|42 rescued and 29 not rescued completed.|71
3223113|NCT02293902|3955051|FG001|COMPLETED|Double-Blind Period (Up to Week 24)|6 rescued and 68 not rescued completed.|74
3223114|NCT02293902|3955052|FG002|COMPLETED|Double-Blind Period (Up to Week 24)|8 rescued and 62 not rescued completed.|70
3223115|NCT02293902|3955053|FG003|COMPLETED|Double-Blind Period (Up to Week 24)||0
3223116|NCT02293902|3955054|FG004|COMPLETED|Double-Blind Period (Up to Week 24)||0
3223117|NCT02293902|3955050|FG000|NOT COMPLETED|Double-Blind Period (Up to Week 24)||11
3223118|NCT02293902|3955051|FG001|NOT COMPLETED|Double-Blind Period (Up to Week 24)||7
3223119|NCT02293902|3955052|FG002|NOT COMPLETED|Double-Blind Period (Up to Week 24)||10
3223120|NCT02293902|3955053|FG003|NOT COMPLETED|Double-Blind Period (Up to Week 24)||0
3223121|NCT02293902|3955054|FG004|NOT COMPLETED|Double-Blind Period (Up to Week 24)||0
3223122|NCT02293902|3955050|FG000|STARTED|Single-Blind Period (Week 25 to Week 52)||0
3223123|NCT02293902|3955051|FG001|STARTED|Single-Blind Period (Week 25 to Week 52)|68 participants not rescued continued same treatment and 6 rescued continued open label treatment.|74
3223124|NCT02293902|3955052|FG002|STARTED|Single-Blind Period (Week 25 to Week 52)|62 participants not rescued continued same treatment and 8 rescued continued open label treatment.|70
3223125|NCT02293902|3955053|FG003|STARTED|Single-Blind Period (Week 25 to Week 52)|14 participants not rescued were switched and 20 rescued continued open label treatment.|34
3223126|NCT02293902|3955054|FG004|STARTED|Single-Blind Period (Week 25 to Week 52)|15 participants not rescued were switched and 22 rescued continued open label treatment.|37
3223127|NCT02293902|3955050|FG000|COMPLETED|Single-Blind Period (Week 25 to Week 52)||0
3223128|NCT02293902|3955051|FG001|COMPLETED|Single-Blind Period (Week 25 to Week 52)|5 rescued and 61 not rescued completed.|66
3223129|NCT02293902|3955052|FG002|COMPLETED|Single-Blind Period (Week 25 to Week 52)|8 rescued and 60 not rescued completed.|68
3223130|NCT02293902|3955053|FG003|COMPLETED|Single-Blind Period (Week 25 to Week 52)|20 rescued and 13 not rescued completed.|33
3223131|NCT02293902|3955054|FG004|COMPLETED|Single-Blind Period (Week 25 to Week 52)|18 rescued and 13 not rescued completed.|31
3223132|NCT02293902|3955050|FG000|NOT COMPLETED|Single-Blind Period (Week 25 to Week 52)||0
3223133|NCT02293902|3955051|FG001|NOT COMPLETED|Single-Blind Period (Week 25 to Week 52)||8
3223134|NCT02293902|3955052|FG002|NOT COMPLETED|Single-Blind Period (Week 25 to Week 52)||2
3223135|NCT02293902|3955053|FG003|NOT COMPLETED|Single-Blind Period (Week 25 to Week 52)||1
3223136|NCT02293902|3955054|FG004|NOT COMPLETED|Single-Blind Period (Week 25 to Week 52)||6
3223137|NCT02293993|3955076|FG000|STARTED|Course 1 (DLT Evaluation Period)||4
3223138|NCT02293993|3955077|FG001|STARTED|Course 1 (DLT Evaluation Period)||6
3223139|NCT02293993|3955078|FG002|STARTED|Course 1 (DLT Evaluation Period)||7
3223140|NCT02293993|3955079|FG003|STARTED|Course 1 (DLT Evaluation Period)||4
3223141|NCT02293993|3955076|FG000|COMPLETED|Course 1 (DLT Evaluation Period)||3
3223142|NCT02293993|3955077|FG001|COMPLETED|Course 1 (DLT Evaluation Period)||6
3223143|NCT02293993|3955078|FG002|COMPLETED|Course 1 (DLT Evaluation Period)||7
3223144|NCT02293993|3955079|FG003|COMPLETED|Course 1 (DLT Evaluation Period)||3
3223145|NCT02293993|3955076|FG000|NOT COMPLETED|Course 1 (DLT Evaluation Period)||1
3223146|NCT02293993|3955077|FG001|NOT COMPLETED|Course 1 (DLT Evaluation Period)||0
3223147|NCT02293993|3955078|FG002|NOT COMPLETED|Course 1 (DLT Evaluation Period)||0
3223148|NCT02293993|3955079|FG003|NOT COMPLETED|Course 1 (DLT Evaluation Period)||1
3223149|NCT02293993|3955076|FG000|STARTED|Course ≥2 (Extended Treatment Period)||2
3223150|NCT02293993|3955077|FG001|STARTED|Course ≥2 (Extended Treatment Period)||5
3223151|NCT02293993|3955078|FG002|STARTED|Course ≥2 (Extended Treatment Period)||6
3223152|NCT02293993|3955079|FG003|STARTED|Course ≥2 (Extended Treatment Period)||3
3223153|NCT02293993|3955076|FG000|COMPLETED|Course ≥2 (Extended Treatment Period)||0
3223154|NCT02293993|3955077|FG001|COMPLETED|Course ≥2 (Extended Treatment Period)||0
3223155|NCT02293993|3955078|FG002|COMPLETED|Course ≥2 (Extended Treatment Period)||1
3223156|NCT02293993|3955079|FG003|COMPLETED|Course ≥2 (Extended Treatment Period)||2
3223157|NCT02293993|3955076|FG000|NOT COMPLETED|Course ≥2 (Extended Treatment Period)||2
3223158|NCT02293993|3955077|FG001|NOT COMPLETED|Course ≥2 (Extended Treatment Period)||5
3368136|NCT03838198|4099777|FG003|COMPLETED|1 Month Follow up Period||21
3368137|NCT03838198|4099774|FG000|NOT COMPLETED|1 Month Follow up Period||2
3368138|NCT03838198|4099775|FG001|NOT COMPLETED|1 Month Follow up Period||0
3368139|NCT03838198|4099776|FG002|NOT COMPLETED|1 Month Follow up Period||1
3368140|NCT03838198|4099777|FG003|NOT COMPLETED|1 Month Follow up Period||1
3368141|NCT03838198|4099774|FG000|STARTED|3 Month Follow up Period||18
3368142|NCT03838198|4099775|FG001|STARTED|3 Month Follow up Period||22
3368143|NCT03838198|4099776|FG002|STARTED|3 Month Follow up Period||17
3368144|NCT03838198|4099777|FG003|STARTED|3 Month Follow up Period||22
3368145|NCT03838198|4099774|FG000|Adolescent Survey Completed|3 Month Follow up Period||16
3368146|NCT03838198|4099775|FG001|Adolescent Survey Completed|3 Month Follow up Period||21
3368147|NCT03838198|4099776|FG002|Adolescent Survey Completed|3 Month Follow up Period||15
3368148|NCT03838198|4099777|FG003|Adolescent Survey Completed|3 Month Follow up Period||21
3368149|NCT03838198|4099774|FG000|COMPLETED|3 Month Follow up Period||15
3368150|NCT03838198|4099775|FG001|COMPLETED|3 Month Follow up Period||19
3368151|NCT03838198|4099776|FG002|COMPLETED|3 Month Follow up Period||14
3368152|NCT03838198|4099777|FG003|COMPLETED|3 Month Follow up Period||18
3368153|NCT03838198|4099774|FG000|NOT COMPLETED|3 Month Follow up Period||3
3368154|NCT03838198|4099775|FG001|NOT COMPLETED|3 Month Follow up Period||3
3368155|NCT03838198|4099776|FG002|NOT COMPLETED|3 Month Follow up Period||3
3368156|NCT03838198|4099777|FG003|NOT COMPLETED|3 Month Follow up Period||4
3368157|NCT03831451|4099790|FG000|STARTED|Overall Study||74
3368158|NCT03831451|4099791|FG001|STARTED|Overall Study||55
3368159|NCT03831451|4099790|FG000|COMPLETED|Overall Study||74
3368160|NCT03831451|4099791|FG001|COMPLETED|Overall Study||55
3368161|NCT03831451|4099790|FG000|NOT COMPLETED|Overall Study||0
3368162|NCT03831451|4099791|FG001|NOT COMPLETED|Overall Study||0
3368163|NCT03822078|4099803|FG000|STARTED|Overall Study||12
3368164|NCT03822078|4099804|FG001|STARTED|Overall Study||6
3223159|NCT02293993|3955078|FG002|NOT COMPLETED|Course ≥2 (Extended Treatment Period)||5
3223160|NCT02293993|3955079|FG003|NOT COMPLETED|Course ≥2 (Extended Treatment Period)||1
3223161|NCT02294019|3955097|FG000|STARTED|Overall Study||738
3223162|NCT02294019|3955097|FG000|COMPLETED|Overall Study||635
3223163|NCT02294019|3955097|FG000|NOT COMPLETED|Overall Study||103
3223164|NCT02294058|3955104|FG000|STARTED|Overall Study||448
3223165|NCT02294058|3955105|FG001|STARTED|Overall Study||451
3223166|NCT02294058|3955106|FG002|STARTED|Overall Study||447
3223167|NCT02294058|3955104|FG000|Safety Population|Overall Study||445
3223168|NCT02294058|3955105|FG001|Safety Population|Overall Study||453
3223169|NCT02294058|3955106|FG002|Safety Population|Overall Study||448
3223170|NCT02294058|3955104|FG000|COMPLETED|Overall Study||412
3223171|NCT02294058|3955105|FG001|COMPLETED|Overall Study||425
3223172|NCT02294058|3955106|FG002|COMPLETED|Overall Study||418
3223173|NCT02294058|3955104|FG000|NOT COMPLETED|Overall Study||36
3223174|NCT02294058|3955105|FG001|NOT COMPLETED|Overall Study||26
3223175|NCT02294058|3955106|FG002|NOT COMPLETED|Overall Study||29
3223176|NCT02294175|3955117|FG000|STARTED|Overall Study||23
3223177|NCT02294175|3955118|FG001|STARTED|Overall Study||22
3223178|NCT02294175|3955117|FG000|COMPLETED|Overall Study||18
3223179|NCT02294175|3955118|FG001|COMPLETED|Overall Study||16
3223180|NCT02294175|3955117|FG000|NOT COMPLETED|Overall Study||5
3223181|NCT02294175|3955118|FG001|NOT COMPLETED|Overall Study||6
3223182|NCT02294227|3955127|FG000|STARTED|Overall Study||114
3223183|NCT02294227|3955128|FG001|STARTED|Overall Study||113
3223184|NCT02294227|3955129|FG002|STARTED|Overall Study||114
3223185|NCT02294227|3955127|FG000|COMPLETED|Overall Study||89
3223186|NCT02294227|3955128|FG001|COMPLETED|Overall Study||88
3223187|NCT02294227|3955129|FG002|COMPLETED|Overall Study||95
3223188|NCT02294227|3955127|FG000|NOT COMPLETED|Overall Study||25
3223189|NCT02294227|3955128|FG001|NOT COMPLETED|Overall Study||25
3223190|NCT02294227|3955129|FG002|NOT COMPLETED|Overall Study||19
3223191|NCT02294253|3955139|FG000|STARTED|Overall Study||30
3223192|NCT02294253|3955139|FG000|COMPLETED|Overall Study||15
3223193|NCT02294253|3955139|FG000|NOT COMPLETED|Overall Study||15
3223194|NCT02294318|3955145|FG000|STARTED|Overall Study||24
3223195|NCT02294318|3955146|FG001|STARTED|Overall Study||23
3223196|NCT02294318|3955145|FG000|COMPLETED|Overall Study||21
3223197|NCT02294318|3955146|FG001|COMPLETED|Overall Study||21
3223198|NCT02294318|3955145|FG000|NOT COMPLETED|Overall Study||3
3223199|NCT02294318|3955146|FG001|NOT COMPLETED|Overall Study||2
3223200|NCT02294396|3955156|FG000|STARTED|Overall Study||167
3223201|NCT02294396|3955157|FG001|STARTED|Overall Study||161
3223202|NCT02294396|3955158|FG002|STARTED|Overall Study||161
3223203|NCT02294396|3955159|FG003|STARTED|Overall Study||160
3223204|NCT02294396|3955156|FG000|COMPLETED|Overall Study||127
3223205|NCT02294396|3955157|FG001|COMPLETED|Overall Study||128
3223206|NCT02294396|3955158|FG002|COMPLETED|Overall Study||126
3223207|NCT02294396|3955159|FG003|COMPLETED|Overall Study||123
3223208|NCT02294396|3955156|FG000|NOT COMPLETED|Overall Study||40
3223209|NCT02294396|3955157|FG001|NOT COMPLETED|Overall Study||33
3223210|NCT02294396|3955158|FG002|NOT COMPLETED|Overall Study||35
3223211|NCT02294396|3955159|FG003|NOT COMPLETED|Overall Study||37
3223212|NCT02294474|3955171|FG000|STARTED|Overall Study||253
3223213|NCT02294474|3955172|FG001|STARTED|Overall Study||252
3223214|NCT02294474|3955171|FG000|COMPLETED|Overall Study||228
3223215|NCT02294474|3955172|FG001|COMPLETED|Overall Study||230
3223216|NCT02294474|3955171|FG000|NOT COMPLETED|Overall Study||25
3223217|NCT02294474|3955172|FG001|NOT COMPLETED|Overall Study||22
3223218|NCT02294604|3955182|FG000|STARTED|Overall Study||80
3223219|NCT02294604|3955183|FG001|STARTED|Overall Study||80
3223220|NCT02294604|3955184|FG002|STARTED|Overall Study||80
3223221|NCT02294604|3955182|FG000|COMPLETED|Overall Study||79
3223222|NCT02294604|3955183|FG001|COMPLETED|Overall Study||77
3223223|NCT02294604|3955184|FG002|COMPLETED|Overall Study||80
3223224|NCT02294604|3955182|FG000|NOT COMPLETED|Overall Study||1
3223225|NCT02294604|3955183|FG001|NOT COMPLETED|Overall Study||3
3223226|NCT02294604|3955184|FG002|NOT COMPLETED|Overall Study||0
3223227|NCT02294630|3955196|FG000|STARTED|Overall Study||37
3223228|NCT02294630|3955197|FG001|STARTED|Overall Study||38
3223229|NCT02294630|3955198|FG002|STARTED|Overall Study||35
3223230|NCT02294630|3955199|FG003|STARTED|Overall Study||39
3223231|NCT02294630|3955196|FG000|COMPLETED|Overall Study||37
3223232|NCT02294630|3955197|FG001|COMPLETED|Overall Study||38
3223233|NCT02294630|3955198|FG002|COMPLETED|Overall Study||35
3223234|NCT02294630|3955199|FG003|COMPLETED|Overall Study||39
3223235|NCT02294630|3955196|FG000|NOT COMPLETED|Overall Study||0
3223236|NCT02294630|3955197|FG001|NOT COMPLETED|Overall Study||0
3223237|NCT02294630|3955198|FG002|NOT COMPLETED|Overall Study||0
3223238|NCT02294630|3955199|FG003|NOT COMPLETED|Overall Study||0
3223239|NCT02294682|3955211|FG000|STARTED|Overall Study||53
3223240|NCT02294682|3955212|FG001|STARTED|Overall Study||53
3223241|NCT02294682|3955211|FG000|COMPLETED|Overall Study||52
3223242|NCT02294682|3955212|FG001|COMPLETED|Overall Study||53
3223243|NCT02294682|3955211|FG000|NOT COMPLETED|Overall Study||1
3223244|NCT02294682|3955212|FG001|NOT COMPLETED|Overall Study||0
3223245|NCT02294734|3955220|FG000|STARTED|Overall Study||63
3368165|NCT03822078|4099805|FG002|STARTED|Overall Study||6
3223246|NCT02294734|3955221|FG001|STARTED|Overall Study||63
3223247|NCT02294734|3955220|FG000|COMPLETED|Overall Study||49
3223248|NCT02294734|3955221|FG001|COMPLETED|Overall Study||55
3223249|NCT02294734|3955220|FG000|NOT COMPLETED|Overall Study||14
3223250|NCT02294734|3955221|FG001|NOT COMPLETED|Overall Study||8
3223251|NCT02294773|3955231|FG000|STARTED|Overall Study||7
3223252|NCT02294773|3955232|FG001|STARTED|Overall Study||6
3223253|NCT02294773|3955231|FG000|COMPLETED|Overall Study||7
3223254|NCT02294773|3955232|FG001|COMPLETED|Overall Study||4
3223255|NCT02294773|3955231|FG000|NOT COMPLETED|Overall Study||0
3223256|NCT02294773|3955232|FG001|NOT COMPLETED|Overall Study||2
3223257|NCT02294786|3955240|FG000|STARTED|Overall Study||30
3223258|NCT02294786|3955241|FG001|STARTED|Overall Study||32
3223259|NCT02294786|3955240|FG000|Safety Population|Overall Study|One subject randomized to Octreotide received only 0.1 mg dose.|29
3223260|NCT02294786|3955241|FG001|Safety Population|Overall Study|The subject was included in the No-Octreotide arm.|33
3223261|NCT02294786|3955240|FG000|ITT Population|Overall Study||30
3223262|NCT02294786|3955241|FG001|ITT Population|Overall Study||32
3223263|NCT02294786|3955240|FG000|COMPLETED|Overall Study||19
3223264|NCT02294786|3955241|FG001|COMPLETED|Overall Study||18
3223265|NCT02294786|3955240|FG000|NOT COMPLETED|Overall Study||11
3223266|NCT02294786|3955241|FG001|NOT COMPLETED|Overall Study||14
3223267|NCT02295020|3955250|FG000|STARTED|Overall Study||20
3223268|NCT02295020|3955251|FG001|STARTED|Overall Study||20
3223269|NCT02295020|3955250|FG000|COMPLETED|Overall Study||17
3223270|NCT02295020|3955251|FG001|COMPLETED|Overall Study||17
3223271|NCT02295020|3955250|FG000|NOT COMPLETED|Overall Study||3
3223272|NCT02295020|3955251|FG001|NOT COMPLETED|Overall Study||3
3223273|NCT02295280|3955265|FG000|STARTED|Overall Study||35
3223274|NCT02295280|3955266|FG001|STARTED|Overall Study||35
3223275|NCT02295280|3955265|FG000|COMPLETED|Overall Study||35
3223276|NCT02295280|3955266|FG001|COMPLETED|Overall Study||34
3223277|NCT02295280|3955265|FG000|NOT COMPLETED|Overall Study||0
3223278|NCT02295280|3955266|FG001|NOT COMPLETED|Overall Study||1
3223279|NCT02295553|3955276|FG000|STARTED|Overall Study||14
3223280|NCT02295553|3955277|FG001|STARTED|Overall Study||14
3223281|NCT02295553|3955278|FG002|STARTED|Overall Study||14
3223282|NCT02295553|3955279|FG003|STARTED|Overall Study||14
3223283|NCT02295553|3955276|FG000|COMPLETED|Overall Study||14
3223284|NCT02295553|3955277|FG001|COMPLETED|Overall Study||14
3223285|NCT02295553|3955278|FG002|COMPLETED|Overall Study||13
3223286|NCT02295553|3955279|FG003|COMPLETED|Overall Study||13
3223287|NCT02295553|3955276|FG000|NOT COMPLETED|Overall Study||0
3223288|NCT02295553|3955277|FG001|NOT COMPLETED|Overall Study||0
3223289|NCT02295553|3955278|FG002|NOT COMPLETED|Overall Study||1
3223290|NCT02295553|3955279|FG003|NOT COMPLETED|Overall Study||1
3223291|NCT02295644|3955293|FG000|STARTED|Overall Study|All groups were randomly allocated to subjects upon the start of their individual trials|7
3223292|NCT02295644|3955294|FG001|STARTED|Overall Study|All groups were randomly allocated to subjects upon the start of their individual trials|7
3223293|NCT02295644|3955295|FG002|STARTED|Overall Study|All groups were randomly allocated to subjects upon the start of their individual trials|7
3223294|NCT02295644|3955296|FG003|STARTED|Overall Study|All groups were randomly allocated to subjects upon the start of their individual trials|7
3223295|NCT02295644|3955293|FG000|COMPLETED|Overall Study||7
3223296|NCT02295644|3955294|FG001|COMPLETED|Overall Study||7
3223297|NCT02295644|3955295|FG002|COMPLETED|Overall Study||6
3223298|NCT02295644|3955296|FG003|COMPLETED|Overall Study||5
3223299|NCT02295644|3955293|FG000|NOT COMPLETED|Overall Study||0
3223300|NCT02295644|3955294|FG001|NOT COMPLETED|Overall Study||0
3223301|NCT02295644|3955295|FG002|NOT COMPLETED|Overall Study||1
3223302|NCT02295644|3955296|FG003|NOT COMPLETED|Overall Study||2
3223303|NCT02295735|3955308|FG000|STARTED|Overall Study||238
3223304|NCT02295735|3955309|FG001|STARTED|Overall Study||237
3223305|NCT02295735|3955308|FG000|COMPLETED|Overall Study||212
3223306|NCT02295735|3955309|FG001|COMPLETED|Overall Study||210
3223307|NCT02295735|3955308|FG000|NOT COMPLETED|Overall Study||26
3223308|NCT02295735|3955309|FG001|NOT COMPLETED|Overall Study||27
3223309|NCT02295774|3955315|FG000|STARTED|Overall Study||13
3223310|NCT02295774|3955315|FG000|COMPLETED|Overall Study||10
3223311|NCT02295774|3955315|FG000|NOT COMPLETED|Overall Study||3
3223312|NCT02295995|3955322|FG000|STARTED|Overall Study||36
3223313|NCT02295995|3955323|FG001|STARTED|Overall Study||18
3223314|NCT02295995|3955322|FG000|COMPLETED|Overall Study||31
3223315|NCT02295995|3955323|FG001|COMPLETED|Overall Study||17
3223316|NCT02295995|3955322|FG000|NOT COMPLETED|Overall Study||5
3223317|NCT02295995|3955323|FG001|NOT COMPLETED|Overall Study||1
3223318|NCT02296099|3955332|FG000|STARTED|Overall Study||57
3223319|NCT02296099|3955333|FG001|STARTED|Overall Study||57
3223320|NCT02296099|3955332|FG000|COMPLETED|Overall Study||54
3223321|NCT02296099|3955333|FG001|COMPLETED|Overall Study||55
3223322|NCT02296099|3955332|FG000|NOT COMPLETED|Overall Study||3
3223323|NCT02296099|3955333|FG001|NOT COMPLETED|Overall Study||2
3223324|NCT02296112|3955339|FG000|STARTED|Overall Study||9
3223325|NCT02296112|3955339|FG000|COMPLETED|Overall Study||0
3223326|NCT02296112|3955339|FG000|NOT COMPLETED|Overall Study||9
3223327|NCT02296125|3955350|FG000|STARTED|Overall Study||279
3223328|NCT02296125|3955351|FG001|STARTED|Overall Study|183 participant received gefitinib and 93 participants received erlotinib.|277
3223329|NCT02296125|3955352|FG002|STARTED|Overall Study|There were 12 participants who were in both the Global and China Extension Osimertinib Arm.|71
3223330|NCT02296125|3955353|FG003|STARTED|Overall Study|There were 7 participants who were in both the Global and China Extension SoC EGFR-TKI Arm.|65
3223331|NCT02296125|3955350|FG000|COMPLETED|Overall Study||61
3223332|NCT02296125|3955351|FG001|COMPLETED|Overall Study||13
3223333|NCT02296125|3955352|FG002|COMPLETED|Overall Study||15
3223334|NCT02296125|3955353|FG003|COMPLETED|Overall Study||3
3223335|NCT02296125|3955350|FG000|NOT COMPLETED|Overall Study||218
3223336|NCT02296125|3955351|FG001|NOT COMPLETED|Overall Study||264
3223337|NCT02296125|3955352|FG002|NOT COMPLETED|Overall Study||56
3223338|NCT02296125|3955353|FG003|NOT COMPLETED|Overall Study||62
3223339|NCT02296138|3955366|FG000|STARTED|Overall Study||3952
3223340|NCT02296138|3955367|FG001|STARTED|Overall Study||3951
3223341|NCT02296138|3955366|FG000|Treated|Overall Study||3941
3223342|NCT02296138|3955367|FG001|Treated|Overall Study||3939
3223343|NCT02296138|3955366|FG000|COMPLETED|Overall Study||3291
3223344|NCT02296138|3955367|FG001|COMPLETED|Overall Study||3451
3223345|NCT02296138|3955366|FG000|NOT COMPLETED|Overall Study||661
3223346|NCT02296138|3955367|FG001|NOT COMPLETED|Overall Study||500
3223347|NCT02296164|3955373|FG000|STARTED|Overall Study|2 patients not eligible as were not on Valchlor at time of study start|298
3223348|NCT02296164|3955373|FG000|COMPLETED|Overall Study||188
3223349|NCT02296164|3955373|FG000|NOT COMPLETED|Overall Study||110
3223350|NCT02296190|3955383|FG000|STARTED|Overall Study||35
3223351|NCT02296190|3955384|FG001|STARTED|Overall Study||41
3223352|NCT02296190|3955385|FG002|STARTED|Overall Study||35
3223353|NCT02296190|3955386|FG003|STARTED|Overall Study||43
3223354|NCT02296190|3955387|FG004|STARTED|Overall Study||36
3223355|NCT02296190|3955388|FG005|STARTED|Overall Study||9
3223356|NCT02296190|3955383|FG000|COMPLETED|Overall Study||21
3223357|NCT02296190|3955384|FG001|COMPLETED|Overall Study||20
3223358|NCT02296190|3955385|FG002|COMPLETED|Overall Study||23
3223359|NCT02296190|3955386|FG003|COMPLETED|Overall Study||20
3223360|NCT02296190|3955387|FG004|COMPLETED|Overall Study||20
3223361|NCT02296190|3955388|FG005|COMPLETED|Overall Study||9
3223362|NCT02296190|3955383|FG000|NOT COMPLETED|Overall Study||14
3223363|NCT02296190|3955384|FG001|NOT COMPLETED|Overall Study||21
3223364|NCT02296190|3955385|FG002|NOT COMPLETED|Overall Study||12
3223365|NCT02296190|3955386|FG003|NOT COMPLETED|Overall Study||23
3223366|NCT02296190|3955387|FG004|NOT COMPLETED|Overall Study||16
3223367|NCT02296190|3955388|FG005|NOT COMPLETED|Overall Study||0
3223368|NCT02296242|3955406|FG000|STARTED|Overall Study||5
3223369|NCT02296242|3955407|FG001|STARTED|Overall Study||6
3223370|NCT02296242|3955408|FG002|STARTED|Overall Study||7
3223371|NCT02296242|3955409|FG003|STARTED|Overall Study||14
3223372|NCT02296242|3955410|FG004|STARTED|Overall Study||21
3223373|NCT02296242|3955406|FG000|COMPLETED|Overall Study||0
3223374|NCT02296242|3955407|FG001|COMPLETED|Overall Study||0
3223375|NCT02296242|3955408|FG002|COMPLETED|Overall Study||0
3223376|NCT02296242|3955409|FG003|COMPLETED|Overall Study||0
3223377|NCT02296242|3955410|FG004|COMPLETED|Overall Study||0
3223378|NCT02296242|3955406|FG000|NOT COMPLETED|Overall Study||5
3223379|NCT02296242|3955407|FG001|NOT COMPLETED|Overall Study||6
3223380|NCT02296242|3955408|FG002|NOT COMPLETED|Overall Study||7
3223381|NCT02296242|3955409|FG003|NOT COMPLETED|Overall Study||14
3223382|NCT02296242|3955410|FG004|NOT COMPLETED|Overall Study||21
3223383|NCT02296320|3955433|FG000|STARTED|Overall Study||102
3223384|NCT02296320|3955434|FG001|STARTED|Overall Study||15
3223385|NCT02296320|3955435|FG002|STARTED|Overall Study||96
3223386|NCT02296320|3955433|FG000|Treated|Overall Study||100
3223387|NCT02296320|3955434|FG001|Treated|Overall Study||15
3223388|NCT02296320|3955435|FG002|Treated|Overall Study||96
3223389|NCT02296320|3955433|FG000|COMPLETED|Overall Study||67
3223390|NCT02296320|3955434|FG001|COMPLETED|Overall Study||10
3223391|NCT02296320|3955435|FG002|COMPLETED|Overall Study||59
3223392|NCT02296320|3955433|FG000|NOT COMPLETED|Overall Study||35
3223393|NCT02296320|3955434|FG001|NOT COMPLETED|Overall Study||5
3223394|NCT02296320|3955435|FG002|NOT COMPLETED|Overall Study||37
3223395|NCT02296346|3955447|FG000|STARTED|Overall Study||7
3223396|NCT02296346|3955448|FG001|STARTED|Overall Study||6
3223397|NCT02296346|3955447|FG000|COMPLETED|Overall Study||2
3223398|NCT02296346|3955448|FG001|COMPLETED|Overall Study||0
3223399|NCT02296346|3955447|FG000|NOT COMPLETED|Overall Study||5
3223400|NCT02296346|3955448|FG001|NOT COMPLETED|Overall Study||6
3223401|NCT02296424|3955458|FG000|STARTED|Part 1|16 patients immediately went into Part II|84
3223402|NCT02296424|3955459|FG001|STARTED|Part 1||98
3223403|NCT02296424|3955460|FG002|STARTED|Part 1||0
3223404|NCT02296424|3955461|FG003|STARTED|Part 1||0
3223405|NCT02296424|3955458|FG000|COMPLETED|Part 1||61
3223406|NCT02296424|3955459|FG001|COMPLETED|Part 1||65
3223407|NCT02296424|3955460|FG002|COMPLETED|Part 1||0
3223408|NCT02296424|3955461|FG003|COMPLETED|Part 1||0
3223409|NCT02296424|3955458|FG000|NOT COMPLETED|Part 1||23
3223410|NCT02296424|3955459|FG001|NOT COMPLETED|Part 1||33
3223411|NCT02296424|3955460|FG002|NOT COMPLETED|Part 1||0
3223412|NCT02296424|3955461|FG003|NOT COMPLETED|Part 1||0
3223413|NCT02296424|3955458|FG000|STARTED|Part 2||0
3223414|NCT02296424|3955459|FG001|STARTED|Part 2||0
3223415|NCT02296424|3955460|FG002|STARTED|Part 2||38
3223416|NCT02296424|3955461|FG003|STARTED|Part 2||37
3223417|NCT02296424|3955458|FG000|COMPLETED|Part 2||0
3223418|NCT02296424|3955459|FG001|COMPLETED|Part 2||0
3223419|NCT02296424|3955460|FG002|COMPLETED|Part 2||35
3223420|NCT02296424|3955461|FG003|COMPLETED|Part 2||37
3223421|NCT02296424|3955458|FG000|NOT COMPLETED|Part 2||0
3223422|NCT02296424|3955459|FG001|NOT COMPLETED|Part 2||0
3223423|NCT02296424|3955460|FG002|NOT COMPLETED|Part 2||3
3223424|NCT02296424|3955461|FG003|NOT COMPLETED|Part 2||0
3223425|NCT02296476|3955472|FG000|STARTED|Overall Study||6
3223426|NCT02296476|3955473|FG001|STARTED|Overall Study||4
3223427|NCT02296476|3955474|FG002|STARTED|Overall Study||2
3223428|NCT02296476|3955472|FG000|COMPLETED|Overall Study||0
3223429|NCT02296476|3955473|FG001|COMPLETED|Overall Study||0
3223430|NCT02296476|3955474|FG002|COMPLETED|Overall Study||0
3223431|NCT02296476|3955472|FG000|NOT COMPLETED|Overall Study||6
3223432|NCT02296476|3955473|FG001|NOT COMPLETED|Overall Study||4
3223433|NCT02296476|3955474|FG002|NOT COMPLETED|Overall Study||2
3223434|NCT02296502|3955486|FG000|STARTED|Overall Study||248
3223435|NCT02296502|3955487|FG001|STARTED|Overall Study||1
3223436|NCT02296502|3955488|FG002|STARTED|Overall Study||30
3223437|NCT02296502|3955489|FG003|STARTED|Overall Study||160
3223438|NCT02296502|3955486|FG000|COMPLETED|Overall Study||248
3223439|NCT02296502|3955487|FG001|COMPLETED|Overall Study||1
3223440|NCT02296502|3955488|FG002|COMPLETED|Overall Study||30
3223441|NCT02296502|3955489|FG003|COMPLETED|Overall Study||160
3223442|NCT02296502|3955486|FG000|NOT COMPLETED|Overall Study||0
3223443|NCT02296502|3955487|FG001|NOT COMPLETED|Overall Study||0
3223444|NCT02296502|3955488|FG002|NOT COMPLETED|Overall Study||0
3223445|NCT02296502|3955489|FG003|NOT COMPLETED|Overall Study||0
3223446|NCT02296606|3955502|FG000|STARTED|Overall Study||127
3223447|NCT02296606|3955502|FG000|COMPLETED|Overall Study||127
3223448|NCT02296606|3955502|FG000|NOT COMPLETED|Overall Study||0
3223449|NCT02296775|3955509|FG000|STARTED|Treatment and Evaluation||91
3223450|NCT02296775|3955510|FG001|STARTED|Treatment and Evaluation||92
3223451|NCT02296775|3955511|FG002|STARTED|Treatment and Evaluation||93
3223452|NCT02296775|3955509|FG000|COMPLETED|Treatment and Evaluation||87
3223453|NCT02296775|3955510|FG001|COMPLETED|Treatment and Evaluation||84
3223454|NCT02296775|3955511|FG002|COMPLETED|Treatment and Evaluation||83
3223455|NCT02296775|3955509|FG000|NOT COMPLETED|Treatment and Evaluation||4
3223456|NCT02296775|3955510|FG001|NOT COMPLETED|Treatment and Evaluation||8
3223457|NCT02296775|3955511|FG002|NOT COMPLETED|Treatment and Evaluation||10
3223458|NCT02296775|3955509|FG000|STARTED|Recovery and Follow-up||87
3223459|NCT02296775|3955510|FG001|STARTED|Recovery and Follow-up||84
3223460|NCT02296775|3955511|FG002|STARTED|Recovery and Follow-up||83
3223461|NCT02296775|3955509|FG000|COMPLETED|Recovery and Follow-up||82
3223462|NCT02296775|3955510|FG001|COMPLETED|Recovery and Follow-up||79
3223463|NCT02296775|3955511|FG002|COMPLETED|Recovery and Follow-up||79
3223464|NCT02296775|3955509|FG000|NOT COMPLETED|Recovery and Follow-up||5
3223465|NCT02296775|3955510|FG001|NOT COMPLETED|Recovery and Follow-up||5
3223466|NCT02296775|3955511|FG002|NOT COMPLETED|Recovery and Follow-up||4
3223467|NCT02296840|3955521|FG000|STARTED|Overall Study||18
3223468|NCT02296840|3955522|FG001|STARTED|Overall Study||27
3223469|NCT02296840|3955521|FG000|COMPLETED|Overall Study||9
3223470|NCT02296840|3955522|FG001|COMPLETED|Overall Study||8
3223471|NCT02296840|3955521|FG000|NOT COMPLETED|Overall Study||9
3223472|NCT02296840|3955522|FG001|NOT COMPLETED|Overall Study||19
3223473|NCT02296853|3955530|FG000|STARTED|Overall Study||10
3223474|NCT02296853|3955531|FG001|STARTED|Overall Study||10
3223475|NCT02296853|3955530|FG000|COMPLETED|Overall Study||10
3223476|NCT02296853|3955531|FG001|COMPLETED|Overall Study||10
3223477|NCT02296853|3955530|FG000|NOT COMPLETED|Overall Study||0
3223478|NCT02296853|3955531|FG001|NOT COMPLETED|Overall Study||0
3223479|NCT02296892|3955540|FG000|STARTED|Overall Study||310
3223480|NCT02296892|3955541|FG001|STARTED|Overall Study||63
3223481|NCT02296892|3955542|FG002|STARTED|Overall Study||73
3223482|NCT02296892|3955540|FG000|Safety Population|Overall Study||303
3223483|NCT02296892|3955541|FG001|Safety Population|Overall Study||59
3223484|NCT02296892|3955542|FG002|Safety Population|Overall Study||69
3223485|NCT02296892|3955540|FG000|Complete Trial Treatment Period|Overall Study||303
3223486|NCT02296892|3955541|FG001|Complete Trial Treatment Period|Overall Study||59
3223487|NCT02296892|3955542|FG002|Complete Trial Treatment Period|Overall Study||69
3223488|NCT02296892|3955540|FG000|COMPLETED|Overall Study||298
3223489|NCT02296892|3955541|FG001|COMPLETED|Overall Study||59
3223490|NCT02296892|3955542|FG002|COMPLETED|Overall Study||68
3223491|NCT02296892|3955540|FG000|NOT COMPLETED|Overall Study||12
3223492|NCT02296892|3955541|FG001|NOT COMPLETED|Overall Study||4
3223493|NCT02296892|3955542|FG002|NOT COMPLETED|Overall Study||5
3223494|NCT02296931|3955552|FG000|STARTED|Overall Study||10
3223495|NCT02296931|3955553|FG001|STARTED|Overall Study||24
3223496|NCT02296931|3955552|FG000|COMPLETED|Overall Study||10
3223497|NCT02296931|3955553|FG001|COMPLETED|Overall Study||22
3223498|NCT02296931|3955552|FG000|NOT COMPLETED|Overall Study||0
3223499|NCT02296931|3955553|FG001|NOT COMPLETED|Overall Study||2
3223500|NCT02297100|3955561|FG000|STARTED|Overall Study||13
3223501|NCT02297100|3955562|FG001|STARTED|Overall Study||14
3223502|NCT02297100|3955561|FG000|COMPLETED|Overall Study||13
3223503|NCT02297100|3955562|FG001|COMPLETED|Overall Study||14
3223504|NCT02297100|3955561|FG000|NOT COMPLETED|Overall Study||0
3223505|NCT02297100|3955562|FG001|NOT COMPLETED|Overall Study||0
3223506|NCT02297308|3955568|FG000|STARTED|Overall Study||90
3223507|NCT02297308|3955568|FG000|COMPLETED|Overall Study||90
3223508|NCT02297308|3955568|FG000|NOT COMPLETED|Overall Study||0
3223509|NCT02297503|3955575|FG000|STARTED|Overall Study||30
3223510|NCT02297503|3955576|FG001|STARTED|Overall Study||31
3223511|NCT02297503|3955575|FG000|Initial Single Treatment|Overall Study||29
3223512|NCT02297503|3955576|FG001|Initial Single Treatment|Overall Study||31
3223513|NCT02297503|3955575|FG000|First Combined Treatment|Overall Study||28
3223514|NCT02297503|3955576|FG001|First Combined Treatment|Overall Study||28
3223515|NCT02297503|3955575|FG000|Second Combined Treatment|Overall Study||28
3223516|NCT02297503|3955576|FG001|Second Combined Treatment|Overall Study||28
3223517|NCT02297503|3955575|FG000|COMPLETED|Overall Study||28
3223518|NCT02297503|3955576|FG001|COMPLETED|Overall Study||27
3223519|NCT02297503|3955575|FG000|NOT COMPLETED|Overall Study||2
3223520|NCT02297503|3955576|FG001|NOT COMPLETED|Overall Study||4
3223521|NCT02297516|3955593|FG000|STARTED|Single Treatment Phase (6 Months)||32
3223522|NCT02297516|3955594|FG001|STARTED|Single Treatment Phase (6 Months)||33
3223523|NCT02297516|3955593|FG000|COMPLETED|Single Treatment Phase (6 Months)||31
3223524|NCT02297516|3955594|FG001|COMPLETED|Single Treatment Phase (6 Months)||31
3223525|NCT02297516|3955593|FG000|NOT COMPLETED|Single Treatment Phase (6 Months)||1
3223526|NCT02297516|3955594|FG001|NOT COMPLETED|Single Treatment Phase (6 Months)||2
3223527|NCT02297516|3955593|FG000|STARTED|Combination Treatment Phase (up to 18 m)||31
3223528|NCT02297516|3955594|FG001|STARTED|Combination Treatment Phase (up to 18 m)||31
3223529|NCT02297516|3955593|FG000|COMPLETED|Combination Treatment Phase (up to 18 m)||31
3223530|NCT02297516|3955594|FG001|COMPLETED|Combination Treatment Phase (up to 18 m)||30
3223531|NCT02297516|3955593|FG000|NOT COMPLETED|Combination Treatment Phase (up to 18 m)||0
3223532|NCT02297516|3955594|FG001|NOT COMPLETED|Combination Treatment Phase (up to 18 m)||1
3223533|NCT02297815|3955609|FG000|STARTED|Overall Study||1604
3223534|NCT02297815|3955610|FG001|STARTED|Overall Study||868
3223535|NCT02297815|3955609|FG000|5-10 Day Interview|Overall Study||1604
3223536|NCT02297815|3955610|FG001|5-10 Day Interview|Overall Study||868
3223537|NCT02297815|3955609|FG000|14-20 Day Interview|Overall Study||1368
3223538|NCT02297815|3955610|FG001|14-20 Day Interview|Overall Study||728
3223539|NCT02297815|3955609|FG000|COMPLETED|Overall Study||1368
3223540|NCT02297815|3955610|FG001|COMPLETED|Overall Study||728
3223541|NCT02297815|3955609|FG000|NOT COMPLETED|Overall Study||236
3223542|NCT02297815|3955610|FG001|NOT COMPLETED|Overall Study||140
3223543|NCT02297841|3955618|FG000|STARTED|Overall Study||209
3223544|NCT02297841|3955618|FG000|Induction Phase|Overall Study||209
3223545|NCT02297841|3955618|FG000|Challenge Phase|Overall Study||201
3223546|NCT02297841|3955618|FG000|COMPLETED|Overall Study||201
3223547|NCT02297841|3955618|FG000|NOT COMPLETED|Overall Study||8
3223548|NCT02298023|3955625|FG000|STARTED|Overall Study||8
3223549|NCT02298023|3955626|FG001|STARTED|Overall Study||8
3223550|NCT02298023|3955627|FG002|STARTED|Overall Study||8
3223551|NCT02298023|3955625|FG000|Intervention|Overall Study|Withdrawal by participant before intervention.|7
3223552|NCT02298023|3955626|FG001|Intervention|Overall Study||8
3223553|NCT02298023|3955627|FG002|Intervention|Overall Study||8
3223554|NCT02298023|3955625|FG000|COMPLETED|Overall Study||7
3223555|NCT02298023|3955626|FG001|COMPLETED|Overall Study||8
3223556|NCT02298023|3955627|FG002|COMPLETED|Overall Study||8
3223557|NCT02298023|3955625|FG000|NOT COMPLETED|Overall Study||1
3223558|NCT02298023|3955626|FG001|NOT COMPLETED|Overall Study||0
3223559|NCT02298023|3955627|FG002|NOT COMPLETED|Overall Study||0
3223560|NCT02298179|3955650|FG000|STARTED|Overall Study||24
3223561|NCT02298179|3955651|FG001|STARTED|Overall Study||24
3223562|NCT02298179|3955652|FG002|STARTED|Overall Study||24
3223563|NCT02298179|3955653|FG003|STARTED|Overall Study||24
3223564|NCT02298179|3955654|FG004|STARTED|Overall Study||24
3223565|NCT02298179|3955655|FG005|STARTED|Overall Study||24
3223566|NCT02298179|3955656|FG006|STARTED|Overall Study||24
3223567|NCT02298179|3955657|FG007|STARTED|Overall Study||24
3223568|NCT02298179|3955658|FG008|STARTED|Overall Study||24
3223569|NCT02298179|3955659|FG009|STARTED|Overall Study||24
3223570|NCT02298179|3955660|FG010|STARTED|Overall Study||24
3223571|NCT02298179|3955661|FG011|STARTED|Overall Study||24
3223572|NCT02298179|3955650|FG000|COMPLETED|Overall Study||24
3223573|NCT02298179|3955651|FG001|COMPLETED|Overall Study||24
3223574|NCT02298179|3955652|FG002|COMPLETED|Overall Study||23
3223575|NCT02298179|3955653|FG003|COMPLETED|Overall Study||24
3223576|NCT02298179|3955654|FG004|COMPLETED|Overall Study||24
3223577|NCT02298179|3955655|FG005|COMPLETED|Overall Study||24
3223578|NCT02298179|3955656|FG006|COMPLETED|Overall Study||24
3223579|NCT02298179|3955657|FG007|COMPLETED|Overall Study||23
3223580|NCT02298179|3955658|FG008|COMPLETED|Overall Study||24
3223581|NCT02298179|3955659|FG009|COMPLETED|Overall Study||24
3223582|NCT02298179|3955660|FG010|COMPLETED|Overall Study||24
3223583|NCT02298179|3955661|FG011|COMPLETED|Overall Study||24
3223584|NCT02298179|3955650|FG000|NOT COMPLETED|Overall Study||0
3223585|NCT02298179|3955651|FG001|NOT COMPLETED|Overall Study||0
3223586|NCT02298179|3955652|FG002|NOT COMPLETED|Overall Study||1
3223587|NCT02298179|3955653|FG003|NOT COMPLETED|Overall Study||0
3223588|NCT02298179|3955654|FG004|NOT COMPLETED|Overall Study||0
3223589|NCT02298179|3955655|FG005|NOT COMPLETED|Overall Study||0
3223590|NCT02298179|3955656|FG006|NOT COMPLETED|Overall Study||0
3223591|NCT02298179|3955657|FG007|NOT COMPLETED|Overall Study||1
3223592|NCT02298179|3955658|FG008|NOT COMPLETED|Overall Study||0
3223593|NCT02298179|3955659|FG009|NOT COMPLETED|Overall Study||0
3223594|NCT02298179|3955660|FG010|NOT COMPLETED|Overall Study||0
3223595|NCT02298179|3955661|FG011|NOT COMPLETED|Overall Study||0
3223596|NCT02298192|3955689|FG000|STARTED|Overall Study||210
3223597|NCT02298192|3955690|FG001|STARTED|Overall Study||210
3223598|NCT02298192|3955689|FG000|COMPLETED|Overall Study||191
3223599|NCT02298192|3955690|FG001|COMPLETED|Overall Study||204
3223600|NCT02298192|3955689|FG000|NOT COMPLETED|Overall Study||19
3223601|NCT02298192|3955690|FG001|NOT COMPLETED|Overall Study||6
3223602|NCT02298322|3955696|FG000|STARTED|Overall Study||60
3223603|NCT02298322|3955696|FG000|COMPLETED|Overall Study||60
3223604|NCT02298322|3955696|FG000|NOT COMPLETED|Overall Study||0
3223605|NCT02298361|3955706|FG000|STARTED|Overall Study||2240
3223606|NCT02298361|3955707|FG001|STARTED|Overall Study||12784
3223607|NCT02298361|3955708|FG002|STARTED|Overall Study||12227
3223608|NCT02298361|3955706|FG000|COMPLETED|Overall Study||2240
3223609|NCT02298361|3955707|FG001|COMPLETED|Overall Study||12784
3223610|NCT02298361|3955708|FG002|COMPLETED|Overall Study||12227
3223611|NCT02298361|3955706|FG000|NOT COMPLETED|Overall Study||0
3223612|NCT02298361|3955707|FG001|NOT COMPLETED|Overall Study||0
3223613|NCT02298361|3955708|FG002|NOT COMPLETED|Overall Study||0
3223614|NCT02298491|3955716|FG000|STARTED|Overall Study||4
3223615|NCT02298491|3955716|FG000|COMPLETED|Overall Study||3
3223616|NCT02298491|3955716|FG000|NOT COMPLETED|Overall Study||1
3223617|NCT02298803|3955722|FG000|STARTED|Overall Study||30
3223618|NCT02298803|3955722|FG000|COMPLETED|Overall Study||30
3223619|NCT02298803|3955722|FG000|NOT COMPLETED|Overall Study||0
3223620|NCT02298842|3955733|FG000|STARTED|First Platelet Donation (Day 0)||44
3223621|NCT02298842|3955734|FG001|STARTED|First Platelet Donation (Day 0)||41
3223622|NCT02298842|3955733|FG000|COMPLETED|First Platelet Donation (Day 0)||38
3223623|NCT02298842|3955734|FG001|COMPLETED|First Platelet Donation (Day 0)||36
3223624|NCT02298842|3955733|FG000|NOT COMPLETED|First Platelet Donation (Day 0)||6
3223625|NCT02298842|3955734|FG001|NOT COMPLETED|First Platelet Donation (Day 0)||5
3223626|NCT02298842|3955733|FG000|STARTED|Second Platelet Donation (Day 6-8)||38
3223627|NCT02298842|3955734|FG001|STARTED|Second Platelet Donation (Day 6-8)||36
3223628|NCT02298842|3955733|FG000|COMPLETED|Second Platelet Donation (Day 6-8)||30
3223629|NCT02298842|3955734|FG001|COMPLETED|Second Platelet Donation (Day 6-8)||30
3223630|NCT02298842|3955733|FG000|NOT COMPLETED|Second Platelet Donation (Day 6-8)||8
3223631|NCT02298842|3955734|FG001|NOT COMPLETED|Second Platelet Donation (Day 6-8)||6
3223632|NCT02298868|3955742|FG000|STARTED|Overall Study||10
3223633|NCT02298868|3955742|FG000|COMPLETED|Overall Study||7
3223634|NCT02298868|3955742|FG000|NOT COMPLETED|Overall Study||3
3223635|NCT02298933|3955746|FG000|STARTED|Overall Study||10
3223636|NCT02298933|3955746|FG000|COMPLETED|Overall Study||10
3223637|NCT02298933|3955746|FG000|NOT COMPLETED|Overall Study||0
3223638|NCT02298946|3955752|FG000|STARTED|Overall Study||8
3223639|NCT02298946|3955753|FG001|STARTED|Overall Study||9
3223640|NCT02298946|3955752|FG000|COMPLETED|Overall Study||4
3223641|NCT02298946|3955753|FG001|COMPLETED|Overall Study||8
3223642|NCT02298946|3955752|FG000|NOT COMPLETED|Overall Study||4
3223643|NCT02298946|3955753|FG001|NOT COMPLETED|Overall Study||1
3223644|NCT02299050|3955760|FG000|STARTED|Overall Study||23
3223645|NCT02299050|3955760|FG000|COMPLETED|Overall Study||15
3223646|NCT02299050|3955760|FG000|NOT COMPLETED|Overall Study||8
3368166|NCT03822078|4099806|FG003|STARTED|Overall Study||8
3368167|NCT03822078|4099807|FG004|STARTED|Overall Study||7
3368168|NCT03822078|4099808|FG005|STARTED|Overall Study||6
3368169|NCT03822078|4099803|FG000|Received Study Drug|Overall Study||10
3368170|NCT03822078|4099804|FG001|Received Study Drug|Overall Study||6
3368171|NCT03822078|4099805|FG002|Received Study Drug|Overall Study||6
3368172|NCT03822078|4099806|FG003|Received Study Drug|Overall Study||6
3368173|NCT03822078|4099807|FG004|Received Study Drug|Overall Study||6
3368174|NCT03822078|4099808|FG005|Received Study Drug|Overall Study||6
3368175|NCT03822078|4099803|FG000|COMPLETED|Overall Study||10
3368176|NCT03822078|4099804|FG001|COMPLETED|Overall Study||6
3368177|NCT03822078|4099805|FG002|COMPLETED|Overall Study||6
3368178|NCT03822078|4099806|FG003|COMPLETED|Overall Study||6
3368179|NCT03822078|4099807|FG004|COMPLETED|Overall Study||6
3368180|NCT03822078|4099808|FG005|COMPLETED|Overall Study||6
3368181|NCT03822078|4099803|FG000|NOT COMPLETED|Overall Study||2
3368182|NCT03822078|4099804|FG001|NOT COMPLETED|Overall Study||0
3368183|NCT03822078|4099805|FG002|NOT COMPLETED|Overall Study||0
3368184|NCT03822078|4099806|FG003|NOT COMPLETED|Overall Study||2
3368185|NCT03822078|4099807|FG004|NOT COMPLETED|Overall Study||1
3368186|NCT03822078|4099808|FG005|NOT COMPLETED|Overall Study||0
3368187|NCT03815240|4099828|FG000|STARTED|Intervention no Dressing||2
3368188|NCT03815240|4099829|FG001|STARTED|Intervention no Dressing||1
3368189|NCT03815240|4099830|FG002|STARTED|Intervention no Dressing||1
3368190|NCT03815240|4099831|FG003|STARTED|Intervention no Dressing||2
3368191|NCT03815240|4099832|FG004|STARTED|Intervention no Dressing||1
3368192|NCT03815240|4099833|FG005|STARTED|Intervention no Dressing||2
3368193|NCT03815240|4099834|FG006|STARTED|Intervention no Dressing||1
3368194|NCT03815240|4099835|FG007|STARTED|Intervention no Dressing||1
3368195|NCT03815240|4099836|FG008|STARTED|Intervention no Dressing||1
3368196|NCT03815240|4099828|FG000|COMPLETED|Intervention no Dressing||2
3368197|NCT03815240|4099829|FG001|COMPLETED|Intervention no Dressing||1
3368198|NCT03815240|4099830|FG002|COMPLETED|Intervention no Dressing||1
3368199|NCT03815240|4099831|FG003|COMPLETED|Intervention no Dressing||2
3368200|NCT03815240|4099832|FG004|COMPLETED|Intervention no Dressing||1
3368201|NCT03815240|4099833|FG005|COMPLETED|Intervention no Dressing||2
3368202|NCT03815240|4099834|FG006|COMPLETED|Intervention no Dressing||1
3368203|NCT03815240|4099835|FG007|COMPLETED|Intervention no Dressing||1
3368204|NCT03815240|4099836|FG008|COMPLETED|Intervention no Dressing||1
3368205|NCT03815240|4099828|FG000|NOT COMPLETED|Intervention no Dressing||0
3368206|NCT03815240|4099829|FG001|NOT COMPLETED|Intervention no Dressing||0
3368207|NCT03815240|4099830|FG002|NOT COMPLETED|Intervention no Dressing||0
3368208|NCT03815240|4099831|FG003|NOT COMPLETED|Intervention no Dressing||0
3368209|NCT03815240|4099832|FG004|NOT COMPLETED|Intervention no Dressing||0
3368210|NCT03815240|4099833|FG005|NOT COMPLETED|Intervention no Dressing||0
3368211|NCT03815240|4099834|FG006|NOT COMPLETED|Intervention no Dressing||0
3368212|NCT03815240|4099835|FG007|NOT COMPLETED|Intervention no Dressing||0
3368213|NCT03815240|4099836|FG008|NOT COMPLETED|Intervention no Dressing||0
3368214|NCT03815240|4099828|FG000|STARTED|Intervention Mepilex Dressing||2
3368215|NCT03815240|4099829|FG001|STARTED|Intervention Mepilex Dressing||1
3223647|NCT02299076|3955766|FG000|STARTED|Overall Study||230
3223648|NCT02299076|3955767|FG001|STARTED|Overall Study||226
3223649|NCT02299076|3955766|FG000|COMPLETED|Overall Study||210
3223650|NCT02299076|3955767|FG001|COMPLETED|Overall Study||212
3223651|NCT02299076|3955766|FG000|NOT COMPLETED|Overall Study||20
3223652|NCT02299076|3955767|FG001|NOT COMPLETED|Overall Study||14
3223653|NCT02299089|3955777|FG000|STARTED|Overall Study||3
3223654|NCT02299089|3955778|FG001|STARTED|Overall Study||4
3223655|NCT02299089|3955779|FG002|STARTED|Overall Study||1
3223656|NCT02299089|3955780|FG003|STARTED|Overall Study||4
3223657|NCT02299089|3955777|FG000|COMPLETED|Overall Study||3
3223658|NCT02299089|3955778|FG001|COMPLETED|Overall Study||4
3223659|NCT02299089|3955779|FG002|COMPLETED|Overall Study||1
3223660|NCT02299089|3955780|FG003|COMPLETED|Overall Study||4
3223661|NCT02299089|3955777|FG000|NOT COMPLETED|Overall Study||0
3223662|NCT02299089|3955778|FG001|NOT COMPLETED|Overall Study||0
3223663|NCT02299089|3955779|FG002|NOT COMPLETED|Overall Study||0
3223664|NCT02299089|3955780|FG003|NOT COMPLETED|Overall Study||0
3223665|NCT02299141|3955800|FG000|STARTED|Overall Study||20
3223666|NCT02299141|3955800|FG000|COMPLETED|Overall Study||20
3223667|NCT02299141|3955800|FG000|NOT COMPLETED|Overall Study||0
3223668|NCT02299167|3955811|FG000|STARTED|Overall Study||35
3223669|NCT02299167|3955811|FG000|Dural Puncture|Overall Study||24
3223670|NCT02299167|3955811|FG000|Success Rate|Overall Study||24
3223671|NCT02299167|3955811|FG000|Adverse Effects|Overall Study||24
3223672|NCT02299167|3955811|FG000|COMPLETED|Overall Study||24
3223673|NCT02299167|3955811|FG000|NOT COMPLETED|Overall Study||11
3223674|NCT02299258|3955817|FG000|STARTED|Overall Study||32
3223675|NCT02299258|3955818|FG001|STARTED|Overall Study||31
3223676|NCT02299258|3955817|FG000|COMPLETED|Overall Study||31
3223677|NCT02299258|3955818|FG001|COMPLETED|Overall Study||30
3223678|NCT02299258|3955817|FG000|NOT COMPLETED|Overall Study||1
3223679|NCT02299258|3955818|FG001|NOT COMPLETED|Overall Study||1
3223680|NCT02299297|3955824|FG000|STARTED|Overall Study||12
3223681|NCT02299297|3955824|FG000|COMPLETED|Overall Study||11
3223682|NCT02299297|3955824|FG000|NOT COMPLETED|Overall Study||1
3223683|NCT02299336|3955828|FG000|STARTED|Overall Study||60
3223684|NCT02299336|3955828|FG000|COMPLETED|Overall Study||46
3223685|NCT02299336|3955828|FG000|NOT COMPLETED|Overall Study||14
3223686|NCT02299349|3955834|FG000|STARTED|Overall Study||35
3223687|NCT02299349|3955835|FG001|STARTED|Overall Study||35
3223688|NCT02299349|3955834|FG000|COMPLETED|Overall Study||35
3223689|NCT02299349|3955835|FG001|COMPLETED|Overall Study||35
3223690|NCT02299349|3955834|FG000|NOT COMPLETED|Overall Study||0
3223691|NCT02299349|3955835|FG001|NOT COMPLETED|Overall Study||0
3223692|NCT02299375|3955843|FG000|STARTED|Overall Study||94
3223693|NCT02299375|3955844|FG001|STARTED|Overall Study||90
3223694|NCT02299375|3955843|FG000|COMPLETED|Overall Study||14
3223695|NCT02299375|3955844|FG001|COMPLETED|Overall Study||10
3223696|NCT02299375|3955843|FG000|NOT COMPLETED|Overall Study||80
3223697|NCT02299375|3955844|FG001|NOT COMPLETED|Overall Study||80
3223698|NCT02299388|3955853|FG000|STARTED|Overall Study||6
3223699|NCT02299388|3955854|FG001|STARTED|Overall Study||5
3223700|NCT02299388|3955853|FG000|COMPLETED|Overall Study||6
3223701|NCT02299388|3955854|FG001|COMPLETED|Overall Study||4
3223702|NCT02299388|3955853|FG000|NOT COMPLETED|Overall Study||0
3223703|NCT02299388|3955854|FG001|NOT COMPLETED|Overall Study||1
3223704|NCT02299427|3955862|FG000|STARTED|Overall Study||35
3223705|NCT02299427|3955863|FG001|STARTED|Overall Study||34
3223706|NCT02299427|3955862|FG000|COMPLETED|Overall Study||12
3223707|NCT02299427|3955863|FG001|COMPLETED|Overall Study||31
3223708|NCT02299427|3955862|FG000|NOT COMPLETED|Overall Study||23
3223709|NCT02299427|3955863|FG001|NOT COMPLETED|Overall Study||3
3223710|NCT02299479|3955869|FG000|STARTED|Overall Study||20
3223711|NCT02299479|3955869|FG000|COMPLETED|Overall Study||18
3223712|NCT02299479|3955869|FG000|NOT COMPLETED|Overall Study||2
3223713|NCT02299570|3955876|FG000|STARTED|Overall Study||45
3223714|NCT02299570|3955877|FG001|STARTED|Overall Study||44
3223715|NCT02299570|3955878|FG002|STARTED|Overall Study||44
3223716|NCT02299570|3955876|FG000|COMPLETED|Overall Study||31
3368216|NCT03815240|4099830|FG002|STARTED|Intervention Mepilex Dressing||1
3368217|NCT03815240|4099831|FG003|STARTED|Intervention Mepilex Dressing||2
3368218|NCT03815240|4099832|FG004|STARTED|Intervention Mepilex Dressing||1
3368219|NCT03815240|4099833|FG005|STARTED|Intervention Mepilex Dressing||2
3368220|NCT03815240|4099834|FG006|STARTED|Intervention Mepilex Dressing||1
3368221|NCT03815240|4099835|FG007|STARTED|Intervention Mepilex Dressing||1
3368222|NCT03815240|4099836|FG008|STARTED|Intervention Mepilex Dressing||1
3368223|NCT03815240|4099828|FG000|COMPLETED|Intervention Mepilex Dressing||2
3368224|NCT03815240|4099829|FG001|COMPLETED|Intervention Mepilex Dressing||1
3368225|NCT03815240|4099830|FG002|COMPLETED|Intervention Mepilex Dressing||1
3223717|NCT02299570|3955877|FG001|COMPLETED|Overall Study||35
3223718|NCT02299570|3955878|FG002|COMPLETED|Overall Study||25
3223719|NCT02299570|3955876|FG000|NOT COMPLETED|Overall Study||14
3223720|NCT02299570|3955877|FG001|NOT COMPLETED|Overall Study||9
3223721|NCT02299570|3955878|FG002|NOT COMPLETED|Overall Study||19
3223722|NCT02299635|3955891|FG000|STARTED|Overall Study||19
3223723|NCT02299635|3955891|FG000|COMPLETED|Overall Study||0
3223724|NCT02299635|3955891|FG000|NOT COMPLETED|Overall Study||19
3223725|NCT02299791|3955897|FG000|STARTED|Overall Study||2053
3223726|NCT02299791|3955898|FG001|STARTED|Overall Study||2803
3223727|NCT02299791|3955897|FG000|COMPLETED|Overall Study||2053
3223728|NCT02299791|3955898|FG001|COMPLETED|Overall Study||2803
3223729|NCT02299791|3955897|FG000|NOT COMPLETED|Overall Study||0
3223730|NCT02299791|3955898|FG001|NOT COMPLETED|Overall Study||0
3223731|NCT02299869|3955908|FG000|STARTED|Overall Study||10
3223732|NCT02299869|3955909|FG001|STARTED|Overall Study||10
3223733|NCT02299869|3955910|FG002|STARTED|Overall Study||10
3223734|NCT02299869|3955911|FG003|STARTED|Overall Study||10
3223735|NCT02299869|3955908|FG000|COMPLETED|Overall Study||10
3223736|NCT02299869|3955909|FG001|COMPLETED|Overall Study||10
3223737|NCT02299869|3955910|FG002|COMPLETED|Overall Study||10
3223738|NCT02299869|3955911|FG003|COMPLETED|Overall Study||10
3223739|NCT02299869|3955908|FG000|NOT COMPLETED|Overall Study||0
3223740|NCT02299869|3955909|FG001|NOT COMPLETED|Overall Study||0
3223741|NCT02299869|3955910|FG002|NOT COMPLETED|Overall Study||0
3223742|NCT02299869|3955911|FG003|NOT COMPLETED|Overall Study||0
3223743|NCT02300025|3955922|FG000|STARTED|Overall Study||10
3223744|NCT02300025|3955923|FG001|STARTED|Overall Study||6
3223745|NCT02300025|3955924|FG002|STARTED|Overall Study||6
3223746|NCT02300025|3955925|FG003|STARTED|Overall Study||6
3223747|NCT02300025|3955922|FG000|COMPLETED|Overall Study||10
3223748|NCT02300025|3955923|FG001|COMPLETED|Overall Study||6
3223749|NCT02300025|3955924|FG002|COMPLETED|Overall Study||6
3223750|NCT02300025|3955925|FG003|COMPLETED|Overall Study||6
3223751|NCT02300025|3955922|FG000|NOT COMPLETED|Overall Study||0
3223752|NCT02300025|3955923|FG001|NOT COMPLETED|Overall Study||0
3223753|NCT02300025|3955924|FG002|NOT COMPLETED|Overall Study||0
3223754|NCT02300025|3955925|FG003|NOT COMPLETED|Overall Study||0
3223755|NCT02300077|3955939|FG000|STARTED|Overall Study||21
3223756|NCT02300077|3955940|FG001|STARTED|Overall Study||18
3223757|NCT02300077|3955941|FG002|STARTED|Overall Study||21
3223758|NCT02300077|3955939|FG000|COMPLETED|Overall Study||21
3223759|NCT02300077|3955940|FG001|COMPLETED|Overall Study||18
3223760|NCT02300077|3955941|FG002|COMPLETED|Overall Study||21
3223761|NCT02300077|3955939|FG000|NOT COMPLETED|Overall Study||0
3223762|NCT02300077|3955940|FG001|NOT COMPLETED|Overall Study||0
3223763|NCT02300077|3955941|FG002|NOT COMPLETED|Overall Study||0
3223764|NCT02300103|3955949|FG000|STARTED|Overall Study||69
3223765|NCT02300103|3955949|FG000|COMPLETED|Overall Study||63
3223766|NCT02300103|3955949|FG000|NOT COMPLETED|Overall Study||6
3223767|NCT02300129|3955953|FG000|STARTED|Period 1 Session 1 (Day 1)||11
3223768|NCT02300129|3955954|FG001|STARTED|Period 1 Session 1 (Day 1)||5
3223769|NCT02300129|3955955|FG002|STARTED|Period 1 Session 1 (Day 1)||7
3223770|NCT02300129|3955956|FG003|STARTED|Period 1 Session 1 (Day 1)||11
3223771|NCT02300129|3955953|FG000|COMPLETED|Period 1 Session 1 (Day 1)||11
3223772|NCT02300129|3955954|FG001|COMPLETED|Period 1 Session 1 (Day 1)||5
3223773|NCT02300129|3955955|FG002|COMPLETED|Period 1 Session 1 (Day 1)||7
3223774|NCT02300129|3955956|FG003|COMPLETED|Period 1 Session 1 (Day 1)||11
3223775|NCT02300129|3955953|FG000|NOT COMPLETED|Period 1 Session 1 (Day 1)||0
3223776|NCT02300129|3955954|FG001|NOT COMPLETED|Period 1 Session 1 (Day 1)||0
3223777|NCT02300129|3955955|FG002|NOT COMPLETED|Period 1 Session 1 (Day 1)||0
3223778|NCT02300129|3955956|FG003|NOT COMPLETED|Period 1 Session 1 (Day 1)||0
3223779|NCT02300129|3955953|FG000|STARTED|Period 1 Session 2 (Day 3)||11
3223780|NCT02300129|3955954|FG001|STARTED|Period 1 Session 2 (Day 3)|Withdrawal consent of 1 subject between Day 1 and Day 3|5
3223781|NCT02300129|3955955|FG002|STARTED|Period 1 Session 2 (Day 3)||7
3223782|NCT02300129|3955956|FG003|STARTED|Period 1 Session 2 (Day 3)||11
3223783|NCT02300129|3955953|FG000|COMPLETED|Period 1 Session 2 (Day 3)||11
3223784|NCT02300129|3955954|FG001|COMPLETED|Period 1 Session 2 (Day 3)||4
3223785|NCT02300129|3955955|FG002|COMPLETED|Period 1 Session 2 (Day 3)||7
3223786|NCT02300129|3955956|FG003|COMPLETED|Period 1 Session 2 (Day 3)||11
3223787|NCT02300129|3955953|FG000|NOT COMPLETED|Period 1 Session 2 (Day 3)||0
3223788|NCT02300129|3955954|FG001|NOT COMPLETED|Period 1 Session 2 (Day 3)||1
3223789|NCT02300129|3955955|FG002|NOT COMPLETED|Period 1 Session 2 (Day 3)||0
3223790|NCT02300129|3955956|FG003|NOT COMPLETED|Period 1 Session 2 (Day 3)||0
3223791|NCT02300129|3955953|FG000|STARTED|Period 1 Session 3 (Day 5)||11
3223792|NCT02300129|3955954|FG001|STARTED|Period 1 Session 3 (Day 5)||4
3223793|NCT02300129|3955955|FG002|STARTED|Period 1 Session 3 (Day 5)||7
3223794|NCT02300129|3955956|FG003|STARTED|Period 1 Session 3 (Day 5)||11
3223795|NCT02300129|3955953|FG000|COMPLETED|Period 1 Session 3 (Day 5)||11
3223796|NCT02300129|3955954|FG001|COMPLETED|Period 1 Session 3 (Day 5)||4
3223797|NCT02300129|3955955|FG002|COMPLETED|Period 1 Session 3 (Day 5)||7
3223798|NCT02300129|3955956|FG003|COMPLETED|Period 1 Session 3 (Day 5)||11
3223799|NCT02300129|3955953|FG000|NOT COMPLETED|Period 1 Session 3 (Day 5)||0
3223800|NCT02300129|3955954|FG001|NOT COMPLETED|Period 1 Session 3 (Day 5)||0
3223801|NCT02300129|3955955|FG002|NOT COMPLETED|Period 1 Session 3 (Day 5)||0
3223802|NCT02300129|3955956|FG003|NOT COMPLETED|Period 1 Session 3 (Day 5)||0
3223803|NCT02300129|3955953|FG000|STARTED|Period 2 Treatment 1 (2 Weeks)||11
3223804|NCT02300129|3955954|FG001|STARTED|Period 2 Treatment 1 (2 Weeks)||4
3223805|NCT02300129|3955955|FG002|STARTED|Period 2 Treatment 1 (2 Weeks)||7
3223806|NCT02300129|3955956|FG003|STARTED|Period 2 Treatment 1 (2 Weeks)|Withdrawal consent of 1 subject between the Period 1 and Period 2|11
3223807|NCT02300129|3955953|FG000|COMPLETED|Period 2 Treatment 1 (2 Weeks)||10
3223808|NCT02300129|3955954|FG001|COMPLETED|Period 2 Treatment 1 (2 Weeks)||4
3223809|NCT02300129|3955955|FG002|COMPLETED|Period 2 Treatment 1 (2 Weeks)||7
3223810|NCT02300129|3955956|FG003|COMPLETED|Period 2 Treatment 1 (2 Weeks)||10
3223811|NCT02300129|3955953|FG000|NOT COMPLETED|Period 2 Treatment 1 (2 Weeks)||1
3223812|NCT02300129|3955954|FG001|NOT COMPLETED|Period 2 Treatment 1 (2 Weeks)||0
3223813|NCT02300129|3955955|FG002|NOT COMPLETED|Period 2 Treatment 1 (2 Weeks)||0
3223814|NCT02300129|3955956|FG003|NOT COMPLETED|Period 2 Treatment 1 (2 Weeks)||1
3223815|NCT02300129|3955953|FG000|STARTED|Period 2 Treatment 2 (2 Weeks)||10
3223816|NCT02300129|3955954|FG001|STARTED|Period 2 Treatment 2 (2 Weeks)||4
3223817|NCT02300129|3955955|FG002|STARTED|Period 2 Treatment 2 (2 Weeks)||7
3223818|NCT02300129|3955956|FG003|STARTED|Period 2 Treatment 2 (2 Weeks)||10
3223819|NCT02300129|3955953|FG000|COMPLETED|Period 2 Treatment 2 (2 Weeks)||10
3223820|NCT02300129|3955954|FG001|COMPLETED|Period 2 Treatment 2 (2 Weeks)||4
3223821|NCT02300129|3955955|FG002|COMPLETED|Period 2 Treatment 2 (2 Weeks)||7
3223822|NCT02300129|3955956|FG003|COMPLETED|Period 2 Treatment 2 (2 Weeks)||10
3223823|NCT02300129|3955953|FG000|NOT COMPLETED|Period 2 Treatment 2 (2 Weeks)||0
3223824|NCT02300129|3955954|FG001|NOT COMPLETED|Period 2 Treatment 2 (2 Weeks)||0
3223825|NCT02300129|3955955|FG002|NOT COMPLETED|Period 2 Treatment 2 (2 Weeks)||0
3223826|NCT02300129|3955956|FG003|NOT COMPLETED|Period 2 Treatment 2 (2 Weeks)||0
3223827|NCT02300220|3955968|FG000|STARTED|Overall Study||72
3223828|NCT02300220|3955969|FG001|STARTED|Overall Study||72
3223829|NCT02300220|3955968|FG000|COMPLETED|Overall Study||68
3223830|NCT02300220|3955969|FG001|COMPLETED|Overall Study||65
3223831|NCT02300220|3955968|FG000|NOT COMPLETED|Overall Study||4
3223832|NCT02300220|3955969|FG001|NOT COMPLETED|Overall Study||7
3223833|NCT02300259|3955978|FG000|STARTED|Period 1||16
3223834|NCT02300259|3955979|FG001|STARTED|Period 1||16
3223835|NCT02300259|3955980|FG002|STARTED|Period 1||16
3223836|NCT02300259|3955978|FG000|Received at Least One Dose of Study Drug|Period 1||16
3223837|NCT02300259|3955979|FG001|Received at Least One Dose of Study Drug|Period 1||16
3223838|NCT02300259|3955980|FG002|Received at Least One Dose of Study Drug|Period 1||16
3223839|NCT02300259|3955978|FG000|COMPLETED|Period 1||16
3223840|NCT02300259|3955979|FG001|COMPLETED|Period 1||16
3223841|NCT02300259|3955980|FG002|COMPLETED|Period 1||14
3223842|NCT02300259|3955978|FG000|NOT COMPLETED|Period 1||0
3223843|NCT02300259|3955979|FG001|NOT COMPLETED|Period 1||0
3223844|NCT02300259|3955980|FG002|NOT COMPLETED|Period 1||2
3223845|NCT02300259|3955978|FG000|STARTED|Period 2||16
3223846|NCT02300259|3955979|FG001|STARTED|Period 2|There was no period 2 for Group 2.|0
3223847|NCT02300259|3955980|FG002|STARTED|Period 2||14
3223848|NCT02300259|3955978|FG000|COMPLETED|Period 2||15
3223849|NCT02300259|3955979|FG001|COMPLETED|Period 2||0
3223850|NCT02300259|3955980|FG002|COMPLETED|Period 2||13
3223851|NCT02300259|3955978|FG000|NOT COMPLETED|Period 2||1
3223852|NCT02300259|3955979|FG001|NOT COMPLETED|Period 2||0
3223853|NCT02300259|3955980|FG002|NOT COMPLETED|Period 2||1
3223854|NCT02300285|3956001|FG000|STARTED|Overall Study||3
3223855|NCT02300285|3956002|FG001|STARTED|Overall Study||3
3223856|NCT02300285|3956001|FG000|COMPLETED|Overall Study||3
3223857|NCT02300285|3956002|FG001|COMPLETED|Overall Study||3
3223858|NCT02300285|3956001|FG000|NOT COMPLETED|Overall Study||0
3223859|NCT02300285|3956002|FG001|NOT COMPLETED|Overall Study||0
3223860|NCT02300298|3956008|FG000|STARTED|Disposition for Nintedanib||10
3223861|NCT02300298|3956009|FG001|STARTED|Disposition for Nintedanib||0
3223862|NCT02300298|3956008|FG000|COMPLETED|Disposition for Nintedanib||0
3223863|NCT02300298|3956009|FG001|COMPLETED|Disposition for Nintedanib||0
3223864|NCT02300298|3956008|FG000|NOT COMPLETED|Disposition for Nintedanib||10
3223865|NCT02300298|3956009|FG001|NOT COMPLETED|Disposition for Nintedanib||0
3223866|NCT02300298|3956008|FG000|STARTED|Disposition for Docetaxel||0
3223867|NCT02300298|3956009|FG001|STARTED|Disposition for Docetaxel||10
3223868|NCT02300298|3956008|FG000|COMPLETED|Disposition for Docetaxel||0
3223869|NCT02300298|3956009|FG001|COMPLETED|Disposition for Docetaxel||0
3223870|NCT02300298|3956008|FG000|NOT COMPLETED|Disposition for Docetaxel||0
3223871|NCT02300298|3956009|FG001|NOT COMPLETED|Disposition for Docetaxel||10
3223872|NCT02300311|3956015|FG000|STARTED|Overall Study||69
3223873|NCT02300311|3956016|FG001|STARTED|Overall Study||69
3223874|NCT02300311|3956015|FG000|COMPLETED|Overall Study||50
3223875|NCT02300311|3956016|FG001|COMPLETED|Overall Study||69
3223876|NCT02300311|3956015|FG000|NOT COMPLETED|Overall Study||19
3223877|NCT02300311|3956016|FG001|NOT COMPLETED|Overall Study||0
3223878|NCT02300545|3956022|FG000|STARTED|Overall Study||56
3223879|NCT02300545|3956022|FG000|COMPLETED|Overall Study||56
3223880|NCT02300545|3956022|FG000|NOT COMPLETED|Overall Study||0
3223881|NCT02300558|3956026|FG000|STARTED|Single Blind Phase (24 Weeks)||41
3223882|NCT02300558|3956026|FG000|COMPLETED|Single Blind Phase (24 Weeks)||35
3223883|NCT02300558|3956026|FG000|NOT COMPLETED|Single Blind Phase (24 Weeks)||6
3223884|NCT02300558|3956026|FG000|STARTED|Open-Label (OL) Extension Phase||32
3223885|NCT02300558|3956026|FG000|COMPLETED|Open-Label (OL) Extension Phase||0
3223886|NCT02300558|3956026|FG000|NOT COMPLETED|Open-Label (OL) Extension Phase||32
3223887|NCT02300610|3956037|FG000|STARTED|Overall Study||3
3223888|NCT02300610|3956038|FG001|STARTED|Overall Study||3
3223889|NCT02300610|3956039|FG002|STARTED|Overall Study||4
3223890|NCT02300610|3956037|FG000|COMPLETED|Overall Study||2
3223891|NCT02300610|3956038|FG001|COMPLETED|Overall Study||3
3223892|NCT02300610|3956039|FG002|COMPLETED|Overall Study||3
3223893|NCT02300610|3956037|FG000|NOT COMPLETED|Overall Study||1
3223894|NCT02300610|3956038|FG001|NOT COMPLETED|Overall Study||0
3223895|NCT02300610|3956039|FG002|NOT COMPLETED|Overall Study||1
3223896|NCT02300727|3956055|FG000|STARTED|Overall Study||0
3223897|NCT02300727|3956056|FG001|STARTED|Overall Study||0
3223898|NCT02300727|3956057|FG002|STARTED|Overall Study||3
3223899|NCT02300727|3956058|FG003|STARTED|Overall Study||3
3223900|NCT02300727|3956059|FG004|STARTED|Overall Study||0
3223901|NCT02300727|3956060|FG005|STARTED|Overall Study||0
3223902|NCT02300727|3956055|FG000|COMPLETED|Overall Study||0
3223903|NCT02300727|3956056|FG001|COMPLETED|Overall Study||0
3223904|NCT02300727|3956057|FG002|COMPLETED|Overall Study||3
3223905|NCT02300727|3956058|FG003|COMPLETED|Overall Study||2
3223906|NCT02300727|3956059|FG004|COMPLETED|Overall Study||0
3223907|NCT02300727|3956060|FG005|COMPLETED|Overall Study||0
3223908|NCT02300727|3956055|FG000|NOT COMPLETED|Overall Study||0
3223909|NCT02300727|3956056|FG001|NOT COMPLETED|Overall Study||0
3223910|NCT02300727|3956057|FG002|NOT COMPLETED|Overall Study||0
3223911|NCT02300727|3956058|FG003|NOT COMPLETED|Overall Study||1
3223912|NCT02300727|3956059|FG004|NOT COMPLETED|Overall Study||0
3223913|NCT02300727|3956060|FG005|NOT COMPLETED|Overall Study||0
3223914|NCT02300987|3956076|FG000|STARTED|Primary Phase : Prior to Cross-over||8
3223915|NCT02300987|3956077|FG001|STARTED|Primary Phase : Prior to Cross-over||2
3223916|NCT02300987|3956076|FG000|COMPLETED|Primary Phase : Prior to Cross-over||2
3223917|NCT02300987|3956077|FG001|COMPLETED|Primary Phase : Prior to Cross-over||0
3223918|NCT02300987|3956076|FG000|NOT COMPLETED|Primary Phase : Prior to Cross-over||6
3223919|NCT02300987|3956077|FG001|NOT COMPLETED|Primary Phase : Prior to Cross-over||2
3223920|NCT02300987|3956076|FG000|STARTED|Secondary Phase : Cross-over to LEE011||1
3223921|NCT02300987|3956077|FG001|STARTED|Secondary Phase : Cross-over to LEE011||2
3223922|NCT02300987|3956076|FG000|COMPLETED|Secondary Phase : Cross-over to LEE011||0
3223923|NCT02300987|3956077|FG001|COMPLETED|Secondary Phase : Cross-over to LEE011||1
3223924|NCT02300987|3956076|FG000|NOT COMPLETED|Secondary Phase : Cross-over to LEE011||1
3223925|NCT02300987|3956077|FG001|NOT COMPLETED|Secondary Phase : Cross-over to LEE011||1
3223926|NCT02301039|3956087|FG000|STARTED|Overall Study||42
3223927|NCT02301039|3956088|FG001|STARTED|Overall Study||42
3223928|NCT02301039|3956089|FG002|STARTED|Overall Study||60
3223929|NCT02301039|3956087|FG000|COMPLETED|Overall Study||42
3223930|NCT02301039|3956088|FG001|COMPLETED|Overall Study||42
3223931|NCT02301039|3956089|FG002|COMPLETED|Overall Study||60
3223932|NCT02301039|3956087|FG000|NOT COMPLETED|Overall Study||0
3223933|NCT02301039|3956088|FG001|NOT COMPLETED|Overall Study||0
3223934|NCT02301039|3956089|FG002|NOT COMPLETED|Overall Study||0
3223935|NCT02301143|3956097|FG000|STARTED|Induction Period||107
3223936|NCT02301143|3956098|FG001|STARTED|Induction Period||0
3223937|NCT02301143|3956097|FG000|COMPLETED|Induction Period||62
3223938|NCT02301143|3956098|FG001|COMPLETED|Induction Period||0
3223939|NCT02301143|3956097|FG000|NOT COMPLETED|Induction Period||45
3223940|NCT02301143|3956098|FG001|NOT COMPLETED|Induction Period||0
3223941|NCT02301143|3956097|FG000|STARTED|Investigator's Choice||0
3223942|NCT02301143|3956098|FG001|STARTED|Investigator's Choice|12 participants continued nab-Paclitaxel/Gemcitabine; 18 started chemoradiation;17 underwent surgery|47
3223943|NCT02301143|3956097|FG000|COMPLETED|Investigator's Choice||0
3223944|NCT02301143|3956098|FG001|COMPLETED|Investigator's Choice|3 participants completed nab-Paclitaxel+Gemcitabine,18 completed chemoradiation,16 had surgery.|37
3223945|NCT02301143|3956097|FG000|NOT COMPLETED|Investigator's Choice||0
3223946|NCT02301143|3956098|FG001|NOT COMPLETED|Investigator's Choice||10
3223947|NCT02301169|3956111|FG000|STARTED|Overall Study||21
3223948|NCT02301169|3956112|FG001|STARTED|Overall Study||21
3223949|NCT02301169|3956111|FG000|COMPLETED|Overall Study||20
3223950|NCT02301169|3956112|FG001|COMPLETED|Overall Study||21
3223951|NCT02301169|3956111|FG000|NOT COMPLETED|Overall Study||1
3223952|NCT02301169|3956112|FG001|NOT COMPLETED|Overall Study||0
3223953|NCT02301299|3956118|FG000|STARTED|Overall Study||1322
3223954|NCT02301299|3956118|FG000|COMPLETED|Overall Study||1322
3223955|NCT02301299|3956118|FG000|NOT COMPLETED|Overall Study||0
3223956|NCT02301364|3956125|FG000|STARTED|Overall Study||4
3223957|NCT02301364|3956125|FG000|COMPLETED|Overall Study||4
3223958|NCT02301364|3956125|FG000|NOT COMPLETED|Overall Study||0
3223959|NCT02301377|3956131|FG000|STARTED|Overall Study||3
3223960|NCT02301377|3956132|FG001|STARTED|Overall Study||2
3223961|NCT02301377|3956131|FG000|COMPLETED|Overall Study||3
3223962|NCT02301377|3956132|FG001|COMPLETED|Overall Study||2
3223963|NCT02301377|3956131|FG000|NOT COMPLETED|Overall Study||0
3223964|NCT02301377|3956132|FG001|NOT COMPLETED|Overall Study||0
3223965|NCT02301390|3956140|FG000|STARTED|Overall Study||27
3223966|NCT02301390|3956141|FG001|STARTED|Overall Study||26
3223967|NCT02301390|3956140|FG000|COMPLETED|Overall Study||17
3223968|NCT02301390|3956141|FG001|COMPLETED|Overall Study||13
3223969|NCT02301390|3956140|FG000|NOT COMPLETED|Overall Study||10
3223970|NCT02301390|3956141|FG001|NOT COMPLETED|Overall Study||13
3223971|NCT02301403|3956149|FG000|STARTED|Overall Study||315
3223972|NCT02301403|3956150|FG001|STARTED|Overall Study||308
3223973|NCT02301403|3956149|FG000|COMPLETED|Overall Study||287
3223974|NCT02301403|3956150|FG001|COMPLETED|Overall Study||267
3223975|NCT02301403|3956149|FG000|NOT COMPLETED|Overall Study||28
3223976|NCT02301403|3956150|FG001|NOT COMPLETED|Overall Study||41
3223977|NCT02301416|3956158|FG000|STARTED|Overall Study||25
3223978|NCT02301416|3956159|FG001|STARTED|Overall Study||40
3223979|NCT02301416|3956158|FG000|COMPLETED|Overall Study||15
3223980|NCT02301416|3956159|FG001|COMPLETED|Overall Study||40
3223981|NCT02301416|3956158|FG000|NOT COMPLETED|Overall Study||10
3223982|NCT02301416|3956159|FG001|NOT COMPLETED|Overall Study||0
3223983|NCT02301429|3956165|FG000|STARTED|Overall Study||16
3223984|NCT02301429|3956165|FG000|COMPLETED|Overall Study||13
3223985|NCT02301429|3956165|FG000|NOT COMPLETED|Overall Study||3
3223986|NCT02301546|3956171|FG000|STARTED|Short-term Effectiveness (~13 Weeks)||73
3223987|NCT02301546|3956172|FG001|STARTED|Short-term Effectiveness (~13 Weeks)||73
3223988|NCT02301546|3956171|FG000|COMPLETED|Short-term Effectiveness (~13 Weeks)||55
3223989|NCT02301546|3956172|FG001|COMPLETED|Short-term Effectiveness (~13 Weeks)||58
3223990|NCT02301546|3956171|FG000|NOT COMPLETED|Short-term Effectiveness (~13 Weeks)||18
3223991|NCT02301546|3956172|FG001|NOT COMPLETED|Short-term Effectiveness (~13 Weeks)||15
3223992|NCT02301546|3956171|FG000|STARTED|Long Term Effectiveness (~1 Year)||55
3223993|NCT02301546|3956172|FG001|STARTED|Long Term Effectiveness (~1 Year)||58
3223994|NCT02301546|3956171|FG000|COMPLETED|Long Term Effectiveness (~1 Year)||43
3223995|NCT02301546|3956172|FG001|COMPLETED|Long Term Effectiveness (~1 Year)||51
3223996|NCT02301546|3956171|FG000|NOT COMPLETED|Long Term Effectiveness (~1 Year)||12
3223997|NCT02301546|3956172|FG001|NOT COMPLETED|Long Term Effectiveness (~1 Year)||7
3223998|NCT02301624|3956180|FG000|STARTED|Blind Induction Phase||56
3223999|NCT02301624|3956181|FG001|STARTED|Blind Induction Phase||61
3224000|NCT02301624|3956180|FG000|Received at Least 1 Dose of Study Drug|Blind Induction Phase||56
3224001|NCT02301624|3956181|FG001|Received at Least 1 Dose of Study Drug|Blind Induction Phase||61
3224002|NCT02301624|3956180|FG000|COMPLETED|Blind Induction Phase||55
3224003|NCT02301624|3956181|FG001|COMPLETED|Blind Induction Phase||61
3224004|NCT02301624|3956180|FG000|NOT COMPLETED|Blind Induction Phase||1
3224005|NCT02301624|3956181|FG001|NOT COMPLETED|Blind Induction Phase||0
3224006|NCT02301624|3956180|FG000|STARTED|Open-label Maintenance Phase||55
3224007|NCT02301624|3956181|FG001|STARTED|Open-label Maintenance Phase||61
3224008|NCT02301624|3956180|FG000|Received at Least 1 Dose of Study Drug|Open-label Maintenance Phase||55
3224009|NCT02301624|3956181|FG001|Received at Least 1 Dose of Study Drug|Open-label Maintenance Phase||61
3224010|NCT02301624|3956180|FG000|COMPLETED|Open-label Maintenance Phase||43
3224011|NCT02301624|3956181|FG001|COMPLETED|Open-label Maintenance Phase||44
3224012|NCT02301624|3956180|FG000|NOT COMPLETED|Open-label Maintenance Phase||12
3224013|NCT02301624|3956181|FG001|NOT COMPLETED|Open-label Maintenance Phase||17
3224014|NCT02301793|3956190|FG000|STARTED|Pre Education Study Period|Nurses had not been randomized|
3224015|NCT02301793|3956191|FG001|STARTED|Pre Education Study Period|Nurses had not been randomized|
3224016|NCT02301793|3956190|FG000|COMPLETED|Pre Education Study Period|Nurses had not been randomized|
3224017|NCT02301793|3956191|FG001|COMPLETED|Pre Education Study Period|Nurses had not been randomized|
3224018|NCT02301793|3956190|FG000|NOT COMPLETED|Pre Education Study Period||
3224019|NCT02301793|3956191|FG001|NOT COMPLETED|Pre Education Study Period||
3224020|NCT02301793|3956190|FG000|STARTED|During and Post Education Study Period||488
3224021|NCT02301793|3956191|FG001|STARTED|During and Post Education Study Period||445
3224022|NCT02301793|3956190|FG000|COMPLETED|During and Post Education Study Period||405
3224023|NCT02301793|3956191|FG001|COMPLETED|During and Post Education Study Period||396
3224024|NCT02301793|3956190|FG000|NOT COMPLETED|During and Post Education Study Period||83
3224025|NCT02301793|3956191|FG001|NOT COMPLETED|During and Post Education Study Period||49
3224026|NCT02301897|3956200|FG000|STARTED|Treatment Course 1||12
3224027|NCT02301897|3956201|FG001|STARTED|Treatment Course 1||17
3224028|NCT02301897|3956202|FG002|STARTED|Treatment Course 1||14
3224029|NCT02301897|3956200|FG000|COMPLETED|Treatment Course 1||9
3224030|NCT02301897|3956201|FG001|COMPLETED|Treatment Course 1||14
3224031|NCT02301897|3956202|FG002|COMPLETED|Treatment Course 1||8
3224032|NCT02301897|3956200|FG000|NOT COMPLETED|Treatment Course 1||3
3224033|NCT02301897|3956201|FG001|NOT COMPLETED|Treatment Course 1||3
3224034|NCT02301897|3956202|FG002|NOT COMPLETED|Treatment Course 1||6
3224035|NCT02301897|3956200|FG000|STARTED|Treatment Course 2||9
3224036|NCT02301897|3956201|FG001|STARTED|Treatment Course 2||14
3224037|NCT02301897|3956202|FG002|STARTED|Treatment Course 2||8
3224038|NCT02301897|3956200|FG000|COMPLETED|Treatment Course 2||8
3224039|NCT02301897|3956201|FG001|COMPLETED|Treatment Course 2||9
3224040|NCT02301897|3956202|FG002|COMPLETED|Treatment Course 2||7
3224041|NCT02301897|3956200|FG000|NOT COMPLETED|Treatment Course 2||1
3224042|NCT02301897|3956201|FG001|NOT COMPLETED|Treatment Course 2||5
3224043|NCT02301897|3956202|FG002|NOT COMPLETED|Treatment Course 2||1
3224044|NCT02301936|3956212|FG000|STARTED|Overall Study||9
3224045|NCT02301936|3956213|FG001|STARTED|Overall Study||1
3224046|NCT02301936|3956212|FG000|COMPLETED|Overall Study||8
3224047|NCT02301936|3956213|FG001|COMPLETED|Overall Study||1
3224048|NCT02301936|3956212|FG000|NOT COMPLETED|Overall Study||1
3224049|NCT02301936|3956213|FG001|NOT COMPLETED|Overall Study||0
3224050|NCT02301975|3956222|FG000|STARTED|Overall Study||504
3224051|NCT02301975|3956223|FG001|STARTED|Overall Study||501
3224052|NCT02301975|3956224|FG002|STARTED|Overall Study||499
3224053|NCT02301975|3956222|FG000|COMPLETED|Overall Study||473
3224054|NCT02301975|3956223|FG001|COMPLETED|Overall Study||476
3224055|NCT02301975|3956224|FG002|COMPLETED|Overall Study||477
3368226|NCT03815240|4099831|FG003|COMPLETED|Intervention Mepilex Dressing||2
3368227|NCT03815240|4099832|FG004|COMPLETED|Intervention Mepilex Dressing||1
3368228|NCT03815240|4099833|FG005|COMPLETED|Intervention Mepilex Dressing||2
3368229|NCT03815240|4099834|FG006|COMPLETED|Intervention Mepilex Dressing||1
3368230|NCT03815240|4099835|FG007|COMPLETED|Intervention Mepilex Dressing||1
3368231|NCT03815240|4099836|FG008|COMPLETED|Intervention Mepilex Dressing||1
3368232|NCT03815240|4099828|FG000|NOT COMPLETED|Intervention Mepilex Dressing||0
3368233|NCT03815240|4099829|FG001|NOT COMPLETED|Intervention Mepilex Dressing||0
3224056|NCT02301975|3956222|FG000|NOT COMPLETED|Overall Study||31
3224057|NCT02301975|3956223|FG001|NOT COMPLETED|Overall Study||25
3224058|NCT02301975|3956224|FG002|NOT COMPLETED|Overall Study||22
3224059|NCT02301988|3956234|FG000|STARTED|Overall Study||76
3224060|NCT02301988|3956235|FG001|STARTED|Overall Study||75
3224061|NCT02301988|3956234|FG000|COMPLETED|Overall Study||66
3224062|NCT02301988|3956235|FG001|COMPLETED|Overall Study||66
3224063|NCT02301988|3956234|FG000|NOT COMPLETED|Overall Study||10
3224064|NCT02301988|3956235|FG001|NOT COMPLETED|Overall Study||9
3224065|NCT02302066|3956245|FG000|STARTED|Overall Study||201
3224066|NCT02302066|3956246|FG001|STARTED|Overall Study||398
3224067|NCT02302066|3956247|FG002|STARTED|Overall Study||1002
3224068|NCT02302066|3956248|FG003|STARTED|Overall Study||199
3224069|NCT02302066|3956245|FG000|Safety Analysis Set|Overall Study||200
3224070|NCT02302066|3956246|FG001|Safety Analysis Set|Overall Study||398
3224071|NCT02302066|3956247|FG002|Safety Analysis Set|Overall Study||998
3224072|NCT02302066|3956248|FG003|Safety Analysis Set|Overall Study||198
3224073|NCT02302066|3956245|FG000|Immunogenicity Subset|Overall Study||92
3224074|NCT02302066|3956246|FG001|Immunogenicity Subset|Overall Study||187
3224075|NCT02302066|3956247|FG002|Immunogenicity Subset|Overall Study||192
3224076|NCT02302066|3956248|FG003|Immunogenicity Subset|Overall Study||94
3224077|NCT02302066|3956245|FG000|Per-Protocol Set (PPS)|Overall Study||83
3224078|NCT02302066|3956246|FG001|Per-Protocol Set (PPS)|Overall Study||171
3224079|NCT02302066|3956247|FG002|Per-Protocol Set (PPS)|Overall Study||174
3224080|NCT02302066|3956248|FG003|Per-Protocol Set (PPS)|Overall Study||81
3224081|NCT02302066|3956245|FG000|COMPLETED|Overall Study||168
3224082|NCT02302066|3956246|FG001|COMPLETED|Overall Study||323
3224083|NCT02302066|3956247|FG002|COMPLETED|Overall Study||830
3224084|NCT02302066|3956248|FG003|COMPLETED|Overall Study||158
3224085|NCT02302066|3956245|FG000|NOT COMPLETED|Overall Study||33
3224086|NCT02302066|3956246|FG001|NOT COMPLETED|Overall Study||75
3224087|NCT02302066|3956247|FG002|NOT COMPLETED|Overall Study||172
3224088|NCT02302066|3956248|FG003|NOT COMPLETED|Overall Study||41
3224089|NCT02302092|3956270|FG000|STARTED|Overall Study||6
3224090|NCT02302092|3956271|FG001|STARTED|Overall Study||7
3224091|NCT02302092|3956270|FG000|COMPLETED|Overall Study||6
3224092|NCT02302092|3956271|FG001|COMPLETED|Overall Study||7
3224093|NCT02302092|3956270|FG000|NOT COMPLETED|Overall Study||0
3224094|NCT02302092|3956271|FG001|NOT COMPLETED|Overall Study||0
3224095|NCT02302157|3956282|FG000|STARTED|Overall Study||3
3224096|NCT02302157|3956283|FG001|STARTED|Overall Study||6
3224097|NCT02302157|3956284|FG002|STARTED|Overall Study||6
3224098|NCT02302157|3956285|FG003|STARTED|Overall Study||6
3224099|NCT02302157|3956286|FG004|STARTED|Overall Study||4
3224100|NCT02302157|3956282|FG000|COMPLETED|Overall Study||3
3224101|NCT02302157|3956283|FG001|COMPLETED|Overall Study||6
3224102|NCT02302157|3956284|FG002|COMPLETED|Overall Study||6
3224103|NCT02302157|3956285|FG003|COMPLETED|Overall Study||6
3224104|NCT02302157|3956286|FG004|COMPLETED|Overall Study||4
3224105|NCT02302157|3956282|FG000|NOT COMPLETED|Overall Study||0
3224106|NCT02302157|3956283|FG001|NOT COMPLETED|Overall Study||0
3224107|NCT02302157|3956284|FG002|NOT COMPLETED|Overall Study||0
3224108|NCT02302157|3956285|FG003|NOT COMPLETED|Overall Study||0
3224109|NCT02302157|3956286|FG004|NOT COMPLETED|Overall Study||0
3224110|NCT02302222|3956305|FG000|STARTED|Overall Study||34
3224111|NCT02302222|3956306|FG001|STARTED|Overall Study||37
3224112|NCT02302222|3956305|FG000|COMPLETED|Overall Study||33
3224113|NCT02302222|3956306|FG001|COMPLETED|Overall Study||31
3224114|NCT02302222|3956305|FG000|NOT COMPLETED|Overall Study||1
3224115|NCT02302222|3956306|FG001|NOT COMPLETED|Overall Study||6
3224116|NCT02302339|3956316|FG000|STARTED|Overall Study||62
3224117|NCT02302339|3956317|FG001|STARTED|Overall Study||34
3224118|NCT02302339|3956318|FG002|STARTED|Overall Study||29
3224119|NCT02302339|3956319|FG003|STARTED|Overall Study||7
3224120|NCT02302339|3956316|FG000|COMPLETED|Overall Study||61
3224121|NCT02302339|3956317|FG001|COMPLETED|Overall Study||32
3224122|NCT02302339|3956318|FG002|COMPLETED|Overall Study||28
3224123|NCT02302339|3956319|FG003|COMPLETED|Overall Study||7
3224124|NCT02302339|3956316|FG000|NOT COMPLETED|Overall Study||1
3224125|NCT02302339|3956317|FG001|NOT COMPLETED|Overall Study||2
3224126|NCT02302339|3956318|FG002|NOT COMPLETED|Overall Study||1
3224127|NCT02302339|3956319|FG003|NOT COMPLETED|Overall Study||0
3224128|NCT02302365|3956330|FG000|STARTED|0-2 Hour Period|Data were collected from 58 WBCD procedures performed in 43 subjects - Full and Safety Analysis Sets|43
3224129|NCT02302365|3956330|FG000|COMPLETED|0-2 Hour Period|The Per-protocol Analysis Set comprised 54 procedures performed in 41 subjects|41
3224130|NCT02302365|3956330|FG000|NOT COMPLETED|0-2 Hour Period||2
3224131|NCT02302365|3956330|FG000|STARTED|0-24 Hour Period|2 of 3 study sites collected additional safety data; 32 pts. 0-24 hour data, 43 pts. 0-2 hour data|32
3224132|NCT02302365|3956330|FG000|COMPLETED|0-24 Hour Period||32
3224133|NCT02302365|3956330|FG000|NOT COMPLETED|0-24 Hour Period||0
3224134|NCT02302716|3956340|FG000|STARTED|Overall Study||249
3224135|NCT02302716|3956341|FG001|STARTED|Overall Study||244
3224136|NCT02302716|3956340|FG000|Received at Least 1 Dose of Study Drug|Overall Study||249
3224137|NCT02302716|3956341|FG001|Received at Least 1 Dose of Study Drug|Overall Study||244
3224138|NCT02302716|3956340|FG000|COMPLETED|Overall Study||230
3224139|NCT02302716|3956341|FG001|COMPLETED|Overall Study||225
3224140|NCT02302716|3956340|FG000|NOT COMPLETED|Overall Study||19
3224141|NCT02302716|3956341|FG001|NOT COMPLETED|Overall Study||19
3224142|NCT02302807|3956349|FG000|STARTED|Overall Study||464
3224143|NCT02302807|3956350|FG001|STARTED|Overall Study||467
3224144|NCT02302807|3956349|FG000|Received Treatment|Overall Study||443
3224145|NCT02302807|3956350|FG001|Received Treatment|Overall Study||459
3224146|NCT02302807|3956349|FG000|COMPLETED|Overall Study|Participants still on chemotherapy were discontinued where that treatment was available locally.|0
3224147|NCT02302807|3956350|FG001|COMPLETED|Overall Study|Participants still receiving atezolizumab had opportunity to continue treatment in extension study.|0
3224148|NCT02302807|3956349|FG000|NOT COMPLETED|Overall Study||464
3224149|NCT02302807|3956350|FG001|NOT COMPLETED|Overall Study||467
3224150|NCT02302846|3956369|FG000|STARTED|Overall Study||5
3224151|NCT02302846|3956369|FG000|COMPLETED|Overall Study||4
3224152|NCT02302846|3956369|FG000|NOT COMPLETED|Overall Study||1
3224153|NCT02303041|3956375|FG000|STARTED|Overall Study||4
3224154|NCT02303041|3956376|FG001|STARTED|Overall Study||6
3224155|NCT02303041|3956375|FG000|COMPLETED|Overall Study||3
3224156|NCT02303041|3956376|FG001|COMPLETED|Overall Study||4
3224157|NCT02303041|3956375|FG000|NOT COMPLETED|Overall Study||1
3224158|NCT02303041|3956376|FG001|NOT COMPLETED|Overall Study||2
3224159|NCT02303093|3956382|FG000|STARTED|Overall Study||344
3224160|NCT02303093|3956382|FG000|COMPLETED|Overall Study||344
3224161|NCT02303093|3956382|FG000|NOT COMPLETED|Overall Study||0
3224162|NCT02303184|3956400|FG000|STARTED|Overall Study||23
3224163|NCT02303184|3956401|FG001|STARTED|Overall Study||23
3224164|NCT02303184|3956400|FG000|COMPLETED|Overall Study||23
3224165|NCT02303184|3956401|FG001|COMPLETED|Overall Study||23
3224166|NCT02303184|3956400|FG000|NOT COMPLETED|Overall Study||0
3224167|NCT02303184|3956401|FG001|NOT COMPLETED|Overall Study||0
3224168|NCT02303262|3956407|FG000|STARTED|Overall Study||20
3224169|NCT02303262|3956407|FG000|COMPLETED|Overall Study||18
3224170|NCT02303262|3956407|FG000|NOT COMPLETED|Overall Study||2
3224171|NCT02303548|3956413|FG000|STARTED|Overall Study||25
3224172|NCT02303548|3956414|FG001|STARTED|Overall Study||25
3224173|NCT02303548|3956413|FG000|COMPLETED|Overall Study||25
3224174|NCT02303548|3956414|FG001|COMPLETED|Overall Study||25
3224175|NCT02303548|3956413|FG000|NOT COMPLETED|Overall Study||0
3224176|NCT02303548|3956414|FG001|NOT COMPLETED|Overall Study||0
3224177|NCT02303574|3956432|FG000|STARTED|Part 1a (Fasted State)- SAD||6
3224178|NCT02303574|3956433|FG001|STARTED|Part 1a (Fasted State)- SAD||6
3224179|NCT02303574|3956434|FG002|STARTED|Part 1a (Fasted State)- SAD||6
3224180|NCT02303574|3956435|FG003|STARTED|Part 1a (Fasted State)- SAD||6
3224181|NCT02303574|3956436|FG004|STARTED|Part 1a (Fasted State)- SAD||6
3224182|NCT02303574|3956437|FG005|STARTED|Part 1a (Fasted State)- SAD||0
3224183|NCT02303574|3956438|FG006|STARTED|Part 1a (Fasted State)- SAD||0
3224184|NCT02303574|3956439|FG007|STARTED|Part 1a (Fasted State)- SAD||0
3224185|NCT02303574|3956440|FG008|STARTED|Part 1a (Fasted State)- SAD||0
3224186|NCT02303574|3956441|FG009|STARTED|Part 1a (Fasted State)- SAD|Participants received AZD7986 matching placebo on Day 1 in fasted state.|15
3224187|NCT02303574|3956432|FG000|COMPLETED|Part 1a (Fasted State)- SAD||6
3224188|NCT02303574|3956433|FG001|COMPLETED|Part 1a (Fasted State)- SAD||6
3224189|NCT02303574|3956434|FG002|COMPLETED|Part 1a (Fasted State)- SAD||5
3224190|NCT02303574|3956435|FG003|COMPLETED|Part 1a (Fasted State)- SAD||6
3224191|NCT02303574|3956436|FG004|COMPLETED|Part 1a (Fasted State)- SAD||6
3224192|NCT02303574|3956437|FG005|COMPLETED|Part 1a (Fasted State)- SAD||0
3224193|NCT02303574|3956438|FG006|COMPLETED|Part 1a (Fasted State)- SAD||0
3224194|NCT02303574|3956439|FG007|COMPLETED|Part 1a (Fasted State)- SAD||0
3224195|NCT02303574|3956440|FG008|COMPLETED|Part 1a (Fasted State)- SAD||0
3224196|NCT02303574|3956441|FG009|COMPLETED|Part 1a (Fasted State)- SAD||15
3224197|NCT02303574|3956432|FG000|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
3224198|NCT02303574|3956433|FG001|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
3224199|NCT02303574|3956434|FG002|NOT COMPLETED|Part 1a (Fasted State)- SAD||1
3224200|NCT02303574|3956435|FG003|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
3224201|NCT02303574|3956436|FG004|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
3224202|NCT02303574|3956437|FG005|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
3224203|NCT02303574|3956438|FG006|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
3224204|NCT02303574|3956439|FG007|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
3224205|NCT02303574|3956440|FG008|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
3224206|NCT02303574|3956441|FG009|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
3224207|NCT02303574|3956432|FG000|STARTED|Part 1b (Fed State) - SAD||0
3224208|NCT02303574|3956433|FG001|STARTED|Part 1b (Fed State) - SAD||0
3224209|NCT02303574|3956434|FG002|STARTED|Part 1b (Fed State) - SAD||0
3224210|NCT02303574|3956435|FG003|STARTED|Part 1b (Fed State) - SAD||0
3224211|NCT02303574|3956436|FG004|STARTED|Part 1b (Fed State) - SAD||0
3224212|NCT02303574|3956437|FG005|STARTED|Part 1b (Fed State) - SAD||5
3224213|NCT02303574|3956438|FG006|STARTED|Part 1b (Fed State) - SAD||0
3224214|NCT02303574|3956439|FG007|STARTED|Part 1b (Fed State) - SAD||0
3224215|NCT02303574|3956440|FG008|STARTED|Part 1b (Fed State) - SAD||0
3224216|NCT02303574|3956441|FG009|STARTED|Part 1b (Fed State) - SAD|Participants received AZD7986 matching placebo on Day 1 in fed state.|3
3224217|NCT02303574|3956432|FG000|COMPLETED|Part 1b (Fed State) - SAD||0
3224218|NCT02303574|3956433|FG001|COMPLETED|Part 1b (Fed State) - SAD||0
3224219|NCT02303574|3956434|FG002|COMPLETED|Part 1b (Fed State) - SAD||0
3224220|NCT02303574|3956435|FG003|COMPLETED|Part 1b (Fed State) - SAD||0
3224221|NCT02303574|3956436|FG004|COMPLETED|Part 1b (Fed State) - SAD||0
3224222|NCT02303574|3956437|FG005|COMPLETED|Part 1b (Fed State) - SAD||5
3224223|NCT02303574|3956438|FG006|COMPLETED|Part 1b (Fed State) - SAD||0
3224224|NCT02303574|3956439|FG007|COMPLETED|Part 1b (Fed State) - SAD||0
3224225|NCT02303574|3956440|FG008|COMPLETED|Part 1b (Fed State) - SAD||0
3224226|NCT02303574|3956441|FG009|COMPLETED|Part 1b (Fed State) - SAD||3
3224227|NCT02303574|3956432|FG000|NOT COMPLETED|Part 1b (Fed State) - SAD||0
3224228|NCT02303574|3956433|FG001|NOT COMPLETED|Part 1b (Fed State) - SAD||0
3224229|NCT02303574|3956434|FG002|NOT COMPLETED|Part 1b (Fed State) - SAD||0
3224230|NCT02303574|3956435|FG003|NOT COMPLETED|Part 1b (Fed State) - SAD||0
3224231|NCT02303574|3956436|FG004|NOT COMPLETED|Part 1b (Fed State) - SAD||0
3224232|NCT02303574|3956437|FG005|NOT COMPLETED|Part 1b (Fed State) - SAD||0
3224233|NCT02303574|3956438|FG006|NOT COMPLETED|Part 1b (Fed State) - SAD||0
3224234|NCT02303574|3956439|FG007|NOT COMPLETED|Part 1b (Fed State) - SAD||0
3224235|NCT02303574|3956440|FG008|NOT COMPLETED|Part 1b (Fed State) - SAD||0
3224236|NCT02303574|3956441|FG009|NOT COMPLETED|Part 1b (Fed State) - SAD||0
3224237|NCT02303574|3956432|FG000|STARTED|Part 2 - Multiple Ascending Dose (MAD)||0
3224238|NCT02303574|3956433|FG001|STARTED|Part 2 - Multiple Ascending Dose (MAD)||0
3224239|NCT02303574|3956434|FG002|STARTED|Part 2 - Multiple Ascending Dose (MAD)||0
3224240|NCT02303574|3956435|FG003|STARTED|Part 2 - Multiple Ascending Dose (MAD)||0
3224241|NCT02303574|3956436|FG004|STARTED|Part 2 - Multiple Ascending Dose (MAD)||0
3224242|NCT02303574|3956437|FG005|STARTED|Part 2 - Multiple Ascending Dose (MAD)||0
3224243|NCT02303574|3956438|FG006|STARTED|Part 2 - Multiple Ascending Dose (MAD)||6
3224244|NCT02303574|3956439|FG007|STARTED|Part 2 - Multiple Ascending Dose (MAD)||8
3224245|NCT02303574|3956440|FG008|STARTED|Part 2 - Multiple Ascending Dose (MAD)||10
3224246|NCT02303574|3956441|FG009|STARTED|Part 2 - Multiple Ascending Dose (MAD)|Participants took AZD7986 matching placebo for 28 days (fasted/fed state, based on part 1b results)|12
3224247|NCT02303574|3956432|FG000|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
3224248|NCT02303574|3956433|FG001|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
3224249|NCT02303574|3956434|FG002|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
3224250|NCT02303574|3956435|FG003|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
3224251|NCT02303574|3956436|FG004|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
3224252|NCT02303574|3956437|FG005|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
3224253|NCT02303574|3956438|FG006|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||6
3224254|NCT02303574|3956439|FG007|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||7
3224255|NCT02303574|3956440|FG008|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||10
3224256|NCT02303574|3956441|FG009|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||12
3224257|NCT02303574|3956432|FG000|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
3224258|NCT02303574|3956433|FG001|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
3224259|NCT02303574|3956434|FG002|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
3224260|NCT02303574|3956435|FG003|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
3224261|NCT02303574|3956436|FG004|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
3224262|NCT02303574|3956437|FG005|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
3224263|NCT02303574|3956438|FG006|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
3224264|NCT02303574|3956439|FG007|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||1
3224265|NCT02303574|3956440|FG008|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
3224266|NCT02303574|3956441|FG009|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
3224267|NCT02303704|3956476|FG000|STARTED|Overall Study||220
3224268|NCT02303704|3956477|FG001|STARTED|Overall Study||228
3224269|NCT02303704|3956476|FG000|COMPLETED|Overall Study||215
3224270|NCT02303704|3956477|FG001|COMPLETED|Overall Study||219
3224271|NCT02303704|3956476|FG000|NOT COMPLETED|Overall Study||5
3224272|NCT02303704|3956477|FG001|NOT COMPLETED|Overall Study||9
3224273|NCT02303743|3956485|FG000|STARTED|Overall Study||108
3224274|NCT02303743|3956486|FG001|STARTED|Overall Study||152
3224275|NCT02303743|3956485|FG000|COMPLETED|Overall Study||108
3224276|NCT02303743|3956486|FG001|COMPLETED|Overall Study||152
3224277|NCT02303743|3956485|FG000|NOT COMPLETED|Overall Study||0
3224278|NCT02303743|3956486|FG001|NOT COMPLETED|Overall Study||0
3224279|NCT02303977|3956492|FG000|STARTED|Overall Study||37
3224280|NCT02303977|3956492|FG000|COMPLETED|Overall Study||37
3224281|NCT02303977|3956492|FG000|NOT COMPLETED|Overall Study||0
3224282|NCT02303990|3956497|FG000|STARTED|Overall Study||59
3224283|NCT02303990|3956497|FG000|COMPLETED|Overall Study||59
3224284|NCT02303990|3956497|FG000|NOT COMPLETED|Overall Study||0
3224285|NCT02304159|3956503|FG000|STARTED|Overall Study||21
3224286|NCT02304159|3956504|FG001|STARTED|Overall Study||18
3224287|NCT02304159|3956503|FG000|COMPLETED|Overall Study||19
3224288|NCT02304159|3956504|FG001|COMPLETED|Overall Study||16
3224289|NCT02304159|3956503|FG000|NOT COMPLETED|Overall Study||2
3224290|NCT02304159|3956504|FG001|NOT COMPLETED|Overall Study||2
3224291|NCT02304380|3956516|FG000|STARTED|Pediatric Claims Data Analysis (Aim 3)||0
3224292|NCT02304380|3956517|FG001|STARTED|Pediatric Claims Data Analysis (Aim 3)||0
3224293|NCT02304380|3956518|FG002|STARTED|Pediatric Claims Data Analysis (Aim 3)||0
3224294|NCT02304380|3956519|FG003|STARTED|Pediatric Claims Data Analysis (Aim 3)||0
3224295|NCT02304380|3956520|FG004|STARTED|Pediatric Claims Data Analysis (Aim 3)||17356
3224296|NCT02304380|3956521|FG005|STARTED|Pediatric Claims Data Analysis (Aim 3)||47026
3224297|NCT02304380|3956516|FG000|COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0
3224298|NCT02304380|3956517|FG001|COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0
3224299|NCT02304380|3956518|FG002|COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0
3224300|NCT02304380|3956519|FG003|COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0
3224301|NCT02304380|3956520|FG004|COMPLETED|Pediatric Claims Data Analysis (Aim 3)|2,096 Caregivers of the 17,356 claims were included in the Caregiver Survey.|17356
3224302|NCT02304380|3956521|FG005|COMPLETED|Pediatric Claims Data Analysis (Aim 3)|Not included in any other portion of the study.|47026
3224303|NCT02304380|3956516|FG000|NOT COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0
3224304|NCT02304380|3956517|FG001|NOT COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0
3224305|NCT02304380|3956518|FG002|NOT COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0
3224306|NCT02304380|3956519|FG003|NOT COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0
3224307|NCT02304380|3956520|FG004|NOT COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0
3224308|NCT02304380|3956521|FG005|NOT COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0
3224309|NCT02304380|3956516|FG000|STARTED|Pediatric Adult Caregiver Survey (Aim 2)||0
3224310|NCT02304380|3956517|FG001|STARTED|Pediatric Adult Caregiver Survey (Aim 2)||0
3224311|NCT02304380|3956518|FG002|STARTED|Pediatric Adult Caregiver Survey (Aim 2)||0
3224312|NCT02304380|3956519|FG003|STARTED|Pediatric Adult Caregiver Survey (Aim 2)||2096
3224313|NCT02304380|3956520|FG004|STARTED|Pediatric Adult Caregiver Survey (Aim 2)||0
3224314|NCT02304380|3956521|FG005|STARTED|Pediatric Adult Caregiver Survey (Aim 2)||0
3224315|NCT02304380|3956516|FG000|COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0
3224316|NCT02304380|3956517|FG001|COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0
3224317|NCT02304380|3956518|FG002|COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0
3224318|NCT02304380|3956519|FG003|COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)|68 Caregivers/Patients of the 2,062 surveyed were included in the Interviews and Focus Group .|2062
3224319|NCT02304380|3956520|FG004|COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0
3224320|NCT02304380|3956521|FG005|COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0
3224321|NCT02304380|3956516|FG000|NOT COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0
3224322|NCT02304380|3956517|FG001|NOT COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0
3224323|NCT02304380|3956518|FG002|NOT COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0
3224324|NCT02304380|3956519|FG003|NOT COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||34
3224325|NCT02304380|3956520|FG004|NOT COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0
3224326|NCT02304380|3956521|FG005|NOT COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0
3224327|NCT02304380|3956516|FG000|STARTED|Interviews & Focus Groups (Aim 1)||0
3224328|NCT02304380|3956517|FG001|STARTED|Interviews & Focus Groups (Aim 1)||35
3224329|NCT02304380|3956518|FG002|STARTED|Interviews & Focus Groups (Aim 1)||33
3224330|NCT02304380|3956519|FG003|STARTED|Interviews & Focus Groups (Aim 1)||0
3224331|NCT02304380|3956520|FG004|STARTED|Interviews & Focus Groups (Aim 1)||0
3224332|NCT02304380|3956521|FG005|STARTED|Interviews & Focus Groups (Aim 1)||0
3224333|NCT02304380|3956516|FG000|COMPLETED|Interviews & Focus Groups (Aim 1)||0
3224334|NCT02304380|3956517|FG001|COMPLETED|Interviews & Focus Groups (Aim 1)||35
3224335|NCT02304380|3956518|FG002|COMPLETED|Interviews & Focus Groups (Aim 1)||33
3224336|NCT02304380|3956519|FG003|COMPLETED|Interviews & Focus Groups (Aim 1)||0
3224337|NCT02304380|3956520|FG004|COMPLETED|Interviews & Focus Groups (Aim 1)||0
3224338|NCT02304380|3956521|FG005|COMPLETED|Interviews & Focus Groups (Aim 1)||0
3224339|NCT02304380|3956516|FG000|NOT COMPLETED|Interviews & Focus Groups (Aim 1)||0
3224340|NCT02304380|3956517|FG001|NOT COMPLETED|Interviews & Focus Groups (Aim 1)||0
3224341|NCT02304380|3956518|FG002|NOT COMPLETED|Interviews & Focus Groups (Aim 1)||0
3224342|NCT02304380|3956519|FG003|NOT COMPLETED|Interviews & Focus Groups (Aim 1)||0
3224343|NCT02304380|3956520|FG004|NOT COMPLETED|Interviews & Focus Groups (Aim 1)||0
3224344|NCT02304380|3956521|FG005|NOT COMPLETED|Interviews & Focus Groups (Aim 1)||0
3224345|NCT02304380|3956516|FG000|STARTED|ACO Stakeholder Interviews (Aim 1)||24
3224346|NCT02304380|3956517|FG001|STARTED|ACO Stakeholder Interviews (Aim 1)||0
3224347|NCT02304380|3956518|FG002|STARTED|ACO Stakeholder Interviews (Aim 1)||0
3224348|NCT02304380|3956519|FG003|STARTED|ACO Stakeholder Interviews (Aim 1)||0
3224349|NCT02304380|3956520|FG004|STARTED|ACO Stakeholder Interviews (Aim 1)||0
3224350|NCT02304380|3956521|FG005|STARTED|ACO Stakeholder Interviews (Aim 1)||0
3224351|NCT02304380|3956516|FG000|COMPLETED|ACO Stakeholder Interviews (Aim 1)||24
3224352|NCT02304380|3956517|FG001|COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
3224353|NCT02304380|3956518|FG002|COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
3224354|NCT02304380|3956519|FG003|COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
3224355|NCT02304380|3956520|FG004|COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
3224356|NCT02304380|3956521|FG005|COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
3224357|NCT02304380|3956516|FG000|NOT COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
3368234|NCT03815240|4099830|FG002|NOT COMPLETED|Intervention Mepilex Dressing||0
3368235|NCT03815240|4099831|FG003|NOT COMPLETED|Intervention Mepilex Dressing||0
3368236|NCT03815240|4099832|FG004|NOT COMPLETED|Intervention Mepilex Dressing||0
3368237|NCT03815240|4099833|FG005|NOT COMPLETED|Intervention Mepilex Dressing||0
3368238|NCT03815240|4099834|FG006|NOT COMPLETED|Intervention Mepilex Dressing||0
3368239|NCT03815240|4099835|FG007|NOT COMPLETED|Intervention Mepilex Dressing||0
3368240|NCT03815240|4099836|FG008|NOT COMPLETED|Intervention Mepilex Dressing||0
3368241|NCT03815240|4099828|FG000|STARTED|Intervention Allevyn Dressing||2
3368242|NCT03815240|4099829|FG001|STARTED|Intervention Allevyn Dressing||1
3368243|NCT03815240|4099830|FG002|STARTED|Intervention Allevyn Dressing||1
3368244|NCT03815240|4099831|FG003|STARTED|Intervention Allevyn Dressing||2
3368245|NCT03815240|4099832|FG004|STARTED|Intervention Allevyn Dressing||1
3368246|NCT03815240|4099833|FG005|STARTED|Intervention Allevyn Dressing||2
3368247|NCT03815240|4099834|FG006|STARTED|Intervention Allevyn Dressing||1
3368248|NCT03815240|4099835|FG007|STARTED|Intervention Allevyn Dressing||1
3368249|NCT03815240|4099836|FG008|STARTED|Intervention Allevyn Dressing||1
3368250|NCT03815240|4099828|FG000|COMPLETED|Intervention Allevyn Dressing||2
3368251|NCT03815240|4099829|FG001|COMPLETED|Intervention Allevyn Dressing||1
3368252|NCT03815240|4099830|FG002|COMPLETED|Intervention Allevyn Dressing||1
3224358|NCT02304380|3956517|FG001|NOT COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
3224359|NCT02304380|3956518|FG002|NOT COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
3224360|NCT02304380|3956519|FG003|NOT COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
3224361|NCT02304380|3956520|FG004|NOT COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
3224362|NCT02304380|3956521|FG005|NOT COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
3224363|NCT02304406|3956535|FG000|STARTED|Overall Study||449
3224364|NCT02304406|3956535|FG000|COMPLETED|Overall Study||449
3224365|NCT02304406|3956535|FG000|NOT COMPLETED|Overall Study||0
3224366|NCT02304432|3956539|FG000|STARTED|Open Label DCS||2
3224367|NCT02304432|3956540|FG001|STARTED|Open Label DCS||0
3224368|NCT02304432|3956541|FG002|STARTED|Open Label DCS||0
3224369|NCT02304432|3956542|FG003|STARTED|Open Label DCS||0
3224370|NCT02304432|3956539|FG000|COMPLETED|Open Label DCS||2
3224371|NCT02304432|3956540|FG001|COMPLETED|Open Label DCS||0
3224372|NCT02304432|3956541|FG002|COMPLETED|Open Label DCS||0
3224373|NCT02304432|3956542|FG003|COMPLETED|Open Label DCS||0
3224374|NCT02304432|3956539|FG000|NOT COMPLETED|Open Label DCS||0
3224375|NCT02304432|3956540|FG001|NOT COMPLETED|Open Label DCS||0
3224376|NCT02304432|3956541|FG002|NOT COMPLETED|Open Label DCS||0
3224377|NCT02304432|3956542|FG003|NOT COMPLETED|Open Label DCS||0
3224378|NCT02304432|3956539|FG000|STARTED|Double-Blind DCS Placebo Crossover||0
3224379|NCT02304432|3956540|FG001|STARTED|Double-Blind DCS Placebo Crossover||1
3224380|NCT02304432|3956541|FG002|STARTED|Double-Blind DCS Placebo Crossover||1
3224381|NCT02304432|3956542|FG003|STARTED|Double-Blind DCS Placebo Crossover||0
3224382|NCT02304432|3956539|FG000|COMPLETED|Double-Blind DCS Placebo Crossover||0
3224383|NCT02304432|3956540|FG001|COMPLETED|Double-Blind DCS Placebo Crossover||1
3224384|NCT02304432|3956541|FG002|COMPLETED|Double-Blind DCS Placebo Crossover||1
3224385|NCT02304432|3956542|FG003|COMPLETED|Double-Blind DCS Placebo Crossover||0
3224386|NCT02304432|3956539|FG000|NOT COMPLETED|Double-Blind DCS Placebo Crossover||0
3224387|NCT02304432|3956540|FG001|NOT COMPLETED|Double-Blind DCS Placebo Crossover||0
3224388|NCT02304432|3956541|FG002|NOT COMPLETED|Double-Blind DCS Placebo Crossover||0
3224389|NCT02304432|3956542|FG003|NOT COMPLETED|Double-Blind DCS Placebo Crossover||0
3224390|NCT02304432|3956539|FG000|STARTED|Second Open Label DCS||0
3224391|NCT02304432|3956540|FG001|STARTED|Second Open Label DCS||0
3224392|NCT02304432|3956541|FG002|STARTED|Second Open Label DCS||0
3224393|NCT02304432|3956542|FG003|STARTED|Second Open Label DCS||2
3224394|NCT02304432|3956539|FG000|COMPLETED|Second Open Label DCS||0
3224395|NCT02304432|3956540|FG001|COMPLETED|Second Open Label DCS||0
3224396|NCT02304432|3956541|FG002|COMPLETED|Second Open Label DCS||0
3224397|NCT02304432|3956542|FG003|COMPLETED|Second Open Label DCS||2
3224398|NCT02304432|3956539|FG000|NOT COMPLETED|Second Open Label DCS||0
3224399|NCT02304432|3956540|FG001|NOT COMPLETED|Second Open Label DCS||0
3224400|NCT02304432|3956541|FG002|NOT COMPLETED|Second Open Label DCS||0
3224401|NCT02304432|3956542|FG003|NOT COMPLETED|Second Open Label DCS||0
3224402|NCT02304484|3956557|FG000|STARTED|Overall Study||770
3224403|NCT02304484|3956557|FG000|COMPLETED|Overall Study||745
3224404|NCT02304484|3956557|FG000|NOT COMPLETED|Overall Study||25
3224405|NCT02304705|3956563|FG000|STARTED|Overall Study||16
3224406|NCT02304705|3956564|FG001|STARTED|Overall Study||17
3224407|NCT02304705|3956563|FG000|COMPLETED|Overall Study||12
3224408|NCT02304705|3956564|FG001|COMPLETED|Overall Study||10
3224409|NCT02304705|3956563|FG000|NOT COMPLETED|Overall Study||4
3224410|NCT02304705|3956564|FG001|NOT COMPLETED|Overall Study||7
3224411|NCT02304757|3956572|FG000|STARTED|Overall Study||70
3224412|NCT02304757|3956573|FG001|STARTED|Overall Study||72
3224413|NCT02304757|3956572|FG000|COMPLETED|Overall Study||70
3224414|NCT02304757|3956573|FG001|COMPLETED|Overall Study||72
3224415|NCT02304757|3956572|FG000|NOT COMPLETED|Overall Study||0
3224416|NCT02304757|3956573|FG001|NOT COMPLETED|Overall Study||0
3224417|NCT02304926|3956581|FG000|STARTED|Overall Study||22
3224418|NCT02304926|3956582|FG001|STARTED|Overall Study||20
3224419|NCT02304926|3956581|FG000|COMPLETED|Overall Study||20
3224420|NCT02304926|3956582|FG001|COMPLETED|Overall Study||19
3224421|NCT02304926|3956581|FG000|NOT COMPLETED|Overall Study||2
3224422|NCT02304926|3956582|FG001|NOT COMPLETED|Overall Study||1
3224423|NCT02305017|3956592|FG000|STARTED|Overall Study||14
3224424|NCT02305017|3956593|FG001|STARTED|Overall Study||14
3224425|NCT02305017|3956592|FG000|COMPLETED|Overall Study||14
3224426|NCT02305017|3956593|FG001|COMPLETED|Overall Study||14
3224427|NCT02305017|3956592|FG000|NOT COMPLETED|Overall Study||0
3224428|NCT02305017|3956593|FG001|NOT COMPLETED|Overall Study||0
3224429|NCT02305238|3956606|FG000|STARTED|Overall Study||124
3224430|NCT02305238|3956607|FG001|STARTED|Overall Study||123
3224431|NCT02305238|3956608|FG002|STARTED|Overall Study||8
3224432|NCT02305238|3956606|FG000|Treated|Overall Study||124
3224433|NCT02305238|3956607|FG001|Treated|Overall Study||123
3224434|NCT02305238|3956608|FG002|Treated|Overall Study||7
3224435|NCT02305238|3956606|FG000|Randomized|Overall Study||124
3224436|NCT02305238|3956607|FG001|Randomized|Overall Study||123
3224437|NCT02305238|3956608|FG002|Randomized|Overall Study||0
3224438|NCT02305238|3956606|FG000|BCVA Post-randomization Assessment|Overall Study||123
3224439|NCT02305238|3956607|FG001|BCVA Post-randomization Assessment|Overall Study||123
3224440|NCT02305238|3956608|FG002|BCVA Post-randomization Assessment|Overall Study||0
3224441|NCT02305238|3956606|FG000|COMPLETED|Overall Study||108
3224442|NCT02305238|3956607|FG001|COMPLETED|Overall Study||104
3224443|NCT02305238|3956608|FG002|COMPLETED|Overall Study||0
3224444|NCT02305238|3956606|FG000|NOT COMPLETED|Overall Study||16
3224445|NCT02305238|3956607|FG001|NOT COMPLETED|Overall Study||19
3224446|NCT02305238|3956608|FG002|NOT COMPLETED|Overall Study||8
3224447|NCT02305277|3956621|FG000|STARTED|Overall Study||15
3224448|NCT02305277|3956622|FG001|STARTED|Overall Study||14
3224449|NCT02305277|3956623|FG002|STARTED|Overall Study||14
3224450|NCT02305277|3956624|FG003|STARTED|Overall Study||14
3224451|NCT02305277|3956625|FG004|STARTED|Overall Study||14
3224452|NCT02305277|3956626|FG005|STARTED|Overall Study||14
3224453|NCT02305277|3956621|FG000|Received CM|Overall Study||15
3224454|NCT02305277|3956622|FG001|Received CM|Overall Study||14
3224455|NCT02305277|3956623|FG002|Received CM|Overall Study||14
3224456|NCT02305277|3956624|FG003|Received CM|Overall Study||14
3224457|NCT02305277|3956625|FG004|Received CM|Overall Study||14
3224458|NCT02305277|3956626|FG005|Received CM|Overall Study||14
3224459|NCT02305277|3956621|FG000|Received TBM|Overall Study||15
3224460|NCT02305277|3956622|FG001|Received TBM|Overall Study||14
3224461|NCT02305277|3956623|FG002|Received TBM|Overall Study||14
3224462|NCT02305277|3956624|FG003|Received TBM|Overall Study||14
3224463|NCT02305277|3956625|FG004|Received TBM|Overall Study||14
3224464|NCT02305277|3956626|FG005|Received TBM|Overall Study||14
3224465|NCT02305277|3956621|FG000|COMPLETED|Overall Study||14
3224466|NCT02305277|3956622|FG001|COMPLETED|Overall Study||14
3224467|NCT02305277|3956623|FG002|COMPLETED|Overall Study||14
3224468|NCT02305277|3956624|FG003|COMPLETED|Overall Study||14
3224469|NCT02305277|3956625|FG004|COMPLETED|Overall Study||13
3224470|NCT02305277|3956626|FG005|COMPLETED|Overall Study||14
3224471|NCT02305277|3956621|FG000|NOT COMPLETED|Overall Study||1
3224472|NCT02305277|3956622|FG001|NOT COMPLETED|Overall Study||0
3224473|NCT02305277|3956623|FG002|NOT COMPLETED|Overall Study||0
3224474|NCT02305277|3956624|FG003|NOT COMPLETED|Overall Study||0
3224475|NCT02305277|3956625|FG004|NOT COMPLETED|Overall Study||1
3224476|NCT02305277|3956626|FG005|NOT COMPLETED|Overall Study||0
3224477|NCT02305316|3956642|FG000|STARTED|Overall Study||14
3224478|NCT02305316|3956643|FG001|STARTED|Overall Study||14
3224479|NCT02305316|3956642|FG000|COMPLETED|Overall Study||14
3224480|NCT02305316|3956643|FG001|COMPLETED|Overall Study||14
3224481|NCT02305316|3956642|FG000|NOT COMPLETED|Overall Study||0
3224482|NCT02305316|3956643|FG001|NOT COMPLETED|Overall Study||0
3224483|NCT02305329|3956653|FG000|STARTED|Overall Study||14
3224484|NCT02305329|3956654|FG001|STARTED|Overall Study||14
3224485|NCT02305329|3956655|FG002|STARTED|Overall Study||14
3224486|NCT02305329|3956656|FG003|STARTED|Overall Study||14
3224487|NCT02305329|3956653|FG000|Period 1|Overall Study||14
3224488|NCT02305329|3956654|FG001|Period 1|Overall Study||14
3224489|NCT02305329|3956655|FG002|Period 1|Overall Study||14
3224490|NCT02305329|3956656|FG003|Period 1|Overall Study||14
3224491|NCT02305329|3956653|FG000|Period 2|Overall Study||14
3224492|NCT02305329|3956654|FG001|Period 2|Overall Study||13
3224493|NCT02305329|3956655|FG002|Period 2|Overall Study||14
3224494|NCT02305329|3956656|FG003|Period 2|Overall Study||14
3224495|NCT02305329|3956653|FG000|COMPLETED|Overall Study||14
3224496|NCT02305329|3956654|FG001|COMPLETED|Overall Study||13
3224497|NCT02305329|3956655|FG002|COMPLETED|Overall Study||14
3224498|NCT02305329|3956656|FG003|COMPLETED|Overall Study||14
3224499|NCT02305329|3956653|FG000|NOT COMPLETED|Overall Study||0
3224500|NCT02305329|3956654|FG001|NOT COMPLETED|Overall Study||1
3224501|NCT02305329|3956655|FG002|NOT COMPLETED|Overall Study||0
3224502|NCT02305329|3956656|FG003|NOT COMPLETED|Overall Study||0
3224503|NCT02305381|3956669|FG000|STARTED|Overall Study||132
3224504|NCT02305381|3956670|FG001|STARTED|Overall Study||132
3224505|NCT02305381|3956671|FG002|STARTED|Overall Study||133
3224506|NCT02305381|3956669|FG000|Exposed|Overall Study||132
3224507|NCT02305381|3956670|FG001|Exposed|Overall Study||131
3224508|NCT02305381|3956671|FG002|Exposed|Overall Study||133
3224509|NCT02305381|3956669|FG000|Premature Discontinuation of Treatment|Overall Study|Subjects who prematurely discontinued treatment were allowed to continue participation in the trial.|14
3224510|NCT02305381|3956670|FG001|Premature Discontinuation of Treatment|Overall Study|Subjects who prematurely discontinued treatment were allowed to continue participation in the trial|16
3224511|NCT02305381|3956671|FG002|Premature Discontinuation of Treatment|Overall Study|Subjects who prematurely discontinued treatment were allowed to continue participation in the trial.|13
3224512|NCT02305381|3956669|FG000|COMPLETED|Overall Study|Subjects who completed the trial.|127
3224513|NCT02305381|3956670|FG001|COMPLETED|Overall Study|Subjects who completed the trial.|127
3224514|NCT02305381|3956671|FG002|COMPLETED|Overall Study|Subjects who completed the trial.|126
3224515|NCT02305381|3956669|FG000|NOT COMPLETED|Overall Study||5
3224516|NCT02305381|3956670|FG001|NOT COMPLETED|Overall Study||5
3224517|NCT02305381|3956671|FG002|NOT COMPLETED|Overall Study||7
3224518|NCT02305446|3956679|FG000|STARTED|Overall Study||55
3224519|NCT02305446|3956679|FG000|COMPLETED|Overall Study||54
3224520|NCT02305446|3956679|FG000|NOT COMPLETED|Overall Study||1
3224521|NCT02305563|3956688|FG000|STARTED|Treatment Period||3
3224522|NCT02305563|3956689|FG001|STARTED|Treatment Period||3
3224523|NCT02305563|3956690|FG002|STARTED|Treatment Period||26
3224524|NCT02305563|3956691|FG003|STARTED|Treatment Period||14
3224525|NCT02305563|3956692|FG004|STARTED|Treatment Period||24
3224526|NCT02305563|3956688|FG000|COMPLETED|Treatment Period|At the time of the Phase 1 lock, 1 participant was still continuing on treatment|1
3224527|NCT02305563|3956689|FG001|COMPLETED|Treatment Period|At the time of the Phase 1 lock, 1 participant was still continuing on treatment|1
3224528|NCT02305563|3956690|FG002|COMPLETED|Treatment Period||0
3224529|NCT02305563|3956691|FG003|COMPLETED|Treatment Period||0
3224530|NCT02305563|3956692|FG004|COMPLETED|Treatment Period||0
3224531|NCT02305563|3956688|FG000|NOT COMPLETED|Treatment Period||2
3224532|NCT02305563|3956689|FG001|NOT COMPLETED|Treatment Period||2
3224533|NCT02305563|3956690|FG002|NOT COMPLETED|Treatment Period||26
3224534|NCT02305563|3956691|FG003|NOT COMPLETED|Treatment Period||14
3224535|NCT02305563|3956692|FG004|NOT COMPLETED|Treatment Period||24
3224536|NCT02305563|3956688|FG000|STARTED|Follow-up Period||3
3224537|NCT02305563|3956689|FG001|STARTED|Follow-up Period||3
3224538|NCT02305563|3956690|FG002|STARTED|Follow-up Period||11
3224539|NCT02305563|3956691|FG003|STARTED|Follow-up Period||6
3224540|NCT02305563|3956692|FG004|STARTED|Follow-up Period||12
3224541|NCT02305563|3956688|FG000|COMPLETED|Follow-up Period||0
3224542|NCT02305563|3956689|FG001|COMPLETED|Follow-up Period||0
3368253|NCT03815240|4099831|FG003|COMPLETED|Intervention Allevyn Dressing||2
3368254|NCT03815240|4099832|FG004|COMPLETED|Intervention Allevyn Dressing||1
3368255|NCT03815240|4099833|FG005|COMPLETED|Intervention Allevyn Dressing||2
3368256|NCT03815240|4099834|FG006|COMPLETED|Intervention Allevyn Dressing||1
3368257|NCT03815240|4099835|FG007|COMPLETED|Intervention Allevyn Dressing||1
3368258|NCT03815240|4099836|FG008|COMPLETED|Intervention Allevyn Dressing||1
3368259|NCT03815240|4099828|FG000|NOT COMPLETED|Intervention Allevyn Dressing||0
3368260|NCT03815240|4099829|FG001|NOT COMPLETED|Intervention Allevyn Dressing||0
3368261|NCT03815240|4099830|FG002|NOT COMPLETED|Intervention Allevyn Dressing||0
3368262|NCT03815240|4099831|FG003|NOT COMPLETED|Intervention Allevyn Dressing||0
3368263|NCT03815240|4099832|FG004|NOT COMPLETED|Intervention Allevyn Dressing||0
3368264|NCT03815240|4099833|FG005|NOT COMPLETED|Intervention Allevyn Dressing||0
3368265|NCT03815240|4099834|FG006|NOT COMPLETED|Intervention Allevyn Dressing||0
3368266|NCT03815240|4099835|FG007|NOT COMPLETED|Intervention Allevyn Dressing||0
3368267|NCT03815240|4099836|FG008|NOT COMPLETED|Intervention Allevyn Dressing||0
3368268|NCT03815240|4099828|FG000|STARTED|Intervention Optifoam Dressing||2
3368269|NCT03815240|4099829|FG001|STARTED|Intervention Optifoam Dressing||1
3368270|NCT03815240|4099830|FG002|STARTED|Intervention Optifoam Dressing||1
3368271|NCT03815240|4099831|FG003|STARTED|Intervention Optifoam Dressing||2
3368272|NCT03815240|4099832|FG004|STARTED|Intervention Optifoam Dressing||1
3368273|NCT03815240|4099833|FG005|STARTED|Intervention Optifoam Dressing||2
3368274|NCT03815240|4099834|FG006|STARTED|Intervention Optifoam Dressing||1
3368275|NCT03815240|4099835|FG007|STARTED|Intervention Optifoam Dressing||1
3368276|NCT03815240|4099836|FG008|STARTED|Intervention Optifoam Dressing||1
3368277|NCT03815240|4099828|FG000|COMPLETED|Intervention Optifoam Dressing||2
3368278|NCT03815240|4099829|FG001|COMPLETED|Intervention Optifoam Dressing||1
3368279|NCT03815240|4099830|FG002|COMPLETED|Intervention Optifoam Dressing||1
3368280|NCT03815240|4099831|FG003|COMPLETED|Intervention Optifoam Dressing||2
3368281|NCT03815240|4099832|FG004|COMPLETED|Intervention Optifoam Dressing||1
3368282|NCT03815240|4099833|FG005|COMPLETED|Intervention Optifoam Dressing||2
3368283|NCT03815240|4099834|FG006|COMPLETED|Intervention Optifoam Dressing||1
3368284|NCT03815240|4099835|FG007|COMPLETED|Intervention Optifoam Dressing||1
3368285|NCT03815240|4099836|FG008|COMPLETED|Intervention Optifoam Dressing||1
3368286|NCT03815240|4099828|FG000|NOT COMPLETED|Intervention Optifoam Dressing||0
3368287|NCT03815240|4099829|FG001|NOT COMPLETED|Intervention Optifoam Dressing||0
3368288|NCT03815240|4099830|FG002|NOT COMPLETED|Intervention Optifoam Dressing||0
3368289|NCT03815240|4099831|FG003|NOT COMPLETED|Intervention Optifoam Dressing||0
3368290|NCT03815240|4099832|FG004|NOT COMPLETED|Intervention Optifoam Dressing||0
3368291|NCT03815240|4099833|FG005|NOT COMPLETED|Intervention Optifoam Dressing||0
3368292|NCT03815240|4099834|FG006|NOT COMPLETED|Intervention Optifoam Dressing||0
3368293|NCT03815240|4099835|FG007|NOT COMPLETED|Intervention Optifoam Dressing||0
3368294|NCT03815240|4099836|FG008|NOT COMPLETED|Intervention Optifoam Dressing||0
3368295|NCT03836859|4099854|FG000|STARTED|Overall Study||20
3368296|NCT03836859|4099855|FG001|STARTED|Overall Study||10
3368297|NCT03836859|4099854|FG000|COMPLETED|Overall Study||20
3368298|NCT03836859|4099855|FG001|COMPLETED|Overall Study||10
3368299|NCT03836859|4099854|FG000|NOT COMPLETED|Overall Study||0
3368300|NCT03836859|4099855|FG001|NOT COMPLETED|Overall Study||0
3368301|NCT03835078|4099861|FG000|STARTED|Overall Study||39
3368302|NCT03835078|4099861|FG000|COMPLETED|Overall Study||39
3368303|NCT03835078|4099861|FG000|NOT COMPLETED|Overall Study||0
3224543|NCT02305563|3956690|FG002|COMPLETED|Follow-up Period||0
3224544|NCT02305563|3956691|FG003|COMPLETED|Follow-up Period||0
3224545|NCT02305563|3956692|FG004|COMPLETED|Follow-up Period||0
3224546|NCT02305563|3956688|FG000|NOT COMPLETED|Follow-up Period||3
3224547|NCT02305563|3956689|FG001|NOT COMPLETED|Follow-up Period||3
3224548|NCT02305563|3956690|FG002|NOT COMPLETED|Follow-up Period||11
3224549|NCT02305563|3956691|FG003|NOT COMPLETED|Follow-up Period||6
3224550|NCT02305563|3956692|FG004|NOT COMPLETED|Follow-up Period||12
3224551|NCT02305732|3956708|FG000|STARTED|Overall Study||90
3224552|NCT02305732|3956708|FG000|COMPLETED|Overall Study||72
3224553|NCT02305732|3956708|FG000|NOT COMPLETED|Overall Study||18
3224554|NCT02305758|3956715|FG000|STARTED|Overall Study||65
3224555|NCT02305758|3956716|FG001|STARTED|Overall Study||65
3224556|NCT02305758|3956715|FG000|COMPLETED|Overall Study||0
3224557|NCT02305758|3956716|FG001|COMPLETED|Overall Study||0
3224558|NCT02305758|3956715|FG000|NOT COMPLETED|Overall Study||65
3224559|NCT02305758|3956716|FG001|NOT COMPLETED|Overall Study||65
3224560|NCT02305797|3956724|FG000|STARTED|Overall Study||247
3224561|NCT02305797|3956725|FG001|STARTED|Overall Study||248
3224562|NCT02305797|3956724|FG000|COMPLETED|Overall Study||202
3224563|NCT02305797|3956725|FG001|COMPLETED|Overall Study||210
3224564|NCT02305797|3956724|FG000|NOT COMPLETED|Overall Study||45
3224565|NCT02305797|3956725|FG001|NOT COMPLETED|Overall Study||38
3224566|NCT02305849|3956734|FG000|STARTED|Overall Study||175
3224567|NCT02305849|3956735|FG001|STARTED|Overall Study||174
3224568|NCT02305849|3956736|FG002|STARTED|Overall Study||85
3224569|NCT02305849|3956737|FG003|STARTED|Overall Study||85
3224570|NCT02305849|3956734|FG000|COMPLETED|Overall Study||148
3224571|NCT02305849|3956735|FG001|COMPLETED|Overall Study||146
3224572|NCT02305849|3956736|FG002|COMPLETED|Overall Study||67
3224573|NCT02305849|3956737|FG003|COMPLETED|Overall Study||66
3224574|NCT02305849|3956734|FG000|NOT COMPLETED|Overall Study||27
3224575|NCT02305849|3956735|FG001|NOT COMPLETED|Overall Study||28
3224576|NCT02305849|3956736|FG002|NOT COMPLETED|Overall Study||18
3224577|NCT02305849|3956737|FG003|NOT COMPLETED|Overall Study||19
3224578|NCT02305888|3956771|FG000|STARTED|Overall Study||63
3224579|NCT02305888|3956772|FG001|STARTED|Overall Study||63
3224580|NCT02305888|3956773|FG002|STARTED|Overall Study||63
3224581|NCT02305888|3956771|FG000|COMPLETED|Overall Study||63
3224582|NCT02305888|3956772|FG001|COMPLETED|Overall Study||62
3224583|NCT02305888|3956773|FG002|COMPLETED|Overall Study||62
3224584|NCT02305888|3956771|FG000|NOT COMPLETED|Overall Study||0
3224585|NCT02305888|3956772|FG001|NOT COMPLETED|Overall Study||1
3224586|NCT02305888|3956773|FG002|NOT COMPLETED|Overall Study||1
3224587|NCT02306265|3956781|FG000|STARTED|Overall Study||250
3224588|NCT02306265|3956781|FG000|COMPLETED|Overall Study||249
3224589|NCT02306265|3956781|FG000|NOT COMPLETED|Overall Study||1
3224590|NCT02306694|3956786|FG000|STARTED|Overall Study||16
3224591|NCT02306694|3956786|FG000|COMPLETED|Overall Study||12
3224592|NCT02306694|3956786|FG000|NOT COMPLETED|Overall Study||4
3224593|NCT02306759|3956792|FG000|STARTED|Overall Study||30
3224594|NCT02306759|3956793|FG001|STARTED|Overall Study||30
3224595|NCT02306759|3956792|FG000|COMPLETED|Overall Study||30
3224596|NCT02306759|3956793|FG001|COMPLETED|Overall Study||30
3224597|NCT02306759|3956792|FG000|NOT COMPLETED|Overall Study||0
3224598|NCT02306759|3956793|FG001|NOT COMPLETED|Overall Study||0
3224599|NCT02306850|3956801|FG000|STARTED|Overall Study||10
3224600|NCT02306850|3956801|FG000|COMPLETED|Overall Study||8
3224601|NCT02306850|3956801|FG000|NOT COMPLETED|Overall Study||2
3224602|NCT02306928|3956806|FG000|STARTED|Overall Study||15
3224603|NCT02306928|3956806|FG000|COMPLETED|Overall Study||15
3224604|NCT02306928|3956806|FG000|NOT COMPLETED|Overall Study||0
3224605|NCT02307123|3956810|FG000|STARTED|Overall Study||483
3224606|NCT02307123|3956810|FG000|COMPLETED|Overall Study||483
3224607|NCT02307123|3956810|FG000|NOT COMPLETED|Overall Study||0
3224608|NCT02307266|3956817|FG000|STARTED|Overall Study||33
3224609|NCT02307266|3956818|FG001|STARTED|Overall Study||33
3224610|NCT02307266|3956819|FG002|STARTED|Overall Study||31
3224611|NCT02307266|3956817|FG000|COMPLETED|Overall Study||25
3224612|NCT02307266|3956818|FG001|COMPLETED|Overall Study||32
3224613|NCT02307266|3956819|FG002|COMPLETED|Overall Study||25
3224614|NCT02307266|3956817|FG000|NOT COMPLETED|Overall Study||8
3224615|NCT02307266|3956818|FG001|NOT COMPLETED|Overall Study||1
3224616|NCT02307266|3956819|FG002|NOT COMPLETED|Overall Study||6
3224617|NCT02307318|3956827|FG000|STARTED|Overall Study||51
3224618|NCT02307318|3956827|FG000|COMPLETED|Overall Study||51
3224619|NCT02307318|3956827|FG000|NOT COMPLETED|Overall Study||0
3224620|NCT02307370|3956831|FG000|STARTED|Overall Study||44
3224621|NCT02307370|3956831|FG000|30 Day Follow-up|Overall Study||40
3224622|NCT02307370|3956831|FG000|180 Day Patient Telephone Contact|Overall Study||25
3224623|NCT02307370|3956831|FG000|COMPLETED|Overall Study||25
3224624|NCT02307370|3956831|FG000|NOT COMPLETED|Overall Study||19
3224625|NCT02307513|3956839|FG000|STARTED|Placebo Controlled Phase (Weeks 0-12)||103
3224626|NCT02307513|3956840|FG001|STARTED|Placebo Controlled Phase (Weeks 0-12)||104
3224627|NCT02307513|3956839|FG000|COMPLETED|Placebo Controlled Phase (Weeks 0-12)||83
3224628|NCT02307513|3956840|FG001|COMPLETED|Placebo Controlled Phase (Weeks 0-12)||96
3224629|NCT02307513|3956839|FG000|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-12)||20
3224630|NCT02307513|3956840|FG001|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-12)||8
3224631|NCT02307513|3956839|FG000|STARTED|Active Treatment Phase (Weeks 13-64)||83
3224632|NCT02307513|3956840|FG001|STARTED|Active Treatment Phase (Weeks 13-64)|1 participant completed Week 12; did not enter into active treatment|95
3224633|NCT02307513|3956839|FG000|COMPLETED|Active Treatment Phase (Weeks 13-64)||68
3224634|NCT02307513|3956840|FG001|COMPLETED|Active Treatment Phase (Weeks 13-64)||75
3224635|NCT02307513|3956839|FG000|NOT COMPLETED|Active Treatment Phase (Weeks 13-64)||15
3224636|NCT02307513|3956840|FG001|NOT COMPLETED|Active Treatment Phase (Weeks 13-64)||20
3224637|NCT02307513|3956839|FG000|STARTED|Long-term Extension||2
3224638|NCT02307513|3956840|FG001|STARTED|Long-term Extension||0
3224639|NCT02307513|3956839|FG000|COMPLETED|Long-term Extension||1
3224640|NCT02307513|3956840|FG001|COMPLETED|Long-term Extension||0
3224641|NCT02307513|3956839|FG000|NOT COMPLETED|Long-term Extension||1
3224642|NCT02307513|3956840|FG001|NOT COMPLETED|Long-term Extension||0
3224643|NCT02307526|3956850|FG000|STARTED|Day 1 - No Drug||10
3224644|NCT02307526|3956850|FG000|COMPLETED|Day 1 - No Drug||10
3224645|NCT02307526|3956850|FG000|NOT COMPLETED|Day 1 - No Drug||0
3224646|NCT02307526|3956850|FG000|STARTED|Day 2 - 60 mg of Pyridostigmine||10
3224647|NCT02307526|3956850|FG000|COMPLETED|Day 2 - 60 mg of Pyridostigmine||10
3224648|NCT02307526|3956850|FG000|NOT COMPLETED|Day 2 - 60 mg of Pyridostigmine||0
3224649|NCT02307552|3956856|FG000|STARTED|Overall Study||1
3224650|NCT02307552|3956856|FG000|COMPLETED|Overall Study||1
3224651|NCT02307552|3956856|FG000|NOT COMPLETED|Overall Study||0
3224652|NCT02307682|3956863|FG000|STARTED|Overall Study||360
3224653|NCT02307682|3956864|FG001|STARTED|Overall Study||361
3224654|NCT02307682|3956865|FG002|STARTED|Overall Study||361
3224655|NCT02307682|3956863|FG000|Randomized and Treated|Overall Study||358
3224656|NCT02307682|3956864|FG001|Randomized and Treated|Overall Study||360
3224657|NCT02307682|3956865|FG002|Randomized and Treated|Overall Study||360
3224658|NCT02307682|3956863|FG000|COMPLETED|Overall Study||310
3224659|NCT02307682|3956864|FG001|COMPLETED|Overall Study||304
3224660|NCT02307682|3956865|FG002|COMPLETED|Overall Study||297
3224661|NCT02307682|3956863|FG000|NOT COMPLETED|Overall Study||50
3224662|NCT02307682|3956864|FG001|NOT COMPLETED|Overall Study||57
3224663|NCT02307682|3956865|FG002|NOT COMPLETED|Overall Study||64
3368304|NCT03834025|4099874|FG000|STARTED|Sent Recruitment Letter (Phase 1)||4150
3368305|NCT03834025|4099875|FG001|STARTED|Sent Recruitment Letter (Phase 1)||3871
3368306|NCT03834025|4099876|FG002|STARTED|Sent Recruitment Letter (Phase 1)||4121
3368307|NCT03834025|4099877|FG003|STARTED|Sent Recruitment Letter (Phase 1)||3693
3368308|NCT03834025|4099878|FG004|STARTED|Sent Recruitment Letter (Phase 1)||0
3368309|NCT03834025|4099879|FG005|STARTED|Sent Recruitment Letter (Phase 1)||0
3368310|NCT03834025|4099880|FG006|STARTED|Sent Recruitment Letter (Phase 1)||0
3368311|NCT03834025|4099874|FG000|Sent Letter|Sent Recruitment Letter (Phase 1)||4150
3368312|NCT03834025|4099875|FG001|Sent Letter|Sent Recruitment Letter (Phase 1)||3871
3368313|NCT03834025|4099876|FG002|Sent Letter|Sent Recruitment Letter (Phase 1)||4121
3368314|NCT03834025|4099877|FG003|Sent Letter|Sent Recruitment Letter (Phase 1)||3693
3368315|NCT03834025|4099878|FG004|Sent Letter|Sent Recruitment Letter (Phase 1)||0
3368316|NCT03834025|4099879|FG005|Sent Letter|Sent Recruitment Letter (Phase 1)||0
3368317|NCT03834025|4099880|FG006|Sent Letter|Sent Recruitment Letter (Phase 1)||0
3368318|NCT03834025|4099874|FG000|Responded to Letter|Sent Recruitment Letter (Phase 1)||36
3368319|NCT03834025|4099875|FG001|Responded to Letter|Sent Recruitment Letter (Phase 1)||36
3368320|NCT03834025|4099876|FG002|Responded to Letter|Sent Recruitment Letter (Phase 1)||44
3368321|NCT03834025|4099877|FG003|Responded to Letter|Sent Recruitment Letter (Phase 1)||44
3368322|NCT03834025|4099878|FG004|Responded to Letter|Sent Recruitment Letter (Phase 1)||0
3368323|NCT03834025|4099879|FG005|Responded to Letter|Sent Recruitment Letter (Phase 1)||0
3368324|NCT03834025|4099880|FG006|Responded to Letter|Sent Recruitment Letter (Phase 1)||0
3368325|NCT03834025|4099874|FG000|COMPLETED|Sent Recruitment Letter (Phase 1)||36
3368326|NCT03834025|4099875|FG001|COMPLETED|Sent Recruitment Letter (Phase 1)||36
3368327|NCT03834025|4099876|FG002|COMPLETED|Sent Recruitment Letter (Phase 1)||44
3368328|NCT03834025|4099877|FG003|COMPLETED|Sent Recruitment Letter (Phase 1)||44
3368329|NCT03834025|4099878|FG004|COMPLETED|Sent Recruitment Letter (Phase 1)||0
3368330|NCT03834025|4099879|FG005|COMPLETED|Sent Recruitment Letter (Phase 1)||0
3368331|NCT03834025|4099880|FG006|COMPLETED|Sent Recruitment Letter (Phase 1)||0
3368332|NCT03834025|4099874|FG000|NOT COMPLETED|Sent Recruitment Letter (Phase 1)||4114
3368333|NCT03834025|4099875|FG001|NOT COMPLETED|Sent Recruitment Letter (Phase 1)||3835
3368334|NCT03834025|4099876|FG002|NOT COMPLETED|Sent Recruitment Letter (Phase 1)||4077
3368335|NCT03834025|4099877|FG003|NOT COMPLETED|Sent Recruitment Letter (Phase 1)||3649
3368336|NCT03834025|4099878|FG004|NOT COMPLETED|Sent Recruitment Letter (Phase 1)||0
3368337|NCT03834025|4099879|FG005|NOT COMPLETED|Sent Recruitment Letter (Phase 1)||0
3368338|NCT03834025|4099880|FG006|NOT COMPLETED|Sent Recruitment Letter (Phase 1)||0
3368339|NCT03834025|4099874|FG000|STARTED|Randomized to Payment Condition(Phase 2)||0
3368340|NCT03834025|4099875|FG001|STARTED|Randomized to Payment Condition(Phase 2)||0
3368341|NCT03834025|4099876|FG002|STARTED|Randomized to Payment Condition(Phase 2)||0
3368342|NCT03834025|4099877|FG003|STARTED|Randomized to Payment Condition(Phase 2)||0
3368343|NCT03834025|4099878|FG004|STARTED|Randomized to Payment Condition(Phase 2)||24
3368344|NCT03834025|4099879|FG005|STARTED|Randomized to Payment Condition(Phase 2)||21
3368345|NCT03834025|4099880|FG006|STARTED|Randomized to Payment Condition(Phase 2)||28
3368346|NCT03834025|4099874|FG000|COMPLETED|Randomized to Payment Condition(Phase 2)||0
3368347|NCT03834025|4099875|FG001|COMPLETED|Randomized to Payment Condition(Phase 2)||0
3368348|NCT03834025|4099876|FG002|COMPLETED|Randomized to Payment Condition(Phase 2)||0
3368349|NCT03834025|4099877|FG003|COMPLETED|Randomized to Payment Condition(Phase 2)||0
3368350|NCT03834025|4099878|FG004|COMPLETED|Randomized to Payment Condition(Phase 2)||24
3368351|NCT03834025|4099879|FG005|COMPLETED|Randomized to Payment Condition(Phase 2)||21
3224664|NCT02307838|3956876|FG000|STARTED|Overall Study||56
3224665|NCT02307838|3956877|FG001|STARTED|Overall Study||64
3224666|NCT02307838|3956878|FG002|STARTED|Overall Study||55
3224667|NCT02307838|3956876|FG000|COMPLETED|Overall Study||56
3224668|NCT02307838|3956877|FG001|COMPLETED|Overall Study||64
3224669|NCT02307838|3956878|FG002|COMPLETED|Overall Study||55
3224670|NCT02307838|3956876|FG000|NOT COMPLETED|Overall Study||0
3224671|NCT02307838|3956877|FG001|NOT COMPLETED|Overall Study||0
3224672|NCT02307838|3956878|FG002|NOT COMPLETED|Overall Study||0
3224673|NCT02307916|3956889|FG000|STARTED|Overall Study||42
3224674|NCT02307916|3956890|FG001|STARTED|Overall Study||15
3224675|NCT02307916|3956889|FG000|COMPLETED|Overall Study||40
3224676|NCT02307916|3956890|FG001|COMPLETED|Overall Study||14
3224677|NCT02307916|3956889|FG000|NOT COMPLETED|Overall Study||2
3224678|NCT02307916|3956890|FG001|NOT COMPLETED|Overall Study||1
3224679|NCT02308007|3956899|FG000|STARTED|Overall Study||159
3224680|NCT02308007|3956900|FG001|STARTED|Overall Study||159
3224681|NCT02308007|3956901|FG002|STARTED|Overall Study||157
3224682|NCT02308007|3956899|FG000|COMPLETED|Overall Study||83
3224683|NCT02308007|3956900|FG001|COMPLETED|Overall Study||84
3224684|NCT02308007|3956901|FG002|COMPLETED|Overall Study||82
3224685|NCT02308007|3956899|FG000|NOT COMPLETED|Overall Study||76
3224686|NCT02308007|3956900|FG001|NOT COMPLETED|Overall Study||75
3224687|NCT02308007|3956901|FG002|NOT COMPLETED|Overall Study||75
3224688|NCT02308020|3956915|FG000|STARTED|Overall Study||27
3224689|NCT02308020|3956916|FG001|STARTED|Overall Study||58
3224690|NCT02308020|3956917|FG002|STARTED|Overall Study||9
3224691|NCT02308020|3956918|FG003|STARTED|Overall Study||28
3224692|NCT02308020|3956919|FG004|STARTED|Overall Study||23
3224693|NCT02308020|3956920|FG005|STARTED|Overall Study||17
3224694|NCT02308020|3956915|FG000|Received at Least One Dose of Study Drug|Overall Study||27
3224695|NCT02308020|3956916|FG001|Received at Least One Dose of Study Drug|Overall Study||58
3224696|NCT02308020|3956917|FG002|Received at Least One Dose of Study Drug|Overall Study||9
3224697|NCT02308020|3956918|FG003|Received at Least One Dose of Study Drug|Overall Study||28
3224698|NCT02308020|3956919|FG004|Received at Least One Dose of Study Drug|Overall Study||23
3224699|NCT02308020|3956920|FG005|Received at Least One Dose of Study Drug|Overall Study||17
3224700|NCT02308020|3956915|FG000|COMPLETED|Overall Study||23
3224701|NCT02308020|3956916|FG001|COMPLETED|Overall Study||38
3224702|NCT02308020|3956917|FG002|COMPLETED|Overall Study||6
3224703|NCT02308020|3956918|FG003|COMPLETED|Overall Study||24
3224704|NCT02308020|3956919|FG004|COMPLETED|Overall Study||19
3224705|NCT02308020|3956920|FG005|COMPLETED|Overall Study||12
3224706|NCT02308020|3956915|FG000|NOT COMPLETED|Overall Study||4
3224707|NCT02308020|3956916|FG001|NOT COMPLETED|Overall Study||20
3224708|NCT02308020|3956917|FG002|NOT COMPLETED|Overall Study||3
3224709|NCT02308020|3956918|FG003|NOT COMPLETED|Overall Study||4
3224710|NCT02308020|3956919|FG004|NOT COMPLETED|Overall Study||4
3224711|NCT02308020|3956920|FG005|NOT COMPLETED|Overall Study||5
3224712|NCT02308033|3956942|FG000|STARTED|Overall Study||102
3224713|NCT02308033|3956943|FG001|STARTED|Overall Study||102
3224714|NCT02308033|3956942|FG000|COMPLETED|Overall Study||76
3224715|NCT02308033|3956943|FG001|COMPLETED|Overall Study||83
3224716|NCT02308033|3956942|FG000|NOT COMPLETED|Overall Study||26
3224717|NCT02308033|3956943|FG001|NOT COMPLETED|Overall Study||19
3224718|NCT02308046|3956951|FG000|STARTED|Overall Study||107
3224719|NCT02308046|3956952|FG001|STARTED|Overall Study||105
3224720|NCT02308046|3956951|FG000|COMPLETED|Overall Study||73
3224721|NCT02308046|3956952|FG001|COMPLETED|Overall Study||67
3224722|NCT02308046|3956951|FG000|NOT COMPLETED|Overall Study||34
3224723|NCT02308046|3956952|FG001|NOT COMPLETED|Overall Study||38
3224724|NCT02308124|3956961|FG000|STARTED|Overall Study||29
3224725|NCT02308124|3956962|FG001|STARTED|Overall Study||29
3224726|NCT02308124|3956963|FG002|STARTED|Overall Study||29
3224727|NCT02308124|3956961|FG000|COMPLETED|Overall Study||23
3224728|NCT02308124|3956962|FG001|COMPLETED|Overall Study||21
3224729|NCT02308124|3956963|FG002|COMPLETED|Overall Study||21
3224730|NCT02308124|3956961|FG000|NOT COMPLETED|Overall Study||6
3224731|NCT02308124|3956962|FG001|NOT COMPLETED|Overall Study||8
3224732|NCT02308124|3956963|FG002|NOT COMPLETED|Overall Study||8
3224733|NCT02308163|3956975|FG000|STARTED|Overall Study||104
3224734|NCT02308163|3956976|FG001|STARTED|Overall Study||102
3224735|NCT02308163|3956977|FG002|STARTED|Overall Study||50
3224736|NCT02308163|3956978|FG003|STARTED|Overall Study||52
3224737|NCT02308163|3956979|FG004|STARTED|Overall Study||201
3224738|NCT02308163|3956975|FG000|COMPLETED|Overall Study||73
3224739|NCT02308163|3956976|FG001|COMPLETED|Overall Study||84
3224740|NCT02308163|3956977|FG002|COMPLETED|Overall Study||36
3224741|NCT02308163|3956978|FG003|COMPLETED|Overall Study||39
3224742|NCT02308163|3956979|FG004|COMPLETED|Overall Study||167
3224743|NCT02308163|3956975|FG000|NOT COMPLETED|Overall Study||31
3224744|NCT02308163|3956976|FG001|NOT COMPLETED|Overall Study||18
3224745|NCT02308163|3956977|FG002|NOT COMPLETED|Overall Study||14
3224746|NCT02308163|3956978|FG003|NOT COMPLETED|Overall Study||13
3224747|NCT02308163|3956979|FG004|NOT COMPLETED|Overall Study||34
3224748|NCT02308189|3957008|FG000|STARTED|Overall Study||17
3224749|NCT02308189|3957009|FG001|STARTED|Overall Study||15
3224750|NCT02308189|3957008|FG000|COMPLETED|Overall Study||16
3224751|NCT02308189|3957009|FG001|COMPLETED|Overall Study||14
3224752|NCT02308189|3957008|FG000|NOT COMPLETED|Overall Study||1
3224753|NCT02308189|3957009|FG001|NOT COMPLETED|Overall Study||1
3224754|NCT02308228|3957017|FG000|STARTED|Overall Study||54
3224755|NCT02308228|3957018|FG001|STARTED|Overall Study||55
3224756|NCT02308228|3957017|FG000|COMPLETED|Overall Study||46
3224757|NCT02308228|3957018|FG001|COMPLETED|Overall Study||48
3224758|NCT02308228|3957017|FG000|NOT COMPLETED|Overall Study||8
3224759|NCT02308228|3957018|FG001|NOT COMPLETED|Overall Study||7
3224760|NCT02308371|3957026|FG000|STARTED|Overall Study|Started enrollment and recruitment 11/26/2014|50
3224761|NCT02308371|3957027|FG001|STARTED|Overall Study|Consider eligible for retrospective enrollment if admitted after 4/1/2012|50
3224762|NCT02308371|3957026|FG000|COMPLETED|Overall Study|Ended enrollment and recruitment 3/1/2016|50
3224763|NCT02308371|3957027|FG001|COMPLETED|Overall Study|Consider eligible for retrospective enrollment if admitted up until 10/15/2012|50
3224764|NCT02308371|3957026|FG000|NOT COMPLETED|Overall Study||0
3224765|NCT02308371|3957027|FG001|NOT COMPLETED|Overall Study||0
3224766|NCT02308501|3957037|FG000|STARTED|Overall Study|25 participants received one drop of Lastacaft in one eye and Tears Naturale in the other eye.|25
3224767|NCT02308501|3957038|FG001|STARTED|Overall Study||25
3224768|NCT02308501|3957037|FG000|Randomized Participant Eyes|Overall Study||25
3224769|NCT02308501|3957038|FG001|Randomized Participant Eyes|Overall Study||25
3224770|NCT02308501|3957037|FG000|COMPLETED|Overall Study||25
3224771|NCT02308501|3957038|FG001|COMPLETED|Overall Study||25
3224772|NCT02308501|3957037|FG000|NOT COMPLETED|Overall Study||0
3224773|NCT02308501|3957038|FG001|NOT COMPLETED|Overall Study||0
3224774|NCT02308540|3957056|FG000|STARTED|Overall Study||17
3224775|NCT02308540|3957057|FG001|STARTED|Overall Study||17
3224776|NCT02308540|3957058|FG002|STARTED|Overall Study||56
3224777|NCT02308540|3957059|FG003|STARTED|Overall Study||56
3224778|NCT02308540|3957060|FG004|STARTED|Overall Study||100
3224779|NCT02308540|3957061|FG005|STARTED|Overall Study||100
3224780|NCT02308540|3957056|FG000|Randomized|Overall Study||17
3224781|NCT02308540|3957057|FG001|Randomized|Overall Study||17
3224782|NCT02308540|3957058|FG002|Randomized|Overall Study||56
3224783|NCT02308540|3957059|FG003|Randomized|Overall Study||56
3224784|NCT02308540|3957060|FG004|Randomized|Overall Study||100
3224785|NCT02308540|3957061|FG005|Randomized|Overall Study||100
3224786|NCT02308540|3957056|FG000|Vaccinated|Overall Study||17
3224787|NCT02308540|3957057|FG001|Vaccinated|Overall Study||17
3224788|NCT02308540|3957058|FG002|Vaccinated|Overall Study||56
3224789|NCT02308540|3957059|FG003|Vaccinated|Overall Study||56
3224790|NCT02308540|3957060|FG004|Vaccinated|Overall Study||100
3224791|NCT02308540|3957061|FG005|Vaccinated|Overall Study||100
3224792|NCT02308540|3957056|FG000|COMPLETED|Overall Study||17
3224793|NCT02308540|3957057|FG001|COMPLETED|Overall Study||17
3224794|NCT02308540|3957058|FG002|COMPLETED|Overall Study||56
3224795|NCT02308540|3957059|FG003|COMPLETED|Overall Study||56
3224796|NCT02308540|3957060|FG004|COMPLETED|Overall Study||100
3224797|NCT02308540|3957061|FG005|COMPLETED|Overall Study||99
3224798|NCT02308540|3957056|FG000|NOT COMPLETED|Overall Study||0
3224799|NCT02308540|3957057|FG001|NOT COMPLETED|Overall Study||0
3224800|NCT02308540|3957058|FG002|NOT COMPLETED|Overall Study||0
3224801|NCT02308540|3957059|FG003|NOT COMPLETED|Overall Study||0
3224802|NCT02308540|3957060|FG004|NOT COMPLETED|Overall Study||0
3224803|NCT02308540|3957061|FG005|NOT COMPLETED|Overall Study||1
3224804|NCT02308696|3957112|FG000|STARTED|Overall Study||222
3224805|NCT02308696|3957113|FG001|STARTED|Overall Study||234
3224806|NCT02308696|3957112|FG000|COMPLETED|Overall Study||169
3224807|NCT02308696|3957113|FG001|COMPLETED|Overall Study||203
3224808|NCT02308696|3957112|FG000|NOT COMPLETED|Overall Study||53
3224809|NCT02308696|3957113|FG001|NOT COMPLETED|Overall Study||31
3224810|NCT02308748|3957119|FG000|STARTED|Period 1||2
3224811|NCT02308748|3957120|FG001|STARTED|Period 1||2
3224812|NCT02308748|3957121|FG002|STARTED|Period 1||2
3224813|NCT02308748|3957122|FG003|STARTED|Period 1||2
3224814|NCT02308748|3957123|FG004|STARTED|Period 1||2
3224815|NCT02308748|3957124|FG005|STARTED|Period 1||3
3224816|NCT02308748|3957125|FG006|STARTED|Period 1||2
3224817|NCT02308748|3957126|FG007|STARTED|Period 1||2
3224818|NCT02308748|3957127|FG008|STARTED|Period 1||2
3224819|NCT02308748|3957128|FG009|STARTED|Period 1||3
3224820|NCT02308748|3957119|FG000|COMPLETED|Period 1||2
3224821|NCT02308748|3957120|FG001|COMPLETED|Period 1||2
3224822|NCT02308748|3957121|FG002|COMPLETED|Period 1|One subject withdraw consent before starting Period 2|1
3224823|NCT02308748|3957122|FG003|COMPLETED|Period 1||2
3224824|NCT02308748|3957123|FG004|COMPLETED|Period 1||2
3224825|NCT02308748|3957124|FG005|COMPLETED|Period 1||3
3224826|NCT02308748|3957125|FG006|COMPLETED|Period 1||2
3224827|NCT02308748|3957126|FG007|COMPLETED|Period 1||2
3368352|NCT03834025|4099880|FG006|COMPLETED|Randomized to Payment Condition(Phase 2)||27
3368353|NCT03834025|4099874|FG000|NOT COMPLETED|Randomized to Payment Condition(Phase 2)||0
3368354|NCT03834025|4099875|FG001|NOT COMPLETED|Randomized to Payment Condition(Phase 2)||0
3368355|NCT03834025|4099876|FG002|NOT COMPLETED|Randomized to Payment Condition(Phase 2)||0
3368356|NCT03834025|4099877|FG003|NOT COMPLETED|Randomized to Payment Condition(Phase 2)||0
3368357|NCT03834025|4099878|FG004|NOT COMPLETED|Randomized to Payment Condition(Phase 2)||0
3368358|NCT03834025|4099879|FG005|NOT COMPLETED|Randomized to Payment Condition(Phase 2)||0
3368359|NCT03834025|4099880|FG006|NOT COMPLETED|Randomized to Payment Condition(Phase 2)||1
3368360|NCT03836677|4099896|FG000|STARTED|Period 1||13
3368361|NCT03836677|4099897|FG001|STARTED|Period 1||10
3368362|NCT03836677|4099896|FG000|COMPLETED|Period 1||13
3368363|NCT03836677|4099897|FG001|COMPLETED|Period 1||9
3368364|NCT03836677|4099896|FG000|NOT COMPLETED|Period 1||0
3224828|NCT02308748|3957127|FG008|COMPLETED|Period 1||2
3224829|NCT02308748|3957128|FG009|COMPLETED|Period 1||3
3368365|NCT03836677|4099897|FG001|NOT COMPLETED|Period 1||1
3368366|NCT03836677|4099896|FG000|STARTED|Washout||13
3224830|NCT02308748|3957119|FG000|NOT COMPLETED|Period 1||0
3224831|NCT02308748|3957120|FG001|NOT COMPLETED|Period 1||0
3224832|NCT02308748|3957121|FG002|NOT COMPLETED|Period 1||1
3224833|NCT02308748|3957122|FG003|NOT COMPLETED|Period 1||0
3224834|NCT02308748|3957123|FG004|NOT COMPLETED|Period 1||0
3224835|NCT02308748|3957124|FG005|NOT COMPLETED|Period 1||0
3224836|NCT02308748|3957125|FG006|NOT COMPLETED|Period 1||0
3224837|NCT02308748|3957126|FG007|NOT COMPLETED|Period 1||0
3224838|NCT02308748|3957127|FG008|NOT COMPLETED|Period 1||0
3224839|NCT02308748|3957128|FG009|NOT COMPLETED|Period 1||0
3224840|NCT02308748|3957119|FG000|STARTED|Period 2||2
3224841|NCT02308748|3957120|FG001|STARTED|Period 2||2
3224842|NCT02308748|3957121|FG002|STARTED|Period 2||1
3224843|NCT02308748|3957122|FG003|STARTED|Period 2||2
3224844|NCT02308748|3957123|FG004|STARTED|Period 2||2
3224845|NCT02308748|3957124|FG005|STARTED|Period 2||3
3224846|NCT02308748|3957125|FG006|STARTED|Period 2||2
3224847|NCT02308748|3957126|FG007|STARTED|Period 2||2
3224848|NCT02308748|3957127|FG008|STARTED|Period 2||2
3224849|NCT02308748|3957128|FG009|STARTED|Period 2||3
3224850|NCT02308748|3957119|FG000|COMPLETED|Period 2||2
3224851|NCT02308748|3957120|FG001|COMPLETED|Period 2||2
3224852|NCT02308748|3957121|FG002|COMPLETED|Period 2||1
3224853|NCT02308748|3957122|FG003|COMPLETED|Period 2||2
3224854|NCT02308748|3957123|FG004|COMPLETED|Period 2||2
3224855|NCT02308748|3957124|FG005|COMPLETED|Period 2||3
3224856|NCT02308748|3957125|FG006|COMPLETED|Period 2||2
3224857|NCT02308748|3957126|FG007|COMPLETED|Period 2||1
3224858|NCT02308748|3957127|FG008|COMPLETED|Period 2||2
3224859|NCT02308748|3957128|FG009|COMPLETED|Period 2||3
3224860|NCT02308748|3957119|FG000|NOT COMPLETED|Period 2||0
3224861|NCT02308748|3957120|FG001|NOT COMPLETED|Period 2||0
3224862|NCT02308748|3957121|FG002|NOT COMPLETED|Period 2||0
3224863|NCT02308748|3957122|FG003|NOT COMPLETED|Period 2||0
3224864|NCT02308748|3957123|FG004|NOT COMPLETED|Period 2||0
3224865|NCT02308748|3957124|FG005|NOT COMPLETED|Period 2||0
3224866|NCT02308748|3957125|FG006|NOT COMPLETED|Period 2||0
3224867|NCT02308748|3957126|FG007|NOT COMPLETED|Period 2||1
3224868|NCT02308748|3957127|FG008|NOT COMPLETED|Period 2||0
3224869|NCT02308748|3957128|FG009|NOT COMPLETED|Period 2||0
3224870|NCT02308748|3957119|FG000|STARTED|Period 3||2
3224871|NCT02308748|3957120|FG001|STARTED|Period 3||2
3224872|NCT02308748|3957121|FG002|STARTED|Period 3||1
3224873|NCT02308748|3957122|FG003|STARTED|Period 3||2
3224874|NCT02308748|3957123|FG004|STARTED|Period 3||2
3224875|NCT02308748|3957124|FG005|STARTED|Period 3||3
3224876|NCT02308748|3957125|FG006|STARTED|Period 3||2
3224877|NCT02308748|3957126|FG007|STARTED|Period 3||1
3224878|NCT02308748|3957127|FG008|STARTED|Period 3||2
3224879|NCT02308748|3957128|FG009|STARTED|Period 3||3
3224880|NCT02308748|3957119|FG000|COMPLETED|Period 3||2
3224881|NCT02308748|3957120|FG001|COMPLETED|Period 3||2
3224882|NCT02308748|3957121|FG002|COMPLETED|Period 3||1
3224883|NCT02308748|3957122|FG003|COMPLETED|Period 3||2
3224884|NCT02308748|3957123|FG004|COMPLETED|Period 3||2
3224885|NCT02308748|3957124|FG005|COMPLETED|Period 3||3
3224886|NCT02308748|3957125|FG006|COMPLETED|Period 3||2
3224887|NCT02308748|3957126|FG007|COMPLETED|Period 3||1
3224888|NCT02308748|3957127|FG008|COMPLETED|Period 3||2
3224889|NCT02308748|3957128|FG009|COMPLETED|Period 3||2
3224890|NCT02308748|3957119|FG000|NOT COMPLETED|Period 3||0
3224891|NCT02308748|3957120|FG001|NOT COMPLETED|Period 3||0
3224892|NCT02308748|3957121|FG002|NOT COMPLETED|Period 3||0
3224893|NCT02308748|3957122|FG003|NOT COMPLETED|Period 3||0
3224894|NCT02308748|3957123|FG004|NOT COMPLETED|Period 3||0
3224895|NCT02308748|3957124|FG005|NOT COMPLETED|Period 3||0
3224896|NCT02308748|3957125|FG006|NOT COMPLETED|Period 3||0
3224897|NCT02308748|3957126|FG007|NOT COMPLETED|Period 3||0
3224898|NCT02308748|3957127|FG008|NOT COMPLETED|Period 3||0
3224899|NCT02308748|3957128|FG009|NOT COMPLETED|Period 3||1
3224900|NCT02308748|3957119|FG000|STARTED|Period 4||2
3224901|NCT02308748|3957120|FG001|STARTED|Period 4||2
3224902|NCT02308748|3957121|FG002|STARTED|Period 4||1
3224903|NCT02308748|3957122|FG003|STARTED|Period 4||2
3224904|NCT02308748|3957123|FG004|STARTED|Period 4||2
3224905|NCT02308748|3957124|FG005|STARTED|Period 4||3
3224906|NCT02308748|3957125|FG006|STARTED|Period 4||2
3224907|NCT02308748|3957126|FG007|STARTED|Period 4||1
3224908|NCT02308748|3957127|FG008|STARTED|Period 4||2
3224909|NCT02308748|3957128|FG009|STARTED|Period 4||2
3224910|NCT02308748|3957119|FG000|COMPLETED|Period 4||2
3224911|NCT02308748|3957120|FG001|COMPLETED|Period 4||2
3224912|NCT02308748|3957121|FG002|COMPLETED|Period 4||1
3224913|NCT02308748|3957122|FG003|COMPLETED|Period 4||2
3224914|NCT02308748|3957123|FG004|COMPLETED|Period 4||2
3224915|NCT02308748|3957124|FG005|COMPLETED|Period 4||3
3224916|NCT02308748|3957125|FG006|COMPLETED|Period 4||2
3224917|NCT02308748|3957126|FG007|COMPLETED|Period 4||1
3224918|NCT02308748|3957127|FG008|COMPLETED|Period 4||2
3224919|NCT02308748|3957128|FG009|COMPLETED|Period 4||2
3224920|NCT02308748|3957119|FG000|NOT COMPLETED|Period 4||0
3224921|NCT02308748|3957120|FG001|NOT COMPLETED|Period 4||0
3224922|NCT02308748|3957121|FG002|NOT COMPLETED|Period 4||0
3224923|NCT02308748|3957122|FG003|NOT COMPLETED|Period 4||0
3224924|NCT02308748|3957123|FG004|NOT COMPLETED|Period 4||0
3224925|NCT02308748|3957124|FG005|NOT COMPLETED|Period 4||0
3224926|NCT02308748|3957125|FG006|NOT COMPLETED|Period 4||0
3224927|NCT02308748|3957126|FG007|NOT COMPLETED|Period 4||0
3224928|NCT02308748|3957127|FG008|NOT COMPLETED|Period 4||0
3224929|NCT02308748|3957128|FG009|NOT COMPLETED|Period 4||0
3224930|NCT02308748|3957119|FG000|STARTED|Period 5||2
3224931|NCT02308748|3957120|FG001|STARTED|Period 5||2
3224932|NCT02308748|3957121|FG002|STARTED|Period 5||1
3224933|NCT02308748|3957122|FG003|STARTED|Period 5||2
3224934|NCT02308748|3957123|FG004|STARTED|Period 5||2
3224935|NCT02308748|3957124|FG005|STARTED|Period 5||3
3224936|NCT02308748|3957125|FG006|STARTED|Period 5||2
3224937|NCT02308748|3957126|FG007|STARTED|Period 5||1
3224938|NCT02308748|3957127|FG008|STARTED|Period 5||2
3224939|NCT02308748|3957128|FG009|STARTED|Period 5||2
3224940|NCT02308748|3957119|FG000|COMPLETED|Period 5||1
3224941|NCT02308748|3957120|FG001|COMPLETED|Period 5||2
3224942|NCT02308748|3957121|FG002|COMPLETED|Period 5||1
3224943|NCT02308748|3957122|FG003|COMPLETED|Period 5||2
3224944|NCT02308748|3957123|FG004|COMPLETED|Period 5||2
3224945|NCT02308748|3957124|FG005|COMPLETED|Period 5||3
3224946|NCT02308748|3957125|FG006|COMPLETED|Period 5||2
3224947|NCT02308748|3957126|FG007|COMPLETED|Period 5||1
3224948|NCT02308748|3957127|FG008|COMPLETED|Period 5||1
3224949|NCT02308748|3957128|FG009|COMPLETED|Period 5||2
3224950|NCT02308748|3957119|FG000|NOT COMPLETED|Period 5||1
3224951|NCT02308748|3957120|FG001|NOT COMPLETED|Period 5||0
3224952|NCT02308748|3957121|FG002|NOT COMPLETED|Period 5||0
3224953|NCT02308748|3957122|FG003|NOT COMPLETED|Period 5||0
3224954|NCT02308748|3957123|FG004|NOT COMPLETED|Period 5||0
3224955|NCT02308748|3957124|FG005|NOT COMPLETED|Period 5||0
3224956|NCT02308748|3957125|FG006|NOT COMPLETED|Period 5||0
3224957|NCT02308748|3957126|FG007|NOT COMPLETED|Period 5||0
3224958|NCT02308748|3957127|FG008|NOT COMPLETED|Period 5||1
3224959|NCT02308748|3957128|FG009|NOT COMPLETED|Period 5||0
3224960|NCT02308787|3957140|FG000|STARTED|Overall Study|Data were collected from 20 PLTD procedures performed in 12 subjects|12
3224961|NCT02308787|3957140|FG000|COMPLETED|Overall Study|Data were collected from 20 PLTD procedures performed in 12 subjects|12
3224962|NCT02308787|3957140|FG000|NOT COMPLETED|Overall Study||0
3224963|NCT02308839|3957144|FG000|STARTED|Overall Study||181
3224964|NCT02308839|3957144|FG000|COMPLETED|Overall Study||72
3224965|NCT02308839|3957144|FG000|NOT COMPLETED|Overall Study||109
3224966|NCT02309099|3957150|FG000|STARTED|Overall Study||7
3224967|NCT02309099|3957151|FG001|STARTED|Overall Study||3
3224968|NCT02309099|3957150|FG000|Cochlear Implantation|Overall Study||7
3224969|NCT02309099|3957151|FG001|Cochlear Implantation|Overall Study||3
3224970|NCT02309099|3957150|FG000|Initial Activation|Overall Study||7
3224971|NCT02309099|3957151|FG001|Initial Activation|Overall Study||3
3224972|NCT02309099|3957150|FG000|Cochlear Implant Use/Follow-Up|Overall Study|5 participants completed cochlear implant use/follow-up (2 did not complete due to adverse event)|5
3224973|NCT02309099|3957151|FG001|Cochlear Implant Use/Follow-Up|Overall Study||3
3224974|NCT02309099|3957150|FG000|COMPLETED|Overall Study|5 participants completed the study (2 did not complete due to adverse event)|5
3224975|NCT02309099|3957151|FG001|COMPLETED|Overall Study||3
3224976|NCT02309099|3957150|FG000|NOT COMPLETED|Overall Study||2
3224977|NCT02309099|3957151|FG001|NOT COMPLETED|Overall Study||0
3224978|NCT02309112|3957160|FG000|STARTED|Overall Study||5
3224979|NCT02309112|3957161|FG001|STARTED|Overall Study||5
3224980|NCT02309112|3957162|FG002|STARTED|Overall Study||5
3224981|NCT02309112|3957160|FG000|Completed Yoga Intervention|Overall Study||4
3224982|NCT02309112|3957161|FG001|Completed Yoga Intervention|Overall Study||5
3224983|NCT02309112|3957162|FG002|Completed Yoga Intervention|Overall Study||4
3224984|NCT02309112|3957160|FG000|COMPLETED|Overall Study||4
3224985|NCT02309112|3957161|FG001|COMPLETED|Overall Study||4
3224986|NCT02309112|3957162|FG002|COMPLETED|Overall Study||4
3224987|NCT02309112|3957160|FG000|NOT COMPLETED|Overall Study||1
3224988|NCT02309112|3957161|FG001|NOT COMPLETED|Overall Study||1
3224989|NCT02309112|3957162|FG002|NOT COMPLETED|Overall Study||1
3224990|NCT02309138|3957174|FG000|STARTED|Overall Study||460
3224991|NCT02309138|3957175|FG001|STARTED|Overall Study||461
3224992|NCT02309138|3957174|FG000|COMPLETED|Overall Study||412
3224993|NCT02309138|3957175|FG001|COMPLETED|Overall Study||443
3224994|NCT02309138|3957174|FG000|NOT COMPLETED|Overall Study||48
3224995|NCT02309138|3957175|FG001|NOT COMPLETED|Overall Study||18
3224996|NCT02309294|3957191|FG000|STARTED|Overall Study||43
3224997|NCT02309294|3957191|FG000|COMPLETED|Overall Study||41
3224998|NCT02309294|3957191|FG000|NOT COMPLETED|Overall Study||2
3224999|NCT02309359|3957200|FG000|STARTED|Overall Study||69
3225000|NCT02309359|3957201|FG001|STARTED|Overall Study||70
3225001|NCT02309359|3957202|FG002|STARTED|Overall Study||68
3225002|NCT02309359|3957203|FG003|STARTED|Overall Study||69
3225003|NCT02309359|3957204|FG004|STARTED|Overall Study||69
3225004|NCT02309359|3957200|FG000|COMPLETED|Overall Study||57
3225005|NCT02309359|3957201|FG001|COMPLETED|Overall Study||62
3225006|NCT02309359|3957202|FG002|COMPLETED|Overall Study||57
3225007|NCT02309359|3957203|FG003|COMPLETED|Overall Study||57
3225008|NCT02309359|3957204|FG004|COMPLETED|Overall Study||60
3225009|NCT02309359|3957200|FG000|NOT COMPLETED|Overall Study||12
3225010|NCT02309359|3957201|FG001|NOT COMPLETED|Overall Study||8
3225011|NCT02309359|3957202|FG002|NOT COMPLETED|Overall Study||11
3225012|NCT02309359|3957203|FG003|NOT COMPLETED|Overall Study||12
3225013|NCT02309359|3957204|FG004|NOT COMPLETED|Overall Study||9
3225014|NCT02309372|3957219|FG000|STARTED|Overall Study||27
3225015|NCT02309372|3957220|FG001|STARTED|Overall Study||27
3225016|NCT02309372|3957219|FG000|COMPLETED|Overall Study||24
3225017|NCT02309372|3957220|FG001|COMPLETED|Overall Study||25
3225018|NCT02309372|3957219|FG000|NOT COMPLETED|Overall Study||3
3225019|NCT02309372|3957220|FG001|NOT COMPLETED|Overall Study||2
3225020|NCT02309411|3957229|FG000|STARTED|Overall Study||25
3225021|NCT02309411|3957230|FG001|STARTED|Overall Study||15
3225022|NCT02309411|3957231|FG002|STARTED|Overall Study||6
3225023|NCT02309411|3957229|FG000|COMPLETED|Overall Study||23
3225024|NCT02309411|3957230|FG001|COMPLETED|Overall Study||14
3225025|NCT02309411|3957231|FG002|COMPLETED|Overall Study||6
3225026|NCT02309411|3957229|FG000|NOT COMPLETED|Overall Study||2
3225027|NCT02309411|3957230|FG001|NOT COMPLETED|Overall Study||1
3225028|NCT02309411|3957231|FG002|NOT COMPLETED|Overall Study||0
3225029|NCT02309489|3957240|FG000|STARTED|Overall Study||583
3225030|NCT02309489|3957241|FG001|STARTED|Overall Study||561
3225031|NCT02309489|3957240|FG000|Follow-up at 3 Months Postpartum|Overall Study||560
3225032|NCT02309489|3957241|FG001|Follow-up at 3 Months Postpartum|Overall Study||541
3225033|NCT02309489|3957240|FG000|COMPLETED|Overall Study||568
3225034|NCT02309489|3957241|FG001|COMPLETED|Overall Study||547
3225035|NCT02309489|3957240|FG000|NOT COMPLETED|Overall Study||15
3225036|NCT02309489|3957241|FG001|NOT COMPLETED|Overall Study||14
3225037|NCT02309515|3957249|FG000|STARTED|Overall Study||5
3225038|NCT02309515|3957250|FG001|STARTED|Overall Study||7
3225039|NCT02309515|3957249|FG000|COMPLETED|Overall Study||5
3225040|NCT02309515|3957250|FG001|COMPLETED|Overall Study||6
3225041|NCT02309515|3957249|FG000|NOT COMPLETED|Overall Study||0
3225042|NCT02309515|3957250|FG001|NOT COMPLETED|Overall Study||1
3225043|NCT02309723|3957259|FG000|STARTED|Overall Study||129
3225044|NCT02309723|3957260|FG001|STARTED|Overall Study||128
3225045|NCT02309723|3957261|FG002|STARTED|Overall Study||129
3225046|NCT02309723|3957259|FG000|COMPLETED|Overall Study||105
3225047|NCT02309723|3957260|FG001|COMPLETED|Overall Study||105
3225048|NCT02309723|3957261|FG002|COMPLETED|Overall Study||105
3225049|NCT02309723|3957259|FG000|NOT COMPLETED|Overall Study||24
3225050|NCT02309723|3957260|FG001|NOT COMPLETED|Overall Study||23
3225051|NCT02309723|3957261|FG002|NOT COMPLETED|Overall Study||24
3225052|NCT02309944|3957271|FG000|STARTED|Overall Study||38
3225053|NCT02309944|3957272|FG001|STARTED|Overall Study||43
3225054|NCT02309944|3957271|FG000|COMPLETED|Overall Study||38
3225055|NCT02309944|3957272|FG001|COMPLETED|Overall Study||43
3225056|NCT02309944|3957271|FG000|NOT COMPLETED|Overall Study||0
3225057|NCT02309944|3957272|FG001|NOT COMPLETED|Overall Study||0
3225058|NCT02310100|3957278|FG000|STARTED|Overall Study|First enrollment|178
3225059|NCT02310100|3957278|FG000|COMPLETED|Overall Study||160
3225060|NCT02310100|3957278|FG000|NOT COMPLETED|Overall Study||18
3225061|NCT02310126|3957285|FG000|STARTED|Period 1 (15 Minutes)||94
3225062|NCT02310126|3957286|FG001|STARTED|Period 1 (15 Minutes)||97
3225063|NCT02310126|3957285|FG000|Hyperopes|Period 1 (15 Minutes)||38
3225064|NCT02310126|3957286|FG001|Hyperopes|Period 1 (15 Minutes)||33
3225065|NCT02310126|3957285|FG000|Myopes|Period 1 (15 Minutes)||56
3225066|NCT02310126|3957286|FG001|Myopes|Period 1 (15 Minutes)||64
3225067|NCT02310126|3957285|FG000|COMPLETED|Period 1 (15 Minutes)||94
3225068|NCT02310126|3957286|FG001|COMPLETED|Period 1 (15 Minutes)||95
3225069|NCT02310126|3957285|FG000|NOT COMPLETED|Period 1 (15 Minutes)||0
3225070|NCT02310126|3957286|FG001|NOT COMPLETED|Period 1 (15 Minutes)||2
3225071|NCT02310126|3957285|FG000|STARTED|Period 2 (15 Minutes)||94
3225072|NCT02310126|3957286|FG001|STARTED|Period 2 (15 Minutes)||95
3225073|NCT02310126|3957285|FG000|Hyperopes|Period 2 (15 Minutes)||38
3225074|NCT02310126|3957286|FG001|Hyperopes|Period 2 (15 Minutes)||32
3225075|NCT02310126|3957285|FG000|Myopes|Period 2 (15 Minutes)||56
3225076|NCT02310126|3957286|FG001|Myopes|Period 2 (15 Minutes)||63
3225077|NCT02310126|3957285|FG000|COMPLETED|Period 2 (15 Minutes)||94
3225078|NCT02310126|3957286|FG001|COMPLETED|Period 2 (15 Minutes)||95
3225079|NCT02310126|3957285|FG000|NOT COMPLETED|Period 2 (15 Minutes)||0
3225080|NCT02310126|3957286|FG001|NOT COMPLETED|Period 2 (15 Minutes)||0
3225081|NCT02310568|3957297|FG000|STARTED|Stage 1 ( 4 Weeks)||15
3225082|NCT02310568|3957298|FG001|STARTED|Stage 1 ( 4 Weeks)||15
3225083|NCT02310568|3957299|FG002|STARTED|Stage 1 ( 4 Weeks)||15
3225084|NCT02310568|3957300|FG003|STARTED|Stage 1 ( 4 Weeks)||24
3225085|NCT02310568|3957301|FG004|STARTED|Stage 1 ( 4 Weeks)||21
3225086|NCT02310568|3957297|FG000|COMPLETED|Stage 1 ( 4 Weeks)||12
3225087|NCT02310568|3957298|FG001|COMPLETED|Stage 1 ( 4 Weeks)||13
3225088|NCT02310568|3957299|FG002|COMPLETED|Stage 1 ( 4 Weeks)||14
3225089|NCT02310568|3957300|FG003|COMPLETED|Stage 1 ( 4 Weeks)||22
3225090|NCT02310568|3957301|FG004|COMPLETED|Stage 1 ( 4 Weeks)||20
3225091|NCT02310568|3957297|FG000|NOT COMPLETED|Stage 1 ( 4 Weeks)||3
3225092|NCT02310568|3957298|FG001|NOT COMPLETED|Stage 1 ( 4 Weeks)||2
3225093|NCT02310568|3957299|FG002|NOT COMPLETED|Stage 1 ( 4 Weeks)||1
3225094|NCT02310568|3957300|FG003|NOT COMPLETED|Stage 1 ( 4 Weeks)||2
3225095|NCT02310568|3957301|FG004|NOT COMPLETED|Stage 1 ( 4 Weeks)||1
3225096|NCT02310568|3957297|FG000|STARTED|Stage 2 (4 Weeks)||12
3225097|NCT02310568|3957298|FG001|STARTED|Stage 2 (4 Weeks)||13
3225098|NCT02310568|3957299|FG002|STARTED|Stage 2 (4 Weeks)||14
3225099|NCT02310568|3957300|FG003|STARTED|Stage 2 (4 Weeks)||22
3225100|NCT02310568|3957301|FG004|STARTED|Stage 2 (4 Weeks)||20
3225101|NCT02310568|3957297|FG000|COMPLETED|Stage 2 (4 Weeks)||11
3225102|NCT02310568|3957298|FG001|COMPLETED|Stage 2 (4 Weeks)||12
3225103|NCT02310568|3957299|FG002|COMPLETED|Stage 2 (4 Weeks)||13
3225104|NCT02310568|3957300|FG003|COMPLETED|Stage 2 (4 Weeks)||17
3225105|NCT02310568|3957301|FG004|COMPLETED|Stage 2 (4 Weeks)||19
3225106|NCT02310568|3957297|FG000|NOT COMPLETED|Stage 2 (4 Weeks)||1
3225107|NCT02310568|3957298|FG001|NOT COMPLETED|Stage 2 (4 Weeks)||1
3225108|NCT02310568|3957299|FG002|NOT COMPLETED|Stage 2 (4 Weeks)||1
3225109|NCT02310568|3957300|FG003|NOT COMPLETED|Stage 2 (4 Weeks)||5
3225110|NCT02310568|3957301|FG004|NOT COMPLETED|Stage 2 (4 Weeks)||1
3225111|NCT02310581|3957323|FG000|STARTED|Overall Study||9
3225112|NCT02310581|3957324|FG001|STARTED|Overall Study||11
3225113|NCT02310581|3957325|FG002|STARTED|Overall Study||10
3225114|NCT02310581|3957326|FG003|STARTED|Overall Study||10
3225115|NCT02310581|3957323|FG000|COMPLETED|Overall Study||6
3225116|NCT02310581|3957324|FG001|COMPLETED|Overall Study||9
3225117|NCT02310581|3957325|FG002|COMPLETED|Overall Study||9
3225118|NCT02310581|3957326|FG003|COMPLETED|Overall Study||9
3225119|NCT02310581|3957323|FG000|NOT COMPLETED|Overall Study||3
3225120|NCT02310581|3957324|FG001|NOT COMPLETED|Overall Study||2
3225121|NCT02310581|3957325|FG002|NOT COMPLETED|Overall Study||1
3225122|NCT02310581|3957326|FG003|NOT COMPLETED|Overall Study||1
3225123|NCT02310646|3957338|FG000|STARTED|First Intervention (Day 1 - Day 7)||109
3225124|NCT02310646|3957339|FG001|STARTED|First Intervention (Day 1 - Day 7)||104
3225125|NCT02310646|3957338|FG000|COMPLETED|First Intervention (Day 1 - Day 7)||107
3225126|NCT02310646|3957339|FG001|COMPLETED|First Intervention (Day 1 - Day 7)||104
3225127|NCT02310646|3957338|FG000|NOT COMPLETED|First Intervention (Day 1 - Day 7)||2
3225128|NCT02310646|3957339|FG001|NOT COMPLETED|First Intervention (Day 1 - Day 7)||0
3225129|NCT02310646|3957338|FG000|STARTED|Second Intervention (Day 8 - Day 14)||107
3225130|NCT02310646|3957339|FG001|STARTED|Second Intervention (Day 8 - Day 14)||104
3225131|NCT02310646|3957338|FG000|COMPLETED|Second Intervention (Day 8 - Day 14)||107
3225132|NCT02310646|3957339|FG001|COMPLETED|Second Intervention (Day 8 - Day 14)||104
3225133|NCT02310646|3957338|FG000|NOT COMPLETED|Second Intervention (Day 8 - Day 14)||0
3225134|NCT02310646|3957339|FG001|NOT COMPLETED|Second Intervention (Day 8 - Day 14)||0
3225135|NCT02310672|3957361|FG000|STARTED|Overall Study||87
3225136|NCT02310672|3957361|FG000|COMPLETED|Overall Study||72
3225137|NCT02310672|3957361|FG000|NOT COMPLETED|Overall Study||15
3225138|NCT02310750|3957376|FG000|STARTED|HP Period 1||7
3225139|NCT02310750|3957377|FG001|STARTED|HP Period 1||6
3225140|NCT02310750|3957378|FG002|STARTED|HP Period 1||6
3225141|NCT02310750|3957379|FG003|STARTED|HP Period 1||6
3225142|NCT02310750|3957380|FG004|STARTED|HP Period 1||8
3225143|NCT02310750|3957381|FG005|STARTED|HP Period 1||8
3225144|NCT02310750|3957382|FG006|STARTED|HP Period 1||13
3225145|NCT02310750|3957383|FG007|STARTED|HP Period 1||0
3225146|NCT02310750|3957384|FG008|STARTED|HP Period 1||0
3225147|NCT02310750|3957385|FG009|STARTED|HP Period 1||0
3225148|NCT02310750|3957386|FG010|STARTED|HP Period 1||2
3225149|NCT02310750|3957387|FG011|STARTED|HP Period 1||2
3225150|NCT02310750|3957388|FG012|STARTED|HP Period 1||2
3225151|NCT02310750|3957389|FG013|STARTED|HP Period 1||2
3225152|NCT02310750|3957390|FG014|STARTED|HP Period 1||2
3225153|NCT02310750|3957391|FG015|STARTED|HP Period 1||2
3225154|NCT02310750|3957376|FG000|COMPLETED|HP Period 1||6
3225155|NCT02310750|3957377|FG001|COMPLETED|HP Period 1||6
3225156|NCT02310750|3957378|FG002|COMPLETED|HP Period 1||6
3225157|NCT02310750|3957379|FG003|COMPLETED|HP Period 1||5
3225158|NCT02310750|3957380|FG004|COMPLETED|HP Period 1||8
3225159|NCT02310750|3957381|FG005|COMPLETED|HP Period 1||8
3225160|NCT02310750|3957382|FG006|COMPLETED|HP Period 1||12
3225161|NCT02310750|3957383|FG007|COMPLETED|HP Period 1||0
3225162|NCT02310750|3957384|FG008|COMPLETED|HP Period 1||0
3225163|NCT02310750|3957385|FG009|COMPLETED|HP Period 1||0
3225164|NCT02310750|3957386|FG010|COMPLETED|HP Period 1||2
3225165|NCT02310750|3957387|FG011|COMPLETED|HP Period 1||2
3225166|NCT02310750|3957388|FG012|COMPLETED|HP Period 1||2
3225167|NCT02310750|3957389|FG013|COMPLETED|HP Period 1||2
3225168|NCT02310750|3957390|FG014|COMPLETED|HP Period 1||2
3225169|NCT02310750|3957391|FG015|COMPLETED|HP Period 1||2
3225170|NCT02310750|3957376|FG000|NOT COMPLETED|HP Period 1||1
3225171|NCT02310750|3957377|FG001|NOT COMPLETED|HP Period 1||0
3225172|NCT02310750|3957378|FG002|NOT COMPLETED|HP Period 1||0
3225173|NCT02310750|3957379|FG003|NOT COMPLETED|HP Period 1||1
3225174|NCT02310750|3957380|FG004|NOT COMPLETED|HP Period 1||0
3225175|NCT02310750|3957381|FG005|NOT COMPLETED|HP Period 1||0
3225176|NCT02310750|3957382|FG006|NOT COMPLETED|HP Period 1||1
3225177|NCT02310750|3957383|FG007|NOT COMPLETED|HP Period 1||0
3225178|NCT02310750|3957384|FG008|NOT COMPLETED|HP Period 1||0
3225179|NCT02310750|3957385|FG009|NOT COMPLETED|HP Period 1||0
3225180|NCT02310750|3957386|FG010|NOT COMPLETED|HP Period 1||0
3225181|NCT02310750|3957387|FG011|NOT COMPLETED|HP Period 1||0
3225182|NCT02310750|3957388|FG012|NOT COMPLETED|HP Period 1||0
3225183|NCT02310750|3957389|FG013|NOT COMPLETED|HP Period 1||0
3225184|NCT02310750|3957390|FG014|NOT COMPLETED|HP Period 1||0
3225185|NCT02310750|3957391|FG015|NOT COMPLETED|HP Period 1||0
3225186|NCT02310750|3957376|FG000|STARTED|HP Washout 1||0
3225187|NCT02310750|3957377|FG001|STARTED|HP Washout 1||0
3225188|NCT02310750|3957378|FG002|STARTED|HP Washout 1||6
3225189|NCT02310750|3957379|FG003|STARTED|HP Washout 1||5
3225190|NCT02310750|3957380|FG004|STARTED|HP Washout 1||8
3225191|NCT02310750|3957381|FG005|STARTED|HP Washout 1||8
3225192|NCT02310750|3957382|FG006|STARTED|HP Washout 1||12
3225193|NCT02310750|3957383|FG007|STARTED|HP Washout 1||0
3225194|NCT02310750|3957384|FG008|STARTED|HP Washout 1||0
3225195|NCT02310750|3957385|FG009|STARTED|HP Washout 1||0
3225196|NCT02310750|3957386|FG010|STARTED|HP Washout 1||2
3225197|NCT02310750|3957387|FG011|STARTED|HP Washout 1||2
3225198|NCT02310750|3957388|FG012|STARTED|HP Washout 1||2
3225199|NCT02310750|3957389|FG013|STARTED|HP Washout 1||2
3225200|NCT02310750|3957390|FG014|STARTED|HP Washout 1||2
3225201|NCT02310750|3957391|FG015|STARTED|HP Washout 1||2
3225202|NCT02310750|3957376|FG000|COMPLETED|HP Washout 1||0
3225203|NCT02310750|3957377|FG001|COMPLETED|HP Washout 1||0
3225204|NCT02310750|3957378|FG002|COMPLETED|HP Washout 1||5
3225205|NCT02310750|3957379|FG003|COMPLETED|HP Washout 1||4
3225206|NCT02310750|3957380|FG004|COMPLETED|HP Washout 1||6
3225207|NCT02310750|3957381|FG005|COMPLETED|HP Washout 1||6
3225208|NCT02310750|3957382|FG006|COMPLETED|HP Washout 1||9
3225209|NCT02310750|3957383|FG007|COMPLETED|HP Washout 1||0
3225210|NCT02310750|3957384|FG008|COMPLETED|HP Washout 1||0
3225211|NCT02310750|3957385|FG009|COMPLETED|HP Washout 1||0
3225212|NCT02310750|3957386|FG010|COMPLETED|HP Washout 1||2
3225213|NCT02310750|3957387|FG011|COMPLETED|HP Washout 1||2
3225214|NCT02310750|3957388|FG012|COMPLETED|HP Washout 1||2
3225215|NCT02310750|3957389|FG013|COMPLETED|HP Washout 1||2
3225216|NCT02310750|3957390|FG014|COMPLETED|HP Washout 1||2
3225217|NCT02310750|3957391|FG015|COMPLETED|HP Washout 1||2
3225218|NCT02310750|3957376|FG000|NOT COMPLETED|HP Washout 1||0
3225219|NCT02310750|3957377|FG001|NOT COMPLETED|HP Washout 1||0
3225220|NCT02310750|3957378|FG002|NOT COMPLETED|HP Washout 1||1
3225221|NCT02310750|3957379|FG003|NOT COMPLETED|HP Washout 1||1
3225222|NCT02310750|3957380|FG004|NOT COMPLETED|HP Washout 1||2
3225223|NCT02310750|3957381|FG005|NOT COMPLETED|HP Washout 1||2
3225224|NCT02310750|3957382|FG006|NOT COMPLETED|HP Washout 1||3
3225225|NCT02310750|3957383|FG007|NOT COMPLETED|HP Washout 1||0
3225226|NCT02310750|3957384|FG008|NOT COMPLETED|HP Washout 1||0
3225227|NCT02310750|3957385|FG009|NOT COMPLETED|HP Washout 1||0
3225228|NCT02310750|3957386|FG010|NOT COMPLETED|HP Washout 1||0
3225229|NCT02310750|3957387|FG011|NOT COMPLETED|HP Washout 1||0
3225230|NCT02310750|3957388|FG012|NOT COMPLETED|HP Washout 1||0
3225231|NCT02310750|3957389|FG013|NOT COMPLETED|HP Washout 1||0
3225232|NCT02310750|3957390|FG014|NOT COMPLETED|HP Washout 1||0
3225233|NCT02310750|3957391|FG015|NOT COMPLETED|HP Washout 1||0
3225234|NCT02310750|3957376|FG000|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
3225235|NCT02310750|3957377|FG001|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
3225236|NCT02310750|3957378|FG002|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||5
3225237|NCT02310750|3957379|FG003|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||4
3225238|NCT02310750|3957380|FG004|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||6
3225239|NCT02310750|3957381|FG005|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||6
3225240|NCT02310750|3957382|FG006|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||9
3225241|NCT02310750|3957383|FG007|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||9
3225242|NCT02310750|3957384|FG008|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||14
3225243|NCT02310750|3957385|FG009|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||7
3225244|NCT02310750|3957386|FG010|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
3368367|NCT03836677|4099897|FG001|STARTED|Washout||9
3368368|NCT03836677|4099896|FG000|COMPLETED|Washout||13
3368369|NCT03836677|4099897|FG001|COMPLETED|Washout||9
3368370|NCT03836677|4099896|FG000|NOT COMPLETED|Washout||0
3368371|NCT03836677|4099897|FG001|NOT COMPLETED|Washout||0
3368372|NCT03836677|4099896|FG000|STARTED|Period 2||13
3368373|NCT03836677|4099897|FG001|STARTED|Period 2||9
3368374|NCT03836677|4099896|FG000|COMPLETED|Period 2||12
3368375|NCT03836677|4099897|FG001|COMPLETED|Period 2||9
3368376|NCT03836677|4099896|FG000|NOT COMPLETED|Period 2||1
3368377|NCT03836677|4099897|FG001|NOT COMPLETED|Period 2||0
3368378|NCT03836989|4099905|FG000|STARTED|Overall Study||4
3368379|NCT03836989|4099906|FG001|STARTED|Overall Study||0
3368380|NCT03836989|4099905|FG000|Subjects > 60 Years Old With Complete Paralysis|Overall Study||1
3368381|NCT03836989|4099906|FG001|Subjects > 60 Years Old With Complete Paralysis|Overall Study||0
3368382|NCT03836989|4099905|FG000|Subjects > 60 Years Old With Incomplete Paralysis|Overall Study||1
3368383|NCT03836989|4099906|FG001|Subjects > 60 Years Old With Incomplete Paralysis|Overall Study||0
3368384|NCT03836989|4099905|FG000|Subject < 60 Years Old + Complete Paralysis < 15 Days Duration|Overall Study||1
3368385|NCT03836989|4099906|FG001|Subject < 60 Years Old + Complete Paralysis < 15 Days Duration|Overall Study||0
3368386|NCT03836989|4099905|FG000|Subjects < 60 Years Old + Complete Paralysis > 15 Days|Overall Study||1
3225245|NCT02310750|3957387|FG011|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
3225246|NCT02310750|3957388|FG012|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
3225247|NCT02310750|3957389|FG013|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
3225248|NCT02310750|3957390|FG014|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
3225249|NCT02310750|3957391|FG015|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
3225250|NCT02310750|3957376|FG000|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
3225251|NCT02310750|3957377|FG001|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
3225252|NCT02310750|3957378|FG002|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||5
3225253|NCT02310750|3957379|FG003|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||3
3225254|NCT02310750|3957380|FG004|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||6
3225255|NCT02310750|3957381|FG005|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||4
3225256|NCT02310750|3957382|FG006|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||9
3225257|NCT02310750|3957383|FG007|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||7
3225258|NCT02310750|3957384|FG008|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||6
3225259|NCT02310750|3957385|FG009|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||4
3225260|NCT02310750|3957386|FG010|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
3225261|NCT02310750|3957387|FG011|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
3225262|NCT02310750|3957388|FG012|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
3225263|NCT02310750|3957389|FG013|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
3225264|NCT02310750|3957390|FG014|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
3225265|NCT02310750|3957391|FG015|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
3225266|NCT02310750|3957376|FG000|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
3225267|NCT02310750|3957377|FG001|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
3225268|NCT02310750|3957378|FG002|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
3225269|NCT02310750|3957379|FG003|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||1
3225270|NCT02310750|3957380|FG004|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
3225271|NCT02310750|3957381|FG005|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
3225272|NCT02310750|3957382|FG006|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
3225273|NCT02310750|3957383|FG007|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
3225274|NCT02310750|3957384|FG008|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||8
3225275|NCT02310750|3957385|FG009|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||3
3225276|NCT02310750|3957386|FG010|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
3225277|NCT02310750|3957387|FG011|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
3225278|NCT02310750|3957388|FG012|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
3225279|NCT02310750|3957389|FG013|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
3225280|NCT02310750|3957390|FG014|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
3225281|NCT02310750|3957391|FG015|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
3225282|NCT02310750|3957376|FG000|STARTED|HP Washout 2||0
3225283|NCT02310750|3957377|FG001|STARTED|HP Washout 2||0
3225284|NCT02310750|3957378|FG002|STARTED|HP Washout 2||0
3225285|NCT02310750|3957379|FG003|STARTED|HP Washout 2||0
3225286|NCT02310750|3957380|FG004|STARTED|HP Washout 2||6
3225287|NCT02310750|3957381|FG005|STARTED|HP Washout 2||0
3225288|NCT02310750|3957382|FG006|STARTED|HP Washout 2||9
3225289|NCT02310750|3957383|FG007|STARTED|HP Washout 2||0
3225290|NCT02310750|3957384|FG008|STARTED|HP Washout 2||0
3225291|NCT02310750|3957385|FG009|STARTED|HP Washout 2||0
3225292|NCT02310750|3957386|FG010|STARTED|HP Washout 2||2
3225293|NCT02310750|3957387|FG011|STARTED|HP Washout 2||2
3225294|NCT02310750|3957388|FG012|STARTED|HP Washout 2||2
3225295|NCT02310750|3957389|FG013|STARTED|HP Washout 2||2
3225296|NCT02310750|3957390|FG014|STARTED|HP Washout 2||2
3225297|NCT02310750|3957391|FG015|STARTED|HP Washout 2||2
3225298|NCT02310750|3957376|FG000|COMPLETED|HP Washout 2||0
3225299|NCT02310750|3957377|FG001|COMPLETED|HP Washout 2||0
3225300|NCT02310750|3957378|FG002|COMPLETED|HP Washout 2||0
3225301|NCT02310750|3957379|FG003|COMPLETED|HP Washout 2||0
3225302|NCT02310750|3957380|FG004|COMPLETED|HP Washout 2||5
3225303|NCT02310750|3957381|FG005|COMPLETED|HP Washout 2||0
3225304|NCT02310750|3957382|FG006|COMPLETED|HP Washout 2||2
3225305|NCT02310750|3957383|FG007|COMPLETED|HP Washout 2||0
3225306|NCT02310750|3957384|FG008|COMPLETED|HP Washout 2||0
3225307|NCT02310750|3957385|FG009|COMPLETED|HP Washout 2||0
3225308|NCT02310750|3957386|FG010|COMPLETED|HP Washout 2||2
3225309|NCT02310750|3957387|FG011|COMPLETED|HP Washout 2||2
3225310|NCT02310750|3957388|FG012|COMPLETED|HP Washout 2||2
3225311|NCT02310750|3957389|FG013|COMPLETED|HP Washout 2||2
3225312|NCT02310750|3957390|FG014|COMPLETED|HP Washout 2||2
3225313|NCT02310750|3957391|FG015|COMPLETED|HP Washout 2||2
3225314|NCT02310750|3957376|FG000|NOT COMPLETED|HP Washout 2||0
3225315|NCT02310750|3957377|FG001|NOT COMPLETED|HP Washout 2||0
3225316|NCT02310750|3957378|FG002|NOT COMPLETED|HP Washout 2||0
3225317|NCT02310750|3957379|FG003|NOT COMPLETED|HP Washout 2||0
3225318|NCT02310750|3957380|FG004|NOT COMPLETED|HP Washout 2||1
3225319|NCT02310750|3957381|FG005|NOT COMPLETED|HP Washout 2||0
3225320|NCT02310750|3957382|FG006|NOT COMPLETED|HP Washout 2||7
3225321|NCT02310750|3957383|FG007|NOT COMPLETED|HP Washout 2||0
3225322|NCT02310750|3957384|FG008|NOT COMPLETED|HP Washout 2||0
3225323|NCT02310750|3957385|FG009|NOT COMPLETED|HP Washout 2||0
3225324|NCT02310750|3957386|FG010|NOT COMPLETED|HP Washout 2||0
3225325|NCT02310750|3957387|FG011|NOT COMPLETED|HP Washout 2||0
3225326|NCT02310750|3957388|FG012|NOT COMPLETED|HP Washout 2||0
3225327|NCT02310750|3957389|FG013|NOT COMPLETED|HP Washout 2||0
3225328|NCT02310750|3957390|FG014|NOT COMPLETED|HP Washout 2||0
3225329|NCT02310750|3957391|FG015|NOT COMPLETED|HP Washout 2||0
3225330|NCT02310750|3957376|FG000|STARTED|HP MAD and Fasted/Fed||0
3225331|NCT02310750|3957377|FG001|STARTED|HP MAD and Fasted/Fed||0
3225332|NCT02310750|3957378|FG002|STARTED|HP MAD and Fasted/Fed||0
3225333|NCT02310750|3957379|FG003|STARTED|HP MAD and Fasted/Fed||0
3225334|NCT02310750|3957380|FG004|STARTED|HP MAD and Fasted/Fed||5
3225335|NCT02310750|3957381|FG005|STARTED|HP MAD and Fasted/Fed||0
3225336|NCT02310750|3957382|FG006|STARTED|HP MAD and Fasted/Fed||2
3225337|NCT02310750|3957383|FG007|STARTED|HP MAD and Fasted/Fed||0
3225338|NCT02310750|3957384|FG008|STARTED|HP MAD and Fasted/Fed||0
3225339|NCT02310750|3957385|FG009|STARTED|HP MAD and Fasted/Fed||0
3225340|NCT02310750|3957386|FG010|STARTED|HP MAD and Fasted/Fed||2
3225341|NCT02310750|3957387|FG011|STARTED|HP MAD and Fasted/Fed||2
3225342|NCT02310750|3957388|FG012|STARTED|HP MAD and Fasted/Fed||2
3225343|NCT02310750|3957389|FG013|STARTED|HP MAD and Fasted/Fed||2
3225344|NCT02310750|3957390|FG014|STARTED|HP MAD and Fasted/Fed||2
3225345|NCT02310750|3957391|FG015|STARTED|HP MAD and Fasted/Fed||2
3225346|NCT02310750|3957376|FG000|COMPLETED|HP MAD and Fasted/Fed||0
3225347|NCT02310750|3957377|FG001|COMPLETED|HP MAD and Fasted/Fed||0
3225348|NCT02310750|3957378|FG002|COMPLETED|HP MAD and Fasted/Fed||0
3225349|NCT02310750|3957379|FG003|COMPLETED|HP MAD and Fasted/Fed||0
3225350|NCT02310750|3957380|FG004|COMPLETED|HP MAD and Fasted/Fed||4
3225351|NCT02310750|3957381|FG005|COMPLETED|HP MAD and Fasted/Fed||0
3225352|NCT02310750|3957382|FG006|COMPLETED|HP MAD and Fasted/Fed||2
3225353|NCT02310750|3957383|FG007|COMPLETED|HP MAD and Fasted/Fed||0
3225354|NCT02310750|3957384|FG008|COMPLETED|HP MAD and Fasted/Fed||0
3225355|NCT02310750|3957385|FG009|COMPLETED|HP MAD and Fasted/Fed||0
3225356|NCT02310750|3957386|FG010|COMPLETED|HP MAD and Fasted/Fed||2
3225357|NCT02310750|3957387|FG011|COMPLETED|HP MAD and Fasted/Fed||2
3225358|NCT02310750|3957388|FG012|COMPLETED|HP MAD and Fasted/Fed||2
3225359|NCT02310750|3957389|FG013|COMPLETED|HP MAD and Fasted/Fed||2
3225360|NCT02310750|3957390|FG014|COMPLETED|HP MAD and Fasted/Fed||2
3225361|NCT02310750|3957391|FG015|COMPLETED|HP MAD and Fasted/Fed||2
3225362|NCT02310750|3957376|FG000|NOT COMPLETED|HP MAD and Fasted/Fed||0
3225363|NCT02310750|3957377|FG001|NOT COMPLETED|HP MAD and Fasted/Fed||0
3225364|NCT02310750|3957378|FG002|NOT COMPLETED|HP MAD and Fasted/Fed||0
3225365|NCT02310750|3957379|FG003|NOT COMPLETED|HP MAD and Fasted/Fed||0
3225366|NCT02310750|3957380|FG004|NOT COMPLETED|HP MAD and Fasted/Fed||1
3225367|NCT02310750|3957381|FG005|NOT COMPLETED|HP MAD and Fasted/Fed||0
3225368|NCT02310750|3957382|FG006|NOT COMPLETED|HP MAD and Fasted/Fed||0
3225369|NCT02310750|3957383|FG007|NOT COMPLETED|HP MAD and Fasted/Fed||0
3225370|NCT02310750|3957384|FG008|NOT COMPLETED|HP MAD and Fasted/Fed||0
3225371|NCT02310750|3957385|FG009|NOT COMPLETED|HP MAD and Fasted/Fed||0
3225372|NCT02310750|3957386|FG010|NOT COMPLETED|HP MAD and Fasted/Fed||0
3225373|NCT02310750|3957387|FG011|NOT COMPLETED|HP MAD and Fasted/Fed||0
3225374|NCT02310750|3957388|FG012|NOT COMPLETED|HP MAD and Fasted/Fed||0
3225375|NCT02310750|3957389|FG013|NOT COMPLETED|HP MAD and Fasted/Fed||0
3225376|NCT02310750|3957390|FG014|NOT COMPLETED|HP MAD and Fasted/Fed||0
3225377|NCT02310750|3957391|FG015|NOT COMPLETED|HP MAD and Fasted/Fed||0
3225378|NCT02310763|3957475|FG000|STARTED|Period 1 (Weeks 1 to 48)||41
3225379|NCT02310763|3957476|FG001|STARTED|Period 1 (Weeks 1 to 48)||39
3225380|NCT02310763|3957477|FG002|STARTED|Period 1 (Weeks 1 to 48)||40
3225381|NCT02310763|3957475|FG000|COMPLETED|Period 1 (Weeks 1 to 48)||38
3225382|NCT02310763|3957476|FG001|COMPLETED|Period 1 (Weeks 1 to 48)||37
3225383|NCT02310763|3957477|FG002|COMPLETED|Period 1 (Weeks 1 to 48)||38
3225384|NCT02310763|3957475|FG000|NOT COMPLETED|Period 1 (Weeks 1 to 48)||3
3225385|NCT02310763|3957476|FG001|NOT COMPLETED|Period 1 (Weeks 1 to 48)||2
3225386|NCT02310763|3957477|FG002|NOT COMPLETED|Period 1 (Weeks 1 to 48)||2
3225387|NCT02310763|3957475|FG000|STARTED|Period 2 (Weeks 49 to 96)||38
3225388|NCT02310763|3957476|FG001|STARTED|Period 2 (Weeks 49 to 96)||37
3225389|NCT02310763|3957477|FG002|STARTED|Period 2 (Weeks 49 to 96)||38
3225390|NCT02310763|3957475|FG000|COMPLETED|Period 2 (Weeks 49 to 96)||22
3225391|NCT02310763|3957476|FG001|COMPLETED|Period 2 (Weeks 49 to 96)||21
3225392|NCT02310763|3957477|FG002|COMPLETED|Period 2 (Weeks 49 to 96)||22
3225393|NCT02310763|3957475|FG000|NOT COMPLETED|Period 2 (Weeks 49 to 96)||16
3225394|NCT02310763|3957476|FG001|NOT COMPLETED|Period 2 (Weeks 49 to 96)||16
3225395|NCT02310763|3957477|FG002|NOT COMPLETED|Period 2 (Weeks 49 to 96)||16
3225396|NCT02310776|3957503|FG000|STARTED|Overall Study||501
3225397|NCT02310776|3957503|FG000|COMPLETED|Overall Study||501
3225398|NCT02310776|3957503|FG000|NOT COMPLETED|Overall Study||0
3225399|NCT02310789|3957507|FG000|STARTED|Overall Study||8
3225400|NCT02310789|3957507|FG000|COMPLETED|Overall Study||7
3225401|NCT02310789|3957507|FG000|NOT COMPLETED|Overall Study||1
3225402|NCT02310906|3957515|FG000|STARTED|Part 1: Double Blind Phase (12 Weeks)||4
3225403|NCT02310906|3957516|FG001|STARTED|Part 1: Double Blind Phase (12 Weeks)||8
3225404|NCT02310906|3957517|FG002|STARTED|Part 1: Double Blind Phase (12 Weeks)||0
3225405|NCT02310906|3957518|FG003|STARTED|Part 1: Double Blind Phase (12 Weeks)||0
3225406|NCT02310906|3957515|FG000|Received 4 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
3225407|NCT02310906|3957516|FG001|Received 4 mg/kg|Part 1: Double Blind Phase (12 Weeks)||8
3225408|NCT02310906|3957517|FG002|Received 4 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
3225409|NCT02310906|3957518|FG003|Received 4 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
3225410|NCT02310906|3957515|FG000|Received 10 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
3225411|NCT02310906|3957516|FG001|Received 10 mg/kg|Part 1: Double Blind Phase (12 Weeks)||8
3225412|NCT02310906|3957517|FG002|Received 10 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
3225413|NCT02310906|3957518|FG003|Received 10 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
3225414|NCT02310906|3957515|FG000|Received 20 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
3225415|NCT02310906|3957516|FG001|Received 20 mg/kg|Part 1: Double Blind Phase (12 Weeks)||8
3225416|NCT02310906|3957517|FG002|Received 20 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
3225417|NCT02310906|3957518|FG003|Received 20 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
3225418|NCT02310906|3957515|FG000|Received 30 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
3225419|NCT02310906|3957516|FG001|Received 30 mg/kg|Part 1: Double Blind Phase (12 Weeks)||8
3225420|NCT02310906|3957517|FG002|Received 30 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
3225421|NCT02310906|3957518|FG003|Received 30 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
3225422|NCT02310906|3957515|FG000|COMPLETED|Part 1: Double Blind Phase (12 Weeks)||4
3225423|NCT02310906|3957516|FG001|COMPLETED|Part 1: Double Blind Phase (12 Weeks)||8
3225424|NCT02310906|3957517|FG002|COMPLETED|Part 1: Double Blind Phase (12 Weeks)||0
3225425|NCT02310906|3957518|FG003|COMPLETED|Part 1: Double Blind Phase (12 Weeks)||0
3225426|NCT02310906|3957515|FG000|NOT COMPLETED|Part 1: Double Blind Phase (12 Weeks)||0
3225427|NCT02310906|3957516|FG001|NOT COMPLETED|Part 1: Double Blind Phase (12 Weeks)||0
3225428|NCT02310906|3957517|FG002|NOT COMPLETED|Part 1: Double Blind Phase (12 Weeks)||0
3225429|NCT02310906|3957518|FG003|NOT COMPLETED|Part 1: Double Blind Phase (12 Weeks)||0
3225430|NCT02310906|3957515|FG000|STARTED|Part 2: Open Label Phase (168 Weeks)||0
3225431|NCT02310906|3957516|FG001|STARTED|Part 2: Open Label Phase (168 Weeks)||0
3225432|NCT02310906|3957517|FG002|STARTED|Part 2: Open Label Phase (168 Weeks)|4 participants from Part 1(Placebo) + 8 participants from Part 1(Golodirsen) +13 new participants|25
3225433|NCT02310906|3957518|FG003|STARTED|Part 2: Open Label Phase (168 Weeks)||14
3225434|NCT02310906|3957515|FG000|COMPLETED|Part 2: Open Label Phase (168 Weeks)||0
3225435|NCT02310906|3957516|FG001|COMPLETED|Part 2: Open Label Phase (168 Weeks)||0
3225436|NCT02310906|3957517|FG002|COMPLETED|Part 2: Open Label Phase (168 Weeks)||23
3225437|NCT02310906|3957518|FG003|COMPLETED|Part 2: Open Label Phase (168 Weeks)||6
3225438|NCT02310906|3957515|FG000|NOT COMPLETED|Part 2: Open Label Phase (168 Weeks)||0
3225439|NCT02310906|3957516|FG001|NOT COMPLETED|Part 2: Open Label Phase (168 Weeks)||0
3225440|NCT02310906|3957517|FG002|NOT COMPLETED|Part 2: Open Label Phase (168 Weeks)||2
3225441|NCT02310906|3957518|FG003|NOT COMPLETED|Part 2: Open Label Phase (168 Weeks)||8
3225442|NCT02311153|3957541|FG000|STARTED|Overall Study||53
3225443|NCT02311153|3957542|FG001|STARTED|Overall Study||49
3225444|NCT02311153|3957541|FG000|COMPLETED|Overall Study||48
3225445|NCT02311153|3957542|FG001|COMPLETED|Overall Study||42
3225446|NCT02311153|3957541|FG000|NOT COMPLETED|Overall Study||5
3225447|NCT02311153|3957542|FG001|NOT COMPLETED|Overall Study||7
3225448|NCT02311309|3957551|FG000|STARTED|Overall Study|There were 863 patients with no peroperative bleeding in the 1439 patients studied|541
3225449|NCT02311309|3957552|FG001|STARTED|Overall Study|There were 863 patients with no peroperative bleeding in the 1439 patients studied|35
3225450|NCT02311309|3957553|FG002|STARTED|Overall Study||863
3225451|NCT02311309|3957551|FG000|COMPLETED|Overall Study||541
3225452|NCT02311309|3957552|FG001|COMPLETED|Overall Study||35
3225453|NCT02311309|3957553|FG002|COMPLETED|Overall Study||863
3225454|NCT02311309|3957551|FG000|NOT COMPLETED|Overall Study||0
3225455|NCT02311309|3957552|FG001|NOT COMPLETED|Overall Study||0
3225456|NCT02311309|3957553|FG002|NOT COMPLETED|Overall Study||0
3225457|NCT02311361|3957565|FG000|STARTED|Overall Study||14
3225458|NCT02311361|3957566|FG001|STARTED|Overall Study||11
3225459|NCT02311361|3957567|FG002|STARTED|Overall Study||19
3225460|NCT02311361|3957568|FG003|STARTED|Overall Study||21
3225461|NCT02311361|3957565|FG000|Received Radiation Therapy Only|Overall Study||0
3225462|NCT02311361|3957566|FG001|Received Radiation Therapy Only|Overall Study||1
3225463|NCT02311361|3957567|FG002|Received Radiation Therapy Only|Overall Study||1
3225464|NCT02311361|3957568|FG003|Received Radiation Therapy Only|Overall Study||1
3225465|NCT02311361|3957565|FG000|COMPLETED|Overall Study||14
3225466|NCT02311361|3957566|FG001|COMPLETED|Overall Study||10
3225467|NCT02311361|3957567|FG002|COMPLETED|Overall Study||19
3225468|NCT02311361|3957568|FG003|COMPLETED|Overall Study||20
3225469|NCT02311361|3957565|FG000|NOT COMPLETED|Overall Study||0
3225470|NCT02311361|3957566|FG001|NOT COMPLETED|Overall Study||1
3225471|NCT02311361|3957567|FG002|NOT COMPLETED|Overall Study||0
3225472|NCT02311361|3957568|FG003|NOT COMPLETED|Overall Study||1
3225473|NCT02311478|3957582|FG000|STARTED|Overall Study||79
3225474|NCT02311478|3957582|FG000|IUD Insertion|Overall Study||78
3225475|NCT02311478|3957582|FG000|COMPLETED|Overall Study||72
3225476|NCT02311478|3957582|FG000|NOT COMPLETED|Overall Study||7
3225477|NCT02311881|3957589|FG000|STARTED|Overall Study|Started refers to all randomized participants.|235
3225478|NCT02311881|3957590|FG001|STARTED|Overall Study|Started refers to all randomized participants.|236
3225479|NCT02311881|3957591|FG002|STARTED|Overall Study|Started refers to all randomized participants.|237
3225480|NCT02311881|3957589|FG000|Safety Population|Overall Study|All treated participants: One participant was randomized but did not receive any treatment.|234
3225481|NCT02311881|3957590|FG001|Safety Population|Overall Study|All treated participants: One participant was randomized but did not receive any treatment.|236
3225482|NCT02311881|3957591|FG002|Safety Population|Overall Study|All treated participants: One participant was randomized but did not receive any treatment.|237
3225483|NCT02311881|3957589|FG000|COMPLETED|Overall Study||200
3225484|NCT02311881|3957590|FG001|COMPLETED|Overall Study||193
3225485|NCT02311881|3957591|FG002|COMPLETED|Overall Study||196
3225486|NCT02311881|3957589|FG000|NOT COMPLETED|Overall Study||35
3225487|NCT02311881|3957590|FG001|NOT COMPLETED|Overall Study||43
3225488|NCT02311881|3957591|FG002|NOT COMPLETED|Overall Study||41
3225489|NCT02311894|3957602|FG000|STARTED|Overall Study||82
3368387|NCT03836989|4099906|FG001|Subjects < 60 Years Old + Complete Paralysis > 15 Days|Overall Study||0
3225490|NCT02311894|3957602|FG000|Modified ITT Population|Overall Study||81
3225491|NCT02311894|3957602|FG000|COMPLETED|Overall Study||78
3225492|NCT02311894|3957602|FG000|NOT COMPLETED|Overall Study||4
3225493|NCT02311907|3957608|FG000|STARTED|Overall Study||94
3225494|NCT02311907|3957609|FG001|STARTED|Overall Study||91
3225495|NCT02311907|3957608|FG000|COMPLETED|Overall Study||94
3225496|NCT02311907|3957609|FG001|COMPLETED|Overall Study||91
3225497|NCT02311907|3957608|FG000|NOT COMPLETED|Overall Study||0
3225498|NCT02311907|3957609|FG001|NOT COMPLETED|Overall Study||0
3225499|NCT02311933|3957617|FG000|STARTED|Overall Study||41
3225500|NCT02311933|3957618|FG001|STARTED|Overall Study||40
3225501|NCT02311933|3957617|FG000|COMPLETED|Overall Study||41
3225502|NCT02311933|3957618|FG001|COMPLETED|Overall Study||40
3225503|NCT02311933|3957617|FG000|NOT COMPLETED|Overall Study||0
3225504|NCT02311933|3957618|FG001|NOT COMPLETED|Overall Study||0
3225505|NCT02311972|3957626|FG000|STARTED|Overall Study||12
3225506|NCT02311972|3957627|FG001|STARTED|Overall Study||8
3225507|NCT02311972|3957626|FG000|COMPLETED|Overall Study||12
3225508|NCT02311972|3957627|FG001|COMPLETED|Overall Study||8
3225509|NCT02311972|3957626|FG000|NOT COMPLETED|Overall Study||0
3225510|NCT02311972|3957627|FG001|NOT COMPLETED|Overall Study||0
3225511|NCT02312063|3957636|FG000|STARTED|Overall Study||23
3225512|NCT02312063|3957637|FG001|STARTED|Overall Study||25
3225513|NCT02312063|3957636|FG000|COMPLETED|Overall Study||23
3225514|NCT02312063|3957637|FG001|COMPLETED|Overall Study||24
3225515|NCT02312063|3957636|FG000|NOT COMPLETED|Overall Study||0
3225516|NCT02312063|3957637|FG001|NOT COMPLETED|Overall Study||1
3225517|NCT02312154|3957644|FG000|STARTED|Overall Study||25
3225518|NCT02312154|3957644|FG000|COMPLETED|Overall Study||24
3225519|NCT02312154|3957644|FG000|NOT COMPLETED|Overall Study||1
3225520|NCT02312206|3957651|FG000|STARTED|Overall Study||130
3225521|NCT02312206|3957652|FG001|STARTED|Overall Study||130
3368388|NCT03836989|4099905|FG000|COMPLETED|Overall Study||4
3368389|NCT03836989|4099906|FG001|COMPLETED|Overall Study||0
3368390|NCT03836989|4099905|FG000|NOT COMPLETED|Overall Study||0
3368391|NCT03836989|4099906|FG001|NOT COMPLETED|Overall Study||0
3368392|NCT03827564|4099917|FG000|STARTED|Overall Study||9
3368393|NCT03827564|4099918|FG001|STARTED|Overall Study||5
3368394|NCT03827564|4099917|FG000|COMPLETED|Overall Study||8
3368395|NCT03827564|4099918|FG001|COMPLETED|Overall Study||5
3368396|NCT03827564|4099917|FG000|NOT COMPLETED|Overall Study||1
3368397|NCT03827564|4099918|FG001|NOT COMPLETED|Overall Study||0
3368398|NCT03824236|4099927|FG000|STARTED|Overall Study||25
3368399|NCT03824236|4099928|FG001|STARTED|Overall Study||24
3368400|NCT03824236|4099929|FG002|STARTED|Overall Study||12
3368401|NCT03824236|4099927|FG000|COMPLETED|Overall Study||25
3368402|NCT03824236|4099928|FG001|COMPLETED|Overall Study||24
3368403|NCT03824236|4099929|FG002|COMPLETED|Overall Study||11
3368404|NCT03824236|4099927|FG000|NOT COMPLETED|Overall Study||0
3368405|NCT03824236|4099928|FG001|NOT COMPLETED|Overall Study||0
3368406|NCT03824236|4099929|FG002|NOT COMPLETED|Overall Study||1
3368407|NCT03811951|4099939|FG000|STARTED|First Intervention (1 Day)||2
3368408|NCT03811951|4099940|FG001|STARTED|First Intervention (1 Day)||2
3368409|NCT03811951|4099939|FG000|COMPLETED|First Intervention (1 Day)||2
3368410|NCT03811951|4099940|FG001|COMPLETED|First Intervention (1 Day)||2
3368411|NCT03811951|4099939|FG000|NOT COMPLETED|First Intervention (1 Day)||0
3368412|NCT03811951|4099940|FG001|NOT COMPLETED|First Intervention (1 Day)||0
3368413|NCT03811951|4099939|FG000|STARTED|Washout (1 Week)||2
3368414|NCT03811951|4099940|FG001|STARTED|Washout (1 Week)||2
3368415|NCT03811951|4099939|FG000|COMPLETED|Washout (1 Week)||2
3368416|NCT03811951|4099940|FG001|COMPLETED|Washout (1 Week)||2
3368417|NCT03811951|4099939|FG000|NOT COMPLETED|Washout (1 Week)||0
3368418|NCT03811951|4099940|FG001|NOT COMPLETED|Washout (1 Week)||0
3368419|NCT03811951|4099939|FG000|STARTED|Second Intervention (1 Day)||2
3368420|NCT03811951|4099940|FG001|STARTED|Second Intervention (1 Day)||2
3368421|NCT03811951|4099939|FG000|COMPLETED|Second Intervention (1 Day)||2
3368422|NCT03811951|4099940|FG001|COMPLETED|Second Intervention (1 Day)||2
3368423|NCT03811951|4099939|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
3368424|NCT03811951|4099940|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
3368425|NCT03810235|4099950|FG000|STARTED|Overall Study||32
3368426|NCT03810235|4099951|FG001|STARTED|Overall Study||31
3368427|NCT03810235|4099950|FG000|Participant Data Analyzed|Overall Study||30
3368428|NCT03810235|4099951|FG001|Participant Data Analyzed|Overall Study||31
3368429|NCT03810235|4099950|FG000|COMPLETED|Overall Study||30
3368430|NCT03810235|4099951|FG001|COMPLETED|Overall Study||31
3368431|NCT03810235|4099950|FG000|NOT COMPLETED|Overall Study||2
3368432|NCT03810235|4099951|FG001|NOT COMPLETED|Overall Study||0
3368433|NCT03806556|4099960|FG000|STARTED|Overall Study||6
3368434|NCT03806556|4099961|FG001|STARTED|Overall Study||5
3225522|NCT02312206|3957651|FG000|Informed Consent Obtained|Overall Study||130
3225523|NCT02312206|3957652|FG001|Informed Consent Obtained|Overall Study||130
3225524|NCT02312206|3957651|FG000|COMPLETED|Overall Study||0
3225525|NCT02312206|3957652|FG001|COMPLETED|Overall Study||0
3225526|NCT02312206|3957651|FG000|NOT COMPLETED|Overall Study||130
3225527|NCT02312206|3957652|FG001|NOT COMPLETED|Overall Study||130
3225528|NCT02312219|3957660|FG000|STARTED|Overall Study||13
3225529|NCT02312219|3957661|FG001|STARTED|Overall Study||22
3368435|NCT03806556|4099960|FG000|COMPLETED|Overall Study||6
3368436|NCT03806556|4099961|FG001|COMPLETED|Overall Study||5
3368437|NCT03806556|4099960|FG000|NOT COMPLETED|Overall Study||0
3368438|NCT03806556|4099961|FG001|NOT COMPLETED|Overall Study||0
3225530|NCT02312219|3957660|FG000|COMPLETED|Overall Study||12
3225531|NCT02312219|3957661|FG001|COMPLETED|Overall Study||16
3225532|NCT02312219|3957660|FG000|NOT COMPLETED|Overall Study||1
3225533|NCT02312219|3957661|FG001|NOT COMPLETED|Overall Study||6
3225534|NCT02312310|3957671|FG000|STARTED|Overall Study||53
3225535|NCT02312310|3957672|FG001|STARTED|Overall Study||53
3225536|NCT02312310|3957673|FG002|STARTED|Overall Study||53
3225537|NCT02312310|3957674|FG003|STARTED|Overall Study||52
3225538|NCT02312310|3957671|FG000|COMPLETED|Overall Study||51
3225539|NCT02312310|3957672|FG001|COMPLETED|Overall Study||51
3225540|NCT02312310|3957673|FG002|COMPLETED|Overall Study||50
3225541|NCT02312310|3957674|FG003|COMPLETED|Overall Study||52
3225542|NCT02312310|3957671|FG000|NOT COMPLETED|Overall Study||2
3225543|NCT02312310|3957672|FG001|NOT COMPLETED|Overall Study||2
3225544|NCT02312310|3957673|FG002|NOT COMPLETED|Overall Study||3
3225545|NCT02312310|3957674|FG003|NOT COMPLETED|Overall Study||0
3225546|NCT02312622|3957691|FG000|STARTED|Overall Study||12
3225547|NCT02312622|3957692|FG001|STARTED|Overall Study||3
3225548|NCT02312622|3957693|FG002|STARTED|Overall Study||12
3225549|NCT02312622|3957691|FG000|COMPLETED|Overall Study||12
3225550|NCT02312622|3957692|FG001|COMPLETED|Overall Study||3
3225551|NCT02312622|3957693|FG002|COMPLETED|Overall Study||12
3225552|NCT02312622|3957691|FG000|NOT COMPLETED|Overall Study||0
3225553|NCT02312622|3957692|FG001|NOT COMPLETED|Overall Study||0
3225554|NCT02312622|3957693|FG002|NOT COMPLETED|Overall Study||0
3225555|NCT02312687|3957704|FG000|STARTED|Overall Study||20
3225556|NCT02312687|3957704|FG000|COMPLETED|Overall Study||19
3225557|NCT02312687|3957704|FG000|NOT COMPLETED|Overall Study||1
3225558|NCT02312713|3957711|FG000|STARTED|Overall Study||140
3225559|NCT02312713|3957712|FG001|STARTED|Overall Study||142
3225560|NCT02312713|3957713|FG002|STARTED|Overall Study||68
3225561|NCT02312713|3957711|FG000|COMPLETED|Overall Study||129
3225562|NCT02312713|3957712|FG001|COMPLETED|Overall Study||112
3225563|NCT02312713|3957713|FG002|COMPLETED|Overall Study||63
3225564|NCT02312713|3957711|FG000|NOT COMPLETED|Overall Study||11
3225565|NCT02312713|3957712|FG001|NOT COMPLETED|Overall Study||30
3225566|NCT02312713|3957713|FG002|NOT COMPLETED|Overall Study||5
3225567|NCT02312726|3957721|FG000|STARTED|Overall Study||38
3225568|NCT02312726|3957722|FG001|STARTED|Overall Study||30
3225569|NCT02312726|3957723|FG002|STARTED|Overall Study||67
3225570|NCT02312726|3957721|FG000|COMPLETED|Overall Study||38
3225571|NCT02312726|3957722|FG001|COMPLETED|Overall Study||30
3225572|NCT02312726|3957723|FG002|COMPLETED|Overall Study||0
3225573|NCT02312726|3957721|FG000|NOT COMPLETED|Overall Study||0
3225574|NCT02312726|3957722|FG001|NOT COMPLETED|Overall Study||0
3225575|NCT02312726|3957723|FG002|NOT COMPLETED|Overall Study||67
3225576|NCT02312739|3957732|FG000|STARTED|Overall Study||36
3225577|NCT02312739|3957733|FG001|STARTED|Overall Study||36
3225578|NCT02312739|3957732|FG000|Withdrawn Prior to Procedure|Overall Study||6
3225579|NCT02312739|3957733|FG001|Withdrawn Prior to Procedure|Overall Study||2
3225580|NCT02312739|3957732|FG000|COMPLETED|Overall Study||30
3225581|NCT02312739|3957733|FG001|COMPLETED|Overall Study||34
3225582|NCT02312739|3957732|FG000|NOT COMPLETED|Overall Study||6
3225583|NCT02312739|3957733|FG001|NOT COMPLETED|Overall Study||2
3225584|NCT02312765|3957741|FG000|STARTED|Overall Study||74
3225585|NCT02312765|3957742|FG001|STARTED|Overall Study||72
3225586|NCT02312765|3957741|FG000|COMPLETED|Overall Study||19
3225587|NCT02312765|3957742|FG001|COMPLETED|Overall Study||36
3225588|NCT02312765|3957741|FG000|NOT COMPLETED|Overall Study||55
3225589|NCT02312765|3957742|FG001|NOT COMPLETED|Overall Study||36
3225590|NCT02312856|3957748|FG000|STARTED|Overall Study||34
3225591|NCT02312856|3957748|FG000|COMPLETED|Overall Study||30
3225592|NCT02312856|3957748|FG000|NOT COMPLETED|Overall Study||4
3225593|NCT02312882|3957752|FG000|STARTED|Overall Study||40
3225594|NCT02312882|3957752|FG000|COMPLETED|Overall Study||36
3225595|NCT02312882|3957752|FG000|NOT COMPLETED|Overall Study||4
3225596|NCT02312934|3957758|FG000|STARTED|Overall Study||11
3225597|NCT02312934|3957759|FG001|STARTED|Overall Study||11
3225598|NCT02312934|3957758|FG000|COMPLETED|Overall Study||9
3225599|NCT02312934|3957759|FG001|COMPLETED|Overall Study||11
3225600|NCT02312934|3957758|FG000|NOT COMPLETED|Overall Study||2
3225601|NCT02312934|3957759|FG001|NOT COMPLETED|Overall Study||0
3225602|NCT02312986|3957766|FG000|STARTED|Overall Study||1
3225603|NCT02312986|3957766|FG000|COMPLETED|Overall Study||1
3225604|NCT02312986|3957766|FG000|NOT COMPLETED|Overall Study||0
3225605|NCT02313155|3957772|FG000|STARTED|Overall Study||55
3225606|NCT02313155|3957773|FG001|STARTED|Overall Study||55
3225607|NCT02313155|3957772|FG000|COMPLETED|Overall Study||55
3225608|NCT02313155|3957773|FG001|COMPLETED|Overall Study||54
3225609|NCT02313155|3957772|FG000|NOT COMPLETED|Overall Study||0
3225610|NCT02313155|3957773|FG001|NOT COMPLETED|Overall Study||1
3225611|NCT02313233|3957781|FG000|STARTED|Overall Study||20
3225612|NCT02313233|3957782|FG001|STARTED|Overall Study||21
3225613|NCT02313233|3957781|FG000|COMPLETED|Overall Study||18
3225614|NCT02313233|3957782|FG001|COMPLETED|Overall Study||18
3225615|NCT02313233|3957781|FG000|NOT COMPLETED|Overall Study||2
3225616|NCT02313233|3957782|FG001|NOT COMPLETED|Overall Study||3
3225617|NCT02313454|3957790|FG000|STARTED|Treatment 1||9
3225618|NCT02313454|3957791|FG001|STARTED|Treatment 1||11
3225619|NCT02313454|3957790|FG000|COMPLETED|Treatment 1||9
3225620|NCT02313454|3957791|FG001|COMPLETED|Treatment 1||11
3225621|NCT02313454|3957790|FG000|NOT COMPLETED|Treatment 1||0
3225622|NCT02313454|3957791|FG001|NOT COMPLETED|Treatment 1||0
3225623|NCT02313454|3957790|FG000|STARTED|Treatment 2|1 participant did not receive the second application.|8
3225624|NCT02313454|3957791|FG001|STARTED|Treatment 2|1 participant did not receive the second application.|10
3225625|NCT02313454|3957790|FG000|COMPLETED|Treatment 2||8
3225626|NCT02313454|3957791|FG001|COMPLETED|Treatment 2||10
3225627|NCT02313454|3957790|FG000|NOT COMPLETED|Treatment 2||0
3225628|NCT02313454|3957791|FG001|NOT COMPLETED|Treatment 2||0
3225629|NCT02313506|3957799|FG000|STARTED|Overall Study||17
3225630|NCT02313506|3957800|FG001|STARTED|Overall Study||17
3225631|NCT02313506|3957799|FG000|COMPLETED|Overall Study||17
3225632|NCT02313506|3957800|FG001|COMPLETED|Overall Study||17
3225633|NCT02313506|3957799|FG000|NOT COMPLETED|Overall Study||0
3225634|NCT02313506|3957800|FG001|NOT COMPLETED|Overall Study||0
3225635|NCT02313558|3957809|FG000|STARTED|Overall Study||50
3225636|NCT02313558|3957810|FG001|STARTED|Overall Study||50
3225637|NCT02313558|3957809|FG000|COMPLETED|Overall Study||44
3225638|NCT02313558|3957810|FG001|COMPLETED|Overall Study||46
3225639|NCT02313558|3957809|FG000|NOT COMPLETED|Overall Study||6
3225640|NCT02313558|3957810|FG001|NOT COMPLETED|Overall Study||4
3225641|NCT02313597|3957818|FG000|STARTED|Overall Study||40
3225642|NCT02313597|3957819|FG001|STARTED|Overall Study||40
3225643|NCT02313597|3957818|FG000|COMPLETED|Overall Study||40
3225644|NCT02313597|3957819|FG001|COMPLETED|Overall Study||40
3225645|NCT02313597|3957818|FG000|NOT COMPLETED|Overall Study||0
3225646|NCT02313597|3957819|FG001|NOT COMPLETED|Overall Study||0
3225647|NCT02313675|3957829|FG000|STARTED|Overall Study||11
3225648|NCT02313675|3957830|FG001|STARTED|Overall Study||11
3225649|NCT02313675|3957831|FG002|STARTED|Overall Study||11
3225650|NCT02313675|3957832|FG003|STARTED|Overall Study||11
3225651|NCT02313675|3957829|FG000|COMPLETED|Overall Study||11
3225652|NCT02313675|3957830|FG001|COMPLETED|Overall Study||11
3225653|NCT02313675|3957831|FG002|COMPLETED|Overall Study||11
3225654|NCT02313675|3957832|FG003|COMPLETED|Overall Study||11
3225655|NCT02313675|3957829|FG000|NOT COMPLETED|Overall Study||0
3225656|NCT02313675|3957830|FG001|NOT COMPLETED|Overall Study||0
3225657|NCT02313675|3957831|FG002|NOT COMPLETED|Overall Study||0
3225658|NCT02313675|3957832|FG003|NOT COMPLETED|Overall Study||0
3225659|NCT02313766|3957845|FG000|STARTED|Overall Study||50
3225660|NCT02313766|3957846|FG001|STARTED|Overall Study||50
3225661|NCT02313766|3957847|FG002|STARTED|Overall Study||50
3225662|NCT02313766|3957845|FG000|COMPLETED|Overall Study||49
3225663|NCT02313766|3957846|FG001|COMPLETED|Overall Study||47
3225664|NCT02313766|3957847|FG002|COMPLETED|Overall Study||50
3225665|NCT02313766|3957845|FG000|NOT COMPLETED|Overall Study||1
3225666|NCT02313766|3957846|FG001|NOT COMPLETED|Overall Study||3
3225667|NCT02313766|3957847|FG002|NOT COMPLETED|Overall Study||0
3225668|NCT02313909|3957857|FG000|STARTED|Overall Study||3609
3225669|NCT02313909|3957858|FG001|STARTED|Overall Study||3604
3225670|NCT02313909|3957857|FG000|Treated|Overall Study||3562
3225671|NCT02313909|3957858|FG001|Treated|Overall Study||3559
3225672|NCT02313909|3957857|FG000|COMPLETED|Overall Study||3552
3225673|NCT02313909|3957858|FG001|COMPLETED|Overall Study||3554
3225674|NCT02313909|3957857|FG000|NOT COMPLETED|Overall Study||57
3225675|NCT02313909|3957858|FG001|NOT COMPLETED|Overall Study||50
3225676|NCT02314000|3957866|FG000|STARTED|Overall Study||75
3225677|NCT02314000|3957867|FG001|STARTED|Overall Study||65
3225678|NCT02314000|3957866|FG000|COMPLETED|Overall Study||62
3225679|NCT02314000|3957867|FG001|COMPLETED|Overall Study||57
3225680|NCT02314000|3957866|FG000|NOT COMPLETED|Overall Study||13
3225681|NCT02314000|3957867|FG001|NOT COMPLETED|Overall Study||8
3225682|NCT02314026|3957874|FG000|STARTED|Overall Study||135
3225683|NCT02314026|3957874|FG000|COMPLETED|Overall Study||107
3225684|NCT02314026|3957874|FG000|NOT COMPLETED|Overall Study||28
3225685|NCT02314052|3957878|FG000|STARTED|Cycle One||3
3225686|NCT02314052|3957879|FG001|STARTED|Cycle One||3
3225687|NCT02314052|3957880|FG002|STARTED|Cycle One||3
3225688|NCT02314052|3957881|FG003|STARTED|Cycle One||3
3225689|NCT02314052|3957882|FG004|STARTED|Cycle One||6
3225690|NCT02314052|3957883|FG005|STARTED|Cycle One||3
3225691|NCT02314052|3957878|FG000|COMPLETED|Cycle One||3
3225692|NCT02314052|3957879|FG001|COMPLETED|Cycle One||3
3225693|NCT02314052|3957880|FG002|COMPLETED|Cycle One||3
3225694|NCT02314052|3957881|FG003|COMPLETED|Cycle One||2
3225695|NCT02314052|3957882|FG004|COMPLETED|Cycle One||6
3225696|NCT02314052|3957883|FG005|COMPLETED|Cycle One||3
3225697|NCT02314052|3957878|FG000|NOT COMPLETED|Cycle One||0
3225698|NCT02314052|3957879|FG001|NOT COMPLETED|Cycle One||0
3225699|NCT02314052|3957880|FG002|NOT COMPLETED|Cycle One||0
3225700|NCT02314052|3957881|FG003|NOT COMPLETED|Cycle One||1
3225701|NCT02314052|3957882|FG004|NOT COMPLETED|Cycle One||0
3225702|NCT02314052|3957883|FG005|NOT COMPLETED|Cycle One||0
3225703|NCT02314052|3957878|FG000|STARTED|Cycle Two||3
3225704|NCT02314052|3957879|FG001|STARTED|Cycle Two||3
3225705|NCT02314052|3957880|FG002|STARTED|Cycle Two||3
3225706|NCT02314052|3957881|FG003|STARTED|Cycle Two||2
3225707|NCT02314052|3957882|FG004|STARTED|Cycle Two||6
3225708|NCT02314052|3957883|FG005|STARTED|Cycle Two||3
3225709|NCT02314052|3957878|FG000|COMPLETED|Cycle Two||3
3225710|NCT02314052|3957879|FG001|COMPLETED|Cycle Two||2
3225711|NCT02314052|3957880|FG002|COMPLETED|Cycle Two||2
3225712|NCT02314052|3957881|FG003|COMPLETED|Cycle Two||1
3225713|NCT02314052|3957882|FG004|COMPLETED|Cycle Two||2
3225714|NCT02314052|3957883|FG005|COMPLETED|Cycle Two||3
3225715|NCT02314052|3957878|FG000|NOT COMPLETED|Cycle Two||0
3225716|NCT02314052|3957879|FG001|NOT COMPLETED|Cycle Two||1
3225717|NCT02314052|3957880|FG002|NOT COMPLETED|Cycle Two||1
3225718|NCT02314052|3957881|FG003|NOT COMPLETED|Cycle Two||1
3225719|NCT02314052|3957882|FG004|NOT COMPLETED|Cycle Two||4
3225720|NCT02314052|3957883|FG005|NOT COMPLETED|Cycle Two||0
3225721|NCT02314052|3957878|FG000|STARTED|Cycle Three||3
3225722|NCT02314052|3957879|FG001|STARTED|Cycle Three||2
3225723|NCT02314052|3957880|FG002|STARTED|Cycle Three||2
3225724|NCT02314052|3957881|FG003|STARTED|Cycle Three||1
3225725|NCT02314052|3957882|FG004|STARTED|Cycle Three||2
3225726|NCT02314052|3957883|FG005|STARTED|Cycle Three||3
3225727|NCT02314052|3957878|FG000|COMPLETED|Cycle Three||3
3225728|NCT02314052|3957879|FG001|COMPLETED|Cycle Three|1 of 2 completers in cohort 2 (subject 02-005) only completed 1 of 2 infusions during this cycle|2
3225729|NCT02314052|3957880|FG002|COMPLETED|Cycle Three||2
3225730|NCT02314052|3957881|FG003|COMPLETED|Cycle Three||1
3225731|NCT02314052|3957882|FG004|COMPLETED|Cycle Three||2
3225732|NCT02314052|3957883|FG005|COMPLETED|Cycle Three||3
3225733|NCT02314052|3957878|FG000|NOT COMPLETED|Cycle Three||0
3225734|NCT02314052|3957879|FG001|NOT COMPLETED|Cycle Three||0
3225735|NCT02314052|3957880|FG002|NOT COMPLETED|Cycle Three||0
3225736|NCT02314052|3957881|FG003|NOT COMPLETED|Cycle Three||0
3225737|NCT02314052|3957882|FG004|NOT COMPLETED|Cycle Three||0
3225738|NCT02314052|3957883|FG005|NOT COMPLETED|Cycle Three||0
3225739|NCT02314052|3957878|FG000|STARTED|Cycle Four||3
3225740|NCT02314052|3957879|FG001|STARTED|Cycle Four||2
3225741|NCT02314052|3957880|FG002|STARTED|Cycle Four||2
3225742|NCT02314052|3957881|FG003|STARTED|Cycle Four||1
3225743|NCT02314052|3957882|FG004|STARTED|Cycle Four||2
3225744|NCT02314052|3957883|FG005|STARTED|Cycle Four||3
3225745|NCT02314052|3957878|FG000|COMPLETED|Cycle Four||0
3225746|NCT02314052|3957879|FG001|COMPLETED|Cycle Four||2
3225747|NCT02314052|3957880|FG002|COMPLETED|Cycle Four||1
3225748|NCT02314052|3957881|FG003|COMPLETED|Cycle Four||0
3225749|NCT02314052|3957882|FG004|COMPLETED|Cycle Four||2
3225750|NCT02314052|3957883|FG005|COMPLETED|Cycle Four||0
3225751|NCT02314052|3957878|FG000|NOT COMPLETED|Cycle Four||3
3225752|NCT02314052|3957879|FG001|NOT COMPLETED|Cycle Four||0
3225753|NCT02314052|3957880|FG002|NOT COMPLETED|Cycle Four||1
3225754|NCT02314052|3957881|FG003|NOT COMPLETED|Cycle Four||1
3225755|NCT02314052|3957882|FG004|NOT COMPLETED|Cycle Four||0
3225756|NCT02314052|3957883|FG005|NOT COMPLETED|Cycle Four||3
3225757|NCT02314052|3957878|FG000|STARTED|Cycle Five||0
3225758|NCT02314052|3957879|FG001|STARTED|Cycle Five||2
3225759|NCT02314052|3957880|FG002|STARTED|Cycle Five||1
3225760|NCT02314052|3957881|FG003|STARTED|Cycle Five|subject missed cycle four but returned for cycle 5|1
3225761|NCT02314052|3957882|FG004|STARTED|Cycle Five||2
3225762|NCT02314052|3957883|FG005|STARTED|Cycle Five||0
3225763|NCT02314052|3957878|FG000|COMPLETED|Cycle Five||0
3225764|NCT02314052|3957879|FG001|COMPLETED|Cycle Five||0
3225765|NCT02314052|3957880|FG002|COMPLETED|Cycle Five||0
3225766|NCT02314052|3957881|FG003|COMPLETED|Cycle Five|subject missed cycle four but returned for cycle 5|1
3225767|NCT02314052|3957882|FG004|COMPLETED|Cycle Five||2
3225768|NCT02314052|3957883|FG005|COMPLETED|Cycle Five||0
3368439|NCT03836664|4099970|FG000|STARTED|Overall Study||14
3368440|NCT03836664|4099971|FG001|STARTED|Overall Study||11
3368441|NCT03836664|4099970|FG000|COMPLETED|Overall Study||11
3368442|NCT03836664|4099971|FG001|COMPLETED|Overall Study||8
3368443|NCT03836664|4099970|FG000|NOT COMPLETED|Overall Study||3
3368444|NCT03836664|4099971|FG001|NOT COMPLETED|Overall Study||3
3368445|NCT03832738|4099984|FG000|STARTED|Overall Study||51
3368446|NCT03832738|4099985|FG001|STARTED|Overall Study||50
3368447|NCT03832738|4099986|FG002|STARTED|Overall Study||51
3368448|NCT03832738|4099984|FG000|COMPLETED|Overall Study||43
3368449|NCT03832738|4099985|FG001|COMPLETED|Overall Study||38
3368450|NCT03832738|4099986|FG002|COMPLETED|Overall Study||32
3368451|NCT03832738|4099984|FG000|NOT COMPLETED|Overall Study||8
3368452|NCT03832738|4099985|FG001|NOT COMPLETED|Overall Study||12
3368453|NCT03832738|4099986|FG002|NOT COMPLETED|Overall Study||19
3368454|NCT03823391|4099996|FG000|STARTED|Period 1: Week 1 to Week 12||17
3368455|NCT03823391|4099997|FG001|STARTED|Period 1: Week 1 to Week 12||31
3368456|NCT03823391|4099996|FG000|COMPLETED|Period 1: Week 1 to Week 12||17
3368457|NCT03823391|4099997|FG001|COMPLETED|Period 1: Week 1 to Week 12||31
3368458|NCT03823391|4099996|FG000|NOT COMPLETED|Period 1: Week 1 to Week 12||0
3368459|NCT03823391|4099997|FG001|NOT COMPLETED|Period 1: Week 1 to Week 12||0
3368460|NCT03823391|4099996|FG000|STARTED|Period 2: Weeks 12 to Week 24||17
3368461|NCT03823391|4099997|FG001|STARTED|Period 2: Weeks 12 to Week 24||31
3368462|NCT03823391|4099996|FG000|COMPLETED|Period 2: Weeks 12 to Week 24||15
3368463|NCT03823391|4099997|FG001|COMPLETED|Period 2: Weeks 12 to Week 24||30
3368464|NCT03823391|4099996|FG000|NOT COMPLETED|Period 2: Weeks 12 to Week 24||2
3368465|NCT03823391|4099997|FG001|NOT COMPLETED|Period 2: Weeks 12 to Week 24||1
3225769|NCT02314052|3957878|FG000|NOT COMPLETED|Cycle Five||0
3225770|NCT02314052|3957879|FG001|NOT COMPLETED|Cycle Five||2
3225771|NCT02314052|3957880|FG002|NOT COMPLETED|Cycle Five||1
3225772|NCT02314052|3957881|FG003|NOT COMPLETED|Cycle Five||0
3225773|NCT02314052|3957882|FG004|NOT COMPLETED|Cycle Five||0
3225774|NCT02314052|3957883|FG005|NOT COMPLETED|Cycle Five||0
3225775|NCT02314052|3957878|FG000|STARTED|Cycles 6 -10.5||0
3225776|NCT02314052|3957879|FG001|STARTED|Cycles 6 -10.5||0
3225777|NCT02314052|3957880|FG002|STARTED|Cycles 6 -10.5||0
3225778|NCT02314052|3957881|FG003|STARTED|Cycles 6 -10.5||1
3225779|NCT02314052|3957882|FG004|STARTED|Cycles 6 -10.5||2
3225780|NCT02314052|3957883|FG005|STARTED|Cycles 6 -10.5||0
3225781|NCT02314052|3957878|FG000|COMPLETED|Cycles 6 -10.5||0
3225782|NCT02314052|3957879|FG001|COMPLETED|Cycles 6 -10.5||0
3225783|NCT02314052|3957880|FG002|COMPLETED|Cycles 6 -10.5||0
3225784|NCT02314052|3957881|FG003|COMPLETED|Cycles 6 -10.5||1
3225785|NCT02314052|3957882|FG004|COMPLETED|Cycles 6 -10.5|Subject 02-014 only completed 1 of 2 doses in cycle 6|2
3225786|NCT02314052|3957883|FG005|COMPLETED|Cycles 6 -10.5||0
3225787|NCT02314052|3957878|FG000|NOT COMPLETED|Cycles 6 -10.5||0
3225788|NCT02314052|3957879|FG001|NOT COMPLETED|Cycles 6 -10.5||0
3225789|NCT02314052|3957880|FG002|NOT COMPLETED|Cycles 6 -10.5||0
3225790|NCT02314052|3957881|FG003|NOT COMPLETED|Cycles 6 -10.5||0
3225791|NCT02314052|3957882|FG004|NOT COMPLETED|Cycles 6 -10.5||0
3225792|NCT02314052|3957883|FG005|NOT COMPLETED|Cycles 6 -10.5||0
3225793|NCT02314104|3957900|FG000|STARTED|Overall Study||71
3225794|NCT02314104|3957901|FG001|STARTED|Overall Study||78
3225795|NCT02314104|3957902|FG002|STARTED|Overall Study||71
3225796|NCT02314104|3957900|FG000|COMPLETED|Overall Study||57
3225797|NCT02314104|3957901|FG001|COMPLETED|Overall Study||58
3225798|NCT02314104|3957902|FG002|COMPLETED|Overall Study||53
3225799|NCT02314104|3957900|FG000|NOT COMPLETED|Overall Study||14
3225800|NCT02314104|3957901|FG001|NOT COMPLETED|Overall Study||20
3225801|NCT02314104|3957902|FG002|NOT COMPLETED|Overall Study||18
3225802|NCT02314117|3957912|FG000|STARTED|Overall Study||326
3225803|NCT02314117|3957913|FG001|STARTED|Overall Study||319
3225804|NCT02314117|3957912|FG000|Received at Least One Dose of Study Drug|Overall Study||323
3225805|NCT02314117|3957913|FG001|Received at Least One Dose of Study Drug|Overall Study||315
3225806|NCT02314117|3957912|FG000|COMPLETED|Overall Study||314
3225807|NCT02314117|3957913|FG001|COMPLETED|Overall Study||303
3225808|NCT02314117|3957912|FG000|NOT COMPLETED|Overall Study||12
3225809|NCT02314117|3957913|FG001|NOT COMPLETED|Overall Study||16
3225810|NCT02314143|3957923|FG000|STARTED|Overall Study||16
3225811|NCT02314143|3957924|FG001|STARTED|Overall Study||16
3225812|NCT02314143|3957925|FG002|STARTED|Overall Study||16
3225813|NCT02314143|3957923|FG000|COMPLETED|Overall Study||8
3225814|NCT02314143|3957924|FG001|COMPLETED|Overall Study||6
3225815|NCT02314143|3957925|FG002|COMPLETED|Overall Study||7
3225816|NCT02314143|3957923|FG000|NOT COMPLETED|Overall Study||8
3225817|NCT02314143|3957924|FG001|NOT COMPLETED|Overall Study||10
3225818|NCT02314143|3957925|FG002|NOT COMPLETED|Overall Study||9
3225819|NCT02314247|3957936|FG000|STARTED|Overall Study||9
3225820|NCT02314247|3957937|FG001|STARTED|Overall Study||6
3225821|NCT02314247|3957938|FG002|STARTED|Overall Study||1
3225822|NCT02314247|3957936|FG000|COMPLETED|Overall Study||0
3225823|NCT02314247|3957937|FG001|COMPLETED|Overall Study||0
3225824|NCT02314247|3957938|FG002|COMPLETED|Overall Study||0
3225825|NCT02314247|3957936|FG000|NOT COMPLETED|Overall Study||9
3225826|NCT02314247|3957937|FG001|NOT COMPLETED|Overall Study||6
3225827|NCT02314247|3957938|FG002|NOT COMPLETED|Overall Study||1
3225828|NCT02314260|3957948|FG000|STARTED|Overall Study||80
3225829|NCT02314260|3957948|FG000|COMPLETED|Overall Study||80
3225830|NCT02314260|3957948|FG000|NOT COMPLETED|Overall Study||0
3225831|NCT02314403|3957952|FG000|STARTED|Overall Study||2
3225832|NCT02314403|3957952|FG000|COMPLETED|Overall Study||2
3225833|NCT02314403|3957952|FG000|NOT COMPLETED|Overall Study||0
3225834|NCT02314520|3957958|FG000|STARTED|Overall Study||72
3225835|NCT02314520|3957959|FG001|STARTED|Overall Study||80
3225836|NCT02314520|3957958|FG000|COMPLETED|Overall Study||72
3225837|NCT02314520|3957959|FG001|COMPLETED|Overall Study||80
3225838|NCT02314520|3957958|FG000|NOT COMPLETED|Overall Study||0
3225839|NCT02314520|3957959|FG001|NOT COMPLETED|Overall Study||0
3225840|NCT02314546|3957968|FG000|STARTED|Overall Study||5
3225841|NCT02314546|3957969|FG001|STARTED|Overall Study||5
3225842|NCT02314546|3957970|FG002|STARTED|Overall Study||5
3225843|NCT02314546|3957968|FG000|COMPLETED|Overall Study||5
3225844|NCT02314546|3957969|FG001|COMPLETED|Overall Study||5
3225845|NCT02314546|3957970|FG002|COMPLETED|Overall Study||5
3225846|NCT02314546|3957968|FG000|NOT COMPLETED|Overall Study||0
3225847|NCT02314546|3957969|FG001|NOT COMPLETED|Overall Study||0
3225848|NCT02314546|3957970|FG002|NOT COMPLETED|Overall Study||0
3225849|NCT02314598|3957979|FG000|STARTED|Overall Study||46
3225850|NCT02314598|3957979|FG000|COMPLETED|Overall Study||46
3225851|NCT02314598|3957979|FG000|NOT COMPLETED|Overall Study||0
3225852|NCT02314637|3957985|FG000|STARTED|Overall Study||151
3225853|NCT02314637|3957986|FG001|STARTED|Overall Study||89
3225854|NCT02314637|3957985|FG000|COMPLETED|Overall Study||135
3225855|NCT02314637|3957986|FG001|COMPLETED|Overall Study||75
3225856|NCT02314637|3957985|FG000|NOT COMPLETED|Overall Study||16
3225857|NCT02314637|3957986|FG001|NOT COMPLETED|Overall Study||14
3225858|NCT02314689|3957992|FG000|STARTED|Overall Study||4
3225859|NCT02314689|3957992|FG000|COMPLETED|Overall Study|Target citrulline level reached with first 4 subjects enrolled at initial IV citrulline of 20 mg/kg|4
3225860|NCT02314689|3957992|FG000|NOT COMPLETED|Overall Study||0
3225861|NCT02314728|3957998|FG000|STARTED|Overall Study||117
3225862|NCT02314728|3957999|FG001|STARTED|Overall Study||113
3225863|NCT02314728|3957998|FG000|COMPLETED|Overall Study||116
3225864|NCT02314728|3957999|FG001|COMPLETED|Overall Study||112
3225865|NCT02314728|3957998|FG000|NOT COMPLETED|Overall Study||1
3225866|NCT02314728|3957999|FG001|NOT COMPLETED|Overall Study||1
3225867|NCT02314780|3958010|FG000|STARTED|Overall Study||9
3225868|NCT02314780|3958011|FG001|STARTED|Overall Study||10
3225869|NCT02314780|3958012|FG002|STARTED|Overall Study||8
3225870|NCT02314780|3958010|FG000|COMPLETED|Overall Study||9
3225871|NCT02314780|3958011|FG001|COMPLETED|Overall Study||7
3225872|NCT02314780|3958012|FG002|COMPLETED|Overall Study||8
3225873|NCT02314780|3958010|FG000|NOT COMPLETED|Overall Study||0
3225874|NCT02314780|3958011|FG001|NOT COMPLETED|Overall Study||3
3225875|NCT02314780|3958012|FG002|NOT COMPLETED|Overall Study||0
3225876|NCT02314936|3958024|FG000|STARTED|Overall Study||48
3225877|NCT02314936|3958025|FG001|STARTED|Overall Study||48
3225878|NCT02314936|3958026|FG002|STARTED|Overall Study||48
3225879|NCT02314936|3958027|FG003|STARTED|Overall Study||48
3225880|NCT02314936|3958024|FG000|COMPLETED|Overall Study||48
3225881|NCT02314936|3958025|FG001|COMPLETED|Overall Study||48
3225882|NCT02314936|3958026|FG002|COMPLETED|Overall Study||46
3225883|NCT02314936|3958027|FG003|COMPLETED|Overall Study||48
3225884|NCT02314936|3958024|FG000|NOT COMPLETED|Overall Study||0
3225885|NCT02314936|3958025|FG001|NOT COMPLETED|Overall Study||0
3225886|NCT02314936|3958026|FG002|NOT COMPLETED|Overall Study||2
3225887|NCT02314936|3958027|FG003|NOT COMPLETED|Overall Study||0
3225888|NCT02315170|3958037|FG000|STARTED|Overall Study||50
3225889|NCT02315170|3958038|FG001|STARTED|Overall Study||50
3225890|NCT02315170|3958037|FG000|COMPLETED|Overall Study||50
3225891|NCT02315170|3958038|FG001|COMPLETED|Overall Study||50
3225892|NCT02315170|3958037|FG000|NOT COMPLETED|Overall Study||0
3225893|NCT02315170|3958038|FG001|NOT COMPLETED|Overall Study||0
3225894|NCT02315261|3958044|FG000|STARTED|Overall Study||364
3225895|NCT02315261|3958044|FG000|COMPLETED|Overall Study||364
3225896|NCT02315261|3958044|FG000|NOT COMPLETED|Overall Study||0
3225897|NCT02315352|3958050|FG000|STARTED|First Intervention (Day 1)||24
3225898|NCT02315352|3958051|FG001|STARTED|First Intervention (Day 1)||24
3225899|NCT02315352|3958052|FG002|STARTED|First Intervention (Day 1)||0
3225900|NCT02315352|3958053|FG003|STARTED|First Intervention (Day 1)||0
3225901|NCT02315352|3958054|FG004|STARTED|First Intervention (Day 1)||0
3225902|NCT02315352|3958055|FG005|STARTED|First Intervention (Day 1)||0
3225903|NCT02315352|3958056|FG006|STARTED|First Intervention (Day 1)||0
3225904|NCT02315352|3958057|FG007|STARTED|First Intervention (Day 1)||0
3225905|NCT02315352|3958050|FG000|COMPLETED|First Intervention (Day 1)||24
3225906|NCT02315352|3958051|FG001|COMPLETED|First Intervention (Day 1)||24
3225907|NCT02315352|3958052|FG002|COMPLETED|First Intervention (Day 1)||0
3225908|NCT02315352|3958053|FG003|COMPLETED|First Intervention (Day 1)||0
3225909|NCT02315352|3958054|FG004|COMPLETED|First Intervention (Day 1)||0
3225910|NCT02315352|3958055|FG005|COMPLETED|First Intervention (Day 1)||0
3225911|NCT02315352|3958056|FG006|COMPLETED|First Intervention (Day 1)||0
3225912|NCT02315352|3958057|FG007|COMPLETED|First Intervention (Day 1)||0
3225913|NCT02315352|3958050|FG000|NOT COMPLETED|First Intervention (Day 1)||0
3225914|NCT02315352|3958051|FG001|NOT COMPLETED|First Intervention (Day 1)||0
3225915|NCT02315352|3958052|FG002|NOT COMPLETED|First Intervention (Day 1)||0
3225916|NCT02315352|3958053|FG003|NOT COMPLETED|First Intervention (Day 1)||0
3225917|NCT02315352|3958054|FG004|NOT COMPLETED|First Intervention (Day 1)||0
3225918|NCT02315352|3958055|FG005|NOT COMPLETED|First Intervention (Day 1)||0
3225919|NCT02315352|3958056|FG006|NOT COMPLETED|First Intervention (Day 1)||0
3225920|NCT02315352|3958057|FG007|NOT COMPLETED|First Intervention (Day 1)||0
3225921|NCT02315352|3958050|FG000|STARTED|Second Intervention (Day 1)||24
3225922|NCT02315352|3958051|FG001|STARTED|Second Intervention (Day 1)||24
3225923|NCT02315352|3958052|FG002|STARTED|Second Intervention (Day 1)||0
3225924|NCT02315352|3958053|FG003|STARTED|Second Intervention (Day 1)||0
3225925|NCT02315352|3958054|FG004|STARTED|Second Intervention (Day 1)||0
3225926|NCT02315352|3958055|FG005|STARTED|Second Intervention (Day 1)||0
3225927|NCT02315352|3958056|FG006|STARTED|Second Intervention (Day 1)||0
3225928|NCT02315352|3958057|FG007|STARTED|Second Intervention (Day 1)||0
3225929|NCT02315352|3958050|FG000|COMPLETED|Second Intervention (Day 1)|Out of 24 subjects completing this period, 1 discontinued before assignment to any sequence on Day 2|24
3225930|NCT02315352|3958051|FG001|COMPLETED|Second Intervention (Day 1)||24
3225931|NCT02315352|3958052|FG002|COMPLETED|Second Intervention (Day 1)||0
3225932|NCT02315352|3958053|FG003|COMPLETED|Second Intervention (Day 1)||0
3225933|NCT02315352|3958054|FG004|COMPLETED|Second Intervention (Day 1)||0
3225934|NCT02315352|3958055|FG005|COMPLETED|Second Intervention (Day 1)||0
3225935|NCT02315352|3958056|FG006|COMPLETED|Second Intervention (Day 1)||0
3225936|NCT02315352|3958057|FG007|COMPLETED|Second Intervention (Day 1)||0
3225937|NCT02315352|3958050|FG000|NOT COMPLETED|Second Intervention (Day 1)||0
3225938|NCT02315352|3958051|FG001|NOT COMPLETED|Second Intervention (Day 1)||0
3225939|NCT02315352|3958052|FG002|NOT COMPLETED|Second Intervention (Day 1)||0
3225940|NCT02315352|3958053|FG003|NOT COMPLETED|Second Intervention (Day 1)||0
3225941|NCT02315352|3958054|FG004|NOT COMPLETED|Second Intervention (Day 1)||0
3225942|NCT02315352|3958055|FG005|NOT COMPLETED|Second Intervention (Day 1)||0
3225943|NCT02315352|3958056|FG006|NOT COMPLETED|Second Intervention (Day 1)||0
3225944|NCT02315352|3958057|FG007|NOT COMPLETED|Second Intervention (Day 1)||0
3225945|NCT02315352|3958050|FG000|STARTED|Third Intervention (Day 2)||0
3225946|NCT02315352|3958051|FG001|STARTED|Third Intervention (Day 2)||0
3225947|NCT02315352|3958052|FG002|STARTED|Third Intervention (Day 2)||7
3225948|NCT02315352|3958053|FG003|STARTED|Third Intervention (Day 2)||8
3225949|NCT02315352|3958054|FG004|STARTED|Third Intervention (Day 2)||8
3225950|NCT02315352|3958055|FG005|STARTED|Third Intervention (Day 2)||7
3225951|NCT02315352|3958056|FG006|STARTED|Third Intervention (Day 2)||9
3225952|NCT02315352|3958057|FG007|STARTED|Third Intervention (Day 2)||8
3225953|NCT02315352|3958050|FG000|COMPLETED|Third Intervention (Day 2)||0
3225954|NCT02315352|3958051|FG001|COMPLETED|Third Intervention (Day 2)||0
3225955|NCT02315352|3958052|FG002|COMPLETED|Third Intervention (Day 2)||7
3225956|NCT02315352|3958053|FG003|COMPLETED|Third Intervention (Day 2)||8
3225957|NCT02315352|3958054|FG004|COMPLETED|Third Intervention (Day 2)||8
3225958|NCT02315352|3958055|FG005|COMPLETED|Third Intervention (Day 2)||7
3225959|NCT02315352|3958056|FG006|COMPLETED|Third Intervention (Day 2)||9
3225960|NCT02315352|3958057|FG007|COMPLETED|Third Intervention (Day 2)||8
3225961|NCT02315352|3958050|FG000|NOT COMPLETED|Third Intervention (Day 2)||0
3225962|NCT02315352|3958051|FG001|NOT COMPLETED|Third Intervention (Day 2)||0
3225963|NCT02315352|3958052|FG002|NOT COMPLETED|Third Intervention (Day 2)||0
3225964|NCT02315352|3958053|FG003|NOT COMPLETED|Third Intervention (Day 2)||0
3225965|NCT02315352|3958054|FG004|NOT COMPLETED|Third Intervention (Day 2)||0
3225966|NCT02315352|3958055|FG005|NOT COMPLETED|Third Intervention (Day 2)||0
3225967|NCT02315352|3958056|FG006|NOT COMPLETED|Third Intervention (Day 2)||0
3225968|NCT02315352|3958057|FG007|NOT COMPLETED|Third Intervention (Day 2)||0
3225969|NCT02315352|3958050|FG000|STARTED|Fourth Intervention (Day 2)||0
3225970|NCT02315352|3958051|FG001|STARTED|Fourth Intervention (Day 2)||0
3225971|NCT02315352|3958052|FG002|STARTED|Fourth Intervention (Day 2)||7
3225972|NCT02315352|3958053|FG003|STARTED|Fourth Intervention (Day 2)||8
3225973|NCT02315352|3958054|FG004|STARTED|Fourth Intervention (Day 2)||8
3225974|NCT02315352|3958055|FG005|STARTED|Fourth Intervention (Day 2)||7
3225975|NCT02315352|3958056|FG006|STARTED|Fourth Intervention (Day 2)||9
3225976|NCT02315352|3958057|FG007|STARTED|Fourth Intervention (Day 2)||8
3225977|NCT02315352|3958050|FG000|COMPLETED|Fourth Intervention (Day 2)||0
3225978|NCT02315352|3958051|FG001|COMPLETED|Fourth Intervention (Day 2)||0
3225979|NCT02315352|3958052|FG002|COMPLETED|Fourth Intervention (Day 2)||7
3225980|NCT02315352|3958053|FG003|COMPLETED|Fourth Intervention (Day 2)||8
3225981|NCT02315352|3958054|FG004|COMPLETED|Fourth Intervention (Day 2)||8
3225982|NCT02315352|3958055|FG005|COMPLETED|Fourth Intervention (Day 2)||7
3225983|NCT02315352|3958056|FG006|COMPLETED|Fourth Intervention (Day 2)||9
3225984|NCT02315352|3958057|FG007|COMPLETED|Fourth Intervention (Day 2)||8
3225985|NCT02315352|3958050|FG000|NOT COMPLETED|Fourth Intervention (Day 2)||0
3225986|NCT02315352|3958051|FG001|NOT COMPLETED|Fourth Intervention (Day 2)||0
3225987|NCT02315352|3958052|FG002|NOT COMPLETED|Fourth Intervention (Day 2)||0
3225988|NCT02315352|3958053|FG003|NOT COMPLETED|Fourth Intervention (Day 2)||0
3225989|NCT02315352|3958054|FG004|NOT COMPLETED|Fourth Intervention (Day 2)||0
3225990|NCT02315352|3958055|FG005|NOT COMPLETED|Fourth Intervention (Day 2)||0
3225991|NCT02315352|3958056|FG006|NOT COMPLETED|Fourth Intervention (Day 2)||0
3225992|NCT02315352|3958057|FG007|NOT COMPLETED|Fourth Intervention (Day 2)||0
3225993|NCT02315352|3958050|FG000|STARTED|Fifth Intervention (Day 2)||0
3225994|NCT02315352|3958051|FG001|STARTED|Fifth Intervention (Day 2)||0
3225995|NCT02315352|3958052|FG002|STARTED|Fifth Intervention (Day 2)||7
3225996|NCT02315352|3958053|FG003|STARTED|Fifth Intervention (Day 2)||8
3225997|NCT02315352|3958054|FG004|STARTED|Fifth Intervention (Day 2)||8
3225998|NCT02315352|3958055|FG005|STARTED|Fifth Intervention (Day 2)||7
3225999|NCT02315352|3958056|FG006|STARTED|Fifth Intervention (Day 2)||9
3226000|NCT02315352|3958057|FG007|STARTED|Fifth Intervention (Day 2)||8
3226001|NCT02315352|3958050|FG000|COMPLETED|Fifth Intervention (Day 2)||0
3226002|NCT02315352|3958051|FG001|COMPLETED|Fifth Intervention (Day 2)||0
3226003|NCT02315352|3958052|FG002|COMPLETED|Fifth Intervention (Day 2)||7
3226004|NCT02315352|3958053|FG003|COMPLETED|Fifth Intervention (Day 2)||8
3226005|NCT02315352|3958054|FG004|COMPLETED|Fifth Intervention (Day 2)||8
3226006|NCT02315352|3958055|FG005|COMPLETED|Fifth Intervention (Day 2)||7
3226007|NCT02315352|3958056|FG006|COMPLETED|Fifth Intervention (Day 2)||9
3226008|NCT02315352|3958057|FG007|COMPLETED|Fifth Intervention (Day 2)||8
3226009|NCT02315352|3958050|FG000|NOT COMPLETED|Fifth Intervention (Day 2)||0
3226010|NCT02315352|3958051|FG001|NOT COMPLETED|Fifth Intervention (Day 2)||0
3226011|NCT02315352|3958052|FG002|NOT COMPLETED|Fifth Intervention (Day 2)||0
3226012|NCT02315352|3958053|FG003|NOT COMPLETED|Fifth Intervention (Day 2)||0
3226013|NCT02315352|3958054|FG004|NOT COMPLETED|Fifth Intervention (Day 2)||0
3226014|NCT02315352|3958055|FG005|NOT COMPLETED|Fifth Intervention (Day 2)||0
3226015|NCT02315352|3958056|FG006|NOT COMPLETED|Fifth Intervention (Day 2)||0
3226016|NCT02315352|3958057|FG007|NOT COMPLETED|Fifth Intervention (Day 2)||0
3226017|NCT02315430|3958069|FG000|STARTED|Overall Study||13
3226018|NCT02315430|3958069|FG000|COMPLETED|Overall Study||13
3226019|NCT02315430|3958069|FG000|NOT COMPLETED|Overall Study||0
3226020|NCT02315534|3958075|FG000|STARTED|Overall Study||4
3226021|NCT02315534|3958076|FG001|STARTED|Overall Study||30
3226022|NCT02315534|3958075|FG000|Assessment of Dose-limiting Toxicity (DLT)|Overall Study||0
3226023|NCT02315534|3958076|FG001|Assessment of Dose-limiting Toxicity (DLT)|Overall Study||0
3226024|NCT02315534|3958075|FG000|Off Treatment Due to Radiologic Disease Progression (PD)|Overall Study||2
3226025|NCT02315534|3958076|FG001|Off Treatment Due to Radiologic Disease Progression (PD)|Overall Study||20
3226026|NCT02315534|3958075|FG000|Off Treatment Due to Clinically Unacceptable Toxicities|Overall Study||1
3226027|NCT02315534|3958076|FG001|Off Treatment Due to Clinically Unacceptable Toxicities|Overall Study||7
3226028|NCT02315534|3958075|FG000|Off Treatment Due to Patient Request|Overall Study||1
3226029|NCT02315534|3958076|FG001|Off Treatment Due to Patient Request|Overall Study||2
3226030|NCT02315534|3958075|FG000|Off Treatment Due to Clinical PD|Overall Study||0
3226031|NCT02315534|3958076|FG001|Off Treatment Due to Clinical PD|Overall Study||1
3226032|NCT02315534|3958075|FG000|COMPLETED|Overall Study||4
3226033|NCT02315534|3958076|FG001|COMPLETED|Overall Study||30
3226034|NCT02315534|3958075|FG000|NOT COMPLETED|Overall Study||0
3226035|NCT02315534|3958076|FG001|NOT COMPLETED|Overall Study||0
3226036|NCT02315560|3958090|FG000|STARTED|Overall Study||25
3226037|NCT02315560|3958090|FG000|COMPLETED|Overall Study||22
3226038|NCT02315560|3958090|FG000|NOT COMPLETED|Overall Study||3
3226039|NCT02315625|3958096|FG000|STARTED|First Intervention||14
3226040|NCT02315625|3958097|FG001|STARTED|First Intervention||2
3226041|NCT02315625|3958096|FG000|COMPLETED|First Intervention||13
3226042|NCT02315625|3958097|FG001|COMPLETED|First Intervention||2
3226043|NCT02315625|3958096|FG000|NOT COMPLETED|First Intervention||1
3226044|NCT02315625|3958097|FG001|NOT COMPLETED|First Intervention||0
3226045|NCT02315625|3958096|FG000|STARTED|Second Intervention||13
3226046|NCT02315625|3958097|FG001|STARTED|Second Intervention||2
3226047|NCT02315625|3958096|FG000|COMPLETED|Second Intervention||9
3226048|NCT02315625|3958097|FG001|COMPLETED|Second Intervention||1
3226049|NCT02315625|3958096|FG000|NOT COMPLETED|Second Intervention||4
3226050|NCT02315625|3958097|FG001|NOT COMPLETED|Second Intervention||1
3226051|NCT02315664|3958107|FG000|STARTED|Overall Study||30
3226052|NCT02315664|3958108|FG001|STARTED|Overall Study||31
3226053|NCT02315664|3958107|FG000|COMPLETED|Overall Study||29
3226054|NCT02315664|3958108|FG001|COMPLETED|Overall Study||27
3226055|NCT02315664|3958107|FG000|NOT COMPLETED|Overall Study||1
3226056|NCT02315664|3958108|FG001|NOT COMPLETED|Overall Study||4
3226057|NCT02315755|3958114|FG000|STARTED|Overall Study||102
3226058|NCT02315755|3958114|FG000|COMPLETED|Overall Study|Participants who died, were considered as 'completed'.|102
3226059|NCT02315755|3958114|FG000|NOT COMPLETED|Overall Study||0
3226060|NCT02315872|3958120|FG000|STARTED|Overall Study||4
3226061|NCT02315872|3958121|FG001|STARTED|Overall Study||4
3226062|NCT02315872|3958120|FG000|COMPLETED|Overall Study||1
3226063|NCT02315872|3958121|FG001|COMPLETED|Overall Study||3
3226064|NCT02315872|3958120|FG000|NOT COMPLETED|Overall Study||3
3226065|NCT02315872|3958121|FG001|NOT COMPLETED|Overall Study||1
3226066|NCT02315989|3958127|FG000|STARTED|Overall Study||6
3226067|NCT02315989|3958127|FG000|COMPLETED|Overall Study||6
3226068|NCT02315989|3958127|FG000|NOT COMPLETED|Overall Study||0
3368466|NCT03820258|4100005|FG000|STARTED|Overall Study||21
3368467|NCT03820258|4100005|FG000|COMPLETED|Overall Study||21
3368468|NCT03820258|4100005|FG000|NOT COMPLETED|Overall Study||0
3368469|NCT03819491|4100011|FG000|STARTED|Before Randomization||24
3368470|NCT03819491|4100012|FG001|STARTED|Before Randomization||0
3368471|NCT03819491|4100011|FG000|COMPLETED|Before Randomization||24
3368472|NCT03819491|4100012|FG001|COMPLETED|Before Randomization||0
3368473|NCT03819491|4100011|FG000|NOT COMPLETED|Before Randomization||0
3368474|NCT03819491|4100012|FG001|NOT COMPLETED|Before Randomization||0
3368475|NCT03819491|4100011|FG000|STARTED|After Randomization||12
3368476|NCT03819491|4100012|FG001|STARTED|After Randomization||12
3368477|NCT03819491|4100011|FG000|COMPLETED|After Randomization||12
3368478|NCT03819491|4100012|FG001|COMPLETED|After Randomization||12
3368479|NCT03819491|4100011|FG000|NOT COMPLETED|After Randomization||0
3368480|NCT03819491|4100012|FG001|NOT COMPLETED|After Randomization||0
3368481|NCT03808298|4100019|FG000|STARTED|Overall Study||57
3368482|NCT03808298|4100019|FG000|COMPLETED|Overall Study||49
3368483|NCT03808298|4100019|FG000|NOT COMPLETED|Overall Study||8
3368484|NCT03836729|4100048|FG000|STARTED|Treatment Period 1 (Up to Day 14)||16
3368485|NCT03836729|4100048|FG000|COMPLETED|Treatment Period 1 (Up to Day 14)||16
3368486|NCT03836729|4100048|FG000|NOT COMPLETED|Treatment Period 1 (Up to Day 14)||0
3368487|NCT03836729|4100048|FG000|STARTED|Treatment Period 2 (Up to Day 7)||16
3368488|NCT03836729|4100048|FG000|COMPLETED|Treatment Period 2 (Up to Day 7)||15
3368489|NCT03836729|4100048|FG000|NOT COMPLETED|Treatment Period 2 (Up to Day 7)||1
3368490|NCT03835975|4100061|FG000|STARTED|Overall Study||253
3368491|NCT03835975|4100062|FG001|STARTED|Overall Study||122
3368492|NCT03835975|4100063|FG002|STARTED|Overall Study||248
3368493|NCT03835975|4100064|FG003|STARTED|Overall Study||127
3368494|NCT03835975|4100065|FG004|STARTED|Overall Study||125
3368495|NCT03835975|4100061|FG000|Vaccinated|Overall Study||253
3368496|NCT03835975|4100062|FG001|Vaccinated|Overall Study||122
3368497|NCT03835975|4100063|FG002|Vaccinated|Overall Study||246
3368498|NCT03835975|4100064|FG003|Vaccinated|Overall Study||127
3368499|NCT03835975|4100065|FG004|Vaccinated|Overall Study||125
3368500|NCT03835975|4100061|FG000|Safety Population|Overall Study||253
3368501|NCT03835975|4100062|FG001|Safety Population|Overall Study||122
3368502|NCT03835975|4100063|FG002|Safety Population|Overall Study||246
3368503|NCT03835975|4100064|FG003|Safety Population|Overall Study||127
3368504|NCT03835975|4100065|FG004|Safety Population|Overall Study||125
3368505|NCT03835975|4100061|FG000|Evaluable Immunogenicity Population (for 20vPnC Cohorts)|Overall Study||247
3368506|NCT03835975|4100062|FG001|Evaluable Immunogenicity Population (for 20vPnC Cohorts)|Overall Study||0
3368507|NCT03835975|4100063|FG002|Evaluable Immunogenicity Population (for 20vPnC Cohorts)|Overall Study||243
3368508|NCT03835975|4100064|FG003|Evaluable Immunogenicity Population (for 20vPnC Cohorts)|Overall Study||0
3368509|NCT03835975|4100065|FG004|Evaluable Immunogenicity Population (for 20vPnC Cohorts)|Overall Study||121
3368510|NCT03835975|4100061|FG000|COMPLETED|Overall Study||250
3368511|NCT03835975|4100062|FG001|COMPLETED|Overall Study||119
3226069|NCT02316002|3958135|FG000|STARTED|Overall Study||51
3226070|NCT02316002|3958135|FG000|COMPLETED|Overall Study||45
3226071|NCT02316002|3958135|FG000|NOT COMPLETED|Overall Study||6
3226072|NCT02316171|3958141|FG000|STARTED|Overall Study||4
3226073|NCT02316171|3958142|FG001|STARTED|Overall Study||6
3226074|NCT02316171|3958143|FG002|STARTED|Overall Study||3
3226075|NCT02316171|3958144|FG003|STARTED|Overall Study||3
3226076|NCT02316171|3958141|FG000|COMPLETED|Overall Study||3
3226077|NCT02316171|3958142|FG001|COMPLETED|Overall Study||6
3226078|NCT02316171|3958143|FG002|COMPLETED|Overall Study||3
3226079|NCT02316171|3958144|FG003|COMPLETED|Overall Study||3
3226080|NCT02316171|3958141|FG000|NOT COMPLETED|Overall Study||1
3226081|NCT02316171|3958142|FG001|NOT COMPLETED|Overall Study||0
3226082|NCT02316171|3958143|FG002|NOT COMPLETED|Overall Study||0
3226083|NCT02316171|3958144|FG003|NOT COMPLETED|Overall Study||0
3226084|NCT02316223|3958153|FG000|STARTED|Overall Study||134
3226085|NCT02316223|3958154|FG001|STARTED|Overall Study||133
3226086|NCT02316223|3958155|FG002|STARTED|Overall Study||139
3226087|NCT02316223|3958153|FG000|COMPLETED|Overall Study||90
3226088|NCT02316223|3958154|FG001|COMPLETED|Overall Study||76
3226089|NCT02316223|3958155|FG002|COMPLETED|Overall Study||95
3226090|NCT02316223|3958153|FG000|NOT COMPLETED|Overall Study||44
3226091|NCT02316223|3958154|FG001|NOT COMPLETED|Overall Study||57
3226092|NCT02316223|3958155|FG002|NOT COMPLETED|Overall Study||44
3226093|NCT02316353|3958165|FG000|STARTED|Overall Study|7 subjects assigned to the CSL830 (40) Arm, were titrated up to the 60 IU/kg arm during the study|63
3226094|NCT02316353|3958166|FG001|STARTED|Overall Study||63
3226095|NCT02316353|3958165|FG000|COMPLETED|Overall Study||55
3226096|NCT02316353|3958166|FG001|COMPLETED|Overall Study||55
3226097|NCT02316353|3958165|FG000|NOT COMPLETED|Overall Study||8
3226098|NCT02316353|3958166|FG001|NOT COMPLETED|Overall Study||8
3226099|NCT02316366|3958177|FG000|STARTED|Overall Study||40
3226100|NCT02316366|3958178|FG001|STARTED|Overall Study||40
3226101|NCT02316366|3958177|FG000|COMPLETED|Overall Study||40
3226102|NCT02316366|3958178|FG001|COMPLETED|Overall Study||40
3226103|NCT02316366|3958177|FG000|NOT COMPLETED|Overall Study||0
3226104|NCT02316366|3958178|FG001|NOT COMPLETED|Overall Study||0
3226105|NCT02316470|3958188|FG000|STARTED|Overall Study||148
3226106|NCT02316470|3958189|FG001|STARTED|Overall Study||152
3226107|NCT02316470|3958190|FG002|STARTED|Overall Study||152
3226108|NCT02316470|3958191|FG003|STARTED|Overall Study||48
3226109|NCT02316470|3958188|FG000|COMPLETED|Overall Study||143
3226110|NCT02316470|3958189|FG001|COMPLETED|Overall Study||146
3226111|NCT02316470|3958190|FG002|COMPLETED|Overall Study||147
3226112|NCT02316470|3958191|FG003|COMPLETED|Overall Study||46
3226113|NCT02316470|3958188|FG000|NOT COMPLETED|Overall Study||5
3226114|NCT02316470|3958189|FG001|NOT COMPLETED|Overall Study||6
3226115|NCT02316470|3958190|FG002|NOT COMPLETED|Overall Study||5
3226116|NCT02316470|3958191|FG003|NOT COMPLETED|Overall Study||2
3226117|NCT02316548|3958203|FG000|STARTED|Overall Study|Randomized|6
3226118|NCT02316548|3958204|FG001|STARTED|Overall Study|Randomized|7
3226119|NCT02316548|3958203|FG000|Eligible Population|Overall Study||6
3226120|NCT02316548|3958204|FG001|Eligible Population|Overall Study||6
3226121|NCT02316548|3958203|FG000|Eligible With Disease Assessment|Overall Study||4
3226122|NCT02316548|3958204|FG001|Eligible With Disease Assessment|Overall Study||1
3226123|NCT02316548|3958203|FG000|Eligible With Adverse Event Data|Overall Study||4
3226124|NCT02316548|3958204|FG001|Eligible With Adverse Event Data|Overall Study||2
3226125|NCT02316548|3958203|FG000|COMPLETED|Overall Study|Eligible patients on study until study termination|6
3226126|NCT02316548|3958204|FG001|COMPLETED|Overall Study|Eligible patients on study until study termination|6
3226127|NCT02316548|3958203|FG000|NOT COMPLETED|Overall Study||0
3226128|NCT02316548|3958204|FG001|NOT COMPLETED|Overall Study||1
3226129|NCT02316613|3958210|FG000|STARTED|Overall Study||260
3226130|NCT02316613|3958210|FG000|Safety Population|Overall Study||255
3226131|NCT02316613|3958210|FG000|Overall Population|Overall Study||241
3226132|NCT02316613|3958210|FG000|COMPLETED|Overall Study||156
3226133|NCT02316613|3958210|FG000|NOT COMPLETED|Overall Study||104
3226134|NCT02316678|3958227|FG000|STARTED|Overall Study||1879
3226135|NCT02316678|3958228|FG001|STARTED|Overall Study||7694
3226136|NCT02316678|3958227|FG000|COMPLETED|Overall Study||1879
3226137|NCT02316678|3958228|FG001|COMPLETED|Overall Study||7694
3226138|NCT02316678|3958227|FG000|NOT COMPLETED|Overall Study||0
3226139|NCT02316678|3958228|FG001|NOT COMPLETED|Overall Study||0
3226140|NCT02316717|3958237|FG000|STARTED|Overall Study||43
3226141|NCT02316717|3958238|FG001|STARTED|Overall Study||46
3226142|NCT02316717|3958239|FG002|STARTED|Overall Study||44
3226143|NCT02316717|3958237|FG000|COMPLETED|Overall Study||32
3226144|NCT02316717|3958238|FG001|COMPLETED|Overall Study||39
3226145|NCT02316717|3958239|FG002|COMPLETED|Overall Study||41
3226146|NCT02316717|3958237|FG000|NOT COMPLETED|Overall Study||11
3226147|NCT02316717|3958238|FG001|NOT COMPLETED|Overall Study||7
3226148|NCT02316717|3958239|FG002|NOT COMPLETED|Overall Study||3
3226149|NCT02316769|3958252|FG000|STARTED|Overall Study||33
3226150|NCT02316769|3958253|FG001|STARTED|Overall Study||33
3226151|NCT02316769|3958252|FG000|COMPLETED|Overall Study||31
3226152|NCT02316769|3958253|FG001|COMPLETED|Overall Study||33
3226153|NCT02316769|3958252|FG000|NOT COMPLETED|Overall Study||2
3226154|NCT02316769|3958253|FG001|NOT COMPLETED|Overall Study||0
3226155|NCT02316847|3958261|FG000|STARTED|Overall Study||9
3226156|NCT02316847|3958262|FG001|STARTED|Overall Study||99
3226157|NCT02316847|3958261|FG000|COMPLETED|Overall Study||0
3226158|NCT02316847|3958262|FG001|COMPLETED|Overall Study||13
3226159|NCT02316847|3958261|FG000|NOT COMPLETED|Overall Study||9
3226160|NCT02316847|3958262|FG001|NOT COMPLETED|Overall Study||86
3226161|NCT02317016|3958270|FG000|STARTED|Part A: Day 1-3 (Rosuvastatin Alone)||44
3226162|NCT02317016|3958270|FG000|COMPLETED|Part A: Day 1-3 (Rosuvastatin Alone)||44
3226163|NCT02317016|3958270|FG000|NOT COMPLETED|Part A: Day 1-3 (Rosuvastatin Alone)||0
3226164|NCT02317016|3958270|FG000|STARTED|Part A: Day 4-31 (AZD9291 Alone)||44
3226165|NCT02317016|3958270|FG000|COMPLETED|Part A: Day 4-31 (AZD9291 Alone)||43
3226166|NCT02317016|3958270|FG000|NOT COMPLETED|Part A: Day 4-31 (AZD9291 Alone)||1
3226167|NCT02317016|3958270|FG000|STARTED|Part A: Day 32-34 (Rosuvastatin+AZD9291)||43
3226168|NCT02317016|3958270|FG000|COMPLETED|Part A: Day 32-34 (Rosuvastatin+AZD9291)||41
3226169|NCT02317016|3958270|FG000|NOT COMPLETED|Part A: Day 32-34 (Rosuvastatin+AZD9291)||2
3226170|NCT02317016|3958270|FG000|STARTED|Part B: Day 35 to End Part B (AZD9291)|41 completed Part A + 1 entered Part B without completing Part A (due to AE) = 42 started Part B|42
3226171|NCT02317016|3958270|FG000|COMPLETED|Part B: Day 35 to End Part B (AZD9291)||11
3226172|NCT02317016|3958270|FG000|NOT COMPLETED|Part B: Day 35 to End Part B (AZD9291)||31
3226173|NCT02317042|3958278|FG000|STARTED|Overall Study||11
3226174|NCT02317042|3958279|FG001|STARTED|Overall Study||14
3226175|NCT02317042|3958278|FG000|COMPLETED|Overall Study||11
3226176|NCT02317042|3958279|FG001|COMPLETED|Overall Study||14
3226177|NCT02317042|3958278|FG000|NOT COMPLETED|Overall Study||0
3226178|NCT02317042|3958279|FG001|NOT COMPLETED|Overall Study||0
3226179|NCT02317432|3958289|FG000|STARTED|Overall Study||153
3226180|NCT02317432|3958290|FG001|STARTED|Overall Study||154
3226181|NCT02317432|3958289|FG000|Completed CBT|Overall Study||118
3226182|NCT02317432|3958290|FG001|Completed CBT|Overall Study|Participants in Enhanced Usual Care did not receive CBT sessions.|0
3226183|NCT02317432|3958289|FG000|Completed InVEST|Overall Study||63
3226184|NCT02317432|3958290|FG001|Completed InVEST|Overall Study|Participants in Enhanced Usual Care did not receive InVEST sessions.|0
3226185|NCT02317432|3958289|FG000|Completed CBT + InVEST Exercise|Overall Study||122
3226186|NCT02317432|3958290|FG001|Completed CBT + InVEST Exercise|Overall Study|Participants in Enhanced Usual Care did not receive either CBT or InVEST sessions.|0
3226187|NCT02317432|3958289|FG000|Completed Enhanced Usual Care|Overall Study|Participants in CBT + InVEST exercise did not receive Enhanced Usual Care.|0
3226188|NCT02317432|3958290|FG001|Completed Enhanced Usual Care|Overall Study||148
3226189|NCT02317432|3958289|FG000|COMPLETED|Overall Study||122
3226190|NCT02317432|3958290|FG001|COMPLETED|Overall Study||148
3226191|NCT02317432|3958289|FG000|NOT COMPLETED|Overall Study||31
3226192|NCT02317432|3958290|FG001|NOT COMPLETED|Overall Study||6
3226193|NCT02317510|3958298|FG000|STARTED|Overall Study||25
3226194|NCT02317510|3958299|FG001|STARTED|Overall Study||25
3226195|NCT02317510|3958298|FG000|COMPLETED|Overall Study||25
3226196|NCT02317510|3958299|FG001|COMPLETED|Overall Study||24
3226197|NCT02317510|3958298|FG000|NOT COMPLETED|Overall Study||0
3226198|NCT02317510|3958299|FG001|NOT COMPLETED|Overall Study||1
3226199|NCT02317549|3958310|FG000|STARTED|Overall Study||5
3226200|NCT02317549|3958311|FG001|STARTED|Overall Study||3
3226201|NCT02317549|3958310|FG000|COMPLETED|Overall Study||5
3226202|NCT02317549|3958311|FG001|COMPLETED|Overall Study||3
3226203|NCT02317549|3958310|FG000|NOT COMPLETED|Overall Study||0
3226204|NCT02317549|3958311|FG001|NOT COMPLETED|Overall Study||0
3226205|NCT02317562|3958317|FG000|STARTED|Overall Study||19
3226206|NCT02317562|3958317|FG000|COMPLETED|Overall Study||5
3226207|NCT02317562|3958317|FG000|NOT COMPLETED|Overall Study||14
3226208|NCT02317575|3958321|FG000|STARTED|Period 1||5
3226209|NCT02317575|3958322|FG001|STARTED|Period 1||6
3226210|NCT02317575|3958323|FG002|STARTED|Period 1||6
3226211|NCT02317575|3958324|FG003|STARTED|Period 1||6
3226212|NCT02317575|3958325|FG004|STARTED|Period 1||6
3226213|NCT02317575|3958321|FG000|Received at Least 1 Dose of Study Drug|Period 1||5
3226214|NCT02317575|3958322|FG001|Received at Least 1 Dose of Study Drug|Period 1||5
3226215|NCT02317575|3958323|FG002|Received at Least 1 Dose of Study Drug|Period 1||6
3226216|NCT02317575|3958324|FG003|Received at Least 1 Dose of Study Drug|Period 1||6
3226217|NCT02317575|3958325|FG004|Received at Least 1 Dose of Study Drug|Period 1||6
3226218|NCT02317575|3958321|FG000|COMPLETED|Period 1||4
3226219|NCT02317575|3958322|FG001|COMPLETED|Period 1||5
3226220|NCT02317575|3958323|FG002|COMPLETED|Period 1||6
3226221|NCT02317575|3958324|FG003|COMPLETED|Period 1||6
3226222|NCT02317575|3958325|FG004|COMPLETED|Period 1||6
3226223|NCT02317575|3958321|FG000|NOT COMPLETED|Period 1||1
3226224|NCT02317575|3958322|FG001|NOT COMPLETED|Period 1||1
3226225|NCT02317575|3958323|FG002|NOT COMPLETED|Period 1||0
3226226|NCT02317575|3958324|FG003|NOT COMPLETED|Period 1||0
3226227|NCT02317575|3958325|FG004|NOT COMPLETED|Period 1||0
3226228|NCT02317575|3958321|FG000|STARTED|Period 2||4
3226229|NCT02317575|3958322|FG001|STARTED|Period 2||5
3226230|NCT02317575|3958323|FG002|STARTED|Period 2||6
3226231|NCT02317575|3958324|FG003|STARTED|Period 2||6
3226232|NCT02317575|3958325|FG004|STARTED|Period 2||6
3226233|NCT02317575|3958321|FG000|COMPLETED|Period 2||4
3226234|NCT02317575|3958322|FG001|COMPLETED|Period 2||5
3226235|NCT02317575|3958323|FG002|COMPLETED|Period 2||6
3226236|NCT02317575|3958324|FG003|COMPLETED|Period 2||6
3226237|NCT02317575|3958325|FG004|COMPLETED|Period 2||6
3226238|NCT02317575|3958321|FG000|NOT COMPLETED|Period 2||0
3226239|NCT02317575|3958322|FG001|NOT COMPLETED|Period 2||0
3226240|NCT02317575|3958323|FG002|NOT COMPLETED|Period 2||0
3226241|NCT02317575|3958324|FG003|NOT COMPLETED|Period 2||0
3368512|NCT03835975|4100063|FG002|COMPLETED|Overall Study||245
3368513|NCT03835975|4100064|FG003|COMPLETED|Overall Study||126
3226242|NCT02317575|3958325|FG004|NOT COMPLETED|Period 2||0
3226243|NCT02317575|3958321|FG000|STARTED|Period 3||4
3226244|NCT02317575|3958322|FG001|STARTED|Period 3||5
3226245|NCT02317575|3958323|FG002|STARTED|Period 3||6
3226246|NCT02317575|3958324|FG003|STARTED|Period 3||6
3226247|NCT02317575|3958325|FG004|STARTED|Period 3||6
3226248|NCT02317575|3958321|FG000|COMPLETED|Period 3||4
3226249|NCT02317575|3958322|FG001|COMPLETED|Period 3||5
3226250|NCT02317575|3958323|FG002|COMPLETED|Period 3||6
3226251|NCT02317575|3958324|FG003|COMPLETED|Period 3||6
3226252|NCT02317575|3958325|FG004|COMPLETED|Period 3||6
3226253|NCT02317575|3958321|FG000|NOT COMPLETED|Period 3||0
3226254|NCT02317575|3958322|FG001|NOT COMPLETED|Period 3||0
3226255|NCT02317575|3958323|FG002|NOT COMPLETED|Period 3||0
3226256|NCT02317575|3958324|FG003|NOT COMPLETED|Period 3||0
3226257|NCT02317575|3958325|FG004|NOT COMPLETED|Period 3||0
3226258|NCT02317575|3958321|FG000|STARTED|Period 4||4
3226259|NCT02317575|3958322|FG001|STARTED|Period 4||5
3226260|NCT02317575|3958323|FG002|STARTED|Period 4||6
3226261|NCT02317575|3958324|FG003|STARTED|Period 4||6
3226262|NCT02317575|3958325|FG004|STARTED|Period 4||6
3226263|NCT02317575|3958321|FG000|COMPLETED|Period 4||4
3226264|NCT02317575|3958322|FG001|COMPLETED|Period 4||5
3226265|NCT02317575|3958323|FG002|COMPLETED|Period 4||6
3226266|NCT02317575|3958324|FG003|COMPLETED|Period 4||6
3226267|NCT02317575|3958325|FG004|COMPLETED|Period 4||6
3226268|NCT02317575|3958321|FG000|NOT COMPLETED|Period 4||0
3226269|NCT02317575|3958322|FG001|NOT COMPLETED|Period 4||0
3226270|NCT02317575|3958323|FG002|NOT COMPLETED|Period 4||0
3226271|NCT02317575|3958324|FG003|NOT COMPLETED|Period 4||0
3226272|NCT02317575|3958325|FG004|NOT COMPLETED|Period 4||0
3226273|NCT02317575|3958321|FG000|STARTED|Period 5||4
3226274|NCT02317575|3958322|FG001|STARTED|Period 5||5
3226275|NCT02317575|3958323|FG002|STARTED|Period 5||6
3226276|NCT02317575|3958324|FG003|STARTED|Period 5||6
3226277|NCT02317575|3958325|FG004|STARTED|Period 5||6
3226278|NCT02317575|3958321|FG000|COMPLETED|Period 5||4
3226279|NCT02317575|3958322|FG001|COMPLETED|Period 5||5
3226280|NCT02317575|3958323|FG002|COMPLETED|Period 5||6
3226281|NCT02317575|3958324|FG003|COMPLETED|Period 5||6
3226282|NCT02317575|3958325|FG004|COMPLETED|Period 5||6
3226283|NCT02317575|3958321|FG000|NOT COMPLETED|Period 5||0
3226284|NCT02317575|3958322|FG001|NOT COMPLETED|Period 5||0
3226285|NCT02317575|3958323|FG002|NOT COMPLETED|Period 5||0
3226286|NCT02317575|3958324|FG003|NOT COMPLETED|Period 5||0
3226287|NCT02317575|3958325|FG004|NOT COMPLETED|Period 5||0
3226288|NCT02317614|3958345|FG000|STARTED|Overall Study||26
3226289|NCT02317614|3958346|FG001|STARTED|Overall Study||25
3226290|NCT02317614|3958345|FG000|COMPLETED|Overall Study||23
3226291|NCT02317614|3958346|FG001|COMPLETED|Overall Study||23
3226292|NCT02317614|3958345|FG000|NOT COMPLETED|Overall Study||3
3226293|NCT02317614|3958346|FG001|NOT COMPLETED|Overall Study||2
3226294|NCT02317627|3958355|FG000|STARTED|Overall Study||13
3226295|NCT02317627|3958356|FG001|STARTED|Overall Study||13
3226296|NCT02317627|3958357|FG002|STARTED|Overall Study||12
3226297|NCT02317627|3958355|FG000|COMPLETED|Overall Study||11
3226298|NCT02317627|3958356|FG001|COMPLETED|Overall Study||8
3226299|NCT02317627|3958357|FG002|COMPLETED|Overall Study||8
3226300|NCT02317627|3958355|FG000|NOT COMPLETED|Overall Study||2
3226301|NCT02317627|3958356|FG001|NOT COMPLETED|Overall Study||5
3226302|NCT02317627|3958357|FG002|NOT COMPLETED|Overall Study||4
3226303|NCT02317692|3958373|FG000|STARTED|Overall Study||69
3226304|NCT02317692|3958374|FG001|STARTED|Overall Study||77
3226305|NCT02317692|3958373|FG000|COMPLETED|Overall Study||63
3226306|NCT02317692|3958374|FG001|COMPLETED|Overall Study||77
3226307|NCT02317692|3958373|FG000|NOT COMPLETED|Overall Study||6
3226308|NCT02317692|3958374|FG001|NOT COMPLETED|Overall Study||0
3226309|NCT02317744|3958382|FG000|STARTED|Overall Study||12
3226310|NCT02317744|3958383|FG001|STARTED|Overall Study||10
3226311|NCT02317744|3958382|FG000|Completed Treatment|Overall Study||10
3226312|NCT02317744|3958383|FG001|Completed Treatment|Overall Study||7
3226313|NCT02317744|3958382|FG000|COMPLETED|Overall Study|One NB participant stopped the treatment but completed assessments.|11
3226314|NCT02317744|3958383|FG001|COMPLETED|Overall Study|One Placebo participant stopped the treatment but completed assessments.|8
3226315|NCT02317744|3958382|FG000|NOT COMPLETED|Overall Study||1
3226316|NCT02317744|3958383|FG001|NOT COMPLETED|Overall Study||2
3226317|NCT02317809|3958389|FG000|STARTED|First Intervention Period (8 Days)||17
3226318|NCT02317809|3958390|FG001|STARTED|First Intervention Period (8 Days)||17
3226319|NCT02317809|3958389|FG000|COMPLETED|First Intervention Period (8 Days)||14
3226320|NCT02317809|3958390|FG001|COMPLETED|First Intervention Period (8 Days)||17
3226321|NCT02317809|3958389|FG000|NOT COMPLETED|First Intervention Period (8 Days)||3
3226322|NCT02317809|3958390|FG001|NOT COMPLETED|First Intervention Period (8 Days)||0
3226323|NCT02317809|3958389|FG000|STARTED|Second Intervention Period (8 Days)||14
3226324|NCT02317809|3958390|FG001|STARTED|Second Intervention Period (8 Days)||17
3226325|NCT02317809|3958389|FG000|COMPLETED|Second Intervention Period (8 Days)||14
3226326|NCT02317809|3958390|FG001|COMPLETED|Second Intervention Period (8 Days)||17
3226327|NCT02317809|3958389|FG000|NOT COMPLETED|Second Intervention Period (8 Days)||0
3226328|NCT02317809|3958390|FG001|NOT COMPLETED|Second Intervention Period (8 Days)||0
3226329|NCT02318095|3958399|FG000|STARTED|Overall Study||40
3226330|NCT02318095|3958399|FG000|COMPLETED|Overall Study||39
3226331|NCT02318095|3958399|FG000|NOT COMPLETED|Overall Study||1
3226332|NCT02318134|3958406|FG000|STARTED|Overall Study||30
3226333|NCT02318134|3958407|FG001|STARTED|Overall Study||30
3226334|NCT02318134|3958406|FG000|COMPLETED|Overall Study||28
3226335|NCT02318134|3958407|FG001|COMPLETED|Overall Study||29
3226336|NCT02318134|3958406|FG000|NOT COMPLETED|Overall Study||2
3226337|NCT02318134|3958407|FG001|NOT COMPLETED|Overall Study||1
3226338|NCT02318303|3958422|FG000|STARTED|Overall Study||159
3226339|NCT02318303|3958423|FG001|STARTED|Overall Study||158
3226340|NCT02318303|3958424|FG002|STARTED|Overall Study||160
3226341|NCT02318303|3958425|FG003|STARTED|Overall Study||158
3226342|NCT02318303|3958426|FG004|STARTED|Overall Study||157
3226343|NCT02318303|3958427|FG005|STARTED|Overall Study||159
3226344|NCT02318303|3958428|FG006|STARTED|Overall Study||160
3226345|NCT02318303|3958422|FG000|COMPLETED|Overall Study||155
3226346|NCT02318303|3958423|FG001|COMPLETED|Overall Study||155
3226347|NCT02318303|3958424|FG002|COMPLETED|Overall Study||157
3226348|NCT02318303|3958425|FG003|COMPLETED|Overall Study||155
3226349|NCT02318303|3958426|FG004|COMPLETED|Overall Study||152
3226350|NCT02318303|3958427|FG005|COMPLETED|Overall Study||153
3226351|NCT02318303|3958428|FG006|COMPLETED|Overall Study||158
3226352|NCT02318303|3958422|FG000|NOT COMPLETED|Overall Study||4
3226353|NCT02318303|3958423|FG001|NOT COMPLETED|Overall Study||3
3226354|NCT02318303|3958424|FG002|NOT COMPLETED|Overall Study||3
3226355|NCT02318303|3958425|FG003|NOT COMPLETED|Overall Study||3
3226356|NCT02318303|3958426|FG004|NOT COMPLETED|Overall Study||5
3226357|NCT02318303|3958427|FG005|NOT COMPLETED|Overall Study||6
3226358|NCT02318303|3958428|FG006|NOT COMPLETED|Overall Study||2
3226359|NCT02318368|3958446|FG000|STARTED|Overall Study||7
3226360|NCT02318368|3958447|FG001|STARTED|Overall Study||3
3226361|NCT02318368|3958446|FG000|COMPLETED|Overall Study||0
3226362|NCT02318368|3958447|FG001|COMPLETED|Overall Study||0
3226363|NCT02318368|3958446|FG000|NOT COMPLETED|Overall Study||7
3226364|NCT02318368|3958447|FG001|NOT COMPLETED|Overall Study||3
3226365|NCT02318550|3958453|FG000|STARTED|Overall Study||262
3226366|NCT02318550|3958453|FG000|COMPLETED|Overall Study||262
3226367|NCT02318550|3958453|FG000|NOT COMPLETED|Overall Study||0
3226368|NCT02318602|3958460|FG000|STARTED|Overall Study||9
3226369|NCT02318602|3958461|FG001|STARTED|Overall Study||26
3226370|NCT02318602|3958462|FG002|STARTED|Overall Study||17
3226371|NCT02318602|3958460|FG000|COMPLETED|Overall Study||8
3226372|NCT02318602|3958461|FG001|COMPLETED|Overall Study||22
3226373|NCT02318602|3958462|FG002|COMPLETED|Overall Study||15
3226374|NCT02318602|3958460|FG000|NOT COMPLETED|Overall Study||1
3226375|NCT02318602|3958461|FG001|NOT COMPLETED|Overall Study||4
3226376|NCT02318602|3958462|FG002|NOT COMPLETED|Overall Study||2
3226377|NCT02318667|3958476|FG000|STARTED|Overall Study||38
3226378|NCT02318667|3958476|FG000|COMPLETED|Overall Study||29
3226379|NCT02318667|3958476|FG000|NOT COMPLETED|Overall Study||9
3226380|NCT02318693|3958486|FG000|STARTED|Overall Study||26
3226381|NCT02318693|3958487|FG001|STARTED|Overall Study||27
3226382|NCT02318693|3958486|FG000|Treated|Overall Study||26
3226383|NCT02318693|3958487|FG001|Treated|Overall Study|1 randomized participant did not receive treatment.|26
3226384|NCT02318693|3958486|FG000|COMPLETED|Overall Study||26
3226385|NCT02318693|3958487|FG001|COMPLETED|Overall Study||26
3226386|NCT02318693|3958486|FG000|NOT COMPLETED|Overall Study||0
3226387|NCT02318693|3958487|FG001|NOT COMPLETED|Overall Study||1
3226388|NCT02318706|3958497|FG000|STARTED|Double-blind Phase||334
3226389|NCT02318706|3958498|FG001|STARTED|Double-blind Phase||166
3226390|NCT02318706|3958499|FG002|STARTED|Double-blind Phase||168
3226391|NCT02318706|3958500|FG003|STARTED|Double-blind Phase||166
3226392|NCT02318706|3958501|FG004|STARTED|Double-blind Phase||0
3226393|NCT02318706|3958497|FG000|COMPLETED|Double-blind Phase||309
3226394|NCT02318706|3958498|FG001|COMPLETED|Double-blind Phase||154
3226395|NCT02318706|3958499|FG002|COMPLETED|Double-blind Phase||150
3226396|NCT02318706|3958500|FG003|COMPLETED|Double-blind Phase||142
3226397|NCT02318706|3958501|FG004|COMPLETED|Double-blind Phase||0
3226398|NCT02318706|3958497|FG000|NOT COMPLETED|Double-blind Phase||25
3226399|NCT02318706|3958498|FG001|NOT COMPLETED|Double-blind Phase||12
3226400|NCT02318706|3958499|FG002|NOT COMPLETED|Double-blind Phase||18
3226401|NCT02318706|3958500|FG003|NOT COMPLETED|Double-blind Phase||24
3226402|NCT02318706|3958501|FG004|NOT COMPLETED|Double-blind Phase||0
3226403|NCT02318706|3958497|FG000|STARTED|Open-label Extension Phase||0
3226404|NCT02318706|3958498|FG001|STARTED|Open-label Extension Phase||0
3226405|NCT02318706|3958499|FG002|STARTED|Open-label Extension Phase||0
3226406|NCT02318706|3958500|FG003|STARTED|Open-label Extension Phase||0
3226407|NCT02318706|3958501|FG004|STARTED|Open-label Extension Phase|A portion of participants who completed the double-blind phase enrolled in the open-label extension.|214
3226408|NCT02318706|3958497|FG000|COMPLETED|Open-label Extension Phase||0
3226409|NCT02318706|3958498|FG001|COMPLETED|Open-label Extension Phase||0
3226410|NCT02318706|3958499|FG002|COMPLETED|Open-label Extension Phase||0
3226411|NCT02318706|3958500|FG003|COMPLETED|Open-label Extension Phase||0
3226412|NCT02318706|3958501|FG004|COMPLETED|Open-label Extension Phase||172
3226413|NCT02318706|3958497|FG000|NOT COMPLETED|Open-label Extension Phase||0
3226414|NCT02318706|3958498|FG001|NOT COMPLETED|Open-label Extension Phase||0
3226415|NCT02318706|3958499|FG002|NOT COMPLETED|Open-label Extension Phase||0
3226416|NCT02318706|3958500|FG003|NOT COMPLETED|Open-label Extension Phase||0
3226417|NCT02318706|3958501|FG004|NOT COMPLETED|Open-label Extension Phase||42
3226418|NCT02318719|3958517|FG000|STARTED|Double-blind Phase||304
3226419|NCT02318719|3958518|FG001|STARTED|Double-blind Phase||153
3226420|NCT02318719|3958519|FG002|STARTED|Double-blind Phase||153
3226421|NCT02318719|3958520|FG003|STARTED|Double-blind Phase||155
3226422|NCT02318719|3958521|FG004|STARTED|Double-blind Phase||0
3226423|NCT02318719|3958517|FG000|Did Not Receive Treatment|Double-blind Phase||1
3226424|NCT02318719|3958518|FG001|Did Not Receive Treatment|Double-blind Phase||1
3226425|NCT02318719|3958519|FG002|Did Not Receive Treatment|Double-blind Phase||0
3226426|NCT02318719|3958520|FG003|Did Not Receive Treatment|Double-blind Phase||0
3226427|NCT02318719|3958521|FG004|Did Not Receive Treatment|Double-blind Phase||0
3226428|NCT02318719|3958517|FG000|COMPLETED|Double-blind Phase||266
3226429|NCT02318719|3958518|FG001|COMPLETED|Double-blind Phase||137
3226430|NCT02318719|3958519|FG002|COMPLETED|Double-blind Phase||128
3226431|NCT02318719|3958520|FG003|COMPLETED|Double-blind Phase||140
3226432|NCT02318719|3958521|FG004|COMPLETED|Double-blind Phase||0
3226433|NCT02318719|3958517|FG000|NOT COMPLETED|Double-blind Phase||38
3226434|NCT02318719|3958518|FG001|NOT COMPLETED|Double-blind Phase||16
3226435|NCT02318719|3958519|FG002|NOT COMPLETED|Double-blind Phase||25
3226436|NCT02318719|3958520|FG003|NOT COMPLETED|Double-blind Phase||15
3226437|NCT02318719|3958521|FG004|NOT COMPLETED|Double-blind Phase||0
3226438|NCT02318719|3958517|FG000|STARTED|Open-label Extension Phase||0
3226439|NCT02318719|3958518|FG001|STARTED|Open-label Extension Phase||0
3226440|NCT02318719|3958519|FG002|STARTED|Open-label Extension Phase||0
3226441|NCT02318719|3958520|FG003|STARTED|Open-label Extension Phase||0
3226442|NCT02318719|3958521|FG004|STARTED|Open-label Extension Phase|A portion of participants who completed the double-blind phase enrolled in the open-label extension.|239
3226443|NCT02318719|3958517|FG000|COMPLETED|Open-label Extension Phase||0
3226444|NCT02318719|3958518|FG001|COMPLETED|Open-label Extension Phase||0
3226445|NCT02318719|3958519|FG002|COMPLETED|Open-label Extension Phase||0
3226446|NCT02318719|3958520|FG003|COMPLETED|Open-label Extension Phase||0
3226447|NCT02318719|3958521|FG004|COMPLETED|Open-label Extension Phase||184
3226448|NCT02318719|3958517|FG000|NOT COMPLETED|Open-label Extension Phase||0
3226449|NCT02318719|3958518|FG001|NOT COMPLETED|Open-label Extension Phase||0
3226450|NCT02318719|3958519|FG002|NOT COMPLETED|Open-label Extension Phase||0
3226451|NCT02318719|3958520|FG003|NOT COMPLETED|Open-label Extension Phase||0
3226452|NCT02318719|3958521|FG004|NOT COMPLETED|Open-label Extension Phase||55
3226453|NCT02318797|3958535|FG000|STARTED|Overall Study||516
3226454|NCT02318797|3958536|FG001|STARTED|Overall Study||713
3226455|NCT02318797|3958535|FG000|COMPLETED|Overall Study||428
3226456|NCT02318797|3958536|FG001|COMPLETED|Overall Study||611
3226457|NCT02318797|3958535|FG000|NOT COMPLETED|Overall Study||88
3226458|NCT02318797|3958536|FG001|NOT COMPLETED|Overall Study||102
3226459|NCT02318940|3958544|FG000|STARTED|Overall Study|in the last patient we lost the record.|50
3226460|NCT02318940|3958545|FG001|STARTED|Overall Study||50
3226461|NCT02318940|3958544|FG000|COMPLETED|Overall Study||49
3226462|NCT02318940|3958545|FG001|COMPLETED|Overall Study||50
3226463|NCT02318940|3958544|FG000|NOT COMPLETED|Overall Study||1
3226464|NCT02318940|3958545|FG001|NOT COMPLETED|Overall Study||0
3226465|NCT02318979|3958553|FG000|STARTED|Overall Study||15
3226466|NCT02318979|3958554|FG001|STARTED|Overall Study||15
3226467|NCT02318979|3958553|FG000|COMPLETED|Overall Study||15
3226468|NCT02318979|3958554|FG001|COMPLETED|Overall Study||15
3226469|NCT02318979|3958553|FG000|NOT COMPLETED|Overall Study||0
3226470|NCT02318979|3958554|FG001|NOT COMPLETED|Overall Study||0
3226471|NCT02318992|3958567|FG000|STARTED|Overall Study||27
3226472|NCT02318992|3958568|FG001|STARTED|Overall Study||27
3226473|NCT02318992|3958569|FG002|STARTED|Overall Study||24
3226474|NCT02318992|3958567|FG000|COMPLETED|Overall Study||25
3226475|NCT02318992|3958568|FG001|COMPLETED|Overall Study||25
3226476|NCT02318992|3958569|FG002|COMPLETED|Overall Study||20
3226477|NCT02318992|3958567|FG000|NOT COMPLETED|Overall Study||2
3226478|NCT02318992|3958568|FG001|NOT COMPLETED|Overall Study||2
3226479|NCT02318992|3958569|FG002|NOT COMPLETED|Overall Study||4
3226480|NCT02319031|3958579|FG000|STARTED|Treatment Period||24
3226481|NCT02319031|3958580|FG001|STARTED|Treatment Period||26
3226482|NCT02319031|3958579|FG000|COMPLETED|Treatment Period||23
3226483|NCT02319031|3958580|FG001|COMPLETED|Treatment Period||26
3226484|NCT02319031|3958579|FG000|NOT COMPLETED|Treatment Period||1
3226485|NCT02319031|3958580|FG001|NOT COMPLETED|Treatment Period||0
3226486|NCT02319031|3958579|FG000|STARTED|Follow-Up Period||23
3226487|NCT02319031|3958580|FG001|STARTED|Follow-Up Period||26
3226488|NCT02319031|3958579|FG000|COMPLETED|Follow-Up Period||23
3226489|NCT02319031|3958580|FG001|COMPLETED|Follow-Up Period||26
3226490|NCT02319031|3958579|FG000|NOT COMPLETED|Follow-Up Period||0
3226491|NCT02319031|3958580|FG001|NOT COMPLETED|Follow-Up Period||0
3226492|NCT02319044|3958589|FG000|STARTED|Overall Study||133
3226493|NCT02319044|3958590|FG001|STARTED|Overall Study||67
3226494|NCT02319044|3958591|FG002|STARTED|Overall Study||67
3226495|NCT02319044|3958589|FG000|COMPLETED|Overall Study||11
3226496|NCT02319044|3958590|FG001|COMPLETED|Overall Study||7
3226497|NCT02319044|3958591|FG002|COMPLETED|Overall Study||0
3226498|NCT02319044|3958589|FG000|NOT COMPLETED|Overall Study||122
3226499|NCT02319044|3958590|FG001|NOT COMPLETED|Overall Study||60
3226500|NCT02319044|3958591|FG002|NOT COMPLETED|Overall Study||67
3226501|NCT02319148|3958603|FG000|STARTED|First Intervention Period||22
3226502|NCT02319148|3958604|FG001|STARTED|First Intervention Period||0
3226503|NCT02319148|3958605|FG002|STARTED|First Intervention Period||0
3226504|NCT02319148|3958606|FG003|STARTED|First Intervention Period||0
3226505|NCT02319148|3958603|FG000|COMPLETED|First Intervention Period||22
3226506|NCT02319148|3958604|FG001|COMPLETED|First Intervention Period||0
3226507|NCT02319148|3958605|FG002|COMPLETED|First Intervention Period||0
3226508|NCT02319148|3958606|FG003|COMPLETED|First Intervention Period||0
3226509|NCT02319148|3958603|FG000|NOT COMPLETED|First Intervention Period||0
3226510|NCT02319148|3958604|FG001|NOT COMPLETED|First Intervention Period||0
3226511|NCT02319148|3958605|FG002|NOT COMPLETED|First Intervention Period||0
3226512|NCT02319148|3958606|FG003|NOT COMPLETED|First Intervention Period||0
3226513|NCT02319148|3958603|FG000|STARTED|Washout Period 4 Days||22
3226514|NCT02319148|3958604|FG001|STARTED|Washout Period 4 Days||0
3226515|NCT02319148|3958605|FG002|STARTED|Washout Period 4 Days||0
3226516|NCT02319148|3958606|FG003|STARTED|Washout Period 4 Days||0
3226517|NCT02319148|3958603|FG000|COMPLETED|Washout Period 4 Days||22
3226518|NCT02319148|3958604|FG001|COMPLETED|Washout Period 4 Days||0
3226519|NCT02319148|3958605|FG002|COMPLETED|Washout Period 4 Days||0
3226520|NCT02319148|3958606|FG003|COMPLETED|Washout Period 4 Days||0
3226521|NCT02319148|3958603|FG000|NOT COMPLETED|Washout Period 4 Days||0
3226522|NCT02319148|3958604|FG001|NOT COMPLETED|Washout Period 4 Days||0
3226523|NCT02319148|3958605|FG002|NOT COMPLETED|Washout Period 4 Days||0
3226524|NCT02319148|3958606|FG003|NOT COMPLETED|Washout Period 4 Days||0
3226525|NCT02319148|3958603|FG000|STARTED|Second Intervention Period||0
3226526|NCT02319148|3958604|FG001|STARTED|Second Intervention Period||7
3226527|NCT02319148|3958605|FG002|STARTED|Second Intervention Period||7
3226528|NCT02319148|3958606|FG003|STARTED|Second Intervention Period||8
3226529|NCT02319148|3958603|FG000|COMPLETED|Second Intervention Period||0
3226530|NCT02319148|3958604|FG001|COMPLETED|Second Intervention Period||6
3226531|NCT02319148|3958605|FG002|COMPLETED|Second Intervention Period||6
3226532|NCT02319148|3958606|FG003|COMPLETED|Second Intervention Period||6
3226533|NCT02319148|3958603|FG000|NOT COMPLETED|Second Intervention Period||0
3226534|NCT02319148|3958604|FG001|NOT COMPLETED|Second Intervention Period||1
3226535|NCT02319148|3958605|FG002|NOT COMPLETED|Second Intervention Period||1
3226536|NCT02319148|3958606|FG003|NOT COMPLETED|Second Intervention Period||2
3226537|NCT02319174|3958625|FG000|STARTED|Overall Study||43
3226538|NCT02319174|3958625|FG000|COMPLETED|Overall Study||42
3226539|NCT02319174|3958625|FG000|NOT COMPLETED|Overall Study||1
3226540|NCT02319304|3958630|FG000|STARTED|Overall Study||3
3226541|NCT02319304|3958630|FG000|COMPLETED|Overall Study||2
3226542|NCT02319304|3958630|FG000|NOT COMPLETED|Overall Study||1
3226543|NCT02319317|3958636|FG000|STARTED|Overall Study||31
3226544|NCT02319317|3958637|FG001|STARTED|Overall Study||29
3226545|NCT02319317|3958636|FG000|COMPLETED|Overall Study||31
3226546|NCT02319317|3958637|FG001|COMPLETED|Overall Study||29
3226547|NCT02319317|3958636|FG000|NOT COMPLETED|Overall Study||0
3226548|NCT02319317|3958637|FG001|NOT COMPLETED|Overall Study||0
3226549|NCT02319369|3958656|FG000|STARTED|Overall Study||7
3226550|NCT02319369|3958657|FG001|STARTED|Overall Study||6
3226551|NCT02319369|3958658|FG002|STARTED|Overall Study||11
3226552|NCT02319369|3958659|FG003|STARTED|Overall Study||8
3226553|NCT02319369|3958660|FG004|STARTED|Overall Study||5
3226554|NCT02319369|3958661|FG005|STARTED|Overall Study||7
3226555|NCT02319369|3958662|FG006|STARTED|Overall Study||3
3226556|NCT02319369|3958663|FG007|STARTED|Overall Study||6
3226557|NCT02319369|3958664|FG008|STARTED|Overall Study||4
3226558|NCT02319369|3958665|FG009|STARTED|Overall Study||9
3226559|NCT02319369|3958666|FG010|STARTED|Overall Study||3
3226560|NCT02319369|3958667|FG011|STARTED|Overall Study||4
3226561|NCT02319369|3958668|FG012|STARTED|Overall Study||1
3226562|NCT02319369|3958656|FG000|COMPLETED|Overall Study||7
3226563|NCT02319369|3958657|FG001|COMPLETED|Overall Study||6
3226564|NCT02319369|3958658|FG002|COMPLETED|Overall Study||11
3226565|NCT02319369|3958659|FG003|COMPLETED|Overall Study||8
3226566|NCT02319369|3958660|FG004|COMPLETED|Overall Study||5
3226567|NCT02319369|3958661|FG005|COMPLETED|Overall Study||7
3226568|NCT02319369|3958662|FG006|COMPLETED|Overall Study||3
3226569|NCT02319369|3958663|FG007|COMPLETED|Overall Study||6
3226570|NCT02319369|3958664|FG008|COMPLETED|Overall Study||4
3226571|NCT02319369|3958665|FG009|COMPLETED|Overall Study||9
3226572|NCT02319369|3958666|FG010|COMPLETED|Overall Study||3
3226573|NCT02319369|3958667|FG011|COMPLETED|Overall Study||4
3226574|NCT02319369|3958668|FG012|COMPLETED|Overall Study||1
3226575|NCT02319369|3958656|FG000|NOT COMPLETED|Overall Study||0
3226576|NCT02319369|3958657|FG001|NOT COMPLETED|Overall Study||0
3226577|NCT02319369|3958658|FG002|NOT COMPLETED|Overall Study||0
3226578|NCT02319369|3958659|FG003|NOT COMPLETED|Overall Study||0
3226579|NCT02319369|3958660|FG004|NOT COMPLETED|Overall Study||0
3226580|NCT02319369|3958661|FG005|NOT COMPLETED|Overall Study||0
3226581|NCT02319369|3958662|FG006|NOT COMPLETED|Overall Study||0
3226582|NCT02319369|3958663|FG007|NOT COMPLETED|Overall Study||0
3226583|NCT02319369|3958664|FG008|NOT COMPLETED|Overall Study||0
3226584|NCT02319369|3958665|FG009|NOT COMPLETED|Overall Study||0
3226585|NCT02319369|3958666|FG010|NOT COMPLETED|Overall Study||0
3226586|NCT02319369|3958667|FG011|NOT COMPLETED|Overall Study||0
3226587|NCT02319369|3958668|FG012|NOT COMPLETED|Overall Study||0
3226588|NCT02319486|3958706|FG000|STARTED|Overall Study||26
3226589|NCT02319486|3958706|FG000|COMPLETED|Overall Study||26
3226590|NCT02319486|3958706|FG000|NOT COMPLETED|Overall Study||0
3226591|NCT02319525|3958714|FG000|STARTED|Overall Study||153
3226592|NCT02319525|3958715|FG001|STARTED|Overall Study||148
3226593|NCT02319525|3958714|FG000|Primary Research Completion|Overall Study||151
3226594|NCT02319525|3958715|FG001|Primary Research Completion|Overall Study||147
3226595|NCT02319525|3958714|FG000|COMPLETED|Overall Study||151
3226596|NCT02319525|3958715|FG001|COMPLETED|Overall Study||147
3226597|NCT02319525|3958714|FG000|NOT COMPLETED|Overall Study||2
3226598|NCT02319525|3958715|FG001|NOT COMPLETED|Overall Study||1
3226599|NCT02319642|3958723|FG000|STARTED|Overall Study||95
3226600|NCT02319642|3958724|FG001|STARTED|Overall Study||251
3226601|NCT02319642|3958723|FG000|COMPLETED|Overall Study||91
3226602|NCT02319642|3958724|FG001|COMPLETED|Overall Study||245
3226603|NCT02319642|3958723|FG000|NOT COMPLETED|Overall Study||4
3226604|NCT02319642|3958724|FG001|NOT COMPLETED|Overall Study||6
3226605|NCT02319668|3958734|FG000|STARTED|Overall Study||19
3226606|NCT02319668|3958735|FG001|STARTED|Overall Study||19
3226607|NCT02319668|3958734|FG000|COMPLETED|Overall Study||19
3226608|NCT02319668|3958735|FG001|COMPLETED|Overall Study||17
3226609|NCT02319668|3958734|FG000|NOT COMPLETED|Overall Study||0
3226610|NCT02319668|3958735|FG001|NOT COMPLETED|Overall Study||2
3226611|NCT02319759|3958746|FG000|STARTED|Week 0 - 16||49
3226612|NCT02319759|3958747|FG001|STARTED|Week 0 - 16||0
3226613|NCT02319759|3958748|FG002|STARTED|Week 0 - 16||100
3226614|NCT02319759|3958749|FG003|STARTED|Week 0 - 16||0
3226615|NCT02319759|3958750|FG004|STARTED|Week 0 - 16||0
3226616|NCT02319759|3958746|FG000|COMPLETED|Week 0 - 16||48
3226617|NCT02319759|3958747|FG001|COMPLETED|Week 0 - 16||0
3226618|NCT02319759|3958748|FG002|COMPLETED|Week 0 - 16||99
3226619|NCT02319759|3958749|FG003|COMPLETED|Week 0 - 16||0
3226620|NCT02319759|3958750|FG004|COMPLETED|Week 0 - 16||0
3226621|NCT02319759|3958746|FG000|NOT COMPLETED|Week 0 - 16||1
3226622|NCT02319759|3958747|FG001|NOT COMPLETED|Week 0 - 16||0
3226623|NCT02319759|3958748|FG002|NOT COMPLETED|Week 0 - 16||1
3226624|NCT02319759|3958749|FG003|NOT COMPLETED|Week 0 - 16||0
3226625|NCT02319759|3958750|FG004|NOT COMPLETED|Week 0 - 16||0
3226626|NCT02319759|3958746|FG000|STARTED|Week 16 - 24||31
3226627|NCT02319759|3958747|FG001|STARTED|Week 16 - 24||0
3226628|NCT02319759|3958748|FG002|STARTED|Week 16 - 24||89
3226629|NCT02319759|3958749|FG003|STARTED|Week 16 - 24||17
3226630|NCT02319759|3958750|FG004|STARTED|Week 16 - 24||10
3226631|NCT02319759|3958746|FG000|COMPLETED|Week 16 - 24||29
3226632|NCT02319759|3958747|FG001|COMPLETED|Week 16 - 24||0
3368514|NCT03835975|4100065|FG004|COMPLETED|Overall Study||125
3368515|NCT03835975|4100061|FG000|NOT COMPLETED|Overall Study||3
3368516|NCT03835975|4100062|FG001|NOT COMPLETED|Overall Study||3
3368517|NCT03835975|4100063|FG002|NOT COMPLETED|Overall Study||3
3368518|NCT03835975|4100064|FG003|NOT COMPLETED|Overall Study||1
3368519|NCT03835975|4100065|FG004|NOT COMPLETED|Overall Study||0
3368520|NCT03821259|4100079|FG000|STARTED|Overall Study||88
3368521|NCT03821259|4100079|FG000|COMPLETED|Overall Study||88
3368522|NCT03821259|4100079|FG000|NOT COMPLETED|Overall Study||0
3368523|NCT03803085|4100085|FG000|STARTED|Overall Study||30
3368524|NCT03803085|4100086|FG001|STARTED|Overall Study||30
3368525|NCT03803085|4100085|FG000|COMPLETED|Overall Study||28
3368526|NCT03803085|4100086|FG001|COMPLETED|Overall Study||28
3368527|NCT03803085|4100085|FG000|NOT COMPLETED|Overall Study||2
3368528|NCT03803085|4100086|FG001|NOT COMPLETED|Overall Study||2
3368529|NCT03801473|4100095|FG000|STARTED|Overall Study||21
3368530|NCT03801473|4100096|FG001|STARTED|Overall Study||21
3368531|NCT03801473|4100095|FG000|COMPLETED|Overall Study||18
3368532|NCT03801473|4100096|FG001|COMPLETED|Overall Study||19
3368533|NCT03801473|4100095|FG000|NOT COMPLETED|Overall Study||3
3368534|NCT03801473|4100096|FG001|NOT COMPLETED|Overall Study||2
3368535|NCT03834168|4100104|FG000|STARTED|Overall Study||19
3368536|NCT03834168|4100105|FG001|STARTED|Overall Study||23
3368537|NCT03834168|4100104|FG000|Total Participant Screened for the Purpose of Eligibility|Overall Study||22
3368538|NCT03834168|4100105|FG001|Total Participant Screened for the Purpose of Eligibility|Overall Study||30
3368539|NCT03834168|4100104|FG000|Ineligible Participants|Overall Study||3
3368540|NCT03834168|4100105|FG001|Ineligible Participants|Overall Study||7
3368541|NCT03834168|4100104|FG000|Unable to Complete the Protocol|Overall Study||0
3368542|NCT03834168|4100105|FG001|Unable to Complete the Protocol|Overall Study||1
3368543|NCT03834168|4100104|FG000|Study Dropouts|Overall Study||1
3368544|NCT03834168|4100105|FG001|Study Dropouts|Overall Study||0
3368545|NCT03834168|4100104|FG000|Participants Received 5 Days of Standardized Meals|Overall Study||19
3368546|NCT03834168|4100105|FG001|Participants Received 5 Days of Standardized Meals|Overall Study||23
3368547|NCT03834168|4100104|FG000|Participants Returned for the 24-h Inpatient Protocol|Overall Study||18
3368548|NCT03834168|4100105|FG001|Participants Returned for the 24-h Inpatient Protocol|Overall Study||23
3368549|NCT03834168|4100104|FG000|COMPLETED|Overall Study||18
3368550|NCT03834168|4100105|FG001|COMPLETED|Overall Study||22
3368551|NCT03834168|4100104|FG000|NOT COMPLETED|Overall Study||1
3368552|NCT03834168|4100105|FG001|NOT COMPLETED|Overall Study||1
3368553|NCT03828149|4100113|FG000|STARTED|First Intervention (Single Dose)||9
3368554|NCT03828149|4100114|FG001|STARTED|First Intervention (Single Dose)||8
3368555|NCT03828149|4100113|FG000|COMPLETED|First Intervention (Single Dose)||9
3368556|NCT03828149|4100114|FG001|COMPLETED|First Intervention (Single Dose)||8
3368557|NCT03828149|4100113|FG000|NOT COMPLETED|First Intervention (Single Dose)||0
3368558|NCT03828149|4100114|FG001|NOT COMPLETED|First Intervention (Single Dose)||0
3368559|NCT03828149|4100113|FG000|STARTED|Washout (6 Days)||9
3368560|NCT03828149|4100114|FG001|STARTED|Washout (6 Days)||8
3368561|NCT03828149|4100113|FG000|COMPLETED|Washout (6 Days)||9
3368562|NCT03828149|4100114|FG001|COMPLETED|Washout (6 Days)||8
3368563|NCT03828149|4100113|FG000|NOT COMPLETED|Washout (6 Days)||0
3368564|NCT03828149|4100114|FG001|NOT COMPLETED|Washout (6 Days)||0
3368565|NCT03828149|4100113|FG000|STARTED|Second Intervention (Single Dose)||9
3226633|NCT02319759|3958748|FG002|COMPLETED|Week 16 - 24||86
3226634|NCT02319759|3958749|FG003|COMPLETED|Week 16 - 24||17
3226635|NCT02319759|3958750|FG004|COMPLETED|Week 16 - 24||10
3226636|NCT02319759|3958746|FG000|NOT COMPLETED|Week 16 - 24||2
3226637|NCT02319759|3958747|FG001|NOT COMPLETED|Week 16 - 24||0
3226638|NCT02319759|3958748|FG002|NOT COMPLETED|Week 16 - 24||3
3226639|NCT02319759|3958749|FG003|NOT COMPLETED|Week 16 - 24||0
3226640|NCT02319759|3958750|FG004|NOT COMPLETED|Week 16 - 24||0
3226641|NCT02319759|3958746|FG000|STARTED|Week 24 - 56||0
3226642|NCT02319759|3958747|FG001|STARTED|Week 24 - 56||29
3226643|NCT02319759|3958748|FG002|STARTED|Week 24 - 56||86
3226644|NCT02319759|3958749|FG003|STARTED|Week 24 - 56||17
3226645|NCT02319759|3958750|FG004|STARTED|Week 24 - 56||10
3226646|NCT02319759|3958746|FG000|COMPLETED|Week 24 - 56||0
3226647|NCT02319759|3958747|FG001|COMPLETED|Week 24 - 56||28
3226648|NCT02319759|3958748|FG002|COMPLETED|Week 24 - 56||84
3226649|NCT02319759|3958749|FG003|COMPLETED|Week 24 - 56||15
3226650|NCT02319759|3958750|FG004|COMPLETED|Week 24 - 56||8
3226651|NCT02319759|3958746|FG000|NOT COMPLETED|Week 24 - 56||0
3226652|NCT02319759|3958747|FG001|NOT COMPLETED|Week 24 - 56||1
3226653|NCT02319759|3958748|FG002|NOT COMPLETED|Week 24 - 56||2
3226654|NCT02319759|3958749|FG003|NOT COMPLETED|Week 24 - 56||2
3226655|NCT02319759|3958750|FG004|NOT COMPLETED|Week 24 - 56||2
3226656|NCT02319824|3958763|FG000|STARTED|Overall Study||2
3226657|NCT02319824|3958763|FG000|COMPLETED|Overall Study||2
3226658|NCT02319824|3958763|FG000|NOT COMPLETED|Overall Study||0
3226659|NCT02319967|3958771|FG000|STARTED|Overall Study||126
3226660|NCT02319967|3958772|FG001|STARTED|Overall Study||126
3226661|NCT02319967|3958773|FG002|STARTED|Overall Study||121
3226662|NCT02319967|3958771|FG000|COMPLETED|Overall Study||78
3226663|NCT02319967|3958772|FG001|COMPLETED|Overall Study||82
3226664|NCT02319967|3958773|FG002|COMPLETED|Overall Study||76
3226665|NCT02319967|3958771|FG000|NOT COMPLETED|Overall Study||48
3226666|NCT02319967|3958772|FG001|NOT COMPLETED|Overall Study||44
3226667|NCT02319967|3958773|FG002|NOT COMPLETED|Overall Study||45
3226668|NCT02320058|3958783|FG000|STARTED|Overall Study||101
3226669|NCT02320058|3958784|FG001|STARTED|Overall Study||18
3226670|NCT02320058|3958783|FG000|COMPLETED|Overall Study||59
3226671|NCT02320058|3958784|FG001|COMPLETED|Overall Study||5
3368566|NCT03828149|4100114|FG001|STARTED|Second Intervention (Single Dose)||8
3368567|NCT03828149|4100113|FG000|COMPLETED|Second Intervention (Single Dose)||9
3368568|NCT03828149|4100114|FG001|COMPLETED|Second Intervention (Single Dose)||8
3368569|NCT03828149|4100113|FG000|NOT COMPLETED|Second Intervention (Single Dose)||0
3368570|NCT03828149|4100114|FG001|NOT COMPLETED|Second Intervention (Single Dose)||0
3368571|NCT03835221|4100120|FG000|STARTED|Methafilcon A||43
3368572|NCT03835221|4100120|FG000|COMPLETED|Methafilcon A||42
3368573|NCT03835221|4100120|FG000|NOT COMPLETED|Methafilcon A||1
3368574|NCT03835221|4100120|FG000|STARTED|Fanfilcon A||42
3368575|NCT03835221|4100120|FG000|COMPLETED|Fanfilcon A||42
3368576|NCT03835221|4100120|FG000|NOT COMPLETED|Fanfilcon A||0
3368577|NCT03819634|4100126|FG000|STARTED|Overall Study||24
3368578|NCT03819634|4100126|FG000|COMPLETED|Overall Study||22
3368579|NCT03819634|4100126|FG000|NOT COMPLETED|Overall Study||2
3368580|NCT03812679|4100130|FG000|STARTED|Overall Study||22
3368581|NCT03812679|4100130|FG000|COMPLETED|Overall Study||14
3368582|NCT03812679|4100130|FG000|NOT COMPLETED|Overall Study||8
3368583|NCT03809052|4100145|FG000|STARTED|Overall Study||6
3368584|NCT03809052|4100146|FG001|STARTED|Overall Study||6
3368585|NCT03809052|4100147|FG002|STARTED|Overall Study||6
3368586|NCT03809052|4100148|FG003|STARTED|Overall Study||6
3368587|NCT03809052|4100149|FG004|STARTED|Overall Study||6
3368588|NCT03809052|4100150|FG005|STARTED|Overall Study||6
3368589|NCT03809052|4100151|FG006|STARTED|Overall Study||6
3368590|NCT03809052|4100152|FG007|STARTED|Overall Study||14
3368591|NCT03809052|4100153|FG008|STARTED|Overall Study||8
3368592|NCT03809052|4100154|FG009|STARTED|Overall Study||8
3368593|NCT03809052|4100155|FG010|STARTED|Overall Study||6
3368594|NCT03809052|4100145|FG000|COMPLETED|Overall Study||6
3368595|NCT03809052|4100146|FG001|COMPLETED|Overall Study||6
3368596|NCT03809052|4100147|FG002|COMPLETED|Overall Study||6
3368597|NCT03809052|4100148|FG003|COMPLETED|Overall Study||6
3368598|NCT03809052|4100149|FG004|COMPLETED|Overall Study||6
3368599|NCT03809052|4100150|FG005|COMPLETED|Overall Study||6
3368600|NCT03809052|4100151|FG006|COMPLETED|Overall Study||6
3368601|NCT03809052|4100152|FG007|COMPLETED|Overall Study||14
3368602|NCT03809052|4100153|FG008|COMPLETED|Overall Study||8
3368603|NCT03809052|4100154|FG009|COMPLETED|Overall Study||8
3368604|NCT03809052|4100155|FG010|COMPLETED|Overall Study||6
3368605|NCT03809052|4100145|FG000|NOT COMPLETED|Overall Study||0
3368606|NCT03809052|4100146|FG001|NOT COMPLETED|Overall Study||0
3368607|NCT03809052|4100147|FG002|NOT COMPLETED|Overall Study||0
3368608|NCT03809052|4100148|FG003|NOT COMPLETED|Overall Study||0
3368609|NCT03809052|4100149|FG004|NOT COMPLETED|Overall Study||0
3368610|NCT03809052|4100150|FG005|NOT COMPLETED|Overall Study||0
3368611|NCT03809052|4100151|FG006|NOT COMPLETED|Overall Study||0
3368612|NCT03809052|4100152|FG007|NOT COMPLETED|Overall Study||0
3368613|NCT03809052|4100153|FG008|NOT COMPLETED|Overall Study||0
3368614|NCT03809052|4100154|FG009|NOT COMPLETED|Overall Study||0
3368615|NCT03809052|4100155|FG010|NOT COMPLETED|Overall Study||0
3368616|NCT03801148|4100185|FG000|STARTED|Period 1 (2 Days)||31
3368617|NCT03801148|4100186|FG001|STARTED|Period 1 (2 Days)||31
3368618|NCT03801148|4100187|FG002|STARTED|Period 1 (2 Days)||30
3368619|NCT03801148|4100188|FG003|STARTED|Period 1 (2 Days)||30
3226672|NCT02320058|3958783|FG000|NOT COMPLETED|Overall Study||42
3226673|NCT02320058|3958784|FG001|NOT COMPLETED|Overall Study||13
3226674|NCT02320123|3958792|FG000|STARTED|Overall Study||10
3226675|NCT02320123|3958793|FG001|STARTED|Overall Study||12
3226676|NCT02320123|3958792|FG000|COMPLETED|Overall Study||0
3226677|NCT02320123|3958793|FG001|COMPLETED|Overall Study||1
3226678|NCT02320123|3958792|FG000|NOT COMPLETED|Overall Study||10
3226679|NCT02320123|3958793|FG001|NOT COMPLETED|Overall Study||11
3226680|NCT02320149|3958805|FG000|STARTED|Overall Study||483
3226681|NCT02320149|3958806|FG001|STARTED|Overall Study||485
3226682|NCT02320149|3958805|FG000|COMPLETED|Overall Study||420
3226683|NCT02320149|3958806|FG001|COMPLETED|Overall Study||405
3226684|NCT02320149|3958805|FG000|NOT COMPLETED|Overall Study||63
3226685|NCT02320149|3958806|FG001|NOT COMPLETED|Overall Study||80
3226686|NCT02320175|3958814|FG000|STARTED|Overall Study|Patients (n=1574); Parents (n=1222); Physicians (n=478); Nurses (n=264).|3538
3226687|NCT02320175|3958815|FG001|STARTED|Overall Study|Patients (n=1532); Parents (n=926); Physicians (n=311); Nurses (n=171).|2940
3226688|NCT02320175|3958814|FG000|COMPLETED|Overall Study|Patients (n=1574); Parents (n=1222); Physicians (n=478); Nurses (n=264).|3538
3226689|NCT02320175|3958815|FG001|COMPLETED|Overall Study|Patients (n=1532); Parents (n=926); Physicians (n=311); Nurses (n=171).|2940
3226690|NCT02320175|3958814|FG000|NOT COMPLETED|Overall Study||0
3226691|NCT02320175|3958815|FG001|NOT COMPLETED|Overall Study||0
3226692|NCT02320214|3958824|FG000|STARTED|Overall Study||30
3226693|NCT02320214|3958824|FG000|COMPLETED|Overall Study||30
3226694|NCT02320214|3958824|FG000|NOT COMPLETED|Overall Study||0
3226695|NCT02320227|3958828|FG000|STARTED|Overall Study||30
3226696|NCT02320227|3958828|FG000|COMPLETED|Overall Study||30
3226697|NCT02320227|3958828|FG000|NOT COMPLETED|Overall Study||0
3226698|NCT02320253|3958836|FG000|STARTED|Overall Study||69
3226699|NCT02320253|3958837|FG001|STARTED|Overall Study||70
3226700|NCT02320253|3958838|FG002|STARTED|Overall Study||72
3226701|NCT02320253|3958836|FG000|COMPLETED|Overall Study||63
3226702|NCT02320253|3958837|FG001|COMPLETED|Overall Study||68
3226703|NCT02320253|3958838|FG002|COMPLETED|Overall Study||70
3226704|NCT02320253|3958836|FG000|NOT COMPLETED|Overall Study||6
3226705|NCT02320253|3958837|FG001|NOT COMPLETED|Overall Study||2
3226706|NCT02320253|3958838|FG002|NOT COMPLETED|Overall Study||2
3226707|NCT02320487|3958846|FG000|STARTED|Overall Study||102
3226708|NCT02320487|3958846|FG000|COMPLETED|Overall Study|Completed = completed the 6-cycle Treatment Period.|81
3226709|NCT02320487|3958846|FG000|NOT COMPLETED|Overall Study||21
3226710|NCT02320695|3958850|FG000|STARTED|Overall Study||60
3226711|NCT02320695|3958850|FG000|Saline|Overall Study||60
3226712|NCT02320695|3958850|FG000|Alcohol|Overall Study||60
3226713|NCT02320695|3958850|FG000|Pain Relieving Cream|Overall Study||59
3226714|NCT02320695|3958850|FG000|Antibiotic/Pain Relieving Ointment|Overall Study||60
3226715|NCT02320695|3958850|FG000|Original Ointment|Overall Study||60
3226716|NCT02320695|3958850|FG000|Pain Relief Ointment|Overall Study||60
3226717|NCT02320695|3958850|FG000|COMPLETED|Overall Study||60
3226718|NCT02320695|3958850|FG000|NOT COMPLETED|Overall Study||0
3226719|NCT02320721|3958861|FG000|STARTED|Overall Study||508
3226720|NCT02320721|3958862|FG001|STARTED|Overall Study||506
3226721|NCT02320721|3958861|FG000|Treated (Safety Population)|Overall Study||508
3226722|NCT02320721|3958862|FG001|Treated (Safety Population)|Overall Study||505
3226723|NCT02320721|3958861|FG000|COMPLETED|Overall Study||481
3226724|NCT02320721|3958862|FG001|COMPLETED|Overall Study||472
3226725|NCT02320721|3958861|FG000|NOT COMPLETED|Overall Study||27
3226726|NCT02320721|3958862|FG001|NOT COMPLETED|Overall Study||34
3226727|NCT02320812|3958868|FG000|STARTED|Overall Study||28
3226728|NCT02320812|3958868|FG000|COMPLETED|Overall Study||28
3226729|NCT02320812|3958868|FG000|NOT COMPLETED|Overall Study||0
3226730|NCT02320838|3958876|FG000|STARTED|First Intervention (1 Day)||8
3226731|NCT02320838|3958877|FG001|STARTED|First Intervention (1 Day)||8
3226732|NCT02320838|3958878|FG002|STARTED|First Intervention (1 Day)||8
3226733|NCT02320838|3958879|FG003|STARTED|First Intervention (1 Day)||7
3226734|NCT02320838|3958880|FG004|STARTED|First Intervention (1 Day)||7
3226735|NCT02320838|3958876|FG000|COMPLETED|First Intervention (1 Day)||8
3226736|NCT02320838|3958877|FG001|COMPLETED|First Intervention (1 Day)||8
3226737|NCT02320838|3958878|FG002|COMPLETED|First Intervention (1 Day)||8
3226738|NCT02320838|3958879|FG003|COMPLETED|First Intervention (1 Day)||7
3226739|NCT02320838|3958880|FG004|COMPLETED|First Intervention (1 Day)||7
3226740|NCT02320838|3958876|FG000|NOT COMPLETED|First Intervention (1 Day)||0
3226741|NCT02320838|3958877|FG001|NOT COMPLETED|First Intervention (1 Day)||0
3226742|NCT02320838|3958878|FG002|NOT COMPLETED|First Intervention (1 Day)||0
3226743|NCT02320838|3958879|FG003|NOT COMPLETED|First Intervention (1 Day)||0
3226744|NCT02320838|3958880|FG004|NOT COMPLETED|First Intervention (1 Day)||0
3226745|NCT02320838|3958876|FG000|STARTED|Washout (1 Day)||8
3226746|NCT02320838|3958877|FG001|STARTED|Washout (1 Day)||8
3226747|NCT02320838|3958878|FG002|STARTED|Washout (1 Day)||8
3226748|NCT02320838|3958879|FG003|STARTED|Washout (1 Day)||7
3226749|NCT02320838|3958880|FG004|STARTED|Washout (1 Day)||7
3226750|NCT02320838|3958876|FG000|COMPLETED|Washout (1 Day)||8
3226751|NCT02320838|3958877|FG001|COMPLETED|Washout (1 Day)||8
3226752|NCT02320838|3958878|FG002|COMPLETED|Washout (1 Day)||8
3226753|NCT02320838|3958879|FG003|COMPLETED|Washout (1 Day)||7
3226754|NCT02320838|3958880|FG004|COMPLETED|Washout (1 Day)||7
3226755|NCT02320838|3958876|FG000|NOT COMPLETED|Washout (1 Day)||0
3226756|NCT02320838|3958877|FG001|NOT COMPLETED|Washout (1 Day)||0
3226757|NCT02320838|3958878|FG002|NOT COMPLETED|Washout (1 Day)||0
3226758|NCT02320838|3958879|FG003|NOT COMPLETED|Washout (1 Day)||0
3226759|NCT02320838|3958880|FG004|NOT COMPLETED|Washout (1 Day)||0
3226760|NCT02320838|3958876|FG000|STARTED|Second Intervention (1 Day)||8
3226761|NCT02320838|3958877|FG001|STARTED|Second Intervention (1 Day)||8
3226762|NCT02320838|3958878|FG002|STARTED|Second Intervention (1 Day)||8
3226763|NCT02320838|3958879|FG003|STARTED|Second Intervention (1 Day)||7
3226764|NCT02320838|3958880|FG004|STARTED|Second Intervention (1 Day)||7
3226765|NCT02320838|3958876|FG000|COMPLETED|Second Intervention (1 Day)||8
3226766|NCT02320838|3958877|FG001|COMPLETED|Second Intervention (1 Day)||8
3226767|NCT02320838|3958878|FG002|COMPLETED|Second Intervention (1 Day)||8
3226768|NCT02320838|3958879|FG003|COMPLETED|Second Intervention (1 Day)||7
3226769|NCT02320838|3958880|FG004|COMPLETED|Second Intervention (1 Day)||7
3226770|NCT02320838|3958876|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
3226771|NCT02320838|3958877|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
3226772|NCT02320838|3958878|FG002|NOT COMPLETED|Second Intervention (1 Day)||0
3226773|NCT02320838|3958879|FG003|NOT COMPLETED|Second Intervention (1 Day)||0
3226774|NCT02320838|3958880|FG004|NOT COMPLETED|Second Intervention (1 Day)||0
3226775|NCT02320838|3958876|FG000|STARTED|Washout (1 Day)||8
3226776|NCT02320838|3958877|FG001|STARTED|Washout (1 Day)||8
3226777|NCT02320838|3958878|FG002|STARTED|Washout (1 Day)||8
3226778|NCT02320838|3958879|FG003|STARTED|Washout (1 Day)||7
3226779|NCT02320838|3958880|FG004|STARTED|Washout (1 Day)||7
3226780|NCT02320838|3958876|FG000|COMPLETED|Washout (1 Day)||8
3226781|NCT02320838|3958877|FG001|COMPLETED|Washout (1 Day)||8
3226782|NCT02320838|3958878|FG002|COMPLETED|Washout (1 Day)||8
3226783|NCT02320838|3958879|FG003|COMPLETED|Washout (1 Day)||7
3226784|NCT02320838|3958880|FG004|COMPLETED|Washout (1 Day)||7
3226785|NCT02320838|3958876|FG000|NOT COMPLETED|Washout (1 Day)||0
3226786|NCT02320838|3958877|FG001|NOT COMPLETED|Washout (1 Day)||0
3226787|NCT02320838|3958878|FG002|NOT COMPLETED|Washout (1 Day)||0
3226788|NCT02320838|3958879|FG003|NOT COMPLETED|Washout (1 Day)||0
3226789|NCT02320838|3958880|FG004|NOT COMPLETED|Washout (1 Day)||0
3226790|NCT02320838|3958876|FG000|STARTED|Third Intervention (1 Day)||8
3226791|NCT02320838|3958877|FG001|STARTED|Third Intervention (1 Day)||8
3226792|NCT02320838|3958878|FG002|STARTED|Third Intervention (1 Day)||8
3226793|NCT02320838|3958879|FG003|STARTED|Third Intervention (1 Day)||7
3226794|NCT02320838|3958880|FG004|STARTED|Third Intervention (1 Day)||7
3226795|NCT02320838|3958876|FG000|COMPLETED|Third Intervention (1 Day)||8
3226796|NCT02320838|3958877|FG001|COMPLETED|Third Intervention (1 Day)||8
3226797|NCT02320838|3958878|FG002|COMPLETED|Third Intervention (1 Day)||8
3226798|NCT02320838|3958879|FG003|COMPLETED|Third Intervention (1 Day)||7
3226799|NCT02320838|3958880|FG004|COMPLETED|Third Intervention (1 Day)||7
3226800|NCT02320838|3958876|FG000|NOT COMPLETED|Third Intervention (1 Day)||0
3226801|NCT02320838|3958877|FG001|NOT COMPLETED|Third Intervention (1 Day)||0
3226802|NCT02320838|3958878|FG002|NOT COMPLETED|Third Intervention (1 Day)||0
3226803|NCT02320838|3958879|FG003|NOT COMPLETED|Third Intervention (1 Day)||0
3226804|NCT02320838|3958880|FG004|NOT COMPLETED|Third Intervention (1 Day)||0
3226805|NCT02320903|3958891|FG000|STARTED|Overall Study||24
3226806|NCT02320903|3958892|FG001|STARTED|Overall Study||32
3226807|NCT02320903|3958893|FG002|STARTED|Overall Study||32
3226808|NCT02320903|3958891|FG000|COMPLETED|Overall Study||16
3226809|NCT02320903|3958892|FG001|COMPLETED|Overall Study||16
3226810|NCT02320903|3958893|FG002|COMPLETED|Overall Study||16
3226811|NCT02320903|3958891|FG000|NOT COMPLETED|Overall Study||8
3226812|NCT02320903|3958892|FG001|NOT COMPLETED|Overall Study||16
3226813|NCT02320903|3958893|FG002|NOT COMPLETED|Overall Study||16
3226814|NCT02321098|3958905|FG000|STARTED|12 Weeks Treament||26
3226815|NCT02321098|3958906|FG001|STARTED|12 Weeks Treament||24
3226816|NCT02321098|3958907|FG002|STARTED|12 Weeks Treament||0
3226817|NCT02321098|3958905|FG000|COMPLETED|12 Weeks Treament||25
3226818|NCT02321098|3958906|FG001|COMPLETED|12 Weeks Treament||23
3226819|NCT02321098|3958907|FG002|COMPLETED|12 Weeks Treament||0
3226820|NCT02321098|3958905|FG000|NOT COMPLETED|12 Weeks Treament||1
3226821|NCT02321098|3958906|FG001|NOT COMPLETED|12 Weeks Treament||1
3226822|NCT02321098|3958907|FG002|NOT COMPLETED|12 Weeks Treament||0
3226823|NCT02321098|3958905|FG000|STARTED|Additional 15 Months Treatment||0
3226824|NCT02321098|3958906|FG001|STARTED|Additional 15 Months Treatment||0
3226825|NCT02321098|3958907|FG002|STARTED|Additional 15 Months Treatment||29
3226826|NCT02321098|3958905|FG000|COMPLETED|Additional 15 Months Treatment||0
3226827|NCT02321098|3958906|FG001|COMPLETED|Additional 15 Months Treatment||0
3226828|NCT02321098|3958907|FG002|COMPLETED|Additional 15 Months Treatment||21
3226829|NCT02321098|3958905|FG000|NOT COMPLETED|Additional 15 Months Treatment||0
3226830|NCT02321098|3958906|FG001|NOT COMPLETED|Additional 15 Months Treatment||0
3226831|NCT02321098|3958907|FG002|NOT COMPLETED|Additional 15 Months Treatment||8
3226832|NCT02321111|3958916|FG000|STARTED|Infusion1||1
3226833|NCT02321111|3958917|FG001|STARTED|Infusion1||4
3226834|NCT02321111|3958918|FG002|STARTED|Infusion1||4
3226835|NCT02321111|3958919|FG003|STARTED|Infusion1||1
3226836|NCT02321111|3958920|FG004|STARTED|Infusion1||0
3226837|NCT02321111|3958921|FG005|STARTED|Infusion1||0
3226838|NCT02321111|3958916|FG000|COMPLETED|Infusion1||1
3226839|NCT02321111|3958917|FG001|COMPLETED|Infusion1||4
3226840|NCT02321111|3958918|FG002|COMPLETED|Infusion1||4
3226841|NCT02321111|3958919|FG003|COMPLETED|Infusion1||1
3226842|NCT02321111|3958920|FG004|COMPLETED|Infusion1||0
3226843|NCT02321111|3958921|FG005|COMPLETED|Infusion1||0
3226844|NCT02321111|3958916|FG000|NOT COMPLETED|Infusion1||0
3226845|NCT02321111|3958917|FG001|NOT COMPLETED|Infusion1||0
3226846|NCT02321111|3958918|FG002|NOT COMPLETED|Infusion1||0
3226847|NCT02321111|3958919|FG003|NOT COMPLETED|Infusion1||0
3226848|NCT02321111|3958920|FG004|NOT COMPLETED|Infusion1||0
3226849|NCT02321111|3958921|FG005|NOT COMPLETED|Infusion1||0
3226850|NCT02321111|3958916|FG000|STARTED|Washout1 (3-4weeks Between Infusions)||1
3226851|NCT02321111|3958917|FG001|STARTED|Washout1 (3-4weeks Between Infusions)||4
3226852|NCT02321111|3958918|FG002|STARTED|Washout1 (3-4weeks Between Infusions)||4
3226853|NCT02321111|3958919|FG003|STARTED|Washout1 (3-4weeks Between Infusions)||1
3226854|NCT02321111|3958920|FG004|STARTED|Washout1 (3-4weeks Between Infusions)||0
3226855|NCT02321111|3958921|FG005|STARTED|Washout1 (3-4weeks Between Infusions)||0
3226856|NCT02321111|3958916|FG000|COMPLETED|Washout1 (3-4weeks Between Infusions)||1
3226857|NCT02321111|3958917|FG001|COMPLETED|Washout1 (3-4weeks Between Infusions)||4
3226858|NCT02321111|3958918|FG002|COMPLETED|Washout1 (3-4weeks Between Infusions)||4
3226859|NCT02321111|3958919|FG003|COMPLETED|Washout1 (3-4weeks Between Infusions)||1
3226860|NCT02321111|3958920|FG004|COMPLETED|Washout1 (3-4weeks Between Infusions)||0
3226861|NCT02321111|3958921|FG005|COMPLETED|Washout1 (3-4weeks Between Infusions)||0
3226862|NCT02321111|3958916|FG000|NOT COMPLETED|Washout1 (3-4weeks Between Infusions)||0
3226863|NCT02321111|3958917|FG001|NOT COMPLETED|Washout1 (3-4weeks Between Infusions)||0
3226864|NCT02321111|3958918|FG002|NOT COMPLETED|Washout1 (3-4weeks Between Infusions)||0
3226865|NCT02321111|3958919|FG003|NOT COMPLETED|Washout1 (3-4weeks Between Infusions)||0
3226866|NCT02321111|3958920|FG004|NOT COMPLETED|Washout1 (3-4weeks Between Infusions)||0
3226867|NCT02321111|3958921|FG005|NOT COMPLETED|Washout1 (3-4weeks Between Infusions)||0
3226868|NCT02321111|3958916|FG000|STARTED|Infusion2||1
3226869|NCT02321111|3958917|FG001|STARTED|Infusion2||4
3226870|NCT02321111|3958918|FG002|STARTED|Infusion2||4
3226871|NCT02321111|3958919|FG003|STARTED|Infusion2||1
3226872|NCT02321111|3958920|FG004|STARTED|Infusion2||0
3226873|NCT02321111|3958921|FG005|STARTED|Infusion2||0
3226874|NCT02321111|3958916|FG000|COMPLETED|Infusion2||1
3226875|NCT02321111|3958917|FG001|COMPLETED|Infusion2||4
3226876|NCT02321111|3958918|FG002|COMPLETED|Infusion2||4
3226877|NCT02321111|3958919|FG003|COMPLETED|Infusion2||1
3226878|NCT02321111|3958920|FG004|COMPLETED|Infusion2||0
3226879|NCT02321111|3958921|FG005|COMPLETED|Infusion2||0
3226880|NCT02321111|3958916|FG000|NOT COMPLETED|Infusion2||0
3226881|NCT02321111|3958917|FG001|NOT COMPLETED|Infusion2||0
3226882|NCT02321111|3958918|FG002|NOT COMPLETED|Infusion2||0
3226883|NCT02321111|3958919|FG003|NOT COMPLETED|Infusion2||0
3226884|NCT02321111|3958920|FG004|NOT COMPLETED|Infusion2||0
3226885|NCT02321111|3958921|FG005|NOT COMPLETED|Infusion2||0
3226886|NCT02321111|3958916|FG000|STARTED|Washout2 (3-4weeks Between Infusions)||1
3226887|NCT02321111|3958917|FG001|STARTED|Washout2 (3-4weeks Between Infusions)||4
3226888|NCT02321111|3958918|FG002|STARTED|Washout2 (3-4weeks Between Infusions)||4
3226889|NCT02321111|3958919|FG003|STARTED|Washout2 (3-4weeks Between Infusions)||1
3226890|NCT02321111|3958920|FG004|STARTED|Washout2 (3-4weeks Between Infusions)||0
3226891|NCT02321111|3958921|FG005|STARTED|Washout2 (3-4weeks Between Infusions)||0
3226892|NCT02321111|3958916|FG000|COMPLETED|Washout2 (3-4weeks Between Infusions)||1
3226893|NCT02321111|3958917|FG001|COMPLETED|Washout2 (3-4weeks Between Infusions)||4
3226894|NCT02321111|3958918|FG002|COMPLETED|Washout2 (3-4weeks Between Infusions)||4
3226895|NCT02321111|3958919|FG003|COMPLETED|Washout2 (3-4weeks Between Infusions)||1
3226896|NCT02321111|3958920|FG004|COMPLETED|Washout2 (3-4weeks Between Infusions)||0
3226897|NCT02321111|3958921|FG005|COMPLETED|Washout2 (3-4weeks Between Infusions)||0
3226898|NCT02321111|3958916|FG000|NOT COMPLETED|Washout2 (3-4weeks Between Infusions)||0
3226899|NCT02321111|3958917|FG001|NOT COMPLETED|Washout2 (3-4weeks Between Infusions)||0
3226900|NCT02321111|3958918|FG002|NOT COMPLETED|Washout2 (3-4weeks Between Infusions)||0
3226901|NCT02321111|3958919|FG003|NOT COMPLETED|Washout2 (3-4weeks Between Infusions)||0
3226902|NCT02321111|3958920|FG004|NOT COMPLETED|Washout2 (3-4weeks Between Infusions)||0
3226903|NCT02321111|3958921|FG005|NOT COMPLETED|Washout2 (3-4weeks Between Infusions)||0
3226904|NCT02321111|3958916|FG000|STARTED|Infusion3||1
3226905|NCT02321111|3958917|FG001|STARTED|Infusion3||4
3226906|NCT02321111|3958918|FG002|STARTED|Infusion3||4
3226907|NCT02321111|3958919|FG003|STARTED|Infusion3||1
3226908|NCT02321111|3958920|FG004|STARTED|Infusion3||0
3226909|NCT02321111|3958921|FG005|STARTED|Infusion3||0
3226910|NCT02321111|3958916|FG000|COMPLETED|Infusion3||1
3226911|NCT02321111|3958917|FG001|COMPLETED|Infusion3||4
3226912|NCT02321111|3958918|FG002|COMPLETED|Infusion3||4
3226913|NCT02321111|3958919|FG003|COMPLETED|Infusion3||1
3226914|NCT02321111|3958920|FG004|COMPLETED|Infusion3||0
3226915|NCT02321111|3958921|FG005|COMPLETED|Infusion3||0
3226916|NCT02321111|3958916|FG000|NOT COMPLETED|Infusion3||0
3226917|NCT02321111|3958917|FG001|NOT COMPLETED|Infusion3||0
3226918|NCT02321111|3958918|FG002|NOT COMPLETED|Infusion3||0
3226919|NCT02321111|3958919|FG003|NOT COMPLETED|Infusion3||0
3226920|NCT02321111|3958920|FG004|NOT COMPLETED|Infusion3||0
3226921|NCT02321111|3958921|FG005|NOT COMPLETED|Infusion3||0
3368620|NCT03801148|4100185|FG000|COMPLETED|Period 1 (2 Days)||30
3368621|NCT03801148|4100186|FG001|COMPLETED|Period 1 (2 Days)||30
3368622|NCT03801148|4100187|FG002|COMPLETED|Period 1 (2 Days)||30
3368623|NCT03801148|4100188|FG003|COMPLETED|Period 1 (2 Days)||30
3368624|NCT03801148|4100185|FG000|NOT COMPLETED|Period 1 (2 Days)||1
3368625|NCT03801148|4100186|FG001|NOT COMPLETED|Period 1 (2 Days)||1
3368626|NCT03801148|4100187|FG002|NOT COMPLETED|Period 1 (2 Days)||0
3368627|NCT03801148|4100188|FG003|NOT COMPLETED|Period 1 (2 Days)||0
3226922|NCT02321319|3958929|FG000|STARTED|Overall Study||5
3368628|NCT03801148|4100185|FG000|STARTED|Washout Period (at Least 5 Days)||30
3226923|NCT02321319|3958929|FG000|COMPLETED|Overall Study||0
3226924|NCT02321319|3958929|FG000|NOT COMPLETED|Overall Study||5
3226925|NCT02321436|3958935|FG000|STARTED|Overall Study||28
3226926|NCT02321436|3958936|FG001|STARTED|Overall Study||14
3226927|NCT02321436|3958935|FG000|COMPLETED|Overall Study||27
3226928|NCT02321436|3958936|FG001|COMPLETED|Overall Study||13
3226929|NCT02321436|3958935|FG000|NOT COMPLETED|Overall Study||1
3226930|NCT02321436|3958936|FG001|NOT COMPLETED|Overall Study||1
3226931|NCT02321462|3958945|FG000|STARTED|Overall Study||147
3226932|NCT02321462|3958946|FG001|STARTED|Overall Study||149
3226933|NCT02321462|3958945|FG000|ITT Population|Overall Study||146
3226934|NCT02321462|3958946|FG001|ITT Population|Overall Study||148
3226935|NCT02321462|3958945|FG000|Treated Patients|Overall Study||147
3226936|NCT02321462|3958946|FG001|Treated Patients|Overall Study||147
3226937|NCT02321462|3958945|FG000|Safety Population|Overall Study||147
3226938|NCT02321462|3958946|FG001|Safety Population|Overall Study||147
3226939|NCT02321462|3958945|FG000|COMPLETED|Overall Study||141
3226940|NCT02321462|3958946|FG001|COMPLETED|Overall Study||146
3226941|NCT02321462|3958945|FG000|NOT COMPLETED|Overall Study||6
3226942|NCT02321462|3958946|FG001|NOT COMPLETED|Overall Study||3
3226943|NCT02321527|3958953|FG000|STARTED|Overall Study||21
3226944|NCT02321527|3958953|FG000|COMPLETED|Overall Study||20
3226945|NCT02321527|3958953|FG000|NOT COMPLETED|Overall Study||1
3226946|NCT02321748|3958959|FG000|STARTED|Overall Study||12
3226947|NCT02321748|3958960|FG001|STARTED|Overall Study||12
3226948|NCT02321748|3958959|FG000|First Intervention (4 Days)|Overall Study||12
3226949|NCT02321748|3958960|FG001|First Intervention (4 Days)|Overall Study||12
3226950|NCT02321748|3958959|FG000|Wasout (2weeks)|Overall Study||12
3226951|NCT02321748|3958960|FG001|Wasout (2weeks)|Overall Study||12
3226952|NCT02321748|3958959|FG000|Second Intervention (4 Days)|Overall Study||12
3226953|NCT02321748|3958960|FG001|Second Intervention (4 Days)|Overall Study||12
3226954|NCT02321748|3958959|FG000|COMPLETED|Overall Study||12
3226955|NCT02321748|3958960|FG001|COMPLETED|Overall Study||12
3226956|NCT02321748|3958959|FG000|NOT COMPLETED|Overall Study||0
3226957|NCT02321748|3958960|FG001|NOT COMPLETED|Overall Study||0
3226958|NCT02321800|3958971|FG000|STARTED|Overall Study||303
3226959|NCT02321800|3958972|FG001|STARTED|Overall Study||149
3226960|NCT02321800|3958971|FG000|Received Study Drug|Overall Study||300
3226961|NCT02321800|3958972|FG001|Received Study Drug|Overall Study||148
3226962|NCT02321800|3958971|FG000|COMPLETED|Overall Study||283
3226963|NCT02321800|3958972|FG001|COMPLETED|Overall Study||138
3226964|NCT02321800|3958971|FG000|NOT COMPLETED|Overall Study||20
3226965|NCT02321800|3958972|FG001|NOT COMPLETED|Overall Study||11
3226966|NCT02321930|3958978|FG000|STARTED|Overall Study||25
3226967|NCT02321930|3958978|FG000|COMPLETED|Overall Study||24
3226968|NCT02321930|3958978|FG000|NOT COMPLETED|Overall Study||1
3226969|NCT02322021|3958986|FG000|STARTED|Core Phase||17
3226970|NCT02322021|3958987|FG001|STARTED|Core Phase||17
3226971|NCT02322021|3958988|FG002|STARTED|Core Phase||19
3226972|NCT02322021|3958989|FG003|STARTED|Core Phase||17
3226973|NCT02322021|3958990|FG004|STARTED|Core Phase||0
3226974|NCT02322021|3958986|FG000|COMPLETED|Core Phase||12
3226975|NCT02322021|3958987|FG001|COMPLETED|Core Phase||9
3226976|NCT02322021|3958988|FG002|COMPLETED|Core Phase||10
3226977|NCT02322021|3958989|FG003|COMPLETED|Core Phase||12
3226978|NCT02322021|3958990|FG004|COMPLETED|Core Phase||0
3226979|NCT02322021|3958986|FG000|NOT COMPLETED|Core Phase||5
3226980|NCT02322021|3958987|FG001|NOT COMPLETED|Core Phase||8
3226981|NCT02322021|3958988|FG002|NOT COMPLETED|Core Phase||9
3226982|NCT02322021|3958989|FG003|NOT COMPLETED|Core Phase||5
3226983|NCT02322021|3958990|FG004|NOT COMPLETED|Core Phase||0
3226984|NCT02322021|3958986|FG000|STARTED|Extension Phase||0
3226985|NCT02322021|3958987|FG001|STARTED|Extension Phase||0
3226986|NCT02322021|3958988|FG002|STARTED|Extension Phase||0
3226987|NCT02322021|3958989|FG003|STARTED|Extension Phase||0
3226988|NCT02322021|3958990|FG004|STARTED|Extension Phase|Participants who completed Core Phase, were eligible and gave consent, entered Extension Phase.|41
3226989|NCT02322021|3958986|FG000|COMPLETED|Extension Phase||0
3226990|NCT02322021|3958987|FG001|COMPLETED|Extension Phase||0
3226991|NCT02322021|3958988|FG002|COMPLETED|Extension Phase||0
3226992|NCT02322021|3958989|FG003|COMPLETED|Extension Phase||0
3226993|NCT02322021|3958990|FG004|COMPLETED|Extension Phase||0
3226994|NCT02322021|3958986|FG000|NOT COMPLETED|Extension Phase||0
3226995|NCT02322021|3958987|FG001|NOT COMPLETED|Extension Phase||0
3226996|NCT02322021|3958988|FG002|NOT COMPLETED|Extension Phase||0
3226997|NCT02322021|3958989|FG003|NOT COMPLETED|Extension Phase||0
3226998|NCT02322021|3958990|FG004|NOT COMPLETED|Extension Phase||41
3226999|NCT02322047|3959009|FG000|STARTED|Overall Study||8
3227000|NCT02322047|3959010|FG001|STARTED|Overall Study||7
3227001|NCT02322047|3959011|FG002|STARTED|Overall Study||7
3227002|NCT02322047|3959012|FG003|STARTED|Overall Study||9
3227003|NCT02322047|3959009|FG000|COMPLETED|Overall Study||6
3227004|NCT02322047|3959010|FG001|COMPLETED|Overall Study||6
3227005|NCT02322047|3959011|FG002|COMPLETED|Overall Study||6
3227006|NCT02322047|3959012|FG003|COMPLETED|Overall Study||7
3227007|NCT02322047|3959009|FG000|NOT COMPLETED|Overall Study||2
3227008|NCT02322047|3959010|FG001|NOT COMPLETED|Overall Study||1
3227009|NCT02322047|3959011|FG002|NOT COMPLETED|Overall Study||1
3227010|NCT02322047|3959012|FG003|NOT COMPLETED|Overall Study||2
3227011|NCT02322125|3959022|FG000|STARTED|Overall Study||12
3227012|NCT02322125|3959022|FG000|COMPLETED|Overall Study||10
3227013|NCT02322125|3959022|FG000|NOT COMPLETED|Overall Study||2
3227014|NCT02322190|3959026|FG000|STARTED|Overall Study||5
3227015|NCT02322190|3959027|FG001|STARTED|Overall Study||0
3227016|NCT02322190|3959026|FG000|COMPLETED|Overall Study||4
3227017|NCT02322190|3959027|FG001|COMPLETED|Overall Study||0
3227018|NCT02322190|3959026|FG000|NOT COMPLETED|Overall Study||1
3227019|NCT02322190|3959027|FG001|NOT COMPLETED|Overall Study||0
3227020|NCT02322216|3959034|FG000|STARTED|Overall Study||126
3227021|NCT02322216|3959035|FG001|STARTED|Overall Study||127
3227022|NCT02322216|3959034|FG000|Treated (Safety Set)|Overall Study||126
3227023|NCT02322216|3959035|FG001|Treated (Safety Set)|Overall Study||126
3227024|NCT02322216|3959034|FG000|Per Protocol Set (PPS)|Overall Study||123
3227025|NCT02322216|3959035|FG001|Per Protocol Set (PPS)|Overall Study||122
3227026|NCT02322216|3959034|FG000|COMPLETED|Overall Study||124
3227027|NCT02322216|3959035|FG001|COMPLETED|Overall Study||123
3227028|NCT02322216|3959034|FG000|NOT COMPLETED|Overall Study||2
3227029|NCT02322216|3959035|FG001|NOT COMPLETED|Overall Study||4
3227030|NCT02322229|3959042|FG000|STARTED|Overall Study||52
3227031|NCT02322229|3959042|FG000|COMPLETED|Overall Study||50
3227032|NCT02322229|3959042|FG000|NOT COMPLETED|Overall Study||2
3227033|NCT02322242|3959049|FG000|STARTED|Overall Study||92
3227034|NCT02322242|3959050|FG001|STARTED|Overall Study||90
3227035|NCT02322242|3959049|FG000|Primary Outcome|Overall Study||92
3227036|NCT02322242|3959050|FG001|Primary Outcome|Overall Study||90
3227037|NCT02322242|3959049|FG000|1 Week Follow-up|Overall Study|2 lost to follow-up for secondary outcomes|90
3227038|NCT02322242|3959050|FG001|1 Week Follow-up|Overall Study|1 lost to follow-up for secondary outcomes|89
3227039|NCT02322242|3959049|FG000|COMPLETED|Overall Study||92
3227040|NCT02322242|3959050|FG001|COMPLETED|Overall Study||90
3227041|NCT02322242|3959049|FG000|NOT COMPLETED|Overall Study||0
3227042|NCT02322242|3959050|FG001|NOT COMPLETED|Overall Study||0
3227043|NCT02322281|3959059|FG000|STARTED|Overall Study||53
3227044|NCT02322281|3959060|FG001|STARTED|Overall Study||22
3227045|NCT02322281|3959061|FG002|STARTED|Overall Study||74
3227046|NCT02322281|3959059|FG000|Crossed Over to Rociletinib 500 mg BID|Overall Study||0
3227047|NCT02322281|3959060|FG001|Crossed Over to Rociletinib 500 mg BID|Overall Study||0
3227048|NCT02322281|3959061|FG002|Crossed Over to Rociletinib 500 mg BID|Overall Study||36
3227049|NCT02322281|3959059|FG000|Crossed Over to Rociletinib 625 mg BID|Overall Study||0
3227050|NCT02322281|3959060|FG001|Crossed Over to Rociletinib 625 mg BID|Overall Study||0
3227051|NCT02322281|3959061|FG002|Crossed Over to Rociletinib 625 mg BID|Overall Study||3
3227052|NCT02322281|3959059|FG000|COMPLETED|Overall Study|Patients who are off study for any reason.|0
3227053|NCT02322281|3959060|FG001|COMPLETED|Overall Study|Patients who are off study for any reason.|0
3227054|NCT02322281|3959061|FG002|COMPLETED|Overall Study|Patients who are off study for any reason.|0
3227055|NCT02322281|3959059|FG000|NOT COMPLETED|Overall Study||53
3227056|NCT02322281|3959060|FG001|NOT COMPLETED|Overall Study||22
3227057|NCT02322281|3959061|FG002|NOT COMPLETED|Overall Study||74
3227058|NCT02322320|3959074|FG000|STARTED|Overall Study||98
3227059|NCT02322320|3959075|FG001|STARTED|Overall Study||86
3227060|NCT02322320|3959076|FG002|STARTED|Overall Study||89
3227061|NCT02322320|3959074|FG000|COMPLETED|Overall Study||98
3227062|NCT02322320|3959075|FG001|COMPLETED|Overall Study||86
3227063|NCT02322320|3959076|FG002|COMPLETED|Overall Study||89
3227064|NCT02322320|3959074|FG000|NOT COMPLETED|Overall Study||0
3227065|NCT02322320|3959075|FG001|NOT COMPLETED|Overall Study||0
3227066|NCT02322320|3959076|FG002|NOT COMPLETED|Overall Study||0
3227067|NCT02322333|3959086|FG000|STARTED|Overall Study||80
3227068|NCT02322333|3959087|FG001|STARTED|Overall Study||77
3227069|NCT02322333|3959086|FG000|COMPLETED|Overall Study||63
3227070|NCT02322333|3959087|FG001|COMPLETED|Overall Study||61
3227071|NCT02322333|3959086|FG000|NOT COMPLETED|Overall Study||17
3227072|NCT02322333|3959087|FG001|NOT COMPLETED|Overall Study||16
3227073|NCT02322411|3959095|FG000|STARTED|Overall Study||14
3227074|NCT02322411|3959096|FG001|STARTED|Overall Study||16
3227075|NCT02322411|3959095|FG000|Randomized|Overall Study||14
3227076|NCT02322411|3959096|FG001|Randomized|Overall Study||16
3227077|NCT02322411|3959095|FG000|All Baseline Measures Analyzed|Overall Study||13
3227078|NCT02322411|3959096|FG001|All Baseline Measures Analyzed|Overall Study||16
3227079|NCT02322411|3959095|FG000|COMPLETED|Overall Study||9
3227080|NCT02322411|3959096|FG001|COMPLETED|Overall Study||9
3227081|NCT02322411|3959095|FG000|NOT COMPLETED|Overall Study||5
3227082|NCT02322411|3959096|FG001|NOT COMPLETED|Overall Study||7
3227083|NCT02322528|3959102|FG000|STARTED|Overall Study||10
3227084|NCT02322528|3959102|FG000|COMPLETED|Overall Study||10
3227085|NCT02322528|3959102|FG000|NOT COMPLETED|Overall Study||0
3227086|NCT02322710|3959108|FG000|STARTED|Overall Study||105
3227087|NCT02322710|3959109|FG001|STARTED|Overall Study||99
3227088|NCT02322710|3959108|FG000|Safety Population|Overall Study||105
3227089|NCT02322710|3959109|FG001|Safety Population|Overall Study||99
3227090|NCT02322710|3959108|FG000|Full Analysis Population|Overall Study||105
3227091|NCT02322710|3959109|FG001|Full Analysis Population|Overall Study||98
3227092|NCT02322710|3959108|FG000|COMPLETED|Overall Study||85
3227093|NCT02322710|3959109|FG001|COMPLETED|Overall Study||73
3227094|NCT02322710|3959108|FG000|NOT COMPLETED|Overall Study||20
3227095|NCT02322710|3959109|FG001|NOT COMPLETED|Overall Study||26
3227096|NCT02322749|3959115|FG000|STARTED|Period 1||8
3227097|NCT02322749|3959116|FG001|STARTED|Period 1||8
3227098|NCT02322749|3959117|FG002|STARTED|Period 1||8
3227099|NCT02322749|3959118|FG003|STARTED|Period 1||8
3227100|NCT02322749|3959119|FG004|STARTED|Period 1||8
3227101|NCT02322749|3959120|FG005|STARTED|Period 1||8
3227102|NCT02322749|3959115|FG000|COMPLETED|Period 1||8
3227103|NCT02322749|3959116|FG001|COMPLETED|Period 1||8
3227104|NCT02322749|3959117|FG002|COMPLETED|Period 1||8
3227105|NCT02322749|3959118|FG003|COMPLETED|Period 1||8
3227106|NCT02322749|3959119|FG004|COMPLETED|Period 1||8
3227107|NCT02322749|3959120|FG005|COMPLETED|Period 1||8
3227108|NCT02322749|3959115|FG000|NOT COMPLETED|Period 1||0
3227109|NCT02322749|3959116|FG001|NOT COMPLETED|Period 1||0
3227110|NCT02322749|3959117|FG002|NOT COMPLETED|Period 1||0
3227111|NCT02322749|3959118|FG003|NOT COMPLETED|Period 1||0
3227112|NCT02322749|3959119|FG004|NOT COMPLETED|Period 1||0
3227113|NCT02322749|3959120|FG005|NOT COMPLETED|Period 1||0
3227114|NCT02322749|3959115|FG000|STARTED|Period 2||8
3227115|NCT02322749|3959116|FG001|STARTED|Period 2||8
3227116|NCT02322749|3959117|FG002|STARTED|Period 2||8
3227117|NCT02322749|3959118|FG003|STARTED|Period 2||8
3227118|NCT02322749|3959119|FG004|STARTED|Period 2||8
3227119|NCT02322749|3959120|FG005|STARTED|Period 2||8
3227120|NCT02322749|3959115|FG000|COMPLETED|Period 2||8
3227121|NCT02322749|3959116|FG001|COMPLETED|Period 2||8
3227122|NCT02322749|3959117|FG002|COMPLETED|Period 2||8
3227123|NCT02322749|3959118|FG003|COMPLETED|Period 2||6
3227124|NCT02322749|3959119|FG004|COMPLETED|Period 2||8
3227125|NCT02322749|3959120|FG005|COMPLETED|Period 2||8
3227126|NCT02322749|3959115|FG000|NOT COMPLETED|Period 2||0
3227127|NCT02322749|3959116|FG001|NOT COMPLETED|Period 2||0
3227128|NCT02322749|3959117|FG002|NOT COMPLETED|Period 2||0
3227129|NCT02322749|3959118|FG003|NOT COMPLETED|Period 2||2
3227130|NCT02322749|3959119|FG004|NOT COMPLETED|Period 2||0
3227131|NCT02322749|3959120|FG005|NOT COMPLETED|Period 2||0
3227132|NCT02322749|3959115|FG000|STARTED|Period 3||8
3227133|NCT02322749|3959116|FG001|STARTED|Period 3||8
3227134|NCT02322749|3959117|FG002|STARTED|Period 3||8
3227135|NCT02322749|3959118|FG003|STARTED|Period 3||6
3227136|NCT02322749|3959119|FG004|STARTED|Period 3||8
3227137|NCT02322749|3959120|FG005|STARTED|Period 3||8
3227138|NCT02322749|3959115|FG000|COMPLETED|Period 3||8
3227139|NCT02322749|3959116|FG001|COMPLETED|Period 3||8
3227140|NCT02322749|3959117|FG002|COMPLETED|Period 3||7
3227141|NCT02322749|3959118|FG003|COMPLETED|Period 3||6
3227142|NCT02322749|3959119|FG004|COMPLETED|Period 3||8
3227143|NCT02322749|3959120|FG005|COMPLETED|Period 3||8
3227144|NCT02322749|3959115|FG000|NOT COMPLETED|Period 3||0
3227145|NCT02322749|3959116|FG001|NOT COMPLETED|Period 3||0
3227146|NCT02322749|3959117|FG002|NOT COMPLETED|Period 3||1
3227147|NCT02322749|3959118|FG003|NOT COMPLETED|Period 3||0
3227148|NCT02322749|3959119|FG004|NOT COMPLETED|Period 3||0
3227149|NCT02322749|3959120|FG005|NOT COMPLETED|Period 3||0
3227150|NCT02322775|3959131|FG000|STARTED|Overall Study||106
3227151|NCT02322775|3959132|FG001|STARTED|Overall Study||105
3227152|NCT02322775|3959131|FG000|COMPLETED|Overall Study||101
3227153|NCT02322775|3959132|FG001|COMPLETED|Overall Study||99
3227154|NCT02322775|3959131|FG000|NOT COMPLETED|Overall Study||5
3227155|NCT02322775|3959132|FG001|NOT COMPLETED|Overall Study||6
3227156|NCT02322788|3959138|FG000|STARTED|Visit 3||15
3227157|NCT02322788|3959139|FG001|STARTED|Visit 3||15
3227158|NCT02322788|3959140|FG002|STARTED|Visit 3||14
3227159|NCT02322788|3959141|FG003|STARTED|Visit 3||16
3227160|NCT02322788|3959138|FG000|COMPLETED|Visit 3||15
3227161|NCT02322788|3959139|FG001|COMPLETED|Visit 3||15
3227162|NCT02322788|3959140|FG002|COMPLETED|Visit 3||14
3227163|NCT02322788|3959141|FG003|COMPLETED|Visit 3||16
3227164|NCT02322788|3959138|FG000|NOT COMPLETED|Visit 3||0
3227165|NCT02322788|3959139|FG001|NOT COMPLETED|Visit 3||0
3227166|NCT02322788|3959140|FG002|NOT COMPLETED|Visit 3||0
3227167|NCT02322788|3959141|FG003|NOT COMPLETED|Visit 3||0
3227168|NCT02322788|3959138|FG000|STARTED|Visit 4||15
3227169|NCT02322788|3959139|FG001|STARTED|Visit 4||14
3227170|NCT02322788|3959140|FG002|STARTED|Visit 4||16
3227171|NCT02322788|3959141|FG003|STARTED|Visit 4||15
3227172|NCT02322788|3959138|FG000|COMPLETED|Visit 4||15
3227173|NCT02322788|3959139|FG001|COMPLETED|Visit 4||14
3227174|NCT02322788|3959140|FG002|COMPLETED|Visit 4||16
3227175|NCT02322788|3959141|FG003|COMPLETED|Visit 4||15
3227176|NCT02322788|3959138|FG000|NOT COMPLETED|Visit 4||0
3227177|NCT02322788|3959139|FG001|NOT COMPLETED|Visit 4||0
3227178|NCT02322788|3959140|FG002|NOT COMPLETED|Visit 4||0
3227179|NCT02322788|3959141|FG003|NOT COMPLETED|Visit 4||0
3227180|NCT02322788|3959138|FG000|STARTED|Visit 5||16
3227181|NCT02322788|3959139|FG001|STARTED|Visit 5||15
3227182|NCT02322788|3959140|FG002|STARTED|Visit 5||15
3227183|NCT02322788|3959141|FG003|STARTED|Visit 5||14
3227184|NCT02322788|3959138|FG000|COMPLETED|Visit 5||16
3227185|NCT02322788|3959139|FG001|COMPLETED|Visit 5||15
3227186|NCT02322788|3959140|FG002|COMPLETED|Visit 5||15
3227187|NCT02322788|3959141|FG003|COMPLETED|Visit 5||14
3227188|NCT02322788|3959138|FG000|NOT COMPLETED|Visit 5||0
3227189|NCT02322788|3959139|FG001|NOT COMPLETED|Visit 5||0
3227190|NCT02322788|3959140|FG002|NOT COMPLETED|Visit 5||0
3227191|NCT02322788|3959141|FG003|NOT COMPLETED|Visit 5||0
3227192|NCT02322788|3959138|FG000|STARTED|Visit 6||14
3227193|NCT02322788|3959139|FG001|STARTED|Visit 6||16
3227194|NCT02322788|3959140|FG002|STARTED|Visit 6||15
3227195|NCT02322788|3959141|FG003|STARTED|Visit 6||15
3227196|NCT02322788|3959138|FG000|COMPLETED|Visit 6||14
3227197|NCT02322788|3959139|FG001|COMPLETED|Visit 6||16
3227198|NCT02322788|3959140|FG002|COMPLETED|Visit 6||15
3227199|NCT02322788|3959141|FG003|COMPLETED|Visit 6||15
3227200|NCT02322788|3959138|FG000|NOT COMPLETED|Visit 6||0
3227201|NCT02322788|3959139|FG001|NOT COMPLETED|Visit 6||0
3227202|NCT02322788|3959140|FG002|NOT COMPLETED|Visit 6||0
3227203|NCT02322788|3959141|FG003|NOT COMPLETED|Visit 6||0
3227204|NCT02322814|3959156|FG000|STARTED|Overall Study||16
3227205|NCT02322814|3959157|FG001|STARTED|Overall Study||43
3227206|NCT02322814|3959158|FG002|STARTED|Overall Study||47
3227207|NCT02322814|3959159|FG003|STARTED|Overall Study||32
3227208|NCT02322814|3959160|FG004|STARTED|Overall Study||31
3227209|NCT02322814|3959156|FG000|COMPLETED|Overall Study||0
3227210|NCT02322814|3959157|FG001|COMPLETED|Overall Study||0
3227211|NCT02322814|3959158|FG002|COMPLETED|Overall Study||0
3227212|NCT02322814|3959159|FG003|COMPLETED|Overall Study||0
3227213|NCT02322814|3959160|FG004|COMPLETED|Overall Study||0
3227214|NCT02322814|3959156|FG000|NOT COMPLETED|Overall Study||16
3227215|NCT02322814|3959157|FG001|NOT COMPLETED|Overall Study||43
3227216|NCT02322814|3959158|FG002|NOT COMPLETED|Overall Study||47
3227217|NCT02322814|3959159|FG003|NOT COMPLETED|Overall Study||32
3227218|NCT02322814|3959160|FG004|NOT COMPLETED|Overall Study||31
3227219|NCT02322866|3959173|FG000|STARTED|Overall Study||515
3227220|NCT02322866|3959174|FG001|STARTED|Overall Study||519
3227221|NCT02322866|3959173|FG000|COMPLETED|Overall Study||444
3227222|NCT02322866|3959174|FG001|COMPLETED|Overall Study||433
3227223|NCT02322866|3959173|FG000|NOT COMPLETED|Overall Study||71
3227224|NCT02322866|3959174|FG001|NOT COMPLETED|Overall Study||86
3227225|NCT02322879|3959182|FG000|STARTED|First Intervention||11
3227226|NCT02322879|3959183|FG001|STARTED|First Intervention||10
3227227|NCT02322879|3959182|FG000|COMPLETED|First Intervention||10
3227228|NCT02322879|3959183|FG001|COMPLETED|First Intervention||10
3227229|NCT02322879|3959182|FG000|NOT COMPLETED|First Intervention||1
3227230|NCT02322879|3959183|FG001|NOT COMPLETED|First Intervention||0
3227231|NCT02322879|3959182|FG000|STARTED|Washout||10
3227232|NCT02322879|3959183|FG001|STARTED|Washout||10
3227233|NCT02322879|3959182|FG000|COMPLETED|Washout||10
3227234|NCT02322879|3959183|FG001|COMPLETED|Washout||10
3227235|NCT02322879|3959182|FG000|NOT COMPLETED|Washout||0
3227236|NCT02322879|3959183|FG001|NOT COMPLETED|Washout||0
3227237|NCT02322879|3959182|FG000|STARTED|Second Intervention||10
3227238|NCT02322879|3959183|FG001|STARTED|Second Intervention||10
3227239|NCT02322879|3959182|FG000|COMPLETED|Second Intervention||10
3227240|NCT02322879|3959183|FG001|COMPLETED|Second Intervention||10
3227241|NCT02322879|3959182|FG000|NOT COMPLETED|Second Intervention||0
3227242|NCT02322879|3959183|FG001|NOT COMPLETED|Second Intervention||0
3227243|NCT02322892|3959191|FG000|STARTED|Overall Study|Number randomized|35
3227244|NCT02322892|3959192|FG001|STARTED|Overall Study|Number randomized|34
3227245|NCT02322892|3959191|FG000|COMPLETED|Overall Study|Received placebo|33
3227246|NCT02322892|3959192|FG001|COMPLETED|Overall Study|Received thiamine|31
3227247|NCT02322892|3959191|FG000|NOT COMPLETED|Overall Study||2
3227248|NCT02322892|3959192|FG001|NOT COMPLETED|Overall Study||3
3227249|NCT02323048|3959203|FG000|STARTED|Overall Study||25
3227250|NCT02323048|3959204|FG001|STARTED|Overall Study||26
3227251|NCT02323048|3959205|FG002|STARTED|Overall Study||23
3227252|NCT02323048|3959206|FG003|STARTED|Overall Study||7
3227253|NCT02323048|3959207|FG004|STARTED|Overall Study||9
3227254|NCT02323048|3959203|FG000|COMPLETED|Overall Study||24
3227255|NCT02323048|3959204|FG001|COMPLETED|Overall Study||24
3227256|NCT02323048|3959205|FG002|COMPLETED|Overall Study||23
3227257|NCT02323048|3959206|FG003|COMPLETED|Overall Study||7
3227258|NCT02323048|3959207|FG004|COMPLETED|Overall Study||9
3227259|NCT02323048|3959203|FG000|NOT COMPLETED|Overall Study||1
3227260|NCT02323048|3959204|FG001|NOT COMPLETED|Overall Study||2
3227261|NCT02323048|3959205|FG002|NOT COMPLETED|Overall Study||0
3227262|NCT02323048|3959206|FG003|NOT COMPLETED|Overall Study||0
3227263|NCT02323048|3959207|FG004|NOT COMPLETED|Overall Study||0
3227264|NCT02323113|3959226|FG000|STARTED|Overall Study||4
3227265|NCT02323113|3959227|FG001|STARTED|Overall Study||7
3227266|NCT02323113|3959228|FG002|STARTED|Overall Study||4
3227267|NCT02323113|3959229|FG003|STARTED|Overall Study||5
3227268|NCT02323113|3959230|FG004|STARTED|Overall Study||9
3227269|NCT02323113|3959231|FG005|STARTED|Overall Study||8
3227270|NCT02323113|3959232|FG006|STARTED|Overall Study||6
3227271|NCT02323113|3959233|FG007|STARTED|Overall Study||0
3227272|NCT02323113|3959226|FG000|COMPLETED|Overall Study||0
3227273|NCT02323113|3959227|FG001|COMPLETED|Overall Study||0
3227274|NCT02323113|3959228|FG002|COMPLETED|Overall Study||0
3227275|NCT02323113|3959229|FG003|COMPLETED|Overall Study||0
3227276|NCT02323113|3959230|FG004|COMPLETED|Overall Study||0
3227277|NCT02323113|3959231|FG005|COMPLETED|Overall Study||0
3368629|NCT03801148|4100186|FG001|STARTED|Washout Period (at Least 5 Days)||30
3368630|NCT03801148|4100187|FG002|STARTED|Washout Period (at Least 5 Days)||30
3368631|NCT03801148|4100188|FG003|STARTED|Washout Period (at Least 5 Days)||30
3368632|NCT03801148|4100185|FG000|COMPLETED|Washout Period (at Least 5 Days)||30
3368633|NCT03801148|4100186|FG001|COMPLETED|Washout Period (at Least 5 Days)||30
3368634|NCT03801148|4100187|FG002|COMPLETED|Washout Period (at Least 5 Days)||29
3368635|NCT03801148|4100188|FG003|COMPLETED|Washout Period (at Least 5 Days)||29
3368636|NCT03801148|4100185|FG000|NOT COMPLETED|Washout Period (at Least 5 Days)||0
3227278|NCT02323113|3959232|FG006|COMPLETED|Overall Study||0
3227279|NCT02323113|3959233|FG007|COMPLETED|Overall Study||0
3227280|NCT02323113|3959226|FG000|NOT COMPLETED|Overall Study||4
3227281|NCT02323113|3959227|FG001|NOT COMPLETED|Overall Study||7
3227282|NCT02323113|3959228|FG002|NOT COMPLETED|Overall Study||4
3227283|NCT02323113|3959229|FG003|NOT COMPLETED|Overall Study||5
3227284|NCT02323113|3959230|FG004|NOT COMPLETED|Overall Study||9
3368637|NCT03801148|4100186|FG001|NOT COMPLETED|Washout Period (at Least 5 Days)||0
3227285|NCT02323113|3959231|FG005|NOT COMPLETED|Overall Study||8
3227286|NCT02323113|3959232|FG006|NOT COMPLETED|Overall Study||6
3227287|NCT02323113|3959233|FG007|NOT COMPLETED|Overall Study||0
3227294|NCT02323204|3959266|FG000|STARTED|Baseline Survey Completion||155
3227295|NCT02323204|3959267|FG001|STARTED|Baseline Survey Completion||155
3227296|NCT02323204|3959268|FG002|STARTED|Baseline Survey Completion||159
3227297|NCT02323204|3959269|FG003|STARTED|Baseline Survey Completion||159
3227298|NCT02323204|3959266|FG000|COMPLETED|Baseline Survey Completion||145
3227299|NCT02323204|3959267|FG001|COMPLETED|Baseline Survey Completion||146
3227300|NCT02323204|3959268|FG002|COMPLETED|Baseline Survey Completion||154
3227301|NCT02323204|3959269|FG003|COMPLETED|Baseline Survey Completion||156
3227302|NCT02323204|3959266|FG000|NOT COMPLETED|Baseline Survey Completion||10
3227303|NCT02323204|3959267|FG001|NOT COMPLETED|Baseline Survey Completion||9
3227304|NCT02323204|3959268|FG002|NOT COMPLETED|Baseline Survey Completion||5
3227305|NCT02323204|3959269|FG003|NOT COMPLETED|Baseline Survey Completion||3
3227306|NCT02323204|3959266|FG000|STARTED|6-week Follow-up Survey Completion||145
3227307|NCT02323204|3959267|FG001|STARTED|6-week Follow-up Survey Completion||146
3227308|NCT02323204|3959268|FG002|STARTED|6-week Follow-up Survey Completion||154
3227309|NCT02323204|3959269|FG003|STARTED|6-week Follow-up Survey Completion||156
3227310|NCT02323204|3959266|FG000|COMPLETED|6-week Follow-up Survey Completion||104
3227311|NCT02323204|3959267|FG001|COMPLETED|6-week Follow-up Survey Completion||110
3227312|NCT02323204|3959268|FG002|COMPLETED|6-week Follow-up Survey Completion||112
3227313|NCT02323204|3959269|FG003|COMPLETED|6-week Follow-up Survey Completion||119
3227314|NCT02323204|3959266|FG000|NOT COMPLETED|6-week Follow-up Survey Completion||41
3227315|NCT02323204|3959267|FG001|NOT COMPLETED|6-week Follow-up Survey Completion||36
3227316|NCT02323204|3959268|FG002|NOT COMPLETED|6-week Follow-up Survey Completion||42
3227317|NCT02323204|3959269|FG003|NOT COMPLETED|6-week Follow-up Survey Completion||37
3227318|NCT02323204|3959266|FG000|STARTED|6-week Follow-up Intervention Booster|Child participants did not receive intervention booster training.|0
3227319|NCT02323204|3959267|FG001|STARTED|6-week Follow-up Intervention Booster|Received intervention-specific booster training via phone between 6-weeks and 1 year post-enrollment|146
3227320|NCT02323204|3959268|FG002|STARTED|6-week Follow-up Intervention Booster|Child participants did not receive intervention booster training.|0
3227321|NCT02323204|3959269|FG003|STARTED|6-week Follow-up Intervention Booster|Received intervention-specific booster training via phone between 6-weeks and 1 year post-enrollment|156
3227322|NCT02323204|3959266|FG000|COMPLETED|6-week Follow-up Intervention Booster||0
3227323|NCT02323204|3959267|FG001|COMPLETED|6-week Follow-up Intervention Booster||103
3227324|NCT02323204|3959268|FG002|COMPLETED|6-week Follow-up Intervention Booster||0
3227325|NCT02323204|3959269|FG003|COMPLETED|6-week Follow-up Intervention Booster||120
3227326|NCT02323204|3959266|FG000|NOT COMPLETED|6-week Follow-up Intervention Booster||0
3227327|NCT02323204|3959267|FG001|NOT COMPLETED|6-week Follow-up Intervention Booster||43
3227328|NCT02323204|3959268|FG002|NOT COMPLETED|6-week Follow-up Intervention Booster||0
3227329|NCT02323204|3959269|FG003|NOT COMPLETED|6-week Follow-up Intervention Booster||36
3227330|NCT02323204|3959266|FG000|STARTED|3-month Follow-up Survey Completion|Participants who completed baseline questionnaires were eligible to complete all subsequent surveys.|145
3227331|NCT02323204|3959267|FG001|STARTED|3-month Follow-up Survey Completion|Participants who completed baseline questionnaires were eligible to complete all subsequent surveys.|146
3227332|NCT02323204|3959268|FG002|STARTED|3-month Follow-up Survey Completion|Participants who completed baseline questionnaires were eligible to complete all subsequent surveys.|154
3227333|NCT02323204|3959269|FG003|STARTED|3-month Follow-up Survey Completion|Participants who completed baseline questionnaires were eligible to complete all subsequent surveys.|156
3227334|NCT02323204|3959266|FG000|COMPLETED|3-month Follow-up Survey Completion||91
3227335|NCT02323204|3959267|FG001|COMPLETED|3-month Follow-up Survey Completion||99
3227336|NCT02323204|3959268|FG002|COMPLETED|3-month Follow-up Survey Completion||113
3227337|NCT02323204|3959269|FG003|COMPLETED|3-month Follow-up Survey Completion||112
3227338|NCT02323204|3959266|FG000|NOT COMPLETED|3-month Follow-up Survey Completion||54
3227339|NCT02323204|3959267|FG001|NOT COMPLETED|3-month Follow-up Survey Completion||47
3227340|NCT02323204|3959268|FG002|NOT COMPLETED|3-month Follow-up Survey Completion||41
3227341|NCT02323204|3959269|FG003|NOT COMPLETED|3-month Follow-up Survey Completion||44
3227342|NCT02323204|3959266|FG000|STARTED|6-month Follow-up Survey Completion|Participants who completed baseline questionnaires were eligible to complete all subsequent surveys.|145
3227343|NCT02323204|3959267|FG001|STARTED|6-month Follow-up Survey Completion|Participants who completed baseline questionnaires were eligible to complete all subsequent surveys.|146
3227344|NCT02323204|3959268|FG002|STARTED|6-month Follow-up Survey Completion|Participants who completed baseline questionnaires were eligible to complete all subsequent surveys.|154
3227345|NCT02323204|3959269|FG003|STARTED|6-month Follow-up Survey Completion|Participants who completed baseline questionnaires were eligible to complete all subsequent surveys.|156
3227346|NCT02323204|3959266|FG000|COMPLETED|6-month Follow-up Survey Completion||96
3227347|NCT02323204|3959267|FG001|COMPLETED|6-month Follow-up Survey Completion||96
3227348|NCT02323204|3959268|FG002|COMPLETED|6-month Follow-up Survey Completion||113
3227349|NCT02323204|3959269|FG003|COMPLETED|6-month Follow-up Survey Completion||112
3227350|NCT02323204|3959266|FG000|NOT COMPLETED|6-month Follow-up Survey Completion||49
3227351|NCT02323204|3959267|FG001|NOT COMPLETED|6-month Follow-up Survey Completion||50
3227352|NCT02323204|3959268|FG002|NOT COMPLETED|6-month Follow-up Survey Completion||41
3227353|NCT02323204|3959269|FG003|NOT COMPLETED|6-month Follow-up Survey Completion||44
3227354|NCT02323217|3959279|FG000|STARTED|Overall Study||18
3227355|NCT02323217|3959279|FG000|COMPLETED|Overall Study||18
3227356|NCT02323217|3959279|FG000|NOT COMPLETED|Overall Study||0
3227357|NCT02323334|3959293|FG000|STARTED|Period 1||4
3227358|NCT02323334|3959294|FG001|STARTED|Period 1||4
3227359|NCT02323334|3959295|FG002|STARTED|Period 1||4
3227360|NCT02323334|3959296|FG003|STARTED|Period 1||4
3227361|NCT02323334|3959297|FG004|STARTED|Period 1||4
3227362|NCT02323334|3959298|FG005|STARTED|Period 1||4
3227363|NCT02323334|3959299|FG006|STARTED|Period 1||6
3227364|NCT02323334|3959300|FG007|STARTED|Period 1||6
3227365|NCT02323334|3959301|FG008|STARTED|Period 1||5
3227366|NCT02323334|3959302|FG009|STARTED|Period 1||7
3227367|NCT02323334|3959303|FG010|STARTED|Period 1||5
3227368|NCT02323334|3959304|FG011|STARTED|Period 1||3
3227369|NCT02323334|3959305|FG012|STARTED|Period 1||9
3227370|NCT02323334|3959306|FG013|STARTED|Period 1||9
3227371|NCT02323334|3959307|FG014|STARTED|Period 1||9
3227372|NCT02323334|3959308|FG015|STARTED|Period 1||9
3227373|NCT02323334|3959309|FG016|STARTED|Period 1||2
3227374|NCT02323334|3959293|FG000|Received at Least One Dose of Study Drug|Period 1||4
3227375|NCT02323334|3959294|FG001|Received at Least One Dose of Study Drug|Period 1||4
3227376|NCT02323334|3959295|FG002|Received at Least One Dose of Study Drug|Period 1||4
3227377|NCT02323334|3959296|FG003|Received at Least One Dose of Study Drug|Period 1||4
3227378|NCT02323334|3959297|FG004|Received at Least One Dose of Study Drug|Period 1||4
3227379|NCT02323334|3959298|FG005|Received at Least One Dose of Study Drug|Period 1||4
3227380|NCT02323334|3959299|FG006|Received at Least One Dose of Study Drug|Period 1||6
3227381|NCT02323334|3959300|FG007|Received at Least One Dose of Study Drug|Period 1||6
3227382|NCT02323334|3959301|FG008|Received at Least One Dose of Study Drug|Period 1||5
3227383|NCT02323334|3959302|FG009|Received at Least One Dose of Study Drug|Period 1||7
3227384|NCT02323334|3959303|FG010|Received at Least One Dose of Study Drug|Period 1||5
3227385|NCT02323334|3959304|FG011|Received at Least One Dose of Study Drug|Period 1||3
3227386|NCT02323334|3959305|FG012|Received at Least One Dose of Study Drug|Period 1||9
3227387|NCT02323334|3959306|FG013|Received at Least One Dose of Study Drug|Period 1||9
3227388|NCT02323334|3959307|FG014|Received at Least One Dose of Study Drug|Period 1||9
3227389|NCT02323334|3959308|FG015|Received at Least One Dose of Study Drug|Period 1||9
3227390|NCT02323334|3959309|FG016|Received at Least One Dose of Study Drug|Period 1||2
3227391|NCT02323334|3959293|FG000|COMPLETED|Period 1||4
3227392|NCT02323334|3959294|FG001|COMPLETED|Period 1||4
3227393|NCT02323334|3959295|FG002|COMPLETED|Period 1||4
3227394|NCT02323334|3959296|FG003|COMPLETED|Period 1||4
3227395|NCT02323334|3959297|FG004|COMPLETED|Period 1||4
3227396|NCT02323334|3959298|FG005|COMPLETED|Period 1||4
3227397|NCT02323334|3959299|FG006|COMPLETED|Period 1||6
3227398|NCT02323334|3959300|FG007|COMPLETED|Period 1||6
3227399|NCT02323334|3959301|FG008|COMPLETED|Period 1||5
3227400|NCT02323334|3959302|FG009|COMPLETED|Period 1||7
3227401|NCT02323334|3959303|FG010|COMPLETED|Period 1||5
3227402|NCT02323334|3959304|FG011|COMPLETED|Period 1||3
3227403|NCT02323334|3959305|FG012|COMPLETED|Period 1||9
3227404|NCT02323334|3959306|FG013|COMPLETED|Period 1||9
3227405|NCT02323334|3959307|FG014|COMPLETED|Period 1||9
3227406|NCT02323334|3959308|FG015|COMPLETED|Period 1||9
3227407|NCT02323334|3959309|FG016|COMPLETED|Period 1||2
3227408|NCT02323334|3959293|FG000|NOT COMPLETED|Period 1||0
3227409|NCT02323334|3959294|FG001|NOT COMPLETED|Period 1||0
3227410|NCT02323334|3959295|FG002|NOT COMPLETED|Period 1||0
3227411|NCT02323334|3959296|FG003|NOT COMPLETED|Period 1||0
3227412|NCT02323334|3959297|FG004|NOT COMPLETED|Period 1||0
3227413|NCT02323334|3959298|FG005|NOT COMPLETED|Period 1||0
3227414|NCT02323334|3959299|FG006|NOT COMPLETED|Period 1||0
3227415|NCT02323334|3959300|FG007|NOT COMPLETED|Period 1||0
3227416|NCT02323334|3959301|FG008|NOT COMPLETED|Period 1||0
3227417|NCT02323334|3959302|FG009|NOT COMPLETED|Period 1||0
3227418|NCT02323334|3959303|FG010|NOT COMPLETED|Period 1||0
3227419|NCT02323334|3959304|FG011|NOT COMPLETED|Period 1||0
3227420|NCT02323334|3959305|FG012|NOT COMPLETED|Period 1||0
3227421|NCT02323334|3959306|FG013|NOT COMPLETED|Period 1||0
3227422|NCT02323334|3959307|FG014|NOT COMPLETED|Period 1||0
3227423|NCT02323334|3959308|FG015|NOT COMPLETED|Period 1||0
3227424|NCT02323334|3959309|FG016|NOT COMPLETED|Period 1||0
3227425|NCT02323334|3959293|FG000|STARTED|Period 2||4
3227426|NCT02323334|3959294|FG001|STARTED|Period 2||4
3227427|NCT02323334|3959295|FG002|STARTED|Period 2||4
3227428|NCT02323334|3959296|FG003|STARTED|Period 2||4
3227429|NCT02323334|3959297|FG004|STARTED|Period 2||4
3227430|NCT02323334|3959298|FG005|STARTED|Period 2||4
3227431|NCT02323334|3959299|FG006|STARTED|Period 2||6
3227432|NCT02323334|3959300|FG007|STARTED|Period 2||6
3227433|NCT02323334|3959301|FG008|STARTED|Period 2|Part B was a single period conducted in parallel to Part A and received last dose in Period 1.|0
3227434|NCT02323334|3959302|FG009|STARTED|Period 2|Part B was a single period conducted in parallel to Part A and received last dose in Period 1.|0
3227435|NCT02323334|3959303|FG010|STARTED|Period 2|Part B was a single period conducted in parallel to Part A and received last dose in Period 1.|0
3227436|NCT02323334|3959304|FG011|STARTED|Period 2|Part B was a single period conducted in parallel to Part A and received last dose in Period 1.|0
3227437|NCT02323334|3959305|FG012|STARTED|Period 2|Part C was a single period conducted in parallel to Part A and received last dose in Period 1.|0
3227438|NCT02323334|3959306|FG013|STARTED|Period 2|Part C was a single period conducted in parallel to Part A and received last dose in Period 1.|0
3227439|NCT02323334|3959307|FG014|STARTED|Period 2|Part C was a single period conducted in parallel to Part A and received last dose in Period 1.|0
3227440|NCT02323334|3959308|FG015|STARTED|Period 2|Part C was a single period conducted in parallel to Part A and received last dose in Period 1.|0
3227441|NCT02323334|3959309|FG016|STARTED|Period 2|Part D was a single period conducted in parallel to Part A and received last dose in Period 1.|0
3227442|NCT02323334|3959293|FG000|COMPLETED|Period 2||4
3227443|NCT02323334|3959294|FG001|COMPLETED|Period 2||4
3227444|NCT02323334|3959295|FG002|COMPLETED|Period 2||4
3227445|NCT02323334|3959296|FG003|COMPLETED|Period 2||4
3227446|NCT02323334|3959297|FG004|COMPLETED|Period 2||4
3227447|NCT02323334|3959298|FG005|COMPLETED|Period 2||4
3227448|NCT02323334|3959299|FG006|COMPLETED|Period 2||6
3227449|NCT02323334|3959300|FG007|COMPLETED|Period 2||6
3227450|NCT02323334|3959301|FG008|COMPLETED|Period 2||0
3227451|NCT02323334|3959302|FG009|COMPLETED|Period 2||0
3227452|NCT02323334|3959303|FG010|COMPLETED|Period 2||0
3227453|NCT02323334|3959304|FG011|COMPLETED|Period 2||0
3227454|NCT02323334|3959305|FG012|COMPLETED|Period 2||0
3227455|NCT02323334|3959306|FG013|COMPLETED|Period 2||0
3227456|NCT02323334|3959307|FG014|COMPLETED|Period 2||0
3227457|NCT02323334|3959308|FG015|COMPLETED|Period 2||0
3227458|NCT02323334|3959309|FG016|COMPLETED|Period 2||0
3227459|NCT02323334|3959293|FG000|NOT COMPLETED|Period 2||0
3227460|NCT02323334|3959294|FG001|NOT COMPLETED|Period 2||0
3227461|NCT02323334|3959295|FG002|NOT COMPLETED|Period 2||0
3227462|NCT02323334|3959296|FG003|NOT COMPLETED|Period 2||0
3227463|NCT02323334|3959297|FG004|NOT COMPLETED|Period 2||0
3227464|NCT02323334|3959298|FG005|NOT COMPLETED|Period 2||0
3227465|NCT02323334|3959299|FG006|NOT COMPLETED|Period 2||0
3227466|NCT02323334|3959300|FG007|NOT COMPLETED|Period 2||0
3227467|NCT02323334|3959301|FG008|NOT COMPLETED|Period 2||0
3227468|NCT02323334|3959302|FG009|NOT COMPLETED|Period 2||0
3227469|NCT02323334|3959303|FG010|NOT COMPLETED|Period 2||0
3227470|NCT02323334|3959304|FG011|NOT COMPLETED|Period 2||0
3227471|NCT02323334|3959305|FG012|NOT COMPLETED|Period 2||0
3227472|NCT02323334|3959306|FG013|NOT COMPLETED|Period 2||0
3227473|NCT02323334|3959307|FG014|NOT COMPLETED|Period 2||0
3227474|NCT02323334|3959308|FG015|NOT COMPLETED|Period 2||0
3227475|NCT02323334|3959309|FG016|NOT COMPLETED|Period 2||0
3227476|NCT02323334|3959293|FG000|STARTED|Period 3||4
3227477|NCT02323334|3959294|FG001|STARTED|Period 3||4
3227478|NCT02323334|3959295|FG002|STARTED|Period 3||4
3227479|NCT02323334|3959296|FG003|STARTED|Period 3||4
3227480|NCT02323334|3959297|FG004|STARTED|Period 3||4
3227481|NCT02323334|3959298|FG005|STARTED|Period 3||4
3227482|NCT02323334|3959299|FG006|STARTED|Period 3|Part A Cohort 3 Food Effect participated in Period 1 and Period 2 only.|0
3227483|NCT02323334|3959300|FG007|STARTED|Period 3|Part A Cohort 3 Food Effect participated in Period 1 and Period 2 only.|0
3227484|NCT02323334|3959301|FG008|STARTED|Period 3||0
3227485|NCT02323334|3959302|FG009|STARTED|Period 3||0
3227486|NCT02323334|3959303|FG010|STARTED|Period 3||0
3227487|NCT02323334|3959304|FG011|STARTED|Period 3||0
3227488|NCT02323334|3959305|FG012|STARTED|Period 3||0
3227489|NCT02323334|3959306|FG013|STARTED|Period 3||0
3227490|NCT02323334|3959307|FG014|STARTED|Period 3||0
3227491|NCT02323334|3959308|FG015|STARTED|Period 3||0
3227492|NCT02323334|3959309|FG016|STARTED|Period 3||0
3227493|NCT02323334|3959293|FG000|COMPLETED|Period 3||3
3227494|NCT02323334|3959294|FG001|COMPLETED|Period 3||4
3227495|NCT02323334|3959295|FG002|COMPLETED|Period 3||3
3227496|NCT02323334|3959296|FG003|COMPLETED|Period 3||4
3227497|NCT02323334|3959297|FG004|COMPLETED|Period 3||4
3227498|NCT02323334|3959298|FG005|COMPLETED|Period 3||4
3227499|NCT02323334|3959299|FG006|COMPLETED|Period 3||0
3227500|NCT02323334|3959300|FG007|COMPLETED|Period 3||0
3227501|NCT02323334|3959301|FG008|COMPLETED|Period 3||0
3227502|NCT02323334|3959302|FG009|COMPLETED|Period 3||0
3227503|NCT02323334|3959303|FG010|COMPLETED|Period 3||0
3227504|NCT02323334|3959304|FG011|COMPLETED|Period 3||0
3227505|NCT02323334|3959305|FG012|COMPLETED|Period 3||0
3227506|NCT02323334|3959306|FG013|COMPLETED|Period 3||0
3227507|NCT02323334|3959307|FG014|COMPLETED|Period 3||0
3227508|NCT02323334|3959308|FG015|COMPLETED|Period 3||0
3227509|NCT02323334|3959309|FG016|COMPLETED|Period 3||0
3227510|NCT02323334|3959293|FG000|NOT COMPLETED|Period 3||1
3227511|NCT02323334|3959294|FG001|NOT COMPLETED|Period 3||0
3227512|NCT02323334|3959295|FG002|NOT COMPLETED|Period 3||1
3227513|NCT02323334|3959296|FG003|NOT COMPLETED|Period 3||0
3227514|NCT02323334|3959297|FG004|NOT COMPLETED|Period 3||0
3227515|NCT02323334|3959298|FG005|NOT COMPLETED|Period 3||0
3227516|NCT02323334|3959299|FG006|NOT COMPLETED|Period 3||0
3227517|NCT02323334|3959300|FG007|NOT COMPLETED|Period 3||0
3227518|NCT02323334|3959301|FG008|NOT COMPLETED|Period 3||0
3227519|NCT02323334|3959302|FG009|NOT COMPLETED|Period 3||0
3227520|NCT02323334|3959303|FG010|NOT COMPLETED|Period 3||0
3227521|NCT02323334|3959304|FG011|NOT COMPLETED|Period 3||0
3227522|NCT02323334|3959305|FG012|NOT COMPLETED|Period 3||0
3227523|NCT02323334|3959306|FG013|NOT COMPLETED|Period 3||0
3227524|NCT02323334|3959307|FG014|NOT COMPLETED|Period 3||0
3227525|NCT02323334|3959308|FG015|NOT COMPLETED|Period 3||0
3227526|NCT02323334|3959309|FG016|NOT COMPLETED|Period 3||0
3227527|NCT02323334|3959293|FG000|STARTED|Period 4||3
3227528|NCT02323334|3959294|FG001|STARTED|Period 4||4
3227529|NCT02323334|3959295|FG002|STARTED|Period 4||3
3227530|NCT02323334|3959296|FG003|STARTED|Period 4||4
3227531|NCT02323334|3959297|FG004|STARTED|Period 4||4
3227532|NCT02323334|3959298|FG005|STARTED|Period 4||4
3227533|NCT02323334|3959299|FG006|STARTED|Period 4||0
3227534|NCT02323334|3959300|FG007|STARTED|Period 4||0
3227535|NCT02323334|3959301|FG008|STARTED|Period 4||0
3227536|NCT02323334|3959302|FG009|STARTED|Period 4||0
3227537|NCT02323334|3959303|FG010|STARTED|Period 4||0
3227538|NCT02323334|3959304|FG011|STARTED|Period 4||0
3227539|NCT02323334|3959305|FG012|STARTED|Period 4||0
3227540|NCT02323334|3959306|FG013|STARTED|Period 4||0
3227541|NCT02323334|3959307|FG014|STARTED|Period 4||0
3227542|NCT02323334|3959308|FG015|STARTED|Period 4||0
3227543|NCT02323334|3959309|FG016|STARTED|Period 4||0
3227544|NCT02323334|3959293|FG000|COMPLETED|Period 4||3
3227545|NCT02323334|3959294|FG001|COMPLETED|Period 4||4
3227546|NCT02323334|3959295|FG002|COMPLETED|Period 4||3
3227547|NCT02323334|3959296|FG003|COMPLETED|Period 4||4
3227548|NCT02323334|3959297|FG004|COMPLETED|Period 4||4
3227549|NCT02323334|3959298|FG005|COMPLETED|Period 4||4
3227550|NCT02323334|3959299|FG006|COMPLETED|Period 4||0
3227551|NCT02323334|3959300|FG007|COMPLETED|Period 4||0
3227552|NCT02323334|3959301|FG008|COMPLETED|Period 4||0
3227553|NCT02323334|3959302|FG009|COMPLETED|Period 4||0
3227554|NCT02323334|3959303|FG010|COMPLETED|Period 4||0
3227555|NCT02323334|3959304|FG011|COMPLETED|Period 4||0
3227556|NCT02323334|3959305|FG012|COMPLETED|Period 4||0
3227557|NCT02323334|3959306|FG013|COMPLETED|Period 4||0
3227558|NCT02323334|3959307|FG014|COMPLETED|Period 4||0
3227559|NCT02323334|3959308|FG015|COMPLETED|Period 4||0
3227560|NCT02323334|3959309|FG016|COMPLETED|Period 4||0
3227561|NCT02323334|3959293|FG000|NOT COMPLETED|Period 4||0
3227562|NCT02323334|3959294|FG001|NOT COMPLETED|Period 4||0
3227563|NCT02323334|3959295|FG002|NOT COMPLETED|Period 4||0
3227564|NCT02323334|3959296|FG003|NOT COMPLETED|Period 4||0
3227565|NCT02323334|3959297|FG004|NOT COMPLETED|Period 4||0
3227566|NCT02323334|3959298|FG005|NOT COMPLETED|Period 4||0
3227567|NCT02323334|3959299|FG006|NOT COMPLETED|Period 4||0
3227568|NCT02323334|3959300|FG007|NOT COMPLETED|Period 4||0
3227569|NCT02323334|3959301|FG008|NOT COMPLETED|Period 4||0
3227570|NCT02323334|3959302|FG009|NOT COMPLETED|Period 4||0
3227571|NCT02323334|3959303|FG010|NOT COMPLETED|Period 4||0
3227572|NCT02323334|3959304|FG011|NOT COMPLETED|Period 4||0
3227573|NCT02323334|3959305|FG012|NOT COMPLETED|Period 4||0
3227574|NCT02323334|3959306|FG013|NOT COMPLETED|Period 4||0
3227575|NCT02323334|3959307|FG014|NOT COMPLETED|Period 4||0
3227576|NCT02323334|3959308|FG015|NOT COMPLETED|Period 4||0
3227577|NCT02323334|3959309|FG016|NOT COMPLETED|Period 4||0
3368638|NCT03801148|4100187|FG002|NOT COMPLETED|Washout Period (at Least 5 Days)||1
3368639|NCT03801148|4100188|FG003|NOT COMPLETED|Washout Period (at Least 5 Days)||1
3368640|NCT03801148|4100185|FG000|STARTED|Period 2 (2 Days)||30
3368641|NCT03801148|4100186|FG001|STARTED|Period 2 (2 Days)||30
3368642|NCT03801148|4100187|FG002|STARTED|Period 2 (2 Days)||29
3368643|NCT03801148|4100188|FG003|STARTED|Period 2 (2 Days)||29
3368644|NCT03801148|4100185|FG000|COMPLETED|Period 2 (2 Days)||30
3368645|NCT03801148|4100186|FG001|COMPLETED|Period 2 (2 Days)||30
3368646|NCT03801148|4100187|FG002|COMPLETED|Period 2 (2 Days)||29
3368647|NCT03801148|4100188|FG003|COMPLETED|Period 2 (2 Days)||29
3368648|NCT03801148|4100185|FG000|NOT COMPLETED|Period 2 (2 Days)||0
3368649|NCT03801148|4100186|FG001|NOT COMPLETED|Period 2 (2 Days)||0
3368650|NCT03801148|4100187|FG002|NOT COMPLETED|Period 2 (2 Days)||0
3368651|NCT03801148|4100188|FG003|NOT COMPLETED|Period 2 (2 Days)||0
3368652|NCT03801148|4100185|FG000|STARTED|Follow-Up (12 Days)||30
3368653|NCT03801148|4100186|FG001|STARTED|Follow-Up (12 Days)||30
3368654|NCT03801148|4100187|FG002|STARTED|Follow-Up (12 Days)||29
3368655|NCT03801148|4100188|FG003|STARTED|Follow-Up (12 Days)||29
3368656|NCT03801148|4100185|FG000|COMPLETED|Follow-Up (12 Days)||30
3368657|NCT03801148|4100186|FG001|COMPLETED|Follow-Up (12 Days)||29
3368658|NCT03801148|4100187|FG002|COMPLETED|Follow-Up (12 Days)||28
3368659|NCT03801148|4100188|FG003|COMPLETED|Follow-Up (12 Days)||29
3368660|NCT03801148|4100185|FG000|NOT COMPLETED|Follow-Up (12 Days)||0
3368661|NCT03801148|4100186|FG001|NOT COMPLETED|Follow-Up (12 Days)||1
3368662|NCT03801148|4100187|FG002|NOT COMPLETED|Follow-Up (12 Days)||1
3368663|NCT03801148|4100188|FG003|NOT COMPLETED|Follow-Up (12 Days)||0
3368664|NCT03832907|4100198|FG000|STARTED|Overall Study||101
3368665|NCT03832907|4100198|FG000|COMPLETED|Overall Study||91
3368666|NCT03832907|4100198|FG000|NOT COMPLETED|Overall Study||10
3368667|NCT03832322|4100204|FG000|STARTED|Overall Study||89
3368668|NCT03832322|4100205|FG001|STARTED|Overall Study||87
3368669|NCT03832322|4100204|FG000|COMPLETED|Overall Study||86
3368670|NCT03832322|4100205|FG001|COMPLETED|Overall Study||86
3368671|NCT03832322|4100204|FG000|NOT COMPLETED|Overall Study||3
3368672|NCT03832322|4100205|FG001|NOT COMPLETED|Overall Study||1
3368673|NCT03832387|4100215|FG000|STARTED|Overall Study||38
3368674|NCT03832387|4100216|FG001|STARTED|Overall Study||39
3368675|NCT03832387|4100215|FG000|COMPLETED|Overall Study||33
3368676|NCT03832387|4100216|FG001|COMPLETED|Overall Study||32
3368677|NCT03832387|4100215|FG000|NOT COMPLETED|Overall Study||5
3368678|NCT03832387|4100216|FG001|NOT COMPLETED|Overall Study||7
3368679|NCT03831971|4100222|FG000|STARTED|Overall Study||12
3368680|NCT03831971|4100222|FG000|COMPLETED|Overall Study||12
3368681|NCT03831971|4100222|FG000|NOT COMPLETED|Overall Study||0
3368682|NCT03831854|4100228|FG000|STARTED|Overall Study||23
3368683|NCT03831854|4100229|FG001|STARTED|Overall Study||23
3368684|NCT03831854|4100228|FG000|COMPLETED|Overall Study||23
3368685|NCT03831854|4100229|FG001|COMPLETED|Overall Study||23
3227578|NCT02323646|3959374|FG000|STARTED|Treatment Course 1||14
3227579|NCT02323646|3959375|FG001|STARTED|Treatment Course 1||13
3227580|NCT02323646|3959376|FG002|STARTED|Treatment Course 1||15
3227581|NCT02323646|3959374|FG000|COMPLETED|Treatment Course 1||11
3227582|NCT02323646|3959375|FG001|COMPLETED|Treatment Course 1||10
3227583|NCT02323646|3959376|FG002|COMPLETED|Treatment Course 1||12
3227584|NCT02323646|3959374|FG000|NOT COMPLETED|Treatment Course 1||3
3227585|NCT02323646|3959375|FG001|NOT COMPLETED|Treatment Course 1||3
3227586|NCT02323646|3959376|FG002|NOT COMPLETED|Treatment Course 1||3
3227587|NCT02323646|3959374|FG000|STARTED|Treatment Course 2||11
3227588|NCT02323646|3959375|FG001|STARTED|Treatment Course 2||10
3227589|NCT02323646|3959376|FG002|STARTED|Treatment Course 2||12
3227590|NCT02323646|3959374|FG000|COMPLETED|Treatment Course 2||10
3227591|NCT02323646|3959375|FG001|COMPLETED|Treatment Course 2||9
3227592|NCT02323646|3959376|FG002|COMPLETED|Treatment Course 2||9
3227593|NCT02323646|3959374|FG000|NOT COMPLETED|Treatment Course 2||1
3227594|NCT02323646|3959375|FG001|NOT COMPLETED|Treatment Course 2||1
3227595|NCT02323646|3959376|FG002|NOT COMPLETED|Treatment Course 2||3
3227596|NCT02323854|3959384|FG000|STARTED|Overall Study||15
3227597|NCT02323854|3959384|FG000|COMPLETED|Overall Study||15
3227598|NCT02323854|3959384|FG000|NOT COMPLETED|Overall Study||0
3227599|NCT02324049|3959388|FG000|STARTED|Part A||11
3227600|NCT02324049|3959388|FG000|Safety Analysis Set|Part A|Participants with informed consent, confirmed MPS IIIB diagnosis, and received any amount of SBC-103|11
3227601|NCT02324049|3959388|FG000|COMPLETED|Part A||11
3227602|NCT02324049|3959388|FG000|NOT COMPLETED|Part A||0
3227603|NCT02324049|3959388|FG000|STARTED|Part B||11
3227604|NCT02324049|3959388|FG000|Safety Analysis Set|Part B||11
3227605|NCT02324049|3959388|FG000|COMPLETED|Part B||11
3227606|NCT02324049|3959388|FG000|NOT COMPLETED|Part B||0
3227607|NCT02324049|3959388|FG000|STARTED|Part C||11
3227608|NCT02324049|3959388|FG000|Safety Analysis Set|Part C||11
3227609|NCT02324049|3959388|FG000|COMPLETED|Part C||0
3227610|NCT02324049|3959388|FG000|NOT COMPLETED|Part C||11
3227611|NCT02324075|3959394|FG000|STARTED|Overall Study||612
3227612|NCT02324075|3959395|FG001|STARTED|Overall Study||614
3227613|NCT02324075|3959394|FG000|COMPLETED|Overall Study||609
3227614|NCT02324075|3959395|FG001|COMPLETED|Overall Study||605
3227615|NCT02324075|3959394|FG000|NOT COMPLETED|Overall Study||3
3227616|NCT02324075|3959395|FG001|NOT COMPLETED|Overall Study||9
3227617|NCT02324153|3959404|FG000|STARTED|Overall Study||41
3227618|NCT02324153|3959405|FG001|STARTED|Overall Study||39
3227619|NCT02324153|3959404|FG000|COMPLETED|Overall Study||33
3227620|NCT02324153|3959405|FG001|COMPLETED|Overall Study||38
3227621|NCT02324153|3959404|FG000|NOT COMPLETED|Overall Study||8
3227622|NCT02324153|3959405|FG001|NOT COMPLETED|Overall Study||1
3227623|NCT02324205|3959411|FG000|STARTED|Overall Study||196
3227624|NCT02324205|3959411|FG000|COMPLETED|Overall Study||159
3227625|NCT02324205|3959411|FG000|NOT COMPLETED|Overall Study||37
3227626|NCT02324270|3959418|FG000|STARTED|Overall Study||218
3227627|NCT02324270|3959419|FG001|STARTED|Overall Study||219
3227628|NCT02324270|3959420|FG002|STARTED|Overall Study||221
3227629|NCT02324270|3959418|FG000|Safety Population|Overall Study||214
3227630|NCT02324270|3959419|FG001|Safety Population|Overall Study||216
3227631|NCT02324270|3959420|FG002|Safety Population|Overall Study||217
3227632|NCT02324270|3959418|FG000|mITT Population|Overall Study||214
3227633|NCT02324270|3959419|FG001|mITT Population|Overall Study||216
3227634|NCT02324270|3959420|FG002|mITT Population|Overall Study||217
3227635|NCT02324270|3959418|FG000|PP Population|Overall Study||180
3227636|NCT02324270|3959419|FG001|PP Population|Overall Study||177
3227637|NCT02324270|3959420|FG002|PP Population|Overall Study||171
3227638|NCT02324270|3959418|FG000|COMPLETED|Overall Study||213
3227639|NCT02324270|3959419|FG001|COMPLETED|Overall Study||212
3227640|NCT02324270|3959420|FG002|COMPLETED|Overall Study||216
3227641|NCT02324270|3959418|FG000|NOT COMPLETED|Overall Study||5
3227642|NCT02324270|3959419|FG001|NOT COMPLETED|Overall Study||7
3227643|NCT02324270|3959420|FG002|NOT COMPLETED|Overall Study||5
3227644|NCT02324335|3959430|FG000|STARTED|Overall Study||30
3227645|NCT02324335|3959431|FG001|STARTED|Overall Study||29
3227646|NCT02324335|3959430|FG000|COMPLETED|Overall Study||21
3227647|NCT02324335|3959431|FG001|COMPLETED|Overall Study||20
3227648|NCT02324335|3959430|FG000|NOT COMPLETED|Overall Study||9
3227649|NCT02324335|3959431|FG001|NOT COMPLETED|Overall Study||9
3227650|NCT02324361|3959439|FG000|STARTED|Overall Study||24
3227651|NCT02324361|3959440|FG001|STARTED|Overall Study||24
3227652|NCT02324361|3959439|FG000|COMPLETED|Overall Study||19
3227653|NCT02324361|3959440|FG001|COMPLETED|Overall Study||22
3227654|NCT02324361|3959439|FG000|NOT COMPLETED|Overall Study||5
3227655|NCT02324361|3959440|FG001|NOT COMPLETED|Overall Study||2
3227656|NCT02324465|3959448|FG000|STARTED|Overall Study||18
3227657|NCT02324465|3959449|FG001|STARTED|Overall Study||22
3227658|NCT02324465|3959448|FG000|COMPLETED|Overall Study||18
3227659|NCT02324465|3959449|FG001|COMPLETED|Overall Study||21
3227660|NCT02324465|3959448|FG000|NOT COMPLETED|Overall Study||0
3227661|NCT02324465|3959449|FG001|NOT COMPLETED|Overall Study||1
3227662|NCT02324504|3959455|FG000|STARTED|Overall Study||60
3227663|NCT02324504|3959455|FG000|COMPLETED|Overall Study||60
3227664|NCT02324504|3959455|FG000|NOT COMPLETED|Overall Study||0
3227665|NCT02324543|3959468|FG000|STARTED|Overall Study||6
3227666|NCT02324543|3959469|FG001|STARTED|Overall Study||6
3227667|NCT02324543|3959470|FG002|STARTED|Overall Study||3
3227668|NCT02324543|3959471|FG003|STARTED|Overall Study||4
3227669|NCT02324543|3959472|FG004|STARTED|Overall Study||4
3227670|NCT02324543|3959473|FG005|STARTED|Overall Study||24
3227671|NCT02324543|3959468|FG000|COMPLETED|Overall Study||6
3227672|NCT02324543|3959469|FG001|COMPLETED|Overall Study||6
3227673|NCT02324543|3959470|FG002|COMPLETED|Overall Study||3
3227674|NCT02324543|3959471|FG003|COMPLETED|Overall Study||4
3227675|NCT02324543|3959472|FG004|COMPLETED|Overall Study||4
3227676|NCT02324543|3959473|FG005|COMPLETED|Overall Study||24
3227677|NCT02324543|3959468|FG000|NOT COMPLETED|Overall Study||0
3227678|NCT02324543|3959469|FG001|NOT COMPLETED|Overall Study||0
3227679|NCT02324543|3959470|FG002|NOT COMPLETED|Overall Study||0
3227680|NCT02324543|3959471|FG003|NOT COMPLETED|Overall Study||0
3227681|NCT02324543|3959472|FG004|NOT COMPLETED|Overall Study||0
3227682|NCT02324543|3959473|FG005|NOT COMPLETED|Overall Study||0
3227683|NCT02324569|3959485|FG000|STARTED|Overall Study||116
3227684|NCT02324569|3959486|FG001|STARTED|Overall Study||124
3227685|NCT02324569|3959485|FG000|COMPLETED|Overall Study||100
3227686|NCT02324569|3959486|FG001|COMPLETED|Overall Study||103
3227687|NCT02324569|3959485|FG000|NOT COMPLETED|Overall Study||16
3227688|NCT02324569|3959486|FG001|NOT COMPLETED|Overall Study||21
3227689|NCT02324660|3959492|FG000|STARTED|Overall Study||169
3227690|NCT02324660|3959492|FG000|COMPLETED|Overall Study||137
3227691|NCT02324660|3959492|FG000|NOT COMPLETED|Overall Study||32
3227692|NCT02324673|3959500|FG000|STARTED|Overall Study||20
3227693|NCT02324673|3959501|FG001|STARTED|Overall Study||20
3227694|NCT02324673|3959502|FG002|STARTED|Overall Study||21
3227695|NCT02324673|3959500|FG000|COMPLETED|Overall Study||20
3227696|NCT02324673|3959501|FG001|COMPLETED|Overall Study||20
3227697|NCT02324673|3959502|FG002|COMPLETED|Overall Study||21
3227698|NCT02324673|3959500|FG000|NOT COMPLETED|Overall Study||0
3227699|NCT02324673|3959501|FG001|NOT COMPLETED|Overall Study||0
3227700|NCT02324673|3959502|FG002|NOT COMPLETED|Overall Study||0
3227701|NCT02324699|3959510|FG000|STARTED|Overall Study||1
3227702|NCT02324699|3959510|FG000|COMPLETED|Overall Study||0
3227703|NCT02324699|3959510|FG000|NOT COMPLETED|Overall Study||1
3227704|NCT02324842|3959517|FG000|STARTED|Overall Study||15
3227705|NCT02324842|3959518|FG001|STARTED|Overall Study||15
3227706|NCT02324842|3959519|FG002|STARTED|Overall Study||15
3227707|NCT02324842|3959517|FG000|COMPLETED|Overall Study||14
3227708|NCT02324842|3959518|FG001|COMPLETED|Overall Study||14
3227709|NCT02324842|3959519|FG002|COMPLETED|Overall Study||13
3227710|NCT02324842|3959517|FG000|NOT COMPLETED|Overall Study||1
3227711|NCT02324842|3959518|FG001|NOT COMPLETED|Overall Study||1
3227712|NCT02324842|3959519|FG002|NOT COMPLETED|Overall Study||2
3227713|NCT02324920|3959529|FG000|STARTED|Overall Study||64
3227714|NCT02324920|3959530|FG001|STARTED|Overall Study||64
3227715|NCT02324920|3959529|FG000|COMPLETED|Overall Study||63
3227716|NCT02324920|3959530|FG001|COMPLETED|Overall Study||64
3227717|NCT02324920|3959529|FG000|NOT COMPLETED|Overall Study||1
3227718|NCT02324920|3959530|FG001|NOT COMPLETED|Overall Study||0
3227719|NCT02324972|3959538|FG000|STARTED|Overall Study||26
3227720|NCT02324972|3959539|FG001|STARTED|Overall Study||28
3227721|NCT02324972|3959538|FG000|COMPLETED|Overall Study||19
3227722|NCT02324972|3959539|FG001|COMPLETED|Overall Study||23
3227723|NCT02324972|3959538|FG000|NOT COMPLETED|Overall Study||7
3227724|NCT02324972|3959539|FG001|NOT COMPLETED|Overall Study||5
3227725|NCT02325219|3959548|FG000|STARTED|Controlled Period (Week 0 - 16)||64
3227726|NCT02325219|3959549|FG001|STARTED|Controlled Period (Week 0 - 16)||65
3227727|NCT02325219|3959550|FG002|STARTED|Controlled Period (Week 0 - 16)||63
3227728|NCT02325219|3959551|FG003|STARTED|Controlled Period (Week 0 - 16)||0
3227729|NCT02325219|3959552|FG004|STARTED|Controlled Period (Week 0 - 16)||0
3227730|NCT02325219|3959548|FG000|COMPLETED|Controlled Period (Week 0 - 16)||52
3227731|NCT02325219|3959549|FG001|COMPLETED|Controlled Period (Week 0 - 16)||63
3227732|NCT02325219|3959550|FG002|COMPLETED|Controlled Period (Week 0 - 16)||62
3227733|NCT02325219|3959551|FG003|COMPLETED|Controlled Period (Week 0 - 16)||0
3227734|NCT02325219|3959552|FG004|COMPLETED|Controlled Period (Week 0 - 16)||0
3227735|NCT02325219|3959548|FG000|NOT COMPLETED|Controlled Period (Week 0 - 16)||12
3227736|NCT02325219|3959549|FG001|NOT COMPLETED|Controlled Period (Week 0 - 16)||2
3227737|NCT02325219|3959550|FG002|NOT COMPLETED|Controlled Period (Week 0 - 16)||1
3227738|NCT02325219|3959551|FG003|NOT COMPLETED|Controlled Period (Week 0 - 16)||0
3227739|NCT02325219|3959552|FG004|NOT COMPLETED|Controlled Period (Week 0 - 16)||0
3227740|NCT02325219|3959548|FG000|STARTED|After Controlled Period (Week 16 - 52)||0
3227741|NCT02325219|3959549|FG001|STARTED|After Controlled Period (Week 16 - 52)||63
3227742|NCT02325219|3959550|FG002|STARTED|After Controlled Period (Week 16 - 52)||62
3227743|NCT02325219|3959551|FG003|STARTED|After Controlled Period (Week 16 - 52)|Participants who completed CP and re-randomized to Guselkumab 50 mg.|26
3227744|NCT02325219|3959552|FG004|STARTED|After Controlled Period (Week 16 - 52)|Participants who completed CP and re-randomized to Guselkumab 100 mg.|26
3227745|NCT02325219|3959548|FG000|COMPLETED|After Controlled Period (Week 16 - 52)||0
3227746|NCT02325219|3959549|FG001|COMPLETED|After Controlled Period (Week 16 - 52)||60
3227747|NCT02325219|3959550|FG002|COMPLETED|After Controlled Period (Week 16 - 52)||62
3227748|NCT02325219|3959551|FG003|COMPLETED|After Controlled Period (Week 16 - 52)||26
3227749|NCT02325219|3959552|FG004|COMPLETED|After Controlled Period (Week 16 - 52)||25
3227750|NCT02325219|3959548|FG000|NOT COMPLETED|After Controlled Period (Week 16 - 52)||0
3227751|NCT02325219|3959549|FG001|NOT COMPLETED|After Controlled Period (Week 16 - 52)||3
3227752|NCT02325219|3959550|FG002|NOT COMPLETED|After Controlled Period (Week 16 - 52)||0
3227753|NCT02325219|3959551|FG003|NOT COMPLETED|After Controlled Period (Week 16 - 52)||0
3227754|NCT02325219|3959552|FG004|NOT COMPLETED|After Controlled Period (Week 16 - 52)||1
3227755|NCT02325401|3959568|FG000|STARTED|Overall Study||6
3227756|NCT02325401|3959569|FG001|STARTED|Overall Study||9
3227757|NCT02325401|3959570|FG002|STARTED|Overall Study||5
3227758|NCT02325401|3959568|FG000|COMPLETED|Overall Study||6
3227759|NCT02325401|3959569|FG001|COMPLETED|Overall Study||8
3227760|NCT02325401|3959570|FG002|COMPLETED|Overall Study||4
3227761|NCT02325401|3959568|FG000|NOT COMPLETED|Overall Study||0
3227762|NCT02325401|3959569|FG001|NOT COMPLETED|Overall Study||1
3227763|NCT02325401|3959570|FG002|NOT COMPLETED|Overall Study||1
3227764|NCT02325414|3959586|FG000|STARTED|Overall Study||30
3227765|NCT02325414|3959587|FG001|STARTED|Overall Study||30
3227766|NCT02325414|3959586|FG000|COMPLETED|Overall Study||22
3227767|NCT02325414|3959587|FG001|COMPLETED|Overall Study||24
3227768|NCT02325414|3959586|FG000|NOT COMPLETED|Overall Study||8
3227769|NCT02325414|3959587|FG001|NOT COMPLETED|Overall Study||6
3227770|NCT02325518|3959597|FG000|STARTED|Overall Study||98
3227771|NCT02325518|3959598|FG001|STARTED|Overall Study||103
3227772|NCT02325518|3959597|FG000|Safety Set|Overall Study||98
3227773|NCT02325518|3959598|FG001|Safety Set|Overall Study||103
3227774|NCT02325518|3959597|FG000|Full Analysis Set (FAS)|Overall Study||98
3227775|NCT02325518|3959598|FG001|Full Analysis Set (FAS)|Overall Study||101
3227776|NCT02325518|3959597|FG000|Per Protocol Set (PPS)|Overall Study||92
3227777|NCT02325518|3959598|FG001|Per Protocol Set (PPS)|Overall Study||97
3227778|NCT02325518|3959597|FG000|COMPLETED|Overall Study||94
3227779|NCT02325518|3959598|FG001|COMPLETED|Overall Study||100
3227780|NCT02325518|3959597|FG000|NOT COMPLETED|Overall Study||4
3227781|NCT02325518|3959598|FG001|NOT COMPLETED|Overall Study||3
3227782|NCT02325687|3959608|FG000|STARTED|Overall Study||16
3227783|NCT02325687|3959609|FG001|STARTED|Overall Study||15
3227784|NCT02325687|3959610|FG002|STARTED|Overall Study||19
3368686|NCT03831854|4100228|FG000|NOT COMPLETED|Overall Study||0
3368687|NCT03831854|4100229|FG001|NOT COMPLETED|Overall Study||0
3368688|NCT03807739|4100239|FG000|STARTED|Overall Study||9
3368689|NCT03807739|4100240|FG001|STARTED|Overall Study||10
3368690|NCT03807739|4100241|FG002|STARTED|Overall Study||9
3368691|NCT03807739|4100242|FG003|STARTED|Overall Study||10
3368692|NCT03807739|4100239|FG000|COMPLETED|Overall Study||7
3368693|NCT03807739|4100240|FG001|COMPLETED|Overall Study||10
3368694|NCT03807739|4100241|FG002|COMPLETED|Overall Study||9
3368695|NCT03807739|4100242|FG003|COMPLETED|Overall Study||10
3368696|NCT03807739|4100239|FG000|NOT COMPLETED|Overall Study||2
3368697|NCT03807739|4100240|FG001|NOT COMPLETED|Overall Study||0
3368698|NCT03807739|4100241|FG002|NOT COMPLETED|Overall Study||0
3368699|NCT03807739|4100242|FG003|NOT COMPLETED|Overall Study||0
3368700|NCT03831282|4100252|FG000|STARTED|Overall Study||12
3368701|NCT03831282|4100252|FG000|COMPLETED|Overall Study||11
3368702|NCT03831282|4100252|FG000|NOT COMPLETED|Overall Study||1
3368703|NCT03824912|4100259|FG000|STARTED|Overall Study||332
3368704|NCT03824912|4100260|FG001|STARTED|Overall Study||335
3368705|NCT03824912|4100261|FG002|STARTED|Overall Study||164
3368706|NCT03824912|4100259|FG000|COMPLETED|Overall Study||192
3368707|NCT03824912|4100260|FG001|COMPLETED|Overall Study||201
3368708|NCT03824912|4100261|FG002|COMPLETED|Overall Study||96
3368709|NCT03824912|4100259|FG000|NOT COMPLETED|Overall Study||140
3368710|NCT03824912|4100260|FG001|NOT COMPLETED|Overall Study||134
3368711|NCT03824912|4100261|FG002|NOT COMPLETED|Overall Study||68
3368712|NCT03822884|4100275|FG000|STARTED|Overall Study||4
3368713|NCT03822884|4100276|FG001|STARTED|Overall Study||4
3368714|NCT03822884|4100277|FG002|STARTED|Overall Study||4
3227785|NCT02325687|3959608|FG000|COMPLETED|Overall Study||12
3368715|NCT03822884|4100278|FG003|STARTED|Overall Study||4
3368716|NCT03822884|4100279|FG004|STARTED|Overall Study||4
3368717|NCT03822884|4100280|FG005|STARTED|Overall Study||4
3368718|NCT03822884|4100275|FG000|COMPLETED|Overall Study||4
3368719|NCT03822884|4100276|FG001|COMPLETED|Overall Study||4
3368720|NCT03822884|4100277|FG002|COMPLETED|Overall Study||4
3227786|NCT02325687|3959609|FG001|COMPLETED|Overall Study||12
3227787|NCT02325687|3959610|FG002|COMPLETED|Overall Study||13
3227788|NCT02325687|3959608|FG000|NOT COMPLETED|Overall Study||4
3227789|NCT02325687|3959609|FG001|NOT COMPLETED|Overall Study||3
3227790|NCT02325687|3959610|FG002|NOT COMPLETED|Overall Study||6
3227791|NCT02325713|3959634|FG000|STARTED|Intervention Period 1 (2 Days)||2
3227792|NCT02325713|3959635|FG001|STARTED|Intervention Period 1 (2 Days)||2
3227793|NCT02325713|3959636|FG002|STARTED|Intervention Period 1 (2 Days)||2
3227794|NCT02325713|3959637|FG003|STARTED|Intervention Period 1 (2 Days)||2
3227795|NCT02325713|3959638|FG004|STARTED|Intervention Period 1 (2 Days)||2
3227796|NCT02325713|3959639|FG005|STARTED|Intervention Period 1 (2 Days)||2
3227797|NCT02325713|3959640|FG006|STARTED|Intervention Period 1 (2 Days)||2
3227798|NCT02325713|3959641|FG007|STARTED|Intervention Period 1 (2 Days)||2
3227799|NCT02325713|3959642|FG008|STARTED|Intervention Period 1 (2 Days)||2
3227800|NCT02325713|3959643|FG009|STARTED|Intervention Period 1 (2 Days)||2
3227801|NCT02325713|3959644|FG010|STARTED|Intervention Period 1 (2 Days)||2
3227802|NCT02325713|3959645|FG011|STARTED|Intervention Period 1 (2 Days)||2
3227803|NCT02325713|3959646|FG012|STARTED|Intervention Period 1 (2 Days)||2
3227804|NCT02325713|3959647|FG013|STARTED|Intervention Period 1 (2 Days)||2
3227805|NCT02325713|3959648|FG014|STARTED|Intervention Period 1 (2 Days)||2
3227806|NCT02325713|3959649|FG015|STARTED|Intervention Period 1 (2 Days)||2
3227807|NCT02325713|3959634|FG000|COMPLETED|Intervention Period 1 (2 Days)||2
3227808|NCT02325713|3959635|FG001|COMPLETED|Intervention Period 1 (2 Days)||2
3227809|NCT02325713|3959636|FG002|COMPLETED|Intervention Period 1 (2 Days)||2
3227810|NCT02325713|3959637|FG003|COMPLETED|Intervention Period 1 (2 Days)||2
3227811|NCT02325713|3959638|FG004|COMPLETED|Intervention Period 1 (2 Days)||2
3227812|NCT02325713|3959639|FG005|COMPLETED|Intervention Period 1 (2 Days)||2
3227813|NCT02325713|3959640|FG006|COMPLETED|Intervention Period 1 (2 Days)||2
3227814|NCT02325713|3959641|FG007|COMPLETED|Intervention Period 1 (2 Days)||2
3227815|NCT02325713|3959642|FG008|COMPLETED|Intervention Period 1 (2 Days)||2
3227816|NCT02325713|3959643|FG009|COMPLETED|Intervention Period 1 (2 Days)||2
3227817|NCT02325713|3959644|FG010|COMPLETED|Intervention Period 1 (2 Days)||1
3227818|NCT02325713|3959645|FG011|COMPLETED|Intervention Period 1 (2 Days)||2
3227819|NCT02325713|3959646|FG012|COMPLETED|Intervention Period 1 (2 Days)||2
3227820|NCT02325713|3959647|FG013|COMPLETED|Intervention Period 1 (2 Days)||2
3227821|NCT02325713|3959648|FG014|COMPLETED|Intervention Period 1 (2 Days)||2
3368721|NCT03822884|4100278|FG003|COMPLETED|Overall Study||4
3368722|NCT03822884|4100279|FG004|COMPLETED|Overall Study||3
3368723|NCT03822884|4100280|FG005|COMPLETED|Overall Study||4
3368724|NCT03822884|4100275|FG000|NOT COMPLETED|Overall Study||0
3368725|NCT03822884|4100276|FG001|NOT COMPLETED|Overall Study||0
3368726|NCT03822884|4100277|FG002|NOT COMPLETED|Overall Study||0
3368727|NCT03822884|4100278|FG003|NOT COMPLETED|Overall Study||0
3368728|NCT03822884|4100279|FG004|NOT COMPLETED|Overall Study||1
3368729|NCT03822884|4100280|FG005|NOT COMPLETED|Overall Study||0
3368730|NCT03816709|4100288|FG000|STARTED|Overall Study||25
3368731|NCT03816709|4100288|FG000|COMPLETED|Overall Study||25
3368732|NCT03816709|4100288|FG000|NOT COMPLETED|Overall Study||0
3368733|NCT03810014|4100296|FG000|STARTED|Overall Study||215
3368734|NCT03810014|4100297|FG001|STARTED|Overall Study||204
3368735|NCT03810014|4100298|FG002|STARTED|Overall Study||210
3368736|NCT03810014|4100299|FG003|STARTED|Overall Study||213
3368737|NCT03810014|4100296|FG000|COMPLETED|Overall Study||213
3368738|NCT03810014|4100297|FG001|COMPLETED|Overall Study||202
3368739|NCT03810014|4100298|FG002|COMPLETED|Overall Study||210
3368740|NCT03810014|4100299|FG003|COMPLETED|Overall Study||211
3368741|NCT03810014|4100296|FG000|NOT COMPLETED|Overall Study||2
3368742|NCT03810014|4100297|FG001|NOT COMPLETED|Overall Study||2
3368743|NCT03810014|4100298|FG002|NOT COMPLETED|Overall Study||0
3368744|NCT03810014|4100299|FG003|NOT COMPLETED|Overall Study||2
3368745|NCT03806270|4100312|FG000|STARTED|Overall Study||15
3368746|NCT03806270|4100313|FG001|STARTED|Overall Study||15
3368747|NCT03806270|4100314|FG002|STARTED|Overall Study||15
3368748|NCT03806270|4100312|FG000|COMPLETED|Overall Study||15
3368749|NCT03806270|4100313|FG001|COMPLETED|Overall Study||15
3368750|NCT03806270|4100314|FG002|COMPLETED|Overall Study||15
3368751|NCT03806270|4100312|FG000|NOT COMPLETED|Overall Study||0
3368752|NCT03806270|4100313|FG001|NOT COMPLETED|Overall Study||0
3368753|NCT03806270|4100314|FG002|NOT COMPLETED|Overall Study||0
3368754|NCT03830892|4100324|FG000|STARTED|Overall Study||25
3368755|NCT03830892|4100325|FG001|STARTED|Overall Study||23
3368756|NCT03830892|4100324|FG000|15 Watts, 10 mg Nicotine|Overall Study||19
3368757|NCT03830892|4100325|FG001|15 Watts, 10 mg Nicotine|Overall Study||17
3368758|NCT03830892|4100324|FG000|15 Watts, 30 mg Nicotine|Overall Study||19
3368759|NCT03830892|4100325|FG001|15 Watts, 30 mg Nicotine|Overall Study||17
3368760|NCT03830892|4100324|FG000|30 Watts, 10 mg Nicotine|Overall Study||19
3368761|NCT03830892|4100325|FG001|30 Watts, 10 mg Nicotine|Overall Study||17
3368762|NCT03830892|4100324|FG000|30 Watts, 30 mg Nicotine|Overall Study||19
3368763|NCT03830892|4100325|FG001|30 Watts, 30 mg Nicotine|Overall Study||17
3368764|NCT03830892|4100324|FG000|Own Brand|Overall Study||19
3368765|NCT03830892|4100325|FG001|Own Brand|Overall Study||17
3368766|NCT03830892|4100324|FG000|COMPLETED|Overall Study||19
3368767|NCT03830892|4100325|FG001|COMPLETED|Overall Study||17
3368768|NCT03830892|4100324|FG000|NOT COMPLETED|Overall Study||6
3368769|NCT03830892|4100325|FG001|NOT COMPLETED|Overall Study||6
3368770|NCT03830307|4100331|FG000|STARTED|Overall Study||5
3368771|NCT03830307|4100331|FG000|COMPLETED|Overall Study||5
3227822|NCT02325713|3959649|FG015|COMPLETED|Intervention Period 1 (2 Days)||2
3227823|NCT02325713|3959634|FG000|NOT COMPLETED|Intervention Period 1 (2 Days)||0
3227824|NCT02325713|3959635|FG001|NOT COMPLETED|Intervention Period 1 (2 Days)||0
3227825|NCT02325713|3959636|FG002|NOT COMPLETED|Intervention Period 1 (2 Days)||0
3227826|NCT02325713|3959637|FG003|NOT COMPLETED|Intervention Period 1 (2 Days)||0
3227827|NCT02325713|3959638|FG004|NOT COMPLETED|Intervention Period 1 (2 Days)||0
3227828|NCT02325713|3959639|FG005|NOT COMPLETED|Intervention Period 1 (2 Days)||0
3227829|NCT02325713|3959640|FG006|NOT COMPLETED|Intervention Period 1 (2 Days)||0
3227830|NCT02325713|3959641|FG007|NOT COMPLETED|Intervention Period 1 (2 Days)||0
3227831|NCT02325713|3959642|FG008|NOT COMPLETED|Intervention Period 1 (2 Days)||0
3227832|NCT02325713|3959643|FG009|NOT COMPLETED|Intervention Period 1 (2 Days)||0
3227833|NCT02325713|3959644|FG010|NOT COMPLETED|Intervention Period 1 (2 Days)||1
3227834|NCT02325713|3959645|FG011|NOT COMPLETED|Intervention Period 1 (2 Days)||0
3227835|NCT02325713|3959646|FG012|NOT COMPLETED|Intervention Period 1 (2 Days)||0
3227836|NCT02325713|3959647|FG013|NOT COMPLETED|Intervention Period 1 (2 Days)||0
3227837|NCT02325713|3959648|FG014|NOT COMPLETED|Intervention Period 1 (2 Days)||0
3227838|NCT02325713|3959649|FG015|NOT COMPLETED|Intervention Period 1 (2 Days)||0
3227839|NCT02325713|3959634|FG000|STARTED|Intervention Period 2 (2 Days)||2
3227840|NCT02325713|3959635|FG001|STARTED|Intervention Period 2 (2 Days)||2
3227841|NCT02325713|3959636|FG002|STARTED|Intervention Period 2 (2 Days)||2
3227842|NCT02325713|3959637|FG003|STARTED|Intervention Period 2 (2 Days)||2
3227843|NCT02325713|3959638|FG004|STARTED|Intervention Period 2 (2 Days)||2
3227844|NCT02325713|3959639|FG005|STARTED|Intervention Period 2 (2 Days)||2
3227845|NCT02325713|3959640|FG006|STARTED|Intervention Period 2 (2 Days)||2
3227846|NCT02325713|3959641|FG007|STARTED|Intervention Period 2 (2 Days)||2
3227847|NCT02325713|3959642|FG008|STARTED|Intervention Period 2 (2 Days)||2
3227848|NCT02325713|3959643|FG009|STARTED|Intervention Period 2 (2 Days)||2
3227849|NCT02325713|3959644|FG010|STARTED|Intervention Period 2 (2 Days)||1
3227850|NCT02325713|3959645|FG011|STARTED|Intervention Period 2 (2 Days)||2
3227851|NCT02325713|3959646|FG012|STARTED|Intervention Period 2 (2 Days)||2
3227852|NCT02325713|3959647|FG013|STARTED|Intervention Period 2 (2 Days)||2
3227853|NCT02325713|3959648|FG014|STARTED|Intervention Period 2 (2 Days)||2
3227854|NCT02325713|3959649|FG015|STARTED|Intervention Period 2 (2 Days)||2
3227855|NCT02325713|3959634|FG000|COMPLETED|Intervention Period 2 (2 Days)||1
3227856|NCT02325713|3959635|FG001|COMPLETED|Intervention Period 2 (2 Days)||2
3227857|NCT02325713|3959636|FG002|COMPLETED|Intervention Period 2 (2 Days)||2
3227858|NCT02325713|3959637|FG003|COMPLETED|Intervention Period 2 (2 Days)||2
3227859|NCT02325713|3959638|FG004|COMPLETED|Intervention Period 2 (2 Days)||2
3227860|NCT02325713|3959639|FG005|COMPLETED|Intervention Period 2 (2 Days)||2
3227861|NCT02325713|3959640|FG006|COMPLETED|Intervention Period 2 (2 Days)||2
3227862|NCT02325713|3959641|FG007|COMPLETED|Intervention Period 2 (2 Days)||2
3227863|NCT02325713|3959642|FG008|COMPLETED|Intervention Period 2 (2 Days)||2
3227864|NCT02325713|3959643|FG009|COMPLETED|Intervention Period 2 (2 Days)||2
3227865|NCT02325713|3959644|FG010|COMPLETED|Intervention Period 2 (2 Days)||1
3227866|NCT02325713|3959645|FG011|COMPLETED|Intervention Period 2 (2 Days)||2
3227867|NCT02325713|3959646|FG012|COMPLETED|Intervention Period 2 (2 Days)||2
3227868|NCT02325713|3959647|FG013|COMPLETED|Intervention Period 2 (2 Days)||2
3227869|NCT02325713|3959648|FG014|COMPLETED|Intervention Period 2 (2 Days)||2
3227870|NCT02325713|3959649|FG015|COMPLETED|Intervention Period 2 (2 Days)||2
3227871|NCT02325713|3959634|FG000|NOT COMPLETED|Intervention Period 2 (2 Days)||1
3227872|NCT02325713|3959635|FG001|NOT COMPLETED|Intervention Period 2 (2 Days)||0
3227873|NCT02325713|3959636|FG002|NOT COMPLETED|Intervention Period 2 (2 Days)||0
3227874|NCT02325713|3959637|FG003|NOT COMPLETED|Intervention Period 2 (2 Days)||0
3227875|NCT02325713|3959638|FG004|NOT COMPLETED|Intervention Period 2 (2 Days)||0
3227876|NCT02325713|3959639|FG005|NOT COMPLETED|Intervention Period 2 (2 Days)||0
3227877|NCT02325713|3959640|FG006|NOT COMPLETED|Intervention Period 2 (2 Days)||0
3227878|NCT02325713|3959641|FG007|NOT COMPLETED|Intervention Period 2 (2 Days)||0
3227879|NCT02325713|3959642|FG008|NOT COMPLETED|Intervention Period 2 (2 Days)||0
3227880|NCT02325713|3959643|FG009|NOT COMPLETED|Intervention Period 2 (2 Days)||0
3227881|NCT02325713|3959644|FG010|NOT COMPLETED|Intervention Period 2 (2 Days)||0
3227882|NCT02325713|3959645|FG011|NOT COMPLETED|Intervention Period 2 (2 Days)||0
3227883|NCT02325713|3959646|FG012|NOT COMPLETED|Intervention Period 2 (2 Days)||0
3227884|NCT02325713|3959647|FG013|NOT COMPLETED|Intervention Period 2 (2 Days)||0
3227885|NCT02325713|3959648|FG014|NOT COMPLETED|Intervention Period 2 (2 Days)||0
3227886|NCT02325713|3959649|FG015|NOT COMPLETED|Intervention Period 2 (2 Days)||0
3227887|NCT02325713|3959634|FG000|STARTED|Intervention Period 3 (2 Days)||1
3227888|NCT02325713|3959635|FG001|STARTED|Intervention Period 3 (2 Days)||2
3227889|NCT02325713|3959636|FG002|STARTED|Intervention Period 3 (2 Days)||2
3227890|NCT02325713|3959637|FG003|STARTED|Intervention Period 3 (2 Days)||2
3227891|NCT02325713|3959638|FG004|STARTED|Intervention Period 3 (2 Days)||2
3227892|NCT02325713|3959639|FG005|STARTED|Intervention Period 3 (2 Days)||2
3227893|NCT02325713|3959640|FG006|STARTED|Intervention Period 3 (2 Days)||2
3227894|NCT02325713|3959641|FG007|STARTED|Intervention Period 3 (2 Days)||2
3227895|NCT02325713|3959642|FG008|STARTED|Intervention Period 3 (2 Days)||2
3227896|NCT02325713|3959643|FG009|STARTED|Intervention Period 3 (2 Days)||2
3227897|NCT02325713|3959644|FG010|STARTED|Intervention Period 3 (2 Days)||1
3227898|NCT02325713|3959645|FG011|STARTED|Intervention Period 3 (2 Days)||2
3227899|NCT02325713|3959646|FG012|STARTED|Intervention Period 3 (2 Days)||2
3227900|NCT02325713|3959647|FG013|STARTED|Intervention Period 3 (2 Days)||2
3227901|NCT02325713|3959648|FG014|STARTED|Intervention Period 3 (2 Days)||2
3227902|NCT02325713|3959649|FG015|STARTED|Intervention Period 3 (2 Days)||2
3227903|NCT02325713|3959634|FG000|COMPLETED|Intervention Period 3 (2 Days)||1
3227904|NCT02325713|3959635|FG001|COMPLETED|Intervention Period 3 (2 Days)||2
3227905|NCT02325713|3959636|FG002|COMPLETED|Intervention Period 3 (2 Days)||2
3227906|NCT02325713|3959637|FG003|COMPLETED|Intervention Period 3 (2 Days)||2
3227907|NCT02325713|3959638|FG004|COMPLETED|Intervention Period 3 (2 Days)||2
3227908|NCT02325713|3959639|FG005|COMPLETED|Intervention Period 3 (2 Days)||2
3227909|NCT02325713|3959640|FG006|COMPLETED|Intervention Period 3 (2 Days)||2
3227910|NCT02325713|3959641|FG007|COMPLETED|Intervention Period 3 (2 Days)||2
3227911|NCT02325713|3959642|FG008|COMPLETED|Intervention Period 3 (2 Days)||2
3227912|NCT02325713|3959643|FG009|COMPLETED|Intervention Period 3 (2 Days)||1
3227913|NCT02325713|3959644|FG010|COMPLETED|Intervention Period 3 (2 Days)||1
3227914|NCT02325713|3959645|FG011|COMPLETED|Intervention Period 3 (2 Days)||2
3227915|NCT02325713|3959646|FG012|COMPLETED|Intervention Period 3 (2 Days)||2
3227916|NCT02325713|3959647|FG013|COMPLETED|Intervention Period 3 (2 Days)||2
3227917|NCT02325713|3959648|FG014|COMPLETED|Intervention Period 3 (2 Days)||2
3227918|NCT02325713|3959649|FG015|COMPLETED|Intervention Period 3 (2 Days)||2
3227919|NCT02325713|3959634|FG000|NOT COMPLETED|Intervention Period 3 (2 Days)||0
3227920|NCT02325713|3959635|FG001|NOT COMPLETED|Intervention Period 3 (2 Days)||0
3227921|NCT02325713|3959636|FG002|NOT COMPLETED|Intervention Period 3 (2 Days)||0
3227922|NCT02325713|3959637|FG003|NOT COMPLETED|Intervention Period 3 (2 Days)||0
3227923|NCT02325713|3959638|FG004|NOT COMPLETED|Intervention Period 3 (2 Days)||0
3227924|NCT02325713|3959639|FG005|NOT COMPLETED|Intervention Period 3 (2 Days)||0
3227925|NCT02325713|3959640|FG006|NOT COMPLETED|Intervention Period 3 (2 Days)||0
3227926|NCT02325713|3959641|FG007|NOT COMPLETED|Intervention Period 3 (2 Days)||0
3227927|NCT02325713|3959642|FG008|NOT COMPLETED|Intervention Period 3 (2 Days)||0
3227928|NCT02325713|3959643|FG009|NOT COMPLETED|Intervention Period 3 (2 Days)||1
3227929|NCT02325713|3959644|FG010|NOT COMPLETED|Intervention Period 3 (2 Days)||0
3227930|NCT02325713|3959645|FG011|NOT COMPLETED|Intervention Period 3 (2 Days)||0
3227931|NCT02325713|3959646|FG012|NOT COMPLETED|Intervention Period 3 (2 Days)||0
3227932|NCT02325713|3959647|FG013|NOT COMPLETED|Intervention Period 3 (2 Days)||0
3227933|NCT02325713|3959648|FG014|NOT COMPLETED|Intervention Period 3 (2 Days)||0
3227934|NCT02325713|3959649|FG015|NOT COMPLETED|Intervention Period 3 (2 Days)||0
3227935|NCT02325713|3959634|FG000|STARTED|Intervention Period 4 (2 Days)||1
3227936|NCT02325713|3959635|FG001|STARTED|Intervention Period 4 (2 Days)||2
3227937|NCT02325713|3959636|FG002|STARTED|Intervention Period 4 (2 Days)||2
3227938|NCT02325713|3959637|FG003|STARTED|Intervention Period 4 (2 Days)||2
3227939|NCT02325713|3959638|FG004|STARTED|Intervention Period 4 (2 Days)||2
3227940|NCT02325713|3959639|FG005|STARTED|Intervention Period 4 (2 Days)||2
3227941|NCT02325713|3959640|FG006|STARTED|Intervention Period 4 (2 Days)||2
3227942|NCT02325713|3959641|FG007|STARTED|Intervention Period 4 (2 Days)||2
3227943|NCT02325713|3959642|FG008|STARTED|Intervention Period 4 (2 Days)||2
3227944|NCT02325713|3959643|FG009|STARTED|Intervention Period 4 (2 Days)||1
3227945|NCT02325713|3959644|FG010|STARTED|Intervention Period 4 (2 Days)||1
3227946|NCT02325713|3959645|FG011|STARTED|Intervention Period 4 (2 Days)||2
3227947|NCT02325713|3959646|FG012|STARTED|Intervention Period 4 (2 Days)||2
3227948|NCT02325713|3959647|FG013|STARTED|Intervention Period 4 (2 Days)||2
3227949|NCT02325713|3959648|FG014|STARTED|Intervention Period 4 (2 Days)||2
3227950|NCT02325713|3959649|FG015|STARTED|Intervention Period 4 (2 Days)||2
3227951|NCT02325713|3959634|FG000|COMPLETED|Intervention Period 4 (2 Days)||1
3227952|NCT02325713|3959635|FG001|COMPLETED|Intervention Period 4 (2 Days)||2
3227953|NCT02325713|3959636|FG002|COMPLETED|Intervention Period 4 (2 Days)||2
3227954|NCT02325713|3959637|FG003|COMPLETED|Intervention Period 4 (2 Days)||2
3227955|NCT02325713|3959638|FG004|COMPLETED|Intervention Period 4 (2 Days)||2
3227956|NCT02325713|3959639|FG005|COMPLETED|Intervention Period 4 (2 Days)||2
3227957|NCT02325713|3959640|FG006|COMPLETED|Intervention Period 4 (2 Days)||2
3227958|NCT02325713|3959641|FG007|COMPLETED|Intervention Period 4 (2 Days)||2
3227959|NCT02325713|3959642|FG008|COMPLETED|Intervention Period 4 (2 Days)||2
3227960|NCT02325713|3959643|FG009|COMPLETED|Intervention Period 4 (2 Days)||1
3227961|NCT02325713|3959644|FG010|COMPLETED|Intervention Period 4 (2 Days)||1
3227962|NCT02325713|3959645|FG011|COMPLETED|Intervention Period 4 (2 Days)||2
3227963|NCT02325713|3959646|FG012|COMPLETED|Intervention Period 4 (2 Days)||2
3227964|NCT02325713|3959647|FG013|COMPLETED|Intervention Period 4 (2 Days)||2
3227965|NCT02325713|3959648|FG014|COMPLETED|Intervention Period 4 (2 Days)||2
3227966|NCT02325713|3959649|FG015|COMPLETED|Intervention Period 4 (2 Days)||2
3227967|NCT02325713|3959634|FG000|NOT COMPLETED|Intervention Period 4 (2 Days)||0
3227968|NCT02325713|3959635|FG001|NOT COMPLETED|Intervention Period 4 (2 Days)||0
3227969|NCT02325713|3959636|FG002|NOT COMPLETED|Intervention Period 4 (2 Days)||0
3227970|NCT02325713|3959637|FG003|NOT COMPLETED|Intervention Period 4 (2 Days)||0
3227971|NCT02325713|3959638|FG004|NOT COMPLETED|Intervention Period 4 (2 Days)||0
3227972|NCT02325713|3959639|FG005|NOT COMPLETED|Intervention Period 4 (2 Days)||0
3227973|NCT02325713|3959640|FG006|NOT COMPLETED|Intervention Period 4 (2 Days)||0
3227974|NCT02325713|3959641|FG007|NOT COMPLETED|Intervention Period 4 (2 Days)||0
3227975|NCT02325713|3959642|FG008|NOT COMPLETED|Intervention Period 4 (2 Days)||0
3227976|NCT02325713|3959643|FG009|NOT COMPLETED|Intervention Period 4 (2 Days)||0
3227977|NCT02325713|3959644|FG010|NOT COMPLETED|Intervention Period 4 (2 Days)||0
3227978|NCT02325713|3959645|FG011|NOT COMPLETED|Intervention Period 4 (2 Days)||0
3227979|NCT02325713|3959646|FG012|NOT COMPLETED|Intervention Period 4 (2 Days)||0
3227980|NCT02325713|3959647|FG013|NOT COMPLETED|Intervention Period 4 (2 Days)||0
3227981|NCT02325713|3959648|FG014|NOT COMPLETED|Intervention Period 4 (2 Days)||0
3227982|NCT02325713|3959649|FG015|NOT COMPLETED|Intervention Period 4 (2 Days)||0
3227983|NCT02325739|3959675|FG000|STARTED|Phase I Part||11
3227984|NCT02325739|3959676|FG001|STARTED|Phase I Part||6
3227985|NCT02325739|3959677|FG002|STARTED|Phase I Part||5
3227986|NCT02325739|3959678|FG003|STARTED|Phase I Part||26
3227987|NCT02325739|3959679|FG004|STARTED|Phase I Part||19
3227988|NCT02325739|3959680|FG005|STARTED|Phase I Part||7
3227989|NCT02325739|3959681|FG006|STARTED|Phase I Part||6
3227990|NCT02325739|3959682|FG007|STARTED|Phase I Part||6
3227991|NCT02325739|3959683|FG008|STARTED|Phase I Part||0
3227992|NCT02325739|3959684|FG009|STARTED|Phase I Part||0
3227993|NCT02325739|3959685|FG010|STARTED|Phase I Part||0
3227994|NCT02325739|3959675|FG000|COMPLETED|Phase I Part||0
3227995|NCT02325739|3959676|FG001|COMPLETED|Phase I Part||0
3227996|NCT02325739|3959677|FG002|COMPLETED|Phase I Part||0
3227997|NCT02325739|3959678|FG003|COMPLETED|Phase I Part||0
3227998|NCT02325739|3959679|FG004|COMPLETED|Phase I Part||0
3227999|NCT02325739|3959680|FG005|COMPLETED|Phase I Part||0
3228000|NCT02325739|3959681|FG006|COMPLETED|Phase I Part||0
3228001|NCT02325739|3959682|FG007|COMPLETED|Phase I Part||0
3228002|NCT02325739|3959683|FG008|COMPLETED|Phase I Part||0
3228003|NCT02325739|3959684|FG009|COMPLETED|Phase I Part||0
3228004|NCT02325739|3959685|FG010|COMPLETED|Phase I Part||0
3228005|NCT02325739|3959675|FG000|NOT COMPLETED|Phase I Part||11
3228006|NCT02325739|3959676|FG001|NOT COMPLETED|Phase I Part||6
3228007|NCT02325739|3959677|FG002|NOT COMPLETED|Phase I Part||5
3228008|NCT02325739|3959678|FG003|NOT COMPLETED|Phase I Part||26
3228009|NCT02325739|3959679|FG004|NOT COMPLETED|Phase I Part||19
3228010|NCT02325739|3959680|FG005|NOT COMPLETED|Phase I Part||7
3228011|NCT02325739|3959681|FG006|NOT COMPLETED|Phase I Part||6
3228012|NCT02325739|3959682|FG007|NOT COMPLETED|Phase I Part||6
3228013|NCT02325739|3959683|FG008|NOT COMPLETED|Phase I Part||0
3228014|NCT02325739|3959684|FG009|NOT COMPLETED|Phase I Part||0
3228015|NCT02325739|3959685|FG010|NOT COMPLETED|Phase I Part||0
3228016|NCT02325739|3959675|FG000|STARTED|Phase II Part||0
3228017|NCT02325739|3959676|FG001|STARTED|Phase II Part||0
3228018|NCT02325739|3959677|FG002|STARTED|Phase II Part||0
3228019|NCT02325739|3959678|FG003|STARTED|Phase II Part||0
3228020|NCT02325739|3959679|FG004|STARTED|Phase II Part||0
3228021|NCT02325739|3959680|FG005|STARTED|Phase II Part||0
3228022|NCT02325739|3959681|FG006|STARTED|Phase II Part||0
3228023|NCT02325739|3959682|FG007|STARTED|Phase II Part||0
3228024|NCT02325739|3959683|FG008|STARTED|Phase II Part||30
3228025|NCT02325739|3959684|FG009|STARTED|Phase II Part||36
3228026|NCT02325739|3959685|FG010|STARTED|Phase II Part||20
3228027|NCT02325739|3959675|FG000|COMPLETED|Phase II Part||0
3228028|NCT02325739|3959676|FG001|COMPLETED|Phase II Part||0
3228029|NCT02325739|3959677|FG002|COMPLETED|Phase II Part||0
3228030|NCT02325739|3959678|FG003|COMPLETED|Phase II Part||0
3228031|NCT02325739|3959679|FG004|COMPLETED|Phase II Part||0
3228032|NCT02325739|3959680|FG005|COMPLETED|Phase II Part||0
3228033|NCT02325739|3959681|FG006|COMPLETED|Phase II Part||0
3228034|NCT02325739|3959682|FG007|COMPLETED|Phase II Part||0
3228035|NCT02325739|3959683|FG008|COMPLETED|Phase II Part||0
3228036|NCT02325739|3959684|FG009|COMPLETED|Phase II Part||0
3228037|NCT02325739|3959685|FG010|COMPLETED|Phase II Part||0
3228038|NCT02325739|3959675|FG000|NOT COMPLETED|Phase II Part||0
3228039|NCT02325739|3959676|FG001|NOT COMPLETED|Phase II Part||0
3228040|NCT02325739|3959677|FG002|NOT COMPLETED|Phase II Part||0
3228041|NCT02325739|3959678|FG003|NOT COMPLETED|Phase II Part||0
3228042|NCT02325739|3959679|FG004|NOT COMPLETED|Phase II Part||0
3228043|NCT02325739|3959680|FG005|NOT COMPLETED|Phase II Part||0
3228044|NCT02325739|3959681|FG006|NOT COMPLETED|Phase II Part||0
3228045|NCT02325739|3959682|FG007|NOT COMPLETED|Phase II Part||0
3228046|NCT02325739|3959683|FG008|NOT COMPLETED|Phase II Part||30
3228047|NCT02325739|3959684|FG009|NOT COMPLETED|Phase II Part||36
3228048|NCT02325739|3959685|FG010|NOT COMPLETED|Phase II Part||20
3228049|NCT02325791|3959734|FG000|STARTED|Overall Study||23
3228050|NCT02325791|3959735|FG001|STARTED|Overall Study||383
3228051|NCT02325791|3959736|FG002|STARTED|Overall Study||385
3228052|NCT02325791|3959737|FG003|STARTED|Overall Study||381
3228053|NCT02325791|3959734|FG000|COMPLETED|Overall Study||23
3228054|NCT02325791|3959735|FG001|COMPLETED|Overall Study||358
3228055|NCT02325791|3959736|FG002|COMPLETED|Overall Study||360
3228056|NCT02325791|3959737|FG003|COMPLETED|Overall Study||355
3228057|NCT02325791|3959734|FG000|NOT COMPLETED|Overall Study||0
3228058|NCT02325791|3959735|FG001|NOT COMPLETED|Overall Study||25
3228059|NCT02325791|3959736|FG002|NOT COMPLETED|Overall Study||25
3228060|NCT02325791|3959737|FG003|NOT COMPLETED|Overall Study||26
3228061|NCT02325856|3959752|FG000|STARTED|Overall Study||148
3228062|NCT02325856|3959753|FG001|STARTED|Overall Study||150
3228063|NCT02325856|3959752|FG000|COMPLETED|Overall Study||128
3228064|NCT02325856|3959753|FG001|COMPLETED|Overall Study||123
3228065|NCT02325856|3959752|FG000|NOT COMPLETED|Overall Study||20
3228066|NCT02325856|3959753|FG001|NOT COMPLETED|Overall Study||27
3228067|NCT02326025|3959761|FG000|STARTED|Overall Study||25
3228068|NCT02326025|3959762|FG001|STARTED|Overall Study||24
3228069|NCT02326025|3959761|FG000|Received at Least 1 Dose of Study Drug|Overall Study||25
3228070|NCT02326025|3959762|FG001|Received at Least 1 Dose of Study Drug|Overall Study||24
3228071|NCT02326025|3959761|FG000|COMPLETED|Overall Study||20
3228072|NCT02326025|3959762|FG001|COMPLETED|Overall Study||19
3228073|NCT02326025|3959761|FG000|NOT COMPLETED|Overall Study||5
3228074|NCT02326025|3959762|FG001|NOT COMPLETED|Overall Study||5
3228075|NCT02326220|3959783|FG000|STARTED|Double-blind Treatment Period|Out of 21 participants, 9 participants entered in open label treatment period|21
3228076|NCT02326220|3959784|FG001|STARTED|Double-blind Treatment Period|Out of 41 participants, 20 participants entered in open label treatment period.|41
3228077|NCT02326220|3959785|FG002|STARTED|Double-blind Treatment Period||0
3228078|NCT02326220|3959783|FG000|COMPLETED|Double-blind Treatment Period||20
3228079|NCT02326220|3959784|FG001|COMPLETED|Double-blind Treatment Period||37
3228080|NCT02326220|3959785|FG002|COMPLETED|Double-blind Treatment Period||0
3228081|NCT02326220|3959783|FG000|NOT COMPLETED|Double-blind Treatment Period||1
3228082|NCT02326220|3959784|FG001|NOT COMPLETED|Double-blind Treatment Period||4
3228083|NCT02326220|3959785|FG002|NOT COMPLETED|Double-blind Treatment Period||0
3228084|NCT02326220|3959783|FG000|STARTED|Open-label Treatment Period||0
3228085|NCT02326220|3959784|FG001|STARTED|Open-label Treatment Period||0
3228086|NCT02326220|3959785|FG002|STARTED|Open-label Treatment Period|29 participants: 9 from Placebo and 20 from Alirocumab 150 mg arm entered in open-label period.|29
3228087|NCT02326220|3959783|FG000|COMPLETED|Open-label Treatment Period||0
3228088|NCT02326220|3959784|FG001|COMPLETED|Open-label Treatment Period||0
3228089|NCT02326220|3959785|FG002|COMPLETED|Open-label Treatment Period||27
3228090|NCT02326220|3959783|FG000|NOT COMPLETED|Open-label Treatment Period||0
3228091|NCT02326220|3959784|FG001|NOT COMPLETED|Open-label Treatment Period||0
3228092|NCT02326220|3959785|FG002|NOT COMPLETED|Open-label Treatment Period||2
3228093|NCT02326233|3959797|FG000|STARTED|Overall Study||95
3228094|NCT02326233|3959798|FG001|STARTED|Overall Study||95
3228095|NCT02326233|3959797|FG000|COMPLETED|Overall Study||95
3228096|NCT02326233|3959798|FG001|COMPLETED|Overall Study||94
3228097|NCT02326233|3959797|FG000|NOT COMPLETED|Overall Study||0
3228098|NCT02326233|3959798|FG001|NOT COMPLETED|Overall Study||1
3228099|NCT02326272|3959807|FG000|STARTED|Initial Period (Week 0 to Week 16)||49
3228100|NCT02326272|3959808|FG001|STARTED|Initial Period (Week 0 to Week 16)||91
3228101|NCT02326272|3959809|FG002|STARTED|Initial Period (Week 0 to Week 16)||87
3228102|NCT02326272|3959810|FG003|STARTED|Initial Period (Week 0 to Week 16)||0
3228103|NCT02326272|3959811|FG004|STARTED|Initial Period (Week 0 to Week 16)||0
3228104|NCT02326272|3959812|FG005|STARTED|Initial Period (Week 0 to Week 16)||0
3228105|NCT02326272|3959813|FG006|STARTED|Initial Period (Week 0 to Week 16)||0
3228106|NCT02326272|3959814|FG007|STARTED|Initial Period (Week 0 to Week 16)||0
3228107|NCT02326272|3959815|FG008|STARTED|Initial Period (Week 0 to Week 16)||0
3228108|NCT02326272|3959816|FG009|STARTED|Initial Period (Week 0 to Week 16)||0
3228109|NCT02326272|3959817|FG010|STARTED|Initial Period (Week 0 to Week 16)||0
3228110|NCT02326272|3959818|FG011|STARTED|Initial Period (Week 0 to Week 16)||0
3228111|NCT02326272|3959819|FG012|STARTED|Initial Period (Week 0 to Week 16)||0
3228112|NCT02326272|3959820|FG013|STARTED|Initial Period (Week 0 to Week 16)||0
3228113|NCT02326272|3959821|FG014|STARTED|Initial Period (Week 0 to Week 16)||0
3228114|NCT02326272|3959807|FG000|Completed Week 16|Initial Period (Week 0 to Week 16)||45
3228115|NCT02326272|3959808|FG001|Completed Week 16|Initial Period (Week 0 to Week 16)||84
3228116|NCT02326272|3959809|FG002|Completed Week 16|Initial Period (Week 0 to Week 16)||83
3228117|NCT02326272|3959810|FG003|Completed Week 16|Initial Period (Week 0 to Week 16)||0
3228118|NCT02326272|3959811|FG004|Completed Week 16|Initial Period (Week 0 to Week 16)||0
3228119|NCT02326272|3959812|FG005|Completed Week 16|Initial Period (Week 0 to Week 16)||0
3228120|NCT02326272|3959813|FG006|Completed Week 16|Initial Period (Week 0 to Week 16)||0
3228121|NCT02326272|3959814|FG007|Completed Week 16|Initial Period (Week 0 to Week 16)||0
3228122|NCT02326272|3959815|FG008|Completed Week 16|Initial Period (Week 0 to Week 16)||0
3228123|NCT02326272|3959816|FG009|Completed Week 16|Initial Period (Week 0 to Week 16)||0
3228124|NCT02326272|3959817|FG010|Completed Week 16|Initial Period (Week 0 to Week 16)||0
3228125|NCT02326272|3959818|FG011|Completed Week 16|Initial Period (Week 0 to Week 16)||0
3228126|NCT02326272|3959819|FG012|Completed Week 16|Initial Period (Week 0 to Week 16)||0
3228127|NCT02326272|3959820|FG013|Completed Week 16|Initial Period (Week 0 to Week 16)||0
3228128|NCT02326272|3959821|FG014|Completed Week 16|Initial Period (Week 0 to Week 16)||0
3228129|NCT02326272|3959807|FG000|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||45
3228130|NCT02326272|3959808|FG001|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||84
3228131|NCT02326272|3959809|FG002|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||81
3228132|NCT02326272|3959810|FG003|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
3228133|NCT02326272|3959811|FG004|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
3228134|NCT02326272|3959812|FG005|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
3228135|NCT02326272|3959813|FG006|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
3228136|NCT02326272|3959814|FG007|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
3228137|NCT02326272|3959815|FG008|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
3228138|NCT02326272|3959816|FG009|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
3228139|NCT02326272|3959817|FG010|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
3228140|NCT02326272|3959818|FG011|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
3368772|NCT03830307|4100331|FG000|NOT COMPLETED|Overall Study||0
3228141|NCT02326272|3959819|FG012|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
3228142|NCT02326272|3959820|FG013|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
3228143|NCT02326272|3959821|FG014|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
3228144|NCT02326272|3959807|FG000|COMPLETED|Initial Period (Week 0 to Week 16)||45
3228145|NCT02326272|3959808|FG001|COMPLETED|Initial Period (Week 0 to Week 16)||84
3228146|NCT02326272|3959809|FG002|COMPLETED|Initial Period (Week 0 to Week 16)||81
3228147|NCT02326272|3959810|FG003|COMPLETED|Initial Period (Week 0 to Week 16)||0
3228148|NCT02326272|3959811|FG004|COMPLETED|Initial Period (Week 0 to Week 16)||0
3228149|NCT02326272|3959812|FG005|COMPLETED|Initial Period (Week 0 to Week 16)||0
3228150|NCT02326272|3959813|FG006|COMPLETED|Initial Period (Week 0 to Week 16)||0
3228151|NCT02326272|3959814|FG007|COMPLETED|Initial Period (Week 0 to Week 16)||0
3228152|NCT02326272|3959815|FG008|COMPLETED|Initial Period (Week 0 to Week 16)||0
3228153|NCT02326272|3959816|FG009|COMPLETED|Initial Period (Week 0 to Week 16)||0
3228154|NCT02326272|3959817|FG010|COMPLETED|Initial Period (Week 0 to Week 16)||0
3228155|NCT02326272|3959818|FG011|COMPLETED|Initial Period (Week 0 to Week 16)||0
3228156|NCT02326272|3959819|FG012|COMPLETED|Initial Period (Week 0 to Week 16)||0
3228157|NCT02326272|3959820|FG013|COMPLETED|Initial Period (Week 0 to Week 16)||0
3228158|NCT02326272|3959821|FG014|COMPLETED|Initial Period (Week 0 to Week 16)||0
3228159|NCT02326272|3959807|FG000|NOT COMPLETED|Initial Period (Week 0 to Week 16)||4
3228160|NCT02326272|3959808|FG001|NOT COMPLETED|Initial Period (Week 0 to Week 16)||7
3228161|NCT02326272|3959809|FG002|NOT COMPLETED|Initial Period (Week 0 to Week 16)||6
3228162|NCT02326272|3959810|FG003|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
3228163|NCT02326272|3959811|FG004|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
3228164|NCT02326272|3959812|FG005|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
3228165|NCT02326272|3959813|FG006|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
3228166|NCT02326272|3959814|FG007|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
3228167|NCT02326272|3959815|FG008|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
3228168|NCT02326272|3959816|FG009|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
3228169|NCT02326272|3959817|FG010|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
3228170|NCT02326272|3959818|FG011|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
3228171|NCT02326272|3959819|FG012|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
3228172|NCT02326272|3959820|FG013|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
3228173|NCT02326272|3959821|FG014|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
3228174|NCT02326272|3959807|FG000|STARTED|Maintenance Period (Week 16 to Week 48)||0
3228175|NCT02326272|3959808|FG001|STARTED|Maintenance Period (Week 16 to Week 48)||0
3228176|NCT02326272|3959809|FG002|STARTED|Maintenance Period (Week 16 to Week 48)||0
3228177|NCT02326272|3959810|FG003|STARTED|Maintenance Period (Week 16 to Week 48)||6
3228178|NCT02326272|3959811|FG004|STARTED|Maintenance Period (Week 16 to Week 48)||5
3228179|NCT02326272|3959812|FG005|STARTED|Maintenance Period (Week 16 to Week 48)||76
3228180|NCT02326272|3959813|FG006|STARTED|Maintenance Period (Week 16 to Week 48)||69
3228181|NCT02326272|3959814|FG007|STARTED|Maintenance Period (Week 16 to Week 48)||34
3228182|NCT02326272|3959815|FG008|STARTED|Maintenance Period (Week 16 to Week 48)||8
3228183|NCT02326272|3959816|FG009|STARTED|Maintenance Period (Week 16 to Week 48)||12
3228184|NCT02326272|3959817|FG010|STARTED|Maintenance Period (Week 16 to Week 48)||0
3228185|NCT02326272|3959818|FG011|STARTED|Maintenance Period (Week 16 to Week 48)||0
3228186|NCT02326272|3959819|FG012|STARTED|Maintenance Period (Week 16 to Week 48)||0
3228187|NCT02326272|3959820|FG013|STARTED|Maintenance Period (Week 16 to Week 48)||0
3228188|NCT02326272|3959821|FG014|STARTED|Maintenance Period (Week 16 to Week 48)||0
3228189|NCT02326272|3959807|FG000|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
3228190|NCT02326272|3959808|FG001|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
3228191|NCT02326272|3959809|FG002|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
3228192|NCT02326272|3959810|FG003|Completed Week 48|Maintenance Period (Week 16 to Week 48)||5
3228193|NCT02326272|3959811|FG004|Completed Week 48|Maintenance Period (Week 16 to Week 48)||3
3228194|NCT02326272|3959812|FG005|Completed Week 48|Maintenance Period (Week 16 to Week 48)||64
3228195|NCT02326272|3959813|FG006|Completed Week 48|Maintenance Period (Week 16 to Week 48)||61
3228196|NCT02326272|3959814|FG007|Completed Week 48|Maintenance Period (Week 16 to Week 48)||27
3228197|NCT02326272|3959815|FG008|Completed Week 48|Maintenance Period (Week 16 to Week 48)||3
3228198|NCT02326272|3959816|FG009|Completed Week 48|Maintenance Period (Week 16 to Week 48)||10
3228199|NCT02326272|3959817|FG010|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
3228200|NCT02326272|3959818|FG011|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
3228201|NCT02326272|3959819|FG012|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
3228202|NCT02326272|3959820|FG013|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
3228203|NCT02326272|3959821|FG014|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
3228204|NCT02326272|3959807|FG000|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
3228205|NCT02326272|3959808|FG001|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
3228206|NCT02326272|3959809|FG002|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
3228207|NCT02326272|3959810|FG003|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||5
3228208|NCT02326272|3959811|FG004|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||3
3228209|NCT02326272|3959812|FG005|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||63
3228210|NCT02326272|3959813|FG006|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||60
3368773|NCT03825042|4100337|FG000|STARTED|Overall Study||40
3228211|NCT02326272|3959814|FG007|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||27
3228212|NCT02326272|3959815|FG008|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||3
3228213|NCT02326272|3959816|FG009|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||10
3228214|NCT02326272|3959817|FG010|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
3228215|NCT02326272|3959818|FG011|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
3228216|NCT02326272|3959819|FG012|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
3228217|NCT02326272|3959820|FG013|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
3228218|NCT02326272|3959821|FG014|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
3228219|NCT02326272|3959807|FG000|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
3228220|NCT02326272|3959808|FG001|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
3228221|NCT02326272|3959809|FG002|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
3228222|NCT02326272|3959810|FG003|COMPLETED|Maintenance Period (Week 16 to Week 48)||5
3228223|NCT02326272|3959811|FG004|COMPLETED|Maintenance Period (Week 16 to Week 48)||3
3228224|NCT02326272|3959812|FG005|COMPLETED|Maintenance Period (Week 16 to Week 48)||63
3228225|NCT02326272|3959813|FG006|COMPLETED|Maintenance Period (Week 16 to Week 48)||60
3228226|NCT02326272|3959814|FG007|COMPLETED|Maintenance Period (Week 16 to Week 48)||27
3228227|NCT02326272|3959815|FG008|COMPLETED|Maintenance Period (Week 16 to Week 48)||3
3228228|NCT02326272|3959816|FG009|COMPLETED|Maintenance Period (Week 16 to Week 48)||10
3228229|NCT02326272|3959817|FG010|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
3228230|NCT02326272|3959818|FG011|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
3228231|NCT02326272|3959819|FG012|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
3228232|NCT02326272|3959820|FG013|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
3228233|NCT02326272|3959821|FG014|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
3228234|NCT02326272|3959807|FG000|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
3228235|NCT02326272|3959808|FG001|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
3228236|NCT02326272|3959809|FG002|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
3228237|NCT02326272|3959810|FG003|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||1
3228238|NCT02326272|3959811|FG004|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||2
3228239|NCT02326272|3959812|FG005|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||13
3228240|NCT02326272|3959813|FG006|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||9
3228241|NCT02326272|3959814|FG007|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||7
3228242|NCT02326272|3959815|FG008|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||5
3228243|NCT02326272|3959816|FG009|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||2
3228244|NCT02326272|3959817|FG010|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
3228245|NCT02326272|3959818|FG011|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
3228246|NCT02326272|3959819|FG012|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
3228247|NCT02326272|3959820|FG013|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
3228248|NCT02326272|3959821|FG014|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
3228249|NCT02326272|3959807|FG000|STARTED|Open-label Period (Week 48 to Week 144)||0
3228250|NCT02326272|3959808|FG001|STARTED|Open-label Period (Week 48 to Week 144)||0
3228251|NCT02326272|3959809|FG002|STARTED|Open-label Period (Week 48 to Week 144)||0
3228252|NCT02326272|3959810|FG003|STARTED|Open-label Period (Week 48 to Week 144)||0
3228253|NCT02326272|3959811|FG004|STARTED|Open-label Period (Week 48 to Week 144)||0
3228254|NCT02326272|3959812|FG005|STARTED|Open-label Period (Week 48 to Week 144)||0
3228255|NCT02326272|3959813|FG006|STARTED|Open-label Period (Week 48 to Week 144)||0
3228256|NCT02326272|3959814|FG007|STARTED|Open-label Period (Week 48 to Week 144)||0
3228257|NCT02326272|3959815|FG008|STARTED|Open-label Period (Week 48 to Week 144)||0
3228258|NCT02326272|3959816|FG009|STARTED|Open-label Period (Week 48 to Week 144)||0
3228259|NCT02326272|3959817|FG010|STARTED|Open-label Period (Week 48 to Week 144)||5
3228260|NCT02326272|3959818|FG011|STARTED|Open-label Period (Week 48 to Week 144)||66
3228261|NCT02326272|3959819|FG012|STARTED|Open-label Period (Week 48 to Week 144)||59
3228262|NCT02326272|3959820|FG013|STARTED|Open-label Period (Week 48 to Week 144)||1
3228263|NCT02326272|3959821|FG014|STARTED|Open-label Period (Week 48 to Week 144)||40
3228264|NCT02326272|3959807|FG000|COMPLETED|Open-label Period (Week 48 to Week 144)||0
3228265|NCT02326272|3959808|FG001|COMPLETED|Open-label Period (Week 48 to Week 144)||0
3228266|NCT02326272|3959809|FG002|COMPLETED|Open-label Period (Week 48 to Week 144)||0
3228267|NCT02326272|3959810|FG003|COMPLETED|Open-label Period (Week 48 to Week 144)||0
3228268|NCT02326272|3959811|FG004|COMPLETED|Open-label Period (Week 48 to Week 144)||0
3228269|NCT02326272|3959812|FG005|COMPLETED|Open-label Period (Week 48 to Week 144)||0
3228270|NCT02326272|3959813|FG006|COMPLETED|Open-label Period (Week 48 to Week 144)||0
3228271|NCT02326272|3959814|FG007|COMPLETED|Open-label Period (Week 48 to Week 144)||0
3228272|NCT02326272|3959815|FG008|COMPLETED|Open-label Period (Week 48 to Week 144)||0
3228273|NCT02326272|3959816|FG009|COMPLETED|Open-label Period (Week 48 to Week 144)||0
3228274|NCT02326272|3959817|FG010|COMPLETED|Open-label Period (Week 48 to Week 144)||2
3228275|NCT02326272|3959818|FG011|COMPLETED|Open-label Period (Week 48 to Week 144)||51
3228276|NCT02326272|3959819|FG012|COMPLETED|Open-label Period (Week 48 to Week 144)||48
3228277|NCT02326272|3959820|FG013|COMPLETED|Open-label Period (Week 48 to Week 144)||1
3228278|NCT02326272|3959821|FG014|COMPLETED|Open-label Period (Week 48 to Week 144)||31
3228279|NCT02326272|3959807|FG000|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
3228280|NCT02326272|3959808|FG001|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
3228281|NCT02326272|3959809|FG002|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
3228282|NCT02326272|3959810|FG003|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
3228283|NCT02326272|3959811|FG004|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
3228284|NCT02326272|3959812|FG005|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
3228285|NCT02326272|3959813|FG006|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
3228286|NCT02326272|3959814|FG007|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
3228287|NCT02326272|3959815|FG008|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
3228288|NCT02326272|3959816|FG009|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
3228289|NCT02326272|3959817|FG010|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||3
3228290|NCT02326272|3959818|FG011|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||15
3228291|NCT02326272|3959819|FG012|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||11
3228292|NCT02326272|3959820|FG013|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
3228293|NCT02326272|3959821|FG014|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||9
3228294|NCT02326298|3959833|FG000|STARTED|Initial Period (Week 0 to Week 16)||51
3228295|NCT02326298|3959834|FG001|STARTED|Initial Period (Week 0 to Week 16)||95
3228296|NCT02326298|3959835|FG002|STARTED|Initial Period (Week 0 to Week 16)||88
3228297|NCT02326298|3959836|FG003|STARTED|Initial Period (Week 0 to Week 16)||0
3228298|NCT02326298|3959837|FG004|STARTED|Initial Period (Week 0 to Week 16)||0
3228299|NCT02326298|3959838|FG005|STARTED|Initial Period (Week 0 to Week 16)||0
3228300|NCT02326298|3959839|FG006|STARTED|Initial Period (Week 0 to Week 16)||0
3228301|NCT02326298|3959840|FG007|STARTED|Initial Period (Week 0 to Week 16)||0
3228302|NCT02326298|3959841|FG008|STARTED|Initial Period (Week 0 to Week 16)||0
3228303|NCT02326298|3959842|FG009|STARTED|Initial Period (Week 0 to Week 16)||0
3228304|NCT02326298|3959843|FG010|STARTED|Initial Period (Week 0 to Week 16)||0
3228305|NCT02326298|3959844|FG011|STARTED|Initial Period (Week 0 to Week 16)||0
3228306|NCT02326298|3959845|FG012|STARTED|Initial Period (Week 0 to Week 16)||0
3228307|NCT02326298|3959846|FG013|STARTED|Initial Period (Week 0 to Week 16)||0
3228308|NCT02326298|3959833|FG000|Completed Week 16|Initial Period (Week 0 to Week 16)||46
3228309|NCT02326298|3959834|FG001|Completed Week 16|Initial Period (Week 0 to Week 16)||92
3228310|NCT02326298|3959835|FG002|Completed Week 16|Initial Period (Week 0 to Week 16)||87
3228311|NCT02326298|3959836|FG003|Completed Week 16|Initial Period (Week 0 to Week 16)||0
3228312|NCT02326298|3959837|FG004|Completed Week 16|Initial Period (Week 0 to Week 16)||0
3228313|NCT02326298|3959838|FG005|Completed Week 16|Initial Period (Week 0 to Week 16)||0
3228314|NCT02326298|3959839|FG006|Completed Week 16|Initial Period (Week 0 to Week 16)||0
3228315|NCT02326298|3959840|FG007|Completed Week 16|Initial Period (Week 0 to Week 16)||0
3228316|NCT02326298|3959841|FG008|Completed Week 16|Initial Period (Week 0 to Week 16)||0
3228317|NCT02326298|3959842|FG009|Completed Week 16|Initial Period (Week 0 to Week 16)||0
3228318|NCT02326298|3959843|FG010|Completed Week 16|Initial Period (Week 0 to Week 16)||0
3228319|NCT02326298|3959844|FG011|Completed Week 16|Initial Period (Week 0 to Week 16)||0
3228320|NCT02326298|3959845|FG012|Completed Week 16|Initial Period (Week 0 to Week 16)||0
3228321|NCT02326298|3959846|FG013|Completed Week 16|Initial Period (Week 0 to Week 16)||0
3228322|NCT02326298|3959833|FG000|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||46
3228323|NCT02326298|3959834|FG001|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||92
3228324|NCT02326298|3959835|FG002|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||85
3228325|NCT02326298|3959836|FG003|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
3228326|NCT02326298|3959837|FG004|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
3228327|NCT02326298|3959838|FG005|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
3228328|NCT02326298|3959839|FG006|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
3228329|NCT02326298|3959840|FG007|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
3228330|NCT02326298|3959841|FG008|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
3228331|NCT02326298|3959842|FG009|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
3228332|NCT02326298|3959843|FG010|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
3228333|NCT02326298|3959844|FG011|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
3228334|NCT02326298|3959845|FG012|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
3228335|NCT02326298|3959846|FG013|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
3228336|NCT02326298|3959833|FG000|COMPLETED|Initial Period (Week 0 to Week 16)||46
3228337|NCT02326298|3959834|FG001|COMPLETED|Initial Period (Week 0 to Week 16)||92
3228338|NCT02326298|3959835|FG002|COMPLETED|Initial Period (Week 0 to Week 16)||85
3228339|NCT02326298|3959836|FG003|COMPLETED|Initial Period (Week 0 to Week 16)||0
3228340|NCT02326298|3959837|FG004|COMPLETED|Initial Period (Week 0 to Week 16)||0
3228341|NCT02326298|3959838|FG005|COMPLETED|Initial Period (Week 0 to Week 16)||0
3228342|NCT02326298|3959839|FG006|COMPLETED|Initial Period (Week 0 to Week 16)||0
3228343|NCT02326298|3959840|FG007|COMPLETED|Initial Period (Week 0 to Week 16)||0
3228344|NCT02326298|3959841|FG008|COMPLETED|Initial Period (Week 0 to Week 16)||0
3228345|NCT02326298|3959842|FG009|COMPLETED|Initial Period (Week 0 to Week 16)||0
3228346|NCT02326298|3959843|FG010|COMPLETED|Initial Period (Week 0 to Week 16)||0
3228347|NCT02326298|3959844|FG011|COMPLETED|Initial Period (Week 0 to Week 16)||0
3228348|NCT02326298|3959845|FG012|COMPLETED|Initial Period (Week 0 to Week 16)||0
3228349|NCT02326298|3959846|FG013|COMPLETED|Initial Period (Week 0 to Week 16)||0
3228350|NCT02326298|3959833|FG000|NOT COMPLETED|Initial Period (Week 0 to Week 16)||5
3228351|NCT02326298|3959834|FG001|NOT COMPLETED|Initial Period (Week 0 to Week 16)||3
3228352|NCT02326298|3959835|FG002|NOT COMPLETED|Initial Period (Week 0 to Week 16)||3
3228353|NCT02326298|3959836|FG003|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
3228354|NCT02326298|3959837|FG004|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
3228355|NCT02326298|3959838|FG005|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
3228356|NCT02326298|3959839|FG006|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
3228357|NCT02326298|3959840|FG007|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
3228358|NCT02326298|3959841|FG008|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
3228359|NCT02326298|3959842|FG009|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
3228360|NCT02326298|3959843|FG010|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
3228361|NCT02326298|3959844|FG011|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
3228362|NCT02326298|3959845|FG012|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
3228363|NCT02326298|3959846|FG013|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
3228364|NCT02326298|3959833|FG000|STARTED|Maintenance Period (Week 16 to Week 48)||0
3228365|NCT02326298|3959834|FG001|STARTED|Maintenance Period (Week 16 to Week 48)||0
3228366|NCT02326298|3959835|FG002|STARTED|Maintenance Period (Week 16 to Week 48)||0
3228367|NCT02326298|3959836|FG003|STARTED|Maintenance Period (Week 16 to Week 48)||3
3228368|NCT02326298|3959837|FG004|STARTED|Maintenance Period (Week 16 to Week 48)||5
3228369|NCT02326298|3959838|FG005|STARTED|Maintenance Period (Week 16 to Week 48)||74
3228370|NCT02326298|3959839|FG006|STARTED|Maintenance Period (Week 16 to Week 48)||77
3228371|NCT02326298|3959840|FG007|STARTED|Maintenance Period (Week 16 to Week 48)||38
3228372|NCT02326298|3959841|FG008|STARTED|Maintenance Period (Week 16 to Week 48)||18
3228373|NCT02326298|3959842|FG009|STARTED|Maintenance Period (Week 16 to Week 48)||8
3228374|NCT02326298|3959843|FG010|STARTED|Maintenance Period (Week 16 to Week 48)||0
3228375|NCT02326298|3959844|FG011|STARTED|Maintenance Period (Week 16 to Week 48)||0
3228376|NCT02326298|3959845|FG012|STARTED|Maintenance Period (Week 16 to Week 48)||0
3228377|NCT02326298|3959846|FG013|STARTED|Maintenance Period (Week 16 to Week 48)||0
3228378|NCT02326298|3959833|FG000|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
3228379|NCT02326298|3959834|FG001|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
3228380|NCT02326298|3959835|FG002|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
3228381|NCT02326298|3959836|FG003|Completed Week 48|Maintenance Period (Week 16 to Week 48)||3
3228382|NCT02326298|3959837|FG004|Completed Week 48|Maintenance Period (Week 16 to Week 48)||5
3228383|NCT02326298|3959838|FG005|Completed Week 48|Maintenance Period (Week 16 to Week 48)||71
3228384|NCT02326298|3959839|FG006|Completed Week 48|Maintenance Period (Week 16 to Week 48)||70
3228385|NCT02326298|3959840|FG007|Completed Week 48|Maintenance Period (Week 16 to Week 48)||33
3228386|NCT02326298|3959841|FG008|Completed Week 48|Maintenance Period (Week 16 to Week 48)||13
3228387|NCT02326298|3959842|FG009|Completed Week 48|Maintenance Period (Week 16 to Week 48)||7
3228388|NCT02326298|3959843|FG010|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
3228389|NCT02326298|3959844|FG011|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
3228390|NCT02326298|3959845|FG012|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
3228391|NCT02326298|3959846|FG013|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
3228392|NCT02326298|3959833|FG000|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
3228393|NCT02326298|3959834|FG001|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
3228394|NCT02326298|3959835|FG002|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
3228395|NCT02326298|3959836|FG003|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||3
3228396|NCT02326298|3959837|FG004|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||5
3228397|NCT02326298|3959838|FG005|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||69
3228398|NCT02326298|3959839|FG006|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||70
3228399|NCT02326298|3959840|FG007|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||33
3228400|NCT02326298|3959841|FG008|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||13
3228401|NCT02326298|3959842|FG009|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||7
3228402|NCT02326298|3959843|FG010|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
3228403|NCT02326298|3959844|FG011|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
3228404|NCT02326298|3959845|FG012|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
3228405|NCT02326298|3959846|FG013|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
3228406|NCT02326298|3959833|FG000|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
3228407|NCT02326298|3959834|FG001|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
3228408|NCT02326298|3959835|FG002|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
3228409|NCT02326298|3959836|FG003|COMPLETED|Maintenance Period (Week 16 to Week 48)||3
3228410|NCT02326298|3959837|FG004|COMPLETED|Maintenance Period (Week 16 to Week 48)||5
3228411|NCT02326298|3959838|FG005|COMPLETED|Maintenance Period (Week 16 to Week 48)||69
3228412|NCT02326298|3959839|FG006|COMPLETED|Maintenance Period (Week 16 to Week 48)||70
3228413|NCT02326298|3959840|FG007|COMPLETED|Maintenance Period (Week 16 to Week 48)||33
3228414|NCT02326298|3959841|FG008|COMPLETED|Maintenance Period (Week 16 to Week 48)||13
3228415|NCT02326298|3959842|FG009|COMPLETED|Maintenance Period (Week 16 to Week 48)||7
3228416|NCT02326298|3959843|FG010|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
3228417|NCT02326298|3959844|FG011|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
3228418|NCT02326298|3959845|FG012|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
3368774|NCT03825042|4100338|FG001|STARTED|Overall Study||40
3228419|NCT02326298|3959846|FG013|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
3228420|NCT02326298|3959833|FG000|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
3228421|NCT02326298|3959834|FG001|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
3228422|NCT02326298|3959835|FG002|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
3228423|NCT02326298|3959836|FG003|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
3228424|NCT02326298|3959837|FG004|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
3228425|NCT02326298|3959838|FG005|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||5
3228426|NCT02326298|3959839|FG006|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||7
3228427|NCT02326298|3959840|FG007|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||5
3228428|NCT02326298|3959841|FG008|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||5
3228429|NCT02326298|3959842|FG009|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||1
3228430|NCT02326298|3959843|FG010|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
3228431|NCT02326298|3959844|FG011|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
3228432|NCT02326298|3959845|FG012|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
3228433|NCT02326298|3959846|FG013|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
3228434|NCT02326298|3959833|FG000|STARTED|Open-label Period (Week 48 to Week 144)||0
3228435|NCT02326298|3959834|FG001|STARTED|Open-label Period (Week 48 to Week 144)||0
3228436|NCT02326298|3959835|FG002|STARTED|Open-label Period (Week 48 to Week 144)||0
3228437|NCT02326298|3959836|FG003|STARTED|Open-label Period (Week 48 to Week 144)||0
3228438|NCT02326298|3959837|FG004|STARTED|Open-label Period (Week 48 to Week 144)||0
3228439|NCT02326298|3959838|FG005|STARTED|Open-label Period (Week 48 to Week 144)||0
3228440|NCT02326298|3959839|FG006|STARTED|Open-label Period (Week 48 to Week 144)||0
3228441|NCT02326298|3959840|FG007|STARTED|Open-label Period (Week 48 to Week 144)||0
3228442|NCT02326298|3959841|FG008|STARTED|Open-label Period (Week 48 to Week 144)||0
3228443|NCT02326298|3959842|FG009|STARTED|Open-label Period (Week 48 to Week 144)||0
3228444|NCT02326298|3959843|FG010|STARTED|Open-label Period (Week 48 to Week 144)||3
3228445|NCT02326298|3959844|FG011|STARTED|Open-label Period (Week 48 to Week 144)||74
3228446|NCT02326298|3959845|FG012|STARTED|Open-label Period (Week 48 to Week 144)||70
3228447|NCT02326298|3959846|FG013|STARTED|Open-label Period (Week 48 to Week 144)||53
3228448|NCT02326298|3959833|FG000|COMPLETED|Open-label Period (Week 48 to Week 144)||0
3228449|NCT02326298|3959834|FG001|COMPLETED|Open-label Period (Week 48 to Week 144)||0
3228450|NCT02326298|3959835|FG002|COMPLETED|Open-label Period (Week 48 to Week 144)||0
3228451|NCT02326298|3959836|FG003|COMPLETED|Open-label Period (Week 48 to Week 144)||0
3228452|NCT02326298|3959837|FG004|COMPLETED|Open-label Period (Week 48 to Week 144)||0
3228453|NCT02326298|3959838|FG005|COMPLETED|Open-label Period (Week 48 to Week 144)||0
3228454|NCT02326298|3959839|FG006|COMPLETED|Open-label Period (Week 48 to Week 144)||0
3228455|NCT02326298|3959840|FG007|COMPLETED|Open-label Period (Week 48 to Week 144)||0
3228456|NCT02326298|3959841|FG008|COMPLETED|Open-label Period (Week 48 to Week 144)||0
3228457|NCT02326298|3959842|FG009|COMPLETED|Open-label Period (Week 48 to Week 144)||0
3228458|NCT02326298|3959843|FG010|COMPLETED|Open-label Period (Week 48 to Week 144)||3
3228459|NCT02326298|3959844|FG011|COMPLETED|Open-label Period (Week 48 to Week 144)||54
3228460|NCT02326298|3959845|FG012|COMPLETED|Open-label Period (Week 48 to Week 144)||51
3228461|NCT02326298|3959846|FG013|COMPLETED|Open-label Period (Week 48 to Week 144)||44
3228462|NCT02326298|3959833|FG000|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
3228463|NCT02326298|3959834|FG001|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
3228464|NCT02326298|3959835|FG002|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
3228465|NCT02326298|3959836|FG003|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
3228466|NCT02326298|3959837|FG004|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
3228467|NCT02326298|3959838|FG005|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
3228468|NCT02326298|3959839|FG006|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
3228469|NCT02326298|3959840|FG007|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
3228470|NCT02326298|3959841|FG008|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
3228471|NCT02326298|3959842|FG009|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
3228472|NCT02326298|3959843|FG010|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
3228473|NCT02326298|3959844|FG011|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||20
3228474|NCT02326298|3959845|FG012|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||19
3228475|NCT02326298|3959846|FG013|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||9
3228476|NCT02326363|3959857|FG000|STARTED|Overall Study||98
3228477|NCT02326363|3959858|FG001|STARTED|Overall Study||106
3228478|NCT02326363|3959857|FG000|COMPLETED|Overall Study||47
3228479|NCT02326363|3959858|FG001|COMPLETED|Overall Study||50
3228480|NCT02326363|3959857|FG000|NOT COMPLETED|Overall Study||51
3228481|NCT02326363|3959858|FG001|NOT COMPLETED|Overall Study||56
3228482|NCT02326467|3959866|FG000|STARTED|Overall Study||10
3228483|NCT02326467|3959866|FG000|COMPLETED|Overall Study||9
3228484|NCT02326467|3959866|FG000|NOT COMPLETED|Overall Study||1
3228485|NCT02326597|3959873|FG000|STARTED|Overall Study||60
3228486|NCT02326597|3959874|FG001|STARTED|Overall Study||60
3228487|NCT02326597|3959873|FG000|COMPLETED|Overall Study||18
3228488|NCT02326597|3959874|FG001|COMPLETED|Overall Study||28
3228489|NCT02326597|3959873|FG000|NOT COMPLETED|Overall Study||42
3228490|NCT02326597|3959874|FG001|NOT COMPLETED|Overall Study||32
3228491|NCT02326649|3959882|FG000|STARTED|Overall Study||33
3228492|NCT02326649|3959882|FG000|COMPLETED|Overall Study||21
3228493|NCT02326649|3959882|FG000|NOT COMPLETED|Overall Study||12
3228494|NCT02326805|3959888|FG000|STARTED|Overall Study||106
3228495|NCT02326805|3959889|FG001|STARTED|Overall Study||48
3228496|NCT02326805|3959888|FG000|COMPLETED|Overall Study||103
3228497|NCT02326805|3959889|FG001|COMPLETED|Overall Study||47
3228498|NCT02326805|3959888|FG000|NOT COMPLETED|Overall Study||3
3228499|NCT02326805|3959889|FG001|NOT COMPLETED|Overall Study||1
3228500|NCT02326844|3959895|FG000|STARTED|Overall Study||3
3228501|NCT02326844|3959895|FG000|COMPLETED|Overall Study||3
3228502|NCT02326844|3959895|FG000|NOT COMPLETED|Overall Study||0
3228503|NCT02326883|3959902|FG000|STARTED|Overall Study||6314
3228504|NCT02326883|3959903|FG001|STARTED|Overall Study||6312
3228505|NCT02326883|3959904|FG002|STARTED|Overall Study||6256
3228506|NCT02326883|3959902|FG000|COMPLETED|Overall Study||6230
3228507|NCT02326883|3959903|FG001|COMPLETED|Overall Study||6227
3228508|NCT02326883|3959904|FG002|COMPLETED|Overall Study||6187
3228509|NCT02326883|3959902|FG000|NOT COMPLETED|Overall Study||84
3228510|NCT02326883|3959903|FG001|NOT COMPLETED|Overall Study||85
3228511|NCT02326883|3959904|FG002|NOT COMPLETED|Overall Study||69
3228512|NCT02326974|3959912|FG000|STARTED|Overall Study||164
3228513|NCT02326974|3959912|FG000|Treated|Overall Study||163
3228514|NCT02326974|3959912|FG000|COMPLETED|Overall Study||157
3228515|NCT02326974|3959912|FG000|NOT COMPLETED|Overall Study||7
3228516|NCT02327013|3959923|FG000|STARTED|Overall Study||49
3228517|NCT02327013|3959924|FG001|STARTED|Overall Study||45
3228518|NCT02327013|3959925|FG002|STARTED|Overall Study||96
3228519|NCT02327013|3959926|FG003|STARTED|Overall Study||21
3228520|NCT02327013|3959927|FG004|STARTED|Overall Study||16
3228521|NCT02327013|3959923|FG000|COMPLETED|Overall Study||36
3228522|NCT02327013|3959924|FG001|COMPLETED|Overall Study||29
3228523|NCT02327013|3959925|FG002|COMPLETED|Overall Study||54
3228524|NCT02327013|3959926|FG003|COMPLETED|Overall Study||20
3228525|NCT02327013|3959927|FG004|COMPLETED|Overall Study||12
3228526|NCT02327013|3959923|FG000|NOT COMPLETED|Overall Study||13
3228527|NCT02327013|3959924|FG001|NOT COMPLETED|Overall Study||16
3228528|NCT02327013|3959925|FG002|NOT COMPLETED|Overall Study||42
3228529|NCT02327013|3959926|FG003|NOT COMPLETED|Overall Study||1
3228530|NCT02327013|3959927|FG004|NOT COMPLETED|Overall Study||4
3228531|NCT02327052|3959947|FG000|STARTED|Overall Study||58
3228532|NCT02327052|3959947|FG000|COMPLETED|Overall Study||58
3228533|NCT02327052|3959947|FG000|NOT COMPLETED|Overall Study||0
3228534|NCT02327117|3959953|FG000|STARTED|Overall Study||45
3228535|NCT02327117|3959954|FG001|STARTED|Overall Study||45
3228536|NCT02327117|3959953|FG000|COMPLETED|Overall Study||45
3228537|NCT02327117|3959954|FG001|COMPLETED|Overall Study||45
3228538|NCT02327117|3959953|FG000|NOT COMPLETED|Overall Study||0
3228539|NCT02327117|3959954|FG001|NOT COMPLETED|Overall Study||0
3228540|NCT02327130|3959960|FG000|STARTED|Overall Study||32
3228541|NCT02327130|3959960|FG000|COMPLETED|Overall Study||20
3228542|NCT02327130|3959960|FG000|NOT COMPLETED|Overall Study||12
3228543|NCT02327143|3959967|FG000|STARTED|Day 1: Time 0 Hrs to 6 Hrs||11
3228544|NCT02327143|3959968|FG001|STARTED|Day 1: Time 0 Hrs to 6 Hrs||0
3228545|NCT02327143|3959967|FG000|COMPLETED|Day 1: Time 0 Hrs to 6 Hrs||11
3228546|NCT02327143|3959968|FG001|COMPLETED|Day 1: Time 0 Hrs to 6 Hrs||0
3228547|NCT02327143|3959967|FG000|NOT COMPLETED|Day 1: Time 0 Hrs to 6 Hrs||0
3228548|NCT02327143|3959968|FG001|NOT COMPLETED|Day 1: Time 0 Hrs to 6 Hrs||0
3228549|NCT02327143|3959967|FG000|STARTED|Day 1: Time 6 Hrs - to Day 9||0
3228550|NCT02327143|3959968|FG001|STARTED|Day 1: Time 6 Hrs - to Day 9||11
3228551|NCT02327143|3959967|FG000|COMPLETED|Day 1: Time 6 Hrs - to Day 9||0
3228552|NCT02327143|3959968|FG001|COMPLETED|Day 1: Time 6 Hrs - to Day 9||11
3228553|NCT02327143|3959967|FG000|NOT COMPLETED|Day 1: Time 6 Hrs - to Day 9||0
3228554|NCT02327143|3959968|FG001|NOT COMPLETED|Day 1: Time 6 Hrs - to Day 9||0
3228555|NCT02327169|3959989|FG000|STARTED|Overall Study||4
3228556|NCT02327169|3959990|FG001|STARTED|Overall Study||3
3228557|NCT02327169|3959991|FG002|STARTED|Overall Study||7
3228558|NCT02327169|3959992|FG003|STARTED|Overall Study||3
3228559|NCT02327169|3959993|FG004|STARTED|Overall Study||8
3228560|NCT02327169|3959994|FG005|STARTED|Overall Study||4
3228561|NCT02327169|3959995|FG006|STARTED|Overall Study||3
3228562|NCT02327169|3959996|FG007|STARTED|Overall Study||4
3228563|NCT02327169|3959997|FG008|STARTED|Overall Study||6
3228564|NCT02327169|3959998|FG009|STARTED|Overall Study||8
3228565|NCT02327169|3959999|FG010|STARTED|Overall Study||6
3228566|NCT02327169|3960000|FG011|STARTED|Overall Study||7
3228567|NCT02327169|3960001|FG012|STARTED|Overall Study||1
3228568|NCT02327169|3960002|FG013|STARTED|Overall Study||7
3228569|NCT02327169|3960003|FG014|STARTED|Overall Study||10
3228570|NCT02327169|3959989|FG000|COMPLETED|Overall Study||0
3228571|NCT02327169|3959990|FG001|COMPLETED|Overall Study||0
3228572|NCT02327169|3959991|FG002|COMPLETED|Overall Study||0
3228573|NCT02327169|3959992|FG003|COMPLETED|Overall Study||0
3228574|NCT02327169|3959993|FG004|COMPLETED|Overall Study||0
3228575|NCT02327169|3959994|FG005|COMPLETED|Overall Study||0
3228576|NCT02327169|3959995|FG006|COMPLETED|Overall Study||0
3228577|NCT02327169|3959996|FG007|COMPLETED|Overall Study||0
3228578|NCT02327169|3959997|FG008|COMPLETED|Overall Study||0
3228579|NCT02327169|3959998|FG009|COMPLETED|Overall Study||0
3228580|NCT02327169|3959999|FG010|COMPLETED|Overall Study||0
3228581|NCT02327169|3960000|FG011|COMPLETED|Overall Study||0
3228582|NCT02327169|3960001|FG012|COMPLETED|Overall Study||0
3228583|NCT02327169|3960002|FG013|COMPLETED|Overall Study||0
3228584|NCT02327169|3960003|FG014|COMPLETED|Overall Study||0
3228585|NCT02327169|3959989|FG000|NOT COMPLETED|Overall Study||4
3228586|NCT02327169|3959990|FG001|NOT COMPLETED|Overall Study||3
3228587|NCT02327169|3959991|FG002|NOT COMPLETED|Overall Study||7
3228588|NCT02327169|3959992|FG003|NOT COMPLETED|Overall Study||3
3228589|NCT02327169|3959993|FG004|NOT COMPLETED|Overall Study||8
3228590|NCT02327169|3959994|FG005|NOT COMPLETED|Overall Study||4
3228591|NCT02327169|3959995|FG006|NOT COMPLETED|Overall Study||3
3228592|NCT02327169|3959996|FG007|NOT COMPLETED|Overall Study||4
3228593|NCT02327169|3959997|FG008|NOT COMPLETED|Overall Study||6
3228594|NCT02327169|3959998|FG009|NOT COMPLETED|Overall Study||8
3228595|NCT02327169|3959999|FG010|NOT COMPLETED|Overall Study||6
3228596|NCT02327169|3960000|FG011|NOT COMPLETED|Overall Study||7
3228597|NCT02327169|3960001|FG012|NOT COMPLETED|Overall Study||1
3228598|NCT02327169|3960002|FG013|NOT COMPLETED|Overall Study||7
3228599|NCT02327169|3960003|FG014|NOT COMPLETED|Overall Study||10
3228600|NCT02327260|3960048|FG000|STARTED|Overall Study||20
3228601|NCT02327260|3960049|FG001|STARTED|Overall Study||24
3228602|NCT02327260|3960050|FG002|STARTED|Overall Study||17
3228603|NCT02327260|3960048|FG000|COMPLETED|Overall Study||14
3228604|NCT02327260|3960049|FG001|COMPLETED|Overall Study||20
3228605|NCT02327260|3960050|FG002|COMPLETED|Overall Study||15
3228606|NCT02327260|3960048|FG000|NOT COMPLETED|Overall Study||6
3228607|NCT02327260|3960049|FG001|NOT COMPLETED|Overall Study||4
3228608|NCT02327260|3960050|FG002|NOT COMPLETED|Overall Study||2
3228609|NCT02327325|3960062|FG000|STARTED|Overall Study||20
3228610|NCT02327325|3960063|FG001|STARTED|Overall Study||20
3228611|NCT02327325|3960064|FG002|STARTED|Overall Study||20
3228612|NCT02327325|3960062|FG000|COMPLETED|Overall Study||19
3228613|NCT02327325|3960063|FG001|COMPLETED|Overall Study||16
3228614|NCT02327325|3960064|FG002|COMPLETED|Overall Study||15
3228615|NCT02327325|3960062|FG000|NOT COMPLETED|Overall Study||1
3228616|NCT02327325|3960063|FG001|NOT COMPLETED|Overall Study||4
3228617|NCT02327325|3960064|FG002|NOT COMPLETED|Overall Study||5
3228618|NCT02327351|3960072|FG000|STARTED|Overall Study||98
3228619|NCT02327351|3960072|FG000|COMPLETED|Overall Study||98
3228620|NCT02327351|3960072|FG000|NOT COMPLETED|Overall Study||0
3228621|NCT02327429|3960080|FG000|STARTED|Overall Study||19
3228622|NCT02327429|3960080|FG000|COMPLETED|Overall Study||17
3228623|NCT02327429|3960080|FG000|NOT COMPLETED|Overall Study||2
3228624|NCT02327741|3960086|FG000|STARTED|Overall Study||502
3228625|NCT02327741|3960087|FG001|STARTED|Overall Study||508
3228626|NCT02327741|3960086|FG000|COMPLETED|Overall Study||502
3228627|NCT02327741|3960087|FG001|COMPLETED|Overall Study||508
3228628|NCT02327741|3960086|FG000|NOT COMPLETED|Overall Study||0
3228629|NCT02327741|3960087|FG001|NOT COMPLETED|Overall Study||0
3228630|NCT02328027|3960095|FG000|STARTED|Overall Study||5
3228631|NCT02328027|3960096|FG001|STARTED|Overall Study||11
3228632|NCT02328027|3960095|FG000|COMPLETED|Overall Study||5
3228633|NCT02328027|3960096|FG001|COMPLETED|Overall Study||10
3228634|NCT02328027|3960095|FG000|NOT COMPLETED|Overall Study||0
3228635|NCT02328027|3960096|FG001|NOT COMPLETED|Overall Study||1
3228636|NCT02328040|3960103|FG000|STARTED|First Intervention (2 Days)||8
3228637|NCT02328040|3960104|FG001|STARTED|First Intervention (2 Days)||9
3228638|NCT02328040|3960103|FG000|COMPLETED|First Intervention (2 Days)||7
3228639|NCT02328040|3960104|FG001|COMPLETED|First Intervention (2 Days)||8
3228640|NCT02328040|3960103|FG000|NOT COMPLETED|First Intervention (2 Days)||1
3228641|NCT02328040|3960104|FG001|NOT COMPLETED|First Intervention (2 Days)||1
3228642|NCT02328040|3960103|FG000|STARTED|Second Intervention (2 Days)||7
3228643|NCT02328040|3960104|FG001|STARTED|Second Intervention (2 Days)||8
3228644|NCT02328040|3960103|FG000|COMPLETED|Second Intervention (2 Days)||7
3228645|NCT02328040|3960104|FG001|COMPLETED|Second Intervention (2 Days)||8
3228646|NCT02328040|3960103|FG000|NOT COMPLETED|Second Intervention (2 Days)||0
3228647|NCT02328040|3960104|FG001|NOT COMPLETED|Second Intervention (2 Days)||0
3228648|NCT02328105|3960110|FG000|STARTED|Overall Study||11
3228649|NCT02328105|3960110|FG000|COMPLETED|Overall Study||0
3228650|NCT02328105|3960110|FG000|NOT COMPLETED|Overall Study||11
3228651|NCT02328326|3960116|FG000|STARTED|Overall Study|3 participant dyads withdrew before 6-month follow up. 3 more care partners withdrew and 1 died.|246
3228652|NCT02328326|3960117|FG001|STARTED|Overall Study|1 participant dyad withdrew from the study between assignment to control arm and 6-month follow up.|232
3228653|NCT02328326|3960116|FG000|6-month Follow Up|Overall Study|We were unable to reach 15 participants. 1 patient died, 1 care partner withdrew before completion.|221
3228654|NCT02328326|3960117|FG001|6-month Follow Up|Overall Study|We were unable to reach 9 participants. 1 patient died, 1 care partner withdrew before completion.|221
3228655|NCT02328326|3960116|FG000|COMPLETED|Overall Study||224
3228656|NCT02328326|3960117|FG001|COMPLETED|Overall Study||224
3228657|NCT02328326|3960116|FG000|NOT COMPLETED|Overall Study||22
3228658|NCT02328326|3960117|FG001|NOT COMPLETED|Overall Study||8
3228659|NCT02328404|3960127|FG000|STARTED|Overall Study||30
3228660|NCT02328404|3960128|FG001|STARTED|Overall Study||30
3228661|NCT02328404|3960127|FG000|COMPLETED|Overall Study||29
3228662|NCT02328404|3960128|FG001|COMPLETED|Overall Study||29
3228663|NCT02328404|3960127|FG000|NOT COMPLETED|Overall Study||1
3228664|NCT02328404|3960128|FG001|NOT COMPLETED|Overall Study||1
3228665|NCT02328547|3960140|FG000|STARTED|First Intervention (12 Weeks)||25
3228666|NCT02328547|3960141|FG001|STARTED|First Intervention (12 Weeks)||23
3228667|NCT02328547|3960140|FG000|COMPLETED|First Intervention (12 Weeks)||22
3228668|NCT02328547|3960141|FG001|COMPLETED|First Intervention (12 Weeks)||23
3228669|NCT02328547|3960140|FG000|NOT COMPLETED|First Intervention (12 Weeks)||3
3228670|NCT02328547|3960141|FG001|NOT COMPLETED|First Intervention (12 Weeks)||0
3228671|NCT02328547|3960140|FG000|STARTED|Second Intervention (12 Weeks)||22
3228672|NCT02328547|3960141|FG001|STARTED|Second Intervention (12 Weeks)||23
3228673|NCT02328547|3960140|FG000|COMPLETED|Second Intervention (12 Weeks)||22
3228674|NCT02328547|3960141|FG001|COMPLETED|Second Intervention (12 Weeks)||23
3228675|NCT02328547|3960140|FG000|NOT COMPLETED|Second Intervention (12 Weeks)||0
3228676|NCT02328547|3960141|FG001|NOT COMPLETED|Second Intervention (12 Weeks)||0
3228677|NCT02328755|3960155|FG000|STARTED|Overall Study||3
3228678|NCT02328755|3960156|FG001|STARTED|Overall Study||33
3228679|NCT02328755|3960155|FG000|COMPLETED|Overall Study|Evaluable for the phase II primary endpoint of relapse at 6-months post-HCT|0
3228680|NCT02328755|3960156|FG001|COMPLETED|Overall Study||31
3228681|NCT02328755|3960155|FG000|NOT COMPLETED|Overall Study||3
3228682|NCT02328755|3960156|FG001|NOT COMPLETED|Overall Study||2
3228683|NCT02328807|3960168|FG000|STARTED|Overall Study||6
3228684|NCT02328807|3960168|FG000|COMPLETED|Overall Study||6
3228685|NCT02328807|3960168|FG000|NOT COMPLETED|Overall Study||0
3228686|NCT02328937|3960174|FG000|STARTED|Period 1||7
3228687|NCT02328937|3960175|FG001|STARTED|Period 1||6
3228688|NCT02328937|3960176|FG002|STARTED|Period 1||7
3228689|NCT02328937|3960177|FG003|STARTED|Period 1||6
3228690|NCT02328937|3960178|FG004|STARTED|Period 1||6
3228691|NCT02328937|3960179|FG005|STARTED|Period 1||6
3228692|NCT02328937|3960174|FG000|COMPLETED|Period 1||7
3228693|NCT02328937|3960175|FG001|COMPLETED|Period 1||6
3228694|NCT02328937|3960176|FG002|COMPLETED|Period 1||7
3228695|NCT02328937|3960177|FG003|COMPLETED|Period 1||5
3228696|NCT02328937|3960178|FG004|COMPLETED|Period 1||6
3228697|NCT02328937|3960179|FG005|COMPLETED|Period 1||6
3228698|NCT02328937|3960174|FG000|NOT COMPLETED|Period 1||0
3228699|NCT02328937|3960175|FG001|NOT COMPLETED|Period 1||0
3228700|NCT02328937|3960176|FG002|NOT COMPLETED|Period 1||0
3228701|NCT02328937|3960177|FG003|NOT COMPLETED|Period 1||1
3228702|NCT02328937|3960178|FG004|NOT COMPLETED|Period 1||0
3228703|NCT02328937|3960179|FG005|NOT COMPLETED|Period 1||0
3228704|NCT02328937|3960174|FG000|STARTED|Period 2||7
3228705|NCT02328937|3960175|FG001|STARTED|Period 2||6
3228706|NCT02328937|3960176|FG002|STARTED|Period 2||7
3228707|NCT02328937|3960177|FG003|STARTED|Period 2||5
3228708|NCT02328937|3960178|FG004|STARTED|Period 2||6
3368775|NCT03825042|4100337|FG000|COMPLETED|Overall Study||38
3368776|NCT03825042|4100338|FG001|COMPLETED|Overall Study||40
3368777|NCT03825042|4100337|FG000|NOT COMPLETED|Overall Study||2
3368778|NCT03825042|4100338|FG001|NOT COMPLETED|Overall Study||0
3368779|NCT03823378|4100350|FG000|STARTED|Overall Study||28
3368780|NCT03823378|4100351|FG001|STARTED|Overall Study||16
3368781|NCT03823378|4100352|FG002|STARTED|Overall Study||12
3368782|NCT03823378|4100353|FG003|STARTED|Overall Study||12
3368783|NCT03823378|4100354|FG004|STARTED|Overall Study||20
3368784|NCT03823378|4100355|FG005|STARTED|Overall Study||9
3368785|NCT03823378|4100350|FG000|COMPLETED|Overall Study||7
3368786|NCT03823378|4100351|FG001|COMPLETED|Overall Study||0
3368787|NCT03823378|4100352|FG002|COMPLETED|Overall Study||2
3368788|NCT03823378|4100353|FG003|COMPLETED|Overall Study||2
3368789|NCT03823378|4100354|FG004|COMPLETED|Overall Study||2
3368790|NCT03823378|4100355|FG005|COMPLETED|Overall Study||1
3368791|NCT03823378|4100350|FG000|NOT COMPLETED|Overall Study||21
3368792|NCT03823378|4100351|FG001|NOT COMPLETED|Overall Study||16
3368793|NCT03823378|4100352|FG002|NOT COMPLETED|Overall Study||10
3368794|NCT03823378|4100353|FG003|NOT COMPLETED|Overall Study||10
3368795|NCT03823378|4100354|FG004|NOT COMPLETED|Overall Study||18
3368796|NCT03823378|4100355|FG005|NOT COMPLETED|Overall Study||8
3368797|NCT03831191|4100373|FG000|STARTED|Induction Period (16 Weeks)||33
3368798|NCT03831191|4100374|FG001|STARTED|Induction Period (16 Weeks)||35
3368799|NCT03831191|4100375|FG002|STARTED|Induction Period (16 Weeks)||34
3368800|NCT03831191|4100376|FG003|STARTED|Induction Period (16 Weeks)||34
3368801|NCT03831191|4100377|FG004|STARTED|Induction Period (16 Weeks)||0
3368802|NCT03831191|4100378|FG005|STARTED|Induction Period (16 Weeks)||0
3368803|NCT03831191|4100379|FG006|STARTED|Induction Period (16 Weeks)||0
3368804|NCT03831191|4100380|FG007|STARTED|Induction Period (16 Weeks)||0
3368805|NCT03831191|4100381|FG008|STARTED|Induction Period (16 Weeks)||0
3368806|NCT03831191|4100382|FG009|STARTED|Induction Period (16 Weeks)||0
3368807|NCT03831191|4100383|FG010|STARTED|Induction Period (16 Weeks)||0
3368808|NCT03831191|4100384|FG011|STARTED|Induction Period (16 Weeks)||0
3368809|NCT03831191|4100385|FG012|STARTED|Induction Period (16 Weeks)||0
3368810|NCT03831191|4100386|FG013|STARTED|Induction Period (16 Weeks)||0
3368811|NCT03831191|4100387|FG014|STARTED|Induction Period (16 Weeks)||0
3368812|NCT03831191|4100373|FG000|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||33
3368813|NCT03831191|4100374|FG001|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||35
3368814|NCT03831191|4100375|FG002|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||34
3368815|NCT03831191|4100376|FG003|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||33
3368816|NCT03831191|4100377|FG004|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
3228709|NCT02328937|3960179|FG005|STARTED|Period 2||6
3228710|NCT02328937|3960174|FG000|COMPLETED|Period 2||7
3228711|NCT02328937|3960175|FG001|COMPLETED|Period 2||6
3228712|NCT02328937|3960176|FG002|COMPLETED|Period 2||6
3228713|NCT02328937|3960177|FG003|COMPLETED|Period 2||5
3228714|NCT02328937|3960178|FG004|COMPLETED|Period 2||6
3228715|NCT02328937|3960179|FG005|COMPLETED|Period 2||6
3228716|NCT02328937|3960174|FG000|NOT COMPLETED|Period 2||0
3228717|NCT02328937|3960175|FG001|NOT COMPLETED|Period 2||0
3228718|NCT02328937|3960176|FG002|NOT COMPLETED|Period 2||1
3228719|NCT02328937|3960177|FG003|NOT COMPLETED|Period 2||0
3228720|NCT02328937|3960178|FG004|NOT COMPLETED|Period 2||0
3228721|NCT02328937|3960179|FG005|NOT COMPLETED|Period 2||0
3228722|NCT02328937|3960174|FG000|STARTED|Period 3||7
3228723|NCT02328937|3960175|FG001|STARTED|Period 3||6
3228724|NCT02328937|3960176|FG002|STARTED|Period 3||6
3228725|NCT02328937|3960177|FG003|STARTED|Period 3||5
3228726|NCT02328937|3960178|FG004|STARTED|Period 3||6
3228727|NCT02328937|3960179|FG005|STARTED|Period 3||6
3228728|NCT02328937|3960174|FG000|COMPLETED|Period 3||7
3228729|NCT02328937|3960175|FG001|COMPLETED|Period 3||6
3228730|NCT02328937|3960176|FG002|COMPLETED|Period 3||6
3228731|NCT02328937|3960177|FG003|COMPLETED|Period 3||5
3228732|NCT02328937|3960178|FG004|COMPLETED|Period 3||6
3228733|NCT02328937|3960179|FG005|COMPLETED|Period 3||6
3228734|NCT02328937|3960174|FG000|NOT COMPLETED|Period 3||0
3228735|NCT02328937|3960175|FG001|NOT COMPLETED|Period 3||0
3228736|NCT02328937|3960176|FG002|NOT COMPLETED|Period 3||0
3228737|NCT02328937|3960177|FG003|NOT COMPLETED|Period 3||0
3228738|NCT02328937|3960178|FG004|NOT COMPLETED|Period 3||0
3228739|NCT02328937|3960179|FG005|NOT COMPLETED|Period 3||0
3228740|NCT02329015|3960189|FG000|STARTED|Overall Study||48
3228741|NCT02329015|3960190|FG001|STARTED|Overall Study||64
3228742|NCT02329015|3960189|FG000|COMPLETED|Overall Study||48
3228743|NCT02329015|3960190|FG001|COMPLETED|Overall Study||64
3228744|NCT02329015|3960189|FG000|NOT COMPLETED|Overall Study||0
3228745|NCT02329015|3960190|FG001|NOT COMPLETED|Overall Study||0
3228746|NCT02329223|3960199|FG000|STARTED|Overall Study||73
3228747|NCT02329223|3960200|FG001|STARTED|Overall Study||71
3228748|NCT02329223|3960201|FG002|STARTED|Overall Study||74
3228749|NCT02329223|3960199|FG000|Full Analysis Set|Overall Study||73
3228750|NCT02329223|3960200|FG001|Full Analysis Set|Overall Study||70
3228751|NCT02329223|3960201|FG002|Full Analysis Set|Overall Study||74
3228752|NCT02329223|3960199|FG000|Safety Set|Overall Study||73
3228753|NCT02329223|3960200|FG001|Safety Set|Overall Study||71
3228754|NCT02329223|3960201|FG002|Safety Set|Overall Study||74
3228755|NCT02329223|3960199|FG000|COMPLETED|Overall Study||72
3228756|NCT02329223|3960200|FG001|COMPLETED|Overall Study||68
3228757|NCT02329223|3960201|FG002|COMPLETED|Overall Study||68
3228758|NCT02329223|3960199|FG000|NOT COMPLETED|Overall Study||1
3228759|NCT02329223|3960200|FG001|NOT COMPLETED|Overall Study||3
3228760|NCT02329223|3960201|FG002|NOT COMPLETED|Overall Study||6
3228761|NCT02329431|3960211|FG000|STARTED|Overall Study||92
3228762|NCT02329431|3960212|FG001|STARTED|Overall Study||89
3228763|NCT02329431|3960211|FG000|Baseline Interview|Overall Study||87
3228764|NCT02329431|3960212|FG001|Baseline Interview|Overall Study||85
3228765|NCT02329431|3960211|FG000|COMPLETED|Overall Study||72
3228766|NCT02329431|3960212|FG001|COMPLETED|Overall Study||76
3228767|NCT02329431|3960211|FG000|NOT COMPLETED|Overall Study||20
3228768|NCT02329431|3960212|FG001|NOT COMPLETED|Overall Study||13
3228769|NCT02329587|3960220|FG000|STARTED|Baseline Thru Post-treatment Assessment||5
3228770|NCT02329587|3960221|FG001|STARTED|Baseline Thru Post-treatment Assessment||7
3228771|NCT02329587|3960220|FG000|Completed All Intervention Sessions|Baseline Thru Post-treatment Assessment||3
3228772|NCT02329587|3960221|FG001|Completed All Intervention Sessions|Baseline Thru Post-treatment Assessment||4
3228773|NCT02329587|3960220|FG000|COMPLETED|Baseline Thru Post-treatment Assessment||4
3228774|NCT02329587|3960221|FG001|COMPLETED|Baseline Thru Post-treatment Assessment||6
3228775|NCT02329587|3960220|FG000|NOT COMPLETED|Baseline Thru Post-treatment Assessment||1
3228776|NCT02329587|3960221|FG001|NOT COMPLETED|Baseline Thru Post-treatment Assessment||1
3228777|NCT02329587|3960220|FG000|STARTED|1-month Follow-up||4
3228778|NCT02329587|3960221|FG001|STARTED|1-month Follow-up||6
3228779|NCT02329587|3960220|FG000|COMPLETED|1-month Follow-up||4
3228780|NCT02329587|3960221|FG001|COMPLETED|1-month Follow-up||5
3228781|NCT02329587|3960220|FG000|NOT COMPLETED|1-month Follow-up||0
3228782|NCT02329587|3960221|FG001|NOT COMPLETED|1-month Follow-up||1
3228783|NCT02329600|3960230|FG000|STARTED|Overall Study||10
3228784|NCT02329600|3960231|FG001|STARTED|Overall Study||15
3228785|NCT02329600|3960232|FG002|STARTED|Overall Study||15
3228786|NCT02329600|3960230|FG000|COMPLETED|Overall Study||10
3228787|NCT02329600|3960231|FG001|COMPLETED|Overall Study||15
3228788|NCT02329600|3960232|FG002|COMPLETED|Overall Study||15
3228789|NCT02329600|3960230|FG000|NOT COMPLETED|Overall Study||0
3228790|NCT02329600|3960231|FG001|NOT COMPLETED|Overall Study||0
3228791|NCT02329600|3960232|FG002|NOT COMPLETED|Overall Study||0
3228792|NCT02329730|3960244|FG000|STARTED|Overall Study||14
3228793|NCT02329730|3960245|FG001|STARTED|Overall Study||14
3228794|NCT02329730|3960246|FG002|STARTED|Overall Study||14
3228795|NCT02329730|3960247|FG003|STARTED|Overall Study||14
3228796|NCT02329730|3960248|FG004|STARTED|Overall Study||14
3228797|NCT02329730|3960249|FG005|STARTED|Overall Study||14
3228798|NCT02329730|3960250|FG006|STARTED|Overall Study||14
3228799|NCT02329730|3960251|FG007|STARTED|Overall Study||14
3228800|NCT02329730|3960252|FG008|STARTED|Overall Study||8
3228801|NCT02329730|3960253|FG009|STARTED|Overall Study||8
3228802|NCT02329730|3960254|FG010|STARTED|Overall Study||8
3228803|NCT02329730|3960255|FG011|STARTED|Overall Study||8
3228804|NCT02329730|3960244|FG000|COMPLETED|Overall Study||14
3228805|NCT02329730|3960245|FG001|COMPLETED|Overall Study||14
3228806|NCT02329730|3960246|FG002|COMPLETED|Overall Study||14
3228807|NCT02329730|3960247|FG003|COMPLETED|Overall Study||14
3228808|NCT02329730|3960248|FG004|COMPLETED|Overall Study||11
3228809|NCT02329730|3960249|FG005|COMPLETED|Overall Study||12
3228810|NCT02329730|3960250|FG006|COMPLETED|Overall Study||13
3228811|NCT02329730|3960251|FG007|COMPLETED|Overall Study||13
3228812|NCT02329730|3960252|FG008|COMPLETED|Overall Study||7
3228813|NCT02329730|3960253|FG009|COMPLETED|Overall Study||7
3228814|NCT02329730|3960254|FG010|COMPLETED|Overall Study||8
3228815|NCT02329730|3960255|FG011|COMPLETED|Overall Study||8
3228816|NCT02329730|3960244|FG000|NOT COMPLETED|Overall Study||0
3228817|NCT02329730|3960245|FG001|NOT COMPLETED|Overall Study||0
3228818|NCT02329730|3960246|FG002|NOT COMPLETED|Overall Study||0
3228819|NCT02329730|3960247|FG003|NOT COMPLETED|Overall Study||0
3228820|NCT02329730|3960248|FG004|NOT COMPLETED|Overall Study||3
3228821|NCT02329730|3960249|FG005|NOT COMPLETED|Overall Study||2
3228822|NCT02329730|3960250|FG006|NOT COMPLETED|Overall Study||1
3228823|NCT02329730|3960251|FG007|NOT COMPLETED|Overall Study||1
3228824|NCT02329730|3960252|FG008|NOT COMPLETED|Overall Study||1
3228825|NCT02329730|3960253|FG009|NOT COMPLETED|Overall Study||1
3228826|NCT02329730|3960254|FG010|NOT COMPLETED|Overall Study||0
3228827|NCT02329730|3960255|FG011|NOT COMPLETED|Overall Study||0
3228828|NCT02329743|3960276|FG000|STARTED|Overall Study||84
3228829|NCT02329743|3960277|FG001|STARTED|Overall Study||87
3228830|NCT02329743|3960278|FG002|STARTED|Overall Study||85
3228831|NCT02329743|3960276|FG000|COMPLETED|Overall Study||78
3228832|NCT02329743|3960277|FG001|COMPLETED|Overall Study||80
3228833|NCT02329743|3960278|FG002|COMPLETED|Overall Study||77
3228834|NCT02329743|3960276|FG000|NOT COMPLETED|Overall Study||6
3228835|NCT02329743|3960277|FG001|NOT COMPLETED|Overall Study||7
3228836|NCT02329743|3960278|FG002|NOT COMPLETED|Overall Study||8
3228837|NCT02329964|3960288|FG000|STARTED|Overall Study||40
3228838|NCT02329964|3960289|FG001|STARTED|Overall Study||40
3228839|NCT02329964|3960288|FG000|COMPLETED|Overall Study||40
3228840|NCT02329964|3960289|FG001|COMPLETED|Overall Study||40
3228841|NCT02329964|3960288|FG000|NOT COMPLETED|Overall Study||0
3228842|NCT02329964|3960289|FG001|NOT COMPLETED|Overall Study||0
3228843|NCT02330055|3960297|FG000|STARTED|Overall Study||50
3228844|NCT02330055|3960298|FG001|STARTED|Overall Study||49
3228845|NCT02330055|3960297|FG000|COMPLETED|Overall Study||40
3228846|NCT02330055|3960298|FG001|COMPLETED|Overall Study||40
3228847|NCT02330055|3960297|FG000|NOT COMPLETED|Overall Study||10
3228848|NCT02330055|3960298|FG001|NOT COMPLETED|Overall Study||9
3228849|NCT02330081|3960304|FG000|STARTED|Overall Study||22
3228850|NCT02330081|3960304|FG000|COMPLETED|Overall Study||14
3228851|NCT02330081|3960304|FG000|NOT COMPLETED|Overall Study||8
3228852|NCT02330094|3960313|FG000|STARTED|Overall Study||8
3228853|NCT02330094|3960314|FG001|STARTED|Overall Study||8
3228854|NCT02330094|3960313|FG000|COMPLETED|Overall Study||8
3228855|NCT02330094|3960314|FG001|COMPLETED|Overall Study||8
3228856|NCT02330094|3960313|FG000|NOT COMPLETED|Overall Study||0
3228857|NCT02330094|3960314|FG001|NOT COMPLETED|Overall Study||0
3228858|NCT02330172|3960322|FG000|STARTED|Overall Study||22
3228859|NCT02330172|3960323|FG001|STARTED|Overall Study||22
3228860|NCT02330172|3960322|FG000|COMPLETED|Overall Study||19
3228861|NCT02330172|3960323|FG001|COMPLETED|Overall Study||21
3228862|NCT02330172|3960322|FG000|NOT COMPLETED|Overall Study||3
3228863|NCT02330172|3960323|FG001|NOT COMPLETED|Overall Study||1
3228864|NCT02330276|3960332|FG000|STARTED|Overall Study||4
3228865|NCT02330276|3960333|FG001|STARTED|Overall Study||4
3228866|NCT02330276|3960334|FG002|STARTED|Overall Study||4
3228867|NCT02330276|3960332|FG000|COMPLETED|Overall Study||4
3228868|NCT02330276|3960333|FG001|COMPLETED|Overall Study||4
3228869|NCT02330276|3960334|FG002|COMPLETED|Overall Study||4
3228870|NCT02330276|3960332|FG000|NOT COMPLETED|Overall Study||0
3228871|NCT02330276|3960333|FG001|NOT COMPLETED|Overall Study||0
3228872|NCT02330276|3960334|FG002|NOT COMPLETED|Overall Study||0
3228873|NCT02330341|3960344|FG000|STARTED|Overall Study||12
3228874|NCT02330341|3960345|FG001|STARTED|Overall Study||12
3228875|NCT02330341|3960344|FG000|COMPLETED|Overall Study||12
3228876|NCT02330341|3960345|FG001|COMPLETED|Overall Study||11
3228877|NCT02330341|3960344|FG000|NOT COMPLETED|Overall Study||0
3228878|NCT02330341|3960345|FG001|NOT COMPLETED|Overall Study||1
3228879|NCT02330523|3960353|FG000|STARTED|Overall Study||21
3228880|NCT02330523|3960354|FG001|STARTED|Overall Study||19
3228881|NCT02330523|3960353|FG000|COMPLETED|Overall Study||21
3228882|NCT02330523|3960354|FG001|COMPLETED|Overall Study||19
3228883|NCT02330523|3960353|FG000|NOT COMPLETED|Overall Study||0
3228884|NCT02330523|3960354|FG001|NOT COMPLETED|Overall Study||0
3228885|NCT02330549|3960362|FG000|STARTED|Overall Study||20
3228886|NCT02330549|3960363|FG001|STARTED|Overall Study||25
3228887|NCT02330549|3960362|FG000|COMPLETED|Overall Study||16
3228888|NCT02330549|3960363|FG001|COMPLETED|Overall Study||24
3228889|NCT02330549|3960362|FG000|NOT COMPLETED|Overall Study||4
3228890|NCT02330549|3960363|FG001|NOT COMPLETED|Overall Study||1
3228891|NCT02330588|3960374|FG000|STARTED|Overall Study||44
3228892|NCT02330588|3960375|FG001|STARTED|Overall Study||43
3228893|NCT02330588|3960376|FG002|STARTED|Overall Study||46
3228894|NCT02330588|3960377|FG003|STARTED|Overall Study||46
3228895|NCT02330588|3960378|FG004|STARTED|Overall Study||47
3228896|NCT02330588|3960374|FG000|COMPLETED|Overall Study||28
3228897|NCT02330588|3960375|FG001|COMPLETED|Overall Study||25
3228898|NCT02330588|3960376|FG002|COMPLETED|Overall Study||31
3228899|NCT02330588|3960377|FG003|COMPLETED|Overall Study||24
3228900|NCT02330588|3960378|FG004|COMPLETED|Overall Study||28
3228901|NCT02330588|3960374|FG000|NOT COMPLETED|Overall Study||16
3228902|NCT02330588|3960375|FG001|NOT COMPLETED|Overall Study||18
3228903|NCT02330588|3960376|FG002|NOT COMPLETED|Overall Study||15
3228904|NCT02330588|3960377|FG003|NOT COMPLETED|Overall Study||22
3228905|NCT02330588|3960378|FG004|NOT COMPLETED|Overall Study||19
3228906|NCT02330627|3960400|FG000|STARTED|Overall Study||16
3228907|NCT02330627|3960401|FG001|STARTED|Overall Study||13
3228908|NCT02330627|3960400|FG000|COMPLETED|Overall Study||15
3228909|NCT02330627|3960401|FG001|COMPLETED|Overall Study||12
3228910|NCT02330627|3960400|FG000|NOT COMPLETED|Overall Study||1
3228911|NCT02330627|3960401|FG001|NOT COMPLETED|Overall Study||1
3228912|NCT02330978|3960407|FG000|STARTED|The First Patient Included at Study||1
3228913|NCT02330978|3960407|FG000|COMPLETED|The First Patient Included at Study||1
3228914|NCT02330978|3960407|FG000|NOT COMPLETED|The First Patient Included at Study||0
3228915|NCT02330978|3960407|FG000|STARTED|The Second Patient Included at Study||1
3228916|NCT02330978|3960407|FG000|COMPLETED|The Second Patient Included at Study||1
3228917|NCT02330978|3960407|FG000|NOT COMPLETED|The Second Patient Included at Study||0
3228918|NCT02331095|3960413|FG000|STARTED|Overall Study||11
3228919|NCT02331095|3960414|FG001|STARTED|Overall Study||10
3228920|NCT02331095|3960413|FG000|COMPLETED|Overall Study||7
3228921|NCT02331095|3960414|FG001|COMPLETED|Overall Study||9
3228922|NCT02331095|3960413|FG000|NOT COMPLETED|Overall Study||4
3228923|NCT02331095|3960414|FG001|NOT COMPLETED|Overall Study||1
3228924|NCT02331108|3960430|FG000|STARTED|Overall Study||51
3228925|NCT02331108|3960431|FG001|STARTED|Overall Study||52
3228926|NCT02331108|3960432|FG002|STARTED|Overall Study||51
3228927|NCT02331108|3960433|FG003|STARTED|Overall Study||51
3228928|NCT02331108|3960434|FG004|STARTED|Overall Study||52
3228929|NCT02331108|3960435|FG005|STARTED|Overall Study||52
3228930|NCT02331108|3960430|FG000|COMPLETED|Overall Study||50
3228931|NCT02331108|3960431|FG001|COMPLETED|Overall Study||50
3228932|NCT02331108|3960432|FG002|COMPLETED|Overall Study||50
3228933|NCT02331108|3960433|FG003|COMPLETED|Overall Study||50
3228934|NCT02331108|3960434|FG004|COMPLETED|Overall Study||50
3228935|NCT02331108|3960435|FG005|COMPLETED|Overall Study||50
3228936|NCT02331108|3960430|FG000|NOT COMPLETED|Overall Study||1
3228937|NCT02331108|3960431|FG001|NOT COMPLETED|Overall Study||2
3228938|NCT02331108|3960432|FG002|NOT COMPLETED|Overall Study||1
3228939|NCT02331108|3960433|FG003|NOT COMPLETED|Overall Study||1
3228940|NCT02331108|3960434|FG004|NOT COMPLETED|Overall Study||2
3228941|NCT02331108|3960435|FG005|NOT COMPLETED|Overall Study||2
3228942|NCT02331368|3960451|FG000|STARTED|Overall Study||32
3228943|NCT02331368|3960451|FG000|COMPLETED|Overall Study||29
3228944|NCT02331368|3960451|FG000|NOT COMPLETED|Overall Study||3
3228945|NCT02331394|3960455|FG000|STARTED|Overall Study||15
3228946|NCT02331394|3960455|FG000|COMPLETED|Overall Study|14 patients, 1 dropped out|14
3228947|NCT02331394|3960455|FG000|NOT COMPLETED|Overall Study||1
3228948|NCT02331407|3960466|FG000|STARTED|Overall Study||9
3228949|NCT02331407|3960466|FG000|COMPLETED|Overall Study||9
3228950|NCT02331407|3960466|FG000|NOT COMPLETED|Overall Study||0
3228951|NCT02331446|3960474|FG000|STARTED|Overall Study||9
3228952|NCT02331446|3960475|FG001|STARTED|Overall Study||11
3228953|NCT02331446|3960476|FG002|STARTED|Overall Study||11
3228954|NCT02331446|3960477|FG003|STARTED|Overall Study||11
3228955|NCT02331446|3960474|FG000|COMPLETED|Overall Study||5
3228956|NCT02331446|3960475|FG001|COMPLETED|Overall Study||6
3228957|NCT02331446|3960476|FG002|COMPLETED|Overall Study||8
3228958|NCT02331446|3960477|FG003|COMPLETED|Overall Study||8
3228959|NCT02331446|3960474|FG000|NOT COMPLETED|Overall Study||4
3228960|NCT02331446|3960475|FG001|NOT COMPLETED|Overall Study||5
3228961|NCT02331446|3960476|FG002|NOT COMPLETED|Overall Study||3
3228962|NCT02331446|3960477|FG003|NOT COMPLETED|Overall Study||3
3228963|NCT02331589|3960489|FG000|STARTED|Overall Study||39
3228964|NCT02331589|3960490|FG001|STARTED|Overall Study||36
3228965|NCT02331589|3960489|FG000|COMPLETED|Overall Study||34
3228966|NCT02331589|3960490|FG001|COMPLETED|Overall Study||31
3228967|NCT02331589|3960489|FG000|NOT COMPLETED|Overall Study||5
3228968|NCT02331589|3960490|FG001|NOT COMPLETED|Overall Study||5
3228969|NCT02331680|3960499|FG000|STARTED|Overall Study||40
3228970|NCT02331680|3960500|FG001|STARTED|Overall Study||40
3228971|NCT02331680|3960501|FG002|STARTED|Overall Study||44
3228972|NCT02331680|3960499|FG000|COMPLETED|Overall Study||34
3228973|NCT02331680|3960500|FG001|COMPLETED|Overall Study||36
3228974|NCT02331680|3960501|FG002|COMPLETED|Overall Study||29
3228975|NCT02331680|3960499|FG000|NOT COMPLETED|Overall Study||6
3228976|NCT02331680|3960500|FG001|NOT COMPLETED|Overall Study||4
3228977|NCT02331680|3960501|FG002|NOT COMPLETED|Overall Study||15
3228978|NCT02331940|3960511|FG000|STARTED|Overall Study||100
3228979|NCT02331940|3960512|FG001|STARTED|Overall Study||100
3228980|NCT02331940|3960511|FG000|COMPLETED|Overall Study||93
3228981|NCT02331940|3960512|FG001|COMPLETED|Overall Study||95
3228982|NCT02331940|3960511|FG000|NOT COMPLETED|Overall Study||7
3228983|NCT02331940|3960512|FG001|NOT COMPLETED|Overall Study||5
3228984|NCT02331992|3960518|FG000|STARTED|Overall Study||34
3228985|NCT02331992|3960518|FG000|COMPLETED|Overall Study||34
3228986|NCT02331992|3960518|FG000|NOT COMPLETED|Overall Study||0
3228987|NCT02332239|3960524|FG000|STARTED|Overall Study||58
3228988|NCT02332239|3960525|FG001|STARTED|Overall Study||58
3228989|NCT02332239|3960524|FG000|COMPLETED|Overall Study||54
3368817|NCT03831191|4100378|FG005|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
3228990|NCT02332239|3960525|FG001|COMPLETED|Overall Study||52
3228991|NCT02332239|3960524|FG000|NOT COMPLETED|Overall Study||4
3228992|NCT02332239|3960525|FG001|NOT COMPLETED|Overall Study||6
3228993|NCT02332291|3960535|FG000|STARTED|Phase 1: Blinded Escitalopram or Placebo||63
3228994|NCT02332291|3960536|FG001|STARTED|Phase 1: Blinded Escitalopram or Placebo||32
3228995|NCT02332291|3960535|FG000|COMPLETED|Phase 1: Blinded Escitalopram or Placebo||59
3228996|NCT02332291|3960536|FG001|COMPLETED|Phase 1: Blinded Escitalopram or Placebo||23
3228997|NCT02332291|3960535|FG000|NOT COMPLETED|Phase 1: Blinded Escitalopram or Placebo||4
3228998|NCT02332291|3960536|FG001|NOT COMPLETED|Phase 1: Blinded Escitalopram or Placebo||9
3228999|NCT02332291|3960535|FG000|STARTED|Phase 2: Open-Label Bupropion||22
3229000|NCT02332291|3960536|FG001|STARTED|Phase 2: Open-Label Bupropion||19
3229001|NCT02332291|3960535|FG000|COMPLETED|Phase 2: Open-Label Bupropion||19
3229002|NCT02332291|3960536|FG001|COMPLETED|Phase 2: Open-Label Bupropion||11
3229003|NCT02332291|3960535|FG000|NOT COMPLETED|Phase 2: Open-Label Bupropion||3
3229004|NCT02332291|3960536|FG001|NOT COMPLETED|Phase 2: Open-Label Bupropion||8
3229005|NCT02332707|3960564|FG000|STARTED|Overall Study||23
3229006|NCT02332707|3960565|FG001|STARTED|Overall Study||24
3229007|NCT02332707|3960566|FG002|STARTED|Overall Study||16
3229008|NCT02332707|3960567|FG003|STARTED|Overall Study||14
3229009|NCT02332707|3960568|FG004|STARTED|Overall Study||23
3229010|NCT02332707|3960569|FG005|STARTED|Overall Study||23
3229011|NCT02332707|3960570|FG006|STARTED|Overall Study||15
3229012|NCT02332707|3960571|FG007|STARTED|Overall Study||16
3229013|NCT02332707|3960572|FG008|STARTED|Overall Study||48
3229014|NCT02332707|3960573|FG009|STARTED|Overall Study||31
3229015|NCT02332707|3960574|FG010|STARTED|Overall Study||31
3229016|NCT02332707|3960575|FG011|STARTED|Overall Study||35
3229017|NCT02332707|3960576|FG012|STARTED|Overall Study||40
3229018|NCT02332707|3960577|FG013|STARTED|Overall Study||15
3229019|NCT02332707|3960578|FG014|STARTED|Overall Study||16
3229020|NCT02332707|3960579|FG015|STARTED|Overall Study||26
3229021|NCT02332707|3960580|FG016|STARTED|Overall Study||30
3229022|NCT02332707|3960581|FG017|STARTED|Overall Study||16
3229023|NCT02332707|3960564|FG000|COMPLETED|Overall Study||23
3229024|NCT02332707|3960565|FG001|COMPLETED|Overall Study||24
3229025|NCT02332707|3960566|FG002|COMPLETED|Overall Study||15
3229026|NCT02332707|3960567|FG003|COMPLETED|Overall Study||13
3229027|NCT02332707|3960568|FG004|COMPLETED|Overall Study||23
3229028|NCT02332707|3960569|FG005|COMPLETED|Overall Study||22
3229029|NCT02332707|3960570|FG006|COMPLETED|Overall Study||15
3229030|NCT02332707|3960571|FG007|COMPLETED|Overall Study||16
3229031|NCT02332707|3960572|FG008|COMPLETED|Overall Study||48
3229032|NCT02332707|3960573|FG009|COMPLETED|Overall Study||28
3229033|NCT02332707|3960574|FG010|COMPLETED|Overall Study||29
3229034|NCT02332707|3960575|FG011|COMPLETED|Overall Study||35
3229035|NCT02332707|3960576|FG012|COMPLETED|Overall Study||35
3229036|NCT02332707|3960577|FG013|COMPLETED|Overall Study||15
3229037|NCT02332707|3960578|FG014|COMPLETED|Overall Study||16
3229038|NCT02332707|3960579|FG015|COMPLETED|Overall Study||26
3229039|NCT02332707|3960580|FG016|COMPLETED|Overall Study||30
3229040|NCT02332707|3960581|FG017|COMPLETED|Overall Study||16
3229041|NCT02332707|3960564|FG000|NOT COMPLETED|Overall Study||0
3229042|NCT02332707|3960565|FG001|NOT COMPLETED|Overall Study||0
3229043|NCT02332707|3960566|FG002|NOT COMPLETED|Overall Study||1
3229044|NCT02332707|3960567|FG003|NOT COMPLETED|Overall Study||1
3229045|NCT02332707|3960568|FG004|NOT COMPLETED|Overall Study||0
3229046|NCT02332707|3960569|FG005|NOT COMPLETED|Overall Study||1
3229047|NCT02332707|3960570|FG006|NOT COMPLETED|Overall Study||0
3229048|NCT02332707|3960571|FG007|NOT COMPLETED|Overall Study||0
3229049|NCT02332707|3960572|FG008|NOT COMPLETED|Overall Study||0
3229050|NCT02332707|3960573|FG009|NOT COMPLETED|Overall Study||3
3229051|NCT02332707|3960574|FG010|NOT COMPLETED|Overall Study||2
3229052|NCT02332707|3960575|FG011|NOT COMPLETED|Overall Study||0
3229053|NCT02332707|3960576|FG012|NOT COMPLETED|Overall Study||5
3229054|NCT02332707|3960577|FG013|NOT COMPLETED|Overall Study||0
3229055|NCT02332707|3960578|FG014|NOT COMPLETED|Overall Study||0
3229056|NCT02332707|3960579|FG015|NOT COMPLETED|Overall Study||0
3229057|NCT02332707|3960580|FG016|NOT COMPLETED|Overall Study||0
3229058|NCT02332707|3960581|FG017|NOT COMPLETED|Overall Study||0
3229059|NCT02332720|3960642|FG000|STARTED|Part A and Part B||21
3229060|NCT02332720|3960643|FG001|STARTED|Part A and Part B||21
3229061|NCT02332720|3960644|FG002|STARTED|Part A and Part B||22
3229062|NCT02332720|3960645|FG003|STARTED|Part A and Part B||22
3229063|NCT02332720|3960646|FG004|STARTED|Part A and Part B||16
3229064|NCT02332720|3960647|FG005|STARTED|Part A and Part B||36
3229065|NCT02332720|3960648|FG006|STARTED|Part A and Part B||37
3229066|NCT02332720|3960649|FG007|STARTED|Part A and Part B||35
3229067|NCT02332720|3960650|FG008|STARTED|Part A and Part B||15
3229068|NCT02332720|3960651|FG009|STARTED|Part A and Part B||14
3229069|NCT02332720|3960652|FG010|STARTED|Part A and Part B||14
3229070|NCT02332720|3960653|FG011|STARTED|Part A and Part B||15
3229071|NCT02332720|3960654|FG012|STARTED|Part A and Part B||16
3229072|NCT02332720|3960655|FG013|STARTED|Part A and Part B||13
3229073|NCT02332720|3960656|FG014|STARTED|Part A and Part B||16
3229074|NCT02332720|3960657|FG015|STARTED|Part A and Part B||14
3229075|NCT02332720|3960658|FG016|STARTED|Part A and Part B||15
3229076|NCT02332720|3960659|FG017|STARTED|Part A and Part B||14
3229077|NCT02332720|3960660|FG018|STARTED|Part A and Part B||21
3229078|NCT02332720|3960661|FG019|STARTED|Part A and Part B||25
3368818|NCT03831191|4100379|FG006|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
3229079|NCT02332720|3960662|FG020|STARTED|Part A and Part B||7
3229080|NCT02332720|3960663|FG021|STARTED|Part A and Part B||0
3229081|NCT02332720|3960664|FG022|STARTED|Part A and Part B||4
3229082|NCT02332720|3960642|FG000|Treated|Part A and Part B||21
3229083|NCT02332720|3960643|FG001|Treated|Part A and Part B||21
3229084|NCT02332720|3960644|FG002|Treated|Part A and Part B||22
3229085|NCT02332720|3960645|FG003|Treated|Part A and Part B||22
3229086|NCT02332720|3960646|FG004|Treated|Part A and Part B||16
3229087|NCT02332720|3960647|FG005|Treated|Part A and Part B||36
3229088|NCT02332720|3960648|FG006|Treated|Part A and Part B||37
3229089|NCT02332720|3960649|FG007|Treated|Part A and Part B||35
3229090|NCT02332720|3960650|FG008|Treated|Part A and Part B||15
3229091|NCT02332720|3960651|FG009|Treated|Part A and Part B||14
3229092|NCT02332720|3960652|FG010|Treated|Part A and Part B||14
3229093|NCT02332720|3960653|FG011|Treated|Part A and Part B||15
3229094|NCT02332720|3960654|FG012|Treated|Part A and Part B||16
3229095|NCT02332720|3960655|FG013|Treated|Part A and Part B||13
3229096|NCT02332720|3960656|FG014|Treated|Part A and Part B||16
3229097|NCT02332720|3960657|FG015|Treated|Part A and Part B||14
3229098|NCT02332720|3960658|FG016|Treated|Part A and Part B||15
3229099|NCT02332720|3960659|FG017|Treated|Part A and Part B||14
3229100|NCT02332720|3960660|FG018|Treated|Part A and Part B||20
3229101|NCT02332720|3960661|FG019|Treated|Part A and Part B||25
3229102|NCT02332720|3960662|FG020|Treated|Part A and Part B||7
3229103|NCT02332720|3960663|FG021|Treated|Part A and Part B||0
3229104|NCT02332720|3960664|FG022|Treated|Part A and Part B||4
3229105|NCT02332720|3960642|FG000|COMPLETED|Part A and Part B||20
3229106|NCT02332720|3960643|FG001|COMPLETED|Part A and Part B||21
3229107|NCT02332720|3960644|FG002|COMPLETED|Part A and Part B||22
3229108|NCT02332720|3960645|FG003|COMPLETED|Part A and Part B||22
3229109|NCT02332720|3960646|FG004|COMPLETED|Part A and Part B||16
3229110|NCT02332720|3960647|FG005|COMPLETED|Part A and Part B||33
3229111|NCT02332720|3960648|FG006|COMPLETED|Part A and Part B||36
3229112|NCT02332720|3960649|FG007|COMPLETED|Part A and Part B||34
3229113|NCT02332720|3960650|FG008|COMPLETED|Part A and Part B||15
3229114|NCT02332720|3960651|FG009|COMPLETED|Part A and Part B||14
3229115|NCT02332720|3960652|FG010|COMPLETED|Part A and Part B||14
3229116|NCT02332720|3960653|FG011|COMPLETED|Part A and Part B||15
3229117|NCT02332720|3960654|FG012|COMPLETED|Part A and Part B||16
3229118|NCT02332720|3960655|FG013|COMPLETED|Part A and Part B||13
3229119|NCT02332720|3960656|FG014|COMPLETED|Part A and Part B||16
3229120|NCT02332720|3960657|FG015|COMPLETED|Part A and Part B||13
3229121|NCT02332720|3960658|FG016|COMPLETED|Part A and Part B||15
3229122|NCT02332720|3960659|FG017|COMPLETED|Part A and Part B||13
3229123|NCT02332720|3960660|FG018|COMPLETED|Part A and Part B||20
3229124|NCT02332720|3960661|FG019|COMPLETED|Part A and Part B||24
3229125|NCT02332720|3960662|FG020|COMPLETED|Part A and Part B||7
3229126|NCT02332720|3960663|FG021|COMPLETED|Part A and Part B||0
3229127|NCT02332720|3960664|FG022|COMPLETED|Part A and Part B||4
3229128|NCT02332720|3960642|FG000|NOT COMPLETED|Part A and Part B||1
3229129|NCT02332720|3960643|FG001|NOT COMPLETED|Part A and Part B||0
3229130|NCT02332720|3960644|FG002|NOT COMPLETED|Part A and Part B||0
3229131|NCT02332720|3960645|FG003|NOT COMPLETED|Part A and Part B||0
3229132|NCT02332720|3960646|FG004|NOT COMPLETED|Part A and Part B||0
3229133|NCT02332720|3960647|FG005|NOT COMPLETED|Part A and Part B||3
3229134|NCT02332720|3960648|FG006|NOT COMPLETED|Part A and Part B||1
3229135|NCT02332720|3960649|FG007|NOT COMPLETED|Part A and Part B||1
3229136|NCT02332720|3960650|FG008|NOT COMPLETED|Part A and Part B||0
3229137|NCT02332720|3960651|FG009|NOT COMPLETED|Part A and Part B||0
3229138|NCT02332720|3960652|FG010|NOT COMPLETED|Part A and Part B||0
3229139|NCT02332720|3960653|FG011|NOT COMPLETED|Part A and Part B||0
3229140|NCT02332720|3960654|FG012|NOT COMPLETED|Part A and Part B||0
3229141|NCT02332720|3960655|FG013|NOT COMPLETED|Part A and Part B||0
3229142|NCT02332720|3960656|FG014|NOT COMPLETED|Part A and Part B||0
3229143|NCT02332720|3960657|FG015|NOT COMPLETED|Part A and Part B||1
3229144|NCT02332720|3960658|FG016|NOT COMPLETED|Part A and Part B||0
3229145|NCT02332720|3960659|FG017|NOT COMPLETED|Part A and Part B||1
3229146|NCT02332720|3960660|FG018|NOT COMPLETED|Part A and Part B||1
3229147|NCT02332720|3960661|FG019|NOT COMPLETED|Part A and Part B||1
3229148|NCT02332720|3960662|FG020|NOT COMPLETED|Part A and Part B||0
3229149|NCT02332720|3960663|FG021|NOT COMPLETED|Part A and Part B||0
3229150|NCT02332720|3960664|FG022|NOT COMPLETED|Part A and Part B||0
3229151|NCT02332720|3960642|FG000|STARTED|Part C|Part A participants who had relapsed were offered the option of retreatment in Part C.|2
3229152|NCT02332720|3960643|FG001|STARTED|Part C|Part A participants who had relapsed were offered the option of retreatment in Part C.|1
3229153|NCT02332720|3960644|FG002|STARTED|Part C|Part A participants who had relapsed were offered the option of retreatment in Part C.|3
3229154|NCT02332720|3960645|FG003|STARTED|Part C|Part A participants who had relapsed were offered the option of retreatment in Part C.|2
3368819|NCT03831191|4100380|FG007|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
3368820|NCT03831191|4100381|FG008|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
3368821|NCT03831191|4100382|FG009|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
3368822|NCT03831191|4100383|FG010|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
3368823|NCT03831191|4100384|FG011|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
3368824|NCT03831191|4100385|FG012|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
3368825|NCT03831191|4100386|FG013|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
3368826|NCT03831191|4100387|FG014|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
3368827|NCT03831191|4100373|FG000|COMPLETED|Induction Period (16 Weeks)||10
3368828|NCT03831191|4100374|FG001|COMPLETED|Induction Period (16 Weeks)||14
3229155|NCT02332720|3960646|FG004|STARTED|Part C|Part B participants were not included in Part C.|0
3229156|NCT02332720|3960647|FG005|STARTED|Part C|Part B participants were not included in Part C.|0
3229157|NCT02332720|3960648|FG006|STARTED|Part C|Part B participants were not included in Part C.|0
3229158|NCT02332720|3960649|FG007|STARTED|Part C|Part B participants were not included in Part C.|0
3229159|NCT02332720|3960650|FG008|STARTED|Part C|Part B participants were not included in Part C.|0
3229160|NCT02332720|3960651|FG009|STARTED|Part C|Part B participants were not included in Part C.|0
3229161|NCT02332720|3960652|FG010|STARTED|Part C|Part B participants were not included in Part C.|0
3229162|NCT02332720|3960653|FG011|STARTED|Part C|Part B participants were not included in Part C.|0
3229163|NCT02332720|3960654|FG012|STARTED|Part C|Part B participants were not included in Part C.|0
3229164|NCT02332720|3960655|FG013|STARTED|Part C|Part B participants were not included in Part C.|0
3229165|NCT02332720|3960656|FG014|STARTED|Part C|Part B participants were not included in Part C.|0
3229166|NCT02332720|3960657|FG015|STARTED|Part C|Part B participants were not included in Part C.|0
3229167|NCT02332720|3960658|FG016|STARTED|Part C|Part B participants were not included in Part C.|0
3229168|NCT02332720|3960659|FG017|STARTED|Part C|Part B participants were not included in Part C.|0
3229169|NCT02332720|3960660|FG018|STARTED|Part C|Part B participants were not included in Part C.|0
3229170|NCT02332720|3960661|FG019|STARTED|Part C|Part B participants were not included in Part C.|0
3229171|NCT02332720|3960662|FG020|STARTED|Part C|Part B participants were not included in Part C.|0
3229172|NCT02332720|3960663|FG021|STARTED|Part C||0
3229173|NCT02332720|3960664|FG022|STARTED|Part C|Part B participants were not included in Part C.|0
3229174|NCT02332720|3960642|FG000|COMPLETED|Part C||2
3229175|NCT02332720|3960643|FG001|COMPLETED|Part C||1
3229176|NCT02332720|3960644|FG002|COMPLETED|Part C||3
3229177|NCT02332720|3960645|FG003|COMPLETED|Part C||2
3229178|NCT02332720|3960646|FG004|COMPLETED|Part C||0
3229179|NCT02332720|3960647|FG005|COMPLETED|Part C||0
3229180|NCT02332720|3960648|FG006|COMPLETED|Part C||0
3229181|NCT02332720|3960649|FG007|COMPLETED|Part C||0
3229182|NCT02332720|3960650|FG008|COMPLETED|Part C||0
3229183|NCT02332720|3960651|FG009|COMPLETED|Part C||0
3229184|NCT02332720|3960652|FG010|COMPLETED|Part C||0
3229185|NCT02332720|3960653|FG011|COMPLETED|Part C||0
3229186|NCT02332720|3960654|FG012|COMPLETED|Part C||0
3229187|NCT02332720|3960655|FG013|COMPLETED|Part C||0
3229188|NCT02332720|3960656|FG014|COMPLETED|Part C||0
3229189|NCT02332720|3960657|FG015|COMPLETED|Part C||0
3229190|NCT02332720|3960658|FG016|COMPLETED|Part C||0
3229191|NCT02332720|3960659|FG017|COMPLETED|Part C||0
3229192|NCT02332720|3960660|FG018|COMPLETED|Part C||0
3229193|NCT02332720|3960661|FG019|COMPLETED|Part C||0
3229194|NCT02332720|3960662|FG020|COMPLETED|Part C||0
3229195|NCT02332720|3960663|FG021|COMPLETED|Part C||0
3229196|NCT02332720|3960664|FG022|COMPLETED|Part C||0
3229197|NCT02332720|3960642|FG000|NOT COMPLETED|Part C||0
3229198|NCT02332720|3960643|FG001|NOT COMPLETED|Part C||0
3229199|NCT02332720|3960644|FG002|NOT COMPLETED|Part C||0
3229200|NCT02332720|3960645|FG003|NOT COMPLETED|Part C||0
3229201|NCT02332720|3960646|FG004|NOT COMPLETED|Part C||0
3229202|NCT02332720|3960647|FG005|NOT COMPLETED|Part C||0
3229203|NCT02332720|3960648|FG006|NOT COMPLETED|Part C||0
3229204|NCT02332720|3960649|FG007|NOT COMPLETED|Part C||0
3229205|NCT02332720|3960650|FG008|NOT COMPLETED|Part C||0
3229206|NCT02332720|3960651|FG009|NOT COMPLETED|Part C||0
3229207|NCT02332720|3960652|FG010|NOT COMPLETED|Part C||0
3229208|NCT02332720|3960653|FG011|NOT COMPLETED|Part C||0
3229209|NCT02332720|3960654|FG012|NOT COMPLETED|Part C||0
3229210|NCT02332720|3960655|FG013|NOT COMPLETED|Part C||0
3229211|NCT02332720|3960656|FG014|NOT COMPLETED|Part C||0
3229212|NCT02332720|3960657|FG015|NOT COMPLETED|Part C||0
3229213|NCT02332720|3960658|FG016|NOT COMPLETED|Part C||0
3229214|NCT02332720|3960659|FG017|NOT COMPLETED|Part C||0
3229215|NCT02332720|3960660|FG018|NOT COMPLETED|Part C||0
3229216|NCT02332720|3960661|FG019|NOT COMPLETED|Part C||0
3229217|NCT02332720|3960662|FG020|NOT COMPLETED|Part C||0
3229218|NCT02332720|3960663|FG021|NOT COMPLETED|Part C||0
3229219|NCT02332720|3960664|FG022|NOT COMPLETED|Part C||0
3229220|NCT02332798|3960729|FG000|STARTED|Overall Study||13
3229221|NCT02332798|3960730|FG001|STARTED|Overall Study||14
3229222|NCT02332798|3960731|FG002|STARTED|Overall Study||12
3229223|NCT02332798|3960729|FG000|COMPLETED|Overall Study||12
3229224|NCT02332798|3960730|FG001|COMPLETED|Overall Study||12
3229225|NCT02332798|3960731|FG002|COMPLETED|Overall Study||11
3229226|NCT02332798|3960729|FG000|NOT COMPLETED|Overall Study||1
3229227|NCT02332798|3960730|FG001|NOT COMPLETED|Overall Study||2
3229228|NCT02332798|3960731|FG002|NOT COMPLETED|Overall Study||1
3229229|NCT02332824|3960745|FG000|STARTED|Overall Study||67
3229230|NCT02332824|3960746|FG001|STARTED|Overall Study||67
3229231|NCT02332824|3960747|FG002|STARTED|Overall Study||74
3229232|NCT02332824|3960748|FG003|STARTED|Overall Study||68
3229233|NCT02332824|3960749|FG004|STARTED|Overall Study||69
3229234|NCT02332824|3960750|FG005|STARTED|Overall Study||70
3229235|NCT02332824|3960745|FG000|COMPLETED|Overall Study||61
3229236|NCT02332824|3960746|FG001|COMPLETED|Overall Study||66
3229237|NCT02332824|3960747|FG002|COMPLETED|Overall Study||72
3229238|NCT02332824|3960748|FG003|COMPLETED|Overall Study||66
3229239|NCT02332824|3960749|FG004|COMPLETED|Overall Study||65
3229240|NCT02332824|3960750|FG005|COMPLETED|Overall Study||69
3229241|NCT02332824|3960745|FG000|NOT COMPLETED|Overall Study||6
3229242|NCT02332824|3960746|FG001|NOT COMPLETED|Overall Study||1
3229243|NCT02332824|3960747|FG002|NOT COMPLETED|Overall Study||2
3229244|NCT02332824|3960748|FG003|NOT COMPLETED|Overall Study||2
3229245|NCT02332824|3960749|FG004|NOT COMPLETED|Overall Study||4
3229246|NCT02332824|3960750|FG005|NOT COMPLETED|Overall Study||1
3229247|NCT02332863|3960766|FG000|STARTED|Overall Study||22
3229248|NCT02332863|3960767|FG001|STARTED|Overall Study||22
3229249|NCT02332863|3960766|FG000|COMPLETED|Overall Study||22
3229250|NCT02332863|3960767|FG001|COMPLETED|Overall Study||22
3229251|NCT02332863|3960766|FG000|NOT COMPLETED|Overall Study||0
3229252|NCT02332863|3960767|FG001|NOT COMPLETED|Overall Study||0
3229253|NCT02332876|3960775|FG000|STARTED|Overall Study||43
3229254|NCT02332876|3960776|FG001|STARTED|Overall Study||44
3229255|NCT02332876|3960775|FG000|COMPLETED|Overall Study||42
3229256|NCT02332876|3960776|FG001|COMPLETED|Overall Study||43
3229257|NCT02332876|3960775|FG000|NOT COMPLETED|Overall Study||1
3229258|NCT02332876|3960776|FG001|NOT COMPLETED|Overall Study||1
3229259|NCT02332889|3960782|FG000|STARTED|Overall Study||1
3229260|NCT02332889|3960782|FG000|COMPLETED|Overall Study||0
3229261|NCT02332889|3960782|FG000|NOT COMPLETED|Overall Study||1
3229262|NCT02332902|3960786|FG000|STARTED|Overall Study||24
3229263|NCT02332902|3960786|FG000|COMPLETED|Overall Study||17
3229264|NCT02332902|3960786|FG000|NOT COMPLETED|Overall Study||7
3368829|NCT03831191|4100375|FG002|COMPLETED|Induction Period (16 Weeks)||13
3368830|NCT03831191|4100376|FG003|COMPLETED|Induction Period (16 Weeks)||11
3368831|NCT03831191|4100377|FG004|COMPLETED|Induction Period (16 Weeks)||0
3368832|NCT03831191|4100378|FG005|COMPLETED|Induction Period (16 Weeks)||0
3368833|NCT03831191|4100379|FG006|COMPLETED|Induction Period (16 Weeks)||0
3368834|NCT03831191|4100380|FG007|COMPLETED|Induction Period (16 Weeks)||0
3368835|NCT03831191|4100381|FG008|COMPLETED|Induction Period (16 Weeks)||0
3368836|NCT03831191|4100382|FG009|COMPLETED|Induction Period (16 Weeks)||0
3368837|NCT03831191|4100383|FG010|COMPLETED|Induction Period (16 Weeks)||0
3368838|NCT03831191|4100384|FG011|COMPLETED|Induction Period (16 Weeks)||0
3368839|NCT03831191|4100385|FG012|COMPLETED|Induction Period (16 Weeks)||0
3368840|NCT03831191|4100386|FG013|COMPLETED|Induction Period (16 Weeks)||0
3368841|NCT03831191|4100387|FG014|COMPLETED|Induction Period (16 Weeks)||0
3368842|NCT03831191|4100373|FG000|NOT COMPLETED|Induction Period (16 Weeks)||23
3368843|NCT03831191|4100374|FG001|NOT COMPLETED|Induction Period (16 Weeks)||21
3368844|NCT03831191|4100375|FG002|NOT COMPLETED|Induction Period (16 Weeks)||21
3368845|NCT03831191|4100376|FG003|NOT COMPLETED|Induction Period (16 Weeks)||23
3368846|NCT03831191|4100377|FG004|NOT COMPLETED|Induction Period (16 Weeks)||0
3368847|NCT03831191|4100378|FG005|NOT COMPLETED|Induction Period (16 Weeks)||0
3368848|NCT03831191|4100379|FG006|NOT COMPLETED|Induction Period (16 Weeks)||0
3368849|NCT03831191|4100380|FG007|NOT COMPLETED|Induction Period (16 Weeks)||0
3368850|NCT03831191|4100381|FG008|NOT COMPLETED|Induction Period (16 Weeks)||0
3368851|NCT03831191|4100382|FG009|NOT COMPLETED|Induction Period (16 Weeks)||0
3368852|NCT03831191|4100383|FG010|NOT COMPLETED|Induction Period (16 Weeks)||0
3368853|NCT03831191|4100384|FG011|NOT COMPLETED|Induction Period (16 Weeks)||0
3368854|NCT03831191|4100385|FG012|NOT COMPLETED|Induction Period (16 Weeks)||0
3368855|NCT03831191|4100386|FG013|NOT COMPLETED|Induction Period (16 Weeks)||0
3368856|NCT03831191|4100387|FG014|NOT COMPLETED|Induction Period (16 Weeks)||0
3368857|NCT03831191|4100373|FG000|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during induction period.|0
3368858|NCT03831191|4100374|FG001|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during induction period.|0
3368859|NCT03831191|4100375|FG002|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during induction period.|0
3368860|NCT03831191|4100376|FG003|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during induction period.|0
3368861|NCT03831191|4100377|FG004|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during maintenance period.|4
3368862|NCT03831191|4100378|FG005|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during maintenance period.|5
3368863|NCT03831191|4100379|FG006|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during maintenance period.|2
3368864|NCT03831191|4100380|FG007|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during maintenance period.|4
3368865|NCT03831191|4100381|FG008|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during maintenance period.|8
3368866|NCT03831191|4100382|FG009|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during maintenance period.|1
3368867|NCT03831191|4100383|FG010|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during maintenance period.|4
3368868|NCT03831191|4100384|FG011|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during maintenance period.|8
3368869|NCT03831191|4100385|FG012|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during maintenance period.|1
3368870|NCT03831191|4100386|FG013|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during maintenance period.|1
3368871|NCT03831191|4100387|FG014|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during maintenance period.|9
3368872|NCT03831191|4100373|FG000|COMPLETED|Maintenance Period (36 Weeks)||0
3368873|NCT03831191|4100374|FG001|COMPLETED|Maintenance Period (36 Weeks)||0
3368874|NCT03831191|4100375|FG002|COMPLETED|Maintenance Period (36 Weeks)||0
3368875|NCT03831191|4100376|FG003|COMPLETED|Maintenance Period (36 Weeks)||0
3368876|NCT03831191|4100377|FG004|COMPLETED|Maintenance Period (36 Weeks)||0
3368877|NCT03831191|4100378|FG005|COMPLETED|Maintenance Period (36 Weeks)||0
3368878|NCT03831191|4100379|FG006|COMPLETED|Maintenance Period (36 Weeks)||0
3368879|NCT03831191|4100380|FG007|COMPLETED|Maintenance Period (36 Weeks)||0
3368880|NCT03831191|4100381|FG008|COMPLETED|Maintenance Period (36 Weeks)||0
3368881|NCT03831191|4100382|FG009|COMPLETED|Maintenance Period (36 Weeks)||0
3368882|NCT03831191|4100383|FG010|COMPLETED|Maintenance Period (36 Weeks)||0
3229265|NCT02332915|3960792|FG000|STARTED|Overall Study||18
3229266|NCT02332915|3960793|FG001|STARTED|Overall Study||18
3229267|NCT02332915|3960792|FG000|COMPLETED|Overall Study||12
3229268|NCT02332915|3960793|FG001|COMPLETED|Overall Study||12
3229269|NCT02332915|3960792|FG000|NOT COMPLETED|Overall Study||6
3229270|NCT02332915|3960793|FG001|NOT COMPLETED|Overall Study||6
3229271|NCT02333045|3960803|FG000|STARTED|Overall Study||1
3229272|NCT02333045|3960804|FG001|STARTED|Overall Study||3
3229273|NCT02333045|3960803|FG000|COMPLETED|Overall Study||1
3229274|NCT02333045|3960804|FG001|COMPLETED|Overall Study||3
3229275|NCT02333045|3960803|FG000|NOT COMPLETED|Overall Study||0
3229276|NCT02333045|3960804|FG001|NOT COMPLETED|Overall Study||0
3229277|NCT02333071|3960812|FG000|STARTED|Core Study||326
3229278|NCT02333071|3960813|FG001|STARTED|Core Study||327
3229279|NCT02333071|3960812|FG000|Received Intervention|Core Study||319
3229280|NCT02333071|3960813|FG001|Received Intervention|Core Study||324
3229281|NCT02333071|3960812|FG000|COMPLETED|Core Study||274
3229282|NCT02333071|3960813|FG001|COMPLETED|Core Study||190
3229283|NCT02333071|3960812|FG000|NOT COMPLETED|Core Study||52
3229284|NCT02333071|3960813|FG001|NOT COMPLETED|Core Study||137
3229285|NCT02333071|3960812|FG000|STARTED|Open Label Extension||239
3229286|NCT02333071|3960813|FG001|STARTED|Open Label Extension||124
3229287|NCT02333071|3960812|FG000|COMPLETED|Open Label Extension||95
3229288|NCT02333071|3960813|FG001|COMPLETED|Open Label Extension||49
3229289|NCT02333071|3960812|FG000|NOT COMPLETED|Open Label Extension||144
3229290|NCT02333071|3960813|FG001|NOT COMPLETED|Open Label Extension||75
3229291|NCT02333331|3960828|FG000|STARTED|Overall Study||19
3229292|NCT02333331|3960829|FG001|STARTED|Overall Study||18
3229293|NCT02333331|3960830|FG002|STARTED|Overall Study||113
3229294|NCT02333331|3960831|FG003|STARTED|Overall Study||67
3229295|NCT02333331|3960828|FG000|COMPLETED|Overall Study||17
3229296|NCT02333331|3960829|FG001|COMPLETED|Overall Study||12
3229297|NCT02333331|3960830|FG002|COMPLETED|Overall Study||95
3229298|NCT02333331|3960831|FG003|COMPLETED|Overall Study||64
3229299|NCT02333331|3960828|FG000|NOT COMPLETED|Overall Study||2
3229300|NCT02333331|3960829|FG001|NOT COMPLETED|Overall Study||6
3229301|NCT02333331|3960830|FG002|NOT COMPLETED|Overall Study||18
3229302|NCT02333331|3960831|FG003|NOT COMPLETED|Overall Study||3
3229303|NCT02333383|3960841|FG000|STARTED|Overall Study||201
3229304|NCT02333383|3960841|FG000|COMPLETED|Overall Study||160
3229305|NCT02333383|3960841|FG000|NOT COMPLETED|Overall Study||41
3229306|NCT02333487|3960848|FG000|STARTED|Overall Study||6
3229307|NCT02333487|3960849|FG001|STARTED|Overall Study||8
3229308|NCT02333487|3960850|FG002|STARTED|Overall Study||8
3229309|NCT02333487|3960848|FG000|COMPLETED|Overall Study||6
3229310|NCT02333487|3960849|FG001|COMPLETED|Overall Study||6
3229311|NCT02333487|3960850|FG002|COMPLETED|Overall Study||8
3229312|NCT02333487|3960848|FG000|NOT COMPLETED|Overall Study||0
3229313|NCT02333487|3960849|FG001|NOT COMPLETED|Overall Study||2
3229314|NCT02333487|3960850|FG002|NOT COMPLETED|Overall Study||0
3229315|NCT02333630|3960861|FG000|STARTED|Overall Study||100
3229316|NCT02333630|3960862|FG001|STARTED|Overall Study||100
3229317|NCT02333630|3960861|FG000|COMPLETED|Overall Study||95
3229318|NCT02333630|3960862|FG001|COMPLETED|Overall Study||98
3229319|NCT02333630|3960861|FG000|NOT COMPLETED|Overall Study||5
3229320|NCT02333630|3960862|FG001|NOT COMPLETED|Overall Study||2
3229321|NCT02334059|3960875|FG000|STARTED|Overall Study||37
3229322|NCT02334059|3960876|FG001|STARTED|Overall Study||34
3229323|NCT02334059|3960877|FG002|STARTED|Overall Study||37
3229324|NCT02334059|3960875|FG000|COMPLETED|Overall Study||37
3229325|NCT02334059|3960876|FG001|COMPLETED|Overall Study||34
3229326|NCT02334059|3960877|FG002|COMPLETED|Overall Study||37
3229327|NCT02334059|3960875|FG000|NOT COMPLETED|Overall Study||0
3229328|NCT02334059|3960876|FG001|NOT COMPLETED|Overall Study||0
3229329|NCT02334059|3960877|FG002|NOT COMPLETED|Overall Study||0
3229330|NCT02334215|3960888|FG000|STARTED|Overall Study||75
3229331|NCT02334215|3960889|FG001|STARTED|Overall Study||74
3229332|NCT02334215|3960890|FG002|STARTED|Overall Study||76
3229333|NCT02334215|3960888|FG000|COMPLETED|Overall Study||68
3229334|NCT02334215|3960889|FG001|COMPLETED|Overall Study||68
3229335|NCT02334215|3960890|FG002|COMPLETED|Overall Study||61
3229336|NCT02334215|3960888|FG000|NOT COMPLETED|Overall Study||7
3229337|NCT02334215|3960889|FG001|NOT COMPLETED|Overall Study||6
3229338|NCT02334215|3960890|FG002|NOT COMPLETED|Overall Study||15
3229339|NCT02334267|3960900|FG000|STARTED|Overall Study||6
3229340|NCT02334267|3960901|FG001|STARTED|Overall Study||5
3229341|NCT02334267|3960900|FG000|COMPLETED|Overall Study||5
3229342|NCT02334267|3960901|FG001|COMPLETED|Overall Study||5
3229343|NCT02334267|3960900|FG000|NOT COMPLETED|Overall Study||1
3229344|NCT02334267|3960901|FG001|NOT COMPLETED|Overall Study||0
3229345|NCT02334306|3960915|FG000|STARTED|Double-blind Period||16
3229346|NCT02334306|3960916|FG001|STARTED|Double-blind Period||16
3229347|NCT02334306|3960915|FG000|COMPLETED|Double-blind Period||15
3229348|NCT02334306|3960916|FG001|COMPLETED|Double-blind Period||14
3229349|NCT02334306|3960915|FG000|NOT COMPLETED|Double-blind Period||1
3229350|NCT02334306|3960916|FG001|NOT COMPLETED|Double-blind Period||2
3229351|NCT02334306|3960915|FG000|STARTED|Open-label Period||15
3229352|NCT02334306|3960916|FG001|STARTED|Open-label Period||14
3229353|NCT02334306|3960915|FG000|COMPLETED|Open-label Period||15
3229354|NCT02334306|3960916|FG001|COMPLETED|Open-label Period||14
3229355|NCT02334306|3960915|FG000|NOT COMPLETED|Open-label Period||0
3229356|NCT02334306|3960916|FG001|NOT COMPLETED|Open-label Period||0
3229357|NCT02334358|3960923|FG000|STARTED|Overall Study||503
3229358|NCT02334358|3960923|FG000|COMPLETED|Overall Study||494
3229359|NCT02334358|3960923|FG000|NOT COMPLETED|Overall Study||9
3229360|NCT02334384|3960929|FG000|STARTED|Overall Study||4
3229361|NCT02334384|3960930|FG001|STARTED|Overall Study||2
3229362|NCT02334384|3960929|FG000|COMPLETED|Overall Study||3
3229363|NCT02334384|3960930|FG001|COMPLETED|Overall Study||1
3229364|NCT02334384|3960929|FG000|NOT COMPLETED|Overall Study||1
3229365|NCT02334384|3960930|FG001|NOT COMPLETED|Overall Study||1
3229366|NCT02334423|3960938|FG000|STARTED|Overall Study||246
3229367|NCT02334423|3960939|FG001|STARTED|Overall Study||84
3229368|NCT02334423|3960938|FG000|COMPLETED|Overall Study||236
3229369|NCT02334423|3960939|FG001|COMPLETED|Overall Study||81
3229370|NCT02334423|3960938|FG000|NOT COMPLETED|Overall Study||10
3229371|NCT02334423|3960939|FG001|NOT COMPLETED|Overall Study||3
3229372|NCT02334436|3960947|FG000|STARTED|Overall Study||246
3229373|NCT02334436|3960948|FG001|STARTED|Overall Study||78
3229374|NCT02334436|3960947|FG000|COMPLETED|Overall Study||237
3229375|NCT02334436|3960948|FG001|COMPLETED|Overall Study||77
3229376|NCT02334436|3960947|FG000|NOT COMPLETED|Overall Study||9
3229377|NCT02334436|3960948|FG001|NOT COMPLETED|Overall Study||1
3229378|NCT02334527|3960954|FG000|STARTED|Overall Study||12
3229379|NCT02334527|3960954|FG000|COMPLETED|Overall Study||12
3229380|NCT02334527|3960954|FG000|NOT COMPLETED|Overall Study||0
3229381|NCT02334683|3960964|FG000|STARTED|First 12 Week Period||10
3229382|NCT02334683|3960965|FG001|STARTED|First 12 Week Period||10
3229383|NCT02334683|3960964|FG000|COMPLETED|First 12 Week Period||9
3229384|NCT02334683|3960965|FG001|COMPLETED|First 12 Week Period||10
3229385|NCT02334683|3960964|FG000|NOT COMPLETED|First 12 Week Period||1
3229386|NCT02334683|3960965|FG001|NOT COMPLETED|First 12 Week Period||0
3229387|NCT02334683|3960964|FG000|STARTED|Second 12 Week Period||9
3229388|NCT02334683|3960965|FG001|STARTED|Second 12 Week Period||10
3229389|NCT02334683|3960964|FG000|COMPLETED|Second 12 Week Period||9
3229390|NCT02334683|3960965|FG001|COMPLETED|Second 12 Week Period||9
3229391|NCT02334683|3960964|FG000|NOT COMPLETED|Second 12 Week Period||0
3229392|NCT02334683|3960965|FG001|NOT COMPLETED|Second 12 Week Period||1
3229393|NCT02334748|3960971|FG000|STARTED|Overall Study||31
3229394|NCT02334748|3960971|FG000|COMPLETED|Overall Study||23
3229395|NCT02334748|3960971|FG000|NOT COMPLETED|Overall Study||8
3229396|NCT02334787|3960979|FG000|STARTED|Overall Study||8
3229397|NCT02334787|3960980|FG001|STARTED|Overall Study||8
3229398|NCT02334787|3960981|FG002|STARTED|Overall Study||8
3229399|NCT02334787|3960982|FG003|STARTED|Overall Study||8
3229400|NCT02334787|3960979|FG000|COMPLETED|Overall Study||8
3229401|NCT02334787|3960980|FG001|COMPLETED|Overall Study||8
3229402|NCT02334787|3960981|FG002|COMPLETED|Overall Study||8
3229403|NCT02334787|3960982|FG003|COMPLETED|Overall Study||8
3229404|NCT02334787|3960979|FG000|NOT COMPLETED|Overall Study||0
3229405|NCT02334787|3960980|FG001|NOT COMPLETED|Overall Study||0
3229406|NCT02334787|3960981|FG002|NOT COMPLETED|Overall Study||0
3229407|NCT02334787|3960982|FG003|NOT COMPLETED|Overall Study||0
3229408|NCT02334800|3961002|FG000|STARTED|Overall Study||7
3229409|NCT02334800|3961003|FG001|STARTED|Overall Study||7
3229410|NCT02334800|3961004|FG002|STARTED|Overall Study||7
3229411|NCT02334800|3961005|FG003|STARTED|Overall Study||7
3229412|NCT02334800|3961002|FG000|Received Treatment|Overall Study||7
3229413|NCT02334800|3961003|FG001|Received Treatment|Overall Study||7
3229414|NCT02334800|3961004|FG002|Received Treatment|Overall Study||7
3229415|NCT02334800|3961005|FG003|Received Treatment|Overall Study||7
3229416|NCT02334800|3961002|FG000|COMPLETED|Overall Study||7
3229417|NCT02334800|3961003|FG001|COMPLETED|Overall Study||7
3229418|NCT02334800|3961004|FG002|COMPLETED|Overall Study||7
3229419|NCT02334800|3961005|FG003|COMPLETED|Overall Study||7
3229420|NCT02334800|3961002|FG000|NOT COMPLETED|Overall Study||0
3229421|NCT02334800|3961003|FG001|NOT COMPLETED|Overall Study||0
3229422|NCT02334800|3961004|FG002|NOT COMPLETED|Overall Study||0
3229423|NCT02334800|3961005|FG003|NOT COMPLETED|Overall Study||0
3229424|NCT02334813|3961017|FG000|STARTED|Overall Study||12
3229425|NCT02334813|3961018|FG001|STARTED|Overall Study||14
3229426|NCT02334813|3961017|FG000|COMPLETED|Overall Study||9
3229427|NCT02334813|3961018|FG001|COMPLETED|Overall Study||13
3229428|NCT02334813|3961017|FG000|NOT COMPLETED|Overall Study||3
3229429|NCT02334813|3961018|FG001|NOT COMPLETED|Overall Study||1
3229430|NCT02334982|3961031|FG000|STARTED|Overall Study||6
3229431|NCT02334982|3961032|FG001|STARTED|Overall Study||5
3229432|NCT02334982|3961033|FG002|STARTED|Overall Study||6
3229433|NCT02334982|3961034|FG003|STARTED|Overall Study||6
3229434|NCT02334982|3961035|FG004|STARTED|Overall Study||6
3229435|NCT02334982|3961036|FG005|STARTED|Overall Study||6
3229436|NCT02334982|3961037|FG006|STARTED|Overall Study||12
3229437|NCT02334982|3961031|FG000|COMPLETED|Overall Study||6
3229438|NCT02334982|3961032|FG001|COMPLETED|Overall Study||5
3229439|NCT02334982|3961033|FG002|COMPLETED|Overall Study||6
3229440|NCT02334982|3961034|FG003|COMPLETED|Overall Study||6
3229441|NCT02334982|3961035|FG004|COMPLETED|Overall Study||6
3229442|NCT02334982|3961036|FG005|COMPLETED|Overall Study||6
3229443|NCT02334982|3961037|FG006|COMPLETED|Overall Study||12
3229444|NCT02334982|3961031|FG000|NOT COMPLETED|Overall Study||0
3229445|NCT02334982|3961032|FG001|NOT COMPLETED|Overall Study||0
3229446|NCT02334982|3961033|FG002|NOT COMPLETED|Overall Study||0
3229447|NCT02334982|3961034|FG003|NOT COMPLETED|Overall Study||0
3229448|NCT02334982|3961035|FG004|NOT COMPLETED|Overall Study||0
3229449|NCT02334982|3961036|FG005|NOT COMPLETED|Overall Study||0
3229450|NCT02334982|3961037|FG006|NOT COMPLETED|Overall Study||0
3229451|NCT02335125|3961066|FG000|STARTED|Overall Study||20
3229452|NCT02335125|3961067|FG001|STARTED|Overall Study||20
3229453|NCT02335125|3961066|FG000|COMPLETED|Overall Study||20
3229454|NCT02335125|3961067|FG001|COMPLETED|Overall Study||20
3229455|NCT02335125|3961066|FG000|NOT COMPLETED|Overall Study||0
3229456|NCT02335125|3961067|FG001|NOT COMPLETED|Overall Study||0
3229457|NCT02335216|3961073|FG000|STARTED|Overall Study||22
3229458|NCT02335216|3961073|FG000|Received Trial System|Overall Study||16
3229459|NCT02335216|3961073|FG000|Received Permanent System|Overall Study||13
3229460|NCT02335216|3961073|FG000|COMPLETED|Overall Study||9
3229461|NCT02335216|3961073|FG000|NOT COMPLETED|Overall Study||13
3229462|NCT02335229|3961077|FG000|STARTED|Overall Study||30
3229463|NCT02335229|3961077|FG000|Received Trial System|Overall Study||10
3229464|NCT02335229|3961077|FG000|Received Permanent System|Overall Study||26
3229465|NCT02335229|3961077|FG000|COMPLETED|Overall Study||23
3229466|NCT02335229|3961077|FG000|NOT COMPLETED|Overall Study||7
3229467|NCT02335294|3961087|FG000|STARTED|Overall Study||39
3229468|NCT02335294|3961088|FG001|STARTED|Overall Study||42
3229469|NCT02335294|3961089|FG002|STARTED|Overall Study||19
3229470|NCT02335294|3961090|FG003|STARTED|Overall Study||39
3229471|NCT02335294|3961091|FG004|STARTED|Overall Study||41
3229472|NCT02335294|3961092|FG005|STARTED|Overall Study||20
3229473|NCT02335294|3961087|FG000|COMPLETED|Overall Study||36
3229474|NCT02335294|3961088|FG001|COMPLETED|Overall Study||38
3229475|NCT02335294|3961089|FG002|COMPLETED|Overall Study||18
3229476|NCT02335294|3961090|FG003|COMPLETED|Overall Study||36
3229477|NCT02335294|3961091|FG004|COMPLETED|Overall Study||39
3229478|NCT02335294|3961092|FG005|COMPLETED|Overall Study||19
3229479|NCT02335294|3961087|FG000|NOT COMPLETED|Overall Study||3
3229480|NCT02335294|3961088|FG001|NOT COMPLETED|Overall Study||4
3229481|NCT02335294|3961089|FG002|NOT COMPLETED|Overall Study||1
3229482|NCT02335294|3961090|FG003|NOT COMPLETED|Overall Study||3
3229483|NCT02335294|3961091|FG004|NOT COMPLETED|Overall Study||2
3229484|NCT02335294|3961092|FG005|NOT COMPLETED|Overall Study||1
3229485|NCT02335346|3961106|FG000|STARTED|Overall Study||93
3229486|NCT02335346|3961106|FG000|Received At Least 1 Dose of Study Drug|Overall Study||93
3229487|NCT02335346|3961106|FG000|COMPLETED|Overall Study||81
3229488|NCT02335346|3961106|FG000|NOT COMPLETED|Overall Study||12
3229489|NCT02335450|3961110|FG000|STARTED|Overall Study||5
3229490|NCT02335450|3961110|FG000|COMPLETED|Overall Study||4
3229491|NCT02335450|3961110|FG000|NOT COMPLETED|Overall Study||1
3229492|NCT02335489|3961120|FG000|STARTED|Overall Study||10
3229493|NCT02335489|3961120|FG000|Received Trial System|Overall Study||9
3229494|NCT02335489|3961120|FG000|Receiving Permanent System|Overall Study||8
3229495|NCT02335489|3961120|FG000|COMPLETED|Overall Study||0
3229496|NCT02335489|3961120|FG000|NOT COMPLETED|Overall Study||10
3229497|NCT02335502|3961124|FG000|STARTED|Overall Study||66
3229498|NCT02335502|3961124|FG000|Received Trial System|Overall Study||65
3229499|NCT02335502|3961124|FG000|Receiving Permanent System|Overall Study||56
3229500|NCT02335502|3961124|FG000|COMPLETED|Overall Study||49
3229501|NCT02335502|3961124|FG000|NOT COMPLETED|Overall Study||17
3229502|NCT02335658|3961130|FG000|STARTED|Overall Study|97 subjects in Cohort 1 and 103 subjects in Cohort 2 started to receive DSP-5423P.|97
3229503|NCT02335658|3961131|FG001|STARTED|Overall Study||103
3229504|NCT02335658|3961130|FG000|COMPLETED|Overall Study|57 subjects in Cohort 1 and 59 subjects in Cohort 2 completed the study.|57
3229505|NCT02335658|3961131|FG001|COMPLETED|Overall Study||59
3229506|NCT02335658|3961130|FG000|NOT COMPLETED|Overall Study||40
3229507|NCT02335658|3961131|FG001|NOT COMPLETED|Overall Study||44
3229508|NCT02335710|3961141|FG000|STARTED|Overall Study||40
3229509|NCT02335710|3961142|FG001|STARTED|Overall Study||10
3229510|NCT02335710|3961141|FG000|COMPLETED|Overall Study||40
3229511|NCT02335710|3961142|FG001|COMPLETED|Overall Study||10
3229512|NCT02335710|3961141|FG000|NOT COMPLETED|Overall Study||0
3229513|NCT02335710|3961142|FG001|NOT COMPLETED|Overall Study||0
3229514|NCT02335905|3961148|FG000|STARTED|Overall Study||11
3229515|NCT02335905|3961148|FG000|COMPLETED|Overall Study||7
3229516|NCT02335905|3961148|FG000|NOT COMPLETED|Overall Study||4
3229517|NCT02335983|3961158|FG000|STARTED|Overall Study||10
3229518|NCT02335983|3961159|FG001|STARTED|Overall Study||12
3229519|NCT02335983|3961160|FG002|STARTED|Overall Study||34
3229520|NCT02335983|3961161|FG003|STARTED|Overall Study||9
3229521|NCT02335983|3961162|FG004|STARTED|Overall Study||9
3229522|NCT02335983|3961163|FG005|STARTED|Overall Study||33
3229523|NCT02335983|3961158|FG000|COMPLETED|Overall Study||2
3229524|NCT02335983|3961159|FG001|COMPLETED|Overall Study||3
3229525|NCT02335983|3961160|FG002|COMPLETED|Overall Study||2
3229526|NCT02335983|3961161|FG003|COMPLETED|Overall Study||0
3229527|NCT02335983|3961162|FG004|COMPLETED|Overall Study||1
3229528|NCT02335983|3961163|FG005|COMPLETED|Overall Study||1
3229529|NCT02335983|3961158|FG000|NOT COMPLETED|Overall Study||8
3229530|NCT02335983|3961159|FG001|NOT COMPLETED|Overall Study||9
3229531|NCT02335983|3961160|FG002|NOT COMPLETED|Overall Study||32
3229532|NCT02335983|3961161|FG003|NOT COMPLETED|Overall Study||9
3229533|NCT02335983|3961162|FG004|NOT COMPLETED|Overall Study||8
3229534|NCT02335983|3961163|FG005|NOT COMPLETED|Overall Study||32
3229535|NCT02336074|3961188|FG000|STARTED|Overall Study||30
3229536|NCT02336074|3961189|FG001|STARTED|Overall Study||30
3229537|NCT02336074|3961188|FG000|COMPLETED|Overall Study||30
3229538|NCT02336074|3961189|FG001|COMPLETED|Overall Study||28
3229539|NCT02336074|3961188|FG000|NOT COMPLETED|Overall Study||0
3229540|NCT02336074|3961189|FG001|NOT COMPLETED|Overall Study||2
3229541|NCT02336165|3961205|FG000|STARTED|Overall Study||40
3229542|NCT02336165|3961206|FG001|STARTED|Overall Study||31
3229543|NCT02336165|3961207|FG002|STARTED|Overall Study||33
3229544|NCT02336165|3961208|FG003|STARTED|Overall Study||33
3229545|NCT02336165|3961209|FG004|STARTED|Overall Study||22
3229546|NCT02336165|3961205|FG000|COMPLETED|Overall Study||6
3229547|NCT02336165|3961206|FG001|COMPLETED|Overall Study||6
3229548|NCT02336165|3961207|FG002|COMPLETED|Overall Study||2
3229549|NCT02336165|3961208|FG003|COMPLETED|Overall Study||2
3229550|NCT02336165|3961209|FG004|COMPLETED|Overall Study||0
3229551|NCT02336165|3961205|FG000|NOT COMPLETED|Overall Study||34
3229552|NCT02336165|3961206|FG001|NOT COMPLETED|Overall Study||25
3229553|NCT02336165|3961207|FG002|NOT COMPLETED|Overall Study||31
3229554|NCT02336165|3961208|FG003|NOT COMPLETED|Overall Study||31
3229555|NCT02336165|3961209|FG004|NOT COMPLETED|Overall Study||22
3229556|NCT02336178|3961225|FG000|STARTED|Overall Study||70
3229557|NCT02336178|3961225|FG000|COMPLETED|Overall Study||66
3229558|NCT02336178|3961225|FG000|NOT COMPLETED|Overall Study||4
3229559|NCT02336282|3961237|FG000|STARTED|Overall Study||33
3229560|NCT02336282|3961237|FG000|COMPLETED|Overall Study||28
3229561|NCT02336282|3961237|FG000|NOT COMPLETED|Overall Study||5
3229562|NCT02336360|3961249|FG000|STARTED|Overall Study||6
3229563|NCT02336360|3961249|FG000|COMPLETED|Overall Study||6
3229564|NCT02336360|3961249|FG000|NOT COMPLETED|Overall Study||0
3229565|NCT02336373|3961253|FG000|STARTED|Overall Study||32
3229566|NCT02336373|3961253|FG000|COMPLETED|Overall Study||14
3229567|NCT02336373|3961253|FG000|NOT COMPLETED|Overall Study||18
3229568|NCT02336438|3961259|FG000|STARTED|Overall Study||11
3229569|NCT02336438|3961259|FG000|COMPLETED|Overall Study||10
3229570|NCT02336438|3961259|FG000|NOT COMPLETED|Overall Study||1
3229571|NCT02336451|3961268|FG000|STARTED|Overall Study||42
3229572|NCT02336451|3961269|FG001|STARTED|Overall Study||40
3229573|NCT02336451|3961270|FG002|STARTED|Overall Study||12
3229574|NCT02336451|3961271|FG003|STARTED|Overall Study||44
3229575|NCT02336451|3961272|FG004|STARTED|Overall Study||18
3229576|NCT02336451|3961268|FG000|COMPLETED|Overall Study||0
3229577|NCT02336451|3961269|FG001|COMPLETED|Overall Study||0
3229578|NCT02336451|3961270|FG002|COMPLETED|Overall Study||0
3229579|NCT02336451|3961271|FG003|COMPLETED|Overall Study||0
3229580|NCT02336451|3961272|FG004|COMPLETED|Overall Study||0
3229581|NCT02336451|3961268|FG000|NOT COMPLETED|Overall Study||42
3229582|NCT02336451|3961269|FG001|NOT COMPLETED|Overall Study||40
3229583|NCT02336451|3961270|FG002|NOT COMPLETED|Overall Study||12
3229584|NCT02336451|3961271|FG003|NOT COMPLETED|Overall Study||44
3229585|NCT02336451|3961272|FG004|NOT COMPLETED|Overall Study||18
3229586|NCT02336555|3961288|FG000|STARTED|Treatment Period 1 (28 Days)||18
3229587|NCT02336555|3961289|FG001|STARTED|Treatment Period 1 (28 Days)||17
3229588|NCT02336555|3961288|FG000|COMPLETED|Treatment Period 1 (28 Days)||16
3229589|NCT02336555|3961289|FG001|COMPLETED|Treatment Period 1 (28 Days)||16
3229590|NCT02336555|3961288|FG000|NOT COMPLETED|Treatment Period 1 (28 Days)||2
3229591|NCT02336555|3961289|FG001|NOT COMPLETED|Treatment Period 1 (28 Days)||1
3229592|NCT02336555|3961288|FG000|STARTED|Treatment Period 2 (28 Days)||16
3229593|NCT02336555|3961289|FG001|STARTED|Treatment Period 2 (28 Days)||16
3229594|NCT02336555|3961288|FG000|COMPLETED|Treatment Period 2 (28 Days)||16
3229595|NCT02336555|3961289|FG001|COMPLETED|Treatment Period 2 (28 Days)||15
3229596|NCT02336555|3961288|FG000|NOT COMPLETED|Treatment Period 2 (28 Days)||0
3229597|NCT02336555|3961289|FG001|NOT COMPLETED|Treatment Period 2 (28 Days)||1
3229598|NCT02336594|3961299|FG000|STARTED|Overall Study||3
3229599|NCT02336594|3961300|FG001|STARTED|Overall Study||4
3229600|NCT02336594|3961301|FG002|STARTED|Overall Study||4
3229601|NCT02336594|3961302|FG003|STARTED|Overall Study||4
3229602|NCT02336594|3961299|FG000|COMPLETED|Overall Study||3
3229603|NCT02336594|3961300|FG001|COMPLETED|Overall Study||4
3229604|NCT02336594|3961301|FG002|COMPLETED|Overall Study||4
3229605|NCT02336594|3961302|FG003|COMPLETED|Overall Study||4
3229606|NCT02336594|3961299|FG000|NOT COMPLETED|Overall Study||0
3229607|NCT02336594|3961300|FG001|NOT COMPLETED|Overall Study||0
3229608|NCT02336594|3961301|FG002|NOT COMPLETED|Overall Study||0
3229609|NCT02336594|3961302|FG003|NOT COMPLETED|Overall Study||0
3229610|NCT02336607|3961319|FG000|STARTED|Overall Study||85
3229611|NCT02336607|3961320|FG001|STARTED|Overall Study||85
3229612|NCT02336607|3961321|FG002|STARTED|Overall Study||92
3229613|NCT02336607|3961322|FG003|STARTED|Overall Study||267
3229614|NCT02336607|3961319|FG000|Patients Included in ITT Population|Overall Study||84
3229615|NCT02336607|3961320|FG001|Patients Included in ITT Population|Overall Study||84
3229616|NCT02336607|3961321|FG002|Patients Included in ITT Population|Overall Study||91
3229617|NCT02336607|3961322|FG003|Patients Included in ITT Population|Overall Study||222
3229618|NCT02336607|3961319|FG000|Patients Included in PP Population|Overall Study||78
3229619|NCT02336607|3961320|FG001|Patients Included in PP Population|Overall Study||75
3229620|NCT02336607|3961321|FG002|Patients Included in PP Population|Overall Study||75
3229621|NCT02336607|3961322|FG003|Patients Included in PP Population|Overall Study||162
3229622|NCT02336607|3961319|FG000|Patients Included in Safety Population|Overall Study||85
3229623|NCT02336607|3961320|FG001|Patients Included in Safety Population|Overall Study||85
3229624|NCT02336607|3961321|FG002|Patients Included in Safety Population|Overall Study||92
3229625|NCT02336607|3961322|FG003|Patients Included in Safety Population|Overall Study||260
3229626|NCT02336607|3961319|FG000|COMPLETED|Overall Study||81
3229627|NCT02336607|3961320|FG001|COMPLETED|Overall Study||75
3229628|NCT02336607|3961321|FG002|COMPLETED|Overall Study||86
3229629|NCT02336607|3961322|FG003|COMPLETED|Overall Study||180
3229630|NCT02336607|3961319|FG000|NOT COMPLETED|Overall Study||4
3229631|NCT02336607|3961320|FG001|NOT COMPLETED|Overall Study||10
3229632|NCT02336607|3961321|FG002|NOT COMPLETED|Overall Study||6
3229633|NCT02336607|3961322|FG003|NOT COMPLETED|Overall Study||87
3229634|NCT02336737|3961332|FG000|STARTED|Overall Study||160
3229635|NCT02336737|3961332|FG000|COMPLETED|Overall Study||147
3229636|NCT02336737|3961332|FG000|NOT COMPLETED|Overall Study||13
3229637|NCT02336815|3961339|FG000|STARTED|Overall Study||79
3229638|NCT02336815|3961340|FG001|STARTED|Overall Study||123
3229639|NCT02336815|3961339|FG000|COMPLETED|Overall Study||0
3229640|NCT02336815|3961340|FG001|COMPLETED|Overall Study||0
3229641|NCT02336815|3961339|FG000|NOT COMPLETED|Overall Study||79
3229642|NCT02336815|3961340|FG001|NOT COMPLETED|Overall Study||123
3229643|NCT02336958|3961350|FG000|STARTED|Overall Study||20
3229644|NCT02336958|3961351|FG001|STARTED|Overall Study||20
3229645|NCT02336958|3961350|FG000|COMPLETED|Overall Study||20
3229646|NCT02336958|3961351|FG001|COMPLETED|Overall Study||20
3229647|NCT02336958|3961350|FG000|NOT COMPLETED|Overall Study||0
3229648|NCT02336958|3961351|FG001|NOT COMPLETED|Overall Study||0
3229649|NCT02337062|3961359|FG000|STARTED|Overall Study||572
3229650|NCT02337062|3961360|FG001|STARTED|Overall Study||575
3229651|NCT02337062|3961359|FG000|COMPLETED|Overall Study||555
3229652|NCT02337062|3961360|FG001|COMPLETED|Overall Study||556
3229653|NCT02337062|3961359|FG000|NOT COMPLETED|Overall Study||17
3229654|NCT02337062|3961360|FG001|NOT COMPLETED|Overall Study||19
3229655|NCT02337218|3961370|FG000|STARTED|Overall Study||17
3229656|NCT02337218|3961371|FG001|STARTED|Overall Study||11
3229657|NCT02337218|3961370|FG000|COMPLETED|Overall Study||17
3229658|NCT02337218|3961371|FG001|COMPLETED|Overall Study||11
3229659|NCT02337218|3961370|FG000|NOT COMPLETED|Overall Study||0
3229660|NCT02337218|3961371|FG001|NOT COMPLETED|Overall Study||0
3229661|NCT02337361|3961379|FG000|STARTED|Baseline Assessment||99
3229662|NCT02337361|3961380|FG001|STARTED|Baseline Assessment||86
3229663|NCT02337361|3961379|FG000|COMPLETED|Baseline Assessment||99
3229664|NCT02337361|3961380|FG001|COMPLETED|Baseline Assessment||86
3229665|NCT02337361|3961379|FG000|NOT COMPLETED|Baseline Assessment||0
3229666|NCT02337361|3961380|FG001|NOT COMPLETED|Baseline Assessment||0
3229667|NCT02337361|3961379|FG000|STARTED|3-month Follow-up||99
3229668|NCT02337361|3961380|FG001|STARTED|3-month Follow-up||86
3229669|NCT02337361|3961379|FG000|COMPLETED|3-month Follow-up||80
3229670|NCT02337361|3961380|FG001|COMPLETED|3-month Follow-up||72
3229671|NCT02337361|3961379|FG000|NOT COMPLETED|3-month Follow-up||19
3229672|NCT02337361|3961380|FG001|NOT COMPLETED|3-month Follow-up||14
3229673|NCT02337361|3961379|FG000|STARTED|6-month Follow-up||80
3229674|NCT02337361|3961380|FG001|STARTED|6-month Follow-up||72
3229675|NCT02337361|3961379|FG000|COMPLETED|6-month Follow-up||78
3229676|NCT02337361|3961380|FG001|COMPLETED|6-month Follow-up||68
3229677|NCT02337361|3961379|FG000|NOT COMPLETED|6-month Follow-up||2
3229678|NCT02337361|3961380|FG001|NOT COMPLETED|6-month Follow-up||4
3229679|NCT02337387|3961391|FG000|STARTED|Overall Study||14
3229680|NCT02337387|3961392|FG001|STARTED|Overall Study||8
3229681|NCT02337387|3961393|FG002|STARTED|Overall Study||3
3229682|NCT02337387|3961394|FG003|STARTED|Overall Study||3
3368883|NCT03831191|4100384|FG011|COMPLETED|Maintenance Period (36 Weeks)||1
3368884|NCT03831191|4100385|FG012|COMPLETED|Maintenance Period (36 Weeks)||0
3229683|NCT02337387|3961391|FG000|Received at Least 1 Dose of Study Drug|Overall Study||14
3229684|NCT02337387|3961392|FG001|Received at Least 1 Dose of Study Drug|Overall Study||8
3229685|NCT02337387|3961393|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3
3229686|NCT02337387|3961394|FG003|Received at Least 1 Dose of Study Drug|Overall Study||3
3229687|NCT02337387|3961391|FG000|COMPLETED|Overall Study||0
3229688|NCT02337387|3961392|FG001|COMPLETED|Overall Study||0
3229689|NCT02337387|3961393|FG002|COMPLETED|Overall Study||0
3229690|NCT02337387|3961394|FG003|COMPLETED|Overall Study||0
3229691|NCT02337387|3961391|FG000|NOT COMPLETED|Overall Study||14
3229692|NCT02337387|3961392|FG001|NOT COMPLETED|Overall Study||8
3229693|NCT02337387|3961393|FG002|NOT COMPLETED|Overall Study||3
3229694|NCT02337387|3961394|FG003|NOT COMPLETED|Overall Study||3
3229695|NCT02337465|3961404|FG000|STARTED|Overall Study||30
3229696|NCT02337465|3961404|FG000|COMPLETED|Overall Study||30
3229697|NCT02337465|3961404|FG000|NOT COMPLETED|Overall Study||0
3229698|NCT02337478|3961408|FG000|STARTED|Overall Study||5
3229699|NCT02337478|3961408|FG000|COMPLETED|Overall Study||0
3229700|NCT02337478|3961408|FG000|NOT COMPLETED|Overall Study||5
3229701|NCT02337491|3961414|FG000|STARTED|Overall Study||50
3229702|NCT02337491|3961415|FG001|STARTED|Overall Study||30
3229703|NCT02337491|3961414|FG000|COMPLETED|Overall Study||0
3229704|NCT02337491|3961415|FG001|COMPLETED|Overall Study||0
3229705|NCT02337491|3961414|FG000|NOT COMPLETED|Overall Study||50
3229706|NCT02337491|3961415|FG001|NOT COMPLETED|Overall Study||30
3229707|NCT02337517|3961422|FG000|STARTED|Overall Study||6
3229708|NCT02337517|3961422|FG000|COMPLETED|Overall Study||6
3229709|NCT02337517|3961422|FG000|NOT COMPLETED|Overall Study||0
3229710|NCT02337530|3961429|FG000|STARTED|Overall Study||20
3229711|NCT02337530|3961430|FG001|STARTED|Overall Study||21
3229712|NCT02337530|3961431|FG002|STARTED|Overall Study||21
3229713|NCT02337530|3961429|FG000|COMPLETED|Overall Study||20
3229714|NCT02337530|3961430|FG001|COMPLETED|Overall Study||21
3229715|NCT02337530|3961431|FG002|COMPLETED|Overall Study||21
3229716|NCT02337530|3961429|FG000|NOT COMPLETED|Overall Study||0
3229717|NCT02337530|3961430|FG001|NOT COMPLETED|Overall Study||0
3229718|NCT02337530|3961431|FG002|NOT COMPLETED|Overall Study||0
3229719|NCT02337725|3961441|FG000|STARTED|Overall Study||126
3229720|NCT02337725|3961442|FG001|STARTED|Overall Study||118
3229721|NCT02337725|3961441|FG000|COMPLETED|Overall Study||100
3229722|NCT02337725|3961442|FG001|COMPLETED|Overall Study||110
3229723|NCT02337725|3961441|FG000|NOT COMPLETED|Overall Study||26
3229724|NCT02337725|3961442|FG001|NOT COMPLETED|Overall Study||8
3229725|NCT02337738|3961451|FG000|STARTED|Overall Study||141
3229726|NCT02337738|3961452|FG001|STARTED|Overall Study||134
3229727|NCT02337738|3961453|FG002|STARTED|Overall Study||129
3229728|NCT02337738|3961451|FG000|COMPLETED|Overall Study||119
3229729|NCT02337738|3961452|FG001|COMPLETED|Overall Study||104
3229730|NCT02337738|3961453|FG002|COMPLETED|Overall Study||103
3229731|NCT02337738|3961451|FG000|NOT COMPLETED|Overall Study||22
3229732|NCT02337738|3961452|FG001|NOT COMPLETED|Overall Study||30
3229733|NCT02337738|3961453|FG002|NOT COMPLETED|Overall Study||26
3229734|NCT02337751|3961463|FG000|STARTED|Overall Study||95
3229735|NCT02337751|3961464|FG001|STARTED|Overall Study||103
3229736|NCT02337751|3961463|FG000|COMPLETED|Overall Study||84
3229737|NCT02337751|3961464|FG001|COMPLETED|Overall Study||87
3229738|NCT02337751|3961463|FG000|NOT COMPLETED|Overall Study||11
3229739|NCT02337751|3961464|FG001|NOT COMPLETED|Overall Study||16
3229740|NCT02337764|3961471|FG000|STARTED|Overall Study||222
3229741|NCT02337764|3961471|FG000|COMPLETED|Overall Study||162
3229742|NCT02337764|3961471|FG000|NOT COMPLETED|Overall Study||60
3229743|NCT02337907|3961481|FG000|STARTED|Overall Study||55
3229744|NCT02337907|3961482|FG001|STARTED|Overall Study||53
3229745|NCT02337907|3961483|FG002|STARTED|Overall Study||55
3229746|NCT02337907|3961484|FG003|STARTED|Overall Study||55
3229747|NCT02337907|3961485|FG004|STARTED|Overall Study||106
3229748|NCT02337907|3961486|FG005|STARTED|Overall Study||5
3229749|NCT02337907|3961481|FG000|COMPLETED|Overall Study||51
3229750|NCT02337907|3961482|FG001|COMPLETED|Overall Study||49
3229751|NCT02337907|3961483|FG002|COMPLETED|Overall Study||54
3229752|NCT02337907|3961484|FG003|COMPLETED|Overall Study||51
3229753|NCT02337907|3961485|FG004|COMPLETED|Overall Study||96
3229754|NCT02337907|3961486|FG005|COMPLETED|Overall Study||4
3229755|NCT02337907|3961481|FG000|NOT COMPLETED|Overall Study||4
3229756|NCT02337907|3961482|FG001|NOT COMPLETED|Overall Study||4
3229757|NCT02337907|3961483|FG002|NOT COMPLETED|Overall Study||1
3229758|NCT02337907|3961484|FG003|NOT COMPLETED|Overall Study||4
3229759|NCT02337907|3961485|FG004|NOT COMPLETED|Overall Study||10
3229760|NCT02337907|3961486|FG005|NOT COMPLETED|Overall Study||1
3229761|NCT02337933|3961503|FG000|STARTED|Overall Study||12
3229762|NCT02337933|3961504|FG001|STARTED|Overall Study||12
3229763|NCT02337933|3961503|FG000|COMPLETED|Overall Study||12
3229764|NCT02337933|3961504|FG001|COMPLETED|Overall Study||12
3229765|NCT02337933|3961503|FG000|NOT COMPLETED|Overall Study||0
3229766|NCT02337933|3961504|FG001|NOT COMPLETED|Overall Study||0
3229767|NCT02337946|3961510|FG000|STARTED|Protocol Treatment 1 Period||164
3229768|NCT02337946|3961511|FG001|STARTED|Protocol Treatment 1 Period||0
3229769|NCT02337946|3961512|FG002|STARTED|Protocol Treatment 1 Period||0
3229770|NCT02337946|3961510|FG000|COMPLETED|Protocol Treatment 1 Period||114
3229771|NCT02337946|3961511|FG001|COMPLETED|Protocol Treatment 1 Period||0
3229772|NCT02337946|3961512|FG002|COMPLETED|Protocol Treatment 1 Period||0
3229773|NCT02337946|3961510|FG000|NOT COMPLETED|Protocol Treatment 1 Period||50
3229774|NCT02337946|3961511|FG001|NOT COMPLETED|Protocol Treatment 1 Period||0
3229775|NCT02337946|3961512|FG002|NOT COMPLETED|Protocol Treatment 1 Period||0
3229776|NCT02337946|3961510|FG000|STARTED|In-between Period||114
3229777|NCT02337946|3961511|FG001|STARTED|In-between Period||0
3229778|NCT02337946|3961512|FG002|STARTED|In-between Period||0
3229779|NCT02337946|3961510|FG000|COMPLETED|In-between Period||113
3229780|NCT02337946|3961511|FG001|COMPLETED|In-between Period||0
3229781|NCT02337946|3961512|FG002|COMPLETED|In-between Period||0
3229782|NCT02337946|3961510|FG000|NOT COMPLETED|In-between Period||1
3229783|NCT02337946|3961511|FG001|NOT COMPLETED|In-between Period||0
3229784|NCT02337946|3961512|FG002|NOT COMPLETED|In-between Period||0
3229785|NCT02337946|3961510|FG000|STARTED|Protocol Treatment 2 Period||0
3229786|NCT02337946|3961511|FG001|STARTED|Protocol Treatment 2 Period||56
3229787|NCT02337946|3961512|FG002|STARTED|Protocol Treatment 2 Period||57
3229788|NCT02337946|3961510|FG000|Safety Population|Protocol Treatment 2 Period||0
3229789|NCT02337946|3961511|FG001|Safety Population|Protocol Treatment 2 Period||56
3229790|NCT02337946|3961512|FG002|Safety Population|Protocol Treatment 2 Period||54
3229791|NCT02337946|3961510|FG000|COMPLETED|Protocol Treatment 2 Period||0
3229792|NCT02337946|3961511|FG001|COMPLETED|Protocol Treatment 2 Period||5
3229793|NCT02337946|3961512|FG002|COMPLETED|Protocol Treatment 2 Period||7
3229794|NCT02337946|3961510|FG000|NOT COMPLETED|Protocol Treatment 2 Period||0
3229795|NCT02337946|3961511|FG001|NOT COMPLETED|Protocol Treatment 2 Period||51
3229796|NCT02337946|3961512|FG002|NOT COMPLETED|Protocol Treatment 2 Period||50
3229797|NCT02337959|3961521|FG000|STARTED|Overall Study||10
3229798|NCT02337959|3961522|FG001|STARTED|Overall Study||10
3229799|NCT02337959|3961523|FG002|STARTED|Overall Study||7
3229800|NCT02337959|3961521|FG000|COMPLETED|Overall Study||10
3229801|NCT02337959|3961522|FG001|COMPLETED|Overall Study||7
3229802|NCT02337959|3961523|FG002|COMPLETED|Overall Study||7
3229803|NCT02337959|3961521|FG000|NOT COMPLETED|Overall Study||0
3229804|NCT02337959|3961522|FG001|NOT COMPLETED|Overall Study||3
3229805|NCT02337959|3961523|FG002|NOT COMPLETED|Overall Study||0
3229806|NCT02338076|3961531|FG000|STARTED|Overall Study||20
3229807|NCT02338076|3961531|FG000|COMPLETED|Overall Study||20
3229808|NCT02338076|3961531|FG000|NOT COMPLETED|Overall Study||0
3229809|NCT02338154|3961537|FG000|STARTED|Overall Study||516
3229810|NCT02338154|3961537|FG000|Enrolled Cohort (Intent to Treat)|Overall Study||516
3229811|NCT02338154|3961537|FG000|INTUITY (Study Valve Cohort)|Overall Study||493
3229812|NCT02338154|3961537|FG000|COMPLETED|Overall Study||373
3229813|NCT02338154|3961537|FG000|NOT COMPLETED|Overall Study||143
3229814|NCT02338193|3961552|FG000|STARTED|Overall Study||20
3229815|NCT02338193|3961553|FG001|STARTED|Overall Study||21
3229816|NCT02338193|3961554|FG002|STARTED|Overall Study||25
3229817|NCT02338193|3961552|FG000|COMPLETED|Overall Study||17
3229818|NCT02338193|3961553|FG001|COMPLETED|Overall Study||17
3229819|NCT02338193|3961554|FG002|COMPLETED|Overall Study||15
3229820|NCT02338193|3961552|FG000|NOT COMPLETED|Overall Study||3
3229821|NCT02338193|3961553|FG001|NOT COMPLETED|Overall Study||4
3229822|NCT02338193|3961554|FG002|NOT COMPLETED|Overall Study||10
3229823|NCT02338336|3961564|FG000|STARTED|Overall Study||26
3229824|NCT02338336|3961565|FG001|STARTED|Overall Study||17
3229825|NCT02338336|3961566|FG002|STARTED|Overall Study||7
3229826|NCT02338336|3961567|FG003|STARTED|Overall Study||4
3229827|NCT02338336|3961564|FG000|COMPLETED|Overall Study||24
3229828|NCT02338336|3961565|FG001|COMPLETED|Overall Study||17
3229829|NCT02338336|3961566|FG002|COMPLETED|Overall Study||7
3229830|NCT02338336|3961567|FG003|COMPLETED|Overall Study||4
3229831|NCT02338336|3961564|FG000|NOT COMPLETED|Overall Study||2
3229832|NCT02338336|3961565|FG001|NOT COMPLETED|Overall Study||0
3229833|NCT02338336|3961566|FG002|NOT COMPLETED|Overall Study||0
3229834|NCT02338336|3961567|FG003|NOT COMPLETED|Overall Study||0
3229835|NCT02338362|3961575|FG000|STARTED|Overall Study||11
3229836|NCT02338362|3961576|FG001|STARTED|Overall Study||11
3229837|NCT02338362|3961575|FG000|COMPLETED|Overall Study||10
3229838|NCT02338362|3961576|FG001|COMPLETED|Overall Study||10
3229839|NCT02338362|3961575|FG000|NOT COMPLETED|Overall Study||1
3229840|NCT02338362|3961576|FG001|NOT COMPLETED|Overall Study||1
3229841|NCT02338492|3961582|FG000|STARTED|Overall Study||81
3229842|NCT02338492|3961582|FG000|Enrolled|Overall Study||81
3229843|NCT02338492|3961582|FG000|Device Implanted|Overall Study||79
3229844|NCT02338492|3961582|FG000|Treatment Failure|Overall Study||2
3229845|NCT02338492|3961582|FG000|COMPLETED|Overall Study||36
3229846|NCT02338492|3961582|FG000|NOT COMPLETED|Overall Study||45
3229847|NCT02338713|3961586|FG000|STARTED|Overall Study||27
3229848|NCT02338713|3961586|FG000|COMPLETED|Overall Study||27
3229849|NCT02338713|3961586|FG000|NOT COMPLETED|Overall Study||0
3229850|NCT02338843|3961594|FG000|STARTED|Overall Study||163
3229851|NCT02338843|3961595|FG001|STARTED|Overall Study||158
3229852|NCT02338843|3961594|FG000|COMPLETED|Overall Study||119
3229853|NCT02338843|3961595|FG001|COMPLETED|Overall Study||100
3229854|NCT02338843|3961594|FG000|NOT COMPLETED|Overall Study||44
3229855|NCT02338843|3961595|FG001|NOT COMPLETED|Overall Study||58
3229856|NCT02338882|3961603|FG000|STARTED|Overall Study||50
3229857|NCT02338882|3961604|FG001|STARTED|Overall Study||50
3229858|NCT02338882|3961603|FG000|COMPLETED|Overall Study||43
3229859|NCT02338882|3961604|FG001|COMPLETED|Overall Study||47
3229860|NCT02338882|3961603|FG000|NOT COMPLETED|Overall Study||7
3229861|NCT02338882|3961604|FG001|NOT COMPLETED|Overall Study||3
3229862|NCT02338960|3961615|FG000|STARTED|Core Study||306
3229863|NCT02338960|3961616|FG001|STARTED|Core Study||308
3229864|NCT02338960|3961615|FG000|Received Intervention|Core Study||303
3229865|NCT02338960|3961616|FG001|Received Intervention|Core Study||301
3229866|NCT02338960|3961615|FG000|COMPLETED|Core Study||219
3229867|NCT02338960|3961616|FG001|COMPLETED|Core Study||173
3229868|NCT02338960|3961615|FG000|NOT COMPLETED|Core Study||87
3229869|NCT02338960|3961616|FG001|NOT COMPLETED|Core Study||135
3229870|NCT02338960|3961615|FG000|STARTED|Open Label Extension||191
3229871|NCT02338960|3961616|FG001|STARTED|Open Label Extension||130
3229872|NCT02338960|3961615|FG000|COMPLETED|Open Label Extension||77
3229873|NCT02338960|3961616|FG001|COMPLETED|Open Label Extension||51
3229874|NCT02338960|3961615|FG000|NOT COMPLETED|Open Label Extension||114
3229875|NCT02338960|3961616|FG001|NOT COMPLETED|Open Label Extension||79
3229876|NCT02338973|3961627|FG000|STARTED|Overall Study||4
3229877|NCT02338973|3961627|FG000|Rod-cone Dystrophy (RCD)|Overall Study||2
3229878|NCT02338973|3961627|FG000|Enhanced S-Cone Syndrome (ESCS)|Overall Study||2
3229879|NCT02338973|3961627|FG000|COMPLETED|Overall Study||4
3229880|NCT02338973|3961627|FG000|NOT COMPLETED|Overall Study||0
3229881|NCT02338999|3961710|FG000|STARTED|First Intervention||39
3229882|NCT02338999|3961711|FG001|STARTED|First Intervention||41
3229883|NCT02338999|3961710|FG000|COMPLETED|First Intervention||36
3229884|NCT02338999|3961711|FG001|COMPLETED|First Intervention||40
3229885|NCT02338999|3961710|FG000|NOT COMPLETED|First Intervention||3
3229886|NCT02338999|3961711|FG001|NOT COMPLETED|First Intervention||1
3229887|NCT02338999|3961710|FG000|STARTED|Washout Period||36
3229888|NCT02338999|3961711|FG001|STARTED|Washout Period||40
3229889|NCT02338999|3961710|FG000|COMPLETED|Washout Period||36
3229890|NCT02338999|3961711|FG001|COMPLETED|Washout Period||38
3229891|NCT02338999|3961710|FG000|NOT COMPLETED|Washout Period||0
3229892|NCT02338999|3961711|FG001|NOT COMPLETED|Washout Period||2
3229893|NCT02338999|3961710|FG000|STARTED|Second Intervention||36
3229894|NCT02338999|3961711|FG001|STARTED|Second Intervention||38
3229895|NCT02338999|3961710|FG000|COMPLETED|Second Intervention||36
3229896|NCT02338999|3961711|FG001|COMPLETED|Second Intervention||36
3229897|NCT02338999|3961710|FG000|NOT COMPLETED|Second Intervention||0
3229898|NCT02338999|3961711|FG001|NOT COMPLETED|Second Intervention||2
3229899|NCT02339038|3961717|FG000|STARTED|Overall Study||600
3229900|NCT02339038|3961717|FG000|COMPLETED|Overall Study||0
3229901|NCT02339038|3961717|FG000|NOT COMPLETED|Overall Study||600
3229902|NCT02339155|3961723|FG000|STARTED|Overall Study||287
3229903|NCT02339155|3961724|FG001|STARTED|Overall Study||286
3229904|NCT02339155|3961723|FG000|Received Study Treatment|Overall Study||286
3229905|NCT02339155|3961724|FG001|Received Study Treatment|Overall Study||280
3229906|NCT02339155|3961723|FG000|COMPLETED|Overall Study||272
3229907|NCT02339155|3961724|FG001|COMPLETED|Overall Study||265
3229908|NCT02339155|3961723|FG000|NOT COMPLETED|Overall Study||15
3229909|NCT02339155|3961724|FG001|NOT COMPLETED|Overall Study||21
3229910|NCT02339246|3961734|FG000|STARTED|First Intervention (7 Days)||0
3229911|NCT02339246|3961735|FG001|STARTED|First Intervention (7 Days)||0
3229912|NCT02339246|3961736|FG002|STARTED|First Intervention (7 Days)||31
3229913|NCT02339246|3961734|FG000|COMPLETED|First Intervention (7 Days)||0
3229914|NCT02339246|3961735|FG001|COMPLETED|First Intervention (7 Days)||0
3229915|NCT02339246|3961736|FG002|COMPLETED|First Intervention (7 Days)||31
3229916|NCT02339246|3961734|FG000|NOT COMPLETED|First Intervention (7 Days)||0
3229917|NCT02339246|3961735|FG001|NOT COMPLETED|First Intervention (7 Days)||0
3229918|NCT02339246|3961736|FG002|NOT COMPLETED|First Intervention (7 Days)||0
3229919|NCT02339246|3961734|FG000|STARTED|Second Intervention (7 Days)||16
3229920|NCT02339246|3961735|FG001|STARTED|Second Intervention (7 Days)||15
3368885|NCT03831191|4100386|FG013|COMPLETED|Maintenance Period (36 Weeks)||0
3368886|NCT03831191|4100387|FG014|COMPLETED|Maintenance Period (36 Weeks)||0
3368887|NCT03831191|4100373|FG000|NOT COMPLETED|Maintenance Period (36 Weeks)||0
3368888|NCT03831191|4100374|FG001|NOT COMPLETED|Maintenance Period (36 Weeks)||0
3368889|NCT03831191|4100375|FG002|NOT COMPLETED|Maintenance Period (36 Weeks)||0
3368890|NCT03831191|4100376|FG003|NOT COMPLETED|Maintenance Period (36 Weeks)||0
3368891|NCT03831191|4100377|FG004|NOT COMPLETED|Maintenance Period (36 Weeks)||4
3368892|NCT03831191|4100378|FG005|NOT COMPLETED|Maintenance Period (36 Weeks)||5
3368893|NCT03831191|4100379|FG006|NOT COMPLETED|Maintenance Period (36 Weeks)||2
3368894|NCT03831191|4100380|FG007|NOT COMPLETED|Maintenance Period (36 Weeks)||4
3368895|NCT03831191|4100381|FG008|NOT COMPLETED|Maintenance Period (36 Weeks)||8
3368896|NCT03831191|4100382|FG009|NOT COMPLETED|Maintenance Period (36 Weeks)||1
3229921|NCT02339246|3961736|FG002|STARTED|Second Intervention (7 Days)||0
3229922|NCT02339246|3961734|FG000|COMPLETED|Second Intervention (7 Days)||16
3229923|NCT02339246|3961735|FG001|COMPLETED|Second Intervention (7 Days)||15
3229924|NCT02339246|3961736|FG002|COMPLETED|Second Intervention (7 Days)||0
3229925|NCT02339246|3961734|FG000|NOT COMPLETED|Second Intervention (7 Days)||0
3229926|NCT02339246|3961735|FG001|NOT COMPLETED|Second Intervention (7 Days)||0
3229927|NCT02339246|3961736|FG002|NOT COMPLETED|Second Intervention (7 Days)||0
3229928|NCT02339246|3961734|FG000|STARTED|Third Period (7 Days)||15
3229929|NCT02339246|3961735|FG001|STARTED|Third Period (7 Days)||16
3229930|NCT02339246|3961736|FG002|STARTED|Third Period (7 Days)||0
3229931|NCT02339246|3961734|FG000|COMPLETED|Third Period (7 Days)||15
3229932|NCT02339246|3961735|FG001|COMPLETED|Third Period (7 Days)||16
3229933|NCT02339246|3961736|FG002|COMPLETED|Third Period (7 Days)||0
3229934|NCT02339246|3961734|FG000|NOT COMPLETED|Third Period (7 Days)||0
3229935|NCT02339246|3961735|FG001|NOT COMPLETED|Third Period (7 Days)||0
3229936|NCT02339246|3961736|FG002|NOT COMPLETED|Third Period (7 Days)||0
3229937|NCT02339285|3961747|FG000|STARTED|Overall Study||10
3229938|NCT02339285|3961748|FG001|STARTED|Overall Study||11
3229939|NCT02339285|3961749|FG002|STARTED|Overall Study||11
3229940|NCT02339285|3961747|FG000|Completed Intervention|Overall Study||10
3229941|NCT02339285|3961748|FG001|Completed Intervention|Overall Study||10
3229942|NCT02339285|3961749|FG002|Completed Intervention|Overall Study||10
3229943|NCT02339285|3961747|FG000|2 Week Follow-up|Overall Study||9
3229944|NCT02339285|3961748|FG001|2 Week Follow-up|Overall Study||10
3229945|NCT02339285|3961749|FG002|2 Week Follow-up|Overall Study||10
3229946|NCT02339285|3961747|FG000|4 Week Follow-up Visit|Overall Study||9
3229947|NCT02339285|3961748|FG001|4 Week Follow-up Visit|Overall Study||8
3229948|NCT02339285|3961749|FG002|4 Week Follow-up Visit|Overall Study||9
3229949|NCT02339285|3961747|FG000|COMPLETED|Overall Study||9
3229950|NCT02339285|3961748|FG001|COMPLETED|Overall Study||8
3229951|NCT02339285|3961749|FG002|COMPLETED|Overall Study||9
3229952|NCT02339285|3961747|FG000|NOT COMPLETED|Overall Study||1
3229953|NCT02339285|3961748|FG001|NOT COMPLETED|Overall Study||3
3229954|NCT02339285|3961749|FG002|NOT COMPLETED|Overall Study||2
3229955|NCT02339389|3961757|FG000|STARTED|Overall Study||57
3229956|NCT02339389|3961757|FG000|COMPLETED|Overall Study||41
3229957|NCT02339389|3961757|FG000|NOT COMPLETED|Overall Study||16
3229958|NCT02339415|3961764|FG000|STARTED|First Period||22
3229959|NCT02339415|3961765|FG001|STARTED|First Period||22
3229960|NCT02339415|3961764|FG000|Received at Least One Dose|First Period||21
3229961|NCT02339415|3961765|FG001|Received at Least One Dose|First Period||20
3229962|NCT02339415|3961764|FG000|COMPLETED|First Period||20
3229963|NCT02339415|3961765|FG001|COMPLETED|First Period||20
3229964|NCT02339415|3961764|FG000|NOT COMPLETED|First Period||2
3229965|NCT02339415|3961765|FG001|NOT COMPLETED|First Period||2
3229966|NCT02339415|3961764|FG000|STARTED|Washout||20
3229967|NCT02339415|3961765|FG001|STARTED|Washout||20
3229968|NCT02339415|3961764|FG000|COMPLETED|Washout||20
3229969|NCT02339415|3961765|FG001|COMPLETED|Washout||20
3229970|NCT02339415|3961764|FG000|NOT COMPLETED|Washout||0
3229971|NCT02339415|3961765|FG001|NOT COMPLETED|Washout||0
3229972|NCT02339415|3961764|FG000|STARTED|Second Period||20
3229973|NCT02339415|3961765|FG001|STARTED|Second Period||20
3229974|NCT02339415|3961764|FG000|COMPLETED|Second Period||19
3229975|NCT02339415|3961765|FG001|COMPLETED|Second Period||18
3229976|NCT02339415|3961764|FG000|NOT COMPLETED|Second Period||1
3229977|NCT02339415|3961765|FG001|NOT COMPLETED|Second Period||2
3229978|NCT02339506|3961773|FG000|STARTED|Period 1 (Placebo or Cosyntropin)||12
3229979|NCT02339506|3961774|FG001|STARTED|Period 1 (Placebo or Cosyntropin)||11
3229980|NCT02339506|3961773|FG000|COMPLETED|Period 1 (Placebo or Cosyntropin)||12
3229981|NCT02339506|3961774|FG001|COMPLETED|Period 1 (Placebo or Cosyntropin)||10
3229982|NCT02339506|3961773|FG000|NOT COMPLETED|Period 1 (Placebo or Cosyntropin)||0
3229983|NCT02339506|3961774|FG001|NOT COMPLETED|Period 1 (Placebo or Cosyntropin)||1
3229984|NCT02339506|3961773|FG000|STARTED|Washout (Period 2)||12
3229985|NCT02339506|3961774|FG001|STARTED|Washout (Period 2)||10
3229986|NCT02339506|3961773|FG000|COMPLETED|Washout (Period 2)||10
3229987|NCT02339506|3961774|FG001|COMPLETED|Washout (Period 2)||10
3229988|NCT02339506|3961773|FG000|NOT COMPLETED|Washout (Period 2)||2
3229989|NCT02339506|3961774|FG001|NOT COMPLETED|Washout (Period 2)||0
3229990|NCT02339506|3961773|FG000|STARTED|Period 3 (Placebo or Cosyntropin)||10
3229991|NCT02339506|3961774|FG001|STARTED|Period 3 (Placebo or Cosyntropin)||10
3229992|NCT02339506|3961773|FG000|COMPLETED|Period 3 (Placebo or Cosyntropin)||10
3229993|NCT02339506|3961774|FG001|COMPLETED|Period 3 (Placebo or Cosyntropin)||10
3229994|NCT02339506|3961773|FG000|NOT COMPLETED|Period 3 (Placebo or Cosyntropin)||0
3229995|NCT02339506|3961774|FG001|NOT COMPLETED|Period 3 (Placebo or Cosyntropin)||0
3229996|NCT02339545|3961780|FG000|STARTED|Overall Study||15
3229997|NCT02339545|3961780|FG000|COMPLETED|Overall Study||15
3229998|NCT02339545|3961780|FG000|NOT COMPLETED|Overall Study||0
3229999|NCT02339558|3961785|FG000|STARTED|Overall Study||45
3230000|NCT02339558|3961785|FG000|COMPLETED|Overall Study||45
3230001|NCT02339558|3961785|FG000|NOT COMPLETED|Overall Study||0
3230002|NCT02339584|3961791|FG000|STARTED|Overall Study||188
3230003|NCT02339584|3961792|FG001|STARTED|Overall Study||191
3230004|NCT02339584|3961791|FG000|COMPLETED|Overall Study||173
3230005|NCT02339584|3961792|FG001|COMPLETED|Overall Study||176
3230006|NCT02339584|3961791|FG000|NOT COMPLETED|Overall Study||15
3230007|NCT02339584|3961792|FG001|NOT COMPLETED|Overall Study||15
3230008|NCT02339831|3961800|FG000|STARTED|Overall Study||58
3230009|NCT02339831|3961801|FG001|STARTED|Overall Study||52
3230010|NCT02339831|3961800|FG000|Lost to Follow Up|Overall Study||20
3230011|NCT02339831|3961801|FG001|Lost to Follow Up|Overall Study||7
3230012|NCT02339831|3961800|FG000|COMPLETED|Overall Study||38
3230013|NCT02339831|3961801|FG001|COMPLETED|Overall Study||45
3230014|NCT02339831|3961800|FG000|NOT COMPLETED|Overall Study||20
3230015|NCT02339831|3961801|FG001|NOT COMPLETED|Overall Study||7
3230016|NCT02339909|3961810|FG000|STARTED|Overall Study||524
3230017|NCT02339909|3961811|FG001|STARTED|Overall Study||375
3230018|NCT02339909|3961812|FG002|STARTED|Overall Study||375
3230019|NCT02339909|3961810|FG000|COMPLETED|Overall Study||435
3230020|NCT02339909|3961811|FG001|COMPLETED|Overall Study||312
3230021|NCT02339909|3961812|FG002|COMPLETED|Overall Study||304
3230022|NCT02339909|3961810|FG000|NOT COMPLETED|Overall Study||89
3230023|NCT02339909|3961811|FG001|NOT COMPLETED|Overall Study||63
3230024|NCT02339909|3961812|FG002|NOT COMPLETED|Overall Study||71
3230025|NCT02340000|3961822|FG000|STARTED|Time Period 1||90
3230026|NCT02340000|3961823|FG001|STARTED|Time Period 1||89
3230027|NCT02340000|3961822|FG000|COMPLETED|Time Period 1||78
3230028|NCT02340000|3961823|FG001|COMPLETED|Time Period 1||74
3230029|NCT02340000|3961822|FG000|NOT COMPLETED|Time Period 1||12
3230030|NCT02340000|3961823|FG001|NOT COMPLETED|Time Period 1||15
3230031|NCT02340000|3961822|FG000|STARTED|Time Period 2||69
3230032|NCT02340000|3961823|FG001|STARTED|Time Period 2||67
3230033|NCT02340000|3961822|FG000|COMPLETED|Time Period 2||50
3230034|NCT02340000|3961823|FG001|COMPLETED|Time Period 2||52
3230035|NCT02340000|3961822|FG000|NOT COMPLETED|Time Period 2||19
3230036|NCT02340000|3961823|FG001|NOT COMPLETED|Time Period 2||15
3230037|NCT02340078|3961836|FG000|STARTED|Overall Study||62
3230038|NCT02340078|3961836|FG000|COMPLETED|Overall Study||61
3230039|NCT02340078|3961836|FG000|NOT COMPLETED|Overall Study||1
3230040|NCT02340091|3961841|FG000|STARTED|Overall Study|All Study Participants|62
3230041|NCT02340091|3961841|FG000|COMPLETED|Overall Study||60
3230042|NCT02340091|3961841|FG000|NOT COMPLETED|Overall Study||2
3230043|NCT02340104|3961846|FG000|STARTED|Overall Study||8
3230044|NCT02340104|3961846|FG000|COMPLETED|Overall Study||8
3230045|NCT02340104|3961846|FG000|NOT COMPLETED|Overall Study||0
3230046|NCT02340156|3961851|FG000|STARTED|Overall Study||1
3230047|NCT02340156|3961851|FG000|COMPLETED|Overall Study||1
3230048|NCT02340156|3961851|FG000|NOT COMPLETED|Overall Study||0
3230049|NCT02340299|3961857|FG000|STARTED|Overall Study||4
3230050|NCT02340299|3961858|FG001|STARTED|Overall Study||2
3368897|NCT03831191|4100383|FG010|NOT COMPLETED|Maintenance Period (36 Weeks)||4
3368898|NCT03831191|4100384|FG011|NOT COMPLETED|Maintenance Period (36 Weeks)||7
3368899|NCT03831191|4100385|FG012|NOT COMPLETED|Maintenance Period (36 Weeks)||1
3368900|NCT03831191|4100386|FG013|NOT COMPLETED|Maintenance Period (36 Weeks)||1
3368901|NCT03831191|4100387|FG014|NOT COMPLETED|Maintenance Period (36 Weeks)||9
3368902|NCT03831191|4100373|FG000|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0
3368903|NCT03831191|4100374|FG001|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0
3368904|NCT03831191|4100375|FG002|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0
3368905|NCT03831191|4100376|FG003|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0
3368906|NCT03831191|4100377|FG004|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0
3368907|NCT03831191|4100378|FG005|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0
3368908|NCT03831191|4100379|FG006|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0
3368909|NCT03831191|4100380|FG007|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0
3368910|NCT03831191|4100381|FG008|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0
3368911|NCT03831191|4100382|FG009|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0
3368912|NCT03831191|4100383|FG010|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0
3368913|NCT03831191|4100384|FG011|STARTED|Post-Treatment Follow-Up Period(8 Weeks)|No participant entered the post follow-up period.|0
3368914|NCT03831191|4100385|FG012|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0
3368915|NCT03831191|4100386|FG013|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0
3368916|NCT03831191|4100387|FG014|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0
3368917|NCT03831191|4100373|FG000|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
3368918|NCT03831191|4100374|FG001|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
3368919|NCT03831191|4100375|FG002|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
3368920|NCT03831191|4100376|FG003|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
3368921|NCT03831191|4100377|FG004|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
3368922|NCT03831191|4100378|FG005|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
3368923|NCT03831191|4100379|FG006|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
3368924|NCT03831191|4100380|FG007|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
3368925|NCT03831191|4100381|FG008|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
3368926|NCT03831191|4100382|FG009|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
3368927|NCT03831191|4100383|FG010|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
3368928|NCT03831191|4100384|FG011|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
3368929|NCT03831191|4100385|FG012|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
3368930|NCT03831191|4100386|FG013|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
3368931|NCT03831191|4100387|FG014|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
3368932|NCT03831191|4100373|FG000|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
3230051|NCT02340299|3961857|FG000|COMPLETED|Overall Study||4
3230052|NCT02340299|3961858|FG001|COMPLETED|Overall Study||2
3230053|NCT02340299|3961857|FG000|NOT COMPLETED|Overall Study||0
3230054|NCT02340299|3961858|FG001|NOT COMPLETED|Overall Study||0
3230055|NCT02340338|3961871|FG000|STARTED|Overall Study|2 vaccine + 1 placebo|2
3230056|NCT02340338|3961872|FG001|STARTED|Overall Study|2 vaccine + 1 placebo|2
3230057|NCT02340338|3961873|FG002|STARTED|Overall Study|3 vaccine + 1 placebo|3
3230058|NCT02340338|3961874|FG003|STARTED|Overall Study|9 vaccine + 3 placebo|9
3230059|NCT02340338|3961875|FG004|STARTED|Overall Study|9 vaccine + 3 placebo|9
3230060|NCT02340338|3961876|FG005|STARTED|Overall Study|9 vaccine + 3 placebo|9
3230061|NCT02340338|3961877|FG006|STARTED|Overall Study|Placebos were randomly assigned to dose groups 1-6, included in the 46 participants.|12
3230062|NCT02340338|3961871|FG000|COMPLETED|Overall Study||2
3230063|NCT02340338|3961872|FG001|COMPLETED|Overall Study||2
3230064|NCT02340338|3961873|FG002|COMPLETED|Overall Study||3
3230065|NCT02340338|3961874|FG003|COMPLETED|Overall Study||9
3230066|NCT02340338|3961875|FG004|COMPLETED|Overall Study||9
3230067|NCT02340338|3961876|FG005|COMPLETED|Overall Study|1 withdrew voluntarily after the first immunization; safety and serum assessment completed.|9
3230068|NCT02340338|3961877|FG006|COMPLETED|Overall Study||12
3230069|NCT02340338|3961871|FG000|NOT COMPLETED|Overall Study||0
3230070|NCT02340338|3961872|FG001|NOT COMPLETED|Overall Study||0
3230071|NCT02340338|3961873|FG002|NOT COMPLETED|Overall Study||0
3230072|NCT02340338|3961874|FG003|NOT COMPLETED|Overall Study||0
3230073|NCT02340338|3961875|FG004|NOT COMPLETED|Overall Study||0
3230074|NCT02340338|3961876|FG005|NOT COMPLETED|Overall Study||0
3230075|NCT02340338|3961877|FG006|NOT COMPLETED|Overall Study||0
3230076|NCT02340520|3961893|FG000|STARTED|Overall Study||11
3230077|NCT02340520|3961893|FG000|COMPLETED|Overall Study||8
3230078|NCT02340520|3961893|FG000|NOT COMPLETED|Overall Study||3
3230079|NCT02340663|3961899|FG000|STARTED|Overall Study||35
3230080|NCT02340663|3961900|FG001|STARTED|Overall Study||32
3230081|NCT02340663|3961899|FG000|Clinical Exam, Impressions|Overall Study||35
3230082|NCT02340663|3961900|FG001|Clinical Exam, Impressions|Overall Study||32
3230083|NCT02340663|3961899|FG000|Splint Delivery, Assessments|Overall Study||33
3230084|NCT02340663|3961900|FG001|Splint Delivery, Assessments|Overall Study||31
3230085|NCT02340663|3961899|FG000|1 Week Follow-up, Assessments|Overall Study||33
3230086|NCT02340663|3961900|FG001|1 Week Follow-up, Assessments|Overall Study||31
3230087|NCT02340663|3961899|FG000|4 Month Follow-up, Assessments|Overall Study||30
3230088|NCT02340663|3961900|FG001|4 Month Follow-up, Assessments|Overall Study||31
3230089|NCT02340663|3961899|FG000|COMPLETED|Overall Study||30
3230090|NCT02340663|3961900|FG001|COMPLETED|Overall Study||31
3230091|NCT02340663|3961899|FG000|NOT COMPLETED|Overall Study||5
3230092|NCT02340663|3961900|FG001|NOT COMPLETED|Overall Study||1
3230093|NCT02340715|3961906|FG000|STARTED|Overall Study|158|158
3230094|NCT02340715|3961906|FG000|COMPLETED|Overall Study|158|158
3230095|NCT02340715|3961906|FG000|NOT COMPLETED|Overall Study||0
3230096|NCT02340767|3961919|FG000|STARTED|Overall Study||28
3230097|NCT02340767|3961920|FG001|STARTED|Overall Study||28
3230098|NCT02340767|3961921|FG002|STARTED|Overall Study||29
3230099|NCT02340767|3961922|FG003|STARTED|Overall Study||500
3230100|NCT02340767|3961923|FG004|STARTED|Overall Study||474
3230101|NCT02340767|3961924|FG005|STARTED|Overall Study||526
3230102|NCT02340767|3961925|FG006|STARTED|Overall Study||525
3230103|NCT02340767|3961926|FG007|STARTED|Overall Study||444
3230104|NCT02340767|3961927|FG008|STARTED|Overall Study||531
3230105|NCT02340767|3961919|FG000|COMPLETED|Overall Study||28
3230106|NCT02340767|3961920|FG001|COMPLETED|Overall Study||28
3230107|NCT02340767|3961921|FG002|COMPLETED|Overall Study||29
3230108|NCT02340767|3961922|FG003|COMPLETED|Overall Study||500
3230109|NCT02340767|3961923|FG004|COMPLETED|Overall Study||474
3230110|NCT02340767|3961924|FG005|COMPLETED|Overall Study||526
3230111|NCT02340767|3961925|FG006|COMPLETED|Overall Study||525
3230112|NCT02340767|3961926|FG007|COMPLETED|Overall Study||444
3230113|NCT02340767|3961927|FG008|COMPLETED|Overall Study||531
3230114|NCT02340767|3961919|FG000|NOT COMPLETED|Overall Study||0
3230115|NCT02340767|3961920|FG001|NOT COMPLETED|Overall Study||0
3230116|NCT02340767|3961921|FG002|NOT COMPLETED|Overall Study||0
3230117|NCT02340767|3961922|FG003|NOT COMPLETED|Overall Study||0
3230118|NCT02340767|3961923|FG004|NOT COMPLETED|Overall Study||0
3230119|NCT02340767|3961924|FG005|NOT COMPLETED|Overall Study||0
3230120|NCT02340767|3961925|FG006|NOT COMPLETED|Overall Study||0
3230121|NCT02340767|3961926|FG007|NOT COMPLETED|Overall Study||0
3230122|NCT02340767|3961927|FG008|NOT COMPLETED|Overall Study||0
3368933|NCT03831191|4100374|FG001|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
3368934|NCT03831191|4100375|FG002|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
3368935|NCT03831191|4100376|FG003|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
3368936|NCT03831191|4100377|FG004|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
3368937|NCT03831191|4100378|FG005|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
3368938|NCT03831191|4100379|FG006|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
3368939|NCT03831191|4100380|FG007|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
3368940|NCT03831191|4100381|FG008|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
3368941|NCT03831191|4100382|FG009|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
3368942|NCT03831191|4100383|FG010|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
3368943|NCT03831191|4100384|FG011|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
3368944|NCT03831191|4100385|FG012|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
3368945|NCT03831191|4100386|FG013|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
3368946|NCT03831191|4100387|FG014|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
3368947|NCT03830281|4100422|FG000|STARTED|Lead-in Period (2 Weeks)||471
3368948|NCT03830281|4100423|FG001|STARTED|Lead-in Period (2 Weeks)||0
3368949|NCT03830281|4100422|FG000|COMPLETED|Lead-in Period (2 Weeks)||432
3368950|NCT03830281|4100423|FG001|COMPLETED|Lead-in Period (2 Weeks)||0
3368951|NCT03830281|4100422|FG000|NOT COMPLETED|Lead-in Period (2 Weeks)||39
3368952|NCT03830281|4100423|FG001|NOT COMPLETED|Lead-in Period (2 Weeks)||0
3368953|NCT03830281|4100422|FG000|STARTED|Treatment Period (16 Weeks)|Pts who completed lead-in period randomized to Humalog or Ultra-Rapid Lispro in treatment period.|217
3368954|NCT03830281|4100423|FG001|STARTED|Treatment Period (16 Weeks)|Pts who completed lead-in period randomized to Humalog or Ultra-Rapid Lispro in treatment period.|215
3230123|NCT02340780|3961942|FG000|STARTED|Overall Study|A total of 14 patients enrolled, one patient was found ineligible after the enrollment.|14
3230124|NCT02340780|3961942|FG000|COMPLETED|Overall Study||13
3230125|NCT02340780|3961942|FG000|NOT COMPLETED|Overall Study||1
3230126|NCT02340806|3961948|FG000|STARTED|Overall Study||108
3230127|NCT02340806|3961949|FG001|STARTED|Overall Study||112
3230128|NCT02340806|3961948|FG000|COMPLETED|Overall Study||102
3230129|NCT02340806|3961949|FG001|COMPLETED|Overall Study||108
3230130|NCT02340806|3961948|FG000|NOT COMPLETED|Overall Study||6
3230131|NCT02340806|3961949|FG001|NOT COMPLETED|Overall Study||4
3230132|NCT02340819|3961955|FG000|STARTED|Overall Study||11
3230133|NCT02340819|3961955|FG000|Started Stage 2|Overall Study||11
3230134|NCT02340819|3961955|FG000|Completed Stage 2|Overall Study||9
3230135|NCT02340819|3961955|FG000|Started Stage 3|Overall Study||8
3230136|NCT02340819|3961955|FG000|Completed Stage 3|Overall Study||7
3230137|NCT02340819|3961955|FG000|Started Stage 4|Overall Study||7
3230138|NCT02340819|3961955|FG000|Completed Stage 4|Overall Study||7
3230139|NCT02340819|3961955|FG000|COMPLETED|Overall Study||7
3230140|NCT02340819|3961955|FG000|NOT COMPLETED|Overall Study||4
3230141|NCT02340949|3961961|FG000|STARTED|Overall Study||115
3230142|NCT02340949|3961962|FG001|STARTED|Overall Study||65
3230143|NCT02340949|3961961|FG000|COMPLETED|Overall Study||99
3230144|NCT02340949|3961962|FG001|COMPLETED|Overall Study||61
3230145|NCT02340949|3961961|FG000|NOT COMPLETED|Overall Study||16
3230146|NCT02340949|3961962|FG001|NOT COMPLETED|Overall Study||4
3230147|NCT02340962|3961970|FG000|STARTED|Overall Study||13
3230148|NCT02340962|3961971|FG001|STARTED|Overall Study||12
3230149|NCT02340962|3961970|FG000|COMPLETED|Overall Study||12
3230150|NCT02340962|3961971|FG001|COMPLETED|Overall Study||12
3230151|NCT02340962|3961970|FG000|NOT COMPLETED|Overall Study||1
3230152|NCT02340962|3961971|FG001|NOT COMPLETED|Overall Study||0
3230153|NCT02340975|3961983|FG000|STARTED|Overall Study||6
3230154|NCT02340975|3961984|FG001|STARTED|Overall Study||27
3230155|NCT02340975|3961985|FG002|STARTED|Overall Study||24
3230156|NCT02340975|3961986|FG003|STARTED|Overall Study||12
3230157|NCT02340975|3961987|FG004|STARTED|Overall Study||25
3230158|NCT02340975|3961988|FG005|STARTED|Overall Study||19
3230159|NCT02340975|3961983|FG000|COMPLETED|Overall Study||0
3230160|NCT02340975|3961984|FG001|COMPLETED|Overall Study||0
3230161|NCT02340975|3961985|FG002|COMPLETED|Overall Study||0
3230162|NCT02340975|3961986|FG003|COMPLETED|Overall Study||0
3230163|NCT02340975|3961987|FG004|COMPLETED|Overall Study||0
3230164|NCT02340975|3961988|FG005|COMPLETED|Overall Study||0
3230165|NCT02340975|3961983|FG000|NOT COMPLETED|Overall Study||6
3230166|NCT02340975|3961984|FG001|NOT COMPLETED|Overall Study||27
3230167|NCT02340975|3961985|FG002|NOT COMPLETED|Overall Study||24
3230168|NCT02340975|3961986|FG003|NOT COMPLETED|Overall Study||12
3230169|NCT02340975|3961987|FG004|NOT COMPLETED|Overall Study||25
3230170|NCT02340975|3961988|FG005|NOT COMPLETED|Overall Study||19
3230171|NCT02341144|3962005|FG000|STARTED|Overall Study||30
3230172|NCT02341144|3962006|FG001|STARTED|Overall Study||31
3230173|NCT02341144|3962005|FG000|COMPLETED|Overall Study||28
3230174|NCT02341144|3962006|FG001|COMPLETED|Overall Study||30
3230175|NCT02341144|3962005|FG000|NOT COMPLETED|Overall Study||2
3230176|NCT02341144|3962006|FG001|NOT COMPLETED|Overall Study||1
3230177|NCT02341417|3962015|FG000|STARTED|Overall Study||13
3230178|NCT02341417|3962016|FG001|STARTED|Overall Study||14
3230179|NCT02341417|3962017|FG002|STARTED|Overall Study||1
3230180|NCT02341417|3962015|FG000|COMPLETED|Overall Study||11
3230181|NCT02341417|3962016|FG001|COMPLETED|Overall Study||12
3230182|NCT02341417|3962017|FG002|COMPLETED|Overall Study||0
3230183|NCT02341417|3962015|FG000|NOT COMPLETED|Overall Study||2
3230184|NCT02341417|3962016|FG001|NOT COMPLETED|Overall Study||2
3230185|NCT02341417|3962017|FG002|NOT COMPLETED|Overall Study||1
3230186|NCT02341456|3962029|FG000|STARTED|Overall Study||7
3230187|NCT02341456|3962030|FG001|STARTED|Overall Study||6
3230188|NCT02341456|3962031|FG002|STARTED|Overall Study||6
3230189|NCT02341456|3962029|FG000|COMPLETED|Overall Study||3
3230190|NCT02341456|3962030|FG001|COMPLETED|Overall Study||0
3230191|NCT02341456|3962031|FG002|COMPLETED|Overall Study||2
3230192|NCT02341456|3962029|FG000|NOT COMPLETED|Overall Study||4
3230193|NCT02341456|3962030|FG001|NOT COMPLETED|Overall Study||6
3230194|NCT02341456|3962031|FG002|NOT COMPLETED|Overall Study||4
3230195|NCT02341482|3962039|FG000|STARTED|Overall Study||13
3230196|NCT02341482|3962039|FG000|COMPLETED|Overall Study||12
3230197|NCT02341482|3962039|FG000|NOT COMPLETED|Overall Study||1
3230198|NCT02341599|3962053|FG000|STARTED|Overall Study||8
3230199|NCT02341599|3962054|FG001|STARTED|Overall Study||8
3230200|NCT02341599|3962055|FG002|STARTED|Overall Study||8
3230201|NCT02341599|3962056|FG003|STARTED|Overall Study||8
3230202|NCT02341599|3962057|FG004|STARTED|Overall Study||8
3230203|NCT02341599|3962053|FG000|COMPLETED|Overall Study||8
3230204|NCT02341599|3962054|FG001|COMPLETED|Overall Study||8
3230205|NCT02341599|3962055|FG002|COMPLETED|Overall Study||8
3230206|NCT02341599|3962056|FG003|COMPLETED|Overall Study||8
3230207|NCT02341599|3962057|FG004|COMPLETED|Overall Study||8
3230208|NCT02341599|3962053|FG000|NOT COMPLETED|Overall Study||0
3230209|NCT02341599|3962054|FG001|NOT COMPLETED|Overall Study||0
3230210|NCT02341599|3962055|FG002|NOT COMPLETED|Overall Study||0
3230211|NCT02341599|3962056|FG003|NOT COMPLETED|Overall Study||0
3230212|NCT02341599|3962057|FG004|NOT COMPLETED|Overall Study||0
3230213|NCT02341859|3962072|FG000|STARTED|First Intervention (1 Day)||10
3230214|NCT02341859|3962073|FG001|STARTED|First Intervention (1 Day)||9
3230215|NCT02341859|3962072|FG000|COMPLETED|First Intervention (1 Day)||10
3230216|NCT02341859|3962073|FG001|COMPLETED|First Intervention (1 Day)||9
3230217|NCT02341859|3962072|FG000|NOT COMPLETED|First Intervention (1 Day)||0
3230218|NCT02341859|3962073|FG001|NOT COMPLETED|First Intervention (1 Day)||0
3230219|NCT02341859|3962072|FG000|STARTED|Second Intervention (1 Day)||10
3230220|NCT02341859|3962073|FG001|STARTED|Second Intervention (1 Day)||9
3230221|NCT02341859|3962072|FG000|COMPLETED|Second Intervention (1 Day)||10
3230222|NCT02341859|3962073|FG001|COMPLETED|Second Intervention (1 Day)||9
3230223|NCT02341859|3962072|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
3230224|NCT02341859|3962073|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
3230225|NCT02342015|3962086|FG000|STARTED|Overall Study||20
3230226|NCT02342015|3962086|FG000|COMPLETED|Overall Study||20
3230227|NCT02342015|3962086|FG000|NOT COMPLETED|Overall Study||0
3230228|NCT02342171|3962092|FG000|STARTED|Overall Study||99
3230229|NCT02342171|3962093|FG001|STARTED|Overall Study||507
3230230|NCT02342171|3962092|FG000|COMPLETED|Overall Study||84
3230231|NCT02342171|3962093|FG001|COMPLETED|Overall Study||418
3230232|NCT02342171|3962092|FG000|NOT COMPLETED|Overall Study||15
3230233|NCT02342171|3962093|FG001|NOT COMPLETED|Overall Study||89
3230234|NCT02342197|3962100|FG000|STARTED|Overall Study||30
3230235|NCT02342197|3962101|FG001|STARTED|Overall Study||30
3230236|NCT02342197|3962100|FG000|COMPLETED|Overall Study||27
3230237|NCT02342197|3962101|FG001|COMPLETED|Overall Study||28
3230238|NCT02342197|3962100|FG000|NOT COMPLETED|Overall Study||3
3230239|NCT02342197|3962101|FG001|NOT COMPLETED|Overall Study||2
3230240|NCT02342223|3962107|FG000|STARTED|Overall Study||20
3230241|NCT02342223|3962107|FG000|COMPLETED|Overall Study||19
3230242|NCT02342223|3962107|FG000|NOT COMPLETED|Overall Study||1
3230243|NCT02342288|3962113|FG000|STARTED|Overall Study|16 patients were not randomized to either arm.|30
3230244|NCT02342288|3962114|FG001|STARTED|Overall Study|various issues listed below caused removal of subjects|33
3230245|NCT02342288|3962113|FG000|COMPLETED|Overall Study||25
3230246|NCT02342288|3962114|FG001|COMPLETED|Overall Study||27
3230247|NCT02342288|3962113|FG000|NOT COMPLETED|Overall Study||5
3230248|NCT02342288|3962114|FG001|NOT COMPLETED|Overall Study||6
3230249|NCT02342314|3962122|FG000|STARTED|Part A||6
3230250|NCT02342314|3962123|FG001|STARTED|Part A||3
3230251|NCT02342314|3962124|FG002|STARTED|Part A||3
3230252|NCT02342314|3962125|FG003|STARTED|Part A||3
3230253|NCT02342314|3962126|FG004|STARTED|Part A||6
3230254|NCT02342314|3962127|FG005|STARTED|Part A||3
3230255|NCT02342314|3962128|FG006|STARTED|Part A||0
3230256|NCT02342314|3962129|FG007|STARTED|Part A||0
3230257|NCT02342314|3962130|FG008|STARTED|Part A||0
3230258|NCT02342314|3962131|FG009|STARTED|Part A||0
3230259|NCT02342314|3962132|FG010|STARTED|Part A||0
3230260|NCT02342314|3962133|FG011|STARTED|Part A||0
3230261|NCT02342314|3962134|FG012|STARTED|Part A||0
3230262|NCT02342314|3962135|FG013|STARTED|Part A||0
3230263|NCT02342314|3962136|FG014|STARTED|Part A||0
3230264|NCT02342314|3962137|FG015|STARTED|Part A||0
3230265|NCT02342314|3962138|FG016|STARTED|Part A||0
3230266|NCT02342314|3962122|FG000|COMPLETED|Part A||6
3230267|NCT02342314|3962123|FG001|COMPLETED|Part A||3
3230268|NCT02342314|3962124|FG002|COMPLETED|Part A||3
3230269|NCT02342314|3962125|FG003|COMPLETED|Part A||3
3230270|NCT02342314|3962126|FG004|COMPLETED|Part A||6
3230271|NCT02342314|3962127|FG005|COMPLETED|Part A||3
3230272|NCT02342314|3962128|FG006|COMPLETED|Part A||0
3230273|NCT02342314|3962129|FG007|COMPLETED|Part A||0
3230274|NCT02342314|3962130|FG008|COMPLETED|Part A||0
3230275|NCT02342314|3962131|FG009|COMPLETED|Part A||0
3230276|NCT02342314|3962132|FG010|COMPLETED|Part A||0
3230277|NCT02342314|3962133|FG011|COMPLETED|Part A||0
3230278|NCT02342314|3962134|FG012|COMPLETED|Part A||0
3230279|NCT02342314|3962135|FG013|COMPLETED|Part A||0
3230280|NCT02342314|3962136|FG014|COMPLETED|Part A||0
3230281|NCT02342314|3962137|FG015|COMPLETED|Part A||0
3230282|NCT02342314|3962138|FG016|COMPLETED|Part A||0
3230283|NCT02342314|3962122|FG000|NOT COMPLETED|Part A||0
3230284|NCT02342314|3962123|FG001|NOT COMPLETED|Part A||0
3230285|NCT02342314|3962124|FG002|NOT COMPLETED|Part A||0
3230286|NCT02342314|3962125|FG003|NOT COMPLETED|Part A||0
3230287|NCT02342314|3962126|FG004|NOT COMPLETED|Part A||0
3230288|NCT02342314|3962127|FG005|NOT COMPLETED|Part A||0
3230289|NCT02342314|3962128|FG006|NOT COMPLETED|Part A||0
3230290|NCT02342314|3962129|FG007|NOT COMPLETED|Part A||0
3230291|NCT02342314|3962130|FG008|NOT COMPLETED|Part A||0
3230292|NCT02342314|3962131|FG009|NOT COMPLETED|Part A||0
3230293|NCT02342314|3962132|FG010|NOT COMPLETED|Part A||0
3230294|NCT02342314|3962133|FG011|NOT COMPLETED|Part A||0
3230295|NCT02342314|3962134|FG012|NOT COMPLETED|Part A||0
3230296|NCT02342314|3962135|FG013|NOT COMPLETED|Part A||0
3230297|NCT02342314|3962136|FG014|NOT COMPLETED|Part A||0
3230298|NCT02342314|3962137|FG015|NOT COMPLETED|Part A||0
3230299|NCT02342314|3962138|FG016|NOT COMPLETED|Part A||0
3230300|NCT02342314|3962122|FG000|STARTED|Part B|Participants received placebo in Part A.|0
3230301|NCT02342314|3962123|FG001|STARTED|Part B|Participants received LY3143753 in Part A.|0
3230302|NCT02342314|3962124|FG002|STARTED|Part B|Participants received LY3143753 in Part A.|0
3230303|NCT02342314|3962125|FG003|STARTED|Part B|Participants received LY3143753 in Part A.|0
3230304|NCT02342314|3962126|FG004|STARTED|Part B|Participants received LY3143753 in Part A.|0
3230305|NCT02342314|3962127|FG005|STARTED|Part B|Participants received LY3143753 in Part A.|0
3230306|NCT02342314|3962128|FG006|STARTED|Part B|Participants received placebo in Part B.|11
3230307|NCT02342314|3962129|FG007|STARTED|Part B|Participants received LY3185643 in Part B.|3
3230308|NCT02342314|3962130|FG008|STARTED|Part B|Participants received LY3185643 in Part B.|3
3230309|NCT02342314|3962131|FG009|STARTED|Part B|Participants received LY3185643 in Part B.|3
3230310|NCT02342314|3962132|FG010|STARTED|Part B|Participants received LY3185643 in Part B.|3
3230311|NCT02342314|3962133|FG011|STARTED|Part B|Participants received LY3185643 in Part B.|3
3230312|NCT02342314|3962134|FG012|STARTED|Part B|Participants received LY3185643 in Part B.|3
3230313|NCT02342314|3962135|FG013|STARTED|Part B|Participants received LY3185643 in Part B.|3
3230314|NCT02342314|3962136|FG014|STARTED|Part B|Participants received LY3185643 in Part B.|3
3230315|NCT02342314|3962137|FG015|STARTED|Part B|Participants received LY3185643 in Part B.|3
3230316|NCT02342314|3962138|FG016|STARTED|Part B|Participants received rGlucagon in Part B.|6
3230317|NCT02342314|3962122|FG000|COMPLETED|Part B||0
3230318|NCT02342314|3962123|FG001|COMPLETED|Part B||0
3230319|NCT02342314|3962124|FG002|COMPLETED|Part B||0
3230320|NCT02342314|3962125|FG003|COMPLETED|Part B||0
3230321|NCT02342314|3962126|FG004|COMPLETED|Part B||0
3230322|NCT02342314|3962127|FG005|COMPLETED|Part B||0
3230323|NCT02342314|3962128|FG006|COMPLETED|Part B||11
3230324|NCT02342314|3962129|FG007|COMPLETED|Part B||3
3230325|NCT02342314|3962130|FG008|COMPLETED|Part B||3
3230326|NCT02342314|3962131|FG009|COMPLETED|Part B||3
3230327|NCT02342314|3962132|FG010|COMPLETED|Part B||3
3230328|NCT02342314|3962133|FG011|COMPLETED|Part B||3
3230329|NCT02342314|3962134|FG012|COMPLETED|Part B||3
3230330|NCT02342314|3962135|FG013|COMPLETED|Part B||3
3230331|NCT02342314|3962136|FG014|COMPLETED|Part B||3
3230332|NCT02342314|3962137|FG015|COMPLETED|Part B||3
3230333|NCT02342314|3962138|FG016|COMPLETED|Part B||6
3230334|NCT02342314|3962122|FG000|NOT COMPLETED|Part B||0
3230335|NCT02342314|3962123|FG001|NOT COMPLETED|Part B||0
3230336|NCT02342314|3962124|FG002|NOT COMPLETED|Part B||0
3230337|NCT02342314|3962125|FG003|NOT COMPLETED|Part B||0
3230338|NCT02342314|3962126|FG004|NOT COMPLETED|Part B||0
3230339|NCT02342314|3962127|FG005|NOT COMPLETED|Part B||0
3230340|NCT02342314|3962128|FG006|NOT COMPLETED|Part B||0
3230341|NCT02342314|3962129|FG007|NOT COMPLETED|Part B||0
3230342|NCT02342314|3962130|FG008|NOT COMPLETED|Part B||0
3230343|NCT02342314|3962131|FG009|NOT COMPLETED|Part B||0
3230344|NCT02342314|3962132|FG010|NOT COMPLETED|Part B||0
3230345|NCT02342314|3962133|FG011|NOT COMPLETED|Part B||0
3230346|NCT02342314|3962134|FG012|NOT COMPLETED|Part B||0
3230347|NCT02342314|3962135|FG013|NOT COMPLETED|Part B||0
3230348|NCT02342314|3962136|FG014|NOT COMPLETED|Part B||0
3230349|NCT02342314|3962137|FG015|NOT COMPLETED|Part B||0
3230350|NCT02342314|3962138|FG016|NOT COMPLETED|Part B||0
3230351|NCT02342327|3962211|FG000|STARTED|Overall Study||60
3230352|NCT02342327|3962212|FG001|STARTED|Overall Study||62
3230353|NCT02342327|3962211|FG000|Completed Quit Day Visit|Overall Study||54
3230354|NCT02342327|3962212|FG001|Completed Quit Day Visit|Overall Study||53
3230355|NCT02342327|3962211|FG000|COMPLETED|Overall Study||39
3230356|NCT02342327|3962212|FG001|COMPLETED|Overall Study||40
3230357|NCT02342327|3962211|FG000|NOT COMPLETED|Overall Study||21
3230358|NCT02342327|3962212|FG001|NOT COMPLETED|Overall Study||22
3230359|NCT02342379|3962218|FG000|STARTED|Overall Study||35
3230360|NCT02342379|3962218|FG000|COMPLETED|Overall Study||35
3230361|NCT02342379|3962218|FG000|NOT COMPLETED|Overall Study||0
3230362|NCT02342418|3962224|FG000|STARTED|Overall Study||9
3230363|NCT02342418|3962225|FG001|STARTED|Overall Study||10
3230364|NCT02342418|3962224|FG000|COMPLETED|Overall Study||9
3230365|NCT02342418|3962225|FG001|COMPLETED|Overall Study||9
3230366|NCT02342418|3962224|FG000|NOT COMPLETED|Overall Study||0
3230367|NCT02342418|3962225|FG001|NOT COMPLETED|Overall Study||1
3230368|NCT02342535|3962231|FG000|STARTED|Overall Study|30 women who participated in the aerobic exercise class and 38 children.|68
3230369|NCT02342535|3962231|FG000|COMPLETED|Overall Study|30 women in aerobic class and 38 kids in kids exercise class|68
3230370|NCT02342535|3962231|FG000|NOT COMPLETED|Overall Study||0
3230371|NCT02342548|3962238|FG000|STARTED|Overall Study||51
3230372|NCT02342548|3962239|FG001|STARTED|Overall Study||71
3230373|NCT02342548|3962240|FG002|STARTED|Overall Study||66
3230374|NCT02342548|3962238|FG000|COMPLETED|Overall Study||17
3230375|NCT02342548|3962239|FG001|COMPLETED|Overall Study||9
3230376|NCT02342548|3962240|FG002|COMPLETED|Overall Study||23
3230377|NCT02342548|3962238|FG000|NOT COMPLETED|Overall Study||34
3230378|NCT02342548|3962239|FG001|NOT COMPLETED|Overall Study||62
3230379|NCT02342548|3962240|FG002|NOT COMPLETED|Overall Study||43
3230380|NCT02342561|3962248|FG000|STARTED|Overall Study||20
3230381|NCT02342561|3962248|FG000|COMPLETED|Overall Study||20
3230382|NCT02342561|3962248|FG000|NOT COMPLETED|Overall Study||0
3368955|NCT03830281|4100422|FG000|COMPLETED|Treatment Period (16 Weeks)||205
3368956|NCT03830281|4100423|FG001|COMPLETED|Treatment Period (16 Weeks)||198
3368957|NCT03830281|4100422|FG000|NOT COMPLETED|Treatment Period (16 Weeks)||12
3368958|NCT03830281|4100423|FG001|NOT COMPLETED|Treatment Period (16 Weeks)||17
3368959|NCT03828734|4100430|FG000|STARTED|Baseline||32
3368960|NCT03828734|4100431|FG001|STARTED|Baseline||26
3368961|NCT03828734|4100430|FG000|COMPLETED|Baseline||32
3368962|NCT03828734|4100431|FG001|COMPLETED|Baseline||26
3368963|NCT03828734|4100430|FG000|NOT COMPLETED|Baseline||0
3368964|NCT03828734|4100431|FG001|NOT COMPLETED|Baseline||0
3368965|NCT03828734|4100430|FG000|STARTED|Pre-Randomization (1 Week)||32
3230383|NCT02342639|3962258|FG000|STARTED|Overall Study||19
3230384|NCT02342639|3962259|FG001|STARTED|Overall Study||19
3230385|NCT02342639|3962258|FG000|COMPLETED|Overall Study||17
3230386|NCT02342639|3962259|FG001|COMPLETED|Overall Study||14
3230387|NCT02342639|3962258|FG000|NOT COMPLETED|Overall Study||2
3230388|NCT02342639|3962259|FG001|NOT COMPLETED|Overall Study||5
3230389|NCT02342678|3962269|FG000|STARTED|Overall Study||28
3230390|NCT02342678|3962270|FG001|STARTED|Overall Study||28
3230391|NCT02342678|3962269|FG000|COMPLETED|Overall Study||27
3230392|NCT02342678|3962270|FG001|COMPLETED|Overall Study||23
3230393|NCT02342678|3962269|FG000|NOT COMPLETED|Overall Study||1
3230394|NCT02342678|3962270|FG001|NOT COMPLETED|Overall Study||5
3230395|NCT02342704|3962278|FG000|STARTED|Overall Study|Safety Population: randomized participants who received at least 1 dose of study treatment.|54
3230396|NCT02342704|3962279|FG001|STARTED|Overall Study|Safety Population: randomized participants who received at least 1 dose of study treatment.|54
3230397|NCT02342704|3962278|FG000|COMPLETED|Overall Study||1
3230398|NCT02342704|3962279|FG001|COMPLETED|Overall Study||3
3230399|NCT02342704|3962278|FG000|NOT COMPLETED|Overall Study||53
3230400|NCT02342704|3962279|FG001|NOT COMPLETED|Overall Study||51
3230401|NCT02342743|3962285|FG000|STARTED|Baseline Period||73
3230402|NCT02342743|3962285|FG000|COMPLETED|Baseline Period||58
3230403|NCT02342743|3962285|FG000|NOT COMPLETED|Baseline Period||15
3368966|NCT03828734|4100431|FG001|STARTED|Pre-Randomization (1 Week)||26
3368967|NCT03828734|4100430|FG000|COMPLETED|Pre-Randomization (1 Week)||29
3368968|NCT03828734|4100431|FG001|COMPLETED|Pre-Randomization (1 Week)||25
3368969|NCT03828734|4100430|FG000|NOT COMPLETED|Pre-Randomization (1 Week)||3
3368970|NCT03828734|4100431|FG001|NOT COMPLETED|Pre-Randomization (1 Week)||1
3368971|NCT03828734|4100430|FG000|STARTED|First Intervention||29
3368972|NCT03828734|4100431|FG001|STARTED|First Intervention||25
3368973|NCT03828734|4100430|FG000|COMPLETED|First Intervention||25
3368974|NCT03828734|4100431|FG001|COMPLETED|First Intervention||25
3368975|NCT03828734|4100430|FG000|NOT COMPLETED|First Intervention||4
3368976|NCT03828734|4100431|FG001|NOT COMPLETED|First Intervention||0
3368977|NCT03828734|4100430|FG000|STARTED|First Washout (1 Week)||25
3368978|NCT03828734|4100431|FG001|STARTED|First Washout (1 Week)||25
3368979|NCT03828734|4100430|FG000|COMPLETED|First Washout (1 Week)||25
3368980|NCT03828734|4100431|FG001|COMPLETED|First Washout (1 Week)||24
3368981|NCT03828734|4100430|FG000|NOT COMPLETED|First Washout (1 Week)||0
3368982|NCT03828734|4100431|FG001|NOT COMPLETED|First Washout (1 Week)||1
3368983|NCT03828734|4100430|FG000|STARTED|Second Intervention||25
3368984|NCT03828734|4100431|FG001|STARTED|Second Intervention||24
3368985|NCT03828734|4100430|FG000|COMPLETED|Second Intervention||25
3368986|NCT03828734|4100431|FG001|COMPLETED|Second Intervention||24
3368987|NCT03828734|4100430|FG000|NOT COMPLETED|Second Intervention||0
3368988|NCT03828734|4100431|FG001|NOT COMPLETED|Second Intervention||0
3368989|NCT03827395|4100439|FG000|STARTED|Overall Study||20
3368990|NCT03827395|4100440|FG001|STARTED|Overall Study||5
3368991|NCT03827395|4100439|FG000|COMPLETED|Overall Study||17
3368992|NCT03827395|4100440|FG001|COMPLETED|Overall Study||3
3368993|NCT03827395|4100439|FG000|NOT COMPLETED|Overall Study||3
3368994|NCT03827395|4100440|FG001|NOT COMPLETED|Overall Study||2
3368995|NCT03819218|4100446|FG000|STARTED|Overall Study||7
3368996|NCT03819218|4100446|FG000|COMPLETED|Overall Study||6
3368997|NCT03819218|4100446|FG000|NOT COMPLETED|Overall Study||1
3368998|NCT03818815|4100452|FG000|STARTED|Overall Study||56
3368999|NCT03818815|4100453|FG001|STARTED|Overall Study||47
3369000|NCT03818815|4100452|FG000|COMPLETED|Overall Study||48
3369001|NCT03818815|4100453|FG001|COMPLETED|Overall Study||42
3369002|NCT03818815|4100452|FG000|NOT COMPLETED|Overall Study||8
3369003|NCT03818815|4100453|FG001|NOT COMPLETED|Overall Study||5
3369004|NCT03828487|4100459|FG000|STARTED|Overall Study||8
3369005|NCT03828487|4100459|FG000|COMPLETED|Overall Study||7
3369006|NCT03828487|4100459|FG000|NOT COMPLETED|Overall Study||1
3369007|NCT03828617|4100467|FG000|STARTED|Overall Study||489
3369008|NCT03828617|4100468|FG001|STARTED|Overall Study||490
3369009|NCT03828617|4100469|FG002|STARTED|Overall Study||486
3369010|NCT03828617|4100470|FG003|STARTED|Overall Study||245
3369011|NCT03828617|4100467|FG000|Vaccinated|Overall Study||488
3369012|NCT03828617|4100468|FG001|Vaccinated|Overall Study||489
3369013|NCT03828617|4100469|FG002|Vaccinated|Overall Study||486
3369014|NCT03828617|4100470|FG003|Vaccinated|Overall Study||245
3369015|NCT03828617|4100467|FG000|Safety Population|Overall Study||488
3369016|NCT03828617|4100468|FG001|Safety Population|Overall Study||489
3369017|NCT03828617|4100469|FG002|Safety Population|Overall Study||486
3369018|NCT03828617|4100470|FG003|Safety Population|Overall Study||245
3369019|NCT03828617|4100467|FG000|Evaluable Immunogenicity Population(EIP)|Overall Study||463
3369020|NCT03828617|4100468|FG001|Evaluable Immunogenicity Population(EIP)|Overall Study||473
3369021|NCT03828617|4100469|FG002|Evaluable Immunogenicity Population(EIP)|Overall Study||456
3369022|NCT03828617|4100470|FG003|Evaluable Immunogenicity Population(EIP)|Overall Study||232
3369023|NCT03828617|4100467|FG000|COMPLETED|Overall Study||465
3369024|NCT03828617|4100468|FG001|COMPLETED|Overall Study||475
3369025|NCT03828617|4100469|FG002|COMPLETED|Overall Study||460
3369026|NCT03828617|4100470|FG003|COMPLETED|Overall Study||235
3369027|NCT03828617|4100467|FG000|NOT COMPLETED|Overall Study||24
3369028|NCT03828617|4100468|FG001|NOT COMPLETED|Overall Study||15
3369029|NCT03828617|4100469|FG002|NOT COMPLETED|Overall Study||26
3369030|NCT03828617|4100470|FG003|NOT COMPLETED|Overall Study||10
3369031|NCT03828539|4100481|FG000|STARTED|Overall Study||389
3369032|NCT03828539|4100482|FG001|STARTED|Overall Study||388
3369033|NCT03828539|4100481|FG000|Full Analysis Set (FAS)|Overall Study||388
3369034|NCT03828539|4100482|FG001|Full Analysis Set (FAS)|Overall Study||388
3369035|NCT03828539|4100481|FG000|Safety Analysis Set (SAF)|Overall Study||388
3369036|NCT03828539|4100482|FG001|Safety Analysis Set (SAF)|Overall Study||388
3230404|NCT02342743|3962285|FG000|STARTED|Treatment Period|7 patients didn't meet inclusion criteria for treatment period, evaluated at the end of the baseline|58
3230405|NCT02342743|3962285|FG000|COMPLETED|Treatment Period||47
3230406|NCT02342743|3962285|FG000|NOT COMPLETED|Treatment Period||11
3230407|NCT02342886|3962294|FG000|STARTED|Overall Study||65
3230408|NCT02342886|3962295|FG001|STARTED|Overall Study||71
3230409|NCT02342886|3962296|FG002|STARTED|Overall Study||67
3230410|NCT02342886|3962297|FG003|STARTED|Overall Study||68
3230411|NCT02342886|3962298|FG004|STARTED|Overall Study||13
3230412|NCT02342886|3962294|FG000|Completed Month 12 Follow-Up|Overall Study||43
3230413|NCT02342886|3962295|FG001|Completed Month 12 Follow-Up|Overall Study||52
3230414|NCT02342886|3962296|FG002|Completed Month 12 Follow-Up|Overall Study||49
3230415|NCT02342886|3962297|FG003|Completed Month 12 Follow-Up|Overall Study||57
3230416|NCT02342886|3962298|FG004|Completed Month 12 Follow-Up|Overall Study||10
3230417|NCT02342886|3962294|FG000|Completed Month 24 Follow-Up|Overall Study||40
3230418|NCT02342886|3962295|FG001|Completed Month 24 Follow-Up|Overall Study||47
3230419|NCT02342886|3962296|FG002|Completed Month 24 Follow-Up|Overall Study||46
3230420|NCT02342886|3962297|FG003|Completed Month 24 Follow-Up|Overall Study||53
3230421|NCT02342886|3962298|FG004|Completed Month 24 Follow-Up|Overall Study||10
3230422|NCT02342886|3962294|FG000|COMPLETED|Overall Study||57
3230423|NCT02342886|3962295|FG001|COMPLETED|Overall Study||63
3230424|NCT02342886|3962296|FG002|COMPLETED|Overall Study||52
3230425|NCT02342886|3962297|FG003|COMPLETED|Overall Study||59
3230426|NCT02342886|3962298|FG004|COMPLETED|Overall Study||10
3230427|NCT02342886|3962294|FG000|NOT COMPLETED|Overall Study||8
3230428|NCT02342886|3962295|FG001|NOT COMPLETED|Overall Study||8
3230429|NCT02342886|3962296|FG002|NOT COMPLETED|Overall Study||15
3230430|NCT02342886|3962297|FG003|NOT COMPLETED|Overall Study||9
3230431|NCT02342886|3962298|FG004|NOT COMPLETED|Overall Study||3
3230432|NCT02343003|3962312|FG000|STARTED|Overall Study||76
3230433|NCT02343003|3962313|FG001|STARTED|Overall Study||75
3230434|NCT02343003|3962312|FG000|COMPLETED|Overall Study||58
3230435|NCT02343003|3962313|FG001|COMPLETED|Overall Study||68
3230436|NCT02343003|3962312|FG000|NOT COMPLETED|Overall Study||18
3230437|NCT02343003|3962313|FG001|NOT COMPLETED|Overall Study||7
3230438|NCT02343081|3962321|FG000|STARTED|First Intervention (Day 3)||8
3230439|NCT02343081|3962322|FG001|STARTED|First Intervention (Day 3)||8
3230440|NCT02343081|3962321|FG000|Received Intervention|First Intervention (Day 3)||8
3230441|NCT02343081|3962322|FG001|Received Intervention|First Intervention (Day 3)||8
3230442|NCT02343081|3962321|FG000|COMPLETED|First Intervention (Day 3)||8
3230443|NCT02343081|3962322|FG001|COMPLETED|First Intervention (Day 3)||8
3230444|NCT02343081|3962321|FG000|NOT COMPLETED|First Intervention (Day 3)||0
3230445|NCT02343081|3962322|FG001|NOT COMPLETED|First Intervention (Day 3)||0
3230446|NCT02343081|3962321|FG000|STARTED|Washout (10 Hours)||8
3230447|NCT02343081|3962322|FG001|STARTED|Washout (10 Hours)||8
3230448|NCT02343081|3962321|FG000|COMPLETED|Washout (10 Hours)||8
3230449|NCT02343081|3962322|FG001|COMPLETED|Washout (10 Hours)||8
3230450|NCT02343081|3962321|FG000|NOT COMPLETED|Washout (10 Hours)||0
3230451|NCT02343081|3962322|FG001|NOT COMPLETED|Washout (10 Hours)||0
3230452|NCT02343081|3962321|FG000|STARTED|Second Intervention (Day 4)||8
3230453|NCT02343081|3962322|FG001|STARTED|Second Intervention (Day 4)||8
3230454|NCT02343081|3962321|FG000|Received Intervention|Second Intervention (Day 4)||8
3230455|NCT02343081|3962322|FG001|Received Intervention|Second Intervention (Day 4)||8
3230456|NCT02343081|3962321|FG000|COMPLETED|Second Intervention (Day 4)||8
3230457|NCT02343081|3962322|FG001|COMPLETED|Second Intervention (Day 4)||8
3230458|NCT02343081|3962321|FG000|NOT COMPLETED|Second Intervention (Day 4)||0
3230459|NCT02343081|3962322|FG001|NOT COMPLETED|Second Intervention (Day 4)||0
3230460|NCT02343276|3962330|FG000|STARTED|Overall Study||164
3230461|NCT02343276|3962331|FG001|STARTED|Overall Study||164
3230462|NCT02343276|3962330|FG000|COMPLETED|Overall Study||164
3230463|NCT02343276|3962331|FG001|COMPLETED|Overall Study||164
3230464|NCT02343276|3962330|FG000|NOT COMPLETED|Overall Study||0
3230465|NCT02343276|3962331|FG001|NOT COMPLETED|Overall Study||0
3230466|NCT02343380|3962339|FG000|STARTED|Overall Study|Morning test (first week)|10
3230467|NCT02343380|3962340|FG001|STARTED|Overall Study|Evening test (first week)|10
3230468|NCT02343380|3962339|FG000|COMPLETED|Overall Study|Evening test (second week)|10
3230469|NCT02343380|3962340|FG001|COMPLETED|Overall Study|Morning test (second week)|10
3230470|NCT02343380|3962339|FG000|NOT COMPLETED|Overall Study||0
3230471|NCT02343380|3962340|FG001|NOT COMPLETED|Overall Study||0
3230472|NCT02343406|3962361|FG000|STARTED|Overall Study||88
3230473|NCT02343406|3962362|FG001|STARTED|Overall Study||86
3230474|NCT02343406|3962363|FG002|STARTED|Overall Study||60
3230475|NCT02343406|3962364|FG003|STARTED|Overall Study||26
3230476|NCT02343406|3962365|FG004|STARTED|Overall Study||6
3230477|NCT02343406|3962361|FG000|COMPLETED|Overall Study||0
3230478|NCT02343406|3962362|FG001|COMPLETED|Overall Study||0
3230479|NCT02343406|3962363|FG002|COMPLETED|Overall Study||2
3230480|NCT02343406|3962364|FG003|COMPLETED|Overall Study||0
3230481|NCT02343406|3962365|FG004|COMPLETED|Overall Study||1
3230482|NCT02343406|3962361|FG000|NOT COMPLETED|Overall Study||88
3230483|NCT02343406|3962362|FG001|NOT COMPLETED|Overall Study||86
3230484|NCT02343406|3962363|FG002|NOT COMPLETED|Overall Study||58
3230485|NCT02343406|3962364|FG003|NOT COMPLETED|Overall Study||26
3230486|NCT02343406|3962365|FG004|NOT COMPLETED|Overall Study||5
3230487|NCT02343458|3962380|FG000|STARTED|Overall Study||555
3230488|NCT02343458|3962381|FG001|STARTED|Overall Study||483
3230489|NCT02343458|3962382|FG002|STARTED|Overall Study||480
3230490|NCT02343458|3962383|FG003|STARTED|Overall Study||238
3230491|NCT02343458|3962380|FG000|COMPLETED|Overall Study||494
3230492|NCT02343458|3962381|FG001|COMPLETED|Overall Study||417
3230493|NCT02343458|3962382|FG002|COMPLETED|Overall Study||417
3230494|NCT02343458|3962383|FG003|COMPLETED|Overall Study||200
3230495|NCT02343458|3962380|FG000|NOT COMPLETED|Overall Study||61
3230496|NCT02343458|3962381|FG001|NOT COMPLETED|Overall Study||66
3230497|NCT02343458|3962382|FG002|NOT COMPLETED|Overall Study||63
3230498|NCT02343458|3962383|FG003|NOT COMPLETED|Overall Study||38
3230499|NCT02343549|3962393|FG000|STARTED|Overall Study||13
3230500|NCT02343549|3962393|FG000|COMPLETED|Overall Study||0
3230501|NCT02343549|3962393|FG000|NOT COMPLETED|Overall Study||13
3230502|NCT02343575|3962399|FG000|STARTED|Overall Study||1
3230503|NCT02343575|3962400|FG001|STARTED|Overall Study||2
3230504|NCT02343575|3962399|FG000|COMPLETED|Overall Study||1
3230505|NCT02343575|3962400|FG001|COMPLETED|Overall Study||2
3230506|NCT02343575|3962399|FG000|NOT COMPLETED|Overall Study||0
3230507|NCT02343575|3962400|FG001|NOT COMPLETED|Overall Study||0
3230508|NCT02343627|3962408|FG000|STARTED|Overall Study||35
3230509|NCT02343627|3962409|FG001|STARTED|Overall Study||12
3230510|NCT02343627|3962408|FG000|COMPLETED|Overall Study||23
3230511|NCT02343627|3962409|FG001|COMPLETED|Overall Study||11
3230512|NCT02343627|3962408|FG000|NOT COMPLETED|Overall Study||12
3230513|NCT02343627|3962409|FG001|NOT COMPLETED|Overall Study||1
3230514|NCT02343939|3962424|FG000|STARTED|Overall Study||3
3230515|NCT02343939|3962425|FG001|STARTED|Overall Study||50
3230516|NCT02343939|3962426|FG002|STARTED|Overall Study||5
3230517|NCT02343939|3962427|FG003|STARTED|Overall Study||6
3230518|NCT02343939|3962428|FG004|STARTED|Overall Study||8
3230519|NCT02343939|3962429|FG005|STARTED|Overall Study||17
3230520|NCT02343939|3962430|FG006|STARTED|Overall Study||15
3230521|NCT02343939|3962431|FG007|STARTED|Overall Study||37
3230522|NCT02343939|3962432|FG008|STARTED|Overall Study||7
3230523|NCT02343939|3962424|FG000|COMPLETED|Overall Study||0
3230524|NCT02343939|3962425|FG001|COMPLETED|Overall Study||2
3230525|NCT02343939|3962426|FG002|COMPLETED|Overall Study||0
3230526|NCT02343939|3962427|FG003|COMPLETED|Overall Study||0
3230527|NCT02343939|3962428|FG004|COMPLETED|Overall Study||0
3230528|NCT02343939|3962429|FG005|COMPLETED|Overall Study||0
3230529|NCT02343939|3962430|FG006|COMPLETED|Overall Study||0
3230530|NCT02343939|3962431|FG007|COMPLETED|Overall Study||0
3230531|NCT02343939|3962432|FG008|COMPLETED|Overall Study||0
3230532|NCT02343939|3962424|FG000|NOT COMPLETED|Overall Study||3
3230533|NCT02343939|3962425|FG001|NOT COMPLETED|Overall Study||48
3230534|NCT02343939|3962426|FG002|NOT COMPLETED|Overall Study||5
3230535|NCT02343939|3962427|FG003|NOT COMPLETED|Overall Study||6
3230536|NCT02343939|3962428|FG004|NOT COMPLETED|Overall Study||8
3230537|NCT02343939|3962429|FG005|NOT COMPLETED|Overall Study||17
3230538|NCT02343939|3962430|FG006|NOT COMPLETED|Overall Study||15
3230539|NCT02343939|3962431|FG007|NOT COMPLETED|Overall Study||37
3230540|NCT02343939|3962432|FG008|NOT COMPLETED|Overall Study||7
3230541|NCT02344004|3962468|FG000|STARTED|Overall Study||224
3230542|NCT02344004|3962469|FG001|STARTED|Overall Study||112
3230543|NCT02344004|3962468|FG000|COMPLETED|Overall Study||163
3230544|NCT02344004|3962469|FG001|COMPLETED|Overall Study||98
3230545|NCT02344004|3962468|FG000|NOT COMPLETED|Overall Study||61
3230546|NCT02344004|3962469|FG001|NOT COMPLETED|Overall Study||14
3230547|NCT02344173|3962476|FG000|STARTED|Enrollment||2035
3230548|NCT02344173|3962476|FG000|COMPLETED|Enrollment||2035
3230549|NCT02344173|3962476|FG000|NOT COMPLETED|Enrollment||0
3230550|NCT02344173|3962476|FG000|STARTED|Procedure||2035
3230551|NCT02344173|3962476|FG000|COMPLETED|Procedure||2028
3230552|NCT02344173|3962476|FG000|NOT COMPLETED|Procedure||7
3230553|NCT02344173|3962476|FG000|STARTED|12-month Visit||2028
3230554|NCT02344173|3962476|FG000|COMPLETED|12-month Visit||1932
3230555|NCT02344173|3962476|FG000|NOT COMPLETED|12-month Visit||96
3230556|NCT02344225|3962485|FG000|STARTED|Overall Study||6
3230557|NCT02344225|3962486|FG001|STARTED|Overall Study||3
3230558|NCT02344225|3962487|FG002|STARTED|Overall Study||5
3230559|NCT02344225|3962485|FG000|COMPLETED|Overall Study||6
3230560|NCT02344225|3962486|FG001|COMPLETED|Overall Study||3
3230561|NCT02344225|3962487|FG002|COMPLETED|Overall Study||5
3230562|NCT02344225|3962485|FG000|NOT COMPLETED|Overall Study||0
3230563|NCT02344225|3962486|FG001|NOT COMPLETED|Overall Study||0
3230564|NCT02344225|3962487|FG002|NOT COMPLETED|Overall Study||0
3230565|NCT02344238|3962498|FG000|STARTED|Overall Study||20
3230566|NCT02344238|3962499|FG001|STARTED|Overall Study||20
3230567|NCT02344238|3962500|FG002|STARTED|Overall Study||20
3230568|NCT02344238|3962498|FG000|COMPLETED|Overall Study||20
3230569|NCT02344238|3962499|FG001|COMPLETED|Overall Study||20
3230570|NCT02344238|3962500|FG002|COMPLETED|Overall Study||20
3230571|NCT02344238|3962498|FG000|NOT COMPLETED|Overall Study||0
3230572|NCT02344238|3962499|FG001|NOT COMPLETED|Overall Study||0
3230573|NCT02344238|3962500|FG002|NOT COMPLETED|Overall Study||0
3230574|NCT02344251|3962511|FG000|STARTED|Overall Study||20
3230575|NCT02344251|3962512|FG001|STARTED|Overall Study||20
3230576|NCT02344251|3962511|FG000|COMPLETED|Overall Study||20
3230577|NCT02344251|3962512|FG001|COMPLETED|Overall Study||20
3230578|NCT02344251|3962511|FG000|NOT COMPLETED|Overall Study||0
3230579|NCT02344251|3962512|FG001|NOT COMPLETED|Overall Study||0
3230580|NCT02344316|3962522|FG000|STARTED|Overall Study||13
3230581|NCT02344316|3962523|FG001|STARTED|Overall Study||13
3230582|NCT02344316|3962522|FG000|COMPLETED|Overall Study||12
3230583|NCT02344316|3962523|FG001|COMPLETED|Overall Study||11
3230584|NCT02344316|3962522|FG000|NOT COMPLETED|Overall Study||1
3230585|NCT02344316|3962523|FG001|NOT COMPLETED|Overall Study||2
3230586|NCT02344342|3962536|FG000|STARTED|Overall Study||13
3230587|NCT02344342|3962537|FG001|STARTED|Overall Study||11
3230588|NCT02344342|3962538|FG002|STARTED|Overall Study||14
3230589|NCT02344342|3962539|FG003|STARTED|Overall Study||13
3230590|NCT02344342|3962536|FG000|COMPLETED|Overall Study||2
3230591|NCT02344342|3962537|FG001|COMPLETED|Overall Study||2
3230592|NCT02344342|3962538|FG002|COMPLETED|Overall Study||0
3230593|NCT02344342|3962539|FG003|COMPLETED|Overall Study||3
3230594|NCT02344342|3962536|FG000|NOT COMPLETED|Overall Study||11
3230595|NCT02344342|3962537|FG001|NOT COMPLETED|Overall Study||9
3230596|NCT02344342|3962538|FG002|NOT COMPLETED|Overall Study||14
3230597|NCT02344342|3962539|FG003|NOT COMPLETED|Overall Study||10
3230598|NCT02344407|3962556|FG000|STARTED|Overall Study||500
3230599|NCT02344407|3962557|FG001|STARTED|Overall Study||500
3230600|NCT02344407|3962558|FG002|STARTED|Overall Study||500
3230601|NCT02344407|3962556|FG000|COMPLETED|Overall Study||492
3230602|NCT02344407|3962557|FG001|COMPLETED|Overall Study||491
3230603|NCT02344407|3962558|FG002|COMPLETED|Overall Study||494
3230604|NCT02344407|3962556|FG000|NOT COMPLETED|Overall Study||8
3230605|NCT02344407|3962557|FG001|NOT COMPLETED|Overall Study||9
3230606|NCT02344407|3962558|FG002|NOT COMPLETED|Overall Study||6
3230607|NCT02344576|3962570|FG000|STARTED|Enrollment|Includes 7 patients who agreed to medical record review only and were excluded from further analysis|142
3230608|NCT02344576|3962571|FG001|STARTED|Enrollment|Includes 8 patients who agreed to medical record review only and were excluded from further analysis|121
3230609|NCT02344576|3962572|FG002|STARTED|Enrollment||111
3230610|NCT02344576|3962573|FG003|STARTED|Enrollment||71
3230611|NCT02344576|3962570|FG000|Agreed to Survey Data Collection|Enrollment||135
3230612|NCT02344576|3962571|FG001|Agreed to Survey Data Collection|Enrollment||113
3230613|NCT02344576|3962572|FG002|Agreed to Survey Data Collection|Enrollment||111
3230614|NCT02344576|3962573|FG003|Agreed to Survey Data Collection|Enrollment||71
3230615|NCT02344576|3962570|FG000|COMPLETED|Enrollment||135
3230616|NCT02344576|3962571|FG001|COMPLETED|Enrollment||113
3230617|NCT02344576|3962572|FG002|COMPLETED|Enrollment||111
3230618|NCT02344576|3962573|FG003|COMPLETED|Enrollment||71
3230619|NCT02344576|3962570|FG000|NOT COMPLETED|Enrollment||7
3230620|NCT02344576|3962571|FG001|NOT COMPLETED|Enrollment||8
3230621|NCT02344576|3962572|FG002|NOT COMPLETED|Enrollment||0
3230622|NCT02344576|3962573|FG003|NOT COMPLETED|Enrollment||0
3230623|NCT02344576|3962570|FG000|STARTED|1-Month Follow-Up||135
3230624|NCT02344576|3962571|FG001|STARTED|1-Month Follow-Up||113
3230625|NCT02344576|3962572|FG002|STARTED|1-Month Follow-Up||111
3230626|NCT02344576|3962573|FG003|STARTED|1-Month Follow-Up||71
3230627|NCT02344576|3962570|FG000|Completed 1-Month Survey|1-Month Follow-Up||104
3230628|NCT02344576|3962571|FG001|Completed 1-Month Survey|1-Month Follow-Up||79
3230629|NCT02344576|3962572|FG002|Completed 1-Month Survey|1-Month Follow-Up||89
3230630|NCT02344576|3962573|FG003|Completed 1-Month Survey|1-Month Follow-Up||53
3230631|NCT02344576|3962570|FG000|COMPLETED|1-Month Follow-Up|Includes 13 patients who were still enrolled at 1-month but did not complete the 1-month survey.|117
3230632|NCT02344576|3962571|FG001|COMPLETED|1-Month Follow-Up|Includes 7 patients who were still enrolled at 1-month but did not complete the 1-month survey.|86
3230633|NCT02344576|3962572|FG002|COMPLETED|1-Month Follow-Up|Includes 3 caregivers who were still enrolled at 1-month but did not complete the 1-month survey.|92
3230634|NCT02344576|3962573|FG003|COMPLETED|1-Month Follow-Up|Includes 5 caregivers who were still enrolled at 1-month but did not complete the 1-month survey.|58
3230635|NCT02344576|3962570|FG000|NOT COMPLETED|1-Month Follow-Up||18
3230636|NCT02344576|3962571|FG001|NOT COMPLETED|1-Month Follow-Up||27
3230637|NCT02344576|3962572|FG002|NOT COMPLETED|1-Month Follow-Up||19
3230638|NCT02344576|3962573|FG003|NOT COMPLETED|1-Month Follow-Up||13
3230639|NCT02344576|3962570|FG000|STARTED|6-Month Follow-Up||117
3230640|NCT02344576|3962571|FG001|STARTED|6-Month Follow-Up||86
3230641|NCT02344576|3962572|FG002|STARTED|6-Month Follow-Up||92
3230642|NCT02344576|3962573|FG003|STARTED|6-Month Follow-Up||58
3230643|NCT02344576|3962570|FG000|Completed 6-Month Survey|6-Month Follow-Up||98
3230644|NCT02344576|3962571|FG001|Completed 6-Month Survey|6-Month Follow-Up||67
3230645|NCT02344576|3962572|FG002|Completed 6-Month Survey|6-Month Follow-Up||78
3230646|NCT02344576|3962573|FG003|Completed 6-Month Survey|6-Month Follow-Up||50
3230647|NCT02344576|3962570|FG000|COMPLETED|6-Month Follow-Up||98
3230648|NCT02344576|3962571|FG001|COMPLETED|6-Month Follow-Up||67
3230649|NCT02344576|3962572|FG002|COMPLETED|6-Month Follow-Up||78
3230650|NCT02344576|3962573|FG003|COMPLETED|6-Month Follow-Up||50
3230651|NCT02344576|3962570|FG000|NOT COMPLETED|6-Month Follow-Up||19
3230652|NCT02344576|3962571|FG001|NOT COMPLETED|6-Month Follow-Up||19
3230653|NCT02344576|3962572|FG002|NOT COMPLETED|6-Month Follow-Up||14
3230654|NCT02344576|3962573|FG003|NOT COMPLETED|6-Month Follow-Up||8
3230655|NCT02344576|3962570|FG000|STARTED|12-Month Medical Record Follow-Up||98
3230656|NCT02344576|3962571|FG001|STARTED|12-Month Medical Record Follow-Up||67
3230657|NCT02344576|3962572|FG002|STARTED|12-Month Medical Record Follow-Up|This period not applicable to caregivers, as medical record review was completed for patients only.|78
3230658|NCT02344576|3962573|FG003|STARTED|12-Month Medical Record Follow-Up|This period not applicable to caregivers, as medical record review was completed for patients only.|50
3230659|NCT02344576|3962570|FG000|COMPLETED|12-Month Medical Record Follow-Up||98
3230660|NCT02344576|3962571|FG001|COMPLETED|12-Month Medical Record Follow-Up||67
3369037|NCT03828539|4100481|FG000|COMPLETED|Overall Study||373
3369038|NCT03828539|4100482|FG001|COMPLETED|Overall Study||366
3230661|NCT02344576|3962572|FG002|COMPLETED|12-Month Medical Record Follow-Up|This period not applicable to caregivers, as medical record review was completed for patients only.|78
3230662|NCT02344576|3962573|FG003|COMPLETED|12-Month Medical Record Follow-Up|This period not applicable to caregivers, as medical record review was completed for patients only.|50
3230663|NCT02344576|3962570|FG000|NOT COMPLETED|12-Month Medical Record Follow-Up||0
3230664|NCT02344576|3962571|FG001|NOT COMPLETED|12-Month Medical Record Follow-Up||0
3230665|NCT02344576|3962572|FG002|NOT COMPLETED|12-Month Medical Record Follow-Up||0
3230666|NCT02344576|3962573|FG003|NOT COMPLETED|12-Month Medical Record Follow-Up||0
3230667|NCT02344628|3962587|FG000|STARTED|Overall Study||291
3230668|NCT02344628|3962588|FG001|STARTED|Overall Study||292
3230669|NCT02344628|3962587|FG000|COMPLETED|Overall Study|4/52 clinical data was available for 283. Serological data 6/12 for 212. Both were available for 200|200
3230670|NCT02344628|3962588|FG001|COMPLETED|Overall Study|4/52 clinical data was available for 286. Serological data 6/12 for 218. Both were available for 206|206
3230671|NCT02344628|3962587|FG000|NOT COMPLETED|Overall Study||91
3230672|NCT02344628|3962588|FG001|NOT COMPLETED|Overall Study||86
3230673|NCT02344745|3962596|FG000|STARTED|Overall Study||40
3230674|NCT02344745|3962597|FG001|STARTED|Overall Study||40
3230675|NCT02344745|3962596|FG000|COMPLETED|Overall Study||38
3230676|NCT02344745|3962597|FG001|COMPLETED|Overall Study||40
3230677|NCT02344745|3962596|FG000|NOT COMPLETED|Overall Study||2
3230678|NCT02344745|3962597|FG001|NOT COMPLETED|Overall Study||0
3230679|NCT02345031|3962605|FG000|STARTED|Overall Study||38
3230680|NCT02345031|3962606|FG001|STARTED|Overall Study||40
3230681|NCT02345031|3962605|FG000|COMPLETED|Overall Study||37
3230682|NCT02345031|3962606|FG001|COMPLETED|Overall Study||39
3230683|NCT02345031|3962605|FG000|NOT COMPLETED|Overall Study||1
3230684|NCT02345031|3962606|FG001|NOT COMPLETED|Overall Study||1
3230685|NCT02345070|3962617|FG000|STARTED|Overall Study||110
3230686|NCT02345070|3962618|FG001|STARTED|Overall Study||109
3230687|NCT02345070|3962619|FG002|STARTED|Overall Study||108
3230688|NCT02345070|3962617|FG000|Treated|Overall Study||109
3230689|NCT02345070|3962618|FG001|Treated|Overall Study||108
3230690|NCT02345070|3962619|FG002|Treated|Overall Study||108
3230691|NCT02345070|3962617|FG000|COMPLETED|Overall Study||90
3230692|NCT02345070|3962618|FG001|COMPLETED|Overall Study||98
3230693|NCT02345070|3962619|FG002|COMPLETED|Overall Study||85
3230694|NCT02345070|3962617|FG000|NOT COMPLETED|Overall Study||20
3230695|NCT02345070|3962618|FG001|NOT COMPLETED|Overall Study||11
3230696|NCT02345070|3962619|FG002|NOT COMPLETED|Overall Study||23
3230697|NCT02345161|3962629|FG000|STARTED|Overall Study||911
3230698|NCT02345161|3962630|FG001|STARTED|Overall Study||899
3230699|NCT02345161|3962629|FG000|COMPLETED|Overall Study||866
3230700|NCT02345161|3962630|FG001|COMPLETED|Overall Study||842
3230701|NCT02345161|3962629|FG000|NOT COMPLETED|Overall Study||45
3230702|NCT02345161|3962630|FG001|NOT COMPLETED|Overall Study||57
3230703|NCT02345226|3962643|FG000|STARTED|Double-Blind Phase||440
3230704|NCT02345226|3962644|FG001|STARTED|Double-Blind Phase||441
3230705|NCT02345226|3962643|FG000|COMPLETED|Double-Blind Phase||371
3230706|NCT02345226|3962644|FG001|COMPLETED|Double-Blind Phase||370
3230707|NCT02345226|3962643|FG000|NOT COMPLETED|Double-Blind Phase||69
3230708|NCT02345226|3962644|FG001|NOT COMPLETED|Double-Blind Phase||71
3230709|NCT02345226|3962643|FG000|STARTED|Open-Label Extension Phase|346 participants completed the Double-Blind Phase, but did not enter Open-Label Extension Phase.|25
3230710|NCT02345226|3962644|FG001|STARTED|Open-Label Extension Phase|349 participants completed the Double-Blind Phase, but did not enter Open-Label Extension Phase.|21
3230711|NCT02345226|3962643|FG000|COMPLETED|Open-Label Extension Phase||25
3230712|NCT02345226|3962644|FG001|COMPLETED|Open-Label Extension Phase||20
3230713|NCT02345226|3962643|FG000|NOT COMPLETED|Open-Label Extension Phase||0
3230714|NCT02345226|3962644|FG001|NOT COMPLETED|Open-Label Extension Phase||1
3230715|NCT02345252|3962654|FG000|STARTED|Double-Blind Phase||316
3230716|NCT02345252|3962655|FG001|STARTED|Double-Blind Phase||316
3230717|NCT02345252|3962654|FG000|COMPLETED|Double-Blind Phase||276
3230718|NCT02345252|3962655|FG001|COMPLETED|Double-Blind Phase||267
3230719|NCT02345252|3962654|FG000|NOT COMPLETED|Double-Blind Phase||40
3230720|NCT02345252|3962655|FG001|NOT COMPLETED|Double-Blind Phase||49
3230721|NCT02345252|3962654|FG000|STARTED|Open-Label Extension Phase|257 participants completed the Double-Blind Phase, but did not enter Open-Label Extension Phase.|19
3230722|NCT02345252|3962655|FG001|STARTED|Open-Label Extension Phase|250 participants completed the Double-Blind Phase, but did not enter Open-Label Extension Phase.|17
3230723|NCT02345252|3962654|FG000|COMPLETED|Open-Label Extension Phase||19
3230724|NCT02345252|3962655|FG001|COMPLETED|Open-Label Extension Phase||17
3230725|NCT02345252|3962654|FG000|NOT COMPLETED|Open-Label Extension Phase||0
3230726|NCT02345252|3962655|FG001|NOT COMPLETED|Open-Label Extension Phase||0
3230727|NCT02345330|3962663|FG000|STARTED|Overall Study||4
3230728|NCT02345330|3962663|FG000|COMPLETED|Overall Study||1
3230729|NCT02345330|3962663|FG000|NOT COMPLETED|Overall Study||3
3230730|NCT02345434|3962669|FG000|STARTED|Overall Study||763
3230731|NCT02345434|3962670|FG001|STARTED|Overall Study||762
3230732|NCT02345434|3962669|FG000|COMPLETED|Overall Study||758
3230733|NCT02345434|3962670|FG001|COMPLETED|Overall Study||760
3369039|NCT03828539|4100481|FG000|NOT COMPLETED|Overall Study||16
3369040|NCT03828539|4100482|FG001|NOT COMPLETED|Overall Study||22
3369041|NCT03824704|4100488|FG000|STARTED|Overall Study||1
3369042|NCT03824704|4100488|FG000|COMPLETED|Overall Study||0
3369043|NCT03824704|4100488|FG000|NOT COMPLETED|Overall Study||1
3369044|NCT03823937|4100494|FG000|STARTED|Overall Study||30
3369045|NCT03823937|4100495|FG001|STARTED|Overall Study||20
3230734|NCT02345434|3962669|FG000|NOT COMPLETED|Overall Study||5
3230735|NCT02345434|3962670|FG001|NOT COMPLETED|Overall Study||2
3230736|NCT02345486|3962678|FG000|STARTED|Overall Study||454
3230737|NCT02345486|3962679|FG001|STARTED|Overall Study||520
3230738|NCT02345486|3962678|FG000|COMPLETED|Overall Study||454
3230739|NCT02345486|3962679|FG001|COMPLETED|Overall Study||520
3230740|NCT02345486|3962678|FG000|NOT COMPLETED|Overall Study||0
3230741|NCT02345486|3962679|FG001|NOT COMPLETED|Overall Study||0
3230742|NCT02345512|3962685|FG000|STARTED|Overall Study||11
3230743|NCT02345512|3962685|FG000|COMPLETED|Overall Study||9
3230744|NCT02345512|3962685|FG000|NOT COMPLETED|Overall Study||2
3230745|NCT02345642|3962696|FG000|STARTED|Overall Study||10
3230746|NCT02345642|3962697|FG001|STARTED|Overall Study||10
3230747|NCT02345642|3962696|FG000|COMPLETED|Overall Study||10
3230748|NCT02345642|3962697|FG001|COMPLETED|Overall Study||10
3230749|NCT02345642|3962696|FG000|NOT COMPLETED|Overall Study||0
3230750|NCT02345642|3962697|FG001|NOT COMPLETED|Overall Study||0
3230751|NCT02345720|3962703|FG000|STARTED|Overall Study||20
3230752|NCT02345720|3962703|FG000|COMPLETED|Overall Study||20
3230753|NCT02345720|3962703|FG000|NOT COMPLETED|Overall Study||0
3230754|NCT02345811|3962707|FG000|STARTED|First Intervention||17
3230755|NCT02345811|3962708|FG001|STARTED|First Intervention||17
3230756|NCT02345811|3962707|FG000|COMPLETED|First Intervention||16
3230757|NCT02345811|3962708|FG001|COMPLETED|First Intervention||16
3230758|NCT02345811|3962707|FG000|NOT COMPLETED|First Intervention||1
3230759|NCT02345811|3962708|FG001|NOT COMPLETED|First Intervention||1
3230760|NCT02345811|3962707|FG000|STARTED|Second Intervention||16
3230761|NCT02345811|3962708|FG001|STARTED|Second Intervention||16
3230762|NCT02345811|3962707|FG000|COMPLETED|Second Intervention||16
3230763|NCT02345811|3962708|FG001|COMPLETED|Second Intervention||16
3230764|NCT02345811|3962707|FG000|NOT COMPLETED|Second Intervention||0
3230765|NCT02345811|3962708|FG001|NOT COMPLETED|Second Intervention||0
3230766|NCT02345889|3962720|FG000|STARTED|Overall Study||316
3230767|NCT02345889|3962721|FG001|STARTED|Overall Study||316
3230768|NCT02345889|3962722|FG002|STARTED|Overall Study||315
3230769|NCT02345889|3962723|FG003|STARTED|Overall Study||315
3230770|NCT02345889|3962720|FG000|COMPLETED|Overall Study||295
3230771|NCT02345889|3962721|FG001|COMPLETED|Overall Study||299
3230772|NCT02345889|3962722|FG002|COMPLETED|Overall Study||295
3230773|NCT02345889|3962723|FG003|COMPLETED|Overall Study||299
3230774|NCT02345889|3962720|FG000|NOT COMPLETED|Overall Study||21
3230775|NCT02345889|3962721|FG001|NOT COMPLETED|Overall Study||17
3230776|NCT02345889|3962722|FG002|NOT COMPLETED|Overall Study||20
3230777|NCT02345889|3962723|FG003|NOT COMPLETED|Overall Study||16
3230778|NCT02346136|3962735|FG000|STARTED|Overall Study||93
3230779|NCT02346136|3962736|FG001|STARTED|Overall Study||87
3230780|NCT02346136|3962735|FG000|COMPLETED|Overall Study||71
3230781|NCT02346136|3962736|FG001|COMPLETED|Overall Study||64
3230782|NCT02346136|3962735|FG000|NOT COMPLETED|Overall Study||22
3230783|NCT02346136|3962736|FG001|NOT COMPLETED|Overall Study||23
3230784|NCT02346240|3962746|FG000|STARTED|Initial Period (Baseline to Week 16)||57
3230785|NCT02346240|3962747|FG001|STARTED|Initial Period (Baseline to Week 16)||170
3230786|NCT02346240|3962748|FG002|STARTED|Initial Period (Baseline to Week 16)||165
3230787|NCT02346240|3962749|FG003|STARTED|Initial Period (Baseline to Week 16)||167
3230788|NCT02346240|3962750|FG004|STARTED|Initial Period (Baseline to Week 16)||0
3230789|NCT02346240|3962751|FG005|STARTED|Initial Period (Baseline to Week 16)||0
3230790|NCT02346240|3962752|FG006|STARTED|Initial Period (Baseline to Week 16)||0
3230791|NCT02346240|3962753|FG007|STARTED|Initial Period (Baseline to Week 16)||0
3230792|NCT02346240|3962754|FG008|STARTED|Initial Period (Baseline to Week 16)||0
3230793|NCT02346240|3962755|FG009|STARTED|Initial Period (Baseline to Week 16)||0
3230794|NCT02346240|3962756|FG010|STARTED|Initial Period (Baseline to Week 16)||0
3230795|NCT02346240|3962757|FG011|STARTED|Initial Period (Baseline to Week 16)||0
3230796|NCT02346240|3962758|FG012|STARTED|Initial Period (Baseline to Week 16)||0
3230797|NCT02346240|3962759|FG013|STARTED|Initial Period (Baseline to Week 16)||0
3230798|NCT02346240|3962760|FG014|STARTED|Initial Period (Baseline to Week 16)||0
3230799|NCT02346240|3962761|FG015|STARTED|Initial Period (Baseline to Week 16)||0
3230800|NCT02346240|3962762|FG016|STARTED|Initial Period (Baseline to Week 16)||0
3230801|NCT02346240|3962763|FG017|STARTED|Initial Period (Baseline to Week 16)||0
3230802|NCT02346240|3962764|FG018|STARTED|Initial Period (Baseline to Week 16)||0
3230803|NCT02346240|3962765|FG019|STARTED|Initial Period (Baseline to Week 16)||0
3230804|NCT02346240|3962766|FG020|STARTED|Initial Period (Baseline to Week 16)||0
3230805|NCT02346240|3962767|FG021|STARTED|Initial Period (Baseline to Week 16)||0
3230806|NCT02346240|3962768|FG022|STARTED|Initial Period (Baseline to Week 16)||0
3230807|NCT02346240|3962769|FG023|STARTED|Initial Period (Baseline to Week 16)||0
3230808|NCT02346240|3962746|FG000|Completed Week 16|Initial Period (Baseline to Week 16)||55
3230809|NCT02346240|3962747|FG001|Completed Week 16|Initial Period (Baseline to Week 16)||159
3230810|NCT02346240|3962748|FG002|Completed Week 16|Initial Period (Baseline to Week 16)||159
3230811|NCT02346240|3962749|FG003|Completed Week 16|Initial Period (Baseline to Week 16)||162
3230812|NCT02346240|3962750|FG004|Completed Week 16|Initial Period (Baseline to Week 16)||0
3230813|NCT02346240|3962751|FG005|Completed Week 16|Initial Period (Baseline to Week 16)||0
3230814|NCT02346240|3962752|FG006|Completed Week 16|Initial Period (Baseline to Week 16)||0
3230815|NCT02346240|3962753|FG007|Completed Week 16|Initial Period (Baseline to Week 16)||0
3230816|NCT02346240|3962754|FG008|Completed Week 16|Initial Period (Baseline to Week 16)||0
3230817|NCT02346240|3962755|FG009|Completed Week 16|Initial Period (Baseline to Week 16)||0
3230818|NCT02346240|3962756|FG010|Completed Week 16|Initial Period (Baseline to Week 16)||0
3230819|NCT02346240|3962757|FG011|Completed Week 16|Initial Period (Baseline to Week 16)||0
3230820|NCT02346240|3962758|FG012|Completed Week 16|Initial Period (Baseline to Week 16)||0
3230821|NCT02346240|3962759|FG013|Completed Week 16|Initial Period (Baseline to Week 16)||0
3230822|NCT02346240|3962760|FG014|Completed Week 16|Initial Period (Baseline to Week 16)||0
3230823|NCT02346240|3962761|FG015|Completed Week 16|Initial Period (Baseline to Week 16)||0
3230824|NCT02346240|3962762|FG016|Completed Week 16|Initial Period (Baseline to Week 16)||0
3230825|NCT02346240|3962763|FG017|Completed Week 16|Initial Period (Baseline to Week 16)||0
3230826|NCT02346240|3962764|FG018|Completed Week 16|Initial Period (Baseline to Week 16)||0
3230827|NCT02346240|3962765|FG019|Completed Week 16|Initial Period (Baseline to Week 16)||0
3230828|NCT02346240|3962766|FG020|Completed Week 16|Initial Period (Baseline to Week 16)||0
3230829|NCT02346240|3962767|FG021|Completed Week 16|Initial Period (Baseline to Week 16)||0
3230830|NCT02346240|3962768|FG022|Completed Week 16|Initial Period (Baseline to Week 16)||0
3230831|NCT02346240|3962769|FG023|Completed Week 16|Initial Period (Baseline to Week 16)||0
3230832|NCT02346240|3962746|FG000|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||55
3230833|NCT02346240|3962747|FG001|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||159
3230834|NCT02346240|3962748|FG002|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||159
3230835|NCT02346240|3962749|FG003|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||160
3230836|NCT02346240|3962750|FG004|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
3230837|NCT02346240|3962751|FG005|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
3230838|NCT02346240|3962752|FG006|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
3230839|NCT02346240|3962753|FG007|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
3230840|NCT02346240|3962754|FG008|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
3230841|NCT02346240|3962755|FG009|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
3230842|NCT02346240|3962756|FG010|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
3230843|NCT02346240|3962757|FG011|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
3230844|NCT02346240|3962758|FG012|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
3230845|NCT02346240|3962759|FG013|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
3230846|NCT02346240|3962760|FG014|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
3230847|NCT02346240|3962761|FG015|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
3230848|NCT02346240|3962762|FG016|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
3230849|NCT02346240|3962763|FG017|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
3230850|NCT02346240|3962764|FG018|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
3230851|NCT02346240|3962765|FG019|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
3230852|NCT02346240|3962766|FG020|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
3230853|NCT02346240|3962767|FG021|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
3230854|NCT02346240|3962768|FG022|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
3230855|NCT02346240|3962769|FG023|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
3230856|NCT02346240|3962746|FG000|COMPLETED|Initial Period (Baseline to Week 16)||55
3230857|NCT02346240|3962747|FG001|COMPLETED|Initial Period (Baseline to Week 16)||159
3230858|NCT02346240|3962748|FG002|COMPLETED|Initial Period (Baseline to Week 16)||159
3230859|NCT02346240|3962749|FG003|COMPLETED|Initial Period (Baseline to Week 16)||160
3230860|NCT02346240|3962750|FG004|COMPLETED|Initial Period (Baseline to Week 16)||0
3230861|NCT02346240|3962751|FG005|COMPLETED|Initial Period (Baseline to Week 16)||0
3230862|NCT02346240|3962752|FG006|COMPLETED|Initial Period (Baseline to Week 16)||0
3230863|NCT02346240|3962753|FG007|COMPLETED|Initial Period (Baseline to Week 16)||0
3230864|NCT02346240|3962754|FG008|COMPLETED|Initial Period (Baseline to Week 16)||0
3230865|NCT02346240|3962755|FG009|COMPLETED|Initial Period (Baseline to Week 16)||0
3230866|NCT02346240|3962756|FG010|COMPLETED|Initial Period (Baseline to Week 16)||0
3230867|NCT02346240|3962757|FG011|COMPLETED|Initial Period (Baseline to Week 16)||0
3230868|NCT02346240|3962758|FG012|COMPLETED|Initial Period (Baseline to Week 16)||0
3230869|NCT02346240|3962759|FG013|COMPLETED|Initial Period (Baseline to Week 16)||0
3230870|NCT02346240|3962760|FG014|COMPLETED|Initial Period (Baseline to Week 16)||0
3230871|NCT02346240|3962761|FG015|COMPLETED|Initial Period (Baseline to Week 16)||0
3230872|NCT02346240|3962762|FG016|COMPLETED|Initial Period (Baseline to Week 16)||0
3230873|NCT02346240|3962763|FG017|COMPLETED|Initial Period (Baseline to Week 16)||0
3230874|NCT02346240|3962764|FG018|COMPLETED|Initial Period (Baseline to Week 16)||0
3230875|NCT02346240|3962765|FG019|COMPLETED|Initial Period (Baseline to Week 16)||0
3230876|NCT02346240|3962766|FG020|COMPLETED|Initial Period (Baseline to Week 16)||0
3230877|NCT02346240|3962767|FG021|COMPLETED|Initial Period (Baseline to Week 16)||0
3230878|NCT02346240|3962768|FG022|COMPLETED|Initial Period (Baseline to Week 16)||0
3230879|NCT02346240|3962769|FG023|COMPLETED|Initial Period (Baseline to Week 16)||0
3230880|NCT02346240|3962746|FG000|NOT COMPLETED|Initial Period (Baseline to Week 16)||2
3230881|NCT02346240|3962747|FG001|NOT COMPLETED|Initial Period (Baseline to Week 16)||11
3230882|NCT02346240|3962748|FG002|NOT COMPLETED|Initial Period (Baseline to Week 16)||6
3230883|NCT02346240|3962749|FG003|NOT COMPLETED|Initial Period (Baseline to Week 16)||7
3230884|NCT02346240|3962750|FG004|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
3230885|NCT02346240|3962751|FG005|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
3230886|NCT02346240|3962752|FG006|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
3230887|NCT02346240|3962753|FG007|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
3230888|NCT02346240|3962754|FG008|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
3230889|NCT02346240|3962755|FG009|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
3230890|NCT02346240|3962756|FG010|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
3230891|NCT02346240|3962757|FG011|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
3230892|NCT02346240|3962758|FG012|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
3230893|NCT02346240|3962759|FG013|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
3230894|NCT02346240|3962760|FG014|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
3230895|NCT02346240|3962761|FG015|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
3230896|NCT02346240|3962762|FG016|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
3230897|NCT02346240|3962763|FG017|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
3230898|NCT02346240|3962764|FG018|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
3230899|NCT02346240|3962765|FG019|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
3230900|NCT02346240|3962766|FG020|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
3230901|NCT02346240|3962767|FG021|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
3230902|NCT02346240|3962768|FG022|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
3230903|NCT02346240|3962769|FG023|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
3230904|NCT02346240|3962746|FG000|STARTED|Maintenance Period (Week 16 to Week 48)||0
3230905|NCT02346240|3962747|FG001|STARTED|Maintenance Period (Week 16 to Week 48)||0
3230906|NCT02346240|3962748|FG002|STARTED|Maintenance Period (Week 16 to Week 48)||0
3230907|NCT02346240|3962749|FG003|STARTED|Maintenance Period (Week 16 to Week 48)||0
3230908|NCT02346240|3962750|FG004|STARTED|Maintenance Period (Week 16 to Week 48)||2
3230909|NCT02346240|3962751|FG005|STARTED|Maintenance Period (Week 16 to Week 48)||24
3230910|NCT02346240|3962752|FG006|STARTED|Maintenance Period (Week 16 to Week 48)||50
3230911|NCT02346240|3962753|FG007|STARTED|Maintenance Period (Week 16 to Week 48)||22
3230912|NCT02346240|3962754|FG008|STARTED|Maintenance Period (Week 16 to Week 48)||44
3230913|NCT02346240|3962755|FG009|STARTED|Maintenance Period (Week 16 to Week 48)||44
3230914|NCT02346240|3962756|FG010|STARTED|Maintenance Period (Week 16 to Week 48)||25
3230915|NCT02346240|3962757|FG011|STARTED|Maintenance Period (Week 16 to Week 48)||50
3230916|NCT02346240|3962758|FG012|STARTED|Maintenance Period (Week 16 to Week 48)||49
3230917|NCT02346240|3962759|FG013|STARTED|Maintenance Period (Week 16 to Week 48)||53
3230918|NCT02346240|3962760|FG014|STARTED|Maintenance Period (Week 16 to Week 48)||85
3230919|NCT02346240|3962761|FG015|STARTED|Maintenance Period (Week 16 to Week 48)||49
3230920|NCT02346240|3962762|FG016|STARTED|Maintenance Period (Week 16 to Week 48)||36
3230921|NCT02346240|3962763|FG017|STARTED|Maintenance Period (Week 16 to Week 48)||0
3230922|NCT02346240|3962764|FG018|STARTED|Maintenance Period (Week 16 to Week 48)||0
3230923|NCT02346240|3962765|FG019|STARTED|Maintenance Period (Week 16 to Week 48)||0
3230924|NCT02346240|3962766|FG020|STARTED|Maintenance Period (Week 16 to Week 48)||0
3230925|NCT02346240|3962767|FG021|STARTED|Maintenance Period (Week 16 to Week 48)||0
3230926|NCT02346240|3962768|FG022|STARTED|Maintenance Period (Week 16 to Week 48)||0
3230927|NCT02346240|3962769|FG023|STARTED|Maintenance Period (Week 16 to Week 48)||0
3230928|NCT02346240|3962746|FG000|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
3230929|NCT02346240|3962747|FG001|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
3230930|NCT02346240|3962748|FG002|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
3230931|NCT02346240|3962749|FG003|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
3230932|NCT02346240|3962750|FG004|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||2
3230933|NCT02346240|3962751|FG005|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||23
3230934|NCT02346240|3962752|FG006|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||48
3230935|NCT02346240|3962753|FG007|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||20
3230936|NCT02346240|3962754|FG008|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||40
3230937|NCT02346240|3962755|FG009|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||43
3230938|NCT02346240|3962756|FG010|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||23
3230939|NCT02346240|3962757|FG011|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||47
3230940|NCT02346240|3962758|FG012|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||49
3369046|NCT03823937|4100494|FG000|COMPLETED|Overall Study||30
3369047|NCT03823937|4100495|FG001|COMPLETED|Overall Study||20
3369048|NCT03823937|4100494|FG000|NOT COMPLETED|Overall Study||0
3369049|NCT03823937|4100495|FG001|NOT COMPLETED|Overall Study||0
3369050|NCT03817879|4100503|FG000|STARTED|Overall Study||35
3369051|NCT03817879|4100504|FG001|STARTED|Overall Study||35
3369052|NCT03817879|4100503|FG000|COMPLETED|Overall Study||30
3369053|NCT03817879|4100504|FG001|COMPLETED|Overall Study||22
3369054|NCT03817879|4100503|FG000|NOT COMPLETED|Overall Study||5
3369055|NCT03817879|4100504|FG001|NOT COMPLETED|Overall Study||13
3369056|NCT03811834|4100510|FG000|STARTED|Period 1 ( 7 Days)||7
3369057|NCT03811834|4100510|FG000|COMPLETED|Period 1 ( 7 Days)||6
3369058|NCT03811834|4100510|FG000|NOT COMPLETED|Period 1 ( 7 Days)||1
3369059|NCT03811834|4100510|FG000|STARTED|Washout Period (9 Days)||6
3369060|NCT03811834|4100510|FG000|COMPLETED|Washout Period (9 Days)||6
3230941|NCT02346240|3962759|FG013|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||46
3230942|NCT02346240|3962760|FG014|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||71
3230943|NCT02346240|3962761|FG015|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||36
3230944|NCT02346240|3962762|FG016|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||30
3230945|NCT02346240|3962763|FG017|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
3230946|NCT02346240|3962764|FG018|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
3230947|NCT02346240|3962765|FG019|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
3230948|NCT02346240|3962766|FG020|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
3230949|NCT02346240|3962767|FG021|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
3230950|NCT02346240|3962768|FG022|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
3230951|NCT02346240|3962769|FG023|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
3230952|NCT02346240|3962746|FG000|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
3230953|NCT02346240|3962747|FG001|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
3230954|NCT02346240|3962748|FG002|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
3230955|NCT02346240|3962749|FG003|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
3230956|NCT02346240|3962750|FG004|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||2
3230957|NCT02346240|3962751|FG005|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||23
3230958|NCT02346240|3962752|FG006|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||48
3230959|NCT02346240|3962753|FG007|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||20
3230960|NCT02346240|3962754|FG008|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||40
3230961|NCT02346240|3962755|FG009|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||43
3230962|NCT02346240|3962756|FG010|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||23
3230963|NCT02346240|3962757|FG011|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||47
3230964|NCT02346240|3962758|FG012|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||49
3230965|NCT02346240|3962759|FG013|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||45
3230966|NCT02346240|3962760|FG014|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||68
3230967|NCT02346240|3962761|FG015|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||35
3230968|NCT02346240|3962762|FG016|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||29
3230969|NCT02346240|3962763|FG017|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
3230970|NCT02346240|3962764|FG018|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
3230971|NCT02346240|3962765|FG019|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
3230972|NCT02346240|3962766|FG020|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
3230973|NCT02346240|3962767|FG021|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
3230974|NCT02346240|3962768|FG022|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
3230975|NCT02346240|3962769|FG023|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
3230976|NCT02346240|3962746|FG000|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
3230977|NCT02346240|3962747|FG001|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
3230978|NCT02346240|3962748|FG002|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
3230979|NCT02346240|3962749|FG003|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
3230980|NCT02346240|3962750|FG004|COMPLETED|Maintenance Period (Week 16 to Week 48)||2
3230981|NCT02346240|3962751|FG005|COMPLETED|Maintenance Period (Week 16 to Week 48)||23
3230982|NCT02346240|3962752|FG006|COMPLETED|Maintenance Period (Week 16 to Week 48)||48
3230983|NCT02346240|3962753|FG007|COMPLETED|Maintenance Period (Week 16 to Week 48)||20
3230984|NCT02346240|3962754|FG008|COMPLETED|Maintenance Period (Week 16 to Week 48)||40
3230985|NCT02346240|3962755|FG009|COMPLETED|Maintenance Period (Week 16 to Week 48)||43
3230986|NCT02346240|3962756|FG010|COMPLETED|Maintenance Period (Week 16 to Week 48)||23
3230987|NCT02346240|3962757|FG011|COMPLETED|Maintenance Period (Week 16 to Week 48)||47
3230988|NCT02346240|3962758|FG012|COMPLETED|Maintenance Period (Week 16 to Week 48)||49
3230989|NCT02346240|3962759|FG013|COMPLETED|Maintenance Period (Week 16 to Week 48)|1 subject completed the Maintenance Period but did not enter the Open-Label Period.|45
3230990|NCT02346240|3962760|FG014|COMPLETED|Maintenance Period (Week 16 to Week 48)|3 subjects completed the Maintenance Period but did not enter the Open-Label Period.|68
3230991|NCT02346240|3962761|FG015|COMPLETED|Maintenance Period (Week 16 to Week 48)|1 subject completed the Maintenance Period but did not enter the Open-Label Period.|35
3230992|NCT02346240|3962762|FG016|COMPLETED|Maintenance Period (Week 16 to Week 48)|1 subject completed the Maintenance Period but did not enter the Open-Label Period.|29
3230993|NCT02346240|3962763|FG017|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
3230994|NCT02346240|3962764|FG018|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
3230995|NCT02346240|3962765|FG019|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
3230996|NCT02346240|3962766|FG020|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
3230997|NCT02346240|3962767|FG021|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
3230998|NCT02346240|3962768|FG022|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
3230999|NCT02346240|3962769|FG023|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
3231000|NCT02346240|3962746|FG000|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
3231001|NCT02346240|3962747|FG001|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
3231002|NCT02346240|3962748|FG002|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
3231003|NCT02346240|3962749|FG003|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
3231004|NCT02346240|3962750|FG004|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
3231005|NCT02346240|3962751|FG005|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||1
3231006|NCT02346240|3962752|FG006|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||2
3231007|NCT02346240|3962753|FG007|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||2
3231008|NCT02346240|3962754|FG008|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||4
3231009|NCT02346240|3962755|FG009|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||1
3231010|NCT02346240|3962756|FG010|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||2
3231011|NCT02346240|3962757|FG011|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||3
3231012|NCT02346240|3962758|FG012|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
3231013|NCT02346240|3962759|FG013|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||8
3231014|NCT02346240|3962760|FG014|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||17
3231015|NCT02346240|3962761|FG015|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||14
3231016|NCT02346240|3962762|FG016|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||7
3231017|NCT02346240|3962763|FG017|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
3231018|NCT02346240|3962764|FG018|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
3231019|NCT02346240|3962765|FG019|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
3231020|NCT02346240|3962766|FG020|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
3231021|NCT02346240|3962767|FG021|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
3231022|NCT02346240|3962768|FG022|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
3231023|NCT02346240|3962769|FG023|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
3231024|NCT02346240|3962746|FG000|STARTED|Open-Label Period (Week 48 to Week 144)||0
3231025|NCT02346240|3962747|FG001|STARTED|Open-Label Period (Week 48 to Week 144)||0
3231026|NCT02346240|3962748|FG002|STARTED|Open-Label Period (Week 48 to Week 144)||0
3231027|NCT02346240|3962749|FG003|STARTED|Open-Label Period (Week 48 to Week 144)||0
3231028|NCT02346240|3962750|FG004|STARTED|Open-Label Period (Week 48 to Week 144)||0
3231029|NCT02346240|3962751|FG005|STARTED|Open-Label Period (Week 48 to Week 144)||0
3231030|NCT02346240|3962752|FG006|STARTED|Open-Label Period (Week 48 to Week 144)||0
3231031|NCT02346240|3962753|FG007|STARTED|Open-Label Period (Week 48 to Week 144)||0
3231032|NCT02346240|3962754|FG008|STARTED|Open-Label Period (Week 48 to Week 144)||0
3231033|NCT02346240|3962755|FG009|STARTED|Open-Label Period (Week 48 to Week 144)||0
3231034|NCT02346240|3962756|FG010|STARTED|Open-Label Period (Week 48 to Week 144)||0
3231035|NCT02346240|3962757|FG011|STARTED|Open-Label Period (Week 48 to Week 144)||0
3231036|NCT02346240|3962758|FG012|STARTED|Open-Label Period (Week 48 to Week 144)||0
3231037|NCT02346240|3962759|FG013|STARTED|Open-Label Period (Week 48 to Week 144)||0
3231038|NCT02346240|3962760|FG014|STARTED|Open-Label Period (Week 48 to Week 144)||0
3231039|NCT02346240|3962761|FG015|STARTED|Open-Label Period (Week 48 to Week 144)||0
3231040|NCT02346240|3962762|FG016|STARTED|Open-Label Period (Week 48 to Week 144)||0
3231041|NCT02346240|3962763|FG017|STARTED|Open-Label Period (Week 48 to Week 144)||34
3231042|NCT02346240|3962764|FG018|STARTED|Open-Label Period (Week 48 to Week 144)||122
3231043|NCT02346240|3962765|FG019|STARTED|Open-Label Period (Week 48 to Week 144)||41
3231044|NCT02346240|3962766|FG020|STARTED|Open-Label Period (Week 48 to Week 144)||48
3231045|NCT02346240|3962767|FG021|STARTED|Open-Label Period (Week 48 to Week 144)||177
3231046|NCT02346240|3962768|FG022|STARTED|Open-Label Period (Week 48 to Week 144)||34
3231047|NCT02346240|3962769|FG023|STARTED|Open-Label Period (Week 48 to Week 144)||16
3231048|NCT02346240|3962746|FG000|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
3231049|NCT02346240|3962747|FG001|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
3231050|NCT02346240|3962748|FG002|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
3231051|NCT02346240|3962749|FG003|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
3231052|NCT02346240|3962750|FG004|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
3231053|NCT02346240|3962751|FG005|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
3231054|NCT02346240|3962752|FG006|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
3231055|NCT02346240|3962753|FG007|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
3369061|NCT03811834|4100510|FG000|NOT COMPLETED|Washout Period (9 Days)||0
3369062|NCT03811834|4100510|FG000|STARTED|Period 2 (10 Days)||6
3369063|NCT03811834|4100510|FG000|COMPLETED|Period 2 (10 Days)||6
3369064|NCT03811834|4100510|FG000|NOT COMPLETED|Period 2 (10 Days)||0
3369065|NCT03806127|4100525|FG000|STARTED|Overall Study||111
3369066|NCT03806127|4100526|FG001|STARTED|Overall Study||111
3369067|NCT03806127|4100525|FG000|COMPLETED|Overall Study||90
3369068|NCT03806127|4100526|FG001|COMPLETED|Overall Study||99
3369069|NCT03806127|4100525|FG000|NOT COMPLETED|Overall Study||21
3369070|NCT03806127|4100526|FG001|NOT COMPLETED|Overall Study||12
3369071|NCT03827473|4100534|FG000|STARTED|Overall Study||1
3369072|NCT03827473|4100535|FG001|STARTED|Overall Study||0
3369073|NCT03827473|4100534|FG000|COMPLETED|Overall Study||0
3369074|NCT03827473|4100535|FG001|COMPLETED|Overall Study||0
3369075|NCT03827473|4100534|FG000|NOT COMPLETED|Overall Study||1
3369076|NCT03827473|4100535|FG001|NOT COMPLETED|Overall Study||0
3369077|NCT03826914|4100543|FG000|STARTED|Overall Study||35
3369078|NCT03826914|4100544|FG001|STARTED|Overall Study||34
3369079|NCT03826914|4100543|FG000|COMPLETED|Overall Study||34
3369080|NCT03826914|4100544|FG001|COMPLETED|Overall Study||33
3369081|NCT03826914|4100543|FG000|NOT COMPLETED|Overall Study||1
3369082|NCT03826914|4100544|FG001|NOT COMPLETED|Overall Study||1
3369083|NCT03812328|4100555|FG000|STARTED|Overall Study||55
3369084|NCT03812328|4100556|FG001|STARTED|Overall Study||63
3231056|NCT02346240|3962754|FG008|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
3231057|NCT02346240|3962755|FG009|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
3231058|NCT02346240|3962756|FG010|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
3231059|NCT02346240|3962757|FG011|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
3231060|NCT02346240|3962758|FG012|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
3231061|NCT02346240|3962759|FG013|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
3231062|NCT02346240|3962760|FG014|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
3231063|NCT02346240|3962761|FG015|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
3231064|NCT02346240|3962762|FG016|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
3231065|NCT02346240|3962763|FG017|COMPLETED|Open-Label Period (Week 48 to Week 144)||31
3231066|NCT02346240|3962764|FG018|COMPLETED|Open-Label Period (Week 48 to Week 144)||105
3231067|NCT02346240|3962765|FG019|COMPLETED|Open-Label Period (Week 48 to Week 144)||34
3231068|NCT02346240|3962766|FG020|COMPLETED|Open-Label Period (Week 48 to Week 144)||45
3231069|NCT02346240|3962767|FG021|COMPLETED|Open-Label Period (Week 48 to Week 144)||146
3231070|NCT02346240|3962768|FG022|COMPLETED|Open-Label Period (Week 48 to Week 144)||27
3231071|NCT02346240|3962769|FG023|COMPLETED|Open-Label Period (Week 48 to Week 144)||8
3231072|NCT02346240|3962746|FG000|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
3231073|NCT02346240|3962747|FG001|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
3231074|NCT02346240|3962748|FG002|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
3231075|NCT02346240|3962749|FG003|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
3231076|NCT02346240|3962750|FG004|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
3231077|NCT02346240|3962751|FG005|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
3231078|NCT02346240|3962752|FG006|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
3231079|NCT02346240|3962753|FG007|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
3231080|NCT02346240|3962754|FG008|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
3231081|NCT02346240|3962755|FG009|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
3231082|NCT02346240|3962756|FG010|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
3231083|NCT02346240|3962757|FG011|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
3231084|NCT02346240|3962758|FG012|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
3231085|NCT02346240|3962759|FG013|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
3231086|NCT02346240|3962760|FG014|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
3231087|NCT02346240|3962761|FG015|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
3231088|NCT02346240|3962762|FG016|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
3231089|NCT02346240|3962763|FG017|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||3
3231090|NCT02346240|3962764|FG018|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||17
3231091|NCT02346240|3962765|FG019|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||7
3231092|NCT02346240|3962766|FG020|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||3
3231093|NCT02346240|3962767|FG021|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||31
3231094|NCT02346240|3962768|FG022|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||7
3231095|NCT02346240|3962769|FG023|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||8
3231096|NCT02346370|3962794|FG000|STARTED|Overall Study||8
3231097|NCT02346370|3962795|FG001|STARTED|Overall Study||4
3231098|NCT02346370|3962796|FG002|STARTED|Overall Study||4
3231099|NCT02346370|3962794|FG000|COMPLETED|Overall Study||0
3231100|NCT02346370|3962795|FG001|COMPLETED|Overall Study||0
3231101|NCT02346370|3962796|FG002|COMPLETED|Overall Study||0
3231102|NCT02346370|3962794|FG000|NOT COMPLETED|Overall Study||8
3231103|NCT02346370|3962795|FG001|NOT COMPLETED|Overall Study||4
3231104|NCT02346370|3962796|FG002|NOT COMPLETED|Overall Study||4
3231105|NCT02346383|3962806|FG000|STARTED|Overall Study||40
3231106|NCT02346383|3962806|FG000|COMPLETED|Overall Study||40
3231107|NCT02346383|3962806|FG000|NOT COMPLETED|Overall Study||0
3231108|NCT02346461|3962816|FG000|STARTED|Overall Study||6
3231109|NCT02346461|3962817|FG001|STARTED|Overall Study||6
3231110|NCT02346461|3962816|FG000|COMPLETED|Overall Study||6
3231111|NCT02346461|3962817|FG001|COMPLETED|Overall Study||6
3231112|NCT02346461|3962816|FG000|NOT COMPLETED|Overall Study||0
3231113|NCT02346461|3962817|FG001|NOT COMPLETED|Overall Study||0
3231114|NCT02346643|3962824|FG000|STARTED|Overall Study||41
3231115|NCT02346643|3962824|FG000|Received Trial System|Overall Study||29
3231116|NCT02346643|3962824|FG000|Received Permanent System|Overall Study||31
3231117|NCT02346643|3962824|FG000|COMPLETED|Overall Study||6
3231118|NCT02346643|3962824|FG000|NOT COMPLETED|Overall Study||35
3231119|NCT02346708|3962830|FG000|STARTED|Overall Study||24
3369085|NCT03812328|4100557|FG002|STARTED|Overall Study||89
3369086|NCT03812328|4100555|FG000|Modified Intent-to-Treat (mITT) Population|Overall Study||48
3369087|NCT03812328|4100556|FG001|Modified Intent-to-Treat (mITT) Population|Overall Study||61
3369088|NCT03812328|4100557|FG002|Modified Intent-to-Treat (mITT) Population|Overall Study||84
3369089|NCT03812328|4100555|FG000|Safety Population|Overall Study||55
3369090|NCT03812328|4100556|FG001|Safety Population|Overall Study||63
3369091|NCT03812328|4100557|FG002|Safety Population|Overall Study||88
3231120|NCT02346708|3962831|FG001|STARTED|Overall Study||25
3231121|NCT02346708|3962830|FG000|COMPLETED|Overall Study||22
3231122|NCT02346708|3962831|FG001|COMPLETED|Overall Study||24
3231123|NCT02346708|3962830|FG000|NOT COMPLETED|Overall Study||2
3231124|NCT02346708|3962831|FG001|NOT COMPLETED|Overall Study||1
3231125|NCT02346721|3962838|FG000|STARTED|Overall Study||111
3231126|NCT02346721|3962838|FG000|COMPLETED|Overall Study||107
3231127|NCT02346721|3962838|FG000|NOT COMPLETED|Overall Study||4
3231128|NCT02346903|3962844|FG000|STARTED|Overall Study||99
3231129|NCT02346903|3962844|FG000|COMPLETED|Overall Study||99
3231130|NCT02346903|3962844|FG000|NOT COMPLETED|Overall Study||0
3231131|NCT02346916|3962848|FG000|STARTED|Overall Study||20
3231132|NCT02346916|3962848|FG000|COMPLETED|Overall Study||20
3231133|NCT02346916|3962848|FG000|NOT COMPLETED|Overall Study||0
3231134|NCT02347072|3962852|FG000|STARTED|Overall Study||80
3231135|NCT02347072|3962852|FG000|GFF MDI 14.4/9.6 µg|Overall Study||75
3231136|NCT02347072|3962852|FG000|Placebo MDI|Overall Study||72
3231137|NCT02347072|3962852|FG000|Spiriva Respimat 5 µg|Overall Study||73
3231138|NCT02347072|3962852|FG000|COMPLETED|Overall Study||62
3231139|NCT02347072|3962852|FG000|NOT COMPLETED|Overall Study||18
3231140|NCT02347085|3962860|FG000|STARTED|Overall Study||43
3231141|NCT02347085|3962860|FG000|GFF MDI 14.4/9.6 µg|Overall Study||40
3231142|NCT02347085|3962860|FG000|Placebo MDI|Overall Study||40
3231143|NCT02347085|3962860|FG000|COMPLETED|Overall Study||33
3231144|NCT02347085|3962860|FG000|NOT COMPLETED|Overall Study||10
3231145|NCT02347098|3962868|FG000|STARTED|Overall Study||63
3231146|NCT02347098|3962869|FG001|STARTED|Overall Study||66
3231147|NCT02347098|3962868|FG000|COMPLETED|Overall Study||56
3231148|NCT02347098|3962869|FG001|COMPLETED|Overall Study||58
3231149|NCT02347098|3962868|FG000|NOT COMPLETED|Overall Study||7
3231150|NCT02347098|3962869|FG001|NOT COMPLETED|Overall Study||8
3231151|NCT02347124|3962877|FG000|STARTED|Overall Study||360
3231152|NCT02347124|3962878|FG001|STARTED|Overall Study||358
3231153|NCT02347124|3962877|FG000|2 Month Follow-up|Overall Study||298
3231154|NCT02347124|3962878|FG001|2 Month Follow-up|Overall Study||275
3231155|NCT02347124|3962877|FG000|COMPLETED|Overall Study||267
3231156|NCT02347124|3962878|FG001|COMPLETED|Overall Study||259
3231157|NCT02347124|3962877|FG000|NOT COMPLETED|Overall Study||93
3231158|NCT02347124|3962878|FG001|NOT COMPLETED|Overall Study||99
3231159|NCT02347176|3962888|FG000|STARTED|Overall Study||51
3231160|NCT02347176|3962889|FG001|STARTED|Overall Study||50
3231161|NCT02347176|3962890|FG002|STARTED|Overall Study||51
3231162|NCT02347176|3962891|FG003|STARTED|Overall Study||52
3231163|NCT02347176|3962888|FG000|COMPLETED|Overall Study||39
3231164|NCT02347176|3962889|FG001|COMPLETED|Overall Study||40
3231165|NCT02347176|3962890|FG002|COMPLETED|Overall Study||43
3231166|NCT02347176|3962891|FG003|COMPLETED|Overall Study||48
3231167|NCT02347176|3962888|FG000|NOT COMPLETED|Overall Study||12
3231168|NCT02347176|3962889|FG001|NOT COMPLETED|Overall Study||10
3231169|NCT02347176|3962890|FG002|NOT COMPLETED|Overall Study||8
3231170|NCT02347176|3962891|FG003|NOT COMPLETED|Overall Study||4
3231171|NCT02347189|3962901|FG000|STARTED|Overall Study||39
3231172|NCT02347189|3962901|FG000|Catheterized|Overall Study||39
3231173|NCT02347189|3962901|FG000|Implanted|Overall Study||30
3231174|NCT02347189|3962901|FG000|Implanted > 24 Hours|Overall Study||30
3231175|NCT02347189|3962901|FG000|COMPLETED|Overall Study||28
3231176|NCT02347189|3962901|FG000|NOT COMPLETED|Overall Study||11
3231177|NCT02347332|3962918|FG000|STARTED|Overall Study||230
3231178|NCT02347332|3962919|FG001|STARTED|Overall Study||229
3231179|NCT02347332|3962918|FG000|COMPLETED|Overall Study|6 patients: suicide(1), unknown cause(5 - 4 at home +1 in city hospital).|0
3231180|NCT02347332|3962919|FG001|COMPLETED|Overall Study|6 patients: unknown cause(2home), PDsuspect(1home+1hosp), sudden death(1home), hypercapnie(1hosp).|0
3231181|NCT02347332|3962918|FG000|NOT COMPLETED|Overall Study||230
3231182|NCT02347332|3962919|FG001|NOT COMPLETED|Overall Study||229
3231183|NCT02347345|3962928|FG000|STARTED|Overall Study||10
3231184|NCT02347345|3962929|FG001|STARTED|Overall Study||12
3231185|NCT02347345|3962930|FG002|STARTED|Overall Study||12
3231186|NCT02347345|3962928|FG000|COMPLETED|Overall Study||10
3231187|NCT02347345|3962929|FG001|COMPLETED|Overall Study||12
3231188|NCT02347345|3962930|FG002|COMPLETED|Overall Study||12
3231189|NCT02347345|3962928|FG000|NOT COMPLETED|Overall Study||0
3231190|NCT02347345|3962929|FG001|NOT COMPLETED|Overall Study||0
3231191|NCT02347345|3962930|FG002|NOT COMPLETED|Overall Study||0
3231192|NCT02347410|3962941|FG000|STARTED|Overall Study||102
3231193|NCT02347410|3962941|FG000|COMPLETED|Overall Study||98
3231194|NCT02347410|3962941|FG000|NOT COMPLETED|Overall Study||4
3231195|NCT02347488|3962951|FG000|STARTED|Overall Study||30
3231196|NCT02347488|3962951|FG000|COMPLETED|Overall Study||30
3231197|NCT02347488|3962951|FG000|NOT COMPLETED|Overall Study||0
3231198|NCT02347605|3962963|FG000|STARTED|Overall Study||10
3231199|NCT02347605|3962964|FG001|STARTED|Overall Study||10
3231200|NCT02347605|3962965|FG002|STARTED|Overall Study||8
3231201|NCT02347605|3962966|FG003|STARTED|Overall Study||10
3231202|NCT02347605|3962967|FG004|STARTED|Overall Study||9
3231203|NCT02347605|3962968|FG005|STARTED|Overall Study||9
3231204|NCT02347605|3962963|FG000|Completed Lab 1|Overall Study||10
3231205|NCT02347605|3962964|FG001|Completed Lab 1|Overall Study||10
3231206|NCT02347605|3962965|FG002|Completed Lab 1|Overall Study||8
3231207|NCT02347605|3962966|FG003|Completed Lab 1|Overall Study||10
3231208|NCT02347605|3962967|FG004|Completed Lab 1|Overall Study||8
3231209|NCT02347605|3962968|FG005|Completed Lab 1|Overall Study||9
3231210|NCT02347605|3962963|FG000|Completed Lab 2|Overall Study||7
3231211|NCT02347605|3962964|FG001|Completed Lab 2|Overall Study||7
3231212|NCT02347605|3962965|FG002|Completed Lab 2|Overall Study||7
3231213|NCT02347605|3962966|FG003|Completed Lab 2|Overall Study||7
3231214|NCT02347605|3962967|FG004|Completed Lab 2|Overall Study||6
3231215|NCT02347605|3962968|FG005|Completed Lab 2|Overall Study||8
3231216|NCT02347605|3962963|FG000|COMPLETED|Overall Study||7
3231217|NCT02347605|3962964|FG001|COMPLETED|Overall Study||7
3231218|NCT02347605|3962965|FG002|COMPLETED|Overall Study||7
3231219|NCT02347605|3962966|FG003|COMPLETED|Overall Study||6
3231220|NCT02347605|3962967|FG004|COMPLETED|Overall Study||6
3231221|NCT02347605|3962968|FG005|COMPLETED|Overall Study||7
3231222|NCT02347605|3962963|FG000|NOT COMPLETED|Overall Study||3
3231223|NCT02347605|3962964|FG001|NOT COMPLETED|Overall Study||3
3231224|NCT02347605|3962965|FG002|NOT COMPLETED|Overall Study||1
3231225|NCT02347605|3962966|FG003|NOT COMPLETED|Overall Study||4
3231226|NCT02347605|3962967|FG004|NOT COMPLETED|Overall Study||3
3231227|NCT02347605|3962968|FG005|NOT COMPLETED|Overall Study||2
3231228|NCT02347631|3962978|FG000|STARTED|Washout 1 (1 Month)||61
3231229|NCT02347631|3962979|FG001|STARTED|Washout 1 (1 Month)||57
3231230|NCT02347631|3962978|FG000|COMPLETED|Washout 1 (1 Month)||61
3231231|NCT02347631|3962979|FG001|COMPLETED|Washout 1 (1 Month)||57
3231232|NCT02347631|3962978|FG000|NOT COMPLETED|Washout 1 (1 Month)||0
3231233|NCT02347631|3962979|FG001|NOT COMPLETED|Washout 1 (1 Month)||0
3231234|NCT02347631|3962978|FG000|STARTED|First Intervention (2 Months)||61
3231235|NCT02347631|3962979|FG001|STARTED|First Intervention (2 Months)||57
3231236|NCT02347631|3962978|FG000|COMPLETED|First Intervention (2 Months)||54
3231237|NCT02347631|3962979|FG001|COMPLETED|First Intervention (2 Months)||51
3231238|NCT02347631|3962978|FG000|NOT COMPLETED|First Intervention (2 Months)||7
3231239|NCT02347631|3962979|FG001|NOT COMPLETED|First Intervention (2 Months)||6
3231240|NCT02347631|3962978|FG000|STARTED|Washout 2 (1 Month)||54
3231241|NCT02347631|3962979|FG001|STARTED|Washout 2 (1 Month)||51
3231242|NCT02347631|3962978|FG000|COMPLETED|Washout 2 (1 Month)||52
3231243|NCT02347631|3962979|FG001|COMPLETED|Washout 2 (1 Month)||48
3231244|NCT02347631|3962978|FG000|NOT COMPLETED|Washout 2 (1 Month)||2
3231245|NCT02347631|3962979|FG001|NOT COMPLETED|Washout 2 (1 Month)||3
3231246|NCT02347631|3962978|FG000|STARTED|Second Intervention (2 Months)||52
3231247|NCT02347631|3962979|FG001|STARTED|Second Intervention (2 Months)||48
3231248|NCT02347631|3962978|FG000|COMPLETED|Second Intervention (2 Months)||39
3231249|NCT02347631|3962979|FG001|COMPLETED|Second Intervention (2 Months)||44
3231250|NCT02347631|3962978|FG000|NOT COMPLETED|Second Intervention (2 Months)||13
3231251|NCT02347631|3962979|FG001|NOT COMPLETED|Second Intervention (2 Months)||4
3231252|NCT02347657|3962989|FG000|STARTED|Overall Study||259
3231253|NCT02347657|3962990|FG001|STARTED|Overall Study||251
3231254|NCT02347657|3962989|FG000|Treated|Overall Study||258
3231255|NCT02347657|3962990|FG001|Treated|Overall Study||251
3231256|NCT02347657|3962989|FG000|COMPLETED|Overall Study||241
3231257|NCT02347657|3962990|FG001|COMPLETED|Overall Study||236
3231258|NCT02347657|3962989|FG000|NOT COMPLETED|Overall Study||18
3231259|NCT02347657|3962990|FG001|NOT COMPLETED|Overall Study||15
3231260|NCT02347761|3963000|FG000|STARTED|All Collected||218
3231261|NCT02347761|3963001|FG001|STARTED|All Collected||217
3231262|NCT02347761|3963002|FG002|STARTED|All Collected||218
3231263|NCT02347761|3963000|FG000|COMPLETED|All Collected||201
3231264|NCT02347761|3963001|FG001|COMPLETED|All Collected||203
3231265|NCT02347761|3963002|FG002|COMPLETED|All Collected||191
3231266|NCT02347761|3963000|FG000|NOT COMPLETED|All Collected||17
3231267|NCT02347761|3963001|FG001|NOT COMPLETED|All Collected||14
3231268|NCT02347761|3963002|FG002|NOT COMPLETED|All Collected||27
3231269|NCT02347761|3963000|FG000|STARTED|On Study Treatment||218
3231270|NCT02347761|3963001|FG001|STARTED|On Study Treatment||217
3231271|NCT02347761|3963002|FG002|STARTED|On Study Treatment||218
3231272|NCT02347761|3963000|FG000|COMPLETED|On Study Treatment||191
3231273|NCT02347761|3963001|FG001|COMPLETED|On Study Treatment||194
3231274|NCT02347761|3963002|FG002|COMPLETED|On Study Treatment||176
3231275|NCT02347761|3963000|FG000|NOT COMPLETED|On Study Treatment||27
3231276|NCT02347761|3963001|FG001|NOT COMPLETED|On Study Treatment||23
3231277|NCT02347761|3963002|FG002|NOT COMPLETED|On Study Treatment||42
3231278|NCT02347774|3963013|FG000|STARTED|Study Participation||214
3231279|NCT02347774|3963014|FG001|STARTED|Study Participation||214
3231280|NCT02347774|3963015|FG002|STARTED|Study Participation|One subject randomized in error to the placebo arm was never dosed .|213
3231281|NCT02347774|3963013|FG000|COMPLETED|Study Participation||199
3231282|NCT02347774|3963014|FG001|COMPLETED|Study Participation||193
3231283|NCT02347774|3963015|FG002|COMPLETED|Study Participation||188
3231284|NCT02347774|3963013|FG000|NOT COMPLETED|Study Participation||15
3231285|NCT02347774|3963014|FG001|NOT COMPLETED|Study Participation||21
3231286|NCT02347774|3963015|FG002|NOT COMPLETED|Study Participation||25
3231287|NCT02347774|3963013|FG000|STARTED|On Study Treatment||214
3231288|NCT02347774|3963014|FG001|STARTED|On Study Treatment||214
3231289|NCT02347774|3963015|FG002|STARTED|On Study Treatment|One subject randomized in error to the placebo arm was never dosed .|213
3231290|NCT02347774|3963013|FG000|COMPLETED|On Study Treatment||190
3231291|NCT02347774|3963014|FG001|COMPLETED|On Study Treatment||183
3231292|NCT02347774|3963015|FG002|COMPLETED|On Study Treatment||177
3231293|NCT02347774|3963013|FG000|NOT COMPLETED|On Study Treatment||24
3231294|NCT02347774|3963014|FG001|NOT COMPLETED|On Study Treatment||31
3231295|NCT02347774|3963015|FG002|NOT COMPLETED|On Study Treatment||36
3231296|NCT02347787|3963025|FG000|STARTED|6 Month Follow-Up||288
3231297|NCT02347787|3963026|FG001|STARTED|6 Month Follow-Up||304
3231298|NCT02347787|3963025|FG000|COMPLETED|6 Month Follow-Up||222
3231299|NCT02347787|3963026|FG001|COMPLETED|6 Month Follow-Up||248
3231300|NCT02347787|3963025|FG000|NOT COMPLETED|6 Month Follow-Up||66
3231301|NCT02347787|3963026|FG001|NOT COMPLETED|6 Month Follow-Up||56
3231302|NCT02347787|3963025|FG000|STARTED|9 Month Follow-Up||288
3231303|NCT02347787|3963026|FG001|STARTED|9 Month Follow-Up||304
3231304|NCT02347787|3963025|FG000|COMPLETED|9 Month Follow-Up||227
3231305|NCT02347787|3963026|FG001|COMPLETED|9 Month Follow-Up||233
3231306|NCT02347787|3963025|FG000|NOT COMPLETED|9 Month Follow-Up||61
3231307|NCT02347787|3963026|FG001|NOT COMPLETED|9 Month Follow-Up||71
3231308|NCT02347813|3963039|FG000|STARTED|First Intervention, 24 Weeks||6
3231309|NCT02347813|3963040|FG001|STARTED|First Intervention, 24 Weeks||6
3231310|NCT02347813|3963039|FG000|COMPLETED|First Intervention, 24 Weeks||4
3231311|NCT02347813|3963040|FG001|COMPLETED|First Intervention, 24 Weeks||4
3231312|NCT02347813|3963039|FG000|NOT COMPLETED|First Intervention, 24 Weeks||2
3231313|NCT02347813|3963040|FG001|NOT COMPLETED|First Intervention, 24 Weeks||2
3231314|NCT02347813|3963039|FG000|STARTED|Second Intervention, 24 Weeks||4
3231315|NCT02347813|3963040|FG001|STARTED|Second Intervention, 24 Weeks||4
3231316|NCT02347813|3963039|FG000|COMPLETED|Second Intervention, 24 Weeks||4
3231317|NCT02347813|3963040|FG001|COMPLETED|Second Intervention, 24 Weeks||4
3231318|NCT02347813|3963039|FG000|NOT COMPLETED|Second Intervention, 24 Weeks||0
3231319|NCT02347813|3963040|FG001|NOT COMPLETED|Second Intervention, 24 Weeks||0
3231320|NCT02347917|3963048|FG000|STARTED|Overall Study||4
3231321|NCT02347917|3963049|FG001|STARTED|Overall Study||24
3231322|NCT02347917|3963048|FG000|Discontinued beforeBBI608 Administration|Overall Study||0
3231323|NCT02347917|3963049|FG001|Discontinued beforeBBI608 Administration|Overall Study||0
3231324|NCT02347917|3963048|FG000|Start BBI608 Administration|Overall Study||4
3231325|NCT02347917|3963049|FG001|Start BBI608 Administration|Overall Study||24
3231326|NCT02347917|3963048|FG000|Discontinued in DLT Evaluation Period|Overall Study||1
3231327|NCT02347917|3963049|FG001|Discontinued in DLT Evaluation Period|Overall Study||0
3231328|NCT02347917|3963048|FG000|Complete DLT Evaluation Period|Overall Study||3
3231329|NCT02347917|3963049|FG001|Complete DLT Evaluation Period|Overall Study||0
3231330|NCT02347917|3963048|FG000|Discontinued After BBI608 Administration|Overall Study||4
3231331|NCT02347917|3963049|FG001|Discontinued After BBI608 Administration|Overall Study||24
3231332|NCT02347917|3963048|FG000|Discontinued Before Survival Observation|Overall Study||0
3231333|NCT02347917|3963049|FG001|Discontinued Before Survival Observation|Overall Study||1
3231334|NCT02347917|3963048|FG000|COMPLETED|Overall Study||4
3231335|NCT02347917|3963049|FG001|COMPLETED|Overall Study||23
3231336|NCT02347917|3963048|FG000|NOT COMPLETED|Overall Study||0
3231337|NCT02347917|3963049|FG001|NOT COMPLETED|Overall Study||1
3231338|NCT02348008|3963065|FG000|STARTED|Overall Study||3
3231339|NCT02348008|3963066|FG001|STARTED|Overall Study||10
3231340|NCT02348008|3963067|FG002|STARTED|Overall Study||48
3231341|NCT02348008|3963065|FG000|COMPLETED|Overall Study||0
3231342|NCT02348008|3963066|FG001|COMPLETED|Overall Study||0
3231343|NCT02348008|3963067|FG002|COMPLETED|Overall Study||29
3231344|NCT02348008|3963065|FG000|NOT COMPLETED|Overall Study||3
3231345|NCT02348008|3963066|FG001|NOT COMPLETED|Overall Study||10
3231346|NCT02348008|3963067|FG002|NOT COMPLETED|Overall Study||19
3231347|NCT02348203|3963075|FG000|STARTED|Overall Study||31
3231348|NCT02348203|3963076|FG001|STARTED|Overall Study||32
3231349|NCT02348203|3963075|FG000|COMPLETED|Overall Study||21
3231350|NCT02348203|3963076|FG001|COMPLETED|Overall Study||22
3231351|NCT02348203|3963075|FG000|NOT COMPLETED|Overall Study||10
3231352|NCT02348203|3963076|FG001|NOT COMPLETED|Overall Study||10
3231353|NCT02348216|3963089|FG000|STARTED|Overall Study||8
3231354|NCT02348216|3963090|FG001|STARTED|Overall Study||81
3231355|NCT02348216|3963091|FG002|STARTED|Overall Study||30
3231356|NCT02348216|3963092|FG003|STARTED|Overall Study||42
3231357|NCT02348216|3963093|FG004|STARTED|Overall Study||46
3231358|NCT02348216|3963094|FG005|STARTED|Overall Study||58
3231359|NCT02348216|3963095|FG006|STARTED|Overall Study||42
3231360|NCT02348216|3963089|FG000|COMPLETED|Overall Study||0
3231361|NCT02348216|3963090|FG001|COMPLETED|Overall Study||0
3231362|NCT02348216|3963091|FG002|COMPLETED|Overall Study||0
3231363|NCT02348216|3963092|FG003|COMPLETED|Overall Study||0
3231364|NCT02348216|3963093|FG004|COMPLETED|Overall Study||0
3231365|NCT02348216|3963094|FG005|COMPLETED|Overall Study||0
3231366|NCT02348216|3963095|FG006|COMPLETED|Overall Study||0
3231367|NCT02348216|3963089|FG000|NOT COMPLETED|Overall Study||8
3231368|NCT02348216|3963090|FG001|NOT COMPLETED|Overall Study||81
3231369|NCT02348216|3963091|FG002|NOT COMPLETED|Overall Study||30
3231370|NCT02348216|3963092|FG003|NOT COMPLETED|Overall Study||42
3231371|NCT02348216|3963093|FG004|NOT COMPLETED|Overall Study||46
3231372|NCT02348216|3963094|FG005|NOT COMPLETED|Overall Study||58
3231373|NCT02348216|3963095|FG006|NOT COMPLETED|Overall Study||42
3231374|NCT02348385|3963135|FG000|STARTED|Overall Study||24
3231375|NCT02348385|3963136|FG001|STARTED|Overall Study||25
3231376|NCT02348385|3963135|FG000|COMPLETED|Overall Study||24
3231377|NCT02348385|3963136|FG001|COMPLETED|Overall Study||25
3231378|NCT02348385|3963135|FG000|NOT COMPLETED|Overall Study||0
3231379|NCT02348385|3963136|FG001|NOT COMPLETED|Overall Study||0
3231380|NCT02348489|3963146|FG000|STARTED|Overall Study||408
3231381|NCT02348489|3963147|FG001|STARTED|Overall Study||407
3231382|NCT02348489|3963146|FG000|COMPLETED|Overall Study||55
3231383|NCT02348489|3963147|FG001|COMPLETED|Overall Study||40
3231384|NCT02348489|3963146|FG000|NOT COMPLETED|Overall Study||353
3231385|NCT02348489|3963147|FG001|NOT COMPLETED|Overall Study||367
3231386|NCT02348593|3963159|FG000|STARTED|Overall Study||59
3231387|NCT02348593|3963160|FG001|STARTED|Overall Study||59
3231388|NCT02348593|3963161|FG002|STARTED|Overall Study||59
3231389|NCT02348593|3963162|FG003|STARTED|Overall Study||59
3231390|NCT02348593|3963159|FG000|COMPLETED|Overall Study||49
3231391|NCT02348593|3963160|FG001|COMPLETED|Overall Study||51
3231392|NCT02348593|3963161|FG002|COMPLETED|Overall Study||43
3231393|NCT02348593|3963162|FG003|COMPLETED|Overall Study||52
3231394|NCT02348593|3963159|FG000|NOT COMPLETED|Overall Study||10
3231395|NCT02348593|3963160|FG001|NOT COMPLETED|Overall Study||8
3231396|NCT02348593|3963161|FG002|NOT COMPLETED|Overall Study||16
3231397|NCT02348593|3963162|FG003|NOT COMPLETED|Overall Study||7
3231398|NCT02348606|3963177|FG000|STARTED|Overall Study||58
3231399|NCT02348606|3963178|FG001|STARTED|Overall Study||62
3231400|NCT02348606|3963179|FG002|STARTED|Overall Study||117
3231401|NCT02348606|3963180|FG003|STARTED|Overall Study||118
3231402|NCT02348606|3963181|FG004|STARTED|Overall Study||119
3231403|NCT02348606|3963177|FG000|COMPLETED|Overall Study||49
3231404|NCT02348606|3963178|FG001|COMPLETED|Overall Study||54
3231405|NCT02348606|3963179|FG002|COMPLETED|Overall Study||106
3231406|NCT02348606|3963180|FG003|COMPLETED|Overall Study||94
3231407|NCT02348606|3963181|FG004|COMPLETED|Overall Study||101
3231408|NCT02348606|3963177|FG000|NOT COMPLETED|Overall Study||9
3231409|NCT02348606|3963178|FG001|NOT COMPLETED|Overall Study||8
3231410|NCT02348606|3963179|FG002|NOT COMPLETED|Overall Study||11
3231411|NCT02348606|3963180|FG003|NOT COMPLETED|Overall Study||24
3231412|NCT02348606|3963181|FG004|NOT COMPLETED|Overall Study||18
3231413|NCT02348619|3963193|FG000|STARTED|Titration Phase||174
3231414|NCT02348619|3963194|FG001|STARTED|Titration Phase||0
3231415|NCT02348619|3963193|FG000|COMPLETED|Titration Phase||157
3231416|NCT02348619|3963194|FG001|COMPLETED|Titration Phase||0
3231417|NCT02348619|3963193|FG000|NOT COMPLETED|Titration Phase||17
3231418|NCT02348619|3963194|FG001|NOT COMPLETED|Titration Phase||0
3231419|NCT02348619|3963193|FG000|STARTED|Stable-Dose Phase||157
3231420|NCT02348619|3963194|FG001|STARTED|Stable-Dose Phase||0
3231421|NCT02348619|3963193|FG000|COMPLETED|Stable-Dose Phase||124
3231422|NCT02348619|3963194|FG001|COMPLETED|Stable-Dose Phase||0
3231423|NCT02348619|3963193|FG000|NOT COMPLETED|Stable-Dose Phase||33
3231424|NCT02348619|3963194|FG001|NOT COMPLETED|Stable-Dose Phase||0
3231425|NCT02348619|3963193|FG000|STARTED|Double-Blind Withdrawal Phase||62
3231426|NCT02348619|3963194|FG001|STARTED|Double-Blind Withdrawal Phase||62
3231427|NCT02348619|3963193|FG000|COMPLETED|Double-Blind Withdrawal Phase||60
3231428|NCT02348619|3963194|FG001|COMPLETED|Double-Blind Withdrawal Phase||62
3231429|NCT02348619|3963193|FG000|NOT COMPLETED|Double-Blind Withdrawal Phase||2
3231430|NCT02348619|3963194|FG001|NOT COMPLETED|Double-Blind Withdrawal Phase||0
3231431|NCT02348632|3963200|FG000|STARTED|Open-label Period||643
3231432|NCT02348632|3963201|FG001|STARTED|Open-label Period||0
3231433|NCT02348632|3963200|FG000|COMPLETED|Open-label Period||458
3231434|NCT02348632|3963201|FG001|COMPLETED|Open-label Period||0
3231435|NCT02348632|3963200|FG000|NOT COMPLETED|Open-label Period||185
3231436|NCT02348632|3963201|FG001|NOT COMPLETED|Open-label Period||0
3231437|NCT02348632|3963200|FG000|STARTED|Randomized Withdrawal Period||140
3231438|NCT02348632|3963201|FG001|STARTED|Randomized Withdrawal Period||142
3231439|NCT02348632|3963200|FG000|COMPLETED|Randomized Withdrawal Period||137
3231440|NCT02348632|3963201|FG001|COMPLETED|Randomized Withdrawal Period||141
3231441|NCT02348632|3963200|FG000|NOT COMPLETED|Randomized Withdrawal Period||3
3231442|NCT02348632|3963201|FG001|NOT COMPLETED|Randomized Withdrawal Period||1
3369092|NCT03812328|4100555|FG000|COMPLETED|Overall Study||55
3369093|NCT03812328|4100556|FG001|COMPLETED|Overall Study||60
3369094|NCT03812328|4100557|FG002|COMPLETED|Overall Study||88
3369095|NCT03812328|4100555|FG000|NOT COMPLETED|Overall Study||0
3369096|NCT03812328|4100556|FG001|NOT COMPLETED|Overall Study||3
3369097|NCT03812328|4100557|FG002|NOT COMPLETED|Overall Study||1
3369098|NCT03808688|4100567|FG000|STARTED|Overall Study||99
3369099|NCT03808688|4100568|FG001|STARTED|Overall Study||161
3369100|NCT03808688|4100567|FG000|COMPLETED|Overall Study||81
3369101|NCT03808688|4100568|FG001|COMPLETED|Overall Study||138
3369102|NCT03808688|4100567|FG000|NOT COMPLETED|Overall Study||18
3369103|NCT03808688|4100568|FG001|NOT COMPLETED|Overall Study||23
3369104|NCT03811093|4100578|FG000|STARTED|Overall Study||20
3369105|NCT03811093|4100579|FG001|STARTED|Overall Study||19
3369106|NCT03811093|4100578|FG000|COMPLETED|Overall Study||18
3369107|NCT03811093|4100579|FG001|COMPLETED|Overall Study||15
3369108|NCT03811093|4100578|FG000|NOT COMPLETED|Overall Study||2
3369109|NCT03811093|4100579|FG001|NOT COMPLETED|Overall Study||4
3369110|NCT03822182|4100591|FG000|STARTED|Overall Study||26
3369111|NCT03822182|4100592|FG001|STARTED|Overall Study||25
3369112|NCT03822182|4100593|FG002|STARTED|Overall Study||27
3369113|NCT03822182|4100591|FG000|COMPLETED|Overall Study||26
3369114|NCT03822182|4100592|FG001|COMPLETED|Overall Study||24
3369115|NCT03822182|4100593|FG002|COMPLETED|Overall Study||26
3369116|NCT03822182|4100591|FG000|NOT COMPLETED|Overall Study||0
3369117|NCT03822182|4100592|FG001|NOT COMPLETED|Overall Study||1
3369118|NCT03822182|4100593|FG002|NOT COMPLETED|Overall Study||1
3369119|NCT03822416|4100604|FG000|STARTED|Overall Study||19
3369120|NCT03822416|4100605|FG001|STARTED|Overall Study||19
3369121|NCT03822416|4100604|FG000|COMPLETED|Overall Study||18
3369122|NCT03822416|4100605|FG001|COMPLETED|Overall Study||18
3369123|NCT03822416|4100604|FG000|NOT COMPLETED|Overall Study||1
3369124|NCT03822416|4100605|FG001|NOT COMPLETED|Overall Study||1
3369125|NCT03809104|4100611|FG000|STARTED|Overall Study||43
3369126|NCT03809104|4100611|FG000|COMPLETED|Overall Study||40
3369127|NCT03809104|4100611|FG000|NOT COMPLETED|Overall Study||3
3369128|NCT03807089|4100617|FG000|STARTED|Overall Study||101
3369129|NCT03807089|4100618|FG001|STARTED|Overall Study||93
3369130|NCT03807089|4100617|FG000|COMPLETED|Overall Study||101
3369131|NCT03807089|4100618|FG001|COMPLETED|Overall Study||93
3369132|NCT03807089|4100617|FG000|NOT COMPLETED|Overall Study||0
3369133|NCT03807089|4100618|FG001|NOT COMPLETED|Overall Study||0
3369134|NCT03806231|4100626|FG000|STARTED|Overall Study||4
3231443|NCT02348658|3963207|FG000|STARTED|Period 1 (7 Days)||6
3231444|NCT02348658|3963208|FG001|STARTED|Period 1 (7 Days)||6
3231445|NCT02348658|3963207|FG000|COMPLETED|Period 1 (7 Days)||6
3231446|NCT02348658|3963208|FG001|COMPLETED|Period 1 (7 Days)||6
3231447|NCT02348658|3963207|FG000|NOT COMPLETED|Period 1 (7 Days)||0
3231448|NCT02348658|3963208|FG001|NOT COMPLETED|Period 1 (7 Days)||0
3231449|NCT02348658|3963207|FG000|STARTED|Washout Period (22 Days)||6
3231450|NCT02348658|3963208|FG001|STARTED|Washout Period (22 Days)||6
3231451|NCT02348658|3963207|FG000|COMPLETED|Washout Period (22 Days)||6
3231452|NCT02348658|3963208|FG001|COMPLETED|Washout Period (22 Days)||6
3231453|NCT02348658|3963207|FG000|NOT COMPLETED|Washout Period (22 Days)||0
3231454|NCT02348658|3963208|FG001|NOT COMPLETED|Washout Period (22 Days)||0
3231455|NCT02348658|3963207|FG000|STARTED|Period 2 (7 Days)||6
3231456|NCT02348658|3963208|FG001|STARTED|Period 2 (7 Days)||6
3231457|NCT02348658|3963207|FG000|COMPLETED|Period 2 (7 Days)||6
3231458|NCT02348658|3963208|FG001|COMPLETED|Period 2 (7 Days)||6
3231459|NCT02348658|3963207|FG000|NOT COMPLETED|Period 2 (7 Days)||0
3231460|NCT02348658|3963208|FG001|NOT COMPLETED|Period 2 (7 Days)||0
3231461|NCT02348684|3963214|FG000|STARTED|Overall Study||20
3231462|NCT02348684|3963214|FG000|COMPLETED|Overall Study||20
3231463|NCT02348684|3963214|FG000|NOT COMPLETED|Overall Study||0
3231464|NCT02348723|3963220|FG000|STARTED|Overall Study||338
3231465|NCT02348723|3963221|FG001|STARTED|Overall Study||338
3231466|NCT02348723|3963220|FG000|COMPLETED|Overall Study||310
3231467|NCT02348723|3963221|FG001|COMPLETED|Overall Study||312
3231468|NCT02348723|3963220|FG000|NOT COMPLETED|Overall Study||28
3231469|NCT02348723|3963221|FG001|NOT COMPLETED|Overall Study||26
3231470|NCT02348775|3963229|FG000|STARTED|Overall Study||8
3231471|NCT02348775|3963230|FG001|STARTED|Overall Study||8
3231472|NCT02348775|3963229|FG000|COMPLETED|Overall Study||8
3231473|NCT02348775|3963230|FG001|COMPLETED|Overall Study||8
3231474|NCT02348775|3963229|FG000|NOT COMPLETED|Overall Study||0
3231475|NCT02348775|3963230|FG001|NOT COMPLETED|Overall Study||0
3231476|NCT02348840|3963240|FG000|STARTED|Overall Study||23
3231477|NCT02348840|3963241|FG001|STARTED|Overall Study||21
3231478|NCT02348840|3963242|FG002|STARTED|Overall Study||425
3231479|NCT02348840|3963243|FG003|STARTED|Overall Study||374
3231480|NCT02348840|3963240|FG000|COMPLETED|Overall Study||21
3231481|NCT02348840|3963241|FG001|COMPLETED|Overall Study||20
3231482|NCT02348840|3963242|FG002|COMPLETED|Overall Study||425
3231483|NCT02348840|3963243|FG003|COMPLETED|Overall Study||374
3231484|NCT02348840|3963240|FG000|NOT COMPLETED|Overall Study||2
3231485|NCT02348840|3963241|FG001|NOT COMPLETED|Overall Study||1
3231486|NCT02348840|3963242|FG002|NOT COMPLETED|Overall Study||0
3231487|NCT02348840|3963243|FG003|NOT COMPLETED|Overall Study||0
3231488|NCT02348918|3963262|FG000|STARTED|Overall Study||39
3231489|NCT02348918|3963263|FG001|STARTED|Overall Study||33
3231490|NCT02348918|3963264|FG002|STARTED|Overall Study||42
3231491|NCT02348918|3963265|FG003|STARTED|Overall Study||24
3231492|NCT02348918|3963266|FG004|STARTED|Overall Study||19
3231493|NCT02348918|3963267|FG005|STARTED|Overall Study||17
3231494|NCT02348918|3963268|FG006|STARTED|Overall Study||13
3231495|NCT02348918|3963269|FG007|STARTED|Overall Study||16
3231496|NCT02348918|3963270|FG008|STARTED|Overall Study||15
3231497|NCT02348918|3963262|FG000|COMPLETED|Overall Study||39
3231498|NCT02348918|3963263|FG001|COMPLETED|Overall Study||33
3231499|NCT02348918|3963264|FG002|COMPLETED|Overall Study||42
3231500|NCT02348918|3963265|FG003|COMPLETED|Overall Study||24
3231501|NCT02348918|3963266|FG004|COMPLETED|Overall Study||19
3231502|NCT02348918|3963267|FG005|COMPLETED|Overall Study||17
3231503|NCT02348918|3963268|FG006|COMPLETED|Overall Study||13
3231504|NCT02348918|3963269|FG007|COMPLETED|Overall Study||16
3231505|NCT02348918|3963270|FG008|COMPLETED|Overall Study||15
3231506|NCT02348918|3963262|FG000|NOT COMPLETED|Overall Study||0
3231507|NCT02348918|3963263|FG001|NOT COMPLETED|Overall Study||0
3231508|NCT02348918|3963264|FG002|NOT COMPLETED|Overall Study||0
3231509|NCT02348918|3963265|FG003|NOT COMPLETED|Overall Study||0
3231510|NCT02348918|3963266|FG004|NOT COMPLETED|Overall Study||0
3231511|NCT02348918|3963267|FG005|NOT COMPLETED|Overall Study||0
3231512|NCT02348918|3963268|FG006|NOT COMPLETED|Overall Study||0
3231513|NCT02348918|3963269|FG007|NOT COMPLETED|Overall Study||0
3231514|NCT02348918|3963270|FG008|NOT COMPLETED|Overall Study||0
3231515|NCT02349048|3963292|FG000|STARTED|Overall Study||59
3231516|NCT02349048|3963293|FG001|STARTED|Overall Study||9
3231517|NCT02349048|3963292|FG000|COMPLETED|Overall Study||54
3231518|NCT02349048|3963293|FG001|COMPLETED|Overall Study||9
3231519|NCT02349048|3963292|FG000|NOT COMPLETED|Overall Study||5
3231520|NCT02349048|3963293|FG001|NOT COMPLETED|Overall Study||0
3231521|NCT02349061|3963301|FG000|STARTED|Main Study: PCP (Up to Week 24)||42
3231522|NCT02349061|3963302|FG001|STARTED|Main Study: PCP (Up to Week 24)||60
3231523|NCT02349061|3963303|FG002|STARTED|Main Study: PCP (Up to Week 24)||0
3231524|NCT02349061|3963301|FG000|COMPLETED|Main Study: PCP (Up to Week 24)||33
3231525|NCT02349061|3963302|FG001|COMPLETED|Main Study: PCP (Up to Week 24)||56
3231526|NCT02349061|3963303|FG002|COMPLETED|Main Study: PCP (Up to Week 24)||0
3231527|NCT02349061|3963301|FG000|NOT COMPLETED|Main Study: PCP (Up to Week 24)||9
3231528|NCT02349061|3963302|FG001|NOT COMPLETED|Main Study: PCP (Up to Week 24)||4
3231529|NCT02349061|3963303|FG002|NOT COMPLETED|Main Study: PCP (Up to Week 24)||0
3231530|NCT02349061|3963301|FG000|STARTED|Main Study: Week 24 to 56||0
3231531|NCT02349061|3963302|FG001|STARTED|Main Study: Week 24 to 56||56
3231532|NCT02349061|3963303|FG002|STARTED|Main Study: Week 24 to 56||33
3231533|NCT02349061|3963301|FG000|COMPLETED|Main Study: Week 24 to 56||0
3231534|NCT02349061|3963302|FG001|COMPLETED|Main Study: Week 24 to 56||53
3231535|NCT02349061|3963303|FG002|COMPLETED|Main Study: Week 24 to 56||30
3231536|NCT02349061|3963301|FG000|NOT COMPLETED|Main Study: Week 24 to 56||0
3231537|NCT02349061|3963302|FG001|NOT COMPLETED|Main Study: Week 24 to 56||3
3231538|NCT02349061|3963303|FG002|NOT COMPLETED|Main Study: Week 24 to 56||3
3231539|NCT02349061|3963301|FG000|STARTED|Study Extension (Week 56 to Week 120)||0
3369135|NCT03806231|4100627|FG001|STARTED|Overall Study||4
3369136|NCT03806231|4100626|FG000|COMPLETED|Overall Study||2
3369137|NCT03806231|4100627|FG001|COMPLETED|Overall Study||4
3369138|NCT03806231|4100626|FG000|NOT COMPLETED|Overall Study||2
3369139|NCT03806231|4100627|FG001|NOT COMPLETED|Overall Study||0
3369140|NCT03804710|4100635|FG000|STARTED|Overall Study||75
3369141|NCT03804710|4100636|FG001|STARTED|Overall Study||74
3369142|NCT03804710|4100635|FG000|COMPLETED|Overall Study||73
3369143|NCT03804710|4100636|FG001|COMPLETED|Overall Study||69
3369144|NCT03804710|4100635|FG000|NOT COMPLETED|Overall Study||2
3369145|NCT03804710|4100636|FG001|NOT COMPLETED|Overall Study||5
3369146|NCT03822377|4100648|FG000|STARTED|Overall Study||65
3369147|NCT03822377|4100649|FG001|STARTED|Overall Study||65
3369148|NCT03822377|4100648|FG000|COMPLETED|Overall Study||65
3369149|NCT03822377|4100649|FG001|COMPLETED|Overall Study||65
3369150|NCT03822377|4100648|FG000|NOT COMPLETED|Overall Study||0
3369151|NCT03822377|4100649|FG001|NOT COMPLETED|Overall Study||0
3369152|NCT03820388|4100660|FG000|STARTED|Overall Study||25
3369153|NCT03820388|4100661|FG001|STARTED|Overall Study||25
3369154|NCT03820388|4100662|FG002|STARTED|Overall Study||25
3369155|NCT03820388|4100660|FG000|COMPLETED|Overall Study||25
3369156|NCT03820388|4100661|FG001|COMPLETED|Overall Study||25
3369157|NCT03820388|4100662|FG002|COMPLETED|Overall Study||25
3369158|NCT03820388|4100660|FG000|NOT COMPLETED|Overall Study||0
3369159|NCT03820388|4100661|FG001|NOT COMPLETED|Overall Study||0
3369160|NCT03820388|4100662|FG002|NOT COMPLETED|Overall Study||0
3369161|NCT03816696|4100670|FG000|STARTED|Period 1 (Up to Day 5)||16
3369162|NCT03816696|4100670|FG000|COMPLETED|Period 1 (Up to Day 5)||16
3369163|NCT03816696|4100670|FG000|NOT COMPLETED|Period 1 (Up to Day 5)||0
3369164|NCT03816696|4100670|FG000|STARTED|Wash Out Period (Days 6 to 9)||16
3369165|NCT03816696|4100670|FG000|COMPLETED|Wash Out Period (Days 6 to 9)||16
3369166|NCT03816696|4100670|FG000|NOT COMPLETED|Wash Out Period (Days 6 to 9)||0
3369167|NCT03816696|4100670|FG000|STARTED|Period 2 (Up to Day 7)||16
3369168|NCT03816696|4100670|FG000|COMPLETED|Period 2 (Up to Day 7)||16
3369169|NCT03816696|4100670|FG000|NOT COMPLETED|Period 2 (Up to Day 7)||0
3369170|NCT03816696|4100670|FG000|STARTED|Period 3 (Up to Day 11)||16
3369171|NCT03816696|4100670|FG000|COMPLETED|Period 3 (Up to Day 11)||16
3369172|NCT03816696|4100670|FG000|NOT COMPLETED|Period 3 (Up to Day 11)||0
3231540|NCT02349061|3963302|FG001|STARTED|Study Extension (Week 56 to Week 120)|Who met study extension inclusion criteria received open-label ustekinumab SC through Week 104.|29
3231541|NCT02349061|3963303|FG002|STARTED|Study Extension (Week 56 to Week 120)|Who met study extension inclusion criteria received open-label ustekinumab SC through Week 104.|17
3231542|NCT02349061|3963301|FG000|COMPLETED|Study Extension (Week 56 to Week 120)||0
3231543|NCT02349061|3963302|FG001|COMPLETED|Study Extension (Week 56 to Week 120)||24
3231544|NCT02349061|3963303|FG002|COMPLETED|Study Extension (Week 56 to Week 120)||14
3231545|NCT02349061|3963301|FG000|NOT COMPLETED|Study Extension (Week 56 to Week 120)||0
3231546|NCT02349061|3963302|FG001|NOT COMPLETED|Study Extension (Week 56 to Week 120)||5
3231547|NCT02349061|3963303|FG002|NOT COMPLETED|Study Extension (Week 56 to Week 120)||3
3231548|NCT02349152|3963315|FG000|STARTED|Overall Study||60
3231549|NCT02349152|3963316|FG001|STARTED|Overall Study||56
3231550|NCT02349152|3963315|FG000|COMPLETED|Overall Study||54
3231551|NCT02349152|3963316|FG001|COMPLETED|Overall Study||52
3231552|NCT02349152|3963315|FG000|NOT COMPLETED|Overall Study||6
3231553|NCT02349152|3963316|FG001|NOT COMPLETED|Overall Study||4
3231554|NCT02349178|3963322|FG000|STARTED|Overall Study||6
3231555|NCT02349178|3963322|FG000|COMPLETED|Overall Study||6
3231556|NCT02349178|3963322|FG000|NOT COMPLETED|Overall Study||0
3231557|NCT02349295|3963329|FG000|STARTED|Double Blind Treatment (Week 0-24)||123
3231558|NCT02349295|3963330|FG001|STARTED|Double Blind Treatment (Week 0-24)||122
3231559|NCT02349295|3963331|FG002|STARTED|Double Blind Treatment (Week 0-24)||118
3231560|NCT02349295|3963332|FG003|STARTED|Double Blind Treatment (Week 0-24)||0
3231561|NCT02349295|3963333|FG004|STARTED|Double Blind Treatment (Week 0-24)||0
3231562|NCT02349295|3963334|FG005|STARTED|Double Blind Treatment (Week 0-24)||0
3231563|NCT02349295|3963335|FG006|STARTED|Double Blind Treatment (Week 0-24)||0
3231564|NCT02349295|3963336|FG007|STARTED|Double Blind Treatment (Week 0-24)||0
3231565|NCT02349295|3963337|FG008|STARTED|Double Blind Treatment (Week 0-24)||0
3231566|NCT02349295|3963338|FG009|STARTED|Double Blind Treatment (Week 0-24)||0
3231567|NCT02349295|3963339|FG010|STARTED|Double Blind Treatment (Week 0-24)||0
3231568|NCT02349295|3963340|FG011|STARTED|Double Blind Treatment (Week 0-24)||0
3231569|NCT02349295|3963341|FG012|STARTED|Double Blind Treatment (Week 0-24)||0
3231570|NCT02349295|3963342|FG013|STARTED|Double Blind Treatment (Week 0-24)||0
3231571|NCT02349295|3963329|FG000|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||123
3231572|NCT02349295|3963330|FG001|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||122
3231573|NCT02349295|3963331|FG002|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||118
3231574|NCT02349295|3963332|FG003|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
3231575|NCT02349295|3963333|FG004|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
3231576|NCT02349295|3963334|FG005|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
3231577|NCT02349295|3963335|FG006|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
3231578|NCT02349295|3963336|FG007|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
3231579|NCT02349295|3963337|FG008|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
3231580|NCT02349295|3963338|FG009|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
3231581|NCT02349295|3963339|FG010|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
3231582|NCT02349295|3963340|FG011|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
3231583|NCT02349295|3963341|FG012|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
3231584|NCT02349295|3963342|FG013|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
3231585|NCT02349295|3963329|FG000|COMPLETED|Double Blind Treatment (Week 0-24)||109
3231586|NCT02349295|3963330|FG001|COMPLETED|Double Blind Treatment (Week 0-24)||111
3231587|NCT02349295|3963331|FG002|COMPLETED|Double Blind Treatment (Week 0-24)||94
3231588|NCT02349295|3963332|FG003|COMPLETED|Double Blind Treatment (Week 0-24)||0
3231589|NCT02349295|3963333|FG004|COMPLETED|Double Blind Treatment (Week 0-24)||0
3231590|NCT02349295|3963334|FG005|COMPLETED|Double Blind Treatment (Week 0-24)||0
3231591|NCT02349295|3963335|FG006|COMPLETED|Double Blind Treatment (Week 0-24)||0
3231592|NCT02349295|3963336|FG007|COMPLETED|Double Blind Treatment (Week 0-24)||0
3231593|NCT02349295|3963337|FG008|COMPLETED|Double Blind Treatment (Week 0-24)||0
3231594|NCT02349295|3963338|FG009|COMPLETED|Double Blind Treatment (Week 0-24)||0
3231595|NCT02349295|3963339|FG010|COMPLETED|Double Blind Treatment (Week 0-24)||0
3231596|NCT02349295|3963340|FG011|COMPLETED|Double Blind Treatment (Week 0-24)||0
3231597|NCT02349295|3963341|FG012|COMPLETED|Double Blind Treatment (Week 0-24)||0
3231598|NCT02349295|3963342|FG013|COMPLETED|Double Blind Treatment (Week 0-24)||0
3231599|NCT02349295|3963329|FG000|NOT COMPLETED|Double Blind Treatment (Week 0-24)||14
3231600|NCT02349295|3963330|FG001|NOT COMPLETED|Double Blind Treatment (Week 0-24)||11
3231601|NCT02349295|3963331|FG002|NOT COMPLETED|Double Blind Treatment (Week 0-24)||24
3231602|NCT02349295|3963332|FG003|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
3231603|NCT02349295|3963333|FG004|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
3231604|NCT02349295|3963334|FG005|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
3231605|NCT02349295|3963335|FG006|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
3231606|NCT02349295|3963336|FG007|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
3231607|NCT02349295|3963337|FG008|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
3231608|NCT02349295|3963338|FG009|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
3231609|NCT02349295|3963339|FG010|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
3231610|NCT02349295|3963340|FG011|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
3231611|NCT02349295|3963341|FG012|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
3231612|NCT02349295|3963342|FG013|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
3231613|NCT02349295|3963329|FG000|STARTED|IR (Week 16-24)|Only IR participants were included.|0
3231614|NCT02349295|3963330|FG001|STARTED|IR (Week 16-24)|Only IR participants were included.|0
3231615|NCT02349295|3963331|FG002|STARTED|IR (Week 16-24)|Only IR participants were included.|0
3231616|NCT02349295|3963332|FG003|STARTED|IR (Week 16-24)|IR from ixekizumab 80 mg Q2W only.|17
3231617|NCT02349295|3963333|FG004|STARTED|IR (Week 16-24)|IR from ixekizumab 80 mg Q4W only.|15
3231618|NCT02349295|3963334|FG005|STARTED|IR (Week 16-24)|IR from placebo who re-randomized (1:1) to ixekizumab 80 mg Q2W.|16
3231619|NCT02349295|3963335|FG006|STARTED|IR (Week 16-24)|IR from placebo who re-randomized (1:1) to ixekizumab 80 mg Q4W.|16
3231620|NCT02349295|3963336|FG007|STARTED|IR (Week 16-24)||0
3231621|NCT02349295|3963337|FG008|STARTED|IR (Week 16-24)||0
3231622|NCT02349295|3963338|FG009|STARTED|IR (Week 16-24)||0
3231623|NCT02349295|3963339|FG010|STARTED|IR (Week 16-24)||0
3231624|NCT02349295|3963340|FG011|STARTED|IR (Week 16-24)||0
3231625|NCT02349295|3963341|FG012|STARTED|IR (Week 16-24)||0
3231626|NCT02349295|3963342|FG013|STARTED|IR (Week 16-24)||0
3231627|NCT02349295|3963329|FG000|COMPLETED|IR (Week 16-24)||0
3231628|NCT02349295|3963330|FG001|COMPLETED|IR (Week 16-24)||0
3231629|NCT02349295|3963331|FG002|COMPLETED|IR (Week 16-24)||0
3231630|NCT02349295|3963332|FG003|COMPLETED|IR (Week 16-24)||16
3231631|NCT02349295|3963333|FG004|COMPLETED|IR (Week 16-24)||15
3231632|NCT02349295|3963334|FG005|COMPLETED|IR (Week 16-24)||16
3231633|NCT02349295|3963335|FG006|COMPLETED|IR (Week 16-24)||16
3231634|NCT02349295|3963336|FG007|COMPLETED|IR (Week 16-24)||0
3231635|NCT02349295|3963337|FG008|COMPLETED|IR (Week 16-24)||0
3231636|NCT02349295|3963338|FG009|COMPLETED|IR (Week 16-24)||0
3231637|NCT02349295|3963339|FG010|COMPLETED|IR (Week 16-24)||0
3231638|NCT02349295|3963340|FG011|COMPLETED|IR (Week 16-24)||0
3231639|NCT02349295|3963341|FG012|COMPLETED|IR (Week 16-24)||0
3231640|NCT02349295|3963342|FG013|COMPLETED|IR (Week 16-24)||0
3231641|NCT02349295|3963329|FG000|NOT COMPLETED|IR (Week 16-24)||0
3231642|NCT02349295|3963330|FG001|NOT COMPLETED|IR (Week 16-24)||0
3231643|NCT02349295|3963331|FG002|NOT COMPLETED|IR (Week 16-24)||0
3231644|NCT02349295|3963332|FG003|NOT COMPLETED|IR (Week 16-24)||1
3231645|NCT02349295|3963333|FG004|NOT COMPLETED|IR (Week 16-24)||0
3231646|NCT02349295|3963334|FG005|NOT COMPLETED|IR (Week 16-24)||0
3231647|NCT02349295|3963335|FG006|NOT COMPLETED|IR (Week 16-24)||0
3231648|NCT02349295|3963336|FG007|NOT COMPLETED|IR (Week 16-24)||0
3231649|NCT02349295|3963337|FG008|NOT COMPLETED|IR (Week 16-24)||0
3231650|NCT02349295|3963338|FG009|NOT COMPLETED|IR (Week 16-24)||0
3231651|NCT02349295|3963339|FG010|NOT COMPLETED|IR (Week 16-24)||0
3231652|NCT02349295|3963340|FG011|NOT COMPLETED|IR (Week 16-24)||0
3231653|NCT02349295|3963341|FG012|NOT COMPLETED|IR (Week 16-24)||0
3231654|NCT02349295|3963342|FG013|NOT COMPLETED|IR (Week 16-24)||0
3231655|NCT02349295|3963329|FG000|STARTED|Long-Term Extension Period (Week 24-156)||0
3231656|NCT02349295|3963330|FG001|STARTED|Long-Term Extension Period (Week 24-156)||0
3231657|NCT02349295|3963331|FG002|STARTED|Long-Term Extension Period (Week 24-156)||0
3231658|NCT02349295|3963332|FG003|STARTED|Long-Term Extension Period (Week 24-156)|Only included combined extension participants.|0
3231659|NCT02349295|3963333|FG004|STARTED|Long-Term Extension Period (Week 24-156)|Only included combined extension participants.|0
3231660|NCT02349295|3963334|FG005|STARTED|Long-Term Extension Period (Week 24-156)|Only included combined extension participants.|0
3231661|NCT02349295|3963335|FG006|STARTED|Long-Term Extension Period (Week 24-156)|Only included combined extension participants.|0
3231662|NCT02349295|3963336|FG007|STARTED|Long-Term Extension Period (Week 24-156)|IxeQ2W participants who entered the long-term extension period.|107
3231663|NCT02349295|3963337|FG008|STARTED|Long-Term Extension Period (Week 24-156)|IxeQ4W participants who entered the long-term extension period.|111
3231664|NCT02349295|3963338|FG009|STARTED|Long-Term Extension Period (Week 24-156)|Placebo/IxeQ2W participants who entered the long-term extension period.|46
3231665|NCT02349295|3963339|FG010|STARTED|Long-Term Extension Period (Week 24-156)|Placebo/IxeQ4W participants who entered the long-term extension period.|46
3231666|NCT02349295|3963340|FG011|STARTED|Long-Term Extension Period (Week 24-156)||0
3231667|NCT02349295|3963341|FG012|STARTED|Long-Term Extension Period (Week 24-156)||0
3231668|NCT02349295|3963342|FG013|STARTED|Long-Term Extension Period (Week 24-156)||0
3231669|NCT02349295|3963329|FG000|COMPLETED|Long-Term Extension Period (Week 24-156)||0
3231670|NCT02349295|3963330|FG001|COMPLETED|Long-Term Extension Period (Week 24-156)||0
3231671|NCT02349295|3963331|FG002|COMPLETED|Long-Term Extension Period (Week 24-156)||0
3231672|NCT02349295|3963332|FG003|COMPLETED|Long-Term Extension Period (Week 24-156)||0
3231673|NCT02349295|3963333|FG004|COMPLETED|Long-Term Extension Period (Week 24-156)||0
3231674|NCT02349295|3963334|FG005|COMPLETED|Long-Term Extension Period (Week 24-156)||0
3231675|NCT02349295|3963335|FG006|COMPLETED|Long-Term Extension Period (Week 24-156)||0
3231676|NCT02349295|3963336|FG007|COMPLETED|Long-Term Extension Period (Week 24-156)||55
3231677|NCT02349295|3963337|FG008|COMPLETED|Long-Term Extension Period (Week 24-156)||70
3231678|NCT02349295|3963338|FG009|COMPLETED|Long-Term Extension Period (Week 24-156)||20
3231679|NCT02349295|3963339|FG010|COMPLETED|Long-Term Extension Period (Week 24-156)||23
3231680|NCT02349295|3963340|FG011|COMPLETED|Long-Term Extension Period (Week 24-156)||0
3231681|NCT02349295|3963341|FG012|COMPLETED|Long-Term Extension Period (Week 24-156)||0
3231682|NCT02349295|3963342|FG013|COMPLETED|Long-Term Extension Period (Week 24-156)||0
3231683|NCT02349295|3963329|FG000|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0
3231684|NCT02349295|3963330|FG001|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0
3231685|NCT02349295|3963331|FG002|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0
3231686|NCT02349295|3963332|FG003|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0
3231687|NCT02349295|3963333|FG004|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0
3231688|NCT02349295|3963334|FG005|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0
3231689|NCT02349295|3963335|FG006|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0
3231690|NCT02349295|3963336|FG007|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||52
3231691|NCT02349295|3963337|FG008|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||41
3231692|NCT02349295|3963338|FG009|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||26
3231693|NCT02349295|3963339|FG010|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||23
3231694|NCT02349295|3963340|FG011|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0
3231695|NCT02349295|3963341|FG012|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0
3231696|NCT02349295|3963342|FG013|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0
3231697|NCT02349295|3963329|FG000|STARTED|Follow-Up Period (Up to 12-24 Weeks)||0
3231698|NCT02349295|3963330|FG001|STARTED|Follow-Up Period (Up to 12-24 Weeks)||0
3231699|NCT02349295|3963331|FG002|STARTED|Follow-Up Period (Up to 12-24 Weeks)||0
3231700|NCT02349295|3963332|FG003|STARTED|Follow-Up Period (Up to 12-24 Weeks)||0
3231701|NCT02349295|3963333|FG004|STARTED|Follow-Up Period (Up to 12-24 Weeks)||0
3231702|NCT02349295|3963334|FG005|STARTED|Follow-Up Period (Up to 12-24 Weeks)||0
3231703|NCT02349295|3963335|FG006|STARTED|Follow-Up Period (Up to 12-24 Weeks)||0
3231704|NCT02349295|3963336|FG007|STARTED|Follow-Up Period (Up to 12-24 Weeks)|Only included post-treatment follow-up participants.|0
3231705|NCT02349295|3963337|FG008|STARTED|Follow-Up Period (Up to 12-24 Weeks)|Only included post-treatment follow-up participants.|0
3231706|NCT02349295|3963338|FG009|STARTED|Follow-Up Period (Up to 12-24 Weeks)|Only included post-treatment follow-up participants.|0
3231707|NCT02349295|3963339|FG010|STARTED|Follow-Up Period (Up to 12-24 Weeks)|Only included post-treatment follow-up participants.|0
3231708|NCT02349295|3963340|FG011|STARTED|Follow-Up Period (Up to 12-24 Weeks)|IxeQ2W participants who entered post-treatment follow-up.|142
3231709|NCT02349295|3963341|FG012|STARTED|Follow-Up Period (Up to 12-24 Weeks)|IxeQ4W participants who entered post-treatment follow-up.|145
3231710|NCT02349295|3963342|FG013|STARTED|Follow-Up Period (Up to 12-24 Weeks)|PBO participants who entered post-treatment follow-up.|17
3231711|NCT02349295|3963329|FG000|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
3231712|NCT02349295|3963330|FG001|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
3231713|NCT02349295|3963331|FG002|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
3231714|NCT02349295|3963332|FG003|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
3231715|NCT02349295|3963333|FG004|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
3231716|NCT02349295|3963334|FG005|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
3231717|NCT02349295|3963335|FG006|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
3231718|NCT02349295|3963336|FG007|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
3231719|NCT02349295|3963337|FG008|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
3231720|NCT02349295|3963338|FG009|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
3231721|NCT02349295|3963339|FG010|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
3231722|NCT02349295|3963340|FG011|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||133
3231723|NCT02349295|3963341|FG012|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||137
3231724|NCT02349295|3963342|FG013|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||16
3231725|NCT02349295|3963329|FG000|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
3231726|NCT02349295|3963330|FG001|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
3231727|NCT02349295|3963331|FG002|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
3231728|NCT02349295|3963332|FG003|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
3231729|NCT02349295|3963333|FG004|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
3231730|NCT02349295|3963334|FG005|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
3231731|NCT02349295|3963335|FG006|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
3231732|NCT02349295|3963336|FG007|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
3231733|NCT02349295|3963337|FG008|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
3231734|NCT02349295|3963338|FG009|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
3231735|NCT02349295|3963339|FG010|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
3231736|NCT02349295|3963340|FG011|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||9
3231737|NCT02349295|3963341|FG012|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||8
3231738|NCT02349295|3963342|FG013|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||1
3231739|NCT02349360|3963369|FG000|STARTED|Overall Study||21
3231740|NCT02349360|3963370|FG001|STARTED|Overall Study||21
3231741|NCT02349360|3963369|FG000|COMPLETED|Overall Study||21
3231742|NCT02349360|3963370|FG001|COMPLETED|Overall Study||20
3231743|NCT02349360|3963369|FG000|NOT COMPLETED|Overall Study||0
3231744|NCT02349360|3963370|FG001|NOT COMPLETED|Overall Study||1
3231745|NCT02349412|3963378|FG000|STARTED|Overall Study||202
3231746|NCT02349412|3963379|FG001|STARTED|Overall Study||203
3231747|NCT02349412|3963378|FG000|Completed Week-12 QOL Assessment Measure|Overall Study||92
3231748|NCT02349412|3963379|FG001|Completed Week-12 QOL Assessment Measure|Overall Study||101
3231749|NCT02349412|3963378|FG000|Completed Week-24 QOL Assessment Measure|Overall Study||68
3231750|NCT02349412|3963379|FG001|Completed Week-24 QOL Assessment Measure|Overall Study||80
3231751|NCT02349412|3963378|FG000|COMPLETED|Overall Study||195
3231752|NCT02349412|3963379|FG001|COMPLETED|Overall Study||196
3231753|NCT02349412|3963378|FG000|NOT COMPLETED|Overall Study||7
3231754|NCT02349412|3963379|FG001|NOT COMPLETED|Overall Study||7
3231755|NCT02349425|3963389|FG000|STARTED|Period 1||15
3231756|NCT02349425|3963390|FG001|STARTED|Period 1||14
3231757|NCT02349425|3963391|FG002|STARTED|Period 1||15
3231758|NCT02349425|3963392|FG003|STARTED|Period 1||15
3231759|NCT02349425|3963389|FG000|COMPLETED|Period 1||14
3231760|NCT02349425|3963390|FG001|COMPLETED|Period 1||13
3231761|NCT02349425|3963391|FG002|COMPLETED|Period 1||15
3231762|NCT02349425|3963392|FG003|COMPLETED|Period 1||15
3231763|NCT02349425|3963389|FG000|NOT COMPLETED|Period 1||1
3231764|NCT02349425|3963390|FG001|NOT COMPLETED|Period 1||1
3231765|NCT02349425|3963391|FG002|NOT COMPLETED|Period 1||0
3231766|NCT02349425|3963392|FG003|NOT COMPLETED|Period 1||0
3231767|NCT02349425|3963389|FG000|STARTED|Period 2||14
3231768|NCT02349425|3963390|FG001|STARTED|Period 2||13
3231769|NCT02349425|3963391|FG002|STARTED|Period 2||15
3231770|NCT02349425|3963392|FG003|STARTED|Period 2||15
3231771|NCT02349425|3963389|FG000|COMPLETED|Period 2||14
3231772|NCT02349425|3963390|FG001|COMPLETED|Period 2||12
3231773|NCT02349425|3963391|FG002|COMPLETED|Period 2||14
3231774|NCT02349425|3963392|FG003|COMPLETED|Period 2||15
3231775|NCT02349425|3963389|FG000|NOT COMPLETED|Period 2||0
3231776|NCT02349425|3963390|FG001|NOT COMPLETED|Period 2||1
3231777|NCT02349425|3963391|FG002|NOT COMPLETED|Period 2||1
3231778|NCT02349425|3963392|FG003|NOT COMPLETED|Period 2||0
3231779|NCT02349438|3963430|FG000|STARTED|Period 1||11
3231780|NCT02349438|3963431|FG001|STARTED|Period 1||10
3231781|NCT02349438|3963430|FG000|COMPLETED|Period 1||11
3231782|NCT02349438|3963431|FG001|COMPLETED|Period 1||10
3231783|NCT02349438|3963430|FG000|NOT COMPLETED|Period 1||0
3231784|NCT02349438|3963431|FG001|NOT COMPLETED|Period 1||0
3231785|NCT02349438|3963430|FG000|STARTED|Period 2||11
3231786|NCT02349438|3963431|FG001|STARTED|Period 2||10
3231787|NCT02349438|3963430|FG000|COMPLETED|Period 2||11
3231788|NCT02349438|3963431|FG001|COMPLETED|Period 2||10
3231789|NCT02349438|3963430|FG000|NOT COMPLETED|Period 2||0
3231790|NCT02349438|3963431|FG001|NOT COMPLETED|Period 2||0
3231791|NCT02349451|3963441|FG000|STARTED|Overall Study||24
3231792|NCT02349451|3963442|FG001|STARTED|Overall Study||72
3231793|NCT02349451|3963443|FG002|STARTED|Overall Study||71
3231794|NCT02349451|3963444|FG003|STARTED|Overall Study||73
3231795|NCT02349451|3963441|FG000|COMPLETED|Overall Study||24
3231796|NCT02349451|3963442|FG001|COMPLETED|Overall Study||71
3231797|NCT02349451|3963443|FG002|COMPLETED|Overall Study||69
3231798|NCT02349451|3963444|FG003|COMPLETED|Overall Study||72
3231799|NCT02349451|3963441|FG000|NOT COMPLETED|Overall Study||0
3231800|NCT02349451|3963442|FG001|NOT COMPLETED|Overall Study||1
3231801|NCT02349451|3963443|FG002|NOT COMPLETED|Overall Study||2
3231802|NCT02349451|3963444|FG003|NOT COMPLETED|Overall Study||1
3231803|NCT02349477|3963459|FG000|STARTED|Overall Study||44
3231804|NCT02349477|3963460|FG001|STARTED|Overall Study||46
3231805|NCT02349477|3963459|FG000|COMPLETED|Overall Study||31
3231806|NCT02349477|3963460|FG001|COMPLETED|Overall Study||28
3231807|NCT02349477|3963459|FG000|NOT COMPLETED|Overall Study||13
3231808|NCT02349477|3963460|FG001|NOT COMPLETED|Overall Study||18
3231809|NCT02349542|3963470|FG000|STARTED|Overall Study||20
3231810|NCT02349542|3963470|FG000|COMPLETED|Overall Study||15
3231811|NCT02349542|3963470|FG000|NOT COMPLETED|Overall Study||5
3231812|NCT02349633|3963488|FG000|STARTED|Overall Study||4
3231813|NCT02349633|3963489|FG001|STARTED|Overall Study||3
3231814|NCT02349633|3963490|FG002|STARTED|Overall Study||4
3231815|NCT02349633|3963491|FG003|STARTED|Overall Study||4
3231816|NCT02349633|3963492|FG004|STARTED|Overall Study||3
3231817|NCT02349633|3963493|FG005|STARTED|Overall Study||4
3231818|NCT02349633|3963494|FG006|STARTED|Overall Study||4
3231819|NCT02349633|3963495|FG007|STARTED|Overall Study||29
3231820|NCT02349633|3963496|FG008|STARTED|Overall Study||5
3231821|NCT02349633|3963497|FG009|STARTED|Overall Study||5
3231822|NCT02349633|3963498|FG010|STARTED|Overall Study|No participants were enrolled in this cohort/arm prior to study termination.|0
3231823|NCT02349633|3963499|FG011|STARTED|Overall Study|No participants were enrolled in this cohort/arm prior to study termination.|0
3231824|NCT02349633|3963500|FG012|STARTED|Overall Study|No participants were enrolled in this cohort/arm prior to study termination.|0
3231825|NCT02349633|3963501|FG013|STARTED|Overall Study|No participants were enrolled in this cohort/arm prior to study termination.|0
3231826|NCT02349633|3963488|FG000|COMPLETED|Overall Study||4
3231827|NCT02349633|3963489|FG001|COMPLETED|Overall Study||2
3231828|NCT02349633|3963490|FG002|COMPLETED|Overall Study||4
3231829|NCT02349633|3963491|FG003|COMPLETED|Overall Study||2
3231830|NCT02349633|3963492|FG004|COMPLETED|Overall Study||1
3231831|NCT02349633|3963493|FG005|COMPLETED|Overall Study||3
3231832|NCT02349633|3963494|FG006|COMPLETED|Overall Study||3
3231833|NCT02349633|3963495|FG007|COMPLETED|Overall Study||13
3231834|NCT02349633|3963496|FG008|COMPLETED|Overall Study||3
3231835|NCT02349633|3963497|FG009|COMPLETED|Overall Study||0
3231836|NCT02349633|3963498|FG010|COMPLETED|Overall Study||0
3231837|NCT02349633|3963499|FG011|COMPLETED|Overall Study||0
3231838|NCT02349633|3963500|FG012|COMPLETED|Overall Study||0
3231839|NCT02349633|3963501|FG013|COMPLETED|Overall Study||0
3231840|NCT02349633|3963488|FG000|NOT COMPLETED|Overall Study||0
3231841|NCT02349633|3963489|FG001|NOT COMPLETED|Overall Study||1
3231842|NCT02349633|3963490|FG002|NOT COMPLETED|Overall Study||0
3231843|NCT02349633|3963491|FG003|NOT COMPLETED|Overall Study||2
3231844|NCT02349633|3963492|FG004|NOT COMPLETED|Overall Study||2
3231845|NCT02349633|3963493|FG005|NOT COMPLETED|Overall Study||1
3231846|NCT02349633|3963494|FG006|NOT COMPLETED|Overall Study||1
3231847|NCT02349633|3963495|FG007|NOT COMPLETED|Overall Study||16
3231848|NCT02349633|3963496|FG008|NOT COMPLETED|Overall Study||2
3231849|NCT02349633|3963497|FG009|NOT COMPLETED|Overall Study||5
3231850|NCT02349633|3963498|FG010|NOT COMPLETED|Overall Study||0
3231851|NCT02349633|3963499|FG011|NOT COMPLETED|Overall Study||0
3231852|NCT02349633|3963500|FG012|NOT COMPLETED|Overall Study||0
3231853|NCT02349633|3963501|FG013|NOT COMPLETED|Overall Study||0
3231854|NCT02349646|3963562|FG000|STARTED|Overall Study||33
3231855|NCT02349646|3963562|FG000|Received Trial System|Overall Study||24
3231856|NCT02349646|3963562|FG000|Receive Permanent System|Overall Study||27
3231857|NCT02349646|3963562|FG000|COMPLETED|Overall Study||16
3231858|NCT02349646|3963562|FG000|NOT COMPLETED|Overall Study||17
3231859|NCT02349685|3963569|FG000|STARTED|Overall Study||89
3231860|NCT02349685|3963570|FG001|STARTED|Overall Study||89
3231861|NCT02349685|3963571|FG002|STARTED|Overall Study||41
3231862|NCT02349685|3963569|FG000|COMPLETED|Overall Study||84
3231863|NCT02349685|3963570|FG001|COMPLETED|Overall Study||87
3231864|NCT02349685|3963571|FG002|COMPLETED|Overall Study||37
3231865|NCT02349685|3963569|FG000|NOT COMPLETED|Overall Study||5
3231866|NCT02349685|3963570|FG001|NOT COMPLETED|Overall Study||2
3231867|NCT02349685|3963571|FG002|NOT COMPLETED|Overall Study||4
3231868|NCT02349711|3963581|FG000|STARTED|Overall Study||87
3231869|NCT02349711|3963582|FG001|STARTED|Overall Study||86
3231870|NCT02349711|3963581|FG000|COMPLETED|Overall Study||84
3231871|NCT02349711|3963582|FG001|COMPLETED|Overall Study||84
3231872|NCT02349711|3963581|FG000|NOT COMPLETED|Overall Study||3
3231873|NCT02349711|3963582|FG001|NOT COMPLETED|Overall Study||2
3231874|NCT02349789|3963588|FG000|STARTED|Overall Study||11
3231875|NCT02349789|3963588|FG000|COMPLETED|Overall Study||9
3231876|NCT02349789|3963588|FG000|NOT COMPLETED|Overall Study||2
3231877|NCT02350127|3963594|FG000|STARTED|4-Month Assessment||44
3231878|NCT02350127|3963595|FG001|STARTED|4-Month Assessment||44
3231879|NCT02350127|3963594|FG000|Completed Baseline|4-Month Assessment|Withdrew prior to baseline due to time constraints (n=1) and lack of interest (n=1)|42
3231880|NCT02350127|3963595|FG001|Completed Baseline|4-Month Assessment|Withdrew prior to baseline due to health issue (n=1)|43
3231881|NCT02350127|3963594|FG000|COMPLETED|4-Month Assessment||33
3231882|NCT02350127|3963595|FG001|COMPLETED|4-Month Assessment||35
3231883|NCT02350127|3963594|FG000|NOT COMPLETED|4-Month Assessment||11
3231884|NCT02350127|3963595|FG001|NOT COMPLETED|4-Month Assessment||9
3231885|NCT02350127|3963594|FG000|STARTED|8-Month Assessment||33
3231886|NCT02350127|3963595|FG001|STARTED|8-Month Assessment||35
3231887|NCT02350127|3963594|FG000|COMPLETED|8-Month Assessment||27
3231888|NCT02350127|3963595|FG001|COMPLETED|8-Month Assessment||26
3231889|NCT02350127|3963594|FG000|NOT COMPLETED|8-Month Assessment||6
3231890|NCT02350127|3963595|FG001|NOT COMPLETED|8-Month Assessment||9
3231891|NCT02350309|3963608|FG000|STARTED|Treatment Period 1 (2 Days)||12
3231892|NCT02350309|3963609|FG001|STARTED|Treatment Period 1 (2 Days)||11
3231893|NCT02350309|3963610|FG002|STARTED|Treatment Period 1 (2 Days)||11
3231894|NCT02350309|3963611|FG003|STARTED|Treatment Period 1 (2 Days)||11
3231895|NCT02350309|3963612|FG004|STARTED|Treatment Period 1 (2 Days)||12
3231896|NCT02350309|3963613|FG005|STARTED|Treatment Period 1 (2 Days)||12
3231897|NCT02350309|3963608|FG000|COMPLETED|Treatment Period 1 (2 Days)||12
3231898|NCT02350309|3963609|FG001|COMPLETED|Treatment Period 1 (2 Days)||11
3231899|NCT02350309|3963610|FG002|COMPLETED|Treatment Period 1 (2 Days)||10
3231900|NCT02350309|3963611|FG003|COMPLETED|Treatment Period 1 (2 Days)||11
3231901|NCT02350309|3963612|FG004|COMPLETED|Treatment Period 1 (2 Days)||12
3231902|NCT02350309|3963613|FG005|COMPLETED|Treatment Period 1 (2 Days)||12
3231903|NCT02350309|3963608|FG000|NOT COMPLETED|Treatment Period 1 (2 Days)||0
3231904|NCT02350309|3963609|FG001|NOT COMPLETED|Treatment Period 1 (2 Days)||0
3231905|NCT02350309|3963610|FG002|NOT COMPLETED|Treatment Period 1 (2 Days)||1
3231906|NCT02350309|3963611|FG003|NOT COMPLETED|Treatment Period 1 (2 Days)||0
3231907|NCT02350309|3963612|FG004|NOT COMPLETED|Treatment Period 1 (2 Days)||0
3231908|NCT02350309|3963613|FG005|NOT COMPLETED|Treatment Period 1 (2 Days)||0
3231909|NCT02350309|3963608|FG000|STARTED|Washout Period 1 (12-16 Days)||12
3231910|NCT02350309|3963609|FG001|STARTED|Washout Period 1 (12-16 Days)||11
3231911|NCT02350309|3963610|FG002|STARTED|Washout Period 1 (12-16 Days)||10
3231912|NCT02350309|3963611|FG003|STARTED|Washout Period 1 (12-16 Days)||11
3231913|NCT02350309|3963612|FG004|STARTED|Washout Period 1 (12-16 Days)||12
3231914|NCT02350309|3963613|FG005|STARTED|Washout Period 1 (12-16 Days)||12
3231915|NCT02350309|3963608|FG000|COMPLETED|Washout Period 1 (12-16 Days)||12
3231916|NCT02350309|3963609|FG001|COMPLETED|Washout Period 1 (12-16 Days)||11
3231917|NCT02350309|3963610|FG002|COMPLETED|Washout Period 1 (12-16 Days)||10
3231918|NCT02350309|3963611|FG003|COMPLETED|Washout Period 1 (12-16 Days)||11
3231919|NCT02350309|3963612|FG004|COMPLETED|Washout Period 1 (12-16 Days)||12
3231920|NCT02350309|3963613|FG005|COMPLETED|Washout Period 1 (12-16 Days)||12
3231921|NCT02350309|3963608|FG000|NOT COMPLETED|Washout Period 1 (12-16 Days)||0
3231922|NCT02350309|3963609|FG001|NOT COMPLETED|Washout Period 1 (12-16 Days)||0
3231923|NCT02350309|3963610|FG002|NOT COMPLETED|Washout Period 1 (12-16 Days)||0
3231924|NCT02350309|3963611|FG003|NOT COMPLETED|Washout Period 1 (12-16 Days)||0
3231925|NCT02350309|3963612|FG004|NOT COMPLETED|Washout Period 1 (12-16 Days)||0
3231926|NCT02350309|3963613|FG005|NOT COMPLETED|Washout Period 1 (12-16 Days)||0
3231927|NCT02350309|3963608|FG000|STARTED|Treatment Period 2 (2 Days)||12
3231928|NCT02350309|3963609|FG001|STARTED|Treatment Period 2 (2 Days)||11
3231929|NCT02350309|3963610|FG002|STARTED|Treatment Period 2 (2 Days)||10
3231930|NCT02350309|3963611|FG003|STARTED|Treatment Period 2 (2 Days)||11
3231931|NCT02350309|3963612|FG004|STARTED|Treatment Period 2 (2 Days)||12
3231932|NCT02350309|3963613|FG005|STARTED|Treatment Period 2 (2 Days)||12
3231933|NCT02350309|3963608|FG000|COMPLETED|Treatment Period 2 (2 Days)||12
3231934|NCT02350309|3963609|FG001|COMPLETED|Treatment Period 2 (2 Days)||11
3231935|NCT02350309|3963610|FG002|COMPLETED|Treatment Period 2 (2 Days)||10
3231936|NCT02350309|3963611|FG003|COMPLETED|Treatment Period 2 (2 Days)||11
3231937|NCT02350309|3963612|FG004|COMPLETED|Treatment Period 2 (2 Days)||12
3231938|NCT02350309|3963613|FG005|COMPLETED|Treatment Period 2 (2 Days)||12
3231939|NCT02350309|3963608|FG000|NOT COMPLETED|Treatment Period 2 (2 Days)||0
3231940|NCT02350309|3963609|FG001|NOT COMPLETED|Treatment Period 2 (2 Days)||0
3231941|NCT02350309|3963610|FG002|NOT COMPLETED|Treatment Period 2 (2 Days)||0
3231942|NCT02350309|3963611|FG003|NOT COMPLETED|Treatment Period 2 (2 Days)||0
3231943|NCT02350309|3963612|FG004|NOT COMPLETED|Treatment Period 2 (2 Days)||0
3231944|NCT02350309|3963613|FG005|NOT COMPLETED|Treatment Period 2 (2 Days)||0
3231945|NCT02350309|3963608|FG000|STARTED|Washout Period 2 (12-16 Days)||12
3231946|NCT02350309|3963609|FG001|STARTED|Washout Period 2 (12-16 Days)||11
3231947|NCT02350309|3963610|FG002|STARTED|Washout Period 2 (12-16 Days)||10
3231948|NCT02350309|3963611|FG003|STARTED|Washout Period 2 (12-16 Days)||11
3231949|NCT02350309|3963612|FG004|STARTED|Washout Period 2 (12-16 Days)||12
3231950|NCT02350309|3963613|FG005|STARTED|Washout Period 2 (12-16 Days)||12
3231951|NCT02350309|3963608|FG000|COMPLETED|Washout Period 2 (12-16 Days)||12
3231952|NCT02350309|3963609|FG001|COMPLETED|Washout Period 2 (12-16 Days)||11
3231953|NCT02350309|3963610|FG002|COMPLETED|Washout Period 2 (12-16 Days)||10
3231954|NCT02350309|3963611|FG003|COMPLETED|Washout Period 2 (12-16 Days)||11
3231955|NCT02350309|3963612|FG004|COMPLETED|Washout Period 2 (12-16 Days)||12
3231956|NCT02350309|3963613|FG005|COMPLETED|Washout Period 2 (12-16 Days)||12
3231957|NCT02350309|3963608|FG000|NOT COMPLETED|Washout Period 2 (12-16 Days)||0
3231958|NCT02350309|3963609|FG001|NOT COMPLETED|Washout Period 2 (12-16 Days)||0
3369173|NCT03821064|4100680|FG000|STARTED|Overall Study||11
3369174|NCT03821064|4100680|FG000|COMPLETED|Overall Study||10
3369175|NCT03821064|4100680|FG000|NOT COMPLETED|Overall Study||1
3369176|NCT03820544|4100686|FG000|STARTED|Overall Study||2
3369177|NCT03820544|4100687|FG001|STARTED|Overall Study||2
3369178|NCT03820544|4100686|FG000|COMPLETED|Overall Study||2
3369179|NCT03820544|4100687|FG001|COMPLETED|Overall Study||2
3369180|NCT03820544|4100686|FG000|NOT COMPLETED|Overall Study||0
3369181|NCT03820544|4100687|FG001|NOT COMPLETED|Overall Study||0
3369182|NCT03820024|4100695|FG000|STARTED|Overall Study||19
3369183|NCT03820024|4100696|FG001|STARTED|Overall Study||20
3369184|NCT03820024|4100695|FG000|COMPLETED|Overall Study||18
3369185|NCT03820024|4100696|FG001|COMPLETED|Overall Study||18
3369186|NCT03820024|4100695|FG000|NOT COMPLETED|Overall Study||1
3369187|NCT03820024|4100696|FG001|NOT COMPLETED|Overall Study||2
3369188|NCT03807544|4100702|FG000|STARTED|Overall Study||17
3369189|NCT03807544|4100702|FG000|COMPLETED|Overall Study||17
3369190|NCT03807544|4100702|FG000|NOT COMPLETED|Overall Study||0
3369191|NCT03809182|4100709|FG000|STARTED|Overall Study||20
3369192|NCT03809182|4100710|FG001|STARTED|Overall Study||20
3369193|NCT03809182|4100709|FG000|COMPLETED|Overall Study||20
3369194|NCT03809182|4100710|FG001|COMPLETED|Overall Study||20
3369195|NCT03809182|4100709|FG000|NOT COMPLETED|Overall Study||0
3369196|NCT03809182|4100710|FG001|NOT COMPLETED|Overall Study||0
3369197|NCT03816761|4100721|FG000|STARTED|First Treatment Period (7 Days)||4
3369198|NCT03816761|4100722|FG001|STARTED|First Treatment Period (7 Days)||4
3369199|NCT03816761|4100723|FG002|STARTED|First Treatment Period (7 Days)||4
3369200|NCT03816761|4100724|FG003|STARTED|First Treatment Period (7 Days)||4
3369201|NCT03816761|4100725|FG004|STARTED|First Treatment Period (7 Days)||4
3369202|NCT03816761|4100726|FG005|STARTED|First Treatment Period (7 Days)||4
3369203|NCT03816761|4100721|FG000|COMPLETED|First Treatment Period (7 Days)||4
3369204|NCT03816761|4100722|FG001|COMPLETED|First Treatment Period (7 Days)||4
3369205|NCT03816761|4100723|FG002|COMPLETED|First Treatment Period (7 Days)||4
3369206|NCT03816761|4100724|FG003|COMPLETED|First Treatment Period (7 Days)||4
3369207|NCT03816761|4100725|FG004|COMPLETED|First Treatment Period (7 Days)||4
3369208|NCT03816761|4100726|FG005|COMPLETED|First Treatment Period (7 Days)||3
3369209|NCT03816761|4100721|FG000|NOT COMPLETED|First Treatment Period (7 Days)||0
3369210|NCT03816761|4100722|FG001|NOT COMPLETED|First Treatment Period (7 Days)||0
3369211|NCT03816761|4100723|FG002|NOT COMPLETED|First Treatment Period (7 Days)||0
3369212|NCT03816761|4100724|FG003|NOT COMPLETED|First Treatment Period (7 Days)||0
3369213|NCT03816761|4100725|FG004|NOT COMPLETED|First Treatment Period (7 Days)||0
3369214|NCT03816761|4100726|FG005|NOT COMPLETED|First Treatment Period (7 Days)||1
3369215|NCT03816761|4100721|FG000|STARTED|Second Treatment Period (7 Days)||4
3369216|NCT03816761|4100722|FG001|STARTED|Second Treatment Period (7 Days)||4
3369217|NCT03816761|4100723|FG002|STARTED|Second Treatment Period (7 Days)||4
3231959|NCT02350309|3963610|FG002|NOT COMPLETED|Washout Period 2 (12-16 Days)||0
3231960|NCT02350309|3963611|FG003|NOT COMPLETED|Washout Period 2 (12-16 Days)||0
3231961|NCT02350309|3963612|FG004|NOT COMPLETED|Washout Period 2 (12-16 Days)||0
3231962|NCT02350309|3963613|FG005|NOT COMPLETED|Washout Period 2 (12-16 Days)||0
3231963|NCT02350309|3963608|FG000|STARTED|Treatment Period 3 (2 Days)||12
3231964|NCT02350309|3963609|FG001|STARTED|Treatment Period 3 (2 Days)||11
3231965|NCT02350309|3963610|FG002|STARTED|Treatment Period 3 (2 Days)||10
3369218|NCT03816761|4100724|FG003|STARTED|Second Treatment Period (7 Days)||4
3369219|NCT03816761|4100725|FG004|STARTED|Second Treatment Period (7 Days)||4
3369220|NCT03816761|4100726|FG005|STARTED|Second Treatment Period (7 Days)||3
3231966|NCT02350309|3963611|FG003|STARTED|Treatment Period 3 (2 Days)||11
3231967|NCT02350309|3963612|FG004|STARTED|Treatment Period 3 (2 Days)||12
3231968|NCT02350309|3963613|FG005|STARTED|Treatment Period 3 (2 Days)||12
3231969|NCT02350309|3963608|FG000|COMPLETED|Treatment Period 3 (2 Days)||12
3231970|NCT02350309|3963609|FG001|COMPLETED|Treatment Period 3 (2 Days)||11
3231971|NCT02350309|3963610|FG002|COMPLETED|Treatment Period 3 (2 Days)||10
3231972|NCT02350309|3963611|FG003|COMPLETED|Treatment Period 3 (2 Days)||11
3231973|NCT02350309|3963612|FG004|COMPLETED|Treatment Period 3 (2 Days)||12
3231974|NCT02350309|3963613|FG005|COMPLETED|Treatment Period 3 (2 Days)||12
3231975|NCT02350309|3963608|FG000|NOT COMPLETED|Treatment Period 3 (2 Days)||0
3231976|NCT02350309|3963609|FG001|NOT COMPLETED|Treatment Period 3 (2 Days)||0
3231977|NCT02350309|3963610|FG002|NOT COMPLETED|Treatment Period 3 (2 Days)||0
3231978|NCT02350309|3963611|FG003|NOT COMPLETED|Treatment Period 3 (2 Days)||0
3231979|NCT02350309|3963612|FG004|NOT COMPLETED|Treatment Period 3 (2 Days)||0
3231980|NCT02350309|3963613|FG005|NOT COMPLETED|Treatment Period 3 (2 Days)||0
3231981|NCT02350309|3963608|FG000|STARTED|Washout Period 3 (12-16 Days)||12
3231982|NCT02350309|3963609|FG001|STARTED|Washout Period 3 (12-16 Days)||11
3231983|NCT02350309|3963610|FG002|STARTED|Washout Period 3 (12-16 Days)||10
3231984|NCT02350309|3963611|FG003|STARTED|Washout Period 3 (12-16 Days)||11
3231985|NCT02350309|3963612|FG004|STARTED|Washout Period 3 (12-16 Days)||12
3231986|NCT02350309|3963613|FG005|STARTED|Washout Period 3 (12-16 Days)||12
3231987|NCT02350309|3963608|FG000|COMPLETED|Washout Period 3 (12-16 Days)||12
3231988|NCT02350309|3963609|FG001|COMPLETED|Washout Period 3 (12-16 Days)||11
3231989|NCT02350309|3963610|FG002|COMPLETED|Washout Period 3 (12-16 Days)||10
3231990|NCT02350309|3963611|FG003|COMPLETED|Washout Period 3 (12-16 Days)||11
3231991|NCT02350309|3963612|FG004|COMPLETED|Washout Period 3 (12-16 Days)||12
3231992|NCT02350309|3963613|FG005|COMPLETED|Washout Period 3 (12-16 Days)||12
3231993|NCT02350309|3963608|FG000|NOT COMPLETED|Washout Period 3 (12-16 Days)||0
3231994|NCT02350309|3963609|FG001|NOT COMPLETED|Washout Period 3 (12-16 Days)||0
3231995|NCT02350309|3963610|FG002|NOT COMPLETED|Washout Period 3 (12-16 Days)||0
3231996|NCT02350309|3963611|FG003|NOT COMPLETED|Washout Period 3 (12-16 Days)||0
3231997|NCT02350309|3963612|FG004|NOT COMPLETED|Washout Period 3 (12-16 Days)||0
3231998|NCT02350309|3963613|FG005|NOT COMPLETED|Washout Period 3 (12-16 Days)||0
3231999|NCT02350309|3963608|FG000|STARTED|Treatment Period 4 (2 Days)||12
3232000|NCT02350309|3963609|FG001|STARTED|Treatment Period 4 (2 Days)||11
3232001|NCT02350309|3963610|FG002|STARTED|Treatment Period 4 (2 Days)||10
3232002|NCT02350309|3963611|FG003|STARTED|Treatment Period 4 (2 Days)||11
3232003|NCT02350309|3963612|FG004|STARTED|Treatment Period 4 (2 Days)||12
3232004|NCT02350309|3963613|FG005|STARTED|Treatment Period 4 (2 Days)||12
3232005|NCT02350309|3963608|FG000|COMPLETED|Treatment Period 4 (2 Days)||12
3232006|NCT02350309|3963609|FG001|COMPLETED|Treatment Period 4 (2 Days)||11
3232007|NCT02350309|3963610|FG002|COMPLETED|Treatment Period 4 (2 Days)||10
3232008|NCT02350309|3963611|FG003|COMPLETED|Treatment Period 4 (2 Days)||11
3232009|NCT02350309|3963612|FG004|COMPLETED|Treatment Period 4 (2 Days)||12
3232010|NCT02350309|3963613|FG005|COMPLETED|Treatment Period 4 (2 Days)||11
3232011|NCT02350309|3963608|FG000|NOT COMPLETED|Treatment Period 4 (2 Days)||0
3232012|NCT02350309|3963609|FG001|NOT COMPLETED|Treatment Period 4 (2 Days)||0
3232013|NCT02350309|3963610|FG002|NOT COMPLETED|Treatment Period 4 (2 Days)||0
3232014|NCT02350309|3963611|FG003|NOT COMPLETED|Treatment Period 4 (2 Days)||0
3232015|NCT02350309|3963612|FG004|NOT COMPLETED|Treatment Period 4 (2 Days)||0
3232016|NCT02350309|3963613|FG005|NOT COMPLETED|Treatment Period 4 (2 Days)||1
3232017|NCT02350478|3963630|FG000|STARTED|Overall Study||25
3232018|NCT02350478|3963631|FG001|STARTED|Overall Study||24
3232019|NCT02350478|3963630|FG000|COMPLETED|Overall Study||20
3232020|NCT02350478|3963631|FG001|COMPLETED|Overall Study||23
3232021|NCT02350478|3963630|FG000|NOT COMPLETED|Overall Study||5
3232022|NCT02350478|3963631|FG001|NOT COMPLETED|Overall Study||1
3232023|NCT02350569|3963637|FG000|STARTED|Main Study (LDV/SOF 4 Weeks)||16
3232024|NCT02350569|3963637|FG000|COMPLETED|Main Study (LDV/SOF 4 Weeks)|1 participant discontinued treatment, but completed follow-up visits and study.|16
3232025|NCT02350569|3963637|FG000|NOT COMPLETED|Main Study (LDV/SOF 4 Weeks)||0
3232026|NCT02350569|3963637|FG000|STARTED|Retreatment (LDV/SOF 12 Weeks)|1 completed treatment (Main Study), experienced virologic failure, and entered Retreatment Phase|1
3232027|NCT02350569|3963637|FG000|COMPLETED|Retreatment (LDV/SOF 12 Weeks)||1
3232028|NCT02350569|3963637|FG000|NOT COMPLETED|Retreatment (LDV/SOF 12 Weeks)||0
3232029|NCT02350647|3963645|FG000|STARTED|Overall Study||32
3232030|NCT02350647|3963646|FG001|STARTED|Overall Study||32
3232031|NCT02350647|3963645|FG000|COMPLETED|Overall Study||26
3232032|NCT02350647|3963646|FG001|COMPLETED|Overall Study||26
3232033|NCT02350647|3963645|FG000|NOT COMPLETED|Overall Study||6
3232034|NCT02350647|3963646|FG001|NOT COMPLETED|Overall Study||6
3232035|NCT02350660|3963654|FG000|STARTED|Overall Study||7
3232036|NCT02350660|3963655|FG001|STARTED|Overall Study||17
3232037|NCT02350660|3963654|FG000|COMPLETED|Overall Study||7
3232038|NCT02350660|3963655|FG001|COMPLETED|Overall Study||17
3232039|NCT02350660|3963654|FG000|NOT COMPLETED|Overall Study||0
3232040|NCT02350660|3963655|FG001|NOT COMPLETED|Overall Study||0
3232041|NCT02350816|3963665|FG000|STARTED|Overall Study||7
3232042|NCT02350816|3963666|FG001|STARTED|Overall Study||6
3232043|NCT02350816|3963667|FG002|STARTED|Overall Study||2
3232044|NCT02350816|3963668|FG003|STARTED|Overall Study||2
3232045|NCT02350816|3963665|FG000|COMPLETED|Overall Study||7
3232046|NCT02350816|3963666|FG001|COMPLETED|Overall Study||6
3232047|NCT02350816|3963667|FG002|COMPLETED|Overall Study||2
3232048|NCT02350816|3963668|FG003|COMPLETED|Overall Study||2
3232049|NCT02350816|3963665|FG000|NOT COMPLETED|Overall Study||0
3232050|NCT02350816|3963666|FG001|NOT COMPLETED|Overall Study||0
3232051|NCT02350816|3963667|FG002|NOT COMPLETED|Overall Study||0
3232052|NCT02350816|3963668|FG003|NOT COMPLETED|Overall Study||0
3232053|NCT02350881|3963678|FG000|STARTED|Overall Study|64 patients were included (6 bilateral)|64
3232054|NCT02350881|3963678|FG000|COMPLETED|Overall Study|64 patients were completed (6 bilateral)|64
3232055|NCT02350881|3963678|FG000|NOT COMPLETED|Overall Study||0
3232056|NCT02350998|3963703|FG000|STARTED|Overall Study||33
3232057|NCT02350998|3963703|FG000|COMPLETED|Overall Study||33
3232058|NCT02350998|3963703|FG000|NOT COMPLETED|Overall Study||0
3232059|NCT02351037|3963712|FG000|STARTED|Overall Study||7
3232060|NCT02351037|3963713|FG001|STARTED|Overall Study||21
3232061|NCT02351037|3963714|FG002|STARTED|Overall Study||8
3232062|NCT02351037|3963712|FG000|COMPLETED|Overall Study||7
3232063|NCT02351037|3963713|FG001|COMPLETED|Overall Study||21
3232064|NCT02351037|3963714|FG002|COMPLETED|Overall Study||8
3232065|NCT02351037|3963712|FG000|NOT COMPLETED|Overall Study||0
3232066|NCT02351037|3963713|FG001|NOT COMPLETED|Overall Study||0
3232067|NCT02351037|3963714|FG002|NOT COMPLETED|Overall Study||0
3232068|NCT02351115|3963727|FG000|STARTED|Overall Study||1
3232069|NCT02351115|3963728|FG001|STARTED|Overall Study||1
3232070|NCT02351115|3963729|FG002|STARTED|Overall Study||1
3232071|NCT02351115|3963730|FG003|STARTED|Overall Study||1
3232072|NCT02351115|3963731|FG004|STARTED|Overall Study||1
3232073|NCT02351115|3963727|FG000|COMPLETED|Overall Study||1
3232074|NCT02351115|3963728|FG001|COMPLETED|Overall Study||1
3232075|NCT02351115|3963729|FG002|COMPLETED|Overall Study||1
3232076|NCT02351115|3963730|FG003|COMPLETED|Overall Study||1
3232077|NCT02351115|3963731|FG004|COMPLETED|Overall Study||1
3232078|NCT02351115|3963727|FG000|NOT COMPLETED|Overall Study||0
3232079|NCT02351115|3963728|FG001|NOT COMPLETED|Overall Study||0
3232080|NCT02351115|3963729|FG002|NOT COMPLETED|Overall Study||0
3232081|NCT02351115|3963730|FG003|NOT COMPLETED|Overall Study||0
3232082|NCT02351115|3963731|FG004|NOT COMPLETED|Overall Study||0
3232083|NCT02351167|3963747|FG000|STARTED|Overall Study||275
3232084|NCT02351167|3963748|FG001|STARTED|Overall Study||274
3232085|NCT02351167|3963749|FG002|STARTED|Overall Study||273
3232086|NCT02351167|3963747|FG000|COMPLETED|Overall Study||256
3232087|NCT02351167|3963748|FG001|COMPLETED|Overall Study||256
3232088|NCT02351167|3963749|FG002|COMPLETED|Overall Study||252
3232089|NCT02351167|3963747|FG000|NOT COMPLETED|Overall Study||19
3232090|NCT02351167|3963748|FG001|NOT COMPLETED|Overall Study||18
3232091|NCT02351167|3963749|FG002|NOT COMPLETED|Overall Study||21
3232092|NCT02351258|3963758|FG000|STARTED|Intervention 1 (12 Months)|Number of participants is not available for this study, only clinic-level data collected.|
3232093|NCT02351258|3963759|FG001|STARTED|Intervention 1 (12 Months)|Number of participants is not available for this study, only clinic-level data collected.|
3232094|NCT02351258|3963758|FG000|COMPLETED|Intervention 1 (12 Months)|Number of participants is not available for this study, only clinic-level data collected.|
3232095|NCT02351258|3963759|FG001|COMPLETED|Intervention 1 (12 Months)|Number of participants is not available for this study, only clinic-level data collected.|
3232096|NCT02351258|3963758|FG000|NOT COMPLETED|Intervention 1 (12 Months)||
3232097|NCT02351258|3963759|FG001|NOT COMPLETED|Intervention 1 (12 Months)||
3232098|NCT02351258|3963758|FG000|STARTED|Washout (2-3 Months)|Number of participants is not available for this study, only clinic-level data collected.|
3232099|NCT02351258|3963759|FG001|STARTED|Washout (2-3 Months)|Number of participants is not available for this study, only clinic-level data collected.|
3232100|NCT02351258|3963758|FG000|COMPLETED|Washout (2-3 Months)|Number of participants is not available for this study, only clinic-level data collected.|
3232101|NCT02351258|3963759|FG001|COMPLETED|Washout (2-3 Months)|Number of participants is not available for this study, only clinic-level data collected.|
3232102|NCT02351258|3963758|FG000|NOT COMPLETED|Washout (2-3 Months)||
3232103|NCT02351258|3963759|FG001|NOT COMPLETED|Washout (2-3 Months)||
3232104|NCT02351258|3963758|FG000|STARTED|Intervention 2 (12 Months)|Number of participants is not available for this study, only clinic-level data collected.|
3232105|NCT02351258|3963759|FG001|STARTED|Intervention 2 (12 Months)|Number of participants is not available for this study, only clinic-level data collected.|
3232106|NCT02351258|3963758|FG000|COMPLETED|Intervention 2 (12 Months)|Number of participants is not available for this study, only clinic-level data collected.|
3232107|NCT02351258|3963759|FG001|COMPLETED|Intervention 2 (12 Months)|Number of participants is not available for this study, only clinic-level data collected.|
3232108|NCT02351258|3963758|FG000|NOT COMPLETED|Intervention 2 (12 Months)||
3232109|NCT02351258|3963759|FG001|NOT COMPLETED|Intervention 2 (12 Months)||
3232110|NCT02351271|3963766|FG000|STARTED|Overall Study||68
3232111|NCT02351271|3963767|FG001|STARTED|Overall Study||62
3232112|NCT02351271|3963766|FG000|COMPLETED|Overall Study||68
3232113|NCT02351271|3963767|FG001|COMPLETED|Overall Study||62
3232114|NCT02351271|3963766|FG000|NOT COMPLETED|Overall Study||0
3232115|NCT02351271|3963767|FG001|NOT COMPLETED|Overall Study||0
3232116|NCT02351349|3963777|FG000|STARTED|Overall Study||6
3232117|NCT02351349|3963778|FG001|STARTED|Overall Study||8
3232118|NCT02351349|3963777|FG000|COMPLETED|Overall Study||4
3232119|NCT02351349|3963778|FG001|COMPLETED|Overall Study||5
3232120|NCT02351349|3963777|FG000|NOT COMPLETED|Overall Study||2
3232121|NCT02351349|3963778|FG001|NOT COMPLETED|Overall Study||3
3232122|NCT02351505|3963789|FG000|STARTED|Overall Study||1
3232123|NCT02351505|3963789|FG000|COMPLETED|Overall Study||1
3232124|NCT02351505|3963789|FG000|NOT COMPLETED|Overall Study||0
3232125|NCT02351700|3963796|FG000|STARTED|Overall Study||28
3232126|NCT02351700|3963797|FG001|STARTED|Overall Study||34
3232127|NCT02351700|3963796|FG000|COMPLETED|Overall Study||28
3232128|NCT02351700|3963797|FG001|COMPLETED|Overall Study||34
3232129|NCT02351700|3963796|FG000|NOT COMPLETED|Overall Study||0
3232130|NCT02351700|3963797|FG001|NOT COMPLETED|Overall Study||0
3232131|NCT02351739|3963807|FG000|STARTED|Overall Study||38
3232132|NCT02351739|3963808|FG001|STARTED|Overall Study||40
3232133|NCT02351739|3963807|FG000|Enrolled|Overall Study||38
3232134|NCT02351739|3963808|FG001|Enrolled|Overall Study||40
3232135|NCT02351739|3963807|FG000|Received Study Medication|Overall Study||35
3232136|NCT02351739|3963808|FG001|Received Study Medication|Overall Study||40
3232137|NCT02351739|3963807|FG000|Discontinued Study|Overall Study||38
3232138|NCT02351739|3963808|FG001|Discontinued Study|Overall Study||40
3232139|NCT02351739|3963807|FG000|COMPLETED|Overall Study||0
3232140|NCT02351739|3963808|FG001|COMPLETED|Overall Study||0
3232141|NCT02351739|3963807|FG000|NOT COMPLETED|Overall Study||38
3232142|NCT02351739|3963808|FG001|NOT COMPLETED|Overall Study||40
3232143|NCT02351817|3963814|FG000|STARTED|Baseline Period||5
3232144|NCT02351817|3963815|FG001|STARTED|Baseline Period||5
3232145|NCT02351817|3963814|FG000|COMPLETED|Baseline Period||5
3232146|NCT02351817|3963815|FG001|COMPLETED|Baseline Period||5
3232147|NCT02351817|3963814|FG000|NOT COMPLETED|Baseline Period||0
3232148|NCT02351817|3963815|FG001|NOT COMPLETED|Baseline Period||0
3232149|NCT02351817|3963814|FG000|STARTED|Period 1||5
3232150|NCT02351817|3963815|FG001|STARTED|Period 1||5
3232151|NCT02351817|3963814|FG000|COMPLETED|Period 1||4
3232152|NCT02351817|3963815|FG001|COMPLETED|Period 1||2
3232153|NCT02351817|3963814|FG000|NOT COMPLETED|Period 1||1
3232154|NCT02351817|3963815|FG001|NOT COMPLETED|Period 1||3
3232155|NCT02351817|3963814|FG000|STARTED|Period 2|Subjects who did not complete Period 1 as planned were allowed to continue to Period 2|5
3232156|NCT02351817|3963815|FG001|STARTED|Period 2|Subjects who did not complete Period 1 as planned were allowed to continue to Period 2|5
3232157|NCT02351817|3963814|FG000|COMPLETED|Period 2||4
3232158|NCT02351817|3963815|FG001|COMPLETED|Period 2||3
3232159|NCT02351817|3963814|FG000|NOT COMPLETED|Period 2||1
3232160|NCT02351817|3963815|FG001|NOT COMPLETED|Period 2||2
3232161|NCT02351934|3963824|FG000|STARTED|Allocation||62
3232162|NCT02351934|3963825|FG001|STARTED|Allocation||61
3232163|NCT02351934|3963824|FG000|Received Allocation|Allocation||56
3232164|NCT02351934|3963825|FG001|Received Allocation|Allocation||61
3232165|NCT02351934|3963824|FG000|COMPLETED|Allocation||56
3232166|NCT02351934|3963825|FG001|COMPLETED|Allocation||61
3232167|NCT02351934|3963824|FG000|NOT COMPLETED|Allocation||6
3232168|NCT02351934|3963825|FG001|NOT COMPLETED|Allocation||0
3232169|NCT02351934|3963824|FG000|STARTED|Follow-Up||56
3232170|NCT02351934|3963825|FG001|STARTED|Follow-Up||61
3232171|NCT02351934|3963824|FG000|COMPLETED|Follow-Up||44
3232172|NCT02351934|3963825|FG001|COMPLETED|Follow-Up||51
3232173|NCT02351934|3963824|FG000|NOT COMPLETED|Follow-Up||12
3232174|NCT02351934|3963825|FG001|NOT COMPLETED|Follow-Up||10
3232175|NCT02351960|3963833|FG000|STARTED|Overall Study||208
3232176|NCT02351960|3963834|FG001|STARTED|Overall Study||88
3232177|NCT02351960|3963833|FG000|COMPLETED|Overall Study||197
3232178|NCT02351960|3963834|FG001|COMPLETED|Overall Study||76
3232179|NCT02351960|3963833|FG000|NOT COMPLETED|Overall Study||11
3232180|NCT02351960|3963834|FG001|NOT COMPLETED|Overall Study||12
3232181|NCT02352090|3963844|FG000|STARTED|Overall Study||20
3232182|NCT02352090|3963845|FG001|STARTED|Overall Study||20
3232183|NCT02352090|3963846|FG002|STARTED|Overall Study||19
3232184|NCT02352090|3963844|FG000|COMPLETED|Overall Study||19
3232185|NCT02352090|3963845|FG001|COMPLETED|Overall Study||20
3232186|NCT02352090|3963846|FG002|COMPLETED|Overall Study||17
3232187|NCT02352090|3963844|FG000|NOT COMPLETED|Overall Study||1
3232188|NCT02352090|3963845|FG001|NOT COMPLETED|Overall Study||0
3232189|NCT02352090|3963846|FG002|NOT COMPLETED|Overall Study||2
3232190|NCT02352259|3963854|FG000|STARTED|Overall Study||23
3232191|NCT02352259|3963854|FG000|COMPLETED|Overall Study||23
3232192|NCT02352259|3963854|FG000|NOT COMPLETED|Overall Study||0
3232193|NCT02352298|3963858|FG000|STARTED|Overall Study||52
3232194|NCT02352298|3963858|FG000|COMPLETED|Overall Study||52
3232195|NCT02352298|3963858|FG000|NOT COMPLETED|Overall Study||0
3232196|NCT02352363|3963865|FG000|STARTED|Overall Study||278
3232197|NCT02352363|3963866|FG001|STARTED|Overall Study||130
3232198|NCT02352363|3963865|FG000|COMPLETED|Overall Study||271
3232199|NCT02352363|3963866|FG001|COMPLETED|Overall Study||127
3232200|NCT02352363|3963865|FG000|NOT COMPLETED|Overall Study||7
3232201|NCT02352363|3963866|FG001|NOT COMPLETED|Overall Study||3
3232202|NCT02352493|3963890|FG000|STARTED|Overall Study||8
3232203|NCT02352493|3963891|FG001|STARTED|Overall Study||3
3232204|NCT02352493|3963892|FG002|STARTED|Overall Study||3
3232205|NCT02352493|3963893|FG003|STARTED|Overall Study||3
3232206|NCT02352493|3963894|FG004|STARTED|Overall Study||3
3232207|NCT02352493|3963895|FG005|STARTED|Overall Study||3
3232208|NCT02352493|3963896|FG006|STARTED|Overall Study||3
3232209|NCT02352493|3963897|FG007|STARTED|Overall Study||3
3232210|NCT02352493|3963898|FG008|STARTED|Overall Study||3
3232211|NCT02352493|3963899|FG009|STARTED|Overall Study||6
3232212|NCT02352493|3963900|FG010|STARTED|Overall Study||3
3232213|NCT02352493|3963901|FG011|STARTED|Overall Study||3
3232214|NCT02352493|3963902|FG012|STARTED|Overall Study||3
3232215|NCT02352493|3963903|FG013|STARTED|Overall Study||3
3232216|NCT02352493|3963904|FG014|STARTED|Overall Study||3
3232217|NCT02352493|3963905|FG015|STARTED|Overall Study||3
3232218|NCT02352493|3963906|FG016|STARTED|Overall Study||3
3232219|NCT02352493|3963907|FG017|STARTED|Overall Study||3
3232220|NCT02352493|3963890|FG000|COMPLETED|Overall Study||8
3232221|NCT02352493|3963891|FG001|COMPLETED|Overall Study||3
3232222|NCT02352493|3963892|FG002|COMPLETED|Overall Study||3
3232223|NCT02352493|3963893|FG003|COMPLETED|Overall Study||3
3232224|NCT02352493|3963894|FG004|COMPLETED|Overall Study||3
3232225|NCT02352493|3963895|FG005|COMPLETED|Overall Study||3
3232226|NCT02352493|3963896|FG006|COMPLETED|Overall Study||2
3232227|NCT02352493|3963897|FG007|COMPLETED|Overall Study||3
3232228|NCT02352493|3963898|FG008|COMPLETED|Overall Study||1
3232229|NCT02352493|3963899|FG009|COMPLETED|Overall Study||5
3232230|NCT02352493|3963900|FG010|COMPLETED|Overall Study||3
3232231|NCT02352493|3963901|FG011|COMPLETED|Overall Study||3
3232232|NCT02352493|3963902|FG012|COMPLETED|Overall Study||2
3232233|NCT02352493|3963903|FG013|COMPLETED|Overall Study||1
3232234|NCT02352493|3963904|FG014|COMPLETED|Overall Study||2
3232235|NCT02352493|3963905|FG015|COMPLETED|Overall Study||3
3232236|NCT02352493|3963906|FG016|COMPLETED|Overall Study||3
3369221|NCT03816761|4100721|FG000|COMPLETED|Second Treatment Period (7 Days)||4
3369222|NCT03816761|4100722|FG001|COMPLETED|Second Treatment Period (7 Days)||4
3369223|NCT03816761|4100723|FG002|COMPLETED|Second Treatment Period (7 Days)||4
3369224|NCT03816761|4100724|FG003|COMPLETED|Second Treatment Period (7 Days)||3
3369225|NCT03816761|4100725|FG004|COMPLETED|Second Treatment Period (7 Days)||4
3369226|NCT03816761|4100726|FG005|COMPLETED|Second Treatment Period (7 Days)||3
3369227|NCT03816761|4100721|FG000|NOT COMPLETED|Second Treatment Period (7 Days)||0
3369228|NCT03816761|4100722|FG001|NOT COMPLETED|Second Treatment Period (7 Days)||0
3369229|NCT03816761|4100723|FG002|NOT COMPLETED|Second Treatment Period (7 Days)||0
3369230|NCT03816761|4100724|FG003|NOT COMPLETED|Second Treatment Period (7 Days)||1
3369231|NCT03816761|4100725|FG004|NOT COMPLETED|Second Treatment Period (7 Days)||0
3369232|NCT03816761|4100726|FG005|NOT COMPLETED|Second Treatment Period (7 Days)||0
3369233|NCT03801044|4100748|FG000|STARTED|Overall Study||21
3369234|NCT03801044|4100748|FG000|COMPLETED|Overall Study||21
3369235|NCT03801044|4100748|FG000|NOT COMPLETED|Overall Study||0
3369236|NCT03805672|4100758|FG000|STARTED|Overall Study||2
3369237|NCT03805672|4100759|FG001|STARTED|Overall Study||2
3369238|NCT03805672|4100758|FG000|COMPLETED|Overall Study||2
3369239|NCT03805672|4100759|FG001|COMPLETED|Overall Study||2
3369240|NCT03805672|4100758|FG000|NOT COMPLETED|Overall Study||0
3369241|NCT03805672|4100759|FG001|NOT COMPLETED|Overall Study||0
3369242|NCT03808493|4100769|FG000|STARTED|Overall Study||12
3369243|NCT03808493|4100770|FG001|STARTED|Overall Study||12
3369244|NCT03808493|4100771|FG002|STARTED|Overall Study||12
3369245|NCT03808493|4100772|FG003|STARTED|Overall Study||12
3369246|NCT03808493|4100769|FG000|COMPLETED|Overall Study||12
3369247|NCT03808493|4100770|FG001|COMPLETED|Overall Study||12
3369248|NCT03808493|4100771|FG002|COMPLETED|Overall Study||12
3369249|NCT03808493|4100772|FG003|COMPLETED|Overall Study||12
3369250|NCT03808493|4100769|FG000|NOT COMPLETED|Overall Study||0
3369251|NCT03808493|4100770|FG001|NOT COMPLETED|Overall Study||0
3369252|NCT03808493|4100771|FG002|NOT COMPLETED|Overall Study||0
3369253|NCT03808493|4100772|FG003|NOT COMPLETED|Overall Study||0
3369254|NCT03815292|4100784|FG000|STARTED|Overall Study||135
3369255|NCT03815292|4100785|FG001|STARTED|Overall Study||140
3369256|NCT03815292|4100784|FG000|COMPLETED|Overall Study||135
3369257|NCT03815292|4100785|FG001|COMPLETED|Overall Study||140
3369258|NCT03815292|4100784|FG000|NOT COMPLETED|Overall Study||0
3369259|NCT03815292|4100785|FG001|NOT COMPLETED|Overall Study||0
3369260|NCT03812510|4100791|FG000|STARTED|Overall Study||426
3369261|NCT03812510|4100791|FG000|COMPLETED|Overall Study||274
3369262|NCT03812510|4100791|FG000|NOT COMPLETED|Overall Study||152
3369263|NCT03802994|4100801|FG000|STARTED|Overall Study||9
3369264|NCT03802994|4100802|FG001|STARTED|Overall Study||12
3369265|NCT03802994|4100803|FG002|STARTED|Overall Study||15
3369266|NCT03802994|4100804|FG003|STARTED|Overall Study||11
3369267|NCT03802994|4100805|FG004|STARTED|Overall Study||10
3369268|NCT03802994|4100801|FG000|COMPLETED|Overall Study||9
3369269|NCT03802994|4100802|FG001|COMPLETED|Overall Study||10
3369270|NCT03802994|4100803|FG002|COMPLETED|Overall Study||12
3369271|NCT03802994|4100804|FG003|COMPLETED|Overall Study||9
3369272|NCT03802994|4100805|FG004|COMPLETED|Overall Study||8
3369273|NCT03802994|4100801|FG000|NOT COMPLETED|Overall Study||0
3369274|NCT03802994|4100802|FG001|NOT COMPLETED|Overall Study||2
3369275|NCT03802994|4100803|FG002|NOT COMPLETED|Overall Study||3
3369276|NCT03802994|4100804|FG003|NOT COMPLETED|Overall Study||2
3369277|NCT03802994|4100805|FG004|NOT COMPLETED|Overall Study||2
3369278|NCT03810183|4100830|FG000|STARTED|Overall Study||6
3369279|NCT03810183|4100831|FG001|STARTED|Overall Study||3
3369280|NCT03810183|4100830|FG000|COMPLETED|Overall Study||4
3369281|NCT03810183|4100831|FG001|COMPLETED|Overall Study||2
3369282|NCT03810183|4100830|FG000|NOT COMPLETED|Overall Study||2
3369283|NCT03810183|4100831|FG001|NOT COMPLETED|Overall Study||1
3369284|NCT03809910|4100838|FG000|STARTED|Period 1 (Visit 2)||20
3369285|NCT03809910|4100839|FG001|STARTED|Period 1 (Visit 2)||19
3369286|NCT03809910|4100838|FG000|COMPLETED|Period 1 (Visit 2)||20
3369287|NCT03809910|4100839|FG001|COMPLETED|Period 1 (Visit 2)||19
3369288|NCT03809910|4100838|FG000|NOT COMPLETED|Period 1 (Visit 2)||0
3369289|NCT03809910|4100839|FG001|NOT COMPLETED|Period 1 (Visit 2)||0
3369290|NCT03809910|4100838|FG000|STARTED|Washout Period 1 (3 Days)||20
3369291|NCT03809910|4100839|FG001|STARTED|Washout Period 1 (3 Days)||19
3232237|NCT02352493|3963907|FG017|COMPLETED|Overall Study||3
3369292|NCT03809910|4100838|FG000|COMPLETED|Washout Period 1 (3 Days)||20
3232238|NCT02352493|3963890|FG000|NOT COMPLETED|Overall Study||0
3232239|NCT02352493|3963891|FG001|NOT COMPLETED|Overall Study||0
3232240|NCT02352493|3963892|FG002|NOT COMPLETED|Overall Study||0
3232241|NCT02352493|3963893|FG003|NOT COMPLETED|Overall Study||0
3232242|NCT02352493|3963894|FG004|NOT COMPLETED|Overall Study||0
3232243|NCT02352493|3963895|FG005|NOT COMPLETED|Overall Study||0
3232244|NCT02352493|3963896|FG006|NOT COMPLETED|Overall Study||1
3232245|NCT02352493|3963897|FG007|NOT COMPLETED|Overall Study||0
3232246|NCT02352493|3963898|FG008|NOT COMPLETED|Overall Study||2
3232247|NCT02352493|3963899|FG009|NOT COMPLETED|Overall Study||1
3232248|NCT02352493|3963900|FG010|NOT COMPLETED|Overall Study||0
3232249|NCT02352493|3963901|FG011|NOT COMPLETED|Overall Study||0
3232250|NCT02352493|3963902|FG012|NOT COMPLETED|Overall Study||1
3232251|NCT02352493|3963903|FG013|NOT COMPLETED|Overall Study||2
3232252|NCT02352493|3963904|FG014|NOT COMPLETED|Overall Study||1
3232253|NCT02352493|3963905|FG015|NOT COMPLETED|Overall Study||0
3232254|NCT02352493|3963906|FG016|NOT COMPLETED|Overall Study||0
3232255|NCT02352493|3963907|FG017|NOT COMPLETED|Overall Study||0
3232256|NCT02352779|3963965|FG000|STARTED|Overall Study||37
3232257|NCT02352779|3963966|FG001|STARTED|Overall Study||36
3232258|NCT02352779|3963967|FG002|STARTED|Overall Study||35
3232259|NCT02352779|3963965|FG000|COMPLETED|Overall Study||29
3232260|NCT02352779|3963966|FG001|COMPLETED|Overall Study||35
3232261|NCT02352779|3963967|FG002|COMPLETED|Overall Study||33
3232262|NCT02352779|3963965|FG000|NOT COMPLETED|Overall Study||8
3232263|NCT02352779|3963966|FG001|NOT COMPLETED|Overall Study||1
3232264|NCT02352779|3963967|FG002|NOT COMPLETED|Overall Study||2
3232265|NCT02352831|3963977|FG000|STARTED|Overall Study||6
3232266|NCT02352831|3963978|FG001|STARTED|Overall Study||10
3232267|NCT02352831|3963977|FG000|COMPLETED|Overall Study||6
3232268|NCT02352831|3963978|FG001|COMPLETED|Overall Study||10
3232269|NCT02352831|3963977|FG000|NOT COMPLETED|Overall Study||0
3232270|NCT02352831|3963978|FG001|NOT COMPLETED|Overall Study||0
3232271|NCT02352844|3963986|FG000|STARTED|Overall Study||12
3232272|NCT02352844|3963986|FG000|COMPLETED|Overall Study||12
3232273|NCT02352844|3963986|FG000|NOT COMPLETED|Overall Study||0
3232274|NCT02352922|3963992|FG000|STARTED|Overall Study||32
3232275|NCT02352922|3963993|FG001|STARTED|Overall Study||32
3232276|NCT02352922|3963992|FG000|COMPLETED|Overall Study|completed POD14 Survey|28
3232277|NCT02352922|3963993|FG001|COMPLETED|Overall Study|Completed POD14 survey|28
3232278|NCT02352922|3963992|FG000|NOT COMPLETED|Overall Study||4
3232279|NCT02352922|3963993|FG001|NOT COMPLETED|Overall Study||4
3232280|NCT02352974|3963999|FG000|STARTED|Main Study||12
3232281|NCT02352974|3963999|FG000|COMPLETED|Main Study||12
3232282|NCT02352974|3963999|FG000|NOT COMPLETED|Main Study||0
3232283|NCT02352974|3963999|FG000|STARTED|Extension|Only 3 out of the 12 patients who completed the main study continued in to the extension period.|3
3232284|NCT02352974|3963999|FG000|COMPLETED|Extension||3
3232285|NCT02352974|3963999|FG000|NOT COMPLETED|Extension||0
3232286|NCT02353091|3964005|FG000|STARTED|Overall Study||13
3232287|NCT02353091|3964006|FG001|STARTED|Overall Study||13
3232288|NCT02353091|3964005|FG000|COMPLETED|Overall Study||13
3232289|NCT02353091|3964006|FG001|COMPLETED|Overall Study||13
3232290|NCT02353091|3964005|FG000|NOT COMPLETED|Overall Study||0
3232291|NCT02353091|3964006|FG001|NOT COMPLETED|Overall Study||0
3232292|NCT02353169|3964025|FG000|STARTED|Overall Study||15
3232293|NCT02353169|3964026|FG001|STARTED|Overall Study||18
3232294|NCT02353169|3964027|FG002|STARTED|Overall Study||16
3232295|NCT02353169|3964028|FG003|STARTED|Overall Study||15
3232296|NCT02353169|3964025|FG000|COMPLETED|Overall Study||12
3232297|NCT02353169|3964026|FG001|COMPLETED|Overall Study||12
3232298|NCT02353169|3964027|FG002|COMPLETED|Overall Study||12
3232299|NCT02353169|3964028|FG003|COMPLETED|Overall Study||12
3232300|NCT02353169|3964025|FG000|NOT COMPLETED|Overall Study||3
3232301|NCT02353169|3964026|FG001|NOT COMPLETED|Overall Study||6
3232302|NCT02353169|3964027|FG002|NOT COMPLETED|Overall Study||4
3232303|NCT02353169|3964028|FG003|NOT COMPLETED|Overall Study||3
3232304|NCT02353299|3964038|FG000|STARTED|First Intervention (1 Night)||13
3232305|NCT02353299|3964039|FG001|STARTED|First Intervention (1 Night)||13
3232306|NCT02353299|3964040|FG002|STARTED|First Intervention (1 Night)||13
3232307|NCT02353299|3964041|FG003|STARTED|First Intervention (1 Night)||13
3232308|NCT02353299|3964038|FG000|COMPLETED|First Intervention (1 Night)||13
3232309|NCT02353299|3964039|FG001|COMPLETED|First Intervention (1 Night)||13
3232310|NCT02353299|3964040|FG002|COMPLETED|First Intervention (1 Night)||13
3232311|NCT02353299|3964041|FG003|COMPLETED|First Intervention (1 Night)||13
3232312|NCT02353299|3964038|FG000|NOT COMPLETED|First Intervention (1 Night)||0
3232313|NCT02353299|3964039|FG001|NOT COMPLETED|First Intervention (1 Night)||0
3232314|NCT02353299|3964040|FG002|NOT COMPLETED|First Intervention (1 Night)||0
3232315|NCT02353299|3964041|FG003|NOT COMPLETED|First Intervention (1 Night)||0
3232316|NCT02353299|3964038|FG000|STARTED|Second Intervention (1 Night)||13
3232317|NCT02353299|3964039|FG001|STARTED|Second Intervention (1 Night)||13
3232318|NCT02353299|3964040|FG002|STARTED|Second Intervention (1 Night)||13
3232319|NCT02353299|3964041|FG003|STARTED|Second Intervention (1 Night)||13
3232320|NCT02353299|3964038|FG000|COMPLETED|Second Intervention (1 Night)||13
3232321|NCT02353299|3964039|FG001|COMPLETED|Second Intervention (1 Night)||13
3232322|NCT02353299|3964040|FG002|COMPLETED|Second Intervention (1 Night)||13
3232323|NCT02353299|3964041|FG003|COMPLETED|Second Intervention (1 Night)||13
3232324|NCT02353299|3964038|FG000|NOT COMPLETED|Second Intervention (1 Night)||0
3232325|NCT02353299|3964039|FG001|NOT COMPLETED|Second Intervention (1 Night)||0
3232326|NCT02353299|3964040|FG002|NOT COMPLETED|Second Intervention (1 Night)||0
3232327|NCT02353299|3964041|FG003|NOT COMPLETED|Second Intervention (1 Night)||0
3232328|NCT02353299|3964038|FG000|STARTED|Third Intervention (1 Night)||13
3232329|NCT02353299|3964039|FG001|STARTED|Third Intervention (1 Night)||13
3232330|NCT02353299|3964040|FG002|STARTED|Third Intervention (1 Night)||13
3232331|NCT02353299|3964041|FG003|STARTED|Third Intervention (1 Night)||13
3232332|NCT02353299|3964038|FG000|COMPLETED|Third Intervention (1 Night)||13
3232333|NCT02353299|3964039|FG001|COMPLETED|Third Intervention (1 Night)||13
3232334|NCT02353299|3964040|FG002|COMPLETED|Third Intervention (1 Night)||13
3232335|NCT02353299|3964041|FG003|COMPLETED|Third Intervention (1 Night)||13
3232336|NCT02353299|3964038|FG000|NOT COMPLETED|Third Intervention (1 Night)||0
3232337|NCT02353299|3964039|FG001|NOT COMPLETED|Third Intervention (1 Night)||0
3232338|NCT02353299|3964040|FG002|NOT COMPLETED|Third Intervention (1 Night)||0
3232339|NCT02353299|3964041|FG003|NOT COMPLETED|Third Intervention (1 Night)||0
3232340|NCT02353299|3964038|FG000|STARTED|Fourth Intervention (1 Night)||13
3232341|NCT02353299|3964039|FG001|STARTED|Fourth Intervention (1 Night)|One patient withdrawn from study prior to start of fourth intervention.|12
3232342|NCT02353299|3964040|FG002|STARTED|Fourth Intervention (1 Night)||13
3232343|NCT02353299|3964041|FG003|STARTED|Fourth Intervention (1 Night)||13
3232344|NCT02353299|3964038|FG000|COMPLETED|Fourth Intervention (1 Night)||13
3232345|NCT02353299|3964039|FG001|COMPLETED|Fourth Intervention (1 Night)||12
3232346|NCT02353299|3964040|FG002|COMPLETED|Fourth Intervention (1 Night)||13
3232347|NCT02353299|3964041|FG003|COMPLETED|Fourth Intervention (1 Night)||13
3232348|NCT02353299|3964038|FG000|NOT COMPLETED|Fourth Intervention (1 Night)||0
3232349|NCT02353299|3964039|FG001|NOT COMPLETED|Fourth Intervention (1 Night)||0
3232350|NCT02353299|3964040|FG002|NOT COMPLETED|Fourth Intervention (1 Night)||0
3232351|NCT02353299|3964041|FG003|NOT COMPLETED|Fourth Intervention (1 Night)||0
3232352|NCT02353442|3964061|FG000|STARTED|Overall Study||28
3232353|NCT02353442|3964062|FG001|STARTED|Overall Study||31
3232354|NCT02353442|3964061|FG000|COMPLETED|Overall Study||25
3232355|NCT02353442|3964062|FG001|COMPLETED|Overall Study||27
3232356|NCT02353442|3964061|FG000|NOT COMPLETED|Overall Study||3
3232357|NCT02353442|3964062|FG001|NOT COMPLETED|Overall Study||4
3232358|NCT02353754|3964070|FG000|STARTED|Overall Study||12
3232359|NCT02353754|3964071|FG001|STARTED|Overall Study||0
3232360|NCT02353754|3964070|FG000|COMPLETED|Overall Study||10
3232361|NCT02353754|3964071|FG001|COMPLETED|Overall Study||0
3232362|NCT02353754|3964070|FG000|NOT COMPLETED|Overall Study||2
3232363|NCT02353754|3964071|FG001|NOT COMPLETED|Overall Study||0
3232364|NCT02353780|3964080|FG000|STARTED|Overall Study||3
3232365|NCT02353780|3964081|FG001|STARTED|Overall Study||3
3232366|NCT02353780|3964082|FG002|STARTED|Overall Study||3
3232367|NCT02353780|3964080|FG000|COMPLETED|Overall Study||3
3232368|NCT02353780|3964081|FG001|COMPLETED|Overall Study||3
3232369|NCT02353780|3964082|FG002|COMPLETED|Overall Study||3
3232370|NCT02353780|3964080|FG000|NOT COMPLETED|Overall Study||0
3232371|NCT02353780|3964081|FG001|NOT COMPLETED|Overall Study||0
3232372|NCT02353780|3964082|FG002|NOT COMPLETED|Overall Study||0
3232373|NCT02353806|3964090|FG000|STARTED|Overall Study||16
3232374|NCT02353806|3964090|FG000|COMPLETED|Overall Study||6
3232375|NCT02353806|3964090|FG000|NOT COMPLETED|Overall Study||10
3232376|NCT02353832|3964096|FG000|STARTED|Overall Study||44
3232377|NCT02353832|3964096|FG000|COMPLETED|Overall Study||44
3232378|NCT02353832|3964096|FG000|NOT COMPLETED|Overall Study||0
3232379|NCT02353871|3964102|FG000|STARTED|Overall Study|Randomised.|125
3232380|NCT02353871|3964103|FG001|STARTED|Overall Study|Randomised. Included a subject who was randomised by mistake (excluded from mITT population).|60
3232381|NCT02353871|3964102|FG000|COMPLETED|Overall Study||122
3232382|NCT02353871|3964103|FG001|COMPLETED|Overall Study||51
3232383|NCT02353871|3964102|FG000|NOT COMPLETED|Overall Study||3
3232384|NCT02353871|3964103|FG001|NOT COMPLETED|Overall Study||9
3232385|NCT02354092|3964111|FG000|STARTED|Overall Study||7
3232386|NCT02354092|3964112|FG001|STARTED|Overall Study||7
3232387|NCT02354092|3964111|FG000|COMPLETED|Overall Study||7
3232388|NCT02354092|3964112|FG001|COMPLETED|Overall Study||7
3232389|NCT02354092|3964111|FG000|NOT COMPLETED|Overall Study||0
3232390|NCT02354092|3964112|FG001|NOT COMPLETED|Overall Study||0
3232391|NCT02354144|3964120|FG000|STARTED|Overall Study||127
3232392|NCT02354144|3964121|FG001|STARTED|Overall Study||128
3232393|NCT02354144|3964120|FG000|COMPLETED|Overall Study|Participants completed all 7 study visits.|48
3232394|NCT02354144|3964121|FG001|COMPLETED|Overall Study|Participants completed all 7 study visits.|51
3232395|NCT02354144|3964120|FG000|NOT COMPLETED|Overall Study||79
3232396|NCT02354144|3964121|FG001|NOT COMPLETED|Overall Study||77
3232397|NCT02354222|3964129|FG000|STARTED|Overall Study||77
3232398|NCT02354222|3964130|FG001|STARTED|Overall Study||77
3232399|NCT02354222|3964129|FG000|COMPLETED|Overall Study||73
3232400|NCT02354222|3964130|FG001|COMPLETED|Overall Study||66
3232401|NCT02354222|3964129|FG000|NOT COMPLETED|Overall Study||4
3232402|NCT02354222|3964130|FG001|NOT COMPLETED|Overall Study||11
3232403|NCT02354235|3964138|FG000|STARTED|Overall Study||70
3232404|NCT02354235|3964139|FG001|STARTED|Overall Study||68
3232405|NCT02354235|3964138|FG000|COMPLETED|Overall Study||67
3232406|NCT02354235|3964139|FG001|COMPLETED|Overall Study||61
3232407|NCT02354235|3964138|FG000|NOT COMPLETED|Overall Study||3
3232408|NCT02354235|3964139|FG001|NOT COMPLETED|Overall Study||7
3232409|NCT02354339|3964147|FG000|STARTED|Overall Study||12
3232410|NCT02354339|3964148|FG001|STARTED|Overall Study||12
3232411|NCT02354339|3964147|FG000|COMPLETED|Overall Study||12
3232412|NCT02354339|3964148|FG001|COMPLETED|Overall Study||12
3232413|NCT02354339|3964147|FG000|NOT COMPLETED|Overall Study||0
3232414|NCT02354339|3964148|FG001|NOT COMPLETED|Overall Study||0
3232415|NCT02354352|3964156|FG000|STARTED|Overall Study||26
3232416|NCT02354352|3964157|FG001|STARTED|Overall Study||26
3232417|NCT02354352|3964156|FG000|2 Weeks|Overall Study||26
3232418|NCT02354352|3964157|FG001|2 Weeks|Overall Study||25
3232419|NCT02354352|3964156|FG000|1 Month|Overall Study||24
3232420|NCT02354352|3964157|FG001|1 Month|Overall Study||23
3232421|NCT02354352|3964156|FG000|2 Months|Overall Study||24
3232422|NCT02354352|3964157|FG001|2 Months|Overall Study||22
3232423|NCT02354352|3964156|FG000|3 Months|Overall Study||25
3232424|NCT02354352|3964157|FG001|3 Months|Overall Study||23
3232425|NCT02354352|3964156|FG000|6 Months|Overall Study||25
3232426|NCT02354352|3964157|FG001|6 Months|Overall Study||23
3232427|NCT02354352|3964156|FG000|9 Months|Overall Study||25
3232428|NCT02354352|3964157|FG001|9 Months|Overall Study||23
3232429|NCT02354352|3964156|FG000|COMPLETED|Overall Study||23
3232430|NCT02354352|3964157|FG001|COMPLETED|Overall Study||23
3232431|NCT02354352|3964156|FG000|NOT COMPLETED|Overall Study||3
3232432|NCT02354352|3964157|FG001|NOT COMPLETED|Overall Study||3
3232433|NCT02354378|3964165|FG000|STARTED|Overall Study||64
3232434|NCT02354378|3964166|FG001|STARTED|Overall Study||20
3232435|NCT02354378|3964165|FG000|COMPLETED|Overall Study||30
3232436|NCT02354378|3964166|FG001|COMPLETED|Overall Study||16
3232437|NCT02354378|3964165|FG000|NOT COMPLETED|Overall Study||34
3232438|NCT02354378|3964166|FG001|NOT COMPLETED|Overall Study||4
3232439|NCT02354417|3964172|FG000|STARTED|Overall Study||3
3232440|NCT02354417|3964172|FG000|COMPLETED|Overall Study||2
3232441|NCT02354417|3964172|FG000|NOT COMPLETED|Overall Study||1
3232442|NCT02354443|3964176|FG000|STARTED|Overall Study||1
3232443|NCT02354443|3964176|FG000|COMPLETED|Overall Study||1
3232444|NCT02354443|3964176|FG000|NOT COMPLETED|Overall Study||0
3232445|NCT02354482|3964180|FG000|STARTED|Patient Communication and Care||2158
3232446|NCT02354482|3964180|FG000|COMPLETED|Patient Communication and Care||2158
3232447|NCT02354482|3964180|FG000|NOT COMPLETED|Patient Communication and Care||0
3232448|NCT02354482|3964180|FG000|STARTED|Home-Based Trust and Plain Language||1979
3232449|NCT02354482|3964180|FG000|COMPLETED|Home-Based Trust and Plain Language||1979
3232450|NCT02354482|3964180|FG000|NOT COMPLETED|Home-Based Trust and Plain Language||0
3232451|NCT02354482|3964180|FG000|STARTED|Hospital-Based Trust and Plain Language||2090
3232452|NCT02354482|3964180|FG000|COMPLETED|Hospital-Based Trust and Plain Language||2090
3232453|NCT02354482|3964180|FG000|NOT COMPLETED|Hospital-Based Trust and Plain Language||0
3232454|NCT02354482|3964180|FG000|STARTED|Patient/Family Caregiver Assessment||3093
3232455|NCT02354482|3964180|FG000|COMPLETED|Patient/Family Caregiver Assessment||3093
3232456|NCT02354482|3964180|FG000|NOT COMPLETED|Patient/Family Caregiver Assessment||0
3232457|NCT02354482|3964180|FG000|STARTED|Assessment and Teach Back||508
3232458|NCT02354482|3964180|FG000|COMPLETED|Assessment and Teach Back||508
3232459|NCT02354482|3964180|FG000|NOT COMPLETED|Assessment and Teach Back||0
3232460|NCT02354482|3964180|FG000|STARTED|Reference||2042
3232461|NCT02354482|3964180|FG000|COMPLETED|Reference||2042
3232462|NCT02354482|3964180|FG000|NOT COMPLETED|Reference||0
3232463|NCT02354508|3964197|FG000|STARTED|Period 1: Core Phase||41
3232464|NCT02354508|3964198|FG001|STARTED|Period 1: Core Phase||29
3232465|NCT02354508|3964199|FG002|STARTED|Period 1: Core Phase||53
3232466|NCT02354508|3964197|FG000|COMPLETED|Period 1: Core Phase||39
3232467|NCT02354508|3964198|FG001|COMPLETED|Period 1: Core Phase||27
3232468|NCT02354508|3964199|FG002|COMPLETED|Period 1: Core Phase||47
3232469|NCT02354508|3964197|FG000|NOT COMPLETED|Period 1: Core Phase||2
3232470|NCT02354508|3964198|FG001|NOT COMPLETED|Period 1: Core Phase||2
3232471|NCT02354508|3964199|FG002|NOT COMPLETED|Period 1: Core Phase||6
3232472|NCT02354508|3964197|FG000|STARTED|Period 2: Extension Phase|not all patients who completed the Core phase went into the Extension phase|26
3232473|NCT02354508|3964198|FG001|STARTED|Period 2: Extension Phase|not all patients who completed the Core phase went into the Extension phase|23
3232474|NCT02354508|3964199|FG002|STARTED|Period 2: Extension Phase|not all patients who completed the Core phase went into the Extension phase|39
3232475|NCT02354508|3964197|FG000|COMPLETED|Period 2: Extension Phase||20
3232476|NCT02354508|3964198|FG001|COMPLETED|Period 2: Extension Phase||19
3232477|NCT02354508|3964199|FG002|COMPLETED|Period 2: Extension Phase||36
3232478|NCT02354508|3964197|FG000|NOT COMPLETED|Period 2: Extension Phase||6
3232479|NCT02354508|3964198|FG001|NOT COMPLETED|Period 2: Extension Phase||4
3232480|NCT02354508|3964199|FG002|NOT COMPLETED|Period 2: Extension Phase||3
3232481|NCT02354508|3964197|FG000|STARTED|Period 3: Post-treatment Follow up Phase||26
3232482|NCT02354508|3964198|FG001|STARTED|Period 3: Post-treatment Follow up Phase||23
3232483|NCT02354508|3964199|FG002|STARTED|Period 3: Post-treatment Follow up Phase||39
3232484|NCT02354508|3964197|FG000|Entered Post-treatment f/up Discontinued|Period 3: Post-treatment Follow up Phase|Entered post-treatment follow-up, discontinued|4
3232485|NCT02354508|3964198|FG001|Entered Post-treatment f/up Discontinued|Period 3: Post-treatment Follow up Phase|Entered post-treatment follow-up, discontinued|3
3232486|NCT02354508|3964199|FG002|Entered Post-treatment f/up Discontinued|Period 3: Post-treatment Follow up Phase|Entered post-treatment follow-up, discontinued|3
3232487|NCT02354508|3964197|FG000|COMPLETED|Period 3: Post-treatment Follow up Phase|Entered post-treatment follow-up, completed|22
3232488|NCT02354508|3964198|FG001|COMPLETED|Period 3: Post-treatment Follow up Phase|Entered post-treatment follow-up, completed|20
3369293|NCT03809910|4100839|FG001|COMPLETED|Washout Period 1 (3 Days)||19
3232489|NCT02354508|3964199|FG002|COMPLETED|Period 3: Post-treatment Follow up Phase|Entered post-treatment follow-up, completed|36
3232490|NCT02354508|3964197|FG000|NOT COMPLETED|Period 3: Post-treatment Follow up Phase||4
3232491|NCT02354508|3964198|FG001|NOT COMPLETED|Period 3: Post-treatment Follow up Phase||3
3232492|NCT02354508|3964199|FG002|NOT COMPLETED|Period 3: Post-treatment Follow up Phase||3
3232493|NCT02354534|3964252|FG000|STARTED|Overall Study||3
3232494|NCT02354534|3964253|FG001|STARTED|Overall Study||9
3232495|NCT02354534|3964254|FG002|STARTED|Overall Study||10
3232496|NCT02354534|3964255|FG003|STARTED|Overall Study||8
3232497|NCT02354534|3964252|FG000|COMPLETED|Overall Study||3
3232498|NCT02354534|3964253|FG001|COMPLETED|Overall Study||9
3232499|NCT02354534|3964254|FG002|COMPLETED|Overall Study||9
3232500|NCT02354534|3964255|FG003|COMPLETED|Overall Study||8
3232501|NCT02354534|3964252|FG000|NOT COMPLETED|Overall Study||0
3232502|NCT02354534|3964253|FG001|NOT COMPLETED|Overall Study||0
3232503|NCT02354534|3964254|FG002|NOT COMPLETED|Overall Study||1
3232504|NCT02354534|3964255|FG003|NOT COMPLETED|Overall Study||0
3232505|NCT02354586|3964265|FG000|STARTED|Overall Study||463
3232506|NCT02354586|3964265|FG000|Ongoing in Study|Overall Study||21
3232507|NCT02354586|3964265|FG000|COMPLETED|Overall Study||122
3232508|NCT02354586|3964265|FG000|NOT COMPLETED|Overall Study||341
3232509|NCT02354599|3964275|FG000|STARTED|Overall Study||6
3232510|NCT02354599|3964276|FG001|STARTED|Overall Study||6
3232511|NCT02354599|3964277|FG002|STARTED|Overall Study||6
3232512|NCT02354599|3964278|FG003|STARTED|Overall Study||6
3232513|NCT02354599|3964279|FG004|STARTED|Overall Study||2
3232514|NCT02354599|3964280|FG005|STARTED|Overall Study||6
3232515|NCT02354599|3964275|FG000|COMPLETED|Overall Study||5
3232516|NCT02354599|3964276|FG001|COMPLETED|Overall Study||5
3232517|NCT02354599|3964277|FG002|COMPLETED|Overall Study||6
3232518|NCT02354599|3964278|FG003|COMPLETED|Overall Study||6
3232519|NCT02354599|3964279|FG004|COMPLETED|Overall Study||2
3232520|NCT02354599|3964280|FG005|COMPLETED|Overall Study||5
3232521|NCT02354599|3964275|FG000|NOT COMPLETED|Overall Study||1
3232522|NCT02354599|3964276|FG001|NOT COMPLETED|Overall Study||1
3232523|NCT02354599|3964277|FG002|NOT COMPLETED|Overall Study||0
3232524|NCT02354599|3964278|FG003|NOT COMPLETED|Overall Study||0
3232525|NCT02354599|3964279|FG004|NOT COMPLETED|Overall Study||0
3232526|NCT02354599|3964280|FG005|NOT COMPLETED|Overall Study||1
3232527|NCT02354690|3964300|FG000|STARTED|Overall Study||13
3232528|NCT02354690|3964300|FG000|COMPLETED|Overall Study||12
3232529|NCT02354690|3964300|FG000|NOT COMPLETED|Overall Study||1
3232530|NCT02354781|3964304|FG000|STARTED|Overall Study||3
3232531|NCT02354781|3964304|FG000|COMPLETED|Overall Study||3
3232532|NCT02354781|3964304|FG000|NOT COMPLETED|Overall Study||0
3232533|NCT02354833|3964311|FG000|STARTED|Overall Study||38
3232534|NCT02354833|3964312|FG001|STARTED|Overall Study||43
3232535|NCT02354833|3964311|FG000|COMPLETED|Overall Study||38
3232536|NCT02354833|3964312|FG001|COMPLETED|Overall Study||43
3232537|NCT02354833|3964311|FG000|NOT COMPLETED|Overall Study||0
3232538|NCT02354833|3964312|FG001|NOT COMPLETED|Overall Study||0
3232539|NCT02354859|3964322|FG000|STARTED|Overall Study||60
3232540|NCT02354859|3964323|FG001|STARTED|Overall Study||59
3232541|NCT02354859|3964322|FG000|COMPLETED|Overall Study||60
3232542|NCT02354859|3964323|FG001|COMPLETED|Overall Study||57
3232543|NCT02354859|3964322|FG000|NOT COMPLETED|Overall Study||0
3232544|NCT02354859|3964323|FG001|NOT COMPLETED|Overall Study||2
3232545|NCT02354924|3964331|FG000|STARTED|Overall Study||40
3232546|NCT02354924|3964332|FG001|STARTED|Overall Study||20
3232547|NCT02354924|3964331|FG000|COMPLETED|Overall Study||40
3232548|NCT02354924|3964332|FG001|COMPLETED|Overall Study||20
3232549|NCT02354924|3964331|FG000|NOT COMPLETED|Overall Study||0
3232550|NCT02354924|3964332|FG001|NOT COMPLETED|Overall Study||0
3232551|NCT02354976|3964343|FG000|STARTED|Overall Study||25
3232552|NCT02354976|3964344|FG001|STARTED|Overall Study||27
3232553|NCT02354976|3964345|FG002|STARTED|Overall Study||26
3232554|NCT02354976|3964343|FG000|COMPLETED|Overall Study||23
3232555|NCT02354976|3964344|FG001|COMPLETED|Overall Study||26
3232556|NCT02354976|3964345|FG002|COMPLETED|Overall Study||23
3232557|NCT02354976|3964343|FG000|NOT COMPLETED|Overall Study||2
3232558|NCT02354976|3964344|FG001|NOT COMPLETED|Overall Study||1
3232559|NCT02354976|3964345|FG002|NOT COMPLETED|Overall Study||3
3232560|NCT02355028|3964355|FG000|STARTED|Overall Study||47
3232561|NCT02355028|3964356|FG001|STARTED|Overall Study||46
3232562|NCT02355028|3964355|FG000|Treated|Overall Study||46
3232563|NCT02355028|3964356|FG001|Treated|Overall Study||45
3232564|NCT02355028|3964355|FG000|COMPLETED|Overall Study||36
3232565|NCT02355028|3964356|FG001|COMPLETED|Overall Study||41
3232566|NCT02355028|3964355|FG000|NOT COMPLETED|Overall Study||11
3232567|NCT02355028|3964356|FG001|NOT COMPLETED|Overall Study||5
3232568|NCT02355067|3964369|FG000|STARTED|Overall Study||20
3232569|NCT02355067|3964370|FG001|STARTED|Overall Study||20
3232570|NCT02355067|3964369|FG000|COMPLETED|Overall Study||12
3232571|NCT02355067|3964370|FG001|COMPLETED|Overall Study||12
3232572|NCT02355067|3964369|FG000|NOT COMPLETED|Overall Study||8
3232573|NCT02355067|3964370|FG001|NOT COMPLETED|Overall Study||8
3232574|NCT02355158|3964376|FG000|STARTED|Overall Study||197
3232575|NCT02355158|3964376|FG000|COMPLETED|Overall Study||47
3232576|NCT02355158|3964376|FG000|NOT COMPLETED|Overall Study||150
3232577|NCT02355210|3964386|FG000|STARTED|Overall Study||19
3232578|NCT02355210|3964387|FG001|STARTED|Overall Study||18
3232579|NCT02355210|3964388|FG002|STARTED|Overall Study||16
3232580|NCT02355210|3964389|FG003|STARTED|Overall Study||17
3232581|NCT02355210|3964390|FG004|STARTED|Overall Study||19
3232582|NCT02355210|3964391|FG005|STARTED|Overall Study||18
3232583|NCT02355210|3964386|FG000|COMPLETED|Overall Study||19
3232584|NCT02355210|3964387|FG001|COMPLETED|Overall Study||18
3232585|NCT02355210|3964388|FG002|COMPLETED|Overall Study||16
3232586|NCT02355210|3964389|FG003|COMPLETED|Overall Study||17
3232587|NCT02355210|3964390|FG004|COMPLETED|Overall Study||19
3232588|NCT02355210|3964391|FG005|COMPLETED|Overall Study||18
3232589|NCT02355210|3964386|FG000|NOT COMPLETED|Overall Study||0
3232590|NCT02355210|3964387|FG001|NOT COMPLETED|Overall Study||0
3232591|NCT02355210|3964388|FG002|NOT COMPLETED|Overall Study||0
3232592|NCT02355210|3964389|FG003|NOT COMPLETED|Overall Study||0
3232593|NCT02355210|3964390|FG004|NOT COMPLETED|Overall Study||0
3232594|NCT02355210|3964391|FG005|NOT COMPLETED|Overall Study||0
3232595|NCT02355275|3964405|FG000|STARTED|Overall Study||22
3232596|NCT02355275|3964405|FG000|COMPLETED|Overall Study||14
3232597|NCT02355275|3964405|FG000|NOT COMPLETED|Overall Study||8
3232598|NCT02355665|3964411|FG000|STARTED|Overall Study||601
3232599|NCT02355665|3964412|FG001|STARTED|Overall Study||597
3232600|NCT02355665|3964411|FG000|COMPLETED|Overall Study||352
3232601|NCT02355665|3964412|FG001|COMPLETED|Overall Study||365
3232602|NCT02355665|3964411|FG000|NOT COMPLETED|Overall Study||249
3232603|NCT02355665|3964412|FG001|NOT COMPLETED|Overall Study||232
3232604|NCT02355691|3964420|FG000|STARTED|Overall Study||7
3232605|NCT02355691|3964421|FG001|STARTED|Overall Study||9
3232606|NCT02355691|3964420|FG000|1st Postop Visit|Overall Study||7
3232607|NCT02355691|3964421|FG001|1st Postop Visit|Overall Study||9
3232608|NCT02355691|3964420|FG000|2nd Postop Visit|Overall Study||7
3232609|NCT02355691|3964421|FG001|2nd Postop Visit|Overall Study||9
3232610|NCT02355691|3964420|FG000|COMPLETED|Overall Study||0
3232611|NCT02355691|3964421|FG001|COMPLETED|Overall Study||0
3232612|NCT02355691|3964420|FG000|NOT COMPLETED|Overall Study||7
3232613|NCT02355691|3964421|FG001|NOT COMPLETED|Overall Study||9
3232614|NCT02355743|3964427|FG000|STARTED|Overall Study||8
3232615|NCT02355743|3964427|FG000|COMPLETED|Overall Study||6
3232616|NCT02355743|3964427|FG000|NOT COMPLETED|Overall Study||2
3232617|NCT02355821|3964433|FG000|STARTED|Overall Study||57
3232618|NCT02355821|3964434|FG001|STARTED|Overall Study||57
3232619|NCT02355821|3964433|FG000|COMPLETED|Overall Study||57
3232620|NCT02355821|3964434|FG001|COMPLETED|Overall Study||57
3232621|NCT02355821|3964433|FG000|NOT COMPLETED|Overall Study||0
3232622|NCT02355821|3964434|FG001|NOT COMPLETED|Overall Study||0
3232623|NCT02355886|3964442|FG000|STARTED|Overall Study||13
3232624|NCT02355886|3964443|FG001|STARTED|Overall Study||12
3232625|NCT02355886|3964442|FG000|COMPLETED|Overall Study||13
3232626|NCT02355886|3964443|FG001|COMPLETED|Overall Study||12
3232627|NCT02355886|3964442|FG000|NOT COMPLETED|Overall Study||0
3232628|NCT02355886|3964443|FG001|NOT COMPLETED|Overall Study||0
3232629|NCT02355977|3964452|FG000|STARTED|Overall Study||21
3232630|NCT02355977|3964453|FG001|STARTED|Overall Study||26
3232631|NCT02355977|3964454|FG002|STARTED|Overall Study||23
3232632|NCT02355977|3964452|FG000|COMPLETED|Overall Study||21
3232633|NCT02355977|3964453|FG001|COMPLETED|Overall Study||26
3232634|NCT02355977|3964454|FG002|COMPLETED|Overall Study||23
3232635|NCT02355977|3964452|FG000|NOT COMPLETED|Overall Study||0
3232636|NCT02355977|3964453|FG001|NOT COMPLETED|Overall Study||0
3232637|NCT02355977|3964454|FG002|NOT COMPLETED|Overall Study||0
3232638|NCT02356003|3964462|FG000|STARTED|Overall Study||10
3232639|NCT02356003|3964462|FG000|COMPLETED|Overall Study||10
3232640|NCT02356003|3964462|FG000|NOT COMPLETED|Overall Study||0
3232641|NCT02356107|3964467|FG000|STARTED|Overall Study||15
3232642|NCT02356107|3964467|FG000|COMPLETED|Overall Study||12
3232643|NCT02356107|3964467|FG000|NOT COMPLETED|Overall Study||3
3232644|NCT02356198|3964473|FG000|STARTED|Overall Study||104
3232645|NCT02356198|3964474|FG001|STARTED|Overall Study||105
3232646|NCT02356198|3964473|FG000|COMPLETED|Overall Study||102
3232647|NCT02356198|3964474|FG001|COMPLETED|Overall Study||98
3232648|NCT02356198|3964473|FG000|NOT COMPLETED|Overall Study||2
3232649|NCT02356198|3964474|FG001|NOT COMPLETED|Overall Study||7
3232650|NCT02356211|3964482|FG000|STARTED|Overall Study||57
3232651|NCT02356211|3964483|FG001|STARTED|Overall Study||52
3232652|NCT02356211|3964482|FG000|COMPLETED|Overall Study||54
3232653|NCT02356211|3964483|FG001|COMPLETED|Overall Study||42
3232654|NCT02356211|3964482|FG000|NOT COMPLETED|Overall Study||3
3232655|NCT02356211|3964483|FG001|NOT COMPLETED|Overall Study||10
3232656|NCT02356471|3964489|FG000|STARTED|Overall Study||34
3232657|NCT02356471|3964489|FG000|COMPLETED|Overall Study||28
3232658|NCT02356471|3964489|FG000|NOT COMPLETED|Overall Study||6
3232659|NCT02356484|3964493|FG000|STARTED|Overall Study||138
3232660|NCT02356484|3964493|FG000|COMPLETED|Overall Study||138
3232661|NCT02356484|3964493|FG000|NOT COMPLETED|Overall Study||0
3369294|NCT03809910|4100838|FG000|NOT COMPLETED|Washout Period 1 (3 Days)||0
3369295|NCT03809910|4100839|FG001|NOT COMPLETED|Washout Period 1 (3 Days)||0
3369296|NCT03809910|4100838|FG000|STARTED|Period 2 (Visit 3)||20
3369297|NCT03809910|4100839|FG001|STARTED|Period 2 (Visit 3)||19
3369298|NCT03809910|4100838|FG000|COMPLETED|Period 2 (Visit 3)||20
3369299|NCT03809910|4100839|FG001|COMPLETED|Period 2 (Visit 3)||19
3369300|NCT03809910|4100838|FG000|NOT COMPLETED|Period 2 (Visit 3)||0
3369301|NCT03809910|4100839|FG001|NOT COMPLETED|Period 2 (Visit 3)||0
3369302|NCT03809910|4100838|FG000|STARTED|Washout Period 2 (3 Days)||20
3369303|NCT03809910|4100839|FG001|STARTED|Washout Period 2 (3 Days)||19
3369304|NCT03809910|4100838|FG000|COMPLETED|Washout Period 2 (3 Days)||20
3232662|NCT02356562|3964499|FG000|STARTED|Overall Study||22
3232663|NCT02356562|3964500|FG001|STARTED|Overall Study||7
3232664|NCT02356562|3964499|FG000|COMPLETED|Overall Study||20
3232665|NCT02356562|3964500|FG001|COMPLETED|Overall Study||6
3232666|NCT02356562|3964499|FG000|NOT COMPLETED|Overall Study||2
3232667|NCT02356562|3964500|FG001|NOT COMPLETED|Overall Study||1
3232668|NCT02356575|3964509|FG000|STARTED|Overall Study||80
3232669|NCT02356575|3964510|FG001|STARTED|Overall Study||80
3232670|NCT02356575|3964509|FG000|COMPLETED|Overall Study||80
3232671|NCT02356575|3964510|FG001|COMPLETED|Overall Study||80
3232672|NCT02356575|3964509|FG000|NOT COMPLETED|Overall Study||0
3232673|NCT02356575|3964510|FG001|NOT COMPLETED|Overall Study||0
3232674|NCT02356588|3964518|FG000|STARTED|Overall Study||107
3232675|NCT02356588|3964519|FG001|STARTED|Overall Study||54
3232676|NCT02356588|3964518|FG000|COMPLETED|Overall Study||102
3232677|NCT02356588|3964519|FG001|COMPLETED|Overall Study||41
3232678|NCT02356588|3964518|FG000|NOT COMPLETED|Overall Study||5
3232679|NCT02356588|3964519|FG001|NOT COMPLETED|Overall Study||13
3232680|NCT02356692|3964525|FG000|STARTED|Overall Study||60
3232681|NCT02356692|3964526|FG001|STARTED|Overall Study||60
3232682|NCT02356692|3964525|FG000|COMPLETED|Overall Study||60
3232683|NCT02356692|3964526|FG001|COMPLETED|Overall Study||60
3232684|NCT02356692|3964525|FG000|NOT COMPLETED|Overall Study||0
3232685|NCT02356692|3964526|FG001|NOT COMPLETED|Overall Study||0
3232686|NCT02356705|3964537|FG000|STARTED|Overall Study||14
3232687|NCT02356705|3964538|FG001|STARTED|Overall Study||14
3232688|NCT02356705|3964539|FG002|STARTED|Overall Study||14
3232689|NCT02356705|3964537|FG000|COMPLETED|Overall Study||14
3232690|NCT02356705|3964538|FG001|COMPLETED|Overall Study||14
3232691|NCT02356705|3964539|FG002|COMPLETED|Overall Study||14
3232692|NCT02356705|3964537|FG000|NOT COMPLETED|Overall Study||0
3232693|NCT02356705|3964538|FG001|NOT COMPLETED|Overall Study||0
3232694|NCT02356705|3964539|FG002|NOT COMPLETED|Overall Study||0
3232695|NCT02356783|3964549|FG000|STARTED|Overall Study||16
3232696|NCT02356783|3964550|FG001|STARTED|Overall Study||17
3232697|NCT02356783|3964549|FG000|COMPLETED|Overall Study||15
3232698|NCT02356783|3964550|FG001|COMPLETED|Overall Study||14
3232699|NCT02356783|3964549|FG000|NOT COMPLETED|Overall Study||1
3232700|NCT02356783|3964550|FG001|NOT COMPLETED|Overall Study||3
3232701|NCT02356887|3964556|FG000|STARTED|Overall Study||12
3232702|NCT02356887|3964556|FG000|COMPLETED|Overall Study||10
3232703|NCT02356887|3964556|FG000|NOT COMPLETED|Overall Study||2
3232704|NCT02356900|3964568|FG000|STARTED|Overall Study||11
3232705|NCT02356900|3964569|FG001|STARTED|Overall Study||10
3232706|NCT02356900|3964568|FG000|COMPLETED|Overall Study||11
3232707|NCT02356900|3964569|FG001|COMPLETED|Overall Study||10
3232708|NCT02356900|3964568|FG000|NOT COMPLETED|Overall Study||0
3232709|NCT02356900|3964569|FG001|NOT COMPLETED|Overall Study||0
3232710|NCT02357043|3964575|FG000|STARTED|Overall Study||368
3232711|NCT02357043|3964575|FG000|COMPLETED|Overall Study||368
3232712|NCT02357043|3964575|FG000|NOT COMPLETED|Overall Study||0
3232713|NCT02357134|3964583|FG000|STARTED|Overall Study||11
3232714|NCT02357134|3964584|FG001|STARTED|Overall Study||11
3232715|NCT02357134|3964585|FG002|STARTED|Overall Study||12
3232716|NCT02357134|3964586|FG003|STARTED|Overall Study||11
3232717|NCT02357134|3964583|FG000|COMPLETED|Overall Study||10
3232718|NCT02357134|3964584|FG001|COMPLETED|Overall Study||11
3232719|NCT02357134|3964585|FG002|COMPLETED|Overall Study||12
3232720|NCT02357134|3964586|FG003|COMPLETED|Overall Study||11
3232721|NCT02357134|3964583|FG000|NOT COMPLETED|Overall Study||1
3232722|NCT02357134|3964584|FG001|NOT COMPLETED|Overall Study||0
3232723|NCT02357134|3964585|FG002|NOT COMPLETED|Overall Study||0
3232724|NCT02357134|3964586|FG003|NOT COMPLETED|Overall Study||0
3232725|NCT02357147|3964598|FG000|STARTED|Combination Treatment Phase||52
3232726|NCT02357147|3964599|FG001|STARTED|Combination Treatment Phase||56
3232727|NCT02357147|3964598|FG000|Treated|Combination Treatment Phase||52
3232728|NCT02357147|3964599|FG001|Treated|Combination Treatment Phase||54
3232729|NCT02357147|3964598|FG000|COMPLETED|Combination Treatment Phase||26
3232730|NCT02357147|3964599|FG001|COMPLETED|Combination Treatment Phase||29
3232731|NCT02357147|3964598|FG000|NOT COMPLETED|Combination Treatment Phase||26
3232732|NCT02357147|3964599|FG001|NOT COMPLETED|Combination Treatment Phase||27
3232733|NCT02357147|3964598|FG000|STARTED|Maintenance Treatment Phase||26
3232734|NCT02357147|3964599|FG001|STARTED|Maintenance Treatment Phase||29
3232735|NCT02357147|3964598|FG000|Treated|Maintenance Treatment Phase||25
3232736|NCT02357147|3964599|FG001|Treated|Maintenance Treatment Phase||29
3232737|NCT02357147|3964598|FG000|COMPLETED|Maintenance Treatment Phase||0
3232738|NCT02357147|3964599|FG001|COMPLETED|Maintenance Treatment Phase||0
3232739|NCT02357147|3964598|FG000|NOT COMPLETED|Maintenance Treatment Phase||26
3232740|NCT02357147|3964599|FG001|NOT COMPLETED|Maintenance Treatment Phase||29
3232741|NCT02357173|3964612|FG000|STARTED|Overall Study||25
3232742|NCT02357173|3964613|FG001|STARTED|Overall Study||21
3232743|NCT02357173|3964614|FG002|STARTED|Overall Study||22
3232744|NCT02357173|3964612|FG000|COMPLETED|Overall Study||19
3232745|NCT02357173|3964613|FG001|COMPLETED|Overall Study||15
3232746|NCT02357173|3964614|FG002|COMPLETED|Overall Study||16
3232747|NCT02357173|3964612|FG000|NOT COMPLETED|Overall Study||6
3232748|NCT02357173|3964613|FG001|NOT COMPLETED|Overall Study||6
3232749|NCT02357173|3964614|FG002|NOT COMPLETED|Overall Study||6
3232750|NCT02357264|3964624|FG000|STARTED|Overall Study||56
3232751|NCT02357264|3964625|FG001|STARTED|Overall Study||130
3232752|NCT02357264|3964624|FG000|COMPLETED|Overall Study||56
3232753|NCT02357264|3964625|FG001|COMPLETED|Overall Study||130
3232754|NCT02357264|3964624|FG000|NOT COMPLETED|Overall Study||0
3232755|NCT02357264|3964625|FG001|NOT COMPLETED|Overall Study||0
3232756|NCT02357290|3964631|FG000|STARTED|Overall Study||40
3232757|NCT02357290|3964631|FG000|Exposed|Overall Study||26
3232758|NCT02357290|3964631|FG000|COMPLETED|Overall Study||14
3232759|NCT02357290|3964631|FG000|NOT COMPLETED|Overall Study||26
3232760|NCT02357342|3964637|FG000|STARTED|First 6 Months||20
3232761|NCT02357342|3964638|FG001|STARTED|First 6 Months||20
3232762|NCT02357342|3964637|FG000|COMPLETED|First 6 Months|2 patients died. Neither deaths were study drug related.|18
3232763|NCT02357342|3964638|FG001|COMPLETED|First 6 Months||20
3232764|NCT02357342|3964637|FG000|NOT COMPLETED|First 6 Months||2
3232765|NCT02357342|3964638|FG001|NOT COMPLETED|First 6 Months||0
3232766|NCT02357342|3964637|FG000|STARTED|Extension Study||4
3232767|NCT02357342|3964638|FG001|STARTED|Extension Study||9
3232768|NCT02357342|3964637|FG000|COMPLETED|Extension Study||4
3232769|NCT02357342|3964638|FG001|COMPLETED|Extension Study||9
3232770|NCT02357342|3964637|FG000|NOT COMPLETED|Extension Study||0
3232771|NCT02357342|3964638|FG001|NOT COMPLETED|Extension Study||0
3232772|NCT02357368|3964648|FG000|STARTED|Overall Study||19
3232773|NCT02357368|3964649|FG001|STARTED|Overall Study||18
3232774|NCT02357368|3964650|FG002|STARTED|Overall Study||14
3232775|NCT02357368|3964651|FG003|STARTED|Overall Study||8
3232776|NCT02357368|3964648|FG000|COMPLETED|Overall Study||13
3232777|NCT02357368|3964649|FG001|COMPLETED|Overall Study||15
3232778|NCT02357368|3964650|FG002|COMPLETED|Overall Study||13
3232779|NCT02357368|3964651|FG003|COMPLETED|Overall Study||5
3232780|NCT02357368|3964648|FG000|NOT COMPLETED|Overall Study||6
3232781|NCT02357368|3964649|FG001|NOT COMPLETED|Overall Study||3
3232782|NCT02357368|3964650|FG002|NOT COMPLETED|Overall Study||1
3232783|NCT02357368|3964651|FG003|NOT COMPLETED|Overall Study||3
3232784|NCT02357394|3964663|FG000|STARTED|Overall Study||4
3232785|NCT02357394|3964664|FG001|STARTED|Overall Study||3
3232786|NCT02357394|3964663|FG000|COMPLETED|Overall Study||4
3232787|NCT02357394|3964664|FG001|COMPLETED|Overall Study||3
3232788|NCT02357394|3964663|FG000|NOT COMPLETED|Overall Study||0
3232789|NCT02357394|3964664|FG001|NOT COMPLETED|Overall Study||0
3232790|NCT02357420|3964674|FG000|STARTED|Overall Study||104
3232791|NCT02357420|3964675|FG001|STARTED|Overall Study||98
3232792|NCT02357420|3964676|FG002|STARTED|Overall Study||109
3232793|NCT02357420|3964677|FG003|STARTED|Overall Study||82
3232794|NCT02357420|3964674|FG000|Full Analysis Set (FAS)|Overall Study||104
3232795|NCT02357420|3964675|FG001|Full Analysis Set (FAS)|Overall Study||98
3232796|NCT02357420|3964676|FG002|Full Analysis Set (FAS)|Overall Study||109
3232797|NCT02357420|3964677|FG003|Full Analysis Set (FAS)|Overall Study|1 participant from safety set did not enter FAS.|81
3232798|NCT02357420|3964674|FG000|COMPLETED|Overall Study|3 participants who discontinued prematurely were included in completed as they fulfilled Visit 8.|92
3232799|NCT02357420|3964675|FG001|COMPLETED|Overall Study|1 participant who discontinued prematurely was included in completed as he/she fulfilled Visit 8.|86
3232800|NCT02357420|3964676|FG002|COMPLETED|Overall Study|1 participant who discontinued prematurely was included in completed as he/she fulfilled Visit 8.|93
3232801|NCT02357420|3964677|FG003|COMPLETED|Overall Study||63
3232802|NCT02357420|3964674|FG000|NOT COMPLETED|Overall Study||12
3232803|NCT02357420|3964675|FG001|NOT COMPLETED|Overall Study||12
3232804|NCT02357420|3964676|FG002|NOT COMPLETED|Overall Study||16
3232805|NCT02357420|3964677|FG003|NOT COMPLETED|Overall Study||19
3232806|NCT02357459|3964690|FG000|STARTED|Overall Study||161
3232807|NCT02357459|3964691|FG001|STARTED|Overall Study||163
3232808|NCT02357459|3964692|FG002|STARTED|Overall Study||162
3232809|NCT02357459|3964690|FG000|COMPLETED|Overall Study||144
3232810|NCT02357459|3964691|FG001|COMPLETED|Overall Study||149
3232811|NCT02357459|3964692|FG002|COMPLETED|Overall Study||150
3369305|NCT03809910|4100839|FG001|COMPLETED|Washout Period 2 (3 Days)||19
3369306|NCT03809910|4100838|FG000|NOT COMPLETED|Washout Period 2 (3 Days)||0
3369307|NCT03809910|4100839|FG001|NOT COMPLETED|Washout Period 2 (3 Days)||0
3369308|NCT03809910|4100838|FG000|STARTED|Period 3 (Visit 4)||20
3369309|NCT03809910|4100839|FG001|STARTED|Period 3 (Visit 4)||19
3369310|NCT03809910|4100838|FG000|COMPLETED|Period 3 (Visit 4)||20
3369311|NCT03809910|4100839|FG001|COMPLETED|Period 3 (Visit 4)||19
3369312|NCT03809910|4100838|FG000|NOT COMPLETED|Period 3 (Visit 4)||0
3369313|NCT03809910|4100839|FG001|NOT COMPLETED|Period 3 (Visit 4)||0
3369314|NCT03806790|4100851|FG000|STARTED|Overall Study||87
3369315|NCT03806790|4100852|FG001|STARTED|Overall Study||95
3369316|NCT03806790|4100851|FG000|COMPLETED|Overall Study||87
3369317|NCT03806790|4100852|FG001|COMPLETED|Overall Study||95
3369318|NCT03806790|4100851|FG000|NOT COMPLETED|Overall Study||0
3369319|NCT03806790|4100852|FG001|NOT COMPLETED|Overall Study||0
3369320|NCT03809611|4100860|FG000|STARTED|Overall Study||62
3369321|NCT03809611|4100861|FG001|STARTED|Overall Study||62
3369322|NCT03809611|4100860|FG000|COMPLETED|Overall Study||61
3369323|NCT03809611|4100861|FG001|COMPLETED|Overall Study||61
3369324|NCT03809611|4100860|FG000|NOT COMPLETED|Overall Study||1
3369325|NCT03809611|4100861|FG001|NOT COMPLETED|Overall Study||1
3369326|NCT03807245|4100871|FG000|STARTED|Overall Study||24
3369327|NCT03807245|4100872|FG001|STARTED|Overall Study||24
3369328|NCT03807245|4100873|FG002|STARTED|Overall Study||12
3369329|NCT03807245|4100871|FG000|COMPLETED|Overall Study||23
3369330|NCT03807245|4100872|FG001|COMPLETED|Overall Study||24
3369331|NCT03807245|4100873|FG002|COMPLETED|Overall Study||12
3369332|NCT03807245|4100871|FG000|NOT COMPLETED|Overall Study||1
3369333|NCT03807245|4100872|FG001|NOT COMPLETED|Overall Study||0
3232812|NCT02357459|3964690|FG000|NOT COMPLETED|Overall Study||17
3232813|NCT02357459|3964691|FG001|NOT COMPLETED|Overall Study||14
3232814|NCT02357459|3964692|FG002|NOT COMPLETED|Overall Study||12
3232815|NCT02357485|3964703|FG000|STARTED|Overall Study|6 subjects, 8 knees ( 2 bilateral & 4 unilateral)|6
3232816|NCT02357485|3964703|FG000|COMPLETED|Overall Study||6
3232817|NCT02357485|3964703|FG000|NOT COMPLETED|Overall Study||0
3232818|NCT02357576|3964710|FG000|STARTED|Treatment Period||12
3232819|NCT02357576|3964711|FG001|STARTED|Treatment Period||9
3232820|NCT02357576|3964710|FG000|COMPLETED|Treatment Period||12
3232821|NCT02357576|3964711|FG001|COMPLETED|Treatment Period||7
3232822|NCT02357576|3964710|FG000|NOT COMPLETED|Treatment Period||0
3232823|NCT02357576|3964711|FG001|NOT COMPLETED|Treatment Period||2
3232824|NCT02357576|3964710|FG000|STARTED|Neurodevelopmental Outcome Follow Up|1 patient exited the study after treatment completion and before returning for follow up visits.|11
3232825|NCT02357576|3964711|FG001|STARTED|Neurodevelopmental Outcome Follow Up||7
3232826|NCT02357576|3964710|FG000|COMPLETED|Neurodevelopmental Outcome Follow Up||6
3232827|NCT02357576|3964711|FG001|COMPLETED|Neurodevelopmental Outcome Follow Up||2
3232828|NCT02357576|3964710|FG000|NOT COMPLETED|Neurodevelopmental Outcome Follow Up||5
3232829|NCT02357576|3964711|FG001|NOT COMPLETED|Neurodevelopmental Outcome Follow Up||5
3232830|NCT02357706|3964717|FG000|STARTED|Overall Study||10
3232831|NCT02357706|3964718|FG001|STARTED|Overall Study||10
3232832|NCT02357706|3964717|FG000|COMPLETED|Overall Study||10
3232833|NCT02357706|3964718|FG001|COMPLETED|Overall Study||10
3232834|NCT02357706|3964717|FG000|NOT COMPLETED|Overall Study||0
3232835|NCT02357706|3964718|FG001|NOT COMPLETED|Overall Study||0
3232836|NCT02357758|3964730|FG000|STARTED|Overall Study||25
3232837|NCT02357758|3964731|FG001|STARTED|Overall Study||20
3232838|NCT02357758|3964732|FG002|STARTED|Overall Study||12
3232839|NCT02357758|3964730|FG000|COMPLETED|Overall Study||9
3232840|NCT02357758|3964731|FG001|COMPLETED|Overall Study||20
3232841|NCT02357758|3964732|FG002|COMPLETED|Overall Study||5
3232842|NCT02357758|3964730|FG000|NOT COMPLETED|Overall Study||16
3232843|NCT02357758|3964731|FG001|NOT COMPLETED|Overall Study||0
3232844|NCT02357758|3964732|FG002|NOT COMPLETED|Overall Study||7
3232845|NCT02357810|3964740|FG000|STARTED|Registered and Started Treatment||178
3232846|NCT02357810|3964740|FG000|Signed Consent|Registered and Started Treatment||178
3232847|NCT02357810|3964740|FG000|Registered to Study|Registered and Started Treatment||152
3232848|NCT02357810|3964740|FG000|Initiated Treatment on Study|Registered and Started Treatment||151
3232849|NCT02357810|3964740|FG000|COMPLETED|Registered and Started Treatment||151
3232850|NCT02357810|3964740|FG000|NOT COMPLETED|Registered and Started Treatment||27
3232851|NCT02357810|3964740|FG000|STARTED|Reached 12 Weeks Response||151
3232852|NCT02357810|3964740|FG000|Completed 4 Weeks/1 Cycle|Reached 12 Weeks Response||151
3232853|NCT02357810|3964740|FG000|Reached 6 Week Response|Reached 12 Weeks Response||129
3232854|NCT02357810|3964740|FG000|Reached 12 Weeks/3 Cycles|Reached 12 Weeks Response||95
3232855|NCT02357810|3964740|FG000|COMPLETED|Reached 12 Weeks Response||95
3232856|NCT02357810|3964740|FG000|NOT COMPLETED|Reached 12 Weeks Response||56
3232857|NCT02357810|3964740|FG000|STARTED|12 Week Response and Further Treatment||95
3232858|NCT02357810|3964740|FG000|Assessed for 12 Week Response|12 Week Response and Further Treatment||95
3232859|NCT02357810|3964740|FG000|Went on to be Treated After Response|12 Week Response and Further Treatment||73
3232860|NCT02357810|3964740|FG000|COMPLETED|12 Week Response and Further Treatment||73
3232861|NCT02357810|3964740|FG000|NOT COMPLETED|12 Week Response and Further Treatment||22
3232862|NCT02357810|3964740|FG000|STARTED|Follow-up at Treatment Discontinuation|All patients that receive at least one dose of study treatment go into follow up phase of the study.|151
3232863|NCT02357810|3964740|FG000|COMPLETED|Follow-up at Treatment Discontinuation||133
3232864|NCT02357810|3964740|FG000|NOT COMPLETED|Follow-up at Treatment Discontinuation||18
3232865|NCT02357836|3964744|FG000|STARTED|Overall Study||13
3232866|NCT02357836|3964744|FG000|COMPLETED|Overall Study||13
3232867|NCT02357836|3964744|FG000|NOT COMPLETED|Overall Study||0
3232868|NCT02357901|3964752|FG000|STARTED|Run-In Period (Days -14 to Day -1)|Received at least one dose of SUBOXONE sublingual film.|665
3232869|NCT02357901|3964753|FG001|STARTED|Run-In Period (Days -14 to Day -1)||0
3232870|NCT02357901|3964754|FG002|STARTED|Run-In Period (Days -14 to Day -1)||0
3232871|NCT02357901|3964755|FG003|STARTED|Run-In Period (Days -14 to Day -1)||0
3232872|NCT02357901|3964752|FG000|COMPLETED|Run-In Period (Days -14 to Day -1)||504
3232873|NCT02357901|3964753|FG001|COMPLETED|Run-In Period (Days -14 to Day -1)||0
3232874|NCT02357901|3964754|FG002|COMPLETED|Run-In Period (Days -14 to Day -1)||0
3232875|NCT02357901|3964755|FG003|COMPLETED|Run-In Period (Days -14 to Day -1)||0
3232876|NCT02357901|3964752|FG000|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||161
3232877|NCT02357901|3964753|FG001|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||0
3232878|NCT02357901|3964754|FG002|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||0
3232879|NCT02357901|3964755|FG003|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||0
3232880|NCT02357901|3964752|FG000|STARTED|Treatment Period (Day 1 to Week 24)||0
3232881|NCT02357901|3964753|FG001|STARTED|Treatment Period (Day 1 to Week 24)||203
3232882|NCT02357901|3964754|FG002|STARTED|Treatment Period (Day 1 to Week 24)||201
3232883|NCT02357901|3964755|FG003|STARTED|Treatment Period (Day 1 to Week 24)||100
3232884|NCT02357901|3964752|FG000|Safety Analysis Set|Treatment Period (Day 1 to Week 24)||0
3232885|NCT02357901|3964753|FG001|Safety Analysis Set|Treatment Period (Day 1 to Week 24)||203
3232886|NCT02357901|3964754|FG002|Safety Analysis Set|Treatment Period (Day 1 to Week 24)||201
3232887|NCT02357901|3964755|FG003|Safety Analysis Set|Treatment Period (Day 1 to Week 24)||100
3232888|NCT02357901|3964752|FG000|Full Analysis Set|Treatment Period (Day 1 to Week 24)||0
3232889|NCT02357901|3964753|FG001|Full Analysis Set|Treatment Period (Day 1 to Week 24)||194
3232890|NCT02357901|3964754|FG002|Full Analysis Set|Treatment Period (Day 1 to Week 24)||196
3232891|NCT02357901|3964755|FG003|Full Analysis Set|Treatment Period (Day 1 to Week 24)||99
3232892|NCT02357901|3964752|FG000|COMPLETED|Treatment Period (Day 1 to Week 24)||0
3232893|NCT02357901|3964753|FG001|COMPLETED|Treatment Period (Day 1 to Week 24)||125
3232894|NCT02357901|3964754|FG002|COMPLETED|Treatment Period (Day 1 to Week 24)||129
3232895|NCT02357901|3964755|FG003|COMPLETED|Treatment Period (Day 1 to Week 24)||34
3232896|NCT02357901|3964752|FG000|NOT COMPLETED|Treatment Period (Day 1 to Week 24)||0
3232897|NCT02357901|3964753|FG001|NOT COMPLETED|Treatment Period (Day 1 to Week 24)||78
3232898|NCT02357901|3964754|FG002|NOT COMPLETED|Treatment Period (Day 1 to Week 24)||72
3232899|NCT02357901|3964755|FG003|NOT COMPLETED|Treatment Period (Day 1 to Week 24)||66
3232900|NCT02357940|3964765|FG000|STARTED|Overall Study||9
3232901|NCT02357940|3964766|FG001|STARTED|Overall Study||32
3232902|NCT02357940|3964765|FG000|COMPLETED|Overall Study||9
3232903|NCT02357940|3964766|FG001|COMPLETED|Overall Study||30
3232904|NCT02357940|3964765|FG000|NOT COMPLETED|Overall Study||0
3232905|NCT02357940|3964766|FG001|NOT COMPLETED|Overall Study||2
3232906|NCT02357979|3964774|FG000|STARTED|Overall Study||60
3232907|NCT02357979|3964775|FG001|STARTED|Overall Study||60
3232908|NCT02357979|3964774|FG000|COMPLETED|Overall Study||55
3232909|NCT02357979|3964775|FG001|COMPLETED|Overall Study||55
3232910|NCT02357979|3964774|FG000|NOT COMPLETED|Overall Study||5
3232911|NCT02357979|3964775|FG001|NOT COMPLETED|Overall Study||5
3232912|NCT02358031|3964784|FG000|STARTED|Overall Study||301
3232913|NCT02358031|3964785|FG001|STARTED|Overall Study||281
3232914|NCT02358031|3964786|FG002|STARTED|Overall Study||300
3232915|NCT02358031|3964784|FG000|Treated|Overall Study||300
3232916|NCT02358031|3964785|FG001|Treated|Overall Study||276
3232917|NCT02358031|3964786|FG002|Treated|Overall Study||287
3232918|NCT02358031|3964784|FG000|Pembro Mono v Control Efficacy Analyses|Overall Study||301
3232919|NCT02358031|3964785|FG001|Pembro Mono v Control Efficacy Analyses|Overall Study||0
3232920|NCT02358031|3964786|FG002|Pembro Mono v Control Efficacy Analyses|Overall Study||300
3232921|NCT02358031|3964784|FG000|Pembro Combo v Control Efficacy Analyses|Overall Study||0
3232922|NCT02358031|3964785|FG001|Pembro Combo v Control Efficacy Analyses|Overall Study||281
3232923|NCT02358031|3964786|FG002|Pembro Combo v Control Efficacy Analyses|Overall Study||278
3232924|NCT02358031|3964784|FG000|COMPLETED|Overall Study||0
3232925|NCT02358031|3964785|FG001|COMPLETED|Overall Study||0
3232926|NCT02358031|3964786|FG002|COMPLETED|Overall Study||0
3232927|NCT02358031|3964784|FG000|NOT COMPLETED|Overall Study||301
3232928|NCT02358031|3964785|FG001|NOT COMPLETED|Overall Study||281
3232929|NCT02358031|3964786|FG002|NOT COMPLETED|Overall Study||300
3232930|NCT02358044|3964796|FG000|STARTED|Overall Study||129
3232931|NCT02358044|3964797|FG001|STARTED|Overall Study||128
3232932|NCT02358044|3964796|FG000|Treated|Overall Study||129
3232933|NCT02358044|3964797|FG001|Treated|Overall Study||126
3232934|NCT02358044|3964796|FG000|COMPLETED|Overall Study|Completed = Completed Follow-up Week 24 (end of study)|127
3232935|NCT02358044|3964797|FG001|COMPLETED|Overall Study|Completed = Completed Follow-up Week 24 (end of study)|121
3232936|NCT02358044|3964796|FG000|NOT COMPLETED|Overall Study||2
3232937|NCT02358044|3964797|FG001|NOT COMPLETED|Overall Study||7
3232938|NCT02358135|3964805|FG000|STARTED|Overall Study||150
3232939|NCT02358135|3964806|FG001|STARTED|Overall Study||150
3232940|NCT02358135|3964805|FG000|Randomized|Overall Study||148
3232941|NCT02358135|3964806|FG001|Randomized|Overall Study||148
3232942|NCT02358135|3964805|FG000|COMPLETED|Overall Study||135
3232943|NCT02358135|3964806|FG001|COMPLETED|Overall Study||131
3232944|NCT02358135|3964805|FG000|NOT COMPLETED|Overall Study||15
3232945|NCT02358135|3964806|FG001|NOT COMPLETED|Overall Study||19
3232946|NCT02358343|3964817|FG000|STARTED|Screening Intervention|90 completed engagement interview|92
3232947|NCT02358343|3964818|FG001|STARTED|Screening Intervention|89 completed control visit|92
3232948|NCT02358343|3964819|FG002|STARTED|Screening Intervention||0
3232949|NCT02358343|3964820|FG003|STARTED|Screening Intervention||0
3232950|NCT02358343|3964821|FG004|STARTED|Screening Intervention||0
3232951|NCT02358343|3964817|FG000|COMPLETED|Screening Intervention||86
3232952|NCT02358343|3964818|FG001|COMPLETED|Screening Intervention||84
3232953|NCT02358343|3964819|FG002|COMPLETED|Screening Intervention||0
3232954|NCT02358343|3964820|FG003|COMPLETED|Screening Intervention||0
3232955|NCT02358343|3964821|FG004|COMPLETED|Screening Intervention||0
3232956|NCT02358343|3964817|FG000|NOT COMPLETED|Screening Intervention||6
3232957|NCT02358343|3964818|FG001|NOT COMPLETED|Screening Intervention||8
3232958|NCT02358343|3964819|FG002|NOT COMPLETED|Screening Intervention||0
3232959|NCT02358343|3964820|FG003|NOT COMPLETED|Screening Intervention||0
3232960|NCT02358343|3964821|FG004|NOT COMPLETED|Screening Intervention||0
3232961|NCT02358343|3964817|FG000|STARTED|Comparative Efficacy Trial / Observation|Participants enrolled in screening intervention enrolled in comparative efficacy trial|0
3232962|NCT02358343|3964818|FG001|STARTED|Comparative Efficacy Trial / Observation|Participants enrolled in screening intervention enrolled in comparative efficacy trial|0
3232963|NCT02358343|3964819|FG002|STARTED|Comparative Efficacy Trial / Observation|44 completed treatment|60
3232964|NCT02358343|3964820|FG003|STARTED|Comparative Efficacy Trial / Observation|47 completed treatment|60
3232965|NCT02358343|3964821|FG004|STARTED|Comparative Efficacy Trial / Observation||20
3232966|NCT02358343|3964817|FG000|COMPLETED|Comparative Efficacy Trial / Observation||0
3232967|NCT02358343|3964818|FG001|COMPLETED|Comparative Efficacy Trial / Observation||0
3232968|NCT02358343|3964819|FG002|COMPLETED|Comparative Efficacy Trial / Observation||55
3232969|NCT02358343|3964820|FG003|COMPLETED|Comparative Efficacy Trial / Observation||58
3232970|NCT02358343|3964821|FG004|COMPLETED|Comparative Efficacy Trial / Observation||18
3232971|NCT02358343|3964817|FG000|NOT COMPLETED|Comparative Efficacy Trial / Observation||0
3232972|NCT02358343|3964818|FG001|NOT COMPLETED|Comparative Efficacy Trial / Observation||0
3232973|NCT02358343|3964819|FG002|NOT COMPLETED|Comparative Efficacy Trial / Observation||5
3232974|NCT02358343|3964820|FG003|NOT COMPLETED|Comparative Efficacy Trial / Observation||2
3232975|NCT02358343|3964821|FG004|NOT COMPLETED|Comparative Efficacy Trial / Observation||2
3232976|NCT02358369|3964835|FG000|STARTED|Pre-Randomization Washout Period||156
3232977|NCT02358369|3964836|FG001|STARTED|Pre-Randomization Washout Period||0
3232978|NCT02358369|3964837|FG002|STARTED|Pre-Randomization Washout Period||0
3232979|NCT02358369|3964838|FG003|STARTED|Pre-Randomization Washout Period||0
3232980|NCT02358369|3964839|FG004|STARTED|Pre-Randomization Washout Period||0
3232981|NCT02358369|3964835|FG000|COMPLETED|Pre-Randomization Washout Period||121
3232982|NCT02358369|3964836|FG001|COMPLETED|Pre-Randomization Washout Period||0
3232983|NCT02358369|3964837|FG002|COMPLETED|Pre-Randomization Washout Period||0
3232984|NCT02358369|3964838|FG003|COMPLETED|Pre-Randomization Washout Period||0
3232985|NCT02358369|3964839|FG004|COMPLETED|Pre-Randomization Washout Period||0
3232986|NCT02358369|3964835|FG000|NOT COMPLETED|Pre-Randomization Washout Period||35
3232987|NCT02358369|3964836|FG001|NOT COMPLETED|Pre-Randomization Washout Period||0
3232988|NCT02358369|3964837|FG002|NOT COMPLETED|Pre-Randomization Washout Period||0
3232989|NCT02358369|3964838|FG003|NOT COMPLETED|Pre-Randomization Washout Period||0
3232990|NCT02358369|3964839|FG004|NOT COMPLETED|Pre-Randomization Washout Period||0
3232991|NCT02358369|3964835|FG000|STARTED|Treatment Period A/B||0
3232992|NCT02358369|3964836|FG001|STARTED|Treatment Period A/B||40
3232993|NCT02358369|3964837|FG002|STARTED|Treatment Period A/B||40
3232994|NCT02358369|3964838|FG003|STARTED|Treatment Period A/B||41
3232995|NCT02358369|3964839|FG004|STARTED|Treatment Period A/B||0
3232996|NCT02358369|3964835|FG000|COMPLETED|Treatment Period A/B||0
3232997|NCT02358369|3964836|FG001|COMPLETED|Treatment Period A/B||38
3232998|NCT02358369|3964837|FG002|COMPLETED|Treatment Period A/B||38
3232999|NCT02358369|3964838|FG003|COMPLETED|Treatment Period A/B||37
3233000|NCT02358369|3964839|FG004|COMPLETED|Treatment Period A/B||0
3233001|NCT02358369|3964835|FG000|NOT COMPLETED|Treatment Period A/B||0
3233002|NCT02358369|3964836|FG001|NOT COMPLETED|Treatment Period A/B||2
3233003|NCT02358369|3964837|FG002|NOT COMPLETED|Treatment Period A/B||2
3233004|NCT02358369|3964838|FG003|NOT COMPLETED|Treatment Period A/B||4
3233005|NCT02358369|3964839|FG004|NOT COMPLETED|Treatment Period A/B||0
3233006|NCT02358369|3964835|FG000|STARTED|Treatment Period C||0
3233007|NCT02358369|3964836|FG001|STARTED|Treatment Period C||0
3233008|NCT02358369|3964837|FG002|STARTED|Treatment Period C||0
3233009|NCT02358369|3964838|FG003|STARTED|Treatment Period C||0
3233010|NCT02358369|3964839|FG004|STARTED|Treatment Period C||113
3233011|NCT02358369|3964835|FG000|COMPLETED|Treatment Period C||0
3233012|NCT02358369|3964836|FG001|COMPLETED|Treatment Period C||0
3233013|NCT02358369|3964837|FG002|COMPLETED|Treatment Period C||0
3233014|NCT02358369|3964838|FG003|COMPLETED|Treatment Period C||0
3233015|NCT02358369|3964839|FG004|COMPLETED|Treatment Period C||106
3233016|NCT02358369|3964835|FG000|NOT COMPLETED|Treatment Period C||0
3233017|NCT02358369|3964836|FG001|NOT COMPLETED|Treatment Period C||0
3233018|NCT02358369|3964837|FG002|NOT COMPLETED|Treatment Period C||0
3233019|NCT02358369|3964838|FG003|NOT COMPLETED|Treatment Period C||0
3233020|NCT02358369|3964839|FG004|NOT COMPLETED|Treatment Period C||7
3233021|NCT02358473|3964849|FG000|STARTED|Overall Study||13
3233022|NCT02358473|3964849|FG000|COMPLETED|Overall Study||0
3233023|NCT02358473|3964849|FG000|NOT COMPLETED|Overall Study||13
3233024|NCT02358603|3964855|FG000|STARTED|Overall Study||40
3233025|NCT02358603|3964856|FG001|STARTED|Overall Study||8
3233026|NCT02358603|3964855|FG000|COMPLETED|Overall Study||40
3233027|NCT02358603|3964856|FG001|COMPLETED|Overall Study||8
3233028|NCT02358603|3964855|FG000|NOT COMPLETED|Overall Study||0
3233029|NCT02358603|3964856|FG001|NOT COMPLETED|Overall Study||0
3233030|NCT02358668|3964865|FG000|STARTED|Overall Study||24
3233031|NCT02358668|3964866|FG001|STARTED|Overall Study||24
3233032|NCT02358668|3964867|FG002|STARTED|Overall Study||12
3233033|NCT02358668|3964865|FG000|COMPLETED|Overall Study||22
3233034|NCT02358668|3964866|FG001|COMPLETED|Overall Study||23
3233035|NCT02358668|3964867|FG002|COMPLETED|Overall Study||12
3233036|NCT02358668|3964865|FG000|NOT COMPLETED|Overall Study||2
3233037|NCT02358668|3964866|FG001|NOT COMPLETED|Overall Study||1
3233038|NCT02358668|3964867|FG002|NOT COMPLETED|Overall Study||0
3233039|NCT02358863|3964875|FG000|STARTED|Overall Study||13
3233040|NCT02358863|3964875|FG000|COMPLETED|Overall Study||10
3233041|NCT02358863|3964875|FG000|NOT COMPLETED|Overall Study||3
3233042|NCT02358876|3964879|FG000|STARTED|Overall Study||32
3233043|NCT02358876|3964879|FG000|COMPLETED|Overall Study|All 32 participants completed the in-clinic portion and 30 out of the 32 completed the home portion.|30
3233044|NCT02358876|3964879|FG000|NOT COMPLETED|Overall Study||2
3233045|NCT02358889|3964886|FG000|STARTED|Overall Study||30
3233046|NCT02358889|3964887|FG001|STARTED|Overall Study||30
3233047|NCT02358889|3964888|FG002|STARTED|Overall Study||28
3233048|NCT02358889|3964886|FG000|COMPLETED|Overall Study||30
3233049|NCT02358889|3964887|FG001|COMPLETED|Overall Study||28
3233050|NCT02358889|3964888|FG002|COMPLETED|Overall Study||27
3233051|NCT02358889|3964886|FG000|NOT COMPLETED|Overall Study||0
3233052|NCT02358889|3964887|FG001|NOT COMPLETED|Overall Study||2
3233053|NCT02358889|3964888|FG002|NOT COMPLETED|Overall Study||1
3233054|NCT02359006|3964898|FG000|STARTED|Overall Study||14
3233055|NCT02359006|3964899|FG001|STARTED|Overall Study||13
3233056|NCT02359006|3964898|FG000|COMPLETED|Overall Study||10
3233057|NCT02359006|3964899|FG001|COMPLETED|Overall Study||10
3233058|NCT02359006|3964898|FG000|NOT COMPLETED|Overall Study||4
3233059|NCT02359006|3964899|FG001|NOT COMPLETED|Overall Study||3
3233060|NCT02359019|3964907|FG000|STARTED|Overall Study||45
3233061|NCT02359019|3964907|FG000|COMPLETED|Overall Study||45
3233062|NCT02359019|3964907|FG000|NOT COMPLETED|Overall Study||0
3233063|NCT02359045|3964913|FG000|STARTED|Overall Study||40
3233064|NCT02359045|3964914|FG001|STARTED|Overall Study||42
3233065|NCT02359045|3964913|FG000|COMPLETED|Overall Study||36
3233066|NCT02359045|3964914|FG001|COMPLETED|Overall Study||39
3233067|NCT02359045|3964913|FG000|NOT COMPLETED|Overall Study||4
3233068|NCT02359045|3964914|FG001|NOT COMPLETED|Overall Study||3
3233069|NCT02359058|3964933|FG000|STARTED|Overall Study||6
3233070|NCT02359058|3964934|FG001|STARTED|Overall Study||6
3233071|NCT02359058|3964935|FG002|STARTED|Overall Study||6
3233072|NCT02359058|3964933|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6
3233073|NCT02359058|3964934|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6
3233074|NCT02359058|3964935|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
3233075|NCT02359058|3964933|FG000|COMPLETED|Overall Study||6
3233076|NCT02359058|3964934|FG001|COMPLETED|Overall Study||6
3233077|NCT02359058|3964935|FG002|COMPLETED|Overall Study||6
3233078|NCT02359058|3964933|FG000|NOT COMPLETED|Overall Study||0
3233079|NCT02359058|3964934|FG001|NOT COMPLETED|Overall Study||0
3233080|NCT02359058|3964935|FG002|NOT COMPLETED|Overall Study||0
3233081|NCT02359110|3964946|FG000|STARTED|Overall Study||55
3233082|NCT02359110|3964947|FG001|STARTED|Overall Study||54
3233083|NCT02359110|3964946|FG000|COMPLETED|Overall Study||55
3233084|NCT02359110|3964947|FG001|COMPLETED|Overall Study||54
3233085|NCT02359110|3964946|FG000|NOT COMPLETED|Overall Study||0
3233086|NCT02359110|3964947|FG001|NOT COMPLETED|Overall Study||0
3233087|NCT02359305|3964955|FG000|STARTED|Overall Study||34
3233088|NCT02359305|3964956|FG001|STARTED|Overall Study||34
3233089|NCT02359305|3964955|FG000|COMPLETED|Overall Study||34
3233090|NCT02359305|3964956|FG001|COMPLETED|Overall Study||34
3233091|NCT02359305|3964955|FG000|NOT COMPLETED|Overall Study||0
3233092|NCT02359305|3964956|FG001|NOT COMPLETED|Overall Study||0
3233093|NCT02359435|3964964|FG000|STARTED|Overall Study||220
3233094|NCT02359435|3964965|FG001|STARTED|Overall Study||220
3233095|NCT02359435|3964964|FG000|COMPLETED|Overall Study||216
3233096|NCT02359435|3964965|FG001|COMPLETED|Overall Study||216
3233097|NCT02359435|3964964|FG000|NOT COMPLETED|Overall Study||4
3233098|NCT02359435|3964965|FG001|NOT COMPLETED|Overall Study||4
3233099|NCT02359552|3964973|FG000|STARTED|Overall Study||25
3233100|NCT02359552|3964974|FG001|STARTED|Overall Study||25
3233101|NCT02359552|3964973|FG000|COMPLETED|Overall Study||22
3233102|NCT02359552|3964974|FG001|COMPLETED|Overall Study||21
3233103|NCT02359552|3964973|FG000|NOT COMPLETED|Overall Study||3
3233104|NCT02359552|3964974|FG001|NOT COMPLETED|Overall Study||4
3233105|NCT02359851|3964980|FG000|STARTED|Overall Study||5
3233106|NCT02359851|3964980|FG000|COMPLETED|Overall Study||3
3233107|NCT02359851|3964980|FG000|NOT COMPLETED|Overall Study||2
3233108|NCT02359877|3964988|FG000|STARTED|Overall Study||34
3233109|NCT02359877|3964989|FG001|STARTED|Overall Study||6
3233110|NCT02359877|3964990|FG002|STARTED|Overall Study||6
3233111|NCT02359877|3964991|FG003|STARTED|Overall Study||14
3233112|NCT02359877|3964988|FG000|COMPLETED|Overall Study||33
3233113|NCT02359877|3964989|FG001|COMPLETED|Overall Study||6
3233114|NCT02359877|3964990|FG002|COMPLETED|Overall Study||6
3233115|NCT02359877|3964991|FG003|COMPLETED|Overall Study||11
3233116|NCT02359877|3964988|FG000|NOT COMPLETED|Overall Study||1
3369334|NCT03807245|4100873|FG002|NOT COMPLETED|Overall Study||0
3369335|NCT03805971|4100881|FG000|STARTED|Overall Study||65
3369336|NCT03805971|4100881|FG000|COMPLETED|Overall Study||62
3369337|NCT03805971|4100881|FG000|NOT COMPLETED|Overall Study||3
3369338|NCT03802916|4100888|FG000|STARTED|Overall Study||15
3369339|NCT03802916|4100889|FG001|STARTED|Overall Study||15
3369340|NCT03802916|4100888|FG000|COMPLETED|Overall Study||15
3369341|NCT03802916|4100889|FG001|COMPLETED|Overall Study||13
3369342|NCT03802916|4100888|FG000|NOT COMPLETED|Overall Study||0
3369343|NCT03802916|4100889|FG001|NOT COMPLETED|Overall Study||2
3369344|NCT03809039|4100906|FG000|STARTED|Part 1|11 subjects (2 subjects in each of Part 1 MT-6345 1 mg, 5 mg, 20 mg, 60 mg, 240 mg, and 1 subject in Part 1 MT-6345 120 mg) received a matching placebo per their respective dose. The subjects are unique subjects, and were not counted more than once across any arms except for Part 2 Placebo.|11
3369345|NCT03809039|4100907|FG001|STARTED|Part 1|The subjects are unique subjects, and were not counted more than once across any arms.|6
3369346|NCT03809039|4100908|FG002|STARTED|Part 1|The subjects are unique subjects, and were not counted more than once across any arms.|6
3369347|NCT03809039|4100909|FG003|STARTED|Part 1|The subjects are unique subjects, and were not counted more than once across any arms except for Part 2 MT-6345 20mg.|6
3369348|NCT03809039|4100910|FG004|STARTED|Part 1|The subjects are unique subjects, and were not counted more than once across any arms.|6
3369349|NCT03809039|4100911|FG005|STARTED|Part 1|The subjects are unique subjects, and were not counted more than once across any arms.|4
3369350|NCT03809039|4100912|FG006|STARTED|Part 1|The subjects are unique subjects, and were not counted more than once across any arms.|5
3369351|NCT03809039|4100913|FG007|STARTED|Part 1||0
3369352|NCT03809039|4100914|FG008|STARTED|Part 1||0
3233117|NCT02359877|3964989|FG001|NOT COMPLETED|Overall Study||0
3233118|NCT02359877|3964990|FG002|NOT COMPLETED|Overall Study||0
3233119|NCT02359877|3964991|FG003|NOT COMPLETED|Overall Study||3
3233120|NCT02359890|3965019|FG000|STARTED|Overall Study|Patients who enrolled in the study are those who signed informed consent forms.|165
3233121|NCT02359890|3965019|FG000|Safety Population|Overall Study|Enrolled subjects who had the study catheter inserted|159
3233122|NCT02359890|3965019|FG000|mITT Population|Overall Study|Enrolled subjects who met the inclusion/exclusion criteria and had the study catheter inserted|155
3233123|NCT02359890|3965019|FG000|Per-Protocol (PP) Population|Overall Study|Subjects part of mITT population who had undergone RF ablation.|155
3233124|NCT02359890|3965019|FG000|COMPLETED|Overall Study||155
3233125|NCT02359890|3965019|FG000|NOT COMPLETED|Overall Study||10
3233126|NCT02359903|3965025|FG000|STARTED|Overall Study||45
3233127|NCT02359903|3965026|FG001|STARTED|Overall Study||45
3233128|NCT02359903|3965025|FG000|COMPLETED|Overall Study||45
3233129|NCT02359903|3965026|FG001|COMPLETED|Overall Study||43
3233130|NCT02359903|3965025|FG000|NOT COMPLETED|Overall Study||0
3233131|NCT02359903|3965026|FG001|NOT COMPLETED|Overall Study||2
3233132|NCT02359916|3965039|FG000|STARTED|Overall Study|The number of unique individuals in this study is unknown|
3233133|NCT02359916|3965040|FG001|STARTED|Overall Study|The number of unique individuals in this study is unknown|
3233134|NCT02359916|3965041|FG002|STARTED|Overall Study|The number of unique individuals in this study is unknown|
3233135|NCT02359916|3965042|FG003|STARTED|Overall Study|The number of unique individuals in this study is unknown|
3233136|NCT02359916|3965043|FG004|STARTED|Overall Study|The number of unique individuals in this study is unknown|
3233137|NCT02359916|3965044|FG005|STARTED|Overall Study|The number of unique individuals in this study is unknown|
3233138|NCT02359916|3965045|FG006|STARTED|Overall Study|The number of unique individuals in this study is unknown|
3233139|NCT02359916|3965039|FG000|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|
3233140|NCT02359916|3965040|FG001|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|
3233141|NCT02359916|3965041|FG002|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|
3233142|NCT02359916|3965042|FG003|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|
3233143|NCT02359916|3965043|FG004|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|
3233144|NCT02359916|3965044|FG005|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|
3233145|NCT02359916|3965045|FG006|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|
3233146|NCT02359916|3965039|FG000|NOT COMPLETED|Overall Study||
3233147|NCT02359916|3965040|FG001|NOT COMPLETED|Overall Study||
3233148|NCT02359916|3965041|FG002|NOT COMPLETED|Overall Study||
3233149|NCT02359916|3965042|FG003|NOT COMPLETED|Overall Study||
3233150|NCT02359916|3965043|FG004|NOT COMPLETED|Overall Study||
3233151|NCT02359916|3965044|FG005|NOT COMPLETED|Overall Study||
3233152|NCT02359916|3965045|FG006|NOT COMPLETED|Overall Study||
3233153|NCT02359955|3965062|FG000|STARTED|Overall Study||10
3233154|NCT02359955|3965063|FG001|STARTED|Overall Study||10
3233155|NCT02359955|3965062|FG000|COMPLETED|Overall Study||10
3233156|NCT02359955|3965063|FG001|COMPLETED|Overall Study||10
3233157|NCT02359955|3965062|FG000|NOT COMPLETED|Overall Study||0
3233158|NCT02359955|3965063|FG001|NOT COMPLETED|Overall Study||0
3233159|NCT02360085|3965079|FG000|STARTED|Overall Study||65
3233160|NCT02360085|3965079|FG000|COMPLETED|Overall Study||49
3233161|NCT02360085|3965079|FG000|NOT COMPLETED|Overall Study||16
3233162|NCT02360098|3965092|FG000|STARTED|Overall Study||36
3233163|NCT02360098|3965092|FG000|COMPLETED|Overall Study||29
3233164|NCT02360098|3965092|FG000|NOT COMPLETED|Overall Study||7
3233165|NCT02360124|3965100|FG000|STARTED|Overall Study||108
3233166|NCT02360124|3965101|FG001|STARTED|Overall Study||107
3233167|NCT02360124|3965102|FG002|STARTED|Overall Study||108
3233168|NCT02360124|3965100|FG000|COMPLETED|Overall Study||80
3233169|NCT02360124|3965101|FG001|COMPLETED|Overall Study||95
3233170|NCT02360124|3965102|FG002|COMPLETED|Overall Study||82
3233171|NCT02360124|3965100|FG000|NOT COMPLETED|Overall Study||28
3233172|NCT02360124|3965101|FG001|NOT COMPLETED|Overall Study||12
3233173|NCT02360124|3965102|FG002|NOT COMPLETED|Overall Study||26
3233174|NCT02360215|3965114|FG000|STARTED|Overall Study||257
3233175|NCT02360215|3965115|FG001|STARTED|Overall Study||261
3233176|NCT02360215|3965114|FG000|All Randomized Participants|Overall Study||257
3233177|NCT02360215|3965115|FG001|All Randomized Participants|Overall Study||261
3233178|NCT02360215|3965114|FG000|Started Protocol Treatment|Overall Study||232
3233179|NCT02360215|3965115|FG001|Started Protocol Treatment|Overall Study||223
3233180|NCT02360215|3965114|FG000|MDASI-BT Symptom Score|Overall Study||249
3233181|NCT02360215|3965115|FG001|MDASI-BT Symptom Score|Overall Study||251
3233182|NCT02360215|3965114|FG000|MDASI-BT Intererence Score|Overall Study||248
3233183|NCT02360215|3965115|FG001|MDASI-BT Intererence Score|Overall Study||251
3233184|NCT02360215|3965114|FG000|MDASI-BT Cognitive Factor Score|Overall Study||249
3233185|NCT02360215|3965115|FG001|MDASI-BT Cognitive Factor Score|Overall Study||251
3233186|NCT02360215|3965114|FG000|MDASI-BT Neurologic Factor Score|Overall Study||249
3233187|NCT02360215|3965115|FG001|MDASI-BT Neurologic Factor Score|Overall Study||251
3233188|NCT02360215|3965114|FG000|HVLT-R Total Recall|Overall Study||256
3233189|NCT02360215|3965115|FG001|HVLT-R Total Recall|Overall Study||259
3233190|NCT02360215|3965114|FG000|HVLT-R Delayed Recall|Overall Study||256
3233191|NCT02360215|3965115|FG001|HVLT-R Delayed Recall|Overall Study||259
3233192|NCT02360215|3965114|FG000|HVLT-R Recognition|Overall Study||255
3233193|NCT02360215|3965115|FG001|HVLT-R Recognition|Overall Study||259
3233194|NCT02360215|3965114|FG000|Trail Making Test (TMT) Part A|Overall Study||256
3233195|NCT02360215|3965115|FG001|Trail Making Test (TMT) Part A|Overall Study||260
3233196|NCT02360215|3965114|FG000|TMT Part B|Overall Study||250
3233197|NCT02360215|3965115|FG001|TMT Part B|Overall Study||257
3233198|NCT02360215|3965114|FG000|Controlled Oral Word Association (COWA)|Overall Study||257
3233199|NCT02360215|3965115|FG001|Controlled Oral Word Association (COWA)|Overall Study||261
3233200|NCT02360215|3965114|FG000|Clinical Trial Battery Composite Score|Overall Study||255
3233201|NCT02360215|3965115|FG001|Clinical Trial Battery Composite Score|Overall Study||259
3233202|NCT02360215|3965114|FG000|EQ-5D-5L Index at 2 Months|Overall Study||142
3233203|NCT02360215|3965115|FG001|EQ-5D-5L Index at 2 Months|Overall Study||125
3233204|NCT02360215|3965114|FG000|EQ-5D-5L Index at 4 Months|Overall Study||110
3233205|NCT02360215|3965115|FG001|EQ-5D-5L Index at 4 Months|Overall Study||96
3233206|NCT02360215|3965114|FG000|EQ-5D-5L Index at 6 Months|Overall Study||79
3233207|NCT02360215|3965115|FG001|EQ-5D-5L Index at 6 Months|Overall Study||70
3233208|NCT02360215|3965114|FG000|EQ-5D-5L Index at 12 Months|Overall Study||56
3233209|NCT02360215|3965115|FG001|EQ-5D-5L Index at 12 Months|Overall Study||45
3233210|NCT02360215|3965114|FG000|EQ-5D-5L VAS at 2 Months|Overall Study||139
3233211|NCT02360215|3965115|FG001|EQ-5D-5L VAS at 2 Months|Overall Study||123
3233212|NCT02360215|3965114|FG000|EQ-5D-5L VAS at 4 Months|Overall Study||104
3233213|NCT02360215|3965115|FG001|EQ-5D-5L VAS at 4 Months|Overall Study||193
3233214|NCT02360215|3965114|FG000|EQ-5D-5L VAS at 6 Months|Overall Study||76
3233215|NCT02360215|3965115|FG001|EQ-5D-5L VAS at 6 Months|Overall Study||69
3233216|NCT02360215|3965114|FG000|EQ-5D-5L VAS at 12 Months|Overall Study||57
3233217|NCT02360215|3965115|FG001|EQ-5D-5L VAS at 12 Months|Overall Study||48
3233218|NCT02360215|3965114|FG000|COMPLETED|Overall Study||257
3233219|NCT02360215|3965115|FG001|COMPLETED|Overall Study||261
3233220|NCT02360215|3965114|FG000|NOT COMPLETED|Overall Study||0
3233221|NCT02360215|3965115|FG001|NOT COMPLETED|Overall Study||0
3233222|NCT02360228|3965125|FG000|STARTED|Overall Study||9
3233223|NCT02360228|3965126|FG001|STARTED|Overall Study||8
3233224|NCT02360228|3965127|FG002|STARTED|Overall Study||8
3233225|NCT02360228|3965125|FG000|COMPLETED|Overall Study||8
3233226|NCT02360228|3965126|FG001|COMPLETED|Overall Study||7
3233227|NCT02360228|3965127|FG002|COMPLETED|Overall Study||7
3233228|NCT02360228|3965125|FG000|NOT COMPLETED|Overall Study||1
3233229|NCT02360228|3965126|FG001|NOT COMPLETED|Overall Study||1
3233230|NCT02360228|3965127|FG002|NOT COMPLETED|Overall Study||1
3233231|NCT02360280|3965137|FG000|STARTED|Overall Study||28
3233232|NCT02360280|3965138|FG001|STARTED|Overall Study||30
3233233|NCT02360280|3965137|FG000|COMPLETED|Overall Study||25
3233234|NCT02360280|3965138|FG001|COMPLETED|Overall Study||29
3233235|NCT02360280|3965137|FG000|NOT COMPLETED|Overall Study||3
3233236|NCT02360280|3965138|FG001|NOT COMPLETED|Overall Study||1
3233237|NCT02360293|3965146|FG000|STARTED|Overall Study||178
3233238|NCT02360293|3965147|FG001|STARTED|Overall Study||179
3233239|NCT02360293|3965146|FG000|6month f/u Survey|Overall Study||110
3233240|NCT02360293|3965147|FG001|6month f/u Survey|Overall Study||105
3233241|NCT02360293|3965146|FG000|6month Physical Activity|Overall Study||122
3233242|NCT02360293|3965147|FG001|6month Physical Activity|Overall Study||108
3233243|NCT02360293|3965146|FG000|12month f/u Survey|Overall Study||102
3233244|NCT02360293|3965147|FG001|12month f/u Survey|Overall Study||83
3233245|NCT02360293|3965146|FG000|12month Physical Activity|Overall Study||68
3233246|NCT02360293|3965147|FG001|12month Physical Activity|Overall Study||59
3233247|NCT02360293|3965146|FG000|COMPLETED|Overall Study||102
3233248|NCT02360293|3965147|FG001|COMPLETED|Overall Study||83
3233249|NCT02360293|3965146|FG000|NOT COMPLETED|Overall Study||76
3233250|NCT02360293|3965147|FG001|NOT COMPLETED|Overall Study||96
3233251|NCT02360319|3965155|FG000|STARTED|Overall Study||255
3233252|NCT02360319|3965156|FG001|STARTED|Overall Study||234
3233253|NCT02360319|3965155|FG000|COMPLETED|Overall Study||167
3233254|NCT02360319|3965156|FG001|COMPLETED|Overall Study||173
3233255|NCT02360319|3965155|FG000|NOT COMPLETED|Overall Study||88
3233256|NCT02360319|3965156|FG001|NOT COMPLETED|Overall Study||61
3233257|NCT02360371|3965164|FG000|STARTED|Overall Study||13
3233258|NCT02360371|3965165|FG001|STARTED|Overall Study||84
3233259|NCT02360371|3965164|FG000|Placebo (Oral)|Overall Study||13
3233260|NCT02360371|3965165|FG001|Placebo (Oral)|Overall Study||69
3233261|NCT02360371|3965164|FG000|Hydromorphone (Oral) 2mg|Overall Study||13
3233262|NCT02360371|3965165|FG001|Hydromorphone (Oral) 2mg|Overall Study||69
3233263|NCT02360371|3965164|FG000|Hydromorphone (Oral) 4mg|Overall Study||13
3233264|NCT02360371|3965165|FG001|Hydromorphone (Oral) 4mg|Overall Study||69
3233265|NCT02360371|3965164|FG000|Hydromorphone (Oral) 8mg|Overall Study||13
3233266|NCT02360371|3965165|FG001|Hydromorphone (Oral) 8mg|Overall Study||69
3233267|NCT02360371|3965164|FG000|COMPLETED|Overall Study||13
3233268|NCT02360371|3965165|FG001|COMPLETED|Overall Study||69
3233269|NCT02360371|3965164|FG000|NOT COMPLETED|Overall Study||0
3233270|NCT02360371|3965165|FG001|NOT COMPLETED|Overall Study||15
3233271|NCT02360397|3965175|FG000|STARTED|Overall Study||6
3233272|NCT02360397|3965175|FG000|COMPLETED|Overall Study||2
3233273|NCT02360397|3965175|FG000|NOT COMPLETED|Overall Study||4
3233274|NCT02360475|3965184|FG000|STARTED|Overall Study||126
3233275|NCT02360475|3965185|FG001|STARTED|Overall Study||124
3233276|NCT02360475|3965186|FG002|STARTED|Overall Study||125
3233277|NCT02360475|3965187|FG003|STARTED|Overall Study||125
3233278|NCT02360475|3965184|FG000|COMPLETED|Overall Study||122
3233279|NCT02360475|3965185|FG001|COMPLETED|Overall Study||111
3233280|NCT02360475|3965186|FG002|COMPLETED|Overall Study||117
3233281|NCT02360475|3965187|FG003|COMPLETED|Overall Study||120
3233282|NCT02360475|3965184|FG000|NOT COMPLETED|Overall Study||4
3233283|NCT02360475|3965185|FG001|NOT COMPLETED|Overall Study||13
3233284|NCT02360475|3965186|FG002|NOT COMPLETED|Overall Study||8
3233285|NCT02360475|3965187|FG003|NOT COMPLETED|Overall Study||5
3233286|NCT02360488|3965199|FG000|STARTED|Overall Study||62
3233287|NCT02360488|3965200|FG001|STARTED|Overall Study||62
3233288|NCT02360488|3965199|FG000|COMPLETED|Overall Study||59
3233289|NCT02360488|3965200|FG001|COMPLETED|Overall Study||55
3233290|NCT02360488|3965199|FG000|NOT COMPLETED|Overall Study||3
3233291|NCT02360488|3965200|FG001|NOT COMPLETED|Overall Study||7
3233292|NCT02360605|3965208|FG000|STARTED|Overall Study||311
3233293|NCT02360605|3965209|FG001|STARTED|Overall Study||309
3233294|NCT02360605|3965208|FG000|COMPLETED|Overall Study||300
3233295|NCT02360605|3965209|FG001|COMPLETED|Overall Study||291
3233296|NCT02360605|3965208|FG000|NOT COMPLETED|Overall Study||11
3233297|NCT02360605|3965209|FG001|NOT COMPLETED|Overall Study||18
3233298|NCT02360631|3965219|FG000|STARTED|Overall Study||300
3233299|NCT02360631|3965220|FG001|STARTED|Overall Study||200
3233300|NCT02360631|3965219|FG000|Week 12|Overall Study||249
3233301|NCT02360631|3965220|FG001|Week 12|Overall Study||165
3233302|NCT02360631|3965219|FG000|COMPLETED|Overall Study||267
3233303|NCT02360631|3965220|FG001|COMPLETED|Overall Study||174
3233304|NCT02360631|3965219|FG000|NOT COMPLETED|Overall Study||33
3233305|NCT02360631|3965220|FG001|NOT COMPLETED|Overall Study||26
3233306|NCT02360774|3965228|FG000|STARTED|Overall Study||15
3233307|NCT02360774|3965229|FG001|STARTED|Overall Study||15
3233308|NCT02360774|3965228|FG000|COMPLETED|Overall Study||12
3233309|NCT02360774|3965229|FG001|COMPLETED|Overall Study||13
3233310|NCT02360774|3965228|FG000|NOT COMPLETED|Overall Study||3
3233311|NCT02360774|3965229|FG001|NOT COMPLETED|Overall Study||2
3233312|NCT02360995|3965240|FG000|STARTED|Overall Study||43
3233313|NCT02360995|3965241|FG001|STARTED|Overall Study||43
3233314|NCT02360995|3965242|FG002|STARTED|Overall Study||43
3233315|NCT02360995|3965240|FG000|COMPLETED|Overall Study||41
3233316|NCT02360995|3965241|FG001|COMPLETED|Overall Study||42
3233317|NCT02360995|3965242|FG002|COMPLETED|Overall Study||41
3233318|NCT02360995|3965240|FG000|NOT COMPLETED|Overall Study||2
3233319|NCT02360995|3965241|FG001|NOT COMPLETED|Overall Study||1
3233320|NCT02360995|3965242|FG002|NOT COMPLETED|Overall Study||2
3233321|NCT02361216|3965252|FG000|STARTED|3 Day Treatment and 8 Week Follow/up||552
3233322|NCT02361216|3965253|FG001|STARTED|3 Day Treatment and 8 Week Follow/up||177
3233323|NCT02361216|3965252|FG000|COMPLETED|3 Day Treatment and 8 Week Follow/up||541
3233324|NCT02361216|3965253|FG001|COMPLETED|3 Day Treatment and 8 Week Follow/up||158
3233325|NCT02361216|3965252|FG000|NOT COMPLETED|3 Day Treatment and 8 Week Follow/up||11
3233326|NCT02361216|3965253|FG001|NOT COMPLETED|3 Day Treatment and 8 Week Follow/up||19
3233327|NCT02361216|3965252|FG000|STARTED|12-month Follow-up||541
3233328|NCT02361216|3965253|FG001|STARTED|12-month Follow-up|1 of the 158 subjects did not receive treatment and was also excluded from the 12-month follow-up.|157
3233329|NCT02361216|3965252|FG000|COMPLETED|12-month Follow-up||489
3233330|NCT02361216|3965253|FG001|COMPLETED|12-month Follow-up||130
3233331|NCT02361216|3965252|FG000|NOT COMPLETED|12-month Follow-up||52
3233332|NCT02361216|3965253|FG001|NOT COMPLETED|12-month Follow-up||27
3233333|NCT02361307|3965264|FG000|STARTED|Overall Study||18
3233334|NCT02361307|3965265|FG001|STARTED|Overall Study||18
3233335|NCT02361307|3965264|FG000|COMPLETED|Overall Study||18
3233336|NCT02361307|3965265|FG001|COMPLETED|Overall Study||17
3233337|NCT02361307|3965264|FG000|NOT COMPLETED|Overall Study||0
3233338|NCT02361307|3965265|FG001|NOT COMPLETED|Overall Study||1
3233339|NCT02361476|3965273|FG000|STARTED|Overall Study||191
3233340|NCT02361476|3965274|FG001|STARTED|Overall Study||188
3233341|NCT02361476|3965273|FG000|COMPLETED|Overall Study||191
3233342|NCT02361476|3965274|FG001|COMPLETED|Overall Study||188
3233343|NCT02361476|3965273|FG000|NOT COMPLETED|Overall Study||0
3233344|NCT02361476|3965274|FG001|NOT COMPLETED|Overall Study||0
3233345|NCT02361736|3965282|FG000|STARTED|Overall Study||60
3233346|NCT02361736|3965283|FG001|STARTED|Overall Study||60
3233347|NCT02361736|3965282|FG000|COMPLETED|Overall Study||59
3233348|NCT02361736|3965283|FG001|COMPLETED|Overall Study||59
3233349|NCT02361736|3965282|FG000|NOT COMPLETED|Overall Study||1
3233350|NCT02361736|3965283|FG001|NOT COMPLETED|Overall Study||1
3233351|NCT02361762|3965291|FG000|STARTED|Overall Study||35
3233352|NCT02361762|3965292|FG001|STARTED|Overall Study||35
3233353|NCT02361762|3965291|FG000|COMPLETED|Overall Study||35
3233354|NCT02361762|3965292|FG001|COMPLETED|Overall Study||33
3233355|NCT02361762|3965291|FG000|NOT COMPLETED|Overall Study||0
3233356|NCT02361762|3965292|FG001|NOT COMPLETED|Overall Study||2
3233357|NCT02362048|3965300|FG000|STARTED|Overall Study|37 enrolled but only 35 received study medication.|37
3233358|NCT02362048|3965301|FG001|STARTED|Overall Study|40 enrolled but only 38 received study medication.|40
3233359|NCT02362048|3965300|FG000|Enrolled|Overall Study||37
3233360|NCT02362048|3965301|FG001|Enrolled|Overall Study||40
3233361|NCT02362048|3965300|FG000|Received Study Medication|Overall Study||35
3233362|NCT02362048|3965301|FG001|Received Study Medication|Overall Study||38
3233363|NCT02362048|3965300|FG000|Discontinued Study|Overall Study||37
3233364|NCT02362048|3965301|FG001|Discontinued Study|Overall Study||40
3233365|NCT02362048|3965300|FG000|COMPLETED|Overall Study||0
3233366|NCT02362048|3965301|FG001|COMPLETED|Overall Study||0
3233367|NCT02362048|3965300|FG000|NOT COMPLETED|Overall Study||37
3233368|NCT02362048|3965301|FG001|NOT COMPLETED|Overall Study||40
3233369|NCT02362191|3965307|FG000|STARTED|Overall Study||5
3233370|NCT02362191|3965307|FG000|COMPLETED|Overall Study||3
3233371|NCT02362191|3965307|FG000|NOT COMPLETED|Overall Study||2
3233372|NCT02362269|3965313|FG000|STARTED|Overall Study||83
3233373|NCT02362269|3965314|FG001|STARTED|Overall Study||86
3233374|NCT02362269|3965313|FG000|COMPLETED|Overall Study||82
3233375|NCT02362269|3965314|FG001|COMPLETED|Overall Study||80
3233376|NCT02362269|3965313|FG000|NOT COMPLETED|Overall Study||1
3233377|NCT02362269|3965314|FG001|NOT COMPLETED|Overall Study||6
3233378|NCT02362282|3965322|FG000|STARTED|Overall Study||5
3233379|NCT02362282|3965323|FG001|STARTED|Overall Study||7
3233380|NCT02362282|3965322|FG000|COMPLETED|Overall Study||4
3233381|NCT02362282|3965323|FG001|COMPLETED|Overall Study||7
3233382|NCT02362282|3965322|FG000|NOT COMPLETED|Overall Study||1
3233383|NCT02362282|3965323|FG001|NOT COMPLETED|Overall Study||0
3233384|NCT02362321|3965331|FG000|STARTED|Overall Study||10
3233385|NCT02362321|3965332|FG001|STARTED|Overall Study||10
3233386|NCT02362321|3965331|FG000|COMPLETED|Overall Study||6
3233387|NCT02362321|3965332|FG001|COMPLETED|Overall Study||10
3233388|NCT02362321|3965331|FG000|NOT COMPLETED|Overall Study||4
3233389|NCT02362321|3965332|FG001|NOT COMPLETED|Overall Study||0
3233390|NCT02362360|3965338|FG000|STARTED|Period 1||26
3233391|NCT02362360|3965339|FG001|STARTED|Period 1||26
3233392|NCT02362360|3965338|FG000|COMPLETED|Period 1||23
3233393|NCT02362360|3965339|FG001|COMPLETED|Period 1||25
3233394|NCT02362360|3965338|FG000|NOT COMPLETED|Period 1||3
3233395|NCT02362360|3965339|FG001|NOT COMPLETED|Period 1||1
3233396|NCT02362360|3965338|FG000|STARTED|Period 2||23
3233397|NCT02362360|3965339|FG001|STARTED|Period 2||25
3233398|NCT02362360|3965338|FG000|COMPLETED|Period 2||23
3233399|NCT02362360|3965339|FG001|COMPLETED|Period 2||25
3233400|NCT02362360|3965338|FG000|NOT COMPLETED|Period 2||0
3233401|NCT02362360|3965339|FG001|NOT COMPLETED|Period 2||0
3233402|NCT02362373|3965345|FG000|STARTED|Overall Study||20
3233403|NCT02362373|3965345|FG000|COMPLETED|Overall Study||20
3233404|NCT02362373|3965345|FG000|NOT COMPLETED|Overall Study||0
3233405|NCT02362412|3965349|FG000|STARTED|Treatment Period II||9
3233406|NCT02362412|3965350|FG001|STARTED|Treatment Period II||11
3233407|NCT02362412|3965349|FG000|TREATED|Treatment Period II||9
3233408|NCT02362412|3965350|FG001|TREATED|Treatment Period II||11
3233409|NCT02362412|3965349|FG000|COMPLETED|Treatment Period II||9
3233410|NCT02362412|3965350|FG001|COMPLETED|Treatment Period II||11
3233411|NCT02362412|3965349|FG000|NOT COMPLETED|Treatment Period II||0
3233412|NCT02362412|3965350|FG001|NOT COMPLETED|Treatment Period II||0
3233413|NCT02362412|3965349|FG000|STARTED|Treatment Period III||9
3233414|NCT02362412|3965350|FG001|STARTED|Treatment Period III||11
3233415|NCT02362412|3965349|FG000|TREATED|Treatment Period III||9
3233416|NCT02362412|3965350|FG001|TREATED|Treatment Period III||11
3233417|NCT02362412|3965349|FG000|COMPLETED|Treatment Period III||9
3233418|NCT02362412|3965350|FG001|COMPLETED|Treatment Period III||10
3233419|NCT02362412|3965349|FG000|NOT COMPLETED|Treatment Period III||0
3233420|NCT02362412|3965350|FG001|NOT COMPLETED|Treatment Period III||1
3233421|NCT02362425|3965366|FG000|STARTED|Phase 1 (up to 6 Months)||53
3233422|NCT02362425|3965367|FG001|STARTED|Phase 1 (up to 6 Months)||10
3233423|NCT02362425|3965368|FG002|STARTED|Phase 1 (up to 6 Months)||0
3233424|NCT02362425|3965369|FG003|STARTED|Phase 1 (up to 6 Months)||0
3233425|NCT02362425|3965366|FG000|COMPLETED|Phase 1 (up to 6 Months)||37
3233426|NCT02362425|3965367|FG001|COMPLETED|Phase 1 (up to 6 Months)||10
3233427|NCT02362425|3965368|FG002|COMPLETED|Phase 1 (up to 6 Months)||0
3233428|NCT02362425|3965369|FG003|COMPLETED|Phase 1 (up to 6 Months)||0
3233429|NCT02362425|3965366|FG000|NOT COMPLETED|Phase 1 (up to 6 Months)||16
3233430|NCT02362425|3965367|FG001|NOT COMPLETED|Phase 1 (up to 6 Months)||0
3233431|NCT02362425|3965368|FG002|NOT COMPLETED|Phase 1 (up to 6 Months)||0
3233432|NCT02362425|3965369|FG003|NOT COMPLETED|Phase 1 (up to 6 Months)||0
3233433|NCT02362425|3965366|FG000|STARTED|Phase 2 (up to 6 Months, Randomized)||0
3233434|NCT02362425|3965367|FG001|STARTED|Phase 2 (up to 6 Months, Randomized)||0
3233435|NCT02362425|3965368|FG002|STARTED|Phase 2 (up to 6 Months, Randomized)||16
3233436|NCT02362425|3965369|FG003|STARTED|Phase 2 (up to 6 Months, Randomized)||17
3233437|NCT02362425|3965366|FG000|COMPLETED|Phase 2 (up to 6 Months, Randomized)||0
3233438|NCT02362425|3965367|FG001|COMPLETED|Phase 2 (up to 6 Months, Randomized)||0
3233439|NCT02362425|3965368|FG002|COMPLETED|Phase 2 (up to 6 Months, Randomized)||15
3233440|NCT02362425|3965369|FG003|COMPLETED|Phase 2 (up to 6 Months, Randomized)||14
3233441|NCT02362425|3965366|FG000|NOT COMPLETED|Phase 2 (up to 6 Months, Randomized)||0
3233442|NCT02362425|3965367|FG001|NOT COMPLETED|Phase 2 (up to 6 Months, Randomized)||0
3233443|NCT02362425|3965368|FG002|NOT COMPLETED|Phase 2 (up to 6 Months, Randomized)||1
3233444|NCT02362425|3965369|FG003|NOT COMPLETED|Phase 2 (up to 6 Months, Randomized)||3
3233445|NCT02362503|3965383|FG000|STARTED|Double-blind Period-Up to 8 Days||69
3233446|NCT02362503|3965384|FG001|STARTED|Double-blind Period-Up to 8 Days||203
3233447|NCT02362503|3965385|FG002|STARTED|Double-blind Period-Up to 8 Days||0
3233448|NCT02362503|3965383|FG000|COMPLETED|Double-blind Period-Up to 8 Days||68
3233449|NCT02362503|3965384|FG001|COMPLETED|Double-blind Period-Up to 8 Days||199
3233450|NCT02362503|3965385|FG002|COMPLETED|Double-blind Period-Up to 8 Days||0
3233451|NCT02362503|3965383|FG000|NOT COMPLETED|Double-blind Period-Up to 8 Days||1
3233452|NCT02362503|3965384|FG001|NOT COMPLETED|Double-blind Period-Up to 8 Days||4
3233453|NCT02362503|3965385|FG002|NOT COMPLETED|Double-blind Period-Up to 8 Days||0
3233454|NCT02362503|3965383|FG000|STARTED|Open Label Period-Up to 96 Weeks||68
3233455|NCT02362503|3965384|FG001|STARTED|Open Label Period-Up to 96 Weeks||199
3233456|NCT02362503|3965385|FG002|STARTED|Open Label Period-Up to 96 Weeks||99
3233457|NCT02362503|3965383|FG000|COMPLETED|Open Label Period-Up to 96 Weeks||0
3233458|NCT02362503|3965384|FG001|COMPLETED|Open Label Period-Up to 96 Weeks||0
3233459|NCT02362503|3965385|FG002|COMPLETED|Open Label Period-Up to 96 Weeks||0
3233460|NCT02362503|3965383|FG000|NOT COMPLETED|Open Label Period-Up to 96 Weeks||68
3233461|NCT02362503|3965384|FG001|NOT COMPLETED|Open Label Period-Up to 96 Weeks||199
3233462|NCT02362503|3965385|FG002|NOT COMPLETED|Open Label Period-Up to 96 Weeks||99
3233463|NCT02362594|3965398|FG000|STARTED|Overall Study||514
3233464|NCT02362594|3965399|FG001|STARTED|Overall Study||505
3233465|NCT02362594|3965398|FG000|Treated|Overall Study||509
3233466|NCT02362594|3965399|FG001|Treated|Overall Study||502
3233467|NCT02362594|3965398|FG000|Continuing Part 1 Adjuvant Therapy|Overall Study||41
3233468|NCT02362594|3965399|FG001|Continuing Part 1 Adjuvant Therapy|Overall Study||21
3233469|NCT02362594|3965398|FG000|COMPLETED|Overall Study||264
3233470|NCT02362594|3965399|FG001|COMPLETED|Overall Study||280
3233471|NCT02362594|3965398|FG000|NOT COMPLETED|Overall Study||250
3233472|NCT02362594|3965399|FG001|NOT COMPLETED|Overall Study||225
3233473|NCT02362646|3965407|FG000|STARTED|Overall Study||106
3233474|NCT02362646|3965408|FG001|STARTED|Overall Study||53
3233475|NCT02362646|3965407|FG000|COMPLETED|Overall Study||68
3233476|NCT02362646|3965408|FG001|COMPLETED|Overall Study||29
3369353|NCT03809039|4100906|FG000|COMPLETED|Part 1||10
3369354|NCT03809039|4100907|FG001|COMPLETED|Part 1||6
3369355|NCT03809039|4100908|FG002|COMPLETED|Part 1||6
3369356|NCT03809039|4100909|FG003|COMPLETED|Part 1||5
3369357|NCT03809039|4100910|FG004|COMPLETED|Part 1||6
3369358|NCT03809039|4100911|FG005|COMPLETED|Part 1||4
3369359|NCT03809039|4100912|FG006|COMPLETED|Part 1||5
3369360|NCT03809039|4100913|FG007|COMPLETED|Part 1||0
3369361|NCT03809039|4100914|FG008|COMPLETED|Part 1||0
3369362|NCT03809039|4100906|FG000|NOT COMPLETED|Part 1||1
3369363|NCT03809039|4100907|FG001|NOT COMPLETED|Part 1||0
3369364|NCT03809039|4100908|FG002|NOT COMPLETED|Part 1||0
3369365|NCT03809039|4100909|FG003|NOT COMPLETED|Part 1||1
3369366|NCT03809039|4100910|FG004|NOT COMPLETED|Part 1||0
3369367|NCT03809039|4100911|FG005|NOT COMPLETED|Part 1||0
3369368|NCT03809039|4100912|FG006|NOT COMPLETED|Part 1||0
3369369|NCT03809039|4100913|FG007|NOT COMPLETED|Part 1||0
3369370|NCT03809039|4100914|FG008|NOT COMPLETED|Part 1||0
3369371|NCT03809039|4100906|FG000|STARTED|Part 2|2 subjects who received a matching placebo per Part 1 MT-6345 20mg were selected to return for Part 2. Out of 2 subjects, only 1 subject received the placebo, and another subject withdrew the consent after Part 1. Therefore, this 1 subject is not a unique subject and was not counted again in the total number of exposed subjects.|1
3369372|NCT03809039|4100907|FG001|STARTED|Part 2||0
3369373|NCT03809039|4100908|FG002|STARTED|Part 2||0
3233477|NCT02362646|3965407|FG000|NOT COMPLETED|Overall Study||38
3233478|NCT02362646|3965408|FG001|NOT COMPLETED|Overall Study||24
3233479|NCT02362672|3965418|FG000|STARTED|Titration Phase||1189
3233480|NCT02362672|3965419|FG001|STARTED|Titration Phase||0
3233481|NCT02362672|3965420|FG002|STARTED|Titration Phase||0
3233482|NCT02362672|3965418|FG000|COMPLETED|Titration Phase||610
3233483|NCT02362672|3965419|FG001|COMPLETED|Titration Phase||0
3233484|NCT02362672|3965420|FG002|COMPLETED|Titration Phase||0
3233485|NCT02362672|3965418|FG000|NOT COMPLETED|Titration Phase||579
3233486|NCT02362672|3965419|FG001|NOT COMPLETED|Titration Phase||0
3233487|NCT02362672|3965420|FG002|NOT COMPLETED|Titration Phase||0
3233488|NCT02362672|3965418|FG000|STARTED|Double-blind Maintenance Phase||0
3233489|NCT02362672|3965419|FG001|STARTED|Double-blind Maintenance Phase||309
3233490|NCT02362672|3965420|FG002|STARTED|Double-blind Maintenance Phase||301
3233491|NCT02362672|3965418|FG000|COMPLETED|Double-blind Maintenance Phase||0
3233492|NCT02362672|3965419|FG001|COMPLETED|Double-blind Maintenance Phase||249
3233493|NCT02362672|3965420|FG002|COMPLETED|Double-blind Maintenance Phase||242
3233494|NCT02362672|3965418|FG000|NOT COMPLETED|Double-blind Maintenance Phase||0
3233495|NCT02362672|3965419|FG001|NOT COMPLETED|Double-blind Maintenance Phase||60
3233496|NCT02362672|3965420|FG002|NOT COMPLETED|Double-blind Maintenance Phase||59
3233497|NCT02362724|3965431|FG000|STARTED|Overall Study||59
3233498|NCT02362724|3965432|FG001|STARTED|Overall Study||30
3233499|NCT02362724|3965431|FG000|COMPLETED|Overall Study||53
3233500|NCT02362724|3965432|FG001|COMPLETED|Overall Study||29
3233501|NCT02362724|3965431|FG000|NOT COMPLETED|Overall Study||6
3233502|NCT02362724|3965432|FG001|NOT COMPLETED|Overall Study||1
3233503|NCT02362789|3965440|FG000|STARTED|Run-in Phase (Week 0 to 16)||130
3233504|NCT02362789|3965441|FG001|STARTED|Run-in Phase (Week 0 to 16)||0
3233505|NCT02362789|3965442|FG002|STARTED|Run-in Phase (Week 0 to 16)||0
3233506|NCT02362789|3965440|FG000|COMPLETED|Run-in Phase (Week 0 to 16)||128
3233507|NCT02362789|3965441|FG001|COMPLETED|Run-in Phase (Week 0 to 16)||0
3233508|NCT02362789|3965442|FG002|COMPLETED|Run-in Phase (Week 0 to 16)||0
3233509|NCT02362789|3965440|FG000|NOT COMPLETED|Run-in Phase (Week 0 to 16)||2
3233510|NCT02362789|3965441|FG001|NOT COMPLETED|Run-in Phase (Week 0 to 16)||0
3233511|NCT02362789|3965442|FG002|NOT COMPLETED|Run-in Phase (Week 0 to 16)||0
3233512|NCT02362789|3965440|FG000|STARTED|Randomized Withdrawal (Wk 16 to 32)|N/A. Run-in phase completed.|0
3233513|NCT02362789|3965441|FG001|STARTED|Randomized Withdrawal (Wk 16 to 32)|Subjects achieving PASI reduction by 98-100% vs. baseline during Run-In|42
3233514|NCT02362789|3965442|FG002|STARTED|Randomized Withdrawal (Wk 16 to 32)|Subjects achieving PASI reduction by 98-100% vs. baseline during Run-In|38
3233515|NCT02362789|3965440|FG000|COMPLETED|Randomized Withdrawal (Wk 16 to 32)||0
3233516|NCT02362789|3965441|FG001|COMPLETED|Randomized Withdrawal (Wk 16 to 32)||38
3233517|NCT02362789|3965442|FG002|COMPLETED|Randomized Withdrawal (Wk 16 to 32)||26
3233518|NCT02362789|3965440|FG000|NOT COMPLETED|Randomized Withdrawal (Wk 16 to 32)||0
3233519|NCT02362789|3965441|FG001|NOT COMPLETED|Randomized Withdrawal (Wk 16 to 32)||4
3233520|NCT02362789|3965442|FG002|NOT COMPLETED|Randomized Withdrawal (Wk 16 to 32)||12
3233521|NCT02363010|3965452|FG000|STARTED|Overall Study||110
3233522|NCT02363010|3965453|FG001|STARTED|Overall Study||105
3233523|NCT02363010|3965454|FG002|STARTED|Overall Study||105
3233524|NCT02363010|3965452|FG000|COMPLETED|Overall Study||88
3233525|NCT02363010|3965453|FG001|COMPLETED|Overall Study||94
3233526|NCT02363010|3965454|FG002|COMPLETED|Overall Study||89
3233527|NCT02363010|3965452|FG000|NOT COMPLETED|Overall Study||22
3233528|NCT02363010|3965453|FG001|NOT COMPLETED|Overall Study||11
3233529|NCT02363010|3965454|FG002|NOT COMPLETED|Overall Study||16
3233530|NCT02363270|3965464|FG000|STARTED|Overall Study||24
3233531|NCT02363270|3965465|FG001|STARTED|Overall Study||24
3233532|NCT02363270|3965464|FG000|COMPLETED|Overall Study||24
3233533|NCT02363270|3965465|FG001|COMPLETED|Overall Study||24
3233534|NCT02363270|3965464|FG000|NOT COMPLETED|Overall Study||0
3233535|NCT02363270|3965465|FG001|NOT COMPLETED|Overall Study||0
3233536|NCT02363283|3965471|FG000|STARTED|Overall Study||37
3233537|NCT02363283|3965471|FG000|COMPLETED|Overall Study||35
3233538|NCT02363283|3965471|FG000|NOT COMPLETED|Overall Study||2
3233539|NCT02363322|3965477|FG000|STARTED|Overall Study||36
3233540|NCT02363322|3965478|FG001|STARTED|Overall Study||36
3233541|NCT02363322|3965477|FG000|COMPLETED|Overall Study||35
3233542|NCT02363322|3965478|FG001|COMPLETED|Overall Study||36
3233543|NCT02363322|3965477|FG000|NOT COMPLETED|Overall Study||1
3233544|NCT02363322|3965478|FG001|NOT COMPLETED|Overall Study||0
3233545|NCT02363439|3965484|FG000|STARTED|Overall Study||5
3233546|NCT02363439|3965484|FG000|COMPLETED|Overall Study||1
3233547|NCT02363439|3965484|FG000|NOT COMPLETED|Overall Study||4
3233548|NCT02363478|3965488|FG000|STARTED|Overall Study||30
3233549|NCT02363478|3965488|FG000|COMPLETED|Overall Study||22
3233550|NCT02363478|3965488|FG000|NOT COMPLETED|Overall Study||8
3233551|NCT02363621|3965495|FG000|STARTED|Overall Study||51
3233552|NCT02363621|3965496|FG001|STARTED|Overall Study||50
3233553|NCT02363621|3965495|FG000|COMPLETED|Overall Study||50
3233554|NCT02363621|3965496|FG001|COMPLETED|Overall Study||50
3233555|NCT02363621|3965495|FG000|NOT COMPLETED|Overall Study||1
3233556|NCT02363621|3965496|FG001|NOT COMPLETED|Overall Study||0
3233557|NCT02363686|3965502|FG000|STARTED|Overall Study||248
3233558|NCT02363686|3965502|FG000|COMPLETED|Overall Study||213
3233559|NCT02363686|3965502|FG000|NOT COMPLETED|Overall Study||35
3233560|NCT02363738|3965508|FG000|STARTED|Overall Study||29
3233561|NCT02363738|3965509|FG001|STARTED|Overall Study||31
3233562|NCT02363738|3965508|FG000|COMPLETED|Overall Study||21
3233563|NCT02363738|3965509|FG001|COMPLETED|Overall Study||26
3233564|NCT02363738|3965508|FG000|NOT COMPLETED|Overall Study||8
3233565|NCT02363738|3965509|FG001|NOT COMPLETED|Overall Study||5
3233566|NCT02363803|3965517|FG000|STARTED|Period 1||17
3233567|NCT02363803|3965518|FG001|STARTED|Period 1||17
3233568|NCT02363803|3965517|FG000|COMPLETED|Period 1||17
3233569|NCT02363803|3965518|FG001|COMPLETED|Period 1||17
3233570|NCT02363803|3965517|FG000|NOT COMPLETED|Period 1||0
3233571|NCT02363803|3965518|FG001|NOT COMPLETED|Period 1||0
3233572|NCT02363803|3965517|FG000|STARTED|Period 2||17
3233573|NCT02363803|3965518|FG001|STARTED|Period 2|One participant did not return for Period 2 treatment|16
3233574|NCT02363803|3965517|FG000|COMPLETED|Period 2||17
3233575|NCT02363803|3965518|FG001|COMPLETED|Period 2||16
3233576|NCT02363803|3965517|FG000|NOT COMPLETED|Period 2||0
3233577|NCT02363803|3965518|FG001|NOT COMPLETED|Period 2||0
3233578|NCT02363907|3965530|FG000|STARTED|Overall Study||30
3233579|NCT02363907|3965530|FG000|COMPLETED|Overall Study||30
3233580|NCT02363907|3965530|FG000|NOT COMPLETED|Overall Study||0
3369374|NCT03809039|4100909|FG003|STARTED|Part 2|6 subjects in Part 1 MT-6345 20mg were selected to return for Part 2. Out of 6 subjects, only 5 subjects received MT-6345, and 1 subject withdrew the consent after Part 1. Therefore, these 5 subjects are not a unique subject and were not counted again in the total number of exposed subjects.|5
3369375|NCT03809039|4100910|FG004|STARTED|Part 2||0
3369376|NCT03809039|4100911|FG005|STARTED|Part 2||0
3369377|NCT03809039|4100912|FG006|STARTED|Part 2||0
3369378|NCT03809039|4100913|FG007|STARTED|Part 2||0
3369379|NCT03809039|4100914|FG008|STARTED|Part 2||0
3369380|NCT03809039|4100906|FG000|COMPLETED|Part 2||1
3369381|NCT03809039|4100907|FG001|COMPLETED|Part 2||0
3369382|NCT03809039|4100908|FG002|COMPLETED|Part 2||0
3369383|NCT03809039|4100909|FG003|COMPLETED|Part 2||5
3233581|NCT02363933|3965534|FG000|STARTED|Overall Study||8
3233582|NCT02363933|3965534|FG000|COMPLETED|Overall Study||2
3233583|NCT02363933|3965534|FG000|NOT COMPLETED|Overall Study||6
3233584|NCT02363946|3965551|FG000|STARTED|Overall Study||4
3233585|NCT02363946|3965552|FG001|STARTED|Overall Study||4
3233586|NCT02363946|3965553|FG002|STARTED|Overall Study||4
3233587|NCT02363946|3965554|FG003|STARTED|Overall Study||4
3233588|NCT02363946|3965555|FG004|STARTED|Overall Study||4
3233589|NCT02363946|3965556|FG005|STARTED|Overall Study||4
3233590|NCT02363946|3965557|FG006|STARTED|Overall Study||4
3233591|NCT02363946|3965558|FG007|STARTED|Overall Study||4
3233592|NCT02363946|3965559|FG008|STARTED|Overall Study||4
3233593|NCT02363946|3965560|FG009|STARTED|Overall Study||18
3233594|NCT02363946|3965561|FG010|STARTED|Overall Study||4
3233595|NCT02363946|3965562|FG011|STARTED|Overall Study||3
3233596|NCT02363946|3965563|FG012|STARTED|Overall Study||4
3233597|NCT02363946|3965551|FG000|COMPLETED|Overall Study||4
3233598|NCT02363946|3965552|FG001|COMPLETED|Overall Study||4
3233599|NCT02363946|3965553|FG002|COMPLETED|Overall Study||4
3233600|NCT02363946|3965554|FG003|COMPLETED|Overall Study||4
3233601|NCT02363946|3965555|FG004|COMPLETED|Overall Study||4
3233602|NCT02363946|3965556|FG005|COMPLETED|Overall Study||4
3233603|NCT02363946|3965557|FG006|COMPLETED|Overall Study||4
3233604|NCT02363946|3965558|FG007|COMPLETED|Overall Study||3
3233605|NCT02363946|3965559|FG008|COMPLETED|Overall Study||4
3233606|NCT02363946|3965560|FG009|COMPLETED|Overall Study||18
3233607|NCT02363946|3965561|FG010|COMPLETED|Overall Study||4
3233608|NCT02363946|3965562|FG011|COMPLETED|Overall Study||3
3233609|NCT02363946|3965563|FG012|COMPLETED|Overall Study||4
3233610|NCT02363946|3965551|FG000|NOT COMPLETED|Overall Study||0
3233611|NCT02363946|3965552|FG001|NOT COMPLETED|Overall Study||0
3233612|NCT02363946|3965553|FG002|NOT COMPLETED|Overall Study||0
3233613|NCT02363946|3965554|FG003|NOT COMPLETED|Overall Study||0
3233614|NCT02363946|3965555|FG004|NOT COMPLETED|Overall Study||0
3233615|NCT02363946|3965556|FG005|NOT COMPLETED|Overall Study||0
3233616|NCT02363946|3965557|FG006|NOT COMPLETED|Overall Study||0
3233617|NCT02363946|3965558|FG007|NOT COMPLETED|Overall Study||1
3233618|NCT02363946|3965559|FG008|NOT COMPLETED|Overall Study||0
3233619|NCT02363946|3965560|FG009|NOT COMPLETED|Overall Study||0
3233620|NCT02363946|3965561|FG010|NOT COMPLETED|Overall Study||0
3233621|NCT02363946|3965562|FG011|NOT COMPLETED|Overall Study||0
3233622|NCT02363946|3965563|FG012|NOT COMPLETED|Overall Study||0
3233623|NCT02363959|3965593|FG000|STARTED|Overall Study||10
3233624|NCT02363959|3965594|FG001|STARTED|Overall Study||10
3233625|NCT02363959|3965593|FG000|COMPLETED|Overall Study||9
3233626|NCT02363959|3965594|FG001|COMPLETED|Overall Study||10
3233627|NCT02363959|3965593|FG000|NOT COMPLETED|Overall Study||1
3233628|NCT02363959|3965594|FG001|NOT COMPLETED|Overall Study||0
3233629|NCT02363972|3965600|FG000|STARTED|Overall Study||103
3233630|NCT02363972|3965600|FG000|COMPLETED|Overall Study||77
3233631|NCT02363972|3965600|FG000|NOT COMPLETED|Overall Study||26
3233632|NCT02363998|3965604|FG000|STARTED|Overall Study||286
3233633|NCT02363998|3965604|FG000|COMPLETED|Overall Study|A subject was defined as completed if at least one dose was taken on Day 7.|168
3233634|NCT02363998|3965604|FG000|NOT COMPLETED|Overall Study||118
3233635|NCT02364037|3965626|FG000|STARTED|Overall Study||502
3233636|NCT02364037|3965627|FG001|STARTED|Overall Study||506
3233637|NCT02364037|3965626|FG000|COMPLETED|Overall Study||458
3233638|NCT02364037|3965627|FG001|COMPLETED|Overall Study||453
3233639|NCT02364037|3965626|FG000|NOT COMPLETED|Overall Study||44
3233640|NCT02364037|3965627|FG001|NOT COMPLETED|Overall Study||53
3233641|NCT02364076|3965633|FG000|STARTED|Overall Study||45
3233642|NCT02364076|3965633|FG000|COMPLETED|Overall Study||40
3233643|NCT02364076|3965633|FG000|NOT COMPLETED|Overall Study||5
3233644|NCT02364180|3965637|FG000|STARTED|Overall Study||11
3233645|NCT02364180|3965637|FG000|COMPLETED|Overall Study||10
3233646|NCT02364180|3965637|FG000|NOT COMPLETED|Overall Study||1
3233647|NCT02364271|3965643|FG000|STARTED|Overall Study||479
3233648|NCT02364271|3965644|FG001|STARTED|Overall Study||123
3233649|NCT02364271|3965643|FG000|COMPLETED|Overall Study||479
3233650|NCT02364271|3965644|FG001|COMPLETED|Overall Study||123
3233651|NCT02364271|3965643|FG000|NOT COMPLETED|Overall Study||0
3233652|NCT02364271|3965644|FG001|NOT COMPLETED|Overall Study||0
3233653|NCT02364336|3965653|FG000|STARTED|Overall Study||1
3233654|NCT02364336|3965654|FG001|STARTED|Overall Study||12
3233655|NCT02364336|3965653|FG000|6 Hours Post First Peginterferon Inject|Overall Study||1
3233656|NCT02364336|3965654|FG001|6 Hours Post First Peginterferon Inject|Overall Study||12
3233657|NCT02364336|3965653|FG000|End of Peginterferon Treatment|Overall Study||1
3233658|NCT02364336|3965654|FG001|End of Peginterferon Treatment|Overall Study||11
3233659|NCT02364336|3965653|FG000|24 Weeks After End of Peginterferon|Overall Study||1
3233660|NCT02364336|3965654|FG001|24 Weeks After End of Peginterferon|Overall Study||11
3233661|NCT02364336|3965653|FG000|48 Weeks After End of Peginterferon|Overall Study||1
3233662|NCT02364336|3965654|FG001|48 Weeks After End of Peginterferon|Overall Study||10
3233663|NCT02364336|3965653|FG000|COMPLETED|Overall Study||1
3233664|NCT02364336|3965654|FG001|COMPLETED|Overall Study||11
3233665|NCT02364336|3965653|FG000|NOT COMPLETED|Overall Study||0
3233666|NCT02364336|3965654|FG001|NOT COMPLETED|Overall Study||1
3233667|NCT02364388|3965661|FG000|STARTED|Overall Study||217
3233668|NCT02364388|3965661|FG000|Biopsied|Overall Study||209
3233669|NCT02364388|3965661|FG000|Excluded|Overall Study||8
3233670|NCT02364388|3965661|FG000|COMPLETED|Overall Study||209
3233671|NCT02364388|3965661|FG000|NOT COMPLETED|Overall Study||8
3233672|NCT02364570|3965665|FG000|STARTED|Overall Study||1
3233673|NCT02364570|3965666|FG001|STARTED|Overall Study||1
3233674|NCT02364570|3965667|FG002|STARTED|Overall Study||2
3233675|NCT02364570|3965668|FG003|STARTED|Overall Study||1
3233676|NCT02364570|3965669|FG004|STARTED|Overall Study||1
3233677|NCT02364570|3965670|FG005|STARTED|Overall Study||1
3233678|NCT02364570|3965671|FG006|STARTED|Overall Study||2
3233679|NCT02364570|3965672|FG007|STARTED|Overall Study||1
3233680|NCT02364570|3965673|FG008|STARTED|Overall Study||2
3233681|NCT02364570|3965674|FG009|STARTED|Overall Study||1
3233682|NCT02364570|3965675|FG010|STARTED|Overall Study||1
3233683|NCT02364570|3965676|FG011|STARTED|Overall Study||1
3233684|NCT02364570|3965677|FG012|STARTED|Overall Study||1
3233685|NCT02364570|3965678|FG013|STARTED|Overall Study||2
3233686|NCT02364570|3965679|FG014|STARTED|Overall Study||1
3233687|NCT02364570|3965680|FG015|STARTED|Overall Study||1
3233688|NCT02364570|3965665|FG000|COMPLETED|Overall Study||1
3233689|NCT02364570|3965666|FG001|COMPLETED|Overall Study||1
3233690|NCT02364570|3965667|FG002|COMPLETED|Overall Study||2
3233691|NCT02364570|3965668|FG003|COMPLETED|Overall Study||1
3233692|NCT02364570|3965669|FG004|COMPLETED|Overall Study||1
3233693|NCT02364570|3965670|FG005|COMPLETED|Overall Study||1
3233694|NCT02364570|3965671|FG006|COMPLETED|Overall Study||2
3233695|NCT02364570|3965672|FG007|COMPLETED|Overall Study||1
3233696|NCT02364570|3965673|FG008|COMPLETED|Overall Study||2
3233697|NCT02364570|3965674|FG009|COMPLETED|Overall Study||1
3233698|NCT02364570|3965675|FG010|COMPLETED|Overall Study||1
3233699|NCT02364570|3965676|FG011|COMPLETED|Overall Study||1
3233700|NCT02364570|3965677|FG012|COMPLETED|Overall Study||1
3233701|NCT02364570|3965678|FG013|COMPLETED|Overall Study||2
3233702|NCT02364570|3965679|FG014|COMPLETED|Overall Study||1
3233703|NCT02364570|3965680|FG015|COMPLETED|Overall Study||1
3233704|NCT02364570|3965665|FG000|NOT COMPLETED|Overall Study||0
3233705|NCT02364570|3965666|FG001|NOT COMPLETED|Overall Study||0
3233706|NCT02364570|3965667|FG002|NOT COMPLETED|Overall Study||0
3233707|NCT02364570|3965668|FG003|NOT COMPLETED|Overall Study||0
3233708|NCT02364570|3965669|FG004|NOT COMPLETED|Overall Study||0
3233709|NCT02364570|3965670|FG005|NOT COMPLETED|Overall Study||0
3233710|NCT02364570|3965671|FG006|NOT COMPLETED|Overall Study||0
3233711|NCT02364570|3965672|FG007|NOT COMPLETED|Overall Study||0
3233712|NCT02364570|3965673|FG008|NOT COMPLETED|Overall Study||0
3233713|NCT02364570|3965674|FG009|NOT COMPLETED|Overall Study||0
3233714|NCT02364570|3965675|FG010|NOT COMPLETED|Overall Study||0
3233715|NCT02364570|3965676|FG011|NOT COMPLETED|Overall Study||0
3233716|NCT02364570|3965677|FG012|NOT COMPLETED|Overall Study||0
3233717|NCT02364570|3965678|FG013|NOT COMPLETED|Overall Study||0
3233718|NCT02364570|3965679|FG014|NOT COMPLETED|Overall Study||0
3233719|NCT02364570|3965680|FG015|NOT COMPLETED|Overall Study||0
3233720|NCT02364700|3965690|FG000|STARTED|Overall Study||12
3233721|NCT02364700|3965690|FG000|COMPLETED|Overall Study||12
3233722|NCT02364700|3965690|FG000|NOT COMPLETED|Overall Study||0
3233723|NCT02364778|3965696|FG000|STARTED|Overall Study||30
3233724|NCT02364778|3965696|FG000|COMPLETED|Overall Study||30
3233725|NCT02364778|3965696|FG000|NOT COMPLETED|Overall Study||0
3233726|NCT02364947|3965705|FG000|STARTED|Overall Study||248
3233727|NCT02364947|3965706|FG001|STARTED|Overall Study||184
3233728|NCT02364947|3965707|FG002|STARTED|Overall Study||245
3233729|NCT02364947|3965705|FG000|COMPLETED|Overall Study||189
3233730|NCT02364947|3965706|FG001|COMPLETED|Overall Study||139
3233731|NCT02364947|3965707|FG002|COMPLETED|Overall Study||219
3233732|NCT02364947|3965705|FG000|NOT COMPLETED|Overall Study||59
3233733|NCT02364947|3965706|FG001|NOT COMPLETED|Overall Study||45
3233734|NCT02364947|3965707|FG002|NOT COMPLETED|Overall Study||26
3233735|NCT02364999|3965717|FG000|STARTED|Overall Study||358
3233736|NCT02364999|3965718|FG001|STARTED|Overall Study||361
3233737|NCT02364999|3965717|FG000|Received Treatment|Overall Study||356
3233738|NCT02364999|3965718|FG001|Received Treatment|Overall Study||358
3233739|NCT02364999|3965717|FG000|COMPLETED|Overall Study||193
3233740|NCT02364999|3965718|FG001|COMPLETED|Overall Study||188
3233741|NCT02364999|3965717|FG000|NOT COMPLETED|Overall Study||165
3233742|NCT02364999|3965718|FG001|NOT COMPLETED|Overall Study||173
3233743|NCT02365064|3965727|FG000|STARTED|Overall Study||31
3233744|NCT02365064|3965728|FG001|STARTED|Overall Study||47
3233745|NCT02365064|3965727|FG000|Included in ITT Analysis|Overall Study||29
3233746|NCT02365064|3965728|FG001|Included in ITT Analysis|Overall Study||32
3233747|NCT02365064|3965727|FG000|COMPLETED|Overall Study||21
3233748|NCT02365064|3965728|FG001|COMPLETED|Overall Study||19
3233749|NCT02365064|3965727|FG000|NOT COMPLETED|Overall Study||10
3233750|NCT02365064|3965728|FG001|NOT COMPLETED|Overall Study||28
3233751|NCT02365285|3965738|FG000|STARTED|Overall Study||7
3233752|NCT02365285|3965739|FG001|STARTED|Overall Study||6
3233753|NCT02365285|3965740|FG002|STARTED|Overall Study||7
3233754|NCT02365285|3965741|FG003|STARTED|Overall Study||3
3233755|NCT02365285|3965738|FG000|COMPLETED|Overall Study||7
3233756|NCT02365285|3965739|FG001|COMPLETED|Overall Study||5
3233757|NCT02365285|3965740|FG002|COMPLETED|Overall Study||6
3233758|NCT02365285|3965741|FG003|COMPLETED|Overall Study||1
3233759|NCT02365285|3965738|FG000|NOT COMPLETED|Overall Study||0
3233760|NCT02365285|3965739|FG001|NOT COMPLETED|Overall Study||1
3233761|NCT02365285|3965740|FG002|NOT COMPLETED|Overall Study||1
3233762|NCT02365285|3965741|FG003|NOT COMPLETED|Overall Study||2
3233763|NCT02365298|3965753|FG000|STARTED|Period 1||14
3233764|NCT02365298|3965754|FG001|STARTED|Period 1||14
3233765|NCT02365298|3965753|FG000|COMPLETED|Period 1||14
3233766|NCT02365298|3965754|FG001|COMPLETED|Period 1||14
3233767|NCT02365298|3965753|FG000|NOT COMPLETED|Period 1||0
3233768|NCT02365298|3965754|FG001|NOT COMPLETED|Period 1||0
3233769|NCT02365298|3965753|FG000|STARTED|Period 2||14
3233770|NCT02365298|3965754|FG001|STARTED|Period 2||14
3233771|NCT02365298|3965753|FG000|COMPLETED|Period 2||12
3233772|NCT02365298|3965754|FG001|COMPLETED|Period 2||12
3233773|NCT02365298|3965753|FG000|NOT COMPLETED|Period 2||2
3233774|NCT02365298|3965754|FG001|NOT COMPLETED|Period 2||2
3233775|NCT02365480|3965762|FG000|STARTED|Overall Study||14
3233776|NCT02365480|3965763|FG001|STARTED|Overall Study||4
3233777|NCT02365480|3965762|FG000|COMPLETED|Overall Study||12
3233778|NCT02365480|3965763|FG001|COMPLETED|Overall Study||4
3233779|NCT02365480|3965762|FG000|NOT COMPLETED|Overall Study||2
3233780|NCT02365480|3965763|FG001|NOT COMPLETED|Overall Study||0
3233781|NCT02365506|3965772|FG000|STARTED|Overall Study||4
3233782|NCT02365506|3965773|FG001|STARTED|Overall Study||4
3233783|NCT02365506|3965774|FG002|STARTED|Overall Study||5
3233784|NCT02365506|3965772|FG000|COMPLETED|Overall Study||4
3233785|NCT02365506|3965773|FG001|COMPLETED|Overall Study||4
3233786|NCT02365506|3965774|FG002|COMPLETED|Overall Study||4
3233787|NCT02365506|3965772|FG000|NOT COMPLETED|Overall Study||0
3233788|NCT02365506|3965773|FG001|NOT COMPLETED|Overall Study||0
3233789|NCT02365506|3965774|FG002|NOT COMPLETED|Overall Study||1
3233790|NCT02365519|3965784|FG000|STARTED|Vehicle Run-In||213
3233791|NCT02365519|3965785|FG001|STARTED|Vehicle Run-In||0
3233792|NCT02365519|3965786|FG002|STARTED|Vehicle Run-In||0
3233793|NCT02365519|3965784|FG000|COMPLETED|Vehicle Run-In||134
3233794|NCT02365519|3965785|FG001|COMPLETED|Vehicle Run-In||0
3233795|NCT02365519|3965786|FG002|COMPLETED|Vehicle Run-In||0
3233796|NCT02365519|3965784|FG000|NOT COMPLETED|Vehicle Run-In||79
3233797|NCT02365519|3965785|FG001|NOT COMPLETED|Vehicle Run-In||0
3233798|NCT02365519|3965786|FG002|NOT COMPLETED|Vehicle Run-In||0
3233799|NCT02365519|3965784|FG000|STARTED|Randomized and Treated||0
3233800|NCT02365519|3965785|FG001|STARTED|Randomized and Treated||69
3233801|NCT02365519|3965786|FG002|STARTED|Randomized and Treated||65
3233802|NCT02365519|3965784|FG000|COMPLETED|Randomized and Treated||0
3233803|NCT02365519|3965785|FG001|COMPLETED|Randomized and Treated||67
3233804|NCT02365519|3965786|FG002|COMPLETED|Randomized and Treated||64
3233805|NCT02365519|3965784|FG000|NOT COMPLETED|Randomized and Treated||0
3233806|NCT02365519|3965785|FG001|NOT COMPLETED|Randomized and Treated||2
3233807|NCT02365519|3965786|FG002|NOT COMPLETED|Randomized and Treated||1
3233808|NCT02365558|3965795|FG000|STARTED|Period 1 (Day 1 Through Day 7)||34
3233809|NCT02365558|3965796|FG001|STARTED|Period 1 (Day 1 Through Day 7)||0
3233810|NCT02365558|3965795|FG000|Received at Least One Dose of Study Drug|Period 1 (Day 1 Through Day 7)||34
3233811|NCT02365558|3965796|FG001|Received at Least One Dose of Study Drug|Period 1 (Day 1 Through Day 7)||0
3233812|NCT02365558|3965795|FG000|COMPLETED|Period 1 (Day 1 Through Day 7)||33
3233813|NCT02365558|3965796|FG001|COMPLETED|Period 1 (Day 1 Through Day 7)||0
3233814|NCT02365558|3965795|FG000|NOT COMPLETED|Period 1 (Day 1 Through Day 7)||1
3233815|NCT02365558|3965796|FG001|NOT COMPLETED|Period 1 (Day 1 Through Day 7)||0
3233816|NCT02365558|3965795|FG000|STARTED|Period 2 (Day 8 Through Day 20)|Participants move to Evacetrapib + Omeprazole for Period 2.|0
3233817|NCT02365558|3965796|FG001|STARTED|Period 2 (Day 8 Through Day 20)|Participants completed Period 1 and entered Evacetrapib + Omeprazole for Period 2.|33
3233818|NCT02365558|3965795|FG000|COMPLETED|Period 2 (Day 8 Through Day 20)||0
3233819|NCT02365558|3965796|FG001|COMPLETED|Period 2 (Day 8 Through Day 20)||32
3233820|NCT02365558|3965795|FG000|NOT COMPLETED|Period 2 (Day 8 Through Day 20)||0
3233821|NCT02365558|3965796|FG001|NOT COMPLETED|Period 2 (Day 8 Through Day 20)||1
3233822|NCT02365584|3965807|FG000|STARTED|Overall Study||21
3233823|NCT02365584|3965808|FG001|STARTED|Overall Study||22
3233824|NCT02365584|3965807|FG000|COMPLETED|Overall Study||9
3233825|NCT02365584|3965808|FG001|COMPLETED|Overall Study||8
3233826|NCT02365584|3965807|FG000|NOT COMPLETED|Overall Study||12
3233827|NCT02365584|3965808|FG001|NOT COMPLETED|Overall Study||14
3233828|NCT02365636|3965817|FG000|STARTED|Overall Study||100
3233829|NCT02365636|3965818|FG001|STARTED|Overall Study||100
3233830|NCT02365636|3965819|FG002|STARTED|Overall Study||100
3233831|NCT02365636|3965817|FG000|Safety Population|Overall Study||100
3233832|NCT02365636|3965818|FG001|Safety Population|Overall Study|2 terminated prior to treatment due to 1) prohibited concomitant medication 2) exclusion criteria|98
3233833|NCT02365636|3965819|FG002|Safety Population|Overall Study||100
3233834|NCT02365636|3965817|FG000|Full Analysis Set|Overall Study||100
3233835|NCT02365636|3965818|FG001|Full Analysis Set|Overall Study||98
3233836|NCT02365636|3965819|FG002|Full Analysis Set|Overall Study||100
3233837|NCT02365636|3965817|FG000|COMPLETED|Overall Study||94
3233838|NCT02365636|3965818|FG001|COMPLETED|Overall Study||93
3233839|NCT02365636|3965819|FG002|COMPLETED|Overall Study||97
3233840|NCT02365636|3965817|FG000|NOT COMPLETED|Overall Study||6
3233841|NCT02365636|3965818|FG001|NOT COMPLETED|Overall Study||7
3233842|NCT02365636|3965819|FG002|NOT COMPLETED|Overall Study||3
3233843|NCT02365714|3965827|FG000|STARTED|Overall Study||2
3233844|NCT02365714|3965827|FG000|COMPLETED|Overall Study||2
3233845|NCT02365714|3965827|FG000|NOT COMPLETED|Overall Study||0
3233846|NCT02365870|3965833|FG000|STARTED|Overall Study||1
3233847|NCT02365870|3965834|FG001|STARTED|Overall Study||3
3233848|NCT02365870|3965833|FG000|COMPLETED|Overall Study||1
3233849|NCT02365870|3965834|FG001|COMPLETED|Overall Study||3
3233850|NCT02365870|3965833|FG000|NOT COMPLETED|Overall Study||0
3233851|NCT02365870|3965834|FG001|NOT COMPLETED|Overall Study||0
3233852|NCT02365961|3965842|FG000|STARTED|Overall Study||41
3233853|NCT02365961|3965843|FG001|STARTED|Overall Study||43
3233854|NCT02365961|3965842|FG000|COMPLETED|Overall Study||41
3233855|NCT02365961|3965843|FG001|COMPLETED|Overall Study||43
3233856|NCT02365961|3965842|FG000|NOT COMPLETED|Overall Study||0
3233857|NCT02365961|3965843|FG001|NOT COMPLETED|Overall Study||0
3233858|NCT02366091|3965853|FG000|STARTED|Overall Study||24
3233859|NCT02366091|3965854|FG001|STARTED|Overall Study||23
3233860|NCT02366091|3965855|FG002|STARTED|Overall Study||24
3233861|NCT02366091|3965856|FG003|STARTED|Overall Study||23
3233862|NCT02366091|3965853|FG000|COMPLETED|Overall Study||21
3233863|NCT02366091|3965854|FG001|COMPLETED|Overall Study||16
3233864|NCT02366091|3965855|FG002|COMPLETED|Overall Study||21
3233865|NCT02366091|3965856|FG003|COMPLETED|Overall Study||22
3233866|NCT02366091|3965853|FG000|NOT COMPLETED|Overall Study||3
3233867|NCT02366091|3965854|FG001|NOT COMPLETED|Overall Study||7
3233868|NCT02366091|3965855|FG002|NOT COMPLETED|Overall Study||3
3233869|NCT02366091|3965856|FG003|NOT COMPLETED|Overall Study||1
3233870|NCT02366130|3965866|FG000|STARTED|Overall Study||45
3233871|NCT02366130|3965866|FG000|COMPLETED|Overall Study||36
3233872|NCT02366130|3965866|FG000|NOT COMPLETED|Overall Study||9
3233873|NCT02366143|3965873|FG000|STARTED|Overall Study||400
3233874|NCT02366143|3965874|FG001|STARTED|Overall Study||400
3233875|NCT02366143|3965875|FG002|STARTED|Overall Study||402
3233876|NCT02366143|3965873|FG000|COMPLETED|Overall Study||0
3233877|NCT02366143|3965874|FG001|COMPLETED|Overall Study||0
3233878|NCT02366143|3965875|FG002|COMPLETED|Overall Study||0
3233879|NCT02366143|3965873|FG000|NOT COMPLETED|Overall Study||400
3233880|NCT02366143|3965874|FG001|NOT COMPLETED|Overall Study||400
3233881|NCT02366143|3965875|FG002|NOT COMPLETED|Overall Study||402
3233882|NCT02366195|3965887|FG000|STARTED|Overall Study||112
3233883|NCT02366195|3965887|FG000|Received Study Drug|Overall Study||111
3233884|NCT02366195|3965887|FG000|COMPLETED|Overall Study||58
3233885|NCT02366195|3965887|FG000|NOT COMPLETED|Overall Study||54
3233886|NCT02366312|3965893|FG000|STARTED|Overall Study||1
3233887|NCT02366312|3965894|FG001|STARTED|Overall Study||1
3233888|NCT02366312|3965893|FG000|COMPLETED|Overall Study||1
3233889|NCT02366312|3965894|FG001|COMPLETED|Overall Study|The subject did not attend the 2-year post-treatment visit (last visit).|0
3233890|NCT02366312|3965893|FG000|NOT COMPLETED|Overall Study||0
3233891|NCT02366312|3965894|FG001|NOT COMPLETED|Overall Study||1
3233892|NCT02366338|3965903|FG000|STARTED|Overall Study||73
3233893|NCT02366338|3965904|FG001|STARTED|Overall Study||39
3233894|NCT02366338|3965905|FG002|STARTED|Overall Study||36
3233895|NCT02366338|3965903|FG000|COMPLETED|Overall Study||73
3233896|NCT02366338|3965904|FG001|COMPLETED|Overall Study||39
3233897|NCT02366338|3965905|FG002|COMPLETED|Overall Study||36
3233898|NCT02366338|3965903|FG000|NOT COMPLETED|Overall Study||0
3233899|NCT02366338|3965904|FG001|NOT COMPLETED|Overall Study||0
3233900|NCT02366338|3965905|FG002|NOT COMPLETED|Overall Study||0
3233901|NCT02366403|3965915|FG000|STARTED|Overall Study||41
3233902|NCT02366403|3965916|FG001|STARTED|Overall Study||44
3233903|NCT02366403|3965915|FG000|COMPLETED|Overall Study||30
3233904|NCT02366403|3965916|FG001|COMPLETED|Overall Study||29
3233905|NCT02366403|3965915|FG000|NOT COMPLETED|Overall Study||11
3233906|NCT02366403|3965916|FG001|NOT COMPLETED|Overall Study||15
3233907|NCT02366468|3965924|FG000|STARTED|Overall Study||68
3233908|NCT02366468|3965925|FG001|STARTED|Overall Study||67
3233909|NCT02366468|3965924|FG000|Full Analysis Set (FAS)|Overall Study||67
3233910|NCT02366468|3965925|FG001|Full Analysis Set (FAS)|Overall Study||66
3233911|NCT02366468|3965924|FG000|Per Protocol Set (PPS)|Overall Study||62
3233912|NCT02366468|3965925|FG001|Per Protocol Set (PPS)|Overall Study||61
3233913|NCT02366468|3965924|FG000|COMPLETED|Overall Study||62
3233914|NCT02366468|3965925|FG001|COMPLETED|Overall Study||58
3233915|NCT02366468|3965924|FG000|NOT COMPLETED|Overall Study||6
3233916|NCT02366468|3965925|FG001|NOT COMPLETED|Overall Study||9
3233917|NCT02366611|3965933|FG000|STARTED|Overall Study||10
3233918|NCT02366611|3965934|FG001|STARTED|Overall Study||1
3233919|NCT02366611|3965933|FG000|COMPLETED|Overall Study||8
3233920|NCT02366611|3965934|FG001|COMPLETED|Overall Study||1
3233921|NCT02366611|3965933|FG000|NOT COMPLETED|Overall Study||2
3233922|NCT02366611|3965934|FG001|NOT COMPLETED|Overall Study||0
3233923|NCT02366637|3965941|FG000|STARTED|First Intervention Period||7
3233924|NCT02366637|3965942|FG001|STARTED|First Intervention Period||6
3233925|NCT02366637|3965941|FG000|COMPLETED|First Intervention Period||1
3233926|NCT02366637|3965942|FG001|COMPLETED|First Intervention Period||1
3233927|NCT02366637|3965941|FG000|NOT COMPLETED|First Intervention Period||6
3233928|NCT02366637|3965942|FG001|NOT COMPLETED|First Intervention Period||5
3233929|NCT02366637|3965941|FG000|STARTED|Washout Period 28 to 49 Days||1
3233930|NCT02366637|3965942|FG001|STARTED|Washout Period 28 to 49 Days||1
3233931|NCT02366637|3965941|FG000|COMPLETED|Washout Period 28 to 49 Days||1
3233932|NCT02366637|3965942|FG001|COMPLETED|Washout Period 28 to 49 Days||1
3233933|NCT02366637|3965941|FG000|NOT COMPLETED|Washout Period 28 to 49 Days||0
3233934|NCT02366637|3965942|FG001|NOT COMPLETED|Washout Period 28 to 49 Days||0
3233935|NCT02366637|3965941|FG000|STARTED|Second Intervention Period||1
3233936|NCT02366637|3965942|FG001|STARTED|Second Intervention Period||1
3233937|NCT02366637|3965941|FG000|COMPLETED|Second Intervention Period||0
3233938|NCT02366637|3965942|FG001|COMPLETED|Second Intervention Period||0
3233939|NCT02366637|3965941|FG000|NOT COMPLETED|Second Intervention Period||1
3233940|NCT02366637|3965942|FG001|NOT COMPLETED|Second Intervention Period||1
3233941|NCT02366663|3965950|FG000|STARTED|Overall Study||2
3233942|NCT02366663|3965951|FG001|STARTED|Overall Study||1
3233943|NCT02366663|3965950|FG000|COMPLETED|Overall Study||2
3233944|NCT02366663|3965951|FG001|COMPLETED|Overall Study||1
3233945|NCT02366663|3965950|FG000|NOT COMPLETED|Overall Study||0
3233946|NCT02366663|3965951|FG001|NOT COMPLETED|Overall Study||0
3233947|NCT02366689|3965960|FG000|STARTED|Overall Study||60
3233948|NCT02366689|3965961|FG001|STARTED|Overall Study||58
3233949|NCT02366689|3965962|FG002|STARTED|Overall Study||61
3233950|NCT02366689|3965960|FG000|COMPLETED|Overall Study||56
3233951|NCT02366689|3965961|FG001|COMPLETED|Overall Study||55
3233952|NCT02366689|3965962|FG002|COMPLETED|Overall Study||59
3233953|NCT02366689|3965960|FG000|NOT COMPLETED|Overall Study||4
3233954|NCT02366689|3965961|FG001|NOT COMPLETED|Overall Study||3
3233955|NCT02366689|3965962|FG002|NOT COMPLETED|Overall Study||2
3233956|NCT02366767|3965972|FG000|STARTED|Overall Study||11
3233957|NCT02366767|3965973|FG001|STARTED|Overall Study||10
3233958|NCT02366767|3965972|FG000|COMPLETED|Overall Study||10
3233959|NCT02366767|3965973|FG001|COMPLETED|Overall Study||10
3233960|NCT02366767|3965972|FG000|NOT COMPLETED|Overall Study||1
3233961|NCT02366767|3965973|FG001|NOT COMPLETED|Overall Study||0
3233962|NCT02366845|3965981|FG000|STARTED|Overall Study||25
3233963|NCT02366845|3965982|FG001|STARTED|Overall Study||25
3233964|NCT02366845|3965981|FG000|COMPLETED|Overall Study||25
3233965|NCT02366845|3965982|FG001|COMPLETED|Overall Study||25
3233966|NCT02366845|3965981|FG000|NOT COMPLETED|Overall Study||0
3233967|NCT02366845|3965982|FG001|NOT COMPLETED|Overall Study||0
3233968|NCT02366871|3965990|FG000|STARTED|Overall Study||204
3233969|NCT02366871|3965991|FG001|STARTED|Overall Study||196
3233970|NCT02366871|3965990|FG000|COMPLETED|Overall Study||204
3233971|NCT02366871|3965991|FG001|COMPLETED|Overall Study||196
3233972|NCT02366871|3965990|FG000|NOT COMPLETED|Overall Study||0
3233973|NCT02366871|3965991|FG001|NOT COMPLETED|Overall Study||0
3233974|NCT02366910|3965997|FG000|STARTED|Overall Study||26
3233975|NCT02366910|3965997|FG000|COMPLETED|Overall Study||21
3233976|NCT02366910|3965997|FG000|NOT COMPLETED|Overall Study||5
3233977|NCT02366923|3966003|FG000|STARTED|Overall Study||28
3233978|NCT02366923|3966003|FG000|COMPLETED|Overall Study||22
3233979|NCT02366923|3966003|FG000|NOT COMPLETED|Overall Study||6
3233980|NCT02366936|3966008|FG000|STARTED|Overall Study||32
3233981|NCT02366936|3966008|FG000|COMPLETED|Overall Study||24
3233982|NCT02366936|3966008|FG000|NOT COMPLETED|Overall Study||8
3233983|NCT02367014|3966016|FG000|STARTED|Overall Study||9
3233984|NCT02367014|3966017|FG001|STARTED|Overall Study||9
3233985|NCT02367014|3966018|FG002|STARTED|Overall Study||9
3233986|NCT02367014|3966019|FG003|STARTED|Overall Study||9
3233987|NCT02367014|3966016|FG000|COMPLETED|Overall Study||9
3233988|NCT02367014|3966017|FG001|COMPLETED|Overall Study||9
3233989|NCT02367014|3966018|FG002|COMPLETED|Overall Study||9
3233990|NCT02367014|3966019|FG003|COMPLETED|Overall Study||9
3233991|NCT02367014|3966016|FG000|NOT COMPLETED|Overall Study||0
3233992|NCT02367014|3966017|FG001|NOT COMPLETED|Overall Study||0
3233993|NCT02367014|3966018|FG002|NOT COMPLETED|Overall Study||0
3233994|NCT02367014|3966019|FG003|NOT COMPLETED|Overall Study||0
3233995|NCT02367066|3966033|FG000|STARTED|Overall Study||10
3233996|NCT02367066|3966034|FG001|STARTED|Overall Study||10
3233997|NCT02367066|3966033|FG000|COMPLETED|Overall Study||10
3233998|NCT02367066|3966034|FG001|COMPLETED|Overall Study||10
3233999|NCT02367066|3966033|FG000|NOT COMPLETED|Overall Study||0
3234000|NCT02367066|3966034|FG001|NOT COMPLETED|Overall Study||0
3234001|NCT02367131|3966045|FG000|STARTED|Overall Study|Started are the treated patients|423
3234002|NCT02367131|3966045|FG000|COMPLETED|Overall Study||201
3234003|NCT02367131|3966045|FG000|NOT COMPLETED|Overall Study||222
3234004|NCT02367352|3966049|FG000|STARTED|Overall Study||9
3234005|NCT02367352|3966050|FG001|STARTED|Overall Study||0
3234006|NCT02367352|3966051|FG002|STARTED|Overall Study||0
3234007|NCT02367352|3966049|FG000|COMPLETED|Overall Study||0
3234008|NCT02367352|3966050|FG001|COMPLETED|Overall Study||0
3234009|NCT02367352|3966051|FG002|COMPLETED|Overall Study||0
3234010|NCT02367352|3966049|FG000|NOT COMPLETED|Overall Study||9
3234011|NCT02367352|3966050|FG001|NOT COMPLETED|Overall Study||0
3234012|NCT02367352|3966051|FG002|NOT COMPLETED|Overall Study||0
3234013|NCT02367391|3966059|FG000|STARTED|Overall Study||76
3234014|NCT02367391|3966060|FG001|STARTED|Overall Study||76
3234015|NCT02367391|3966059|FG000|COMPLETED|Overall Study||74
3234016|NCT02367391|3966060|FG001|COMPLETED|Overall Study||76
3234017|NCT02367391|3966059|FG000|NOT COMPLETED|Overall Study||2
3234018|NCT02367391|3966060|FG001|NOT COMPLETED|Overall Study||0
3234019|NCT02367430|3966066|FG000|STARTED|Overall Study||14
3234020|NCT02367430|3966066|FG000|COMPLETED|Overall Study||11
3234021|NCT02367430|3966066|FG000|NOT COMPLETED|Overall Study||3
3234022|NCT02367521|3966072|FG000|STARTED|Overall Study||17
3234023|NCT02367521|3966073|FG001|STARTED|Overall Study||17
3234024|NCT02367521|3966072|FG000|COMPLETED|Overall Study||13
3234025|NCT02367521|3966073|FG001|COMPLETED|Overall Study||17
3234026|NCT02367521|3966072|FG000|NOT COMPLETED|Overall Study||4
3234027|NCT02367521|3966073|FG001|NOT COMPLETED|Overall Study||0
3234028|NCT02367599|3966081|FG000|STARTED|Overall Study||48
3234029|NCT02367599|3966082|FG001|STARTED|Overall Study||48
3234030|NCT02367599|3966081|FG000|COMPLETED|Overall Study||48
3234031|NCT02367599|3966082|FG001|COMPLETED|Overall Study||48
3234032|NCT02367599|3966081|FG000|NOT COMPLETED|Overall Study||0
3234033|NCT02367599|3966082|FG001|NOT COMPLETED|Overall Study||0
3234034|NCT02367716|3966088|FG000|STARTED|Overall Study||121
3234035|NCT02367716|3966088|FG000|COMPLETED|Overall Study||120
3234036|NCT02367716|3966088|FG000|NOT COMPLETED|Overall Study||1
3234037|NCT02367729|3966095|FG000|STARTED|Overall Study||60
3234038|NCT02367729|3966096|FG001|STARTED|Overall Study||55
3234039|NCT02367729|3966095|FG000|COMPLETED|Overall Study||57
3234040|NCT02367729|3966096|FG001|COMPLETED|Overall Study||47
3234041|NCT02367729|3966095|FG000|NOT COMPLETED|Overall Study||3
3234042|NCT02367729|3966096|FG001|NOT COMPLETED|Overall Study||8
3234043|NCT02367781|3966105|FG000|STARTED|Overall Study||483
3234044|NCT02367781|3966106|FG001|STARTED|Overall Study||240
3234045|NCT02367781|3966105|FG000|COMPLETED|Overall Study||0
3234046|NCT02367781|3966106|FG001|COMPLETED|Overall Study||0
3234047|NCT02367781|3966105|FG000|NOT COMPLETED|Overall Study||483
3234048|NCT02367781|3966106|FG001|NOT COMPLETED|Overall Study||240
3234049|NCT02367794|3966117|FG000|STARTED|Overall Study||340
3234050|NCT02367794|3966118|FG001|STARTED|Overall Study||343
3234051|NCT02367794|3966119|FG002|STARTED|Overall Study||338
3234052|NCT02367794|3966117|FG000|COMPLETED|Overall Study||82
3234053|NCT02367794|3966118|FG001|COMPLETED|Overall Study||103
3234054|NCT02367794|3966119|FG002|COMPLETED|Overall Study||89
3234055|NCT02367794|3966117|FG000|NOT COMPLETED|Overall Study||258
3234056|NCT02367794|3966118|FG001|NOT COMPLETED|Overall Study||240
3234057|NCT02367794|3966119|FG002|NOT COMPLETED|Overall Study||249
3234058|NCT02367820|3966131|FG000|STARTED|Overall Study||638
3234059|NCT02367820|3966131|FG000|COMPLETED|Overall Study||402
3234060|NCT02367820|3966131|FG000|NOT COMPLETED|Overall Study||236
3234061|NCT02367833|3966144|FG000|STARTED|Overall Study||9
3234062|NCT02367833|3966145|FG001|STARTED|Overall Study||9
3234063|NCT02367833|3966146|FG002|STARTED|Overall Study||8
3234064|NCT02367833|3966144|FG000|COMPLETED|Overall Study||8
3234065|NCT02367833|3966145|FG001|COMPLETED|Overall Study||8
3234066|NCT02367833|3966146|FG002|COMPLETED|Overall Study||8
3234067|NCT02367833|3966144|FG000|NOT COMPLETED|Overall Study||1
3234068|NCT02367833|3966145|FG001|NOT COMPLETED|Overall Study||1
3234069|NCT02367833|3966146|FG002|NOT COMPLETED|Overall Study||0
3234070|NCT02367859|3966154|FG000|STARTED|Overall Study||1
3234071|NCT02367859|3966154|FG000|COMPLETED|Overall Study||1
3234072|NCT02367859|3966154|FG000|NOT COMPLETED|Overall Study||0
3234073|NCT02367872|3966166|FG000|STARTED|Overall Study||6
3234074|NCT02367872|3966167|FG001|STARTED|Overall Study||6
3234075|NCT02367872|3966168|FG002|STARTED|Overall Study||6
3234076|NCT02367872|3966169|FG003|STARTED|Overall Study||6
3234077|NCT02367872|3966170|FG004|STARTED|Overall Study||6
3234078|NCT02367872|3966171|FG005|STARTED|Overall Study||6
3234079|NCT02367872|3966172|FG006|STARTED|Overall Study||6
3234080|NCT02367872|3966173|FG007|STARTED|Overall Study||6
3234081|NCT02367872|3966166|FG000|COMPLETED|Overall Study||6
3234082|NCT02367872|3966167|FG001|COMPLETED|Overall Study||6
3234083|NCT02367872|3966168|FG002|COMPLETED|Overall Study||6
3234084|NCT02367872|3966169|FG003|COMPLETED|Overall Study||6
3234085|NCT02367872|3966170|FG004|COMPLETED|Overall Study||6
3234086|NCT02367872|3966171|FG005|COMPLETED|Overall Study||6
3234087|NCT02367872|3966172|FG006|COMPLETED|Overall Study||6
3234088|NCT02367872|3966173|FG007|COMPLETED|Overall Study||6
3234089|NCT02367872|3966166|FG000|NOT COMPLETED|Overall Study||0
3234090|NCT02367872|3966167|FG001|NOT COMPLETED|Overall Study||0
3234091|NCT02367872|3966168|FG002|NOT COMPLETED|Overall Study||0
3234092|NCT02367872|3966169|FG003|NOT COMPLETED|Overall Study||0
3234093|NCT02367872|3966170|FG004|NOT COMPLETED|Overall Study||0
3234094|NCT02367872|3966171|FG005|NOT COMPLETED|Overall Study||0
3234095|NCT02367872|3966172|FG006|NOT COMPLETED|Overall Study||0
3234096|NCT02367872|3966173|FG007|NOT COMPLETED|Overall Study||0
3234097|NCT02367885|3966203|FG000|STARTED|Overall Study||33
3234098|NCT02367885|3966204|FG001|STARTED|Overall Study||33
3234099|NCT02367885|3966205|FG002|STARTED|Overall Study||33
3234100|NCT02367885|3966203|FG000|COMPLETED|Overall Study||31
3234101|NCT02367885|3966204|FG001|COMPLETED|Overall Study||33
3234102|NCT02367885|3966205|FG002|COMPLETED|Overall Study||33
3234103|NCT02367885|3966203|FG000|NOT COMPLETED|Overall Study||2
3234104|NCT02367885|3966204|FG001|NOT COMPLETED|Overall Study||0
3234105|NCT02367885|3966205|FG002|NOT COMPLETED|Overall Study||0
3234106|NCT02367911|3966218|FG000|STARTED|Overall Study||71
3234107|NCT02367911|3966219|FG001|STARTED|Overall Study||73
3234108|NCT02367911|3966218|FG000|COMPLETED|Overall Study||66
3369384|NCT03809039|4100910|FG004|COMPLETED|Part 2||0
3234109|NCT02367911|3966219|FG001|COMPLETED|Overall Study||69
3234110|NCT02367911|3966218|FG000|NOT COMPLETED|Overall Study||5
3234111|NCT02367911|3966219|FG001|NOT COMPLETED|Overall Study||4
3234112|NCT02368093|3966227|FG000|STARTED|Overall Study||24
3234113|NCT02368093|3966228|FG001|STARTED|Overall Study||24
3234114|NCT02368093|3966227|FG000|COMPLETED|Overall Study||24
3234115|NCT02368093|3966228|FG001|COMPLETED|Overall Study||24
3234116|NCT02368093|3966227|FG000|NOT COMPLETED|Overall Study||0
3234117|NCT02368093|3966228|FG001|NOT COMPLETED|Overall Study||0
3234118|NCT02368210|3966236|FG000|STARTED|Overall Study||75
3234119|NCT02368210|3966237|FG001|STARTED|Overall Study||76
3234120|NCT02368210|3966236|FG000|COMPLETED|Overall Study||74
3234121|NCT02368210|3966237|FG001|COMPLETED|Overall Study||75
3234122|NCT02368210|3966236|FG000|NOT COMPLETED|Overall Study||1
3234123|NCT02368210|3966237|FG001|NOT COMPLETED|Overall Study||1
3234124|NCT02368314|3966245|FG000|STARTED|Overall Study||64
3234125|NCT02368314|3966246|FG001|STARTED|Overall Study||60
3234126|NCT02368314|3966245|FG000|COMPLETED|Overall Study||61
3234127|NCT02368314|3966246|FG001|COMPLETED|Overall Study||57
3234128|NCT02368314|3966245|FG000|NOT COMPLETED|Overall Study||3
3234129|NCT02368314|3966246|FG001|NOT COMPLETED|Overall Study||3
3234130|NCT02368431|3966254|FG000|STARTED|Overall Study||46
3234131|NCT02368431|3966255|FG001|STARTED|Overall Study||46
3234132|NCT02368431|3966254|FG000|COMPLETED|Overall Study||22
3234133|NCT02368431|3966255|FG001|COMPLETED|Overall Study||27
3234134|NCT02368431|3966254|FG000|NOT COMPLETED|Overall Study||24
3234135|NCT02368431|3966255|FG001|NOT COMPLETED|Overall Study||19
3234136|NCT02368457|3966263|FG000|STARTED|Overall Study||12
3234137|NCT02368457|3966264|FG001|STARTED|Overall Study||12
3234138|NCT02368457|3966263|FG000|COMPLETED|Overall Study||12
3234139|NCT02368457|3966264|FG001|COMPLETED|Overall Study||12
3234140|NCT02368457|3966263|FG000|NOT COMPLETED|Overall Study||0
3234141|NCT02368457|3966264|FG001|NOT COMPLETED|Overall Study||0
3234142|NCT02368691|3966271|FG000|STARTED|Overall Study|32 subjects were enrolled and received at least one dose of study drug|32
3234143|NCT02368691|3966271|FG000|COMPLETED|Overall Study||0
3234144|NCT02368691|3966271|FG000|NOT COMPLETED|Overall Study||32
3234145|NCT02369068|3966277|FG000|STARTED|1 Month||10
3234146|NCT02369068|3966278|FG001|STARTED|1 Month||11
3234147|NCT02369068|3966277|FG000|COMPLETED|1 Month||9
3234148|NCT02369068|3966278|FG001|COMPLETED|1 Month||10
3234149|NCT02369068|3966277|FG000|NOT COMPLETED|1 Month||1
3234150|NCT02369068|3966278|FG001|NOT COMPLETED|1 Month||1
3234151|NCT02369068|3966277|FG000|STARTED|3 Months||9
3234152|NCT02369068|3966278|FG001|STARTED|3 Months||10
3234153|NCT02369068|3966277|FG000|COMPLETED|3 Months||9
3234154|NCT02369068|3966278|FG001|COMPLETED|3 Months||8
3234155|NCT02369068|3966277|FG000|NOT COMPLETED|3 Months||0
3234156|NCT02369068|3966278|FG001|NOT COMPLETED|3 Months||2
3234157|NCT02369068|3966277|FG000|STARTED|6 Months||9
3234158|NCT02369068|3966278|FG001|STARTED|6 Months||8
3234159|NCT02369068|3966277|FG000|COMPLETED|6 Months||9
3234160|NCT02369068|3966278|FG001|COMPLETED|6 Months||7
3234161|NCT02369068|3966277|FG000|NOT COMPLETED|6 Months||0
3234162|NCT02369068|3966278|FG001|NOT COMPLETED|6 Months||1
3234163|NCT02369159|3966286|FG000|STARTED|Overall Study||114
3234164|NCT02369159|3966287|FG001|STARTED|Overall Study||23
3234165|NCT02369159|3966286|FG000|ITT Population|Overall Study||114
3234166|NCT02369159|3966287|FG001|ITT Population|Overall Study||23
3234167|NCT02369159|3966286|FG000|Safety Population|Overall Study||107
3234168|NCT02369159|3966287|FG001|Safety Population|Overall Study||23
3234169|NCT02369159|3966286|FG000|ITTI Population|Overall Study||81
3234170|NCT02369159|3966287|FG001|ITTI Population|Overall Study||16
3234171|NCT02369159|3966286|FG000|E-R Population|Overall Study||80
3234172|NCT02369159|3966287|FG001|E-R Population|Overall Study|Milestone only applied to Peramivir group|0
3234173|NCT02369159|3966286|FG000|COMPLETED|Overall Study||106
3234174|NCT02369159|3966287|FG001|COMPLETED|Overall Study||21
3234175|NCT02369159|3966286|FG000|NOT COMPLETED|Overall Study||8
3234176|NCT02369159|3966287|FG001|NOT COMPLETED|Overall Study||2
3234177|NCT02369172|3966304|FG000|STARTED|Overall Study||24
3234178|NCT02369172|3966304|FG000|COMPLETED|Overall Study||24
3234179|NCT02369172|3966304|FG000|NOT COMPLETED|Overall Study||0
3234180|NCT02369211|3966328|FG000|STARTED|Overall Study||43
3234181|NCT02369211|3966329|FG001|STARTED|Overall Study||43
3234182|NCT02369211|3966328|FG000|COMPLETED|Overall Study||43
3234183|NCT02369211|3966329|FG001|COMPLETED|Overall Study||41
3234184|NCT02369211|3966328|FG000|NOT COMPLETED|Overall Study||0
3234185|NCT02369211|3966329|FG001|NOT COMPLETED|Overall Study||2
3234186|NCT02369341|3966337|FG000|STARTED|Overall Study||63
3234187|NCT02369341|3966338|FG001|STARTED|Overall Study||57
3234188|NCT02369341|3966337|FG000|COMPLETED|Overall Study||62
3234189|NCT02369341|3966338|FG001|COMPLETED|Overall Study||57
3234190|NCT02369341|3966337|FG000|NOT COMPLETED|Overall Study||1
3234191|NCT02369341|3966338|FG001|NOT COMPLETED|Overall Study||0
3234192|NCT02369484|3966348|FG000|STARTED|Overall Study||13
3234193|NCT02369484|3966348|FG000|COMPLETED|Overall Study||13
3234194|NCT02369484|3966348|FG000|NOT COMPLETED|Overall Study||0
3234195|NCT02369510|3966355|FG000|STARTED|Overall Study||23
3234196|NCT02369510|3966356|FG001|STARTED|Overall Study||22
3234197|NCT02369510|3966357|FG002|STARTED|Overall Study||23
3234198|NCT02369510|3966355|FG000|COMPLETED|Overall Study||21
3234199|NCT02369510|3966356|FG001|COMPLETED|Overall Study||19
3234200|NCT02369510|3966357|FG002|COMPLETED|Overall Study||17
3234201|NCT02369510|3966355|FG000|NOT COMPLETED|Overall Study||2
3234202|NCT02369510|3966356|FG001|NOT COMPLETED|Overall Study||3
3234203|NCT02369510|3966357|FG002|NOT COMPLETED|Overall Study||6
3234204|NCT02369796|3966370|FG000|STARTED|Overall Study||3
3234205|NCT02369796|3966371|FG001|STARTED|Overall Study||3
3234206|NCT02369796|3966372|FG002|STARTED|Overall Study||3
3234207|NCT02369796|3966373|FG003|STARTED|Overall Study||3
3234208|NCT02369796|3966374|FG004|STARTED|Overall Study||3
3234209|NCT02369796|3966370|FG000|COMPLETED|Overall Study||3
3234210|NCT02369796|3966371|FG001|COMPLETED|Overall Study||3
3234211|NCT02369796|3966372|FG002|COMPLETED|Overall Study||3
3234212|NCT02369796|3966373|FG003|COMPLETED|Overall Study||3
3234213|NCT02369796|3966374|FG004|COMPLETED|Overall Study||3
3234214|NCT02369796|3966370|FG000|NOT COMPLETED|Overall Study||0
3234215|NCT02369796|3966371|FG001|NOT COMPLETED|Overall Study||0
3234216|NCT02369796|3966372|FG002|NOT COMPLETED|Overall Study||0
3234217|NCT02369796|3966373|FG003|NOT COMPLETED|Overall Study||0
3234218|NCT02369796|3966374|FG004|NOT COMPLETED|Overall Study||0
3234219|NCT02369835|3966388|FG000|STARTED|Overall Study||64
3234220|NCT02369835|3966389|FG001|STARTED|Overall Study||68
3234221|NCT02369835|3966388|FG000|COMPLETED|Overall Study|Reasons that participants did not complete for the Primary Outcome are not available.|53
3234222|NCT02369835|3966389|FG001|COMPLETED|Overall Study|Reasons that participants did not complete for the Primary Outcome are not available.|55
3234223|NCT02369835|3966388|FG000|NOT COMPLETED|Overall Study||11
3234224|NCT02369835|3966389|FG001|NOT COMPLETED|Overall Study||13
3234225|NCT02369848|3966395|FG000|STARTED|Overall Study||60
3234226|NCT02369848|3966395|FG000|30 Day Primary Safety Endpoint|Overall Study||58
3234227|NCT02369848|3966395|FG000|12 Month Primary Endpoint|Overall Study||30
3234228|NCT02369848|3966395|FG000|COMPLETED|Overall Study||56
3234229|NCT02369848|3966395|FG000|NOT COMPLETED|Overall Study||4
3234230|NCT02369874|3966402|FG000|STARTED|Overall Study||247
3234231|NCT02369874|3966403|FG001|STARTED|Overall Study||240
3234232|NCT02369874|3966404|FG002|STARTED|Overall Study||249
3234233|NCT02369874|3966402|FG000|Received Treatment|Overall Study||246
3234234|NCT02369874|3966403|FG001|Received Treatment|Overall Study||237
3234235|NCT02369874|3966404|FG002|Received Treatment|Overall Study||240
3234236|NCT02369874|3966402|FG000|COMPLETED|Overall Study||203
3234237|NCT02369874|3966403|FG001|COMPLETED|Overall Study||183
3234238|NCT02369874|3966404|FG002|COMPLETED|Overall Study||188
3234239|NCT02369874|3966402|FG000|NOT COMPLETED|Overall Study||44
3234240|NCT02369874|3966403|FG001|NOT COMPLETED|Overall Study||57
3234241|NCT02369874|3966404|FG002|NOT COMPLETED|Overall Study||61
3234242|NCT02369900|3966414|FG000|STARTED|Overall Study||18
3234243|NCT02369900|3966415|FG001|STARTED|Overall Study||22
3234244|NCT02369900|3966414|FG000|COMPLETED|Overall Study||18
3369385|NCT03809039|4100911|FG005|COMPLETED|Part 2||0
3369386|NCT03809039|4100912|FG006|COMPLETED|Part 2||0
3369387|NCT03809039|4100913|FG007|COMPLETED|Part 2||0
3369388|NCT03809039|4100914|FG008|COMPLETED|Part 2||0
3369389|NCT03809039|4100906|FG000|NOT COMPLETED|Part 2||0
3369390|NCT03809039|4100907|FG001|NOT COMPLETED|Part 2||0
3369391|NCT03809039|4100908|FG002|NOT COMPLETED|Part 2||0
3369392|NCT03809039|4100909|FG003|NOT COMPLETED|Part 2||0
3369393|NCT03809039|4100910|FG004|NOT COMPLETED|Part 2||0
3369394|NCT03809039|4100911|FG005|NOT COMPLETED|Part 2||0
3369395|NCT03809039|4100912|FG006|NOT COMPLETED|Part 2||0
3369396|NCT03809039|4100913|FG007|NOT COMPLETED|Part 2||0
3369397|NCT03809039|4100914|FG008|NOT COMPLETED|Part 2||0
3369398|NCT03809039|4100906|FG000|STARTED|Part 3||0
3369399|NCT03809039|4100907|FG001|STARTED|Part 3||0
3369400|NCT03809039|4100908|FG002|STARTED|Part 3||0
3369401|NCT03809039|4100909|FG003|STARTED|Part 3||0
3369402|NCT03809039|4100910|FG004|STARTED|Part 3||0
3369403|NCT03809039|4100911|FG005|STARTED|Part 3||0
3369404|NCT03809039|4100912|FG006|STARTED|Part 3||0
3369405|NCT03809039|4100913|FG007|STARTED|Part 3|The subjects are unique subjects, and were not counted more than once across any arms.|2
3369406|NCT03809039|4100914|FG008|STARTED|Part 3|The subjects are unique subjects, and were not counted more than once across any arms.|6
3369407|NCT03809039|4100906|FG000|COMPLETED|Part 3||0
3369408|NCT03809039|4100907|FG001|COMPLETED|Part 3||0
3369409|NCT03809039|4100908|FG002|COMPLETED|Part 3||0
3369410|NCT03809039|4100909|FG003|COMPLETED|Part 3||0
3369411|NCT03809039|4100910|FG004|COMPLETED|Part 3||0
3369412|NCT03809039|4100911|FG005|COMPLETED|Part 3||0
3369413|NCT03809039|4100912|FG006|COMPLETED|Part 3||0
3369414|NCT03809039|4100913|FG007|COMPLETED|Part 3||0
3369415|NCT03809039|4100914|FG008|COMPLETED|Part 3||0
3369416|NCT03809039|4100906|FG000|NOT COMPLETED|Part 3||0
3369417|NCT03809039|4100907|FG001|NOT COMPLETED|Part 3||0
3369418|NCT03809039|4100908|FG002|NOT COMPLETED|Part 3||0
3369419|NCT03809039|4100909|FG003|NOT COMPLETED|Part 3||0
3369420|NCT03809039|4100910|FG004|NOT COMPLETED|Part 3||0
3369421|NCT03809039|4100911|FG005|NOT COMPLETED|Part 3||0
3369422|NCT03809039|4100912|FG006|NOT COMPLETED|Part 3||0
3369423|NCT03809039|4100913|FG007|NOT COMPLETED|Part 3||2
3369424|NCT03809039|4100914|FG008|NOT COMPLETED|Part 3||6
3369425|NCT03807700|4100949|FG000|STARTED|Overall Study||60
3369426|NCT03807700|4100950|FG001|STARTED|Overall Study||59
3369427|NCT03807700|4100949|FG000|COMPLETED|Overall Study||58
3369428|NCT03807700|4100950|FG001|COMPLETED|Overall Study||58
3369429|NCT03807700|4100949|FG000|NOT COMPLETED|Overall Study||2
3369430|NCT03807700|4100950|FG001|NOT COMPLETED|Overall Study||1
3369431|NCT03804918|4100957|FG000|STARTED|Overall Study||17
3369432|NCT03804918|4100957|FG000|COMPLETED|Overall Study||16
3369433|NCT03804918|4100957|FG000|NOT COMPLETED|Overall Study||1
3369434|NCT03805386|4100963|FG000|STARTED|Overall Study||32
3369435|NCT03805386|4100964|FG001|STARTED|Overall Study||33
3369436|NCT03805386|4100963|FG000|COMPLETED|Overall Study||32
3369437|NCT03805386|4100964|FG001|COMPLETED|Overall Study||33
3369438|NCT03805386|4100963|FG000|NOT COMPLETED|Overall Study||0
3369439|NCT03805386|4100964|FG001|NOT COMPLETED|Overall Study||0
3369440|NCT03803475|4100973|FG000|STARTED|Overall Study||485
3369441|NCT03803475|4100973|FG000|COMPLETED|Overall Study||484
3234245|NCT02369900|3966415|FG001|COMPLETED|Overall Study||22
3234246|NCT02369900|3966414|FG000|NOT COMPLETED|Overall Study||0
3369442|NCT03803475|4100973|FG000|NOT COMPLETED|Overall Study||1
3369443|NCT03802227|4100979|FG000|STARTED|Overall Study||4
3369444|NCT03802227|4100980|FG001|STARTED|Overall Study||4
3369445|NCT03802227|4100979|FG000|COMPLETED|Overall Study||4
3369446|NCT03802227|4100980|FG001|COMPLETED|Overall Study||4
3369447|NCT03802227|4100979|FG000|NOT COMPLETED|Overall Study||0
3369448|NCT03802227|4100980|FG001|NOT COMPLETED|Overall Study||0
3369449|NCT03802864|4100990|FG000|STARTED|Overall Study||25
3369450|NCT03802864|4100991|FG001|STARTED|Overall Study||25
3234247|NCT02369900|3966415|FG001|NOT COMPLETED|Overall Study||0
3234248|NCT02370004|3966421|FG000|STARTED|Overall Study||11
3234249|NCT02370004|3966421|FG000|COMPLETED|Overall Study||10
3234250|NCT02370004|3966421|FG000|NOT COMPLETED|Overall Study||1
3234251|NCT02370043|3966430|FG000|STARTED|Overall Study||3
3234252|NCT02370043|3966431|FG001|STARTED|Overall Study||3
3234253|NCT02370043|3966432|FG002|STARTED|Overall Study||3
3234254|NCT02370043|3966433|FG003|STARTED|Overall Study||3
3234255|NCT02370043|3966434|FG004|STARTED|Overall Study||3
3234256|NCT02370043|3966435|FG005|STARTED|Overall Study||4
3234257|NCT02370043|3966430|FG000|COMPLETED|Overall Study||3
3234258|NCT02370043|3966431|FG001|COMPLETED|Overall Study||3
3234259|NCT02370043|3966432|FG002|COMPLETED|Overall Study||3
3234260|NCT02370043|3966433|FG003|COMPLETED|Overall Study||3
3234261|NCT02370043|3966434|FG004|COMPLETED|Overall Study||2
3234262|NCT02370043|3966435|FG005|COMPLETED|Overall Study||3
3234263|NCT02370043|3966430|FG000|NOT COMPLETED|Overall Study||0
3234264|NCT02370043|3966431|FG001|NOT COMPLETED|Overall Study||0
3234265|NCT02370043|3966432|FG002|NOT COMPLETED|Overall Study||0
3234266|NCT02370043|3966433|FG003|NOT COMPLETED|Overall Study||0
3234267|NCT02370043|3966434|FG004|NOT COMPLETED|Overall Study||1
3234268|NCT02370043|3966435|FG005|NOT COMPLETED|Overall Study||1
3234269|NCT02370056|3966465|FG000|STARTED|Overall Study||27
3234270|NCT02370056|3966466|FG001|STARTED|Overall Study||26
3234271|NCT02370056|3966465|FG000|COMPLETED|Overall Study||27
3234272|NCT02370056|3966466|FG001|COMPLETED|Overall Study||26
3234273|NCT02370056|3966465|FG000|NOT COMPLETED|Overall Study||0
3234274|NCT02370056|3966466|FG001|NOT COMPLETED|Overall Study||0
3234275|NCT02370095|3966474|FG000|STARTED|Overall Study||10
3234276|NCT02370095|3966475|FG001|STARTED|Overall Study||4
3234277|NCT02370095|3966474|FG000|COMPLETED|Overall Study||10
3234278|NCT02370095|3966475|FG001|COMPLETED|Overall Study||3
3234279|NCT02370095|3966474|FG000|NOT COMPLETED|Overall Study||0
3234280|NCT02370095|3966475|FG001|NOT COMPLETED|Overall Study||1
3234281|NCT02370121|3966483|FG000|STARTED|Overall Study||12
3234282|NCT02370121|3966484|FG001|STARTED|Overall Study||12
3234283|NCT02370121|3966483|FG000|COMPLETED|Overall Study|One patient did not complete the study due to early withdrawl|11
3234284|NCT02370121|3966484|FG001|COMPLETED|Overall Study|One patient did not complete the study due to early withdrawl|11
3234285|NCT02370121|3966483|FG000|NOT COMPLETED|Overall Study||1
3234286|NCT02370121|3966484|FG001|NOT COMPLETED|Overall Study||1
3234287|NCT02370160|3966490|FG000|STARTED|Overall Study||9
3234288|NCT02370160|3966491|FG001|STARTED|Overall Study||6
3234289|NCT02370160|3966492|FG002|STARTED|Overall Study||3
3234290|NCT02370160|3966490|FG000|COMPLETED|Overall Study||6
3234291|NCT02370160|3966491|FG001|COMPLETED|Overall Study||2
3234292|NCT02370160|3966492|FG002|COMPLETED|Overall Study||2
3234293|NCT02370160|3966490|FG000|NOT COMPLETED|Overall Study||3
3234294|NCT02370160|3966491|FG001|NOT COMPLETED|Overall Study||4
3234295|NCT02370160|3966492|FG002|NOT COMPLETED|Overall Study||1
3234296|NCT02370238|3966507|FG000|STARTED|Overall Study||62
3234297|NCT02370238|3966508|FG001|STARTED|Overall Study||61
3234298|NCT02370238|3966507|FG000|ITT Population|Overall Study||62
3234299|NCT02370238|3966508|FG001|ITT Population|Overall Study||61
3234300|NCT02370238|3966507|FG000|Safety Population|Overall Study||61
3234301|NCT02370238|3966508|FG001|Safety Population|Overall Study||60
3234302|NCT02370238|3966507|FG000|Responsable-evaluable Population|Overall Study||57
3234303|NCT02370238|3966508|FG001|Responsable-evaluable Population|Overall Study||54
3234304|NCT02370238|3966507|FG000|COMPLETED|Overall Study||15
3234305|NCT02370238|3966508|FG001|COMPLETED|Overall Study||16
3234306|NCT02370238|3966507|FG000|NOT COMPLETED|Overall Study||47
3234307|NCT02370238|3966508|FG001|NOT COMPLETED|Overall Study||45
3234308|NCT02370251|3966518|FG000|STARTED|Overall Study||63
3234309|NCT02370251|3966518|FG000|COMPLETED|Overall Study||52
3234310|NCT02370251|3966518|FG000|NOT COMPLETED|Overall Study||11
3234311|NCT02370368|3966524|FG000|STARTED|Overall Study||14
3234312|NCT02370368|3966525|FG001|STARTED|Overall Study||13
3234313|NCT02370368|3966524|FG000|COMPLETED|Overall Study||8
3234314|NCT02370368|3966525|FG001|COMPLETED|Overall Study||7
3234315|NCT02370368|3966524|FG000|NOT COMPLETED|Overall Study||6
3234316|NCT02370368|3966525|FG001|NOT COMPLETED|Overall Study||6
3234317|NCT02370394|3966533|FG000|STARTED|Overall Study||28
3234318|NCT02370394|3966534|FG001|STARTED|Overall Study||25
3234319|NCT02370394|3966533|FG000|COMPLETED|Overall Study||26
3234320|NCT02370394|3966534|FG001|COMPLETED|Overall Study||23
3234321|NCT02370394|3966533|FG000|NOT COMPLETED|Overall Study||2
3234322|NCT02370394|3966534|FG001|NOT COMPLETED|Overall Study||2
3234323|NCT02370407|3966543|FG000|STARTED|Overall Study||20
3234324|NCT02370407|3966544|FG001|STARTED|Overall Study||20
3234325|NCT02370407|3966543|FG000|COMPLETED|Overall Study||20
3234326|NCT02370407|3966544|FG001|COMPLETED|Overall Study||20
3234327|NCT02370407|3966543|FG000|NOT COMPLETED|Overall Study||0
3234328|NCT02370407|3966544|FG001|NOT COMPLETED|Overall Study||0
3234329|NCT02370420|3966556|FG000|STARTED|Overall Study||29
3234330|NCT02370420|3966557|FG001|STARTED|Overall Study||27
3234331|NCT02370420|3966556|FG000|COMPLETED|Overall Study||15
3234332|NCT02370420|3966557|FG001|COMPLETED|Overall Study||15
3234333|NCT02370420|3966556|FG000|NOT COMPLETED|Overall Study||14
3234334|NCT02370420|3966557|FG001|NOT COMPLETED|Overall Study||12
3234335|NCT02370498|3966565|FG000|STARTED|Overall Study||296
3234336|NCT02370498|3966566|FG001|STARTED|Overall Study||296
3234337|NCT02370498|3966565|FG000|Treated|Overall Study||294
3234338|NCT02370498|3966566|FG001|Treated|Overall Study||276
3234339|NCT02370498|3966565|FG000|PD-L1 Positive Participants|Overall Study||196
3234340|NCT02370498|3966566|FG001|PD-L1 Positive Participants|Overall Study||199
3234341|NCT02370498|3966565|FG000|COMPLETED|Overall Study||0
3234342|NCT02370498|3966566|FG001|COMPLETED|Overall Study||0
3234343|NCT02370498|3966565|FG000|NOT COMPLETED|Overall Study||296
3234344|NCT02370498|3966566|FG001|NOT COMPLETED|Overall Study||296
3234345|NCT02370511|3966575|FG000|STARTED|Overall Study||31
3234346|NCT02370511|3966576|FG001|STARTED|Overall Study||30
3234347|NCT02370511|3966577|FG002|STARTED|Overall Study||30
3234348|NCT02370511|3966575|FG000|COMPLETED|Overall Study||19
3234349|NCT02370511|3966576|FG001|COMPLETED|Overall Study||19
3234350|NCT02370511|3966577|FG002|COMPLETED|Overall Study||29
3234351|NCT02370511|3966575|FG000|NOT COMPLETED|Overall Study||12
3234352|NCT02370511|3966576|FG001|NOT COMPLETED|Overall Study||11
3234353|NCT02370511|3966577|FG002|NOT COMPLETED|Overall Study||1
3234354|NCT02370537|3966588|FG000|STARTED|Part A (Open-label Recruitment)||16
3234355|NCT02370537|3966589|FG001|STARTED|Part A (Open-label Recruitment)||16
3234356|NCT02370537|3966590|FG002|STARTED|Part A (Open-label Recruitment)||283
3234357|NCT02370537|3966588|FG000|COMPLETED|Part A (Open-label Recruitment)||16
3234358|NCT02370537|3966589|FG001|COMPLETED|Part A (Open-label Recruitment)||15
3234359|NCT02370537|3966590|FG002|COMPLETED|Part A (Open-label Recruitment)||282
3234360|NCT02370537|3966588|FG000|NOT COMPLETED|Part A (Open-label Recruitment)||0
3234361|NCT02370537|3966589|FG001|NOT COMPLETED|Part A (Open-label Recruitment)||1
3234362|NCT02370537|3966590|FG002|NOT COMPLETED|Part A (Open-label Recruitment)||1
3234363|NCT02370537|3966588|FG000|STARTED|Part B||16
3234364|NCT02370537|3966589|FG001|STARTED|Part B||15
3234365|NCT02370537|3966590|FG002|STARTED|Part B||282
3234366|NCT02370537|3966588|FG000|Eligible for Randomisation|Part B||15
3234367|NCT02370537|3966589|FG001|Eligible for Randomisation|Part B||13
3234368|NCT02370537|3966590|FG002|Eligible for Randomisation|Part B||23
3234369|NCT02370537|3966588|FG000|Period 1 Sequence AB|Part B||8
3234370|NCT02370537|3966589|FG001|Period 1 Sequence AB|Part B||6
3234371|NCT02370537|3966590|FG002|Period 1 Sequence AB|Part B||11
3234372|NCT02370537|3966588|FG000|Period 1 Sequence BA|Part B||7
3234373|NCT02370537|3966589|FG001|Period 1 Sequence BA|Part B||7
3234374|NCT02370537|3966590|FG002|Period 1 Sequence BA|Part B||12
3234375|NCT02370537|3966588|FG000|Period 2 Sequence AB|Part B||8
3234376|NCT02370537|3966589|FG001|Period 2 Sequence AB|Part B||5
3234377|NCT02370537|3966590|FG002|Period 2 Sequence AB|Part B||11
3234378|NCT02370537|3966588|FG000|Period 2 Sequence BA|Part B||7
3234379|NCT02370537|3966589|FG001|Period 2 Sequence BA|Part B||7
3234380|NCT02370537|3966590|FG002|Period 2 Sequence BA|Part B||12
3234381|NCT02370537|3966588|FG000|COMPLETED|Part B||15
3234382|NCT02370537|3966589|FG001|COMPLETED|Part B||12
3234383|NCT02370537|3966590|FG002|COMPLETED|Part B||23
3234384|NCT02370537|3966588|FG000|NOT COMPLETED|Part B||1
3234385|NCT02370537|3966589|FG001|NOT COMPLETED|Part B||3
3234386|NCT02370537|3966590|FG002|NOT COMPLETED|Part B||259
3234387|NCT02370602|3966613|FG000|STARTED|Overall Study||1
3234388|NCT02370602|3966614|FG001|STARTED|Overall Study||2
3234389|NCT02370602|3966615|FG002|STARTED|Overall Study||2
3234390|NCT02370602|3966616|FG003|STARTED|Overall Study||3
3234391|NCT02370602|3966617|FG004|STARTED|Overall Study||3
3234392|NCT02370602|3966618|FG005|STARTED|Overall Study||2
3234393|NCT02370602|3966613|FG000|COMPLETED|Overall Study||0
3234394|NCT02370602|3966614|FG001|COMPLETED|Overall Study||2
3234395|NCT02370602|3966615|FG002|COMPLETED|Overall Study||2
3234396|NCT02370602|3966616|FG003|COMPLETED|Overall Study||3
3234397|NCT02370602|3966617|FG004|COMPLETED|Overall Study||3
3234398|NCT02370602|3966618|FG005|COMPLETED|Overall Study||2
3234399|NCT02370602|3966613|FG000|NOT COMPLETED|Overall Study||1
3234400|NCT02370602|3966614|FG001|NOT COMPLETED|Overall Study||0
3234401|NCT02370602|3966615|FG002|NOT COMPLETED|Overall Study||0
3234402|NCT02370602|3966616|FG003|NOT COMPLETED|Overall Study||0
3234403|NCT02370602|3966617|FG004|NOT COMPLETED|Overall Study||0
3234404|NCT02370602|3966618|FG005|NOT COMPLETED|Overall Study||0
3234405|NCT02370615|3966637|FG000|STARTED|Overall Study||16
3234406|NCT02370615|3966638|FG001|STARTED|Overall Study||18
3234407|NCT02370615|3966637|FG000|COMPLETED|Overall Study||15
3234408|NCT02370615|3966638|FG001|COMPLETED|Overall Study||18
3234409|NCT02370615|3966637|FG000|NOT COMPLETED|Overall Study||1
3234410|NCT02370615|3966638|FG001|NOT COMPLETED|Overall Study||0
3234411|NCT02370641|3966653|FG000|STARTED|Overall Study||18
3234412|NCT02370641|3966654|FG001|STARTED|Overall Study||8
3234413|NCT02370641|3966653|FG000|COMPLETED|Overall Study||14
3234414|NCT02370641|3966654|FG001|COMPLETED|Overall Study||6
3234415|NCT02370641|3966653|FG000|NOT COMPLETED|Overall Study||4
3234416|NCT02370641|3966654|FG001|NOT COMPLETED|Overall Study||2
3369451|NCT03802864|4100990|FG000|COMPLETED|Overall Study||25
3369452|NCT03802864|4100991|FG001|COMPLETED|Overall Study||25
3369453|NCT03802864|4100990|FG000|NOT COMPLETED|Overall Study||0
3369454|NCT03802864|4100991|FG001|NOT COMPLETED|Overall Study||0
3369455|NCT03801265|4100999|FG000|STARTED|Overall Study||23
3369456|NCT03801265|4101000|FG001|STARTED|Overall Study||23
3369457|NCT03801265|4100999|FG000|COMPLETED|Overall Study||23
3369458|NCT03801265|4101000|FG001|COMPLETED|Overall Study||23
3369459|NCT03801265|4100999|FG000|NOT COMPLETED|Overall Study||0
3369460|NCT03801265|4101000|FG001|NOT COMPLETED|Overall Study||0
3369461|NCT03802344|4101009|FG000|STARTED|Overall Study||213
3369462|NCT03802344|4101010|FG001|STARTED|Overall Study||209
3369463|NCT03802344|4101011|FG002|STARTED|Overall Study||68
3369464|NCT03802344|4101009|FG000|COMPLETED|Overall Study||205
3234417|NCT02370667|3966663|FG000|STARTED|Overall Study||10
3234418|NCT02370667|3966664|FG001|STARTED|Overall Study||11
3234419|NCT02370667|3966665|FG002|STARTED|Overall Study||10
3234420|NCT02370667|3966663|FG000|COMPLETED|Overall Study||10
3234421|NCT02370667|3966664|FG001|COMPLETED|Overall Study||10
3234422|NCT02370667|3966665|FG002|COMPLETED|Overall Study||10
3234423|NCT02370667|3966663|FG000|NOT COMPLETED|Overall Study||0
3234424|NCT02370667|3966664|FG001|NOT COMPLETED|Overall Study||1
3234425|NCT02370667|3966665|FG002|NOT COMPLETED|Overall Study||0
3234426|NCT02370693|3966676|FG000|STARTED|Overall Study||3
3234427|NCT02370693|3966677|FG001|STARTED|Overall Study||4
3234428|NCT02370693|3966676|FG000|COMPLETED|Overall Study||2
3234429|NCT02370693|3966677|FG001|COMPLETED|Overall Study||3
3234430|NCT02370693|3966676|FG000|NOT COMPLETED|Overall Study||1
3234431|NCT02370693|3966677|FG001|NOT COMPLETED|Overall Study||1
3234432|NCT02370784|3966685|FG000|STARTED|Overall Study||10
3234433|NCT02370784|3966686|FG001|STARTED|Overall Study||14
3234434|NCT02370784|3966685|FG000|COMPLETED|Overall Study||10
3234435|NCT02370784|3966686|FG001|COMPLETED|Overall Study||13
3234436|NCT02370784|3966685|FG000|NOT COMPLETED|Overall Study||0
3234437|NCT02370784|3966686|FG001|NOT COMPLETED|Overall Study||1
3234438|NCT02370810|3966696|FG000|STARTED|Overall Study||73
3234439|NCT02370810|3966697|FG001|STARTED|Overall Study||73
3234440|NCT02370810|3966696|FG000|COMPLETED|Overall Study||50
3234441|NCT02370810|3966697|FG001|COMPLETED|Overall Study||54
3234442|NCT02370810|3966696|FG000|NOT COMPLETED|Overall Study||23
3234443|NCT02370810|3966697|FG001|NOT COMPLETED|Overall Study||19
3234444|NCT02370914|3966705|FG000|STARTED|Overall Study||84
3234445|NCT02370914|3966705|FG000|COMPLETED|Overall Study||82
3234446|NCT02370914|3966705|FG000|NOT COMPLETED|Overall Study||2
3234447|NCT02371187|3966711|FG000|STARTED|Overall Study||18
3234448|NCT02371187|3966712|FG001|STARTED|Overall Study||19
3234449|NCT02371187|3966711|FG000|COMPLETED|Overall Study||15
3234450|NCT02371187|3966712|FG001|COMPLETED|Overall Study||15
3234451|NCT02371187|3966711|FG000|NOT COMPLETED|Overall Study||3
3234452|NCT02371187|3966712|FG001|NOT COMPLETED|Overall Study||4
3234453|NCT02371252|3966720|FG000|STARTED|Overall Study||70
3234454|NCT02371252|3966721|FG001|STARTED|Overall Study||70
3234455|NCT02371252|3966720|FG000|COMPLETED|Overall Study||70
3234456|NCT02371252|3966721|FG001|COMPLETED|Overall Study||70
3234457|NCT02371252|3966720|FG000|NOT COMPLETED|Overall Study||0
3234458|NCT02371252|3966721|FG001|NOT COMPLETED|Overall Study||0
3234459|NCT02371356|3966732|FG000|STARTED|Overall Study||1320
3234460|NCT02371356|3966733|FG001|STARTED|Overall Study||7354
3234461|NCT02371356|3966734|FG002|STARTED|Overall Study||2804
3234462|NCT02371356|3966735|FG003|STARTED|Overall Study||7423
3234463|NCT02371356|3966736|FG004|STARTED|Overall Study||72183
3234464|NCT02371356|3966732|FG000|COMPLETED|Overall Study||1320
3234465|NCT02371356|3966733|FG001|COMPLETED|Overall Study||7354
3234466|NCT02371356|3966734|FG002|COMPLETED|Overall Study||2804
3234467|NCT02371356|3966735|FG003|COMPLETED|Overall Study||7423
3234468|NCT02371356|3966736|FG004|COMPLETED|Overall Study||72183
3234469|NCT02371356|3966732|FG000|NOT COMPLETED|Overall Study||0
3234470|NCT02371356|3966733|FG001|NOT COMPLETED|Overall Study||0
3234471|NCT02371356|3966734|FG002|NOT COMPLETED|Overall Study||0
3234472|NCT02371356|3966735|FG003|NOT COMPLETED|Overall Study||0
3234473|NCT02371356|3966736|FG004|NOT COMPLETED|Overall Study||0
3234474|NCT02371369|3966750|FG000|STARTED|Part 1||61
3234475|NCT02371369|3966751|FG001|STARTED|Part 1||59
3234476|NCT02371369|3966750|FG000|COMPLETED|Part 1||52
3234477|NCT02371369|3966751|FG001|COMPLETED|Part 1||48
3234478|NCT02371369|3966750|FG000|NOT COMPLETED|Part 1||9
3234479|NCT02371369|3966751|FG001|NOT COMPLETED|Part 1||11
3234480|NCT02371369|3966750|FG000|STARTED|Part 2|N=48; Only participants who were eligible to receive treatment in Part 2.|48
3234481|NCT02371369|3966751|FG001|STARTED|Part 2|N=30; Only participants who were eligible to receive treatment in Part 2.|30
3234482|NCT02371369|3966750|FG000|COMPLETED|Part 2||39
3234483|NCT02371369|3966751|FG001|COMPLETED|Part 2||26
3234484|NCT02371369|3966750|FG000|NOT COMPLETED|Part 2||9
3234485|NCT02371369|3966751|FG001|NOT COMPLETED|Part 2||4
3234486|NCT02371395|3966772|FG000|STARTED|Overall Study||1000
3234487|NCT02371395|3966772|FG000|COMPLETED|Overall Study||1000
3234488|NCT02371395|3966772|FG000|NOT COMPLETED|Overall Study||0
3234489|NCT02371616|3966778|FG000|STARTED|Overall Study||150
3234490|NCT02371616|3966779|FG001|STARTED|Overall Study||154
3234491|NCT02371616|3966778|FG000|COMPLETED|Overall Study||146
3234492|NCT02371616|3966779|FG001|COMPLETED|Overall Study||147
3234493|NCT02371616|3966778|FG000|NOT COMPLETED|Overall Study||4
3234494|NCT02371616|3966779|FG001|NOT COMPLETED|Overall Study||7
3234495|NCT02371629|3966787|FG000|STARTED|Overall Study||388
3234496|NCT02371629|3966788|FG001|STARTED|Overall Study||388
3234497|NCT02371629|3966787|FG000|COMPLETED|Overall Study||362
3234498|NCT02371629|3966788|FG001|COMPLETED|Overall Study||363
3234499|NCT02371629|3966787|FG000|NOT COMPLETED|Overall Study||26
3234500|NCT02371629|3966788|FG001|NOT COMPLETED|Overall Study||25
3234501|NCT02371668|3966796|FG000|STARTED|Overall Study||49
3234502|NCT02371668|3966797|FG001|STARTED|Overall Study||42
3234503|NCT02371668|3966796|FG000|COMPLETED|Overall Study||49
3234504|NCT02371668|3966797|FG001|COMPLETED|Overall Study||42
3234505|NCT02371668|3966796|FG000|NOT COMPLETED|Overall Study||0
3234506|NCT02371668|3966797|FG001|NOT COMPLETED|Overall Study||0
3234507|NCT02371746|3966810|FG000|STARTED|Overall Study||7
3234508|NCT02371746|3966811|FG001|STARTED|Overall Study||10
3234509|NCT02371746|3966812|FG002|STARTED|Overall Study||2
3234510|NCT02371746|3966813|FG003|STARTED|Overall Study||2
3234511|NCT02371746|3966814|FG004|STARTED|Overall Study||5
3234512|NCT02371746|3966815|FG005|STARTED|Overall Study||6
3234513|NCT02371746|3966816|FG006|STARTED|Overall Study||9
3234514|NCT02371746|3966810|FG000|COMPLETED|Overall Study||7
3234515|NCT02371746|3966811|FG001|COMPLETED|Overall Study||10
3234516|NCT02371746|3966812|FG002|COMPLETED|Overall Study||2
3234517|NCT02371746|3966813|FG003|COMPLETED|Overall Study||2
3234518|NCT02371746|3966814|FG004|COMPLETED|Overall Study||5
3234519|NCT02371746|3966815|FG005|COMPLETED|Overall Study||6
3234520|NCT02371746|3966816|FG006|COMPLETED|Overall Study||8
3234521|NCT02371746|3966810|FG000|NOT COMPLETED|Overall Study||0
3234522|NCT02371746|3966811|FG001|NOT COMPLETED|Overall Study||0
3234523|NCT02371746|3966812|FG002|NOT COMPLETED|Overall Study||0
3234524|NCT02371746|3966813|FG003|NOT COMPLETED|Overall Study||0
3234525|NCT02371746|3966814|FG004|NOT COMPLETED|Overall Study||0
3234526|NCT02371746|3966815|FG005|NOT COMPLETED|Overall Study||0
3234527|NCT02371746|3966816|FG006|NOT COMPLETED|Overall Study||1
3234528|NCT02371759|3966840|FG000|STARTED|Overall Study||32
3234529|NCT02371759|3966841|FG001|STARTED|Overall Study||31
3234530|NCT02371759|3966842|FG002|STARTED|Overall Study||33
3234531|NCT02371759|3966843|FG003|STARTED|Overall Study||31
3234532|NCT02371759|3966844|FG004|STARTED|Overall Study||27
3234533|NCT02371759|3966845|FG005|STARTED|Overall Study||26
3234534|NCT02371759|3966846|FG006|STARTED|Overall Study||25
3234535|NCT02371759|3966847|FG007|STARTED|Overall Study||28
3234536|NCT02371759|3966840|FG000|COMPLETED|Overall Study||29
3234537|NCT02371759|3966841|FG001|COMPLETED|Overall Study||30
3234538|NCT02371759|3966842|FG002|COMPLETED|Overall Study||32
3234539|NCT02371759|3966843|FG003|COMPLETED|Overall Study||31
3234540|NCT02371759|3966844|FG004|COMPLETED|Overall Study||24
3234541|NCT02371759|3966845|FG005|COMPLETED|Overall Study||25
3234542|NCT02371759|3966846|FG006|COMPLETED|Overall Study||25
3234543|NCT02371759|3966847|FG007|COMPLETED|Overall Study||24
3234544|NCT02371759|3966840|FG000|NOT COMPLETED|Overall Study||3
3234545|NCT02371759|3966841|FG001|NOT COMPLETED|Overall Study||1
3234546|NCT02371759|3966842|FG002|NOT COMPLETED|Overall Study||1
3234547|NCT02371759|3966843|FG003|NOT COMPLETED|Overall Study||0
3234548|NCT02371759|3966844|FG004|NOT COMPLETED|Overall Study||3
3234549|NCT02371759|3966845|FG005|NOT COMPLETED|Overall Study||1
3234550|NCT02371759|3966846|FG006|NOT COMPLETED|Overall Study||0
3234551|NCT02371759|3966847|FG007|NOT COMPLETED|Overall Study||4
3234552|NCT02371785|3966865|FG000|STARTED|Overall Study||20
3234553|NCT02371785|3966865|FG000|COMPLETED|Overall Study||20
3234554|NCT02371785|3966865|FG000|NOT COMPLETED|Overall Study||0
3234555|NCT02371850|3966875|FG000|STARTED|Overall Study||10
3234556|NCT02371850|3966875|FG000|COMPLETED|Overall Study||10
3234557|NCT02371850|3966875|FG000|NOT COMPLETED|Overall Study||0
3234558|NCT02371876|3966886|FG000|STARTED|Overall Study||134
3234559|NCT02371876|3966886|FG000|COMPLETED|Overall Study||134
3234560|NCT02371876|3966886|FG000|NOT COMPLETED|Overall Study||0
3234561|NCT02371980|3966894|FG000|STARTED|Open-label Period||1106
3369465|NCT03802344|4101010|FG001|COMPLETED|Overall Study||203
3369466|NCT03802344|4101011|FG002|COMPLETED|Overall Study||55
3369467|NCT03802344|4101009|FG000|NOT COMPLETED|Overall Study||8
3369468|NCT03802344|4101010|FG001|NOT COMPLETED|Overall Study||6
3369469|NCT03802344|4101011|FG002|NOT COMPLETED|Overall Study||13
3369470|NCT03801928|4101026|FG000|STARTED|Overall Study||18
3369471|NCT03801928|4101027|FG001|STARTED|Overall Study||21
3369472|NCT03801928|4101028|FG002|STARTED|Overall Study||9
3369473|NCT03801928|4101029|FG003|STARTED|Overall Study||21
3234562|NCT02371980|3966895|FG001|STARTED|Open-label Period||0
3234563|NCT02371980|3966896|FG002|STARTED|Open-label Period||0
3234564|NCT02371980|3966897|FG003|STARTED|Open-label Period||0
3369474|NCT03801928|4101030|FG004|STARTED|Overall Study||36
3234565|NCT02371980|3966898|FG004|STARTED|Open-label Period||0
3234566|NCT02371980|3966894|FG000|COMPLETED|Open-label Period||580
3234567|NCT02371980|3966895|FG001|COMPLETED|Open-label Period||0
3234568|NCT02371980|3966896|FG002|COMPLETED|Open-label Period||0
3234569|NCT02371980|3966897|FG003|COMPLETED|Open-label Period||0
3234570|NCT02371980|3966898|FG004|COMPLETED|Open-label Period||0
3234571|NCT02371980|3966894|FG000|NOT COMPLETED|Open-label Period||526
3234572|NCT02371980|3966895|FG001|NOT COMPLETED|Open-label Period||0
3234573|NCT02371980|3966896|FG002|NOT COMPLETED|Open-label Period||0
3234574|NCT02371980|3966897|FG003|NOT COMPLETED|Open-label Period||0
3234575|NCT02371980|3966898|FG004|NOT COMPLETED|Open-label Period||0
3234576|NCT02371980|3966894|FG000|STARTED|Double-blind Period||0
3234577|NCT02371980|3966895|FG001|STARTED|Double-blind Period||151
3234578|NCT02371980|3966896|FG002|STARTED|Double-blind Period||140
3234579|NCT02371980|3966897|FG003|STARTED|Double-blind Period||145
3234580|NCT02371980|3966898|FG004|STARTED|Double-blind Period||144
3234581|NCT02371980|3966894|FG000|COMPLETED|Double-blind Period||0
3234582|NCT02371980|3966895|FG001|COMPLETED|Double-blind Period||70
3234583|NCT02371980|3966896|FG002|COMPLETED|Double-blind Period||84
3234584|NCT02371980|3966897|FG003|COMPLETED|Double-blind Period||96
3234585|NCT02371980|3966898|FG004|COMPLETED|Double-blind Period||86
3234586|NCT02371980|3966894|FG000|NOT COMPLETED|Double-blind Period||0
3234587|NCT02371980|3966895|FG001|NOT COMPLETED|Double-blind Period||81
3234588|NCT02371980|3966896|FG002|NOT COMPLETED|Double-blind Period||56
3234589|NCT02371980|3966897|FG003|NOT COMPLETED|Double-blind Period||49
3234590|NCT02371980|3966898|FG004|NOT COMPLETED|Double-blind Period||58
3234591|NCT02372006|3966912|FG000|STARTED|Overall Study||8
3234592|NCT02372006|3966913|FG001|STARTED|Overall Study||9
3234593|NCT02372006|3966914|FG002|STARTED|Overall Study||39
3234594|NCT02372006|3966912|FG000|COMPLETED|Overall Study||0
3234595|NCT02372006|3966913|FG001|COMPLETED|Overall Study||0
3234596|NCT02372006|3966914|FG002|COMPLETED|Overall Study||0
3234597|NCT02372006|3966912|FG000|NOT COMPLETED|Overall Study||8
3234598|NCT02372006|3966913|FG001|NOT COMPLETED|Overall Study||9
3234599|NCT02372006|3966914|FG002|NOT COMPLETED|Overall Study||39
3234600|NCT02372058|3966923|FG000|STARTED|Overall Study||103
3234601|NCT02372058|3966923|FG000|COMPLETED|Overall Study||100
3234602|NCT02372058|3966923|FG000|NOT COMPLETED|Overall Study||3
3234603|NCT02372071|3966929|FG000|STARTED|Overall Study||111
3234604|NCT02372071|3966929|FG000|COMPLETED|Overall Study||93
3234605|NCT02372071|3966929|FG000|NOT COMPLETED|Overall Study||18
3234606|NCT02372097|3966936|FG000|STARTED|First Intervention Period (8 Days)||12
3234607|NCT02372097|3966937|FG001|STARTED|First Intervention Period (8 Days)||12
3234608|NCT02372097|3966936|FG000|COMPLETED|First Intervention Period (8 Days)||12
3234609|NCT02372097|3966937|FG001|COMPLETED|First Intervention Period (8 Days)||12
3234610|NCT02372097|3966936|FG000|NOT COMPLETED|First Intervention Period (8 Days)||0
3234611|NCT02372097|3966937|FG001|NOT COMPLETED|First Intervention Period (8 Days)||0
3234612|NCT02372097|3966936|FG000|STARTED|Wash Out Period (13 Days)||12
3234613|NCT02372097|3966937|FG001|STARTED|Wash Out Period (13 Days)||12
3234614|NCT02372097|3966936|FG000|COMPLETED|Wash Out Period (13 Days)||12
3234615|NCT02372097|3966937|FG001|COMPLETED|Wash Out Period (13 Days)||12
3234616|NCT02372097|3966936|FG000|NOT COMPLETED|Wash Out Period (13 Days)||0
3234617|NCT02372097|3966937|FG001|NOT COMPLETED|Wash Out Period (13 Days)||0
3234618|NCT02372097|3966936|FG000|STARTED|Second Intervention Period (8 Days)||12
3234619|NCT02372097|3966937|FG001|STARTED|Second Intervention Period (8 Days)||12
3234620|NCT02372097|3966936|FG000|COMPLETED|Second Intervention Period (8 Days)||12
3234621|NCT02372097|3966937|FG001|COMPLETED|Second Intervention Period (8 Days)||12
3234622|NCT02372097|3966936|FG000|NOT COMPLETED|Second Intervention Period (8 Days)||0
3234623|NCT02372097|3966937|FG001|NOT COMPLETED|Second Intervention Period (8 Days)||0
3234624|NCT02372136|3966945|FG000|STARTED|Overall Study||62
3234625|NCT02372136|3966946|FG001|STARTED|Overall Study||58
3234626|NCT02372136|3966945|FG000|COMPLETED|Overall Study||59
3234627|NCT02372136|3966946|FG001|COMPLETED|Overall Study||57
3234628|NCT02372136|3966945|FG000|NOT COMPLETED|Overall Study||3
3234629|NCT02372136|3966946|FG001|NOT COMPLETED|Overall Study||1
3234630|NCT02372253|3966956|FG000|STARTED|Overall Study||13
3234631|NCT02372253|3966957|FG001|STARTED|Overall Study||13
3234632|NCT02372253|3966956|FG000|COMPLETED|Overall Study||11
3234633|NCT02372253|3966957|FG001|COMPLETED|Overall Study||13
3234634|NCT02372253|3966956|FG000|NOT COMPLETED|Overall Study||2
3234635|NCT02372253|3966957|FG001|NOT COMPLETED|Overall Study||0
3234636|NCT02372344|3966965|FG000|STARTED|Period 1 (Visit 2)||14
3234637|NCT02372344|3966966|FG001|STARTED|Period 1 (Visit 2)||14
3234638|NCT02372344|3966967|FG002|STARTED|Period 1 (Visit 2)||14
3234639|NCT02372344|3966965|FG000|COMPLETED|Period 1 (Visit 2)||14
3234640|NCT02372344|3966966|FG001|COMPLETED|Period 1 (Visit 2)||14
3234641|NCT02372344|3966967|FG002|COMPLETED|Period 1 (Visit 2)||14
3234642|NCT02372344|3966965|FG000|NOT COMPLETED|Period 1 (Visit 2)||0
3234643|NCT02372344|3966966|FG001|NOT COMPLETED|Period 1 (Visit 2)||0
3234644|NCT02372344|3966967|FG002|NOT COMPLETED|Period 1 (Visit 2)||0
3234645|NCT02372344|3966965|FG000|STARTED|Period 2 (Visit 3)||14
3234646|NCT02372344|3966966|FG001|STARTED|Period 2 (Visit 3)||14
3234647|NCT02372344|3966967|FG002|STARTED|Period 2 (Visit 3)||14
3234648|NCT02372344|3966965|FG000|COMPLETED|Period 2 (Visit 3)||14
3234649|NCT02372344|3966966|FG001|COMPLETED|Period 2 (Visit 3)||14
3234650|NCT02372344|3966967|FG002|COMPLETED|Period 2 (Visit 3)||14
3234651|NCT02372344|3966965|FG000|NOT COMPLETED|Period 2 (Visit 3)||0
3234652|NCT02372344|3966966|FG001|NOT COMPLETED|Period 2 (Visit 3)||0
3234653|NCT02372344|3966967|FG002|NOT COMPLETED|Period 2 (Visit 3)||0
3234654|NCT02372344|3966965|FG000|STARTED|Period 3 (Visit 4)||14
3234655|NCT02372344|3966966|FG001|STARTED|Period 3 (Visit 4)||14
3234656|NCT02372344|3966967|FG002|STARTED|Period 3 (Visit 4)||14
3234657|NCT02372344|3966965|FG000|COMPLETED|Period 3 (Visit 4)||14
3234658|NCT02372344|3966966|FG001|COMPLETED|Period 3 (Visit 4)||14
3234659|NCT02372344|3966967|FG002|COMPLETED|Period 3 (Visit 4)||14
3234660|NCT02372344|3966965|FG000|NOT COMPLETED|Period 3 (Visit 4)||0
3234661|NCT02372344|3966966|FG001|NOT COMPLETED|Period 3 (Visit 4)||0
3234662|NCT02372344|3966967|FG002|NOT COMPLETED|Period 3 (Visit 4)||0
3234663|NCT02372383|3966977|FG000|STARTED|First Intervention (1 Day)||10
3234664|NCT02372383|3966978|FG001|STARTED|First Intervention (1 Day)||11
3234665|NCT02372383|3966979|FG002|STARTED|First Intervention (1 Day)||10
3234666|NCT02372383|3966977|FG000|COMPLETED|First Intervention (1 Day)||10
3234667|NCT02372383|3966978|FG001|COMPLETED|First Intervention (1 Day)||10
3234668|NCT02372383|3966979|FG002|COMPLETED|First Intervention (1 Day)||10
3234669|NCT02372383|3966977|FG000|NOT COMPLETED|First Intervention (1 Day)||0
3234670|NCT02372383|3966978|FG001|NOT COMPLETED|First Intervention (1 Day)||1
3234671|NCT02372383|3966979|FG002|NOT COMPLETED|First Intervention (1 Day)||0
3234672|NCT02372383|3966977|FG000|STARTED|Washout (14 Days)||10
3234673|NCT02372383|3966978|FG001|STARTED|Washout (14 Days)||10
3234674|NCT02372383|3966979|FG002|STARTED|Washout (14 Days)||10
3234675|NCT02372383|3966977|FG000|COMPLETED|Washout (14 Days)||10
3234676|NCT02372383|3966978|FG001|COMPLETED|Washout (14 Days)||10
3234677|NCT02372383|3966979|FG002|COMPLETED|Washout (14 Days)||10
3234678|NCT02372383|3966977|FG000|NOT COMPLETED|Washout (14 Days)||0
3234679|NCT02372383|3966978|FG001|NOT COMPLETED|Washout (14 Days)||0
3234680|NCT02372383|3966979|FG002|NOT COMPLETED|Washout (14 Days)||0
3234681|NCT02372383|3966977|FG000|STARTED|Second Intervention (1 Day)||10
3234682|NCT02372383|3966978|FG001|STARTED|Second Intervention (1 Day)||10
3234683|NCT02372383|3966979|FG002|STARTED|Second Intervention (1 Day)||10
3234684|NCT02372383|3966977|FG000|COMPLETED|Second Intervention (1 Day)||10
3234685|NCT02372383|3966978|FG001|COMPLETED|Second Intervention (1 Day)||10
3234686|NCT02372383|3966979|FG002|COMPLETED|Second Intervention (1 Day)||10
3234687|NCT02372383|3966977|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
3234688|NCT02372383|3966978|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
3234689|NCT02372383|3966979|FG002|NOT COMPLETED|Second Intervention (1 Day)||0
3234690|NCT02372396|3966991|FG000|STARTED|Overall Study||17
3234691|NCT02372396|3966992|FG001|STARTED|Overall Study||20
3234692|NCT02372396|3966991|FG000|Began Intervention|Overall Study||14
3234693|NCT02372396|3966992|FG001|Began Intervention|Overall Study||14
3234694|NCT02372396|3966991|FG000|COMPLETED|Overall Study||10
3234695|NCT02372396|3966992|FG001|COMPLETED|Overall Study||11
3234696|NCT02372396|3966991|FG000|NOT COMPLETED|Overall Study||7
3234697|NCT02372396|3966992|FG001|NOT COMPLETED|Overall Study||9
3234698|NCT02372682|3967000|FG000|STARTED|Overall Study||78
3234699|NCT02372682|3967001|FG001|STARTED|Overall Study||93
3234700|NCT02372682|3967000|FG000|COMPLETED|Overall Study||70
3234701|NCT02372682|3967001|FG001|COMPLETED|Overall Study||79
3234702|NCT02372682|3967000|FG000|NOT COMPLETED|Overall Study||8
3234703|NCT02372682|3967001|FG001|NOT COMPLETED|Overall Study||14
3234704|NCT02372799|3967017|FG000|STARTED|Treatment Period||186
3234705|NCT02372799|3967018|FG001|STARTED|Treatment Period||187
3234706|NCT02372799|3967019|FG002|STARTED|Treatment Period||97
3234707|NCT02372799|3967017|FG000|COMPLETED|Treatment Period||152
3234708|NCT02372799|3967018|FG001|COMPLETED|Treatment Period||155
3234709|NCT02372799|3967019|FG002|COMPLETED|Treatment Period||82
3234710|NCT02372799|3967017|FG000|NOT COMPLETED|Treatment Period||34
3234711|NCT02372799|3967018|FG001|NOT COMPLETED|Treatment Period||32
3234712|NCT02372799|3967019|FG002|NOT COMPLETED|Treatment Period||15
3234713|NCT02372799|3967017|FG000|STARTED|Down-taper Period||152
3234714|NCT02372799|3967018|FG001|STARTED|Down-taper Period||159
3234715|NCT02372799|3967019|FG002|STARTED|Down-taper Period||82
3234716|NCT02372799|3967017|FG000|COMPLETED|Down-taper Period||151
3234717|NCT02372799|3967018|FG001|COMPLETED|Down-taper Period||157
3234718|NCT02372799|3967019|FG002|COMPLETED|Down-taper Period||80
3234719|NCT02372799|3967017|FG000|NOT COMPLETED|Down-taper Period||1
3234720|NCT02372799|3967018|FG001|NOT COMPLETED|Down-taper Period||2
3234721|NCT02372799|3967019|FG002|NOT COMPLETED|Down-taper Period||2
3234722|NCT02373098|3967029|FG000|STARTED|Overall Study||66
3234723|NCT02373098|3967030|FG001|STARTED|Overall Study||60
3234724|NCT02373098|3967029|FG000|COMPLETED|Overall Study||54
3234725|NCT02373098|3967030|FG001|COMPLETED|Overall Study||60
3234726|NCT02373098|3967029|FG000|NOT COMPLETED|Overall Study||12
3234727|NCT02373098|3967030|FG001|NOT COMPLETED|Overall Study||0
3234728|NCT02373124|3967042|FG000|STARTED|Overall Study||4
3234729|NCT02373124|3967042|FG000|COMPLETED|Overall Study||3
3234730|NCT02373124|3967042|FG000|NOT COMPLETED|Overall Study||1
3234731|NCT02373137|3967048|FG000|STARTED|Overall Study||19
3234732|NCT02373137|3967049|FG001|STARTED|Overall Study||19
3234733|NCT02373137|3967048|FG000|3-Month Follow-Up|Overall Study||19
3234734|NCT02373137|3967049|FG001|3-Month Follow-Up|Overall Study||19
3234735|NCT02373137|3967048|FG000|6-Month Follow-Up|Overall Study||19
3234736|NCT02373137|3967049|FG001|6-Month Follow-Up|Overall Study||18
3234737|NCT02373137|3967048|FG000|12-Month Follow-Up|Overall Study||19
3234738|NCT02373137|3967049|FG001|12-Month Follow-Up|Overall Study||19
3234739|NCT02373137|3967048|FG000|COMPLETED|Overall Study||18
3234740|NCT02373137|3967049|FG001|COMPLETED|Overall Study||18
3234741|NCT02373137|3967048|FG000|NOT COMPLETED|Overall Study||1
3234742|NCT02373137|3967049|FG001|NOT COMPLETED|Overall Study||1
3234743|NCT02373202|3967060|FG000|STARTED|Overall Study||15
3234744|NCT02373202|3967061|FG001|STARTED|Overall Study||15
3234745|NCT02373202|3967062|FG002|STARTED|Overall Study||30
3234746|NCT02373202|3967063|FG003|STARTED|Overall Study||31
3234747|NCT02373202|3967060|FG000|COMPLETED|Overall Study||13
3234748|NCT02373202|3967061|FG001|COMPLETED|Overall Study||9
3234749|NCT02373202|3967062|FG002|COMPLETED|Overall Study||27
3234750|NCT02373202|3967063|FG003|COMPLETED|Overall Study||30
3234751|NCT02373202|3967060|FG000|NOT COMPLETED|Overall Study||2
3234752|NCT02373202|3967061|FG001|NOT COMPLETED|Overall Study||6
3234753|NCT02373202|3967062|FG002|NOT COMPLETED|Overall Study||3
3234754|NCT02373202|3967063|FG003|NOT COMPLETED|Overall Study||1
3234755|NCT02373371|3967075|FG000|STARTED|Overall Study||13
3234756|NCT02373371|3967076|FG001|STARTED|Overall Study||13
3234757|NCT02373371|3967075|FG000|COMPLETED|Overall Study||13
3234758|NCT02373371|3967076|FG001|COMPLETED|Overall Study||13
3234759|NCT02373371|3967075|FG000|NOT COMPLETED|Overall Study||0
3234760|NCT02373371|3967076|FG001|NOT COMPLETED|Overall Study||0
3234761|NCT02373813|3967085|FG000|STARTED|Run-In Period||371
3234762|NCT02373813|3967086|FG001|STARTED|Run-In Period||0
3234763|NCT02373813|3967087|FG002|STARTED|Run-In Period||0
3234764|NCT02373813|3967088|FG003|STARTED|Run-In Period||0
3234765|NCT02373813|3967085|FG000|Treated|Run-In Period||368
3234766|NCT02373813|3967086|FG001|Treated|Run-In Period||0
3234767|NCT02373813|3967087|FG002|Treated|Run-In Period||0
3234768|NCT02373813|3967088|FG003|Treated|Run-In Period||0
3234769|NCT02373813|3967085|FG000|COMPLETED|Run-In Period|1 participant who completed the run-in period had no end of study case report form.|255
3234770|NCT02373813|3967086|FG001|COMPLETED|Run-In Period||0
3234771|NCT02373813|3967087|FG002|COMPLETED|Run-In Period||0
3234772|NCT02373813|3967088|FG003|COMPLETED|Run-In Period||0
3234773|NCT02373813|3967085|FG000|NOT COMPLETED|Run-In Period||116
3234774|NCT02373813|3967086|FG001|NOT COMPLETED|Run-In Period||0
3234775|NCT02373813|3967087|FG002|NOT COMPLETED|Run-In Period||0
3234776|NCT02373813|3967088|FG003|NOT COMPLETED|Run-In Period||0
3234777|NCT02373813|3967085|FG000|STARTED|Double-Blind Treatment Period||0
3234778|NCT02373813|3967086|FG001|STARTED|Double-Blind Treatment Period||101
3234779|NCT02373813|3967087|FG002|STARTED|Double-Blind Treatment Period||101
3234780|NCT02373813|3967088|FG003|STARTED|Double-Blind Treatment Period||51
3234781|NCT02373813|3967085|FG000|Received Investigational Product (IP)|Double-Blind Treatment Period||0
3234782|NCT02373813|3967086|FG001|Received Investigational Product (IP)|Double-Blind Treatment Period||101
3234783|NCT02373813|3967087|FG002|Received Investigational Product (IP)|Double-Blind Treatment Period||100
3234784|NCT02373813|3967088|FG003|Received Investigational Product (IP)|Double-Blind Treatment Period||51
3234785|NCT02373813|3967085|FG000|Received Rescue Treatment|Double-Blind Treatment Period||0
3234786|NCT02373813|3967086|FG001|Received Rescue Treatment|Double-Blind Treatment Period||52
3234787|NCT02373813|3967087|FG002|Received Rescue Treatment|Double-Blind Treatment Period||36
3234788|NCT02373813|3967088|FG003|Received Rescue Treatment|Double-Blind Treatment Period||15
3234789|NCT02373813|3967085|FG000|COMPLETED|Double-Blind Treatment Period||0
3234790|NCT02373813|3967086|FG001|COMPLETED|Double-Blind Treatment Period||88
3234791|NCT02373813|3967087|FG002|COMPLETED|Double-Blind Treatment Period||92
3234792|NCT02373813|3967088|FG003|COMPLETED|Double-Blind Treatment Period||47
3234793|NCT02373813|3967085|FG000|NOT COMPLETED|Double-Blind Treatment Period||0
3234794|NCT02373813|3967086|FG001|NOT COMPLETED|Double-Blind Treatment Period||13
3234795|NCT02373813|3967087|FG002|NOT COMPLETED|Double-Blind Treatment Period||9
3234796|NCT02373813|3967088|FG003|NOT COMPLETED|Double-Blind Treatment Period||4
3234797|NCT02373852|3967099|FG000|STARTED|Overall Study|Includes patients from a previous retrospective study NCT01042444|12
3234798|NCT02373852|3967099|FG000|COMPLETED|Overall Study||11
3234799|NCT02373852|3967099|FG000|NOT COMPLETED|Overall Study||1
3234800|NCT02374060|3967106|FG000|STARTED|Overall Study||65
3234801|NCT02374060|3967107|FG001|STARTED|Overall Study||63
3234802|NCT02374060|3967108|FG002|STARTED|Overall Study||64
3234803|NCT02374060|3967106|FG000|COMPLETED|Overall Study||63
3234804|NCT02374060|3967107|FG001|COMPLETED|Overall Study||62
3234805|NCT02374060|3967108|FG002|COMPLETED|Overall Study||61
3234806|NCT02374060|3967106|FG000|NOT COMPLETED|Overall Study||2
3234807|NCT02374060|3967107|FG001|NOT COMPLETED|Overall Study||1
3234808|NCT02374060|3967108|FG002|NOT COMPLETED|Overall Study||3
3234809|NCT02374099|3967118|FG000|STARTED|Overall Study||48
3234810|NCT02374099|3967119|FG001|STARTED|Overall Study||49
3234811|NCT02374099|3967118|FG000|Participants Treated|Overall Study|2 participants randomized, but not treated|46
3234812|NCT02374099|3967119|FG001|Participants Treated|Overall Study|1 participant randomized, but not treated|48
3234813|NCT02374099|3967118|FG000|COMPLETED|Overall Study||0
3234814|NCT02374099|3967119|FG001|COMPLETED|Overall Study||0
3234815|NCT02374099|3967118|FG000|NOT COMPLETED|Overall Study||48
3234816|NCT02374099|3967119|FG001|NOT COMPLETED|Overall Study||49
3234817|NCT02374138|3967127|FG000|STARTED|Six Month Follow Up||110
3234818|NCT02374138|3967128|FG001|STARTED|Six Month Follow Up||107
3234819|NCT02374138|3967127|FG000|COMPLETED|Six Month Follow Up|6 Month Follow Up|102
3234820|NCT02374138|3967128|FG001|COMPLETED|Six Month Follow Up|6 Month Follow Up|93
3234821|NCT02374138|3967127|FG000|NOT COMPLETED|Six Month Follow Up||8
3234822|NCT02374138|3967128|FG001|NOT COMPLETED|Six Month Follow Up||14
3234823|NCT02374138|3967127|FG000|STARTED|Twelve Month FollowUp||110
3234824|NCT02374138|3967128|FG001|STARTED|Twelve Month FollowUp||107
3234825|NCT02374138|3967127|FG000|COMPLETED|Twelve Month FollowUp||101
3234826|NCT02374138|3967128|FG001|COMPLETED|Twelve Month FollowUp||95
3234827|NCT02374138|3967127|FG000|NOT COMPLETED|Twelve Month FollowUp||9
3234828|NCT02374138|3967128|FG001|NOT COMPLETED|Twelve Month FollowUp||12
3234829|NCT02374164|3967138|FG000|STARTED|Treatment Period 1||12
3234830|NCT02374164|3967139|FG001|STARTED|Treatment Period 1||12
3234831|NCT02374164|3967140|FG002|STARTED|Treatment Period 1||12
3234832|NCT02374164|3967138|FG000|COMPLETED|Treatment Period 1||12
3234833|NCT02374164|3967139|FG001|COMPLETED|Treatment Period 1||12
3234834|NCT02374164|3967140|FG002|COMPLETED|Treatment Period 1||12
3234835|NCT02374164|3967138|FG000|NOT COMPLETED|Treatment Period 1||0
3234836|NCT02374164|3967139|FG001|NOT COMPLETED|Treatment Period 1||0
3234837|NCT02374164|3967140|FG002|NOT COMPLETED|Treatment Period 1||0
3234838|NCT02374164|3967138|FG000|STARTED|Treatment Period 2||12
3234839|NCT02374164|3967139|FG001|STARTED|Treatment Period 2||12
3234840|NCT02374164|3967140|FG002|STARTED|Treatment Period 2||12
3234841|NCT02374164|3967138|FG000|COMPLETED|Treatment Period 2||12
3234842|NCT02374164|3967139|FG001|COMPLETED|Treatment Period 2||12
3234843|NCT02374164|3967140|FG002|COMPLETED|Treatment Period 2||12
3234844|NCT02374164|3967138|FG000|NOT COMPLETED|Treatment Period 2||0
3234845|NCT02374164|3967139|FG001|NOT COMPLETED|Treatment Period 2||0
3234846|NCT02374164|3967140|FG002|NOT COMPLETED|Treatment Period 2||0
3234847|NCT02374164|3967138|FG000|STARTED|Treatment Period 3||12
3234848|NCT02374164|3967139|FG001|STARTED|Treatment Period 3|One participant was Lost-to-Follow-Up prior to treatment A.|11
3234849|NCT02374164|3967140|FG002|STARTED|Treatment Period 3||12
3234850|NCT02374164|3967138|FG000|COMPLETED|Treatment Period 3||12
3234851|NCT02374164|3967139|FG001|COMPLETED|Treatment Period 3||11
3234852|NCT02374164|3967140|FG002|COMPLETED|Treatment Period 3||12
3234853|NCT02374164|3967138|FG000|NOT COMPLETED|Treatment Period 3||0
3234854|NCT02374164|3967139|FG001|NOT COMPLETED|Treatment Period 3||0
3234855|NCT02374164|3967140|FG002|NOT COMPLETED|Treatment Period 3||0
3234856|NCT02374255|3967152|FG000|STARTED|Overall Study||155
3234857|NCT02374255|3967153|FG001|STARTED|Overall Study||110
3234858|NCT02374255|3967154|FG002|STARTED|Overall Study||11
3234859|NCT02374255|3967155|FG003|STARTED|Overall Study||11
3234860|NCT02374255|3967152|FG000|COMPLETED|Overall Study||153
3234861|NCT02374255|3967153|FG001|COMPLETED|Overall Study||110
3234862|NCT02374255|3967154|FG002|COMPLETED|Overall Study||11
3234863|NCT02374255|3967155|FG003|COMPLETED|Overall Study||11
3234864|NCT02374255|3967152|FG000|NOT COMPLETED|Overall Study||2
3234865|NCT02374255|3967153|FG001|NOT COMPLETED|Overall Study||0
3234866|NCT02374255|3967154|FG002|NOT COMPLETED|Overall Study||0
3234867|NCT02374255|3967155|FG003|NOT COMPLETED|Overall Study||0
3234868|NCT02374307|3967173|FG000|STARTED|3-months Follow-up||77
3234869|NCT02374307|3967174|FG001|STARTED|3-months Follow-up||78
3234870|NCT02374307|3967173|FG000|COMPLETED|3-months Follow-up||69
3234871|NCT02374307|3967174|FG001|COMPLETED|3-months Follow-up||69
3234872|NCT02374307|3967173|FG000|NOT COMPLETED|3-months Follow-up||8
3234873|NCT02374307|3967174|FG001|NOT COMPLETED|3-months Follow-up||9
3234874|NCT02374307|3967173|FG000|STARTED|6-months Follow-up|5 subjects missed the first follow-up, but continued the study and were assessed at 6 months.|74
3234875|NCT02374307|3967174|FG001|STARTED|6-months Follow-up|1 subject missed the first follow-up, but continued the study and was assessed at 6 months.|70
3234876|NCT02374307|3967173|FG000|COMPLETED|6-months Follow-up||71
3234877|NCT02374307|3967174|FG001|COMPLETED|6-months Follow-up||64
3234878|NCT02374307|3967173|FG000|NOT COMPLETED|6-months Follow-up||3
3234879|NCT02374307|3967174|FG001|NOT COMPLETED|6-months Follow-up||6
3234880|NCT02374346|3967180|FG000|STARTED|Overall Study||494
3234881|NCT02374346|3967180|FG000|COMPLETED|Overall Study||446
3234882|NCT02374346|3967180|FG000|NOT COMPLETED|Overall Study||48
3234883|NCT02374398|3967190|FG000|STARTED|Overall Study||31
3234884|NCT02374398|3967191|FG001|STARTED|Overall Study||32
3234885|NCT02374398|3967192|FG002|STARTED|Overall Study||32
3234886|NCT02374398|3967193|FG003|STARTED|Overall Study||32
3234887|NCT02374398|3967190|FG000|COMPLETED|Overall Study||29
3234888|NCT02374398|3967191|FG001|COMPLETED|Overall Study||31
3234889|NCT02374398|3967192|FG002|COMPLETED|Overall Study||29
3234890|NCT02374398|3967193|FG003|COMPLETED|Overall Study||32
3234891|NCT02374398|3967190|FG000|NOT COMPLETED|Overall Study||2
3234892|NCT02374398|3967191|FG001|NOT COMPLETED|Overall Study||1
3234893|NCT02374398|3967192|FG002|NOT COMPLETED|Overall Study||3
3234894|NCT02374398|3967193|FG003|NOT COMPLETED|Overall Study||0
3234895|NCT02374463|3967206|FG000|STARTED|Overall Study||15
3234896|NCT02374463|3967207|FG001|STARTED|Overall Study||12
3234897|NCT02374463|3967206|FG000|COMPLETED|Overall Study||12
3234898|NCT02374463|3967207|FG001|COMPLETED|Overall Study||9
3234899|NCT02374463|3967206|FG000|NOT COMPLETED|Overall Study||3
3234900|NCT02374463|3967207|FG001|NOT COMPLETED|Overall Study||3
3234901|NCT02374593|3967216|FG000|STARTED|Overall Study||24
3234902|NCT02374593|3967217|FG001|STARTED|Overall Study||44
3234903|NCT02374593|3967216|FG000|COMPLETED|Overall Study||22
3234904|NCT02374593|3967217|FG001|COMPLETED|Overall Study||44
3234905|NCT02374593|3967216|FG000|NOT COMPLETED|Overall Study||2
3234906|NCT02374593|3967217|FG001|NOT COMPLETED|Overall Study||0
3234907|NCT02374671|3967230|FG000|STARTED|Observation (Deferred Implantation)||0
3234908|NCT02374671|3967231|FG001|STARTED|Observation (Deferred Implantation)||0
3234909|NCT02374671|3967232|FG002|STARTED|Observation (Deferred Implantation)||31
3234910|NCT02374671|3967230|FG000|COMPLETED|Observation (Deferred Implantation)||0
3234911|NCT02374671|3967231|FG001|COMPLETED|Observation (Deferred Implantation)||0
3234912|NCT02374671|3967232|FG002|COMPLETED|Observation (Deferred Implantation)||26
3234913|NCT02374671|3967230|FG000|NOT COMPLETED|Observation (Deferred Implantation)||0
3234914|NCT02374671|3967231|FG001|NOT COMPLETED|Observation (Deferred Implantation)||0
3234915|NCT02374671|3967232|FG002|NOT COMPLETED|Observation (Deferred Implantation)||5
3234916|NCT02374671|3967230|FG000|STARTED|Implantation- Nonrandomized & Randomized|(8) subjects were unilaterally implanted|306
3234917|NCT02374671|3967231|FG001|STARTED|Implantation- Nonrandomized & Randomized|(1) subject was unilaterally implanted|28
3234918|NCT02374671|3967232|FG002|STARTED|Implantation- Nonrandomized & Randomized|(3) subjects were unilaterally implanted|26
3234919|NCT02374671|3967230|FG000|COMPLETED|Implantation- Nonrandomized & Randomized||281
3234920|NCT02374671|3967231|FG001|COMPLETED|Implantation- Nonrandomized & Randomized||27
3234921|NCT02374671|3967232|FG002|COMPLETED|Implantation- Nonrandomized & Randomized|(1) unilaterally implanted subject discontinued (1 eye)|23
3234922|NCT02374671|3967230|FG000|NOT COMPLETED|Implantation- Nonrandomized & Randomized||25
3234923|NCT02374671|3967231|FG001|NOT COMPLETED|Implantation- Nonrandomized & Randomized||1
3234924|NCT02374671|3967232|FG002|NOT COMPLETED|Implantation- Nonrandomized & Randomized||3
3234925|NCT02374918|3967242|FG000|STARTED|Overall Study||17
3234926|NCT02374918|3967243|FG001|STARTED|Overall Study||18
3234927|NCT02374918|3967244|FG002|STARTED|Overall Study||22
3234928|NCT02374918|3967245|FG003|STARTED|Overall Study||20
3234929|NCT02374918|3967242|FG000|COMPLETED|Overall Study||14
3234930|NCT02374918|3967243|FG001|COMPLETED|Overall Study||17
3234931|NCT02374918|3967244|FG002|COMPLETED|Overall Study||18
3234932|NCT02374918|3967245|FG003|COMPLETED|Overall Study||18
3369475|NCT03801928|4101031|FG005|STARTED|Overall Study||10
3369476|NCT03801928|4101026|FG000|COMPLETED|Overall Study||12
3369477|NCT03801928|4101027|FG001|COMPLETED|Overall Study||18
3369478|NCT03801928|4101028|FG002|COMPLETED|Overall Study||4
3369479|NCT03801928|4101029|FG003|COMPLETED|Overall Study||13
3369480|NCT03801928|4101030|FG004|COMPLETED|Overall Study||32
3369481|NCT03801928|4101031|FG005|COMPLETED|Overall Study||5
3369482|NCT03801928|4101026|FG000|NOT COMPLETED|Overall Study||6
3369483|NCT03801928|4101027|FG001|NOT COMPLETED|Overall Study||3
3369484|NCT03801928|4101028|FG002|NOT COMPLETED|Overall Study||5
3369485|NCT03801928|4101029|FG003|NOT COMPLETED|Overall Study||8
3369486|NCT03801928|4101030|FG004|NOT COMPLETED|Overall Study||4
3369487|NCT03801928|4101031|FG005|NOT COMPLETED|Overall Study||5
3369488|NCT03800173|4101053|FG000|STARTED|Overall Study||8
3369489|NCT03800173|4101054|FG001|STARTED|Overall Study||6
3369490|NCT03800173|4101055|FG002|STARTED|Overall Study||6
3369491|NCT03800173|4101056|FG003|STARTED|Overall Study||6
3369492|NCT03800173|4101057|FG004|STARTED|Overall Study||6
3369493|NCT03800173|4101053|FG000|Safety Population|Overall Study||8
3369494|NCT03800173|4101054|FG001|Safety Population|Overall Study||6
3369495|NCT03800173|4101055|FG002|Safety Population|Overall Study||6
3369496|NCT03800173|4101056|FG003|Safety Population|Overall Study||6
3369497|NCT03800173|4101057|FG004|Safety Population|Overall Study||6
3369498|NCT03800173|4101053|FG000|PK Population|Overall Study||0
3369499|NCT03800173|4101054|FG001|PK Population|Overall Study||6
3369500|NCT03800173|4101055|FG002|PK Population|Overall Study||6
3369501|NCT03800173|4101056|FG003|PK Population|Overall Study||6
3369502|NCT03800173|4101057|FG004|PK Population|Overall Study||6
3369503|NCT03800173|4101053|FG000|COMPLETED|Overall Study||8
3369504|NCT03800173|4101054|FG001|COMPLETED|Overall Study||6
3369505|NCT03800173|4101055|FG002|COMPLETED|Overall Study||6
3369506|NCT03800173|4101056|FG003|COMPLETED|Overall Study||6
3369507|NCT03800173|4101057|FG004|COMPLETED|Overall Study||5
3369508|NCT03800173|4101053|FG000|NOT COMPLETED|Overall Study||0
3369509|NCT03800173|4101054|FG001|NOT COMPLETED|Overall Study||0
3369510|NCT03800173|4101055|FG002|NOT COMPLETED|Overall Study||0
3369511|NCT03800173|4101056|FG003|NOT COMPLETED|Overall Study||0
3369512|NCT03800173|4101057|FG004|NOT COMPLETED|Overall Study||1
3234933|NCT02374918|3967242|FG000|NOT COMPLETED|Overall Study||3
3234934|NCT02374918|3967243|FG001|NOT COMPLETED|Overall Study||1
3234935|NCT02374918|3967244|FG002|NOT COMPLETED|Overall Study||4
3234936|NCT02374918|3967245|FG003|NOT COMPLETED|Overall Study||2
3234937|NCT02374957|3967255|FG000|STARTED|Overall Study||11
3234938|NCT02374957|3967256|FG001|STARTED|Overall Study||9
3234939|NCT02374957|3967255|FG000|COMPLETED|Overall Study||10
3234940|NCT02374957|3967256|FG001|COMPLETED|Overall Study||9
3234941|NCT02374957|3967255|FG000|NOT COMPLETED|Overall Study||1
3234942|NCT02374957|3967256|FG001|NOT COMPLETED|Overall Study||0
3234943|NCT02375347|3967262|FG000|STARTED|Overall Study||13
3234944|NCT02375347|3967262|FG000|COMPLETED|Overall Study||12
3234945|NCT02375347|3967262|FG000|NOT COMPLETED|Overall Study||1
3234946|NCT02375373|3967266|FG000|STARTED|Overall Study||12
3234947|NCT02375373|3967266|FG000|COMPLETED|Overall Study||1
3234948|NCT02375373|3967266|FG000|NOT COMPLETED|Overall Study||11
3234949|NCT02375698|3967272|FG000|STARTED|Overall Study||16
3234950|NCT02375698|3967273|FG001|STARTED|Overall Study||6
3234951|NCT02375698|3967272|FG000|COMPLETED|Overall Study||14
3234952|NCT02375698|3967273|FG001|COMPLETED|Overall Study||4
3234953|NCT02375698|3967272|FG000|NOT COMPLETED|Overall Study||2
3234954|NCT02375698|3967273|FG001|NOT COMPLETED|Overall Study||2
3234955|NCT02375724|3967281|FG000|STARTED|Overall Study||135
3234956|NCT02375724|3967282|FG001|STARTED|Overall Study||134
3234957|NCT02375724|3967281|FG000|COMPLETED|Overall Study||129
3234958|NCT02375724|3967282|FG001|COMPLETED|Overall Study||128
3234959|NCT02375724|3967281|FG000|NOT COMPLETED|Overall Study||6
3234960|NCT02375724|3967282|FG001|NOT COMPLETED|Overall Study||6
3234961|NCT02375971|3967291|FG000|STARTED|Treatment (Day 1 - Baseline)||74
3234962|NCT02375971|3967292|FG001|STARTED|Treatment (Day 1 - Baseline)||77
3234963|NCT02375971|3967293|FG002|STARTED|Treatment (Day 1 - Baseline)||74
3234964|NCT02375971|3967291|FG000|Safety Set|Treatment (Day 1 - Baseline)||73
3234965|NCT02375971|3967292|FG001|Safety Set|Treatment (Day 1 - Baseline)||76
3234966|NCT02375971|3967293|FG002|Safety Set|Treatment (Day 1 - Baseline)||69
3234967|NCT02375971|3967291|FG000|VEGF Set|Treatment (Day 1 - Baseline)||19
3234968|NCT02375971|3967292|FG001|VEGF Set|Treatment (Day 1 - Baseline)||26
3234969|NCT02375971|3967293|FG002|VEGF Set|Treatment (Day 1 - Baseline)||51
3234970|NCT02375971|3967291|FG000|PK Set|Treatment (Day 1 - Baseline)||49
3234971|NCT02375971|3967292|FG001|PK Set|Treatment (Day 1 - Baseline)||46
3234972|NCT02375971|3967293|FG002|PK Set|Treatment (Day 1 - Baseline)||0
3234973|NCT02375971|3967291|FG000|COMPLETED|Treatment (Day 1 - Baseline)||73
3234974|NCT02375971|3967292|FG001|COMPLETED|Treatment (Day 1 - Baseline)||76
3234975|NCT02375971|3967293|FG002|COMPLETED|Treatment (Day 1 - Baseline)||69
3234976|NCT02375971|3967291|FG000|NOT COMPLETED|Treatment (Day 1 - Baseline)||1
3234977|NCT02375971|3967292|FG001|NOT COMPLETED|Treatment (Day 1 - Baseline)||1
3234978|NCT02375971|3967293|FG002|NOT COMPLETED|Treatment (Day 1 - Baseline)||5
3234979|NCT02375971|3967291|FG000|STARTED|Follow-Up Phase (up to Day 169)||73
3234980|NCT02375971|3967292|FG001|STARTED|Follow-Up Phase (up to Day 169)||76
3234981|NCT02375971|3967293|FG002|STARTED|Follow-Up Phase (up to Day 169)||69
3234982|NCT02375971|3967291|FG000|COMPLETED|Follow-Up Phase (up to Day 169)||66
3234983|NCT02375971|3967292|FG001|COMPLETED|Follow-Up Phase (up to Day 169)||71
3234984|NCT02375971|3967293|FG002|COMPLETED|Follow-Up Phase (up to Day 169)||64
3234985|NCT02375971|3967291|FG000|NOT COMPLETED|Follow-Up Phase (up to Day 169)||7
3234986|NCT02375971|3967292|FG001|NOT COMPLETED|Follow-Up Phase (up to Day 169)||5
3234987|NCT02375971|3967293|FG002|NOT COMPLETED|Follow-Up Phase (up to Day 169)||5
3234988|NCT02375984|3967301|FG000|STARTED|Overall Study||1
3234989|NCT02375984|3967301|FG000|COMPLETED|Overall Study||1
3234990|NCT02375984|3967301|FG000|NOT COMPLETED|Overall Study||0
3234991|NCT02376010|3967307|FG000|STARTED|Overall Study||55
3234992|NCT02376010|3967308|FG001|STARTED|Overall Study||55
3234993|NCT02376010|3967307|FG000|COMPLETED|Overall Study||46
3234994|NCT02376010|3967308|FG001|COMPLETED|Overall Study||51
3234995|NCT02376010|3967307|FG000|NOT COMPLETED|Overall Study||9
3234996|NCT02376010|3967308|FG001|NOT COMPLETED|Overall Study||4
3234997|NCT02376166|3967314|FG000|STARTED|Overall Study||15
3234998|NCT02376166|3967314|FG000|COMPLETED|Overall Study||12
3234999|NCT02376166|3967314|FG000|NOT COMPLETED|Overall Study||3
3235000|NCT02376179|3967318|FG000|STARTED|Overall Study||84
3235001|NCT02376179|3967318|FG000|COMPLETED|Overall Study||84
3235002|NCT02376179|3967318|FG000|NOT COMPLETED|Overall Study||0
3235003|NCT02376257|3967325|FG000|STARTED|Overall Study||13
3235004|NCT02376257|3967326|FG001|STARTED|Overall Study||12
3235005|NCT02376257|3967327|FG002|STARTED|Overall Study||11
3235006|NCT02376257|3967325|FG000|COMPLETED|Overall Study||13
3235007|NCT02376257|3967326|FG001|COMPLETED|Overall Study||12
3235008|NCT02376257|3967327|FG002|COMPLETED|Overall Study||11
3235009|NCT02376257|3967325|FG000|NOT COMPLETED|Overall Study||0
3235010|NCT02376257|3967326|FG001|NOT COMPLETED|Overall Study||0
3235011|NCT02376257|3967327|FG002|NOT COMPLETED|Overall Study||0
3235012|NCT02376283|3967338|FG000|STARTED|Overall Study||27
3235013|NCT02376283|3967339|FG001|STARTED|Overall Study||30
3235014|NCT02376283|3967340|FG002|STARTED|Overall Study||30
3235015|NCT02376283|3967338|FG000|COMPLETED|Overall Study||27
3235016|NCT02376283|3967339|FG001|COMPLETED|Overall Study||30
3235017|NCT02376283|3967340|FG002|COMPLETED|Overall Study||30
3235018|NCT02376283|3967338|FG000|NOT COMPLETED|Overall Study||0
3235019|NCT02376283|3967339|FG001|NOT COMPLETED|Overall Study||0
3235020|NCT02376283|3967340|FG002|NOT COMPLETED|Overall Study||0
3235021|NCT02376361|3967351|FG000|STARTED|Overall Study||229
3235022|NCT02376361|3967352|FG001|STARTED|Overall Study||207
3235023|NCT02376361|3967351|FG000|COMPLETED|Overall Study||58
3235024|NCT02376361|3967352|FG001|COMPLETED|Overall Study||90
3235025|NCT02376361|3967351|FG000|NOT COMPLETED|Overall Study||171
3235026|NCT02376361|3967352|FG001|NOT COMPLETED|Overall Study||117
3235027|NCT02376530|3967362|FG000|STARTED|Overall Study||196
3235028|NCT02376530|3967363|FG001|STARTED|Overall Study||198
3235029|NCT02376530|3967364|FG002|STARTED|Overall Study||197
3235030|NCT02376530|3967365|FG003|STARTED|Overall Study||197
3235031|NCT02376530|3967362|FG000|COMPLETED|Overall Study||196
3235032|NCT02376530|3967363|FG001|COMPLETED|Overall Study||198
3235033|NCT02376530|3967364|FG002|COMPLETED|Overall Study||197
3235034|NCT02376530|3967365|FG003|COMPLETED|Overall Study||197
3235035|NCT02376530|3967362|FG000|NOT COMPLETED|Overall Study||0
3235036|NCT02376530|3967363|FG001|NOT COMPLETED|Overall Study||0
3235037|NCT02376530|3967364|FG002|NOT COMPLETED|Overall Study||0
3235038|NCT02376530|3967365|FG003|NOT COMPLETED|Overall Study||0
3235039|NCT02376790|3967378|FG000|STARTED|Overall Study||284
3235040|NCT02376790|3967379|FG001|STARTED|Overall Study||284
3235041|NCT02376790|3967380|FG002|STARTED|Overall Study||283
3235042|NCT02376790|3967378|FG000|Received Treatment|Overall Study||282
3235043|NCT02376790|3967379|FG001|Received Treatment|Overall Study||284
3235044|NCT02376790|3967380|FG002|Received Treatment|Overall Study||282
3235045|NCT02376790|3967378|FG000|COMPLETED|Overall Study||224
3235046|NCT02376790|3967379|FG001|COMPLETED|Overall Study||237
3235047|NCT02376790|3967380|FG002|COMPLETED|Overall Study||230
3235048|NCT02376790|3967378|FG000|NOT COMPLETED|Overall Study||60
3235049|NCT02376790|3967379|FG001|NOT COMPLETED|Overall Study||47
3235050|NCT02376790|3967380|FG002|NOT COMPLETED|Overall Study||53
3235051|NCT02376998|3967388|FG000|STARTED|Overall Study||20
3235052|NCT02376998|3967388|FG000|COMPLETED|Overall Study||11
3235053|NCT02376998|3967388|FG000|NOT COMPLETED|Overall Study||9
3235054|NCT02377063|3967392|FG000|STARTED|Overall Study||25
3235055|NCT02377063|3967392|FG000|COMPLETED|Overall Study||20
3235056|NCT02377063|3967392|FG000|NOT COMPLETED|Overall Study||5
3235057|NCT02377349|3967398|FG000|STARTED|Overall Study||341
3235058|NCT02377349|3967399|FG001|STARTED|Overall Study||346
3235059|NCT02377349|3967398|FG000|COMPLETED|Overall Study||325
3235060|NCT02377349|3967399|FG001|COMPLETED|Overall Study||335
3235061|NCT02377349|3967398|FG000|NOT COMPLETED|Overall Study||16
3235062|NCT02377349|3967399|FG001|NOT COMPLETED|Overall Study||11
3235063|NCT02377362|3967427|FG000|STARTED|Part A First Treatment||4
3235064|NCT02377362|3967428|FG001|STARTED|Part A First Treatment||4
3235065|NCT02377362|3967429|FG002|STARTED|Part A First Treatment||4
3235066|NCT02377362|3967430|FG003|STARTED|Part A First Treatment||4
3235067|NCT02377362|3967431|FG004|STARTED|Part A First Treatment||4
3235068|NCT02377362|3967432|FG005|STARTED|Part A First Treatment||4
3235069|NCT02377362|3967433|FG006|STARTED|Part A First Treatment||0
3235070|NCT02377362|3967434|FG007|STARTED|Part A First Treatment||0
3235071|NCT02377362|3967435|FG008|STARTED|Part A First Treatment||0
3235072|NCT02377362|3967436|FG009|STARTED|Part A First Treatment||0
3235073|NCT02377362|3967437|FG010|STARTED|Part A First Treatment||0
3235074|NCT02377362|3967438|FG011|STARTED|Part A First Treatment||0
3235075|NCT02377362|3967439|FG012|STARTED|Part A First Treatment||0
3235076|NCT02377362|3967427|FG000|COMPLETED|Part A First Treatment||4
3235077|NCT02377362|3967428|FG001|COMPLETED|Part A First Treatment||4
3235078|NCT02377362|3967429|FG002|COMPLETED|Part A First Treatment||4
3235079|NCT02377362|3967430|FG003|COMPLETED|Part A First Treatment||4
3235080|NCT02377362|3967431|FG004|COMPLETED|Part A First Treatment||4
3235081|NCT02377362|3967432|FG005|COMPLETED|Part A First Treatment||4
3235082|NCT02377362|3967433|FG006|COMPLETED|Part A First Treatment||0
3235083|NCT02377362|3967434|FG007|COMPLETED|Part A First Treatment||0
3235084|NCT02377362|3967435|FG008|COMPLETED|Part A First Treatment||0
3235085|NCT02377362|3967436|FG009|COMPLETED|Part A First Treatment||0
3235086|NCT02377362|3967437|FG010|COMPLETED|Part A First Treatment||0
3235087|NCT02377362|3967438|FG011|COMPLETED|Part A First Treatment||0
3235088|NCT02377362|3967439|FG012|COMPLETED|Part A First Treatment||0
3235089|NCT02377362|3967427|FG000|NOT COMPLETED|Part A First Treatment||0
3235090|NCT02377362|3967428|FG001|NOT COMPLETED|Part A First Treatment||0
3235091|NCT02377362|3967429|FG002|NOT COMPLETED|Part A First Treatment||0
3235092|NCT02377362|3967430|FG003|NOT COMPLETED|Part A First Treatment||0
3235093|NCT02377362|3967431|FG004|NOT COMPLETED|Part A First Treatment||0
3235094|NCT02377362|3967432|FG005|NOT COMPLETED|Part A First Treatment||0
3235095|NCT02377362|3967433|FG006|NOT COMPLETED|Part A First Treatment||0
3235096|NCT02377362|3967434|FG007|NOT COMPLETED|Part A First Treatment||0
3235097|NCT02377362|3967435|FG008|NOT COMPLETED|Part A First Treatment||0
3235098|NCT02377362|3967436|FG009|NOT COMPLETED|Part A First Treatment||0
3235099|NCT02377362|3967437|FG010|NOT COMPLETED|Part A First Treatment||0
3235100|NCT02377362|3967438|FG011|NOT COMPLETED|Part A First Treatment||0
3235101|NCT02377362|3967439|FG012|NOT COMPLETED|Part A First Treatment||0
3235102|NCT02377362|3967427|FG000|STARTED|Part A Second Treatment||4
3235103|NCT02377362|3967428|FG001|STARTED|Part A Second Treatment||4
3235104|NCT02377362|3967429|FG002|STARTED|Part A Second Treatment||4
3235105|NCT02377362|3967430|FG003|STARTED|Part A Second Treatment||4
3235106|NCT02377362|3967431|FG004|STARTED|Part A Second Treatment||4
3235107|NCT02377362|3967432|FG005|STARTED|Part A Second Treatment||4
3235108|NCT02377362|3967433|FG006|STARTED|Part A Second Treatment||0
3235109|NCT02377362|3967434|FG007|STARTED|Part A Second Treatment||0
3235110|NCT02377362|3967435|FG008|STARTED|Part A Second Treatment||0
3235111|NCT02377362|3967436|FG009|STARTED|Part A Second Treatment||0
3235112|NCT02377362|3967437|FG010|STARTED|Part A Second Treatment||0
3235113|NCT02377362|3967438|FG011|STARTED|Part A Second Treatment||0
3235114|NCT02377362|3967439|FG012|STARTED|Part A Second Treatment||0
3235115|NCT02377362|3967427|FG000|COMPLETED|Part A Second Treatment||4
3235116|NCT02377362|3967428|FG001|COMPLETED|Part A Second Treatment||4
3235117|NCT02377362|3967429|FG002|COMPLETED|Part A Second Treatment||4
3235118|NCT02377362|3967430|FG003|COMPLETED|Part A Second Treatment||4
3235119|NCT02377362|3967431|FG004|COMPLETED|Part A Second Treatment||3
3235120|NCT02377362|3967432|FG005|COMPLETED|Part A Second Treatment||4
3235121|NCT02377362|3967433|FG006|COMPLETED|Part A Second Treatment||0
3235122|NCT02377362|3967434|FG007|COMPLETED|Part A Second Treatment||0
3235123|NCT02377362|3967435|FG008|COMPLETED|Part A Second Treatment||0
3235124|NCT02377362|3967436|FG009|COMPLETED|Part A Second Treatment||0
3235125|NCT02377362|3967437|FG010|COMPLETED|Part A Second Treatment||0
3235126|NCT02377362|3967438|FG011|COMPLETED|Part A Second Treatment||0
3235127|NCT02377362|3967439|FG012|COMPLETED|Part A Second Treatment||0
3235128|NCT02377362|3967427|FG000|NOT COMPLETED|Part A Second Treatment||0
3235129|NCT02377362|3967428|FG001|NOT COMPLETED|Part A Second Treatment||0
3235130|NCT02377362|3967429|FG002|NOT COMPLETED|Part A Second Treatment||0
3235131|NCT02377362|3967430|FG003|NOT COMPLETED|Part A Second Treatment||0
3235132|NCT02377362|3967431|FG004|NOT COMPLETED|Part A Second Treatment||1
3235133|NCT02377362|3967432|FG005|NOT COMPLETED|Part A Second Treatment||0
3235134|NCT02377362|3967433|FG006|NOT COMPLETED|Part A Second Treatment||0
3235135|NCT02377362|3967434|FG007|NOT COMPLETED|Part A Second Treatment||0
3235136|NCT02377362|3967435|FG008|NOT COMPLETED|Part A Second Treatment||0
3235137|NCT02377362|3967436|FG009|NOT COMPLETED|Part A Second Treatment||0
3235138|NCT02377362|3967437|FG010|NOT COMPLETED|Part A Second Treatment||0
3235139|NCT02377362|3967438|FG011|NOT COMPLETED|Part A Second Treatment||0
3235140|NCT02377362|3967439|FG012|NOT COMPLETED|Part A Second Treatment||0
3235141|NCT02377362|3967427|FG000|STARTED|Part A Third Treatment||4
3235142|NCT02377362|3967428|FG001|STARTED|Part A Third Treatment||4
3235143|NCT02377362|3967429|FG002|STARTED|Part A Third Treatment||4
3235144|NCT02377362|3967430|FG003|STARTED|Part A Third Treatment||4
3235145|NCT02377362|3967431|FG004|STARTED|Part A Third Treatment||3
3235146|NCT02377362|3967432|FG005|STARTED|Part A Third Treatment||4
3235147|NCT02377362|3967433|FG006|STARTED|Part A Third Treatment||0
3235148|NCT02377362|3967434|FG007|STARTED|Part A Third Treatment||0
3235149|NCT02377362|3967435|FG008|STARTED|Part A Third Treatment||0
3235150|NCT02377362|3967436|FG009|STARTED|Part A Third Treatment||0
3235151|NCT02377362|3967437|FG010|STARTED|Part A Third Treatment||0
3235152|NCT02377362|3967438|FG011|STARTED|Part A Third Treatment||0
3235153|NCT02377362|3967439|FG012|STARTED|Part A Third Treatment||0
3235154|NCT02377362|3967427|FG000|COMPLETED|Part A Third Treatment||4
3235155|NCT02377362|3967428|FG001|COMPLETED|Part A Third Treatment||4
3235156|NCT02377362|3967429|FG002|COMPLETED|Part A Third Treatment||4
3235157|NCT02377362|3967430|FG003|COMPLETED|Part A Third Treatment||0
3235158|NCT02377362|3967431|FG004|COMPLETED|Part A Third Treatment||0
3235159|NCT02377362|3967432|FG005|COMPLETED|Part A Third Treatment||0
3235160|NCT02377362|3967433|FG006|COMPLETED|Part A Third Treatment||0
3235161|NCT02377362|3967434|FG007|COMPLETED|Part A Third Treatment||0
3235162|NCT02377362|3967435|FG008|COMPLETED|Part A Third Treatment||0
3235163|NCT02377362|3967436|FG009|COMPLETED|Part A Third Treatment||0
3235164|NCT02377362|3967437|FG010|COMPLETED|Part A Third Treatment||0
3235165|NCT02377362|3967438|FG011|COMPLETED|Part A Third Treatment||0
3235166|NCT02377362|3967439|FG012|COMPLETED|Part A Third Treatment||0
3235167|NCT02377362|3967427|FG000|NOT COMPLETED|Part A Third Treatment||0
3235168|NCT02377362|3967428|FG001|NOT COMPLETED|Part A Third Treatment||0
3235169|NCT02377362|3967429|FG002|NOT COMPLETED|Part A Third Treatment||0
3235170|NCT02377362|3967430|FG003|NOT COMPLETED|Part A Third Treatment||4
3235171|NCT02377362|3967431|FG004|NOT COMPLETED|Part A Third Treatment||3
3235172|NCT02377362|3967432|FG005|NOT COMPLETED|Part A Third Treatment||4
3235173|NCT02377362|3967433|FG006|NOT COMPLETED|Part A Third Treatment||0
3235174|NCT02377362|3967434|FG007|NOT COMPLETED|Part A Third Treatment||0
3235175|NCT02377362|3967435|FG008|NOT COMPLETED|Part A Third Treatment||0
3235176|NCT02377362|3967436|FG009|NOT COMPLETED|Part A Third Treatment||0
3235177|NCT02377362|3967437|FG010|NOT COMPLETED|Part A Third Treatment||0
3235178|NCT02377362|3967438|FG011|NOT COMPLETED|Part A Third Treatment||0
3235179|NCT02377362|3967439|FG012|NOT COMPLETED|Part A Third Treatment||0
3235180|NCT02377362|3967427|FG000|STARTED|Part B Overall||0
3235181|NCT02377362|3967428|FG001|STARTED|Part B Overall||0
3235182|NCT02377362|3967429|FG002|STARTED|Part B Overall||0
3235183|NCT02377362|3967430|FG003|STARTED|Part B Overall||0
3235184|NCT02377362|3967431|FG004|STARTED|Part B Overall||0
3235185|NCT02377362|3967432|FG005|STARTED|Part B Overall||0
3235186|NCT02377362|3967433|FG006|STARTED|Part B Overall||6
3235187|NCT02377362|3967434|FG007|STARTED|Part B Overall||6
3235188|NCT02377362|3967435|FG008|STARTED|Part B Overall||6
3235189|NCT02377362|3967436|FG009|STARTED|Part B Overall||7
3235190|NCT02377362|3967437|FG010|STARTED|Part B Overall||6
3235191|NCT02377362|3967438|FG011|STARTED|Part B Overall||7
3235192|NCT02377362|3967439|FG012|STARTED|Part B Overall||12
3235193|NCT02377362|3967427|FG000|COMPLETED|Part B Overall||0
3235194|NCT02377362|3967428|FG001|COMPLETED|Part B Overall||0
3235195|NCT02377362|3967429|FG002|COMPLETED|Part B Overall||0
3235196|NCT02377362|3967430|FG003|COMPLETED|Part B Overall||0
3235197|NCT02377362|3967431|FG004|COMPLETED|Part B Overall||0
3235198|NCT02377362|3967432|FG005|COMPLETED|Part B Overall||0
3235199|NCT02377362|3967433|FG006|COMPLETED|Part B Overall||4
3235200|NCT02377362|3967434|FG007|COMPLETED|Part B Overall||5
3235201|NCT02377362|3967435|FG008|COMPLETED|Part B Overall||6
3235202|NCT02377362|3967436|FG009|COMPLETED|Part B Overall||6
3235203|NCT02377362|3967437|FG010|COMPLETED|Part B Overall||6
3235204|NCT02377362|3967438|FG011|COMPLETED|Part B Overall||6
3235205|NCT02377362|3967439|FG012|COMPLETED|Part B Overall||12
3235206|NCT02377362|3967427|FG000|NOT COMPLETED|Part B Overall||0
3235207|NCT02377362|3967428|FG001|NOT COMPLETED|Part B Overall||0
3235208|NCT02377362|3967429|FG002|NOT COMPLETED|Part B Overall||0
3235209|NCT02377362|3967430|FG003|NOT COMPLETED|Part B Overall||0
3235210|NCT02377362|3967431|FG004|NOT COMPLETED|Part B Overall||0
3235211|NCT02377362|3967432|FG005|NOT COMPLETED|Part B Overall||0
3235212|NCT02377362|3967433|FG006|NOT COMPLETED|Part B Overall||2
3235213|NCT02377362|3967434|FG007|NOT COMPLETED|Part B Overall||1
3235214|NCT02377362|3967435|FG008|NOT COMPLETED|Part B Overall||0
3235215|NCT02377362|3967436|FG009|NOT COMPLETED|Part B Overall||1
3235216|NCT02377362|3967437|FG010|NOT COMPLETED|Part B Overall||0
3235217|NCT02377362|3967438|FG011|NOT COMPLETED|Part B Overall||1
3235218|NCT02377362|3967439|FG012|NOT COMPLETED|Part B Overall||0
3235219|NCT02377427|3967479|FG000|STARTED|Part A (Up to Week 20)||26
3235220|NCT02377427|3967480|FG001|STARTED|Part A (Up to Week 20)||10
3235221|NCT02377427|3967481|FG002|STARTED|Part A (Up to Week 20)||0
3235222|NCT02377427|3967482|FG003|STARTED|Part A (Up to Week 20)||0
3235223|NCT02377427|3967483|FG004|STARTED|Part A (Up to Week 20)||0
3235224|NCT02377427|3967479|FG000|COMPLETED|Part A (Up to Week 20)||22
3235225|NCT02377427|3967480|FG001|COMPLETED|Part A (Up to Week 20)||10
3235226|NCT02377427|3967481|FG002|COMPLETED|Part A (Up to Week 20)||0
3235227|NCT02377427|3967482|FG003|COMPLETED|Part A (Up to Week 20)||0
3235228|NCT02377427|3967483|FG004|COMPLETED|Part A (Up to Week 20)||0
3235229|NCT02377427|3967479|FG000|NOT COMPLETED|Part A (Up to Week 20)||4
3235230|NCT02377427|3967480|FG001|NOT COMPLETED|Part A (Up to Week 20)||0
3235231|NCT02377427|3967481|FG002|NOT COMPLETED|Part A (Up to Week 20)||0
3235232|NCT02377427|3967482|FG003|NOT COMPLETED|Part A (Up to Week 20)||0
3235233|NCT02377427|3967483|FG004|NOT COMPLETED|Part A (Up to Week 20)||0
3235234|NCT02377427|3967479|FG000|STARTED|Part B (From Week 20 and up to Week 80)||0
3235235|NCT02377427|3967480|FG001|STARTED|Part B (From Week 20 and up to Week 80)||0
3235236|NCT02377427|3967481|FG002|STARTED|Part B (From Week 20 and up to Week 80)|Two participants of PartA chose not to continue in PartB;4 shifted to PartB Mepolizumab 40/100mg arm|16
3235237|NCT02377427|3967482|FG003|STARTED|Part B (From Week 20 and up to Week 80)||10
3235238|NCT02377427|3967483|FG004|STARTED|Part B (From Week 20 and up to Week 80)||4
3235239|NCT02377427|3967479|FG000|COMPLETED|Part B (From Week 20 and up to Week 80)||0
3235240|NCT02377427|3967480|FG001|COMPLETED|Part B (From Week 20 and up to Week 80)||0
3235241|NCT02377427|3967481|FG002|COMPLETED|Part B (From Week 20 and up to Week 80)||15
3235242|NCT02377427|3967482|FG003|COMPLETED|Part B (From Week 20 and up to Week 80)||10
3235243|NCT02377427|3967483|FG004|COMPLETED|Part B (From Week 20 and up to Week 80)||4
3235244|NCT02377427|3967479|FG000|NOT COMPLETED|Part B (From Week 20 and up to Week 80)||0
3235245|NCT02377427|3967480|FG001|NOT COMPLETED|Part B (From Week 20 and up to Week 80)||0
3235246|NCT02377427|3967481|FG002|NOT COMPLETED|Part B (From Week 20 and up to Week 80)||1
3235247|NCT02377427|3967482|FG003|NOT COMPLETED|Part B (From Week 20 and up to Week 80)||0
3235248|NCT02377427|3967483|FG004|NOT COMPLETED|Part B (From Week 20 and up to Week 80)||0
3235249|NCT02377466|3967498|FG000|STARTED|Overall Study||13
3235250|NCT02377466|3967499|FG001|STARTED|Overall Study||12
3235251|NCT02377466|3967498|FG000|Treated|Overall Study||13
3235252|NCT02377466|3967499|FG001|Treated|Overall Study||10
3235253|NCT02377466|3967498|FG000|COMPLETED|Overall Study||13
3235254|NCT02377466|3967499|FG001|COMPLETED|Overall Study||10
3235255|NCT02377466|3967498|FG000|NOT COMPLETED|Overall Study||0
3235256|NCT02377466|3967499|FG001|NOT COMPLETED|Overall Study||2
3235257|NCT02377674|3967512|FG000|STARTED|Overall Study||5
3235258|NCT02377674|3967512|FG000|COMPLETED|Overall Study||5
3235259|NCT02377674|3967512|FG000|NOT COMPLETED|Overall Study||0
3235260|NCT02377700|3967516|FG000|STARTED|Overall Study||5
3235261|NCT02377700|3967516|FG000|COMPLETED|Overall Study||5
3235262|NCT02377700|3967516|FG000|NOT COMPLETED|Overall Study||0
3235263|NCT02377752|3967524|FG000|STARTED|Overall Study||7
3235264|NCT02377752|3967525|FG001|STARTED|Overall Study||6
3235265|NCT02377752|3967526|FG002|STARTED|Overall Study||6
3235266|NCT02377752|3967527|FG003|STARTED|Overall Study||6
3235267|NCT02377752|3967524|FG000|Received at Least 1 Dose of Study Drug|Overall Study||7
3235268|NCT02377752|3967525|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6
3235269|NCT02377752|3967526|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
3235270|NCT02377752|3967527|FG003|Received at Least 1 Dose of Study Drug|Overall Study||6
3235271|NCT02377752|3967524|FG000|COMPLETED|Overall Study||7
3235272|NCT02377752|3967525|FG001|COMPLETED|Overall Study||6
3235273|NCT02377752|3967526|FG002|COMPLETED|Overall Study||6
3235274|NCT02377752|3967527|FG003|COMPLETED|Overall Study||6
3235275|NCT02377752|3967524|FG000|NOT COMPLETED|Overall Study||0
3235276|NCT02377752|3967525|FG001|NOT COMPLETED|Overall Study||0
3235277|NCT02377752|3967526|FG002|NOT COMPLETED|Overall Study||0
3235278|NCT02377752|3967527|FG003|NOT COMPLETED|Overall Study||0
3235279|NCT02377817|3967542|FG000|STARTED|Overall Study||13
3235280|NCT02377817|3967543|FG001|STARTED|Overall Study||10
3235281|NCT02377817|3967542|FG000|COMPLETED|Overall Study||10
3235282|NCT02377817|3967543|FG001|COMPLETED|Overall Study||10
3235283|NCT02377817|3967542|FG000|NOT COMPLETED|Overall Study||3
3235284|NCT02377817|3967543|FG001|NOT COMPLETED|Overall Study||0
3235285|NCT02377921|3967553|FG000|STARTED|Overall Study||45
3235286|NCT02377921|3967554|FG001|STARTED|Overall Study||44
3235287|NCT02377921|3967553|FG000|COMPLETED|Overall Study||44
3235288|NCT02377921|3967554|FG001|COMPLETED|Overall Study||43
3235289|NCT02377921|3967553|FG000|NOT COMPLETED|Overall Study||1
3235290|NCT02377921|3967554|FG001|NOT COMPLETED|Overall Study||1
3235291|NCT02377947|3967560|FG000|STARTED|Overall Study||50
3235292|NCT02377947|3967560|FG000|COMPLETED|Overall Study||50
3235293|NCT02377947|3967560|FG000|NOT COMPLETED|Overall Study||0
3235294|NCT02377986|3967564|FG000|STARTED|Overall Study||5
3235295|NCT02377986|3967564|FG000|COMPLETED|Overall Study||5
3235296|NCT02377986|3967564|FG000|NOT COMPLETED|Overall Study||0
3235297|NCT02378025|3967570|FG000|STARTED|Overall Study||39
3235298|NCT02378025|3967571|FG001|STARTED|Overall Study||36
3235299|NCT02378025|3967570|FG000|COMPLETED|Overall Study||26
3235300|NCT02378025|3967571|FG001|COMPLETED|Overall Study||15
3235301|NCT02378025|3967570|FG000|NOT COMPLETED|Overall Study||13
3235302|NCT02378025|3967571|FG001|NOT COMPLETED|Overall Study||21
3235303|NCT02378038|3967577|FG000|STARTED|Overall Study||5
3235304|NCT02378038|3967577|FG000|COMPLETED|Overall Study||0
3235305|NCT02378038|3967577|FG000|NOT COMPLETED|Overall Study||5
3235306|NCT02378207|3967585|FG000|STARTED|Overall Study||24
3235307|NCT02378207|3967586|FG001|STARTED|Overall Study||24
3235308|NCT02378207|3967587|FG002|STARTED|Overall Study||24
3235309|NCT02378207|3967588|FG003|STARTED|Overall Study||12
3235310|NCT02378207|3967585|FG000|COMPLETED|Overall Study||24
3235311|NCT02378207|3967586|FG001|COMPLETED|Overall Study||21
3235312|NCT02378207|3967587|FG002|COMPLETED|Overall Study||22
3235313|NCT02378207|3967588|FG003|COMPLETED|Overall Study||11
3235314|NCT02378207|3967585|FG000|NOT COMPLETED|Overall Study||0
3235315|NCT02378207|3967586|FG001|NOT COMPLETED|Overall Study||3
3235316|NCT02378207|3967587|FG002|NOT COMPLETED|Overall Study||2
3235317|NCT02378207|3967588|FG003|NOT COMPLETED|Overall Study||1
3235318|NCT02378220|3967600|FG000|STARTED|Overall Study||53
3235319|NCT02378220|3967601|FG001|STARTED|Overall Study||57
3235320|NCT02378220|3967600|FG000|COMPLETED|Overall Study||47
3235321|NCT02378220|3967601|FG001|COMPLETED|Overall Study||56
3235322|NCT02378220|3967600|FG000|NOT COMPLETED|Overall Study||6
3235323|NCT02378220|3967601|FG001|NOT COMPLETED|Overall Study||1
3235324|NCT02378402|3967611|FG000|STARTED|Overall Study||25
3235325|NCT02378402|3967612|FG001|STARTED|Overall Study||25
3235326|NCT02378402|3967613|FG002|STARTED|Overall Study||21
3235327|NCT02378402|3967611|FG000|COMPLETED|Overall Study||25
3235328|NCT02378402|3967612|FG001|COMPLETED|Overall Study||23
3235329|NCT02378402|3967613|FG002|COMPLETED|Overall Study||21
3235330|NCT02378402|3967611|FG000|NOT COMPLETED|Overall Study||0
3235331|NCT02378402|3967612|FG001|NOT COMPLETED|Overall Study||2
3235332|NCT02378402|3967613|FG002|NOT COMPLETED|Overall Study||0
3235333|NCT02378480|3967623|FG000|STARTED|Overall Study||329
3235334|NCT02378480|3967624|FG001|STARTED|Overall Study||326
3235335|NCT02378480|3967623|FG000|COMPLETED|Overall Study||301
3235336|NCT02378480|3967624|FG001|COMPLETED|Overall Study||294
3235337|NCT02378480|3967623|FG000|NOT COMPLETED|Overall Study||28
3235338|NCT02378480|3967624|FG001|NOT COMPLETED|Overall Study||32
3235339|NCT02378506|3967630|FG000|STARTED|Overall Study||188
3235340|NCT02378506|3967630|FG000|Treated|Overall Study||187
3235341|NCT02378506|3967630|FG000|COMPLETED|Overall Study||163
3235342|NCT02378506|3967630|FG000|NOT COMPLETED|Overall Study||25
3235343|NCT02378662|3967636|FG000|STARTED|Overall Study||2
3235344|NCT02378662|3967637|FG001|STARTED|Overall Study||0
3235345|NCT02378662|3967636|FG000|Harvesting|Overall Study||2
3235346|NCT02378662|3967637|FG001|Harvesting|Overall Study||0
3235347|NCT02378662|3967636|FG000|Implantation|Overall Study||2
3235348|NCT02378662|3967637|FG001|Implantation|Overall Study||0
3235349|NCT02378662|3967636|FG000|COMPLETED|Overall Study||0
3235350|NCT02378662|3967637|FG001|COMPLETED|Overall Study||0
3235351|NCT02378662|3967636|FG000|NOT COMPLETED|Overall Study||2
3235352|NCT02378662|3967637|FG001|NOT COMPLETED|Overall Study||0
3235353|NCT02378714|3967647|FG000|STARTED|Overall Study||68
3235354|NCT02378714|3967648|FG001|STARTED|Overall Study||68
3235355|NCT02378714|3967649|FG002|STARTED|Overall Study||81
3235356|NCT02378714|3967650|FG003|STARTED|Overall Study||83
3235357|NCT02378714|3967647|FG000|COMPLETED|Overall Study||39
3235358|NCT02378714|3967648|FG001|COMPLETED|Overall Study||29
3235359|NCT02378714|3967649|FG002|COMPLETED|Overall Study||51
3235360|NCT02378714|3967650|FG003|COMPLETED|Overall Study||51
3235361|NCT02378714|3967647|FG000|NOT COMPLETED|Overall Study||29
3235362|NCT02378714|3967648|FG001|NOT COMPLETED|Overall Study||39
3235363|NCT02378714|3967649|FG002|NOT COMPLETED|Overall Study||30
3235364|NCT02378714|3967650|FG003|NOT COMPLETED|Overall Study||32
3235365|NCT02378753|3967684|FG000|STARTED|Overall Study||4319
3235366|NCT02378753|3967685|FG001|STARTED|Overall Study||4332
3235367|NCT02378753|3967684|FG000|COMPLETED|Overall Study||4101
3235368|NCT02378753|3967685|FG001|COMPLETED|Overall Study||3637
3235369|NCT02378753|3967684|FG000|NOT COMPLETED|Overall Study||218
3235370|NCT02378753|3967685|FG001|NOT COMPLETED|Overall Study||695
3235371|NCT02378844|3967693|FG000|STARTED|Run-in Period||169
3235372|NCT02378844|3967694|FG001|STARTED|Run-in Period||172
3235373|NCT02378844|3967695|FG002|STARTED|Run-in Period||136
3235374|NCT02378844|3967693|FG000|COMPLETED|Run-in Period||165
3235375|NCT02378844|3967694|FG001|COMPLETED|Run-in Period||167
3235376|NCT02378844|3967695|FG002|COMPLETED|Run-in Period||0
3235377|NCT02378844|3967693|FG000|NOT COMPLETED|Run-in Period||4
3235378|NCT02378844|3967694|FG001|NOT COMPLETED|Run-in Period||5
3235379|NCT02378844|3967695|FG002|NOT COMPLETED|Run-in Period||136
3235380|NCT02378844|3967693|FG000|STARTED|Randomized Period (Double Blind)||165
3235381|NCT02378844|3967694|FG001|STARTED|Randomized Period (Double Blind)||167
3235382|NCT02378844|3967695|FG002|STARTED|Randomized Period (Double Blind)||0
3235383|NCT02378844|3967693|FG000|COMPLETED|Randomized Period (Double Blind)||142
3235384|NCT02378844|3967694|FG001|COMPLETED|Randomized Period (Double Blind)||135
3235385|NCT02378844|3967695|FG002|COMPLETED|Randomized Period (Double Blind)||0
3235386|NCT02378844|3967693|FG000|NOT COMPLETED|Randomized Period (Double Blind)||23
3235387|NCT02378844|3967694|FG001|NOT COMPLETED|Randomized Period (Double Blind)||32
3235388|NCT02378844|3967695|FG002|NOT COMPLETED|Randomized Period (Double Blind)||0
3235389|NCT02378844|3967693|FG000|STARTED|Open Label Period||142
3235390|NCT02378844|3967694|FG001|STARTED|Open Label Period||135
3235391|NCT02378844|3967695|FG002|STARTED|Open Label Period||0
3235392|NCT02378844|3967693|FG000|COMPLETED|Open Label Period||99
3235393|NCT02378844|3967694|FG001|COMPLETED|Open Label Period||87
3235394|NCT02378844|3967695|FG002|COMPLETED|Open Label Period||0
3235395|NCT02378844|3967693|FG000|NOT COMPLETED|Open Label Period||43
3235396|NCT02378844|3967694|FG001|NOT COMPLETED|Open Label Period||48
3235397|NCT02378844|3967695|FG002|NOT COMPLETED|Open Label Period||0
3235398|NCT02378883|3967705|FG000|STARTED|Enrollment|Participants consented and assessed for eligibility|121
3235399|NCT02378883|3967705|FG000|COMPLETED|Enrollment|Attempted with study device - intent to treat population|112
3235400|NCT02378883|3967705|FG000|NOT COMPLETED|Enrollment||9
3235401|NCT02378883|3967705|FG000|STARTED|Discharge||112
3235402|NCT02378883|3967705|FG000|COMPLETED|Discharge||112
3235403|NCT02378883|3967705|FG000|NOT COMPLETED|Discharge||0
3235404|NCT02378883|3967705|FG000|STARTED|30 Day Follow-Up||112
3235405|NCT02378883|3967705|FG000|COMPLETED|30 Day Follow-Up||106
3235406|NCT02378883|3967705|FG000|NOT COMPLETED|30 Day Follow-Up||6
3235407|NCT02378883|3967705|FG000|STARTED|12 Months Follow-Up|Two deaths occurred between 30 day FU and prior to 12 month FU.|46
3235408|NCT02378883|3967705|FG000|COMPLETED|12 Months Follow-Up||41
3235409|NCT02378883|3967705|FG000|NOT COMPLETED|12 Months Follow-Up||5
3235410|NCT02378935|3967717|FG000|STARTED|Overall Study||34
3235411|NCT02378935|3967718|FG001|STARTED|Overall Study||36
3235412|NCT02378935|3967719|FG002|STARTED|Overall Study||33
3235413|NCT02378935|3967720|FG003|STARTED|Overall Study||31
3235414|NCT02378935|3967721|FG004|STARTED|Overall Study||31
3235415|NCT02378935|3967722|FG005|STARTED|Overall Study||32
3235416|NCT02378935|3967723|FG006|STARTED|Overall Study||8
3235417|NCT02378935|3967717|FG000|COMPLETED|Overall Study||24
3235418|NCT02378935|3967718|FG001|COMPLETED|Overall Study||36
3235419|NCT02378935|3967719|FG002|COMPLETED|Overall Study||30
3235420|NCT02378935|3967720|FG003|COMPLETED|Overall Study||25
3235421|NCT02378935|3967721|FG004|COMPLETED|Overall Study||31
3235422|NCT02378935|3967722|FG005|COMPLETED|Overall Study||32
3235423|NCT02378935|3967723|FG006|COMPLETED|Overall Study||8
3235424|NCT02378935|3967717|FG000|NOT COMPLETED|Overall Study||10
3235425|NCT02378935|3967718|FG001|NOT COMPLETED|Overall Study||0
3235426|NCT02378935|3967719|FG002|NOT COMPLETED|Overall Study||3
3235427|NCT02378935|3967720|FG003|NOT COMPLETED|Overall Study||6
3235428|NCT02378935|3967721|FG004|NOT COMPLETED|Overall Study||0
3235429|NCT02378935|3967722|FG005|NOT COMPLETED|Overall Study||0
3235430|NCT02378935|3967723|FG006|NOT COMPLETED|Overall Study||0
3235431|NCT02378961|3967743|FG000|STARTED|Overall Study||33
3235432|NCT02378961|3967744|FG001|STARTED|Overall Study||30
3235433|NCT02378961|3967745|FG002|STARTED|Overall Study||36
3235434|NCT02378961|3967746|FG003|STARTED|Overall Study||29
3235435|NCT02378961|3967743|FG000|COMPLETED|Overall Study||29
3235436|NCT02378961|3967744|FG001|COMPLETED|Overall Study||28
3235437|NCT02378961|3967745|FG002|COMPLETED|Overall Study||35
3235438|NCT02378961|3967746|FG003|COMPLETED|Overall Study||28
3235439|NCT02378961|3967743|FG000|NOT COMPLETED|Overall Study||4
3235440|NCT02378961|3967744|FG001|NOT COMPLETED|Overall Study||2
3235441|NCT02378961|3967745|FG002|NOT COMPLETED|Overall Study||1
3235442|NCT02378961|3967746|FG003|NOT COMPLETED|Overall Study||1
3235443|NCT02379052|3967758|FG000|STARTED|Overall Study||24
3235444|NCT02379052|3967759|FG001|STARTED|Overall Study||23
3235445|NCT02379052|3967758|FG000|COMPLETED|Overall Study||18
3235446|NCT02379052|3967759|FG001|COMPLETED|Overall Study||18
3235447|NCT02379052|3967758|FG000|NOT COMPLETED|Overall Study||6
3235448|NCT02379052|3967759|FG001|NOT COMPLETED|Overall Study||5
3235449|NCT02379078|3967767|FG000|STARTED|Overall Study||111
3235450|NCT02379078|3967768|FG001|STARTED|Overall Study||114
3235451|NCT02379078|3967767|FG000|COMPLETED|Overall Study||72
3235452|NCT02379078|3967768|FG001|COMPLETED|Overall Study||79
3235453|NCT02379078|3967767|FG000|NOT COMPLETED|Overall Study||39
3235454|NCT02379078|3967768|FG001|NOT COMPLETED|Overall Study||35
3235455|NCT02379091|3967778|FG000|STARTED|Overall Study||27
3235456|NCT02379091|3967779|FG001|STARTED|Overall Study||28
3235457|NCT02379091|3967780|FG002|STARTED|Overall Study||25
3235458|NCT02379091|3967781|FG003|STARTED|Overall Study||28
3235459|NCT02379091|3967778|FG000|Full Analysis Set|Overall Study|One participant was excluded because of data collection issues.|26
3235460|NCT02379091|3967779|FG001|Full Analysis Set|Overall Study||28
3235461|NCT02379091|3967780|FG002|Full Analysis Set|Overall Study|One participant was excluded because of data collection issues.|24
3235462|NCT02379091|3967781|FG003|Full Analysis Set|Overall Study||28
3235463|NCT02379091|3967778|FG000|COMPLETED|Overall Study||15
3235464|NCT02379091|3967779|FG001|COMPLETED|Overall Study||18
3235465|NCT02379091|3967780|FG002|COMPLETED|Overall Study||18
3235466|NCT02379091|3967781|FG003|COMPLETED|Overall Study||14
3235467|NCT02379091|3967778|FG000|NOT COMPLETED|Overall Study||12
3235468|NCT02379091|3967779|FG001|NOT COMPLETED|Overall Study||10
3235469|NCT02379091|3967780|FG002|NOT COMPLETED|Overall Study||7
3235470|NCT02379091|3967781|FG003|NOT COMPLETED|Overall Study||14
3235471|NCT02379117|3967795|FG000|STARTED|Overall Study||30
3235472|NCT02379117|3967796|FG001|STARTED|Overall Study||31
3235473|NCT02379117|3967795|FG000|COMPLETED|Overall Study||30
3235474|NCT02379117|3967796|FG001|COMPLETED|Overall Study||31
3235475|NCT02379117|3967795|FG000|NOT COMPLETED|Overall Study||0
3235476|NCT02379117|3967796|FG001|NOT COMPLETED|Overall Study||0
3235477|NCT02379195|3967802|FG000|STARTED|Overall Study||12
3235478|NCT02379195|3967802|FG000|COMPLETED|Overall Study||12
3235479|NCT02379195|3967802|FG000|NOT COMPLETED|Overall Study||0
3235480|NCT02379221|3967806|FG000|STARTED|Overall Study||49
3235481|NCT02379221|3967806|FG000|COMPLETED|Overall Study||48
3235482|NCT02379221|3967806|FG000|NOT COMPLETED|Overall Study||1
3235483|NCT02379247|3967819|FG000|STARTED|Overall Study||3
3235484|NCT02379247|3967820|FG001|STARTED|Overall Study||3
3235485|NCT02379247|3967821|FG002|STARTED|Overall Study||7
3235486|NCT02379247|3967822|FG003|STARTED|Overall Study||30
3235487|NCT02379247|3967819|FG000|COMPLETED|Overall Study||3
3235488|NCT02379247|3967820|FG001|COMPLETED|Overall Study||3
3235489|NCT02379247|3967821|FG002|COMPLETED|Overall Study||7
3235490|NCT02379247|3967822|FG003|COMPLETED|Overall Study||30
3235491|NCT02379247|3967819|FG000|NOT COMPLETED|Overall Study||0
3235492|NCT02379247|3967820|FG001|NOT COMPLETED|Overall Study||0
3235493|NCT02379247|3967821|FG002|NOT COMPLETED|Overall Study||0
3235494|NCT02379247|3967822|FG003|NOT COMPLETED|Overall Study||0
3235495|NCT02379273|3967835|FG000|STARTED|Overall Study||35
3235496|NCT02379273|3967835|FG000|COMPLETED|Overall Study|Completed 5 years postactivation.|35
3235497|NCT02379273|3967835|FG000|NOT COMPLETED|Overall Study||0
3235498|NCT02379442|3967839|FG000|STARTED|Overall Study||1
3235499|NCT02379442|3967839|FG000|COMPLETED|Overall Study||1
3235500|NCT02379442|3967839|FG000|NOT COMPLETED|Overall Study||0
3369513|NCT03799783|4101073|FG000|STARTED|Overall Study||19
3369514|NCT03799783|4101073|FG000|COMPLETED|Overall Study||19
3369515|NCT03799783|4101073|FG000|NOT COMPLETED|Overall Study||0
3369516|NCT03800030|4101077|FG000|STARTED|Baseline||4
3369517|NCT03800030|4101078|FG001|STARTED|Baseline||4
3369518|NCT03800030|4101079|FG002|STARTED|Baseline||4
3369519|NCT03800030|4101080|FG003|STARTED|Baseline||6
3369520|NCT03800030|4101081|FG004|STARTED|Baseline||4
3369521|NCT03800030|4101082|FG005|STARTED|Baseline||4
3369522|NCT03800030|4101077|FG000|COMPLETED|Baseline||4
3369523|NCT03800030|4101078|FG001|COMPLETED|Baseline||4
3369524|NCT03800030|4101079|FG002|COMPLETED|Baseline||4
3369525|NCT03800030|4101080|FG003|COMPLETED|Baseline||6
3369526|NCT03800030|4101081|FG004|COMPLETED|Baseline||4
3369527|NCT03800030|4101082|FG005|COMPLETED|Baseline||4
3369528|NCT03800030|4101077|FG000|NOT COMPLETED|Baseline||0
3369529|NCT03800030|4101078|FG001|NOT COMPLETED|Baseline||0
3369530|NCT03800030|4101079|FG002|NOT COMPLETED|Baseline||0
3369531|NCT03800030|4101080|FG003|NOT COMPLETED|Baseline||0
3369532|NCT03800030|4101081|FG004|NOT COMPLETED|Baseline||0
3369533|NCT03800030|4101082|FG005|NOT COMPLETED|Baseline||0
3369534|NCT03800030|4101077|FG000|STARTED|Pre-Randomization Period (1 Week)||4
3369535|NCT03800030|4101078|FG001|STARTED|Pre-Randomization Period (1 Week)||4
3369536|NCT03800030|4101079|FG002|STARTED|Pre-Randomization Period (1 Week)||4
3369537|NCT03800030|4101080|FG003|STARTED|Pre-Randomization Period (1 Week)||6
3369538|NCT03800030|4101081|FG004|STARTED|Pre-Randomization Period (1 Week)||4
3369539|NCT03800030|4101082|FG005|STARTED|Pre-Randomization Period (1 Week)||4
3369540|NCT03800030|4101077|FG000|COMPLETED|Pre-Randomization Period (1 Week)||4
3369541|NCT03800030|4101078|FG001|COMPLETED|Pre-Randomization Period (1 Week)||4
3369542|NCT03800030|4101079|FG002|COMPLETED|Pre-Randomization Period (1 Week)||4
3369543|NCT03800030|4101080|FG003|COMPLETED|Pre-Randomization Period (1 Week)||6
3369544|NCT03800030|4101081|FG004|COMPLETED|Pre-Randomization Period (1 Week)||4
3369545|NCT03800030|4101082|FG005|COMPLETED|Pre-Randomization Period (1 Week)||4
3369546|NCT03800030|4101077|FG000|NOT COMPLETED|Pre-Randomization Period (1 Week)||0
3369547|NCT03800030|4101078|FG001|NOT COMPLETED|Pre-Randomization Period (1 Week)||0
3369548|NCT03800030|4101079|FG002|NOT COMPLETED|Pre-Randomization Period (1 Week)||0
3369549|NCT03800030|4101080|FG003|NOT COMPLETED|Pre-Randomization Period (1 Week)||0
3369550|NCT03800030|4101081|FG004|NOT COMPLETED|Pre-Randomization Period (1 Week)||0
3369551|NCT03800030|4101082|FG005|NOT COMPLETED|Pre-Randomization Period (1 Week)||0
3369552|NCT03800030|4101077|FG000|STARTED|First Intervention||4
3369553|NCT03800030|4101078|FG001|STARTED|First Intervention||4
3369554|NCT03800030|4101079|FG002|STARTED|First Intervention||4
3369555|NCT03800030|4101080|FG003|STARTED|First Intervention||6
3369556|NCT03800030|4101081|FG004|STARTED|First Intervention||4
3369557|NCT03800030|4101082|FG005|STARTED|First Intervention||4
3369558|NCT03800030|4101077|FG000|COMPLETED|First Intervention||4
3369559|NCT03800030|4101078|FG001|COMPLETED|First Intervention||4
3369560|NCT03800030|4101079|FG002|COMPLETED|First Intervention||4
3369561|NCT03800030|4101080|FG003|COMPLETED|First Intervention||6
3369562|NCT03800030|4101081|FG004|COMPLETED|First Intervention||4
3369563|NCT03800030|4101082|FG005|COMPLETED|First Intervention||4
3369564|NCT03800030|4101077|FG000|NOT COMPLETED|First Intervention||0
3369565|NCT03800030|4101078|FG001|NOT COMPLETED|First Intervention||0
3369566|NCT03800030|4101079|FG002|NOT COMPLETED|First Intervention||0
3235501|NCT02379637|3967845|FG000|STARTED|Overall Study||35
3235502|NCT02379637|3967846|FG001|STARTED|Overall Study||35
3235503|NCT02379637|3967845|FG000|COMPLETED|Overall Study||33
3235504|NCT02379637|3967846|FG001|COMPLETED|Overall Study||34
3235505|NCT02379637|3967845|FG000|NOT COMPLETED|Overall Study||2
3235506|NCT02379637|3967846|FG001|NOT COMPLETED|Overall Study||1
3235507|NCT02379728|3967854|FG000|STARTED|Overall Study||84
3235508|NCT02379728|3967855|FG001|STARTED|Overall Study||16
3235509|NCT02379728|3967856|FG002|STARTED|Overall Study||84
3235510|NCT02379728|3967857|FG003|STARTED|Overall Study||16
3235511|NCT02379728|3967854|FG000|COMPLETED|Overall Study||78
3235512|NCT02379728|3967855|FG001|COMPLETED|Overall Study||16
3235513|NCT02379728|3967856|FG002|COMPLETED|Overall Study||74
3235514|NCT02379728|3967857|FG003|COMPLETED|Overall Study||13
3235515|NCT02379728|3967854|FG000|NOT COMPLETED|Overall Study||6
3235516|NCT02379728|3967855|FG001|NOT COMPLETED|Overall Study||0
3235517|NCT02379728|3967856|FG002|NOT COMPLETED|Overall Study||10
3235518|NCT02379728|3967857|FG003|NOT COMPLETED|Overall Study||3
3235519|NCT02379858|3967868|FG000|STARTED|Overall Study||6
3235520|NCT02379858|3967869|FG001|STARTED|Overall Study||4
3235521|NCT02379858|3967868|FG000|COMPLETED|Overall Study||6
3235522|NCT02379858|3967869|FG001|COMPLETED|Overall Study||4
3235523|NCT02379858|3967868|FG000|NOT COMPLETED|Overall Study||0
3235524|NCT02379858|3967869|FG001|NOT COMPLETED|Overall Study||0
3369567|NCT03800030|4101080|FG003|NOT COMPLETED|First Intervention||0
3369568|NCT03800030|4101081|FG004|NOT COMPLETED|First Intervention||0
3369569|NCT03800030|4101082|FG005|NOT COMPLETED|First Intervention||0
3369570|NCT03800030|4101077|FG000|STARTED|First Washout (1 Week)||4
3369571|NCT03800030|4101078|FG001|STARTED|First Washout (1 Week)||4
3369572|NCT03800030|4101079|FG002|STARTED|First Washout (1 Week)||4
3369573|NCT03800030|4101080|FG003|STARTED|First Washout (1 Week)||6
3369574|NCT03800030|4101081|FG004|STARTED|First Washout (1 Week)||4
3369575|NCT03800030|4101082|FG005|STARTED|First Washout (1 Week)||4
3369576|NCT03800030|4101077|FG000|COMPLETED|First Washout (1 Week)||4
3369577|NCT03800030|4101078|FG001|COMPLETED|First Washout (1 Week)||4
3369578|NCT03800030|4101079|FG002|COMPLETED|First Washout (1 Week)||4
3369579|NCT03800030|4101080|FG003|COMPLETED|First Washout (1 Week)||6
3369580|NCT03800030|4101081|FG004|COMPLETED|First Washout (1 Week)||4
3369581|NCT03800030|4101082|FG005|COMPLETED|First Washout (1 Week)||4
3369582|NCT03800030|4101077|FG000|NOT COMPLETED|First Washout (1 Week)||0
3369583|NCT03800030|4101078|FG001|NOT COMPLETED|First Washout (1 Week)||0
3369584|NCT03800030|4101079|FG002|NOT COMPLETED|First Washout (1 Week)||0
3369585|NCT03800030|4101080|FG003|NOT COMPLETED|First Washout (1 Week)||0
3369586|NCT03800030|4101081|FG004|NOT COMPLETED|First Washout (1 Week)||0
3369587|NCT03800030|4101082|FG005|NOT COMPLETED|First Washout (1 Week)||0
3369588|NCT03800030|4101077|FG000|STARTED|Second Intervention||4
3369589|NCT03800030|4101078|FG001|STARTED|Second Intervention||4
3369590|NCT03800030|4101079|FG002|STARTED|Second Intervention||4
3369591|NCT03800030|4101080|FG003|STARTED|Second Intervention||6
3369592|NCT03800030|4101081|FG004|STARTED|Second Intervention||4
3369593|NCT03800030|4101082|FG005|STARTED|Second Intervention||4
3369594|NCT03800030|4101077|FG000|COMPLETED|Second Intervention||4
3369595|NCT03800030|4101078|FG001|COMPLETED|Second Intervention||4
3369596|NCT03800030|4101079|FG002|COMPLETED|Second Intervention||4
3369597|NCT03800030|4101080|FG003|COMPLETED|Second Intervention||5
3369598|NCT03800030|4101081|FG004|COMPLETED|Second Intervention||4
3369599|NCT03800030|4101082|FG005|COMPLETED|Second Intervention||4
3369600|NCT03800030|4101077|FG000|NOT COMPLETED|Second Intervention||0
3369601|NCT03800030|4101078|FG001|NOT COMPLETED|Second Intervention||0
3369602|NCT03800030|4101079|FG002|NOT COMPLETED|Second Intervention||0
3369603|NCT03800030|4101080|FG003|NOT COMPLETED|Second Intervention||1
3369604|NCT03800030|4101081|FG004|NOT COMPLETED|Second Intervention||0
3369605|NCT03800030|4101082|FG005|NOT COMPLETED|Second Intervention||0
3369606|NCT03800030|4101077|FG000|STARTED|Second Washout (1 Week)||4
3369607|NCT03800030|4101078|FG001|STARTED|Second Washout (1 Week)||4
3369608|NCT03800030|4101079|FG002|STARTED|Second Washout (1 Week)||4
3369609|NCT03800030|4101080|FG003|STARTED|Second Washout (1 Week)||5
3369610|NCT03800030|4101081|FG004|STARTED|Second Washout (1 Week)||4
3369611|NCT03800030|4101082|FG005|STARTED|Second Washout (1 Week)||4
3369612|NCT03800030|4101077|FG000|COMPLETED|Second Washout (1 Week)||4
3369613|NCT03800030|4101078|FG001|COMPLETED|Second Washout (1 Week)||4
3369614|NCT03800030|4101079|FG002|COMPLETED|Second Washout (1 Week)||4
3369615|NCT03800030|4101080|FG003|COMPLETED|Second Washout (1 Week)||4
3369616|NCT03800030|4101081|FG004|COMPLETED|Second Washout (1 Week)||4
3369617|NCT03800030|4101082|FG005|COMPLETED|Second Washout (1 Week)||4
3369618|NCT03800030|4101077|FG000|NOT COMPLETED|Second Washout (1 Week)||0
3235525|NCT02379923|3967875|FG000|STARTED|Overall Study||163
3235526|NCT02379923|3967875|FG000|COMPLETED|Overall Study||158
3235527|NCT02379923|3967875|FG000|NOT COMPLETED|Overall Study||5
3235528|NCT02380183|3967884|FG000|STARTED|Overall Study||36
3235529|NCT02380183|3967885|FG001|STARTED|Overall Study||34
3235530|NCT02380183|3967884|FG000|COMPLETED|Overall Study||36
3235531|NCT02380183|3967885|FG001|COMPLETED|Overall Study||34
3235532|NCT02380183|3967884|FG000|NOT COMPLETED|Overall Study||0
3235533|NCT02380183|3967885|FG001|NOT COMPLETED|Overall Study||0
3235534|NCT02380248|3967891|FG000|STARTED|Overall Study||200
3235535|NCT02380248|3967891|FG000|COMPLETED|Overall Study||186
3235536|NCT02380248|3967891|FG000|NOT COMPLETED|Overall Study||14
3235537|NCT02380261|3967896|FG000|STARTED|Overall Study||35
3235538|NCT02380261|3967896|FG000|COMPLETED|Overall Study||35
3235539|NCT02380261|3967896|FG000|NOT COMPLETED|Overall Study||0
3235540|NCT02380287|3967908|FG000|STARTED|Overall Study||1
3235541|NCT02380287|3967909|FG001|STARTED|Overall Study||3
3235542|NCT02380287|3967910|FG002|STARTED|Overall Study||3
3235543|NCT02380287|3967911|FG003|STARTED|Overall Study||3
3235544|NCT02380287|3967912|FG004|STARTED|Overall Study||3
3235545|NCT02380287|3967913|FG005|STARTED|Overall Study||3
3235546|NCT02380287|3967914|FG006|STARTED|Overall Study||3
3235547|NCT02380287|3967915|FG007|STARTED|Overall Study||3
3235548|NCT02380287|3967908|FG000|COMPLETED|Overall Study||1
3235549|NCT02380287|3967909|FG001|COMPLETED|Overall Study||3
3235550|NCT02380287|3967910|FG002|COMPLETED|Overall Study||2
3235551|NCT02380287|3967911|FG003|COMPLETED|Overall Study||3
3235552|NCT02380287|3967912|FG004|COMPLETED|Overall Study||3
3235553|NCT02380287|3967913|FG005|COMPLETED|Overall Study||3
3235554|NCT02380287|3967914|FG006|COMPLETED|Overall Study||3
3235555|NCT02380287|3967915|FG007|COMPLETED|Overall Study||3
3235556|NCT02380287|3967908|FG000|NOT COMPLETED|Overall Study||0
3235557|NCT02380287|3967909|FG001|NOT COMPLETED|Overall Study||0
3235558|NCT02380287|3967910|FG002|NOT COMPLETED|Overall Study||1
3235559|NCT02380287|3967911|FG003|NOT COMPLETED|Overall Study||0
3235560|NCT02380287|3967912|FG004|NOT COMPLETED|Overall Study||0
3235561|NCT02380287|3967913|FG005|NOT COMPLETED|Overall Study||0
3235562|NCT02380287|3967914|FG006|NOT COMPLETED|Overall Study||0
3235563|NCT02380287|3967915|FG007|NOT COMPLETED|Overall Study||0
3235564|NCT02380612|3967940|FG000|STARTED|Overall Study||30
3235565|NCT02380612|3967940|FG000|COMPLETED|Overall Study||27
3235566|NCT02380612|3967940|FG000|NOT COMPLETED|Overall Study||3
3235567|NCT02380677|3967959|FG000|STARTED|Overall Study||1
3235568|NCT02380677|3967960|FG001|STARTED|Overall Study||1
3235569|NCT02380677|3967961|FG002|STARTED|Overall Study||3
3235570|NCT02380677|3967962|FG003|STARTED|Overall Study||3
3235571|NCT02380677|3967963|FG004|STARTED|Overall Study||6
3235572|NCT02380677|3967964|FG005|STARTED|Overall Study||6
3235573|NCT02380677|3967965|FG006|STARTED|Overall Study||3
3235574|NCT02380677|3967966|FG007|STARTED|Overall Study||4
3235575|NCT02380677|3967967|FG008|STARTED|Overall Study||4
3235576|NCT02380677|3967968|FG009|STARTED|Overall Study||2
3235577|NCT02380677|3967969|FG010|STARTED|Overall Study||4
3235578|NCT02380677|3967970|FG011|STARTED|Overall Study||5
3235579|NCT02380677|3967959|FG000|COMPLETED|Overall Study||0
3235580|NCT02380677|3967960|FG001|COMPLETED|Overall Study||0
3235581|NCT02380677|3967961|FG002|COMPLETED|Overall Study||0
3235582|NCT02380677|3967962|FG003|COMPLETED|Overall Study||0
3235583|NCT02380677|3967963|FG004|COMPLETED|Overall Study||0
3235584|NCT02380677|3967964|FG005|COMPLETED|Overall Study||0
3235585|NCT02380677|3967965|FG006|COMPLETED|Overall Study||0
3235586|NCT02380677|3967966|FG007|COMPLETED|Overall Study||0
3235587|NCT02380677|3967967|FG008|COMPLETED|Overall Study||0
3235588|NCT02380677|3967968|FG009|COMPLETED|Overall Study||0
3235589|NCT02380677|3967969|FG010|COMPLETED|Overall Study||0
3235590|NCT02380677|3967970|FG011|COMPLETED|Overall Study||0
3235591|NCT02380677|3967959|FG000|NOT COMPLETED|Overall Study||1
3235592|NCT02380677|3967960|FG001|NOT COMPLETED|Overall Study||1
3235593|NCT02380677|3967961|FG002|NOT COMPLETED|Overall Study||3
3235594|NCT02380677|3967962|FG003|NOT COMPLETED|Overall Study||3
3235595|NCT02380677|3967963|FG004|NOT COMPLETED|Overall Study||6
3235596|NCT02380677|3967964|FG005|NOT COMPLETED|Overall Study||6
3235597|NCT02380677|3967965|FG006|NOT COMPLETED|Overall Study||3
3235598|NCT02380677|3967966|FG007|NOT COMPLETED|Overall Study||4
3235599|NCT02380677|3967967|FG008|NOT COMPLETED|Overall Study||4
3235600|NCT02380677|3967968|FG009|NOT COMPLETED|Overall Study||2
3235601|NCT02380677|3967969|FG010|NOT COMPLETED|Overall Study||4
3235602|NCT02380677|3967970|FG011|NOT COMPLETED|Overall Study||5
3235603|NCT02380690|3968000|FG000|STARTED|Overall Study||119
3235604|NCT02380690|3968001|FG001|STARTED|Overall Study||94
3235605|NCT02380690|3968000|FG000|COMPLETED|Overall Study||85
3235606|NCT02380690|3968001|FG001|COMPLETED|Overall Study||82
3235607|NCT02380690|3968000|FG000|NOT COMPLETED|Overall Study||34
3235608|NCT02380690|3968001|FG001|NOT COMPLETED|Overall Study||12
3235609|NCT02380703|3968009|FG000|STARTED|Overall Study||114
3235610|NCT02380703|3968010|FG001|STARTED|Overall Study||114
3235611|NCT02380703|3968009|FG000|Month 3|Overall Study||104
3235612|NCT02380703|3968010|FG001|Month 3|Overall Study||109
3235613|NCT02380703|3968009|FG000|Month 6|Overall Study||102
3235614|NCT02380703|3968010|FG001|Month 6|Overall Study||107
3235615|NCT02380703|3968009|FG000|Month 12|Overall Study||99
3235616|NCT02380703|3968010|FG001|Month 12|Overall Study||100
3235617|NCT02380703|3968009|FG000|COMPLETED|Overall Study||78
3235618|NCT02380703|3968010|FG001|COMPLETED|Overall Study||78
3235619|NCT02380703|3968009|FG000|NOT COMPLETED|Overall Study||36
3235620|NCT02380703|3968010|FG001|NOT COMPLETED|Overall Study||36
3235621|NCT02380742|3968018|FG000|STARTED|Overall Study||28
3235622|NCT02380742|3968019|FG001|STARTED|Overall Study||26
3235623|NCT02380742|3968018|FG000|COMPLETED|Overall Study||27
3235624|NCT02380742|3968019|FG001|COMPLETED|Overall Study||26
3235625|NCT02380742|3968018|FG000|NOT COMPLETED|Overall Study||1
3235626|NCT02380742|3968019|FG001|NOT COMPLETED|Overall Study||0
3235627|NCT02380859|3968027|FG000|STARTED|Overall Study||19
3235628|NCT02380859|3968028|FG001|STARTED|Overall Study||13
3235629|NCT02380859|3968027|FG000|COMPLETED|Overall Study||17
3235630|NCT02380859|3968028|FG001|COMPLETED|Overall Study||13
3235631|NCT02380859|3968027|FG000|NOT COMPLETED|Overall Study||2
3235632|NCT02380859|3968028|FG001|NOT COMPLETED|Overall Study||0
3235633|NCT02381015|3968038|FG000|STARTED|Visit 1 - Enrollment||175
3235634|NCT02381015|3968039|FG001|STARTED|Visit 1 - Enrollment||175
3235635|NCT02381015|3968040|FG002|STARTED|Visit 1 - Enrollment||175
3235636|NCT02381015|3968041|FG003|STARTED|Visit 1 - Enrollment||175
3235637|NCT02381015|3968038|FG000|COMPLETED|Visit 1 - Enrollment||175
3235638|NCT02381015|3968039|FG001|COMPLETED|Visit 1 - Enrollment||173
3235639|NCT02381015|3968040|FG002|COMPLETED|Visit 1 - Enrollment||175
3235640|NCT02381015|3968041|FG003|COMPLETED|Visit 1 - Enrollment||172
3235641|NCT02381015|3968038|FG000|NOT COMPLETED|Visit 1 - Enrollment||0
3235642|NCT02381015|3968039|FG001|NOT COMPLETED|Visit 1 - Enrollment||2
3235643|NCT02381015|3968040|FG002|NOT COMPLETED|Visit 1 - Enrollment||0
3235644|NCT02381015|3968041|FG003|NOT COMPLETED|Visit 1 - Enrollment||3
3235645|NCT02381015|3968038|FG000|STARTED|Visit 2 - Results DIsclosure||175
3235646|NCT02381015|3968039|FG001|STARTED|Visit 2 - Results DIsclosure||173
3235647|NCT02381015|3968040|FG002|STARTED|Visit 2 - Results DIsclosure||175
3235648|NCT02381015|3968041|FG003|STARTED|Visit 2 - Results DIsclosure||172
3235649|NCT02381015|3968038|FG000|COMPLETED|Visit 2 - Results DIsclosure||172
3235650|NCT02381015|3968039|FG001|COMPLETED|Visit 2 - Results DIsclosure||168
3235651|NCT02381015|3968040|FG002|COMPLETED|Visit 2 - Results DIsclosure||173
3235652|NCT02381015|3968041|FG003|COMPLETED|Visit 2 - Results DIsclosure||169
3235653|NCT02381015|3968038|FG000|NOT COMPLETED|Visit 2 - Results DIsclosure||3
3235654|NCT02381015|3968039|FG001|NOT COMPLETED|Visit 2 - Results DIsclosure||5
3235655|NCT02381015|3968040|FG002|NOT COMPLETED|Visit 2 - Results DIsclosure||2
3235656|NCT02381015|3968041|FG003|NOT COMPLETED|Visit 2 - Results DIsclosure||3
3235657|NCT02381015|3968038|FG000|STARTED|Visit 3 - 3 Months Followup||172
3235658|NCT02381015|3968039|FG001|STARTED|Visit 3 - 3 Months Followup||168
3235659|NCT02381015|3968040|FG002|STARTED|Visit 3 - 3 Months Followup||173
3235660|NCT02381015|3968041|FG003|STARTED|Visit 3 - 3 Months Followup||169
3235661|NCT02381015|3968038|FG000|COMPLETED|Visit 3 - 3 Months Followup||172
3235662|NCT02381015|3968039|FG001|COMPLETED|Visit 3 - 3 Months Followup||168
3235663|NCT02381015|3968040|FG002|COMPLETED|Visit 3 - 3 Months Followup||173
3235664|NCT02381015|3968041|FG003|COMPLETED|Visit 3 - 3 Months Followup||169
3235665|NCT02381015|3968038|FG000|NOT COMPLETED|Visit 3 - 3 Months Followup||0
3235666|NCT02381015|3968039|FG001|NOT COMPLETED|Visit 3 - 3 Months Followup||0
3235667|NCT02381015|3968040|FG002|NOT COMPLETED|Visit 3 - 3 Months Followup||0
3235668|NCT02381015|3968041|FG003|NOT COMPLETED|Visit 3 - 3 Months Followup||0
3235669|NCT02381015|3968038|FG000|STARTED|Year 3 Chart Review||172
3235670|NCT02381015|3968039|FG001|STARTED|Year 3 Chart Review||168
3235671|NCT02381015|3968040|FG002|STARTED|Year 3 Chart Review||173
3235672|NCT02381015|3968041|FG003|STARTED|Year 3 Chart Review||169
3235673|NCT02381015|3968038|FG000|COMPLETED|Year 3 Chart Review||125
3235674|NCT02381015|3968039|FG001|COMPLETED|Year 3 Chart Review||134
3235675|NCT02381015|3968040|FG002|COMPLETED|Year 3 Chart Review||115
3235676|NCT02381015|3968041|FG003|COMPLETED|Year 3 Chart Review||118
3235677|NCT02381015|3968038|FG000|NOT COMPLETED|Year 3 Chart Review||47
3235678|NCT02381015|3968039|FG001|NOT COMPLETED|Year 3 Chart Review||34
3235679|NCT02381015|3968040|FG002|NOT COMPLETED|Year 3 Chart Review||58
3235680|NCT02381015|3968041|FG003|NOT COMPLETED|Year 3 Chart Review||51
3235681|NCT02381288|3968060|FG000|STARTED|Overall Study||5
3235682|NCT02381288|3968061|FG001|STARTED|Overall Study||2
3235683|NCT02381288|3968062|FG002|STARTED|Overall Study||5
3235684|NCT02381288|3968063|FG003|STARTED|Overall Study||5
3235685|NCT02381288|3968060|FG000|COMPLETED|Overall Study||5
3235686|NCT02381288|3968061|FG001|COMPLETED|Overall Study||2
3235687|NCT02381288|3968062|FG002|COMPLETED|Overall Study||5
3235688|NCT02381288|3968063|FG003|COMPLETED|Overall Study||5
3235689|NCT02381288|3968060|FG000|NOT COMPLETED|Overall Study||0
3235690|NCT02381288|3968061|FG001|NOT COMPLETED|Overall Study||0
3235691|NCT02381288|3968062|FG002|NOT COMPLETED|Overall Study||0
3235692|NCT02381288|3968063|FG003|NOT COMPLETED|Overall Study||0
3235693|NCT02381392|3968078|FG000|STARTED|Overall Study||11
3235694|NCT02381392|3968079|FG001|STARTED|Overall Study||12
3235695|NCT02381392|3968078|FG000|COMPLETED|Overall Study||11
3235696|NCT02381392|3968079|FG001|COMPLETED|Overall Study||12
3235697|NCT02381392|3968078|FG000|NOT COMPLETED|Overall Study||0
3235698|NCT02381392|3968079|FG001|NOT COMPLETED|Overall Study||0
3235699|NCT02381418|3968085|FG000|STARTED|Overall Study||120
3235700|NCT02381418|3968085|FG000|COMPLETED|Overall Study||120
3235701|NCT02381418|3968085|FG000|NOT COMPLETED|Overall Study||0
3235702|NCT02381652|3968093|FG000|STARTED|Overall Study|Cingal injection in 13-01 study; receiving a 2nd Cingal injection in 13-02|94
3235703|NCT02381652|3968094|FG001|STARTED|Overall Study|Monovisc injection in 13-01 study; receiving a Cingal injection in 13-02|98
3235704|NCT02381652|3968095|FG002|STARTED|Overall Study|Saline injection in 13-01 study; receiving a Cingal injection in 13-02|50
3235705|NCT02381652|3968093|FG000|COMPLETED|Overall Study||94
3235706|NCT02381652|3968094|FG001|COMPLETED|Overall Study||98
3235707|NCT02381652|3968095|FG002|COMPLETED|Overall Study||49
3235708|NCT02381652|3968093|FG000|NOT COMPLETED|Overall Study||0
3235709|NCT02381652|3968094|FG001|NOT COMPLETED|Overall Study||0
3235710|NCT02381652|3968095|FG002|NOT COMPLETED|Overall Study||1
3235711|NCT02381678|3968102|FG000|STARTED|Overall Study||54
3235712|NCT02381678|3968103|FG001|STARTED|Overall Study||139
3235713|NCT02381678|3968104|FG002|STARTED|Overall Study||32
3235714|NCT02381678|3968102|FG000|COMPLETED|Overall Study||54
3235715|NCT02381678|3968103|FG001|COMPLETED|Overall Study||139
3235716|NCT02381678|3968104|FG002|COMPLETED|Overall Study||32
3235717|NCT02381678|3968102|FG000|NOT COMPLETED|Overall Study||0
3235718|NCT02381678|3968103|FG001|NOT COMPLETED|Overall Study||0
3235719|NCT02381678|3968104|FG002|NOT COMPLETED|Overall Study||0
3235720|NCT02381795|3968110|FG000|STARTED|Overall Study||10
3235721|NCT02381795|3968110|FG000|COMPLETED|Overall Study||7
3235722|NCT02381795|3968110|FG000|NOT COMPLETED|Overall Study||3
3235723|NCT02382016|3968116|FG000|STARTED|Double-blind (DB) Treatment Period||43
3235724|NCT02382016|3968117|FG001|STARTED|Double-blind (DB) Treatment Period||42
3235725|NCT02382016|3968116|FG000|COMPLETED|Double-blind (DB) Treatment Period||39
3235726|NCT02382016|3968117|FG001|COMPLETED|Double-blind (DB) Treatment Period||41
3235727|NCT02382016|3968116|FG000|NOT COMPLETED|Double-blind (DB) Treatment Period||4
3235728|NCT02382016|3968117|FG001|NOT COMPLETED|Double-blind (DB) Treatment Period||1
3235729|NCT02382016|3968116|FG000|STARTED|Open-label (OL) Treatment Period||80
3235730|NCT02382016|3968117|FG001|STARTED|Open-label (OL) Treatment Period||0
3235731|NCT02382016|3968116|FG000|COMPLETED|Open-label (OL) Treatment Period||71
3235732|NCT02382016|3968117|FG001|COMPLETED|Open-label (OL) Treatment Period||0
3235733|NCT02382016|3968116|FG000|NOT COMPLETED|Open-label (OL) Treatment Period||9
3235734|NCT02382016|3968117|FG001|NOT COMPLETED|Open-label (OL) Treatment Period||0
3235735|NCT02382016|3968116|FG000|STARTED|OL Extension Period|Participants(French site) who completed DB,OL periods, consented receiving macitentan in OLE period.|33
3235736|NCT02382016|3968117|FG001|STARTED|OL Extension Period||0
3235737|NCT02382016|3968116|FG000|COMPLETED|OL Extension Period||27
3235738|NCT02382016|3968117|FG001|COMPLETED|OL Extension Period||0
3235739|NCT02382016|3968116|FG000|NOT COMPLETED|OL Extension Period||6
3235740|NCT02382016|3968117|FG001|NOT COMPLETED|OL Extension Period||0
3235741|NCT02382133|3968125|FG000|STARTED|Overall Study||43
3235742|NCT02382133|3968125|FG000|COMPLETED|Overall Study||10
3235743|NCT02382133|3968125|FG000|NOT COMPLETED|Overall Study||33
3235744|NCT02382276|3968132|FG000|STARTED|Overall Study||137
3235745|NCT02382276|3968133|FG001|STARTED|Overall Study||94
3235746|NCT02382276|3968134|FG002|STARTED|Overall Study||172
3235747|NCT02382276|3968132|FG000|COMPLETED|Overall Study||126
3235748|NCT02382276|3968133|FG001|COMPLETED|Overall Study||84
3235749|NCT02382276|3968134|FG002|COMPLETED|Overall Study||133
3235750|NCT02382276|3968132|FG000|NOT COMPLETED|Overall Study||11
3235751|NCT02382276|3968133|FG001|NOT COMPLETED|Overall Study||10
3235752|NCT02382276|3968134|FG002|NOT COMPLETED|Overall Study||39
3235753|NCT02382640|3968144|FG000|STARTED|Intervention Period 1 (3 Days)||9
3235754|NCT02382640|3968145|FG001|STARTED|Intervention Period 1 (3 Days)||9
3235755|NCT02382640|3968146|FG002|STARTED|Intervention Period 1 (3 Days)||9
3235756|NCT02382640|3968147|FG003|STARTED|Intervention Period 1 (3 Days)||9
3235757|NCT02382640|3968144|FG000|COMPLETED|Intervention Period 1 (3 Days)||9
3235758|NCT02382640|3968145|FG001|COMPLETED|Intervention Period 1 (3 Days)||9
3235759|NCT02382640|3968146|FG002|COMPLETED|Intervention Period 1 (3 Days)||9
3235760|NCT02382640|3968147|FG003|COMPLETED|Intervention Period 1 (3 Days)||9
3235761|NCT02382640|3968144|FG000|NOT COMPLETED|Intervention Period 1 (3 Days)||0
3235762|NCT02382640|3968145|FG001|NOT COMPLETED|Intervention Period 1 (3 Days)||0
3235763|NCT02382640|3968146|FG002|NOT COMPLETED|Intervention Period 1 (3 Days)||0
3235764|NCT02382640|3968147|FG003|NOT COMPLETED|Intervention Period 1 (3 Days)||0
3235765|NCT02382640|3968144|FG000|STARTED|Washout Period 1 (7 Days)||9
3235766|NCT02382640|3968145|FG001|STARTED|Washout Period 1 (7 Days)||9
3235767|NCT02382640|3968146|FG002|STARTED|Washout Period 1 (7 Days)||9
3235768|NCT02382640|3968147|FG003|STARTED|Washout Period 1 (7 Days)||9
3235769|NCT02382640|3968144|FG000|COMPLETED|Washout Period 1 (7 Days)||9
3235770|NCT02382640|3968145|FG001|COMPLETED|Washout Period 1 (7 Days)||9
3235771|NCT02382640|3968146|FG002|COMPLETED|Washout Period 1 (7 Days)||9
3235772|NCT02382640|3968147|FG003|COMPLETED|Washout Period 1 (7 Days)||9
3235773|NCT02382640|3968144|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0
3235774|NCT02382640|3968145|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0
3235775|NCT02382640|3968146|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||0
3235776|NCT02382640|3968147|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||0
3235777|NCT02382640|3968144|FG000|STARTED|Intervention Period 2 (3 Days)||9
3235778|NCT02382640|3968145|FG001|STARTED|Intervention Period 2 (3 Days)||9
3235779|NCT02382640|3968146|FG002|STARTED|Intervention Period 2 (3 Days)||9
3235780|NCT02382640|3968147|FG003|STARTED|Intervention Period 2 (3 Days)||9
3235781|NCT02382640|3968144|FG000|COMPLETED|Intervention Period 2 (3 Days)||9
3235782|NCT02382640|3968145|FG001|COMPLETED|Intervention Period 2 (3 Days)||9
3235783|NCT02382640|3968146|FG002|COMPLETED|Intervention Period 2 (3 Days)||9
3235784|NCT02382640|3968147|FG003|COMPLETED|Intervention Period 2 (3 Days)||9
3235785|NCT02382640|3968144|FG000|NOT COMPLETED|Intervention Period 2 (3 Days)||0
3235786|NCT02382640|3968145|FG001|NOT COMPLETED|Intervention Period 2 (3 Days)||0
3235787|NCT02382640|3968146|FG002|NOT COMPLETED|Intervention Period 2 (3 Days)||0
3235788|NCT02382640|3968147|FG003|NOT COMPLETED|Intervention Period 2 (3 Days)||0
3235789|NCT02382640|3968144|FG000|STARTED|Washout Period 2 (7 Days)||9
3235790|NCT02382640|3968145|FG001|STARTED|Washout Period 2 (7 Days)||9
3235791|NCT02382640|3968146|FG002|STARTED|Washout Period 2 (7 Days)||9
3235792|NCT02382640|3968147|FG003|STARTED|Washout Period 2 (7 Days)||9
3235793|NCT02382640|3968144|FG000|COMPLETED|Washout Period 2 (7 Days)||9
3235794|NCT02382640|3968145|FG001|COMPLETED|Washout Period 2 (7 Days)||9
3235795|NCT02382640|3968146|FG002|COMPLETED|Washout Period 2 (7 Days)||9
3235796|NCT02382640|3968147|FG003|COMPLETED|Washout Period 2 (7 Days)||9
3235797|NCT02382640|3968144|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||0
3235798|NCT02382640|3968145|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0
3235799|NCT02382640|3968146|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0
3235800|NCT02382640|3968147|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||0
3235801|NCT02382640|3968144|FG000|STARTED|Intervention Period 3 (3 Days)||9
3235802|NCT02382640|3968145|FG001|STARTED|Intervention Period 3 (3 Days)||9
3235803|NCT02382640|3968146|FG002|STARTED|Intervention Period 3 (3 Days)||9
3235804|NCT02382640|3968147|FG003|STARTED|Intervention Period 3 (3 Days)||9
3235805|NCT02382640|3968144|FG000|COMPLETED|Intervention Period 3 (3 Days)||9
3235806|NCT02382640|3968145|FG001|COMPLETED|Intervention Period 3 (3 Days)||9
3235807|NCT02382640|3968146|FG002|COMPLETED|Intervention Period 3 (3 Days)||9
3235808|NCT02382640|3968147|FG003|COMPLETED|Intervention Period 3 (3 Days)||9
3235809|NCT02382640|3968144|FG000|NOT COMPLETED|Intervention Period 3 (3 Days)||0
3235810|NCT02382640|3968145|FG001|NOT COMPLETED|Intervention Period 3 (3 Days)||0
3235811|NCT02382640|3968146|FG002|NOT COMPLETED|Intervention Period 3 (3 Days)||0
3235812|NCT02382640|3968147|FG003|NOT COMPLETED|Intervention Period 3 (3 Days)||0
3235813|NCT02382640|3968144|FG000|STARTED|Washout Period 3 (7 Days)||9
3235814|NCT02382640|3968145|FG001|STARTED|Washout Period 3 (7 Days)||9
3235815|NCT02382640|3968146|FG002|STARTED|Washout Period 3 (7 Days)||9
3235816|NCT02382640|3968147|FG003|STARTED|Washout Period 3 (7 Days)||9
3235817|NCT02382640|3968144|FG000|COMPLETED|Washout Period 3 (7 Days)||9
3235818|NCT02382640|3968145|FG001|COMPLETED|Washout Period 3 (7 Days)||9
3235819|NCT02382640|3968146|FG002|COMPLETED|Washout Period 3 (7 Days)||9
3235820|NCT02382640|3968147|FG003|COMPLETED|Washout Period 3 (7 Days)||9
3235821|NCT02382640|3968144|FG000|NOT COMPLETED|Washout Period 3 (7 Days)||0
3235822|NCT02382640|3968145|FG001|NOT COMPLETED|Washout Period 3 (7 Days)||0
3235823|NCT02382640|3968146|FG002|NOT COMPLETED|Washout Period 3 (7 Days)||0
3235824|NCT02382640|3968147|FG003|NOT COMPLETED|Washout Period 3 (7 Days)||0
3235825|NCT02382640|3968144|FG000|STARTED|Intervention Period 4 (3 Days)||9
3235826|NCT02382640|3968145|FG001|STARTED|Intervention Period 4 (3 Days)||9
3235827|NCT02382640|3968146|FG002|STARTED|Intervention Period 4 (3 Days)||9
3235828|NCT02382640|3968147|FG003|STARTED|Intervention Period 4 (3 Days)||9
3235829|NCT02382640|3968144|FG000|COMPLETED|Intervention Period 4 (3 Days)||8
3235830|NCT02382640|3968145|FG001|COMPLETED|Intervention Period 4 (3 Days)||9
3235831|NCT02382640|3968146|FG002|COMPLETED|Intervention Period 4 (3 Days)||9
3235832|NCT02382640|3968147|FG003|COMPLETED|Intervention Period 4 (3 Days)||9
3235833|NCT02382640|3968144|FG000|NOT COMPLETED|Intervention Period 4 (3 Days)||1
3235834|NCT02382640|3968145|FG001|NOT COMPLETED|Intervention Period 4 (3 Days)||0
3235835|NCT02382640|3968146|FG002|NOT COMPLETED|Intervention Period 4 (3 Days)||0
3235836|NCT02382640|3968147|FG003|NOT COMPLETED|Intervention Period 4 (3 Days)||0
3235837|NCT02382705|3968157|FG000|STARTED|Overall Study||57
3235838|NCT02382705|3968157|FG000|COMPLETED|Overall Study||33
3235839|NCT02382705|3968157|FG000|NOT COMPLETED|Overall Study||24
3235840|NCT02382744|3968163|FG000|STARTED|Overall Study||40
3235841|NCT02382744|3968164|FG001|STARTED|Overall Study||40
3235842|NCT02382744|3968163|FG000|Allocated|Overall Study||40
3235843|NCT02382744|3968164|FG001|Allocated|Overall Study||40
3235844|NCT02382744|3968163|FG000|Analyzed|Overall Study||40
3235845|NCT02382744|3968164|FG001|Analyzed|Overall Study||40
3235846|NCT02382744|3968163|FG000|COMPLETED|Overall Study||40
3235847|NCT02382744|3968164|FG001|COMPLETED|Overall Study||40
3235848|NCT02382744|3968163|FG000|NOT COMPLETED|Overall Study||0
3235849|NCT02382744|3968164|FG001|NOT COMPLETED|Overall Study||0
3235850|NCT02382796|3968174|FG000|STARTED|Overall Study||7
3235851|NCT02382796|3968174|FG000|COMPLETED|Overall Study||0
3235852|NCT02382796|3968174|FG000|NOT COMPLETED|Overall Study||7
3235853|NCT02382848|3968178|FG000|STARTED|First Intervention (3 Weeks)||3
3235854|NCT02382848|3968179|FG001|STARTED|First Intervention (3 Weeks)||5
3235855|NCT02382848|3968178|FG000|COMPLETED|First Intervention (3 Weeks)||3
3235856|NCT02382848|3968179|FG001|COMPLETED|First Intervention (3 Weeks)||5
3235857|NCT02382848|3968178|FG000|NOT COMPLETED|First Intervention (3 Weeks)||0
3235858|NCT02382848|3968179|FG001|NOT COMPLETED|First Intervention (3 Weeks)||0
3235859|NCT02382848|3968178|FG000|STARTED|Washout (1 Week)||3
3235860|NCT02382848|3968179|FG001|STARTED|Washout (1 Week)||5
3235861|NCT02382848|3968178|FG000|COMPLETED|Washout (1 Week)||3
3235862|NCT02382848|3968179|FG001|COMPLETED|Washout (1 Week)||5
3235863|NCT02382848|3968178|FG000|NOT COMPLETED|Washout (1 Week)||0
3235864|NCT02382848|3968179|FG001|NOT COMPLETED|Washout (1 Week)||0
3235865|NCT02382848|3968178|FG000|STARTED|Second Intervention (3 Weeks)||3
3235866|NCT02382848|3968179|FG001|STARTED|Second Intervention (3 Weeks)||5
3235867|NCT02382848|3968178|FG000|COMPLETED|Second Intervention (3 Weeks)||3
3235868|NCT02382848|3968179|FG001|COMPLETED|Second Intervention (3 Weeks)||5
3235869|NCT02382848|3968178|FG000|NOT COMPLETED|Second Intervention (3 Weeks)||0
3235870|NCT02382848|3968179|FG001|NOT COMPLETED|Second Intervention (3 Weeks)||0
3235871|NCT02382913|3968195|FG000|STARTED|Overall Study||27
3235872|NCT02382913|3968196|FG001|STARTED|Overall Study||36
3235873|NCT02382913|3968197|FG002|STARTED|Overall Study||32
3235874|NCT02382913|3968198|FG003|STARTED|Overall Study||27
3369619|NCT03800030|4101078|FG001|NOT COMPLETED|Second Washout (1 Week)||0
3369620|NCT03800030|4101079|FG002|NOT COMPLETED|Second Washout (1 Week)||0
3369621|NCT03800030|4101080|FG003|NOT COMPLETED|Second Washout (1 Week)||1
3369622|NCT03800030|4101081|FG004|NOT COMPLETED|Second Washout (1 Week)||0
3369623|NCT03800030|4101082|FG005|NOT COMPLETED|Second Washout (1 Week)||0
3369624|NCT03800030|4101077|FG000|STARTED|Third Intervention||4
3369625|NCT03800030|4101078|FG001|STARTED|Third Intervention||4
3235875|NCT02382913|3968199|FG004|STARTED|Overall Study||33
3235876|NCT02382913|3968200|FG005|STARTED|Overall Study||30
3235877|NCT02382913|3968201|FG006|STARTED|Overall Study||37
3235878|NCT02382913|3968202|FG007|STARTED|Overall Study||30
3235879|NCT02382913|3968203|FG008|STARTED|Overall Study||30
3235880|NCT02382913|3968204|FG009|STARTED|Overall Study||33
3235881|NCT02382913|3968195|FG000|COMPLETED|Overall Study||27
3235882|NCT02382913|3968196|FG001|COMPLETED|Overall Study||36
3235883|NCT02382913|3968197|FG002|COMPLETED|Overall Study||32
3235884|NCT02382913|3968198|FG003|COMPLETED|Overall Study||27
3235885|NCT02382913|3968199|FG004|COMPLETED|Overall Study||33
3235886|NCT02382913|3968200|FG005|COMPLETED|Overall Study||30
3235887|NCT02382913|3968201|FG006|COMPLETED|Overall Study||37
3235888|NCT02382913|3968202|FG007|COMPLETED|Overall Study||30
3235889|NCT02382913|3968203|FG008|COMPLETED|Overall Study||30
3235890|NCT02382913|3968204|FG009|COMPLETED|Overall Study||33
3235891|NCT02382913|3968195|FG000|NOT COMPLETED|Overall Study||0
3235892|NCT02382913|3968196|FG001|NOT COMPLETED|Overall Study||0
3235893|NCT02382913|3968197|FG002|NOT COMPLETED|Overall Study||0
3235894|NCT02382913|3968198|FG003|NOT COMPLETED|Overall Study||0
3235895|NCT02382913|3968199|FG004|NOT COMPLETED|Overall Study||0
3235896|NCT02382913|3968200|FG005|NOT COMPLETED|Overall Study||0
3235897|NCT02382913|3968201|FG006|NOT COMPLETED|Overall Study||0
3235898|NCT02382913|3968202|FG007|NOT COMPLETED|Overall Study||0
3235899|NCT02382913|3968203|FG008|NOT COMPLETED|Overall Study||0
3235900|NCT02382913|3968204|FG009|NOT COMPLETED|Overall Study||0
3235901|NCT02382939|3968228|FG000|STARTED|Overall Study||31
3235902|NCT02382939|3968229|FG001|STARTED|Overall Study||61
3235903|NCT02382939|3968228|FG000|Exposed|Overall Study||31
3235904|NCT02382939|3968229|FG001|Exposed|Overall Study||61
3235905|NCT02382939|3968228|FG000|COMPLETED|Overall Study||28
3235906|NCT02382939|3968229|FG001|COMPLETED|Overall Study||58
3235907|NCT02382939|3968228|FG000|NOT COMPLETED|Overall Study||3
3235908|NCT02382939|3968229|FG001|NOT COMPLETED|Overall Study||3
3235909|NCT02382991|3968238|FG000|STARTED|Overall Study||17
3235910|NCT02382991|3968239|FG001|STARTED|Overall Study||18
3235911|NCT02382991|3968238|FG000|COMPLETED|Overall Study||15
3235912|NCT02382991|3968239|FG001|COMPLETED|Overall Study||15
3235913|NCT02382991|3968238|FG000|NOT COMPLETED|Overall Study||2
3235914|NCT02382991|3968239|FG001|NOT COMPLETED|Overall Study||3
3235915|NCT02383017|3968246|FG000|STARTED|Overall Study||15
3235916|NCT02383017|3968247|FG001|STARTED|Overall Study||13
3235917|NCT02383017|3968246|FG000|COMPLETED|Overall Study||10
3235918|NCT02383017|3968247|FG001|COMPLETED|Overall Study||11
3235919|NCT02383017|3968246|FG000|NOT COMPLETED|Overall Study||5
3235920|NCT02383017|3968247|FG001|NOT COMPLETED|Overall Study||2
3235921|NCT02383043|3968256|FG000|STARTED|Overall Study||9
3235922|NCT02383043|3968257|FG001|STARTED|Overall Study||5
3235923|NCT02383043|3968258|FG002|STARTED|Overall Study||4
3235924|NCT02383043|3968256|FG000|COMPLETED|Overall Study||7
3235925|NCT02383043|3968257|FG001|COMPLETED|Overall Study||5
3235926|NCT02383043|3968258|FG002|COMPLETED|Overall Study||4
3235927|NCT02383043|3968256|FG000|NOT COMPLETED|Overall Study||2
3235928|NCT02383043|3968257|FG001|NOT COMPLETED|Overall Study||0
3235929|NCT02383043|3968258|FG002|NOT COMPLETED|Overall Study||0
3235930|NCT02383056|3968269|FG000|STARTED|Overall Study||7
3235931|NCT02383056|3968270|FG001|STARTED|Overall Study||7
3235932|NCT02383056|3968269|FG000|COMPLETED|Overall Study||6
3235933|NCT02383056|3968270|FG001|COMPLETED|Overall Study||5
3235934|NCT02383056|3968269|FG000|NOT COMPLETED|Overall Study||1
3235935|NCT02383056|3968270|FG001|NOT COMPLETED|Overall Study||2
3235936|NCT02383173|3968278|FG000|STARTED|Overall Study||88
3235937|NCT02383173|3968279|FG001|STARTED|Overall Study||46
3235938|NCT02383173|3968278|FG000|COMPLETED|Overall Study||88
3235939|NCT02383173|3968279|FG001|COMPLETED|Overall Study||44
3235940|NCT02383173|3968278|FG000|NOT COMPLETED|Overall Study||0
3235941|NCT02383173|3968279|FG001|NOT COMPLETED|Overall Study||2
3235942|NCT02383355|3968287|FG000|STARTED|Overall Study||19
3235943|NCT02383355|3968288|FG001|STARTED|Overall Study||21
3235944|NCT02383355|3968287|FG000|COMPLETED|Overall Study||17
3235945|NCT02383355|3968288|FG001|COMPLETED|Overall Study||21
3235946|NCT02383355|3968287|FG000|NOT COMPLETED|Overall Study||2
3235947|NCT02383355|3968288|FG001|NOT COMPLETED|Overall Study||0
3235948|NCT02383420|3968297|FG000|STARTED|Overall Study||10
3235949|NCT02383420|3968298|FG001|STARTED|Overall Study||10
3235950|NCT02383420|3968299|FG002|STARTED|Overall Study||3
3235951|NCT02383420|3968297|FG000|COMPLETED|Overall Study||8
3235952|NCT02383420|3968298|FG001|COMPLETED|Overall Study||10
3235953|NCT02383420|3968299|FG002|COMPLETED|Overall Study||3
3235954|NCT02383420|3968297|FG000|NOT COMPLETED|Overall Study||2
3235955|NCT02383420|3968298|FG001|NOT COMPLETED|Overall Study||0
3235956|NCT02383420|3968299|FG002|NOT COMPLETED|Overall Study||0
3235957|NCT02383472|3968309|FG000|STARTED|Overall Study||23
3235958|NCT02383472|3968310|FG001|STARTED|Overall Study||30
3369626|NCT03800030|4101079|FG002|STARTED|Third Intervention||4
3235959|NCT02383472|3968309|FG000|COMPLETED|Overall Study||22
3235960|NCT02383472|3968310|FG001|COMPLETED|Overall Study||29
3235961|NCT02383472|3968309|FG000|NOT COMPLETED|Overall Study||1
3235962|NCT02383472|3968310|FG001|NOT COMPLETED|Overall Study||1
3235963|NCT02383576|3968320|FG000|STARTED|Overall Study||94
3235964|NCT02383576|3968321|FG001|STARTED|Overall Study||91
3235965|NCT02383576|3968320|FG000|COMPLETED|Overall Study||31
3235966|NCT02383576|3968321|FG001|COMPLETED|Overall Study||46
3235967|NCT02383576|3968320|FG000|NOT COMPLETED|Overall Study||63
3235968|NCT02383576|3968321|FG001|NOT COMPLETED|Overall Study||45
3235969|NCT02383589|3968329|FG000|STARTED|Treatment Period||67
3235970|NCT02383589|3968330|FG001|STARTED|Treatment Period||68
3235971|NCT02383589|3968329|FG000|COMPLETED|Treatment Period||66
3235972|NCT02383589|3968330|FG001|COMPLETED|Treatment Period||58
3235973|NCT02383589|3968329|FG000|NOT COMPLETED|Treatment Period||1
3235974|NCT02383589|3968330|FG001|NOT COMPLETED|Treatment Period||10
3235975|NCT02383589|3968329|FG000|STARTED|Safety Follow-up (SFU)||66
3235976|NCT02383589|3968330|FG001|STARTED|Safety Follow-up (SFU)||58
3235977|NCT02383589|3968329|FG000|COMPLETED|Safety Follow-up (SFU)||59
3235978|NCT02383589|3968330|FG001|COMPLETED|Safety Follow-up (SFU)||53
3235979|NCT02383589|3968329|FG000|NOT COMPLETED|Safety Follow-up (SFU)||7
3235980|NCT02383589|3968330|FG001|NOT COMPLETED|Safety Follow-up (SFU)||5
3235981|NCT02383667|3968338|FG000|STARTED|Overall Study||20
3235982|NCT02383667|3968338|FG000|COMPLETED|Overall Study||20
3235983|NCT02383667|3968338|FG000|NOT COMPLETED|Overall Study||0
3235984|NCT02383706|3968342|FG000|STARTED|Overall Study||108
3235985|NCT02383706|3968342|FG000|COMPLETED|Overall Study||80
3235986|NCT02383706|3968342|FG000|NOT COMPLETED|Overall Study||28
3235987|NCT02383719|3968347|FG000|STARTED|Overall Study||18
3235988|NCT02383719|3968347|FG000|COMPLETED|Overall Study||18
3235989|NCT02383719|3968347|FG000|NOT COMPLETED|Overall Study||0
3235990|NCT02383758|3968353|FG000|STARTED|Overall Study||10
3235991|NCT02383758|3968354|FG001|STARTED|Overall Study||10
3235992|NCT02383758|3968353|FG000|COMPLETED|Overall Study||10
3235993|NCT02383758|3968354|FG001|COMPLETED|Overall Study||8
3235994|NCT02383758|3968353|FG000|NOT COMPLETED|Overall Study||0
3235995|NCT02383758|3968354|FG001|NOT COMPLETED|Overall Study||2
3235996|NCT02383862|3968362|FG000|STARTED|Baseline||151
3235997|NCT02383862|3968363|FG001|STARTED|Baseline||149
3235998|NCT02383862|3968362|FG000|COMPLETED|Baseline||151
3235999|NCT02383862|3968363|FG001|COMPLETED|Baseline||149
3236000|NCT02383862|3968362|FG000|NOT COMPLETED|Baseline||0
3236001|NCT02383862|3968363|FG001|NOT COMPLETED|Baseline||0
3236002|NCT02383862|3968362|FG000|STARTED|3 Month Follow up||151
3236003|NCT02383862|3968363|FG001|STARTED|3 Month Follow up||149
3236004|NCT02383862|3968362|FG000|COMPLETED|3 Month Follow up||128
3236005|NCT02383862|3968363|FG001|COMPLETED|3 Month Follow up||128
3236006|NCT02383862|3968362|FG000|NOT COMPLETED|3 Month Follow up||23
3236007|NCT02383862|3968363|FG001|NOT COMPLETED|3 Month Follow up||21
3236008|NCT02383940|3968378|FG000|STARTED|Overall Study||44
3236009|NCT02383940|3968379|FG001|STARTED|Overall Study||43
3236010|NCT02383940|3968378|FG000|Treated|Overall Study||42
3236011|NCT02383940|3968379|FG001|Treated|Overall Study||43
3236012|NCT02383940|3968378|FG000|COMPLETED|Overall Study||35
3236013|NCT02383940|3968379|FG001|COMPLETED|Overall Study||40
3236014|NCT02383940|3968378|FG000|NOT COMPLETED|Overall Study||9
3236015|NCT02383940|3968379|FG001|NOT COMPLETED|Overall Study||3
3236016|NCT02383966|3968387|FG000|STARTED|Overall Study||164
3236017|NCT02383966|3968388|FG001|STARTED|Overall Study||79
3236018|NCT02383966|3968387|FG000|COMPLETED|Overall Study||138
3236019|NCT02383966|3968388|FG001|COMPLETED|Overall Study||72
3236020|NCT02383966|3968387|FG000|NOT COMPLETED|Overall Study||26
3236021|NCT02383966|3968388|FG001|NOT COMPLETED|Overall Study||7
3236022|NCT02384044|3968396|FG000|STARTED|Overall Study||15
3236023|NCT02384044|3968397|FG001|STARTED|Overall Study||15
3236024|NCT02384044|3968396|FG000|COMPLETED|Overall Study||15
3236025|NCT02384044|3968397|FG001|COMPLETED|Overall Study||15
3236026|NCT02384044|3968396|FG000|NOT COMPLETED|Overall Study||0
3236027|NCT02384044|3968397|FG001|NOT COMPLETED|Overall Study||0
3236028|NCT02384070|3968406|FG000|STARTED|Overall Study||100
3236029|NCT02384070|3968407|FG001|STARTED|Overall Study||100
3236030|NCT02384070|3968408|FG002|STARTED|Overall Study||100
3236031|NCT02384070|3968406|FG000|COMPLETED|Overall Study||100
3236032|NCT02384070|3968407|FG001|COMPLETED|Overall Study||100
3369627|NCT03800030|4101080|FG003|STARTED|Third Intervention||4
3369628|NCT03800030|4101081|FG004|STARTED|Third Intervention||4
3369629|NCT03800030|4101082|FG005|STARTED|Third Intervention||4
3369630|NCT03800030|4101077|FG000|COMPLETED|Third Intervention||4
3369631|NCT03800030|4101078|FG001|COMPLETED|Third Intervention||4
3369632|NCT03800030|4101079|FG002|COMPLETED|Third Intervention||4
3369633|NCT03800030|4101080|FG003|COMPLETED|Third Intervention||4
3369634|NCT03800030|4101081|FG004|COMPLETED|Third Intervention||4
3369635|NCT03800030|4101082|FG005|COMPLETED|Third Intervention||4
3369636|NCT03800030|4101077|FG000|NOT COMPLETED|Third Intervention||0
3369637|NCT03800030|4101078|FG001|NOT COMPLETED|Third Intervention||0
3369638|NCT03800030|4101079|FG002|NOT COMPLETED|Third Intervention||0
3369639|NCT03800030|4101080|FG003|NOT COMPLETED|Third Intervention||0
3369640|NCT03800030|4101081|FG004|NOT COMPLETED|Third Intervention||0
3369641|NCT03800030|4101082|FG005|NOT COMPLETED|Third Intervention||0
3369642|NCT03799211|4101092|FG000|STARTED|Overall Study||36
3369643|NCT03799211|4101093|FG001|STARTED|Overall Study||40
3369644|NCT03799211|4101092|FG000|COMPLETED|Overall Study||32
3369645|NCT03799211|4101093|FG001|COMPLETED|Overall Study||27
3236033|NCT02384070|3968408|FG002|COMPLETED|Overall Study||100
3236034|NCT02384070|3968406|FG000|NOT COMPLETED|Overall Study||0
3236035|NCT02384070|3968407|FG001|NOT COMPLETED|Overall Study||0
3236036|NCT02384070|3968408|FG002|NOT COMPLETED|Overall Study||0
3236037|NCT02384096|3968418|FG000|STARTED|First Intervention (7 Days)||5
3236038|NCT02384096|3968419|FG001|STARTED|First Intervention (7 Days)||7
3236039|NCT02384096|3968418|FG000|COMPLETED|First Intervention (7 Days)||4
3369646|NCT03799211|4101092|FG000|NOT COMPLETED|Overall Study||4
3236040|NCT02384096|3968419|FG001|COMPLETED|First Intervention (7 Days)||7
3236041|NCT02384096|3968418|FG000|NOT COMPLETED|First Intervention (7 Days)||1
3236042|NCT02384096|3968419|FG001|NOT COMPLETED|First Intervention (7 Days)||0
3236043|NCT02384096|3968418|FG000|STARTED|Second Intervention (7 Days)||4
3236044|NCT02384096|3968419|FG001|STARTED|Second Intervention (7 Days)||7
3236045|NCT02384096|3968418|FG000|COMPLETED|Second Intervention (7 Days)||4
3236046|NCT02384096|3968419|FG001|COMPLETED|Second Intervention (7 Days)||6
3236047|NCT02384096|3968418|FG000|NOT COMPLETED|Second Intervention (7 Days)||0
3236048|NCT02384096|3968419|FG001|NOT COMPLETED|Second Intervention (7 Days)||1
3236049|NCT02384200|3968426|FG000|STARTED|Overall Study||43
3236050|NCT02384200|3968427|FG001|STARTED|Overall Study||43
3236051|NCT02384200|3968426|FG000|COMPLETED|Overall Study||43
3236052|NCT02384200|3968427|FG001|COMPLETED|Overall Study||43
3236053|NCT02384200|3968426|FG000|NOT COMPLETED|Overall Study||0
3236054|NCT02384200|3968427|FG001|NOT COMPLETED|Overall Study||0
3236055|NCT02384382|3968433|FG000|STARTED|Overall Study||23
3236056|NCT02384382|3968433|FG000|COMPLETED|Overall Study||0
3236057|NCT02384382|3968433|FG000|NOT COMPLETED|Overall Study||23
3236058|NCT02384395|3968437|FG000|STARTED|Overall Study||40
3236059|NCT02384395|3968437|FG000|Enrolled|Overall Study||40
3236060|NCT02384395|3968437|FG000|Initiated Treatment|Overall Study||37
3236061|NCT02384395|3968437|FG000|Completed Week 24|Overall Study||34
3236062|NCT02384395|3968437|FG000|Completed Week 48|Overall Study||33
3236063|NCT02384395|3968437|FG000|Completed Week 96|Overall Study||30
3236064|NCT02384395|3968437|FG000|COMPLETED|Overall Study||30
3236065|NCT02384395|3968437|FG000|NOT COMPLETED|Overall Study||10
3236066|NCT02384460|3968443|FG000|STARTED|Overall Study||82
3236067|NCT02384460|3968444|FG001|STARTED|Overall Study||87
3236068|NCT02384460|3968443|FG000|Received at Least 1 Dose of Study Drug|Overall Study||82
3236069|NCT02384460|3968444|FG001|Received at Least 1 Dose of Study Drug|Overall Study||87
3236070|NCT02384460|3968443|FG000|COMPLETED|Overall Study||75
3236071|NCT02384460|3968444|FG001|COMPLETED|Overall Study||80
3236072|NCT02384460|3968443|FG000|NOT COMPLETED|Overall Study||7
3236073|NCT02384460|3968444|FG001|NOT COMPLETED|Overall Study||7
3236074|NCT02384538|3968452|FG000|STARTED|Overall Study||67
3236075|NCT02384538|3968453|FG001|STARTED|Overall Study||64
3236076|NCT02384538|3968452|FG000|COMPLETED|Overall Study||61
3236077|NCT02384538|3968453|FG001|COMPLETED|Overall Study||49
3236078|NCT02384538|3968452|FG000|NOT COMPLETED|Overall Study||6
3236079|NCT02384538|3968453|FG001|NOT COMPLETED|Overall Study||15
3236080|NCT02384941|3968462|FG000|STARTED|Overall Study||268
3236081|NCT02384941|3968463|FG001|STARTED|Overall Study||263
3236082|NCT02384941|3968464|FG002|STARTED|Overall Study||262
3236083|NCT02384941|3968462|FG000|COMPLETED|Overall Study||218
3236084|NCT02384941|3968463|FG001|COMPLETED|Overall Study||228
3236085|NCT02384941|3968464|FG002|COMPLETED|Overall Study||221
3236086|NCT02384941|3968462|FG000|NOT COMPLETED|Overall Study||50
3236087|NCT02384941|3968463|FG001|NOT COMPLETED|Overall Study||35
3236088|NCT02384941|3968464|FG002|NOT COMPLETED|Overall Study||41
3236089|NCT02385084|3968473|FG000|STARTED|Period 1||3
3236090|NCT02385084|3968474|FG001|STARTED|Period 1||3
3236091|NCT02385084|3968475|FG002|STARTED|Period 1||3
3236092|NCT02385084|3968476|FG003|STARTED|Period 1||3
3236093|NCT02385084|3968477|FG004|STARTED|Period 1||3
3236094|NCT02385084|3968478|FG005|STARTED|Period 1||3
3236095|NCT02385084|3968473|FG000|Received LY2409021|Period 1||3
3236096|NCT02385084|3968474|FG001|Received LY2409021|Period 1||3
3236097|NCT02385084|3968475|FG002|Received LY2409021|Period 1||3
3236098|NCT02385084|3968476|FG003|Received LY2409021|Period 1||3
3236099|NCT02385084|3968477|FG004|Received LY2409021|Period 1||3
3236100|NCT02385084|3968478|FG005|Received LY2409021|Period 1||3
3236101|NCT02385084|3968473|FG000|Washout|Period 1||3
3236102|NCT02385084|3968474|FG001|Washout|Period 1||3
3236103|NCT02385084|3968475|FG002|Washout|Period 1||3
3236104|NCT02385084|3968476|FG003|Washout|Period 1||3
3236105|NCT02385084|3968477|FG004|Washout|Period 1||3
3236106|NCT02385084|3968478|FG005|Washout|Period 1||3
3236107|NCT02385084|3968473|FG000|COMPLETED|Period 1||3
3236108|NCT02385084|3968474|FG001|COMPLETED|Period 1||3
3236109|NCT02385084|3968475|FG002|COMPLETED|Period 1||3
3236110|NCT02385084|3968476|FG003|COMPLETED|Period 1||3
3236111|NCT02385084|3968477|FG004|COMPLETED|Period 1||3
3236112|NCT02385084|3968478|FG005|COMPLETED|Period 1||3
3236113|NCT02385084|3968473|FG000|NOT COMPLETED|Period 1||0
3236114|NCT02385084|3968474|FG001|NOT COMPLETED|Period 1||0
3236115|NCT02385084|3968475|FG002|NOT COMPLETED|Period 1||0
3236116|NCT02385084|3968476|FG003|NOT COMPLETED|Period 1||0
3236117|NCT02385084|3968477|FG004|NOT COMPLETED|Period 1||0
3236118|NCT02385084|3968478|FG005|NOT COMPLETED|Period 1||0
3236119|NCT02385084|3968473|FG000|STARTED|Period 2|1 participant discontinued after Period 1 - physician decision. Did not enter Period 2.|2
3236120|NCT02385084|3968474|FG001|STARTED|Period 2||3
3236121|NCT02385084|3968475|FG002|STARTED|Period 2||3
3236122|NCT02385084|3968476|FG003|STARTED|Period 2||3
3236123|NCT02385084|3968477|FG004|STARTED|Period 2||3
3236124|NCT02385084|3968478|FG005|STARTED|Period 2||3
3236125|NCT02385084|3968473|FG000|Received LY2409021|Period 2||2
3236126|NCT02385084|3968474|FG001|Received LY2409021|Period 2||3
3236127|NCT02385084|3968475|FG002|Received LY2409021|Period 2||3
3236128|NCT02385084|3968476|FG003|Received LY2409021|Period 2||3
3236129|NCT02385084|3968477|FG004|Received LY2409021|Period 2||3
3236130|NCT02385084|3968478|FG005|Received LY2409021|Period 2||3
3236131|NCT02385084|3968473|FG000|Washout|Period 2||2
3236132|NCT02385084|3968474|FG001|Washout|Period 2||3
3236133|NCT02385084|3968475|FG002|Washout|Period 2||3
3236134|NCT02385084|3968476|FG003|Washout|Period 2||3
3236135|NCT02385084|3968477|FG004|Washout|Period 2||3
3236136|NCT02385084|3968478|FG005|Washout|Period 2||3
3236137|NCT02385084|3968473|FG000|COMPLETED|Period 2||2
3236138|NCT02385084|3968474|FG001|COMPLETED|Period 2||3
3236139|NCT02385084|3968475|FG002|COMPLETED|Period 2||2
3236140|NCT02385084|3968476|FG003|COMPLETED|Period 2||3
3236141|NCT02385084|3968477|FG004|COMPLETED|Period 2||3
3236142|NCT02385084|3968478|FG005|COMPLETED|Period 2||3
3236143|NCT02385084|3968473|FG000|NOT COMPLETED|Period 2||0
3236144|NCT02385084|3968474|FG001|NOT COMPLETED|Period 2||0
3236145|NCT02385084|3968475|FG002|NOT COMPLETED|Period 2||1
3236146|NCT02385084|3968476|FG003|NOT COMPLETED|Period 2||0
3236147|NCT02385084|3968477|FG004|NOT COMPLETED|Period 2||0
3236148|NCT02385084|3968478|FG005|NOT COMPLETED|Period 2||0
3236149|NCT02385084|3968473|FG000|STARTED|Period 3||2
3236150|NCT02385084|3968474|FG001|STARTED|Period 3||3
3236151|NCT02385084|3968475|FG002|STARTED|Period 3|1 participant discontinued after Period 2 - adverse event. Did not enter Period 3.|1
3236152|NCT02385084|3968476|FG003|STARTED|Period 3||3
3236153|NCT02385084|3968477|FG004|STARTED|Period 3|1 participant discontinued after Period 2 - adverse event. Did not enter Period 3.|2
3236154|NCT02385084|3968478|FG005|STARTED|Period 3||3
3236155|NCT02385084|3968473|FG000|Received LY2409021|Period 3||2
3236156|NCT02385084|3968474|FG001|Received LY2409021|Period 3||3
3236157|NCT02385084|3968475|FG002|Received LY2409021|Period 3||1
3236158|NCT02385084|3968476|FG003|Received LY2409021|Period 3||3
3236159|NCT02385084|3968477|FG004|Received LY2409021|Period 3||2
3236160|NCT02385084|3968478|FG005|Received LY2409021|Period 3||3
3236161|NCT02385084|3968473|FG000|Washout|Period 3||2
3236162|NCT02385084|3968474|FG001|Washout|Period 3||3
3236163|NCT02385084|3968475|FG002|Washout|Period 3||1
3236164|NCT02385084|3968476|FG003|Washout|Period 3||3
3236165|NCT02385084|3968477|FG004|Washout|Period 3||2
3236166|NCT02385084|3968478|FG005|Washout|Period 3||3
3236167|NCT02385084|3968473|FG000|COMPLETED|Period 3||2
3236168|NCT02385084|3968474|FG001|COMPLETED|Period 3||3
3236169|NCT02385084|3968475|FG002|COMPLETED|Period 3||1
3236170|NCT02385084|3968476|FG003|COMPLETED|Period 3||3
3236171|NCT02385084|3968477|FG004|COMPLETED|Period 3||2
3236172|NCT02385084|3968478|FG005|COMPLETED|Period 3||3
3236173|NCT02385084|3968473|FG000|NOT COMPLETED|Period 3||0
3236174|NCT02385084|3968474|FG001|NOT COMPLETED|Period 3||0
3236175|NCT02385084|3968475|FG002|NOT COMPLETED|Period 3||0
3236176|NCT02385084|3968476|FG003|NOT COMPLETED|Period 3||0
3236177|NCT02385084|3968477|FG004|NOT COMPLETED|Period 3||0
3236178|NCT02385084|3968478|FG005|NOT COMPLETED|Period 3||0
3236179|NCT02385097|3968489|FG000|STARTED|Overall Study||106
3236180|NCT02385097|3968490|FG001|STARTED|Overall Study||105
3236181|NCT02385097|3968489|FG000|COMPLETED|Overall Study||106
3236182|NCT02385097|3968490|FG001|COMPLETED|Overall Study||105
3236183|NCT02385097|3968489|FG000|NOT COMPLETED|Overall Study||0
3236184|NCT02385097|3968490|FG001|NOT COMPLETED|Overall Study||0
3236185|NCT02385240|3968499|FG000|STARTED|Overall Study||183
3236186|NCT02385240|3968500|FG001|STARTED|Overall Study||184
3236187|NCT02385240|3968501|FG002|STARTED|Overall Study||185
3236188|NCT02385240|3968499|FG000|COMPLETED|Overall Study||182
3236189|NCT02385240|3968500|FG001|COMPLETED|Overall Study||178
3236190|NCT02385240|3968501|FG002|COMPLETED|Overall Study||184
3236191|NCT02385240|3968499|FG000|NOT COMPLETED|Overall Study||1
3236192|NCT02385240|3968500|FG001|NOT COMPLETED|Overall Study||6
3236193|NCT02385240|3968501|FG002|NOT COMPLETED|Overall Study||1
3236194|NCT02385318|3968512|FG000|STARTED|Overall Study||204
3236195|NCT02385318|3968513|FG001|STARTED|Overall Study||210
3236196|NCT02385318|3968514|FG002|STARTED|Overall Study||105
3236197|NCT02385318|3968512|FG000|COMPLETED|Overall Study||200
3236198|NCT02385318|3968513|FG001|COMPLETED|Overall Study||203
3236199|NCT02385318|3968514|FG002|COMPLETED|Overall Study||99
3236200|NCT02385318|3968512|FG000|NOT COMPLETED|Overall Study||4
3236201|NCT02385318|3968513|FG001|NOT COMPLETED|Overall Study||7
3236202|NCT02385318|3968514|FG002|NOT COMPLETED|Overall Study||6
3236203|NCT02385526|3968525|FG000|STARTED|Overall Study||22
3236204|NCT02385526|3968526|FG001|STARTED|Overall Study||20
3236205|NCT02385526|3968527|FG002|STARTED|Overall Study||20
3236206|NCT02385526|3968525|FG000|COMPLETED|Overall Study||20
3236207|NCT02385526|3968526|FG001|COMPLETED|Overall Study||17
3236208|NCT02385526|3968527|FG002|COMPLETED|Overall Study||20
3236209|NCT02385526|3968525|FG000|NOT COMPLETED|Overall Study||2
3236210|NCT02385526|3968526|FG001|NOT COMPLETED|Overall Study||3
3236211|NCT02385526|3968527|FG002|NOT COMPLETED|Overall Study||0
3236212|NCT02385669|3968535|FG000|STARTED|Overall Study||3
3236213|NCT02385669|3968535|FG000|COMPLETED|Overall Study||1
3236214|NCT02385669|3968535|FG000|NOT COMPLETED|Overall Study||2
3236215|NCT02385708|3968541|FG000|STARTED|Overall Study||81
3236216|NCT02385708|3968542|FG001|STARTED|Overall Study||82
3236217|NCT02385708|3968541|FG000|Intervention Started|Overall Study||81
3236218|NCT02385708|3968542|FG001|Intervention Started|Overall Study||82
3236219|NCT02385708|3968541|FG000|COMPLETED|Overall Study||73
3236220|NCT02385708|3968542|FG001|COMPLETED|Overall Study||67
3236221|NCT02385708|3968541|FG000|NOT COMPLETED|Overall Study||8
3236222|NCT02385708|3968542|FG001|NOT COMPLETED|Overall Study||15
3236223|NCT02385721|3968548|FG000|STARTED|Overall Study||601
3236224|NCT02385721|3968548|FG000|COMPLETED|Overall Study||371
3236225|NCT02385721|3968548|FG000|NOT COMPLETED|Overall Study||230
3236226|NCT02385799|3968554|FG000|STARTED|Overall Study||26
3236227|NCT02385799|3968555|FG001|STARTED|Overall Study||32
3236228|NCT02385799|3968554|FG000|Completed End-of-Treatment Visit|Overall Study||21
3236229|NCT02385799|3968555|FG001|Completed End-of-Treatment Visit|Overall Study||26
3236230|NCT02385799|3968554|FG000|COMPLETED|Overall Study||21
3236231|NCT02385799|3968555|FG001|COMPLETED|Overall Study||24
3236232|NCT02385799|3968554|FG000|NOT COMPLETED|Overall Study||5
3236233|NCT02385799|3968555|FG001|NOT COMPLETED|Overall Study||8
3236234|NCT02386098|3968566|FG000|STARTED|Stage 1 (96 Weeks)||43
3236235|NCT02386098|3968567|FG001|STARTED|Stage 1 (96 Weeks)||43
3236236|NCT02386098|3968568|FG002|STARTED|Stage 1 (96 Weeks)||0
3236237|NCT02386098|3968569|FG003|STARTED|Stage 1 (96 Weeks)||0
3236238|NCT02386098|3968570|FG004|STARTED|Stage 1 (96 Weeks)||0
3236239|NCT02386098|3968566|FG000|COMPLETED|Stage 1 (96 Weeks)||0
3236240|NCT02386098|3968567|FG001|COMPLETED|Stage 1 (96 Weeks)||0
3236241|NCT02386098|3968568|FG002|COMPLETED|Stage 1 (96 Weeks)||0
3236242|NCT02386098|3968569|FG003|COMPLETED|Stage 1 (96 Weeks)||0
3236243|NCT02386098|3968570|FG004|COMPLETED|Stage 1 (96 Weeks)||0
3236244|NCT02386098|3968566|FG000|NOT COMPLETED|Stage 1 (96 Weeks)||43
3236245|NCT02386098|3968567|FG001|NOT COMPLETED|Stage 1 (96 Weeks)||43
3236246|NCT02386098|3968568|FG002|NOT COMPLETED|Stage 1 (96 Weeks)||0
3236247|NCT02386098|3968569|FG003|NOT COMPLETED|Stage 1 (96 Weeks)||0
3236248|NCT02386098|3968570|FG004|NOT COMPLETED|Stage 1 (96 Weeks)||0
3236249|NCT02386098|3968566|FG000|STARTED|Stage 2 (96 Weeks)||0
3236250|NCT02386098|3968567|FG001|STARTED|Stage 2 (96 Weeks)||0
3236251|NCT02386098|3968568|FG002|STARTED|Stage 2 (96 Weeks)||0
3236252|NCT02386098|3968569|FG003|STARTED|Stage 2 (96 Weeks)||0
3236253|NCT02386098|3968570|FG004|STARTED|Stage 2 (96 Weeks)||0
3236254|NCT02386098|3968566|FG000|COMPLETED|Stage 2 (96 Weeks)||0
3236255|NCT02386098|3968567|FG001|COMPLETED|Stage 2 (96 Weeks)||0
3236256|NCT02386098|3968568|FG002|COMPLETED|Stage 2 (96 Weeks)||0
3236257|NCT02386098|3968569|FG003|COMPLETED|Stage 2 (96 Weeks)||0
3236258|NCT02386098|3968570|FG004|COMPLETED|Stage 2 (96 Weeks)||0
3236259|NCT02386098|3968566|FG000|NOT COMPLETED|Stage 2 (96 Weeks)||0
3236260|NCT02386098|3968567|FG001|NOT COMPLETED|Stage 2 (96 Weeks)||0
3236261|NCT02386098|3968568|FG002|NOT COMPLETED|Stage 2 (96 Weeks)||0
3236262|NCT02386098|3968569|FG003|NOT COMPLETED|Stage 2 (96 Weeks)||0
3236263|NCT02386098|3968570|FG004|NOT COMPLETED|Stage 2 (96 Weeks)||0
3236264|NCT02386189|3968584|FG000|STARTED|Overall Study||30
3236265|NCT02386189|3968585|FG001|STARTED|Overall Study||33
3236266|NCT02386189|3968584|FG000|COMPLETED|Overall Study||26
3236267|NCT02386189|3968585|FG001|COMPLETED|Overall Study||30
3236268|NCT02386189|3968584|FG000|NOT COMPLETED|Overall Study||4
3236269|NCT02386189|3968585|FG001|NOT COMPLETED|Overall Study||3
3236270|NCT02386319|3968593|FG000|STARTED|Overall Study||18
3236271|NCT02386319|3968594|FG001|STARTED|Overall Study||18
3236272|NCT02386319|3968593|FG000|COMPLETED|Overall Study||16
3236273|NCT02386319|3968594|FG001|COMPLETED|Overall Study||17
3236274|NCT02386319|3968593|FG000|NOT COMPLETED|Overall Study||2
3236275|NCT02386319|3968594|FG001|NOT COMPLETED|Overall Study||1
3236276|NCT02386345|3968600|FG000|STARTED|Overall Study||299
3236277|NCT02386345|3968600|FG000|COMPLETED|Overall Study||197
3236278|NCT02386345|3968600|FG000|NOT COMPLETED|Overall Study||102
3236279|NCT02386605|3968606|FG000|STARTED|Overall Study||41
3236280|NCT02386605|3968607|FG001|STARTED|Overall Study||38
3236281|NCT02386605|3968606|FG000|COMPLETED|Overall Study||34
3236282|NCT02386605|3968607|FG001|COMPLETED|Overall Study||28
3236283|NCT02386605|3968606|FG000|NOT COMPLETED|Overall Study||7
3236284|NCT02386605|3968607|FG001|NOT COMPLETED|Overall Study||10
3236285|NCT02386995|3968613|FG000|STARTED|Overall Study||30
3236286|NCT02386995|3968613|FG000|COMPLETED|Overall Study||30
3236287|NCT02386995|3968613|FG000|NOT COMPLETED|Overall Study||0
3236288|NCT02387008|3968621|FG000|STARTED|Overall Study||2
3236289|NCT02387008|3968622|FG001|STARTED|Overall Study||0
3236290|NCT02387008|3968623|FG002|STARTED|Overall Study||4
3236291|NCT02387008|3968621|FG000|COMPLETED|Overall Study||2
3236292|NCT02387008|3968622|FG001|COMPLETED|Overall Study||0
3236293|NCT02387008|3968623|FG002|COMPLETED|Overall Study||4
3236294|NCT02387008|3968621|FG000|NOT COMPLETED|Overall Study||0
3236295|NCT02387008|3968622|FG001|NOT COMPLETED|Overall Study||0
3236296|NCT02387008|3968623|FG002|NOT COMPLETED|Overall Study||0
3236297|NCT02387164|3968633|FG000|STARTED|Overall Study||13
3236298|NCT02387164|3968634|FG001|STARTED|Overall Study||13
3236299|NCT02387164|3968633|FG000|COMPLETED|Overall Study||10
3236300|NCT02387164|3968634|FG001|COMPLETED|Overall Study||11
3236301|NCT02387164|3968633|FG000|NOT COMPLETED|Overall Study||3
3236302|NCT02387164|3968634|FG001|NOT COMPLETED|Overall Study||2
3236303|NCT02387216|3968642|FG000|STARTED|Overall Study||103
3236304|NCT02387216|3968643|FG001|STARTED|Overall Study||49
3236305|NCT02387216|3968642|FG000|COMPLETED|Overall Study||3
3236306|NCT02387216|3968643|FG001|COMPLETED|Overall Study||2
3236307|NCT02387216|3968642|FG000|NOT COMPLETED|Overall Study||100
3236308|NCT02387216|3968643|FG001|NOT COMPLETED|Overall Study||47
3236309|NCT02387268|3968649|FG000|STARTED|Overall Study||10
3236310|NCT02387268|3968649|FG000|COMPLETED|Overall Study||9
3236311|NCT02387268|3968649|FG000|NOT COMPLETED|Overall Study||1
3236312|NCT02387294|3968655|FG000|STARTED|Overall Study||60
3236313|NCT02387294|3968656|FG001|STARTED|Overall Study||60
3236314|NCT02387294|3968655|FG000|COMPLETED|Overall Study||60
3236315|NCT02387294|3968656|FG001|COMPLETED|Overall Study||60
3236316|NCT02387294|3968655|FG000|NOT COMPLETED|Overall Study||0
3236317|NCT02387294|3968656|FG001|NOT COMPLETED|Overall Study||0
3236318|NCT02387359|3968666|FG000|STARTED|Overall Study||354
3236319|NCT02387359|3968667|FG001|STARTED|Overall Study||351
3236320|NCT02387359|3968668|FG002|STARTED|Overall Study||349
3236321|NCT02387359|3968666|FG000|COMPLETED|Overall Study||295
3236322|NCT02387359|3968667|FG001|COMPLETED|Overall Study||309
3236323|NCT02387359|3968668|FG002|COMPLETED|Overall Study||293
3236324|NCT02387359|3968666|FG000|NOT COMPLETED|Overall Study||59
3236325|NCT02387359|3968667|FG001|NOT COMPLETED|Overall Study||42
3236326|NCT02387359|3968668|FG002|NOT COMPLETED|Overall Study||56
3236327|NCT02387372|3968678|FG000|STARTED|Overall Study||27
3236328|NCT02387372|3968679|FG001|STARTED|Overall Study||10
3236329|NCT02387372|3968678|FG000|Treated|Overall Study||26
3236330|NCT02387372|3968679|FG001|Treated|Overall Study||10
3236331|NCT02387372|3968678|FG000|COMPLETED|Overall Study||26
3236332|NCT02387372|3968679|FG001|COMPLETED|Overall Study||10
3236333|NCT02387372|3968678|FG000|NOT COMPLETED|Overall Study||1
3236334|NCT02387372|3968679|FG001|NOT COMPLETED|Overall Study||0
3236335|NCT02387476|3968695|FG000|STARTED|Overall Study||25
3236336|NCT02387476|3968696|FG001|STARTED|Overall Study||22
3236337|NCT02387476|3968695|FG000|COMPLETED|Overall Study||19
3236338|NCT02387476|3968696|FG001|COMPLETED|Overall Study||17
3236339|NCT02387476|3968695|FG000|NOT COMPLETED|Overall Study||6
3236340|NCT02387476|3968696|FG001|NOT COMPLETED|Overall Study||5
3236341|NCT02387502|3968707|FG000|STARTED|Overall Study||40
3236342|NCT02387502|3968708|FG001|STARTED|Overall Study||40
3236343|NCT02387502|3968709|FG002|STARTED|Overall Study||40
3236344|NCT02387502|3968707|FG000|COMPLETED|Overall Study||40
3236345|NCT02387502|3968708|FG001|COMPLETED|Overall Study||40
3236346|NCT02387502|3968709|FG002|COMPLETED|Overall Study||40
3236347|NCT02387502|3968707|FG000|NOT COMPLETED|Overall Study||0
3236348|NCT02387502|3968708|FG001|NOT COMPLETED|Overall Study||0
3236349|NCT02387502|3968709|FG002|NOT COMPLETED|Overall Study||0
3236350|NCT02387554|3968721|FG000|STARTED|Overall Study|A,C,ALC: intervention (8 days), L: intervention (4 days), Each period washout (14days)|10
3236351|NCT02387554|3968722|FG001|STARTED|Overall Study|A,C,ALC: intervention (8 days), L: intervention (4 days), Each period washout (14days)|7
3236352|NCT02387554|3968723|FG002|STARTED|Overall Study|A,C,ALC: intervention (8 days), L: intervention (4 days), Each period washout (14days)|8
3236353|NCT02387554|3968724|FG003|STARTED|Overall Study|A,C,ALC: intervention (8 days), L: intervention (4 days), Each period washout (14days)|8
3236354|NCT02387554|3968721|FG000|COMPLETED|Overall Study||7
3236355|NCT02387554|3968722|FG001|COMPLETED|Overall Study||7
3236356|NCT02387554|3968723|FG002|COMPLETED|Overall Study||6
3236357|NCT02387554|3968724|FG003|COMPLETED|Overall Study||6
3236358|NCT02387554|3968721|FG000|NOT COMPLETED|Overall Study||3
3236359|NCT02387554|3968722|FG001|NOT COMPLETED|Overall Study||0
3236360|NCT02387554|3968723|FG002|NOT COMPLETED|Overall Study||2
3236361|NCT02387554|3968724|FG003|NOT COMPLETED|Overall Study||2
3236362|NCT02387580|3968740|FG000|STARTED|Overall Study||8
3236363|NCT02387580|3968741|FG001|STARTED|Overall Study||8
3236364|NCT02387580|3968742|FG002|STARTED|Overall Study||8
3236365|NCT02387580|3968743|FG003|STARTED|Overall Study||8
3236366|NCT02387580|3968744|FG004|STARTED|Overall Study||8
3236367|NCT02387580|3968745|FG005|STARTED|Overall Study||8
3236368|NCT02387580|3968740|FG000|COMPLETED|Overall Study||8
3236369|NCT02387580|3968741|FG001|COMPLETED|Overall Study||8
3236370|NCT02387580|3968742|FG002|COMPLETED|Overall Study||8
3236371|NCT02387580|3968743|FG003|COMPLETED|Overall Study||7
3236372|NCT02387580|3968744|FG004|COMPLETED|Overall Study||8
3236373|NCT02387580|3968745|FG005|COMPLETED|Overall Study||8
3236374|NCT02387580|3968740|FG000|NOT COMPLETED|Overall Study||0
3236375|NCT02387580|3968741|FG001|NOT COMPLETED|Overall Study||0
3236376|NCT02387580|3968742|FG002|NOT COMPLETED|Overall Study||0
3236377|NCT02387580|3968743|FG003|NOT COMPLETED|Overall Study||1
3236378|NCT02387580|3968744|FG004|NOT COMPLETED|Overall Study||0
3236379|NCT02387580|3968745|FG005|NOT COMPLETED|Overall Study||0
3236380|NCT02387710|3968761|FG000|STARTED|First Study Night||9
3236381|NCT02387710|3968762|FG001|STARTED|First Study Night||9
3236382|NCT02387710|3968761|FG000|COMPLETED|First Study Night||9
3236383|NCT02387710|3968762|FG001|COMPLETED|First Study Night||9
3236384|NCT02387710|3968761|FG000|NOT COMPLETED|First Study Night||0
3236385|NCT02387710|3968762|FG001|NOT COMPLETED|First Study Night||0
3236386|NCT02387710|3968761|FG000|STARTED|Second Study Night||9
3236387|NCT02387710|3968762|FG001|STARTED|Second Study Night|2 patients did not come back for excessive sleep disruption due to the equipment|7
3236388|NCT02387710|3968761|FG000|COMPLETED|Second Study Night||9
3236389|NCT02387710|3968762|FG001|COMPLETED|Second Study Night||7
3236390|NCT02387710|3968761|FG000|NOT COMPLETED|Second Study Night||0
3236391|NCT02387710|3968762|FG001|NOT COMPLETED|Second Study Night||0
3236392|NCT02387749|3968770|FG000|STARTED|Overall Study||10
3236393|NCT02387749|3968770|FG000|COMPLETED|Overall Study||10
3236394|NCT02387749|3968770|FG000|NOT COMPLETED|Overall Study||0
3236395|NCT02387762|3968781|FG000|STARTED|Overall Study||16
3236396|NCT02387762|3968782|FG001|STARTED|Overall Study||15
3236397|NCT02387762|3968781|FG000|COMPLETED|Overall Study||15
3236398|NCT02387762|3968782|FG001|COMPLETED|Overall Study||15
3236399|NCT02387762|3968781|FG000|NOT COMPLETED|Overall Study||1
3236400|NCT02387762|3968782|FG001|NOT COMPLETED|Overall Study||0
3236401|NCT02387801|3968790|FG000|STARTED|Induction Dosing Period||6
3236402|NCT02387801|3968791|FG001|STARTED|Induction Dosing Period||6
3236403|NCT02387801|3968790|FG000|COMPLETED|Induction Dosing Period||6
3236404|NCT02387801|3968791|FG001|COMPLETED|Induction Dosing Period||6
3236405|NCT02387801|3968790|FG000|NOT COMPLETED|Induction Dosing Period||0
3236406|NCT02387801|3968791|FG001|NOT COMPLETED|Induction Dosing Period||0
3236407|NCT02387801|3968790|FG000|STARTED|Maintenance Dosing Period|All participants from Induction Dosing Period went to ixe Q4W arm during Maintenance Dosing Period.|0
3236408|NCT02387801|3968791|FG001|STARTED|Maintenance Dosing Period||12
3236409|NCT02387801|3968790|FG000|COMPLETED|Maintenance Dosing Period||0
3236410|NCT02387801|3968791|FG001|COMPLETED|Maintenance Dosing Period||12
3236411|NCT02387801|3968790|FG000|NOT COMPLETED|Maintenance Dosing Period||0
3236412|NCT02387801|3968791|FG001|NOT COMPLETED|Maintenance Dosing Period||0
3236413|NCT02387801|3968790|FG000|STARTED|Post-Treatment Follow-up||0
3236414|NCT02387801|3968791|FG001|STARTED|Post-Treatment Follow-up||12
3236415|NCT02387801|3968790|FG000|COMPLETED|Post-Treatment Follow-up||0
3236416|NCT02387801|3968791|FG001|COMPLETED|Post-Treatment Follow-up||12
3236417|NCT02387801|3968790|FG000|NOT COMPLETED|Post-Treatment Follow-up||0
3236418|NCT02387801|3968791|FG001|NOT COMPLETED|Post-Treatment Follow-up||0
3236419|NCT02387814|3968803|FG000|STARTED|Overall Study||10
3236420|NCT02387814|3968804|FG001|STARTED|Overall Study||9
3236421|NCT02387814|3968805|FG002|STARTED|Overall Study||10
3236422|NCT02387814|3968806|FG003|STARTED|Overall Study||6
3236423|NCT02387814|3968803|FG000|Received Abemaciclib|Overall Study||10
3236424|NCT02387814|3968804|FG001|Received Abemaciclib|Overall Study||9
3236425|NCT02387814|3968805|FG002|Received Abemaciclib|Overall Study||10
3236426|NCT02387814|3968806|FG003|Received Abemaciclib|Overall Study||6
3236427|NCT02387814|3968803|FG000|COMPLETED|Overall Study||10
3236428|NCT02387814|3968804|FG001|COMPLETED|Overall Study||9
3236429|NCT02387814|3968805|FG002|COMPLETED|Overall Study||10
3236430|NCT02387814|3968806|FG003|COMPLETED|Overall Study||6
3236431|NCT02387814|3968803|FG000|NOT COMPLETED|Overall Study||0
3236432|NCT02387814|3968804|FG001|NOT COMPLETED|Overall Study||0
3236433|NCT02387814|3968805|FG002|NOT COMPLETED|Overall Study||0
3236434|NCT02387814|3968806|FG003|NOT COMPLETED|Overall Study||0
3236435|NCT02387840|3968822|FG000|STARTED|Overall Study||4
3236436|NCT02387840|3968823|FG001|STARTED|Overall Study||6
3236437|NCT02387840|3968824|FG002|STARTED|Overall Study||6
3236438|NCT02387840|3968825|FG003|STARTED|Overall Study||8
3236439|NCT02387840|3968826|FG004|STARTED|Overall Study||4
3236440|NCT02387840|3968827|FG005|STARTED|Overall Study||6
3236441|NCT02387840|3968822|FG000|COMPLETED|Overall Study||4
3236442|NCT02387840|3968823|FG001|COMPLETED|Overall Study||6
3236443|NCT02387840|3968824|FG002|COMPLETED|Overall Study||6
3236444|NCT02387840|3968825|FG003|COMPLETED|Overall Study||8
3236445|NCT02387840|3968826|FG004|COMPLETED|Overall Study||4
3236446|NCT02387840|3968827|FG005|COMPLETED|Overall Study||5
3236447|NCT02387840|3968822|FG000|NOT COMPLETED|Overall Study||0
3236448|NCT02387840|3968823|FG001|NOT COMPLETED|Overall Study||0
3236449|NCT02387840|3968824|FG002|NOT COMPLETED|Overall Study||0
3236450|NCT02387840|3968825|FG003|NOT COMPLETED|Overall Study||0
3236451|NCT02387840|3968826|FG004|NOT COMPLETED|Overall Study||0
3236452|NCT02387840|3968827|FG005|NOT COMPLETED|Overall Study||1
3236453|NCT02387853|3968847|FG000|STARTED|Overall Study||106
3236454|NCT02387853|3968847|FG000|COMPLETED|Overall Study||103
3236455|NCT02387853|3968847|FG000|NOT COMPLETED|Overall Study||3
3236456|NCT02387957|3968854|FG000|STARTED|Overall Study||21
3236457|NCT02387957|3968855|FG001|STARTED|Overall Study||21
3236458|NCT02387957|3968856|FG002|STARTED|Overall Study||21
3236459|NCT02387957|3968854|FG000|COMPLETED|Overall Study|The study was discontinued|0
3236460|NCT02387957|3968855|FG001|COMPLETED|Overall Study|The study was discontinued|0
3236461|NCT02387957|3968856|FG002|COMPLETED|Overall Study|The study was discontinued|1
3236462|NCT02387957|3968854|FG000|NOT COMPLETED|Overall Study||21
3236463|NCT02387957|3968855|FG001|NOT COMPLETED|Overall Study||21
3236464|NCT02387957|3968856|FG002|NOT COMPLETED|Overall Study||20
3369647|NCT03799211|4101093|FG001|NOT COMPLETED|Overall Study||13
3369648|NCT03798717|4101107|FG000|STARTED|Overall Study||4
3369649|NCT03798717|4101108|FG001|STARTED|Overall Study||3
3369650|NCT03798717|4101109|FG002|STARTED|Overall Study||3
3369651|NCT03798717|4101110|FG003|STARTED|Overall Study||4
3369652|NCT03798717|4101111|FG004|STARTED|Overall Study||3
3369653|NCT03798717|4101112|FG005|STARTED|Overall Study||3
3369654|NCT03798717|4101107|FG000|COMPLETED|Overall Study||2
3369655|NCT03798717|4101108|FG001|COMPLETED|Overall Study||2
3369656|NCT03798717|4101109|FG002|COMPLETED|Overall Study||2
3369657|NCT03798717|4101110|FG003|COMPLETED|Overall Study||2
3369658|NCT03798717|4101111|FG004|COMPLETED|Overall Study||2
3369659|NCT03798717|4101112|FG005|COMPLETED|Overall Study||2
3369660|NCT03798717|4101107|FG000|NOT COMPLETED|Overall Study||2
3369661|NCT03798717|4101108|FG001|NOT COMPLETED|Overall Study||1
3369662|NCT03798717|4101109|FG002|NOT COMPLETED|Overall Study||1
3369663|NCT03798717|4101110|FG003|NOT COMPLETED|Overall Study||2
3369664|NCT03798717|4101111|FG004|NOT COMPLETED|Overall Study||1
3236465|NCT02387970|3968866|FG000|STARTED|Overall Study||27
3236466|NCT02387970|3968867|FG001|STARTED|Overall Study||25
3369665|NCT03798717|4101112|FG005|NOT COMPLETED|Overall Study||1
3369666|NCT03798483|4101121|FG000|STARTED|Overall Study||15
3369667|NCT03798483|4101121|FG000|Returned All Follow-up Outcome Data|Overall Study||11
3369668|NCT03798483|4101121|FG000|COMPLETED|Overall Study||13
3369669|NCT03798483|4101121|FG000|NOT COMPLETED|Overall Study||2
3369670|NCT03798366|4101131|FG000|STARTED|Overall Study||21
3369671|NCT03798366|4101132|FG001|STARTED|Overall Study||12
3369672|NCT03798366|4101131|FG000|COMPLETED|Overall Study||21
3369673|NCT03798366|4101132|FG001|COMPLETED|Overall Study||11
3236467|NCT02387970|3968866|FG000|COMPLETED|Overall Study||26
3236468|NCT02387970|3968867|FG001|COMPLETED|Overall Study||23
3236469|NCT02387970|3968866|FG000|NOT COMPLETED|Overall Study||1
3236470|NCT02387970|3968867|FG001|NOT COMPLETED|Overall Study||2
3236471|NCT02387983|3968873|FG000|STARTED|Overall Study||65
3236472|NCT02387983|3968873|FG000|COMPLETED|Overall Study||58
3236473|NCT02387983|3968873|FG000|NOT COMPLETED|Overall Study||7
3236474|NCT02387996|3968877|FG000|STARTED|Overall Study||270
3236475|NCT02387996|3968877|FG000|COMPLETED|Overall Study|Completed equals continuing in the Treatment Period|66
3236476|NCT02387996|3968877|FG000|NOT COMPLETED|Overall Study||204
3236477|NCT02388074|3968881|FG000|STARTED|Overall Study||25
3236478|NCT02388074|3968881|FG000|COMPLETED|Overall Study||22
3236479|NCT02388074|3968881|FG000|NOT COMPLETED|Overall Study||3
3236480|NCT02388165|3968887|FG000|STARTED|Overall Study||1726
3236481|NCT02388165|3968888|FG001|STARTED|Overall Study||1724
3236482|NCT02388165|3968887|FG000|Vaccinated (Safety Population)|Overall Study||1708
3236483|NCT02388165|3968888|FG001|Vaccinated (Safety Population)|Overall Study||1709
3236484|NCT02388165|3968887|FG000|COMPLETED|Overall Study||1599
3236485|NCT02388165|3968888|FG001|COMPLETED|Overall Study||1594
3236486|NCT02388165|3968887|FG000|NOT COMPLETED|Overall Study||127
3236487|NCT02388165|3968888|FG001|NOT COMPLETED|Overall Study||130
3236488|NCT02388191|3968896|FG000|STARTED|Overall Study||59
3236489|NCT02388191|3968897|FG001|STARTED|Overall Study||60
3236490|NCT02388191|3968896|FG000|COMPLETED|Overall Study||58
3236491|NCT02388191|3968897|FG001|COMPLETED|Overall Study||60
3236492|NCT02388191|3968896|FG000|NOT COMPLETED|Overall Study||1
3236493|NCT02388191|3968897|FG001|NOT COMPLETED|Overall Study||0
3236494|NCT02388269|3968907|FG000|STARTED|Overall Study||41
3236495|NCT02388269|3968908|FG001|STARTED|Overall Study||40
3236496|NCT02388269|3968909|FG002|STARTED|Overall Study||10
3236497|NCT02388269|3968907|FG000|Randomised Period|Overall Study||41
3236498|NCT02388269|3968908|FG001|Randomised Period|Overall Study||40
3236499|NCT02388269|3968909|FG002|Randomised Period|Overall Study||0
3236500|NCT02388269|3968907|FG000|Open Label|Overall Study||37
3236501|NCT02388269|3968908|FG001|Open Label|Overall Study||38
3236502|NCT02388269|3968909|FG002|Open Label|Overall Study||0
3236503|NCT02388269|3968907|FG000|COMPLETED|Overall Study||32
3236504|NCT02388269|3968908|FG001|COMPLETED|Overall Study||38
3236505|NCT02388269|3968909|FG002|COMPLETED|Overall Study||0
3236506|NCT02388269|3968907|FG000|NOT COMPLETED|Overall Study||9
3236507|NCT02388269|3968908|FG001|NOT COMPLETED|Overall Study||2
3236508|NCT02388269|3968909|FG002|NOT COMPLETED|Overall Study||10
3236509|NCT02388295|3968936|FG000|STARTED|Dose Escalation Week 1|Number randomized to treatment|19
3236510|NCT02388295|3968937|FG001|STARTED|Dose Escalation Week 1|Number randomized to treatment|19
3236511|NCT02388295|3968938|FG002|STARTED|Dose Escalation Week 1|Number randomized to treatment|20
3236512|NCT02388295|3968936|FG000|COMPLETED|Dose Escalation Week 1||17
3236513|NCT02388295|3968937|FG001|COMPLETED|Dose Escalation Week 1||16
3236514|NCT02388295|3968938|FG002|COMPLETED|Dose Escalation Week 1||18
3236515|NCT02388295|3968936|FG000|NOT COMPLETED|Dose Escalation Week 1||2
3236516|NCT02388295|3968937|FG001|NOT COMPLETED|Dose Escalation Week 1||3
3236517|NCT02388295|3968938|FG002|NOT COMPLETED|Dose Escalation Week 1||2
3236518|NCT02388295|3968936|FG000|STARTED|Dose Escalation Week 2||17
3236519|NCT02388295|3968937|FG001|STARTED|Dose Escalation Week 2||16
3236520|NCT02388295|3968938|FG002|STARTED|Dose Escalation Week 2||18
3236521|NCT02388295|3968936|FG000|COMPLETED|Dose Escalation Week 2||16
3236522|NCT02388295|3968937|FG001|COMPLETED|Dose Escalation Week 2||14
3236523|NCT02388295|3968938|FG002|COMPLETED|Dose Escalation Week 2||17
3236524|NCT02388295|3968936|FG000|NOT COMPLETED|Dose Escalation Week 2||1
3236525|NCT02388295|3968937|FG001|NOT COMPLETED|Dose Escalation Week 2||2
3236526|NCT02388295|3968938|FG002|NOT COMPLETED|Dose Escalation Week 2||1
3236527|NCT02388295|3968936|FG000|STARTED|Treatment Weeks 3 to 12||16
3236528|NCT02388295|3968937|FG001|STARTED|Treatment Weeks 3 to 12||14
3236529|NCT02388295|3968938|FG002|STARTED|Treatment Weeks 3 to 12||17
3236530|NCT02388295|3968936|FG000|COMPLETED|Treatment Weeks 3 to 12||15
3236531|NCT02388295|3968937|FG001|COMPLETED|Treatment Weeks 3 to 12||13
3236532|NCT02388295|3968938|FG002|COMPLETED|Treatment Weeks 3 to 12||17
3236533|NCT02388295|3968936|FG000|NOT COMPLETED|Treatment Weeks 3 to 12||1
3236534|NCT02388295|3968937|FG001|NOT COMPLETED|Treatment Weeks 3 to 12||1
3236535|NCT02388295|3968938|FG002|NOT COMPLETED|Treatment Weeks 3 to 12||0
3236536|NCT02388321|3968948|FG000|STARTED|Overall Study||11
3236537|NCT02388321|3968949|FG001|STARTED|Overall Study||11
3236538|NCT02388321|3968948|FG000|COMPLETED|Overall Study||11
3236539|NCT02388321|3968949|FG001|COMPLETED|Overall Study||11
3236540|NCT02388321|3968948|FG000|NOT COMPLETED|Overall Study||0
3236541|NCT02388321|3968949|FG001|NOT COMPLETED|Overall Study||0
3369674|NCT03798366|4101131|FG000|NOT COMPLETED|Overall Study||0
3369675|NCT03798366|4101132|FG001|NOT COMPLETED|Overall Study||1
3369676|NCT03799952|4101140|FG000|STARTED|Overall Study||31
3369677|NCT03799952|4101141|FG001|STARTED|Overall Study||31
3369678|NCT03799952|4101140|FG000|COMPLETED|Overall Study||30
3369679|NCT03799952|4101141|FG001|COMPLETED|Overall Study||29
3369680|NCT03799952|4101140|FG000|NOT COMPLETED|Overall Study||1
3369681|NCT03799952|4101141|FG001|NOT COMPLETED|Overall Study||2
3369682|NCT03797872|4101149|FG000|STARTED|Overall Study||1
3369683|NCT03797872|4101150|FG001|STARTED|Overall Study||0
3369684|NCT03797872|4101149|FG000|COMPLETED|Overall Study||0
3369685|NCT03797872|4101150|FG001|COMPLETED|Overall Study||0
3369686|NCT03797872|4101149|FG000|NOT COMPLETED|Overall Study||1
3236542|NCT02388347|3968960|FG000|STARTED|Overall Study||8
3236543|NCT02388347|3968961|FG001|STARTED|Overall Study||6
3236544|NCT02388347|3968962|FG002|STARTED|Overall Study||6
3236545|NCT02388347|3968963|FG003|STARTED|Overall Study||6
3236546|NCT02388347|3968964|FG004|STARTED|Overall Study||6
3236547|NCT02388347|3968960|FG000|COMPLETED|Overall Study||8
3236548|NCT02388347|3968961|FG001|COMPLETED|Overall Study||6
3236549|NCT02388347|3968962|FG002|COMPLETED|Overall Study||5
3236550|NCT02388347|3968963|FG003|COMPLETED|Overall Study||6
3236551|NCT02388347|3968964|FG004|COMPLETED|Overall Study||6
3236552|NCT02388347|3968960|FG000|NOT COMPLETED|Overall Study||0
3236553|NCT02388347|3968961|FG001|NOT COMPLETED|Overall Study||0
3236554|NCT02388347|3968962|FG002|NOT COMPLETED|Overall Study||1
3236555|NCT02388347|3968963|FG003|NOT COMPLETED|Overall Study||0
3236556|NCT02388347|3968964|FG004|NOT COMPLETED|Overall Study||0
3236557|NCT02388386|3968980|FG000|STARTED|Overall Study||10
3236558|NCT02388386|3968980|FG000|COMPLETED|Overall Study||10
3236559|NCT02388386|3968980|FG000|NOT COMPLETED|Overall Study||0
3236560|NCT02388568|3968990|FG000|STARTED|Overall Study||69
3236561|NCT02388568|3968991|FG001|STARTED|Overall Study||68
3236562|NCT02388568|3968990|FG000|COMPLETED|Overall Study||59
3236563|NCT02388568|3968991|FG001|COMPLETED|Overall Study||53
3236564|NCT02388568|3968990|FG000|NOT COMPLETED|Overall Study||10
3236565|NCT02388568|3968991|FG001|NOT COMPLETED|Overall Study||15
3236566|NCT02388633|3968997|FG000|STARTED|Overall Study||8
3236567|NCT02388633|3968997|FG000|COMPLETED|Overall Study||8
3236568|NCT02388633|3968997|FG000|NOT COMPLETED|Overall Study||0
3236569|NCT02388646|3969004|FG000|STARTED|Overall Study||20
3236570|NCT02388646|3969005|FG001|STARTED|Overall Study||20
3236571|NCT02388646|3969006|FG002|STARTED|Overall Study||20
3236572|NCT02388646|3969004|FG000|COMPLETED|Overall Study||16
3236573|NCT02388646|3969005|FG001|COMPLETED|Overall Study||19
3236574|NCT02388646|3969006|FG002|COMPLETED|Overall Study||14
3236575|NCT02388646|3969004|FG000|NOT COMPLETED|Overall Study||4
3236576|NCT02388646|3969005|FG001|NOT COMPLETED|Overall Study||1
3236577|NCT02388646|3969006|FG002|NOT COMPLETED|Overall Study||6
3236578|NCT02388724|3969016|FG000|STARTED|Overall Study||244
3236579|NCT02388724|3969017|FG001|STARTED|Overall Study||237
3236580|NCT02388724|3969016|FG000|Safety Set: Randomized But Not Treated|Overall Study||0
3236581|NCT02388724|3969017|FG001|Safety Set: Randomized But Not Treated|Overall Study||2
3236582|NCT02388724|3969016|FG000|COMPLETED|Overall Study||232
3236583|NCT02388724|3969017|FG001|COMPLETED|Overall Study||224
3236584|NCT02388724|3969016|FG000|NOT COMPLETED|Overall Study||12
3236585|NCT02388724|3969017|FG001|NOT COMPLETED|Overall Study||13
3236586|NCT02388737|3969026|FG000|STARTED|Overall Study||235
3236587|NCT02388737|3969027|FG001|STARTED|Overall Study||226
3236588|NCT02388737|3969028|FG002|STARTED|Overall Study||242
3236589|NCT02388737|3969026|FG000|COMPLETED|Overall Study||181
3236590|NCT02388737|3969027|FG001|COMPLETED|Overall Study||166
3236591|NCT02388737|3969028|FG002|COMPLETED|Overall Study||180
3236592|NCT02388737|3969026|FG000|NOT COMPLETED|Overall Study||54
3236593|NCT02388737|3969027|FG001|NOT COMPLETED|Overall Study||60
3236594|NCT02388737|3969028|FG002|NOT COMPLETED|Overall Study||62
3236595|NCT02388763|3969036|FG000|STARTED|Habitual, 10 Days of Wear||32
3236596|NCT02388763|3969037|FG001|STARTED|Habitual, 10 Days of Wear||32
3236597|NCT02388763|3969036|FG000|COMPLETED|Habitual, 10 Days of Wear||31
3236598|NCT02388763|3969037|FG001|COMPLETED|Habitual, 10 Days of Wear||31
3236599|NCT02388763|3969036|FG000|NOT COMPLETED|Habitual, 10 Days of Wear||1
3236600|NCT02388763|3969037|FG001|NOT COMPLETED|Habitual, 10 Days of Wear||1
3236601|NCT02388763|3969036|FG000|STARTED|Period 1, 10 Days of Wear||31
3236602|NCT02388763|3969037|FG001|STARTED|Period 1, 10 Days of Wear||31
3236603|NCT02388763|3969036|FG000|COMPLETED|Period 1, 10 Days of Wear||30
3236604|NCT02388763|3969037|FG001|COMPLETED|Period 1, 10 Days of Wear||30
3236605|NCT02388763|3969036|FG000|NOT COMPLETED|Period 1, 10 Days of Wear||1
3236606|NCT02388763|3969037|FG001|NOT COMPLETED|Period 1, 10 Days of Wear||1
3236607|NCT02388763|3969036|FG000|STARTED|Period 2, 10 Days of Wear||30
3236608|NCT02388763|3969037|FG001|STARTED|Period 2, 10 Days of Wear||30
3236609|NCT02388763|3969036|FG000|COMPLETED|Period 2, 10 Days of Wear||30
3236610|NCT02388763|3969037|FG001|COMPLETED|Period 2, 10 Days of Wear||30
3236611|NCT02388763|3969036|FG000|NOT COMPLETED|Period 2, 10 Days of Wear||0
3236612|NCT02388763|3969037|FG001|NOT COMPLETED|Period 2, 10 Days of Wear||0
3236613|NCT02388815|3969046|FG000|STARTED|Overall Study||89
3236614|NCT02388815|3969046|FG000|COMPLETED|Overall Study||85
3236615|NCT02388815|3969046|FG000|NOT COMPLETED|Overall Study||4
3236616|NCT02388880|3969050|FG000|STARTED|Overall Study||3
3236617|NCT02388880|3969050|FG000|COMPLETED|Overall Study||3
3236618|NCT02388880|3969050|FG000|NOT COMPLETED|Overall Study||0
3236619|NCT02388906|3969056|FG000|STARTED|Pre-Treatment Period||453
3236620|NCT02388906|3969057|FG001|STARTED|Pre-Treatment Period||453
3236621|NCT02388906|3969056|FG000|COMPLETED|Pre-Treatment Period||452
3236622|NCT02388906|3969057|FG001|COMPLETED|Pre-Treatment Period||453
3236623|NCT02388906|3969056|FG000|NOT COMPLETED|Pre-Treatment Period||1
3236624|NCT02388906|3969057|FG001|NOT COMPLETED|Pre-Treatment Period||0
3236625|NCT02388906|3969056|FG000|STARTED|Treatment Period||452
3236626|NCT02388906|3969057|FG001|STARTED|Treatment Period||453
3236627|NCT02388906|3969056|FG000|COMPLETED|Treatment Period||275
3236628|NCT02388906|3969057|FG001|COMPLETED|Treatment Period||122
3236629|NCT02388906|3969056|FG000|NOT COMPLETED|Treatment Period||177
3236630|NCT02388906|3969057|FG001|NOT COMPLETED|Treatment Period||331
3236631|NCT02388932|3969063|FG000|STARTED|Overall Study||3
3236632|NCT02388932|3969063|FG000|COMPLETED|Overall Study||2
3236633|NCT02388932|3969063|FG000|NOT COMPLETED|Overall Study||1
3236634|NCT02388997|3969070|FG000|STARTED|Overall Study||15
3236635|NCT02388997|3969071|FG001|STARTED|Overall Study||16
3236636|NCT02388997|3969070|FG000|COMPLETED|Overall Study||12
3236637|NCT02388997|3969071|FG001|COMPLETED|Overall Study||10
3236638|NCT02388997|3969070|FG000|NOT COMPLETED|Overall Study||3
3236639|NCT02388997|3969071|FG001|NOT COMPLETED|Overall Study||6
3236640|NCT02389088|3969077|FG000|STARTED|Overall Study - Phase I||9
3236641|NCT02389088|3969077|FG000|COMPLETED|Overall Study - Phase I||9
3236642|NCT02389088|3969077|FG000|NOT COMPLETED|Overall Study - Phase I||0
3236643|NCT02389088|3969077|FG000|STARTED|Phase II - All Study Participants||9
3236644|NCT02389088|3969077|FG000|COMPLETED|Phase II - All Study Participants||9
3236645|NCT02389088|3969077|FG000|NOT COMPLETED|Phase II - All Study Participants||0
3236646|NCT02389101|3969091|FG000|STARTED|Overall Study||21
3236647|NCT02389101|3969091|FG000|COMPLETED|Overall Study||21
3236648|NCT02389101|3969091|FG000|NOT COMPLETED|Overall Study||0
3236649|NCT02389361|3969097|FG000|STARTED|Overall Study||24
3236650|NCT02389361|3969098|FG001|STARTED|Overall Study||27
3236651|NCT02389361|3969097|FG000|COMPLETED|Overall Study||24
3236652|NCT02389361|3969098|FG001|COMPLETED|Overall Study||27
3236653|NCT02389361|3969097|FG000|NOT COMPLETED|Overall Study||0
3236654|NCT02389361|3969098|FG001|NOT COMPLETED|Overall Study||0
3236655|NCT02389374|3969107|FG000|STARTED|Overall Study||55
3236656|NCT02389374|3969108|FG001|STARTED|Overall Study||115
3236657|NCT02389374|3969109|FG002|STARTED|Overall Study||11
3236658|NCT02389374|3969107|FG000|COMPLETED|Overall Study||46
3236659|NCT02389374|3969108|FG001|COMPLETED|Overall Study||87
3236660|NCT02389374|3969109|FG002|COMPLETED|Overall Study||10
3236661|NCT02389374|3969107|FG000|NOT COMPLETED|Overall Study||9
3236662|NCT02389374|3969108|FG001|NOT COMPLETED|Overall Study||28
3236663|NCT02389374|3969109|FG002|NOT COMPLETED|Overall Study||1
3236664|NCT02389452|3969118|FG000|STARTED|Overall Study||394
3236665|NCT02389452|3969118|FG000|Participants Received Repeat Injection|Overall Study|Repeat injection based on physician's assessment of efficacy and safety at Week 26, 39 or 52.|11
3236666|NCT02389452|3969118|FG000|COMPLETED|Overall Study||369
3236667|NCT02389452|3969118|FG000|NOT COMPLETED|Overall Study||25
3236668|NCT02389621|3969125|FG000|STARTED|Treatment Period||108
3236669|NCT02389621|3969126|FG001|STARTED|Treatment Period||107
3236670|NCT02389621|3969125|FG000|Received Study Drug|Treatment Period||107
3236671|NCT02389621|3969126|FG001|Received Study Drug|Treatment Period||107
3236672|NCT02389621|3969125|FG000|COMPLETED|Treatment Period||107
3236673|NCT02389621|3969126|FG001|COMPLETED|Treatment Period||106
3236674|NCT02389621|3969125|FG000|NOT COMPLETED|Treatment Period||1
3236675|NCT02389621|3969126|FG001|NOT COMPLETED|Treatment Period||1
3236676|NCT02389621|3969125|FG000|STARTED|Posttreatment Period||107
3236677|NCT02389621|3969126|FG001|STARTED|Posttreatment Period||106
3236678|NCT02389621|3969125|FG000|COMPLETED|Posttreatment Period||98
3236679|NCT02389621|3969126|FG001|COMPLETED|Posttreatment Period||102
3236680|NCT02389621|3969125|FG000|NOT COMPLETED|Posttreatment Period||9
3236681|NCT02389621|3969126|FG001|NOT COMPLETED|Posttreatment Period||4
3236682|NCT02389725|3969138|FG000|STARTED|Overall Study||59
3369687|NCT03797872|4101150|FG001|NOT COMPLETED|Overall Study||0
3369688|NCT03799614|4101158|FG000|STARTED|Overall Study||15
3369689|NCT03799614|4101159|FG001|STARTED|Overall Study||15
3369690|NCT03799614|4101158|FG000|COMPLETED|Overall Study||15
3369691|NCT03799614|4101159|FG001|COMPLETED|Overall Study||15
3369692|NCT03799614|4101158|FG000|NOT COMPLETED|Overall Study||0
3369693|NCT03799614|4101159|FG001|NOT COMPLETED|Overall Study||0
3369694|NCT03799484|4101168|FG000|STARTED|Overall Study||14
3369695|NCT03799484|4101168|FG000|COMPLETED|Overall Study||14
3369696|NCT03799484|4101168|FG000|NOT COMPLETED|Overall Study||0
3369697|NCT03796728|4101175|FG000|STARTED|Overall Study||60
3369698|NCT03796728|4101175|FG000|COMPLETED|Overall Study||36
3369699|NCT03796728|4101175|FG000|NOT COMPLETED|Overall Study||24
3369700|NCT03797144|4101181|FG000|STARTED|Enrollment||16
3369701|NCT03797144|4101182|FG001|STARTED|Enrollment||11
3369702|NCT03797144|4101181|FG000|COMPLETED|Enrollment||12
3369703|NCT03797144|4101182|FG001|COMPLETED|Enrollment||10
3369704|NCT03797144|4101181|FG000|NOT COMPLETED|Enrollment||4
3369705|NCT03797144|4101182|FG001|NOT COMPLETED|Enrollment||1
3369706|NCT03797144|4101181|FG000|STARTED|Surgery||12
3369707|NCT03797144|4101182|FG001|STARTED|Surgery||10
3369708|NCT03797144|4101181|FG000|COMPLETED|Surgery||11
3369709|NCT03797144|4101182|FG001|COMPLETED|Surgery||10
3369710|NCT03797144|4101181|FG000|NOT COMPLETED|Surgery||1
3369711|NCT03797144|4101182|FG001|NOT COMPLETED|Surgery||0
3369712|NCT03797144|4101181|FG000|STARTED|3 Month||11
3369713|NCT03797144|4101182|FG001|STARTED|3 Month||10
3369714|NCT03797144|4101181|FG000|COMPLETED|3 Month||9
3369715|NCT03797144|4101182|FG001|COMPLETED|3 Month||10
3369716|NCT03797144|4101181|FG000|NOT COMPLETED|3 Month||2
3369717|NCT03797144|4101182|FG001|NOT COMPLETED|3 Month||0
3369718|NCT03797144|4101181|FG000|STARTED|12 Month||9
3236683|NCT02389725|3969139|FG001|STARTED|Overall Study||60
3236684|NCT02389725|3969138|FG000|COMPLETED|Overall Study||59
3236685|NCT02389725|3969139|FG001|COMPLETED|Overall Study||60
3236686|NCT02389725|3969138|FG000|NOT COMPLETED|Overall Study||0
3369719|NCT03797144|4101182|FG001|STARTED|12 Month||10
3369720|NCT03797144|4101181|FG000|COMPLETED|12 Month||1
3369721|NCT03797144|4101182|FG001|COMPLETED|12 Month||1
3369722|NCT03797144|4101181|FG000|NOT COMPLETED|12 Month||8
3369723|NCT03797144|4101182|FG001|NOT COMPLETED|12 Month||9
3236687|NCT02389725|3969139|FG001|NOT COMPLETED|Overall Study||0
3236688|NCT02389738|3969147|FG000|STARTED|Overall Study||6
3236689|NCT02389738|3969147|FG000|COMPLETED|Overall Study||5
3236690|NCT02389738|3969147|FG000|NOT COMPLETED|Overall Study||1
3236691|NCT02389764|3969151|FG000|STARTED|Overall Study||9
3236692|NCT02389764|3969151|FG000|COMPLETED|Overall Study||0
3236693|NCT02389764|3969151|FG000|NOT COMPLETED|Overall Study||9
3236694|NCT02389816|3969158|FG000|STARTED|Overall Study||164
3236695|NCT02389816|3969159|FG001|STARTED|Overall Study||165
3236696|NCT02389816|3969160|FG002|STARTED|Overall Study||164
3236697|NCT02389816|3969158|FG000|COMPLETED|Overall Study||149
3236698|NCT02389816|3969159|FG001|COMPLETED|Overall Study||152
3236699|NCT02389816|3969160|FG002|COMPLETED|Overall Study||152
3236700|NCT02389816|3969158|FG000|NOT COMPLETED|Overall Study||15
3236701|NCT02389816|3969159|FG001|NOT COMPLETED|Overall Study||13
3236702|NCT02389816|3969160|FG002|NOT COMPLETED|Overall Study||12
3236703|NCT02389829|3969170|FG000|STARTED|Overall Study||64
3236704|NCT02389829|3969171|FG001|STARTED|Overall Study||63
3236705|NCT02389829|3969170|FG000|COMPLETED|Overall Study||64
3236706|NCT02389829|3969171|FG001|COMPLETED|Overall Study||62
3236707|NCT02389829|3969170|FG000|NOT COMPLETED|Overall Study||0
3236708|NCT02389829|3969171|FG001|NOT COMPLETED|Overall Study||1
3236709|NCT02389881|3969184|FG000|STARTED|Overall Study||6
3236710|NCT02389881|3969185|FG001|STARTED|Overall Study||6
3236711|NCT02389881|3969186|FG002|STARTED|Overall Study||6
3236712|NCT02389881|3969187|FG003|STARTED|Overall Study||6
3236713|NCT02389881|3969188|FG004|STARTED|Overall Study||6
3236714|NCT02389881|3969189|FG005|STARTED|Overall Study||8
3236715|NCT02389881|3969190|FG006|STARTED|Overall Study||2
3236716|NCT02389881|3969184|FG000|COMPLETED|Overall Study||6
3236717|NCT02389881|3969185|FG001|COMPLETED|Overall Study||6
3236718|NCT02389881|3969186|FG002|COMPLETED|Overall Study||6
3236719|NCT02389881|3969187|FG003|COMPLETED|Overall Study||6
3236720|NCT02389881|3969188|FG004|COMPLETED|Overall Study||6
3236721|NCT02389881|3969189|FG005|COMPLETED|Overall Study||8
3236722|NCT02389881|3969190|FG006|COMPLETED|Overall Study||2
3236723|NCT02389881|3969184|FG000|NOT COMPLETED|Overall Study||0
3236724|NCT02389881|3969185|FG001|NOT COMPLETED|Overall Study||0
3236725|NCT02389881|3969186|FG002|NOT COMPLETED|Overall Study||0
3236726|NCT02389881|3969187|FG003|NOT COMPLETED|Overall Study||0
3236727|NCT02389881|3969188|FG004|NOT COMPLETED|Overall Study||0
3236728|NCT02389881|3969189|FG005|NOT COMPLETED|Overall Study||0
3236729|NCT02389881|3969190|FG006|NOT COMPLETED|Overall Study||0
3236730|NCT02389894|3969209|FG000|STARTED|Overall Study||133
3236731|NCT02389894|3969210|FG001|STARTED|Overall Study||118
3236732|NCT02389894|3969211|FG002|STARTED|Overall Study||132
3236733|NCT02389894|3969209|FG000|COMPLETED|Overall Study||125
3236734|NCT02389894|3969210|FG001|COMPLETED|Overall Study||108
3236735|NCT02389894|3969211|FG002|COMPLETED|Overall Study||123
3236736|NCT02389894|3969209|FG000|NOT COMPLETED|Overall Study||8
3236737|NCT02389894|3969210|FG001|NOT COMPLETED|Overall Study||10
3236738|NCT02389894|3969211|FG002|NOT COMPLETED|Overall Study||9
3236739|NCT02389946|3969221|FG000|STARTED|Overall Study||884
3236740|NCT02389946|3969222|FG001|STARTED|Overall Study||450
3236741|NCT02389946|3969221|FG000|COMPLETED|Overall Study||860
3236742|NCT02389946|3969222|FG001|COMPLETED|Overall Study||435
3236743|NCT02389946|3969221|FG000|NOT COMPLETED|Overall Study||24
3236744|NCT02389946|3969222|FG001|NOT COMPLETED|Overall Study||15
3236745|NCT02389959|3969230|FG000|STARTED|Overall Study||20
3236746|NCT02389959|3969231|FG001|STARTED|Overall Study||20
3236747|NCT02389959|3969230|FG000|COMPLETED|Overall Study||18
3236748|NCT02389959|3969231|FG001|COMPLETED|Overall Study||19
3236749|NCT02389959|3969230|FG000|NOT COMPLETED|Overall Study||2
3236750|NCT02389959|3969231|FG001|NOT COMPLETED|Overall Study||1
3236751|NCT02389998|3969239|FG000|STARTED|Overall Study||16
3236752|NCT02389998|3969240|FG001|STARTED|Overall Study||15
3236753|NCT02389998|3969239|FG000|COMPLETED|Overall Study||15
3236754|NCT02389998|3969240|FG001|COMPLETED|Overall Study||15
3236755|NCT02389998|3969239|FG000|NOT COMPLETED|Overall Study||1
3236756|NCT02389998|3969240|FG001|NOT COMPLETED|Overall Study||0
3236757|NCT02390050|3969252|FG000|STARTED|Overall Study||72
3236758|NCT02390050|3969253|FG001|STARTED|Overall Study||72
3236759|NCT02390050|3969254|FG002|STARTED|Overall Study||72
3236760|NCT02390050|3969255|FG003|STARTED|Overall Study||76
3236761|NCT02390050|3969252|FG000|COMPLETED|Overall Study||65
3236762|NCT02390050|3969253|FG001|COMPLETED|Overall Study||67
3236763|NCT02390050|3969254|FG002|COMPLETED|Overall Study||68
3236764|NCT02390050|3969255|FG003|COMPLETED|Overall Study||69
3236765|NCT02390050|3969252|FG000|NOT COMPLETED|Overall Study||7
3236766|NCT02390050|3969253|FG001|NOT COMPLETED|Overall Study||5
3236767|NCT02390050|3969254|FG002|NOT COMPLETED|Overall Study||4
3236768|NCT02390050|3969255|FG003|NOT COMPLETED|Overall Study||7
3236769|NCT02390076|3969268|FG000|STARTED|Overall Study||18
3236770|NCT02390076|3969269|FG001|STARTED|Overall Study||18
3236771|NCT02390076|3969270|FG002|STARTED|Overall Study||15
3236772|NCT02390076|3969268|FG000|COMPLETED|Overall Study||16
3236773|NCT02390076|3969269|FG001|COMPLETED|Overall Study||17
3236774|NCT02390076|3969270|FG002|COMPLETED|Overall Study||11
3236775|NCT02390076|3969268|FG000|NOT COMPLETED|Overall Study||2
3236776|NCT02390076|3969269|FG001|NOT COMPLETED|Overall Study||1
3236777|NCT02390076|3969270|FG002|NOT COMPLETED|Overall Study||4
3236778|NCT02390167|3969278|FG000|STARTED|Overall Study||376
3236779|NCT02390167|3969278|FG000|With Diabetes|Overall Study||333
3236780|NCT02390167|3969278|FG000|Without Diabetes|Overall Study||43
3236781|NCT02390167|3969278|FG000|COMPLETED|Overall Study||375
3236782|NCT02390167|3969278|FG000|NOT COMPLETED|Overall Study||1
3236783|NCT02390219|3969286|FG000|STARTED|Overall Study||46
3236784|NCT02390219|3969286|FG000|COMPLETED|Overall Study||33
3236785|NCT02390219|3969286|FG000|NOT COMPLETED|Overall Study||13
3236786|NCT02390557|3969293|FG000|STARTED|Wave 1||160
3236787|NCT02390557|3969294|FG001|STARTED|Wave 1||156
3236788|NCT02390557|3969295|FG002|STARTED|Wave 1||135
3236789|NCT02390557|3969293|FG000|COMPLETED|Wave 1||160
3236790|NCT02390557|3969294|FG001|COMPLETED|Wave 1||156
3236791|NCT02390557|3969295|FG002|COMPLETED|Wave 1||135
3236792|NCT02390557|3969293|FG000|NOT COMPLETED|Wave 1||0
3236793|NCT02390557|3969294|FG001|NOT COMPLETED|Wave 1||0
3236794|NCT02390557|3969295|FG002|NOT COMPLETED|Wave 1||0
3236795|NCT02390557|3969293|FG000|STARTED|Wave 2||160
3236796|NCT02390557|3969294|FG001|STARTED|Wave 2||156
3236797|NCT02390557|3969295|FG002|STARTED|Wave 2||135
3236798|NCT02390557|3969293|FG000|COMPLETED|Wave 2||88
3236799|NCT02390557|3969294|FG001|COMPLETED|Wave 2||115
3236800|NCT02390557|3969295|FG002|COMPLETED|Wave 2||112
3236801|NCT02390557|3969293|FG000|NOT COMPLETED|Wave 2||72
3236802|NCT02390557|3969294|FG001|NOT COMPLETED|Wave 2||41
3236803|NCT02390557|3969295|FG002|NOT COMPLETED|Wave 2||23
3236804|NCT02390791|3969305|FG000|STARTED|Overall Study||40
3236805|NCT02390791|3969306|FG001|STARTED|Overall Study||45
3236806|NCT02390791|3969305|FG000|COMPLETED|Overall Study||40
3236807|NCT02390791|3969306|FG001|COMPLETED|Overall Study||45
3236808|NCT02390791|3969305|FG000|NOT COMPLETED|Overall Study||0
3236809|NCT02390791|3969306|FG001|NOT COMPLETED|Overall Study||0
3236810|NCT02390908|3969317|FG000|STARTED|Overall Study||40
3236811|NCT02390908|3969318|FG001|STARTED|Overall Study||22
3236812|NCT02390908|3969319|FG002|STARTED|Overall Study||22
3236813|NCT02390908|3969320|FG003|STARTED|Overall Study||90
3236814|NCT02390908|3969321|FG004|STARTED|Overall Study||120
3236815|NCT02390908|3969317|FG000|COMPLETED|Overall Study||40
3236816|NCT02390908|3969318|FG001|COMPLETED|Overall Study||22
3236817|NCT02390908|3969319|FG002|COMPLETED|Overall Study||22
3236818|NCT02390908|3969320|FG003|COMPLETED|Overall Study||90
3236819|NCT02390908|3969321|FG004|COMPLETED|Overall Study||120
3236820|NCT02390908|3969317|FG000|NOT COMPLETED|Overall Study||0
3236821|NCT02390908|3969318|FG001|NOT COMPLETED|Overall Study||0
3236822|NCT02390908|3969319|FG002|NOT COMPLETED|Overall Study||0
3236823|NCT02390908|3969320|FG003|NOT COMPLETED|Overall Study||0
3236824|NCT02390908|3969321|FG004|NOT COMPLETED|Overall Study||0
3236825|NCT02391038|3969338|FG000|STARTED|Overall Study||3
3236826|NCT02391038|3969339|FG001|STARTED|Overall Study||3
3236827|NCT02391038|3969340|FG002|STARTED|Overall Study||6
3236828|NCT02391038|3969338|FG000|COMPLETED|Overall Study||0
3236829|NCT02391038|3969339|FG001|COMPLETED|Overall Study||0
3236830|NCT02391038|3969340|FG002|COMPLETED|Overall Study||0
3236831|NCT02391038|3969338|FG000|NOT COMPLETED|Overall Study||3
3236832|NCT02391038|3969339|FG001|NOT COMPLETED|Overall Study||3
3236833|NCT02391038|3969340|FG002|NOT COMPLETED|Overall Study||6
3236834|NCT02391116|3969349|FG000|STARTED|Treatment||67
3236835|NCT02391116|3969349|FG000|Included in Per Protocol Set|Treatment||40
3236836|NCT02391116|3969349|FG000|COMPLETED|Treatment|Reasons for completion in this period included death (2), PD (50) and lack of efficacy (1)|53
3236837|NCT02391116|3969349|FG000|NOT COMPLETED|Treatment||14
3236838|NCT02391116|3969349|FG000|STARTED|Safety Follow-up|This period excludes 2 deaths on treatment and 9 participants entering active follow-up|56
3236839|NCT02391116|3969349|FG000|COMPLETED|Safety Follow-up|14 participants were considered completed due to death|43
3236840|NCT02391116|3969349|FG000|NOT COMPLETED|Safety Follow-up||13
3236841|NCT02391116|3969349|FG000|STARTED|Active Follow-up|This period incorporates safety follow-up with radiological|9
3236842|NCT02391116|3969349|FG000|COMPLETED|Active Follow-up|Reasons for completion in this period included death (2) and PD (4)|6
3236843|NCT02391116|3969349|FG000|NOT COMPLETED|Active Follow-up||3
3236844|NCT02391116|3969349|FG000|STARTED|Survival Follow-up|21 participants discontinued from treatment didn't enter due to withdrawal by subject (3) and death|46
3236845|NCT02391116|3969349|FG000|COMPLETED|Survival Follow-up|Reason for completed in this period included death (35) and clinical endpoint reached (7)|42
3236846|NCT02391116|3969349|FG000|NOT COMPLETED|Survival Follow-up||4
3236847|NCT02391311|3969362|FG000|STARTED|Overall Study||21
3236848|NCT02391311|3969363|FG001|STARTED|Overall Study||21
3236849|NCT02391311|3969362|FG000|COMPLETED|Overall Study||18
3236850|NCT02391311|3969363|FG001|COMPLETED|Overall Study||19
3236851|NCT02391311|3969362|FG000|NOT COMPLETED|Overall Study||3
3236852|NCT02391311|3969363|FG001|NOT COMPLETED|Overall Study||2
3236853|NCT02391337|3969371|FG000|STARTED|Baseline||80
3236854|NCT02391337|3969372|FG001|STARTED|Baseline||81
3236855|NCT02391337|3969371|FG000|COMPLETED|Baseline||80
3236856|NCT02391337|3969372|FG001|COMPLETED|Baseline||81
3236857|NCT02391337|3969371|FG000|NOT COMPLETED|Baseline||0
3236858|NCT02391337|3969372|FG001|NOT COMPLETED|Baseline||0
3236859|NCT02391337|3969371|FG000|STARTED|6 Months Follow-up||80
3236860|NCT02391337|3969372|FG001|STARTED|6 Months Follow-up||81
3236861|NCT02391337|3969371|FG000|COMPLETED|6 Months Follow-up||74
3236862|NCT02391337|3969372|FG001|COMPLETED|6 Months Follow-up||76
3236863|NCT02391337|3969371|FG000|NOT COMPLETED|6 Months Follow-up||6
3236864|NCT02391337|3969372|FG001|NOT COMPLETED|6 Months Follow-up||5
3236865|NCT02391337|3969371|FG000|STARTED|12 Months Follow-up||74
3236866|NCT02391337|3969372|FG001|STARTED|12 Months Follow-up||76
3236867|NCT02391337|3969371|FG000|COMPLETED|12 Months Follow-up||72
3236868|NCT02391337|3969372|FG001|COMPLETED|12 Months Follow-up||73
3236869|NCT02391337|3969371|FG000|NOT COMPLETED|12 Months Follow-up||2
3236870|NCT02391337|3969372|FG001|NOT COMPLETED|12 Months Follow-up||3
3236871|NCT02391350|3969380|FG000|STARTED|Overall Study||110
3236872|NCT02391350|3969381|FG001|STARTED|Overall Study||110
3236873|NCT02391350|3969380|FG000|4-week Follow-up|Overall Study||106
3236874|NCT02391350|3969381|FG001|4-week Follow-up|Overall Study||105
3236875|NCT02391350|3969380|FG000|6-month Follow-up|Overall Study||100
3236876|NCT02391350|3969381|FG001|6-month Follow-up|Overall Study||96
3236877|NCT02391350|3969380|FG000|COMPLETED|Overall Study||98
3236878|NCT02391350|3969381|FG001|COMPLETED|Overall Study||93
3236879|NCT02391350|3969380|FG000|NOT COMPLETED|Overall Study||12
3236880|NCT02391350|3969381|FG001|NOT COMPLETED|Overall Study||17
3236881|NCT02391363|3969389|FG000|STARTED|Overall Study||70
3236882|NCT02391363|3969390|FG001|STARTED|Overall Study||64
3236883|NCT02391363|3969389|FG000|COMPLETED|Overall Study||59
3236884|NCT02391363|3969390|FG001|COMPLETED|Overall Study||56
3236885|NCT02391363|3969389|FG000|NOT COMPLETED|Overall Study||11
3236886|NCT02391363|3969390|FG001|NOT COMPLETED|Overall Study||8
3236887|NCT02391545|3969398|FG000|STARTED|Overall Study||27
3236888|NCT02391545|3969399|FG001|STARTED|Overall Study||28
3236889|NCT02391545|3969398|FG000|COMPLETED|Overall Study||1
3236890|NCT02391545|3969399|FG001|COMPLETED|Overall Study||0
3236891|NCT02391545|3969398|FG000|NOT COMPLETED|Overall Study||26
3236892|NCT02391545|3969399|FG001|NOT COMPLETED|Overall Study||28
3236893|NCT02391584|3969408|FG000|STARTED|Primary Endpoint (6-weeks)||31
3236894|NCT02391584|3969409|FG001|STARTED|Primary Endpoint (6-weeks)||29
3236895|NCT02391584|3969408|FG000|COMPLETED|Primary Endpoint (6-weeks)||29
3236896|NCT02391584|3969409|FG001|COMPLETED|Primary Endpoint (6-weeks)||27
3236897|NCT02391584|3969408|FG000|NOT COMPLETED|Primary Endpoint (6-weeks)||2
3236898|NCT02391584|3969409|FG001|NOT COMPLETED|Primary Endpoint (6-weeks)||2
3236899|NCT02391584|3969408|FG000|STARTED|3 Month|Includes 30 balloon dilation and 23 crossover participants|53
3236900|NCT02391584|3969409|FG001|STARTED|3 Month|23 Crossover participants are included in balloon dilation arm for remainder of study visits.|0
3236901|NCT02391584|3969408|FG000|COMPLETED|3 Month||52
3236902|NCT02391584|3969409|FG001|COMPLETED|3 Month||0
3236903|NCT02391584|3969408|FG000|NOT COMPLETED|3 Month||1
3236904|NCT02391584|3969409|FG001|NOT COMPLETED|3 Month||0
3236905|NCT02391584|3969408|FG000|STARTED|6 Month||52
3236906|NCT02391584|3969409|FG001|STARTED|6 Month||0
3236907|NCT02391584|3969408|FG000|COMPLETED|6 Month||51
3236908|NCT02391584|3969409|FG001|COMPLETED|6 Month||0
3236909|NCT02391584|3969408|FG000|NOT COMPLETED|6 Month||1
3236910|NCT02391584|3969409|FG001|NOT COMPLETED|6 Month||0
3236911|NCT02391584|3969408|FG000|STARTED|12 Month (End of Study)||51
3236912|NCT02391584|3969409|FG001|STARTED|12 Month (End of Study)||0
3236913|NCT02391584|3969408|FG000|COMPLETED|12 Month (End of Study)||49
3236914|NCT02391584|3969409|FG001|COMPLETED|12 Month (End of Study)||0
3236915|NCT02391584|3969408|FG000|NOT COMPLETED|12 Month (End of Study)||2
3236916|NCT02391584|3969409|FG001|NOT COMPLETED|12 Month (End of Study)||0
3236917|NCT02391701|3969420|FG000|STARTED|Overall Study||367
3236918|NCT02391701|3969421|FG001|STARTED|Overall Study||353
3236919|NCT02391701|3969420|FG000|COMPLETED|Overall Study||346
3236920|NCT02391701|3969421|FG001|COMPLETED|Overall Study||315
3236921|NCT02391701|3969420|FG000|NOT COMPLETED|Overall Study||21
3236922|NCT02391701|3969421|FG001|NOT COMPLETED|Overall Study||38
3236923|NCT02391714|3969429|FG000|STARTED|Overall Study||40
3236924|NCT02391714|3969430|FG001|STARTED|Overall Study||40
3236925|NCT02391714|3969429|FG000|COMPLETED|Overall Study||40
3236926|NCT02391714|3969430|FG001|COMPLETED|Overall Study||40
3236927|NCT02391714|3969429|FG000|NOT COMPLETED|Overall Study||0
3236928|NCT02391714|3969430|FG001|NOT COMPLETED|Overall Study||0
3236929|NCT02391948|3969443|FG000|STARTED|Baseline||227
3236930|NCT02391948|3969444|FG001|STARTED|Baseline||161
3236931|NCT02391948|3969445|FG002|STARTED|Baseline||80
3236932|NCT02391948|3969446|FG003|STARTED|Baseline||129
3236933|NCT02391948|3969447|FG004|STARTED|Baseline||111
3236934|NCT02391948|3969443|FG000|COMPLETED|Baseline||227
3236935|NCT02391948|3969444|FG001|COMPLETED|Baseline||161
3236936|NCT02391948|3969445|FG002|COMPLETED|Baseline||80
3236937|NCT02391948|3969446|FG003|COMPLETED|Baseline||129
3236938|NCT02391948|3969447|FG004|COMPLETED|Baseline||111
3236939|NCT02391948|3969443|FG000|NOT COMPLETED|Baseline||0
3236940|NCT02391948|3969444|FG001|NOT COMPLETED|Baseline||0
3236941|NCT02391948|3969445|FG002|NOT COMPLETED|Baseline||0
3236942|NCT02391948|3969446|FG003|NOT COMPLETED|Baseline||0
3236943|NCT02391948|3969447|FG004|NOT COMPLETED|Baseline||0
3236944|NCT02391948|3969443|FG000|STARTED|6-month Assessment||227
3236945|NCT02391948|3969444|FG001|STARTED|6-month Assessment||161
3236946|NCT02391948|3969445|FG002|STARTED|6-month Assessment||80
3236947|NCT02391948|3969446|FG003|STARTED|6-month Assessment||129
3236948|NCT02391948|3969447|FG004|STARTED|6-month Assessment||111
3236949|NCT02391948|3969443|FG000|COMPLETED|6-month Assessment||148
3236950|NCT02391948|3969444|FG001|COMPLETED|6-month Assessment||105
3236951|NCT02391948|3969445|FG002|COMPLETED|6-month Assessment||49
3236952|NCT02391948|3969446|FG003|COMPLETED|6-month Assessment||84
3236953|NCT02391948|3969447|FG004|COMPLETED|6-month Assessment||85
3236954|NCT02391948|3969443|FG000|NOT COMPLETED|6-month Assessment||79
3236955|NCT02391948|3969444|FG001|NOT COMPLETED|6-month Assessment||56
3236956|NCT02391948|3969445|FG002|NOT COMPLETED|6-month Assessment||31
3236957|NCT02391948|3969446|FG003|NOT COMPLETED|6-month Assessment||45
3236958|NCT02391948|3969447|FG004|NOT COMPLETED|6-month Assessment||26
3369724|NCT03797144|4101181|FG000|STARTED|24 Month||1
3236959|NCT02391948|3969443|FG000|STARTED|12-month Assessment|Started at 12-month is not equal to Completed at 6-month: 77 of the Not Completed remained active.|225
3236960|NCT02391948|3969444|FG001|STARTED|12-month Assessment|Started at 12-month is not equal to Completed at 6-month: 51 of the Not Completed remained active.|156
3236961|NCT02391948|3969445|FG002|STARTED|12-month Assessment|Started at 12-month is not equal to Completed at 6-month: 28 of the Not Completed remained active.|77
3236962|NCT02391948|3969446|FG003|STARTED|12-month Assessment|Started at 12-month is not equal to Completed at 6-month: 41 of the Not Completed remained active.|125
3236963|NCT02391948|3969447|FG004|STARTED|12-month Assessment|Started at 12-month is not equal to Completed at 6-month: 24 of the Not Completed remained active.|109
3236964|NCT02391948|3969443|FG000|COMPLETED|12-month Assessment||217
3236965|NCT02391948|3969444|FG001|COMPLETED|12-month Assessment||147
3236966|NCT02391948|3969445|FG002|COMPLETED|12-month Assessment||73
3236967|NCT02391948|3969446|FG003|COMPLETED|12-month Assessment||116
3236968|NCT02391948|3969447|FG004|COMPLETED|12-month Assessment||103
3236969|NCT02391948|3969443|FG000|NOT COMPLETED|12-month Assessment||8
3236970|NCT02391948|3969444|FG001|NOT COMPLETED|12-month Assessment||9
3236971|NCT02391948|3969445|FG002|NOT COMPLETED|12-month Assessment||4
3236972|NCT02391948|3969446|FG003|NOT COMPLETED|12-month Assessment||9
3236973|NCT02391948|3969447|FG004|NOT COMPLETED|12-month Assessment||6
3236974|NCT02391948|3969443|FG000|STARTED|18-month Assessment|Started at 18-month is not equal to Completed at 12-month: 2 of the Not Completed remained active.|219
3236975|NCT02391948|3969444|FG001|STARTED|18-month Assessment|Started at 18-month is not equal to Completed at 12-month: 4 of the Not Completed remained active.|151
3236976|NCT02391948|3969445|FG002|STARTED|18-month Assessment|Started at 18-month is not equal to Completed at 12-month: 1 of the Not Completed remained active.|74
3236977|NCT02391948|3969446|FG003|STARTED|18-month Assessment|Started at 18-month is not equal to Completed at 12-month: 3 of the Not Completed remained active.|119
3236978|NCT02391948|3969447|FG004|STARTED|18-month Assessment|Started at 18-month is not equal to Completed at 12-month: 2 of the Not Completed remained active.|105
3236979|NCT02391948|3969443|FG000|COMPLETED|18-month Assessment||147
3236980|NCT02391948|3969444|FG001|COMPLETED|18-month Assessment||101
3236981|NCT02391948|3969445|FG002|COMPLETED|18-month Assessment||48
3236982|NCT02391948|3969446|FG003|COMPLETED|18-month Assessment||83
3236983|NCT02391948|3969447|FG004|COMPLETED|18-month Assessment||75
3236984|NCT02391948|3969443|FG000|NOT COMPLETED|18-month Assessment||72
3236985|NCT02391948|3969444|FG001|NOT COMPLETED|18-month Assessment||50
3236986|NCT02391948|3969445|FG002|NOT COMPLETED|18-month Assessment||26
3236987|NCT02391948|3969446|FG003|NOT COMPLETED|18-month Assessment||36
3236988|NCT02391948|3969447|FG004|NOT COMPLETED|18-month Assessment||30
3236989|NCT02391948|3969443|FG000|STARTED|24-month Assessment|Started at 24-month is not equal to Completed at 18-month: 2 of the Not Completed remained active.|149
3236990|NCT02391948|3969444|FG001|STARTED|24-month Assessment|Started at 24-month is not equal to Completed at 18-month: 6 of the Not Completed remained active.|107
3236991|NCT02391948|3969445|FG002|STARTED|24-month Assessment|Started at 24-month is not equal to Completed at 18-month: 3 of the Not Completed remained active.|51
3236992|NCT02391948|3969446|FG003|STARTED|24-month Assessment|Started at 24-month is not equal to Completed at 18-month: 1 of the Not Completed remained active.|84
3236993|NCT02391948|3969447|FG004|STARTED|24-month Assessment|Started at 24-month is not equal to Completed at 18-month: 4 of the Not Completed remained active.|79
3236994|NCT02391948|3969443|FG000|COMPLETED|24-month Assessment||135
3236995|NCT02391948|3969444|FG001|COMPLETED|24-month Assessment||97
3236996|NCT02391948|3969445|FG002|COMPLETED|24-month Assessment||48
3236997|NCT02391948|3969446|FG003|COMPLETED|24-month Assessment||75
3236998|NCT02391948|3969447|FG004|COMPLETED|24-month Assessment||69
3236999|NCT02391948|3969443|FG000|NOT COMPLETED|24-month Assessment||14
3237000|NCT02391948|3969444|FG001|NOT COMPLETED|24-month Assessment||10
3237001|NCT02391948|3969445|FG002|NOT COMPLETED|24-month Assessment||3
3237002|NCT02391948|3969446|FG003|NOT COMPLETED|24-month Assessment||9
3237003|NCT02391948|3969447|FG004|NOT COMPLETED|24-month Assessment||10
3237004|NCT02391961|3969464|FG000|STARTED|First Intervention (4 Weeks)||10
3237005|NCT02391961|3969465|FG001|STARTED|First Intervention (4 Weeks)||9
3237006|NCT02391961|3969464|FG000|COMPLETED|First Intervention (4 Weeks)||8
3237007|NCT02391961|3969465|FG001|COMPLETED|First Intervention (4 Weeks)||9
3237008|NCT02391961|3969464|FG000|NOT COMPLETED|First Intervention (4 Weeks)||2
3237009|NCT02391961|3969465|FG001|NOT COMPLETED|First Intervention (4 Weeks)||0
3237010|NCT02391961|3969464|FG000|STARTED|Washout (2 Weeks)||8
3237011|NCT02391961|3969465|FG001|STARTED|Washout (2 Weeks)||9
3237012|NCT02391961|3969464|FG000|COMPLETED|Washout (2 Weeks)||7
3237013|NCT02391961|3969465|FG001|COMPLETED|Washout (2 Weeks)||8
3237014|NCT02391961|3969464|FG000|NOT COMPLETED|Washout (2 Weeks)||1
3237015|NCT02391961|3969465|FG001|NOT COMPLETED|Washout (2 Weeks)||1
3237016|NCT02391961|3969464|FG000|STARTED|Second Intervention (4 Weeks)||7
3237017|NCT02391961|3969465|FG001|STARTED|Second Intervention (4 Weeks)||8
3237018|NCT02391961|3969464|FG000|COMPLETED|Second Intervention (4 Weeks)||6
3237019|NCT02391961|3969465|FG001|COMPLETED|Second Intervention (4 Weeks)||7
3237020|NCT02391961|3969464|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||1
3237021|NCT02391961|3969465|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||1
3237022|NCT02391987|3969473|FG000|STARTED|Overall Study||54
3237023|NCT02391987|3969474|FG001|STARTED|Overall Study||58
3237024|NCT02391987|3969473|FG000|COMPLETED|Overall Study||54
3369725|NCT03797144|4101182|FG001|STARTED|24 Month||1
3237025|NCT02391987|3969474|FG001|COMPLETED|Overall Study||58
3237026|NCT02391987|3969473|FG000|NOT COMPLETED|Overall Study||0
3237027|NCT02391987|3969474|FG001|NOT COMPLETED|Overall Study||0
3237028|NCT02392000|3969480|FG000|STARTED|Overall Study||38
3237029|NCT02392000|3969480|FG000|COMPLETED|Overall Study||11
3237030|NCT02392000|3969480|FG000|NOT COMPLETED|Overall Study||27
3237031|NCT02392104|3969485|FG000|STARTED|Overall Study|one participant enrolled but was removed prior to starting study protocol|50
3237032|NCT02392104|3969485|FG000|COMPLETED|Overall Study||39
3237033|NCT02392104|3969485|FG000|NOT COMPLETED|Overall Study||11
3237034|NCT02392195|3969489|FG000|STARTED|Overall Study||10
3237035|NCT02392195|3969489|FG000|COMPLETED|Overall Study||2
3237036|NCT02392195|3969489|FG000|NOT COMPLETED|Overall Study||8
3237037|NCT02392208|3969493|FG000|STARTED|Telavancin Before Hemodialysis||8
3237038|NCT02392208|3969493|FG000|COMPLETED|Telavancin Before Hemodialysis||8
3237039|NCT02392208|3969493|FG000|NOT COMPLETED|Telavancin Before Hemodialysis||0
3237040|NCT02392208|3969493|FG000|STARTED|Telavancin After Hemodialysis||8
3237041|NCT02392208|3969493|FG000|COMPLETED|Telavancin After Hemodialysis||8
3237042|NCT02392208|3969493|FG000|NOT COMPLETED|Telavancin After Hemodialysis||0
3237043|NCT02392234|3969504|FG000|STARTED|Treatment Period 1 (8 Weeks)||41
3237044|NCT02392234|3969505|FG001|STARTED|Treatment Period 1 (8 Weeks)||43
3237045|NCT02392234|3969506|FG002|STARTED|Treatment Period 1 (8 Weeks)||40
3237046|NCT02392234|3969507|FG003|STARTED|Treatment Period 1 (8 Weeks)||42
3237047|NCT02392234|3969508|FG004|STARTED|Treatment Period 1 (8 Weeks)||41
3237048|NCT02392234|3969509|FG005|STARTED|Treatment Period 1 (8 Weeks)||41
3237049|NCT02392234|3969504|FG000|Treated|Treatment Period 1 (8 Weeks)||41
3237050|NCT02392234|3969505|FG001|Treated|Treatment Period 1 (8 Weeks)||43
3237051|NCT02392234|3969506|FG002|Treated|Treatment Period 1 (8 Weeks)||39
3237052|NCT02392234|3969507|FG003|Treated|Treatment Period 1 (8 Weeks)||42
3237053|NCT02392234|3969508|FG004|Treated|Treatment Period 1 (8 Weeks)||40
3237054|NCT02392234|3969509|FG005|Treated|Treatment Period 1 (8 Weeks)||41
3237055|NCT02392234|3969504|FG000|COMPLETED|Treatment Period 1 (8 Weeks)||38
3237056|NCT02392234|3969505|FG001|COMPLETED|Treatment Period 1 (8 Weeks)||43
3237057|NCT02392234|3969506|FG002|COMPLETED|Treatment Period 1 (8 Weeks)||38
3237058|NCT02392234|3969507|FG003|COMPLETED|Treatment Period 1 (8 Weeks)||41
3237059|NCT02392234|3969508|FG004|COMPLETED|Treatment Period 1 (8 Weeks)||37
3237060|NCT02392234|3969509|FG005|COMPLETED|Treatment Period 1 (8 Weeks)||38
3237061|NCT02392234|3969504|FG000|NOT COMPLETED|Treatment Period 1 (8 Weeks)||3
3237062|NCT02392234|3969505|FG001|NOT COMPLETED|Treatment Period 1 (8 Weeks)||0
3237063|NCT02392234|3969506|FG002|NOT COMPLETED|Treatment Period 1 (8 Weeks)||2
3237064|NCT02392234|3969507|FG003|NOT COMPLETED|Treatment Period 1 (8 Weeks)||1
3237065|NCT02392234|3969508|FG004|NOT COMPLETED|Treatment Period 1 (8 Weeks)||4
3237066|NCT02392234|3969509|FG005|NOT COMPLETED|Treatment Period 1 (8 Weeks)||3
3237067|NCT02392234|3969504|FG000|STARTED|Treatment Period 2 (8 Weeks)||38
3237068|NCT02392234|3969505|FG001|STARTED|Treatment Period 2 (8 Weeks)||43
3237069|NCT02392234|3969506|FG002|STARTED|Treatment Period 2 (8 Weeks)||38
3237070|NCT02392234|3969507|FG003|STARTED|Treatment Period 2 (8 Weeks)||41
3237071|NCT02392234|3969508|FG004|STARTED|Treatment Period 2 (8 Weeks)||37
3237072|NCT02392234|3969509|FG005|STARTED|Treatment Period 2 (8 Weeks)||38
3237073|NCT02392234|3969504|FG000|COMPLETED|Treatment Period 2 (8 Weeks)||37
3237074|NCT02392234|3969505|FG001|COMPLETED|Treatment Period 2 (8 Weeks)||43
3237075|NCT02392234|3969506|FG002|COMPLETED|Treatment Period 2 (8 Weeks)||38
3237076|NCT02392234|3969507|FG003|COMPLETED|Treatment Period 2 (8 Weeks)||41
3237077|NCT02392234|3969508|FG004|COMPLETED|Treatment Period 2 (8 Weeks)||37
3237078|NCT02392234|3969509|FG005|COMPLETED|Treatment Period 2 (8 Weeks)||38
3237079|NCT02392234|3969504|FG000|NOT COMPLETED|Treatment Period 2 (8 Weeks)||1
3237080|NCT02392234|3969505|FG001|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0
3237081|NCT02392234|3969506|FG002|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0
3237082|NCT02392234|3969507|FG003|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0
3237083|NCT02392234|3969508|FG004|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0
3237084|NCT02392234|3969509|FG005|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0
3237085|NCT02392247|3969520|FG000|STARTED|Overall Study||52
3237086|NCT02392247|3969520|FG000|COMPLETED|Overall Study||50
3237087|NCT02392247|3969520|FG000|NOT COMPLETED|Overall Study||2
3237088|NCT02392286|3969526|FG000|STARTED|Overall Study||7
3237089|NCT02392286|3969527|FG001|STARTED|Overall Study||8
3237090|NCT02392286|3969526|FG000|COMPLETED|Overall Study||4
3237091|NCT02392286|3969527|FG001|COMPLETED|Overall Study||6
3237092|NCT02392286|3969526|FG000|NOT COMPLETED|Overall Study||3
3237093|NCT02392286|3969527|FG001|NOT COMPLETED|Overall Study||2
3237094|NCT02392351|3969535|FG000|STARTED|Overall Study||34
3237095|NCT02392351|3969536|FG001|STARTED|Overall Study||17
3237096|NCT02392351|3969535|FG000|COMPLETED|Overall Study|Primary endpoint: only observational results available.|0
3237097|NCT02392351|3969536|FG001|COMPLETED|Overall Study|Primary endpoint: only observational results available.|0
3237098|NCT02392351|3969535|FG000|NOT COMPLETED|Overall Study||34
3237099|NCT02392351|3969536|FG001|NOT COMPLETED|Overall Study||17
3237100|NCT02392403|3969542|FG000|STARTED|Overall Study||45
3237101|NCT02392403|3969542|FG000|COMPLETED|Overall Study||42
3237102|NCT02392403|3969542|FG000|NOT COMPLETED|Overall Study||3
3237103|NCT02392481|3969550|FG000|STARTED|Overall Study||10
3237104|NCT02392481|3969551|FG001|STARTED|Overall Study||12
3237105|NCT02392481|3969552|FG002|STARTED|Overall Study||20
3237106|NCT02392481|3969553|FG003|STARTED|Overall Study||27
3237107|NCT02392481|3969550|FG000|COMPLETED|Overall Study||10
3237108|NCT02392481|3969551|FG001|COMPLETED|Overall Study||12
3237109|NCT02392481|3969552|FG002|COMPLETED|Overall Study||18
3237110|NCT02392481|3969553|FG003|COMPLETED|Overall Study||25
3237111|NCT02392481|3969550|FG000|NOT COMPLETED|Overall Study||0
3237112|NCT02392481|3969551|FG001|NOT COMPLETED|Overall Study||0
3237113|NCT02392481|3969552|FG002|NOT COMPLETED|Overall Study||2
3237114|NCT02392481|3969553|FG003|NOT COMPLETED|Overall Study||2
3237115|NCT02392494|3969566|FG000|STARTED|Overall Study||3
3237116|NCT02392494|3969567|FG001|STARTED|Overall Study||3
3237117|NCT02392494|3969568|FG002|STARTED|Overall Study||3
3237118|NCT02392494|3969569|FG003|STARTED|Overall Study||0
3237119|NCT02392494|3969566|FG000|COMPLETED|Overall Study||3
3237120|NCT02392494|3969567|FG001|COMPLETED|Overall Study||3
3237121|NCT02392494|3969568|FG002|COMPLETED|Overall Study||3
3237122|NCT02392494|3969569|FG003|COMPLETED|Overall Study||0
3237123|NCT02392494|3969566|FG000|NOT COMPLETED|Overall Study||0
3237124|NCT02392494|3969567|FG001|NOT COMPLETED|Overall Study||0
3237125|NCT02392494|3969568|FG002|NOT COMPLETED|Overall Study||0
3237126|NCT02392494|3969569|FG003|NOT COMPLETED|Overall Study||0
3237127|NCT02392507|3969577|FG000|STARTED|Induction Regimen||54
3237128|NCT02392507|3969577|FG000|Received at Least 1 Dose of Study Drug|Induction Regimen||54
3237129|NCT02392507|3969577|FG000|COMPLETED|Induction Regimen||47
3237130|NCT02392507|3969577|FG000|NOT COMPLETED|Induction Regimen||7
3237131|NCT02392507|3969577|FG000|STARTED|Maintenance Regimen|After induction regimen participants with disease response are eligible for maintenance regimen.|34
3237132|NCT02392507|3969577|FG000|COMPLETED|Maintenance Regimen||32
3237133|NCT02392507|3969577|FG000|NOT COMPLETED|Maintenance Regimen||2
3237134|NCT02392559|3969588|FG000|STARTED|Overall Study||53
3237135|NCT02392559|3969589|FG001|STARTED|Overall Study||105
3237136|NCT02392559|3969588|FG000|Randomized and Dosed|Overall Study||53
3237137|NCT02392559|3969589|FG001|Randomized and Dosed|Overall Study||104
3237138|NCT02392559|3969588|FG000|COMPLETED|Overall Study||53
3237139|NCT02392559|3969589|FG001|COMPLETED|Overall Study||104
3237140|NCT02392559|3969588|FG000|NOT COMPLETED|Overall Study||0
3237141|NCT02392559|3969589|FG001|NOT COMPLETED|Overall Study||1
3237142|NCT02392611|3969605|FG000|STARTED|Overall Study||2
3237143|NCT02392611|3969606|FG001|STARTED|Overall Study||1
3237144|NCT02392611|3969607|FG002|STARTED|Overall Study||1
3237145|NCT02392611|3969608|FG003|STARTED|Overall Study||9
3237146|NCT02392611|3969609|FG004|STARTED|Overall Study||6
3237147|NCT02392611|3969610|FG005|STARTED|Overall Study||4
3237148|NCT02392611|3969611|FG006|STARTED|Overall Study||4
3237149|NCT02392611|3969612|FG007|STARTED|Overall Study||3
3237150|NCT02392611|3969613|FG008|STARTED|Overall Study||3
3237151|NCT02392611|3969605|FG000|COMPLETED|Overall Study||1
3237152|NCT02392611|3969606|FG001|COMPLETED|Overall Study||1
3237153|NCT02392611|3969607|FG002|COMPLETED|Overall Study||1
3237154|NCT02392611|3969608|FG003|COMPLETED|Overall Study||3
3237155|NCT02392611|3969609|FG004|COMPLETED|Overall Study||5
3237156|NCT02392611|3969610|FG005|COMPLETED|Overall Study||3
3237157|NCT02392611|3969611|FG006|COMPLETED|Overall Study||3
3237158|NCT02392611|3969612|FG007|COMPLETED|Overall Study||3
3237159|NCT02392611|3969613|FG008|COMPLETED|Overall Study||3
3237160|NCT02392611|3969605|FG000|NOT COMPLETED|Overall Study||1
3237161|NCT02392611|3969606|FG001|NOT COMPLETED|Overall Study||0
3237162|NCT02392611|3969607|FG002|NOT COMPLETED|Overall Study||0
3237163|NCT02392611|3969608|FG003|NOT COMPLETED|Overall Study||6
3237164|NCT02392611|3969609|FG004|NOT COMPLETED|Overall Study||1
3237165|NCT02392611|3969610|FG005|NOT COMPLETED|Overall Study||1
3237166|NCT02392611|3969611|FG006|NOT COMPLETED|Overall Study||1
3237167|NCT02392611|3969612|FG007|NOT COMPLETED|Overall Study||0
3237168|NCT02392611|3969613|FG008|NOT COMPLETED|Overall Study||0
3237169|NCT02392624|3969636|FG000|STARTED|Overall Study||71
3237170|NCT02392624|3969637|FG001|STARTED|Overall Study||81
3237171|NCT02392624|3969638|FG002|STARTED|Overall Study||53
3237172|NCT02392624|3969636|FG000|COMPLETED|Overall Study||0
3237173|NCT02392624|3969637|FG001|COMPLETED|Overall Study||66
3237174|NCT02392624|3969638|FG002|COMPLETED|Overall Study||40
3237175|NCT02392624|3969636|FG000|NOT COMPLETED|Overall Study||71
3237176|NCT02392624|3969637|FG001|NOT COMPLETED|Overall Study||15
3237177|NCT02392624|3969638|FG002|NOT COMPLETED|Overall Study||13
3237178|NCT02392767|3969648|FG000|STARTED|Overall Study||12
3237179|NCT02392767|3969649|FG001|STARTED|Overall Study||13
3237180|NCT02392767|3969648|FG000|COMPLETED|Overall Study||12
3237181|NCT02392767|3969649|FG001|COMPLETED|Overall Study||13
3237182|NCT02392767|3969648|FG000|NOT COMPLETED|Overall Study||0
3237183|NCT02392767|3969649|FG001|NOT COMPLETED|Overall Study||0
3237184|NCT02392806|3969659|FG000|STARTED|Overall Study||22
3237185|NCT02392806|3969660|FG001|STARTED|Overall Study||21
3237186|NCT02392806|3969659|FG000|COMPLETED|Overall Study||22
3237187|NCT02392806|3969660|FG001|COMPLETED|Overall Study||21
3237188|NCT02392806|3969659|FG000|NOT COMPLETED|Overall Study||0
3237189|NCT02392806|3969660|FG001|NOT COMPLETED|Overall Study||0
3237190|NCT02393209|3969668|FG000|STARTED|Overall Study||6
3237191|NCT02393209|3969669|FG001|STARTED|Overall Study||8
3237192|NCT02393209|3969670|FG002|STARTED|Overall Study||0
3237193|NCT02393209|3969671|FG003|STARTED|Overall Study||0
3237194|NCT02393209|3969668|FG000|COMPLETED|Overall Study||0
3237195|NCT02393209|3969669|FG001|COMPLETED|Overall Study||0
3237196|NCT02393209|3969670|FG002|COMPLETED|Overall Study||0
3237197|NCT02393209|3969671|FG003|COMPLETED|Overall Study||0
3237198|NCT02393209|3969668|FG000|NOT COMPLETED|Overall Study||6
3237199|NCT02393209|3969669|FG001|NOT COMPLETED|Overall Study||8
3237200|NCT02393209|3969670|FG002|NOT COMPLETED|Overall Study||0
3237201|NCT02393209|3969671|FG003|NOT COMPLETED|Overall Study||0
3237202|NCT02393339|3969682|FG000|STARTED|Overall Study||58
3237203|NCT02393339|3969683|FG001|STARTED|Overall Study||56
3237204|NCT02393339|3969682|FG000|COMPLETED|Overall Study||51
3237205|NCT02393339|3969683|FG001|COMPLETED|Overall Study||51
3237206|NCT02393339|3969682|FG000|NOT COMPLETED|Overall Study||7
3237207|NCT02393339|3969683|FG001|NOT COMPLETED|Overall Study||5
3237208|NCT02393378|3969691|FG000|STARTED|Overall Study||3
3237209|NCT02393378|3969692|FG001|STARTED|Overall Study||4
3237210|NCT02393378|3969691|FG000|COMPLETED|Overall Study||3
3237211|NCT02393378|3969692|FG001|COMPLETED|Overall Study||4
3237212|NCT02393378|3969691|FG000|NOT COMPLETED|Overall Study||0
3237213|NCT02393378|3969692|FG001|NOT COMPLETED|Overall Study||0
3237214|NCT02393417|3969702|FG000|STARTED|Overall Study||43
3237215|NCT02393417|3969703|FG001|STARTED|Overall Study||45
3237216|NCT02393417|3969704|FG002|STARTED|Overall Study||40
3237217|NCT02393417|3969705|FG003|STARTED|Overall Study||41
3237218|NCT02393417|3969702|FG000|Completed Treatment|Overall Study||30
3237219|NCT02393417|3969703|FG001|Completed Treatment|Overall Study||34
3237220|NCT02393417|3969704|FG002|Completed Treatment|Overall Study||32
3237221|NCT02393417|3969705|FG003|Completed Treatment|Overall Study||30
3237222|NCT02393417|3969702|FG000|COMPLETED|Overall Study||28
3237223|NCT02393417|3969703|FG001|COMPLETED|Overall Study||32
3237224|NCT02393417|3969704|FG002|COMPLETED|Overall Study||30
3237225|NCT02393417|3969705|FG003|COMPLETED|Overall Study||29
3237226|NCT02393417|3969702|FG000|NOT COMPLETED|Overall Study||15
3237227|NCT02393417|3969703|FG001|NOT COMPLETED|Overall Study||13
3237228|NCT02393417|3969704|FG002|NOT COMPLETED|Overall Study||10
3237229|NCT02393417|3969705|FG003|NOT COMPLETED|Overall Study||12
3237230|NCT02393547|3969716|FG000|STARTED|Overall Study||20
3237231|NCT02393547|3969716|FG000|COMPLETED|Overall Study||14
3237232|NCT02393547|3969716|FG000|NOT COMPLETED|Overall Study||6
3237233|NCT02393677|3969722|FG000|STARTED|Overall Study||40
3237234|NCT02393677|3969723|FG001|STARTED|Overall Study||40
3237235|NCT02393677|3969722|FG000|COMPLETED|Overall Study||40
3237236|NCT02393677|3969723|FG001|COMPLETED|Overall Study||40
3237237|NCT02393677|3969722|FG000|NOT COMPLETED|Overall Study||0
3237238|NCT02393677|3969723|FG001|NOT COMPLETED|Overall Study||0
3237239|NCT02393690|3969731|FG000|STARTED|Overall Study||29
3237240|NCT02393690|3969732|FG001|STARTED|Overall Study||31
3237241|NCT02393690|3969731|FG000|COMPLETED|Overall Study||29
3237242|NCT02393690|3969732|FG001|COMPLETED|Overall Study||31
3237243|NCT02393690|3969731|FG000|NOT COMPLETED|Overall Study||0
3237244|NCT02393690|3969732|FG001|NOT COMPLETED|Overall Study||0
3237245|NCT02393755|3969740|FG000|STARTED|Overall Study||3
3237246|NCT02393755|3969741|FG001|STARTED|Overall Study||39
3237247|NCT02393755|3969740|FG000|COMPLETED|Overall Study||3
3237248|NCT02393755|3969741|FG001|COMPLETED|Overall Study||32
3237249|NCT02393755|3969740|FG000|NOT COMPLETED|Overall Study||0
3237250|NCT02393755|3969741|FG001|NOT COMPLETED|Overall Study||7
3237251|NCT02393950|3969748|FG000|STARTED|Overall Study||9
3237252|NCT02393950|3969749|FG001|STARTED|Overall Study||9
3237253|NCT02393950|3969748|FG000|Period 1|Overall Study|6 subjects ODM-106 Capsule B 2 mg and 2 subjects on placebo|8
3237254|NCT02393950|3969749|FG001|Period 1|Overall Study|6 subjects ODM-106 Capsule B 100 mg (1 x 100mg) and 2 subjects on placebo|8
3237255|NCT02393950|3969748|FG000|Period 2|Overall Study|6 subjects ODM-106 Capsule B 10 mg and 2 subjects on placebo|8
3237256|NCT02393950|3969749|FG001|Period 2|Overall Study|6 subjects ODM-106 Capsule B 100 mg (10 x 10mg) and 2 subjects on placebo|8
3237257|NCT02393950|3969748|FG000|Period 3|Overall Study|6 subjects ODM-106 Capsule B 25 mg and 2 subjects on placebo|8
3237258|NCT02393950|3969749|FG001|Period 3|Overall Study|6 subjects ODM-106 Capsule B 200 mg (20 x 10mg) and 2 subjects on placebo|8
3237259|NCT02393950|3969748|FG000|Period 4|Overall Study|6 subjects ODM-106 Capsule B 50 mg and 2 subjects on placebo|8
3237260|NCT02393950|3969749|FG001|Period 4|Overall Study|6 subjects ODM-106 Capsule A 100 mg (10 x 10mg) and 2 subjects on placebo|8
3237261|NCT02393950|3969748|FG000|COMPLETED|Overall Study||8
3237262|NCT02393950|3969749|FG001|COMPLETED|Overall Study||8
3369726|NCT03797144|4101181|FG000|COMPLETED|24 Month||0
3369727|NCT03797144|4101182|FG001|COMPLETED|24 Month||0
3369728|NCT03797144|4101181|FG000|NOT COMPLETED|24 Month||1
3369729|NCT03797144|4101182|FG001|NOT COMPLETED|24 Month||1
3369730|NCT03782571|4101189|FG000|STARTED|Period 1||6
3369731|NCT03782571|4101190|FG001|STARTED|Period 1||6
3369732|NCT03782571|4101191|FG002|STARTED|Period 1||6
3369733|NCT03782571|4101192|FG003|STARTED|Period 1||7
3369734|NCT03782571|4101189|FG000|COMPLETED|Period 1||5
3369735|NCT03782571|4101190|FG001|COMPLETED|Period 1||6
3369736|NCT03782571|4101191|FG002|COMPLETED|Period 1||6
3369737|NCT03782571|4101192|FG003|COMPLETED|Period 1||7
3369738|NCT03782571|4101189|FG000|NOT COMPLETED|Period 1||1
3369739|NCT03782571|4101190|FG001|NOT COMPLETED|Period 1||0
3369740|NCT03782571|4101191|FG002|NOT COMPLETED|Period 1||0
3369741|NCT03782571|4101192|FG003|NOT COMPLETED|Period 1||0
3369742|NCT03782571|4101189|FG000|STARTED|Period 2||5
3369743|NCT03782571|4101190|FG001|STARTED|Period 2||6
3369744|NCT03782571|4101191|FG002|STARTED|Period 2||6
3369745|NCT03782571|4101192|FG003|STARTED|Period 2||7
3369746|NCT03782571|4101189|FG000|COMPLETED|Period 2||5
3369747|NCT03782571|4101190|FG001|COMPLETED|Period 2||6
3369748|NCT03782571|4101191|FG002|COMPLETED|Period 2||6
3237263|NCT02393950|3969748|FG000|NOT COMPLETED|Overall Study||1
3237264|NCT02393950|3969749|FG001|NOT COMPLETED|Overall Study||1
3237265|NCT02394275|3969784|FG000|STARTED|Overall Study||140
3237266|NCT02394275|3969784|FG000|Safety Population|Overall Study||133
3237267|NCT02394275|3969784|FG000|Evaluable at 13 Weeks|Overall Study||133
3237268|NCT02394275|3969784|FG000|COMPLETED|Overall Study||111
3237269|NCT02394275|3969784|FG000|NOT COMPLETED|Overall Study||29
3237270|NCT02394340|3969789|FG000|STARTED|Overall Study||20
3237271|NCT02394340|3969789|FG000|Received at Least 1 Dose of Study Drug|Overall Study||20
3237272|NCT02394340|3969789|FG000|COMPLETED|Overall Study||18
3237273|NCT02394340|3969789|FG000|NOT COMPLETED|Overall Study||2
3237274|NCT02394457|3969795|FG000|STARTED|Overall Study||15
3237275|NCT02394457|3969796|FG001|STARTED|Overall Study||13
3237276|NCT02394457|3969795|FG000|COMPLETED|Overall Study||15
3237277|NCT02394457|3969796|FG001|COMPLETED|Overall Study||13
3237278|NCT02394457|3969795|FG000|NOT COMPLETED|Overall Study||0
3237279|NCT02394457|3969796|FG001|NOT COMPLETED|Overall Study||0
3237280|NCT02394561|3969804|FG000|STARTED|CORE Phase||185
3237281|NCT02394561|3969805|FG001|STARTED|CORE Phase||246
3237282|NCT02394561|3969804|FG000|Full Analysis Set|CORE Phase||185
3237283|NCT02394561|3969805|FG001|Full Analysis Set|CORE Phase||246
3237284|NCT02394561|3969804|FG000|Safety Set|CORE Phase||185
3237285|NCT02394561|3969805|FG001|Safety Set|CORE Phase||246
3237286|NCT02394561|3969804|FG000|ITT Set|CORE Phase||184
3237287|NCT02394561|3969805|FG001|ITT Set|CORE Phase||246
3237288|NCT02394561|3969804|FG000|COMPLETED|CORE Phase||172
3237289|NCT02394561|3969805|FG001|COMPLETED|CORE Phase||227
3237290|NCT02394561|3969804|FG000|NOT COMPLETED|CORE Phase||13
3237291|NCT02394561|3969805|FG001|NOT COMPLETED|CORE Phase||19
3237292|NCT02394561|3969804|FG000|STARTED|Extension Phase||162
3237293|NCT02394561|3969805|FG001|STARTED|Extension Phase||219
3237294|NCT02394561|3969804|FG000|COMPLETED|Extension Phase||151
3237295|NCT02394561|3969805|FG001|COMPLETED|Extension Phase||207
3237296|NCT02394561|3969804|FG000|NOT COMPLETED|Extension Phase||11
3237297|NCT02394561|3969805|FG001|NOT COMPLETED|Extension Phase||12
3237298|NCT02394600|3969816|FG000|STARTED|Overall Study||47
3237299|NCT02394600|3969817|FG001|STARTED|Overall Study||46
3237300|NCT02394600|3969816|FG000|COMPLETED|Overall Study||43
3237301|NCT02394600|3969817|FG001|COMPLETED|Overall Study||44
3237302|NCT02394600|3969816|FG000|NOT COMPLETED|Overall Study||4
3237303|NCT02394600|3969817|FG001|NOT COMPLETED|Overall Study||2
3237304|NCT02394730|3969825|FG000|STARTED|Overall Study||34
3237305|NCT02394730|3969826|FG001|STARTED|Overall Study||31
3237306|NCT02394730|3969825|FG000|COMPLETED|Overall Study||33
3237307|NCT02394730|3969826|FG001|COMPLETED|Overall Study||30
3237308|NCT02394730|3969825|FG000|NOT COMPLETED|Overall Study||1
3237309|NCT02394730|3969826|FG001|NOT COMPLETED|Overall Study||1
3237310|NCT02394756|3969832|FG000|STARTED|Period 1||7
3237311|NCT02394756|3969833|FG001|STARTED|Period 1||7
3237312|NCT02394756|3969834|FG002|STARTED|Period 1||7
3237313|NCT02394756|3969835|FG003|STARTED|Period 1||7
3237314|NCT02394756|3969836|FG004|STARTED|Period 1||7
3237315|NCT02394756|3969837|FG005|STARTED|Period 1||7
3237316|NCT02394756|3969832|FG000|COMPLETED|Period 1||7
3237317|NCT02394756|3969833|FG001|COMPLETED|Period 1||6
3237318|NCT02394756|3969834|FG002|COMPLETED|Period 1||6
3237319|NCT02394756|3969835|FG003|COMPLETED|Period 1||6
3237320|NCT02394756|3969836|FG004|COMPLETED|Period 1||7
3237321|NCT02394756|3969837|FG005|COMPLETED|Period 1||6
3237322|NCT02394756|3969832|FG000|NOT COMPLETED|Period 1||0
3237323|NCT02394756|3969833|FG001|NOT COMPLETED|Period 1||1
3237324|NCT02394756|3969834|FG002|NOT COMPLETED|Period 1||1
3237325|NCT02394756|3969835|FG003|NOT COMPLETED|Period 1||1
3237326|NCT02394756|3969836|FG004|NOT COMPLETED|Period 1||0
3237327|NCT02394756|3969837|FG005|NOT COMPLETED|Period 1||1
3237328|NCT02394756|3969832|FG000|STARTED|Period 2||7
3237329|NCT02394756|3969833|FG001|STARTED|Period 2||6
3237330|NCT02394756|3969834|FG002|STARTED|Period 2||6
3237331|NCT02394756|3969835|FG003|STARTED|Period 2||6
3237332|NCT02394756|3969836|FG004|STARTED|Period 2||7
3237333|NCT02394756|3969837|FG005|STARTED|Period 2||6
3237334|NCT02394756|3969832|FG000|COMPLETED|Period 2||7
3237335|NCT02394756|3969833|FG001|COMPLETED|Period 2||6
3237336|NCT02394756|3969834|FG002|COMPLETED|Period 2||6
3237337|NCT02394756|3969835|FG003|COMPLETED|Period 2||6
3237338|NCT02394756|3969836|FG004|COMPLETED|Period 2||6
3237339|NCT02394756|3969837|FG005|COMPLETED|Period 2||6
3237340|NCT02394756|3969832|FG000|NOT COMPLETED|Period 2||0
3237341|NCT02394756|3969833|FG001|NOT COMPLETED|Period 2||0
3237342|NCT02394756|3969834|FG002|NOT COMPLETED|Period 2||0
3237343|NCT02394756|3969835|FG003|NOT COMPLETED|Period 2||0
3237344|NCT02394756|3969836|FG004|NOT COMPLETED|Period 2||1
3237345|NCT02394756|3969837|FG005|NOT COMPLETED|Period 2||0
3237346|NCT02394756|3969832|FG000|STARTED|Period 3||7
3237347|NCT02394756|3969833|FG001|STARTED|Period 3||6
3237348|NCT02394756|3969834|FG002|STARTED|Period 3||6
3237349|NCT02394756|3969835|FG003|STARTED|Period 3||6
3237350|NCT02394756|3969836|FG004|STARTED|Period 3||6
3237351|NCT02394756|3969837|FG005|STARTED|Period 3||6
3237352|NCT02394756|3969832|FG000|COMPLETED|Period 3||7
3237353|NCT02394756|3969833|FG001|COMPLETED|Period 3||6
3237354|NCT02394756|3969834|FG002|COMPLETED|Period 3||6
3237355|NCT02394756|3969835|FG003|COMPLETED|Period 3||6
3237356|NCT02394756|3969836|FG004|COMPLETED|Period 3||6
3237357|NCT02394756|3969837|FG005|COMPLETED|Period 3||6
3237358|NCT02394756|3969832|FG000|NOT COMPLETED|Period 3||0
3237359|NCT02394756|3969833|FG001|NOT COMPLETED|Period 3||0
3237360|NCT02394756|3969834|FG002|NOT COMPLETED|Period 3||0
3237361|NCT02394756|3969835|FG003|NOT COMPLETED|Period 3||0
3237362|NCT02394756|3969836|FG004|NOT COMPLETED|Period 3||0
3237363|NCT02394756|3969837|FG005|NOT COMPLETED|Period 3||0
3237364|NCT02394769|3969848|FG000|STARTED|Overall Study||60
3237365|NCT02394769|3969849|FG001|STARTED|Overall Study||60
3237366|NCT02394769|3969850|FG002|STARTED|Overall Study||60
3237367|NCT02394769|3969848|FG000|COMPLETED|Overall Study||58
3237368|NCT02394769|3969849|FG001|COMPLETED|Overall Study||57
3237369|NCT02394769|3969850|FG002|COMPLETED|Overall Study||54
3237370|NCT02394769|3969848|FG000|NOT COMPLETED|Overall Study||2
3237371|NCT02394769|3969849|FG001|NOT COMPLETED|Overall Study||3
3237372|NCT02394769|3969850|FG002|NOT COMPLETED|Overall Study||6
3237373|NCT02394808|3969858|FG000|STARTED|Period 1||25
3237374|NCT02394808|3969859|FG001|STARTED|Period 1||29
3237375|NCT02394808|3969858|FG000|COMPLETED|Period 1||25
3237376|NCT02394808|3969859|FG001|COMPLETED|Period 1||28
3237377|NCT02394808|3969858|FG000|NOT COMPLETED|Period 1||0
3237378|NCT02394808|3969859|FG001|NOT COMPLETED|Period 1||1
3237379|NCT02394808|3969858|FG000|STARTED|Period 2||25
3237380|NCT02394808|3969859|FG001|STARTED|Period 2||28
3237381|NCT02394808|3969858|FG000|COMPLETED|Period 2||24
3237382|NCT02394808|3969859|FG001|COMPLETED|Period 2||28
3237383|NCT02394808|3969858|FG000|NOT COMPLETED|Period 2||1
3237384|NCT02394808|3969859|FG001|NOT COMPLETED|Period 2||0
3237385|NCT02394912|3969865|FG000|STARTED|Overall Study||21
3237386|NCT02394912|3969865|FG000|COMPLETED|Overall Study||21
3237387|NCT02394912|3969865|FG000|NOT COMPLETED|Overall Study||0
3237388|NCT02394925|3969871|FG000|STARTED|Overall Study||108
3237389|NCT02394925|3969871|FG000|COMPLETED|Overall Study||79
3237390|NCT02394925|3969871|FG000|NOT COMPLETED|Overall Study||29
3237391|NCT02394951|3969877|FG000|STARTED|Period I||12
3237392|NCT02394951|3969878|FG001|STARTED|Period I||14
3237393|NCT02394951|3969877|FG000|COMPLETED|Period I||11
3237394|NCT02394951|3969878|FG001|COMPLETED|Period I||13
3237395|NCT02394951|3969877|FG000|NOT COMPLETED|Period I||1
3237396|NCT02394951|3969878|FG001|NOT COMPLETED|Period I||1
3237397|NCT02394951|3969877|FG000|STARTED|Period II||11
3237398|NCT02394951|3969878|FG001|STARTED|Period II||13
3237399|NCT02394951|3969877|FG000|COMPLETED|Period II||11
3237400|NCT02394951|3969878|FG001|COMPLETED|Period II||9
3237401|NCT02394951|3969877|FG000|NOT COMPLETED|Period II||0
3237402|NCT02394951|3969878|FG001|NOT COMPLETED|Period II||4
3237403|NCT02395042|3969887|FG000|STARTED|Treatment 1 Period||12
3237404|NCT02395042|3969888|FG001|STARTED|Treatment 1 Period||31
3237405|NCT02395042|3969889|FG002|STARTED|Treatment 1 Period||16
3237406|NCT02395042|3969887|FG000|COMPLETED|Treatment 1 Period||9
3237407|NCT02395042|3969888|FG001|COMPLETED|Treatment 1 Period||25
3237408|NCT02395042|3969889|FG002|COMPLETED|Treatment 1 Period||14
3237409|NCT02395042|3969887|FG000|NOT COMPLETED|Treatment 1 Period||3
3237410|NCT02395042|3969888|FG001|NOT COMPLETED|Treatment 1 Period||6
3237411|NCT02395042|3969889|FG002|NOT COMPLETED|Treatment 1 Period||2
3237412|NCT02395042|3969887|FG000|STARTED|Treatment 2 Period|Not all participants participated in Treatment 2 Period.|10
3237413|NCT02395042|3969888|FG001|STARTED|Treatment 2 Period|Not all participants participated in Treatment 2 Period.|24
3237414|NCT02395042|3969889|FG002|STARTED|Treatment 2 Period|Not all participants participated in Treatment 2 Period.|13
3237415|NCT02395042|3969887|FG000|COMPLETED|Treatment 2 Period||9
3237416|NCT02395042|3969888|FG001|COMPLETED|Treatment 2 Period||23
3237417|NCT02395042|3969889|FG002|COMPLETED|Treatment 2 Period||13
3237418|NCT02395042|3969887|FG000|NOT COMPLETED|Treatment 2 Period||1
3237419|NCT02395042|3969888|FG001|NOT COMPLETED|Treatment 2 Period||1
3237420|NCT02395042|3969889|FG002|NOT COMPLETED|Treatment 2 Period||0
3237421|NCT02395055|3969902|FG000|STARTED|Overall Study||47
3237422|NCT02395055|3969903|FG001|STARTED|Overall Study||47
3237423|NCT02395055|3969902|FG000|COMPLETED|Overall Study||40
3237424|NCT02395055|3969903|FG001|COMPLETED|Overall Study||44
3237425|NCT02395055|3969902|FG000|NOT COMPLETED|Overall Study||7
3237426|NCT02395055|3969903|FG001|NOT COMPLETED|Overall Study||3
3237427|NCT02395081|3969912|FG000|STARTED|Overall Study||119
3237428|NCT02395081|3969913|FG001|STARTED|Overall Study||121
3237429|NCT02395081|3969914|FG002|STARTED|Overall Study||120
3237430|NCT02395081|3969912|FG000|COMPLETED|Overall Study||112
3237431|NCT02395081|3969913|FG001|COMPLETED|Overall Study||116
3237432|NCT02395081|3969914|FG002|COMPLETED|Overall Study||116
3237433|NCT02395081|3969912|FG000|NOT COMPLETED|Overall Study||7
3237434|NCT02395081|3969913|FG001|NOT COMPLETED|Overall Study||5
3237435|NCT02395081|3969914|FG002|NOT COMPLETED|Overall Study||4
3237436|NCT02395133|3969929|FG000|STARTED|Overall Study||83
3237437|NCT02395133|3969930|FG001|STARTED|Overall Study||84
3237438|NCT02395133|3969931|FG002|STARTED|Overall Study||86
3237439|NCT02395133|3969932|FG003|STARTED|Overall Study||169
3237440|NCT02395133|3969929|FG000|COMPLETED|Overall Study||69
3237441|NCT02395133|3969930|FG001|COMPLETED|Overall Study||75
3237442|NCT02395133|3969931|FG002|COMPLETED|Overall Study||76
3237443|NCT02395133|3969932|FG003|COMPLETED|Overall Study||155
3237444|NCT02395133|3969929|FG000|NOT COMPLETED|Overall Study||14
3237445|NCT02395133|3969930|FG001|NOT COMPLETED|Overall Study||9
3237446|NCT02395133|3969931|FG002|NOT COMPLETED|Overall Study||10
3237447|NCT02395133|3969932|FG003|NOT COMPLETED|Overall Study||14
3237448|NCT02395172|3969944|FG000|STARTED|Overall Study||396
3237449|NCT02395172|3969945|FG001|STARTED|Overall Study||396
3237450|NCT02395172|3969944|FG000|Treated|Overall Study||393
3237451|NCT02395172|3969945|FG001|Treated|Overall Study||365
3237452|NCT02395172|3969944|FG000|COMPLETED|Overall Study||393
3237453|NCT02395172|3969945|FG001|COMPLETED|Overall Study||365
3237454|NCT02395172|3969944|FG000|NOT COMPLETED|Overall Study||3
3237455|NCT02395172|3969945|FG001|NOT COMPLETED|Overall Study||31
3237456|NCT02395185|3969951|FG000|STARTED|Overall Study|32 guardians participated with these infants. one infant did not have a guardian participate.|33
3237457|NCT02395185|3969951|FG000|Sequence 1 (s,s,m,m,w,w)|Overall Study|one of the participants in this milestone did not have a guardian enrolled due to age.|2
3237458|NCT02395185|3969951|FG000|Sequence 2 (w,s,s,m,m,w)|Overall Study||2
3237459|NCT02395185|3969951|FG000|Sequence 3 (w,w,s,s,m,m)|Overall Study||2
3237460|NCT02395185|3969951|FG000|Sequence 4 (m,w,w,s,s,m)|Overall Study||2
3237461|NCT02395185|3969951|FG000|Sequence 5 (m,m,w,w,s,s)|Overall Study||2
3237462|NCT02395185|3969951|FG000|Sequence 6 (s,m,m,w,w,s)|Overall Study||2
3237463|NCT02395185|3969951|FG000|Sequence 7 (s,s,w,w,m,m)|Overall Study||2
3237464|NCT02395185|3969951|FG000|Sequence 8 (m,s,s,w,w,m)|Overall Study||2
3237465|NCT02395185|3969951|FG000|Sequence 9 (m,m,s,s,w,w)|Overall Study||2
3237466|NCT02395185|3969951|FG000|Sequence 10 (w,m,m,s,s,w)|Overall Study||2
3237467|NCT02395185|3969951|FG000|Sequence 11 (w,w,m,m,s,s)|Overall Study||2
3237468|NCT02395185|3969951|FG000|Sequence 12 (s,w,w,m,m,s)|Overall Study||2
3237469|NCT02395185|3969951|FG000|Sequence 13 (s,m,w,m,s,w)|Overall Study||2
3237470|NCT02395185|3969951|FG000|Sequence 14 (w,s,m,w,m,s)|Overall Study||2
3237471|NCT02395185|3969951|FG000|Sequence 15 (s,w,s,m,w,m)|Overall Study||2
3237472|NCT02395185|3969951|FG000|Sequence 16 (m,s,w,s,m,w)|Overall Study||1
3237473|NCT02395185|3969951|FG000|Sequence 17 (w,m,s,w,s,m)|Overall Study||1
3237474|NCT02395185|3969951|FG000|Sequence 18 (m,w,m,s,w,s)|Overall Study||1
3237475|NCT02395185|3969951|FG000|COMPLETED|Overall Study||33
3237476|NCT02395185|3969951|FG000|NOT COMPLETED|Overall Study||0
3237477|NCT02395302|3969959|FG000|STARTED|Overall Study||28
3237478|NCT02395302|3969959|FG000|COMPLETED|Overall Study||14
3237479|NCT02395302|3969959|FG000|NOT COMPLETED|Overall Study||14
3237480|NCT02395471|3969965|FG000|STARTED|Overall Study||129
3237481|NCT02395471|3969966|FG001|STARTED|Overall Study||62
3237482|NCT02395471|3969965|FG000|COMPLETED|Overall Study||122
3237483|NCT02395471|3969966|FG001|COMPLETED|Overall Study||59
3237484|NCT02395471|3969965|FG000|NOT COMPLETED|Overall Study||7
3237485|NCT02395471|3969966|FG001|NOT COMPLETED|Overall Study||3
3237486|NCT02395536|3969983|FG000|STARTED|Overall Study||264
3237487|NCT02395536|3969984|FG001|STARTED|Overall Study||257
3237488|NCT02395536|3969983|FG000|REVEAL LINQ Insertion|Overall Study||251
3237489|NCT02395536|3969984|FG001|REVEAL LINQ Insertion|Overall Study||231
3237490|NCT02395536|3969983|FG000|COMPLETED|Overall Study||244
3237491|NCT02395536|3969984|FG001|COMPLETED|Overall Study||227
3237492|NCT02395536|3969983|FG000|NOT COMPLETED|Overall Study||20
3237493|NCT02395536|3969984|FG001|NOT COMPLETED|Overall Study||30
3237494|NCT02395627|3969993|FG000|STARTED|Overall Study||18
3237495|NCT02395627|3969994|FG001|STARTED|Overall Study||16
3237496|NCT02395627|3969995|FG002|STARTED|Overall Study||4
3237497|NCT02395627|3969993|FG000|COMPLETED|Overall Study||15
3237498|NCT02395627|3969994|FG001|COMPLETED|Overall Study||13
3237499|NCT02395627|3969995|FG002|COMPLETED|Overall Study||4
3237500|NCT02395627|3969993|FG000|NOT COMPLETED|Overall Study||3
3237501|NCT02395627|3969994|FG001|NOT COMPLETED|Overall Study||3
3237502|NCT02395627|3969995|FG002|NOT COMPLETED|Overall Study||0
3237503|NCT02395653|3970005|FG000|STARTED|Overall Study||71
3237504|NCT02395653|3970005|FG000|Received at Least 1 Dose of Study Drug|Overall Study||61
3237505|NCT02395653|3970005|FG000|COMPLETED|Overall Study||59
3237506|NCT02395653|3970005|FG000|NOT COMPLETED|Overall Study||12
3237507|NCT02395692|3970009|FG000|STARTED|Overall Study||19
3237508|NCT02395692|3970010|FG001|STARTED|Overall Study||0
3237509|NCT02395692|3970009|FG000|COMPLETED|Overall Study||19
3237510|NCT02395692|3970010|FG001|COMPLETED|Overall Study||0
3237511|NCT02395692|3970009|FG000|NOT COMPLETED|Overall Study||0
3237512|NCT02395692|3970010|FG001|NOT COMPLETED|Overall Study||0
3237513|NCT02395822|3970017|FG000|STARTED|Overall Study||17
3237514|NCT02395822|3970017|FG000|COMPLETED|Overall Study||15
3369749|NCT03782571|4101192|FG003|COMPLETED|Period 2||7
3369750|NCT03782571|4101189|FG000|NOT COMPLETED|Period 2||0
3369751|NCT03782571|4101190|FG001|NOT COMPLETED|Period 2||0
3369752|NCT03782571|4101191|FG002|NOT COMPLETED|Period 2||0
3369753|NCT03782571|4101192|FG003|NOT COMPLETED|Period 2||0
3369754|NCT03782571|4101189|FG000|STARTED|Period 3||5
3369755|NCT03782571|4101190|FG001|STARTED|Period 3||6
3369756|NCT03782571|4101191|FG002|STARTED|Period 3||6
3369757|NCT03782571|4101192|FG003|STARTED|Period 3||7
3369758|NCT03782571|4101189|FG000|COMPLETED|Period 3||3
3369759|NCT03782571|4101190|FG001|COMPLETED|Period 3||6
3369760|NCT03782571|4101191|FG002|COMPLETED|Period 3||6
3369761|NCT03782571|4101192|FG003|COMPLETED|Period 3||7
3369762|NCT03782571|4101189|FG000|NOT COMPLETED|Period 3||2
3369763|NCT03782571|4101190|FG001|NOT COMPLETED|Period 3||0
3369764|NCT03782571|4101191|FG002|NOT COMPLETED|Period 3||0
3369765|NCT03782571|4101192|FG003|NOT COMPLETED|Period 3||0
3369766|NCT03782571|4101189|FG000|STARTED|Period 4||3
3369767|NCT03782571|4101190|FG001|STARTED|Period 4||6
3369768|NCT03782571|4101191|FG002|STARTED|Period 4||6
3369769|NCT03782571|4101192|FG003|STARTED|Period 4||7
3369770|NCT03782571|4101189|FG000|COMPLETED|Period 4||3
3369771|NCT03782571|4101190|FG001|COMPLETED|Period 4||6
3369772|NCT03782571|4101191|FG002|COMPLETED|Period 4||6
3369773|NCT03782571|4101192|FG003|COMPLETED|Period 4||7
3369774|NCT03782571|4101189|FG000|NOT COMPLETED|Period 4||0
3237515|NCT02395822|3970017|FG000|NOT COMPLETED|Overall Study||2
3369775|NCT03782571|4101190|FG001|NOT COMPLETED|Period 4||0
3369776|NCT03782571|4101191|FG002|NOT COMPLETED|Period 4||0
3369777|NCT03782571|4101192|FG003|NOT COMPLETED|Period 4||0
3369778|NCT03796260|4101206|FG000|STARTED|Period 1||7
3369779|NCT03796260|4101207|FG001|STARTED|Period 1||7
3369780|NCT03796260|4101206|FG000|COMPLETED|Period 1||7
3369781|NCT03796260|4101207|FG001|COMPLETED|Period 1||7
3369782|NCT03796260|4101206|FG000|NOT COMPLETED|Period 1||0
3369783|NCT03796260|4101207|FG001|NOT COMPLETED|Period 1||0
3369784|NCT03796260|4101206|FG000|STARTED|Period 2||7
3369785|NCT03796260|4101207|FG001|STARTED|Period 2||7
3369786|NCT03796260|4101206|FG000|COMPLETED|Period 2||7
3369787|NCT03796260|4101207|FG001|COMPLETED|Period 2||7
3369788|NCT03796260|4101206|FG000|NOT COMPLETED|Period 2||0
3369789|NCT03796260|4101207|FG001|NOT COMPLETED|Period 2||0
3369790|NCT03796039|4101215|FG000|STARTED|Overall Study||50
3369791|NCT03796039|4101216|FG001|STARTED|Overall Study||47
3369792|NCT03796039|4101215|FG000|COMPLETED|Overall Study||41
3369793|NCT03796039|4101216|FG001|COMPLETED|Overall Study||42
3369794|NCT03796039|4101215|FG000|NOT COMPLETED|Overall Study||9
3369795|NCT03796039|4101216|FG001|NOT COMPLETED|Overall Study||5
3369796|NCT03783780|4101222|FG000|STARTED|Overall Study||21
3369797|NCT03783780|4101222|FG000|COMPLETED|Overall Study||20
3369798|NCT03783780|4101222|FG000|NOT COMPLETED|Overall Study||1
3369799|NCT03780959|4101230|FG000|STARTED|Part 1||69
3369800|NCT03780959|4101231|FG001|STARTED|Part 1||0
3369801|NCT03780959|4101232|FG002|STARTED|Part 1||0
3369802|NCT03780959|4101230|FG000|COMPLETED|Part 1||64
3369803|NCT03780959|4101231|FG001|COMPLETED|Part 1||0
3369804|NCT03780959|4101232|FG002|COMPLETED|Part 1||0
3369805|NCT03780959|4101230|FG000|NOT COMPLETED|Part 1||5
3369806|NCT03780959|4101231|FG001|NOT COMPLETED|Part 1||0
3369807|NCT03780959|4101232|FG002|NOT COMPLETED|Part 1||0
3369808|NCT03780959|4101230|FG000|STARTED|Part 2||0
3369809|NCT03780959|4101231|FG001|STARTED|Part 2||26
3369810|NCT03780959|4101232|FG002|STARTED|Part 2||25
3369811|NCT03780959|4101230|FG000|COMPLETED|Part 2||0
3369812|NCT03780959|4101231|FG001|COMPLETED|Part 2||7
3369813|NCT03780959|4101232|FG002|COMPLETED|Part 2||19
3369814|NCT03780959|4101230|FG000|NOT COMPLETED|Part 2||0
3369815|NCT03780959|4101231|FG001|NOT COMPLETED|Part 2||19
3369816|NCT03780959|4101232|FG002|NOT COMPLETED|Part 2||6
3369817|NCT03796182|4101242|FG000|STARTED|Period 1||6
3369818|NCT03796182|4101243|FG001|STARTED|Period 1||6
3369819|NCT03796182|4101242|FG000|COMPLETED|Period 1||6
3369820|NCT03796182|4101243|FG001|COMPLETED|Period 1||6
3369821|NCT03796182|4101242|FG000|NOT COMPLETED|Period 1||0
3369822|NCT03796182|4101243|FG001|NOT COMPLETED|Period 1||0
3369823|NCT03796182|4101242|FG000|STARTED|Washout Period||6
3369824|NCT03796182|4101243|FG001|STARTED|Washout Period||6
3369825|NCT03796182|4101242|FG000|COMPLETED|Washout Period||6
3369826|NCT03796182|4101243|FG001|COMPLETED|Washout Period||6
3369827|NCT03796182|4101242|FG000|NOT COMPLETED|Washout Period||0
3369828|NCT03796182|4101243|FG001|NOT COMPLETED|Washout Period||0
3369829|NCT03796182|4101242|FG000|STARTED|Period 2||6
3369830|NCT03796182|4101243|FG001|STARTED|Period 2||6
3369831|NCT03796182|4101242|FG000|COMPLETED|Period 2||6
3369832|NCT03796182|4101243|FG001|COMPLETED|Period 2||6
3369833|NCT03796182|4101242|FG000|NOT COMPLETED|Period 2||0
3369834|NCT03796182|4101243|FG001|NOT COMPLETED|Period 2||0
3369835|NCT03796013|4101251|FG000|STARTED|Period 1||14
3369836|NCT03796013|4101252|FG001|STARTED|Period 1||14
3369837|NCT03796013|4101251|FG000|COMPLETED|Period 1||14
3369838|NCT03796013|4101252|FG001|COMPLETED|Period 1||14
3369839|NCT03796013|4101251|FG000|NOT COMPLETED|Period 1||0
3369840|NCT03796013|4101252|FG001|NOT COMPLETED|Period 1||0
3369841|NCT03796013|4101251|FG000|STARTED|Period 2||14
3369842|NCT03796013|4101252|FG001|STARTED|Period 2||14
3369843|NCT03796013|4101251|FG000|COMPLETED|Period 2||14
3369844|NCT03796013|4101252|FG001|COMPLETED|Period 2||14
3369845|NCT03796013|4101251|FG000|NOT COMPLETED|Period 2||0
3369846|NCT03796013|4101252|FG001|NOT COMPLETED|Period 2||0
3369847|NCT03796676|4101261|FG000|STARTED|Overall Study||96
3369848|NCT03796676|4101262|FG001|STARTED|Overall Study||95
3369849|NCT03796676|4101263|FG002|STARTED|Overall Study||94
3369850|NCT03796676|4101261|FG000|COMPLETED|Overall Study||90
3369851|NCT03796676|4101262|FG001|COMPLETED|Overall Study||92
3369852|NCT03796676|4101263|FG002|COMPLETED|Overall Study||91
3369853|NCT03796676|4101261|FG000|NOT COMPLETED|Overall Study||6
3369854|NCT03796676|4101262|FG001|NOT COMPLETED|Overall Study||3
3369855|NCT03796676|4101263|FG002|NOT COMPLETED|Overall Study||3
3369856|NCT03795753|4101276|FG000|STARTED|Overall Study||23
3369857|NCT03795753|4101277|FG001|STARTED|Overall Study||13
3369858|NCT03795753|4101276|FG000|COMPLETED|Overall Study||23
3369859|NCT03795753|4101277|FG001|COMPLETED|Overall Study||13
3369860|NCT03795753|4101276|FG000|NOT COMPLETED|Overall Study||0
3369861|NCT03795753|4101277|FG001|NOT COMPLETED|Overall Study||0
3369862|NCT03792477|4101288|FG000|STARTED|Overall Study||6
3369863|NCT03792477|4101289|FG001|STARTED|Overall Study||6
3369864|NCT03792477|4101290|FG002|STARTED|Overall Study||21
3369865|NCT03792477|4101291|FG003|STARTED|Overall Study||21
3369866|NCT03792477|4101292|FG004|STARTED|Overall Study||20
3369867|NCT03792477|4101288|FG000|COMPLETED|Overall Study||6
3369868|NCT03792477|4101289|FG001|COMPLETED|Overall Study||6
3369869|NCT03792477|4101290|FG002|COMPLETED|Overall Study||19
3369870|NCT03792477|4101291|FG003|COMPLETED|Overall Study||20
3369871|NCT03792477|4101292|FG004|COMPLETED|Overall Study||19
3237516|NCT02395978|3970026|FG000|STARTED|Overall Study||6
3237517|NCT02395978|3970027|FG001|STARTED|Overall Study||6
3237518|NCT02395978|3970028|FG002|STARTED|Overall Study||21
3237519|NCT02395978|3970029|FG003|STARTED|Overall Study||19
3237520|NCT02395978|3970030|FG004|STARTED|Overall Study||20
3237521|NCT02395978|3970026|FG000|COMPLETED|Overall Study||6
3237522|NCT02395978|3970027|FG001|COMPLETED|Overall Study||6
3237523|NCT02395978|3970028|FG002|COMPLETED|Overall Study||19
3237524|NCT02395978|3970029|FG003|COMPLETED|Overall Study||14
3237525|NCT02395978|3970030|FG004|COMPLETED|Overall Study||15
3237526|NCT02395978|3970026|FG000|NOT COMPLETED|Overall Study||0
3237527|NCT02395978|3970027|FG001|NOT COMPLETED|Overall Study||0
3237528|NCT02395978|3970028|FG002|NOT COMPLETED|Overall Study||2
3237529|NCT02395978|3970029|FG003|NOT COMPLETED|Overall Study||5
3237530|NCT02395978|3970030|FG004|NOT COMPLETED|Overall Study||5
3237531|NCT02395991|3970043|FG000|STARTED|Overall Study||60
3237532|NCT02395991|3970043|FG000|COMPLETED|Overall Study||59
3237533|NCT02395991|3970043|FG000|NOT COMPLETED|Overall Study||1
3237534|NCT02396147|3970050|FG000|STARTED|Period 1||27
3237535|NCT02396147|3970051|FG001|STARTED|Period 1||27
3237536|NCT02396147|3970050|FG000|COMPLETED|Period 1||27
3237537|NCT02396147|3970051|FG001|COMPLETED|Period 1||27
3237538|NCT02396147|3970050|FG000|NOT COMPLETED|Period 1||0
3237539|NCT02396147|3970051|FG001|NOT COMPLETED|Period 1||0
3237540|NCT02396147|3970050|FG000|STARTED|Period 2||27
3237541|NCT02396147|3970051|FG001|STARTED|Period 2||27
3237542|NCT02396147|3970050|FG000|COMPLETED|Period 2||27
3237543|NCT02396147|3970051|FG001|COMPLETED|Period 2||27
3237544|NCT02396147|3970050|FG000|NOT COMPLETED|Period 2||0
3237545|NCT02396147|3970051|FG001|NOT COMPLETED|Period 2||0
3237546|NCT02396147|3970050|FG000|STARTED|Period 3||27
3237547|NCT02396147|3970051|FG001|STARTED|Period 3||27
3237548|NCT02396147|3970050|FG000|COMPLETED|Period 3||27
3237549|NCT02396147|3970051|FG001|COMPLETED|Period 3||27
3237550|NCT02396147|3970050|FG000|NOT COMPLETED|Period 3||0
3237551|NCT02396147|3970051|FG001|NOT COMPLETED|Period 3||0
3237552|NCT02396160|3970067|FG000|STARTED|Overall Study||75
3237553|NCT02396160|3970068|FG001|STARTED|Overall Study||75
3237554|NCT02396160|3970067|FG000|COMPLETED|Overall Study||69
3237555|NCT02396160|3970068|FG001|COMPLETED|Overall Study||73
3237556|NCT02396160|3970067|FG000|NOT COMPLETED|Overall Study||6
3237557|NCT02396160|3970068|FG001|NOT COMPLETED|Overall Study||2
3237558|NCT02396212|3970074|FG000|STARTED|Overall Study||19
3237559|NCT02396212|3970074|FG000|COMPLETED|Overall Study||16
3237560|NCT02396212|3970074|FG000|NOT COMPLETED|Overall Study||3
3237561|NCT02396251|3970080|FG000|STARTED|Overall Study||36
3237562|NCT02396251|3970081|FG001|STARTED|Overall Study||12
3237563|NCT02396251|3970080|FG000|COMPLETED|Overall Study||23
3369872|NCT03792477|4101288|FG000|NOT COMPLETED|Overall Study||0
3369873|NCT03792477|4101289|FG001|NOT COMPLETED|Overall Study||0
3369874|NCT03792477|4101290|FG002|NOT COMPLETED|Overall Study||2
3369875|NCT03792477|4101291|FG003|NOT COMPLETED|Overall Study||1
3369876|NCT03792477|4101292|FG004|NOT COMPLETED|Overall Study||1
3369877|NCT03783962|4101300|FG000|STARTED|Overall Study||28
3369878|NCT03783962|4101301|FG001|STARTED|Overall Study||28
3369879|NCT03783962|4101300|FG000|COMPLETED|Overall Study||25
3369880|NCT03783962|4101301|FG001|COMPLETED|Overall Study||21
3369881|NCT03783962|4101300|FG000|NOT COMPLETED|Overall Study||3
3369882|NCT03783962|4101301|FG001|NOT COMPLETED|Overall Study||7
3369883|NCT03782272|4101309|FG000|STARTED|Overall Study||6
3369884|NCT03782272|4101310|FG001|STARTED|Overall Study||6
3369885|NCT03782272|4101309|FG000|COMPLETED|Overall Study||6
3369886|NCT03782272|4101310|FG001|COMPLETED|Overall Study||6
3369887|NCT03782272|4101309|FG000|NOT COMPLETED|Overall Study||0
3369888|NCT03782272|4101310|FG001|NOT COMPLETED|Overall Study||0
3369889|NCT03779724|4101319|FG000|STARTED|Overall Study||25
3369890|NCT03779724|4101320|FG001|STARTED|Overall Study||25
3369891|NCT03779724|4101319|FG000|COMPLETED|Overall Study||19
3369892|NCT03779724|4101320|FG001|COMPLETED|Overall Study||21
3369893|NCT03779724|4101319|FG000|NOT COMPLETED|Overall Study||6
3369894|NCT03779724|4101320|FG001|NOT COMPLETED|Overall Study||4
3369895|NCT03775915|4101330|FG000|STARTED|Overall Study||12
3369896|NCT03775915|4101331|FG001|STARTED|Overall Study||12
3369897|NCT03775915|4101330|FG000|COMPLETED|Overall Study||12
3369898|NCT03775915|4101331|FG001|COMPLETED|Overall Study||12
3369899|NCT03775915|4101330|FG000|NOT COMPLETED|Overall Study||0
3369900|NCT03775915|4101331|FG001|NOT COMPLETED|Overall Study||0
3369901|NCT03794752|4101337|FG000|STARTED|Overall Study||8
3369902|NCT03794752|4101337|FG000|COMPLETED|Overall Study||8
3369903|NCT03794752|4101337|FG000|NOT COMPLETED|Overall Study||0
3369904|NCT03794024|4101347|FG000|STARTED|Overall Study||1
3369905|NCT03794024|4101348|FG001|STARTED|Overall Study||0
3369906|NCT03794024|4101347|FG000|COMPLETED|Overall Study||0
3369907|NCT03794024|4101348|FG001|COMPLETED|Overall Study||0
3369908|NCT03794024|4101347|FG000|NOT COMPLETED|Overall Study||1
3369909|NCT03794024|4101348|FG001|NOT COMPLETED|Overall Study||0
3369910|NCT03793751|4101356|FG000|STARTED|Overall Study||60
3369911|NCT03793751|4101357|FG001|STARTED|Overall Study||60
3369912|NCT03793751|4101356|FG000|COMPLETED|Overall Study||60
3369913|NCT03793751|4101357|FG001|COMPLETED|Overall Study||60
3369914|NCT03793751|4101356|FG000|NOT COMPLETED|Overall Study||0
3237564|NCT02396251|3970081|FG001|COMPLETED|Overall Study||7
3237565|NCT02396251|3970080|FG000|NOT COMPLETED|Overall Study||13
3369915|NCT03793751|4101357|FG001|NOT COMPLETED|Overall Study||0
3369916|NCT03793556|4101365|FG000|STARTED|Overall Study||35
3237566|NCT02396251|3970081|FG001|NOT COMPLETED|Overall Study||5
3237567|NCT02396316|3970088|FG000|STARTED|Overall Study||27
3237568|NCT02396316|3970089|FG001|STARTED|Overall Study||27
3237569|NCT02396316|3970088|FG000|Treated|Overall Study||27
3237570|NCT02396316|3970089|FG001|Treated|Overall Study||27
3237571|NCT02396316|3970088|FG000|Received Sham Injection at Week 1|Overall Study||10
3237572|NCT02396316|3970089|FG001|Received Sham Injection at Week 1|Overall Study||0
3237573|NCT02396316|3970088|FG000|Received AFL Injection at Week 1|Overall Study||0
3237574|NCT02396316|3970089|FG001|Received AFL Injection at Week 1|Overall Study||22
3237575|NCT02396316|3970088|FG000|Received Active Injection at Week 5|Overall Study||4
3237576|NCT02396316|3970089|FG001|Received Active Injection at Week 5|Overall Study||4
3237577|NCT02396316|3970088|FG000|Received Active Injection at Week 9|Overall Study||2
3237578|NCT02396316|3970089|FG001|Received Active Injection at Week 9|Overall Study||1
3237579|NCT02396316|3970088|FG000|COMPLETED|Overall Study||20
3237580|NCT02396316|3970089|FG001|COMPLETED|Overall Study||22
3237581|NCT02396316|3970088|FG000|NOT COMPLETED|Overall Study||7
3237582|NCT02396316|3970089|FG001|NOT COMPLETED|Overall Study||5
3237583|NCT02396381|3970101|FG000|STARTED|Overall Study||488
3237584|NCT02396381|3970102|FG001|STARTED|Overall Study||496
3237585|NCT02396381|3970101|FG000|Full Analysis Set - As Exposed (FAS-EX)|Overall Study||414
3237586|NCT02396381|3970102|FG001|Full Analysis Set - As Exposed (FAS-EX)|Overall Study||443
3369917|NCT03793556|4101366|FG001|STARTED|Overall Study||36
3369918|NCT03793556|4101365|FG000|COMPLETED|Overall Study||22
3369919|NCT03793556|4101366|FG001|COMPLETED|Overall Study||34
3369920|NCT03793556|4101365|FG000|NOT COMPLETED|Overall Study||13
3369921|NCT03793556|4101366|FG001|NOT COMPLETED|Overall Study||2
3369922|NCT03785548|4101377|FG000|STARTED|Overall Study||73
3369923|NCT03785548|4101378|FG001|STARTED|Overall Study||74
3369924|NCT03785548|4101377|FG000|COMPLETED|Overall Study||71
3369925|NCT03785548|4101378|FG001|COMPLETED|Overall Study||74
3369926|NCT03785548|4101377|FG000|NOT COMPLETED|Overall Study||2
3369927|NCT03785548|4101378|FG001|NOT COMPLETED|Overall Study||0
3369928|NCT03782701|4101384|FG000|STARTED|Overall Study||43
3369929|NCT03782701|4101384|FG000|Lumify|Overall Study||43
3369930|NCT03782701|4101384|FG000|Saline Solution|Overall Study||43
3369931|NCT03782701|4101384|FG000|COMPLETED|Overall Study||43
3369932|NCT03782701|4101384|FG000|NOT COMPLETED|Overall Study||0
3369933|NCT03773133|4101390|FG000|STARTED|Overall Study||8
3369934|NCT03773133|4101390|FG000|Received the Screening IIP|Overall Study||8
3369935|NCT03773133|4101390|FG000|Received the Therapeutic IRPP|Overall Study||0
3369936|NCT03773133|4101390|FG000|COMPLETED|Overall Study||0
3369937|NCT03773133|4101390|FG000|NOT COMPLETED|Overall Study||8
3369938|NCT03792737|4101398|FG000|STARTED|Overall Study||166
3369939|NCT03792737|4101399|FG001|STARTED|Overall Study||167
3369940|NCT03792737|4101400|FG002|STARTED|Overall Study||167
3369941|NCT03792737|4101398|FG000|Safety Analysis Set|Overall Study||162
3369942|NCT03792737|4101399|FG001|Safety Analysis Set|Overall Study|one subject didn't participate screen visit or randomize, but receive IP treatment by mistake.|161
3369943|NCT03792737|4101400|FG002|Safety Analysis Set|Overall Study||162
3369944|NCT03792737|4101398|FG000|Full Analysis Set|Overall Study||162
3369945|NCT03792737|4101399|FG001|Full Analysis Set|Overall Study||160
3369946|NCT03792737|4101400|FG002|Full Analysis Set|Overall Study||162
3369947|NCT03792737|4101398|FG000|COMPLETED|Overall Study||160
3369948|NCT03792737|4101399|FG001|COMPLETED|Overall Study||159
3369949|NCT03792737|4101400|FG002|COMPLETED|Overall Study||158
3369950|NCT03792737|4101398|FG000|NOT COMPLETED|Overall Study||6
3369951|NCT03792737|4101399|FG001|NOT COMPLETED|Overall Study||8
3369952|NCT03792737|4101400|FG002|NOT COMPLETED|Overall Study||9
3369953|NCT03792672|4101408|FG000|STARTED|Treatment Period 1 (1 Day)||4
3369954|NCT03792672|4101409|FG001|STARTED|Treatment Period 1 (1 Day)||4
3369955|NCT03792672|4101410|FG002|STARTED|Treatment Period 1 (1 Day)||4
3369956|NCT03792672|4101411|FG003|STARTED|Treatment Period 1 (1 Day)||4
3369957|NCT03792672|4101412|FG004|STARTED|Treatment Period 1 (1 Day)||4
3369958|NCT03792672|4101413|FG005|STARTED|Treatment Period 1 (1 Day)||4
3369959|NCT03792672|4101408|FG000|COMPLETED|Treatment Period 1 (1 Day)||4
3369960|NCT03792672|4101409|FG001|COMPLETED|Treatment Period 1 (1 Day)||4
3369961|NCT03792672|4101410|FG002|COMPLETED|Treatment Period 1 (1 Day)||4
3369962|NCT03792672|4101411|FG003|COMPLETED|Treatment Period 1 (1 Day)||4
3369963|NCT03792672|4101412|FG004|COMPLETED|Treatment Period 1 (1 Day)||4
3369964|NCT03792672|4101413|FG005|COMPLETED|Treatment Period 1 (1 Day)||4
3369965|NCT03792672|4101408|FG000|NOT COMPLETED|Treatment Period 1 (1 Day)||0
3369966|NCT03792672|4101409|FG001|NOT COMPLETED|Treatment Period 1 (1 Day)||0
3369967|NCT03792672|4101410|FG002|NOT COMPLETED|Treatment Period 1 (1 Day)||0
3369968|NCT03792672|4101411|FG003|NOT COMPLETED|Treatment Period 1 (1 Day)||0
3369969|NCT03792672|4101412|FG004|NOT COMPLETED|Treatment Period 1 (1 Day)||0
3369970|NCT03792672|4101413|FG005|NOT COMPLETED|Treatment Period 1 (1 Day)||0
3237587|NCT02396381|3970101|FG000|COMPLETED|Overall Study||381
3237588|NCT02396381|3970102|FG001|COMPLETED|Overall Study||422
3237589|NCT02396381|3970101|FG000|NOT COMPLETED|Overall Study||107
3369971|NCT03792672|4101408|FG000|STARTED|Washout Period 1 (10 Days)||4
3369972|NCT03792672|4101409|FG001|STARTED|Washout Period 1 (10 Days)||4
3369973|NCT03792672|4101410|FG002|STARTED|Washout Period 1 (10 Days)||4
3369974|NCT03792672|4101411|FG003|STARTED|Washout Period 1 (10 Days)||4
3369975|NCT03792672|4101412|FG004|STARTED|Washout Period 1 (10 Days)||4
3369976|NCT03792672|4101413|FG005|STARTED|Washout Period 1 (10 Days)||4
3369977|NCT03792672|4101408|FG000|COMPLETED|Washout Period 1 (10 Days)||4
3237590|NCT02396381|3970102|FG001|NOT COMPLETED|Overall Study||74
3237591|NCT02396420|3970111|FG000|STARTED|Overall Study||2
3237592|NCT02396420|3970111|FG000|1 Month Post PAE|Overall Study||2
3237593|NCT02396420|3970111|FG000|3 Months Post PAE|Overall Study||2
3237594|NCT02396420|3970111|FG000|6 Months Post PAE|Overall Study||2
3237595|NCT02396420|3970111|FG000|COMPLETED|Overall Study||1
3237596|NCT02396420|3970111|FG000|NOT COMPLETED|Overall Study||1
3237597|NCT02396511|3970116|FG000|STARTED|Overall Study||2
3237598|NCT02396511|3970116|FG000|COMPLETED|Overall Study||2
3237599|NCT02396511|3970116|FG000|NOT COMPLETED|Overall Study||0
3237600|NCT02396537|3970122|FG000|STARTED|Overall Study||40
3237601|NCT02396537|3970123|FG001|STARTED|Overall Study||37
3237602|NCT02396537|3970122|FG000|COMPLETED|Overall Study||40
3237603|NCT02396537|3970123|FG001|COMPLETED|Overall Study||36
3237604|NCT02396537|3970122|FG000|NOT COMPLETED|Overall Study||0
3237605|NCT02396537|3970123|FG001|NOT COMPLETED|Overall Study||1
3237606|NCT02396732|3970131|FG000|STARTED|Overall Study||14
3237607|NCT02396732|3970132|FG001|STARTED|Overall Study||17
3237608|NCT02396732|3970131|FG000|COMPLETED|Overall Study||14
3237609|NCT02396732|3970132|FG001|COMPLETED|Overall Study||17
3237610|NCT02396732|3970131|FG000|NOT COMPLETED|Overall Study||0
3237611|NCT02396732|3970132|FG001|NOT COMPLETED|Overall Study||0
3237612|NCT02396745|3970138|FG000|STARTED|Overall Study||1
3237613|NCT02396745|3970138|FG000|COMPLETED|Overall Study||1
3237614|NCT02396745|3970138|FG000|NOT COMPLETED|Overall Study||0
3237615|NCT02396758|3970146|FG000|STARTED|Overall Study||38
3237616|NCT02396758|3970147|FG001|STARTED|Overall Study||37
3237617|NCT02396758|3970148|FG002|STARTED|Overall Study||38
3237618|NCT02396758|3970149|FG003|STARTED|Overall Study||18
3237619|NCT02396758|3970146|FG000|COMPLETED|Overall Study||26
3237620|NCT02396758|3970147|FG001|COMPLETED|Overall Study||31
3237621|NCT02396758|3970148|FG002|COMPLETED|Overall Study||34
3237622|NCT02396758|3970149|FG003|COMPLETED|Overall Study||13
3237623|NCT02396758|3970146|FG000|NOT COMPLETED|Overall Study||12
3237624|NCT02396758|3970147|FG001|NOT COMPLETED|Overall Study||6
3237625|NCT02396758|3970148|FG002|NOT COMPLETED|Overall Study||4
3237626|NCT02396758|3970149|FG003|NOT COMPLETED|Overall Study||5
3237627|NCT02396849|3970161|FG000|STARTED|Overall Study||29
3237628|NCT02396849|3970162|FG001|STARTED|Overall Study||30
3237629|NCT02396849|3970161|FG000|COMPLETED|Overall Study||27
3237630|NCT02396849|3970162|FG001|COMPLETED|Overall Study||28
3237631|NCT02396849|3970161|FG000|NOT COMPLETED|Overall Study||2
3237632|NCT02396849|3970162|FG001|NOT COMPLETED|Overall Study||2
3237633|NCT02396953|3970173|FG000|STARTED|Overall Study||9
3237634|NCT02396953|3970174|FG001|STARTED|Overall Study||9
3237635|NCT02396953|3970175|FG002|STARTED|Overall Study||10
3237636|NCT02396953|3970173|FG000|COMPLETED|Overall Study||5
3237637|NCT02396953|3970174|FG001|COMPLETED|Overall Study||6
3237638|NCT02396953|3970175|FG002|COMPLETED|Overall Study||7
3237639|NCT02396953|3970173|FG000|NOT COMPLETED|Overall Study||4
3237640|NCT02396953|3970174|FG001|NOT COMPLETED|Overall Study||3
3237641|NCT02396953|3970175|FG002|NOT COMPLETED|Overall Study||3
3237642|NCT02397057|3970192|FG000|STARTED|Overall Study|"Two Normal Saline participants received Injectafer. The data presented is considered accurate."|105
3237643|NCT02397057|3970193|FG001|STARTED|Overall Study||104
3237644|NCT02397057|3970192|FG000|COMPLETED|Overall Study||94
3237645|NCT02397057|3970193|FG001|COMPLETED|Overall Study||91
3237646|NCT02397057|3970192|FG000|NOT COMPLETED|Overall Study||11
3237647|NCT02397057|3970193|FG001|NOT COMPLETED|Overall Study||13
3237648|NCT02397096|3970201|FG000|STARTED|Day 1 to Week 24||447
3237649|NCT02397096|3970202|FG001|STARTED|Day 1 to Week 24||223
3237650|NCT02397096|3970201|FG000|COMPLETED|Day 1 to Week 24||427
3237651|NCT02397096|3970202|FG001|COMPLETED|Day 1 to Week 24||209
3237652|NCT02397096|3970201|FG000|NOT COMPLETED|Day 1 to Week 24||20
3237653|NCT02397096|3970202|FG001|NOT COMPLETED|Day 1 to Week 24||14
3237654|NCT02397096|3970201|FG000|STARTED|Week 24 to Week 48||427
3237655|NCT02397096|3970202|FG001|STARTED|Week 24 to Week 48||209
3237656|NCT02397096|3970201|FG000|COMPLETED|Week 24 to Week 48||407
3237657|NCT02397096|3970202|FG001|COMPLETED|Week 24 to Week 48||202
3237658|NCT02397096|3970201|FG000|NOT COMPLETED|Week 24 to Week 48||20
3237659|NCT02397096|3970202|FG001|NOT COMPLETED|Week 24 to Week 48||7
3237660|NCT02397096|3970201|FG000|STARTED|Study Extensions|The extension study is optional; not all eligible participants enrolled.|399
3237661|NCT02397096|3970202|FG001|STARTED|Study Extensions|The extension study is optional; not all eligible participants enrolled.|202
3237662|NCT02397096|3970201|FG000|COMPLETED|Study Extensions|The extension study is ongoing.|0
3237663|NCT02397096|3970202|FG001|COMPLETED|Study Extensions|The extension study is ongoing.|0
3237664|NCT02397096|3970201|FG000|NOT COMPLETED|Study Extensions||399
3237665|NCT02397096|3970202|FG001|NOT COMPLETED|Study Extensions||202
3237666|NCT02397122|3970214|FG000|STARTED|Overall Study||20
3237667|NCT02397122|3970215|FG001|STARTED|Overall Study||20
3237668|NCT02397122|3970214|FG000|COMPLETED|Overall Study||20
3237669|NCT02397122|3970215|FG001|COMPLETED|Overall Study||20
3237670|NCT02397122|3970214|FG000|NOT COMPLETED|Overall Study||0
3237671|NCT02397122|3970215|FG001|NOT COMPLETED|Overall Study||0
3237672|NCT02397265|3970225|FG000|STARTED|First Intervention of Three||2
3237673|NCT02397265|3970226|FG001|STARTED|First Intervention of Three||2
3237674|NCT02397265|3970227|FG002|STARTED|First Intervention of Three||2
3237675|NCT02397265|3970225|FG000|COMPLETED|First Intervention of Three||2
3237676|NCT02397265|3970226|FG001|COMPLETED|First Intervention of Three||2
3369978|NCT03792672|4101409|FG001|COMPLETED|Washout Period 1 (10 Days)||4
3237677|NCT02397265|3970227|FG002|COMPLETED|First Intervention of Three||2
3237678|NCT02397265|3970225|FG000|NOT COMPLETED|First Intervention of Three||0
3237679|NCT02397265|3970226|FG001|NOT COMPLETED|First Intervention of Three||0
3237680|NCT02397265|3970227|FG002|NOT COMPLETED|First Intervention of Three||0
3237681|NCT02397265|3970225|FG000|STARTED|Second Intervention of Three||2
3237682|NCT02397265|3970226|FG001|STARTED|Second Intervention of Three||2
3237683|NCT02397265|3970227|FG002|STARTED|Second Intervention of Three||2
3237684|NCT02397265|3970225|FG000|COMPLETED|Second Intervention of Three||2
3237685|NCT02397265|3970226|FG001|COMPLETED|Second Intervention of Three||2
3237686|NCT02397265|3970227|FG002|COMPLETED|Second Intervention of Three||2
3237687|NCT02397265|3970225|FG000|NOT COMPLETED|Second Intervention of Three||0
3237688|NCT02397265|3970226|FG001|NOT COMPLETED|Second Intervention of Three||0
3237689|NCT02397265|3970227|FG002|NOT COMPLETED|Second Intervention of Three||0
3237690|NCT02397265|3970225|FG000|STARTED|Third Intervention of Three||2
3237691|NCT02397265|3970226|FG001|STARTED|Third Intervention of Three||2
3237692|NCT02397265|3970227|FG002|STARTED|Third Intervention of Three||2
3237693|NCT02397265|3970225|FG000|COMPLETED|Third Intervention of Three||2
3237694|NCT02397265|3970226|FG001|COMPLETED|Third Intervention of Three||2
3237695|NCT02397265|3970227|FG002|COMPLETED|Third Intervention of Three||2
3237696|NCT02397265|3970225|FG000|NOT COMPLETED|Third Intervention of Three||0
3237697|NCT02397265|3970226|FG001|NOT COMPLETED|Third Intervention of Three||0
3237698|NCT02397265|3970227|FG002|NOT COMPLETED|Third Intervention of Three||0
3237699|NCT02397278|3970237|FG000|STARTED|Overall Study||7
3237700|NCT02397278|3970238|FG001|STARTED|Overall Study||8
3237701|NCT02397278|3970237|FG000|COMPLETED|Overall Study||6
3237702|NCT02397278|3970238|FG001|COMPLETED|Overall Study||5
3237703|NCT02397278|3970237|FG000|NOT COMPLETED|Overall Study||1
3237704|NCT02397278|3970238|FG001|NOT COMPLETED|Overall Study||3
3237705|NCT02397291|3970246|FG000|STARTED|Overall Study||19
3237706|NCT02397291|3970247|FG001|STARTED|Overall Study||5
3237707|NCT02397291|3970246|FG000|COMPLETED|Overall Study||19
3237708|NCT02397291|3970247|FG001|COMPLETED|Overall Study||5
3237709|NCT02397291|3970246|FG000|NOT COMPLETED|Overall Study||0
3237710|NCT02397291|3970247|FG001|NOT COMPLETED|Overall Study||0
3237711|NCT02397408|3970253|FG000|STARTED|Overall Study||18
3237712|NCT02397408|3970253|FG000|Completed Surgery Per Protocol|Overall Study||16
3369979|NCT03792672|4101410|FG002|COMPLETED|Washout Period 1 (10 Days)||4
3369980|NCT03792672|4101411|FG003|COMPLETED|Washout Period 1 (10 Days)||4
3369981|NCT03792672|4101412|FG004|COMPLETED|Washout Period 1 (10 Days)||4
3369982|NCT03792672|4101413|FG005|COMPLETED|Washout Period 1 (10 Days)||4
3369983|NCT03792672|4101408|FG000|NOT COMPLETED|Washout Period 1 (10 Days)||0
3369984|NCT03792672|4101409|FG001|NOT COMPLETED|Washout Period 1 (10 Days)||0
3369985|NCT03792672|4101410|FG002|NOT COMPLETED|Washout Period 1 (10 Days)||0
3369986|NCT03792672|4101411|FG003|NOT COMPLETED|Washout Period 1 (10 Days)||0
3369987|NCT03792672|4101412|FG004|NOT COMPLETED|Washout Period 1 (10 Days)||0
3369988|NCT03792672|4101413|FG005|NOT COMPLETED|Washout Period 1 (10 Days)||0
3369989|NCT03792672|4101408|FG000|STARTED|Treatment Period 2 (1 Day)||4
3369990|NCT03792672|4101409|FG001|STARTED|Treatment Period 2 (1 Day)||4
3369991|NCT03792672|4101410|FG002|STARTED|Treatment Period 2 (1 Day)||4
3369992|NCT03792672|4101411|FG003|STARTED|Treatment Period 2 (1 Day)||4
3369993|NCT03792672|4101412|FG004|STARTED|Treatment Period 2 (1 Day)||4
3369994|NCT03792672|4101413|FG005|STARTED|Treatment Period 2 (1 Day)||4
3369995|NCT03792672|4101408|FG000|COMPLETED|Treatment Period 2 (1 Day)||4
3369996|NCT03792672|4101409|FG001|COMPLETED|Treatment Period 2 (1 Day)||4
3369997|NCT03792672|4101410|FG002|COMPLETED|Treatment Period 2 (1 Day)||4
3369998|NCT03792672|4101411|FG003|COMPLETED|Treatment Period 2 (1 Day)||4
3369999|NCT03792672|4101412|FG004|COMPLETED|Treatment Period 2 (1 Day)||4
3370000|NCT03792672|4101413|FG005|COMPLETED|Treatment Period 2 (1 Day)||4
3370001|NCT03792672|4101408|FG000|NOT COMPLETED|Treatment Period 2 (1 Day)||0
3370002|NCT03792672|4101409|FG001|NOT COMPLETED|Treatment Period 2 (1 Day)||0
3370003|NCT03792672|4101410|FG002|NOT COMPLETED|Treatment Period 2 (1 Day)||0
3370004|NCT03792672|4101411|FG003|NOT COMPLETED|Treatment Period 2 (1 Day)||0
3370005|NCT03792672|4101412|FG004|NOT COMPLETED|Treatment Period 2 (1 Day)||0
3370006|NCT03792672|4101413|FG005|NOT COMPLETED|Treatment Period 2 (1 Day)||0
3370007|NCT03792672|4101408|FG000|STARTED|Washout Period 2 (10 Days)||4
3370008|NCT03792672|4101409|FG001|STARTED|Washout Period 2 (10 Days)||4
3370009|NCT03792672|4101410|FG002|STARTED|Washout Period 2 (10 Days)||4
3370010|NCT03792672|4101411|FG003|STARTED|Washout Period 2 (10 Days)||4
3237713|NCT02397408|3970253|FG000|COMPLETED|Overall Study||12
3237714|NCT02397408|3970253|FG000|NOT COMPLETED|Overall Study||6
3237715|NCT02397447|3970259|FG000|STARTED|Overall Study||12
3237716|NCT02397447|3970260|FG001|STARTED|Overall Study||12
3237717|NCT02397447|3970259|FG000|COMPLETED|Overall Study||10
3237718|NCT02397447|3970260|FG001|COMPLETED|Overall Study||10
3237719|NCT02397447|3970259|FG000|NOT COMPLETED|Overall Study||2
3237720|NCT02397447|3970260|FG001|NOT COMPLETED|Overall Study||2
3237721|NCT02397460|3970274|FG000|STARTED|Treatment Period 1||7
3237722|NCT02397460|3970275|FG001|STARTED|Treatment Period 1||7
3237723|NCT02397460|3970276|FG002|STARTED|Treatment Period 1||6
3237724|NCT02397460|3970277|FG003|STARTED|Treatment Period 1||6
3237725|NCT02397460|3970278|FG004|STARTED|Treatment Period 1||6
3237726|NCT02397460|3970279|FG005|STARTED|Treatment Period 1||6
3237727|NCT02397460|3970280|FG006|STARTED|Treatment Period 1||6
3237728|NCT02397460|3970281|FG007|STARTED|Treatment Period 1||6
3237729|NCT02397460|3970274|FG000|COMPLETED|Treatment Period 1||7
3237730|NCT02397460|3970275|FG001|COMPLETED|Treatment Period 1||7
3237731|NCT02397460|3970276|FG002|COMPLETED|Treatment Period 1||6
3237732|NCT02397460|3970277|FG003|COMPLETED|Treatment Period 1||6
3237733|NCT02397460|3970278|FG004|COMPLETED|Treatment Period 1||6
3237734|NCT02397460|3970279|FG005|COMPLETED|Treatment Period 1||6
3237735|NCT02397460|3970280|FG006|COMPLETED|Treatment Period 1||6
3237736|NCT02397460|3970281|FG007|COMPLETED|Treatment Period 1||6
3237737|NCT02397460|3970274|FG000|NOT COMPLETED|Treatment Period 1||0
3237738|NCT02397460|3970275|FG001|NOT COMPLETED|Treatment Period 1||0
3237739|NCT02397460|3970276|FG002|NOT COMPLETED|Treatment Period 1||0
3237740|NCT02397460|3970277|FG003|NOT COMPLETED|Treatment Period 1||0
3237741|NCT02397460|3970278|FG004|NOT COMPLETED|Treatment Period 1||0
3237742|NCT02397460|3970279|FG005|NOT COMPLETED|Treatment Period 1||0
3237743|NCT02397460|3970280|FG006|NOT COMPLETED|Treatment Period 1||0
3237744|NCT02397460|3970281|FG007|NOT COMPLETED|Treatment Period 1||0
3237745|NCT02397460|3970274|FG000|STARTED|Treatment Period 2||7
3237746|NCT02397460|3970275|FG001|STARTED|Treatment Period 2||7
3237747|NCT02397460|3970276|FG002|STARTED|Treatment Period 2||6
3237748|NCT02397460|3970277|FG003|STARTED|Treatment Period 2||6
3237749|NCT02397460|3970278|FG004|STARTED|Treatment Period 2||6
3237750|NCT02397460|3970279|FG005|STARTED|Treatment Period 2||6
3237751|NCT02397460|3970280|FG006|STARTED|Treatment Period 2||6
3237752|NCT02397460|3970281|FG007|STARTED|Treatment Period 2||6
3237753|NCT02397460|3970274|FG000|COMPLETED|Treatment Period 2||7
3237754|NCT02397460|3970275|FG001|COMPLETED|Treatment Period 2||7
3237755|NCT02397460|3970276|FG002|COMPLETED|Treatment Period 2||6
3237756|NCT02397460|3970277|FG003|COMPLETED|Treatment Period 2||6
3237757|NCT02397460|3970278|FG004|COMPLETED|Treatment Period 2||6
3237758|NCT02397460|3970279|FG005|COMPLETED|Treatment Period 2||6
3237759|NCT02397460|3970280|FG006|COMPLETED|Treatment Period 2||6
3237760|NCT02397460|3970281|FG007|COMPLETED|Treatment Period 2||5
3237761|NCT02397460|3970274|FG000|NOT COMPLETED|Treatment Period 2||0
3237762|NCT02397460|3970275|FG001|NOT COMPLETED|Treatment Period 2||0
3237763|NCT02397460|3970276|FG002|NOT COMPLETED|Treatment Period 2||0
3237764|NCT02397460|3970277|FG003|NOT COMPLETED|Treatment Period 2||0
3237765|NCT02397460|3970278|FG004|NOT COMPLETED|Treatment Period 2||0
3237766|NCT02397460|3970279|FG005|NOT COMPLETED|Treatment Period 2||0
3237767|NCT02397460|3970280|FG006|NOT COMPLETED|Treatment Period 2||0
3237768|NCT02397460|3970281|FG007|NOT COMPLETED|Treatment Period 2||1
3237769|NCT02397460|3970274|FG000|STARTED|Treatment Period 3||7
3237770|NCT02397460|3970275|FG001|STARTED|Treatment Period 3||7
3237771|NCT02397460|3970276|FG002|STARTED|Treatment Period 3||6
3237772|NCT02397460|3970277|FG003|STARTED|Treatment Period 3||6
3237773|NCT02397460|3970278|FG004|STARTED|Treatment Period 3||6
3237774|NCT02397460|3970279|FG005|STARTED|Treatment Period 3||6
3237775|NCT02397460|3970280|FG006|STARTED|Treatment Period 3||6
3237776|NCT02397460|3970281|FG007|STARTED|Treatment Period 3||5
3237777|NCT02397460|3970274|FG000|COMPLETED|Treatment Period 3||7
3237778|NCT02397460|3970275|FG001|COMPLETED|Treatment Period 3||7
3237779|NCT02397460|3970276|FG002|COMPLETED|Treatment Period 3||6
3237780|NCT02397460|3970277|FG003|COMPLETED|Treatment Period 3||6
3237781|NCT02397460|3970278|FG004|COMPLETED|Treatment Period 3||6
3237782|NCT02397460|3970279|FG005|COMPLETED|Treatment Period 3||6
3237783|NCT02397460|3970280|FG006|COMPLETED|Treatment Period 3||6
3237784|NCT02397460|3970281|FG007|COMPLETED|Treatment Period 3||5
3237785|NCT02397460|3970274|FG000|NOT COMPLETED|Treatment Period 3||0
3237786|NCT02397460|3970275|FG001|NOT COMPLETED|Treatment Period 3||0
3237787|NCT02397460|3970276|FG002|NOT COMPLETED|Treatment Period 3||0
3237788|NCT02397460|3970277|FG003|NOT COMPLETED|Treatment Period 3||0
3237789|NCT02397460|3970278|FG004|NOT COMPLETED|Treatment Period 3||0
3237790|NCT02397460|3970279|FG005|NOT COMPLETED|Treatment Period 3||0
3237791|NCT02397460|3970280|FG006|NOT COMPLETED|Treatment Period 3||0
3237792|NCT02397460|3970281|FG007|NOT COMPLETED|Treatment Period 3||0
3237793|NCT02397460|3970274|FG000|STARTED|Treatment Period 4||7
3237794|NCT02397460|3970275|FG001|STARTED|Treatment Period 4||7
3237795|NCT02397460|3970276|FG002|STARTED|Treatment Period 4||6
3237796|NCT02397460|3970277|FG003|STARTED|Treatment Period 4||6
3237797|NCT02397460|3970278|FG004|STARTED|Treatment Period 4||6
3237798|NCT02397460|3970279|FG005|STARTED|Treatment Period 4||6
3237799|NCT02397460|3970280|FG006|STARTED|Treatment Period 4||6
3237800|NCT02397460|3970281|FG007|STARTED|Treatment Period 4||5
3237801|NCT02397460|3970274|FG000|COMPLETED|Treatment Period 4||7
3237802|NCT02397460|3970275|FG001|COMPLETED|Treatment Period 4||6
3237803|NCT02397460|3970276|FG002|COMPLETED|Treatment Period 4||6
3237804|NCT02397460|3970277|FG003|COMPLETED|Treatment Period 4||6
3237805|NCT02397460|3970278|FG004|COMPLETED|Treatment Period 4||5
3237806|NCT02397460|3970279|FG005|COMPLETED|Treatment Period 4||6
3237807|NCT02397460|3970280|FG006|COMPLETED|Treatment Period 4||6
3237808|NCT02397460|3970281|FG007|COMPLETED|Treatment Period 4||5
3237809|NCT02397460|3970274|FG000|NOT COMPLETED|Treatment Period 4||0
3237810|NCT02397460|3970275|FG001|NOT COMPLETED|Treatment Period 4||1
3237811|NCT02397460|3970276|FG002|NOT COMPLETED|Treatment Period 4||0
3237812|NCT02397460|3970277|FG003|NOT COMPLETED|Treatment Period 4||0
3237813|NCT02397460|3970278|FG004|NOT COMPLETED|Treatment Period 4||1
3237814|NCT02397460|3970279|FG005|NOT COMPLETED|Treatment Period 4||0
3237815|NCT02397460|3970280|FG006|NOT COMPLETED|Treatment Period 4||0
3237816|NCT02397460|3970281|FG007|NOT COMPLETED|Treatment Period 4||0
3237817|NCT02397473|3970357|FG000|STARTED|Treatment Phase||57
3237818|NCT02397473|3970358|FG001|STARTED|Treatment Phase||52
3237819|NCT02397473|3970357|FG000|Received at Least One Dose of Study Drug|Treatment Phase||57
3237820|NCT02397473|3970358|FG001|Received at Least One Dose of Study Drug|Treatment Phase||49
3237821|NCT02397473|3970357|FG000|COMPLETED|Treatment Phase||45
3237822|NCT02397473|3970358|FG001|COMPLETED|Treatment Phase||45
3237823|NCT02397473|3970357|FG000|NOT COMPLETED|Treatment Phase||12
3237824|NCT02397473|3970358|FG001|NOT COMPLETED|Treatment Phase||7
3237825|NCT02397473|3970357|FG000|STARTED|Post Treatment Follow-up Phase|Participants who discontinued treatment period had an option to enter post treatment phase.|50
3237826|NCT02397473|3970358|FG001|STARTED|Post Treatment Follow-up Phase||47
3237827|NCT02397473|3970357|FG000|COMPLETED|Post Treatment Follow-up Phase||47
3237828|NCT02397473|3970358|FG001|COMPLETED|Post Treatment Follow-up Phase||45
3237829|NCT02397473|3970357|FG000|NOT COMPLETED|Post Treatment Follow-up Phase||3
3237830|NCT02397473|3970358|FG001|NOT COMPLETED|Post Treatment Follow-up Phase||2
3237831|NCT02397564|3970367|FG000|STARTED|Overall Study||20
3237832|NCT02397564|3970367|FG000|COMPLETED|Overall Study||16
3237833|NCT02397564|3970367|FG000|NOT COMPLETED|Overall Study||4
3237834|NCT02397655|3970372|FG000|STARTED|Overall Study||12012
3237835|NCT02397655|3970372|FG000|COMPLETED|Overall Study||10711
3237836|NCT02397655|3970372|FG000|NOT COMPLETED|Overall Study||1301
3237837|NCT02397694|3970378|FG000|STARTED|Double-Blinded Phase||65
3237838|NCT02397694|3970379|FG001|STARTED|Double-Blinded Phase||33
3237839|NCT02397694|3970378|FG000|COMPLETED|Double-Blinded Phase||62
3237840|NCT02397694|3970379|FG001|COMPLETED|Double-Blinded Phase||30
3237841|NCT02397694|3970378|FG000|NOT COMPLETED|Double-Blinded Phase||3
3237842|NCT02397694|3970379|FG001|NOT COMPLETED|Double-Blinded Phase||3
3237843|NCT02397694|3970378|FG000|STARTED|Open Label Extension Phase||62
3237844|NCT02397694|3970379|FG001|STARTED|Open Label Extension Phase||30
3237845|NCT02397694|3970378|FG000|COMPLETED|Open Label Extension Phase||54
3237846|NCT02397694|3970379|FG001|COMPLETED|Open Label Extension Phase||29
3237847|NCT02397694|3970378|FG000|NOT COMPLETED|Open Label Extension Phase||8
3237848|NCT02397694|3970379|FG001|NOT COMPLETED|Open Label Extension Phase||1
3237849|NCT02397707|3970392|FG000|STARTED|Overall Study||14
3237850|NCT02397707|3970393|FG001|STARTED|Overall Study||10
3237851|NCT02397707|3970394|FG002|STARTED|Overall Study||9
3237852|NCT02397707|3970392|FG000|COMPLETED|Overall Study||14
3237853|NCT02397707|3970393|FG001|COMPLETED|Overall Study||10
3237854|NCT02397707|3970394|FG002|COMPLETED|Overall Study||9
3237855|NCT02397707|3970392|FG000|NOT COMPLETED|Overall Study||0
3237856|NCT02397707|3970393|FG001|NOT COMPLETED|Overall Study||0
3237857|NCT02397707|3970394|FG002|NOT COMPLETED|Overall Study||0
3237858|NCT02397785|3970405|FG000|STARTED|Overall Study||24
3237859|NCT02397785|3970406|FG001|STARTED|Overall Study||34
3237860|NCT02397785|3970405|FG000|COMPLETED|Overall Study||22
3237861|NCT02397785|3970406|FG001|COMPLETED|Overall Study||25
3237862|NCT02397785|3970405|FG000|NOT COMPLETED|Overall Study||2
3237863|NCT02397785|3970406|FG001|NOT COMPLETED|Overall Study||9
3237864|NCT02397837|3970414|FG000|STARTED|Overall Study||33
3237865|NCT02397837|3970415|FG001|STARTED|Overall Study||30
3237866|NCT02397837|3970414|FG000|COMPLETED|Overall Study||26
3237867|NCT02397837|3970415|FG001|COMPLETED|Overall Study||24
3237868|NCT02397837|3970414|FG000|NOT COMPLETED|Overall Study||7
3237869|NCT02397837|3970415|FG001|NOT COMPLETED|Overall Study||6
3237870|NCT02397889|3970423|FG000|STARTED|Overall Study||15
3237871|NCT02397889|3970424|FG001|STARTED|Overall Study||15
3237872|NCT02397889|3970423|FG000|COMPLETED|Overall Study||14
3237873|NCT02397889|3970424|FG001|COMPLETED|Overall Study||15
3237874|NCT02397889|3970423|FG000|NOT COMPLETED|Overall Study||1
3237875|NCT02397889|3970424|FG001|NOT COMPLETED|Overall Study||0
3237876|NCT02397915|3970430|FG000|STARTED|Period 1||150
3237877|NCT02397915|3970431|FG001|STARTED|Period 1||150
3237878|NCT02397915|3970432|FG002|STARTED|Period 1||0
3237879|NCT02397915|3970433|FG003|STARTED|Period 1||0
3237880|NCT02397915|3970430|FG000|COMPLETED|Period 1||149
3237881|NCT02397915|3970431|FG001|COMPLETED|Period 1||149
3237882|NCT02397915|3970432|FG002|COMPLETED|Period 1||0
3237883|NCT02397915|3970433|FG003|COMPLETED|Period 1||0
3237884|NCT02397915|3970430|FG000|NOT COMPLETED|Period 1||1
3237885|NCT02397915|3970431|FG001|NOT COMPLETED|Period 1||1
3237886|NCT02397915|3970432|FG002|NOT COMPLETED|Period 1||0
3237887|NCT02397915|3970433|FG003|NOT COMPLETED|Period 1||0
3237888|NCT02397915|3970430|FG000|STARTED|Period 2||0
3237889|NCT02397915|3970431|FG001|STARTED|Period 2||0
3237890|NCT02397915|3970432|FG002|STARTED|Period 2||149
3237891|NCT02397915|3970433|FG003|STARTED|Period 2||149
3237892|NCT02397915|3970430|FG000|COMPLETED|Period 2||0
3237893|NCT02397915|3970431|FG001|COMPLETED|Period 2||0
3237894|NCT02397915|3970432|FG002|COMPLETED|Period 2||149
3237895|NCT02397915|3970433|FG003|COMPLETED|Period 2||149
3237896|NCT02397915|3970430|FG000|NOT COMPLETED|Period 2||0
3237897|NCT02397915|3970431|FG001|NOT COMPLETED|Period 2||0
3237898|NCT02397915|3970432|FG002|NOT COMPLETED|Period 2||0
3237899|NCT02397915|3970433|FG003|NOT COMPLETED|Period 2||0
3237900|NCT02397954|3970441|FG000|STARTED|Overall Study||4
3237901|NCT02397954|3970441|FG000|COMPLETED|Overall Study||4
3237902|NCT02397954|3970441|FG000|NOT COMPLETED|Overall Study||0
3237903|NCT02398188|3970447|FG000|STARTED|Overall Study||398
3237904|NCT02398188|3970448|FG001|STARTED|Overall Study||395
3237905|NCT02398188|3970447|FG000|COMPLETED|Overall Study||371
3237906|NCT02398188|3970448|FG001|COMPLETED|Overall Study||361
3237907|NCT02398188|3970447|FG000|NOT COMPLETED|Overall Study||27
3237908|NCT02398188|3970448|FG001|NOT COMPLETED|Overall Study||34
3237909|NCT02398227|3970456|FG000|STARTED|Overall Study||83
3237910|NCT02398227|3970457|FG001|STARTED|Overall Study||89
3237911|NCT02398227|3970456|FG000|COMPLETED|Overall Study||56
3237912|NCT02398227|3970457|FG001|COMPLETED|Overall Study||71
3237913|NCT02398227|3970456|FG000|NOT COMPLETED|Overall Study||27
3237914|NCT02398227|3970457|FG001|NOT COMPLETED|Overall Study||18
3237915|NCT02398409|3970465|FG000|STARTED|Overall Study||69
3237916|NCT02398409|3970466|FG001|STARTED|Overall Study||68
3237917|NCT02398409|3970465|FG000|COMPLETED|Overall Study||67
3237918|NCT02398409|3970466|FG001|COMPLETED|Overall Study||63
3237919|NCT02398409|3970465|FG000|NOT COMPLETED|Overall Study||2
3237920|NCT02398409|3970466|FG001|NOT COMPLETED|Overall Study||5
3237921|NCT02399085|3970472|FG000|STARTED|Overall Study||81
3237922|NCT02399085|3970472|FG000|COMPLETED|Overall Study|30 patients completed the combination treatment on both study drugs (12 cycles).|30
3237923|NCT02399085|3970472|FG000|NOT COMPLETED|Overall Study||51
3237924|NCT02399163|3970476|FG000|STARTED|Overall Study||62
3237925|NCT02399163|3970476|FG000|COMPLETED|Overall Study||53
3237926|NCT02399163|3970476|FG000|NOT COMPLETED|Overall Study||9
3237927|NCT02399228|3970488|FG000|STARTED|Overall Study||13
3237928|NCT02399228|3970488|FG000|COMPLETED|Overall Study||7
3237929|NCT02399228|3970488|FG000|NOT COMPLETED|Overall Study||6
3237930|NCT02399254|3970492|FG000|STARTED|Overall Study||21
3237931|NCT02399254|3970492|FG000|COMPLETED|Overall Study||19
3237932|NCT02399254|3970492|FG000|NOT COMPLETED|Overall Study||2
3237933|NCT02399345|3970497|FG000|STARTED|Overall Study||10
3237934|NCT02399345|3970497|FG000|COMPLETED|Overall Study||10
3237935|NCT02399345|3970497|FG000|NOT COMPLETED|Overall Study||0
3237936|NCT02399475|3970503|FG000|STARTED|Overall Study||7
3237937|NCT02399475|3970504|FG001|STARTED|Overall Study||7
3237938|NCT02399475|3970503|FG000|COMPLETED|Overall Study||6
3237939|NCT02399475|3970504|FG001|COMPLETED|Overall Study||7
3237940|NCT02399475|3970503|FG000|NOT COMPLETED|Overall Study||1
3237941|NCT02399475|3970504|FG001|NOT COMPLETED|Overall Study||0
3237942|NCT02399917|3970513|FG000|STARTED|Overall Study||6
3237943|NCT02399917|3970514|FG001|STARTED|Overall Study||6
3237944|NCT02399917|3970515|FG002|STARTED|Overall Study||24
3237945|NCT02399917|3970513|FG000|COMPLETED|Overall Study||6
3237946|NCT02399917|3970514|FG001|COMPLETED|Overall Study||6
3237947|NCT02399917|3970515|FG002|COMPLETED|Overall Study||24
3237948|NCT02399917|3970513|FG000|NOT COMPLETED|Overall Study||0
3237949|NCT02399917|3970514|FG001|NOT COMPLETED|Overall Study||0
3237950|NCT02399917|3970515|FG002|NOT COMPLETED|Overall Study||0
3237951|NCT02400073|3970524|FG000|STARTED|Overall Study||122
3237952|NCT02400073|3970524|FG000|COMPLETED|Overall Study||111
3237953|NCT02400073|3970524|FG000|NOT COMPLETED|Overall Study||11
3237954|NCT02400307|3970530|FG000|STARTED|Overall Study||11
3237955|NCT02400307|3970531|FG001|STARTED|Overall Study||8
3237956|NCT02400307|3970530|FG000|COMPLETED|Overall Study||10
3237957|NCT02400307|3970531|FG001|COMPLETED|Overall Study||8
3237958|NCT02400307|3970530|FG000|NOT COMPLETED|Overall Study||1
3237959|NCT02400307|3970531|FG001|NOT COMPLETED|Overall Study||0
3237960|NCT02400333|3970541|FG000|STARTED|Overall Study||9
3237961|NCT02400333|3970542|FG001|STARTED|Overall Study||9
3237962|NCT02400333|3970543|FG002|STARTED|Overall Study||9
3237963|NCT02400333|3970544|FG003|STARTED|Overall Study||9
3237964|NCT02400333|3970541|FG000|COMPLETED|Overall Study||8
3237965|NCT02400333|3970542|FG001|COMPLETED|Overall Study||8
3237966|NCT02400333|3970543|FG002|COMPLETED|Overall Study||7
3237967|NCT02400333|3970544|FG003|COMPLETED|Overall Study||7
3237968|NCT02400333|3970541|FG000|NOT COMPLETED|Overall Study||1
3237969|NCT02400333|3970542|FG001|NOT COMPLETED|Overall Study||1
3237970|NCT02400333|3970543|FG002|NOT COMPLETED|Overall Study||2
3237971|NCT02400333|3970544|FG003|NOT COMPLETED|Overall Study||2
3237972|NCT02400346|3970555|FG000|STARTED|Overall Study||132
3237973|NCT02400346|3970555|FG000|COMPLETED|Overall Study||88
3237974|NCT02400346|3970555|FG000|NOT COMPLETED|Overall Study||44
3237975|NCT02400437|3970559|FG000|STARTED|Overall Study||26
3237976|NCT02400437|3970559|FG000|COMPLETED|Overall Study||26
3237977|NCT02400437|3970559|FG000|NOT COMPLETED|Overall Study||0
3237978|NCT02400463|3970565|FG000|STARTED|Overall Study||6
3237979|NCT02400463|3970565|FG000|COMPLETED|Overall Study||6
3237980|NCT02400463|3970565|FG000|NOT COMPLETED|Overall Study||0
3237981|NCT02400580|3970571|FG000|STARTED|Overall Study||91
3237982|NCT02400580|3970572|FG001|STARTED|Overall Study||92
3237983|NCT02400580|3970571|FG000|COMPLETED|Overall Study||89
3237984|NCT02400580|3970572|FG001|COMPLETED|Overall Study||91
3237985|NCT02400580|3970571|FG000|NOT COMPLETED|Overall Study||2
3237986|NCT02400580|3970572|FG001|NOT COMPLETED|Overall Study||1
3237987|NCT02400710|3970580|FG000|STARTED|Overall Study||10
3237988|NCT02400710|3970581|FG001|STARTED|Overall Study||10
3237989|NCT02400710|3970580|FG000|COMPLETED|Overall Study||10
3237990|NCT02400710|3970581|FG001|COMPLETED|Overall Study||10
3237991|NCT02400710|3970580|FG000|NOT COMPLETED|Overall Study||0
3237992|NCT02400710|3970581|FG001|NOT COMPLETED|Overall Study||0
3237993|NCT02400736|3970589|FG000|STARTED|Overall Study||58
3237994|NCT02400736|3970590|FG001|STARTED|Overall Study||61
3237995|NCT02400736|3970589|FG000|COMPLETED|Overall Study||47
3237996|NCT02400736|3970590|FG001|COMPLETED|Overall Study||53
3237997|NCT02400736|3970589|FG000|NOT COMPLETED|Overall Study||11
3237998|NCT02400736|3970590|FG001|NOT COMPLETED|Overall Study||8
3237999|NCT02400749|3970600|FG000|STARTED|Week 0 -16||50
3238000|NCT02400749|3970601|FG001|STARTED|Week 0 -16||50
3238001|NCT02400749|3970600|FG000|COMPLETED|Week 0 -16||39
3238002|NCT02400749|3970601|FG001|COMPLETED|Week 0 -16||44
3238003|NCT02400749|3970600|FG000|NOT COMPLETED|Week 0 -16||11
3238004|NCT02400749|3970601|FG001|NOT COMPLETED|Week 0 -16||6
3238005|NCT02400749|3970600|FG000|STARTED|Week 17 - 32||39
3238006|NCT02400749|3970601|FG001|STARTED|Week 17 - 32||44
3238007|NCT02400749|3970600|FG000|COMPLETED|Week 17 - 32||34
3238008|NCT02400749|3970601|FG001|COMPLETED|Week 17 - 32||41
3238009|NCT02400749|3970600|FG000|NOT COMPLETED|Week 17 - 32||5
3238010|NCT02400749|3970601|FG001|NOT COMPLETED|Week 17 - 32||3
3238011|NCT02400905|3970607|FG000|STARTED|Overall Study||271
3238012|NCT02400905|3970607|FG000|30-Days Follow-up|Overall Study||268
3238013|NCT02400905|3970607|FG000|12-Months Follow-up|Overall Study||256
3238014|NCT02400905|3970607|FG000|24-Months Follow-up|Overall Study||225
3238015|NCT02400905|3970607|FG000|36 Months-Follow-up|Overall Study||208
3238016|NCT02400905|3970607|FG000|COMPLETED|Overall Study||208
3238017|NCT02400905|3970607|FG000|NOT COMPLETED|Overall Study||63
3238018|NCT02400996|3970612|FG000|STARTED|Overall Study||40
3238019|NCT02400996|3970612|FG000|COMPLETED|Overall Study||40
3238020|NCT02400996|3970612|FG000|NOT COMPLETED|Overall Study||0
3238021|NCT02401022|3970618|FG000|STARTED|Overall Study||104
3238022|NCT02401022|3970619|FG001|STARTED|Overall Study||110
3238023|NCT02401022|3970618|FG000|COMPLETED|Overall Study||89
3238024|NCT02401022|3970619|FG001|COMPLETED|Overall Study||90
3238025|NCT02401022|3970618|FG000|NOT COMPLETED|Overall Study||15
3238026|NCT02401022|3970619|FG001|NOT COMPLETED|Overall Study||20
3238027|NCT02401048|3970627|FG000|STARTED|Overall Study||27
3238028|NCT02401048|3970628|FG001|STARTED|Overall Study||34
3238029|NCT02401048|3970627|FG000|COMPLETED|Overall Study||5
3238030|NCT02401048|3970628|FG001|COMPLETED|Overall Study||4
3238031|NCT02401048|3970627|FG000|NOT COMPLETED|Overall Study||22
3238032|NCT02401048|3970628|FG001|NOT COMPLETED|Overall Study||30
3238033|NCT02401230|3970642|FG000|STARTED|Overall Study||26
3238034|NCT02401230|3970643|FG001|STARTED|Overall Study||25
3238035|NCT02401230|3970644|FG002|STARTED|Overall Study||25
3238036|NCT02401230|3970642|FG000|COMPLETED|Overall Study||20
3238037|NCT02401230|3970643|FG001|COMPLETED|Overall Study||19
3238038|NCT02401230|3970644|FG002|COMPLETED|Overall Study||21
3238039|NCT02401230|3970642|FG000|NOT COMPLETED|Overall Study||6
3238040|NCT02401230|3970643|FG001|NOT COMPLETED|Overall Study||6
3238041|NCT02401230|3970644|FG002|NOT COMPLETED|Overall Study||4
3238042|NCT02401256|3970656|FG000|STARTED|Overall Study||70
3238043|NCT02401256|3970656|FG000|Finished Phase 1|Overall Study||64
3238044|NCT02401256|3970656|FG000|Finished Phase 2|Overall Study||58
3238045|NCT02401256|3970656|FG000|Finished Phase 3|Overall Study||53
3238046|NCT02401256|3970656|FG000|Analysed|Overall Study|Volunteers that completed at least until Phase 2 inpatient visit (Volunteers with Efavirenz PK data)|61
3238047|NCT02401256|3970656|FG000|COMPLETED|Overall Study||53
3238048|NCT02401256|3970656|FG000|NOT COMPLETED|Overall Study||17
3238049|NCT02401412|3970664|FG000|STARTED|Overall Study||89
3238050|NCT02401412|3970665|FG001|STARTED|Overall Study||81
3238051|NCT02401412|3970664|FG000|Received Study Device|Overall Study||89
3238052|NCT02401412|3970665|FG001|Received Study Device|Overall Study||80
3238053|NCT02401412|3970664|FG000|COMPLETED|Overall Study||59
3238054|NCT02401412|3970665|FG001|COMPLETED|Overall Study||49
3238055|NCT02401412|3970664|FG000|NOT COMPLETED|Overall Study||30
3238056|NCT02401412|3970665|FG001|NOT COMPLETED|Overall Study||32
3238057|NCT02401464|3970675|FG000|STARTED|Intervention Period 1 (6 Days)||13
3238058|NCT02401464|3970676|FG001|STARTED|Intervention Period 1 (6 Days)||13
3238059|NCT02401464|3970677|FG002|STARTED|Intervention Period 1 (6 Days)||13
3238060|NCT02401464|3970678|FG003|STARTED|Intervention Period 1 (6 Days)||13
3238061|NCT02401464|3970675|FG000|COMPLETED|Intervention Period 1 (6 Days)||13
3238062|NCT02401464|3970676|FG001|COMPLETED|Intervention Period 1 (6 Days)||13
3238063|NCT02401464|3970677|FG002|COMPLETED|Intervention Period 1 (6 Days)||13
3238064|NCT02401464|3970678|FG003|COMPLETED|Intervention Period 1 (6 Days)||13
3238065|NCT02401464|3970675|FG000|NOT COMPLETED|Intervention Period 1 (6 Days)||0
3238066|NCT02401464|3970676|FG001|NOT COMPLETED|Intervention Period 1 (6 Days)||0
3238067|NCT02401464|3970677|FG002|NOT COMPLETED|Intervention Period 1 (6 Days)||0
3238068|NCT02401464|3970678|FG003|NOT COMPLETED|Intervention Period 1 (6 Days)||0
3238069|NCT02401464|3970675|FG000|STARTED|Washout Period (At Least 6 Days)||13
3238070|NCT02401464|3970676|FG001|STARTED|Washout Period (At Least 6 Days)||13
3238071|NCT02401464|3970677|FG002|STARTED|Washout Period (At Least 6 Days)||13
3238072|NCT02401464|3970678|FG003|STARTED|Washout Period (At Least 6 Days)||13
3238073|NCT02401464|3970675|FG000|COMPLETED|Washout Period (At Least 6 Days)||13
3238074|NCT02401464|3970676|FG001|COMPLETED|Washout Period (At Least 6 Days)||13
3238075|NCT02401464|3970677|FG002|COMPLETED|Washout Period (At Least 6 Days)||13
3238076|NCT02401464|3970678|FG003|COMPLETED|Washout Period (At Least 6 Days)||13
3238077|NCT02401464|3970675|FG000|NOT COMPLETED|Washout Period (At Least 6 Days)||0
3238078|NCT02401464|3970676|FG001|NOT COMPLETED|Washout Period (At Least 6 Days)||0
3238079|NCT02401464|3970677|FG002|NOT COMPLETED|Washout Period (At Least 6 Days)||0
3238080|NCT02401464|3970678|FG003|NOT COMPLETED|Washout Period (At Least 6 Days)||0
3238081|NCT02401464|3970675|FG000|STARTED|Intervention Period 2 (6 Days)||13
3238082|NCT02401464|3970676|FG001|STARTED|Intervention Period 2 (6 Days)||13
3238083|NCT02401464|3970677|FG002|STARTED|Intervention Period 2 (6 Days)||13
3238084|NCT02401464|3970678|FG003|STARTED|Intervention Period 2 (6 Days)||13
3238085|NCT02401464|3970675|FG000|COMPLETED|Intervention Period 2 (6 Days)||13
3238086|NCT02401464|3970676|FG001|COMPLETED|Intervention Period 2 (6 Days)||13
3238087|NCT02401464|3970677|FG002|COMPLETED|Intervention Period 2 (6 Days)||13
3238088|NCT02401464|3970678|FG003|COMPLETED|Intervention Period 2 (6 Days)||13
3238089|NCT02401464|3970675|FG000|NOT COMPLETED|Intervention Period 2 (6 Days)||0
3238090|NCT02401464|3970676|FG001|NOT COMPLETED|Intervention Period 2 (6 Days)||0
3238091|NCT02401464|3970677|FG002|NOT COMPLETED|Intervention Period 2 (6 Days)||0
3238092|NCT02401464|3970678|FG003|NOT COMPLETED|Intervention Period 2 (6 Days)||0
3238093|NCT02401529|3970692|FG000|STARTED|Overall Study||59
3238094|NCT02401529|3970693|FG001|STARTED|Overall Study||57
3238095|NCT02401529|3970692|FG000|COMPLETED|Overall Study||50
3238096|NCT02401529|3970693|FG001|COMPLETED|Overall Study||50
3238097|NCT02401529|3970692|FG000|NOT COMPLETED|Overall Study||9
3238098|NCT02401529|3970693|FG001|NOT COMPLETED|Overall Study||7
3238099|NCT02401542|3970703|FG000|STARTED|Overall Study||41
3238100|NCT02401542|3970704|FG001|STARTED|Overall Study||30
3238101|NCT02401542|3970705|FG002|STARTED|Overall Study||0
3238102|NCT02401542|3970703|FG000|COMPLETED|Overall Study||40
3238103|NCT02401542|3970704|FG001|COMPLETED|Overall Study||30
3238104|NCT02401542|3970705|FG002|COMPLETED|Overall Study||0
3238105|NCT02401542|3970703|FG000|NOT COMPLETED|Overall Study||1
3238106|NCT02401542|3970704|FG001|NOT COMPLETED|Overall Study||0
3238107|NCT02401542|3970705|FG002|NOT COMPLETED|Overall Study||0
3238108|NCT02401555|3970718|FG000|STARTED|Overall Study||87
3238109|NCT02401555|3970719|FG001|STARTED|Overall Study||212
3238110|NCT02401555|3970720|FG002|STARTED|Overall Study||120
3238111|NCT02401555|3970718|FG000|COMPLETED|Overall Study||87
3238112|NCT02401555|3970719|FG001|COMPLETED|Overall Study||212
3238113|NCT02401555|3970720|FG002|COMPLETED|Overall Study||120
3238114|NCT02401555|3970718|FG000|NOT COMPLETED|Overall Study||0
3238115|NCT02401555|3970719|FG001|NOT COMPLETED|Overall Study||0
3238116|NCT02401555|3970720|FG002|NOT COMPLETED|Overall Study||0
3238117|NCT02401672|3970730|FG000|STARTED|Overall Study||22
3238118|NCT02401672|3970731|FG001|STARTED|Overall Study||20
3238119|NCT02401672|3970730|FG000|COMPLETED|Overall Study||21
3238120|NCT02401672|3970731|FG001|COMPLETED|Overall Study||17
3238121|NCT02401672|3970730|FG000|NOT COMPLETED|Overall Study||1
3238122|NCT02401672|3970731|FG001|NOT COMPLETED|Overall Study||3
3238123|NCT02401867|3970737|FG000|STARTED|Enrolled||150
3238124|NCT02401867|3970737|FG000|COMPLETED|Enrolled||150
3238125|NCT02401867|3970737|FG000|NOT COMPLETED|Enrolled||0
3238126|NCT02401867|3970737|FG000|STARTED|Specimen Collection||150
3238127|NCT02401867|3970737|FG000|COMPLETED|Specimen Collection|Completed both vaginal self-swab and provider-collected cervical swab|140
3238128|NCT02401867|3970737|FG000|NOT COMPLETED|Specimen Collection||10
3238129|NCT02401867|3970737|FG000|STARTED|Analysis||140
3238130|NCT02401867|3970737|FG000|COMPLETED|Analysis|Comparative analysis of vaginal HPV DNA results and cervical HPV DNA results|131
3238131|NCT02401867|3970737|FG000|NOT COMPLETED|Analysis||9
3238132|NCT02402062|3970742|FG000|STARTED|Overall Study||17
3238133|NCT02402062|3970742|FG000|COMPLETED|Overall Study||17
3238134|NCT02402062|3970742|FG000|NOT COMPLETED|Overall Study||0
3238135|NCT02402127|3970752|FG000|STARTED|First Wear Period (1 Day)||4
3238136|NCT02402127|3970753|FG001|STARTED|First Wear Period (1 Day)||4
3238137|NCT02402127|3970754|FG002|STARTED|First Wear Period (1 Day)||4
3238138|NCT02402127|3970755|FG003|STARTED|First Wear Period (1 Day)||4
3238139|NCT02402127|3970756|FG004|STARTED|First Wear Period (1 Day)||4
3238140|NCT02402127|3970757|FG005|STARTED|First Wear Period (1 Day)||4
3238141|NCT02402127|3970752|FG000|Randomized and Treated|First Wear Period (1 Day)||4
3238142|NCT02402127|3970753|FG001|Randomized and Treated|First Wear Period (1 Day)||4
3238143|NCT02402127|3970754|FG002|Randomized and Treated|First Wear Period (1 Day)||4
3238144|NCT02402127|3970755|FG003|Randomized and Treated|First Wear Period (1 Day)||4
3238145|NCT02402127|3970756|FG004|Randomized and Treated|First Wear Period (1 Day)||4
3238146|NCT02402127|3970757|FG005|Randomized and Treated|First Wear Period (1 Day)||4
3238147|NCT02402127|3970752|FG000|COMPLETED|First Wear Period (1 Day)||4
3238148|NCT02402127|3970753|FG001|COMPLETED|First Wear Period (1 Day)||4
3238149|NCT02402127|3970754|FG002|COMPLETED|First Wear Period (1 Day)||4
3238150|NCT02402127|3970755|FG003|COMPLETED|First Wear Period (1 Day)||4
3238151|NCT02402127|3970756|FG004|COMPLETED|First Wear Period (1 Day)||4
3238152|NCT02402127|3970757|FG005|COMPLETED|First Wear Period (1 Day)||4
3238153|NCT02402127|3970752|FG000|NOT COMPLETED|First Wear Period (1 Day)||0
3238154|NCT02402127|3970753|FG001|NOT COMPLETED|First Wear Period (1 Day)||0
3238155|NCT02402127|3970754|FG002|NOT COMPLETED|First Wear Period (1 Day)||0
3238156|NCT02402127|3970755|FG003|NOT COMPLETED|First Wear Period (1 Day)||0
3238157|NCT02402127|3970756|FG004|NOT COMPLETED|First Wear Period (1 Day)||0
3238158|NCT02402127|3970757|FG005|NOT COMPLETED|First Wear Period (1 Day)||0
3238159|NCT02402127|3970752|FG000|STARTED|Second Wear Period (1 Day)||4
3238160|NCT02402127|3970753|FG001|STARTED|Second Wear Period (1 Day)||4
3238161|NCT02402127|3970754|FG002|STARTED|Second Wear Period (1 Day)||4
3238162|NCT02402127|3970755|FG003|STARTED|Second Wear Period (1 Day)||4
3238163|NCT02402127|3970756|FG004|STARTED|Second Wear Period (1 Day)||4
3238164|NCT02402127|3970757|FG005|STARTED|Second Wear Period (1 Day)||4
3238165|NCT02402127|3970752|FG000|COMPLETED|Second Wear Period (1 Day)||4
3238166|NCT02402127|3970753|FG001|COMPLETED|Second Wear Period (1 Day)||4
3238167|NCT02402127|3970754|FG002|COMPLETED|Second Wear Period (1 Day)||4
3238168|NCT02402127|3970755|FG003|COMPLETED|Second Wear Period (1 Day)||4
3238169|NCT02402127|3970756|FG004|COMPLETED|Second Wear Period (1 Day)||4
3238170|NCT02402127|3970757|FG005|COMPLETED|Second Wear Period (1 Day)||4
3238171|NCT02402127|3970752|FG000|NOT COMPLETED|Second Wear Period (1 Day)||0
3238172|NCT02402127|3970753|FG001|NOT COMPLETED|Second Wear Period (1 Day)||0
3238173|NCT02402127|3970754|FG002|NOT COMPLETED|Second Wear Period (1 Day)||0
3238174|NCT02402127|3970755|FG003|NOT COMPLETED|Second Wear Period (1 Day)||0
3238175|NCT02402127|3970756|FG004|NOT COMPLETED|Second Wear Period (1 Day)||0
3238176|NCT02402127|3970757|FG005|NOT COMPLETED|Second Wear Period (1 Day)||0
3238177|NCT02402127|3970752|FG000|STARTED|Third Wear Period (1 Day)||4
3238178|NCT02402127|3970753|FG001|STARTED|Third Wear Period (1 Day)||4
3238179|NCT02402127|3970754|FG002|STARTED|Third Wear Period (1 Day)||4
3238180|NCT02402127|3970755|FG003|STARTED|Third Wear Period (1 Day)||4
3238181|NCT02402127|3970756|FG004|STARTED|Third Wear Period (1 Day)||4
3238182|NCT02402127|3970757|FG005|STARTED|Third Wear Period (1 Day)||4
3238183|NCT02402127|3970752|FG000|COMPLETED|Third Wear Period (1 Day)||4
3238184|NCT02402127|3970753|FG001|COMPLETED|Third Wear Period (1 Day)||4
3238185|NCT02402127|3970754|FG002|COMPLETED|Third Wear Period (1 Day)||4
3238186|NCT02402127|3970755|FG003|COMPLETED|Third Wear Period (1 Day)||4
3238187|NCT02402127|3970756|FG004|COMPLETED|Third Wear Period (1 Day)||4
3238188|NCT02402127|3970757|FG005|COMPLETED|Third Wear Period (1 Day)||4
3238189|NCT02402127|3970752|FG000|NOT COMPLETED|Third Wear Period (1 Day)||0
3238190|NCT02402127|3970753|FG001|NOT COMPLETED|Third Wear Period (1 Day)||0
3238191|NCT02402127|3970754|FG002|NOT COMPLETED|Third Wear Period (1 Day)||0
3238192|NCT02402127|3970755|FG003|NOT COMPLETED|Third Wear Period (1 Day)||0
3238193|NCT02402127|3970756|FG004|NOT COMPLETED|Third Wear Period (1 Day)||0
3238194|NCT02402127|3970757|FG005|NOT COMPLETED|Third Wear Period (1 Day)||0
3238195|NCT02402153|3970768|FG000|STARTED|Overall Study||18
3238196|NCT02402153|3970768|FG000|COMPLETED|Overall Study||18
3238197|NCT02402153|3970768|FG000|NOT COMPLETED|Overall Study||0
3238198|NCT02402166|3970772|FG000|STARTED|Overall Study||24
3238199|NCT02402166|3970772|FG000|COMPLETED|Overall Study||19
3238200|NCT02402166|3970772|FG000|NOT COMPLETED|Overall Study||5
3238201|NCT02402218|3970793|FG000|STARTED|Overall Study||36
3238202|NCT02402218|3970794|FG001|STARTED|Overall Study||54
3238203|NCT02402218|3970795|FG002|STARTED|Overall Study||54
3238204|NCT02402218|3970793|FG000|Initiated Treatment With LDV/SOF|Overall Study||24
3238205|NCT02402218|3970794|FG001|Initiated Treatment With LDV/SOF|Overall Study||45
3238206|NCT02402218|3970795|FG002|Initiated Treatment With LDV/SOF|Overall Study||41
3238207|NCT02402218|3970793|FG000|Completed Treatment With LDV/SOF|Overall Study||23
3238208|NCT02402218|3970794|FG001|Completed Treatment With LDV/SOF|Overall Study||42
3238209|NCT02402218|3970795|FG002|Completed Treatment With LDV/SOF|Overall Study||39
3238210|NCT02402218|3970793|FG000|Achieved Sustained Virologic Response|Overall Study||22
3238211|NCT02402218|3970794|FG001|Achieved Sustained Virologic Response|Overall Study||41
3238212|NCT02402218|3970795|FG002|Achieved Sustained Virologic Response|Overall Study||37
3238213|NCT02402218|3970793|FG000|COMPLETED|Overall Study||22
3238214|NCT02402218|3970794|FG001|COMPLETED|Overall Study||41
3238215|NCT02402218|3970795|FG002|COMPLETED|Overall Study||37
3238216|NCT02402218|3970793|FG000|NOT COMPLETED|Overall Study||14
3238217|NCT02402218|3970794|FG001|NOT COMPLETED|Overall Study||13
3238218|NCT02402218|3970795|FG002|NOT COMPLETED|Overall Study||17
3238219|NCT02402296|3970805|FG000|STARTED|Overall Study||15
3238220|NCT02402296|3970806|FG001|STARTED|Overall Study||15
3238221|NCT02402296|3970805|FG000|COMPLETED|Overall Study||15
3238222|NCT02402296|3970806|FG001|COMPLETED|Overall Study||15
3238223|NCT02402296|3970805|FG000|NOT COMPLETED|Overall Study||0
3238224|NCT02402296|3970806|FG001|NOT COMPLETED|Overall Study||0
3238225|NCT02402322|3970815|FG000|STARTED|Pretreatment||27
3238226|NCT02402322|3970816|FG001|STARTED|Pretreatment||25
3238227|NCT02402322|3970817|FG002|STARTED|Pretreatment||25
3238228|NCT02402322|3970815|FG000|Posttreatment Measures|Pretreatment||24
3238229|NCT02402322|3970816|FG001|Posttreatment Measures|Pretreatment||24
3238230|NCT02402322|3970817|FG002|Posttreatment Measures|Pretreatment||24
3238231|NCT02402322|3970815|FG000|COMPLETED|Pretreatment||24
3238232|NCT02402322|3970816|FG001|COMPLETED|Pretreatment||24
3238233|NCT02402322|3970817|FG002|COMPLETED|Pretreatment||24
3238234|NCT02402322|3970815|FG000|NOT COMPLETED|Pretreatment||3
3238235|NCT02402322|3970816|FG001|NOT COMPLETED|Pretreatment||1
3238236|NCT02402322|3970817|FG002|NOT COMPLETED|Pretreatment||1
3238237|NCT02402322|3970815|FG000|STARTED|Follow-up||24
3238238|NCT02402322|3970816|FG001|STARTED|Follow-up||24
3238239|NCT02402322|3970817|FG002|STARTED|Follow-up|These individuals were not evaluated at this follow-up as they started an alternative treatment.|24
3238240|NCT02402322|3970815|FG000|COMPLETED|Follow-up||18
3238241|NCT02402322|3970816|FG001|COMPLETED|Follow-up||21
3238242|NCT02402322|3970817|FG002|COMPLETED|Follow-up||0
3238243|NCT02402322|3970815|FG000|NOT COMPLETED|Follow-up||6
3238244|NCT02402322|3970816|FG001|NOT COMPLETED|Follow-up||3
3238245|NCT02402322|3970817|FG002|NOT COMPLETED|Follow-up||24
3238246|NCT02402452|3970827|FG000|STARTED|Overall Study||10
3238247|NCT02402452|3970828|FG001|STARTED|Overall Study||10
3238248|NCT02402452|3970827|FG000|COMPLETED|Overall Study||10
3238249|NCT02402452|3970828|FG001|COMPLETED|Overall Study||10
3238250|NCT02402452|3970827|FG000|NOT COMPLETED|Overall Study||0
3238251|NCT02402452|3970828|FG001|NOT COMPLETED|Overall Study||0
3238252|NCT02402764|3970834|FG000|STARTED|Overall Study||10
3238253|NCT02402764|3970834|FG000|COMPLETED|Overall Study||10
3238254|NCT02402764|3970834|FG000|NOT COMPLETED|Overall Study||0
3238255|NCT02402881|3970840|FG000|STARTED|Pre-Intervention Study Period||2222
3238256|NCT02402881|3970841|FG001|STARTED|Pre-Intervention Study Period||5657
3238257|NCT02402881|3970840|FG000|COMPLETED|Pre-Intervention Study Period||2222
3238258|NCT02402881|3970841|FG001|COMPLETED|Pre-Intervention Study Period||5657
3238259|NCT02402881|3970840|FG000|NOT COMPLETED|Pre-Intervention Study Period||0
3238260|NCT02402881|3970841|FG001|NOT COMPLETED|Pre-Intervention Study Period||0
3238261|NCT02402881|3970840|FG000|STARTED|Post-Intervention Study Period||3111
3238262|NCT02402881|3970841|FG001|STARTED|Post-Intervention Study Period||8662
3238263|NCT02402881|3970840|FG000|COMPLETED|Post-Intervention Study Period||3111
3238264|NCT02402881|3970841|FG001|COMPLETED|Post-Intervention Study Period||8662
3238265|NCT02402881|3970840|FG000|NOT COMPLETED|Post-Intervention Study Period||0
3238266|NCT02402881|3970841|FG001|NOT COMPLETED|Post-Intervention Study Period||0
3238267|NCT02402907|3970849|FG000|STARTED|Overall Study||682
3238268|NCT02402907|3970850|FG001|STARTED|Overall Study||674
3238269|NCT02402907|3970849|FG000|COMPLETED|Overall Study||662
3238270|NCT02402907|3970850|FG001|COMPLETED|Overall Study||647
3238271|NCT02402907|3970849|FG000|NOT COMPLETED|Overall Study||20
3370011|NCT03792672|4101412|FG004|STARTED|Washout Period 2 (10 Days)||4
3370012|NCT03792672|4101413|FG005|STARTED|Washout Period 2 (10 Days)||4
3370013|NCT03792672|4101408|FG000|COMPLETED|Washout Period 2 (10 Days)||4
3370014|NCT03792672|4101409|FG001|COMPLETED|Washout Period 2 (10 Days)||4
3370015|NCT03792672|4101410|FG002|COMPLETED|Washout Period 2 (10 Days)||4
3370016|NCT03792672|4101411|FG003|COMPLETED|Washout Period 2 (10 Days)||4
3370017|NCT03792672|4101412|FG004|COMPLETED|Washout Period 2 (10 Days)||4
3370018|NCT03792672|4101413|FG005|COMPLETED|Washout Period 2 (10 Days)||4
3370019|NCT03792672|4101408|FG000|NOT COMPLETED|Washout Period 2 (10 Days)||0
3370020|NCT03792672|4101409|FG001|NOT COMPLETED|Washout Period 2 (10 Days)||0
3370021|NCT03792672|4101410|FG002|NOT COMPLETED|Washout Period 2 (10 Days)||0
3370022|NCT03792672|4101411|FG003|NOT COMPLETED|Washout Period 2 (10 Days)||0
3370023|NCT03792672|4101412|FG004|NOT COMPLETED|Washout Period 2 (10 Days)||0
3370024|NCT03792672|4101413|FG005|NOT COMPLETED|Washout Period 2 (10 Days)||0
3370025|NCT03792672|4101408|FG000|STARTED|Treatment Period 3 (1 Day)||4
3370026|NCT03792672|4101409|FG001|STARTED|Treatment Period 3 (1 Day)||4
3370027|NCT03792672|4101410|FG002|STARTED|Treatment Period 3 (1 Day)||4
3370028|NCT03792672|4101411|FG003|STARTED|Treatment Period 3 (1 Day)||4
3370029|NCT03792672|4101412|FG004|STARTED|Treatment Period 3 (1 Day)||4
3370030|NCT03792672|4101413|FG005|STARTED|Treatment Period 3 (1 Day)||4
3370031|NCT03792672|4101408|FG000|COMPLETED|Treatment Period 3 (1 Day)||4
3370032|NCT03792672|4101409|FG001|COMPLETED|Treatment Period 3 (1 Day)||4
3370033|NCT03792672|4101410|FG002|COMPLETED|Treatment Period 3 (1 Day)||4
3370034|NCT03792672|4101411|FG003|COMPLETED|Treatment Period 3 (1 Day)||4
3370035|NCT03792672|4101412|FG004|COMPLETED|Treatment Period 3 (1 Day)||4
3370036|NCT03792672|4101413|FG005|COMPLETED|Treatment Period 3 (1 Day)||4
3370037|NCT03792672|4101408|FG000|NOT COMPLETED|Treatment Period 3 (1 Day)||0
3370038|NCT03792672|4101409|FG001|NOT COMPLETED|Treatment Period 3 (1 Day)||0
3370039|NCT03792672|4101410|FG002|NOT COMPLETED|Treatment Period 3 (1 Day)||0
3370040|NCT03792672|4101411|FG003|NOT COMPLETED|Treatment Period 3 (1 Day)||0
3370041|NCT03792672|4101412|FG004|NOT COMPLETED|Treatment Period 3 (1 Day)||0
3370042|NCT03792672|4101413|FG005|NOT COMPLETED|Treatment Period 3 (1 Day)||0
3370043|NCT03792672|4101408|FG000|STARTED|Washout Period 3 (10 Days)||4
3370044|NCT03792672|4101409|FG001|STARTED|Washout Period 3 (10 Days)||4
3370045|NCT03792672|4101410|FG002|STARTED|Washout Period 3 (10 Days)||4
3370046|NCT03792672|4101411|FG003|STARTED|Washout Period 3 (10 Days)||4
3370047|NCT03792672|4101412|FG004|STARTED|Washout Period 3 (10 Days)||4
3370048|NCT03792672|4101413|FG005|STARTED|Washout Period 3 (10 Days)||4
3370049|NCT03792672|4101408|FG000|COMPLETED|Washout Period 3 (10 Days)||3
3370050|NCT03792672|4101409|FG001|COMPLETED|Washout Period 3 (10 Days)||4
3370051|NCT03792672|4101410|FG002|COMPLETED|Washout Period 3 (10 Days)||3
3370052|NCT03792672|4101411|FG003|COMPLETED|Washout Period 3 (10 Days)||2
3370053|NCT03792672|4101412|FG004|COMPLETED|Washout Period 3 (10 Days)||4
3370054|NCT03792672|4101413|FG005|COMPLETED|Washout Period 3 (10 Days)||4
3370055|NCT03792672|4101408|FG000|NOT COMPLETED|Washout Period 3 (10 Days)||1
3370056|NCT03792672|4101409|FG001|NOT COMPLETED|Washout Period 3 (10 Days)||0
3370057|NCT03792672|4101410|FG002|NOT COMPLETED|Washout Period 3 (10 Days)||1
3370058|NCT03792672|4101411|FG003|NOT COMPLETED|Washout Period 3 (10 Days)||2
3370059|NCT03792672|4101412|FG004|NOT COMPLETED|Washout Period 3 (10 Days)||0
3370060|NCT03792672|4101413|FG005|NOT COMPLETED|Washout Period 3 (10 Days)||0
3370061|NCT03792672|4101408|FG000|STARTED|Treatment Period 4 (2 Days)||3
3370062|NCT03792672|4101409|FG001|STARTED|Treatment Period 4 (2 Days)||4
3370063|NCT03792672|4101410|FG002|STARTED|Treatment Period 4 (2 Days)||3
3370064|NCT03792672|4101411|FG003|STARTED|Treatment Period 4 (2 Days)||2
3370065|NCT03792672|4101412|FG004|STARTED|Treatment Period 4 (2 Days)||4
3370066|NCT03792672|4101413|FG005|STARTED|Treatment Period 4 (2 Days)||4
3370067|NCT03792672|4101408|FG000|COMPLETED|Treatment Period 4 (2 Days)||2
3370068|NCT03792672|4101409|FG001|COMPLETED|Treatment Period 4 (2 Days)||4
3370069|NCT03792672|4101410|FG002|COMPLETED|Treatment Period 4 (2 Days)||3
3370070|NCT03792672|4101411|FG003|COMPLETED|Treatment Period 4 (2 Days)||2
3370071|NCT03792672|4101412|FG004|COMPLETED|Treatment Period 4 (2 Days)||4
3370072|NCT03792672|4101413|FG005|COMPLETED|Treatment Period 4 (2 Days)||4
3370073|NCT03792672|4101408|FG000|NOT COMPLETED|Treatment Period 4 (2 Days)||1
3370074|NCT03792672|4101409|FG001|NOT COMPLETED|Treatment Period 4 (2 Days)||0
3370075|NCT03792672|4101410|FG002|NOT COMPLETED|Treatment Period 4 (2 Days)||0
3238272|NCT02402907|3970850|FG001|NOT COMPLETED|Overall Study||27
3238273|NCT02402933|3970856|FG000|STARTED|Overall Study||26
3238274|NCT02402933|3970856|FG000|Received at Least One Dose of Study Drug|Overall Study||22
3238275|NCT02402933|3970856|FG000|COMPLETED|Overall Study||12
3238276|NCT02402933|3970856|FG000|NOT COMPLETED|Overall Study||14
3238277|NCT02403180|3970862|FG000|STARTED|Pre-Treatment Period||36
3238278|NCT02403180|3970863|FG001|STARTED|Pre-Treatment Period||34
3238279|NCT02403180|3970862|FG000|COMPLETED|Pre-Treatment Period||36
3238280|NCT02403180|3970863|FG001|COMPLETED|Pre-Treatment Period||33
3238281|NCT02403180|3970862|FG000|NOT COMPLETED|Pre-Treatment Period||0
3238282|NCT02403180|3970863|FG001|NOT COMPLETED|Pre-Treatment Period||1
3238283|NCT02403180|3970862|FG000|STARTED|Period 1 (5 Days)||36
3238284|NCT02403180|3970863|FG001|STARTED|Period 1 (5 Days)||33
3238285|NCT02403180|3970862|FG000|Randomized|Period 1 (5 Days)||36
3238286|NCT02403180|3970863|FG001|Randomized|Period 1 (5 Days)||33
3238287|NCT02403180|3970862|FG000|COMPLETED|Period 1 (5 Days)||36
3238288|NCT02403180|3970863|FG001|COMPLETED|Period 1 (5 Days)||33
3238289|NCT02403180|3970862|FG000|NOT COMPLETED|Period 1 (5 Days)||0
3238290|NCT02403180|3970863|FG001|NOT COMPLETED|Period 1 (5 Days)||0
3238291|NCT02403180|3970862|FG000|STARTED|Period 2 (5 Days)||36
3238292|NCT02403180|3970863|FG001|STARTED|Period 2 (5 Days)||33
3238293|NCT02403180|3970862|FG000|COMPLETED|Period 2 (5 Days)||36
3238294|NCT02403180|3970863|FG001|COMPLETED|Period 2 (5 Days)||32
3238295|NCT02403180|3970862|FG000|NOT COMPLETED|Period 2 (5 Days)||0
3238296|NCT02403180|3970863|FG001|NOT COMPLETED|Period 2 (5 Days)||1
3238297|NCT02403206|3970871|FG000|STARTED|Overall Study||194
3238298|NCT02403206|3970872|FG001|STARTED|Overall Study||196
3238299|NCT02403206|3970871|FG000|Treated Prior to Randomization|Overall Study||0
3238300|NCT02403206|3970872|FG001|Treated Prior to Randomization|Overall Study||1
3238301|NCT02403206|3970871|FG000|Randomized and Treated|Overall Study||188
3238302|NCT02403206|3970872|FG001|Randomized and Treated|Overall Study||190
3238303|NCT02403206|3970871|FG000|COMPLETED|Overall Study||183
3238304|NCT02403206|3970872|FG001|COMPLETED|Overall Study||186
3238305|NCT02403206|3970871|FG000|NOT COMPLETED|Overall Study||11
3238306|NCT02403206|3970872|FG001|NOT COMPLETED|Overall Study||10
3238307|NCT02403271|3970879|FG000|STARTED|Period 1|All Phase 1b participants went on to participate in Phase 2.|7
3238308|NCT02403271|3970880|FG001|STARTED|Period 1||0
3238309|NCT02403271|3970879|FG000|COMPLETED|Period 1||6
3238310|NCT02403271|3970880|FG001|COMPLETED|Period 1||0
3238311|NCT02403271|3970879|FG000|NOT COMPLETED|Period 1||1
3238312|NCT02403271|3970880|FG001|NOT COMPLETED|Period 1||0
3238313|NCT02403271|3970879|FG000|STARTED|Period 2||0
3238314|NCT02403271|3970880|FG001|STARTED|Period 2|Phase 2 includes all subjects who participated in Phase 1b.|124
3238315|NCT02403271|3970879|FG000|COMPLETED|Period 2||0
3238316|NCT02403271|3970880|FG001|COMPLETED|Period 2||0
3238317|NCT02403271|3970879|FG000|NOT COMPLETED|Period 2||0
3238318|NCT02403271|3970880|FG001|NOT COMPLETED|Period 2||124
3238319|NCT02403479|3970888|FG000|STARTED|Overall Study||10
3238320|NCT02403479|3970889|FG001|STARTED|Overall Study||12
3238321|NCT02403479|3970888|FG000|COMPLETED|Overall Study||8
3238322|NCT02403479|3970889|FG001|COMPLETED|Overall Study||12
3238323|NCT02403479|3970888|FG000|NOT COMPLETED|Overall Study||2
3238324|NCT02403479|3970889|FG001|NOT COMPLETED|Overall Study||0
3238325|NCT02403622|3970897|FG000|STARTED|Overall Study||15
3238326|NCT02403622|3970897|FG000|COMPLETED|Overall Study||13
3238327|NCT02403622|3970897|FG000|NOT COMPLETED|Overall Study||2
3238328|NCT02403635|3970901|FG000|STARTED|Overall Study||27
3238329|NCT02403635|3970901|FG000|Screening (28 Days)|Overall Study||27
3238330|NCT02403635|3970901|FG000|Received the First Dose|Overall Study||18
3238331|NCT02403635|3970901|FG000|COMPLETED|Overall Study||18
3238332|NCT02403635|3970901|FG000|NOT COMPLETED|Overall Study||9
3238333|NCT02403674|3970923|FG000|STARTED|Overall Study||368
3238334|NCT02403674|3970924|FG001|STARTED|Overall Study||366
3238335|NCT02403674|3970923|FG000|Treated|Overall Study||364
3238336|NCT02403674|3970924|FG001|Treated|Overall Study||364
3238337|NCT02403674|3970923|FG000|COMPLETED|Overall Study||313
3238338|NCT02403674|3970924|FG001|COMPLETED|Overall Study||303
3238339|NCT02403674|3970923|FG000|NOT COMPLETED|Overall Study||55
3238340|NCT02403674|3970924|FG001|NOT COMPLETED|Overall Study||63
3238341|NCT02403778|3970932|FG000|STARTED|Overall Study||6
3238342|NCT02403778|3970933|FG001|STARTED|Overall Study||4
3238343|NCT02403778|3970932|FG000|COMPLETED|Overall Study||6
3238344|NCT02403778|3970933|FG001|COMPLETED|Overall Study||4
3238345|NCT02403778|3970932|FG000|NOT COMPLETED|Overall Study||0
3238346|NCT02403778|3970933|FG001|NOT COMPLETED|Overall Study||0
3238347|NCT02403817|3970941|FG000|STARTED|Overall Study||28
3238348|NCT02403817|3970942|FG001|STARTED|Overall Study||2
3238349|NCT02403817|3970941|FG000|COMPLETED|Overall Study||23
3238350|NCT02403817|3970942|FG001|COMPLETED|Overall Study||2
3238351|NCT02403817|3970941|FG000|NOT COMPLETED|Overall Study||5
3238352|NCT02403817|3970942|FG001|NOT COMPLETED|Overall Study||0
3238353|NCT02403830|3970948|FG000|STARTED|Visit 1||15
3238354|NCT02403830|3970949|FG001|STARTED|Visit 1||15
3238355|NCT02403830|3970948|FG000|COMPLETED|Visit 1||15
3238356|NCT02403830|3970949|FG001|COMPLETED|Visit 1||15
3238357|NCT02403830|3970948|FG000|NOT COMPLETED|Visit 1||0
3238358|NCT02403830|3970949|FG001|NOT COMPLETED|Visit 1||0
3238359|NCT02403830|3970948|FG000|STARTED|Visit 2|One subject completed visit 1 and then withdrew from the study for an adverse event (nausea).|14
3238360|NCT02403830|3970949|FG001|STARTED|Visit 2||15
3238361|NCT02403830|3970948|FG000|COMPLETED|Visit 2||14
3238362|NCT02403830|3970949|FG001|COMPLETED|Visit 2||15
3238363|NCT02403830|3970948|FG000|NOT COMPLETED|Visit 2||0
3238364|NCT02403830|3970949|FG001|NOT COMPLETED|Visit 2||0
3238365|NCT02403895|3970955|FG000|STARTED|Overall Study||11
3238366|NCT02403895|3970955|FG000|COMPLETED|Overall Study||11
3238367|NCT02403895|3970955|FG000|NOT COMPLETED|Overall Study||0
3238368|NCT02403986|3970961|FG000|STARTED|Overall Study||26
3238369|NCT02403986|3970962|FG001|STARTED|Overall Study||27
3238370|NCT02403986|3970961|FG000|COMPLETED|Overall Study||21
3238371|NCT02403986|3970962|FG001|COMPLETED|Overall Study||23
3238372|NCT02403986|3970961|FG000|NOT COMPLETED|Overall Study||5
3238373|NCT02403986|3970962|FG001|NOT COMPLETED|Overall Study||4
3238374|NCT02403999|3970971|FG000|STARTED|Overall Study||10
3238375|NCT02403999|3970972|FG001|STARTED|Overall Study||10
3238376|NCT02403999|3970973|FG002|STARTED|Overall Study||11
3238377|NCT02403999|3970971|FG000|COMPLETED|Overall Study||10
3238378|NCT02403999|3970972|FG001|COMPLETED|Overall Study||10
3238379|NCT02403999|3970973|FG002|COMPLETED|Overall Study||11
3238380|NCT02403999|3970971|FG000|NOT COMPLETED|Overall Study||0
3238381|NCT02403999|3970972|FG001|NOT COMPLETED|Overall Study||0
3238382|NCT02403999|3970973|FG002|NOT COMPLETED|Overall Study||0
3238383|NCT02404025|3970981|FG000|STARTED|Overall Study||10
3238384|NCT02404025|3970981|FG000|COMPLETED|Overall Study||6
3238385|NCT02404025|3970981|FG000|NOT COMPLETED|Overall Study||4
3238386|NCT02404103|3970987|FG000|STARTED|Overall Study||14
3238387|NCT02404103|3970988|FG001|STARTED|Overall Study||12
3238388|NCT02404103|3970987|FG000|COMPLETED|Overall Study||10
3238389|NCT02404103|3970988|FG001|COMPLETED|Overall Study||9
3238390|NCT02404103|3970987|FG000|NOT COMPLETED|Overall Study||4
3238391|NCT02404103|3970988|FG001|NOT COMPLETED|Overall Study||3
3238392|NCT02404168|3971004|FG000|STARTED|Overall Study||4
3238393|NCT02404168|3971004|FG000|COMPLETED|Overall Study||4
3238394|NCT02404168|3971004|FG000|NOT COMPLETED|Overall Study||0
3238395|NCT02404220|3971014|FG000|STARTED|Overall Study||5
3238396|NCT02404220|3971015|FG001|STARTED|Overall Study||8
3238397|NCT02404220|3971016|FG002|STARTED|Overall Study||7
3238398|NCT02404220|3971017|FG003|STARTED|Overall Study||10
3238399|NCT02404220|3971014|FG000|COMPLETED|Overall Study||0
3238400|NCT02404220|3971015|FG001|COMPLETED|Overall Study||0
3238401|NCT02404220|3971016|FG002|COMPLETED|Overall Study||0
3238402|NCT02404220|3971017|FG003|COMPLETED|Overall Study||0
3238403|NCT02404220|3971014|FG000|NOT COMPLETED|Overall Study||5
3238404|NCT02404220|3971015|FG001|NOT COMPLETED|Overall Study||8
3238405|NCT02404220|3971016|FG002|NOT COMPLETED|Overall Study||7
3238406|NCT02404220|3971017|FG003|NOT COMPLETED|Overall Study||10
3238407|NCT02404285|3971029|FG000|STARTED|Overall Study||33
3238408|NCT02404285|3971030|FG001|STARTED|Overall Study||35
3238409|NCT02404285|3971029|FG000|COMPLETED|Overall Study||31
3238410|NCT02404285|3971030|FG001|COMPLETED|Overall Study||33
3238411|NCT02404285|3971029|FG000|NOT COMPLETED|Overall Study||2
3238412|NCT02404285|3971030|FG001|NOT COMPLETED|Overall Study||2
3238413|NCT02404311|3971047|FG000|STARTED|Part A: Month 0-18||210
3238414|NCT02404311|3971048|FG001|STARTED|Part A: Month 0-18||42
3238415|NCT02404311|3971049|FG002|STARTED|Part A: Month 0-18||0
3238416|NCT02404311|3971050|FG003|STARTED|Part A: Month 0-18||0
3238417|NCT02404311|3971051|FG004|STARTED|Part A: Month 0-18||0
3238418|NCT02404311|3971047|FG000|Per Protocol|Part A: Month 0-18||185
3238419|NCT02404311|3971048|FG001|Per Protocol|Part A: Month 0-18||37
3238420|NCT02404311|3971049|FG002|Per Protocol|Part A: Month 0-18||0
3238421|NCT02404311|3971050|FG003|Per Protocol|Part A: Month 0-18||0
3238422|NCT02404311|3971051|FG004|Per Protocol|Part A: Month 0-18||0
3238423|NCT02404311|3971047|FG000|Month 6.5 Immunogenicity Timepoint|Part A: Month 0-18||194
3238424|NCT02404311|3971048|FG001|Month 6.5 Immunogenicity Timepoint|Part A: Month 0-18||37
3238425|NCT02404311|3971049|FG002|Month 6.5 Immunogenicity Timepoint|Part A: Month 0-18||0
3238426|NCT02404311|3971050|FG003|Month 6.5 Immunogenicity Timepoint|Part A: Month 0-18||0
3238427|NCT02404311|3971051|FG004|Month 6.5 Immunogenicity Timepoint|Part A: Month 0-18||0
3238428|NCT02404311|3971047|FG000|Month 12.5 Immunogenicity Timepoint|Part A: Month 0-18||186
3238429|NCT02404311|3971048|FG001|Month 12.5 Immunogenicity Timepoint|Part A: Month 0-18||33
3238430|NCT02404311|3971049|FG002|Month 12.5 Immunogenicity Timepoint|Part A: Month 0-18||0
3238431|NCT02404311|3971050|FG003|Month 12.5 Immunogenicity Timepoint|Part A: Month 0-18||0
3238432|NCT02404311|3971051|FG004|Month 12.5 Immunogenicity Timepoint|Part A: Month 0-18||0
3238433|NCT02404311|3971047|FG000|COMPLETED|Part A: Month 0-18||184
3238434|NCT02404311|3971048|FG001|COMPLETED|Part A: Month 0-18||36
3238435|NCT02404311|3971049|FG002|COMPLETED|Part A: Month 0-18||0
3238436|NCT02404311|3971050|FG003|COMPLETED|Part A: Month 0-18||0
3238437|NCT02404311|3971051|FG004|COMPLETED|Part A: Month 0-18||0
3238438|NCT02404311|3971047|FG000|NOT COMPLETED|Part A: Month 0-18||26
3238439|NCT02404311|3971048|FG001|NOT COMPLETED|Part A: Month 0-18||6
3238440|NCT02404311|3971049|FG002|NOT COMPLETED|Part A: Month 0-18||0
3238441|NCT02404311|3971050|FG003|NOT COMPLETED|Part A: Month 0-18||0
3238442|NCT02404311|3971051|FG004|NOT COMPLETED|Part A: Month 0-18||0
3238443|NCT02404311|3971047|FG000|STARTED|Part B: Month 30-36||0
3238444|NCT02404311|3971048|FG001|STARTED|Part B: Month 30-36||0
3238445|NCT02404311|3971049|FG002|STARTED|Part B: Month 30-36||32
3238446|NCT02404311|3971050|FG003|STARTED|Part B: Month 30-36||31
3238447|NCT02404311|3971051|FG004|STARTED|Part B: Month 30-36||7
3238448|NCT02404311|3971047|FG000|Month 30.5 Immunogenicity Timepoint|Part B: Month 30-36||0
3238449|NCT02404311|3971048|FG001|Month 30.5 Immunogenicity Timepoint|Part B: Month 30-36||0
3238450|NCT02404311|3971049|FG002|Month 30.5 Immunogenicity Timepoint|Part B: Month 30-36||28
3238451|NCT02404311|3971050|FG003|Month 30.5 Immunogenicity Timepoint|Part B: Month 30-36||30
3238452|NCT02404311|3971051|FG004|Month 30.5 Immunogenicity Timepoint|Part B: Month 30-36||6
3238453|NCT02404311|3971047|FG000|COMPLETED|Part B: Month 30-36||0
3238454|NCT02404311|3971048|FG001|COMPLETED|Part B: Month 30-36||0
3238455|NCT02404311|3971049|FG002|COMPLETED|Part B: Month 30-36||32
3238456|NCT02404311|3971050|FG003|COMPLETED|Part B: Month 30-36||31
3238457|NCT02404311|3971051|FG004|COMPLETED|Part B: Month 30-36||7
3238458|NCT02404311|3971047|FG000|NOT COMPLETED|Part B: Month 30-36||0
3238459|NCT02404311|3971048|FG001|NOT COMPLETED|Part B: Month 30-36||0
3238460|NCT02404311|3971049|FG002|NOT COMPLETED|Part B: Month 30-36||0
3238461|NCT02404311|3971050|FG003|NOT COMPLETED|Part B: Month 30-36||0
3238462|NCT02404311|3971051|FG004|NOT COMPLETED|Part B: Month 30-36||0
3238463|NCT02404350|3971067|FG000|STARTED|Overall Study||222
3238464|NCT02404350|3971068|FG001|STARTED|Overall Study||220
3238465|NCT02404350|3971069|FG002|STARTED|Overall Study||222
3238466|NCT02404350|3971070|FG003|STARTED|Overall Study||332
3238467|NCT02404350|3971067|FG000|COMPLETED|Overall Study||207
3238468|NCT02404350|3971068|FG001|COMPLETED|Overall Study||214
3238469|NCT02404350|3971069|FG002|COMPLETED|Overall Study||216
3238470|NCT02404350|3971070|FG003|COMPLETED|Overall Study||295
3238471|NCT02404350|3971067|FG000|NOT COMPLETED|Overall Study||15
3238472|NCT02404350|3971068|FG001|NOT COMPLETED|Overall Study||6
3238473|NCT02404350|3971069|FG002|NOT COMPLETED|Overall Study||6
3238474|NCT02404350|3971070|FG003|NOT COMPLETED|Overall Study||37
3370076|NCT03792672|4101411|FG003|NOT COMPLETED|Treatment Period 4 (2 Days)||0
3370077|NCT03792672|4101412|FG004|NOT COMPLETED|Treatment Period 4 (2 Days)||0
3370078|NCT03792672|4101413|FG005|NOT COMPLETED|Treatment Period 4 (2 Days)||0
3370079|NCT03786744|4101425|FG000|STARTED|Overall Study||10
3370080|NCT03786744|4101426|FG001|STARTED|Overall Study||10
3370081|NCT03786744|4101425|FG000|COMPLETED|Overall Study||10
3370082|NCT03786744|4101426|FG001|COMPLETED|Overall Study||10
3370083|NCT03786744|4101425|FG000|NOT COMPLETED|Overall Study||0
3370084|NCT03786744|4101426|FG001|NOT COMPLETED|Overall Study||0
3370085|NCT03782181|4101435|FG000|STARTED|Overall Study||20
3370086|NCT03782181|4101436|FG001|STARTED|Overall Study||20
3370087|NCT03782181|4101435|FG000|COMPLETED|Overall Study||20
3370088|NCT03782181|4101436|FG001|COMPLETED|Overall Study||20
3370089|NCT03782181|4101435|FG000|NOT COMPLETED|Overall Study||0
3370090|NCT03782181|4101436|FG001|NOT COMPLETED|Overall Study||0
3370091|NCT03792191|4101445|FG000|STARTED|Overall Study||140
3370092|NCT03792191|4101446|FG001|STARTED|Overall Study||140
3370093|NCT03792191|4101445|FG000|COMPLETED|Overall Study||140
3370094|NCT03792191|4101446|FG001|COMPLETED|Overall Study||140
3370095|NCT03792191|4101445|FG000|NOT COMPLETED|Overall Study||0
3370096|NCT03792191|4101446|FG001|NOT COMPLETED|Overall Study||0
3370097|NCT03791489|4101452|FG000|STARTED|30 Days||30
3370098|NCT03791489|4101452|FG000|COMPLETED|30 Days||30
3370099|NCT03791489|4101452|FG000|NOT COMPLETED|30 Days||0
3370100|NCT03791489|4101452|FG000|STARTED|90 Days (Primary Endpoint)||30
3370101|NCT03791489|4101452|FG000|COMPLETED|90 Days (Primary Endpoint)||30
3370102|NCT03791489|4101452|FG000|NOT COMPLETED|90 Days (Primary Endpoint)||0
3370103|NCT03790865|4101459|FG000|STARTED|Overall Study||52
3370104|NCT03790865|4101460|FG001|STARTED|Overall Study||52
3370105|NCT03790865|4101461|FG002|STARTED|Overall Study||54
3370106|NCT03790865|4101459|FG000|COMPLETED|Overall Study||52
3370107|NCT03790865|4101460|FG001|COMPLETED|Overall Study||50
3370108|NCT03790865|4101461|FG002|COMPLETED|Overall Study||54
3370109|NCT03790865|4101459|FG000|NOT COMPLETED|Overall Study||0
3370110|NCT03790865|4101460|FG001|NOT COMPLETED|Overall Study||2
3370111|NCT03790865|4101461|FG002|NOT COMPLETED|Overall Study||0
3370112|NCT03784300|4101475|FG000|STARTED|Overall Study||6
3370113|NCT03784300|4101476|FG001|STARTED|Overall Study||2
3370114|NCT03784300|4101477|FG002|STARTED|Overall Study||6
3370115|NCT03784300|4101478|FG003|STARTED|Overall Study||2
3370116|NCT03784300|4101479|FG004|STARTED|Overall Study||6
3370117|NCT03784300|4101480|FG005|STARTED|Overall Study||2
3370118|NCT03784300|4101475|FG000|COMPLETED|Overall Study||6
3370119|NCT03784300|4101476|FG001|COMPLETED|Overall Study||2
3370120|NCT03784300|4101477|FG002|COMPLETED|Overall Study||6
3370121|NCT03784300|4101478|FG003|COMPLETED|Overall Study||2
3370122|NCT03784300|4101479|FG004|COMPLETED|Overall Study||6
3370123|NCT03784300|4101480|FG005|COMPLETED|Overall Study||2
3370124|NCT03784300|4101475|FG000|NOT COMPLETED|Overall Study||0
3370125|NCT03784300|4101476|FG001|NOT COMPLETED|Overall Study||0
3370126|NCT03784300|4101477|FG002|NOT COMPLETED|Overall Study||0
3370127|NCT03784300|4101478|FG003|NOT COMPLETED|Overall Study||0
3370128|NCT03784300|4101479|FG004|NOT COMPLETED|Overall Study||0
3370129|NCT03784300|4101480|FG005|NOT COMPLETED|Overall Study||0
3370130|NCT03790878|4101497|FG000|STARTED|Overall Study||26
3370131|NCT03790878|4101498|FG001|STARTED|Overall Study||27
3370132|NCT03790878|4101499|FG002|STARTED|Overall Study||27
3370133|NCT03790878|4101497|FG000|COMPLETED|Overall Study||26
3370134|NCT03790878|4101498|FG001|COMPLETED|Overall Study||27
3370135|NCT03790878|4101499|FG002|COMPLETED|Overall Study||27
3370136|NCT03790878|4101497|FG000|NOT COMPLETED|Overall Study||0
3370137|NCT03790878|4101498|FG001|NOT COMPLETED|Overall Study||0
3370138|NCT03790878|4101499|FG002|NOT COMPLETED|Overall Study||0
3370139|NCT03789474|4101509|FG000|STARTED|Overall Study||30
3370140|NCT03789474|4101510|FG001|STARTED|Overall Study||30
3370141|NCT03789474|4101509|FG000|COMPLETED|Overall Study||30
3370142|NCT03789474|4101510|FG001|COMPLETED|Overall Study||30
3238475|NCT02404389|3971086|FG000|STARTED|Overall Study||20
3238476|NCT02404389|3971087|FG001|STARTED|Overall Study||20
3238477|NCT02404389|3971088|FG002|STARTED|Overall Study||11
3238478|NCT02404389|3971089|FG003|STARTED|Overall Study||10
3238479|NCT02404389|3971090|FG004|STARTED|Overall Study||21
3238480|NCT02404389|3971086|FG000|COMPLETED|Overall Study||18
3238481|NCT02404389|3971087|FG001|COMPLETED|Overall Study||20
3238482|NCT02404389|3971088|FG002|COMPLETED|Overall Study||10
3238483|NCT02404389|3971089|FG003|COMPLETED|Overall Study||9
3238484|NCT02404389|3971090|FG004|COMPLETED|Overall Study||18
3238485|NCT02404389|3971086|FG000|NOT COMPLETED|Overall Study||2
3238486|NCT02404389|3971087|FG001|NOT COMPLETED|Overall Study||0
3238487|NCT02404389|3971088|FG002|NOT COMPLETED|Overall Study||1
3238488|NCT02404389|3971089|FG003|NOT COMPLETED|Overall Study||1
3238489|NCT02404389|3971090|FG004|NOT COMPLETED|Overall Study||3
3238490|NCT02404441|3971114|FG000|STARTED|Phase 1 Part||16
3238491|NCT02404441|3971115|FG001|STARTED|Phase 1 Part||15
3238492|NCT02404441|3971116|FG002|STARTED|Phase 1 Part||11
3238493|NCT02404441|3971117|FG003|STARTED|Phase 1 Part||6
3238494|NCT02404441|3971118|FG004|STARTED|Phase 1 Part||10
3238495|NCT02404441|3971119|FG005|STARTED|Phase 1 Part||0
3238496|NCT02404441|3971120|FG006|STARTED|Phase 1 Part||0
3238497|NCT02404441|3971121|FG007|STARTED|Phase 1 Part||0
3238498|NCT02404441|3971122|FG008|STARTED|Phase 1 Part||0
3238499|NCT02404441|3971123|FG009|STARTED|Phase 1 Part||0
3238500|NCT02404441|3971114|FG000|COMPLETED|Phase 1 Part||0
3238501|NCT02404441|3971115|FG001|COMPLETED|Phase 1 Part||0
3238502|NCT02404441|3971116|FG002|COMPLETED|Phase 1 Part||0
3238503|NCT02404441|3971117|FG003|COMPLETED|Phase 1 Part||0
3238504|NCT02404441|3971118|FG004|COMPLETED|Phase 1 Part||0
3238505|NCT02404441|3971119|FG005|COMPLETED|Phase 1 Part||0
3238506|NCT02404441|3971120|FG006|COMPLETED|Phase 1 Part||0
3238507|NCT02404441|3971121|FG007|COMPLETED|Phase 1 Part||0
3238508|NCT02404441|3971122|FG008|COMPLETED|Phase 1 Part||0
3238509|NCT02404441|3971123|FG009|COMPLETED|Phase 1 Part||0
3238510|NCT02404441|3971114|FG000|NOT COMPLETED|Phase 1 Part||16
3238511|NCT02404441|3971115|FG001|NOT COMPLETED|Phase 1 Part||15
3238512|NCT02404441|3971116|FG002|NOT COMPLETED|Phase 1 Part||11
3238513|NCT02404441|3971117|FG003|NOT COMPLETED|Phase 1 Part||6
3238514|NCT02404441|3971118|FG004|NOT COMPLETED|Phase 1 Part||10
3238515|NCT02404441|3971119|FG005|NOT COMPLETED|Phase 1 Part||0
3238516|NCT02404441|3971120|FG006|NOT COMPLETED|Phase 1 Part||0
3238517|NCT02404441|3971121|FG007|NOT COMPLETED|Phase 1 Part||0
3238518|NCT02404441|3971122|FG008|NOT COMPLETED|Phase 1 Part||0
3238519|NCT02404441|3971123|FG009|NOT COMPLETED|Phase 1 Part||0
3238520|NCT02404441|3971114|FG000|STARTED|Phase 2 Part||0
3238521|NCT02404441|3971115|FG001|STARTED|Phase 2 Part||0
3238522|NCT02404441|3971116|FG002|STARTED|Phase 2 Part||0
3238523|NCT02404441|3971117|FG003|STARTED|Phase 2 Part||0
3238524|NCT02404441|3971118|FG004|STARTED|Phase 2 Part||0
3238525|NCT02404441|3971119|FG005|STARTED|Phase 2 Part||59
3238526|NCT02404441|3971120|FG006|STARTED|Phase 2 Part||61
3370143|NCT03789474|4101509|FG000|NOT COMPLETED|Overall Study||0
3370144|NCT03789474|4101510|FG001|NOT COMPLETED|Overall Study||0
3370145|NCT03789175|4101516|FG000|STARTED|Week 0 to Week 12 of NR||1
3370146|NCT03789175|4101516|FG000|COMPLETED|Week 0 to Week 12 of NR||1
3370147|NCT03789175|4101516|FG000|NOT COMPLETED|Week 0 to Week 12 of NR||0
3370148|NCT03789175|4101516|FG000|STARTED|Week 12 to Week 24 of NR||1
3370149|NCT03789175|4101516|FG000|COMPLETED|Week 12 to Week 24 of NR|Participant did not meet primary endpoint and completed study at week 24|1
3370150|NCT03789175|4101516|FG000|NOT COMPLETED|Week 12 to Week 24 of NR||0
3370151|NCT03787615|4101522|FG000|STARTED|Overall Study||31
3370152|NCT03787615|4101522|FG000|COMPLETED|Overall Study||27
3370153|NCT03787615|4101522|FG000|NOT COMPLETED|Overall Study||4
3370154|NCT03786718|4101527|FG000|STARTED|Overall Study||67
3370155|NCT03786718|4101527|FG000|COMPLETED|Overall Study||60
3370156|NCT03786718|4101527|FG000|NOT COMPLETED|Overall Study||7
3370157|NCT03784963|4101536|FG000|STARTED|Overall Study||12
3370158|NCT03784963|4101537|FG001|STARTED|Overall Study||10
3370159|NCT03784963|4101538|FG002|STARTED|Overall Study||1
3370160|NCT03784963|4101539|FG003|STARTED|Overall Study||0
3370161|NCT03784963|4101536|FG000|COMPLETED|Overall Study||0
3370162|NCT03784963|4101537|FG001|COMPLETED|Overall Study||0
3370163|NCT03784963|4101538|FG002|COMPLETED|Overall Study||0
3370164|NCT03784963|4101539|FG003|COMPLETED|Overall Study||0
3370165|NCT03784963|4101536|FG000|NOT COMPLETED|Overall Study||12
3370166|NCT03784963|4101537|FG001|NOT COMPLETED|Overall Study||10
3370167|NCT03784963|4101538|FG002|NOT COMPLETED|Overall Study||1
3370168|NCT03784963|4101539|FG003|NOT COMPLETED|Overall Study||0
3370169|NCT03771274|4101549|FG000|STARTED|Overall Study||39
3370170|NCT03771274|4101549|FG000|COMPLETED|Overall Study||39
3370171|NCT03771274|4101549|FG000|NOT COMPLETED|Overall Study||0
3370172|NCT03787472|4101553|FG000|STARTED|Period 1||23
3370173|NCT03787472|4101554|FG001|STARTED|Period 1||22
3370174|NCT03787472|4101553|FG000|COMPLETED|Period 1||23
3370175|NCT03787472|4101554|FG001|COMPLETED|Period 1||22
3370176|NCT03787472|4101553|FG000|NOT COMPLETED|Period 1||0
3370177|NCT03787472|4101554|FG001|NOT COMPLETED|Period 1||0
3370178|NCT03787472|4101553|FG000|STARTED|Period 2||23
3370179|NCT03787472|4101554|FG001|STARTED|Period 2||22
3370180|NCT03787472|4101553|FG000|COMPLETED|Period 2||23
3370181|NCT03787472|4101554|FG001|COMPLETED|Period 2||22
3238527|NCT02404441|3971121|FG007|STARTED|Phase 2 Part||40
3238528|NCT02404441|3971122|FG008|STARTED|Phase 2 Part||59
3238529|NCT02404441|3971123|FG009|STARTED|Phase 2 Part||42
3238530|NCT02404441|3971114|FG000|Entered Post-treatment Follow-up|Phase 2 Part||0
3238531|NCT02404441|3971115|FG001|Entered Post-treatment Follow-up|Phase 2 Part||0
3238532|NCT02404441|3971116|FG002|Entered Post-treatment Follow-up|Phase 2 Part||0
3238533|NCT02404441|3971117|FG003|Entered Post-treatment Follow-up|Phase 2 Part||0
3238534|NCT02404441|3971118|FG004|Entered Post-treatment Follow-up|Phase 2 Part||0
3238535|NCT02404441|3971119|FG005|Entered Post-treatment Follow-up|Phase 2 Part||2
3238536|NCT02404441|3971120|FG006|Entered Post-treatment Follow-up|Phase 2 Part||6
3238537|NCT02404441|3971121|FG007|Entered Post-treatment Follow-up|Phase 2 Part||1
3238538|NCT02404441|3971122|FG008|Entered Post-treatment Follow-up|Phase 2 Part||6
3238539|NCT02404441|3971123|FG009|Entered Post-treatment Follow-up|Phase 2 Part||1
3238540|NCT02404441|3971114|FG000|No Longer Being Followed for Post-treatment Follow-up|Phase 2 Part||0
3238541|NCT02404441|3971115|FG001|No Longer Being Followed for Post-treatment Follow-up|Phase 2 Part||0
3238542|NCT02404441|3971116|FG002|No Longer Being Followed for Post-treatment Follow-up|Phase 2 Part||0
3238543|NCT02404441|3971117|FG003|No Longer Being Followed for Post-treatment Follow-up|Phase 2 Part||0
3238544|NCT02404441|3971118|FG004|No Longer Being Followed for Post-treatment Follow-up|Phase 2 Part||0
3238545|NCT02404441|3971119|FG005|No Longer Being Followed for Post-treatment Follow-up|Phase 2 Part||2
3238546|NCT02404441|3971120|FG006|No Longer Being Followed for Post-treatment Follow-up|Phase 2 Part||6
3238547|NCT02404441|3971121|FG007|No Longer Being Followed for Post-treatment Follow-up|Phase 2 Part||1
3238548|NCT02404441|3971122|FG008|No Longer Being Followed for Post-treatment Follow-up|Phase 2 Part||6
3238549|NCT02404441|3971123|FG009|No Longer Being Followed for Post-treatment Follow-up|Phase 2 Part||1
3238550|NCT02404441|3971114|FG000|Entered Survival Follow-up|Phase 2 Part||0
3238551|NCT02404441|3971115|FG001|Entered Survival Follow-up|Phase 2 Part||0
3238552|NCT02404441|3971116|FG002|Entered Survival Follow-up|Phase 2 Part||0
3238553|NCT02404441|3971117|FG003|Entered Survival Follow-up|Phase 2 Part||0
3238554|NCT02404441|3971118|FG004|Entered Survival Follow-up|Phase 2 Part||0
3238555|NCT02404441|3971119|FG005|Entered Survival Follow-up|Phase 2 Part||38
3238556|NCT02404441|3971120|FG006|Entered Survival Follow-up|Phase 2 Part||34
3238557|NCT02404441|3971121|FG007|Entered Survival Follow-up|Phase 2 Part||26
3238558|NCT02404441|3971122|FG008|Entered Survival Follow-up|Phase 2 Part||35
3238559|NCT02404441|3971123|FG009|Entered Survival Follow-up|Phase 2 Part||25
3238560|NCT02404441|3971114|FG000|COMPLETED|Phase 2 Part||0
3238561|NCT02404441|3971115|FG001|COMPLETED|Phase 2 Part||0
3238562|NCT02404441|3971116|FG002|COMPLETED|Phase 2 Part||0
3238563|NCT02404441|3971117|FG003|COMPLETED|Phase 2 Part||0
3238564|NCT02404441|3971118|FG004|COMPLETED|Phase 2 Part||0
3238565|NCT02404441|3971119|FG005|COMPLETED|Phase 2 Part||0
3238566|NCT02404441|3971120|FG006|COMPLETED|Phase 2 Part||0
3238567|NCT02404441|3971121|FG007|COMPLETED|Phase 2 Part||0
3238568|NCT02404441|3971122|FG008|COMPLETED|Phase 2 Part||0
3238569|NCT02404441|3971123|FG009|COMPLETED|Phase 2 Part||0
3238570|NCT02404441|3971114|FG000|NOT COMPLETED|Phase 2 Part||0
3238571|NCT02404441|3971115|FG001|NOT COMPLETED|Phase 2 Part||0
3238572|NCT02404441|3971116|FG002|NOT COMPLETED|Phase 2 Part||0
3238573|NCT02404441|3971117|FG003|NOT COMPLETED|Phase 2 Part||0
3238574|NCT02404441|3971118|FG004|NOT COMPLETED|Phase 2 Part||0
3238575|NCT02404441|3971119|FG005|NOT COMPLETED|Phase 2 Part||59
3238576|NCT02404441|3971120|FG006|NOT COMPLETED|Phase 2 Part||61
3238577|NCT02404441|3971121|FG007|NOT COMPLETED|Phase 2 Part||40
3238578|NCT02404441|3971122|FG008|NOT COMPLETED|Phase 2 Part||59
3238579|NCT02404441|3971123|FG009|NOT COMPLETED|Phase 2 Part||42
3238580|NCT02404493|3971169|FG000|STARTED|Overall Study||17
3238581|NCT02404493|3971170|FG001|STARTED|Overall Study||6
3238582|NCT02404493|3971169|FG000|COMPLETED|Overall Study||16
3238583|NCT02404493|3971170|FG001|COMPLETED|Overall Study||5
3238584|NCT02404493|3971169|FG000|NOT COMPLETED|Overall Study||1
3238585|NCT02404493|3971170|FG001|NOT COMPLETED|Overall Study||1
3238586|NCT02404532|3971176|FG000|STARTED|Overall Study||29
3370182|NCT03787472|4101553|FG000|NOT COMPLETED|Period 2||0
3370183|NCT03787472|4101554|FG001|NOT COMPLETED|Period 2||0
3370184|NCT03787212|4101560|FG000|STARTED|Period 1||2
3370185|NCT03787212|4101561|FG001|STARTED|Period 1||2
3370186|NCT03787212|4101560|FG000|COMPLETED|Period 1||2
3370187|NCT03787212|4101561|FG001|COMPLETED|Period 1||2
3370188|NCT03787212|4101560|FG000|NOT COMPLETED|Period 1||0
3370189|NCT03787212|4101561|FG001|NOT COMPLETED|Period 1||0
3370190|NCT03787212|4101560|FG000|STARTED|Period 1||2
3370191|NCT03787212|4101561|FG001|STARTED|Period 1||2
3370192|NCT03787212|4101560|FG000|COMPLETED|Period 1||0
3370193|NCT03787212|4101561|FG001|COMPLETED|Period 1||0
3370194|NCT03787212|4101560|FG000|NOT COMPLETED|Period 1||2
3370195|NCT03787212|4101561|FG001|NOT COMPLETED|Period 1||2
3370196|NCT03784001|4101570|FG000|STARTED|Overall Study||46
3370197|NCT03784001|4101571|FG001|STARTED|Overall Study||38
3238587|NCT02404532|3971176|FG000|COMPLETED|Overall Study||29
3238588|NCT02404532|3971176|FG000|NOT COMPLETED|Overall Study||0
3238589|NCT02404610|3971187|FG000|STARTED|Overall Study||54
3238590|NCT02404610|3971188|FG001|STARTED|Overall Study||53
3238591|NCT02404610|3971187|FG000|COMPLETED|Overall Study||54
3238592|NCT02404610|3971188|FG001|COMPLETED|Overall Study||53
3238593|NCT02404610|3971187|FG000|NOT COMPLETED|Overall Study||0
3238594|NCT02404610|3971188|FG001|NOT COMPLETED|Overall Study||0
3238595|NCT02404649|3971196|FG000|STARTED|Overall Study||17
3238596|NCT02404649|3971197|FG001|STARTED|Overall Study||16
3370198|NCT03784001|4101572|FG002|STARTED|Overall Study||41
3238597|NCT02404649|3971196|FG000|COMPLETED|Overall Study||16
3238598|NCT02404649|3971197|FG001|COMPLETED|Overall Study||14
3238599|NCT02404649|3971196|FG000|NOT COMPLETED|Overall Study||1
3238600|NCT02404649|3971197|FG001|NOT COMPLETED|Overall Study||2
3238601|NCT02404792|3971205|FG000|STARTED|Overall Study||32
3238602|NCT02404792|3971206|FG001|STARTED|Overall Study||37
3238603|NCT02404792|3971205|FG000|COMPLETED|Overall Study||27
3238604|NCT02404792|3971206|FG001|COMPLETED|Overall Study||29
3238605|NCT02404792|3971205|FG000|NOT COMPLETED|Overall Study||5
3238606|NCT02404792|3971206|FG001|NOT COMPLETED|Overall Study||8
3238607|NCT02404805|3971220|FG000|STARTED|Overall Study||5
3238608|NCT02404805|3971221|FG001|STARTED|Overall Study||3
3238609|NCT02404805|3971222|FG002|STARTED|Overall Study||5
3238610|NCT02404805|3971223|FG003|STARTED|Overall Study||5
3238611|NCT02404805|3971224|FG004|STARTED|Overall Study||3
3238612|NCT02404805|3971225|FG005|STARTED|Overall Study||4
3238613|NCT02404805|3971220|FG000|COMPLETED|Overall Study||4
3238614|NCT02404805|3971221|FG001|COMPLETED|Overall Study||3
3238615|NCT02404805|3971222|FG002|COMPLETED|Overall Study||5
3238616|NCT02404805|3971223|FG003|COMPLETED|Overall Study||5
3238617|NCT02404805|3971224|FG004|COMPLETED|Overall Study||3
3238618|NCT02404805|3971225|FG005|COMPLETED|Overall Study||4
3238619|NCT02404805|3971220|FG000|NOT COMPLETED|Overall Study||1
3238620|NCT02404805|3971221|FG001|NOT COMPLETED|Overall Study||0
3238621|NCT02404805|3971222|FG002|NOT COMPLETED|Overall Study||0
3238622|NCT02404805|3971223|FG003|NOT COMPLETED|Overall Study||0
3238623|NCT02404805|3971224|FG004|NOT COMPLETED|Overall Study||0
3238624|NCT02404805|3971225|FG005|NOT COMPLETED|Overall Study||0
3238625|NCT02405091|3971237|FG000|STARTED|Overall Study||49
3238626|NCT02405091|3971238|FG001|STARTED|Overall Study||107
3238627|NCT02405091|3971239|FG002|STARTED|Overall Study||11
3238628|NCT02405091|3971237|FG000|COMPLETED|Overall Study||20
3238629|NCT02405091|3971238|FG001|COMPLETED|Overall Study||74
3238630|NCT02405091|3971239|FG002|COMPLETED|Overall Study||9
3238631|NCT02405091|3971237|FG000|NOT COMPLETED|Overall Study||29
3238632|NCT02405091|3971238|FG001|NOT COMPLETED|Overall Study||33
3238633|NCT02405091|3971239|FG002|NOT COMPLETED|Overall Study||2
3238634|NCT02405195|3971250|FG000|STARTED|Overall Study||18
3238635|NCT02405195|3971250|FG000|COMPLETED|Overall Study||18
3238636|NCT02405195|3971250|FG000|NOT COMPLETED|Overall Study||0
3238637|NCT02405325|3971256|FG000|STARTED|Overall Study||267
3238638|NCT02405325|3971257|FG001|STARTED|Overall Study||209
3238639|NCT02405325|3971256|FG000|COMPLETED|Overall Study||203
3238640|NCT02405325|3971257|FG001|COMPLETED|Overall Study||175
3238641|NCT02405325|3971256|FG000|NOT COMPLETED|Overall Study||64
3238642|NCT02405325|3971257|FG001|NOT COMPLETED|Overall Study||34
3238643|NCT02405390|3971265|FG000|STARTED|Overall Study||46
3238644|NCT02405390|3971266|FG001|STARTED|Overall Study||46
3238645|NCT02405390|3971265|FG000|COMPLETED|Overall Study||46
3238646|NCT02405390|3971266|FG001|COMPLETED|Overall Study||46
3238647|NCT02405390|3971265|FG000|NOT COMPLETED|Overall Study||0
3238648|NCT02405390|3971266|FG001|NOT COMPLETED|Overall Study||0
3238649|NCT02405429|3971272|FG000|STARTED|Overall Study||49
3238650|NCT02405429|3971272|FG000|COMPLETED|Overall Study||49
3238651|NCT02405429|3971272|FG000|NOT COMPLETED|Overall Study||0
3238652|NCT02405442|3971280|FG000|STARTED|Double-Blind Phase (up to Week 8)||53
3238653|NCT02405442|3971281|FG001|STARTED|Double-Blind Phase (up to Week 8)||53
3238654|NCT02405442|3971282|FG002|STARTED|Double-Blind Phase (up to Week 8)||53
3238655|NCT02405442|3971283|FG003|STARTED|Double-Blind Phase (up to Week 8)||28
3238656|NCT02405442|3971280|FG000|COMPLETED|Double-Blind Phase (up to Week 8)||52
3238657|NCT02405442|3971281|FG001|COMPLETED|Double-Blind Phase (up to Week 8)||48
3238658|NCT02405442|3971282|FG002|COMPLETED|Double-Blind Phase (up to Week 8)||47
3238659|NCT02405442|3971283|FG003|COMPLETED|Double-Blind Phase (up to Week 8)||27
3238660|NCT02405442|3971280|FG000|NOT COMPLETED|Double-Blind Phase (up to Week 8)||1
3238661|NCT02405442|3971281|FG001|NOT COMPLETED|Double-Blind Phase (up to Week 8)||5
3238662|NCT02405442|3971282|FG002|NOT COMPLETED|Double-Blind Phase (up to Week 8)||6
3238663|NCT02405442|3971283|FG003|NOT COMPLETED|Double-Blind Phase (up to Week 8)||1
3238664|NCT02405442|3971280|FG000|STARTED|Open-Label Phase (up to Week 52)||52
3238665|NCT02405442|3971281|FG001|STARTED|Open-Label Phase (up to Week 52)||48
3238666|NCT02405442|3971282|FG002|STARTED|Open-Label Phase (up to Week 52)||47
3238667|NCT02405442|3971283|FG003|STARTED|Open-Label Phase (up to Week 52)|1 participant completed Double-Blind Phase, but did not continue in Open-Label Phase.|26
3238668|NCT02405442|3971280|FG000|COMPLETED|Open-Label Phase (up to Week 52)||4
3238669|NCT02405442|3971281|FG001|COMPLETED|Open-Label Phase (up to Week 52)||3
3238670|NCT02405442|3971282|FG002|COMPLETED|Open-Label Phase (up to Week 52)||2
3238671|NCT02405442|3971283|FG003|COMPLETED|Open-Label Phase (up to Week 52)||2
3238672|NCT02405442|3971280|FG000|NOT COMPLETED|Open-Label Phase (up to Week 52)||48
3238673|NCT02405442|3971281|FG001|NOT COMPLETED|Open-Label Phase (up to Week 52)||45
3238674|NCT02405442|3971282|FG002|NOT COMPLETED|Open-Label Phase (up to Week 52)||45
3238675|NCT02405442|3971283|FG003|NOT COMPLETED|Open-Label Phase (up to Week 52)||24
3238676|NCT02405442|3971280|FG000|STARTED|Extended Treatment Phase(up to Week 208)|1 participant completed Open-Label Phase, but did not continue in Extended Treatment Phase.|3
3238677|NCT02405442|3971281|FG001|STARTED|Extended Treatment Phase(up to Week 208)|1 participant completed Open-Label Phase, but did not continue in Extended Treatment Phase.|2
3238678|NCT02405442|3971282|FG002|STARTED|Extended Treatment Phase(up to Week 208)||2
3238679|NCT02405442|3971283|FG003|STARTED|Extended Treatment Phase(up to Week 208)||2
3370199|NCT03784001|4101570|FG000|COMPLETED|Overall Study||44
3238680|NCT02405442|3971280|FG000|COMPLETED|Extended Treatment Phase(up to Week 208)||0
3238681|NCT02405442|3971281|FG001|COMPLETED|Extended Treatment Phase(up to Week 208)||0
3238682|NCT02405442|3971282|FG002|COMPLETED|Extended Treatment Phase(up to Week 208)||0
3238683|NCT02405442|3971283|FG003|COMPLETED|Extended Treatment Phase(up to Week 208)||0
3238684|NCT02405442|3971280|FG000|NOT COMPLETED|Extended Treatment Phase(up to Week 208)||3
3238685|NCT02405442|3971281|FG001|NOT COMPLETED|Extended Treatment Phase(up to Week 208)||2
3238686|NCT02405442|3971282|FG002|NOT COMPLETED|Extended Treatment Phase(up to Week 208)||2
3238687|NCT02405442|3971283|FG003|NOT COMPLETED|Extended Treatment Phase(up to Week 208)||2
3238688|NCT02405780|3971301|FG000|STARTED|Period I||216
3238689|NCT02405780|3971302|FG001|STARTED|Period I||108
3238690|NCT02405780|3971303|FG002|STARTED|Period I||108
3238691|NCT02405780|3971304|FG003|STARTED|Period I||213
3238692|NCT02405780|3971301|FG000|COMPLETED|Period I||189
3238693|NCT02405780|3971302|FG001|COMPLETED|Period I||100
3238694|NCT02405780|3971303|FG002|COMPLETED|Period I||93
3238695|NCT02405780|3971304|FG003|COMPLETED|Period I||190
3238696|NCT02405780|3971301|FG000|NOT COMPLETED|Period I||27
3238697|NCT02405780|3971302|FG001|NOT COMPLETED|Period I||8
3238698|NCT02405780|3971303|FG002|NOT COMPLETED|Period I||15
3238699|NCT02405780|3971304|FG003|NOT COMPLETED|Period I||23
3238700|NCT02405780|3971301|FG000|STARTED|Period II||189
3238701|NCT02405780|3971302|FG001|STARTED|Period II||100
3238702|NCT02405780|3971303|FG002|STARTED|Period II||93
3238703|NCT02405780|3971304|FG003|STARTED|Period II||190
3238704|NCT02405780|3971301|FG000|COMPLETED|Period II||174
3238705|NCT02405780|3971302|FG001|COMPLETED|Period II||88
3238706|NCT02405780|3971303|FG002|COMPLETED|Period II||81
3238707|NCT02405780|3971304|FG003|COMPLETED|Period II||172
3238708|NCT02405780|3971301|FG000|NOT COMPLETED|Period II||15
3238709|NCT02405780|3971302|FG001|NOT COMPLETED|Period II||12
3238710|NCT02405780|3971303|FG002|NOT COMPLETED|Period II||12
3238711|NCT02405780|3971304|FG003|NOT COMPLETED|Period II||18
3238712|NCT02405962|3971331|FG000|STARTED|Overall Study||84
3238713|NCT02405962|3971332|FG001|STARTED|Overall Study||84
3238714|NCT02405962|3971331|FG000|Post-intervention|Overall Study||80
3238715|NCT02405962|3971332|FG001|Post-intervention|Overall Study||81
3238716|NCT02405962|3971331|FG000|3 Months After the Intervention|Overall Study||80
3238717|NCT02405962|3971332|FG001|3 Months After the Intervention|Overall Study||79
3238718|NCT02405962|3971331|FG000|COMPLETED|Overall Study||83
3238719|NCT02405962|3971332|FG001|COMPLETED|Overall Study||79
3238720|NCT02405962|3971331|FG000|NOT COMPLETED|Overall Study||1
3238721|NCT02405962|3971332|FG001|NOT COMPLETED|Overall Study||5
3238722|NCT02406027|3971341|FG000|STARTED|Double-blind Treatment Phase (Period 1)||35
3238723|NCT02406027|3971342|FG001|STARTED|Double-blind Treatment Phase (Period 1)||29
3238724|NCT02406027|3971343|FG002|STARTED|Double-blind Treatment Phase (Period 1)||26
3238725|NCT02406027|3971344|FG003|STARTED|Double-blind Treatment Phase (Period 1)||0
3238726|NCT02406027|3971345|FG004|STARTED|Double-blind Treatment Phase (Period 1)||0
3238727|NCT02406027|3971346|FG005|STARTED|Double-blind Treatment Phase (Period 1)||0
3238728|NCT02406027|3971347|FG006|STARTED|Double-blind Treatment Phase (Period 1)||0
3238729|NCT02406027|3971341|FG000|Asymptomatic at Risk|Double-blind Treatment Phase (Period 1)||6
3238730|NCT02406027|3971342|FG001|Asymptomatic at Risk|Double-blind Treatment Phase (Period 1)||8
3238731|NCT02406027|3971343|FG002|Asymptomatic at Risk|Double-blind Treatment Phase (Period 1)||6
3238732|NCT02406027|3971344|FG003|Asymptomatic at Risk|Double-blind Treatment Phase (Period 1)||0
3238733|NCT02406027|3971345|FG004|Asymptomatic at Risk|Double-blind Treatment Phase (Period 1)||0
3238734|NCT02406027|3971346|FG005|Asymptomatic at Risk|Double-blind Treatment Phase (Period 1)||0
3238735|NCT02406027|3971347|FG006|Asymptomatic at Risk|Double-blind Treatment Phase (Period 1)||0
3238736|NCT02406027|3971341|FG000|Prodromal|Double-blind Treatment Phase (Period 1)||29
3238737|NCT02406027|3971342|FG001|Prodromal|Double-blind Treatment Phase (Period 1)||21
3238738|NCT02406027|3971343|FG002|Prodromal|Double-blind Treatment Phase (Period 1)||20
3238739|NCT02406027|3971344|FG003|Prodromal|Double-blind Treatment Phase (Period 1)||0
3238740|NCT02406027|3971345|FG004|Prodromal|Double-blind Treatment Phase (Period 1)||0
3238741|NCT02406027|3971346|FG005|Prodromal|Double-blind Treatment Phase (Period 1)||0
3238742|NCT02406027|3971347|FG006|Prodromal|Double-blind Treatment Phase (Period 1)||0
3238743|NCT02406027|3971341|FG000|COMPLETED|Double-blind Treatment Phase (Period 1)||29
3238744|NCT02406027|3971342|FG001|COMPLETED|Double-blind Treatment Phase (Period 1)||26
3238745|NCT02406027|3971343|FG002|COMPLETED|Double-blind Treatment Phase (Period 1)||22
3238746|NCT02406027|3971344|FG003|COMPLETED|Double-blind Treatment Phase (Period 1)||0
3238747|NCT02406027|3971345|FG004|COMPLETED|Double-blind Treatment Phase (Period 1)||0
3238748|NCT02406027|3971346|FG005|COMPLETED|Double-blind Treatment Phase (Period 1)||0
3238749|NCT02406027|3971347|FG006|COMPLETED|Double-blind Treatment Phase (Period 1)||0
3238750|NCT02406027|3971341|FG000|NOT COMPLETED|Double-blind Treatment Phase (Period 1)||6
3238751|NCT02406027|3971342|FG001|NOT COMPLETED|Double-blind Treatment Phase (Period 1)||3
3238752|NCT02406027|3971343|FG002|NOT COMPLETED|Double-blind Treatment Phase (Period 1)||4
3238753|NCT02406027|3971344|FG003|NOT COMPLETED|Double-blind Treatment Phase (Period 1)||0
3238754|NCT02406027|3971345|FG004|NOT COMPLETED|Double-blind Treatment Phase (Period 1)||0
3238755|NCT02406027|3971346|FG005|NOT COMPLETED|Double-blind Treatment Phase (Period 1)||0
3238756|NCT02406027|3971347|FG006|NOT COMPLETED|Double-blind Treatment Phase (Period 1)||0
3238757|NCT02406027|3971341|FG000|STARTED|Open-label Phase (Period 2)||0
3238758|NCT02406027|3971342|FG001|STARTED|Open-label Phase (Period 2)||0
3238759|NCT02406027|3971343|FG002|STARTED|Open-label Phase (Period 2)||0
3238760|NCT02406027|3971344|FG003|STARTED|Open-label Phase (Period 2)||15
3238761|NCT02406027|3971345|FG004|STARTED|Open-label Phase (Period 2)||14
3238762|NCT02406027|3971346|FG005|STARTED|Open-label Phase (Period 2)||26
3238763|NCT02406027|3971347|FG006|STARTED|Open-label Phase (Period 2)||22
3238764|NCT02406027|3971341|FG000|COMPLETED|Open-label Phase (Period 2)||0
3238765|NCT02406027|3971342|FG001|COMPLETED|Open-label Phase (Period 2)||0
3238766|NCT02406027|3971343|FG002|COMPLETED|Open-label Phase (Period 2)||0
3238767|NCT02406027|3971344|FG003|COMPLETED|Open-label Phase (Period 2)||0
3238768|NCT02406027|3971345|FG004|COMPLETED|Open-label Phase (Period 2)||0
3238769|NCT02406027|3971346|FG005|COMPLETED|Open-label Phase (Period 2)||0
3238770|NCT02406027|3971347|FG006|COMPLETED|Open-label Phase (Period 2)||0
3238771|NCT02406027|3971341|FG000|NOT COMPLETED|Open-label Phase (Period 2)||0
3238772|NCT02406027|3971342|FG001|NOT COMPLETED|Open-label Phase (Period 2)||0
3238773|NCT02406027|3971343|FG002|NOT COMPLETED|Open-label Phase (Period 2)||0
3238774|NCT02406027|3971344|FG003|NOT COMPLETED|Open-label Phase (Period 2)||15
3238775|NCT02406027|3971345|FG004|NOT COMPLETED|Open-label Phase (Period 2)||14
3238776|NCT02406027|3971346|FG005|NOT COMPLETED|Open-label Phase (Period 2)||26
3238777|NCT02406027|3971347|FG006|NOT COMPLETED|Open-label Phase (Period 2)||22
3238778|NCT02406248|3971363|FG000|STARTED|Overall Study||108
3238779|NCT02406248|3971363|FG000|COMPLETED|Overall Study||99
3238780|NCT02406248|3971363|FG000|NOT COMPLETED|Overall Study||9
3238781|NCT02406261|3971369|FG000|STARTED|Period 1||50
3238782|NCT02406261|3971370|FG001|STARTED|Period 1||32
3238783|NCT02406261|3971369|FG000|Received at Least One Dose of Study Drug|Period 1||50
3238784|NCT02406261|3971370|FG001|Received at Least One Dose of Study Drug|Period 1||32
3238785|NCT02406261|3971369|FG000|COMPLETED|Period 1||47
3238786|NCT02406261|3971370|FG001|COMPLETED|Period 1||32
3238787|NCT02406261|3971369|FG000|NOT COMPLETED|Period 1||3
3238788|NCT02406261|3971370|FG001|NOT COMPLETED|Period 1||0
3238789|NCT02406261|3971369|FG000|STARTED|Period 2|Cohort A participated in Period 1 only|0
3238790|NCT02406261|3971370|FG001|STARTED|Period 2||32
3238791|NCT02406261|3971369|FG000|COMPLETED|Period 2||0
3238792|NCT02406261|3971370|FG001|COMPLETED|Period 2||29
3238793|NCT02406261|3971369|FG000|NOT COMPLETED|Period 2||0
3238794|NCT02406261|3971370|FG001|NOT COMPLETED|Period 2||3
3238795|NCT02406443|3971379|FG000|STARTED|Overall Study||18
3238796|NCT02406443|3971380|FG001|STARTED|Overall Study||18
3238797|NCT02406443|3971379|FG000|COMPLETED|Overall Study||16
3238798|NCT02406443|3971380|FG001|COMPLETED|Overall Study||16
3238799|NCT02406443|3971379|FG000|NOT COMPLETED|Overall Study||2
3238800|NCT02406443|3971380|FG001|NOT COMPLETED|Overall Study||2
3238801|NCT02406495|3971386|FG000|STARTED|Overall Study||40
3238802|NCT02406495|3971386|FG000|COMPLETED|Overall Study||40
3238803|NCT02406495|3971386|FG000|NOT COMPLETED|Overall Study||0
3238804|NCT02406573|3971399|FG000|STARTED|Overall Study||30
3238805|NCT02406573|3971399|FG000|COMPLETED|Overall Study||30
3238806|NCT02406573|3971399|FG000|NOT COMPLETED|Overall Study||0
3238807|NCT02406586|3971406|FG000|STARTED|Overall Study||12
3238808|NCT02406586|3971407|FG001|STARTED|Overall Study||12
3238809|NCT02406586|3971408|FG002|STARTED|Overall Study||12
3238810|NCT02406586|3971406|FG000|COMPLETED|Overall Study||11
3238811|NCT02406586|3971407|FG001|COMPLETED|Overall Study||8
3238812|NCT02406586|3971408|FG002|COMPLETED|Overall Study||10
3238813|NCT02406586|3971406|FG000|NOT COMPLETED|Overall Study||1
3238814|NCT02406586|3971407|FG001|NOT COMPLETED|Overall Study||4
3238815|NCT02406586|3971408|FG002|NOT COMPLETED|Overall Study||2
3238816|NCT02406612|3971421|FG000|STARTED|Overall Study||26
3238817|NCT02406612|3971422|FG001|STARTED|Overall Study||21
3238818|NCT02406612|3971421|FG000|COMPLETED|Overall Study||22
3238819|NCT02406612|3971422|FG001|COMPLETED|Overall Study||17
3238820|NCT02406612|3971421|FG000|NOT COMPLETED|Overall Study||4
3238821|NCT02406612|3971422|FG001|NOT COMPLETED|Overall Study||4
3238822|NCT02406651|3971428|FG000|STARTED|Overall Study||30
3238823|NCT02406651|3971428|FG000|COMPLETED|Overall Study||27
3238824|NCT02406651|3971428|FG000|NOT COMPLETED|Overall Study||3
3238825|NCT02406677|3971435|FG000|STARTED|Overall Study||6436
3238826|NCT02406677|3971436|FG001|STARTED|Overall Study||4565
3238827|NCT02406677|3971435|FG000|COMPLETED|Overall Study||6135
3238828|NCT02406677|3971436|FG001|COMPLETED|Overall Study||3967
3238829|NCT02406677|3971435|FG000|NOT COMPLETED|Overall Study||301
3238830|NCT02406677|3971436|FG001|NOT COMPLETED|Overall Study||598
3238831|NCT02406742|3971449|FG000|STARTED|Overall Study||14
3238832|NCT02406742|3971450|FG001|STARTED|Overall Study||16
3238833|NCT02406742|3971451|FG002|STARTED|Overall Study||16
3238834|NCT02406742|3971449|FG000|Dose Escalation 1|Overall Study||3
3238835|NCT02406742|3971450|FG001|Dose Escalation 1|Overall Study||0
3238836|NCT02406742|3971451|FG002|Dose Escalation 1|Overall Study||0
3238837|NCT02406742|3971449|FG000|Dose Escalation 2|Overall Study||9
3238838|NCT02406742|3971450|FG001|Dose Escalation 2|Overall Study||5
3238839|NCT02406742|3971451|FG002|Dose Escalation 2|Overall Study||3
3238840|NCT02406742|3971449|FG000|Dose Escalation 3|Overall Study||2
3238841|NCT02406742|3971450|FG001|Dose Escalation 3|Overall Study||3
3238842|NCT02406742|3971451|FG002|Dose Escalation 3|Overall Study||3
3238843|NCT02406742|3971449|FG000|Dose Escalation 4|Overall Study||0
3238844|NCT02406742|3971450|FG001|Dose Escalation 4|Overall Study||3
3238845|NCT02406742|3971451|FG002|Dose Escalation 4|Overall Study||3
3238846|NCT02406742|3971449|FG000|Dose Escalation 5|Overall Study||0
3238847|NCT02406742|3971450|FG001|Dose Escalation 5|Overall Study||5
3238848|NCT02406742|3971451|FG002|Dose Escalation 5|Overall Study||5
3238849|NCT02406742|3971449|FG000|COMPLETED|Overall Study||0
3238850|NCT02406742|3971450|FG001|COMPLETED|Overall Study||0
3238851|NCT02406742|3971451|FG002|COMPLETED|Overall Study||0
3238852|NCT02406742|3971449|FG000|NOT COMPLETED|Overall Study||14
3238853|NCT02406742|3971450|FG001|NOT COMPLETED|Overall Study||16
3238854|NCT02406742|3971451|FG002|NOT COMPLETED|Overall Study||16
3238855|NCT02406859|3971462|FG000|STARTED|Part 1 - Manometric Parameters||15
3238856|NCT02406859|3971463|FG001|STARTED|Part 1 - Manometric Parameters||14
3238857|NCT02406859|3971464|FG002|STARTED|Part 1 - Manometric Parameters||21
3238858|NCT02406859|3971462|FG000|COMPLETED|Part 1 - Manometric Parameters||12
3238859|NCT02406859|3971463|FG001|COMPLETED|Part 1 - Manometric Parameters||13
3238860|NCT02406859|3971464|FG002|COMPLETED|Part 1 - Manometric Parameters||17
3238861|NCT02406859|3971462|FG000|NOT COMPLETED|Part 1 - Manometric Parameters||3
3238862|NCT02406859|3971463|FG001|NOT COMPLETED|Part 1 - Manometric Parameters||1
3238863|NCT02406859|3971464|FG002|NOT COMPLETED|Part 1 - Manometric Parameters||4
3238864|NCT02406859|3971462|FG000|STARTED|Part 2 - Biofeedback Training||12
3238865|NCT02406859|3971463|FG001|STARTED|Part 2 - Biofeedback Training||13
3238866|NCT02406859|3971464|FG002|STARTED|Part 2 - Biofeedback Training||17
3238867|NCT02406859|3971462|FG000|COMPLETED|Part 2 - Biofeedback Training||12
3238868|NCT02406859|3971463|FG001|COMPLETED|Part 2 - Biofeedback Training||13
3238869|NCT02406859|3971464|FG002|COMPLETED|Part 2 - Biofeedback Training||17
3238870|NCT02406859|3971462|FG000|NOT COMPLETED|Part 2 - Biofeedback Training||0
3238871|NCT02406859|3971463|FG001|NOT COMPLETED|Part 2 - Biofeedback Training||0
3238872|NCT02406859|3971464|FG002|NOT COMPLETED|Part 2 - Biofeedback Training||0
3238873|NCT02406885|3971483|FG000|STARTED|Overall Study||17
3238874|NCT02406885|3971484|FG001|STARTED|Overall Study||16
3238875|NCT02406885|3971483|FG000|COMPLETED|Overall Study||14
3238876|NCT02406885|3971484|FG001|COMPLETED|Overall Study||14
3238877|NCT02406885|3971483|FG000|NOT COMPLETED|Overall Study||3
3238878|NCT02406885|3971484|FG001|NOT COMPLETED|Overall Study||2
3238879|NCT02406937|3971493|FG000|STARTED|Overall Study||60
3238880|NCT02406937|3971494|FG001|STARTED|Overall Study||60
3238881|NCT02406937|3971495|FG002|STARTED|Overall Study||60
3238882|NCT02406937|3971493|FG000|COMPLETED|Overall Study||59
3238883|NCT02406937|3971494|FG001|COMPLETED|Overall Study||59
3238884|NCT02406937|3971495|FG002|COMPLETED|Overall Study||58
3238885|NCT02406937|3971493|FG000|NOT COMPLETED|Overall Study||1
3238886|NCT02406937|3971494|FG001|NOT COMPLETED|Overall Study||1
3238887|NCT02406937|3971495|FG002|NOT COMPLETED|Overall Study||2
3238888|NCT02407041|3971506|FG000|STARTED|Overall Study||5
3238889|NCT02407041|3971506|FG000|COMPLETED|Overall Study||5
3238890|NCT02407041|3971506|FG000|NOT COMPLETED|Overall Study||0
3238891|NCT02407054|3971513|FG000|STARTED|Overall Study||13
3238892|NCT02407054|3971514|FG001|STARTED|Overall Study||65
3238893|NCT02407054|3971515|FG002|STARTED|Overall Study||64
3238894|NCT02407054|3971513|FG000|Received at Least One Dose of Study Drug|Overall Study||13
3238895|NCT02407054|3971514|FG001|Received at Least One Dose of Study Drug|Overall Study||65
3238896|NCT02407054|3971515|FG002|Received at Least One Dose of Study Drug|Overall Study||64
3238897|NCT02407054|3971513|FG000|COMPLETED|Overall Study||6
3238898|NCT02407054|3971514|FG001|COMPLETED|Overall Study||47
3238899|NCT02407054|3971515|FG002|COMPLETED|Overall Study||57
3238900|NCT02407054|3971513|FG000|NOT COMPLETED|Overall Study||7
3238901|NCT02407054|3971514|FG001|NOT COMPLETED|Overall Study||18
3238902|NCT02407054|3971515|FG002|NOT COMPLETED|Overall Study||7
3238903|NCT02407132|3971526|FG000|STARTED|Immediate Post-intervention||110
3238904|NCT02407132|3971527|FG001|STARTED|Immediate Post-intervention||111
3238905|NCT02407132|3971526|FG000|COMPLETED|Immediate Post-intervention||107
3238906|NCT02407132|3971527|FG001|COMPLETED|Immediate Post-intervention||101
3238907|NCT02407132|3971526|FG000|NOT COMPLETED|Immediate Post-intervention||3
3238908|NCT02407132|3971527|FG001|NOT COMPLETED|Immediate Post-intervention||10
3238909|NCT02407132|3971526|FG000|STARTED|6 Months Post-intervention||107
3238910|NCT02407132|3971527|FG001|STARTED|6 Months Post-intervention||101
3238911|NCT02407132|3971526|FG000|COMPLETED|6 Months Post-intervention||96
3238912|NCT02407132|3971527|FG001|COMPLETED|6 Months Post-intervention||92
3238913|NCT02407132|3971526|FG000|NOT COMPLETED|6 Months Post-intervention||11
3238914|NCT02407132|3971527|FG001|NOT COMPLETED|6 Months Post-intervention||9
3238915|NCT02407132|3971526|FG000|STARTED|12 Months Post-intervention||96
3238916|NCT02407132|3971527|FG001|STARTED|12 Months Post-intervention||92
3238917|NCT02407132|3971526|FG000|COMPLETED|12 Months Post-intervention||83
3238918|NCT02407132|3971527|FG001|COMPLETED|12 Months Post-intervention||90
3238919|NCT02407132|3971526|FG000|NOT COMPLETED|12 Months Post-intervention||13
3238920|NCT02407132|3971527|FG001|NOT COMPLETED|12 Months Post-intervention||2
3238921|NCT02407223|3971536|FG000|STARTED|Overall Study||116
3238922|NCT02407223|3971537|FG001|STARTED|Overall Study||118
3238923|NCT02407223|3971538|FG002|STARTED|Overall Study||122
3238924|NCT02407223|3971536|FG000|Early Escape at Week 16|Overall Study|Study discontinuation/completion reported under randomization group|22
3238925|NCT02407223|3971537|FG001|Early Escape at Week 16|Overall Study||0
3238926|NCT02407223|3971538|FG002|Early Escape at Week 16|Overall Study||0
3238927|NCT02407223|3971536|FG000|Cross Over at Week 24|Overall Study|Study discontinuation/completion reported under randomization group|60
3238928|NCT02407223|3971537|FG001|Cross Over at Week 24|Overall Study||0
3238929|NCT02407223|3971538|FG002|Cross Over at Week 24|Overall Study||0
3238930|NCT02407223|3971536|FG000|Qualified Re-randomization at Week 52|Overall Study||0
3238931|NCT02407223|3971537|FG001|Qualified Re-randomization at Week 52|Overall Study||3
3238932|NCT02407223|3971538|FG002|Qualified Re-randomization at Week 52|Overall Study||2
3238933|NCT02407223|3971536|FG000|COMPLETED|Overall Study||0
3238934|NCT02407223|3971537|FG001|COMPLETED|Overall Study||0
3238935|NCT02407223|3971538|FG002|COMPLETED|Overall Study||0
3238936|NCT02407223|3971536|FG000|NOT COMPLETED|Overall Study||116
3238937|NCT02407223|3971537|FG001|NOT COMPLETED|Overall Study||118
3238938|NCT02407223|3971538|FG002|NOT COMPLETED|Overall Study||122
3238939|NCT02407249|3971548|FG000|STARTED|Overall Study||73
3238940|NCT02407249|3971548|FG000|Treated|Overall Study||60
3238941|NCT02407249|3971548|FG000|COMPLETED|Overall Study||47
3238942|NCT02407249|3971548|FG000|NOT COMPLETED|Overall Study||26
3238943|NCT02407457|3971554|FG000|STARTED|Baseline||235
3238944|NCT02407457|3971555|FG001|STARTED|Baseline||220
3238945|NCT02407457|3971554|FG000|COMPLETED|Baseline||235
3238946|NCT02407457|3971555|FG001|COMPLETED|Baseline||220
3238947|NCT02407457|3971554|FG000|NOT COMPLETED|Baseline||0
3238948|NCT02407457|3971555|FG001|NOT COMPLETED|Baseline||0
3238949|NCT02407457|3971554|FG000|STARTED|1 Month||235
3238950|NCT02407457|3971555|FG001|STARTED|1 Month||220
3238951|NCT02407457|3971554|FG000|COMPLETED|1 Month||229
3238952|NCT02407457|3971555|FG001|COMPLETED|1 Month||213
3238953|NCT02407457|3971554|FG000|NOT COMPLETED|1 Month||6
3238954|NCT02407457|3971555|FG001|NOT COMPLETED|1 Month||7
3238955|NCT02407457|3971554|FG000|STARTED|6-Month||231
3238956|NCT02407457|3971555|FG001|STARTED|6-Month||219
3238957|NCT02407457|3971554|FG000|COMPLETED|6-Month||211
3238958|NCT02407457|3971555|FG001|COMPLETED|6-Month||194
3238959|NCT02407457|3971554|FG000|NOT COMPLETED|6-Month||20
3238960|NCT02407457|3971555|FG001|NOT COMPLETED|6-Month||25
3238961|NCT02407457|3971554|FG000|STARTED|1 Year||227
3238962|NCT02407457|3971555|FG001|STARTED|1 Year||208
3238963|NCT02407457|3971554|FG000|COMPLETED|1 Year||194
3238964|NCT02407457|3971555|FG001|COMPLETED|1 Year||180
3238965|NCT02407457|3971554|FG000|NOT COMPLETED|1 Year||33
3238966|NCT02407457|3971555|FG001|NOT COMPLETED|1 Year||28
3238967|NCT02407457|3971554|FG000|STARTED|2-year||218
3238968|NCT02407457|3971555|FG001|STARTED|2-year||194
3238969|NCT02407457|3971554|FG000|COMPLETED|2-year||184
3238970|NCT02407457|3971555|FG001|COMPLETED|2-year||159
3238971|NCT02407457|3971554|FG000|NOT COMPLETED|2-year||34
3238972|NCT02407457|3971555|FG001|NOT COMPLETED|2-year||35
3238973|NCT02407457|3971554|FG000|STARTED|3-year||198
3238974|NCT02407457|3971555|FG001|STARTED|3-year||175
3238975|NCT02407457|3971554|FG000|COMPLETED|3-year||156
3238976|NCT02407457|3971555|FG001|COMPLETED|3-year||137
3238977|NCT02407457|3971554|FG000|NOT COMPLETED|3-year||42
3238978|NCT02407457|3971555|FG001|NOT COMPLETED|3-year||38
3238979|NCT02407457|3971554|FG000|STARTED|4-year||181
3238980|NCT02407457|3971555|FG001|STARTED|4-year||156
3238981|NCT02407457|3971554|FG000|COMPLETED|4-year||100
3238982|NCT02407457|3971555|FG001|COMPLETED|4-year||95
3238983|NCT02407457|3971554|FG000|NOT COMPLETED|4-year||81
3238984|NCT02407457|3971555|FG001|NOT COMPLETED|4-year||61
3238985|NCT02407457|3971554|FG000|STARTED|5-year||123
3238986|NCT02407457|3971555|FG001|STARTED|5-year||113
3238987|NCT02407457|3971554|FG000|COMPLETED|5-year|Due to the time frame of the study - subjects have not passed 5-year.|31
3238988|NCT02407457|3971555|FG001|COMPLETED|5-year||36
3238989|NCT02407457|3971554|FG000|NOT COMPLETED|5-year||92
3238990|NCT02407457|3971555|FG001|NOT COMPLETED|5-year||77
3238991|NCT02407704|3971565|FG000|STARTED|Overall Study||2
3238992|NCT02407704|3971566|FG001|STARTED|Overall Study||3
3238993|NCT02407704|3971567|FG002|STARTED|Overall Study||5
3238994|NCT02407704|3971568|FG003|STARTED|Overall Study||5
3238995|NCT02407704|3971565|FG000|COMPLETED|Overall Study||2
3238996|NCT02407704|3971566|FG001|COMPLETED|Overall Study||3
3238997|NCT02407704|3971567|FG002|COMPLETED|Overall Study||4
3238998|NCT02407704|3971568|FG003|COMPLETED|Overall Study||2
3238999|NCT02407704|3971565|FG000|NOT COMPLETED|Overall Study||0
3239000|NCT02407704|3971566|FG001|NOT COMPLETED|Overall Study||0
3239001|NCT02407704|3971567|FG002|NOT COMPLETED|Overall Study||1
3239002|NCT02407704|3971568|FG003|NOT COMPLETED|Overall Study||3
3239003|NCT02407756|3971586|FG000|STARTED|Overall Study||20
3239004|NCT02407756|3971587|FG001|STARTED|Overall Study||18
3239005|NCT02407756|3971588|FG002|STARTED|Overall Study||20
3239006|NCT02407756|3971589|FG003|STARTED|Overall Study||19
3239007|NCT02407756|3971586|FG000|Treated|Overall Study||20
3239008|NCT02407756|3971587|FG001|Treated|Overall Study||18
3239009|NCT02407756|3971588|FG002|Treated|Overall Study||20
3239010|NCT02407756|3971589|FG003|Treated|Overall Study||19
3239011|NCT02407756|3971586|FG000|COMPLETED|Overall Study||20
3239012|NCT02407756|3971587|FG001|COMPLETED|Overall Study||18
3239013|NCT02407756|3971588|FG002|COMPLETED|Overall Study||20
3239014|NCT02407756|3971589|FG003|COMPLETED|Overall Study||19
3239015|NCT02407756|3971586|FG000|NOT COMPLETED|Overall Study||0
3239016|NCT02407756|3971587|FG001|NOT COMPLETED|Overall Study||0
3239017|NCT02407756|3971588|FG002|NOT COMPLETED|Overall Study||0
3239018|NCT02407756|3971589|FG003|NOT COMPLETED|Overall Study||0
3239019|NCT02407990|3971607|FG000|STARTED|Overall Study||3
3239020|NCT02407990|3971608|FG001|STARTED|Overall Study||26
3239021|NCT02407990|3971609|FG002|STARTED|Overall Study||26
3239022|NCT02407990|3971610|FG003|STARTED|Overall Study||7
3239023|NCT02407990|3971611|FG004|STARTED|Overall Study||21
3239024|NCT02407990|3971612|FG005|STARTED|Overall Study||20
3239025|NCT02407990|3971613|FG006|STARTED|Overall Study||13
3239026|NCT02407990|3971614|FG007|STARTED|Overall Study||335
3239027|NCT02407990|3971607|FG000|COMPLETED|Overall Study||0
3239028|NCT02407990|3971608|FG001|COMPLETED|Overall Study||0
3239029|NCT02407990|3971609|FG002|COMPLETED|Overall Study||0
3239030|NCT02407990|3971610|FG003|COMPLETED|Overall Study||0
3239031|NCT02407990|3971611|FG004|COMPLETED|Overall Study||0
3239032|NCT02407990|3971612|FG005|COMPLETED|Overall Study||0
3239033|NCT02407990|3971613|FG006|COMPLETED|Overall Study||0
3239034|NCT02407990|3971614|FG007|COMPLETED|Overall Study||0
3239035|NCT02407990|3971607|FG000|NOT COMPLETED|Overall Study||3
3239036|NCT02407990|3971608|FG001|NOT COMPLETED|Overall Study||26
3239037|NCT02407990|3971609|FG002|NOT COMPLETED|Overall Study||26
3239038|NCT02407990|3971610|FG003|NOT COMPLETED|Overall Study||7
3239039|NCT02407990|3971611|FG004|NOT COMPLETED|Overall Study||21
3239040|NCT02407990|3971612|FG005|NOT COMPLETED|Overall Study||20
3239041|NCT02407990|3971613|FG006|NOT COMPLETED|Overall Study||13
3239042|NCT02407990|3971614|FG007|NOT COMPLETED|Overall Study||335
3239043|NCT02408016|3971641|FG000|STARTED|Overall Study||6
3239044|NCT02408016|3971642|FG001|STARTED|Overall Study||4
3239045|NCT02408016|3971643|FG002|STARTED|Overall Study||0
3239046|NCT02408016|3971641|FG000|COMPLETED|Overall Study||0
3239047|NCT02408016|3971642|FG001|COMPLETED|Overall Study||1
3239048|NCT02408016|3971643|FG002|COMPLETED|Overall Study||0
3239049|NCT02408016|3971641|FG000|NOT COMPLETED|Overall Study||6
3239050|NCT02408016|3971642|FG001|NOT COMPLETED|Overall Study||3
3239051|NCT02408016|3971643|FG002|NOT COMPLETED|Overall Study||0
3239052|NCT02408068|3971651|FG000|STARTED|Treatment 1 (1.5 Days)||3
3239053|NCT02408068|3971652|FG001|STARTED|Treatment 1 (1.5 Days)||3
3239054|NCT02408068|3971653|FG002|STARTED|Treatment 1 (1.5 Days)||3
3239055|NCT02408068|3971654|FG003|STARTED|Treatment 1 (1.5 Days)||3
3239056|NCT02408068|3971655|FG004|STARTED|Treatment 1 (1.5 Days)||3
3239057|NCT02408068|3971656|FG005|STARTED|Treatment 1 (1.5 Days)||3
3239058|NCT02408068|3971651|FG000|COMPLETED|Treatment 1 (1.5 Days)||3
3239059|NCT02408068|3971652|FG001|COMPLETED|Treatment 1 (1.5 Days)||3
3239060|NCT02408068|3971653|FG002|COMPLETED|Treatment 1 (1.5 Days)||3
3239061|NCT02408068|3971654|FG003|COMPLETED|Treatment 1 (1.5 Days)||3
3239062|NCT02408068|3971655|FG004|COMPLETED|Treatment 1 (1.5 Days)||3
3239063|NCT02408068|3971656|FG005|COMPLETED|Treatment 1 (1.5 Days)||3
3239064|NCT02408068|3971651|FG000|NOT COMPLETED|Treatment 1 (1.5 Days)||0
3239065|NCT02408068|3971652|FG001|NOT COMPLETED|Treatment 1 (1.5 Days)||0
3239066|NCT02408068|3971653|FG002|NOT COMPLETED|Treatment 1 (1.5 Days)||0
3239067|NCT02408068|3971654|FG003|NOT COMPLETED|Treatment 1 (1.5 Days)||0
3239068|NCT02408068|3971655|FG004|NOT COMPLETED|Treatment 1 (1.5 Days)||0
3239069|NCT02408068|3971656|FG005|NOT COMPLETED|Treatment 1 (1.5 Days)||0
3239070|NCT02408068|3971651|FG000|STARTED|Washout Period 1 (7 Days)||3
3239071|NCT02408068|3971652|FG001|STARTED|Washout Period 1 (7 Days)||3
3239072|NCT02408068|3971653|FG002|STARTED|Washout Period 1 (7 Days)||3
3239073|NCT02408068|3971654|FG003|STARTED|Washout Period 1 (7 Days)||3
3239074|NCT02408068|3971655|FG004|STARTED|Washout Period 1 (7 Days)||3
3239075|NCT02408068|3971656|FG005|STARTED|Washout Period 1 (7 Days)||3
3239076|NCT02408068|3971651|FG000|COMPLETED|Washout Period 1 (7 Days)||3
3239077|NCT02408068|3971652|FG001|COMPLETED|Washout Period 1 (7 Days)||3
3239078|NCT02408068|3971653|FG002|COMPLETED|Washout Period 1 (7 Days)||3
3239079|NCT02408068|3971654|FG003|COMPLETED|Washout Period 1 (7 Days)||3
3239080|NCT02408068|3971655|FG004|COMPLETED|Washout Period 1 (7 Days)||3
3239081|NCT02408068|3971656|FG005|COMPLETED|Washout Period 1 (7 Days)||3
3239082|NCT02408068|3971651|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0
3239083|NCT02408068|3971652|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0
3239084|NCT02408068|3971653|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||0
3239085|NCT02408068|3971654|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||0
3239086|NCT02408068|3971655|FG004|NOT COMPLETED|Washout Period 1 (7 Days)||0
3239087|NCT02408068|3971656|FG005|NOT COMPLETED|Washout Period 1 (7 Days)||0
3239088|NCT02408068|3971651|FG000|STARTED|Treatment 2 (1.5 Days)||3
3239089|NCT02408068|3971652|FG001|STARTED|Treatment 2 (1.5 Days)||3
3239090|NCT02408068|3971653|FG002|STARTED|Treatment 2 (1.5 Days)||3
3239091|NCT02408068|3971654|FG003|STARTED|Treatment 2 (1.5 Days)||3
3239092|NCT02408068|3971655|FG004|STARTED|Treatment 2 (1.5 Days)||3
3239093|NCT02408068|3971656|FG005|STARTED|Treatment 2 (1.5 Days)||3
3239094|NCT02408068|3971651|FG000|COMPLETED|Treatment 2 (1.5 Days)||3
3239095|NCT02408068|3971652|FG001|COMPLETED|Treatment 2 (1.5 Days)||3
3239096|NCT02408068|3971653|FG002|COMPLETED|Treatment 2 (1.5 Days)||3
3239097|NCT02408068|3971654|FG003|COMPLETED|Treatment 2 (1.5 Days)||3
3239098|NCT02408068|3971655|FG004|COMPLETED|Treatment 2 (1.5 Days)||3
3239099|NCT02408068|3971656|FG005|COMPLETED|Treatment 2 (1.5 Days)||3
3239100|NCT02408068|3971651|FG000|NOT COMPLETED|Treatment 2 (1.5 Days)||0
3239101|NCT02408068|3971652|FG001|NOT COMPLETED|Treatment 2 (1.5 Days)||0
3239102|NCT02408068|3971653|FG002|NOT COMPLETED|Treatment 2 (1.5 Days)||0
3239103|NCT02408068|3971654|FG003|NOT COMPLETED|Treatment 2 (1.5 Days)||0
3239104|NCT02408068|3971655|FG004|NOT COMPLETED|Treatment 2 (1.5 Days)||0
3239105|NCT02408068|3971656|FG005|NOT COMPLETED|Treatment 2 (1.5 Days)||0
3239106|NCT02408068|3971651|FG000|STARTED|Washout Period 2 (7 Days)||3
3239107|NCT02408068|3971652|FG001|STARTED|Washout Period 2 (7 Days)||3
3239108|NCT02408068|3971653|FG002|STARTED|Washout Period 2 (7 Days)||3
3239109|NCT02408068|3971654|FG003|STARTED|Washout Period 2 (7 Days)||3
3239110|NCT02408068|3971655|FG004|STARTED|Washout Period 2 (7 Days)||3
3239111|NCT02408068|3971656|FG005|STARTED|Washout Period 2 (7 Days)||3
3239112|NCT02408068|3971651|FG000|COMPLETED|Washout Period 2 (7 Days)||3
3239113|NCT02408068|3971652|FG001|COMPLETED|Washout Period 2 (7 Days)||3
3239114|NCT02408068|3971653|FG002|COMPLETED|Washout Period 2 (7 Days)||3
3239115|NCT02408068|3971654|FG003|COMPLETED|Washout Period 2 (7 Days)||3
3239116|NCT02408068|3971655|FG004|COMPLETED|Washout Period 2 (7 Days)||3
3239117|NCT02408068|3971656|FG005|COMPLETED|Washout Period 2 (7 Days)||3
3239118|NCT02408068|3971651|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||0
3239119|NCT02408068|3971652|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0
3239120|NCT02408068|3971653|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0
3239121|NCT02408068|3971654|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||0
3239122|NCT02408068|3971655|FG004|NOT COMPLETED|Washout Period 2 (7 Days)||0
3239123|NCT02408068|3971656|FG005|NOT COMPLETED|Washout Period 2 (7 Days)||0
3239124|NCT02408068|3971651|FG000|STARTED|Treatment 3 (1.5 Days)||3
3239125|NCT02408068|3971652|FG001|STARTED|Treatment 3 (1.5 Days)||3
3239126|NCT02408068|3971653|FG002|STARTED|Treatment 3 (1.5 Days)||3
3239127|NCT02408068|3971654|FG003|STARTED|Treatment 3 (1.5 Days)||3
3239128|NCT02408068|3971655|FG004|STARTED|Treatment 3 (1.5 Days)||3
3239129|NCT02408068|3971656|FG005|STARTED|Treatment 3 (1.5 Days)||3
3239130|NCT02408068|3971651|FG000|COMPLETED|Treatment 3 (1.5 Days)||3
3239131|NCT02408068|3971652|FG001|COMPLETED|Treatment 3 (1.5 Days)||3
3239132|NCT02408068|3971653|FG002|COMPLETED|Treatment 3 (1.5 Days)||2
3239133|NCT02408068|3971654|FG003|COMPLETED|Treatment 3 (1.5 Days)||3
3239134|NCT02408068|3971655|FG004|COMPLETED|Treatment 3 (1.5 Days)||3
3239135|NCT02408068|3971656|FG005|COMPLETED|Treatment 3 (1.5 Days)||3
3239136|NCT02408068|3971651|FG000|NOT COMPLETED|Treatment 3 (1.5 Days)||0
3370200|NCT03784001|4101571|FG001|COMPLETED|Overall Study||38
3370201|NCT03784001|4101572|FG002|COMPLETED|Overall Study||40
3370202|NCT03784001|4101570|FG000|NOT COMPLETED|Overall Study||2
3370203|NCT03784001|4101571|FG001|NOT COMPLETED|Overall Study||0
3370204|NCT03784001|4101572|FG002|NOT COMPLETED|Overall Study||1
3370205|NCT03784898|4101580|FG000|STARTED|Overall Study||13
3370206|NCT03784898|4101580|FG000|COMPLETED|Overall Study||13
3370207|NCT03784898|4101580|FG000|NOT COMPLETED|Overall Study||0
3370208|NCT03783702|4101586|FG000|STARTED|Overall Study||56
3370209|NCT03783702|4101587|FG001|STARTED|Overall Study||62
3370210|NCT03783702|4101586|FG000|COMPLETED|Overall Study||49
3370211|NCT03783702|4101587|FG001|COMPLETED|Overall Study||51
3370212|NCT03783702|4101586|FG000|NOT COMPLETED|Overall Study||7
3370213|NCT03783702|4101587|FG001|NOT COMPLETED|Overall Study||11
3370214|NCT03781479|4101596|FG000|STARTED|Overall Study||6
3370215|NCT03781479|4101597|FG001|STARTED|Overall Study||6
3370216|NCT03781479|4101598|FG002|STARTED|Overall Study||1
3370217|NCT03781479|4101596|FG000|COMPLETED|Overall Study||6
3370218|NCT03781479|4101597|FG001|COMPLETED|Overall Study||6
3370219|NCT03781479|4101598|FG002|COMPLETED|Overall Study||0
3370220|NCT03781479|4101596|FG000|NOT COMPLETED|Overall Study||0
3370221|NCT03781479|4101597|FG001|NOT COMPLETED|Overall Study||0
3370222|NCT03781479|4101598|FG002|NOT COMPLETED|Overall Study||1
3370223|NCT03781037|4101604|FG000|STARTED|Overall Study||18
3370224|NCT03781037|4101604|FG000|COMPLETED|Overall Study||18
3370225|NCT03781037|4101604|FG000|NOT COMPLETED|Overall Study||0
3370226|NCT03784079|4101616|FG000|STARTED|Part 1: Up to Day 24||6
3370227|NCT03784079|4101617|FG001|STARTED|Part 1: Up to Day 24||6
3370228|NCT03784079|4101618|FG002|STARTED|Part 1: Up to Day 24||2
3370229|NCT03784079|4101619|FG003|STARTED|Part 1: Up to Day 24||0
3370230|NCT03784079|4101620|FG004|STARTED|Part 1: Up to Day 24||0
3370231|NCT03784079|4101621|FG005|STARTED|Part 1: Up to Day 24||0
3370232|NCT03784079|4101622|FG006|STARTED|Part 1: Up to Day 24||0
3370233|NCT03784079|4101616|FG000|COMPLETED|Part 1: Up to Day 24||6
3370234|NCT03784079|4101617|FG001|COMPLETED|Part 1: Up to Day 24||6
3370235|NCT03784079|4101618|FG002|COMPLETED|Part 1: Up to Day 24||2
3370236|NCT03784079|4101619|FG003|COMPLETED|Part 1: Up to Day 24||0
3370237|NCT03784079|4101620|FG004|COMPLETED|Part 1: Up to Day 24||0
3370238|NCT03784079|4101621|FG005|COMPLETED|Part 1: Up to Day 24||0
3370239|NCT03784079|4101622|FG006|COMPLETED|Part 1: Up to Day 24||0
3370240|NCT03784079|4101616|FG000|NOT COMPLETED|Part 1: Up to Day 24||0
3370241|NCT03784079|4101617|FG001|NOT COMPLETED|Part 1: Up to Day 24||0
3370242|NCT03784079|4101618|FG002|NOT COMPLETED|Part 1: Up to Day 24||0
3370243|NCT03784079|4101619|FG003|NOT COMPLETED|Part 1: Up to Day 24||0
3370244|NCT03784079|4101620|FG004|NOT COMPLETED|Part 1: Up to Day 24||0
3370245|NCT03784079|4101621|FG005|NOT COMPLETED|Part 1: Up to Day 24||0
3370246|NCT03784079|4101622|FG006|NOT COMPLETED|Part 1: Up to Day 24||0
3370247|NCT03784079|4101616|FG000|STARTED|Part 2: Up to Day 12||0
3370248|NCT03784079|4101617|FG001|STARTED|Part 2: Up to Day 12||0
3370249|NCT03784079|4101618|FG002|STARTED|Part 2: Up to Day 12||0
3370250|NCT03784079|4101619|FG003|STARTED|Part 2: Up to Day 12||6
3370251|NCT03784079|4101620|FG004|STARTED|Part 2: Up to Day 12||6
3370252|NCT03784079|4101621|FG005|STARTED|Part 2: Up to Day 12||6
3370253|NCT03784079|4101622|FG006|STARTED|Part 2: Up to Day 12||2
3370254|NCT03784079|4101616|FG000|COMPLETED|Part 2: Up to Day 12||0
3370255|NCT03784079|4101617|FG001|COMPLETED|Part 2: Up to Day 12||0
3370256|NCT03784079|4101618|FG002|COMPLETED|Part 2: Up to Day 12||0
3370257|NCT03784079|4101619|FG003|COMPLETED|Part 2: Up to Day 12||6
3370258|NCT03784079|4101620|FG004|COMPLETED|Part 2: Up to Day 12||6
3370259|NCT03784079|4101621|FG005|COMPLETED|Part 2: Up to Day 12||6
3370260|NCT03784079|4101622|FG006|COMPLETED|Part 2: Up to Day 12||2
3370261|NCT03784079|4101616|FG000|NOT COMPLETED|Part 2: Up to Day 12||0
3239137|NCT02408068|3971652|FG001|NOT COMPLETED|Treatment 3 (1.5 Days)||0
3239138|NCT02408068|3971653|FG002|NOT COMPLETED|Treatment 3 (1.5 Days)||1
3239139|NCT02408068|3971654|FG003|NOT COMPLETED|Treatment 3 (1.5 Days)||0
3239140|NCT02408068|3971655|FG004|NOT COMPLETED|Treatment 3 (1.5 Days)||0
3239141|NCT02408068|3971656|FG005|NOT COMPLETED|Treatment 3 (1.5 Days)||0
3239142|NCT02408120|3971669|FG000|STARTED|Overall Study||112
3239143|NCT02408120|3971670|FG001|STARTED|Overall Study||112
3239144|NCT02408120|3971669|FG000|COMPLETED|Overall Study||108
3239145|NCT02408120|3971670|FG001|COMPLETED|Overall Study||107
3239146|NCT02408120|3971669|FG000|NOT COMPLETED|Overall Study||4
3239147|NCT02408120|3971670|FG001|NOT COMPLETED|Overall Study||5
3239148|NCT02408198|3971678|FG000|STARTED|Overall Study||13
3239149|NCT02408198|3971679|FG001|STARTED|Overall Study||5
3239150|NCT02408198|3971678|FG000|COMPLETED|Overall Study||10
3239151|NCT02408198|3971679|FG001|COMPLETED|Overall Study||5
3239152|NCT02408198|3971678|FG000|NOT COMPLETED|Overall Study||3
3239153|NCT02408198|3971679|FG001|NOT COMPLETED|Overall Study||0
3239154|NCT02408263|3971685|FG000|STARTED|Overall Study||25
3239155|NCT02408263|3971686|FG001|STARTED|Overall Study||25
3239156|NCT02408263|3971685|FG000|COMPLETED|Overall Study||25
3239157|NCT02408263|3971686|FG001|COMPLETED|Overall Study||25
3239158|NCT02408263|3971685|FG000|NOT COMPLETED|Overall Study||0
3239159|NCT02408263|3971686|FG001|NOT COMPLETED|Overall Study||0
3239160|NCT02408315|3971693|FG000|STARTED|Overall Study||148
3239161|NCT02408315|3971694|FG001|STARTED|Overall Study||152
3239162|NCT02408315|3971693|FG000|COMPLETED|Overall Study||148
3239163|NCT02408315|3971694|FG001|COMPLETED|Overall Study||152
3239164|NCT02408315|3971693|FG000|NOT COMPLETED|Overall Study||0
3239165|NCT02408315|3971694|FG001|NOT COMPLETED|Overall Study||0
3239166|NCT02408445|3971702|FG000|STARTED|Overall Study||10
3239167|NCT02408445|3971703|FG001|STARTED|Overall Study||10
3239168|NCT02408445|3971702|FG000|COMPLETED|Overall Study||10
3239169|NCT02408445|3971703|FG001|COMPLETED|Overall Study||10
3239170|NCT02408445|3971702|FG000|NOT COMPLETED|Overall Study||0
3239171|NCT02408445|3971703|FG001|NOT COMPLETED|Overall Study||0
3239172|NCT02408484|3971708|FG000|STARTED|Overall Study||15
3239173|NCT02408484|3971708|FG000|SAF Population|Overall Study||14
3239174|NCT02408484|3971708|FG000|FAS Population|Overall Study||14
3239175|NCT02408484|3971708|FG000|PK Population|Overall Study||13
3239176|NCT02408484|3971708|FG000|firstBLEED Population|Overall Study||8
3239177|NCT02408484|3971708|FG000|BLEED Population|Overall Study||8
3239178|NCT02408484|3971708|FG000|SURG Population|Overall Study||3
3239179|NCT02408484|3971708|FG000|COMPLETED|Overall Study||11
3239180|NCT02408484|3971708|FG000|NOT COMPLETED|Overall Study||4
3239181|NCT02408523|3971730|FG000|STARTED|Overall Study||121
3239182|NCT02408523|3971731|FG001|STARTED|Overall Study||121
3239183|NCT02408523|3971730|FG000|Completed Treatment Period|Overall Study||110
3239184|NCT02408523|3971731|FG001|Completed Treatment Period|Overall Study||103
3239185|NCT02408523|3971730|FG000|Enrolled Transition Period|Overall Study||108
3239186|NCT02408523|3971731|FG001|Enrolled Transition Period|Overall Study||101
3239187|NCT02408523|3971730|FG000|Enrolled Taper Period|Overall Study||7
3239188|NCT02408523|3971731|FG001|Enrolled Taper Period|Overall Study||9
3239189|NCT02408523|3971730|FG000|Enrolled Safety Folllow-up Period|Overall Study||10
3239190|NCT02408523|3971731|FG001|Enrolled Safety Folllow-up Period|Overall Study||11
3239191|NCT02408523|3971730|FG000|COMPLETED|Overall Study||110
3239192|NCT02408523|3971731|FG001|COMPLETED|Overall Study||103
3239193|NCT02408523|3971730|FG000|NOT COMPLETED|Overall Study||11
3239194|NCT02408523|3971731|FG001|NOT COMPLETED|Overall Study||18
3239195|NCT02408692|3971748|FG000|STARTED|Overall Study||5
3239196|NCT02408692|3971749|FG001|STARTED|Overall Study||5
3239197|NCT02408692|3971750|FG002|STARTED|Overall Study||5
3239198|NCT02408692|3971748|FG000|COMPLETED|Overall Study||5
3239199|NCT02408692|3971749|FG001|COMPLETED|Overall Study||5
3239200|NCT02408692|3971750|FG002|COMPLETED|Overall Study||5
3239201|NCT02408692|3971748|FG000|NOT COMPLETED|Overall Study||0
3239202|NCT02408692|3971749|FG001|NOT COMPLETED|Overall Study||0
3239203|NCT02408692|3971750|FG002|NOT COMPLETED|Overall Study||0
3239204|NCT02408796|3971758|FG000|STARTED|Overall Study||39
3239205|NCT02408796|3971758|FG000|COMPLETED|Overall Study||39
3239206|NCT02408796|3971758|FG000|NOT COMPLETED|Overall Study||0
3239207|NCT02408965|3971764|FG000|STARTED|Overall Study||140
3239208|NCT02408965|3971765|FG001|STARTED|Overall Study||144
3239209|NCT02408965|3971764|FG000|COMPLETED|Overall Study||140
3239210|NCT02408965|3971765|FG001|COMPLETED|Overall Study||144
3239211|NCT02408965|3971764|FG000|NOT COMPLETED|Overall Study||0
3239212|NCT02408965|3971765|FG001|NOT COMPLETED|Overall Study||0
3239213|NCT02409277|3971774|FG000|STARTED|Overall Study||267
3239214|NCT02409277|3971775|FG001|STARTED|Overall Study||60
3239215|NCT02409277|3971776|FG002|STARTED|Overall Study||599
3239216|NCT02409277|3971774|FG000|3 Months Follow-up|Overall Study||178
3239217|NCT02409277|3971775|FG001|3 Months Follow-up|Overall Study||40
3239218|NCT02409277|3971776|FG002|3 Months Follow-up|Overall Study||599
3239219|NCT02409277|3971774|FG000|6 Months Follow-up|Overall Study||182
3239220|NCT02409277|3971775|FG001|6 Months Follow-up|Overall Study||42
3239221|NCT02409277|3971776|FG002|6 Months Follow-up|Overall Study||599
3239222|NCT02409277|3971774|FG000|12 Months Follow-up|Overall Study||167
3239223|NCT02409277|3971775|FG001|12 Months Follow-up|Overall Study||43
3239224|NCT02409277|3971776|FG002|12 Months Follow-up|Overall Study||599
3239225|NCT02409277|3971774|FG000|COMPLETED|Overall Study||167
3239226|NCT02409277|3971775|FG001|COMPLETED|Overall Study||43
3239227|NCT02409277|3971776|FG002|COMPLETED|Overall Study||599
3239228|NCT02409277|3971774|FG000|NOT COMPLETED|Overall Study||100
3239229|NCT02409277|3971775|FG001|NOT COMPLETED|Overall Study||17
3239230|NCT02409277|3971776|FG002|NOT COMPLETED|Overall Study||0
3239231|NCT02409329|3971804|FG000|STARTED|Overall Study||127
3239232|NCT02409329|3971805|FG001|STARTED|Overall Study||126
3239233|NCT02409329|3971806|FG002|STARTED|Overall Study||253
3239234|NCT02409329|3971804|FG000|COMPLETED|Overall Study||122
3239235|NCT02409329|3971805|FG001|COMPLETED|Overall Study||120
3239236|NCT02409329|3971806|FG002|COMPLETED|Overall Study||244
3239237|NCT02409329|3971804|FG000|NOT COMPLETED|Overall Study||5
3239238|NCT02409329|3971805|FG001|NOT COMPLETED|Overall Study||6
3239239|NCT02409329|3971806|FG002|NOT COMPLETED|Overall Study||9
3239240|NCT02409459|3971817|FG000|STARTED|Overall Study||41
3239241|NCT02409459|3971818|FG001|STARTED|Overall Study||40
3239242|NCT02409459|3971817|FG000|COMPLETED|Overall Study||40
3239243|NCT02409459|3971818|FG001|COMPLETED|Overall Study||39
3239244|NCT02409459|3971817|FG000|NOT COMPLETED|Overall Study||1
3239245|NCT02409459|3971818|FG001|NOT COMPLETED|Overall Study||1
3239246|NCT02409667|3971824|FG000|STARTED|Treatment Period 1, Baseline to Week 24||1647
3239247|NCT02409667|3971825|FG001|STARTED|Treatment Period 1, Baseline to Week 24||0
3239248|NCT02409667|3971826|FG002|STARTED|Treatment Period 1, Baseline to Week 24||0
3239249|NCT02409667|3971827|FG003|STARTED|Treatment Period 1, Baseline to Week 24||0
3239250|NCT02409667|3971828|FG004|STARTED|Treatment Period 1, Baseline to Week 24||0
3239251|NCT02409667|3971824|FG000|COMPLETED|Treatment Period 1, Baseline to Week 24||1526
3239252|NCT02409667|3971825|FG001|COMPLETED|Treatment Period 1, Baseline to Week 24||0
3239253|NCT02409667|3971826|FG002|COMPLETED|Treatment Period 1, Baseline to Week 24||0
3239254|NCT02409667|3971827|FG003|COMPLETED|Treatment Period 1, Baseline to Week 24||0
3239255|NCT02409667|3971828|FG004|COMPLETED|Treatment Period 1, Baseline to Week 24||0
3239256|NCT02409667|3971824|FG000|NOT COMPLETED|Treatment Period 1, Baseline to Week 24||121
3239257|NCT02409667|3971825|FG001|NOT COMPLETED|Treatment Period 1, Baseline to Week 24||0
3239258|NCT02409667|3971826|FG002|NOT COMPLETED|Treatment Period 1, Baseline to Week 24||0
3239259|NCT02409667|3971827|FG003|NOT COMPLETED|Treatment Period 1, Baseline to Week 24||0
3239260|NCT02409667|3971828|FG004|NOT COMPLETED|Treatment Period 1, Baseline to Week 24||0
3239261|NCT02409667|3971824|FG000|STARTED|Treatment Period 2, Week 24 to Week 52)||0
3239262|NCT02409667|3971825|FG001|STARTED|Treatment Period 2, Week 24 to Week 52)||644
3239263|NCT02409667|3971826|FG002|STARTED|Treatment Period 2, Week 24 to Week 52)||662
3239264|NCT02409667|3971827|FG003|STARTED|Treatment Period 2, Week 24 to Week 52)||114
3239265|NCT02409667|3971828|FG004|STARTED|Treatment Period 2, Week 24 to Week 52)||93
3239266|NCT02409667|3971824|FG000|COMPLETED|Treatment Period 2, Week 24 to Week 52)||0
3239267|NCT02409667|3971825|FG001|COMPLETED|Treatment Period 2, Week 24 to Week 52)||621
3239268|NCT02409667|3971826|FG002|COMPLETED|Treatment Period 2, Week 24 to Week 52)||641
3239269|NCT02409667|3971827|FG003|COMPLETED|Treatment Period 2, Week 24 to Week 52)||106
3239270|NCT02409667|3971828|FG004|COMPLETED|Treatment Period 2, Week 24 to Week 52)||90
3239271|NCT02409667|3971824|FG000|NOT COMPLETED|Treatment Period 2, Week 24 to Week 52)||0
3239272|NCT02409667|3971825|FG001|NOT COMPLETED|Treatment Period 2, Week 24 to Week 52)||23
3239273|NCT02409667|3971826|FG002|NOT COMPLETED|Treatment Period 2, Week 24 to Week 52)||21
3239274|NCT02409667|3971827|FG003|NOT COMPLETED|Treatment Period 2, Week 24 to Week 52)||8
3239275|NCT02409667|3971828|FG004|NOT COMPLETED|Treatment Period 2, Week 24 to Week 52)||3
3239276|NCT02409680|3971841|FG000|STARTED|Overall Study||5990
3239277|NCT02409680|3971842|FG001|STARTED|Overall Study||5986
3239278|NCT02409680|3971841|FG000|Treated|Overall Study||5943
3239279|NCT02409680|3971842|FG001|Treated|Overall Study||5936
3239280|NCT02409680|3971841|FG000|Included in mITT Analysis|Overall Study||5787
3239281|NCT02409680|3971842|FG001|Included in mITT Analysis|Overall Study||5771
3239282|NCT02409680|3971841|FG000|COMPLETED|Overall Study||5975
3239283|NCT02409680|3971842|FG001|COMPLETED|Overall Study||5956
3239284|NCT02409680|3971841|FG000|NOT COMPLETED|Overall Study||15
3239285|NCT02409680|3971842|FG001|NOT COMPLETED|Overall Study||30
3239286|NCT02409719|3971850|FG000|STARTED|Overall Study||31
3239287|NCT02409719|3971851|FG001|STARTED|Overall Study||45
3239288|NCT02409719|3971850|FG000|2 Weeks|Overall Study||28
3239289|NCT02409719|3971851|FG001|2 Weeks|Overall Study||42
3239290|NCT02409719|3971850|FG000|4 Weeks|Overall Study||28
3239291|NCT02409719|3971851|FG001|4 Weeks|Overall Study||42
3239292|NCT02409719|3971850|FG000|6 Weeks|Overall Study||28
3239293|NCT02409719|3971851|FG001|6 Weeks|Overall Study||42
3239294|NCT02409719|3971850|FG000|3 Months|Overall Study||28
3239295|NCT02409719|3971851|FG001|3 Months|Overall Study||42
3239296|NCT02409719|3971850|FG000|6 Months|Overall Study||28
3239297|NCT02409719|3971851|FG001|6 Months|Overall Study||42
3239298|NCT02409719|3971850|FG000|12 Months|Overall Study||28
3239299|NCT02409719|3971851|FG001|12 Months|Overall Study||42
3239300|NCT02409719|3971850|FG000|COMPLETED|Overall Study||28
3239301|NCT02409719|3971851|FG001|COMPLETED|Overall Study||42
3239302|NCT02409719|3971850|FG000|NOT COMPLETED|Overall Study||3
3239303|NCT02409719|3971851|FG001|NOT COMPLETED|Overall Study||3
3239304|NCT02409732|3971857|FG000|STARTED|Overall Study|First patient consented on 4/23/15|20
3239305|NCT02409732|3971857|FG000|COMPLETED|Overall Study||14
3239306|NCT02409732|3971857|FG000|NOT COMPLETED|Overall Study||6
3239307|NCT02409784|3971862|FG000|STARTED|Overall Study||10
3239308|NCT02409784|3971862|FG000|COMPLETED|Overall Study||10
3239309|NCT02409784|3971862|FG000|NOT COMPLETED|Overall Study||0
3239310|NCT02409914|3971867|FG000|STARTED|Overall Study||7
3239311|NCT02409914|3971867|FG000|COMPLETED|Overall Study||7
3239312|NCT02409914|3971867|FG000|NOT COMPLETED|Overall Study||0
3239313|NCT02409927|3971871|FG000|STARTED|Overall Study||10
3239314|NCT02409927|3971871|FG000|COMPLETED|Overall Study||10
3239315|NCT02409927|3971871|FG000|NOT COMPLETED|Overall Study||0
3239316|NCT02410018|3971877|FG000|STARTED|Overall Study||2
3239317|NCT02410018|3971878|FG001|STARTED|Overall Study||1
3239318|NCT02410018|3971877|FG000|COMPLETED|Overall Study||2
3239319|NCT02410018|3971878|FG001|COMPLETED|Overall Study||1
3239320|NCT02410018|3971877|FG000|NOT COMPLETED|Overall Study||0
3239321|NCT02410018|3971878|FG001|NOT COMPLETED|Overall Study||0
3239322|NCT02410161|3971886|FG000|STARTED|Overall Study||10
3239323|NCT02410161|3971887|FG001|STARTED|Overall Study||10
3239324|NCT02410161|3971886|FG000|COMPLETED|Overall Study||10
3239325|NCT02410161|3971887|FG001|COMPLETED|Overall Study||10
3239326|NCT02410161|3971886|FG000|NOT COMPLETED|Overall Study||0
3239327|NCT02410161|3971887|FG001|NOT COMPLETED|Overall Study||0
3239328|NCT02410200|3971893|FG000|STARTED|Overall Study||22
3239329|NCT02410200|3971893|FG000|COMPLETED|Overall Study||20
3239330|NCT02410200|3971893|FG000|NOT COMPLETED|Overall Study||2
3239331|NCT02410213|3971897|FG000|STARTED|Overall Study||16
3239332|NCT02410213|3971898|FG001|STARTED|Overall Study||19
3239333|NCT02410213|3971897|FG000|COMPLETED|Overall Study||16
3239334|NCT02410213|3971898|FG001|COMPLETED|Overall Study||19
3239335|NCT02410213|3971897|FG000|NOT COMPLETED|Overall Study||0
3239336|NCT02410213|3971898|FG001|NOT COMPLETED|Overall Study||0
3239337|NCT02410252|3971904|FG000|STARTED|Overall Study||25
3239338|NCT02410252|3971904|FG000|COMPLETED|Overall Study||19
3239339|NCT02410252|3971904|FG000|NOT COMPLETED|Overall Study||6
3239340|NCT02410278|3971912|FG000|STARTED|Run-in Period||102
3239341|NCT02410278|3971913|FG001|STARTED|Run-in Period||0
3239342|NCT02410278|3971914|FG002|STARTED|Run-in Period||0
3239343|NCT02410278|3971912|FG000|Received at Least 1 Dose of DMF|Run-in Period||98
3239344|NCT02410278|3971913|FG001|Received at Least 1 Dose of DMF|Run-in Period||0
3239345|NCT02410278|3971914|FG002|Received at Least 1 Dose of DMF|Run-in Period||0
3239346|NCT02410278|3971912|FG000|COMPLETED|Run-in Period||64
3239347|NCT02410278|3971913|FG001|COMPLETED|Run-in Period||0
3239348|NCT02410278|3971914|FG002|COMPLETED|Run-in Period||0
3239349|NCT02410278|3971912|FG000|NOT COMPLETED|Run-in Period||38
3239350|NCT02410278|3971913|FG001|NOT COMPLETED|Run-in Period||0
3239351|NCT02410278|3971914|FG002|NOT COMPLETED|Run-in Period||0
3239352|NCT02410278|3971912|FG000|STARTED|Study Treatment Period||0
3239353|NCT02410278|3971913|FG001|STARTED|Study Treatment Period||31
3239354|NCT02410278|3971914|FG002|STARTED|Study Treatment Period||33
3239355|NCT02410278|3971912|FG000|Modified Intent-to Treat(mITT)Population|Study Treatment Period||0
3239356|NCT02410278|3971913|FG001|Modified Intent-to Treat(mITT)Population|Study Treatment Period||30
3239357|NCT02410278|3971914|FG002|Modified Intent-to Treat(mITT)Population|Study Treatment Period||33
3239358|NCT02410278|3971912|FG000|Completed Randomized Study Treatment|Study Treatment Period||0
3239359|NCT02410278|3971913|FG001|Completed Randomized Study Treatment|Study Treatment Period||20
3239360|NCT02410278|3971914|FG002|Completed Randomized Study Treatment|Study Treatment Period||29
3239361|NCT02410278|3971912|FG000|COMPLETED|Study Treatment Period||0
3239362|NCT02410278|3971913|FG001|COMPLETED|Study Treatment Period||20
3239363|NCT02410278|3971914|FG002|COMPLETED|Study Treatment Period||29
3239364|NCT02410278|3971912|FG000|NOT COMPLETED|Study Treatment Period||0
3239365|NCT02410278|3971913|FG001|NOT COMPLETED|Study Treatment Period||11
3239366|NCT02410278|3971914|FG002|NOT COMPLETED|Study Treatment Period||4
3239367|NCT02410291|3971923|FG000|STARTED|Overall Study||29
3239368|NCT02410291|3971924|FG001|STARTED|Overall Study||29
3239369|NCT02410291|3971923|FG000|COMPLETED|Overall Study||29
3239370|NCT02410291|3971924|FG001|COMPLETED|Overall Study||29
3239371|NCT02410291|3971923|FG000|NOT COMPLETED|Overall Study||0
3239372|NCT02410291|3971924|FG001|NOT COMPLETED|Overall Study||0
3239373|NCT02410382|3971932|FG000|STARTED|Overall Study||0
3239374|NCT02410382|3971933|FG001|STARTED|Overall Study||0
3239375|NCT02410382|3971932|FG000|COMPLETED|Overall Study|Study was terminated by IRB - attempts made to obtain info were unsuccessful.|0
3239376|NCT02410382|3971933|FG001|COMPLETED|Overall Study||0
3239377|NCT02410382|3971932|FG000|NOT COMPLETED|Overall Study||0
3239378|NCT02410382|3971933|FG001|NOT COMPLETED|Overall Study||0
3239379|NCT02410629|3971941|FG000|STARTED|Overall Study||8
3239380|NCT02410629|3971942|FG001|STARTED|Overall Study||9
3239381|NCT02410629|3971941|FG000|COMPLETED|Overall Study|5 subjects from the music glove group were crossed over to conventional hand exercise group.|5
3239382|NCT02410629|3971942|FG001|COMPLETED|Overall Study|6 subjects from the conventional hand exercise group were crossed over to music glove group.|6
3239383|NCT02410629|3971941|FG000|NOT COMPLETED|Overall Study||3
3239384|NCT02410629|3971942|FG001|NOT COMPLETED|Overall Study||3
3239385|NCT02410707|3971948|FG000|STARTED|Overall Study||43
3239386|NCT02410707|3971948|FG000|COMPLETED|Overall Study||43
3239387|NCT02410707|3971948|FG000|NOT COMPLETED|Overall Study||0
3239388|NCT02410772|3971957|FG000|STARTED|Overall Study||829
3239389|NCT02410772|3971958|FG001|STARTED|Overall Study||838
3239390|NCT02410772|3971959|FG002|STARTED|Overall Study||849
3239391|NCT02410772|3971957|FG000|Microbiologically Eligible Analysis Population|Overall Study||768
3239392|NCT02410772|3971958|FG001|Microbiologically Eligible Analysis Population|Overall Study||784
3239393|NCT02410772|3971959|FG002|Microbiologically Eligible Analysis Population|Overall Study||791
3239394|NCT02410772|3971957|FG000|Assessable Population|Overall Study||726
3239395|NCT02410772|3971958|FG001|Assessable Population|Overall Study||752
3239396|NCT02410772|3971959|FG002|Assessable Population|Overall Study||756
3239397|NCT02410772|3971957|FG000|COMPLETED|Overall Study||726
3239398|NCT02410772|3971958|FG001|COMPLETED|Overall Study||752
3239399|NCT02410772|3971959|FG002|COMPLETED|Overall Study||756
3239400|NCT02410772|3971957|FG000|NOT COMPLETED|Overall Study||103
3239401|NCT02410772|3971958|FG001|NOT COMPLETED|Overall Study||86
3239402|NCT02410772|3971959|FG002|NOT COMPLETED|Overall Study||93
3239403|NCT02410798|3971967|FG000|STARTED|Overall Study||12
3239404|NCT02410798|3971967|FG000|COMPLETED|Overall Study||12
3239405|NCT02410798|3971967|FG000|NOT COMPLETED|Overall Study||0
3239406|NCT02410811|3971976|FG000|STARTED|Overall Study||5
3239407|NCT02410811|3971977|FG001|STARTED|Overall Study||10
3239408|NCT02410811|3971978|FG002|STARTED|Overall Study||11
3239409|NCT02410811|3971979|FG003|STARTED|Overall Study||7
3239410|NCT02410811|3971976|FG000|COMPLETED|Overall Study||5
3239411|NCT02410811|3971977|FG001|COMPLETED|Overall Study||10
3239412|NCT02410811|3971978|FG002|COMPLETED|Overall Study||10
3239413|NCT02410811|3971979|FG003|COMPLETED|Overall Study||7
3239414|NCT02410811|3971976|FG000|NOT COMPLETED|Overall Study||0
3239415|NCT02410811|3971977|FG001|NOT COMPLETED|Overall Study||0
3239416|NCT02410811|3971978|FG002|NOT COMPLETED|Overall Study||1
3239417|NCT02410811|3971979|FG003|NOT COMPLETED|Overall Study||0
3239418|NCT02410824|3971989|FG000|STARTED|First Intervention (One Week)||22
3239419|NCT02410824|3971990|FG001|STARTED|First Intervention (One Week)||23
3239420|NCT02410824|3971989|FG000|COMPLETED|First Intervention (One Week)||22
3239421|NCT02410824|3971990|FG001|COMPLETED|First Intervention (One Week)||22
3239422|NCT02410824|3971989|FG000|NOT COMPLETED|First Intervention (One Week)||0
3239423|NCT02410824|3971990|FG001|NOT COMPLETED|First Intervention (One Week)||1
3239424|NCT02410824|3971989|FG000|STARTED|Second Intervention (One Week)||22
3239425|NCT02410824|3971990|FG001|STARTED|Second Intervention (One Week)||22
3239426|NCT02410824|3971989|FG000|COMPLETED|Second Intervention (One Week)||22
3239427|NCT02410824|3971990|FG001|COMPLETED|Second Intervention (One Week)||22
3239428|NCT02410824|3971989|FG000|NOT COMPLETED|Second Intervention (One Week)||0
3239429|NCT02410824|3971990|FG001|NOT COMPLETED|Second Intervention (One Week)||0
3239430|NCT02410837|3971997|FG000|STARTED|Overall Study||1388
3239431|NCT02410837|3971997|FG000|Procedure|Overall Study||1388
3239432|NCT02410837|3971997|FG000|1-Month|Overall Study||1374
3239433|NCT02410837|3971997|FG000|12-Month|Overall Study||1121
3239434|NCT02410837|3971997|FG000|24-Month|Overall Study||900
3239435|NCT02410837|3971997|FG000|COMPLETED|Overall Study||900
3239436|NCT02410837|3971997|FG000|NOT COMPLETED|Overall Study||488
3239437|NCT02410967|3972003|FG000|STARTED|Treatment Phase (4 Weeks)||27
3239438|NCT02410967|3972004|FG001|STARTED|Treatment Phase (4 Weeks)||26
3239439|NCT02410967|3972003|FG000|COMPLETED|Treatment Phase (4 Weeks)||26
3239440|NCT02410967|3972004|FG001|COMPLETED|Treatment Phase (4 Weeks)||22
3239441|NCT02410967|3972003|FG000|NOT COMPLETED|Treatment Phase (4 Weeks)||1
3239442|NCT02410967|3972004|FG001|NOT COMPLETED|Treatment Phase (4 Weeks)||4
3239443|NCT02410967|3972003|FG000|STARTED|Follow-up Phase (8 Weeks)||26
3239444|NCT02410967|3972004|FG001|STARTED|Follow-up Phase (8 Weeks)||22
3239445|NCT02410967|3972003|FG000|COMPLETED|Follow-up Phase (8 Weeks)||22
3239446|NCT02410967|3972004|FG001|COMPLETED|Follow-up Phase (8 Weeks)||16
3239447|NCT02410967|3972003|FG000|NOT COMPLETED|Follow-up Phase (8 Weeks)||4
3239448|NCT02410967|3972004|FG001|NOT COMPLETED|Follow-up Phase (8 Weeks)||6
3239449|NCT02411084|3972012|FG000|STARTED|Overall Study||18
3239450|NCT02411084|3972013|FG001|STARTED|Overall Study||18
3239451|NCT02411084|3972012|FG000|COMPLETED|Overall Study||5
3239452|NCT02411084|3972013|FG001|COMPLETED|Overall Study||5
3239453|NCT02411084|3972012|FG000|NOT COMPLETED|Overall Study||13
3239454|NCT02411084|3972013|FG001|NOT COMPLETED|Overall Study||13
3239455|NCT02411110|3972021|FG000|STARTED|Treatment Period 1||65
3239456|NCT02411110|3972022|FG001|STARTED|Treatment Period 1||66
3239457|NCT02411110|3972021|FG000|COMPLETED|Treatment Period 1||56
3239458|NCT02411110|3972022|FG001|COMPLETED|Treatment Period 1||59
3239459|NCT02411110|3972021|FG000|NOT COMPLETED|Treatment Period 1||9
3239460|NCT02411110|3972022|FG001|NOT COMPLETED|Treatment Period 1||7
3239461|NCT02411110|3972021|FG000|STARTED|Treatment Period 2|Period 2 was optional.|50
3239462|NCT02411110|3972022|FG001|STARTED|Treatment Period 2|Period 2 was optional.|48
3239463|NCT02411110|3972021|FG000|COMPLETED|Treatment Period 2||49
3239464|NCT02411110|3972022|FG001|COMPLETED|Treatment Period 2||44
3239465|NCT02411110|3972021|FG000|NOT COMPLETED|Treatment Period 2||1
3239466|NCT02411110|3972022|FG001|NOT COMPLETED|Treatment Period 2||4
3239467|NCT02411201|3972030|FG000|STARTED|Overall Study||51
3239468|NCT02411201|3972030|FG000|COMPLETED|Overall Study||45
3239469|NCT02411201|3972030|FG000|NOT COMPLETED|Overall Study||6
3239470|NCT02411292|3972036|FG000|STARTED|Overall Study||110
3239471|NCT02411292|3972036|FG000|COMPLETED|Overall Study||89
3239472|NCT02411292|3972036|FG000|NOT COMPLETED|Overall Study||21
3370262|NCT03784079|4101617|FG001|NOT COMPLETED|Part 2: Up to Day 12||0
3370263|NCT03784079|4101618|FG002|NOT COMPLETED|Part 2: Up to Day 12||0
3370264|NCT03784079|4101619|FG003|NOT COMPLETED|Part 2: Up to Day 12||0
3370265|NCT03784079|4101620|FG004|NOT COMPLETED|Part 2: Up to Day 12||0
3370266|NCT03784079|4101621|FG005|NOT COMPLETED|Part 2: Up to Day 12||0
3370267|NCT03784079|4101622|FG006|NOT COMPLETED|Part 2: Up to Day 12||0
3370268|NCT03783039|4101645|FG000|STARTED|Overall Study||119
3370269|NCT03783039|4101646|FG001|STARTED|Overall Study||115
3370270|NCT03783039|4101645|FG000|COMPLETED|Overall Study||117
3370271|NCT03783039|4101646|FG001|COMPLETED|Overall Study||114
3370272|NCT03783039|4101645|FG000|NOT COMPLETED|Overall Study||2
3370273|NCT03783039|4101646|FG001|NOT COMPLETED|Overall Study||1
3239473|NCT02411396|3972042|FG000|STARTED|Overall Study||483
3239474|NCT02411396|3972042|FG000|COMPLETED|Overall Study||442
3239475|NCT02411396|3972042|FG000|NOT COMPLETED|Overall Study||41
3239476|NCT02411448|3972054|FG000|STARTED|Overall Study||14
3239477|NCT02411448|3972055|FG001|STARTED|Overall Study||224
3239478|NCT02411448|3972056|FG002|STARTED|Overall Study||225
3239479|NCT02411448|3972054|FG000|Received at Least One Dose of Study Drug|Overall Study||14
3239480|NCT02411448|3972055|FG001|Received at Least One Dose of Study Drug|Overall Study||221
3239481|NCT02411448|3972056|FG002|Received at Least One Dose of Study Drug|Overall Study||225
3239482|NCT02411448|3972054|FG000|COMPLETED|Overall Study||10
3239483|NCT02411448|3972055|FG001|COMPLETED|Overall Study||141
3239484|NCT02411448|3972056|FG002|COMPLETED|Overall Study||173
3239485|NCT02411448|3972054|FG000|NOT COMPLETED|Overall Study||4
3239486|NCT02411448|3972055|FG001|NOT COMPLETED|Overall Study||83
3239487|NCT02411448|3972056|FG002|NOT COMPLETED|Overall Study||52
3239488|NCT02411461|3972071|FG000|STARTED|Overall Study||16
3239489|NCT02411461|3972072|FG001|STARTED|Overall Study||8
3239490|NCT02411461|3972073|FG002|STARTED|Overall Study||15
3239491|NCT02411461|3972071|FG000|COMPLETED|Overall Study||16
3239492|NCT02411461|3972072|FG001|COMPLETED|Overall Study||8
3239493|NCT02411461|3972073|FG002|COMPLETED|Overall Study||15
3239494|NCT02411461|3972071|FG000|NOT COMPLETED|Overall Study||0
3239495|NCT02411461|3972072|FG001|NOT COMPLETED|Overall Study||0
3239496|NCT02411461|3972073|FG002|NOT COMPLETED|Overall Study||0
3239497|NCT02411539|3972083|FG000|STARTED|Overall Study||20
3239498|NCT02411539|3972084|FG001|STARTED|Overall Study||20
3239499|NCT02411539|3972083|FG000|COMPLETED|Overall Study||18
3239500|NCT02411539|3972084|FG001|COMPLETED|Overall Study||19
3239501|NCT02411539|3972083|FG000|NOT COMPLETED|Overall Study||2
3239502|NCT02411539|3972084|FG001|NOT COMPLETED|Overall Study||1
3239503|NCT02411565|3972095|FG000|STARTED|Overall Study||1
3239504|NCT02411565|3972096|FG001|STARTED|Overall Study||2
3239505|NCT02411565|3972095|FG000|COMPLETED|Overall Study||1
3239506|NCT02411565|3972096|FG001|COMPLETED|Overall Study||2
3239507|NCT02411565|3972095|FG000|NOT COMPLETED|Overall Study||0
3239508|NCT02411565|3972096|FG001|NOT COMPLETED|Overall Study||0
3239509|NCT02411578|3972104|FG000|STARTED|Crossover Trial Phase||8
3239510|NCT02411578|3972105|FG001|STARTED|Crossover Trial Phase||12
3239511|NCT02411578|3972104|FG000|COMPLETED|Crossover Trial Phase||8
3239512|NCT02411578|3972105|FG001|COMPLETED|Crossover Trial Phase||11
3239513|NCT02411578|3972104|FG000|NOT COMPLETED|Crossover Trial Phase||0
3239514|NCT02411578|3972105|FG001|NOT COMPLETED|Crossover Trial Phase||1
3239515|NCT02411578|3972104|FG000|STARTED|Extension Phase||8
3239516|NCT02411578|3972105|FG001|STARTED|Extension Phase|2 Crossover Trial participants could not continue due to study syringes expiration|9
3239517|NCT02411578|3972104|FG000|COMPLETED|Extension Phase||8
3239518|NCT02411578|3972105|FG001|COMPLETED|Extension Phase||9
3239519|NCT02411578|3972104|FG000|NOT COMPLETED|Extension Phase||0
3239520|NCT02411578|3972105|FG001|NOT COMPLETED|Extension Phase||0
3239521|NCT02411591|3972116|FG000|STARTED|Overall Study||3
3239522|NCT02411591|3972117|FG001|STARTED|Overall Study||57
3239523|NCT02411591|3972118|FG002|STARTED|Overall Study||6
3239524|NCT02411591|3972116|FG000|Part A|Overall Study||3
3239525|NCT02411591|3972117|FG001|Part A|Overall Study||6
3239526|NCT02411591|3972118|FG002|Part A|Overall Study||6
3239527|NCT02411591|3972116|FG000|Expansion Cohort Part B|Overall Study||0
3239528|NCT02411591|3972117|FG001|Expansion Cohort Part B|Overall Study||51
3239529|NCT02411591|3972118|FG002|Expansion Cohort Part B|Overall Study||0
3239530|NCT02411591|3972116|FG000|Progressive Disease|Overall Study||3
3239531|NCT02411591|3972117|FG001|Progressive Disease|Overall Study||42
3239532|NCT02411591|3972118|FG002|Progressive Disease|Overall Study||3
3239533|NCT02411591|3972116|FG000|Death|Overall Study||0
3239534|NCT02411591|3972117|FG001|Death|Overall Study||2
3239535|NCT02411591|3972118|FG002|Death|Overall Study||0
3239536|NCT02411591|3972116|FG000|COMPLETED|Overall Study||3
3239537|NCT02411591|3972117|FG001|COMPLETED|Overall Study||47
3239538|NCT02411591|3972118|FG002|COMPLETED|Overall Study||3
3239539|NCT02411591|3972116|FG000|NOT COMPLETED|Overall Study||0
3239540|NCT02411591|3972117|FG001|NOT COMPLETED|Overall Study||10
3239541|NCT02411591|3972118|FG002|NOT COMPLETED|Overall Study||3
3239542|NCT02411747|3972136|FG000|STARTED|Overall Study||16
3239543|NCT02411747|3972137|FG001|STARTED|Overall Study||16
3239544|NCT02411747|3972136|FG000|Simulation Training Completed|Overall Study||16
3239545|NCT02411747|3972137|FG001|Simulation Training Completed|Overall Study||16
3239546|NCT02411747|3972136|FG000|COMPLETED|Overall Study||13
3239547|NCT02411747|3972137|FG001|COMPLETED|Overall Study||12
3239548|NCT02411747|3972136|FG000|NOT COMPLETED|Overall Study||3
3239549|NCT02411747|3972137|FG001|NOT COMPLETED|Overall Study||4
3239550|NCT02411916|3972145|FG000|STARTED|Overall Study||73
3239551|NCT02411916|3972146|FG001|STARTED|Overall Study||70
3239552|NCT02411916|3972145|FG000|COMPLETED|Overall Study||73
3239553|NCT02411916|3972146|FG001|COMPLETED|Overall Study||70
3239554|NCT02411916|3972145|FG000|NOT COMPLETED|Overall Study||0
3239555|NCT02411916|3972146|FG001|NOT COMPLETED|Overall Study||0
3239556|NCT02411929|3972152|FG000|STARTED|Period 1||8
3239557|NCT02411929|3972152|FG000|COMPLETED|Period 1||8
3239558|NCT02411929|3972152|FG000|NOT COMPLETED|Period 1||0
3239559|NCT02411929|3972152|FG000|STARTED|Washout Period||8
3239560|NCT02411929|3972152|FG000|COMPLETED|Washout Period||8
3239561|NCT02411929|3972152|FG000|NOT COMPLETED|Washout Period||0
3239562|NCT02411929|3972152|FG000|STARTED|Period 2||8
3239563|NCT02411929|3972152|FG000|COMPLETED|Period 2||8
3239564|NCT02411929|3972152|FG000|NOT COMPLETED|Period 2||0
3239565|NCT02412098|3972164|FG000|STARTED|Overall Study||14
3239566|NCT02412098|3972165|FG001|STARTED|Overall Study||14
3239567|NCT02412098|3972166|FG002|STARTED|Overall Study||21
3239568|NCT02412098|3972164|FG000|COMPLETED|Overall Study||14
3239569|NCT02412098|3972165|FG001|COMPLETED|Overall Study||14
3239570|NCT02412098|3972166|FG002|COMPLETED|Overall Study||21
3239571|NCT02412098|3972164|FG000|NOT COMPLETED|Overall Study||0
3239572|NCT02412098|3972165|FG001|NOT COMPLETED|Overall Study||0
3239573|NCT02412098|3972166|FG002|NOT COMPLETED|Overall Study||0
3239574|NCT02412111|3972180|FG000|STARTED|Ivacaftor Run-in Period (4 Weeks)||156
3239575|NCT02412111|3972181|FG001|STARTED|Ivacaftor Run-in Period (4 Weeks)||0
3239576|NCT02412111|3972182|FG002|STARTED|Ivacaftor Run-in Period (4 Weeks)||0
3239577|NCT02412111|3972180|FG000|COMPLETED|Ivacaftor Run-in Period (4 Weeks)||153
3239578|NCT02412111|3972181|FG001|COMPLETED|Ivacaftor Run-in Period (4 Weeks)||0
3239579|NCT02412111|3972182|FG002|COMPLETED|Ivacaftor Run-in Period (4 Weeks)||0
3239580|NCT02412111|3972180|FG000|NOT COMPLETED|Ivacaftor Run-in Period (4 Weeks)||3
3239581|NCT02412111|3972181|FG001|NOT COMPLETED|Ivacaftor Run-in Period (4 Weeks)||0
3239582|NCT02412111|3972182|FG002|NOT COMPLETED|Ivacaftor Run-in Period (4 Weeks)||0
3239583|NCT02412111|3972180|FG000|STARTED|Active Comparator Period (8 Weeks)||0
3239584|NCT02412111|3972181|FG001|STARTED|Active Comparator Period (8 Weeks)||76
3239585|NCT02412111|3972182|FG002|STARTED|Active Comparator Period (8 Weeks)||75
3239586|NCT02412111|3972180|FG000|Full Analysis Set|Active Comparator Period (8 Weeks)||0
3239587|NCT02412111|3972181|FG001|Full Analysis Set|Active Comparator Period (8 Weeks)||76
3239588|NCT02412111|3972182|FG002|Full Analysis Set|Active Comparator Period (8 Weeks)||74
3239589|NCT02412111|3972180|FG000|COMPLETED|Active Comparator Period (8 Weeks)||0
3239590|NCT02412111|3972181|FG001|COMPLETED|Active Comparator Period (8 Weeks)||75
3239591|NCT02412111|3972182|FG002|COMPLETED|Active Comparator Period (8 Weeks)||69
3239592|NCT02412111|3972180|FG000|NOT COMPLETED|Active Comparator Period (8 Weeks)||0
3239593|NCT02412111|3972181|FG001|NOT COMPLETED|Active Comparator Period (8 Weeks)||1
3239594|NCT02412111|3972182|FG002|NOT COMPLETED|Active Comparator Period (8 Weeks)||6
3239595|NCT02412228|3972192|FG000|STARTED|Overall Study||12
3239596|NCT02412228|3972192|FG000|COMPLETED|Overall Study||12
3239597|NCT02412228|3972192|FG000|NOT COMPLETED|Overall Study||0
3239598|NCT02412306|3972201|FG000|STARTED|Overall Study||5
3239599|NCT02412306|3972202|FG001|STARTED|Overall Study||9
3239600|NCT02412306|3972203|FG002|STARTED|Overall Study||21
3239601|NCT02412306|3972204|FG003|STARTED|Overall Study||14
3239602|NCT02412306|3972205|FG004|STARTED|Overall Study||17
3239603|NCT02412306|3972201|FG000|COMPLETED|Overall Study||0
3239604|NCT02412306|3972202|FG001|COMPLETED|Overall Study||1
3239605|NCT02412306|3972203|FG002|COMPLETED|Overall Study||5
3239606|NCT02412306|3972204|FG003|COMPLETED|Overall Study||14
3239607|NCT02412306|3972205|FG004|COMPLETED|Overall Study||15
3239608|NCT02412306|3972201|FG000|NOT COMPLETED|Overall Study||5
3239609|NCT02412306|3972202|FG001|NOT COMPLETED|Overall Study||8
3239610|NCT02412306|3972203|FG002|NOT COMPLETED|Overall Study||16
3239611|NCT02412306|3972204|FG003|NOT COMPLETED|Overall Study||0
3239612|NCT02412306|3972205|FG004|NOT COMPLETED|Overall Study||2
3239613|NCT02412371|3972232|FG000|STARTED|Overall Study||7
3239614|NCT02412371|3972233|FG001|STARTED|Overall Study||9
3239615|NCT02412371|3972234|FG002|STARTED|Overall Study||7
3239616|NCT02412371|3972235|FG003|STARTED|Overall Study||8
3239617|NCT02412371|3972236|FG004|STARTED|Overall Study||12
3239618|NCT02412371|3972237|FG005|STARTED|Overall Study||5
3239619|NCT02412371|3972232|FG000|COMPLETED|Overall Study||0
3239620|NCT02412371|3972233|FG001|COMPLETED|Overall Study||0
3239621|NCT02412371|3972234|FG002|COMPLETED|Overall Study||0
3239622|NCT02412371|3972235|FG003|COMPLETED|Overall Study||0
3239623|NCT02412371|3972236|FG004|COMPLETED|Overall Study||0
3239624|NCT02412371|3972237|FG005|COMPLETED|Overall Study||0
3239625|NCT02412371|3972232|FG000|NOT COMPLETED|Overall Study||7
3239626|NCT02412371|3972233|FG001|NOT COMPLETED|Overall Study||9
3239627|NCT02412371|3972234|FG002|NOT COMPLETED|Overall Study||7
3239628|NCT02412371|3972235|FG003|NOT COMPLETED|Overall Study||8
3239629|NCT02412371|3972236|FG004|NOT COMPLETED|Overall Study||12
3239630|NCT02412371|3972237|FG005|NOT COMPLETED|Overall Study||5
3239631|NCT02412436|3972252|FG000|STARTED|Overall Study||62
3239632|NCT02412436|3972252|FG000|COMPLETED|Overall Study||44
3239633|NCT02412436|3972252|FG000|NOT COMPLETED|Overall Study||18
3239634|NCT02412488|3972256|FG000|STARTED|Overall Study||192
3239635|NCT02412488|3972256|FG000|Reveal LINQ Implanted|Overall Study||191
3239636|NCT02412488|3972256|FG000|COMPLETED|Overall Study||174
3239637|NCT02412488|3972256|FG000|NOT COMPLETED|Overall Study||18
3239638|NCT02412501|3972260|FG000|STARTED|Overall Study||101
3239639|NCT02412501|3972260|FG000|COMPLETED|Overall Study||101
3239640|NCT02412501|3972260|FG000|NOT COMPLETED|Overall Study||0
3239641|NCT02412631|3972267|FG000|STARTED|Overall Study||44
3239642|NCT02412631|3972268|FG001|STARTED|Overall Study||40
3239643|NCT02412631|3972267|FG000|COMPLETED|Overall Study||18
3239644|NCT02412631|3972268|FG001|COMPLETED|Overall Study||16
3239645|NCT02412631|3972267|FG000|NOT COMPLETED|Overall Study||26
3239646|NCT02412631|3972268|FG001|NOT COMPLETED|Overall Study||24
3370274|NCT03783130|4101656|FG000|STARTED|Overall Study||3
3370275|NCT03783130|4101657|FG001|STARTED|Overall Study||3
3370276|NCT03783130|4101658|FG002|STARTED|Overall Study||5
3370277|NCT03783130|4101659|FG003|STARTED|Overall Study||5
3370278|NCT03783130|4101656|FG000|Received All Product Administrations|Overall Study||3
3239647|NCT02412644|3972276|FG000|STARTED|Overall Study||21
3239648|NCT02412644|3972277|FG001|STARTED|Overall Study||8
3239649|NCT02412644|3972276|FG000|COMPLETED|Overall Study||6
3239650|NCT02412644|3972277|FG001|COMPLETED|Overall Study||4
3239651|NCT02412644|3972276|FG000|NOT COMPLETED|Overall Study||15
3239652|NCT02412644|3972277|FG001|NOT COMPLETED|Overall Study||4
3239653|NCT02412657|3972290|FG000|STARTED|Overall Study||25
3239654|NCT02412657|3972291|FG001|STARTED|Overall Study||25
3239655|NCT02412657|3972292|FG002|STARTED|Overall Study||25
3239656|NCT02412657|3972290|FG000|COMPLETED|Overall Study||24
3239657|NCT02412657|3972291|FG001|COMPLETED|Overall Study||23
3239658|NCT02412657|3972292|FG002|COMPLETED|Overall Study||22
3239659|NCT02412657|3972290|FG000|NOT COMPLETED|Overall Study||1
3239660|NCT02412657|3972291|FG001|NOT COMPLETED|Overall Study||2
3239661|NCT02412657|3972292|FG002|NOT COMPLETED|Overall Study||3
3239662|NCT02412722|3972306|FG000|STARTED|Overall Study||11
3239663|NCT02412722|3972307|FG001|STARTED|Overall Study||8
3239664|NCT02412722|3972308|FG002|STARTED|Overall Study||7
3239665|NCT02412722|3972309|FG003|STARTED|Overall Study||15
3239666|NCT02412722|3972310|FG004|STARTED|Overall Study||7
3239667|NCT02412722|3972311|FG005|STARTED|Overall Study||13
3239668|NCT02412722|3972306|FG000|Safety Population|Overall Study||11
3239669|NCT02412722|3972307|FG001|Safety Population|Overall Study||6
3239670|NCT02412722|3972308|FG002|Safety Population|Overall Study||7
3239671|NCT02412722|3972309|FG003|Safety Population|Overall Study||15
3239672|NCT02412722|3972310|FG004|Safety Population|Overall Study||7
3239673|NCT02412722|3972311|FG005|Safety Population|Overall Study||13
3239674|NCT02412722|3972306|FG000|COMPLETED|Overall Study||0
3239675|NCT02412722|3972307|FG001|COMPLETED|Overall Study||0
3239676|NCT02412722|3972308|FG002|COMPLETED|Overall Study||0
3239677|NCT02412722|3972309|FG003|COMPLETED|Overall Study||0
3239678|NCT02412722|3972310|FG004|COMPLETED|Overall Study||0
3239679|NCT02412722|3972311|FG005|COMPLETED|Overall Study||0
3239680|NCT02412722|3972306|FG000|NOT COMPLETED|Overall Study||11
3239681|NCT02412722|3972307|FG001|NOT COMPLETED|Overall Study||8
3239682|NCT02412722|3972308|FG002|NOT COMPLETED|Overall Study||7
3239683|NCT02412722|3972309|FG003|NOT COMPLETED|Overall Study||15
3239684|NCT02412722|3972310|FG004|NOT COMPLETED|Overall Study||7
3239685|NCT02412722|3972311|FG005|NOT COMPLETED|Overall Study||13
3239686|NCT02412761|3972345|FG000|STARTED|First Intervention (2 Weeks)||5
3239687|NCT02412761|3972346|FG001|STARTED|First Intervention (2 Weeks)||6
3239688|NCT02412761|3972347|FG002|STARTED|First Intervention (2 Weeks)||5
3239689|NCT02412761|3972348|FG003|STARTED|First Intervention (2 Weeks)||8
3239690|NCT02412761|3972349|FG004|STARTED|First Intervention (2 Weeks)||4
3239691|NCT02412761|3972350|FG005|STARTED|First Intervention (2 Weeks)||7
3239692|NCT02412761|3972345|FG000|COMPLETED|First Intervention (2 Weeks)||5
3239693|NCT02412761|3972346|FG001|COMPLETED|First Intervention (2 Weeks)||5
3239694|NCT02412761|3972347|FG002|COMPLETED|First Intervention (2 Weeks)||4
3239695|NCT02412761|3972348|FG003|COMPLETED|First Intervention (2 Weeks)||8
3239696|NCT02412761|3972349|FG004|COMPLETED|First Intervention (2 Weeks)||4
3239697|NCT02412761|3972350|FG005|COMPLETED|First Intervention (2 Weeks)||6
3239698|NCT02412761|3972345|FG000|NOT COMPLETED|First Intervention (2 Weeks)||0
3239699|NCT02412761|3972346|FG001|NOT COMPLETED|First Intervention (2 Weeks)||1
3239700|NCT02412761|3972347|FG002|NOT COMPLETED|First Intervention (2 Weeks)||1
3239701|NCT02412761|3972348|FG003|NOT COMPLETED|First Intervention (2 Weeks)||0
3239702|NCT02412761|3972349|FG004|NOT COMPLETED|First Intervention (2 Weeks)||0
3239703|NCT02412761|3972350|FG005|NOT COMPLETED|First Intervention (2 Weeks)||1
3239704|NCT02412761|3972345|FG000|STARTED|Second Intervention (2 Weeks)||5
3239705|NCT02412761|3972346|FG001|STARTED|Second Intervention (2 Weeks)||5
3370279|NCT03783130|4101657|FG001|Received All Product Administrations|Overall Study||3
3370280|NCT03783130|4101658|FG002|Received All Product Administrations|Overall Study||5
3370281|NCT03783130|4101659|FG003|Received All Product Administrations|Overall Study||5
3370282|NCT03783130|4101656|FG000|COMPLETED|Overall Study||3
3370283|NCT03783130|4101657|FG001|COMPLETED|Overall Study||3
3370284|NCT03783130|4101658|FG002|COMPLETED|Overall Study||5
3370285|NCT03783130|4101659|FG003|COMPLETED|Overall Study||5
3370286|NCT03783130|4101656|FG000|NOT COMPLETED|Overall Study||0
3370287|NCT03783130|4101657|FG001|NOT COMPLETED|Overall Study||0
3370288|NCT03783130|4101658|FG002|NOT COMPLETED|Overall Study||0
3370289|NCT03783130|4101659|FG003|NOT COMPLETED|Overall Study||0
3370290|NCT03776175|4101674|FG000|STARTED|Treatment Period (42 Days)||14
3370291|NCT03776175|4101675|FG001|STARTED|Treatment Period (42 Days)||29
3370292|NCT03776175|4101676|FG002|STARTED|Treatment Period (42 Days)||28
3370293|NCT03776175|4101677|FG003|STARTED|Treatment Period (42 Days)||28
3370294|NCT03776175|4101674|FG000|Treated|Treatment Period (42 Days)||14
3370295|NCT03776175|4101675|FG001|Treated|Treatment Period (42 Days)||29
3370296|NCT03776175|4101676|FG002|Treated|Treatment Period (42 Days)||28
3370297|NCT03776175|4101677|FG003|Treated|Treatment Period (42 Days)||28
3370298|NCT03776175|4101674|FG000|COMPLETED|Treatment Period (42 Days)||13
3370299|NCT03776175|4101675|FG001|COMPLETED|Treatment Period (42 Days)||22
3239706|NCT02412761|3972347|FG002|STARTED|Second Intervention (2 Weeks)||4
3239707|NCT02412761|3972348|FG003|STARTED|Second Intervention (2 Weeks)||8
3239708|NCT02412761|3972349|FG004|STARTED|Second Intervention (2 Weeks)||4
3239709|NCT02412761|3972350|FG005|STARTED|Second Intervention (2 Weeks)||6
3239710|NCT02412761|3972345|FG000|COMPLETED|Second Intervention (2 Weeks)||5
3239711|NCT02412761|3972346|FG001|COMPLETED|Second Intervention (2 Weeks)||5
3239712|NCT02412761|3972347|FG002|COMPLETED|Second Intervention (2 Weeks)||4
3239713|NCT02412761|3972348|FG003|COMPLETED|Second Intervention (2 Weeks)||8
3239714|NCT02412761|3972349|FG004|COMPLETED|Second Intervention (2 Weeks)||4
3239715|NCT02412761|3972350|FG005|COMPLETED|Second Intervention (2 Weeks)||6
3239716|NCT02412761|3972345|FG000|NOT COMPLETED|Second Intervention (2 Weeks)||0
3239717|NCT02412761|3972346|FG001|NOT COMPLETED|Second Intervention (2 Weeks)||0
3239718|NCT02412761|3972347|FG002|NOT COMPLETED|Second Intervention (2 Weeks)||0
3239719|NCT02412761|3972348|FG003|NOT COMPLETED|Second Intervention (2 Weeks)||0
3239720|NCT02412761|3972349|FG004|NOT COMPLETED|Second Intervention (2 Weeks)||0
3239721|NCT02412761|3972350|FG005|NOT COMPLETED|Second Intervention (2 Weeks)||0
3239722|NCT02412761|3972345|FG000|STARTED|Third Intervention (2 Weeks)||5
3239723|NCT02412761|3972346|FG001|STARTED|Third Intervention (2 Weeks)||5
3239724|NCT02412761|3972347|FG002|STARTED|Third Intervention (2 Weeks)||4
3239725|NCT02412761|3972348|FG003|STARTED|Third Intervention (2 Weeks)||8
3239726|NCT02412761|3972349|FG004|STARTED|Third Intervention (2 Weeks)||4
3239727|NCT02412761|3972350|FG005|STARTED|Third Intervention (2 Weeks)||6
3239728|NCT02412761|3972345|FG000|COMPLETED|Third Intervention (2 Weeks)||5
3239729|NCT02412761|3972346|FG001|COMPLETED|Third Intervention (2 Weeks)||5
3239730|NCT02412761|3972347|FG002|COMPLETED|Third Intervention (2 Weeks)||4
3239731|NCT02412761|3972348|FG003|COMPLETED|Third Intervention (2 Weeks)||8
3239732|NCT02412761|3972349|FG004|COMPLETED|Third Intervention (2 Weeks)||4
3239733|NCT02412761|3972350|FG005|COMPLETED|Third Intervention (2 Weeks)||6
3239734|NCT02412761|3972345|FG000|NOT COMPLETED|Third Intervention (2 Weeks)||0
3239735|NCT02412761|3972346|FG001|NOT COMPLETED|Third Intervention (2 Weeks)||0
3239736|NCT02412761|3972347|FG002|NOT COMPLETED|Third Intervention (2 Weeks)||0
3239737|NCT02412761|3972348|FG003|NOT COMPLETED|Third Intervention (2 Weeks)||0
3239738|NCT02412761|3972349|FG004|NOT COMPLETED|Third Intervention (2 Weeks)||0
3239739|NCT02412761|3972350|FG005|NOT COMPLETED|Third Intervention (2 Weeks)||0
3239740|NCT02412852|3972362|FG000|STARTED|Overall Study||4
3239741|NCT02412852|3972363|FG001|STARTED|Overall Study||8
3239742|NCT02412852|3972364|FG002|STARTED|Overall Study||5
3239743|NCT02412852|3972365|FG003|STARTED|Overall Study||9
3239744|NCT02412852|3972362|FG000|COMPLETED|Overall Study||4
3239745|NCT02412852|3972363|FG001|COMPLETED|Overall Study||7
3239746|NCT02412852|3972364|FG002|COMPLETED|Overall Study||5
3239747|NCT02412852|3972365|FG003|COMPLETED|Overall Study||8
3239748|NCT02412852|3972362|FG000|NOT COMPLETED|Overall Study||0
3239749|NCT02412852|3972363|FG001|NOT COMPLETED|Overall Study||1
3239750|NCT02412852|3972364|FG002|NOT COMPLETED|Overall Study||0
3239751|NCT02412852|3972365|FG003|NOT COMPLETED|Overall Study||1
3239752|NCT02412878|3972375|FG000|STARTED|Overall Study||238
3239753|NCT02412878|3972376|FG001|STARTED|Overall Study||240
3239754|NCT02412878|3972375|FG000|Received Carfilzomib|Overall Study||235
3239755|NCT02412878|3972376|FG001|Received Carfilzomib|Overall Study||238
3239756|NCT02412878|3972375|FG000|COMPLETED|Overall Study||217
3239757|NCT02412878|3972376|FG001|COMPLETED|Overall Study||227
3239758|NCT02412878|3972375|FG000|NOT COMPLETED|Overall Study||21
3239759|NCT02412878|3972376|FG001|NOT COMPLETED|Overall Study||13
3239760|NCT02412956|3972384|FG000|STARTED|Overall Study||44
3239761|NCT02412956|3972385|FG001|STARTED|Overall Study||47
3239762|NCT02412956|3972386|FG002|STARTED|Overall Study||8
3239763|NCT02412956|3972384|FG000|COMPLETED|Overall Study||35
3239764|NCT02412956|3972385|FG001|COMPLETED|Overall Study||30
3239765|NCT02412956|3972386|FG002|COMPLETED|Overall Study||8
3239766|NCT02412956|3972384|FG000|NOT COMPLETED|Overall Study||9
3239767|NCT02412956|3972385|FG001|NOT COMPLETED|Overall Study||17
3239768|NCT02412956|3972386|FG002|NOT COMPLETED|Overall Study||0
3239769|NCT02412982|3972394|FG000|STARTED|Primary Endpoint||51
3239770|NCT02412982|3972395|FG001|STARTED|Primary Endpoint||52
3370300|NCT03776175|4101676|FG002|COMPLETED|Treatment Period (42 Days)||24
3370301|NCT03776175|4101677|FG003|COMPLETED|Treatment Period (42 Days)||26
3370302|NCT03776175|4101674|FG000|NOT COMPLETED|Treatment Period (42 Days)||1
3370303|NCT03776175|4101675|FG001|NOT COMPLETED|Treatment Period (42 Days)||7
3370304|NCT03776175|4101676|FG002|NOT COMPLETED|Treatment Period (42 Days)||4
3370305|NCT03776175|4101677|FG003|NOT COMPLETED|Treatment Period (42 Days)||2
3370306|NCT03776175|4101674|FG000|STARTED|Follow-Up Period (35 Days)||13
3370307|NCT03776175|4101675|FG001|STARTED|Follow-Up Period (35 Days)||22
3370308|NCT03776175|4101676|FG002|STARTED|Follow-Up Period (35 Days)||24
3370309|NCT03776175|4101677|FG003|STARTED|Follow-Up Period (35 Days)||26
3370310|NCT03776175|4101674|FG000|COMPLETED|Follow-Up Period (35 Days)||13
3370311|NCT03776175|4101675|FG001|COMPLETED|Follow-Up Period (35 Days)||22
3370312|NCT03776175|4101676|FG002|COMPLETED|Follow-Up Period (35 Days)||24
3370313|NCT03776175|4101677|FG003|COMPLETED|Follow-Up Period (35 Days)||24
3370314|NCT03776175|4101674|FG000|NOT COMPLETED|Follow-Up Period (35 Days)||0
3370315|NCT03776175|4101675|FG001|NOT COMPLETED|Follow-Up Period (35 Days)||0
3370316|NCT03776175|4101676|FG002|NOT COMPLETED|Follow-Up Period (35 Days)||0
3370317|NCT03776175|4101677|FG003|NOT COMPLETED|Follow-Up Period (35 Days)||2
3370318|NCT03771963|4101687|FG000|STARTED|Overall Study||200
3370319|NCT03771963|4101687|FG000|COMPLETED|Overall Study||168
3370320|NCT03771963|4101687|FG000|NOT COMPLETED|Overall Study||32
3370321|NCT03771352|4101691|FG000|STARTED|Overall Study||55
3239771|NCT02412982|3972394|FG000|COMPLETED|Primary Endpoint||47
3239772|NCT02412982|3972395|FG001|COMPLETED|Primary Endpoint||49
3239773|NCT02412982|3972394|FG000|NOT COMPLETED|Primary Endpoint||4
3239774|NCT02412982|3972395|FG001|NOT COMPLETED|Primary Endpoint||3
3239775|NCT02412982|3972394|FG000|STARTED|Intervention Group: Randomization|Control group patients did not undergo randomization (see study protocol section)|0
3239776|NCT02412982|3972395|FG001|STARTED|Intervention Group: Randomization|52 patients in the intervention group underwent 1:1 randomization to the two intervention study arms: 26 patients in 40 mg every 12 hours with escalation to 50 mg every 12 hours and 26 patients in 30 mg every 8 hours.|52
3239777|NCT02412982|3972394|FG000|COMPLETED|Intervention Group: Randomization||0
3239778|NCT02412982|3972395|FG001|COMPLETED|Intervention Group: Randomization||51
3239779|NCT02412982|3972394|FG000|NOT COMPLETED|Intervention Group: Randomization||0
3239780|NCT02412982|3972395|FG001|NOT COMPLETED|Intervention Group: Randomization||1
3239781|NCT02413008|3972403|FG000|STARTED|Overall Study||50
3239782|NCT02413008|3972404|FG001|STARTED|Overall Study||11
3239783|NCT02413008|3972403|FG000|COMPLETED|Overall Study||43
3239784|NCT02413008|3972404|FG001|COMPLETED|Overall Study||9
3239785|NCT02413008|3972403|FG000|NOT COMPLETED|Overall Study||7
3239786|NCT02413008|3972404|FG001|NOT COMPLETED|Overall Study||2
3239787|NCT02413034|3972415|FG000|STARTED|Overall Study||14
3239788|NCT02413034|3972416|FG001|STARTED|Overall Study||14
3239789|NCT02413034|3972415|FG000|COMPLETED|Overall Study||14
3239790|NCT02413034|3972416|FG001|COMPLETED|Overall Study||14
3239791|NCT02413034|3972415|FG000|NOT COMPLETED|Overall Study||0
3239792|NCT02413034|3972416|FG001|NOT COMPLETED|Overall Study||0
3239793|NCT02413151|3972424|FG000|STARTED|Overall Study||32
3239794|NCT02413151|3972425|FG001|STARTED|Overall Study||30
3239795|NCT02413151|3972424|FG000|COMPLETED|Overall Study||22
3239796|NCT02413151|3972425|FG001|COMPLETED|Overall Study||28
3239797|NCT02413151|3972424|FG000|NOT COMPLETED|Overall Study||10
3239798|NCT02413151|3972425|FG001|NOT COMPLETED|Overall Study||2
3239799|NCT02413190|3972432|FG000|STARTED|Overall Study||94
3239800|NCT02413190|3972432|FG000|COMPLETED|Overall Study||94
3239801|NCT02413190|3972432|FG000|NOT COMPLETED|Overall Study||0
3239802|NCT02413203|3972438|FG000|STARTED|Overall Study||10
3239803|NCT02413203|3972439|FG001|STARTED|Overall Study||10
3239804|NCT02413203|3972438|FG000|COMPLETED|Overall Study||10
3239805|NCT02413203|3972439|FG001|COMPLETED|Overall Study||10
3239806|NCT02413203|3972438|FG000|NOT COMPLETED|Overall Study||0
3239807|NCT02413203|3972439|FG001|NOT COMPLETED|Overall Study||0
3239808|NCT02413229|3972453|FG000|STARTED|Overall Study||25
3239809|NCT02413229|3972454|FG001|STARTED|Overall Study||12
3239810|NCT02413229|3972455|FG002|STARTED|Overall Study||26
3239811|NCT02413229|3972456|FG003|STARTED|Overall Study||12
3239812|NCT02413229|3972457|FG004|STARTED|Overall Study||24
3239813|NCT02413229|3972458|FG005|STARTED|Overall Study||12
3239814|NCT02413229|3972459|FG006|STARTED|Overall Study||25
3239815|NCT02413229|3972460|FG007|STARTED|Overall Study||15
3239816|NCT02413229|3972453|FG000|COMPLETED|Overall Study||24
3239817|NCT02413229|3972454|FG001|COMPLETED|Overall Study||11
3239818|NCT02413229|3972455|FG002|COMPLETED|Overall Study||25
3239819|NCT02413229|3972456|FG003|COMPLETED|Overall Study||11
3239820|NCT02413229|3972457|FG004|COMPLETED|Overall Study||21
3239821|NCT02413229|3972458|FG005|COMPLETED|Overall Study||12
3239822|NCT02413229|3972459|FG006|COMPLETED|Overall Study||25
3239823|NCT02413229|3972460|FG007|COMPLETED|Overall Study||11
3239824|NCT02413229|3972453|FG000|NOT COMPLETED|Overall Study||1
3239825|NCT02413229|3972454|FG001|NOT COMPLETED|Overall Study||1
3239826|NCT02413229|3972455|FG002|NOT COMPLETED|Overall Study||1
3239827|NCT02413229|3972456|FG003|NOT COMPLETED|Overall Study||1
3239828|NCT02413229|3972457|FG004|NOT COMPLETED|Overall Study||3
3239829|NCT02413229|3972458|FG005|NOT COMPLETED|Overall Study||0
3239830|NCT02413229|3972459|FG006|NOT COMPLETED|Overall Study||0
3239831|NCT02413229|3972460|FG007|NOT COMPLETED|Overall Study||4
3239832|NCT02413255|3972495|FG000|STARTED|Overall Study||18
3239833|NCT02413255|3972496|FG001|STARTED|Overall Study||6
3239834|NCT02413255|3972497|FG002|STARTED|Overall Study||6
3239835|NCT02413255|3972498|FG003|STARTED|Overall Study||6
3239836|NCT02413255|3972499|FG004|STARTED|Overall Study||6
3239837|NCT02413255|3972500|FG005|STARTED|Overall Study||6
3239838|NCT02413255|3972501|FG006|STARTED|Overall Study||6
3239839|NCT02413255|3972502|FG007|STARTED|Overall Study||6
3239840|NCT02413255|3972503|FG008|STARTED|Overall Study||6
3239841|NCT02413255|3972504|FG009|STARTED|Overall Study||6
3239842|NCT02413255|3972505|FG010|STARTED|Overall Study||12
3239843|NCT02413255|3972506|FG011|STARTED|Overall Study||6
3239844|NCT02413255|3972507|FG012|STARTED|Overall Study||6
3239845|NCT02413255|3972508|FG013|STARTED|Overall Study||6
3239846|NCT02413255|3972509|FG014|STARTED|Overall Study||6
3239847|NCT02413255|3972510|FG015|STARTED|Overall Study||6
3239848|NCT02413255|3972511|FG016|STARTED|Overall Study||6
3239849|NCT02413255|3972495|FG000|COMPLETED|Overall Study||18
3239850|NCT02413255|3972496|FG001|COMPLETED|Overall Study||6
3239851|NCT02413255|3972497|FG002|COMPLETED|Overall Study||6
3239852|NCT02413255|3972498|FG003|COMPLETED|Overall Study||6
3239853|NCT02413255|3972499|FG004|COMPLETED|Overall Study||6
3239854|NCT02413255|3972500|FG005|COMPLETED|Overall Study||6
3239855|NCT02413255|3972501|FG006|COMPLETED|Overall Study||6
3239856|NCT02413255|3972502|FG007|COMPLETED|Overall Study||6
3239857|NCT02413255|3972503|FG008|COMPLETED|Overall Study||6
3370322|NCT03771352|4101691|FG000|COMPLETED|Overall Study|The fellow eye of one subject was not implanted per the discretion of the investigator.|51
3370323|NCT03771352|4101691|FG000|NOT COMPLETED|Overall Study||4
3370324|NCT03773796|4101695|FG000|STARTED|Overall Study||22
3370325|NCT03773796|4101695|FG000|COMPLETED|Overall Study||19
3239858|NCT02413255|3972504|FG009|COMPLETED|Overall Study||6
3370326|NCT03773796|4101695|FG000|NOT COMPLETED|Overall Study||3
3239859|NCT02413255|3972505|FG010|COMPLETED|Overall Study||12
3239860|NCT02413255|3972506|FG011|COMPLETED|Overall Study||6
3239861|NCT02413255|3972507|FG012|COMPLETED|Overall Study||6
3239862|NCT02413255|3972508|FG013|COMPLETED|Overall Study||6
3239863|NCT02413255|3972509|FG014|COMPLETED|Overall Study||5
3239864|NCT02413255|3972510|FG015|COMPLETED|Overall Study||6
3239865|NCT02413255|3972511|FG016|COMPLETED|Overall Study||6
3239866|NCT02413255|3972495|FG000|NOT COMPLETED|Overall Study||0
3239867|NCT02413255|3972496|FG001|NOT COMPLETED|Overall Study||0
3239868|NCT02413255|3972497|FG002|NOT COMPLETED|Overall Study||0
3239869|NCT02413255|3972498|FG003|NOT COMPLETED|Overall Study||0
3239870|NCT02413255|3972499|FG004|NOT COMPLETED|Overall Study||0
3239871|NCT02413255|3972500|FG005|NOT COMPLETED|Overall Study||0
3239872|NCT02413255|3972501|FG006|NOT COMPLETED|Overall Study||0
3239873|NCT02413255|3972502|FG007|NOT COMPLETED|Overall Study||0
3239874|NCT02413255|3972503|FG008|NOT COMPLETED|Overall Study||0
3239875|NCT02413255|3972504|FG009|NOT COMPLETED|Overall Study||0
3239876|NCT02413255|3972505|FG010|NOT COMPLETED|Overall Study||0
3239877|NCT02413255|3972506|FG011|NOT COMPLETED|Overall Study||0
3239878|NCT02413255|3972507|FG012|NOT COMPLETED|Overall Study||0
3239879|NCT02413255|3972508|FG013|NOT COMPLETED|Overall Study||0
3239880|NCT02413255|3972509|FG014|NOT COMPLETED|Overall Study||1
3239881|NCT02413255|3972510|FG015|NOT COMPLETED|Overall Study||0
3239882|NCT02413255|3972511|FG016|NOT COMPLETED|Overall Study||0
3239883|NCT02413294|3972562|FG000|STARTED|Overall Study||12
3239884|NCT02413294|3972562|FG000|COMPLETED|Overall Study||11
3239885|NCT02413294|3972562|FG000|NOT COMPLETED|Overall Study||1
3239886|NCT02413320|3972568|FG000|STARTED|Overall Study||49
3239887|NCT02413320|3972569|FG001|STARTED|Overall Study||52
3239888|NCT02413320|3972568|FG000|COMPLETED|Overall Study||48
3239889|NCT02413320|3972569|FG001|COMPLETED|Overall Study||52
3239890|NCT02413320|3972568|FG000|NOT COMPLETED|Overall Study||1
3239891|NCT02413320|3972569|FG001|NOT COMPLETED|Overall Study||0
3239892|NCT02413333|3972579|FG000|STARTED|Period 1||66
3239893|NCT02413333|3972580|FG001|STARTED|Period 1||66
3239894|NCT02413333|3972579|FG000|Randomized and Treated|Period 1||66
3239895|NCT02413333|3972580|FG001|Randomized and Treated|Period 1||66
3239896|NCT02413333|3972579|FG000|COMPLETED|Period 1||65
3239897|NCT02413333|3972580|FG001|COMPLETED|Period 1||65
3239898|NCT02413333|3972579|FG000|NOT COMPLETED|Period 1||1
3239899|NCT02413333|3972580|FG001|NOT COMPLETED|Period 1||1
3239900|NCT02413333|3972579|FG000|STARTED|Period 2||65
3239901|NCT02413333|3972580|FG001|STARTED|Period 2||65
3239902|NCT02413333|3972579|FG000|COMPLETED|Period 2||64
3239903|NCT02413333|3972580|FG001|COMPLETED|Period 2||65
3239904|NCT02413333|3972579|FG000|NOT COMPLETED|Period 2||1
3239905|NCT02413333|3972580|FG001|NOT COMPLETED|Period 2||0
3239906|NCT02413346|3972588|FG000|STARTED|Overall Study||236
3239907|NCT02413346|3972589|FG001|STARTED|Overall Study||247
3239908|NCT02413346|3972588|FG000|COMPLETED|Overall Study||177
3239909|NCT02413346|3972589|FG001|COMPLETED|Overall Study||177
3239910|NCT02413346|3972588|FG000|NOT COMPLETED|Overall Study||59
3239911|NCT02413346|3972589|FG001|NOT COMPLETED|Overall Study||70
3239912|NCT02413372|3972598|FG000|STARTED|Treatment||25
3239913|NCT02413372|3972599|FG001|STARTED|Treatment||24
3239914|NCT02413372|3972600|FG002|STARTED|Treatment||26
3239915|NCT02413372|3972598|FG000|COMPLETED|Treatment||24
3239916|NCT02413372|3972599|FG001|COMPLETED|Treatment||22
3239917|NCT02413372|3972600|FG002|COMPLETED|Treatment||25
3239918|NCT02413372|3972598|FG000|NOT COMPLETED|Treatment||1
3239919|NCT02413372|3972599|FG001|NOT COMPLETED|Treatment||2
3239920|NCT02413372|3972600|FG002|NOT COMPLETED|Treatment||1
3239921|NCT02413372|3972598|FG000|STARTED|Follow-up||22
3239922|NCT02413372|3972599|FG001|STARTED|Follow-up||21
3239923|NCT02413372|3972600|FG002|STARTED|Follow-up||25
3239924|NCT02413372|3972598|FG000|COMPLETED|Follow-up||20
3239925|NCT02413372|3972599|FG001|COMPLETED|Follow-up||20
3239926|NCT02413372|3972600|FG002|COMPLETED|Follow-up||23
3239927|NCT02413372|3972598|FG000|NOT COMPLETED|Follow-up||2
3239928|NCT02413372|3972599|FG001|NOT COMPLETED|Follow-up||1
3239929|NCT02413372|3972600|FG002|NOT COMPLETED|Follow-up||2
3239930|NCT02413398|3972610|FG000|STARTED|Overall Study||160
3239931|NCT02413398|3972611|FG001|STARTED|Overall Study||161
3239932|NCT02413398|3972610|FG000|COMPLETED|Overall Study||156
3239933|NCT02413398|3972611|FG001|COMPLETED|Overall Study||154
3239934|NCT02413398|3972610|FG000|NOT COMPLETED|Overall Study||4
3239935|NCT02413398|3972611|FG001|NOT COMPLETED|Overall Study||7
3239936|NCT02413463|3972619|FG000|STARTED|Overall Study||30
3239937|NCT02413463|3972620|FG001|STARTED|Overall Study||30
3239938|NCT02413463|3972619|FG000|COMPLETED|Overall Study||25
3239939|NCT02413463|3972620|FG001|COMPLETED|Overall Study||28
3239940|NCT02413463|3972619|FG000|NOT COMPLETED|Overall Study||5
3239941|NCT02413463|3972620|FG001|NOT COMPLETED|Overall Study||2
3239942|NCT02413489|3972629|FG000|STARTED|Overall Study||15
3239943|NCT02413489|3972630|FG001|STARTED|Overall Study||16
3239944|NCT02413489|3972631|FG002|STARTED|Overall Study||5
3239945|NCT02413489|3972629|FG000|COMPLETED|Overall Study||0
3239946|NCT02413489|3972630|FG001|COMPLETED|Overall Study||0
3239947|NCT02413489|3972631|FG002|COMPLETED|Overall Study||0
3239948|NCT02413489|3972629|FG000|NOT COMPLETED|Overall Study||15
3239949|NCT02413489|3972630|FG001|NOT COMPLETED|Overall Study||16
3239950|NCT02413489|3972631|FG002|NOT COMPLETED|Overall Study||5
3239951|NCT02413580|3972639|FG000|STARTED|Overall Study||49
3239952|NCT02413580|3972639|FG000|COMPLETED|Overall Study||46
3239953|NCT02413580|3972639|FG000|NOT COMPLETED|Overall Study||3
3239954|NCT02413593|3972643|FG000|STARTED|Overall Study||111
3239955|NCT02413593|3972643|FG000|COMPLETED|Overall Study||107
3239956|NCT02413593|3972643|FG000|NOT COMPLETED|Overall Study||4
3239957|NCT02413684|3972647|FG000|STARTED|Overall Study||53
3239958|NCT02413684|3972647|FG000|COMPLETED|Overall Study||40
3239959|NCT02413684|3972647|FG000|NOT COMPLETED|Overall Study||13
3239960|NCT02413879|3972651|FG000|STARTED|Overall Study||86
3239961|NCT02413879|3972651|FG000|COMPLETED|Overall Study||86
3239962|NCT02413879|3972651|FG000|NOT COMPLETED|Overall Study||0
3239963|NCT02413918|3972655|FG000|STARTED|Overall Study||41
3239964|NCT02413918|3972655|FG000|COMPLETED|Overall Study||16
3239965|NCT02413918|3972655|FG000|NOT COMPLETED|Overall Study||25
3239966|NCT02413996|3972664|FG000|STARTED|Overall Study||44
3239967|NCT02413996|3972665|FG001|STARTED|Overall Study||41
3239968|NCT02413996|3972664|FG000|COMPLETED|Overall Study||35
3239969|NCT02413996|3972665|FG001|COMPLETED|Overall Study||39
3239970|NCT02413996|3972664|FG000|NOT COMPLETED|Overall Study||9
3239971|NCT02413996|3972665|FG001|NOT COMPLETED|Overall Study||2
3239972|NCT02414204|3972673|FG000|STARTED|Overall Study||2
3239973|NCT02414204|3972674|FG001|STARTED|Overall Study||2
3239974|NCT02414204|3972673|FG000|COMPLETED|Overall Study||2
3239975|NCT02414204|3972674|FG001|COMPLETED|Overall Study||2
3239976|NCT02414204|3972673|FG000|NOT COMPLETED|Overall Study||0
3239977|NCT02414204|3972674|FG001|NOT COMPLETED|Overall Study||0
3239978|NCT02414243|3972682|FG000|STARTED|Overall Study||19
3239979|NCT02414243|3972683|FG001|STARTED|Overall Study||21
3239980|NCT02414243|3972682|FG000|Moved to the Other Group|Overall Study||17
3239981|NCT02414243|3972683|FG001|Moved to the Other Group|Overall Study||20
3239982|NCT02414243|3972682|FG000|Entered Open Challenge at Home|Overall Study||17
3239983|NCT02414243|3972683|FG001|Entered Open Challenge at Home|Overall Study||20
3239984|NCT02414243|3972682|FG000|COMPLETED|Overall Study||13
3239985|NCT02414243|3972683|FG001|COMPLETED|Overall Study||17
3239986|NCT02414243|3972682|FG000|NOT COMPLETED|Overall Study||6
3239987|NCT02414243|3972683|FG001|NOT COMPLETED|Overall Study||4
3239988|NCT02414633|3972690|FG000|STARTED|Overall Study||148
3239989|NCT02414633|3972690|FG000|COMPLETED|Overall Study||148
3239990|NCT02414633|3972690|FG000|NOT COMPLETED|Overall Study||0
3239991|NCT02414828|3972698|FG000|STARTED|Overall Study||11
3239992|NCT02414828|3972699|FG001|STARTED|Overall Study||10
3239993|NCT02414828|3972700|FG002|STARTED|Overall Study||20
3239994|NCT02414828|3972701|FG003|STARTED|Overall Study||31
3239995|NCT02414828|3972698|FG000|COMPLETED|Overall Study||11
3239996|NCT02414828|3972699|FG001|COMPLETED|Overall Study||9
3239997|NCT02414828|3972700|FG002|COMPLETED|Overall Study||19
3239998|NCT02414828|3972701|FG003|COMPLETED|Overall Study||29
3239999|NCT02414828|3972698|FG000|NOT COMPLETED|Overall Study||0
3240000|NCT02414828|3972699|FG001|NOT COMPLETED|Overall Study||1
3240001|NCT02414828|3972700|FG002|NOT COMPLETED|Overall Study||1
3240002|NCT02414828|3972701|FG003|NOT COMPLETED|Overall Study||2
3240003|NCT02414841|3972714|FG000|STARTED|Overall Study||405
3240004|NCT02414841|3972715|FG001|STARTED|Overall Study||208
3240005|NCT02414841|3972714|FG000|COMPLETED|Overall Study||349
3240006|NCT02414841|3972715|FG001|COMPLETED|Overall Study||175
3240007|NCT02414841|3972714|FG000|NOT COMPLETED|Overall Study||56
3240008|NCT02414841|3972715|FG001|NOT COMPLETED|Overall Study||33
3240009|NCT02414854|3972727|FG000|STARTED|Overall Study||317
3240010|NCT02414854|3972728|FG001|STARTED|Overall Study||631
3240011|NCT02414854|3972729|FG002|STARTED|Overall Study||321
3240012|NCT02414854|3972730|FG003|STARTED|Overall Study||633
3240013|NCT02414854|3972727|FG000|Treated|Overall Study|2 got other treatment (1 each dupilumab 200+300) than assigned + were allocated to those in AE table|315
3240014|NCT02414854|3972728|FG001|Treated|Overall Study||629
3240015|NCT02414854|3972729|FG002|Treated|Overall Study||321
3240016|NCT02414854|3972730|FG003|Treated|Overall Study|1 got other treatment (dupilumab 200) than assigned + was allocated to that in AE table|632
3240017|NCT02414854|3972727|FG000|COMPLETED|Overall Study||295
3240018|NCT02414854|3972728|FG001|COMPLETED|Overall Study||586
3240019|NCT02414854|3972729|FG002|COMPLETED|Overall Study||301
3240020|NCT02414854|3972730|FG003|COMPLETED|Overall Study||582
3240021|NCT02414854|3972727|FG000|NOT COMPLETED|Overall Study||22
3240022|NCT02414854|3972728|FG001|NOT COMPLETED|Overall Study||45
3240023|NCT02414854|3972729|FG002|NOT COMPLETED|Overall Study||20
3240024|NCT02414854|3972730|FG003|NOT COMPLETED|Overall Study||51
3240025|NCT02414932|3972742|FG000|STARTED|Overall Study||3
3240026|NCT02414932|3972743|FG001|STARTED|Overall Study||3
3240027|NCT02414932|3972742|FG000|COMPLETED|Overall Study||0
3240028|NCT02414932|3972743|FG001|COMPLETED|Overall Study||0
3240029|NCT02414932|3972742|FG000|NOT COMPLETED|Overall Study||3
3240030|NCT02414932|3972743|FG001|NOT COMPLETED|Overall Study||3
3240031|NCT02414958|3972752|FG000|STARTED|Overall Study||243
3240032|NCT02414958|3972753|FG001|STARTED|Overall Study||243
3240033|NCT02414958|3972754|FG002|STARTED|Overall Study||244
3240034|NCT02414958|3972752|FG000|COMPLETED|Overall Study||211
3240035|NCT02414958|3972753|FG001|COMPLETED|Overall Study||223
3240036|NCT02414958|3972754|FG002|COMPLETED|Overall Study||230
3240037|NCT02414958|3972752|FG000|NOT COMPLETED|Overall Study||32
3240038|NCT02414958|3972753|FG001|NOT COMPLETED|Overall Study||20
3240039|NCT02414958|3972754|FG002|NOT COMPLETED|Overall Study||14
3240040|NCT02415127|3972764|FG000|STARTED|Overall Study||47
3240041|NCT02415127|3972765|FG001|STARTED|Overall Study||45
3240042|NCT02415127|3972764|FG000|COMPLETED|Overall Study||46
3240043|NCT02415127|3972765|FG001|COMPLETED|Overall Study||45
3240044|NCT02415127|3972764|FG000|NOT COMPLETED|Overall Study||1
3240045|NCT02415127|3972765|FG001|NOT COMPLETED|Overall Study||0
3240046|NCT02415244|3972773|FG000|STARTED|Overall Study||50
3240047|NCT02415244|3972774|FG001|STARTED|Overall Study||25
3240048|NCT02415244|3972773|FG000|COMPLETED|Overall Study||50
3240049|NCT02415244|3972774|FG001|COMPLETED|Overall Study||25
3240050|NCT02415244|3972773|FG000|NOT COMPLETED|Overall Study||0
3240051|NCT02415244|3972774|FG001|NOT COMPLETED|Overall Study||0
3240052|NCT02415400|3972784|FG000|STARTED|Overall Study||1153
3240053|NCT02415400|3972785|FG001|STARTED|Overall Study||1153
3240054|NCT02415400|3972786|FG002|STARTED|Overall Study||1154
3240055|NCT02415400|3972787|FG003|STARTED|Overall Study||1154
3240056|NCT02415400|3972784|FG000|COMPLETED|Overall Study||1087
3240057|NCT02415400|3972785|FG001|COMPLETED|Overall Study||1091
3240058|NCT02415400|3972786|FG002|COMPLETED|Overall Study||1069
3240059|NCT02415400|3972787|FG003|COMPLETED|Overall Study||1071
3240060|NCT02415400|3972784|FG000|NOT COMPLETED|Overall Study||66
3240061|NCT02415400|3972785|FG001|NOT COMPLETED|Overall Study||62
3240062|NCT02415400|3972786|FG002|NOT COMPLETED|Overall Study||85
3240063|NCT02415400|3972787|FG003|NOT COMPLETED|Overall Study||83
3240064|NCT02415439|3972814|FG000|STARTED|Overall Study||6
3240065|NCT02415439|3972815|FG001|STARTED|Overall Study||6
3240066|NCT02415439|3972816|FG002|STARTED|Overall Study||6
3240067|NCT02415439|3972817|FG003|STARTED|Overall Study||6
3240068|NCT02415439|3972818|FG004|STARTED|Overall Study||6
3240069|NCT02415439|3972819|FG005|STARTED|Overall Study||6
3240070|NCT02415439|3972820|FG006|STARTED|Overall Study||6
3240071|NCT02415439|3972821|FG007|STARTED|Overall Study||12
3240072|NCT02415439|3972822|FG008|STARTED|Overall Study||6
3240073|NCT02415439|3972823|FG009|STARTED|Overall Study||6
3240074|NCT02415439|3972824|FG010|STARTED|Overall Study||6
3240075|NCT02415439|3972825|FG011|STARTED|Overall Study||6
3240076|NCT02415439|3972826|FG012|STARTED|Overall Study||8
3240077|NCT02415439|3972814|FG000|COMPLETED|Overall Study||6
3240078|NCT02415439|3972815|FG001|COMPLETED|Overall Study||6
3240079|NCT02415439|3972816|FG002|COMPLETED|Overall Study||6
3240080|NCT02415439|3972817|FG003|COMPLETED|Overall Study||6
3240081|NCT02415439|3972818|FG004|COMPLETED|Overall Study||6
3240082|NCT02415439|3972819|FG005|COMPLETED|Overall Study||6
3240083|NCT02415439|3972820|FG006|COMPLETED|Overall Study||6
3240084|NCT02415439|3972821|FG007|COMPLETED|Overall Study||12
3240085|NCT02415439|3972822|FG008|COMPLETED|Overall Study||5
3240086|NCT02415439|3972823|FG009|COMPLETED|Overall Study||6
3240087|NCT02415439|3972824|FG010|COMPLETED|Overall Study||6
3240088|NCT02415439|3972825|FG011|COMPLETED|Overall Study||6
3240089|NCT02415439|3972826|FG012|COMPLETED|Overall Study||8
3240090|NCT02415439|3972814|FG000|NOT COMPLETED|Overall Study||0
3240091|NCT02415439|3972815|FG001|NOT COMPLETED|Overall Study||0
3240092|NCT02415439|3972816|FG002|NOT COMPLETED|Overall Study||0
3240093|NCT02415439|3972817|FG003|NOT COMPLETED|Overall Study||0
3240094|NCT02415439|3972818|FG004|NOT COMPLETED|Overall Study||0
3240095|NCT02415439|3972819|FG005|NOT COMPLETED|Overall Study||0
3240096|NCT02415439|3972820|FG006|NOT COMPLETED|Overall Study||0
3240097|NCT02415439|3972821|FG007|NOT COMPLETED|Overall Study||0
3240098|NCT02415439|3972822|FG008|NOT COMPLETED|Overall Study||1
3240099|NCT02415439|3972823|FG009|NOT COMPLETED|Overall Study||0
3240100|NCT02415439|3972824|FG010|NOT COMPLETED|Overall Study||0
3240101|NCT02415439|3972825|FG011|NOT COMPLETED|Overall Study||0
3240102|NCT02415439|3972826|FG012|NOT COMPLETED|Overall Study||0
3240103|NCT02415556|3972860|FG000|STARTED|Overall Study||57
3240104|NCT02415556|3972861|FG001|STARTED|Overall Study||58
3240105|NCT02415556|3972862|FG002|STARTED|Overall Study||65
3240106|NCT02415556|3972863|FG003|STARTED|Overall Study||64
3240107|NCT02415556|3972860|FG000|COMPLETED|Overall Study||32
3240108|NCT02415556|3972861|FG001|COMPLETED|Overall Study||37
3240109|NCT02415556|3972862|FG002|COMPLETED|Overall Study||43
3240110|NCT02415556|3972863|FG003|COMPLETED|Overall Study||44
3240111|NCT02415556|3972860|FG000|NOT COMPLETED|Overall Study||25
3240112|NCT02415556|3972861|FG001|NOT COMPLETED|Overall Study||21
3240113|NCT02415556|3972862|FG002|NOT COMPLETED|Overall Study||22
3240114|NCT02415556|3972863|FG003|NOT COMPLETED|Overall Study||20
3240115|NCT02415595|3972877|FG000|STARTED|Overall Study||50
3240116|NCT02415595|3972878|FG001|STARTED|Overall Study||52
3240117|NCT02415595|3972879|FG002|STARTED|Overall Study||51
3370327|NCT03782233|4101701|FG000|STARTED|Overall Study||50
3370328|NCT03782233|4101702|FG001|STARTED|Overall Study||33
3370329|NCT03782233|4101701|FG000|COMPLETED|Overall Study||46
3370330|NCT03782233|4101702|FG001|COMPLETED|Overall Study||31
3370331|NCT03782233|4101701|FG000|NOT COMPLETED|Overall Study||4
3370332|NCT03782233|4101702|FG001|NOT COMPLETED|Overall Study||2
3370333|NCT03781375|4101712|FG000|STARTED|Double-blind Phase||12
3370334|NCT03781375|4101713|FG001|STARTED|Double-blind Phase||13
3370335|NCT03781375|4101712|FG000|Received Study Drug|Double-blind Phase||12
3370336|NCT03781375|4101713|FG001|Received Study Drug|Double-blind Phase||13
3370337|NCT03781375|4101712|FG000|COMPLETED|Double-blind Phase||5
3370338|NCT03781375|4101713|FG001|COMPLETED|Double-blind Phase||7
3370339|NCT03781375|4101712|FG000|NOT COMPLETED|Double-blind Phase||7
3370340|NCT03781375|4101713|FG001|NOT COMPLETED|Double-blind Phase||6
3370341|NCT03781375|4101712|FG000|STARTED|Open-label Phase||11
3240118|NCT02415595|3972880|FG003|STARTED|Overall Study||53
3240119|NCT02415595|3972877|FG000|COMPLETED|Overall Study||0
3240120|NCT02415595|3972878|FG001|COMPLETED|Overall Study||0
3240121|NCT02415595|3972879|FG002|COMPLETED|Overall Study||0
3240122|NCT02415595|3972880|FG003|COMPLETED|Overall Study||0
3240123|NCT02415595|3972877|FG000|NOT COMPLETED|Overall Study||50
3240124|NCT02415595|3972878|FG001|NOT COMPLETED|Overall Study||52
3240125|NCT02415595|3972879|FG002|NOT COMPLETED|Overall Study||51
3240126|NCT02415595|3972880|FG003|NOT COMPLETED|Overall Study||53
3240127|NCT02415608|3972893|FG000|STARTED|Overall Study||3
3240128|NCT02415608|3972894|FG001|STARTED|Overall Study||1
3240129|NCT02415608|3972893|FG000|COMPLETED|Overall Study||3
3240130|NCT02415608|3972894|FG001|COMPLETED|Overall Study||1
3240131|NCT02415608|3972893|FG000|NOT COMPLETED|Overall Study||0
3240132|NCT02415608|3972894|FG001|NOT COMPLETED|Overall Study||0
3240133|NCT02415842|3972913|FG000|STARTED|Overall Study||29
3240134|NCT02415842|3972914|FG001|STARTED|Overall Study||29
3240135|NCT02415842|3972915|FG002|STARTED|Overall Study||29
3240136|NCT02415842|3972916|FG003|STARTED|Overall Study||27
3240137|NCT02415842|3972917|FG004|STARTED|Overall Study||30
3240138|NCT02415842|3972918|FG005|STARTED|Overall Study||30
3240139|NCT02415842|3972919|FG006|STARTED|Overall Study||30
3240140|NCT02415842|3972920|FG007|STARTED|Overall Study||26
3240141|NCT02415842|3972921|FG008|STARTED|Overall Study||29
3240142|NCT02415842|3972922|FG009|STARTED|Overall Study||53
3240143|NCT02415842|3972923|FG010|STARTED|Overall Study||49
3240144|NCT02415842|3972924|FG011|STARTED|Overall Study||33
3240145|NCT02415842|3972925|FG012|STARTED|Overall Study||20
3240146|NCT02415842|3972913|FG000|COMPLETED|Overall Study||29
3240147|NCT02415842|3972914|FG001|COMPLETED|Overall Study||29
3240148|NCT02415842|3972915|FG002|COMPLETED|Overall Study||29
3240149|NCT02415842|3972916|FG003|COMPLETED|Overall Study||27
3240150|NCT02415842|3972917|FG004|COMPLETED|Overall Study||30
3240151|NCT02415842|3972918|FG005|COMPLETED|Overall Study||30
3240152|NCT02415842|3972919|FG006|COMPLETED|Overall Study||30
3240153|NCT02415842|3972920|FG007|COMPLETED|Overall Study||26
3240154|NCT02415842|3972921|FG008|COMPLETED|Overall Study||29
3240155|NCT02415842|3972922|FG009|COMPLETED|Overall Study||53
3240156|NCT02415842|3972923|FG010|COMPLETED|Overall Study||49
3240157|NCT02415842|3972924|FG011|COMPLETED|Overall Study||33
3240158|NCT02415842|3972925|FG012|COMPLETED|Overall Study||20
3240159|NCT02415842|3972913|FG000|NOT COMPLETED|Overall Study||0
3240160|NCT02415842|3972914|FG001|NOT COMPLETED|Overall Study||0
3240161|NCT02415842|3972915|FG002|NOT COMPLETED|Overall Study||0
3240162|NCT02415842|3972916|FG003|NOT COMPLETED|Overall Study||0
3240163|NCT02415842|3972917|FG004|NOT COMPLETED|Overall Study||0
3240164|NCT02415842|3972918|FG005|NOT COMPLETED|Overall Study||0
3240165|NCT02415842|3972919|FG006|NOT COMPLETED|Overall Study||0
3240166|NCT02415842|3972920|FG007|NOT COMPLETED|Overall Study||0
3240167|NCT02415842|3972921|FG008|NOT COMPLETED|Overall Study||0
3240168|NCT02415842|3972922|FG009|NOT COMPLETED|Overall Study||0
3240169|NCT02415842|3972923|FG010|NOT COMPLETED|Overall Study||0
3240170|NCT02415842|3972924|FG011|NOT COMPLETED|Overall Study||0
3240171|NCT02415842|3972925|FG012|NOT COMPLETED|Overall Study||0
3240172|NCT02415855|3972972|FG000|STARTED|Overall Study||37
3240173|NCT02415855|3972973|FG001|STARTED|Overall Study||64
3240174|NCT02415855|3972972|FG000|COMPLETED|Overall Study||34
3240175|NCT02415855|3972973|FG001|COMPLETED|Overall Study||62
3240176|NCT02415855|3972972|FG000|NOT COMPLETED|Overall Study||3
3240177|NCT02415855|3972973|FG001|NOT COMPLETED|Overall Study||2
3240178|NCT02415959|3972984|FG000|STARTED|Overall Study||14
3240179|NCT02415959|3972985|FG001|STARTED|Overall Study||14
3240180|NCT02415959|3972986|FG002|STARTED|Overall Study||14
3240181|NCT02415959|3972987|FG003|STARTED|Overall Study||14
3240182|NCT02415959|3972988|FG004|STARTED|Overall Study||14
3240183|NCT02415959|3972984|FG000|COMPLETED|Overall Study||14
3240184|NCT02415959|3972985|FG001|COMPLETED|Overall Study||13
3240185|NCT02415959|3972986|FG002|COMPLETED|Overall Study||14
3240186|NCT02415959|3972987|FG003|COMPLETED|Overall Study||13
3240187|NCT02415959|3972988|FG004|COMPLETED|Overall Study||14
3240188|NCT02415959|3972984|FG000|NOT COMPLETED|Overall Study||0
3240189|NCT02415959|3972985|FG001|NOT COMPLETED|Overall Study||1
3240190|NCT02415959|3972986|FG002|NOT COMPLETED|Overall Study||0
3240191|NCT02415959|3972987|FG003|NOT COMPLETED|Overall Study||1
3240192|NCT02415959|3972988|FG004|NOT COMPLETED|Overall Study||0
3240193|NCT02415998|3973000|FG000|STARTED|Overall Study||25
3240194|NCT02415998|3973000|FG000|COMPLETED|Overall Study||20
3240195|NCT02415998|3973000|FG000|NOT COMPLETED|Overall Study||5
3240196|NCT02416102|3973007|FG000|STARTED|Overall Study||16
3240197|NCT02416102|3973008|FG001|STARTED|Overall Study||15
3240198|NCT02416102|3973009|FG002|STARTED|Overall Study||0
3240199|NCT02416102|3973007|FG000|COMPLETED|Overall Study||7
3240200|NCT02416102|3973008|FG001|COMPLETED|Overall Study||7
3240201|NCT02416102|3973009|FG002|COMPLETED|Overall Study||0
3240202|NCT02416102|3973007|FG000|NOT COMPLETED|Overall Study||9
3240203|NCT02416102|3973008|FG001|NOT COMPLETED|Overall Study||8
3240204|NCT02416102|3973009|FG002|NOT COMPLETED|Overall Study||0
3240205|NCT02416180|3973017|FG000|STARTED|Overall Study||111
3240206|NCT02416180|3973017|FG000|COMPLETED|Overall Study||110
3240207|NCT02416180|3973017|FG000|NOT COMPLETED|Overall Study||1
3240208|NCT02416193|3973023|FG000|STARTED|Overall Study||15
3240209|NCT02416193|3973024|FG001|STARTED|Overall Study||15
3240210|NCT02416193|3973023|FG000|COMPLETED|Overall Study||15
3240211|NCT02416193|3973024|FG001|COMPLETED|Overall Study||15
3240212|NCT02416193|3973023|FG000|NOT COMPLETED|Overall Study||0
3240213|NCT02416193|3973024|FG001|NOT COMPLETED|Overall Study||0
3240214|NCT02416453|3973041|FG000|STARTED|Overall Study||10
3240215|NCT02416453|3973042|FG001|STARTED|Overall Study||10
3240216|NCT02416453|3973043|FG002|STARTED|Overall Study||10
3240217|NCT02416453|3973044|FG003|STARTED|Overall Study||112
3240218|NCT02416453|3973045|FG004|STARTED|Overall Study||13
3240219|NCT02416453|3973046|FG005|STARTED|Overall Study||114
3240220|NCT02416453|3973047|FG006|STARTED|Overall Study||13
3240221|NCT02416453|3973048|FG007|STARTED|Overall Study||106
3240222|NCT02416453|3973049|FG008|STARTED|Overall Study||18
3240223|NCT02416453|3973050|FG009|STARTED|Overall Study||13
3240224|NCT02416453|3973051|FG010|STARTED|Overall Study||2
3240225|NCT02416453|3973041|FG000|COMPLETED|Overall Study||7
3240226|NCT02416453|3973042|FG001|COMPLETED|Overall Study||7
3240227|NCT02416453|3973043|FG002|COMPLETED|Overall Study||9
3240228|NCT02416453|3973044|FG003|COMPLETED|Overall Study||97
3240229|NCT02416453|3973045|FG004|COMPLETED|Overall Study||12
3240230|NCT02416453|3973046|FG005|COMPLETED|Overall Study||98
3240231|NCT02416453|3973047|FG006|COMPLETED|Overall Study||11
3240232|NCT02416453|3973048|FG007|COMPLETED|Overall Study||94
3240233|NCT02416453|3973049|FG008|COMPLETED|Overall Study||13
3240234|NCT02416453|3973050|FG009|COMPLETED|Overall Study||13
3240235|NCT02416453|3973051|FG010|COMPLETED|Overall Study||2
3240236|NCT02416453|3973041|FG000|NOT COMPLETED|Overall Study||3
3240237|NCT02416453|3973042|FG001|NOT COMPLETED|Overall Study||3
3240238|NCT02416453|3973043|FG002|NOT COMPLETED|Overall Study||1
3240239|NCT02416453|3973044|FG003|NOT COMPLETED|Overall Study||15
3240240|NCT02416453|3973045|FG004|NOT COMPLETED|Overall Study||1
3240241|NCT02416453|3973046|FG005|NOT COMPLETED|Overall Study||16
3240242|NCT02416453|3973047|FG006|NOT COMPLETED|Overall Study||2
3240243|NCT02416453|3973048|FG007|NOT COMPLETED|Overall Study||12
3240244|NCT02416453|3973049|FG008|NOT COMPLETED|Overall Study||5
3240245|NCT02416453|3973050|FG009|NOT COMPLETED|Overall Study||0
3240246|NCT02416453|3973051|FG010|NOT COMPLETED|Overall Study||0
3240247|NCT02416622|3973084|FG000|STARTED|Overall Study||6
3240248|NCT02416622|3973085|FG001|STARTED|Overall Study||8
3240249|NCT02416622|3973086|FG002|STARTED|Overall Study||13
3240250|NCT02416622|3973084|FG000|Completed Month 12|Overall Study||6
3240251|NCT02416622|3973085|FG001|Completed Month 12|Overall Study||8
3240252|NCT02416622|3973086|FG002|Completed Month 12|Overall Study||13
3240253|NCT02416622|3973084|FG000|Started Long-Term Follow-Up|Overall Study||6
3240254|NCT02416622|3973085|FG001|Started Long-Term Follow-Up|Overall Study||8
3240255|NCT02416622|3973086|FG002|Started Long-Term Follow-Up|Overall Study||13
3240256|NCT02416622|3973084|FG000|COMPLETED|Overall Study||0
3240257|NCT02416622|3973085|FG001|COMPLETED|Overall Study||0
3240258|NCT02416622|3973086|FG002|COMPLETED|Overall Study||0
3240259|NCT02416622|3973084|FG000|NOT COMPLETED|Overall Study||6
3240260|NCT02416622|3973085|FG001|NOT COMPLETED|Overall Study||8
3240261|NCT02416622|3973086|FG002|NOT COMPLETED|Overall Study||13
3240262|NCT02416713|3973098|FG000|STARTED|Overall Study||8
3240263|NCT02416713|3973099|FG001|STARTED|Overall Study||9
3240264|NCT02416713|3973100|FG002|STARTED|Overall Study||8
3240265|NCT02416713|3973101|FG003|STARTED|Overall Study||10
3240266|NCT02416713|3973098|FG000|COMPLETED|Overall Study||8
3240267|NCT02416713|3973099|FG001|COMPLETED|Overall Study||9
3240268|NCT02416713|3973100|FG002|COMPLETED|Overall Study||8
3240269|NCT02416713|3973101|FG003|COMPLETED|Overall Study||10
3240270|NCT02416713|3973098|FG000|NOT COMPLETED|Overall Study||0
3240271|NCT02416713|3973099|FG001|NOT COMPLETED|Overall Study||0
3240272|NCT02416713|3973100|FG002|NOT COMPLETED|Overall Study||0
3240273|NCT02416713|3973101|FG003|NOT COMPLETED|Overall Study||0
3240274|NCT02416791|3973114|FG000|STARTED|6 Weeks||3
3240275|NCT02416791|3973115|FG001|STARTED|6 Weeks||3
3240276|NCT02416791|3973116|FG002|STARTED|6 Weeks||3
3240277|NCT02416791|3973114|FG000|COMPLETED|6 Weeks||3
3240278|NCT02416791|3973115|FG001|COMPLETED|6 Weeks||3
3240279|NCT02416791|3973116|FG002|COMPLETED|6 Weeks||3
3240280|NCT02416791|3973114|FG000|NOT COMPLETED|6 Weeks||0
3240281|NCT02416791|3973115|FG001|NOT COMPLETED|6 Weeks||0
3240282|NCT02416791|3973116|FG002|NOT COMPLETED|6 Weeks||0
3240283|NCT02416791|3973114|FG000|STARTED|6 Months||3
3240284|NCT02416791|3973115|FG001|STARTED|6 Months||3
3240285|NCT02416791|3973116|FG002|STARTED|6 Months||3
3240286|NCT02416791|3973114|FG000|COMPLETED|6 Months||3
3240287|NCT02416791|3973115|FG001|COMPLETED|6 Months||3
3240288|NCT02416791|3973116|FG002|COMPLETED|6 Months||2
3240289|NCT02416791|3973114|FG000|NOT COMPLETED|6 Months||0
3240290|NCT02416791|3973115|FG001|NOT COMPLETED|6 Months||0
3240291|NCT02416791|3973116|FG002|NOT COMPLETED|6 Months||1
3240292|NCT02416908|3973127|FG000|STARTED|Dose Escalation Phase||6
3240293|NCT02416908|3973128|FG001|STARTED|Dose Escalation Phase||0
3240294|NCT02416908|3973129|FG002|STARTED|Dose Escalation Phase||34
3240295|NCT02416908|3973130|FG003|STARTED|Dose Escalation Phase||0
3240296|NCT02416908|3973127|FG000|COMPLETED|Dose Escalation Phase||6
3240297|NCT02416908|3973128|FG001|COMPLETED|Dose Escalation Phase||0
3240298|NCT02416908|3973129|FG002|COMPLETED|Dose Escalation Phase||30
3240299|NCT02416908|3973130|FG003|COMPLETED|Dose Escalation Phase||0
3240300|NCT02416908|3973127|FG000|NOT COMPLETED|Dose Escalation Phase||0
3240301|NCT02416908|3973128|FG001|NOT COMPLETED|Dose Escalation Phase||0
3240302|NCT02416908|3973129|FG002|NOT COMPLETED|Dose Escalation Phase||4
3240303|NCT02416908|3973130|FG003|NOT COMPLETED|Dose Escalation Phase||0
3240304|NCT02416908|3973127|FG000|STARTED|Maintenance Phase||0
3240305|NCT02416908|3973128|FG001|STARTED|Maintenance Phase||0
3240306|NCT02416908|3973129|FG002|STARTED|Maintenance Phase||0
3240307|NCT02416908|3973130|FG003|STARTED|Maintenance Phase||2
3240308|NCT02416908|3973127|FG000|COMPLETED|Maintenance Phase||0
3240309|NCT02416908|3973128|FG001|COMPLETED|Maintenance Phase||0
3240310|NCT02416908|3973129|FG002|COMPLETED|Maintenance Phase||0
3240311|NCT02416908|3973130|FG003|COMPLETED|Maintenance Phase||2
3240312|NCT02416908|3973127|FG000|NOT COMPLETED|Maintenance Phase||0
3240313|NCT02416908|3973128|FG001|NOT COMPLETED|Maintenance Phase||0
3240314|NCT02416908|3973129|FG002|NOT COMPLETED|Maintenance Phase||0
3240315|NCT02416908|3973130|FG003|NOT COMPLETED|Maintenance Phase||0
3240316|NCT02416934|3973139|FG000|STARTED|Overall Study||36
3240317|NCT02416934|3973140|FG001|STARTED|Overall Study||38
3240318|NCT02416934|3973139|FG000|Double Blind (0-52 Weeks)|Overall Study||36
3240319|NCT02416934|3973140|FG001|Double Blind (0-52 Weeks)|Overall Study||38
3240320|NCT02416934|3973139|FG000|Last Participant Completed 1 yr|Overall Study||33
3240321|NCT02416934|3973140|FG001|Last Participant Completed 1 yr|Overall Study||31
3240322|NCT02416934|3973139|FG000|COMPLETED|Overall Study||33
3240323|NCT02416934|3973140|FG001|COMPLETED|Overall Study||31
3240324|NCT02416934|3973139|FG000|NOT COMPLETED|Overall Study||3
3240325|NCT02416934|3973140|FG001|NOT COMPLETED|Overall Study||7
3240326|NCT02416973|3973155|FG000|STARTED|Overall Study||14
3240327|NCT02416973|3973156|FG001|STARTED|Overall Study||13
3240328|NCT02416973|3973157|FG002|STARTED|Overall Study||14
3240329|NCT02416973|3973155|FG000|COMPLETED|Overall Study||13
3240330|NCT02416973|3973156|FG001|COMPLETED|Overall Study||10
3240331|NCT02416973|3973157|FG002|COMPLETED|Overall Study||13
3240332|NCT02416973|3973155|FG000|NOT COMPLETED|Overall Study||1
3240333|NCT02416973|3973156|FG001|NOT COMPLETED|Overall Study||3
3240334|NCT02416973|3973157|FG002|NOT COMPLETED|Overall Study||1
3240335|NCT02417064|3973168|FG000|STARTED|Double-blind Induction Phase (4 Weeks)||117
3240336|NCT02417064|3973169|FG001|STARTED|Double-blind Induction Phase (4 Weeks)||116
3240337|NCT02417064|3973170|FG002|STARTED|Double-blind Induction Phase (4 Weeks)||113
3240338|NCT02417064|3973168|FG000|Full Analysis Set (FAS)|Double-blind Induction Phase (4 Weeks)||115
3240339|NCT02417064|3973169|FG001|Full Analysis Set (FAS)|Double-blind Induction Phase (4 Weeks)||114
3240340|NCT02417064|3973170|FG002|Full Analysis Set (FAS)|Double-blind Induction Phase (4 Weeks)||113
3240341|NCT02417064|3973168|FG000|Safety Analysis Set|Double-blind Induction Phase (4 Weeks)||115
3240342|NCT02417064|3973169|FG001|Safety Analysis Set|Double-blind Induction Phase (4 Weeks)||116
3240343|NCT02417064|3973170|FG002|Safety Analysis Set|Double-blind Induction Phase (4 Weeks)||113
3240344|NCT02417064|3973168|FG000|COMPLETED|Double-blind Induction Phase (4 Weeks)||111
3240345|NCT02417064|3973169|FG001|COMPLETED|Double-blind Induction Phase (4 Weeks)||97
3240346|NCT02417064|3973170|FG002|COMPLETED|Double-blind Induction Phase (4 Weeks)||107
3240347|NCT02417064|3973168|FG000|NOT COMPLETED|Double-blind Induction Phase (4 Weeks)||6
3240348|NCT02417064|3973169|FG001|NOT COMPLETED|Double-blind Induction Phase (4 Weeks)||19
3240349|NCT02417064|3973170|FG002|NOT COMPLETED|Double-blind Induction Phase (4 Weeks)||6
3240350|NCT02417064|3973168|FG000|STARTED|Follow-up Phase (24 Weeks)||47
3240351|NCT02417064|3973169|FG001|STARTED|Follow-up Phase (24 Weeks)||52
3240352|NCT02417064|3973170|FG002|STARTED|Follow-up Phase (24 Weeks)||69
3240353|NCT02417064|3973168|FG000|COMPLETED|Follow-up Phase (24 Weeks)||8
3240354|NCT02417064|3973169|FG001|COMPLETED|Follow-up Phase (24 Weeks)||10
3240355|NCT02417064|3973170|FG002|COMPLETED|Follow-up Phase (24 Weeks)||18
3240356|NCT02417064|3973168|FG000|NOT COMPLETED|Follow-up Phase (24 Weeks)||39
3240357|NCT02417064|3973169|FG001|NOT COMPLETED|Follow-up Phase (24 Weeks)||42
3240358|NCT02417064|3973170|FG002|NOT COMPLETED|Follow-up Phase (24 Weeks)||51
3240359|NCT02417129|3973181|FG000|STARTED|Overall Study||2
3240360|NCT02417129|3973182|FG001|STARTED|Overall Study||0
3240361|NCT02417129|3973181|FG000|COMPLETED|Overall Study||2
3240362|NCT02417129|3973182|FG001|COMPLETED|Overall Study||0
3240363|NCT02417129|3973181|FG000|NOT COMPLETED|Overall Study||0
3240364|NCT02417129|3973182|FG001|NOT COMPLETED|Overall Study||0
3240365|NCT02417233|3973191|FG000|STARTED|Overall Study||169
3240366|NCT02417233|3973192|FG001|STARTED|Overall Study||289
3240367|NCT02417233|3973193|FG002|STARTED|Overall Study||298
3240368|NCT02417233|3973191|FG000|COMPLETED|Overall Study||133
3240369|NCT02417233|3973192|FG001|COMPLETED|Overall Study||238
3240370|NCT02417233|3973193|FG002|COMPLETED|Overall Study||239
3240371|NCT02417233|3973191|FG000|NOT COMPLETED|Overall Study||36
3240372|NCT02417233|3973192|FG001|NOT COMPLETED|Overall Study||51
3240373|NCT02417233|3973193|FG002|NOT COMPLETED|Overall Study||59
3240374|NCT02417246|3973204|FG000|STARTED|Phase 1 Brand Name Metoprolol ER||24
3240375|NCT02417246|3973205|FG001|STARTED|Phase 1 Brand Name Metoprolol ER||24
3240376|NCT02417246|3973204|FG000|COMPLETED|Phase 1 Brand Name Metoprolol ER||20
3240377|NCT02417246|3973205|FG001|COMPLETED|Phase 1 Brand Name Metoprolol ER||20
3240378|NCT02417246|3973204|FG000|NOT COMPLETED|Phase 1 Brand Name Metoprolol ER||4
3240379|NCT02417246|3973205|FG001|NOT COMPLETED|Phase 1 Brand Name Metoprolol ER||4
3240380|NCT02417246|3973204|FG000|STARTED|Phase 2 1st Generic Administered||20
3240381|NCT02417246|3973205|FG001|STARTED|Phase 2 1st Generic Administered||20
3240382|NCT02417246|3973204|FG000|COMPLETED|Phase 2 1st Generic Administered||19
3240383|NCT02417246|3973205|FG001|COMPLETED|Phase 2 1st Generic Administered||20
3240384|NCT02417246|3973204|FG000|NOT COMPLETED|Phase 2 1st Generic Administered||1
3240385|NCT02417246|3973205|FG001|NOT COMPLETED|Phase 2 1st Generic Administered||0
3240386|NCT02417246|3973204|FG000|STARTED|Phase 3 Brand Name Metoprolol ER #2||19
3240387|NCT02417246|3973205|FG001|STARTED|Phase 3 Brand Name Metoprolol ER #2||20
3240388|NCT02417246|3973204|FG000|COMPLETED|Phase 3 Brand Name Metoprolol ER #2||18
3240389|NCT02417246|3973205|FG001|COMPLETED|Phase 3 Brand Name Metoprolol ER #2||20
3240390|NCT02417246|3973204|FG000|NOT COMPLETED|Phase 3 Brand Name Metoprolol ER #2||1
3240391|NCT02417246|3973205|FG001|NOT COMPLETED|Phase 3 Brand Name Metoprolol ER #2||0
3240392|NCT02417246|3973204|FG000|STARTED|Phase 4 2nd Generic Administered||18
3240393|NCT02417246|3973205|FG001|STARTED|Phase 4 2nd Generic Administered||20
3240394|NCT02417246|3973204|FG000|COMPLETED|Phase 4 2nd Generic Administered||18
3240395|NCT02417246|3973205|FG001|COMPLETED|Phase 4 2nd Generic Administered||20
3240396|NCT02417246|3973204|FG000|NOT COMPLETED|Phase 4 2nd Generic Administered||0
3240397|NCT02417246|3973205|FG001|NOT COMPLETED|Phase 4 2nd Generic Administered||0
3240398|NCT02417376|3973215|FG000|STARTED|Overall Study||35
3240399|NCT02417376|3973216|FG001|STARTED|Overall Study||35
3240400|NCT02417376|3973215|FG000|COMPLETED|Overall Study||30
3240401|NCT02417376|3973216|FG001|COMPLETED|Overall Study||25
3240402|NCT02417376|3973215|FG000|NOT COMPLETED|Overall Study||5
3240403|NCT02417376|3973216|FG001|NOT COMPLETED|Overall Study||10
3240404|NCT02417441|3973224|FG000|STARTED|Overall Study||645
3240405|NCT02417441|3973225|FG001|STARTED|Overall Study||325
3240406|NCT02417441|3973224|FG000|COMPLETED|Overall Study||593
3240407|NCT02417441|3973225|FG001|COMPLETED|Overall Study||306
3240408|NCT02417441|3973224|FG000|NOT COMPLETED|Overall Study||52
3240409|NCT02417441|3973225|FG001|NOT COMPLETED|Overall Study||19
3240410|NCT02417532|3973232|FG000|STARTED|Overall Study||56
3240411|NCT02417532|3973232|FG000|COMPLETED|Overall Study||56
3240412|NCT02417532|3973232|FG000|NOT COMPLETED|Overall Study||0
3240413|NCT02417753|3973238|FG000|STARTED|Overall Study||1
3240414|NCT02417753|3973238|FG000|COMPLETED|Overall Study||0
3240415|NCT02417753|3973238|FG000|NOT COMPLETED|Overall Study||1
3240416|NCT02417831|3973242|FG000|STARTED|Period 1: Treatment Period 1 + Washout||17
3240417|NCT02417831|3973243|FG001|STARTED|Period 1: Treatment Period 1 + Washout||17
3240418|NCT02417831|3973242|FG000|COMPLETED|Period 1: Treatment Period 1 + Washout||17
3240419|NCT02417831|3973243|FG001|COMPLETED|Period 1: Treatment Period 1 + Washout||17
3240420|NCT02417831|3973242|FG000|NOT COMPLETED|Period 1: Treatment Period 1 + Washout||0
3240421|NCT02417831|3973243|FG001|NOT COMPLETED|Period 1: Treatment Period 1 + Washout||0
3240422|NCT02417831|3973242|FG000|STARTED|Period 2: Treatment Period 2 + Washout||17
3240423|NCT02417831|3973243|FG001|STARTED|Period 2: Treatment Period 2 + Washout||17
3240424|NCT02417831|3973242|FG000|COMPLETED|Period 2: Treatment Period 2 + Washout||17
3240425|NCT02417831|3973243|FG001|COMPLETED|Period 2: Treatment Period 2 + Washout||17
3240426|NCT02417831|3973242|FG000|NOT COMPLETED|Period 2: Treatment Period 2 + Washout||0
3240427|NCT02417831|3973243|FG001|NOT COMPLETED|Period 2: Treatment Period 2 + Washout||0
3240428|NCT02417844|3973249|FG000|STARTED|Overall Study||17
3240429|NCT02417844|3973250|FG001|STARTED|Overall Study||17
3240430|NCT02417844|3973249|FG000|COMPLETED|Overall Study||17
3240431|NCT02417844|3973250|FG001|COMPLETED|Overall Study||17
3240432|NCT02417844|3973249|FG000|NOT COMPLETED|Overall Study||0
3240433|NCT02417844|3973250|FG001|NOT COMPLETED|Overall Study||0
3240434|NCT02417935|3973258|FG000|STARTED|Treatment Period||151
3240435|NCT02417935|3973259|FG001|STARTED|Treatment Period||153
3240436|NCT02417935|3973258|FG000|Received at Least One Dose of Study Drug|Treatment Period||151
3240437|NCT02417935|3973259|FG001|Received at Least One Dose of Study Drug|Treatment Period||152
3240438|NCT02417935|3973258|FG000|COMPLETED|Treatment Period||130
3240439|NCT02417935|3973259|FG001|COMPLETED|Treatment Period||137
3240440|NCT02417935|3973258|FG000|NOT COMPLETED|Treatment Period||21
3240441|NCT02417935|3973259|FG001|NOT COMPLETED|Treatment Period||16
3240442|NCT02417935|3973258|FG000|STARTED|Tapering Period|Participants who discontinued treatment period had an option to enter the taper period|134
3240443|NCT02417935|3973259|FG001|STARTED|Tapering Period|Participants who discontinued treatment period had an option to enter the taper period|142
3240444|NCT02417935|3973258|FG000|COMPLETED|Tapering Period||134
3240445|NCT02417935|3973259|FG001|COMPLETED|Tapering Period||142
3240446|NCT02417935|3973258|FG000|NOT COMPLETED|Tapering Period||0
3240447|NCT02417935|3973259|FG001|NOT COMPLETED|Tapering Period||0
3240448|NCT02417961|3973265|FG000|STARTED|Overall Study||116
3240449|NCT02417961|3973265|FG000|COMPLETED|Overall Study||112
3240450|NCT02417961|3973265|FG000|NOT COMPLETED|Overall Study||4
3240451|NCT02418000|3973274|FG000|STARTED|Cohort 1: E6201 240 mg/m^2 Weekly||7
3240452|NCT02418000|3973275|FG001|STARTED|Cohort 1: E6201 240 mg/m^2 Weekly||0
3240453|NCT02418000|3973276|FG002|STARTED|Cohort 1: E6201 240 mg/m^2 Weekly||0
3240454|NCT02418000|3973277|FG003|STARTED|Cohort 1: E6201 240 mg/m^2 Weekly||0
3240455|NCT02418000|3973278|FG004|STARTED|Cohort 1: E6201 240 mg/m^2 Weekly||0
3240456|NCT02418000|3973274|FG000|COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
3240457|NCT02418000|3973275|FG001|COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
3240458|NCT02418000|3973276|FG002|COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
3240459|NCT02418000|3973277|FG003|COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
3240460|NCT02418000|3973278|FG004|COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
3240461|NCT02418000|3973274|FG000|NOT COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||7
3240462|NCT02418000|3973275|FG001|NOT COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
3240463|NCT02418000|3973276|FG002|NOT COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
3240464|NCT02418000|3973277|FG003|NOT COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
3240465|NCT02418000|3973278|FG004|NOT COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
3240466|NCT02418000|3973274|FG000|STARTED|Cohort 2: E6201 320 mg/m^2 Weekly||0
3240467|NCT02418000|3973275|FG001|STARTED|Cohort 2: E6201 320 mg/m^2 Weekly||10
3240468|NCT02418000|3973276|FG002|STARTED|Cohort 2: E6201 320 mg/m^2 Weekly||0
3240469|NCT02418000|3973277|FG003|STARTED|Cohort 2: E6201 320 mg/m^2 Weekly||0
3240470|NCT02418000|3973278|FG004|STARTED|Cohort 2: E6201 320 mg/m^2 Weekly||0
3240471|NCT02418000|3973274|FG000|COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
3240472|NCT02418000|3973275|FG001|COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
3240473|NCT02418000|3973276|FG002|COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
3240474|NCT02418000|3973277|FG003|COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
3240475|NCT02418000|3973278|FG004|COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
3240476|NCT02418000|3973274|FG000|NOT COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
3240477|NCT02418000|3973275|FG001|NOT COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||10
3240478|NCT02418000|3973276|FG002|NOT COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
3240479|NCT02418000|3973277|FG003|NOT COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
3240480|NCT02418000|3973278|FG004|NOT COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
3240481|NCT02418000|3973274|FG000|STARTED|Cohort 3: 160 mg/m^2 Twice Weekly||0
3240482|NCT02418000|3973275|FG001|STARTED|Cohort 3: 160 mg/m^2 Twice Weekly||0
3240483|NCT02418000|3973276|FG002|STARTED|Cohort 3: 160 mg/m^2 Twice Weekly||3
3240484|NCT02418000|3973277|FG003|STARTED|Cohort 3: 160 mg/m^2 Twice Weekly||0
3240485|NCT02418000|3973278|FG004|STARTED|Cohort 3: 160 mg/m^2 Twice Weekly||0
3240486|NCT02418000|3973274|FG000|COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
3240487|NCT02418000|3973275|FG001|COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
3240488|NCT02418000|3973276|FG002|COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
3240489|NCT02418000|3973277|FG003|COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
3240490|NCT02418000|3973278|FG004|COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
3240491|NCT02418000|3973274|FG000|NOT COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
3240492|NCT02418000|3973275|FG001|NOT COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
3240493|NCT02418000|3973276|FG002|NOT COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||3
3240494|NCT02418000|3973277|FG003|NOT COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
3240495|NCT02418000|3973278|FG004|NOT COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
3240496|NCT02418000|3973274|FG000|STARTED|Cohort 4: 240 mg/m^2 Twice Weekly||0
3240497|NCT02418000|3973275|FG001|STARTED|Cohort 4: 240 mg/m^2 Twice Weekly||0
3240498|NCT02418000|3973276|FG002|STARTED|Cohort 4: 240 mg/m^2 Twice Weekly||0
3240499|NCT02418000|3973277|FG003|STARTED|Cohort 4: 240 mg/m^2 Twice Weekly||3
3240500|NCT02418000|3973278|FG004|STARTED|Cohort 4: 240 mg/m^2 Twice Weekly||0
3240501|NCT02418000|3973274|FG000|COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
3240502|NCT02418000|3973275|FG001|COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
3240503|NCT02418000|3973276|FG002|COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
3240504|NCT02418000|3973277|FG003|COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
3240505|NCT02418000|3973278|FG004|COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
3240506|NCT02418000|3973274|FG000|NOT COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
3240507|NCT02418000|3973275|FG001|NOT COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
3240508|NCT02418000|3973276|FG002|NOT COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
3240509|NCT02418000|3973277|FG003|NOT COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||3
3240510|NCT02418000|3973278|FG004|NOT COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
3240511|NCT02418000|3973274|FG000|STARTED|Cohort 5: 320 mg/m^2 Twice Weekly||0
3240512|NCT02418000|3973275|FG001|STARTED|Cohort 5: 320 mg/m^2 Twice Weekly||0
3240513|NCT02418000|3973276|FG002|STARTED|Cohort 5: 320 mg/m^2 Twice Weekly||0
3240514|NCT02418000|3973277|FG003|STARTED|Cohort 5: 320 mg/m^2 Twice Weekly||0
3240515|NCT02418000|3973278|FG004|STARTED|Cohort 5: 320 mg/m^2 Twice Weekly||4
3240516|NCT02418000|3973274|FG000|COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
3240517|NCT02418000|3973275|FG001|COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
3240518|NCT02418000|3973276|FG002|COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
3240519|NCT02418000|3973277|FG003|COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
3240520|NCT02418000|3973278|FG004|COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
3240521|NCT02418000|3973274|FG000|NOT COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
3240522|NCT02418000|3973275|FG001|NOT COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
3240523|NCT02418000|3973276|FG002|NOT COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
3240524|NCT02418000|3973277|FG003|NOT COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
3370342|NCT03781375|4101713|FG001|STARTED|Open-label Phase||9
3370343|NCT03781375|4101712|FG000|Received Study Drug|Open-label Phase||10
3370344|NCT03781375|4101713|FG001|Received Study Drug|Open-label Phase||9
3370345|NCT03781375|4101712|FG000|COMPLETED|Open-label Phase||8
3370346|NCT03781375|4101713|FG001|COMPLETED|Open-label Phase||6
3370347|NCT03781375|4101712|FG000|NOT COMPLETED|Open-label Phase||3
3370348|NCT03781375|4101713|FG001|NOT COMPLETED|Open-label Phase||3
3370349|NCT03781336|4101722|FG000|STARTED|Overall Study||45
3370350|NCT03781336|4101723|FG001|STARTED|Overall Study||37
3370351|NCT03781336|4101722|FG000|COMPLETED|Overall Study|All participants were included in the analysis (Intent to treat)|43
3370352|NCT03781336|4101723|FG001|COMPLETED|Overall Study|All participants were included in the analysis (Intent to treat)|35
3370353|NCT03781336|4101722|FG000|NOT COMPLETED|Overall Study||2
3370354|NCT03781336|4101723|FG001|NOT COMPLETED|Overall Study||2
3370355|NCT03780400|4101729|FG000|STARTED|Overall Study||60
3370356|NCT03780400|4101729|FG000|COMPLETED|Overall Study||53
3370357|NCT03780400|4101729|FG000|NOT COMPLETED|Overall Study||7
3370358|NCT03779997|4101735|FG000|STARTED|Overall Study||39
3370359|NCT03779997|4101736|FG001|STARTED|Overall Study||39
3370360|NCT03779997|4101735|FG000|Completed at Least One Visit|Overall Study||39
3370361|NCT03779997|4101736|FG001|Completed at Least One Visit|Overall Study||39
3370362|NCT03779997|4101735|FG000|COMPLETED|Overall Study||39
3370363|NCT03779997|4101736|FG001|COMPLETED|Overall Study||39
3370364|NCT03779997|4101735|FG000|NOT COMPLETED|Overall Study||0
3370365|NCT03779997|4101736|FG001|NOT COMPLETED|Overall Study||0
3370366|NCT03779503|4101742|FG000|STARTED|First Intervention||28
3370367|NCT03779503|4101743|FG001|STARTED|First Intervention||27
3370368|NCT03779503|4101742|FG000|COMPLETED|First Intervention||27
3240525|NCT02418000|3973278|FG004|NOT COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||4
3240526|NCT02418026|3973304|FG000|STARTED|Overall Study||44
3240527|NCT02418026|3973305|FG001|STARTED|Overall Study||35
3240528|NCT02418026|3973304|FG000|COMPLETED|Overall Study||44
3240529|NCT02418026|3973305|FG001|COMPLETED|Overall Study||35
3240530|NCT02418026|3973304|FG000|NOT COMPLETED|Overall Study||0
3240531|NCT02418026|3973305|FG001|NOT COMPLETED|Overall Study||0
3240532|NCT02418156|3973311|FG000|STARTED|Overall Study||38
3240533|NCT02418156|3973311|FG000|COMPLETED|Overall Study||21
3240534|NCT02418156|3973311|FG000|NOT COMPLETED|Overall Study||17
3240535|NCT02418182|3973317|FG000|STARTED|Overall Study||49
3240536|NCT02418182|3973318|FG001|STARTED|Overall Study||50
3240537|NCT02418182|3973317|FG000|COMPLETED|Overall Study||31
3240538|NCT02418182|3973318|FG001|COMPLETED|Overall Study||33
3240539|NCT02418182|3973317|FG000|NOT COMPLETED|Overall Study||18
3240540|NCT02418182|3973318|FG001|NOT COMPLETED|Overall Study||17
3240541|NCT02418234|3973324|FG000|STARTED|Overall Study||314
3240542|NCT02418234|3973324|FG000|COMPLETED|Overall Study||314
3240543|NCT02418234|3973324|FG000|NOT COMPLETED|Overall Study||0
3240544|NCT02418312|3973334|FG000|STARTED|Overall Study||114
3240545|NCT02418312|3973335|FG001|STARTED|Overall Study||114
3240546|NCT02418312|3973334|FG000|COMPLETED|Overall Study||114
3240547|NCT02418312|3973335|FG001|COMPLETED|Overall Study||114
3240548|NCT02418312|3973334|FG000|NOT COMPLETED|Overall Study||0
3240549|NCT02418312|3973335|FG001|NOT COMPLETED|Overall Study||0
3240550|NCT02418455|3973341|FG000|STARTED|48-Week Treatment Period||8
3240551|NCT02418455|3973341|FG000|Emergency IND (eIND)|48-Week Treatment Period||1
3240552|NCT02418455|3973341|FG000|COMPLETED|48-Week Treatment Period||7
3240553|NCT02418455|3973341|FG000|NOT COMPLETED|48-Week Treatment Period||1
3240554|NCT02418455|3973341|FG000|STARTED|Continuation Period||7
3240555|NCT02418455|3973341|FG000|COMPLETED|Continuation Period||0
3240556|NCT02418455|3973341|FG000|NOT COMPLETED|Continuation Period||7
3240557|NCT02418468|3973349|FG000|STARTED|Overall Study||13
3240558|NCT02418468|3973350|FG001|STARTED|Overall Study||11
3240559|NCT02418468|3973349|FG000|COMPLETED|Overall Study||11
3240560|NCT02418468|3973350|FG001|COMPLETED|Overall Study||10
3240561|NCT02418468|3973349|FG000|NOT COMPLETED|Overall Study||2
3240562|NCT02418468|3973350|FG001|NOT COMPLETED|Overall Study||1
3240563|NCT02418546|3973359|FG000|STARTED|Overall Study||26
3240564|NCT02418546|3973360|FG001|STARTED|Overall Study||26
3240565|NCT02418546|3973361|FG002|STARTED|Overall Study||26
3240566|NCT02418546|3973359|FG000|COMPLETED|Overall Study||19
3240567|NCT02418546|3973360|FG001|COMPLETED|Overall Study||20
3240568|NCT02418546|3973361|FG002|COMPLETED|Overall Study||23
3240569|NCT02418546|3973359|FG000|NOT COMPLETED|Overall Study||7
3240570|NCT02418546|3973360|FG001|NOT COMPLETED|Overall Study||6
3240571|NCT02418546|3973361|FG002|NOT COMPLETED|Overall Study||3
3240572|NCT02418585|3973371|FG000|STARTED|Double Blind (DB) Phase (4 Weeks)||116
3240573|NCT02418585|3973372|FG001|STARTED|Double Blind (DB) Phase (4 Weeks)||111
3240574|NCT02418585|3973371|FG000|Safety Analysis Set|Double Blind (DB) Phase (4 Weeks)||115
3240575|NCT02418585|3973372|FG001|Safety Analysis Set|Double Blind (DB) Phase (4 Weeks)||109
3240576|NCT02418585|3973371|FG000|Full Analysis Set|Double Blind (DB) Phase (4 Weeks)||114
3240577|NCT02418585|3973372|FG001|Full Analysis Set|Double Blind (DB) Phase (4 Weeks)||109
3240578|NCT02418585|3973371|FG000|COMPLETED|Double Blind (DB) Phase (4 Weeks)||98
3240579|NCT02418585|3973372|FG001|COMPLETED|Double Blind (DB) Phase (4 Weeks)||99
3240580|NCT02418585|3973371|FG000|NOT COMPLETED|Double Blind (DB) Phase (4 Weeks)||18
3240581|NCT02418585|3973372|FG001|NOT COMPLETED|Double Blind (DB) Phase (4 Weeks)||12
3240582|NCT02418585|3973371|FG000|STARTED|Follow-up Phase (24 Weeks)||34
3240583|NCT02418585|3973372|FG001|STARTED|Follow-up Phase (24 Weeks)||52
3240584|NCT02418585|3973371|FG000|COMPLETED|Follow-up Phase (24 Weeks)||16
3240585|NCT02418585|3973372|FG001|COMPLETED|Follow-up Phase (24 Weeks)||27
3240586|NCT02418585|3973371|FG000|NOT COMPLETED|Follow-up Phase (24 Weeks)||18
3240587|NCT02418585|3973372|FG001|NOT COMPLETED|Follow-up Phase (24 Weeks)||25
3240588|NCT02418676|3973383|FG000|STARTED|Overall Study||5
3240589|NCT02418676|3973384|FG001|STARTED|Overall Study||5
3240590|NCT02418676|3973385|FG002|STARTED|Overall Study||5
3240591|NCT02418676|3973383|FG000|COMPLETED|Overall Study||5
3240592|NCT02418676|3973384|FG001|COMPLETED|Overall Study||5
3240593|NCT02418676|3973385|FG002|COMPLETED|Overall Study||5
3240594|NCT02418676|3973383|FG000|NOT COMPLETED|Overall Study||0
3240595|NCT02418676|3973384|FG001|NOT COMPLETED|Overall Study||0
3240596|NCT02418676|3973385|FG002|NOT COMPLETED|Overall Study||0
3240597|NCT02418754|3973396|FG000|STARTED|Period 1 (Day 1 to Week 12)||103
3240598|NCT02418754|3973397|FG001|STARTED|Period 1 (Day 1 to Week 12)||200
3240599|NCT02418754|3973398|FG002|STARTED|Period 1 (Day 1 to Week 12)||202
3240600|NCT02418754|3973399|FG003|STARTED|Period 1 (Day 1 to Week 12)||0
3240601|NCT02418754|3973400|FG004|STARTED|Period 1 (Day 1 to Week 12)||0
3240602|NCT02418754|3973396|FG000|COMPLETED|Period 1 (Day 1 to Week 12)||101
3240603|NCT02418754|3973397|FG001|COMPLETED|Period 1 (Day 1 to Week 12)||196
3240604|NCT02418754|3973398|FG002|COMPLETED|Period 1 (Day 1 to Week 12)||200
3240605|NCT02418754|3973399|FG003|COMPLETED|Period 1 (Day 1 to Week 12)||0
3240606|NCT02418754|3973400|FG004|COMPLETED|Period 1 (Day 1 to Week 12)||0
3240607|NCT02418754|3973396|FG000|NOT COMPLETED|Period 1 (Day 1 to Week 12)||2
3240608|NCT02418754|3973397|FG001|NOT COMPLETED|Period 1 (Day 1 to Week 12)||4
3240609|NCT02418754|3973398|FG002|NOT COMPLETED|Period 1 (Day 1 to Week 12)||2
3240610|NCT02418754|3973399|FG003|NOT COMPLETED|Period 1 (Day 1 to Week 12)||0
3240611|NCT02418754|3973400|FG004|NOT COMPLETED|Period 1 (Day 1 to Week 12)||0
3240612|NCT02418754|3973396|FG000|STARTED|Period 2 (Day 1 to Week 52/End of Study)||103
3240613|NCT02418754|3973397|FG001|STARTED|Period 2 (Day 1 to Week 52/End of Study)||106
3240614|NCT02418754|3973398|FG002|STARTED|Period 2 (Day 1 to Week 52/End of Study)||108
3240615|NCT02418754|3973399|FG003|STARTED|Period 2 (Day 1 to Week 52/End of Study)||94
3240616|NCT02418754|3973400|FG004|STARTED|Period 2 (Day 1 to Week 52/End of Study)||94
3240617|NCT02418754|3973396|FG000|COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||70
3240618|NCT02418754|3973397|FG001|COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||64
3240619|NCT02418754|3973398|FG002|COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||71
3240620|NCT02418754|3973399|FG003|COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||67
3240621|NCT02418754|3973400|FG004|COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||67
3240622|NCT02418754|3973396|FG000|NOT COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||33
3240623|NCT02418754|3973397|FG001|NOT COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||42
3240624|NCT02418754|3973398|FG002|NOT COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||37
3240625|NCT02418754|3973399|FG003|NOT COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||27
3240626|NCT02418754|3973400|FG004|NOT COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||27
3240627|NCT02418819|3973414|FG000|STARTED|Overall Study||22
3240628|NCT02418819|3973415|FG001|STARTED|Overall Study||16
3240629|NCT02418819|3973416|FG002|STARTED|Overall Study||33
3240630|NCT02418819|3973417|FG003|STARTED|Overall Study||29
3240631|NCT02418819|3973414|FG000|COMPLETED|Overall Study||21
3240632|NCT02418819|3973415|FG001|COMPLETED|Overall Study||16
3240633|NCT02418819|3973416|FG002|COMPLETED|Overall Study||29
3240634|NCT02418819|3973417|FG003|COMPLETED|Overall Study||28
3240635|NCT02418819|3973414|FG000|NOT COMPLETED|Overall Study||1
3240636|NCT02418819|3973415|FG001|NOT COMPLETED|Overall Study||0
3240637|NCT02418819|3973416|FG002|NOT COMPLETED|Overall Study||4
3240638|NCT02418819|3973417|FG003|NOT COMPLETED|Overall Study||1
3240639|NCT02418845|3973429|FG000|STARTED|Overall Study||125
3240640|NCT02418845|3973430|FG001|STARTED|Overall Study||64
3240641|NCT02418845|3973429|FG000|COMPLETED|Overall Study||109
3240642|NCT02418845|3973430|FG001|COMPLETED|Overall Study||52
3240643|NCT02418845|3973429|FG000|NOT COMPLETED|Overall Study||16
3240644|NCT02418845|3973430|FG001|NOT COMPLETED|Overall Study||12
3240645|NCT02418910|3973436|FG000|STARTED|Overall Study||50
3240646|NCT02418910|3973436|FG000|COMPLETED|Overall Study||43
3240647|NCT02418910|3973436|FG000|NOT COMPLETED|Overall Study||7
3240648|NCT02418949|3973444|FG000|STARTED|Overall Study||23
3240649|NCT02418949|3973445|FG001|STARTED|Overall Study||22
3240650|NCT02418949|3973446|FG002|STARTED|Overall Study||26
3240651|NCT02418949|3973447|FG003|STARTED|Overall Study||25
3240652|NCT02418949|3973444|FG000|COMPLETED|Overall Study||20
3240653|NCT02418949|3973445|FG001|COMPLETED|Overall Study||21
3240654|NCT02418949|3973446|FG002|COMPLETED|Overall Study||23
3240655|NCT02418949|3973447|FG003|COMPLETED|Overall Study||24
3240656|NCT02418949|3973444|FG000|NOT COMPLETED|Overall Study||3
3240657|NCT02418949|3973445|FG001|NOT COMPLETED|Overall Study||1
3240658|NCT02418949|3973446|FG002|NOT COMPLETED|Overall Study||3
3240659|NCT02418949|3973447|FG003|NOT COMPLETED|Overall Study||1
3240660|NCT02419001|3973459|FG000|STARTED|Period 1- Ceftriaxone Without SYN-004||6
3240661|NCT02419001|3973460|FG001|STARTED|Period 1- Ceftriaxone Without SYN-004||5
3240662|NCT02419001|3973459|FG000|COMPLETED|Period 1- Ceftriaxone Without SYN-004|The Adverse Event (AE) was with ceftriaxone, not with Investigational Product (IP)|5
3240663|NCT02419001|3973460|FG001|COMPLETED|Period 1- Ceftriaxone Without SYN-004||5
3240664|NCT02419001|3973459|FG000|NOT COMPLETED|Period 1- Ceftriaxone Without SYN-004||1
3240665|NCT02419001|3973460|FG001|NOT COMPLETED|Period 1- Ceftriaxone Without SYN-004||0
3240666|NCT02419001|3973459|FG000|STARTED|Period 2- Ceftriaxone With SYN-004||5
3240667|NCT02419001|3973460|FG001|STARTED|Period 2- Ceftriaxone With SYN-004||5
3240668|NCT02419001|3973459|FG000|COMPLETED|Period 2- Ceftriaxone With SYN-004||5
3240669|NCT02419001|3973460|FG001|COMPLETED|Period 2- Ceftriaxone With SYN-004||5
3240670|NCT02419001|3973459|FG000|NOT COMPLETED|Period 2- Ceftriaxone With SYN-004||0
3240671|NCT02419001|3973460|FG001|NOT COMPLETED|Period 2- Ceftriaxone With SYN-004||0
3240672|NCT02419313|3973466|FG000|STARTED|First Intervention||18
3240673|NCT02419313|3973467|FG001|STARTED|First Intervention||15
3240674|NCT02419313|3973466|FG000|COMPLETED|First Intervention||16
3240675|NCT02419313|3973467|FG001|COMPLETED|First Intervention||15
3240676|NCT02419313|3973466|FG000|NOT COMPLETED|First Intervention||2
3240677|NCT02419313|3973467|FG001|NOT COMPLETED|First Intervention||0
3240678|NCT02419313|3973466|FG000|STARTED|Second Intervention||16
3240679|NCT02419313|3973467|FG001|STARTED|Second Intervention||15
3240680|NCT02419313|3973466|FG000|COMPLETED|Second Intervention||15
3240681|NCT02419313|3973467|FG001|COMPLETED|Second Intervention||15
3240682|NCT02419313|3973466|FG000|NOT COMPLETED|Second Intervention||1
3240683|NCT02419313|3973467|FG001|NOT COMPLETED|Second Intervention||0
3240684|NCT02419469|3973473|FG000|STARTED|Overall Study||1
3240685|NCT02419469|3973473|FG000|COMPLETED|Overall Study||0
3240686|NCT02419469|3973473|FG000|NOT COMPLETED|Overall Study||1
3240687|NCT02419508|3973479|FG000|STARTED|Overall Study||96
3240688|NCT02419508|3973480|FG001|STARTED|Overall Study||92
3240689|NCT02419508|3973479|FG000|Full Analysis Set|Overall Study||95
3240690|NCT02419508|3973480|FG001|Full Analysis Set|Overall Study||92
3240691|NCT02419508|3973479|FG000|Safety Analysis Set|Overall Study||95
3240692|NCT02419508|3973480|FG001|Safety Analysis Set|Overall Study||92
3240693|NCT02419508|3973479|FG000|COMPLETED|Overall Study||86
3240694|NCT02419508|3973480|FG001|COMPLETED|Overall Study||88
3240695|NCT02419508|3973479|FG000|NOT COMPLETED|Overall Study||10
3240696|NCT02419508|3973480|FG001|NOT COMPLETED|Overall Study||4
3240697|NCT02419521|3973486|FG000|STARTED|Overall Study||75
3240698|NCT02419521|3973486|FG000|COMPLETED|Overall Study||74
3240699|NCT02419521|3973486|FG000|NOT COMPLETED|Overall Study||1
3240700|NCT02419547|3973490|FG000|STARTED|Overall Study||11
3240701|NCT02419547|3973490|FG000|COMPLETED|Overall Study||11
3240702|NCT02419547|3973490|FG000|NOT COMPLETED|Overall Study||0
3240703|NCT02419573|3973496|FG000|STARTED|Overall Study||1499
3240704|NCT02419573|3973497|FG001|STARTED|Overall Study||1505
3240705|NCT02419573|3973496|FG000|COMPLETED|Overall Study||1495
3240706|NCT02419573|3973497|FG001|COMPLETED|Overall Study||1505
3240707|NCT02419573|3973496|FG000|NOT COMPLETED|Overall Study||4
3240708|NCT02419573|3973497|FG001|NOT COMPLETED|Overall Study||0
3240709|NCT02419612|3973505|FG000|STARTED|Short-term Treatment Period||227
3240710|NCT02419612|3973506|FG001|STARTED|Short-term Treatment Period||217
3240711|NCT02419612|3973505|FG000|Recevied Treatment|Short-term Treatment Period||227
3240712|NCT02419612|3973506|FG001|Recevied Treatment|Short-term Treatment Period||216
3240713|NCT02419612|3973505|FG000|COMPLETED|Short-term Treatment Period||210
3240714|NCT02419612|3973506|FG001|COMPLETED|Short-term Treatment Period||194
3240715|NCT02419612|3973505|FG000|NOT COMPLETED|Short-term Treatment Period||17
3240716|NCT02419612|3973506|FG001|NOT COMPLETED|Short-term Treatment Period||23
3240717|NCT02419612|3973505|FG000|STARTED|Long-term Treatment Period|Not all subjects who completed the previous period were eligible to enter the long-term period.|196
3240718|NCT02419612|3973506|FG001|STARTED|Long-term Treatment Period|Not all subjects who completed the previous period were eligible to enter the long-term period.|186
3240719|NCT02419612|3973505|FG000|Received Treatment|Long-term Treatment Period||196
3240720|NCT02419612|3973506|FG001|Received Treatment|Long-term Treatment Period||183
3240721|NCT02419612|3973505|FG000|COMPLETED|Long-term Treatment Period||174
3240722|NCT02419612|3973506|FG001|COMPLETED|Long-term Treatment Period||164
3240723|NCT02419612|3973505|FG000|NOT COMPLETED|Long-term Treatment Period||22
3240724|NCT02419612|3973506|FG001|NOT COMPLETED|Long-term Treatment Period||22
3240725|NCT02419690|3973514|FG000|STARTED|Overall Study||122
3240726|NCT02419690|3973515|FG001|STARTED|Overall Study||122
3240727|NCT02419690|3973514|FG000|COMPLETED|Overall Study||122
3240728|NCT02419690|3973515|FG001|COMPLETED|Overall Study||122
3240729|NCT02419690|3973514|FG000|NOT COMPLETED|Overall Study||0
3240730|NCT02419690|3973515|FG001|NOT COMPLETED|Overall Study||0
3240731|NCT02419755|3973523|FG000|STARTED|Overall Study||6
3240732|NCT02419755|3973524|FG001|STARTED|Overall Study||6
3240733|NCT02419755|3973523|FG000|COMPLETED|Overall Study||3
3240734|NCT02419755|3973524|FG001|COMPLETED|Overall Study||2
3240735|NCT02419755|3973523|FG000|NOT COMPLETED|Overall Study||3
3240736|NCT02419755|3973524|FG001|NOT COMPLETED|Overall Study||4
3240737|NCT02419807|3973530|FG000|STARTED|Overall Study||102
3240738|NCT02419807|3973530|FG000|COMPLETED|Overall Study||92
3240739|NCT02419807|3973530|FG000|NOT COMPLETED|Overall Study||10
3240740|NCT02419924|3973534|FG000|STARTED|Overall Study||12
3240741|NCT02419924|3973534|FG000|COMPLETED|Overall Study||12
3240742|NCT02419924|3973534|FG000|NOT COMPLETED|Overall Study||0
3240743|NCT02419937|3973540|FG000|STARTED|Overall Study||12
3240744|NCT02419937|3973541|FG001|STARTED|Overall Study||16
3240745|NCT02419937|3973540|FG000|COMPLETED|Overall Study||11
3240746|NCT02419937|3973541|FG001|COMPLETED|Overall Study||16
3240747|NCT02419937|3973540|FG000|NOT COMPLETED|Overall Study||1
3240748|NCT02419937|3973541|FG001|NOT COMPLETED|Overall Study||0
3240749|NCT02420015|3973549|FG000|STARTED|Overall Study||21
3240750|NCT02420015|3973550|FG001|STARTED|Overall Study||13
3240751|NCT02420015|3973549|FG000|COMPLETED|Overall Study||21
3240752|NCT02420015|3973550|FG001|COMPLETED|Overall Study||13
3240753|NCT02420015|3973549|FG000|NOT COMPLETED|Overall Study||0
3240754|NCT02420015|3973550|FG001|NOT COMPLETED|Overall Study||0
3370369|NCT03779503|4101743|FG001|COMPLETED|First Intervention||26
3370370|NCT03779503|4101742|FG000|NOT COMPLETED|First Intervention||1
3370371|NCT03779503|4101743|FG001|NOT COMPLETED|First Intervention||1
3370372|NCT03779503|4101742|FG000|STARTED|Second Intervention||27
3370373|NCT03779503|4101743|FG001|STARTED|Second Intervention||26
3370374|NCT03779503|4101742|FG000|COMPLETED|Second Intervention||27
3370375|NCT03779503|4101743|FG001|COMPLETED|Second Intervention||26
3370376|NCT03779503|4101742|FG000|NOT COMPLETED|Second Intervention||0
3370377|NCT03779503|4101743|FG001|NOT COMPLETED|Second Intervention||0
3370378|NCT03780010|4101751|FG000|STARTED|Overall Study||3
3370379|NCT03780010|4101752|FG001|STARTED|Overall Study||12
3370380|NCT03780010|4101751|FG000|COMPLETED|Overall Study||3
3370381|NCT03780010|4101752|FG001|COMPLETED|Overall Study||12
3370382|NCT03780010|4101751|FG000|NOT COMPLETED|Overall Study||0
3370383|NCT03780010|4101752|FG001|NOT COMPLETED|Overall Study||0
3370384|NCT03778190|4101769|FG000|STARTED|Overall Study||10
3370385|NCT03778190|4101769|FG000|COMPLETED|Overall Study||10
3370386|NCT03778190|4101769|FG000|NOT COMPLETED|Overall Study||0
3370387|NCT03777059|4101777|FG000|STARTED|DB Treatment Period (Up to Week 12)||223
3370388|NCT03777059|4101778|FG001|STARTED|DB Treatment Period (Up to Week 12)||222
3370389|NCT03777059|4101779|FG002|STARTED|DB Treatment Period (Up to Week 12)||230
3370390|NCT03777059|4101780|FG003|STARTED|DB Treatment Period (Up to Week 12)||235
3370391|NCT03777059|4101777|FG000|Treated: Safety Population|DB Treatment Period (Up to Week 12)||222
3370392|NCT03777059|4101778|FG001|Treated: Safety Population|DB Treatment Period (Up to Week 12)||221
3370393|NCT03777059|4101779|FG002|Treated: Safety Population|DB Treatment Period (Up to Week 12)||228
3240755|NCT02420041|3973558|FG000|STARTED|Overall Study||14
3240756|NCT02420041|3973559|FG001|STARTED|Overall Study||14
3240757|NCT02420041|3973558|FG000|COMPLETED|Overall Study||14
3240758|NCT02420041|3973559|FG001|COMPLETED|Overall Study||14
3240759|NCT02420041|3973558|FG000|NOT COMPLETED|Overall Study||0
3240760|NCT02420041|3973559|FG001|NOT COMPLETED|Overall Study||0
3240761|NCT02420093|3973567|FG000|STARTED|Overall Study||9
3240762|NCT02420093|3973568|FG001|STARTED|Overall Study||8
3240763|NCT02420093|3973567|FG000|COMPLETED|Overall Study||8
3240764|NCT02420093|3973568|FG001|COMPLETED|Overall Study||7
3240765|NCT02420093|3973567|FG000|NOT COMPLETED|Overall Study||1
3240766|NCT02420093|3973568|FG001|NOT COMPLETED|Overall Study||1
3240767|NCT02420210|3973574|FG000|STARTED|Overall Study||2
3240768|NCT02420210|3973574|FG000|COMPLETED|Overall Study||2
3240769|NCT02420210|3973574|FG000|NOT COMPLETED|Overall Study||0
3240770|NCT02420223|3973580|FG000|STARTED|Overall Study||12
3240771|NCT02420223|3973581|FG001|STARTED|Overall Study||13
3240772|NCT02420223|3973580|FG000|COMPLETED|Overall Study||11
3240773|NCT02420223|3973581|FG001|COMPLETED|Overall Study||11
3240774|NCT02420223|3973580|FG000|NOT COMPLETED|Overall Study||1
3240775|NCT02420223|3973581|FG001|NOT COMPLETED|Overall Study||2
3240776|NCT02420262|3973589|FG000|STARTED|Overall Study||252
3240777|NCT02420262|3973590|FG001|STARTED|Overall Study||254
3240778|NCT02420262|3973589|FG000|Exposed|Overall Study||252
3240779|NCT02420262|3973590|FG001|Exposed|Overall Study|One subject withdrew consent before exposure to trial product due to personal reasons.|253
3240780|NCT02420262|3973589|FG000|COMPLETED|Overall Study||250
3240781|NCT02420262|3973590|FG001|COMPLETED|Overall Study||249
3240782|NCT02420262|3973589|FG000|NOT COMPLETED|Overall Study||2
3240783|NCT02420262|3973590|FG001|NOT COMPLETED|Overall Study||5
3240784|NCT02420327|3973596|FG000|STARTED|Overall Study||43
3240785|NCT02420327|3973596|FG000|COMPLETED|Overall Study||27
3240786|NCT02420327|3973596|FG000|NOT COMPLETED|Overall Study||16
3240787|NCT02420353|3973608|FG000|STARTED|Overall Study||10
3240788|NCT02420353|3973609|FG001|STARTED|Overall Study||10
3240789|NCT02420353|3973608|FG000|Allocation to Intervention|Overall Study||10
3240790|NCT02420353|3973609|FG001|Allocation to Intervention|Overall Study||10
3240791|NCT02420353|3973608|FG000|COMPLETED|Overall Study||10
3240792|NCT02420353|3973609|FG001|COMPLETED|Overall Study||9
3240793|NCT02420353|3973608|FG000|NOT COMPLETED|Overall Study||0
3240794|NCT02420353|3973609|FG001|NOT COMPLETED|Overall Study||1
3240795|NCT02420379|3973617|FG000|STARTED|Overall Study||26
3240796|NCT02420379|3973618|FG001|STARTED|Overall Study||7
3240797|NCT02420379|3973617|FG000|COMPLETED|Overall Study||25
3240798|NCT02420379|3973618|FG001|COMPLETED|Overall Study||3
3240799|NCT02420379|3973617|FG000|NOT COMPLETED|Overall Study||1
3240800|NCT02420379|3973618|FG001|NOT COMPLETED|Overall Study||4
3240801|NCT02420639|3973624|FG000|STARTED|Overall Study|Study obtained 12 patients|12
3240802|NCT02420639|3973624|FG000|COMPLETED|Overall Study|Total of 12 patients enrolled|12
3240803|NCT02420639|3973624|FG000|NOT COMPLETED|Overall Study||0
3240804|NCT02420691|3973628|FG000|STARTED|Overall Study||20
3240805|NCT02420691|3973628|FG000|COMPLETED|Overall Study||14
3240806|NCT02420691|3973628|FG000|NOT COMPLETED|Overall Study||6
3240807|NCT02420873|3973635|FG000|STARTED|Overall Study||9
3240808|NCT02420873|3973636|FG001|STARTED|Overall Study||0
3240809|NCT02420873|3973637|FG002|STARTED|Overall Study||0
3240810|NCT02420873|3973635|FG000|COMPLETED|Overall Study||9
3240811|NCT02420873|3973636|FG001|COMPLETED|Overall Study||0
3240812|NCT02420873|3973637|FG002|COMPLETED|Overall Study||0
3240813|NCT02420873|3973635|FG000|NOT COMPLETED|Overall Study||0
3370394|NCT03777059|4101780|FG003|Treated: Safety Population|DB Treatment Period (Up to Week 12)||231
3370395|NCT03777059|4101777|FG000|COMPLETED|DB Treatment Period (Up to Week 12)||201
3370396|NCT03777059|4101778|FG001|COMPLETED|DB Treatment Period (Up to Week 12)||193
3370397|NCT03777059|4101779|FG002|COMPLETED|DB Treatment Period (Up to Week 12)||207
3370398|NCT03777059|4101780|FG003|COMPLETED|DB Treatment Period (Up to Week 12)||204
3370399|NCT03777059|4101777|FG000|NOT COMPLETED|DB Treatment Period (Up to Week 12)||22
3370400|NCT03777059|4101778|FG001|NOT COMPLETED|DB Treatment Period (Up to Week 12)||29
3370401|NCT03777059|4101779|FG002|NOT COMPLETED|DB Treatment Period (Up to Week 12)||23
3370402|NCT03777059|4101780|FG003|NOT COMPLETED|DB Treatment Period (Up to Week 12)||31
3370403|NCT03777059|4101777|FG000|STARTED|Follow-Up Period (Weeks 12 to 16)||46
3370404|NCT03777059|4101778|FG001|STARTED|Follow-Up Period (Weeks 12 to 16)||54
3370405|NCT03777059|4101779|FG002|STARTED|Follow-Up Period (Weeks 12 to 16)||38
3370406|NCT03777059|4101780|FG003|STARTED|Follow-Up Period (Weeks 12 to 16)||45
3370407|NCT03777059|4101777|FG000|COMPLETED|Follow-Up Period (Weeks 12 to 16)||41
3370408|NCT03777059|4101778|FG001|COMPLETED|Follow-Up Period (Weeks 12 to 16)||49
3370409|NCT03777059|4101779|FG002|COMPLETED|Follow-Up Period (Weeks 12 to 16)||32
3370410|NCT03777059|4101780|FG003|COMPLETED|Follow-Up Period (Weeks 12 to 16)||36
3370411|NCT03777059|4101777|FG000|NOT COMPLETED|Follow-Up Period (Weeks 12 to 16)||5
3370412|NCT03777059|4101778|FG001|NOT COMPLETED|Follow-Up Period (Weeks 12 to 16)||5
3370413|NCT03777059|4101779|FG002|NOT COMPLETED|Follow-Up Period (Weeks 12 to 16)||6
3240814|NCT02420873|3973636|FG001|NOT COMPLETED|Overall Study||0
3240815|NCT02420873|3973637|FG002|NOT COMPLETED|Overall Study||0
3240816|NCT02420951|3973647|FG000|STARTED|Overall Study||25
3240817|NCT02420951|3973648|FG001|STARTED|Overall Study||25
3240818|NCT02420951|3973647|FG000|COMPLETED|Overall Study||25
3240819|NCT02420951|3973648|FG001|COMPLETED|Overall Study||25
3240820|NCT02420951|3973647|FG000|NOT COMPLETED|Overall Study||0
3240821|NCT02420951|3973648|FG001|NOT COMPLETED|Overall Study||0
3240822|NCT02421055|3973656|FG000|STARTED|Overall Study||34
3240823|NCT02421055|3973657|FG001|STARTED|Overall Study||50
3240824|NCT02421055|3973658|FG002|STARTED|Overall Study||74
3240825|NCT02421055|3973656|FG000|Pre-operative Serum Sample (Minimum)|Overall Study||34
3240826|NCT02421055|3973657|FG001|Pre-operative Serum Sample (Minimum)|Overall Study||50
3240827|NCT02421055|3973658|FG002|Pre-operative Serum Sample (Minimum)|Overall Study||74
3240828|NCT02421055|3973656|FG000|Pre-operative Complete Sample Set|Overall Study||23
3240829|NCT02421055|3973657|FG001|Pre-operative Complete Sample Set|Overall Study||22
3240830|NCT02421055|3973658|FG002|Pre-operative Complete Sample Set|Overall Study||36
3240831|NCT02421055|3973656|FG000|Post-operative Serum Sample (Minimum)|Overall Study||0
3240832|NCT02421055|3973657|FG001|Post-operative Serum Sample (Minimum)|Overall Study||23
3240833|NCT02421055|3973658|FG002|Post-operative Serum Sample (Minimum)|Overall Study||26
3240834|NCT02421055|3973656|FG000|Post-operative Complete Sample Set|Overall Study||0
3240835|NCT02421055|3973657|FG001|Post-operative Complete Sample Set|Overall Study||13
3240836|NCT02421055|3973658|FG002|Post-operative Complete Sample Set|Overall Study||14
3240837|NCT02421055|3973656|FG000|COMPLETED|Overall Study||0
3240838|NCT02421055|3973657|FG001|COMPLETED|Overall Study||50
3240839|NCT02421055|3973658|FG002|COMPLETED|Overall Study||74
3240840|NCT02421055|3973656|FG000|NOT COMPLETED|Overall Study||34
3240841|NCT02421055|3973657|FG001|NOT COMPLETED|Overall Study||0
3240842|NCT02421055|3973658|FG002|NOT COMPLETED|Overall Study||0
3240843|NCT02421094|3973669|FG000|STARTED|Overall Study||15
3240844|NCT02421094|3973670|FG001|STARTED|Overall Study||15
3240845|NCT02421094|3973669|FG000|COMPLETED|Overall Study||15
3240846|NCT02421094|3973670|FG001|COMPLETED|Overall Study||15
3240847|NCT02421094|3973669|FG000|NOT COMPLETED|Overall Study||0
3240848|NCT02421094|3973670|FG001|NOT COMPLETED|Overall Study||0
3240849|NCT02421120|3973676|FG000|STARTED|Overall Study||21
3240850|NCT02421120|3973676|FG000|COMPLETED|Overall Study||20
3240851|NCT02421120|3973676|FG000|NOT COMPLETED|Overall Study||1
3240852|NCT02421146|3973684|FG000|STARTED|Overall Study||2
3240853|NCT02421146|3973685|FG001|STARTED|Overall Study||4
3240854|NCT02421146|3973686|FG002|STARTED|Overall Study||3
3240855|NCT02421146|3973687|FG003|STARTED|Overall Study||3
3240856|NCT02421146|3973684|FG000|COMPLETED|Overall Study||2
3240857|NCT02421146|3973685|FG001|COMPLETED|Overall Study||4
3240858|NCT02421146|3973686|FG002|COMPLETED|Overall Study||3
3240859|NCT02421146|3973687|FG003|COMPLETED|Overall Study||3
3240860|NCT02421146|3973684|FG000|NOT COMPLETED|Overall Study||0
3240861|NCT02421146|3973685|FG001|NOT COMPLETED|Overall Study||0
3240862|NCT02421146|3973686|FG002|NOT COMPLETED|Overall Study||0
3240863|NCT02421146|3973687|FG003|NOT COMPLETED|Overall Study||0
3240864|NCT02421172|3973699|FG000|STARTED|Period 1||33
3240865|NCT02421172|3973700|FG001|STARTED|Period 1||33
3240866|NCT02421172|3973701|FG002|STARTED|Period 1||0
3240867|NCT02421172|3973702|FG003|STARTED|Period 1||0
3240868|NCT02421172|3973703|FG004|STARTED|Period 1||0
3240869|NCT02421172|3973699|FG000|PD Analysis Set Period 1|Period 1||31
3240870|NCT02421172|3973700|FG001|PD Analysis Set Period 1|Period 1||33
3240871|NCT02421172|3973701|FG002|PD Analysis Set Period 1|Period 1||0
3240872|NCT02421172|3973702|FG003|PD Analysis Set Period 1|Period 1||0
3240873|NCT02421172|3973703|FG004|PD Analysis Set Period 1|Period 1||0
3240874|NCT02421172|3973699|FG000|PK Analysis Set Period 1|Period 1||33
3240875|NCT02421172|3973700|FG001|PK Analysis Set Period 1|Period 1||0
3240876|NCT02421172|3973701|FG002|PK Analysis Set Period 1|Period 1||0
3240877|NCT02421172|3973702|FG003|PK Analysis Set Period 1|Period 1||0
3240878|NCT02421172|3973703|FG004|PK Analysis Set Period 1|Period 1||0
3240879|NCT02421172|3973699|FG000|COMPLETED|Period 1||29
3240880|NCT02421172|3973700|FG001|COMPLETED|Period 1||31
3240881|NCT02421172|3973701|FG002|COMPLETED|Period 1||0
3240882|NCT02421172|3973702|FG003|COMPLETED|Period 1||0
3240883|NCT02421172|3973703|FG004|COMPLETED|Period 1||0
3240884|NCT02421172|3973699|FG000|NOT COMPLETED|Period 1||4
3240885|NCT02421172|3973700|FG001|NOT COMPLETED|Period 1||2
3240886|NCT02421172|3973701|FG002|NOT COMPLETED|Period 1||0
3240887|NCT02421172|3973702|FG003|NOT COMPLETED|Period 1||0
3240888|NCT02421172|3973703|FG004|NOT COMPLETED|Period 1||0
3240889|NCT02421172|3973699|FG000|STARTED|Period 2||0
3240890|NCT02421172|3973700|FG001|STARTED|Period 2||0
3240891|NCT02421172|3973701|FG002|STARTED|Period 2||29
3240892|NCT02421172|3973702|FG003|STARTED|Period 2||16
3240893|NCT02421172|3973703|FG004|STARTED|Period 2||15
3240894|NCT02421172|3973699|FG000|COMPLETED|Period 2||0
3240895|NCT02421172|3973700|FG001|COMPLETED|Period 2||0
3240896|NCT02421172|3973701|FG002|COMPLETED|Period 2||22
3240897|NCT02421172|3973702|FG003|COMPLETED|Period 2||13
3240898|NCT02421172|3973703|FG004|COMPLETED|Period 2||14
3240899|NCT02421172|3973699|FG000|NOT COMPLETED|Period 2||0
3240900|NCT02421172|3973700|FG001|NOT COMPLETED|Period 2||0
3240901|NCT02421172|3973701|FG002|NOT COMPLETED|Period 2||7
3240902|NCT02421172|3973702|FG003|NOT COMPLETED|Period 2||3
3240903|NCT02421172|3973703|FG004|NOT COMPLETED|Period 2||1
3240904|NCT02421211|3973716|FG000|STARTED|Overall Study||20
3240905|NCT02421211|3973717|FG001|STARTED|Overall Study||20
3240906|NCT02421211|3973716|FG000|COMPLETED|Overall Study||20
3240907|NCT02421211|3973717|FG001|COMPLETED|Overall Study||20
3240908|NCT02421211|3973716|FG000|NOT COMPLETED|Overall Study||0
3240909|NCT02421211|3973717|FG001|NOT COMPLETED|Overall Study||0
3240910|NCT02421224|3973736|FG000|STARTED|Overall Study||444
3240911|NCT02421224|3973737|FG001|STARTED|Overall Study||397
3240912|NCT02421224|3973738|FG002|STARTED|Overall Study||508
3240913|NCT02421224|3973739|FG003|STARTED|Overall Study||482
3240914|NCT02421224|3973740|FG004|STARTED|Overall Study||495
3240915|NCT02421224|3973741|FG005|STARTED|Overall Study||515
3240916|NCT02421224|3973742|FG006|STARTED|Overall Study||489
3240917|NCT02421224|3973743|FG007|STARTED|Overall Study||364
3240918|NCT02421224|3973744|FG008|STARTED|Overall Study||496
3240919|NCT02421224|3973736|FG000|COMPLETED|Overall Study||442
3240920|NCT02421224|3973737|FG001|COMPLETED|Overall Study||394
3240921|NCT02421224|3973738|FG002|COMPLETED|Overall Study||507
3240922|NCT02421224|3973739|FG003|COMPLETED|Overall Study||479
3240923|NCT02421224|3973740|FG004|COMPLETED|Overall Study||491
3240924|NCT02421224|3973741|FG005|COMPLETED|Overall Study||513
3240925|NCT02421224|3973742|FG006|COMPLETED|Overall Study||489
3240926|NCT02421224|3973743|FG007|COMPLETED|Overall Study||362
3240927|NCT02421224|3973744|FG008|COMPLETED|Overall Study||495
3240928|NCT02421224|3973736|FG000|NOT COMPLETED|Overall Study||2
3240929|NCT02421224|3973737|FG001|NOT COMPLETED|Overall Study||3
3240930|NCT02421224|3973738|FG002|NOT COMPLETED|Overall Study||1
3240931|NCT02421224|3973739|FG003|NOT COMPLETED|Overall Study||3
3240932|NCT02421224|3973740|FG004|NOT COMPLETED|Overall Study||4
3240933|NCT02421224|3973741|FG005|NOT COMPLETED|Overall Study||2
3240934|NCT02421224|3973742|FG006|NOT COMPLETED|Overall Study||0
3240935|NCT02421224|3973743|FG007|NOT COMPLETED|Overall Study||2
3240936|NCT02421224|3973744|FG008|NOT COMPLETED|Overall Study||1
3240937|NCT02421354|3973764|FG000|STARTED|Overall Study||8
3240938|NCT02421354|3973764|FG000|COMPLETED|Overall Study||8
3240939|NCT02421354|3973764|FG000|NOT COMPLETED|Overall Study||0
3240940|NCT02421419|3973771|FG000|STARTED|Overall Study||6
3240941|NCT02421419|3973772|FG001|STARTED|Overall Study||11
3240942|NCT02421419|3973773|FG002|STARTED|Overall Study||9
3240943|NCT02421419|3973771|FG000|COMPLETED|Overall Study||6
3240944|NCT02421419|3973772|FG001|COMPLETED|Overall Study||11
3240945|NCT02421419|3973773|FG002|COMPLETED|Overall Study||8
3240946|NCT02421419|3973771|FG000|NOT COMPLETED|Overall Study||0
3240947|NCT02421419|3973772|FG001|NOT COMPLETED|Overall Study||0
3240948|NCT02421419|3973773|FG002|NOT COMPLETED|Overall Study||1
3240949|NCT02421510|3973784|FG000|STARTED|Overall Study||258
3240950|NCT02421510|3973785|FG001|STARTED|Overall Study||261
3240951|NCT02421510|3973786|FG002|STARTED|Overall Study||263
3240952|NCT02421510|3973784|FG000|Completed the 24 Week Treatment Period|Overall Study||236
3240953|NCT02421510|3973785|FG001|Completed the 24 Week Treatment Period|Overall Study||239
3240954|NCT02421510|3973786|FG002|Completed the 24 Week Treatment Period|Overall Study||240
3240955|NCT02421510|3973784|FG000|COMPLETED|Overall Study||225
3240956|NCT02421510|3973785|FG001|COMPLETED|Overall Study||226
3240957|NCT02421510|3973786|FG002|COMPLETED|Overall Study||227
3240958|NCT02421510|3973784|FG000|NOT COMPLETED|Overall Study||33
3240959|NCT02421510|3973785|FG001|NOT COMPLETED|Overall Study||35
3240960|NCT02421510|3973786|FG002|NOT COMPLETED|Overall Study||36
3240961|NCT02421588|3973796|FG000|STARTED|Overall Study||221
3240962|NCT02421588|3973797|FG001|STARTED|Overall Study||221
3240963|NCT02421588|3973796|FG000|COMPLETED|Overall Study||0
3240964|NCT02421588|3973797|FG001|COMPLETED|Overall Study||0
3240965|NCT02421588|3973796|FG000|NOT COMPLETED|Overall Study||221
3240966|NCT02421588|3973797|FG001|NOT COMPLETED|Overall Study||221
3240967|NCT02421601|3973803|FG000|STARTED|Overall Study||991
3240968|NCT02421601|3973803|FG000|COMPLETED|Overall Study||909
3240969|NCT02421601|3973803|FG000|NOT COMPLETED|Overall Study||82
3240970|NCT02421666|3973809|FG000|STARTED|Overall Study Baseline||272
3240971|NCT02421666|3973810|FG001|STARTED|Overall Study Baseline||260
3240972|NCT02421666|3973809|FG000|COMPLETED|Overall Study Baseline||272
3240973|NCT02421666|3973810|FG001|COMPLETED|Overall Study Baseline||260
3240974|NCT02421666|3973809|FG000|NOT COMPLETED|Overall Study Baseline||0
3240975|NCT02421666|3973810|FG001|NOT COMPLETED|Overall Study Baseline||0
3240976|NCT02421666|3973809|FG000|STARTED|6-month Follow-up||272
3240977|NCT02421666|3973810|FG001|STARTED|6-month Follow-up||260
3240978|NCT02421666|3973809|FG000|COMPLETED|6-month Follow-up||259
3240979|NCT02421666|3973810|FG001|COMPLETED|6-month Follow-up||247
3240980|NCT02421666|3973809|FG000|NOT COMPLETED|6-month Follow-up||13
3240981|NCT02421666|3973810|FG001|NOT COMPLETED|6-month Follow-up||13
3240982|NCT02421666|3973809|FG000|STARTED|12-month Follow-up||259
3240983|NCT02421666|3973810|FG001|STARTED|12-month Follow-up||247
3240984|NCT02421666|3973809|FG000|COMPLETED|12-month Follow-up||248
3240985|NCT02421666|3973810|FG001|COMPLETED|12-month Follow-up||231
3240986|NCT02421666|3973809|FG000|NOT COMPLETED|12-month Follow-up||11
3240987|NCT02421666|3973810|FG001|NOT COMPLETED|12-month Follow-up||16
3240988|NCT02421757|3973818|FG000|STARTED|Overall Study||11
3240989|NCT02421757|3973819|FG001|STARTED|Overall Study||9
3240990|NCT02421757|3973818|FG000|COMPLETED|Overall Study||11
3240991|NCT02421757|3973819|FG001|COMPLETED|Overall Study||9
3240992|NCT02421757|3973818|FG000|NOT COMPLETED|Overall Study||0
3240993|NCT02421757|3973819|FG001|NOT COMPLETED|Overall Study||0
3240994|NCT02421887|3973827|FG000|STARTED|Overall Study||85
3240995|NCT02421887|3973828|FG001|STARTED|Overall Study||86
3240996|NCT02421887|3973827|FG000|COMPLETED|Overall Study||68
3240997|NCT02421887|3973828|FG001|COMPLETED|Overall Study||77
3240998|NCT02421887|3973827|FG000|NOT COMPLETED|Overall Study||17
3240999|NCT02421887|3973828|FG001|NOT COMPLETED|Overall Study||9
3241000|NCT02421952|3973834|FG000|STARTED|Overall Study||208
3241001|NCT02421952|3973834|FG000|Excluded From PACU and Post-Analysis|Overall Study||16
3241002|NCT02421952|3973834|FG000|Included in PACU Analysis|Overall Study||192
3241003|NCT02421952|3973834|FG000|COMPLETED|Overall Study||99
3241004|NCT02421952|3973834|FG000|NOT COMPLETED|Overall Study||109
3241005|NCT02422186|3973843|FG000|STARTED|Double-blind Induction Phase (4 Weeks)||72
3241006|NCT02422186|3973844|FG001|STARTED|Double-blind Induction Phase (4 Weeks)||66
3241007|NCT02422186|3973843|FG000|Full Analysis Set (FAS)|Double-blind Induction Phase (4 Weeks)||72
3241008|NCT02422186|3973844|FG001|Full Analysis Set (FAS)|Double-blind Induction Phase (4 Weeks)||65
3241009|NCT02422186|3973843|FG000|Safety Analysis Set|Double-blind Induction Phase (4 Weeks)||72
3241010|NCT02422186|3973844|FG001|Safety Analysis Set|Double-blind Induction Phase (4 Weeks)||65
3241011|NCT02422186|3973843|FG000|COMPLETED|Double-blind Induction Phase (4 Weeks)||62
3241012|NCT02422186|3973844|FG001|COMPLETED|Double-blind Induction Phase (4 Weeks)||60
3241013|NCT02422186|3973843|FG000|NOT COMPLETED|Double-blind Induction Phase (4 Weeks)||10
3241014|NCT02422186|3973844|FG001|NOT COMPLETED|Double-blind Induction Phase (4 Weeks)||6
3241015|NCT02422186|3973843|FG000|STARTED|Follow-up Phase (2 Weeks)||12
3241016|NCT02422186|3973844|FG001|STARTED|Follow-up Phase (2 Weeks)||3
3241017|NCT02422186|3973843|FG000|COMPLETED|Follow-up Phase (2 Weeks)||8
3241018|NCT02422186|3973844|FG001|COMPLETED|Follow-up Phase (2 Weeks)||3
3241019|NCT02422186|3973843|FG000|NOT COMPLETED|Follow-up Phase (2 Weeks)||4
3241020|NCT02422186|3973844|FG001|NOT COMPLETED|Follow-up Phase (2 Weeks)||0
3241021|NCT02422264|3973854|FG000|STARTED|Overall Study||296
3241022|NCT02422264|3973855|FG001|STARTED|Overall Study||305
3241023|NCT02422264|3973854|FG000|COMPLETED|Overall Study||291
3241024|NCT02422264|3973855|FG001|COMPLETED|Overall Study||301
3241025|NCT02422264|3973854|FG000|NOT COMPLETED|Overall Study||5
3241026|NCT02422264|3973855|FG001|NOT COMPLETED|Overall Study||4
3241027|NCT02422290|3973861|FG000|STARTED|Overall Study||5
3241028|NCT02422290|3973861|FG000|COMPLETED|Overall Study||5
3241029|NCT02422290|3973861|FG000|NOT COMPLETED|Overall Study||0
3241030|NCT02422446|3973867|FG000|STARTED|Overall Study||1
3241031|NCT02422446|3973868|FG001|STARTED|Overall Study||1
3241032|NCT02422446|3973867|FG000|COMPLETED|Overall Study||1
3241033|NCT02422446|3973868|FG001|COMPLETED|Overall Study||1
3241034|NCT02422446|3973867|FG000|NOT COMPLETED|Overall Study||0
3241035|NCT02422446|3973868|FG001|NOT COMPLETED|Overall Study||0
3241036|NCT02422511|3973882|FG000|STARTED|Overall Study||255
3241037|NCT02422511|3973883|FG001|STARTED|Overall Study||128
3241038|NCT02422511|3973884|FG002|STARTED|Overall Study||257
3241039|NCT02422511|3973885|FG003|STARTED|Overall Study||129
3241040|NCT02422511|3973886|FG004|STARTED|Overall Study||66
3241041|NCT02422511|3973887|FG005|STARTED|Overall Study||33
3241042|NCT02422511|3973888|FG006|STARTED|Overall Study||68
3241043|NCT02422511|3973889|FG007|STARTED|Overall Study||34
3241044|NCT02422511|3973882|FG000|Received Disclosure|Overall Study||158
3241045|NCT02422511|3973883|FG001|Received Disclosure|Overall Study|Newborns did not receive disclosure|79
3241046|NCT02422511|3973884|FG002|Received Disclosure|Overall Study||194
3241047|NCT02422511|3973885|FG003|Received Disclosure|Overall Study||97
3241048|NCT02422511|3973886|FG004|Received Disclosure|Overall Study||43
3241049|NCT02422511|3973887|FG005|Received Disclosure|Overall Study||21
3241050|NCT02422511|3973888|FG006|Received Disclosure|Overall Study||38
3241051|NCT02422511|3973889|FG007|Received Disclosure|Overall Study||19
3241052|NCT02422511|3973882|FG000|COMPLETED|Overall Study||143
3241053|NCT02422511|3973883|FG001|COMPLETED|Overall Study|Newborns did not complete survey|0
3241054|NCT02422511|3973884|FG002|COMPLETED|Overall Study||168
3241055|NCT02422511|3973885|FG003|COMPLETED|Overall Study|Newborns did not complete survey|0
3241056|NCT02422511|3973886|FG004|COMPLETED|Overall Study||39
3241057|NCT02422511|3973887|FG005|COMPLETED|Overall Study|Newborns did not complete survey|0
3241058|NCT02422511|3973888|FG006|COMPLETED|Overall Study||38
3241059|NCT02422511|3973889|FG007|COMPLETED|Overall Study|Newborns did not complete survey|0
3241060|NCT02422511|3973882|FG000|NOT COMPLETED|Overall Study||112
3241061|NCT02422511|3973883|FG001|NOT COMPLETED|Overall Study||128
3241062|NCT02422511|3973884|FG002|NOT COMPLETED|Overall Study||89
3241063|NCT02422511|3973885|FG003|NOT COMPLETED|Overall Study||129
3241064|NCT02422511|3973886|FG004|NOT COMPLETED|Overall Study||27
3241065|NCT02422511|3973887|FG005|NOT COMPLETED|Overall Study||33
3241066|NCT02422511|3973888|FG006|NOT COMPLETED|Overall Study||30
3241067|NCT02422511|3973889|FG007|NOT COMPLETED|Overall Study||34
3241068|NCT02422940|3973909|FG000|STARTED|Overall Study||152
3241069|NCT02422940|3973910|FG001|STARTED|Overall Study||142
3241070|NCT02422940|3973909|FG000|COMPLETED|Overall Study||31
3241071|NCT02422940|3973910|FG001|COMPLETED|Overall Study||21
3241072|NCT02422940|3973909|FG000|NOT COMPLETED|Overall Study||121
3241073|NCT02422940|3973910|FG001|NOT COMPLETED|Overall Study||121
3241074|NCT02423109|3973916|FG000|STARTED|Lens 1||19
3241075|NCT02423109|3973917|FG001|STARTED|Lens 1||14
3241076|NCT02423109|3973916|FG000|COMPLETED|Lens 1||18
3241077|NCT02423109|3973917|FG001|COMPLETED|Lens 1||14
3241078|NCT02423109|3973916|FG000|NOT COMPLETED|Lens 1||1
3241079|NCT02423109|3973917|FG001|NOT COMPLETED|Lens 1||0
3241080|NCT02423109|3973916|FG000|STARTED|Lens 2||18
3241081|NCT02423109|3973917|FG001|STARTED|Lens 2||14
3241082|NCT02423109|3973916|FG000|COMPLETED|Lens 2||18
3241083|NCT02423109|3973917|FG001|COMPLETED|Lens 2||14
3241084|NCT02423109|3973916|FG000|NOT COMPLETED|Lens 2||0
3241085|NCT02423109|3973917|FG001|NOT COMPLETED|Lens 2||0
3241086|NCT02423122|3973927|FG000|STARTED|Overall Study||9
3241087|NCT02423122|3973928|FG001|STARTED|Overall Study||7
3241088|NCT02423122|3973927|FG000|COMPLETED|Overall Study||9
3241089|NCT02423122|3973928|FG001|COMPLETED|Overall Study||7
3241090|NCT02423122|3973927|FG000|NOT COMPLETED|Overall Study||0
3241091|NCT02423122|3973928|FG001|NOT COMPLETED|Overall Study||0
3241092|NCT02423200|3973936|FG000|STARTED|Overall Study||8
3241093|NCT02423200|3973937|FG001|STARTED|Overall Study||1
3241094|NCT02423200|3973936|FG000|COMPLETED|Overall Study||7
3241095|NCT02423200|3973937|FG001|COMPLETED|Overall Study||1
3241096|NCT02423200|3973936|FG000|NOT COMPLETED|Overall Study||1
3241097|NCT02423200|3973937|FG001|NOT COMPLETED|Overall Study||0
3241098|NCT02423291|3973944|FG000|STARTED|Overall Study|Patients enrolled|15
3241099|NCT02423291|3973944|FG000|COMPLETED|Overall Study|Patients that have completed therapy|0
3241100|NCT02423291|3973944|FG000|NOT COMPLETED|Overall Study||15
3241101|NCT02423317|3973950|FG000|STARTED|Overall Study||30
3241102|NCT02423317|3973951|FG001|STARTED|Overall Study||30
3241103|NCT02423317|3973950|FG000|COMPLETED|Overall Study||30
3241104|NCT02423317|3973951|FG001|COMPLETED|Overall Study||30
3241105|NCT02423317|3973950|FG000|NOT COMPLETED|Overall Study||0
3241106|NCT02423317|3973951|FG001|NOT COMPLETED|Overall Study||0
3241107|NCT02423343|3973963|FG000|STARTED|Overall Study||3
3241108|NCT02423343|3973964|FG001|STARTED|Overall Study||5
3241109|NCT02423343|3973965|FG002|STARTED|Overall Study||3
3241110|NCT02423343|3973966|FG003|STARTED|Overall Study||4
3241111|NCT02423343|3973967|FG004|STARTED|Overall Study||25
3241112|NCT02423343|3973968|FG005|STARTED|Overall Study||1
3241113|NCT02423343|3973963|FG000|Received at Least One Dose of Study Drug|Overall Study||3
3241114|NCT02423343|3973964|FG001|Received at Least One Dose of Study Drug|Overall Study||5
3241115|NCT02423343|3973965|FG002|Received at Least One Dose of Study Drug|Overall Study||3
3241116|NCT02423343|3973966|FG003|Received at Least One Dose of Study Drug|Overall Study||4
3241117|NCT02423343|3973967|FG004|Received at Least One Dose of Study Drug|Overall Study||25
3241118|NCT02423343|3973968|FG005|Received at Least One Dose of Study Drug|Overall Study||1
3241119|NCT02423343|3973963|FG000|COMPLETED|Overall Study||3
3241120|NCT02423343|3973964|FG001|COMPLETED|Overall Study||4
3241121|NCT02423343|3973965|FG002|COMPLETED|Overall Study||3
3241122|NCT02423343|3973966|FG003|COMPLETED|Overall Study||4
3241123|NCT02423343|3973967|FG004|COMPLETED|Overall Study||20
3241124|NCT02423343|3973968|FG005|COMPLETED|Overall Study||1
3241125|NCT02423343|3973963|FG000|NOT COMPLETED|Overall Study||0
3241126|NCT02423343|3973964|FG001|NOT COMPLETED|Overall Study||1
3241127|NCT02423343|3973965|FG002|NOT COMPLETED|Overall Study||0
3241128|NCT02423343|3973966|FG003|NOT COMPLETED|Overall Study||0
3241129|NCT02423343|3973967|FG004|NOT COMPLETED|Overall Study||5
3241130|NCT02423343|3973968|FG005|NOT COMPLETED|Overall Study||0
3241131|NCT02423408|3973998|FG000|STARTED|Overall Study||83
3241132|NCT02423408|3973999|FG001|STARTED|Overall Study||82
3241133|NCT02423408|3973998|FG000|COMPLETED|Overall Study||82
3241134|NCT02423408|3973999|FG001|COMPLETED|Overall Study||80
3241135|NCT02423408|3973998|FG000|NOT COMPLETED|Overall Study||1
3241136|NCT02423408|3973999|FG001|NOT COMPLETED|Overall Study||2
3241137|NCT02423447|3974005|FG000|STARTED|Overall Study||13
3241138|NCT02423447|3974006|FG001|STARTED|Overall Study||12
3241139|NCT02423447|3974005|FG000|COMPLETED|Overall Study||13
3241140|NCT02423447|3974006|FG001|COMPLETED|Overall Study||12
3241141|NCT02423447|3974005|FG000|NOT COMPLETED|Overall Study||0
3241142|NCT02423447|3974006|FG001|NOT COMPLETED|Overall Study||0
3241143|NCT02423577|3974017|FG000|STARTED|Overall Study||53
3241144|NCT02423577|3974018|FG001|STARTED|Overall Study||26
3241145|NCT02423577|3974017|FG000|COMPLETED|Overall Study||53
3241146|NCT02423577|3974018|FG001|COMPLETED|Overall Study||26
3241147|NCT02423577|3974017|FG000|NOT COMPLETED|Overall Study||0
3241148|NCT02423577|3974018|FG001|NOT COMPLETED|Overall Study||0
3241149|NCT02423798|3974024|FG000|STARTED|Overall Study||24
3241150|NCT02423798|3974024|FG000|COMPLETED|Overall Study||21
3241151|NCT02423798|3974024|FG000|NOT COMPLETED|Overall Study||3
3241152|NCT02423980|3974029|FG000|STARTED|Overall Study||7
3241153|NCT02423980|3974029|FG000|COMPLETED|Overall Study||7
3241154|NCT02423980|3974029|FG000|NOT COMPLETED|Overall Study||0
3241155|NCT02423993|3974039|FG000|STARTED|Overall Study||19
3241156|NCT02423993|3974040|FG001|STARTED|Overall Study||16
3241157|NCT02423993|3974041|FG002|STARTED|Overall Study||23
3241158|NCT02423993|3974042|FG003|STARTED|Overall Study||19
3241159|NCT02423993|3974039|FG000|COMPLETED|Overall Study||19
3241160|NCT02423993|3974040|FG001|COMPLETED|Overall Study||16
3241161|NCT02423993|3974041|FG002|COMPLETED|Overall Study||23
3241162|NCT02423993|3974042|FG003|COMPLETED|Overall Study||19
3370414|NCT03777059|4101780|FG003|NOT COMPLETED|Follow-Up Period (Weeks 12 to 16)||9
3241163|NCT02423993|3974039|FG000|NOT COMPLETED|Overall Study||0
3241164|NCT02423993|3974040|FG001|NOT COMPLETED|Overall Study||0
3241165|NCT02423993|3974041|FG002|NOT COMPLETED|Overall Study||0
3241166|NCT02423993|3974042|FG003|NOT COMPLETED|Overall Study||0
3241167|NCT02424097|3974054|FG000|STARTED|Overall Study||20
3241168|NCT02424097|3974055|FG001|STARTED|Overall Study||20
3241169|NCT02424097|3974054|FG000|COMPLETED|Overall Study||19
3241170|NCT02424097|3974055|FG001|COMPLETED|Overall Study||18
3241171|NCT02424097|3974054|FG000|NOT COMPLETED|Overall Study||1
3241172|NCT02424097|3974055|FG001|NOT COMPLETED|Overall Study||2
3241173|NCT02424149|3974063|FG000|STARTED|Overall Study||54
3241174|NCT02424149|3974064|FG001|STARTED|Overall Study||53
3241175|NCT02424149|3974063|FG000|COMPLETED|Overall Study||52
3241176|NCT02424149|3974064|FG001|COMPLETED|Overall Study||52
3241177|NCT02424149|3974063|FG000|NOT COMPLETED|Overall Study||2
3241178|NCT02424149|3974064|FG001|NOT COMPLETED|Overall Study||1
3241179|NCT02424175|3974070|FG000|STARTED|Overall Study||10
3241180|NCT02424175|3974070|FG000|COMPLETED|Overall Study||10
3241181|NCT02424175|3974070|FG000|NOT COMPLETED|Overall Study||0
3241182|NCT02424253|3974076|FG000|STARTED|Overall Study||65
3241183|NCT02424253|3974077|FG001|STARTED|Overall Study||33
3241184|NCT02424253|3974076|FG000|COMPLETED|Overall Study||54
3241185|NCT02424253|3974077|FG001|COMPLETED|Overall Study||24
3241186|NCT02424253|3974076|FG000|NOT COMPLETED|Overall Study||11
3241187|NCT02424253|3974077|FG001|NOT COMPLETED|Overall Study||9
3241188|NCT02424344|3974085|FG000|STARTED|Overall Study||134
3241189|NCT02424344|3974086|FG001|STARTED|Overall Study||133
3241190|NCT02424344|3974085|FG000|COMPLETED|Overall Study||127
3241191|NCT02424344|3974086|FG001|COMPLETED|Overall Study||123
3241192|NCT02424344|3974085|FG000|NOT COMPLETED|Overall Study||7
3241193|NCT02424344|3974086|FG001|NOT COMPLETED|Overall Study||10
3241194|NCT02424357|3974094|FG000|STARTED|Overall Study||35
3241195|NCT02424357|3974095|FG001|STARTED|Overall Study||30
3241196|NCT02424357|3974094|FG000|COMPLETED|Overall Study||35
3241197|NCT02424357|3974095|FG001|COMPLETED|Overall Study||30
3241198|NCT02424357|3974094|FG000|NOT COMPLETED|Overall Study||0
3241199|NCT02424357|3974095|FG001|NOT COMPLETED|Overall Study||0
3241200|NCT02424383|3974103|FG000|STARTED|Overall Study||1005
3241201|NCT02424383|3974103|FG000|Per-Protocol Population|Overall Study||966
3241202|NCT02424383|3974103|FG000|COMPLETED|Overall Study||629
3241203|NCT02424383|3974103|FG000|NOT COMPLETED|Overall Study||376
3241204|NCT02424526|3974109|FG000|STARTED|Overall Study||9
3241205|NCT02424526|3974110|FG001|STARTED|Overall Study||10
3241206|NCT02424526|3974109|FG000|COMPLETED|Overall Study||9
3241207|NCT02424526|3974110|FG001|COMPLETED|Overall Study||10
3241208|NCT02424526|3974109|FG000|NOT COMPLETED|Overall Study||0
3241209|NCT02424526|3974110|FG001|NOT COMPLETED|Overall Study||0
3241210|NCT02424539|3974121|FG000|STARTED|Overall Study||120
3241211|NCT02424539|3974122|FG001|STARTED|Overall Study||119
3241212|NCT02424539|3974123|FG002|STARTED|Overall Study||119
3241213|NCT02424539|3974121|FG000|COMPLETED|Overall Study||106
3241214|NCT02424539|3974122|FG001|COMPLETED|Overall Study||111
3241215|NCT02424539|3974123|FG002|COMPLETED|Overall Study||111
3241216|NCT02424539|3974121|FG000|NOT COMPLETED|Overall Study||14
3241217|NCT02424539|3974122|FG001|NOT COMPLETED|Overall Study||8
3241218|NCT02424539|3974123|FG002|NOT COMPLETED|Overall Study||8
3241219|NCT02424578|3974133|FG000|STARTED|Overall Study||15
3241220|NCT02424578|3974134|FG001|STARTED|Overall Study||15
3241221|NCT02424578|3974133|FG000|COMPLETED|Overall Study||15
3241222|NCT02424578|3974134|FG001|COMPLETED|Overall Study||14
3241223|NCT02424578|3974133|FG000|NOT COMPLETED|Overall Study||0
3241224|NCT02424578|3974134|FG001|NOT COMPLETED|Overall Study||1
3241225|NCT02424591|3974142|FG000|STARTED|Overall Study||22
3241226|NCT02424591|3974143|FG001|STARTED|Overall Study||23
3241227|NCT02424591|3974142|FG000|COMPLETED|Overall Study||20
3241228|NCT02424591|3974143|FG001|COMPLETED|Overall Study||20
3241229|NCT02424591|3974142|FG000|NOT COMPLETED|Overall Study||2
3241230|NCT02424591|3974143|FG001|NOT COMPLETED|Overall Study||3
3241231|NCT02424630|3974151|FG000|STARTED|Overall Study||25
3241232|NCT02424630|3974152|FG001|STARTED|Overall Study||27
3241233|NCT02424630|3974151|FG000|COMPLETED|Overall Study||24
3241234|NCT02424630|3974152|FG001|COMPLETED|Overall Study||24
3241235|NCT02424630|3974151|FG000|NOT COMPLETED|Overall Study||1
3241236|NCT02424630|3974152|FG001|NOT COMPLETED|Overall Study||3
3241237|NCT02424734|3974161|FG000|STARTED|Overall Study||4
3241238|NCT02424734|3974162|FG001|STARTED|Overall Study||5
3241239|NCT02424734|3974163|FG002|STARTED|Overall Study||2
3241240|NCT02424734|3974161|FG000|Treated|Overall Study||4
3241241|NCT02424734|3974162|FG001|Treated|Overall Study||5
3241242|NCT02424734|3974163|FG002|Treated|Overall Study||2
3241243|NCT02424734|3974161|FG000|COMPLETED|Overall Study||2
3241244|NCT02424734|3974162|FG001|COMPLETED|Overall Study||3
3241245|NCT02424734|3974163|FG002|COMPLETED|Overall Study||2
3241246|NCT02424734|3974161|FG000|NOT COMPLETED|Overall Study||2
3241247|NCT02424734|3974162|FG001|NOT COMPLETED|Overall Study||2
3241248|NCT02424734|3974163|FG002|NOT COMPLETED|Overall Study||0
3241249|NCT02424799|3974178|FG000|STARTED|Part A (Up to Day 11)||9
3241250|NCT02424799|3974179|FG001|STARTED|Part A (Up to Day 11)||8
3241251|NCT02424799|3974180|FG002|STARTED|Part A (Up to Day 11)||0
3241252|NCT02424799|3974181|FG003|STARTED|Part A (Up to Day 11)||0
3241253|NCT02424799|3974182|FG004|STARTED|Part A (Up to Day 11)||0
3241254|NCT02424799|3974183|FG005|STARTED|Part A (Up to Day 11)||0
3241255|NCT02424799|3974178|FG000|COMPLETED|Part A (Up to Day 11)||9
3241256|NCT02424799|3974179|FG001|COMPLETED|Part A (Up to Day 11)||8
3241257|NCT02424799|3974180|FG002|COMPLETED|Part A (Up to Day 11)||0
3241258|NCT02424799|3974181|FG003|COMPLETED|Part A (Up to Day 11)||0
3370415|NCT03772522|4101792|FG000|STARTED|Pre-intervention||12
3241259|NCT02424799|3974182|FG004|COMPLETED|Part A (Up to Day 11)||0
3241260|NCT02424799|3974183|FG005|COMPLETED|Part A (Up to Day 11)||0
3241261|NCT02424799|3974178|FG000|NOT COMPLETED|Part A (Up to Day 11)||0
3241262|NCT02424799|3974179|FG001|NOT COMPLETED|Part A (Up to Day 11)||0
3241263|NCT02424799|3974180|FG002|NOT COMPLETED|Part A (Up to Day 11)||0
3241264|NCT02424799|3974181|FG003|NOT COMPLETED|Part A (Up to Day 11)||0
3241265|NCT02424799|3974182|FG004|NOT COMPLETED|Part A (Up to Day 11)||0
3241266|NCT02424799|3974183|FG005|NOT COMPLETED|Part A (Up to Day 11)||0
3241267|NCT02424799|3974178|FG000|STARTED|Part B (Up to Day 19)||0
3241268|NCT02424799|3974179|FG001|STARTED|Part B (Up to Day 19)||0
3241269|NCT02424799|3974180|FG002|STARTED|Part B (Up to Day 19)||3
3241270|NCT02424799|3974181|FG003|STARTED|Part B (Up to Day 19)||9
3241271|NCT02424799|3974182|FG004|STARTED|Part B (Up to Day 19)||0
3241272|NCT02424799|3974183|FG005|STARTED|Part B (Up to Day 19)||0
3241273|NCT02424799|3974178|FG000|COMPLETED|Part B (Up to Day 19)||0
3241274|NCT02424799|3974179|FG001|COMPLETED|Part B (Up to Day 19)||0
3241275|NCT02424799|3974180|FG002|COMPLETED|Part B (Up to Day 19)||3
3241276|NCT02424799|3974181|FG003|COMPLETED|Part B (Up to Day 19)||9
3241277|NCT02424799|3974182|FG004|COMPLETED|Part B (Up to Day 19)||0
3241278|NCT02424799|3974183|FG005|COMPLETED|Part B (Up to Day 19)||0
3241279|NCT02424799|3974178|FG000|NOT COMPLETED|Part B (Up to Day 19)||0
3241280|NCT02424799|3974179|FG001|NOT COMPLETED|Part B (Up to Day 19)||0
3241281|NCT02424799|3974180|FG002|NOT COMPLETED|Part B (Up to Day 19)||0
3241282|NCT02424799|3974181|FG003|NOT COMPLETED|Part B (Up to Day 19)||0
3241283|NCT02424799|3974182|FG004|NOT COMPLETED|Part B (Up to Day 19)||0
3241284|NCT02424799|3974183|FG005|NOT COMPLETED|Part B (Up to Day 19)||0
3241285|NCT02424799|3974178|FG000|STARTED|Part C (Up to Day 23)||0
3241286|NCT02424799|3974179|FG001|STARTED|Part C (Up to Day 23)||0
3241287|NCT02424799|3974180|FG002|STARTED|Part C (Up to Day 23)||0
3241288|NCT02424799|3974181|FG003|STARTED|Part C (Up to Day 23)||0
3241289|NCT02424799|3974182|FG004|STARTED|Part C (Up to Day 23)||1
3241290|NCT02424799|3974183|FG005|STARTED|Part C (Up to Day 23)||4
3241291|NCT02424799|3974178|FG000|COMPLETED|Part C (Up to Day 23)||0
3241292|NCT02424799|3974179|FG001|COMPLETED|Part C (Up to Day 23)||0
3241293|NCT02424799|3974180|FG002|COMPLETED|Part C (Up to Day 23)||0
3241294|NCT02424799|3974181|FG003|COMPLETED|Part C (Up to Day 23)||0
3241295|NCT02424799|3974182|FG004|COMPLETED|Part C (Up to Day 23)||1
3241296|NCT02424799|3974183|FG005|COMPLETED|Part C (Up to Day 23)||4
3241297|NCT02424799|3974178|FG000|NOT COMPLETED|Part C (Up to Day 23)||0
3241298|NCT02424799|3974179|FG001|NOT COMPLETED|Part C (Up to Day 23)||0
3241299|NCT02424799|3974180|FG002|NOT COMPLETED|Part C (Up to Day 23)||0
3241300|NCT02424799|3974181|FG003|NOT COMPLETED|Part C (Up to Day 23)||0
3241301|NCT02424799|3974182|FG004|NOT COMPLETED|Part C (Up to Day 23)||0
3241302|NCT02424799|3974183|FG005|NOT COMPLETED|Part C (Up to Day 23)||0
3241303|NCT02424968|3974215|FG000|STARTED|Overall Study||18
3241304|NCT02424968|3974215|FG000|COMPLETED|Overall Study||18
3241305|NCT02424968|3974215|FG000|NOT COMPLETED|Overall Study||0
3241306|NCT02425098|3974221|FG000|STARTED|Overall Study||176
3241307|NCT02425098|3974222|FG001|STARTED|Overall Study||175
3241308|NCT02425098|3974221|FG000|COMPLETED|Overall Study||163
3241309|NCT02425098|3974222|FG001|COMPLETED|Overall Study||159
3241310|NCT02425098|3974221|FG000|NOT COMPLETED|Overall Study||13
3241311|NCT02425098|3974222|FG001|NOT COMPLETED|Overall Study||16
3241312|NCT02425111|3974228|FG000|STARTED|Part A: Treatment Period||101
3241313|NCT02425111|3974228|FG000|COMPLETED|Part A: Treatment Period||78
3241314|NCT02425111|3974228|FG000|NOT COMPLETED|Part A: Treatment Period||23
3241315|NCT02425111|3974228|FG000|STARTED|Part B: Treatment Extension Period||56
3241316|NCT02425111|3974228|FG000|COMPLETED|Part B: Treatment Extension Period||46
3241317|NCT02425111|3974228|FG000|NOT COMPLETED|Part B: Treatment Extension Period||10
3241318|NCT02425306|3974237|FG000|STARTED|Overall Study||3
3241319|NCT02425306|3974238|FG001|STARTED|Overall Study||7
3241320|NCT02425306|3974239|FG002|STARTED|Overall Study||6
3241321|NCT02425306|3974240|FG003|STARTED|Overall Study||32
3241322|NCT02425306|3974237|FG000|COMPLETED|Overall Study||3
3241323|NCT02425306|3974238|FG001|COMPLETED|Overall Study||6
3241324|NCT02425306|3974239|FG002|COMPLETED|Overall Study||5
3241325|NCT02425306|3974240|FG003|COMPLETED|Overall Study||18
3241326|NCT02425306|3974237|FG000|NOT COMPLETED|Overall Study||0
3241327|NCT02425306|3974238|FG001|NOT COMPLETED|Overall Study||1
3241328|NCT02425306|3974239|FG002|NOT COMPLETED|Overall Study||1
3241329|NCT02425306|3974240|FG003|NOT COMPLETED|Overall Study||14
3241330|NCT02425449|3974255|FG000|STARTED|Overall Study||0
3241331|NCT02425449|3974256|FG001|STARTED|Overall Study||4
3241332|NCT02425449|3974257|FG002|STARTED|Overall Study||5
3241333|NCT02425449|3974258|FG003|STARTED|Overall Study||5
3241334|NCT02425449|3974259|FG004|STARTED|Overall Study||5
3241335|NCT02425449|3974255|FG000|COMPLETED|Overall Study||0
3241336|NCT02425449|3974256|FG001|COMPLETED|Overall Study||4
3241337|NCT02425449|3974257|FG002|COMPLETED|Overall Study||5
3241338|NCT02425449|3974258|FG003|COMPLETED|Overall Study||5
3241339|NCT02425449|3974259|FG004|COMPLETED|Overall Study||5
3241340|NCT02425449|3974255|FG000|NOT COMPLETED|Overall Study||0
3241341|NCT02425449|3974256|FG001|NOT COMPLETED|Overall Study||0
3241342|NCT02425449|3974257|FG002|NOT COMPLETED|Overall Study||0
3241343|NCT02425449|3974258|FG003|NOT COMPLETED|Overall Study||0
3241344|NCT02425449|3974259|FG004|NOT COMPLETED|Overall Study||0
3241345|NCT02425826|3974273|FG000|STARTED|Placebo-controlled Phase (Week 0 - 16)||148
3241346|NCT02425826|3974274|FG001|STARTED|Placebo-controlled Phase (Week 0 - 16)||73
3241347|NCT02425826|3974275|FG002|STARTED|Placebo-controlled Phase (Week 0 - 16)||0
3241348|NCT02425826|3974273|FG000|Intent to Treat|Placebo-controlled Phase (Week 0 - 16)|ITT = includes participants who received at least one dose of study drug.|147
3241349|NCT02425826|3974274|FG001|Intent to Treat|Placebo-controlled Phase (Week 0 - 16)|ITT = includes participants who received at least one dose of study drug.|73
3241350|NCT02425826|3974275|FG002|Intent to Treat|Placebo-controlled Phase (Week 0 - 16)||0
3241351|NCT02425826|3974273|FG000|COMPLETED|Placebo-controlled Phase (Week 0 - 16)|Completed = participants who completed Week 16|121
3241352|NCT02425826|3974274|FG001|COMPLETED|Placebo-controlled Phase (Week 0 - 16)|Completed = participants who completed Week 16|64
3241353|NCT02425826|3974275|FG002|COMPLETED|Placebo-controlled Phase (Week 0 - 16)||0
3241354|NCT02425826|3974273|FG000|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 16)||27
3241355|NCT02425826|3974274|FG001|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 16)||9
3241356|NCT02425826|3974275|FG002|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 16)||0
3241357|NCT02425826|3974273|FG000|STARTED|Apremilast Extension Phase (Weeks 16-52)||121
3241358|NCT02425826|3974274|FG001|STARTED|Apremilast Extension Phase (Weeks 16-52)||0
3241359|NCT02425826|3974275|FG002|STARTED|Apremilast Extension Phase (Weeks 16-52)||64
3241360|NCT02425826|3974273|FG000|Received Treatment|Apremilast Extension Phase (Weeks 16-52)||121
3241361|NCT02425826|3974274|FG001|Received Treatment|Apremilast Extension Phase (Weeks 16-52)||0
3241362|NCT02425826|3974275|FG002|Received Treatment|Apremilast Extension Phase (Weeks 16-52)||64
3241363|NCT02425826|3974273|FG000|COMPLETED|Apremilast Extension Phase (Weeks 16-52)||86
3241364|NCT02425826|3974274|FG001|COMPLETED|Apremilast Extension Phase (Weeks 16-52)||0
3241365|NCT02425826|3974275|FG002|COMPLETED|Apremilast Extension Phase (Weeks 16-52)||50
3241366|NCT02425826|3974273|FG000|NOT COMPLETED|Apremilast Extension Phase (Weeks 16-52)||35
3241367|NCT02425826|3974274|FG001|NOT COMPLETED|Apremilast Extension Phase (Weeks 16-52)||0
3241368|NCT02425826|3974275|FG002|NOT COMPLETED|Apremilast Extension Phase (Weeks 16-52)||14
3241369|NCT02425826|3974273|FG000|STARTED|Post-Treatment Observational Follow-Up||81
3241370|NCT02425826|3974274|FG001|STARTED|Post-Treatment Observational Follow-Up||0
3241371|NCT02425826|3974275|FG002|STARTED|Post-Treatment Observational Follow-Up||49
3241372|NCT02425826|3974273|FG000|COMPLETED|Post-Treatment Observational Follow-Up||80
3241373|NCT02425826|3974274|FG001|COMPLETED|Post-Treatment Observational Follow-Up||0
3241374|NCT02425826|3974275|FG002|COMPLETED|Post-Treatment Observational Follow-Up||49
3241375|NCT02425826|3974273|FG000|NOT COMPLETED|Post-Treatment Observational Follow-Up||1
3241376|NCT02425826|3974274|FG001|NOT COMPLETED|Post-Treatment Observational Follow-Up||0
3241377|NCT02425826|3974275|FG002|NOT COMPLETED|Post-Treatment Observational Follow-Up||0
3241378|NCT02425891|3974287|FG000|STARTED|Overall Study||451
3241379|NCT02425891|3974288|FG001|STARTED|Overall Study||451
3241380|NCT02425891|3974287|FG000|COMPLETED|Overall Study||0
3241381|NCT02425891|3974288|FG001|COMPLETED|Overall Study||0
3241382|NCT02425891|3974287|FG000|NOT COMPLETED|Overall Study||451
3241383|NCT02425891|3974288|FG001|NOT COMPLETED|Overall Study||451
3241384|NCT02425956|3974295|FG000|STARTED|Overall Study||21
3241385|NCT02425956|3974295|FG000|COMPLETED|Overall Study||21
3241386|NCT02425956|3974295|FG000|NOT COMPLETED|Overall Study||0
3241387|NCT02426086|3974301|FG000|STARTED|Overall Study||48
3241388|NCT02426086|3974302|FG001|STARTED|Overall Study||59
3241389|NCT02426086|3974301|FG000|Treated|Overall Study||48
3241390|NCT02426086|3974302|FG001|Treated|Overall Study||59
3241391|NCT02426086|3974301|FG000|COMPLETED|Overall Study||0
3241392|NCT02426086|3974302|FG001|COMPLETED|Overall Study||0
3241393|NCT02426086|3974301|FG000|NOT COMPLETED|Overall Study||48
3241394|NCT02426086|3974302|FG001|NOT COMPLETED|Overall Study||59
3241395|NCT02426138|3974315|FG000|STARTED|First Intervention (12 Weeks)||21
3241396|NCT02426138|3974316|FG001|STARTED|First Intervention (12 Weeks)||23
3241397|NCT02426138|3974315|FG000|COMPLETED|First Intervention (12 Weeks)||20
3241398|NCT02426138|3974316|FG001|COMPLETED|First Intervention (12 Weeks)||22
3241399|NCT02426138|3974315|FG000|NOT COMPLETED|First Intervention (12 Weeks)||1
3241400|NCT02426138|3974316|FG001|NOT COMPLETED|First Intervention (12 Weeks)||1
3241401|NCT02426138|3974315|FG000|STARTED|Second Intervention (12 Weeks)||20
3241402|NCT02426138|3974316|FG001|STARTED|Second Intervention (12 Weeks)||22
3241403|NCT02426138|3974315|FG000|COMPLETED|Second Intervention (12 Weeks)||20
3241404|NCT02426138|3974316|FG001|COMPLETED|Second Intervention (12 Weeks)||22
3241405|NCT02426138|3974315|FG000|NOT COMPLETED|Second Intervention (12 Weeks)||0
3241406|NCT02426138|3974316|FG001|NOT COMPLETED|Second Intervention (12 Weeks)||0
3241407|NCT02426138|3974315|FG000|STARTED|Intent to Treat Population Milestone||20
3241408|NCT02426138|3974316|FG001|STARTED|Intent to Treat Population Milestone||22
3241409|NCT02426138|3974315|FG000|COMPLETED|Intent to Treat Population Milestone||20
3241410|NCT02426138|3974316|FG001|COMPLETED|Intent to Treat Population Milestone||22
3241411|NCT02426138|3974315|FG000|NOT COMPLETED|Intent to Treat Population Milestone||0
3241412|NCT02426138|3974316|FG001|NOT COMPLETED|Intent to Treat Population Milestone||0
3241413|NCT02426476|3974326|FG000|STARTED|Overall Study||57
3241414|NCT02426476|3974327|FG001|STARTED|Overall Study||56
3241415|NCT02426476|3974326|FG000|COMPLETED|Overall Study||38
3241416|NCT02426476|3974327|FG001|COMPLETED|Overall Study||39
3241417|NCT02426476|3974326|FG000|NOT COMPLETED|Overall Study||19
3241418|NCT02426476|3974327|FG001|NOT COMPLETED|Overall Study||17
3241419|NCT02426541|3974337|FG000|STARTED|Overall Study||16
3241420|NCT02426541|3974338|FG001|STARTED|Overall Study||16
3241421|NCT02426541|3974337|FG000|COMPLETED|Overall Study||15
3241422|NCT02426541|3974338|FG001|COMPLETED|Overall Study||16
3241423|NCT02426541|3974337|FG000|NOT COMPLETED|Overall Study||1
3241424|NCT02426541|3974338|FG001|NOT COMPLETED|Overall Study||0
3241425|NCT02426580|3974346|FG000|STARTED|Overall Study|April 2015|70
3241426|NCT02426580|3974347|FG001|STARTED|Overall Study|January 2014|70
3241427|NCT02426580|3974346|FG000|COMPLETED|Overall Study|the last patient enrolled in this group in April 2017|59
3241428|NCT02426580|3974347|FG001|COMPLETED|Overall Study|the last patient in this group enrolled in April 2017|54
3241429|NCT02426580|3974346|FG000|NOT COMPLETED|Overall Study||11
3241430|NCT02426580|3974347|FG001|NOT COMPLETED|Overall Study||16
3241431|NCT02426658|3974353|FG000|STARTED|Overall Study||16
3241432|NCT02426658|3974353|FG000|COMPLETED|Overall Study||13
3241433|NCT02426658|3974353|FG000|NOT COMPLETED|Overall Study||3
3241434|NCT02426749|3974359|FG000|STARTED|Overall Study||12
3241435|NCT02426749|3974360|FG001|STARTED|Overall Study||10
3241436|NCT02426749|3974359|FG000|COMPLETED|Overall Study||9
3241437|NCT02426749|3974360|FG001|COMPLETED|Overall Study||9
3241438|NCT02426749|3974359|FG000|NOT COMPLETED|Overall Study||3
3241439|NCT02426749|3974360|FG001|NOT COMPLETED|Overall Study||1
3241440|NCT02426918|3974371|FG000|STARTED|Overall Study||110
3241441|NCT02426918|3974372|FG001|STARTED|Overall Study||109
3241442|NCT02426918|3974373|FG002|STARTED|Overall Study||111
3241443|NCT02426918|3974371|FG000|Safety Population|Overall Study||110
3241444|NCT02426918|3974372|FG001|Safety Population|Overall Study||107
3241445|NCT02426918|3974373|FG002|Safety Population|Overall Study||107
3241446|NCT02426918|3974371|FG000|COMPLETED|Overall Study||93
3241447|NCT02426918|3974372|FG001|COMPLETED|Overall Study||90
3241448|NCT02426918|3974373|FG002|COMPLETED|Overall Study||97
3241449|NCT02426918|3974371|FG000|NOT COMPLETED|Overall Study||17
3241450|NCT02426918|3974372|FG001|NOT COMPLETED|Overall Study||19
3241451|NCT02426918|3974373|FG002|NOT COMPLETED|Overall Study||14
3241452|NCT02427100|3974383|FG000|STARTED|Overall Study||15
3241453|NCT02427100|3974384|FG001|STARTED|Overall Study||17
3241454|NCT02427100|3974383|FG000|COMPLETED|Overall Study||15
3241455|NCT02427100|3974384|FG001|COMPLETED|Overall Study||15
3241456|NCT02427100|3974383|FG000|NOT COMPLETED|Overall Study||0
3241457|NCT02427100|3974384|FG001|NOT COMPLETED|Overall Study||2
3241458|NCT02427399|3974395|FG000|STARTED|Overall Study||220
3241459|NCT02427399|3974396|FG001|STARTED|Overall Study||220
3241460|NCT02427399|3974397|FG002|STARTED|Overall Study||220
3241461|NCT02427399|3974398|FG003|STARTED|Overall Study||220
3241462|NCT02427399|3974399|FG004|STARTED|Overall Study||220
3241463|NCT02427399|3974395|FG000|COMPLETED|Overall Study||206
3241464|NCT02427399|3974396|FG001|COMPLETED|Overall Study||204
3241465|NCT02427399|3974397|FG002|COMPLETED|Overall Study||208
3241466|NCT02427399|3974398|FG003|COMPLETED|Overall Study||202
3241467|NCT02427399|3974399|FG004|COMPLETED|Overall Study||205
3241468|NCT02427399|3974395|FG000|NOT COMPLETED|Overall Study||14
3241469|NCT02427399|3974396|FG001|NOT COMPLETED|Overall Study||16
3241470|NCT02427399|3974397|FG002|NOT COMPLETED|Overall Study||12
3241471|NCT02427399|3974398|FG003|NOT COMPLETED|Overall Study||18
3241472|NCT02427399|3974399|FG004|NOT COMPLETED|Overall Study||15
3241473|NCT02427477|3974413|FG000|STARTED|Period 1||60
3241474|NCT02427477|3974414|FG001|STARTED|Period 1||60
3241475|NCT02427477|3974413|FG000|COMPLETED|Period 1||59
3241476|NCT02427477|3974414|FG001|COMPLETED|Period 1||60
3241477|NCT02427477|3974413|FG000|NOT COMPLETED|Period 1||1
3241478|NCT02427477|3974414|FG001|NOT COMPLETED|Period 1||0
3241479|NCT02427477|3974413|FG000|STARTED|Period 2||59
3241480|NCT02427477|3974414|FG001|STARTED|Period 2||60
3241481|NCT02427477|3974413|FG000|COMPLETED|Period 2||59
3241482|NCT02427477|3974414|FG001|COMPLETED|Period 2||60
3241483|NCT02427477|3974413|FG000|NOT COMPLETED|Period 2||0
3241484|NCT02427477|3974414|FG001|NOT COMPLETED|Period 2||0
3241485|NCT02427477|3974413|FG000|STARTED|Period 3||59
3241486|NCT02427477|3974414|FG001|STARTED|Period 3||60
3241487|NCT02427477|3974413|FG000|COMPLETED|Period 3||59
3241488|NCT02427477|3974414|FG001|COMPLETED|Period 3||60
3241489|NCT02427477|3974413|FG000|NOT COMPLETED|Period 3||0
3241490|NCT02427477|3974414|FG001|NOT COMPLETED|Period 3||0
3241491|NCT02427607|3974420|FG000|STARTED|Overall Study||7
3241492|NCT02427607|3974420|FG000|COMPLETED|Overall Study||6
3241493|NCT02427607|3974420|FG000|NOT COMPLETED|Overall Study||1
3241494|NCT02427646|3974426|FG000|STARTED|Overall Study||24
3241495|NCT02427646|3974427|FG001|STARTED|Overall Study||28
3241496|NCT02427646|3974426|FG000|COMPLETED|Overall Study||16
3241497|NCT02427646|3974427|FG001|COMPLETED|Overall Study||14
3241498|NCT02427646|3974426|FG000|NOT COMPLETED|Overall Study||8
3241499|NCT02427646|3974427|FG001|NOT COMPLETED|Overall Study||14
3241500|NCT02427672|3974437|FG000|STARTED|Overall Study||40
3241501|NCT02427672|3974438|FG001|STARTED|Overall Study||44
3241502|NCT02427672|3974437|FG000|COMPLETED|Overall Study||39
3241503|NCT02427672|3974438|FG001|COMPLETED|Overall Study||42
3241504|NCT02427672|3974437|FG000|NOT COMPLETED|Overall Study||1
3241505|NCT02427672|3974438|FG001|NOT COMPLETED|Overall Study||2
3241506|NCT02427737|3974446|FG000|STARTED|OSU Baseline Q4FY15||4158
3241507|NCT02427737|3974447|FG001|STARTED|OSU Baseline Q4FY15||3446
3241508|NCT02427737|3974446|FG000|COMPLETED|OSU Baseline Q4FY15||3940
3241509|NCT02427737|3974447|FG001|COMPLETED|OSU Baseline Q4FY15||3230
3241510|NCT02427737|3974446|FG000|NOT COMPLETED|OSU Baseline Q4FY15||218
3241511|NCT02427737|3974447|FG001|NOT COMPLETED|OSU Baseline Q4FY15||216
3241512|NCT02427737|3974446|FG000|STARTED|OSU Q1FY16 (First Post-Training Quarter)||4030
3241513|NCT02427737|3974447|FG001|STARTED|OSU Q1FY16 (First Post-Training Quarter)||3246
3241514|NCT02427737|3974446|FG000|COMPLETED|OSU Q1FY16 (First Post-Training Quarter)||3815
3241515|NCT02427737|3974447|FG001|COMPLETED|OSU Q1FY16 (First Post-Training Quarter)||3032
3241516|NCT02427737|3974446|FG000|NOT COMPLETED|OSU Q1FY16 (First Post-Training Quarter)||215
3241517|NCT02427737|3974447|FG001|NOT COMPLETED|OSU Q1FY16 (First Post-Training Quarter)||214
3241518|NCT02427737|3974446|FG000|STARTED|OSU Q2FY16(Second Post Training Quarter)||4121
3241519|NCT02427737|3974447|FG001|STARTED|OSU Q2FY16(Second Post Training Quarter)||3070
3241520|NCT02427737|3974446|FG000|COMPLETED|OSU Q2FY16(Second Post Training Quarter)||3907
3241521|NCT02427737|3974447|FG001|COMPLETED|OSU Q2FY16(Second Post Training Quarter)||2857
3241522|NCT02427737|3974446|FG000|NOT COMPLETED|OSU Q2FY16(Second Post Training Quarter)||214
3241523|NCT02427737|3974447|FG001|NOT COMPLETED|OSU Q2FY16(Second Post Training Quarter)||213
3241524|NCT02427737|3974446|FG000|STARTED|OSU Q3FY16 (Third Post Training Quarter)||4148
3241525|NCT02427737|3974447|FG001|STARTED|OSU Q3FY16 (Third Post Training Quarter)||2931
3241526|NCT02427737|3974446|FG000|COMPLETED|OSU Q3FY16 (Third Post Training Quarter)||3928
3241527|NCT02427737|3974447|FG001|COMPLETED|OSU Q3FY16 (Third Post Training Quarter)||2716
3241528|NCT02427737|3974446|FG000|NOT COMPLETED|OSU Q3FY16 (Third Post Training Quarter)||220
3241529|NCT02427737|3974447|FG001|NOT COMPLETED|OSU Q3FY16 (Third Post Training Quarter)||215
3241530|NCT02427737|3974446|FG000|STARTED|Duke Pre- and Post-Training Groups|Note this is a pre-training to post-training comparison.|9658
3241531|NCT02427737|3974447|FG001|STARTED|Duke Pre- and Post-Training Groups|Note Control=Baseline|4446
3241532|NCT02427737|3974446|FG000|COMPLETED|Duke Pre- and Post-Training Groups||8879
3241533|NCT02427737|3974447|FG001|COMPLETED|Duke Pre- and Post-Training Groups||4051
3241534|NCT02427737|3974446|FG000|NOT COMPLETED|Duke Pre- and Post-Training Groups||779
3241535|NCT02427737|3974447|FG001|NOT COMPLETED|Duke Pre- and Post-Training Groups||395
3241536|NCT02427750|3974463|FG000|STARTED|Overall Study||63
3241537|NCT02427750|3974464|FG001|STARTED|Overall Study||63
3241538|NCT02427750|3974463|FG000|COMPLETED|Overall Study||63
3241539|NCT02427750|3974464|FG001|COMPLETED|Overall Study||63
3241540|NCT02427750|3974463|FG000|NOT COMPLETED|Overall Study||0
3241541|NCT02427750|3974464|FG001|NOT COMPLETED|Overall Study||0
3241542|NCT02427802|3974474|FG000|STARTED|Overall Study||305
3241543|NCT02427802|3974475|FG001|STARTED|Overall Study||154
3241544|NCT02427802|3974476|FG002|STARTED|Overall Study||153
3241545|NCT02427802|3974474|FG000|COMPLETED|Overall Study||246
3241546|NCT02427802|3974475|FG001|COMPLETED|Overall Study||120
3241547|NCT02427802|3974476|FG002|COMPLETED|Overall Study||110
3241548|NCT02427802|3974474|FG000|NOT COMPLETED|Overall Study||59
3241549|NCT02427802|3974475|FG001|NOT COMPLETED|Overall Study||34
3241550|NCT02427802|3974476|FG002|NOT COMPLETED|Overall Study||43
3241551|NCT02427841|3974484|FG000|STARTED|Overall Study||19
3241552|NCT02427841|3974484|FG000|COMPLETED|Overall Study||11
3241553|NCT02427841|3974484|FG000|NOT COMPLETED|Overall Study||8
3241554|NCT02427958|3974488|FG000|STARTED|Overall Study||307
3241555|NCT02427958|3974488|FG000|COMPLETED|Overall Study||283
3241556|NCT02427958|3974488|FG000|NOT COMPLETED|Overall Study||24
3241557|NCT02427984|3974495|FG000|STARTED|Overall Study||53
3241558|NCT02427984|3974496|FG001|STARTED|Overall Study||45
3241559|NCT02427984|3974497|FG002|STARTED|Overall Study||50
3241560|NCT02427984|3974495|FG000|COMPLETED|Overall Study||40
3241561|NCT02427984|3974496|FG001|COMPLETED|Overall Study||40
3241562|NCT02427984|3974497|FG002|COMPLETED|Overall Study||32
3241563|NCT02427984|3974495|FG000|NOT COMPLETED|Overall Study||13
3241564|NCT02427984|3974496|FG001|NOT COMPLETED|Overall Study||5
3241565|NCT02427984|3974497|FG002|NOT COMPLETED|Overall Study||18
3241566|NCT02428192|3974508|FG000|STARTED|Overall Study||12
3241567|NCT02428192|3974509|FG001|STARTED|Overall Study||8
3241568|NCT02428192|3974508|FG000|COMPLETED|Overall Study||0
3241569|NCT02428192|3974509|FG001|COMPLETED|Overall Study||7
3241570|NCT02428192|3974508|FG000|NOT COMPLETED|Overall Study||12
3241571|NCT02428192|3974509|FG001|NOT COMPLETED|Overall Study||1
3241572|NCT02428296|3974516|FG000|STARTED|Overall Study||39
3241573|NCT02428296|3974516|FG000|Treated|Overall Study||39
3241574|NCT02428296|3974516|FG000|COMPLETED|Overall Study|Number of participants who completed the full course of treatment.|30
3241575|NCT02428296|3974516|FG000|NOT COMPLETED|Overall Study||9
3241576|NCT02428309|3974523|FG000|STARTED|Overall Study||1
3241577|NCT02428309|3974523|FG000|COMPLETED|Overall Study|The enrolled participant completed treatment and was followed through week 152, per protocol.|1
3241578|NCT02428309|3974523|FG000|NOT COMPLETED|Overall Study||0
3241579|NCT02428413|3974530|FG000|STARTED|Overall Study||64
3241580|NCT02428413|3974531|FG001|STARTED|Overall Study||61
3241581|NCT02428413|3974530|FG000|COMPLETED|Overall Study||56
3241582|NCT02428413|3974531|FG001|COMPLETED|Overall Study||52
3241583|NCT02428413|3974530|FG000|NOT COMPLETED|Overall Study||8
3241584|NCT02428413|3974531|FG001|NOT COMPLETED|Overall Study||9
3241585|NCT02428478|3974537|FG000|STARTED|First Study Night||9
3241586|NCT02428478|3974538|FG001|STARTED|First Study Night||8
3241587|NCT02428478|3974537|FG000|COMPLETED|First Study Night||9
3241588|NCT02428478|3974538|FG001|COMPLETED|First Study Night||8
3241589|NCT02428478|3974537|FG000|NOT COMPLETED|First Study Night||0
3241590|NCT02428478|3974538|FG001|NOT COMPLETED|First Study Night||0
3241591|NCT02428478|3974537|FG000|STARTED|Second Study Night|1 participant did not return for the second study night|8
3241592|NCT02428478|3974538|FG001|STARTED|Second Study Night|2 participants did not return for the second study night|6
3241593|NCT02428478|3974537|FG000|COMPLETED|Second Study Night||8
3241594|NCT02428478|3974538|FG001|COMPLETED|Second Study Night||6
3241595|NCT02428478|3974537|FG000|NOT COMPLETED|Second Study Night||0
3241596|NCT02428478|3974538|FG001|NOT COMPLETED|Second Study Night||0
3241597|NCT02428595|3974544|FG000|STARTED|Fitting||137
3241598|NCT02428595|3974544|FG000|COMPLETED|Fitting||73
3241599|NCT02428595|3974544|FG000|NOT COMPLETED|Fitting||64
3241600|NCT02428595|3974544|FG000|STARTED|Treatment||73
3241601|NCT02428595|3974544|FG000|COMPLETED|Treatment||54
3241602|NCT02428595|3974544|FG000|NOT COMPLETED|Treatment||19
3241603|NCT02428608|3974557|FG000|STARTED|Overall Study||570
3241604|NCT02428608|3974557|FG000|COMPLETED|Overall Study||487
3241605|NCT02428608|3974557|FG000|NOT COMPLETED|Overall Study||83
3241606|NCT02428699|3974562|FG000|STARTED|Period 1||25
3241607|NCT02428699|3974563|FG001|STARTED|Period 1||25
3241608|NCT02428699|3974562|FG000|COMPLETED|Period 1||25
3241609|NCT02428699|3974563|FG001|COMPLETED|Period 1||25
3241610|NCT02428699|3974562|FG000|NOT COMPLETED|Period 1||0
3241611|NCT02428699|3974563|FG001|NOT COMPLETED|Period 1||0
3241612|NCT02428699|3974562|FG000|STARTED|Washout Period 1||25
3241613|NCT02428699|3974563|FG001|STARTED|Washout Period 1||25
3241614|NCT02428699|3974562|FG000|COMPLETED|Washout Period 1||24
3241615|NCT02428699|3974563|FG001|COMPLETED|Washout Period 1||23
3241616|NCT02428699|3974562|FG000|NOT COMPLETED|Washout Period 1||1
3241617|NCT02428699|3974563|FG001|NOT COMPLETED|Washout Period 1||2
3241618|NCT02428699|3974562|FG000|STARTED|Period 2||24
3241619|NCT02428699|3974563|FG001|STARTED|Period 2||23
3241620|NCT02428699|3974562|FG000|COMPLETED|Period 2||24
3241621|NCT02428699|3974563|FG001|COMPLETED|Period 2||23
3241622|NCT02428699|3974562|FG000|NOT COMPLETED|Period 2||0
3241623|NCT02428699|3974563|FG001|NOT COMPLETED|Period 2||0
3241624|NCT02428855|3974574|FG000|STARTED|Overall Study||8
3241625|NCT02428855|3974574|FG000|COMPLETED|Overall Study||6
3241626|NCT02428855|3974574|FG000|NOT COMPLETED|Overall Study||2
3241627|NCT02429115|3974584|FG000|STARTED|Overall Study||52
3241628|NCT02429115|3974585|FG001|STARTED|Overall Study||52
3241629|NCT02429115|3974586|FG002|STARTED|Overall Study||51
3241630|NCT02429115|3974587|FG003|STARTED|Overall Study||29
3241631|NCT02429115|3974588|FG004|STARTED|Overall Study||29
3241632|NCT02429115|3974589|FG005|STARTED|Overall Study||28
3241633|NCT02429115|3974584|FG000|COMPLETED|Overall Study||40
3241634|NCT02429115|3974585|FG001|COMPLETED|Overall Study||42
3241635|NCT02429115|3974586|FG002|COMPLETED|Overall Study||35
3241636|NCT02429115|3974587|FG003|COMPLETED|Overall Study||21
3241637|NCT02429115|3974588|FG004|COMPLETED|Overall Study||22
3241638|NCT02429115|3974589|FG005|COMPLETED|Overall Study||27
3241639|NCT02429115|3974584|FG000|NOT COMPLETED|Overall Study||12
3241640|NCT02429115|3974585|FG001|NOT COMPLETED|Overall Study||10
3241641|NCT02429115|3974586|FG002|NOT COMPLETED|Overall Study||16
3241642|NCT02429115|3974587|FG003|NOT COMPLETED|Overall Study||8
3241643|NCT02429115|3974588|FG004|NOT COMPLETED|Overall Study||7
3241644|NCT02429115|3974589|FG005|NOT COMPLETED|Overall Study||1
3241645|NCT02429258|3974605|FG000|STARTED|Overall Study||50
3241646|NCT02429258|3974606|FG001|STARTED|Overall Study||50
3241647|NCT02429258|3974605|FG000|COMPLETED|Overall Study||48
3241648|NCT02429258|3974606|FG001|COMPLETED|Overall Study||49
3241649|NCT02429258|3974605|FG000|NOT COMPLETED|Overall Study||2
3241650|NCT02429258|3974606|FG001|NOT COMPLETED|Overall Study||1
3241651|NCT02429310|3974614|FG000|STARTED|Overall Study||22
3241652|NCT02429310|3974615|FG001|STARTED|Overall Study||20
3241653|NCT02429310|3974614|FG000|COMPLETED|Overall Study||20
3241654|NCT02429310|3974615|FG001|COMPLETED|Overall Study||17
3241655|NCT02429310|3974614|FG000|NOT COMPLETED|Overall Study||2
3241656|NCT02429310|3974615|FG001|NOT COMPLETED|Overall Study||3
3370416|NCT03772522|4101793|FG001|STARTED|Pre-intervention||15
3370417|NCT03772522|4101792|FG000|COMPLETED|Pre-intervention||9
3370418|NCT03772522|4101793|FG001|COMPLETED|Pre-intervention||11
3370419|NCT03772522|4101792|FG000|NOT COMPLETED|Pre-intervention||3
3370420|NCT03772522|4101793|FG001|NOT COMPLETED|Pre-intervention||4
3370421|NCT03772522|4101792|FG000|STARTED|Intervention||9
3370422|NCT03772522|4101793|FG001|STARTED|Intervention||11
3370423|NCT03772522|4101792|FG000|COMPLETED|Intervention||8
3370424|NCT03772522|4101793|FG001|COMPLETED|Intervention||11
3370425|NCT03772522|4101792|FG000|NOT COMPLETED|Intervention||1
3370426|NCT03772522|4101793|FG001|NOT COMPLETED|Intervention||0
3370427|NCT03772522|4101792|FG000|STARTED|Post-intervention Follow-up||8
3370428|NCT03772522|4101793|FG001|STARTED|Post-intervention Follow-up||11
3370429|NCT03772522|4101792|FG000|COMPLETED|Post-intervention Follow-up||7
3370430|NCT03772522|4101793|FG001|COMPLETED|Post-intervention Follow-up||11
3370431|NCT03772522|4101792|FG000|NOT COMPLETED|Post-intervention Follow-up||1
3370432|NCT03772522|4101793|FG001|NOT COMPLETED|Post-intervention Follow-up||0
3370433|NCT03772327|4101805|FG000|STARTED|Overall Study||30
3370434|NCT03772327|4101806|FG001|STARTED|Overall Study||33
3370435|NCT03772327|4101805|FG000|Week 0 Visit|Overall Study|2 participants were lost to follow up after randomization prior to any study interventions.|28
3370436|NCT03772327|4101806|FG001|Week 0 Visit|Overall Study||33
3370437|NCT03772327|4101805|FG000|COMPLETED|Overall Study||25
3370438|NCT03772327|4101806|FG001|COMPLETED|Overall Study||26
3370439|NCT03772327|4101805|FG000|NOT COMPLETED|Overall Study||5
3370440|NCT03772327|4101806|FG001|NOT COMPLETED|Overall Study||7
3370441|NCT03777865|4101812|FG000|STARTED|Overall Study||100
3370442|NCT03777865|4101812|FG000|COMPLETED|Overall Study||100
3370443|NCT03777865|4101812|FG000|NOT COMPLETED|Overall Study||0
3370444|NCT03774576|4101816|FG000|STARTED|Period 1||14
3370445|NCT03774576|4101816|FG000|COMPLETED|Period 1||14
3370446|NCT03774576|4101816|FG000|NOT COMPLETED|Period 1||0
3370447|NCT03774576|4101816|FG000|STARTED|Period 2||14
3370448|NCT03774576|4101816|FG000|COMPLETED|Period 2||13
3370449|NCT03774576|4101816|FG000|NOT COMPLETED|Period 2||1
3370450|NCT03776539|4101829|FG000|STARTED|Overall Study||6
3370451|NCT03776539|4101830|FG001|STARTED|Overall Study||6
3370452|NCT03776539|4101831|FG002|STARTED|Overall Study||6
3370453|NCT03776539|4101832|FG003|STARTED|Overall Study||6
3370454|NCT03776539|4101829|FG000|COMPLETED|Overall Study||6
3370455|NCT03776539|4101830|FG001|COMPLETED|Overall Study||6
3370456|NCT03776539|4101831|FG002|COMPLETED|Overall Study||6
3370457|NCT03776539|4101832|FG003|COMPLETED|Overall Study||6
3241657|NCT02429427|3974623|FG000|STARTED|Overall Study||1763
3241658|NCT02429427|3974624|FG001|STARTED|Overall Study||876
3241659|NCT02429427|3974623|FG000|COMPLETED|Overall Study||1392
3241660|NCT02429427|3974624|FG001|COMPLETED|Overall Study||697
3241661|NCT02429427|3974623|FG000|NOT COMPLETED|Overall Study||371
3241662|NCT02429427|3974624|FG001|NOT COMPLETED|Overall Study||179
3241663|NCT02429778|3974632|FG000|STARTED|Overall Study||20
3241664|NCT02429778|3974633|FG001|STARTED|Overall Study||20
3241665|NCT02429778|3974632|FG000|COMPLETED|Overall Study||13
3241666|NCT02429778|3974633|FG001|COMPLETED|Overall Study||20
3241667|NCT02429778|3974632|FG000|NOT COMPLETED|Overall Study||7
3241668|NCT02429778|3974633|FG001|NOT COMPLETED|Overall Study||0
3241669|NCT02429856|3974641|FG000|STARTED|Overall Study||49
3241670|NCT02429856|3974642|FG001|STARTED|Overall Study||51
3241671|NCT02429856|3974641|FG000|COMPLETED|Overall Study||30
3241672|NCT02429856|3974642|FG001|COMPLETED|Overall Study||32
3241673|NCT02429856|3974641|FG000|NOT COMPLETED|Overall Study||19
3241674|NCT02429856|3974642|FG001|NOT COMPLETED|Overall Study||19
3241675|NCT02429869|3974650|FG000|STARTED|Overall Study||10
3241676|NCT02429869|3974650|FG000|COMPLETED|Overall Study||10
3241677|NCT02429869|3974650|FG000|NOT COMPLETED|Overall Study||0
3241678|NCT02429934|3974656|FG000|STARTED|Overall Study||15
3241679|NCT02429934|3974657|FG001|STARTED|Overall Study||13
3241680|NCT02429934|3974656|FG000|COMPLETED|Overall Study||11
3241681|NCT02429934|3974657|FG001|COMPLETED|Overall Study||10
3241682|NCT02429934|3974656|FG000|NOT COMPLETED|Overall Study||4
3241683|NCT02429934|3974657|FG001|NOT COMPLETED|Overall Study||3
3241684|NCT02430090|3974668|FG000|STARTED|Overall Study||15
3241685|NCT02430090|3974669|FG001|STARTED|Overall Study||15
3241686|NCT02430090|3974670|FG002|STARTED|Overall Study||15
3241687|NCT02430090|3974668|FG000|COMPLETED|Overall Study||15
3241688|NCT02430090|3974669|FG001|COMPLETED|Overall Study||15
3241689|NCT02430090|3974670|FG002|COMPLETED|Overall Study||15
3241690|NCT02430090|3974668|FG000|NOT COMPLETED|Overall Study||0
3241691|NCT02430090|3974669|FG001|NOT COMPLETED|Overall Study||0
3241692|NCT02430090|3974670|FG002|NOT COMPLETED|Overall Study||0
3241693|NCT02430311|3974680|FG000|STARTED|Part A||20
3241694|NCT02430311|3974681|FG001|STARTED|Part A||16
3241695|NCT02430311|3974680|FG000|Received Olaparib|Part A||20
3241696|NCT02430311|3974681|FG001|Received Olaparib|Part A||16
3241697|NCT02430311|3974680|FG000|Received Paclitaxel|Part A|Cohort 1 patients are planned to receive olaparib monotherapy|0
3241698|NCT02430311|3974681|FG001|Received Paclitaxel|Part A||16
3241699|NCT02430311|3974680|FG000|COMPLETED|Part A||19
3241700|NCT02430311|3974681|FG001|COMPLETED|Part A||15
3241701|NCT02430311|3974680|FG000|NOT COMPLETED|Part A||1
3241702|NCT02430311|3974681|FG001|NOT COMPLETED|Part A||1
3241703|NCT02430311|3974680|FG000|STARTED|Part B||19
3241704|NCT02430311|3974681|FG001|STARTED|Part B||15
3241705|NCT02430311|3974680|FG000|Received Olaparib|Part B||19
3241706|NCT02430311|3974681|FG001|Received Olaparib|Part B||15
3241707|NCT02430311|3974680|FG000|Received Paclitaxel|Part B|Cohort 1 patients are planned to receive olaparib monotherapy|0
3241708|NCT02430311|3974681|FG001|Received Paclitaxel|Part B||14
3241709|NCT02430311|3974680|FG000|COMPLETED|Part B||9
3241710|NCT02430311|3974681|FG001|COMPLETED|Part B||7
3241711|NCT02430311|3974680|FG000|NOT COMPLETED|Part B||10
3241712|NCT02430311|3974681|FG001|NOT COMPLETED|Part B||8
3241713|NCT02430337|3974698|FG000|STARTED|Overall Study||11
3241714|NCT02430337|3974699|FG001|STARTED|Overall Study||20
3241715|NCT02430337|3974698|FG000|COMPLETED|Overall Study||11
3241716|NCT02430337|3974699|FG001|COMPLETED|Overall Study||20
3241717|NCT02430337|3974698|FG000|NOT COMPLETED|Overall Study||0
3241718|NCT02430337|3974699|FG001|NOT COMPLETED|Overall Study||0
3241719|NCT02430389|3974709|FG000|STARTED|Overall Study||10
3241720|NCT02430389|3974710|FG001|STARTED|Overall Study||10
3241721|NCT02430389|3974709|FG000|COMPLETED|Overall Study||10
3241722|NCT02430389|3974710|FG001|COMPLETED|Overall Study||10
3241723|NCT02430389|3974709|FG000|NOT COMPLETED|Overall Study||0
3241724|NCT02430389|3974710|FG001|NOT COMPLETED|Overall Study||0
3241725|NCT02430480|3974718|FG000|STARTED|Overall Study||39
3241726|NCT02430480|3974718|FG000|COMPLETED|Overall Study||36
3241727|NCT02430480|3974718|FG000|NOT COMPLETED|Overall Study||3
3241728|NCT02430818|3974727|FG000|STARTED|Overall Study||7
3241729|NCT02430818|3974728|FG001|STARTED|Overall Study||6
3241730|NCT02430818|3974727|FG000|COMPLETED|Overall Study||7
3241731|NCT02430818|3974728|FG001|COMPLETED|Overall Study||6
3241732|NCT02430818|3974727|FG000|NOT COMPLETED|Overall Study||0
3241733|NCT02430818|3974728|FG001|NOT COMPLETED|Overall Study||0
3241734|NCT02430870|3974746|FG000|STARTED|Part 1||6
3241735|NCT02430870|3974747|FG001|STARTED|Part 1||6
3241736|NCT02430870|3974748|FG002|STARTED|Part 1||4
3241737|NCT02430870|3974749|FG003|STARTED|Part 1||0
3241738|NCT02430870|3974750|FG004|STARTED|Part 1||0
3241739|NCT02430870|3974751|FG005|STARTED|Part 1||0
3241740|NCT02430870|3974752|FG006|STARTED|Part 1||0
3241741|NCT02430870|3974753|FG007|STARTED|Part 1||0
3241742|NCT02430870|3974746|FG000|COMPLETED|Part 1||6
3241743|NCT02430870|3974747|FG001|COMPLETED|Part 1||6
3241744|NCT02430870|3974748|FG002|COMPLETED|Part 1||4
3241745|NCT02430870|3974749|FG003|COMPLETED|Part 1||0
3241746|NCT02430870|3974750|FG004|COMPLETED|Part 1||0
3241747|NCT02430870|3974751|FG005|COMPLETED|Part 1||0
3241748|NCT02430870|3974752|FG006|COMPLETED|Part 1||0
3241749|NCT02430870|3974753|FG007|COMPLETED|Part 1||0
3241750|NCT02430870|3974746|FG000|NOT COMPLETED|Part 1||0
3241751|NCT02430870|3974747|FG001|NOT COMPLETED|Part 1||0
3241752|NCT02430870|3974748|FG002|NOT COMPLETED|Part 1||0
3241753|NCT02430870|3974749|FG003|NOT COMPLETED|Part 1||0
3241754|NCT02430870|3974750|FG004|NOT COMPLETED|Part 1||0
3241755|NCT02430870|3974751|FG005|NOT COMPLETED|Part 1||0
3241756|NCT02430870|3974752|FG006|NOT COMPLETED|Part 1||0
3241757|NCT02430870|3974753|FG007|NOT COMPLETED|Part 1||0
3241758|NCT02430870|3974746|FG000|STARTED|Part 2||0
3241759|NCT02430870|3974747|FG001|STARTED|Part 2||0
3241760|NCT02430870|3974748|FG002|STARTED|Part 2||0
3241761|NCT02430870|3974749|FG003|STARTED|Part 2||6
3241762|NCT02430870|3974750|FG004|STARTED|Part 2||6
3241763|NCT02430870|3974751|FG005|STARTED|Part 2||6
3241764|NCT02430870|3974752|FG006|STARTED|Part 2||6
3241765|NCT02430870|3974753|FG007|STARTED|Part 2||8
3241766|NCT02430870|3974746|FG000|COMPLETED|Part 2||0
3241767|NCT02430870|3974747|FG001|COMPLETED|Part 2||0
3241768|NCT02430870|3974748|FG002|COMPLETED|Part 2||0
3241769|NCT02430870|3974749|FG003|COMPLETED|Part 2||6
3241770|NCT02430870|3974750|FG004|COMPLETED|Part 2||6
3241771|NCT02430870|3974751|FG005|COMPLETED|Part 2||6
3241772|NCT02430870|3974752|FG006|COMPLETED|Part 2||5
3241773|NCT02430870|3974753|FG007|COMPLETED|Part 2||7
3241774|NCT02430870|3974746|FG000|NOT COMPLETED|Part 2||0
3241775|NCT02430870|3974747|FG001|NOT COMPLETED|Part 2||0
3241776|NCT02430870|3974748|FG002|NOT COMPLETED|Part 2||0
3241777|NCT02430870|3974749|FG003|NOT COMPLETED|Part 2||0
3241778|NCT02430870|3974750|FG004|NOT COMPLETED|Part 2||0
3241779|NCT02430870|3974751|FG005|NOT COMPLETED|Part 2||0
3241780|NCT02430870|3974752|FG006|NOT COMPLETED|Part 2||1
3241781|NCT02430870|3974753|FG007|NOT COMPLETED|Part 2||1
3241782|NCT02431052|3974776|FG000|STARTED|Overall Study||53
3241783|NCT02431052|3974777|FG001|STARTED|Overall Study||50
3241784|NCT02431052|3974778|FG002|STARTED|Overall Study||106
3241785|NCT02431052|3974779|FG003|STARTED|Overall Study||110
3241786|NCT02431052|3974780|FG004|STARTED|Overall Study||101
3241787|NCT02431052|3974776|FG000|COMPLETED|Overall Study||42
3241788|NCT02431052|3974777|FG001|COMPLETED|Overall Study||46
3241789|NCT02431052|3974778|FG002|COMPLETED|Overall Study||94
3241790|NCT02431052|3974779|FG003|COMPLETED|Overall Study||94
3241791|NCT02431052|3974780|FG004|COMPLETED|Overall Study||86
3241792|NCT02431052|3974776|FG000|NOT COMPLETED|Overall Study||11
3241793|NCT02431052|3974777|FG001|NOT COMPLETED|Overall Study||4
3241794|NCT02431052|3974778|FG002|NOT COMPLETED|Overall Study||12
3241795|NCT02431052|3974779|FG003|NOT COMPLETED|Overall Study||16
3241796|NCT02431052|3974780|FG004|NOT COMPLETED|Overall Study||15
3241797|NCT02431260|3974811|FG000|STARTED|Overall Study||4
3241798|NCT02431260|3974812|FG001|STARTED|Overall Study||5
3241799|NCT02431260|3974813|FG002|STARTED|Overall Study||6
3241800|NCT02431260|3974814|FG003|STARTED|Overall Study||5
3241801|NCT02431260|3974815|FG004|STARTED|Overall Study||3
3241802|NCT02431260|3974816|FG005|STARTED|Overall Study||4
3241803|NCT02431260|3974817|FG006|STARTED|Overall Study||4
3241804|NCT02431260|3974818|FG007|STARTED|Overall Study||3
3241805|NCT02431260|3974819|FG008|STARTED|Overall Study||8
3241806|NCT02431260|3974820|FG009|STARTED|Overall Study||8
3241807|NCT02431260|3974821|FG010|STARTED|Overall Study||4
3241808|NCT02431260|3974822|FG011|STARTED|Overall Study||4
3241809|NCT02431260|3974823|FG012|STARTED|Overall Study||10
3241810|NCT02431260|3974824|FG013|STARTED|Overall Study||1
3241811|NCT02431260|3974811|FG000|COMPLETED|Overall Study||0
3241812|NCT02431260|3974812|FG001|COMPLETED|Overall Study||0
3241813|NCT02431260|3974813|FG002|COMPLETED|Overall Study||0
3241814|NCT02431260|3974814|FG003|COMPLETED|Overall Study||0
3241815|NCT02431260|3974815|FG004|COMPLETED|Overall Study||0
3241816|NCT02431260|3974816|FG005|COMPLETED|Overall Study||0
3241817|NCT02431260|3974817|FG006|COMPLETED|Overall Study||0
3241818|NCT02431260|3974818|FG007|COMPLETED|Overall Study||0
3241819|NCT02431260|3974819|FG008|COMPLETED|Overall Study||0
3241820|NCT02431260|3974820|FG009|COMPLETED|Overall Study||0
3241821|NCT02431260|3974821|FG010|COMPLETED|Overall Study||0
3241822|NCT02431260|3974822|FG011|COMPLETED|Overall Study||0
3241823|NCT02431260|3974823|FG012|COMPLETED|Overall Study||0
3241824|NCT02431260|3974824|FG013|COMPLETED|Overall Study||0
3241825|NCT02431260|3974811|FG000|NOT COMPLETED|Overall Study||4
3241826|NCT02431260|3974812|FG001|NOT COMPLETED|Overall Study||5
3241827|NCT02431260|3974813|FG002|NOT COMPLETED|Overall Study||6
3241828|NCT02431260|3974814|FG003|NOT COMPLETED|Overall Study||5
3241829|NCT02431260|3974815|FG004|NOT COMPLETED|Overall Study||3
3241830|NCT02431260|3974816|FG005|NOT COMPLETED|Overall Study||4
3241831|NCT02431260|3974817|FG006|NOT COMPLETED|Overall Study||4
3241832|NCT02431260|3974818|FG007|NOT COMPLETED|Overall Study||3
3241833|NCT02431260|3974819|FG008|NOT COMPLETED|Overall Study||8
3241834|NCT02431260|3974820|FG009|NOT COMPLETED|Overall Study||8
3241835|NCT02431260|3974821|FG010|NOT COMPLETED|Overall Study||4
3241836|NCT02431260|3974822|FG011|NOT COMPLETED|Overall Study||4
3241837|NCT02431260|3974823|FG012|NOT COMPLETED|Overall Study||10
3241838|NCT02431260|3974824|FG013|NOT COMPLETED|Overall Study||1
3241839|NCT02431273|3974867|FG000|STARTED|TDF (Single IVR)||6
3241840|NCT02431273|3974867|FG000|COMPLETED|TDF (Single IVR)||6
3241841|NCT02431273|3974867|FG000|NOT COMPLETED|TDF (Single IVR)||0
3241842|NCT02431273|3974867|FG000|STARTED|TDF-FTC (Dual IVR)||6
3241843|NCT02431273|3974867|FG000|COMPLETED|TDF-FTC (Dual IVR)||6
3241844|NCT02431273|3974867|FG000|NOT COMPLETED|TDF-FTC (Dual IVR)||0
3241845|NCT02431273|3974867|FG000|STARTED|TDF-FTC-MVC (Triple IVR)||6
3241846|NCT02431273|3974867|FG000|COMPLETED|TDF-FTC-MVC (Triple IVR)||6
3241847|NCT02431273|3974867|FG000|NOT COMPLETED|TDF-FTC-MVC (Triple IVR)||0
3241848|NCT02431299|3974877|FG000|STARTED|Overall Study||236
3241849|NCT02431299|3974878|FG001|STARTED|Overall Study||63
3241850|NCT02431299|3974877|FG000|COMPLETED|Overall Study||183
3241851|NCT02431299|3974878|FG001|COMPLETED|Overall Study||62
3241852|NCT02431299|3974877|FG000|NOT COMPLETED|Overall Study||53
3241853|NCT02431299|3974878|FG001|NOT COMPLETED|Overall Study||1
3241854|NCT02431364|3974889|FG000|STARTED|Overall Study||8
3241855|NCT02431364|3974890|FG001|STARTED|Overall Study||6
3241856|NCT02431364|3974891|FG002|STARTED|Overall Study||6
3241857|NCT02431364|3974892|FG003|STARTED|Overall Study||7
3241858|NCT02431364|3974893|FG004|STARTED|Overall Study||6
3241859|NCT02431364|3974889|FG000|Treated|Overall Study||8
3241860|NCT02431364|3974890|FG001|Treated|Overall Study||6
3241861|NCT02431364|3974891|FG002|Treated|Overall Study||6
3241862|NCT02431364|3974892|FG003|Treated|Overall Study||6
3241863|NCT02431364|3974893|FG004|Treated|Overall Study||6
3241864|NCT02431364|3974889|FG000|COMPLETED|Overall Study||8
3241865|NCT02431364|3974890|FG001|COMPLETED|Overall Study||5
3241866|NCT02431364|3974891|FG002|COMPLETED|Overall Study||6
3241867|NCT02431364|3974892|FG003|COMPLETED|Overall Study||6
3241868|NCT02431364|3974893|FG004|COMPLETED|Overall Study||6
3241869|NCT02431364|3974889|FG000|NOT COMPLETED|Overall Study||0
3241870|NCT02431364|3974890|FG001|NOT COMPLETED|Overall Study||1
3241871|NCT02431364|3974891|FG002|NOT COMPLETED|Overall Study||0
3241872|NCT02431364|3974892|FG003|NOT COMPLETED|Overall Study||1
3241873|NCT02431364|3974893|FG004|NOT COMPLETED|Overall Study||0
3241874|NCT02431455|3974911|FG000|STARTED|Overall Study||112
3241875|NCT02431455|3974912|FG001|STARTED|Overall Study||112
3241876|NCT02431455|3974911|FG000|COMPLETED|Overall Study||112
3241877|NCT02431455|3974912|FG001|COMPLETED|Overall Study||112
3241878|NCT02431455|3974911|FG000|NOT COMPLETED|Overall Study||0
3241879|NCT02431455|3974912|FG001|NOT COMPLETED|Overall Study||0
3241880|NCT02431468|3974921|FG000|STARTED|Overall Study||46
3241881|NCT02431468|3974922|FG001|STARTED|Overall Study||47
3241882|NCT02431468|3974923|FG002|STARTED|Overall Study||48
3241883|NCT02431468|3974921|FG000|COMPLETED|Overall Study||38
3241884|NCT02431468|3974922|FG001|COMPLETED|Overall Study||29
3241885|NCT02431468|3974923|FG002|COMPLETED|Overall Study||39
3241886|NCT02431468|3974921|FG000|NOT COMPLETED|Overall Study||8
3241887|NCT02431468|3974922|FG001|NOT COMPLETED|Overall Study||18
3241888|NCT02431468|3974923|FG002|NOT COMPLETED|Overall Study||9
3241889|NCT02431533|3974939|FG000|STARTED|Overall Study||25
3241890|NCT02431533|3974940|FG001|STARTED|Overall Study||25
3241891|NCT02431533|3974939|FG000|COMPLETED|Overall Study||23
3241892|NCT02431533|3974940|FG001|COMPLETED|Overall Study||22
3241893|NCT02431533|3974939|FG000|NOT COMPLETED|Overall Study||2
3241894|NCT02431533|3974940|FG001|NOT COMPLETED|Overall Study||3
3241895|NCT02431559|3974950|FG000|STARTED|Overall Study||3
3241896|NCT02431559|3974951|FG001|STARTED|Overall Study||4
3241897|NCT02431559|3974952|FG002|STARTED|Overall Study||6
3241898|NCT02431559|3974953|FG003|STARTED|Overall Study||40
3241899|NCT02431559|3974950|FG000|COMPLETED|Overall Study||1
3241900|NCT02431559|3974951|FG001|COMPLETED|Overall Study||1
3241901|NCT02431559|3974952|FG002|COMPLETED|Overall Study||2
3241902|NCT02431559|3974953|FG003|COMPLETED|Overall Study||9
3241903|NCT02431559|3974950|FG000|NOT COMPLETED|Overall Study||2
3241904|NCT02431559|3974951|FG001|NOT COMPLETED|Overall Study||3
3241905|NCT02431559|3974952|FG002|NOT COMPLETED|Overall Study||4
3241906|NCT02431559|3974953|FG003|NOT COMPLETED|Overall Study||31
3241907|NCT02431572|3974966|FG000|STARTED|Overall Study||1
3241908|NCT02431572|3974967|FG001|STARTED|Overall Study||1
3241909|NCT02431572|3974968|FG002|STARTED|Overall Study||9
3241910|NCT02431572|3974966|FG000|COMPLETED|Overall Study||0
3241911|NCT02431572|3974967|FG001|COMPLETED|Overall Study||1
3241912|NCT02431572|3974968|FG002|COMPLETED|Overall Study||9
3241913|NCT02431572|3974966|FG000|NOT COMPLETED|Overall Study||1
3241914|NCT02431572|3974967|FG001|NOT COMPLETED|Overall Study||0
3241915|NCT02431572|3974968|FG002|NOT COMPLETED|Overall Study||0
3241916|NCT02431598|3974976|FG000|STARTED|Overall Study||6
3241917|NCT02431598|3974977|FG001|STARTED|Overall Study||9
3241918|NCT02431598|3974978|FG002|STARTED|Overall Study||9
3241919|NCT02431598|3974979|FG003|STARTED|Overall Study||7
3241920|NCT02431598|3974980|FG004|STARTED|Overall Study||7
3241921|NCT02431598|3974981|FG005|STARTED|Overall Study||6
3241922|NCT02431598|3974976|FG000|COMPLETED|Overall Study||6
3241923|NCT02431598|3974977|FG001|COMPLETED|Overall Study||9
3241924|NCT02431598|3974978|FG002|COMPLETED|Overall Study||9
3241925|NCT02431598|3974979|FG003|COMPLETED|Overall Study||7
3241926|NCT02431598|3974980|FG004|COMPLETED|Overall Study||7
3241927|NCT02431598|3974981|FG005|COMPLETED|Overall Study||6
3241928|NCT02431598|3974976|FG000|NOT COMPLETED|Overall Study||0
3241929|NCT02431598|3974977|FG001|NOT COMPLETED|Overall Study||0
3241930|NCT02431598|3974978|FG002|NOT COMPLETED|Overall Study||0
3241931|NCT02431598|3974979|FG003|NOT COMPLETED|Overall Study||0
3241932|NCT02431598|3974980|FG004|NOT COMPLETED|Overall Study||0
3241933|NCT02431598|3974981|FG005|NOT COMPLETED|Overall Study||0
3241934|NCT02431637|3974998|FG000|STARTED|Overall Study||6
3241935|NCT02431637|3974998|FG000|COMPLETED|Overall Study||6
3241936|NCT02431637|3974998|FG000|NOT COMPLETED|Overall Study||0
3241937|NCT02431650|3975004|FG000|STARTED|Overall Study||5
3241938|NCT02431650|3975005|FG001|STARTED|Overall Study||6
3241939|NCT02431650|3975004|FG000|COMPLETED|Overall Study||5
3241940|NCT02431650|3975005|FG001|COMPLETED|Overall Study||6
3241941|NCT02431650|3975004|FG000|NOT COMPLETED|Overall Study||0
3241942|NCT02431650|3975005|FG001|NOT COMPLETED|Overall Study||0
3241943|NCT02431676|3975014|FG000|STARTED|Overall Study||40
3241944|NCT02431676|3975015|FG001|STARTED|Overall Study||39
3241945|NCT02431676|3975016|FG002|STARTED|Overall Study||42
3241946|NCT02431676|3975014|FG000|COMPLETED|Overall Study||40
3241947|NCT02431676|3975015|FG001|COMPLETED|Overall Study||38
3241948|NCT02431676|3975016|FG002|COMPLETED|Overall Study||40
3241949|NCT02431676|3975014|FG000|NOT COMPLETED|Overall Study||0
3241950|NCT02431676|3975015|FG001|NOT COMPLETED|Overall Study||1
3241951|NCT02431676|3975016|FG002|NOT COMPLETED|Overall Study||2
3241952|NCT02431741|3975024|FG000|STARTED|Overall Study||14
3241953|NCT02431741|3975024|FG000|COMPLETED|Overall Study||14
3241954|NCT02431741|3975024|FG000|NOT COMPLETED|Overall Study||0
3241955|NCT02431754|3975030|FG000|STARTED|Period 1 (8 Weeks)||85
3241956|NCT02431754|3975031|FG001|STARTED|Period 1 (8 Weeks)||86
3241957|NCT02431754|3975030|FG000|Received at Least One Dose of Study Drug|Period 1 (8 Weeks)||85
3241958|NCT02431754|3975031|FG001|Received at Least One Dose of Study Drug|Period 1 (8 Weeks)||86
3241959|NCT02431754|3975030|FG000|COMPLETED|Period 1 (8 Weeks)||79
3241960|NCT02431754|3975031|FG001|COMPLETED|Period 1 (8 Weeks)||82
3241961|NCT02431754|3975030|FG000|NOT COMPLETED|Period 1 (8 Weeks)||6
3241962|NCT02431754|3975031|FG001|NOT COMPLETED|Period 1 (8 Weeks)||4
3241963|NCT02431754|3975030|FG000|STARTED|Wash-out Period (4 Weeks)||79
3241964|NCT02431754|3975031|FG001|STARTED|Wash-out Period (4 Weeks)||82
3241965|NCT02431754|3975030|FG000|COMPLETED|Wash-out Period (4 Weeks)||75
3241966|NCT02431754|3975031|FG001|COMPLETED|Wash-out Period (4 Weeks)||82
3241967|NCT02431754|3975030|FG000|NOT COMPLETED|Wash-out Period (4 Weeks)||4
3241968|NCT02431754|3975031|FG001|NOT COMPLETED|Wash-out Period (4 Weeks)||0
3241969|NCT02431754|3975030|FG000|STARTED|Period 2 (8 Weeks)||75
3241970|NCT02431754|3975031|FG001|STARTED|Period 2 (8 Weeks)||82
3241971|NCT02431754|3975030|FG000|COMPLETED|Period 2 (8 Weeks)||74
3241972|NCT02431754|3975031|FG001|COMPLETED|Period 2 (8 Weeks)||78
3241973|NCT02431754|3975030|FG000|NOT COMPLETED|Period 2 (8 Weeks)||1
3241974|NCT02431754|3975031|FG001|NOT COMPLETED|Period 2 (8 Weeks)||4
3241975|NCT02431793|3975042|FG000|STARTED|Overall Study||202
3241976|NCT02431793|3975043|FG001|STARTED|Overall Study||243
3241977|NCT02431793|3975044|FG002|STARTED|Overall Study||207
3241978|NCT02431793|3975042|FG000|Completed T1 (3-5 Days Post Enrollment)|Overall Study||136
3241979|NCT02431793|3975043|FG001|Completed T1 (3-5 Days Post Enrollment)|Overall Study||180
3241980|NCT02431793|3975044|FG002|Completed T1 (3-5 Days Post Enrollment)|Overall Study||143
3241981|NCT02431793|3975042|FG000|Completed T2 (7-14 Days Post Enrollment)|Overall Study||95
3241982|NCT02431793|3975043|FG001|Completed T2 (7-14 Days Post Enrollment)|Overall Study||141
3241983|NCT02431793|3975044|FG002|Completed T2 (7-14 Days Post Enrollment)|Overall Study||107
3241984|NCT02431793|3975042|FG000|Completed T3 (30 Days Post Enrollment)|Overall Study||85
3241985|NCT02431793|3975043|FG001|Completed T3 (30 Days Post Enrollment)|Overall Study||113
3241986|NCT02431793|3975044|FG002|Completed T3 (30 Days Post Enrollment)|Overall Study||93
3241987|NCT02431793|3975042|FG000|COMPLETED|Overall Study||83
3241988|NCT02431793|3975043|FG001|COMPLETED|Overall Study||109
3241989|NCT02431793|3975044|FG002|COMPLETED|Overall Study||90
3241990|NCT02431793|3975042|FG000|NOT COMPLETED|Overall Study||119
3241991|NCT02431793|3975043|FG001|NOT COMPLETED|Overall Study||134
3241992|NCT02431793|3975044|FG002|NOT COMPLETED|Overall Study||117
3241993|NCT02431806|3975056|FG000|STARTED|Double-blind Treatment Period||142
3241994|NCT02431806|3975057|FG001|STARTED|Double-blind Treatment Period||136
3241995|NCT02431806|3975058|FG002|STARTED|Double-blind Treatment Period||139
3241996|NCT02431806|3975059|FG003|STARTED|Double-blind Treatment Period||135
3241997|NCT02431806|3975056|FG000|Safety Population|Double-blind Treatment Period||141
3241998|NCT02431806|3975057|FG001|Safety Population|Double-blind Treatment Period||134
3241999|NCT02431806|3975058|FG002|Safety Population|Double-blind Treatment Period||138
3242000|NCT02431806|3975059|FG003|Safety Population|Double-blind Treatment Period||134
3370458|NCT03776539|4101829|FG000|NOT COMPLETED|Overall Study||0
3370459|NCT03776539|4101830|FG001|NOT COMPLETED|Overall Study||0
3370460|NCT03776539|4101831|FG002|NOT COMPLETED|Overall Study||0
3370461|NCT03776539|4101832|FG003|NOT COMPLETED|Overall Study||0
3370462|NCT03772041|4101844|FG000|STARTED|Overall Study||149
3370463|NCT03772041|4101845|FG001|STARTED|Overall Study||145
3370464|NCT03772041|4101844|FG000|COMPLETED|Overall Study||135
3370465|NCT03772041|4101845|FG001|COMPLETED|Overall Study||135
3370466|NCT03772041|4101844|FG000|NOT COMPLETED|Overall Study||14
3370467|NCT03772041|4101845|FG001|NOT COMPLETED|Overall Study||10
3370468|NCT03775681|4101851|FG000|STARTED|Overall Study||33
3370469|NCT03775681|4101851|FG000|COMPLETED|Overall Study||30
3370470|NCT03775681|4101851|FG000|NOT COMPLETED|Overall Study||3
3370471|NCT03774823|4101857|FG000|STARTED|Overall Study||5
3370472|NCT03774823|4101858|FG001|STARTED|Overall Study||5
3370473|NCT03774823|4101857|FG000|COMPLETED|Overall Study||4
3370474|NCT03774823|4101858|FG001|COMPLETED|Overall Study||4
3370475|NCT03774823|4101857|FG000|NOT COMPLETED|Overall Study||1
3370476|NCT03774823|4101858|FG001|NOT COMPLETED|Overall Study||1
3370477|NCT03774745|4101866|FG000|STARTED|Overall Study||6
3370478|NCT03774745|4101867|FG001|STARTED|Overall Study||6
3370479|NCT03774745|4101866|FG000|Follow-Up 1|Overall Study||5
3370480|NCT03774745|4101867|FG001|Follow-Up 1|Overall Study||6
3370481|NCT03774745|4101866|FG000|Follow-up 2|Overall Study||4
3242001|NCT02431806|3975056|FG000|COMPLETED|Double-blind Treatment Period||117
3370482|NCT03774745|4101867|FG001|Follow-up 2|Overall Study||2
3370483|NCT03774745|4101866|FG000|COMPLETED|Overall Study||4
3370484|NCT03774745|4101867|FG001|COMPLETED|Overall Study||2
3242002|NCT02431806|3975057|FG001|COMPLETED|Double-blind Treatment Period||115
3242003|NCT02431806|3975058|FG002|COMPLETED|Double-blind Treatment Period||107
3242004|NCT02431806|3975059|FG003|COMPLETED|Double-blind Treatment Period||109
3242005|NCT02431806|3975056|FG000|NOT COMPLETED|Double-blind Treatment Period||25
3242006|NCT02431806|3975057|FG001|NOT COMPLETED|Double-blind Treatment Period||21
3242007|NCT02431806|3975058|FG002|NOT COMPLETED|Double-blind Treatment Period||32
3242008|NCT02431806|3975059|FG003|NOT COMPLETED|Double-blind Treatment Period||26
3242009|NCT02431806|3975056|FG000|STARTED|Double-blind Down-taper Period||111
3242010|NCT02431806|3975057|FG001|STARTED|Double-blind Down-taper Period||109
3242011|NCT02431806|3975058|FG002|STARTED|Double-blind Down-taper Period||104
3242012|NCT02431806|3975059|FG003|STARTED|Double-blind Down-taper Period||107
3242013|NCT02431806|3975056|FG000|COMPLETED|Double-blind Down-taper Period||111
3242014|NCT02431806|3975057|FG001|COMPLETED|Double-blind Down-taper Period||109
3242015|NCT02431806|3975058|FG002|COMPLETED|Double-blind Down-taper Period||104
3242016|NCT02431806|3975059|FG003|COMPLETED|Double-blind Down-taper Period||107
3242017|NCT02431806|3975056|FG000|NOT COMPLETED|Double-blind Down-taper Period||0
3242018|NCT02431806|3975057|FG001|NOT COMPLETED|Double-blind Down-taper Period||0
3242019|NCT02431806|3975058|FG002|NOT COMPLETED|Double-blind Down-taper Period||0
3242020|NCT02431806|3975059|FG003|NOT COMPLETED|Double-blind Down-taper Period||0
3242021|NCT02432040|3975071|FG000|STARTED|Overall Study||14
3242022|NCT02432040|3975072|FG001|STARTED|Overall Study||14
3242023|NCT02432040|3975071|FG000|COMPLETED|Overall Study||6
3242024|NCT02432040|3975072|FG001|COMPLETED|Overall Study||8
3242025|NCT02432040|3975071|FG000|NOT COMPLETED|Overall Study||8
3242026|NCT02432040|3975072|FG001|NOT COMPLETED|Overall Study||6
3242027|NCT02432105|3975081|FG000|STARTED|Overall Study||164
3242028|NCT02432105|3975082|FG001|STARTED|Overall Study||110
3242029|NCT02432105|3975083|FG002|STARTED|Overall Study||111
3242030|NCT02432105|3975081|FG000|COMPLETED|Overall Study||162
3242031|NCT02432105|3975082|FG001|COMPLETED|Overall Study||108
3242032|NCT02432105|3975083|FG002|COMPLETED|Overall Study||108
3242033|NCT02432105|3975081|FG000|NOT COMPLETED|Overall Study||2
3242034|NCT02432105|3975082|FG001|NOT COMPLETED|Overall Study||2
3242035|NCT02432105|3975083|FG002|NOT COMPLETED|Overall Study||3
3242036|NCT02432144|3975092|FG000|STARTED|Overall Study||12
3242037|NCT02432144|3975092|FG000|COMPLETED|Overall Study||11
3242038|NCT02432144|3975092|FG000|NOT COMPLETED|Overall Study||1
3242039|NCT02432183|3975100|FG000|STARTED|Overall Study||44
3242040|NCT02432183|3975101|FG001|STARTED|Overall Study||47
3242041|NCT02432183|3975102|FG002|STARTED|Overall Study||26
3242042|NCT02432183|3975103|FG003|STARTED|Overall Study||17
3242043|NCT02432183|3975100|FG000|COMPLETED|Overall Study||44
3242044|NCT02432183|3975101|FG001|COMPLETED|Overall Study||47
3242045|NCT02432183|3975102|FG002|COMPLETED|Overall Study||26
3242046|NCT02432183|3975103|FG003|COMPLETED|Overall Study||17
3242047|NCT02432183|3975100|FG000|NOT COMPLETED|Overall Study||0
3242048|NCT02432183|3975101|FG001|NOT COMPLETED|Overall Study||0
3242049|NCT02432183|3975102|FG002|NOT COMPLETED|Overall Study||0
3242050|NCT02432183|3975103|FG003|NOT COMPLETED|Overall Study||0
3242051|NCT02432235|3975125|FG000|STARTED|Overall Study||2
3242052|NCT02432235|3975126|FG001|STARTED|Overall Study||2
3242053|NCT02432235|3975127|FG002|STARTED|Overall Study||2
3242054|NCT02432235|3975128|FG003|STARTED|Overall Study||3
3242055|NCT02432235|3975129|FG004|STARTED|Overall Study||2
3242056|NCT02432235|3975130|FG005|STARTED|Overall Study||20
3242057|NCT02432235|3975131|FG006|STARTED|Overall Study||41
3242058|NCT02432235|3975132|FG007|STARTED|Overall Study||29
3242059|NCT02432235|3975133|FG008|STARTED|Overall Study||26
3242060|NCT02432235|3975134|FG009|STARTED|Overall Study||3
3242061|NCT02432235|3975135|FG010|STARTED|Overall Study||2
3242062|NCT02432235|3975136|FG011|STARTED|Overall Study||1
3242063|NCT02432235|3975125|FG000|COMPLETED|Overall Study||1
3242064|NCT02432235|3975126|FG001|COMPLETED|Overall Study||0
3242065|NCT02432235|3975127|FG002|COMPLETED|Overall Study||0
3242066|NCT02432235|3975128|FG003|COMPLETED|Overall Study||1
3242067|NCT02432235|3975129|FG004|COMPLETED|Overall Study||0
3242068|NCT02432235|3975130|FG005|COMPLETED|Overall Study||8
3242069|NCT02432235|3975131|FG006|COMPLETED|Overall Study||23
3242070|NCT02432235|3975132|FG007|COMPLETED|Overall Study||9
3242071|NCT02432235|3975133|FG008|COMPLETED|Overall Study||5
3242072|NCT02432235|3975134|FG009|COMPLETED|Overall Study||0
3242073|NCT02432235|3975135|FG010|COMPLETED|Overall Study||1
3242074|NCT02432235|3975136|FG011|COMPLETED|Overall Study||0
3242075|NCT02432235|3975125|FG000|NOT COMPLETED|Overall Study||1
3242076|NCT02432235|3975126|FG001|NOT COMPLETED|Overall Study||2
3242077|NCT02432235|3975127|FG002|NOT COMPLETED|Overall Study||2
3242078|NCT02432235|3975128|FG003|NOT COMPLETED|Overall Study||2
3242079|NCT02432235|3975129|FG004|NOT COMPLETED|Overall Study||2
3242080|NCT02432235|3975130|FG005|NOT COMPLETED|Overall Study||12
3242081|NCT02432235|3975131|FG006|NOT COMPLETED|Overall Study||18
3242082|NCT02432235|3975132|FG007|NOT COMPLETED|Overall Study||20
3242083|NCT02432235|3975133|FG008|NOT COMPLETED|Overall Study||21
3242084|NCT02432235|3975134|FG009|NOT COMPLETED|Overall Study||3
3242085|NCT02432235|3975135|FG010|NOT COMPLETED|Overall Study||1
3242086|NCT02432235|3975136|FG011|NOT COMPLETED|Overall Study||1
3242087|NCT02432274|3975172|FG000|STARTED|Overall Study||3
3242088|NCT02432274|3975173|FG001|STARTED|Overall Study||9
3242089|NCT02432274|3975174|FG002|STARTED|Overall Study||11
3242090|NCT02432274|3975175|FG003|STARTED|Overall Study||1
3242091|NCT02432274|3975176|FG004|STARTED|Overall Study||31
3242092|NCT02432274|3975177|FG005|STARTED|Overall Study||7
3242093|NCT02432274|3975178|FG006|STARTED|Overall Study||15
3242094|NCT02432274|3975179|FG007|STARTED|Overall Study||20
3242095|NCT02432274|3975172|FG000|Underwent Run-in Period|Overall Study||1
3242096|NCT02432274|3975173|FG001|Underwent Run-in Period|Overall Study||1
3242097|NCT02432274|3975174|FG002|Underwent Run-in Period|Overall Study||0
3242098|NCT02432274|3975175|FG003|Underwent Run-in Period|Overall Study||0
3242099|NCT02432274|3975176|FG004|Underwent Run-in Period|Overall Study||0
3242100|NCT02432274|3975177|FG005|Underwent Run-in Period|Overall Study||0
3242101|NCT02432274|3975178|FG006|Underwent Run-in Period|Overall Study||0
3242102|NCT02432274|3975179|FG007|Underwent Run-in Period|Overall Study||0
3242103|NCT02432274|3975172|FG000|Treated (Safety Population)|Overall Study|2 participants assigned to lenvatinib17mg/m^2 actually received 11mg/m^2 (dose capped at 24 mg/day).|5
3242104|NCT02432274|3975173|FG001|Treated (Safety Population)|Overall Study|2 participants assigned to lenvatinib17mg/m^2 actually received 14mg/m^2 (dose capped at 24 mg/day).|11
3242105|NCT02432274|3975174|FG002|Treated (Safety Population)|Overall Study||7
3242106|NCT02432274|3975175|FG003|Treated (Safety Population)|Overall Study||1
3242107|NCT02432274|3975176|FG004|Treated (Safety Population)|Overall Study||31
3242108|NCT02432274|3975177|FG005|Treated (Safety Population)|Overall Study|4 participants assigned to lenvatinib14mg/m^2 actually received 11mg/m^2 (dose capped at 24 mg/day).|11
3242109|NCT02432274|3975178|FG006|Treated (Safety Population)|Overall Study||11
3242110|NCT02432274|3975179|FG007|Treated (Safety Population)|Overall Study||20
3242111|NCT02432274|3975172|FG000|COMPLETED|Overall Study||0
3242112|NCT02432274|3975173|FG001|COMPLETED|Overall Study||0
3242113|NCT02432274|3975174|FG002|COMPLETED|Overall Study||0
3242114|NCT02432274|3975175|FG003|COMPLETED|Overall Study||0
3242115|NCT02432274|3975176|FG004|COMPLETED|Overall Study||0
3242116|NCT02432274|3975177|FG005|COMPLETED|Overall Study||0
3242117|NCT02432274|3975178|FG006|COMPLETED|Overall Study||0
3242118|NCT02432274|3975179|FG007|COMPLETED|Overall Study||0
3242119|NCT02432274|3975172|FG000|NOT COMPLETED|Overall Study||3
3242120|NCT02432274|3975173|FG001|NOT COMPLETED|Overall Study||9
3242121|NCT02432274|3975174|FG002|NOT COMPLETED|Overall Study||11
3242122|NCT02432274|3975175|FG003|NOT COMPLETED|Overall Study||1
3242123|NCT02432274|3975176|FG004|NOT COMPLETED|Overall Study||31
3242124|NCT02432274|3975177|FG005|NOT COMPLETED|Overall Study||7
3370485|NCT03774745|4101866|FG000|NOT COMPLETED|Overall Study||2
3370486|NCT03774745|4101867|FG001|NOT COMPLETED|Overall Study||4
3370487|NCT03774433|4101873|FG000|STARTED|Overall Study||114
3370488|NCT03774433|4101873|FG000|COMPLETED|Overall Study|Participants who completed at least 12 EMAs for inclusion in data analysis|100
3370489|NCT03774433|4101873|FG000|NOT COMPLETED|Overall Study||14
3370490|NCT03771560|4101877|FG000|STARTED|Overall Study||18
3370491|NCT03771560|4101877|FG000|COMPLETED|Overall Study||12
3370492|NCT03771560|4101877|FG000|NOT COMPLETED|Overall Study||6
3370493|NCT03770091|4101884|FG000|STARTED|Overall Study||15
3370494|NCT03770091|4101885|FG001|STARTED|Overall Study||13
3370495|NCT03770091|4101886|FG002|STARTED|Overall Study||12
3370496|NCT03770091|4101884|FG000|COMPLETED|Overall Study||15
3370497|NCT03770091|4101885|FG001|COMPLETED|Overall Study||13
3370498|NCT03770091|4101886|FG002|COMPLETED|Overall Study||12
3370499|NCT03770091|4101884|FG000|NOT COMPLETED|Overall Study||0
3370500|NCT03770091|4101885|FG001|NOT COMPLETED|Overall Study||0
3370501|NCT03770091|4101886|FG002|NOT COMPLETED|Overall Study||0
3370502|NCT03769896|4101896|FG000|STARTED|Open-label Phase||47
3370503|NCT03769896|4101897|FG001|STARTED|Open-label Phase||0
3370504|NCT03769896|4101896|FG000|COMPLETED|Open-label Phase||38
3370505|NCT03769896|4101897|FG001|COMPLETED|Open-label Phase||0
3370506|NCT03769896|4101896|FG000|NOT COMPLETED|Open-label Phase||9
3370507|NCT03769896|4101897|FG001|NOT COMPLETED|Open-label Phase||0
3370508|NCT03769896|4101896|FG000|STARTED|Double-blind Treatment Phase||19
3370509|NCT03769896|4101897|FG001|STARTED|Double-blind Treatment Phase||19
3370510|NCT03769896|4101896|FG000|COMPLETED|Double-blind Treatment Phase||19
3370511|NCT03769896|4101897|FG001|COMPLETED|Double-blind Treatment Phase||19
3370512|NCT03769896|4101896|FG000|NOT COMPLETED|Double-blind Treatment Phase||0
3370513|NCT03769896|4101897|FG001|NOT COMPLETED|Double-blind Treatment Phase||0
3370514|NCT03769649|4101904|FG000|STARTED|Overall Study||15
3370515|NCT03769649|4101904|FG000|COMPLETED|Overall Study||11
3370516|NCT03769649|4101904|FG000|NOT COMPLETED|Overall Study||4
3370517|NCT03769207|4101908|FG000|STARTED|Overall Study||17
3370518|NCT03769207|4101908|FG000|Attended First Study Visit|Overall Study||11
3370519|NCT03769207|4101908|FG000|ECG Patch Shipped|Overall Study||11
3370520|NCT03769207|4101908|FG000|ECG Patch Returned and Readable|Overall Study||9
3370521|NCT03769207|4101908|FG000|Attended Second Study Visit|Overall Study||6
3370522|NCT03769207|4101908|FG000|COMPLETED|Overall Study||6
3370523|NCT03769207|4101908|FG000|NOT COMPLETED|Overall Study||11
3370524|NCT03768856|4101912|FG000|STARTED|Overall Study||5
3370525|NCT03768856|4101912|FG000|COMPLETED|Overall Study||5
3370526|NCT03768856|4101912|FG000|NOT COMPLETED|Overall Study||0
3370527|NCT03768726|4101918|FG000|STARTED|Treatment Phase||10
3370528|NCT03768726|4101919|FG001|STARTED|Treatment Phase||13
3370529|NCT03768726|4101918|FG000|COMPLETED|Treatment Phase||2
3370530|NCT03768726|4101919|FG001|COMPLETED|Treatment Phase||10
3370531|NCT03768726|4101918|FG000|NOT COMPLETED|Treatment Phase||8
3370532|NCT03768726|4101919|FG001|NOT COMPLETED|Treatment Phase||3
3370533|NCT03768726|4101918|FG000|STARTED|Follow-Up|Participants were followed up after completion or discontinuation of treatment.|8
3370534|NCT03768726|4101919|FG001|STARTED|Follow-Up|Participants were followed up after completion or discontinuation of treatment.|12
3242125|NCT02432274|3975178|FG006|NOT COMPLETED|Overall Study||15
3242126|NCT02432274|3975179|FG007|NOT COMPLETED|Overall Study||20
3242127|NCT02432287|3975211|FG000|STARTED|First Intervention||8
3242128|NCT02432287|3975212|FG001|STARTED|First Intervention||8
3242129|NCT02432287|3975211|FG000|COMPLETED|First Intervention||8
3242130|NCT02432287|3975212|FG001|COMPLETED|First Intervention||7
3242131|NCT02432287|3975211|FG000|NOT COMPLETED|First Intervention||0
3242132|NCT02432287|3975212|FG001|NOT COMPLETED|First Intervention||1
3242133|NCT02432287|3975211|FG000|STARTED|Washout Period||7
3242134|NCT02432287|3975212|FG001|STARTED|Washout Period||7
3242135|NCT02432287|3975211|FG000|COMPLETED|Washout Period||7
3242136|NCT02432287|3975212|FG001|COMPLETED|Washout Period||7
3242137|NCT02432287|3975211|FG000|NOT COMPLETED|Washout Period||0
3242138|NCT02432287|3975212|FG001|NOT COMPLETED|Washout Period||0
3242139|NCT02432287|3975211|FG000|STARTED|Second Intervention||7
3242140|NCT02432287|3975212|FG001|STARTED|Second Intervention||7
3242141|NCT02432287|3975211|FG000|COMPLETED|Second Intervention||7
3242142|NCT02432287|3975212|FG001|COMPLETED|Second Intervention||7
3242143|NCT02432287|3975211|FG000|NOT COMPLETED|Second Intervention||0
3242144|NCT02432287|3975212|FG001|NOT COMPLETED|Second Intervention||0
3242145|NCT02432300|3975220|FG000|STARTED|Overall Study||17
3242146|NCT02432300|3975220|FG000|COMPLETED|Overall Study||13
3242147|NCT02432300|3975220|FG000|NOT COMPLETED|Overall Study||4
3242148|NCT02432456|3975226|FG000|STARTED|Overall Study||75
3242149|NCT02432456|3975227|FG001|STARTED|Overall Study||75
3242150|NCT02432456|3975226|FG000|COMPLETED|Overall Study||75
3242151|NCT02432456|3975227|FG001|COMPLETED|Overall Study||75
3242152|NCT02432456|3975226|FG000|NOT COMPLETED|Overall Study||0
3242153|NCT02432456|3975227|FG001|NOT COMPLETED|Overall Study||0
3242154|NCT02432703|3975235|FG000|STARTED|Overall Study||75
3242155|NCT02432703|3975236|FG001|STARTED|Overall Study||74
3242156|NCT02432703|3975235|FG000|COMPLETED|Overall Study||53
3242157|NCT02432703|3975236|FG001|COMPLETED|Overall Study||56
3242158|NCT02432703|3975235|FG000|NOT COMPLETED|Overall Study||22
3242159|NCT02432703|3975236|FG001|NOT COMPLETED|Overall Study||18
3242160|NCT02432716|3975242|FG000|STARTED|Overall Study||6
3242161|NCT02432716|3975243|FG001|STARTED|Overall Study||6
3242162|NCT02432716|3975242|FG000|COMPLETED|Overall Study||6
3242163|NCT02432716|3975243|FG001|COMPLETED|Overall Study||6
3242164|NCT02432716|3975242|FG000|NOT COMPLETED|Overall Study||0
3242165|NCT02432716|3975243|FG001|NOT COMPLETED|Overall Study||0
3242166|NCT02432729|3975251|FG000|STARTED|Month 3 Visit||720
3242167|NCT02432729|3975251|FG000|COMPLETED|Month 3 Visit||718
3242168|NCT02432729|3975251|FG000|NOT COMPLETED|Month 3 Visit||2
3242169|NCT02432729|3975251|FG000|STARTED|Month 6 Visit||718
3242170|NCT02432729|3975251|FG000|COMPLETED|Month 6 Visit||632
3242171|NCT02432729|3975251|FG000|NOT COMPLETED|Month 6 Visit||86
3242172|NCT02432729|3975251|FG000|STARTED|Month 12 Visit||632
3242173|NCT02432729|3975251|FG000|COMPLETED|Month 12 Visit||436
3242174|NCT02432729|3975251|FG000|NOT COMPLETED|Month 12 Visit||196
3242175|NCT02432742|3975256|FG000|STARTED|Overall Study||100
3242176|NCT02432742|3975256|FG000|COMPLETED|Overall Study||95
3242177|NCT02432742|3975256|FG000|NOT COMPLETED|Overall Study||5
3242178|NCT02433080|3975263|FG000|STARTED|Overall Study||26
3242179|NCT02433080|3975264|FG001|STARTED|Overall Study||28
3242180|NCT02433080|3975263|FG000|8 Weeks|Overall Study||25
3242181|NCT02433080|3975264|FG001|8 Weeks|Overall Study||24
3242182|NCT02433080|3975263|FG000|COMPLETED|Overall Study||25
3242183|NCT02433080|3975264|FG001|COMPLETED|Overall Study||24
3242184|NCT02433080|3975263|FG000|NOT COMPLETED|Overall Study||1
3242185|NCT02433080|3975264|FG001|NOT COMPLETED|Overall Study||4
3242186|NCT02433288|3975273|FG000|STARTED|Overall Study||443
3242187|NCT02433288|3975274|FG001|STARTED|Overall Study||442
3242188|NCT02433288|3975273|FG000|COMPLETED|Overall Study||320
3242189|NCT02433288|3975274|FG001|COMPLETED|Overall Study||316
3242190|NCT02433288|3975273|FG000|NOT COMPLETED|Overall Study||123
3242191|NCT02433288|3975274|FG001|NOT COMPLETED|Overall Study||126
3242192|NCT02433340|3975284|FG000|STARTED|Overall Study||42
3242193|NCT02433340|3975285|FG001|STARTED|Overall Study||37
3242194|NCT02433340|3975286|FG002|STARTED|Overall Study||39
3242195|NCT02433340|3975287|FG003|STARTED|Overall Study||40
3242196|NCT02433340|3975284|FG000|COMPLETED|Overall Study||40
3242197|NCT02433340|3975285|FG001|COMPLETED|Overall Study||35
3242198|NCT02433340|3975286|FG002|COMPLETED|Overall Study||37
3242199|NCT02433340|3975287|FG003|COMPLETED|Overall Study||38
3242200|NCT02433340|3975284|FG000|NOT COMPLETED|Overall Study||2
3242201|NCT02433340|3975285|FG001|NOT COMPLETED|Overall Study||2
3242202|NCT02433340|3975286|FG002|NOT COMPLETED|Overall Study||2
3242203|NCT02433340|3975287|FG003|NOT COMPLETED|Overall Study||2
3242204|NCT02433366|3975301|FG000|STARTED|Overall Study||411
3242205|NCT02433366|3975302|FG001|STARTED|Overall Study||802
3242206|NCT02433366|3975301|FG000|COMPLETED|Overall Study||411
3242207|NCT02433366|3975302|FG001|COMPLETED|Overall Study||802
3242208|NCT02433366|3975301|FG000|NOT COMPLETED|Overall Study||0
3242209|NCT02433366|3975302|FG001|NOT COMPLETED|Overall Study||0
3242210|NCT02433379|3975308|FG000|STARTED|Overall Study||1173
3242211|NCT02433379|3975308|FG000|COMPLETED|Overall Study||852
3242212|NCT02433379|3975308|FG000|NOT COMPLETED|Overall Study||321
3242213|NCT02433483|3975314|FG000|STARTED|Overall Study||2
3242214|NCT02433483|3975314|FG000|COMPLETED|Overall Study||0
3242215|NCT02433483|3975314|FG000|NOT COMPLETED|Overall Study||2
3242216|NCT02433496|3975321|FG000|STARTED|Overall Study|This includes patients (29956) and providers (34).|29990
3242217|NCT02433496|3975322|FG001|STARTED|Overall Study|This includes patients (13296) and providers (13).|13309
3242218|NCT02433496|3975323|FG002|STARTED|Overall Study|This includes patients (9813) and providers (20).|9833
3242219|NCT02433496|3975321|FG000|COMPLETED|Overall Study|This includes patients (29956) and providers (34).|29990
3242220|NCT02433496|3975322|FG001|COMPLETED|Overall Study|This includes patients (13296) and providers (13).|13309
3242221|NCT02433496|3975323|FG002|COMPLETED|Overall Study|This includes patients (9813) and providers (20).|9833
3242222|NCT02433496|3975321|FG000|NOT COMPLETED|Overall Study||0
3242223|NCT02433496|3975322|FG001|NOT COMPLETED|Overall Study||0
3242224|NCT02433496|3975323|FG002|NOT COMPLETED|Overall Study||0
3242225|NCT02433613|3975330|FG000|STARTED|Overall Study||1071
3242226|NCT02433613|3975330|FG000|COMPLETED|Overall Study||1054
3242227|NCT02433613|3975330|FG000|NOT COMPLETED|Overall Study||17
3242228|NCT02433665|3975336|FG000|STARTED|Overall Study||77
3242229|NCT02433665|3975337|FG001|STARTED|Overall Study||79
3242230|NCT02433665|3975336|FG000|COMPLETED|Overall Study||77
3242231|NCT02433665|3975337|FG001|COMPLETED|Overall Study||79
3242232|NCT02433665|3975336|FG000|NOT COMPLETED|Overall Study||0
3242233|NCT02433665|3975337|FG001|NOT COMPLETED|Overall Study||0
3242234|NCT02433678|3975345|FG000|STARTED|Overall Study||26
3242235|NCT02433678|3975346|FG001|STARTED|Overall Study||26
3242236|NCT02433678|3975345|FG000|COMPLETED|Overall Study||25
3242237|NCT02433678|3975346|FG001|COMPLETED|Overall Study||24
3242238|NCT02433678|3975345|FG000|NOT COMPLETED|Overall Study||1
3242239|NCT02433678|3975346|FG001|NOT COMPLETED|Overall Study||2
3242240|NCT02433834|3975352|FG000|STARTED|Overall Study||248
3242241|NCT02433834|3975352|FG000|GP MDI 28.8 µg|Overall Study||112
3242242|NCT02433834|3975352|FG000|GP MDI 14.4 µg|Overall Study||230
3242243|NCT02433834|3975352|FG000|GP MDI 7.2 µg|Overall Study||228
3242244|NCT02433834|3975352|FG000|GP MDI 3.6 µg|Overall Study||118
3242245|NCT02433834|3975352|FG000|GP MDI 1.9 µg|Overall Study||107
3242246|NCT02433834|3975352|FG000|Placebo MDI|Overall Study||174
3242247|NCT02433834|3975352|FG000|SAL 50 µg|Overall Study||167
3242248|NCT02433834|3975352|FG000|COMPLETED|Overall Study|Subject PT001101-040014 did not complete Period 4 but completed the study. CSR states 210 completed.|211
3242249|NCT02433834|3975352|FG000|NOT COMPLETED|Overall Study||37
3242250|NCT02433977|3975368|FG000|STARTED|Overall Study||6
3242251|NCT02433977|3975368|FG000|COMPLETED|Overall Study||6
3242252|NCT02433977|3975368|FG000|NOT COMPLETED|Overall Study||0
3242253|NCT02434081|3975372|FG000|STARTED|Overall Study|Only patients enrolled after protocol amendments 1 (n=43) and 2 (n=36) were analysed (concurrent CRT+Nivo). Patients who received CRT and sequentially Nivo (enrolled under original protocol (n=12) or protocol amendment 1 (n=3)) were not included in the analysis population.|79
3242254|NCT02434081|3975372|FG000|COMPLETED|Overall Study||31
3242255|NCT02434081|3975372|FG000|NOT COMPLETED|Overall Study||48
3242256|NCT02434328|3975378|FG000|STARTED|Overall Study||372
3242257|NCT02434328|3975379|FG001|STARTED|Overall Study||371
3242258|NCT02434328|3975378|FG000|Randomized and Treated|Overall Study||370
3242259|NCT02434328|3975379|FG001|Randomized and Treated|Overall Study||369
3242260|NCT02434328|3975378|FG000|COMPLETED|Overall Study||342
3242261|NCT02434328|3975379|FG001|COMPLETED|Overall Study||329
3242262|NCT02434328|3975378|FG000|NOT COMPLETED|Overall Study||30
3242263|NCT02434328|3975379|FG001|NOT COMPLETED|Overall Study||42
3242264|NCT02434471|3975386|FG000|STARTED|Overall Study||34
3242265|NCT02434471|3975386|FG000|COMPLETED|Overall Study||25
3242266|NCT02434471|3975386|FG000|NOT COMPLETED|Overall Study||9
3242267|NCT02434497|3975391|FG000|STARTED|Overall Study||9
3242268|NCT02434497|3975391|FG000|COMPLETED|Overall Study||4
3242269|NCT02434497|3975391|FG000|NOT COMPLETED|Overall Study||5
3242270|NCT02434523|3975399|FG000|STARTED|Overall Study||15
3242271|NCT02434523|3975400|FG001|STARTED|Overall Study||15
3242272|NCT02434523|3975399|FG000|COMPLETED|Overall Study||10
3242273|NCT02434523|3975400|FG001|COMPLETED|Overall Study||9
3242274|NCT02434523|3975399|FG000|NOT COMPLETED|Overall Study||5
3242275|NCT02434523|3975400|FG001|NOT COMPLETED|Overall Study||6
3242276|NCT02434770|3975411|FG000|STARTED|Week 1 to Week 18||250
3242277|NCT02434770|3975412|FG001|STARTED|Week 1 to Week 18||250
3242278|NCT02434770|3975413|FG002|STARTED|Week 1 to Week 18||250
3242279|NCT02434770|3975411|FG000|Received at Least One Vaccination|Week 1 to Week 18||249
3242280|NCT02434770|3975412|FG001|Received at Least One Vaccination|Week 1 to Week 18||250
3242281|NCT02434770|3975413|FG002|Received at Least One Vaccination|Week 1 to Week 18||250
3242282|NCT02434770|3975411|FG000|COMPLETED|Week 1 to Week 18||235
3242283|NCT02434770|3975412|FG001|COMPLETED|Week 1 to Week 18||228
3242284|NCT02434770|3975413|FG002|COMPLETED|Week 1 to Week 18||233
3242285|NCT02434770|3975411|FG000|NOT COMPLETED|Week 1 to Week 18||15
3242286|NCT02434770|3975412|FG001|NOT COMPLETED|Week 1 to Week 18||22
3242287|NCT02434770|3975413|FG002|NOT COMPLETED|Week 1 to Week 18||17
3242288|NCT02434770|3975411|FG000|STARTED|Week 18 to Week||235
3242289|NCT02434770|3975412|FG001|STARTED|Week 18 to Week||228
3242290|NCT02434770|3975413|FG002|STARTED|Week 18 to Week||233
3242291|NCT02434770|3975411|FG000|COMPLETED|Week 18 to Week||227
3242292|NCT02434770|3975412|FG001|COMPLETED|Week 18 to Week||220
3242293|NCT02434770|3975413|FG002|COMPLETED|Week 18 to Week||227
3242294|NCT02434770|3975411|FG000|NOT COMPLETED|Week 18 to Week||8
3242295|NCT02434770|3975412|FG001|NOT COMPLETED|Week 18 to Week||8
3242296|NCT02434770|3975413|FG002|NOT COMPLETED|Week 18 to Week||6
3242297|NCT02434939|3975425|FG000|STARTED|Overall Study||120
3242298|NCT02434939|3975426|FG001|STARTED|Overall Study||120
3242299|NCT02434939|3975425|FG000|COMPLETED|Overall Study||83
3242300|NCT02434939|3975426|FG001|COMPLETED|Overall Study||71
3242301|NCT02434939|3975425|FG000|NOT COMPLETED|Overall Study||37
3242302|NCT02434939|3975426|FG001|NOT COMPLETED|Overall Study||49
3242303|NCT02435069|3975433|FG000|STARTED|Preoperative Baseline Phase||5
3242304|NCT02435069|3975434|FG001|STARTED|Preoperative Baseline Phase||0
3242305|NCT02435069|3975435|FG002|STARTED|Preoperative Baseline Phase||0
3242306|NCT02435069|3975436|FG003|STARTED|Preoperative Baseline Phase||0
3242307|NCT02435069|3975437|FG004|STARTED|Preoperative Baseline Phase||0
3242308|NCT02435069|3975433|FG000|COMPLETED|Preoperative Baseline Phase||5
3242309|NCT02435069|3975434|FG001|COMPLETED|Preoperative Baseline Phase||0
3242310|NCT02435069|3975435|FG002|COMPLETED|Preoperative Baseline Phase||0
3242311|NCT02435069|3975436|FG003|COMPLETED|Preoperative Baseline Phase||0
3242312|NCT02435069|3975437|FG004|COMPLETED|Preoperative Baseline Phase||0
3242313|NCT02435069|3975433|FG000|NOT COMPLETED|Preoperative Baseline Phase||0
3242314|NCT02435069|3975434|FG001|NOT COMPLETED|Preoperative Baseline Phase||0
3242315|NCT02435069|3975435|FG002|NOT COMPLETED|Preoperative Baseline Phase||0
3242316|NCT02435069|3975436|FG003|NOT COMPLETED|Preoperative Baseline Phase||0
3242317|NCT02435069|3975437|FG004|NOT COMPLETED|Preoperative Baseline Phase||0
3242318|NCT02435069|3975433|FG000|STARTED|Dose Response - First Intervention||0
3242319|NCT02435069|3975434|FG001|STARTED|Dose Response - First Intervention||3
3242320|NCT02435069|3975435|FG002|STARTED|Dose Response - First Intervention||2
3242321|NCT02435069|3975436|FG003|STARTED|Dose Response - First Intervention||0
3242322|NCT02435069|3975437|FG004|STARTED|Dose Response - First Intervention||0
3242323|NCT02435069|3975433|FG000|COMPLETED|Dose Response - First Intervention||0
3242324|NCT02435069|3975434|FG001|COMPLETED|Dose Response - First Intervention||2
3242325|NCT02435069|3975435|FG002|COMPLETED|Dose Response - First Intervention||1
3242326|NCT02435069|3975436|FG003|COMPLETED|Dose Response - First Intervention||0
3242327|NCT02435069|3975437|FG004|COMPLETED|Dose Response - First Intervention||0
3242328|NCT02435069|3975433|FG000|NOT COMPLETED|Dose Response - First Intervention||0
3242329|NCT02435069|3975434|FG001|NOT COMPLETED|Dose Response - First Intervention||1
3242330|NCT02435069|3975435|FG002|NOT COMPLETED|Dose Response - First Intervention||1
3242331|NCT02435069|3975436|FG003|NOT COMPLETED|Dose Response - First Intervention||0
3242332|NCT02435069|3975437|FG004|NOT COMPLETED|Dose Response - First Intervention||0
3242333|NCT02435069|3975433|FG000|STARTED|Effectiveness - Second Intervention||0
3242334|NCT02435069|3975434|FG001|STARTED|Effectiveness - Second Intervention||0
3242335|NCT02435069|3975435|FG002|STARTED|Effectiveness - Second Intervention||0
3242336|NCT02435069|3975436|FG003|STARTED|Effectiveness - Second Intervention||1
3242337|NCT02435069|3975437|FG004|STARTED|Effectiveness - Second Intervention||1
3242338|NCT02435069|3975433|FG000|COMPLETED|Effectiveness - Second Intervention||0
3242339|NCT02435069|3975434|FG001|COMPLETED|Effectiveness - Second Intervention||0
3242340|NCT02435069|3975435|FG002|COMPLETED|Effectiveness - Second Intervention||0
3242341|NCT02435069|3975436|FG003|COMPLETED|Effectiveness - Second Intervention||1
3242342|NCT02435069|3975437|FG004|COMPLETED|Effectiveness - Second Intervention||0
3242343|NCT02435069|3975433|FG000|NOT COMPLETED|Effectiveness - Second Intervention||0
3242344|NCT02435069|3975434|FG001|NOT COMPLETED|Effectiveness - Second Intervention||0
3242345|NCT02435069|3975435|FG002|NOT COMPLETED|Effectiveness - Second Intervention||0
3242346|NCT02435069|3975436|FG003|NOT COMPLETED|Effectiveness - Second Intervention||0
3242347|NCT02435069|3975437|FG004|NOT COMPLETED|Effectiveness - Second Intervention||1
3242348|NCT02435147|3975457|FG000|STARTED|Overall Study||86
3242349|NCT02435147|3975457|FG000|COMPLETED|Overall Study||75
3242350|NCT02435147|3975457|FG000|NOT COMPLETED|Overall Study||11
3242351|NCT02435277|3975465|FG000|STARTED|Overall Study||12
3242352|NCT02435277|3975466|FG001|STARTED|Overall Study||16
3242353|NCT02435277|3975467|FG002|STARTED|Overall Study||11
3242354|NCT02435277|3975468|FG003|STARTED|Overall Study||11
3242355|NCT02435277|3975465|FG000|COMPLETED|Overall Study||10
3242356|NCT02435277|3975466|FG001|COMPLETED|Overall Study||15
3242357|NCT02435277|3975467|FG002|COMPLETED|Overall Study||11
3242358|NCT02435277|3975468|FG003|COMPLETED|Overall Study||11
3242359|NCT02435277|3975465|FG000|NOT COMPLETED|Overall Study||2
3242360|NCT02435277|3975466|FG001|NOT COMPLETED|Overall Study||1
3242361|NCT02435277|3975467|FG002|NOT COMPLETED|Overall Study||0
3242362|NCT02435277|3975468|FG003|NOT COMPLETED|Overall Study||0
3242363|NCT02435381|3975478|FG000|STARTED|Overall Study||5
3242364|NCT02435381|3975479|FG001|STARTED|Overall Study||6
3242365|NCT02435381|3975478|FG000|COMPLETED|Overall Study||3
3242366|NCT02435381|3975479|FG001|COMPLETED|Overall Study||5
3242367|NCT02435381|3975478|FG000|NOT COMPLETED|Overall Study||2
3242368|NCT02435381|3975479|FG001|NOT COMPLETED|Overall Study||1
3242369|NCT02435511|3975495|FG000|STARTED|Overall Study|Defined as enrolled and completed baseline|202
3242370|NCT02435511|3975496|FG001|STARTED|Overall Study|Defined as enrolled and completed baseline|209
3242371|NCT02435511|3975495|FG000|COMPLETED|Overall Study|Defined as completing the 3 month follow-up, not necessarily all time points|158
3242372|NCT02435511|3975496|FG001|COMPLETED|Overall Study|Defined as completing the 3 month follow-up; not necessarily all time points|174
3242373|NCT02435511|3975495|FG000|NOT COMPLETED|Overall Study||44
3242374|NCT02435511|3975496|FG001|NOT COMPLETED|Overall Study||35
3242375|NCT02435524|3975506|FG000|STARTED|Baseline Survey||1111
3242376|NCT02435524|3975507|FG001|STARTED|Baseline Survey||1177
3242377|NCT02435524|3975506|FG000|COMPLETED|Baseline Survey|Design: 2 independent cross-sectional surveys; baseline & endline participants not same individuals|1111
3242378|NCT02435524|3975507|FG001|COMPLETED|Baseline Survey|Design: 2 independent cross-sectional surveys; baseline & endline participants not same individuals|1177
3242379|NCT02435524|3975506|FG000|NOT COMPLETED|Baseline Survey||0
3242380|NCT02435524|3975507|FG001|NOT COMPLETED|Baseline Survey||0
3242381|NCT02435524|3975506|FG000|STARTED|Endline Survey||1092
3242382|NCT02435524|3975507|FG001|STARTED|Endline Survey||1161
3242383|NCT02435524|3975506|FG000|COMPLETED|Endline Survey|Design: 2 independent cross-sectional surveys; baseline & endline participants not same individuals|1092
3242384|NCT02435524|3975507|FG001|COMPLETED|Endline Survey|Design: 2 independent cross-sectional surveys; baseline & endline participants not same individuals|1161
3242385|NCT02435524|3975506|FG000|NOT COMPLETED|Endline Survey||0
3242386|NCT02435524|3975507|FG001|NOT COMPLETED|Endline Survey||0
3242387|NCT02435680|3975516|FG000|STARTED|Overall Study||21
3242388|NCT02435680|3975517|FG001|STARTED|Overall Study||13
3242389|NCT02435680|3975518|FG002|STARTED|Overall Study||16
3242390|NCT02435680|3975516|FG000|COMPLETED|Overall Study||0
3242391|NCT02435680|3975517|FG001|COMPLETED|Overall Study||0
3242392|NCT02435680|3975518|FG002|COMPLETED|Overall Study||0
3242393|NCT02435680|3975516|FG000|NOT COMPLETED|Overall Study||21
3242394|NCT02435680|3975517|FG001|NOT COMPLETED|Overall Study||13
3242395|NCT02435680|3975518|FG002|NOT COMPLETED|Overall Study||16
3242396|NCT02435706|3975532|FG000|STARTED|Overall Study||18
3242397|NCT02435706|3975533|FG001|STARTED|Overall Study||21
3242398|NCT02435706|3975532|FG000|COMPLETED|Overall Study||16
3242399|NCT02435706|3975533|FG001|COMPLETED|Overall Study||20
3242400|NCT02435706|3975532|FG000|NOT COMPLETED|Overall Study||2
3242401|NCT02435706|3975533|FG001|NOT COMPLETED|Overall Study||1
3242402|NCT02435836|3975539|FG000|STARTED|Overall Study||631
3242403|NCT02435836|3975539|FG000|COMPLETED|Overall Study||0
3242404|NCT02435836|3975539|FG000|NOT COMPLETED|Overall Study||631
3242405|NCT02435849|3975543|FG000|STARTED|Overall Study||97
3242406|NCT02435849|3975543|FG000|Enrolled and Infused|Overall Study||79
3242407|NCT02435849|3975543|FG000|Enrolled But Not Infused|Overall Study||18
3242408|NCT02435849|3975543|FG000|Discontinued Study Follow-up|Overall Study||34
3242409|NCT02435849|3975543|FG000|COMPLETED|Overall Study||0
3242410|NCT02435849|3975543|FG000|NOT COMPLETED|Overall Study||97
3242411|NCT02435901|3975547|FG000|STARTED|Overall Study||29
3242412|NCT02435901|3975547|FG000|COMPLETED|Overall Study||29
3242413|NCT02435901|3975547|FG000|NOT COMPLETED|Overall Study||0
3242414|NCT02435914|3975556|FG000|STARTED|Overall Study||58
3242415|NCT02435914|3975557|FG001|STARTED|Overall Study||59
3242416|NCT02435914|3975558|FG002|STARTED|Overall Study||60
3242417|NCT02435914|3975559|FG003|STARTED|Overall Study||59
3242418|NCT02435914|3975556|FG000|COMPLETED|Overall Study||57
3242419|NCT02435914|3975557|FG001|COMPLETED|Overall Study||58
3242420|NCT02435914|3975558|FG002|COMPLETED|Overall Study||59
3242421|NCT02435914|3975559|FG003|COMPLETED|Overall Study||59
3242422|NCT02435914|3975556|FG000|NOT COMPLETED|Overall Study||1
3242423|NCT02435914|3975557|FG001|NOT COMPLETED|Overall Study||1
3242424|NCT02435914|3975558|FG002|NOT COMPLETED|Overall Study||1
3242425|NCT02435914|3975559|FG003|NOT COMPLETED|Overall Study||0
3242426|NCT02435966|3975572|FG000|STARTED|Overall Study||47
3242427|NCT02435966|3975573|FG001|STARTED|Overall Study||54
3242428|NCT02435966|3975574|FG002|STARTED|Overall Study||30
3242429|NCT02435966|3975572|FG000|First Intervention|Overall Study||47
3242430|NCT02435966|3975573|FG001|First Intervention|Overall Study||54
3242431|NCT02435966|3975574|FG002|First Intervention|Overall Study||30
3242432|NCT02435966|3975572|FG000|Second Intervention|Overall Study||47
3242433|NCT02435966|3975573|FG001|Second Intervention|Overall Study||53
3242434|NCT02435966|3975574|FG002|Second Intervention|Overall Study||30
3242435|NCT02435966|3975572|FG000|Follow-up|Overall Study||47
3242436|NCT02435966|3975573|FG001|Follow-up|Overall Study||53
3242437|NCT02435966|3975574|FG002|Follow-up|Overall Study||30
3242438|NCT02435966|3975572|FG000|COMPLETED|Overall Study||47
3242439|NCT02435966|3975573|FG001|COMPLETED|Overall Study||53
3242440|NCT02435966|3975574|FG002|COMPLETED|Overall Study||30
3242441|NCT02435966|3975572|FG000|NOT COMPLETED|Overall Study||0
3242442|NCT02435966|3975573|FG001|NOT COMPLETED|Overall Study||1
3242443|NCT02435966|3975574|FG002|NOT COMPLETED|Overall Study||0
3242444|NCT02435992|3975587|FG000|STARTED|Overall Study||429
3242445|NCT02435992|3975588|FG001|STARTED|Overall Study||216
3242446|NCT02435992|3975589|FG002|STARTED|Overall Study||367
3242447|NCT02435992|3975590|FG003|STARTED|Overall Study||0
3242448|NCT02435992|3975591|FG004|STARTED|Overall Study||0
3242449|NCT02435992|3975587|FG000|Transition to Maintenance Period|Overall Study||233
3242450|NCT02435992|3975588|FG001|Transition to Maintenance Period|Overall Study||69
3242451|NCT02435992|3975589|FG002|Transition to Maintenance Period|Overall Study||224
3242452|NCT02435992|3975590|FG003|Transition to Maintenance Period|Overall Study||0
3242453|NCT02435992|3975591|FG004|Transition to Maintenance Period|Overall Study||0
3242454|NCT02435992|3975587|FG000|Treated in Maintenance Period|Overall Study||0
3242455|NCT02435992|3975588|FG001|Treated in Maintenance Period|Overall Study||69
3242456|NCT02435992|3975589|FG002|Treated in Maintenance Period|Overall Study||0
3242457|NCT02435992|3975590|FG003|Treated in Maintenance Period|Overall Study|Randomized from cohort 1 and 2 RCP1063 treatment|230
3242458|NCT02435992|3975591|FG004|Treated in Maintenance Period|Overall Study|Randomized from cohort 1 and 2 RCP1063 treatment|227
3242459|NCT02435992|3975587|FG000|COMPLETED|Overall Study||401
3242460|NCT02435992|3975588|FG001|COMPLETED|Overall Study||192
3242461|NCT02435992|3975589|FG002|COMPLETED|Overall Study||324
3242462|NCT02435992|3975590|FG003|COMPLETED|Overall Study||0
3242463|NCT02435992|3975591|FG004|COMPLETED|Overall Study||0
3242464|NCT02435992|3975587|FG000|NOT COMPLETED|Overall Study||28
3242465|NCT02435992|3975588|FG001|NOT COMPLETED|Overall Study||24
3242466|NCT02435992|3975589|FG002|NOT COMPLETED|Overall Study||43
3242467|NCT02435992|3975590|FG003|NOT COMPLETED|Overall Study||0
3242468|NCT02435992|3975591|FG004|NOT COMPLETED|Overall Study||0
3242469|NCT02436005|3975603|FG000|STARTED|First Intervention||12
3242470|NCT02436005|3975604|FG001|STARTED|First Intervention||13
3242471|NCT02436005|3975603|FG000|COMPLETED|First Intervention||12
3242472|NCT02436005|3975604|FG001|COMPLETED|First Intervention||13
3242473|NCT02436005|3975603|FG000|NOT COMPLETED|First Intervention||0
3242474|NCT02436005|3975604|FG001|NOT COMPLETED|First Intervention||0
3242475|NCT02436005|3975603|FG000|STARTED|Second Intervention||12
3242476|NCT02436005|3975604|FG001|STARTED|Second Intervention||13
3242477|NCT02436005|3975603|FG000|COMPLETED|Second Intervention||12
3242478|NCT02436005|3975604|FG001|COMPLETED|Second Intervention||12
3242479|NCT02436005|3975603|FG000|NOT COMPLETED|Second Intervention||0
3242480|NCT02436005|3975604|FG001|NOT COMPLETED|Second Intervention||1
3242481|NCT02436031|3975610|FG000|STARTED|First Study Night||8
3242482|NCT02436031|3975611|FG001|STARTED|First Study Night||8
3242483|NCT02436031|3975610|FG000|COMPLETED|First Study Night||8
3242484|NCT02436031|3975611|FG001|COMPLETED|First Study Night||8
3242485|NCT02436031|3975610|FG000|NOT COMPLETED|First Study Night||0
3242486|NCT02436031|3975611|FG001|NOT COMPLETED|First Study Night||0
3242487|NCT02436031|3975610|FG000|STARTED|Second Study Night|1 participant did not tolerate the study setup so did not participate in the second study night|7
3242488|NCT02436031|3975611|FG001|STARTED|Second Study Night||8
3242489|NCT02436031|3975610|FG000|COMPLETED|Second Study Night||7
3242490|NCT02436031|3975611|FG001|COMPLETED|Second Study Night||8
3242491|NCT02436031|3975610|FG000|NOT COMPLETED|Second Study Night||0
3242492|NCT02436031|3975611|FG001|NOT COMPLETED|Second Study Night||0
3242493|NCT02436135|3975619|FG000|STARTED|Overall Study||6
3242494|NCT02436135|3975620|FG001|STARTED|Overall Study||4
3242495|NCT02436135|3975619|FG000|COMPLETED|Overall Study||0
3242496|NCT02436135|3975620|FG001|COMPLETED|Overall Study||0
3242497|NCT02436135|3975619|FG000|NOT COMPLETED|Overall Study||6
3242498|NCT02436135|3975620|FG001|NOT COMPLETED|Overall Study||4
3242499|NCT02436200|3975626|FG000|STARTED|Overall Study||21
3242500|NCT02436200|3975626|FG000|COMPLETED|Overall Study||20
3242501|NCT02436200|3975626|FG000|NOT COMPLETED|Overall Study||1
3242502|NCT02436239|3975634|FG000|STARTED|Open-Lable Treatment Period||122
3242503|NCT02436239|3975635|FG001|STARTED|Open-Lable Treatment Period||131
3242504|NCT02436239|3975636|FG002|STARTED|Open-Lable Treatment Period||65
3242505|NCT02436239|3975637|FG003|STARTED|Open-Lable Treatment Period||12
3242506|NCT02436239|3975634|FG000|COMPLETED|Open-Lable Treatment Period||89
3242507|NCT02436239|3975635|FG001|COMPLETED|Open-Lable Treatment Period||97
3242508|NCT02436239|3975636|FG002|COMPLETED|Open-Lable Treatment Period||38
3242509|NCT02436239|3975637|FG003|COMPLETED|Open-Lable Treatment Period||7
3242510|NCT02436239|3975634|FG000|NOT COMPLETED|Open-Lable Treatment Period||33
3242511|NCT02436239|3975635|FG001|NOT COMPLETED|Open-Lable Treatment Period||34
3242512|NCT02436239|3975636|FG002|NOT COMPLETED|Open-Lable Treatment Period||27
3242513|NCT02436239|3975637|FG003|NOT COMPLETED|Open-Lable Treatment Period||5
3242514|NCT02436239|3975634|FG000|STARTED|Down-Taper Period|Enrollment permitted for participants who had not completed previous open-label treatment period.|90
3242515|NCT02436239|3975635|FG001|STARTED|Down-Taper Period|Enrollment permitted for participants who had not completed previous open-label treatment period.|103
3242516|NCT02436239|3975636|FG002|STARTED|Down-Taper Period|Enrollment permitted for participants who had not completed previous open-label treatment period.|44
3242517|NCT02436239|3975637|FG003|STARTED|Down-Taper Period|One participant who completed the open-label treatment period did not enter the down-taper period.|6
3242518|NCT02436239|3975634|FG000|COMPLETED|Down-Taper Period||86
3242519|NCT02436239|3975635|FG001|COMPLETED|Down-Taper Period||99
3242520|NCT02436239|3975636|FG002|COMPLETED|Down-Taper Period||43
3242521|NCT02436239|3975637|FG003|COMPLETED|Down-Taper Period||4
3242522|NCT02436239|3975634|FG000|NOT COMPLETED|Down-Taper Period||4
3242523|NCT02436239|3975635|FG001|NOT COMPLETED|Down-Taper Period||4
3242524|NCT02436239|3975636|FG002|NOT COMPLETED|Down-Taper Period||1
3242525|NCT02436239|3975637|FG003|NOT COMPLETED|Down-Taper Period||2
3242526|NCT02436304|3975650|FG000|STARTED|Overall Study||153
3242527|NCT02436304|3975651|FG001|STARTED|Overall Study||102
3242528|NCT02436304|3975652|FG002|STARTED|Overall Study||101
3242529|NCT02436304|3975650|FG000|COMPLETED|Overall Study||153
3242530|NCT02436304|3975651|FG001|COMPLETED|Overall Study||100
3242531|NCT02436304|3975652|FG002|COMPLETED|Overall Study||100
3242532|NCT02436304|3975650|FG000|NOT COMPLETED|Overall Study||0
3242533|NCT02436304|3975651|FG001|NOT COMPLETED|Overall Study||2
3242534|NCT02436304|3975652|FG002|NOT COMPLETED|Overall Study||1
3242535|NCT02436330|3975663|FG000|STARTED|Cohort 1||14
3242536|NCT02436330|3975664|FG001|STARTED|Cohort 1||4
3242537|NCT02436330|3975663|FG000|COMPLETED|Cohort 1||9
3242538|NCT02436330|3975664|FG001|COMPLETED|Cohort 1||1
3242539|NCT02436330|3975663|FG000|NOT COMPLETED|Cohort 1||5
3242540|NCT02436330|3975664|FG001|NOT COMPLETED|Cohort 1||3
3242541|NCT02436330|3975663|FG000|STARTED|Cohort 2||14
3242542|NCT02436330|3975664|FG001|STARTED|Cohort 2||10
3242543|NCT02436330|3975663|FG000|COMPLETED|Cohort 2||10
3242544|NCT02436330|3975664|FG001|COMPLETED|Cohort 2||7
3242545|NCT02436330|3975663|FG000|NOT COMPLETED|Cohort 2||4
3242546|NCT02436330|3975664|FG001|NOT COMPLETED|Cohort 2||3
3242547|NCT02436330|3975663|FG000|STARTED|Cohort 3||12
3242548|NCT02436330|3975664|FG001|STARTED|Cohort 3|Enrollment too low to have control group. All subjects in this cohort received intervention.|0
3242549|NCT02436330|3975663|FG000|COMPLETED|Cohort 3||7
3242550|NCT02436330|3975664|FG001|COMPLETED|Cohort 3||0
3242551|NCT02436330|3975663|FG000|NOT COMPLETED|Cohort 3||5
3242552|NCT02436330|3975664|FG001|NOT COMPLETED|Cohort 3||0
3242553|NCT02436330|3975663|FG000|STARTED|Cohort 4||6
3242554|NCT02436330|3975664|FG001|STARTED|Cohort 4|Enrollment too low to have control group. All subjects in this cohort received intervention.|0
3242555|NCT02436330|3975663|FG000|COMPLETED|Cohort 4||4
3242556|NCT02436330|3975664|FG001|COMPLETED|Cohort 4||0
3242557|NCT02436330|3975663|FG000|NOT COMPLETED|Cohort 4||2
3242558|NCT02436330|3975664|FG001|NOT COMPLETED|Cohort 4||0
3242559|NCT02436330|3975663|FG000|STARTED|Cohort 5||10
3242560|NCT02436330|3975664|FG001|STARTED|Cohort 5||5
3242561|NCT02436330|3975663|FG000|COMPLETED|Cohort 5||4
3242562|NCT02436330|3975664|FG001|COMPLETED|Cohort 5||1
3242563|NCT02436330|3975663|FG000|NOT COMPLETED|Cohort 5||6
3242564|NCT02436330|3975664|FG001|NOT COMPLETED|Cohort 5||4
3242565|NCT02436330|3975663|FG000|STARTED|Cohort 6||4
3242566|NCT02436330|3975664|FG001|STARTED|Cohort 6||5
3242567|NCT02436330|3975663|FG000|COMPLETED|Cohort 6||1
3242568|NCT02436330|3975664|FG001|COMPLETED|Cohort 6||4
3242569|NCT02436330|3975663|FG000|NOT COMPLETED|Cohort 6||3
3242570|NCT02436330|3975664|FG001|NOT COMPLETED|Cohort 6||1
3242571|NCT02436356|3975679|FG000|STARTED|Overall Study||33
3242572|NCT02436356|3975680|FG001|STARTED|Overall Study||11
3242573|NCT02436356|3975681|FG002|STARTED|Overall Study||4
3242574|NCT02436356|3975679|FG000|High Energy Fracture|Overall Study||14
3242575|NCT02436356|3975680|FG001|High Energy Fracture|Overall Study||0
3242576|NCT02436356|3975681|FG002|High Energy Fracture|Overall Study||4
3242577|NCT02436356|3975679|FG000|Low Energy Fracture|Overall Study||19
3242578|NCT02436356|3975680|FG001|Low Energy Fracture|Overall Study||0
3242579|NCT02436356|3975681|FG002|Low Energy Fracture|Overall Study||0
3242580|NCT02436356|3975679|FG000|COMPLETED|Overall Study||28
3242581|NCT02436356|3975680|FG001|COMPLETED|Overall Study||10
3242582|NCT02436356|3975681|FG002|COMPLETED|Overall Study||2
3242583|NCT02436356|3975679|FG000|NOT COMPLETED|Overall Study||5
3242584|NCT02436356|3975680|FG001|NOT COMPLETED|Overall Study||1
3242585|NCT02436356|3975681|FG002|NOT COMPLETED|Overall Study||2
3242586|NCT02436408|3975694|FG000|STARTED|Overall Study||35
3242587|NCT02436408|3975694|FG000|COMPLETED|Overall Study||34
3242588|NCT02436408|3975694|FG000|NOT COMPLETED|Overall Study||1
3242589|NCT02436577|3975704|FG000|STARTED|Overall Study||7
3242590|NCT02436577|3975705|FG001|STARTED|Overall Study||7
3242591|NCT02436577|3975706|FG002|STARTED|Overall Study||7
3242592|NCT02436577|3975707|FG003|STARTED|Overall Study||7
3242593|NCT02436577|3975708|FG004|STARTED|Overall Study||7
3242594|NCT02436577|3975709|FG005|STARTED|Overall Study||7
3242595|NCT02436577|3975704|FG000|COMPLETED|Overall Study||7
3242596|NCT02436577|3975705|FG001|COMPLETED|Overall Study||6
3242597|NCT02436577|3975706|FG002|COMPLETED|Overall Study||7
3242598|NCT02436577|3975707|FG003|COMPLETED|Overall Study||7
3242599|NCT02436577|3975708|FG004|COMPLETED|Overall Study||7
3242600|NCT02436577|3975709|FG005|COMPLETED|Overall Study||7
3242601|NCT02436577|3975704|FG000|NOT COMPLETED|Overall Study||0
3242602|NCT02436577|3975705|FG001|NOT COMPLETED|Overall Study||1
3242603|NCT02436577|3975706|FG002|NOT COMPLETED|Overall Study||0
3242604|NCT02436577|3975707|FG003|NOT COMPLETED|Overall Study||0
3242605|NCT02436577|3975708|FG004|NOT COMPLETED|Overall Study||0
3242606|NCT02436577|3975709|FG005|NOT COMPLETED|Overall Study||0
3242607|NCT02436668|3975719|FG000|STARTED|Overall Study||213
3242608|NCT02436668|3975720|FG001|STARTED|Overall Study||211
3242609|NCT02436668|3975719|FG000|COMPLETED|Overall Study||212
3242610|NCT02436668|3975720|FG001|COMPLETED|Overall Study||207
3242611|NCT02436668|3975719|FG000|NOT COMPLETED|Overall Study||1
3242612|NCT02436668|3975720|FG001|NOT COMPLETED|Overall Study||4
3242613|NCT02436681|3975729|FG000|STARTED|Overall Study||41
3242614|NCT02436681|3975729|FG000|COMPLETED|Overall Study||27
3242615|NCT02436681|3975729|FG000|NOT COMPLETED|Overall Study||14
3242616|NCT02436759|3975735|FG000|STARTED|Overall Study||94
3242617|NCT02436759|3975736|FG001|STARTED|Overall Study||46
3242618|NCT02436759|3975735|FG000|Subjects Randomized|Overall Study||94
3242619|NCT02436759|3975736|FG001|Subjects Randomized|Overall Study||46
3242620|NCT02436759|3975735|FG000|Subjects Treated|Overall Study||94
3242621|NCT02436759|3975736|FG001|Subjects Treated|Overall Study||46
3242622|NCT02436759|3975735|FG000|COMPLETED|Overall Study||90
3242623|NCT02436759|3975736|FG001|COMPLETED|Overall Study||45
3242624|NCT02436759|3975735|FG000|NOT COMPLETED|Overall Study||4
3242625|NCT02436759|3975736|FG001|NOT COMPLETED|Overall Study||1
3242626|NCT02436811|3975745|FG000|STARTED|Overall Study||60
3242627|NCT02436811|3975746|FG001|STARTED|Overall Study||60
3242628|NCT02436811|3975747|FG002|STARTED|Overall Study||60
3242629|NCT02436811|3975745|FG000|COMPLETED|Overall Study||58
3242630|NCT02436811|3975746|FG001|COMPLETED|Overall Study||51
3242631|NCT02436811|3975747|FG002|COMPLETED|Overall Study||53
3242632|NCT02436811|3975745|FG000|NOT COMPLETED|Overall Study||2
3242633|NCT02436811|3975746|FG001|NOT COMPLETED|Overall Study||9
3242634|NCT02436811|3975747|FG002|NOT COMPLETED|Overall Study||7
3242635|NCT02436876|3975759|FG000|STARTED|Overall Study||6
3242636|NCT02436876|3975760|FG001|STARTED|Overall Study||9
3242637|NCT02436876|3975761|FG002|STARTED|Overall Study||7
3242638|NCT02436876|3975762|FG003|STARTED|Overall Study||7
3242639|NCT02436876|3975759|FG000|Treated|Overall Study||6
3242640|NCT02436876|3975760|FG001|Treated|Overall Study||6
3242641|NCT02436876|3975761|FG002|Treated|Overall Study||6
3242642|NCT02436876|3975762|FG003|Treated|Overall Study||7
3242643|NCT02436876|3975759|FG000|COMPLETED|Overall Study||5
3242644|NCT02436876|3975760|FG001|COMPLETED|Overall Study||5
3242645|NCT02436876|3975761|FG002|COMPLETED|Overall Study||5
3242646|NCT02436876|3975762|FG003|COMPLETED|Overall Study||5
3242647|NCT02436876|3975759|FG000|NOT COMPLETED|Overall Study||1
3242648|NCT02436876|3975760|FG001|NOT COMPLETED|Overall Study||4
3242649|NCT02436876|3975761|FG002|NOT COMPLETED|Overall Study||2
3242650|NCT02436876|3975762|FG003|NOT COMPLETED|Overall Study||2
3242651|NCT02436889|3975779|FG000|STARTED|Overall Study||12
3242652|NCT02436889|3975780|FG001|STARTED|Overall Study||11
3242653|NCT02436889|3975779|FG000|COMPLETED|Overall Study||11
3242654|NCT02436889|3975780|FG001|COMPLETED|Overall Study||10
3242655|NCT02436889|3975779|FG000|NOT COMPLETED|Overall Study||1
3242656|NCT02436889|3975780|FG001|NOT COMPLETED|Overall Study||1
3242657|NCT02436915|3975788|FG000|STARTED|Overall Study||9
3242658|NCT02436915|3975789|FG001|STARTED|Overall Study||10
3242659|NCT02436915|3975788|FG000|COMPLETED|Overall Study||9
3242660|NCT02436915|3975789|FG001|COMPLETED|Overall Study||9
3242661|NCT02436915|3975788|FG000|NOT COMPLETED|Overall Study||0
3242662|NCT02436915|3975789|FG001|NOT COMPLETED|Overall Study||1
3242663|NCT02437084|3975797|FG000|STARTED|Overall Study||75
3242664|NCT02437084|3975797|FG000|COMPLETED|Overall Study||72
3242665|NCT02437084|3975797|FG000|NOT COMPLETED|Overall Study||3
3242666|NCT02437162|3975804|FG000|STARTED|Overall Study||116
3242667|NCT02437162|3975805|FG001|STARTED|Overall Study||116
3242668|NCT02437162|3975806|FG002|STARTED|Overall Study||115
3242669|NCT02437162|3975804|FG000|Treated|Overall Study||116
3242670|NCT02437162|3975805|FG001|Treated|Overall Study||116
3242671|NCT02437162|3975806|FG002|Treated|Overall Study||114
3242672|NCT02437162|3975804|FG000|Early Escape at Week 16|Overall Study|Study discontinuation/completion reported under randomization group|26
3242673|NCT02437162|3975805|FG001|Early Escape at Week 16|Overall Study|Study discontinuation/completion reported under randomization group|21
3242674|NCT02437162|3975806|FG002|Early Escape at Week 16|Overall Study|Study discontinuation/completion reported under randomization group|14
3242675|NCT02437162|3975804|FG000|Cross Over at Week 24|Overall Study|Out of 87: crossed over to Ustekinumab 45 mg (n=44) and Ustekinumab 90 mg (n=43)|87
3242676|NCT02437162|3975805|FG001|Cross Over at Week 24|Overall Study||0
3242677|NCT02437162|3975806|FG002|Cross Over at Week 24|Overall Study||0
3242678|NCT02437162|3975804|FG000|COMPLETED|Overall Study||9
3242679|NCT02437162|3975805|FG001|COMPLETED|Overall Study||8
3242680|NCT02437162|3975806|FG002|COMPLETED|Overall Study||6
3242681|NCT02437162|3975804|FG000|NOT COMPLETED|Overall Study||107
3242682|NCT02437162|3975805|FG001|NOT COMPLETED|Overall Study||108
3242683|NCT02437162|3975806|FG002|NOT COMPLETED|Overall Study||109
3242684|NCT02437188|3975821|FG000|STARTED|Overall Study||44
3242685|NCT02437188|3975822|FG001|STARTED|Overall Study||44
3242686|NCT02437188|3975821|FG000|COMPLETED|Overall Study||40
3242687|NCT02437188|3975822|FG001|COMPLETED|Overall Study||35
3242688|NCT02437188|3975821|FG000|NOT COMPLETED|Overall Study||4
3242689|NCT02437188|3975822|FG001|NOT COMPLETED|Overall Study||9
3242690|NCT02437253|3975833|FG000|STARTED|Overall Study||1
3242691|NCT02437253|3975834|FG001|STARTED|Overall Study||1
3242692|NCT02437253|3975833|FG000|COMPLETED|Overall Study||1
3242693|NCT02437253|3975834|FG001|COMPLETED|Overall Study||1
3242694|NCT02437253|3975833|FG000|NOT COMPLETED|Overall Study||0
3242695|NCT02437253|3975834|FG001|NOT COMPLETED|Overall Study||0
3242696|NCT02437305|3975844|FG000|STARTED|Overall Study||50
3242697|NCT02437305|3975845|FG001|STARTED|Overall Study||50
3242698|NCT02437305|3975844|FG000|COMPLETED|Overall Study||32
3242699|NCT02437305|3975845|FG001|COMPLETED|Overall Study||38
3242700|NCT02437305|3975844|FG000|NOT COMPLETED|Overall Study||18
3242701|NCT02437305|3975845|FG001|NOT COMPLETED|Overall Study||12
3242702|NCT02437344|3975851|FG000|STARTED|Overall Study||16
3242703|NCT02437344|3975851|FG000|COMPLETED|Overall Study||15
3242704|NCT02437344|3975851|FG000|NOT COMPLETED|Overall Study||1
3242705|NCT02437383|3975857|FG000|STARTED|Overall Study||100
3242706|NCT02437383|3975858|FG001|STARTED|Overall Study||100
3242707|NCT02437383|3975857|FG000|COMPLETED|Overall Study||87
3242708|NCT02437383|3975858|FG001|COMPLETED|Overall Study||87
3242709|NCT02437383|3975857|FG000|NOT COMPLETED|Overall Study||13
3242710|NCT02437383|3975858|FG001|NOT COMPLETED|Overall Study||13
3370535|NCT03768726|4101918|FG000|Received Treatment|Follow-Up||8
3370536|NCT03768726|4101919|FG001|Received Treatment|Follow-Up||12
3370537|NCT03768726|4101918|FG000|COMPLETED|Follow-Up||2
3370538|NCT03768726|4101919|FG001|COMPLETED|Follow-Up||9
3370539|NCT03768726|4101918|FG000|NOT COMPLETED|Follow-Up||6
3370540|NCT03768726|4101919|FG001|NOT COMPLETED|Follow-Up||3
3370541|NCT03768206|4101927|FG000|STARTED|Overall Study||24
3370542|NCT03768206|4101928|FG001|STARTED|Overall Study||21
3370543|NCT03768206|4101927|FG000|COMPLETED|Overall Study||22
3370544|NCT03768206|4101928|FG001|COMPLETED|Overall Study||19
3370545|NCT03768206|4101927|FG000|NOT COMPLETED|Overall Study||2
3370546|NCT03768206|4101928|FG001|NOT COMPLETED|Overall Study||2
3370547|NCT03767894|4101935|FG000|STARTED|Overall Study||12
3370548|NCT03767894|4101935|FG000|COMPLETED|Overall Study||11
3370549|NCT03767894|4101935|FG000|NOT COMPLETED|Overall Study||1
3370550|NCT03767738|4101941|FG000|STARTED|Overall Study||35
3370551|NCT03767738|4101942|FG001|STARTED|Overall Study||30
3370552|NCT03767738|4101941|FG000|COMPLETED|Overall Study||35
3370553|NCT03767738|4101942|FG001|COMPLETED|Overall Study||30
3370554|NCT03767738|4101941|FG000|NOT COMPLETED|Overall Study||0
3370555|NCT03767738|4101942|FG001|NOT COMPLETED|Overall Study||0
3370556|NCT03767153|4101950|FG000|STARTED|Overall Study||14
3242711|NCT02437409|3975864|FG000|STARTED|Overall Study|Eventually 100 evaluable patients, attrition rate of 15%|115
3242712|NCT02437409|3975864|FG000|COMPLETED|Overall Study|In total 100 patients fulfilled the in-and exclusion criteria,15 patients were excluded/discontinued|100
3242713|NCT02437409|3975864|FG000|NOT COMPLETED|Overall Study||15
3242714|NCT02437487|3975871|FG000|STARTED|Overall Study||59
3242715|NCT02437487|3975872|FG001|STARTED|Overall Study||30
3242716|NCT02437487|3975871|FG000|Actual Treatment Received|Overall Study||60
3242717|NCT02437487|3975872|FG001|Actual Treatment Received|Overall Study||29
3242718|NCT02437487|3975871|FG000|Intention-to-Treat Population|Overall Study||59
3242719|NCT02437487|3975872|FG001|Intention-to-Treat Population|Overall Study||30
3242720|NCT02437487|3975871|FG000|COMPLETED|Overall Study||32
3242721|NCT02437487|3975872|FG001|COMPLETED|Overall Study||16
3242722|NCT02437487|3975871|FG000|NOT COMPLETED|Overall Study||27
3242723|NCT02437487|3975872|FG001|NOT COMPLETED|Overall Study||14
3242724|NCT02437513|3975878|FG000|STARTED|Overall Study||2
3242725|NCT02437513|3975878|FG000|COMPLETED|Overall Study||0
3242726|NCT02437513|3975878|FG000|NOT COMPLETED|Overall Study||2
3242727|NCT02437669|3975882|FG000|STARTED|Overall Study||35
3242728|NCT02437669|3975882|FG000|COMPLETED|Overall Study||35
3242729|NCT02437669|3975882|FG000|NOT COMPLETED|Overall Study||0
3242730|NCT02437864|3975889|FG000|STARTED|Overall Study||200
3242731|NCT02437864|3975890|FG001|STARTED|Overall Study||160
3242732|NCT02437864|3975889|FG000|COMPLETED|Overall Study||196
3242733|NCT02437864|3975890|FG001|COMPLETED|Overall Study||160
3242734|NCT02437864|3975889|FG000|NOT COMPLETED|Overall Study||4
3370557|NCT03767153|4101951|FG001|STARTED|Overall Study||11
3370558|NCT03767153|4101950|FG000|COMPLETED|Overall Study||14
3370559|NCT03767153|4101951|FG001|COMPLETED|Overall Study||11
3370560|NCT03767153|4101950|FG000|NOT COMPLETED|Overall Study||0
3370561|NCT03767153|4101951|FG001|NOT COMPLETED|Overall Study||0
3370562|NCT03767062|4101959|FG000|STARTED|Overall Study||45
3370563|NCT03767062|4101960|FG001|STARTED|Overall Study||45
3370564|NCT03767062|4101959|FG000|COMPLETED|Overall Study||37
3370565|NCT03767062|4101960|FG001|COMPLETED|Overall Study||41
3370566|NCT03767062|4101959|FG000|NOT COMPLETED|Overall Study||8
3370567|NCT03767062|4101960|FG001|NOT COMPLETED|Overall Study||4
3370568|NCT03766646|4101968|FG000|STARTED|Overall Study||19
3370569|NCT03766646|4101969|FG001|STARTED|Overall Study||15
3370570|NCT03766646|4101968|FG000|COMPLETED|Overall Study||18
3370571|NCT03766646|4101969|FG001|COMPLETED|Overall Study||12
3370572|NCT03766646|4101968|FG000|NOT COMPLETED|Overall Study||1
3370573|NCT03766646|4101969|FG001|NOT COMPLETED|Overall Study||3
3370574|NCT03766373|4101977|FG000|STARTED|Overall Study||12
3370575|NCT03766373|4101978|FG001|STARTED|Overall Study||12
3370576|NCT03766373|4101977|FG000|COMPLETED|Overall Study||12
3370577|NCT03766373|4101978|FG001|COMPLETED|Overall Study||12
3370578|NCT03766373|4101977|FG000|NOT COMPLETED|Overall Study||0
3370579|NCT03766373|4101978|FG001|NOT COMPLETED|Overall Study||0
3370580|NCT03766165|4101986|FG000|STARTED|Overall Study||19
3370581|NCT03766165|4101987|FG001|STARTED|Overall Study||19
3370582|NCT03766165|4101986|FG000|COMPLETED|Overall Study||19
3370583|NCT03766165|4101987|FG001|COMPLETED|Overall Study||19
3370584|NCT03766165|4101986|FG000|NOT COMPLETED|Overall Study||0
3370585|NCT03766165|4101987|FG001|NOT COMPLETED|Overall Study||0
3370586|NCT03765996|4101996|FG000|STARTED|Overall Study||18
3370587|NCT03765996|4101997|FG001|STARTED|Overall Study||18
3370588|NCT03765996|4101996|FG000|COMPLETED|Overall Study||14
3370589|NCT03765996|4101997|FG001|COMPLETED|Overall Study||18
3370590|NCT03765996|4101996|FG000|NOT COMPLETED|Overall Study||4
3370591|NCT03765996|4101997|FG001|NOT COMPLETED|Overall Study||0
3370592|NCT03765762|4102005|FG000|STARTED|Overall Study||18
3370593|NCT03765762|4102006|FG001|STARTED|Overall Study||8
3370594|NCT03765762|4102005|FG000|COMPLETED|Overall Study||18
3370595|NCT03765762|4102006|FG001|COMPLETED|Overall Study||8
3370596|NCT03765762|4102005|FG000|NOT COMPLETED|Overall Study||0
3370597|NCT03765762|4102006|FG001|NOT COMPLETED|Overall Study||0
3370598|NCT03765502|4102015|FG000|STARTED|Simulation 1||20
3370599|NCT03765502|4102016|FG001|STARTED|Simulation 1||13
3370600|NCT03765502|4102017|FG002|STARTED|Simulation 1||33
3370601|NCT03765502|4102018|FG003|STARTED|Simulation 1||16
3370602|NCT03765502|4102019|FG004|STARTED|Simulation 1||17
3370603|NCT03765502|4102015|FG000|COMPLETED|Simulation 1||20
3370604|NCT03765502|4102016|FG001|COMPLETED|Simulation 1||13
3370605|NCT03765502|4102017|FG002|COMPLETED|Simulation 1||33
3370606|NCT03765502|4102018|FG003|COMPLETED|Simulation 1||16
3370607|NCT03765502|4102019|FG004|COMPLETED|Simulation 1||17
3370608|NCT03765502|4102015|FG000|NOT COMPLETED|Simulation 1||0
3370609|NCT03765502|4102016|FG001|NOT COMPLETED|Simulation 1||0
3370610|NCT03765502|4102017|FG002|NOT COMPLETED|Simulation 1||0
3370611|NCT03765502|4102018|FG003|NOT COMPLETED|Simulation 1||0
3370612|NCT03765502|4102019|FG004|NOT COMPLETED|Simulation 1||0
3370613|NCT03765502|4102015|FG000|STARTED|Simulation 2||20
3370614|NCT03765502|4102016|FG001|STARTED|Simulation 2|Participant completed Period 1 GEK simulation but did not return for the Period 2 NG simulation.|12
3370615|NCT03765502|4102017|FG002|STARTED|Simulation 2|PWD completed Period 1 GEK simulation but did not return for the Period 2 NG simulation.|32
3370616|NCT03765502|4102018|FG003|STARTED|Simulation 2||16
3370617|NCT03765502|4102019|FG004|STARTED|Simulation 2||17
3370618|NCT03765502|4102015|FG000|COMPLETED|Simulation 2||20
3370619|NCT03765502|4102016|FG001|COMPLETED|Simulation 2||12
3370620|NCT03765502|4102017|FG002|COMPLETED|Simulation 2||32
3370621|NCT03765502|4102018|FG003|COMPLETED|Simulation 2||16
3242735|NCT02437864|3975890|FG001|NOT COMPLETED|Overall Study||0
3242736|NCT02437890|3975901|FG000|STARTED|Overall Study||62
3242737|NCT02437890|3975902|FG001|STARTED|Overall Study||64
3242738|NCT02437890|3975903|FG002|STARTED|Overall Study||62
3242739|NCT02437890|3975904|FG003|STARTED|Overall Study||62
3242740|NCT02437890|3975905|FG004|STARTED|Overall Study||62
3242741|NCT02437890|3975901|FG000|COMPLETED|Overall Study||54
3242742|NCT02437890|3975902|FG001|COMPLETED|Overall Study||48
3242743|NCT02437890|3975903|FG002|COMPLETED|Overall Study||47
3242744|NCT02437890|3975904|FG003|COMPLETED|Overall Study||40
3242745|NCT02437890|3975905|FG004|COMPLETED|Overall Study||46
3242746|NCT02437890|3975901|FG000|NOT COMPLETED|Overall Study||8
3242747|NCT02437890|3975902|FG001|NOT COMPLETED|Overall Study||16
3242748|NCT02437890|3975903|FG002|NOT COMPLETED|Overall Study||15
3242749|NCT02437890|3975904|FG003|NOT COMPLETED|Overall Study||22
3242750|NCT02437890|3975905|FG004|NOT COMPLETED|Overall Study||16
3242751|NCT02437903|3975921|FG000|STARTED|Overall Study||30
3242752|NCT02437903|3975921|FG000|COMPLETED|Overall Study||25
3242753|NCT02437903|3975921|FG000|NOT COMPLETED|Overall Study||5
3242754|NCT02438137|3975928|FG000|STARTED|Overall Study||44
3242755|NCT02438137|3975929|FG001|STARTED|Overall Study||21
3242756|NCT02438137|3975928|FG000|COMPLETED|Overall Study||36
3242757|NCT02438137|3975929|FG001|COMPLETED|Overall Study||15
3242758|NCT02438137|3975928|FG000|NOT COMPLETED|Overall Study||8
3242759|NCT02438137|3975929|FG001|NOT COMPLETED|Overall Study||6
3242760|NCT02438280|3975939|FG000|STARTED|Overall Study||14
3242761|NCT02438280|3975940|FG001|STARTED|Overall Study||13
3242762|NCT02438280|3975939|FG000|COMPLETED|Overall Study||13
3242763|NCT02438280|3975940|FG001|COMPLETED|Overall Study||13
3242764|NCT02438280|3975939|FG000|NOT COMPLETED|Overall Study||1
3242765|NCT02438280|3975940|FG001|NOT COMPLETED|Overall Study||0
3242766|NCT02438371|3975949|FG000|STARTED|Overall Study||24
3242767|NCT02438371|3975950|FG001|STARTED|Overall Study||25
3242768|NCT02438371|3975949|FG000|Received Intervention|Overall Study||24
3242769|NCT02438371|3975950|FG001|Received Intervention|Overall Study||25
3242770|NCT02438371|3975949|FG000|COMPLETED|Overall Study||20
3242771|NCT02438371|3975950|FG001|COMPLETED|Overall Study||22
3242772|NCT02438371|3975949|FG000|NOT COMPLETED|Overall Study||4
3242773|NCT02438371|3975950|FG001|NOT COMPLETED|Overall Study||3
3242774|NCT02438384|3975959|FG000|STARTED|Overall Study||25
3242775|NCT02438384|3975960|FG001|STARTED|Overall Study||25
3242776|NCT02438384|3975961|FG002|STARTED|Overall Study||25
3242777|NCT02438384|3975959|FG000|COMPLETED|Overall Study||17
3242778|NCT02438384|3975960|FG001|COMPLETED|Overall Study||19
3242779|NCT02438384|3975961|FG002|COMPLETED|Overall Study||21
3242780|NCT02438384|3975959|FG000|NOT COMPLETED|Overall Study||8
3242781|NCT02438384|3975960|FG001|NOT COMPLETED|Overall Study||6
3242782|NCT02438384|3975961|FG002|NOT COMPLETED|Overall Study||4
3242783|NCT02438423|3975973|FG000|STARTED|Overall Study||25
3242784|NCT02438423|3975974|FG001|STARTED|Overall Study||25
3242785|NCT02438423|3975975|FG002|STARTED|Overall Study||25
3242786|NCT02438423|3975976|FG003|STARTED|Overall Study||25
3242787|NCT02438423|3975973|FG000|COMPLETED|Overall Study||25
3242788|NCT02438423|3975974|FG001|COMPLETED|Overall Study||25
3242789|NCT02438423|3975975|FG002|COMPLETED|Overall Study||25
3242790|NCT02438423|3975976|FG003|COMPLETED|Overall Study||25
3242791|NCT02438423|3975973|FG000|NOT COMPLETED|Overall Study||0
3242792|NCT02438423|3975974|FG001|NOT COMPLETED|Overall Study||0
3242793|NCT02438423|3975975|FG002|NOT COMPLETED|Overall Study||0
3242794|NCT02438423|3975976|FG003|NOT COMPLETED|Overall Study||0
3242795|NCT02438475|3975990|FG000|STARTED|Overall Study||104
3242796|NCT02438475|3975991|FG001|STARTED|Overall Study||104
3242797|NCT02438475|3975990|FG000|COMPLETED|Overall Study||102
3242798|NCT02438475|3975991|FG001|COMPLETED|Overall Study||104
3242799|NCT02438475|3975990|FG000|NOT COMPLETED|Overall Study||2
3242800|NCT02438475|3975991|FG001|NOT COMPLETED|Overall Study||0
3242801|NCT02438540|3975999|FG000|STARTED|Overall Study||19
3242802|NCT02438540|3976000|FG001|STARTED|Overall Study||20
3242803|NCT02438540|3975999|FG000|COMPLETED|Overall Study||19
3242804|NCT02438540|3976000|FG001|COMPLETED|Overall Study||20
3242805|NCT02438540|3975999|FG000|NOT COMPLETED|Overall Study||0
3242806|NCT02438540|3976000|FG001|NOT COMPLETED|Overall Study||0
3242807|NCT02438722|3976009|FG000|STARTED|Overall Study||83
3242808|NCT02438722|3976010|FG001|STARTED|Overall Study||85
3242809|NCT02438722|3976009|FG000|Participants Evaluable for Adverse Events|Overall Study||78
3242810|NCT02438722|3976010|FG001|Participants Evaluable for Adverse Events|Overall Study||85
3242811|NCT02438722|3976009|FG000|COMPLETED|Overall Study||0
3242812|NCT02438722|3976010|FG001|COMPLETED|Overall Study||0
3242813|NCT02438722|3976009|FG000|NOT COMPLETED|Overall Study||83
3242814|NCT02438722|3976010|FG001|NOT COMPLETED|Overall Study||85
3242815|NCT02438787|3976019|FG000|STARTED|Overall Study||104
3242816|NCT02438787|3976020|FG001|STARTED|Overall Study||106
3242817|NCT02438787|3976021|FG002|STARTED|Overall Study||105
3242818|NCT02438787|3976019|FG000|Early Escape at Week 16|Overall Study|Study discontinuation/completion reported under randomization group|21
3242819|NCT02438787|3976020|FG001|Early Escape at Week 16|Overall Study|Study discontinuation/completion reported under randomization group|21
3242820|NCT02438787|3976021|FG002|Early Escape at Week 16|Overall Study|Study discontinuation/completion reported under randomization group|20
3242821|NCT02438787|3976019|FG000|Cross Over at Week 24|Overall Study|Out of 43: crossed over to Ustekinumab 45 mg (n=21) and Ustekinumab 90 mg (n=22)|43
3242822|NCT02438787|3976020|FG001|Cross Over at Week 24|Overall Study||0
3242823|NCT02438787|3976021|FG002|Cross Over at Week 24|Overall Study||0
3242824|NCT02438787|3976019|FG000|COMPLETED|Overall Study||23
3242825|NCT02438787|3976020|FG001|COMPLETED|Overall Study||23
3242826|NCT02438787|3976021|FG002|COMPLETED|Overall Study||22
3242827|NCT02438787|3976019|FG000|NOT COMPLETED|Overall Study||81
3242828|NCT02438787|3976020|FG001|NOT COMPLETED|Overall Study||83
3242829|NCT02438787|3976021|FG002|NOT COMPLETED|Overall Study||83
3242830|NCT02438813|3976034|FG000|STARTED|Overall Study||1029
3242831|NCT02438813|3976034|FG000|Received Treatment for SMF|Overall Study||676
3242832|NCT02438813|3976034|FG000|Did Not ReceiveTreatment for SMF|Overall Study||353
3242833|NCT02438813|3976034|FG000|COMPLETED|Overall Study||504
3242834|NCT02438813|3976034|FG000|NOT COMPLETED|Overall Study||525
3242835|NCT02438826|3976050|FG000|STARTED|Double-Blind Treatment Phase||123
3242836|NCT02438826|3976051|FG001|STARTED|Double-Blind Treatment Phase||117
3242837|NCT02438826|3976052|FG002|STARTED|Double-Blind Treatment Phase||0
3242838|NCT02438826|3976053|FG003|STARTED|Double-Blind Treatment Phase||0
3242839|NCT02438826|3976050|FG000|Received at Least 1 Dose of Study Drug|Double-Blind Treatment Phase||120
3242840|NCT02438826|3976051|FG001|Received at Least 1 Dose of Study Drug|Double-Blind Treatment Phase||117
3242841|NCT02438826|3976052|FG002|Received at Least 1 Dose of Study Drug|Double-Blind Treatment Phase||0
3242842|NCT02438826|3976053|FG003|Received at Least 1 Dose of Study Drug|Double-Blind Treatment Phase||0
3242843|NCT02438826|3976050|FG000|COMPLETED|Double-Blind Treatment Phase||117
3242844|NCT02438826|3976051|FG001|COMPLETED|Double-Blind Treatment Phase||113
3242845|NCT02438826|3976052|FG002|COMPLETED|Double-Blind Treatment Phase||0
3242846|NCT02438826|3976053|FG003|COMPLETED|Double-Blind Treatment Phase||0
3242847|NCT02438826|3976050|FG000|NOT COMPLETED|Double-Blind Treatment Phase||6
3242848|NCT02438826|3976051|FG001|NOT COMPLETED|Double-Blind Treatment Phase||4
3242849|NCT02438826|3976052|FG002|NOT COMPLETED|Double-Blind Treatment Phase||0
3242850|NCT02438826|3976053|FG003|NOT COMPLETED|Double-Blind Treatment Phase||0
3242851|NCT02438826|3976050|FG000|STARTED|Open-Label Treatment Phase|This period is optional phase, one participant chose not to enter the open-label phase.|116
3242852|NCT02438826|3976051|FG001|STARTED|Open-Label Treatment Phase||113
3242853|NCT02438826|3976052|FG002|STARTED|Open-Label Treatment Phase||0
3242854|NCT02438826|3976053|FG003|STARTED|Open-Label Treatment Phase||0
3242855|NCT02438826|3976050|FG000|COMPLETED|Open-Label Treatment Phase||72
3242856|NCT02438826|3976051|FG001|COMPLETED|Open-Label Treatment Phase||80
3242857|NCT02438826|3976052|FG002|COMPLETED|Open-Label Treatment Phase||0
3242858|NCT02438826|3976053|FG003|COMPLETED|Open-Label Treatment Phase||0
3242859|NCT02438826|3976050|FG000|NOT COMPLETED|Open-Label Treatment Phase||44
3242860|NCT02438826|3976051|FG001|NOT COMPLETED|Open-Label Treatment Phase||33
3242861|NCT02438826|3976052|FG002|NOT COMPLETED|Open-Label Treatment Phase||0
3242862|NCT02438826|3976053|FG003|NOT COMPLETED|Open-Label Treatment Phase||0
3242863|NCT02438826|3976050|FG000|STARTED|Post-Treatment Phase|Participants who discontinued Open-Label Treatment also had the option to enter Post-Treatment Phase|93
3242864|NCT02438826|3976051|FG001|STARTED|Post-Treatment Phase|Participants who discontinued Open-Label Treatment also had the option to enter Post-Treatment Phase|93
3242865|NCT02438826|3976052|FG002|STARTED|Post-Treatment Phase|Participants entered from Double-Blind Treatment Phase.|2
3242866|NCT02438826|3976053|FG003|STARTED|Post-Treatment Phase|Participants entered from Double-Blind Treatment Phase.|4
3242867|NCT02438826|3976050|FG000|COMPLETED|Post-Treatment Phase||84
3242868|NCT02438826|3976051|FG001|COMPLETED|Post-Treatment Phase||92
3242869|NCT02438826|3976052|FG002|COMPLETED|Post-Treatment Phase||2
3242870|NCT02438826|3976053|FG003|COMPLETED|Post-Treatment Phase||4
3242871|NCT02438826|3976050|FG000|NOT COMPLETED|Post-Treatment Phase||9
3242872|NCT02438826|3976051|FG001|NOT COMPLETED|Post-Treatment Phase||1
3242873|NCT02438826|3976052|FG002|NOT COMPLETED|Post-Treatment Phase||0
3242874|NCT02438826|3976053|FG003|NOT COMPLETED|Post-Treatment Phase||0
3242875|NCT02439138|3976068|FG000|STARTED|Overall Study||5
3242876|NCT02439138|3976068|FG000|COMPLETED|Overall Study||2
3242877|NCT02439138|3976068|FG000|NOT COMPLETED|Overall Study||3
3242878|NCT02439164|3976074|FG000|STARTED|Overall Study||18
3242879|NCT02439164|3976075|FG001|STARTED|Overall Study||18
3242880|NCT02439164|3976074|FG000|COMPLETED|Overall Study||18
3242881|NCT02439164|3976075|FG001|COMPLETED|Overall Study||18
3242882|NCT02439164|3976074|FG000|NOT COMPLETED|Overall Study||0
3242883|NCT02439164|3976075|FG001|NOT COMPLETED|Overall Study||0
3242884|NCT02439281|3976084|FG000|STARTED|Overall Study||24
3242885|NCT02439281|3976085|FG001|STARTED|Overall Study||26
3242886|NCT02439281|3976084|FG000|COMPLETED|Overall Study||24
3242887|NCT02439281|3976085|FG001|COMPLETED|Overall Study||26
3242888|NCT02439281|3976084|FG000|NOT COMPLETED|Overall Study||0
3242889|NCT02439281|3976085|FG001|NOT COMPLETED|Overall Study||0
3242890|NCT02439320|3976096|FG000|STARTED|Overall Study||744
3242891|NCT02439320|3976097|FG001|STARTED|Overall Study||745
3242892|NCT02439320|3976098|FG002|STARTED|Overall Study||742
3242893|NCT02439320|3976096|FG000|Confirmed Eligibility|Overall Study||710
3242894|NCT02439320|3976097|FG001|Confirmed Eligibility|Overall Study||695
3242895|NCT02439320|3976098|FG002|Confirmed Eligibility|Overall Study||705
3242896|NCT02439320|3976096|FG000|1st Dose (by 4 Hours Migraine Onset)|Overall Study||630
3242897|NCT02439320|3976097|FG001|1st Dose (by 4 Hours Migraine Onset)|Overall Study||609
3242898|NCT02439320|3976098|FG002|1st Dose (by 4 Hours Migraine Onset)|Overall Study||617
3242899|NCT02439320|3976096|FG000|2nd Dose (After 2 Hour Assessment)|Overall Study||289
3242900|NCT02439320|3976097|FG001|2nd Dose (After 2 Hour Assessment)|Overall Study||238
3242901|NCT02439320|3976098|FG002|2nd Dose (After 2 Hour Assessment)|Overall Study||401
3242902|NCT02439320|3976096|FG000|COMPLETED|Overall Study||648
3242903|NCT02439320|3976097|FG001|COMPLETED|Overall Study||631
3242904|NCT02439320|3976098|FG002|COMPLETED|Overall Study||643
3242905|NCT02439320|3976096|FG000|NOT COMPLETED|Overall Study||96
3242906|NCT02439320|3976097|FG001|NOT COMPLETED|Overall Study||114
3242907|NCT02439320|3976098|FG002|NOT COMPLETED|Overall Study||99
3242908|NCT02439710|3976112|FG000|STARTED|Overall Study||656
3242909|NCT02439710|3976112|FG000|COMPLETED|Overall Study||656
3242910|NCT02439710|3976112|FG000|NOT COMPLETED|Overall Study||0
3242911|NCT02439749|3976118|FG000|STARTED|Overall Study||182
3242912|NCT02439749|3976119|FG001|STARTED|Overall Study||184
3242913|NCT02439749|3976118|FG000|COMPLETED|Overall Study||153
3242914|NCT02439749|3976119|FG001|COMPLETED|Overall Study||147
3242915|NCT02439749|3976118|FG000|NOT COMPLETED|Overall Study||29
3242916|NCT02439749|3976119|FG001|NOT COMPLETED|Overall Study||37
3242917|NCT02439814|3976127|FG000|STARTED|Overall Study||11
3242918|NCT02439814|3976128|FG001|STARTED|Overall Study||10
3242919|NCT02439814|3976127|FG000|COMPLETED|Overall Study||11
3242920|NCT02439814|3976128|FG001|COMPLETED|Overall Study||10
3242921|NCT02439814|3976127|FG000|NOT COMPLETED|Overall Study||0
3242922|NCT02439814|3976128|FG001|NOT COMPLETED|Overall Study||0
3242923|NCT02439879|3976136|FG000|STARTED|Overall Study||16
3242924|NCT02439879|3976137|FG001|STARTED|Overall Study||17
3242925|NCT02439879|3976136|FG000|COMPLETED|Overall Study||16
3242926|NCT02439879|3976137|FG001|COMPLETED|Overall Study||17
3242927|NCT02439879|3976136|FG000|NOT COMPLETED|Overall Study||0
3242928|NCT02439879|3976137|FG001|NOT COMPLETED|Overall Study||0
3242929|NCT02440022|3976145|FG000|STARTED|Overall Study||141
3242930|NCT02440022|3976146|FG001|STARTED|Overall Study||144
3242931|NCT02440022|3976145|FG000|COMPLETED|Overall Study||114
3242932|NCT02440022|3976146|FG001|COMPLETED|Overall Study||131
3242933|NCT02440022|3976145|FG000|NOT COMPLETED|Overall Study||27
3242934|NCT02440022|3976146|FG001|NOT COMPLETED|Overall Study||13
3242935|NCT02440139|3976152|FG000|STARTED|Overall Study|12 radiologists read 324 CT cases|12
3242936|NCT02440139|3976152|FG000|COMPLETED|Overall Study|12 radiologists read 324 CT cases|12
3242937|NCT02440139|3976152|FG000|NOT COMPLETED|Overall Study||0
3242938|NCT02440178|3976160|FG000|STARTED|Overall Study||66
3242939|NCT02440178|3976160|FG000|COMPLETED|Overall Study||46
3242940|NCT02440178|3976160|FG000|NOT COMPLETED|Overall Study||20
3242941|NCT02440204|3976169|FG000|STARTED|Overall Study||22
3242942|NCT02440204|3976170|FG001|STARTED|Overall Study||24
3242943|NCT02440204|3976171|FG002|STARTED|Overall Study||22
3242944|NCT02440204|3976169|FG000|COMPLETED|Overall Study||22
3242945|NCT02440204|3976170|FG001|COMPLETED|Overall Study||24
3370622|NCT03765502|4102019|FG004|COMPLETED|Simulation 2||17
3370623|NCT03765502|4102015|FG000|NOT COMPLETED|Simulation 2||0
3370624|NCT03765502|4102016|FG001|NOT COMPLETED|Simulation 2||0
3370625|NCT03765502|4102017|FG002|NOT COMPLETED|Simulation 2||0
3370626|NCT03765502|4102018|FG003|NOT COMPLETED|Simulation 2||0
3370627|NCT03765502|4102019|FG004|NOT COMPLETED|Simulation 2||0
3370628|NCT03765164|4102041|FG000|STARTED|Pre-intervention||78
3370629|NCT03765164|4102042|FG001|STARTED|Pre-intervention||78
3370630|NCT03765164|4102041|FG000|COMPLETED|Pre-intervention||73
3370631|NCT03765164|4102042|FG001|COMPLETED|Pre-intervention||72
3370632|NCT03765164|4102041|FG000|NOT COMPLETED|Pre-intervention||5
3370633|NCT03765164|4102042|FG001|NOT COMPLETED|Pre-intervention||6
3370634|NCT03765164|4102041|FG000|STARTED|Post-intervention||73
3242946|NCT02440204|3976171|FG002|COMPLETED|Overall Study||22
3242947|NCT02440204|3976169|FG000|NOT COMPLETED|Overall Study||0
3242948|NCT02440204|3976170|FG001|NOT COMPLETED|Overall Study||0
3370635|NCT03765164|4102042|FG001|STARTED|Post-intervention||72
3370636|NCT03765164|4102041|FG000|COMPLETED|Post-intervention||0
3242949|NCT02440204|3976171|FG002|NOT COMPLETED|Overall Study||0
3242950|NCT02440308|3976179|FG000|STARTED|Overall Study||10
3242951|NCT02440308|3976179|FG000|COMPLETED|Overall Study||10
3242952|NCT02440308|3976179|FG000|NOT COMPLETED|Overall Study||0
3242953|NCT02440334|3976183|FG000|STARTED|Overall Study||53
3242954|NCT02440334|3976183|FG000|COMPLETED|Overall Study||53
3242955|NCT02440334|3976183|FG000|NOT COMPLETED|Overall Study||0
3370637|NCT03765164|4102042|FG001|COMPLETED|Post-intervention||0
3370638|NCT03765164|4102041|FG000|NOT COMPLETED|Post-intervention||73
3370639|NCT03765164|4102042|FG001|NOT COMPLETED|Post-intervention||72
3242956|NCT02440425|3976187|FG000|STARTED|Overall Study||42
3242957|NCT02440425|3976187|FG000|COMPLETED|Overall Study||37
3242958|NCT02440425|3976187|FG000|NOT COMPLETED|Overall Study||5
3242959|NCT02440451|3976191|FG000|STARTED|Overall Study||15
3242960|NCT02440451|3976191|FG000|COMPLETED|Overall Study||15
3242961|NCT02440451|3976191|FG000|NOT COMPLETED|Overall Study||0
3242962|NCT02440568|3976199|FG000|STARTED|Overall Study||5
3242963|NCT02440568|3976200|FG001|STARTED|Overall Study||4
3242964|NCT02440568|3976201|FG002|STARTED|Overall Study||10
3242965|NCT02440568|3976202|FG003|STARTED|Overall Study||3
3242966|NCT02440568|3976199|FG000|COMPLETED|Overall Study||1
3242967|NCT02440568|3976200|FG001|COMPLETED|Overall Study||1
3242968|NCT02440568|3976201|FG002|COMPLETED|Overall Study||5
3242969|NCT02440568|3976202|FG003|COMPLETED|Overall Study||1
3242970|NCT02440568|3976199|FG000|NOT COMPLETED|Overall Study||4
3242971|NCT02440568|3976200|FG001|NOT COMPLETED|Overall Study||3
3242972|NCT02440568|3976201|FG002|NOT COMPLETED|Overall Study||5
3242973|NCT02440568|3976202|FG003|NOT COMPLETED|Overall Study||2
3242974|NCT02440594|3976221|FG000|STARTED|Overall Study||509
3242975|NCT02440594|3976222|FG001|STARTED|Overall Study||509
3242976|NCT02440594|3976223|FG002|STARTED|Overall Study||436
3242977|NCT02440594|3976224|FG003|STARTED|Overall Study||429
3242978|NCT02440594|3976225|FG004|STARTED|Overall Study||55
3242979|NCT02440594|3976226|FG005|STARTED|Overall Study||54
3242980|NCT02440594|3976227|FG006|STARTED|Overall Study||150
3242981|NCT02440594|3976228|FG007|STARTED|Overall Study||290
3242982|NCT02440594|3976221|FG000|COMPLETED|Overall Study||377
3242983|NCT02440594|3976222|FG001|COMPLETED|Overall Study||401
3242984|NCT02440594|3976223|FG002|COMPLETED|Overall Study||319
3242985|NCT02440594|3976224|FG003|COMPLETED|Overall Study||340
3242986|NCT02440594|3976225|FG004|COMPLETED|Overall Study||46
3242987|NCT02440594|3976226|FG005|COMPLETED|Overall Study||47
3242988|NCT02440594|3976227|FG006|COMPLETED|Overall Study||113
3242989|NCT02440594|3976228|FG007|COMPLETED|Overall Study||234
3242990|NCT02440594|3976221|FG000|NOT COMPLETED|Overall Study||132
3242991|NCT02440594|3976222|FG001|NOT COMPLETED|Overall Study||108
3242992|NCT02440594|3976223|FG002|NOT COMPLETED|Overall Study||117
3242993|NCT02440594|3976224|FG003|NOT COMPLETED|Overall Study||89
3242994|NCT02440594|3976225|FG004|NOT COMPLETED|Overall Study||9
3242995|NCT02440594|3976226|FG005|NOT COMPLETED|Overall Study||7
3242996|NCT02440594|3976227|FG006|NOT COMPLETED|Overall Study||37
3242997|NCT02440594|3976228|FG007|NOT COMPLETED|Overall Study||56
3242998|NCT02440633|3976253|FG000|STARTED|Overall Study||8
3242999|NCT02440633|3976253|FG000|COMPLETED|Overall Study||8
3243000|NCT02440633|3976253|FG000|NOT COMPLETED|Overall Study||0
3243001|NCT02440659|3976263|FG000|STARTED|Overall Study||1997
3243002|NCT02440659|3976264|FG001|STARTED|Overall Study||949
3243003|NCT02440659|3976263|FG000|COMPLETED|Overall Study||1346
3243004|NCT02440659|3976264|FG001|COMPLETED|Overall Study||614
3243005|NCT02440659|3976263|FG000|NOT COMPLETED|Overall Study||651
3243006|NCT02440659|3976264|FG001|NOT COMPLETED|Overall Study||335
3243007|NCT02440789|3976270|FG000|STARTED|Overall Study||32
3243008|NCT02440789|3976270|FG000|Initiated Sirolimus|Overall Study||30
3243009|NCT02440789|3976270|FG000|Completed 20 Weeks of Sirolimus|Overall Study||16
3243010|NCT02440789|3976270|FG000|COMPLETED|Overall Study||28
3243011|NCT02440789|3976270|FG000|NOT COMPLETED|Overall Study||4
3243012|NCT02441062|3976274|FG000|STARTED|Overall Study||122
3243013|NCT02441062|3976274|FG000|COMPLETED|Overall Study||122
3243014|NCT02441062|3976274|FG000|NOT COMPLETED|Overall Study||0
3243015|NCT02441114|3976278|FG000|STARTED|Period1||10
3243016|NCT02441114|3976278|FG000|COMPLETED|Period1||10
3243017|NCT02441114|3976278|FG000|NOT COMPLETED|Period1||0
3243018|NCT02441114|3976278|FG000|STARTED|Washout1||10
3243019|NCT02441114|3976278|FG000|COMPLETED|Washout1||10
3243020|NCT02441114|3976278|FG000|NOT COMPLETED|Washout1||0
3243021|NCT02441114|3976278|FG000|STARTED|Period2||10
3243022|NCT02441114|3976278|FG000|COMPLETED|Period2||10
3243023|NCT02441114|3976278|FG000|NOT COMPLETED|Period2||0
3243024|NCT02441114|3976278|FG000|STARTED|Washout2||10
3243025|NCT02441114|3976278|FG000|COMPLETED|Washout2||6
3243026|NCT02441114|3976278|FG000|NOT COMPLETED|Washout2||4
3243027|NCT02441114|3976278|FG000|STARTED|Period3||6
3243028|NCT02441114|3976278|FG000|COMPLETED|Period3||6
3243029|NCT02441114|3976278|FG000|NOT COMPLETED|Period3||0
3243030|NCT02441179|3976284|FG000|STARTED|Overall Study||18
3243031|NCT02441179|3976285|FG001|STARTED|Overall Study||17
3243032|NCT02441179|3976284|FG000|COMPLETED|Overall Study||17
3243033|NCT02441179|3976285|FG001|COMPLETED|Overall Study||16
3243034|NCT02441179|3976284|FG000|NOT COMPLETED|Overall Study||1
3243035|NCT02441179|3976285|FG001|NOT COMPLETED|Overall Study||1
3243036|NCT02441218|3976294|FG000|STARTED|Overall Study||3241
3243037|NCT02441218|3976295|FG001|STARTED|Overall Study||3264
3243038|NCT02441218|3976294|FG000|COMPLETED|Overall Study||2663
3243039|NCT02441218|3976295|FG001|COMPLETED|Overall Study||2652
3243040|NCT02441218|3976294|FG000|NOT COMPLETED|Overall Study||578
3243041|NCT02441218|3976295|FG001|NOT COMPLETED|Overall Study||612
3243042|NCT02441283|3976301|FG000|STARTED|Overall Study||377
3243043|NCT02441283|3976301|FG000|COMPLETED|Overall Study||287
3243044|NCT02441283|3976301|FG000|NOT COMPLETED|Overall Study||90
3243045|NCT02441309|3976308|FG000|STARTED|Overall Study||3
3243046|NCT02441309|3976309|FG001|STARTED|Overall Study||2
3243047|NCT02441309|3976310|FG002|STARTED|Overall Study||3
3243048|NCT02441309|3976308|FG000|Received Allocated Intervention|Overall Study||1
3243049|NCT02441309|3976309|FG001|Received Allocated Intervention|Overall Study||2
3243050|NCT02441309|3976310|FG002|Received Allocated Intervention|Overall Study||3
3243051|NCT02441309|3976308|FG000|COMPLETED|Overall Study||0
3243052|NCT02441309|3976309|FG001|COMPLETED|Overall Study||0
3243053|NCT02441309|3976310|FG002|COMPLETED|Overall Study||0
3243054|NCT02441309|3976308|FG000|NOT COMPLETED|Overall Study||3
3243055|NCT02441309|3976309|FG001|NOT COMPLETED|Overall Study||2
3243056|NCT02441309|3976310|FG002|NOT COMPLETED|Overall Study||3
3243057|NCT02441517|3976321|FG000|STARTED|Overall Study||4
3243058|NCT02441517|3976321|FG000|Received Treatment|Overall Study||4
3243059|NCT02441517|3976321|FG000|COMPLETED|Overall Study||0
3243060|NCT02441517|3976321|FG000|NOT COMPLETED|Overall Study||4
3243061|NCT02441946|3976328|FG000|STARTED|Cycle 1 Period 1 (2 Weeks)||74
3243062|NCT02441946|3976329|FG001|STARTED|Cycle 1 Period 1 (2 Weeks)||76
3243063|NCT02441946|3976330|FG002|STARTED|Cycle 1 Period 1 (2 Weeks)||74
3243064|NCT02441946|3976328|FG000|Received at Least One Dose of Study Drug|Cycle 1 Period 1 (2 Weeks)||74
3243065|NCT02441946|3976329|FG001|Received at Least One Dose of Study Drug|Cycle 1 Period 1 (2 Weeks)|1 participant did not receive drug due to an error in randomization.|75
3243066|NCT02441946|3976330|FG002|Received at Least One Dose of Study Drug|Cycle 1 Period 1 (2 Weeks)||74
3243067|NCT02441946|3976328|FG000|COMPLETED|Cycle 1 Period 1 (2 Weeks)||72
3243068|NCT02441946|3976329|FG001|COMPLETED|Cycle 1 Period 1 (2 Weeks)||71
3243069|NCT02441946|3976330|FG002|COMPLETED|Cycle 1 Period 1 (2 Weeks)||74
3243070|NCT02441946|3976328|FG000|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||2
3243071|NCT02441946|3976329|FG001|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||5
3243072|NCT02441946|3976330|FG002|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||0
3243073|NCT02441946|3976328|FG000|STARTED|Cycle 2-5 Period 2 (14 Weeks)|All 217 participants were assigned to abemaciclib + anastrozole post cycle 1.|217
3243074|NCT02441946|3976329|FG001|STARTED|Cycle 2-5 Period 2 (14 Weeks)|All 217 participants were assigned abemaciclib + anastrozole post cycle 1.|0
3243075|NCT02441946|3976330|FG002|STARTED|Cycle 2-5 Period 2 (14 Weeks)|All 217 participants were assigned abemaciclib + anastrozole post cycle 1.|0
3243076|NCT02441946|3976328|FG000|Received at Least One Dose of Study Drug|Cycle 2-5 Period 2 (14 Weeks)||217
3243077|NCT02441946|3976329|FG001|Received at Least One Dose of Study Drug|Cycle 2-5 Period 2 (14 Weeks)||0
3243078|NCT02441946|3976330|FG002|Received at Least One Dose of Study Drug|Cycle 2-5 Period 2 (14 Weeks)||0
3243079|NCT02441946|3976328|FG000|Progressive Disease|Cycle 2-5 Period 2 (14 Weeks)||5
3243080|NCT02441946|3976329|FG001|Progressive Disease|Cycle 2-5 Period 2 (14 Weeks)||0
3243081|NCT02441946|3976330|FG002|Progressive Disease|Cycle 2-5 Period 2 (14 Weeks)||0
3243082|NCT02441946|3976328|FG000|COMPLETED|Cycle 2-5 Period 2 (14 Weeks)||190
3243083|NCT02441946|3976329|FG001|COMPLETED|Cycle 2-5 Period 2 (14 Weeks)||0
3243084|NCT02441946|3976330|FG002|COMPLETED|Cycle 2-5 Period 2 (14 Weeks)||0
3243085|NCT02441946|3976328|FG000|NOT COMPLETED|Cycle 2-5 Period 2 (14 Weeks)||27
3243086|NCT02441946|3976329|FG001|NOT COMPLETED|Cycle 2-5 Period 2 (14 Weeks)||0
3243087|NCT02441946|3976330|FG002|NOT COMPLETED|Cycle 2-5 Period 2 (14 Weeks)||0
3243088|NCT02441946|3976328|FG000|STARTED|Extension Period (8 Weeks)|All participants who did not discontinue continued to the extension period.|42
3243089|NCT02441946|3976329|FG001|STARTED|Extension Period (8 Weeks)||0
3243090|NCT02441946|3976330|FG002|STARTED|Extension Period (8 Weeks)||0
3243091|NCT02441946|3976328|FG000|COMPLETED|Extension Period (8 Weeks)||40
3243092|NCT02441946|3976329|FG001|COMPLETED|Extension Period (8 Weeks)||0
3243093|NCT02441946|3976330|FG002|COMPLETED|Extension Period (8 Weeks)||0
3243094|NCT02441946|3976328|FG000|NOT COMPLETED|Extension Period (8 Weeks)||2
3243095|NCT02441946|3976329|FG001|NOT COMPLETED|Extension Period (8 Weeks)||0
3243096|NCT02441946|3976330|FG002|NOT COMPLETED|Extension Period (8 Weeks)||0
3243097|NCT02442206|3976343|FG000|STARTED|Period 1||30
3243098|NCT02442206|3976344|FG001|STARTED|Period 1||32
3243099|NCT02442206|3976343|FG000|COMPLETED|Period 1||29
3243100|NCT02442206|3976344|FG001|COMPLETED|Period 1||29
3243101|NCT02442206|3976343|FG000|NOT COMPLETED|Period 1||1
3243102|NCT02442206|3976344|FG001|NOT COMPLETED|Period 1||3
3243103|NCT02442206|3976343|FG000|STARTED|Period 2||29
3243104|NCT02442206|3976344|FG001|STARTED|Period 2||29
3243105|NCT02442206|3976343|FG000|COMPLETED|Period 2||28
3243106|NCT02442206|3976344|FG001|COMPLETED|Period 2||29
3243107|NCT02442206|3976343|FG000|NOT COMPLETED|Period 2||1
3243108|NCT02442206|3976344|FG001|NOT COMPLETED|Period 2||0
3243109|NCT02442271|3976351|FG000|STARTED|Overall Study||222
3243110|NCT02442271|3976351|FG000|COMPLETED|Overall Study||218
3243111|NCT02442271|3976351|FG000|NOT COMPLETED|Overall Study||4
3243112|NCT02442284|3976369|FG000|STARTED|Overall Study||99
3243113|NCT02442284|3976369|FG000|COMPLETED|Overall Study||92
3243114|NCT02442284|3976369|FG000|NOT COMPLETED|Overall Study||7
3243115|NCT02442310|3976373|FG000|STARTED|Overall Study||20
3243116|NCT02442310|3976373|FG000|COMPLETED|Overall Study||17
3243117|NCT02442310|3976373|FG000|NOT COMPLETED|Overall Study||3
3243118|NCT02442336|3976383|FG000|STARTED|Overall Study||80
3243119|NCT02442336|3976383|FG000|Developmental Phase|Overall Study||6
3243120|NCT02442336|3976383|FG000|Evaluation Phase|Overall Study||74
3243121|NCT02442336|3976383|FG000|Provided Access to Intervention|Overall Study||55
3243122|NCT02442336|3976383|FG000|COMPLETED|Overall Study||44
3243123|NCT02442336|3976383|FG000|NOT COMPLETED|Overall Study||36
3243124|NCT02442622|3976389|FG000|STARTED|Overall Study||15
3243125|NCT02442622|3976390|FG001|STARTED|Overall Study||17
3243126|NCT02442622|3976389|FG000|COMPLETED|Overall Study||12
3243127|NCT02442622|3976390|FG001|COMPLETED|Overall Study||16
3243128|NCT02442622|3976389|FG000|NOT COMPLETED|Overall Study||3
3243129|NCT02442622|3976390|FG001|NOT COMPLETED|Overall Study||1
3243130|NCT02442687|3976399|FG000|STARTED|Overall Study||21
3243131|NCT02442687|3976400|FG001|STARTED|Overall Study||22
3243132|NCT02442687|3976401|FG002|STARTED|Overall Study||22
3243133|NCT02442687|3976399|FG000|COMPLETED|Overall Study||13
3243134|NCT02442687|3976400|FG001|COMPLETED|Overall Study||11
3243135|NCT02442687|3976401|FG002|COMPLETED|Overall Study||19
3243136|NCT02442687|3976399|FG000|NOT COMPLETED|Overall Study||8
3243137|NCT02442687|3976400|FG001|NOT COMPLETED|Overall Study||11
3243138|NCT02442687|3976401|FG002|NOT COMPLETED|Overall Study||3
3243139|NCT02442700|3976412|FG000|STARTED|First 12 Weeks||12
3243140|NCT02442700|3976413|FG001|STARTED|First 12 Weeks||12
3243141|NCT02442700|3976412|FG000|COMPLETED|First 12 Weeks||12
3243142|NCT02442700|3976413|FG001|COMPLETED|First 12 Weeks||12
3243143|NCT02442700|3976412|FG000|NOT COMPLETED|First 12 Weeks||0
3243144|NCT02442700|3976413|FG001|NOT COMPLETED|First 12 Weeks||0
3243145|NCT02442700|3976412|FG000|STARTED|Later 12 Weeks||12
3243146|NCT02442700|3976413|FG001|STARTED|Later 12 Weeks||12
3243147|NCT02442700|3976412|FG000|COMPLETED|Later 12 Weeks||12
3243148|NCT02442700|3976413|FG001|COMPLETED|Later 12 Weeks||12
3243149|NCT02442700|3976412|FG000|NOT COMPLETED|Later 12 Weeks||0
3243150|NCT02442700|3976413|FG001|NOT COMPLETED|Later 12 Weeks||0
3243151|NCT02442804|3976421|FG000|STARTED|Overall Study||8
3243152|NCT02442804|3976422|FG001|STARTED|Overall Study||8
3243153|NCT02442804|3976421|FG000|COMPLETED|Overall Study||7
3243154|NCT02442804|3976422|FG001|COMPLETED|Overall Study||7
3243155|NCT02442804|3976421|FG000|NOT COMPLETED|Overall Study||1
3243156|NCT02442804|3976422|FG001|NOT COMPLETED|Overall Study||1
3243157|NCT02442830|3976430|FG000|STARTED|Overall Study||42
3243158|NCT02442830|3976431|FG001|STARTED|Overall Study||45
3243159|NCT02442830|3976430|FG000|COMPLETED|Overall Study||42
3243160|NCT02442830|3976431|FG001|COMPLETED|Overall Study||44
3243161|NCT02442830|3976430|FG000|NOT COMPLETED|Overall Study||0
3243162|NCT02442830|3976431|FG001|NOT COMPLETED|Overall Study||1
3243163|NCT02442856|3976438|FG000|STARTED|Overall Study||21
3243164|NCT02442856|3976438|FG000|COMPLETED|Overall Study||21
3243165|NCT02442856|3976438|FG000|NOT COMPLETED|Overall Study||0
3243166|NCT02442869|3976448|FG000|STARTED|Overall Study||18
3243167|NCT02442869|3976449|FG001|STARTED|Overall Study||29
3243168|NCT02442869|3976450|FG002|STARTED|Overall Study||6
3243169|NCT02442869|3976451|FG003|STARTED|Overall Study||2
3243170|NCT02442869|3976452|FG004|STARTED|Overall Study||5
3243171|NCT02442869|3976453|FG005|STARTED|Overall Study||2
3243172|NCT02442869|3976448|FG000|COMPLETED|Overall Study||13
3243173|NCT02442869|3976449|FG001|COMPLETED|Overall Study||20
3243174|NCT02442869|3976450|FG002|COMPLETED|Overall Study||6
3243175|NCT02442869|3976451|FG003|COMPLETED|Overall Study||1
3243176|NCT02442869|3976452|FG004|COMPLETED|Overall Study||3
3243177|NCT02442869|3976453|FG005|COMPLETED|Overall Study||2
3243178|NCT02442869|3976448|FG000|NOT COMPLETED|Overall Study||5
3243179|NCT02442869|3976449|FG001|NOT COMPLETED|Overall Study||9
3243180|NCT02442869|3976450|FG002|NOT COMPLETED|Overall Study||0
3243181|NCT02442869|3976451|FG003|NOT COMPLETED|Overall Study||1
3243182|NCT02442869|3976452|FG004|NOT COMPLETED|Overall Study||2
3243183|NCT02442869|3976453|FG005|NOT COMPLETED|Overall Study||0
3243184|NCT02443103|3976477|FG000|STARTED|Overall Study||4
3243185|NCT02443103|3976477|FG000|COMPLETED|Overall Study||1
3243186|NCT02443103|3976477|FG000|NOT COMPLETED|Overall Study||3
3243187|NCT02443155|3976485|FG000|STARTED|Overall Study||77
3243188|NCT02443155|3976486|FG001|STARTED|Overall Study||77
3243189|NCT02443155|3976487|FG002|STARTED|Overall Study||76
3243190|NCT02443155|3976488|FG003|STARTED|Overall Study||77
3243191|NCT02443155|3976485|FG000|Full Analysis Set|Overall Study||77
3243192|NCT02443155|3976486|FG001|Full Analysis Set|Overall Study||77
3243193|NCT02443155|3976487|FG002|Full Analysis Set|Overall Study||76
3243194|NCT02443155|3976488|FG003|Full Analysis Set|Overall Study||77
3243195|NCT02443155|3976485|FG000|PK Analysis Set|Overall Study||21
3243196|NCT02443155|3976486|FG001|PK Analysis Set|Overall Study||21
3243197|NCT02443155|3976487|FG002|PK Analysis Set|Overall Study||22
3243198|NCT02443155|3976488|FG003|PK Analysis Set|Overall Study||20
3243199|NCT02443155|3976485|FG000|Safety Analysis Set|Overall Study||77
3243200|NCT02443155|3976486|FG001|Safety Analysis Set|Overall Study||77
3243201|NCT02443155|3976487|FG002|Safety Analysis Set|Overall Study||76
3243202|NCT02443155|3976488|FG003|Safety Analysis Set|Overall Study||77
3243203|NCT02443155|3976485|FG000|COMPLETED|Overall Study||65
3243204|NCT02443155|3976486|FG001|COMPLETED|Overall Study||63
3243205|NCT02443155|3976487|FG002|COMPLETED|Overall Study||67
3243206|NCT02443155|3976488|FG003|COMPLETED|Overall Study||61
3243207|NCT02443155|3976485|FG000|NOT COMPLETED|Overall Study||12
3243208|NCT02443155|3976486|FG001|NOT COMPLETED|Overall Study||14
3243209|NCT02443155|3976487|FG002|NOT COMPLETED|Overall Study||9
3243210|NCT02443155|3976488|FG003|NOT COMPLETED|Overall Study||16
3243211|NCT02443298|3976501|FG000|STARTED|Overall Study||105
3243212|NCT02443298|3976502|FG001|STARTED|Overall Study||109
3243213|NCT02443298|3976501|FG000|COMPLETED|Overall Study||101
3243214|NCT02443298|3976502|FG001|COMPLETED|Overall Study||104
3243215|NCT02443298|3976501|FG000|NOT COMPLETED|Overall Study||4
3243216|NCT02443298|3976502|FG001|NOT COMPLETED|Overall Study||5
3243217|NCT02443337|3976510|FG000|STARTED|Overall Study||15
3243218|NCT02443337|3976511|FG001|STARTED|Overall Study||16
3243219|NCT02443337|3976510|FG000|Received at Least One Dose of Study Drug|Overall Study||15
3243220|NCT02443337|3976511|FG001|Received at Least One Dose of Study Drug|Overall Study||16
3243221|NCT02443337|3976510|FG000|COMPLETED|Overall Study||10
3243222|NCT02443337|3976511|FG001|COMPLETED|Overall Study||14
3243223|NCT02443337|3976510|FG000|NOT COMPLETED|Overall Study||5
3243224|NCT02443337|3976511|FG001|NOT COMPLETED|Overall Study||2
3243225|NCT02443402|3976524|FG000|STARTED|Overall Study||36
3243226|NCT02443402|3976525|FG001|STARTED|Overall Study||31
3243227|NCT02443402|3976524|FG000|COMPLETED|Overall Study||32
3243228|NCT02443402|3976525|FG001|COMPLETED|Overall Study||28
3243229|NCT02443402|3976524|FG000|NOT COMPLETED|Overall Study||4
3243230|NCT02443402|3976525|FG001|NOT COMPLETED|Overall Study||3
3243231|NCT02443519|3976533|FG000|STARTED|Overall Study||31
3243232|NCT02443519|3976534|FG001|STARTED|Overall Study||29
3243233|NCT02443519|3976533|FG000|COMPLETED|Overall Study||29
3243234|NCT02443519|3976534|FG001|COMPLETED|Overall Study||26
3243235|NCT02443519|3976533|FG000|NOT COMPLETED|Overall Study||2
3243236|NCT02443519|3976534|FG001|NOT COMPLETED|Overall Study||3
3243237|NCT02443571|3976543|FG000|STARTED|Overall Study||596
3243238|NCT02443571|3976544|FG001|STARTED|Overall Study||95
3243239|NCT02443571|3976545|FG002|STARTED|Overall Study||23
3243240|NCT02443571|3976543|FG000|COMPLETED|Overall Study||596
3243241|NCT02443571|3976544|FG001|COMPLETED|Overall Study||95
3243242|NCT02443571|3976545|FG002|COMPLETED|Overall Study||23
3243243|NCT02443571|3976543|FG000|NOT COMPLETED|Overall Study||0
3243244|NCT02443571|3976544|FG001|NOT COMPLETED|Overall Study||0
3243245|NCT02443571|3976545|FG002|NOT COMPLETED|Overall Study||0
3243246|NCT02443688|3976556|FG000|STARTED|Overall Study||66
3243247|NCT02443688|3976557|FG001|STARTED|Overall Study||67
3243248|NCT02443688|3976558|FG002|STARTED|Overall Study||67
3243249|NCT02443688|3976556|FG000|COMPLETED|Overall Study||54
3243250|NCT02443688|3976557|FG001|COMPLETED|Overall Study||58
3243251|NCT02443688|3976558|FG002|COMPLETED|Overall Study||55
3243252|NCT02443688|3976556|FG000|NOT COMPLETED|Overall Study||12
3243253|NCT02443688|3976557|FG001|NOT COMPLETED|Overall Study||9
3243254|NCT02443688|3976558|FG002|NOT COMPLETED|Overall Study||12
3243255|NCT02443740|3976574|FG000|STARTED|Intervention Period 1 (3 Days)||2
3243256|NCT02443740|3976575|FG001|STARTED|Intervention Period 1 (3 Days)||2
3243257|NCT02443740|3976576|FG002|STARTED|Intervention Period 1 (3 Days)||2
3243258|NCT02443740|3976577|FG003|STARTED|Intervention Period 1 (3 Days)||3
3243259|NCT02443740|3976578|FG004|STARTED|Intervention Period 1 (3 Days)||2
3243260|NCT02443740|3976579|FG005|STARTED|Intervention Period 1 (3 Days)||4
3243261|NCT02443740|3976580|FG006|STARTED|Intervention Period 1 (3 Days)||3
3243262|NCT02443740|3976581|FG007|STARTED|Intervention Period 1 (3 Days)||2
3243263|NCT02443740|3976582|FG008|STARTED|Intervention Period 1 (3 Days)||6
3243264|NCT02443740|3976583|FG009|STARTED|Intervention Period 1 (3 Days)||3
3243265|NCT02443740|3976584|FG010|STARTED|Intervention Period 1 (3 Days)||3
3243266|NCT02443740|3976574|FG000|COMPLETED|Intervention Period 1 (3 Days)||1
3243267|NCT02443740|3976575|FG001|COMPLETED|Intervention Period 1 (3 Days)||2
3243268|NCT02443740|3976576|FG002|COMPLETED|Intervention Period 1 (3 Days)||2
3243269|NCT02443740|3976577|FG003|COMPLETED|Intervention Period 1 (3 Days)||3
3243270|NCT02443740|3976578|FG004|COMPLETED|Intervention Period 1 (3 Days)||2
3243271|NCT02443740|3976579|FG005|COMPLETED|Intervention Period 1 (3 Days)||2
3243272|NCT02443740|3976580|FG006|COMPLETED|Intervention Period 1 (3 Days)||2
3243273|NCT02443740|3976581|FG007|COMPLETED|Intervention Period 1 (3 Days)||2
3243274|NCT02443740|3976582|FG008|COMPLETED|Intervention Period 1 (3 Days)||6
3243275|NCT02443740|3976583|FG009|COMPLETED|Intervention Period 1 (3 Days)||3
3243276|NCT02443740|3976584|FG010|COMPLETED|Intervention Period 1 (3 Days)||3
3243277|NCT02443740|3976574|FG000|NOT COMPLETED|Intervention Period 1 (3 Days)||1
3243278|NCT02443740|3976575|FG001|NOT COMPLETED|Intervention Period 1 (3 Days)||0
3243279|NCT02443740|3976576|FG002|NOT COMPLETED|Intervention Period 1 (3 Days)||0
3243280|NCT02443740|3976577|FG003|NOT COMPLETED|Intervention Period 1 (3 Days)||0
3243281|NCT02443740|3976578|FG004|NOT COMPLETED|Intervention Period 1 (3 Days)||0
3243282|NCT02443740|3976579|FG005|NOT COMPLETED|Intervention Period 1 (3 Days)||2
3243283|NCT02443740|3976580|FG006|NOT COMPLETED|Intervention Period 1 (3 Days)||1
3243284|NCT02443740|3976581|FG007|NOT COMPLETED|Intervention Period 1 (3 Days)||0
3243285|NCT02443740|3976582|FG008|NOT COMPLETED|Intervention Period 1 (3 Days)||0
3243286|NCT02443740|3976583|FG009|NOT COMPLETED|Intervention Period 1 (3 Days)||0
3243287|NCT02443740|3976584|FG010|NOT COMPLETED|Intervention Period 1 (3 Days)||0
3243288|NCT02443740|3976574|FG000|STARTED|Washout Period 1 (7 Days)||1
3243289|NCT02443740|3976575|FG001|STARTED|Washout Period 1 (7 Days)||2
3243290|NCT02443740|3976576|FG002|STARTED|Washout Period 1 (7 Days)||2
3243291|NCT02443740|3976577|FG003|STARTED|Washout Period 1 (7 Days)||3
3243292|NCT02443740|3976578|FG004|STARTED|Washout Period 1 (7 Days)||2
3243293|NCT02443740|3976579|FG005|STARTED|Washout Period 1 (7 Days)||2
3243294|NCT02443740|3976580|FG006|STARTED|Washout Period 1 (7 Days)||2
3243295|NCT02443740|3976581|FG007|STARTED|Washout Period 1 (7 Days)||2
3243296|NCT02443740|3976582|FG008|STARTED|Washout Period 1 (7 Days)||0
3243297|NCT02443740|3976583|FG009|STARTED|Washout Period 1 (7 Days)||3
3243298|NCT02443740|3976584|FG010|STARTED|Washout Period 1 (7 Days)||3
3243299|NCT02443740|3976574|FG000|COMPLETED|Washout Period 1 (7 Days)||1
3243300|NCT02443740|3976575|FG001|COMPLETED|Washout Period 1 (7 Days)||2
3243301|NCT02443740|3976576|FG002|COMPLETED|Washout Period 1 (7 Days)||2
3243302|NCT02443740|3976577|FG003|COMPLETED|Washout Period 1 (7 Days)||3
3243303|NCT02443740|3976578|FG004|COMPLETED|Washout Period 1 (7 Days)||2
3243304|NCT02443740|3976579|FG005|COMPLETED|Washout Period 1 (7 Days)||2
3243305|NCT02443740|3976580|FG006|COMPLETED|Washout Period 1 (7 Days)||2
3243306|NCT02443740|3976581|FG007|COMPLETED|Washout Period 1 (7 Days)||2
3243307|NCT02443740|3976582|FG008|COMPLETED|Washout Period 1 (7 Days)||0
3243308|NCT02443740|3976583|FG009|COMPLETED|Washout Period 1 (7 Days)||3
3243309|NCT02443740|3976584|FG010|COMPLETED|Washout Period 1 (7 Days)||3
3243310|NCT02443740|3976574|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0
3243311|NCT02443740|3976575|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0
3243312|NCT02443740|3976576|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||0
3243313|NCT02443740|3976577|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||0
3243314|NCT02443740|3976578|FG004|NOT COMPLETED|Washout Period 1 (7 Days)||0
3243315|NCT02443740|3976579|FG005|NOT COMPLETED|Washout Period 1 (7 Days)||0
3243316|NCT02443740|3976580|FG006|NOT COMPLETED|Washout Period 1 (7 Days)||0
3243317|NCT02443740|3976581|FG007|NOT COMPLETED|Washout Period 1 (7 Days)||0
3243318|NCT02443740|3976582|FG008|NOT COMPLETED|Washout Period 1 (7 Days)||0
3243319|NCT02443740|3976583|FG009|NOT COMPLETED|Washout Period 1 (7 Days)||0
3243320|NCT02443740|3976584|FG010|NOT COMPLETED|Washout Period 1 (7 Days)||0
3243321|NCT02443740|3976574|FG000|STARTED|Intervention Period 2 (3 Days)||1
3243322|NCT02443740|3976575|FG001|STARTED|Intervention Period 2 (3 Days)||2
3243323|NCT02443740|3976576|FG002|STARTED|Intervention Period 2 (3 Days)||2
3243324|NCT02443740|3976577|FG003|STARTED|Intervention Period 2 (3 Days)||3
3243325|NCT02443740|3976578|FG004|STARTED|Intervention Period 2 (3 Days)||2
3243326|NCT02443740|3976579|FG005|STARTED|Intervention Period 2 (3 Days)||2
3243327|NCT02443740|3976580|FG006|STARTED|Intervention Period 2 (3 Days)||2
3243328|NCT02443740|3976581|FG007|STARTED|Intervention Period 2 (3 Days)||2
3243329|NCT02443740|3976582|FG008|STARTED|Intervention Period 2 (3 Days)||0
3243330|NCT02443740|3976583|FG009|STARTED|Intervention Period 2 (3 Days)||3
3243331|NCT02443740|3976584|FG010|STARTED|Intervention Period 2 (3 Days)||3
3243332|NCT02443740|3976574|FG000|COMPLETED|Intervention Period 2 (3 Days)||1
3243333|NCT02443740|3976575|FG001|COMPLETED|Intervention Period 2 (3 Days)||2
3243334|NCT02443740|3976576|FG002|COMPLETED|Intervention Period 2 (3 Days)||2
3243335|NCT02443740|3976577|FG003|COMPLETED|Intervention Period 2 (3 Days)||3
3243336|NCT02443740|3976578|FG004|COMPLETED|Intervention Period 2 (3 Days)||2
3243337|NCT02443740|3976579|FG005|COMPLETED|Intervention Period 2 (3 Days)||2
3243338|NCT02443740|3976580|FG006|COMPLETED|Intervention Period 2 (3 Days)||2
3243339|NCT02443740|3976581|FG007|COMPLETED|Intervention Period 2 (3 Days)||2
3243340|NCT02443740|3976582|FG008|COMPLETED|Intervention Period 2 (3 Days)||0
3243341|NCT02443740|3976583|FG009|COMPLETED|Intervention Period 2 (3 Days)||3
3243342|NCT02443740|3976584|FG010|COMPLETED|Intervention Period 2 (3 Days)||3
3243343|NCT02443740|3976574|FG000|NOT COMPLETED|Intervention Period 2 (3 Days)||0
3243344|NCT02443740|3976575|FG001|NOT COMPLETED|Intervention Period 2 (3 Days)||0
3243345|NCT02443740|3976576|FG002|NOT COMPLETED|Intervention Period 2 (3 Days)||0
3243346|NCT02443740|3976577|FG003|NOT COMPLETED|Intervention Period 2 (3 Days)||0
3243347|NCT02443740|3976578|FG004|NOT COMPLETED|Intervention Period 2 (3 Days)||0
3243348|NCT02443740|3976579|FG005|NOT COMPLETED|Intervention Period 2 (3 Days)||0
3243349|NCT02443740|3976580|FG006|NOT COMPLETED|Intervention Period 2 (3 Days)||0
3243350|NCT02443740|3976581|FG007|NOT COMPLETED|Intervention Period 2 (3 Days)||0
3243351|NCT02443740|3976582|FG008|NOT COMPLETED|Intervention Period 2 (3 Days)||0
3243352|NCT02443740|3976583|FG009|NOT COMPLETED|Intervention Period 2 (3 Days)||0
3243353|NCT02443740|3976584|FG010|NOT COMPLETED|Intervention Period 2 (3 Days)||0
3243354|NCT02443740|3976574|FG000|STARTED|Washout Period 2 (7 Days)||1
3243355|NCT02443740|3976575|FG001|STARTED|Washout Period 2 (7 Days)||2
3243356|NCT02443740|3976576|FG002|STARTED|Washout Period 2 (7 Days)||2
3243357|NCT02443740|3976577|FG003|STARTED|Washout Period 2 (7 Days)||3
3243358|NCT02443740|3976578|FG004|STARTED|Washout Period 2 (7 Days)||2
3243359|NCT02443740|3976579|FG005|STARTED|Washout Period 2 (7 Days)||2
3243360|NCT02443740|3976580|FG006|STARTED|Washout Period 2 (7 Days)||2
3243361|NCT02443740|3976581|FG007|STARTED|Washout Period 2 (7 Days)||2
3243362|NCT02443740|3976582|FG008|STARTED|Washout Period 2 (7 Days)||0
3243363|NCT02443740|3976583|FG009|STARTED|Washout Period 2 (7 Days)||0
3243364|NCT02443740|3976584|FG010|STARTED|Washout Period 2 (7 Days)||0
3243365|NCT02443740|3976574|FG000|COMPLETED|Washout Period 2 (7 Days)||1
3243366|NCT02443740|3976575|FG001|COMPLETED|Washout Period 2 (7 Days)||2
3243367|NCT02443740|3976576|FG002|COMPLETED|Washout Period 2 (7 Days)||2
3243368|NCT02443740|3976577|FG003|COMPLETED|Washout Period 2 (7 Days)||3
3243369|NCT02443740|3976578|FG004|COMPLETED|Washout Period 2 (7 Days)||2
3243370|NCT02443740|3976579|FG005|COMPLETED|Washout Period 2 (7 Days)||2
3243371|NCT02443740|3976580|FG006|COMPLETED|Washout Period 2 (7 Days)||2
3243372|NCT02443740|3976581|FG007|COMPLETED|Washout Period 2 (7 Days)||2
3243373|NCT02443740|3976582|FG008|COMPLETED|Washout Period 2 (7 Days)||0
3243374|NCT02443740|3976583|FG009|COMPLETED|Washout Period 2 (7 Days)||0
3243375|NCT02443740|3976584|FG010|COMPLETED|Washout Period 2 (7 Days)||0
3243376|NCT02443740|3976574|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||0
3243377|NCT02443740|3976575|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0
3243378|NCT02443740|3976576|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0
3243379|NCT02443740|3976577|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||0
3243380|NCT02443740|3976578|FG004|NOT COMPLETED|Washout Period 2 (7 Days)||0
3243381|NCT02443740|3976579|FG005|NOT COMPLETED|Washout Period 2 (7 Days)||0
3243382|NCT02443740|3976580|FG006|NOT COMPLETED|Washout Period 2 (7 Days)||0
3243383|NCT02443740|3976581|FG007|NOT COMPLETED|Washout Period 2 (7 Days)||0
3243384|NCT02443740|3976582|FG008|NOT COMPLETED|Washout Period 2 (7 Days)||0
3243385|NCT02443740|3976583|FG009|NOT COMPLETED|Washout Period 2 (7 Days)||0
3243386|NCT02443740|3976584|FG010|NOT COMPLETED|Washout Period 2 (7 Days)||0
3243387|NCT02443740|3976574|FG000|STARTED|Intervention Period 3 (3 Days)||1
3243388|NCT02443740|3976575|FG001|STARTED|Intervention Period 3 (3 Days)||2
3243389|NCT02443740|3976576|FG002|STARTED|Intervention Period 3 (3 Days)||2
3243390|NCT02443740|3976577|FG003|STARTED|Intervention Period 3 (3 Days)||3
3243391|NCT02443740|3976578|FG004|STARTED|Intervention Period 3 (3 Days)||2
3243392|NCT02443740|3976579|FG005|STARTED|Intervention Period 3 (3 Days)||2
3243393|NCT02443740|3976580|FG006|STARTED|Intervention Period 3 (3 Days)||2
3243394|NCT02443740|3976581|FG007|STARTED|Intervention Period 3 (3 Days)||2
3243395|NCT02443740|3976582|FG008|STARTED|Intervention Period 3 (3 Days)||0
3243396|NCT02443740|3976583|FG009|STARTED|Intervention Period 3 (3 Days)||0
3243397|NCT02443740|3976584|FG010|STARTED|Intervention Period 3 (3 Days)||0
3243398|NCT02443740|3976574|FG000|COMPLETED|Intervention Period 3 (3 Days)||1
3243399|NCT02443740|3976575|FG001|COMPLETED|Intervention Period 3 (3 Days)||2
3243400|NCT02443740|3976576|FG002|COMPLETED|Intervention Period 3 (3 Days)||2
3243401|NCT02443740|3976577|FG003|COMPLETED|Intervention Period 3 (3 Days)||3
3243402|NCT02443740|3976578|FG004|COMPLETED|Intervention Period 3 (3 Days)||2
3243403|NCT02443740|3976579|FG005|COMPLETED|Intervention Period 3 (3 Days)||2
3243404|NCT02443740|3976580|FG006|COMPLETED|Intervention Period 3 (3 Days)||2
3243405|NCT02443740|3976581|FG007|COMPLETED|Intervention Period 3 (3 Days)||2
3243406|NCT02443740|3976582|FG008|COMPLETED|Intervention Period 3 (3 Days)||0
3243407|NCT02443740|3976583|FG009|COMPLETED|Intervention Period 3 (3 Days)||0
3243408|NCT02443740|3976584|FG010|COMPLETED|Intervention Period 3 (3 Days)||0
3243409|NCT02443740|3976574|FG000|NOT COMPLETED|Intervention Period 3 (3 Days)||0
3243410|NCT02443740|3976575|FG001|NOT COMPLETED|Intervention Period 3 (3 Days)||0
3243411|NCT02443740|3976576|FG002|NOT COMPLETED|Intervention Period 3 (3 Days)||0
3243412|NCT02443740|3976577|FG003|NOT COMPLETED|Intervention Period 3 (3 Days)||0
3243413|NCT02443740|3976578|FG004|NOT COMPLETED|Intervention Period 3 (3 Days)||0
3243414|NCT02443740|3976579|FG005|NOT COMPLETED|Intervention Period 3 (3 Days)||0
3243415|NCT02443740|3976580|FG006|NOT COMPLETED|Intervention Period 3 (3 Days)||0
3243416|NCT02443740|3976581|FG007|NOT COMPLETED|Intervention Period 3 (3 Days)||0
3243417|NCT02443740|3976582|FG008|NOT COMPLETED|Intervention Period 3 (3 Days)||0
3243418|NCT02443740|3976583|FG009|NOT COMPLETED|Intervention Period 3 (3 Days)||0
3243419|NCT02443740|3976584|FG010|NOT COMPLETED|Intervention Period 3 (3 Days)||0
3243420|NCT02443740|3976574|FG000|STARTED|Washout Period 3 (7 Days)||1
3243421|NCT02443740|3976575|FG001|STARTED|Washout Period 3 (7 Days)||2
3243422|NCT02443740|3976576|FG002|STARTED|Washout Period 3 (7 Days)||2
3243423|NCT02443740|3976577|FG003|STARTED|Washout Period 3 (7 Days)||3
3243424|NCT02443740|3976578|FG004|STARTED|Washout Period 3 (7 Days)||2
3243425|NCT02443740|3976579|FG005|STARTED|Washout Period 3 (7 Days)||2
3243426|NCT02443740|3976580|FG006|STARTED|Washout Period 3 (7 Days)||2
3243427|NCT02443740|3976581|FG007|STARTED|Washout Period 3 (7 Days)||2
3243428|NCT02443740|3976582|FG008|STARTED|Washout Period 3 (7 Days)||0
3243429|NCT02443740|3976583|FG009|STARTED|Washout Period 3 (7 Days)||0
3243430|NCT02443740|3976584|FG010|STARTED|Washout Period 3 (7 Days)||0
3243431|NCT02443740|3976574|FG000|COMPLETED|Washout Period 3 (7 Days)||1
3243432|NCT02443740|3976575|FG001|COMPLETED|Washout Period 3 (7 Days)||2
3243433|NCT02443740|3976576|FG002|COMPLETED|Washout Period 3 (7 Days)||2
3243434|NCT02443740|3976577|FG003|COMPLETED|Washout Period 3 (7 Days)||3
3243435|NCT02443740|3976578|FG004|COMPLETED|Washout Period 3 (7 Days)||2
3243436|NCT02443740|3976579|FG005|COMPLETED|Washout Period 3 (7 Days)||2
3243437|NCT02443740|3976580|FG006|COMPLETED|Washout Period 3 (7 Days)||2
3243438|NCT02443740|3976581|FG007|COMPLETED|Washout Period 3 (7 Days)||2
3243439|NCT02443740|3976582|FG008|COMPLETED|Washout Period 3 (7 Days)||0
3243440|NCT02443740|3976583|FG009|COMPLETED|Washout Period 3 (7 Days)||0
3243441|NCT02443740|3976584|FG010|COMPLETED|Washout Period 3 (7 Days)||0
3243442|NCT02443740|3976574|FG000|NOT COMPLETED|Washout Period 3 (7 Days)||0
3243443|NCT02443740|3976575|FG001|NOT COMPLETED|Washout Period 3 (7 Days)||0
3243444|NCT02443740|3976576|FG002|NOT COMPLETED|Washout Period 3 (7 Days)||0
3243445|NCT02443740|3976577|FG003|NOT COMPLETED|Washout Period 3 (7 Days)||0
3243446|NCT02443740|3976578|FG004|NOT COMPLETED|Washout Period 3 (7 Days)||0
3243447|NCT02443740|3976579|FG005|NOT COMPLETED|Washout Period 3 (7 Days)||0
3243448|NCT02443740|3976580|FG006|NOT COMPLETED|Washout Period 3 (7 Days)||0
3243449|NCT02443740|3976581|FG007|NOT COMPLETED|Washout Period 3 (7 Days)||0
3243450|NCT02443740|3976582|FG008|NOT COMPLETED|Washout Period 3 (7 Days)||0
3243451|NCT02443740|3976583|FG009|NOT COMPLETED|Washout Period 3 (7 Days)||0
3243452|NCT02443740|3976584|FG010|NOT COMPLETED|Washout Period 3 (7 Days)||0
3243453|NCT02443740|3976574|FG000|STARTED|Intervention Period 4 (3 Days)||1
3243454|NCT02443740|3976575|FG001|STARTED|Intervention Period 4 (3 Days)||2
3243455|NCT02443740|3976576|FG002|STARTED|Intervention Period 4 (3 Days)||2
3243456|NCT02443740|3976577|FG003|STARTED|Intervention Period 4 (3 Days)||3
3243457|NCT02443740|3976578|FG004|STARTED|Intervention Period 4 (3 Days)||2
3243458|NCT02443740|3976579|FG005|STARTED|Intervention Period 4 (3 Days)||2
3243459|NCT02443740|3976580|FG006|STARTED|Intervention Period 4 (3 Days)||2
3243460|NCT02443740|3976581|FG007|STARTED|Intervention Period 4 (3 Days)||2
3243461|NCT02443740|3976582|FG008|STARTED|Intervention Period 4 (3 Days)||0
3243462|NCT02443740|3976583|FG009|STARTED|Intervention Period 4 (3 Days)||0
3243463|NCT02443740|3976584|FG010|STARTED|Intervention Period 4 (3 Days)||0
3243464|NCT02443740|3976574|FG000|COMPLETED|Intervention Period 4 (3 Days)||1
3243465|NCT02443740|3976575|FG001|COMPLETED|Intervention Period 4 (3 Days)||2
3243466|NCT02443740|3976576|FG002|COMPLETED|Intervention Period 4 (3 Days)||2
3243467|NCT02443740|3976577|FG003|COMPLETED|Intervention Period 4 (3 Days)||3
3243468|NCT02443740|3976578|FG004|COMPLETED|Intervention Period 4 (3 Days)||2
3243469|NCT02443740|3976579|FG005|COMPLETED|Intervention Period 4 (3 Days)||2
3243470|NCT02443740|3976580|FG006|COMPLETED|Intervention Period 4 (3 Days)||2
3243471|NCT02443740|3976581|FG007|COMPLETED|Intervention Period 4 (3 Days)||2
3243472|NCT02443740|3976582|FG008|COMPLETED|Intervention Period 4 (3 Days)||0
3243473|NCT02443740|3976583|FG009|COMPLETED|Intervention Period 4 (3 Days)||0
3243474|NCT02443740|3976584|FG010|COMPLETED|Intervention Period 4 (3 Days)||0
3243475|NCT02443740|3976574|FG000|NOT COMPLETED|Intervention Period 4 (3 Days)||0
3243476|NCT02443740|3976575|FG001|NOT COMPLETED|Intervention Period 4 (3 Days)||0
3243477|NCT02443740|3976576|FG002|NOT COMPLETED|Intervention Period 4 (3 Days)||0
3243478|NCT02443740|3976577|FG003|NOT COMPLETED|Intervention Period 4 (3 Days)||0
3243479|NCT02443740|3976578|FG004|NOT COMPLETED|Intervention Period 4 (3 Days)||0
3243480|NCT02443740|3976579|FG005|NOT COMPLETED|Intervention Period 4 (3 Days)||0
3243481|NCT02443740|3976580|FG006|NOT COMPLETED|Intervention Period 4 (3 Days)||0
3243482|NCT02443740|3976581|FG007|NOT COMPLETED|Intervention Period 4 (3 Days)||0
3243483|NCT02443740|3976582|FG008|NOT COMPLETED|Intervention Period 4 (3 Days)||0
3243484|NCT02443740|3976583|FG009|NOT COMPLETED|Intervention Period 4 (3 Days)||0
3243485|NCT02443740|3976584|FG010|NOT COMPLETED|Intervention Period 4 (3 Days)||0
3243486|NCT02443792|3976616|FG000|STARTED|Overall Study||50
3243487|NCT02443792|3976617|FG001|STARTED|Overall Study||25
3243488|NCT02443792|3976616|FG000|COMPLETED|Overall Study||43
3243489|NCT02443792|3976617|FG001|COMPLETED|Overall Study||23
3243490|NCT02443792|3976616|FG000|NOT COMPLETED|Overall Study||7
3243491|NCT02443792|3976617|FG001|NOT COMPLETED|Overall Study||2
3243492|NCT02443805|3976625|FG000|STARTED|Overall Study||802
3243493|NCT02443805|3976626|FG001|STARTED|Overall Study||805
3243494|NCT02443805|3976625|FG000|COMPLETED|Overall Study||589
3243495|NCT02443805|3976626|FG001|COMPLETED|Overall Study||678
3243496|NCT02443805|3976625|FG000|NOT COMPLETED|Overall Study||213
3243497|NCT02443805|3976626|FG001|NOT COMPLETED|Overall Study||127
3243498|NCT02443883|3976636|FG000|STARTED|Overall Study||40
3243499|NCT02443883|3976637|FG001|STARTED|Overall Study||42
3243500|NCT02443883|3976638|FG002|STARTED|Overall Study||41
3243501|NCT02443883|3976639|FG003|STARTED|Overall Study||41
3243502|NCT02443883|3976636|FG000|Received at Least One Dose of Study Drug|Overall Study||38
3243503|NCT02443883|3976637|FG001|Received at Least One Dose of Study Drug|Overall Study||42
3243504|NCT02443883|3976638|FG002|Received at Least One Dose of Study Drug|Overall Study||41
3243505|NCT02443883|3976639|FG003|Received at Least One Dose of Study Drug|Overall Study||40
3243506|NCT02443883|3976636|FG000|COMPLETED|Overall Study||34
3243507|NCT02443883|3976637|FG001|COMPLETED|Overall Study||38
3243508|NCT02443883|3976638|FG002|COMPLETED|Overall Study||40
3243509|NCT02443883|3976639|FG003|COMPLETED|Overall Study||36
3243510|NCT02443883|3976636|FG000|NOT COMPLETED|Overall Study||6
3243511|NCT02443883|3976637|FG001|NOT COMPLETED|Overall Study||4
3243512|NCT02443883|3976638|FG002|NOT COMPLETED|Overall Study||1
3243513|NCT02443883|3976639|FG003|NOT COMPLETED|Overall Study||5
3243514|NCT02444143|3976651|FG000|STARTED|Overall Study||10
3243515|NCT02444143|3976652|FG001|STARTED|Overall Study||10
3243516|NCT02444143|3976651|FG000|COMPLETED|Overall Study||10
3243517|NCT02444143|3976652|FG001|COMPLETED|Overall Study|1 patient withdrawal|9
3243518|NCT02444143|3976651|FG000|NOT COMPLETED|Overall Study||0
3243519|NCT02444143|3976652|FG001|NOT COMPLETED|Overall Study||1
3243520|NCT02444182|3976662|FG000|STARTED|Overall Study||54
3243521|NCT02444182|3976663|FG001|STARTED|Overall Study||54
3243522|NCT02444182|3976662|FG000|COMPLETED|Overall Study||52
3243523|NCT02444182|3976663|FG001|COMPLETED|Overall Study||49
3243524|NCT02444182|3976662|FG000|NOT COMPLETED|Overall Study||2
3243525|NCT02444182|3976663|FG001|NOT COMPLETED|Overall Study||5
3243526|NCT02444234|3976669|FG000|STARTED|First Intervention (3 Days)||6
3243527|NCT02444234|3976670|FG001|STARTED|First Intervention (3 Days)||5
3243528|NCT02444234|3976669|FG000|COMPLETED|First Intervention (3 Days)||6
3243529|NCT02444234|3976670|FG001|COMPLETED|First Intervention (3 Days)||5
3243530|NCT02444234|3976669|FG000|NOT COMPLETED|First Intervention (3 Days)||0
3243531|NCT02444234|3976670|FG001|NOT COMPLETED|First Intervention (3 Days)||0
3243532|NCT02444234|3976669|FG000|STARTED|Washout (2 Day Minimum)||6
3243533|NCT02444234|3976670|FG001|STARTED|Washout (2 Day Minimum)||5
3243534|NCT02444234|3976669|FG000|COMPLETED|Washout (2 Day Minimum)||6
3243535|NCT02444234|3976670|FG001|COMPLETED|Washout (2 Day Minimum)||5
3243536|NCT02444234|3976669|FG000|NOT COMPLETED|Washout (2 Day Minimum)||0
3243537|NCT02444234|3976670|FG001|NOT COMPLETED|Washout (2 Day Minimum)||0
3243538|NCT02444234|3976669|FG000|STARTED|Second Intervention (3 Days)||6
3243539|NCT02444234|3976670|FG001|STARTED|Second Intervention (3 Days)||5
3243540|NCT02444234|3976669|FG000|COMPLETED|Second Intervention (3 Days)||6
3243541|NCT02444234|3976670|FG001|COMPLETED|Second Intervention (3 Days)||5
3243542|NCT02444234|3976669|FG000|NOT COMPLETED|Second Intervention (3 Days)||0
3243543|NCT02444234|3976670|FG001|NOT COMPLETED|Second Intervention (3 Days)||0
3243544|NCT02444533|3976680|FG000|STARTED|Overall Study||17
3243545|NCT02444533|3976681|FG001|STARTED|Overall Study||22
3243546|NCT02444533|3976680|FG000|COMPLETED|Overall Study||15
3243547|NCT02444533|3976681|FG001|COMPLETED|Overall Study||18
3243548|NCT02444533|3976680|FG000|NOT COMPLETED|Overall Study||2
3243549|NCT02444533|3976681|FG001|NOT COMPLETED|Overall Study||4
3243550|NCT02444663|3976687|FG000|STARTED|Clinician Valgus||9
3243551|NCT02444663|3976687|FG000|COMPLETED|Clinician Valgus||9
3243552|NCT02444663|3976687|FG000|NOT COMPLETED|Clinician Valgus||0
3243553|NCT02444663|3976687|FG000|STARTED|Clinician Varus||9
3243554|NCT02444663|3976687|FG000|COMPLETED|Clinician Varus||9
3243555|NCT02444663|3976687|FG000|NOT COMPLETED|Clinician Varus||0
3243556|NCT02444663|3976687|FG000|STARTED|Device Valgus 0N||9
3243557|NCT02444663|3976687|FG000|COMPLETED|Device Valgus 0N||9
3243558|NCT02444663|3976687|FG000|NOT COMPLETED|Device Valgus 0N||0
3243559|NCT02444663|3976687|FG000|STARTED|Device Valgus 10N||9
3243560|NCT02444663|3976687|FG000|COMPLETED|Device Valgus 10N||9
3243561|NCT02444663|3976687|FG000|NOT COMPLETED|Device Valgus 10N||0
3243562|NCT02444663|3976687|FG000|STARTED|Device Valgus 20N||9
3243563|NCT02444663|3976687|FG000|COMPLETED|Device Valgus 20N||9
3243564|NCT02444663|3976687|FG000|NOT COMPLETED|Device Valgus 20N||0
3243565|NCT02444663|3976687|FG000|STARTED|Device Valgus 30N||9
3243566|NCT02444663|3976687|FG000|COMPLETED|Device Valgus 30N||9
3243567|NCT02444663|3976687|FG000|NOT COMPLETED|Device Valgus 30N||0
3243568|NCT02444663|3976687|FG000|STARTED|Device Varus 0N||9
3243569|NCT02444663|3976687|FG000|COMPLETED|Device Varus 0N||9
3243570|NCT02444663|3976687|FG000|NOT COMPLETED|Device Varus 0N||0
3243571|NCT02444663|3976687|FG000|STARTED|Device Varus 10N||9
3243572|NCT02444663|3976687|FG000|COMPLETED|Device Varus 10N||9
3243573|NCT02444663|3976687|FG000|NOT COMPLETED|Device Varus 10N||0
3243574|NCT02444663|3976687|FG000|STARTED|Device Varus 20N||9
3243575|NCT02444663|3976687|FG000|COMPLETED|Device Varus 20N||9
3243576|NCT02444663|3976687|FG000|NOT COMPLETED|Device Varus 20N||0
3243577|NCT02444663|3976687|FG000|STARTED|Device Varus 30N||9
3243578|NCT02444663|3976687|FG000|COMPLETED|Device Varus 30N||9
3243579|NCT02444663|3976687|FG000|NOT COMPLETED|Device Varus 30N||0
3243580|NCT02444715|3976711|FG000|STARTED|Overall Study||46
3243581|NCT02444715|3976712|FG001|STARTED|Overall Study||48
3243582|NCT02444715|3976711|FG000|COMPLETED|Overall Study||36
3243583|NCT02444715|3976712|FG001|COMPLETED|Overall Study||32
3243584|NCT02444715|3976711|FG000|NOT COMPLETED|Overall Study||10
3243585|NCT02444715|3976712|FG001|NOT COMPLETED|Overall Study||16
3243586|NCT02444793|3976723|FG000|STARTED|Overall Study||11
3243587|NCT02444793|3976724|FG001|STARTED|Overall Study||6
3243588|NCT02444793|3976725|FG002|STARTED|Overall Study||4
3243589|NCT02444793|3976726|FG003|STARTED|Overall Study||3
3243590|NCT02444793|3976723|FG000|COMPLETED|Overall Study||0
3243591|NCT02444793|3976724|FG001|COMPLETED|Overall Study||0
3243592|NCT02444793|3976725|FG002|COMPLETED|Overall Study||0
3243593|NCT02444793|3976726|FG003|COMPLETED|Overall Study||0
3243594|NCT02444793|3976723|FG000|NOT COMPLETED|Overall Study||11
3243595|NCT02444793|3976724|FG001|NOT COMPLETED|Overall Study||6
3243596|NCT02444793|3976725|FG002|NOT COMPLETED|Overall Study||4
3243597|NCT02444793|3976726|FG003|NOT COMPLETED|Overall Study||3
3243598|NCT02444936|3976739|FG000|STARTED|Overall Study||10
3243599|NCT02444936|3976740|FG001|STARTED|Overall Study||12
3243600|NCT02444936|3976739|FG000|COMPLETED|Overall Study||10
3243601|NCT02444936|3976740|FG001|COMPLETED|Overall Study||12
3243602|NCT02444936|3976739|FG000|NOT COMPLETED|Overall Study||0
3243603|NCT02444936|3976740|FG001|NOT COMPLETED|Overall Study||0
3243604|NCT02444988|3976748|FG000|STARTED|Overall Study||2646
3243605|NCT02444988|3976749|FG001|STARTED|Overall Study||2735
3243606|NCT02444988|3976748|FG000|COMPLETED|Overall Study||2646
3243607|NCT02444988|3976749|FG001|COMPLETED|Overall Study||2735
3370640|NCT03765138|4102048|FG000|STARTED|Overall Study||1
3370641|NCT03765138|4102048|FG000|COMPLETED|Overall Study||0
3370642|NCT03765138|4102048|FG000|NOT COMPLETED|Overall Study||1
3370643|NCT03764449|4102055|FG000|STARTED|Overall Study||8
3370644|NCT03764449|4102056|FG001|STARTED|Overall Study||8
3370645|NCT03764449|4102055|FG000|COMPLETED|Overall Study||8
3370646|NCT03764449|4102056|FG001|COMPLETED|Overall Study||8
3370647|NCT03764449|4102055|FG000|NOT COMPLETED|Overall Study||0
3370648|NCT03764449|4102056|FG001|NOT COMPLETED|Overall Study||0
3370649|NCT03763929|4102071|FG000|STARTED|Overall Study||2
3370650|NCT03763929|4102072|FG001|STARTED|Overall Study||4
3370651|NCT03763929|4102071|FG000|COMPLETED|Overall Study||2
3370652|NCT03763929|4102072|FG001|COMPLETED|Overall Study||4
3370653|NCT03763929|4102071|FG000|NOT COMPLETED|Overall Study||0
3370654|NCT03763929|4102072|FG001|NOT COMPLETED|Overall Study||0
3370655|NCT03763747|4102078|FG000|STARTED|Overall Study||200
3370656|NCT03763747|4102078|FG000|COMPLETED|Overall Study||200
3370657|NCT03763747|4102078|FG000|NOT COMPLETED|Overall Study||0
3370658|NCT03763175|4102085|FG000|STARTED|Overall Study||20
3370659|NCT03763175|4102086|FG001|STARTED|Overall Study||19
3370660|NCT03763175|4102087|FG002|STARTED|Overall Study||20
3370661|NCT03763175|4102085|FG000|COMPLETED|Overall Study||19
3370662|NCT03763175|4102086|FG001|COMPLETED|Overall Study||17
3370663|NCT03763175|4102087|FG002|COMPLETED|Overall Study||19
3370664|NCT03763175|4102085|FG000|NOT COMPLETED|Overall Study||1
3370665|NCT03763175|4102086|FG001|NOT COMPLETED|Overall Study||2
3370666|NCT03763175|4102087|FG002|NOT COMPLETED|Overall Study||1
3370667|NCT03763058|4102095|FG000|STARTED|Overall Study||20
3370668|NCT03763058|4102095|FG000|COMPLETED|Overall Study||18
3243608|NCT02444988|3976748|FG000|NOT COMPLETED|Overall Study||0
3243609|NCT02444988|3976749|FG001|NOT COMPLETED|Overall Study||0
3370669|NCT03763058|4102095|FG000|NOT COMPLETED|Overall Study||2
3370670|NCT03762993|4102101|FG000|STARTED|Overall Study||21
3370671|NCT03762993|4102102|FG001|STARTED|Overall Study||10
3370672|NCT03762993|4102101|FG000|COMPLETED|Overall Study||21
3370673|NCT03762993|4102102|FG001|COMPLETED|Overall Study||10
3243610|NCT02445014|3976755|FG000|STARTED|Overall Study||3
3243611|NCT02445014|3976755|FG000|COMPLETED|Overall Study||3
3243612|NCT02445014|3976755|FG000|NOT COMPLETED|Overall Study||0
3243613|NCT02445027|3976759|FG000|STARTED|Overall Study||60
3243614|NCT02445027|3976759|FG000|COMPLETED|Overall Study||45
3243615|NCT02445027|3976759|FG000|NOT COMPLETED|Overall Study||15
3243616|NCT02445196|3976765|FG000|STARTED|Overall Study||62
3243617|NCT02445196|3976766|FG001|STARTED|Overall Study||58
3243618|NCT02445196|3976765|FG000|COMPLETED|Overall Study||51
3243619|NCT02445196|3976766|FG001|COMPLETED|Overall Study||52
3243620|NCT02445196|3976765|FG000|NOT COMPLETED|Overall Study||11
3243621|NCT02445196|3976766|FG001|NOT COMPLETED|Overall Study||6
3243622|NCT02445287|3976774|FG000|STARTED|Overall Study||35
3243623|NCT02445287|3976775|FG001|STARTED|Overall Study||13
3243624|NCT02445287|3976774|FG000|COMPLETED|Overall Study||35
3243625|NCT02445287|3976775|FG001|COMPLETED|Overall Study||13
3243626|NCT02445287|3976774|FG000|NOT COMPLETED|Overall Study||0
3243627|NCT02445287|3976775|FG001|NOT COMPLETED|Overall Study||0
3243628|NCT02445326|3976788|FG000|STARTED|Overall Study||35
3243629|NCT02445326|3976789|FG001|STARTED|Overall Study||38
3243630|NCT02445326|3976788|FG000|COMPLETED|Overall Study||33
3243631|NCT02445326|3976789|FG001|COMPLETED|Overall Study||37
3243632|NCT02445326|3976788|FG000|NOT COMPLETED|Overall Study||2
3243633|NCT02445326|3976789|FG001|NOT COMPLETED|Overall Study||1
3243634|NCT02445573|3976797|FG000|STARTED|Overall Study||40
3243635|NCT02445573|3976798|FG001|STARTED|Overall Study||40
3243636|NCT02445573|3976797|FG000|COMPLETED|Overall Study||39
3243637|NCT02445573|3976798|FG001|COMPLETED|Overall Study||38
3243638|NCT02445573|3976797|FG000|NOT COMPLETED|Overall Study||1
3243639|NCT02445573|3976798|FG001|NOT COMPLETED|Overall Study||2
3243640|NCT02445586|3976804|FG000|STARTED|Overall Study||52
3243641|NCT02445586|3976804|FG000|Received at Least One Dose of Study Drug|Overall Study||52
3243642|NCT02445586|3976804|FG000|COMPLETED|Overall Study||13
3243643|NCT02445586|3976804|FG000|NOT COMPLETED|Overall Study||39
3243644|NCT02445625|3976808|FG000|STARTED|Overall Study||15
3243645|NCT02445625|3976808|FG000|COMPLETED|Overall Study||15
3243646|NCT02445625|3976808|FG000|NOT COMPLETED|Overall Study||0
3243647|NCT02445755|3976813|FG000|STARTED|Overall Study|Neonates will be tested with 3 transcutaneous (TcB) devices +/-30 minutes of routine bilirubin labs|113
3243648|NCT02445755|3976813|FG000|COMPLETED|Overall Study||100
3243649|NCT02445755|3976813|FG000|NOT COMPLETED|Overall Study||13
3243650|NCT02445794|3976824|FG000|STARTED|Overall Study||6
3243651|NCT02445794|3976825|FG001|STARTED|Overall Study||3
3243652|NCT02445794|3976826|FG002|STARTED|Overall Study||7
3243653|NCT02445794|3976827|FG003|STARTED|Overall Study||3
3243654|NCT02445794|3976824|FG000|COMPLETED|Overall Study||6
3243655|NCT02445794|3976825|FG001|COMPLETED|Overall Study||3
3243656|NCT02445794|3976826|FG002|COMPLETED|Overall Study||5
3243657|NCT02445794|3976827|FG003|COMPLETED|Overall Study||3
3243658|NCT02445794|3976824|FG000|NOT COMPLETED|Overall Study||0
3243659|NCT02445794|3976825|FG001|NOT COMPLETED|Overall Study||0
3243660|NCT02445794|3976826|FG002|NOT COMPLETED|Overall Study||2
3243661|NCT02445794|3976827|FG003|NOT COMPLETED|Overall Study||0
3243662|NCT02445807|3976844|FG000|STARTED|Overall Study||176
3243663|NCT02445807|3976845|FG001|STARTED|Overall Study||89
3243664|NCT02445807|3976844|FG000|COMPLETED|Overall Study||176
3243665|NCT02445807|3976845|FG001|COMPLETED|Overall Study||89
3243666|NCT02445807|3976844|FG000|NOT COMPLETED|Overall Study||0
3243667|NCT02445807|3976845|FG001|NOT COMPLETED|Overall Study||0
3243668|NCT02445859|3976853|FG000|STARTED|Overall Study||45
3243669|NCT02445859|3976854|FG001|STARTED|Overall Study||45
3243670|NCT02445859|3976853|FG000|COMPLETED|Overall Study||43
3243671|NCT02445859|3976854|FG001|COMPLETED|Overall Study||42
3243672|NCT02445859|3976853|FG000|NOT COMPLETED|Overall Study||2
3243673|NCT02445859|3976854|FG001|NOT COMPLETED|Overall Study||3
3243674|NCT02445911|3976864|FG000|STARTED|Overall Study||20
3243675|NCT02445911|3976865|FG001|STARTED|Overall Study||20
3243676|NCT02445911|3976866|FG002|STARTED|Overall Study||21
3243677|NCT02445911|3976867|FG003|STARTED|Overall Study||20
3243678|NCT02445911|3976864|FG000|COMPLETED|Overall Study||20
3243679|NCT02445911|3976865|FG001|COMPLETED|Overall Study||20
3243680|NCT02445911|3976866|FG002|COMPLETED|Overall Study||21
3243681|NCT02445911|3976867|FG003|COMPLETED|Overall Study||20
3243682|NCT02445911|3976864|FG000|NOT COMPLETED|Overall Study||0
3243683|NCT02445911|3976865|FG001|NOT COMPLETED|Overall Study||0
3243684|NCT02445911|3976866|FG002|NOT COMPLETED|Overall Study||0
3243685|NCT02445911|3976867|FG003|NOT COMPLETED|Overall Study||0
3243686|NCT02445963|3976881|FG000|STARTED|Overall Study||9
3243687|NCT02445963|3976882|FG001|STARTED|Overall Study||9
3243688|NCT02445963|3976883|FG002|STARTED|Overall Study||10
3243689|NCT02445963|3976884|FG003|STARTED|Overall Study||10
3243690|NCT02445963|3976881|FG000|COMPLETED|Overall Study||7
3243691|NCT02445963|3976882|FG001|COMPLETED|Overall Study||9
3243692|NCT02445963|3976883|FG002|COMPLETED|Overall Study||9
3243693|NCT02445963|3976884|FG003|COMPLETED|Overall Study||10
3243694|NCT02445963|3976881|FG000|NOT COMPLETED|Overall Study||2
3243695|NCT02445963|3976882|FG001|NOT COMPLETED|Overall Study||0
3243696|NCT02445963|3976883|FG002|NOT COMPLETED|Overall Study||1
3243697|NCT02445963|3976884|FG003|NOT COMPLETED|Overall Study||0
3243698|NCT02446015|3976898|FG000|STARTED|Overall Study||34
3243699|NCT02446015|3976899|FG001|STARTED|Overall Study||63
3243700|NCT02446015|3976898|FG000|COMPLETED|Overall Study||33
3243701|NCT02446015|3976899|FG001|COMPLETED|Overall Study||62
3243702|NCT02446015|3976898|FG000|NOT COMPLETED|Overall Study||1
3243703|NCT02446015|3976899|FG001|NOT COMPLETED|Overall Study||1
3243704|NCT02446171|3976910|FG000|STARTED|Overall Study||11
3243705|NCT02446171|3976911|FG001|STARTED|Overall Study||11
3243706|NCT02446171|3976912|FG002|STARTED|Overall Study||11
3243707|NCT02446171|3976913|FG003|STARTED|Overall Study||11
3243708|NCT02446171|3976910|FG000|COMPLETED|Overall Study||11
3243709|NCT02446171|3976911|FG001|COMPLETED|Overall Study||11
3243710|NCT02446171|3976912|FG002|COMPLETED|Overall Study||9
3243711|NCT02446171|3976913|FG003|COMPLETED|Overall Study||11
3243712|NCT02446171|3976910|FG000|NOT COMPLETED|Overall Study||0
3243713|NCT02446171|3976911|FG001|NOT COMPLETED|Overall Study||0
3243714|NCT02446171|3976912|FG002|NOT COMPLETED|Overall Study||2
3243715|NCT02446171|3976913|FG003|NOT COMPLETED|Overall Study||0
3243716|NCT02446223|3976925|FG000|STARTED|Overall Study||21
3243717|NCT02446223|3976925|FG000|COMPLETED|Overall Study||20
3243718|NCT02446223|3976925|FG000|NOT COMPLETED|Overall Study||1
3243719|NCT02446314|3976933|FG000|STARTED|Zero to Twelve Weeks.||30
3243720|NCT02446314|3976934|FG001|STARTED|Zero to Twelve Weeks.||30
3243721|NCT02446314|3976935|FG002|STARTED|Zero to Twelve Weeks.||31
3243722|NCT02446314|3976936|FG003|STARTED|Zero to Twelve Weeks.||31
3243723|NCT02446314|3976933|FG000|COMPLETED|Zero to Twelve Weeks.||27
3243724|NCT02446314|3976934|FG001|COMPLETED|Zero to Twelve Weeks.||29
3243725|NCT02446314|3976935|FG002|COMPLETED|Zero to Twelve Weeks.||31
3243726|NCT02446314|3976936|FG003|COMPLETED|Zero to Twelve Weeks.||29
3243727|NCT02446314|3976933|FG000|NOT COMPLETED|Zero to Twelve Weeks.||3
3243728|NCT02446314|3976934|FG001|NOT COMPLETED|Zero to Twelve Weeks.||1
3243729|NCT02446314|3976935|FG002|NOT COMPLETED|Zero to Twelve Weeks.||0
3243730|NCT02446314|3976936|FG003|NOT COMPLETED|Zero to Twelve Weeks.||2
3243731|NCT02446314|3976933|FG000|STARTED|Thirteen to Twenty Four Weeks||27
3243732|NCT02446314|3976934|FG001|STARTED|Thirteen to Twenty Four Weeks||29
3243733|NCT02446314|3976935|FG002|STARTED|Thirteen to Twenty Four Weeks||31
3243734|NCT02446314|3976936|FG003|STARTED|Thirteen to Twenty Four Weeks||29
3243735|NCT02446314|3976933|FG000|COMPLETED|Thirteen to Twenty Four Weeks||27
3243736|NCT02446314|3976934|FG001|COMPLETED|Thirteen to Twenty Four Weeks||28
3243737|NCT02446314|3976935|FG002|COMPLETED|Thirteen to Twenty Four Weeks||29
3243738|NCT02446314|3976936|FG003|COMPLETED|Thirteen to Twenty Four Weeks||28
3243739|NCT02446314|3976933|FG000|NOT COMPLETED|Thirteen to Twenty Four Weeks||0
3243740|NCT02446314|3976934|FG001|NOT COMPLETED|Thirteen to Twenty Four Weeks||1
3243741|NCT02446314|3976935|FG002|NOT COMPLETED|Thirteen to Twenty Four Weeks||2
3243742|NCT02446314|3976936|FG003|NOT COMPLETED|Thirteen to Twenty Four Weeks||1
3243743|NCT02446418|3976952|FG000|STARTED|Overall Study||210
3243744|NCT02446418|3976953|FG001|STARTED|Overall Study||210
3243745|NCT02446418|3976952|FG000|COMPLETED|Overall Study||192
3243746|NCT02446418|3976953|FG001|COMPLETED|Overall Study||194
3243747|NCT02446418|3976952|FG000|NOT COMPLETED|Overall Study||18
3243748|NCT02446418|3976953|FG001|NOT COMPLETED|Overall Study||16
3243749|NCT02446483|3976959|FG000|STARTED|Period 1: Intervention Period 1||30
3243750|NCT02446483|3976960|FG001|STARTED|Period 1: Intervention Period 1||30
3243751|NCT02446483|3976959|FG000|COMPLETED|Period 1: Intervention Period 1||30
3243752|NCT02446483|3976960|FG001|COMPLETED|Period 1: Intervention Period 1||30
3243753|NCT02446483|3976959|FG000|NOT COMPLETED|Period 1: Intervention Period 1||0
3243754|NCT02446483|3976960|FG001|NOT COMPLETED|Period 1: Intervention Period 1||0
3243755|NCT02446483|3976959|FG000|STARTED|Period 2: Washout Period (7 Days)||30
3243756|NCT02446483|3976960|FG001|STARTED|Period 2: Washout Period (7 Days)||30
3243757|NCT02446483|3976959|FG000|COMPLETED|Period 2: Washout Period (7 Days)||30
3243758|NCT02446483|3976960|FG001|COMPLETED|Period 2: Washout Period (7 Days)||30
3243759|NCT02446483|3976959|FG000|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
3243760|NCT02446483|3976960|FG001|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
3243761|NCT02446483|3976959|FG000|STARTED|Period 3: Intervention Period 2||30
3243762|NCT02446483|3976960|FG001|STARTED|Period 3: Intervention Period 2||30
3243763|NCT02446483|3976959|FG000|COMPLETED|Period 3: Intervention Period 2||30
3243764|NCT02446483|3976960|FG001|COMPLETED|Period 3: Intervention Period 2||30
3243765|NCT02446483|3976959|FG000|NOT COMPLETED|Period 3: Intervention Period 2||0
3243766|NCT02446483|3976960|FG001|NOT COMPLETED|Period 3: Intervention Period 2||0
3370674|NCT03762993|4102101|FG000|NOT COMPLETED|Overall Study||0
3370675|NCT03762993|4102102|FG001|NOT COMPLETED|Overall Study||0
3370676|NCT03762681|4102116|FG000|STARTED|Part 1||8
3370677|NCT03762681|4102117|FG001|STARTED|Part 1||8
3370678|NCT03762681|4102118|FG002|STARTED|Part 1||8
3370679|NCT03762681|4102119|FG003|STARTED|Part 1||8
3370680|NCT03762681|4102120|FG004|STARTED|Part 1||8
3370681|NCT03762681|4102121|FG005|STARTED|Part 1||0
3370682|NCT03762681|4102122|FG006|STARTED|Part 1||0
3370683|NCT03762681|4102123|FG007|STARTED|Part 1||0
3370684|NCT03762681|4102116|FG000|COMPLETED|Part 1||8
3370685|NCT03762681|4102117|FG001|COMPLETED|Part 1||8
3370686|NCT03762681|4102118|FG002|COMPLETED|Part 1||8
3370687|NCT03762681|4102119|FG003|COMPLETED|Part 1||7
3370688|NCT03762681|4102120|FG004|COMPLETED|Part 1||8
3370689|NCT03762681|4102121|FG005|COMPLETED|Part 1||0
3370690|NCT03762681|4102122|FG006|COMPLETED|Part 1||0
3370691|NCT03762681|4102123|FG007|COMPLETED|Part 1||0
3370692|NCT03762681|4102116|FG000|NOT COMPLETED|Part 1||0
3370693|NCT03762681|4102117|FG001|NOT COMPLETED|Part 1||0
3370694|NCT03762681|4102118|FG002|NOT COMPLETED|Part 1||0
3370695|NCT03762681|4102119|FG003|NOT COMPLETED|Part 1||1
3370696|NCT03762681|4102120|FG004|NOT COMPLETED|Part 1||0
3370697|NCT03762681|4102121|FG005|NOT COMPLETED|Part 1||0
3243767|NCT02446496|3976966|FG000|STARTED|Overall Study||24
3243768|NCT02446496|3976966|FG000|COMPLETED|Overall Study||24
3243769|NCT02446496|3976966|FG000|NOT COMPLETED|Overall Study||0
3243770|NCT02446613|3976974|FG000|STARTED|Overall Study||6
3243771|NCT02446613|3976975|FG001|STARTED|Overall Study||10
3243772|NCT02446613|3976974|FG000|COMPLETED|Overall Study||6
3243773|NCT02446613|3976975|FG001|COMPLETED|Overall Study||10
3243774|NCT02446613|3976974|FG000|NOT COMPLETED|Overall Study||0
3243775|NCT02446613|3976975|FG001|NOT COMPLETED|Overall Study||0
3243776|NCT02446691|3976985|FG000|STARTED|Overall Study||128
3243777|NCT02446691|3976985|FG000|COMPLETED|Overall Study||117
3243778|NCT02446691|3976985|FG000|NOT COMPLETED|Overall Study||11
3243779|NCT02446717|3976994|FG000|STARTED|Overall Study||6
3243780|NCT02446717|3976995|FG001|STARTED|Overall Study||22
3243781|NCT02446717|3976996|FG002|STARTED|Overall Study||22
3243782|NCT02446717|3976997|FG003|STARTED|Overall Study||44
3243783|NCT02446717|3976998|FG004|STARTED|Overall Study||47
3243784|NCT02446717|3976994|FG000|COMPLETED|Overall Study||6
3243785|NCT02446717|3976995|FG001|COMPLETED|Overall Study||21
3243786|NCT02446717|3976996|FG002|COMPLETED|Overall Study||20
3243787|NCT02446717|3976997|FG003|COMPLETED|Overall Study||43
3243788|NCT02446717|3976998|FG004|COMPLETED|Overall Study||46
3243789|NCT02446717|3976994|FG000|NOT COMPLETED|Overall Study||0
3243790|NCT02446717|3976995|FG001|NOT COMPLETED|Overall Study||1
3243791|NCT02446717|3976996|FG002|NOT COMPLETED|Overall Study||2
3243792|NCT02446717|3976997|FG003|NOT COMPLETED|Overall Study||1
3243793|NCT02446717|3976998|FG004|NOT COMPLETED|Overall Study||1
3243794|NCT02446743|3977012|FG000|STARTED|Overall Study||276
3243795|NCT02446743|3977013|FG001|STARTED|Overall Study||255
3243796|NCT02446743|3977012|FG000|COMPLETED|Overall Study||271
3243797|NCT02446743|3977013|FG001|COMPLETED|Overall Study||250
3243798|NCT02446743|3977012|FG000|NOT COMPLETED|Overall Study||5
3243799|NCT02446743|3977013|FG001|NOT COMPLETED|Overall Study||5
3243800|NCT02446769|3977028|FG000|STARTED|Screening Period||18
3243801|NCT02446769|3977029|FG001|STARTED|Screening Period||0
3243802|NCT02446769|3977030|FG002|STARTED|Screening Period||0
3243803|NCT02446769|3977028|FG000|COMPLETED|Screening Period||7
3243804|NCT02446769|3977029|FG001|COMPLETED|Screening Period||0
3243805|NCT02446769|3977030|FG002|COMPLETED|Screening Period||0
3243806|NCT02446769|3977028|FG000|NOT COMPLETED|Screening Period||11
3243807|NCT02446769|3977029|FG001|NOT COMPLETED|Screening Period||0
3243808|NCT02446769|3977030|FG002|NOT COMPLETED|Screening Period||0
3243809|NCT02446769|3977028|FG000|STARTED|Study Period||0
3243810|NCT02446769|3977029|FG001|STARTED|Study Period||4
3243811|NCT02446769|3977030|FG002|STARTED|Study Period||3
3243812|NCT02446769|3977028|FG000|COMPLETED|Study Period||0
3243813|NCT02446769|3977029|FG001|COMPLETED|Study Period||2
3243814|NCT02446769|3977030|FG002|COMPLETED|Study Period||3
3243815|NCT02446769|3977028|FG000|NOT COMPLETED|Study Period||0
3243816|NCT02446769|3977029|FG001|NOT COMPLETED|Study Period||2
3243817|NCT02446769|3977030|FG002|NOT COMPLETED|Study Period||0
3243818|NCT02446847|3977039|FG000|STARTED|Overall Study||8
3243819|NCT02446847|3977040|FG001|STARTED|Overall Study||8
3243820|NCT02446847|3977039|FG000|COMPLETED|Overall Study||8
3243821|NCT02446847|3977040|FG001|COMPLETED|Overall Study||6
3243822|NCT02446847|3977039|FG000|NOT COMPLETED|Overall Study||0
3243823|NCT02446847|3977040|FG001|NOT COMPLETED|Overall Study||2
3243824|NCT02446886|3977048|FG000|STARTED|Overall Study||8
3243825|NCT02446886|3977049|FG001|STARTED|Overall Study||7
3243826|NCT02446886|3977048|FG000|COMPLETED|Overall Study||6
3243827|NCT02446886|3977049|FG001|COMPLETED|Overall Study||3
3243828|NCT02446886|3977048|FG000|NOT COMPLETED|Overall Study||2
3243829|NCT02446886|3977049|FG001|NOT COMPLETED|Overall Study||4
3243830|NCT02446899|3977058|FG000|STARTED|Overall Study||181
3243831|NCT02446899|3977059|FG001|STARTED|Overall Study||184
3243832|NCT02446899|3977058|FG000|Received Study Drug|Overall Study||180
3243833|NCT02446899|3977059|FG001|Received Study Drug|Overall Study||182
3243834|NCT02446899|3977058|FG000|COMPLETED|Overall Study||156
3243835|NCT02446899|3977059|FG001|COMPLETED|Overall Study||136
3243836|NCT02446899|3977058|FG000|NOT COMPLETED|Overall Study||25
3243837|NCT02446899|3977059|FG001|NOT COMPLETED|Overall Study||48
3243838|NCT02446912|3977068|FG000|STARTED|Overall Study||93
3243839|NCT02446912|3977069|FG001|STARTED|Overall Study||180
3243840|NCT02446912|3977070|FG002|STARTED|Overall Study||184
3243841|NCT02446912|3977068|FG000|Participants Who Completed Week 52|Overall Study||80
3243842|NCT02446912|3977069|FG001|Participants Who Completed Week 52|Overall Study||153
3243843|NCT02446912|3977070|FG002|Participants Who Completed Week 52|Overall Study||157
3243844|NCT02446912|3977068|FG000|COMPLETED|Overall Study||75
3243845|NCT02446912|3977069|FG001|COMPLETED|Overall Study||145
3243846|NCT02446912|3977070|FG002|COMPLETED|Overall Study||149
3243847|NCT02446912|3977068|FG000|NOT COMPLETED|Overall Study||18
3243848|NCT02446912|3977069|FG001|NOT COMPLETED|Overall Study||35
3243849|NCT02446912|3977070|FG002|NOT COMPLETED|Overall Study||35
3243850|NCT02446990|3977080|FG000|STARTED|Overall Study||9550
3243851|NCT02446990|3977081|FG001|STARTED|Overall Study||9552
3243852|NCT02446990|3977080|FG000|COMPLETED|Overall Study||8830
3243853|NCT02446990|3977081|FG001|COMPLETED|Overall Study||8894
3243854|NCT02446990|3977080|FG000|NOT COMPLETED|Overall Study||720
3243855|NCT02446990|3977081|FG001|NOT COMPLETED|Overall Study||658
3243856|NCT02447003|3977089|FG000|STARTED|Overall Study||170
3243857|NCT02447003|3977090|FG001|STARTED|Overall Study||84
3243858|NCT02447003|3977089|FG000|COMPLETED|Overall Study||0
3243859|NCT02447003|3977090|FG001|COMPLETED|Overall Study||0
3243860|NCT02447003|3977089|FG000|NOT COMPLETED|Overall Study||170
3243861|NCT02447003|3977090|FG001|NOT COMPLETED|Overall Study||84
3243862|NCT02447029|3977100|FG000|STARTED|Overall Study||72
3243863|NCT02447029|3977101|FG001|STARTED|Overall Study||70
3243864|NCT02447029|3977100|FG000|Treated|Overall Study||69
3243865|NCT02447029|3977101|FG001|Treated|Overall Study||68
3243866|NCT02447029|3977100|FG000|COMPLETED|Overall Study||69
3243867|NCT02447029|3977101|FG001|COMPLETED|Overall Study||68
3243868|NCT02447029|3977100|FG000|NOT COMPLETED|Overall Study||3
3243869|NCT02447029|3977101|FG001|NOT COMPLETED|Overall Study||2
3243870|NCT02447081|3977107|FG000|STARTED|Overall Study||1088
3243871|NCT02447081|3977107|FG000|COMPLETED|Overall Study||864
3243872|NCT02447081|3977107|FG000|NOT COMPLETED|Overall Study||224
3243873|NCT02447172|3977114|FG000|STARTED|Overall Study||262
3243874|NCT02447172|3977115|FG001|STARTED|Overall Study||130
3243875|NCT02447172|3977116|FG002|STARTED|Overall Study||132
3243876|NCT02447172|3977114|FG000|COMPLETED|Overall Study||231
3243877|NCT02447172|3977115|FG001|COMPLETED|Overall Study||115
3243878|NCT02447172|3977116|FG002|COMPLETED|Overall Study||114
3243879|NCT02447172|3977114|FG000|NOT COMPLETED|Overall Study||31
3243880|NCT02447172|3977115|FG001|NOT COMPLETED|Overall Study||15
3243881|NCT02447172|3977116|FG002|NOT COMPLETED|Overall Study||18
3243882|NCT02447250|3977124|FG000|STARTED|First Dose (180 mcg Albuterol)||14
3243883|NCT02447250|3977124|FG000|COMPLETED|First Dose (180 mcg Albuterol)||14
3243884|NCT02447250|3977124|FG000|NOT COMPLETED|First Dose (180 mcg Albuterol)||0
3243885|NCT02447250|3977124|FG000|STARTED|Second Dose (270 mcg Albuterol)||14
3243886|NCT02447250|3977124|FG000|COMPLETED|Second Dose (270 mcg Albuterol)||13
3243887|NCT02447250|3977124|FG000|NOT COMPLETED|Second Dose (270 mcg Albuterol)||1
3243888|NCT02447250|3977124|FG000|STARTED|Third Dose (360 mcg Albuterol)||13
3243889|NCT02447250|3977124|FG000|COMPLETED|Third Dose (360 mcg Albuterol)||8
3243890|NCT02447250|3977124|FG000|NOT COMPLETED|Third Dose (360 mcg Albuterol)||5
3243891|NCT02447302|3977132|FG000|STARTED|Overall Study||52
3243892|NCT02447302|3977133|FG001|STARTED|Overall Study||50
3243893|NCT02447302|3977134|FG002|STARTED|Overall Study||54
3243894|NCT02447302|3977132|FG000|COMPLETED|Overall Study||47
3243895|NCT02447302|3977133|FG001|COMPLETED|Overall Study||46
3243896|NCT02447302|3977134|FG002|COMPLETED|Overall Study||48
3243897|NCT02447302|3977132|FG000|NOT COMPLETED|Overall Study||5
3243898|NCT02447302|3977133|FG001|NOT COMPLETED|Overall Study||4
3243899|NCT02447302|3977134|FG002|NOT COMPLETED|Overall Study||6
3243900|NCT02447328|3977142|FG000|STARTED|Overall Study|Enrolment 85 Screening Failure 2 starting study drug 83|83
3243901|NCT02447328|3977142|FG000|COMPLETED|Overall Study||82
3243902|NCT02447328|3977142|FG000|NOT COMPLETED|Overall Study||1
3243903|NCT02447432|3977148|FG000|STARTED|Epoch 001||160
3243904|NCT02447432|3977149|FG001|STARTED|Epoch 001||160
3243905|NCT02447432|3977148|FG000|COMPLETED|Epoch 001||155
3243906|NCT02447432|3977149|FG001|COMPLETED|Epoch 001||147
3243907|NCT02447432|3977148|FG000|NOT COMPLETED|Epoch 001||5
3243908|NCT02447432|3977149|FG001|NOT COMPLETED|Epoch 001||13
3243909|NCT02447432|3977148|FG000|STARTED|Epoch 002||152
3243910|NCT02447432|3977149|FG001|STARTED|Epoch 002||145
3243911|NCT02447432|3977148|FG000|COMPLETED|Epoch 002||152
3243912|NCT02447432|3977149|FG001|COMPLETED|Epoch 002||145
3243913|NCT02447432|3977148|FG000|NOT COMPLETED|Epoch 002||0
3243914|NCT02447432|3977149|FG001|NOT COMPLETED|Epoch 002||0
3243915|NCT02447458|3977161|FG000|STARTED|Overall Study||5
3243916|NCT02447458|3977162|FG001|STARTED|Overall Study||6
3243917|NCT02447458|3977163|FG002|STARTED|Overall Study||6
3243918|NCT02447458|3977164|FG003|STARTED|Overall Study||6
3243919|NCT02447458|3977165|FG004|STARTED|Overall Study||6
3243920|NCT02447458|3977166|FG005|STARTED|Overall Study||10
3243921|NCT02447458|3977161|FG000|COMPLETED|Overall Study||5
3243922|NCT02447458|3977162|FG001|COMPLETED|Overall Study||6
3243923|NCT02447458|3977163|FG002|COMPLETED|Overall Study||5
3243924|NCT02447458|3977164|FG003|COMPLETED|Overall Study||6
3243925|NCT02447458|3977165|FG004|COMPLETED|Overall Study||6
3243926|NCT02447458|3977166|FG005|COMPLETED|Overall Study||10
3243927|NCT02447458|3977161|FG000|NOT COMPLETED|Overall Study||0
3243928|NCT02447458|3977162|FG001|NOT COMPLETED|Overall Study||0
3243929|NCT02447458|3977163|FG002|NOT COMPLETED|Overall Study||1
3243930|NCT02447458|3977164|FG003|NOT COMPLETED|Overall Study||0
3243931|NCT02447458|3977165|FG004|NOT COMPLETED|Overall Study||0
3243932|NCT02447458|3977166|FG005|NOT COMPLETED|Overall Study||0
3243933|NCT02447497|3977189|FG000|STARTED|Overall Study||25
3243934|NCT02447497|3977190|FG001|STARTED|Overall Study||25
3243935|NCT02447497|3977191|FG002|STARTED|Overall Study||23
3243936|NCT02447497|3977192|FG003|STARTED|Overall Study||23
3243937|NCT02447497|3977189|FG000|COMPLETED|Overall Study||19
3243938|NCT02447497|3977190|FG001|COMPLETED|Overall Study||19
3243939|NCT02447497|3977191|FG002|COMPLETED|Overall Study||21
3243940|NCT02447497|3977192|FG003|COMPLETED|Overall Study||21
3243941|NCT02447497|3977189|FG000|NOT COMPLETED|Overall Study||6
3243942|NCT02447497|3977190|FG001|NOT COMPLETED|Overall Study||6
3243943|NCT02447497|3977191|FG002|NOT COMPLETED|Overall Study||2
3243944|NCT02447497|3977192|FG003|NOT COMPLETED|Overall Study||2
3243945|NCT02447575|3977210|FG000|STARTED|Overall Study|23 subjects were enrolled in the study: http://dx.doi.org/10.1016/j.chest.2016.08.017|23
3243946|NCT02447575|3977210|FG000|COMPLETED|Overall Study||23
3243947|NCT02447575|3977210|FG000|NOT COMPLETED|Overall Study||0
3243948|NCT02447718|3977216|FG000|STARTED|Overall Study||78
3243949|NCT02447718|3977217|FG001|STARTED|Overall Study||78
3243950|NCT02447718|3977216|FG000|Received Prevnar®13|Overall Study||74
3243951|NCT02447718|3977217|FG001|Received Prevnar®13|Overall Study|Do not receive vaccination|0
3243952|NCT02447718|3977216|FG000|Received Pediacel®|Overall Study||73
3243953|NCT02447718|3977217|FG001|Received Pediacel®|Overall Study|Do not receive vaccination|0
3243954|NCT02447718|3977216|FG000|Received Pneumovax® 23|Overall Study||73
3243955|NCT02447718|3977217|FG001|Received Pneumovax® 23|Overall Study|Do not receive vaccination|0
3243956|NCT02447718|3977216|FG000|COMPLETED|Overall Study||66
3243957|NCT02447718|3977217|FG001|COMPLETED|Overall Study||78
3243958|NCT02447718|3977216|FG000|NOT COMPLETED|Overall Study||12
3243959|NCT02447718|3977217|FG001|NOT COMPLETED|Overall Study||0
3243960|NCT02447744|3977226|FG000|STARTED|Overall Study|6 subjects are enrolled in the mindfulness program after serving on the waiting list control group|21
3243961|NCT02447744|3977227|FG001|STARTED|Overall Study||22
3243962|NCT02447744|3977226|FG000|COMPLETED|Overall Study||15
3243963|NCT02447744|3977227|FG001|COMPLETED|Overall Study||21
3243964|NCT02447744|3977226|FG000|NOT COMPLETED|Overall Study||6
3243965|NCT02447744|3977227|FG001|NOT COMPLETED|Overall Study||1
3243966|NCT02447848|3977233|FG000|STARTED|Overall Study||76
3243967|NCT02447848|3977233|FG000|COMPLETED|Overall Study||65
3243968|NCT02447848|3977233|FG000|NOT COMPLETED|Overall Study||11
3243969|NCT02447926|3977237|FG000|STARTED|Overall Study||1
3243970|NCT02447926|3977237|FG000|COMPLETED|Overall Study||1
3243971|NCT02447926|3977237|FG000|NOT COMPLETED|Overall Study||0
3243972|NCT02447952|3977241|FG000|STARTED|Overall Study||25
3243973|NCT02447952|3977241|FG000|COMPLETED|Overall Study||18
3243974|NCT02447952|3977241|FG000|NOT COMPLETED|Overall Study||7
3243975|NCT02447991|3977247|FG000|STARTED|Overall Study||45
3243976|NCT02447991|3977248|FG001|STARTED|Overall Study||89
3243977|NCT02447991|3977247|FG000|COMPLETED|Overall Study||35
3243978|NCT02447991|3977248|FG001|COMPLETED|Overall Study||59
3243979|NCT02447991|3977247|FG000|NOT COMPLETED|Overall Study||10
3243980|NCT02447991|3977248|FG001|NOT COMPLETED|Overall Study||30
3243981|NCT02448043|3977260|FG000|STARTED|Overall Study||23
3243982|NCT02448043|3977261|FG001|STARTED|Overall Study||22
3243983|NCT02448043|3977260|FG000|COMPLETED|Overall Study||20
3243984|NCT02448043|3977261|FG001|COMPLETED|Overall Study||18
3243985|NCT02448043|3977260|FG000|NOT COMPLETED|Overall Study||3
3243986|NCT02448043|3977261|FG001|NOT COMPLETED|Overall Study||4
3243987|NCT02448303|3977272|FG000|STARTED|Overall Study||38
3243988|NCT02448303|3977273|FG001|STARTED|Overall Study||36
3243989|NCT02448303|3977272|FG000|Enrolled|Overall Study||38
3243990|NCT02448303|3977273|FG001|Enrolled|Overall Study||36
3243991|NCT02448303|3977272|FG000|Received Study Medication|Overall Study||33
3243992|NCT02448303|3977273|FG001|Received Study Medication|Overall Study||35
3243993|NCT02448303|3977272|FG000|Discontinued Study|Overall Study||38
3243994|NCT02448303|3977273|FG001|Discontinued Study|Overall Study||36
3243995|NCT02448303|3977272|FG000|COMPLETED|Overall Study||0
3243996|NCT02448303|3977273|FG001|COMPLETED|Overall Study||0
3243997|NCT02448303|3977272|FG000|NOT COMPLETED|Overall Study||38
3243998|NCT02448303|3977273|FG001|NOT COMPLETED|Overall Study||36
3243999|NCT02448368|3977281|FG000|STARTED|Overall Study||2
3244000|NCT02448368|3977282|FG001|STARTED|Overall Study||2
3244001|NCT02448368|3977283|FG002|STARTED|Overall Study||2
3244002|NCT02448368|3977284|FG003|STARTED|Overall Study||2
3244003|NCT02448368|3977285|FG004|STARTED|Overall Study||2
3244004|NCT02448368|3977286|FG005|STARTED|Overall Study||2
3244005|NCT02448368|3977287|FG006|STARTED|Overall Study||2
3244006|NCT02448368|3977288|FG007|STARTED|Overall Study||2
3370698|NCT03762681|4102122|FG006|NOT COMPLETED|Part 1||0
3370699|NCT03762681|4102123|FG007|NOT COMPLETED|Part 1||0
3370700|NCT03762681|4102116|FG000|STARTED|Part 2a||0
3370701|NCT03762681|4102117|FG001|STARTED|Part 2a||0
3370702|NCT03762681|4102118|FG002|STARTED|Part 2a||0
3370703|NCT03762681|4102119|FG003|STARTED|Part 2a||0
3370704|NCT03762681|4102120|FG004|STARTED|Part 2a||0
3370705|NCT03762681|4102121|FG005|STARTED|Part 2a||2
3370706|NCT03762681|4102122|FG006|STARTED|Part 2a||8
3370707|NCT03762681|4102123|FG007|STARTED|Part 2a||5
3370708|NCT03762681|4102116|FG000|COMPLETED|Part 2a||0
3370709|NCT03762681|4102117|FG001|COMPLETED|Part 2a||0
3370710|NCT03762681|4102118|FG002|COMPLETED|Part 2a||0
3370711|NCT03762681|4102119|FG003|COMPLETED|Part 2a||0
3370712|NCT03762681|4102120|FG004|COMPLETED|Part 2a||0
3370713|NCT03762681|4102121|FG005|COMPLETED|Part 2a||2
3370714|NCT03762681|4102122|FG006|COMPLETED|Part 2a||8
3370715|NCT03762681|4102123|FG007|COMPLETED|Part 2a||4
3370716|NCT03762681|4102116|FG000|NOT COMPLETED|Part 2a||0
3370717|NCT03762681|4102117|FG001|NOT COMPLETED|Part 2a||0
3370718|NCT03762681|4102118|FG002|NOT COMPLETED|Part 2a||0
3370719|NCT03762681|4102119|FG003|NOT COMPLETED|Part 2a||0
3370720|NCT03762681|4102120|FG004|NOT COMPLETED|Part 2a||0
3370721|NCT03762681|4102121|FG005|NOT COMPLETED|Part 2a||0
3370722|NCT03762681|4102122|FG006|NOT COMPLETED|Part 2a||0
3370723|NCT03762681|4102123|FG007|NOT COMPLETED|Part 2a||1
3370724|NCT03762668|4102152|FG000|STARTED|Period 1, First Week of Wear||30
3370725|NCT03762668|4102153|FG001|STARTED|Period 1, First Week of Wear||30
3370726|NCT03762668|4102152|FG000|COMPLETED|Period 1, First Week of Wear||30
3370727|NCT03762668|4102153|FG001|COMPLETED|Period 1, First Week of Wear||29
3244007|NCT02448368|3977289|FG008|STARTED|Overall Study||2
3244008|NCT02448368|3977290|FG009|STARTED|Overall Study||2
3244009|NCT02448368|3977291|FG010|STARTED|Overall Study||5
3370728|NCT03762668|4102152|FG000|NOT COMPLETED|Period 1, First Week of Wear||0
3370729|NCT03762668|4102153|FG001|NOT COMPLETED|Period 1, First Week of Wear||1
3370730|NCT03762668|4102152|FG000|STARTED|Period 2, Second Week of Wear||30
3244010|NCT02448368|3977292|FG011|STARTED|Overall Study||5
3244011|NCT02448368|3977293|FG012|STARTED|Overall Study||5
3244012|NCT02448368|3977281|FG000|COMPLETED|Overall Study||2
3244013|NCT02448368|3977282|FG001|COMPLETED|Overall Study||2
3244014|NCT02448368|3977283|FG002|COMPLETED|Overall Study||2
3244015|NCT02448368|3977284|FG003|COMPLETED|Overall Study||2
3244016|NCT02448368|3977285|FG004|COMPLETED|Overall Study||2
3244017|NCT02448368|3977286|FG005|COMPLETED|Overall Study||2
3244018|NCT02448368|3977287|FG006|COMPLETED|Overall Study||2
3244019|NCT02448368|3977288|FG007|COMPLETED|Overall Study||2
3244020|NCT02448368|3977289|FG008|COMPLETED|Overall Study||2
3244021|NCT02448368|3977290|FG009|COMPLETED|Overall Study||2
3244022|NCT02448368|3977291|FG010|COMPLETED|Overall Study||5
3244023|NCT02448368|3977292|FG011|COMPLETED|Overall Study||5
3244024|NCT02448368|3977293|FG012|COMPLETED|Overall Study||5
3244025|NCT02448368|3977281|FG000|NOT COMPLETED|Overall Study||0
3244026|NCT02448368|3977282|FG001|NOT COMPLETED|Overall Study||0
3244027|NCT02448368|3977283|FG002|NOT COMPLETED|Overall Study||0
3370731|NCT03762668|4102153|FG001|STARTED|Period 2, Second Week of Wear||29
3370732|NCT03762668|4102152|FG000|COMPLETED|Period 2, Second Week of Wear||30
3370733|NCT03762668|4102153|FG001|COMPLETED|Period 2, Second Week of Wear||29
3370734|NCT03762668|4102152|FG000|NOT COMPLETED|Period 2, Second Week of Wear||0
3370735|NCT03762668|4102153|FG001|NOT COMPLETED|Period 2, Second Week of Wear||0
3370736|NCT03762616|4102159|FG000|STARTED|Overall Study||120
3370737|NCT03762616|4102159|FG000|COMPLETED|Overall Study||118
3370738|NCT03762616|4102159|FG000|NOT COMPLETED|Overall Study||2
3370739|NCT03762213|4102167|FG000|STARTED|Overall Study||16
3370740|NCT03762213|4102168|FG001|STARTED|Overall Study||14
3370741|NCT03762213|4102167|FG000|COMPLETED|Overall Study||16
3370742|NCT03762213|4102168|FG001|COMPLETED|Overall Study||14
3370743|NCT03762213|4102167|FG000|NOT COMPLETED|Overall Study||0
3370744|NCT03762213|4102168|FG001|NOT COMPLETED|Overall Study||0
3370745|NCT03762200|4102174|FG000|STARTED|Overall Study||103
3370746|NCT03762200|4102174|FG000|COMPLETED|Overall Study||101
3370747|NCT03762200|4102174|FG000|NOT COMPLETED|Overall Study||2
3370748|NCT03761368|4102180|FG000|STARTED|Overall Study||50
3370749|NCT03761368|4102181|FG001|STARTED|Overall Study||51
3370750|NCT03761368|4102180|FG000|COMPLETED|Overall Study||50
3370751|NCT03761368|4102181|FG001|COMPLETED|Overall Study||51
3370752|NCT03761368|4102180|FG000|NOT COMPLETED|Overall Study||0
3370753|NCT03761368|4102181|FG001|NOT COMPLETED|Overall Study||0
3370754|NCT03761147|4102189|FG000|STARTED|Overall Study||32
3370755|NCT03761147|4102190|FG001|STARTED|Overall Study||32
3370756|NCT03761147|4102189|FG000|COMPLETED|Overall Study||25
3370757|NCT03761147|4102190|FG001|COMPLETED|Overall Study||28
3370758|NCT03761147|4102189|FG000|NOT COMPLETED|Overall Study||7
3370759|NCT03761147|4102190|FG001|NOT COMPLETED|Overall Study||4
3370760|NCT03760913|4102215|FG000|STARTED|Overall Study||17
3370761|NCT03760913|4102216|FG001|STARTED|Overall Study||3
3370762|NCT03760913|4102217|FG002|STARTED|Overall Study||6
3370763|NCT03760913|4102218|FG003|STARTED|Overall Study||3
3370764|NCT03760913|4102219|FG004|STARTED|Overall Study||6
3370765|NCT03760913|4102220|FG005|STARTED|Overall Study||3
3370766|NCT03760913|4102221|FG006|STARTED|Overall Study||6
3370767|NCT03760913|4102222|FG007|STARTED|Overall Study||3
3370768|NCT03760913|4102223|FG008|STARTED|Overall Study||3
3370769|NCT03760913|4102224|FG009|STARTED|Overall Study||6
3370770|NCT03760913|4102225|FG010|STARTED|Overall Study||6
3370771|NCT03760913|4102226|FG011|STARTED|Overall Study||6
3370772|NCT03760913|4102227|FG012|STARTED|Overall Study||12
3370773|NCT03760913|4102228|FG013|STARTED|Overall Study||6
3370774|NCT03760913|4102229|FG014|STARTED|Overall Study||6
3370775|NCT03760913|4102230|FG015|STARTED|Overall Study||6
3370776|NCT03760913|4102231|FG016|STARTED|Overall Study||6
3370777|NCT03760913|4102232|FG017|STARTED|Overall Study||6
3370778|NCT03760913|4102233|FG018|STARTED|Overall Study||6
3370779|NCT03760913|4102215|FG000|COMPLETED|Overall Study||17
3370780|NCT03760913|4102216|FG001|COMPLETED|Overall Study||3
3370781|NCT03760913|4102217|FG002|COMPLETED|Overall Study||6
3370782|NCT03760913|4102218|FG003|COMPLETED|Overall Study||3
3370783|NCT03760913|4102219|FG004|COMPLETED|Overall Study||6
3370784|NCT03760913|4102220|FG005|COMPLETED|Overall Study||3
3370785|NCT03760913|4102221|FG006|COMPLETED|Overall Study||6
3370786|NCT03760913|4102222|FG007|COMPLETED|Overall Study||3
3370787|NCT03760913|4102223|FG008|COMPLETED|Overall Study||3
3370788|NCT03760913|4102224|FG009|COMPLETED|Overall Study||6
3370789|NCT03760913|4102225|FG010|COMPLETED|Overall Study||6
3370790|NCT03760913|4102226|FG011|COMPLETED|Overall Study||6
3370791|NCT03760913|4102227|FG012|COMPLETED|Overall Study||12
3370792|NCT03760913|4102228|FG013|COMPLETED|Overall Study||6
3370793|NCT03760913|4102229|FG014|COMPLETED|Overall Study||6
3370794|NCT03760913|4102230|FG015|COMPLETED|Overall Study||6
3370795|NCT03760913|4102231|FG016|COMPLETED|Overall Study||6
3370796|NCT03760913|4102232|FG017|COMPLETED|Overall Study||6
3370797|NCT03760913|4102233|FG018|COMPLETED|Overall Study||6
3370798|NCT03760913|4102215|FG000|NOT COMPLETED|Overall Study||0
3370799|NCT03760913|4102216|FG001|NOT COMPLETED|Overall Study||0
3370800|NCT03760913|4102217|FG002|NOT COMPLETED|Overall Study||0
3370801|NCT03760913|4102218|FG003|NOT COMPLETED|Overall Study||0
3244028|NCT02448368|3977284|FG003|NOT COMPLETED|Overall Study||0
3370802|NCT03760913|4102219|FG004|NOT COMPLETED|Overall Study||0
3370803|NCT03760913|4102220|FG005|NOT COMPLETED|Overall Study||0
3370804|NCT03760913|4102221|FG006|NOT COMPLETED|Overall Study||0
3370805|NCT03760913|4102222|FG007|NOT COMPLETED|Overall Study||0
3244029|NCT02448368|3977285|FG004|NOT COMPLETED|Overall Study||0
3244030|NCT02448368|3977286|FG005|NOT COMPLETED|Overall Study||0
3244031|NCT02448368|3977287|FG006|NOT COMPLETED|Overall Study||0
3244032|NCT02448368|3977288|FG007|NOT COMPLETED|Overall Study||0
3244033|NCT02448368|3977289|FG008|NOT COMPLETED|Overall Study||0
3244034|NCT02448368|3977290|FG009|NOT COMPLETED|Overall Study||0
3244035|NCT02448368|3977291|FG010|NOT COMPLETED|Overall Study||0
3244036|NCT02448368|3977292|FG011|NOT COMPLETED|Overall Study||0
3244037|NCT02448368|3977293|FG012|NOT COMPLETED|Overall Study||0
3244038|NCT02448446|3977320|FG000|STARTED|Overall Study||13
3244039|NCT02448446|3977321|FG001|STARTED|Overall Study||12
3244040|NCT02448446|3977320|FG000|COMPLETED|Overall Study||12
3244041|NCT02448446|3977321|FG001|COMPLETED|Overall Study||12
3244042|NCT02448446|3977320|FG000|NOT COMPLETED|Overall Study||1
3244043|NCT02448446|3977321|FG001|NOT COMPLETED|Overall Study||0
3244044|NCT02448537|3977330|FG000|STARTED|Overall Study||20
3244045|NCT02448537|3977331|FG001|STARTED|Overall Study||10
3244046|NCT02448537|3977332|FG002|STARTED|Overall Study||12
3244047|NCT02448537|3977330|FG000|COMPLETED|Overall Study||19
3244048|NCT02448537|3977331|FG001|COMPLETED|Overall Study||9
3244049|NCT02448537|3977332|FG002|COMPLETED|Overall Study||11
3244050|NCT02448537|3977330|FG000|NOT COMPLETED|Overall Study||1
3244051|NCT02448537|3977331|FG001|NOT COMPLETED|Overall Study||1
3244052|NCT02448537|3977332|FG002|NOT COMPLETED|Overall Study||1
3244053|NCT02448563|3977344|FG000|STARTED|Overall Study|Randomized after completing Visit 2|32
3244054|NCT02448563|3977345|FG001|STARTED|Overall Study|Randomized after completing Visit 2|30
3244055|NCT02448563|3977344|FG000|COMPLETED|Overall Study||16
3244056|NCT02448563|3977345|FG001|COMPLETED|Overall Study||19
3244057|NCT02448563|3977344|FG000|NOT COMPLETED|Overall Study||16
3244058|NCT02448563|3977345|FG001|NOT COMPLETED|Overall Study||11
3244059|NCT02448641|3977358|FG000|STARTED|Overall Study||55
3244060|NCT02448641|3977359|FG001|STARTED|Overall Study||56
3244061|NCT02448641|3977360|FG002|STARTED|Overall Study||52
3244062|NCT02448641|3977358|FG000|COMPLETED|Overall Study||54
3244063|NCT02448641|3977359|FG001|COMPLETED|Overall Study||51
3244064|NCT02448641|3977360|FG002|COMPLETED|Overall Study||48
3244065|NCT02448641|3977358|FG000|NOT COMPLETED|Overall Study||1
3244066|NCT02448641|3977359|FG001|NOT COMPLETED|Overall Study||5
3244067|NCT02448641|3977360|FG002|NOT COMPLETED|Overall Study||4
3244068|NCT02448654|3977377|FG000|STARTED|Overall Study||19
3244069|NCT02448654|3977378|FG001|STARTED|Overall Study||17
3244070|NCT02448654|3977377|FG000|Started Pills (Tolcapone or Placebo)|Overall Study||17
3244071|NCT02448654|3977378|FG001|Started Pills (Tolcapone or Placebo)|Overall Study||15
3244072|NCT02448654|3977377|FG000|COMPLETED|Overall Study||16
3244073|NCT02448654|3977378|FG001|COMPLETED|Overall Study||13
3244074|NCT02448654|3977377|FG000|NOT COMPLETED|Overall Study||3
3244075|NCT02448654|3977378|FG001|NOT COMPLETED|Overall Study||4
3244076|NCT02448706|3977384|FG000|STARTED|Overall Study||25
3244077|NCT02448706|3977385|FG001|STARTED|Overall Study||24
3244078|NCT02448706|3977384|FG000|Withdrew for Personal Reasons|Overall Study||1
3244079|NCT02448706|3977385|FG001|Withdrew for Personal Reasons|Overall Study||1
3244080|NCT02448706|3977384|FG000|Completed Baseline Testing|Overall Study||24
3244081|NCT02448706|3977385|FG001|Completed Baseline Testing|Overall Study||23
3244082|NCT02448706|3977384|FG000|COMPLETED|Overall Study||20
3244083|NCT02448706|3977385|FG001|COMPLETED|Overall Study||20
3244084|NCT02448706|3977384|FG000|NOT COMPLETED|Overall Study||5
3244085|NCT02448706|3977385|FG001|NOT COMPLETED|Overall Study||4
3244086|NCT02448719|3977404|FG000|STARTED|Overall Study||12
3244087|NCT02448719|3977405|FG001|STARTED|Overall Study||6
3244088|NCT02448719|3977406|FG002|STARTED|Overall Study||6
3244089|NCT02448719|3977407|FG003|STARTED|Overall Study||6
3244090|NCT02448719|3977408|FG004|STARTED|Overall Study||6
3244091|NCT02448719|3977409|FG005|STARTED|Overall Study||6
3244092|NCT02448719|3977410|FG006|STARTED|Overall Study||6
3244093|NCT02448719|3977411|FG007|STARTED|Overall Study||6
3244094|NCT02448719|3977412|FG008|STARTED|Overall Study||6
3244095|NCT02448719|3977413|FG009|STARTED|Overall Study||6
3244096|NCT02448719|3977414|FG010|STARTED|Overall Study||6
3244097|NCT02448719|3977404|FG000|COMPLETED|Overall Study||12
3244098|NCT02448719|3977405|FG001|COMPLETED|Overall Study||6
3244099|NCT02448719|3977406|FG002|COMPLETED|Overall Study||6
3244100|NCT02448719|3977407|FG003|COMPLETED|Overall Study||6
3244101|NCT02448719|3977408|FG004|COMPLETED|Overall Study||5
3244102|NCT02448719|3977409|FG005|COMPLETED|Overall Study||6
3244103|NCT02448719|3977410|FG006|COMPLETED|Overall Study||6
3244104|NCT02448719|3977411|FG007|COMPLETED|Overall Study||6
3244105|NCT02448719|3977412|FG008|COMPLETED|Overall Study||6
3244106|NCT02448719|3977413|FG009|COMPLETED|Overall Study||6
3244107|NCT02448719|3977414|FG010|COMPLETED|Overall Study||6
3244108|NCT02448719|3977404|FG000|NOT COMPLETED|Overall Study||0
3244109|NCT02448719|3977405|FG001|NOT COMPLETED|Overall Study||0
3244110|NCT02448719|3977406|FG002|NOT COMPLETED|Overall Study||0
3244111|NCT02448719|3977407|FG003|NOT COMPLETED|Overall Study||0
3244112|NCT02448719|3977408|FG004|NOT COMPLETED|Overall Study||1
3244113|NCT02448719|3977409|FG005|NOT COMPLETED|Overall Study||0
3244114|NCT02448719|3977410|FG006|NOT COMPLETED|Overall Study||0
3244115|NCT02448719|3977411|FG007|NOT COMPLETED|Overall Study||0
3244116|NCT02448719|3977412|FG008|NOT COMPLETED|Overall Study||0
3244117|NCT02448719|3977413|FG009|NOT COMPLETED|Overall Study||0
3244118|NCT02448719|3977414|FG010|NOT COMPLETED|Overall Study||0
3244119|NCT02448771|3977475|FG000|STARTED|Overall Study||36
3244120|NCT02448771|3977475|FG000|COMPLETED|Overall Study||0
3244121|NCT02448771|3977475|FG000|NOT COMPLETED|Overall Study||36
3244122|NCT02448810|3977488|FG000|STARTED|Overall Study||3
3244123|NCT02448810|3977489|FG001|STARTED|Overall Study||3
3244124|NCT02448810|3977490|FG002|STARTED|Overall Study||3
3244125|NCT02448810|3977491|FG003|STARTED|Overall Study||3
3244126|NCT02448810|3977492|FG004|STARTED|Overall Study||31
3244127|NCT02448810|3977493|FG005|STARTED|Overall Study||16
3244128|NCT02448810|3977494|FG006|STARTED|Overall Study||18
3244129|NCT02448810|3977495|FG007|STARTED|Overall Study||8
3244130|NCT02448810|3977488|FG000|Treated|Overall Study||3
3244131|NCT02448810|3977489|FG001|Treated|Overall Study||3
3244132|NCT02448810|3977490|FG002|Treated|Overall Study||3
3244133|NCT02448810|3977491|FG003|Treated|Overall Study||3
3244134|NCT02448810|3977492|FG004|Treated|Overall Study||29
3244135|NCT02448810|3977493|FG005|Treated|Overall Study||13
3244136|NCT02448810|3977494|FG006|Treated|Overall Study||18
3244137|NCT02448810|3977495|FG007|Treated|Overall Study||7
3244138|NCT02448810|3977488|FG000|COMPLETED|Overall Study||0
3244139|NCT02448810|3977489|FG001|COMPLETED|Overall Study||0
3244140|NCT02448810|3977490|FG002|COMPLETED|Overall Study||0
3244141|NCT02448810|3977491|FG003|COMPLETED|Overall Study||0
3244142|NCT02448810|3977492|FG004|COMPLETED|Overall Study||0
3244143|NCT02448810|3977493|FG005|COMPLETED|Overall Study||0
3244144|NCT02448810|3977494|FG006|COMPLETED|Overall Study||0
3244145|NCT02448810|3977495|FG007|COMPLETED|Overall Study||0
3244146|NCT02448810|3977488|FG000|NOT COMPLETED|Overall Study||3
3244147|NCT02448810|3977489|FG001|NOT COMPLETED|Overall Study||3
3244148|NCT02448810|3977490|FG002|NOT COMPLETED|Overall Study||3
3244149|NCT02448810|3977491|FG003|NOT COMPLETED|Overall Study||3
3244150|NCT02448810|3977492|FG004|NOT COMPLETED|Overall Study||31
3244151|NCT02448810|3977493|FG005|NOT COMPLETED|Overall Study||16
3244152|NCT02448810|3977494|FG006|NOT COMPLETED|Overall Study||18
3244153|NCT02448810|3977495|FG007|NOT COMPLETED|Overall Study||8
3244154|NCT02448862|3977519|FG000|STARTED|Overall Study||4525
3244155|NCT02448862|3977520|FG001|STARTED|Overall Study||6050
3244156|NCT02448862|3977519|FG000|COMPLETED|Overall Study||4525
3244157|NCT02448862|3977520|FG001|COMPLETED|Overall Study||6050
3244158|NCT02448862|3977519|FG000|NOT COMPLETED|Overall Study||0
3244159|NCT02448862|3977520|FG001|NOT COMPLETED|Overall Study||0
3244160|NCT02448875|3977529|FG000|STARTED|Overall Study||60
3244161|NCT02448875|3977530|FG001|STARTED|Overall Study||21
3244162|NCT02448875|3977531|FG002|STARTED|Overall Study||61
3244163|NCT02448875|3977529|FG000|Completed Dose Selection Phase|Overall Study||20
3244164|NCT02448875|3977530|FG001|Completed Dose Selection Phase|Overall Study||21
3244165|NCT02448875|3977531|FG002|Completed Dose Selection Phase|Overall Study||20
3244166|NCT02448875|3977529|FG000|Full Analysis Set|Overall Study||60
3244167|NCT02448875|3977530|FG001|Full Analysis Set|Overall Study||21
3244168|NCT02448875|3977531|FG002|Full Analysis Set|Overall Study||61
3244169|NCT02448875|3977529|FG000|Safety Analysis Set|Overall Study||60
3244170|NCT02448875|3977530|FG001|Safety Analysis Set|Overall Study||21
3244171|NCT02448875|3977531|FG002|Safety Analysis Set|Overall Study||61
3244172|NCT02448875|3977529|FG000|COMPLETED|Overall Study||53
3244173|NCT02448875|3977530|FG001|COMPLETED|Overall Study||20
3244174|NCT02448875|3977531|FG002|COMPLETED|Overall Study||60
3244175|NCT02448875|3977529|FG000|NOT COMPLETED|Overall Study||7
3244176|NCT02448875|3977530|FG001|NOT COMPLETED|Overall Study||1
3244177|NCT02448875|3977531|FG002|NOT COMPLETED|Overall Study||1
3244178|NCT02448914|3977542|FG000|STARTED|First Intervention (1 Day)||6
3244179|NCT02448914|3977543|FG001|STARTED|First Intervention (1 Day)||5
3244180|NCT02448914|3977542|FG000|COMPLETED|First Intervention (1 Day)||6
3244181|NCT02448914|3977543|FG001|COMPLETED|First Intervention (1 Day)||5
3244182|NCT02448914|3977542|FG000|NOT COMPLETED|First Intervention (1 Day)||0
3244183|NCT02448914|3977543|FG001|NOT COMPLETED|First Intervention (1 Day)||0
3244184|NCT02448914|3977542|FG000|STARTED|Second Intervention (1 Day)||6
3244185|NCT02448914|3977543|FG001|STARTED|Second Intervention (1 Day)||5
3244186|NCT02448914|3977542|FG000|COMPLETED|Second Intervention (1 Day)||6
3244187|NCT02448914|3977543|FG001|COMPLETED|Second Intervention (1 Day)||5
3244188|NCT02448914|3977542|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
3244189|NCT02448914|3977543|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
3244190|NCT02449018|3977552|FG000|STARTED|Overall Study||64
3244191|NCT02449018|3977553|FG001|STARTED|Overall Study||28
3244192|NCT02449018|3977552|FG000|COMPLETED|Overall Study||52
3244193|NCT02449018|3977553|FG001|COMPLETED|Overall Study||26
3244194|NCT02449018|3977552|FG000|NOT COMPLETED|Overall Study||12
3244195|NCT02449018|3977553|FG001|NOT COMPLETED|Overall Study||2
3244196|NCT02449044|3977559|FG000|STARTED|Overall Study||111
3244197|NCT02449044|3977559|FG000|COMPLETED|Overall Study|Participants who completed Weeks 58, 106 and 216 visit.|47
3244198|NCT02449044|3977559|FG000|NOT COMPLETED|Overall Study||64
3244199|NCT02449174|3977565|FG000|STARTED|Overall Study||36
3244200|NCT02449174|3977566|FG001|STARTED|Overall Study||32
3244201|NCT02449174|3977565|FG000|COMPLETED|Overall Study||36
3244202|NCT02449174|3977566|FG001|COMPLETED|Overall Study||32
3244203|NCT02449174|3977565|FG000|NOT COMPLETED|Overall Study||0
3244204|NCT02449174|3977566|FG001|NOT COMPLETED|Overall Study||0
3244205|NCT02449291|3977575|FG000|STARTED|Overall Study||191
3244206|NCT02449291|3977576|FG001|STARTED|Overall Study||188
3244207|NCT02449291|3977577|FG002|STARTED|Overall Study||181
3244208|NCT02449291|3977575|FG000|COMPLETED|Overall Study||186
3244209|NCT02449291|3977576|FG001|COMPLETED|Overall Study||186
3244210|NCT02449291|3977577|FG002|COMPLETED|Overall Study||180
3244211|NCT02449291|3977575|FG000|NOT COMPLETED|Overall Study||5
3244212|NCT02449291|3977576|FG001|NOT COMPLETED|Overall Study||2
3244213|NCT02449291|3977577|FG002|NOT COMPLETED|Overall Study||1
3244214|NCT02449356|3977590|FG000|STARTED|Overall Study||30
3244215|NCT02449356|3977591|FG001|STARTED|Overall Study||30
3244216|NCT02449356|3977590|FG000|COMPLETED|Overall Study||30
3244217|NCT02449356|3977591|FG001|COMPLETED|Overall Study||30
3244218|NCT02449356|3977590|FG000|NOT COMPLETED|Overall Study||0
3244219|NCT02449356|3977591|FG001|NOT COMPLETED|Overall Study||0
3244220|NCT02449434|3977601|FG000|STARTED|Overall Study||300
3244221|NCT02449434|3977602|FG001|STARTED|Overall Study||300
3244222|NCT02449434|3977601|FG000|COMPLETED|Overall Study||300
3244223|NCT02449434|3977602|FG001|COMPLETED|Overall Study||300
3244224|NCT02449434|3977601|FG000|NOT COMPLETED|Overall Study||0
3244225|NCT02449434|3977602|FG001|NOT COMPLETED|Overall Study||0
3244226|NCT02449473|3977610|FG000|STARTED|Overall Study||39
3244227|NCT02449473|3977611|FG001|STARTED|Overall Study||40
3244228|NCT02449473|3977610|FG000|COMPLETED|Overall Study||39
3244229|NCT02449473|3977611|FG001|COMPLETED|Overall Study||40
3244230|NCT02449473|3977610|FG000|NOT COMPLETED|Overall Study||0
3244231|NCT02449473|3977611|FG001|NOT COMPLETED|Overall Study||0
3244232|NCT02449798|3977617|FG000|STARTED|Overall Study||120
3244233|NCT02449798|3977617|FG000|COMPLETED|Overall Study||120
3244234|NCT02449798|3977617|FG000|NOT COMPLETED|Overall Study||0
3244235|NCT02449889|3977624|FG000|STARTED|Overall Study||58
3244236|NCT02449889|3977625|FG001|STARTED|Overall Study||58
3244237|NCT02449889|3977626|FG002|STARTED|Overall Study||60
3244238|NCT02449889|3977624|FG000|COMPLETED|Overall Study||57
3244239|NCT02449889|3977625|FG001|COMPLETED|Overall Study||52
3244240|NCT02449889|3977626|FG002|COMPLETED|Overall Study||59
3244241|NCT02449889|3977624|FG000|NOT COMPLETED|Overall Study||1
3244242|NCT02449889|3977625|FG001|NOT COMPLETED|Overall Study||6
3244243|NCT02449889|3977626|FG002|NOT COMPLETED|Overall Study||1
3244244|NCT02449902|3977636|FG000|STARTED|Overall Study||24
3244245|NCT02449902|3977637|FG001|STARTED|Overall Study||26
3244246|NCT02449902|3977636|FG000|COMPLETED|Overall Study||24
3244247|NCT02449902|3977637|FG001|COMPLETED|Overall Study||24
3244248|NCT02449902|3977636|FG000|NOT COMPLETED|Overall Study||0
3244249|NCT02449902|3977637|FG001|NOT COMPLETED|Overall Study||2
3244250|NCT02449915|3977647|FG000|STARTED|Overall Study||35
3244251|NCT02449915|3977648|FG001|STARTED|Overall Study||35
3244252|NCT02449915|3977647|FG000|COMPLETED|Overall Study||33
3244253|NCT02449915|3977648|FG001|COMPLETED|Overall Study||31
3244254|NCT02449915|3977647|FG000|NOT COMPLETED|Overall Study||2
3244255|NCT02449915|3977648|FG001|NOT COMPLETED|Overall Study||4
3244256|NCT02450383|3977656|FG000|STARTED|Overall Study||10
3244257|NCT02450383|3977657|FG001|STARTED|Overall Study||10
3244258|NCT02450383|3977656|FG000|COMPLETED|Overall Study||10
3244259|NCT02450383|3977657|FG001|COMPLETED|Overall Study||10
3244260|NCT02450383|3977656|FG000|NOT COMPLETED|Overall Study||0
3244261|NCT02450383|3977657|FG001|NOT COMPLETED|Overall Study||0
3244262|NCT02450487|3977663|FG000|STARTED|Overall Study||105
3244263|NCT02450487|3977663|FG000|COMPLETED|Overall Study||102
3244264|NCT02450487|3977663|FG000|NOT COMPLETED|Overall Study||3
3244265|NCT02450526|3977672|FG000|STARTED|DB Period (Cycle 1)||325
3244266|NCT02450526|3977673|FG001|STARTED|DB Period (Cycle 1)||66
3244267|NCT02450526|3977674|FG002|STARTED|DB Period (Cycle 1)||107
3244268|NCT02450526|3977675|FG003|STARTED|DB Period (Cycle 1)||22
3244269|NCT02450526|3977676|FG004|STARTED|DB Period (Cycle 1)|This arm was not included in DB Period (Cycle 1).|0
3244270|NCT02450526|3977672|FG000|Safety Population|DB Period (Cycle 1)||326
3244271|NCT02450526|3977673|FG001|Safety Population|DB Period (Cycle 1)||66
3244272|NCT02450526|3977674|FG002|Safety Population|DB Period (Cycle 1)||107
3244273|NCT02450526|3977675|FG003|Safety Population|DB Period (Cycle 1)||21
3244274|NCT02450526|3977676|FG004|Safety Population|DB Period (Cycle 1)||0
3244275|NCT02450526|3977672|FG000|COMPLETED|DB Period (Cycle 1)||294
3244276|NCT02450526|3977673|FG001|COMPLETED|DB Period (Cycle 1)||63
3244277|NCT02450526|3977674|FG002|COMPLETED|DB Period (Cycle 1)||97
3244278|NCT02450526|3977675|FG003|COMPLETED|DB Period (Cycle 1)||20
3244279|NCT02450526|3977676|FG004|COMPLETED|DB Period (Cycle 1)|This arm was not included in DB Period (Cycle 1).|0
3244280|NCT02450526|3977672|FG000|NOT COMPLETED|DB Period (Cycle 1)||31
3244281|NCT02450526|3977673|FG001|NOT COMPLETED|DB Period (Cycle 1)||3
3244282|NCT02450526|3977674|FG002|NOT COMPLETED|DB Period (Cycle 1)||10
3244283|NCT02450526|3977675|FG003|NOT COMPLETED|DB Period (Cycle 1)||2
3244284|NCT02450526|3977676|FG004|NOT COMPLETED|DB Period (Cycle 1)||0
3244285|NCT02450526|3977672|FG000|STARTED|OL Period (Cycles 2-5)|This arm was not included in OL Period (Cycles 2-5).|0
3244286|NCT02450526|3977673|FG001|STARTED|OL Period (Cycles 2-5)|This arm was not included in OL Period (Cycles 2-5).|0
3244287|NCT02450526|3977674|FG002|STARTED|OL Period (Cycles 2-5)|This arm was not included in OL Period (Cycles 2-5).|0
3244288|NCT02450526|3977675|FG003|STARTED|OL Period (Cycles 2-5)|This arm was not included in OL Period (Cycles 2-5).|0
3244289|NCT02450526|3977676|FG004|STARTED|OL Period (Cycles 2-5)|Nine subjects completed the DB Period but were not eligible for retreatment in the OL Period.|465
3244290|NCT02450526|3977672|FG000|Safety Population|OL Period (Cycles 2-5)||0
3244291|NCT02450526|3977673|FG001|Safety Population|OL Period (Cycles 2-5)||0
3244292|NCT02450526|3977674|FG002|Safety Population|OL Period (Cycles 2-5)||0
3244293|NCT02450526|3977675|FG003|Safety Population|OL Period (Cycles 2-5)||0
3244294|NCT02450526|3977676|FG004|Safety Population|OL Period (Cycles 2-5)||465
3244295|NCT02450526|3977672|FG000|Discontinued During Cycle 2|OL Period (Cycles 2-5)||0
3244296|NCT02450526|3977673|FG001|Discontinued During Cycle 2|OL Period (Cycles 2-5)||0
3244297|NCT02450526|3977674|FG002|Discontinued During Cycle 2|OL Period (Cycles 2-5)||0
3244298|NCT02450526|3977675|FG003|Discontinued During Cycle 2|OL Period (Cycles 2-5)||0
3244299|NCT02450526|3977676|FG004|Discontinued During Cycle 2|OL Period (Cycles 2-5)||28
3244300|NCT02450526|3977672|FG000|Discontinued During Cycle 3|OL Period (Cycles 2-5)||0
3244301|NCT02450526|3977673|FG001|Discontinued During Cycle 3|OL Period (Cycles 2-5)||0
3244302|NCT02450526|3977674|FG002|Discontinued During Cycle 3|OL Period (Cycles 2-5)||0
3244303|NCT02450526|3977675|FG003|Discontinued During Cycle 3|OL Period (Cycles 2-5)||0
3244304|NCT02450526|3977676|FG004|Discontinued During Cycle 3|OL Period (Cycles 2-5)||11
3244305|NCT02450526|3977672|FG000|Discontinued During Cycle 4|OL Period (Cycles 2-5)||0
3244306|NCT02450526|3977673|FG001|Discontinued During Cycle 4|OL Period (Cycles 2-5)||0
3244307|NCT02450526|3977674|FG002|Discontinued During Cycle 4|OL Period (Cycles 2-5)||0
3244308|NCT02450526|3977675|FG003|Discontinued During Cycle 4|OL Period (Cycles 2-5)||0
3244309|NCT02450526|3977676|FG004|Discontinued During Cycle 4|OL Period (Cycles 2-5)||2
3244310|NCT02450526|3977672|FG000|Discontinued During Cycle 5|OL Period (Cycles 2-5)||0
3244311|NCT02450526|3977673|FG001|Discontinued During Cycle 5|OL Period (Cycles 2-5)||0
3244312|NCT02450526|3977674|FG002|Discontinued During Cycle 5|OL Period (Cycles 2-5)||0
3244313|NCT02450526|3977675|FG003|Discontinued During Cycle 5|OL Period (Cycles 2-5)||0
3244314|NCT02450526|3977676|FG004|Discontinued During Cycle 5|OL Period (Cycles 2-5)||0
3244315|NCT02450526|3977672|FG000|COMPLETED|OL Period (Cycles 2-5)||0
3244316|NCT02450526|3977673|FG001|COMPLETED|OL Period (Cycles 2-5)||0
3244317|NCT02450526|3977674|FG002|COMPLETED|OL Period (Cycles 2-5)||0
3244318|NCT02450526|3977675|FG003|COMPLETED|OL Period (Cycles 2-5)||0
3244319|NCT02450526|3977676|FG004|COMPLETED|OL Period (Cycles 2-5)||424
3244320|NCT02450526|3977672|FG000|NOT COMPLETED|OL Period (Cycles 2-5)||0
3244321|NCT02450526|3977673|FG001|NOT COMPLETED|OL Period (Cycles 2-5)||0
3244322|NCT02450526|3977674|FG002|NOT COMPLETED|OL Period (Cycles 2-5)||0
3244323|NCT02450526|3977675|FG003|NOT COMPLETED|OL Period (Cycles 2-5)||0
3244324|NCT02450526|3977676|FG004|NOT COMPLETED|OL Period (Cycles 2-5)||41
3244325|NCT02450539|3977698|FG000|STARTED|Overall Study||106
3244326|NCT02450539|3977699|FG001|STARTED|Overall Study||53
3244327|NCT02450539|3977698|FG000|Received at Least One Dose of Study Drug|Overall Study||106
3244328|NCT02450539|3977699|FG001|Received at Least One Dose of Study Drug|Overall Study||52
3244329|NCT02450539|3977698|FG000|COMPLETED|Overall Study||90
3244330|NCT02450539|3977699|FG001|COMPLETED|Overall Study||46
3244331|NCT02450539|3977698|FG000|NOT COMPLETED|Overall Study||16
3244332|NCT02450539|3977699|FG001|NOT COMPLETED|Overall Study||7
3244333|NCT02450552|3977711|FG000|STARTED|Overall Study||19
3244334|NCT02450552|3977712|FG001|STARTED|Overall Study||23
3244335|NCT02450552|3977713|FG002|STARTED|Overall Study||23
3244336|NCT02450552|3977711|FG000|COMPLETED|Overall Study||14
3244337|NCT02450552|3977712|FG001|COMPLETED|Overall Study||23
3244338|NCT02450552|3977713|FG002|COMPLETED|Overall Study||18
3244339|NCT02450552|3977711|FG000|NOT COMPLETED|Overall Study||5
3244340|NCT02450552|3977712|FG001|NOT COMPLETED|Overall Study||0
3244341|NCT02450552|3977713|FG002|NOT COMPLETED|Overall Study||5
3244342|NCT02450578|3977725|FG000|STARTED|Overall Study||6
3244343|NCT02450578|3977726|FG001|STARTED|Overall Study||6
3244344|NCT02450578|3977727|FG002|STARTED|Overall Study||6
3244345|NCT02450578|3977728|FG003|STARTED|Overall Study||4
3244346|NCT02450578|3977725|FG000|COMPLETED|Overall Study||5
3244347|NCT02450578|3977726|FG001|COMPLETED|Overall Study||6
3244348|NCT02450578|3977727|FG002|COMPLETED|Overall Study||6
3244349|NCT02450578|3977728|FG003|COMPLETED|Overall Study||4
3244350|NCT02450578|3977725|FG000|NOT COMPLETED|Overall Study||1
3244351|NCT02450578|3977726|FG001|NOT COMPLETED|Overall Study||0
3244352|NCT02450578|3977727|FG002|NOT COMPLETED|Overall Study||0
3244353|NCT02450578|3977728|FG003|NOT COMPLETED|Overall Study||0
3244354|NCT02450747|3977742|FG000|STARTED|Overall Study||39
3244355|NCT02450747|3977742|FG000|COMPLETED|Overall Study||39
3244356|NCT02450747|3977742|FG000|NOT COMPLETED|Overall Study||0
3244357|NCT02450799|3977753|FG000|STARTED|Overall Study||31
3244358|NCT02450799|3977754|FG001|STARTED|Overall Study||37
3244359|NCT02450799|3977755|FG002|STARTED|Overall Study||30
3244360|NCT02450799|3977753|FG000|COMPLETED|Overall Study||31
3244361|NCT02450799|3977754|FG001|COMPLETED|Overall Study||37
3244362|NCT02450799|3977755|FG002|COMPLETED|Overall Study||30
3244363|NCT02450799|3977753|FG000|NOT COMPLETED|Overall Study||0
3244364|NCT02450799|3977754|FG001|NOT COMPLETED|Overall Study||0
3244365|NCT02450799|3977755|FG002|NOT COMPLETED|Overall Study||0
3244366|NCT02450903|3977766|FG000|STARTED|Overall Study||20
3244367|NCT02450903|3977766|FG000|Entered Post-treatment Effic. f/u Phase|Overall Study||4
3244368|NCT02450903|3977766|FG000|Entered Survival Follow-up Phase|Overall Study||15
3244369|NCT02450903|3977766|FG000|COMPLETED|Overall Study||0
3244370|NCT02450903|3977766|FG000|NOT COMPLETED|Overall Study||20
3244371|NCT02451007|3977770|FG000|STARTED|Overall Study||39
3244372|NCT02451007|3977770|FG000|COMPLETED|Overall Study||32
3244373|NCT02451007|3977770|FG000|NOT COMPLETED|Overall Study||7
3244374|NCT02451124|3977774|FG000|STARTED|Overall Study||156
3244375|NCT02451124|3977774|FG000|COMPLETED|Overall Study||155
3244376|NCT02451124|3977774|FG000|NOT COMPLETED|Overall Study||1
3244377|NCT02451137|3977784|FG000|STARTED|Overall Study||1651
3244378|NCT02451137|3977785|FG001|STARTED|Overall Study||1653
3244379|NCT02451137|3977784|FG000|Treated|Overall Study||1632
3244380|NCT02451137|3977785|FG001|Treated|Overall Study||1626
3244381|NCT02451137|3977784|FG000|Safety Population|Overall Study|4 participants received Standard of Care instead of Toujeo.|1637
3244382|NCT02451137|3977785|FG001|Safety Population|Overall Study|9 participants received Toujeo instead of Standard of Care.|1621
3244383|NCT02451137|3977784|FG000|COMPLETED|Overall Study||1405
3244384|NCT02451137|3977785|FG001|COMPLETED|Overall Study||1355
3244385|NCT02451137|3977784|FG000|NOT COMPLETED|Overall Study||246
3244386|NCT02451137|3977785|FG001|NOT COMPLETED|Overall Study||298
3244387|NCT02451150|3977793|FG000|STARTED|Overall Study||3
3244388|NCT02451150|3977794|FG001|STARTED|Overall Study||3
3244389|NCT02451150|3977793|FG000|COMPLETED|Overall Study||3
3244390|NCT02451150|3977794|FG001|COMPLETED|Overall Study||3
3244391|NCT02451150|3977793|FG000|NOT COMPLETED|Overall Study||0
3244392|NCT02451150|3977794|FG001|NOT COMPLETED|Overall Study||0
3244393|NCT02451202|3977802|FG000|STARTED|Overall Study||51
3244394|NCT02451202|3977803|FG001|STARTED|Overall Study||51
3244395|NCT02451202|3977802|FG000|COMPLETED|Overall Study||49
3244396|NCT02451202|3977803|FG001|COMPLETED|Overall Study||48
3244397|NCT02451202|3977802|FG000|NOT COMPLETED|Overall Study||2
3244398|NCT02451202|3977803|FG001|NOT COMPLETED|Overall Study||3
3244399|NCT02451358|3977815|FG000|STARTED|Overall Study||100
3244400|NCT02451358|3977816|FG001|STARTED|Overall Study||100
3244401|NCT02451358|3977817|FG002|STARTED|Overall Study||100
3244402|NCT02451358|3977818|FG003|STARTED|Overall Study||100
3244403|NCT02451358|3977815|FG000|Vaccinated at Day 0|Overall Study||100
3244404|NCT02451358|3977816|FG001|Vaccinated at Day 0|Overall Study||100
3244405|NCT02451358|3977817|FG002|Vaccinated at Day 0|Overall Study||100
3244406|NCT02451358|3977818|FG003|Vaccinated at Day 0|Overall Study||100
3244407|NCT02451358|3977815|FG000|Vaccinated at Day 28|Overall Study||99
3244408|NCT02451358|3977816|FG001|Vaccinated at Day 28|Overall Study||98
3244409|NCT02451358|3977817|FG002|Vaccinated at Day 28|Overall Study|Participants aged 9 years and older received only 1 dose of Quadrivalent Influenza Vaccine.|0
3244410|NCT02451358|3977818|FG003|Vaccinated at Day 28|Overall Study|Participants aged 9 years and older received only 1 dose of Quadrivalent Influenza Vaccine.|0
3244411|NCT02451358|3977815|FG000|COMPLETED|Overall Study||99
3244412|NCT02451358|3977816|FG001|COMPLETED|Overall Study||98
3244413|NCT02451358|3977817|FG002|COMPLETED|Overall Study||99
3244414|NCT02451358|3977818|FG003|COMPLETED|Overall Study||100
3244415|NCT02451358|3977815|FG000|NOT COMPLETED|Overall Study||1
3244416|NCT02451358|3977816|FG001|NOT COMPLETED|Overall Study||2
3244417|NCT02451358|3977817|FG002|NOT COMPLETED|Overall Study||1
3244418|NCT02451358|3977818|FG003|NOT COMPLETED|Overall Study||0
3244419|NCT02451488|3977830|FG000|STARTED|Overall Study||4
3244420|NCT02451488|3977831|FG001|STARTED|Overall Study||4
3244421|NCT02451488|3977830|FG000|COMPLETED|Overall Study||4
3244422|NCT02451488|3977831|FG001|COMPLETED|Overall Study||4
3244423|NCT02451488|3977830|FG000|NOT COMPLETED|Overall Study||0
3244424|NCT02451488|3977831|FG001|NOT COMPLETED|Overall Study||0
3244425|NCT02451514|3977840|FG000|STARTED|Overall Study||33
3244426|NCT02451514|3977841|FG001|STARTED|Overall Study||46
3244427|NCT02451514|3977842|FG002|STARTED|Overall Study||50
3244428|NCT02451514|3977840|FG000|COMPLETED|Overall Study||33
3244429|NCT02451514|3977841|FG001|COMPLETED|Overall Study||46
3244430|NCT02451514|3977842|FG002|COMPLETED|Overall Study||50
3244431|NCT02451514|3977840|FG000|NOT COMPLETED|Overall Study||0
3244432|NCT02451514|3977841|FG001|NOT COMPLETED|Overall Study||0
3244433|NCT02451514|3977842|FG002|NOT COMPLETED|Overall Study||0
3244434|NCT02451670|3977860|FG000|STARTED|Overall Study||5264
3244435|NCT02451670|3977861|FG001|STARTED|Overall Study||5083
3244436|NCT02451670|3977860|FG000|COMPLETED|Overall Study||4550
3244437|NCT02451670|3977861|FG001|COMPLETED|Overall Study||4387
3244438|NCT02451670|3977860|FG000|NOT COMPLETED|Overall Study||714
3244439|NCT02451670|3977861|FG001|NOT COMPLETED|Overall Study||696
3244440|NCT02451696|3977869|FG000|STARTED|Overall Study||5
3244441|NCT02451696|3977870|FG001|STARTED|Overall Study||10
3244442|NCT02451696|3977869|FG000|COMPLETED|Overall Study||4
3244443|NCT02451696|3977870|FG001|COMPLETED|Overall Study||10
3244444|NCT02451696|3977869|FG000|NOT COMPLETED|Overall Study||1
3244445|NCT02451696|3977870|FG001|NOT COMPLETED|Overall Study||0
3244446|NCT02451839|3977878|FG000|STARTED|Overall Study||72
3244447|NCT02451839|3977879|FG001|STARTED|Overall Study||59
3244448|NCT02451839|3977880|FG002|STARTED|Overall Study||37
3244449|NCT02451839|3977878|FG000|Baseline WHODAS Data Recorded|Overall Study||70
3244450|NCT02451839|3977879|FG001|Baseline WHODAS Data Recorded|Overall Study||57
3244451|NCT02451839|3977880|FG002|Baseline WHODAS Data Recorded|Overall Study||37
3244452|NCT02451839|3977878|FG000|COMPLETED|Overall Study||44
3244453|NCT02451839|3977879|FG001|COMPLETED|Overall Study||40
3244454|NCT02451839|3977880|FG002|COMPLETED|Overall Study||30
3244455|NCT02451839|3977878|FG000|NOT COMPLETED|Overall Study||28
3244456|NCT02451839|3977879|FG001|NOT COMPLETED|Overall Study||19
3244457|NCT02451839|3977880|FG002|NOT COMPLETED|Overall Study||7
3244458|NCT02451917|3977890|FG000|STARTED|First Intervention (24 Weeks)||16
3244459|NCT02451917|3977891|FG001|STARTED|First Intervention (24 Weeks)||18
3244460|NCT02451917|3977890|FG000|COMPLETED|First Intervention (24 Weeks)||14
3244461|NCT02451917|3977891|FG001|COMPLETED|First Intervention (24 Weeks)||15
3244462|NCT02451917|3977890|FG000|NOT COMPLETED|First Intervention (24 Weeks)||2
3244463|NCT02451917|3977891|FG001|NOT COMPLETED|First Intervention (24 Weeks)||3
3244464|NCT02451917|3977890|FG000|STARTED|Second Intervention (24 Weeks)||14
3244465|NCT02451917|3977891|FG001|STARTED|Second Intervention (24 Weeks)||15
3244466|NCT02451917|3977890|FG000|COMPLETED|Second Intervention (24 Weeks)||14
3244467|NCT02451917|3977891|FG001|COMPLETED|Second Intervention (24 Weeks)||15
3244468|NCT02451917|3977890|FG000|NOT COMPLETED|Second Intervention (24 Weeks)||0
3244469|NCT02451917|3977891|FG001|NOT COMPLETED|Second Intervention (24 Weeks)||0
3244470|NCT02451930|3977903|FG000|STARTED|Overall Study||3
3244471|NCT02451930|3977904|FG001|STARTED|Overall Study||68
3244472|NCT02451930|3977903|FG000|Received at Least One Dose of Study Drug|Overall Study||3
3244473|NCT02451930|3977904|FG001|Received at Least One Dose of Study Drug|Overall Study||68
3244474|NCT02451930|3977903|FG000|Part A Cohort 2 Participants|Overall Study||0
3244475|NCT02451930|3977904|FG001|Part A Cohort 2 Participants|Overall Study||6
3244476|NCT02451930|3977903|FG000|Part B Participants|Overall Study||0
3244477|NCT02451930|3977904|FG001|Part B Participants|Overall Study||55
3244478|NCT02451930|3977903|FG000|Part C Participants|Overall Study||0
3244479|NCT02451930|3977904|FG001|Part C Participants|Overall Study||7
3244480|NCT02451930|3977903|FG000|COMPLETED|Overall Study||1
3244481|NCT02451930|3977904|FG001|COMPLETED|Overall Study||38
3244482|NCT02451930|3977903|FG000|NOT COMPLETED|Overall Study||2
3244483|NCT02451930|3977904|FG001|NOT COMPLETED|Overall Study||30
3244484|NCT02451943|3977922|FG000|STARTED|Overall Study||258
3244485|NCT02451943|3977923|FG001|STARTED|Overall Study||251
3244486|NCT02451943|3977922|FG000|Received at Least One Dose of Study Drug|Overall Study||257
3244487|NCT02451943|3977923|FG001|Received at Least One Dose of Study Drug|Overall Study||249
3244488|NCT02451943|3977922|FG000|Leiomyosarcoma (LMS) Population|Overall Study||119
3370806|NCT03760913|4102223|FG008|NOT COMPLETED|Overall Study||0
3370807|NCT03760913|4102224|FG009|NOT COMPLETED|Overall Study||0
3370808|NCT03760913|4102225|FG010|NOT COMPLETED|Overall Study||0
3370809|NCT03760913|4102226|FG011|NOT COMPLETED|Overall Study||0
3370810|NCT03760913|4102227|FG012|NOT COMPLETED|Overall Study||0
3370811|NCT03760913|4102228|FG013|NOT COMPLETED|Overall Study||0
3370812|NCT03760913|4102229|FG014|NOT COMPLETED|Overall Study||0
3370813|NCT03760913|4102230|FG015|NOT COMPLETED|Overall Study||0
3370814|NCT03760913|4102231|FG016|NOT COMPLETED|Overall Study||0
3370815|NCT03760913|4102232|FG017|NOT COMPLETED|Overall Study||0
3370816|NCT03760913|4102233|FG018|NOT COMPLETED|Overall Study||0
3370817|NCT03760796|4102286|FG000|STARTED|Overall Study||200
3370818|NCT03760796|4102287|FG001|STARTED|Overall Study||864
3370819|NCT03760796|4102286|FG000|COMPLETED|Overall Study||200
3370820|NCT03760796|4102287|FG001|COMPLETED|Overall Study||864
3370821|NCT03760796|4102286|FG000|NOT COMPLETED|Overall Study||0
3370822|NCT03760796|4102287|FG001|NOT COMPLETED|Overall Study||0
3370823|NCT03760640|4102295|FG000|STARTED|Period 1||20
3370824|NCT03760640|4102296|FG001|STARTED|Period 1||22
3370825|NCT03760640|4102295|FG000|Received at Least 1 Dose of Study Drug|Period 1||20
3370826|NCT03760640|4102296|FG001|Received at Least 1 Dose of Study Drug|Period 1||22
3370827|NCT03760640|4102295|FG000|COMPLETED|Period 1||20
3370828|NCT03760640|4102296|FG001|COMPLETED|Period 1||22
3370829|NCT03760640|4102295|FG000|NOT COMPLETED|Period 1||0
3370830|NCT03760640|4102296|FG001|NOT COMPLETED|Period 1||0
3370831|NCT03760640|4102295|FG000|STARTED|Period 2||20
3370832|NCT03760640|4102296|FG001|STARTED|Period 2||22
3370833|NCT03760640|4102295|FG000|COMPLETED|Period 2||20
3370834|NCT03760640|4102296|FG001|COMPLETED|Period 2||22
3370835|NCT03760640|4102295|FG000|NOT COMPLETED|Period 2||0
3370836|NCT03760640|4102296|FG001|NOT COMPLETED|Period 2||0
3244489|NCT02451943|3977923|FG001|Leiomyosarcoma (LMS) Population|Overall Study||115
3244490|NCT02451943|3977922|FG000|COMPLETED|Overall Study||238
3244491|NCT02451943|3977923|FG001|COMPLETED|Overall Study||227
3244492|NCT02451943|3977922|FG000|NOT COMPLETED|Overall Study||20
3244493|NCT02451943|3977923|FG001|NOT COMPLETED|Overall Study||24
3244494|NCT02451995|3977931|FG000|STARTED|Overall Study||42
3244495|NCT02451995|3977932|FG001|STARTED|Overall Study||41
3244496|NCT02451995|3977931|FG000|COMPLETED|Overall Study||42
3244497|NCT02451995|3977932|FG001|COMPLETED|Overall Study||41
3244498|NCT02451995|3977931|FG000|NOT COMPLETED|Overall Study||0
3244499|NCT02451995|3977932|FG001|NOT COMPLETED|Overall Study||0
3244500|NCT02452034|3977944|FG000|STARTED|Overall Study||16
3244501|NCT02452034|3977945|FG001|STARTED|Overall Study||21
3244502|NCT02452034|3977946|FG002|STARTED|Overall Study||15
3244503|NCT02452034|3977947|FG003|STARTED|Overall Study||17
3244504|NCT02452034|3977948|FG004|STARTED|Overall Study||20
3244505|NCT02452034|3977949|FG005|STARTED|Overall Study||29
3244506|NCT02452034|3977944|FG000|Treated|Overall Study||14
3244507|NCT02452034|3977945|FG001|Treated|Overall Study||21
3244508|NCT02452034|3977946|FG002|Treated|Overall Study||15
3244509|NCT02452034|3977947|FG003|Treated|Overall Study||16
3244510|NCT02452034|3977948|FG004|Treated|Overall Study||20
3244511|NCT02452034|3977949|FG005|Treated|Overall Study||29
3244512|NCT02452034|3977944|FG000|COMPLETED|Overall Study||14
3244513|NCT02452034|3977945|FG001|COMPLETED|Overall Study||20
3244514|NCT02452034|3977946|FG002|COMPLETED|Overall Study||14
3244515|NCT02452034|3977947|FG003|COMPLETED|Overall Study||16
3244516|NCT02452034|3977948|FG004|COMPLETED|Overall Study||19
3244517|NCT02452034|3977949|FG005|COMPLETED|Overall Study||26
3244518|NCT02452034|3977944|FG000|NOT COMPLETED|Overall Study||2
3244519|NCT02452034|3977945|FG001|NOT COMPLETED|Overall Study||1
3244520|NCT02452034|3977946|FG002|NOT COMPLETED|Overall Study||1
3244521|NCT02452034|3977947|FG003|NOT COMPLETED|Overall Study||1
3244522|NCT02452034|3977948|FG004|NOT COMPLETED|Overall Study||1
3244523|NCT02452034|3977949|FG005|NOT COMPLETED|Overall Study||3
3244524|NCT02452047|3977966|FG000|STARTED|Overall Study||31
3244525|NCT02452047|3977967|FG001|STARTED|Overall Study||16
3244526|NCT02452047|3977968|FG002|STARTED|Overall Study||3
3244527|NCT02452047|3977966|FG000|COMPLETED|Overall Study||27
3244528|NCT02452047|3977967|FG001|COMPLETED|Overall Study||11
3244529|NCT02452047|3977968|FG002|COMPLETED|Overall Study||1
3244530|NCT02452047|3977966|FG000|NOT COMPLETED|Overall Study||4
3244531|NCT02452047|3977967|FG001|NOT COMPLETED|Overall Study||5
3244532|NCT02452047|3977968|FG002|NOT COMPLETED|Overall Study||2
3244533|NCT02452060|3977978|FG000|STARTED|Overall Study||46
3244534|NCT02452060|3977979|FG001|STARTED|Overall Study||44
3244535|NCT02452060|3977978|FG000|COMPLETED|Overall Study||46
3244536|NCT02452060|3977979|FG001|COMPLETED|Overall Study||44
3244537|NCT02452060|3977978|FG000|NOT COMPLETED|Overall Study||0
3244538|NCT02452060|3977979|FG001|NOT COMPLETED|Overall Study||0
3244539|NCT02452190|3977987|FG000|STARTED|Overall Study||232
3244540|NCT02452190|3977988|FG001|STARTED|Overall Study||236
3244541|NCT02452190|3977987|FG000|Intent to Treat (ITT) Population|Overall Study||230
3244542|NCT02452190|3977988|FG001|Intent to Treat (ITT) Population|Overall Study||234
3244543|NCT02452190|3977987|FG000|Safety Population|Overall Study||231
3244544|NCT02452190|3977988|FG001|Safety Population|Overall Study||237
3244545|NCT02452190|3977987|FG000|COMPLETED|Overall Study||197
3244546|NCT02452190|3977988|FG001|COMPLETED|Overall Study||212
3244547|NCT02452190|3977987|FG000|NOT COMPLETED|Overall Study||35
3244548|NCT02452190|3977988|FG001|NOT COMPLETED|Overall Study||24
3244549|NCT02452320|3977996|FG000|STARTED|Overall Study||64
3244550|NCT02452320|3977997|FG001|STARTED|Overall Study||64
3244551|NCT02452320|3977996|FG000|COMPLETED|Overall Study||64
3244552|NCT02452320|3977997|FG001|COMPLETED|Overall Study||63
3244553|NCT02452320|3977996|FG000|NOT COMPLETED|Overall Study||0
3244554|NCT02452320|3977997|FG001|NOT COMPLETED|Overall Study||1
3244555|NCT02452346|3978003|FG000|STARTED|Overall Study||12
3244556|NCT02452346|3978003|FG000|COMPLETED|Overall Study||3
3244557|NCT02452346|3978003|FG000|NOT COMPLETED|Overall Study||9
3244558|NCT02452424|3978018|FG000|STARTED|Overall Study||4
3244559|NCT02452424|3978019|FG001|STARTED|Overall Study||3
3244560|NCT02452424|3978020|FG002|STARTED|Overall Study||7
3244561|NCT02452424|3978021|FG003|STARTED|Overall Study||9
3244562|NCT02452424|3978022|FG004|STARTED|Overall Study||4
3244563|NCT02452424|3978023|FG005|STARTED|Overall Study||6
3244564|NCT02452424|3978024|FG006|STARTED|Overall Study||13
3244565|NCT02452424|3978025|FG007|STARTED|Overall Study||8
3244566|NCT02452424|3978026|FG008|STARTED|Overall Study||15
3244567|NCT02452424|3978027|FG009|STARTED|Overall Study||3
3244568|NCT02452424|3978028|FG010|STARTED|Overall Study||6
3244569|NCT02452424|3978018|FG000|COMPLETED|Overall Study||2
3244570|NCT02452424|3978019|FG001|COMPLETED|Overall Study||0
3244571|NCT02452424|3978020|FG002|COMPLETED|Overall Study||0
3244572|NCT02452424|3978021|FG003|COMPLETED|Overall Study||1
3244573|NCT02452424|3978022|FG004|COMPLETED|Overall Study||2
3244574|NCT02452424|3978023|FG005|COMPLETED|Overall Study||5
3244575|NCT02452424|3978024|FG006|COMPLETED|Overall Study||3
3244576|NCT02452424|3978025|FG007|COMPLETED|Overall Study||4
3244577|NCT02452424|3978026|FG008|COMPLETED|Overall Study||9
3244578|NCT02452424|3978027|FG009|COMPLETED|Overall Study||1
3244579|NCT02452424|3978028|FG010|COMPLETED|Overall Study||4
3244580|NCT02452424|3978018|FG000|NOT COMPLETED|Overall Study||2
3244581|NCT02452424|3978019|FG001|NOT COMPLETED|Overall Study||3
3244582|NCT02452424|3978020|FG002|NOT COMPLETED|Overall Study||7
3244583|NCT02452424|3978021|FG003|NOT COMPLETED|Overall Study||8
3244584|NCT02452424|3978022|FG004|NOT COMPLETED|Overall Study||2
3244585|NCT02452424|3978023|FG005|NOT COMPLETED|Overall Study||1
3244586|NCT02452424|3978024|FG006|NOT COMPLETED|Overall Study||10
3244587|NCT02452424|3978025|FG007|NOT COMPLETED|Overall Study||4
3244588|NCT02452424|3978026|FG008|NOT COMPLETED|Overall Study||6
3244589|NCT02452424|3978027|FG009|NOT COMPLETED|Overall Study||2
3244590|NCT02452424|3978028|FG010|NOT COMPLETED|Overall Study||2
3244591|NCT02452463|3978057|FG000|STARTED|Overall Study||5
3244592|NCT02452463|3978058|FG001|STARTED|Overall Study||3
3244593|NCT02452463|3978059|FG002|STARTED|Overall Study|"No participants were enrolled in the Arm III (Nintedanib, Durvalumab) Arm."|0
3244594|NCT02452463|3978057|FG000|COMPLETED|Overall Study||3
3244595|NCT02452463|3978058|FG001|COMPLETED|Overall Study||1
3244596|NCT02452463|3978059|FG002|COMPLETED|Overall Study||0
3244597|NCT02452463|3978057|FG000|NOT COMPLETED|Overall Study||2
3244598|NCT02452463|3978058|FG001|NOT COMPLETED|Overall Study||2
3244599|NCT02452463|3978059|FG002|NOT COMPLETED|Overall Study||0
3244600|NCT02452476|3978069|FG000|STARTED|Overall Study||64
3244601|NCT02452476|3978070|FG001|STARTED|Overall Study||59
3244602|NCT02452476|3978069|FG000|COMPLETED|Overall Study||53
3244603|NCT02452476|3978070|FG001|COMPLETED|Overall Study||49
3244604|NCT02452476|3978069|FG000|NOT COMPLETED|Overall Study||11
3244605|NCT02452476|3978070|FG001|NOT COMPLETED|Overall Study||10
3244606|NCT02452528|3978078|FG000|STARTED|Overall Study||2
3244607|NCT02452528|3978079|FG001|STARTED|Overall Study||2
3244608|NCT02452528|3978078|FG000|COMPLETED|Overall Study||1
3244609|NCT02452528|3978079|FG001|COMPLETED|Overall Study||1
3244610|NCT02452528|3978078|FG000|NOT COMPLETED|Overall Study||1
3244611|NCT02452528|3978079|FG001|NOT COMPLETED|Overall Study||1
3244612|NCT02452762|3978087|FG000|STARTED|Overall Study||45
3244613|NCT02452762|3978088|FG001|STARTED|Overall Study||22
3244614|NCT02452762|3978087|FG000|COMPLETED|Overall Study||40
3244615|NCT02452762|3978088|FG001|COMPLETED|Overall Study||19
3244616|NCT02452762|3978087|FG000|NOT COMPLETED|Overall Study||5
3244617|NCT02452762|3978088|FG001|NOT COMPLETED|Overall Study||3
3244618|NCT02452866|3978095|FG000|STARTED|Overall Study||325
3244619|NCT02452866|3978095|FG000|COMPLETED|Overall Study||321
3244620|NCT02452866|3978095|FG000|NOT COMPLETED|Overall Study||4
3244621|NCT02452892|3978103|FG000|STARTED|Week 1 Initial Randommization||41
3244622|NCT02452892|3978104|FG001|STARTED|Week 1 Initial Randommization||40
3244623|NCT02452892|3978105|FG002|STARTED|Week 1 Initial Randommization||41
3244624|NCT02452892|3978106|FG003|STARTED|Week 1 Initial Randommization||0
3244625|NCT02452892|3978103|FG000|COMPLETED|Week 1 Initial Randommization||40
3244626|NCT02452892|3978104|FG001|COMPLETED|Week 1 Initial Randommization||40
3244627|NCT02452892|3978105|FG002|COMPLETED|Week 1 Initial Randommization||40
3244628|NCT02452892|3978106|FG003|COMPLETED|Week 1 Initial Randommization||0
3244629|NCT02452892|3978103|FG000|NOT COMPLETED|Week 1 Initial Randommization||1
3244630|NCT02452892|3978104|FG001|NOT COMPLETED|Week 1 Initial Randommization||0
3244631|NCT02452892|3978105|FG002|NOT COMPLETED|Week 1 Initial Randommization||1
3244632|NCT02452892|3978106|FG003|NOT COMPLETED|Week 1 Initial Randommization||0
3244633|NCT02452892|3978103|FG000|STARTED|Week 2 Stratification & Re-Randomization|Week 1 Participants that started LFMS sham (27), LFMS 20min (19), and LFMS 60min (19)|65
3244634|NCT02452892|3978104|FG001|STARTED|Week 2 Stratification & Re-Randomization|Week 1 Participants that Started LFMS Sham (0), LFMS 20min (7), and LFMS 60min(0).|7
3244635|NCT02452892|3978105|FG002|STARTED|Week 2 Stratification & Re-Randomization|Week 1 Participants that Started LFMS Sham (0),LFMS 20min (0), LFMS 60min (7)|7
3244636|NCT02452892|3978106|FG003|STARTED|Week 2 Stratification & Re-Randomization|Week 1 Participants that Started LFMS Sham (13), LFMS 20min (14), and LFMS 60 min (14).|41
3244637|NCT02452892|3978103|FG000|Non-reponders|Week 2 Stratification & Re-Randomization||38
3244638|NCT02452892|3978104|FG001|Non-reponders|Week 2 Stratification & Re-Randomization||0
3244639|NCT02452892|3978105|FG002|Non-reponders|Week 2 Stratification & Re-Randomization||0
3244640|NCT02452892|3978106|FG003|Non-reponders|Week 2 Stratification & Re-Randomization||41
3244641|NCT02452892|3978103|FG000|Responders|Week 2 Stratification & Re-Randomization||27
3244642|NCT02452892|3978104|FG001|Responders|Week 2 Stratification & Re-Randomization||7
3244643|NCT02452892|3978105|FG002|Responders|Week 2 Stratification & Re-Randomization||7
3244644|NCT02452892|3978106|FG003|Responders|Week 2 Stratification & Re-Randomization||0
3244645|NCT02452892|3978103|FG000|COMPLETED|Week 2 Stratification & Re-Randomization||63
3244646|NCT02452892|3978104|FG001|COMPLETED|Week 2 Stratification & Re-Randomization||7
3244647|NCT02452892|3978105|FG002|COMPLETED|Week 2 Stratification & Re-Randomization||7
3244648|NCT02452892|3978106|FG003|COMPLETED|Week 2 Stratification & Re-Randomization||39
3244649|NCT02452892|3978103|FG000|NOT COMPLETED|Week 2 Stratification & Re-Randomization||2
3244650|NCT02452892|3978104|FG001|NOT COMPLETED|Week 2 Stratification & Re-Randomization||0
3244651|NCT02452892|3978105|FG002|NOT COMPLETED|Week 2 Stratification & Re-Randomization||0
3244652|NCT02452892|3978106|FG003|NOT COMPLETED|Week 2 Stratification & Re-Randomization||2
3244653|NCT02452892|3978103|FG000|STARTED|Follow-up||63
3244654|NCT02452892|3978104|FG001|STARTED|Follow-up||7
3244655|NCT02452892|3978105|FG002|STARTED|Follow-up||7
3244656|NCT02452892|3978106|FG003|STARTED|Follow-up||39
3244657|NCT02452892|3978103|FG000|COMPLETED|Follow-up||62
3244658|NCT02452892|3978104|FG001|COMPLETED|Follow-up||7
3244659|NCT02452892|3978105|FG002|COMPLETED|Follow-up||7
3244660|NCT02452892|3978106|FG003|COMPLETED|Follow-up||38
3244661|NCT02452892|3978103|FG000|NOT COMPLETED|Follow-up||1
3244662|NCT02452892|3978104|FG001|NOT COMPLETED|Follow-up||0
3244663|NCT02452892|3978105|FG002|NOT COMPLETED|Follow-up||0
3244664|NCT02452892|3978106|FG003|NOT COMPLETED|Follow-up||1
3244665|NCT02452931|3978119|FG000|STARTED|Overall Study||64
3244666|NCT02452931|3978119|FG000|COMPLETED|Overall Study||60
3244667|NCT02452931|3978119|FG000|NOT COMPLETED|Overall Study||4
3244668|NCT02452944|3978125|FG000|STARTED|Overall Study||31
3244669|NCT02452944|3978126|FG001|STARTED|Overall Study||31
3244670|NCT02452944|3978125|FG000|COMPLETED|Overall Study||31
3244671|NCT02452944|3978126|FG001|COMPLETED|Overall Study||31
3244672|NCT02452944|3978125|FG000|NOT COMPLETED|Overall Study||0
3244673|NCT02452944|3978126|FG001|NOT COMPLETED|Overall Study||0
3244674|NCT02453048|3978139|FG000|STARTED|Overall Study||12
3244675|NCT02453048|3978140|FG001|STARTED|Overall Study||12
3244676|NCT02453048|3978141|FG002|STARTED|Overall Study||12
3244677|NCT02453048|3978142|FG003|STARTED|Overall Study||12
3244678|NCT02453048|3978143|FG004|STARTED|Overall Study||6
3244679|NCT02453048|3978139|FG000|6-month Follow-up|Overall Study||12
3244680|NCT02453048|3978140|FG001|6-month Follow-up|Overall Study||12
3244681|NCT02453048|3978141|FG002|6-month Follow-up|Overall Study||12
3244682|NCT02453048|3978142|FG003|6-month Follow-up|Overall Study||12
3244683|NCT02453048|3978143|FG004|6-month Follow-up|Overall Study||6
3244684|NCT02453048|3978139|FG000|COMPLETED|Overall Study||12
3244685|NCT02453048|3978140|FG001|COMPLETED|Overall Study||11
3244686|NCT02453048|3978141|FG002|COMPLETED|Overall Study||10
3244687|NCT02453048|3978142|FG003|COMPLETED|Overall Study||12
3244688|NCT02453048|3978143|FG004|COMPLETED|Overall Study||0
3244689|NCT02453048|3978139|FG000|NOT COMPLETED|Overall Study||0
3244690|NCT02453048|3978140|FG001|NOT COMPLETED|Overall Study||1
3244691|NCT02453048|3978141|FG002|NOT COMPLETED|Overall Study||2
3244692|NCT02453048|3978142|FG003|NOT COMPLETED|Overall Study||0
3244693|NCT02453048|3978143|FG004|NOT COMPLETED|Overall Study||6
3244694|NCT02453113|3978155|FG000|STARTED|Overall Study||10
3244695|NCT02453113|3978155|FG000|COMPLETED|Overall Study||10
3244696|NCT02453113|3978155|FG000|NOT COMPLETED|Overall Study||0
3244697|NCT02453191|3978159|FG000|STARTED|Overall Study||30
3244698|NCT02453191|3978159|FG000|COMPLETED|Overall Study||29
3244699|NCT02453191|3978159|FG000|NOT COMPLETED|Overall Study||1
3244700|NCT02453256|3978165|FG000|STARTED|Double Blind Period||106
3244701|NCT02453256|3978166|FG001|STARTED|Double Blind Period||104
3244702|NCT02453256|3978165|FG000|COMPLETED|Double Blind Period||93
3244703|NCT02453256|3978166|FG001|COMPLETED|Double Blind Period||95
3244704|NCT02453256|3978165|FG000|NOT COMPLETED|Double Blind Period||13
3244705|NCT02453256|3978166|FG001|NOT COMPLETED|Double Blind Period||9
3244706|NCT02453256|3978165|FG000|STARTED|Open Label Period||89
3244707|NCT02453256|3978166|FG001|STARTED|Open Label Period||92
3244708|NCT02453256|3978165|FG000|COMPLETED|Open Label Period||82
3244709|NCT02453256|3978166|FG001|COMPLETED|Open Label Period||85
3244710|NCT02453256|3978165|FG000|NOT COMPLETED|Open Label Period||7
3244711|NCT02453256|3978166|FG001|NOT COMPLETED|Open Label Period||7
3244712|NCT02453282|3978182|FG000|STARTED|Overall Study||374
3244713|NCT02453282|3978183|FG001|STARTED|Overall Study||372
3244714|NCT02453282|3978184|FG002|STARTED|Overall Study||372
3244715|NCT02453282|3978182|FG000|Received Treatment|Overall Study||369
3244716|NCT02453282|3978183|FG001|Received Treatment|Overall Study||371
3244717|NCT02453282|3978184|FG002|Received Treatment|Overall Study||352
3244718|NCT02453282|3978182|FG000|COMPLETED|Overall Study||0
3244719|NCT02453282|3978183|FG001|COMPLETED|Overall Study||0
3244720|NCT02453282|3978184|FG002|COMPLETED|Overall Study||0
3244721|NCT02453282|3978182|FG000|NOT COMPLETED|Overall Study||374
3244722|NCT02453282|3978183|FG001|NOT COMPLETED|Overall Study||372
3244723|NCT02453282|3978184|FG002|NOT COMPLETED|Overall Study||372
3244724|NCT02453321|3978197|FG000|STARTED|Overall Study||20
3244725|NCT02453321|3978198|FG001|STARTED|Overall Study||21
3244726|NCT02453321|3978199|FG002|STARTED|Overall Study||21
3244727|NCT02453321|3978197|FG000|COMPLETED|Overall Study||19
3244728|NCT02453321|3978198|FG001|COMPLETED|Overall Study||19
3244729|NCT02453321|3978199|FG002|COMPLETED|Overall Study||19
3244730|NCT02453321|3978197|FG000|NOT COMPLETED|Overall Study||1
3244731|NCT02453321|3978198|FG001|NOT COMPLETED|Overall Study||2
3244732|NCT02453321|3978199|FG002|NOT COMPLETED|Overall Study||2
3244733|NCT02453334|3978212|FG000|STARTED|Overall Study||122
3244734|NCT02453334|3978213|FG001|STARTED|Overall Study||122
3244735|NCT02453334|3978212|FG000|COMPLETED|Overall Study||81
3244736|NCT02453334|3978213|FG001|COMPLETED|Overall Study||82
3244737|NCT02453334|3978212|FG000|NOT COMPLETED|Overall Study||41
3244738|NCT02453334|3978213|FG001|NOT COMPLETED|Overall Study||40
3370837|NCT03760510|4102304|FG000|STARTED|Overall Study||250
3370838|NCT03760510|4102305|FG001|STARTED|Overall Study||250
3370839|NCT03760510|4102304|FG000|COMPLETED|Overall Study||145
3370840|NCT03760510|4102305|FG001|COMPLETED|Overall Study||153
3370841|NCT03760510|4102304|FG000|NOT COMPLETED|Overall Study||105
3370842|NCT03760510|4102305|FG001|NOT COMPLETED|Overall Study||97
3370843|NCT03760250|4102311|FG000|STARTED|Overall Study||6
3370844|NCT03760250|4102311|FG000|COMPLETED|Overall Study||4
3370845|NCT03760250|4102311|FG000|NOT COMPLETED|Overall Study||2
3370846|NCT03759600|4102315|FG000|STARTED|Overall Study||20
3370847|NCT03759600|4102315|FG000|COMPLETED|Overall Study||0
3370848|NCT03759600|4102315|FG000|NOT COMPLETED|Overall Study||20
3370849|NCT03759340|4102319|FG000|STARTED|Overall Study||56
3370850|NCT03759340|4102319|FG000|COMPLETED|Overall Study||0
3370851|NCT03759340|4102319|FG000|NOT COMPLETED|Overall Study||56
3370852|NCT03758716|4102323|FG000|STARTED|Overall Study||12
3370853|NCT03758716|4102323|FG000|COMPLETED|Overall Study||12
3244739|NCT02453347|3978219|FG000|STARTED|Overall Study||6
3244740|NCT02453347|3978219|FG000|COMPLETED|Overall Study||6
3244741|NCT02453347|3978219|FG000|NOT COMPLETED|Overall Study||0
3244742|NCT02453360|3978226|FG000|STARTED|Overall Study||20
3244743|NCT02453360|3978227|FG001|STARTED|Overall Study||20
3244744|NCT02453360|3978228|FG002|STARTED|Overall Study||20
3244745|NCT02453360|3978226|FG000|COMPLETED|Overall Study||20
3244746|NCT02453360|3978227|FG001|COMPLETED|Overall Study||20
3244747|NCT02453360|3978228|FG002|COMPLETED|Overall Study||20
3244748|NCT02453360|3978226|FG000|NOT COMPLETED|Overall Study||0
3244749|NCT02453360|3978227|FG001|NOT COMPLETED|Overall Study||0
3244750|NCT02453360|3978228|FG002|NOT COMPLETED|Overall Study||0
3244751|NCT02453386|3978239|FG000|STARTED|Overall Study||151
3244752|NCT02453386|3978240|FG001|STARTED|Overall Study||149
3244753|NCT02453386|3978241|FG002|STARTED|Overall Study||149
3244754|NCT02453386|3978239|FG000|COMPLETED|Overall Study||102
3244755|NCT02453386|3978240|FG001|COMPLETED|Overall Study||100
3244756|NCT02453386|3978241|FG002|COMPLETED|Overall Study||108
3244757|NCT02453386|3978239|FG000|NOT COMPLETED|Overall Study||49
3244758|NCT02453386|3978240|FG001|NOT COMPLETED|Overall Study||49
3244759|NCT02453386|3978241|FG002|NOT COMPLETED|Overall Study||41
3244760|NCT02453555|3978258|FG000|STARTED|24-week Double-blind Treatment Period|Started are treated subjects.|182
3244761|NCT02453555|3978259|FG001|STARTED|24-week Double-blind Treatment Period|Started are treated subjects.|93
3244762|NCT02453555|3978260|FG002|STARTED|24-week Double-blind Treatment Period|This reporting group is not applicable in this period.|0
3244763|NCT02453555|3978261|FG003|STARTED|24-week Double-blind Treatment Period|This reporting group is not applicable in this period.|0
3244764|NCT02453555|3978262|FG004|STARTED|24-week Double-blind Treatment Period|This reporting group is not applicable in this period.|0
3244765|NCT02453555|3978263|FG005|STARTED|24-week Double-blind Treatment Period|This reporting group is not applicable in this period.|0
3244766|NCT02453555|3978258|FG000|COMPLETED|24-week Double-blind Treatment Period||177
3244767|NCT02453555|3978259|FG001|COMPLETED|24-week Double-blind Treatment Period||86
3244768|NCT02453555|3978260|FG002|COMPLETED|24-week Double-blind Treatment Period||0
3244769|NCT02453555|3978261|FG003|COMPLETED|24-week Double-blind Treatment Period||0
3244770|NCT02453555|3978262|FG004|COMPLETED|24-week Double-blind Treatment Period||0
3244771|NCT02453555|3978263|FG005|COMPLETED|24-week Double-blind Treatment Period||0
3244772|NCT02453555|3978258|FG000|NOT COMPLETED|24-week Double-blind Treatment Period||5
3244773|NCT02453555|3978259|FG001|NOT COMPLETED|24-week Double-blind Treatment Period||7
3244774|NCT02453555|3978260|FG002|NOT COMPLETED|24-week Double-blind Treatment Period||0
3244775|NCT02453555|3978261|FG003|NOT COMPLETED|24-week Double-blind Treatment Period||0
3244776|NCT02453555|3978262|FG004|NOT COMPLETED|24-week Double-blind Treatment Period||0
3370854|NCT03758716|4102323|FG000|NOT COMPLETED|Overall Study||0
3370855|NCT03758365|4102327|FG000|STARTED|Overall Study||36
3370856|NCT03758365|4102327|FG000|MC2-01 Cream|Overall Study||36
3370857|NCT03758365|4102327|FG000|Clobetasol Propionate 0.05% Lotion|Overall Study||36
3370858|NCT03758365|4102327|FG000|Betamethasone Dipropionate 0.05% Cream|Overall Study||36
3370859|NCT03758365|4102327|FG000|Triamcinolone Acetonide 0,1% Cream|Overall Study||36
3370860|NCT03758365|4102327|FG000|Hydrocortisone Butyrate 0.1% Cream|Overall Study||36
3370861|NCT03758365|4102327|FG000|Desonide 0.05% Cream|Overall Study||36
3370862|NCT03758365|4102327|FG000|Vehicle Cream|Overall Study||36
3370863|NCT03758365|4102327|FG000|COMPLETED|Overall Study||36
3370864|NCT03758365|4102327|FG000|NOT COMPLETED|Overall Study||0
3370865|NCT03758157|4102338|FG000|STARTED|Overall Study||110
3370866|NCT03758157|4102338|FG000|COMPLETED|Overall Study||110
3370867|NCT03758157|4102338|FG000|NOT COMPLETED|Overall Study||0
3370868|NCT03757988|4102342|FG000|STARTED|Overall Study||17
3370869|NCT03757988|4102342|FG000|COMPLETED|Overall Study||16
3370870|NCT03757988|4102342|FG000|NOT COMPLETED|Overall Study||1
3370871|NCT03757312|4102349|FG000|STARTED|Overall Study||5
3370872|NCT03757312|4102350|FG001|STARTED|Overall Study||9
3370873|NCT03757312|4102349|FG000|COMPLETED|Overall Study||5
3370874|NCT03757312|4102350|FG001|COMPLETED|Overall Study||9
3370875|NCT03757312|4102349|FG000|NOT COMPLETED|Overall Study||0
3370876|NCT03757312|4102350|FG001|NOT COMPLETED|Overall Study||0
3370877|NCT03757234|4102363|FG000|STARTED|Overall Study||75
3370878|NCT03757234|4102364|FG001|STARTED|Overall Study||18
3370879|NCT03757234|4102365|FG002|STARTED|Overall Study||17
3370880|NCT03757234|4102366|FG003|STARTED|Overall Study||17
3370881|NCT03757234|4102367|FG004|STARTED|Overall Study||74
3370882|NCT03757234|4102363|FG000|Completed PTE Visit|Overall Study||72
3370883|NCT03757234|4102364|FG001|Completed PTE Visit|Overall Study||16
3370884|NCT03757234|4102365|FG002|Completed PTE Visit|Overall Study||17
3370885|NCT03757234|4102366|FG003|Completed PTE Visit|Overall Study||16
3370886|NCT03757234|4102367|FG004|Completed PTE Visit|Overall Study||71
3370887|NCT03757234|4102363|FG000|COMPLETED|Overall Study||72
3370888|NCT03757234|4102364|FG001|COMPLETED|Overall Study||16
3370889|NCT03757234|4102365|FG002|COMPLETED|Overall Study||17
3370890|NCT03757234|4102366|FG003|COMPLETED|Overall Study||16
3370891|NCT03757234|4102367|FG004|COMPLETED|Overall Study||70
3370892|NCT03757234|4102363|FG000|NOT COMPLETED|Overall Study||3
3370893|NCT03757234|4102364|FG001|NOT COMPLETED|Overall Study||2
3370894|NCT03757234|4102365|FG002|NOT COMPLETED|Overall Study||0
3370895|NCT03757234|4102366|FG003|NOT COMPLETED|Overall Study||1
3370896|NCT03757234|4102367|FG004|NOT COMPLETED|Overall Study||4
3370897|NCT03757039|4102383|FG000|STARTED|Overall Study||32
3370898|NCT03757039|4102384|FG001|STARTED|Overall Study||9
3370899|NCT03757039|4102383|FG000|AOHG MF|Overall Study||11
3244777|NCT02453555|3978263|FG005|NOT COMPLETED|24-week Double-blind Treatment Period||0
3244778|NCT02453555|3978258|FG000|STARTED|Extension Period|This reporting group is not applicable in this period.|0
3244779|NCT02453555|3978259|FG001|STARTED|Extension Period|This reporting group is not applicable in this period.|0
3244780|NCT02453555|3978260|FG002|STARTED|Extension Period||126
3244781|NCT02453555|3978261|FG003|STARTED|Extension Period||51
3244782|NCT02453555|3978262|FG004|STARTED|Extension Period||80
3244783|NCT02453555|3978263|FG005|STARTED|Extension Period||6
3244784|NCT02453555|3978258|FG000|COMPLETED|Extension Period||0
3244785|NCT02453555|3978259|FG001|COMPLETED|Extension Period||0
3244786|NCT02453555|3978260|FG002|COMPLETED|Extension Period||123
3244787|NCT02453555|3978261|FG003|COMPLETED|Extension Period||49
3244788|NCT02453555|3978262|FG004|COMPLETED|Extension Period||79
3244789|NCT02453555|3978263|FG005|COMPLETED|Extension Period||5
3244790|NCT02453555|3978258|FG000|NOT COMPLETED|Extension Period||0
3244791|NCT02453555|3978259|FG001|NOT COMPLETED|Extension Period||0
3244792|NCT02453555|3978260|FG002|NOT COMPLETED|Extension Period||3
3244793|NCT02453555|3978261|FG003|NOT COMPLETED|Extension Period||2
3244794|NCT02453555|3978262|FG004|NOT COMPLETED|Extension Period||1
3244795|NCT02453555|3978263|FG005|NOT COMPLETED|Extension Period||1
3244796|NCT02453581|3978273|FG000|STARTED|Overall Study||8
3244797|NCT02453581|3978274|FG001|STARTED|Overall Study||8
3244798|NCT02453581|3978275|FG002|STARTED|Overall Study||8
3244799|NCT02453581|3978273|FG000|COMPLETED|Overall Study||8
3244800|NCT02453581|3978274|FG001|COMPLETED|Overall Study||8
3244801|NCT02453581|3978275|FG002|COMPLETED|Overall Study||8
3244802|NCT02453581|3978273|FG000|NOT COMPLETED|Overall Study||0
3244803|NCT02453581|3978274|FG001|NOT COMPLETED|Overall Study||0
3244804|NCT02453581|3978275|FG002|NOT COMPLETED|Overall Study||0
3244805|NCT02453672|3978295|FG000|STARTED|Overall Study||40
3244806|NCT02453672|3978296|FG001|STARTED|Overall Study||40
3244807|NCT02453672|3978297|FG002|STARTED|Overall Study||39
3244808|NCT02453672|3978295|FG000|COMPLETED|Overall Study||37
3244809|NCT02453672|3978296|FG001|COMPLETED|Overall Study||38
3244810|NCT02453672|3978297|FG002|COMPLETED|Overall Study||38
3244811|NCT02453672|3978295|FG000|NOT COMPLETED|Overall Study||3
3244812|NCT02453672|3978296|FG001|NOT COMPLETED|Overall Study||2
3244813|NCT02453672|3978297|FG002|NOT COMPLETED|Overall Study||1
3244814|NCT02453685|3978307|FG000|STARTED|Overall Study||168
3244815|NCT02453685|3978308|FG001|STARTED|Overall Study||167
3244816|NCT02453685|3978307|FG000|Exposed|Overall Study||166
3244817|NCT02453685|3978308|FG001|Exposed|Overall Study||166
3244818|NCT02453685|3978307|FG000|COMPLETED|Overall Study||149
3244819|NCT02453685|3978308|FG001|COMPLETED|Overall Study||155
3244820|NCT02453685|3978307|FG000|NOT COMPLETED|Overall Study||19
3244821|NCT02453685|3978308|FG001|NOT COMPLETED|Overall Study||12
3244822|NCT02453711|3978323|FG000|STARTED|Overall Study||103
3244823|NCT02453711|3978324|FG001|STARTED|Overall Study||102
3244824|NCT02453711|3978325|FG002|STARTED|Overall Study||103
3244825|NCT02453711|3978326|FG003|STARTED|Overall Study||103
3244826|NCT02453711|3978327|FG004|STARTED|Overall Study||102
3244827|NCT02453711|3978328|FG005|STARTED|Overall Study||102
3244828|NCT02453711|3978329|FG006|STARTED|Overall Study||103
3244829|NCT02453711|3978330|FG007|STARTED|Overall Study||103
3244830|NCT02453711|3978331|FG008|STARTED|Overall Study||136
3244831|NCT02453711|3978323|FG000|Full Analysis Set|Overall Study||103
3244832|NCT02453711|3978324|FG001|Full Analysis Set|Overall Study||102
3244833|NCT02453711|3978325|FG002|Full Analysis Set|Overall Study||103
3244834|NCT02453711|3978326|FG003|Full Analysis Set|Overall Study||103
3244835|NCT02453711|3978327|FG004|Full Analysis Set|Overall Study||102
3244836|NCT02453711|3978328|FG005|Full Analysis Set|Overall Study||102
3244837|NCT02453711|3978329|FG006|Full Analysis Set|Overall Study||103
3244838|NCT02453711|3978330|FG007|Full Analysis Set|Overall Study||103
3244839|NCT02453711|3978331|FG008|Full Analysis Set|Overall Study||136
3244840|NCT02453711|3978323|FG000|Safety Analysis Set|Overall Study||103
3244841|NCT02453711|3978324|FG001|Safety Analysis Set|Overall Study||102
3244842|NCT02453711|3978325|FG002|Safety Analysis Set|Overall Study||103
3244843|NCT02453711|3978326|FG003|Safety Analysis Set|Overall Study||103
3244844|NCT02453711|3978327|FG004|Safety Analysis Set|Overall Study||102
3244845|NCT02453711|3978328|FG005|Safety Analysis Set|Overall Study||102
3244846|NCT02453711|3978329|FG006|Safety Analysis Set|Overall Study||103
3244847|NCT02453711|3978330|FG007|Safety Analysis Set|Overall Study||103
3244848|NCT02453711|3978331|FG008|Safety Analysis Set|Overall Study||136
3244849|NCT02453711|3978323|FG000|COMPLETED|Overall Study||92
3244850|NCT02453711|3978324|FG001|COMPLETED|Overall Study||95
3244851|NCT02453711|3978325|FG002|COMPLETED|Overall Study||94
3244852|NCT02453711|3978326|FG003|COMPLETED|Overall Study||96
3244853|NCT02453711|3978327|FG004|COMPLETED|Overall Study||100
3244854|NCT02453711|3978328|FG005|COMPLETED|Overall Study||96
3244855|NCT02453711|3978329|FG006|COMPLETED|Overall Study||100
3244856|NCT02453711|3978330|FG007|COMPLETED|Overall Study||96
3244857|NCT02453711|3978331|FG008|COMPLETED|Overall Study||123
3244858|NCT02453711|3978323|FG000|NOT COMPLETED|Overall Study||11
3244859|NCT02453711|3978324|FG001|NOT COMPLETED|Overall Study||7
3244860|NCT02453711|3978325|FG002|NOT COMPLETED|Overall Study||9
3244861|NCT02453711|3978326|FG003|NOT COMPLETED|Overall Study||7
3244862|NCT02453711|3978327|FG004|NOT COMPLETED|Overall Study||2
3244863|NCT02453711|3978328|FG005|NOT COMPLETED|Overall Study||6
3244864|NCT02453711|3978329|FG006|NOT COMPLETED|Overall Study||3
3244865|NCT02453711|3978330|FG007|NOT COMPLETED|Overall Study||7
3244866|NCT02453711|3978331|FG008|NOT COMPLETED|Overall Study||13
3244867|NCT02453750|3978351|FG000|STARTED|Overall Study||21
3244868|NCT02453750|3978351|FG000|COMPLETED|Overall Study||21
3244869|NCT02453750|3978351|FG000|NOT COMPLETED|Overall Study||0
3244870|NCT02453841|3978358|FG000|STARTED|Overall Study||30
3244871|NCT02453841|3978358|FG000|COMPLETED|Overall Study||27
3244872|NCT02453841|3978358|FG000|NOT COMPLETED|Overall Study||3
3244873|NCT02454075|3978362|FG000|STARTED|Overall Study||3
3244874|NCT02454075|3978362|FG000|COMPLETED|Overall Study||3
3244875|NCT02454075|3978362|FG000|NOT COMPLETED|Overall Study||0
3244876|NCT02454101|3978370|FG000|STARTED|Overall Study||150
3244877|NCT02454101|3978371|FG001|STARTED|Overall Study||150
3244878|NCT02454101|3978370|FG000|COMPLETED|Overall Study||145
3244879|NCT02454101|3978371|FG001|COMPLETED|Overall Study||143
3244880|NCT02454101|3978370|FG000|NOT COMPLETED|Overall Study||5
3244881|NCT02454101|3978371|FG001|NOT COMPLETED|Overall Study||7
3244882|NCT02454127|3978381|FG000|STARTED|Overall Study||40
3244883|NCT02454127|3978382|FG001|STARTED|Overall Study||40
3244884|NCT02454127|3978383|FG002|STARTED|Overall Study||40
3244885|NCT02454127|3978384|FG003|STARTED|Overall Study||40
3244886|NCT02454127|3978381|FG000|COMPLETED|Overall Study||21
3244887|NCT02454127|3978382|FG001|COMPLETED|Overall Study||26
3244888|NCT02454127|3978383|FG002|COMPLETED|Overall Study||26
3244889|NCT02454127|3978384|FG003|COMPLETED|Overall Study||20
3244890|NCT02454127|3978381|FG000|NOT COMPLETED|Overall Study||19
3244891|NCT02454127|3978382|FG001|NOT COMPLETED|Overall Study||14
3244892|NCT02454127|3978383|FG002|NOT COMPLETED|Overall Study||14
3244893|NCT02454127|3978384|FG003|NOT COMPLETED|Overall Study||20
3244894|NCT02454153|3978396|FG000|STARTED|Overall Study||92
3244895|NCT02454153|3978397|FG001|STARTED|Overall Study||92
3244896|NCT02454153|3978396|FG000|COMPLETED|Overall Study||92
3244897|NCT02454153|3978397|FG001|COMPLETED|Overall Study||92
3244898|NCT02454153|3978396|FG000|NOT COMPLETED|Overall Study||0
3244899|NCT02454153|3978397|FG001|NOT COMPLETED|Overall Study||0
3244900|NCT02454179|3978406|FG000|STARTED|Overall Study||39
3244901|NCT02454179|3978407|FG001|STARTED|Overall Study||39
3244902|NCT02454179|3978406|FG000|Enrolled|Overall Study||39
3244903|NCT02454179|3978407|FG001|Enrolled|Overall Study||39
3244904|NCT02454179|3978406|FG000|Received Study Medication|Overall Study||39
3244905|NCT02454179|3978407|FG001|Received Study Medication|Overall Study||37
3244906|NCT02454179|3978406|FG000|Discontinue Study|Overall Study||39
3244907|NCT02454179|3978407|FG001|Discontinue Study|Overall Study||39
3244908|NCT02454179|3978406|FG000|COMPLETED|Overall Study||0
3244909|NCT02454179|3978407|FG001|COMPLETED|Overall Study||0
3244910|NCT02454179|3978406|FG000|NOT COMPLETED|Overall Study||39
3244911|NCT02454179|3978407|FG001|NOT COMPLETED|Overall Study||39
3244912|NCT02454283|3978415|FG000|STARTED|Overall Study||26
3244913|NCT02454283|3978416|FG001|STARTED|Overall Study||15
3244914|NCT02454283|3978415|FG000|COMPLETED|Overall Study||26
3244915|NCT02454283|3978416|FG001|COMPLETED|Overall Study||15
3244916|NCT02454283|3978415|FG000|NOT COMPLETED|Overall Study||0
3244917|NCT02454283|3978416|FG001|NOT COMPLETED|Overall Study||0
3244918|NCT02454296|3978424|FG000|STARTED|Overall Study||20
3244919|NCT02454296|3978425|FG001|STARTED|Overall Study||21
3244920|NCT02454296|3978424|FG000|COMPLETED|Overall Study||20
3244921|NCT02454296|3978425|FG001|COMPLETED|Overall Study||21
3244922|NCT02454296|3978424|FG000|NOT COMPLETED|Overall Study||0
3244923|NCT02454296|3978425|FG001|NOT COMPLETED|Overall Study||0
3244924|NCT02454478|3978433|FG000|STARTED|Overall Study||7
3244925|NCT02454478|3978433|FG000|COMPLETED|Overall Study||6
3244926|NCT02454478|3978433|FG000|NOT COMPLETED|Overall Study||1
3244927|NCT02454530|3978439|FG000|STARTED|Overall Study||552
3244928|NCT02454530|3978440|FG001|STARTED|Overall Study||608
3244929|NCT02454530|3978439|FG000|COMPLETED|Overall Study||482
3244930|NCT02454530|3978440|FG001|COMPLETED|Overall Study||481
3244931|NCT02454530|3978439|FG000|NOT COMPLETED|Overall Study||70
3244932|NCT02454530|3978440|FG001|NOT COMPLETED|Overall Study||127
3244933|NCT02454608|3978450|FG000|STARTED|Double-Blind Period||15
3244934|NCT02454608|3978451|FG001|STARTED|Double-Blind Period||14
3244935|NCT02454608|3978452|FG002|STARTED|Double-Blind Period|This arm is not part of this period of the study|0
3244936|NCT02454608|3978450|FG000|COMPLETED|Double-Blind Period||15
3244937|NCT02454608|3978451|FG001|COMPLETED|Double-Blind Period||12
3244938|NCT02454608|3978452|FG002|COMPLETED|Double-Blind Period|This arm is not part of this period of the study|0
3244939|NCT02454608|3978450|FG000|NOT COMPLETED|Double-Blind Period||0
3244940|NCT02454608|3978451|FG001|NOT COMPLETED|Double-Blind Period||2
3244941|NCT02454608|3978452|FG002|NOT COMPLETED|Double-Blind Period||0
3244942|NCT02454608|3978450|FG000|STARTED|Open Label Period|This arm is not part of this period of the study|0
3244943|NCT02454608|3978451|FG001|STARTED|Open Label Period|This arm is not part of this period of the study|0
3244944|NCT02454608|3978452|FG002|STARTED|Open Label Period||29
3244945|NCT02454608|3978450|FG000|COMPLETED|Open Label Period|This arm is not part of this period of the study|0
3244946|NCT02454608|3978451|FG001|COMPLETED|Open Label Period|This arm is not part of this period of the study|0
3244947|NCT02454608|3978452|FG002|COMPLETED|Open Label Period||10
3244948|NCT02454608|3978450|FG000|NOT COMPLETED|Open Label Period||0
3244949|NCT02454608|3978451|FG001|NOT COMPLETED|Open Label Period||0
3244950|NCT02454608|3978452|FG002|NOT COMPLETED|Open Label Period||19
3244951|NCT02454959|3978460|FG000|STARTED|Overall Study||79
3244952|NCT02454959|3978460|FG000|GFF MDI (PT003) With Aerochamber|Overall Study||73
3244953|NCT02454959|3978460|FG000|GFF MDI (PT003) Without Aerochamber|Overall Study||77
3244954|NCT02454959|3978460|FG000|COMPLETED|Overall Study||70
3244955|NCT02454959|3978460|FG000|NOT COMPLETED|Overall Study||9
3244956|NCT02454972|3978475|FG000|STARTED|Overall Study||19
3244957|NCT02454972|3978476|FG001|STARTED|Overall Study||19
3244958|NCT02454972|3978477|FG002|STARTED|Overall Study||76
3244959|NCT02454972|3978478|FG003|STARTED|Overall Study||29
3244960|NCT02454972|3978479|FG004|STARTED|Overall Study||24
3244961|NCT02454972|3978480|FG005|STARTED|Overall Study||15
3244962|NCT02454972|3978481|FG006|STARTED|Overall Study||21
3244963|NCT02454972|3978482|FG007|STARTED|Overall Study||32
3244964|NCT02454972|3978483|FG008|STARTED|Overall Study||110
3244965|NCT02454972|3978475|FG000|Treated|Overall Study||19
3244966|NCT02454972|3978476|FG001|Treated|Overall Study||19
3244967|NCT02454972|3978477|FG002|Treated|Overall Study||73
3244968|NCT02454972|3978478|FG003|Treated|Overall Study||28
3244969|NCT02454972|3978479|FG004|Treated|Overall Study||23
3244970|NCT02454972|3978480|FG005|Treated|Overall Study||15
3244971|NCT02454972|3978481|FG006|Treated|Overall Study||21
3244972|NCT02454972|3978482|FG007|Treated|Overall Study||32
3244973|NCT02454972|3978483|FG008|Treated|Overall Study||105
3244974|NCT02454972|3978475|FG000|COMPLETED|Overall Study||0
3244975|NCT02454972|3978476|FG001|COMPLETED|Overall Study||0
3244976|NCT02454972|3978477|FG002|COMPLETED|Overall Study||0
3244977|NCT02454972|3978478|FG003|COMPLETED|Overall Study||0
3244978|NCT02454972|3978479|FG004|COMPLETED|Overall Study||0
3244979|NCT02454972|3978480|FG005|COMPLETED|Overall Study||0
3244980|NCT02454972|3978481|FG006|COMPLETED|Overall Study||0
3244981|NCT02454972|3978482|FG007|COMPLETED|Overall Study||0
3244982|NCT02454972|3978483|FG008|COMPLETED|Overall Study||0
3244983|NCT02454972|3978475|FG000|NOT COMPLETED|Overall Study||19
3244984|NCT02454972|3978476|FG001|NOT COMPLETED|Overall Study||19
3244985|NCT02454972|3978477|FG002|NOT COMPLETED|Overall Study||76
3244986|NCT02454972|3978478|FG003|NOT COMPLETED|Overall Study||29
3244987|NCT02454972|3978479|FG004|NOT COMPLETED|Overall Study||24
3244988|NCT02454972|3978480|FG005|NOT COMPLETED|Overall Study||15
3244989|NCT02454972|3978481|FG006|NOT COMPLETED|Overall Study||21
3244990|NCT02454972|3978482|FG007|NOT COMPLETED|Overall Study||32
3244991|NCT02454972|3978483|FG008|NOT COMPLETED|Overall Study||110
3244992|NCT02455050|3978499|FG000|STARTED|Treatment Period 1||20
3244993|NCT02455050|3978500|FG001|STARTED|Treatment Period 1||19
3244994|NCT02455050|3978501|FG002|STARTED|Treatment Period 1||20
3244995|NCT02455050|3978502|FG003|STARTED|Treatment Period 1||20
3244996|NCT02455050|3978499|FG000|COMPLETED|Treatment Period 1||19
3244997|NCT02455050|3978500|FG001|COMPLETED|Treatment Period 1||18
3244998|NCT02455050|3978501|FG002|COMPLETED|Treatment Period 1||19
3244999|NCT02455050|3978502|FG003|COMPLETED|Treatment Period 1||18
3245000|NCT02455050|3978499|FG000|NOT COMPLETED|Treatment Period 1||1
3245001|NCT02455050|3978500|FG001|NOT COMPLETED|Treatment Period 1||1
3245002|NCT02455050|3978501|FG002|NOT COMPLETED|Treatment Period 1||1
3245003|NCT02455050|3978502|FG003|NOT COMPLETED|Treatment Period 1||2
3245004|NCT02455050|3978499|FG000|STARTED|Treatment Period 2||19
3245005|NCT02455050|3978500|FG001|STARTED|Treatment Period 2||18
3245006|NCT02455050|3978501|FG002|STARTED|Treatment Period 2||19
3245007|NCT02455050|3978502|FG003|STARTED|Treatment Period 2||18
3245008|NCT02455050|3978499|FG000|COMPLETED|Treatment Period 2||18
3245009|NCT02455050|3978500|FG001|COMPLETED|Treatment Period 2||18
3245010|NCT02455050|3978501|FG002|COMPLETED|Treatment Period 2||17
3245011|NCT02455050|3978502|FG003|COMPLETED|Treatment Period 2||17
3245012|NCT02455050|3978499|FG000|NOT COMPLETED|Treatment Period 2||1
3245013|NCT02455050|3978500|FG001|NOT COMPLETED|Treatment Period 2||0
3245014|NCT02455050|3978501|FG002|NOT COMPLETED|Treatment Period 2||2
3245015|NCT02455050|3978502|FG003|NOT COMPLETED|Treatment Period 2||1
3245016|NCT02455076|3978527|FG000|STARTED|Inpatient||47
3245017|NCT02455076|3978528|FG001|STARTED|Inpatient||51
3245018|NCT02455076|3978529|FG002|STARTED|Inpatient||52
3245019|NCT02455076|3978530|FG003|STARTED|Inpatient||0
3245020|NCT02455076|3978531|FG004|STARTED|Inpatient||0
3245021|NCT02455076|3978527|FG000|COMPLETED|Inpatient||43
3245022|NCT02455076|3978528|FG001|COMPLETED|Inpatient||50
3245023|NCT02455076|3978529|FG002|COMPLETED|Inpatient||52
3245024|NCT02455076|3978530|FG003|COMPLETED|Inpatient||0
3245025|NCT02455076|3978531|FG004|COMPLETED|Inpatient||0
3245026|NCT02455076|3978527|FG000|NOT COMPLETED|Inpatient||4
3245027|NCT02455076|3978528|FG001|NOT COMPLETED|Inpatient||1
3245028|NCT02455076|3978529|FG002|NOT COMPLETED|Inpatient||0
3245029|NCT02455076|3978530|FG003|NOT COMPLETED|Inpatient||0
3245030|NCT02455076|3978531|FG004|NOT COMPLETED|Inpatient||0
3245031|NCT02455076|3978527|FG000|STARTED|Outpatient||0
3245032|NCT02455076|3978528|FG001|STARTED|Outpatient||0
3245033|NCT02455076|3978529|FG002|STARTED|Outpatient||0
3245034|NCT02455076|3978530|FG003|STARTED|Outpatient||48
3245035|NCT02455076|3978531|FG004|STARTED|Outpatient||55
3245036|NCT02455076|3978527|FG000|COMPLETED|Outpatient||0
3245037|NCT02455076|3978528|FG001|COMPLETED|Outpatient||0
3245038|NCT02455076|3978529|FG002|COMPLETED|Outpatient||0
3245039|NCT02455076|3978530|FG003|COMPLETED|Outpatient||42
3245040|NCT02455076|3978531|FG004|COMPLETED|Outpatient||43
3245041|NCT02455076|3978527|FG000|NOT COMPLETED|Outpatient||0
3245042|NCT02455076|3978528|FG001|NOT COMPLETED|Outpatient||0
3245043|NCT02455076|3978529|FG002|NOT COMPLETED|Outpatient||0
3245044|NCT02455076|3978530|FG003|NOT COMPLETED|Outpatient||6
3245045|NCT02455076|3978531|FG004|NOT COMPLETED|Outpatient||12
3245046|NCT02455167|3978543|FG000|STARTED|Overall Study||4
3245047|NCT02455167|3978543|FG000|COMPLETED|Overall Study||4
3245048|NCT02455167|3978543|FG000|NOT COMPLETED|Overall Study||0
3245049|NCT02455336|3978549|FG000|STARTED|Overall Study||15
3245050|NCT02455336|3978550|FG001|STARTED|Overall Study||8
3245051|NCT02455336|3978549|FG000|COMPLETED|Overall Study||10
3245052|NCT02455336|3978550|FG001|COMPLETED|Overall Study||6
3245053|NCT02455336|3978549|FG000|NOT COMPLETED|Overall Study||5
3245054|NCT02455336|3978550|FG001|NOT COMPLETED|Overall Study||2
3245055|NCT02455388|3978558|FG000|STARTED|Overall Study||18
3245056|NCT02455388|3978559|FG001|STARTED|Overall Study||15
3245057|NCT02455388|3978560|FG002|STARTED|Overall Study||337
3245058|NCT02455388|3978558|FG000|COMPLETED|Overall Study||17
3245059|NCT02455388|3978559|FG001|COMPLETED|Overall Study||15
3245060|NCT02455388|3978560|FG002|COMPLETED|Overall Study||326
3245061|NCT02455388|3978558|FG000|NOT COMPLETED|Overall Study||1
3245062|NCT02455388|3978559|FG001|NOT COMPLETED|Overall Study||0
3245063|NCT02455388|3978560|FG002|NOT COMPLETED|Overall Study||11
3245064|NCT02455453|3978568|FG000|STARTED|Overall Study||47
3245065|NCT02455453|3978568|FG000|COMPLETED|Overall Study||47
3245066|NCT02455453|3978568|FG000|NOT COMPLETED|Overall Study||0
3245067|NCT02455518|3978576|FG000|STARTED|Overall Study||104
3245068|NCT02455518|3978577|FG001|STARTED|Overall Study||104
3245069|NCT02455518|3978578|FG002|STARTED|Overall Study||104
3245070|NCT02455518|3978579|FG003|STARTED|Overall Study||104
3245071|NCT02455518|3978576|FG000|COMPLETED|Overall Study||104
3245072|NCT02455518|3978577|FG001|COMPLETED|Overall Study||103
3245073|NCT02455518|3978578|FG002|COMPLETED|Overall Study||103
3245074|NCT02455518|3978579|FG003|COMPLETED|Overall Study||101
3245075|NCT02455518|3978576|FG000|NOT COMPLETED|Overall Study||0
3245076|NCT02455518|3978577|FG001|NOT COMPLETED|Overall Study||1
3245077|NCT02455518|3978578|FG002|NOT COMPLETED|Overall Study||1
3245078|NCT02455518|3978579|FG003|NOT COMPLETED|Overall Study||3
3245079|NCT02455557|3978589|FG000|STARTED|Overall Study||66
3245080|NCT02455557|3978589|FG000|COMPLETED|Overall Study||64
3245081|NCT02455557|3978589|FG000|NOT COMPLETED|Overall Study||2
3245082|NCT02456103|3978593|FG000|STARTED|Overall Study||246
3245083|NCT02456103|3978593|FG000|As-Treated Population|Overall Study||245
3245084|NCT02456103|3978593|FG000|Intent-to-treat (ITT) Population|Overall Study||244
3245085|NCT02456103|3978593|FG000|COMPLETED|Overall Study||0
3245086|NCT02456103|3978593|FG000|NOT COMPLETED|Overall Study||246
3245087|NCT02456636|3978600|FG000|STARTED|Overall Study||478
3245088|NCT02456636|3978601|FG001|STARTED|Overall Study||479
3245089|NCT02456636|3978602|FG002|STARTED|Overall Study||475
3245090|NCT02456636|3978600|FG000|6 Month|Overall Study||474
3245091|NCT02456636|3978601|FG001|6 Month|Overall Study||474
3245092|NCT02456636|3978602|FG002|6 Month|Overall Study||468
3245093|NCT02456636|3978600|FG000|18 Month|Overall Study||467
3245094|NCT02456636|3978601|FG001|18 Month|Overall Study||463
3245095|NCT02456636|3978602|FG002|18 Month|Overall Study||461
3245096|NCT02456636|3978600|FG000|COMPLETED|Overall Study||410
3245097|NCT02456636|3978601|FG001|COMPLETED|Overall Study||410
3245098|NCT02456636|3978602|FG002|COMPLETED|Overall Study||400
3245099|NCT02456636|3978600|FG000|NOT COMPLETED|Overall Study||68
3245100|NCT02456636|3978601|FG001|NOT COMPLETED|Overall Study||69
3245101|NCT02456636|3978602|FG002|NOT COMPLETED|Overall Study||75
3245102|NCT02456662|3978612|FG000|STARTED|Overall Study||159
3245103|NCT02456662|3978613|FG001|STARTED|Overall Study||160
3245104|NCT02456662|3978612|FG000|COMPLETED|Overall Study||157
3245105|NCT02456662|3978613|FG001|COMPLETED|Overall Study||159
3245106|NCT02456662|3978612|FG000|NOT COMPLETED|Overall Study||2
3245107|NCT02456662|3978613|FG001|NOT COMPLETED|Overall Study||1
3245108|NCT02456727|3978621|FG000|STARTED|Overall Study||389
3245109|NCT02456727|3978622|FG001|STARTED|Overall Study||390
3245110|NCT02456727|3978621|FG000|Initiated Treatment|Overall Study||346
3245111|NCT02456727|3978622|FG001|Initiated Treatment|Overall Study||360
3245112|NCT02456727|3978621|FG000|6 Week|Overall Study||298
3245113|NCT02456727|3978622|FG001|6 Week|Overall Study||320
3245114|NCT02456727|3978621|FG000|12 Week|Overall Study||295
3245115|NCT02456727|3978622|FG001|12 Week|Overall Study||310
3370900|NCT03757039|4102384|FG001|AOHG MF|Overall Study||0
3370901|NCT03757039|4102383|FG000|DT1 MF|Overall Study||11
3370902|NCT03757039|4102384|FG001|DT1 MF|Overall Study||0
3370903|NCT03757039|4102383|FG000|DACP MF|Overall Study||10
3370904|NCT03757039|4102384|FG001|DACP MF|Overall Study||0
3370905|NCT03757039|4102383|FG000|COMPLETED|Overall Study||32
3370906|NCT03757039|4102384|FG001|COMPLETED|Overall Study||9
3370907|NCT03757039|4102383|FG000|NOT COMPLETED|Overall Study||0
3370908|NCT03757039|4102384|FG001|NOT COMPLETED|Overall Study||0
3370909|NCT03756883|4102395|FG000|STARTED|Overall Study||485
3370910|NCT03756883|4102396|FG001|STARTED|Overall Study||413
3370911|NCT03756883|4102397|FG002|STARTED|Overall Study||101
3370912|NCT03756883|4102395|FG000|COMPLETED|Overall Study||472
3370913|NCT03756883|4102396|FG001|COMPLETED|Overall Study||402
3370914|NCT03756883|4102397|FG002|COMPLETED|Overall Study||94
3370915|NCT03756883|4102395|FG000|NOT COMPLETED|Overall Study||13
3370916|NCT03756883|4102396|FG001|NOT COMPLETED|Overall Study||11
3370917|NCT03756883|4102397|FG002|NOT COMPLETED|Overall Study||7
3370918|NCT03756506|4102407|FG000|STARTED|Overall Study||7
3370919|NCT03756506|4102408|FG001|STARTED|Overall Study||6
3245116|NCT02456727|3978621|FG000|24 Week|Overall Study||280
3245117|NCT02456727|3978622|FG001|24 Week|Overall Study||284
3245118|NCT02456727|3978621|FG000|COMPLETED|Overall Study||280
3245119|NCT02456727|3978622|FG001|COMPLETED|Overall Study||284
3245120|NCT02456727|3978621|FG000|NOT COMPLETED|Overall Study||109
3245121|NCT02456727|3978622|FG001|NOT COMPLETED|Overall Study||106
3370920|NCT03756506|4102407|FG000|COMPLETED|Overall Study||6
3370921|NCT03756506|4102408|FG001|COMPLETED|Overall Study||6
3245122|NCT02456740|3978647|FG000|STARTED|Double-blind Treatment Phase (24 Weeks)||319
3245123|NCT02456740|3978648|FG001|STARTED|Double-blind Treatment Phase (24 Weeks)||317
3245124|NCT02456740|3978649|FG002|STARTED|Double-blind Treatment Phase (24 Weeks)||319
3245125|NCT02456740|3978650|FG003|STARTED|Double-blind Treatment Phase (24 Weeks)||0
3245126|NCT02456740|3978651|FG004|STARTED|Double-blind Treatment Phase (24 Weeks)||0
3245127|NCT02456740|3978652|FG005|STARTED|Double-blind Treatment Phase (24 Weeks)||0
3245128|NCT02456740|3978653|FG006|STARTED|Double-blind Treatment Phase (24 Weeks)||0
3245129|NCT02456740|3978654|FG007|STARTED|Double-blind Treatment Phase (24 Weeks)||0
3245130|NCT02456740|3978655|FG008|STARTED|Double-blind Treatment Phase (24 Weeks)||0
3245131|NCT02456740|3978647|FG000|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||319
3245132|NCT02456740|3978648|FG001|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||314
3245133|NCT02456740|3978649|FG002|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||319
3245134|NCT02456740|3978650|FG003|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||0
3245135|NCT02456740|3978651|FG004|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||0
3245136|NCT02456740|3978652|FG005|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||0
3245137|NCT02456740|3978653|FG006|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||0
3245138|NCT02456740|3978654|FG007|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||0
3245139|NCT02456740|3978655|FG008|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||0
3245140|NCT02456740|3978647|FG000|COMPLETED|Double-blind Treatment Phase (24 Weeks)||282
3245141|NCT02456740|3978648|FG001|COMPLETED|Double-blind Treatment Phase (24 Weeks)||284
3245142|NCT02456740|3978649|FG002|COMPLETED|Double-blind Treatment Phase (24 Weeks)||292
3245143|NCT02456740|3978650|FG003|COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
3245144|NCT02456740|3978651|FG004|COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
3245145|NCT02456740|3978652|FG005|COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
3245146|NCT02456740|3978653|FG006|COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
3245147|NCT02456740|3978654|FG007|COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
3245148|NCT02456740|3978655|FG008|COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
3245149|NCT02456740|3978647|FG000|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||37
3245150|NCT02456740|3978648|FG001|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||33
3245151|NCT02456740|3978649|FG002|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||27
3245152|NCT02456740|3978650|FG003|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
3245153|NCT02456740|3978651|FG004|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
3245154|NCT02456740|3978652|FG005|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
3245155|NCT02456740|3978653|FG006|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
3245156|NCT02456740|3978654|FG007|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
3245157|NCT02456740|3978655|FG008|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
3245158|NCT02456740|3978647|FG000|STARTED|Active Treatment Phase (Weeks 24 - 52)||0
3245159|NCT02456740|3978648|FG001|STARTED|Active Treatment Phase (Weeks 24 - 52)||0
3245160|NCT02456740|3978649|FG002|STARTED|Active Treatment Phase (Weeks 24 - 52)||0
3245161|NCT02456740|3978650|FG003|STARTED|Active Treatment Phase (Weeks 24 - 52)||138
3245162|NCT02456740|3978651|FG004|STARTED|Active Treatment Phase (Weeks 24 - 52)||140
3245163|NCT02456740|3978652|FG005|STARTED|Active Treatment Phase (Weeks 24 - 52)||143
3245164|NCT02456740|3978653|FG006|STARTED|Active Treatment Phase (Weeks 24 - 52)||140
3245165|NCT02456740|3978654|FG007|STARTED|Active Treatment Phase (Weeks 24 - 52)||140
3245166|NCT02456740|3978655|FG008|STARTED|Active Treatment Phase (Weeks 24 - 52)||144
3245167|NCT02456740|3978647|FG000|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
3245168|NCT02456740|3978648|FG001|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
3245169|NCT02456740|3978649|FG002|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
3245170|NCT02456740|3978650|FG003|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||124
3245171|NCT02456740|3978651|FG004|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||123
3245172|NCT02456740|3978652|FG005|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||130
3245173|NCT02456740|3978653|FG006|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||131
3245174|NCT02456740|3978654|FG007|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||128
3245175|NCT02456740|3978655|FG008|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||126
3245176|NCT02456740|3978647|FG000|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
3245177|NCT02456740|3978648|FG001|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
3245178|NCT02456740|3978649|FG002|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
3245179|NCT02456740|3978650|FG003|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||14
3245180|NCT02456740|3978651|FG004|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||17
3245181|NCT02456740|3978652|FG005|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||13
3245182|NCT02456740|3978653|FG006|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||9
3245183|NCT02456740|3978654|FG007|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||12
3245184|NCT02456740|3978655|FG008|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||18
3245185|NCT02456896|3978667|FG000|STARTED|Overall Study||25
3245186|NCT02456896|3978668|FG001|STARTED|Overall Study||25
3245187|NCT02456896|3978667|FG000|COMPLETED|Overall Study||19
3245188|NCT02456896|3978668|FG001|COMPLETED|Overall Study||21
3245189|NCT02456896|3978667|FG000|NOT COMPLETED|Overall Study||6
3245190|NCT02456896|3978668|FG001|NOT COMPLETED|Overall Study||4
3245191|NCT02456909|3978676|FG000|STARTED|Overall Study||88
3245192|NCT02456909|3978677|FG001|STARTED|Overall Study||88
3245193|NCT02456909|3978676|FG000|COMPLETED|Overall Study||64
3245194|NCT02456909|3978677|FG001|COMPLETED|Overall Study||61
3245195|NCT02456909|3978676|FG000|NOT COMPLETED|Overall Study||24
3245196|NCT02456909|3978677|FG001|NOT COMPLETED|Overall Study||27
3245197|NCT02457065|3978685|FG000|STARTED|Overall Study||27
3245198|NCT02457065|3978686|FG001|STARTED|Overall Study||27
3245199|NCT02457065|3978685|FG000|COMPLETED|Overall Study||18
3245200|NCT02457065|3978686|FG001|COMPLETED|Overall Study||16
3245201|NCT02457065|3978685|FG000|NOT COMPLETED|Overall Study||9
3245202|NCT02457065|3978686|FG001|NOT COMPLETED|Overall Study||11
3245203|NCT02457182|3978694|FG000|STARTED|Overall Study||9
3245204|NCT02457182|3978695|FG001|STARTED|Overall Study||11
3245205|NCT02457182|3978694|FG000|COMPLETED|Overall Study||8
3245206|NCT02457182|3978695|FG001|COMPLETED|Overall Study||11
3245207|NCT02457182|3978694|FG000|NOT COMPLETED|Overall Study||1
3245208|NCT02457182|3978695|FG001|NOT COMPLETED|Overall Study||0
3245209|NCT02457195|3978701|FG000|STARTED|Overall Study||50
3245210|NCT02457195|3978701|FG000|COMPLETED|Overall Study||41
3245211|NCT02457195|3978701|FG000|NOT COMPLETED|Overall Study||9
3245212|NCT02457247|3978709|FG000|STARTED|Period 1||68
3245213|NCT02457247|3978710|FG001|STARTED|Period 1||70
3245214|NCT02457247|3978711|FG002|STARTED|Period 1||68
3245215|NCT02457247|3978712|FG003|STARTED|Period 1||70
3245216|NCT02457247|3978709|FG000|COMPLETED|Period 1||66
3245217|NCT02457247|3978710|FG001|COMPLETED|Period 1||68
3245218|NCT02457247|3978711|FG002|COMPLETED|Period 1||68
3245219|NCT02457247|3978712|FG003|COMPLETED|Period 1||70
3245220|NCT02457247|3978709|FG000|NOT COMPLETED|Period 1||2
3245221|NCT02457247|3978710|FG001|NOT COMPLETED|Period 1||2
3245222|NCT02457247|3978711|FG002|NOT COMPLETED|Period 1||0
3245223|NCT02457247|3978712|FG003|NOT COMPLETED|Period 1||0
3245224|NCT02457247|3978709|FG000|STARTED|Period 2||66
3245225|NCT02457247|3978710|FG001|STARTED|Period 2||68
3245226|NCT02457247|3978711|FG002|STARTED|Period 2||68
3245227|NCT02457247|3978712|FG003|STARTED|Period 2||70
3245228|NCT02457247|3978709|FG000|COMPLETED|Period 2||64
3245229|NCT02457247|3978710|FG001|COMPLETED|Period 2||65
3245230|NCT02457247|3978711|FG002|COMPLETED|Period 2||68
3245231|NCT02457247|3978712|FG003|COMPLETED|Period 2||70
3245232|NCT02457247|3978709|FG000|NOT COMPLETED|Period 2||2
3245233|NCT02457247|3978710|FG001|NOT COMPLETED|Period 2||3
3245234|NCT02457247|3978711|FG002|NOT COMPLETED|Period 2||0
3245235|NCT02457247|3978712|FG003|NOT COMPLETED|Period 2||0
3245236|NCT02457260|3978731|FG000|STARTED|Overall Study||12
3245237|NCT02457260|3978732|FG001|STARTED|Overall Study||7
3245238|NCT02457260|3978733|FG002|STARTED|Overall Study||2
3245239|NCT02457260|3978731|FG000|COMPLETED|Overall Study||10
3245240|NCT02457260|3978732|FG001|COMPLETED|Overall Study||4
3245241|NCT02457260|3978733|FG002|COMPLETED|Overall Study||1
3245242|NCT02457260|3978731|FG000|NOT COMPLETED|Overall Study||2
3245243|NCT02457260|3978732|FG001|NOT COMPLETED|Overall Study||3
3245244|NCT02457260|3978733|FG002|NOT COMPLETED|Overall Study||1
3245245|NCT02457325|3978744|FG000|STARTED|First Intervention (1 Day)||25
3245246|NCT02457325|3978745|FG001|STARTED|First Intervention (1 Day)||25
3245247|NCT02457325|3978744|FG000|COMPLETED|First Intervention (1 Day)||23
3245248|NCT02457325|3978745|FG001|COMPLETED|First Intervention (1 Day)||23
3245249|NCT02457325|3978744|FG000|NOT COMPLETED|First Intervention (1 Day)||2
3245250|NCT02457325|3978745|FG001|NOT COMPLETED|First Intervention (1 Day)||2
3245251|NCT02457325|3978744|FG000|STARTED|Washout (1-2 Months)||23
3245252|NCT02457325|3978745|FG001|STARTED|Washout (1-2 Months)||23
3245253|NCT02457325|3978744|FG000|COMPLETED|Washout (1-2 Months)||23
3245254|NCT02457325|3978745|FG001|COMPLETED|Washout (1-2 Months)||23
3245255|NCT02457325|3978744|FG000|NOT COMPLETED|Washout (1-2 Months)||0
3245256|NCT02457325|3978745|FG001|NOT COMPLETED|Washout (1-2 Months)||0
3245257|NCT02457325|3978744|FG000|STARTED|Second Intervention (1 Day)||23
3245258|NCT02457325|3978745|FG001|STARTED|Second Intervention (1 Day)||23
3245259|NCT02457325|3978744|FG000|COMPLETED|Second Intervention (1 Day)||23
3245260|NCT02457325|3978745|FG001|COMPLETED|Second Intervention (1 Day)||23
3245261|NCT02457325|3978744|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
3245262|NCT02457325|3978745|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
3245263|NCT02457403|3978753|FG000|STARTED|Overall Study|34 participants|34
3245264|NCT02457403|3978754|FG001|STARTED|Overall Study|34 historic controls|34
3245265|NCT02457403|3978753|FG000|COMPLETED|Overall Study||34
3245266|NCT02457403|3978754|FG001|COMPLETED|Overall Study||34
3245267|NCT02457403|3978753|FG000|NOT COMPLETED|Overall Study||0
3245268|NCT02457403|3978754|FG001|NOT COMPLETED|Overall Study||0
3245269|NCT02457520|3978762|FG000|STARTED|Active Treatment Phase|All subjects received treatment according to the same regimen.|201
3245270|NCT02457520|3978762|FG000|COMPLETED|Active Treatment Phase||167
3245271|NCT02457520|3978762|FG000|NOT COMPLETED|Active Treatment Phase||34
3245272|NCT02457520|3978762|FG000|STARTED|Post-treatment Period||167
3245273|NCT02457520|3978762|FG000|COMPLETED|Post-treatment Period||119
3245274|NCT02457520|3978762|FG000|NOT COMPLETED|Post-treatment Period||48
3245275|NCT02457546|3978794|FG000|STARTED|Overall Study||114
3245276|NCT02457546|3978795|FG001|STARTED|Overall Study||120
3245277|NCT02457546|3978794|FG000|COMPLETED|Overall Study||105
3245278|NCT02457546|3978795|FG001|COMPLETED|Overall Study||116
3245279|NCT02457546|3978794|FG000|NOT COMPLETED|Overall Study||9
3245280|NCT02457546|3978795|FG001|NOT COMPLETED|Overall Study||4
3245281|NCT02457611|3978801|FG000|STARTED|Overall Study||26
3245282|NCT02457611|3978801|FG000|COMPLETED|Overall Study||23
3245283|NCT02457611|3978801|FG000|NOT COMPLETED|Overall Study||3
3245284|NCT02457637|3978805|FG000|STARTED|Recruitment|2600 is the number of inpatients who met our eligibility.|2600
3370922|NCT03756506|4102407|FG000|NOT COMPLETED|Overall Study||1
3245285|NCT02457637|3978805|FG000|COMPLETED|Recruitment|2361 patients were excluded according to our exclusion criteria,2600 patients remained.|2600
3245286|NCT02457637|3978805|FG000|NOT COMPLETED|Recruitment||0
3245287|NCT02457637|3978805|FG000|STARTED|28-Days Hospitalization and Observation||2600
3245288|NCT02457637|3978805|FG000|Liver Transplantation|28-Days Hospitalization and Observation||124
3245289|NCT02457637|3978805|FG000|Death|28-Days Hospitalization and Observation||74
3245290|NCT02457637|3978805|FG000|COMPLETED|28-Days Hospitalization and Observation|Death and receiving Liver transplantation are two end points of our observation.|2600
3245291|NCT02457637|3978805|FG000|NOT COMPLETED|28-Days Hospitalization and Observation||0
3245292|NCT02457637|3978805|FG000|STARTED|Clinic or Telephone Follow-up||2600
3245293|NCT02457637|3978805|FG000|One-year Liver Transplantation|Clinic or Telephone Follow-up||182
3245294|NCT02457637|3978805|FG000|One-year Death|Clinic or Telephone Follow-up||475
3245295|NCT02457637|3978805|FG000|COMPLETED|Clinic or Telephone Follow-up||2529
3245296|NCT02457637|3978805|FG000|NOT COMPLETED|Clinic or Telephone Follow-up||71
3245297|NCT02457728|3978810|FG000|STARTED|Overall Study||34
3245298|NCT02457728|3978810|FG000|COMPLETED|Overall Study||34
3245299|NCT02457728|3978810|FG000|NOT COMPLETED|Overall Study||0
3245300|NCT02457793|3978820|FG000|STARTED|Overall Study||1
3245301|NCT02457793|3978821|FG001|STARTED|Overall Study||5
3245302|NCT02457793|3978822|FG002|STARTED|Overall Study||3
3245303|NCT02457793|3978823|FG003|STARTED|Overall Study||5
3245304|NCT02457793|3978824|FG004|STARTED|Overall Study||4
3245305|NCT02457793|3978825|FG005|STARTED|Overall Study||6
3245306|NCT02457793|3978820|FG000|COMPLETED|Overall Study||0
3245307|NCT02457793|3978821|FG001|COMPLETED|Overall Study||1
3245308|NCT02457793|3978822|FG002|COMPLETED|Overall Study||0
3245309|NCT02457793|3978823|FG003|COMPLETED|Overall Study||0
3370923|NCT03756506|4102408|FG001|NOT COMPLETED|Overall Study||0
3370924|NCT03756285|4102416|FG000|STARTED|Overall Study||27
3370925|NCT03756285|4102417|FG001|STARTED|Overall Study||14
3370926|NCT03756285|4102416|FG000|COMPLETED|Overall Study||24
3370927|NCT03756285|4102417|FG001|COMPLETED|Overall Study||9
3370928|NCT03756285|4102416|FG000|NOT COMPLETED|Overall Study||3
3370929|NCT03756285|4102417|FG001|NOT COMPLETED|Overall Study||5
3370930|NCT03756129|4102430|FG000|STARTED|Overall Study||11
3370931|NCT03756129|4102431|FG001|STARTED|Overall Study||10
3370932|NCT03756129|4102432|FG002|STARTED|Overall Study||10
3370933|NCT03756129|4102433|FG003|STARTED|Overall Study|1 participant in this group was randomized but not treated, and is not included in this data set.|9
3370934|NCT03756129|4102434|FG004|STARTED|Overall Study|1 participant in this group was randomized but not treated, and is not included in this data set.|10
3370935|NCT03756129|4102435|FG005|STARTED|Overall Study||20
3370936|NCT03756129|4102430|FG000|COMPLETED|Overall Study||8
3370937|NCT03756129|4102431|FG001|COMPLETED|Overall Study||8
3370938|NCT03756129|4102432|FG002|COMPLETED|Overall Study||7
3370939|NCT03756129|4102433|FG003|COMPLETED|Overall Study||6
3370940|NCT03756129|4102434|FG004|COMPLETED|Overall Study||9
3370941|NCT03756129|4102435|FG005|COMPLETED|Overall Study||15
3370942|NCT03756129|4102430|FG000|NOT COMPLETED|Overall Study||3
3370943|NCT03756129|4102431|FG001|NOT COMPLETED|Overall Study||2
3370944|NCT03756129|4102432|FG002|NOT COMPLETED|Overall Study||3
3370945|NCT03756129|4102433|FG003|NOT COMPLETED|Overall Study||3
3370946|NCT03756129|4102434|FG004|NOT COMPLETED|Overall Study||1
3370947|NCT03756129|4102435|FG005|NOT COMPLETED|Overall Study||5
3370948|NCT03756038|4102459|FG000|STARTED|Overall Study||1
3370949|NCT03756038|4102460|FG001|STARTED|Overall Study||0
3370950|NCT03756038|4102459|FG000|COMPLETED|Overall Study||1
3370951|NCT03756038|4102460|FG001|COMPLETED|Overall Study||0
3370952|NCT03756038|4102459|FG000|NOT COMPLETED|Overall Study||0
3370953|NCT03756038|4102460|FG001|NOT COMPLETED|Overall Study||0
3370954|NCT03756012|4102466|FG000|STARTED|Overall Study||15
3370955|NCT03756012|4102466|FG000|COMPLETED|Overall Study||15
3370956|NCT03756012|4102466|FG000|NOT COMPLETED|Overall Study||0
3370957|NCT03755882|4102471|FG000|STARTED|Period 1||23
3370958|NCT03755882|4102472|FG001|STARTED|Period 1||22
3370959|NCT03755882|4102471|FG000|COMPLETED|Period 1||19
3370960|NCT03755882|4102472|FG001|COMPLETED|Period 1||22
3370961|NCT03755882|4102471|FG000|NOT COMPLETED|Period 1||4
3370962|NCT03755882|4102472|FG001|NOT COMPLETED|Period 1||0
3370963|NCT03755882|4102471|FG000|STARTED|Period 2||19
3370964|NCT03755882|4102472|FG001|STARTED|Period 2||22
3370965|NCT03755882|4102471|FG000|COMPLETED|Period 2||19
3370966|NCT03755882|4102472|FG001|COMPLETED|Period 2||22
3370967|NCT03755882|4102471|FG000|NOT COMPLETED|Period 2||0
3370968|NCT03755882|4102472|FG001|NOT COMPLETED|Period 2||0
3370969|NCT03755661|4102480|FG000|STARTED|Overall Study||12
3370970|NCT03755661|4102481|FG001|STARTED|Overall Study||12
3370971|NCT03755661|4102480|FG000|COMPLETED|Overall Study||11
3370972|NCT03755661|4102481|FG001|COMPLETED|Overall Study||12
3370973|NCT03755661|4102480|FG000|NOT COMPLETED|Overall Study||1
3370974|NCT03755661|4102481|FG001|NOT COMPLETED|Overall Study||0
3370975|NCT03754582|4102487|FG000|STARTED|Pretreatment Phase||21
3370976|NCT03754582|4102488|FG001|STARTED|Pretreatment Phase||0
3245310|NCT02457793|3978824|FG004|COMPLETED|Overall Study||0
3245311|NCT02457793|3978825|FG005|COMPLETED|Overall Study||0
3245312|NCT02457793|3978820|FG000|NOT COMPLETED|Overall Study||1
3245313|NCT02457793|3978821|FG001|NOT COMPLETED|Overall Study||4
3245314|NCT02457793|3978822|FG002|NOT COMPLETED|Overall Study||3
3245315|NCT02457793|3978823|FG003|NOT COMPLETED|Overall Study||5
3245316|NCT02457793|3978824|FG004|NOT COMPLETED|Overall Study||4
3245317|NCT02457793|3978825|FG005|NOT COMPLETED|Overall Study||6
3245318|NCT02457819|3978840|FG000|STARTED|Overall Study||237
3245319|NCT02457819|3978840|FG000|Safety Population|Overall Study||236
3245320|NCT02457819|3978840|FG000|COMPLETED|Overall Study||138
3245321|NCT02457819|3978840|FG000|NOT COMPLETED|Overall Study||99
3245322|NCT02457897|3978844|FG000|STARTED|Part 1 Short-term (2 Weeks) Study||7
3245323|NCT02457897|3978844|FG000|COMPLETED|Part 1 Short-term (2 Weeks) Study||7
3245324|NCT02457897|3978844|FG000|NOT COMPLETED|Part 1 Short-term (2 Weeks) Study||0
3245325|NCT02457897|3978844|FG000|STARTED|Part 2 Long-term (6 Month) Study|Two patients were not eligible for Part 2 study because their HbA1c was less than 7.|5
3245326|NCT02457897|3978844|FG000|COMPLETED|Part 2 Long-term (6 Month) Study||5
3245327|NCT02457897|3978844|FG000|NOT COMPLETED|Part 2 Long-term (6 Month) Study||0
3245328|NCT02458092|3978850|FG000|STARTED|Overall Study||20
3245329|NCT02458092|3978851|FG001|STARTED|Overall Study||10
3245330|NCT02458092|3978850|FG000|COMPLETED|Overall Study||19
3245331|NCT02458092|3978851|FG001|COMPLETED|Overall Study||10
3245332|NCT02458092|3978850|FG000|NOT COMPLETED|Overall Study||1
3245333|NCT02458092|3978851|FG001|NOT COMPLETED|Overall Study||0
3245334|NCT02458235|3978858|FG000|STARTED|Overall Study||17
3245335|NCT02458235|3978858|FG000|COMPLETED|Overall Study||17
3245336|NCT02458235|3978858|FG000|NOT COMPLETED|Overall Study||0
3245337|NCT02458287|3978866|FG000|STARTED|Overall Study||50
3245338|NCT02458287|3978867|FG001|STARTED|Overall Study||100
3245339|NCT02458287|3978868|FG002|STARTED|Overall Study||49
3245340|NCT02458287|3978869|FG003|STARTED|Overall Study||100
3245341|NCT02458287|3978866|FG000|COMPLETED|Overall Study||50
3245342|NCT02458287|3978867|FG001|COMPLETED|Overall Study||96
3245343|NCT02458287|3978868|FG002|COMPLETED|Overall Study||46
3245344|NCT02458287|3978869|FG003|COMPLETED|Overall Study||97
3245345|NCT02458287|3978866|FG000|NOT COMPLETED|Overall Study||0
3245346|NCT02458287|3978867|FG001|NOT COMPLETED|Overall Study||4
3245347|NCT02458287|3978868|FG002|NOT COMPLETED|Overall Study||3
3245348|NCT02458287|3978869|FG003|NOT COMPLETED|Overall Study||3
3245349|NCT02458352|3978885|FG000|STARTED|Overall Study||105
3245350|NCT02458352|3978885|FG000|COMPLETED|Overall Study||105
3245351|NCT02458352|3978885|FG000|NOT COMPLETED|Overall Study||0
3245352|NCT02458365|3978893|FG000|STARTED|Overall Study||2000
3245353|NCT02458365|3978894|FG001|STARTED|Overall Study||1901
3245354|NCT02458365|3978893|FG000|COMPLETED|Overall Study||1723
3245355|NCT02458365|3978894|FG001|COMPLETED|Overall Study||1607
3245356|NCT02458365|3978893|FG000|NOT COMPLETED|Overall Study||277
3245357|NCT02458365|3978894|FG001|NOT COMPLETED|Overall Study||294
3245358|NCT02458469|3978901|FG000|STARTED|First Intervention (2 Weeks)||3
3245359|NCT02458469|3978902|FG001|STARTED|First Intervention (2 Weeks)||2
3245360|NCT02458469|3978903|FG002|STARTED|First Intervention (2 Weeks)||3
3245361|NCT02458469|3978904|FG003|STARTED|First Intervention (2 Weeks)||0
3245362|NCT02458469|3978905|FG004|STARTED|First Intervention (2 Weeks)||1
3245363|NCT02458469|3978906|FG005|STARTED|First Intervention (2 Weeks)||2
3245364|NCT02458469|3978901|FG000|COMPLETED|First Intervention (2 Weeks)||2
3245365|NCT02458469|3978902|FG001|COMPLETED|First Intervention (2 Weeks)||2
3245366|NCT02458469|3978903|FG002|COMPLETED|First Intervention (2 Weeks)||2
3245367|NCT02458469|3978904|FG003|COMPLETED|First Intervention (2 Weeks)||0
3245368|NCT02458469|3978905|FG004|COMPLETED|First Intervention (2 Weeks)||1
3245369|NCT02458469|3978906|FG005|COMPLETED|First Intervention (2 Weeks)||2
3245370|NCT02458469|3978901|FG000|NOT COMPLETED|First Intervention (2 Weeks)||1
3245371|NCT02458469|3978902|FG001|NOT COMPLETED|First Intervention (2 Weeks)||0
3245372|NCT02458469|3978903|FG002|NOT COMPLETED|First Intervention (2 Weeks)||1
3245373|NCT02458469|3978904|FG003|NOT COMPLETED|First Intervention (2 Weeks)||0
3245374|NCT02458469|3978905|FG004|NOT COMPLETED|First Intervention (2 Weeks)||0
3245375|NCT02458469|3978906|FG005|NOT COMPLETED|First Intervention (2 Weeks)||0
3245376|NCT02458469|3978901|FG000|STARTED|First Washout (2 Weeks)||2
3245377|NCT02458469|3978902|FG001|STARTED|First Washout (2 Weeks)||2
3245378|NCT02458469|3978903|FG002|STARTED|First Washout (2 Weeks)||2
3245379|NCT02458469|3978904|FG003|STARTED|First Washout (2 Weeks)||0
3245380|NCT02458469|3978905|FG004|STARTED|First Washout (2 Weeks)||1
3245381|NCT02458469|3978906|FG005|STARTED|First Washout (2 Weeks)||2
3245382|NCT02458469|3978901|FG000|COMPLETED|First Washout (2 Weeks)||2
3245383|NCT02458469|3978902|FG001|COMPLETED|First Washout (2 Weeks)||2
3245384|NCT02458469|3978903|FG002|COMPLETED|First Washout (2 Weeks)||2
3245385|NCT02458469|3978904|FG003|COMPLETED|First Washout (2 Weeks)||0
3245386|NCT02458469|3978905|FG004|COMPLETED|First Washout (2 Weeks)||1
3245387|NCT02458469|3978906|FG005|COMPLETED|First Washout (2 Weeks)||2
3245388|NCT02458469|3978901|FG000|NOT COMPLETED|First Washout (2 Weeks)||0
3245389|NCT02458469|3978902|FG001|NOT COMPLETED|First Washout (2 Weeks)||0
3245390|NCT02458469|3978903|FG002|NOT COMPLETED|First Washout (2 Weeks)||0
3245391|NCT02458469|3978904|FG003|NOT COMPLETED|First Washout (2 Weeks)||0
3245392|NCT02458469|3978905|FG004|NOT COMPLETED|First Washout (2 Weeks)||0
3245393|NCT02458469|3978906|FG005|NOT COMPLETED|First Washout (2 Weeks)||0
3245394|NCT02458469|3978901|FG000|STARTED|Second Intervention (2 Weeks)||2
3245395|NCT02458469|3978902|FG001|STARTED|Second Intervention (2 Weeks)||2
3245396|NCT02458469|3978903|FG002|STARTED|Second Intervention (2 Weeks)||2
3245397|NCT02458469|3978904|FG003|STARTED|Second Intervention (2 Weeks)||0
3245398|NCT02458469|3978905|FG004|STARTED|Second Intervention (2 Weeks)||1
3245399|NCT02458469|3978906|FG005|STARTED|Second Intervention (2 Weeks)||2
3245400|NCT02458469|3978901|FG000|COMPLETED|Second Intervention (2 Weeks)||2
3245401|NCT02458469|3978902|FG001|COMPLETED|Second Intervention (2 Weeks)||2
3245402|NCT02458469|3978903|FG002|COMPLETED|Second Intervention (2 Weeks)||2
3245403|NCT02458469|3978904|FG003|COMPLETED|Second Intervention (2 Weeks)||0
3245404|NCT02458469|3978905|FG004|COMPLETED|Second Intervention (2 Weeks)||1
3245405|NCT02458469|3978906|FG005|COMPLETED|Second Intervention (2 Weeks)||1
3245406|NCT02458469|3978901|FG000|NOT COMPLETED|Second Intervention (2 Weeks)||0
3245407|NCT02458469|3978902|FG001|NOT COMPLETED|Second Intervention (2 Weeks)||0
3245408|NCT02458469|3978903|FG002|NOT COMPLETED|Second Intervention (2 Weeks)||0
3245409|NCT02458469|3978904|FG003|NOT COMPLETED|Second Intervention (2 Weeks)||0
3245410|NCT02458469|3978905|FG004|NOT COMPLETED|Second Intervention (2 Weeks)||0
3245411|NCT02458469|3978906|FG005|NOT COMPLETED|Second Intervention (2 Weeks)||1
3245412|NCT02458469|3978901|FG000|STARTED|Second Washout (2 Weeks)||2
3245413|NCT02458469|3978902|FG001|STARTED|Second Washout (2 Weeks)||2
3245414|NCT02458469|3978903|FG002|STARTED|Second Washout (2 Weeks)||2
3245415|NCT02458469|3978904|FG003|STARTED|Second Washout (2 Weeks)||0
3245416|NCT02458469|3978905|FG004|STARTED|Second Washout (2 Weeks)||1
3245417|NCT02458469|3978906|FG005|STARTED|Second Washout (2 Weeks)||1
3245418|NCT02458469|3978901|FG000|COMPLETED|Second Washout (2 Weeks)||2
3245419|NCT02458469|3978902|FG001|COMPLETED|Second Washout (2 Weeks)||2
3245420|NCT02458469|3978903|FG002|COMPLETED|Second Washout (2 Weeks)||2
3245421|NCT02458469|3978904|FG003|COMPLETED|Second Washout (2 Weeks)||0
3245422|NCT02458469|3978905|FG004|COMPLETED|Second Washout (2 Weeks)||1
3245423|NCT02458469|3978906|FG005|COMPLETED|Second Washout (2 Weeks)||1
3245424|NCT02458469|3978901|FG000|NOT COMPLETED|Second Washout (2 Weeks)||0
3245425|NCT02458469|3978902|FG001|NOT COMPLETED|Second Washout (2 Weeks)||0
3245426|NCT02458469|3978903|FG002|NOT COMPLETED|Second Washout (2 Weeks)||0
3245427|NCT02458469|3978904|FG003|NOT COMPLETED|Second Washout (2 Weeks)||0
3245428|NCT02458469|3978905|FG004|NOT COMPLETED|Second Washout (2 Weeks)||0
3245429|NCT02458469|3978906|FG005|NOT COMPLETED|Second Washout (2 Weeks)||0
3245430|NCT02458469|3978901|FG000|STARTED|Third Intervention (2 Weeks)||2
3245431|NCT02458469|3978902|FG001|STARTED|Third Intervention (2 Weeks)||2
3245432|NCT02458469|3978903|FG002|STARTED|Third Intervention (2 Weeks)||2
3245433|NCT02458469|3978904|FG003|STARTED|Third Intervention (2 Weeks)||0
3245434|NCT02458469|3978905|FG004|STARTED|Third Intervention (2 Weeks)||1
3245435|NCT02458469|3978906|FG005|STARTED|Third Intervention (2 Weeks)||1
3245436|NCT02458469|3978901|FG000|COMPLETED|Third Intervention (2 Weeks)||2
3245437|NCT02458469|3978902|FG001|COMPLETED|Third Intervention (2 Weeks)||2
3245438|NCT02458469|3978903|FG002|COMPLETED|Third Intervention (2 Weeks)||2
3245439|NCT02458469|3978904|FG003|COMPLETED|Third Intervention (2 Weeks)||0
3245440|NCT02458469|3978905|FG004|COMPLETED|Third Intervention (2 Weeks)||1
3245441|NCT02458469|3978906|FG005|COMPLETED|Third Intervention (2 Weeks)||1
3245442|NCT02458469|3978901|FG000|NOT COMPLETED|Third Intervention (2 Weeks)||0
3245443|NCT02458469|3978902|FG001|NOT COMPLETED|Third Intervention (2 Weeks)||0
3245444|NCT02458469|3978903|FG002|NOT COMPLETED|Third Intervention (2 Weeks)||0
3245445|NCT02458469|3978904|FG003|NOT COMPLETED|Third Intervention (2 Weeks)||0
3245446|NCT02458469|3978905|FG004|NOT COMPLETED|Third Intervention (2 Weeks)||0
3245447|NCT02458469|3978906|FG005|NOT COMPLETED|Third Intervention (2 Weeks)||0
3245448|NCT02458638|3978914|FG000|STARTED|Overall Study||474
3245449|NCT02458638|3978914|FG000|COMPLETED|Overall Study||15
3245450|NCT02458638|3978914|FG000|NOT COMPLETED|Overall Study||459
3245451|NCT02458690|3978920|FG000|STARTED|Overall Study||107
3245452|NCT02458690|3978921|FG001|STARTED|Overall Study||109
3245453|NCT02458690|3978920|FG000|COMPLETED|Overall Study||99
3245454|NCT02458690|3978921|FG001|COMPLETED|Overall Study||100
3245455|NCT02458690|3978920|FG000|NOT COMPLETED|Overall Study||8
3245456|NCT02458690|3978921|FG001|NOT COMPLETED|Overall Study||9
3245457|NCT02458768|3978929|FG000|STARTED|Overall Study||57
3245458|NCT02458768|3978930|FG001|STARTED|Overall Study||55
3245459|NCT02458768|3978929|FG000|COMPLETED|Overall Study||50
3245460|NCT02458768|3978930|FG001|COMPLETED|Overall Study||50
3245461|NCT02458768|3978929|FG000|NOT COMPLETED|Overall Study||7
3245462|NCT02458768|3978930|FG001|NOT COMPLETED|Overall Study||5
3245463|NCT02459093|3978938|FG000|STARTED|Overall Study||275
3245464|NCT02459093|3978939|FG001|STARTED|Overall Study||275
3245465|NCT02459093|3978938|FG000|COMPLETED|Overall Study||263
3245466|NCT02459093|3978939|FG001|COMPLETED|Overall Study||257
3245467|NCT02459093|3978938|FG000|NOT COMPLETED|Overall Study||12
3245468|NCT02459093|3978939|FG001|NOT COMPLETED|Overall Study||18
3245469|NCT02459119|3978945|FG000|STARTED|Overall Study||17
3245470|NCT02459119|3978945|FG000|COMPLETED|Overall Study||17
3245471|NCT02459119|3978945|FG000|NOT COMPLETED|Overall Study||0
3370977|NCT03754582|4102489|FG002|STARTED|Pretreatment Phase||0
3370978|NCT03754582|4102487|FG000|COMPLETED|Pretreatment Phase||21
3370979|NCT03754582|4102488|FG001|COMPLETED|Pretreatment Phase||0
3370980|NCT03754582|4102489|FG002|COMPLETED|Pretreatment Phase||0
3370981|NCT03754582|4102487|FG000|NOT COMPLETED|Pretreatment Phase||0
3370982|NCT03754582|4102488|FG001|NOT COMPLETED|Pretreatment Phase||0
3370983|NCT03754582|4102489|FG002|NOT COMPLETED|Pretreatment Phase||0
3245472|NCT02459197|3978951|FG000|STARTED|Overall Study||58
3245473|NCT02459197|3978952|FG001|STARTED|Overall Study||56
3245474|NCT02459197|3978951|FG000|COMPLETED|Overall Study||58
3245475|NCT02459197|3978952|FG001|COMPLETED|Overall Study||55
3245476|NCT02459197|3978951|FG000|NOT COMPLETED|Overall Study||0
3245477|NCT02459197|3978952|FG001|NOT COMPLETED|Overall Study||1
3245478|NCT02459262|3978969|FG000|STARTED|Overall Study||8
3245479|NCT02459262|3978970|FG001|STARTED|Overall Study||8
3245480|NCT02459262|3978971|FG002|STARTED|Overall Study||8
3245481|NCT02459262|3978972|FG003|STARTED|Overall Study||8
3245482|NCT02459262|3978973|FG004|STARTED|Overall Study||8
3245483|NCT02459262|3978974|FG005|STARTED|Overall Study||8
3245484|NCT02459262|3978975|FG006|STARTED|Overall Study||12
3245485|NCT02459262|3978976|FG007|STARTED|Overall Study||45
3245486|NCT02459262|3978977|FG008|STARTED|Overall Study||45
3245487|NCT02459262|3978978|FG009|STARTED|Overall Study||45
3245488|NCT02459262|3978979|FG010|STARTED|Overall Study||45
3245489|NCT02459262|3978969|FG000|COMPLETED|Overall Study||8
3245490|NCT02459262|3978970|FG001|COMPLETED|Overall Study||8
3245491|NCT02459262|3978971|FG002|COMPLETED|Overall Study||8
3245492|NCT02459262|3978972|FG003|COMPLETED|Overall Study||8
3245493|NCT02459262|3978973|FG004|COMPLETED|Overall Study||8
3245494|NCT02459262|3978974|FG005|COMPLETED|Overall Study||8
3245495|NCT02459262|3978975|FG006|COMPLETED|Overall Study||12
3245496|NCT02459262|3978976|FG007|COMPLETED|Overall Study||45
3245497|NCT02459262|3978977|FG008|COMPLETED|Overall Study||45
3245498|NCT02459262|3978978|FG009|COMPLETED|Overall Study||44
3245499|NCT02459262|3978979|FG010|COMPLETED|Overall Study||45
3245500|NCT02459262|3978969|FG000|NOT COMPLETED|Overall Study||0
3245501|NCT02459262|3978970|FG001|NOT COMPLETED|Overall Study||0
3245502|NCT02459262|3978971|FG002|NOT COMPLETED|Overall Study||0
3245503|NCT02459262|3978972|FG003|NOT COMPLETED|Overall Study||0
3245504|NCT02459262|3978973|FG004|NOT COMPLETED|Overall Study||0
3245505|NCT02459262|3978974|FG005|NOT COMPLETED|Overall Study||0
3245506|NCT02459262|3978975|FG006|NOT COMPLETED|Overall Study||0
3245507|NCT02459262|3978976|FG007|NOT COMPLETED|Overall Study||0
3245508|NCT02459262|3978977|FG008|NOT COMPLETED|Overall Study||0
3245509|NCT02459262|3978978|FG009|NOT COMPLETED|Overall Study||1
3245510|NCT02459262|3978979|FG010|NOT COMPLETED|Overall Study||0
3245511|NCT02459275|3979005|FG000|STARTED|Overall Study||19
3245512|NCT02459275|3979006|FG001|STARTED|Overall Study||17
3245513|NCT02459275|3979005|FG000|COMPLETED|Overall Study||19
3245514|NCT02459275|3979006|FG001|COMPLETED|Overall Study||17
3245515|NCT02459275|3979005|FG000|NOT COMPLETED|Overall Study||0
3245516|NCT02459275|3979006|FG001|NOT COMPLETED|Overall Study||0
3245517|NCT02459418|3979014|FG000|STARTED|Overall Study||21
3245518|NCT02459418|3979015|FG001|STARTED|Overall Study||21
3245519|NCT02459418|3979014|FG000|Received First Treatment|Overall Study||21
3245520|NCT02459418|3979015|FG001|Received First Treatment|Overall Study||21
3245521|NCT02459418|3979014|FG000|Received Second Treatment|Overall Study||13
3245522|NCT02459418|3979015|FG001|Received Second Treatment|Overall Study||15
3245523|NCT02459418|3979014|FG000|COMPLETED|Overall Study||13
3245524|NCT02459418|3979015|FG001|COMPLETED|Overall Study||15
3245525|NCT02459418|3979014|FG000|NOT COMPLETED|Overall Study||8
3245526|NCT02459418|3979015|FG001|NOT COMPLETED|Overall Study||6
3245527|NCT02459587|3979026|FG000|STARTED|3-Month Follow-up Assessment||157
3245528|NCT02459587|3979027|FG001|STARTED|3-Month Follow-up Assessment||150
3245529|NCT02459587|3979026|FG000|COMPLETED|3-Month Follow-up Assessment||125
3245530|NCT02459587|3979027|FG001|COMPLETED|3-Month Follow-up Assessment||119
3245531|NCT02459587|3979026|FG000|NOT COMPLETED|3-Month Follow-up Assessment||32
3245532|NCT02459587|3979027|FG001|NOT COMPLETED|3-Month Follow-up Assessment||31
3245533|NCT02459587|3979026|FG000|STARTED|6-month Follow-up Assessment|Total excludes participants who withdrew participation or were deceased prior to follow-up.|152
3245534|NCT02459587|3979027|FG001|STARTED|6-month Follow-up Assessment|Total excludes participants who withdrew participation or were deceased prior to follow-up.|141
3245535|NCT02459587|3979026|FG000|COMPLETED|6-month Follow-up Assessment||128
3245536|NCT02459587|3979027|FG001|COMPLETED|6-month Follow-up Assessment||116
3245537|NCT02459587|3979026|FG000|NOT COMPLETED|6-month Follow-up Assessment||24
3245538|NCT02459587|3979027|FG001|NOT COMPLETED|6-month Follow-up Assessment||25
3245539|NCT02459587|3979026|FG000|STARTED|12-month Follow-up Assessment|Total excludes participants who withdrew participation or were deceased prior to follow-up.|149
3245540|NCT02459587|3979027|FG001|STARTED|12-month Follow-up Assessment|Total excludes participants who withdrew participation or were deceased prior to follow-up.|138
3245541|NCT02459587|3979026|FG000|COMPLETED|12-month Follow-up Assessment||127
3245542|NCT02459587|3979027|FG001|COMPLETED|12-month Follow-up Assessment||111
3245543|NCT02459587|3979026|FG000|NOT COMPLETED|12-month Follow-up Assessment||22
3245544|NCT02459587|3979027|FG001|NOT COMPLETED|12-month Follow-up Assessment||27
3245545|NCT02459665|3979038|FG000|STARTED|Overall Study||17
3245546|NCT02459665|3979039|FG001|STARTED|Overall Study||17
3245547|NCT02459665|3979040|FG002|STARTED|Overall Study||17
3245548|NCT02459665|3979041|FG003|STARTED|Overall Study||17
3245549|NCT02459665|3979038|FG000|Day 7 Visit|Overall Study||17
3245550|NCT02459665|3979039|FG001|Day 7 Visit|Overall Study||17
3245551|NCT02459665|3979040|FG002|Day 7 Visit|Overall Study||17
3245552|NCT02459665|3979041|FG003|Day 7 Visit|Overall Study||16
3245553|NCT02459665|3979038|FG000|Month 1 Visit|Overall Study||17
3245554|NCT02459665|3979039|FG001|Month 1 Visit|Overall Study||17
3245555|NCT02459665|3979040|FG002|Month 1 Visit|Overall Study||17
3245556|NCT02459665|3979041|FG003|Month 1 Visit|Overall Study||16
3245557|NCT02459665|3979038|FG000|Month 2 Visit|Overall Study||17
3245558|NCT02459665|3979039|FG001|Month 2 Visit|Overall Study||16
3245559|NCT02459665|3979040|FG002|Month 2 Visit|Overall Study||17
3245560|NCT02459665|3979041|FG003|Month 2 Visit|Overall Study||16
3245561|NCT02459665|3979038|FG000|Month 6 Visit|Overall Study||17
3245562|NCT02459665|3979039|FG001|Month 6 Visit|Overall Study||16
3245563|NCT02459665|3979040|FG002|Month 6 Visit|Overall Study||16
3245564|NCT02459665|3979041|FG003|Month 6 Visit|Overall Study||15
3245565|NCT02459665|3979038|FG000|COMPLETED|Overall Study||17
3245566|NCT02459665|3979039|FG001|COMPLETED|Overall Study||16
3245567|NCT02459665|3979040|FG002|COMPLETED|Overall Study||16
3245568|NCT02459665|3979041|FG003|COMPLETED|Overall Study||15
3245569|NCT02459665|3979038|FG000|NOT COMPLETED|Overall Study||0
3245570|NCT02459665|3979039|FG001|NOT COMPLETED|Overall Study||1
3245571|NCT02459665|3979040|FG002|NOT COMPLETED|Overall Study||1
3245572|NCT02459665|3979041|FG003|NOT COMPLETED|Overall Study||2
3245573|NCT02459795|3979061|FG000|STARTED|Overall Study||187
3245574|NCT02459795|3979062|FG001|STARTED|Overall Study||189
3245575|NCT02459795|3979063|FG002|STARTED|Overall Study||93
3245576|NCT02459795|3979061|FG000|COMPLETED|Overall Study||181
3245577|NCT02459795|3979062|FG001|COMPLETED|Overall Study||186
3245578|NCT02459795|3979063|FG002|COMPLETED|Overall Study||92
3245579|NCT02459795|3979061|FG000|NOT COMPLETED|Overall Study||6
3245580|NCT02459795|3979062|FG001|NOT COMPLETED|Overall Study||3
3245581|NCT02459795|3979063|FG002|NOT COMPLETED|Overall Study||1
3245582|NCT02459899|3979075|FG000|STARTED|Overall Study||36
3245583|NCT02459899|3979076|FG001|STARTED|Overall Study||35
3245584|NCT02459899|3979077|FG002|STARTED|Overall Study||35
3245585|NCT02459899|3979078|FG003|STARTED|Overall Study||35
3245586|NCT02459899|3979075|FG000|COMPLETED|Overall Study||33
3245587|NCT02459899|3979076|FG001|COMPLETED|Overall Study||29
3245588|NCT02459899|3979077|FG002|COMPLETED|Overall Study||35
3245589|NCT02459899|3979078|FG003|COMPLETED|Overall Study||33
3245590|NCT02459899|3979075|FG000|NOT COMPLETED|Overall Study||3
3245591|NCT02459899|3979076|FG001|NOT COMPLETED|Overall Study||6
3245592|NCT02459899|3979077|FG002|NOT COMPLETED|Overall Study||0
3245593|NCT02459899|3979078|FG003|NOT COMPLETED|Overall Study||2
3245594|NCT02459951|3979088|FG000|STARTED|Overall Study||10
3245595|NCT02459951|3979088|FG000|COMPLETED|Overall Study||9
3245596|NCT02459951|3979088|FG000|NOT COMPLETED|Overall Study||1
3245597|NCT02459964|3979096|FG000|STARTED|Overall Study||42
3245598|NCT02459964|3979097|FG001|STARTED|Overall Study||40
3245599|NCT02459964|3979098|FG002|STARTED|Overall Study||2
3245600|NCT02459964|3979096|FG000|COMPLETED|Overall Study||42
3245601|NCT02459964|3979097|FG001|COMPLETED|Overall Study||40
3245602|NCT02459964|3979098|FG002|COMPLETED|Overall Study||0
3245603|NCT02459964|3979096|FG000|NOT COMPLETED|Overall Study||0
3245604|NCT02459964|3979097|FG001|NOT COMPLETED|Overall Study||0
3245605|NCT02459964|3979098|FG002|NOT COMPLETED|Overall Study||2
3245606|NCT02460172|3979105|FG000|STARTED|Overall Study||25
3245607|NCT02460172|3979105|FG000|COMPLETED|Overall Study||25
3245608|NCT02460172|3979105|FG000|NOT COMPLETED|Overall Study||0
3245609|NCT02460198|3979113|FG000|STARTED|Overall Study||61
3245610|NCT02460198|3979114|FG001|STARTED|Overall Study||63
3245611|NCT02460198|3979113|FG000|COMPLETED|Overall Study||0
3245612|NCT02460198|3979114|FG001|COMPLETED|Overall Study||0
3245613|NCT02460198|3979113|FG000|NOT COMPLETED|Overall Study||61
3245614|NCT02460198|3979114|FG001|NOT COMPLETED|Overall Study||63
3245615|NCT02460263|3979120|FG000|STARTED|In-Center Period||30
3245616|NCT02460263|3979120|FG000|COMPLETED|In-Center Period||30
3245617|NCT02460263|3979120|FG000|NOT COMPLETED|In-Center Period||0
3245618|NCT02460263|3979120|FG000|STARTED|Transition Period||30
3245619|NCT02460263|3979120|FG000|COMPLETED|Transition Period||28
3245620|NCT02460263|3979120|FG000|NOT COMPLETED|Transition Period||2
3245621|NCT02460263|3979120|FG000|STARTED|In-Home Period||28
3245622|NCT02460263|3979120|FG000|COMPLETED|In-Home Period||28
3370984|NCT03754582|4102487|FG000|STARTED|Treatment Phase||0
3370985|NCT03754582|4102488|FG001|STARTED|Treatment Phase||21
3370986|NCT03754582|4102489|FG002|STARTED|Treatment Phase||0
3370987|NCT03754582|4102487|FG000|COMPLETED|Treatment Phase||0
3370988|NCT03754582|4102488|FG001|COMPLETED|Treatment Phase||20
3370989|NCT03754582|4102489|FG002|COMPLETED|Treatment Phase||0
3370990|NCT03754582|4102487|FG000|NOT COMPLETED|Treatment Phase||0
3370991|NCT03754582|4102488|FG001|NOT COMPLETED|Treatment Phase||1
3370992|NCT03754582|4102489|FG002|NOT COMPLETED|Treatment Phase||0
3370993|NCT03754582|4102487|FG000|STARTED|Follow-up Phase||0
3370994|NCT03754582|4102488|FG001|STARTED|Follow-up Phase||0
3370995|NCT03754582|4102489|FG002|STARTED|Follow-up Phase|1 participant who discontinued in Treatment Phase was assessed at Follow-up Visit.|21
3370996|NCT03754582|4102487|FG000|COMPLETED|Follow-up Phase||0
3370997|NCT03754582|4102488|FG001|COMPLETED|Follow-up Phase||0
3370998|NCT03754582|4102489|FG002|COMPLETED|Follow-up Phase||20
3370999|NCT03754582|4102487|FG000|NOT COMPLETED|Follow-up Phase||0
3371000|NCT03754582|4102488|FG001|NOT COMPLETED|Follow-up Phase||0
3371001|NCT03754582|4102489|FG002|NOT COMPLETED|Follow-up Phase||1
3371002|NCT03754556|4102505|FG000|STARTED|Overall Study||326658
3245623|NCT02460263|3979120|FG000|NOT COMPLETED|In-Home Period||0
3245624|NCT02460380|3979130|FG000|STARTED|Overall Study||45
3371003|NCT03754556|4102505|FG000|COMPLETED|Overall Study||326658
3371004|NCT03754556|4102505|FG000|NOT COMPLETED|Overall Study||0
3245625|NCT02460380|3979131|FG001|STARTED|Overall Study||23
3245626|NCT02460380|3979130|FG000|COMPLETED|Overall Study||35
3371005|NCT03753113|4102511|FG000|STARTED|Overall Study||12
3245627|NCT02460380|3979131|FG001|COMPLETED|Overall Study||18
3245628|NCT02460380|3979130|FG000|NOT COMPLETED|Overall Study||10
3245629|NCT02460380|3979131|FG001|NOT COMPLETED|Overall Study||5
3245630|NCT02460458|3979138|FG000|STARTED|Retrospective Phase||265
3245631|NCT02460458|3979138|FG000|COMPLETED|Retrospective Phase||265
3245632|NCT02460458|3979138|FG000|NOT COMPLETED|Retrospective Phase||0
3245633|NCT02460458|3979138|FG000|STARTED|Confirmatory Phase||265
3245634|NCT02460458|3979138|FG000|COMPLETED|Confirmatory Phase||177
3245635|NCT02460458|3979138|FG000|NOT COMPLETED|Confirmatory Phase||88
3245636|NCT02460458|3979138|FG000|STARTED|First Prospective Phase||177
3245637|NCT02460458|3979138|FG000|COMPLETED|First Prospective Phase||161
3245638|NCT02460458|3979138|FG000|NOT COMPLETED|First Prospective Phase||16
3245639|NCT02460458|3979138|FG000|STARTED|Confirmation of Clinical Phase Data||161
3245640|NCT02460458|3979138|FG000|COMPLETED|Confirmation of Clinical Phase Data||152
3245641|NCT02460458|3979138|FG000|NOT COMPLETED|Confirmation of Clinical Phase Data||9
3245642|NCT02460458|3979138|FG000|STARTED|Second Prospective Phase||152
3245643|NCT02460458|3979138|FG000|COMPLETED|Second Prospective Phase|Information not available yet, anticipated date is december 2022|0
3245644|NCT02460458|3979138|FG000|NOT COMPLETED|Second Prospective Phase||152
3245645|NCT02460562|3979144|FG000|STARTED|Overall Study||74
3245646|NCT02460562|3979145|FG001|STARTED|Overall Study||76
3245647|NCT02460562|3979144|FG000|COMPLETED|Overall Study||59
3245648|NCT02460562|3979145|FG001|COMPLETED|Overall Study||60
3245649|NCT02460562|3979144|FG000|NOT COMPLETED|Overall Study||15
3245650|NCT02460562|3979145|FG001|NOT COMPLETED|Overall Study||16
3245651|NCT02460575|3979153|FG000|STARTED|Overall Study||40
3245652|NCT02460575|3979154|FG001|STARTED|Overall Study||20
3245653|NCT02460575|3979153|FG000|COMPLETED|Overall Study||39
3245654|NCT02460575|3979154|FG001|COMPLETED|Overall Study||20
3245655|NCT02460575|3979153|FG000|NOT COMPLETED|Overall Study||1
3245656|NCT02460575|3979154|FG001|NOT COMPLETED|Overall Study||0
3245657|NCT02460666|3979162|FG000|STARTED|Overall Study||89
3245658|NCT02460666|3979163|FG001|STARTED|Overall Study||89
3245659|NCT02460666|3979162|FG000|COMPLETED|Overall Study||62
3245660|NCT02460666|3979163|FG001|COMPLETED|Overall Study||63
3245661|NCT02460666|3979162|FG000|NOT COMPLETED|Overall Study||27
3245662|NCT02460666|3979163|FG001|NOT COMPLETED|Overall Study||26
3245663|NCT02460679|3979169|FG000|STARTED|Overall Study||19
3245664|NCT02460679|3979169|FG000|Received at Least 1 Dose of Study Drug|Overall Study||19
3245665|NCT02460679|3979169|FG000|COMPLETED|Overall Study||14
3245666|NCT02460679|3979169|FG000|NOT COMPLETED|Overall Study||5
3245667|NCT02460822|3979173|FG000|STARTED|Overall Study||16
3245668|NCT02460822|3979173|FG000|COMPLETED|Overall Study||15
3245669|NCT02460822|3979173|FG000|NOT COMPLETED|Overall Study||1
3245670|NCT02460978|3979180|FG000|STARTED|Overall Study||271
3245671|NCT02460978|3979181|FG001|STARTED|Overall Study||270
3245672|NCT02460978|3979182|FG002|STARTED|Overall Study||272
3245673|NCT02460978|3979180|FG000|COMPLETED|Overall Study||244
3245674|NCT02460978|3979181|FG001|COMPLETED|Overall Study||245
3245675|NCT02460978|3979182|FG002|COMPLETED|Overall Study||239
3245676|NCT02460978|3979180|FG000|NOT COMPLETED|Overall Study||27
3245677|NCT02460978|3979181|FG001|NOT COMPLETED|Overall Study||25
3245678|NCT02460978|3979182|FG002|NOT COMPLETED|Overall Study||33
3245679|NCT02460991|3979192|FG000|STARTED|Overall Study||0
3245680|NCT02460991|3979193|FG001|STARTED|Overall Study||2
3245681|NCT02460991|3979192|FG000|COMPLETED|Overall Study||0
3245682|NCT02460991|3979193|FG001|COMPLETED|Overall Study||0
3245683|NCT02460991|3979192|FG000|NOT COMPLETED|Overall Study||0
3245684|NCT02460991|3979193|FG001|NOT COMPLETED|Overall Study||2
3245685|NCT02461134|3979204|FG000|STARTED|Overall Study||1
3245686|NCT02461134|3979204|FG000|COMPLETED|Overall Study||0
3245687|NCT02461134|3979204|FG000|NOT COMPLETED|Overall Study||1
3245688|NCT02461160|3979221|FG000|STARTED|Overall Study||8
3245689|NCT02461160|3979222|FG001|STARTED|Overall Study||6
3245690|NCT02461160|3979223|FG002|STARTED|Overall Study||6
3245691|NCT02461160|3979224|FG003|STARTED|Overall Study||12
3245692|NCT02461160|3979225|FG004|STARTED|Overall Study||6
3245693|NCT02461160|3979226|FG005|STARTED|Overall Study||6
3245694|NCT02461160|3979227|FG006|STARTED|Overall Study||6
3245695|NCT02461160|3979228|FG007|STARTED|Overall Study||6
3245696|NCT02461160|3979229|FG008|STARTED|Overall Study||12
3245697|NCT02461160|3979230|FG009|STARTED|Overall Study||4
3245698|NCT02461160|3979231|FG010|STARTED|Overall Study||4
3245699|NCT02461160|3979232|FG011|STARTED|Overall Study||4
3245700|NCT02461160|3979233|FG012|STARTED|Overall Study||8
3245701|NCT02461160|3979221|FG000|COMPLETED|Overall Study||8
3245702|NCT02461160|3979222|FG001|COMPLETED|Overall Study||6
3245703|NCT02461160|3979223|FG002|COMPLETED|Overall Study||6
3245704|NCT02461160|3979224|FG003|COMPLETED|Overall Study||12
3245705|NCT02461160|3979225|FG004|COMPLETED|Overall Study||6
3245706|NCT02461160|3979226|FG005|COMPLETED|Overall Study||6
3245707|NCT02461160|3979227|FG006|COMPLETED|Overall Study||6
3245708|NCT02461160|3979228|FG007|COMPLETED|Overall Study||5
3245709|NCT02461160|3979229|FG008|COMPLETED|Overall Study||12
3245710|NCT02461160|3979230|FG009|COMPLETED|Overall Study||4
3245711|NCT02461160|3979231|FG010|COMPLETED|Overall Study||4
3245712|NCT02461160|3979232|FG011|COMPLETED|Overall Study||4
3245713|NCT02461160|3979233|FG012|COMPLETED|Overall Study||8
3245714|NCT02461160|3979221|FG000|NOT COMPLETED|Overall Study||0
3245715|NCT02461160|3979222|FG001|NOT COMPLETED|Overall Study||0
3245716|NCT02461160|3979223|FG002|NOT COMPLETED|Overall Study||0
3245717|NCT02461160|3979224|FG003|NOT COMPLETED|Overall Study||0
3245718|NCT02461160|3979225|FG004|NOT COMPLETED|Overall Study||0
3245719|NCT02461160|3979226|FG005|NOT COMPLETED|Overall Study||0
3245720|NCT02461160|3979227|FG006|NOT COMPLETED|Overall Study||0
3245721|NCT02461160|3979228|FG007|NOT COMPLETED|Overall Study||1
3245722|NCT02461160|3979229|FG008|NOT COMPLETED|Overall Study||0
3245723|NCT02461160|3979230|FG009|NOT COMPLETED|Overall Study||0
3245724|NCT02461160|3979231|FG010|NOT COMPLETED|Overall Study||0
3245725|NCT02461160|3979232|FG011|NOT COMPLETED|Overall Study||0
3245726|NCT02461160|3979233|FG012|NOT COMPLETED|Overall Study||0
3245727|NCT02461290|3979282|FG000|STARTED|Overall Study||99
3245728|NCT02461290|3979282|FG000|COMPLETED|Overall Study||89
3245729|NCT02461290|3979282|FG000|NOT COMPLETED|Overall Study||10
3245730|NCT02461433|3979288|FG000|STARTED|Overall Study||1
3245731|NCT02461433|3979289|FG001|STARTED|Overall Study||1
3245732|NCT02461433|3979288|FG000|COMPLETED|Overall Study||1
3245733|NCT02461433|3979289|FG001|COMPLETED|Overall Study||1
3245734|NCT02461433|3979288|FG000|NOT COMPLETED|Overall Study||0
3245735|NCT02461433|3979289|FG001|NOT COMPLETED|Overall Study||0
3245736|NCT02461563|3979299|FG000|STARTED|Overall Study||3
3245737|NCT02461563|3979300|FG001|STARTED|Overall Study||3
3245738|NCT02461563|3979301|FG002|STARTED|Overall Study||3
3245739|NCT02461563|3979302|FG003|STARTED|Overall Study||3
3245740|NCT02461563|3979299|FG000|COMPLETED|Overall Study||3
3245741|NCT02461563|3979300|FG001|COMPLETED|Overall Study||3
3245742|NCT02461563|3979301|FG002|COMPLETED|Overall Study||3
3245743|NCT02461563|3979302|FG003|COMPLETED|Overall Study||3
3245744|NCT02461563|3979299|FG000|NOT COMPLETED|Overall Study||0
3245745|NCT02461563|3979300|FG001|NOT COMPLETED|Overall Study||0
3245746|NCT02461563|3979301|FG002|NOT COMPLETED|Overall Study||0
3245747|NCT02461563|3979302|FG003|NOT COMPLETED|Overall Study||0
3245748|NCT02461589|3979328|FG000|STARTED|Overall Study||64
3245749|NCT02461589|3979329|FG001|STARTED|Overall Study||63
3245750|NCT02461589|3979330|FG002|STARTED|Overall Study||65
3245751|NCT02461589|3979331|FG003|STARTED|Overall Study||63
3245752|NCT02461589|3979332|FG004|STARTED|Overall Study||64
3245753|NCT02461589|3979333|FG005|STARTED|Overall Study||64
3245754|NCT02461589|3979334|FG006|STARTED|Overall Study||64
3245755|NCT02461589|3979335|FG007|STARTED|Overall Study||65
3245756|NCT02461589|3979336|FG008|STARTED|Overall Study||129
3245757|NCT02461589|3979337|FG009|STARTED|Overall Study||65
3245758|NCT02461589|3979328|FG000|Exposed|Overall Study||64
3245759|NCT02461589|3979329|FG001|Exposed|Overall Study||63
3245760|NCT02461589|3979330|FG002|Exposed|Overall Study||65
3245761|NCT02461589|3979331|FG003|Exposed|Overall Study||63
3245762|NCT02461589|3979332|FG004|Exposed|Overall Study||64
3245763|NCT02461589|3979333|FG005|Exposed|Overall Study||64
3245764|NCT02461589|3979334|FG006|Exposed|Overall Study||64
3245765|NCT02461589|3979335|FG007|Exposed|Overall Study||65
3245766|NCT02461589|3979336|FG008|Exposed|Overall Study||129
3245767|NCT02461589|3979337|FG009|Exposed|Overall Study||64
3245768|NCT02461589|3979328|FG000|COMPLETED|Overall Study||58
3245769|NCT02461589|3979329|FG001|COMPLETED|Overall Study||61
3245770|NCT02461589|3979330|FG002|COMPLETED|Overall Study||60
3245771|NCT02461589|3979331|FG003|COMPLETED|Overall Study||58
3245772|NCT02461589|3979332|FG004|COMPLETED|Overall Study||62
3245773|NCT02461589|3979333|FG005|COMPLETED|Overall Study||61
3245774|NCT02461589|3979334|FG006|COMPLETED|Overall Study||58
3245775|NCT02461589|3979335|FG007|COMPLETED|Overall Study||60
3245776|NCT02461589|3979336|FG008|COMPLETED|Overall Study||123
3245777|NCT02461589|3979337|FG009|COMPLETED|Overall Study||60
3245778|NCT02461589|3979328|FG000|NOT COMPLETED|Overall Study||6
3245779|NCT02461589|3979329|FG001|NOT COMPLETED|Overall Study||2
3245780|NCT02461589|3979330|FG002|NOT COMPLETED|Overall Study||5
3245781|NCT02461589|3979331|FG003|NOT COMPLETED|Overall Study||5
3245782|NCT02461589|3979332|FG004|NOT COMPLETED|Overall Study||2
3245783|NCT02461589|3979333|FG005|NOT COMPLETED|Overall Study||3
3245784|NCT02461589|3979334|FG006|NOT COMPLETED|Overall Study||6
3245785|NCT02461589|3979335|FG007|NOT COMPLETED|Overall Study||5
3245786|NCT02461589|3979336|FG008|NOT COMPLETED|Overall Study||6
3245787|NCT02461589|3979337|FG009|NOT COMPLETED|Overall Study||5
3245788|NCT02461628|3979361|FG000|STARTED|Overall Study||3733
3245789|NCT02461628|3979362|FG001|STARTED|Overall Study||3632
3245790|NCT02461628|3979361|FG000|Baseline Survey|Overall Study||1038
3245791|NCT02461628|3979362|FG001|Baseline Survey|Overall Study||974
3245792|NCT02461628|3979361|FG000|6 Month Survey|Overall Study||814
3245793|NCT02461628|3979362|FG001|6 Month Survey|Overall Study||832
3245794|NCT02461628|3979361|FG000|12 Month Survey|Overall Study||882
3245795|NCT02461628|3979362|FG001|12 Month Survey|Overall Study||914
3245796|NCT02461628|3979361|FG000|18 Month Survey|Overall Study||995
3245797|NCT02461628|3979362|FG001|18 Month Survey|Overall Study||905
3245798|NCT02461628|3979361|FG000|COMPLETED|Overall Study||3729
3245799|NCT02461628|3979362|FG001|COMPLETED|Overall Study||3625
3245800|NCT02461628|3979361|FG000|NOT COMPLETED|Overall Study||4
3245801|NCT02461628|3979362|FG001|NOT COMPLETED|Overall Study||7
3245802|NCT02461693|3979370|FG000|STARTED|Overall Study||103
3245803|NCT02461693|3979371|FG001|STARTED|Overall Study||102
3245804|NCT02461693|3979370|FG000|COMPLETED|Overall Study||103
3245805|NCT02461693|3979371|FG001|COMPLETED|Overall Study||102
3245806|NCT02461693|3979370|FG000|NOT COMPLETED|Overall Study||0
3245807|NCT02461693|3979371|FG001|NOT COMPLETED|Overall Study||0
3245808|NCT02461745|3979379|FG000|STARTED|Overall Study||130
3245809|NCT02461745|3979380|FG001|STARTED|Overall Study||70
3245810|NCT02461745|3979379|FG000|COMPLETED|Overall Study||116
3245811|NCT02461745|3979380|FG001|COMPLETED|Overall Study||66
3245812|NCT02461745|3979379|FG000|NOT COMPLETED|Overall Study||14
3245813|NCT02461745|3979380|FG001|NOT COMPLETED|Overall Study||4
3245814|NCT02461758|3979392|FG000|STARTED|Overall Study||20
3245815|NCT02461758|3979393|FG001|STARTED|Overall Study||20
3245816|NCT02461758|3979394|FG002|STARTED|Overall Study||26
3245817|NCT02461758|3979395|FG003|STARTED|Overall Study||15
3245818|NCT02461758|3979392|FG000|COMPLETED|Overall Study||20
3245819|NCT02461758|3979393|FG001|COMPLETED|Overall Study||19
3245820|NCT02461758|3979394|FG002|COMPLETED|Overall Study||25
3245821|NCT02461758|3979395|FG003|COMPLETED|Overall Study||15
3245822|NCT02461758|3979392|FG000|NOT COMPLETED|Overall Study||0
3245823|NCT02461758|3979393|FG001|NOT COMPLETED|Overall Study||1
3245824|NCT02461758|3979394|FG002|NOT COMPLETED|Overall Study||1
3245825|NCT02461758|3979395|FG003|NOT COMPLETED|Overall Study||0
3245826|NCT02461771|3979411|FG000|STARTED|Overall Study||3
3245827|NCT02461771|3979412|FG001|STARTED|Overall Study||3
3245828|NCT02461771|3979413|FG002|STARTED|Overall Study||7
3245829|NCT02461771|3979411|FG000|COMPLETED|Overall Study||3
3245830|NCT02461771|3979412|FG001|COMPLETED|Overall Study||3
3245831|NCT02461771|3979413|FG002|COMPLETED|Overall Study||7
3245832|NCT02461771|3979411|FG000|NOT COMPLETED|Overall Study||0
3245833|NCT02461771|3979412|FG001|NOT COMPLETED|Overall Study||0
3245834|NCT02461771|3979413|FG002|NOT COMPLETED|Overall Study||0
3245835|NCT02461966|3979424|FG000|STARTED|Overall Study||160
3245836|NCT02461966|3979425|FG001|STARTED|Overall Study||80
3245837|NCT02461966|3979426|FG002|STARTED|Overall Study||60
3245838|NCT02461966|3979424|FG000|COMPLETED|Overall Study||160
3245839|NCT02461966|3979425|FG001|COMPLETED|Overall Study||80
3245840|NCT02461966|3979426|FG002|COMPLETED|Overall Study||60
3245841|NCT02461966|3979424|FG000|NOT COMPLETED|Overall Study||0
3245842|NCT02461966|3979425|FG001|NOT COMPLETED|Overall Study||0
3245843|NCT02461966|3979426|FG002|NOT COMPLETED|Overall Study||0
3245844|NCT02461992|3979434|FG000|STARTED|Overall Study||13
3245845|NCT02461992|3979434|FG000|COMPLETED|Overall Study||13
3245846|NCT02461992|3979434|FG000|NOT COMPLETED|Overall Study||0
3245847|NCT02462057|3979443|FG000|STARTED|Overall Study||791
3245848|NCT02462057|3979444|FG001|STARTED|Overall Study||793
3245849|NCT02462057|3979445|FG002|STARTED|Overall Study||812
3245850|NCT02462057|3979446|FG003|STARTED|Overall Study||752
3245851|NCT02462057|3979447|FG004|STARTED|Overall Study||758
3245852|NCT02462057|3979443|FG000|COMPLETED|Overall Study||737
3245853|NCT02462057|3979444|FG001|COMPLETED|Overall Study||753
3245854|NCT02462057|3979445|FG002|COMPLETED|Overall Study||766
3245855|NCT02462057|3979446|FG003|COMPLETED|Overall Study||701
3245856|NCT02462057|3979447|FG004|COMPLETED|Overall Study||708
3245857|NCT02462057|3979443|FG000|NOT COMPLETED|Overall Study||54
3245858|NCT02462057|3979444|FG001|NOT COMPLETED|Overall Study||40
3245859|NCT02462057|3979445|FG002|NOT COMPLETED|Overall Study||46
3245860|NCT02462057|3979446|FG003|NOT COMPLETED|Overall Study||51
3245861|NCT02462057|3979447|FG004|NOT COMPLETED|Overall Study||50
3245862|NCT02462070|3979461|FG000|STARTED|Overall Study||135
3245863|NCT02462070|3979462|FG001|STARTED|Overall Study||68
3245864|NCT02462070|3979461|FG000|COMPLETED|Overall Study||112
3245865|NCT02462070|3979462|FG001|COMPLETED|Overall Study||57
3245866|NCT02462070|3979461|FG000|NOT COMPLETED|Overall Study||23
3245867|NCT02462070|3979462|FG001|NOT COMPLETED|Overall Study||11
3371006|NCT03753113|4102512|FG001|STARTED|Overall Study||12
3371007|NCT03753113|4102511|FG000|COMPLETED|Overall Study||12
3371008|NCT03753113|4102512|FG001|COMPLETED|Overall Study||12
3371009|NCT03753113|4102511|FG000|NOT COMPLETED|Overall Study||0
3371010|NCT03753113|4102512|FG001|NOT COMPLETED|Overall Study||0
3371011|NCT03752567|4102518|FG000|STARTED|Overall Study||40
3371012|NCT03752567|4102518|FG000|COMPLETED|Overall Study||40
3371013|NCT03752567|4102518|FG000|NOT COMPLETED|Overall Study||0
3371014|NCT03752528|4102522|FG000|STARTED|Part A||53
3371015|NCT03752528|4102522|FG000|COMPLETED|Part A||51
3371016|NCT03752528|4102522|FG000|NOT COMPLETED|Part A||2
3371017|NCT03752528|4102522|FG000|STARTED|Part B||24
3371018|NCT03752528|4102522|FG000|COMPLETED|Part B||20
3371019|NCT03752528|4102522|FG000|NOT COMPLETED|Part B||4
3371020|NCT03752151|4102529|FG000|STARTED|Overall Study||77
3371021|NCT03752151|4102529|FG000|COMPLETED|Overall Study||75
3371022|NCT03752151|4102529|FG000|NOT COMPLETED|Overall Study||2
3371023|NCT03751657|4102536|FG000|STARTED|Overall Study||125
3371024|NCT03751657|4102537|FG001|STARTED|Overall Study||122
3371025|NCT03751657|4102536|FG000|COMPLETED|Overall Study||122
3371026|NCT03751657|4102537|FG001|COMPLETED|Overall Study||119
3371027|NCT03751657|4102536|FG000|NOT COMPLETED|Overall Study||3
3371028|NCT03751657|4102537|FG001|NOT COMPLETED|Overall Study||3
3371029|NCT03751280|4102545|FG000|STARTED|Overall Study||56
3371030|NCT03751280|4102546|FG001|STARTED|Overall Study||56
3371031|NCT03751280|4102545|FG000|Full Analysis Set (FAS)|Overall Study||54
3371032|NCT03751280|4102546|FG001|Full Analysis Set (FAS)|Overall Study||55
3371033|NCT03751280|4102545|FG000|Safety Set (SAF)|Overall Study||55
3371034|NCT03751280|4102546|FG001|Safety Set (SAF)|Overall Study||55
3371035|NCT03751280|4102545|FG000|COMPLETED|Overall Study||48
3371036|NCT03751280|4102546|FG001|COMPLETED|Overall Study||44
3371037|NCT03751280|4102545|FG000|NOT COMPLETED|Overall Study||8
3371038|NCT03751280|4102546|FG001|NOT COMPLETED|Overall Study||12
3371039|NCT03751020|4102556|FG000|STARTED|Overall Study||36
3371040|NCT03751020|4102557|FG001|STARTED|Overall Study||36
3371041|NCT03751020|4102558|FG002|STARTED|Overall Study||36
3371042|NCT03751020|4102556|FG000|Post Intervention|Overall Study||33
3245868|NCT02462083|3979468|FG000|STARTED|Overall Study||555
3245869|NCT02462083|3979468|FG000|Safety Population|Overall Study||550
3245870|NCT02462083|3979468|FG000|COMPLETED|Overall Study||136
3245871|NCT02462083|3979468|FG000|NOT COMPLETED|Overall Study||419
3245872|NCT02462122|3979474|FG000|STARTED|Overall Study||141
3245873|NCT02462122|3979475|FG001|STARTED|Overall Study||74
3245874|NCT02462122|3979474|FG000|COMPLETED|Overall Study||120
3245875|NCT02462122|3979475|FG001|COMPLETED|Overall Study||61
3245876|NCT02462122|3979474|FG000|NOT COMPLETED|Overall Study||21
3245877|NCT02462122|3979475|FG001|NOT COMPLETED|Overall Study||13
3245878|NCT02462148|3979484|FG000|STARTED|Overall Study||37
3245879|NCT02462148|3979485|FG001|STARTED|Overall Study||36
3245880|NCT02462148|3979486|FG002|STARTED|Overall Study||12
3245881|NCT02462148|3979484|FG000|COMPLETED|Overall Study||36
3245882|NCT02462148|3979485|FG001|COMPLETED|Overall Study||36
3245883|NCT02462148|3979486|FG002|COMPLETED|Overall Study||12
3245884|NCT02462148|3979484|FG000|NOT COMPLETED|Overall Study||1
3245885|NCT02462148|3979485|FG001|NOT COMPLETED|Overall Study||0
3245886|NCT02462148|3979486|FG002|NOT COMPLETED|Overall Study||0
3245887|NCT02462291|3979499|FG000|STARTED|Overall Study||82
3245888|NCT02462291|3979500|FG001|STARTED|Overall Study||81
3245889|NCT02462291|3979499|FG000|COMPLETED|Overall Study||77
3245890|NCT02462291|3979500|FG001|COMPLETED|Overall Study||75
3245891|NCT02462291|3979499|FG000|NOT COMPLETED|Overall Study||5
3245892|NCT02462291|3979500|FG001|NOT COMPLETED|Overall Study||6
3245893|NCT02462382|3979510|FG000|STARTED|Overall Study||24
3245894|NCT02462382|3979511|FG001|STARTED|Overall Study||27
3245895|NCT02462382|3979510|FG000|COMPLETED|Overall Study||24
3245896|NCT02462382|3979511|FG001|COMPLETED|Overall Study||27
3245897|NCT02462382|3979510|FG000|NOT COMPLETED|Overall Study||0
3245898|NCT02462382|3979511|FG001|NOT COMPLETED|Overall Study||0
3245899|NCT02462473|3979517|FG000|STARTED|Overall Study||9
3245900|NCT02462473|3979517|FG000|COMPLETED|Overall Study||5
3245901|NCT02462473|3979517|FG000|NOT COMPLETED|Overall Study||4
3245902|NCT02462486|3979524|FG000|STARTED|Overall Study||316
3245903|NCT02462486|3979525|FG001|STARTED|Overall Study||315
3245904|NCT02462486|3979526|FG002|STARTED|Overall Study||318
3245905|NCT02462486|3979524|FG000|COMPLETED|Overall Study||222
3245906|NCT02462486|3979525|FG001|COMPLETED|Overall Study||223
3245907|NCT02462486|3979526|FG002|COMPLETED|Overall Study||266
3245908|NCT02462486|3979524|FG000|NOT COMPLETED|Overall Study||94
3245909|NCT02462486|3979525|FG001|NOT COMPLETED|Overall Study||92
3245910|NCT02462486|3979526|FG002|NOT COMPLETED|Overall Study||52
3245911|NCT02462720|3979534|FG000|STARTED|Part 1||18
3245912|NCT02462720|3979535|FG001|STARTED|Part 1||17
3245913|NCT02462720|3979534|FG000|COMPLETED|Part 1||18
3245914|NCT02462720|3979535|FG001|COMPLETED|Part 1||17
3245915|NCT02462720|3979534|FG000|NOT COMPLETED|Part 1||0
3245916|NCT02462720|3979535|FG001|NOT COMPLETED|Part 1||0
3245917|NCT02462720|3979534|FG000|STARTED|Part 2||18
3245918|NCT02462720|3979535|FG001|STARTED|Part 2||17
3245919|NCT02462720|3979534|FG000|COMPLETED|Part 2||17
3245920|NCT02462720|3979535|FG001|COMPLETED|Part 2||16
3245921|NCT02462720|3979534|FG000|NOT COMPLETED|Part 2||1
3245922|NCT02462720|3979535|FG001|NOT COMPLETED|Part 2||1
3245923|NCT02462759|3979545|FG000|STARTED|Part 1: Double Blind||7
3245924|NCT02462759|3979546|FG001|STARTED|Part 1: Double Blind||14
3245925|NCT02462759|3979547|FG002|STARTED|Part 1: Double Blind||0
3245926|NCT02462759|3979545|FG000|COMPLETED|Part 1: Double Blind||6
3245927|NCT02462759|3979546|FG001|COMPLETED|Part 1: Double Blind||14
3245928|NCT02462759|3979547|FG002|COMPLETED|Part 1: Double Blind||0
3245929|NCT02462759|3979545|FG000|NOT COMPLETED|Part 1: Double Blind||1
3245930|NCT02462759|3979546|FG001|NOT COMPLETED|Part 1: Double Blind||0
3245931|NCT02462759|3979547|FG002|NOT COMPLETED|Part 1: Double Blind||0
3245932|NCT02462759|3979545|FG000|STARTED|Part 2: Open-Label Phase||0
3245933|NCT02462759|3979546|FG001|STARTED|Part 2: Open-Label Phase||0
3245934|NCT02462759|3979547|FG002|STARTED|Part 2: Open-Label Phase||20
3245935|NCT02462759|3979545|FG000|COMPLETED|Part 2: Open-Label Phase||0
3245936|NCT02462759|3979546|FG001|COMPLETED|Part 2: Open-Label Phase||0
3245937|NCT02462759|3979547|FG002|COMPLETED|Part 2: Open-Label Phase||20
3245938|NCT02462759|3979545|FG000|NOT COMPLETED|Part 2: Open-Label Phase||0
3245939|NCT02462759|3979546|FG001|NOT COMPLETED|Part 2: Open-Label Phase||0
3245940|NCT02462759|3979547|FG002|NOT COMPLETED|Part 2: Open-Label Phase||0
3245941|NCT02462928|3979561|FG000|STARTED|Overall Study||314
3245942|NCT02462928|3979562|FG001|STARTED|Overall Study||313
3245943|NCT02462928|3979563|FG002|STARTED|Overall Study||312
3245944|NCT02462928|3979561|FG000|COMPLETED|Overall Study||224
3245945|NCT02462928|3979562|FG001|COMPLETED|Overall Study||221
3245946|NCT02462928|3979563|FG002|COMPLETED|Overall Study||255
3245947|NCT02462928|3979561|FG000|NOT COMPLETED|Overall Study||90
3245948|NCT02462928|3979562|FG001|NOT COMPLETED|Overall Study||92
3245949|NCT02462928|3979563|FG002|NOT COMPLETED|Overall Study||57
3245950|NCT02462967|3979574|FG000|STARTED|Overall Study||54
3245951|NCT02462967|3979575|FG001|STARTED|Overall Study||54
3245952|NCT02462967|3979576|FG002|STARTED|Overall Study||54
3245953|NCT02462967|3979574|FG000|COMPLETED|Overall Study||52
3245954|NCT02462967|3979575|FG001|COMPLETED|Overall Study||48
3245955|NCT02462967|3979576|FG002|COMPLETED|Overall Study||51
3245956|NCT02462967|3979574|FG000|NOT COMPLETED|Overall Study||2
3245957|NCT02462967|3979575|FG001|NOT COMPLETED|Overall Study||6
3245958|NCT02462967|3979576|FG002|NOT COMPLETED|Overall Study||3
3245959|NCT02463032|3979586|FG000|STARTED|Overall Study||72
3245960|NCT02463032|3979587|FG001|STARTED|Overall Study||64
3245961|NCT02463032|3979586|FG000|COMPLETED|Overall Study||1
3245962|NCT02463032|3979587|FG001|COMPLETED|Overall Study||0
3245963|NCT02463032|3979586|FG000|NOT COMPLETED|Overall Study||71
3245964|NCT02463032|3979587|FG001|NOT COMPLETED|Overall Study||64
3245965|NCT02463071|3979596|FG000|STARTED|Overall Study||152
3245966|NCT02463071|3979597|FG001|STARTED|Overall Study||154
3245967|NCT02463071|3979598|FG002|STARTED|Overall Study||77
3245968|NCT02463071|3979596|FG000|COMPLETED|Overall Study||140
3245969|NCT02463071|3979597|FG001|COMPLETED|Overall Study||138
3245970|NCT02463071|3979598|FG002|COMPLETED|Overall Study||71
3245971|NCT02463071|3979596|FG000|NOT COMPLETED|Overall Study||12
3245972|NCT02463071|3979597|FG001|NOT COMPLETED|Overall Study||16
3245973|NCT02463071|3979598|FG002|NOT COMPLETED|Overall Study||6
3245974|NCT02463097|3979606|FG000|STARTED|Overall Study||124
3245975|NCT02463097|3979606|FG000|COMPLETED|Overall Study||123
3245976|NCT02463097|3979606|FG000|NOT COMPLETED|Overall Study||1
3245977|NCT02463227|3979610|FG000|STARTED|Overall Study||14
3245978|NCT02463227|3979610|FG000|COMPLETED|Overall Study||14
3245979|NCT02463227|3979610|FG000|NOT COMPLETED|Overall Study||0
3245980|NCT02463331|3979616|FG000|STARTED|Overall Study||26
3245981|NCT02463331|3979617|FG001|STARTED|Overall Study||31
3245982|NCT02463331|3979616|FG000|COMPLETED|Overall Study||10
3245983|NCT02463331|3979617|FG001|COMPLETED|Overall Study||25
3245984|NCT02463331|3979616|FG000|NOT COMPLETED|Overall Study||16
3245985|NCT02463331|3979617|FG001|NOT COMPLETED|Overall Study||6
3245986|NCT02463357|3979628|FG000|STARTED|Overall Study||20
3245987|NCT02463357|3979629|FG001|STARTED|Overall Study||20
3245988|NCT02463357|3979630|FG002|STARTED|Overall Study||20
3245989|NCT02463357|3979631|FG003|STARTED|Overall Study||19
3245990|NCT02463357|3979632|FG004|STARTED|Overall Study||20
3245991|NCT02463357|3979628|FG000|COMPLETED|Overall Study||19
3245992|NCT02463357|3979629|FG001|COMPLETED|Overall Study||20
3245993|NCT02463357|3979630|FG002|COMPLETED|Overall Study||20
3245994|NCT02463357|3979631|FG003|COMPLETED|Overall Study||19
3245995|NCT02463357|3979632|FG004|COMPLETED|Overall Study||19
3245996|NCT02463357|3979628|FG000|NOT COMPLETED|Overall Study||1
3245997|NCT02463357|3979629|FG001|NOT COMPLETED|Overall Study||0
3245998|NCT02463357|3979630|FG002|NOT COMPLETED|Overall Study||0
3245999|NCT02463357|3979631|FG003|NOT COMPLETED|Overall Study||0
3246000|NCT02463357|3979632|FG004|NOT COMPLETED|Overall Study||1
3246001|NCT02463409|3979644|FG000|STARTED|Overall Study||6
3246002|NCT02463409|3979644|FG000|COMPLETED|Overall Study||4
3246003|NCT02463409|3979644|FG000|NOT COMPLETED|Overall Study||2
3246004|NCT02463487|3979650|FG000|STARTED|Overall Study||75
3246005|NCT02463487|3979651|FG001|STARTED|Overall Study||75
3371043|NCT03751020|4102557|FG001|Post Intervention|Overall Study||33
3371044|NCT03751020|4102558|FG002|Post Intervention|Overall Study||30
3371045|NCT03751020|4102556|FG000|3 Month Follow Up|Overall Study||27
3371046|NCT03751020|4102557|FG001|3 Month Follow Up|Overall Study||32
3371047|NCT03751020|4102558|FG002|3 Month Follow Up|Overall Study||26
3371048|NCT03751020|4102556|FG000|COMPLETED|Overall Study||27
3371049|NCT03751020|4102557|FG001|COMPLETED|Overall Study||32
3371050|NCT03751020|4102558|FG002|COMPLETED|Overall Study||26
3371051|NCT03751020|4102556|FG000|NOT COMPLETED|Overall Study||9
3371052|NCT03751020|4102557|FG001|NOT COMPLETED|Overall Study||4
3371053|NCT03751020|4102558|FG002|NOT COMPLETED|Overall Study||10
3371054|NCT03750955|4102568|FG000|STARTED|Hygiene Phase of 2 Weeks|No intervention during the hygiene phase.|16
3371055|NCT03750955|4102569|FG001|STARTED|Hygiene Phase of 2 Weeks|No intervention during the hygiene phase.|16
3371056|NCT03750955|4102568|FG000|COMPLETED|Hygiene Phase of 2 Weeks||13
3371057|NCT03750955|4102569|FG001|COMPLETED|Hygiene Phase of 2 Weeks||13
3371058|NCT03750955|4102568|FG000|NOT COMPLETED|Hygiene Phase of 2 Weeks||3
3371059|NCT03750955|4102569|FG001|NOT COMPLETED|Hygiene Phase of 2 Weeks||3
3371060|NCT03750955|4102568|FG000|STARTED|Gingivitis Induction Phase of 2 Weeks||13
3371061|NCT03750955|4102569|FG001|STARTED|Gingivitis Induction Phase of 2 Weeks||13
3371062|NCT03750955|4102568|FG000|COMPLETED|Gingivitis Induction Phase of 2 Weeks|6 participants randomized to L maxillary sextant SIBO; 7 randomized to R maxillary sextant SIBO.|13
3371063|NCT03750955|4102569|FG001|COMPLETED|Gingivitis Induction Phase of 2 Weeks|6 randomized to R max. sextant oral hygiene maintenance (OHM); 7 randomized to L max. sextant OHM.|13
3371064|NCT03750955|4102568|FG000|NOT COMPLETED|Gingivitis Induction Phase of 2 Weeks||0
3371065|NCT03750955|4102569|FG001|NOT COMPLETED|Gingivitis Induction Phase of 2 Weeks||0
3371066|NCT03750955|4102568|FG000|STARTED|Resolution Phase of 2 Weeks|No stent in use; oral hygiene resumed.|13
3371067|NCT03750955|4102569|FG001|STARTED|Resolution Phase of 2 Weeks|Oral hygiene maintenance continued.|13
3371068|NCT03750955|4102568|FG000|COMPLETED|Resolution Phase of 2 Weeks||13
3371069|NCT03750955|4102569|FG001|COMPLETED|Resolution Phase of 2 Weeks||13
3371070|NCT03750955|4102568|FG000|NOT COMPLETED|Resolution Phase of 2 Weeks||0
3371071|NCT03750955|4102569|FG001|NOT COMPLETED|Resolution Phase of 2 Weeks||0
3371072|NCT03750695|4102577|FG000|STARTED|Overall Study||8
3371073|NCT03750695|4102578|FG001|STARTED|Overall Study||8
3371074|NCT03750695|4102577|FG000|COMPLETED|Overall Study||8
3371075|NCT03750695|4102578|FG001|COMPLETED|Overall Study||7
3371076|NCT03750695|4102577|FG000|NOT COMPLETED|Overall Study||0
3371077|NCT03750695|4102578|FG001|NOT COMPLETED|Overall Study||1
3371078|NCT03748992|4102589|FG000|STARTED|Overall Study||10
3371079|NCT03748992|4102589|FG000|COMPLETED|Overall Study||10
3371080|NCT03748992|4102589|FG000|NOT COMPLETED|Overall Study||0
3246006|NCT02463487|3979650|FG000|COMPLETED|Overall Study||65
3246007|NCT02463487|3979651|FG001|COMPLETED|Overall Study||65
3246008|NCT02463487|3979650|FG000|NOT COMPLETED|Overall Study||10
3246009|NCT02463487|3979651|FG001|NOT COMPLETED|Overall Study||10
3246010|NCT02463799|3979659|FG000|STARTED|Overall Study||16
3246011|NCT02463799|3979660|FG001|STARTED|Overall Study||16
3246012|NCT02463799|3979659|FG000|COMPLETED|Overall Study||16
3246013|NCT02463799|3979660|FG001|COMPLETED|Overall Study||16
3246014|NCT02463799|3979659|FG000|NOT COMPLETED|Overall Study||0
3246015|NCT02463799|3979660|FG001|NOT COMPLETED|Overall Study||0
3246016|NCT02464033|3979666|FG000|STARTED|Overall Study||20
3246017|NCT02464033|3979666|FG000|COMPLETED|Overall Study||20
3246018|NCT02464033|3979666|FG000|NOT COMPLETED|Overall Study||0
3246019|NCT02464059|3979671|FG000|STARTED|Overall Study||23
3246020|NCT02464059|3979671|FG000|COMPLETED|Overall Study||17
3246021|NCT02464059|3979671|FG000|NOT COMPLETED|Overall Study||6
3246022|NCT02464163|3979679|FG000|STARTED|Overall Study||102
3246023|NCT02464163|3979680|FG001|STARTED|Overall Study||102
3246024|NCT02464163|3979681|FG002|STARTED|Overall Study||102
3246025|NCT02464163|3979682|FG003|STARTED|Overall Study||101
3246026|NCT02464163|3979679|FG000|COMPLETED|Overall Study||99
3246027|NCT02464163|3979680|FG001|COMPLETED|Overall Study||94
3246028|NCT02464163|3979681|FG002|COMPLETED|Overall Study||97
3246029|NCT02464163|3979682|FG003|COMPLETED|Overall Study||96
3246030|NCT02464163|3979679|FG000|NOT COMPLETED|Overall Study||3
3246031|NCT02464163|3979680|FG001|NOT COMPLETED|Overall Study||8
3246032|NCT02464163|3979681|FG002|NOT COMPLETED|Overall Study||5
3246033|NCT02464163|3979682|FG003|NOT COMPLETED|Overall Study||5
3246034|NCT02464176|3979695|FG000|STARTED|Overall Study||50
3246035|NCT02464176|3979696|FG001|STARTED|Overall Study||50
3246036|NCT02464176|3979697|FG002|STARTED|Overall Study||15
3246037|NCT02464176|3979695|FG000|COMPLETED|Overall Study||50
3246038|NCT02464176|3979696|FG001|COMPLETED|Overall Study||50
3246039|NCT02464176|3979697|FG002|COMPLETED|Overall Study||15
3246040|NCT02464176|3979695|FG000|NOT COMPLETED|Overall Study||0
3246041|NCT02464176|3979696|FG001|NOT COMPLETED|Overall Study||0
3246042|NCT02464176|3979697|FG002|NOT COMPLETED|Overall Study||0
3246043|NCT02464449|3979707|FG000|STARTED|Overall Study||166
3246044|NCT02464449|3979708|FG001|STARTED|Overall Study||112
3246045|NCT02464449|3979707|FG000|COMPLETED|Overall Study||151
3246046|NCT02464449|3979708|FG001|COMPLETED|Overall Study||100
3246047|NCT02464449|3979707|FG000|NOT COMPLETED|Overall Study||15
3246048|NCT02464449|3979708|FG001|NOT COMPLETED|Overall Study||12
3246049|NCT02464540|3979714|FG000|STARTED|Overall Study||11
3246050|NCT02464540|3979715|FG001|STARTED|Overall Study||11
3246051|NCT02464540|3979714|FG000|COMPLETED|Overall Study||11
3246052|NCT02464540|3979715|FG001|COMPLETED|Overall Study||11
3246053|NCT02464540|3979714|FG000|NOT COMPLETED|Overall Study||0
3246054|NCT02464540|3979715|FG001|NOT COMPLETED|Overall Study||0
3246055|NCT02464657|3979724|FG000|STARTED|Overall Study||3
3246056|NCT02464657|3979725|FG001|STARTED|Overall Study||2
3246057|NCT02464657|3979726|FG002|STARTED|Overall Study||39
3246058|NCT02464657|3979724|FG000|COMPLETED|Overall Study||3
3246059|NCT02464657|3979725|FG001|COMPLETED|Overall Study||2
3246060|NCT02464657|3979726|FG002|COMPLETED|Overall Study||39
3246061|NCT02464657|3979724|FG000|NOT COMPLETED|Overall Study||0
3246062|NCT02464657|3979725|FG001|NOT COMPLETED|Overall Study||0
3246063|NCT02464657|3979726|FG002|NOT COMPLETED|Overall Study||0
3246064|NCT02464917|3979737|FG000|STARTED|Overall Study||35
3246065|NCT02464917|3979738|FG001|STARTED|Overall Study||35
3246066|NCT02464917|3979737|FG000|COMPLETED|Overall Study||35
3246067|NCT02464917|3979738|FG001|COMPLETED|Overall Study||35
3246068|NCT02464917|3979737|FG000|NOT COMPLETED|Overall Study||0
3246069|NCT02464917|3979738|FG001|NOT COMPLETED|Overall Study||0
3246070|NCT02465034|3979746|FG000|STARTED|Overall Study||19
3246071|NCT02465034|3979747|FG001|STARTED|Overall Study||26
3246072|NCT02465034|3979746|FG000|Started PAS|Overall Study||12
3246073|NCT02465034|3979747|FG001|Started PAS|Overall Study||21
3246074|NCT02465034|3979746|FG000|Completed PAS|Overall Study||9
3246075|NCT02465034|3979747|FG001|Completed PAS|Overall Study||20
3246076|NCT02465034|3979746|FG000|Started CC-PAS|Overall Study||16
3246077|NCT02465034|3979747|FG001|Started CC-PAS|Overall Study||0
3246078|NCT02465034|3979746|FG000|Completed CC-PAS|Overall Study||16
3246079|NCT02465034|3979747|FG001|Completed CC-PAS|Overall Study||0
3246080|NCT02465034|3979746|FG000|COMPLETED|Overall Study||16
3246081|NCT02465034|3979747|FG001|COMPLETED|Overall Study||20
3246082|NCT02465034|3979746|FG000|NOT COMPLETED|Overall Study||3
3246083|NCT02465034|3979747|FG001|NOT COMPLETED|Overall Study||6
3246084|NCT02465073|3979764|FG000|STARTED|Overall Study||17
3246085|NCT02465073|3979765|FG001|STARTED|Overall Study||16
3246086|NCT02465073|3979766|FG002|STARTED|Overall Study||16
3246087|NCT02465073|3979764|FG000|COMPLETED|Overall Study||15
3246088|NCT02465073|3979765|FG001|COMPLETED|Overall Study||15
3246089|NCT02465073|3979766|FG002|COMPLETED|Overall Study||15
3246090|NCT02465073|3979764|FG000|NOT COMPLETED|Overall Study||2
3246091|NCT02465073|3979765|FG001|NOT COMPLETED|Overall Study||1
3246092|NCT02465073|3979766|FG002|NOT COMPLETED|Overall Study||1
3246093|NCT02465099|3979776|FG000|STARTED|Overall Study||45
3246094|NCT02465099|3979777|FG001|STARTED|Overall Study||19
3246095|NCT02465099|3979776|FG000|COMPLETED|Overall Study||45
3246096|NCT02465099|3979777|FG001|COMPLETED|Overall Study||19
3246097|NCT02465099|3979776|FG000|NOT COMPLETED|Overall Study||0
3246098|NCT02465099|3979777|FG001|NOT COMPLETED|Overall Study||0
3246099|NCT02465203|3979786|FG000|STARTED|Overall Study||56
3246100|NCT02465203|3979787|FG001|STARTED|Overall Study||36
3246101|NCT02465203|3979788|FG002|STARTED|Overall Study||13
3246102|NCT02465203|3979786|FG000|COMPLETED|Overall Study||0
3246103|NCT02465203|3979787|FG001|COMPLETED|Overall Study||0
3246104|NCT02465203|3979788|FG002|COMPLETED|Overall Study||0
3246105|NCT02465203|3979786|FG000|NOT COMPLETED|Overall Study||56
3246106|NCT02465203|3979787|FG001|NOT COMPLETED|Overall Study||36
3246107|NCT02465203|3979788|FG002|NOT COMPLETED|Overall Study||13
3246108|NCT02465216|3979800|FG000|STARTED|Overall Study||15
3246109|NCT02465216|3979801|FG001|STARTED|Overall Study||5
3246110|NCT02465216|3979802|FG002|STARTED|Overall Study||14
3246111|NCT02465216|3979803|FG003|STARTED|Overall Study||14
3246112|NCT02465216|3979804|FG004|STARTED|Overall Study||12
3246113|NCT02465216|3979800|FG000|COMPLETED|Overall Study||12
3246114|NCT02465216|3979801|FG001|COMPLETED|Overall Study||5
3246115|NCT02465216|3979802|FG002|COMPLETED|Overall Study||13
3246116|NCT02465216|3979803|FG003|COMPLETED|Overall Study||12
3246117|NCT02465216|3979804|FG004|COMPLETED|Overall Study||9
3246118|NCT02465216|3979800|FG000|NOT COMPLETED|Overall Study||3
3246119|NCT02465216|3979801|FG001|NOT COMPLETED|Overall Study||0
3246120|NCT02465216|3979802|FG002|NOT COMPLETED|Overall Study||1
3246121|NCT02465216|3979803|FG003|NOT COMPLETED|Overall Study||2
3246122|NCT02465216|3979804|FG004|NOT COMPLETED|Overall Study||3
3246123|NCT02465372|3979818|FG000|STARTED|Overall Study||349
3246124|NCT02465372|3979819|FG001|STARTED|Overall Study||250
3246125|NCT02465372|3979818|FG000|COMPLETED|Overall Study||227
3246126|NCT02465372|3979819|FG001|COMPLETED|Overall Study||153
3246127|NCT02465372|3979818|FG000|NOT COMPLETED|Overall Study||122
3246128|NCT02465372|3979819|FG001|NOT COMPLETED|Overall Study||97
3246129|NCT02465437|3979829|FG000|STARTED|Overall Study||9
3246130|NCT02465437|3979830|FG001|STARTED|Overall Study||9
3246131|NCT02465437|3979831|FG002|STARTED|Overall Study||9
3246132|NCT02465437|3979832|FG003|STARTED|Overall Study||15
3246133|NCT02465437|3979829|FG000|COMPLETED|Overall Study||8
3246134|NCT02465437|3979830|FG001|COMPLETED|Overall Study||8
3246135|NCT02465437|3979831|FG002|COMPLETED|Overall Study||8
3246136|NCT02465437|3979832|FG003|COMPLETED|Overall Study||14
3246137|NCT02465437|3979829|FG000|NOT COMPLETED|Overall Study||1
3246138|NCT02465437|3979830|FG001|NOT COMPLETED|Overall Study||1
3246139|NCT02465437|3979831|FG002|NOT COMPLETED|Overall Study||1
3246140|NCT02465437|3979832|FG003|NOT COMPLETED|Overall Study||1
3246141|NCT02465450|3979843|FG000|STARTED|Treatment Period 1||26
3246142|NCT02465450|3979844|FG001|STARTED|Treatment Period 1||24
3246143|NCT02465450|3979845|FG002|STARTED|Treatment Period 1||35
3246144|NCT02465450|3979846|FG003|STARTED|Treatment Period 1||0
3246145|NCT02465450|3979847|FG004|STARTED|Treatment Period 1||0
3246146|NCT02465450|3979848|FG005|STARTED|Treatment Period 1||0
3246147|NCT02465450|3979843|FG000|COMPLETED|Treatment Period 1||24
3246148|NCT02465450|3979844|FG001|COMPLETED|Treatment Period 1||23
3246149|NCT02465450|3979845|FG002|COMPLETED|Treatment Period 1||34
3246150|NCT02465450|3979846|FG003|COMPLETED|Treatment Period 1||0
3246151|NCT02465450|3979847|FG004|COMPLETED|Treatment Period 1||0
3246152|NCT02465450|3979848|FG005|COMPLETED|Treatment Period 1||0
3246153|NCT02465450|3979843|FG000|NOT COMPLETED|Treatment Period 1||2
3246154|NCT02465450|3979844|FG001|NOT COMPLETED|Treatment Period 1||1
3246155|NCT02465450|3979845|FG002|NOT COMPLETED|Treatment Period 1||1
3246156|NCT02465450|3979846|FG003|NOT COMPLETED|Treatment Period 1||0
3246157|NCT02465450|3979847|FG004|NOT COMPLETED|Treatment Period 1||0
3246158|NCT02465450|3979848|FG005|NOT COMPLETED|Treatment Period 1||0
3246159|NCT02465450|3979843|FG000|STARTED|Treatment Period 2||0
3246160|NCT02465450|3979844|FG001|STARTED|Treatment Period 2||0
3246161|NCT02465450|3979845|FG002|STARTED|Treatment Period 2||0
3246162|NCT02465450|3979846|FG003|STARTED|Treatment Period 2||30
3246163|NCT02465450|3979847|FG004|STARTED|Treatment Period 2||28
3246164|NCT02465450|3979848|FG005|STARTED|Treatment Period 2||23
3246165|NCT02465450|3979843|FG000|COMPLETED|Treatment Period 2||0
3246166|NCT02465450|3979844|FG001|COMPLETED|Treatment Period 2||0
3246167|NCT02465450|3979845|FG002|COMPLETED|Treatment Period 2||0
3246168|NCT02465450|3979846|FG003|COMPLETED|Treatment Period 2||27
3246169|NCT02465450|3979847|FG004|COMPLETED|Treatment Period 2||24
3246170|NCT02465450|3979848|FG005|COMPLETED|Treatment Period 2||23
3246171|NCT02465450|3979843|FG000|NOT COMPLETED|Treatment Period 2||0
3246172|NCT02465450|3979844|FG001|NOT COMPLETED|Treatment Period 2||0
3246173|NCT02465450|3979845|FG002|NOT COMPLETED|Treatment Period 2||0
3246174|NCT02465450|3979846|FG003|NOT COMPLETED|Treatment Period 2||3
3246175|NCT02465450|3979847|FG004|NOT COMPLETED|Treatment Period 2||4
3246176|NCT02465450|3979848|FG005|NOT COMPLETED|Treatment Period 2||0
3246177|NCT02465463|3979868|FG000|STARTED|Overall Study||8
3246178|NCT02465463|3979869|FG001|STARTED|Overall Study||5
3246179|NCT02465463|3979868|FG000|COMPLETED|Overall Study||4
3246180|NCT02465463|3979869|FG001|COMPLETED|Overall Study||4
3246181|NCT02465463|3979868|FG000|NOT COMPLETED|Overall Study||4
3246182|NCT02465463|3979869|FG001|NOT COMPLETED|Overall Study||1
3246183|NCT02465489|3979876|FG000|STARTED|Overall Study||20
3246184|NCT02465489|3979876|FG000|COMPLETED|Overall Study||15
3246185|NCT02465489|3979876|FG000|NOT COMPLETED|Overall Study||5
3246186|NCT02465515|3979890|FG000|STARTED|Overall Study||4732
3246187|NCT02465515|3979891|FG001|STARTED|Overall Study||4731
3246188|NCT02465515|3979890|FG000|COMPLETED|Overall Study||4578
3246189|NCT02465515|3979891|FG001|COMPLETED|Overall Study||4620
3246190|NCT02465515|3979890|FG000|NOT COMPLETED|Overall Study||154
3246191|NCT02465515|3979891|FG001|NOT COMPLETED|Overall Study||111
3246192|NCT02465528|3979901|FG000|STARTED|Overall Study||1
3246193|NCT02465528|3979902|FG001|STARTED|Overall Study||4
3246194|NCT02465528|3979903|FG002|STARTED|Overall Study||12
3246195|NCT02465528|3979904|FG003|STARTED|Overall Study||5
3246196|NCT02465528|3979901|FG000|COMPLETED|Overall Study||0
3246197|NCT02465528|3979902|FG001|COMPLETED|Overall Study||0
3246198|NCT02465528|3979903|FG002|COMPLETED|Overall Study||0
3246199|NCT02465528|3979904|FG003|COMPLETED|Overall Study||0
3246200|NCT02465528|3979901|FG000|NOT COMPLETED|Overall Study||1
3246201|NCT02465528|3979902|FG001|NOT COMPLETED|Overall Study||4
3246202|NCT02465528|3979903|FG002|NOT COMPLETED|Overall Study||12
3246203|NCT02465528|3979904|FG003|NOT COMPLETED|Overall Study||5
3246204|NCT02465567|3979920|FG000|STARTED|Overall Study||2157
3246205|NCT02465567|3979921|FG001|STARTED|Overall Study||2137
3246206|NCT02465567|3979922|FG002|STARTED|Overall Study||2143
3246207|NCT02465567|3979923|FG003|STARTED|Overall Study||2151
3246208|NCT02465567|3979920|FG000|COMPLETED|Overall Study||1708
3246209|NCT02465567|3979921|FG001|COMPLETED|Overall Study||1713
3246210|NCT02465567|3979922|FG002|COMPLETED|Overall Study||1580
3246211|NCT02465567|3979923|FG003|COMPLETED|Overall Study||1643
3246212|NCT02465567|3979920|FG000|NOT COMPLETED|Overall Study||449
3246213|NCT02465567|3979921|FG001|NOT COMPLETED|Overall Study||424
3246214|NCT02465567|3979922|FG002|NOT COMPLETED|Overall Study||563
3246215|NCT02465567|3979923|FG003|NOT COMPLETED|Overall Study||508
3246216|NCT02465632|3979936|FG000|STARTED|Overall Study||440
3246217|NCT02465632|3979937|FG001|STARTED|Overall Study||440
3246218|NCT02465632|3979938|FG002|STARTED|Overall Study||220
3246219|NCT02465632|3979936|FG000|COMPLETED|Overall Study||409
3246220|NCT02465632|3979937|FG001|COMPLETED|Overall Study||417
3246221|NCT02465632|3979938|FG002|COMPLETED|Overall Study||203
3246222|NCT02465632|3979936|FG000|NOT COMPLETED|Overall Study||31
3246223|NCT02465632|3979937|FG001|NOT COMPLETED|Overall Study||23
3246224|NCT02465632|3979938|FG002|NOT COMPLETED|Overall Study||17
3246225|NCT02465866|3979947|FG000|STARTED|Period 1||5
3246226|NCT02465866|3979948|FG001|STARTED|Period 1||5
3246227|NCT02465866|3979949|FG002|STARTED|Period 1||5
3246228|NCT02465866|3979950|FG003|STARTED|Period 1||5
3246229|NCT02465866|3979947|FG000|COMPLETED|Period 1||5
3246230|NCT02465866|3979948|FG001|COMPLETED|Period 1||5
3246231|NCT02465866|3979949|FG002|COMPLETED|Period 1||5
3246232|NCT02465866|3979950|FG003|COMPLETED|Period 1||5
3246233|NCT02465866|3979947|FG000|NOT COMPLETED|Period 1||0
3246234|NCT02465866|3979948|FG001|NOT COMPLETED|Period 1||0
3246235|NCT02465866|3979949|FG002|NOT COMPLETED|Period 1||0
3246236|NCT02465866|3979950|FG003|NOT COMPLETED|Period 1||0
3246237|NCT02465866|3979947|FG000|STARTED|Period 1: Washout (14 Days)||5
3246238|NCT02465866|3979948|FG001|STARTED|Period 1: Washout (14 Days)||5
3246239|NCT02465866|3979949|FG002|STARTED|Period 1: Washout (14 Days)||5
3246240|NCT02465866|3979950|FG003|STARTED|Period 1: Washout (14 Days)||5
3246241|NCT02465866|3979947|FG000|COMPLETED|Period 1: Washout (14 Days)||5
3246242|NCT02465866|3979948|FG001|COMPLETED|Period 1: Washout (14 Days)||5
3246243|NCT02465866|3979949|FG002|COMPLETED|Period 1: Washout (14 Days)||5
3246244|NCT02465866|3979950|FG003|COMPLETED|Period 1: Washout (14 Days)||5
3246245|NCT02465866|3979947|FG000|NOT COMPLETED|Period 1: Washout (14 Days)||0
3246246|NCT02465866|3979948|FG001|NOT COMPLETED|Period 1: Washout (14 Days)||0
3246247|NCT02465866|3979949|FG002|NOT COMPLETED|Period 1: Washout (14 Days)||0
3246248|NCT02465866|3979950|FG003|NOT COMPLETED|Period 1: Washout (14 Days)||0
3246249|NCT02465866|3979947|FG000|STARTED|Period 2||5
3246250|NCT02465866|3979948|FG001|STARTED|Period 2||5
3246251|NCT02465866|3979949|FG002|STARTED|Period 2||5
3246252|NCT02465866|3979950|FG003|STARTED|Period 2||5
3246253|NCT02465866|3979947|FG000|COMPLETED|Period 2||5
3246254|NCT02465866|3979948|FG001|COMPLETED|Period 2||5
3246255|NCT02465866|3979949|FG002|COMPLETED|Period 2||5
3246256|NCT02465866|3979950|FG003|COMPLETED|Period 2||5
3246257|NCT02465866|3979947|FG000|NOT COMPLETED|Period 2||0
3246258|NCT02465866|3979948|FG001|NOT COMPLETED|Period 2||0
3246259|NCT02465866|3979949|FG002|NOT COMPLETED|Period 2||0
3246260|NCT02465866|3979950|FG003|NOT COMPLETED|Period 2||0
3246261|NCT02465866|3979947|FG000|STARTED|Period 2: Washout (14 Days)||5
3246262|NCT02465866|3979948|FG001|STARTED|Period 2: Washout (14 Days)||5
3246263|NCT02465866|3979949|FG002|STARTED|Period 2: Washout (14 Days)||5
3246264|NCT02465866|3979950|FG003|STARTED|Period 2: Washout (14 Days)||5
3246265|NCT02465866|3979947|FG000|COMPLETED|Period 2: Washout (14 Days)||5
3246266|NCT02465866|3979948|FG001|COMPLETED|Period 2: Washout (14 Days)||5
3246267|NCT02465866|3979949|FG002|COMPLETED|Period 2: Washout (14 Days)||5
3246268|NCT02465866|3979950|FG003|COMPLETED|Period 2: Washout (14 Days)||5
3246269|NCT02465866|3979947|FG000|NOT COMPLETED|Period 2: Washout (14 Days)||0
3246270|NCT02465866|3979948|FG001|NOT COMPLETED|Period 2: Washout (14 Days)||0
3246271|NCT02465866|3979949|FG002|NOT COMPLETED|Period 2: Washout (14 Days)||0
3246272|NCT02465866|3979950|FG003|NOT COMPLETED|Period 2: Washout (14 Days)||0
3246273|NCT02465866|3979947|FG000|STARTED|Period 3||5
3246274|NCT02465866|3979948|FG001|STARTED|Period 3||5
3246275|NCT02465866|3979949|FG002|STARTED|Period 3||5
3246276|NCT02465866|3979950|FG003|STARTED|Period 3||5
3246277|NCT02465866|3979947|FG000|COMPLETED|Period 3||5
3246278|NCT02465866|3979948|FG001|COMPLETED|Period 3||4
3246279|NCT02465866|3979949|FG002|COMPLETED|Period 3||5
3246280|NCT02465866|3979950|FG003|COMPLETED|Period 3||5
3246281|NCT02465866|3979947|FG000|NOT COMPLETED|Period 3||0
3246282|NCT02465866|3979948|FG001|NOT COMPLETED|Period 3||1
3246283|NCT02465866|3979949|FG002|NOT COMPLETED|Period 3||0
3246284|NCT02465866|3979950|FG003|NOT COMPLETED|Period 3||0
3246285|NCT02465866|3979947|FG000|STARTED|Period 3: Washout (14 Days)||5
3246286|NCT02465866|3979948|FG001|STARTED|Period 3: Washout (14 Days)||4
3246287|NCT02465866|3979949|FG002|STARTED|Period 3: Washout (14 Days)||5
3246288|NCT02465866|3979950|FG003|STARTED|Period 3: Washout (14 Days)||5
3246289|NCT02465866|3979947|FG000|COMPLETED|Period 3: Washout (14 Days)||5
3246290|NCT02465866|3979948|FG001|COMPLETED|Period 3: Washout (14 Days)||4
3246291|NCT02465866|3979949|FG002|COMPLETED|Period 3: Washout (14 Days)||5
3246292|NCT02465866|3979950|FG003|COMPLETED|Period 3: Washout (14 Days)||5
3246293|NCT02465866|3979947|FG000|NOT COMPLETED|Period 3: Washout (14 Days)||0
3246294|NCT02465866|3979948|FG001|NOT COMPLETED|Period 3: Washout (14 Days)||0
3246295|NCT02465866|3979949|FG002|NOT COMPLETED|Period 3: Washout (14 Days)||0
3246296|NCT02465866|3979950|FG003|NOT COMPLETED|Period 3: Washout (14 Days)||0
3246297|NCT02465866|3979947|FG000|STARTED|Period 4||5
3246298|NCT02465866|3979948|FG001|STARTED|Period 4||4
3246299|NCT02465866|3979949|FG002|STARTED|Period 4||5
3246300|NCT02465866|3979950|FG003|STARTED|Period 4||5
3246301|NCT02465866|3979947|FG000|COMPLETED|Period 4||5
3246302|NCT02465866|3979948|FG001|COMPLETED|Period 4||4
3246303|NCT02465866|3979949|FG002|COMPLETED|Period 4||5
3246304|NCT02465866|3979950|FG003|COMPLETED|Period 4||5
3246305|NCT02465866|3979947|FG000|NOT COMPLETED|Period 4||0
3246306|NCT02465866|3979948|FG001|NOT COMPLETED|Period 4||0
3246307|NCT02465866|3979949|FG002|NOT COMPLETED|Period 4||0
3246308|NCT02465866|3979950|FG003|NOT COMPLETED|Period 4||0
3246309|NCT02465866|3979947|FG000|STARTED|Period 4: Washout (14 Days)||5
3246310|NCT02465866|3979948|FG001|STARTED|Period 4: Washout (14 Days)||4
3246311|NCT02465866|3979949|FG002|STARTED|Period 4: Washout (14 Days)||5
3246312|NCT02465866|3979950|FG003|STARTED|Period 4: Washout (14 Days)||5
3246313|NCT02465866|3979947|FG000|COMPLETED|Period 4: Washout (14 Days)||5
3246314|NCT02465866|3979948|FG001|COMPLETED|Period 4: Washout (14 Days)||4
3246315|NCT02465866|3979949|FG002|COMPLETED|Period 4: Washout (14 Days)||5
3246316|NCT02465866|3979950|FG003|COMPLETED|Period 4: Washout (14 Days)||5
3246317|NCT02465866|3979947|FG000|NOT COMPLETED|Period 4: Washout (14 Days)||0
3246318|NCT02465866|3979948|FG001|NOT COMPLETED|Period 4: Washout (14 Days)||0
3246319|NCT02465866|3979949|FG002|NOT COMPLETED|Period 4: Washout (14 Days)||0
3246320|NCT02465866|3979950|FG003|NOT COMPLETED|Period 4: Washout (14 Days)||0
3246321|NCT02465931|3979962|FG000|STARTED|Overall Study||55
3246322|NCT02465931|3979963|FG001|STARTED|Overall Study||56
3246323|NCT02465931|3979962|FG000|COMPLETED|Overall Study||44
3246324|NCT02465931|3979963|FG001|COMPLETED|Overall Study||45
3246325|NCT02465931|3979962|FG000|NOT COMPLETED|Overall Study||11
3246326|NCT02465931|3979963|FG001|NOT COMPLETED|Overall Study||11
3246327|NCT02466009|3979969|FG000|STARTED|Overall Study||27
3246328|NCT02466009|3979969|FG000|COMPLETED|Overall Study||27
3246329|NCT02466009|3979969|FG000|NOT COMPLETED|Overall Study||0
3246330|NCT02466087|3979973|FG000|STARTED|First Intervention: Weeks 1-6||62
3246331|NCT02466087|3979974|FG001|STARTED|First Intervention: Weeks 1-6||64
3246332|NCT02466087|3979973|FG000|COMPLETED|First Intervention: Weeks 1-6||55
3246333|NCT02466087|3979974|FG001|COMPLETED|First Intervention: Weeks 1-6||57
3246334|NCT02466087|3979973|FG000|NOT COMPLETED|First Intervention: Weeks 1-6||7
3246335|NCT02466087|3979974|FG001|NOT COMPLETED|First Intervention: Weeks 1-6||7
3246336|NCT02466087|3979973|FG000|STARTED|Second Intervention: Weeks 7-12||55
3246337|NCT02466087|3979974|FG001|STARTED|Second Intervention: Weeks 7-12||57
3246338|NCT02466087|3979973|FG000|COMPLETED|Second Intervention: Weeks 7-12||55
3246339|NCT02466087|3979974|FG001|COMPLETED|Second Intervention: Weeks 7-12||57
3246340|NCT02466087|3979973|FG000|NOT COMPLETED|Second Intervention: Weeks 7-12||0
3246341|NCT02466087|3979974|FG001|NOT COMPLETED|Second Intervention: Weeks 7-12||0
3246342|NCT02466126|3979983|FG000|STARTED|Baseline||109
3246343|NCT02466126|3979984|FG001|STARTED|Baseline||80
3246344|NCT02466126|3979983|FG000|COMPLETED|Baseline||109
3246345|NCT02466126|3979984|FG001|COMPLETED|Baseline||80
3246346|NCT02466126|3979983|FG000|NOT COMPLETED|Baseline||0
3246347|NCT02466126|3979984|FG001|NOT COMPLETED|Baseline||0
3246348|NCT02466126|3979983|FG000|STARTED|4 Month Assessment||109
3246349|NCT02466126|3979984|FG001|STARTED|4 Month Assessment||80
3246350|NCT02466126|3979983|FG000|COMPLETED|4 Month Assessment||93
3246351|NCT02466126|3979984|FG001|COMPLETED|4 Month Assessment||71
3246352|NCT02466126|3979983|FG000|NOT COMPLETED|4 Month Assessment||16
3246353|NCT02466126|3979984|FG001|NOT COMPLETED|4 Month Assessment||9
3246354|NCT02466126|3979983|FG000|STARTED|8 Month Assessment||93
3246355|NCT02466126|3979984|FG001|STARTED|8 Month Assessment||71
3246356|NCT02466126|3979983|FG000|COMPLETED|8 Month Assessment||86
3246357|NCT02466126|3979984|FG001|COMPLETED|8 Month Assessment||68
3246358|NCT02466126|3979983|FG000|NOT COMPLETED|8 Month Assessment||7
3246359|NCT02466126|3979984|FG001|NOT COMPLETED|8 Month Assessment||3
3246360|NCT02466126|3979983|FG000|STARTED|12 Month Assessment||86
3246361|NCT02466126|3979984|FG001|STARTED|12 Month Assessment||68
3246362|NCT02466126|3979983|FG000|COMPLETED|12 Month Assessment||85
3246363|NCT02466126|3979984|FG001|COMPLETED|12 Month Assessment||66
3246364|NCT02466126|3979983|FG000|NOT COMPLETED|12 Month Assessment||1
3246365|NCT02466126|3979984|FG001|NOT COMPLETED|12 Month Assessment||2
3246366|NCT02466230|3979990|FG000|STARTED|Overall Study||28
3246367|NCT02466230|3979990|FG000|COMPLETED|Overall Study||28
3246368|NCT02466230|3979990|FG000|NOT COMPLETED|Overall Study||0
3246369|NCT02466386|3979994|FG000|STARTED|Overall Study||113
3246370|NCT02466386|3979994|FG000|COMPLETED|Overall Study||69
3246371|NCT02466386|3979994|FG000|NOT COMPLETED|Overall Study||44
3246372|NCT02466399|3980000|FG000|STARTED|Overall Study||53
3246373|NCT02466399|3980001|FG001|STARTED|Overall Study||27
3246374|NCT02466399|3980000|FG000|COMPLETED|Overall Study||51
3246375|NCT02466399|3980001|FG001|COMPLETED|Overall Study||27
3246376|NCT02466399|3980000|FG000|NOT COMPLETED|Overall Study||2
3246377|NCT02466399|3980001|FG001|NOT COMPLETED|Overall Study||0
3246378|NCT02466412|3980009|FG000|STARTED|Washout Period of 1 Day (Day -1)||24
3246379|NCT02466412|3980010|FG001|STARTED|Washout Period of 1 Day (Day -1)||24
3246380|NCT02466412|3980009|FG000|COMPLETED|Washout Period of 1 Day (Day -1)||24
3246381|NCT02466412|3980010|FG001|COMPLETED|Washout Period of 1 Day (Day -1)||24
3246382|NCT02466412|3980009|FG000|NOT COMPLETED|Washout Period of 1 Day (Day -1)||0
3246383|NCT02466412|3980010|FG001|NOT COMPLETED|Washout Period of 1 Day (Day -1)||0
3246384|NCT02466412|3980009|FG000|STARTED|First Intervention (Day 1)||24
3246385|NCT02466412|3980010|FG001|STARTED|First Intervention (Day 1)||24
3246386|NCT02466412|3980009|FG000|COMPLETED|First Intervention (Day 1)||24
3246387|NCT02466412|3980010|FG001|COMPLETED|First Intervention (Day 1)||24
3246388|NCT02466412|3980009|FG000|NOT COMPLETED|First Intervention (Day 1)||0
3246389|NCT02466412|3980010|FG001|NOT COMPLETED|First Intervention (Day 1)||0
3246390|NCT02466412|3980009|FG000|STARTED|Washout Period of 1 Day (Day 2)||24
3246391|NCT02466412|3980010|FG001|STARTED|Washout Period of 1 Day (Day 2)||24
3246392|NCT02466412|3980009|FG000|COMPLETED|Washout Period of 1 Day (Day 2)||24
3246393|NCT02466412|3980010|FG001|COMPLETED|Washout Period of 1 Day (Day 2)||24
3246394|NCT02466412|3980009|FG000|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
3246395|NCT02466412|3980010|FG001|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
3246396|NCT02466412|3980009|FG000|STARTED|Second Intervention (Day 3)||24
3246397|NCT02466412|3980010|FG001|STARTED|Second Intervention (Day 3)||24
3246398|NCT02466412|3980009|FG000|COMPLETED|Second Intervention (Day 3)||24
3246399|NCT02466412|3980010|FG001|COMPLETED|Second Intervention (Day 3)||24
3246400|NCT02466412|3980009|FG000|NOT COMPLETED|Second Intervention (Day 3)||0
3246401|NCT02466412|3980010|FG001|NOT COMPLETED|Second Intervention (Day 3)||0
3246402|NCT02466425|3980019|FG000|STARTED|Overall Study||132
3246403|NCT02466425|3980020|FG001|STARTED|Overall Study||132
3246404|NCT02466425|3980019|FG000|Treated|Overall Study||131
3246405|NCT02466425|3980020|FG001|Treated|Overall Study||132
3246406|NCT02466425|3980019|FG000|COMPLETED|Overall Study||118
3246407|NCT02466425|3980020|FG001|COMPLETED|Overall Study||116
3246408|NCT02466425|3980019|FG000|NOT COMPLETED|Overall Study||14
3246409|NCT02466425|3980020|FG001|NOT COMPLETED|Overall Study||16
3246410|NCT02466516|3980031|FG000|STARTED|Overall Study||20
3246411|NCT02466516|3980032|FG001|STARTED|Overall Study||22
3246412|NCT02466516|3980033|FG002|STARTED|Overall Study||10
3246413|NCT02466516|3980034|FG003|STARTED|Overall Study||10
3246414|NCT02466516|3980035|FG004|STARTED|Overall Study||10
3246415|NCT02466516|3980031|FG000|COMPLETED|Overall Study||16
3246416|NCT02466516|3980032|FG001|COMPLETED|Overall Study||21
3246417|NCT02466516|3980033|FG002|COMPLETED|Overall Study||9
3246418|NCT02466516|3980034|FG003|COMPLETED|Overall Study||10
3246419|NCT02466516|3980035|FG004|COMPLETED|Overall Study||10
3246420|NCT02466516|3980031|FG000|NOT COMPLETED|Overall Study||4
3246421|NCT02466516|3980032|FG001|NOT COMPLETED|Overall Study||1
3246422|NCT02466516|3980033|FG002|NOT COMPLETED|Overall Study||1
3246423|NCT02466516|3980034|FG003|NOT COMPLETED|Overall Study||0
3246424|NCT02466516|3980035|FG004|NOT COMPLETED|Overall Study||0
3246425|NCT02466555|3980047|FG000|STARTED|Overall Study||30
3246426|NCT02466555|3980047|FG000|COMPLETED|Overall Study||28
3246427|NCT02466555|3980047|FG000|NOT COMPLETED|Overall Study||2
3246428|NCT02466646|3980055|FG000|STARTED|Overall Study||14
3246429|NCT02466646|3980056|FG001|STARTED|Overall Study||14
3246430|NCT02466646|3980057|FG002|STARTED|Overall Study||14
3246431|NCT02466646|3980055|FG000|COMPLETED|Overall Study||14
3246432|NCT02466646|3980056|FG001|COMPLETED|Overall Study||14
3246433|NCT02466646|3980057|FG002|COMPLETED|Overall Study||14
3246434|NCT02466646|3980055|FG000|NOT COMPLETED|Overall Study||0
3246435|NCT02466646|3980056|FG001|NOT COMPLETED|Overall Study||0
3246436|NCT02466646|3980057|FG002|NOT COMPLETED|Overall Study||0
3246437|NCT02466659|3980070|FG000|STARTED|Overall Study||5
3246438|NCT02466659|3980071|FG001|STARTED|Overall Study||3
3246439|NCT02466659|3980070|FG000|COMPLETED|Overall Study||0
3246440|NCT02466659|3980071|FG001|COMPLETED|Overall Study||1
3246441|NCT02466659|3980070|FG000|NOT COMPLETED|Overall Study||5
3246442|NCT02466659|3980071|FG001|NOT COMPLETED|Overall Study||2
3246443|NCT02466958|3980079|FG000|STARTED|Overall Study||17
3246444|NCT02466958|3980080|FG001|STARTED|Overall Study||12
3246445|NCT02466958|3980079|FG000|COMPLETED|Overall Study||7
3246446|NCT02466958|3980080|FG001|COMPLETED|Overall Study||9
3246447|NCT02466958|3980079|FG000|NOT COMPLETED|Overall Study||10
3246448|NCT02466958|3980080|FG001|NOT COMPLETED|Overall Study||3
3246449|NCT02467075|3980088|FG000|STARTED|Initial CT Scan||0
3246450|NCT02467075|3980089|FG001|STARTED|Initial CT Scan||1
3246451|NCT02467075|3980088|FG000|COMPLETED|Initial CT Scan||0
3246452|NCT02467075|3980089|FG001|COMPLETED|Initial CT Scan||1
3246453|NCT02467075|3980088|FG000|NOT COMPLETED|Initial CT Scan||0
3246454|NCT02467075|3980089|FG001|NOT COMPLETED|Initial CT Scan||0
3246455|NCT02467075|3980088|FG000|STARTED|48 Hour Follow-up||0
3246456|NCT02467075|3980089|FG001|STARTED|48 Hour Follow-up||1
3246457|NCT02467075|3980088|FG000|COMPLETED|48 Hour Follow-up||0
3246458|NCT02467075|3980089|FG001|COMPLETED|48 Hour Follow-up||1
3246459|NCT02467075|3980088|FG000|NOT COMPLETED|48 Hour Follow-up||0
3246460|NCT02467075|3980089|FG001|NOT COMPLETED|48 Hour Follow-up||0
3246461|NCT02467075|3980088|FG000|STARTED|72 Hour Follow-up||0
3246462|NCT02467075|3980089|FG001|STARTED|72 Hour Follow-up||1
3246463|NCT02467075|3980088|FG000|COMPLETED|72 Hour Follow-up||0
3246464|NCT02467075|3980089|FG001|COMPLETED|72 Hour Follow-up||1
3246465|NCT02467075|3980088|FG000|NOT COMPLETED|72 Hour Follow-up||0
3246466|NCT02467075|3980089|FG001|NOT COMPLETED|72 Hour Follow-up||0
3246467|NCT02467075|3980088|FG000|STARTED|30 Day Follow-up||0
3246468|NCT02467075|3980089|FG001|STARTED|30 Day Follow-up||1
3246469|NCT02467075|3980088|FG000|COMPLETED|30 Day Follow-up||0
3246470|NCT02467075|3980089|FG001|COMPLETED|30 Day Follow-up||1
3246471|NCT02467075|3980088|FG000|NOT COMPLETED|30 Day Follow-up||0
3246472|NCT02467075|3980089|FG001|NOT COMPLETED|30 Day Follow-up||0
3246473|NCT02467166|3980097|FG000|STARTED|Overall Study||36
3246474|NCT02467166|3980097|FG000|COMPLETED|Overall Study||36
3246475|NCT02467166|3980097|FG000|NOT COMPLETED|Overall Study||0
3246476|NCT02467179|3980103|FG000|STARTED|Overall Study||25
3246477|NCT02467179|3980104|FG001|STARTED|Overall Study||25
3246478|NCT02467179|3980103|FG000|COMPLETED|Overall Study||25
3246479|NCT02467179|3980104|FG001|COMPLETED|Overall Study||25
3246480|NCT02467179|3980103|FG000|NOT COMPLETED|Overall Study||0
3246481|NCT02467179|3980104|FG001|NOT COMPLETED|Overall Study||0
3246482|NCT02467192|3980110|FG000|STARTED|Overall Study||203
3246483|NCT02467192|3980110|FG000|COMPLETED|Overall Study||200
3246484|NCT02467192|3980110|FG000|NOT COMPLETED|Overall Study||3
3246485|NCT02467387|3980118|FG000|STARTED|First Intervention||11
3246486|NCT02467387|3980119|FG001|STARTED|First Intervention||12
3246487|NCT02467387|3980118|FG000|Received Treatment as Randomized|First Intervention||10
3246488|NCT02467387|3980119|FG001|Received Treatment as Randomized|First Intervention||12
3246489|NCT02467387|3980118|FG000|COMPLETED|First Intervention||10
3246490|NCT02467387|3980119|FG001|COMPLETED|First Intervention||12
3246491|NCT02467387|3980118|FG000|NOT COMPLETED|First Intervention||1
3246492|NCT02467387|3980119|FG001|NOT COMPLETED|First Intervention||0
3246493|NCT02467387|3980118|FG000|STARTED|Second Intervention||10
3246494|NCT02467387|3980119|FG001|STARTED|Second Intervention||12
3246495|NCT02467387|3980118|FG000|COMPLETED|Second Intervention||7
3246496|NCT02467387|3980119|FG001|COMPLETED|Second Intervention||12
3246497|NCT02467387|3980118|FG000|NOT COMPLETED|Second Intervention||3
3371081|NCT03748979|4102604|FG000|STARTED|Overall Study||6
3371082|NCT03748979|4102605|FG001|STARTED|Overall Study||6
3371083|NCT03748979|4102606|FG002|STARTED|Overall Study||6
3371084|NCT03748979|4102607|FG003|STARTED|Overall Study||6
3371085|NCT03748979|4102608|FG004|STARTED|Overall Study||4
3371086|NCT03748979|4102609|FG005|STARTED|Overall Study||4
3371087|NCT03748979|4102610|FG006|STARTED|Overall Study||5
3371088|NCT03748979|4102611|FG007|STARTED|Overall Study||5
3246498|NCT02467387|3980119|FG001|NOT COMPLETED|Second Intervention||0
3246499|NCT02467465|3980129|FG000|STARTED|Overall Study||15
3246500|NCT02467465|3980130|FG001|STARTED|Overall Study||15
3246501|NCT02467465|3980129|FG000|COMPLETED|Overall Study||15
3246502|NCT02467465|3980130|FG001|COMPLETED|Overall Study||15
3246503|NCT02467465|3980129|FG000|NOT COMPLETED|Overall Study||0
3246504|NCT02467465|3980130|FG001|NOT COMPLETED|Overall Study||0
3246505|NCT02467491|3980138|FG000|STARTED|Overall Study||12
3246506|NCT02467491|3980138|FG000|COMPLETED|Overall Study||12
3246507|NCT02467491|3980138|FG000|NOT COMPLETED|Overall Study||0
3246508|NCT02467504|3980144|FG000|STARTED|Overall Study||23
3246509|NCT02467504|3980145|FG001|STARTED|Overall Study||24
3246510|NCT02467504|3980144|FG000|COMPLETED|Overall Study||17
3246511|NCT02467504|3980145|FG001|COMPLETED|Overall Study||23
3246512|NCT02467504|3980144|FG000|NOT COMPLETED|Overall Study||6
3246513|NCT02467504|3980145|FG001|NOT COMPLETED|Overall Study||1
3246514|NCT02467621|3980153|FG000|STARTED|Overall Study||1645
3246515|NCT02467621|3980154|FG001|STARTED|Overall Study||1653
3246516|NCT02467621|3980153|FG000|COMPLETED|Overall Study||1644
3246517|NCT02467621|3980154|FG001|COMPLETED|Overall Study||1647
3246518|NCT02467621|3980153|FG000|NOT COMPLETED|Overall Study||1
3246519|NCT02467621|3980154|FG001|NOT COMPLETED|Overall Study||6
3246520|NCT02467777|3980162|FG000|STARTED|Overall Study||23
3246521|NCT02467777|3980163|FG001|STARTED|Overall Study||27
3246522|NCT02467777|3980162|FG000|COMPLETED|Overall Study||23
3246523|NCT02467777|3980163|FG001|COMPLETED|Overall Study||27
3246524|NCT02467777|3980162|FG000|NOT COMPLETED|Overall Study||0
3246525|NCT02467777|3980163|FG001|NOT COMPLETED|Overall Study||0
3246526|NCT02467842|3980172|FG000|STARTED|Overall Study||752
3246527|NCT02467842|3980173|FG001|STARTED|Overall Study||373
3246528|NCT02467842|3980174|FG002|STARTED|Overall Study||378
3246529|NCT02467842|3980172|FG000|COMPLETED|Overall Study||752
3246530|NCT02467842|3980173|FG001|COMPLETED|Overall Study||373
3246531|NCT02467842|3980174|FG002|COMPLETED|Overall Study||378
3246532|NCT02467842|3980172|FG000|NOT COMPLETED|Overall Study||0
3246533|NCT02467842|3980173|FG001|NOT COMPLETED|Overall Study||0
3246534|NCT02467842|3980174|FG002|NOT COMPLETED|Overall Study||0
3246535|NCT02468154|3980186|FG000|STARTED|Overall Study||29
3371089|NCT03748979|4102612|FG008|STARTED|Overall Study||4
3371090|NCT03748979|4102613|FG009|STARTED|Overall Study||5
3246536|NCT02468154|3980187|FG001|STARTED|Overall Study||28
3246537|NCT02468154|3980186|FG000|COMPLETED|Overall Study||29
3246538|NCT02468154|3980187|FG001|COMPLETED|Overall Study||28
3246539|NCT02468154|3980186|FG000|NOT COMPLETED|Overall Study||0
3246540|NCT02468154|3980187|FG001|NOT COMPLETED|Overall Study||0
3246541|NCT02468193|3980193|FG000|STARTED|Overall Study||9
3246542|NCT02468193|3980193|FG000|Completed Week-12 (Study Period I)|Overall Study||7
3246543|NCT02468193|3980193|FG000|Discontinued at or Prior to Week-12|Overall Study||2
3246544|NCT02468193|3980193|FG000|Completed Week-12, Did Not Enter Per. II|Overall Study||3
3246545|NCT02468193|3980193|FG000|Completed Week-12, Entered Study Per. II|Overall Study||4
3246546|NCT02468193|3980193|FG000|Completed Week-48 (Study Period II)|Overall Study||2
3246547|NCT02468193|3980193|FG000|Discontinued at or Prior to Week48|Overall Study||2
3246548|NCT02468193|3980193|FG000|Compl. Wk-48, Didn't Enter Opt. Ext. Per|Overall Study||0
3246549|NCT02468193|3980193|FG000|Compl. Wk-48, Entered Opt. Ext. Period|Overall Study||2
3246550|NCT02468193|3980193|FG000|Completed Optional Extension Period|Overall Study||0
3246551|NCT02468193|3980193|FG000|Discontinued Study in Optional Ext. Per.|Overall Study||2
3246552|NCT02468193|3980193|FG000|COMPLETED|Overall Study||3
3246553|NCT02468193|3980193|FG000|NOT COMPLETED|Overall Study||6
3246554|NCT02468414|3980215|FG000|STARTED|Overall Study||3
3246555|NCT02468414|3980216|FG001|STARTED|Overall Study||0
3246556|NCT02468414|3980215|FG000|Successfully Screened|Overall Study||2
3246557|NCT02468414|3980216|FG001|Successfully Screened|Overall Study||0
3246558|NCT02468414|3980215|FG000|Harvesting|Overall Study||1
3246559|NCT02468414|3980216|FG001|Harvesting|Overall Study||0
3246560|NCT02468414|3980215|FG000|Implantation|Overall Study||1
3246561|NCT02468414|3980216|FG001|Implantation|Overall Study||0
3246562|NCT02468414|3980215|FG000|Safety Follow-up|Overall Study||0
3246563|NCT02468414|3980216|FG001|Safety Follow-up|Overall Study||0
3246564|NCT02468414|3980215|FG000|COMPLETED|Overall Study||0
3246565|NCT02468414|3980216|FG001|COMPLETED|Overall Study||0
3246566|NCT02468414|3980215|FG000|NOT COMPLETED|Overall Study||3
3246567|NCT02468414|3980216|FG001|NOT COMPLETED|Overall Study||0
3246568|NCT02468557|3980222|FG000|STARTED|Overall Study||16
3246569|NCT02468557|3980222|FG000|COMPLETED|Overall Study||0
3246570|NCT02468557|3980222|FG000|NOT COMPLETED|Overall Study||16
3246571|NCT02468570|3980232|FG000|STARTED|Overall Study||6
3246572|NCT02468570|3980233|FG001|STARTED|Overall Study||3
3246573|NCT02468570|3980232|FG000|COMPLETED|Overall Study||6
3246574|NCT02468570|3980233|FG001|COMPLETED|Overall Study||3
3371091|NCT03748979|4102614|FG010|STARTED|Overall Study||6
3371092|NCT03748979|4102604|FG000|COMPLETED|Overall Study||6
3371093|NCT03748979|4102605|FG001|COMPLETED|Overall Study||6
3371094|NCT03748979|4102606|FG002|COMPLETED|Overall Study||6
3371095|NCT03748979|4102607|FG003|COMPLETED|Overall Study||6
3371096|NCT03748979|4102608|FG004|COMPLETED|Overall Study||4
3371097|NCT03748979|4102609|FG005|COMPLETED|Overall Study||4
3371098|NCT03748979|4102610|FG006|COMPLETED|Overall Study||5
3371099|NCT03748979|4102611|FG007|COMPLETED|Overall Study||5
3371100|NCT03748979|4102612|FG008|COMPLETED|Overall Study||4
3371101|NCT03748979|4102613|FG009|COMPLETED|Overall Study||5
3371102|NCT03748979|4102614|FG010|COMPLETED|Overall Study||6
3371103|NCT03748979|4102604|FG000|NOT COMPLETED|Overall Study||0
3371104|NCT03748979|4102605|FG001|NOT COMPLETED|Overall Study||0
3371105|NCT03748979|4102606|FG002|NOT COMPLETED|Overall Study||0
3371106|NCT03748979|4102607|FG003|NOT COMPLETED|Overall Study||0
3371107|NCT03748979|4102608|FG004|NOT COMPLETED|Overall Study||0
3371108|NCT03748979|4102609|FG005|NOT COMPLETED|Overall Study||0
3371109|NCT03748979|4102610|FG006|NOT COMPLETED|Overall Study||0
3371110|NCT03748979|4102611|FG007|NOT COMPLETED|Overall Study||0
3371111|NCT03748979|4102612|FG008|NOT COMPLETED|Overall Study||0
3371112|NCT03748979|4102613|FG009|NOT COMPLETED|Overall Study||0
3371113|NCT03748979|4102614|FG010|NOT COMPLETED|Overall Study||0
3371114|NCT03748758|4102654|FG000|STARTED|Overall Study||12
3371115|NCT03748758|4102655|FG001|STARTED|Overall Study||12
3371116|NCT03748758|4102656|FG002|STARTED|Overall Study||6
3371117|NCT03748758|4102654|FG000|COMPLETED|Overall Study||12
3371118|NCT03748758|4102655|FG001|COMPLETED|Overall Study||12
3371119|NCT03748758|4102656|FG002|COMPLETED|Overall Study||5
3371120|NCT03748758|4102654|FG000|NOT COMPLETED|Overall Study||0
3371121|NCT03748758|4102655|FG001|NOT COMPLETED|Overall Study||0
3371122|NCT03748758|4102656|FG002|NOT COMPLETED|Overall Study||1
3371123|NCT03748706|4102686|FG000|STARTED|Overall Study||13
3371124|NCT03748706|4102686|FG000|COMPLETED|Overall Study||12
3371125|NCT03748706|4102686|FG000|NOT COMPLETED|Overall Study||1
3371126|NCT03748264|4102693|FG000|STARTED|Overall Study||21
3371127|NCT03748264|4102694|FG001|STARTED|Overall Study||21
3371128|NCT03748264|4102695|FG002|STARTED|Overall Study||20
3371129|NCT03748264|4102693|FG000|COMPLETED|Overall Study||21
3371130|NCT03748264|4102694|FG001|COMPLETED|Overall Study||21
3371131|NCT03748264|4102695|FG002|COMPLETED|Overall Study||20
3371132|NCT03748264|4102693|FG000|NOT COMPLETED|Overall Study||0
3371133|NCT03748264|4102694|FG001|NOT COMPLETED|Overall Study||0
3371134|NCT03748264|4102695|FG002|NOT COMPLETED|Overall Study||0
3371135|NCT03747497|4102705|FG000|STARTED|Overall Study||131
3371136|NCT03747497|4102706|FG001|STARTED|Overall Study||65
3371137|NCT03747497|4102705|FG000|COMPLETED|Overall Study||106
3371138|NCT03747497|4102706|FG001|COMPLETED|Overall Study||55
3371139|NCT03747497|4102705|FG000|NOT COMPLETED|Overall Study||25
3371140|NCT03747497|4102706|FG001|NOT COMPLETED|Overall Study||10
3371141|NCT03746405|4102714|FG000|STARTED|Overall Study||10
3246575|NCT02468570|3980232|FG000|NOT COMPLETED|Overall Study||0
3246576|NCT02468570|3980233|FG001|NOT COMPLETED|Overall Study||0
3246577|NCT02468648|3980239|FG000|STARTED|Overall Study||72
3246578|NCT02468648|3980239|FG000|COMPLETED|Overall Study||71
3246579|NCT02468648|3980239|FG000|NOT COMPLETED|Overall Study||1
3246580|NCT02468674|3980252|FG000|STARTED|Overall Study||5
3246581|NCT02468674|3980253|FG001|STARTED|Overall Study||5
3246582|NCT02468674|3980254|FG002|STARTED|Overall Study||5
3246583|NCT02468674|3980255|FG003|STARTED|Overall Study||4
3246584|NCT02468674|3980256|FG004|STARTED|Overall Study||7
3246585|NCT02468674|3980257|FG005|STARTED|Overall Study||7
3246586|NCT02468674|3980258|FG006|STARTED|Overall Study||15
3246587|NCT02468674|3980259|FG007|STARTED|Overall Study||69
3246588|NCT02468674|3980260|FG008|STARTED|Overall Study||43
3246589|NCT02468674|3980252|FG000|COMPLETED|Overall Study||4
3246590|NCT02468674|3980253|FG001|COMPLETED|Overall Study||5
3246591|NCT02468674|3980254|FG002|COMPLETED|Overall Study||5
3246592|NCT02468674|3980255|FG003|COMPLETED|Overall Study||3
3246593|NCT02468674|3980256|FG004|COMPLETED|Overall Study||6
3246594|NCT02468674|3980257|FG005|COMPLETED|Overall Study||6
3246595|NCT02468674|3980258|FG006|COMPLETED|Overall Study||14
3246596|NCT02468674|3980259|FG007|COMPLETED|Overall Study||65
3246597|NCT02468674|3980260|FG008|COMPLETED|Overall Study||40
3246598|NCT02468674|3980252|FG000|NOT COMPLETED|Overall Study||1
3246599|NCT02468674|3980253|FG001|NOT COMPLETED|Overall Study||0
3246600|NCT02468674|3980254|FG002|NOT COMPLETED|Overall Study||0
3246601|NCT02468674|3980255|FG003|NOT COMPLETED|Overall Study||1
3246602|NCT02468674|3980256|FG004|NOT COMPLETED|Overall Study||1
3246603|NCT02468674|3980257|FG005|NOT COMPLETED|Overall Study||1
3246604|NCT02468674|3980258|FG006|NOT COMPLETED|Overall Study||1
3246605|NCT02468674|3980259|FG007|NOT COMPLETED|Overall Study||4
3246606|NCT02468674|3980260|FG008|NOT COMPLETED|Overall Study||3
3246607|NCT02468700|3980282|FG000|STARTED|Overall Study||22
3246608|NCT02468700|3980283|FG001|STARTED|Overall Study||21
3246609|NCT02468700|3980282|FG000|COMPLETED|Overall Study||20
3246610|NCT02468700|3980283|FG001|COMPLETED|Overall Study||19
3246611|NCT02468700|3980282|FG000|NOT COMPLETED|Overall Study||2
3246612|NCT02468700|3980283|FG001|NOT COMPLETED|Overall Study||2
3246613|NCT02468804|3980291|FG000|STARTED|Overall Study||37
3246614|NCT02468804|3980292|FG001|STARTED|Overall Study||58
3246615|NCT02468804|3980291|FG000|COMPLETED|Overall Study||36
3246616|NCT02468804|3980292|FG001|COMPLETED|Overall Study||50
3246617|NCT02468804|3980291|FG000|NOT COMPLETED|Overall Study||1
3246618|NCT02468804|3980292|FG001|NOT COMPLETED|Overall Study||8
3246619|NCT02468830|3980298|FG000|STARTED|Overall Study||58
3246620|NCT02468830|3980298|FG000|COMPLETED|Overall Study||55
3246621|NCT02468830|3980298|FG000|NOT COMPLETED|Overall Study||3
3246622|NCT02468934|3980302|FG000|STARTED|Overall Study||27
3246623|NCT02468934|3980302|FG000|Enrolled/Received Leads|Overall Study||24
3246624|NCT02468934|3980302|FG000|Underwent Total Knee Arthroplasty|Overall Study||20
3246625|NCT02468934|3980302|FG000|COMPLETED|Overall Study||20
3246626|NCT02468934|3980302|FG000|NOT COMPLETED|Overall Study||7
3246627|NCT02469038|3980310|FG000|STARTED|Overall Study||26
3246628|NCT02469038|3980311|FG001|STARTED|Overall Study||24
3246629|NCT02469038|3980310|FG000|COMPLETED|Overall Study||22
3246630|NCT02469038|3980311|FG001|COMPLETED|Overall Study||19
3246631|NCT02469038|3980310|FG000|NOT COMPLETED|Overall Study||4
3246632|NCT02469038|3980311|FG001|NOT COMPLETED|Overall Study||5
3246633|NCT02469064|3980319|FG000|STARTED|Overall Study||64
3246634|NCT02469064|3980320|FG001|STARTED|Overall Study||62
3246635|NCT02469064|3980319|FG000|COMPLETED|Overall Study||63
3246636|NCT02469064|3980320|FG001|COMPLETED|Overall Study||59
3246637|NCT02469064|3980319|FG000|NOT COMPLETED|Overall Study||1
3246638|NCT02469064|3980320|FG001|NOT COMPLETED|Overall Study||3
3246639|NCT02469077|3980328|FG000|STARTED|Pre Randomization - Pre Intervention||44
3246640|NCT02469077|3980329|FG001|STARTED|Pre Randomization - Pre Intervention||49
3246641|NCT02469077|3980328|FG000|Pre Intervention Placebo|Pre Randomization - Pre Intervention||44
3246642|NCT02469077|3980329|FG001|Pre Intervention Placebo|Pre Randomization - Pre Intervention||49
3246643|NCT02469077|3980328|FG000|Pre Intervention Morpine|Pre Randomization - Pre Intervention||44
3246644|NCT02469077|3980329|FG001|Pre Intervention Morpine|Pre Randomization - Pre Intervention||49
3246645|NCT02469077|3980328|FG000|Pre Intervention Naloxone|Pre Randomization - Pre Intervention||44
3246646|NCT02469077|3980329|FG001|Pre Intervention Naloxone|Pre Randomization - Pre Intervention||49
3246647|NCT02469077|3980328|FG000|COMPLETED|Pre Randomization - Pre Intervention||44
3246648|NCT02469077|3980329|FG001|COMPLETED|Pre Randomization - Pre Intervention||49
3246649|NCT02469077|3980328|FG000|NOT COMPLETED|Pre Randomization - Pre Intervention||0
3246650|NCT02469077|3980329|FG001|NOT COMPLETED|Pre Randomization - Pre Intervention||0
3246651|NCT02469077|3980328|FG000|STARTED|Post Randomization/Intervention Period||44
3246652|NCT02469077|3980329|FG001|STARTED|Post Randomization/Intervention Period||49
3246653|NCT02469077|3980328|FG000|COMPLETED|Post Randomization/Intervention Period||40
3246654|NCT02469077|3980329|FG001|COMPLETED|Post Randomization/Intervention Period||45
3246655|NCT02469077|3980328|FG000|NOT COMPLETED|Post Randomization/Intervention Period||4
3246656|NCT02469077|3980329|FG001|NOT COMPLETED|Post Randomization/Intervention Period||4
3246657|NCT02469077|3980328|FG000|STARTED|Post Intervention /Followup||40
3246658|NCT02469077|3980329|FG001|STARTED|Post Intervention /Followup||45
3246659|NCT02469077|3980328|FG000|Post Intervention Placebo|Post Intervention /Followup||39
3246660|NCT02469077|3980329|FG001|Post Intervention Placebo|Post Intervention /Followup||45
3246661|NCT02469077|3980328|FG000|Post Intervention Morphine|Post Intervention /Followup||40
3246662|NCT02469077|3980329|FG001|Post Intervention Morphine|Post Intervention /Followup||45
3246663|NCT02469077|3980328|FG000|Post Intervention Naloxone|Post Intervention /Followup||39
3246664|NCT02469077|3980329|FG001|Post Intervention Naloxone|Post Intervention /Followup||44
3246665|NCT02469077|3980328|FG000|COMPLETED|Post Intervention /Followup||38
3246666|NCT02469077|3980329|FG001|COMPLETED|Post Intervention /Followup||44
3246667|NCT02469077|3980328|FG000|NOT COMPLETED|Post Intervention /Followup||2
3246668|NCT02469077|3980329|FG001|NOT COMPLETED|Post Intervention /Followup||1
3246669|NCT02469090|3980341|FG000|STARTED|Period 1: Dose Titration Phase||141
3246670|NCT02469090|3980342|FG001|STARTED|Period 1: Dose Titration Phase||0
3246671|NCT02469090|3980343|FG002|STARTED|Period 1: Dose Titration Phase||0
3246672|NCT02469090|3980341|FG000|COMPLETED|Period 1: Dose Titration Phase||109
3246673|NCT02469090|3980342|FG001|COMPLETED|Period 1: Dose Titration Phase||0
3246674|NCT02469090|3980343|FG002|COMPLETED|Period 1: Dose Titration Phase||0
3246675|NCT02469090|3980341|FG000|NOT COMPLETED|Period 1: Dose Titration Phase||32
3246676|NCT02469090|3980342|FG001|NOT COMPLETED|Period 1: Dose Titration Phase||0
3246677|NCT02469090|3980343|FG002|NOT COMPLETED|Period 1: Dose Titration Phase||0
3246678|NCT02469090|3980341|FG000|STARTED|Period 2: Maintenance Treatment Phase|Subjects who completed the Titration Phase were eligible to proceed to Maintenance Treatment Phase|0
3246679|NCT02469090|3980342|FG001|STARTED|Period 2: Maintenance Treatment Phase|subjects who completed the Titration Phase and were randomized to Placebo in the Maintenance Phase|55
3246680|NCT02469090|3980343|FG002|STARTED|Period 2: Maintenance Treatment Phase|subjects who completed the Titration Phase and were randomized to APL-130277 Maintenance Phase|54
3246681|NCT02469090|3980341|FG000|COMPLETED|Period 2: Maintenance Treatment Phase||0
3246682|NCT02469090|3980342|FG001|COMPLETED|Period 2: Maintenance Treatment Phase||46
3246683|NCT02469090|3980343|FG002|COMPLETED|Period 2: Maintenance Treatment Phase||34
3246684|NCT02469090|3980341|FG000|NOT COMPLETED|Period 2: Maintenance Treatment Phase||0
3246685|NCT02469090|3980342|FG001|NOT COMPLETED|Period 2: Maintenance Treatment Phase||9
3246686|NCT02469090|3980343|FG002|NOT COMPLETED|Period 2: Maintenance Treatment Phase||20
3246687|NCT02469116|3980350|FG000|STARTED|Overall Study||18
3246688|NCT02469116|3980350|FG000|COMPLETED|Overall Study||18
3246689|NCT02469116|3980350|FG000|NOT COMPLETED|Overall Study||0
3246690|NCT02469168|3980356|FG000|STARTED|Overall Study||1
3246691|NCT02469168|3980357|FG001|STARTED|Overall Study||0
3246692|NCT02469168|3980356|FG000|COMPLETED|Overall Study||0
3246693|NCT02469168|3980357|FG001|COMPLETED|Overall Study||0
3246694|NCT02469168|3980356|FG000|NOT COMPLETED|Overall Study||1
3246695|NCT02469168|3980357|FG001|NOT COMPLETED|Overall Study||0
3246696|NCT02469246|3980365|FG000|STARTED|Double-Blind Phase||285
3246697|NCT02469246|3980366|FG001|STARTED|Double-Blind Phase||282
3246698|NCT02469246|3980365|FG000|COMPLETED|Double-Blind Phase||218
3246699|NCT02469246|3980366|FG001|COMPLETED|Double-Blind Phase||226
3246700|NCT02469246|3980365|FG000|NOT COMPLETED|Double-Blind Phase||67
3246701|NCT02469246|3980366|FG001|NOT COMPLETED|Double-Blind Phase||56
3246702|NCT02469246|3980365|FG000|STARTED|Open-Label Extension (OLE)|Only participants in countries where F/TAF was not commercially available were eligible for the OLE.|6
3246703|NCT02469246|3980366|FG001|STARTED|Open-Label Extension (OLE)|Only participants in countries where F/TAF was not commercially available were eligible for the OLE.|5
3246704|NCT02469246|3980365|FG000|COMPLETED|Open-Label Extension (OLE)||6
3246705|NCT02469246|3980366|FG001|COMPLETED|Open-Label Extension (OLE)||5
3246706|NCT02469246|3980365|FG000|NOT COMPLETED|Open-Label Extension (OLE)||0
3246707|NCT02469246|3980366|FG001|NOT COMPLETED|Open-Label Extension (OLE)||0
3246708|NCT02469298|3980378|FG000|STARTED|Overall Study||15
3246709|NCT02469298|3980379|FG001|STARTED|Overall Study||7
3246710|NCT02469298|3980380|FG002|STARTED|Overall Study||16
3246711|NCT02469298|3980381|FG003|STARTED|Overall Study||7
3246712|NCT02469298|3980378|FG000|COMPLETED|Overall Study||14
3246713|NCT02469298|3980379|FG001|COMPLETED|Overall Study||6
3246714|NCT02469298|3980380|FG002|COMPLETED|Overall Study||14
3246715|NCT02469298|3980381|FG003|COMPLETED|Overall Study||5
3246716|NCT02469298|3980378|FG000|NOT COMPLETED|Overall Study||1
3246717|NCT02469298|3980379|FG001|NOT COMPLETED|Overall Study||1
3246718|NCT02469298|3980380|FG002|NOT COMPLETED|Overall Study||2
3246719|NCT02469298|3980381|FG003|NOT COMPLETED|Overall Study||2
3246720|NCT02469389|3980400|FG000|STARTED|Overall Study||53
3246721|NCT02469389|3980401|FG001|STARTED|Overall Study||52
3246722|NCT02469389|3980400|FG000|Completed 12-week Assessment|Overall Study|13 lost to contact or refused|40
3246723|NCT02469389|3980401|FG001|Completed 12-week Assessment|Overall Study|8 lost to contact or refused|44
3246724|NCT02469389|3980400|FG000|Completed 24-week Assessment|Overall Study|16 lost to contact or refused|37
3246725|NCT02469389|3980401|FG001|Completed 24-week Assessment|Overall Study|6 lost to contact or refused|46
3246726|NCT02469389|3980400|FG000|COMPLETED|Overall Study||37
3246727|NCT02469389|3980401|FG001|COMPLETED|Overall Study||44
3246728|NCT02469389|3980400|FG000|NOT COMPLETED|Overall Study||16
3246729|NCT02469389|3980401|FG001|NOT COMPLETED|Overall Study||8
3246730|NCT02469597|3980409|FG000|STARTED|Overall Study||22
3246731|NCT02469597|3980410|FG001|STARTED|Overall Study||24
3246732|NCT02469597|3980409|FG000|COMPLETED|Overall Study||22
3246733|NCT02469597|3980410|FG001|COMPLETED|Overall Study||24
3246734|NCT02469597|3980409|FG000|NOT COMPLETED|Overall Study||0
3246735|NCT02469597|3980410|FG001|NOT COMPLETED|Overall Study||0
3246736|NCT02469610|3980418|FG000|STARTED|Overall Study||34
3246737|NCT02469610|3980419|FG001|STARTED|Overall Study||31
3371142|NCT03746405|4102715|FG001|STARTED|Overall Study||8
3246738|NCT02469610|3980418|FG000|COMPLETED|Overall Study||30
3246739|NCT02469610|3980419|FG001|COMPLETED|Overall Study||30
3246740|NCT02469610|3980418|FG000|NOT COMPLETED|Overall Study||4
3246741|NCT02469610|3980419|FG001|NOT COMPLETED|Overall Study||1
3246742|NCT02469623|3980425|FG000|STARTED|Overall Study||85
3246743|NCT02469623|3980425|FG000|COMPLETED|Overall Study||72
3246744|NCT02469623|3980425|FG000|NOT COMPLETED|Overall Study||13
3246745|NCT02469701|3980430|FG000|STARTED|Overall Study||10
3246746|NCT02469701|3980430|FG000|COMPLETED|Overall Study||10
3246747|NCT02469701|3980430|FG000|NOT COMPLETED|Overall Study||0
3246748|NCT02469714|3980436|FG000|STARTED|Overall Study||55
3246749|NCT02469714|3980437|FG001|STARTED|Overall Study||55
3246750|NCT02469714|3980436|FG000|4 Month Follow-Up|Overall Study||50
3246751|NCT02469714|3980437|FG001|4 Month Follow-Up|Overall Study||51
3246752|NCT02469714|3980436|FG000|8 Month Follow-Up|Overall Study||49
3246753|NCT02469714|3980437|FG001|8 Month Follow-Up|Overall Study||50
3246754|NCT02469714|3980436|FG000|COMPLETED|Overall Study||47
3246755|NCT02469714|3980437|FG001|COMPLETED|Overall Study||50
3246756|NCT02469714|3980436|FG000|NOT COMPLETED|Overall Study||8
3246757|NCT02469714|3980437|FG001|NOT COMPLETED|Overall Study||5
3246758|NCT02469857|3980445|FG000|STARTED|Overall Study||143
3246759|NCT02469857|3980446|FG001|STARTED|Overall Study||147
3246760|NCT02469857|3980445|FG000|COMPLETED|Overall Study||118
3246761|NCT02469857|3980446|FG001|COMPLETED|Overall Study||115
3246762|NCT02469857|3980445|FG000|NOT COMPLETED|Overall Study||25
3246763|NCT02469857|3980446|FG001|NOT COMPLETED|Overall Study||32
3246764|NCT02469870|3980456|FG000|STARTED|Overall Study||77
3246765|NCT02469870|3980457|FG001|STARTED|Overall Study||79
3246766|NCT02469870|3980456|FG000|COMPLETED|Overall Study||73
3246767|NCT02469870|3980457|FG001|COMPLETED|Overall Study||72
3246768|NCT02469870|3980456|FG000|NOT COMPLETED|Overall Study||4
3246769|NCT02469870|3980457|FG001|NOT COMPLETED|Overall Study||7
3246770|NCT02469896|3980468|FG000|STARTED|Overall Study||8
3246771|NCT02469896|3980469|FG001|STARTED|Overall Study||14
3246772|NCT02469896|3980468|FG000|COMPLETED|Overall Study||6
3246773|NCT02469896|3980469|FG001|COMPLETED|Overall Study||14
3246774|NCT02469896|3980468|FG000|NOT COMPLETED|Overall Study||2
3246775|NCT02469896|3980469|FG001|NOT COMPLETED|Overall Study||0
3246776|NCT02469961|3980481|FG000|STARTED|Overall Study||25
3246777|NCT02469961|3980482|FG001|STARTED|Overall Study||25
3246778|NCT02469961|3980481|FG000|COMPLETED|Overall Study||21
3246779|NCT02469961|3980482|FG001|COMPLETED|Overall Study||24
3246780|NCT02469961|3980481|FG000|NOT COMPLETED|Overall Study||4
3246781|NCT02469961|3980482|FG001|NOT COMPLETED|Overall Study||1
3246782|NCT02470091|3980495|FG000|STARTED|Overall Study||16
3246783|NCT02470091|3980496|FG001|STARTED|Overall Study||40
3246784|NCT02470091|3980495|FG000|Follow-up Report|Overall Study||1
3246785|NCT02470091|3980496|FG001|Follow-up Report|Overall Study||10
3246786|NCT02470091|3980495|FG000|COMPLETED|Overall Study||15
3246787|NCT02470091|3980496|FG001|COMPLETED|Overall Study||38
3246788|NCT02470091|3980495|FG000|NOT COMPLETED|Overall Study||1
3246789|NCT02470091|3980496|FG001|NOT COMPLETED|Overall Study||2
3246790|NCT02470234|3980507|FG000|STARTED|Overall Study||5
3246791|NCT02470234|3980508|FG001|STARTED|Overall Study||3
3246792|NCT02470234|3980509|FG002|STARTED|Overall Study||2
3246793|NCT02470234|3980507|FG000|COMPLETED|Overall Study||5
3246794|NCT02470234|3980508|FG001|COMPLETED|Overall Study||3
3246795|NCT02470234|3980509|FG002|COMPLETED|Overall Study||2
3246796|NCT02470234|3980507|FG000|NOT COMPLETED|Overall Study||0
3246797|NCT02470234|3980508|FG001|NOT COMPLETED|Overall Study||0
3246798|NCT02470234|3980509|FG002|NOT COMPLETED|Overall Study||0
3246799|NCT02470312|3980524|FG000|STARTED|Overall Study||147
3246800|NCT02470312|3980525|FG001|STARTED|Overall Study||431
3246801|NCT02470312|3980524|FG000|COMPLETED|Overall Study||142
3246802|NCT02470312|3980525|FG001|COMPLETED|Overall Study||419
3246803|NCT02470312|3980524|FG000|NOT COMPLETED|Overall Study||5
3246804|NCT02470312|3980525|FG001|NOT COMPLETED|Overall Study||12
3371143|NCT03746405|4102714|FG000|COMPLETED|Overall Study||7
3371144|NCT03746405|4102715|FG001|COMPLETED|Overall Study||6
3371145|NCT03746405|4102714|FG000|NOT COMPLETED|Overall Study||3
3371146|NCT03746405|4102715|FG001|NOT COMPLETED|Overall Study||2
3371147|NCT03745937|4102725|FG000|STARTED|Overall Study||2
3371148|NCT03745937|4102726|FG001|STARTED|Overall Study||6
3371149|NCT03745937|4102727|FG002|STARTED|Overall Study||3
3371150|NCT03745937|4102728|FG003|STARTED|Overall Study||9
3371151|NCT03745937|4102725|FG000|COMPLETED|Overall Study||2
3371152|NCT03745937|4102726|FG001|COMPLETED|Overall Study||5
3371153|NCT03745937|4102727|FG002|COMPLETED|Overall Study||3
3371154|NCT03745937|4102728|FG003|COMPLETED|Overall Study||7
3371155|NCT03745937|4102725|FG000|NOT COMPLETED|Overall Study||0
3371156|NCT03745937|4102726|FG001|NOT COMPLETED|Overall Study||1
3371157|NCT03745937|4102727|FG002|NOT COMPLETED|Overall Study||0
3371158|NCT03745937|4102728|FG003|NOT COMPLETED|Overall Study||2
3371159|NCT03745222|4102742|FG000|STARTED|Overall Study||0
3371160|NCT03745222|4102743|FG001|STARTED|Overall Study||1
3371161|NCT03745222|4102744|FG002|STARTED|Overall Study||0
3371162|NCT03745222|4102742|FG000|COMPLETED|Overall Study||0
3371163|NCT03745222|4102743|FG001|COMPLETED|Overall Study||0
3371164|NCT03745222|4102744|FG002|COMPLETED|Overall Study||0
3371165|NCT03745222|4102742|FG000|NOT COMPLETED|Overall Study||0
3371166|NCT03745222|4102743|FG001|NOT COMPLETED|Overall Study||1
3371167|NCT03745222|4102744|FG002|NOT COMPLETED|Overall Study||0
3371168|NCT03745092|4102754|FG000|STARTED|Overall Study||26
3246805|NCT02470390|3980533|FG000|STARTED|Overall Study||6
3246806|NCT02470390|3980534|FG001|STARTED|Overall Study||7
3246807|NCT02470390|3980533|FG000|COMPLETED|Overall Study||6
3246808|NCT02470390|3980534|FG001|COMPLETED|Overall Study||6
3246809|NCT02470390|3980533|FG000|NOT COMPLETED|Overall Study||0
3246810|NCT02470390|3980534|FG001|NOT COMPLETED|Overall Study||1
3246811|NCT02470403|3980547|FG000|STARTED|Overall Study||44
3246812|NCT02470403|3980548|FG001|STARTED|Overall Study||44
3246813|NCT02470403|3980549|FG002|STARTED|Overall Study||40
3246814|NCT02470403|3980550|FG003|STARTED|Overall Study||43
3246815|NCT02470403|3980551|FG004|STARTED|Overall Study||10
3246816|NCT02470403|3980547|FG000|Dysglycemic|Overall Study||24
3246817|NCT02470403|3980548|FG001|Dysglycemic|Overall Study||24
3246818|NCT02470403|3980549|FG002|Dysglycemic|Overall Study||20
3246819|NCT02470403|3980550|FG003|Dysglycemic|Overall Study||20
3246820|NCT02470403|3980551|FG004|Dysglycemic|Overall Study||5
3246821|NCT02470403|3980547|FG000|Normoglycemic|Overall Study||20
3246822|NCT02470403|3980548|FG001|Normoglycemic|Overall Study||20
3246823|NCT02470403|3980549|FG002|Normoglycemic|Overall Study||20
3246824|NCT02470403|3980550|FG003|Normoglycemic|Overall Study||23
3246825|NCT02470403|3980551|FG004|Normoglycemic|Overall Study||5
3246826|NCT02470403|3980547|FG000|COMPLETED|Overall Study||42
3246827|NCT02470403|3980548|FG001|COMPLETED|Overall Study||43
3246828|NCT02470403|3980549|FG002|COMPLETED|Overall Study||40
3246829|NCT02470403|3980550|FG003|COMPLETED|Overall Study||39
3246830|NCT02470403|3980551|FG004|COMPLETED|Overall Study||10
3246831|NCT02470403|3980547|FG000|NOT COMPLETED|Overall Study||2
3246832|NCT02470403|3980548|FG001|NOT COMPLETED|Overall Study||1
3246833|NCT02470403|3980549|FG002|NOT COMPLETED|Overall Study||0
3246834|NCT02470403|3980550|FG003|NOT COMPLETED|Overall Study||4
3246835|NCT02470403|3980551|FG004|NOT COMPLETED|Overall Study||0
3246836|NCT02470429|3980568|FG000|STARTED|Overall Study||50
3246837|NCT02470429|3980569|FG001|STARTED|Overall Study||49
3246838|NCT02470429|3980568|FG000|COMPLETED|Overall Study||48
3246839|NCT02470429|3980569|FG001|COMPLETED|Overall Study||49
3246840|NCT02470429|3980568|FG000|NOT COMPLETED|Overall Study||2
3246841|NCT02470429|3980569|FG001|NOT COMPLETED|Overall Study||0
3246842|NCT02470494|3980576|FG000|STARTED|Overall Study||46
3246843|NCT02470494|3980576|FG000|COMPLETED|Overall Study||41
3246844|NCT02470494|3980576|FG000|NOT COMPLETED|Overall Study||5
3246845|NCT02470585|3980583|FG000|STARTED|Overall Study||375
3246846|NCT02470585|3980584|FG001|STARTED|Overall Study||383
3246847|NCT02470585|3980585|FG002|STARTED|Overall Study||382
3246848|NCT02470585|3980583|FG000|Received Study Drug|Overall Study||371
3246849|NCT02470585|3980584|FG001|Received Study Drug|Overall Study||376
3246850|NCT02470585|3980585|FG002|Received Study Drug|Overall Study||377
3246851|NCT02470585|3980583|FG000|COMPLETED|Overall Study||268
3246852|NCT02470585|3980584|FG001|COMPLETED|Overall Study||266
3246853|NCT02470585|3980585|FG002|COMPLETED|Overall Study||257
3246854|NCT02470585|3980583|FG000|NOT COMPLETED|Overall Study||107
3246855|NCT02470585|3980584|FG001|NOT COMPLETED|Overall Study||117
3246856|NCT02470585|3980585|FG002|NOT COMPLETED|Overall Study||125
3246857|NCT02470741|3980595|FG000|STARTED|Overall Study||6
3246858|NCT02470741|3980596|FG001|STARTED|Overall Study||6
3246859|NCT02470741|3980595|FG000|COMPLETED|Overall Study||3
3246860|NCT02470741|3980596|FG001|COMPLETED|Overall Study||4
3246861|NCT02470741|3980595|FG000|NOT COMPLETED|Overall Study||3
3246862|NCT02470741|3980596|FG001|NOT COMPLETED|Overall Study||2
3246863|NCT02470754|3980602|FG000|STARTED|Overall Study||19
3246864|NCT02470754|3980603|FG001|STARTED|Overall Study||19
3246865|NCT02470754|3980602|FG000|COMPLETED|Overall Study||17
3246866|NCT02470754|3980603|FG001|COMPLETED|Overall Study||19
3246867|NCT02470754|3980602|FG000|NOT COMPLETED|Overall Study||2
3246868|NCT02470754|3980603|FG001|NOT COMPLETED|Overall Study||0
3246869|NCT02470806|3980611|FG000|STARTED|Overall Study||80
3246870|NCT02470806|3980612|FG001|STARTED|Overall Study|The Safety analysis included 164, ITT was 161, and Per Protocol was 115 subjects (total both arms).|84
3246871|NCT02470806|3980611|FG000|COMPLETED|Overall Study||62
3246872|NCT02470806|3980612|FG001|COMPLETED|Overall Study||42
3246873|NCT02470806|3980611|FG000|NOT COMPLETED|Overall Study||18
3246874|NCT02470806|3980612|FG001|NOT COMPLETED|Overall Study||42
3246875|NCT02470910|3980618|FG000|STARTED|Overall Study||15
3246876|NCT02470910|3980618|FG000|COMPLETED|Overall Study||15
3246877|NCT02470910|3980618|FG000|NOT COMPLETED|Overall Study||0
3246878|NCT02470949|3980625|FG000|STARTED|First Intervention||4
3246879|NCT02470949|3980626|FG001|STARTED|First Intervention||5
3246880|NCT02470949|3980625|FG000|COMPLETED|First Intervention||4
3246881|NCT02470949|3980626|FG001|COMPLETED|First Intervention||5
3246882|NCT02470949|3980625|FG000|NOT COMPLETED|First Intervention||0
3246883|NCT02470949|3980626|FG001|NOT COMPLETED|First Intervention||0
3246884|NCT02470949|3980625|FG000|STARTED|Washout Period for a Minimum of 4 Weeks||4
3246885|NCT02470949|3980626|FG001|STARTED|Washout Period for a Minimum of 4 Weeks||5
3246886|NCT02470949|3980625|FG000|COMPLETED|Washout Period for a Minimum of 4 Weeks||4
3246887|NCT02470949|3980626|FG001|COMPLETED|Washout Period for a Minimum of 4 Weeks||5
3246888|NCT02470949|3980625|FG000|NOT COMPLETED|Washout Period for a Minimum of 4 Weeks||0
3246889|NCT02470949|3980626|FG001|NOT COMPLETED|Washout Period for a Minimum of 4 Weeks||0
3246890|NCT02470949|3980625|FG000|STARTED|Second Intervention||4
3246891|NCT02470949|3980626|FG001|STARTED|Second Intervention||2
3246892|NCT02470949|3980625|FG000|COMPLETED|Second Intervention||4
3246893|NCT02470949|3980626|FG001|COMPLETED|Second Intervention||2
3246894|NCT02470949|3980625|FG000|NOT COMPLETED|Second Intervention||0
3246895|NCT02470949|3980626|FG001|NOT COMPLETED|Second Intervention||0
3246896|NCT02471014|3980636|FG000|STARTED|Overall Study||25
3246897|NCT02471014|3980637|FG001|STARTED|Overall Study||25
3246898|NCT02471014|3980636|FG000|COMPLETED|Overall Study||23
3246899|NCT02471014|3980637|FG001|COMPLETED|Overall Study||23
3246900|NCT02471014|3980636|FG000|NOT COMPLETED|Overall Study||2
3246901|NCT02471014|3980637|FG001|NOT COMPLETED|Overall Study||2
3246902|NCT02471183|3980643|FG000|STARTED|Main Treatment Period||34
3246903|NCT02471183|3980643|FG000|COMPLETED|Main Treatment Period||32
3246904|NCT02471183|3980643|FG000|NOT COMPLETED|Main Treatment Period||2
3246905|NCT02471183|3980643|FG000|STARTED|Extended Treatment Period||32
3246906|NCT02471183|3980643|FG000|COMPLETED|Extended Treatment Period||31
3246907|NCT02471183|3980643|FG000|NOT COMPLETED|Extended Treatment Period||1
3246908|NCT02471313|3980647|FG000|STARTED|Overall Study||3
3246909|NCT02471313|3980647|FG000|COMPLETED|Overall Study||3
3246910|NCT02471313|3980647|FG000|NOT COMPLETED|Overall Study||0
3246911|NCT02471326|3980651|FG000|STARTED|Overall Study||10
3246912|NCT02471326|3980651|FG000|COMPLETED|Overall Study||9
3246913|NCT02471326|3980651|FG000|NOT COMPLETED|Overall Study||1
3246914|NCT02471404|3980658|FG000|STARTED|Overall Study||314
3246915|NCT02471404|3980659|FG001|STARTED|Overall Study||312
3246916|NCT02471404|3980660|FG002|STARTED|Overall Study||313
3246917|NCT02471404|3980658|FG000|COMPLETED|Overall Study||281
3246918|NCT02471404|3980659|FG001|COMPLETED|Overall Study||298
3246919|NCT02471404|3980660|FG002|COMPLETED|Overall Study||288
3246920|NCT02471404|3980658|FG000|NOT COMPLETED|Overall Study||33
3246921|NCT02471404|3980659|FG001|NOT COMPLETED|Overall Study||14
3246922|NCT02471404|3980660|FG002|NOT COMPLETED|Overall Study||25
3246923|NCT02471521|3980670|FG000|STARTED|Overall Study||60
3246924|NCT02471521|3980671|FG001|STARTED|Overall Study||60
3246925|NCT02471521|3980670|FG000|COMPLETED|Overall Study||60
3246926|NCT02471521|3980671|FG001|COMPLETED|Overall Study||52
3246927|NCT02471521|3980670|FG000|NOT COMPLETED|Overall Study||0
3246928|NCT02471521|3980671|FG001|NOT COMPLETED|Overall Study||8
3246929|NCT02471586|3980680|FG000|STARTED|Overall Study||158
3246930|NCT02471586|3980681|FG001|STARTED|Overall Study||146
3246931|NCT02471586|3980682|FG002|STARTED|Overall Study||146
3246932|NCT02471586|3980680|FG000|COMPLETED|Overall Study||153
3246933|NCT02471586|3980681|FG001|COMPLETED|Overall Study||136
3246934|NCT02471586|3980682|FG002|COMPLETED|Overall Study||142
3246935|NCT02471586|3980680|FG000|NOT COMPLETED|Overall Study||5
3246936|NCT02471586|3980681|FG001|NOT COMPLETED|Overall Study||10
3246937|NCT02471586|3980682|FG002|NOT COMPLETED|Overall Study||4
3246938|NCT02471612|3980692|FG000|STARTED|Overall Study||159
3246939|NCT02471612|3980692|FG000|COMPLETED|Overall Study||157
3246940|NCT02471612|3980692|FG000|NOT COMPLETED|Overall Study||2
3246941|NCT02471651|3980711|FG000|STARTED|Overall Study||20
3246942|NCT02471651|3980712|FG001|STARTED|Overall Study||20
3246943|NCT02471651|3980711|FG000|COMPLETED|Overall Study||15
3246944|NCT02471651|3980712|FG001|COMPLETED|Overall Study||15
3246945|NCT02471651|3980711|FG000|NOT COMPLETED|Overall Study||5
3246946|NCT02471651|3980712|FG001|NOT COMPLETED|Overall Study||5
3246947|NCT02471716|3980723|FG000|STARTED|Overall Study||3
3246948|NCT02471716|3980724|FG001|STARTED|Overall Study||3
3246949|NCT02471716|3980725|FG002|STARTED|Overall Study||3
3246950|NCT02471716|3980726|FG003|STARTED|Overall Study||33
3246951|NCT02471716|3980727|FG004|STARTED|Overall Study||24
3246952|NCT02471716|3980723|FG000|COMPLETED|Overall Study||3
3246953|NCT02471716|3980724|FG001|COMPLETED|Overall Study||2
3246954|NCT02471716|3980725|FG002|COMPLETED|Overall Study||3
3246955|NCT02471716|3980726|FG003|COMPLETED|Overall Study||18
3246956|NCT02471716|3980727|FG004|COMPLETED|Overall Study||8
3246957|NCT02471716|3980723|FG000|NOT COMPLETED|Overall Study||0
3246958|NCT02471716|3980724|FG001|NOT COMPLETED|Overall Study||1
3246959|NCT02471716|3980725|FG002|NOT COMPLETED|Overall Study||0
3246960|NCT02471716|3980726|FG003|NOT COMPLETED|Overall Study||15
3246961|NCT02471716|3980727|FG004|NOT COMPLETED|Overall Study||16
3246962|NCT02471755|3980743|FG000|STARTED|Overall Study||45
3246963|NCT02471755|3980744|FG001|STARTED|Overall Study||45
3246964|NCT02471755|3980743|FG000|COMPLETED|Overall Study||44
3246965|NCT02471755|3980744|FG001|COMPLETED|Overall Study||44
3246966|NCT02471755|3980743|FG000|NOT COMPLETED|Overall Study||1
3246967|NCT02471755|3980744|FG001|NOT COMPLETED|Overall Study||1
3246968|NCT02472145|3980753|FG000|STARTED|Overall Study||10
3246969|NCT02472145|3980754|FG001|STARTED|Overall Study||159
3246970|NCT02472145|3980755|FG002|STARTED|Overall Study||157
3246971|NCT02472145|3980753|FG000|Treated|Overall Study||10
3246972|NCT02472145|3980754|FG001|Treated|Overall Study||156
3246973|NCT02472145|3980755|FG002|Treated|Overall Study||156
3246974|NCT02472145|3980753|FG000|Safety|Overall Study||10
3246975|NCT02472145|3980754|FG001|Safety|Overall Study|9 participants who received decitabine,not JNJ-56022473 included,3 untreated participant excluded.|165
3246976|NCT02472145|3980755|FG002|Safety|Overall Study|1 participant who was not treated and 9 participants who received only decitabine were excluded.|147
3246977|NCT02472145|3980753|FG000|COMPLETED|Overall Study||0
3246978|NCT02472145|3980754|FG001|COMPLETED|Overall Study||0
3246979|NCT02472145|3980755|FG002|COMPLETED|Overall Study||0
3246980|NCT02472145|3980753|FG000|NOT COMPLETED|Overall Study||10
3246981|NCT02472145|3980754|FG001|NOT COMPLETED|Overall Study||159
3246982|NCT02472145|3980755|FG002|NOT COMPLETED|Overall Study||157
3246983|NCT02472223|3980764|FG000|STARTED|Overall Study||16
3246984|NCT02472223|3980765|FG001|STARTED|Overall Study||12
3246985|NCT02472223|3980764|FG000|COMPLETED|Overall Study||10
3246986|NCT02472223|3980765|FG001|COMPLETED|Overall Study||7
3246987|NCT02472223|3980764|FG000|NOT COMPLETED|Overall Study||6
3246988|NCT02472223|3980765|FG001|NOT COMPLETED|Overall Study||5
3246989|NCT02472262|3980774|FG000|STARTED|Overall Study||117
3246990|NCT02472262|3980775|FG001|STARTED|Overall Study||120
3246991|NCT02472262|3980776|FG002|STARTED|Overall Study||118
3246992|NCT02472262|3980774|FG000|COMPLETED|Overall Study||99
3246993|NCT02472262|3980775|FG001|COMPLETED|Overall Study||99
3246994|NCT02472262|3980776|FG002|COMPLETED|Overall Study||93
3246995|NCT02472262|3980774|FG000|NOT COMPLETED|Overall Study||18
3246996|NCT02472262|3980775|FG001|NOT COMPLETED|Overall Study||21
3246997|NCT02472262|3980776|FG002|NOT COMPLETED|Overall Study||25
3246998|NCT02472314|3980786|FG000|STARTED|Overall Study||34
3246999|NCT02472314|3980787|FG001|STARTED|Overall Study||36
3247000|NCT02472314|3980786|FG000|COMPLETED|Overall Study||34
3247001|NCT02472314|3980787|FG001|COMPLETED|Overall Study||36
3247002|NCT02472314|3980786|FG000|NOT COMPLETED|Overall Study||0
3247003|NCT02472314|3980787|FG001|NOT COMPLETED|Overall Study||0
3247004|NCT02472353|3980795|FG000|STARTED|Overall Study||14
3247005|NCT02472353|3980796|FG001|STARTED|Overall Study||16
3247006|NCT02472353|3980795|FG000|COMPLETED|Overall Study||10
3247007|NCT02472353|3980796|FG001|COMPLETED|Overall Study||10
3247008|NCT02472353|3980795|FG000|NOT COMPLETED|Overall Study||4
3247009|NCT02472353|3980796|FG001|NOT COMPLETED|Overall Study||6
3247010|NCT02472366|3980804|FG000|STARTED|Overall Study|6 subjects receiving ILUVIEN, 7 eyes receiving ILUVIEN|6
3247011|NCT02472366|3980805|FG001|STARTED|Overall Study||10
3247012|NCT02472366|3980804|FG000|COMPLETED|Overall Study||5
3247013|NCT02472366|3980805|FG001|COMPLETED|Overall Study||10
3247014|NCT02472366|3980804|FG000|NOT COMPLETED|Overall Study||1
3247015|NCT02472366|3980805|FG001|NOT COMPLETED|Overall Study||0
3247016|NCT02472405|3980811|FG000|STARTED|Overall Study||18
3247017|NCT02472405|3980811|FG000|COMPLETED|Overall Study||8
3247018|NCT02472405|3980811|FG000|NOT COMPLETED|Overall Study||10
3247019|NCT02472457|3980819|FG000|STARTED|Overall Study|1 subject followed the Specific Carbohydrate Diet|8
3247020|NCT02472457|3980820|FG001|STARTED|Overall Study||11
3247021|NCT02472457|3980819|FG000|COMPLETED|Overall Study||8
3247022|NCT02472457|3980820|FG001|COMPLETED|Overall Study||10
3247023|NCT02472457|3980819|FG000|NOT COMPLETED|Overall Study||0
3247024|NCT02472457|3980820|FG001|NOT COMPLETED|Overall Study||1
3247025|NCT02472522|3980828|FG000|STARTED|Overall Study||50
3247026|NCT02472522|3980829|FG001|STARTED|Overall Study||50
3247027|NCT02472522|3980828|FG000|COMPLETED|Overall Study||50
3247028|NCT02472522|3980829|FG001|COMPLETED|Overall Study||50
3247029|NCT02472522|3980828|FG000|NOT COMPLETED|Overall Study||0
3247030|NCT02472522|3980829|FG001|NOT COMPLETED|Overall Study||0
3247031|NCT02472652|3980837|FG000|STARTED|Overall Study||2
3247032|NCT02472652|3980837|FG000|COMPLETED|Overall Study||1
3247033|NCT02472652|3980837|FG000|NOT COMPLETED|Overall Study||1
3247034|NCT02472730|3980843|FG000|STARTED|Overall Study||110
3247035|NCT02472730|3980844|FG001|STARTED|Overall Study||109
3247036|NCT02472730|3980843|FG000|COMPLETED|Overall Study||101
3247037|NCT02472730|3980844|FG001|COMPLETED|Overall Study||102
3247038|NCT02472730|3980843|FG000|NOT COMPLETED|Overall Study||9
3247039|NCT02472730|3980844|FG001|NOT COMPLETED|Overall Study||7
3247040|NCT02472756|3980850|FG000|STARTED|Induction (Approximately 6 Months)||41
3247041|NCT02472756|3980850|FG000|Treated|Induction (Approximately 6 Months)||40
3247042|NCT02472756|3980850|FG000|COMPLETED|Induction (Approximately 6 Months)||39
3247043|NCT02472756|3980850|FG000|NOT COMPLETED|Induction (Approximately 6 Months)||2
3247044|NCT02472756|3980850|FG000|STARTED|Maintenance (Approximately 2 Years)|Out of 39 participants who completed induction period, 19 did not continue in maintenance period.|20
3247045|NCT02472756|3980850|FG000|COMPLETED|Maintenance (Approximately 2 Years)||10
3247046|NCT02472756|3980850|FG000|NOT COMPLETED|Maintenance (Approximately 2 Years)||10
3247047|NCT02472795|3980859|FG000|STARTED|Overall Study||12
3247048|NCT02472795|3980860|FG001|STARTED|Overall Study||12
3247049|NCT02472795|3980861|FG002|STARTED|Overall Study||13
3247050|NCT02472795|3980862|FG003|STARTED|Overall Study||13
3247051|NCT02472795|3980863|FG004|STARTED|Overall Study||17
3247052|NCT02472795|3980859|FG000|Pharmacodynamic Set|Overall Study||12
3247053|NCT02472795|3980860|FG001|Pharmacodynamic Set|Overall Study||10
3247054|NCT02472795|3980861|FG002|Pharmacodynamic Set|Overall Study||13
3247055|NCT02472795|3980862|FG003|Pharmacodynamic Set|Overall Study||13
3247056|NCT02472795|3980863|FG004|Pharmacodynamic Set|Overall Study||16
3247057|NCT02472795|3980859|FG000|Modified Pharmacodynamic Analysis Set|Overall Study||12
3247058|NCT02472795|3980860|FG001|Modified Pharmacodynamic Analysis Set|Overall Study||10
3247059|NCT02472795|3980861|FG002|Modified Pharmacodynamic Analysis Set|Overall Study||13
3247060|NCT02472795|3980862|FG003|Modified Pharmacodynamic Analysis Set|Overall Study||9
3247061|NCT02472795|3980863|FG004|Modified Pharmacodynamic Analysis Set|Overall Study||16
3247062|NCT02472795|3980859|FG000|COMPLETED|Overall Study||12
3247063|NCT02472795|3980860|FG001|COMPLETED|Overall Study||11
3247064|NCT02472795|3980861|FG002|COMPLETED|Overall Study||13
3247065|NCT02472795|3980862|FG003|COMPLETED|Overall Study||13
3247066|NCT02472795|3980863|FG004|COMPLETED|Overall Study||14
3247067|NCT02472795|3980859|FG000|NOT COMPLETED|Overall Study||0
3247068|NCT02472795|3980860|FG001|NOT COMPLETED|Overall Study||1
3247069|NCT02472795|3980861|FG002|NOT COMPLETED|Overall Study||0
3247070|NCT02472795|3980862|FG003|NOT COMPLETED|Overall Study||0
3247071|NCT02472795|3980863|FG004|NOT COMPLETED|Overall Study||3
3247072|NCT02472847|3980877|FG000|STARTED|Overall Study||24
3247073|NCT02472847|3980878|FG001|STARTED|Overall Study||26
3247074|NCT02472847|3980877|FG000|COMPLETED|Overall Study||23
3247075|NCT02472847|3980878|FG001|COMPLETED|Overall Study||21
3247076|NCT02472847|3980877|FG000|NOT COMPLETED|Overall Study||1
3247077|NCT02472847|3980878|FG001|NOT COMPLETED|Overall Study||5
3247078|NCT02472886|3980887|FG000|STARTED|Overall Study||67
3247079|NCT02472886|3980888|FG001|STARTED|Overall Study||59
3247080|NCT02472886|3980889|FG002|STARTED|Overall Study||27
3247081|NCT02472886|3980887|FG000|COMPLETED|Overall Study||67
3247082|NCT02472886|3980888|FG001|COMPLETED|Overall Study||57
3247083|NCT02472886|3980889|FG002|COMPLETED|Overall Study||26
3247084|NCT02472886|3980887|FG000|NOT COMPLETED|Overall Study||0
3247085|NCT02472886|3980888|FG001|NOT COMPLETED|Overall Study||2
3247086|NCT02472886|3980889|FG002|NOT COMPLETED|Overall Study||1
3247087|NCT02472977|3980905|FG000|STARTED|Overall Study||6
3247088|NCT02472977|3980906|FG001|STARTED|Overall Study||27
3247089|NCT02472977|3980907|FG002|STARTED|Overall Study||8
3247090|NCT02472977|3980905|FG000|COMPLETED|Overall Study||0
3247091|NCT02472977|3980906|FG001|COMPLETED|Overall Study||0
3247092|NCT02472977|3980907|FG002|COMPLETED|Overall Study||0
3247093|NCT02472977|3980905|FG000|NOT COMPLETED|Overall Study||6
3247094|NCT02472977|3980906|FG001|NOT COMPLETED|Overall Study||27
3247095|NCT02472977|3980907|FG002|NOT COMPLETED|Overall Study||8
3247096|NCT02473250|3980915|FG000|STARTED|Overall Study||40
3247097|NCT02473250|3980915|FG000|COMPLETED|Overall Study||20
3247098|NCT02473250|3980915|FG000|NOT COMPLETED|Overall Study||20
3247099|NCT02473289|3980922|FG000|STARTED|Overall Study||99
3247100|NCT02473289|3980923|FG001|STARTED|Overall Study||94
3247101|NCT02473289|3980922|FG000|COMPLETED|Overall Study||88
3247102|NCT02473289|3980923|FG001|COMPLETED|Overall Study||81
3247103|NCT02473289|3980922|FG000|NOT COMPLETED|Overall Study||11
3247104|NCT02473289|3980923|FG001|NOT COMPLETED|Overall Study||13
3247105|NCT02473367|3980929|FG000|STARTED|Period 1||20
3247106|NCT02473367|3980929|FG000|COMPLETED|Period 1||20
3247107|NCT02473367|3980929|FG000|NOT COMPLETED|Period 1||0
3247108|NCT02473367|3980929|FG000|STARTED|Wait 1||20
3247109|NCT02473367|3980929|FG000|COMPLETED|Wait 1||19
3247110|NCT02473367|3980929|FG000|NOT COMPLETED|Wait 1||1
3247111|NCT02473367|3980929|FG000|STARTED|Period 2||19
3247112|NCT02473367|3980929|FG000|COMPLETED|Period 2||19
3247113|NCT02473367|3980929|FG000|NOT COMPLETED|Period 2||0
3247114|NCT02473367|3980929|FG000|STARTED|Wait 2||19
3247115|NCT02473367|3980929|FG000|COMPLETED|Wait 2||19
3247116|NCT02473367|3980929|FG000|NOT COMPLETED|Wait 2||0
3247117|NCT02473367|3980929|FG000|STARTED|Period 3||19
3247118|NCT02473367|3980929|FG000|COMPLETED|Period 3||19
3247119|NCT02473367|3980929|FG000|NOT COMPLETED|Period 3||0
3247120|NCT02473367|3980929|FG000|STARTED|Wait 3||19
3247121|NCT02473367|3980929|FG000|COMPLETED|Wait 3||19
3247122|NCT02473367|3980929|FG000|NOT COMPLETED|Wait 3||0
3247123|NCT02473367|3980929|FG000|STARTED|Period 4||19
3247124|NCT02473367|3980929|FG000|COMPLETED|Period 4||18
3247125|NCT02473367|3980929|FG000|NOT COMPLETED|Period 4||1
3247126|NCT02473393|3980943|FG000|STARTED|Overall Study||5
3247127|NCT02473393|3980944|FG001|STARTED|Overall Study||12
3247128|NCT02473393|3980945|FG002|STARTED|Overall Study||13
3247129|NCT02473393|3980946|FG003|STARTED|Overall Study||13
3247130|NCT02473393|3980943|FG000|COMPLETED|Overall Study||5
3247131|NCT02473393|3980944|FG001|COMPLETED|Overall Study||12
3247132|NCT02473393|3980945|FG002|COMPLETED|Overall Study||11
3247133|NCT02473393|3980946|FG003|COMPLETED|Overall Study||12
3247134|NCT02473393|3980943|FG000|NOT COMPLETED|Overall Study||0
3247135|NCT02473393|3980944|FG001|NOT COMPLETED|Overall Study||0
3247136|NCT02473393|3980945|FG002|NOT COMPLETED|Overall Study||2
3247137|NCT02473393|3980946|FG003|NOT COMPLETED|Overall Study||1
3247138|NCT02473471|3980956|FG000|STARTED|Overall Study||35
3247139|NCT02473471|3980956|FG000|Received Allocated Intervention|Overall Study||33
3247140|NCT02473471|3980956|FG000|Randomized Not Treated|Overall Study||2
3247141|NCT02473471|3980956|FG000|COMPLETED|Overall Study||32
3247142|NCT02473471|3980956|FG000|NOT COMPLETED|Overall Study||3
3247143|NCT02473510|3980968|FG000|STARTED|Overall Study||60
3247144|NCT02473510|3980969|FG001|STARTED|Overall Study||240
3247145|NCT02473510|3980968|FG000|COMPLETED|Overall Study||59
3247146|NCT02473510|3980969|FG001|COMPLETED|Overall Study||238
3247147|NCT02473510|3980968|FG000|NOT COMPLETED|Overall Study||1
3247148|NCT02473510|3980969|FG001|NOT COMPLETED|Overall Study||2
3247149|NCT02473614|3980975|FG000|STARTED|First Intervention (3 Weeks)||6
3247150|NCT02473614|3980976|FG001|STARTED|First Intervention (3 Weeks)||5
3247151|NCT02473614|3980975|FG000|COMPLETED|First Intervention (3 Weeks)||5
3247152|NCT02473614|3980976|FG001|COMPLETED|First Intervention (3 Weeks)||5
3247153|NCT02473614|3980975|FG000|NOT COMPLETED|First Intervention (3 Weeks)||1
3247154|NCT02473614|3980976|FG001|NOT COMPLETED|First Intervention (3 Weeks)||0
3247155|NCT02473614|3980975|FG000|STARTED|Wash Out Period (3 Weeks)||5
3247156|NCT02473614|3980976|FG001|STARTED|Wash Out Period (3 Weeks)||5
3247157|NCT02473614|3980975|FG000|COMPLETED|Wash Out Period (3 Weeks)||5
3247158|NCT02473614|3980976|FG001|COMPLETED|Wash Out Period (3 Weeks)||5
3247159|NCT02473614|3980975|FG000|NOT COMPLETED|Wash Out Period (3 Weeks)||0
3247160|NCT02473614|3980976|FG001|NOT COMPLETED|Wash Out Period (3 Weeks)||0
3247161|NCT02473614|3980975|FG000|STARTED|Second Intervention (3 Weeks)||5
3247162|NCT02473614|3980976|FG001|STARTED|Second Intervention (3 Weeks)||5
3247163|NCT02473614|3980975|FG000|COMPLETED|Second Intervention (3 Weeks)||5
3247164|NCT02473614|3980976|FG001|COMPLETED|Second Intervention (3 Weeks)||5
3247165|NCT02473614|3980975|FG000|NOT COMPLETED|Second Intervention (3 Weeks)||0
3247166|NCT02473614|3980976|FG001|NOT COMPLETED|Second Intervention (3 Weeks)||0
3247167|NCT02473640|3980983|FG000|STARTED|Treatment Period 1||15
3247168|NCT02473640|3980983|FG000|COMPLETED|Treatment Period 1||14
3247169|NCT02473640|3980983|FG000|NOT COMPLETED|Treatment Period 1||1
3247170|NCT02473640|3980983|FG000|STARTED|Run-in Phase||14
3247171|NCT02473640|3980983|FG000|COMPLETED|Run-in Phase||14
3247172|NCT02473640|3980983|FG000|NOT COMPLETED|Run-in Phase||0
3247173|NCT02473640|3980983|FG000|STARTED|Treatment Period 2||14
3247174|NCT02473640|3980983|FG000|COMPLETED|Treatment Period 2||14
3247175|NCT02473640|3980983|FG000|NOT COMPLETED|Treatment Period 2||0
3247176|NCT02473718|3980992|FG000|STARTED|Overall Study||41
3247177|NCT02473718|3980993|FG001|STARTED|Overall Study||41
3247178|NCT02473718|3980992|FG000|COMPLETED|Overall Study||41
3247179|NCT02473718|3980993|FG001|COMPLETED|Overall Study||41
3247180|NCT02473718|3980992|FG000|NOT COMPLETED|Overall Study||0
3247181|NCT02473718|3980993|FG001|NOT COMPLETED|Overall Study||0
3247182|NCT02473783|3981001|FG000|STARTED|Overall Study||20
3247183|NCT02473783|3981002|FG001|STARTED|Overall Study||17
3247184|NCT02473783|3981001|FG000|COMPLETED|Overall Study||20
3247185|NCT02473783|3981002|FG001|COMPLETED|Overall Study||17
3247186|NCT02473783|3981001|FG000|NOT COMPLETED|Overall Study||0
3247187|NCT02473783|3981002|FG001|NOT COMPLETED|Overall Study||0
3247188|NCT02473913|3981011|FG000|STARTED|Overall Study||11
3247189|NCT02473913|3981012|FG001|STARTED|Overall Study||11
3247190|NCT02473913|3981011|FG000|COMPLETED|Overall Study||8
3247191|NCT02473913|3981012|FG001|COMPLETED|Overall Study||8
3247192|NCT02473913|3981011|FG000|NOT COMPLETED|Overall Study||3
3247193|NCT02473913|3981012|FG001|NOT COMPLETED|Overall Study||3
3247194|NCT02473952|3981020|FG000|STARTED|Overall Study||30
3247195|NCT02473952|3981021|FG001|STARTED|Overall Study||32
3247196|NCT02473952|3981020|FG000|COMPLETED|Overall Study||28
3247197|NCT02473952|3981021|FG001|COMPLETED|Overall Study||24
3247198|NCT02473952|3981020|FG000|NOT COMPLETED|Overall Study||2
3247199|NCT02473952|3981021|FG001|NOT COMPLETED|Overall Study||8
3247200|NCT02473965|3981029|FG000|STARTED|Overall Study||30
3247201|NCT02473965|3981030|FG001|STARTED|Overall Study||30
3247202|NCT02473965|3981029|FG000|COMPLETED|Overall Study||18
3247203|NCT02473965|3981030|FG001|COMPLETED|Overall Study||20
3247204|NCT02473965|3981029|FG000|NOT COMPLETED|Overall Study||12
3247205|NCT02473965|3981030|FG001|NOT COMPLETED|Overall Study||10
3247206|NCT02473991|3981036|FG000|STARTED|Overall Study||395
3247207|NCT02473991|3981036|FG000|COMPLETED|Overall Study||395
3247208|NCT02473991|3981036|FG000|NOT COMPLETED|Overall Study||0
3247209|NCT02474069|3981040|FG000|STARTED|Selection Phase (SP)||772
3247210|NCT02474069|3981041|FG001|STARTED|Selection Phase (SP)||0
3247211|NCT02474069|3981042|FG002|STARTED|Selection Phase (SP)||0
3247212|NCT02474069|3981040|FG000|COMPLETED|Selection Phase (SP)||749
3247213|NCT02474069|3981041|FG001|COMPLETED|Selection Phase (SP)||0
3247214|NCT02474069|3981042|FG002|COMPLETED|Selection Phase (SP)||0
3247215|NCT02474069|3981040|FG000|NOT COMPLETED|Selection Phase (SP)||23
3247216|NCT02474069|3981041|FG001|NOT COMPLETED|Selection Phase (SP)||0
3247217|NCT02474069|3981042|FG002|NOT COMPLETED|Selection Phase (SP)||0
3247218|NCT02474069|3981040|FG000|STARTED|Comparative Dosing Phase (CDP)||0
3247219|NCT02474069|3981041|FG001|STARTED|Comparative Dosing Phase (CDP)||162
3247220|NCT02474069|3981042|FG002|STARTED|Comparative Dosing Phase (CDP)||163
3247221|NCT02474069|3981040|FG000|COMPLETED|Comparative Dosing Phase (CDP)||0
3247222|NCT02474069|3981041|FG001|COMPLETED|Comparative Dosing Phase (CDP)||153
3247223|NCT02474069|3981042|FG002|COMPLETED|Comparative Dosing Phase (CDP)||157
3247224|NCT02474069|3981040|FG000|NOT COMPLETED|Comparative Dosing Phase (CDP)||0
3247225|NCT02474069|3981041|FG001|NOT COMPLETED|Comparative Dosing Phase (CDP)||9
3247226|NCT02474069|3981042|FG002|NOT COMPLETED|Comparative Dosing Phase (CDP)||6
3247227|NCT02474082|3981054|FG000|STARTED|Overall Study||105
3247228|NCT02474082|3981055|FG001|STARTED|Overall Study||97
3247229|NCT02474082|3981054|FG000|Full Analysis Set (FAS)|Overall Study||105
3247230|NCT02474082|3981055|FG001|Full Analysis Set (FAS)|Overall Study||95
3247231|NCT02474082|3981054|FG000|COMPLETED|Overall Study||99
3247232|NCT02474082|3981055|FG001|COMPLETED|Overall Study||43
3247233|NCT02474082|3981054|FG000|NOT COMPLETED|Overall Study||6
3247234|NCT02474082|3981055|FG001|NOT COMPLETED|Overall Study||54
3247235|NCT02474199|3981063|FG000|STARTED|Overall Study||5
3247236|NCT02474199|3981064|FG001|STARTED|Overall Study|Insufficient numbers of darTregs for infusion (4 of these 5 participants)|5
3247237|NCT02474199|3981065|FG002|STARTED|Overall Study||2
3247238|NCT02474199|3981066|FG003|STARTED|Overall Study||3
3247239|NCT02474199|3981063|FG000|COMPLETED|Overall Study||3
3247240|NCT02474199|3981064|FG001|COMPLETED|Overall Study||2
3247241|NCT02474199|3981065|FG002|COMPLETED|Overall Study||0
3247242|NCT02474199|3981066|FG003|COMPLETED|Overall Study||0
3247243|NCT02474199|3981063|FG000|NOT COMPLETED|Overall Study||2
3247244|NCT02474199|3981064|FG001|NOT COMPLETED|Overall Study||3
3247245|NCT02474199|3981065|FG002|NOT COMPLETED|Overall Study||2
3247246|NCT02474199|3981066|FG003|NOT COMPLETED|Overall Study||3
3247247|NCT02474355|3981073|FG000|STARTED|Overall Study||3014
3247248|NCT02474355|3981073|FG000|COMPLETED|Overall Study||1386
3247249|NCT02474355|3981073|FG000|NOT COMPLETED|Overall Study||1628
3247250|NCT02474407|3981077|FG000|STARTED|First Intervention (14 Days)||39
3247251|NCT02474407|3981078|FG001|STARTED|First Intervention (14 Days)||39
3247252|NCT02474407|3981077|FG000|COMPLETED|First Intervention (14 Days)||39
3247253|NCT02474407|3981078|FG001|COMPLETED|First Intervention (14 Days)||39
3247254|NCT02474407|3981077|FG000|NOT COMPLETED|First Intervention (14 Days)||0
3247255|NCT02474407|3981078|FG001|NOT COMPLETED|First Intervention (14 Days)||0
3247256|NCT02474407|3981077|FG000|STARTED|Washout (14 Days)||39
3247257|NCT02474407|3981078|FG001|STARTED|Washout (14 Days)||39
3247258|NCT02474407|3981077|FG000|COMPLETED|Washout (14 Days)||39
3247259|NCT02474407|3981078|FG001|COMPLETED|Washout (14 Days)||39
3247260|NCT02474407|3981077|FG000|NOT COMPLETED|Washout (14 Days)||0
3247261|NCT02474407|3981078|FG001|NOT COMPLETED|Washout (14 Days)||0
3247262|NCT02474407|3981077|FG000|STARTED|Second Intervention (14 Days)||39
3247263|NCT02474407|3981078|FG001|STARTED|Second Intervention (14 Days)||39
3247264|NCT02474407|3981077|FG000|COMPLETED|Second Intervention (14 Days)||39
3247265|NCT02474407|3981078|FG001|COMPLETED|Second Intervention (14 Days)||39
3247266|NCT02474407|3981077|FG000|NOT COMPLETED|Second Intervention (14 Days)||0
3247267|NCT02474407|3981078|FG001|NOT COMPLETED|Second Intervention (14 Days)||0
3247268|NCT02474498|3981107|FG000|STARTED|Overall Study||13
3247269|NCT02474498|3981108|FG001|STARTED|Overall Study||14
3247270|NCT02474498|3981109|FG002|STARTED|Overall Study||14
3247271|NCT02474498|3981107|FG000|COMPLETED|Overall Study||13
3247272|NCT02474498|3981108|FG001|COMPLETED|Overall Study||14
3247273|NCT02474498|3981109|FG002|COMPLETED|Overall Study||14
3247274|NCT02474498|3981107|FG000|NOT COMPLETED|Overall Study||0
3247275|NCT02474498|3981108|FG001|NOT COMPLETED|Overall Study||0
3247276|NCT02474498|3981109|FG002|NOT COMPLETED|Overall Study||0
3247277|NCT02474589|3981123|FG000|STARTED|Overall Study||359
3247278|NCT02474589|3981124|FG001|STARTED|Overall Study||90
3247279|NCT02474589|3981123|FG000|COMPLETED|Overall Study||334
3247280|NCT02474589|3981124|FG001|COMPLETED|Overall Study||85
3247281|NCT02474589|3981123|FG000|NOT COMPLETED|Overall Study||25
3247282|NCT02474589|3981124|FG001|NOT COMPLETED|Overall Study||5
3247283|NCT02474901|3981132|FG000|STARTED|Overall Study||45
3247284|NCT02474901|3981133|FG001|STARTED|Overall Study||56
3247285|NCT02474901|3981132|FG000|COMPLETED|Overall Study||44
3247286|NCT02474901|3981133|FG001|COMPLETED|Overall Study||56
3247287|NCT02474901|3981132|FG000|NOT COMPLETED|Overall Study||1
3247288|NCT02474901|3981133|FG001|NOT COMPLETED|Overall Study||0
3247289|NCT02475031|3981141|FG000|STARTED|Overall Study||35
3247290|NCT02475031|3981142|FG001|STARTED|Overall Study||35
3247291|NCT02475031|3981141|FG000|COMPLETED|Overall Study||35
3247292|NCT02475031|3981142|FG001|COMPLETED|Overall Study||35
3247293|NCT02475031|3981141|FG000|NOT COMPLETED|Overall Study||0
3247294|NCT02475031|3981142|FG001|NOT COMPLETED|Overall Study||0
3247295|NCT02475070|3981152|FG000|STARTED|Overall Study||17
3247296|NCT02475070|3981153|FG001|STARTED|Overall Study||11
3247297|NCT02475070|3981152|FG000|COMPLETED|Overall Study||17
3247298|NCT02475070|3981153|FG001|COMPLETED|Overall Study||11
3247299|NCT02475070|3981152|FG000|NOT COMPLETED|Overall Study||0
3247300|NCT02475070|3981153|FG001|NOT COMPLETED|Overall Study||0
3247301|NCT02475265|3981160|FG000|STARTED|Overall Study||11
3247302|NCT02475265|3981160|FG000|COMPLETED|Overall Study||8
3247303|NCT02475265|3981160|FG000|NOT COMPLETED|Overall Study||3
3247304|NCT02475278|3981164|FG000|STARTED|Overall Study||50
3247305|NCT02475278|3981164|FG000|COMPLETED|Overall Study||48
3247306|NCT02475278|3981164|FG000|NOT COMPLETED|Overall Study||2
3247307|NCT02475369|3981168|FG000|STARTED|Run-in Washout Period #1 (7 Days)||10
3247308|NCT02475369|3981169|FG001|STARTED|Run-in Washout Period #1 (7 Days)||11
3247309|NCT02475369|3981168|FG000|COMPLETED|Run-in Washout Period #1 (7 Days)||3
3247310|NCT02475369|3981169|FG001|COMPLETED|Run-in Washout Period #1 (7 Days)||9
3247311|NCT02475369|3981168|FG000|NOT COMPLETED|Run-in Washout Period #1 (7 Days)||7
3247312|NCT02475369|3981169|FG001|NOT COMPLETED|Run-in Washout Period #1 (7 Days)||2
3247313|NCT02475369|3981168|FG000|STARTED|Treatment Period #1 (10 Days)||3
3247314|NCT02475369|3981169|FG001|STARTED|Treatment Period #1 (10 Days)||9
3247315|NCT02475369|3981168|FG000|COMPLETED|Treatment Period #1 (10 Days)||3
3247316|NCT02475369|3981169|FG001|COMPLETED|Treatment Period #1 (10 Days)||9
3247317|NCT02475369|3981168|FG000|NOT COMPLETED|Treatment Period #1 (10 Days)||0
3247318|NCT02475369|3981169|FG001|NOT COMPLETED|Treatment Period #1 (10 Days)||0
3247319|NCT02475369|3981168|FG000|STARTED|Run-in Washout Period #2 (7 Days)||3
3247320|NCT02475369|3981169|FG001|STARTED|Run-in Washout Period #2 (7 Days)||9
3247321|NCT02475369|3981168|FG000|COMPLETED|Run-in Washout Period #2 (7 Days)||3
3247322|NCT02475369|3981169|FG001|COMPLETED|Run-in Washout Period #2 (7 Days)||9
3247323|NCT02475369|3981168|FG000|NOT COMPLETED|Run-in Washout Period #2 (7 Days)||0
3247324|NCT02475369|3981169|FG001|NOT COMPLETED|Run-in Washout Period #2 (7 Days)||0
3247325|NCT02475369|3981168|FG000|STARTED|Treatment Period #2 (10 Days)||3
3247326|NCT02475369|3981169|FG001|STARTED|Treatment Period #2 (10 Days)||9
3247327|NCT02475369|3981168|FG000|COMPLETED|Treatment Period #2 (10 Days)||3
3247328|NCT02475369|3981169|FG001|COMPLETED|Treatment Period #2 (10 Days)||9
3247329|NCT02475369|3981168|FG000|NOT COMPLETED|Treatment Period #2 (10 Days)||0
3247330|NCT02475369|3981169|FG001|NOT COMPLETED|Treatment Period #2 (10 Days)||0
3247331|NCT02475395|3981182|FG000|STARTED|Overall Study||258
3247332|NCT02475395|3981183|FG001|STARTED|Overall Study||14
3247333|NCT02475395|3981182|FG000|COMPLETED|Overall Study||228
3247334|NCT02475395|3981183|FG001|COMPLETED|Overall Study||11
3247335|NCT02475395|3981182|FG000|NOT COMPLETED|Overall Study||30
3247336|NCT02475395|3981183|FG001|NOT COMPLETED|Overall Study||3
3247337|NCT02475564|3981191|FG000|STARTED|Overall Study||22
3247338|NCT02475564|3981192|FG001|STARTED|Overall Study||22
3247339|NCT02475564|3981191|FG000|COMPLETED|Overall Study||18
3247340|NCT02475564|3981192|FG001|COMPLETED|Overall Study||21
3247341|NCT02475564|3981191|FG000|NOT COMPLETED|Overall Study||4
3247342|NCT02475564|3981192|FG001|NOT COMPLETED|Overall Study||1
3247343|NCT02475629|3981198|FG000|STARTED|Overall Study||40
3247344|NCT02475629|3981198|FG000|COMPLETED|Overall Study||31
3247345|NCT02475629|3981198|FG000|NOT COMPLETED|Overall Study||9
3247346|NCT02475655|3981204|FG000|STARTED|Overall Study||40
3247347|NCT02475655|3981205|FG001|STARTED|Overall Study||20
3247348|NCT02475655|3981204|FG000|COMPLETED|Overall Study||40
3247349|NCT02475655|3981205|FG001|COMPLETED|Overall Study||19
3247350|NCT02475655|3981204|FG000|NOT COMPLETED|Overall Study||0
3247351|NCT02475655|3981205|FG001|NOT COMPLETED|Overall Study||1
3247352|NCT02475733|3981213|FG000|STARTED|Overall Study||61
3247353|NCT02475733|3981214|FG001|STARTED|Overall Study||22
3247354|NCT02475733|3981213|FG000|COMPLETED|Overall Study||59
3247355|NCT02475733|3981214|FG001|COMPLETED|Overall Study||22
3247356|NCT02475733|3981213|FG000|NOT COMPLETED|Overall Study||2
3247357|NCT02475733|3981214|FG001|NOT COMPLETED|Overall Study||0
3247358|NCT02475837|3981222|FG000|STARTED|Overall Study||6
3247359|NCT02475837|3981223|FG001|STARTED|Overall Study||7
3247360|NCT02475837|3981222|FG000|COMPLETED|Overall Study||6
3247361|NCT02475837|3981223|FG001|COMPLETED|Overall Study||7
3247362|NCT02475837|3981222|FG000|NOT COMPLETED|Overall Study||0
3247363|NCT02475837|3981223|FG001|NOT COMPLETED|Overall Study||0
3247364|NCT02475850|3981231|FG000|STARTED|Overall Study||2802
3247365|NCT02475850|3981232|FG001|STARTED|Overall Study||2649
3247366|NCT02475850|3981231|FG000|COMPLETED|Overall Study||2209
3247367|NCT02475850|3981232|FG001|COMPLETED|Overall Study||2165
3247368|NCT02475850|3981231|FG000|NOT COMPLETED|Overall Study||593
3247369|NCT02475850|3981232|FG001|NOT COMPLETED|Overall Study||484
3247370|NCT02475954|3981241|FG000|STARTED|Overall Study||87
3247371|NCT02475954|3981242|FG001|STARTED|Overall Study||87
3247372|NCT02475954|3981241|FG000|COMPLETED|Overall Study||73
3247373|NCT02475954|3981242|FG001|COMPLETED|Overall Study||75
3247374|NCT02475954|3981241|FG000|NOT COMPLETED|Overall Study||14
3247375|NCT02475954|3981242|FG001|NOT COMPLETED|Overall Study||12
3247376|NCT02475980|3981249|FG000|STARTED|Overall Study||13
3247377|NCT02475980|3981249|FG000|COMPLETED|Overall Study||8
3247378|NCT02475980|3981249|FG000|NOT COMPLETED|Overall Study||5
3247379|NCT02476006|3981253|FG000|STARTED|Overall Study||998
3247380|NCT02476006|3981253|FG000|Treated|Overall Study||994
3247381|NCT02476006|3981253|FG000|COMPLETED|Overall Study||878
3247382|NCT02476006|3981253|FG000|NOT COMPLETED|Overall Study||120
3247383|NCT02476032|3981260|FG000|STARTED|Overall Study||20
3247384|NCT02476032|3981261|FG001|STARTED|Overall Study||20
3247385|NCT02476032|3981262|FG002|STARTED|Overall Study||20
3247386|NCT02476032|3981260|FG000|COMPLETED|Overall Study||20
3247387|NCT02476032|3981261|FG001|COMPLETED|Overall Study||19
3247388|NCT02476032|3981262|FG002|COMPLETED|Overall Study||19
3247389|NCT02476032|3981260|FG000|NOT COMPLETED|Overall Study||0
3247390|NCT02476032|3981261|FG001|NOT COMPLETED|Overall Study||1
3247391|NCT02476032|3981262|FG002|NOT COMPLETED|Overall Study||1
3247392|NCT02476175|3981273|FG000|STARTED|Overall Study||35
3247393|NCT02476175|3981273|FG000|COMPLETED|Overall Study||33
3247394|NCT02476175|3981273|FG000|NOT COMPLETED|Overall Study||2
3247395|NCT02476201|3981277|FG000|STARTED|Overall Study||105
3247396|NCT02476201|3981277|FG000|Implant Attempts|Overall Study||103
3247397|NCT02476201|3981277|FG000|Sucessful Implants|Overall Study||102
3247398|NCT02476201|3981277|FG000|6 Months Visit|Overall Study||82
3247399|NCT02476201|3981277|FG000|COMPLETED|Overall Study||79
3247400|NCT02476201|3981277|FG000|NOT COMPLETED|Overall Study||26
3247401|NCT02476357|3981284|FG000|STARTED|Overall Study||40
3247402|NCT02476357|3981285|FG001|STARTED|Overall Study||40
3247403|NCT02476357|3981284|FG000|COMPLETED|Overall Study||40
3247404|NCT02476357|3981285|FG001|COMPLETED|Overall Study||40
3247405|NCT02476357|3981284|FG000|NOT COMPLETED|Overall Study||0
3247406|NCT02476357|3981285|FG001|NOT COMPLETED|Overall Study||0
3247407|NCT02476422|3981295|FG000|STARTED|Overall Study|"started = Randomized Set/Full analysis set/Safety set"|166
3247408|NCT02476422|3981296|FG001|STARTED|Overall Study||162
3247409|NCT02476422|3981295|FG000|COMPLETED|Overall Study||166
3247410|NCT02476422|3981296|FG001|COMPLETED|Overall Study||161
3247411|NCT02476422|3981295|FG000|NOT COMPLETED|Overall Study||0
3247412|NCT02476422|3981296|FG001|NOT COMPLETED|Overall Study||1
3247413|NCT02476448|3981306|FG000|STARTED|Overall Study|one given phenazopyridine pre-op and was analyzed in her randomization group per intention to treat|44
3247414|NCT02476448|3981307|FG001|STARTED|Overall Study||44
3247415|NCT02476448|3981308|FG002|STARTED|Overall Study||44
3247416|NCT02476448|3981309|FG003|STARTED|Overall Study||44
3247417|NCT02476448|3981306|FG000|COMPLETED|Overall Study||44
3247418|NCT02476448|3981307|FG001|COMPLETED|Overall Study||44
3247419|NCT02476448|3981308|FG002|COMPLETED|Overall Study||44
3247420|NCT02476448|3981309|FG003|COMPLETED|Overall Study||44
3247421|NCT02476448|3981306|FG000|NOT COMPLETED|Overall Study||0
3247422|NCT02476448|3981307|FG001|NOT COMPLETED|Overall Study||0
3247423|NCT02476448|3981308|FG002|NOT COMPLETED|Overall Study||0
3247424|NCT02476448|3981309|FG003|NOT COMPLETED|Overall Study||0
3247425|NCT02476565|3981321|FG000|STARTED|Overall Study||20
3247426|NCT02476565|3981322|FG001|STARTED|Overall Study||19
3247427|NCT02476565|3981321|FG000|COMPLETED|Overall Study||20
3247428|NCT02476565|3981322|FG001|COMPLETED|Overall Study||19
3247429|NCT02476565|3981321|FG000|NOT COMPLETED|Overall Study||0
3247430|NCT02476565|3981322|FG001|NOT COMPLETED|Overall Study||0
3247431|NCT02476578|3981330|FG000|STARTED|Overall Study||4310
3247432|NCT02476578|3981331|FG001|STARTED|Overall Study||4274
3247433|NCT02476578|3981330|FG000|Died Before Email Was Sent|Overall Study||35
3247434|NCT02476578|3981331|FG001|Died Before Email Was Sent|Overall Study||43
3247435|NCT02476578|3981330|FG000|Left Before End of Trial|Overall Study||6
3247436|NCT02476578|3981331|FG001|Left Before End of Trial|Overall Study||13
3247437|NCT02476578|3981330|FG000|COMPLETED|Overall Study||4269
3247438|NCT02476578|3981331|FG001|COMPLETED|Overall Study||4218
3247439|NCT02476578|3981330|FG000|NOT COMPLETED|Overall Study||41
3247440|NCT02476578|3981331|FG001|NOT COMPLETED|Overall Study||56
3247441|NCT02476617|3981337|FG000|STARTED|Overall Study||25
3247442|NCT02476617|3981337|FG000|COMPLETED|Overall Study||23
3247443|NCT02476617|3981337|FG000|NOT COMPLETED|Overall Study||2
3247444|NCT02476890|3981345|FG000|STARTED|Overall Study|Crossover study|6
3247445|NCT02476890|3981346|FG001|STARTED|Overall Study|Crossover study|6
3247446|NCT02476890|3981347|FG002|STARTED|Overall Study|Crossover study|12
3247447|NCT02476890|3981348|FG003|STARTED|Overall Study|Crossover study|12
3247448|NCT02476890|3981345|FG000|Washout|Overall Study||6
3247449|NCT02476890|3981346|FG001|Washout|Overall Study||6
3247450|NCT02476890|3981347|FG002|Washout|Overall Study||12
3247451|NCT02476890|3981348|FG003|Washout|Overall Study||12
3247452|NCT02476890|3981345|FG000|COMPLETED|Overall Study||6
3247453|NCT02476890|3981346|FG001|COMPLETED|Overall Study||6
3247454|NCT02476890|3981347|FG002|COMPLETED|Overall Study||12
3247455|NCT02476890|3981348|FG003|COMPLETED|Overall Study||12
3247456|NCT02476890|3981345|FG000|NOT COMPLETED|Overall Study||0
3247457|NCT02476890|3981346|FG001|NOT COMPLETED|Overall Study||0
3247458|NCT02476890|3981347|FG002|NOT COMPLETED|Overall Study||0
3247459|NCT02476890|3981348|FG003|NOT COMPLETED|Overall Study||0
3247460|NCT02477020|3981362|FG000|STARTED|Overall Study||81
3247461|NCT02477020|3981363|FG001|STARTED|Overall Study||83
3247462|NCT02477020|3981362|FG000|COMPLETED|Overall Study|Completed = participants who completed study treatment.|51
3247463|NCT02477020|3981363|FG001|COMPLETED|Overall Study|Completed = participants who completed study treatment.|55
3247464|NCT02477020|3981362|FG000|NOT COMPLETED|Overall Study||30
3247465|NCT02477020|3981363|FG001|NOT COMPLETED|Overall Study||28
3247466|NCT02477111|3981369|FG000|STARTED|Overall Study||150
3247467|NCT02477111|3981369|FG000|COMPLETED|Overall Study|All participants who were assessed for one year|139
3247468|NCT02477111|3981369|FG000|NOT COMPLETED|Overall Study||11
3247469|NCT02477215|3981379|FG000|STARTED|Dose Escalation Phase||4
3247470|NCT02477215|3981380|FG001|STARTED|Dose Escalation Phase||8
3247471|NCT02477215|3981381|FG002|STARTED|Dose Escalation Phase||6
3247472|NCT02477215|3981379|FG000|COMPLETED|Dose Escalation Phase||3
3247473|NCT02477215|3981380|FG001|COMPLETED|Dose Escalation Phase||6
3247474|NCT02477215|3981381|FG002|COMPLETED|Dose Escalation Phase||6
3247475|NCT02477215|3981379|FG000|NOT COMPLETED|Dose Escalation Phase||1
3247476|NCT02477215|3981380|FG001|NOT COMPLETED|Dose Escalation Phase||2
3247477|NCT02477215|3981381|FG002|NOT COMPLETED|Dose Escalation Phase||0
3247478|NCT02477215|3981379|FG000|STARTED|Fixed Dose Phase|No subjects were started in this group as it was not the optimal dose.|0
3247479|NCT02477215|3981380|FG001|STARTED|Fixed Dose Phase|Subjects in Period 1 did not continue into Period 2. This is a new subject population.|20
3247480|NCT02477215|3981381|FG002|STARTED|Fixed Dose Phase|No subjects were started in this group as it was not the optimal dose.|0
3247481|NCT02477215|3981379|FG000|COMPLETED|Fixed Dose Phase||0
3247482|NCT02477215|3981380|FG001|COMPLETED|Fixed Dose Phase||13
3247483|NCT02477215|3981381|FG002|COMPLETED|Fixed Dose Phase||0
3247484|NCT02477215|3981379|FG000|NOT COMPLETED|Fixed Dose Phase||0
3247485|NCT02477215|3981380|FG001|NOT COMPLETED|Fixed Dose Phase||7
3247486|NCT02477215|3981381|FG002|NOT COMPLETED|Fixed Dose Phase||0
3247487|NCT02477319|3981396|FG000|STARTED|Overall Study||55
3247488|NCT02477319|3981397|FG001|STARTED|Overall Study||40
3247489|NCT02477319|3981398|FG002|STARTED|Overall Study||164
3247490|NCT02477319|3981399|FG003|STARTED|Overall Study||193
3247491|NCT02477319|3981396|FG000|COMPLETED|Overall Study||55
3247492|NCT02477319|3981397|FG001|COMPLETED|Overall Study||37
3247493|NCT02477319|3981398|FG002|COMPLETED|Overall Study||149
3247494|NCT02477319|3981399|FG003|COMPLETED|Overall Study||171
3247495|NCT02477319|3981396|FG000|NOT COMPLETED|Overall Study||0
3247496|NCT02477319|3981397|FG001|NOT COMPLETED|Overall Study||3
3247497|NCT02477319|3981398|FG002|NOT COMPLETED|Overall Study||15
3247498|NCT02477319|3981399|FG003|NOT COMPLETED|Overall Study||22
3247499|NCT02477332|3981412|FG000|STARTED|Overall Study||43
3247500|NCT02477332|3981413|FG001|STARTED|Overall Study||84
3247501|NCT02477332|3981414|FG002|STARTED|Overall Study||85
3247502|NCT02477332|3981415|FG003|STARTED|Overall Study||85
3247503|NCT02477332|3981416|FG004|STARTED|Overall Study||43
3247504|NCT02477332|3981417|FG005|STARTED|Overall Study||42
3247505|NCT02477332|3981412|FG000|COMPLETED|Overall Study||40
3247506|NCT02477332|3981413|FG001|COMPLETED|Overall Study||77
3247507|NCT02477332|3981414|FG002|COMPLETED|Overall Study||73
3247508|NCT02477332|3981415|FG003|COMPLETED|Overall Study||72
3247509|NCT02477332|3981416|FG004|COMPLETED|Overall Study||39
3247510|NCT02477332|3981417|FG005|COMPLETED|Overall Study||37
3247511|NCT02477332|3981412|FG000|NOT COMPLETED|Overall Study||3
3247512|NCT02477332|3981413|FG001|NOT COMPLETED|Overall Study||7
3247513|NCT02477332|3981414|FG002|NOT COMPLETED|Overall Study||12
3247514|NCT02477332|3981415|FG003|NOT COMPLETED|Overall Study||13
3247515|NCT02477332|3981416|FG004|NOT COMPLETED|Overall Study||4
3247516|NCT02477332|3981417|FG005|NOT COMPLETED|Overall Study||5
3247517|NCT02477423|3981435|FG000|STARTED|Overall Study||12
3247518|NCT02477423|3981436|FG001|STARTED|Overall Study||15
3247519|NCT02477423|3981435|FG000|COMPLETED|Overall Study||11
3247520|NCT02477423|3981436|FG001|COMPLETED|Overall Study||11
3247521|NCT02477423|3981435|FG000|NOT COMPLETED|Overall Study||1
3247522|NCT02477423|3981436|FG001|NOT COMPLETED|Overall Study||4
3247523|NCT02477527|3981442|FG000|STARTED|Overall Study||27
3247524|NCT02477527|3981442|FG000|COMPLETED|Overall Study||21
3247525|NCT02477527|3981442|FG000|NOT COMPLETED|Overall Study||6
3247526|NCT02477553|3981448|FG000|STARTED|Overall Study||364
3247527|NCT02477553|3981449|FG001|STARTED|Overall Study||364
3247528|NCT02477553|3981448|FG000|COMPLETED|Overall Study||344
3247529|NCT02477553|3981449|FG001|COMPLETED|Overall Study||344
3247530|NCT02477553|3981448|FG000|NOT COMPLETED|Overall Study||20
3247531|NCT02477553|3981449|FG001|NOT COMPLETED|Overall Study||20
3247532|NCT02477605|3981457|FG000|STARTED|Overall Study||68
3247533|NCT02477605|3981458|FG001|STARTED|Overall Study||68
3247534|NCT02477605|3981457|FG000|Randomized and Treated|Overall Study||67
3247535|NCT02477605|3981458|FG001|Randomized and Treated|Overall Study||68
3247536|NCT02477605|3981457|FG000|COMPLETED|Overall Study||67
3247537|NCT02477605|3981458|FG001|COMPLETED|Overall Study||64
3247538|NCT02477605|3981457|FG000|NOT COMPLETED|Overall Study||1
3247539|NCT02477605|3981458|FG001|NOT COMPLETED|Overall Study||4
3247540|NCT02477670|3981470|FG000|STARTED|Stage 1||47
3247541|NCT02477670|3981471|FG001|STARTED|Stage 1||80
3247542|NCT02477670|3981472|FG002|STARTED|Stage 1||0
3247543|NCT02477670|3981473|FG003|STARTED|Stage 1||0
3247544|NCT02477670|3981474|FG004|STARTED|Stage 1||0
3247545|NCT02477670|3981475|FG005|STARTED|Stage 1||0
3247546|NCT02477670|3981476|FG006|STARTED|Stage 1||0
3247547|NCT02477670|3981470|FG000|COMPLETED|Stage 1||43
3247548|NCT02477670|3981471|FG001|COMPLETED|Stage 1||67
3247549|NCT02477670|3981472|FG002|COMPLETED|Stage 1||0
3247550|NCT02477670|3981473|FG003|COMPLETED|Stage 1||0
3247551|NCT02477670|3981474|FG004|COMPLETED|Stage 1||0
3247552|NCT02477670|3981475|FG005|COMPLETED|Stage 1||0
3247553|NCT02477670|3981476|FG006|COMPLETED|Stage 1||0
3247554|NCT02477670|3981470|FG000|NOT COMPLETED|Stage 1||4
3247555|NCT02477670|3981471|FG001|NOT COMPLETED|Stage 1||13
3247556|NCT02477670|3981472|FG002|NOT COMPLETED|Stage 1||0
3247557|NCT02477670|3981473|FG003|NOT COMPLETED|Stage 1||0
3247558|NCT02477670|3981474|FG004|NOT COMPLETED|Stage 1||0
3247559|NCT02477670|3981475|FG005|NOT COMPLETED|Stage 1||0
3247560|NCT02477670|3981476|FG006|NOT COMPLETED|Stage 1||0
3247561|NCT02477670|3981470|FG000|STARTED|Stage 2||0
3247562|NCT02477670|3981471|FG001|STARTED|Stage 2||0
3247563|NCT02477670|3981472|FG002|STARTED|Stage 2||30
3247564|NCT02477670|3981473|FG003|STARTED|Stage 2||33
3247565|NCT02477670|3981474|FG004|STARTED|Stage 2||2
3247566|NCT02477670|3981475|FG005|STARTED|Stage 2||1
3247567|NCT02477670|3981476|FG006|STARTED|Stage 2||42
3247568|NCT02477670|3981470|FG000|COMPLETED|Stage 2||0
3247569|NCT02477670|3981471|FG001|COMPLETED|Stage 2||0
3247570|NCT02477670|3981472|FG002|COMPLETED|Stage 2||28
3247571|NCT02477670|3981473|FG003|COMPLETED|Stage 2||32
3247572|NCT02477670|3981474|FG004|COMPLETED|Stage 2||2
3247573|NCT02477670|3981475|FG005|COMPLETED|Stage 2||1
3247574|NCT02477670|3981476|FG006|COMPLETED|Stage 2||42
3247575|NCT02477670|3981470|FG000|NOT COMPLETED|Stage 2||0
3247576|NCT02477670|3981471|FG001|NOT COMPLETED|Stage 2||0
3247577|NCT02477670|3981472|FG002|NOT COMPLETED|Stage 2||2
3247578|NCT02477670|3981473|FG003|NOT COMPLETED|Stage 2||1
3247579|NCT02477670|3981474|FG004|NOT COMPLETED|Stage 2||0
3247580|NCT02477670|3981475|FG005|NOT COMPLETED|Stage 2||0
3247581|NCT02477670|3981476|FG006|NOT COMPLETED|Stage 2||0
3247582|NCT02477709|3981487|FG000|STARTED|Overall Study||6
3247583|NCT02477709|3981487|FG000|COMPLETED|Overall Study||6
3247584|NCT02477709|3981487|FG000|NOT COMPLETED|Overall Study||0
3247585|NCT02477800|3981494|FG000|STARTED|Placebo-Controlled Period||545
3247586|NCT02477800|3981495|FG001|STARTED|Placebo-Controlled Period||547
3247587|NCT02477800|3981496|FG002|STARTED|Placebo-Controlled Period||555
3247588|NCT02477800|3981497|FG003|STARTED|Placebo-Controlled Period||0
3247589|NCT02477800|3981498|FG004|STARTED|Placebo-Controlled Period||0
3247590|NCT02477800|3981499|FG005|STARTED|Placebo-Controlled Period||0
3247591|NCT02477800|3981500|FG006|STARTED|Placebo-Controlled Period||0
3247592|NCT02477800|3981494|FG000|COMPLETED|Placebo-Controlled Period||325
3247593|NCT02477800|3981495|FG001|COMPLETED|Placebo-Controlled Period||325
3247594|NCT02477800|3981496|FG002|COMPLETED|Placebo-Controlled Period||288
3247595|NCT02477800|3981497|FG003|COMPLETED|Placebo-Controlled Period||0
3247596|NCT02477800|3981498|FG004|COMPLETED|Placebo-Controlled Period||0
3247597|NCT02477800|3981499|FG005|COMPLETED|Placebo-Controlled Period||0
3247598|NCT02477800|3981500|FG006|COMPLETED|Placebo-Controlled Period||0
3247599|NCT02477800|3981494|FG000|NOT COMPLETED|Placebo-Controlled Period||220
3247600|NCT02477800|3981495|FG001|NOT COMPLETED|Placebo-Controlled Period||222
3247601|NCT02477800|3981496|FG002|NOT COMPLETED|Placebo-Controlled Period||267
3247602|NCT02477800|3981497|FG003|NOT COMPLETED|Placebo-Controlled Period||0
3247603|NCT02477800|3981498|FG004|NOT COMPLETED|Placebo-Controlled Period||0
3247604|NCT02477800|3981499|FG005|NOT COMPLETED|Placebo-Controlled Period||0
3247605|NCT02477800|3981500|FG006|NOT COMPLETED|Placebo-Controlled Period||0
3247606|NCT02477800|3981494|FG000|STARTED|Long Term Extension Period||0
3247607|NCT02477800|3981495|FG001|STARTED|Long Term Extension Period||0
3247608|NCT02477800|3981496|FG002|STARTED|Long Term Extension Period||0
3247609|NCT02477800|3981497|FG003|STARTED|Long Term Extension Period|12 PC completers did not enter LTE.|150
3247610|NCT02477800|3981498|FG004|STARTED|Long Term Extension Period|11 PC completers did not enter LTE.|152
3247611|NCT02477800|3981499|FG005|STARTED|Long Term Extension Period|26 PC completers did not enter LTE.|299
3247612|NCT02477800|3981500|FG006|STARTED|Long Term Extension Period|37 PC completers did not enter LTE.|251
3247613|NCT02477800|3981494|FG000|COMPLETED|Long Term Extension Period||0
3247614|NCT02477800|3981495|FG001|COMPLETED|Long Term Extension Period||0
3247615|NCT02477800|3981496|FG002|COMPLETED|Long Term Extension Period||0
3247616|NCT02477800|3981497|FG003|COMPLETED|Long Term Extension Period||0
3247617|NCT02477800|3981498|FG004|COMPLETED|Long Term Extension Period||0
3247618|NCT02477800|3981499|FG005|COMPLETED|Long Term Extension Period||0
3247619|NCT02477800|3981500|FG006|COMPLETED|Long Term Extension Period||0
3247620|NCT02477800|3981494|FG000|NOT COMPLETED|Long Term Extension Period||0
3247621|NCT02477800|3981495|FG001|NOT COMPLETED|Long Term Extension Period||0
3247622|NCT02477800|3981496|FG002|NOT COMPLETED|Long Term Extension Period||0
3247623|NCT02477800|3981497|FG003|NOT COMPLETED|Long Term Extension Period||150
3247624|NCT02477800|3981498|FG004|NOT COMPLETED|Long Term Extension Period||152
3247625|NCT02477800|3981499|FG005|NOT COMPLETED|Long Term Extension Period||299
3247626|NCT02477800|3981500|FG006|NOT COMPLETED|Long Term Extension Period||251
3247627|NCT02477839|3981514|FG000|STARTED|Overall Study||127
3247628|NCT02477839|3981515|FG001|STARTED|Overall Study||128
3247629|NCT02477839|3981514|FG000|Completed Transition Period|Overall Study||124
3247630|NCT02477839|3981515|FG001|Completed Transition Period|Overall Study||117
3247631|NCT02477839|3981514|FG000|Completed Taper After Maintenance|Overall Study||0
3247632|NCT02477839|3981515|FG001|Completed Taper After Maintenance|Overall Study||1
3247633|NCT02477839|3981514|FG000|COMPLETED|Overall Study||124
3247634|NCT02477839|3981515|FG001|COMPLETED|Overall Study||118
3247635|NCT02477839|3981514|FG000|NOT COMPLETED|Overall Study||3
3247636|NCT02477839|3981515|FG001|NOT COMPLETED|Overall Study||10
3247637|NCT02478164|3981523|FG000|STARTED|Overall Study|17 participants enrolled. 15 of 17 received ponatinib as 2 participants withdrew prior to ponatinib.|15
3247638|NCT02478164|3981523|FG000|COMPLETED|Overall Study||0
3247639|NCT02478164|3981523|FG000|NOT COMPLETED|Overall Study||15
3247640|NCT02478359|3981529|FG000|STARTED|Overall Study||1349
3247641|NCT02478359|3981530|FG001|STARTED|Overall Study||1358
3247642|NCT02478359|3981529|FG000|Intention-to-treat Population Month 12|Overall Study|Disenrolled from health plan: 106|1243
3247643|NCT02478359|3981530|FG001|Intention-to-treat Population Month 12|Overall Study|Disenrolled from health plan: 65|1293
3247644|NCT02478359|3981529|FG000|COMPLETED|Overall Study||1243
3247645|NCT02478359|3981530|FG001|COMPLETED|Overall Study||1293
3247646|NCT02478359|3981529|FG000|NOT COMPLETED|Overall Study||106
3247647|NCT02478359|3981530|FG001|NOT COMPLETED|Overall Study||65
3247648|NCT02478372|3981540|FG000|STARTED|Overall Study||121
3247649|NCT02478372|3981541|FG001|STARTED|Overall Study||121
3247650|NCT02478372|3981540|FG000|Recieved Allocation Intervention|Overall Study||109
3247651|NCT02478372|3981541|FG001|Recieved Allocation Intervention|Overall Study||113
3247652|NCT02478372|3981540|FG000|Reviewed at Six Weeks|Overall Study|Routine follow up at six weeks - one patient refused to attend|108
3247653|NCT02478372|3981541|FG001|Reviewed at Six Weeks|Overall Study|Routine follow up at six weeks|113
3247654|NCT02478372|3981540|FG000|Reviewed at One Year|Overall Study|Routine follow up at one year|108
3247655|NCT02478372|3981541|FG001|Reviewed at One Year|Overall Study|Routine folow up at one year - four patients did not attend, two patients died|107
3247656|NCT02478372|3981540|FG000|COMPLETED|Overall Study||108
3247657|NCT02478372|3981541|FG001|COMPLETED|Overall Study||107
3247658|NCT02478372|3981540|FG000|NOT COMPLETED|Overall Study||13
3247659|NCT02478372|3981541|FG001|NOT COMPLETED|Overall Study||14
3371169|NCT03745092|4102755|FG001|STARTED|Overall Study||23
3371170|NCT03745092|4102754|FG000|COMPLETED|Overall Study||26
3371171|NCT03745092|4102755|FG001|COMPLETED|Overall Study||23
3371172|NCT03745092|4102754|FG000|NOT COMPLETED|Overall Study||0
3371173|NCT03745092|4102755|FG001|NOT COMPLETED|Overall Study||0
3371174|NCT03744780|4102761|FG000|STARTED|Overall Study||32
3371175|NCT03744780|4102761|FG000|COMPLETED|Overall Study||32
3371176|NCT03744780|4102761|FG000|NOT COMPLETED|Overall Study||0
3371177|NCT03743311|4102768|FG000|STARTED|Overall Study||311
3371178|NCT03743311|4102769|FG001|STARTED|Overall Study||298
3371179|NCT03743311|4102770|FG002|STARTED|Overall Study||423
3371180|NCT03743311|4102768|FG000|COMPLETED|Overall Study||311
3371181|NCT03743311|4102769|FG001|COMPLETED|Overall Study||298
3371182|NCT03743311|4102770|FG002|COMPLETED|Overall Study||423
3371183|NCT03743311|4102768|FG000|NOT COMPLETED|Overall Study||0
3371184|NCT03743311|4102769|FG001|NOT COMPLETED|Overall Study||0
3371185|NCT03743311|4102770|FG002|NOT COMPLETED|Overall Study||0
3371186|NCT03743038|4102779|FG000|STARTED|Overall Study||12
3371187|NCT03743038|4102779|FG000|Test Article A|Overall Study||12
3371188|NCT03743038|4102779|FG000|Test Article B|Overall Study||12
3371189|NCT03743038|4102779|FG000|COMPLETED|Overall Study||11
3371190|NCT03743038|4102779|FG000|NOT COMPLETED|Overall Study||1
3371191|NCT03742973|4102787|FG000|STARTED|Overall Study||0
3371192|NCT03742973|4102788|FG001|STARTED|Overall Study||0
3371193|NCT03742973|4102787|FG000|COMPLETED|Overall Study||0
3371194|NCT03742973|4102788|FG001|COMPLETED|Overall Study||0
3371195|NCT03742973|4102787|FG000|NOT COMPLETED|Overall Study||0
3371196|NCT03742973|4102788|FG001|NOT COMPLETED|Overall Study||0
3371197|NCT03742440|4102794|FG000|STARTED|Overall Study||40
3371198|NCT03742440|4102794|FG000|COMPLETED|Overall Study||40
3371199|NCT03742440|4102794|FG000|NOT COMPLETED|Overall Study||0
3371200|NCT03742427|4102798|FG000|STARTED|Overall Study||50
3371201|NCT03742427|4102798|FG000|COMPLETED|Overall Study||50
3371202|NCT03742427|4102798|FG000|NOT COMPLETED|Overall Study||0
3371203|NCT03742271|4102802|FG000|STARTED|Overall Study||127
3371204|NCT03742271|4102802|FG000|COMPLETED|Overall Study||115
3371205|NCT03742271|4102802|FG000|NOT COMPLETED|Overall Study||12
3247660|NCT02478398|3981549|FG000|STARTED|Overall Study||513
3247661|NCT02478398|3981550|FG001|STARTED|Overall Study||512
3247662|NCT02478398|3981549|FG000|Treated|Overall Study||512
3247663|NCT02478398|3981550|FG001|Treated|Overall Study||510
3247664|NCT02478398|3981549|FG000|COMPLETED|Overall Study||461
3247665|NCT02478398|3981550|FG001|COMPLETED|Overall Study||491
3247666|NCT02478398|3981549|FG000|NOT COMPLETED|Overall Study||52
3247667|NCT02478398|3981550|FG001|NOT COMPLETED|Overall Study||21
3247668|NCT02478463|3981557|FG000|STARTED|Treatment Period 1 (Up to Day 29)||19
3247669|NCT02478463|3981557|FG000|COMPLETED|Treatment Period 1 (Up to Day 29)||18
3247670|NCT02478463|3981557|FG000|NOT COMPLETED|Treatment Period 1 (Up to Day 29)||1
3247671|NCT02478463|3981557|FG000|STARTED|Washout Period (Up to 42 Days)||18
3247672|NCT02478463|3981557|FG000|COMPLETED|Washout Period (Up to 42 Days)||17
3247673|NCT02478463|3981557|FG000|NOT COMPLETED|Washout Period (Up to 42 Days)||1
3247674|NCT02478463|3981557|FG000|STARTED|Treatment Period 2 (Up to 52 Weeks)||17
3247675|NCT02478463|3981557|FG000|COMPLETED|Treatment Period 2 (Up to 52 Weeks)||16
3247676|NCT02478463|3981557|FG000|NOT COMPLETED|Treatment Period 2 (Up to 52 Weeks)||1
3247677|NCT02478489|3981565|FG000|STARTED|Overall Study||123
3247678|NCT02478489|3981566|FG001|STARTED|Overall Study||125
3247679|NCT02478489|3981565|FG000|COMPLETED|Overall Study||108
3247680|NCT02478489|3981566|FG001|COMPLETED|Overall Study||109
3247681|NCT02478489|3981565|FG000|NOT COMPLETED|Overall Study||15
3247682|NCT02478489|3981566|FG001|NOT COMPLETED|Overall Study||16
3247683|NCT02478580|3981574|FG000|STARTED|Overall Study||34
3247684|NCT02478580|3981575|FG001|STARTED|Overall Study||33
3247685|NCT02478580|3981574|FG000|COMPLETED|Overall Study||34
3247686|NCT02478580|3981575|FG001|COMPLETED|Overall Study||33
3247687|NCT02478580|3981574|FG000|NOT COMPLETED|Overall Study||0
3247688|NCT02478580|3981575|FG001|NOT COMPLETED|Overall Study||0
3247689|NCT02478632|3981585|FG000|STARTED|Early Switch Phase (Up to Week 52)||53
3247690|NCT02478632|3981586|FG001|STARTED|Early Switch Phase (Up to Week 52)||49
3247691|NCT02478632|3981585|FG000|COMPLETED|Early Switch Phase (Up to Week 52)||49
3247692|NCT02478632|3981586|FG001|COMPLETED|Early Switch Phase (Up to Week 52)||44
3247693|NCT02478632|3981585|FG000|NOT COMPLETED|Early Switch Phase (Up to Week 52)||4
3247694|NCT02478632|3981586|FG001|NOT COMPLETED|Early Switch Phase (Up to Week 52)||5
3247695|NCT02478632|3981585|FG000|STARTED|Late Switch Phase (Week 52 to Week 148)||49
3247696|NCT02478632|3981586|FG001|STARTED|Late Switch Phase (Week 52 to Week 148)||44
3247697|NCT02478632|3981585|FG000|COMPLETED|Late Switch Phase (Week 52 to Week 148)||42
3247698|NCT02478632|3981586|FG001|COMPLETED|Late Switch Phase (Week 52 to Week 148)||40
3247699|NCT02478632|3981585|FG000|NOT COMPLETED|Late Switch Phase (Week 52 to Week 148)||7
3247700|NCT02478632|3981586|FG001|NOT COMPLETED|Late Switch Phase (Week 52 to Week 148)||4
3371206|NCT03742154|4102808|FG000|STARTED|Overall Study||50
3371207|NCT03742154|4102809|FG001|STARTED|Overall Study||49
3371208|NCT03742154|4102808|FG000|COMPLETED|Overall Study||50
3371209|NCT03742154|4102809|FG001|COMPLETED|Overall Study||49
3371210|NCT03742154|4102808|FG000|NOT COMPLETED|Overall Study||0
3371211|NCT03742154|4102809|FG001|NOT COMPLETED|Overall Study||0
3371212|NCT03741725|4102818|FG000|STARTED|Overall Study||101
3371213|NCT03741725|4102819|FG001|STARTED|Overall Study||100
3371214|NCT03741725|4102820|FG002|STARTED|Overall Study||100
3371215|NCT03741725|4102818|FG000|COMPLETED|Overall Study||101
3371216|NCT03741725|4102819|FG001|COMPLETED|Overall Study||100
3371217|NCT03741725|4102820|FG002|COMPLETED|Overall Study||100
3371218|NCT03741725|4102818|FG000|NOT COMPLETED|Overall Study||0
3371219|NCT03741725|4102819|FG001|NOT COMPLETED|Overall Study||0
3371220|NCT03741725|4102820|FG002|NOT COMPLETED|Overall Study||0
3371221|NCT03741088|4102831|FG000|STARTED|Overall Study||8
3371222|NCT03741088|4102831|FG000|COMPLETED|Overall Study||5
3371223|NCT03741088|4102831|FG000|NOT COMPLETED|Overall Study||3
3371224|NCT03741062|4102837|FG000|STARTED|Overall Study||5
3371225|NCT03741062|4102838|FG001|STARTED|Overall Study||6
3371226|NCT03741062|4102837|FG000|COMPLETED|Overall Study||4
3371227|NCT03741062|4102838|FG001|COMPLETED|Overall Study||6
3371228|NCT03741062|4102837|FG000|NOT COMPLETED|Overall Study||1
3371229|NCT03741062|4102838|FG001|NOT COMPLETED|Overall Study||0
3371230|NCT03740659|4102847|FG000|STARTED|Overall Study||42
3371231|NCT03740659|4102848|FG001|STARTED|Overall Study||42
3371232|NCT03740659|4102849|FG002|STARTED|Overall Study||41
3371233|NCT03740659|4102847|FG000|COMPLETED|Overall Study||42
3371234|NCT03740659|4102848|FG001|COMPLETED|Overall Study||42
3371235|NCT03740659|4102849|FG002|COMPLETED|Overall Study||41
3371236|NCT03740659|4102847|FG000|NOT COMPLETED|Overall Study||0
3371237|NCT03740659|4102848|FG001|NOT COMPLETED|Overall Study||0
3371238|NCT03740659|4102849|FG002|NOT COMPLETED|Overall Study||0
3371239|NCT03740152|4102857|FG000|STARTED|Overall Study||10
3371240|NCT03740152|4102857|FG000|COMPLETED|Overall Study||10
3371241|NCT03740152|4102857|FG000|NOT COMPLETED|Overall Study||0
3371242|NCT03739866|4102869|FG000|STARTED|Overall Study||6
3371243|NCT03739866|4102870|FG001|STARTED|Overall Study||6
3371244|NCT03739866|4102871|FG002|STARTED|Overall Study||7
3371245|NCT03739866|4102872|FG003|STARTED|Overall Study||6
3371246|NCT03739866|4102873|FG004|STARTED|Overall Study||6
3371247|NCT03739866|4102874|FG005|STARTED|Overall Study||10
3371248|NCT03739866|4102875|FG006|STARTED|Overall Study||7
3371249|NCT03739866|4102876|FG007|STARTED|Overall Study||5
3371250|NCT03739866|4102869|FG000|COMPLETED|Overall Study||6
3371251|NCT03739866|4102870|FG001|COMPLETED|Overall Study||6
3371252|NCT03739866|4102871|FG002|COMPLETED|Overall Study||6
3371253|NCT03739866|4102872|FG003|COMPLETED|Overall Study||5
3247701|NCT02478671|3981595|FG000|STARTED|Overall Study||4
3247702|NCT02478671|3981595|FG000|COMPLETED|Overall Study||4
3247703|NCT02478671|3981595|FG000|NOT COMPLETED|Overall Study||0
3247704|NCT02479139|3981606|FG000|STARTED|Overall Study||27
3247705|NCT02479139|3981607|FG001|STARTED|Overall Study||22
3247706|NCT02479139|3981608|FG002|STARTED|Overall Study||28
3247707|NCT02479139|3981609|FG003|STARTED|Overall Study||21
3247708|NCT02479139|3981610|FG004|STARTED|Overall Study||22
3247709|NCT02479139|3981611|FG005|STARTED|Overall Study||25
3247710|NCT02479139|3981606|FG000|COMPLETED|Overall Study||19
3247711|NCT02479139|3981607|FG001|COMPLETED|Overall Study||12
3247712|NCT02479139|3981608|FG002|COMPLETED|Overall Study||21
3247713|NCT02479139|3981609|FG003|COMPLETED|Overall Study||14
3247714|NCT02479139|3981610|FG004|COMPLETED|Overall Study||17
3247715|NCT02479139|3981611|FG005|COMPLETED|Overall Study||19
3247716|NCT02479139|3981606|FG000|NOT COMPLETED|Overall Study||8
3247717|NCT02479139|3981607|FG001|NOT COMPLETED|Overall Study||10
3247718|NCT02479139|3981608|FG002|NOT COMPLETED|Overall Study||7
3247719|NCT02479139|3981609|FG003|NOT COMPLETED|Overall Study||7
3247720|NCT02479139|3981610|FG004|NOT COMPLETED|Overall Study||5
3247721|NCT02479139|3981611|FG005|NOT COMPLETED|Overall Study||6
3247722|NCT02479412|3981634|FG000|STARTED|Overall Study||6
3247723|NCT02479412|3981635|FG001|STARTED|Overall Study||6
3247724|NCT02479412|3981636|FG002|STARTED|Overall Study||6
3247725|NCT02479412|3981637|FG003|STARTED|Overall Study||7
3247726|NCT02479412|3981638|FG004|STARTED|Overall Study||6
3247727|NCT02479412|3981639|FG005|STARTED|Overall Study||5
3247728|NCT02479412|3981640|FG006|STARTED|Overall Study||6
3247729|NCT02479412|3981641|FG007|STARTED|Overall Study||5
3247730|NCT02479412|3981642|FG008|STARTED|Overall Study||7
3247731|NCT02479412|3981634|FG000|COMPLETED|Overall Study||6
3247732|NCT02479412|3981635|FG001|COMPLETED|Overall Study||6
3247733|NCT02479412|3981636|FG002|COMPLETED|Overall Study||4
3247734|NCT02479412|3981637|FG003|COMPLETED|Overall Study||6
3247735|NCT02479412|3981638|FG004|COMPLETED|Overall Study||5
3247736|NCT02479412|3981639|FG005|COMPLETED|Overall Study||5
3247737|NCT02479412|3981640|FG006|COMPLETED|Overall Study||6
3247738|NCT02479412|3981641|FG007|COMPLETED|Overall Study||4
3247739|NCT02479412|3981642|FG008|COMPLETED|Overall Study||6
3247740|NCT02479412|3981634|FG000|NOT COMPLETED|Overall Study||0
3247741|NCT02479412|3981635|FG001|NOT COMPLETED|Overall Study||0
3247742|NCT02479412|3981636|FG002|NOT COMPLETED|Overall Study||2
3247743|NCT02479412|3981637|FG003|NOT COMPLETED|Overall Study||1
3247744|NCT02479412|3981638|FG004|NOT COMPLETED|Overall Study||1
3247745|NCT02479412|3981639|FG005|NOT COMPLETED|Overall Study||0
3247746|NCT02479412|3981640|FG006|NOT COMPLETED|Overall Study||0
3247747|NCT02479412|3981641|FG007|NOT COMPLETED|Overall Study||1
3247748|NCT02479412|3981642|FG008|NOT COMPLETED|Overall Study||1
3247749|NCT02479763|3981660|FG000|STARTED|Overall Study||53
3247750|NCT02479763|3981661|FG001|STARTED|Overall Study||53
3247751|NCT02479763|3981660|FG000|COMPLETED|Overall Study||50
3247752|NCT02479763|3981661|FG001|COMPLETED|Overall Study||50
3247753|NCT02479763|3981660|FG000|NOT COMPLETED|Overall Study||3
3247754|NCT02479763|3981661|FG001|NOT COMPLETED|Overall Study||3
3247755|NCT02479802|3981667|FG000|STARTED|Overall Study||13
3247756|NCT02479802|3981667|FG000|COMPLETED|Overall Study||11
3247757|NCT02479802|3981667|FG000|NOT COMPLETED|Overall Study||2
3247758|NCT02479880|3981673|FG000|STARTED|Overall Study||15
3247759|NCT02479880|3981674|FG001|STARTED|Overall Study||15
3247760|NCT02479880|3981673|FG000|COMPLETED|Overall Study||2
3247761|NCT02479880|3981674|FG001|COMPLETED|Overall Study||2
3247762|NCT02479880|3981673|FG000|NOT COMPLETED|Overall Study||13
3247763|NCT02479880|3981674|FG001|NOT COMPLETED|Overall Study||13
3247764|NCT02480010|3981682|FG000|STARTED|Overall Study||35
3247765|NCT02480010|3981683|FG001|STARTED|Overall Study||33
3247766|NCT02480010|3981682|FG000|COMPLETED|Overall Study||0
3247767|NCT02480010|3981683|FG001|COMPLETED|Overall Study||0
3247768|NCT02480010|3981682|FG000|NOT COMPLETED|Overall Study||35
3247769|NCT02480010|3981683|FG001|NOT COMPLETED|Overall Study||33
3247770|NCT02480114|3981691|FG000|STARTED|Overall Study||41
3247771|NCT02480114|3981692|FG001|STARTED|Overall Study||38
3247772|NCT02480114|3981691|FG000|COMPLETED|Overall Study||32
3247773|NCT02480114|3981692|FG001|COMPLETED|Overall Study||30
3247774|NCT02480114|3981691|FG000|NOT COMPLETED|Overall Study||9
3247775|NCT02480114|3981692|FG001|NOT COMPLETED|Overall Study||8
3247776|NCT02480153|3981700|FG000|STARTED|Period 1: First Dose to Week 26 Pre-dose||297
3247777|NCT02480153|3981701|FG001|STARTED|Period 1: First Dose to Week 26 Pre-dose||300
3247778|NCT02480153|3981702|FG002|STARTED|Period 1: First Dose to Week 26 Pre-dose||0
3247779|NCT02480153|3981700|FG000|Received Treatment|Period 1: First Dose to Week 26 Pre-dose||297
3247780|NCT02480153|3981701|FG001|Received Treatment|Period 1: First Dose to Week 26 Pre-dose||299
3247781|NCT02480153|3981702|FG002|Received Treatment|Period 1: First Dose to Week 26 Pre-dose||0
3371254|NCT03739866|4102873|FG004|COMPLETED|Overall Study||5
3371255|NCT03739866|4102874|FG005|COMPLETED|Overall Study||10
3371256|NCT03739866|4102875|FG006|COMPLETED|Overall Study||7
3371257|NCT03739866|4102876|FG007|COMPLETED|Overall Study||5
3247782|NCT02480153|3981700|FG000|COMPLETED|Period 1: First Dose to Week 26 Pre-dose||293
3247783|NCT02480153|3981701|FG001|COMPLETED|Period 1: First Dose to Week 26 Pre-dose||284
3247784|NCT02480153|3981702|FG002|COMPLETED|Period 1: First Dose to Week 26 Pre-dose||0
3247785|NCT02480153|3981700|FG000|NOT COMPLETED|Period 1: First Dose to Week 26 Pre-dose||4
3247786|NCT02480153|3981701|FG001|NOT COMPLETED|Period 1: First Dose to Week 26 Pre-dose||16
3247787|NCT02480153|3981702|FG002|NOT COMPLETED|Period 1: First Dose to Week 26 Pre-dose||0
3247788|NCT02480153|3981700|FG000|STARTED|Period 2: Week 26 to Week 52 Pre-dose||283
3247789|NCT02480153|3981701|FG001|STARTED|Period 2: Week 26 to Week 52 Pre-dose||135
3247790|NCT02480153|3981702|FG002|STARTED|Period 2: Week 26 to Week 52 Pre-dose||134
3247791|NCT02480153|3981700|FG000|Received Treatment|Period 2: Week 26 to Week 52 Pre-dose||283
3247792|NCT02480153|3981701|FG001|Received Treatment|Period 2: Week 26 to Week 52 Pre-dose||135
3247793|NCT02480153|3981702|FG002|Received Treatment|Period 2: Week 26 to Week 52 Pre-dose||133
3247794|NCT02480153|3981700|FG000|COMPLETED|Period 2: Week 26 to Week 52 Pre-dose||263
3247795|NCT02480153|3981701|FG001|COMPLETED|Period 2: Week 26 to Week 52 Pre-dose||122
3247796|NCT02480153|3981702|FG002|COMPLETED|Period 2: Week 26 to Week 52 Pre-dose||127
3247797|NCT02480153|3981700|FG000|NOT COMPLETED|Period 2: Week 26 to Week 52 Pre-dose||20
3247798|NCT02480153|3981701|FG001|NOT COMPLETED|Period 2: Week 26 to Week 52 Pre-dose||13
3247799|NCT02480153|3981702|FG002|NOT COMPLETED|Period 2: Week 26 to Week 52 Pre-dose||7
3247800|NCT02480153|3981700|FG000|STARTED|Period 3: Week 52 Dosing to Week 78||259
3247801|NCT02480153|3981701|FG001|STARTED|Period 3: Week 52 Dosing to Week 78||121
3247802|NCT02480153|3981702|FG002|STARTED|Period 3: Week 52 Dosing to Week 78||127
3247803|NCT02480153|3981700|FG000|Received Treatment|Period 3: Week 52 Dosing to Week 78||258
3247804|NCT02480153|3981701|FG001|Received Treatment|Period 3: Week 52 Dosing to Week 78||120
3247805|NCT02480153|3981702|FG002|Received Treatment|Period 3: Week 52 Dosing to Week 78||127
3247806|NCT02480153|3981700|FG000|COMPLETED|Period 3: Week 52 Dosing to Week 78||252
3247807|NCT02480153|3981701|FG001|COMPLETED|Period 3: Week 52 Dosing to Week 78||118
3247808|NCT02480153|3981702|FG002|COMPLETED|Period 3: Week 52 Dosing to Week 78||123
3247809|NCT02480153|3981700|FG000|NOT COMPLETED|Period 3: Week 52 Dosing to Week 78||7
3247810|NCT02480153|3981701|FG001|NOT COMPLETED|Period 3: Week 52 Dosing to Week 78||3
3247811|NCT02480153|3981702|FG002|NOT COMPLETED|Period 3: Week 52 Dosing to Week 78||4
3247812|NCT02480166|3981728|FG000|STARTED|Overall Study||20
3247813|NCT02480166|3981729|FG001|STARTED|Overall Study||36
3247814|NCT02480166|3981730|FG002|STARTED|Overall Study||4
3247815|NCT02480166|3981728|FG000|COMPLETED|Overall Study||20
3247816|NCT02480166|3981729|FG001|COMPLETED|Overall Study||36
3247817|NCT02480166|3981730|FG002|COMPLETED|Overall Study||4
3247818|NCT02480166|3981728|FG000|NOT COMPLETED|Overall Study||0
3247819|NCT02480166|3981729|FG001|NOT COMPLETED|Overall Study||0
3247820|NCT02480166|3981730|FG002|NOT COMPLETED|Overall Study||0
3247821|NCT02480439|3981742|FG000|STARTED|Treatment Period 1||8
3247822|NCT02480439|3981743|FG001|STARTED|Treatment Period 1||8
3247823|NCT02480439|3981744|FG002|STARTED|Treatment Period 1||8
3247824|NCT02480439|3981742|FG000|COMPLETED|Treatment Period 1||8
3247825|NCT02480439|3981743|FG001|COMPLETED|Treatment Period 1||8
3247826|NCT02480439|3981744|FG002|COMPLETED|Treatment Period 1||8
3247827|NCT02480439|3981742|FG000|NOT COMPLETED|Treatment Period 1||0
3247828|NCT02480439|3981743|FG001|NOT COMPLETED|Treatment Period 1||0
3247829|NCT02480439|3981744|FG002|NOT COMPLETED|Treatment Period 1||0
3247830|NCT02480439|3981742|FG000|STARTED|Treatment Period 2||8
3247831|NCT02480439|3981743|FG001|STARTED|Treatment Period 2|1 Participant was withdrawn due to an Adverse Event after completing Period 1.|7
3247832|NCT02480439|3981744|FG002|STARTED|Treatment Period 2||8
3247833|NCT02480439|3981742|FG000|COMPLETED|Treatment Period 2||8
3247834|NCT02480439|3981743|FG001|COMPLETED|Treatment Period 2||7
3247835|NCT02480439|3981744|FG002|COMPLETED|Treatment Period 2||8
3247836|NCT02480439|3981742|FG000|NOT COMPLETED|Treatment Period 2||0
3247837|NCT02480439|3981743|FG001|NOT COMPLETED|Treatment Period 2||0
3247838|NCT02480439|3981744|FG002|NOT COMPLETED|Treatment Period 2||0
3247839|NCT02480439|3981742|FG000|STARTED|Treatment Period 3||8
3247840|NCT02480439|3981743|FG001|STARTED|Treatment Period 3||7
3247841|NCT02480439|3981744|FG002|STARTED|Treatment Period 3|1 Participant was withdrawn due to an Adverse Event after completing Period 2.|7
3247842|NCT02480439|3981742|FG000|COMPLETED|Treatment Period 3||8
3247843|NCT02480439|3981743|FG001|COMPLETED|Treatment Period 3||7
3247844|NCT02480439|3981744|FG002|COMPLETED|Treatment Period 3||7
3247845|NCT02480439|3981742|FG000|NOT COMPLETED|Treatment Period 3||0
3247846|NCT02480439|3981743|FG001|NOT COMPLETED|Treatment Period 3||0
3247847|NCT02480439|3981744|FG002|NOT COMPLETED|Treatment Period 3||0
3247848|NCT02480582|3981752|FG000|STARTED|Overall Study||7
3247849|NCT02480582|3981753|FG001|STARTED|Overall Study||7
3247850|NCT02480582|3981754|FG002|STARTED|Overall Study||7
3247851|NCT02480582|3981755|FG003|STARTED|Overall Study||7
3247852|NCT02480582|3981756|FG004|STARTED|Overall Study||7
3247853|NCT02480582|3981757|FG005|STARTED|Overall Study||7
3247854|NCT02480582|3981752|FG000|COMPLETED|Overall Study||7
3247855|NCT02480582|3981753|FG001|COMPLETED|Overall Study||7
3247856|NCT02480582|3981754|FG002|COMPLETED|Overall Study||7
3247857|NCT02480582|3981755|FG003|COMPLETED|Overall Study||7
3247858|NCT02480582|3981756|FG004|COMPLETED|Overall Study||7
3247859|NCT02480582|3981757|FG005|COMPLETED|Overall Study||7
3247860|NCT02480582|3981752|FG000|NOT COMPLETED|Overall Study||0
3247861|NCT02480582|3981753|FG001|NOT COMPLETED|Overall Study||0
3247862|NCT02480582|3981754|FG002|NOT COMPLETED|Overall Study||0
3247863|NCT02480582|3981755|FG003|NOT COMPLETED|Overall Study||0
3247864|NCT02480582|3981756|FG004|NOT COMPLETED|Overall Study||0
3247865|NCT02480582|3981757|FG005|NOT COMPLETED|Overall Study||0
3247866|NCT02480621|3981772|FG000|STARTED|Randomization||44
3247867|NCT02480621|3981773|FG001|STARTED|Randomization||40
3247868|NCT02480621|3981772|FG000|COMPLETED|Randomization||43
3247869|NCT02480621|3981773|FG001|COMPLETED|Randomization||39
3247870|NCT02480621|3981772|FG000|NOT COMPLETED|Randomization||1
3247871|NCT02480621|3981773|FG001|NOT COMPLETED|Randomization||1
3247872|NCT02480621|3981772|FG000|STARTED|Follow Up||43
3247873|NCT02480621|3981773|FG001|STARTED|Follow Up||39
3247874|NCT02480621|3981772|FG000|COMPLETED|Follow Up||39
3247875|NCT02480621|3981773|FG001|COMPLETED|Follow Up||37
3247876|NCT02480621|3981772|FG000|NOT COMPLETED|Follow Up||4
3247877|NCT02480621|3981773|FG001|NOT COMPLETED|Follow Up||2
3247878|NCT02480712|3981779|FG000|STARTED|Overall Study||107
3247879|NCT02480712|3981779|FG000|COMPLETED|Overall Study||96
3247880|NCT02480712|3981779|FG000|NOT COMPLETED|Overall Study||11
3247881|NCT02480764|3981792|FG000|STARTED|Overall Study||199
3247882|NCT02480764|3981793|FG001|STARTED|Overall Study||209
3247883|NCT02480764|3981794|FG002|STARTED|Overall Study||204
3247884|NCT02480764|3981792|FG000|COMPLETED|Overall Study||189
3247885|NCT02480764|3981793|FG001|COMPLETED|Overall Study||189
3247886|NCT02480764|3981794|FG002|COMPLETED|Overall Study||183
3247887|NCT02480764|3981792|FG000|NOT COMPLETED|Overall Study||10
3247888|NCT02480764|3981793|FG001|NOT COMPLETED|Overall Study||20
3247889|NCT02480764|3981794|FG002|NOT COMPLETED|Overall Study||21
3247890|NCT02480920|3981802|FG000|STARTED|Overall Study||2738
3247891|NCT02480920|3981802|FG000|COMPLETED|Overall Study||2738
3247892|NCT02480920|3981802|FG000|NOT COMPLETED|Overall Study||0
3247893|NCT02480998|3981808|FG000|STARTED|Overall Study||56
3247894|NCT02480998|3981809|FG001|STARTED|Overall Study||28
3247895|NCT02480998|3981808|FG000|COMPLETED|Overall Study||56
3247896|NCT02480998|3981809|FG001|COMPLETED|Overall Study||28
3247897|NCT02480998|3981808|FG000|NOT COMPLETED|Overall Study||0
3247898|NCT02480998|3981809|FG001|NOT COMPLETED|Overall Study||0
3247899|NCT02481050|3981817|FG000|STARTED|Overall Study||58
3247900|NCT02481050|3981817|FG000|COMPLETED|Overall Study||0
3247901|NCT02481050|3981817|FG000|NOT COMPLETED|Overall Study||58
3247902|NCT02481141|3981823|FG000|STARTED|Overall Study||35
3247903|NCT02481141|3981824|FG001|STARTED|Overall Study||18
3247904|NCT02481141|3981823|FG000|COMPLETED|Overall Study||26
3247905|NCT02481141|3981824|FG001|COMPLETED|Overall Study||13
3247906|NCT02481141|3981823|FG000|NOT COMPLETED|Overall Study||9
3247907|NCT02481141|3981824|FG001|NOT COMPLETED|Overall Study||5
3247908|NCT02481206|3981853|FG000|STARTED|Overall Study||34
3247909|NCT02481206|3981854|FG001|STARTED|Overall Study||32
3247910|NCT02481206|3981853|FG000|COMPLETED|Overall Study||29
3247911|NCT02481206|3981854|FG001|COMPLETED|Overall Study||31
3247912|NCT02481206|3981853|FG000|NOT COMPLETED|Overall Study||5
3247913|NCT02481206|3981854|FG001|NOT COMPLETED|Overall Study||1
3247914|NCT02481219|3981864|FG000|STARTED|Overall Study||60
3247915|NCT02481219|3981865|FG001|STARTED|Overall Study||62
3247916|NCT02481219|3981864|FG000|COMPLETED|Overall Study||58
3247917|NCT02481219|3981865|FG001|COMPLETED|Overall Study||61
3247918|NCT02481219|3981864|FG000|NOT COMPLETED|Overall Study||2
3247919|NCT02481219|3981865|FG001|NOT COMPLETED|Overall Study||1
3247920|NCT02481258|3981877|FG000|STARTED|Overall Study||12
3247921|NCT02481258|3981878|FG001|STARTED|Overall Study||11
3247922|NCT02481258|3981877|FG000|COMPLETED|Overall Study||12
3247923|NCT02481258|3981878|FG001|COMPLETED|Overall Study||11
3247924|NCT02481258|3981877|FG000|NOT COMPLETED|Overall Study||0
3247925|NCT02481258|3981878|FG001|NOT COMPLETED|Overall Study||0
3247926|NCT02481297|3981888|FG000|STARTED|Overall Study||1
3247927|NCT02481297|3981889|FG001|STARTED|Overall Study||6
3247928|NCT02481297|3981888|FG000|COMPLETED|Overall Study||1
3247929|NCT02481297|3981889|FG001|COMPLETED|Overall Study||6
3247930|NCT02481297|3981888|FG000|NOT COMPLETED|Overall Study||0
3247931|NCT02481297|3981889|FG001|NOT COMPLETED|Overall Study||0
3247932|NCT02481375|3981899|FG000|STARTED|Overall Study||206
3247933|NCT02481375|3981900|FG001|STARTED|Overall Study||202
3247934|NCT02481375|3981901|FG002|STARTED|Overall Study||201
3247935|NCT02481375|3981902|FG003|STARTED|Overall Study||200
3247936|NCT02481375|3981899|FG000|COMPLETED|Overall Study||192
3247937|NCT02481375|3981900|FG001|COMPLETED|Overall Study||191
3247938|NCT02481375|3981901|FG002|COMPLETED|Overall Study||191
3247939|NCT02481375|3981902|FG003|COMPLETED|Overall Study||186
3247940|NCT02481375|3981899|FG000|NOT COMPLETED|Overall Study||14
3247941|NCT02481375|3981900|FG001|NOT COMPLETED|Overall Study||11
3247942|NCT02481375|3981901|FG002|NOT COMPLETED|Overall Study||10
3247943|NCT02481375|3981902|FG003|NOT COMPLETED|Overall Study||14
3247944|NCT02481440|3981912|FG000|STARTED|Overall Study||102
3247945|NCT02481440|3981912|FG000|COMPLETED|Overall Study||41
3247946|NCT02481440|3981912|FG000|NOT COMPLETED|Overall Study||61
3247947|NCT02481505|3981919|FG000|STARTED|Overall Study||15
3247948|NCT02481505|3981920|FG001|STARTED|Overall Study||15
3247949|NCT02481505|3981921|FG002|STARTED|Overall Study||15
3247950|NCT02481505|3981919|FG000|COMPLETED|Overall Study||15
3247951|NCT02481505|3981920|FG001|COMPLETED|Overall Study||15
3247952|NCT02481505|3981921|FG002|COMPLETED|Overall Study||15
3247953|NCT02481505|3981919|FG000|NOT COMPLETED|Overall Study||0
3247954|NCT02481505|3981920|FG001|NOT COMPLETED|Overall Study||0
3247955|NCT02481505|3981921|FG002|NOT COMPLETED|Overall Study||0
3247956|NCT02481557|3981931|FG000|STARTED|Overall Study||17
3247957|NCT02481557|3981932|FG001|STARTED|Overall Study||19
3247958|NCT02481557|3981931|FG000|COMPLETED|Overall Study||17
3247959|NCT02481557|3981932|FG001|COMPLETED|Overall Study||19
3247960|NCT02481557|3981931|FG000|NOT COMPLETED|Overall Study||0
3247961|NCT02481557|3981932|FG001|NOT COMPLETED|Overall Study||0
3247962|NCT02481596|3981941|FG000|STARTED|Overall Study||126
3247963|NCT02481596|3981942|FG001|STARTED|Overall Study||127
3247964|NCT02481596|3981943|FG002|STARTED|Overall Study||253
3247965|NCT02481596|3981941|FG000|COMPLETED|Overall Study||123
3247966|NCT02481596|3981942|FG001|COMPLETED|Overall Study||126
3247967|NCT02481596|3981943|FG002|COMPLETED|Overall Study||245
3247968|NCT02481596|3981941|FG000|NOT COMPLETED|Overall Study||3
3247969|NCT02481596|3981942|FG001|NOT COMPLETED|Overall Study||1
3247970|NCT02481596|3981943|FG002|NOT COMPLETED|Overall Study||8
3247971|NCT02481713|3981953|FG000|STARTED|Overall Study||56
3247972|NCT02481713|3981954|FG001|STARTED|Overall Study||58
3247973|NCT02481713|3981953|FG000|COMPLETED|Overall Study||40
3247974|NCT02481713|3981954|FG001|COMPLETED|Overall Study||42
3247975|NCT02481713|3981953|FG000|NOT COMPLETED|Overall Study||16
3247976|NCT02481713|3981954|FG001|NOT COMPLETED|Overall Study||16
3247977|NCT02481869|3981962|FG000|STARTED|Overall Study||5
3247978|NCT02481869|3981963|FG001|STARTED|Overall Study||6
3247979|NCT02481869|3981962|FG000|COMPLETED|Overall Study||0
3247980|NCT02481869|3981963|FG001|COMPLETED|Overall Study||2
3247981|NCT02481869|3981962|FG000|NOT COMPLETED|Overall Study||5
3247982|NCT02481869|3981963|FG001|NOT COMPLETED|Overall Study||4
3247983|NCT02481934|3981970|FG000|STARTED|Overall Study||5
3247984|NCT02481934|3981970|FG000|COMPLETED|Overall Study||3
3247985|NCT02481934|3981970|FG000|NOT COMPLETED|Overall Study||2
3247986|NCT02481947|3981976|FG000|STARTED|Overall Study||230
3247987|NCT02481947|3981977|FG001|STARTED|Overall Study||229
3247988|NCT02481947|3981976|FG000|COMPLETED|Overall Study||184
3247989|NCT02481947|3981977|FG001|COMPLETED|Overall Study||193
3247990|NCT02481947|3981976|FG000|NOT COMPLETED|Overall Study||46
3247991|NCT02481947|3981977|FG001|NOT COMPLETED|Overall Study||36
3247992|NCT02482025|3981985|FG000|STARTED|Overall Study||122
3247993|NCT02482025|3981986|FG001|STARTED|Overall Study||118
3247994|NCT02482025|3981985|FG000|COMPLETED|Overall Study||122
3247995|NCT02482025|3981986|FG001|COMPLETED|Overall Study||118
3247996|NCT02482025|3981985|FG000|NOT COMPLETED|Overall Study||0
3247997|NCT02482025|3981986|FG001|NOT COMPLETED|Overall Study||0
3247998|NCT02482129|3981994|FG000|STARTED|Overall Study||32
3247999|NCT02482129|3981995|FG001|STARTED|Overall Study||11
3248000|NCT02482129|3981994|FG000|Treated, as Randomized|Overall Study||30
3248001|NCT02482129|3981995|FG001|Treated, as Randomized|Overall Study||9
3248002|NCT02482129|3981994|FG000|COMPLETED|Overall Study||26
3248003|NCT02482129|3981995|FG001|COMPLETED|Overall Study||9
3248004|NCT02482129|3981994|FG000|NOT COMPLETED|Overall Study||6
3248005|NCT02482129|3981995|FG001|NOT COMPLETED|Overall Study||2
3248006|NCT02482233|3982005|FG000|STARTED|Overall Study||10
3371258|NCT03739866|4102869|FG000|NOT COMPLETED|Overall Study||0
3371259|NCT03739866|4102870|FG001|NOT COMPLETED|Overall Study||0
3371260|NCT03739866|4102871|FG002|NOT COMPLETED|Overall Study||1
3371261|NCT03739866|4102872|FG003|NOT COMPLETED|Overall Study||1
3371262|NCT03739866|4102873|FG004|NOT COMPLETED|Overall Study||1
3371263|NCT03739866|4102874|FG005|NOT COMPLETED|Overall Study||0
3371264|NCT03739866|4102875|FG006|NOT COMPLETED|Overall Study||0
3371265|NCT03739866|4102876|FG007|NOT COMPLETED|Overall Study||0
3371266|NCT03739684|4102898|FG000|STARTED|Overall Study||208
3371267|NCT03739684|4102898|FG000|COMPLETED|Overall Study||195
3371268|NCT03739684|4102898|FG000|NOT COMPLETED|Overall Study||13
3371269|NCT03739528|4102904|FG000|STARTED|Overall Study||403
3371270|NCT03739528|4102905|FG001|STARTED|Overall Study||405
3371271|NCT03739528|4102904|FG000|Received at Least One Treatment|Overall Study||395
3248007|NCT02482233|3982006|FG001|STARTED|Overall Study||20
3248008|NCT02482233|3982005|FG000|COMPLETED|Overall Study||9
3248009|NCT02482233|3982006|FG001|COMPLETED|Overall Study||19
3248010|NCT02482233|3982005|FG000|NOT COMPLETED|Overall Study||1
3248011|NCT02482233|3982006|FG001|NOT COMPLETED|Overall Study||1
3248012|NCT02482298|3982017|FG000|STARTED|Overall Study||30
3248013|NCT02482298|3982018|FG001|STARTED|Overall Study||27
3248014|NCT02482298|3982019|FG002|STARTED|Overall Study||30
3248015|NCT02482298|3982017|FG000|COMPLETED|Overall Study||28
3248016|NCT02482298|3982018|FG001|COMPLETED|Overall Study||24
3248017|NCT02482298|3982019|FG002|COMPLETED|Overall Study||27
3248018|NCT02482298|3982017|FG000|NOT COMPLETED|Overall Study||2
3248019|NCT02482298|3982018|FG001|NOT COMPLETED|Overall Study||3
3248020|NCT02482298|3982019|FG002|NOT COMPLETED|Overall Study||3
3248021|NCT02482428|3982032|FG000|STARTED|Overall Study||24
3248022|NCT02482428|3982033|FG001|STARTED|Overall Study||22
3248023|NCT02482428|3982034|FG002|STARTED|Overall Study||10
3248024|NCT02482428|3982035|FG003|STARTED|Overall Study||10
3248025|NCT02482428|3982036|FG004|STARTED|Overall Study||22
3248026|NCT02482428|3982032|FG000|COMPLETED|Overall Study||15
3248027|NCT02482428|3982033|FG001|COMPLETED|Overall Study||10
3248028|NCT02482428|3982034|FG002|COMPLETED|Overall Study||9
3248029|NCT02482428|3982035|FG003|COMPLETED|Overall Study||8
3248030|NCT02482428|3982036|FG004|COMPLETED|Overall Study||15
3248031|NCT02482428|3982032|FG000|NOT COMPLETED|Overall Study||9
3248032|NCT02482428|3982033|FG001|NOT COMPLETED|Overall Study||12
3248033|NCT02482428|3982034|FG002|NOT COMPLETED|Overall Study||1
3248034|NCT02482428|3982035|FG003|NOT COMPLETED|Overall Study||2
3248035|NCT02482428|3982036|FG004|NOT COMPLETED|Overall Study||7
3248036|NCT02482571|3982050|FG000|STARTED|Overall Study||25
3248037|NCT02482571|3982050|FG000|COMPLETED|Overall Study||17
3248038|NCT02482571|3982050|FG000|NOT COMPLETED|Overall Study||8
3248039|NCT02482610|3982055|FG000|STARTED|Overall Study||4
3248040|NCT02482610|3982056|FG001|STARTED|Overall Study||5
3248041|NCT02482610|3982057|FG002|STARTED|Overall Study||2
3248042|NCT02482610|3982058|FG003|STARTED|Overall Study||3
3248043|NCT02482610|3982059|FG004|STARTED|Overall Study||3
3248044|NCT02482610|3982060|FG005|STARTED|Overall Study||5
3248045|NCT02482610|3982055|FG000|COMPLETED|Overall Study||4
3248046|NCT02482610|3982056|FG001|COMPLETED|Overall Study||5
3248047|NCT02482610|3982057|FG002|COMPLETED|Overall Study||2
3248048|NCT02482610|3982058|FG003|COMPLETED|Overall Study||3
3248049|NCT02482610|3982059|FG004|COMPLETED|Overall Study||3
3248050|NCT02482610|3982060|FG005|COMPLETED|Overall Study||5
3248051|NCT02482610|3982055|FG000|NOT COMPLETED|Overall Study||0
3248052|NCT02482610|3982056|FG001|NOT COMPLETED|Overall Study||0
3248053|NCT02482610|3982057|FG002|NOT COMPLETED|Overall Study||0
3248054|NCT02482610|3982058|FG003|NOT COMPLETED|Overall Study||0
3248055|NCT02482610|3982059|FG004|NOT COMPLETED|Overall Study||0
3248056|NCT02482610|3982060|FG005|NOT COMPLETED|Overall Study||0
3248057|NCT02482675|3982071|FG000|STARTED|Overall Study||1
3248058|NCT02482675|3982072|FG001|STARTED|Overall Study||1
3248059|NCT02482675|3982073|FG002|STARTED|Overall Study||1
3248060|NCT02482675|3982074|FG003|STARTED|Overall Study||1
3248061|NCT02482675|3982075|FG004|STARTED|Overall Study||1
3248062|NCT02482675|3982076|FG005|STARTED|Overall Study||1
3248063|NCT02482675|3982077|FG006|STARTED|Overall Study||1
3248064|NCT02482675|3982078|FG007|STARTED|Overall Study||1
3248065|NCT02482675|3982079|FG008|STARTED|Overall Study||1
3248066|NCT02482675|3982080|FG009|STARTED|Overall Study||1
3248067|NCT02482675|3982081|FG010|STARTED|Overall Study||1
3248068|NCT02482675|3982082|FG011|STARTED|Overall Study||1
3248069|NCT02482675|3982083|FG012|STARTED|Overall Study||1
3248070|NCT02482675|3982084|FG013|STARTED|Overall Study||1
3248071|NCT02482675|3982085|FG014|STARTED|Overall Study||1
3248072|NCT02482675|3982086|FG015|STARTED|Overall Study||1
3248073|NCT02482675|3982087|FG016|STARTED|Overall Study||1
3248074|NCT02482675|3982088|FG017|STARTED|Overall Study||1
3248075|NCT02482675|3982089|FG018|STARTED|Overall Study||1
3248076|NCT02482675|3982090|FG019|STARTED|Overall Study||1
3248077|NCT02482675|3982091|FG020|STARTED|Overall Study||1
3248078|NCT02482675|3982092|FG021|STARTED|Overall Study||1
3248079|NCT02482675|3982093|FG022|STARTED|Overall Study||1
3248080|NCT02482675|3982071|FG000|COMPLETED|Overall Study||1
3248081|NCT02482675|3982072|FG001|COMPLETED|Overall Study||1
3248082|NCT02482675|3982073|FG002|COMPLETED|Overall Study||1
3248083|NCT02482675|3982074|FG003|COMPLETED|Overall Study||1
3248084|NCT02482675|3982075|FG004|COMPLETED|Overall Study||1
3248085|NCT02482675|3982076|FG005|COMPLETED|Overall Study||1
3248086|NCT02482675|3982077|FG006|COMPLETED|Overall Study||1
3248087|NCT02482675|3982078|FG007|COMPLETED|Overall Study||1
3248088|NCT02482675|3982079|FG008|COMPLETED|Overall Study||1
3248089|NCT02482675|3982080|FG009|COMPLETED|Overall Study||1
3248090|NCT02482675|3982081|FG010|COMPLETED|Overall Study||1
3248091|NCT02482675|3982082|FG011|COMPLETED|Overall Study||1
3248092|NCT02482675|3982083|FG012|COMPLETED|Overall Study||1
3248093|NCT02482675|3982084|FG013|COMPLETED|Overall Study||1
3248094|NCT02482675|3982085|FG014|COMPLETED|Overall Study||1
3248095|NCT02482675|3982086|FG015|COMPLETED|Overall Study||1
3248096|NCT02482675|3982087|FG016|COMPLETED|Overall Study||1
3248097|NCT02482675|3982088|FG017|COMPLETED|Overall Study||1
3248098|NCT02482675|3982089|FG018|COMPLETED|Overall Study||1
3248099|NCT02482675|3982090|FG019|COMPLETED|Overall Study||1
3248100|NCT02482675|3982091|FG020|COMPLETED|Overall Study||1
3248101|NCT02482675|3982092|FG021|COMPLETED|Overall Study||1
3248102|NCT02482675|3982093|FG022|COMPLETED|Overall Study||1
3248103|NCT02482675|3982071|FG000|NOT COMPLETED|Overall Study||0
3248104|NCT02482675|3982072|FG001|NOT COMPLETED|Overall Study||0
3248105|NCT02482675|3982073|FG002|NOT COMPLETED|Overall Study||0
3248106|NCT02482675|3982074|FG003|NOT COMPLETED|Overall Study||0
3248107|NCT02482675|3982075|FG004|NOT COMPLETED|Overall Study||0
3248108|NCT02482675|3982076|FG005|NOT COMPLETED|Overall Study||0
3248109|NCT02482675|3982077|FG006|NOT COMPLETED|Overall Study||0
3248110|NCT02482675|3982078|FG007|NOT COMPLETED|Overall Study||0
3248111|NCT02482675|3982079|FG008|NOT COMPLETED|Overall Study||0
3248112|NCT02482675|3982080|FG009|NOT COMPLETED|Overall Study||0
3248113|NCT02482675|3982081|FG010|NOT COMPLETED|Overall Study||0
3248114|NCT02482675|3982082|FG011|NOT COMPLETED|Overall Study||0
3248115|NCT02482675|3982083|FG012|NOT COMPLETED|Overall Study||0
3248116|NCT02482675|3982084|FG013|NOT COMPLETED|Overall Study||0
3248117|NCT02482675|3982085|FG014|NOT COMPLETED|Overall Study||0
3248118|NCT02482675|3982086|FG015|NOT COMPLETED|Overall Study||0
3248119|NCT02482675|3982087|FG016|NOT COMPLETED|Overall Study||0
3248120|NCT02482675|3982088|FG017|NOT COMPLETED|Overall Study||0
3248121|NCT02482675|3982089|FG018|NOT COMPLETED|Overall Study||0
3248122|NCT02482675|3982090|FG019|NOT COMPLETED|Overall Study||0
3248123|NCT02482675|3982091|FG020|NOT COMPLETED|Overall Study||0
3248124|NCT02482675|3982092|FG021|NOT COMPLETED|Overall Study||0
3248125|NCT02482675|3982093|FG022|NOT COMPLETED|Overall Study||0
3248126|NCT02482805|3982106|FG000|STARTED|Overall Study||26
3248127|NCT02482805|3982107|FG001|STARTED|Overall Study||27
3248128|NCT02482805|3982108|FG002|STARTED|Overall Study||20
3248129|NCT02482805|3982106|FG000|COMPLETED|Overall Study||22
3248130|NCT02482805|3982107|FG001|COMPLETED|Overall Study||23
3248131|NCT02482805|3982108|FG002|COMPLETED|Overall Study||20
3248132|NCT02482805|3982106|FG000|NOT COMPLETED|Overall Study||4
3248133|NCT02482805|3982107|FG001|NOT COMPLETED|Overall Study||4
3248134|NCT02482805|3982108|FG002|NOT COMPLETED|Overall Study||0
3248135|NCT02482870|3982116|FG000|STARTED|Period 1 - First 60 Patients||30
3248136|NCT02482870|3982117|FG001|STARTED|Period 1 - First 60 Patients||30
3248137|NCT02482870|3982116|FG000|COMPLETED|Period 1 - First 60 Patients||30
3248138|NCT02482870|3982117|FG001|COMPLETED|Period 1 - First 60 Patients||30
3248139|NCT02482870|3982116|FG000|NOT COMPLETED|Period 1 - First 60 Patients||0
3248140|NCT02482870|3982117|FG001|NOT COMPLETED|Period 1 - First 60 Patients||0
3248141|NCT02482870|3982116|FG000|STARTED|Period 2 - Rest of the Study||186
3248142|NCT02482870|3982117|FG001|STARTED|Period 2 - Rest of the Study||202
3248143|NCT02482870|3982116|FG000|COMPLETED|Period 2 - Rest of the Study||186
3248144|NCT02482870|3982117|FG001|COMPLETED|Period 2 - Rest of the Study||202
3248145|NCT02482870|3982116|FG000|NOT COMPLETED|Period 2 - Rest of the Study||0
3248146|NCT02482870|3982117|FG001|NOT COMPLETED|Period 2 - Rest of the Study||0
3248147|NCT02482935|3982131|FG000|STARTED|Period 1||15
3248148|NCT02482935|3982132|FG001|STARTED|Period 1||15
3248149|NCT02482935|3982131|FG000|Received Abemaciclib|Period 1||15
3248150|NCT02482935|3982132|FG001|Received Abemaciclib|Period 1||15
3248151|NCT02482935|3982131|FG000|Washout|Period 1||15
3248152|NCT02482935|3982132|FG001|Washout|Period 1||15
3248153|NCT02482935|3982131|FG000|COMPLETED|Period 1||14
3248154|NCT02482935|3982132|FG001|COMPLETED|Period 1||15
3248155|NCT02482935|3982131|FG000|NOT COMPLETED|Period 1||1
3248156|NCT02482935|3982132|FG001|NOT COMPLETED|Period 1||0
3248157|NCT02482935|3982131|FG000|STARTED|Period 2||14
3248158|NCT02482935|3982132|FG001|STARTED|Period 2||15
3248159|NCT02482935|3982131|FG000|Received Abemaciclib|Period 2||14
3248160|NCT02482935|3982132|FG001|Received Abemaciclib|Period 2||15
3248161|NCT02482935|3982131|FG000|Follow-up|Period 2||14
3248162|NCT02482935|3982132|FG001|Follow-up|Period 2||15
3248163|NCT02482935|3982131|FG000|COMPLETED|Period 2||14
3248164|NCT02482935|3982132|FG001|COMPLETED|Period 2||15
3248165|NCT02482935|3982131|FG000|NOT COMPLETED|Period 2||0
3248166|NCT02482935|3982132|FG001|NOT COMPLETED|Period 2||0
3248167|NCT02483000|3982138|FG000|STARTED|Overall Study||3
3248168|NCT02483000|3982138|FG000|COMPLETED|Overall Study||3
3248169|NCT02483000|3982138|FG000|NOT COMPLETED|Overall Study||0
3248170|NCT02483416|3982147|FG000|STARTED|Overall Study||21
3248171|NCT02483416|3982148|FG001|STARTED|Overall Study||7
3248172|NCT02483416|3982147|FG000|COMPLETED|Overall Study||18
3248173|NCT02483416|3982148|FG001|COMPLETED|Overall Study||6
3248174|NCT02483416|3982147|FG000|NOT COMPLETED|Overall Study||3
3248175|NCT02483416|3982148|FG001|NOT COMPLETED|Overall Study||1
3248176|NCT02483520|3982157|FG000|STARTED|Overall Study||92
3248177|NCT02483520|3982158|FG001|STARTED|Overall Study||97
3248178|NCT02483520|3982157|FG000|Caregivers|Overall Study||50
3248179|NCT02483520|3982158|FG001|Caregivers|Overall Study||56
3248180|NCT02483520|3982157|FG000|Persons With Dementia|Overall Study||42
3248181|NCT02483520|3982158|FG001|Persons With Dementia|Overall Study||41
3248182|NCT02483520|3982157|FG000|COMPLETED|Overall Study||81
3248183|NCT02483520|3982158|FG001|COMPLETED|Overall Study||73
3248184|NCT02483520|3982157|FG000|NOT COMPLETED|Overall Study||11
3248185|NCT02483520|3982158|FG001|NOT COMPLETED|Overall Study||24
3248186|NCT02483572|3982166|FG000|STARTED|Overall Study||2
3248187|NCT02483572|3982167|FG001|STARTED|Overall Study||2
3248188|NCT02483572|3982166|FG000|COMPLETED|Overall Study||0
3248189|NCT02483572|3982167|FG001|COMPLETED|Overall Study||1
3248190|NCT02483572|3982166|FG000|NOT COMPLETED|Overall Study||2
3248191|NCT02483572|3982167|FG001|NOT COMPLETED|Overall Study||1
3248192|NCT02483585|3982175|FG000|STARTED|Double-blind Treatment Phase||291
3248193|NCT02483585|3982176|FG001|STARTED|Double-blind Treatment Phase||286
3248194|NCT02483585|3982175|FG000|Received Treatment|Double-blind Treatment Phase||289
3248195|NCT02483585|3982176|FG001|Received Treatment|Double-blind Treatment Phase||283
3248196|NCT02483585|3982175|FG000|COMPLETED|Double-blind Treatment Phase||275
3248197|NCT02483585|3982176|FG001|COMPLETED|Double-blind Treatment Phase||271
3248198|NCT02483585|3982175|FG000|NOT COMPLETED|Double-blind Treatment Phase||16
3248199|NCT02483585|3982176|FG001|NOT COMPLETED|Double-blind Treatment Phase||15
3248200|NCT02483585|3982175|FG000|STARTED|Open-label Treatment Phase|Five participants who completed the double-blind phase did not enter the open-label treatment phase|270
3248201|NCT02483585|3982176|FG001|STARTED|Open-label Treatment Phase|Three participants who completed the double-blind phase did not enter the open-label treatment phase|268
3248202|NCT02483585|3982175|FG000|COMPLETED|Open-label Treatment Phase||243
3248203|NCT02483585|3982176|FG001|COMPLETED|Open-label Treatment Phase||243
3248204|NCT02483585|3982175|FG000|NOT COMPLETED|Open-label Treatment Phase||27
3248205|NCT02483585|3982176|FG001|NOT COMPLETED|Open-label Treatment Phase||25
3248206|NCT02483611|3982189|FG000|STARTED|Overall Study||16
3248207|NCT02483611|3982190|FG001|STARTED|Overall Study||16
3248208|NCT02483611|3982191|FG002|STARTED|Overall Study||16
3248209|NCT02483611|3982189|FG000|COMPLETED|Overall Study||16
3248210|NCT02483611|3982190|FG001|COMPLETED|Overall Study||16
3248211|NCT02483611|3982191|FG002|COMPLETED|Overall Study|One patient required decurarization|15
3248212|NCT02483611|3982189|FG000|NOT COMPLETED|Overall Study||0
3248213|NCT02483611|3982190|FG001|NOT COMPLETED|Overall Study||0
3248214|NCT02483611|3982191|FG002|NOT COMPLETED|Overall Study||1
3248215|NCT02483676|3982201|FG000|STARTED|Overall Study||23
3248216|NCT02483676|3982202|FG001|STARTED|Overall Study||22
3248217|NCT02483676|3982201|FG000|COMPLETED|Overall Study||17
3248218|NCT02483676|3982202|FG001|COMPLETED|Overall Study||17
3248219|NCT02483676|3982201|FG000|NOT COMPLETED|Overall Study||6
3248220|NCT02483676|3982202|FG001|NOT COMPLETED|Overall Study||5
3248221|NCT02483975|3982210|FG000|STARTED|Overall Study||56
3248222|NCT02483975|3982211|FG001|STARTED|Overall Study||55
3248223|NCT02483975|3982210|FG000|COMPLETED|Overall Study||54
3248224|NCT02483975|3982211|FG001|COMPLETED|Overall Study|Subject reported as not completed due to AE was discontinued due to exacerbation, was not an AE/SAE|53
3248225|NCT02483975|3982210|FG000|NOT COMPLETED|Overall Study||2
3248226|NCT02483975|3982211|FG001|NOT COMPLETED|Overall Study||2
3248227|NCT02484092|3982220|FG000|STARTED|Overall Study||15
3248228|NCT02484092|3982220|FG000|COMPLETED|Overall Study||15
3248229|NCT02484092|3982220|FG000|NOT COMPLETED|Overall Study||0
3248230|NCT02484222|3982224|FG000|STARTED|Overall Study||80
3248231|NCT02484222|3982224|FG000|COMPLETED|Overall Study||77
3248232|NCT02484222|3982224|FG000|NOT COMPLETED|Overall Study||3
3248233|NCT02484443|3982230|FG000|STARTED|Overall Study||41
3248234|NCT02484443|3982230|FG000|COMPLETED|Overall Study||9
3248235|NCT02484443|3982230|FG000|NOT COMPLETED|Overall Study||32
3248236|NCT02484547|3982237|FG000|STARTED|Placebo-Controlled Period||548
3248237|NCT02484547|3982238|FG001|STARTED|Placebo-Controlled Period||543
3248238|NCT02484547|3982239|FG002|STARTED|Placebo-Controlled Period||547
3248239|NCT02484547|3982240|FG003|STARTED|Placebo-Controlled Period||0
3248240|NCT02484547|3982241|FG004|STARTED|Placebo-Controlled Period||0
3248241|NCT02484547|3982242|FG005|STARTED|Placebo-Controlled Period||0
3248242|NCT02484547|3982243|FG006|STARTED|Placebo-Controlled Period||0
3248243|NCT02484547|3982237|FG000|COMPLETED|Placebo-Controlled Period||288
3248244|NCT02484547|3982238|FG001|COMPLETED|Placebo-Controlled Period||291
3248245|NCT02484547|3982239|FG002|COMPLETED|Placebo-Controlled Period||295
3248246|NCT02484547|3982240|FG003|COMPLETED|Placebo-Controlled Period||0
3248247|NCT02484547|3982241|FG004|COMPLETED|Placebo-Controlled Period||0
3248248|NCT02484547|3982242|FG005|COMPLETED|Placebo-Controlled Period||0
3248249|NCT02484547|3982243|FG006|COMPLETED|Placebo-Controlled Period||0
3248250|NCT02484547|3982237|FG000|NOT COMPLETED|Placebo-Controlled Period||260
3248251|NCT02484547|3982238|FG001|NOT COMPLETED|Placebo-Controlled Period||252
3248252|NCT02484547|3982239|FG002|NOT COMPLETED|Placebo-Controlled Period||252
3248253|NCT02484547|3982240|FG003|NOT COMPLETED|Placebo-Controlled Period||0
3248254|NCT02484547|3982241|FG004|NOT COMPLETED|Placebo-Controlled Period||0
3248255|NCT02484547|3982242|FG005|NOT COMPLETED|Placebo-Controlled Period||0
3248256|NCT02484547|3982243|FG006|NOT COMPLETED|Placebo-Controlled Period||0
3248257|NCT02484547|3982237|FG000|STARTED|Long-Term Extension Period||0
3248258|NCT02484547|3982238|FG001|STARTED|Long-Term Extension Period||0
3248259|NCT02484547|3982239|FG002|STARTED|Long-Term Extension Period||0
3248260|NCT02484547|3982240|FG003|STARTED|Long-Term Extension Period|11 PC completers did not enter LTE.|131
3248261|NCT02484547|3982241|FG004|STARTED|Long-Term Extension Period|14 PC completers did not enter LTE.|132
3248262|NCT02484547|3982242|FG005|STARTED|Long-Term Extension Period|40 PC completers did not enter LTE.|251
3248263|NCT02484547|3982243|FG006|STARTED|Long-Term Extension Period|38 PC completers did not enter LTE.|257
3248264|NCT02484547|3982237|FG000|COMPLETED|Long-Term Extension Period||0
3248265|NCT02484547|3982238|FG001|COMPLETED|Long-Term Extension Period||0
3248266|NCT02484547|3982239|FG002|COMPLETED|Long-Term Extension Period||0
3248267|NCT02484547|3982240|FG003|COMPLETED|Long-Term Extension Period||0
3248268|NCT02484547|3982241|FG004|COMPLETED|Long-Term Extension Period||0
3248269|NCT02484547|3982242|FG005|COMPLETED|Long-Term Extension Period||0
3248270|NCT02484547|3982243|FG006|COMPLETED|Long-Term Extension Period||0
3248271|NCT02484547|3982237|FG000|NOT COMPLETED|Long-Term Extension Period||0
3248272|NCT02484547|3982238|FG001|NOT COMPLETED|Long-Term Extension Period||0
3248273|NCT02484547|3982239|FG002|NOT COMPLETED|Long-Term Extension Period||0
3248274|NCT02484547|3982240|FG003|NOT COMPLETED|Long-Term Extension Period||131
3248275|NCT02484547|3982241|FG004|NOT COMPLETED|Long-Term Extension Period||132
3248276|NCT02484547|3982242|FG005|NOT COMPLETED|Long-Term Extension Period||251
3248277|NCT02484547|3982243|FG006|NOT COMPLETED|Long-Term Extension Period||257
3248278|NCT02484651|3982257|FG000|STARTED|Overall Study|35 patients were randomized|35
3248279|NCT02484651|3982258|FG001|STARTED|Overall Study|35 patients were randomized|35
3248280|NCT02484651|3982257|FG000|End of Clinical Study|Overall Study||35
3248281|NCT02484651|3982258|FG001|End of Clinical Study|Overall Study||35
3248282|NCT02484651|3982257|FG000|Data Analysis|Overall Study||32
3248283|NCT02484651|3982258|FG001|Data Analysis|Overall Study||31
3248284|NCT02484651|3982257|FG000|COMPLETED|Overall Study||32
3248285|NCT02484651|3982258|FG001|COMPLETED|Overall Study||31
3248286|NCT02484651|3982257|FG000|NOT COMPLETED|Overall Study||3
3248287|NCT02484651|3982258|FG001|NOT COMPLETED|Overall Study||4
3248288|NCT02484690|3982270|FG000|STARTED|Overall Study||68
3248289|NCT02484690|3982271|FG001|STARTED|Overall Study||46
3248290|NCT02484690|3982272|FG002|STARTED|Overall Study||39
3248291|NCT02484690|3982273|FG003|STARTED|Overall Study||46
3248292|NCT02484690|3982274|FG004|STARTED|Overall Study||64
3248293|NCT02484690|3982270|FG000|Received at Least One Dose of Study Drug|Overall Study||67
3248294|NCT02484690|3982271|FG001|Received at Least One Dose of Study Drug|Overall Study||46
3248295|NCT02484690|3982272|FG002|Received at Least One Dose of Study Drug|Overall Study||39
3248296|NCT02484690|3982273|FG003|Received at Least One Dose of Study Drug|Overall Study||46
3248297|NCT02484690|3982274|FG004|Received at Least One Dose of Study Drug|Overall Study||64
3248298|NCT02484690|3982270|FG000|COMPLETED|Overall Study||64
3248299|NCT02484690|3982271|FG001|COMPLETED|Overall Study||40
3248300|NCT02484690|3982272|FG002|COMPLETED|Overall Study||36
3248301|NCT02484690|3982273|FG003|COMPLETED|Overall Study||44
3248302|NCT02484690|3982274|FG004|COMPLETED|Overall Study||58
3248303|NCT02484690|3982270|FG000|NOT COMPLETED|Overall Study||4
3248304|NCT02484690|3982271|FG001|NOT COMPLETED|Overall Study||6
3248305|NCT02484690|3982272|FG002|NOT COMPLETED|Overall Study||3
3248306|NCT02484690|3982273|FG003|NOT COMPLETED|Overall Study||2
3248307|NCT02484690|3982274|FG004|NOT COMPLETED|Overall Study||6
3248308|NCT02484729|3982297|FG000|STARTED|Overall Study||16
3248309|NCT02484729|3982298|FG001|STARTED|Overall Study||6
3248310|NCT02484729|3982299|FG002|STARTED|Overall Study||6
3248311|NCT02484729|3982300|FG003|STARTED|Overall Study||6
3248312|NCT02484729|3982301|FG004|STARTED|Overall Study||5
3248313|NCT02484729|3982302|FG005|STARTED|Overall Study||6
3248314|NCT02484729|3982303|FG006|STARTED|Overall Study||5
3248315|NCT02484729|3982304|FG007|STARTED|Overall Study||6
3248316|NCT02484729|3982305|FG008|STARTED|Overall Study||6
3248317|NCT02484729|3982306|FG009|STARTED|Overall Study||8
3248318|NCT02484729|3982297|FG000|COMPLETED|Overall Study||16
3248319|NCT02484729|3982298|FG001|COMPLETED|Overall Study||6
3248320|NCT02484729|3982299|FG002|COMPLETED|Overall Study||6
3248321|NCT02484729|3982300|FG003|COMPLETED|Overall Study||6
3248322|NCT02484729|3982301|FG004|COMPLETED|Overall Study||5
3248323|NCT02484729|3982302|FG005|COMPLETED|Overall Study||6
3248324|NCT02484729|3982303|FG006|COMPLETED|Overall Study||5
3248325|NCT02484729|3982304|FG007|COMPLETED|Overall Study||6
3248326|NCT02484729|3982305|FG008|COMPLETED|Overall Study||6
3248327|NCT02484729|3982306|FG009|COMPLETED|Overall Study||7
3248328|NCT02484729|3982297|FG000|NOT COMPLETED|Overall Study||0
3248329|NCT02484729|3982298|FG001|NOT COMPLETED|Overall Study||0
3248330|NCT02484729|3982299|FG002|NOT COMPLETED|Overall Study||0
3248331|NCT02484729|3982300|FG003|NOT COMPLETED|Overall Study||0
3248332|NCT02484729|3982301|FG004|NOT COMPLETED|Overall Study||0
3248333|NCT02484729|3982302|FG005|NOT COMPLETED|Overall Study||0
3248334|NCT02484729|3982303|FG006|NOT COMPLETED|Overall Study||0
3248335|NCT02484729|3982304|FG007|NOT COMPLETED|Overall Study||0
3248336|NCT02484729|3982305|FG008|NOT COMPLETED|Overall Study||0
3248337|NCT02484729|3982306|FG009|NOT COMPLETED|Overall Study||1
3248338|NCT02484807|3982346|FG000|STARTED|Overall Study||39
3248339|NCT02484807|3982347|FG001|STARTED|Overall Study||7
3248340|NCT02484807|3982348|FG002|STARTED|Overall Study||19
3248341|NCT02484807|3982349|FG003|STARTED|Overall Study||21
3248342|NCT02484807|3982350|FG004|STARTED|Overall Study||33
3248343|NCT02484807|3982351|FG005|STARTED|Overall Study||6
3248344|NCT02484807|3982346|FG000|COMPLETED|Overall Study||39
3248345|NCT02484807|3982347|FG001|COMPLETED|Overall Study||7
3248346|NCT02484807|3982348|FG002|COMPLETED|Overall Study||19
3248347|NCT02484807|3982349|FG003|COMPLETED|Overall Study||21
3248348|NCT02484807|3982350|FG004|COMPLETED|Overall Study||33
3248349|NCT02484807|3982351|FG005|COMPLETED|Overall Study||6
3248350|NCT02484807|3982346|FG000|NOT COMPLETED|Overall Study||0
3248351|NCT02484807|3982347|FG001|NOT COMPLETED|Overall Study||0
3248352|NCT02484807|3982348|FG002|NOT COMPLETED|Overall Study||0
3248353|NCT02484807|3982349|FG003|NOT COMPLETED|Overall Study||0
3248354|NCT02484807|3982350|FG004|NOT COMPLETED|Overall Study||0
3248355|NCT02484807|3982351|FG005|NOT COMPLETED|Overall Study||0
3248356|NCT02484859|3982368|FG000|STARTED|Overall Study||44
3248357|NCT02484859|3982369|FG001|STARTED|Overall Study||44
3248358|NCT02484859|3982368|FG000|COMPLETED|Overall Study||44
3248359|NCT02484859|3982369|FG001|COMPLETED|Overall Study||44
3248360|NCT02484859|3982368|FG000|NOT COMPLETED|Overall Study||0
3248361|NCT02484859|3982369|FG001|NOT COMPLETED|Overall Study||0
3248362|NCT02484898|3982377|FG000|STARTED|Overall Study||200
3248363|NCT02484898|3982377|FG000|COMPLETED|Overall Study||182
3248364|NCT02484898|3982377|FG000|NOT COMPLETED|Overall Study||18
3248365|NCT02484911|3982383|FG000|STARTED|Overall Study||60
3248366|NCT02484911|3982384|FG001|STARTED|Overall Study||60
3248367|NCT02484911|3982383|FG000|COMPLETED|Overall Study||56
3248368|NCT02484911|3982384|FG001|COMPLETED|Overall Study||58
3248369|NCT02484911|3982383|FG000|NOT COMPLETED|Overall Study||4
3248370|NCT02484911|3982384|FG001|NOT COMPLETED|Overall Study||2
3248371|NCT02485158|3982391|FG000|STARTED|Overall Study||28
3248372|NCT02485158|3982391|FG000|COMPLETED|Overall Study||24
3248373|NCT02485158|3982391|FG000|NOT COMPLETED|Overall Study||4
3248374|NCT02485301|3982402|FG000|STARTED|Overall Study||1509
3248375|NCT02485301|3982403|FG001|STARTED|Overall Study||1504
3248376|NCT02485301|3982402|FG000|COMPLETED|Overall Study||1471
3248377|NCT02485301|3982403|FG001|COMPLETED|Overall Study||1455
3248378|NCT02485301|3982402|FG000|NOT COMPLETED|Overall Study||38
3248379|NCT02485301|3982403|FG001|NOT COMPLETED|Overall Study||49
3248380|NCT02485353|3982409|FG000|STARTED|Overall Study||2
3248381|NCT02485353|3982409|FG000|COMPLETED|Overall Study||0
3248382|NCT02485353|3982409|FG000|NOT COMPLETED|Overall Study||2
3248383|NCT02485483|3982415|FG000|STARTED|Overall Study||277
3248384|NCT02485483|3982416|FG001|STARTED|Overall Study||1015
3248385|NCT02485483|3982415|FG000|COMPLETED|Overall Study||223
3248386|NCT02485483|3982416|FG001|COMPLETED|Overall Study||1015
3248387|NCT02485483|3982415|FG000|NOT COMPLETED|Overall Study||54
3248388|NCT02485483|3982416|FG001|NOT COMPLETED|Overall Study||0
3248389|NCT02485561|3982425|FG000|STARTED|Overall Study||161
3248390|NCT02485561|3982426|FG001|STARTED|Overall Study||157
3248391|NCT02485561|3982427|FG002|STARTED|Overall Study||159
3248392|NCT02485561|3982425|FG000|Completed 1 mo Survey|Overall Study||145
3248393|NCT02485561|3982426|FG001|Completed 1 mo Survey|Overall Study||138
3248394|NCT02485561|3982427|FG002|Completed 1 mo Survey|Overall Study||144
3248395|NCT02485561|3982425|FG000|COMPLETED|Overall Study||133
3248396|NCT02485561|3982426|FG001|COMPLETED|Overall Study||118
3248397|NCT02485561|3982427|FG002|COMPLETED|Overall Study||136
3248398|NCT02485561|3982425|FG000|NOT COMPLETED|Overall Study||28
3248399|NCT02485561|3982426|FG001|NOT COMPLETED|Overall Study||39
3248400|NCT02485561|3982427|FG002|NOT COMPLETED|Overall Study||23
3248401|NCT02485704|3982437|FG000|STARTED|Overall Study||154
3248402|NCT02485704|3982438|FG001|STARTED|Overall Study||126
3248403|NCT02485704|3982437|FG000|COMPLETED|Overall Study||149
3248404|NCT02485704|3982438|FG001|COMPLETED|Overall Study||118
3248405|NCT02485704|3982437|FG000|NOT COMPLETED|Overall Study||5
3248406|NCT02485704|3982438|FG001|NOT COMPLETED|Overall Study||8
3248407|NCT02485717|3982447|FG000|STARTED|Overall Study||142
3248408|NCT02485717|3982448|FG001|STARTED|Overall Study||129
3248409|NCT02485717|3982449|FG002|STARTED|Overall Study||20
3248410|NCT02485717|3982447|FG000|COMPLETED|Overall Study||136
3248411|NCT02485717|3982448|FG001|COMPLETED|Overall Study||127
3248412|NCT02485717|3982449|FG002|COMPLETED|Overall Study||19
3248413|NCT02485717|3982447|FG000|NOT COMPLETED|Overall Study||6
3248414|NCT02485717|3982448|FG001|NOT COMPLETED|Overall Study||2
3248415|NCT02485717|3982449|FG002|NOT COMPLETED|Overall Study||1
3248416|NCT02485834|3982457|FG000|STARTED|Overall Study||3
3248417|NCT02485834|3982458|FG001|STARTED|Overall Study||2
3248418|NCT02485834|3982457|FG000|COMPLETED|Overall Study||3
3248419|NCT02485834|3982458|FG001|COMPLETED|Overall Study||2
3248420|NCT02485834|3982457|FG000|NOT COMPLETED|Overall Study||0
3248421|NCT02485834|3982458|FG001|NOT COMPLETED|Overall Study||0
3248422|NCT02485912|3982465|FG000|STARTED|Overall Study||20
3248423|NCT02485912|3982466|FG001|STARTED|Overall Study||20
3248424|NCT02485912|3982465|FG000|COMPLETED|Overall Study||20
3248425|NCT02485912|3982466|FG001|COMPLETED|Overall Study||20
3248426|NCT02485912|3982465|FG000|NOT COMPLETED|Overall Study||0
3248427|NCT02485912|3982466|FG001|NOT COMPLETED|Overall Study||0
3248428|NCT02485925|3982472|FG000|STARTED|Overall Study||200
3248429|NCT02485925|3982472|FG000|Safety Population|Overall Study||200
3248430|NCT02485925|3982472|FG000|Intent to Treat (ITT) Population|Overall Study||193
3248431|NCT02485925|3982472|FG000|Per-Protocol Population|Overall Study||166
3248432|NCT02485925|3982472|FG000|COMPLETED|Overall Study||185
3248433|NCT02485925|3982472|FG000|NOT COMPLETED|Overall Study||15
3248434|NCT02485964|3982476|FG000|STARTED|Overall Study||10
3248435|NCT02485964|3982476|FG000|COMPLETED|Overall Study||10
3248436|NCT02485964|3982476|FG000|NOT COMPLETED|Overall Study||0
3248437|NCT02486016|3982480|FG000|STARTED|Overall Study|Same 10 volunteers completed Apotex, Duragesic and Mylan arms of the study; crossover study.|10
3248438|NCT02486016|3982480|FG000|COMPLETED|Overall Study||10
3248439|NCT02486016|3982480|FG000|NOT COMPLETED|Overall Study||0
3248440|NCT02486211|3982490|FG000|STARTED|Overall Study||7
3248441|NCT02486211|3982491|FG001|STARTED|Overall Study||7
3248442|NCT02486211|3982490|FG000|COMPLETED|Overall Study||6
3248443|NCT02486211|3982491|FG001|COMPLETED|Overall Study||7
3248444|NCT02486211|3982490|FG000|NOT COMPLETED|Overall Study||1
3248445|NCT02486211|3982491|FG001|NOT COMPLETED|Overall Study||0
3248446|NCT02486263|3982500|FG000|STARTED|Overall Study||40
3248447|NCT02486263|3982501|FG001|STARTED|Overall Study||36
3248448|NCT02486263|3982500|FG000|COMPLETED|Overall Study||37
3248449|NCT02486263|3982501|FG001|COMPLETED|Overall Study||35
3248450|NCT02486263|3982500|FG000|NOT COMPLETED|Overall Study||3
3248451|NCT02486263|3982501|FG001|NOT COMPLETED|Overall Study||1
3248452|NCT02486302|3982509|FG000|STARTED|Overall Study||1534
3248453|NCT02486302|3982509|FG000|Treated|Overall Study||1523
3248454|NCT02486302|3982509|FG000|COMPLETED|Overall Study||858
3248455|NCT02486302|3982509|FG000|NOT COMPLETED|Overall Study||676
3248456|NCT02486328|3982524|FG000|STARTED|Overall Study||52
3248457|NCT02486328|3982525|FG001|STARTED|Overall Study||51
3248458|NCT02486328|3982524|FG000|COMPLETED|Overall Study||50
3248459|NCT02486328|3982525|FG001|COMPLETED|Overall Study||50
3248460|NCT02486328|3982524|FG000|NOT COMPLETED|Overall Study||2
3248461|NCT02486328|3982525|FG001|NOT COMPLETED|Overall Study||1
3248462|NCT02486406|3982535|FG000|STARTED|Overall Study||12
3248463|NCT02486406|3982536|FG001|STARTED|Overall Study||26
3248464|NCT02486406|3982537|FG002|STARTED|Overall Study||12
3248465|NCT02486406|3982538|FG003|STARTED|Overall Study||14
3248466|NCT02486406|3982535|FG000|COMPLETED|Overall Study||10
3248467|NCT02486406|3982536|FG001|COMPLETED|Overall Study||23
3248468|NCT02486406|3982537|FG002|COMPLETED|Overall Study||10
3248469|NCT02486406|3982538|FG003|COMPLETED|Overall Study||10
3248470|NCT02486406|3982535|FG000|NOT COMPLETED|Overall Study||2
3248471|NCT02486406|3982536|FG001|NOT COMPLETED|Overall Study||3
3248472|NCT02486406|3982537|FG002|NOT COMPLETED|Overall Study||2
3248473|NCT02486406|3982538|FG003|NOT COMPLETED|Overall Study||4
3248474|NCT02486588|3982576|FG000|STARTED|Overall Study||1188
3248475|NCT02486588|3982577|FG001|STARTED|Overall Study||1252
3248476|NCT02486588|3982578|FG002|STARTED|Overall Study||1220
3248477|NCT02486588|3982579|FG003|STARTED|Overall Study||1206
3248478|NCT02486588|3982580|FG004|STARTED|Overall Study||1243
3248479|NCT02486588|3982581|FG005|STARTED|Overall Study||1205
3248480|NCT02486588|3982576|FG000|COMPLETED|Overall Study||450
3248481|NCT02486588|3982577|FG001|COMPLETED|Overall Study||502
3248482|NCT02486588|3982578|FG002|COMPLETED|Overall Study||465
3248483|NCT02486588|3982579|FG003|COMPLETED|Overall Study||468
3248484|NCT02486588|3982580|FG004|COMPLETED|Overall Study||497
3248485|NCT02486588|3982581|FG005|COMPLETED|Overall Study||459
3248486|NCT02486588|3982576|FG000|NOT COMPLETED|Overall Study||738
3248487|NCT02486588|3982577|FG001|NOT COMPLETED|Overall Study||750
3248488|NCT02486588|3982578|FG002|NOT COMPLETED|Overall Study||755
3248489|NCT02486588|3982579|FG003|NOT COMPLETED|Overall Study||738
3248490|NCT02486588|3982580|FG004|NOT COMPLETED|Overall Study||746
3248491|NCT02486588|3982581|FG005|NOT COMPLETED|Overall Study||746
3248492|NCT02486627|3982602|FG000|STARTED|Overall Study||306
3248493|NCT02486627|3982603|FG001|STARTED|Overall Study||303
3248494|NCT02486627|3982602|FG000|COMPLETED|Overall Study||299
3248495|NCT02486627|3982603|FG001|COMPLETED|Overall Study||294
3248496|NCT02486627|3982602|FG000|NOT COMPLETED|Overall Study||7
3248497|NCT02486627|3982603|FG001|NOT COMPLETED|Overall Study||9
3248498|NCT02486653|3982611|FG000|STARTED|Overall Study||76
3248499|NCT02486653|3982612|FG001|STARTED|Overall Study||75
3248500|NCT02486653|3982611|FG000|COMPLETED|Overall Study||70
3248501|NCT02486653|3982612|FG001|COMPLETED|Overall Study||71
3248502|NCT02486653|3982611|FG000|NOT COMPLETED|Overall Study||6
3248503|NCT02486653|3982612|FG001|NOT COMPLETED|Overall Study||4
3248504|NCT02486692|3982620|FG000|STARTED|Overall Study||30
3248505|NCT02486692|3982621|FG001|STARTED|Overall Study||30
3248506|NCT02486692|3982620|FG000|COMPLETED|Overall Study||26
3248507|NCT02486692|3982621|FG001|COMPLETED|Overall Study||23
3248508|NCT02486692|3982620|FG000|NOT COMPLETED|Overall Study||4
3248509|NCT02486692|3982621|FG001|NOT COMPLETED|Overall Study||7
3248510|NCT02486757|3982627|FG000|STARTED|Overall Study||6
3248511|NCT02486757|3982627|FG000|COMPLETED|Overall Study||5
3248512|NCT02486757|3982627|FG000|NOT COMPLETED|Overall Study||1
3248513|NCT02486796|3982633|FG000|STARTED|Overall Study||3
3248514|NCT02486796|3982634|FG001|STARTED|Overall Study||2
3248515|NCT02486796|3982633|FG000|COMPLETED|Overall Study||1
3248516|NCT02486796|3982634|FG001|COMPLETED|Overall Study||1
3248517|NCT02486796|3982633|FG000|NOT COMPLETED|Overall Study||2
3248518|NCT02486796|3982634|FG001|NOT COMPLETED|Overall Study||1
3248519|NCT02486939|3982642|FG000|STARTED|Overall Study||225
3248520|NCT02486939|3982643|FG001|STARTED|Overall Study||134
3248521|NCT02486939|3982642|FG000|COMPLETED|Overall Study||224
3248522|NCT02486939|3982643|FG001|COMPLETED|Overall Study||132
3248523|NCT02486939|3982642|FG000|NOT COMPLETED|Overall Study||1
3248524|NCT02486939|3982643|FG001|NOT COMPLETED|Overall Study||2
3248525|NCT02486952|3982649|FG000|STARTED|Overall Study||154
3248526|NCT02486952|3982649|FG000|Started Induction Therapy|Overall Study||151
3248527|NCT02486952|3982649|FG000|COMPLETED|Overall Study||104
3248528|NCT02486952|3982649|FG000|NOT COMPLETED|Overall Study||50
3248529|NCT02487030|3982660|FG000|STARTED|Overall Study||43
3248530|NCT02487030|3982661|FG001|STARTED|Overall Study||42
3248531|NCT02487030|3982662|FG002|STARTED|Overall Study||43
3248532|NCT02487030|3982663|FG003|STARTED|Overall Study||42
3248533|NCT02487030|3982664|FG004|STARTED|Overall Study||36
3248534|NCT02487030|3982665|FG005|STARTED|Overall Study||38
3248535|NCT02487030|3982666|FG006|STARTED|Overall Study||11
3248536|NCT02487030|3982660|FG000|COMPLETED|Overall Study||41
3248537|NCT02487030|3982661|FG001|COMPLETED|Overall Study||38
3248538|NCT02487030|3982662|FG002|COMPLETED|Overall Study||41
3248539|NCT02487030|3982663|FG003|COMPLETED|Overall Study||40
3248540|NCT02487030|3982664|FG004|COMPLETED|Overall Study||34
3248541|NCT02487030|3982665|FG005|COMPLETED|Overall Study||37
3248542|NCT02487030|3982666|FG006|COMPLETED|Overall Study||11
3248543|NCT02487030|3982660|FG000|NOT COMPLETED|Overall Study||2
3248544|NCT02487030|3982661|FG001|NOT COMPLETED|Overall Study||4
3248545|NCT02487030|3982662|FG002|NOT COMPLETED|Overall Study||2
3248546|NCT02487030|3982663|FG003|NOT COMPLETED|Overall Study||2
3248547|NCT02487030|3982664|FG004|NOT COMPLETED|Overall Study||2
3248548|NCT02487030|3982665|FG005|NOT COMPLETED|Overall Study||1
3248549|NCT02487030|3982666|FG006|NOT COMPLETED|Overall Study||0
3248550|NCT02487056|3982683|FG000|STARTED|Overall Study||1622
3248551|NCT02487056|3982683|FG000|COMPLETED|Overall Study||1606
3248552|NCT02487056|3982683|FG000|NOT COMPLETED|Overall Study||16
3248553|NCT02487199|3982690|FG000|STARTED|Overall Study||13
3248554|NCT02487199|3982691|FG001|STARTED|Overall Study||5
3248555|NCT02487199|3982690|FG000|COMPLETED|Overall Study||13
3248556|NCT02487199|3982691|FG001|COMPLETED|Overall Study||4
3248557|NCT02487199|3982690|FG000|NOT COMPLETED|Overall Study||0
3248558|NCT02487199|3982691|FG001|NOT COMPLETED|Overall Study||1
3248559|NCT02487225|3982699|FG000|STARTED|Overall Study||45
3248560|NCT02487225|3982700|FG001|STARTED|Overall Study||38
3248561|NCT02487225|3982699|FG000|COMPLETED|Overall Study||18
3248562|NCT02487225|3982700|FG001|COMPLETED|Overall Study||8
3248563|NCT02487225|3982699|FG000|NOT COMPLETED|Overall Study||27
3248564|NCT02487225|3982700|FG001|NOT COMPLETED|Overall Study||30
3248565|NCT02487303|3982709|FG000|STARTED|Overall Study||49
3248566|NCT02487303|3982710|FG001|STARTED|Overall Study||51
3248567|NCT02487303|3982711|FG002|STARTED|Overall Study||48
3248568|NCT02487303|3982709|FG000|COMPLETED|Overall Study||47
3248569|NCT02487303|3982710|FG001|COMPLETED|Overall Study||47
3248570|NCT02487303|3982711|FG002|COMPLETED|Overall Study||47
3248571|NCT02487303|3982709|FG000|NOT COMPLETED|Overall Study||2
3248572|NCT02487303|3982710|FG001|NOT COMPLETED|Overall Study||4
3248573|NCT02487303|3982711|FG002|NOT COMPLETED|Overall Study||1
3248574|NCT02487446|3982722|FG000|STARTED|Period 1||178
3248575|NCT02487446|3982723|FG001|STARTED|Period 1||179
3248576|NCT02487446|3982722|FG000|COMPLETED|Period 1||165
3248577|NCT02487446|3982723|FG001|COMPLETED|Period 1||171
3248578|NCT02487446|3982722|FG000|NOT COMPLETED|Period 1||13
3248579|NCT02487446|3982723|FG001|NOT COMPLETED|Period 1||8
3248580|NCT02487446|3982722|FG000|STARTED|Washout||165
3248581|NCT02487446|3982723|FG001|STARTED|Washout||171
3248582|NCT02487446|3982722|FG000|COMPLETED|Washout||162
3248583|NCT02487446|3982723|FG001|COMPLETED|Washout||163
3248584|NCT02487446|3982722|FG000|NOT COMPLETED|Washout||3
3248585|NCT02487446|3982723|FG001|NOT COMPLETED|Washout||8
3248586|NCT02487446|3982722|FG000|STARTED|Period 2||162
3248587|NCT02487446|3982723|FG001|STARTED|Period 2||163
3248588|NCT02487446|3982722|FG000|COMPLETED|Period 2||154
3248589|NCT02487446|3982723|FG001|COMPLETED|Period 2||158
3248590|NCT02487446|3982722|FG000|NOT COMPLETED|Period 2||8
3248591|NCT02487446|3982723|FG001|NOT COMPLETED|Period 2||5
3248592|NCT02487472|3982730|FG000|STARTED|Overall Study||101
3248593|NCT02487472|3982730|FG000|COMPLETED|Overall Study||90
3248594|NCT02487472|3982730|FG000|NOT COMPLETED|Overall Study||11
3248595|NCT02487485|3982738|FG000|STARTED|Overall Study||12
3248596|NCT02487485|3982739|FG001|STARTED|Overall Study||11
3248597|NCT02487485|3982738|FG000|COMPLETED|Overall Study||9
3248598|NCT02487485|3982739|FG001|COMPLETED|Overall Study||8
3248599|NCT02487485|3982738|FG000|NOT COMPLETED|Overall Study||3
3248600|NCT02487485|3982739|FG001|NOT COMPLETED|Overall Study||3
3371272|NCT03739528|4102905|FG001|Received at Least One Treatment|Overall Study||393
3371273|NCT03739528|4102904|FG000|COMPLETED|Overall Study||388
3371274|NCT03739528|4102905|FG001|COMPLETED|Overall Study||388
3371275|NCT03739528|4102904|FG000|NOT COMPLETED|Overall Study||15
3371276|NCT03739528|4102905|FG001|NOT COMPLETED|Overall Study||17
3371277|NCT03739242|4102916|FG000|STARTED|Overall Study||44
3371278|NCT03739242|4102917|FG001|STARTED|Overall Study||44
3371279|NCT03739242|4102916|FG000|COMPLETED|Overall Study||43
3371280|NCT03739242|4102917|FG001|COMPLETED|Overall Study||42
3371281|NCT03739242|4102916|FG000|NOT COMPLETED|Overall Study||1
3371282|NCT03739242|4102917|FG001|NOT COMPLETED|Overall Study||2
3371283|NCT03738865|4102925|FG000|STARTED|Overall Study||66
3371284|NCT03738865|4102926|FG001|STARTED|Overall Study||66
3371285|NCT03738865|4102925|FG000|COMPLETED|Overall Study||61
3371286|NCT03738865|4102926|FG001|COMPLETED|Overall Study||62
3371287|NCT03738865|4102925|FG000|NOT COMPLETED|Overall Study||5
3371288|NCT03738865|4102926|FG001|NOT COMPLETED|Overall Study||4
3371289|NCT03738826|4102934|FG000|STARTED|Overall Study||130
3371290|NCT03738826|4102935|FG001|STARTED|Overall Study||5
3371291|NCT03738826|4102934|FG000|COMPLETED|Overall Study||130
3371292|NCT03738826|4102935|FG001|COMPLETED|Overall Study||5
3371293|NCT03738826|4102934|FG000|NOT COMPLETED|Overall Study||0
3371294|NCT03738826|4102935|FG001|NOT COMPLETED|Overall Study||0
3371295|NCT03738475|4102943|FG000|STARTED|Overall Study||16
3371296|NCT03738475|4102944|FG001|STARTED|Overall Study||18
3371297|NCT03738475|4102943|FG000|COMPLETED|Overall Study||15
3371298|NCT03738475|4102944|FG001|COMPLETED|Overall Study||18
3371299|NCT03738475|4102943|FG000|NOT COMPLETED|Overall Study||1
3371300|NCT03738475|4102944|FG001|NOT COMPLETED|Overall Study||0
3371301|NCT03738241|4102960|FG000|STARTED|Overall Study||38
3371302|NCT03738241|4102961|FG001|STARTED|Overall Study||40
3371303|NCT03738241|4102962|FG002|STARTED|Overall Study||24
3371304|NCT03738241|4102963|FG003|STARTED|Overall Study||18
3371305|NCT03738241|4102964|FG004|STARTED|Overall Study||40
3371306|NCT03738241|4102965|FG005|STARTED|Overall Study||44
3371307|NCT03738241|4102966|FG006|STARTED|Overall Study||20
3371308|NCT03738241|4102967|FG007|STARTED|Overall Study||16
3371309|NCT03738241|4102968|FG008|STARTED|Overall Study||29
3371310|NCT03738241|4102969|FG009|STARTED|Overall Study||35
3371311|NCT03738241|4102960|FG000|COMPLETED|Overall Study||37
3371312|NCT03738241|4102961|FG001|COMPLETED|Overall Study||40
3371313|NCT03738241|4102962|FG002|COMPLETED|Overall Study||24
3371314|NCT03738241|4102963|FG003|COMPLETED|Overall Study||18
3371315|NCT03738241|4102964|FG004|COMPLETED|Overall Study||40
3371316|NCT03738241|4102965|FG005|COMPLETED|Overall Study||44
3371317|NCT03738241|4102966|FG006|COMPLETED|Overall Study||20
3371318|NCT03738241|4102967|FG007|COMPLETED|Overall Study||16
3371319|NCT03738241|4102968|FG008|COMPLETED|Overall Study||28
3371320|NCT03738241|4102969|FG009|COMPLETED|Overall Study||34
3371321|NCT03738241|4102960|FG000|NOT COMPLETED|Overall Study||1
3371322|NCT03738241|4102961|FG001|NOT COMPLETED|Overall Study||0
3371323|NCT03738241|4102962|FG002|NOT COMPLETED|Overall Study||0
3371324|NCT03738241|4102963|FG003|NOT COMPLETED|Overall Study||0
3371325|NCT03738241|4102964|FG004|NOT COMPLETED|Overall Study||0
3371326|NCT03738241|4102965|FG005|NOT COMPLETED|Overall Study||0
3371327|NCT03738241|4102966|FG006|NOT COMPLETED|Overall Study||0
3371328|NCT03738241|4102967|FG007|NOT COMPLETED|Overall Study||0
3371329|NCT03738241|4102968|FG008|NOT COMPLETED|Overall Study||1
3371330|NCT03738241|4102969|FG009|NOT COMPLETED|Overall Study||1
3371331|NCT03738163|4102991|FG000|STARTED|Overall Study||121
3371332|NCT03738163|4102991|FG000|COMPLETED|Overall Study||114
3371333|NCT03738163|4102991|FG000|NOT COMPLETED|Overall Study||7
3371334|NCT03738020|4102995|FG000|STARTED|Overall Study||58
3248601|NCT02487498|3982745|FG000|STARTED|Period: Period 1||178
3248602|NCT02487498|3982746|FG001|STARTED|Period: Period 1||177
3248603|NCT02487498|3982745|FG000|COMPLETED|Period: Period 1||172
3248604|NCT02487498|3982746|FG001|COMPLETED|Period: Period 1||166
3248605|NCT02487498|3982745|FG000|NOT COMPLETED|Period: Period 1||6
3248606|NCT02487498|3982746|FG001|NOT COMPLETED|Period: Period 1||11
3248607|NCT02487498|3982745|FG000|STARTED|Period: Washout||172
3248608|NCT02487498|3982746|FG001|STARTED|Period: Washout||166
3248609|NCT02487498|3982745|FG000|COMPLETED|Period: Washout||170
3248610|NCT02487498|3982746|FG001|COMPLETED|Period: Washout||159
3248611|NCT02487498|3982745|FG000|NOT COMPLETED|Period: Washout||2
3248612|NCT02487498|3982746|FG001|NOT COMPLETED|Period: Washout||7
3248613|NCT02487498|3982745|FG000|STARTED|Period: Period 2||170
3248614|NCT02487498|3982746|FG001|STARTED|Period: Period 2||159
3248615|NCT02487498|3982745|FG000|COMPLETED|Period: Period 2||164
3248616|NCT02487498|3982746|FG001|COMPLETED|Period: Period 2||154
3248617|NCT02487498|3982745|FG000|NOT COMPLETED|Period: Period 2||6
3248618|NCT02487498|3982746|FG001|NOT COMPLETED|Period: Period 2||5
3248619|NCT02487563|3982756|FG000|STARTED|Overall Study||32
3248620|NCT02487563|3982757|FG001|STARTED|Overall Study||33
3248621|NCT02487563|3982758|FG002|STARTED|Overall Study||32
3248622|NCT02487563|3982756|FG000|COMPLETED|Overall Study||30
3248623|NCT02487563|3982757|FG001|COMPLETED|Overall Study||30
3248624|NCT02487563|3982758|FG002|COMPLETED|Overall Study||31
3248625|NCT02487563|3982756|FG000|NOT COMPLETED|Overall Study||2
3248626|NCT02487563|3982757|FG001|NOT COMPLETED|Overall Study||3
3248627|NCT02487563|3982758|FG002|NOT COMPLETED|Overall Study||1
3248628|NCT02487771|3982771|FG000|STARTED|Overall Study||91
3248629|NCT02487771|3982772|FG001|STARTED|Overall Study||99
3248630|NCT02487771|3982771|FG000|COMPLETED|Overall Study||81
3248631|NCT02487771|3982772|FG001|COMPLETED|Overall Study||85
3248632|NCT02487771|3982771|FG000|NOT COMPLETED|Overall Study||10
3248633|NCT02487771|3982772|FG001|NOT COMPLETED|Overall Study||14
3248634|NCT02487810|3982780|FG000|STARTED|Overall Study||98
3248635|NCT02487810|3982781|FG001|STARTED|Overall Study||102
3248636|NCT02487810|3982780|FG000|COMPLETED|Overall Study||97
3248637|NCT02487810|3982781|FG001|COMPLETED|Overall Study||102
3248638|NCT02487810|3982780|FG000|NOT COMPLETED|Overall Study||1
3248639|NCT02487810|3982781|FG001|NOT COMPLETED|Overall Study||0
3248640|NCT02487966|3982791|FG000|STARTED|Overall Study||29
3248641|NCT02487966|3982792|FG001|STARTED|Overall Study||28
3248642|NCT02487966|3982793|FG002|STARTED|Overall Study||28
3248643|NCT02487966|3982794|FG003|STARTED|Overall Study||27
3248644|NCT02487966|3982791|FG000|COMPLETED|Overall Study||28
3248645|NCT02487966|3982792|FG001|COMPLETED|Overall Study||24
3248646|NCT02487966|3982793|FG002|COMPLETED|Overall Study||26
3248647|NCT02487966|3982794|FG003|COMPLETED|Overall Study||25
3248648|NCT02487966|3982791|FG000|NOT COMPLETED|Overall Study||1
3248649|NCT02487966|3982792|FG001|NOT COMPLETED|Overall Study||4
3248650|NCT02487966|3982793|FG002|NOT COMPLETED|Overall Study||2
3248651|NCT02487966|3982794|FG003|NOT COMPLETED|Overall Study||2
3248652|NCT02488005|3982804|FG000|STARTED|Overall Study||15
3248653|NCT02488005|3982804|FG000|COMPLETED|Overall Study||13
3248654|NCT02488005|3982804|FG000|NOT COMPLETED|Overall Study||2
3248655|NCT02488018|3982808|FG000|STARTED|Overall Study||10
3248656|NCT02488018|3982808|FG000|COMPLETED|Overall Study||10
3248657|NCT02488018|3982808|FG000|NOT COMPLETED|Overall Study||0
3248658|NCT02488070|3982812|FG000|STARTED|Overall Study||10
3248659|NCT02488070|3982812|FG000|COMPLETED|Overall Study||10
3248660|NCT02488070|3982812|FG000|NOT COMPLETED|Overall Study||0
3248661|NCT02488109|3982819|FG000|STARTED|Treatment in Hospital||60
3248662|NCT02488109|3982820|FG001|STARTED|Treatment in Hospital||56
3248663|NCT02488109|3982819|FG000|Received Treatment|Treatment in Hospital||60
3248664|NCT02488109|3982820|FG001|Received Treatment|Treatment in Hospital||51
3248665|NCT02488109|3982819|FG000|Included in mITT Analysis|Treatment in Hospital||60
3248666|NCT02488109|3982820|FG001|Included in mITT Analysis|Treatment in Hospital||51
3248667|NCT02488109|3982819|FG000|COMPLETED|Treatment in Hospital||60
3248668|NCT02488109|3982820|FG001|COMPLETED|Treatment in Hospital||51
3248669|NCT02488109|3982819|FG000|NOT COMPLETED|Treatment in Hospital||0
3248670|NCT02488109|3982820|FG001|NOT COMPLETED|Treatment in Hospital||5
3248671|NCT02488109|3982819|FG000|STARTED|12-month Follow-Up||60
3248672|NCT02488109|3982820|FG001|STARTED|12-month Follow-Up||51
3248673|NCT02488109|3982819|FG000|Included in mITT Analysis|12-month Follow-Up||60
3248674|NCT02488109|3982820|FG001|Included in mITT Analysis|12-month Follow-Up||51
3248675|NCT02488109|3982819|FG000|COMPLETED|12-month Follow-Up||56
3248676|NCT02488109|3982820|FG001|COMPLETED|12-month Follow-Up||44
3248677|NCT02488109|3982819|FG000|NOT COMPLETED|12-month Follow-Up||4
3248678|NCT02488109|3982820|FG001|NOT COMPLETED|12-month Follow-Up||7
3248679|NCT02488239|3982828|FG000|STARTED|Overall Study||64
3248680|NCT02488239|3982828|FG000|COMPLETED|Overall Study||54
3248681|NCT02488239|3982828|FG000|NOT COMPLETED|Overall Study||10
3248682|NCT02488317|3982835|FG000|STARTED|Overall Study||117
3248683|NCT02488317|3982836|FG001|STARTED|Overall Study||117
3248684|NCT02488317|3982835|FG000|COMPLETED|Overall Study||63
3248685|NCT02488317|3982836|FG001|COMPLETED|Overall Study||70
3248686|NCT02488317|3982835|FG000|NOT COMPLETED|Overall Study||54
3248687|NCT02488317|3982836|FG001|NOT COMPLETED|Overall Study||47
3248688|NCT02488330|3982846|FG000|STARTED|Overall Study||12
3248689|NCT02488330|3982846|FG000|COMPLETED|Overall Study||0
3248690|NCT02488330|3982846|FG000|NOT COMPLETED|Overall Study||12
3248691|NCT02488681|3982850|FG000|STARTED|Overall Study|Patients with Micra implant attempt|276
3248692|NCT02488681|3982850|FG000|COMPLETED|Overall Study|Patients successfully implanted with Micra|269
3248693|NCT02488681|3982850|FG000|NOT COMPLETED|Overall Study||7
3248694|NCT02488824|3982856|FG000|STARTED|Overall Study||21
3248695|NCT02488824|3982857|FG001|STARTED|Overall Study||20
3248696|NCT02488824|3982856|FG000|COMPLETED|Overall Study||20
3248697|NCT02488824|3982857|FG001|COMPLETED|Overall Study||19
3248698|NCT02488824|3982856|FG000|NOT COMPLETED|Overall Study||1
3248699|NCT02488824|3982857|FG001|NOT COMPLETED|Overall Study||1
3248700|NCT02488915|3982863|FG000|STARTED|Overall Study||228
3248701|NCT02488915|3982863|FG000|COMPLETED|Overall Study||202
3248702|NCT02488915|3982863|FG000|NOT COMPLETED|Overall Study||26
3248703|NCT02488980|3982870|FG000|STARTED|Overall Study||104
3248704|NCT02488980|3982871|FG001|STARTED|Overall Study||101
3248705|NCT02488980|3982872|FG002|STARTED|Overall Study||101
3248706|NCT02488980|3982870|FG000|COMPLETED|Overall Study||102
3248707|NCT02488980|3982871|FG001|COMPLETED|Overall Study||99
3248708|NCT02488980|3982872|FG002|COMPLETED|Overall Study||99
3248709|NCT02488980|3982870|FG000|NOT COMPLETED|Overall Study||2
3248710|NCT02488980|3982871|FG001|NOT COMPLETED|Overall Study||2
3248711|NCT02488980|3982872|FG002|NOT COMPLETED|Overall Study||2
3248712|NCT02489045|3982880|FG000|STARTED|Overall Study||178
3248713|NCT02489045|3982880|FG000|COMPLETED|Overall Study||125
3248714|NCT02489045|3982880|FG000|NOT COMPLETED|Overall Study||53
3248715|NCT02489045|3982880|FG000|STARTED|Follow-up|"Only subjects with portal hypertension in overall study were eligible to progress to follow-up"|21
3248716|NCT02489045|3982880|FG000|COMPLETED|Follow-up||11
3248717|NCT02489045|3982880|FG000|NOT COMPLETED|Follow-up||10
3248718|NCT02489110|3982886|FG000|STARTED|Overall Study||75
3248719|NCT02489110|3982887|FG001|STARTED|Overall Study||75
3248720|NCT02489110|3982886|FG000|COMPLETED|Overall Study||48
3248721|NCT02489110|3982887|FG001|COMPLETED|Overall Study||50
3248722|NCT02489110|3982886|FG000|NOT COMPLETED|Overall Study||27
3248723|NCT02489110|3982887|FG001|NOT COMPLETED|Overall Study||25
3248724|NCT02489123|3982893|FG000|STARTED|Overall Study||8
3248725|NCT02489123|3982893|FG000|COMPLETED|Overall Study||8
3248726|NCT02489123|3982893|FG000|NOT COMPLETED|Overall Study||0
3248727|NCT02489227|3982900|FG000|STARTED|Overall Study||274
3248728|NCT02489227|3982901|FG001|STARTED|Overall Study||135
3248729|NCT02489227|3982902|FG002|STARTED|Overall Study||136
3248730|NCT02489227|3982900|FG000|COMPLETED|Overall Study||220
3248731|NCT02489227|3982901|FG001|COMPLETED|Overall Study||101
3248732|NCT02489227|3982902|FG002|COMPLETED|Overall Study||117
3248733|NCT02489227|3982900|FG000|NOT COMPLETED|Overall Study||54
3248734|NCT02489227|3982901|FG001|NOT COMPLETED|Overall Study||34
3248735|NCT02489227|3982902|FG002|NOT COMPLETED|Overall Study||19
3248736|NCT02489279|3982914|FG000|STARTED|Overall Study||44
3248737|NCT02489279|3982915|FG001|STARTED|Overall Study||41
3248738|NCT02489279|3982914|FG000|COMPLETED|Overall Study||32
3248739|NCT02489279|3982915|FG001|COMPLETED|Overall Study||31
3248740|NCT02489279|3982914|FG000|NOT COMPLETED|Overall Study||12
3248741|NCT02489279|3982915|FG001|NOT COMPLETED|Overall Study||10
3248742|NCT02489344|3982921|FG000|STARTED|ACT13739 (Initial Study): 26 Weeks||11
3248743|NCT02489344|3982921|FG000|COMPLETED|ACT13739 (Initial Study): 26 Weeks||9
3248744|NCT02489344|3982921|FG000|NOT COMPLETED|ACT13739 (Initial Study): 26 Weeks||2
3248745|NCT02489344|3982921|FG000|STARTED|LTS14116 (Extension Study): 31 Months||8
3248746|NCT02489344|3982921|FG000|COMPLETED|LTS14116 (Extension Study): 31 Months||5
3248747|NCT02489344|3982921|FG000|NOT COMPLETED|LTS14116 (Extension Study): 31 Months||3
3248748|NCT02489357|3982925|FG000|STARTED|Overall Study||12
3248749|NCT02489357|3982925|FG000|COMPLETED|Overall Study||12
3248750|NCT02489357|3982925|FG000|NOT COMPLETED|Overall Study||0
3248751|NCT02489500|3982931|FG000|STARTED|Overall Study||2
3248752|NCT02489500|3982932|FG001|STARTED|Overall Study||1
3248753|NCT02489500|3982931|FG000|COMPLETED|Overall Study||1
3248754|NCT02489500|3982932|FG001|COMPLETED|Overall Study||0
3248755|NCT02489500|3982931|FG000|NOT COMPLETED|Overall Study||1
3248756|NCT02489500|3982932|FG001|NOT COMPLETED|Overall Study||1
3248757|NCT02489630|3982940|FG000|STARTED|Overall Study||53
3248758|NCT02489630|3982941|FG001|STARTED|Overall Study||63
3248759|NCT02489630|3982940|FG000|COMPLETED|Overall Study||51
3248760|NCT02489630|3982941|FG001|COMPLETED|Overall Study||61
3248761|NCT02489630|3982940|FG000|NOT COMPLETED|Overall Study||2
3248762|NCT02489630|3982941|FG001|NOT COMPLETED|Overall Study||2
3248763|NCT02489734|3982949|FG000|STARTED|Overall Study||56
3371335|NCT03738020|4102995|FG000|COMPLETED|Overall Study||57
3371336|NCT03738020|4102995|FG000|NOT COMPLETED|Overall Study||1
3371337|NCT03736928|4103007|FG000|STARTED|Overall Study||80
3371338|NCT03736928|4103008|FG001|STARTED|Overall Study||80
3371339|NCT03736928|4103009|FG002|STARTED|Overall Study||80
3371340|NCT03736928|4103010|FG003|STARTED|Overall Study||81
3371341|NCT03736928|4103011|FG004|STARTED|Overall Study||78
3248764|NCT02489734|3982950|FG001|STARTED|Overall Study||53
3248765|NCT02489734|3982949|FG000|COMPLETED|Overall Study||39
3248766|NCT02489734|3982950|FG001|COMPLETED|Overall Study||53
3248767|NCT02489734|3982949|FG000|NOT COMPLETED|Overall Study||17
3248768|NCT02489734|3982950|FG001|NOT COMPLETED|Overall Study||0
3248769|NCT02489773|3982958|FG000|STARTED|Overall Study||98
3248770|NCT02489773|3982959|FG001|STARTED|Overall Study||52
3248771|NCT02489773|3982958|FG000|COMPLETED|Overall Study||91
3248772|NCT02489773|3982959|FG001|COMPLETED|Overall Study||50
3248773|NCT02489773|3982958|FG000|NOT COMPLETED|Overall Study||7
3248774|NCT02489773|3982959|FG001|NOT COMPLETED|Overall Study||2
3248775|NCT02489799|3982967|FG000|STARTED|Overall Study||45
3248776|NCT02489799|3982968|FG001|STARTED|Overall Study||47
3248777|NCT02489799|3982967|FG000|Presurgical Consent Visit (V2)|Overall Study||40
3248778|NCT02489799|3982968|FG001|Presurgical Consent Visit (V2)|Overall Study||39
3248779|NCT02489799|3982967|FG000|Postsurgical One Week Visit (V3)|Overall Study||40
3248780|NCT02489799|3982968|FG001|Postsurgical One Week Visit (V3)|Overall Study||39
3248781|NCT02489799|3982967|FG000|COMPLETED|Overall Study||36
3248782|NCT02489799|3982968|FG001|COMPLETED|Overall Study||38
3248783|NCT02489799|3982967|FG000|NOT COMPLETED|Overall Study||9
3248784|NCT02489799|3982968|FG001|NOT COMPLETED|Overall Study||9
3248785|NCT02489968|3982976|FG000|STARTED|Open-label Treatment Period||439
3248786|NCT02489968|3982977|FG001|STARTED|Open-label Treatment Period|1 subject did not receive treatment and hence excluded. Started represents treated numbers.|440
3248787|NCT02489968|3982978|FG002|STARTED|Open-label Treatment Period||0
3248788|NCT02489968|3982979|FG003|STARTED|Open-label Treatment Period||0
3248789|NCT02489968|3982980|FG004|STARTED|Open-label Treatment Period||0
3248790|NCT02489968|3982981|FG005|STARTED|Open-label Treatment Period||0
3248791|NCT02489968|3982976|FG000|COMPLETED|Open-label Treatment Period||215
3248792|NCT02489968|3982977|FG001|COMPLETED|Open-label Treatment Period||232
3248793|NCT02489968|3982978|FG002|COMPLETED|Open-label Treatment Period||0
3248794|NCT02489968|3982979|FG003|COMPLETED|Open-label Treatment Period||0
3248795|NCT02489968|3982980|FG004|COMPLETED|Open-label Treatment Period||0
3248796|NCT02489968|3982981|FG005|COMPLETED|Open-label Treatment Period||0
3248797|NCT02489968|3982976|FG000|NOT COMPLETED|Open-label Treatment Period||224
3248798|NCT02489968|3982977|FG001|NOT COMPLETED|Open-label Treatment Period||208
3248799|NCT02489968|3982978|FG002|NOT COMPLETED|Open-label Treatment Period||0
3248800|NCT02489968|3982979|FG003|NOT COMPLETED|Open-label Treatment Period||0
3248801|NCT02489968|3982980|FG004|NOT COMPLETED|Open-label Treatment Period||0
3248802|NCT02489968|3982981|FG005|NOT COMPLETED|Open-label Treatment Period||0
3248803|NCT02489968|3982976|FG000|STARTED|Double-blind Treatment Period||0
3248804|NCT02489968|3982977|FG001|STARTED|Double-blind Treatment Period||0
3248805|NCT02489968|3982978|FG002|STARTED|Double-blind Treatment Period||107
3248806|NCT02489968|3982979|FG003|STARTED|Double-blind Treatment Period||108
3248807|NCT02489968|3982980|FG004|STARTED|Double-blind Treatment Period||116
3248808|NCT02489968|3982981|FG005|STARTED|Double-blind Treatment Period||116
3248809|NCT02489968|3982976|FG000|COMPLETED|Double-blind Treatment Period||0
3248810|NCT02489968|3982977|FG001|COMPLETED|Double-blind Treatment Period||0
3248811|NCT02489968|3982978|FG002|COMPLETED|Double-blind Treatment Period||105
3248812|NCT02489968|3982979|FG003|COMPLETED|Double-blind Treatment Period||100
3248813|NCT02489968|3982980|FG004|COMPLETED|Double-blind Treatment Period||110
3248814|NCT02489968|3982981|FG005|COMPLETED|Double-blind Treatment Period||108
3248815|NCT02489968|3982976|FG000|NOT COMPLETED|Double-blind Treatment Period||0
3248816|NCT02489968|3982977|FG001|NOT COMPLETED|Double-blind Treatment Period||0
3248817|NCT02489968|3982978|FG002|NOT COMPLETED|Double-blind Treatment Period||2
3248818|NCT02489968|3982979|FG003|NOT COMPLETED|Double-blind Treatment Period||8
3248819|NCT02489968|3982980|FG004|NOT COMPLETED|Double-blind Treatment Period||6
3248820|NCT02489968|3982981|FG005|NOT COMPLETED|Double-blind Treatment Period||8
3248821|NCT02489981|3982993|FG000|STARTED|Overall Study||340
3248822|NCT02489981|3982993|FG000|COMPLETED|Overall Study||213
3248823|NCT02489981|3982993|FG000|NOT COMPLETED|Overall Study||127
3248824|NCT02490293|3982999|FG000|STARTED|Overall Study||96
3248825|NCT02490293|3983000|FG001|STARTED|Overall Study||102
3248826|NCT02490293|3982999|FG000|COMPLETED|Overall Study||94
3248827|NCT02490293|3983000|FG001|COMPLETED|Overall Study||99
3248828|NCT02490293|3982999|FG000|NOT COMPLETED|Overall Study||2
3248829|NCT02490293|3983000|FG001|NOT COMPLETED|Overall Study||3
3248830|NCT02490371|3983008|FG000|STARTED|Overall Study||12
3248831|NCT02490371|3983009|FG001|STARTED|Overall Study||12
3248832|NCT02490371|3983008|FG000|COMPLETED|Overall Study||11
3248833|NCT02490371|3983009|FG001|COMPLETED|Overall Study||11
3248834|NCT02490371|3983008|FG000|NOT COMPLETED|Overall Study||1
3248835|NCT02490371|3983009|FG001|NOT COMPLETED|Overall Study||1
3248836|NCT02490475|3983019|FG000|STARTED|Period 1: First 6 Cycles||6
3248837|NCT02490475|3983020|FG001|STARTED|Period 1: First 6 Cycles||2
3248838|NCT02490475|3983021|FG002|STARTED|Period 1: First 6 Cycles||6
3248839|NCT02490475|3983022|FG003|STARTED|Period 1: First 6 Cycles||5
3248840|NCT02490475|3983019|FG000|COMPLETED|Period 1: First 6 Cycles||0
3248841|NCT02490475|3983020|FG001|COMPLETED|Period 1: First 6 Cycles||0
3248842|NCT02490475|3983021|FG002|COMPLETED|Period 1: First 6 Cycles||0
3248843|NCT02490475|3983022|FG003|COMPLETED|Period 1: First 6 Cycles||0
3248844|NCT02490475|3983019|FG000|NOT COMPLETED|Period 1: First 6 Cycles||6
3248845|NCT02490475|3983020|FG001|NOT COMPLETED|Period 1: First 6 Cycles||2
3248846|NCT02490475|3983021|FG002|NOT COMPLETED|Period 1: First 6 Cycles||6
3248847|NCT02490475|3983022|FG003|NOT COMPLETED|Period 1: First 6 Cycles||5
3248848|NCT02490475|3983019|FG000|STARTED|Period 2: Extension Phase||1
3248849|NCT02490475|3983020|FG001|STARTED|Period 2: Extension Phase||0
3248850|NCT02490475|3983021|FG002|STARTED|Period 2: Extension Phase||3
3248851|NCT02490475|3983022|FG003|STARTED|Period 2: Extension Phase||1
3248852|NCT02490475|3983019|FG000|COMPLETED|Period 2: Extension Phase||0
3248853|NCT02490475|3983020|FG001|COMPLETED|Period 2: Extension Phase||0
3248854|NCT02490475|3983021|FG002|COMPLETED|Period 2: Extension Phase||0
3248855|NCT02490475|3983022|FG003|COMPLETED|Period 2: Extension Phase||0
3248856|NCT02490475|3983019|FG000|NOT COMPLETED|Period 2: Extension Phase||1
3248857|NCT02490475|3983020|FG001|NOT COMPLETED|Period 2: Extension Phase||0
3248858|NCT02490475|3983021|FG002|NOT COMPLETED|Period 2: Extension Phase||3
3248859|NCT02490475|3983022|FG003|NOT COMPLETED|Period 2: Extension Phase||1
3248860|NCT02490631|3983045|FG000|STARTED|Overall Study||79
3248861|NCT02490631|3983046|FG001|STARTED|Overall Study||78
3248862|NCT02490631|3983045|FG000|COMPLETED|Overall Study||76
3248863|NCT02490631|3983046|FG001|COMPLETED|Overall Study||75
3248864|NCT02490631|3983045|FG000|NOT COMPLETED|Overall Study||3
3248865|NCT02490631|3983046|FG001|NOT COMPLETED|Overall Study||3
3248866|NCT02490670|3983054|FG000|STARTED|Period 1 (19 Days)||14
3248867|NCT02490670|3983055|FG001|STARTED|Period 1 (19 Days)||14
3248868|NCT02490670|3983054|FG000|COMPLETED|Period 1 (19 Days)||14
3248869|NCT02490670|3983055|FG001|COMPLETED|Period 1 (19 Days)||14
3248870|NCT02490670|3983054|FG000|NOT COMPLETED|Period 1 (19 Days)||0
3248871|NCT02490670|3983055|FG001|NOT COMPLETED|Period 1 (19 Days)||0
3248872|NCT02490670|3983054|FG000|STARTED|Washout Period (7 Days)||14
3248873|NCT02490670|3983055|FG001|STARTED|Washout Period (7 Days)||14
3248874|NCT02490670|3983054|FG000|COMPLETED|Washout Period (7 Days)||14
3248875|NCT02490670|3983055|FG001|COMPLETED|Washout Period (7 Days)||14
3248876|NCT02490670|3983054|FG000|NOT COMPLETED|Washout Period (7 Days)||0
3248877|NCT02490670|3983055|FG001|NOT COMPLETED|Washout Period (7 Days)||0
3248878|NCT02490670|3983054|FG000|STARTED|Period 2 (19 Days)||14
3248879|NCT02490670|3983055|FG001|STARTED|Period 2 (19 Days)||14
3248880|NCT02490670|3983054|FG000|COMPLETED|Period 2 (19 Days)||14
3248881|NCT02490670|3983055|FG001|COMPLETED|Period 2 (19 Days)||14
3248882|NCT02490670|3983054|FG000|NOT COMPLETED|Period 2 (19 Days)||0
3248883|NCT02490670|3983055|FG001|NOT COMPLETED|Period 2 (19 Days)||0
3248884|NCT02490878|3983063|FG000|STARTED|Overall Study||10
3248885|NCT02490878|3983064|FG001|STARTED|Overall Study||9
3248886|NCT02490878|3983063|FG000|Eligible Participants|Overall Study||10
3248887|NCT02490878|3983064|FG001|Eligible Participants|Overall Study||8
3248888|NCT02490878|3983063|FG000|COMPLETED|Overall Study||10
3248889|NCT02490878|3983064|FG001|COMPLETED|Overall Study||6
3248890|NCT02490878|3983063|FG000|NOT COMPLETED|Overall Study||0
3248891|NCT02490878|3983064|FG001|NOT COMPLETED|Overall Study||3
3248892|NCT02491073|3983072|FG000|STARTED|Overall Study||37
3248893|NCT02491073|3983073|FG001|STARTED|Overall Study||34
3248894|NCT02491073|3983072|FG000|COMPLETED|Overall Study||36
3248895|NCT02491073|3983073|FG001|COMPLETED|Overall Study||34
3248896|NCT02491073|3983072|FG000|NOT COMPLETED|Overall Study||1
3248897|NCT02491073|3983073|FG001|NOT COMPLETED|Overall Study||0
3248898|NCT02491359|3983095|FG000|STARTED|Overall Study||20
3248899|NCT02491359|3983095|FG000|COMPLETED|Overall Study||4
3248900|NCT02491359|3983095|FG000|NOT COMPLETED|Overall Study||16
3248901|NCT02491437|3983103|FG000|STARTED|Overall Study||520
3248902|NCT02491437|3983104|FG001|STARTED|Overall Study||514
3248903|NCT02491437|3983103|FG000|Safety Sample|Overall Study||518
3248904|NCT02491437|3983104|FG001|Safety Sample|Overall Study||512
3248905|NCT02491437|3983103|FG000|Full Analysis Sample|Overall Study||494
3248906|NCT02491437|3983104|FG001|Full Analysis Sample|Overall Study||489
3248907|NCT02491437|3983103|FG000|COMPLETED|Overall Study||168
3248908|NCT02491437|3983104|FG001|COMPLETED|Overall Study||157
3248909|NCT02491437|3983103|FG000|NOT COMPLETED|Overall Study||352
3248910|NCT02491437|3983104|FG001|NOT COMPLETED|Overall Study||357
3248911|NCT02491463|3983116|FG000|STARTED|Overall Study||7
3248912|NCT02491463|3983117|FG001|STARTED|Overall Study||31
3248913|NCT02491463|3983118|FG002|STARTED|Overall Study||19
3248914|NCT02491463|3983119|FG003|STARTED|Overall Study||15
3248915|NCT02491463|3983116|FG000|COMPLETED|Overall Study||5
3248916|NCT02491463|3983117|FG001|COMPLETED|Overall Study||21
3248917|NCT02491463|3983118|FG002|COMPLETED|Overall Study||15
3248918|NCT02491463|3983119|FG003|COMPLETED|Overall Study||14
3248919|NCT02491463|3983116|FG000|NOT COMPLETED|Overall Study||2
3248920|NCT02491463|3983117|FG001|NOT COMPLETED|Overall Study||10
3248921|NCT02491463|3983118|FG002|NOT COMPLETED|Overall Study||4
3248922|NCT02491463|3983119|FG003|NOT COMPLETED|Overall Study||1
3248923|NCT02491671|3983131|FG000|STARTED|Overall Study||129
3248924|NCT02491671|3983132|FG001|STARTED|Overall Study||131
3248925|NCT02491671|3983131|FG000|COMPLETED|Overall Study||118
3248926|NCT02491671|3983132|FG001|COMPLETED|Overall Study||118
3248927|NCT02491671|3983131|FG000|NOT COMPLETED|Overall Study||11
3248928|NCT02491671|3983132|FG001|NOT COMPLETED|Overall Study||13
3248929|NCT02491684|3983140|FG000|STARTED|Pre-treatment Phase||61
3248930|NCT02491684|3983141|FG001|STARTED|Pre-treatment Phase||60
3248931|NCT02491684|3983140|FG000|COMPLETED|Pre-treatment Phase||61
3248932|NCT02491684|3983141|FG001|COMPLETED|Pre-treatment Phase||60
3248933|NCT02491684|3983140|FG000|NOT COMPLETED|Pre-treatment Phase||0
3248934|NCT02491684|3983141|FG001|NOT COMPLETED|Pre-treatment Phase||0
3248935|NCT02491684|3983140|FG000|STARTED|Treatment Phase||61
3248936|NCT02491684|3983141|FG001|STARTED|Treatment Phase||60
3371342|NCT03736928|4103007|FG000|COMPLETED|Overall Study||73
3371343|NCT03736928|4103008|FG001|COMPLETED|Overall Study||78
3371344|NCT03736928|4103009|FG002|COMPLETED|Overall Study||75
3371345|NCT03736928|4103010|FG003|COMPLETED|Overall Study||76
3371346|NCT03736928|4103011|FG004|COMPLETED|Overall Study||67
3371347|NCT03736928|4103007|FG000|NOT COMPLETED|Overall Study||7
3371348|NCT03736928|4103008|FG001|NOT COMPLETED|Overall Study||2
3371349|NCT03736928|4103009|FG002|NOT COMPLETED|Overall Study||5
3371350|NCT03736928|4103010|FG003|NOT COMPLETED|Overall Study||5
3371351|NCT03736928|4103011|FG004|NOT COMPLETED|Overall Study||11
3371352|NCT03736785|4103026|FG000|STARTED|Overall Study||135
3248937|NCT02491684|3983140|FG000|COMPLETED|Treatment Phase||58
3248938|NCT02491684|3983141|FG001|COMPLETED|Treatment Phase||57
3248939|NCT02491684|3983140|FG000|NOT COMPLETED|Treatment Phase||3
3248940|NCT02491684|3983141|FG001|NOT COMPLETED|Treatment Phase||3
3248941|NCT02491788|3983149|FG000|STARTED|Overall Study||8
3248942|NCT02491788|3983150|FG001|STARTED|Overall Study||11
3248943|NCT02491788|3983149|FG000|COMPLETED|Overall Study||8
3248944|NCT02491788|3983150|FG001|COMPLETED|Overall Study||11
3248945|NCT02491788|3983149|FG000|NOT COMPLETED|Overall Study||0
3248946|NCT02491788|3983150|FG001|NOT COMPLETED|Overall Study||0
3248947|NCT02491892|3983158|FG000|STARTED|Overall Study||41
3248948|NCT02491892|3983159|FG001|STARTED|Overall Study||38
3248949|NCT02491892|3983158|FG000|Treated|Overall Study||41
3248950|NCT02491892|3983159|FG001|Treated|Overall Study|One participant was randomized but died before receiving study medication.|37
3248951|NCT02491892|3983158|FG000|COMPLETED|Overall Study||0
3248952|NCT02491892|3983159|FG001|COMPLETED|Overall Study||0
3248953|NCT02491892|3983158|FG000|NOT COMPLETED|Overall Study||41
3248954|NCT02491892|3983159|FG001|NOT COMPLETED|Overall Study||38
3248955|NCT02491944|3983165|FG000|STARTED|Overall Study||10
3248956|NCT02491944|3983165|FG000|COMPLETED|Overall Study||10
3248957|NCT02491944|3983165|FG000|NOT COMPLETED|Overall Study||0
3248958|NCT02492100|3983169|FG000|STARTED|Overall Study||47
3248959|NCT02492100|3983169|FG000|COMPLETED|Overall Study||46
3248960|NCT02492100|3983169|FG000|NOT COMPLETED|Overall Study||1
3248961|NCT02492165|3983178|FG000|STARTED|Overall Study||100
3371353|NCT03736785|4103027|FG001|STARTED|Overall Study||132
3371354|NCT03736785|4103028|FG002|STARTED|Overall Study||132
3371355|NCT03736785|4103026|FG000|COMPLETED|Overall Study||118
3371356|NCT03736785|4103027|FG001|COMPLETED|Overall Study||115
3371357|NCT03736785|4103028|FG002|COMPLETED|Overall Study||118
3371358|NCT03736785|4103026|FG000|NOT COMPLETED|Overall Study||17
3371359|NCT03736785|4103027|FG001|NOT COMPLETED|Overall Study||17
3371360|NCT03736785|4103028|FG002|NOT COMPLETED|Overall Study||14
3371361|NCT03736031|4103039|FG000|STARTED|Overall Study||56
3371362|NCT03736031|4103040|FG001|STARTED|Overall Study||46
3371363|NCT03736031|4103039|FG000|COMPLETED|Overall Study||24
3371364|NCT03736031|4103040|FG001|COMPLETED|Overall Study||40
3371365|NCT03736031|4103039|FG000|NOT COMPLETED|Overall Study||32
3371366|NCT03736031|4103040|FG001|NOT COMPLETED|Overall Study||6
3371367|NCT03735862|4103046|FG000|STARTED|Overall Study||73
3371368|NCT03735862|4103046|FG000|COMPLETED|Overall Study||73
3371369|NCT03735862|4103046|FG000|NOT COMPLETED|Overall Study||0
3371370|NCT03734991|4103052|FG000|STARTED|Overall Study||249
3371371|NCT03734991|4103053|FG001|STARTED|Overall Study||127
3371372|NCT03734991|4103052|FG000|Withdrawn Before Treatment|Overall Study||2
3371373|NCT03734991|4103053|FG001|Withdrawn Before Treatment|Overall Study||3
3371374|NCT03734991|4103052|FG000|Withdrawn Before TOC|Overall Study||59
3371375|NCT03734991|4103053|FG001|Withdrawn Before TOC|Overall Study||41
3371376|NCT03734991|4103052|FG000|Completed the TOC Visit|Overall Study||188
3371377|NCT03734991|4103053|FG001|Completed the TOC Visit|Overall Study||83
3371378|NCT03734991|4103052|FG000|Withdrawn At or After the TOC Visit|Overall Study||5
3371379|NCT03734991|4103053|FG001|Withdrawn At or After the TOC Visit|Overall Study||3
3371380|NCT03734991|4103052|FG000|COMPLETED|Overall Study||183
3371381|NCT03734991|4103053|FG001|COMPLETED|Overall Study||80
3371382|NCT03734991|4103052|FG000|NOT COMPLETED|Overall Study||66
3371383|NCT03734991|4103053|FG001|NOT COMPLETED|Overall Study||47
3371384|NCT03734822|4103059|FG000|STARTED|Overall Study||47
3371385|NCT03734822|4103059|FG000|COMPLETED|Overall Study||47
3371386|NCT03734822|4103059|FG000|NOT COMPLETED|Overall Study||0
3371387|NCT03734601|4103063|FG000|STARTED|Overall Study||22
3371388|NCT03734601|4103063|FG000|COMPLETED|Overall Study||22
3371389|NCT03734601|4103063|FG000|NOT COMPLETED|Overall Study||0
3371390|NCT03733899|4103067|FG000|STARTED|Period 1||3
3371391|NCT03733899|4103068|FG001|STARTED|Period 1||3
3371392|NCT03733899|4103069|FG002|STARTED|Period 1||3
3371393|NCT03733899|4103070|FG003|STARTED|Period 1||4
3371394|NCT03733899|4103071|FG004|STARTED|Period 1||4
3371395|NCT03733899|4103072|FG005|STARTED|Period 1||3
3371396|NCT03733899|4103067|FG000|COMPLETED|Period 1||3
3371397|NCT03733899|4103068|FG001|COMPLETED|Period 1||3
3371398|NCT03733899|4103069|FG002|COMPLETED|Period 1||3
3371399|NCT03733899|4103070|FG003|COMPLETED|Period 1||4
3371400|NCT03733899|4103071|FG004|COMPLETED|Period 1||4
3371401|NCT03733899|4103072|FG005|COMPLETED|Period 1||2
3371402|NCT03733899|4103067|FG000|NOT COMPLETED|Period 1||0
3371403|NCT03733899|4103068|FG001|NOT COMPLETED|Period 1||0
3371404|NCT03733899|4103069|FG002|NOT COMPLETED|Period 1||0
3371405|NCT03733899|4103070|FG003|NOT COMPLETED|Period 1||0
3371406|NCT03733899|4103071|FG004|NOT COMPLETED|Period 1||0
3371407|NCT03733899|4103072|FG005|NOT COMPLETED|Period 1||1
3248962|NCT02492165|3983179|FG001|STARTED|Overall Study||60
3248963|NCT02492165|3983180|FG002|STARTED|Overall Study||60
3248964|NCT02492165|3983181|FG003|STARTED|Overall Study||30
3371408|NCT03733899|4103067|FG000|STARTED|Period 2||3
3371409|NCT03733899|4103068|FG001|STARTED|Period 2||3
3371410|NCT03733899|4103069|FG002|STARTED|Period 2||3
3371411|NCT03733899|4103070|FG003|STARTED|Period 2||4
3371412|NCT03733899|4103071|FG004|STARTED|Period 2||4
3371413|NCT03733899|4103072|FG005|STARTED|Period 2||2
3371414|NCT03733899|4103067|FG000|COMPLETED|Period 2||3
3371415|NCT03733899|4103068|FG001|COMPLETED|Period 2||2
3371416|NCT03733899|4103069|FG002|COMPLETED|Period 2||3
3371417|NCT03733899|4103070|FG003|COMPLETED|Period 2||4
3371418|NCT03733899|4103071|FG004|COMPLETED|Period 2||4
3371419|NCT03733899|4103072|FG005|COMPLETED|Period 2||2
3248965|NCT02492165|3983178|FG000|COMPLETED|Overall Study||100
3248966|NCT02492165|3983179|FG001|COMPLETED|Overall Study||59
3248967|NCT02492165|3983180|FG002|COMPLETED|Overall Study||60
3248968|NCT02492165|3983181|FG003|COMPLETED|Overall Study||30
3248969|NCT02492165|3983178|FG000|NOT COMPLETED|Overall Study||0
3248970|NCT02492165|3983179|FG001|NOT COMPLETED|Overall Study||1
3248971|NCT02492165|3983180|FG002|NOT COMPLETED|Overall Study||0
3248972|NCT02492165|3983181|FG003|NOT COMPLETED|Overall Study||0
3248973|NCT02492451|3983194|FG000|STARTED|Overall Study||40
3248974|NCT02492451|3983195|FG001|STARTED|Overall Study||39
3248975|NCT02492451|3983196|FG002|STARTED|Overall Study||39
3248976|NCT02492451|3983194|FG000|COMPLETED|Overall Study||40
3248977|NCT02492451|3983195|FG001|COMPLETED|Overall Study||39
3248978|NCT02492451|3983196|FG002|COMPLETED|Overall Study||39
3248979|NCT02492451|3983194|FG000|NOT COMPLETED|Overall Study||0
3248980|NCT02492451|3983195|FG001|NOT COMPLETED|Overall Study||0
3248981|NCT02492451|3983196|FG002|NOT COMPLETED|Overall Study||0
3248982|NCT02492750|3983207|FG000|STARTED|Overall Study||4
3248983|NCT02492750|3983208|FG001|STARTED|Overall Study||4
3248984|NCT02492750|3983209|FG002|STARTED|Overall Study||6
3248985|NCT02492750|3983207|FG000|COMPLETED|Overall Study||4
3248986|NCT02492750|3983208|FG001|COMPLETED|Overall Study||4
3248987|NCT02492750|3983209|FG002|COMPLETED|Overall Study||6
3248988|NCT02492750|3983207|FG000|NOT COMPLETED|Overall Study||0
3248989|NCT02492750|3983208|FG001|NOT COMPLETED|Overall Study||0
3248990|NCT02492750|3983209|FG002|NOT COMPLETED|Overall Study||0
3248991|NCT02492763|3983221|FG000|STARTED|Overall Study||46
3248992|NCT02492763|3983222|FG001|STARTED|Overall Study||44
3248993|NCT02492763|3983223|FG002|STARTED|Overall Study||43
3248994|NCT02492763|3983224|FG003|STARTED|Overall Study||43
3248995|NCT02492763|3983221|FG000|Treated|Overall Study||46
3248996|NCT02492763|3983222|FG001|Treated|Overall Study||44
3248997|NCT02492763|3983223|FG002|Treated|Overall Study||43
3248998|NCT02492763|3983224|FG003|Treated|Overall Study||42
3248999|NCT02492763|3983221|FG000|COMPLETED|Overall Study||30
3249000|NCT02492763|3983222|FG001|COMPLETED|Overall Study||29
3249001|NCT02492763|3983223|FG002|COMPLETED|Overall Study||33
3249002|NCT02492763|3983224|FG003|COMPLETED|Overall Study||30
3249003|NCT02492763|3983221|FG000|NOT COMPLETED|Overall Study||16
3249004|NCT02492763|3983222|FG001|NOT COMPLETED|Overall Study||15
3249005|NCT02492763|3983223|FG002|NOT COMPLETED|Overall Study||10
3249006|NCT02492763|3983224|FG003|NOT COMPLETED|Overall Study||13
3249007|NCT02492802|3983234|FG000|STARTED|Overall Study||64
3249008|NCT02492802|3983234|FG000|COMPLETED|Overall Study||64
3249009|NCT02492802|3983234|FG000|NOT COMPLETED|Overall Study||0
3249010|NCT02492841|3983241|FG000|STARTED|Overall Study||56
3249011|NCT02492841|3983242|FG001|STARTED|Overall Study||53
3249012|NCT02492841|3983243|FG002|STARTED|Overall Study||60
3249013|NCT02492841|3983241|FG000|COMPLETED|Overall Study||22
3249014|NCT02492841|3983242|FG001|COMPLETED|Overall Study||22
3249015|NCT02492841|3983243|FG002|COMPLETED|Overall Study||25
3249016|NCT02492841|3983241|FG000|NOT COMPLETED|Overall Study||34
3249017|NCT02492841|3983242|FG001|NOT COMPLETED|Overall Study||31
3249018|NCT02492841|3983243|FG002|NOT COMPLETED|Overall Study||35
3249019|NCT02492854|3983256|FG000|STARTED|Overall Study||5
3249020|NCT02492854|3983257|FG001|STARTED|Overall Study||3
3249021|NCT02492854|3983256|FG000|COMPLETED|Overall Study||5
3249022|NCT02492854|3983257|FG001|COMPLETED|Overall Study||3
3249023|NCT02492854|3983256|FG000|NOT COMPLETED|Overall Study||0
3249024|NCT02492854|3983257|FG001|NOT COMPLETED|Overall Study||0
3249025|NCT02492880|3983263|FG000|STARTED|Overall Study||15
3249026|NCT02492880|3983263|FG000|COMPLETED|Overall Study||13
3249027|NCT02492880|3983263|FG000|NOT COMPLETED|Overall Study||2
3249028|NCT02492958|3983271|FG000|STARTED|Overall Study||34
3249029|NCT02492958|3983272|FG001|STARTED|Overall Study||34
3249030|NCT02492958|3983273|FG002|STARTED|Overall Study||34
3249031|NCT02492958|3983274|FG003|STARTED|Overall Study||34
3249032|NCT02492958|3983271|FG000|COMPLETED|Overall Study||33
3249033|NCT02492958|3983272|FG001|COMPLETED|Overall Study||34
3249034|NCT02492958|3983273|FG002|COMPLETED|Overall Study||32
3249035|NCT02492958|3983274|FG003|COMPLETED|Overall Study||34
3249036|NCT02492958|3983271|FG000|NOT COMPLETED|Overall Study||1
3249037|NCT02492958|3983272|FG001|NOT COMPLETED|Overall Study||0
3249038|NCT02492958|3983273|FG002|NOT COMPLETED|Overall Study||2
3249039|NCT02492958|3983274|FG003|NOT COMPLETED|Overall Study||0
3249040|NCT02492984|3983286|FG000|STARTED|Overall Study||73
3249041|NCT02492984|3983287|FG001|STARTED|Overall Study||14
3249042|NCT02492984|3983286|FG000|COMPLETED|Overall Study||70
3249043|NCT02492984|3983287|FG001|COMPLETED|Overall Study||14
3249044|NCT02492984|3983286|FG000|NOT COMPLETED|Overall Study||3
3249045|NCT02492984|3983287|FG001|NOT COMPLETED|Overall Study||0
3249046|NCT02492997|3983298|FG000|STARTED|Overall Study||21
3249047|NCT02492997|3983299|FG001|STARTED|Overall Study||21
3249048|NCT02492997|3983298|FG000|COMPLETED|Overall Study||19
3249049|NCT02492997|3983299|FG001|COMPLETED|Overall Study||20
3249050|NCT02492997|3983298|FG000|NOT COMPLETED|Overall Study||2
3249051|NCT02492997|3983299|FG001|NOT COMPLETED|Overall Study||1
3249052|NCT02493036|3983308|FG000|STARTED|Overall Study||17
3249053|NCT02493036|3983309|FG001|STARTED|Overall Study||20
3249054|NCT02493036|3983310|FG002|STARTED|Overall Study||17
3249055|NCT02493036|3983308|FG000|COMPLETED|Overall Study||16
3249056|NCT02493036|3983309|FG001|COMPLETED|Overall Study||18
3249057|NCT02493036|3983310|FG002|COMPLETED|Overall Study||15
3249058|NCT02493036|3983308|FG000|NOT COMPLETED|Overall Study||1
3249059|NCT02493036|3983309|FG001|NOT COMPLETED|Overall Study||2
3249060|NCT02493036|3983310|FG002|NOT COMPLETED|Overall Study||2
3249061|NCT02493062|3983318|FG000|STARTED|Overall Study||35
3249062|NCT02493062|3983318|FG000|COMPLETED|Overall Study||23
3249063|NCT02493062|3983318|FG000|NOT COMPLETED|Overall Study||12
3249064|NCT02493088|3983322|FG000|STARTED|Overall Study||11
3249065|NCT02493088|3983322|FG000|COMPLETED|Overall Study||11
3249066|NCT02493088|3983322|FG000|NOT COMPLETED|Overall Study||0
3249067|NCT02493127|3983328|FG000|STARTED|Overall Study||61
3249068|NCT02493127|3983329|FG001|STARTED|Overall Study||61
3249069|NCT02493127|3983328|FG000|COMPLETED|Overall Study||60
3249070|NCT02493127|3983329|FG001|COMPLETED|Overall Study||60
3249071|NCT02493127|3983328|FG000|NOT COMPLETED|Overall Study||1
3249072|NCT02493127|3983329|FG001|NOT COMPLETED|Overall Study||1
3249073|NCT02493257|3983339|FG000|STARTED|Overall Study||11
3249074|NCT02493257|3983340|FG001|STARTED|Overall Study||11
3249075|NCT02493257|3983339|FG000|4 Week Follow up|Overall Study||11
3249076|NCT02493257|3983340|FG001|4 Week Follow up|Overall Study||11
3249077|NCT02493257|3983339|FG000|12 Week Follow up|Overall Study||10
3249078|NCT02493257|3983340|FG001|12 Week Follow up|Overall Study||10
3249079|NCT02493257|3983339|FG000|COMPLETED|Overall Study||10
3249080|NCT02493257|3983340|FG001|COMPLETED|Overall Study||10
3249081|NCT02493257|3983339|FG000|NOT COMPLETED|Overall Study||1
3249082|NCT02493257|3983340|FG001|NOT COMPLETED|Overall Study||1
3249083|NCT02493361|3983346|FG000|STARTED|Overall Study||24
3249084|NCT02493361|3983346|FG000|Week 24 Assessment|Overall Study||21
3249085|NCT02493361|3983346|FG000|COMPLETED|Overall Study||21
3249086|NCT02493361|3983346|FG000|NOT COMPLETED|Overall Study||3
3249087|NCT02493452|3983353|FG000|STARTED|Overall Study||379
3249088|NCT02493452|3983354|FG001|STARTED|Overall Study||377
3249089|NCT02493452|3983355|FG002|STARTED|Overall Study||379
3249090|NCT02493452|3983353|FG000|COMPLETED|Overall Study||329
3249091|NCT02493452|3983354|FG001|COMPLETED|Overall Study||328
3249092|NCT02493452|3983355|FG002|COMPLETED|Overall Study||325
3249093|NCT02493452|3983353|FG000|NOT COMPLETED|Overall Study||50
3249094|NCT02493452|3983354|FG001|NOT COMPLETED|Overall Study||49
3249095|NCT02493452|3983355|FG002|NOT COMPLETED|Overall Study||54
3249096|NCT02493517|3983365|FG000|STARTED|Overall Study||64
3249097|NCT02493517|3983366|FG001|STARTED|Overall Study||64
3249098|NCT02493517|3983365|FG000|COMPLETED|Overall Study||62
3249099|NCT02493517|3983366|FG001|COMPLETED|Overall Study||57
3249100|NCT02493517|3983365|FG000|NOT COMPLETED|Overall Study||2
3249101|NCT02493517|3983366|FG001|NOT COMPLETED|Overall Study||7
3249102|NCT02493608|3983376|FG000|STARTED|Overall Study||48
3249103|NCT02493608|3983377|FG001|STARTED|Overall Study||48
3249104|NCT02493608|3983376|FG000|COMPLETED|Overall Study||48
3249105|NCT02493608|3983377|FG001|COMPLETED|Overall Study||48
3249106|NCT02493608|3983376|FG000|NOT COMPLETED|Overall Study||0
3249107|NCT02493608|3983377|FG001|NOT COMPLETED|Overall Study||0
3249108|NCT02493621|3983385|FG000|STARTED|Overall Study||58
3249109|NCT02493621|3983386|FG001|STARTED|Overall Study||58
3249110|NCT02493621|3983385|FG000|COMPLETED|Overall Study||58
3249111|NCT02493621|3983386|FG001|COMPLETED|Overall Study||58
3249112|NCT02493621|3983385|FG000|NOT COMPLETED|Overall Study||0
3249113|NCT02493621|3983386|FG001|NOT COMPLETED|Overall Study||0
3249114|NCT02493660|3983394|FG000|STARTED|Overall Study|ITT|93
3249115|NCT02493660|3983395|FG001|STARTED|Overall Study|ITT|91
3249116|NCT02493660|3983394|FG000|COMPLETED|Overall Study||93
3249117|NCT02493660|3983395|FG001|COMPLETED|Overall Study|Investigator requested subject be discontinued prior to any post-procedure efficacy assessments.|90
3249118|NCT02493660|3983394|FG000|NOT COMPLETED|Overall Study||0
3249119|NCT02493660|3983395|FG001|NOT COMPLETED|Overall Study||1
3249120|NCT02493712|3983404|FG000|STARTED|Overall Study||16
3249121|NCT02493712|3983405|FG001|STARTED|Overall Study||18
3249122|NCT02493712|3983406|FG002|STARTED|Overall Study||17
3249123|NCT02493712|3983404|FG000|COMPLETED|Overall Study||14
3249124|NCT02493712|3983405|FG001|COMPLETED|Overall Study||12
3249125|NCT02493712|3983406|FG002|COMPLETED|Overall Study||11
3249126|NCT02493712|3983404|FG000|NOT COMPLETED|Overall Study||2
3249127|NCT02493712|3983405|FG001|NOT COMPLETED|Overall Study||6
3249128|NCT02493712|3983406|FG002|NOT COMPLETED|Overall Study||6
3249129|NCT02493764|3983416|FG000|STARTED|Overall Study||268
3249130|NCT02493764|3983417|FG001|STARTED|Overall Study||269
3249131|NCT02493764|3983416|FG000|COMPLETED|Overall Study||185
3249132|NCT02493764|3983417|FG001|COMPLETED|Overall Study||187
3249133|NCT02493764|3983416|FG000|NOT COMPLETED|Overall Study||83
3249134|NCT02493764|3983417|FG001|NOT COMPLETED|Overall Study||82
3249135|NCT02493777|3983425|FG000|STARTED|Overall Study||65
3249136|NCT02493777|3983426|FG001|STARTED|Overall Study||54
3249137|NCT02493777|3983425|FG000|COMPLETED|Overall Study||65
3249138|NCT02493777|3983426|FG001|COMPLETED|Overall Study||53
3249139|NCT02493777|3983425|FG000|NOT COMPLETED|Overall Study||0
3249140|NCT02493777|3983426|FG001|NOT COMPLETED|Overall Study||1
3249141|NCT02493855|3983435|FG000|STARTED|Overall Study||21
3249142|NCT02493855|3983436|FG001|STARTED|Overall Study||19
3249143|NCT02493855|3983437|FG002|STARTED|Overall Study||6
3249144|NCT02493855|3983435|FG000|COMPLETED|Overall Study||19
3249145|NCT02493855|3983436|FG001|COMPLETED|Overall Study||18
3249146|NCT02493855|3983437|FG002|COMPLETED|Overall Study||6
3249147|NCT02493855|3983435|FG000|NOT COMPLETED|Overall Study||2
3249148|NCT02493855|3983436|FG001|NOT COMPLETED|Overall Study||1
3249149|NCT02493855|3983437|FG002|NOT COMPLETED|Overall Study||0
3371420|NCT03733899|4103067|FG000|NOT COMPLETED|Period 2||0
3249150|NCT02493868|3983445|FG000|STARTED|Induction Phase: DE Participants||437
3249151|NCT02493868|3983446|FG001|STARTED|Induction Phase: DE Participants||0
3249152|NCT02493868|3983445|FG000|COMPLETED|Induction Phase: DE Participants|Participants who completed and met predefined response criteria continued to OP phase.|273
3249153|NCT02493868|3983446|FG001|COMPLETED|Induction Phase: DE Participants||0
3249154|NCT02493868|3983445|FG000|NOT COMPLETED|Induction Phase: DE Participants||164
3249155|NCT02493868|3983446|FG001|NOT COMPLETED|Induction Phase: DE Participants||0
3249156|NCT02493868|3983445|FG000|STARTED|Optimization Phase: DE+TE Participants|Total participants: direct-entry (273) + esketamine-treated transferred-entry participants (182).|455
3249157|NCT02493868|3983446|FG001|STARTED|Optimization Phase: DE+TE Participants|Placebo treated transferred-entry participant.|86
3249158|NCT02493868|3983445|FG000|COMPLETED|Optimization Phase: DE+TE Participants|Participants who completed and met predefined remission/response criteria randomized to MA phase|297
3249159|NCT02493868|3983446|FG001|COMPLETED|Optimization Phase: DE+TE Participants|Participants who completed and met predefined remission/response criteria continued to MA phase.|54
3249160|NCT02493868|3983445|FG000|NOT COMPLETED|Optimization Phase: DE+TE Participants||158
3249161|NCT02493868|3983446|FG001|NOT COMPLETED|Optimization Phase: DE+TE Participants||32
3249162|NCT02493868|3983445|FG000|STARTED|Maintenance Phase: DE+TE Participants|152 participants randomized from intranasal esketamine arm after OP phase: DE (90) + TE (62)|152
3249163|NCT02493868|3983446|FG001|STARTED|Maintenance Phase: DE+TE Participants|145 participants randomized from intranasal esketamine arm after OP phase+54 continued from OP phase|199
3249164|NCT02493868|3983445|FG000|Stable Remitters|Maintenance Phase: DE+TE Participants||90
3249165|NCT02493868|3983446|FG001|Stable Remitters|Maintenance Phase: DE+TE Participants||86
3249166|NCT02493868|3983445|FG000|Stable Responders|Maintenance Phase: DE+TE Participants||62
3249167|NCT02493868|3983446|FG001|Stable Responders|Maintenance Phase: DE+TE Participants||59
3249168|NCT02493868|3983445|FG000|COMPLETED|Maintenance Phase: DE+TE Participants||139
3249169|NCT02493868|3983446|FG001|COMPLETED|Maintenance Phase: DE+TE Participants||177
3249170|NCT02493868|3983445|FG000|NOT COMPLETED|Maintenance Phase: DE+TE Participants||13
3249171|NCT02493868|3983446|FG001|NOT COMPLETED|Maintenance Phase: DE+TE Participants||22
3249172|NCT02493868|3983445|FG000|STARTED|Follow-up Phase||481
3249173|NCT02493868|3983446|FG001|STARTED|Follow-up Phase||64
3249174|NCT02493868|3983445|FG000|COMPLETED|Follow-up Phase||470
3249175|NCT02493868|3983446|FG001|COMPLETED|Follow-up Phase||62
3249176|NCT02493868|3983445|FG000|NOT COMPLETED|Follow-up Phase||11
3249177|NCT02493868|3983446|FG001|NOT COMPLETED|Follow-up Phase||2
3249178|NCT02493946|3983461|FG000|STARTED|DB Period||126
3249179|NCT02493946|3983462|FG001|STARTED|DB Period||64
3249180|NCT02493946|3983463|FG002|STARTED|DB Period||0
3249181|NCT02493946|3983461|FG000|COMPLETED|DB Period||118
3249182|NCT02493946|3983462|FG001|COMPLETED|DB Period||59
3249183|NCT02493946|3983463|FG002|COMPLETED|DB Period||0
3249184|NCT02493946|3983461|FG000|NOT COMPLETED|DB Period||8
3249185|NCT02493946|3983462|FG001|NOT COMPLETED|DB Period||5
3249186|NCT02493946|3983463|FG002|NOT COMPLETED|DB Period||0
3249187|NCT02493946|3983461|FG000|STARTED|Open Label Period|Only the BTX-A-HAC Solution 50 U - LT Analyses arm is applicable for this period.|0
3249188|NCT02493946|3983462|FG001|STARTED|Open Label Period|Only the BTX-A-HAC Solution 50 U - LT Analyses arm is applicable for this period.|0
3249189|NCT02493946|3983463|FG002|STARTED|Open Label Period|The previous period relates to DB period only, this period relates to OL treatment only.|595
3249190|NCT02493946|3983461|FG000|COMPLETED|Open Label Period||0
3249191|NCT02493946|3983462|FG001|COMPLETED|Open Label Period||0
3249192|NCT02493946|3983463|FG002|COMPLETED|Open Label Period||509
3249193|NCT02493946|3983461|FG000|NOT COMPLETED|Open Label Period||0
3249194|NCT02493946|3983462|FG001|NOT COMPLETED|Open Label Period||0
3249195|NCT02493946|3983463|FG002|NOT COMPLETED|Open Label Period||86
3249196|NCT02494076|3983473|FG000|STARTED|Overall Study||26
3249197|NCT02494076|3983474|FG001|STARTED|Overall Study||26
3249198|NCT02494076|3983473|FG000|COMPLETED|Overall Study||26
3249199|NCT02494076|3983474|FG001|COMPLETED|Overall Study||26
3249200|NCT02494076|3983473|FG000|NOT COMPLETED|Overall Study||0
3249201|NCT02494076|3983474|FG001|NOT COMPLETED|Overall Study||0
3249202|NCT02494102|3983482|FG000|STARTED|Overall Study||42
3249203|NCT02494102|3983483|FG001|STARTED|Overall Study||47
3249204|NCT02494102|3983482|FG000|COMPLETED|Overall Study||42
3249205|NCT02494102|3983483|FG001|COMPLETED|Overall Study||47
3249206|NCT02494102|3983482|FG000|NOT COMPLETED|Overall Study||0
3249207|NCT02494102|3983483|FG001|NOT COMPLETED|Overall Study||0
3249208|NCT02494180|3983491|FG000|STARTED|Overall Study||85
3249209|NCT02494180|3983492|FG001|STARTED|Overall Study||85
3249210|NCT02494180|3983491|FG000|COMPLETED|Overall Study||85
3249211|NCT02494180|3983492|FG001|COMPLETED|Overall Study||85
3249212|NCT02494180|3983491|FG000|NOT COMPLETED|Overall Study||0
3249213|NCT02494180|3983492|FG001|NOT COMPLETED|Overall Study||0
3249214|NCT02494297|3983498|FG000|STARTED|Overall Study||1597
3249215|NCT02494297|3983498|FG000|COMPLETED|Overall Study|As there was no Follow-Up in this study, participation equals completion|1597
3249216|NCT02494297|3983498|FG000|NOT COMPLETED|Overall Study||0
3249217|NCT02494323|3983502|FG000|STARTED|Overall Study||70
3249218|NCT02494323|3983502|FG000|COMPLETED|Overall Study||70
3249219|NCT02494323|3983502|FG000|NOT COMPLETED|Overall Study||0
3249220|NCT02494336|3983508|FG000|STARTED|Overall Study||24
3249221|NCT02494336|3983509|FG001|STARTED|Overall Study||24
3249222|NCT02494336|3983508|FG000|COMPLETED|Overall Study||24
3249223|NCT02494336|3983509|FG001|COMPLETED|Overall Study||24
3249224|NCT02494336|3983508|FG000|NOT COMPLETED|Overall Study||0
3249225|NCT02494336|3983509|FG001|NOT COMPLETED|Overall Study||0
3249226|NCT02494401|3983517|FG000|STARTED|Overall Study||134
3249227|NCT02494401|3983518|FG001|STARTED|Overall Study||133
3249228|NCT02494401|3983517|FG000|Week 16|Overall Study||123
3249229|NCT02494401|3983518|FG001|Week 16|Overall Study||124
3249230|NCT02494401|3983517|FG000|6 Month Follow up|Overall Study||109
3249231|NCT02494401|3983518|FG001|6 Month Follow up|Overall Study||106
3249232|NCT02494401|3983517|FG000|COMPLETED|Overall Study||109
3249233|NCT02494401|3983518|FG001|COMPLETED|Overall Study||106
3249234|NCT02494401|3983517|FG000|NOT COMPLETED|Overall Study||25
3249235|NCT02494401|3983518|FG001|NOT COMPLETED|Overall Study||27
3249236|NCT02494440|3983524|FG000|STARTED|Overall Study||90
3249237|NCT02494440|3983524|FG000|COMPLETED|Overall Study||90
3249238|NCT02494440|3983524|FG000|NOT COMPLETED|Overall Study||0
3249239|NCT02494518|3983531|FG000|STARTED|Overall Study||11
3249240|NCT02494518|3983532|FG001|STARTED|Overall Study||12
3249241|NCT02494518|3983533|FG002|STARTED|Overall Study||11
3249242|NCT02494518|3983531|FG000|COMPLETED|Overall Study||10
3249243|NCT02494518|3983532|FG001|COMPLETED|Overall Study||10
3249244|NCT02494518|3983533|FG002|COMPLETED|Overall Study||8
3249245|NCT02494518|3983531|FG000|NOT COMPLETED|Overall Study||1
3249246|NCT02494518|3983532|FG001|NOT COMPLETED|Overall Study||2
3249247|NCT02494518|3983533|FG002|NOT COMPLETED|Overall Study||3
3249248|NCT02494583|3983544|FG000|STARTED|Overall Study||256
3249249|NCT02494583|3983545|FG001|STARTED|Overall Study||257
3249250|NCT02494583|3983546|FG002|STARTED|Overall Study||250
3249251|NCT02494583|3983544|FG000|Treated|Overall Study|1 participant randomized to the pembro combo arm received pembrolizumab monotherapy by mistake.|254
3249252|NCT02494583|3983545|FG001|Treated|Overall Study||250
3249253|NCT02494583|3983546|FG002|Treated|Overall Study||244
3249254|NCT02494583|3983544|FG000|COMPLETED|Overall Study||0
3249255|NCT02494583|3983545|FG001|COMPLETED|Overall Study||0
3249256|NCT02494583|3983546|FG002|COMPLETED|Overall Study||0
3249257|NCT02494583|3983544|FG000|NOT COMPLETED|Overall Study||256
3249258|NCT02494583|3983545|FG001|NOT COMPLETED|Overall Study||257
3249259|NCT02494583|3983546|FG002|NOT COMPLETED|Overall Study||250
3249260|NCT02494596|3983554|FG000|STARTED|Overall Study||5
3249261|NCT02494596|3983555|FG001|STARTED|Overall Study||7
3249262|NCT02494596|3983556|FG002|STARTED|Overall Study||7
3249263|NCT02494596|3983554|FG000|COMPLETED|Overall Study||2
3249264|NCT02494596|3983555|FG001|COMPLETED|Overall Study||2
3249265|NCT02494596|3983556|FG002|COMPLETED|Overall Study||6
3249266|NCT02494596|3983554|FG000|NOT COMPLETED|Overall Study||3
3249267|NCT02494596|3983555|FG001|NOT COMPLETED|Overall Study||5
3249268|NCT02494596|3983556|FG002|NOT COMPLETED|Overall Study||1
3249269|NCT02494713|3983567|FG000|STARTED|Overall Study||4
3249270|NCT02494713|3983567|FG000|COMPLETED|Overall Study||4
3249271|NCT02494713|3983567|FG000|NOT COMPLETED|Overall Study||0
3249272|NCT02494778|3983571|FG000|STARTED|Overall Study||248
3249273|NCT02494778|3983571|FG000|COMPLETED|Overall Study||27
3249274|NCT02494778|3983571|FG000|NOT COMPLETED|Overall Study||221
3249275|NCT02494817|3983577|FG000|STARTED|Overall Study|representing 81 couples|162
3249276|NCT02494817|3983578|FG001|STARTED|Overall Study|representing 68 couples|136
3249277|NCT02494817|3983577|FG000|3 Month Assessment|Overall Study|represents 59 couples and 7 partnered men|125
3249278|NCT02494817|3983578|FG001|3 Month Assessment|Overall Study|represents 44 couples and 4 partnered men|92
3249279|NCT02494817|3983577|FG000|6 Month Assessment|Overall Study|represents 52 couples and 11 partnered men|115
3249280|NCT02494817|3983578|FG001|6 Month Assessment|Overall Study|represents 45 couples and 8 partnered men|98
3249281|NCT02494817|3983577|FG000|COMPLETED|Overall Study|49 couples and 9 partnered men completed all 3 assessments (baseline, 3- and 6-month)|107
3249282|NCT02494817|3983578|FG001|COMPLETED|Overall Study|41 couples and 5 partnered men completed all 3 assessments (baseline, 3- and 6-month)|87
3249283|NCT02494817|3983577|FG000|NOT COMPLETED|Overall Study||55
3249284|NCT02494817|3983578|FG001|NOT COMPLETED|Overall Study||49
3249285|NCT02495025|3983586|FG000|STARTED|Overall Study||77
3249286|NCT02495025|3983587|FG001|STARTED|Overall Study||75
3249287|NCT02495025|3983586|FG000|COMPLETED|Overall Study||51
3249288|NCT02495025|3983587|FG001|COMPLETED|Overall Study||61
3249289|NCT02495025|3983586|FG000|NOT COMPLETED|Overall Study||26
3249290|NCT02495025|3983587|FG001|NOT COMPLETED|Overall Study||14
3249291|NCT02495038|3983596|FG000|STARTED|Overall Study||27
3249292|NCT02495038|3983597|FG001|STARTED|Overall Study||27
3249293|NCT02495038|3983598|FG002|STARTED|Overall Study||27
3249294|NCT02495038|3983596|FG000|COMPLETED|Overall Study||27
3249295|NCT02495038|3983597|FG001|COMPLETED|Overall Study||27
3249296|NCT02495038|3983598|FG002|COMPLETED|Overall Study||27
3249297|NCT02495038|3983596|FG000|NOT COMPLETED|Overall Study||0
3249298|NCT02495038|3983597|FG001|NOT COMPLETED|Overall Study||0
3249299|NCT02495038|3983598|FG002|NOT COMPLETED|Overall Study||0
3249300|NCT02495103|3983608|FG000|STARTED|Overall Study||3
3249301|NCT02495103|3983609|FG001|STARTED|Overall Study||4
3249302|NCT02495103|3983608|FG000|COMPLETED|Overall Study||3
3249303|NCT02495103|3983609|FG001|COMPLETED|Overall Study||4
3249304|NCT02495103|3983608|FG000|NOT COMPLETED|Overall Study||0
3249305|NCT02495103|3983609|FG001|NOT COMPLETED|Overall Study||0
3249306|NCT02495168|3983620|FG000|STARTED|Overall Study||504
3249307|NCT02495168|3983621|FG001|STARTED|Overall Study||516
3249308|NCT02495168|3983622|FG002|STARTED|Overall Study||127
3249309|NCT02495168|3983620|FG000|Safety Population|Overall Study||501
3249310|NCT02495168|3983621|FG001|Safety Population|Overall Study||514
3249311|NCT02495168|3983622|FG002|Safety Population|Overall Study||126
3249312|NCT02495168|3983620|FG000|Modified Intent-to-Treat Population|Overall Study||468
3249313|NCT02495168|3983621|FG001|Modified Intent-to-Treat Population|Overall Study||478
3249314|NCT02495168|3983622|FG002|Modified Intent-to-Treat Population|Overall Study||111
3249315|NCT02495168|3983620|FG000|Day1 Per-protocol Set (D1PPS) Population|Overall Study||437
3249316|NCT02495168|3983621|FG001|Day1 Per-protocol Set (D1PPS) Population|Overall Study||437
3249317|NCT02495168|3983622|FG002|Day1 Per-protocol Set (D1PPS) Population|Overall Study||99
3249318|NCT02495168|3983620|FG000|Day 42 (D42PPS) Population|Overall Study||382
3249319|NCT02495168|3983621|FG001|Day 42 (D42PPS) Population|Overall Study||383
3249320|NCT02495168|3983622|FG002|Day 42 (D42PPS) Population|Overall Study||88
3249321|NCT02495168|3983620|FG000|COMPLETED|Overall Study||466
3249322|NCT02495168|3983621|FG001|COMPLETED|Overall Study||462
3249323|NCT02495168|3983622|FG002|COMPLETED|Overall Study||110
3249324|NCT02495168|3983620|FG000|NOT COMPLETED|Overall Study||38
3249325|NCT02495168|3983621|FG001|NOT COMPLETED|Overall Study||54
3249326|NCT02495168|3983622|FG002|NOT COMPLETED|Overall Study||17
3249327|NCT02495233|3983632|FG000|STARTED|Overall Study||3
3249328|NCT02495233|3983633|FG001|STARTED|Overall Study||7
3249329|NCT02495233|3983632|FG000|COMPLETED|Overall Study||3
3249330|NCT02495233|3983633|FG001|COMPLETED|Overall Study||6
3249331|NCT02495233|3983632|FG000|NOT COMPLETED|Overall Study||0
3249332|NCT02495233|3983633|FG001|NOT COMPLETED|Overall Study||1
3249333|NCT02495259|3983642|FG000|STARTED|Overall Study||7
3249334|NCT02495259|3983643|FG001|STARTED|Overall Study||4
3249335|NCT02495259|3983644|FG002|STARTED|Overall Study||8
3249336|NCT02495259|3983642|FG000|COMPLETED|Overall Study||7
3249337|NCT02495259|3983643|FG001|COMPLETED|Overall Study||3
3249338|NCT02495259|3983644|FG002|COMPLETED|Overall Study||8
3249339|NCT02495259|3983642|FG000|NOT COMPLETED|Overall Study||0
3249340|NCT02495259|3983643|FG001|NOT COMPLETED|Overall Study||1
3249341|NCT02495259|3983644|FG002|NOT COMPLETED|Overall Study||0
3249342|NCT02495389|3983652|FG000|STARTED|Overall Study||84
3249343|NCT02495389|3983652|FG000|COMPLETED|Overall Study||44
3249344|NCT02495389|3983652|FG000|NOT COMPLETED|Overall Study||40
3249345|NCT02495454|3983656|FG000|STARTED|Overall Study||34
3249346|NCT02495454|3983656|FG000|COMPLETED|Overall Study|One case excluded for violation of inclusion criteria (transformed lymphoma)|33
3249347|NCT02495454|3983656|FG000|NOT COMPLETED|Overall Study||1
3249348|NCT02495467|3983663|FG000|STARTED|First Intervention (4 Weeks)||114
3249349|NCT02495467|3983664|FG001|STARTED|First Intervention (4 Weeks)||118
3249350|NCT02495467|3983663|FG000|COMPLETED|First Intervention (4 Weeks)||114
3249351|NCT02495467|3983664|FG001|COMPLETED|First Intervention (4 Weeks)|One subject completed visits in treatment Period 1 but never used treatment|118
3249352|NCT02495467|3983663|FG000|NOT COMPLETED|First Intervention (4 Weeks)||0
3249353|NCT02495467|3983664|FG001|NOT COMPLETED|First Intervention (4 Weeks)||0
3249354|NCT02495467|3983663|FG000|STARTED|Washout (1 Week)||114
3249355|NCT02495467|3983664|FG001|STARTED|Washout (1 Week)||118
3249356|NCT02495467|3983663|FG000|COMPLETED|Washout (1 Week)||112
3249357|NCT02495467|3983664|FG001|COMPLETED|Washout (1 Week)||116
3249358|NCT02495467|3983663|FG000|NOT COMPLETED|Washout (1 Week)||2
3249359|NCT02495467|3983664|FG001|NOT COMPLETED|Washout (1 Week)||2
3249360|NCT02495467|3983663|FG000|STARTED|Second Intervention (4 Weeks)||112
3249361|NCT02495467|3983664|FG001|STARTED|Second Intervention (4 Weeks)||116
3249362|NCT02495467|3983663|FG000|COMPLETED|Second Intervention (4 Weeks)||112
3249363|NCT02495467|3983664|FG001|COMPLETED|Second Intervention (4 Weeks)||113
3249364|NCT02495467|3983663|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||0
3249365|NCT02495467|3983664|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||3
3249366|NCT02495623|3983673|FG000|STARTED|Overall Study||25
3249367|NCT02495623|3983674|FG001|STARTED|Overall Study||26
3249368|NCT02495623|3983675|FG002|STARTED|Overall Study||28
3249369|NCT02495623|3983673|FG000|Dosed|Overall Study||22
3249370|NCT02495623|3983674|FG001|Dosed|Overall Study||19
3249371|NCT02495623|3983675|FG002|Dosed|Overall Study||22
3249372|NCT02495623|3983673|FG000|COMPLETED|Overall Study||20
3249373|NCT02495623|3983674|FG001|COMPLETED|Overall Study||17
3249374|NCT02495623|3983675|FG002|COMPLETED|Overall Study||20
3249375|NCT02495623|3983673|FG000|NOT COMPLETED|Overall Study||5
3249376|NCT02495623|3983674|FG001|NOT COMPLETED|Overall Study||9
3249377|NCT02495623|3983675|FG002|NOT COMPLETED|Overall Study||8
3249378|NCT02495779|3983683|FG000|STARTED|Overall Study||54
3249379|NCT02495779|3983683|FG000|COMPLETED|Overall Study||48
3249380|NCT02495779|3983683|FG000|NOT COMPLETED|Overall Study||6
3249381|NCT02495831|3983687|FG000|STARTED|First Intervention||13
3249382|NCT02495831|3983688|FG001|STARTED|First Intervention||10
3249383|NCT02495831|3983687|FG000|COMPLETED|First Intervention||13
3249384|NCT02495831|3983688|FG001|COMPLETED|First Intervention||10
3249385|NCT02495831|3983687|FG000|NOT COMPLETED|First Intervention||0
3249386|NCT02495831|3983688|FG001|NOT COMPLETED|First Intervention||0
3249387|NCT02495831|3983687|FG000|STARTED|Second Intervention|One participant withdrew at the end of period 1|12
3249388|NCT02495831|3983688|FG001|STARTED|Second Intervention||10
3249389|NCT02495831|3983687|FG000|COMPLETED|Second Intervention||12
3249390|NCT02495831|3983688|FG001|COMPLETED|Second Intervention||10
3249391|NCT02495831|3983687|FG000|NOT COMPLETED|Second Intervention||0
3249392|NCT02495831|3983688|FG001|NOT COMPLETED|Second Intervention||0
3371421|NCT03733899|4103068|FG001|NOT COMPLETED|Period 2||1
3371422|NCT03733899|4103069|FG002|NOT COMPLETED|Period 2||0
3371423|NCT03733899|4103070|FG003|NOT COMPLETED|Period 2||0
3371424|NCT03733899|4103071|FG004|NOT COMPLETED|Period 2||0
3371425|NCT03733899|4103072|FG005|NOT COMPLETED|Period 2||0
3371426|NCT03733899|4103067|FG000|STARTED|Period 3||3
3249393|NCT02495844|3983696|FG000|STARTED|Overall Study||27
3249394|NCT02495844|3983697|FG001|STARTED|Overall Study||28
3249395|NCT02495844|3983696|FG000|COMPLETED|Overall Study||26
3249396|NCT02495844|3983697|FG001|COMPLETED|Overall Study||24
3249397|NCT02495844|3983696|FG000|NOT COMPLETED|Overall Study||1
3249398|NCT02495844|3983697|FG001|NOT COMPLETED|Overall Study||4
3249399|NCT02495857|3983708|FG000|STARTED|Overall Study||200
3249400|NCT02495857|3983709|FG001|STARTED|Overall Study||200
3249401|NCT02495857|3983710|FG002|STARTED|Overall Study||199
3249402|NCT02495857|3983708|FG000|COMPLETED|Overall Study||178
3249403|NCT02495857|3983709|FG001|COMPLETED|Overall Study||184
3249404|NCT02495857|3983710|FG002|COMPLETED|Overall Study||181
3249405|NCT02495857|3983708|FG000|NOT COMPLETED|Overall Study||22
3249406|NCT02495857|3983709|FG001|NOT COMPLETED|Overall Study||16
3249407|NCT02495857|3983710|FG002|NOT COMPLETED|Overall Study||18
3249408|NCT02495883|3983720|FG000|STARTED|Overall Study||32
3249409|NCT02495883|3983721|FG001|STARTED|Overall Study||24
3249410|NCT02495883|3983720|FG000|COMPLETED|Overall Study||31
3249411|NCT02495883|3983721|FG001|COMPLETED|Overall Study||24
3249412|NCT02495883|3983720|FG000|NOT COMPLETED|Overall Study||1
3249413|NCT02495883|3983721|FG001|NOT COMPLETED|Overall Study||0
3249414|NCT02495948|3983726|FG000|STARTED|Period 1, First 30 Days of Wear||83
3249415|NCT02495948|3983727|FG001|STARTED|Period 1, First 30 Days of Wear||84
3249416|NCT02495948|3983726|FG000|COMPLETED|Period 1, First 30 Days of Wear||83
3249417|NCT02495948|3983727|FG001|COMPLETED|Period 1, First 30 Days of Wear||83
3249418|NCT02495948|3983726|FG000|NOT COMPLETED|Period 1, First 30 Days of Wear||0
3249419|NCT02495948|3983727|FG001|NOT COMPLETED|Period 1, First 30 Days of Wear||1
3249420|NCT02495948|3983726|FG000|STARTED|Period 2, Second 30 Days of Wear||83
3249421|NCT02495948|3983727|FG001|STARTED|Period 2, Second 30 Days of Wear||83
3249422|NCT02495948|3983726|FG000|COMPLETED|Period 2, Second 30 Days of Wear||82
3249423|NCT02495948|3983727|FG001|COMPLETED|Period 2, Second 30 Days of Wear||82
3249424|NCT02495948|3983726|FG000|NOT COMPLETED|Period 2, Second 30 Days of Wear||1
3249425|NCT02495948|3983727|FG001|NOT COMPLETED|Period 2, Second 30 Days of Wear||1
3249426|NCT02496000|3983737|FG000|STARTED|Overall Study||64
3249427|NCT02496000|3983738|FG001|STARTED|Overall Study||61
3249428|NCT02496000|3983739|FG002|STARTED|Overall Study||63
3249429|NCT02496000|3983737|FG000|COMPLETED|Overall Study||62
3249430|NCT02496000|3983738|FG001|COMPLETED|Overall Study||56
3249431|NCT02496000|3983739|FG002|COMPLETED|Overall Study||61
3249432|NCT02496000|3983737|FG000|NOT COMPLETED|Overall Study||2
3249433|NCT02496000|3983738|FG001|NOT COMPLETED|Overall Study||5
3249434|NCT02496000|3983739|FG002|NOT COMPLETED|Overall Study||2
3249435|NCT02496091|3983748|FG000|STARTED|Overall Study||144
3249436|NCT02496091|3983748|FG000|COMPLETED|Overall Study||142
3249437|NCT02496091|3983748|FG000|NOT COMPLETED|Overall Study||2
3249438|NCT02496221|3983753|FG000|STARTED|Treatment Period 1 - 4 Days||10
3249439|NCT02496221|3983754|FG001|STARTED|Treatment Period 1 - 4 Days||10
3249440|NCT02496221|3983753|FG000|COMPLETED|Treatment Period 1 - 4 Days||10
3249441|NCT02496221|3983754|FG001|COMPLETED|Treatment Period 1 - 4 Days||10
3249442|NCT02496221|3983753|FG000|NOT COMPLETED|Treatment Period 1 - 4 Days||0
3249443|NCT02496221|3983754|FG001|NOT COMPLETED|Treatment Period 1 - 4 Days||0
3249444|NCT02496221|3983753|FG000|STARTED|Treatment Period 2 - 4 Days||10
3249445|NCT02496221|3983754|FG001|STARTED|Treatment Period 2 - 4 Days||10
3249446|NCT02496221|3983753|FG000|COMPLETED|Treatment Period 2 - 4 Days||8
3249447|NCT02496221|3983754|FG001|COMPLETED|Treatment Period 2 - 4 Days||9
3249448|NCT02496221|3983753|FG000|NOT COMPLETED|Treatment Period 2 - 4 Days||2
3249449|NCT02496221|3983754|FG001|NOT COMPLETED|Treatment Period 2 - 4 Days||1
3249450|NCT02496533|3983764|FG000|STARTED|Overall Study||105
3249451|NCT02496533|3983765|FG001|STARTED|Overall Study||112
3249452|NCT02496533|3983764|FG000|COMPLETED|Overall Study||102
3249453|NCT02496533|3983765|FG001|COMPLETED|Overall Study||106
3249454|NCT02496533|3983764|FG000|NOT COMPLETED|Overall Study||3
3249455|NCT02496533|3983765|FG001|NOT COMPLETED|Overall Study||6
3249456|NCT02496702|3983773|FG000|STARTED|Overall Study||30
3249457|NCT02496702|3983774|FG001|STARTED|Overall Study||30
3249458|NCT02496702|3983773|FG000|Received Allocated Intervention|Overall Study||21
3249459|NCT02496702|3983774|FG001|Received Allocated Intervention|Overall Study||0
3249460|NCT02496702|3983773|FG000|Did Not Receive Allocated Intervention|Overall Study||9
3371427|NCT03733899|4103068|FG001|STARTED|Period 3||2
3371428|NCT03733899|4103069|FG002|STARTED|Period 3||3
3371429|NCT03733899|4103070|FG003|STARTED|Period 3||4
3371430|NCT03733899|4103071|FG004|STARTED|Period 3||4
3371431|NCT03733899|4103072|FG005|STARTED|Period 3||2
3371432|NCT03733899|4103067|FG000|COMPLETED|Period 3||2
3371433|NCT03733899|4103068|FG001|COMPLETED|Period 3||2
3371434|NCT03733899|4103069|FG002|COMPLETED|Period 3||3
3371435|NCT03733899|4103070|FG003|COMPLETED|Period 3||4
3371436|NCT03733899|4103071|FG004|COMPLETED|Period 3||4
3371437|NCT03733899|4103072|FG005|COMPLETED|Period 3||2
3371438|NCT03733899|4103067|FG000|NOT COMPLETED|Period 3||1
3371439|NCT03733899|4103068|FG001|NOT COMPLETED|Period 3||0
3371440|NCT03733899|4103069|FG002|NOT COMPLETED|Period 3||0
3371441|NCT03733899|4103070|FG003|NOT COMPLETED|Period 3||0
3249461|NCT02496702|3983774|FG001|Did Not Receive Allocated Intervention|Overall Study||0
3249462|NCT02496702|3983773|FG000|COMPLETED|Overall Study||22
3249463|NCT02496702|3983774|FG001|COMPLETED|Overall Study||22
3249464|NCT02496702|3983773|FG000|NOT COMPLETED|Overall Study||8
3371442|NCT03733899|4103071|FG004|NOT COMPLETED|Period 3||0
3371443|NCT03733899|4103072|FG005|NOT COMPLETED|Period 3||0
3249465|NCT02496702|3983774|FG001|NOT COMPLETED|Overall Study||8
3249466|NCT02496767|3983784|FG000|STARTED|Open-label Lead-in Phase||744
3249467|NCT02496767|3983785|FG001|STARTED|Open-label Lead-in Phase||0
3249468|NCT02496767|3983786|FG002|STARTED|Open-label Lead-in Phase||0
3249469|NCT02496767|3983787|FG003|STARTED|Open-label Lead-in Phase||0
3249470|NCT02496767|3983788|FG004|STARTED|Open-label Lead-in Phase||0
3249471|NCT02496767|3983789|FG005|STARTED|Open-label Lead-in Phase||0
3249472|NCT02496767|3983790|FG006|STARTED|Open-label Lead-in Phase||0
3249473|NCT02496767|3983791|FG007|STARTED|Open-label Lead-in Phase||0
3249474|NCT02496767|3983784|FG000|COMPLETED|Open-label Lead-in Phase||565
3249475|NCT02496767|3983785|FG001|COMPLETED|Open-label Lead-in Phase||0
3249476|NCT02496767|3983786|FG002|COMPLETED|Open-label Lead-in Phase||0
3249477|NCT02496767|3983787|FG003|COMPLETED|Open-label Lead-in Phase||0
3249478|NCT02496767|3983788|FG004|COMPLETED|Open-label Lead-in Phase||0
3249479|NCT02496767|3983789|FG005|COMPLETED|Open-label Lead-in Phase||0
3249480|NCT02496767|3983790|FG006|COMPLETED|Open-label Lead-in Phase||0
3249481|NCT02496767|3983791|FG007|COMPLETED|Open-label Lead-in Phase||0
3249482|NCT02496767|3983784|FG000|NOT COMPLETED|Open-label Lead-in Phase||179
3249483|NCT02496767|3983785|FG001|NOT COMPLETED|Open-label Lead-in Phase||0
3249484|NCT02496767|3983786|FG002|NOT COMPLETED|Open-label Lead-in Phase||0
3249485|NCT02496767|3983787|FG003|NOT COMPLETED|Open-label Lead-in Phase||0
3249486|NCT02496767|3983788|FG004|NOT COMPLETED|Open-label Lead-in Phase||0
3249487|NCT02496767|3983789|FG005|NOT COMPLETED|Open-label Lead-in Phase||0
3249488|NCT02496767|3983790|FG006|NOT COMPLETED|Open-label Lead-in Phase||0
3249489|NCT02496767|3983791|FG007|NOT COMPLETED|Open-label Lead-in Phase||0
3249490|NCT02496767|3983784|FG000|STARTED|Double-blind, Placebo-controlled Phase||0
3249491|NCT02496767|3983785|FG001|STARTED|Double-blind, Placebo-controlled Phase||188
3249492|NCT02496767|3983786|FG002|STARTED|Double-blind, Placebo-controlled Phase||126
3249493|NCT02496767|3983787|FG003|STARTED|Double-blind, Placebo-controlled Phase||126
3249494|NCT02496767|3983788|FG004|STARTED|Double-blind, Placebo-controlled Phase||125
3249495|NCT02496767|3983789|FG005|STARTED|Double-blind, Placebo-controlled Phase||0
3249496|NCT02496767|3983790|FG006|STARTED|Double-blind, Placebo-controlled Phase||0
3249497|NCT02496767|3983791|FG007|STARTED|Double-blind, Placebo-controlled Phase||0
3249498|NCT02496767|3983784|FG000|COMPLETED|Double-blind, Placebo-controlled Phase||0
3249499|NCT02496767|3983785|FG001|COMPLETED|Double-blind, Placebo-controlled Phase||132
3249500|NCT02496767|3983786|FG002|COMPLETED|Double-blind, Placebo-controlled Phase||80
3249501|NCT02496767|3983787|FG003|COMPLETED|Double-blind, Placebo-controlled Phase||65
3249502|NCT02496767|3983788|FG004|COMPLETED|Double-blind, Placebo-controlled Phase||59
3249503|NCT02496767|3983789|FG005|COMPLETED|Double-blind, Placebo-controlled Phase||0
3249504|NCT02496767|3983790|FG006|COMPLETED|Double-blind, Placebo-controlled Phase||0
3249505|NCT02496767|3983791|FG007|COMPLETED|Double-blind, Placebo-controlled Phase||0
3249506|NCT02496767|3983784|FG000|NOT COMPLETED|Double-blind, Placebo-controlled Phase||0
3249507|NCT02496767|3983785|FG001|NOT COMPLETED|Double-blind, Placebo-controlled Phase||56
3249508|NCT02496767|3983786|FG002|NOT COMPLETED|Double-blind, Placebo-controlled Phase||46
3249509|NCT02496767|3983787|FG003|NOT COMPLETED|Double-blind, Placebo-controlled Phase||61
3249510|NCT02496767|3983788|FG004|NOT COMPLETED|Double-blind, Placebo-controlled Phase||66
3249511|NCT02496767|3983789|FG005|NOT COMPLETED|Double-blind, Placebo-controlled Phase||0
3249512|NCT02496767|3983790|FG006|NOT COMPLETED|Double-blind, Placebo-controlled Phase||0
3249513|NCT02496767|3983791|FG007|NOT COMPLETED|Double-blind, Placebo-controlled Phase||0
3249514|NCT02496767|3983784|FG000|STARTED|Double-blind, Withdrawal Phase||0
3249515|NCT02496767|3983785|FG001|STARTED|Double-blind, Withdrawal Phase||0
3249516|NCT02496767|3983786|FG002|STARTED|Double-blind, Withdrawal Phase||0
3249517|NCT02496767|3983787|FG003|STARTED|Double-blind, Withdrawal Phase||0
3249518|NCT02496767|3983788|FG004|STARTED|Double-blind, Withdrawal Phase||0
3249519|NCT02496767|3983789|FG005|STARTED|Double-blind, Withdrawal Phase||132
3249520|NCT02496767|3983790|FG006|STARTED|Double-blind, Withdrawal Phase||103
3249521|NCT02496767|3983791|FG007|STARTED|Double-blind, Withdrawal Phase||101
3249522|NCT02496767|3983784|FG000|COMPLETED|Double-blind, Withdrawal Phase||0
3249523|NCT02496767|3983785|FG001|COMPLETED|Double-blind, Withdrawal Phase||0
3249524|NCT02496767|3983786|FG002|COMPLETED|Double-blind, Withdrawal Phase||0
3249525|NCT02496767|3983787|FG003|COMPLETED|Double-blind, Withdrawal Phase||0
3249526|NCT02496767|3983788|FG004|COMPLETED|Double-blind, Withdrawal Phase||0
3249527|NCT02496767|3983789|FG005|COMPLETED|Double-blind, Withdrawal Phase||126
3249528|NCT02496767|3983790|FG006|COMPLETED|Double-blind, Withdrawal Phase||99
3249529|NCT02496767|3983791|FG007|COMPLETED|Double-blind, Withdrawal Phase||96
3249530|NCT02496767|3983784|FG000|NOT COMPLETED|Double-blind, Withdrawal Phase||0
3249531|NCT02496767|3983785|FG001|NOT COMPLETED|Double-blind, Withdrawal Phase||0
3249532|NCT02496767|3983786|FG002|NOT COMPLETED|Double-blind, Withdrawal Phase||0
3249533|NCT02496767|3983787|FG003|NOT COMPLETED|Double-blind, Withdrawal Phase||0
3249534|NCT02496767|3983788|FG004|NOT COMPLETED|Double-blind, Withdrawal Phase||0
3249535|NCT02496767|3983789|FG005|NOT COMPLETED|Double-blind, Withdrawal Phase||6
3249536|NCT02496767|3983790|FG006|NOT COMPLETED|Double-blind, Withdrawal Phase||4
3249537|NCT02496767|3983791|FG007|NOT COMPLETED|Double-blind, Withdrawal Phase||5
3249538|NCT02496884|3983809|FG000|STARTED|Overall Study||17
3249539|NCT02496884|3983810|FG001|STARTED|Overall Study||34
3249540|NCT02496884|3983811|FG002|STARTED|Overall Study||1
3249541|NCT02496884|3983812|FG003|STARTED|Overall Study||4
3249542|NCT02496884|3983809|FG000|Safety Analysis Set|Overall Study||17
3249543|NCT02496884|3983810|FG001|Safety Analysis Set|Overall Study||34
3249544|NCT02496884|3983811|FG002|Safety Analysis Set|Overall Study||1
3249545|NCT02496884|3983812|FG003|Safety Analysis Set|Overall Study||4
3249546|NCT02496884|3983809|FG000|Modified Intent to Treat Set (mITT)|Overall Study||17
3249547|NCT02496884|3983810|FG001|Modified Intent to Treat Set (mITT)|Overall Study||34
3249548|NCT02496884|3983811|FG002|Modified Intent to Treat Set (mITT)|Overall Study||1
3249549|NCT02496884|3983812|FG003|Modified Intent to Treat Set (mITT)|Overall Study||4
3249550|NCT02496884|3983809|FG000|Pharmacokinetic (PK) Analysis Set|Overall Study||0
3249551|NCT02496884|3983810|FG001|Pharmacokinetic (PK) Analysis Set|Overall Study||33
3249552|NCT02496884|3983811|FG002|Pharmacokinetic (PK) Analysis Set|Overall Study||0
3249553|NCT02496884|3983812|FG003|Pharmacokinetic (PK) Analysis Set|Overall Study||4
3249554|NCT02496884|3983809|FG000|Completed Treatment Per Protocol|Overall Study||16
3249555|NCT02496884|3983810|FG001|Completed Treatment Per Protocol|Overall Study||27
3249556|NCT02496884|3983811|FG002|Completed Treatment Per Protocol|Overall Study||1
3249557|NCT02496884|3983812|FG003|Completed Treatment Per Protocol|Overall Study||3
3249558|NCT02496884|3983809|FG000|COMPLETED|Overall Study||15
3249559|NCT02496884|3983810|FG001|COMPLETED|Overall Study||31
3249560|NCT02496884|3983811|FG002|COMPLETED|Overall Study||1
3249561|NCT02496884|3983812|FG003|COMPLETED|Overall Study||4
3249562|NCT02496884|3983809|FG000|NOT COMPLETED|Overall Study||2
3249563|NCT02496884|3983810|FG001|NOT COMPLETED|Overall Study||3
3249564|NCT02496884|3983811|FG002|NOT COMPLETED|Overall Study||0
3249565|NCT02496884|3983812|FG003|NOT COMPLETED|Overall Study||0
3249566|NCT02497001|3983826|FG000|STARTED|Overall Study||640
3249567|NCT02497001|3983827|FG001|STARTED|Overall Study||627
3249568|NCT02497001|3983828|FG002|STARTED|Overall Study||316
3249569|NCT02497001|3983829|FG003|STARTED|Overall Study||319
3249570|NCT02497001|3983826|FG000|COMPLETED|Overall Study||566
3249571|NCT02497001|3983827|FG001|COMPLETED|Overall Study||524
3249572|NCT02497001|3983828|FG002|COMPLETED|Overall Study||266
3249573|NCT02497001|3983829|FG003|COMPLETED|Overall Study||278
3249574|NCT02497001|3983826|FG000|NOT COMPLETED|Overall Study||74
3249575|NCT02497001|3983827|FG001|NOT COMPLETED|Overall Study||103
3249576|NCT02497001|3983828|FG002|NOT COMPLETED|Overall Study||50
3249577|NCT02497001|3983829|FG003|NOT COMPLETED|Overall Study||41
3249578|NCT02497040|3983845|FG000|STARTED|Overall Study||30
3249579|NCT02497040|3983846|FG001|STARTED|Overall Study||30
3249580|NCT02497040|3983847|FG002|STARTED|Overall Study||30
3249581|NCT02497040|3983845|FG000|COMPLETED|Overall Study||30
3249582|NCT02497040|3983846|FG001|COMPLETED|Overall Study||30
3249583|NCT02497040|3983847|FG002|COMPLETED|Overall Study||30
3249584|NCT02497040|3983845|FG000|NOT COMPLETED|Overall Study||0
3249585|NCT02497040|3983846|FG001|NOT COMPLETED|Overall Study||0
3249586|NCT02497040|3983847|FG002|NOT COMPLETED|Overall Study||0
3249587|NCT02497235|3983860|FG000|STARTED|Overall Study||2
3249588|NCT02497235|3983861|FG001|STARTED|Overall Study||2
3249589|NCT02497235|3983862|FG002|STARTED|Overall Study||2
3249590|NCT02497235|3983863|FG003|STARTED|Overall Study||2
3249591|NCT02497235|3983864|FG004|STARTED|Overall Study||3
3249592|NCT02497235|3983860|FG000|COMPLETED|Overall Study||2
3249593|NCT02497235|3983861|FG001|COMPLETED|Overall Study||2
3249594|NCT02497235|3983862|FG002|COMPLETED|Overall Study||2
3249595|NCT02497235|3983863|FG003|COMPLETED|Overall Study||2
3249596|NCT02497235|3983864|FG004|COMPLETED|Overall Study||3
3249597|NCT02497235|3983860|FG000|NOT COMPLETED|Overall Study||0
3249598|NCT02497235|3983861|FG001|NOT COMPLETED|Overall Study||0
3249599|NCT02497235|3983862|FG002|NOT COMPLETED|Overall Study||0
3249600|NCT02497235|3983863|FG003|NOT COMPLETED|Overall Study||0
3249601|NCT02497235|3983864|FG004|NOT COMPLETED|Overall Study||0
3249602|NCT02497287|3983879|FG000|STARTED|Induction Phase (4 Weeks)|Included DE participants (691) and non-responders from TRD3005 (88).|779
3249603|NCT02497287|3983879|FG000|COMPLETED|Induction Phase (4 Weeks)||580
3249604|NCT02497287|3983879|FG000|NOT COMPLETED|Induction Phase (4 Weeks)||199
3249605|NCT02497287|3983879|FG000|STARTED|Optimization/Maintenance (48 Weeks)|Included who completed IND phase (580) + responders from TRD3005 (23).|603
3249606|NCT02497287|3983879|FG000|COMPLETED|Optimization/Maintenance (48 Weeks)||150
3249607|NCT02497287|3983879|FG000|NOT COMPLETED|Optimization/Maintenance (48 Weeks)||453
3249608|NCT02497287|3983879|FG000|STARTED|Follow-up Phase (4 Week)|Included non-responders (IND phase) or discontinued treatment phase or completed OP/MA phase.|357
3249609|NCT02497287|3983879|FG000|COMPLETED|Follow-up Phase (4 Week)||326
3249610|NCT02497287|3983879|FG000|NOT COMPLETED|Follow-up Phase (4 Week)||31
3249611|NCT02497391|3983885|FG000|STARTED|Period 1 (14 Days)||16
3249612|NCT02497391|3983886|FG001|STARTED|Period 1 (14 Days)||15
3249613|NCT02497391|3983887|FG002|STARTED|Period 1 (14 Days)||16
3249614|NCT02497391|3983888|FG003|STARTED|Period 1 (14 Days)||16
3249615|NCT02497391|3983889|FG004|STARTED|Period 1 (14 Days)||16
3249616|NCT02497391|3983890|FG005|STARTED|Period 1 (14 Days)||16
3249617|NCT02497391|3983885|FG000|Received at Least 1 Dose of Study Drug|Period 1 (14 Days)||16
3249618|NCT02497391|3983886|FG001|Received at Least 1 Dose of Study Drug|Period 1 (14 Days)||15
3249619|NCT02497391|3983887|FG002|Received at Least 1 Dose of Study Drug|Period 1 (14 Days)||16
3249620|NCT02497391|3983888|FG003|Received at Least 1 Dose of Study Drug|Period 1 (14 Days)||16
3249621|NCT02497391|3983889|FG004|Received at Least 1 Dose of Study Drug|Period 1 (14 Days)||16
3249622|NCT02497391|3983890|FG005|Received at Least 1 Dose of Study Drug|Period 1 (14 Days)||16
3249623|NCT02497391|3983885|FG000|COMPLETED|Period 1 (14 Days)||16
3249624|NCT02497391|3983886|FG001|COMPLETED|Period 1 (14 Days)||15
3249625|NCT02497391|3983887|FG002|COMPLETED|Period 1 (14 Days)||16
3249626|NCT02497391|3983888|FG003|COMPLETED|Period 1 (14 Days)||16
3249627|NCT02497391|3983889|FG004|COMPLETED|Period 1 (14 Days)||16
3249628|NCT02497391|3983890|FG005|COMPLETED|Period 1 (14 Days)||16
3249629|NCT02497391|3983885|FG000|NOT COMPLETED|Period 1 (14 Days)||0
3249630|NCT02497391|3983886|FG001|NOT COMPLETED|Period 1 (14 Days)||0
3249631|NCT02497391|3983887|FG002|NOT COMPLETED|Period 1 (14 Days)||0
3249632|NCT02497391|3983888|FG003|NOT COMPLETED|Period 1 (14 Days)||0
3249633|NCT02497391|3983889|FG004|NOT COMPLETED|Period 1 (14 Days)||0
3249634|NCT02497391|3983890|FG005|NOT COMPLETED|Period 1 (14 Days)||0
3249635|NCT02497391|3983885|FG000|STARTED|Period 2 (14 Days)||16
3249636|NCT02497391|3983886|FG001|STARTED|Period 2 (14 Days)||15
3249637|NCT02497391|3983887|FG002|STARTED|Period 2 (14 Days)||16
3249638|NCT02497391|3983888|FG003|STARTED|Period 2 (14 Days)||16
3249639|NCT02497391|3983889|FG004|STARTED|Period 2 (14 Days)||16
3249640|NCT02497391|3983890|FG005|STARTED|Period 2 (14 Days)||16
3249641|NCT02497391|3983885|FG000|COMPLETED|Period 2 (14 Days)||12
3249642|NCT02497391|3983886|FG001|COMPLETED|Period 2 (14 Days)||14
3249643|NCT02497391|3983887|FG002|COMPLETED|Period 2 (14 Days)||13
3249644|NCT02497391|3983888|FG003|COMPLETED|Period 2 (14 Days)||13
3249645|NCT02497391|3983889|FG004|COMPLETED|Period 2 (14 Days)||14
3249646|NCT02497391|3983890|FG005|COMPLETED|Period 2 (14 Days)||13
3249647|NCT02497391|3983885|FG000|NOT COMPLETED|Period 2 (14 Days)||4
3249648|NCT02497391|3983886|FG001|NOT COMPLETED|Period 2 (14 Days)||1
3249649|NCT02497391|3983887|FG002|NOT COMPLETED|Period 2 (14 Days)||3
3249650|NCT02497391|3983888|FG003|NOT COMPLETED|Period 2 (14 Days)||3
3249651|NCT02497391|3983889|FG004|NOT COMPLETED|Period 2 (14 Days)||2
3249652|NCT02497391|3983890|FG005|NOT COMPLETED|Period 2 (14 Days)||3
3249653|NCT02497391|3983885|FG000|STARTED|Period 3 (14 Days)||12
3249654|NCT02497391|3983886|FG001|STARTED|Period 3 (14 Days)||14
3249655|NCT02497391|3983887|FG002|STARTED|Period 3 (14 Days)||13
3249656|NCT02497391|3983888|FG003|STARTED|Period 3 (14 Days)||13
3249657|NCT02497391|3983889|FG004|STARTED|Period 3 (14 Days)||14
3249658|NCT02497391|3983890|FG005|STARTED|Period 3 (14 Days)||13
3249659|NCT02497391|3983885|FG000|COMPLETED|Period 3 (14 Days)||12
3249660|NCT02497391|3983886|FG001|COMPLETED|Period 3 (14 Days)||13
3249661|NCT02497391|3983887|FG002|COMPLETED|Period 3 (14 Days)||12
3249662|NCT02497391|3983888|FG003|COMPLETED|Period 3 (14 Days)||13
3249663|NCT02497391|3983889|FG004|COMPLETED|Period 3 (14 Days)||13
3249664|NCT02497391|3983890|FG005|COMPLETED|Period 3 (14 Days)||13
3249665|NCT02497391|3983885|FG000|NOT COMPLETED|Period 3 (14 Days)||0
3249666|NCT02497391|3983886|FG001|NOT COMPLETED|Period 3 (14 Days)||1
3249667|NCT02497391|3983887|FG002|NOT COMPLETED|Period 3 (14 Days)||1
3249668|NCT02497391|3983888|FG003|NOT COMPLETED|Period 3 (14 Days)||0
3249669|NCT02497391|3983889|FG004|NOT COMPLETED|Period 3 (14 Days)||1
3249670|NCT02497391|3983890|FG005|NOT COMPLETED|Period 3 (14 Days)||0
3249671|NCT02497404|3983898|FG000|STARTED|Overall Study||40
3249672|NCT02497404|3983898|FG000|COMPLETED|Overall Study||39
3249673|NCT02497404|3983898|FG000|NOT COMPLETED|Overall Study||1
3249674|NCT02497469|3983904|FG000|STARTED|Overall Study||386
3249675|NCT02497469|3983905|FG001|STARTED|Overall Study||385
3249676|NCT02497469|3983904|FG000|Safety Analysis Set|Overall Study||386
3249677|NCT02497469|3983905|FG001|Safety Analysis Set|Overall Study||383
3249678|NCT02497469|3983904|FG000|COMPLETED|Overall Study||217
3249679|NCT02497469|3983905|FG001|COMPLETED|Overall Study||270
3249680|NCT02497469|3983904|FG000|NOT COMPLETED|Overall Study||169
3249681|NCT02497469|3983905|FG001|NOT COMPLETED|Overall Study||115
3249682|NCT02497612|3983915|FG000|STARTED|Overall Study||93
3249683|NCT02497612|3983916|FG001|STARTED|Overall Study||94
3249684|NCT02497612|3983917|FG002|STARTED|Overall Study||97
3249685|NCT02497612|3983918|FG003|STARTED|Overall Study||93
3249686|NCT02497612|3983915|FG000|Treated|Overall Study||92
3249687|NCT02497612|3983916|FG001|Treated|Overall Study||94
3249688|NCT02497612|3983917|FG002|Treated|Overall Study||96
3249689|NCT02497612|3983918|FG003|Treated|Overall Study||91
3249690|NCT02497612|3983915|FG000|Cohort 1: >14 Years to <70 Years|Overall Study||14
3249691|NCT02497612|3983916|FG001|Cohort 1: >14 Years to <70 Years|Overall Study||15
3249692|NCT02497612|3983917|FG002|Cohort 1: >14 Years to <70 Years|Overall Study||18
3249693|NCT02497612|3983918|FG003|Cohort 1: >14 Years to <70 Years|Overall Study||16
3249694|NCT02497612|3983915|FG000|Cohort 2: >5 Years to <=14 Years|Overall Study||6
3249695|NCT02497612|3983916|FG001|Cohort 2: >5 Years to <=14 Years|Overall Study||5
3249696|NCT02497612|3983917|FG002|Cohort 2: >5 Years to <=14 Years|Overall Study||6
3249697|NCT02497612|3983918|FG003|Cohort 2: >5 Years to <=14 Years|Overall Study||5
3249698|NCT02497612|3983915|FG000|Cohort 3: >2 Years to <=5 Years|Overall Study||66
3249699|NCT02497612|3983916|FG001|Cohort 3: >2 Years to <=5 Years|Overall Study||66
3249700|NCT02497612|3983917|FG002|Cohort 3: >2 Years to <=5 Years|Overall Study||67
3249701|NCT02497612|3983918|FG003|Cohort 3: >2 Years to <=5 Years|Overall Study||65
3249702|NCT02497612|3983915|FG000|Cohort 4: >6 Months to <=2 Years|Overall Study||7
3249703|NCT02497612|3983916|FG001|Cohort 4: >6 Months to <=2 Years|Overall Study||8
3249704|NCT02497612|3983917|FG002|Cohort 4: >6 Months to <=2 Years|Overall Study||6
3249705|NCT02497612|3983918|FG003|Cohort 4: >6 Months to <=2 Years|Overall Study||7
3249706|NCT02497612|3983915|FG000|COMPLETED|Overall Study||27
3249707|NCT02497612|3983916|FG001|COMPLETED|Overall Study||37
3249708|NCT02497612|3983917|FG002|COMPLETED|Overall Study||48
3249709|NCT02497612|3983918|FG003|COMPLETED|Overall Study||46
3249710|NCT02497612|3983915|FG000|NOT COMPLETED|Overall Study||66
3249711|NCT02497612|3983916|FG001|NOT COMPLETED|Overall Study||57
3249712|NCT02497612|3983917|FG002|NOT COMPLETED|Overall Study||49
3249713|NCT02497612|3983918|FG003|NOT COMPLETED|Overall Study||47
3249714|NCT02497755|3983930|FG000|STARTED|Overall Study||18
3249715|NCT02497755|3983931|FG001|STARTED|Overall Study||1
3249716|NCT02497755|3983930|FG000|COMPLETED|Overall Study||17
3249717|NCT02497755|3983931|FG001|COMPLETED|Overall Study||1
3249718|NCT02497755|3983930|FG000|NOT COMPLETED|Overall Study||1
3249719|NCT02497755|3983931|FG001|NOT COMPLETED|Overall Study||0
3249720|NCT02497781|3983940|FG000|STARTED|Overall Study||68
3249721|NCT02497781|3983941|FG001|STARTED|Overall Study||29
3249722|NCT02497781|3983940|FG000|Treated|Overall Study||67
3249723|NCT02497781|3983941|FG001|Treated|Overall Study||28
3249724|NCT02497781|3983940|FG000|COMPLETED|Overall Study||64
3249725|NCT02497781|3983941|FG001|COMPLETED|Overall Study||26
3249726|NCT02497781|3983940|FG000|NOT COMPLETED|Overall Study||4
3249727|NCT02497781|3983941|FG001|NOT COMPLETED|Overall Study||3
3249728|NCT02497937|3983947|FG000|STARTED|Period 1 (Up to 7 Days)||6
3249729|NCT02497937|3983948|FG001|STARTED|Period 1 (Up to 7 Days)||5
3249730|NCT02497937|3983947|FG000|COMPLETED|Period 1 (Up to 7 Days)||6
3249731|NCT02497937|3983948|FG001|COMPLETED|Period 1 (Up to 7 Days)||5
3249732|NCT02497937|3983947|FG000|NOT COMPLETED|Period 1 (Up to 7 Days)||0
3249733|NCT02497937|3983948|FG001|NOT COMPLETED|Period 1 (Up to 7 Days)||0
3249734|NCT02497937|3983947|FG000|STARTED|Washout Period (Up to 14 Days)||6
3249735|NCT02497937|3983948|FG001|STARTED|Washout Period (Up to 14 Days)||5
3249736|NCT02497937|3983947|FG000|COMPLETED|Washout Period (Up to 14 Days)||6
3249737|NCT02497937|3983948|FG001|COMPLETED|Washout Period (Up to 14 Days)||5
3249738|NCT02497937|3983947|FG000|NOT COMPLETED|Washout Period (Up to 14 Days)||0
3249739|NCT02497937|3983948|FG001|NOT COMPLETED|Washout Period (Up to 14 Days)||0
3249740|NCT02497937|3983947|FG000|STARTED|Period 2 (Up to 7 Days)||6
3249741|NCT02497937|3983948|FG001|STARTED|Period 2 (Up to 7 Days)||5
3249742|NCT02497937|3983947|FG000|COMPLETED|Period 2 (Up to 7 Days)||6
3249743|NCT02497937|3983948|FG001|COMPLETED|Period 2 (Up to 7 Days)||5
3249744|NCT02497937|3983947|FG000|NOT COMPLETED|Period 2 (Up to 7 Days)||0
3249745|NCT02497937|3983948|FG001|NOT COMPLETED|Period 2 (Up to 7 Days)||0
3249746|NCT02497976|3983957|FG000|STARTED|Overall Study||28
3249747|NCT02497976|3983958|FG001|STARTED|Overall Study||14
3249748|NCT02497976|3983957|FG000|COMPLETED|Overall Study||26
3249749|NCT02497976|3983958|FG001|COMPLETED|Overall Study||13
3249750|NCT02497976|3983957|FG000|NOT COMPLETED|Overall Study||2
3249751|NCT02497976|3983958|FG001|NOT COMPLETED|Overall Study||1
3249752|NCT02498067|3983964|FG000|STARTED|Overall Study||104
3249753|NCT02498067|3983964|FG000|COMPLETED|Overall Study||71
3249754|NCT02498067|3983964|FG000|NOT COMPLETED|Overall Study||33
3249755|NCT02498236|3983978|FG000|STARTED|Overall Study||6
3249756|NCT02498236|3983979|FG001|STARTED|Overall Study||6
3249757|NCT02498236|3983980|FG002|STARTED|Overall Study||6
3249758|NCT02498236|3983981|FG003|STARTED|Overall Study||6
3249759|NCT02498236|3983982|FG004|STARTED|Overall Study||7
3249760|NCT02498236|3983983|FG005|STARTED|Overall Study||6
3249761|NCT02498236|3983984|FG006|STARTED|Overall Study||7
3249762|NCT02498236|3983985|FG007|STARTED|Overall Study||7
3249763|NCT02498236|3983978|FG000|Randomized|Overall Study||6
3249764|NCT02498236|3983979|FG001|Randomized|Overall Study||6
3249765|NCT02498236|3983980|FG002|Randomized|Overall Study||6
3249766|NCT02498236|3983981|FG003|Randomized|Overall Study||6
3249767|NCT02498236|3983982|FG004|Randomized|Overall Study||7
3249768|NCT02498236|3983983|FG005|Randomized|Overall Study||6
3249769|NCT02498236|3983984|FG006|Randomized|Overall Study||7
3249770|NCT02498236|3983985|FG007|Randomized|Overall Study||7
3249771|NCT02498236|3983978|FG000|COMPLETED|Overall Study||5
3249772|NCT02498236|3983979|FG001|COMPLETED|Overall Study||6
3249773|NCT02498236|3983980|FG002|COMPLETED|Overall Study||6
3249774|NCT02498236|3983981|FG003|COMPLETED|Overall Study||6
3249775|NCT02498236|3983982|FG004|COMPLETED|Overall Study||6
3249776|NCT02498236|3983983|FG005|COMPLETED|Overall Study||6
3249777|NCT02498236|3983984|FG006|COMPLETED|Overall Study||6
3249778|NCT02498236|3983985|FG007|COMPLETED|Overall Study||6
3249779|NCT02498236|3983978|FG000|NOT COMPLETED|Overall Study||1
3249780|NCT02498236|3983979|FG001|NOT COMPLETED|Overall Study||0
3249781|NCT02498236|3983980|FG002|NOT COMPLETED|Overall Study||0
3249782|NCT02498236|3983981|FG003|NOT COMPLETED|Overall Study||0
3249783|NCT02498236|3983982|FG004|NOT COMPLETED|Overall Study||1
3249784|NCT02498236|3983983|FG005|NOT COMPLETED|Overall Study||0
3249785|NCT02498236|3983984|FG006|NOT COMPLETED|Overall Study||1
3249786|NCT02498236|3983985|FG007|NOT COMPLETED|Overall Study||1
3249787|NCT02498418|3984009|FG000|STARTED|Overall Study||247
3249788|NCT02498418|3984010|FG001|STARTED|Overall Study||248
3249789|NCT02498418|3984011|FG002|STARTED|Overall Study||244
3249790|NCT02498418|3984009|FG000|Safety Population|Overall Study||246
3249791|NCT02498418|3984010|FG001|Safety Population|Overall Study||247
3249792|NCT02498418|3984011|FG002|Safety Population|Overall Study||244
3249793|NCT02498418|3984009|FG000|Modified Intent-to-treat Population|Overall Study||183
3249794|NCT02498418|3984010|FG001|Modified Intent-to-treat Population|Overall Study||186
3249795|NCT02498418|3984011|FG002|Modified Intent-to-treat Population|Overall Study||180
3249796|NCT02498418|3984009|FG000|Per-protocol Analysis Set|Overall Study||182
3249797|NCT02498418|3984010|FG001|Per-protocol Analysis Set|Overall Study||181
3249798|NCT02498418|3984011|FG002|Per-protocol Analysis Set|Overall Study||176
3249799|NCT02498418|3984009|FG000|COMPLETED|Overall Study||245
3249800|NCT02498418|3984010|FG001|COMPLETED|Overall Study||246
3249801|NCT02498418|3984011|FG002|COMPLETED|Overall Study||238
3249802|NCT02498418|3984009|FG000|NOT COMPLETED|Overall Study||2
3249803|NCT02498418|3984010|FG001|NOT COMPLETED|Overall Study||2
3249804|NCT02498418|3984011|FG002|NOT COMPLETED|Overall Study||6
3249805|NCT02498483|3984021|FG000|STARTED|Overall Study||6
3249806|NCT02498483|3984022|FG001|STARTED|Overall Study||5
3249807|NCT02498483|3984021|FG000|COMPLETED|Overall Study||6
3249808|NCT02498483|3984022|FG001|COMPLETED|Overall Study||5
3249809|NCT02498483|3984021|FG000|NOT COMPLETED|Overall Study||0
3249810|NCT02498483|3984022|FG001|NOT COMPLETED|Overall Study||0
3249811|NCT02498522|3984030|FG000|STARTED|Overall Study||85
3249812|NCT02498522|3984031|FG001|STARTED|Overall Study||85
3249813|NCT02498522|3984030|FG000|COMPLETED|Overall Study||83
3249814|NCT02498522|3984031|FG001|COMPLETED|Overall Study||83
3249815|NCT02498522|3984030|FG000|NOT COMPLETED|Overall Study||2
3249816|NCT02498522|3984031|FG001|NOT COMPLETED|Overall Study||2
3249817|NCT02498652|3984039|FG000|STARTED|Overall Study||20
3249818|NCT02498652|3984040|FG001|STARTED|Overall Study||21
3249819|NCT02498652|3984039|FG000|COMPLETED|Overall Study||20
3249820|NCT02498652|3984040|FG001|COMPLETED|Overall Study|One subject was withdrawn due to noncompliance/protocol violation|20
3249821|NCT02498652|3984039|FG000|NOT COMPLETED|Overall Study||0
3249822|NCT02498652|3984040|FG001|NOT COMPLETED|Overall Study||1
3249823|NCT02498678|3984066|FG000|STARTED|Overall Study||25
3249824|NCT02498678|3984067|FG001|STARTED|Overall Study||25
3249825|NCT02498678|3984066|FG000|COMPLETED|Overall Study||25
3249826|NCT02498678|3984067|FG001|COMPLETED|Overall Study||23
3249827|NCT02498678|3984066|FG000|NOT COMPLETED|Overall Study||0
3249828|NCT02498678|3984067|FG001|NOT COMPLETED|Overall Study||2
3249829|NCT02498769|3984075|FG000|STARTED|Overall Study||63
3249830|NCT02498769|3984076|FG001|STARTED|Overall Study||67
3249831|NCT02498769|3984075|FG000|COMPLETED|Overall Study||63
3249832|NCT02498769|3984076|FG001|COMPLETED|Overall Study||67
3249833|NCT02498769|3984075|FG000|NOT COMPLETED|Overall Study||0
3249834|NCT02498769|3984076|FG001|NOT COMPLETED|Overall Study||0
3249835|NCT02498821|3984084|FG000|STARTED|Overall Study||63
3249836|NCT02498821|3984085|FG001|STARTED|Overall Study||65
3249837|NCT02498821|3984084|FG000|COMPLETED|Overall Study||60
3249838|NCT02498821|3984085|FG001|COMPLETED|Overall Study||60
3249839|NCT02498821|3984084|FG000|NOT COMPLETED|Overall Study||3
3249840|NCT02498821|3984085|FG001|NOT COMPLETED|Overall Study||5
3249841|NCT02498834|3984093|FG000|STARTED|Overall Study||185
3249842|NCT02498834|3984094|FG001|STARTED|Overall Study||174
3249843|NCT02498834|3984093|FG000|COMPLETED|Overall Study||175
3249844|NCT02498834|3984094|FG001|COMPLETED|Overall Study||164
3249845|NCT02498834|3984093|FG000|NOT COMPLETED|Overall Study||10
3249846|NCT02498834|3984094|FG001|NOT COMPLETED|Overall Study||10
3249847|NCT02499029|3984102|FG000|STARTED|Overall Study||18
3249848|NCT02499029|3984103|FG001|STARTED|Overall Study||17
3249849|NCT02499029|3984102|FG000|COMPLETED|Overall Study||13
3249850|NCT02499029|3984103|FG001|COMPLETED|Overall Study||14
3249851|NCT02499029|3984102|FG000|NOT COMPLETED|Overall Study||5
3249852|NCT02499029|3984103|FG001|NOT COMPLETED|Overall Study||3
3249853|NCT02499081|3984109|FG000|STARTED|Overall Study||20
3249854|NCT02499081|3984109|FG000|COMPLETED|Overall Study||1
3249855|NCT02499081|3984109|FG000|NOT COMPLETED|Overall Study||19
3249856|NCT02499120|3984115|FG000|STARTED|Overall Study||65
3249857|NCT02499120|3984116|FG001|STARTED|Overall Study||60
3249858|NCT02499120|3984115|FG000|Received Treatment|Overall Study||64
3249859|NCT02499120|3984116|FG001|Received Treatment|Overall Study||60
3249860|NCT02499120|3984115|FG000|COMPLETED|Overall Study||0
3249861|NCT02499120|3984116|FG001|COMPLETED|Overall Study||0
3249862|NCT02499120|3984115|FG000|NOT COMPLETED|Overall Study||65
3249863|NCT02499120|3984116|FG001|NOT COMPLETED|Overall Study||60
3249864|NCT02499146|3984122|FG000|STARTED|Overall Study||26
3249865|NCT02499146|3984122|FG000|COMPLETED|Overall Study||0
3249866|NCT02499146|3984122|FG000|NOT COMPLETED|Overall Study||26
3249867|NCT02499159|3984128|FG000|STARTED|Randomization||50
3249868|NCT02499159|3984129|FG001|STARTED|Randomization||50
3249869|NCT02499159|3984128|FG000|COMPLETED|Randomization||49
3249870|NCT02499159|3984129|FG001|COMPLETED|Randomization||49
3249871|NCT02499159|3984128|FG000|NOT COMPLETED|Randomization||1
3249872|NCT02499159|3984129|FG001|NOT COMPLETED|Randomization||1
3249873|NCT02499159|3984128|FG000|STARTED|30-Day Follow-Up Phone Call||49
3249874|NCT02499159|3984129|FG001|STARTED|30-Day Follow-Up Phone Call||49
3249875|NCT02499159|3984128|FG000|COMPLETED|30-Day Follow-Up Phone Call||42
3249876|NCT02499159|3984129|FG001|COMPLETED|30-Day Follow-Up Phone Call||47
3249877|NCT02499159|3984128|FG000|NOT COMPLETED|30-Day Follow-Up Phone Call||7
3249878|NCT02499159|3984129|FG001|NOT COMPLETED|30-Day Follow-Up Phone Call||2
3249879|NCT02499172|3984139|FG000|STARTED|Overall Study||900
3249880|NCT02499172|3984140|FG001|STARTED|Overall Study||899
3249881|NCT02499172|3984141|FG002|STARTED|Overall Study||523
3249882|NCT02499172|3984142|FG003|STARTED|Overall Study||436
3249883|NCT02499172|3984139|FG000|COMPLETED|Overall Study||835
3249884|NCT02499172|3984140|FG001|COMPLETED|Overall Study||835
3249885|NCT02499172|3984141|FG002|COMPLETED|Overall Study||0
3249886|NCT02499172|3984142|FG003|COMPLETED|Overall Study||0
3249887|NCT02499172|3984139|FG000|NOT COMPLETED|Overall Study||65
3249888|NCT02499172|3984140|FG001|NOT COMPLETED|Overall Study||64
3249889|NCT02499172|3984141|FG002|NOT COMPLETED|Overall Study||523
3249890|NCT02499172|3984142|FG003|NOT COMPLETED|Overall Study||436
3249891|NCT02499263|3984152|FG000|STARTED|Overall Study||146
3249892|NCT02499263|3984152|FG000|COMPLETED|Overall Study||84
3249893|NCT02499263|3984152|FG000|NOT COMPLETED|Overall Study||62
3249894|NCT02499380|3984156|FG000|STARTED|Overall Study||20
3249895|NCT02499380|3984156|FG000|COMPLETED|Overall Study||17
3249896|NCT02499380|3984156|FG000|NOT COMPLETED|Overall Study||3
3249897|NCT02499406|3984160|FG000|STARTED|Overall Study||17
3249898|NCT02499406|3984160|FG000|COMPLETED|Overall Study||13
3249899|NCT02499406|3984160|FG000|NOT COMPLETED|Overall Study||4
3249900|NCT02499497|3984168|FG000|STARTED|Overall Study||36
3249901|NCT02499497|3984169|FG001|STARTED|Overall Study||28
3249902|NCT02499497|3984170|FG002|STARTED|Overall Study||36
3249903|NCT02499497|3984171|FG003|STARTED|Overall Study||14
3249904|NCT02499497|3984168|FG000|COMPLETED|Overall Study||32
3249905|NCT02499497|3984169|FG001|COMPLETED|Overall Study||22
3249906|NCT02499497|3984170|FG002|COMPLETED|Overall Study||35
3249907|NCT02499497|3984171|FG003|COMPLETED|Overall Study||13
3249908|NCT02499497|3984168|FG000|NOT COMPLETED|Overall Study||4
3249909|NCT02499497|3984169|FG001|NOT COMPLETED|Overall Study||6
3249910|NCT02499497|3984170|FG002|NOT COMPLETED|Overall Study||1
3249911|NCT02499497|3984171|FG003|NOT COMPLETED|Overall Study||1
3249912|NCT02499575|3984183|FG000|STARTED|Overall Study||1
3249913|NCT02499575|3984184|FG001|STARTED|Overall Study||1
3249914|NCT02499575|3984183|FG000|COMPLETED|Overall Study||1
3249915|NCT02499575|3984184|FG001|COMPLETED|Overall Study||0
3249916|NCT02499575|3984183|FG000|NOT COMPLETED|Overall Study||0
3249917|NCT02499575|3984184|FG001|NOT COMPLETED|Overall Study||1
3249918|NCT02499692|3984190|FG000|STARTED|Overall Study||103
3249919|NCT02499692|3984190|FG000|COMPLETED|Overall Study||103
3249920|NCT02499692|3984190|FG000|NOT COMPLETED|Overall Study||0
3249921|NCT02499770|3984196|FG000|STARTED|Overall Study||19
3371444|NCT03733483|4103085|FG000|STARTED|Overall Study||12
3371445|NCT03733483|4103085|FG000|COMPLETED|Overall Study||12
3371446|NCT03733483|4103085|FG000|NOT COMPLETED|Overall Study||0
3371447|NCT03733470|4103091|FG000|STARTED|Overall Study||8
3371448|NCT03733470|4103092|FG001|STARTED|Overall Study||11
3371449|NCT03733470|4103091|FG000|COMPLETED|Overall Study||7
3371450|NCT03733470|4103092|FG001|COMPLETED|Overall Study||10
3371451|NCT03733470|4103091|FG000|NOT COMPLETED|Overall Study||1
3371452|NCT03733470|4103092|FG001|NOT COMPLETED|Overall Study||1
3371453|NCT03733301|4103101|FG000|STARTED|Overall Study||109
3371454|NCT03733301|4103102|FG001|STARTED|Overall Study||109
3371455|NCT03733301|4103103|FG002|STARTED|Overall Study||111
3371456|NCT03733301|4103101|FG000|Received One Dose of Study Drug|Overall Study||108
3371457|NCT03733301|4103102|FG001|Received One Dose of Study Drug|Overall Study||109
3371458|NCT03733301|4103103|FG002|Received One Dose of Study Drug|Overall Study||111
3371459|NCT03733301|4103101|FG000|COMPLETED|Overall Study||102
3371460|NCT03733301|4103102|FG001|COMPLETED|Overall Study||100
3371461|NCT03733301|4103103|FG002|COMPLETED|Overall Study||107
3371462|NCT03733301|4103101|FG000|NOT COMPLETED|Overall Study||7
3371463|NCT03733301|4103102|FG001|NOT COMPLETED|Overall Study||9
3371464|NCT03733301|4103103|FG002|NOT COMPLETED|Overall Study||4
3371465|NCT03732638|4103114|FG000|STARTED|Overall Study||370
3371466|NCT03732638|4103115|FG001|STARTED|Overall Study||371
3371467|NCT03732638|4103114|FG000|COMPLETED|Overall Study||316
3371468|NCT03732638|4103115|FG001|COMPLETED|Overall Study||310
3371469|NCT03732638|4103114|FG000|NOT COMPLETED|Overall Study||54
3371470|NCT03732638|4103115|FG001|NOT COMPLETED|Overall Study||61
3371471|NCT03732248|4103124|FG000|STARTED|Overall Study||11
3371472|NCT03732248|4103125|FG001|STARTED|Overall Study||10
3371473|NCT03732248|4103124|FG000|COMPLETED|Overall Study||10
3371474|NCT03732248|4103125|FG001|COMPLETED|Overall Study||10
3371475|NCT03732248|4103124|FG000|NOT COMPLETED|Overall Study||1
3371476|NCT03732248|4103125|FG001|NOT COMPLETED|Overall Study||0
3371477|NCT03731182|4103133|FG000|STARTED|Overall Study||70
3371478|NCT03731182|4103134|FG001|STARTED|Overall Study||34
3371479|NCT03731182|4103133|FG000|V114 or Prevnar 13™ Vaccination (Day 1)|Overall Study||69
3371480|NCT03731182|4103134|FG001|V114 or Prevnar 13™ Vaccination (Day 1)|Overall Study||34
3371481|NCT03731182|4103133|FG000|COMPLETED|Overall Study||65
3371482|NCT03731182|4103134|FG001|COMPLETED|Overall Study||34
3371483|NCT03731182|4103133|FG000|NOT COMPLETED|Overall Study||5
3371484|NCT03731182|4103134|FG001|NOT COMPLETED|Overall Study||0
3371485|NCT03730961|4103143|FG000|STARTED|Overall Study||12
3371486|NCT03730961|4103144|FG001|STARTED|Overall Study||11
3371487|NCT03730961|4103143|FG000|Period 1 Completion|Overall Study||12
3371488|NCT03730961|4103144|FG001|Period 1 Completion|Overall Study||11
3371489|NCT03730961|4103143|FG000|Period 2 Completion|Overall Study|1 participant did not complete Period 2 due to hypotension but remained in the study|11
3371490|NCT03730961|4103144|FG001|Period 2 Completion|Overall Study|1 participant discontinued study due to AE|10
3371491|NCT03730961|4103143|FG000|COMPLETED|Overall Study||12
3371492|NCT03730961|4103144|FG001|COMPLETED|Overall Study||10
3371493|NCT03730961|4103143|FG000|NOT COMPLETED|Overall Study||0
3371494|NCT03730961|4103144|FG001|NOT COMPLETED|Overall Study||1
3371495|NCT03730116|4103150|FG000|STARTED|Inclusion|Planned to include 1920 pts, included 1909|1909
3371496|NCT03730116|4103150|FG000|FVFP|Inclusion||1909
3371497|NCT03730116|4103150|FG000|COMPLETED|Inclusion||1909
3371498|NCT03730116|4103150|FG000|NOT COMPLETED|Inclusion||0
3371499|NCT03730116|4103150|FG000|STARTED|1 Month After Inclusion||1909
3371500|NCT03730116|4103150|FG000|1 Month After Inclusion|1 Month After Inclusion||1909
3371501|NCT03730116|4103150|FG000|COMPLETED|1 Month After Inclusion||1909
3371502|NCT03730116|4103150|FG000|NOT COMPLETED|1 Month After Inclusion||0
3371503|NCT03730116|4103150|FG000|STARTED|3 Month After Inclusion||1909
3371504|NCT03730116|4103150|FG000|3 Month After Inclusion|3 Month After Inclusion||1909
3249922|NCT02499770|3984197|FG001|STARTED|Overall Study||77
3249923|NCT02499770|3984196|FG000|COMPLETED|Overall Study||0
3249924|NCT02499770|3984197|FG001|COMPLETED|Overall Study||0
3249925|NCT02499770|3984196|FG000|NOT COMPLETED|Overall Study||19
3249926|NCT02499770|3984197|FG001|NOT COMPLETED|Overall Study||77
3249927|NCT02499783|3984211|FG000|STARTED|DB Period/Placebo-Controlled: Weeks 0-4||102
3249928|NCT02499783|3984212|FG001|STARTED|DB Period/Placebo-Controlled: Weeks 0-4||103
3249929|NCT02499783|3984213|FG002|STARTED|DB Period/Placebo-Controlled: Weeks 0-4||0
3249930|NCT02499783|3984211|FG000|COMPLETED|DB Period/Placebo-Controlled: Weeks 0-4||98
3249931|NCT02499783|3984212|FG001|COMPLETED|DB Period/Placebo-Controlled: Weeks 0-4||98
3249932|NCT02499783|3984213|FG002|COMPLETED|DB Period/Placebo-Controlled: Weeks 0-4||0
3249933|NCT02499783|3984211|FG000|NOT COMPLETED|DB Period/Placebo-Controlled: Weeks 0-4||4
3249934|NCT02499783|3984212|FG001|NOT COMPLETED|DB Period/Placebo-Controlled: Weeks 0-4||5
3249935|NCT02499783|3984213|FG002|NOT COMPLETED|DB Period/Placebo-Controlled: Weeks 0-4||0
3249936|NCT02499783|3984211|FG000|STARTED|DB Period: Weeks 0-8||102
3249937|NCT02499783|3984212|FG001|STARTED|DB Period: Weeks 0-8||103
3249938|NCT02499783|3984213|FG002|STARTED|DB Period: Weeks 0-8||0
3249939|NCT02499783|3984211|FG000|COMPLETED|DB Period: Weeks 0-8||92
3249940|NCT02499783|3984212|FG001|COMPLETED|DB Period: Weeks 0-8||96
3249941|NCT02499783|3984213|FG002|COMPLETED|DB Period: Weeks 0-8||0
3249942|NCT02499783|3984211|FG000|NOT COMPLETED|DB Period: Weeks 0-8||10
3249943|NCT02499783|3984212|FG001|NOT COMPLETED|DB Period: Weeks 0-8||7
3249944|NCT02499783|3984213|FG002|NOT COMPLETED|DB Period: Weeks 0-8||0
3249945|NCT02499783|3984211|FG000|STARTED|Open Label Period: Weeks 8 to 26||0
3249946|NCT02499783|3984212|FG001|STARTED|Open Label Period: Weeks 8 to 26||0
3249947|NCT02499783|3984213|FG002|STARTED|Open Label Period: Weeks 8 to 26||188
3249948|NCT02499783|3984211|FG000|COMPLETED|Open Label Period: Weeks 8 to 26||0
3249949|NCT02499783|3984212|FG001|COMPLETED|Open Label Period: Weeks 8 to 26||0
3249950|NCT02499783|3984213|FG002|COMPLETED|Open Label Period: Weeks 8 to 26||159
3249951|NCT02499783|3984211|FG000|NOT COMPLETED|Open Label Period: Weeks 8 to 26||0
3249952|NCT02499783|3984212|FG001|NOT COMPLETED|Open Label Period: Weeks 8 to 26||0
3249953|NCT02499783|3984213|FG002|NOT COMPLETED|Open Label Period: Weeks 8 to 26||29
3249954|NCT02499952|3984223|FG000|STARTED|Overall Study||12
3249955|NCT02499952|3984223|FG000|COMPLETED|Overall Study||2
3249956|NCT02499952|3984223|FG000|NOT COMPLETED|Overall Study||10
3249957|NCT02500043|3984229|FG000|STARTED|Overall Study||337
3249958|NCT02500043|3984230|FG001|STARTED|Overall Study||170
3249959|NCT02500043|3984229|FG000|As-Treated (AT) Population|Overall Study||335
3249960|NCT02500043|3984230|FG001|As-Treated (AT) Population|Overall Study||168
3249961|NCT02500043|3984229|FG000|COMPLETED|Overall Study||0
3249962|NCT02500043|3984230|FG001|COMPLETED|Overall Study||0
3249963|NCT02500043|3984229|FG000|NOT COMPLETED|Overall Study||337
3249964|NCT02500043|3984230|FG001|NOT COMPLETED|Overall Study||170
3249965|NCT02500056|3984238|FG000|STARTED|Overall Study||70
3249966|NCT02500056|3984239|FG001|STARTED|Overall Study||73
3249967|NCT02500056|3984238|FG000|COMPLETED|Overall Study||63
3249968|NCT02500056|3984239|FG001|COMPLETED|Overall Study||65
3249969|NCT02500056|3984238|FG000|NOT COMPLETED|Overall Study||7
3249970|NCT02500056|3984239|FG001|NOT COMPLETED|Overall Study||8
3249971|NCT02500368|3984245|FG000|STARTED|First Intervention (1 Week)||20
3249972|NCT02500368|3984246|FG001|STARTED|First Intervention (1 Week)||20
3249973|NCT02500368|3984245|FG000|COMPLETED|First Intervention (1 Week)||20
3249974|NCT02500368|3984246|FG001|COMPLETED|First Intervention (1 Week)||20
3249975|NCT02500368|3984245|FG000|NOT COMPLETED|First Intervention (1 Week)||0
3249976|NCT02500368|3984246|FG001|NOT COMPLETED|First Intervention (1 Week)||0
3249977|NCT02500368|3984245|FG000|STARTED|Second Intervention (1 Week)||20
3249978|NCT02500368|3984246|FG001|STARTED|Second Intervention (1 Week)||20
3249979|NCT02500368|3984245|FG000|COMPLETED|Second Intervention (1 Week)||20
3249980|NCT02500368|3984246|FG001|COMPLETED|Second Intervention (1 Week)||20
3249981|NCT02500368|3984245|FG000|NOT COMPLETED|Second Intervention (1 Week)||0
3249982|NCT02500368|3984246|FG001|NOT COMPLETED|Second Intervention (1 Week)||0
3249983|NCT02500537|3984254|FG000|STARTED|Overall Study||60
3249984|NCT02500537|3984255|FG001|STARTED|Overall Study||40
3249985|NCT02500537|3984254|FG000|COMPLETED|Overall Study||57
3249986|NCT02500537|3984255|FG001|COMPLETED|Overall Study||39
3249987|NCT02500537|3984254|FG000|NOT COMPLETED|Overall Study||3
3249988|NCT02500537|3984255|FG001|NOT COMPLETED|Overall Study||1
3249989|NCT02500550|3984262|FG000|STARTED|Overall Study||15
3249990|NCT02500550|3984262|FG000|COMPLETED|Overall Study||8
3249991|NCT02500550|3984262|FG000|NOT COMPLETED|Overall Study||7
3249992|NCT02500602|3984268|FG000|STARTED|Treatment Phase||74
3249993|NCT02500602|3984269|FG001|STARTED|Treatment Phase||70
3249994|NCT02500602|3984268|FG000|COMPLETED|Treatment Phase||68
3249995|NCT02500602|3984269|FG001|COMPLETED|Treatment Phase||69
3249996|NCT02500602|3984268|FG000|NOT COMPLETED|Treatment Phase||6
3249997|NCT02500602|3984269|FG001|NOT COMPLETED|Treatment Phase||1
3249998|NCT02500602|3984268|FG000|STARTED|Follow Up Phase||68
3249999|NCT02500602|3984269|FG001|STARTED|Follow Up Phase||69
3250000|NCT02500602|3984268|FG000|COMPLETED|Follow Up Phase||53
3250001|NCT02500602|3984269|FG001|COMPLETED|Follow Up Phase||47
3250002|NCT02500602|3984268|FG000|NOT COMPLETED|Follow Up Phase||15
3250003|NCT02500602|3984269|FG001|NOT COMPLETED|Follow Up Phase||22
3250004|NCT02500628|3984279|FG000|STARTED|Overall Study||38
3250005|NCT02500628|3984280|FG001|STARTED|Overall Study||23
3250006|NCT02500628|3984279|FG000|COMPLETED|Overall Study||38
3250007|NCT02500628|3984280|FG001|COMPLETED|Overall Study||23
3250008|NCT02500628|3984279|FG000|NOT COMPLETED|Overall Study||0
3250009|NCT02500628|3984280|FG001|NOT COMPLETED|Overall Study||0
3250010|NCT02500641|3984290|FG000|STARTED|Overall Study||98
3250011|NCT02500641|3984291|FG001|STARTED|Overall Study||98
3250012|NCT02500641|3984290|FG000|COMPLETED|Overall Study||88
3250013|NCT02500641|3984291|FG001|COMPLETED|Overall Study||86
3250014|NCT02500641|3984290|FG000|NOT COMPLETED|Overall Study||10
3250015|NCT02500641|3984291|FG001|NOT COMPLETED|Overall Study||12
3250016|NCT02500706|3984300|FG000|STARTED|Overall Study||342
3250017|NCT02500706|3984301|FG001|STARTED|Overall Study||341
3250018|NCT02500706|3984302|FG002|STARTED|Overall Study||342
3250019|NCT02500706|3984300|FG000|Exposed|Overall Study||342
3250020|NCT02500706|3984301|FG001|Exposed|Overall Study||341
3250021|NCT02500706|3984302|FG002|Exposed|Overall Study||342
3250022|NCT02500706|3984300|FG000|COMPLETED|Overall Study||338
3250023|NCT02500706|3984301|FG001|COMPLETED|Overall Study||334
3250024|NCT02500706|3984302|FG002|COMPLETED|Overall Study||335
3250025|NCT02500706|3984300|FG000|NOT COMPLETED|Overall Study||4
3250026|NCT02500706|3984301|FG001|NOT COMPLETED|Overall Study||7
3250027|NCT02500706|3984302|FG002|NOT COMPLETED|Overall Study||7
3250028|NCT02500719|3984312|FG000|STARTED|Overall Study||14
3250029|NCT02500719|3984313|FG001|STARTED|Overall Study||16
3250030|NCT02500719|3984312|FG000|COMPLETED|Overall Study||11
3250031|NCT02500719|3984313|FG001|COMPLETED|Overall Study||9
3250032|NCT02500719|3984312|FG000|NOT COMPLETED|Overall Study||3
3250033|NCT02500719|3984313|FG001|NOT COMPLETED|Overall Study||7
3250034|NCT02500732|3984321|FG000|STARTED|Overall Study||27
3250035|NCT02500732|3984322|FG001|STARTED|Overall Study||30
3250036|NCT02500732|3984321|FG000|COMPLETED|Overall Study||27
3250037|NCT02500732|3984322|FG001|COMPLETED|Overall Study|Not true event in 1 participant (pseudosyncope)|29
3250038|NCT02500732|3984321|FG000|NOT COMPLETED|Overall Study||0
3250039|NCT02500732|3984322|FG001|NOT COMPLETED|Overall Study||1
3250040|NCT02500758|3984330|FG000|STARTED|First Intervention (2 Minutes)||15
3250041|NCT02500758|3984331|FG001|STARTED|First Intervention (2 Minutes)||15
3250042|NCT02500758|3984330|FG000|COMPLETED|First Intervention (2 Minutes)||15
3250043|NCT02500758|3984331|FG001|COMPLETED|First Intervention (2 Minutes)||14
3250044|NCT02500758|3984330|FG000|NOT COMPLETED|First Intervention (2 Minutes)||0
3250045|NCT02500758|3984331|FG001|NOT COMPLETED|First Intervention (2 Minutes)||1
3250046|NCT02500758|3984330|FG000|STARTED|Washout (1 Week)||15
3250047|NCT02500758|3984331|FG001|STARTED|Washout (1 Week)||14
3250048|NCT02500758|3984330|FG000|COMPLETED|Washout (1 Week)||13
3250049|NCT02500758|3984331|FG001|COMPLETED|Washout (1 Week)||12
3250050|NCT02500758|3984330|FG000|NOT COMPLETED|Washout (1 Week)||2
3250051|NCT02500758|3984331|FG001|NOT COMPLETED|Washout (1 Week)||2
3250052|NCT02500758|3984330|FG000|STARTED|Second Intervention (2 Minutes)||13
3250053|NCT02500758|3984331|FG001|STARTED|Second Intervention (2 Minutes)||12
3250054|NCT02500758|3984330|FG000|COMPLETED|Second Intervention (2 Minutes)||10
3250055|NCT02500758|3984331|FG001|COMPLETED|Second Intervention (2 Minutes)||10
3250056|NCT02500758|3984330|FG000|NOT COMPLETED|Second Intervention (2 Minutes)||3
3250057|NCT02500758|3984331|FG001|NOT COMPLETED|Second Intervention (2 Minutes)||2
3250058|NCT02500836|3984341|FG000|STARTED|Overall Study||259
3250059|NCT02500836|3984342|FG001|STARTED|Overall Study||259
3250060|NCT02500836|3984343|FG002|STARTED|Overall Study||128
3250061|NCT02500836|3984341|FG000|COMPLETED|Overall Study||256
3250062|NCT02500836|3984342|FG001|COMPLETED|Overall Study||254
3250063|NCT02500836|3984343|FG002|COMPLETED|Overall Study||127
3250064|NCT02500836|3984341|FG000|NOT COMPLETED|Overall Study||3
3250065|NCT02500836|3984342|FG001|NOT COMPLETED|Overall Study||5
3250066|NCT02500836|3984343|FG002|NOT COMPLETED|Overall Study||1
3250067|NCT02500979|3984353|FG000|STARTED|Period 1||16
3250068|NCT02500979|3984354|FG001|STARTED|Period 1||17
3250069|NCT02500979|3984353|FG000|COMPLETED|Period 1||12
3250070|NCT02500979|3984354|FG001|COMPLETED|Period 1||16
3250071|NCT02500979|3984353|FG000|NOT COMPLETED|Period 1||4
3250072|NCT02500979|3984354|FG001|NOT COMPLETED|Period 1||1
3250073|NCT02500979|3984353|FG000|STARTED|Period 2||12
3250074|NCT02500979|3984354|FG001|STARTED|Period 2||16
3250075|NCT02500979|3984353|FG000|COMPLETED|Period 2||11
3250076|NCT02500979|3984354|FG001|COMPLETED|Period 2||16
3250077|NCT02500979|3984353|FG000|NOT COMPLETED|Period 2||1
3250078|NCT02500979|3984354|FG001|NOT COMPLETED|Period 2||0
3250079|NCT02501135|3984360|FG000|STARTED|Overall Study||281
3250080|NCT02501135|3984360|FG000|COMPLETED|Overall Study||281
3250081|NCT02501135|3984360|FG000|NOT COMPLETED|Overall Study||0
3250082|NCT02501161|3984372|FG000|STARTED|Overall Study||506
3250083|NCT02501161|3984373|FG001|STARTED|Overall Study||506
3250084|NCT02501161|3984372|FG000|Exposed|Overall Study||506
3250085|NCT02501161|3984373|FG001|Exposed|Overall Study||504
3250086|NCT02501161|3984372|FG000|COMPLETED|Overall Study||484
3250087|NCT02501161|3984373|FG001|COMPLETED|Overall Study||481
3250088|NCT02501161|3984372|FG000|NOT COMPLETED|Overall Study||22
3250089|NCT02501161|3984373|FG001|NOT COMPLETED|Overall Study||25
3250090|NCT02501265|3984383|FG000|STARTED|Overall Study||63
3250091|NCT02501265|3984384|FG001|STARTED|Overall Study||30
3250092|NCT02501265|3984385|FG002|STARTED|Overall Study||64
3250093|NCT02501265|3984386|FG003|STARTED|Overall Study||31
3250094|NCT02501265|3984383|FG000|COMPLETED|Overall Study||46
3371505|NCT03730116|4103150|FG000|COMPLETED|3 Month After Inclusion||1892
3371506|NCT03730116|4103150|FG000|NOT COMPLETED|3 Month After Inclusion||17
3371507|NCT03730103|4103160|FG000|STARTED|Overall Study||61
3371508|NCT03730103|4103161|FG001|STARTED|Overall Study||52
3371509|NCT03730103|4103160|FG000|COMPLETED|Overall Study||61
3250095|NCT02501265|3984384|FG001|COMPLETED|Overall Study||21
3371510|NCT03730103|4103161|FG001|COMPLETED|Overall Study||47
3250096|NCT02501265|3984385|FG002|COMPLETED|Overall Study||46
3250097|NCT02501265|3984386|FG003|COMPLETED|Overall Study||23
3250098|NCT02501265|3984383|FG000|NOT COMPLETED|Overall Study||17
3250099|NCT02501265|3984384|FG001|NOT COMPLETED|Overall Study||9
3250100|NCT02501265|3984385|FG002|NOT COMPLETED|Overall Study||18
3250101|NCT02501265|3984386|FG003|NOT COMPLETED|Overall Study||8
3250102|NCT02501473|3984403|FG000|STARTED|Overall Study||3
3250103|NCT02501473|3984404|FG001|STARTED|Overall Study||3
3250104|NCT02501473|3984405|FG002|STARTED|Overall Study||13
3250105|NCT02501473|3984406|FG003|STARTED|Overall Study||14
3250106|NCT02501473|3984407|FG004|STARTED|Overall Study||4
3250107|NCT02501473|3984408|FG005|STARTED|Overall Study||14
3250108|NCT02501473|3984409|FG006|STARTED|Overall Study||1
3250109|NCT02501473|3984410|FG007|STARTED|Overall Study||0
3250110|NCT02501473|3984403|FG000|Treated|Overall Study||3
3250111|NCT02501473|3984404|FG001|Treated|Overall Study||3
3250112|NCT02501473|3984405|FG002|Treated|Overall Study||13
3250113|NCT02501473|3984406|FG003|Treated|Overall Study||13
3250114|NCT02501473|3984407|FG004|Treated|Overall Study||4
3250115|NCT02501473|3984408|FG005|Treated|Overall Study||14
3250116|NCT02501473|3984409|FG006|Treated|Overall Study||1
3250117|NCT02501473|3984410|FG007|Treated|Overall Study||0
3250118|NCT02501473|3984403|FG000|COMPLETED|Overall Study||0
3250119|NCT02501473|3984404|FG001|COMPLETED|Overall Study||0
3250120|NCT02501473|3984405|FG002|COMPLETED|Overall Study||0
3250121|NCT02501473|3984406|FG003|COMPLETED|Overall Study||0
3250122|NCT02501473|3984407|FG004|COMPLETED|Overall Study||0
3250123|NCT02501473|3984408|FG005|COMPLETED|Overall Study||0
3250124|NCT02501473|3984409|FG006|COMPLETED|Overall Study||0
3250125|NCT02501473|3984410|FG007|COMPLETED|Overall Study||0
3250126|NCT02501473|3984403|FG000|NOT COMPLETED|Overall Study||3
3250127|NCT02501473|3984404|FG001|NOT COMPLETED|Overall Study||3
3250128|NCT02501473|3984405|FG002|NOT COMPLETED|Overall Study||13
3250129|NCT02501473|3984406|FG003|NOT COMPLETED|Overall Study||14
3250130|NCT02501473|3984407|FG004|NOT COMPLETED|Overall Study||4
3250131|NCT02501473|3984408|FG005|NOT COMPLETED|Overall Study||14
3250132|NCT02501473|3984409|FG006|NOT COMPLETED|Overall Study||1
3250133|NCT02501473|3984410|FG007|NOT COMPLETED|Overall Study||0
3250134|NCT02501538|3984426|FG000|STARTED|Overall Study||23
3250135|NCT02501538|3984426|FG000|COMPLETED|Overall Study||20
3250136|NCT02501538|3984426|FG000|NOT COMPLETED|Overall Study||3
3250137|NCT02501590|3984435|FG000|STARTED|Overall Study||13
3250138|NCT02501590|3984436|FG001|STARTED|Overall Study||35
3250139|NCT02501590|3984435|FG000|COMPLETED|Overall Study||13
3250140|NCT02501590|3984436|FG001|COMPLETED|Overall Study||35
3250141|NCT02501590|3984435|FG000|NOT COMPLETED|Overall Study||0
3250142|NCT02501590|3984436|FG001|NOT COMPLETED|Overall Study||0
3250143|NCT02501629|3984444|FG000|STARTED|Overall Study||89
3250144|NCT02501629|3984445|FG001|STARTED|Overall Study||88
3250145|NCT02501629|3984444|FG000|COMPLETED|Overall Study||84
3250146|NCT02501629|3984445|FG001|COMPLETED|Overall Study||81
3250147|NCT02501629|3984444|FG000|NOT COMPLETED|Overall Study||5
3250148|NCT02501629|3984445|FG001|NOT COMPLETED|Overall Study||7
3250149|NCT02501642|3984453|FG000|STARTED|Overall Study|Start of study: 10.1.2014|238
3250150|NCT02501642|3984454|FG001|STARTED|Overall Study|Start of study: 10.1.2014|241
3250151|NCT02501642|3984453|FG000|COMPLETED|Overall Study|Study ended 9.30.2018|231
3250152|NCT02501642|3984454|FG001|COMPLETED|Overall Study|Study ended 9.30.2018|230
3250153|NCT02501642|3984453|FG000|NOT COMPLETED|Overall Study||7
3250154|NCT02501642|3984454|FG001|NOT COMPLETED|Overall Study||11
3250155|NCT02501811|3984464|FG000|STARTED|Overall Study||33
3250156|NCT02501811|3984465|FG001|STARTED|Overall Study||29
3250157|NCT02501811|3984466|FG002|STARTED|Overall Study||31
3250158|NCT02501811|3984467|FG003|STARTED|Overall Study||32
3250159|NCT02501811|3984464|FG000|COMPLETED|Overall Study|includes 1 participant who completed final study visit but died within 30 days after final visit.|29
3250160|NCT02501811|3984465|FG001|COMPLETED|Overall Study||23
3250161|NCT02501811|3984466|FG002|COMPLETED|Overall Study||25
3250162|NCT02501811|3984467|FG003|COMPLETED|Overall Study|includes 1 participant who completed final study visit but died within 30 days after final visit.|25
3250163|NCT02501811|3984464|FG000|NOT COMPLETED|Overall Study||4
3250164|NCT02501811|3984465|FG001|NOT COMPLETED|Overall Study||6
3250165|NCT02501811|3984466|FG002|NOT COMPLETED|Overall Study||6
3250166|NCT02501811|3984467|FG003|NOT COMPLETED|Overall Study||7
3250167|NCT02501902|3984485|FG000|STARTED|Overall Study||3
3250168|NCT02501902|3984486|FG001|STARTED|Overall Study||7
3250169|NCT02501902|3984487|FG002|STARTED|Overall Study||4
3250170|NCT02501902|3984488|FG003|STARTED|Overall Study||11
3250171|NCT02501902|3984489|FG004|STARTED|Overall Study||11
3250172|NCT02501902|3984490|FG005|STARTED|Overall Study||11
3250173|NCT02501902|3984491|FG006|STARTED|Overall Study||9
3250174|NCT02501902|3984492|FG007|STARTED|Overall Study||20
3250175|NCT02501902|3984485|FG000|COMPLETED|Overall Study||0
3250176|NCT02501902|3984486|FG001|COMPLETED|Overall Study||0
3250177|NCT02501902|3984487|FG002|COMPLETED|Overall Study||0
3250178|NCT02501902|3984488|FG003|COMPLETED|Overall Study||0
3250179|NCT02501902|3984489|FG004|COMPLETED|Overall Study||0
3250180|NCT02501902|3984490|FG005|COMPLETED|Overall Study||0
3250181|NCT02501902|3984491|FG006|COMPLETED|Overall Study||0
3250182|NCT02501902|3984492|FG007|COMPLETED|Overall Study||0
3250183|NCT02501902|3984485|FG000|NOT COMPLETED|Overall Study||3
3250184|NCT02501902|3984486|FG001|NOT COMPLETED|Overall Study||7
3250185|NCT02501902|3984487|FG002|NOT COMPLETED|Overall Study||4
3250186|NCT02501902|3984488|FG003|NOT COMPLETED|Overall Study||11
3250187|NCT02501902|3984489|FG004|NOT COMPLETED|Overall Study||11
3250188|NCT02501902|3984490|FG005|NOT COMPLETED|Overall Study||11
3250189|NCT02501902|3984491|FG006|NOT COMPLETED|Overall Study||9
3250190|NCT02501902|3984492|FG007|NOT COMPLETED|Overall Study||20
3250191|NCT02501928|3984518|FG000|STARTED|Overall Study|No participant was assigned to this arm, in this LTE study.|0
3250192|NCT02501928|3984519|FG001|STARTED|Overall Study||2
3250193|NCT02501928|3984520|FG002|STARTED|Overall Study|No participant was assigned to this arm, in this LTE study.|0
3250194|NCT02501928|3984521|FG003|STARTED|Overall Study|No participant was assigned to this arm, in this LTE study.|0
3250195|NCT02501928|3984522|FG004|STARTED|Overall Study||7
3250196|NCT02501928|3984523|FG005|STARTED|Overall Study||3
3250197|NCT02501928|3984518|FG000|COMPLETED|Overall Study||0
3250198|NCT02501928|3984519|FG001|COMPLETED|Overall Study||2
3250199|NCT02501928|3984520|FG002|COMPLETED|Overall Study||0
3250200|NCT02501928|3984521|FG003|COMPLETED|Overall Study||0
3250201|NCT02501928|3984522|FG004|COMPLETED|Overall Study||6
3250202|NCT02501928|3984523|FG005|COMPLETED|Overall Study||3
3250203|NCT02501928|3984518|FG000|NOT COMPLETED|Overall Study||0
3250204|NCT02501928|3984519|FG001|NOT COMPLETED|Overall Study||0
3250205|NCT02501928|3984520|FG002|NOT COMPLETED|Overall Study||0
3250206|NCT02501928|3984521|FG003|NOT COMPLETED|Overall Study||0
3250207|NCT02501928|3984522|FG004|NOT COMPLETED|Overall Study||1
3250208|NCT02501928|3984523|FG005|NOT COMPLETED|Overall Study||0
3250209|NCT02502019|3984540|FG000|STARTED|Overall Study||27
3250210|NCT02502019|3984540|FG000|COMPLETED|Overall Study||27
3250211|NCT02502019|3984540|FG000|NOT COMPLETED|Overall Study||0
3250212|NCT02502097|3984548|FG000|STARTED|Period 1||4
3250213|NCT02502097|3984549|FG001|STARTED|Period 1||3
3250214|NCT02502097|3984550|FG002|STARTED|Period 1||22
3250215|NCT02502097|3984551|FG003|STARTED|Period 1||22
3250216|NCT02502097|3984548|FG000|COMPLETED|Period 1||4
3250217|NCT02502097|3984549|FG001|COMPLETED|Period 1||3
3250218|NCT02502097|3984550|FG002|COMPLETED|Period 1||21
3250219|NCT02502097|3984551|FG003|COMPLETED|Period 1||22
3250220|NCT02502097|3984548|FG000|NOT COMPLETED|Period 1||0
3250221|NCT02502097|3984549|FG001|NOT COMPLETED|Period 1||0
3250222|NCT02502097|3984550|FG002|NOT COMPLETED|Period 1||1
3250223|NCT02502097|3984551|FG003|NOT COMPLETED|Period 1||0
3250224|NCT02502097|3984548|FG000|STARTED|Wash Out Period||4
3250225|NCT02502097|3984549|FG001|STARTED|Wash Out Period||3
3250226|NCT02502097|3984550|FG002|STARTED|Wash Out Period||21
3250227|NCT02502097|3984551|FG003|STARTED|Wash Out Period||22
3250228|NCT02502097|3984548|FG000|COMPLETED|Wash Out Period||4
3250229|NCT02502097|3984549|FG001|COMPLETED|Wash Out Period||2
3250230|NCT02502097|3984550|FG002|COMPLETED|Wash Out Period||20
3250231|NCT02502097|3984551|FG003|COMPLETED|Wash Out Period||21
3250232|NCT02502097|3984548|FG000|NOT COMPLETED|Wash Out Period||0
3250233|NCT02502097|3984549|FG001|NOT COMPLETED|Wash Out Period||1
3250234|NCT02502097|3984550|FG002|NOT COMPLETED|Wash Out Period||1
3250235|NCT02502097|3984551|FG003|NOT COMPLETED|Wash Out Period||1
3250236|NCT02502097|3984548|FG000|STARTED|Period 2||4
3250237|NCT02502097|3984549|FG001|STARTED|Period 2||2
3250238|NCT02502097|3984550|FG002|STARTED|Period 2||20
3250239|NCT02502097|3984551|FG003|STARTED|Period 2||21
3250240|NCT02502097|3984548|FG000|COMPLETED|Period 2||4
3250241|NCT02502097|3984549|FG001|COMPLETED|Period 2||2
3250242|NCT02502097|3984550|FG002|COMPLETED|Period 2||19
3250243|NCT02502097|3984551|FG003|COMPLETED|Period 2||21
3250244|NCT02502097|3984548|FG000|NOT COMPLETED|Period 2||0
3250245|NCT02502097|3984549|FG001|NOT COMPLETED|Period 2||0
3250246|NCT02502097|3984550|FG002|NOT COMPLETED|Period 2||1
3250247|NCT02502097|3984551|FG003|NOT COMPLETED|Period 2||0
3250248|NCT02502149|3984558|FG000|STARTED|PK1 Assessment Period||24
3250249|NCT02502149|3984559|FG001|STARTED|PK1 Assessment Period||0
3250250|NCT02502149|3984560|FG002|STARTED|PK1 Assessment Period||0
3250251|NCT02502149|3984561|FG003|STARTED|PK1 Assessment Period||0
3250252|NCT02502149|3984562|FG004|STARTED|PK1 Assessment Period||0
3250253|NCT02502149|3984558|FG000|COMPLETED|PK1 Assessment Period||24
3250254|NCT02502149|3984559|FG001|COMPLETED|PK1 Assessment Period||0
3250255|NCT02502149|3984560|FG002|COMPLETED|PK1 Assessment Period||0
3250256|NCT02502149|3984561|FG003|COMPLETED|PK1 Assessment Period||0
3250257|NCT02502149|3984562|FG004|COMPLETED|PK1 Assessment Period||0
3250258|NCT02502149|3984558|FG000|NOT COMPLETED|PK1 Assessment Period||0
3250259|NCT02502149|3984559|FG001|NOT COMPLETED|PK1 Assessment Period||0
3250260|NCT02502149|3984560|FG002|NOT COMPLETED|PK1 Assessment Period||0
3250261|NCT02502149|3984561|FG003|NOT COMPLETED|PK1 Assessment Period||0
3250262|NCT02502149|3984562|FG004|NOT COMPLETED|PK1 Assessment Period||0
3250263|NCT02502149|3984558|FG000|STARTED|Intermediate||24
3250264|NCT02502149|3984559|FG001|STARTED|Intermediate||0
3250265|NCT02502149|3984560|FG002|STARTED|Intermediate||0
3250266|NCT02502149|3984561|FG003|STARTED|Intermediate||0
3250267|NCT02502149|3984562|FG004|STARTED|Intermediate||0
3250268|NCT02502149|3984558|FG000|COMPLETED|Intermediate||23
3250269|NCT02502149|3984559|FG001|COMPLETED|Intermediate||0
3250270|NCT02502149|3984560|FG002|COMPLETED|Intermediate||0
3250271|NCT02502149|3984561|FG003|COMPLETED|Intermediate||0
3250272|NCT02502149|3984562|FG004|COMPLETED|Intermediate||0
3250273|NCT02502149|3984558|FG000|NOT COMPLETED|Intermediate||1
3250274|NCT02502149|3984559|FG001|NOT COMPLETED|Intermediate||0
3250275|NCT02502149|3984560|FG002|NOT COMPLETED|Intermediate||0
3250276|NCT02502149|3984561|FG003|NOT COMPLETED|Intermediate||0
3250277|NCT02502149|3984562|FG004|NOT COMPLETED|Intermediate||0
3250278|NCT02502149|3984558|FG000|STARTED|PK2 Assessment Period||0
3250279|NCT02502149|3984559|FG001|STARTED|PK2 Assessment Period||11
3250280|NCT02502149|3984560|FG002|STARTED|PK2 Assessment Period||12
3250281|NCT02502149|3984561|FG003|STARTED|PK2 Assessment Period||0
3250282|NCT02502149|3984562|FG004|STARTED|PK2 Assessment Period||0
3250283|NCT02502149|3984558|FG000|COMPLETED|PK2 Assessment Period||0
3250284|NCT02502149|3984559|FG001|COMPLETED|PK2 Assessment Period||11
3250285|NCT02502149|3984560|FG002|COMPLETED|PK2 Assessment Period||12
3250286|NCT02502149|3984561|FG003|COMPLETED|PK2 Assessment Period||0
3250287|NCT02502149|3984562|FG004|COMPLETED|PK2 Assessment Period||0
3250288|NCT02502149|3984558|FG000|NOT COMPLETED|PK2 Assessment Period||0
3250289|NCT02502149|3984559|FG001|NOT COMPLETED|PK2 Assessment Period||0
3250290|NCT02502149|3984560|FG002|NOT COMPLETED|PK2 Assessment Period||0
3250291|NCT02502149|3984561|FG003|NOT COMPLETED|PK2 Assessment Period||0
3250292|NCT02502149|3984562|FG004|NOT COMPLETED|PK2 Assessment Period||0
3250293|NCT02502149|3984558|FG000|STARTED|Treatment Period||0
3250294|NCT02502149|3984559|FG001|STARTED|Treatment Period||0
3250295|NCT02502149|3984560|FG002|STARTED|Treatment Period||0
3250296|NCT02502149|3984561|FG003|STARTED|Treatment Period||11
3250297|NCT02502149|3984562|FG004|STARTED|Treatment Period||12
3250298|NCT02502149|3984558|FG000|COMPLETED|Treatment Period||0
3250299|NCT02502149|3984559|FG001|COMPLETED|Treatment Period||0
3250300|NCT02502149|3984560|FG002|COMPLETED|Treatment Period||0
3250301|NCT02502149|3984561|FG003|COMPLETED|Treatment Period||11
3250302|NCT02502149|3984562|FG004|COMPLETED|Treatment Period||12
3250303|NCT02502149|3984558|FG000|NOT COMPLETED|Treatment Period||0
3250304|NCT02502149|3984559|FG001|NOT COMPLETED|Treatment Period||0
3250305|NCT02502149|3984560|FG002|NOT COMPLETED|Treatment Period||0
3250306|NCT02502149|3984561|FG003|NOT COMPLETED|Treatment Period||0
3250307|NCT02502149|3984562|FG004|NOT COMPLETED|Treatment Period||0
3250308|NCT02502461|3984581|FG000|STARTED|Overall Study||46
3250309|NCT02502461|3984582|FG001|STARTED|Overall Study||44
3250310|NCT02502461|3984581|FG000|COMPLETED|Overall Study||46
3250311|NCT02502461|3984582|FG001|COMPLETED|Overall Study||44
3250312|NCT02502461|3984581|FG000|NOT COMPLETED|Overall Study||0
3250313|NCT02502461|3984582|FG001|NOT COMPLETED|Overall Study||0
3250314|NCT02502487|3984591|FG000|STARTED|Overall Study||86
3250315|NCT02502487|3984592|FG001|STARTED|Overall Study||86
3250316|NCT02502487|3984593|FG002|STARTED|Overall Study||86
3250317|NCT02502487|3984591|FG000|COMPLETED|Overall Study||86
3250318|NCT02502487|3984592|FG001|COMPLETED|Overall Study||86
3250319|NCT02502487|3984593|FG002|COMPLETED|Overall Study||86
3250320|NCT02502487|3984591|FG000|NOT COMPLETED|Overall Study||0
3250321|NCT02502487|3984592|FG001|NOT COMPLETED|Overall Study||0
3250322|NCT02502487|3984593|FG002|NOT COMPLETED|Overall Study||0
3250323|NCT02502526|3984604|FG000|STARTED|Overall Study||62
3250324|NCT02502526|3984605|FG001|STARTED|Overall Study||59
3250325|NCT02502526|3984606|FG002|STARTED|Overall Study||61
3250326|NCT02502526|3984604|FG000|Intent-to-Treat (ITT)|Overall Study||57
3250327|NCT02502526|3984605|FG001|Intent-to-Treat (ITT)|Overall Study||57
3250328|NCT02502526|3984606|FG002|Intent-to-Treat (ITT)|Overall Study||59
3250329|NCT02502526|3984604|FG000|COMPLETED|Overall Study||56
3250330|NCT02502526|3984605|FG001|COMPLETED|Overall Study||55
3250331|NCT02502526|3984606|FG002|COMPLETED|Overall Study||55
3250332|NCT02502526|3984604|FG000|NOT COMPLETED|Overall Study||6
3250333|NCT02502526|3984605|FG001|NOT COMPLETED|Overall Study||4
3250334|NCT02502526|3984606|FG002|NOT COMPLETED|Overall Study||6
3250335|NCT02502734|3984615|FG000|STARTED|Double-blind Treatment Period 1||30
3250336|NCT02502734|3984616|FG001|STARTED|Double-blind Treatment Period 1||30
3250337|NCT02502734|3984615|FG000|COMPLETED|Double-blind Treatment Period 1||29
3250338|NCT02502734|3984616|FG001|COMPLETED|Double-blind Treatment Period 1||30
3250339|NCT02502734|3984615|FG000|NOT COMPLETED|Double-blind Treatment Period 1||1
3250340|NCT02502734|3984616|FG001|NOT COMPLETED|Double-blind Treatment Period 1||0
3250341|NCT02502734|3984615|FG000|STARTED|Washout Period||29
3250342|NCT02502734|3984616|FG001|STARTED|Washout Period||30
3250343|NCT02502734|3984615|FG000|COMPLETED|Washout Period||28
3250344|NCT02502734|3984616|FG001|COMPLETED|Washout Period||30
3250345|NCT02502734|3984615|FG000|NOT COMPLETED|Washout Period||1
3250346|NCT02502734|3984616|FG001|NOT COMPLETED|Washout Period||0
3250347|NCT02502734|3984615|FG000|STARTED|Double-blind Treatment Period 2||28
3250348|NCT02502734|3984616|FG001|STARTED|Double-blind Treatment Period 2||30
3250349|NCT02502734|3984615|FG000|COMPLETED|Double-blind Treatment Period 2||28
3250350|NCT02502734|3984616|FG001|COMPLETED|Double-blind Treatment Period 2||30
3250351|NCT02502734|3984615|FG000|NOT COMPLETED|Double-blind Treatment Period 2||0
3250352|NCT02502734|3984616|FG001|NOT COMPLETED|Double-blind Treatment Period 2||0
3250353|NCT02502864|3984624|FG000|STARTED|Overall Study||9
3250354|NCT02502864|3984624|FG000|COMPLETED|Overall Study||8
3250355|NCT02502864|3984624|FG000|NOT COMPLETED|Overall Study||1
3250356|NCT02503085|3984628|FG000|STARTED|Period 1||7
3250357|NCT02503085|3984629|FG001|STARTED|Period 1||7
3250358|NCT02503085|3984630|FG002|STARTED|Period 1||7
3250359|NCT02503085|3984631|FG003|STARTED|Period 1||7
3250360|NCT02503085|3984628|FG000|COMPLETED|Period 1||7
3250361|NCT02503085|3984629|FG001|COMPLETED|Period 1||7
3250362|NCT02503085|3984630|FG002|COMPLETED|Period 1||7
3250363|NCT02503085|3984631|FG003|COMPLETED|Period 1||7
3250364|NCT02503085|3984628|FG000|NOT COMPLETED|Period 1||0
3250365|NCT02503085|3984629|FG001|NOT COMPLETED|Period 1||0
3250366|NCT02503085|3984630|FG002|NOT COMPLETED|Period 1||0
3250367|NCT02503085|3984631|FG003|NOT COMPLETED|Period 1||0
3250368|NCT02503085|3984628|FG000|STARTED|Period 1: Washout (3 to 7 Days)||7
3250369|NCT02503085|3984629|FG001|STARTED|Period 1: Washout (3 to 7 Days)||7
3250370|NCT02503085|3984630|FG002|STARTED|Period 1: Washout (3 to 7 Days)||7
3250371|NCT02503085|3984631|FG003|STARTED|Period 1: Washout (3 to 7 Days)||7
3250372|NCT02503085|3984628|FG000|COMPLETED|Period 1: Washout (3 to 7 Days)||7
3250373|NCT02503085|3984629|FG001|COMPLETED|Period 1: Washout (3 to 7 Days)||7
3250374|NCT02503085|3984630|FG002|COMPLETED|Period 1: Washout (3 to 7 Days)||7
3250375|NCT02503085|3984631|FG003|COMPLETED|Period 1: Washout (3 to 7 Days)||7
3250376|NCT02503085|3984628|FG000|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
3250377|NCT02503085|3984629|FG001|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
3250378|NCT02503085|3984630|FG002|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
3250379|NCT02503085|3984631|FG003|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
3250380|NCT02503085|3984628|FG000|STARTED|Period 2||7
3250381|NCT02503085|3984629|FG001|STARTED|Period 2||7
3250382|NCT02503085|3984630|FG002|STARTED|Period 2||7
3250383|NCT02503085|3984631|FG003|STARTED|Period 2||7
3250384|NCT02503085|3984628|FG000|COMPLETED|Period 2||7
3250385|NCT02503085|3984629|FG001|COMPLETED|Period 2||7
3250386|NCT02503085|3984630|FG002|COMPLETED|Period 2||7
3250387|NCT02503085|3984631|FG003|COMPLETED|Period 2||7
3250388|NCT02503085|3984628|FG000|NOT COMPLETED|Period 2||0
3250389|NCT02503085|3984629|FG001|NOT COMPLETED|Period 2||0
3250390|NCT02503085|3984630|FG002|NOT COMPLETED|Period 2||0
3250391|NCT02503085|3984631|FG003|NOT COMPLETED|Period 2||0
3250392|NCT02503085|3984628|FG000|STARTED|Period 2: Washout (3 to 7 Days)||7
3250393|NCT02503085|3984629|FG001|STARTED|Period 2: Washout (3 to 7 Days)||7
3250394|NCT02503085|3984630|FG002|STARTED|Period 2: Washout (3 to 7 Days)||7
3250395|NCT02503085|3984631|FG003|STARTED|Period 2: Washout (3 to 7 Days)||7
3250396|NCT02503085|3984628|FG000|COMPLETED|Period 2: Washout (3 to 7 Days)||6
3250397|NCT02503085|3984629|FG001|COMPLETED|Period 2: Washout (3 to 7 Days)||7
3250398|NCT02503085|3984630|FG002|COMPLETED|Period 2: Washout (3 to 7 Days)||6
3250399|NCT02503085|3984631|FG003|COMPLETED|Period 2: Washout (3 to 7 Days)||7
3250400|NCT02503085|3984628|FG000|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||1
3250401|NCT02503085|3984629|FG001|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||0
3250402|NCT02503085|3984630|FG002|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||1
3250403|NCT02503085|3984631|FG003|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||0
3250404|NCT02503085|3984628|FG000|STARTED|Period 3||6
3250405|NCT02503085|3984629|FG001|STARTED|Period 3||7
3250406|NCT02503085|3984630|FG002|STARTED|Period 3||6
3250407|NCT02503085|3984631|FG003|STARTED|Period 3||7
3250408|NCT02503085|3984628|FG000|COMPLETED|Period 3||6
3250409|NCT02503085|3984629|FG001|COMPLETED|Period 3||7
3250410|NCT02503085|3984630|FG002|COMPLETED|Period 3||6
3250411|NCT02503085|3984631|FG003|COMPLETED|Period 3||7
3250412|NCT02503085|3984628|FG000|NOT COMPLETED|Period 3||0
3250413|NCT02503085|3984629|FG001|NOT COMPLETED|Period 3||0
3250414|NCT02503085|3984630|FG002|NOT COMPLETED|Period 3||0
3250415|NCT02503085|3984631|FG003|NOT COMPLETED|Period 3||0
3250416|NCT02503085|3984628|FG000|STARTED|Period 3: Washout (3 to 7 Days)||6
3250417|NCT02503085|3984629|FG001|STARTED|Period 3: Washout (3 to 7 Days)||7
3250418|NCT02503085|3984630|FG002|STARTED|Period 3: Washout (3 to 7 Days)||6
3250419|NCT02503085|3984631|FG003|STARTED|Period 3: Washout (3 to 7 Days)||7
3250420|NCT02503085|3984628|FG000|COMPLETED|Period 3: Washout (3 to 7 Days)||6
3250421|NCT02503085|3984629|FG001|COMPLETED|Period 3: Washout (3 to 7 Days)||7
3250422|NCT02503085|3984630|FG002|COMPLETED|Period 3: Washout (3 to 7 Days)||6
3250423|NCT02503085|3984631|FG003|COMPLETED|Period 3: Washout (3 to 7 Days)||7
3250424|NCT02503085|3984628|FG000|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
3250425|NCT02503085|3984629|FG001|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
3250426|NCT02503085|3984630|FG002|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
3250427|NCT02503085|3984631|FG003|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
3250428|NCT02503085|3984628|FG000|STARTED|Period 4||6
3250429|NCT02503085|3984629|FG001|STARTED|Period 4||7
3250430|NCT02503085|3984630|FG002|STARTED|Period 4||6
3250431|NCT02503085|3984631|FG003|STARTED|Period 4||7
3250432|NCT02503085|3984628|FG000|COMPLETED|Period 4||6
3250433|NCT02503085|3984629|FG001|COMPLETED|Period 4||7
3250434|NCT02503085|3984630|FG002|COMPLETED|Period 4||6
3250435|NCT02503085|3984631|FG003|COMPLETED|Period 4||7
3250436|NCT02503085|3984628|FG000|NOT COMPLETED|Period 4||0
3250437|NCT02503085|3984629|FG001|NOT COMPLETED|Period 4||0
3250438|NCT02503085|3984630|FG002|NOT COMPLETED|Period 4||0
3250439|NCT02503085|3984631|FG003|NOT COMPLETED|Period 4||0
3250440|NCT02503202|3984643|FG000|STARTED|Base Study: Up to Month 6||266
3250441|NCT02503202|3984644|FG001|STARTED|Base Study: Up to Month 6||265
3250442|NCT02503202|3984645|FG002|STARTED|Base Study: Up to Month 6||267
3250443|NCT02503202|3984646|FG003|STARTED|Base Study: Up to Month 6||266
3250444|NCT02503202|3984647|FG004|STARTED|Base Study: Up to Month 6||133
3250445|NCT02503202|3984643|FG000|Vaccinated|Base Study: Up to Month 6||266
3250446|NCT02503202|3984644|FG001|Vaccinated|Base Study: Up to Month 6||265
3250447|NCT02503202|3984645|FG002|Vaccinated|Base Study: Up to Month 6||266
3250448|NCT02503202|3984646|FG003|Vaccinated|Base Study: Up to Month 6||264
3250449|NCT02503202|3984647|FG004|Vaccinated|Base Study: Up to Month 6||133
3250450|NCT02503202|3984643|FG000|COMPLETED|Base Study: Up to Month 6||248
3250451|NCT02503202|3984644|FG001|COMPLETED|Base Study: Up to Month 6||253
3250452|NCT02503202|3984645|FG002|COMPLETED|Base Study: Up to Month 6||252
3250453|NCT02503202|3984646|FG003|COMPLETED|Base Study: Up to Month 6||255
3250454|NCT02503202|3984647|FG004|COMPLETED|Base Study: Up to Month 6||130
3250455|NCT02503202|3984643|FG000|NOT COMPLETED|Base Study: Up to Month 6||18
3250456|NCT02503202|3984644|FG001|NOT COMPLETED|Base Study: Up to Month 6||12
3250457|NCT02503202|3984645|FG002|NOT COMPLETED|Base Study: Up to Month 6||15
3250458|NCT02503202|3984646|FG003|NOT COMPLETED|Base Study: Up to Month 6||11
3250459|NCT02503202|3984647|FG004|NOT COMPLETED|Base Study: Up to Month 6||3
3250460|NCT02503202|3984643|FG000|STARTED|Extension: Month 6 to 24||119
3250461|NCT02503202|3984644|FG001|STARTED|Extension: Month 6 to 24||130
3250462|NCT02503202|3984645|FG002|STARTED|Extension: Month 6 to 24||112
3250463|NCT02503202|3984646|FG003|STARTED|Extension: Month 6 to 24||137
3250464|NCT02503202|3984647|FG004|STARTED|Extension: Month 6 to 24||68
3250465|NCT02503202|3984643|FG000|COMPLETED|Extension: Month 6 to 24||108
3250466|NCT02503202|3984644|FG001|COMPLETED|Extension: Month 6 to 24||114
3250467|NCT02503202|3984645|FG002|COMPLETED|Extension: Month 6 to 24||103
3250468|NCT02503202|3984646|FG003|COMPLETED|Extension: Month 6 to 24||119
3250469|NCT02503202|3984647|FG004|COMPLETED|Extension: Month 6 to 24||67
3250470|NCT02503202|3984643|FG000|NOT COMPLETED|Extension: Month 6 to 24||11
3250471|NCT02503202|3984644|FG001|NOT COMPLETED|Extension: Month 6 to 24||16
3250472|NCT02503202|3984645|FG002|NOT COMPLETED|Extension: Month 6 to 24||9
3250473|NCT02503202|3984646|FG003|NOT COMPLETED|Extension: Month 6 to 24||18
3250474|NCT02503202|3984647|FG004|NOT COMPLETED|Extension: Month 6 to 24||1
3250475|NCT02503215|3984659|FG000|STARTED|Overall Study||17
3250476|NCT02503215|3984659|FG000|COMPLETED|Overall Study||14
3250477|NCT02503215|3984659|FG000|NOT COMPLETED|Overall Study||3
3250478|NCT02503254|3984665|FG000|STARTED|Overall Study||41
3250479|NCT02503254|3984666|FG001|STARTED|Overall Study||39
3250480|NCT02503254|3984665|FG000|COMPLETED|Overall Study||41
3250481|NCT02503254|3984666|FG001|COMPLETED|Overall Study||39
3250482|NCT02503254|3984665|FG000|NOT COMPLETED|Overall Study||0
3250483|NCT02503254|3984666|FG001|NOT COMPLETED|Overall Study||0
3250484|NCT02503332|3984676|FG000|STARTED|Overall Study||86
3250485|NCT02503332|3984677|FG001|STARTED|Overall Study||79
3250486|NCT02503332|3984678|FG002|STARTED|Overall Study||41
3250487|NCT02503332|3984679|FG003|STARTED|Overall Study||40
3250488|NCT02503332|3984676|FG000|COMPLETED|Overall Study||52
3250489|NCT02503332|3984677|FG001|COMPLETED|Overall Study||60
3250490|NCT02503332|3984678|FG002|COMPLETED|Overall Study||33
3250491|NCT02503332|3984679|FG003|COMPLETED|Overall Study||36
3250492|NCT02503332|3984676|FG000|NOT COMPLETED|Overall Study||34
3250493|NCT02503332|3984677|FG001|NOT COMPLETED|Overall Study||19
3250494|NCT02503332|3984678|FG002|NOT COMPLETED|Overall Study||8
3250495|NCT02503332|3984679|FG003|NOT COMPLETED|Overall Study||4
3250496|NCT02503410|3984695|FG000|STARTED|Overall Study||4
3250497|NCT02503410|3984696|FG001|STARTED|Overall Study||3
3250498|NCT02503410|3984695|FG000|COMPLETED|Overall Study||4
3250499|NCT02503410|3984696|FG001|COMPLETED|Overall Study||3
3250500|NCT02503410|3984695|FG000|NOT COMPLETED|Overall Study||0
3250501|NCT02503410|3984696|FG001|NOT COMPLETED|Overall Study||0
3250502|NCT02503501|3984709|FG000|STARTED|Overall Study||19
3250503|NCT02503501|3984710|FG001|STARTED|Overall Study||16
3250504|NCT02503501|3984709|FG000|COMPLETED|Overall Study||18
3250505|NCT02503501|3984710|FG001|COMPLETED|Overall Study||13
3250506|NCT02503501|3984709|FG000|NOT COMPLETED|Overall Study||1
3250507|NCT02503501|3984710|FG001|NOT COMPLETED|Overall Study||3
3250508|NCT02503540|3984716|FG000|STARTED|Overall Study||31
3250509|NCT02503540|3984716|FG000|COMPLETED|Overall Study||28
3250510|NCT02503540|3984716|FG000|NOT COMPLETED|Overall Study||3
3250511|NCT02503735|3984720|FG000|STARTED|Overall Study||10
3250512|NCT02503735|3984720|FG000|SVR 12 (12week Post Treatment RNA Neg)|Overall Study||8
3250513|NCT02503735|3984720|FG000|COMPLETED|Overall Study||10
3250514|NCT02503735|3984720|FG000|NOT COMPLETED|Overall Study||0
3250515|NCT02503787|3984730|FG000|STARTED|Enrollment||64
3250516|NCT02503787|3984730|FG000|COMPLETED|Enrollment||44
3250517|NCT02503787|3984730|FG000|NOT COMPLETED|Enrollment||20
3250518|NCT02503787|3984730|FG000|STARTED|Device Trial (HD Programming Trial)||44
3250519|NCT02503787|3984730|FG000|COMPLETED|Device Trial (HD Programming Trial)||37
3250520|NCT02503787|3984730|FG000|NOT COMPLETED|Device Trial (HD Programming Trial)||7
3250521|NCT02503787|3984730|FG000|STARTED|Successful Trial (≥50% Pain Relief)||37
3250522|NCT02503787|3984730|FG000|COMPLETED|Successful Trial (≥50% Pain Relief)||32
3250523|NCT02503787|3984730|FG000|NOT COMPLETED|Successful Trial (≥50% Pain Relief)||5
3250524|NCT02503787|3984730|FG000|STARTED|Implant to 3 Month Endpoint||32
3250525|NCT02503787|3984730|FG000|COMPLETED|Implant to 3 Month Endpoint||29
3250526|NCT02503787|3984730|FG000|NOT COMPLETED|Implant to 3 Month Endpoint||3
3250527|NCT02503852|3984738|FG000|STARTED|Overall Study||16
3250528|NCT02503852|3984739|FG001|STARTED|Overall Study||22
3250529|NCT02503852|3984740|FG002|STARTED|Overall Study||24
3250530|NCT02503852|3984741|FG003|STARTED|Overall Study||9
3250531|NCT02503852|3984738|FG000|COMPLETED|Overall Study||12
3250532|NCT02503852|3984739|FG001|COMPLETED|Overall Study||19
3250533|NCT02503852|3984740|FG002|COMPLETED|Overall Study||21
3250534|NCT02503852|3984741|FG003|COMPLETED|Overall Study||8
3250535|NCT02503852|3984738|FG000|NOT COMPLETED|Overall Study||4
3250536|NCT02503852|3984739|FG001|NOT COMPLETED|Overall Study||3
3250537|NCT02503852|3984740|FG002|NOT COMPLETED|Overall Study||3
3250538|NCT02503852|3984741|FG003|NOT COMPLETED|Overall Study||1
3250539|NCT02503865|3984754|FG000|STARTED|Overall Study||70
3250540|NCT02503865|3984755|FG001|STARTED|Overall Study||269
3250541|NCT02503865|3984756|FG002|STARTED|Overall Study||66
3250542|NCT02503865|3984754|FG000|COMPLETED|Overall Study||65
3250543|NCT02503865|3984755|FG001|COMPLETED|Overall Study||222
3250544|NCT02503865|3984756|FG002|COMPLETED|Overall Study||64
3250545|NCT02503865|3984754|FG000|NOT COMPLETED|Overall Study||5
3250546|NCT02503865|3984755|FG001|NOT COMPLETED|Overall Study||47
3250547|NCT02503865|3984756|FG002|NOT COMPLETED|Overall Study||2
3250548|NCT02503982|3984765|FG000|STARTED|Overall Study||13
3250549|NCT02503982|3984765|FG000|COMPLETED|Overall Study||13
3250550|NCT02503982|3984765|FG000|NOT COMPLETED|Overall Study||0
3250551|NCT02504073|3984769|FG000|STARTED|Overall Study||54
3250552|NCT02504073|3984769|FG000|COMPLETED|Overall Study||54
3250553|NCT02504073|3984769|FG000|NOT COMPLETED|Overall Study||0
3250554|NCT02504216|3984776|FG000|STARTED|Overall Study||3286
3250555|NCT02504216|3984777|FG001|STARTED|Overall Study||3278
3250556|NCT02504216|3984776|FG000|Received Treatment|Overall Study||3256
3250557|NCT02504216|3984777|FG001|Received Treatment|Overall Study||3248
3250558|NCT02504216|3984776|FG000|COMPLETED|Overall Study||3275
3250559|NCT02504216|3984777|FG001|COMPLETED|Overall Study||3263
3250560|NCT02504216|3984776|FG000|NOT COMPLETED|Overall Study||11
3250561|NCT02504216|3984777|FG001|NOT COMPLETED|Overall Study||15
3250562|NCT02504268|3984786|FG000|STARTED|Overall Study||451
3250563|NCT02504268|3984787|FG001|STARTED|Overall Study||301
3250564|NCT02504268|3984788|FG002|STARTED|Overall Study||242
3250565|NCT02504268|3984789|FG003|STARTED|Overall Study||0
3250566|NCT02504268|3984790|FG004|STARTED|Overall Study||0
3250567|NCT02504268|3984791|FG005|STARTED|Overall Study||0
3250568|NCT02504268|3984792|FG006|STARTED|Overall Study||0
3250569|NCT02504268|3984793|FG007|STARTED|Overall Study||0
3250570|NCT02504268|3984794|FG008|STARTED|Overall Study||0
3250571|NCT02504268|3984786|FG000|Induction to Open Label|Overall Study||289
3250572|NCT02504268|3984787|FG001|Induction to Open Label|Overall Study||196
3250573|NCT02504268|3984788|FG002|Induction to Open Label|Overall Study||147
3250574|NCT02504268|3984789|FG003|Induction to Open Label|Overall Study||0
3250575|NCT02504268|3984790|FG004|Induction to Open Label|Overall Study||0
3250576|NCT02504268|3984791|FG005|Induction to Open Label|Overall Study||0
3250577|NCT02504268|3984792|FG006|Induction to Open Label|Overall Study||0
3250578|NCT02504268|3984793|FG007|Induction to Open Label|Overall Study||0
3250579|NCT02504268|3984794|FG008|Induction to Open Label|Overall Study||0
3250580|NCT02504268|3984786|FG000|Early Escaped to Open Label|Overall Study||10
3250581|NCT02504268|3984787|FG001|Early Escaped to Open Label|Overall Study||21
3250582|NCT02504268|3984788|FG002|Early Escaped to Open Label|Overall Study||8
3250583|NCT02504268|3984789|FG003|Early Escaped to Open Label|Overall Study||0
3250584|NCT02504268|3984790|FG004|Early Escaped to Open Label|Overall Study||0
3250585|NCT02504268|3984791|FG005|Early Escaped to Open Label|Overall Study||0
3250586|NCT02504268|3984792|FG006|Early Escaped to Open Label|Overall Study||0
3250587|NCT02504268|3984793|FG007|Early Escaped to Open Label|Overall Study||0
3250588|NCT02504268|3984794|FG008|Early Escaped to Open Label|Overall Study||0
3250589|NCT02504268|3984786|FG000|Induction to De-Escalation|Overall Study||94
3250590|NCT02504268|3984787|FG001|Induction to De-Escalation|Overall Study||37
3250591|NCT02504268|3984788|FG002|Induction to De-Escalation|Overall Study||53
3250592|NCT02504268|3984789|FG003|Induction to De-Escalation|Overall Study||0
3250593|NCT02504268|3984790|FG004|Induction to De-Escalation|Overall Study||0
3250594|NCT02504268|3984791|FG005|Induction to De-Escalation|Overall Study||0
3250595|NCT02504268|3984792|FG006|Induction to De-Escalation|Overall Study||0
3250596|NCT02504268|3984793|FG007|Induction to De-Escalation|Overall Study||0
3250597|NCT02504268|3984794|FG008|Induction to De-Escalation|Overall Study||0
3250598|NCT02504268|3984786|FG000|Randomized in De-Escalation Period|Overall Study||0
3250599|NCT02504268|3984787|FG001|Randomized in De-Escalation Period|Overall Study||0
3250600|NCT02504268|3984788|FG002|Randomized in De-Escalation Period|Overall Study||0
3250601|NCT02504268|3984789|FG003|Randomized in De-Escalation Period|Overall Study||50
3250602|NCT02504268|3984790|FG004|Randomized in De-Escalation Period|Overall Study||50
3250603|NCT02504268|3984791|FG005|Randomized in De-Escalation Period|Overall Study||47
3371511|NCT03730103|4103160|FG000|NOT COMPLETED|Overall Study||0
3371512|NCT03730103|4103161|FG001|NOT COMPLETED|Overall Study||5
3371513|NCT03729960|4103167|FG000|STARTED|Overall Study||20
3371514|NCT03729960|4103167|FG000|COMPLETED|Overall Study||20
3371515|NCT03729960|4103167|FG000|NOT COMPLETED|Overall Study||0
3371516|NCT03729024|4103172|FG000|STARTED|Overall Study||21
3371517|NCT03729024|4103172|FG000|COMPLETED|Overall Study||21
3371518|NCT03729024|4103172|FG000|NOT COMPLETED|Overall Study||0
3371519|NCT03728790|4103178|FG000|STARTED|Overall Study||112
3371520|NCT03728790|4103179|FG001|STARTED|Overall Study||101
3371521|NCT03728790|4103178|FG000|COMPLETED|Overall Study||112
3371522|NCT03728790|4103179|FG001|COMPLETED|Overall Study||101
3371523|NCT03728790|4103178|FG000|NOT COMPLETED|Overall Study||0
3371524|NCT03728790|4103179|FG001|NOT COMPLETED|Overall Study||0
3250604|NCT02504268|3984792|FG006|Randomized in De-Escalation Period|Overall Study||37
3250605|NCT02504268|3984793|FG007|Randomized in De-Escalation Period|Overall Study||0
3250606|NCT02504268|3984794|FG008|Randomized in De-Escalation Period|Overall Study||0
3250607|NCT02504268|3984786|FG000|De-Escalation to Open Label Extension|Overall Study||0
3250608|NCT02504268|3984787|FG001|De-Escalation to Open Label Extension|Overall Study||0
3250609|NCT02504268|3984788|FG002|De-Escalation to Open Label Extension|Overall Study||0
3250610|NCT02504268|3984789|FG003|De-Escalation to Open Label Extension|Overall Study||36
3250611|NCT02504268|3984790|FG004|De-Escalation to Open Label Extension|Overall Study||30
3250612|NCT02504268|3984791|FG005|De-Escalation to Open Label Extension|Overall Study||32
3250613|NCT02504268|3984792|FG006|De-Escalation to Open Label Extension|Overall Study||22
3250614|NCT02504268|3984793|FG007|De-Escalation to Open Label Extension|Overall Study||0
3250615|NCT02504268|3984794|FG008|De-Escalation to Open Label Extension|Overall Study||0
3250616|NCT02504268|3984786|FG000|Early Escaped De-Escalation to Open Label Period|Overall Study||0
3250617|NCT02504268|3984787|FG001|Early Escaped De-Escalation to Open Label Period|Overall Study||0
3250618|NCT02504268|3984788|FG002|Early Escaped De-Escalation to Open Label Period|Overall Study||0
3250619|NCT02504268|3984789|FG003|Early Escaped De-Escalation to Open Label Period|Overall Study||2
3250620|NCT02504268|3984790|FG004|Early Escaped De-Escalation to Open Label Period|Overall Study||5
3250621|NCT02504268|3984791|FG005|Early Escaped De-Escalation to Open Label Period|Overall Study||4
3250622|NCT02504268|3984792|FG006|Early Escaped De-Escalation to Open Label Period|Overall Study||3
3250623|NCT02504268|3984793|FG007|Early Escaped De-Escalation to Open Label Period|Overall Study||0
3250624|NCT02504268|3984794|FG008|Early Escaped De-Escalation to Open Label Period|Overall Study||0
3250625|NCT02504268|3984786|FG000|Open Label and Open Label Extension Period|Overall Study||0
3250626|NCT02504268|3984787|FG001|Open Label and Open Label Extension Period|Overall Study||0
3250627|NCT02504268|3984788|FG002|Open Label and Open Label Extension Period|Overall Study||0
3250628|NCT02504268|3984789|FG003|Open Label and Open Label Extension Period|Overall Study||0
3250629|NCT02504268|3984790|FG004|Open Label and Open Label Extension Period|Overall Study||0
3250630|NCT02504268|3984791|FG005|Open Label and Open Label Extension Period|Overall Study||0
3250631|NCT02504268|3984792|FG006|Open Label and Open Label Extension Period|Overall Study||0
3250632|NCT02504268|3984793|FG007|Open Label and Open Label Extension Period|Overall Study||685
3250633|NCT02504268|3984794|FG008|Open Label and Open Label Extension Period|Overall Study||120
3250634|NCT02504268|3984786|FG000|COMPLETED|Overall Study||388
3250635|NCT02504268|3984787|FG001|COMPLETED|Overall Study||233
3250636|NCT02504268|3984788|FG002|COMPLETED|Overall Study||201
3250637|NCT02504268|3984789|FG003|COMPLETED|Overall Study||0
3250638|NCT02504268|3984790|FG004|COMPLETED|Overall Study||0
3250639|NCT02504268|3984791|FG005|COMPLETED|Overall Study||0
3250640|NCT02504268|3984792|FG006|COMPLETED|Overall Study||0
3250641|NCT02504268|3984793|FG007|COMPLETED|Overall Study||0
3250642|NCT02504268|3984794|FG008|COMPLETED|Overall Study||0
3250643|NCT02504268|3984786|FG000|NOT COMPLETED|Overall Study||63
3250644|NCT02504268|3984787|FG001|NOT COMPLETED|Overall Study||68
3250645|NCT02504268|3984788|FG002|NOT COMPLETED|Overall Study||41
3250646|NCT02504268|3984789|FG003|NOT COMPLETED|Overall Study||0
3250647|NCT02504268|3984790|FG004|NOT COMPLETED|Overall Study||0
3250648|NCT02504268|3984791|FG005|NOT COMPLETED|Overall Study||0
3250649|NCT02504268|3984792|FG006|NOT COMPLETED|Overall Study||0
3250650|NCT02504268|3984793|FG007|NOT COMPLETED|Overall Study||0
3250651|NCT02504268|3984794|FG008|NOT COMPLETED|Overall Study||0
3250652|NCT02504294|3984816|FG000|STARTED|Overall Study||212
3250653|NCT02504294|3984817|FG001|STARTED|Overall Study||206
3250654|NCT02504294|3984816|FG000|COMPLETED|Overall Study||156
3250655|NCT02504294|3984817|FG001|COMPLETED|Overall Study||158
3250656|NCT02504294|3984816|FG000|NOT COMPLETED|Overall Study||56
3250657|NCT02504294|3984817|FG001|NOT COMPLETED|Overall Study||48
3250658|NCT02504320|3984827|FG000|STARTED|Treatment Period 1||19
3250659|NCT02504320|3984828|FG001|STARTED|Treatment Period 1||19
3250660|NCT02504320|3984829|FG002|STARTED|Treatment Period 1||20
3250661|NCT02504320|3984830|FG003|STARTED|Treatment Period 1||20
3250662|NCT02504320|3984827|FG000|COMPLETED|Treatment Period 1||19
3250663|NCT02504320|3984828|FG001|COMPLETED|Treatment Period 1||19
3250664|NCT02504320|3984829|FG002|COMPLETED|Treatment Period 1||19
3250665|NCT02504320|3984830|FG003|COMPLETED|Treatment Period 1||20
3250666|NCT02504320|3984827|FG000|NOT COMPLETED|Treatment Period 1||0
3250667|NCT02504320|3984828|FG001|NOT COMPLETED|Treatment Period 1||0
3250668|NCT02504320|3984829|FG002|NOT COMPLETED|Treatment Period 1||1
3250669|NCT02504320|3984830|FG003|NOT COMPLETED|Treatment Period 1||0
3250670|NCT02504320|3984827|FG000|STARTED|Treatment Period 2||19
3250671|NCT02504320|3984828|FG001|STARTED|Treatment Period 2||19
3250672|NCT02504320|3984829|FG002|STARTED|Treatment Period 2||19
3250673|NCT02504320|3984830|FG003|STARTED|Treatment Period 2||20
3250674|NCT02504320|3984827|FG000|COMPLETED|Treatment Period 2||19
3250675|NCT02504320|3984828|FG001|COMPLETED|Treatment Period 2||18
3250676|NCT02504320|3984829|FG002|COMPLETED|Treatment Period 2||19
3250677|NCT02504320|3984830|FG003|COMPLETED|Treatment Period 2||20
3250678|NCT02504320|3984827|FG000|NOT COMPLETED|Treatment Period 2||0
3250679|NCT02504320|3984828|FG001|NOT COMPLETED|Treatment Period 2||1
3250680|NCT02504320|3984829|FG002|NOT COMPLETED|Treatment Period 2||0
3250681|NCT02504320|3984830|FG003|NOT COMPLETED|Treatment Period 2||0
3250682|NCT02504320|3984827|FG000|STARTED|Treatment Period 3||19
3250683|NCT02504320|3984828|FG001|STARTED|Treatment Period 3||18
3250684|NCT02504320|3984829|FG002|STARTED|Treatment Period 3||19
3250685|NCT02504320|3984830|FG003|STARTED|Treatment Period 3||20
3250686|NCT02504320|3984827|FG000|COMPLETED|Treatment Period 3||19
3250687|NCT02504320|3984828|FG001|COMPLETED|Treatment Period 3||18
3250688|NCT02504320|3984829|FG002|COMPLETED|Treatment Period 3||18
3250689|NCT02504320|3984830|FG003|COMPLETED|Treatment Period 3||19
3250690|NCT02504320|3984827|FG000|NOT COMPLETED|Treatment Period 3||0
3250691|NCT02504320|3984828|FG001|NOT COMPLETED|Treatment Period 3||0
3250692|NCT02504320|3984829|FG002|NOT COMPLETED|Treatment Period 3||1
3250693|NCT02504320|3984830|FG003|NOT COMPLETED|Treatment Period 3||1
3250694|NCT02504320|3984827|FG000|STARTED|Treatment Period 4||19
3250695|NCT02504320|3984828|FG001|STARTED|Treatment Period 4||18
3250696|NCT02504320|3984829|FG002|STARTED|Treatment Period 4||18
3250697|NCT02504320|3984830|FG003|STARTED|Treatment Period 4||19
3250698|NCT02504320|3984827|FG000|COMPLETED|Treatment Period 4||19
3250699|NCT02504320|3984828|FG001|COMPLETED|Treatment Period 4||18
3250700|NCT02504320|3984829|FG002|COMPLETED|Treatment Period 4||18
3250701|NCT02504320|3984830|FG003|COMPLETED|Treatment Period 4||19
3250702|NCT02504320|3984827|FG000|NOT COMPLETED|Treatment Period 4||0
3250703|NCT02504320|3984828|FG001|NOT COMPLETED|Treatment Period 4||0
3250704|NCT02504320|3984829|FG002|NOT COMPLETED|Treatment Period 4||0
3250705|NCT02504320|3984830|FG003|NOT COMPLETED|Treatment Period 4||0
3250706|NCT02504424|3984840|FG000|STARTED|Overall Study||50
3250707|NCT02504424|3984840|FG000|COMPLETED|Overall Study||48
3250708|NCT02504424|3984840|FG000|NOT COMPLETED|Overall Study||2
3371525|NCT03728348|4103185|FG000|STARTED|Overall Study||983
3371526|NCT03728348|4103185|FG000|Did Not Complete Study Procedures|Overall Study||107
3371527|NCT03728348|4103185|FG000|Multi-target DNA Test Excluded|Overall Study||15
3371528|NCT03728348|4103185|FG000|Colonoscopy Excluded|Overall Study||19
3371529|NCT03728348|4103185|FG000|COMPLETED|Overall Study||842
3371530|NCT03728348|4103185|FG000|NOT COMPLETED|Overall Study||141
3371531|NCT03728140|4103191|FG000|STARTED|Overall Study|embryo transfer with self-spent culture medium|160
3371532|NCT03728140|4103192|FG001|STARTED|Overall Study|embryo transfer with new culture medium|175
3371533|NCT03728140|4103191|FG000|COMPLETED|Overall Study||150
3371534|NCT03728140|4103192|FG001|COMPLETED|Overall Study||168
3371535|NCT03728140|4103191|FG000|NOT COMPLETED|Overall Study||10
3371536|NCT03728140|4103192|FG001|NOT COMPLETED|Overall Study||7
3371537|NCT03727854|4103200|FG000|STARTED|Overall Study||20
3371538|NCT03727854|4103201|FG001|STARTED|Overall Study||20
3371539|NCT03727854|4103200|FG000|COMPLETED|Overall Study||20
3371540|NCT03727854|4103201|FG001|COMPLETED|Overall Study||20
3371541|NCT03727854|4103200|FG000|NOT COMPLETED|Overall Study||0
3371542|NCT03727854|4103201|FG001|NOT COMPLETED|Overall Study||0
3371543|NCT03727425|4103207|FG000|STARTED|Overall Study||55
3371544|NCT03727425|4103207|FG000|COMPLETED|Overall Study||55
3371545|NCT03727425|4103207|FG000|NOT COMPLETED|Overall Study||0
3371546|NCT03727347|4103211|FG000|STARTED|Overall Study||50
3371547|NCT03727347|4103211|FG000|2-week Evaluation|Overall Study||50
3371548|NCT03727347|4103211|FG000|4-week Evaluation|Overall Study||50
3371549|NCT03727347|4103211|FG000|12-week Primary Endpoint Evaluation|Overall Study||50
3371550|NCT03727347|4103211|FG000|26-week Evaluation|Overall Study||48
3371551|NCT03727347|4103211|FG000|52-week Evaluation|Overall Study||47
3371552|NCT03727347|4103211|FG000|COMPLETED|Overall Study||47
3371553|NCT03727347|4103211|FG000|NOT COMPLETED|Overall Study||3
3371554|NCT03726996|4103224|FG000|STARTED|Overall Study||4
3371555|NCT03726996|4103224|FG000|COMPLETED|Overall Study||0
3371556|NCT03726996|4103224|FG000|NOT COMPLETED|Overall Study||4
3371557|NCT03726164|4103230|FG000|STARTED|Overall Study||310
3371558|NCT03726164|4103231|FG001|STARTED|Overall Study||316
3371559|NCT03726164|4103230|FG000|COMPLETED|Overall Study||99
3371560|NCT03726164|4103231|FG001|COMPLETED|Overall Study||119
3371561|NCT03726164|4103230|FG000|NOT COMPLETED|Overall Study||211
3371562|NCT03726164|4103231|FG001|NOT COMPLETED|Overall Study||197
3371563|NCT03725852|4103239|FG000|STARTED|Overall Study||45
3371564|NCT03725852|4103240|FG001|STARTED|Overall Study||23
3371565|NCT03725852|4103239|FG000|COMPLETED|Overall Study||41
3371566|NCT03725852|4103240|FG001|COMPLETED|Overall Study||23
3371567|NCT03725852|4103239|FG000|NOT COMPLETED|Overall Study||4
3371568|NCT03725852|4103240|FG001|NOT COMPLETED|Overall Study||0
3371569|NCT03725722|4103251|FG000|STARTED|Overall Study||49
3371570|NCT03725722|4103252|FG001|STARTED|Overall Study||50
3371571|NCT03725722|4103253|FG002|STARTED|Overall Study||50
3371572|NCT03725722|4103254|FG003|STARTED|Overall Study||52
3371573|NCT03725722|4103255|FG004|STARTED|Overall Study||50
3371574|NCT03725722|4103251|FG000|COMPLETED|Overall Study||38
3371575|NCT03725722|4103252|FG001|COMPLETED|Overall Study||44
3371576|NCT03725722|4103253|FG002|COMPLETED|Overall Study||44
3371577|NCT03725722|4103254|FG003|COMPLETED|Overall Study||46
3371578|NCT03725722|4103255|FG004|COMPLETED|Overall Study||36
3371579|NCT03725722|4103251|FG000|NOT COMPLETED|Overall Study||11
3371580|NCT03725722|4103252|FG001|NOT COMPLETED|Overall Study||6
3371581|NCT03725722|4103253|FG002|NOT COMPLETED|Overall Study||6
3371582|NCT03725722|4103254|FG003|NOT COMPLETED|Overall Study||6
3371583|NCT03725722|4103255|FG004|NOT COMPLETED|Overall Study||14
3371584|NCT03725098|4103269|FG000|STARTED|Overall Study||53
3371585|NCT03725098|4103270|FG001|STARTED|Overall Study||52
3371586|NCT03725098|4103269|FG000|COMPLETED|Overall Study||53
3371587|NCT03725098|4103270|FG001|COMPLETED|Overall Study||52
3371588|NCT03725098|4103269|FG000|NOT COMPLETED|Overall Study||0
3371589|NCT03725098|4103270|FG001|NOT COMPLETED|Overall Study||0
3371590|NCT03725085|4103276|FG000|STARTED|Overall Study||552
3250709|NCT02504502|3984847|FG000|STARTED|Routine Care vs. Enhanced Report||24
3250710|NCT02504502|3984848|FG001|STARTED|Routine Care vs. Enhanced Report||28
3250711|NCT02504502|3984847|FG000|COMPLETED|Routine Care vs. Enhanced Report||20
3250712|NCT02504502|3984848|FG001|COMPLETED|Routine Care vs. Enhanced Report||21
3250713|NCT02504502|3984847|FG000|NOT COMPLETED|Routine Care vs. Enhanced Report||4
3250714|NCT02504502|3984848|FG001|NOT COMPLETED|Routine Care vs. Enhanced Report||7
3250715|NCT02504502|3984847|FG000|STARTED|Crossover to Enhanced Report||20
3250716|NCT02504502|3984848|FG001|STARTED|Crossover to Enhanced Report|The enhanced report arm was completed in first period and does not carry forward to period 2.|0
3250717|NCT02504502|3984847|FG000|COMPLETED|Crossover to Enhanced Report||15
3250718|NCT02504502|3984848|FG001|COMPLETED|Crossover to Enhanced Report|the enhanced report arm was completed in first period and does not carry forward to period 2|0
3250719|NCT02504502|3984847|FG000|NOT COMPLETED|Crossover to Enhanced Report||5
3250720|NCT02504502|3984848|FG001|NOT COMPLETED|Crossover to Enhanced Report||0
3250721|NCT02504541|3984854|FG000|STARTED|Overall Study||133
3250722|NCT02504541|3984854|FG000|COMPLETED|Overall Study||113
3250723|NCT02504541|3984854|FG000|NOT COMPLETED|Overall Study||20
3250724|NCT02504554|3984860|FG000|STARTED|Overall Study|1 participant was switched from the oral group to the rectal group due to nausea/vomiting.|12
3250725|NCT02504554|3984861|FG001|STARTED|Overall Study||6
3250726|NCT02504554|3984860|FG000|COMPLETED|Overall Study||12
3250727|NCT02504554|3984861|FG001|COMPLETED|Overall Study||6
3250728|NCT02504554|3984860|FG000|NOT COMPLETED|Overall Study||0
3250729|NCT02504554|3984861|FG001|NOT COMPLETED|Overall Study||0
3250730|NCT02504619|3984867|FG000|STARTED|Overall Study||1
3250731|NCT02504619|3984867|FG000|COMPLETED|Overall Study||1
3250732|NCT02504619|3984867|FG000|NOT COMPLETED|Overall Study||0
3250733|NCT02504645|3984874|FG000|STARTED|Overall Study||101
3250734|NCT02504645|3984875|FG001|STARTED|Overall Study||101
3250735|NCT02504645|3984874|FG000|COMPLETED|Overall Study||77
3250736|NCT02504645|3984875|FG001|COMPLETED|Overall Study||76
3250737|NCT02504645|3984874|FG000|NOT COMPLETED|Overall Study||24
3250738|NCT02504645|3984875|FG001|NOT COMPLETED|Overall Study||25
3250739|NCT02504671|3984887|FG000|STARTED|Overall Study||37
3250740|NCT02504671|3984888|FG001|STARTED|Overall Study||37
3250741|NCT02504671|3984889|FG002|STARTED|Overall Study||37
3250742|NCT02504671|3984890|FG003|STARTED|Overall Study||37
3250743|NCT02504671|3984891|FG004|STARTED|Overall Study||37
3250744|NCT02504671|3984892|FG005|STARTED|Overall Study||37
3250745|NCT02504671|3984887|FG000|COMPLETED|Overall Study||25
3250746|NCT02504671|3984888|FG001|COMPLETED|Overall Study||23
3250747|NCT02504671|3984889|FG002|COMPLETED|Overall Study||27
3250748|NCT02504671|3984890|FG003|COMPLETED|Overall Study||27
3250749|NCT02504671|3984891|FG004|COMPLETED|Overall Study||25
3250750|NCT02504671|3984892|FG005|COMPLETED|Overall Study||23
3250751|NCT02504671|3984887|FG000|NOT COMPLETED|Overall Study||12
3250752|NCT02504671|3984888|FG001|NOT COMPLETED|Overall Study||14
3250753|NCT02504671|3984889|FG002|NOT COMPLETED|Overall Study||10
3250754|NCT02504671|3984890|FG003|NOT COMPLETED|Overall Study||10
3250755|NCT02504671|3984891|FG004|NOT COMPLETED|Overall Study||12
3250756|NCT02504671|3984892|FG005|NOT COMPLETED|Overall Study||14
3250757|NCT02504723|3984908|FG000|STARTED|Overall Study||60
3250758|NCT02504723|3984909|FG001|STARTED|Overall Study||61
3250759|NCT02504723|3984908|FG000|COMPLETED|Overall Study||60
3250760|NCT02504723|3984909|FG001|COMPLETED|Overall Study||61
3250761|NCT02504723|3984908|FG000|NOT COMPLETED|Overall Study||0
3250762|NCT02504723|3984909|FG001|NOT COMPLETED|Overall Study||0
3250763|NCT02504775|3984915|FG000|STARTED|Period 1||14
3250764|NCT02504775|3984916|FG001|STARTED|Period 1||14
3250765|NCT02504775|3984915|FG000|COMPLETED|Period 1||14
3250766|NCT02504775|3984916|FG001|COMPLETED|Period 1||14
3250767|NCT02504775|3984915|FG000|NOT COMPLETED|Period 1||0
3250768|NCT02504775|3984916|FG001|NOT COMPLETED|Period 1||0
3250769|NCT02504775|3984915|FG000|STARTED|Washout||14
3250770|NCT02504775|3984916|FG001|STARTED|Washout||14
3250771|NCT02504775|3984915|FG000|COMPLETED|Washout||14
3250772|NCT02504775|3984916|FG001|COMPLETED|Washout||14
3250773|NCT02504775|3984915|FG000|NOT COMPLETED|Washout||0
3250774|NCT02504775|3984916|FG001|NOT COMPLETED|Washout||0
3250775|NCT02504775|3984915|FG000|STARTED|Period 2||14
3250776|NCT02504775|3984916|FG001|STARTED|Period 2||14
3250777|NCT02504775|3984915|FG000|COMPLETED|Period 2||14
3250778|NCT02504775|3984916|FG001|COMPLETED|Period 2||14
3250779|NCT02504775|3984915|FG000|NOT COMPLETED|Period 2||0
3250780|NCT02504775|3984916|FG001|NOT COMPLETED|Period 2||0
3250781|NCT02504827|3984924|FG000|STARTED|Overall Study||12
3250782|NCT02504827|3984924|FG000|COMPLETED|Overall Study||11
3250783|NCT02504827|3984924|FG000|NOT COMPLETED|Overall Study||1
3250784|NCT02504892|3984928|FG000|STARTED|Overall Study||3
3250785|NCT02504892|3984928|FG000|COMPLETED|Overall Study||1
3250786|NCT02504892|3984928|FG000|NOT COMPLETED|Overall Study||2
3250787|NCT02504931|3984934|FG000|STARTED|Overall Study||26
3250788|NCT02504931|3984935|FG001|STARTED|Overall Study||23
3250789|NCT02504931|3984934|FG000|COMPLETED|Overall Study||14
3250790|NCT02504931|3984935|FG001|COMPLETED|Overall Study||13
3250791|NCT02504931|3984934|FG000|NOT COMPLETED|Overall Study||12
3250792|NCT02504931|3984935|FG001|NOT COMPLETED|Overall Study||10
3250793|NCT02505217|3984943|FG000|STARTED|Overall Study||105
3250794|NCT02505217|3984944|FG001|STARTED|Overall Study||95
3250795|NCT02505217|3984943|FG000|COMPLETED|Overall Study||104
3250796|NCT02505217|3984944|FG001|COMPLETED|Overall Study||93
3250797|NCT02505217|3984943|FG000|NOT COMPLETED|Overall Study||1
3250798|NCT02505217|3984944|FG001|NOT COMPLETED|Overall Study||2
3250799|NCT02505269|3984950|FG000|STARTED|Overall Study||34
3250800|NCT02505269|3984950|FG000|COMPLETED|Overall Study||34
3250801|NCT02505269|3984950|FG000|NOT COMPLETED|Overall Study||0
3250802|NCT02505334|3984956|FG000|STARTED|Main Treatment Period||233
3250803|NCT02505334|3984957|FG001|STARTED|Main Treatment Period||233
3250804|NCT02505334|3984956|FG000|COMPLETED|Main Treatment Period||218
3250805|NCT02505334|3984957|FG001|COMPLETED|Main Treatment Period||194
3250806|NCT02505334|3984956|FG000|NOT COMPLETED|Main Treatment Period||15
3250807|NCT02505334|3984957|FG001|NOT COMPLETED|Main Treatment Period||39
3250808|NCT02505334|3984956|FG000|STARTED|Extension Treatment Period|6 subjects withdrew from the trial after the main period and prior to entering the extension period|212
3250809|NCT02505334|3984957|FG001|STARTED|Extension Treatment Period|This treatment arm is not considered for this period as the subjects were treated for 26 weeks|0
3250810|NCT02505334|3984956|FG000|COMPLETED|Extension Treatment Period||194
3250811|NCT02505334|3984957|FG001|COMPLETED|Extension Treatment Period||0
3250812|NCT02505334|3984956|FG000|NOT COMPLETED|Extension Treatment Period||18
3250813|NCT02505334|3984957|FG001|NOT COMPLETED|Extension Treatment Period||0
3250814|NCT02505542|3984963|FG000|STARTED|Part A: Open-Label Period||736
3250815|NCT02505542|3984964|FG001|STARTED|Part A: Open-Label Period||0
3250816|NCT02505542|3984965|FG002|STARTED|Part A: Open-Label Period||0
3250817|NCT02505542|3984966|FG003|STARTED|Part A: Open-Label Period||0
3250818|NCT02505542|3984963|FG000|COMPLETED|Part A: Open-Label Period||659
3250819|NCT02505542|3984964|FG001|COMPLETED|Part A: Open-Label Period||0
3250820|NCT02505542|3984965|FG002|COMPLETED|Part A: Open-Label Period||0
3250821|NCT02505542|3984966|FG003|COMPLETED|Part A: Open-Label Period||0
3250822|NCT02505542|3984963|FG000|NOT COMPLETED|Part A: Open-Label Period||77
3250823|NCT02505542|3984964|FG001|NOT COMPLETED|Part A: Open-Label Period||0
3250824|NCT02505542|3984965|FG002|NOT COMPLETED|Part A: Open-Label Period||0
3250825|NCT02505542|3984966|FG003|NOT COMPLETED|Part A: Open-Label Period||0
3250826|NCT02505542|3984963|FG000|STARTED|Completed Part A, Did Not Enter Part B||659
3250827|NCT02505542|3984964|FG001|STARTED|Completed Part A, Did Not Enter Part B||0
3250828|NCT02505542|3984965|FG002|STARTED|Completed Part A, Did Not Enter Part B||0
3250829|NCT02505542|3984966|FG003|STARTED|Completed Part A, Did Not Enter Part B||0
3250830|NCT02505542|3984963|FG000|COMPLETED|Completed Part A, Did Not Enter Part B||313
3250831|NCT02505542|3984964|FG001|COMPLETED|Completed Part A, Did Not Enter Part B||0
3250832|NCT02505542|3984965|FG002|COMPLETED|Completed Part A, Did Not Enter Part B||0
3250833|NCT02505542|3984966|FG003|COMPLETED|Completed Part A, Did Not Enter Part B||0
3250834|NCT02505542|3984963|FG000|NOT COMPLETED|Completed Part A, Did Not Enter Part B||346
3250835|NCT02505542|3984964|FG001|NOT COMPLETED|Completed Part A, Did Not Enter Part B||0
3250836|NCT02505542|3984965|FG002|NOT COMPLETED|Completed Part A, Did Not Enter Part B||0
3250837|NCT02505542|3984966|FG003|NOT COMPLETED|Completed Part A, Did Not Enter Part B||0
3250838|NCT02505542|3984963|FG000|STARTED|Part B: Double-Blind Period||0
3250839|NCT02505542|3984964|FG001|STARTED|Part B: Double-Blind Period||104
3250840|NCT02505542|3984965|FG002|STARTED|Part B: Double-Blind Period||104
3250841|NCT02505542|3984966|FG003|STARTED|Part B: Double-Blind Period||105
3250842|NCT02505542|3984963|FG000|Started Escape Period|Part B: Double-Blind Period||0
3250843|NCT02505542|3984964|FG001|Started Escape Period|Part B: Double-Blind Period||73
3250844|NCT02505542|3984965|FG002|Started Escape Period|Part B: Double-Blind Period||7
3250845|NCT02505542|3984966|FG003|Started Escape Period|Part B: Double-Blind Period||15
3250846|NCT02505542|3984963|FG000|COMPLETED|Part B: Double-Blind Period||0
3250847|NCT02505542|3984964|FG001|COMPLETED|Part B: Double-Blind Period||92
3250848|NCT02505542|3984965|FG002|COMPLETED|Part B: Double-Blind Period||95
3250849|NCT02505542|3984966|FG003|COMPLETED|Part B: Double-Blind Period||98
3250850|NCT02505542|3984963|FG000|NOT COMPLETED|Part B: Double-Blind Period||0
3250851|NCT02505542|3984964|FG001|NOT COMPLETED|Part B: Double-Blind Period||12
3250852|NCT02505542|3984965|FG002|NOT COMPLETED|Part B: Double-Blind Period||9
3250853|NCT02505542|3984966|FG003|NOT COMPLETED|Part B: Double-Blind Period||7
3250854|NCT02505867|3984994|FG000|STARTED|Overall Study||6
3250855|NCT02505867|3984995|FG001|STARTED|Overall Study||6
3250856|NCT02505867|3984994|FG000|COMPLETED|Overall Study||0
3250857|NCT02505867|3984995|FG001|COMPLETED|Overall Study||0
3250858|NCT02505867|3984994|FG000|NOT COMPLETED|Overall Study||6
3250859|NCT02505867|3984995|FG001|NOT COMPLETED|Overall Study||6
3250860|NCT02505919|3985003|FG000|STARTED|Treatment||117
3250861|NCT02505919|3985004|FG001|STARTED|Treatment||67
3250862|NCT02505919|3985003|FG000|COMPLETED|Treatment||116
3250863|NCT02505919|3985004|FG001|COMPLETED|Treatment||65
3250864|NCT02505919|3985003|FG000|NOT COMPLETED|Treatment||1
3250865|NCT02505919|3985004|FG001|NOT COMPLETED|Treatment||2
3250866|NCT02505919|3985003|FG000|STARTED|1 Week Follow-Up||116
3250867|NCT02505919|3985004|FG001|STARTED|1 Week Follow-Up||65
3250868|NCT02505919|3985003|FG000|COMPLETED|1 Week Follow-Up||116
3250869|NCT02505919|3985004|FG001|COMPLETED|1 Week Follow-Up||65
3250870|NCT02505919|3985003|FG000|NOT COMPLETED|1 Week Follow-Up||0
3250871|NCT02505919|3985004|FG001|NOT COMPLETED|1 Week Follow-Up||0
3250872|NCT02505919|3985003|FG000|STARTED|1 Month Follow-Up||116
3250873|NCT02505919|3985004|FG001|STARTED|1 Month Follow-Up||65
3250874|NCT02505919|3985003|FG000|COMPLETED|1 Month Follow-Up||116
3250875|NCT02505919|3985004|FG001|COMPLETED|1 Month Follow-Up||65
3250876|NCT02505919|3985003|FG000|NOT COMPLETED|1 Month Follow-Up||0
3250877|NCT02505919|3985004|FG001|NOT COMPLETED|1 Month Follow-Up||0
3250878|NCT02505919|3985003|FG000|STARTED|3 Months Follow-Up||116
3250879|NCT02505919|3985004|FG001|STARTED|3 Months Follow-Up||65
3250880|NCT02505919|3985003|FG000|COMPLETED|3 Months Follow-Up||116
3250881|NCT02505919|3985004|FG001|COMPLETED|3 Months Follow-Up||65
3250882|NCT02505919|3985003|FG000|NOT COMPLETED|3 Months Follow-Up||0
3250883|NCT02505919|3985004|FG001|NOT COMPLETED|3 Months Follow-Up||0
3250884|NCT02505919|3985003|FG000|STARTED|6 Months Follow-Up||116
3250885|NCT02505919|3985004|FG001|STARTED|6 Months Follow-Up||65
3250886|NCT02505919|3985003|FG000|COMPLETED|6 Months Follow-Up||116
3250887|NCT02505919|3985004|FG001|COMPLETED|6 Months Follow-Up||63
3250888|NCT02505919|3985003|FG000|NOT COMPLETED|6 Months Follow-Up||0
3250889|NCT02505919|3985004|FG001|NOT COMPLETED|6 Months Follow-Up||2
3250890|NCT02505919|3985003|FG000|STARTED|12 Months Follow-Up||116
3250891|NCT02505919|3985004|FG001|STARTED|12 Months Follow-Up||63
3250892|NCT02505919|3985003|FG000|COMPLETED|12 Months Follow-Up||115
3250893|NCT02505919|3985004|FG001|COMPLETED|12 Months Follow-Up||61
3250894|NCT02505919|3985003|FG000|NOT COMPLETED|12 Months Follow-Up||1
3250895|NCT02505919|3985004|FG001|NOT COMPLETED|12 Months Follow-Up||2
3250896|NCT02505919|3985003|FG000|STARTED|24 Months Follow-Up||115
3250897|NCT02505919|3985004|FG001|STARTED|24 Months Follow-Up||61
3250898|NCT02505919|3985003|FG000|COMPLETED|24 Months Follow-Up||112
3250899|NCT02505919|3985004|FG001|COMPLETED|24 Months Follow-Up||60
3250900|NCT02505919|3985003|FG000|NOT COMPLETED|24 Months Follow-Up||3
3250901|NCT02505919|3985004|FG001|NOT COMPLETED|24 Months Follow-Up||1
3250902|NCT02505919|3985003|FG000|STARTED|36 Months Follow-Up||112
3250903|NCT02505919|3985004|FG001|STARTED|36 Months Follow-Up||60
3250904|NCT02505919|3985003|FG000|COMPLETED|36 Months Follow-Up||97
3250905|NCT02505919|3985004|FG001|COMPLETED|36 Months Follow-Up||55
3250906|NCT02505919|3985003|FG000|NOT COMPLETED|36 Months Follow-Up||15
3250907|NCT02505919|3985004|FG001|NOT COMPLETED|36 Months Follow-Up||5
3250908|NCT02505945|3985012|FG000|STARTED|Overall Study||102
3250909|NCT02505945|3985013|FG001|STARTED|Overall Study||50
3250910|NCT02505945|3985012|FG000|COMPLETED|Overall Study||80
3250911|NCT02505945|3985013|FG001|COMPLETED|Overall Study||46
3250912|NCT02505945|3985012|FG000|NOT COMPLETED|Overall Study||22
3250913|NCT02505945|3985013|FG001|NOT COMPLETED|Overall Study||4
3250914|NCT02506036|3985021|FG000|STARTED|First Intervention (4-6 Weeks)||3
3250915|NCT02506036|3985022|FG001|STARTED|First Intervention (4-6 Weeks)||3
3250916|NCT02506036|3985021|FG000|COMPLETED|First Intervention (4-6 Weeks)||2
3250917|NCT02506036|3985022|FG001|COMPLETED|First Intervention (4-6 Weeks)||1
3250918|NCT02506036|3985021|FG000|NOT COMPLETED|First Intervention (4-6 Weeks)||1
3250919|NCT02506036|3985022|FG001|NOT COMPLETED|First Intervention (4-6 Weeks)||2
3250920|NCT02506036|3985021|FG000|STARTED|Washout (1-2 Weeks)||2
3250921|NCT02506036|3985022|FG001|STARTED|Washout (1-2 Weeks)||1
3250922|NCT02506036|3985021|FG000|COMPLETED|Washout (1-2 Weeks)||2
3250923|NCT02506036|3985022|FG001|COMPLETED|Washout (1-2 Weeks)||1
3250924|NCT02506036|3985021|FG000|NOT COMPLETED|Washout (1-2 Weeks)||0
3250925|NCT02506036|3985022|FG001|NOT COMPLETED|Washout (1-2 Weeks)||0
3250926|NCT02506036|3985021|FG000|STARTED|Second Intervention (4-6 Weeks)||2
3250927|NCT02506036|3985022|FG001|STARTED|Second Intervention (4-6 Weeks)||1
3250928|NCT02506036|3985021|FG000|COMPLETED|Second Intervention (4-6 Weeks)||2
3250929|NCT02506036|3985022|FG001|COMPLETED|Second Intervention (4-6 Weeks)||1
3250930|NCT02506036|3985021|FG000|NOT COMPLETED|Second Intervention (4-6 Weeks)||0
3250931|NCT02506036|3985022|FG001|NOT COMPLETED|Second Intervention (4-6 Weeks)||0
3250932|NCT02506114|3985031|FG000|STARTED|Overall Study||5
3250933|NCT02506114|3985032|FG001|STARTED|Overall Study||4
3250934|NCT02506114|3985033|FG002|STARTED|Overall Study||6
3250935|NCT02506114|3985031|FG000|COMPLETED|Overall Study||5
3250936|NCT02506114|3985032|FG001|COMPLETED|Overall Study||4
3250937|NCT02506114|3985033|FG002|COMPLETED|Overall Study||6
3250938|NCT02506114|3985031|FG000|NOT COMPLETED|Overall Study||0
3250939|NCT02506114|3985032|FG001|NOT COMPLETED|Overall Study||0
3250940|NCT02506114|3985033|FG002|NOT COMPLETED|Overall Study||0
3250941|NCT02506257|3985045|FG000|STARTED|Overall Study||26
3250942|NCT02506257|3985046|FG001|STARTED|Overall Study||28
3250943|NCT02506257|3985047|FG002|STARTED|Overall Study||27
3250944|NCT02506257|3985048|FG003|STARTED|Overall Study||9
3250945|NCT02506257|3985045|FG000|COMPLETED|Overall Study||26
3250946|NCT02506257|3985046|FG001|COMPLETED|Overall Study||26
3250947|NCT02506257|3985047|FG002|COMPLETED|Overall Study||23
3250948|NCT02506257|3985048|FG003|COMPLETED|Overall Study||9
3250949|NCT02506257|3985045|FG000|NOT COMPLETED|Overall Study||0
3250950|NCT02506257|3985046|FG001|NOT COMPLETED|Overall Study||2
3250951|NCT02506257|3985047|FG002|NOT COMPLETED|Overall Study||4
3250952|NCT02506257|3985048|FG003|NOT COMPLETED|Overall Study||0
3250953|NCT02506309|3985060|FG000|STARTED|Overall Study||84
3250954|NCT02506309|3985061|FG001|STARTED|Overall Study||84
3250955|NCT02506309|3985060|FG000|COMPLETED|Overall Study||66
3250956|NCT02506309|3985061|FG001|COMPLETED|Overall Study||64
3250957|NCT02506309|3985060|FG000|NOT COMPLETED|Overall Study||18
3250958|NCT02506309|3985061|FG001|NOT COMPLETED|Overall Study||20
3250959|NCT02506634|3985075|FG000|STARTED|Overall Study||374
3250960|NCT02506634|3985075|FG000|Participants Who Were Diagnosed as GERD|Overall Study||154
3250961|NCT02506634|3985075|FG000|Participants Who Received PPI Treatment|Overall Study||357
3250962|NCT02506634|3985075|FG000|Participants Who Finished GERDQ|Overall Study||342
3250963|NCT02506634|3985075|FG000|COMPLETED|Overall Study||357
3250964|NCT02506634|3985075|FG000|NOT COMPLETED|Overall Study||17
3250965|NCT02506660|3985115|FG000|STARTED|Overall Study||64
3250966|NCT02506660|3985116|FG001|STARTED|Overall Study||64
3250967|NCT02506660|3985115|FG000|COMPLETED|Overall Study||62
3250968|NCT02506660|3985116|FG001|COMPLETED|Overall Study||63
3250969|NCT02506660|3985115|FG000|NOT COMPLETED|Overall Study||2
3250970|NCT02506660|3985116|FG001|NOT COMPLETED|Overall Study||1
3250971|NCT02506673|3985124|FG000|STARTED|Overall Study||13
3250972|NCT02506673|3985125|FG001|STARTED|Overall Study||13
3250973|NCT02506673|3985124|FG000|COMPLETED|Overall Study||13
3250974|NCT02506673|3985125|FG001|COMPLETED|Overall Study||13
3250975|NCT02506673|3985124|FG000|NOT COMPLETED|Overall Study||0
3250976|NCT02506673|3985125|FG001|NOT COMPLETED|Overall Study||0
3250977|NCT02506816|3985131|FG000|STARTED|Overall Study||36
3250978|NCT02506816|3985131|FG000|Samples Availability|Overall Study|31 of 36 patients had valid samples for analysis of biomarkers (primary and secondary analysis)|31
3250979|NCT02506816|3985131|FG000|COMPLETED|Overall Study||33
3250980|NCT02506816|3985131|FG000|NOT COMPLETED|Overall Study||3
3250981|NCT02506868|3985137|FG000|STARTED|Main Period of Study (24 Weeks)||98
3250982|NCT02506868|3985138|FG001|STARTED|Main Period of Study (24 Weeks)||98
3250983|NCT02506868|3985137|FG000|mITT Population|Main Period of Study (24 Weeks)||98
3250984|NCT02506868|3985138|FG001|mITT Population|Main Period of Study (24 Weeks)|One patient from Aranesp group was excluded prior to the first administration|97
3250985|NCT02506868|3985137|FG000|Per Protocol Population|Main Period of Study (24 Weeks)||86
3250986|NCT02506868|3985138|FG001|Per Protocol Population|Main Period of Study (24 Weeks)||90
3250987|NCT02506868|3985137|FG000|COMPLETED|Main Period of Study (24 Weeks)||86
3250988|NCT02506868|3985138|FG001|COMPLETED|Main Period of Study (24 Weeks)||90
3250989|NCT02506868|3985137|FG000|NOT COMPLETED|Main Period of Study (24 Weeks)||12
3250990|NCT02506868|3985138|FG001|NOT COMPLETED|Main Period of Study (24 Weeks)||8
3250991|NCT02506868|3985137|FG000|STARTED|Additional Period of Study (Until 52W)||86
3250992|NCT02506868|3985138|FG001|STARTED|Additional Period of Study (Until 52W)||90
3250993|NCT02506868|3985137|FG000|COMPLETED|Additional Period of Study (Until 52W)||83
3250994|NCT02506868|3985138|FG001|COMPLETED|Additional Period of Study (Until 52W)||85
3250995|NCT02506868|3985137|FG000|NOT COMPLETED|Additional Period of Study (Until 52W)||3
3250996|NCT02506868|3985138|FG001|NOT COMPLETED|Additional Period of Study (Until 52W)||5
3250997|NCT02506881|3985152|FG000|STARTED|First Intervention (Day 1)||13
3250998|NCT02506881|3985153|FG001|STARTED|First Intervention (Day 1)||12
3250999|NCT02506881|3985154|FG002|STARTED|First Intervention (Day 1)||25
3251000|NCT02506881|3985155|FG003|STARTED|First Intervention (Day 1)||24
3251001|NCT02506881|3985152|FG000|COMPLETED|First Intervention (Day 1)||12
3251002|NCT02506881|3985153|FG001|COMPLETED|First Intervention (Day 1)||12
3251003|NCT02506881|3985154|FG002|COMPLETED|First Intervention (Day 1)||12
3251004|NCT02506881|3985155|FG003|COMPLETED|First Intervention (Day 1)||12
3251005|NCT02506881|3985152|FG000|NOT COMPLETED|First Intervention (Day 1)||1
3251006|NCT02506881|3985153|FG001|NOT COMPLETED|First Intervention (Day 1)||0
3251007|NCT02506881|3985154|FG002|NOT COMPLETED|First Intervention (Day 1)||13
3251008|NCT02506881|3985155|FG003|NOT COMPLETED|First Intervention (Day 1)||12
3251009|NCT02506881|3985152|FG000|STARTED|Washout (at Least 25 Days)||12
3251010|NCT02506881|3985153|FG001|STARTED|Washout (at Least 25 Days)||12
3251011|NCT02506881|3985154|FG002|STARTED|Washout (at Least 25 Days)||12
3251012|NCT02506881|3985155|FG003|STARTED|Washout (at Least 25 Days)||12
3251013|NCT02506881|3985152|FG000|COMPLETED|Washout (at Least 25 Days)||12
3251014|NCT02506881|3985153|FG001|COMPLETED|Washout (at Least 25 Days)||12
3251015|NCT02506881|3985154|FG002|COMPLETED|Washout (at Least 25 Days)||12
3251016|NCT02506881|3985155|FG003|COMPLETED|Washout (at Least 25 Days)||12
3251017|NCT02506881|3985152|FG000|NOT COMPLETED|Washout (at Least 25 Days)||0
3251018|NCT02506881|3985153|FG001|NOT COMPLETED|Washout (at Least 25 Days)||0
3251019|NCT02506881|3985154|FG002|NOT COMPLETED|Washout (at Least 25 Days)||0
3251020|NCT02506881|3985155|FG003|NOT COMPLETED|Washout (at Least 25 Days)||0
3251021|NCT02506881|3985152|FG000|STARTED|Second Intervention (Day 1)||12
3251022|NCT02506881|3985153|FG001|STARTED|Second Intervention (Day 1)||12
3251023|NCT02506881|3985154|FG002|STARTED|Second Intervention (Day 1)||12
3251024|NCT02506881|3985155|FG003|STARTED|Second Intervention (Day 1)||12
3251025|NCT02506881|3985152|FG000|COMPLETED|Second Intervention (Day 1)||12
3251026|NCT02506881|3985153|FG001|COMPLETED|Second Intervention (Day 1)||12
3251027|NCT02506881|3985154|FG002|COMPLETED|Second Intervention (Day 1)||12
3251028|NCT02506881|3985155|FG003|COMPLETED|Second Intervention (Day 1)||12
3251029|NCT02506881|3985152|FG000|NOT COMPLETED|Second Intervention (Day 1)||0
3251030|NCT02506881|3985153|FG001|NOT COMPLETED|Second Intervention (Day 1)||0
3251031|NCT02506881|3985154|FG002|NOT COMPLETED|Second Intervention (Day 1)||0
3251032|NCT02506881|3985155|FG003|NOT COMPLETED|Second Intervention (Day 1)||0
3251033|NCT02507011|3985175|FG000|STARTED|First Intervention||1
3251034|NCT02507011|3985176|FG001|STARTED|First Intervention||1
3251035|NCT02507011|3985175|FG000|COMPLETED|First Intervention||1
3251036|NCT02507011|3985176|FG001|COMPLETED|First Intervention||1
3251037|NCT02507011|3985175|FG000|NOT COMPLETED|First Intervention||0
3251038|NCT02507011|3985176|FG001|NOT COMPLETED|First Intervention||0
3251039|NCT02507011|3985175|FG000|STARTED|Second Intervention||1
3251040|NCT02507011|3985176|FG001|STARTED|Second Intervention||1
3251041|NCT02507011|3985175|FG000|COMPLETED|Second Intervention||1
3251042|NCT02507011|3985176|FG001|COMPLETED|Second Intervention||1
3251043|NCT02507011|3985175|FG000|NOT COMPLETED|Second Intervention||0
3251044|NCT02507011|3985176|FG001|NOT COMPLETED|Second Intervention||0
3251045|NCT02507219|3985182|FG000|STARTED|Overall Study||5
3251046|NCT02507219|3985183|FG001|STARTED|Overall Study||4
3251047|NCT02507219|3985184|FG002|STARTED|Overall Study||3
3251048|NCT02507219|3985185|FG003|STARTED|Overall Study||3
3251049|NCT02507219|3985186|FG004|STARTED|Overall Study||4
3251050|NCT02507219|3985187|FG005|STARTED|Overall Study||3
3251051|NCT02507219|3985182|FG000|COMPLETED|Overall Study||4
3251052|NCT02507219|3985183|FG001|COMPLETED|Overall Study||4
3251053|NCT02507219|3985184|FG002|COMPLETED|Overall Study||3
3251054|NCT02507219|3985185|FG003|COMPLETED|Overall Study||3
3251055|NCT02507219|3985186|FG004|COMPLETED|Overall Study||3
3251056|NCT02507219|3985187|FG005|COMPLETED|Overall Study||3
3251057|NCT02507219|3985182|FG000|NOT COMPLETED|Overall Study||1
3251058|NCT02507219|3985183|FG001|NOT COMPLETED|Overall Study||0
3251059|NCT02507219|3985184|FG002|NOT COMPLETED|Overall Study||0
3251060|NCT02507219|3985185|FG003|NOT COMPLETED|Overall Study||0
3251061|NCT02507219|3985186|FG004|NOT COMPLETED|Overall Study||1
3251062|NCT02507219|3985187|FG005|NOT COMPLETED|Overall Study||0
3251063|NCT02507297|3985197|FG000|STARTED|Overall Study||16
3251064|NCT02507297|3985198|FG001|STARTED|Overall Study||13
3251065|NCT02507297|3985197|FG000|COMPLETED|Overall Study||15
3251066|NCT02507297|3985198|FG001|COMPLETED|Overall Study||12
3251067|NCT02507297|3985197|FG000|NOT COMPLETED|Overall Study||1
3251068|NCT02507297|3985198|FG001|NOT COMPLETED|Overall Study||1
3251069|NCT02507349|3985206|FG000|STARTED|Overall Study||1232
3251070|NCT02507349|3985207|FG001|STARTED|Overall Study||1211
3251071|NCT02507349|3985206|FG000|COMPLETED|Overall Study||1045
3251072|NCT02507349|3985207|FG001|COMPLETED|Overall Study||1050
3251073|NCT02507349|3985206|FG000|NOT COMPLETED|Overall Study||187
3251074|NCT02507349|3985207|FG001|NOT COMPLETED|Overall Study||161
3251075|NCT02507375|3985215|FG000|STARTED|Overall Study||6
3251076|NCT02507375|3985216|FG001|STARTED|Overall Study|Two patients in cohort 2 did not begin treatment in Cycle 1 so were not included in the analysis set|9
3251077|NCT02507375|3985215|FG000|Cycle 1|Overall Study||6
3251078|NCT02507375|3985216|FG001|Cycle 1|Overall Study||9
3251079|NCT02507375|3985215|FG000|Received Pertuzumab|Overall Study||6
3251080|NCT02507375|3985216|FG001|Received Pertuzumab|Overall Study||6
3251081|NCT02507375|3985215|FG000|Cycle 2|Overall Study||5
3251082|NCT02507375|3985216|FG001|Cycle 2|Overall Study||5
3251083|NCT02507375|3985215|FG000|Cycle 3|Overall Study||4
3251084|NCT02507375|3985216|FG001|Cycle 3|Overall Study||5
3251085|NCT02507375|3985215|FG000|Cycle 4|Overall Study||4
3251086|NCT02507375|3985216|FG001|Cycle 4|Overall Study||2
3251087|NCT02507375|3985215|FG000|Cycle 5|Overall Study||3
3251088|NCT02507375|3985216|FG001|Cycle 5|Overall Study||1
3251089|NCT02507375|3985215|FG000|Cycle 6|Overall Study||3
3251090|NCT02507375|3985216|FG001|Cycle 6|Overall Study||1
3251091|NCT02507375|3985215|FG000|Extension Period|Overall Study||2
3251092|NCT02507375|3985216|FG001|Extension Period|Overall Study||1
3251093|NCT02507375|3985215|FG000|COMPLETED|Overall Study||2
3251094|NCT02507375|3985216|FG001|COMPLETED|Overall Study||1
3251095|NCT02507375|3985215|FG000|NOT COMPLETED|Overall Study||4
3251096|NCT02507375|3985216|FG001|NOT COMPLETED|Overall Study||8
3251097|NCT02507388|3985228|FG000|STARTED|Overall Study||25
3251098|NCT02507388|3985229|FG001|STARTED|Overall Study||25
3251099|NCT02507388|3985228|FG000|COMPLETED|Overall Study||25
3251100|NCT02507388|3985229|FG001|COMPLETED|Overall Study||25
3251101|NCT02507388|3985228|FG000|NOT COMPLETED|Overall Study||0
3251102|NCT02507388|3985229|FG001|NOT COMPLETED|Overall Study||0
3251103|NCT02507752|3985236|FG000|STARTED|Overall Study||72
3251104|NCT02507752|3985236|FG000|COMPLETED|Overall Study||55
3251105|NCT02507752|3985236|FG000|NOT COMPLETED|Overall Study||17
3251106|NCT02508077|3985240|FG000|STARTED|Overall Study||1
3251107|NCT02508077|3985240|FG000|COMPLETED|Overall Study||1
3251108|NCT02508077|3985240|FG000|NOT COMPLETED|Overall Study||0
3251109|NCT02508103|3985246|FG000|STARTED|Overall Study||5
3251110|NCT02508103|3985247|FG001|STARTED|Overall Study||5
3251111|NCT02508103|3985246|FG000|COMPLETED|Overall Study||5
3251112|NCT02508103|3985247|FG001|COMPLETED|Overall Study||5
3251113|NCT02508103|3985246|FG000|NOT COMPLETED|Overall Study||0
3251114|NCT02508103|3985247|FG001|NOT COMPLETED|Overall Study||0
3251115|NCT02508116|3985255|FG000|STARTED|Overall Study||252
3251116|NCT02508116|3985256|FG001|STARTED|Overall Study||257
3251117|NCT02508116|3985255|FG000|Received Intervention as Randomized|Overall Study||249
3251118|NCT02508116|3985256|FG001|Received Intervention as Randomized|Overall Study||255
3251119|NCT02508116|3985255|FG000|COMPLETED|Overall Study||244
3371591|NCT03725085|4103276|FG000|COMPLETED|Overall Study||550
3371592|NCT03725085|4103276|FG000|NOT COMPLETED|Overall Study||2
3251120|NCT02508116|3985256|FG001|COMPLETED|Overall Study||250
3251121|NCT02508116|3985255|FG000|NOT COMPLETED|Overall Study||8
3251122|NCT02508116|3985256|FG001|NOT COMPLETED|Overall Study||7
3251123|NCT02508194|3985264|FG000|STARTED|Overall Study||949
3251124|NCT02508194|3985265|FG001|STARTED|Overall Study||951
3251125|NCT02508194|3985264|FG000|COMPLETED|Overall Study||897
3251126|NCT02508194|3985265|FG001|COMPLETED|Overall Study||907
3251127|NCT02508194|3985264|FG000|NOT COMPLETED|Overall Study||52
3251128|NCT02508194|3985265|FG001|NOT COMPLETED|Overall Study||44
3251129|NCT02508207|3985273|FG000|STARTED|Overall Study||7
3251130|NCT02508207|3985274|FG001|STARTED|Overall Study||27
3251131|NCT02508207|3985273|FG000|COMPLETED|Overall Study||7
3251132|NCT02508207|3985274|FG001|COMPLETED|Overall Study||27
3251133|NCT02508207|3985273|FG000|NOT COMPLETED|Overall Study||0
3251134|NCT02508207|3985274|FG001|NOT COMPLETED|Overall Study||0
3251135|NCT02508259|3985282|FG000|STARTED|Overall Study||5
3251136|NCT02508259|3985283|FG001|STARTED|Overall Study||5
3251137|NCT02508259|3985282|FG000|COMPLETED|Overall Study||5
3251138|NCT02508259|3985283|FG001|COMPLETED|Overall Study||5
3251139|NCT02508259|3985282|FG000|NOT COMPLETED|Overall Study||0
3251140|NCT02508259|3985283|FG001|NOT COMPLETED|Overall Study||0
3251141|NCT02508389|3985292|FG000|STARTED|Overall Study||73
3251142|NCT02508389|3985293|FG001|STARTED|Overall Study||76
3251143|NCT02508389|3985294|FG002|STARTED|Overall Study||74
3251144|NCT02508389|3985292|FG000|COMPLETED|Overall Study||45
3251145|NCT02508389|3985293|FG001|COMPLETED|Overall Study||45
3251146|NCT02508389|3985294|FG002|COMPLETED|Overall Study||42
3251147|NCT02508389|3985292|FG000|NOT COMPLETED|Overall Study||28
3251148|NCT02508389|3985293|FG001|NOT COMPLETED|Overall Study||31
3251149|NCT02508389|3985294|FG002|NOT COMPLETED|Overall Study||32
3251150|NCT02508428|3985304|FG000|STARTED|Overall Study||114
3251151|NCT02508428|3985305|FG001|STARTED|Overall Study||111
3251152|NCT02508428|3985304|FG000|COMPLETED|Overall Study||62
3251153|NCT02508428|3985305|FG001|COMPLETED|Overall Study||44
3251154|NCT02508428|3985304|FG000|NOT COMPLETED|Overall Study||52
3251155|NCT02508428|3985305|FG001|NOT COMPLETED|Overall Study||67
3251156|NCT02508480|3985313|FG000|STARTED|Overall Study||95
3251157|NCT02508480|3985314|FG001|STARTED|Overall Study||97
3251158|NCT02508480|3985313|FG000|Post-Treatment Assessment|Overall Study||87
3251159|NCT02508480|3985314|FG001|Post-Treatment Assessment|Overall Study||89
3251160|NCT02508480|3985313|FG000|Three Month Follow-up|Overall Study||84
3251161|NCT02508480|3985314|FG001|Three Month Follow-up|Overall Study||86
3251162|NCT02508480|3985313|FG000|Six-Month Follow-Up|Overall Study||84
3251163|NCT02508480|3985314|FG001|Six-Month Follow-Up|Overall Study||86
3251164|NCT02508480|3985313|FG000|COMPLETED|Overall Study||90
3251165|NCT02508480|3985314|FG001|COMPLETED|Overall Study||93
3251166|NCT02508480|3985313|FG000|NOT COMPLETED|Overall Study||5
3251167|NCT02508480|3985314|FG001|NOT COMPLETED|Overall Study||4
3251168|NCT02508532|3985327|FG000|STARTED|Part 1 - Dose Determining Period||6
3251169|NCT02508532|3985328|FG001|STARTED|Part 1 - Dose Determining Period||6
3251170|NCT02508532|3985329|FG002|STARTED|Part 1 - Dose Determining Period||6
3251171|NCT02508532|3985330|FG003|STARTED|Part 1 - Dose Determining Period||6
3251172|NCT02508532|3985331|FG004|STARTED|Part 1 - Dose Determining Period||6
3251173|NCT02508532|3985332|FG005|STARTED|Part 1 - Dose Determining Period||6
3251174|NCT02508532|3985333|FG006|STARTED|Part 1 - Dose Determining Period||7
3251175|NCT02508532|3985334|FG007|STARTED|Part 1 - Dose Determining Period||3
3251176|NCT02508532|3985335|FG008|STARTED|Part 1 - Dose Determining Period|This group includes patients enrolled in Part 1 and Part 2 at a starting dose of 300 or 400 mg QD. This group was not used to determine the MTD in Part 1|0
3251177|NCT02508532|3985327|FG000|Patients From Part 1 Included in the Part 2 Analyses|Part 1 - Dose Determining Period||0
3251178|NCT02508532|3985328|FG001|Patients From Part 1 Included in the Part 2 Analyses|Part 1 - Dose Determining Period||0
3251179|NCT02508532|3985329|FG002|Patients From Part 1 Included in the Part 2 Analyses|Part 1 - Dose Determining Period||0
3251180|NCT02508532|3985330|FG003|Patients From Part 1 Included in the Part 2 Analyses|Part 1 - Dose Determining Period||0
3251181|NCT02508532|3985331|FG004|Patients From Part 1 Included in the Part 2 Analyses|Part 1 - Dose Determining Period||0
3251182|NCT02508532|3985332|FG005|Patients From Part 1 Included in the Part 2 Analyses|Part 1 - Dose Determining Period||6
3251183|NCT02508532|3985333|FG006|Patients From Part 1 Included in the Part 2 Analyses|Part 1 - Dose Determining Period||7
3371593|NCT03725033|4103283|FG000|STARTED|Overall Study||105
3371594|NCT03725033|4103284|FG001|STARTED|Overall Study||97
3371595|NCT03725033|4103283|FG000|COMPLETED|Overall Study||105
3371596|NCT03725033|4103284|FG001|COMPLETED|Overall Study||97
3371597|NCT03725033|4103283|FG000|NOT COMPLETED|Overall Study||0
3371598|NCT03725033|4103284|FG001|NOT COMPLETED|Overall Study||0
3371599|NCT03724981|4103292|FG000|STARTED|First Device||156
3371600|NCT03724981|4103293|FG001|STARTED|First Device||156
3371601|NCT03724981|4103292|FG000|COMPLETED|First Device||155
3371602|NCT03724981|4103293|FG001|COMPLETED|First Device||155
3371603|NCT03724981|4103292|FG000|NOT COMPLETED|First Device||1
3371604|NCT03724981|4103293|FG001|NOT COMPLETED|First Device||1
3371605|NCT03724981|4103292|FG000|STARTED|Second Device||155
3371606|NCT03724981|4103293|FG001|STARTED|Second Device||155
3371607|NCT03724981|4103292|FG000|COMPLETED|Second Device||155
3371608|NCT03724981|4103293|FG001|COMPLETED|Second Device||155
3371609|NCT03724981|4103292|FG000|NOT COMPLETED|Second Device||0
3371610|NCT03724981|4103293|FG001|NOT COMPLETED|Second Device||0
3371611|NCT03724968|4103303|FG000|STARTED|Overall Study||0
3371612|NCT03724968|4103304|FG001|STARTED|Overall Study||2
3371613|NCT03724968|4103303|FG000|COMPLETED|Overall Study||0
3371614|NCT03724968|4103304|FG001|COMPLETED|Overall Study||0
3371615|NCT03724968|4103303|FG000|NOT COMPLETED|Overall Study||0
3371616|NCT03724968|4103304|FG001|NOT COMPLETED|Overall Study||2
3371617|NCT03724877|4103312|FG000|STARTED|Overall Study||6921
3371618|NCT03724877|4103313|FG001|STARTED|Overall Study||1932
3371619|NCT03724877|4103312|FG000|COMPLETED|Overall Study||6921
3371620|NCT03724877|4103313|FG001|COMPLETED|Overall Study||1932
3371621|NCT03724877|4103312|FG000|NOT COMPLETED|Overall Study||0
3371622|NCT03724877|4103313|FG001|NOT COMPLETED|Overall Study||0
3371623|NCT03724253|4103324|FG000|STARTED|Overall Study||5
3371624|NCT03724253|4103325|FG001|STARTED|Overall Study||5
3371625|NCT03724253|4103326|FG002|STARTED|Overall Study||5
3371626|NCT03724253|4103327|FG003|STARTED|Overall Study||3
3371627|NCT03724253|4103328|FG004|STARTED|Overall Study||1
3371628|NCT03724253|4103324|FG000|COMPLETED|Overall Study||5
3371629|NCT03724253|4103325|FG001|COMPLETED|Overall Study||5
3371630|NCT03724253|4103326|FG002|COMPLETED|Overall Study||5
3371631|NCT03724253|4103327|FG003|COMPLETED|Overall Study||3
3371632|NCT03724253|4103328|FG004|COMPLETED|Overall Study||1
3371633|NCT03724253|4103324|FG000|NOT COMPLETED|Overall Study||0
3251184|NCT02508532|3985334|FG007|Patients From Part 1 Included in the Part 2 Analyses|Part 1 - Dose Determining Period||0
3251185|NCT02508532|3985335|FG008|Patients From Part 1 Included in the Part 2 Analyses|Part 1 - Dose Determining Period||0
3251186|NCT02508532|3985327|FG000|COMPLETED|Part 1 - Dose Determining Period||6
3251187|NCT02508532|3985328|FG001|COMPLETED|Part 1 - Dose Determining Period||6
3251188|NCT02508532|3985329|FG002|COMPLETED|Part 1 - Dose Determining Period||6
3251189|NCT02508532|3985330|FG003|COMPLETED|Part 1 - Dose Determining Period||6
3251190|NCT02508532|3985331|FG004|COMPLETED|Part 1 - Dose Determining Period||6
3251191|NCT02508532|3985332|FG005|COMPLETED|Part 1 - Dose Determining Period||6
3251192|NCT02508532|3985333|FG006|COMPLETED|Part 1 - Dose Determining Period||6
3251193|NCT02508532|3985334|FG007|COMPLETED|Part 1 - Dose Determining Period||2
3251194|NCT02508532|3985335|FG008|COMPLETED|Part 1 - Dose Determining Period||0
3251195|NCT02508532|3985327|FG000|NOT COMPLETED|Part 1 - Dose Determining Period||0
3251196|NCT02508532|3985328|FG001|NOT COMPLETED|Part 1 - Dose Determining Period||0
3251197|NCT02508532|3985329|FG002|NOT COMPLETED|Part 1 - Dose Determining Period||0
3251198|NCT02508532|3985330|FG003|NOT COMPLETED|Part 1 - Dose Determining Period||0
3251199|NCT02508532|3985331|FG004|NOT COMPLETED|Part 1 - Dose Determining Period||0
3251200|NCT02508532|3985332|FG005|NOT COMPLETED|Part 1 - Dose Determining Period||0
3251201|NCT02508532|3985333|FG006|NOT COMPLETED|Part 1 - Dose Determining Period||1
3251202|NCT02508532|3985334|FG007|NOT COMPLETED|Part 1 - Dose Determining Period||1
3251203|NCT02508532|3985335|FG008|NOT COMPLETED|Part 1 - Dose Determining Period||0
3251204|NCT02508532|3985327|FG000|STARTED|Part 2 - Treatment|These patients are not included in Part 2 analyses|0
3251205|NCT02508532|3985328|FG001|STARTED|Part 2 - Treatment|These patients are not included in Part 2 analyses|0
3251206|NCT02508532|3985329|FG002|STARTED|Part 2 - Treatment|These patients are not included in Part 2 analyses|0
3251207|NCT02508532|3985330|FG003|STARTED|Part 2 - Treatment|These patients are not included in Part 2 analyses|0
3251208|NCT02508532|3985331|FG004|STARTED|Part 2 - Treatment|These patients are not included in Part 2 analyses|0
3251209|NCT02508532|3985332|FG005|STARTED|Part 2 - Treatment|"Part 1 Only:~6 Patients from this group are included in the 300 or 400 mg QD group."|0
3251210|NCT02508532|3985333|FG006|STARTED|Part 2 - Treatment|"Part 1 Only:~7 Patients from this group are included in the 300 or 400 mg QD group."|0
3251211|NCT02508532|3985334|FG007|STARTED|Part 2 - Treatment|These patients are not included in Part 2 analyses|0
3251212|NCT02508532|3985335|FG008|STARTED|Part 2 - Treatment|Includes 13 patients enrolled in Part 1 at a starting dose of 300 mg (n = 6) or 400 mg (n = 7) QD.|217
3251213|NCT02508532|3985327|FG000|COMPLETED|Part 2 - Treatment||0
3251214|NCT02508532|3985328|FG001|COMPLETED|Part 2 - Treatment||0
3251215|NCT02508532|3985329|FG002|COMPLETED|Part 2 - Treatment||0
3251216|NCT02508532|3985330|FG003|COMPLETED|Part 2 - Treatment||0
3251217|NCT02508532|3985331|FG004|COMPLETED|Part 2 - Treatment||0
3251218|NCT02508532|3985332|FG005|COMPLETED|Part 2 - Treatment||0
3251219|NCT02508532|3985333|FG006|COMPLETED|Part 2 - Treatment||0
3251220|NCT02508532|3985334|FG007|COMPLETED|Part 2 - Treatment||0
3251221|NCT02508532|3985335|FG008|COMPLETED|Part 2 - Treatment||0
3251222|NCT02508532|3985327|FG000|NOT COMPLETED|Part 2 - Treatment||0
3251223|NCT02508532|3985328|FG001|NOT COMPLETED|Part 2 - Treatment||0
3251224|NCT02508532|3985329|FG002|NOT COMPLETED|Part 2 - Treatment||0
3251225|NCT02508532|3985330|FG003|NOT COMPLETED|Part 2 - Treatment||0
3251226|NCT02508532|3985331|FG004|NOT COMPLETED|Part 2 - Treatment||0
3251227|NCT02508532|3985332|FG005|NOT COMPLETED|Part 2 - Treatment||0
3251228|NCT02508532|3985333|FG006|NOT COMPLETED|Part 2 - Treatment||0
3251229|NCT02508532|3985334|FG007|NOT COMPLETED|Part 2 - Treatment||0
3251230|NCT02508532|3985335|FG008|NOT COMPLETED|Part 2 - Treatment||217
3251231|NCT02508532|3985327|FG000|STARTED|Part 1 and Part 2 End of Study||6
3251232|NCT02508532|3985328|FG001|STARTED|Part 1 and Part 2 End of Study||6
3251233|NCT02508532|3985329|FG002|STARTED|Part 1 and Part 2 End of Study||6
3251234|NCT02508532|3985330|FG003|STARTED|Part 1 and Part 2 End of Study||6
3251235|NCT02508532|3985331|FG004|STARTED|Part 1 and Part 2 End of Study||6
3251236|NCT02508532|3985332|FG005|STARTED|Part 1 and Part 2 End of Study|These 6 patients are included in the 300 or 400 mg QD dose group|0
3251237|NCT02508532|3985333|FG006|STARTED|Part 1 and Part 2 End of Study|These 7 patients are included in the 300 or 400 mg QD dose group|0
3251238|NCT02508532|3985334|FG007|STARTED|Part 1 and Part 2 End of Study||3
3251239|NCT02508532|3985335|FG008|STARTED|Part 1 and Part 2 End of Study|Includes 13 patients enrolled in Part 1 at a starting dose of 300 mg (n = 6) or 400 mg (n = 7) QD.|217
3251240|NCT02508532|3985327|FG000|COMPLETED|Part 1 and Part 2 End of Study||0
3251241|NCT02508532|3985328|FG001|COMPLETED|Part 1 and Part 2 End of Study||0
3251242|NCT02508532|3985329|FG002|COMPLETED|Part 1 and Part 2 End of Study||0
3251243|NCT02508532|3985330|FG003|COMPLETED|Part 1 and Part 2 End of Study||0
3251244|NCT02508532|3985331|FG004|COMPLETED|Part 1 and Part 2 End of Study||0
3251245|NCT02508532|3985332|FG005|COMPLETED|Part 1 and Part 2 End of Study||0
3251246|NCT02508532|3985333|FG006|COMPLETED|Part 1 and Part 2 End of Study||0
3251247|NCT02508532|3985334|FG007|COMPLETED|Part 1 and Part 2 End of Study||0
3251248|NCT02508532|3985335|FG008|COMPLETED|Part 1 and Part 2 End of Study||0
3251249|NCT02508532|3985327|FG000|NOT COMPLETED|Part 1 and Part 2 End of Study||6
3251250|NCT02508532|3985328|FG001|NOT COMPLETED|Part 1 and Part 2 End of Study||6
3251251|NCT02508532|3985329|FG002|NOT COMPLETED|Part 1 and Part 2 End of Study||6
3251252|NCT02508532|3985330|FG003|NOT COMPLETED|Part 1 and Part 2 End of Study||6
3251253|NCT02508532|3985331|FG004|NOT COMPLETED|Part 1 and Part 2 End of Study||6
3251254|NCT02508532|3985332|FG005|NOT COMPLETED|Part 1 and Part 2 End of Study||0
3251255|NCT02508532|3985333|FG006|NOT COMPLETED|Part 1 and Part 2 End of Study||0
3251256|NCT02508532|3985334|FG007|NOT COMPLETED|Part 1 and Part 2 End of Study||3
3251257|NCT02508532|3985335|FG008|NOT COMPLETED|Part 1 and Part 2 End of Study||217
3251258|NCT02508636|3985364|FG000|STARTED|Overall Study||11
3251259|NCT02508636|3985364|FG000|COMPLETED|Overall Study||11
3251260|NCT02508636|3985364|FG000|NOT COMPLETED|Overall Study||0
3251261|NCT02508649|3985372|FG000|STARTED|Overall Study||283
3251262|NCT02508649|3985373|FG001|STARTED|Overall Study||197
3251263|NCT02508649|3985374|FG002|STARTED|Overall Study||189
3251264|NCT02508649|3985375|FG003|STARTED|Overall Study||199
3251265|NCT02508649|3985372|FG000|Dosed|Overall Study||266
3251266|NCT02508649|3985373|FG001|Dosed|Overall Study||191
3251267|NCT02508649|3985374|FG002|Dosed|Overall Study||177
3251268|NCT02508649|3985375|FG003|Dosed|Overall Study||194
3251269|NCT02508649|3985372|FG000|COMPLETED|Overall Study||265
3251270|NCT02508649|3985373|FG001|COMPLETED|Overall Study||184
3251271|NCT02508649|3985374|FG002|COMPLETED|Overall Study||174
3251272|NCT02508649|3985375|FG003|COMPLETED|Overall Study||189
3251273|NCT02508649|3985372|FG000|NOT COMPLETED|Overall Study||18
3251274|NCT02508649|3985373|FG001|NOT COMPLETED|Overall Study||13
3251275|NCT02508649|3985374|FG002|NOT COMPLETED|Overall Study||15
3251276|NCT02508649|3985375|FG003|NOT COMPLETED|Overall Study||10
3251277|NCT02508701|3985392|FG000|STARTED|Overall Study||9
3251278|NCT02508701|3985393|FG001|STARTED|Overall Study||6
3251279|NCT02508701|3985394|FG002|STARTED|Overall Study||5
3251280|NCT02508701|3985395|FG003|STARTED|Overall Study||4
3251281|NCT02508701|3985392|FG000|COMPLETED|Overall Study||0
3251282|NCT02508701|3985393|FG001|COMPLETED|Overall Study||1
3251283|NCT02508701|3985394|FG002|COMPLETED|Overall Study||0
3251284|NCT02508701|3985395|FG003|COMPLETED|Overall Study||1
3251285|NCT02508701|3985392|FG000|NOT COMPLETED|Overall Study||9
3251286|NCT02508701|3985393|FG001|NOT COMPLETED|Overall Study||5
3251287|NCT02508701|3985394|FG002|NOT COMPLETED|Overall Study||5
3251288|NCT02508701|3985395|FG003|NOT COMPLETED|Overall Study||3
3251289|NCT02508935|3985409|FG000|STARTED|Overall Study||23
3251290|NCT02508935|3985409|FG000|COMPLETED|Overall Study||0
3251291|NCT02508935|3985409|FG000|NOT COMPLETED|Overall Study||23
3251292|NCT02509026|3985415|FG000|STARTED|Induction Period (24 Weeks)||210
3251293|NCT02509026|3985415|FG000|Treated|Induction Period (24 Weeks)||209
3251294|NCT02509026|3985415|FG000|COMPLETED|Induction Period (24 Weeks)||188
3251295|NCT02509026|3985415|FG000|NOT COMPLETED|Induction Period (24 Weeks)||22
3251296|NCT02509026|3985415|FG000|STARTED|Withdrawal Period (40 Weeks)|Participants who completed Period 1 and achieved ASDAS-CRP<1.3 were eligible to enter into Period 2|119
3251297|NCT02509026|3985415|FG000|COMPLETED|Withdrawal Period (40 Weeks)||112
3251298|NCT02509026|3985415|FG000|NOT COMPLETED|Withdrawal Period (40 Weeks)||7
3251299|NCT02509026|3985415|FG000|STARTED|Retreatment Period (12 Weeks)|Participants who completed Period 2 and achieved ASDAS-ESR>=2.1 were eligible to enter into Period 3|88
3251300|NCT02509026|3985415|FG000|Treated|Retreatment Period (12 Weeks)||87
3251301|NCT02509026|3985415|FG000|COMPLETED|Retreatment Period (12 Weeks)||84
3251302|NCT02509026|3985415|FG000|NOT COMPLETED|Retreatment Period (12 Weeks)||4
3251303|NCT02509065|3985424|FG000|STARTED|Overall Study||1
3251304|NCT02509065|3985425|FG001|STARTED|Overall Study||1
3251305|NCT02509065|3985426|FG002|STARTED|Overall Study||2
3251306|NCT02509065|3985427|FG003|STARTED|Overall Study||1
3251307|NCT02509065|3985428|FG004|STARTED|Overall Study||1
3251308|NCT02509065|3985429|FG005|STARTED|Overall Study||1
3251309|NCT02509065|3985430|FG006|STARTED|Overall Study||1
3251310|NCT02509065|3985431|FG007|STARTED|Overall Study||1
3251311|NCT02509065|3985432|FG008|STARTED|Overall Study||1
3251312|NCT02509065|3985433|FG009|STARTED|Overall Study||1
3251313|NCT02509065|3985434|FG010|STARTED|Overall Study||1
3251314|NCT02509065|3985435|FG011|STARTED|Overall Study||1
3251315|NCT02509065|3985436|FG012|STARTED|Overall Study||1
3251316|NCT02509065|3985437|FG013|STARTED|Overall Study||1
3251317|NCT02509065|3985438|FG014|STARTED|Overall Study||1
3251318|NCT02509065|3985439|FG015|STARTED|Overall Study||1
3251319|NCT02509065|3985440|FG016|STARTED|Overall Study||1
3251320|NCT02509065|3985441|FG017|STARTED|Overall Study||1
3251321|NCT02509065|3985442|FG018|STARTED|Overall Study||1
3251322|NCT02509065|3985443|FG019|STARTED|Overall Study||1
3251323|NCT02509065|3985444|FG020|STARTED|Overall Study||1
3251324|NCT02509065|3985445|FG021|STARTED|Overall Study||1
3251325|NCT02509065|3985446|FG022|STARTED|Overall Study||1
3251326|NCT02509065|3985424|FG000|COMPLETED|Overall Study||1
3251327|NCT02509065|3985425|FG001|COMPLETED|Overall Study||1
3251328|NCT02509065|3985426|FG002|COMPLETED|Overall Study||2
3251329|NCT02509065|3985427|FG003|COMPLETED|Overall Study||1
3251330|NCT02509065|3985428|FG004|COMPLETED|Overall Study||1
3251331|NCT02509065|3985429|FG005|COMPLETED|Overall Study||1
3251332|NCT02509065|3985430|FG006|COMPLETED|Overall Study||1
3251333|NCT02509065|3985431|FG007|COMPLETED|Overall Study||1
3251334|NCT02509065|3985432|FG008|COMPLETED|Overall Study||1
3251335|NCT02509065|3985433|FG009|COMPLETED|Overall Study||1
3251336|NCT02509065|3985434|FG010|COMPLETED|Overall Study||1
3251337|NCT02509065|3985435|FG011|COMPLETED|Overall Study||1
3251338|NCT02509065|3985436|FG012|COMPLETED|Overall Study||1
3251339|NCT02509065|3985437|FG013|COMPLETED|Overall Study||1
3251340|NCT02509065|3985438|FG014|COMPLETED|Overall Study||1
3251341|NCT02509065|3985439|FG015|COMPLETED|Overall Study||1
3251342|NCT02509065|3985440|FG016|COMPLETED|Overall Study||1
3251343|NCT02509065|3985441|FG017|COMPLETED|Overall Study||1
3251344|NCT02509065|3985442|FG018|COMPLETED|Overall Study||1
3251345|NCT02509065|3985443|FG019|COMPLETED|Overall Study||1
3251346|NCT02509065|3985444|FG020|COMPLETED|Overall Study||1
3251347|NCT02509065|3985445|FG021|COMPLETED|Overall Study||1
3251348|NCT02509065|3985446|FG022|COMPLETED|Overall Study||1
3251349|NCT02509065|3985424|FG000|NOT COMPLETED|Overall Study||0
3251350|NCT02509065|3985425|FG001|NOT COMPLETED|Overall Study||0
3251351|NCT02509065|3985426|FG002|NOT COMPLETED|Overall Study||0
3251352|NCT02509065|3985427|FG003|NOT COMPLETED|Overall Study||0
3251353|NCT02509065|3985428|FG004|NOT COMPLETED|Overall Study||0
3251354|NCT02509065|3985429|FG005|NOT COMPLETED|Overall Study||0
3251355|NCT02509065|3985430|FG006|NOT COMPLETED|Overall Study||0
3251356|NCT02509065|3985431|FG007|NOT COMPLETED|Overall Study||0
3251357|NCT02509065|3985432|FG008|NOT COMPLETED|Overall Study||0
3251358|NCT02509065|3985433|FG009|NOT COMPLETED|Overall Study||0
3251359|NCT02509065|3985434|FG010|NOT COMPLETED|Overall Study||0
3251360|NCT02509065|3985435|FG011|NOT COMPLETED|Overall Study||0
3251361|NCT02509065|3985436|FG012|NOT COMPLETED|Overall Study||0
3251362|NCT02509065|3985437|FG013|NOT COMPLETED|Overall Study||0
3251363|NCT02509065|3985438|FG014|NOT COMPLETED|Overall Study||0
3251364|NCT02509065|3985439|FG015|NOT COMPLETED|Overall Study||0
3251365|NCT02509065|3985440|FG016|NOT COMPLETED|Overall Study||0
3251366|NCT02509065|3985441|FG017|NOT COMPLETED|Overall Study||0
3251367|NCT02509065|3985442|FG018|NOT COMPLETED|Overall Study||0
3251368|NCT02509065|3985443|FG019|NOT COMPLETED|Overall Study||0
3251369|NCT02509065|3985444|FG020|NOT COMPLETED|Overall Study||0
3251370|NCT02509065|3985445|FG021|NOT COMPLETED|Overall Study||0
3251371|NCT02509065|3985446|FG022|NOT COMPLETED|Overall Study||0
3251372|NCT02509078|3985464|FG000|STARTED|Overall Study||502
3251373|NCT02509078|3985465|FG001|STARTED|Overall Study||506
3251374|NCT02509078|3985464|FG000|COMPLETED|Overall Study||501
3251375|NCT02509078|3985465|FG001|COMPLETED|Overall Study||505
3251376|NCT02509078|3985464|FG000|NOT COMPLETED|Overall Study||1
3251377|NCT02509078|3985465|FG001|NOT COMPLETED|Overall Study||1
3251378|NCT02509117|3985483|FG000|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||2
3251379|NCT02509117|3985484|FG001|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||2
3251380|NCT02509117|3985485|FG002|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||2
3251381|NCT02509117|3985486|FG003|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||2
3251382|NCT02509117|3985487|FG004|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||8
3251383|NCT02509117|3985488|FG005|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||8
3251384|NCT02509117|3985489|FG006|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||8
3251385|NCT02509117|3985490|FG007|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||8
3251386|NCT02509117|3985491|FG008|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||4
3251387|NCT02509117|3985492|FG009|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||10
3251388|NCT02509117|3985483|FG000|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||2
3251389|NCT02509117|3985484|FG001|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||1
3251390|NCT02509117|3985485|FG002|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||2
3251391|NCT02509117|3985486|FG003|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||2
3251392|NCT02509117|3985487|FG004|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||8
3251393|NCT02509117|3985488|FG005|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||8
3251394|NCT02509117|3985489|FG006|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||8
3251395|NCT02509117|3985490|FG007|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||8
3251396|NCT02509117|3985491|FG008|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||4
3251397|NCT02509117|3985492|FG009|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||10
3251398|NCT02509117|3985483|FG000|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||2
3251399|NCT02509117|3985484|FG001|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||1
3251400|NCT02509117|3985485|FG002|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||2
3251401|NCT02509117|3985486|FG003|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||2
3251402|NCT02509117|3985487|FG004|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||8
3251403|NCT02509117|3985488|FG005|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||8
3251404|NCT02509117|3985489|FG006|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||8
3251405|NCT02509117|3985490|FG007|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||8
3251406|NCT02509117|3985491|FG008|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||4
3251407|NCT02509117|3985492|FG009|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||8
3251408|NCT02509117|3985483|FG000|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0
3251409|NCT02509117|3985484|FG001|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||1
3251410|NCT02509117|3985485|FG002|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0
3251411|NCT02509117|3985486|FG003|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0
3251412|NCT02509117|3985487|FG004|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0
3251413|NCT02509117|3985488|FG005|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0
3251414|NCT02509117|3985489|FG006|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0
3251415|NCT02509117|3985490|FG007|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0
3251416|NCT02509117|3985491|FG008|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0
3251417|NCT02509117|3985492|FG009|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||2
3251418|NCT02509117|3985483|FG000|STARTED|Washout Period 1 (Part A: 7 Days)||2
3251419|NCT02509117|3985484|FG001|STARTED|Washout Period 1 (Part A: 7 Days)||1
3251420|NCT02509117|3985485|FG002|STARTED|Washout Period 1 (Part A: 7 Days)||2
3251421|NCT02509117|3985486|FG003|STARTED|Washout Period 1 (Part A: 7 Days)||2
3251422|NCT02509117|3985487|FG004|STARTED|Washout Period 1 (Part A: 7 Days)||0
3251423|NCT02509117|3985488|FG005|STARTED|Washout Period 1 (Part A: 7 Days)||0
3251424|NCT02509117|3985489|FG006|STARTED|Washout Period 1 (Part A: 7 Days)||0
3251425|NCT02509117|3985490|FG007|STARTED|Washout Period 1 (Part A: 7 Days)||0
3251426|NCT02509117|3985491|FG008|STARTED|Washout Period 1 (Part A: 7 Days)||0
3251427|NCT02509117|3985492|FG009|STARTED|Washout Period 1 (Part A: 7 Days)||0
3251428|NCT02509117|3985483|FG000|COMPLETED|Washout Period 1 (Part A: 7 Days)||2
3251429|NCT02509117|3985484|FG001|COMPLETED|Washout Period 1 (Part A: 7 Days)||1
3251430|NCT02509117|3985485|FG002|COMPLETED|Washout Period 1 (Part A: 7 Days)||2
3251431|NCT02509117|3985486|FG003|COMPLETED|Washout Period 1 (Part A: 7 Days)||2
3251432|NCT02509117|3985487|FG004|COMPLETED|Washout Period 1 (Part A: 7 Days)||0
3251433|NCT02509117|3985488|FG005|COMPLETED|Washout Period 1 (Part A: 7 Days)||0
3251434|NCT02509117|3985489|FG006|COMPLETED|Washout Period 1 (Part A: 7 Days)||0
3251435|NCT02509117|3985490|FG007|COMPLETED|Washout Period 1 (Part A: 7 Days)||0
3251436|NCT02509117|3985491|FG008|COMPLETED|Washout Period 1 (Part A: 7 Days)||0
3251437|NCT02509117|3985492|FG009|COMPLETED|Washout Period 1 (Part A: 7 Days)||0
3251438|NCT02509117|3985483|FG000|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
3251439|NCT02509117|3985484|FG001|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
3251440|NCT02509117|3985485|FG002|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
3251441|NCT02509117|3985486|FG003|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
3251442|NCT02509117|3985487|FG004|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
3251443|NCT02509117|3985488|FG005|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
3251444|NCT02509117|3985489|FG006|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
3251445|NCT02509117|3985490|FG007|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
3251446|NCT02509117|3985491|FG008|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
3251447|NCT02509117|3985492|FG009|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
3251448|NCT02509117|3985483|FG000|STARTED|Period 2 -Part A: 4 Days||2
3251449|NCT02509117|3985484|FG001|STARTED|Period 2 -Part A: 4 Days|1 participant was added in intervention period 2|2
3251450|NCT02509117|3985485|FG002|STARTED|Period 2 -Part A: 4 Days||2
3251451|NCT02509117|3985486|FG003|STARTED|Period 2 -Part A: 4 Days||2
3251452|NCT02509117|3985487|FG004|STARTED|Period 2 -Part A: 4 Days||0
3251453|NCT02509117|3985488|FG005|STARTED|Period 2 -Part A: 4 Days||0
3251454|NCT02509117|3985489|FG006|STARTED|Period 2 -Part A: 4 Days||0
3251455|NCT02509117|3985490|FG007|STARTED|Period 2 -Part A: 4 Days||0
3251456|NCT02509117|3985491|FG008|STARTED|Period 2 -Part A: 4 Days||0
3251457|NCT02509117|3985492|FG009|STARTED|Period 2 -Part A: 4 Days||0
3251458|NCT02509117|3985483|FG000|Treated|Period 2 -Part A: 4 Days||2
3251459|NCT02509117|3985484|FG001|Treated|Period 2 -Part A: 4 Days||2
3251460|NCT02509117|3985485|FG002|Treated|Period 2 -Part A: 4 Days||2
3251461|NCT02509117|3985486|FG003|Treated|Period 2 -Part A: 4 Days||2
3251462|NCT02509117|3985487|FG004|Treated|Period 2 -Part A: 4 Days||0
3251463|NCT02509117|3985488|FG005|Treated|Period 2 -Part A: 4 Days||0
3251464|NCT02509117|3985489|FG006|Treated|Period 2 -Part A: 4 Days||0
3251465|NCT02509117|3985490|FG007|Treated|Period 2 -Part A: 4 Days||0
3251466|NCT02509117|3985491|FG008|Treated|Period 2 -Part A: 4 Days||0
3251467|NCT02509117|3985492|FG009|Treated|Period 2 -Part A: 4 Days||0
3251468|NCT02509117|3985483|FG000|COMPLETED|Period 2 -Part A: 4 Days||2
3251469|NCT02509117|3985484|FG001|COMPLETED|Period 2 -Part A: 4 Days||2
3251470|NCT02509117|3985485|FG002|COMPLETED|Period 2 -Part A: 4 Days||2
3251471|NCT02509117|3985486|FG003|COMPLETED|Period 2 -Part A: 4 Days||2
3251472|NCT02509117|3985487|FG004|COMPLETED|Period 2 -Part A: 4 Days||0
3251473|NCT02509117|3985488|FG005|COMPLETED|Period 2 -Part A: 4 Days||0
3251474|NCT02509117|3985489|FG006|COMPLETED|Period 2 -Part A: 4 Days||0
3251475|NCT02509117|3985490|FG007|COMPLETED|Period 2 -Part A: 4 Days||0
3251476|NCT02509117|3985491|FG008|COMPLETED|Period 2 -Part A: 4 Days||0
3251477|NCT02509117|3985492|FG009|COMPLETED|Period 2 -Part A: 4 Days||0
3251478|NCT02509117|3985483|FG000|NOT COMPLETED|Period 2 -Part A: 4 Days||0
3251479|NCT02509117|3985484|FG001|NOT COMPLETED|Period 2 -Part A: 4 Days||0
3251480|NCT02509117|3985485|FG002|NOT COMPLETED|Period 2 -Part A: 4 Days||0
3251481|NCT02509117|3985486|FG003|NOT COMPLETED|Period 2 -Part A: 4 Days||0
3251482|NCT02509117|3985487|FG004|NOT COMPLETED|Period 2 -Part A: 4 Days||0
3251483|NCT02509117|3985488|FG005|NOT COMPLETED|Period 2 -Part A: 4 Days||0
3251484|NCT02509117|3985489|FG006|NOT COMPLETED|Period 2 -Part A: 4 Days||0
3251485|NCT02509117|3985490|FG007|NOT COMPLETED|Period 2 -Part A: 4 Days||0
3251486|NCT02509117|3985491|FG008|NOT COMPLETED|Period 2 -Part A: 4 Days||0
3251487|NCT02509117|3985492|FG009|NOT COMPLETED|Period 2 -Part A: 4 Days||0
3251488|NCT02509117|3985483|FG000|STARTED|Washout Period 2 (Part A: 7 Days)||2
3251489|NCT02509117|3985484|FG001|STARTED|Washout Period 2 (Part A: 7 Days)||2
3251490|NCT02509117|3985485|FG002|STARTED|Washout Period 2 (Part A: 7 Days)||2
3251491|NCT02509117|3985486|FG003|STARTED|Washout Period 2 (Part A: 7 Days)||2
3251492|NCT02509117|3985487|FG004|STARTED|Washout Period 2 (Part A: 7 Days)||0
3251493|NCT02509117|3985488|FG005|STARTED|Washout Period 2 (Part A: 7 Days)||0
3251494|NCT02509117|3985489|FG006|STARTED|Washout Period 2 (Part A: 7 Days)||0
3251495|NCT02509117|3985490|FG007|STARTED|Washout Period 2 (Part A: 7 Days)||0
3251496|NCT02509117|3985491|FG008|STARTED|Washout Period 2 (Part A: 7 Days)||0
3251497|NCT02509117|3985492|FG009|STARTED|Washout Period 2 (Part A: 7 Days)||0
3251498|NCT02509117|3985483|FG000|COMPLETED|Washout Period 2 (Part A: 7 Days)||2
3251499|NCT02509117|3985484|FG001|COMPLETED|Washout Period 2 (Part A: 7 Days)||2
3251500|NCT02509117|3985485|FG002|COMPLETED|Washout Period 2 (Part A: 7 Days)||2
3251501|NCT02509117|3985486|FG003|COMPLETED|Washout Period 2 (Part A: 7 Days)||2
3251502|NCT02509117|3985487|FG004|COMPLETED|Washout Period 2 (Part A: 7 Days)||0
3251503|NCT02509117|3985488|FG005|COMPLETED|Washout Period 2 (Part A: 7 Days)||0
3251504|NCT02509117|3985489|FG006|COMPLETED|Washout Period 2 (Part A: 7 Days)||0
3251505|NCT02509117|3985490|FG007|COMPLETED|Washout Period 2 (Part A: 7 Days)||0
3251506|NCT02509117|3985491|FG008|COMPLETED|Washout Period 2 (Part A: 7 Days)||0
3251507|NCT02509117|3985492|FG009|COMPLETED|Washout Period 2 (Part A: 7 Days)||0
3251508|NCT02509117|3985483|FG000|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
3251509|NCT02509117|3985484|FG001|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
3251510|NCT02509117|3985485|FG002|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
3251511|NCT02509117|3985486|FG003|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
3251512|NCT02509117|3985487|FG004|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
3251513|NCT02509117|3985488|FG005|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
3251514|NCT02509117|3985489|FG006|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
3251515|NCT02509117|3985490|FG007|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
3251516|NCT02509117|3985491|FG008|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
3251517|NCT02509117|3985492|FG009|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
3251518|NCT02509117|3985483|FG000|STARTED|Period 3 -Part A: 4 Days||2
3251519|NCT02509117|3985484|FG001|STARTED|Period 3 -Part A: 4 Days||2
3251520|NCT02509117|3985485|FG002|STARTED|Period 3 -Part A: 4 Days||2
3251521|NCT02509117|3985486|FG003|STARTED|Period 3 -Part A: 4 Days||2
3251522|NCT02509117|3985487|FG004|STARTED|Period 3 -Part A: 4 Days||0
3251523|NCT02509117|3985488|FG005|STARTED|Period 3 -Part A: 4 Days||0
3251524|NCT02509117|3985489|FG006|STARTED|Period 3 -Part A: 4 Days||0
3251525|NCT02509117|3985490|FG007|STARTED|Period 3 -Part A: 4 Days||0
3251526|NCT02509117|3985491|FG008|STARTED|Period 3 -Part A: 4 Days||0
3251527|NCT02509117|3985492|FG009|STARTED|Period 3 -Part A: 4 Days||0
3251528|NCT02509117|3985483|FG000|COMPLETED|Period 3 -Part A: 4 Days||2
3251529|NCT02509117|3985484|FG001|COMPLETED|Period 3 -Part A: 4 Days||2
3251530|NCT02509117|3985485|FG002|COMPLETED|Period 3 -Part A: 4 Days||2
3251531|NCT02509117|3985486|FG003|COMPLETED|Period 3 -Part A: 4 Days||2
3251532|NCT02509117|3985487|FG004|COMPLETED|Period 3 -Part A: 4 Days||0
3251533|NCT02509117|3985488|FG005|COMPLETED|Period 3 -Part A: 4 Days||0
3251534|NCT02509117|3985489|FG006|COMPLETED|Period 3 -Part A: 4 Days||0
3251535|NCT02509117|3985490|FG007|COMPLETED|Period 3 -Part A: 4 Days||0
3251536|NCT02509117|3985491|FG008|COMPLETED|Period 3 -Part A: 4 Days||0
3251537|NCT02509117|3985492|FG009|COMPLETED|Period 3 -Part A: 4 Days||0
3251538|NCT02509117|3985483|FG000|NOT COMPLETED|Period 3 -Part A: 4 Days||0
3251539|NCT02509117|3985484|FG001|NOT COMPLETED|Period 3 -Part A: 4 Days||0
3251540|NCT02509117|3985485|FG002|NOT COMPLETED|Period 3 -Part A: 4 Days||0
3251541|NCT02509117|3985486|FG003|NOT COMPLETED|Period 3 -Part A: 4 Days||0
3251542|NCT02509117|3985487|FG004|NOT COMPLETED|Period 3 -Part A: 4 Days||0
3251543|NCT02509117|3985488|FG005|NOT COMPLETED|Period 3 -Part A: 4 Days||0
3251544|NCT02509117|3985489|FG006|NOT COMPLETED|Period 3 -Part A: 4 Days||0
3251545|NCT02509117|3985490|FG007|NOT COMPLETED|Period 3 -Part A: 4 Days||0
3251546|NCT02509117|3985491|FG008|NOT COMPLETED|Period 3 -Part A: 4 Days||0
3251547|NCT02509117|3985492|FG009|NOT COMPLETED|Period 3 -Part A: 4 Days||0
3251548|NCT02509117|3985483|FG000|STARTED|Washout Period 3 (Part A: 7 Days)||2
3251549|NCT02509117|3985484|FG001|STARTED|Washout Period 3 (Part A: 7 Days)||2
3251550|NCT02509117|3985485|FG002|STARTED|Washout Period 3 (Part A: 7 Days)||2
3251551|NCT02509117|3985486|FG003|STARTED|Washout Period 3 (Part A: 7 Days)||2
3251552|NCT02509117|3985487|FG004|STARTED|Washout Period 3 (Part A: 7 Days)||0
3251553|NCT02509117|3985488|FG005|STARTED|Washout Period 3 (Part A: 7 Days)||0
3251554|NCT02509117|3985489|FG006|STARTED|Washout Period 3 (Part A: 7 Days)||0
3251555|NCT02509117|3985490|FG007|STARTED|Washout Period 3 (Part A: 7 Days)||0
3251556|NCT02509117|3985491|FG008|STARTED|Washout Period 3 (Part A: 7 Days)||0
3251557|NCT02509117|3985492|FG009|STARTED|Washout Period 3 (Part A: 7 Days)||0
3251558|NCT02509117|3985483|FG000|COMPLETED|Washout Period 3 (Part A: 7 Days)||2
3251559|NCT02509117|3985484|FG001|COMPLETED|Washout Period 3 (Part A: 7 Days)||2
3251560|NCT02509117|3985485|FG002|COMPLETED|Washout Period 3 (Part A: 7 Days)||2
3251561|NCT02509117|3985486|FG003|COMPLETED|Washout Period 3 (Part A: 7 Days)||2
3251562|NCT02509117|3985487|FG004|COMPLETED|Washout Period 3 (Part A: 7 Days)||0
3251563|NCT02509117|3985488|FG005|COMPLETED|Washout Period 3 (Part A: 7 Days)||0
3251564|NCT02509117|3985489|FG006|COMPLETED|Washout Period 3 (Part A: 7 Days)||0
3251565|NCT02509117|3985490|FG007|COMPLETED|Washout Period 3 (Part A: 7 Days)||0
3251566|NCT02509117|3985491|FG008|COMPLETED|Washout Period 3 (Part A: 7 Days)||0
3251567|NCT02509117|3985492|FG009|COMPLETED|Washout Period 3 (Part A: 7 Days)||0
3251568|NCT02509117|3985483|FG000|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
3251569|NCT02509117|3985484|FG001|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
3251570|NCT02509117|3985485|FG002|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
3251571|NCT02509117|3985486|FG003|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
3251572|NCT02509117|3985487|FG004|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
3251573|NCT02509117|3985488|FG005|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
3251574|NCT02509117|3985489|FG006|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
3251575|NCT02509117|3985490|FG007|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
3251576|NCT02509117|3985491|FG008|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
3251577|NCT02509117|3985492|FG009|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
3251578|NCT02509117|3985483|FG000|STARTED|Period 4 -Part A: 4 Days||2
3251579|NCT02509117|3985484|FG001|STARTED|Period 4 -Part A: 4 Days||2
3251580|NCT02509117|3985485|FG002|STARTED|Period 4 -Part A: 4 Days||2
3251581|NCT02509117|3985486|FG003|STARTED|Period 4 -Part A: 4 Days||2
3251582|NCT02509117|3985487|FG004|STARTED|Period 4 -Part A: 4 Days||0
3251583|NCT02509117|3985488|FG005|STARTED|Period 4 -Part A: 4 Days||0
3251584|NCT02509117|3985489|FG006|STARTED|Period 4 -Part A: 4 Days||0
3251585|NCT02509117|3985490|FG007|STARTED|Period 4 -Part A: 4 Days||0
3251586|NCT02509117|3985491|FG008|STARTED|Period 4 -Part A: 4 Days||0
3251587|NCT02509117|3985492|FG009|STARTED|Period 4 -Part A: 4 Days||0
3251588|NCT02509117|3985483|FG000|COMPLETED|Period 4 -Part A: 4 Days||2
3251589|NCT02509117|3985484|FG001|COMPLETED|Period 4 -Part A: 4 Days||2
3251590|NCT02509117|3985485|FG002|COMPLETED|Period 4 -Part A: 4 Days||2
3251591|NCT02509117|3985486|FG003|COMPLETED|Period 4 -Part A: 4 Days||2
3251592|NCT02509117|3985487|FG004|COMPLETED|Period 4 -Part A: 4 Days||0
3251593|NCT02509117|3985488|FG005|COMPLETED|Period 4 -Part A: 4 Days||0
3251594|NCT02509117|3985489|FG006|COMPLETED|Period 4 -Part A: 4 Days||0
3251595|NCT02509117|3985490|FG007|COMPLETED|Period 4 -Part A: 4 Days||0
3251596|NCT02509117|3985491|FG008|COMPLETED|Period 4 -Part A: 4 Days||0
3251597|NCT02509117|3985492|FG009|COMPLETED|Period 4 -Part A: 4 Days||0
3251598|NCT02509117|3985483|FG000|NOT COMPLETED|Period 4 -Part A: 4 Days||0
3251599|NCT02509117|3985484|FG001|NOT COMPLETED|Period 4 -Part A: 4 Days||0
3251600|NCT02509117|3985485|FG002|NOT COMPLETED|Period 4 -Part A: 4 Days||0
3251601|NCT02509117|3985486|FG003|NOT COMPLETED|Period 4 -Part A: 4 Days||0
3251602|NCT02509117|3985487|FG004|NOT COMPLETED|Period 4 -Part A: 4 Days||0
3251603|NCT02509117|3985488|FG005|NOT COMPLETED|Period 4 -Part A: 4 Days||0
3251604|NCT02509117|3985489|FG006|NOT COMPLETED|Period 4 -Part A: 4 Days||0
3251605|NCT02509117|3985490|FG007|NOT COMPLETED|Period 4 -Part A: 4 Days||0
3251606|NCT02509117|3985491|FG008|NOT COMPLETED|Period 4 -Part A: 4 Days||0
3251607|NCT02509117|3985492|FG009|NOT COMPLETED|Period 4 -Part A: 4 Days||0
3251608|NCT02509156|3985532|FG000|STARTED|Open-Label Lead-In Phase||6
3251609|NCT02509156|3985533|FG001|STARTED|Open-Label Lead-In Phase||0
3251610|NCT02509156|3985532|FG000|COMPLETED|Open-Label Lead-In Phase||6
3251611|NCT02509156|3985533|FG001|COMPLETED|Open-Label Lead-In Phase||0
3251612|NCT02509156|3985532|FG000|NOT COMPLETED|Open-Label Lead-In Phase||0
3251613|NCT02509156|3985533|FG001|NOT COMPLETED|Open-Label Lead-In Phase||0
3251614|NCT02509156|3985532|FG000|STARTED|Randomized Phase|Includes randomized participants only|14
3251615|NCT02509156|3985533|FG001|STARTED|Randomized Phase||17
3251616|NCT02509156|3985532|FG000|COMPLETED|Randomized Phase||12
3251617|NCT02509156|3985533|FG001|COMPLETED|Randomized Phase||16
3251618|NCT02509156|3985532|FG000|NOT COMPLETED|Randomized Phase||2
3251619|NCT02509156|3985533|FG001|NOT COMPLETED|Randomized Phase||1
3251620|NCT02509481|3985541|FG000|STARTED|Overall Study||1265
3251621|NCT02509481|3985542|FG001|STARTED|Overall Study||1447
3251622|NCT02509481|3985541|FG000|COMPLETED|Overall Study||1265
3251623|NCT02509481|3985542|FG001|COMPLETED|Overall Study||1447
3251624|NCT02509481|3985541|FG000|NOT COMPLETED|Overall Study||0
3251625|NCT02509481|3985542|FG001|NOT COMPLETED|Overall Study||0
3251626|NCT02509585|3985548|FG000|STARTED|Overall Study||18
3251627|NCT02509585|3985548|FG000|COMPLETED|Overall Study||18
3251628|NCT02509585|3985548|FG000|NOT COMPLETED|Overall Study||0
3251629|NCT02509624|3985557|FG000|STARTED|Overall Study||10
3251630|NCT02509624|3985558|FG001|STARTED|Overall Study||10
3251631|NCT02509624|3985559|FG002|STARTED|Overall Study||10
3251632|NCT02509624|3985560|FG003|STARTED|Overall Study||22
3251633|NCT02509624|3985557|FG000|COMPLETED|Overall Study||10
3251634|NCT02509624|3985558|FG001|COMPLETED|Overall Study||10
3251635|NCT02509624|3985559|FG002|COMPLETED|Overall Study||10
3251636|NCT02509624|3985560|FG003|COMPLETED|Overall Study||22
3251637|NCT02509624|3985557|FG000|NOT COMPLETED|Overall Study||0
3251638|NCT02509624|3985558|FG001|NOT COMPLETED|Overall Study||0
3251639|NCT02509624|3985559|FG002|NOT COMPLETED|Overall Study||0
3251640|NCT02509624|3985560|FG003|NOT COMPLETED|Overall Study||0
3251641|NCT02509767|3985575|FG000|STARTED|Overall Study||201
3251642|NCT02509767|3985576|FG001|STARTED|Overall Study||200
3251643|NCT02509767|3985575|FG000|COMPLETED|Overall Study||157
3251644|NCT02509767|3985576|FG001|COMPLETED|Overall Study||159
3251645|NCT02509767|3985575|FG000|NOT COMPLETED|Overall Study||44
3251646|NCT02509767|3985576|FG001|NOT COMPLETED|Overall Study||41
3251647|NCT02509936|3985587|FG000|STARTED|Overall Study||163
3251648|NCT02509936|3985588|FG001|STARTED|Overall Study||161
3251649|NCT02509936|3985587|FG000|COMPLETED|Overall Study||151
3251650|NCT02509936|3985588|FG001|COMPLETED|Overall Study||145
3251651|NCT02509936|3985587|FG000|NOT COMPLETED|Overall Study||12
3251652|NCT02509936|3985588|FG001|NOT COMPLETED|Overall Study||16
3251653|NCT02510001|3985602|FG000|STARTED|Overall Study||6
3251654|NCT02510001|3985603|FG001|STARTED|Overall Study||5
3251655|NCT02510001|3985604|FG002|STARTED|Overall Study||6
3251656|NCT02510001|3985605|FG003|STARTED|Overall Study||8
3251657|NCT02510001|3985606|FG004|STARTED|Overall Study||8
3251658|NCT02510001|3985607|FG005|STARTED|Overall Study||7
3251659|NCT02510001|3985608|FG006|STARTED|Overall Study||5
3251660|NCT02510001|3985609|FG007|STARTED|Overall Study||37
3251661|NCT02510001|3985602|FG000|COMPLETED|Overall Study||6
3251662|NCT02510001|3985603|FG001|COMPLETED|Overall Study||5
3251663|NCT02510001|3985604|FG002|COMPLETED|Overall Study||6
3251664|NCT02510001|3985605|FG003|COMPLETED|Overall Study||6
3251665|NCT02510001|3985606|FG004|COMPLETED|Overall Study||4
3251666|NCT02510001|3985607|FG005|COMPLETED|Overall Study||5
3251667|NCT02510001|3985608|FG006|COMPLETED|Overall Study||3
3251668|NCT02510001|3985609|FG007|COMPLETED|Overall Study||30
3251669|NCT02510001|3985602|FG000|NOT COMPLETED|Overall Study||0
3251670|NCT02510001|3985603|FG001|NOT COMPLETED|Overall Study||0
3251671|NCT02510001|3985604|FG002|NOT COMPLETED|Overall Study||0
3251672|NCT02510001|3985605|FG003|NOT COMPLETED|Overall Study||2
3251673|NCT02510001|3985606|FG004|NOT COMPLETED|Overall Study||4
3251674|NCT02510001|3985607|FG005|NOT COMPLETED|Overall Study||2
3251675|NCT02510001|3985608|FG006|NOT COMPLETED|Overall Study||2
3251676|NCT02510001|3985609|FG007|NOT COMPLETED|Overall Study||7
3251677|NCT02510014|3985647|FG000|STARTED|Run-In Period (Days -14 to Day -1)||508
3251678|NCT02510014|3985648|FG001|STARTED|Run-In Period (Days -14 to Day -1)||267
3251679|NCT02510014|3985647|FG000|COMPLETED|Run-In Period (Days -14 to Day -1)||412
3251680|NCT02510014|3985648|FG001|COMPLETED|Run-In Period (Days -14 to Day -1)||257
3251681|NCT02510014|3985647|FG000|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||96
3251682|NCT02510014|3985648|FG001|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||10
3251683|NCT02510014|3985647|FG000|STARTED|Treatment Period||412
3251684|NCT02510014|3985648|FG001|STARTED|Treatment Period||257
3251685|NCT02510014|3985647|FG000|COMPLETED|Treatment Period||206
3251686|NCT02510014|3985648|FG001|COMPLETED|Treatment Period||200
3251687|NCT02510014|3985647|FG000|NOT COMPLETED|Treatment Period||206
3251688|NCT02510014|3985648|FG001|NOT COMPLETED|Treatment Period||57
3251689|NCT02510144|3985656|FG000|STARTED|Overall Study||39
3251690|NCT02510144|3985657|FG001|STARTED|Overall Study||41
3251691|NCT02510144|3985656|FG000|COMPLETED|Overall Study||39
3251692|NCT02510144|3985657|FG001|COMPLETED|Overall Study||41
3251693|NCT02510144|3985656|FG000|NOT COMPLETED|Overall Study||0
3251694|NCT02510144|3985657|FG001|NOT COMPLETED|Overall Study||0
3251695|NCT02510664|3985666|FG000|STARTED|Overall Study||84
3251696|NCT02510664|3985667|FG001|STARTED|Overall Study||84
3251697|NCT02510664|3985668|FG002|STARTED|Overall Study||4
3251698|NCT02510664|3985666|FG000|COMPLETED|Overall Study||64
3251699|NCT02510664|3985667|FG001|COMPLETED|Overall Study||64
3251700|NCT02510664|3985668|FG002|COMPLETED|Overall Study||4
3251701|NCT02510664|3985666|FG000|NOT COMPLETED|Overall Study||20
3251702|NCT02510664|3985667|FG001|NOT COMPLETED|Overall Study||20
3251703|NCT02510664|3985668|FG002|NOT COMPLETED|Overall Study||0
3251704|NCT02510794|3985685|FG000|STARTED|Overall Study||59
3251705|NCT02510794|3985686|FG001|STARTED|Overall Study||62
3251706|NCT02510794|3985687|FG002|STARTED|Overall Study||63
3251707|NCT02510794|3985688|FG003|STARTED|Overall Study||41
3251708|NCT02510794|3985685|FG000|COMPLETED|Overall Study||51
3251709|NCT02510794|3985686|FG001|COMPLETED|Overall Study||56
3251710|NCT02510794|3985687|FG002|COMPLETED|Overall Study||56
3251711|NCT02510794|3985688|FG003|COMPLETED|Overall Study||36
3251712|NCT02510794|3985685|FG000|NOT COMPLETED|Overall Study||8
3251713|NCT02510794|3985686|FG001|NOT COMPLETED|Overall Study||6
3251714|NCT02510794|3985687|FG002|NOT COMPLETED|Overall Study||7
3251715|NCT02510794|3985688|FG003|NOT COMPLETED|Overall Study||5
3251716|NCT02510820|3985700|FG000|STARTED|First Intervention (4 Weeks)||21
3251717|NCT02510820|3985701|FG001|STARTED|First Intervention (4 Weeks)||27
3251718|NCT02510820|3985700|FG000|COMPLETED|First Intervention (4 Weeks)||21
3251719|NCT02510820|3985701|FG001|COMPLETED|First Intervention (4 Weeks)||26
3251720|NCT02510820|3985700|FG000|NOT COMPLETED|First Intervention (4 Weeks)||0
3251721|NCT02510820|3985701|FG001|NOT COMPLETED|First Intervention (4 Weeks)||1
3251722|NCT02510820|3985700|FG000|STARTED|Washout (1 Week)||21
3251723|NCT02510820|3985701|FG001|STARTED|Washout (1 Week)||26
3251724|NCT02510820|3985700|FG000|COMPLETED|Washout (1 Week)||21
3251725|NCT02510820|3985701|FG001|COMPLETED|Washout (1 Week)||26
3251726|NCT02510820|3985700|FG000|NOT COMPLETED|Washout (1 Week)||0
3251727|NCT02510820|3985701|FG001|NOT COMPLETED|Washout (1 Week)||0
3251728|NCT02510820|3985700|FG000|STARTED|Second Intervention (4 Weeks)||21
3251729|NCT02510820|3985701|FG001|STARTED|Second Intervention (4 Weeks)||26
3251730|NCT02510820|3985700|FG000|COMPLETED|Second Intervention (4 Weeks)||20
3251731|NCT02510820|3985701|FG001|COMPLETED|Second Intervention (4 Weeks)||26
3251732|NCT02510820|3985700|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||1
3251733|NCT02510820|3985701|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||0
3251734|NCT02511184|3985710|FG000|STARTED|Overall Study||2
3251735|NCT02511184|3985711|FG001|STARTED|Overall Study||7
3251736|NCT02511184|3985710|FG000|COMPLETED|Overall Study||0
3251737|NCT02511184|3985711|FG001|COMPLETED|Overall Study||0
3251738|NCT02511184|3985710|FG000|NOT COMPLETED|Overall Study||2
3251739|NCT02511184|3985711|FG001|NOT COMPLETED|Overall Study||7
3251740|NCT02511236|3985720|FG000|STARTED|Overall Study||165
3251741|NCT02511236|3985721|FG001|STARTED|Overall Study||191
3251742|NCT02511236|3985720|FG000|COMPLETED|Overall Study||125
3251743|NCT02511236|3985721|FG001|COMPLETED|Overall Study||146
3251744|NCT02511236|3985720|FG000|NOT COMPLETED|Overall Study||40
3251745|NCT02511236|3985721|FG001|NOT COMPLETED|Overall Study||45
3251746|NCT02511379|3985727|FG000|STARTED|Overall Study||14
3251747|NCT02511379|3985727|FG000|COMPLETED|Overall Study||14
3251748|NCT02511379|3985727|FG000|NOT COMPLETED|Overall Study||0
3251749|NCT02511431|3985737|FG000|STARTED|Treatment||4
3251750|NCT02511431|3985738|FG001|STARTED|Treatment||4
3251751|NCT02511431|3985739|FG002|STARTED|Treatment||4
3251752|NCT02511431|3985740|FG003|STARTED|Treatment||3
3251753|NCT02511431|3985741|FG004|STARTED|Treatment||3
3251754|NCT02511431|3985742|FG005|STARTED|Treatment||3
3251755|NCT02511431|3985737|FG000|COMPLETED|Treatment||4
3251756|NCT02511431|3985738|FG001|COMPLETED|Treatment||4
3251757|NCT02511431|3985739|FG002|COMPLETED|Treatment||3
3251758|NCT02511431|3985740|FG003|COMPLETED|Treatment||3
3251759|NCT02511431|3985741|FG004|COMPLETED|Treatment||3
3251760|NCT02511431|3985742|FG005|COMPLETED|Treatment||2
3251761|NCT02511431|3985737|FG000|NOT COMPLETED|Treatment||0
3251762|NCT02511431|3985738|FG001|NOT COMPLETED|Treatment||0
3251763|NCT02511431|3985739|FG002|NOT COMPLETED|Treatment||1
3251764|NCT02511431|3985740|FG003|NOT COMPLETED|Treatment||0
3251765|NCT02511431|3985741|FG004|NOT COMPLETED|Treatment||0
3251766|NCT02511431|3985742|FG005|NOT COMPLETED|Treatment||1
3251767|NCT02511431|3985737|FG000|STARTED|Post-treatment Follow-up||4
3251768|NCT02511431|3985738|FG001|STARTED|Post-treatment Follow-up||4
3251769|NCT02511431|3985739|FG002|STARTED|Post-treatment Follow-up||3
3251770|NCT02511431|3985740|FG003|STARTED|Post-treatment Follow-up||3
3251771|NCT02511431|3985741|FG004|STARTED|Post-treatment Follow-up||3
3251772|NCT02511431|3985742|FG005|STARTED|Post-treatment Follow-up||2
3251773|NCT02511431|3985737|FG000|COMPLETED|Post-treatment Follow-up||4
3251774|NCT02511431|3985738|FG001|COMPLETED|Post-treatment Follow-up||4
3251775|NCT02511431|3985739|FG002|COMPLETED|Post-treatment Follow-up||3
3251776|NCT02511431|3985740|FG003|COMPLETED|Post-treatment Follow-up||3
3251777|NCT02511431|3985741|FG004|COMPLETED|Post-treatment Follow-up||3
3251778|NCT02511431|3985742|FG005|COMPLETED|Post-treatment Follow-up||2
3251779|NCT02511431|3985737|FG000|NOT COMPLETED|Post-treatment Follow-up||0
3251780|NCT02511431|3985738|FG001|NOT COMPLETED|Post-treatment Follow-up||0
3251781|NCT02511431|3985739|FG002|NOT COMPLETED|Post-treatment Follow-up||0
3251782|NCT02511431|3985740|FG003|NOT COMPLETED|Post-treatment Follow-up||0
3251783|NCT02511431|3985741|FG004|NOT COMPLETED|Post-treatment Follow-up||0
3251784|NCT02511431|3985742|FG005|NOT COMPLETED|Post-treatment Follow-up||0
3251785|NCT02511535|3985760|FG000|STARTED|Overall Study||49
3251786|NCT02511535|3985761|FG001|STARTED|Overall Study||21
3251787|NCT02511535|3985762|FG002|STARTED|Overall Study||49
3251788|NCT02511535|3985760|FG000|COMPLETED|Overall Study||49
3251789|NCT02511535|3985761|FG001|COMPLETED|Overall Study||21
3251790|NCT02511535|3985762|FG002|COMPLETED|Overall Study||49
3251791|NCT02511535|3985760|FG000|NOT COMPLETED|Overall Study||0
3251792|NCT02511535|3985761|FG001|NOT COMPLETED|Overall Study||0
3251793|NCT02511535|3985762|FG002|NOT COMPLETED|Overall Study||0
3251794|NCT02511561|3985773|FG000|STARTED|Overall Study||25
3251795|NCT02511561|3985774|FG001|STARTED|Overall Study||25
3251796|NCT02511561|3985775|FG002|STARTED|Overall Study||25
3251797|NCT02511561|3985773|FG000|COMPLETED|Overall Study||25
3251798|NCT02511561|3985774|FG001|COMPLETED|Overall Study||25
3251799|NCT02511561|3985775|FG002|COMPLETED|Overall Study||25
3251800|NCT02511561|3985773|FG000|NOT COMPLETED|Overall Study||0
3251801|NCT02511561|3985774|FG001|NOT COMPLETED|Overall Study||0
3251802|NCT02511561|3985775|FG002|NOT COMPLETED|Overall Study||0
3251803|NCT02511587|3985786|FG000|STARTED|Overall Study||58
3251804|NCT02511587|3985787|FG001|STARTED|Overall Study||58
3251805|NCT02511587|3985786|FG000|COMPLETED|Overall Study||58
3251806|NCT02511587|3985787|FG001|COMPLETED|Overall Study||58
3251807|NCT02511587|3985786|FG000|NOT COMPLETED|Overall Study||0
3251808|NCT02511587|3985787|FG001|NOT COMPLETED|Overall Study||0
3251809|NCT02511678|3985793|FG000|STARTED|Overall Study||73
3251810|NCT02511678|3985793|FG000|Intent-to-Treat (ITT) Population|Overall Study|Participants for whom cryoablation via Galil Medical cryoablation system was attempted or performed.|66
3251811|NCT02511678|3985793|FG000|Participants Discontinued Pre-Treatment|Overall Study||7
3251812|NCT02511678|3985793|FG000|Safety Population|Overall Study|Participants for whom received the complete study cryoablation procedure.|65
3251813|NCT02511678|3985793|FG000|COMPLETED|Overall Study||37
3251814|NCT02511678|3985793|FG000|NOT COMPLETED|Overall Study||36
3251815|NCT02511717|3985800|FG000|STARTED|Overall Study||10
3251816|NCT02511717|3985801|FG001|STARTED|Overall Study||10
3251817|NCT02511717|3985800|FG000|COMPLETED|Overall Study||8
3251818|NCT02511717|3985801|FG001|COMPLETED|Overall Study||10
3251819|NCT02511717|3985800|FG000|NOT COMPLETED|Overall Study||2
3251820|NCT02511717|3985801|FG001|NOT COMPLETED|Overall Study||0
3251821|NCT02511730|3985807|FG000|STARTED|First Reading Session||50
3251822|NCT02511730|3985808|FG001|STARTED|First Reading Session||50
3251823|NCT02511730|3985807|FG000|COMPLETED|First Reading Session||50
3251824|NCT02511730|3985808|FG001|COMPLETED|First Reading Session||50
3251825|NCT02511730|3985807|FG000|NOT COMPLETED|First Reading Session||0
3251826|NCT02511730|3985808|FG001|NOT COMPLETED|First Reading Session||0
3251827|NCT02511730|3985807|FG000|STARTED|4 Week Memory Washout Period||50
3251828|NCT02511730|3985808|FG001|STARTED|4 Week Memory Washout Period||50
3251829|NCT02511730|3985807|FG000|COMPLETED|4 Week Memory Washout Period||50
3251830|NCT02511730|3985808|FG001|COMPLETED|4 Week Memory Washout Period||50
3251831|NCT02511730|3985807|FG000|NOT COMPLETED|4 Week Memory Washout Period||0
3251832|NCT02511730|3985808|FG001|NOT COMPLETED|4 Week Memory Washout Period||0
3251833|NCT02511730|3985807|FG000|STARTED|Session Reading Session||50
3371634|NCT03724253|4103325|FG001|NOT COMPLETED|Overall Study||0
3371635|NCT03724253|4103326|FG002|NOT COMPLETED|Overall Study||0
3371636|NCT03724253|4103327|FG003|NOT COMPLETED|Overall Study||0
3371637|NCT03724253|4103328|FG004|NOT COMPLETED|Overall Study||0
3371638|NCT03723980|4103342|FG000|STARTED|Overall Study||40
3371639|NCT03723980|4103343|FG001|STARTED|Overall Study||40
3371640|NCT03723980|4103342|FG000|COMPLETED|Overall Study||33
3371641|NCT03723980|4103343|FG001|COMPLETED|Overall Study||35
3371642|NCT03723980|4103342|FG000|NOT COMPLETED|Overall Study||7
3371643|NCT03723980|4103343|FG001|NOT COMPLETED|Overall Study||5
3371644|NCT03723603|4103355|FG000|STARTED|Overall Study||8
3371645|NCT03723603|4103355|FG000|COMPLETED|Overall Study||5
3371646|NCT03723603|4103355|FG000|NOT COMPLETED|Overall Study||3
3371647|NCT03723447|4103361|FG000|STARTED|Overall Study||50
3371648|NCT03723447|4103362|FG001|STARTED|Overall Study||51
3371649|NCT03723447|4103361|FG000|COMPLETED|Overall Study||50
3371650|NCT03723447|4103362|FG001|COMPLETED|Overall Study||51
3371651|NCT03723447|4103361|FG000|NOT COMPLETED|Overall Study||0
3251834|NCT02511730|3985808|FG001|STARTED|Session Reading Session||50
3251835|NCT02511730|3985807|FG000|COMPLETED|Session Reading Session||50
3251836|NCT02511730|3985808|FG001|COMPLETED|Session Reading Session||50
3251837|NCT02511730|3985807|FG000|NOT COMPLETED|Session Reading Session||0
3251838|NCT02511730|3985808|FG001|NOT COMPLETED|Session Reading Session||0
3251839|NCT02511782|3985817|FG000|STARTED|Overall Study||51
3251840|NCT02511782|3985818|FG001|STARTED|Overall Study||2
3251841|NCT02511782|3985819|FG002|STARTED|Overall Study||10
3251842|NCT02511782|3985817|FG000|COMPLETED|Overall Study||50
3251843|NCT02511782|3985818|FG001|COMPLETED|Overall Study||2
3251844|NCT02511782|3985819|FG002|COMPLETED|Overall Study||10
3251845|NCT02511782|3985817|FG000|NOT COMPLETED|Overall Study||1
3251846|NCT02511782|3985818|FG001|NOT COMPLETED|Overall Study||0
3251847|NCT02511782|3985819|FG002|NOT COMPLETED|Overall Study||0
3251848|NCT02512042|3985829|FG000|STARTED|Overall Study||495
3251849|NCT02512042|3985830|FG001|STARTED|Overall Study||478
3251850|NCT02512042|3985829|FG000|COMPLETED|Overall Study||472
3251851|NCT02512042|3985830|FG001|COMPLETED|Overall Study||453
3251852|NCT02512042|3985829|FG000|NOT COMPLETED|Overall Study||23
3251853|NCT02512042|3985830|FG001|NOT COMPLETED|Overall Study||25
3251854|NCT02512068|3985838|FG000|STARTED|Overall Study||55
3251855|NCT02512068|3985839|FG001|STARTED|Overall Study||52
3251856|NCT02512068|3985838|FG000|COMPLETED|Overall Study||43
3251857|NCT02512068|3985839|FG001|COMPLETED|Overall Study||39
3251858|NCT02512068|3985838|FG000|NOT COMPLETED|Overall Study||12
3251859|NCT02512068|3985839|FG001|NOT COMPLETED|Overall Study||13
3251860|NCT02512094|3985845|FG000|STARTED|Overall Study||53
3251861|NCT02512094|3985845|FG000|COMPLETED|Overall Study||53
3251862|NCT02512094|3985845|FG000|NOT COMPLETED|Overall Study||0
3251863|NCT02512224|3985851|FG000|STARTED|Overall Study||2912
3251864|NCT02512224|3985852|FG001|STARTED|Overall Study||2912
3251865|NCT02512224|3985851|FG000|COMPLETED|Overall Study||2912
3251866|NCT02512224|3985852|FG001|COMPLETED|Overall Study||2912
3251867|NCT02512224|3985851|FG000|NOT COMPLETED|Overall Study||0
3251868|NCT02512224|3985852|FG001|NOT COMPLETED|Overall Study||0
3251869|NCT02512276|3985860|FG000|STARTED|Overall Study||2038
3251870|NCT02512276|3985861|FG001|STARTED|Overall Study||2040
3251871|NCT02512276|3985860|FG000|COMPLETED|Overall Study||2030
3251872|NCT02512276|3985861|FG001|COMPLETED|Overall Study||2029
3251873|NCT02512276|3985860|FG000|NOT COMPLETED|Overall Study||8
3251874|NCT02512276|3985861|FG001|NOT COMPLETED|Overall Study||11
3251875|NCT02512302|3985867|FG000|STARTED|Period 1||3
3251876|NCT02512302|3985868|FG001|STARTED|Period 1||3
3251877|NCT02512302|3985869|FG002|STARTED|Period 1||4
3251878|NCT02512302|3985870|FG003|STARTED|Period 1||3
3251879|NCT02512302|3985871|FG004|STARTED|Period 1||3
3251880|NCT02512302|3985872|FG005|STARTED|Period 1||3
3251881|NCT02512302|3985873|FG006|STARTED|Period 1||2
3251882|NCT02512302|3985874|FG007|STARTED|Period 1||3
3251883|NCT02512302|3985875|FG008|STARTED|Period 1||3
3251884|NCT02512302|3985876|FG009|STARTED|Period 1||3
3251885|NCT02512302|3985867|FG000|COMPLETED|Period 1||3
3251886|NCT02512302|3985868|FG001|COMPLETED|Period 1||2
3251887|NCT02512302|3985869|FG002|COMPLETED|Period 1||4
3251888|NCT02512302|3985870|FG003|COMPLETED|Period 1||3
3251889|NCT02512302|3985871|FG004|COMPLETED|Period 1||3
3251890|NCT02512302|3985872|FG005|COMPLETED|Period 1||3
3251891|NCT02512302|3985873|FG006|COMPLETED|Period 1||2
3251892|NCT02512302|3985874|FG007|COMPLETED|Period 1||3
3251893|NCT02512302|3985875|FG008|COMPLETED|Period 1||3
3251894|NCT02512302|3985876|FG009|COMPLETED|Period 1||3
3251895|NCT02512302|3985867|FG000|NOT COMPLETED|Period 1||0
3251896|NCT02512302|3985868|FG001|NOT COMPLETED|Period 1||1
3251897|NCT02512302|3985869|FG002|NOT COMPLETED|Period 1||0
3251898|NCT02512302|3985870|FG003|NOT COMPLETED|Period 1||0
3251899|NCT02512302|3985871|FG004|NOT COMPLETED|Period 1||0
3251900|NCT02512302|3985872|FG005|NOT COMPLETED|Period 1||0
3251901|NCT02512302|3985873|FG006|NOT COMPLETED|Period 1||0
3251902|NCT02512302|3985874|FG007|NOT COMPLETED|Period 1||0
3251903|NCT02512302|3985875|FG008|NOT COMPLETED|Period 1||0
3251904|NCT02512302|3985876|FG009|NOT COMPLETED|Period 1||0
3251905|NCT02512302|3985867|FG000|STARTED|Period 2||3
3251906|NCT02512302|3985868|FG001|STARTED|Period 2||2
3251907|NCT02512302|3985869|FG002|STARTED|Period 2||4
3251908|NCT02512302|3985870|FG003|STARTED|Period 2||3
3251909|NCT02512302|3985871|FG004|STARTED|Period 2||3
3251910|NCT02512302|3985872|FG005|STARTED|Period 2||3
3251911|NCT02512302|3985873|FG006|STARTED|Period 2||2
3251912|NCT02512302|3985874|FG007|STARTED|Period 2||3
3251913|NCT02512302|3985875|FG008|STARTED|Period 2||3
3251914|NCT02512302|3985876|FG009|STARTED|Period 2||3
3251915|NCT02512302|3985867|FG000|COMPLETED|Period 2||3
3251916|NCT02512302|3985868|FG001|COMPLETED|Period 2||2
3251917|NCT02512302|3985869|FG002|COMPLETED|Period 2||4
3251918|NCT02512302|3985870|FG003|COMPLETED|Period 2||3
3251919|NCT02512302|3985871|FG004|COMPLETED|Period 2||3
3251920|NCT02512302|3985872|FG005|COMPLETED|Period 2||3
3251921|NCT02512302|3985873|FG006|COMPLETED|Period 2||2
3251922|NCT02512302|3985874|FG007|COMPLETED|Period 2||3
3251923|NCT02512302|3985875|FG008|COMPLETED|Period 2||3
3251924|NCT02512302|3985876|FG009|COMPLETED|Period 2||2
3251925|NCT02512302|3985867|FG000|NOT COMPLETED|Period 2||0
3251926|NCT02512302|3985868|FG001|NOT COMPLETED|Period 2||0
3251927|NCT02512302|3985869|FG002|NOT COMPLETED|Period 2||0
3251928|NCT02512302|3985870|FG003|NOT COMPLETED|Period 2||0
3251929|NCT02512302|3985871|FG004|NOT COMPLETED|Period 2||0
3251930|NCT02512302|3985872|FG005|NOT COMPLETED|Period 2||0
3251931|NCT02512302|3985873|FG006|NOT COMPLETED|Period 2||0
3251932|NCT02512302|3985874|FG007|NOT COMPLETED|Period 2||0
3251933|NCT02512302|3985875|FG008|NOT COMPLETED|Period 2||0
3251934|NCT02512302|3985876|FG009|NOT COMPLETED|Period 2||1
3251935|NCT02512302|3985867|FG000|STARTED|Period 3||3
3251936|NCT02512302|3985868|FG001|STARTED|Period 3||2
3251937|NCT02512302|3985869|FG002|STARTED|Period 3||4
3251938|NCT02512302|3985870|FG003|STARTED|Period 3||3
3251939|NCT02512302|3985871|FG004|STARTED|Period 3||3
3251940|NCT02512302|3985872|FG005|STARTED|Period 3||3
3251941|NCT02512302|3985873|FG006|STARTED|Period 3||2
3251942|NCT02512302|3985874|FG007|STARTED|Period 3||3
3251943|NCT02512302|3985875|FG008|STARTED|Period 3||3
3251944|NCT02512302|3985876|FG009|STARTED|Period 3||2
3251945|NCT02512302|3985867|FG000|COMPLETED|Period 3||3
3251946|NCT02512302|3985868|FG001|COMPLETED|Period 3||2
3251947|NCT02512302|3985869|FG002|COMPLETED|Period 3||3
3251948|NCT02512302|3985870|FG003|COMPLETED|Period 3||3
3251949|NCT02512302|3985871|FG004|COMPLETED|Period 3||3
3251950|NCT02512302|3985872|FG005|COMPLETED|Period 3||3
3251951|NCT02512302|3985873|FG006|COMPLETED|Period 3||2
3251952|NCT02512302|3985874|FG007|COMPLETED|Period 3||3
3251953|NCT02512302|3985875|FG008|COMPLETED|Period 3||3
3251954|NCT02512302|3985876|FG009|COMPLETED|Period 3||2
3251955|NCT02512302|3985867|FG000|NOT COMPLETED|Period 3||0
3251956|NCT02512302|3985868|FG001|NOT COMPLETED|Period 3||0
3251957|NCT02512302|3985869|FG002|NOT COMPLETED|Period 3||1
3251958|NCT02512302|3985870|FG003|NOT COMPLETED|Period 3||0
3251959|NCT02512302|3985871|FG004|NOT COMPLETED|Period 3||0
3251960|NCT02512302|3985872|FG005|NOT COMPLETED|Period 3||0
3251961|NCT02512302|3985873|FG006|NOT COMPLETED|Period 3||0
3251962|NCT02512302|3985874|FG007|NOT COMPLETED|Period 3||0
3251963|NCT02512302|3985875|FG008|NOT COMPLETED|Period 3||0
3251964|NCT02512302|3985876|FG009|NOT COMPLETED|Period 3||0
3251965|NCT02512302|3985867|FG000|STARTED|Period 4||3
3251966|NCT02512302|3985868|FG001|STARTED|Period 4||2
3251967|NCT02512302|3985869|FG002|STARTED|Period 4||3
3251968|NCT02512302|3985870|FG003|STARTED|Period 4||3
3251969|NCT02512302|3985871|FG004|STARTED|Period 4||3
3251970|NCT02512302|3985872|FG005|STARTED|Period 4||3
3251971|NCT02512302|3985873|FG006|STARTED|Period 4||2
3251972|NCT02512302|3985874|FG007|STARTED|Period 4||3
3251973|NCT02512302|3985875|FG008|STARTED|Period 4||3
3251974|NCT02512302|3985876|FG009|STARTED|Period 4||2
3251975|NCT02512302|3985867|FG000|COMPLETED|Period 4||3
3251976|NCT02512302|3985868|FG001|COMPLETED|Period 4||2
3251977|NCT02512302|3985869|FG002|COMPLETED|Period 4||3
3251978|NCT02512302|3985870|FG003|COMPLETED|Period 4||3
3251979|NCT02512302|3985871|FG004|COMPLETED|Period 4||3
3251980|NCT02512302|3985872|FG005|COMPLETED|Period 4||3
3251981|NCT02512302|3985873|FG006|COMPLETED|Period 4||1
3251982|NCT02512302|3985874|FG007|COMPLETED|Period 4||3
3251983|NCT02512302|3985875|FG008|COMPLETED|Period 4||3
3251984|NCT02512302|3985876|FG009|COMPLETED|Period 4||2
3251985|NCT02512302|3985867|FG000|NOT COMPLETED|Period 4||0
3251986|NCT02512302|3985868|FG001|NOT COMPLETED|Period 4||0
3251987|NCT02512302|3985869|FG002|NOT COMPLETED|Period 4||0
3251988|NCT02512302|3985870|FG003|NOT COMPLETED|Period 4||0
3251989|NCT02512302|3985871|FG004|NOT COMPLETED|Period 4||0
3251990|NCT02512302|3985872|FG005|NOT COMPLETED|Period 4||0
3251991|NCT02512302|3985873|FG006|NOT COMPLETED|Period 4||1
3251992|NCT02512302|3985874|FG007|NOT COMPLETED|Period 4||0
3251993|NCT02512302|3985875|FG008|NOT COMPLETED|Period 4||0
3251994|NCT02512302|3985876|FG009|NOT COMPLETED|Period 4||0
3251995|NCT02512302|3985867|FG000|STARTED|Period 5||3
3251996|NCT02512302|3985868|FG001|STARTED|Period 5||2
3251997|NCT02512302|3985869|FG002|STARTED|Period 5||3
3251998|NCT02512302|3985870|FG003|STARTED|Period 5||3
3251999|NCT02512302|3985871|FG004|STARTED|Period 5||3
3252000|NCT02512302|3985872|FG005|STARTED|Period 5||3
3252001|NCT02512302|3985873|FG006|STARTED|Period 5||1
3252002|NCT02512302|3985874|FG007|STARTED|Period 5||3
3252003|NCT02512302|3985875|FG008|STARTED|Period 5||3
3252004|NCT02512302|3985876|FG009|STARTED|Period 5||2
3252005|NCT02512302|3985867|FG000|COMPLETED|Period 5||3
3252006|NCT02512302|3985868|FG001|COMPLETED|Period 5||2
3252007|NCT02512302|3985869|FG002|COMPLETED|Period 5||3
3252008|NCT02512302|3985870|FG003|COMPLETED|Period 5||3
3252009|NCT02512302|3985871|FG004|COMPLETED|Period 5||3
3252010|NCT02512302|3985872|FG005|COMPLETED|Period 5||3
3252011|NCT02512302|3985873|FG006|COMPLETED|Period 5||1
3252012|NCT02512302|3985874|FG007|COMPLETED|Period 5||3
3252013|NCT02512302|3985875|FG008|COMPLETED|Period 5||3
3252014|NCT02512302|3985876|FG009|COMPLETED|Period 5||2
3252015|NCT02512302|3985867|FG000|NOT COMPLETED|Period 5||0
3252016|NCT02512302|3985868|FG001|NOT COMPLETED|Period 5||0
3252017|NCT02512302|3985869|FG002|NOT COMPLETED|Period 5||0
3252018|NCT02512302|3985870|FG003|NOT COMPLETED|Period 5||0
3252019|NCT02512302|3985871|FG004|NOT COMPLETED|Period 5||0
3252020|NCT02512302|3985872|FG005|NOT COMPLETED|Period 5||0
3252021|NCT02512302|3985873|FG006|NOT COMPLETED|Period 5||0
3252022|NCT02512302|3985874|FG007|NOT COMPLETED|Period 5||0
3252023|NCT02512302|3985875|FG008|NOT COMPLETED|Period 5||0
3252024|NCT02512302|3985876|FG009|NOT COMPLETED|Period 5||0
3252025|NCT02512393|3985891|FG000|STARTED|Overall Study||21
3252026|NCT02512393|3985892|FG001|STARTED|Overall Study||20
3252027|NCT02512393|3985891|FG000|COMPLETED|Overall Study||20
3252028|NCT02512393|3985892|FG001|COMPLETED|Overall Study||20
3252029|NCT02512393|3985891|FG000|NOT COMPLETED|Overall Study||1
3252030|NCT02512393|3985892|FG001|NOT COMPLETED|Overall Study||0
3252031|NCT02512419|3985900|FG000|STARTED|Overall Study||24
3252032|NCT02512419|3985901|FG001|STARTED|Overall Study||24
3252033|NCT02512419|3985900|FG000|COMPLETED|Overall Study|2 participants became ineligible after enrolling therefore were not included in analysis.|22
3252034|NCT02512419|3985901|FG001|COMPLETED|Overall Study||24
3252035|NCT02512419|3985900|FG000|NOT COMPLETED|Overall Study||2
3252036|NCT02512419|3985901|FG001|NOT COMPLETED|Overall Study||0
3252037|NCT02512575|3985917|FG000|STARTED|Overall Study||6
3252038|NCT02512575|3985918|FG001|STARTED|Overall Study||6
3252039|NCT02512575|3985919|FG002|STARTED|Overall Study||6
3252040|NCT02512575|3985920|FG003|STARTED|Overall Study||6
3252041|NCT02512575|3985921|FG004|STARTED|Overall Study||6
3252042|NCT02512575|3985922|FG005|STARTED|Overall Study||6
3252043|NCT02512575|3985923|FG006|STARTED|Overall Study||6
3252044|NCT02512575|3985924|FG007|STARTED|Overall Study||6
3252045|NCT02512575|3985925|FG008|STARTED|Overall Study||6
3252046|NCT02512575|3985926|FG009|STARTED|Overall Study||18
3252047|NCT02512575|3985917|FG000|COMPLETED|Overall Study||6
3252048|NCT02512575|3985918|FG001|COMPLETED|Overall Study||6
3252049|NCT02512575|3985919|FG002|COMPLETED|Overall Study||6
3252050|NCT02512575|3985920|FG003|COMPLETED|Overall Study||6
3252051|NCT02512575|3985921|FG004|COMPLETED|Overall Study||6
3252052|NCT02512575|3985922|FG005|COMPLETED|Overall Study||6
3252053|NCT02512575|3985923|FG006|COMPLETED|Overall Study||6
3252054|NCT02512575|3985924|FG007|COMPLETED|Overall Study||6
3252055|NCT02512575|3985925|FG008|COMPLETED|Overall Study||6
3252056|NCT02512575|3985926|FG009|COMPLETED|Overall Study||18
3252057|NCT02512575|3985917|FG000|NOT COMPLETED|Overall Study||0
3252058|NCT02512575|3985918|FG001|NOT COMPLETED|Overall Study||0
3252059|NCT02512575|3985919|FG002|NOT COMPLETED|Overall Study||0
3252060|NCT02512575|3985920|FG003|NOT COMPLETED|Overall Study||0
3252061|NCT02512575|3985921|FG004|NOT COMPLETED|Overall Study||0
3252062|NCT02512575|3985922|FG005|NOT COMPLETED|Overall Study||0
3252063|NCT02512575|3985923|FG006|NOT COMPLETED|Overall Study||0
3252064|NCT02512575|3985924|FG007|NOT COMPLETED|Overall Study||0
3252065|NCT02512575|3985925|FG008|NOT COMPLETED|Overall Study||0
3252066|NCT02512575|3985926|FG009|NOT COMPLETED|Overall Study||0
3252067|NCT02512679|3985948|FG000|STARTED|Overall Study||20
3252068|NCT02512679|3985949|FG001|STARTED|Overall Study||0
3252069|NCT02512679|3985948|FG000|COMPLETED|Overall Study||20
3252070|NCT02512679|3985949|FG001|COMPLETED|Overall Study||0
3252071|NCT02512679|3985948|FG000|NOT COMPLETED|Overall Study||0
3252072|NCT02512679|3985949|FG001|NOT COMPLETED|Overall Study||0
3252073|NCT02512783|3985955|FG000|STARTED|Overall Study||96
3252074|NCT02512783|3985956|FG001|STARTED|Overall Study||75
3252075|NCT02512783|3985955|FG000|COMPLETED|Overall Study||96
3252076|NCT02512783|3985956|FG001|COMPLETED|Overall Study||75
3252077|NCT02512783|3985955|FG000|NOT COMPLETED|Overall Study||0
3252078|NCT02512783|3985956|FG001|NOT COMPLETED|Overall Study||0
3252079|NCT02512809|3985965|FG000|STARTED|Overall Study||25
3252080|NCT02512809|3985965|FG000|COMPLETED|Overall Study||25
3252081|NCT02512809|3985965|FG000|NOT COMPLETED|Overall Study||0
3252082|NCT02512861|3985971|FG000|STARTED|Overall Study||44
3252083|NCT02512861|3985972|FG001|STARTED|Overall Study||49
3252084|NCT02512861|3985971|FG000|COMPLETED|Overall Study||38
3252085|NCT02512861|3985972|FG001|COMPLETED|Overall Study||40
3252086|NCT02512861|3985971|FG000|NOT COMPLETED|Overall Study||6
3252087|NCT02512861|3985972|FG001|NOT COMPLETED|Overall Study||9
3252088|NCT02512874|3985978|FG000|STARTED|Overall Study||65
3252089|NCT02512874|3985978|FG000|COMPLETED|Overall Study||63
3252090|NCT02512874|3985978|FG000|NOT COMPLETED|Overall Study||2
3252091|NCT02512900|3985984|FG000|STARTED|Overall Study||11
3252092|NCT02512900|3985985|FG001|STARTED|Overall Study||10
3252093|NCT02512900|3985984|FG000|COMPLETED|Overall Study||11
3252094|NCT02512900|3985985|FG001|COMPLETED|Overall Study||10
3252095|NCT02512900|3985984|FG000|NOT COMPLETED|Overall Study||0
3252096|NCT02512900|3985985|FG001|NOT COMPLETED|Overall Study||0
3252097|NCT02512965|3985994|FG000|STARTED|Overall Study||115
3252098|NCT02512965|3985995|FG001|STARTED|Overall Study||114
3252099|NCT02512965|3985994|FG000|COMPLETED|Overall Study||115
3252100|NCT02512965|3985995|FG001|COMPLETED|Overall Study|4 patients did not receive any dose of the assigned treatment.|110
3252101|NCT02512965|3985994|FG000|NOT COMPLETED|Overall Study||0
3252102|NCT02512965|3985995|FG001|NOT COMPLETED|Overall Study||4
3252103|NCT02513095|3986003|FG000|STARTED|Overall Study||17
3252104|NCT02513095|3986004|FG001|STARTED|Overall Study||17
3252105|NCT02513095|3986003|FG000|Treatment Phase - Up to 120 Minutes|Overall Study||17
3252106|NCT02513095|3986004|FG001|Treatment Phase - Up to 120 Minutes|Overall Study||17
3252107|NCT02513095|3986003|FG000|COMPLETED|Overall Study||17
3252108|NCT02513095|3986004|FG001|COMPLETED|Overall Study||17
3252109|NCT02513095|3986003|FG000|NOT COMPLETED|Overall Study||0
3252110|NCT02513095|3986004|FG001|NOT COMPLETED|Overall Study||0
3252111|NCT02513121|3986012|FG000|STARTED|Overall Study||20
3252112|NCT02513121|3986013|FG001|STARTED|Overall Study||20
3252113|NCT02513121|3986012|FG000|COMPLETED|Overall Study||20
3252114|NCT02513121|3986013|FG001|COMPLETED|Overall Study||20
3252115|NCT02513121|3986012|FG000|NOT COMPLETED|Overall Study||0
3252116|NCT02513121|3986013|FG001|NOT COMPLETED|Overall Study||0
3252117|NCT02513160|3986025|FG000|STARTED|Run-In Period (Days -14 to Day -1)|Enrolled|713
3252118|NCT02513160|3986026|FG001|STARTED|Run-In Period (Days -14 to Day -1)||0
3252119|NCT02513160|3986027|FG002|STARTED|Run-In Period (Days -14 to Day -1)||0
3252120|NCT02513160|3986028|FG003|STARTED|Run-In Period (Days -14 to Day -1)||0
3252121|NCT02513160|3986025|FG000|COMPLETED|Run-In Period (Days -14 to Day -1)||425
3252122|NCT02513160|3986026|FG001|COMPLETED|Run-In Period (Days -14 to Day -1)||0
3252123|NCT02513160|3986027|FG002|COMPLETED|Run-In Period (Days -14 to Day -1)||0
3252124|NCT02513160|3986028|FG003|COMPLETED|Run-In Period (Days -14 to Day -1)||0
3252125|NCT02513160|3986025|FG000|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||288
3252126|NCT02513160|3986026|FG001|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||0
3252127|NCT02513160|3986027|FG002|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||0
3252128|NCT02513160|3986028|FG003|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||0
3252129|NCT02513160|3986025|FG000|STARTED|Treatment Period (Day 0 to Week 6)|Randomized|107
3252130|NCT02513160|3986026|FG001|STARTED|Treatment Period (Day 0 to Week 6)|Randomized|108
3252131|NCT02513160|3986027|FG002|STARTED|Treatment Period (Day 0 to Week 6)|Randomized|105
3252132|NCT02513160|3986028|FG003|STARTED|Treatment Period (Day 0 to Week 6)|Randomized|105
3252133|NCT02513160|3986025|FG000|COMPLETED|Treatment Period (Day 0 to Week 6)||101
3252134|NCT02513160|3986026|FG001|COMPLETED|Treatment Period (Day 0 to Week 6)||104
3252135|NCT02513160|3986027|FG002|COMPLETED|Treatment Period (Day 0 to Week 6)||104
3252136|NCT02513160|3986028|FG003|COMPLETED|Treatment Period (Day 0 to Week 6)||103
3252137|NCT02513160|3986025|FG000|NOT COMPLETED|Treatment Period (Day 0 to Week 6)||6
3252138|NCT02513160|3986026|FG001|NOT COMPLETED|Treatment Period (Day 0 to Week 6)||4
3252139|NCT02513160|3986027|FG002|NOT COMPLETED|Treatment Period (Day 0 to Week 6)||1
3252140|NCT02513160|3986028|FG003|NOT COMPLETED|Treatment Period (Day 0 to Week 6)||2
3252141|NCT02513212|3986041|FG000|STARTED|Overall Study||12
3252142|NCT02513212|3986042|FG001|STARTED|Overall Study||12
3252143|NCT02513212|3986041|FG000|COMPLETED|Overall Study||11
3252144|NCT02513212|3986042|FG001|COMPLETED|Overall Study||12
3252145|NCT02513212|3986041|FG000|NOT COMPLETED|Overall Study||1
3252146|NCT02513212|3986042|FG001|NOT COMPLETED|Overall Study||0
3252147|NCT02513446|3986050|FG000|STARTED|Period 1||8
3252148|NCT02513446|3986051|FG001|STARTED|Period 1||8
3252149|NCT02513446|3986050|FG000|COMPLETED|Period 1||8
3252150|NCT02513446|3986051|FG001|COMPLETED|Period 1||8
3252151|NCT02513446|3986050|FG000|NOT COMPLETED|Period 1||0
3252152|NCT02513446|3986051|FG001|NOT COMPLETED|Period 1||0
3252153|NCT02513446|3986050|FG000|STARTED|Washout Period of 10 Days||8
3252154|NCT02513446|3986051|FG001|STARTED|Washout Period of 10 Days||8
3252155|NCT02513446|3986050|FG000|COMPLETED|Washout Period of 10 Days||8
3252156|NCT02513446|3986051|FG001|COMPLETED|Washout Period of 10 Days||8
3252157|NCT02513446|3986050|FG000|NOT COMPLETED|Washout Period of 10 Days||0
3252158|NCT02513446|3986051|FG001|NOT COMPLETED|Washout Period of 10 Days||0
3252159|NCT02513446|3986050|FG000|STARTED|Period 2||8
3252160|NCT02513446|3986051|FG001|STARTED|Period 2||8
3252161|NCT02513446|3986050|FG000|COMPLETED|Period 2||8
3252162|NCT02513446|3986051|FG001|COMPLETED|Period 2||8
3252163|NCT02513446|3986050|FG000|NOT COMPLETED|Period 2||0
3252164|NCT02513446|3986051|FG001|NOT COMPLETED|Period 2||0
3252165|NCT02513459|3986058|FG000|STARTED|Overall Study||65
3252166|NCT02513459|3986058|FG000|COMPLETED|Overall Study||44
3252167|NCT02513459|3986058|FG000|NOT COMPLETED|Overall Study||21
3252168|NCT02513472|3986069|FG000|STARTED|Overall Study||66
3252169|NCT02513472|3986070|FG001|STARTED|Overall Study||101
3252170|NCT02513472|3986069|FG000|Phase 1b Safety run-in|Overall Study||3
3252171|NCT02513472|3986070|FG001|Phase 1b Safety run-in|Overall Study||4
3252172|NCT02513472|3986069|FG000|Phase 2|Overall Study||63
3252173|NCT02513472|3986070|FG001|Phase 2|Overall Study||97
3252174|NCT02513472|3986069|FG000|COMPLETED|Overall Study|Treatment ongoing at data cutoff.|1
3252175|NCT02513472|3986070|FG001|COMPLETED|Overall Study|Treatment ongoing at data cutoff.|8
3252176|NCT02513472|3986069|FG000|NOT COMPLETED|Overall Study||65
3252177|NCT02513472|3986070|FG001|NOT COMPLETED|Overall Study||93
3252178|NCT02513498|3986079|FG000|STARTED|Overall Study||50
3252179|NCT02513498|3986079|FG000|COMPLETED|Overall Study||26
3252180|NCT02513498|3986079|FG000|NOT COMPLETED|Overall Study||24
3371652|NCT03723447|4103362|FG001|NOT COMPLETED|Overall Study||0
3371653|NCT03723070|4103368|FG000|STARTED|Overall Study||88
3371654|NCT03723070|4103368|FG000|COMPLETED|Overall Study||79
3371655|NCT03723070|4103368|FG000|NOT COMPLETED|Overall Study||9
3371656|NCT03720210|4103372|FG000|STARTED|Overall Study||1
3371657|NCT03720210|4103372|FG000|COMPLETED|Overall Study||0
3371658|NCT03720210|4103372|FG000|NOT COMPLETED|Overall Study||1
3371659|NCT03718455|4103376|FG000|STARTED|Overall Study||1
3371660|NCT03718455|4103376|FG000|COMPLETED|Overall Study||1
3371661|NCT03718455|4103376|FG000|NOT COMPLETED|Overall Study||0
3371662|NCT03718143|4103380|FG000|STARTED|Overall Study||3
3371663|NCT03718143|4103381|FG001|STARTED|Overall Study||2
3371664|NCT03718143|4103382|FG002|STARTED|Overall Study||1
3371665|NCT03718143|4103380|FG000|COMPLETED|Overall Study||0
3371666|NCT03718143|4103381|FG001|COMPLETED|Overall Study||0
3371667|NCT03718143|4103382|FG002|COMPLETED|Overall Study||0
3371668|NCT03718143|4103380|FG000|NOT COMPLETED|Overall Study||3
3371669|NCT03718143|4103381|FG001|NOT COMPLETED|Overall Study||2
3371670|NCT03718143|4103382|FG002|NOT COMPLETED|Overall Study||1
3371671|NCT03709576|4103390|FG000|STARTED|Overall Study||3
3371672|NCT03709576|4103390|FG000|COMPLETED|Overall Study||2
3371673|NCT03709576|4103390|FG000|NOT COMPLETED|Overall Study||1
3371674|NCT03704636|4103395|FG000|STARTED|Overall Study||23
3371675|NCT03704636|4103395|FG000|COMPLETED|Overall Study||20
3371676|NCT03704636|4103395|FG000|NOT COMPLETED|Overall Study||3
3371677|NCT03703791|4103401|FG000|STARTED|Overall Study||0
3252181|NCT02513550|3986091|FG000|STARTED|Double Blind Treatment Period||310
3252182|NCT02513550|3986092|FG001|STARTED|Double Blind Treatment Period||306
3252183|NCT02513550|3986093|FG002|STARTED|Double Blind Treatment Period||611
3252184|NCT02513550|3986094|FG003|STARTED|Double Blind Treatment Period||9
3252185|NCT02513550|3986095|FG004|STARTED|Double Blind Treatment Period||5
3252186|NCT02513550|3986096|FG005|STARTED|Double Blind Treatment Period||16
3252187|NCT02513550|3986091|FG000|Received at Least One Dose of Study Drug|Double Blind Treatment Period||310
3252188|NCT02513550|3986092|FG001|Received at Least One Dose of Study Drug|Double Blind Treatment Period||306
3252189|NCT02513550|3986093|FG002|Received at Least One Dose of Study Drug|Double Blind Treatment Period||609
3252190|NCT02513550|3986094|FG003|Received at Least One Dose of Study Drug|Double Blind Treatment Period||9
3252191|NCT02513550|3986095|FG004|Received at Least One Dose of Study Drug|Double Blind Treatment Period||5
3252192|NCT02513550|3986096|FG005|Received at Least One Dose of Study Drug|Double Blind Treatment Period||16
3252193|NCT02513550|3986091|FG000|COMPLETED|Double Blind Treatment Period||274
3252194|NCT02513550|3986092|FG001|COMPLETED|Double Blind Treatment Period||268
3252195|NCT02513550|3986093|FG002|COMPLETED|Double Blind Treatment Period||537
3252196|NCT02513550|3986094|FG003|COMPLETED|Double Blind Treatment Period||9
3252197|NCT02513550|3986095|FG004|COMPLETED|Double Blind Treatment Period||4
3252198|NCT02513550|3986096|FG005|COMPLETED|Double Blind Treatment Period||15
3252199|NCT02513550|3986091|FG000|NOT COMPLETED|Double Blind Treatment Period||36
3252200|NCT02513550|3986092|FG001|NOT COMPLETED|Double Blind Treatment Period||38
3252201|NCT02513550|3986093|FG002|NOT COMPLETED|Double Blind Treatment Period||74
3252202|NCT02513550|3986094|FG003|NOT COMPLETED|Double Blind Treatment Period||0
3252203|NCT02513550|3986095|FG004|NOT COMPLETED|Double Blind Treatment Period||1
3252204|NCT02513550|3986096|FG005|NOT COMPLETED|Double Blind Treatment Period||1
3252205|NCT02513550|3986091|FG000|STARTED|Post-Treatment Follow-up Period|Participants who discontinued double blind phase had an option to enter post-treatment phase.|285
3252206|NCT02513550|3986092|FG001|STARTED|Post-Treatment Follow-up Period|Participants who discontinued double blind phase had an option to enter post-treatment phase.|283
3252207|NCT02513550|3986093|FG002|STARTED|Post-Treatment Follow-up Period|Participants who discontinued double blind phase had an option to enter post-treatment phase.|559
3252208|NCT02513550|3986094|FG003|STARTED|Post-Treatment Follow-up Period|Participants who discontinued double blind phase had an option to enter post-treatment phase.|9
3252209|NCT02513550|3986095|FG004|STARTED|Post-Treatment Follow-up Period|Participants who discontinued double blind phase had an option to enter post-treatment phase.|4
3252210|NCT02513550|3986096|FG005|STARTED|Post-Treatment Follow-up Period|Participants who discontinued double blind phase had an option to enter post-treatment phase.|15
3252211|NCT02513550|3986091|FG000|COMPLETED|Post-Treatment Follow-up Period||254
3252212|NCT02513550|3986092|FG001|COMPLETED|Post-Treatment Follow-up Period||244
3252213|NCT02513550|3986093|FG002|COMPLETED|Post-Treatment Follow-up Period||496
3252214|NCT02513550|3986094|FG003|COMPLETED|Post-Treatment Follow-up Period||9
3252215|NCT02513550|3986095|FG004|COMPLETED|Post-Treatment Follow-up Period||4
3252216|NCT02513550|3986096|FG005|COMPLETED|Post-Treatment Follow-up Period||15
3252217|NCT02513550|3986091|FG000|NOT COMPLETED|Post-Treatment Follow-up Period||31
3252218|NCT02513550|3986092|FG001|NOT COMPLETED|Post-Treatment Follow-up Period||39
3252219|NCT02513550|3986093|FG002|NOT COMPLETED|Post-Treatment Follow-up Period||63
3252220|NCT02513550|3986094|FG003|NOT COMPLETED|Post-Treatment Follow-up Period||0
3252221|NCT02513550|3986095|FG004|NOT COMPLETED|Post-Treatment Follow-up Period||0
3252222|NCT02513550|3986096|FG005|NOT COMPLETED|Post-Treatment Follow-up Period||0
3252223|NCT02513641|3986118|FG000|STARTED|Overall Study||8
3252224|NCT02513641|3986118|FG000|COMPLETED|Overall Study||8
3252225|NCT02513641|3986118|FG000|NOT COMPLETED|Overall Study||0
3252226|NCT02513719|3986122|FG000|STARTED|At 8 Months Clinical Follow-up||312
3252227|NCT02513719|3986122|FG000|COMPLETED|At 8 Months Clinical Follow-up||312
3252228|NCT02513719|3986122|FG000|NOT COMPLETED|At 8 Months Clinical Follow-up||0
3252229|NCT02513719|3986122|FG000|STARTED|At 1 Year Clinical Follow-up||312
3252230|NCT02513719|3986122|FG000|COMPLETED|At 1 Year Clinical Follow-up||305
3252231|NCT02513719|3986122|FG000|NOT COMPLETED|At 1 Year Clinical Follow-up||7
3252232|NCT02513719|3986122|FG000|STARTED|At 2 Years Clinical Follow-up||305
3252233|NCT02513719|3986122|FG000|COMPLETED|At 2 Years Clinical Follow-up||300
3252234|NCT02513719|3986122|FG000|NOT COMPLETED|At 2 Years Clinical Follow-up||5
3252235|NCT02513719|3986122|FG000|STARTED|At 3 Years Clinical Follow-up||300
3252236|NCT02513719|3986122|FG000|COMPLETED|At 3 Years Clinical Follow-up||289
3252237|NCT02513719|3986122|FG000|NOT COMPLETED|At 3 Years Clinical Follow-up||11
3252238|NCT02513719|3986122|FG000|STARTED|At 4 Years Clinical Follow-up||289
3252239|NCT02513719|3986122|FG000|COMPLETED|At 4 Years Clinical Follow-up||273
3252240|NCT02513719|3986122|FG000|NOT COMPLETED|At 4 Years Clinical Follow-up||16
3252241|NCT02513719|3986122|FG000|STARTED|At 5 Years Clinical Follow-up||273
3252242|NCT02513719|3986122|FG000|COMPLETED|At 5 Years Clinical Follow-up||254
3252243|NCT02513719|3986122|FG000|NOT COMPLETED|At 5 Years Clinical Follow-up||19
3252244|NCT02513732|3986126|FG000|STARTED|Overall Study||100
3252245|NCT02513732|3986126|FG000|COMPLETED|Overall Study||78
3252246|NCT02513732|3986126|FG000|NOT COMPLETED|Overall Study||22
3252247|NCT02513745|3986132|FG000|STARTED|Overall Study||42
3252248|NCT02513745|3986133|FG001|STARTED|Overall Study||42
3252249|NCT02513745|3986132|FG000|COMPLETED|Overall Study||39
3252250|NCT02513745|3986133|FG001|COMPLETED|Overall Study||39
3252251|NCT02513745|3986132|FG000|NOT COMPLETED|Overall Study||3
3252252|NCT02513745|3986133|FG001|NOT COMPLETED|Overall Study||3
3252253|NCT02513771|3986141|FG000|STARTED|Overall Study||45
3252254|NCT02513771|3986142|FG001|STARTED|Overall Study||45
3252255|NCT02513771|3986141|FG000|COMPLETED|Overall Study||43
3252256|NCT02513771|3986142|FG001|COMPLETED|Overall Study||44
3252257|NCT02513771|3986141|FG000|NOT COMPLETED|Overall Study||2
3252258|NCT02513771|3986142|FG001|NOT COMPLETED|Overall Study||1
3252259|NCT02513823|3986148|FG000|STARTED|Overall Study||27
3252260|NCT02513823|3986148|FG000|COMPLETED|Overall Study||22
3252261|NCT02513823|3986148|FG000|NOT COMPLETED|Overall Study||5
3371678|NCT03703791|4103402|FG001|STARTED|Overall Study||1
3371679|NCT03703791|4103401|FG000|COMPLETED|Overall Study||0
3371680|NCT03703791|4103402|FG001|COMPLETED|Overall Study||0
3371681|NCT03703791|4103401|FG000|NOT COMPLETED|Overall Study||0
3371682|NCT03703791|4103402|FG001|NOT COMPLETED|Overall Study||1
3371683|NCT03701295|4103408|FG000|STARTED|Overall Study||1
3371684|NCT03701295|4103408|FG000|COMPLETED|Overall Study||1
3371685|NCT03701295|4103408|FG000|NOT COMPLETED|Overall Study||0
3371686|NCT03697551|4103412|FG000|STARTED|Overall Study||4
3371687|NCT03697551|4103412|FG000|COMPLETED|Overall Study||4
3371688|NCT03697551|4103412|FG000|NOT COMPLETED|Overall Study||0
3371689|NCT03694821|4103419|FG000|STARTED|Overall Study||4
3371690|NCT03694821|4103420|FG001|STARTED|Overall Study||8
3371691|NCT03694821|4103421|FG002|STARTED|Overall Study||6
3371692|NCT03694821|4103419|FG000|COMPLETED|Overall Study||0
3371693|NCT03694821|4103420|FG001|COMPLETED|Overall Study||0
3371694|NCT03694821|4103421|FG002|COMPLETED|Overall Study||2
3371695|NCT03694821|4103419|FG000|NOT COMPLETED|Overall Study||4
3371696|NCT03694821|4103420|FG001|NOT COMPLETED|Overall Study||8
3371697|NCT03694821|4103421|FG002|NOT COMPLETED|Overall Study||4
3371698|NCT03686969|4103431|FG000|STARTED|Overall Study||1
3371699|NCT03686969|4103432|FG001|STARTED|Overall Study||0
3371700|NCT03686969|4103431|FG000|COMPLETED|Overall Study||0
3371701|NCT03686969|4103432|FG001|COMPLETED|Overall Study||0
3371702|NCT03686969|4103431|FG000|NOT COMPLETED|Overall Study||1
3371703|NCT03686969|4103432|FG001|NOT COMPLETED|Overall Study||0
3371704|NCT03682367|4103440|FG000|STARTED|Overall Study||4
3371705|NCT03682367|4103441|FG001|STARTED|Overall Study||4
3371706|NCT03682367|4103440|FG000|COMPLETED|Overall Study|Withdrawn due to non-compliance|2
3371707|NCT03682367|4103441|FG001|COMPLETED|Overall Study|Patients withdrawn due to confounding neuropathic pain or exited early from study.|0
3371708|NCT03682367|4103440|FG000|NOT COMPLETED|Overall Study||2
3371709|NCT03682367|4103441|FG001|NOT COMPLETED|Overall Study||4
3371710|NCT03680911|4103449|FG000|STARTED|Visit 1 (Baseline)||3
3371711|NCT03680911|4103450|FG001|STARTED|Visit 1 (Baseline)||4
3371712|NCT03680911|4103449|FG000|COMPLETED|Visit 1 (Baseline)||3
3371713|NCT03680911|4103450|FG001|COMPLETED|Visit 1 (Baseline)||4
3371714|NCT03680911|4103449|FG000|NOT COMPLETED|Visit 1 (Baseline)||0
3371715|NCT03680911|4103450|FG001|NOT COMPLETED|Visit 1 (Baseline)||0
3371716|NCT03680911|4103449|FG000|STARTED|At Home Treatment||3
3371717|NCT03680911|4103450|FG001|STARTED|At Home Treatment||4
3371718|NCT03680911|4103449|FG000|COMPLETED|At Home Treatment||0
3371719|NCT03680911|4103450|FG001|COMPLETED|At Home Treatment||1
3371720|NCT03680911|4103449|FG000|NOT COMPLETED|At Home Treatment||3
3371721|NCT03680911|4103450|FG001|NOT COMPLETED|At Home Treatment||3
3371722|NCT03680911|4103449|FG000|STARTED|Visit 2 (1 Month Follow up)||0
3371723|NCT03680911|4103450|FG001|STARTED|Visit 2 (1 Month Follow up)||1
3371724|NCT03680911|4103449|FG000|COMPLETED|Visit 2 (1 Month Follow up)||0
3371725|NCT03680911|4103450|FG001|COMPLETED|Visit 2 (1 Month Follow up)||1
3371726|NCT03680911|4103449|FG000|NOT COMPLETED|Visit 2 (1 Month Follow up)||0
3371727|NCT03680911|4103450|FG001|NOT COMPLETED|Visit 2 (1 Month Follow up)||0
3371728|NCT03680911|4103449|FG000|STARTED|Visit 3 (4 Month Follow up)||0
3371729|NCT03680911|4103450|FG001|STARTED|Visit 3 (4 Month Follow up)||1
3371730|NCT03680911|4103449|FG000|COMPLETED|Visit 3 (4 Month Follow up)||0
3371731|NCT03680911|4103450|FG001|COMPLETED|Visit 3 (4 Month Follow up)||0
3371732|NCT03680911|4103449|FG000|NOT COMPLETED|Visit 3 (4 Month Follow up)||0
3371733|NCT03680911|4103450|FG001|NOT COMPLETED|Visit 3 (4 Month Follow up)||1
3371734|NCT03656692|4103456|FG000|STARTED|Overall Study||5
3371735|NCT03656692|4103456|FG000|COMPLETED|Overall Study||2
3371736|NCT03656692|4103456|FG000|NOT COMPLETED|Overall Study||3
3371737|NCT03648983|4103460|FG000|STARTED|Overall Study||95
3371738|NCT03648983|4103460|FG000|COMPLETED|Overall Study||0
3371739|NCT03648983|4103460|FG000|NOT COMPLETED|Overall Study||95
3371740|NCT03643159|4103467|FG000|STARTED|Overall Study||2
3371741|NCT03643159|4103467|FG000|Received At Least 1 Dose Of Study Drug|Overall Study||2
3371742|NCT03643159|4103467|FG000|COMPLETED|Overall Study||0
3371743|NCT03643159|4103467|FG000|NOT COMPLETED|Overall Study||2
3371744|NCT03632655|4103474|FG000|STARTED|Overall Study||22
3371745|NCT03632655|4103475|FG001|STARTED|Overall Study||16
3371746|NCT03632655|4103474|FG000|COMPLETED|Overall Study||0
3371747|NCT03632655|4103475|FG001|COMPLETED|Overall Study||0
3371748|NCT03632655|4103474|FG000|NOT COMPLETED|Overall Study||22
3371749|NCT03632655|4103475|FG001|NOT COMPLETED|Overall Study||16
3371750|NCT03630120|4103485|FG000|STARTED|Overall Study||2
3371751|NCT03630120|4103486|FG001|STARTED|Overall Study||2
3371752|NCT03630120|4103487|FG002|STARTED|Overall Study||1
3371753|NCT03630120|4103488|FG003|STARTED|Overall Study||1
3371754|NCT03630120|4103485|FG000|COMPLETED|Overall Study||2
3371755|NCT03630120|4103486|FG001|COMPLETED|Overall Study||1
3371756|NCT03630120|4103487|FG002|COMPLETED|Overall Study||0
3371757|NCT03630120|4103488|FG003|COMPLETED|Overall Study||0
3371758|NCT03630120|4103485|FG000|NOT COMPLETED|Overall Study||0
3252262|NCT02513940|3986152|FG000|STARTED|Overall Study|This was a crossover study, with a total n=14. All 14 subjects completed each phase of the study|2
3252263|NCT02513940|3986153|FG001|STARTED|Overall Study||3
3252264|NCT02513940|3986154|FG002|STARTED|Overall Study||2
3252265|NCT02513940|3986155|FG003|STARTED|Overall Study||2
3252266|NCT02513940|3986156|FG004|STARTED|Overall Study||2
3252267|NCT02513940|3986157|FG005|STARTED|Overall Study||3
3252268|NCT02513940|3986152|FG000|COMPLETED|Overall Study||2
3252269|NCT02513940|3986153|FG001|COMPLETED|Overall Study||3
3252270|NCT02513940|3986154|FG002|COMPLETED|Overall Study||2
3252271|NCT02513940|3986155|FG003|COMPLETED|Overall Study||2
3252272|NCT02513940|3986156|FG004|COMPLETED|Overall Study||2
3252273|NCT02513940|3986157|FG005|COMPLETED|Overall Study||3
3252274|NCT02513940|3986152|FG000|NOT COMPLETED|Overall Study||0
3252275|NCT02513940|3986153|FG001|NOT COMPLETED|Overall Study||0
3252276|NCT02513940|3986154|FG002|NOT COMPLETED|Overall Study||0
3252277|NCT02513940|3986155|FG003|NOT COMPLETED|Overall Study||0
3252278|NCT02513940|3986156|FG004|NOT COMPLETED|Overall Study||0
3252279|NCT02513940|3986157|FG005|NOT COMPLETED|Overall Study||0
3252280|NCT02514044|3986167|FG000|STARTED|Dexedrine+tDCS+Speech Therapy (1 Day)||10
3252281|NCT02514044|3986167|FG000|COMPLETED|Dexedrine+tDCS+Speech Therapy (1 Day)||10
3252282|NCT02514044|3986167|FG000|NOT COMPLETED|Dexedrine+tDCS+Speech Therapy (1 Day)||0
3252283|NCT02514044|3986167|FG000|STARTED|Washout (1 Week)||10
3252284|NCT02514044|3986167|FG000|COMPLETED|Washout (1 Week)||10
3252285|NCT02514044|3986167|FG000|NOT COMPLETED|Washout (1 Week)||0
3252286|NCT02514044|3986167|FG000|STARTED|Placebo+tDCS+Speech Therapy (1 Day)||10
3252287|NCT02514044|3986167|FG000|COMPLETED|Placebo+tDCS+Speech Therapy (1 Day)||10
3252288|NCT02514044|3986167|FG000|NOT COMPLETED|Placebo+tDCS+Speech Therapy (1 Day)||0
3252289|NCT02514070|3986177|FG000|STARTED|Weeks 0 to Week 6||19
3252290|NCT02514070|3986178|FG001|STARTED|Weeks 0 to Week 6||20
3252291|NCT02514070|3986177|FG000|COMPLETED|Weeks 0 to Week 6||17
3252292|NCT02514070|3986178|FG001|COMPLETED|Weeks 0 to Week 6||16
3252293|NCT02514070|3986177|FG000|NOT COMPLETED|Weeks 0 to Week 6||2
3252294|NCT02514070|3986178|FG001|NOT COMPLETED|Weeks 0 to Week 6||4
3252295|NCT02514070|3986177|FG000|STARTED|Week 6 to Week 14 - Washout Period||17
3371759|NCT03630120|4103486|FG001|NOT COMPLETED|Overall Study||1
3371760|NCT03630120|4103487|FG002|NOT COMPLETED|Overall Study||1
3371761|NCT03630120|4103488|FG003|NOT COMPLETED|Overall Study||1
3371762|NCT03621657|4103501|FG000|STARTED|Overall Study||0
3371763|NCT03621657|4103502|FG001|STARTED|Overall Study||0
3371764|NCT03621657|4103503|FG002|STARTED|Overall Study||1
3371765|NCT03621657|4103501|FG000|COMPLETED|Overall Study||0
3371766|NCT03621657|4103502|FG001|COMPLETED|Overall Study||0
3371767|NCT03621657|4103503|FG002|COMPLETED|Overall Study||1
3371768|NCT03621657|4103501|FG000|NOT COMPLETED|Overall Study||0
3371769|NCT03621657|4103502|FG001|NOT COMPLETED|Overall Study||0
3371770|NCT03621657|4103503|FG002|NOT COMPLETED|Overall Study||0
3371771|NCT03615508|4103513|FG000|STARTED|Overall Study||1
3371772|NCT03615508|4103513|FG000|COMPLETED|Overall Study||1
3371773|NCT03615508|4103513|FG000|NOT COMPLETED|Overall Study||0
3371774|NCT03615144|4103519|FG000|STARTED|Overall Study||1
3371775|NCT03615144|4103520|FG001|STARTED|Overall Study||0
3371776|NCT03615144|4103519|FG000|COMPLETED|Overall Study||0
3371777|NCT03615144|4103520|FG001|COMPLETED|Overall Study||0
3371778|NCT03615144|4103519|FG000|NOT COMPLETED|Overall Study||1
3371779|NCT03615144|4103520|FG001|NOT COMPLETED|Overall Study||0
3371780|NCT03605303|4103526|FG000|STARTED|Period 1||2
3371781|NCT03605303|4103527|FG001|STARTED|Period 1||1
3371782|NCT03605303|4103526|FG000|COMPLETED|Period 1||0
3371783|NCT03605303|4103527|FG001|COMPLETED|Period 1||0
3371784|NCT03605303|4103526|FG000|NOT COMPLETED|Period 1||2
3371785|NCT03605303|4103527|FG001|NOT COMPLETED|Period 1||1
3371786|NCT03605303|4103526|FG000|STARTED|Period 2||0
3371787|NCT03605303|4103527|FG001|STARTED|Period 2||0
3371788|NCT03605303|4103526|FG000|COMPLETED|Period 2||0
3371789|NCT03605303|4103527|FG001|COMPLETED|Period 2||0
3371790|NCT03605303|4103526|FG000|NOT COMPLETED|Period 2||0
3371791|NCT03605303|4103527|FG001|NOT COMPLETED|Period 2||0
3371792|NCT03600740|4103533|FG000|STARTED|Overall Study||1
3371793|NCT03600740|4103533|FG000|COMPLETED|Overall Study||0
3371794|NCT03600740|4103533|FG000|NOT COMPLETED|Overall Study||1
3371795|NCT03598140|4103539|FG000|STARTED|Overall Study||10
3371796|NCT03598140|4103540|FG001|STARTED|Overall Study||11
3371797|NCT03598140|4103539|FG000|COMPLETED|Overall Study||9
3371798|NCT03598140|4103540|FG001|COMPLETED|Overall Study||11
3371799|NCT03598140|4103539|FG000|NOT COMPLETED|Overall Study||1
3371800|NCT03598140|4103540|FG001|NOT COMPLETED|Overall Study||0
3371801|NCT03598036|4103548|FG000|STARTED|Overall Study||5
3371802|NCT03598036|4103549|FG001|STARTED|Overall Study|Trial ended prematurely before any patients were enrolled into Cohort 2|0
3371803|NCT03598036|4103548|FG000|Week 1: 7.9 mg Twice Daily|Overall Study||5
3371804|NCT03598036|4103549|FG001|Week 1: 7.9 mg Twice Daily|Overall Study||0
3371805|NCT03598036|4103548|FG000|Week 2: 15.9 mg Twice Daily|Overall Study||5
3371806|NCT03598036|4103549|FG001|Week 2: 15.9 mg Twice Daily|Overall Study||0
3371807|NCT03598036|4103548|FG000|Weeks 3 - 24: 23.7 mg Twice Daily|Overall Study|1 subject withdrew at Week 12|5
3371808|NCT03598036|4103549|FG001|Weeks 3 - 24: 23.7 mg Twice Daily|Overall Study||0
3371809|NCT03598036|4103548|FG000|COMPLETED|Overall Study||4
3371810|NCT03598036|4103549|FG001|COMPLETED|Overall Study||0
3371811|NCT03598036|4103548|FG000|NOT COMPLETED|Overall Study||1
3371812|NCT03598036|4103549|FG001|NOT COMPLETED|Overall Study||0
3371813|NCT03591458|4103559|FG000|STARTED|Overall Study||1
3252296|NCT02514070|3986178|FG001|STARTED|Week 6 to Week 14 - Washout Period||16
3252297|NCT02514070|3986177|FG000|COMPLETED|Week 6 to Week 14 - Washout Period||17
3252298|NCT02514070|3986178|FG001|COMPLETED|Week 6 to Week 14 - Washout Period||16
3252299|NCT02514070|3986177|FG000|NOT COMPLETED|Week 6 to Week 14 - Washout Period||0
3252300|NCT02514070|3986178|FG001|NOT COMPLETED|Week 6 to Week 14 - Washout Period||0
3252301|NCT02514070|3986177|FG000|STARTED|Week 14 to Week 20||17
3252302|NCT02514070|3986178|FG001|STARTED|Week 14 to Week 20||16
3252303|NCT02514070|3986177|FG000|COMPLETED|Week 14 to Week 20||16
3252304|NCT02514070|3986178|FG001|COMPLETED|Week 14 to Week 20||14
3252305|NCT02514070|3986177|FG000|NOT COMPLETED|Week 14 to Week 20||1
3252306|NCT02514070|3986178|FG001|NOT COMPLETED|Week 14 to Week 20||2
3252307|NCT02514122|3986190|FG000|STARTED|Overall Study||32
3252308|NCT02514122|3986191|FG001|STARTED|Overall Study||29
3252309|NCT02514122|3986190|FG000|COMPLETED|Overall Study|one participant dropped out for religious reasons; one for needle phobia|30
3252310|NCT02514122|3986191|FG001|COMPLETED|Overall Study||29
3252311|NCT02514122|3986190|FG000|NOT COMPLETED|Overall Study||2
3252312|NCT02514122|3986191|FG001|NOT COMPLETED|Overall Study||0
3252313|NCT02514174|3986197|FG000|STARTED|Overall Study||25
3252314|NCT02514174|3986197|FG000|COMPLETED|Overall Study||0
3252315|NCT02514174|3986197|FG000|NOT COMPLETED|Overall Study||25
3252316|NCT02514473|3986203|FG000|STARTED|Overall Study||101
3252317|NCT02514473|3986204|FG001|STARTED|Overall Study||103
3252318|NCT02514473|3986203|FG000|COMPLETED|Overall Study||98
3252319|NCT02514473|3986204|FG001|COMPLETED|Overall Study||98
3252320|NCT02514473|3986203|FG000|NOT COMPLETED|Overall Study||3
3252321|NCT02514473|3986204|FG001|NOT COMPLETED|Overall Study||5
3252322|NCT02514551|3986213|FG000|STARTED|Overall Study||123
3252323|NCT02514551|3986214|FG001|STARTED|Overall Study||122
3252324|NCT02514551|3986213|FG000|Received at Least One Dose of Study Drug|Overall Study||123
3252325|NCT02514551|3986214|FG001|Received at Least One Dose of Study Drug|Overall Study||120
3252326|NCT02514551|3986213|FG000|COMPLETED|Overall Study||123
3252327|NCT02514551|3986214|FG001|COMPLETED|Overall Study||119
3252328|NCT02514551|3986213|FG000|NOT COMPLETED|Overall Study||0
3252329|NCT02514551|3986214|FG001|NOT COMPLETED|Overall Study||3
3252330|NCT02514577|3986223|FG000|STARTED|Overall Study||143
3252331|NCT02514577|3986224|FG001|STARTED|Overall Study||74
3252332|NCT02514577|3986223|FG000|Intent-to-Treat (ITT) Population|Overall Study||143
3252333|NCT02514577|3986224|FG001|Intent-to-Treat (ITT) Population|Overall Study||74
3252334|NCT02514577|3986223|FG000|Safety Population|Overall Study||142
3252335|NCT02514577|3986224|FG001|Safety Population|Overall Study||72
3252336|NCT02514577|3986223|FG000|COMPLETED|Overall Study||129
3252337|NCT02514577|3986224|FG001|COMPLETED|Overall Study||61
3252338|NCT02514577|3986223|FG000|NOT COMPLETED|Overall Study||14
3252339|NCT02514577|3986224|FG001|NOT COMPLETED|Overall Study||13
3252340|NCT02514746|3986232|FG000|STARTED|Overall Study||437
3252341|NCT02514746|3986233|FG001|STARTED|Overall Study||124
3252342|NCT02514746|3986232|FG000|Valid Serology 3 Years Post Primary Dose|Overall Study||437
3252343|NCT02514746|3986233|FG001|Valid Serology 3 Years Post Primary Dose|Overall Study||123
3252344|NCT02514746|3986232|FG000|Valid Serology 4 Years Post Primary Dose|Overall Study||424
3252345|NCT02514746|3986233|FG001|Valid Serology 4 Years Post Primary Dose|Overall Study||109
3252346|NCT02514746|3986232|FG000|Received CD-JEV Booster Vaccine|Overall Study||424
3252347|NCT02514746|3986233|FG001|Received CD-JEV Booster Vaccine|Overall Study||109
3252348|NCT02514746|3986232|FG000|COMPLETED|Overall Study||415
3252349|NCT02514746|3986233|FG001|COMPLETED|Overall Study||109
3252350|NCT02514746|3986232|FG000|NOT COMPLETED|Overall Study||22
3252351|NCT02514746|3986233|FG001|NOT COMPLETED|Overall Study||15
3252352|NCT02514772|3986243|FG000|STARTED|Overall Study||53
3252353|NCT02514772|3986244|FG001|STARTED|Overall Study||54
3252354|NCT02514772|3986243|FG000|COMPLETED|Overall Study||50
3252355|NCT02514772|3986244|FG001|COMPLETED|Overall Study||52
3252356|NCT02514772|3986243|FG000|NOT COMPLETED|Overall Study||3
3252357|NCT02514772|3986244|FG001|NOT COMPLETED|Overall Study||2
3252358|NCT02514824|3986254|FG000|STARTED|Overall Study||4
3252359|NCT02514824|3986255|FG001|STARTED|Overall Study||5
3252360|NCT02514824|3986256|FG002|STARTED|Overall Study||0
3252361|NCT02514824|3986257|FG003|STARTED|Overall Study||0
3252362|NCT02514824|3986254|FG000|Evaluable for Dose-limiting Toxicity|Overall Study||3
3252363|NCT02514824|3986255|FG001|Evaluable for Dose-limiting Toxicity|Overall Study||5
3252364|NCT02514824|3986256|FG002|Evaluable for Dose-limiting Toxicity|Overall Study||0
3252365|NCT02514824|3986257|FG003|Evaluable for Dose-limiting Toxicity|Overall Study||0
3252366|NCT02514824|3986254|FG000|COMPLETED|Overall Study||3
3252367|NCT02514824|3986255|FG001|COMPLETED|Overall Study||4
3252368|NCT02514824|3986256|FG002|COMPLETED|Overall Study||0
3252369|NCT02514824|3986257|FG003|COMPLETED|Overall Study||0
3252370|NCT02514824|3986254|FG000|NOT COMPLETED|Overall Study||1
3252371|NCT02514824|3986255|FG001|NOT COMPLETED|Overall Study||1
3252372|NCT02514824|3986256|FG002|NOT COMPLETED|Overall Study||0
3252373|NCT02514824|3986257|FG003|NOT COMPLETED|Overall Study||0
3252374|NCT02514889|3986266|FG000|STARTED|Randomization/Allocation to Condition||131
3252375|NCT02514889|3986267|FG001|STARTED|Randomization/Allocation to Condition||130
3252376|NCT02514889|3986266|FG000|COMPLETED|Randomization/Allocation to Condition||111
3252377|NCT02514889|3986267|FG001|COMPLETED|Randomization/Allocation to Condition||106
3252378|NCT02514889|3986266|FG000|NOT COMPLETED|Randomization/Allocation to Condition||20
3252379|NCT02514889|3986267|FG001|NOT COMPLETED|Randomization/Allocation to Condition||24
3252380|NCT02514889|3986266|FG000|STARTED|Intervention Participation||111
3252381|NCT02514889|3986267|FG001|STARTED|Intervention Participation||106
3252382|NCT02514889|3986266|FG000|COMPLETED|Intervention Participation||102
3252383|NCT02514889|3986267|FG001|COMPLETED|Intervention Participation||98
3252384|NCT02514889|3986266|FG000|NOT COMPLETED|Intervention Participation||9
3252385|NCT02514889|3986267|FG001|NOT COMPLETED|Intervention Participation||8
3252386|NCT02514889|3986266|FG000|STARTED|Follow-up Assessment Participation||102
3252387|NCT02514889|3986267|FG001|STARTED|Follow-up Assessment Participation||98
3252388|NCT02514889|3986266|FG000|COMPLETED|Follow-up Assessment Participation||92
3252389|NCT02514889|3986267|FG001|COMPLETED|Follow-up Assessment Participation||86
3252390|NCT02514889|3986266|FG000|NOT COMPLETED|Follow-up Assessment Participation||10
3252391|NCT02514889|3986267|FG001|NOT COMPLETED|Follow-up Assessment Participation||12
3252392|NCT02515045|3986275|FG000|STARTED|Overall Study||29
3252393|NCT02515045|3986276|FG001|STARTED|Overall Study||30
3252394|NCT02515045|3986277|FG002|STARTED|Overall Study||59
3252395|NCT02515045|3986275|FG000|COMPLETED|Overall Study||29
3252396|NCT02515045|3986276|FG001|COMPLETED|Overall Study||26
3252397|NCT02515045|3986277|FG002|COMPLETED|Overall Study||55
3252398|NCT02515045|3986275|FG000|NOT COMPLETED|Overall Study||0
3252399|NCT02515045|3986276|FG001|NOT COMPLETED|Overall Study||4
3252400|NCT02515045|3986277|FG002|NOT COMPLETED|Overall Study||4
3252401|NCT02515058|3986287|FG000|STARTED|Overall Study||21
3252402|NCT02515058|3986288|FG001|STARTED|Overall Study||22
3252403|NCT02515058|3986287|FG000|COMPLETED|Overall Study||18
3252404|NCT02515058|3986288|FG001|COMPLETED|Overall Study||20
3252405|NCT02515058|3986287|FG000|NOT COMPLETED|Overall Study||3
3252406|NCT02515058|3986288|FG001|NOT COMPLETED|Overall Study||2
3252407|NCT02515097|3986296|FG000|STARTED|Overall Study||142
3252408|NCT02515097|3986297|FG001|STARTED|Overall Study||71
3252409|NCT02515097|3986296|FG000|Intent-to-Treat (ITT) Population|Overall Study||142
3252410|NCT02515097|3986297|FG001|Intent-to-Treat (ITT) Population|Overall Study||71
3252411|NCT02515097|3986296|FG000|Safety Population|Overall Study||142
3252412|NCT02515097|3986297|FG001|Safety Population|Overall Study||70
3252413|NCT02515097|3986296|FG000|COMPLETED|Overall Study||135
3252414|NCT02515097|3986297|FG001|COMPLETED|Overall Study||65
3252415|NCT02515097|3986296|FG000|NOT COMPLETED|Overall Study||7
3252416|NCT02515097|3986297|FG001|NOT COMPLETED|Overall Study||6
3252417|NCT02515253|3986305|FG000|STARTED|Overall Study||17
3252418|NCT02515253|3986306|FG001|STARTED|Overall Study||16
3252419|NCT02515253|3986305|FG000|COMPLETED|Overall Study||10
3252420|NCT02515253|3986306|FG001|COMPLETED|Overall Study||8
3252421|NCT02515253|3986305|FG000|NOT COMPLETED|Overall Study||7
3252422|NCT02515253|3986306|FG001|NOT COMPLETED|Overall Study||8
3252423|NCT02515279|3986312|FG000|STARTED|Overall Study||463
3252424|NCT02515279|3986312|FG000|COMPLETED|Overall Study||359
3252425|NCT02515279|3986312|FG000|NOT COMPLETED|Overall Study||104
3252426|NCT02515305|3986319|FG000|STARTED|Overall Study||385
3252427|NCT02515305|3986320|FG001|STARTED|Overall Study||378
3252428|NCT02515305|3986321|FG002|STARTED|Overall Study||127
3252429|NCT02515305|3986319|FG000|COMPLETED|Overall Study||356
3252430|NCT02515305|3986320|FG001|COMPLETED|Overall Study||343
3252431|NCT02515305|3986321|FG002|COMPLETED|Overall Study||113
3252432|NCT02515305|3986319|FG000|NOT COMPLETED|Overall Study||29
3252433|NCT02515305|3986320|FG001|NOT COMPLETED|Overall Study||35
3252434|NCT02515305|3986321|FG002|NOT COMPLETED|Overall Study||14
3252435|NCT02515331|3986332|FG000|STARTED|Overall Study||17
3252436|NCT02515331|3986333|FG001|STARTED|Overall Study||15
3252437|NCT02515331|3986334|FG002|STARTED|Overall Study||32
3252438|NCT02515331|3986332|FG000|Primary Pharmacodynamic Analysis Set|Overall Study||15
3252439|NCT02515331|3986333|FG001|Primary Pharmacodynamic Analysis Set|Overall Study||14
3252440|NCT02515331|3986334|FG002|Primary Pharmacodynamic Analysis Set|Overall Study||29
3252441|NCT02515331|3986332|FG000|Pharmacokinetic (PK) Analysis Set|Overall Study||17
3252442|NCT02515331|3986333|FG001|Pharmacokinetic (PK) Analysis Set|Overall Study||15
3252443|NCT02515331|3986334|FG002|Pharmacokinetic (PK) Analysis Set|Overall Study||0
3252444|NCT02515331|3986332|FG000|COMPLETED|Overall Study||15
3252445|NCT02515331|3986333|FG001|COMPLETED|Overall Study||15
3252446|NCT02515331|3986334|FG002|COMPLETED|Overall Study||28
3252447|NCT02515331|3986332|FG000|NOT COMPLETED|Overall Study||2
3252448|NCT02515331|3986333|FG001|NOT COMPLETED|Overall Study||0
3252449|NCT02515331|3986334|FG002|NOT COMPLETED|Overall Study||4
3252450|NCT02515630|3986344|FG000|STARTED|Overall Study||41
3371814|NCT03591458|4103560|FG001|STARTED|Overall Study||1
3371815|NCT03591458|4103559|FG000|COMPLETED|Overall Study||1
3371816|NCT03591458|4103560|FG001|COMPLETED|Overall Study||1
3371817|NCT03591458|4103559|FG000|NOT COMPLETED|Overall Study||0
3371818|NCT03591458|4103560|FG001|NOT COMPLETED|Overall Study||0
3371819|NCT03590743|4103568|FG000|STARTED|Overall Study||2
3371820|NCT03590743|4103569|FG001|STARTED|Overall Study||3
3371821|NCT03590743|4103568|FG000|COMPLETED|Overall Study||2
3371822|NCT03590743|4103569|FG001|COMPLETED|Overall Study||2
3371823|NCT03590743|4103568|FG000|NOT COMPLETED|Overall Study||0
3371824|NCT03590743|4103569|FG001|NOT COMPLETED|Overall Study||1
3371825|NCT03580382|4103577|FG000|STARTED|Overall Study||0
3371826|NCT03580382|4103578|FG001|STARTED|Overall Study||3
3371827|NCT03580382|4103577|FG000|COMPLETED|Overall Study||0
3371828|NCT03580382|4103578|FG001|COMPLETED|Overall Study||0
3371829|NCT03580382|4103577|FG000|NOT COMPLETED|Overall Study||0
3252451|NCT02515630|3986344|FG000|COMPLETED|Overall Study||25
3252452|NCT02515630|3986344|FG000|NOT COMPLETED|Overall Study||16
3252453|NCT02515656|3986353|FG000|STARTED|Overall Study||326
3252454|NCT02515656|3986354|FG001|STARTED|Overall Study||332
3252455|NCT02515656|3986353|FG000|Full Analysis Set (FAS)|Overall Study||302
3252456|NCT02515656|3986354|FG001|Full Analysis Set (FAS)|Overall Study||309
3252457|NCT02515656|3986353|FG000|Per Protocol Set (PPS)|Overall Study||277
3252458|NCT02515656|3986354|FG001|Per Protocol Set (PPS)|Overall Study||275
3252459|NCT02515656|3986353|FG000|Safety Population|Overall Study||325
3252460|NCT02515656|3986354|FG001|Safety Population|Overall Study||328
3252461|NCT02515656|3986353|FG000|COMPLETED|Overall Study||270
3252462|NCT02515656|3986354|FG001|COMPLETED|Overall Study||261
3252463|NCT02515656|3986353|FG000|NOT COMPLETED|Overall Study||56
3252464|NCT02515656|3986354|FG001|NOT COMPLETED|Overall Study||71
3252465|NCT02515669|3986364|FG000|STARTED|24 Week Double-Blind Phase||11
3252466|NCT02515669|3986365|FG001|STARTED|24 Week Double-Blind Phase||7
3252467|NCT02515669|3986366|FG002|STARTED|24 Week Double-Blind Phase||6
3252468|NCT02515669|3986367|FG003|STARTED|24 Week Double-Blind Phase||19
3252469|NCT02515669|3986364|FG000|COMPLETED|24 Week Double-Blind Phase||11
3252470|NCT02515669|3986365|FG001|COMPLETED|24 Week Double-Blind Phase||7
3252471|NCT02515669|3986366|FG002|COMPLETED|24 Week Double-Blind Phase||6
3252472|NCT02515669|3986367|FG003|COMPLETED|24 Week Double-Blind Phase||19
3252473|NCT02515669|3986364|FG000|NOT COMPLETED|24 Week Double-Blind Phase||0
3252474|NCT02515669|3986365|FG001|NOT COMPLETED|24 Week Double-Blind Phase||0
3252475|NCT02515669|3986366|FG002|NOT COMPLETED|24 Week Double-Blind Phase||0
3252476|NCT02515669|3986367|FG003|NOT COMPLETED|24 Week Double-Blind Phase||0
3252477|NCT02515669|3986364|FG000|STARTED|228 Week Open-Label Phase|Double-blind (DB) placebo participants switched to RO7239361 (RO) for the open label phase.|0
3252478|NCT02515669|3986365|FG001|STARTED|228 Week Open-Label Phase|2 DB placebo participants switched to the Panel 1 RO cohort for the open-label phase.|9
3252479|NCT02515669|3986366|FG002|STARTED|228 Week Open-Label Phase|2 DB placebo participants switched to the Panel 2 RO cohort for the open-label phase.|8
3252480|NCT02515669|3986367|FG003|STARTED|228 Week Open-Label Phase|7 DB placebo participants switched to the Panel 3/Expansion RO cohort for the open-label phase.|26
3252481|NCT02515669|3986364|FG000|COMPLETED|228 Week Open-Label Phase||0
3252482|NCT02515669|3986365|FG001|COMPLETED|228 Week Open-Label Phase||0
3252483|NCT02515669|3986366|FG002|COMPLETED|228 Week Open-Label Phase||0
3252484|NCT02515669|3986367|FG003|COMPLETED|228 Week Open-Label Phase||0
3252485|NCT02515669|3986364|FG000|NOT COMPLETED|228 Week Open-Label Phase||0
3252486|NCT02515669|3986365|FG001|NOT COMPLETED|228 Week Open-Label Phase||9
3252487|NCT02515669|3986366|FG002|NOT COMPLETED|228 Week Open-Label Phase||8
3252488|NCT02515669|3986367|FG003|NOT COMPLETED|228 Week Open-Label Phase||26
3252489|NCT02515825|3986399|FG000|STARTED|Overall Study||70
3252490|NCT02515825|3986400|FG001|STARTED|Overall Study||31
3252491|NCT02515825|3986399|FG000|COMPLETED|Overall Study||70
3252492|NCT02515825|3986400|FG001|COMPLETED|Overall Study||31
3252493|NCT02515825|3986399|FG000|NOT COMPLETED|Overall Study||0
3252494|NCT02515825|3986400|FG001|NOT COMPLETED|Overall Study||0
3252495|NCT02515890|3986412|FG000|STARTED|Overall Study||7
3252496|NCT02515890|3986413|FG001|STARTED|Overall Study||4
3252497|NCT02515890|3986414|FG002|STARTED|Overall Study||5
3252498|NCT02515890|3986415|FG003|STARTED|Overall Study||8
3252499|NCT02515890|3986416|FG004|STARTED|Overall Study||8
3252500|NCT02515890|3986412|FG000|COMPLETED|Overall Study||7
3252501|NCT02515890|3986413|FG001|COMPLETED|Overall Study||4
3252502|NCT02515890|3986414|FG002|COMPLETED|Overall Study||5
3252503|NCT02515890|3986415|FG003|COMPLETED|Overall Study||8
3252504|NCT02515890|3986416|FG004|COMPLETED|Overall Study||8
3252505|NCT02515890|3986412|FG000|NOT COMPLETED|Overall Study||0
3252506|NCT02515890|3986413|FG001|NOT COMPLETED|Overall Study||0
3252507|NCT02515890|3986414|FG002|NOT COMPLETED|Overall Study||0
3252508|NCT02515890|3986415|FG003|NOT COMPLETED|Overall Study||0
3252509|NCT02515890|3986416|FG004|NOT COMPLETED|Overall Study||0
3252510|NCT02515942|3986430|FG000|STARTED|Overall Study||36
3252511|NCT02515942|3986431|FG001|STARTED|Overall Study||39
3252512|NCT02515942|3986432|FG002|STARTED|Overall Study||39
3252513|NCT02515942|3986430|FG000|Safety Analysis Set|Overall Study||36
3252514|NCT02515942|3986431|FG001|Safety Analysis Set|Overall Study||39
3252515|NCT02515942|3986432|FG002|Safety Analysis Set|Overall Study||39
3252516|NCT02515942|3986430|FG000|Full Analysis Set (FAS)|Overall Study||35
3252517|NCT02515942|3986431|FG001|Full Analysis Set (FAS)|Overall Study||37
3252518|NCT02515942|3986432|FG002|Full Analysis Set (FAS)|Overall Study||38
3252519|NCT02515942|3986430|FG000|Per Protocol Analysis Set (PPS)|Overall Study||30
3252520|NCT02515942|3986431|FG001|Per Protocol Analysis Set (PPS)|Overall Study||35
3252521|NCT02515942|3986432|FG002|Per Protocol Analysis Set (PPS)|Overall Study||34
3252522|NCT02515942|3986430|FG000|Pharmacokinetics (PK) Analysis Set|Overall Study||36
3252523|NCT02515942|3986431|FG001|Pharmacokinetics (PK) Analysis Set|Overall Study||39
3252524|NCT02515942|3986432|FG002|Pharmacokinetics (PK) Analysis Set|Overall Study||0
3252525|NCT02515942|3986430|FG000|Completed Day 85|Overall Study||35
3252526|NCT02515942|3986431|FG001|Completed Day 85|Overall Study||38
3252527|NCT02515942|3986432|FG002|Completed Day 85|Overall Study||37
3252528|NCT02515942|3986430|FG000|Completed Day 169|Overall Study||32
3252529|NCT02515942|3986431|FG001|Completed Day 169|Overall Study||37
3252530|NCT02515942|3986432|FG002|Completed Day 169|Overall Study||37
3252531|NCT02515942|3986430|FG000|Completed Day 253|Overall Study|One subject missed Day 253 visit|29
3252532|NCT02515942|3986431|FG001|Completed Day 253|Overall Study||37
3252533|NCT02515942|3986432|FG002|Completed Day 253|Overall Study||36
3252534|NCT02515942|3986430|FG000|Completed Day 337|Overall Study||30
3252535|NCT02515942|3986431|FG001|Completed Day 337|Overall Study||36
3252536|NCT02515942|3986432|FG002|Completed Day 337|Overall Study||35
3252537|NCT02515942|3986430|FG000|COMPLETED|Overall Study||29
3252538|NCT02515942|3986431|FG001|COMPLETED|Overall Study||36
3252539|NCT02515942|3986432|FG002|COMPLETED|Overall Study||35
3252540|NCT02515942|3986430|FG000|NOT COMPLETED|Overall Study||7
3252541|NCT02515942|3986431|FG001|NOT COMPLETED|Overall Study||3
3252542|NCT02515942|3986432|FG002|NOT COMPLETED|Overall Study||4
3252543|NCT02515994|3986444|FG000|STARTED|Overall Study||109
3252544|NCT02515994|3986445|FG001|STARTED|Overall Study||112
3252545|NCT02515994|3986444|FG000|COMPLETED|Overall Study||99
3252546|NCT02515994|3986445|FG001|COMPLETED|Overall Study||105
3252547|NCT02515994|3986444|FG000|NOT COMPLETED|Overall Study||10
3252548|NCT02515994|3986445|FG001|NOT COMPLETED|Overall Study||7
3252549|NCT02516046|3986451|FG000|STARTED|Overall Study|Total number of subjects scanned|156
3252550|NCT02516046|3986451|FG000|Died While on Study|Overall Study||73
3252551|NCT02516046|3986451|FG000|Valid Autopsy Results and PET Scan|Overall Study|includes 3 front-runners|67
3252552|NCT02516046|3986451|FG000|COMPLETED|Overall Study|Completed = included in autopsy cohort|64
3252553|NCT02516046|3986451|FG000|NOT COMPLETED|Overall Study||92
3252554|NCT02516098|3986467|FG000|STARTED|Period 1||28
3252555|NCT02516098|3986468|FG001|STARTED|Period 1||28
3252556|NCT02516098|3986467|FG000|COMPLETED|Period 1||27
3252557|NCT02516098|3986468|FG001|COMPLETED|Period 1||28
3252558|NCT02516098|3986467|FG000|NOT COMPLETED|Period 1||1
3252559|NCT02516098|3986468|FG001|NOT COMPLETED|Period 1||0
3252560|NCT02516098|3986467|FG000|STARTED|Washout After Period 1||27
3252561|NCT02516098|3986468|FG001|STARTED|Washout After Period 1||28
3252562|NCT02516098|3986467|FG000|COMPLETED|Washout After Period 1||27
3252563|NCT02516098|3986468|FG001|COMPLETED|Washout After Period 1||27
3252564|NCT02516098|3986467|FG000|NOT COMPLETED|Washout After Period 1||0
3252565|NCT02516098|3986468|FG001|NOT COMPLETED|Washout After Period 1||1
3252566|NCT02516098|3986467|FG000|STARTED|Period 2||27
3252567|NCT02516098|3986468|FG001|STARTED|Period 2||27
3252568|NCT02516098|3986467|FG000|COMPLETED|Period 2||27
3252569|NCT02516098|3986468|FG001|COMPLETED|Period 2||26
3252570|NCT02516098|3986467|FG000|NOT COMPLETED|Period 2||0
3252571|NCT02516098|3986468|FG001|NOT COMPLETED|Period 2||1
3252572|NCT02516098|3986467|FG000|STARTED|Washout After Period 2||27
3252573|NCT02516098|3986468|FG001|STARTED|Washout After Period 2||26
3252574|NCT02516098|3986467|FG000|COMPLETED|Washout After Period 2||27
3252575|NCT02516098|3986468|FG001|COMPLETED|Washout After Period 2||26
3252576|NCT02516098|3986467|FG000|NOT COMPLETED|Washout After Period 2||0
3252577|NCT02516098|3986468|FG001|NOT COMPLETED|Washout After Period 2||0
3252578|NCT02516150|3986474|FG000|STARTED|Overall Study||15
3252579|NCT02516150|3986474|FG000|COMPLETED|Overall Study||15
3252580|NCT02516150|3986474|FG000|NOT COMPLETED|Overall Study||0
3252581|NCT02516163|3986480|FG000|STARTED|Overall Study||52
3252582|NCT02516163|3986480|FG000|COMPLETED|Overall Study||24
3252583|NCT02516163|3986480|FG000|NOT COMPLETED|Overall Study||28
3252584|NCT02516202|3986487|FG000|STARTED|Overall Study||102
3252585|NCT02516202|3986488|FG001|STARTED|Overall Study||100
3252586|NCT02516202|3986489|FG002|STARTED|Overall Study||100
3252587|NCT02516202|3986487|FG000|COMPLETED|Overall Study||100
3252588|NCT02516202|3986488|FG001|COMPLETED|Overall Study||99
3252589|NCT02516202|3986489|FG002|COMPLETED|Overall Study||97
3252590|NCT02516202|3986487|FG000|NOT COMPLETED|Overall Study||2
3252591|NCT02516202|3986488|FG001|NOT COMPLETED|Overall Study||1
3252592|NCT02516202|3986489|FG002|NOT COMPLETED|Overall Study||3
3252593|NCT02516306|3986499|FG000|STARTED|Period 1: Day 1 - 7||50
3252594|NCT02516306|3986500|FG001|STARTED|Period 1: Day 1 - 7||25
3252595|NCT02516306|3986499|FG000|COMPLETED|Period 1: Day 1 - 7||50
3252596|NCT02516306|3986500|FG001|COMPLETED|Period 1: Day 1 - 7||25
3252597|NCT02516306|3986499|FG000|NOT COMPLETED|Period 1: Day 1 - 7||0
3252598|NCT02516306|3986500|FG001|NOT COMPLETED|Period 1: Day 1 - 7||0
3252599|NCT02516306|3986499|FG000|STARTED|Period 2: Day 8 - 91||50
3252600|NCT02516306|3986500|FG001|STARTED|Period 2: Day 8 - 91||25
3252601|NCT02516306|3986499|FG000|COMPLETED|Period 2: Day 8 - 91||49
3252602|NCT02516306|3986500|FG001|COMPLETED|Period 2: Day 8 - 91||23
3252603|NCT02516306|3986499|FG000|NOT COMPLETED|Period 2: Day 8 - 91||1
3252604|NCT02516306|3986500|FG001|NOT COMPLETED|Period 2: Day 8 - 91||2
3252605|NCT02516332|3986509|FG000|STARTED|Overall Study||52
3252606|NCT02516332|3986510|FG001|STARTED|Overall Study||53
3252607|NCT02516332|3986511|FG002|STARTED|Overall Study||23
3252608|NCT02516332|3986509|FG000|COMPLETED|Overall Study||50
3252609|NCT02516332|3986510|FG001|COMPLETED|Overall Study||52
3252610|NCT02516332|3986511|FG002|COMPLETED|Overall Study||21
3252611|NCT02516332|3986509|FG000|NOT COMPLETED|Overall Study||2
3252612|NCT02516332|3986510|FG001|NOT COMPLETED|Overall Study||1
3252613|NCT02516332|3986511|FG002|NOT COMPLETED|Overall Study||2
3252614|NCT02516410|3986521|FG000|STARTED|Overall Study||85
3252615|NCT02516410|3986522|FG001|STARTED|Overall Study||83
3252616|NCT02516410|3986521|FG000|COMPLETED|Overall Study||85
3252617|NCT02516410|3986522|FG001|COMPLETED|Overall Study||81
3252618|NCT02516410|3986521|FG000|NOT COMPLETED|Overall Study||0
3252619|NCT02516410|3986522|FG001|NOT COMPLETED|Overall Study||2
3252620|NCT02516579|3986529|FG000|STARTED|Overall Study||1906
3252621|NCT02516579|3986529|FG000|COMPLETED|Overall Study||1906
3252622|NCT02516579|3986529|FG000|NOT COMPLETED|Overall Study||0
3252623|NCT02516592|3986535|FG000|STARTED|Overall Study||251
3252624|NCT02516592|3986536|FG001|STARTED|Overall Study||251
3252625|NCT02516592|3986535|FG000|Full Analysis Set|Overall Study||248
3252626|NCT02516592|3986536|FG001|Full Analysis Set|Overall Study||250
3252627|NCT02516592|3986535|FG000|COMPLETED|Overall Study||235
3252628|NCT02516592|3986536|FG001|COMPLETED|Overall Study||238
3252629|NCT02516592|3986535|FG000|NOT COMPLETED|Overall Study||16
3252630|NCT02516592|3986536|FG001|NOT COMPLETED|Overall Study||13
3252631|NCT02516605|3986547|FG000|STARTED|Overall Study||11
3252632|NCT02516605|3986548|FG001|STARTED|Overall Study||9
3252633|NCT02516605|3986549|FG002|STARTED|Overall Study||12
3252634|NCT02516605|3986550|FG003|STARTED|Overall Study||8
3252635|NCT02516605|3986551|FG004|STARTED|Overall Study||21
3252636|NCT02516605|3986547|FG000|COMPLETED|Overall Study||11
3252637|NCT02516605|3986548|FG001|COMPLETED|Overall Study||9
3252638|NCT02516605|3986549|FG002|COMPLETED|Overall Study||12
3252639|NCT02516605|3986550|FG003|COMPLETED|Overall Study||7
3252640|NCT02516605|3986551|FG004|COMPLETED|Overall Study||20
3252641|NCT02516605|3986547|FG000|NOT COMPLETED|Overall Study||0
3252642|NCT02516605|3986548|FG001|NOT COMPLETED|Overall Study||0
3252643|NCT02516605|3986549|FG002|NOT COMPLETED|Overall Study||0
3252644|NCT02516605|3986550|FG003|NOT COMPLETED|Overall Study||1
3252645|NCT02516605|3986551|FG004|NOT COMPLETED|Overall Study||1
3252646|NCT02516982|3986571|FG000|STARTED|Overall Study||305
3252647|NCT02516982|3986572|FG001|STARTED|Overall Study||292
3252648|NCT02516982|3986573|FG002|STARTED|Overall Study||174
3252649|NCT02516982|3986574|FG003|STARTED|Overall Study||175
3252650|NCT02516982|3986571|FG000|COMPLETED|Overall Study||273
3252651|NCT02516982|3986572|FG001|COMPLETED|Overall Study||257
3252652|NCT02516982|3986573|FG002|COMPLETED|Overall Study||126
3252653|NCT02516982|3986574|FG003|COMPLETED|Overall Study||125
3252654|NCT02516982|3986571|FG000|NOT COMPLETED|Overall Study||32
3252655|NCT02516982|3986572|FG001|NOT COMPLETED|Overall Study||35
3252656|NCT02516982|3986573|FG002|NOT COMPLETED|Overall Study||48
3252657|NCT02516982|3986574|FG003|NOT COMPLETED|Overall Study||50
3252658|NCT02517021|3986586|FG000|STARTED|Overall Study||203
3252659|NCT02517021|3986587|FG001|STARTED|Overall Study||202
3252660|NCT02517021|3986586|FG000|COMPLETED|Overall Study||120
3252661|NCT02517021|3986587|FG001|COMPLETED|Overall Study||117
3252662|NCT02517021|3986586|FG000|NOT COMPLETED|Overall Study||83
3252663|NCT02517021|3986587|FG001|NOT COMPLETED|Overall Study||85
3252664|NCT02517047|3986593|FG000|STARTED|Overall Study||26
3252665|NCT02517047|3986593|FG000|COMPLETED|Overall Study||24
3252666|NCT02517047|3986593|FG000|NOT COMPLETED|Overall Study||2
3252667|NCT02517268|3986600|FG000|STARTED|Overall Study||40
3252668|NCT02517268|3986601|FG001|STARTED|Overall Study||37
3252669|NCT02517268|3986600|FG000|COMPLETED|Overall Study||39
3252670|NCT02517268|3986601|FG001|COMPLETED|Overall Study||37
3252671|NCT02517268|3986600|FG000|NOT COMPLETED|Overall Study||1
3252672|NCT02517268|3986601|FG001|NOT COMPLETED|Overall Study||0
3252673|NCT02517463|3986609|FG000|STARTED|Overall Study||369
3252674|NCT02517463|3986610|FG001|STARTED|Overall Study||331
3252675|NCT02517463|3986609|FG000|COMPLETED|Overall Study||364
3252676|NCT02517463|3986610|FG001|COMPLETED|Overall Study||329
3252677|NCT02517463|3986609|FG000|NOT COMPLETED|Overall Study||5
3252678|NCT02517463|3986610|FG001|NOT COMPLETED|Overall Study||2
3252679|NCT02517515|3986618|FG000|STARTED|Overall Study||325
3252680|NCT02517515|3986619|FG001|STARTED|Overall Study||325
3252681|NCT02517515|3986618|FG000|COMPLETED|Overall Study||323
3252682|NCT02517515|3986619|FG001|COMPLETED|Overall Study||323
3252683|NCT02517515|3986618|FG000|NOT COMPLETED|Overall Study||2
3252684|NCT02517515|3986619|FG001|NOT COMPLETED|Overall Study||2
3252685|NCT02517528|3986626|FG000|STARTED|Overall Study||104
3252686|NCT02517528|3986626|FG000|COMPLETED|Overall Study||103
3252687|NCT02517528|3986626|FG000|NOT COMPLETED|Overall Study||1
3252688|NCT02517541|3986630|FG000|STARTED|Baseline Period (Own Product)||74
3252689|NCT02517541|3986630|FG000|COMPLETED|Baseline Period (Own Product)||73
3252690|NCT02517541|3986630|FG000|NOT COMPLETED|Baseline Period (Own Product)||1
3252691|NCT02517541|3986630|FG000|STARTED|Test Period (SenSura Mio Convex Soft)||73
3252692|NCT02517541|3986630|FG000|COMPLETED|Test Period (SenSura Mio Convex Soft)||61
3252693|NCT02517541|3986630|FG000|NOT COMPLETED|Test Period (SenSura Mio Convex Soft)||12
3252694|NCT02517567|3986636|FG000|STARTED|First Exposure (8 Hours)||6
3252695|NCT02517567|3986637|FG001|STARTED|First Exposure (8 Hours)||8
3252696|NCT02517567|3986638|FG002|STARTED|First Exposure (8 Hours)||7
3252697|NCT02517567|3986639|FG003|STARTED|First Exposure (8 Hours)||8
3252698|NCT02517567|3986636|FG000|COMPLETED|First Exposure (8 Hours)||6
3252699|NCT02517567|3986637|FG001|COMPLETED|First Exposure (8 Hours)||8
3252700|NCT02517567|3986638|FG002|COMPLETED|First Exposure (8 Hours)||7
3252701|NCT02517567|3986639|FG003|COMPLETED|First Exposure (8 Hours)||8
3252702|NCT02517567|3986636|FG000|NOT COMPLETED|First Exposure (8 Hours)||0
3252703|NCT02517567|3986637|FG001|NOT COMPLETED|First Exposure (8 Hours)||0
3252704|NCT02517567|3986638|FG002|NOT COMPLETED|First Exposure (8 Hours)||0
3252705|NCT02517567|3986639|FG003|NOT COMPLETED|First Exposure (8 Hours)||0
3252706|NCT02517567|3986636|FG000|STARTED|Second Exposure (8 Hours)||6
3252707|NCT02517567|3986637|FG001|STARTED|Second Exposure (8 Hours)||8
3252708|NCT02517567|3986638|FG002|STARTED|Second Exposure (8 Hours)||7
3252709|NCT02517567|3986639|FG003|STARTED|Second Exposure (8 Hours)||8
3252710|NCT02517567|3986636|FG000|COMPLETED|Second Exposure (8 Hours)||6
3252711|NCT02517567|3986637|FG001|COMPLETED|Second Exposure (8 Hours)||8
3252712|NCT02517567|3986638|FG002|COMPLETED|Second Exposure (8 Hours)||7
3252713|NCT02517567|3986639|FG003|COMPLETED|Second Exposure (8 Hours)||8
3252714|NCT02517567|3986636|FG000|NOT COMPLETED|Second Exposure (8 Hours)||0
3252715|NCT02517567|3986637|FG001|NOT COMPLETED|Second Exposure (8 Hours)||0
3252716|NCT02517567|3986638|FG002|NOT COMPLETED|Second Exposure (8 Hours)||0
3252717|NCT02517567|3986639|FG003|NOT COMPLETED|Second Exposure (8 Hours)||0
3252718|NCT02517567|3986636|FG000|STARTED|Third Exposure (8 Hours)||6
3252719|NCT02517567|3986637|FG001|STARTED|Third Exposure (8 Hours)||8
3252720|NCT02517567|3986638|FG002|STARTED|Third Exposure (8 Hours)||7
3252721|NCT02517567|3986639|FG003|STARTED|Third Exposure (8 Hours)||8
3252722|NCT02517567|3986636|FG000|COMPLETED|Third Exposure (8 Hours)||6
3252723|NCT02517567|3986637|FG001|COMPLETED|Third Exposure (8 Hours)||8
3252724|NCT02517567|3986638|FG002|COMPLETED|Third Exposure (8 Hours)||7
3252725|NCT02517567|3986639|FG003|COMPLETED|Third Exposure (8 Hours)||8
3252726|NCT02517567|3986636|FG000|NOT COMPLETED|Third Exposure (8 Hours)||0
3252727|NCT02517567|3986637|FG001|NOT COMPLETED|Third Exposure (8 Hours)||0
3252728|NCT02517567|3986638|FG002|NOT COMPLETED|Third Exposure (8 Hours)||0
3252729|NCT02517567|3986639|FG003|NOT COMPLETED|Third Exposure (8 Hours)||0
3252730|NCT02517567|3986636|FG000|STARTED|Fourth Exposure (8 Hours)||6
3252731|NCT02517567|3986637|FG001|STARTED|Fourth Exposure (8 Hours)||8
3252732|NCT02517567|3986638|FG002|STARTED|Fourth Exposure (8 Hours)|One subject discontinued between Period 3 and Period 4 (withdrawal by subject)|6
3252733|NCT02517567|3986639|FG003|STARTED|Fourth Exposure (8 Hours)||8
3252734|NCT02517567|3986636|FG000|COMPLETED|Fourth Exposure (8 Hours)||6
3252735|NCT02517567|3986637|FG001|COMPLETED|Fourth Exposure (8 Hours)||8
3252736|NCT02517567|3986638|FG002|COMPLETED|Fourth Exposure (8 Hours)||6
3252737|NCT02517567|3986639|FG003|COMPLETED|Fourth Exposure (8 Hours)||8
3252738|NCT02517567|3986636|FG000|NOT COMPLETED|Fourth Exposure (8 Hours)||0
3252739|NCT02517567|3986637|FG001|NOT COMPLETED|Fourth Exposure (8 Hours)||0
3252740|NCT02517567|3986638|FG002|NOT COMPLETED|Fourth Exposure (8 Hours)||0
3252741|NCT02517567|3986639|FG003|NOT COMPLETED|Fourth Exposure (8 Hours)||0
3252742|NCT02517580|3986648|FG000|STARTED|Overall Study||60
3252743|NCT02517580|3986648|FG000|COMPLETED|Overall Study||56
3252744|NCT02517580|3986648|FG000|NOT COMPLETED|Overall Study||4
3252745|NCT02517658|3986655|FG000|STARTED|Overall Study||33
3252746|NCT02517658|3986656|FG001|STARTED|Overall Study||33
3252747|NCT02517658|3986657|FG002|STARTED|Overall Study||33
3252748|NCT02517658|3986655|FG000|COMPLETED|Overall Study||33
3252749|NCT02517658|3986656|FG001|COMPLETED|Overall Study||33
3252750|NCT02517658|3986657|FG002|COMPLETED|Overall Study||33
3252751|NCT02517658|3986655|FG000|NOT COMPLETED|Overall Study||0
3252752|NCT02517658|3986656|FG001|NOT COMPLETED|Overall Study||0
3252753|NCT02517658|3986657|FG002|NOT COMPLETED|Overall Study||0
3252754|NCT02517866|3986665|FG000|STARTED|Overall Study||289
3252755|NCT02517866|3986666|FG001|STARTED|Overall Study||90
3252756|NCT02517866|3986667|FG002|STARTED|Overall Study||1
3371830|NCT03580382|4103578|FG001|NOT COMPLETED|Overall Study||3
3371831|NCT03572634|4103585|FG000|STARTED|Overall Study||1
3371832|NCT03572634|4103586|FG001|STARTED|Overall Study||2
3371833|NCT03572634|4103585|FG000|COMPLETED|Overall Study||1
3371834|NCT03572634|4103586|FG001|COMPLETED|Overall Study||2
3371835|NCT03572634|4103585|FG000|NOT COMPLETED|Overall Study||0
3371836|NCT03572634|4103586|FG001|NOT COMPLETED|Overall Study||0
3371837|NCT03571646|4103595|FG000|STARTED|Overall Study||3
3371838|NCT03571646|4103596|FG001|STARTED|Overall Study||3
3371839|NCT03571646|4103595|FG000|COMPLETED|Overall Study||1
3371840|NCT03571646|4103596|FG001|COMPLETED|Overall Study||2
3371841|NCT03571646|4103595|FG000|NOT COMPLETED|Overall Study||2
3371842|NCT03571646|4103596|FG001|NOT COMPLETED|Overall Study||1
3371843|NCT03565328|4103602|FG000|STARTED|Overall Study||1
3371844|NCT03565328|4103602|FG000|COMPLETED|Overall Study||1
3371845|NCT03565328|4103602|FG000|NOT COMPLETED|Overall Study||0
3371846|NCT03544242|4103609|FG000|STARTED|Overall Study||1
3371847|NCT03544242|4103610|FG001|STARTED|Overall Study||1
3371848|NCT03544242|4103611|FG002|STARTED|Overall Study||2
3371849|NCT03544242|4103609|FG000|COMPLETED|Overall Study||1
3371850|NCT03544242|4103610|FG001|COMPLETED|Overall Study||1
3371851|NCT03544242|4103611|FG002|COMPLETED|Overall Study||2
3371852|NCT03544242|4103609|FG000|NOT COMPLETED|Overall Study||0
3371853|NCT03544242|4103610|FG001|NOT COMPLETED|Overall Study||0
3371854|NCT03544242|4103611|FG002|NOT COMPLETED|Overall Study||0
3252757|NCT02517866|3986665|FG000|COMPLETED|Overall Study||269
3252758|NCT02517866|3986666|FG001|COMPLETED|Overall Study||84
3252759|NCT02517866|3986667|FG002|COMPLETED|Overall Study||1
3252760|NCT02517866|3986665|FG000|NOT COMPLETED|Overall Study||20
3252761|NCT02517866|3986666|FG001|NOT COMPLETED|Overall Study||6
3252762|NCT02517866|3986667|FG002|NOT COMPLETED|Overall Study||0
3252763|NCT02517905|3986679|FG000|STARTED|Overall Study||107
3252764|NCT02517905|3986680|FG001|STARTED|Overall Study||59
3252765|NCT02517905|3986679|FG000|COMPLETED|Overall Study||97
3252766|NCT02517905|3986680|FG001|COMPLETED|Overall Study||57
3252767|NCT02517905|3986679|FG000|NOT COMPLETED|Overall Study||10
3252768|NCT02517905|3986680|FG001|NOT COMPLETED|Overall Study||2
3252769|NCT02517996|3986688|FG000|STARTED|Overall Study||8
3252770|NCT02517996|3986689|FG001|STARTED|Overall Study||9
3252771|NCT02517996|3986688|FG000|COMPLETED|Overall Study||8
3252772|NCT02517996|3986689|FG001|COMPLETED|Overall Study||9
3371855|NCT03543358|4103619|FG000|STARTED|Overall Study||3
3371856|NCT03543358|4103620|FG001|STARTED|Overall Study||0
3371857|NCT03543358|4103619|FG000|Received Treatment or Retreatment|Overall Study||0
3371858|NCT03543358|4103620|FG001|Received Treatment or Retreatment|Overall Study||0
3371859|NCT03543358|4103619|FG000|COMPLETED|Overall Study||0
3252773|NCT02517996|3986688|FG000|NOT COMPLETED|Overall Study||0
3252774|NCT02517996|3986689|FG001|NOT COMPLETED|Overall Study||0
3252775|NCT02518048|3986695|FG000|STARTED|Overall Study||35
3252776|NCT02518048|3986695|FG000|COMPLETED|Overall Study||34
3252777|NCT02518048|3986695|FG000|NOT COMPLETED|Overall Study||1
3252778|NCT02518113|3986704|FG000|STARTED|Overall Study||6
3252779|NCT02518113|3986705|FG001|STARTED|Overall Study||12
3252780|NCT02518113|3986706|FG002|STARTED|Overall Study||15
3252781|NCT02518113|3986707|FG003|STARTED|Overall Study||3
3252782|NCT02518113|3986704|FG000|COMPLETED|Overall Study||3
3252783|NCT02518113|3986705|FG001|COMPLETED|Overall Study||7
3252784|NCT02518113|3986706|FG002|COMPLETED|Overall Study||11
3252785|NCT02518113|3986707|FG003|COMPLETED|Overall Study||3
3252786|NCT02518113|3986704|FG000|NOT COMPLETED|Overall Study||3
3252787|NCT02518113|3986705|FG001|NOT COMPLETED|Overall Study||5
3252788|NCT02518113|3986706|FG002|NOT COMPLETED|Overall Study||4
3252789|NCT02518113|3986707|FG003|NOT COMPLETED|Overall Study||0
3252790|NCT02518191|3986722|FG000|STARTED|Overall Study||171
3252791|NCT02518191|3986723|FG001|STARTED|Overall Study||174
3252792|NCT02518191|3986722|FG000|COMPLETED|Overall Study||165
3252793|NCT02518191|3986723|FG001|COMPLETED|Overall Study||165
3252794|NCT02518191|3986722|FG000|NOT COMPLETED|Overall Study||6
3252795|NCT02518191|3986723|FG001|NOT COMPLETED|Overall Study||9
3252796|NCT02518230|3986733|FG000|STARTED|Overall Study||11
3252797|NCT02518230|3986734|FG001|STARTED|Overall Study||11
3252798|NCT02518230|3986733|FG000|COMPLETED|Overall Study||11
3252799|NCT02518230|3986734|FG001|COMPLETED|Overall Study||11
3252800|NCT02518230|3986733|FG000|NOT COMPLETED|Overall Study||0
3252801|NCT02518230|3986734|FG001|NOT COMPLETED|Overall Study||0
3252802|NCT02518464|3986741|FG000|STARTED|Overall Study||40
3252803|NCT02518464|3986741|FG000|COMPLETED|Overall Study||38
3252804|NCT02518464|3986741|FG000|NOT COMPLETED|Overall Study||2
3252805|NCT02518490|3986745|FG000|STARTED|Overall Study||18
3252806|NCT02518490|3986746|FG001|STARTED|Overall Study||18
3252807|NCT02518490|3986745|FG000|COMPLETED|Overall Study||17
3252808|NCT02518490|3986746|FG001|COMPLETED|Overall Study||17
3252809|NCT02518490|3986745|FG000|NOT COMPLETED|Overall Study||1
3252810|NCT02518490|3986746|FG001|NOT COMPLETED|Overall Study||1
3252811|NCT02518620|3986755|FG000|STARTED|Overall Study||257
3252812|NCT02518620|3986756|FG001|STARTED|Overall Study||149
3252813|NCT02518620|3986755|FG000|COMPLETED|Overall Study||205
3252814|NCT02518620|3986756|FG001|COMPLETED|Overall Study||123
3252815|NCT02518620|3986755|FG000|NOT COMPLETED|Overall Study||52
3252816|NCT02518620|3986756|FG001|NOT COMPLETED|Overall Study||26
3252817|NCT02518685|3986766|FG000|STARTED|Overall Study||213
3252818|NCT02518685|3986767|FG001|STARTED|Overall Study||89
3252819|NCT02518685|3986766|FG000|Safety Cohort|Overall Study|Randomized to and successfully received TPS (171) + Open-Label TPS-treated Subjects (32)|203
3252820|NCT02518685|3986767|FG001|Safety Cohort|Overall Study||89
3252821|NCT02518685|3986766|FG000|Randomized Cohort|Overall Study||181
3252822|NCT02518685|3986767|FG001|Randomized Cohort|Overall Study||89
3252823|NCT02518685|3986766|FG000|Enrolled|Overall Study|Includes 171 Successful device deployments, 10 unsuccessful delivery attempts and 32 Open-Label|213
3252824|NCT02518685|3986767|FG001|Enrolled|Overall Study||89
3252825|NCT02518685|3986766|FG000|Per Protocol Analysis|Overall Study|Three TPS-treated subjects were inadvertently unblinded, excluding them from efficacy analyses.|168
3252826|NCT02518685|3986767|FG001|Per Protocol Analysis|Overall Study||89
3252827|NCT02518685|3986766|FG000|COMPLETED|Overall Study|Randomized Completers (139) plus Open-Label Completers (25)|164
3252828|NCT02518685|3986767|FG001|COMPLETED|Overall Study||79
3252829|NCT02518685|3986766|FG000|NOT COMPLETED|Overall Study||49
3252830|NCT02518685|3986767|FG001|NOT COMPLETED|Overall Study||10
3252831|NCT02518919|3986777|FG000|STARTED|Overall Study||21
3252832|NCT02518919|3986778|FG001|STARTED|Overall Study||21
3252833|NCT02518919|3986779|FG002|STARTED|Overall Study||21
3252834|NCT02518919|3986777|FG000|COMPLETED|Overall Study||20
3252835|NCT02518919|3986778|FG001|COMPLETED|Overall Study||20
3252836|NCT02518919|3986779|FG002|COMPLETED|Overall Study||19
3252837|NCT02518919|3986777|FG000|NOT COMPLETED|Overall Study||1
3252838|NCT02518919|3986778|FG001|NOT COMPLETED|Overall Study||1
3252839|NCT02518919|3986779|FG002|NOT COMPLETED|Overall Study||2
3252840|NCT02518971|3986789|FG000|STARTED|Overall Study||87
3252841|NCT02518971|3986790|FG001|STARTED|Overall Study||87
3252842|NCT02518971|3986789|FG000|COMPLETED|Overall Study||64
3252843|NCT02518971|3986790|FG001|COMPLETED|Overall Study||67
3252844|NCT02518971|3986789|FG000|NOT COMPLETED|Overall Study||23
3252845|NCT02518971|3986790|FG001|NOT COMPLETED|Overall Study||20
3252846|NCT02518997|3986797|FG000|STARTED|Overall Study||18
3252847|NCT02518997|3986797|FG000|COMPLETED|Overall Study||18
3252848|NCT02518997|3986797|FG000|NOT COMPLETED|Overall Study||0
3252849|NCT02519023|3986806|FG000|STARTED|Overall Study||49
3252850|NCT02519023|3986807|FG001|STARTED|Overall Study||38
3252851|NCT02519023|3986806|FG000|COMPLETED|Overall Study||31
3252852|NCT02519023|3986807|FG001|COMPLETED|Overall Study||31
3252853|NCT02519023|3986806|FG000|NOT COMPLETED|Overall Study||18
3252854|NCT02519023|3986807|FG001|NOT COMPLETED|Overall Study||7
3252855|NCT02519036|3986819|FG000|STARTED|Overall Study||12
3252856|NCT02519036|3986820|FG001|STARTED|Overall Study||3
3252857|NCT02519036|3986821|FG002|STARTED|Overall Study||6
3252858|NCT02519036|3986822|FG003|STARTED|Overall Study||6
3252859|NCT02519036|3986823|FG004|STARTED|Overall Study||9
3252860|NCT02519036|3986824|FG005|STARTED|Overall Study||10
3252861|NCT02519036|3986819|FG000|COMPLETED|Overall Study||12
3252862|NCT02519036|3986820|FG001|COMPLETED|Overall Study||3
3252863|NCT02519036|3986821|FG002|COMPLETED|Overall Study||6
3252864|NCT02519036|3986822|FG003|COMPLETED|Overall Study||6
3252865|NCT02519036|3986823|FG004|COMPLETED|Overall Study||9
3252866|NCT02519036|3986824|FG005|COMPLETED|Overall Study||10
3252867|NCT02519036|3986819|FG000|NOT COMPLETED|Overall Study||0
3252868|NCT02519036|3986820|FG001|NOT COMPLETED|Overall Study||0
3252869|NCT02519036|3986821|FG002|NOT COMPLETED|Overall Study||0
3252870|NCT02519036|3986822|FG003|NOT COMPLETED|Overall Study||0
3252871|NCT02519036|3986823|FG004|NOT COMPLETED|Overall Study||0
3252872|NCT02519036|3986824|FG005|NOT COMPLETED|Overall Study||0
3252873|NCT02519231|3986845|FG000|STARTED|Overall Study||14
3252874|NCT02519231|3986846|FG001|STARTED|Overall Study||14
3252875|NCT02519231|3986845|FG000|COMPLETED|Overall Study|One was lost to follow up and never took the treatment. another never turned in bleeding diary.|12
3252876|NCT02519231|3986846|FG001|COMPLETED|Overall Study|Six participants never turned in their bleeding diaries.|8
3252877|NCT02519231|3986845|FG000|NOT COMPLETED|Overall Study||2
3252878|NCT02519231|3986846|FG001|NOT COMPLETED|Overall Study||6
3252879|NCT02519244|3986854|FG000|STARTED|Overall Study||10
3252880|NCT02519244|3986854|FG000|COMPLETED|Overall Study||10
3252881|NCT02519244|3986854|FG000|NOT COMPLETED|Overall Study||0
3252882|NCT02519387|3986858|FG000|STARTED|Overall Study||78
3252883|NCT02519387|3986858|FG000|COMPLETED|Overall Study||56
3252884|NCT02519387|3986858|FG000|NOT COMPLETED|Overall Study||22
3252885|NCT02519491|3986864|FG000|STARTED|Overall Study||219
3252886|NCT02519491|3986865|FG001|STARTED|Overall Study||219
3252887|NCT02519491|3986864|FG000|COMPLETED|Overall Study||219
3252888|NCT02519491|3986865|FG001|COMPLETED|Overall Study||219
3252889|NCT02519491|3986864|FG000|NOT COMPLETED|Overall Study||0
3252890|NCT02519491|3986865|FG001|NOT COMPLETED|Overall Study||0
3252891|NCT02519504|3986873|FG000|STARTED|Overall Study||319
3252892|NCT02519504|3986874|FG001|STARTED|Overall Study||247
3252893|NCT02519504|3986873|FG000|Attended Direct Testing|Overall Study||212
3252894|NCT02519504|3986874|FG001|Attended Direct Testing|Overall Study||149
3252895|NCT02519504|3986873|FG000|COMPLETED|Overall Study||206
3252896|NCT02519504|3986874|FG001|COMPLETED|Overall Study||144
3252897|NCT02519504|3986873|FG000|NOT COMPLETED|Overall Study||113
3252898|NCT02519504|3986874|FG001|NOT COMPLETED|Overall Study||103
3252899|NCT02519595|3986883|FG000|STARTED|Overall Study||58
3252900|NCT02519595|3986884|FG001|STARTED|Overall Study||57
3252901|NCT02519595|3986885|FG002|STARTED|Overall Study||56
3252902|NCT02519595|3986883|FG000|COMPLETED|Overall Study||50
3252903|NCT02519595|3986884|FG001|COMPLETED|Overall Study||35
3252904|NCT02519595|3986885|FG002|COMPLETED|Overall Study||40
3252905|NCT02519595|3986883|FG000|NOT COMPLETED|Overall Study||8
3252906|NCT02519595|3986884|FG001|NOT COMPLETED|Overall Study||22
3252907|NCT02519595|3986885|FG002|NOT COMPLETED|Overall Study||16
3252908|NCT02519621|3986896|FG000|STARTED|Overall Study||30
3252909|NCT02519621|3986897|FG001|STARTED|Overall Study||30
3252910|NCT02519621|3986898|FG002|STARTED|Overall Study||30
3252911|NCT02519621|3986896|FG000|COMPLETED|Overall Study||30
3252912|NCT02519621|3986897|FG001|COMPLETED|Overall Study||30
3252913|NCT02519621|3986898|FG002|COMPLETED|Overall Study||30
3252914|NCT02519621|3986896|FG000|NOT COMPLETED|Overall Study||0
3252915|NCT02519621|3986897|FG001|NOT COMPLETED|Overall Study||0
3252916|NCT02519621|3986898|FG002|NOT COMPLETED|Overall Study||0
3252917|NCT02519842|3986908|FG000|STARTED|Base Study: Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6.|38
3252918|NCT02519842|3986909|FG001|STARTED|Base Study: Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6.|37
3252919|NCT02519842|3986910|FG002|STARTED|Base Study: Cycle 1||0
3252920|NCT02519842|3986908|FG000|Treated|Base Study: Cycle 1||37
3252921|NCT02519842|3986909|FG001|Treated|Base Study: Cycle 1||34
3252922|NCT02519842|3986910|FG002|Treated|Base Study: Cycle 1||0
3252923|NCT02519842|3986908|FG000|COMPLETED|Base Study: Cycle 1||36
3252924|NCT02519842|3986909|FG001|COMPLETED|Base Study: Cycle 1||34
3252925|NCT02519842|3986910|FG002|COMPLETED|Base Study: Cycle 1||0
3252926|NCT02519842|3986908|FG000|NOT COMPLETED|Base Study: Cycle 1||2
3252927|NCT02519842|3986909|FG001|NOT COMPLETED|Base Study: Cycle 1||3
3252928|NCT02519842|3986910|FG002|NOT COMPLETED|Base Study: Cycle 1||0
3252929|NCT02519842|3986908|FG000|STARTED|Optional Extension: Cycles 2-6|27 participants from this arm in Cycle 1 entered optional Cycles 2-6|0
3252930|NCT02519842|3986909|FG001|STARTED|Optional Extension: Cycles 2-6|28 participants from this arm in Cycle 1 entered optional Cycles 2-6|0
3252931|NCT02519842|3986910|FG002|STARTED|Optional Extension: Cycles 2-6|Enrollment in Cycles 2-6 was optional.|55
3252932|NCT02519842|3986908|FG000|Treated|Optional Extension: Cycles 2-6||0
3252933|NCT02519842|3986909|FG001|Treated|Optional Extension: Cycles 2-6||0
3252934|NCT02519842|3986910|FG002|Treated|Optional Extension: Cycles 2-6||55
3252935|NCT02519842|3986908|FG000|COMPLETED|Optional Extension: Cycles 2-6||0
3252936|NCT02519842|3986909|FG001|COMPLETED|Optional Extension: Cycles 2-6||0
3252937|NCT02519842|3986910|FG002|COMPLETED|Optional Extension: Cycles 2-6||26
3252938|NCT02519842|3986908|FG000|NOT COMPLETED|Optional Extension: Cycles 2-6||0
3252939|NCT02519842|3986909|FG001|NOT COMPLETED|Optional Extension: Cycles 2-6||0
3252940|NCT02519842|3986910|FG002|NOT COMPLETED|Optional Extension: Cycles 2-6||29
3252941|NCT02519855|3986920|FG000|STARTED|Overall Study|Participants are included as treated|441
3252942|NCT02519855|3986921|FG001|STARTED|Overall Study|Participants are included as treated|441
3252943|NCT02519855|3986920|FG000|Vaccinated on Day 1|Overall Study||440
3252944|NCT02519855|3986921|FG001|Vaccinated on Day 1|Overall Study||441
3252945|NCT02519855|3986920|FG000|Vaccinated at Week 4|Overall Study||432
3252946|NCT02519855|3986921|FG001|Vaccinated at Week 4|Overall Study||424
3252947|NCT02519855|3986920|FG000|COMPLETED|Overall Study||438
3252948|NCT02519855|3986921|FG001|COMPLETED|Overall Study||437
3252949|NCT02519855|3986920|FG000|NOT COMPLETED|Overall Study||3
3252950|NCT02519855|3986921|FG001|NOT COMPLETED|Overall Study||4
3252951|NCT02520011|3986930|FG000|STARTED|Overall Study||11
3252952|NCT02520011|3986931|FG001|STARTED|Overall Study||79
3252953|NCT02520011|3986932|FG002|STARTED|Overall Study||14
3252954|NCT02520011|3986930|FG000|Stage 1|Overall Study||0
3252955|NCT02520011|3986931|FG001|Stage 1|Overall Study||32
3252956|NCT02520011|3986932|FG002|Stage 1|Overall Study||10
3252957|NCT02520011|3986930|FG000|Stage 2|Overall Study||11
3252958|NCT02520011|3986931|FG001|Stage 2|Overall Study||47
3252959|NCT02520011|3986932|FG002|Stage 2|Overall Study||4
3252960|NCT02520011|3986930|FG000|COMPLETED|Overall Study||6
3252961|NCT02520011|3986931|FG001|COMPLETED|Overall Study||33
3252962|NCT02520011|3986932|FG002|COMPLETED|Overall Study||5
3252963|NCT02520011|3986930|FG000|NOT COMPLETED|Overall Study||5
3252964|NCT02520011|3986931|FG001|NOT COMPLETED|Overall Study||46
3252965|NCT02520011|3986932|FG002|NOT COMPLETED|Overall Study||9
3252966|NCT02520089|3986947|FG000|STARTED|Overall Study||12
3252967|NCT02520089|3986948|FG001|STARTED|Overall Study||11
3252968|NCT02520089|3986947|FG000|COMPLETED|Overall Study||9
3252969|NCT02520089|3986948|FG001|COMPLETED|Overall Study||7
3252970|NCT02520089|3986947|FG000|NOT COMPLETED|Overall Study||3
3252971|NCT02520089|3986948|FG001|NOT COMPLETED|Overall Study||4
3252972|NCT02520284|3986957|FG000|STARTED|Blinded Induction Phase: Up to Week 8||54
3252973|NCT02520284|3986958|FG001|STARTED|Blinded Induction Phase: Up to Week 8||56
3252974|NCT02520284|3986959|FG002|STARTED|Blinded Induction Phase: Up to Week 8||55
3252975|NCT02520284|3986957|FG000|COMPLETED|Blinded Induction Phase: Up to Week 8||52
3252976|NCT02520284|3986958|FG001|COMPLETED|Blinded Induction Phase: Up to Week 8|1 Participant completed Blinded Induction Phase but did not continue further in study.|52
3252977|NCT02520284|3986959|FG002|COMPLETED|Blinded Induction Phase: Up to Week 8|1 Participant completed Blinded Induction Phase but did not continue further in study.|53
3252978|NCT02520284|3986957|FG000|NOT COMPLETED|Blinded Induction Phase: Up to Week 8||2
3252979|NCT02520284|3986958|FG001|NOT COMPLETED|Blinded Induction Phase: Up to Week 8||4
3252980|NCT02520284|3986959|FG002|NOT COMPLETED|Blinded Induction Phase: Up to Week 8||2
3252981|NCT02520284|3986957|FG000|STARTED|Blinded Maintenance Phase: Up to Week 51|Participants achieving EBS remission and/or MCS response continued in Blinded Maintenance Phase.|20
3252982|NCT02520284|3986958|FG001|STARTED|Blinded Maintenance Phase: Up to Week 51|Participants achieving EBS remission and/or MCS response continued in Blinded Maintenance Phase.|16
3252983|NCT02520284|3986959|FG002|STARTED|Blinded Maintenance Phase: Up to Week 51|Participants achieving EBS remission and/or MCS response continued in Blinded Maintenance Phase.|18
3252984|NCT02520284|3986957|FG000|COMPLETED|Blinded Maintenance Phase: Up to Week 51||0
3252985|NCT02520284|3986958|FG001|COMPLETED|Blinded Maintenance Phase: Up to Week 51||0
3252986|NCT02520284|3986959|FG002|COMPLETED|Blinded Maintenance Phase: Up to Week 51||0
3252987|NCT02520284|3986957|FG000|NOT COMPLETED|Blinded Maintenance Phase: Up to Week 51||20
3252988|NCT02520284|3986958|FG001|NOT COMPLETED|Blinded Maintenance Phase: Up to Week 51||16
3252989|NCT02520284|3986959|FG002|NOT COMPLETED|Blinded Maintenance Phase: Up to Week 51||18
3252990|NCT02520284|3986957|FG000|STARTED|Open-Label MaintenancePhase: Upto Week51|Participants achieving neither EBS remission nor MCS response entered Open-Label Maintenance Phase.|32
3252991|NCT02520284|3986958|FG001|STARTED|Open-Label MaintenancePhase: Upto Week51|Participants achieving neither EBS remission nor MCS response entered Open-Label Maintenance Phase.|35
3252992|NCT02520284|3986959|FG002|STARTED|Open-Label MaintenancePhase: Upto Week51|Participants achieving neither EBS remission nor MCS response entered Open-Label Maintenance Phase.|34
3252993|NCT02520284|3986957|FG000|COMPLETED|Open-Label MaintenancePhase: Upto Week51||0
3252994|NCT02520284|3986958|FG001|COMPLETED|Open-Label MaintenancePhase: Upto Week51||0
3371860|NCT03543358|4103620|FG001|COMPLETED|Overall Study||0
3371861|NCT03543358|4103619|FG000|NOT COMPLETED|Overall Study||3
3371862|NCT03543358|4103620|FG001|NOT COMPLETED|Overall Study||0
3371863|NCT03538015|4103627|FG000|STARTED|Overall Study||0
3371864|NCT03538015|4103628|FG001|STARTED|Overall Study||0
3371865|NCT03538015|4103629|FG002|STARTED|Overall Study||1
3371866|NCT03538015|4103627|FG000|COMPLETED|Overall Study||0
3371867|NCT03538015|4103628|FG001|COMPLETED|Overall Study||0
3371868|NCT03538015|4103629|FG002|COMPLETED|Overall Study||0
3371869|NCT03538015|4103627|FG000|NOT COMPLETED|Overall Study||0
3371870|NCT03538015|4103628|FG001|NOT COMPLETED|Overall Study||0
3371871|NCT03538015|4103629|FG002|NOT COMPLETED|Overall Study||1
3371872|NCT03534362|4103639|FG000|STARTED|Overall Study||0
3371873|NCT03534362|4103640|FG001|STARTED|Overall Study||1
3371874|NCT03534362|4103639|FG000|COMPLETED|Overall Study||0
3371875|NCT03534362|4103640|FG001|COMPLETED|Overall Study||1
3371876|NCT03534362|4103639|FG000|NOT COMPLETED|Overall Study||0
3371877|NCT03534362|4103640|FG001|NOT COMPLETED|Overall Study||0
3371878|NCT03509207|4103648|FG000|STARTED|Overall Study||3
3371879|NCT03509207|4103648|FG000|COMPLETED|Overall Study||1
3371880|NCT03509207|4103648|FG000|NOT COMPLETED|Overall Study||2
3371881|NCT03505372|4103652|FG000|STARTED|Overall Study||5
3371882|NCT03505372|4103652|FG000|COMPLETED|Overall Study||5
3371883|NCT03505372|4103652|FG000|NOT COMPLETED|Overall Study||0
3371884|NCT03500406|4103658|FG000|STARTED|Overall Study||4
3371885|NCT03500406|4103659|FG001|STARTED|Overall Study||20
3371886|NCT03500406|4103658|FG000|COMPLETED|Overall Study||4
3252995|NCT02520284|3986959|FG002|COMPLETED|Open-Label MaintenancePhase: Upto Week51||0
3252996|NCT02520284|3986957|FG000|NOT COMPLETED|Open-Label MaintenancePhase: Upto Week51||32
3252997|NCT02520284|3986958|FG001|NOT COMPLETED|Open-Label MaintenancePhase: Upto Week51||35
3252998|NCT02520284|3986959|FG002|NOT COMPLETED|Open-Label MaintenancePhase: Upto Week51||34
3252999|NCT02520310|3986973|FG000|STARTED|At 30 Days Clinical Follow-up||30
3253000|NCT02520310|3986973|FG000|COMPLETED|At 30 Days Clinical Follow-up||30
3253001|NCT02520310|3986973|FG000|NOT COMPLETED|At 30 Days Clinical Follow-up||0
3253002|NCT02520310|3986973|FG000|STARTED|At 6 Months Clinical Follow-up||30
3253003|NCT02520310|3986973|FG000|COMPLETED|At 6 Months Clinical Follow-up||29
3253004|NCT02520310|3986973|FG000|NOT COMPLETED|At 6 Months Clinical Follow-up||1
3253005|NCT02520310|3986973|FG000|STARTED|At 1 Year Clinical Follow-up||29
3253006|NCT02520310|3986973|FG000|COMPLETED|At 1 Year Clinical Follow-up||28
3253007|NCT02520310|3986973|FG000|NOT COMPLETED|At 1 Year Clinical Follow-up||1
3253008|NCT02520310|3986973|FG000|STARTED|At 2 Year Clinical Follow-up||28
3253009|NCT02520310|3986973|FG000|COMPLETED|At 2 Year Clinical Follow-up||28
3253010|NCT02520310|3986973|FG000|NOT COMPLETED|At 2 Year Clinical Follow-up||0
3253011|NCT02520310|3986973|FG000|STARTED|AT 3 Year Clinical Follow-up||28
3253012|NCT02520310|3986973|FG000|COMPLETED|AT 3 Year Clinical Follow-up||24
3253013|NCT02520310|3986973|FG000|NOT COMPLETED|AT 3 Year Clinical Follow-up||4
3253014|NCT02520310|3986973|FG000|STARTED|AT 4 Year Clinical Follow-up||24
3253015|NCT02520310|3986973|FG000|COMPLETED|AT 4 Year Clinical Follow-up||22
3253016|NCT02520310|3986973|FG000|NOT COMPLETED|AT 4 Year Clinical Follow-up||2
3253017|NCT02520388|3986981|FG000|STARTED|Overall Study||82
3253018|NCT02520388|3986982|FG001|STARTED|Overall Study||81
3253019|NCT02520388|3986981|FG000|Treated|Overall Study||81
3253020|NCT02520388|3986982|FG001|Treated|Overall Study||80
3253021|NCT02520388|3986981|FG000|COMPLETED|Overall Study||73
3253022|NCT02520388|3986982|FG001|COMPLETED|Overall Study||65
3253023|NCT02520388|3986981|FG000|NOT COMPLETED|Overall Study||9
3253024|NCT02520388|3986982|FG001|NOT COMPLETED|Overall Study||16
3253025|NCT02520414|3986988|FG000|STARTED|Overall Study||10
3253026|NCT02520414|3986988|FG000|COMPLETED|Overall Study||10
3253027|NCT02520414|3986988|FG000|NOT COMPLETED|Overall Study||0
3253028|NCT02520518|3986996|FG000|STARTED|Overall Study||3
3253029|NCT02520518|3986997|FG001|STARTED|Overall Study||1
3253030|NCT02520518|3986998|FG002|STARTED|Overall Study||3
3253031|NCT02520518|3986999|FG003|STARTED|Overall Study||2
3253032|NCT02520518|3986996|FG000|COMPLETED|Overall Study||3
3253033|NCT02520518|3986997|FG001|COMPLETED|Overall Study||1
3253034|NCT02520518|3986998|FG002|COMPLETED|Overall Study||1
3253035|NCT02520518|3986999|FG003|COMPLETED|Overall Study||1
3253036|NCT02520518|3986996|FG000|NOT COMPLETED|Overall Study||0
3253037|NCT02520518|3986997|FG001|NOT COMPLETED|Overall Study||0
3253038|NCT02520518|3986998|FG002|NOT COMPLETED|Overall Study||2
3253039|NCT02520518|3986999|FG003|NOT COMPLETED|Overall Study||1
3253040|NCT02520531|3987013|FG000|STARTED|Overall Study||42
3253041|NCT02520531|3987014|FG001|STARTED|Overall Study||42
3253042|NCT02520531|3987013|FG000|COMPLETED|Overall Study||36
3253043|NCT02520531|3987014|FG001|COMPLETED|Overall Study||36
3253044|NCT02520531|3987013|FG000|NOT COMPLETED|Overall Study||6
3253045|NCT02520531|3987014|FG001|NOT COMPLETED|Overall Study||6
3253046|NCT02521181|3987023|FG000|STARTED|Overall Study||52
3253047|NCT02521181|3987024|FG001|STARTED|Overall Study||90
3253048|NCT02521181|3987025|FG002|STARTED|Overall Study||52
3253049|NCT02521181|3987023|FG000|COMPLETED|Overall Study|All patients included in primary analysis|52
3253050|NCT02521181|3987024|FG001|COMPLETED|Overall Study|All patients included in primary analysis|90
3253051|NCT02521181|3987025|FG002|COMPLETED|Overall Study|All patients included in primary analysis|52
3253052|NCT02521181|3987023|FG000|NOT COMPLETED|Overall Study||0
3253053|NCT02521181|3987024|FG001|NOT COMPLETED|Overall Study||0
3253054|NCT02521181|3987025|FG002|NOT COMPLETED|Overall Study||0
3253055|NCT02521259|3987035|FG000|STARTED|Overall Study||35
3253056|NCT02521259|3987036|FG001|STARTED|Overall Study||33
3253057|NCT02521259|3987035|FG000|COMPLETED|Overall Study||34
3253058|NCT02521259|3987036|FG001|COMPLETED|Overall Study||28
3253059|NCT02521259|3987035|FG000|NOT COMPLETED|Overall Study||1
3253060|NCT02521259|3987036|FG001|NOT COMPLETED|Overall Study||5
3253061|NCT02521376|3987046|FG000|STARTED|Overall Study||8
3253062|NCT02521376|3987047|FG001|STARTED|Overall Study||18
3253063|NCT02521376|3987048|FG002|STARTED|Overall Study||10
3253064|NCT02521376|3987049|FG003|STARTED|Overall Study||20
3253065|NCT02521376|3987046|FG000|COMPLETED|Overall Study||7
3253066|NCT02521376|3987047|FG001|COMPLETED|Overall Study||18
3253067|NCT02521376|3987048|FG002|COMPLETED|Overall Study||10
3253068|NCT02521376|3987049|FG003|COMPLETED|Overall Study||20
3253069|NCT02521376|3987046|FG000|NOT COMPLETED|Overall Study||1
3253070|NCT02521376|3987047|FG001|NOT COMPLETED|Overall Study||0
3253071|NCT02521376|3987048|FG002|NOT COMPLETED|Overall Study||0
3253072|NCT02521376|3987049|FG003|NOT COMPLETED|Overall Study||0
3253073|NCT02521766|3987069|FG000|STARTED|Overall Study||49
3253074|NCT02521766|3987070|FG001|STARTED|Overall Study||65
3253075|NCT02521766|3987069|FG000|Per Protocol|Overall Study||47
3253076|NCT02521766|3987070|FG001|Per Protocol|Overall Study||65
3253077|NCT02521766|3987069|FG000|COMPLETED|Overall Study||44
3253078|NCT02521766|3987070|FG001|COMPLETED|Overall Study||62
3253079|NCT02521766|3987069|FG000|NOT COMPLETED|Overall Study||5
3253080|NCT02521766|3987070|FG001|NOT COMPLETED|Overall Study||3
3253081|NCT02521792|3987087|FG000|STARTED|Overall Study||6
3253082|NCT02521792|3987087|FG000|Received Treatment|Overall Study||4
3253083|NCT02521792|3987087|FG000|COMPLETED|Overall Study||0
3253084|NCT02521792|3987087|FG000|NOT COMPLETED|Overall Study||6
3253085|NCT02521870|3987099|FG000|STARTED|Phase 1: Dose Escalation||6
3253086|NCT02521870|3987100|FG001|STARTED|Phase 1: Dose Escalation||5
3253087|NCT02521870|3987101|FG002|STARTED|Phase 1: Dose Escalation||5
3253088|NCT02521870|3987102|FG003|STARTED|Phase 1: Dose Escalation||6
3253089|NCT02521870|3987103|FG004|STARTED|Phase 1: Dose Escalation||0
3253090|NCT02521870|3987104|FG005|STARTED|Phase 1: Dose Escalation||0
3253091|NCT02521870|3987105|FG006|STARTED|Phase 1: Dose Escalation||0
3253092|NCT02521870|3987106|FG007|STARTED|Phase 1: Dose Escalation||0
3253093|NCT02521870|3987107|FG008|STARTED|Phase 1: Dose Escalation||0
3253094|NCT02521870|3987108|FG009|STARTED|Phase 1: Dose Escalation||0
3253095|NCT02521870|3987109|FG010|STARTED|Phase 1: Dose Escalation||0
3253096|NCT02521870|3987110|FG011|STARTED|Phase 1: Dose Escalation||0
3253097|NCT02521870|3987099|FG000|Completed SD-101 Treatment (up to 11 Doses)|Phase 1: Dose Escalation||3
3253098|NCT02521870|3987100|FG001|Completed SD-101 Treatment (up to 11 Doses)|Phase 1: Dose Escalation||3
3253099|NCT02521870|3987101|FG002|Completed SD-101 Treatment (up to 11 Doses)|Phase 1: Dose Escalation||0
3253100|NCT02521870|3987102|FG003|Completed SD-101 Treatment (up to 11 Doses)|Phase 1: Dose Escalation||1
3253101|NCT02521870|3987103|FG004|Completed SD-101 Treatment (up to 11 Doses)|Phase 1: Dose Escalation||0
3253102|NCT02521870|3987104|FG005|Completed SD-101 Treatment (up to 11 Doses)|Phase 1: Dose Escalation||0
3253103|NCT02521870|3987105|FG006|Completed SD-101 Treatment (up to 11 Doses)|Phase 1: Dose Escalation||0
3253104|NCT02521870|3987106|FG007|Completed SD-101 Treatment (up to 11 Doses)|Phase 1: Dose Escalation||0
3253105|NCT02521870|3987107|FG008|Completed SD-101 Treatment (up to 11 Doses)|Phase 1: Dose Escalation||0
3253106|NCT02521870|3987108|FG009|Completed SD-101 Treatment (up to 11 Doses)|Phase 1: Dose Escalation||0
3253107|NCT02521870|3987109|FG010|Completed SD-101 Treatment (up to 11 Doses)|Phase 1: Dose Escalation||0
3253108|NCT02521870|3987110|FG011|Completed SD-101 Treatment (up to 11 Doses)|Phase 1: Dose Escalation||0
3253109|NCT02521870|3987099|FG000|COMPLETED|Phase 1: Dose Escalation||1
3253110|NCT02521870|3987100|FG001|COMPLETED|Phase 1: Dose Escalation||1
3253111|NCT02521870|3987101|FG002|COMPLETED|Phase 1: Dose Escalation||1
3253112|NCT02521870|3987102|FG003|COMPLETED|Phase 1: Dose Escalation||0
3253113|NCT02521870|3987103|FG004|COMPLETED|Phase 1: Dose Escalation||0
3253114|NCT02521870|3987104|FG005|COMPLETED|Phase 1: Dose Escalation||0
3253115|NCT02521870|3987105|FG006|COMPLETED|Phase 1: Dose Escalation||0
3253116|NCT02521870|3987106|FG007|COMPLETED|Phase 1: Dose Escalation||0
3253117|NCT02521870|3987107|FG008|COMPLETED|Phase 1: Dose Escalation||0
3253118|NCT02521870|3987108|FG009|COMPLETED|Phase 1: Dose Escalation||0
3253119|NCT02521870|3987109|FG010|COMPLETED|Phase 1: Dose Escalation||0
3253120|NCT02521870|3987110|FG011|COMPLETED|Phase 1: Dose Escalation||0
3253121|NCT02521870|3987099|FG000|NOT COMPLETED|Phase 1: Dose Escalation||5
3253122|NCT02521870|3987100|FG001|NOT COMPLETED|Phase 1: Dose Escalation||4
3253123|NCT02521870|3987101|FG002|NOT COMPLETED|Phase 1: Dose Escalation||4
3253124|NCT02521870|3987102|FG003|NOT COMPLETED|Phase 1: Dose Escalation||6
3371887|NCT03500406|4103659|FG001|COMPLETED|Overall Study||20
3371888|NCT03500406|4103658|FG000|NOT COMPLETED|Overall Study||0
3371889|NCT03500406|4103659|FG001|NOT COMPLETED|Overall Study||0
3371890|NCT03500341|4103665|FG000|STARTED|Overall Study||16
3371891|NCT03500341|4103665|FG000|COMPLETED|Overall Study||14
3371892|NCT03500341|4103665|FG000|NOT COMPLETED|Overall Study||2
3371893|NCT03500159|4103671|FG000|STARTED|Overall Study||2
3371894|NCT03500159|4103672|FG001|STARTED|Overall Study||1
3371895|NCT03500159|4103671|FG000|COMPLETED|Overall Study||0
3371896|NCT03500159|4103672|FG001|COMPLETED|Overall Study||0
3371897|NCT03500159|4103671|FG000|NOT COMPLETED|Overall Study||2
3371898|NCT03500159|4103672|FG001|NOT COMPLETED|Overall Study||1
3371899|NCT03490916|4103680|FG000|STARTED|Overall Study||0
3371900|NCT03490916|4103681|FG001|STARTED|Overall Study||0
3371901|NCT03490916|4103680|FG000|COMPLETED|Overall Study||0
3371902|NCT03490916|4103681|FG001|COMPLETED|Overall Study||0
3371903|NCT03490916|4103680|FG000|NOT COMPLETED|Overall Study||0
3371904|NCT03490916|4103681|FG001|NOT COMPLETED|Overall Study||0
3371905|NCT03483051|4103689|FG000|STARTED|First Treatment, Pre Crossover||2
3371906|NCT03483051|4103690|FG001|STARTED|First Treatment, Pre Crossover||1
3371907|NCT03483051|4103689|FG000|COMPLETED|First Treatment, Pre Crossover||2
3371908|NCT03483051|4103690|FG001|COMPLETED|First Treatment, Pre Crossover||1
3371909|NCT03483051|4103689|FG000|NOT COMPLETED|First Treatment, Pre Crossover||0
3371910|NCT03483051|4103690|FG001|NOT COMPLETED|First Treatment, Pre Crossover||0
3371911|NCT03483051|4103689|FG000|STARTED|Second Treatment, After Crossover||2
3371912|NCT03483051|4103690|FG001|STARTED|Second Treatment, After Crossover||1
3371913|NCT03483051|4103689|FG000|COMPLETED|Second Treatment, After Crossover||2
3371914|NCT03483051|4103690|FG001|COMPLETED|Second Treatment, After Crossover||1
3371915|NCT03483051|4103689|FG000|NOT COMPLETED|Second Treatment, After Crossover||0
3371916|NCT03483051|4103690|FG001|NOT COMPLETED|Second Treatment, After Crossover||0
3371917|NCT03477903|4103698|FG000|STARTED|Overall Study||1
3371918|NCT03477903|4103698|FG000|COMPLETED|Overall Study||0
3371919|NCT03477903|4103698|FG000|NOT COMPLETED|Overall Study||1
3371920|NCT03469258|4103702|FG000|STARTED|Overall Study||4
3371921|NCT03469258|4103702|FG000|COMPLETED|Overall Study||0
3371922|NCT03469258|4103702|FG000|NOT COMPLETED|Overall Study||4
3371923|NCT03466658|4103706|FG000|STARTED|Overall Study||17
3371924|NCT03466658|4103706|FG000|COMPLETED|Overall Study||14
3371925|NCT03466658|4103706|FG000|NOT COMPLETED|Overall Study||3
3253125|NCT02521870|3987103|FG004|NOT COMPLETED|Phase 1: Dose Escalation||0
3253126|NCT02521870|3987104|FG005|NOT COMPLETED|Phase 1: Dose Escalation||0
3253127|NCT02521870|3987105|FG006|NOT COMPLETED|Phase 1: Dose Escalation||0
3253128|NCT02521870|3987106|FG007|NOT COMPLETED|Phase 1: Dose Escalation||0
3253129|NCT02521870|3987107|FG008|NOT COMPLETED|Phase 1: Dose Escalation||0
3253130|NCT02521870|3987108|FG009|NOT COMPLETED|Phase 1: Dose Escalation||0
3253131|NCT02521870|3987109|FG010|NOT COMPLETED|Phase 1: Dose Escalation||0
3253132|NCT02521870|3987110|FG011|NOT COMPLETED|Phase 1: Dose Escalation||0
3253133|NCT02521870|3987099|FG000|STARTED|Phase 2: Dose Expansion||0
3253134|NCT02521870|3987100|FG001|STARTED|Phase 2: Dose Expansion||0
3253135|NCT02521870|3987101|FG002|STARTED|Phase 2: Dose Expansion||0
3253136|NCT02521870|3987102|FG003|STARTED|Phase 2: Dose Expansion||0
3253137|NCT02521870|3987103|FG004|STARTED|Phase 2: Dose Expansion||57
3253138|NCT02521870|3987104|FG005|STARTED|Phase 2: Dose Expansion||25
3253139|NCT02521870|3987105|FG006|STARTED|Phase 2: Dose Expansion||23
3253140|NCT02521870|3987106|FG007|STARTED|Phase 2: Dose Expansion||9
3253141|NCT02521870|3987107|FG008|STARTED|Phase 2: Dose Expansion||24
3253142|NCT02521870|3987108|FG009|STARTED|Phase 2: Dose Expansion||28
3253143|NCT02521870|3987109|FG010|STARTED|Phase 2: Dose Expansion||23
3253144|NCT02521870|3987110|FG011|STARTED|Phase 2: Dose Expansion||30
3253145|NCT02521870|3987099|FG000|Completed SD-101 Treatment (up to 11 Doses)|Phase 2: Dose Expansion||0
3253146|NCT02521870|3987100|FG001|Completed SD-101 Treatment (up to 11 Doses)|Phase 2: Dose Expansion||0
3253147|NCT02521870|3987101|FG002|Completed SD-101 Treatment (up to 11 Doses)|Phase 2: Dose Expansion||0
3253148|NCT02521870|3987102|FG003|Completed SD-101 Treatment (up to 11 Doses)|Phase 2: Dose Expansion||0
3253149|NCT02521870|3987103|FG004|Completed SD-101 Treatment (up to 11 Doses)|Phase 2: Dose Expansion||25
3253150|NCT02521870|3987104|FG005|Completed SD-101 Treatment (up to 11 Doses)|Phase 2: Dose Expansion||7
3253151|NCT02521870|3987105|FG006|Completed SD-101 Treatment (up to 11 Doses)|Phase 2: Dose Expansion||3
3253152|NCT02521870|3987106|FG007|Completed SD-101 Treatment (up to 11 Doses)|Phase 2: Dose Expansion||2
3253153|NCT02521870|3987107|FG008|Completed SD-101 Treatment (up to 11 Doses)|Phase 2: Dose Expansion||9
3253154|NCT02521870|3987108|FG009|Completed SD-101 Treatment (up to 11 Doses)|Phase 2: Dose Expansion||5
3253155|NCT02521870|3987109|FG010|Completed SD-101 Treatment (up to 11 Doses)|Phase 2: Dose Expansion||1
3253156|NCT02521870|3987110|FG011|Completed SD-101 Treatment (up to 11 Doses)|Phase 2: Dose Expansion||11
3253157|NCT02521870|3987099|FG000|Completed SD-101 Treatment Cycle 2 (up to 22 Doses)|Phase 2: Dose Expansion||0
3253158|NCT02521870|3987100|FG001|Completed SD-101 Treatment Cycle 2 (up to 22 Doses)|Phase 2: Dose Expansion||0
3253159|NCT02521870|3987101|FG002|Completed SD-101 Treatment Cycle 2 (up to 22 Doses)|Phase 2: Dose Expansion||0
3253160|NCT02521870|3987102|FG003|Completed SD-101 Treatment Cycle 2 (up to 22 Doses)|Phase 2: Dose Expansion||0
3253161|NCT02521870|3987103|FG004|Completed SD-101 Treatment Cycle 2 (up to 22 Doses)|Phase 2: Dose Expansion||7
3253162|NCT02521870|3987104|FG005|Completed SD-101 Treatment Cycle 2 (up to 22 Doses)|Phase 2: Dose Expansion||1
3253163|NCT02521870|3987105|FG006|Completed SD-101 Treatment Cycle 2 (up to 22 Doses)|Phase 2: Dose Expansion||0
3253164|NCT02521870|3987106|FG007|Completed SD-101 Treatment Cycle 2 (up to 22 Doses)|Phase 2: Dose Expansion||0
3253165|NCT02521870|3987107|FG008|Completed SD-101 Treatment Cycle 2 (up to 22 Doses)|Phase 2: Dose Expansion||0
3253166|NCT02521870|3987108|FG009|Completed SD-101 Treatment Cycle 2 (up to 22 Doses)|Phase 2: Dose Expansion||0
3253167|NCT02521870|3987109|FG010|Completed SD-101 Treatment Cycle 2 (up to 22 Doses)|Phase 2: Dose Expansion||0
3253168|NCT02521870|3987110|FG011|Completed SD-101 Treatment Cycle 2 (up to 22 Doses)|Phase 2: Dose Expansion||0
3253169|NCT02521870|3987099|FG000|COMPLETED|Phase 2: Dose Expansion||0
3253170|NCT02521870|3987100|FG001|COMPLETED|Phase 2: Dose Expansion||0
3253171|NCT02521870|3987101|FG002|COMPLETED|Phase 2: Dose Expansion||0
3253172|NCT02521870|3987102|FG003|COMPLETED|Phase 2: Dose Expansion||0
3253173|NCT02521870|3987103|FG004|COMPLETED|Phase 2: Dose Expansion||5
3253174|NCT02521870|3987104|FG005|COMPLETED|Phase 2: Dose Expansion||0
3253175|NCT02521870|3987105|FG006|COMPLETED|Phase 2: Dose Expansion||0
3253176|NCT02521870|3987106|FG007|COMPLETED|Phase 2: Dose Expansion||0
3253177|NCT02521870|3987107|FG008|COMPLETED|Phase 2: Dose Expansion|4 participants completed pembrolizumab treatment (up to 35 cycles).|2
3253178|NCT02521870|3987108|FG009|COMPLETED|Phase 2: Dose Expansion||0
3253179|NCT02521870|3987109|FG010|COMPLETED|Phase 2: Dose Expansion||0
3253180|NCT02521870|3987110|FG011|COMPLETED|Phase 2: Dose Expansion||0
3253181|NCT02521870|3987099|FG000|NOT COMPLETED|Phase 2: Dose Expansion||0
3253182|NCT02521870|3987100|FG001|NOT COMPLETED|Phase 2: Dose Expansion||0
3253183|NCT02521870|3987101|FG002|NOT COMPLETED|Phase 2: Dose Expansion||0
3253184|NCT02521870|3987102|FG003|NOT COMPLETED|Phase 2: Dose Expansion||0
3253185|NCT02521870|3987103|FG004|NOT COMPLETED|Phase 2: Dose Expansion||52
3253186|NCT02521870|3987104|FG005|NOT COMPLETED|Phase 2: Dose Expansion||25
3253187|NCT02521870|3987105|FG006|NOT COMPLETED|Phase 2: Dose Expansion||23
3253188|NCT02521870|3987106|FG007|NOT COMPLETED|Phase 2: Dose Expansion||9
3253189|NCT02521870|3987107|FG008|NOT COMPLETED|Phase 2: Dose Expansion||22
3253190|NCT02521870|3987108|FG009|NOT COMPLETED|Phase 2: Dose Expansion||28
3253191|NCT02521870|3987109|FG010|NOT COMPLETED|Phase 2: Dose Expansion||23
3253192|NCT02521870|3987110|FG011|NOT COMPLETED|Phase 2: Dose Expansion||30
3253193|NCT02521948|3987140|FG000|STARTED|Overall Study||50
3253194|NCT02521948|3987140|FG000|COMPLETED|Overall Study||37
3253195|NCT02521948|3987140|FG000|NOT COMPLETED|Overall Study||13
3253196|NCT02521974|3987149|FG000|STARTED|Overall Study||50
3253197|NCT02521974|3987150|FG001|STARTED|Overall Study||114
3253198|NCT02521974|3987149|FG000|COMPLETED|Overall Study||47
3253199|NCT02521974|3987150|FG001|COMPLETED|Overall Study||110
3253200|NCT02521974|3987149|FG000|NOT COMPLETED|Overall Study||3
3253201|NCT02521974|3987150|FG001|NOT COMPLETED|Overall Study||4
3253202|NCT02522104|3987160|FG000|STARTED|Overall Study||13
3253203|NCT02522104|3987161|FG001|STARTED|Overall Study||15
3253204|NCT02522104|3987162|FG002|STARTED|Overall Study||12
3253205|NCT02522104|3987160|FG000|COMPLETED|Overall Study||10
3253206|NCT02522104|3987161|FG001|COMPLETED|Overall Study||12
3253207|NCT02522104|3987162|FG002|COMPLETED|Overall Study||5
3253208|NCT02522104|3987160|FG000|NOT COMPLETED|Overall Study||3
3253209|NCT02522104|3987161|FG001|NOT COMPLETED|Overall Study||3
3253210|NCT02522104|3987162|FG002|NOT COMPLETED|Overall Study||7
3253211|NCT02522286|3987177|FG000|STARTED|Overall Study||78
3253212|NCT02522286|3987178|FG001|STARTED|Overall Study||75
3253213|NCT02522286|3987179|FG002|STARTED|Overall Study||75
3253214|NCT02522286|3987180|FG003|STARTED|Overall Study||78
3253215|NCT02522286|3987177|FG000|COMPLETED|Overall Study||75
3253216|NCT02522286|3987178|FG001|COMPLETED|Overall Study||75
3253217|NCT02522286|3987179|FG002|COMPLETED|Overall Study||75
3253218|NCT02522286|3987180|FG003|COMPLETED|Overall Study||75
3253219|NCT02522286|3987177|FG000|NOT COMPLETED|Overall Study||3
3371926|NCT03465891|4103714|FG000|STARTED|Overall Study||1
3371927|NCT03465891|4103715|FG001|STARTED|Overall Study||1
3371928|NCT03465891|4103714|FG000|COMPLETED|Overall Study||0
3371929|NCT03465891|4103715|FG001|COMPLETED|Overall Study||0
3371930|NCT03465891|4103714|FG000|NOT COMPLETED|Overall Study||1
3371931|NCT03465891|4103715|FG001|NOT COMPLETED|Overall Study||1
3371932|NCT03465735|4103723|FG000|STARTED|Overall Study||8
3371933|NCT03465735|4103724|FG001|STARTED|Overall Study||7
3371934|NCT03465735|4103723|FG000|COMPLETED|Overall Study||7
3371935|NCT03465735|4103724|FG001|COMPLETED|Overall Study||5
3371936|NCT03465735|4103723|FG000|NOT COMPLETED|Overall Study||1
3371937|NCT03465735|4103724|FG001|NOT COMPLETED|Overall Study||2
3371938|NCT03461705|4103730|FG000|STARTED|Overall Study||5
3371939|NCT03461705|4103730|FG000|COMPLETED|Overall Study||5
3371940|NCT03461705|4103730|FG000|NOT COMPLETED|Overall Study||0
3371941|NCT03457818|4103736|FG000|STARTED|Overall Study||4
3371942|NCT03457818|4103737|FG001|STARTED|Overall Study||4
3371943|NCT03457818|4103736|FG000|COMPLETED|Overall Study|Study terminated|0
3371944|NCT03457818|4103737|FG001|COMPLETED|Overall Study|study terminated|0
3371945|NCT03457818|4103736|FG000|NOT COMPLETED|Overall Study||4
3371946|NCT03457818|4103737|FG001|NOT COMPLETED|Overall Study||4
3371947|NCT03455556|4103743|FG000|STARTED|Overall Study||1
3371948|NCT03455556|4103743|FG000|COMPLETED|Overall Study||1
3371949|NCT03455556|4103743|FG000|NOT COMPLETED|Overall Study||0
3371950|NCT03447639|4103749|FG000|STARTED|Overall Study|No patients were randomized to the Povidone-Iodine irrigation arm|0
3371951|NCT03447639|4103750|FG001|STARTED|Overall Study|3 patients were randomized to the Standard of Care arm.|3
3371952|NCT03447639|4103749|FG000|COMPLETED|Overall Study|No patients were randomized to the Povidone-Iodine irrigation arm|0
3371953|NCT03447639|4103750|FG001|COMPLETED|Overall Study|2 patients were withdrawn because their catheters had to be re-inserted.|1
3371954|NCT03447639|4103749|FG000|NOT COMPLETED|Overall Study||0
3371955|NCT03447639|4103750|FG001|NOT COMPLETED|Overall Study||2
3371956|NCT03429712|4103756|FG000|STARTED|Overall Study||19
3371957|NCT03429712|4103756|FG000|COMPLETED|Overall Study||10
3371958|NCT03429712|4103756|FG000|NOT COMPLETED|Overall Study||9
3371959|NCT03426137|4103763|FG000|STARTED|Overall Study||0
3371960|NCT03426137|4103764|FG001|STARTED|Overall Study||0
3371961|NCT03426137|4103765|FG002|STARTED|Overall Study||0
3371962|NCT03426137|4103763|FG000|COMPLETED|Overall Study||0
3371963|NCT03426137|4103764|FG001|COMPLETED|Overall Study||0
3371964|NCT03426137|4103765|FG002|COMPLETED|Overall Study||0
3371965|NCT03426137|4103763|FG000|NOT COMPLETED|Overall Study||0
3371966|NCT03426137|4103764|FG001|NOT COMPLETED|Overall Study||0
3371967|NCT03426137|4103765|FG002|NOT COMPLETED|Overall Study||0
3371968|NCT03425799|4103775|FG000|STARTED|Overall Study|Study terminated due to low recruitment|0
3371969|NCT03425799|4103776|FG001|STARTED|Overall Study|Study terminated due to low recruitment|0
3371970|NCT03425799|4103775|FG000|COMPLETED|Overall Study|Study terminated due to low recruitment|0
3371971|NCT03425799|4103776|FG001|COMPLETED|Overall Study|Study terminated due to low recruitment|0
3371972|NCT03425799|4103775|FG000|NOT COMPLETED|Overall Study||0
3371973|NCT03425799|4103776|FG001|NOT COMPLETED|Overall Study||0
3371974|NCT03423654|4103784|FG000|STARTED|Overall Study||3
3371975|NCT03423654|4103785|FG001|STARTED|Overall Study||3
3371976|NCT03423654|4103784|FG000|COMPLETED|Overall Study||3
3371977|NCT03423654|4103785|FG001|COMPLETED|Overall Study||3
3371978|NCT03423654|4103784|FG000|NOT COMPLETED|Overall Study||0
3371979|NCT03423654|4103785|FG001|NOT COMPLETED|Overall Study||0
3371980|NCT03387059|4103793|FG000|STARTED|Overall Study||5
3371981|NCT03387059|4103794|FG001|STARTED|Overall Study||4
3371982|NCT03387059|4103793|FG000|COMPLETED|Overall Study||0
3371983|NCT03387059|4103794|FG001|COMPLETED|Overall Study||0
3371984|NCT03387059|4103793|FG000|NOT COMPLETED|Overall Study||5
3371985|NCT03387059|4103794|FG001|NOT COMPLETED|Overall Study||4
3371986|NCT03382925|4103802|FG000|STARTED|Overall Study||10
3371987|NCT03382925|4103803|FG001|STARTED|Overall Study||6
3371988|NCT03382925|4103802|FG000|COMPLETED|Overall Study||10
3371989|NCT03382925|4103803|FG001|COMPLETED|Overall Study||6
3371990|NCT03382925|4103802|FG000|NOT COMPLETED|Overall Study||0
3371991|NCT03382925|4103803|FG001|NOT COMPLETED|Overall Study||0
3371992|NCT03379233|4103811|FG000|STARTED|Overall Study||1
3253220|NCT02522286|3987178|FG001|NOT COMPLETED|Overall Study||0
3253221|NCT02522286|3987179|FG002|NOT COMPLETED|Overall Study||0
3253222|NCT02522286|3987180|FG003|NOT COMPLETED|Overall Study||3
3253223|NCT02522299|3987192|FG000|STARTED|Overall Study||22
3253224|NCT02522299|3987193|FG001|STARTED|Overall Study||22
3253225|NCT02522299|3987192|FG000|COMPLETED|Overall Study||18
3253226|NCT02522299|3987193|FG001|COMPLETED|Overall Study||21
3253227|NCT02522299|3987192|FG000|NOT COMPLETED|Overall Study||4
3253228|NCT02522299|3987193|FG001|NOT COMPLETED|Overall Study||1
3253229|NCT02522325|3987213|FG000|STARTED|Overall Study||15
3253230|NCT02522325|3987214|FG001|STARTED|Overall Study||15
3253231|NCT02522325|3987213|FG000|COMPLETED|Overall Study||15
3253232|NCT02522325|3987214|FG001|COMPLETED|Overall Study||14
3253233|NCT02522325|3987213|FG000|NOT COMPLETED|Overall Study||0
3253234|NCT02522325|3987214|FG001|NOT COMPLETED|Overall Study||1
3371993|NCT03379233|4103812|FG001|STARTED|Overall Study||6
3371994|NCT03379233|4103811|FG000|COMPLETED|Overall Study||0
3371995|NCT03379233|4103812|FG001|COMPLETED|Overall Study||0
3371996|NCT03379233|4103811|FG000|NOT COMPLETED|Overall Study||1
3371997|NCT03379233|4103812|FG001|NOT COMPLETED|Overall Study||6
3371998|NCT03370536|4103818|FG000|STARTED|Overall Study||1
3371999|NCT03370536|4103818|FG000|COMPLETED|Overall Study||0
3372000|NCT03370536|4103818|FG000|NOT COMPLETED|Overall Study||1
3372001|NCT03363633|4103822|FG000|STARTED|Overall Study||12
3372002|NCT03363633|4103822|FG000|COMPLETED|Overall Study|See note in Pre-Assignment Details|0
3372003|NCT03363633|4103822|FG000|NOT COMPLETED|Overall Study||12
3372004|NCT03361228|4103828|FG000|STARTED|Overall Study||4
3372005|NCT03361228|4103829|FG001|STARTED|Overall Study||1
3372006|NCT03361228|4103828|FG000|COMPLETED|Overall Study||0
3372007|NCT03361228|4103829|FG001|COMPLETED|Overall Study||0
3372008|NCT03361228|4103828|FG000|NOT COMPLETED|Overall Study||4
3372009|NCT03361228|4103829|FG001|NOT COMPLETED|Overall Study||1
3372010|NCT03360903|4103837|FG000|STARTED|First Intervention||4
3372011|NCT03360903|4103838|FG001|STARTED|First Intervention||4
3372012|NCT03360903|4103837|FG000|COMPLETED|First Intervention||4
3372013|NCT03360903|4103838|FG001|COMPLETED|First Intervention||4
3372014|NCT03360903|4103837|FG000|NOT COMPLETED|First Intervention||0
3372015|NCT03360903|4103838|FG001|NOT COMPLETED|First Intervention||0
3372016|NCT03360903|4103837|FG000|STARTED|Washout (2 Weeks)||4
3372017|NCT03360903|4103838|FG001|STARTED|Washout (2 Weeks)||4
3372018|NCT03360903|4103837|FG000|COMPLETED|Washout (2 Weeks)||4
3372019|NCT03360903|4103838|FG001|COMPLETED|Washout (2 Weeks)||4
3372020|NCT03360903|4103837|FG000|NOT COMPLETED|Washout (2 Weeks)||0
3372021|NCT03360903|4103838|FG001|NOT COMPLETED|Washout (2 Weeks)||0
3372022|NCT03360903|4103837|FG000|STARTED|Second Intervention||4
3372023|NCT03360903|4103838|FG001|STARTED|Second Intervention||4
3372024|NCT03360903|4103837|FG000|COMPLETED|Second Intervention||4
3372025|NCT03360903|4103838|FG001|COMPLETED|Second Intervention||4
3372026|NCT03360903|4103837|FG000|NOT COMPLETED|Second Intervention||0
3372027|NCT03360903|4103838|FG001|NOT COMPLETED|Second Intervention||0
3372028|NCT03359174|4103844|FG000|STARTED|Overall Study||2
3372029|NCT03359174|4103844|FG000|COMPLETED|Overall Study||1
3372030|NCT03359174|4103844|FG000|NOT COMPLETED|Overall Study||1
3372031|NCT03352882|4103848|FG000|STARTED|Overall Study||1
3372032|NCT03352882|4103848|FG000|COMPLETED|Overall Study||1
3372033|NCT03352882|4103848|FG000|NOT COMPLETED|Overall Study||0
3372034|NCT03348904|4103855|FG000|STARTED|Overall Study||0
3372035|NCT03348904|4103856|FG001|STARTED|Overall Study||2
3372036|NCT03348904|4103857|FG002|STARTED|Overall Study||0
3372037|NCT03348904|4103855|FG000|COMPLETED|Overall Study||0
3372038|NCT03348904|4103856|FG001|COMPLETED|Overall Study||1
3372039|NCT03348904|4103857|FG002|COMPLETED|Overall Study||0
3372040|NCT03348904|4103855|FG000|NOT COMPLETED|Overall Study||0
3372041|NCT03348904|4103856|FG001|NOT COMPLETED|Overall Study||1
3372042|NCT03348904|4103857|FG002|NOT COMPLETED|Overall Study||0
3372043|NCT03345901|4103865|FG000|STARTED|Overall Study||18
3372044|NCT03345901|4103865|FG000|COMPLETED|Overall Study||0
3372045|NCT03345901|4103865|FG000|NOT COMPLETED|Overall Study||18
3372046|NCT03344562|4103872|FG000|STARTED|Overall Study||10
3372047|NCT03344562|4103873|FG001|STARTED|Overall Study||9
3372048|NCT03344562|4103872|FG000|COMPLETED|Overall Study||8
3372049|NCT03344562|4103873|FG001|COMPLETED|Overall Study||9
3372050|NCT03344562|4103872|FG000|NOT COMPLETED|Overall Study||2
3372051|NCT03344562|4103873|FG001|NOT COMPLETED|Overall Study||0
3372052|NCT03342638|4103881|FG000|STARTED|Overall Study||34
3372053|NCT03342638|4103882|FG001|STARTED|Overall Study||32
3372054|NCT03342638|4103881|FG000|COMPLETED|Overall Study||33
3372055|NCT03342638|4103882|FG001|COMPLETED|Overall Study||31
3372056|NCT03342638|4103881|FG000|NOT COMPLETED|Overall Study||1
3372057|NCT03342638|4103882|FG001|NOT COMPLETED|Overall Study||1
3372058|NCT03342157|4103890|FG000|STARTED|Overall Study||1
3372059|NCT03342157|4103891|FG001|STARTED|Overall Study||1
3372060|NCT03342157|4103890|FG000|COMPLETED|Overall Study||1
3372061|NCT03342157|4103891|FG001|COMPLETED|Overall Study||1
3372062|NCT03342157|4103890|FG000|NOT COMPLETED|Overall Study||0
3372063|NCT03342157|4103891|FG001|NOT COMPLETED|Overall Study||0
3372064|NCT03339401|4103899|FG000|STARTED|Overall Study||20
3372065|NCT03339401|4103900|FG001|STARTED|Overall Study||9
3372066|NCT03339401|4103899|FG000|COMPLETED|Overall Study||11
3372067|NCT03339401|4103900|FG001|COMPLETED|Overall Study||5
3372068|NCT03339401|4103899|FG000|NOT COMPLETED|Overall Study||9
3372069|NCT03339401|4103900|FG001|NOT COMPLETED|Overall Study||4
3253235|NCT02522377|3987222|FG000|STARTED|Overall Study||7
3253236|NCT02522377|3987223|FG001|STARTED|Overall Study||5
3253237|NCT02522377|3987222|FG000|COMPLETED|Overall Study||3
3253238|NCT02522377|3987223|FG001|COMPLETED|Overall Study||5
3253239|NCT02522377|3987222|FG000|NOT COMPLETED|Overall Study||4
3253240|NCT02522377|3987223|FG001|NOT COMPLETED|Overall Study||0
3253241|NCT02522403|3987231|FG000|STARTED|Overall Study||17
3253242|NCT02522403|3987232|FG001|STARTED|Overall Study||19
3253243|NCT02522403|3987231|FG000|COMPLETED|Overall Study||13
3253244|NCT02522403|3987232|FG001|COMPLETED|Overall Study||13
3253245|NCT02522403|3987231|FG000|NOT COMPLETED|Overall Study||4
3253246|NCT02522403|3987232|FG001|NOT COMPLETED|Overall Study||6
3253247|NCT02522442|3987240|FG000|STARTED|Overall Study||26
3253248|NCT02522442|3987241|FG001|STARTED|Overall Study||22
3253249|NCT02522442|3987240|FG000|COMPLETED|Overall Study||26
3253250|NCT02522442|3987241|FG001|COMPLETED|Overall Study||22
3253251|NCT02522442|3987240|FG000|NOT COMPLETED|Overall Study||0
3253252|NCT02522442|3987241|FG001|NOT COMPLETED|Overall Study||0
3253253|NCT02522481|3987247|FG000|STARTED|Overall Study||175
3253254|NCT02522481|3987247|FG000|COMPLETED|Overall Study||172
3253255|NCT02522481|3987247|FG000|NOT COMPLETED|Overall Study||3
3253256|NCT02522494|3987260|FG000|STARTED|Overall Study||51
3253257|NCT02522494|3987261|FG001|STARTED|Overall Study||51
3253258|NCT02522494|3987260|FG000|Post-CVT Visit Interview|Overall Study||37
3253259|NCT02522494|3987261|FG001|Post-CVT Visit Interview|Overall Study||48
3253260|NCT02522494|3987260|FG000|4-Week Follow Up|Overall Study||37
3253261|NCT02522494|3987261|FG001|4-Week Follow Up|Overall Study||46
3253262|NCT02522494|3987260|FG000|COMPLETED|Overall Study||37
3253263|NCT02522494|3987261|FG001|COMPLETED|Overall Study||46
3253264|NCT02522494|3987260|FG000|NOT COMPLETED|Overall Study||14
3253265|NCT02522494|3987261|FG001|NOT COMPLETED|Overall Study||5
3253266|NCT02522624|3987269|FG000|STARTED|Overall Study||165
3253267|NCT02522624|3987270|FG001|STARTED|Overall Study||163
3253268|NCT02522624|3987269|FG000|COMPLETED|Overall Study|Discontinued intervention due to technical failure (n=1)|164
3253269|NCT02522624|3987270|FG001|COMPLETED|Overall Study||163
3253270|NCT02522624|3987269|FG000|NOT COMPLETED|Overall Study||1
3253271|NCT02522624|3987270|FG001|NOT COMPLETED|Overall Study||0
3253272|NCT02522715|3987278|FG000|STARTED|Overall Study||3
3253273|NCT02522715|3987279|FG001|STARTED|Overall Study|+1 early withdrawal|33
3253274|NCT02522715|3987278|FG000|COMPLETED|Overall Study||3
3253275|NCT02522715|3987279|FG001|COMPLETED|Overall Study||33
3253276|NCT02522715|3987278|FG000|NOT COMPLETED|Overall Study||0
3253277|NCT02522715|3987279|FG001|NOT COMPLETED|Overall Study||0
3253278|NCT02522728|3987287|FG000|STARTED|Overall Study||28
3253279|NCT02522728|3987288|FG001|STARTED|Overall Study||30
3253280|NCT02522728|3987287|FG000|COMPLETED|Overall Study||16
3253281|NCT02522728|3987288|FG001|COMPLETED|Overall Study||19
3253282|NCT02522728|3987287|FG000|NOT COMPLETED|Overall Study||12
3253283|NCT02522728|3987288|FG001|NOT COMPLETED|Overall Study||11
3253284|NCT02522767|3987296|FG000|STARTED|Double-blind||114
3253285|NCT02522767|3987297|FG001|STARTED|Double-blind||114
3253286|NCT02522767|3987296|FG000|COMPLETED|Double-blind||103
3253287|NCT02522767|3987297|FG001|COMPLETED|Double-blind||90
3253288|NCT02522767|3987296|FG000|NOT COMPLETED|Double-blind||11
3253289|NCT02522767|3987297|FG001|NOT COMPLETED|Double-blind||24
3253290|NCT02522767|3987296|FG000|STARTED|Open-label|Subjects provided their consent to receive additional 8 weeks open-label treatment with mesalamine.|88
3253291|NCT02522767|3987297|FG001|STARTED|Open-label|Subjects provided their consent to receive additional 8 weeks open-label treatment with mesalamine.|82
3253292|NCT02522767|3987296|FG000|COMPLETED|Open-label||83
3253293|NCT02522767|3987297|FG001|COMPLETED|Open-label||75
3253294|NCT02522767|3987296|FG000|NOT COMPLETED|Open-label||5
3253295|NCT02522767|3987297|FG001|NOT COMPLETED|Open-label||7
3253296|NCT02522780|3987307|FG000|STARTED|Overall Study||138
3253297|NCT02522780|3987308|FG001|STARTED|Overall Study||138
3253298|NCT02522780|3987307|FG000|Treated|Overall Study||137
3253299|NCT02522780|3987308|FG001|Treated|Overall Study||135
3253300|NCT02522780|3987307|FG000|Intention-to-treat (ITT) Population|Overall Study||136
3253301|NCT02522780|3987308|FG001|Intention-to-treat (ITT) Population|Overall Study||136
3253302|NCT02522780|3987307|FG000|COMPLETED|Overall Study||121
3253303|NCT02522780|3987308|FG001|COMPLETED|Overall Study||111
3253304|NCT02522780|3987307|FG000|NOT COMPLETED|Overall Study||17
3253305|NCT02522780|3987308|FG001|NOT COMPLETED|Overall Study||27
3253306|NCT02522845|3987317|FG000|STARTED|Overall Study||100
3253307|NCT02522845|3987318|FG001|STARTED|Overall Study||104
3253308|NCT02522845|3987317|FG000|COMPLETED|Overall Study||63
3253309|NCT02522845|3987318|FG001|COMPLETED|Overall Study||69
3253310|NCT02522845|3987317|FG000|NOT COMPLETED|Overall Study||37
3253311|NCT02522845|3987318|FG001|NOT COMPLETED|Overall Study||35
3253312|NCT02522884|3987324|FG000|STARTED|Overall Study|Intent to Treat (ITT) population.|213
3253313|NCT02522884|3987324|FG000|COMPLETED|Overall Study|Completed 12-month follow-up.|195
3253314|NCT02522884|3987324|FG000|NOT COMPLETED|Overall Study||18
3253315|NCT02523196|3987328|FG000|STARTED|Overall Study||20
3253316|NCT02523196|3987328|FG000|Received HVPG|Overall Study||20
3253317|NCT02523196|3987328|FG000|Received HQ Shunt|Overall Study||20
3253318|NCT02523196|3987328|FG000|COMPLETED|Overall Study||20
3253319|NCT02523196|3987328|FG000|NOT COMPLETED|Overall Study||0
3253320|NCT02523235|3987339|FG000|STARTED|Overall Study||56
3253321|NCT02523235|3987340|FG001|STARTED|Overall Study||58
3253322|NCT02523235|3987339|FG000|COMPLETED|Overall Study||56
3253323|NCT02523235|3987340|FG001|COMPLETED|Overall Study||58
3253324|NCT02523235|3987339|FG000|NOT COMPLETED|Overall Study||0
3253325|NCT02523235|3987340|FG001|NOT COMPLETED|Overall Study||0
3253326|NCT02523586|3987347|FG000|STARTED|Overall Study||14
3253327|NCT02523586|3987347|FG000|COMPLETED|Overall Study||10
3253328|NCT02523586|3987347|FG000|NOT COMPLETED|Overall Study||4
3253329|NCT02523599|3987360|FG000|STARTED|Overall Study||204
3253330|NCT02523599|3987361|FG001|STARTED|Overall Study||101
3253331|NCT02523599|3987360|FG000|Randomized But Not Treated|Overall Study||1
3253332|NCT02523599|3987361|FG001|Randomized But Not Treated|Overall Study||0
3253333|NCT02523599|3987360|FG000|COMPLETED|Overall Study||196
3253334|NCT02523599|3987361|FG001|COMPLETED|Overall Study||100
3253335|NCT02523599|3987360|FG000|NOT COMPLETED|Overall Study||8
3253336|NCT02523599|3987361|FG001|NOT COMPLETED|Overall Study||1
3253337|NCT02523690|3987369|FG000|STARTED|Overall Study||3
3253338|NCT02523690|3987370|FG001|STARTED|Overall Study||2
3253339|NCT02523690|3987369|FG000|COMPLETED|Overall Study||3
3253340|NCT02523690|3987370|FG001|COMPLETED|Overall Study||2
3253341|NCT02523690|3987369|FG000|NOT COMPLETED|Overall Study||0
3253342|NCT02523690|3987370|FG001|NOT COMPLETED|Overall Study||0
3253343|NCT02523924|3987376|FG000|STARTED|Overall Study||31
3253344|NCT02523924|3987376|FG000|COMPLETED|Overall Study||31
3253345|NCT02523924|3987376|FG000|NOT COMPLETED|Overall Study||0
3253346|NCT02524054|3987382|FG000|STARTED|Overall Study||7
3253347|NCT02524054|3987383|FG001|STARTED|Overall Study||9
3253348|NCT02524054|3987384|FG002|STARTED|Overall Study||8
3253349|NCT02524054|3987382|FG000|COMPLETED|Overall Study||7
3253350|NCT02524054|3987383|FG001|COMPLETED|Overall Study||9
3253351|NCT02524054|3987384|FG002|COMPLETED|Overall Study||8
3253352|NCT02524054|3987382|FG000|NOT COMPLETED|Overall Study||0
3253353|NCT02524054|3987383|FG001|NOT COMPLETED|Overall Study||0
3253354|NCT02524054|3987384|FG002|NOT COMPLETED|Overall Study||0
3253355|NCT02524106|3987396|FG000|STARTED|Overall Study||6
3253356|NCT02524106|3987397|FG001|STARTED|Overall Study||5
3253357|NCT02524106|3987396|FG000|COMPLETED|Overall Study||6
3253358|NCT02524106|3987397|FG001|COMPLETED|Overall Study||5
3253359|NCT02524106|3987396|FG000|NOT COMPLETED|Overall Study||0
3253360|NCT02524106|3987397|FG001|NOT COMPLETED|Overall Study||0
3253361|NCT02524119|3987403|FG000|STARTED|Overall Study||5
3253362|NCT02524119|3987403|FG000|COMPLETED|Overall Study||5
3253363|NCT02524119|3987403|FG000|NOT COMPLETED|Overall Study||0
3253364|NCT02524145|3987410|FG000|STARTED|Overall Study||15
3253365|NCT02524145|3987411|FG001|STARTED|Overall Study||15
3253366|NCT02524145|3987412|FG002|STARTED|Overall Study||10
3253367|NCT02524145|3987410|FG000|COMPLETED|Overall Study||13
3253368|NCT02524145|3987411|FG001|COMPLETED|Overall Study||13
3253369|NCT02524145|3987412|FG002|COMPLETED|Overall Study||7
3253370|NCT02524145|3987410|FG000|NOT COMPLETED|Overall Study||2
3253371|NCT02524145|3987411|FG001|NOT COMPLETED|Overall Study||2
3253372|NCT02524145|3987412|FG002|NOT COMPLETED|Overall Study||3
3253373|NCT02524158|3987422|FG000|STARTED|12-weeks Assessment||76
3253374|NCT02524158|3987423|FG001|STARTED|12-weeks Assessment||76
3253375|NCT02524158|3987422|FG000|COMPLETED|12-weeks Assessment||57
3253376|NCT02524158|3987423|FG001|COMPLETED|12-weeks Assessment||63
3253377|NCT02524158|3987422|FG000|NOT COMPLETED|12-weeks Assessment||19
3253378|NCT02524158|3987423|FG001|NOT COMPLETED|12-weeks Assessment||13
3253379|NCT02524158|3987422|FG000|STARTED|6-month Assessment||76
3253380|NCT02524158|3987423|FG001|STARTED|6-month Assessment||76
3253381|NCT02524158|3987422|FG000|COMPLETED|6-month Assessment||54
3253382|NCT02524158|3987423|FG001|COMPLETED|6-month Assessment||55
3253383|NCT02524158|3987422|FG000|NOT COMPLETED|6-month Assessment||22
3253384|NCT02524158|3987423|FG001|NOT COMPLETED|6-month Assessment||21
3253385|NCT02524418|3987432|FG000|STARTED|Overall Study||88
3253386|NCT02524418|3987432|FG000|COMPLETED|Overall Study||75
3253387|NCT02524418|3987432|FG000|NOT COMPLETED|Overall Study||13
3253388|NCT02524561|3987442|FG000|STARTED|Baseline: Pre-randomization Mammogram|Consented to MDBHAS|168
3253389|NCT02524561|3987443|FG001|STARTED|Baseline: Pre-randomization Mammogram|Consented to MDBHAS|162
3253390|NCT02524561|3987444|FG002|STARTED|Baseline: Pre-randomization Mammogram|Consented to MDBHAS.|187
3253391|NCT02524561|3987442|FG000|Obtained Baseline Mammogram|Baseline: Pre-randomization Mammogram||137
3253392|NCT02524561|3987443|FG001|Obtained Baseline Mammogram|Baseline: Pre-randomization Mammogram||133
3253393|NCT02524561|3987444|FG002|Obtained Baseline Mammogram|Baseline: Pre-randomization Mammogram||151
3253394|NCT02524561|3987442|FG000|COMPLETED|Baseline: Pre-randomization Mammogram||168
3253395|NCT02524561|3987443|FG001|COMPLETED|Baseline: Pre-randomization Mammogram||162
3253396|NCT02524561|3987444|FG002|COMPLETED|Baseline: Pre-randomization Mammogram||187
3253397|NCT02524561|3987442|FG000|NOT COMPLETED|Baseline: Pre-randomization Mammogram||0
3253398|NCT02524561|3987443|FG001|NOT COMPLETED|Baseline: Pre-randomization Mammogram||0
3253399|NCT02524561|3987444|FG002|NOT COMPLETED|Baseline: Pre-randomization Mammogram||0
3253400|NCT02524561|3987442|FG000|STARTED|Year 1: Post Randomization Mammograms|Consented to MDBHAS|168
3253401|NCT02524561|3987443|FG001|STARTED|Year 1: Post Randomization Mammograms|Consented to MDBHAS|162
3372070|NCT03339245|4103908|FG000|STARTED|Overall Study||6
3372071|NCT03339245|4103909|FG001|STARTED|Overall Study||7
3372072|NCT03339245|4103908|FG000|COMPLETED|Overall Study|"1 withdrawn due to elevated glucose during pre-intervention testing~1 withdrawn for personal reason"|4
3372073|NCT03339245|4103909|FG001|COMPLETED|Overall Study|1 withdrawn due to elevated glucose on baseline testing|6
3372074|NCT03339245|4103908|FG000|NOT COMPLETED|Overall Study||2
3372075|NCT03339245|4103909|FG001|NOT COMPLETED|Overall Study||1
3372076|NCT03333746|4103915|FG000|STARTED|Overall Study||1
3253402|NCT02524561|3987444|FG002|STARTED|Year 1: Post Randomization Mammograms|Consented to MDBHAS|187
3253403|NCT02524561|3987442|FG000|Obtained Mammogam|Year 1: Post Randomization Mammograms|Obtained post-randomization mammogram|136
3253404|NCT02524561|3987443|FG001|Obtained Mammogam|Year 1: Post Randomization Mammograms|Obtained post randomization mammogram|123
3253405|NCT02524561|3987444|FG002|Obtained Mammogam|Year 1: Post Randomization Mammograms|Obtained post randomization mammogram|148
3253406|NCT02524561|3987442|FG000|COMPLETED|Year 1: Post Randomization Mammograms||168
3253407|NCT02524561|3987443|FG001|COMPLETED|Year 1: Post Randomization Mammograms||162
3253408|NCT02524561|3987444|FG002|COMPLETED|Year 1: Post Randomization Mammograms||187
3253409|NCT02524561|3987442|FG000|NOT COMPLETED|Year 1: Post Randomization Mammograms||0
3253410|NCT02524561|3987443|FG001|NOT COMPLETED|Year 1: Post Randomization Mammograms||0
3253411|NCT02524561|3987444|FG002|NOT COMPLETED|Year 1: Post Randomization Mammograms||0
3253412|NCT02524561|3987442|FG000|STARTED|Final: Year 3 or 4 Post-randomization|Consented to MDBHAS|168
3253413|NCT02524561|3987443|FG001|STARTED|Final: Year 3 or 4 Post-randomization|Consented to MDBHAS|162
3253414|NCT02524561|3987444|FG002|STARTED|Final: Year 3 or 4 Post-randomization|Consented to MDBHAS|187
3253415|NCT02524561|3987442|FG000|Obtained Year 3 or 4 Mammogram|Final: Year 3 or 4 Post-randomization||143
3253416|NCT02524561|3987443|FG001|Obtained Year 3 or 4 Mammogram|Final: Year 3 or 4 Post-randomization||139
3253417|NCT02524561|3987444|FG002|Obtained Year 3 or 4 Mammogram|Final: Year 3 or 4 Post-randomization||151
3253418|NCT02524561|3987442|FG000|COMPLETED|Final: Year 3 or 4 Post-randomization||168
3253419|NCT02524561|3987443|FG001|COMPLETED|Final: Year 3 or 4 Post-randomization||162
3253420|NCT02524561|3987444|FG002|COMPLETED|Final: Year 3 or 4 Post-randomization||187
3253421|NCT02524561|3987442|FG000|NOT COMPLETED|Final: Year 3 or 4 Post-randomization||0
3253422|NCT02524561|3987443|FG001|NOT COMPLETED|Final: Year 3 or 4 Post-randomization||0
3253423|NCT02524561|3987444|FG002|NOT COMPLETED|Final: Year 3 or 4 Post-randomization||0
3253424|NCT02524665|3987452|FG000|STARTED|Overall Study||20
3253425|NCT02524665|3987452|FG000|COMPLETED|Overall Study||19
3253426|NCT02524665|3987452|FG000|NOT COMPLETED|Overall Study||1
3253427|NCT02524730|3987457|FG000|STARTED|Overall Study||205
3253428|NCT02524730|3987457|FG000|COMPLETED|Overall Study||159
3253429|NCT02524730|3987457|FG000|NOT COMPLETED|Overall Study||46
3253430|NCT02524769|3987461|FG000|STARTED|Overall Study||27
3253431|NCT02524769|3987461|FG000|COMPLETED|Overall Study||17
3253432|NCT02524769|3987461|FG000|NOT COMPLETED|Overall Study||10
3253433|NCT02524847|3987465|FG000|STARTED|Overall Study||29
3253434|NCT02524847|3987465|FG000|Completed Treatment Up to Week 12|Overall Study||14
3253435|NCT02524847|3987465|FG000|Started Second Line Treatment|Overall Study||5
3253436|NCT02524847|3987465|FG000|COMPLETED|Overall Study||15
3253437|NCT02524847|3987465|FG000|NOT COMPLETED|Overall Study||14
3253438|NCT02524977|3987472|FG000|STARTED|Overall Study||738
3253439|NCT02524977|3987473|FG001|STARTED|Overall Study||846
3253440|NCT02524977|3987472|FG000|COMPLETED|Overall Study||692
3253441|NCT02524977|3987473|FG001|COMPLETED|Overall Study||801
3253442|NCT02524977|3987472|FG000|NOT COMPLETED|Overall Study||46
3253443|NCT02524977|3987473|FG001|NOT COMPLETED|Overall Study||45
3253444|NCT02525055|3987487|FG000|STARTED|Overall Study||6
3253445|NCT02525055|3987488|FG001|STARTED|Overall Study||6
3253446|NCT02525055|3987489|FG002|STARTED|Overall Study||6
3253447|NCT02525055|3987490|FG003|STARTED|Overall Study||6
3253448|NCT02525055|3987491|FG004|STARTED|Overall Study||6
3253449|NCT02525055|3987492|FG005|STARTED|Overall Study||16
3253450|NCT02525055|3987487|FG000|COMPLETED|Overall Study||6
3253451|NCT02525055|3987488|FG001|COMPLETED|Overall Study||6
3253452|NCT02525055|3987489|FG002|COMPLETED|Overall Study||6
3253453|NCT02525055|3987490|FG003|COMPLETED|Overall Study||6
3253454|NCT02525055|3987491|FG004|COMPLETED|Overall Study||6
3253455|NCT02525055|3987492|FG005|COMPLETED|Overall Study||16
3253456|NCT02525055|3987487|FG000|NOT COMPLETED|Overall Study||0
3253457|NCT02525055|3987488|FG001|NOT COMPLETED|Overall Study||0
3253458|NCT02525055|3987489|FG002|NOT COMPLETED|Overall Study||0
3253459|NCT02525055|3987490|FG003|NOT COMPLETED|Overall Study||0
3253460|NCT02525055|3987491|FG004|NOT COMPLETED|Overall Study||0
3253461|NCT02525055|3987492|FG005|NOT COMPLETED|Overall Study||0
3253462|NCT02525094|3987508|FG000|STARTED|Overall Study||57
3253463|NCT02525094|3987509|FG001|STARTED|Overall Study||56
3253464|NCT02525094|3987508|FG000|Treated|Overall Study||56
3253465|NCT02525094|3987509|FG001|Treated|Overall Study||55
3253466|NCT02525094|3987508|FG000|COMPLETED|Overall Study||49
3253467|NCT02525094|3987509|FG001|COMPLETED|Overall Study||48
3253468|NCT02525094|3987508|FG000|NOT COMPLETED|Overall Study||8
3253469|NCT02525094|3987509|FG001|NOT COMPLETED|Overall Study||8
3253470|NCT02525133|3987518|FG000|STARTED|Overall Study||213
3253471|NCT02525133|3987519|FG001|STARTED|Overall Study||106
3253472|NCT02525133|3987518|FG000|Randomized But Not Treated|Overall Study||4
3253473|NCT02525133|3987519|FG001|Randomized But Not Treated|Overall Study||0
3253474|NCT02525133|3987518|FG000|COMPLETED|Overall Study||203
3253475|NCT02525133|3987519|FG001|COMPLETED|Overall Study||103
3253476|NCT02525133|3987518|FG000|NOT COMPLETED|Overall Study||10
3253477|NCT02525133|3987519|FG001|NOT COMPLETED|Overall Study||3
3253478|NCT02525263|3987525|FG000|STARTED|Overall Study|The single patient in this trial was enrolled on 18 July 2016.|1
3253479|NCT02525263|3987525|FG000|COMPLETED|Overall Study|The trial was completed when the patient reached the specified endpoint of starting hemodialysis.|1
3253480|NCT02525263|3987525|FG000|NOT COMPLETED|Overall Study||0
3253481|NCT02525471|3987531|FG000|STARTED|Overall Study||24
3253482|NCT02525471|3987531|FG000|Randomized/Treated|Overall Study||16
3253483|NCT02525471|3987531|FG000|COMPLETED|Overall Study||13
3253484|NCT02525471|3987531|FG000|NOT COMPLETED|Overall Study||11
3253485|NCT02525523|3987538|FG000|STARTED|Overall Study||69
3253486|NCT02525523|3987539|FG001|STARTED|Overall Study||69
3253487|NCT02525523|3987538|FG000|COMPLETED|Overall Study||46
3253488|NCT02525523|3987539|FG001|COMPLETED|Overall Study||44
3253489|NCT02525523|3987538|FG000|NOT COMPLETED|Overall Study||23
3253490|NCT02525523|3987539|FG001|NOT COMPLETED|Overall Study||25
3253491|NCT02525536|3987548|FG000|STARTED|Overall Study||6
3253492|NCT02525536|3987549|FG001|STARTED|Overall Study||6
3253493|NCT02525536|3987550|FG002|STARTED|Overall Study||6
3253494|NCT02525536|3987548|FG000|COMPLETED|Overall Study||6
3253495|NCT02525536|3987549|FG001|COMPLETED|Overall Study||6
3253496|NCT02525536|3987550|FG002|COMPLETED|Overall Study||6
3253497|NCT02525536|3987548|FG000|NOT COMPLETED|Overall Study||0
3253498|NCT02525536|3987549|FG001|NOT COMPLETED|Overall Study||0
3253499|NCT02525536|3987550|FG002|NOT COMPLETED|Overall Study||0
3253500|NCT02525549|3987561|FG000|STARTED|Overall Study||365
3253501|NCT02525549|3987562|FG001|STARTED|Overall Study||360
3253502|NCT02525549|3987563|FG002|STARTED|Overall Study||178
3253503|NCT02525549|3987561|FG000|COMPLETED|Overall Study||330
3253504|NCT02525549|3987562|FG001|COMPLETED|Overall Study||307
3253505|NCT02525549|3987563|FG002|COMPLETED|Overall Study||159
3253506|NCT02525549|3987561|FG000|NOT COMPLETED|Overall Study||35
3253507|NCT02525549|3987562|FG001|NOT COMPLETED|Overall Study||53
3253508|NCT02525549|3987563|FG002|NOT COMPLETED|Overall Study||19
3253509|NCT02525575|3987571|FG000|STARTED|Overall Study||37
3253510|NCT02525575|3987571|FG000|COMPLETED|Overall Study||22
3253511|NCT02525575|3987571|FG000|NOT COMPLETED|Overall Study||15
3253512|NCT02525588|3987577|FG000|STARTED|Overall Study||48
3253513|NCT02525588|3987578|FG001|STARTED|Overall Study||48
3253514|NCT02525588|3987577|FG000|COMPLETED|Overall Study||42
3253515|NCT02525588|3987578|FG001|COMPLETED|Overall Study||45
3253516|NCT02525588|3987577|FG000|NOT COMPLETED|Overall Study||6
3253517|NCT02525588|3987578|FG001|NOT COMPLETED|Overall Study||3
3253518|NCT02525627|3987586|FG000|STARTED|Overall Study||16
3253519|NCT02525627|3987587|FG001|STARTED|Overall Study||18
3253520|NCT02525627|3987586|FG000|COMPLETED|Overall Study||2
3253521|NCT02525627|3987587|FG001|COMPLETED|Overall Study||5
3253522|NCT02525627|3987586|FG000|NOT COMPLETED|Overall Study||14
3253523|NCT02525627|3987587|FG001|NOT COMPLETED|Overall Study||13
3253524|NCT02525653|3987593|FG000|STARTED|Overall Study||40
3253525|NCT02525653|3987593|FG000|COMPLETED|Overall Study||40
3253526|NCT02525653|3987593|FG000|NOT COMPLETED|Overall Study||0
3253527|NCT02525718|3987599|FG000|STARTED|Overall Study||23
3253528|NCT02525718|3987600|FG001|STARTED|Overall Study||24
3253529|NCT02525718|3987599|FG000|COMPLETED|Overall Study||22
3253530|NCT02525718|3987600|FG001|COMPLETED|Overall Study||23
3253531|NCT02525718|3987599|FG000|NOT COMPLETED|Overall Study||1
3253532|NCT02525718|3987600|FG001|NOT COMPLETED|Overall Study||1
3253533|NCT02525744|3987606|FG000|STARTED|Period 1||6
3253534|NCT02525744|3987607|FG001|STARTED|Period 1||6
3253535|NCT02525744|3987608|FG002|STARTED|Period 1||6
3253536|NCT02525744|3987609|FG003|STARTED|Period 1||6
3253537|NCT02525744|3987606|FG000|Received at Least 1 Dose of Study Drug|Period 1||6
3253538|NCT02525744|3987607|FG001|Received at Least 1 Dose of Study Drug|Period 1||6
3253539|NCT02525744|3987608|FG002|Received at Least 1 Dose of Study Drug|Period 1||5
3253540|NCT02525744|3987609|FG003|Received at Least 1 Dose of Study Drug|Period 1||6
3253541|NCT02525744|3987606|FG000|COMPLETED|Period 1||6
3253542|NCT02525744|3987607|FG001|COMPLETED|Period 1||6
3253543|NCT02525744|3987608|FG002|COMPLETED|Period 1||5
3253544|NCT02525744|3987609|FG003|COMPLETED|Period 1||6
3253545|NCT02525744|3987606|FG000|NOT COMPLETED|Period 1||0
3253546|NCT02525744|3987607|FG001|NOT COMPLETED|Period 1||0
3253547|NCT02525744|3987608|FG002|NOT COMPLETED|Period 1||1
3253548|NCT02525744|3987609|FG003|NOT COMPLETED|Period 1||0
3253549|NCT02525744|3987606|FG000|STARTED|Period 2||6
3253550|NCT02525744|3987607|FG001|STARTED|Period 2||6
3253551|NCT02525744|3987608|FG002|STARTED|Period 2||5
3253552|NCT02525744|3987609|FG003|STARTED|Period 2||6
3253553|NCT02525744|3987606|FG000|Received at Least 1 Dose of Study Drug|Period 2||6
3253554|NCT02525744|3987607|FG001|Received at Least 1 Dose of Study Drug|Period 2||6
3253555|NCT02525744|3987608|FG002|Received at Least 1 Dose of Study Drug|Period 2||5
3253556|NCT02525744|3987609|FG003|Received at Least 1 Dose of Study Drug|Period 2||6
3253557|NCT02525744|3987606|FG000|COMPLETED|Period 2||6
3253558|NCT02525744|3987607|FG001|COMPLETED|Period 2||6
3253559|NCT02525744|3987608|FG002|COMPLETED|Period 2||5
3253560|NCT02525744|3987609|FG003|COMPLETED|Period 2||6
3253561|NCT02525744|3987606|FG000|NOT COMPLETED|Period 2||0
3253562|NCT02525744|3987607|FG001|NOT COMPLETED|Period 2||0
3253563|NCT02525744|3987608|FG002|NOT COMPLETED|Period 2||0
3253564|NCT02525744|3987609|FG003|NOT COMPLETED|Period 2||0
3253565|NCT02525744|3987606|FG000|STARTED|Period 3||6
3253566|NCT02525744|3987607|FG001|STARTED|Period 3||6
3253567|NCT02525744|3987608|FG002|STARTED|Period 3||5
3253568|NCT02525744|3987609|FG003|STARTED|Period 3||6
3253569|NCT02525744|3987606|FG000|Received at Least 1 Dose of Study Drug|Period 3||6
3253570|NCT02525744|3987607|FG001|Received at Least 1 Dose of Study Drug|Period 3||6
3253571|NCT02525744|3987608|FG002|Received at Least 1 Dose of Study Drug|Period 3||5
3253572|NCT02525744|3987609|FG003|Received at Least 1 Dose of Study Drug|Period 3||6
3253573|NCT02525744|3987606|FG000|COMPLETED|Period 3||6
3253574|NCT02525744|3987607|FG001|COMPLETED|Period 3||5
3253575|NCT02525744|3987608|FG002|COMPLETED|Period 3||5
3253576|NCT02525744|3987609|FG003|COMPLETED|Period 3||6
3253577|NCT02525744|3987606|FG000|NOT COMPLETED|Period 3||0
3253578|NCT02525744|3987607|FG001|NOT COMPLETED|Period 3||1
3253579|NCT02525744|3987608|FG002|NOT COMPLETED|Period 3||0
3253580|NCT02525744|3987609|FG003|NOT COMPLETED|Period 3||0
3253581|NCT02525744|3987606|FG000|STARTED|Period 4||6
3253582|NCT02525744|3987607|FG001|STARTED|Period 4||5
3253583|NCT02525744|3987608|FG002|STARTED|Period 4||5
3253584|NCT02525744|3987609|FG003|STARTED|Period 4||6
3253585|NCT02525744|3987606|FG000|Received at Least 1 Dose of Study Drug|Period 4||6
3253586|NCT02525744|3987607|FG001|Received at Least 1 Dose of Study Drug|Period 4||5
3253587|NCT02525744|3987608|FG002|Received at Least 1 Dose of Study Drug|Period 4||5
3253588|NCT02525744|3987609|FG003|Received at Least 1 Dose of Study Drug|Period 4||6
3253589|NCT02525744|3987606|FG000|COMPLETED|Period 4||5
3253590|NCT02525744|3987607|FG001|COMPLETED|Period 4||5
3253591|NCT02525744|3987608|FG002|COMPLETED|Period 4||5
3253592|NCT02525744|3987609|FG003|COMPLETED|Period 4||6
3253593|NCT02525744|3987606|FG000|NOT COMPLETED|Period 4||1
3253594|NCT02525744|3987607|FG001|NOT COMPLETED|Period 4||0
3253595|NCT02525744|3987608|FG002|NOT COMPLETED|Period 4||0
3253596|NCT02525744|3987609|FG003|NOT COMPLETED|Period 4||0
3253597|NCT02525744|3987606|FG000|STARTED|Period 5||5
3253598|NCT02525744|3987607|FG001|STARTED|Period 5||5
3253599|NCT02525744|3987608|FG002|STARTED|Period 5||5
3253600|NCT02525744|3987609|FG003|STARTED|Period 5||6
3253601|NCT02525744|3987606|FG000|Received at Least 1 Dose of Study Drug|Period 5||4
3253602|NCT02525744|3987607|FG001|Received at Least 1 Dose of Study Drug|Period 5||5
3253603|NCT02525744|3987608|FG002|Received at Least 1 Dose of Study Drug|Period 5||5
3253604|NCT02525744|3987609|FG003|Received at Least 1 Dose of Study Drug|Period 5||6
3253605|NCT02525744|3987606|FG000|COMPLETED|Period 5||4
3253606|NCT02525744|3987607|FG001|COMPLETED|Period 5||5
3253607|NCT02525744|3987608|FG002|COMPLETED|Period 5||5
3253608|NCT02525744|3987609|FG003|COMPLETED|Period 5||6
3253609|NCT02525744|3987606|FG000|NOT COMPLETED|Period 5||1
3253610|NCT02525744|3987607|FG001|NOT COMPLETED|Period 5||0
3253611|NCT02525744|3987608|FG002|NOT COMPLETED|Period 5||0
3253612|NCT02525744|3987609|FG003|NOT COMPLETED|Period 5||0
3253613|NCT02525861|3987621|FG000|STARTED|Overall Study||18
3253614|NCT02525861|3987622|FG001|STARTED|Overall Study||16
3253615|NCT02525861|3987621|FG000|COMPLETED|Overall Study||17
3253616|NCT02525861|3987622|FG001|COMPLETED|Overall Study||14
3253617|NCT02525861|3987621|FG000|NOT COMPLETED|Overall Study||1
3253618|NCT02525861|3987622|FG001|NOT COMPLETED|Overall Study||2
3253619|NCT02525874|3987630|FG000|STARTED|Overall Study||218
3253620|NCT02525874|3987630|FG000|COMPLETED|Overall Study||158
3253621|NCT02525874|3987630|FG000|NOT COMPLETED|Overall Study||60
3253622|NCT02526160|3987636|FG000|STARTED|Double-Blind (Placebo-Controlled) Period||66
3253623|NCT02526160|3987637|FG001|STARTED|Double-Blind (Placebo-Controlled) Period||68
3253624|NCT02526160|3987636|FG000|COMPLETED|Double-Blind (Placebo-Controlled) Period||66
3253625|NCT02526160|3987637|FG001|COMPLETED|Double-Blind (Placebo-Controlled) Period||67
3253626|NCT02526160|3987636|FG000|NOT COMPLETED|Double-Blind (Placebo-Controlled) Period||0
3253627|NCT02526160|3987637|FG001|NOT COMPLETED|Double-Blind (Placebo-Controlled) Period||1
3253628|NCT02526160|3987636|FG000|STARTED|Open-label Treatment Continuation Period||66
3253629|NCT02526160|3987637|FG001|STARTED|Open-label Treatment Continuation Period||67
3253630|NCT02526160|3987636|FG000|COMPLETED|Open-label Treatment Continuation Period||63
3253631|NCT02526160|3987637|FG001|COMPLETED|Open-label Treatment Continuation Period||63
3253632|NCT02526160|3987636|FG000|NOT COMPLETED|Open-label Treatment Continuation Period||3
3253633|NCT02526160|3987637|FG001|NOT COMPLETED|Open-label Treatment Continuation Period||4
3253634|NCT02526160|3987636|FG000|STARTED|Open-Label Treatment Extension Period I||63
3253635|NCT02526160|3987637|FG001|STARTED|Open-Label Treatment Extension Period I||63
3253636|NCT02526160|3987636|FG000|COMPLETED|Open-Label Treatment Extension Period I||60
3253637|NCT02526160|3987637|FG001|COMPLETED|Open-Label Treatment Extension Period I||59
3253638|NCT02526160|3987636|FG000|NOT COMPLETED|Open-Label Treatment Extension Period I||3
3253639|NCT02526160|3987637|FG001|NOT COMPLETED|Open-Label Treatment Extension Period I||4
3253640|NCT02526160|3987636|FG000|STARTED|Open-Label Treatment Extension Period II||52
3253641|NCT02526160|3987637|FG001|STARTED|Open-Label Treatment Extension Period II||49
3253642|NCT02526160|3987636|FG000|COMPLETED|Open-Label Treatment Extension Period II||51
3253643|NCT02526160|3987637|FG001|COMPLETED|Open-Label Treatment Extension Period II||49
3253644|NCT02526160|3987636|FG000|NOT COMPLETED|Open-Label Treatment Extension Period II||1
3253645|NCT02526160|3987637|FG001|NOT COMPLETED|Open-Label Treatment Extension Period II||0
3253646|NCT02526212|3987650|FG000|STARTED|Overall Study||10
3253647|NCT02526212|3987651|FG001|STARTED|Overall Study||8
3253648|NCT02526212|3987650|FG000|COMPLETED|Overall Study||8
3253649|NCT02526212|3987651|FG001|COMPLETED|Overall Study||7
3253650|NCT02526212|3987650|FG000|NOT COMPLETED|Overall Study||2
3253651|NCT02526212|3987651|FG001|NOT COMPLETED|Overall Study||1
3253652|NCT02526277|3987661|FG000|STARTED|Overall Study||8
3253653|NCT02526277|3987662|FG001|STARTED|Overall Study||6
3253654|NCT02526277|3987663|FG002|STARTED|Overall Study||7
3253655|NCT02526277|3987664|FG003|STARTED|Overall Study||7
3253656|NCT02526277|3987661|FG000|COMPLETED|Overall Study||8
3253657|NCT02526277|3987662|FG001|COMPLETED|Overall Study||6
3253658|NCT02526277|3987663|FG002|COMPLETED|Overall Study||7
3253659|NCT02526277|3987664|FG003|COMPLETED|Overall Study||7
3253660|NCT02526277|3987661|FG000|NOT COMPLETED|Overall Study||0
3253661|NCT02526277|3987662|FG001|NOT COMPLETED|Overall Study||0
3253662|NCT02526277|3987663|FG002|NOT COMPLETED|Overall Study||0
3253663|NCT02526277|3987664|FG003|NOT COMPLETED|Overall Study||0
3253664|NCT02526290|3987677|FG000|STARTED|Overall Study||97
3253665|NCT02526290|3987677|FG000|COMPLETED|Overall Study||89
3253666|NCT02526290|3987677|FG000|NOT COMPLETED|Overall Study||8
3253667|NCT02526524|3987687|FG000|STARTED|Overall Study||94
3253668|NCT02526524|3987688|FG001|STARTED|Overall Study||95
3253669|NCT02526524|3987689|FG002|STARTED|Overall Study||96
3253670|NCT02526524|3987690|FG003|STARTED|Overall Study||96
3253671|NCT02526524|3987691|FG004|STARTED|Overall Study||96
3253672|NCT02526524|3987692|FG005|STARTED|Overall Study||94
3253673|NCT02526524|3987687|FG000|COMPLETED|Overall Study||82
3253674|NCT02526524|3987688|FG001|COMPLETED|Overall Study||86
3253675|NCT02526524|3987689|FG002|COMPLETED|Overall Study||70
3253676|NCT02526524|3987690|FG003|COMPLETED|Overall Study||89
3253677|NCT02526524|3987691|FG004|COMPLETED|Overall Study||72
3253678|NCT02526524|3987692|FG005|COMPLETED|Overall Study||73
3253679|NCT02526524|3987687|FG000|NOT COMPLETED|Overall Study||12
3253680|NCT02526524|3987688|FG001|NOT COMPLETED|Overall Study||9
3253681|NCT02526524|3987689|FG002|NOT COMPLETED|Overall Study||26
3253682|NCT02526524|3987690|FG003|NOT COMPLETED|Overall Study||7
3253683|NCT02526524|3987691|FG004|NOT COMPLETED|Overall Study||24
3253684|NCT02526524|3987692|FG005|NOT COMPLETED|Overall Study||21
3253685|NCT02526550|3987706|FG000|STARTED|Overall Study||50
3253686|NCT02526550|3987706|FG000|COMPLETED|Overall Study||49
3253687|NCT02526550|3987706|FG000|NOT COMPLETED|Overall Study||1
3253688|NCT02526654|3987712|FG000|STARTED|Overall Study||79
3253689|NCT02526654|3987713|FG001|STARTED|Overall Study||36
3253690|NCT02526654|3987712|FG000|COMPLETED|Overall Study||79
3253691|NCT02526654|3987713|FG001|COMPLETED|Overall Study||36
3253692|NCT02526654|3987712|FG000|NOT COMPLETED|Overall Study||0
3253693|NCT02526654|3987713|FG001|NOT COMPLETED|Overall Study||0
3253694|NCT02526667|3987722|FG000|STARTED|Abdomen||284
3253695|NCT02526667|3987723|FG001|STARTED|Abdomen||56
3253696|NCT02526667|3987724|FG002|STARTED|Abdomen||281
3253697|NCT02526667|3987722|FG000|COMPLETED|Abdomen||284
3253698|NCT02526667|3987723|FG001|COMPLETED|Abdomen||56
3253699|NCT02526667|3987724|FG002|COMPLETED|Abdomen||281
3253700|NCT02526667|3987722|FG000|NOT COMPLETED|Abdomen||0
3253701|NCT02526667|3987723|FG001|NOT COMPLETED|Abdomen||0
3253702|NCT02526667|3987724|FG002|NOT COMPLETED|Abdomen||0
3253703|NCT02526667|3987722|FG000|STARTED|Groin||290
3253704|NCT02526667|3987723|FG001|STARTED|Groin||56
3253705|NCT02526667|3987724|FG002|STARTED|Groin||294
3253706|NCT02526667|3987722|FG000|COMPLETED|Groin||290
3253707|NCT02526667|3987723|FG001|COMPLETED|Groin||56
3253708|NCT02526667|3987724|FG002|COMPLETED|Groin||294
3253709|NCT02526667|3987722|FG000|NOT COMPLETED|Groin||0
3253710|NCT02526667|3987723|FG001|NOT COMPLETED|Groin||0
3253711|NCT02526667|3987724|FG002|NOT COMPLETED|Groin||0
3253712|NCT02526680|3987738|FG000|STARTED|Overall Study||27
3253713|NCT02526680|3987738|FG000|COMPLETED|Overall Study||27
3372077|NCT03333746|4103915|FG000|COMPLETED|Overall Study||0
3372078|NCT03333746|4103915|FG000|NOT COMPLETED|Overall Study||1
3372079|NCT03329404|4103921|FG000|STARTED|Overall Study||4
3372080|NCT03329404|4103922|FG001|STARTED|Overall Study||5
3372081|NCT03329404|4103921|FG000|COMPLETED|Overall Study||3
3372082|NCT03329404|4103922|FG001|COMPLETED|Overall Study||1
3372083|NCT03329404|4103921|FG000|NOT COMPLETED|Overall Study||1
3372084|NCT03329404|4103922|FG001|NOT COMPLETED|Overall Study||4
3372085|NCT03326869|4103930|FG000|STARTED|Overall Study||1
3372086|NCT03326869|4103931|FG001|STARTED|Overall Study||1
3253714|NCT02526680|3987738|FG000|NOT COMPLETED|Overall Study||0
3253715|NCT02526693|3987745|FG000|STARTED|Overall Study||53
3253716|NCT02526693|3987746|FG001|STARTED|Overall Study||51
3253717|NCT02526693|3987745|FG000|COMPLETED|Overall Study||50
3253718|NCT02526693|3987746|FG001|COMPLETED|Overall Study||50
3253719|NCT02526693|3987745|FG000|NOT COMPLETED|Overall Study||3
3253720|NCT02526693|3987746|FG001|NOT COMPLETED|Overall Study||1
3372087|NCT03326869|4103930|FG000|COMPLETED|Overall Study||0
3253721|NCT02527148|3987758|FG000|STARTED|Overall Study||50
3253722|NCT02527148|3987759|FG001|STARTED|Overall Study||50
3253723|NCT02527148|3987758|FG000|COMPLETED|Overall Study||49
3253724|NCT02527148|3987759|FG001|COMPLETED|Overall Study||50
3253725|NCT02527148|3987758|FG000|NOT COMPLETED|Overall Study||1
3253726|NCT02527148|3987759|FG001|NOT COMPLETED|Overall Study||0
3253727|NCT02527161|3987767|FG000|STARTED|Overall Study|All results are reported by knee throughout record. Participant=knee.|205
3253728|NCT02527161|3987767|FG000|COMPLETED|Overall Study|Completed/Not completed counts are for knees at the 5 year outcome interval.|73
3253729|NCT02527161|3987767|FG000|NOT COMPLETED|Overall Study||132
3253730|NCT02527265|3987774|FG000|STARTED|Overall Study||15
3253731|NCT02527265|3987775|FG001|STARTED|Overall Study||15
3253732|NCT02527265|3987774|FG000|COMPLETED|Overall Study||13
3253733|NCT02527265|3987775|FG001|COMPLETED|Overall Study||11
3253734|NCT02527265|3987774|FG000|NOT COMPLETED|Overall Study||2
3253735|NCT02527265|3987775|FG001|NOT COMPLETED|Overall Study||4
3253736|NCT02527343|3987783|FG000|STARTED|RT Period: Weeks 1 to 52||19
3253737|NCT02527343|3987784|FG001|STARTED|RT Period: Weeks 1 to 52||21
3253738|NCT02527343|3987785|FG002|STARTED|RT Period: Weeks 1 to 52||0
3253739|NCT02527343|3987786|FG003|STARTED|RT Period: Weeks 1 to 52||0
3253740|NCT02527343|3987787|FG004|STARTED|RT Period: Weeks 1 to 52||0
3253741|NCT02527343|3987788|FG005|STARTED|RT Period: Weeks 1 to 52||0
3253742|NCT02527343|3987783|FG000|COMPLETED|RT Period: Weeks 1 to 52||13
3253743|NCT02527343|3987784|FG001|COMPLETED|RT Period: Weeks 1 to 52||14
3253744|NCT02527343|3987785|FG002|COMPLETED|RT Period: Weeks 1 to 52||0
3253745|NCT02527343|3987786|FG003|COMPLETED|RT Period: Weeks 1 to 52||0
3253746|NCT02527343|3987787|FG004|COMPLETED|RT Period: Weeks 1 to 52||0
3253747|NCT02527343|3987788|FG005|COMPLETED|RT Period: Weeks 1 to 52||0
3253748|NCT02527343|3987783|FG000|NOT COMPLETED|RT Period: Weeks 1 to 52||6
3253749|NCT02527343|3987784|FG001|NOT COMPLETED|RT Period: Weeks 1 to 52||7
3253750|NCT02527343|3987785|FG002|NOT COMPLETED|RT Period: Weeks 1 to 52||0
3253751|NCT02527343|3987786|FG003|NOT COMPLETED|RT Period: Weeks 1 to 52||0
3253752|NCT02527343|3987787|FG004|NOT COMPLETED|RT Period: Weeks 1 to 52||0
3253753|NCT02527343|3987788|FG005|NOT COMPLETED|RT Period: Weeks 1 to 52||0
3253754|NCT02527343|3987783|FG000|STARTED|RT Post Treatment Follow-up: Weeks 54-65||0
3253755|NCT02527343|3987784|FG001|STARTED|RT Post Treatment Follow-up: Weeks 54-65||0
3253756|NCT02527343|3987785|FG002|STARTED|RT Post Treatment Follow-up: Weeks 54-65|Only those participants who were entered in the 13-week post-treatment follow-up period after the randomized treatment period.|7
3253757|NCT02527343|3987786|FG003|STARTED|RT Post Treatment Follow-up: Weeks 54-65|Only those participants who were entered in the 13-week post-treatment follow-up period after the randomized treatment period.|9
3253758|NCT02527343|3987787|FG004|STARTED|RT Post Treatment Follow-up: Weeks 54-65||0
3253759|NCT02527343|3987788|FG005|STARTED|RT Post Treatment Follow-up: Weeks 54-65||0
3253760|NCT02527343|3987783|FG000|COMPLETED|RT Post Treatment Follow-up: Weeks 54-65||0
3253761|NCT02527343|3987784|FG001|COMPLETED|RT Post Treatment Follow-up: Weeks 54-65||0
3253762|NCT02527343|3987785|FG002|COMPLETED|RT Post Treatment Follow-up: Weeks 54-65||6
3253763|NCT02527343|3987786|FG003|COMPLETED|RT Post Treatment Follow-up: Weeks 54-65||7
3253764|NCT02527343|3987787|FG004|COMPLETED|RT Post Treatment Follow-up: Weeks 54-65||0
3253765|NCT02527343|3987788|FG005|COMPLETED|RT Post Treatment Follow-up: Weeks 54-65||0
3253766|NCT02527343|3987783|FG000|NOT COMPLETED|RT Post Treatment Follow-up: Weeks 54-65||0
3253767|NCT02527343|3987784|FG001|NOT COMPLETED|RT Post Treatment Follow-up: Weeks 54-65||0
3253768|NCT02527343|3987785|FG002|NOT COMPLETED|RT Post Treatment Follow-up: Weeks 54-65||1
3253769|NCT02527343|3987786|FG003|NOT COMPLETED|RT Post Treatment Follow-up: Weeks 54-65||2
3253770|NCT02527343|3987787|FG004|NOT COMPLETED|RT Post Treatment Follow-up: Weeks 54-65||0
3253771|NCT02527343|3987788|FG005|NOT COMPLETED|RT Post Treatment Follow-up: Weeks 54-65||0
3253772|NCT02527343|3987783|FG000|STARTED|OLE Period-Year 1: Week 53 to 104||0
3253773|NCT02527343|3987784|FG001|STARTED|OLE Period-Year 1: Week 53 to 104||0
3253774|NCT02527343|3987785|FG002|STARTED|OLE Period-Year 1: Week 53 to 104||0
3253775|NCT02527343|3987786|FG003|STARTED|OLE Period-Year 1: Week 53 to 104||0
3253776|NCT02527343|3987787|FG004|STARTED|OLE Period-Year 1: Week 53 to 104|Only those participants who were entered the in the OLE period (first OLE period) after the randomized treatment period.|12
3253777|NCT02527343|3987788|FG005|STARTED|OLE Period-Year 1: Week 53 to 104|Only those participants who were entered the in the OLE period (first OLE period) after the randomized treatment period.|12
3253778|NCT02527343|3987783|FG000|COMPLETED|OLE Period-Year 1: Week 53 to 104||0
3253779|NCT02527343|3987784|FG001|COMPLETED|OLE Period-Year 1: Week 53 to 104||0
3253780|NCT02527343|3987785|FG002|COMPLETED|OLE Period-Year 1: Week 53 to 104||0
3253781|NCT02527343|3987786|FG003|COMPLETED|OLE Period-Year 1: Week 53 to 104||0
3253782|NCT02527343|3987787|FG004|COMPLETED|OLE Period-Year 1: Week 53 to 104||1
3253783|NCT02527343|3987788|FG005|COMPLETED|OLE Period-Year 1: Week 53 to 104||3
3253784|NCT02527343|3987783|FG000|NOT COMPLETED|OLE Period-Year 1: Week 53 to 104||0
3253785|NCT02527343|3987784|FG001|NOT COMPLETED|OLE Period-Year 1: Week 53 to 104||0
3253786|NCT02527343|3987785|FG002|NOT COMPLETED|OLE Period-Year 1: Week 53 to 104||0
3253787|NCT02527343|3987786|FG003|NOT COMPLETED|OLE Period-Year 1: Week 53 to 104||0
3253788|NCT02527343|3987787|FG004|NOT COMPLETED|OLE Period-Year 1: Week 53 to 104||11
3253789|NCT02527343|3987788|FG005|NOT COMPLETED|OLE Period-Year 1: Week 53 to 104||9
3253790|NCT02527343|3987783|FG000|STARTED|OLE Period-Year 2: Week 105 to 156||0
3253791|NCT02527343|3987784|FG001|STARTED|OLE Period-Year 2: Week 105 to 156||0
3253792|NCT02527343|3987785|FG002|STARTED|OLE Period-Year 2: Week 105 to 156||0
3253793|NCT02527343|3987786|FG003|STARTED|OLE Period-Year 2: Week 105 to 156||0
3253794|NCT02527343|3987787|FG004|STARTED|OLE Period-Year 2: Week 105 to 156|Only those participants who were continuing the dosing for up to an additional 52 weeks in the second OLE period.|1
3253795|NCT02527343|3987788|FG005|STARTED|OLE Period-Year 2: Week 105 to 156|Only those participants who were continuing the dosing for up to an additional 52 weeks in the second OLE period.|2
3253796|NCT02527343|3987783|FG000|COMPLETED|OLE Period-Year 2: Week 105 to 156||0
3253797|NCT02527343|3987784|FG001|COMPLETED|OLE Period-Year 2: Week 105 to 156||0
3253798|NCT02527343|3987785|FG002|COMPLETED|OLE Period-Year 2: Week 105 to 156||0
3253799|NCT02527343|3987786|FG003|COMPLETED|OLE Period-Year 2: Week 105 to 156||0
3253800|NCT02527343|3987787|FG004|COMPLETED|OLE Period-Year 2: Week 105 to 156||0
3253801|NCT02527343|3987788|FG005|COMPLETED|OLE Period-Year 2: Week 105 to 156||0
3253802|NCT02527343|3987783|FG000|NOT COMPLETED|OLE Period-Year 2: Week 105 to 156||0
3253803|NCT02527343|3987784|FG001|NOT COMPLETED|OLE Period-Year 2: Week 105 to 156||0
3253804|NCT02527343|3987785|FG002|NOT COMPLETED|OLE Period-Year 2: Week 105 to 156||0
3253805|NCT02527343|3987786|FG003|NOT COMPLETED|OLE Period-Year 2: Week 105 to 156||0
3253806|NCT02527343|3987787|FG004|NOT COMPLETED|OLE Period-Year 2: Week 105 to 156||1
3253807|NCT02527343|3987788|FG005|NOT COMPLETED|OLE Period-Year 2: Week 105 to 156||2
3253808|NCT02527343|3987783|FG000|STARTED|PT Follow-up: Weeks 104 to 169||0
3253809|NCT02527343|3987784|FG001|STARTED|PT Follow-up: Weeks 104 to 169||0
3253810|NCT02527343|3987785|FG002|STARTED|PT Follow-up: Weeks 104 to 169||0
3253811|NCT02527343|3987786|FG003|STARTED|PT Follow-up: Weeks 104 to 169||0
3253812|NCT02527343|3987787|FG004|STARTED|PT Follow-up: Weeks 104 to 169|Participants who were entered in the post-treatment follow-up after the OLE Period.|12
3253813|NCT02527343|3987788|FG005|STARTED|PT Follow-up: Weeks 104 to 169|Participants who were entered in the post-treatment follow-up after the OLE Period.|12
3253814|NCT02527343|3987783|FG000|COMPLETED|PT Follow-up: Weeks 104 to 169||0
3253815|NCT02527343|3987784|FG001|COMPLETED|PT Follow-up: Weeks 104 to 169||0
3253816|NCT02527343|3987785|FG002|COMPLETED|PT Follow-up: Weeks 104 to 169||0
3253817|NCT02527343|3987786|FG003|COMPLETED|PT Follow-up: Weeks 104 to 169||0
3253818|NCT02527343|3987787|FG004|COMPLETED|PT Follow-up: Weeks 104 to 169||11
3253819|NCT02527343|3987788|FG005|COMPLETED|PT Follow-up: Weeks 104 to 169||11
3253820|NCT02527343|3987783|FG000|NOT COMPLETED|PT Follow-up: Weeks 104 to 169||0
3253821|NCT02527343|3987784|FG001|NOT COMPLETED|PT Follow-up: Weeks 104 to 169||0
3253822|NCT02527343|3987785|FG002|NOT COMPLETED|PT Follow-up: Weeks 104 to 169||0
3253823|NCT02527343|3987786|FG003|NOT COMPLETED|PT Follow-up: Weeks 104 to 169||0
3253824|NCT02527343|3987787|FG004|NOT COMPLETED|PT Follow-up: Weeks 104 to 169||1
3253825|NCT02527343|3987788|FG005|NOT COMPLETED|PT Follow-up: Weeks 104 to 169||1
3253826|NCT02527421|3987805|FG000|STARTED|Overall Study||2
3253827|NCT02527421|3987806|FG001|STARTED|Overall Study||1
3253828|NCT02527421|3987805|FG000|COMPLETED|Overall Study||1
3253829|NCT02527421|3987806|FG001|COMPLETED|Overall Study||1
3253830|NCT02527421|3987805|FG000|NOT COMPLETED|Overall Study||1
3253831|NCT02527421|3987806|FG001|NOT COMPLETED|Overall Study||0
3253832|NCT02527512|3987814|FG000|STARTED|Overall Study||85
3253833|NCT02527512|3987815|FG001|STARTED|Overall Study||82
3253834|NCT02527512|3987814|FG000|COMPLETED|Overall Study||77
3253835|NCT02527512|3987815|FG001|COMPLETED|Overall Study||76
3253836|NCT02527512|3987814|FG000|NOT COMPLETED|Overall Study||8
3253837|NCT02527512|3987815|FG001|NOT COMPLETED|Overall Study||6
3253838|NCT02527681|3987825|FG000|STARTED|Overall Study||15
3253839|NCT02527681|3987825|FG000|COMPLETED|Overall Study||15
3253840|NCT02527681|3987825|FG000|NOT COMPLETED|Overall Study||0
3253841|NCT02527694|3987831|FG000|STARTED|Overall Study||20
3253842|NCT02527694|3987832|FG001|STARTED|Overall Study||29
3253843|NCT02527694|3987831|FG000|COMPLETED|Overall Study||10
3253844|NCT02527694|3987832|FG001|COMPLETED|Overall Study||21
3253845|NCT02527694|3987831|FG000|NOT COMPLETED|Overall Study||10
3253846|NCT02527694|3987832|FG001|NOT COMPLETED|Overall Study||8
3253847|NCT02528188|3987843|FG000|STARTED|Overall Study||1008
3253848|NCT02528188|3987844|FG001|STARTED|Overall Study||1005
3253849|NCT02528188|3987845|FG002|STARTED|Overall Study||1008
3253850|NCT02528188|3987843|FG000|Treated|Overall Study||1002
3253851|NCT02528188|3987844|FG001|Treated|Overall Study||998
3253852|NCT02528188|3987845|FG002|Treated|Overall Study||996
3253853|NCT02528188|3987843|FG000|COMPLETED|Overall Study||741
3253854|NCT02528188|3987844|FG001|COMPLETED|Overall Study||729
3253855|NCT02528188|3987845|FG002|COMPLETED|Overall Study||757
3253856|NCT02528188|3987843|FG000|NOT COMPLETED|Overall Study||267
3253857|NCT02528188|3987844|FG001|NOT COMPLETED|Overall Study||276
3253858|NCT02528188|3987845|FG002|NOT COMPLETED|Overall Study||251
3253859|NCT02528214|3987855|FG000|STARTED|Overall Study||107
3253860|NCT02528214|3987856|FG001|STARTED|Overall Study||103
3253861|NCT02528214|3987855|FG000|Treated|Overall Study||107
3253862|NCT02528214|3987856|FG001|Treated|Overall Study||103
3253863|NCT02528214|3987855|FG000|COMPLETED|Overall Study||107
3253864|NCT02528214|3987856|FG001|COMPLETED|Overall Study||100
3253865|NCT02528214|3987855|FG000|NOT COMPLETED|Overall Study||0
3253866|NCT02528214|3987856|FG001|NOT COMPLETED|Overall Study||3
3253867|NCT02528253|3987868|FG000|STARTED|Overall Study||205
3253868|NCT02528253|3987869|FG001|STARTED|Overall Study||204
3253869|NCT02528253|3987870|FG002|STARTED|Overall Study||407
3253870|NCT02528253|3987871|FG003|STARTED|Overall Study||407
3253871|NCT02528253|3987872|FG004|STARTED|Overall Study||602
3253872|NCT02528253|3987868|FG000|Intent to Treat Population|Overall Study||202
3253873|NCT02528253|3987869|FG001|Intent to Treat Population|Overall Study||204
3253874|NCT02528253|3987870|FG002|Intent to Treat Population|Overall Study||407
3253875|NCT02528253|3987871|FG003|Intent to Treat Population|Overall Study||407
3253876|NCT02528253|3987872|FG004|Intent to Treat Population|Overall Study|3 participants randomized to placebo arm received tramadol during the course of study|605
3253877|NCT02528253|3987868|FG000|Treated at Week 16|Overall Study||99
3253878|NCT02528253|3987869|FG001|Treated at Week 16|Overall Study||95
3253879|NCT02528253|3987870|FG002|Treated at Week 16|Overall Study||236
3253880|NCT02528253|3987871|FG003|Treated at Week 16|Overall Study||242
3253881|NCT02528253|3987872|FG004|Treated at Week 16|Overall Study||307
3253882|NCT02528253|3987868|FG000|COMPLETED|Overall Study||130
3253883|NCT02528253|3987869|FG001|COMPLETED|Overall Study||134
3253884|NCT02528253|3987870|FG002|COMPLETED|Overall Study||267
3253885|NCT02528253|3987871|FG003|COMPLETED|Overall Study||271
3253886|NCT02528253|3987872|FG004|COMPLETED|Overall Study||379
3253887|NCT02528253|3987868|FG000|NOT COMPLETED|Overall Study||75
3253888|NCT02528253|3987869|FG001|NOT COMPLETED|Overall Study||70
3253889|NCT02528253|3987870|FG002|NOT COMPLETED|Overall Study||140
3253890|NCT02528253|3987871|FG003|NOT COMPLETED|Overall Study||136
3253891|NCT02528253|3987872|FG004|NOT COMPLETED|Overall Study||223
3253892|NCT02528305|3987903|FG000|STARTED|Overall Study||12
3253893|NCT02528305|3987903|FG000|End of Control Period Assessment|Overall Study||11
3253894|NCT02528305|3987903|FG000|End of Intervention Period Assessment|Overall Study||9
3253895|NCT02528305|3987903|FG000|COMPLETED|Overall Study||9
3253896|NCT02528305|3987903|FG000|NOT COMPLETED|Overall Study||3
3253897|NCT02528318|3987914|FG000|STARTED|Overall Study||8
3253898|NCT02528318|3987915|FG001|STARTED|Overall Study||8
3253899|NCT02528318|3987916|FG002|STARTED|Overall Study||8
3253900|NCT02528318|3987917|FG003|STARTED|Overall Study|Study was terminated prior to initiation of this intervention|0
3253901|NCT02528318|3987918|FG004|STARTED|Overall Study||24
3253902|NCT02528318|3987914|FG000|COMPLETED|Overall Study||8
3253903|NCT02528318|3987915|FG001|COMPLETED|Overall Study||8
3253904|NCT02528318|3987916|FG002|COMPLETED|Overall Study||8
3253905|NCT02528318|3987917|FG003|COMPLETED|Overall Study||0
3253906|NCT02528318|3987918|FG004|COMPLETED|Overall Study||24
3253907|NCT02528318|3987914|FG000|NOT COMPLETED|Overall Study||0
3253908|NCT02528318|3987915|FG001|NOT COMPLETED|Overall Study||0
3253909|NCT02528318|3987916|FG002|NOT COMPLETED|Overall Study||0
3253910|NCT02528318|3987917|FG003|NOT COMPLETED|Overall Study||0
3253911|NCT02528318|3987918|FG004|NOT COMPLETED|Overall Study||0
3253912|NCT02528331|3987930|FG000|STARTED|Overall Study||2
3253913|NCT02528331|3987930|FG000|COMPLETED|Overall Study||0
3253914|NCT02528331|3987930|FG000|NOT COMPLETED|Overall Study||2
3253915|NCT02528357|3987953|FG000|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||1
3253916|NCT02528357|3987954|FG001|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||1
3253917|NCT02528357|3987955|FG002|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||8
3253918|NCT02528357|3987956|FG003|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||10
3253919|NCT02528357|3987957|FG004|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||10
3253920|NCT02528357|3987958|FG005|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||4
3253921|NCT02528357|3987959|FG006|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||7
3253922|NCT02528357|3987960|FG007|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||4
3253923|NCT02528357|3987961|FG008|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||0
3253924|NCT02528357|3987962|FG009|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||0
3253925|NCT02528357|3987963|FG010|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||0
3253926|NCT02528357|3987964|FG011|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||0
3253927|NCT02528357|3987965|FG012|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||0
3253928|NCT02528357|3987966|FG013|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||0
3253929|NCT02528357|3987967|FG014|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||0
3253930|NCT02528357|3987968|FG015|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||0
3253931|NCT02528357|3987969|FG016|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||0
3253932|NCT02528357|3987970|FG017|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||0
3253933|NCT02528357|3987971|FG018|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||0
3253934|NCT02528357|3987953|FG000|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||1
3253935|NCT02528357|3987954|FG001|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
3253936|NCT02528357|3987955|FG002|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||6
3253937|NCT02528357|3987956|FG003|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||9
3253938|NCT02528357|3987957|FG004|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||6
3253939|NCT02528357|3987958|FG005|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||2
3253940|NCT02528357|3987959|FG006|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||5
3253941|NCT02528357|3987960|FG007|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||2
3253942|NCT02528357|3987961|FG008|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
3253943|NCT02528357|3987962|FG009|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
3253944|NCT02528357|3987963|FG010|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
3253945|NCT02528357|3987964|FG011|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
3253946|NCT02528357|3987965|FG012|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
3253947|NCT02528357|3987966|FG013|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
3253948|NCT02528357|3987967|FG014|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
3253949|NCT02528357|3987968|FG015|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
3253950|NCT02528357|3987969|FG016|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
3253951|NCT02528357|3987970|FG017|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
3253952|NCT02528357|3987971|FG018|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
3253953|NCT02528357|3987953|FG000|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
3253954|NCT02528357|3987954|FG001|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||1
3253955|NCT02528357|3987955|FG002|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||2
3253956|NCT02528357|3987956|FG003|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||1
3253957|NCT02528357|3987957|FG004|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||4
3253958|NCT02528357|3987958|FG005|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||2
3253959|NCT02528357|3987959|FG006|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||2
3253960|NCT02528357|3987960|FG007|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||2
3253961|NCT02528357|3987961|FG008|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
3253962|NCT02528357|3987962|FG009|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
3253963|NCT02528357|3987963|FG010|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
3253964|NCT02528357|3987964|FG011|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
3253965|NCT02528357|3987965|FG012|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
3253966|NCT02528357|3987966|FG013|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
3253967|NCT02528357|3987967|FG014|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
3253968|NCT02528357|3987968|FG015|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
3253969|NCT02528357|3987969|FG016|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
3253970|NCT02528357|3987970|FG017|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
3253971|NCT02528357|3987971|FG018|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
3253972|NCT02528357|3987953|FG000|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
3253973|NCT02528357|3987954|FG001|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
3253974|NCT02528357|3987955|FG002|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
3253975|NCT02528357|3987956|FG003|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
3253976|NCT02528357|3987957|FG004|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
3253977|NCT02528357|3987958|FG005|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
3253978|NCT02528357|3987959|FG006|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
3253979|NCT02528357|3987960|FG007|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
3253980|NCT02528357|3987961|FG008|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||5
3253981|NCT02528357|3987962|FG009|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||5
3253982|NCT02528357|3987963|FG010|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||10
3253983|NCT02528357|3987964|FG011|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||12
3253984|NCT02528357|3987965|FG012|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||14
3253985|NCT02528357|3987966|FG013|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||12
3253986|NCT02528357|3987967|FG014|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||12
3253987|NCT02528357|3987968|FG015|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||4
3253988|NCT02528357|3987969|FG016|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
3253989|NCT02528357|3987970|FG017|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
3253990|NCT02528357|3987971|FG018|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
3253991|NCT02528357|3987953|FG000|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
3253992|NCT02528357|3987954|FG001|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
3253993|NCT02528357|3987955|FG002|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
3253994|NCT02528357|3987956|FG003|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
3253995|NCT02528357|3987957|FG004|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
3253996|NCT02528357|3987958|FG005|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
3253997|NCT02528357|3987959|FG006|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
3253998|NCT02528357|3987960|FG007|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
3253999|NCT02528357|3987961|FG008|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||4
3254000|NCT02528357|3987962|FG009|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||4
3254001|NCT02528357|3987963|FG010|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||7
3254002|NCT02528357|3987964|FG011|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||9
3254003|NCT02528357|3987965|FG012|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||9
3254004|NCT02528357|3987966|FG013|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||6
3254005|NCT02528357|3987967|FG014|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||5
3372088|NCT03326869|4103931|FG001|COMPLETED|Overall Study||0
3372089|NCT03326869|4103930|FG000|NOT COMPLETED|Overall Study||1
3372090|NCT03326869|4103931|FG001|NOT COMPLETED|Overall Study||1
3372091|NCT03325114|4103937|FG000|STARTED|Overall Study||1
3372092|NCT03325114|4103937|FG000|COMPLETED|Overall Study||0
3372093|NCT03325114|4103937|FG000|NOT COMPLETED|Overall Study||1
3372094|NCT03319407|4103941|FG000|STARTED|Overall Study||21
3372095|NCT03319407|4103941|FG000|COMPLETED|Overall Study||0
3372096|NCT03319407|4103941|FG000|NOT COMPLETED|Overall Study||21
3372097|NCT03316105|4103947|FG000|STARTED|Overall Study||9
3372098|NCT03316105|4103948|FG001|STARTED|Overall Study||7
3372099|NCT03316105|4103947|FG000|COMPLETED|Overall Study||9
3372100|NCT03316105|4103948|FG001|COMPLETED|Overall Study||7
3372101|NCT03316105|4103947|FG000|NOT COMPLETED|Overall Study||0
3372102|NCT03316105|4103948|FG001|NOT COMPLETED|Overall Study||0
3372103|NCT03305055|4103956|FG000|STARTED|Overall Study||2
3372104|NCT03305055|4103957|FG001|STARTED|Overall Study||2
3254006|NCT02528357|3987968|FG015|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||4
3254007|NCT02528357|3987969|FG016|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
3254008|NCT02528357|3987970|FG017|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
3254009|NCT02528357|3987971|FG018|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
3254010|NCT02528357|3987953|FG000|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
3254011|NCT02528357|3987954|FG001|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
3254012|NCT02528357|3987955|FG002|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
3254013|NCT02528357|3987956|FG003|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
3254014|NCT02528357|3987957|FG004|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
3254015|NCT02528357|3987958|FG005|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
3254016|NCT02528357|3987959|FG006|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
3254017|NCT02528357|3987960|FG007|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
3254018|NCT02528357|3987961|FG008|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||1
3254019|NCT02528357|3987962|FG009|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||1
3254020|NCT02528357|3987963|FG010|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||3
3254021|NCT02528357|3987964|FG011|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||3
3254022|NCT02528357|3987965|FG012|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||5
3254023|NCT02528357|3987966|FG013|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||6
3254024|NCT02528357|3987967|FG014|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||7
3254025|NCT02528357|3987968|FG015|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
3254026|NCT02528357|3987969|FG016|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
3254027|NCT02528357|3987970|FG017|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
3254028|NCT02528357|3987971|FG018|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
3254029|NCT02528357|3987953|FG000|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
3254030|NCT02528357|3987954|FG001|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
3254031|NCT02528357|3987955|FG002|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
3254032|NCT02528357|3987956|FG003|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
3254033|NCT02528357|3987957|FG004|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
3254034|NCT02528357|3987958|FG005|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
3254035|NCT02528357|3987959|FG006|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
3254036|NCT02528357|3987960|FG007|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
3254037|NCT02528357|3987961|FG008|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
3254038|NCT02528357|3987962|FG009|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
3372105|NCT03305055|4103956|FG000|COMPLETED|Overall Study||1
3372106|NCT03305055|4103957|FG001|COMPLETED|Overall Study||0
3372107|NCT03305055|4103956|FG000|NOT COMPLETED|Overall Study||1
3372108|NCT03305055|4103957|FG001|NOT COMPLETED|Overall Study||2
3372109|NCT03303469|4103963|FG000|STARTED|Overall Study||3
3372110|NCT03303469|4103963|FG000|COMPLETED|Overall Study||1
3372111|NCT03303469|4103963|FG000|NOT COMPLETED|Overall Study||2
3372112|NCT03302247|4103967|FG000|STARTED|Overall Study||3
3372113|NCT03302247|4103967|FG000|COMPLETED|Overall Study||0
3372114|NCT03302247|4103967|FG000|NOT COMPLETED|Overall Study||3
3372115|NCT03300024|4103973|FG000|STARTED|Overall Study||4
3372116|NCT03300024|4103974|FG001|STARTED|Overall Study||6
3372117|NCT03300024|4103973|FG000|COMPLETED|Overall Study||0
3372118|NCT03300024|4103974|FG001|COMPLETED|Overall Study||0
3372119|NCT03300024|4103973|FG000|NOT COMPLETED|Overall Study||4
3372120|NCT03300024|4103974|FG001|NOT COMPLETED|Overall Study||6
3254039|NCT02528357|3987963|FG010|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
3254040|NCT02528357|3987964|FG011|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
3254041|NCT02528357|3987965|FG012|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
3254042|NCT02528357|3987966|FG013|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
3254043|NCT02528357|3987967|FG014|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
3254044|NCT02528357|3987968|FG015|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
3254045|NCT02528357|3987969|FG016|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||9
3254046|NCT02528357|3987970|FG017|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||8
3254047|NCT02528357|3987971|FG018|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||5
3254048|NCT02528357|3987953|FG000|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
3254049|NCT02528357|3987954|FG001|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
3254050|NCT02528357|3987955|FG002|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
3254051|NCT02528357|3987956|FG003|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
3254052|NCT02528357|3987957|FG004|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
3254053|NCT02528357|3987958|FG005|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
3254054|NCT02528357|3987959|FG006|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
3254055|NCT02528357|3987960|FG007|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
3254056|NCT02528357|3987961|FG008|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
3254057|NCT02528357|3987962|FG009|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
3254058|NCT02528357|3987963|FG010|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
3254059|NCT02528357|3987964|FG011|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
3254060|NCT02528357|3987965|FG012|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
3254061|NCT02528357|3987966|FG013|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
3254062|NCT02528357|3987967|FG014|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
3254063|NCT02528357|3987968|FG015|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
3254064|NCT02528357|3987969|FG016|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||6
3254065|NCT02528357|3987970|FG017|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||4
3254066|NCT02528357|3987971|FG018|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||2
3254067|NCT02528357|3987953|FG000|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
3254068|NCT02528357|3987954|FG001|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
3254069|NCT02528357|3987955|FG002|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
3254070|NCT02528357|3987956|FG003|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
3254071|NCT02528357|3987957|FG004|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
3254072|NCT02528357|3987958|FG005|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
3254073|NCT02528357|3987959|FG006|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
3254074|NCT02528357|3987960|FG007|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
3254075|NCT02528357|3987961|FG008|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
3254076|NCT02528357|3987962|FG009|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
3254077|NCT02528357|3987963|FG010|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
3254078|NCT02528357|3987964|FG011|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
3254079|NCT02528357|3987965|FG012|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
3254080|NCT02528357|3987966|FG013|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
3254081|NCT02528357|3987967|FG014|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
3254082|NCT02528357|3987968|FG015|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
3254083|NCT02528357|3987969|FG016|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||3
3254084|NCT02528357|3987970|FG017|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||4
3254085|NCT02528357|3987971|FG018|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||3
3254086|NCT02528370|3988013|FG000|STARTED|Overall Study||119
3254087|NCT02528370|3988014|FG001|STARTED|Overall Study||78
3254088|NCT02528370|3988013|FG000|COMPLETED|Overall Study||102
3254089|NCT02528370|3988014|FG001|COMPLETED|Overall Study||77
3254090|NCT02528370|3988013|FG000|NOT COMPLETED|Overall Study||17
3254091|NCT02528370|3988014|FG001|NOT COMPLETED|Overall Study||1
3254092|NCT02528409|3988022|FG000|STARTED|Overall Study||40
3254093|NCT02528409|3988023|FG001|STARTED|Overall Study||40
3254094|NCT02528409|3988022|FG000|COMPLETED|Overall Study||18
3254095|NCT02528409|3988023|FG001|COMPLETED|Overall Study||24
3254096|NCT02528409|3988022|FG000|NOT COMPLETED|Overall Study||22
3254097|NCT02528409|3988023|FG001|NOT COMPLETED|Overall Study||16
3254098|NCT02528721|3988031|FG000|STARTED|Overall Study||203
3254099|NCT02528721|3988032|FG001|STARTED|Overall Study||79
3254100|NCT02528721|3988031|FG000|COMPLETED|Overall Study||196
3254101|NCT02528721|3988032|FG001|COMPLETED|Overall Study||76
3254102|NCT02528721|3988031|FG000|NOT COMPLETED|Overall Study||7
3254103|NCT02528721|3988032|FG001|NOT COMPLETED|Overall Study||3
3254104|NCT02528786|3988038|FG000|STARTED|Overall Study||8
3254105|NCT02528786|3988038|FG000|COMPLETED|Overall Study||8
3254106|NCT02528786|3988038|FG000|NOT COMPLETED|Overall Study||0
3254107|NCT02528942|3988042|FG000|STARTED|Overall Study||101
3254108|NCT02528942|3988042|FG000|COMPLETED|Overall Study||67
3254109|NCT02528942|3988042|FG000|NOT COMPLETED|Overall Study||34
3254110|NCT02529072|3988048|FG000|STARTED|Overall Study||3
3254111|NCT02529072|3988049|FG001|STARTED|Overall Study||3
3254112|NCT02529072|3988048|FG000|COMPLETED|Overall Study||3
3254113|NCT02529072|3988049|FG001|COMPLETED|Overall Study||3
3254114|NCT02529072|3988048|FG000|NOT COMPLETED|Overall Study||0
3254115|NCT02529072|3988049|FG001|NOT COMPLETED|Overall Study||0
3372121|NCT03283709|4103984|FG000|STARTED|Overall Study||0
3254116|NCT02529137|3988055|FG000|STARTED|Overall Study||2000
3254117|NCT02529137|3988055|FG000|COMPLETED|Overall Study||1992
3254118|NCT02529137|3988055|FG000|NOT COMPLETED|Overall Study||8
3254119|NCT02529488|3988060|FG000|STARTED|Overall Study||149
3254120|NCT02529488|3988060|FG000|COMPLETED|Overall Study||145
3254121|NCT02529488|3988060|FG000|NOT COMPLETED|Overall Study||4
3254122|NCT02529553|3988077|FG000|STARTED|Overall Study||1
3254123|NCT02529553|3988078|FG001|STARTED|Overall Study||1
3254124|NCT02529553|3988079|FG002|STARTED|Overall Study||1
3254125|NCT02529553|3988080|FG003|STARTED|Overall Study||3
3254126|NCT02529553|3988081|FG004|STARTED|Overall Study||3
3254127|NCT02529553|3988082|FG005|STARTED|Overall Study||4
3254128|NCT02529553|3988083|FG006|STARTED|Overall Study||3
3254129|NCT02529553|3988084|FG007|STARTED|Overall Study||6
3254130|NCT02529553|3988085|FG008|STARTED|Overall Study||3
3254131|NCT02529553|3988077|FG000|COMPLETED|Overall Study||0
3254132|NCT02529553|3988078|FG001|COMPLETED|Overall Study||0
3254133|NCT02529553|3988079|FG002|COMPLETED|Overall Study||0
3254134|NCT02529553|3988080|FG003|COMPLETED|Overall Study||0
3254135|NCT02529553|3988081|FG004|COMPLETED|Overall Study||0
3254136|NCT02529553|3988082|FG005|COMPLETED|Overall Study||0
3254137|NCT02529553|3988083|FG006|COMPLETED|Overall Study||0
3254138|NCT02529553|3988084|FG007|COMPLETED|Overall Study||0
3254139|NCT02529553|3988085|FG008|COMPLETED|Overall Study||0
3254140|NCT02529553|3988077|FG000|NOT COMPLETED|Overall Study||1
3254141|NCT02529553|3988078|FG001|NOT COMPLETED|Overall Study||1
3254142|NCT02529553|3988079|FG002|NOT COMPLETED|Overall Study||1
3254143|NCT02529553|3988080|FG003|NOT COMPLETED|Overall Study||3
3254144|NCT02529553|3988081|FG004|NOT COMPLETED|Overall Study||3
3254145|NCT02529553|3988082|FG005|NOT COMPLETED|Overall Study||4
3254146|NCT02529553|3988083|FG006|NOT COMPLETED|Overall Study||3
3254147|NCT02529553|3988084|FG007|NOT COMPLETED|Overall Study||6
3254148|NCT02529553|3988085|FG008|NOT COMPLETED|Overall Study||3
3254149|NCT02529995|3988108|FG000|STARTED|Part A||15
3254150|NCT02529995|3988109|FG001|STARTED|Part A||16
3254151|NCT02529995|3988108|FG000|COMPLETED|Part A|'Completed' means 'Completed the Study', i.e. zero patient completed the study in part A.|0
3254152|NCT02529995|3988109|FG001|COMPLETED|Part A|'Completed' means 'Completed the Study', i.e. zero patient completed the study in part A.|0
3254153|NCT02529995|3988108|FG000|NOT COMPLETED|Part A||15
3254154|NCT02529995|3988109|FG001|NOT COMPLETED|Part A||16
3254155|NCT02529995|3988108|FG000|STARTED|Part B||15
3254156|NCT02529995|3988109|FG001|STARTED|Part B||16
3254157|NCT02529995|3988108|FG000|COMPLETED|Part B||9
3254158|NCT02529995|3988109|FG001|COMPLETED|Part B||4
3254159|NCT02529995|3988108|FG000|NOT COMPLETED|Part B||6
3254160|NCT02529995|3988109|FG001|NOT COMPLETED|Part B||12
3254161|NCT02530125|3988115|FG000|STARTED|Completed Treatment||4
3254162|NCT02530125|3988115|FG000|COMPLETED|Completed Treatment||3
3254163|NCT02530125|3988115|FG000|NOT COMPLETED|Completed Treatment||1
3254164|NCT02530125|3988115|FG000|STARTED|Followed for Survival for 2 Years||3
3254165|NCT02530125|3988115|FG000|COMPLETED|Followed for Survival for 2 Years||0
3254166|NCT02530125|3988115|FG000|NOT COMPLETED|Followed for Survival for 2 Years||3
3254167|NCT02530151|3988121|FG000|STARTED|Overall Study||37
3254168|NCT02530151|3988122|FG001|STARTED|Overall Study||33
3254169|NCT02530151|3988121|FG000|COMPLETED|Overall Study||16
3254170|NCT02530151|3988122|FG001|COMPLETED|Overall Study||17
3254171|NCT02530151|3988121|FG000|NOT COMPLETED|Overall Study||21
3254172|NCT02530151|3988122|FG001|NOT COMPLETED|Overall Study||16
3254173|NCT02530242|3988130|FG000|STARTED|Overall Study||16
3254174|NCT02530242|3988131|FG001|STARTED|Overall Study||16
3254175|NCT02530242|3988130|FG000|COMPLETED|Overall Study||16
3254176|NCT02530242|3988131|FG001|COMPLETED|Overall Study||15
3254177|NCT02530242|3988130|FG000|NOT COMPLETED|Overall Study||0
3254178|NCT02530242|3988131|FG001|NOT COMPLETED|Overall Study||1
3254179|NCT02530281|3988139|FG000|STARTED|Overall Study||229
3254180|NCT02530281|3988140|FG001|STARTED|Overall Study||115
3254181|NCT02530281|3988139|FG000|COMPLETED|Overall Study||208
3254182|NCT02530281|3988140|FG001|COMPLETED|Overall Study||112
3254183|NCT02530281|3988139|FG000|NOT COMPLETED|Overall Study||21
3254184|NCT02530281|3988140|FG001|NOT COMPLETED|Overall Study||3
3254185|NCT02530294|3988150|FG000|STARTED|Overall Study||234
3254186|NCT02530294|3988151|FG001|STARTED|Overall Study||119
3254187|NCT02530294|3988150|FG000|COMPLETED|Overall Study||218
3254188|NCT02530294|3988151|FG001|COMPLETED|Overall Study||113
3254189|NCT02530294|3988150|FG000|NOT COMPLETED|Overall Study||16
3254190|NCT02530294|3988151|FG001|NOT COMPLETED|Overall Study||6
3254191|NCT02530385|3988159|FG000|STARTED|Overall Study||12
3254192|NCT02530385|3988160|FG001|STARTED|Overall Study||12
3254193|NCT02530385|3988159|FG000|COMPLETED|Overall Study||12
3254194|NCT02530385|3988160|FG001|COMPLETED|Overall Study||11
3254195|NCT02530385|3988159|FG000|NOT COMPLETED|Overall Study||0
3254196|NCT02530385|3988160|FG001|NOT COMPLETED|Overall Study||1
3254197|NCT02530450|3988168|FG000|STARTED|Overall Study||16
3254198|NCT02530450|3988169|FG001|STARTED|Overall Study||14
3372122|NCT03283709|4103985|FG001|STARTED|Overall Study||1
3254199|NCT02530450|3988168|FG000|COMPLETED|Overall Study||10
3254200|NCT02530450|3988169|FG001|COMPLETED|Overall Study||9
3254201|NCT02530450|3988168|FG000|NOT COMPLETED|Overall Study||6
3254202|NCT02530450|3988169|FG001|NOT COMPLETED|Overall Study||5
3254203|NCT02530476|3988179|FG000|STARTED|Overall Study||4
3254204|NCT02530476|3988180|FG001|STARTED|Overall Study||3
3254205|NCT02530476|3988181|FG002|STARTED|Overall Study||7
3254206|NCT02530476|3988182|FG003|STARTED|Overall Study||3
3254207|NCT02530476|3988179|FG000|COMPLETED|Overall Study||4
3254208|NCT02530476|3988180|FG001|COMPLETED|Overall Study||3
3254209|NCT02530476|3988181|FG002|COMPLETED|Overall Study||7
3254210|NCT02530476|3988182|FG003|COMPLETED|Overall Study||3
3254211|NCT02530476|3988179|FG000|NOT COMPLETED|Overall Study||0
3254212|NCT02530476|3988180|FG001|NOT COMPLETED|Overall Study||0
3254213|NCT02530476|3988181|FG002|NOT COMPLETED|Overall Study||0
3254214|NCT02530476|3988182|FG003|NOT COMPLETED|Overall Study||0
3254215|NCT02530515|3988195|FG000|STARTED|Overall Study||0
3254216|NCT02530515|3988196|FG001|STARTED|Overall Study||0
3254217|NCT02530515|3988197|FG002|STARTED|Overall Study||8
3254218|NCT02530515|3988195|FG000|COMPLETED|Overall Study||0
3254219|NCT02530515|3988196|FG001|COMPLETED|Overall Study||0
3254220|NCT02530515|3988197|FG002|COMPLETED|Overall Study||8
3254221|NCT02530515|3988195|FG000|NOT COMPLETED|Overall Study||0
3254222|NCT02530515|3988196|FG001|NOT COMPLETED|Overall Study||0
3254223|NCT02530515|3988197|FG002|NOT COMPLETED|Overall Study||0
3254224|NCT02530528|3988205|FG000|STARTED|Overall Study||13
3254225|NCT02530528|3988206|FG001|STARTED|Overall Study||13
3254226|NCT02530528|3988207|FG002|STARTED|Overall Study||14
3254227|NCT02530528|3988208|FG003|STARTED|Overall Study||14
3254228|NCT02530528|3988209|FG004|STARTED|Overall Study||13
3254229|NCT02530528|3988210|FG005|STARTED|Overall Study||13
3254230|NCT02530528|3988211|FG006|STARTED|Overall Study||14
3254231|NCT02530528|3988212|FG007|STARTED|Overall Study||14
3254232|NCT02530528|3988205|FG000|COMPLETED|Overall Study|13 participants received CHG Cloth|12
3254233|NCT02530528|3988206|FG001|COMPLETED|Overall Study||12
3254234|NCT02530528|3988207|FG002|COMPLETED|Overall Study|14 participants received CHG cloth|12
3254235|NCT02530528|3988208|FG003|COMPLETED|Overall Study||12
3254236|NCT02530528|3988209|FG004|COMPLETED|Overall Study|13 participants received CHG cloth|12
3254237|NCT02530528|3988210|FG005|COMPLETED|Overall Study||12
3254238|NCT02530528|3988211|FG006|COMPLETED|Overall Study|14 participants received comparator CHG.|12
3254239|NCT02530528|3988212|FG007|COMPLETED|Overall Study||12
3254240|NCT02530528|3988205|FG000|NOT COMPLETED|Overall Study||1
3254241|NCT02530528|3988206|FG001|NOT COMPLETED|Overall Study||1
3254242|NCT02530528|3988207|FG002|NOT COMPLETED|Overall Study||2
3254243|NCT02530528|3988208|FG003|NOT COMPLETED|Overall Study||2
3254244|NCT02530528|3988209|FG004|NOT COMPLETED|Overall Study||1
3254245|NCT02530528|3988210|FG005|NOT COMPLETED|Overall Study||1
3254246|NCT02530528|3988211|FG006|NOT COMPLETED|Overall Study||2
3254247|NCT02530528|3988212|FG007|NOT COMPLETED|Overall Study||2
3254248|NCT02530541|3988226|FG000|STARTED|Overall Study||21
3254249|NCT02530541|3988227|FG001|STARTED|Overall Study||23
3254250|NCT02530541|3988228|FG002|STARTED|Overall Study||22
3254251|NCT02530541|3988229|FG003|STARTED|Overall Study||21
3254252|NCT02530541|3988230|FG004|STARTED|Overall Study||20
3254253|NCT02530541|3988231|FG005|STARTED|Overall Study||19
3254254|NCT02530541|3988226|FG000|COMPLETED|Overall Study||14
3254255|NCT02530541|3988227|FG001|COMPLETED|Overall Study||15
3254256|NCT02530541|3988228|FG002|COMPLETED|Overall Study||14
3254257|NCT02530541|3988229|FG003|COMPLETED|Overall Study||15
3254258|NCT02530541|3988230|FG004|COMPLETED|Overall Study||15
3254259|NCT02530541|3988231|FG005|COMPLETED|Overall Study||14
3254260|NCT02530541|3988226|FG000|NOT COMPLETED|Overall Study||7
3254261|NCT02530541|3988227|FG001|NOT COMPLETED|Overall Study||8
3254262|NCT02530541|3988228|FG002|NOT COMPLETED|Overall Study||8
3254263|NCT02530541|3988229|FG003|NOT COMPLETED|Overall Study||6
3254264|NCT02530541|3988230|FG004|NOT COMPLETED|Overall Study||5
3254265|NCT02530541|3988231|FG005|NOT COMPLETED|Overall Study||5
3254266|NCT02530554|3988240|FG000|STARTED|Overall Study||12
3254267|NCT02530554|3988241|FG001|STARTED|Overall Study||14
3254268|NCT02530554|3988242|FG002|STARTED|Overall Study||12
3254269|NCT02530554|3988243|FG003|STARTED|Overall Study||14
3254270|NCT02530554|3988240|FG000|COMPLETED|Overall Study||12
3254271|NCT02530554|3988241|FG001|COMPLETED|Overall Study||14
3254272|NCT02530554|3988242|FG002|COMPLETED|Overall Study||12
3254273|NCT02530554|3988243|FG003|COMPLETED|Overall Study||14
3254274|NCT02530554|3988240|FG000|NOT COMPLETED|Overall Study||0
3254275|NCT02530554|3988241|FG001|NOT COMPLETED|Overall Study||0
3254276|NCT02530554|3988242|FG002|NOT COMPLETED|Overall Study||0
3254277|NCT02530554|3988243|FG003|NOT COMPLETED|Overall Study||0
3254278|NCT02530619|3988250|FG000|STARTED|Registered for Study||26
3372123|NCT03283709|4103984|FG000|COMPLETED|Overall Study||0
3372124|NCT03283709|4103985|FG001|COMPLETED|Overall Study||0
3372125|NCT03283709|4103984|FG000|NOT COMPLETED|Overall Study||0
3372126|NCT03283709|4103985|FG001|NOT COMPLETED|Overall Study||1
3372127|NCT03277183|4103993|FG000|STARTED|Overall Study||3
3372128|NCT03277183|4103994|FG001|STARTED|Overall Study||2
3372129|NCT03277183|4103993|FG000|COMPLETED|Overall Study||0
3372130|NCT03277183|4103994|FG001|COMPLETED|Overall Study||0
3372131|NCT03277183|4103993|FG000|NOT COMPLETED|Overall Study||3
3372132|NCT03277183|4103994|FG001|NOT COMPLETED|Overall Study||2
3372133|NCT03269968|4104002|FG000|STARTED|Overall Study||0
3372134|NCT03269968|4104003|FG001|STARTED|Overall Study||0
3372135|NCT03269968|4104002|FG000|COMPLETED|Overall Study||0
3372136|NCT03269968|4104003|FG001|COMPLETED|Overall Study||0
3372137|NCT03269968|4104002|FG000|NOT COMPLETED|Overall Study||0
3254279|NCT02530619|3988250|FG000|Registered|Registered for Study||26
3254280|NCT02530619|3988250|FG000|Received 1st Dose of Alisertib|Registered for Study||24
3254281|NCT02530619|3988250|FG000|COMPLETED|Registered for Study||24
3254282|NCT02530619|3988250|FG000|NOT COMPLETED|Registered for Study||2
3254283|NCT02530619|3988250|FG000|STARTED|Completed 1st Cycle of Treatment||24
3254284|NCT02530619|3988250|FG000|COMPLETED|Completed 1st Cycle of Treatment||24
3254285|NCT02530619|3988250|FG000|NOT COMPLETED|Completed 1st Cycle of Treatment||0
3254286|NCT02530619|3988250|FG000|STARTED|Continued Treatment Cycles 2 Through 6||24
3254287|NCT02530619|3988250|FG000|COMPLETED|Continued Treatment Cycles 2 Through 6||14
3254288|NCT02530619|3988250|FG000|NOT COMPLETED|Continued Treatment Cycles 2 Through 6||10
3254289|NCT02530619|3988250|FG000|STARTED|Continued Treatment Cycle 7+||14
3254290|NCT02530619|3988250|FG000|COMPLETED|Continued Treatment Cycle 7+||14
3254291|NCT02530619|3988250|FG000|NOT COMPLETED|Continued Treatment Cycle 7+||0
3254292|NCT02530619|3988250|FG000|STARTED|Follow-up Period (6 Months)|Patients who received at least one dose of study drug go into follow-up.|21
3254293|NCT02530619|3988250|FG000|COMPLETED|Follow-up Period (6 Months)||10
3254294|NCT02530619|3988250|FG000|NOT COMPLETED|Follow-up Period (6 Months)||11
3254295|NCT02530671|3988256|FG000|STARTED|Overall Study||55
3254296|NCT02530671|3988257|FG001|STARTED|Overall Study||55
3254297|NCT02530671|3988256|FG000|COMPLETED|Overall Study||52
3254298|NCT02530671|3988257|FG001|COMPLETED|Overall Study||55
3254299|NCT02530671|3988256|FG000|NOT COMPLETED|Overall Study||3
3254300|NCT02530671|3988257|FG001|NOT COMPLETED|Overall Study||0
3254301|NCT02530905|3988265|FG000|STARTED|Double-Blind Period (12 Weeks)||4
3254302|NCT02530905|3988266|FG001|STARTED|Double-Blind Period (12 Weeks)||8
3254303|NCT02530905|3988267|FG002|STARTED|Double-Blind Period (12 Weeks)||0
3254304|NCT02530905|3988265|FG000|Received 4 mg/kg|Double-Blind Period (12 Weeks)||0
3254305|NCT02530905|3988266|FG001|Received 4 mg/kg|Double-Blind Period (12 Weeks)||8
3254306|NCT02530905|3988267|FG002|Received 4 mg/kg|Double-Blind Period (12 Weeks)||0
3254307|NCT02530905|3988265|FG000|Received 10 mg/kg|Double-Blind Period (12 Weeks)||0
3254308|NCT02530905|3988266|FG001|Received 10 mg/kg|Double-Blind Period (12 Weeks)||8
3254309|NCT02530905|3988267|FG002|Received 10 mg/kg|Double-Blind Period (12 Weeks)||0
3254310|NCT02530905|3988265|FG000|Received 20 mg/kg|Double-Blind Period (12 Weeks)||0
3254311|NCT02530905|3988266|FG001|Received 20 mg/kg|Double-Blind Period (12 Weeks)||8
3254312|NCT02530905|3988267|FG002|Received 20 mg/kg|Double-Blind Period (12 Weeks)||0
3254313|NCT02530905|3988265|FG000|Received 30 mg/kg|Double-Blind Period (12 Weeks)||0
3254314|NCT02530905|3988266|FG001|Received 30 mg/kg|Double-Blind Period (12 Weeks)||8
3254315|NCT02530905|3988267|FG002|Received 30 mg/kg|Double-Blind Period (12 Weeks)||0
3254316|NCT02530905|3988265|FG000|COMPLETED|Double-Blind Period (12 Weeks)||4
3254317|NCT02530905|3988266|FG001|COMPLETED|Double-Blind Period (12 Weeks)||8
3254318|NCT02530905|3988267|FG002|COMPLETED|Double-Blind Period (12 Weeks)||0
3254319|NCT02530905|3988265|FG000|NOT COMPLETED|Double-Blind Period (12 Weeks)||0
3254320|NCT02530905|3988266|FG001|NOT COMPLETED|Double-Blind Period (12 Weeks)||0
3254321|NCT02530905|3988267|FG002|NOT COMPLETED|Double-Blind Period (12 Weeks)||0
3254322|NCT02530905|3988265|FG000|STARTED|Open Label Extension Period (132 Weeks)||0
3254323|NCT02530905|3988266|FG001|STARTED|Open Label Extension Period (132 Weeks)||0
3254324|NCT02530905|3988267|FG002|STARTED|Open Label Extension Period (132 Weeks)|All participants from the double-blind period amenable to exon 45 skipping were enrolled to open-label extension period.|12
3254325|NCT02530905|3988265|FG000|COMPLETED|Open Label Extension Period (132 Weeks)||0
3254326|NCT02530905|3988266|FG001|COMPLETED|Open Label Extension Period (132 Weeks)||0
3254327|NCT02530905|3988267|FG002|COMPLETED|Open Label Extension Period (132 Weeks)||11
3254328|NCT02530905|3988265|FG000|NOT COMPLETED|Open Label Extension Period (132 Weeks)||0
3254329|NCT02530905|3988266|FG001|NOT COMPLETED|Open Label Extension Period (132 Weeks)||0
3254330|NCT02530905|3988267|FG002|NOT COMPLETED|Open Label Extension Period (132 Weeks)||1
3254331|NCT02530970|3988289|FG000|STARTED|Overall Study||1025
3254332|NCT02530970|3988289|FG000|COMPLETED|Overall Study||891
3254333|NCT02530970|3988289|FG000|NOT COMPLETED|Overall Study||134
3254334|NCT02530996|3988293|FG000|STARTED|First Intervention||6
3254335|NCT02530996|3988294|FG001|STARTED|First Intervention||6
3254336|NCT02530996|3988293|FG000|COMPLETED|First Intervention||6
3254337|NCT02530996|3988294|FG001|COMPLETED|First Intervention||6
3254338|NCT02530996|3988293|FG000|NOT COMPLETED|First Intervention||0
3254339|NCT02530996|3988294|FG001|NOT COMPLETED|First Intervention||0
3254340|NCT02530996|3988293|FG000|STARTED|Washout (5 Days)||6
3254341|NCT02530996|3988294|FG001|STARTED|Washout (5 Days)||6
3254342|NCT02530996|3988293|FG000|COMPLETED|Washout (5 Days)||6
3254343|NCT02530996|3988294|FG001|COMPLETED|Washout (5 Days)||6
3254344|NCT02530996|3988293|FG000|NOT COMPLETED|Washout (5 Days)||0
3254345|NCT02530996|3988294|FG001|NOT COMPLETED|Washout (5 Days)||0
3254346|NCT02530996|3988293|FG000|STARTED|Second Intervention||6
3254347|NCT02530996|3988294|FG001|STARTED|Second Intervention||6
3254348|NCT02530996|3988293|FG000|COMPLETED|Second Intervention||6
3254349|NCT02530996|3988294|FG001|COMPLETED|Second Intervention||6
3254350|NCT02530996|3988293|FG000|NOT COMPLETED|Second Intervention||0
3254351|NCT02530996|3988294|FG001|NOT COMPLETED|Second Intervention||0
3254352|NCT02531022|3988306|FG000|STARTED|Overall Study||55
3254353|NCT02531022|3988307|FG001|STARTED|Overall Study||50
3254354|NCT02531022|3988306|FG000|COMPLETED|Overall Study||55
3254355|NCT02531022|3988307|FG001|COMPLETED|Overall Study||48
3254356|NCT02531022|3988306|FG000|NOT COMPLETED|Overall Study||0
3254357|NCT02531022|3988307|FG001|NOT COMPLETED|Overall Study||2
3254358|NCT02531035|3988315|FG000|STARTED|Overall Study||705
3254359|NCT02531035|3988316|FG001|STARTED|Overall Study||700
3254360|NCT02531035|3988315|FG000|Treated|Overall Study||703
3254361|NCT02531035|3988316|FG001|Treated|Overall Study||699
3254362|NCT02531035|3988315|FG000|COMPLETED|Overall Study||624
3254363|NCT02531035|3988316|FG001|COMPLETED|Overall Study||605
3254364|NCT02531035|3988315|FG000|NOT COMPLETED|Overall Study||81
3254365|NCT02531035|3988316|FG001|NOT COMPLETED|Overall Study||95
3372138|NCT03269968|4104003|FG001|NOT COMPLETED|Overall Study||0
3372139|NCT03248141|4104011|FG000|STARTED|Overall Study||11
3372140|NCT03248141|4104012|FG001|STARTED|Overall Study|No enrollment occurred in this arm prior to study termination.|0
3372141|NCT03248141|4104011|FG000|COMPLETED|Overall Study|Participants who were present in the study till termination were considered as completed.|11
3372142|NCT03248141|4104012|FG001|COMPLETED|Overall Study||0
3372143|NCT03248141|4104011|FG000|NOT COMPLETED|Overall Study||0
3372144|NCT03248141|4104012|FG001|NOT COMPLETED|Overall Study||0
3372145|NCT03263806|4104020|FG000|STARTED|Overall Study||6
3372146|NCT03263806|4104021|FG001|STARTED|Overall Study||7
3372147|NCT03263806|4104020|FG000|COMPLETED|Overall Study|Study Terminated due to lack of enrollment|0
3372148|NCT03263806|4104021|FG001|COMPLETED|Overall Study|Study Terminated due to lack of enrollment|0
3372149|NCT03263806|4104020|FG000|NOT COMPLETED|Overall Study||6
3372150|NCT03263806|4104021|FG001|NOT COMPLETED|Overall Study||7
3372151|NCT03261531|4104027|FG000|STARTED|Overall Study||7
3372152|NCT03261531|4104027|FG000|COMPLETED|Overall Study||3
3372153|NCT03261531|4104027|FG000|NOT COMPLETED|Overall Study||4
3372154|NCT03251326|4104031|FG000|STARTED|Overall Study||0
3372155|NCT03251326|4104032|FG001|STARTED|Overall Study||0
3372156|NCT03251326|4104033|FG002|STARTED|Overall Study||0
3372157|NCT03251326|4104034|FG003|STARTED|Overall Study||0
3372158|NCT03251326|4104031|FG000|COMPLETED|Overall Study||0
3372159|NCT03251326|4104032|FG001|COMPLETED|Overall Study||0
3372160|NCT03251326|4104033|FG002|COMPLETED|Overall Study||0
3372161|NCT03251326|4104034|FG003|COMPLETED|Overall Study||0
3372162|NCT03251326|4104031|FG000|NOT COMPLETED|Overall Study||0
3372163|NCT03251326|4104032|FG001|NOT COMPLETED|Overall Study||0
3372164|NCT03251326|4104033|FG002|NOT COMPLETED|Overall Study||0
3372165|NCT03251326|4104034|FG003|NOT COMPLETED|Overall Study||0
3372166|NCT03219372|4104046|FG000|STARTED|Overall Study||1
3372167|NCT03219372|4104047|FG001|STARTED|Overall Study||0
3372168|NCT03219372|4104046|FG000|COMPLETED|Overall Study||0
3372169|NCT03219372|4104047|FG001|COMPLETED|Overall Study||0
3372170|NCT03219372|4104046|FG000|NOT COMPLETED|Overall Study||1
3372171|NCT03219372|4104047|FG001|NOT COMPLETED|Overall Study||0
3372172|NCT03217175|4104053|FG000|STARTED|Overall Study||4
3372173|NCT03217175|4104054|FG001|STARTED|Overall Study||1
3372174|NCT03217175|4104053|FG000|COMPLETED|Overall Study||0
3372175|NCT03217175|4104054|FG001|COMPLETED|Overall Study||0
3372176|NCT03217175|4104053|FG000|NOT COMPLETED|Overall Study||4
3372177|NCT03217175|4104054|FG001|NOT COMPLETED|Overall Study||1
3372178|NCT03231397|4104064|FG000|STARTED|Overall Study||0
3372179|NCT03231397|4104065|FG001|STARTED|Overall Study||1
3372180|NCT03231397|4104066|FG002|STARTED|Overall Study||1
3372181|NCT03231397|4104067|FG003|STARTED|Overall Study||0
3372182|NCT03231397|4104064|FG000|COMPLETED|Overall Study||0
3372183|NCT03231397|4104065|FG001|COMPLETED|Overall Study||1
3372184|NCT03231397|4104066|FG002|COMPLETED|Overall Study||1
3372185|NCT03231397|4104067|FG003|COMPLETED|Overall Study||0
3372186|NCT03231397|4104064|FG000|NOT COMPLETED|Overall Study||0
3372187|NCT03231397|4104065|FG001|NOT COMPLETED|Overall Study||0
3372188|NCT03231397|4104066|FG002|NOT COMPLETED|Overall Study||0
3372189|NCT03231397|4104067|FG003|NOT COMPLETED|Overall Study||0
3372190|NCT03232892|4104077|FG000|STARTED|Overall Study||1
3372191|NCT03232892|4104077|FG000|COMPLETED|Overall Study||1
3372192|NCT03232892|4104077|FG000|NOT COMPLETED|Overall Study||0
3372193|NCT03223662|4104081|FG000|STARTED|Overall Study||2
3372194|NCT03223662|4104081|FG000|COMPLETED|Overall Study||0
3372195|NCT03223662|4104081|FG000|NOT COMPLETED|Overall Study||2
3372196|NCT03212144|4104087|FG000|STARTED|First Sequence (4 Weeks)||2
3372197|NCT03212144|4104088|FG001|STARTED|First Sequence (4 Weeks)||1
3372198|NCT03212144|4104087|FG000|COMPLETED|First Sequence (4 Weeks)||1
3372199|NCT03212144|4104088|FG001|COMPLETED|First Sequence (4 Weeks)||1
3372200|NCT03212144|4104087|FG000|NOT COMPLETED|First Sequence (4 Weeks)||1
3372201|NCT03212144|4104088|FG001|NOT COMPLETED|First Sequence (4 Weeks)||0
3372202|NCT03212144|4104087|FG000|STARTED|Washout (4 Weeks)||1
3372203|NCT03212144|4104088|FG001|STARTED|Washout (4 Weeks)||1
3372204|NCT03212144|4104087|FG000|COMPLETED|Washout (4 Weeks)||1
3372205|NCT03212144|4104088|FG001|COMPLETED|Washout (4 Weeks)||1
3372206|NCT03212144|4104087|FG000|NOT COMPLETED|Washout (4 Weeks)||0
3372207|NCT03212144|4104088|FG001|NOT COMPLETED|Washout (4 Weeks)||0
3372208|NCT03212144|4104087|FG000|STARTED|Second Sequence (4 Weeks)||1
3372209|NCT03212144|4104088|FG001|STARTED|Second Sequence (4 Weeks)||1
3372210|NCT03212144|4104087|FG000|COMPLETED|Second Sequence (4 Weeks)||0
3372211|NCT03212144|4104088|FG001|COMPLETED|Second Sequence (4 Weeks)||0
3372212|NCT03212144|4104087|FG000|NOT COMPLETED|Second Sequence (4 Weeks)||1
3372213|NCT03212144|4104088|FG001|NOT COMPLETED|Second Sequence (4 Weeks)||1
3372214|NCT03218163|4104094|FG000|STARTED|Overall Study||0
3372215|NCT03218163|4104094|FG000|COMPLETED|Overall Study||0
3372216|NCT03218163|4104094|FG000|NOT COMPLETED|Overall Study||0
3372217|NCT03172520|4104098|FG000|STARTED|Overall Study||10
3372218|NCT03172520|4104098|FG000|COMPLETED|Overall Study||0
3372219|NCT03172520|4104098|FG000|NOT COMPLETED|Overall Study||10
3372220|NCT03204539|4104104|FG000|STARTED|Overall Study||0
3372221|NCT03204539|4104105|FG001|STARTED|Overall Study||1
3372222|NCT03204539|4104104|FG000|COMPLETED|Overall Study||0
3372223|NCT03204539|4104105|FG001|COMPLETED|Overall Study||0
3372224|NCT03204539|4104104|FG000|NOT COMPLETED|Overall Study||0
3254366|NCT02531113|3988322|FG000|STARTED|Induction Period: Week 0 to 12||69
3254367|NCT02531113|3988322|FG000|COMPLETED|Induction Period: Week 0 to 12||58
3254368|NCT02531113|3988322|FG000|NOT COMPLETED|Induction Period: Week 0 to 12||11
3254369|NCT02531113|3988322|FG000|STARTED|Extension Period: Week 12 up to Week 160|6 participants completed induction; did not advance to extension due to lack efficacy.|52
3254370|NCT02531113|3988322|FG000|COMPLETED|Extension Period: Week 12 up to Week 160||14
3254371|NCT02531113|3988322|FG000|NOT COMPLETED|Extension Period: Week 12 up to Week 160||38
3254372|NCT02531321|3988328|FG000|STARTED|Overall Study||7
3254373|NCT02531321|3988329|FG001|STARTED|Overall Study||10
3254374|NCT02531321|3988328|FG000|COMPLETED|Overall Study||5
3254375|NCT02531321|3988329|FG001|COMPLETED|Overall Study||10
3254376|NCT02531321|3988328|FG000|NOT COMPLETED|Overall Study||2
3254377|NCT02531321|3988329|FG001|NOT COMPLETED|Overall Study||0
3254378|NCT02531373|3988344|FG000|STARTED|Overall Study||20
3254379|NCT02531373|3988345|FG001|STARTED|Overall Study||20
3254380|NCT02531373|3988346|FG002|STARTED|Overall Study||20
3254381|NCT02531373|3988347|FG003|STARTED|Overall Study||20
3254382|NCT02531373|3988348|FG004|STARTED|Overall Study||51
3254383|NCT02531373|3988349|FG005|STARTED|Overall Study||51
3254384|NCT02531373|3988350|FG006|STARTED|Overall Study||52
3254385|NCT02531373|3988351|FG007|STARTED|Overall Study||52
3254386|NCT02531373|3988352|FG008|STARTED|Overall Study||52
3254387|NCT02531373|3988344|FG000|Vaccination 1|Overall Study||20
3254388|NCT02531373|3988345|FG001|Vaccination 1|Overall Study||20
3254389|NCT02531373|3988346|FG002|Vaccination 1|Overall Study||20
3254390|NCT02531373|3988347|FG003|Vaccination 1|Overall Study||20
3254391|NCT02531373|3988348|FG004|Vaccination 1|Overall Study||50
3254392|NCT02531373|3988349|FG005|Vaccination 1|Overall Study||50
3254393|NCT02531373|3988350|FG006|Vaccination 1|Overall Study||52
3254394|NCT02531373|3988351|FG007|Vaccination 1|Overall Study||52
3254395|NCT02531373|3988352|FG008|Vaccination 1|Overall Study||52
3254396|NCT02531373|3988344|FG000|Vaccination 2|Overall Study||0
3254397|NCT02531373|3988345|FG001|Vaccination 2|Overall Study||0
3254398|NCT02531373|3988346|FG002|Vaccination 2|Overall Study||0
3254399|NCT02531373|3988347|FG003|Vaccination 2|Overall Study||0
3254400|NCT02531373|3988348|FG004|Vaccination 2|Overall Study||49
3254401|NCT02531373|3988349|FG005|Vaccination 2|Overall Study||48
3254402|NCT02531373|3988350|FG006|Vaccination 2|Overall Study||50
3254403|NCT02531373|3988351|FG007|Vaccination 2|Overall Study||51
3254404|NCT02531373|3988352|FG008|Vaccination 2|Overall Study||51
3254405|NCT02531373|3988344|FG000|Vaccination 3|Overall Study||0
3254406|NCT02531373|3988345|FG001|Vaccination 3|Overall Study||0
3254407|NCT02531373|3988346|FG002|Vaccination 3|Overall Study||0
3254408|NCT02531373|3988347|FG003|Vaccination 3|Overall Study||0
3254409|NCT02531373|3988348|FG004|Vaccination 3|Overall Study||48
3254410|NCT02531373|3988349|FG005|Vaccination 3|Overall Study||47
3254411|NCT02531373|3988350|FG006|Vaccination 3|Overall Study||49
3254412|NCT02531373|3988351|FG007|Vaccination 3|Overall Study||51
3254413|NCT02531373|3988352|FG008|Vaccination 3|Overall Study||49
3254414|NCT02531373|3988344|FG000|Vaccination 4|Overall Study||0
3254415|NCT02531373|3988345|FG001|Vaccination 4|Overall Study||0
3254416|NCT02531373|3988346|FG002|Vaccination 4|Overall Study||0
3254417|NCT02531373|3988347|FG003|Vaccination 4|Overall Study||0
3254418|NCT02531373|3988348|FG004|Vaccination 4|Overall Study||44
3254419|NCT02531373|3988349|FG005|Vaccination 4|Overall Study||43
3254420|NCT02531373|3988350|FG006|Vaccination 4|Overall Study||43
3254421|NCT02531373|3988351|FG007|Vaccination 4|Overall Study||43
3254422|NCT02531373|3988352|FG008|Vaccination 4|Overall Study||43
3254423|NCT02531373|3988344|FG000|COMPLETED|Overall Study||20
3254424|NCT02531373|3988345|FG001|COMPLETED|Overall Study||20
3254425|NCT02531373|3988346|FG002|COMPLETED|Overall Study||20
3254426|NCT02531373|3988347|FG003|COMPLETED|Overall Study||20
3254427|NCT02531373|3988348|FG004|COMPLETED|Overall Study||43
3254428|NCT02531373|3988349|FG005|COMPLETED|Overall Study||42
3254429|NCT02531373|3988350|FG006|COMPLETED|Overall Study||41
3254430|NCT02531373|3988351|FG007|COMPLETED|Overall Study||43
3254431|NCT02531373|3988352|FG008|COMPLETED|Overall Study||43
3254432|NCT02531373|3988344|FG000|NOT COMPLETED|Overall Study||0
3254433|NCT02531373|3988345|FG001|NOT COMPLETED|Overall Study||0
3254434|NCT02531373|3988346|FG002|NOT COMPLETED|Overall Study||0
3254435|NCT02531373|3988347|FG003|NOT COMPLETED|Overall Study||0
3254436|NCT02531373|3988348|FG004|NOT COMPLETED|Overall Study||8
3254437|NCT02531373|3988349|FG005|NOT COMPLETED|Overall Study||9
3254438|NCT02531373|3988350|FG006|NOT COMPLETED|Overall Study||11
3254439|NCT02531373|3988351|FG007|NOT COMPLETED|Overall Study||9
3254440|NCT02531373|3988352|FG008|NOT COMPLETED|Overall Study||9
3254441|NCT02531438|3988375|FG000|STARTED|Overall Study||386
3254442|NCT02531438|3988376|FG001|STARTED|Overall Study||388
3254443|NCT02531438|3988375|FG000|COMPLETED|Overall Study||356
3254444|NCT02531438|3988376|FG001|COMPLETED|Overall Study||362
3254445|NCT02531438|3988375|FG000|NOT COMPLETED|Overall Study||30
3254446|NCT02531438|3988376|FG001|NOT COMPLETED|Overall Study||26
3254447|NCT02531633|3988387|FG000|STARTED|Part A (52 Weeks)||42
3254448|NCT02531633|3988388|FG001|STARTED|Part A (52 Weeks)||39
3254449|NCT02531633|3988389|FG002|STARTED|Part A (52 Weeks)||26
3254450|NCT02531633|3988390|FG003|STARTED|Part A (52 Weeks)||27
3254451|NCT02531633|3988391|FG004|STARTED|Part A (52 Weeks)||27
3254452|NCT02531633|3988392|FG005|STARTED|Part A (52 Weeks)||0
3254453|NCT02531633|3988393|FG006|STARTED|Part A (52 Weeks)||0
3254454|NCT02531633|3988394|FG007|STARTED|Part A (52 Weeks)||0
3254455|NCT02531633|3988395|FG008|STARTED|Part A (52 Weeks)||0
3254456|NCT02531633|3988396|FG009|STARTED|Part A (52 Weeks)||0
3254457|NCT02531633|3988387|FG000|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||1
3254458|NCT02531633|3988388|FG001|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||0
3254459|NCT02531633|3988389|FG002|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||1
3254460|NCT02531633|3988390|FG003|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||0
3254461|NCT02531633|3988391|FG004|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||0
3254462|NCT02531633|3988392|FG005|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||0
3254463|NCT02531633|3988393|FG006|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||0
3254464|NCT02531633|3988394|FG007|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||0
3254465|NCT02531633|3988395|FG008|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||0
3254466|NCT02531633|3988396|FG009|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||0
3254467|NCT02531633|3988387|FG000|COMPLETED|Part A (52 Weeks)||8
3254468|NCT02531633|3988388|FG001|COMPLETED|Part A (52 Weeks)||5
3254469|NCT02531633|3988389|FG002|COMPLETED|Part A (52 Weeks)||4
3254470|NCT02531633|3988390|FG003|COMPLETED|Part A (52 Weeks)||5
3254471|NCT02531633|3988391|FG004|COMPLETED|Part A (52 Weeks)||4
3254472|NCT02531633|3988392|FG005|COMPLETED|Part A (52 Weeks)||0
3254473|NCT02531633|3988393|FG006|COMPLETED|Part A (52 Weeks)||0
3254474|NCT02531633|3988394|FG007|COMPLETED|Part A (52 Weeks)||0
3254475|NCT02531633|3988395|FG008|COMPLETED|Part A (52 Weeks)||0
3254476|NCT02531633|3988396|FG009|COMPLETED|Part A (52 Weeks)||0
3254477|NCT02531633|3988387|FG000|NOT COMPLETED|Part A (52 Weeks)||34
3254478|NCT02531633|3988388|FG001|NOT COMPLETED|Part A (52 Weeks)||34
3254479|NCT02531633|3988389|FG002|NOT COMPLETED|Part A (52 Weeks)||22
3254480|NCT02531633|3988390|FG003|NOT COMPLETED|Part A (52 Weeks)||22
3254481|NCT02531633|3988391|FG004|NOT COMPLETED|Part A (52 Weeks)||23
3254482|NCT02531633|3988392|FG005|NOT COMPLETED|Part A (52 Weeks)||0
3254483|NCT02531633|3988393|FG006|NOT COMPLETED|Part A (52 Weeks)||0
3254484|NCT02531633|3988394|FG007|NOT COMPLETED|Part A (52 Weeks)||0
3254485|NCT02531633|3988395|FG008|NOT COMPLETED|Part A (52 Weeks)||0
3254486|NCT02531633|3988396|FG009|NOT COMPLETED|Part A (52 Weeks)||0
3254487|NCT02531633|3988387|FG000|STARTED|Part B (104 Weeks)||0
3254488|NCT02531633|3988388|FG001|STARTED|Part B (104 Weeks)||0
3254489|NCT02531633|3988389|FG002|STARTED|Part B (104 Weeks)||0
3254490|NCT02531633|3988390|FG003|STARTED|Part B (104 Weeks)||0
3254491|NCT02531633|3988391|FG004|STARTED|Part B (104 Weeks)||0
3254492|NCT02531633|3988392|FG005|STARTED|Part B (104 Weeks)||8
3254493|NCT02531633|3988393|FG006|STARTED|Part B (104 Weeks)||5
3254494|NCT02531633|3988394|FG007|STARTED|Part B (104 Weeks)||4
3254495|NCT02531633|3988395|FG008|STARTED|Part B (104 Weeks)||5
3254496|NCT02531633|3988396|FG009|STARTED|Part B (104 Weeks)||4
3254497|NCT02531633|3988387|FG000|COMPLETED|Part B (104 Weeks)||0
3254498|NCT02531633|3988388|FG001|COMPLETED|Part B (104 Weeks)||0
3254499|NCT02531633|3988389|FG002|COMPLETED|Part B (104 Weeks)||0
3254500|NCT02531633|3988390|FG003|COMPLETED|Part B (104 Weeks)||0
3254501|NCT02531633|3988391|FG004|COMPLETED|Part B (104 Weeks)||0
3254502|NCT02531633|3988392|FG005|COMPLETED|Part B (104 Weeks)||0
3254503|NCT02531633|3988393|FG006|COMPLETED|Part B (104 Weeks)||0
3254504|NCT02531633|3988394|FG007|COMPLETED|Part B (104 Weeks)||0
3254505|NCT02531633|3988395|FG008|COMPLETED|Part B (104 Weeks)||0
3254506|NCT02531633|3988396|FG009|COMPLETED|Part B (104 Weeks)||0
3254507|NCT02531633|3988387|FG000|NOT COMPLETED|Part B (104 Weeks)||0
3254508|NCT02531633|3988388|FG001|NOT COMPLETED|Part B (104 Weeks)||0
3254509|NCT02531633|3988389|FG002|NOT COMPLETED|Part B (104 Weeks)||0
3254510|NCT02531633|3988390|FG003|NOT COMPLETED|Part B (104 Weeks)||0
3254511|NCT02531633|3988391|FG004|NOT COMPLETED|Part B (104 Weeks)||0
3254512|NCT02531633|3988392|FG005|NOT COMPLETED|Part B (104 Weeks)||8
3254513|NCT02531633|3988393|FG006|NOT COMPLETED|Part B (104 Weeks)||5
3254514|NCT02531633|3988394|FG007|NOT COMPLETED|Part B (104 Weeks)||4
3254515|NCT02531633|3988395|FG008|NOT COMPLETED|Part B (104 Weeks)||5
3254516|NCT02531633|3988396|FG009|NOT COMPLETED|Part B (104 Weeks)||4
3254517|NCT02531646|3988439|FG000|STARTED|Overall Study||37
3254518|NCT02531646|3988440|FG001|STARTED|Overall Study||18
3254519|NCT02531646|3988441|FG002|STARTED|Overall Study||11
3254520|NCT02531646|3988439|FG000|COMPLETED|Overall Study||32
3254521|NCT02531646|3988440|FG001|COMPLETED|Overall Study||17
3254522|NCT02531646|3988441|FG002|COMPLETED|Overall Study||11
3254523|NCT02531646|3988439|FG000|NOT COMPLETED|Overall Study||5
3254524|NCT02531646|3988440|FG001|NOT COMPLETED|Overall Study||1
3254525|NCT02531646|3988441|FG002|NOT COMPLETED|Overall Study||0
3254526|NCT02531698|3988451|FG000|STARTED|Overall Study||294
3254527|NCT02531698|3988452|FG001|STARTED|Overall Study||106
3254528|NCT02531698|3988451|FG000|COMPLETED|Overall Study||283
3254529|NCT02531698|3988452|FG001|COMPLETED|Overall Study||104
3254530|NCT02531698|3988451|FG000|NOT COMPLETED|Overall Study||11
3254531|NCT02531698|3988452|FG001|NOT COMPLETED|Overall Study||2
3254532|NCT02531802|3988488|FG000|STARTED|Received Vaccination 1||15
3254533|NCT02531802|3988489|FG001|STARTED|Received Vaccination 1||15
3254534|NCT02531802|3988490|FG002|STARTED|Received Vaccination 1||15
3254535|NCT02531802|3988491|FG003|STARTED|Received Vaccination 1||15
3254536|NCT02531802|3988492|FG004|STARTED|Received Vaccination 1||15
3254537|NCT02531802|3988493|FG005|STARTED|Received Vaccination 1||3
3254538|NCT02531802|3988494|FG006|STARTED|Received Vaccination 1||15
3254539|NCT02531802|3988495|FG007|STARTED|Received Vaccination 1||15
3254540|NCT02531802|3988496|FG008|STARTED|Received Vaccination 1||15
3254541|NCT02531802|3988497|FG009|STARTED|Received Vaccination 1||52
3254542|NCT02531802|3988498|FG010|STARTED|Received Vaccination 1||15
3254543|NCT02531802|3988499|FG011|STARTED|Received Vaccination 1||15
3254544|NCT02531802|3988500|FG012|STARTED|Received Vaccination 1||15
3254545|NCT02531802|3988501|FG013|STARTED|Received Vaccination 1||15
3254546|NCT02531802|3988502|FG014|STARTED|Received Vaccination 1||40
3254547|NCT02531802|3988503|FG015|STARTED|Received Vaccination 1||30
3254548|NCT02531802|3988504|FG016|STARTED|Received Vaccination 1||30
3254549|NCT02531802|3988505|FG017|STARTED|Received Vaccination 1||30
3254550|NCT02531802|3988506|FG018|STARTED|Received Vaccination 1||30
3254551|NCT02531802|3988507|FG019|STARTED|Received Vaccination 1||30
3254552|NCT02531802|3988508|FG020|STARTED|Received Vaccination 1||50
3254553|NCT02531802|3988488|FG000|COMPLETED|Received Vaccination 1||15
3254554|NCT02531802|3988489|FG001|COMPLETED|Received Vaccination 1||15
3254555|NCT02531802|3988490|FG002|COMPLETED|Received Vaccination 1||15
3254556|NCT02531802|3988491|FG003|COMPLETED|Received Vaccination 1||15
3254557|NCT02531802|3988492|FG004|COMPLETED|Received Vaccination 1||15
3254558|NCT02531802|3988493|FG005|COMPLETED|Received Vaccination 1||3
3254559|NCT02531802|3988494|FG006|COMPLETED|Received Vaccination 1||15
3254560|NCT02531802|3988495|FG007|COMPLETED|Received Vaccination 1||15
3254561|NCT02531802|3988496|FG008|COMPLETED|Received Vaccination 1||15
3254562|NCT02531802|3988497|FG009|COMPLETED|Received Vaccination 1||52
3254563|NCT02531802|3988498|FG010|COMPLETED|Received Vaccination 1||15
3254564|NCT02531802|3988499|FG011|COMPLETED|Received Vaccination 1||15
3254565|NCT02531802|3988500|FG012|COMPLETED|Received Vaccination 1||15
3254566|NCT02531802|3988501|FG013|COMPLETED|Received Vaccination 1||15
3254567|NCT02531802|3988502|FG014|COMPLETED|Received Vaccination 1||40
3254568|NCT02531802|3988503|FG015|COMPLETED|Received Vaccination 1||30
3254569|NCT02531802|3988504|FG016|COMPLETED|Received Vaccination 1||30
3254570|NCT02531802|3988505|FG017|COMPLETED|Received Vaccination 1||30
3254571|NCT02531802|3988506|FG018|COMPLETED|Received Vaccination 1||30
3254572|NCT02531802|3988507|FG019|COMPLETED|Received Vaccination 1||30
3254573|NCT02531802|3988508|FG020|COMPLETED|Received Vaccination 1||50
3254574|NCT02531802|3988488|FG000|NOT COMPLETED|Received Vaccination 1||0
3254575|NCT02531802|3988489|FG001|NOT COMPLETED|Received Vaccination 1||0
3254576|NCT02531802|3988490|FG002|NOT COMPLETED|Received Vaccination 1||0
3254577|NCT02531802|3988491|FG003|NOT COMPLETED|Received Vaccination 1||0
3254578|NCT02531802|3988492|FG004|NOT COMPLETED|Received Vaccination 1||0
3254579|NCT02531802|3988493|FG005|NOT COMPLETED|Received Vaccination 1||0
3254580|NCT02531802|3988494|FG006|NOT COMPLETED|Received Vaccination 1||0
3254581|NCT02531802|3988495|FG007|NOT COMPLETED|Received Vaccination 1||0
3254582|NCT02531802|3988496|FG008|NOT COMPLETED|Received Vaccination 1||0
3254583|NCT02531802|3988497|FG009|NOT COMPLETED|Received Vaccination 1||0
3254584|NCT02531802|3988498|FG010|NOT COMPLETED|Received Vaccination 1||0
3254585|NCT02531802|3988499|FG011|NOT COMPLETED|Received Vaccination 1||0
3254586|NCT02531802|3988500|FG012|NOT COMPLETED|Received Vaccination 1||0
3254587|NCT02531802|3988501|FG013|NOT COMPLETED|Received Vaccination 1||0
3254588|NCT02531802|3988502|FG014|NOT COMPLETED|Received Vaccination 1||0
3254589|NCT02531802|3988503|FG015|NOT COMPLETED|Received Vaccination 1||0
3254590|NCT02531802|3988504|FG016|NOT COMPLETED|Received Vaccination 1||0
3254591|NCT02531802|3988505|FG017|NOT COMPLETED|Received Vaccination 1||0
3254592|NCT02531802|3988506|FG018|NOT COMPLETED|Received Vaccination 1||0
3254593|NCT02531802|3988507|FG019|NOT COMPLETED|Received Vaccination 1||0
3254594|NCT02531802|3988508|FG020|NOT COMPLETED|Received Vaccination 1||0
3254595|NCT02531802|3988488|FG000|STARTED|Received Vaccination 2||15
3254596|NCT02531802|3988489|FG001|STARTED|Received Vaccination 2||15
3254597|NCT02531802|3988490|FG002|STARTED|Received Vaccination 2||15
3254598|NCT02531802|3988491|FG003|STARTED|Received Vaccination 2||15
3254599|NCT02531802|3988492|FG004|STARTED|Received Vaccination 2||15
3254600|NCT02531802|3988493|FG005|STARTED|Received Vaccination 2||3
3254601|NCT02531802|3988494|FG006|STARTED|Received Vaccination 2||15
3254602|NCT02531802|3988495|FG007|STARTED|Received Vaccination 2||15
3254603|NCT02531802|3988496|FG008|STARTED|Received Vaccination 2||15
3254604|NCT02531802|3988497|FG009|STARTED|Received Vaccination 2||52
3254605|NCT02531802|3988498|FG010|STARTED|Received Vaccination 2||15
3254606|NCT02531802|3988499|FG011|STARTED|Received Vaccination 2||15
3254607|NCT02531802|3988500|FG012|STARTED|Received Vaccination 2||15
3254608|NCT02531802|3988501|FG013|STARTED|Received Vaccination 2||15
3254609|NCT02531802|3988502|FG014|STARTED|Received Vaccination 2||40
3254610|NCT02531802|3988503|FG015|STARTED|Received Vaccination 2||30
3254611|NCT02531802|3988504|FG016|STARTED|Received Vaccination 2||30
3254612|NCT02531802|3988505|FG017|STARTED|Received Vaccination 2||30
3254613|NCT02531802|3988506|FG018|STARTED|Received Vaccination 2||30
3254614|NCT02531802|3988507|FG019|STARTED|Received Vaccination 2||30
3254615|NCT02531802|3988508|FG020|STARTED|Received Vaccination 2||50
3254616|NCT02531802|3988488|FG000|COMPLETED|Received Vaccination 2||15
3254617|NCT02531802|3988489|FG001|COMPLETED|Received Vaccination 2||15
3254618|NCT02531802|3988490|FG002|COMPLETED|Received Vaccination 2||14
3254619|NCT02531802|3988491|FG003|COMPLETED|Received Vaccination 2||15
3254620|NCT02531802|3988492|FG004|COMPLETED|Received Vaccination 2||15
3254621|NCT02531802|3988493|FG005|COMPLETED|Received Vaccination 2||0
3254622|NCT02531802|3988494|FG006|COMPLETED|Received Vaccination 2||15
3254623|NCT02531802|3988495|FG007|COMPLETED|Received Vaccination 2||15
3254624|NCT02531802|3988496|FG008|COMPLETED|Received Vaccination 2||15
3254625|NCT02531802|3988497|FG009|COMPLETED|Received Vaccination 2||49
3254626|NCT02531802|3988498|FG010|COMPLETED|Received Vaccination 2||13
3254627|NCT02531802|3988499|FG011|COMPLETED|Received Vaccination 2||15
3254628|NCT02531802|3988500|FG012|COMPLETED|Received Vaccination 2||13
3254629|NCT02531802|3988501|FG013|COMPLETED|Received Vaccination 2||13
3254630|NCT02531802|3988502|FG014|COMPLETED|Received Vaccination 2||39
3254631|NCT02531802|3988503|FG015|COMPLETED|Received Vaccination 2||30
3254632|NCT02531802|3988504|FG016|COMPLETED|Received Vaccination 2||30
3254633|NCT02531802|3988505|FG017|COMPLETED|Received Vaccination 2||26
3254634|NCT02531802|3988506|FG018|COMPLETED|Received Vaccination 2||27
3254635|NCT02531802|3988507|FG019|COMPLETED|Received Vaccination 2||29
3254636|NCT02531802|3988508|FG020|COMPLETED|Received Vaccination 2||49
3254637|NCT02531802|3988488|FG000|NOT COMPLETED|Received Vaccination 2||0
3254638|NCT02531802|3988489|FG001|NOT COMPLETED|Received Vaccination 2||0
3254639|NCT02531802|3988490|FG002|NOT COMPLETED|Received Vaccination 2||1
3254640|NCT02531802|3988491|FG003|NOT COMPLETED|Received Vaccination 2||0
3254641|NCT02531802|3988492|FG004|NOT COMPLETED|Received Vaccination 2||0
3254642|NCT02531802|3988493|FG005|NOT COMPLETED|Received Vaccination 2||3
3254643|NCT02531802|3988494|FG006|NOT COMPLETED|Received Vaccination 2||0
3254644|NCT02531802|3988495|FG007|NOT COMPLETED|Received Vaccination 2||0
3254645|NCT02531802|3988496|FG008|NOT COMPLETED|Received Vaccination 2||0
3254646|NCT02531802|3988497|FG009|NOT COMPLETED|Received Vaccination 2||3
3254647|NCT02531802|3988498|FG010|NOT COMPLETED|Received Vaccination 2||2
3254648|NCT02531802|3988499|FG011|NOT COMPLETED|Received Vaccination 2||0
3254649|NCT02531802|3988500|FG012|NOT COMPLETED|Received Vaccination 2||2
3254650|NCT02531802|3988501|FG013|NOT COMPLETED|Received Vaccination 2||2
3254651|NCT02531802|3988502|FG014|NOT COMPLETED|Received Vaccination 2||1
3254652|NCT02531802|3988503|FG015|NOT COMPLETED|Received Vaccination 2||0
3254653|NCT02531802|3988504|FG016|NOT COMPLETED|Received Vaccination 2||0
3254654|NCT02531802|3988505|FG017|NOT COMPLETED|Received Vaccination 2||4
3254655|NCT02531802|3988506|FG018|NOT COMPLETED|Received Vaccination 2||3
3254656|NCT02531802|3988507|FG019|NOT COMPLETED|Received Vaccination 2||1
3254657|NCT02531802|3988508|FG020|NOT COMPLETED|Received Vaccination 2||1
3254658|NCT02531867|3988581|FG000|STARTED|Overall Study||13
3254659|NCT02531867|3988581|FG000|COMPLETED|Overall Study||13
3254660|NCT02531867|3988581|FG000|NOT COMPLETED|Overall Study||0
3254661|NCT02531971|3988587|FG000|STARTED|Overall Study||11
3254662|NCT02531971|3988588|FG001|STARTED|Overall Study||13
3254663|NCT02531971|3988587|FG000|COMPLETED|Overall Study||11
3254664|NCT02531971|3988588|FG001|COMPLETED|Overall Study||13
3254665|NCT02531971|3988587|FG000|NOT COMPLETED|Overall Study||0
3254666|NCT02531971|3988588|FG001|NOT COMPLETED|Overall Study||0
3254667|NCT02532010|3988597|FG000|STARTED|Overall Study||9
3254668|NCT02532010|3988598|FG001|STARTED|Overall Study||4
3254669|NCT02532010|3988597|FG000|COMPLETED|Overall Study||0
3254670|NCT02532010|3988598|FG001|COMPLETED|Overall Study||0
3254671|NCT02532010|3988597|FG000|NOT COMPLETED|Overall Study||9
3254672|NCT02532010|3988598|FG001|NOT COMPLETED|Overall Study||4
3254673|NCT02532036|3988604|FG000|STARTED|Overall Study||2
3254674|NCT02532036|3988605|FG001|STARTED|Overall Study||0
3254675|NCT02532036|3988604|FG000|COMPLETED|Overall Study||2
3254676|NCT02532036|3988605|FG001|COMPLETED|Overall Study||0
3254677|NCT02532036|3988604|FG000|NOT COMPLETED|Overall Study||0
3254678|NCT02532036|3988605|FG001|NOT COMPLETED|Overall Study||0
3254679|NCT02532179|3988609|FG000|STARTED|Overall Study||12
3254680|NCT02532179|3988609|FG000|COMPLETED|Overall Study||9
3254681|NCT02532179|3988609|FG000|NOT COMPLETED|Overall Study||3
3254682|NCT02532283|3988615|FG000|STARTED|Overall Study||64
3254683|NCT02532283|3988616|FG001|STARTED|Overall Study||35
3254684|NCT02532283|3988615|FG000|Full Analysis Set|Overall Study||63
3254685|NCT02532283|3988616|FG001|Full Analysis Set|Overall Study||32
3254686|NCT02532283|3988615|FG000|COMPLETED|Overall Study||55
3254687|NCT02532283|3988616|FG001|COMPLETED|Overall Study||30
3254688|NCT02532283|3988615|FG000|NOT COMPLETED|Overall Study||9
3254689|NCT02532283|3988616|FG001|NOT COMPLETED|Overall Study||5
3254690|NCT02532374|3988624|FG000|STARTED|Overall Study||16
3254691|NCT02532374|3988624|FG000|Nicorette Inhalator (Visit 3)|Overall Study||15
3254692|NCT02532374|3988624|FG000|P3L 50 μg/Puff (Visit 4)|Overall Study||15
3254693|NCT02532374|3988624|FG000|P3L 80 μg/Puff (Visit 5)|Overall Study||14
3254694|NCT02532374|3988624|FG000|P3L150 μg/Puff (Visit 6)|Overall Study||14
3254695|NCT02532374|3988624|FG000|COMPLETED|Overall Study||14
3254696|NCT02532374|3988624|FG000|NOT COMPLETED|Overall Study||2
3254697|NCT02532465|3988638|FG000|STARTED|Overall Study||25
3254698|NCT02532465|3988639|FG001|STARTED|Overall Study||25
3254699|NCT02532465|3988638|FG000|COMPLETED|Overall Study||24
3254700|NCT02532465|3988639|FG001|COMPLETED|Overall Study||24
3254701|NCT02532465|3988638|FG000|NOT COMPLETED|Overall Study||1
3372225|NCT03204539|4104105|FG001|NOT COMPLETED|Overall Study||1
3372226|NCT03206216|4104113|FG000|STARTED|Overall Study||0
3372227|NCT03206216|4104114|FG001|STARTED|Overall Study||1
3372228|NCT03206216|4104113|FG000|COMPLETED|Overall Study||0
3254702|NCT02532465|3988639|FG001|NOT COMPLETED|Overall Study||1
3254703|NCT02532517|3988645|FG000|STARTED|Overall Study||45
3254704|NCT02532517|3988645|FG000|mITT Analysis Set|Overall Study||44
3254705|NCT02532517|3988645|FG000|COMPLETED|Overall Study||28
3254706|NCT02532517|3988645|FG000|NOT COMPLETED|Overall Study||17
3254707|NCT02532543|3988653|FG000|STARTED|Overall Study||3
3254708|NCT02532543|3988654|FG001|STARTED|Overall Study||4
3254709|NCT02532543|3988655|FG002|STARTED|Overall Study||5
3254710|NCT02532543|3988656|FG003|STARTED|Overall Study||4
3254711|NCT02532543|3988653|FG000|COMPLETED|Overall Study||3
3254712|NCT02532543|3988654|FG001|COMPLETED|Overall Study||4
3254713|NCT02532543|3988655|FG002|COMPLETED|Overall Study||4
3254714|NCT02532543|3988656|FG003|COMPLETED|Overall Study||4
3254715|NCT02532543|3988653|FG000|NOT COMPLETED|Overall Study||0
3254716|NCT02532543|3988654|FG001|NOT COMPLETED|Overall Study||0
3254717|NCT02532543|3988655|FG002|NOT COMPLETED|Overall Study||1
3254718|NCT02532543|3988656|FG003|NOT COMPLETED|Overall Study||0
3254719|NCT02532556|3988666|FG000|STARTED|Overall Study||12
3254720|NCT02532556|3988666|FG000|COMPLETED|Overall Study||12
3254721|NCT02532556|3988666|FG000|NOT COMPLETED|Overall Study||0
3254722|NCT02532647|3988679|FG000|STARTED|Overall Study||32
3254723|NCT02532647|3988680|FG001|STARTED|Overall Study||16
3254724|NCT02532647|3988681|FG002|STARTED|Overall Study||31
3254725|NCT02532647|3988679|FG000|Safety Population|Overall Study||31
3254726|NCT02532647|3988680|FG001|Safety Population|Overall Study||16
3254727|NCT02532647|3988681|FG002|Safety Population|Overall Study||30
3254728|NCT02532647|3988679|FG000|COMPLETED|Overall Study||31
3254729|NCT02532647|3988680|FG001|COMPLETED|Overall Study||16
3254730|NCT02532647|3988681|FG002|COMPLETED|Overall Study||30
3254731|NCT02532647|3988679|FG000|NOT COMPLETED|Overall Study||1
3254732|NCT02532647|3988680|FG001|NOT COMPLETED|Overall Study||0
3254733|NCT02532647|3988681|FG002|NOT COMPLETED|Overall Study||1
3254734|NCT02532764|3988699|FG000|STARTED|Single Ascending Dose (SAD) Cohorts||6
3254735|NCT02532764|3988700|FG001|STARTED|Single Ascending Dose (SAD) Cohorts||6
3254736|NCT02532764|3988701|FG002|STARTED|Single Ascending Dose (SAD) Cohorts||9
3254737|NCT02532764|3988702|FG003|STARTED|Single Ascending Dose (SAD) Cohorts||6
3254738|NCT02532764|3988703|FG004|STARTED|Single Ascending Dose (SAD) Cohorts||9
3254739|NCT02532764|3988704|FG005|STARTED|Single Ascending Dose (SAD) Cohorts||0
3254740|NCT02532764|3988705|FG006|STARTED|Single Ascending Dose (SAD) Cohorts||0
3254741|NCT02532764|3988706|FG007|STARTED|Single Ascending Dose (SAD) Cohorts||0
3254742|NCT02532764|3988707|FG008|STARTED|Single Ascending Dose (SAD) Cohorts||0
3254743|NCT02532764|3988708|FG009|STARTED|Single Ascending Dose (SAD) Cohorts||0
3254744|NCT02532764|3988699|FG000|COMPLETED|Single Ascending Dose (SAD) Cohorts||6
3254745|NCT02532764|3988700|FG001|COMPLETED|Single Ascending Dose (SAD) Cohorts||6
3254746|NCT02532764|3988701|FG002|COMPLETED|Single Ascending Dose (SAD) Cohorts||9
3254747|NCT02532764|3988702|FG003|COMPLETED|Single Ascending Dose (SAD) Cohorts||6
3254748|NCT02532764|3988703|FG004|COMPLETED|Single Ascending Dose (SAD) Cohorts||9
3254749|NCT02532764|3988704|FG005|COMPLETED|Single Ascending Dose (SAD) Cohorts||0
3254750|NCT02532764|3988705|FG006|COMPLETED|Single Ascending Dose (SAD) Cohorts||0
3254751|NCT02532764|3988706|FG007|COMPLETED|Single Ascending Dose (SAD) Cohorts||0
3254752|NCT02532764|3988707|FG008|COMPLETED|Single Ascending Dose (SAD) Cohorts||0
3254753|NCT02532764|3988708|FG009|COMPLETED|Single Ascending Dose (SAD) Cohorts||0
3254754|NCT02532764|3988699|FG000|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
3254755|NCT02532764|3988700|FG001|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
3254756|NCT02532764|3988701|FG002|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
3254757|NCT02532764|3988702|FG003|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
3254758|NCT02532764|3988703|FG004|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
3254759|NCT02532764|3988704|FG005|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
3254760|NCT02532764|3988705|FG006|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
3254761|NCT02532764|3988706|FG007|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
3254762|NCT02532764|3988707|FG008|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
3254763|NCT02532764|3988708|FG009|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
3254764|NCT02532764|3988699|FG000|STARTED|Multiple Ascending Dose (MAD) Cohorst||0
3254765|NCT02532764|3988700|FG001|STARTED|Multiple Ascending Dose (MAD) Cohorst||0
3254766|NCT02532764|3988701|FG002|STARTED|Multiple Ascending Dose (MAD) Cohorst||0
3254767|NCT02532764|3988702|FG003|STARTED|Multiple Ascending Dose (MAD) Cohorst||0
3254768|NCT02532764|3988703|FG004|STARTED|Multiple Ascending Dose (MAD) Cohorst||0
3254769|NCT02532764|3988704|FG005|STARTED|Multiple Ascending Dose (MAD) Cohorst||6
3254770|NCT02532764|3988705|FG006|STARTED|Multiple Ascending Dose (MAD) Cohorst||6
3254771|NCT02532764|3988706|FG007|STARTED|Multiple Ascending Dose (MAD) Cohorst||7
3254772|NCT02532764|3988707|FG008|STARTED|Multiple Ascending Dose (MAD) Cohorst||6
3254773|NCT02532764|3988708|FG009|STARTED|Multiple Ascending Dose (MAD) Cohorst||9
3254774|NCT02532764|3988699|FG000|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
3254775|NCT02532764|3988700|FG001|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
3254776|NCT02532764|3988701|FG002|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
3254777|NCT02532764|3988702|FG003|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
3254778|NCT02532764|3988703|FG004|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
3254779|NCT02532764|3988704|FG005|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||6
3254780|NCT02532764|3988705|FG006|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||6
3254781|NCT02532764|3988706|FG007|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||6
3254782|NCT02532764|3988707|FG008|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||5
3254783|NCT02532764|3988708|FG009|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||8
3254784|NCT02532764|3988699|FG000|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
3254785|NCT02532764|3988700|FG001|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
3254786|NCT02532764|3988701|FG002|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
3254787|NCT02532764|3988702|FG003|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
3254788|NCT02532764|3988703|FG004|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
3254789|NCT02532764|3988704|FG005|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
3254790|NCT02532764|3988705|FG006|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
3254791|NCT02532764|3988706|FG007|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||1
3254792|NCT02532764|3988707|FG008|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||1
3254793|NCT02532764|3988708|FG009|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||1
3254794|NCT02532855|3988737|FG000|STARTED|Overall Study||307
3254795|NCT02532855|3988738|FG001|STARTED|Overall Study||307
3254796|NCT02532855|3988737|FG000|Treated|Overall Study||307
3254797|NCT02532855|3988738|FG001|Treated|Overall Study|One participant had a protocol violation, was randomized but did not take study medication.|306
3254798|NCT02532855|3988737|FG000|COMPLETED|Overall Study||299
3254799|NCT02532855|3988738|FG001|COMPLETED|Overall Study||296
3254800|NCT02532855|3988737|FG000|NOT COMPLETED|Overall Study||8
3254801|NCT02532855|3988738|FG001|NOT COMPLETED|Overall Study||11
3254802|NCT02532933|3988746|FG000|STARTED|Overall Study||22
3254803|NCT02532933|3988747|FG001|STARTED|Overall Study||22
3254804|NCT02532933|3988746|FG000|COMPLETED|Overall Study||16
3254805|NCT02532933|3988747|FG001|COMPLETED|Overall Study||16
3254806|NCT02532933|3988746|FG000|NOT COMPLETED|Overall Study||6
3254807|NCT02532933|3988747|FG001|NOT COMPLETED|Overall Study||6
3254808|NCT02532972|3988753|FG000|STARTED|Overall Study||11
3254809|NCT02532972|3988753|FG000|COMPLETED|Overall Study||10
3254810|NCT02532972|3988753|FG000|NOT COMPLETED|Overall Study||1
3254811|NCT02532998|3988757|FG000|STARTED|Overall Study||23
3254812|NCT02532998|3988757|FG000|COMPLETED|Overall Study||23
3254813|NCT02532998|3988757|FG000|NOT COMPLETED|Overall Study||0
3254814|NCT02533063|3988773|FG000|STARTED|Intervention 1 (8 Weeks)||16
3254815|NCT02533063|3988774|FG001|STARTED|Intervention 1 (8 Weeks)||16
3254816|NCT02533063|3988773|FG000|COMPLETED|Intervention 1 (8 Weeks)||14
3254817|NCT02533063|3988774|FG001|COMPLETED|Intervention 1 (8 Weeks)||11
3254818|NCT02533063|3988773|FG000|NOT COMPLETED|Intervention 1 (8 Weeks)||2
3254819|NCT02533063|3988774|FG001|NOT COMPLETED|Intervention 1 (8 Weeks)||5
3254820|NCT02533063|3988773|FG000|STARTED|Washout (4 Weeks)||14
3254821|NCT02533063|3988774|FG001|STARTED|Washout (4 Weeks)||11
3254822|NCT02533063|3988773|FG000|COMPLETED|Washout (4 Weeks)||14
3254823|NCT02533063|3988774|FG001|COMPLETED|Washout (4 Weeks)||11
3254824|NCT02533063|3988773|FG000|NOT COMPLETED|Washout (4 Weeks)||0
3254825|NCT02533063|3988774|FG001|NOT COMPLETED|Washout (4 Weeks)||0
3254826|NCT02533063|3988773|FG000|STARTED|Intervention 2 (8 Weeks)||14
3254827|NCT02533063|3988774|FG001|STARTED|Intervention 2 (8 Weeks)||11
3254828|NCT02533063|3988773|FG000|COMPLETED|Intervention 2 (8 Weeks)||14
3254829|NCT02533063|3988774|FG001|COMPLETED|Intervention 2 (8 Weeks)||11
3254830|NCT02533063|3988773|FG000|NOT COMPLETED|Intervention 2 (8 Weeks)||0
3254831|NCT02533063|3988774|FG001|NOT COMPLETED|Intervention 2 (8 Weeks)||0
3254832|NCT02533089|3988783|FG000|STARTED|Overall Study||605
3254833|NCT02533089|3988784|FG001|STARTED|Overall Study||548
3254834|NCT02533089|3988783|FG000|COMPLETED|Overall Study|4 HC accrued no eligable patients 11 HC no patients with outcome data 241 cases missing outcome|364
3254835|NCT02533089|3988784|FG001|COMPLETED|Overall Study|6 HC accrued no eligible patients 8 HC no patients with outcome data 114 cases missing outcome|434
3254836|NCT02533089|3988783|FG000|NOT COMPLETED|Overall Study||241
3254837|NCT02533089|3988784|FG001|NOT COMPLETED|Overall Study||114
3254838|NCT02533167|3988790|FG000|STARTED|Overall Study||70
3254839|NCT02533167|3988790|FG000|COMPLETED|Overall Study||55
3254840|NCT02533167|3988790|FG000|NOT COMPLETED|Overall Study||15
3254841|NCT02533180|3988797|FG000|STARTED|Overall Study||39
3254842|NCT02533180|3988798|FG001|STARTED|Overall Study||61
3254843|NCT02533180|3988797|FG000|COMPLETED|Overall Study||0
3254844|NCT02533180|3988798|FG001|COMPLETED|Overall Study||14
3254845|NCT02533180|3988797|FG000|NOT COMPLETED|Overall Study||39
3254846|NCT02533180|3988798|FG001|NOT COMPLETED|Overall Study||47
3254847|NCT02533258|3988803|FG000|STARTED|Overall Study||13
3254848|NCT02533258|3988803|FG000|COMPLETED|Overall Study||5
3254849|NCT02533258|3988803|FG000|NOT COMPLETED|Overall Study||8
3254850|NCT02533375|3988807|FG000|STARTED|Overall Study||10
3254851|NCT02533375|3988807|FG000|COMPLETED|Overall Study||5
3254852|NCT02533375|3988807|FG000|NOT COMPLETED|Overall Study||5
3254853|NCT02533401|3988811|FG000|STARTED|Overall Study||34
3254854|NCT02533401|3988811|FG000|COMPLETED|Overall Study||23
3254855|NCT02533401|3988811|FG000|NOT COMPLETED|Overall Study||11
3254856|NCT02533427|3988815|FG000|STARTED|Overall Study||15
3254857|NCT02533427|3988815|FG000|COMPLETED|Overall Study||15
3254858|NCT02533427|3988815|FG000|NOT COMPLETED|Overall Study||0
3254859|NCT02533453|3988822|FG000|STARTED|Overall Study||110
3254860|NCT02533453|3988822|FG000|COMPLETED|Overall Study||101
3254861|NCT02533453|3988822|FG000|NOT COMPLETED|Overall Study||9
3254862|NCT02533466|3988828|FG000|STARTED|Overall Study||16
3254863|NCT02533466|3988829|FG001|STARTED|Overall Study||14
3254864|NCT02533466|3988828|FG000|COMPLETED|Overall Study||16
3254865|NCT02533466|3988829|FG001|COMPLETED|Overall Study||14
3254866|NCT02533466|3988828|FG000|NOT COMPLETED|Overall Study||0
3254867|NCT02533466|3988829|FG001|NOT COMPLETED|Overall Study||0
3254868|NCT02533505|3988837|FG000|STARTED|Overall Study||26
3254869|NCT02533505|3988838|FG001|STARTED|Overall Study||25
3254870|NCT02533505|3988837|FG000|COMPLETED|Overall Study||23
3254871|NCT02533505|3988838|FG001|COMPLETED|Overall Study||24
3254872|NCT02533505|3988837|FG000|NOT COMPLETED|Overall Study||3
3254873|NCT02533505|3988838|FG001|NOT COMPLETED|Overall Study||1
3254874|NCT02533570|3988847|FG000|STARTED|Overall Study||4
3254875|NCT02533570|3988848|FG001|STARTED|Overall Study||8
3254876|NCT02533570|3988849|FG002|STARTED|Overall Study||8
3254877|NCT02533570|3988847|FG000|COMPLETED|Overall Study||4
3254878|NCT02533570|3988848|FG001|COMPLETED|Overall Study||7
3254879|NCT02533570|3988849|FG002|COMPLETED|Overall Study||7
3254880|NCT02533570|3988847|FG000|NOT COMPLETED|Overall Study||0
3254881|NCT02533570|3988848|FG001|NOT COMPLETED|Overall Study||1
3254882|NCT02533570|3988849|FG002|NOT COMPLETED|Overall Study||1
3254883|NCT02533674|3988865|FG000|STARTED|Dose Level I||5
3254884|NCT02533674|3988866|FG001|STARTED|Dose Level I||0
3254885|NCT02533674|3988867|FG002|STARTED|Dose Level I||0
3254886|NCT02533674|3988868|FG003|STARTED|Dose Level I||0
3254887|NCT02533674|3988869|FG004|STARTED|Dose Level I||0
3254888|NCT02533674|3988870|FG005|STARTED|Dose Level I||0
3254889|NCT02533674|3988871|FG006|STARTED|Dose Level I||0
3254890|NCT02533674|3988872|FG007|STARTED|Dose Level I||0
3254891|NCT02533674|3988865|FG000|COMPLETED|Dose Level I||0
3254892|NCT02533674|3988866|FG001|COMPLETED|Dose Level I||0
3254893|NCT02533674|3988867|FG002|COMPLETED|Dose Level I||0
3254894|NCT02533674|3988868|FG003|COMPLETED|Dose Level I||0
3254895|NCT02533674|3988869|FG004|COMPLETED|Dose Level I||0
3254896|NCT02533674|3988870|FG005|COMPLETED|Dose Level I||0
3254897|NCT02533674|3988871|FG006|COMPLETED|Dose Level I||0
3254898|NCT02533674|3988872|FG007|COMPLETED|Dose Level I||0
3254899|NCT02533674|3988865|FG000|NOT COMPLETED|Dose Level I||5
3254900|NCT02533674|3988866|FG001|NOT COMPLETED|Dose Level I||0
3254901|NCT02533674|3988867|FG002|NOT COMPLETED|Dose Level I||0
3254902|NCT02533674|3988868|FG003|NOT COMPLETED|Dose Level I||0
3254903|NCT02533674|3988869|FG004|NOT COMPLETED|Dose Level I||0
3254904|NCT02533674|3988870|FG005|NOT COMPLETED|Dose Level I||0
3254905|NCT02533674|3988871|FG006|NOT COMPLETED|Dose Level I||0
3254906|NCT02533674|3988872|FG007|NOT COMPLETED|Dose Level I||0
3254907|NCT02533674|3988865|FG000|STARTED|Dose Level II||0
3254908|NCT02533674|3988866|FG001|STARTED|Dose Level II||7
3254909|NCT02533674|3988867|FG002|STARTED|Dose Level II||0
3254910|NCT02533674|3988868|FG003|STARTED|Dose Level II||0
3254911|NCT02533674|3988869|FG004|STARTED|Dose Level II||0
3254912|NCT02533674|3988870|FG005|STARTED|Dose Level II||0
3254913|NCT02533674|3988871|FG006|STARTED|Dose Level II||0
3254914|NCT02533674|3988872|FG007|STARTED|Dose Level II||0
3254915|NCT02533674|3988865|FG000|COMPLETED|Dose Level II||0
3254916|NCT02533674|3988866|FG001|COMPLETED|Dose Level II||0
3254917|NCT02533674|3988867|FG002|COMPLETED|Dose Level II||0
3254918|NCT02533674|3988868|FG003|COMPLETED|Dose Level II||0
3254919|NCT02533674|3988869|FG004|COMPLETED|Dose Level II||0
3254920|NCT02533674|3988870|FG005|COMPLETED|Dose Level II||0
3254921|NCT02533674|3988871|FG006|COMPLETED|Dose Level II||0
3254922|NCT02533674|3988872|FG007|COMPLETED|Dose Level II||0
3254923|NCT02533674|3988865|FG000|NOT COMPLETED|Dose Level II||0
3254924|NCT02533674|3988866|FG001|NOT COMPLETED|Dose Level II||7
3254925|NCT02533674|3988867|FG002|NOT COMPLETED|Dose Level II||0
3254926|NCT02533674|3988868|FG003|NOT COMPLETED|Dose Level II||0
3254927|NCT02533674|3988869|FG004|NOT COMPLETED|Dose Level II||0
3254928|NCT02533674|3988870|FG005|NOT COMPLETED|Dose Level II||0
3254929|NCT02533674|3988871|FG006|NOT COMPLETED|Dose Level II||0
3254930|NCT02533674|3988872|FG007|NOT COMPLETED|Dose Level II||0
3254931|NCT02533674|3988865|FG000|STARTED|Dose Level III||0
3254932|NCT02533674|3988866|FG001|STARTED|Dose Level III||0
3254933|NCT02533674|3988867|FG002|STARTED|Dose Level III||4
3254934|NCT02533674|3988868|FG003|STARTED|Dose Level III||0
3254935|NCT02533674|3988869|FG004|STARTED|Dose Level III||0
3254936|NCT02533674|3988870|FG005|STARTED|Dose Level III||0
3254937|NCT02533674|3988871|FG006|STARTED|Dose Level III||0
3254938|NCT02533674|3988872|FG007|STARTED|Dose Level III||0
3254939|NCT02533674|3988865|FG000|COMPLETED|Dose Level III||0
3254940|NCT02533674|3988866|FG001|COMPLETED|Dose Level III||0
3254941|NCT02533674|3988867|FG002|COMPLETED|Dose Level III||0
3254942|NCT02533674|3988868|FG003|COMPLETED|Dose Level III||0
3254943|NCT02533674|3988869|FG004|COMPLETED|Dose Level III||0
3254944|NCT02533674|3988870|FG005|COMPLETED|Dose Level III||0
3254945|NCT02533674|3988871|FG006|COMPLETED|Dose Level III||0
3254946|NCT02533674|3988872|FG007|COMPLETED|Dose Level III||0
3254947|NCT02533674|3988865|FG000|NOT COMPLETED|Dose Level III||0
3254948|NCT02533674|3988866|FG001|NOT COMPLETED|Dose Level III||0
3254949|NCT02533674|3988867|FG002|NOT COMPLETED|Dose Level III||4
3254950|NCT02533674|3988868|FG003|NOT COMPLETED|Dose Level III||0
3254951|NCT02533674|3988869|FG004|NOT COMPLETED|Dose Level III||0
3254952|NCT02533674|3988870|FG005|NOT COMPLETED|Dose Level III||0
3254953|NCT02533674|3988871|FG006|NOT COMPLETED|Dose Level III||0
3254954|NCT02533674|3988872|FG007|NOT COMPLETED|Dose Level III||0
3254955|NCT02533674|3988865|FG000|STARTED|Dose Level IV||0
3254956|NCT02533674|3988866|FG001|STARTED|Dose Level IV||0
3254957|NCT02533674|3988867|FG002|STARTED|Dose Level IV||0
3254958|NCT02533674|3988868|FG003|STARTED|Dose Level IV||5
3254959|NCT02533674|3988869|FG004|STARTED|Dose Level IV||0
3254960|NCT02533674|3988870|FG005|STARTED|Dose Level IV||0
3254961|NCT02533674|3988871|FG006|STARTED|Dose Level IV||0
3254962|NCT02533674|3988872|FG007|STARTED|Dose Level IV||0
3254963|NCT02533674|3988865|FG000|COMPLETED|Dose Level IV||0
3254964|NCT02533674|3988866|FG001|COMPLETED|Dose Level IV||0
3254965|NCT02533674|3988867|FG002|COMPLETED|Dose Level IV||0
3254966|NCT02533674|3988868|FG003|COMPLETED|Dose Level IV||0
3254967|NCT02533674|3988869|FG004|COMPLETED|Dose Level IV||0
3254968|NCT02533674|3988870|FG005|COMPLETED|Dose Level IV||0
3254969|NCT02533674|3988871|FG006|COMPLETED|Dose Level IV||0
3254970|NCT02533674|3988872|FG007|COMPLETED|Dose Level IV||0
3254971|NCT02533674|3988865|FG000|NOT COMPLETED|Dose Level IV||0
3254972|NCT02533674|3988866|FG001|NOT COMPLETED|Dose Level IV||0
3254973|NCT02533674|3988867|FG002|NOT COMPLETED|Dose Level IV||0
3254974|NCT02533674|3988868|FG003|NOT COMPLETED|Dose Level IV||5
3254975|NCT02533674|3988869|FG004|NOT COMPLETED|Dose Level IV||0
3254976|NCT02533674|3988870|FG005|NOT COMPLETED|Dose Level IV||0
3254977|NCT02533674|3988871|FG006|NOT COMPLETED|Dose Level IV||0
3254978|NCT02533674|3988872|FG007|NOT COMPLETED|Dose Level IV||0
3254979|NCT02533674|3988865|FG000|STARTED|Dose Level V||0
3254980|NCT02533674|3988866|FG001|STARTED|Dose Level V||0
3254981|NCT02533674|3988867|FG002|STARTED|Dose Level V||0
3254982|NCT02533674|3988868|FG003|STARTED|Dose Level V||0
3254983|NCT02533674|3988869|FG004|STARTED|Dose Level V||5
3254984|NCT02533674|3988870|FG005|STARTED|Dose Level V||0
3254985|NCT02533674|3988871|FG006|STARTED|Dose Level V||0
3254986|NCT02533674|3988872|FG007|STARTED|Dose Level V||0
3254987|NCT02533674|3988865|FG000|COMPLETED|Dose Level V||0
3254988|NCT02533674|3988866|FG001|COMPLETED|Dose Level V||0
3254989|NCT02533674|3988867|FG002|COMPLETED|Dose Level V||0
3254990|NCT02533674|3988868|FG003|COMPLETED|Dose Level V||0
3254991|NCT02533674|3988869|FG004|COMPLETED|Dose Level V||0
3254992|NCT02533674|3988870|FG005|COMPLETED|Dose Level V||0
3254993|NCT02533674|3988871|FG006|COMPLETED|Dose Level V||0
3254994|NCT02533674|3988872|FG007|COMPLETED|Dose Level V||0
3254995|NCT02533674|3988865|FG000|NOT COMPLETED|Dose Level V||0
3254996|NCT02533674|3988866|FG001|NOT COMPLETED|Dose Level V||0
3254997|NCT02533674|3988867|FG002|NOT COMPLETED|Dose Level V||0
3254998|NCT02533674|3988868|FG003|NOT COMPLETED|Dose Level V||0
3254999|NCT02533674|3988869|FG004|NOT COMPLETED|Dose Level V||5
3255000|NCT02533674|3988870|FG005|NOT COMPLETED|Dose Level V||0
3255001|NCT02533674|3988871|FG006|NOT COMPLETED|Dose Level V||0
3255002|NCT02533674|3988872|FG007|NOT COMPLETED|Dose Level V||0
3255003|NCT02533674|3988865|FG000|STARTED|Dose Level VI||0
3255004|NCT02533674|3988866|FG001|STARTED|Dose Level VI||0
3255005|NCT02533674|3988867|FG002|STARTED|Dose Level VI||0
3255006|NCT02533674|3988868|FG003|STARTED|Dose Level VI||0
3255007|NCT02533674|3988869|FG004|STARTED|Dose Level VI||0
3255008|NCT02533674|3988870|FG005|STARTED|Dose Level VI||9
3255009|NCT02533674|3988871|FG006|STARTED|Dose Level VI||0
3255010|NCT02533674|3988872|FG007|STARTED|Dose Level VI||0
3255011|NCT02533674|3988865|FG000|COMPLETED|Dose Level VI||0
3255012|NCT02533674|3988866|FG001|COMPLETED|Dose Level VI||0
3255013|NCT02533674|3988867|FG002|COMPLETED|Dose Level VI||0
3255014|NCT02533674|3988868|FG003|COMPLETED|Dose Level VI||0
3255015|NCT02533674|3988869|FG004|COMPLETED|Dose Level VI||0
3255016|NCT02533674|3988870|FG005|COMPLETED|Dose Level VI||0
3255017|NCT02533674|3988871|FG006|COMPLETED|Dose Level VI||0
3255018|NCT02533674|3988872|FG007|COMPLETED|Dose Level VI||0
3255019|NCT02533674|3988865|FG000|NOT COMPLETED|Dose Level VI||0
3255020|NCT02533674|3988866|FG001|NOT COMPLETED|Dose Level VI||0
3255021|NCT02533674|3988867|FG002|NOT COMPLETED|Dose Level VI||0
3255022|NCT02533674|3988868|FG003|NOT COMPLETED|Dose Level VI||0
3255023|NCT02533674|3988869|FG004|NOT COMPLETED|Dose Level VI||0
3255024|NCT02533674|3988870|FG005|NOT COMPLETED|Dose Level VI||9
3255025|NCT02533674|3988871|FG006|NOT COMPLETED|Dose Level VI||0
3255026|NCT02533674|3988872|FG007|NOT COMPLETED|Dose Level VI||0
3255027|NCT02533674|3988865|FG000|STARTED|Dose Level VII||0
3255028|NCT02533674|3988866|FG001|STARTED|Dose Level VII||0
3255029|NCT02533674|3988867|FG002|STARTED|Dose Level VII||0
3255030|NCT02533674|3988868|FG003|STARTED|Dose Level VII||0
3255031|NCT02533674|3988869|FG004|STARTED|Dose Level VII||0
3255032|NCT02533674|3988870|FG005|STARTED|Dose Level VII||0
3255033|NCT02533674|3988871|FG006|STARTED|Dose Level VII||16
3255034|NCT02533674|3988872|FG007|STARTED|Dose Level VII||0
3255035|NCT02533674|3988865|FG000|COMPLETED|Dose Level VII||0
3255036|NCT02533674|3988866|FG001|COMPLETED|Dose Level VII||0
3255037|NCT02533674|3988867|FG002|COMPLETED|Dose Level VII||0
3255038|NCT02533674|3988868|FG003|COMPLETED|Dose Level VII||0
3255039|NCT02533674|3988869|FG004|COMPLETED|Dose Level VII||0
3255040|NCT02533674|3988870|FG005|COMPLETED|Dose Level VII||0
3255041|NCT02533674|3988871|FG006|COMPLETED|Dose Level VII||0
3255042|NCT02533674|3988872|FG007|COMPLETED|Dose Level VII||0
3255043|NCT02533674|3988865|FG000|NOT COMPLETED|Dose Level VII||0
3255044|NCT02533674|3988866|FG001|NOT COMPLETED|Dose Level VII||0
3255045|NCT02533674|3988867|FG002|NOT COMPLETED|Dose Level VII||0
3255046|NCT02533674|3988868|FG003|NOT COMPLETED|Dose Level VII||0
3255047|NCT02533674|3988869|FG004|NOT COMPLETED|Dose Level VII||0
3255048|NCT02533674|3988870|FG005|NOT COMPLETED|Dose Level VII||0
3255049|NCT02533674|3988871|FG006|NOT COMPLETED|Dose Level VII||16
3255050|NCT02533674|3988872|FG007|NOT COMPLETED|Dose Level VII||0
3255051|NCT02533674|3988865|FG000|STARTED|Dose Level VIII||0
3255052|NCT02533674|3988866|FG001|STARTED|Dose Level VIII||0
3255053|NCT02533674|3988867|FG002|STARTED|Dose Level VIII||0
3255054|NCT02533674|3988868|FG003|STARTED|Dose Level VIII||0
3255055|NCT02533674|3988869|FG004|STARTED|Dose Level VIII||0
3255056|NCT02533674|3988870|FG005|STARTED|Dose Level VIII||0
3255057|NCT02533674|3988871|FG006|STARTED|Dose Level VIII||0
3255058|NCT02533674|3988872|FG007|STARTED|Dose Level VIII||6
3255059|NCT02533674|3988865|FG000|COMPLETED|Dose Level VIII||0
3255060|NCT02533674|3988866|FG001|COMPLETED|Dose Level VIII||0
3255061|NCT02533674|3988867|FG002|COMPLETED|Dose Level VIII||0
3255062|NCT02533674|3988868|FG003|COMPLETED|Dose Level VIII||0
3255063|NCT02533674|3988869|FG004|COMPLETED|Dose Level VIII||0
3255064|NCT02533674|3988870|FG005|COMPLETED|Dose Level VIII||0
3255065|NCT02533674|3988871|FG006|COMPLETED|Dose Level VIII||0
3255066|NCT02533674|3988872|FG007|COMPLETED|Dose Level VIII||0
3255067|NCT02533674|3988865|FG000|NOT COMPLETED|Dose Level VIII||0
3255068|NCT02533674|3988866|FG001|NOT COMPLETED|Dose Level VIII||0
3255069|NCT02533674|3988867|FG002|NOT COMPLETED|Dose Level VIII||0
3255070|NCT02533674|3988868|FG003|NOT COMPLETED|Dose Level VIII||0
3255071|NCT02533674|3988869|FG004|NOT COMPLETED|Dose Level VIII||0
3255072|NCT02533674|3988870|FG005|NOT COMPLETED|Dose Level VIII||0
3255073|NCT02533674|3988871|FG006|NOT COMPLETED|Dose Level VIII||0
3255074|NCT02533674|3988872|FG007|NOT COMPLETED|Dose Level VIII||6
3255075|NCT02533726|3988892|FG000|STARTED|Initial Allocation||659
3255076|NCT02533726|3988893|FG001|STARTED|Initial Allocation||653
3255077|NCT02533726|3988892|FG000|COMPLETED|Initial Allocation||659
3255078|NCT02533726|3988893|FG001|COMPLETED|Initial Allocation||653
3255079|NCT02533726|3988892|FG000|NOT COMPLETED|Initial Allocation||0
3255080|NCT02533726|3988893|FG001|NOT COMPLETED|Initial Allocation||0
3255081|NCT02533726|3988892|FG000|STARTED|Treatment|54 participants allocated to Standard Care actually received Optimal Turning|709
3255082|NCT02533726|3988893|FG001|STARTED|Treatment|4 participants allocated to Optimal Turning actually received Standard Care|603
3255083|NCT02533726|3988892|FG000|Per Protocol Population|Treatment||671
3255084|NCT02533726|3988893|FG001|Per Protocol Population|Treatment||555
3255085|NCT02533726|3988892|FG000|COMPLETED|Treatment||709
3255086|NCT02533726|3988893|FG001|COMPLETED|Treatment||603
3255087|NCT02533726|3988892|FG000|NOT COMPLETED|Treatment||0
3255088|NCT02533726|3988893|FG001|NOT COMPLETED|Treatment||0
3255089|NCT02533921|3988901|FG000|STARTED|Overall Study||104
3255090|NCT02533921|3988902|FG001|STARTED|Overall Study||106
3255091|NCT02533921|3988901|FG000|COMPLETED|Overall Study||88
3255092|NCT02533921|3988902|FG001|COMPLETED|Overall Study||95
3255093|NCT02533921|3988901|FG000|NOT COMPLETED|Overall Study||16
3255094|NCT02533921|3988902|FG001|NOT COMPLETED|Overall Study||11
3255095|NCT02533934|3988910|FG000|STARTED|Overall Study||42
3255096|NCT02533934|3988911|FG001|STARTED|Overall Study||26
3255097|NCT02533934|3988910|FG000|COMPLETED|Overall Study||42
3255098|NCT02533934|3988911|FG001|COMPLETED|Overall Study||26
3255099|NCT02533934|3988910|FG000|NOT COMPLETED|Overall Study||0
3255100|NCT02533934|3988911|FG001|NOT COMPLETED|Overall Study||0
3255101|NCT02533999|3988919|FG000|STARTED|Overall Study||38
3255102|NCT02533999|3988920|FG001|STARTED|Overall Study||37
3255103|NCT02533999|3988919|FG000|COMPLETED|Overall Study||32
3255104|NCT02533999|3988920|FG001|COMPLETED|Overall Study||30
3255105|NCT02533999|3988919|FG000|NOT COMPLETED|Overall Study||6
3255106|NCT02533999|3988920|FG001|NOT COMPLETED|Overall Study||7
3255107|NCT02534129|3988926|FG000|STARTED|Overall Study||13
3255108|NCT02534129|3988927|FG001|STARTED|Overall Study||13
3255109|NCT02534129|3988926|FG000|COMPLETED|Overall Study||13
3255110|NCT02534129|3988927|FG001|COMPLETED|Overall Study||13
3255111|NCT02534129|3988926|FG000|NOT COMPLETED|Overall Study||0
3255112|NCT02534129|3988927|FG001|NOT COMPLETED|Overall Study||0
3255113|NCT02534285|3988935|FG000|STARTED|Overall Study||50
3255114|NCT02534285|3988936|FG001|STARTED|Overall Study||50
3255115|NCT02534285|3988935|FG000|COMPLETED|Overall Study||50
3255116|NCT02534285|3988936|FG001|COMPLETED|Overall Study||50
3255117|NCT02534285|3988935|FG000|NOT COMPLETED|Overall Study||0
3255118|NCT02534285|3988936|FG001|NOT COMPLETED|Overall Study||0
3255119|NCT02534324|3988944|FG000|STARTED|Overall Study||98
3255120|NCT02534324|3988945|FG001|STARTED|Overall Study||48
3255121|NCT02534324|3988944|FG000|COMPLETED|Overall Study||73
3255122|NCT02534324|3988945|FG001|COMPLETED|Overall Study||40
3255123|NCT02534324|3988944|FG000|NOT COMPLETED|Overall Study||25
3255124|NCT02534324|3988945|FG001|NOT COMPLETED|Overall Study||8
3255125|NCT02534350|3988953|FG000|STARTED|Overall Study||41
3255126|NCT02534350|3988954|FG001|STARTED|Overall Study||20
3255127|NCT02534350|3988953|FG000|COMPLETED|Overall Study||37
3255128|NCT02534350|3988954|FG001|COMPLETED|Overall Study||20
3255129|NCT02534350|3988953|FG000|NOT COMPLETED|Overall Study||4
3255130|NCT02534350|3988954|FG001|NOT COMPLETED|Overall Study||0
3255131|NCT02534493|3988960|FG000|STARTED|Overall Study||13
3255132|NCT02534493|3988960|FG000|COMPLETED|Overall Study||11
3255133|NCT02534493|3988960|FG000|NOT COMPLETED|Overall Study||2
3255134|NCT02534883|3988968|FG000|STARTED|Overall Study||8
3255135|NCT02534883|3988969|FG001|STARTED|Overall Study||3
3255136|NCT02534883|3988968|FG000|COMPLETED|Overall Study||0
3255137|NCT02534883|3988969|FG001|COMPLETED|Overall Study||0
3255138|NCT02534883|3988968|FG000|NOT COMPLETED|Overall Study||8
3255139|NCT02534883|3988969|FG001|NOT COMPLETED|Overall Study||3
3255140|NCT02534896|3988978|FG000|STARTED|Overall Study||49
3255141|NCT02534896|3988979|FG001|STARTED|Overall Study||52
3255142|NCT02534896|3988980|FG002|STARTED|Overall Study||49
3255143|NCT02534896|3988978|FG000|COMPLETED|Overall Study||45
3255144|NCT02534896|3988979|FG001|COMPLETED|Overall Study||51
3255145|NCT02534896|3988980|FG002|COMPLETED|Overall Study||48
3255146|NCT02534896|3988978|FG000|NOT COMPLETED|Overall Study||4
3255147|NCT02534896|3988979|FG001|NOT COMPLETED|Overall Study||1
3255148|NCT02534896|3988980|FG002|NOT COMPLETED|Overall Study||1
3255149|NCT02534935|3988991|FG000|STARTED|Stage 1: 24 Months||44
3255150|NCT02534935|3988992|FG001|STARTED|Stage 1: 24 Months||220
3255151|NCT02534935|3988993|FG002|STARTED|Stage 1: 24 Months||132
3255152|NCT02534935|3988991|FG000|COMPLETED|Stage 1: 24 Months||44
3255153|NCT02534935|3988992|FG001|COMPLETED|Stage 1: 24 Months||210
3255154|NCT02534935|3988993|FG002|COMPLETED|Stage 1: 24 Months||127
3255155|NCT02534935|3988991|FG000|NOT COMPLETED|Stage 1: 24 Months||0
3255156|NCT02534935|3988992|FG001|NOT COMPLETED|Stage 1: 24 Months||10
3255157|NCT02534935|3988993|FG002|NOT COMPLETED|Stage 1: 24 Months||5
3255158|NCT02534935|3988991|FG000|STARTED|Stage 2: 8 Months|Participants entered into Stage 2.|40
3255159|NCT02534935|3988992|FG001|STARTED|Stage 2: 8 Months|Participants who received all 3 doses and entered Stage 2.|174
3255160|NCT02534935|3988993|FG002|STARTED|Stage 2: 8 Months|Participants of HAV/Saline were not eligible for Stage 2.|0
3255161|NCT02534935|3988991|FG000|COMPLETED|Stage 2: 8 Months||40
3255162|NCT02534935|3988992|FG001|COMPLETED|Stage 2: 8 Months||170
3255163|NCT02534935|3988993|FG002|COMPLETED|Stage 2: 8 Months||0
3255164|NCT02534935|3988991|FG000|NOT COMPLETED|Stage 2: 8 Months||0
3255165|NCT02534935|3988992|FG001|NOT COMPLETED|Stage 2: 8 Months||4
3255166|NCT02534935|3988993|FG002|NOT COMPLETED|Stage 2: 8 Months||0
3255167|NCT02534935|3988991|FG000|STARTED|Stage 2: Booster Phase (6 Months)|Participants were not eligible for Booster vaccination in Stage 2.|0
3255168|NCT02534935|3988992|FG001|STARTED|Stage 2: Booster Phase (6 Months)|Participants who received 3 doses of bivalent rLP2086 in Stage 1 and gave consent for booster vaccination.|148
3255169|NCT02534935|3988993|FG002|STARTED|Stage 2: Booster Phase (6 Months)|Participants of HAV/Saline were not eligible for Stage 2.|0
3255170|NCT02534935|3988991|FG000|COMPLETED|Stage 2: Booster Phase (6 Months)||0
3255171|NCT02534935|3988992|FG001|COMPLETED|Stage 2: Booster Phase (6 Months)||147
3255172|NCT02534935|3988993|FG002|COMPLETED|Stage 2: Booster Phase (6 Months)||0
3372229|NCT03206216|4104114|FG001|COMPLETED|Overall Study||0
3372230|NCT03206216|4104113|FG000|NOT COMPLETED|Overall Study||0
3372231|NCT03206216|4104114|FG001|NOT COMPLETED|Overall Study||1
3372232|NCT03195660|4104120|FG000|STARTED|Overall Study||2
3372233|NCT03195660|4104120|FG000|COMPLETED|Overall Study||0
3372234|NCT03195660|4104120|FG000|NOT COMPLETED|Overall Study||2
3372235|NCT03195465|4104124|FG000|STARTED|Overall Study||0
3372236|NCT03195465|4104124|FG000|COMPLETED|Overall Study||0
3372237|NCT03195465|4104124|FG000|NOT COMPLETED|Overall Study||0
3372238|NCT03166618|4104130|FG000|STARTED|Overall Study||0
3372239|NCT03166618|4104131|FG001|STARTED|Overall Study||1
3372240|NCT03166618|4104130|FG000|COMPLETED|Overall Study||0
3372241|NCT03166618|4104131|FG001|COMPLETED|Overall Study||0
3372242|NCT03166618|4104130|FG000|NOT COMPLETED|Overall Study||0
3372243|NCT03166618|4104131|FG001|NOT COMPLETED|Overall Study||1
3372244|NCT03169530|4104139|FG000|STARTED|Overall Study||15
3372245|NCT03169530|4104140|FG001|STARTED|Overall Study||17
3372246|NCT03169530|4104139|FG000|COMPLETED|Overall Study||0
3372247|NCT03169530|4104140|FG001|COMPLETED|Overall Study||0
3372248|NCT03169530|4104139|FG000|NOT COMPLETED|Overall Study||15
3372249|NCT03169530|4104140|FG001|NOT COMPLETED|Overall Study||17
3372250|NCT03189433|4104148|FG000|STARTED|Overall Study||2
3372251|NCT03189433|4104149|FG001|STARTED|Overall Study||0
3372252|NCT03189433|4104148|FG000|COMPLETED|Overall Study||0
3372253|NCT03189433|4104149|FG001|COMPLETED|Overall Study||0
3372254|NCT03189433|4104148|FG000|NOT COMPLETED|Overall Study||2
3372255|NCT03189433|4104149|FG001|NOT COMPLETED|Overall Study||0
3372256|NCT03151226|4104155|FG000|STARTED|Overall Study||3
3372257|NCT03151226|4104155|FG000|COMPLETED|Overall Study||0
3372258|NCT03151226|4104155|FG000|NOT COMPLETED|Overall Study||3
3372259|NCT03165747|4104161|FG000|STARTED|Overall Study||0
3372260|NCT03165747|4104162|FG001|STARTED|Overall Study||0
3372261|NCT03165747|4104161|FG000|COMPLETED|Overall Study||0
3372262|NCT03165747|4104162|FG001|COMPLETED|Overall Study||0
3372263|NCT03165747|4104161|FG000|NOT COMPLETED|Overall Study||0
3372264|NCT03165747|4104162|FG001|NOT COMPLETED|Overall Study||0
3372265|NCT03168906|4104170|FG000|STARTED|Overall Study||6
3372266|NCT03168906|4104171|FG001|STARTED|Overall Study||6
3372267|NCT03168906|4104170|FG000|COMPLETED|Overall Study|Study discontinued due to futile nature of drug|0
3372268|NCT03168906|4104171|FG001|COMPLETED|Overall Study|Study discontinued due to futile nature of drug|0
3372269|NCT03168906|4104170|FG000|NOT COMPLETED|Overall Study||6
3372270|NCT03168906|4104171|FG001|NOT COMPLETED|Overall Study||6
3372271|NCT03178201|4104178|FG000|STARTED|Overall Study||5
3372272|NCT03178201|4104178|FG000|COMPLETED|Overall Study||0
3372273|NCT03178201|4104178|FG000|NOT COMPLETED|Overall Study||5
3372274|NCT03172026|4104184|FG000|STARTED|Overall Study||2
3372275|NCT03172026|4104185|FG001|STARTED|Overall Study||0
3372276|NCT03172026|4104184|FG000|8 Week Assessment|Overall Study||0
3372277|NCT03172026|4104185|FG001|8 Week Assessment|Overall Study||0
3372278|NCT03172026|4104184|FG000|6 Month Assessment|Overall Study||0
3372279|NCT03172026|4104185|FG001|6 Month Assessment|Overall Study||0
3372280|NCT03172026|4104184|FG000|COMPLETED|Overall Study||0
3372281|NCT03172026|4104185|FG001|COMPLETED|Overall Study||0
3372282|NCT03172026|4104184|FG000|NOT COMPLETED|Overall Study||2
3372283|NCT03172026|4104185|FG001|NOT COMPLETED|Overall Study||0
3372284|NCT03152526|4104194|FG000|STARTED|Overall Study|No participants were enrolled on this arm.|0
3372285|NCT03152526|4104195|FG001|STARTED|Overall Study|One participant was enrolled on this arm.|1
3372286|NCT03152526|4104194|FG000|COMPLETED|Overall Study|No participants were enrolled on this arm.|0
3372287|NCT03152526|4104195|FG001|COMPLETED|Overall Study|The one participant enrolled on this arm withdrew from the study early.|0
3372288|NCT03152526|4104194|FG000|NOT COMPLETED|Overall Study||0
3372289|NCT03152526|4104195|FG001|NOT COMPLETED|Overall Study||1
3372290|NCT03161964|4104203|FG000|STARTED|Overall Study||1
3372291|NCT03161964|4104204|FG001|STARTED|Overall Study||1
3372292|NCT03161964|4104203|FG000|COMPLETED|Overall Study||1
3372293|NCT03161964|4104204|FG001|COMPLETED|Overall Study||0
3372294|NCT03161964|4104203|FG000|NOT COMPLETED|Overall Study||0
3255173|NCT02534935|3988991|FG000|NOT COMPLETED|Stage 2: Booster Phase (6 Months)||0
3255174|NCT02534935|3988992|FG001|NOT COMPLETED|Stage 2: Booster Phase (6 Months)||1
3255175|NCT02534935|3988993|FG002|NOT COMPLETED|Stage 2: Booster Phase (6 Months)||0
3255176|NCT02535000|3989021|FG000|STARTED|Overall Study||30
3255177|NCT02535000|3989022|FG001|STARTED|Overall Study||30
3255178|NCT02535000|3989021|FG000|COMPLETED|Overall Study||29
3255179|NCT02535000|3989022|FG001|COMPLETED|Overall Study||28
3255180|NCT02535000|3989021|FG000|NOT COMPLETED|Overall Study||1
3255181|NCT02535000|3989022|FG001|NOT COMPLETED|Overall Study||2
3255182|NCT02535026|3989028|FG000|STARTED|Overall Study||580
3255183|NCT02535026|3989028|FG000|COMPLETED|Overall Study||580
3255184|NCT02535026|3989028|FG000|NOT COMPLETED|Overall Study||0
3255185|NCT02535065|3989042|FG000|STARTED|Overall Study||62
3255186|NCT02535065|3989042|FG000|1-Month Follow-up|Overall Study||62
3255187|NCT02535065|3989042|FG000|12-Month Follow-up|Overall Study||61
3255188|NCT02535065|3989042|FG000|COMPLETED|Overall Study||0
3255189|NCT02535065|3989042|FG000|NOT COMPLETED|Overall Study||62
3255190|NCT02535364|3989046|FG000|STARTED|Part A Screening Through Leukapheresis||82
3255191|NCT02535364|3989046|FG000|COMPLETED|Part A Screening Through Leukapheresis||57
3255192|NCT02535364|3989046|FG000|NOT COMPLETED|Part A Screening Through Leukapheresis||25
3255193|NCT02535364|3989046|FG000|STARTED|Part B Screening||57
3255194|NCT02535364|3989046|FG000|COMPLETED|Part B Screening||40
3255195|NCT02535364|3989046|FG000|NOT COMPLETED|Part B Screening||17
3255196|NCT02535364|3989046|FG000|STARTED|Study Treatment||40
3255197|NCT02535364|3989046|FG000|COMPLETED|Study Treatment||38
3255198|NCT02535364|3989046|FG000|NOT COMPLETED|Study Treatment||2
3255199|NCT02535364|3989046|FG000|STARTED|12-Month Follow-up Period||38
3255200|NCT02535364|3989046|FG000|COMPLETED|12-Month Follow-up Period||3
3255201|NCT02535364|3989046|FG000|NOT COMPLETED|12-Month Follow-up Period||35
3255202|NCT02535416|3989059|FG000|STARTED|Overall Study||4
3255203|NCT02535416|3989060|FG001|STARTED|Overall Study||2
3255204|NCT02535416|3989061|FG002|STARTED|Overall Study||4
3255205|NCT02535416|3989062|FG003|STARTED|Overall Study||4
3255206|NCT02535416|3989063|FG004|STARTED|Overall Study||4
3255207|NCT02535416|3989064|FG005|STARTED|Overall Study||4
3255208|NCT02535416|3989065|FG006|STARTED|Overall Study||6
3255209|NCT02535416|3989066|FG007|STARTED|Overall Study||6
3255210|NCT02535416|3989067|FG008|STARTED|Overall Study||6
3255211|NCT02535416|3989059|FG000|COMPLETED|Overall Study||3
3255212|NCT02535416|3989060|FG001|COMPLETED|Overall Study||2
3255213|NCT02535416|3989061|FG002|COMPLETED|Overall Study||4
3255214|NCT02535416|3989062|FG003|COMPLETED|Overall Study||4
3255215|NCT02535416|3989063|FG004|COMPLETED|Overall Study||4
3255216|NCT02535416|3989064|FG005|COMPLETED|Overall Study||4
3255217|NCT02535416|3989065|FG006|COMPLETED|Overall Study||6
3255218|NCT02535416|3989066|FG007|COMPLETED|Overall Study||6
3255219|NCT02535416|3989067|FG008|COMPLETED|Overall Study||6
3255220|NCT02535416|3989059|FG000|NOT COMPLETED|Overall Study||1
3255221|NCT02535416|3989060|FG001|NOT COMPLETED|Overall Study||0
3255222|NCT02535416|3989061|FG002|NOT COMPLETED|Overall Study||0
3255223|NCT02535416|3989062|FG003|NOT COMPLETED|Overall Study||0
3255224|NCT02535416|3989063|FG004|NOT COMPLETED|Overall Study||0
3255225|NCT02535416|3989064|FG005|NOT COMPLETED|Overall Study||0
3255226|NCT02535416|3989065|FG006|NOT COMPLETED|Overall Study||0
3255227|NCT02535416|3989066|FG007|NOT COMPLETED|Overall Study||0
3255228|NCT02535416|3989067|FG008|NOT COMPLETED|Overall Study||0
3255229|NCT02535481|3989093|FG000|STARTED|Overall Study||22
3255230|NCT02535481|3989094|FG001|STARTED|Overall Study||22
3255231|NCT02535481|3989093|FG000|COMPLETED|Overall Study||22
3255232|NCT02535481|3989094|FG001|COMPLETED|Overall Study||22
3255233|NCT02535481|3989093|FG000|NOT COMPLETED|Overall Study||0
3255234|NCT02535481|3989094|FG001|NOT COMPLETED|Overall Study||0
3255235|NCT02535572|3989102|FG000|STARTED|Overall Study||21
3255236|NCT02535572|3989103|FG001|STARTED|Overall Study||20
3255237|NCT02535572|3989102|FG000|COMPLETED|Overall Study||17
3255238|NCT02535572|3989103|FG001|COMPLETED|Overall Study||17
3255239|NCT02535572|3989102|FG000|NOT COMPLETED|Overall Study||4
3255240|NCT02535572|3989103|FG001|NOT COMPLETED|Overall Study||3
3255241|NCT02535611|3989112|FG000|STARTED|Overall Study||27
3255242|NCT02535611|3989113|FG001|STARTED|Overall Study||20
3255243|NCT02535611|3989112|FG000|COMPLETED|Overall Study||27
3255244|NCT02535611|3989113|FG001|COMPLETED|Overall Study||20
3255245|NCT02535611|3989112|FG000|NOT COMPLETED|Overall Study||0
3255246|NCT02535611|3989113|FG001|NOT COMPLETED|Overall Study||0
3255247|NCT02535715|3989119|FG000|STARTED|Overall Study||4
3255248|NCT02535715|3989120|FG001|STARTED|Overall Study||4
3255249|NCT02535715|3989121|FG002|STARTED|Overall Study||3
3255250|NCT02535715|3989119|FG000|COMPLETED|Overall Study||4
3255251|NCT02535715|3989120|FG001|COMPLETED|Overall Study||4
3255252|NCT02535715|3989121|FG002|COMPLETED|Overall Study||2
3255253|NCT02535715|3989119|FG000|NOT COMPLETED|Overall Study||0
3255254|NCT02535715|3989120|FG001|NOT COMPLETED|Overall Study||0
3255255|NCT02535715|3989121|FG002|NOT COMPLETED|Overall Study||1
3255256|NCT02535741|3989132|FG000|STARTED|Overall Study||168
3255257|NCT02535741|3989132|FG000|COMPLETED|Overall Study|Completed cases at 2 years follow-up|136
3255258|NCT02535741|3989132|FG000|NOT COMPLETED|Overall Study||32
3255259|NCT02535806|3989137|FG000|STARTED|Overall Study||2
3255260|NCT02535806|3989137|FG000|COMPLETED|Overall Study||2
3255261|NCT02535806|3989137|FG000|NOT COMPLETED|Overall Study||0
3255262|NCT02535949|3989144|FG000|STARTED|Overall Study||50
3255263|NCT02535949|3989145|FG001|STARTED|Overall Study||50
3255264|NCT02535949|3989146|FG002|STARTED|Overall Study||50
3255265|NCT02535949|3989144|FG000|COMPLETED|Overall Study||49
3255266|NCT02535949|3989145|FG001|COMPLETED|Overall Study||50
3255267|NCT02535949|3989146|FG002|COMPLETED|Overall Study||50
3255268|NCT02535949|3989144|FG000|NOT COMPLETED|Overall Study||1
3255269|NCT02535949|3989145|FG001|NOT COMPLETED|Overall Study||0
3255270|NCT02535949|3989146|FG002|NOT COMPLETED|Overall Study||0
3255271|NCT02536040|3989157|FG000|STARTED|Overall Study||30
3255272|NCT02536040|3989158|FG001|STARTED|Overall Study||36
3255273|NCT02536040|3989157|FG000|COMPLETED|Overall Study||29
3255274|NCT02536040|3989158|FG001|COMPLETED|Overall Study||35
3255275|NCT02536040|3989157|FG000|NOT COMPLETED|Overall Study||1
3255276|NCT02536040|3989158|FG001|NOT COMPLETED|Overall Study||1
3255277|NCT02536105|3989164|FG000|STARTED|Concerta Open Label||80
3255278|NCT02536105|3989164|FG000|Completion of Phase|Concerta Open Label||76
3255279|NCT02536105|3989164|FG000|COMPLETED|Concerta Open Label||72
3255280|NCT02536105|3989164|FG000|NOT COMPLETED|Concerta Open Label||8
3255281|NCT02536105|3989164|FG000|STARTED|Placebo||74
3255282|NCT02536105|3989164|FG000|Completion of Placebo Day|Placebo||74
3255283|NCT02536105|3989164|FG000|COMPLETED|Placebo||72
3255284|NCT02536105|3989164|FG000|NOT COMPLETED|Placebo||2
3255285|NCT02536105|3989164|FG000|STARTED|Methylphenidate HCl ER Tablet 1||72
3255286|NCT02536105|3989164|FG000|Completion of MPH HCl ER Tab 1 Day|Methylphenidate HCl ER Tablet 1||72
3255287|NCT02536105|3989164|FG000|COMPLETED|Methylphenidate HCl ER Tablet 1||72
3255288|NCT02536105|3989164|FG000|NOT COMPLETED|Methylphenidate HCl ER Tablet 1||0
3255289|NCT02536105|3989164|FG000|STARTED|Methylphenidate HCl ER Tablet 2||73
3255290|NCT02536105|3989164|FG000|Completion of MPH HCl ER Tablet 2 Phase|Methylphenidate HCl ER Tablet 2||73
3255291|NCT02536105|3989164|FG000|COMPLETED|Methylphenidate HCl ER Tablet 2||72
3255292|NCT02536105|3989164|FG000|NOT COMPLETED|Methylphenidate HCl ER Tablet 2||1
3255293|NCT02536105|3989164|FG000|STARTED|Methylphenidate HCl ER Suspension||74
3255294|NCT02536105|3989164|FG000|Completion of MPH HCl ER Susp Phase|Methylphenidate HCl ER Suspension||74
3255295|NCT02536105|3989164|FG000|COMPLETED|Methylphenidate HCl ER Suspension||72
3255296|NCT02536105|3989164|FG000|NOT COMPLETED|Methylphenidate HCl ER Suspension||2
3255297|NCT02536196|3989177|FG000|STARTED|Overall Study||262
3255298|NCT02536196|3989178|FG001|STARTED|Overall Study||121
3255299|NCT02536196|3989179|FG002|STARTED|Overall Study||95
3255300|NCT02536196|3989177|FG000|COMPLETED|Overall Study||233
3255301|NCT02536196|3989178|FG001|COMPLETED|Overall Study||107
3255302|NCT02536196|3989179|FG002|COMPLETED|Overall Study||95
3255303|NCT02536196|3989177|FG000|NOT COMPLETED|Overall Study||29
3255304|NCT02536196|3989178|FG001|NOT COMPLETED|Overall Study||14
3255305|NCT02536196|3989179|FG002|NOT COMPLETED|Overall Study||0
3255306|NCT02536248|3989188|FG000|STARTED|First Intervention (6 Weeks)||10
3255307|NCT02536248|3989189|FG001|STARTED|First Intervention (6 Weeks)||10
3255308|NCT02536248|3989188|FG000|COMPLETED|First Intervention (6 Weeks)||10
3255309|NCT02536248|3989189|FG001|COMPLETED|First Intervention (6 Weeks)||10
3255310|NCT02536248|3989188|FG000|NOT COMPLETED|First Intervention (6 Weeks)||0
3255311|NCT02536248|3989189|FG001|NOT COMPLETED|First Intervention (6 Weeks)||0
3255312|NCT02536248|3989188|FG000|STARTED|Wash-out (14 Days)||10
3255313|NCT02536248|3989189|FG001|STARTED|Wash-out (14 Days)||10
3255314|NCT02536248|3989188|FG000|COMPLETED|Wash-out (14 Days)||10
3255315|NCT02536248|3989189|FG001|COMPLETED|Wash-out (14 Days)||10
3255316|NCT02536248|3989188|FG000|NOT COMPLETED|Wash-out (14 Days)||0
3255317|NCT02536248|3989189|FG001|NOT COMPLETED|Wash-out (14 Days)||0
3255318|NCT02536248|3989188|FG000|STARTED|Second Intervention (6 Weeks)||10
3255319|NCT02536248|3989189|FG001|STARTED|Second Intervention (6 Weeks)||10
3255320|NCT02536248|3989188|FG000|COMPLETED|Second Intervention (6 Weeks)||10
3255321|NCT02536248|3989189|FG001|COMPLETED|Second Intervention (6 Weeks)||10
3255322|NCT02536248|3989188|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||0
3255323|NCT02536248|3989189|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||0
3255324|NCT02536313|3989197|FG000|STARTED|Overall Study||24
3255325|NCT02536313|3989198|FG001|STARTED|Overall Study||25
3255326|NCT02536313|3989197|FG000|COMPLETED|Overall Study||24
3255327|NCT02536313|3989198|FG001|COMPLETED|Overall Study||24
3255328|NCT02536313|3989197|FG000|NOT COMPLETED|Overall Study||0
3255329|NCT02536313|3989198|FG001|NOT COMPLETED|Overall Study||1
3255330|NCT02536378|3989208|FG000|STARTED|Overall Study||632
3255331|NCT02536378|3989209|FG001|STARTED|Overall Study||60
3255332|NCT02536378|3989208|FG000|COMPLETED|Overall Study||625
3255333|NCT02536378|3989209|FG001|COMPLETED|Overall Study||53
3255334|NCT02536378|3989208|FG000|NOT COMPLETED|Overall Study||7
3255335|NCT02536378|3989209|FG001|NOT COMPLETED|Overall Study||7
3255336|NCT02536404|3989219|FG000|STARTED|Overall Study||112
3255337|NCT02536404|3989220|FG001|STARTED|Overall Study||6
3255338|NCT02536404|3989219|FG000|COMPLETED|Overall Study||92
3255339|NCT02536404|3989220|FG001|COMPLETED|Overall Study||5
3255340|NCT02536404|3989219|FG000|NOT COMPLETED|Overall Study||20
3255341|NCT02536404|3989220|FG001|NOT COMPLETED|Overall Study||1
3255342|NCT02536508|3989229|FG000|STARTED|Overall Study||194
3255343|NCT02536508|3989230|FG001|STARTED|Overall Study||174
3255344|NCT02536508|3989231|FG002|STARTED|Overall Study||88
3255345|NCT02536508|3989229|FG000|COMPLETED|Overall Study||142
3255346|NCT02536508|3989230|FG001|COMPLETED|Overall Study||130
3255347|NCT02536508|3989231|FG002|COMPLETED|Overall Study||65
3255348|NCT02536508|3989229|FG000|NOT COMPLETED|Overall Study||52
3255349|NCT02536508|3989230|FG001|NOT COMPLETED|Overall Study||44
3255350|NCT02536508|3989231|FG002|NOT COMPLETED|Overall Study||23
3255351|NCT02536664|3989241|FG000|STARTED|Overall Study||312
3255352|NCT02536664|3989242|FG001|STARTED|Overall Study||177
3255353|NCT02536664|3989241|FG000|COMPLETED|Overall Study||205
3255354|NCT02536664|3989242|FG001|COMPLETED|Overall Study||97
3255355|NCT02536664|3989241|FG000|NOT COMPLETED|Overall Study||107
3255356|NCT02536664|3989242|FG001|NOT COMPLETED|Overall Study||80
3255357|NCT02536781|3989250|FG000|STARTED|Overall Study||36
3255358|NCT02536781|3989251|FG001|STARTED|Overall Study||34
3255359|NCT02536781|3989250|FG000|COMPLETED|Overall Study||34
3255360|NCT02536781|3989251|FG001|COMPLETED|Overall Study||34
3255361|NCT02536781|3989250|FG000|NOT COMPLETED|Overall Study||2
3255362|NCT02536781|3989251|FG001|NOT COMPLETED|Overall Study||0
3255363|NCT02536794|3989257|FG000|STARTED|Reached 1st Response Assessment||30
3255364|NCT02536794|3989257|FG000|Started Treatment|Reached 1st Response Assessment||30
3255365|NCT02536794|3989257|FG000|Attempted First Cycle|Reached 1st Response Assessment||30
3255366|NCT02536794|3989257|FG000|Attempted Second Cycle|Reached 1st Response Assessment||24
3255367|NCT02536794|3989257|FG000|Reached First Response|Reached 1st Response Assessment||24
3255368|NCT02536794|3989257|FG000|COMPLETED|Reached 1st Response Assessment||24
3255369|NCT02536794|3989257|FG000|NOT COMPLETED|Reached 1st Response Assessment||6
3255370|NCT02536794|3989257|FG000|STARTED|Continued Treatment After 1st Response||24
3255371|NCT02536794|3989257|FG000|Went on to Start Cycle 3|Continued Treatment After 1st Response||16
3255372|NCT02536794|3989257|FG000|COMPLETED|Continued Treatment After 1st Response||16
3255373|NCT02536794|3989257|FG000|NOT COMPLETED|Continued Treatment After 1st Response||8
3255374|NCT02536794|3989257|FG000|STARTED|Follow up for 3 Years or Death|one patient did not go into follow up as treatment was discontinued due to a protocol violation|29
3255375|NCT02536794|3989257|FG000|COMPLETED|Follow up for 3 Years or Death||29
3255376|NCT02536794|3989257|FG000|NOT COMPLETED|Follow up for 3 Years or Death||0
3255377|NCT02536833|3989265|FG000|STARTED|Overall Study||112
3255378|NCT02536833|3989266|FG001|STARTED|Overall Study||117
3255379|NCT02536833|3989267|FG002|STARTED|Overall Study||110
3255380|NCT02536833|3989268|FG003|STARTED|Overall Study||116
3255381|NCT02536833|3989265|FG000|COMPLETED|Overall Study||103
3255382|NCT02536833|3989266|FG001|COMPLETED|Overall Study||107
3255383|NCT02536833|3989267|FG002|COMPLETED|Overall Study||95
3255384|NCT02536833|3989268|FG003|COMPLETED|Overall Study||97
3255385|NCT02536833|3989265|FG000|NOT COMPLETED|Overall Study||9
3255386|NCT02536833|3989266|FG001|NOT COMPLETED|Overall Study||10
3255387|NCT02536833|3989267|FG002|NOT COMPLETED|Overall Study||15
3255388|NCT02536833|3989268|FG003|NOT COMPLETED|Overall Study||19
3255389|NCT02536846|3989279|FG000|STARTED|Overall Study||10
3255390|NCT02536846|3989279|FG000|COMPLETED|Overall Study||9
3255391|NCT02536846|3989279|FG000|NOT COMPLETED|Overall Study||1
3255392|NCT02536963|3989284|FG000|STARTED|Overall Study||318
3255393|NCT02536963|3989284|FG000|COMPLETED|Overall Study||300
3255394|NCT02536963|3989284|FG000|NOT COMPLETED|Overall Study||18
3255395|NCT02536976|3989290|FG000|STARTED|Overall Study|2 weeks single blind placebo run-in|3
3255396|NCT02536976|3989291|FG001|STARTED|Overall Study|2 weeks single blind placebo run-in. 1 participant terminated due to unrelated failing health|2
3255397|NCT02536976|3989290|FG000|Randomization|Overall Study|2 weeks double blind mirabegron|3
3255398|NCT02536976|3989291|FG001|Randomization|Overall Study|2 weeks double blind placebo matching mirabegron|1
3372295|NCT03161964|4104204|FG001|NOT COMPLETED|Overall Study||1
3372296|NCT03150160|4104212|FG000|STARTED|Overall Study||0
3372297|NCT03150160|4104213|FG001|STARTED|Overall Study||1
3372298|NCT03150160|4104212|FG000|COMPLETED|Overall Study||0
3372299|NCT03150160|4104213|FG001|COMPLETED|Overall Study||1
3372300|NCT03150160|4104212|FG000|NOT COMPLETED|Overall Study||0
3372301|NCT03150160|4104213|FG001|NOT COMPLETED|Overall Study||0
3372302|NCT03137225|4104221|FG000|STARTED|First 4 Hour Measurement Period||1
3372303|NCT03137225|4104222|FG001|STARTED|First 4 Hour Measurement Period||0
3372304|NCT03137225|4104221|FG000|COMPLETED|First 4 Hour Measurement Period||1
3372305|NCT03137225|4104222|FG001|COMPLETED|First 4 Hour Measurement Period||0
3372306|NCT03137225|4104221|FG000|NOT COMPLETED|First 4 Hour Measurement Period||0
3372307|NCT03137225|4104222|FG001|NOT COMPLETED|First 4 Hour Measurement Period||0
3372308|NCT03137225|4104221|FG000|STARTED|Second 4 Hour Measurement Period||1
3372309|NCT03137225|4104222|FG001|STARTED|Second 4 Hour Measurement Period||0
3372310|NCT03137225|4104221|FG000|COMPLETED|Second 4 Hour Measurement Period||1
3372311|NCT03137225|4104222|FG001|COMPLETED|Second 4 Hour Measurement Period||0
3372312|NCT03137225|4104221|FG000|NOT COMPLETED|Second 4 Hour Measurement Period||0
3372313|NCT03137225|4104222|FG001|NOT COMPLETED|Second 4 Hour Measurement Period||0
3372314|NCT03123393|4104230|FG000|STARTED|Overall Study||24
3372315|NCT03123393|4104231|FG001|STARTED|Overall Study||25
3372316|NCT03123393|4104230|FG000|COMPLETED|Overall Study||3
3372317|NCT03123393|4104231|FG001|COMPLETED|Overall Study||2
3372318|NCT03123393|4104230|FG000|NOT COMPLETED|Overall Study||21
3372319|NCT03123393|4104231|FG001|NOT COMPLETED|Overall Study||23
3372320|NCT03123328|4104237|FG000|STARTED|Overall Study||380
3372321|NCT03123328|4104237|FG000|COMPLETED|Overall Study||351
3372322|NCT03123328|4104237|FG000|NOT COMPLETED|Overall Study||29
3372323|NCT03119662|4104243|FG000|STARTED|Overall Study||2
3372324|NCT03119662|4104244|FG001|STARTED|Overall Study||2
3372325|NCT03119662|4104243|FG000|COMPLETED|Overall Study||2
3372326|NCT03119662|4104244|FG001|COMPLETED|Overall Study||1
3372327|NCT03119662|4104243|FG000|NOT COMPLETED|Overall Study||0
3255399|NCT02536976|3989290|FG000|Dose Escalation and Maintenance|Overall Study|10 weeks double blind mirabegron|3
3255400|NCT02536976|3989291|FG001|Dose Escalation and Maintenance|Overall Study|10 weeks double blind placebo matching mirabegron|1
3255401|NCT02536976|3989290|FG000|Washout|Overall Study||3
3255402|NCT02536976|3989291|FG001|Washout|Overall Study||1
3255403|NCT02536976|3989290|FG000|COMPLETED|Overall Study||3
3255404|NCT02536976|3989291|FG001|COMPLETED|Overall Study||1
3255405|NCT02536976|3989290|FG000|NOT COMPLETED|Overall Study||0
3255406|NCT02536976|3989291|FG001|NOT COMPLETED|Overall Study||1
3255407|NCT02537015|3989299|FG000|STARTED|Overall Study||81
3255408|NCT02537015|3989299|FG000|COMPLETED|Overall Study||75
3255409|NCT02537015|3989299|FG000|NOT COMPLETED|Overall Study||6
3255410|NCT02537431|3989303|FG000|STARTED|Open-Label Period (Week 0 to Week 48)|Screened and received at least 1 dose of study drug.|14
3255411|NCT02537431|3989303|FG000|COMPLETED|Open-Label Period (Week 0 to Week 48)|Completed Open-Label Period (Week 0 - Week 48)|13
3255412|NCT02537431|3989303|FG000|NOT COMPLETED|Open-Label Period (Week 0 to Week 48)||1
3255413|NCT02537431|3989303|FG000|STARTED|Treatment Extension Period I||13
3255414|NCT02537431|3989303|FG000|COMPLETED|Treatment Extension Period I||13
3255415|NCT02537431|3989303|FG000|NOT COMPLETED|Treatment Extension Period I||0
3255416|NCT02537431|3989303|FG000|STARTED|Treatment Extension Period II|5 participants completing Treatment Extension Period I did not enter Treatment Extension Period II|8
3255417|NCT02537431|3989303|FG000|COMPLETED|Treatment Extension Period II||8
3255418|NCT02537431|3989303|FG000|NOT COMPLETED|Treatment Extension Period II||0
3255419|NCT02537444|3989309|FG000|STARTED|Overall Study||39
3255420|NCT02537444|3989310|FG001|STARTED|Overall Study||39
3255421|NCT02537444|3989309|FG000|Enrolled|Overall Study||39
3255422|NCT02537444|3989310|FG001|Enrolled|Overall Study||39
3255423|NCT02537444|3989309|FG000|Received Study Medication|Overall Study||38
3255424|NCT02537444|3989310|FG001|Received Study Medication|Overall Study||39
3255425|NCT02537444|3989309|FG000|Discontinued Study|Overall Study||39
3255426|NCT02537444|3989310|FG001|Discontinued Study|Overall Study||39
3255427|NCT02537444|3989309|FG000|COMPLETED|Overall Study||0
3255428|NCT02537444|3989310|FG001|COMPLETED|Overall Study||0
3255429|NCT02537444|3989309|FG000|NOT COMPLETED|Overall Study||39
3255430|NCT02537444|3989310|FG001|NOT COMPLETED|Overall Study||39
3255431|NCT02537522|3989316|FG000|STARTED|Phase I - Contralateral||34
3255432|NCT02537522|3989317|FG001|STARTED|Phase I - Contralateral||37
3255433|NCT02537522|3989318|FG002|STARTED|Phase I - Contralateral||0
3255434|NCT02537522|3989319|FG003|STARTED|Phase I - Contralateral||0
3255435|NCT02537522|3989316|FG000|COMPLETED|Phase I - Contralateral||19
3255436|NCT02537522|3989317|FG001|COMPLETED|Phase I - Contralateral||27
3255437|NCT02537522|3989318|FG002|COMPLETED|Phase I - Contralateral||0
3255438|NCT02537522|3989319|FG003|COMPLETED|Phase I - Contralateral||0
3255439|NCT02537522|3989316|FG000|NOT COMPLETED|Phase I - Contralateral||15
3255440|NCT02537522|3989317|FG001|NOT COMPLETED|Phase I - Contralateral||10
3255441|NCT02537522|3989318|FG002|NOT COMPLETED|Phase I - Contralateral||0
3255442|NCT02537522|3989319|FG003|NOT COMPLETED|Phase I - Contralateral||0
3255443|NCT02537522|3989316|FG000|STARTED|Phase II - Period 1 Bilateral||0
3255444|NCT02537522|3989317|FG001|STARTED|Phase II - Period 1 Bilateral||0
3255445|NCT02537522|3989318|FG002|STARTED|Phase II - Period 1 Bilateral||23
3255446|NCT02537522|3989319|FG003|STARTED|Phase II - Period 1 Bilateral||23
3255447|NCT02537522|3989316|FG000|COMPLETED|Phase II - Period 1 Bilateral||0
3255448|NCT02537522|3989317|FG001|COMPLETED|Phase II - Period 1 Bilateral||0
3255449|NCT02537522|3989318|FG002|COMPLETED|Phase II - Period 1 Bilateral||23
3255450|NCT02537522|3989319|FG003|COMPLETED|Phase II - Period 1 Bilateral||22
3255451|NCT02537522|3989316|FG000|NOT COMPLETED|Phase II - Period 1 Bilateral||0
3255452|NCT02537522|3989317|FG001|NOT COMPLETED|Phase II - Period 1 Bilateral||0
3255453|NCT02537522|3989318|FG002|NOT COMPLETED|Phase II - Period 1 Bilateral||0
3255454|NCT02537522|3989319|FG003|NOT COMPLETED|Phase II - Period 1 Bilateral||1
3255455|NCT02537522|3989316|FG000|STARTED|Phase II - Period 2 Bilateral||0
3255456|NCT02537522|3989317|FG001|STARTED|Phase II - Period 2 Bilateral||0
3255457|NCT02537522|3989318|FG002|STARTED|Phase II - Period 2 Bilateral||23
3255458|NCT02537522|3989319|FG003|STARTED|Phase II - Period 2 Bilateral||22
3255459|NCT02537522|3989316|FG000|COMPLETED|Phase II - Period 2 Bilateral||0
3255460|NCT02537522|3989317|FG001|COMPLETED|Phase II - Period 2 Bilateral||0
3255461|NCT02537522|3989318|FG002|COMPLETED|Phase II - Period 2 Bilateral||23
3255462|NCT02537522|3989319|FG003|COMPLETED|Phase II - Period 2 Bilateral||22
3255463|NCT02537522|3989316|FG000|NOT COMPLETED|Phase II - Period 2 Bilateral||0
3255464|NCT02537522|3989317|FG001|NOT COMPLETED|Phase II - Period 2 Bilateral||0
3255465|NCT02537522|3989318|FG002|NOT COMPLETED|Phase II - Period 2 Bilateral||0
3255466|NCT02537522|3989319|FG003|NOT COMPLETED|Phase II - Period 2 Bilateral||0
3255467|NCT02537574|3989328|FG000|STARTED|Overall Study||126
3255468|NCT02537574|3989329|FG001|STARTED|Overall Study||126
3255469|NCT02537574|3989330|FG002|STARTED|Overall Study||126
3255470|NCT02537574|3989328|FG000|COMPLETED|Overall Study||27
3255471|NCT02537574|3989329|FG001|COMPLETED|Overall Study||23
3255472|NCT02537574|3989330|FG002|COMPLETED|Overall Study||18
3255473|NCT02537574|3989328|FG000|NOT COMPLETED|Overall Study||99
3255474|NCT02537574|3989329|FG001|NOT COMPLETED|Overall Study||103
3255475|NCT02537574|3989330|FG002|NOT COMPLETED|Overall Study||108
3255476|NCT02537717|3989338|FG000|STARTED|Overall Study||17
3255477|NCT02537717|3989338|FG000|COMPLETED|Overall Study||17
3255478|NCT02537717|3989338|FG000|NOT COMPLETED|Overall Study||0
3255479|NCT02537730|3989345|FG000|STARTED|First Intervention (7 Days)||17
3255480|NCT02537730|3989346|FG001|STARTED|First Intervention (7 Days)||16
3255481|NCT02537730|3989345|FG000|COMPLETED|First Intervention (7 Days)||17
3255482|NCT02537730|3989346|FG001|COMPLETED|First Intervention (7 Days)||16
3255483|NCT02537730|3989345|FG000|NOT COMPLETED|First Intervention (7 Days)||0
3255484|NCT02537730|3989346|FG001|NOT COMPLETED|First Intervention (7 Days)||0
3255485|NCT02537730|3989345|FG000|STARTED|Second Intervention (7 Days)||17
3255486|NCT02537730|3989346|FG001|STARTED|Second Intervention (7 Days)||16
3255487|NCT02537730|3989345|FG000|COMPLETED|Second Intervention (7 Days)||17
3255488|NCT02537730|3989346|FG001|COMPLETED|Second Intervention (7 Days)||16
3255489|NCT02537730|3989345|FG000|NOT COMPLETED|Second Intervention (7 Days)||0
3255490|NCT02537730|3989346|FG001|NOT COMPLETED|Second Intervention (7 Days)||0
3255491|NCT02537873|3989354|FG000|STARTED|Overall Study||17
3255492|NCT02537873|3989355|FG001|STARTED|Overall Study||8
3255493|NCT02537873|3989354|FG000|COMPLETED|Overall Study||9
3255494|NCT02537873|3989355|FG001|COMPLETED|Overall Study||4
3255495|NCT02537873|3989354|FG000|NOT COMPLETED|Overall Study||8
3255496|NCT02537873|3989355|FG001|NOT COMPLETED|Overall Study||4
3255497|NCT02537951|3989362|FG000|STARTED|Overall Study||10
3255498|NCT02537951|3989362|FG000|COMPLETED|Overall Study||10
3255499|NCT02537951|3989362|FG000|NOT COMPLETED|Overall Study||0
3255500|NCT02538016|3989370|FG000|STARTED|Overall Study||4
3255501|NCT02538016|3989370|FG000|COMPLETED|Overall Study||4
3255502|NCT02538016|3989370|FG000|NOT COMPLETED|Overall Study||0
3255503|NCT02538029|3989377|FG000|STARTED|Overall Study||24
3255504|NCT02538029|3989378|FG001|STARTED|Overall Study||10
3255505|NCT02538029|3989379|FG002|STARTED|Overall Study||11
3255506|NCT02538029|3989377|FG000|COMPLETED|Overall Study||23
3255507|NCT02538029|3989378|FG001|COMPLETED|Overall Study||10
3255508|NCT02538029|3989379|FG002|COMPLETED|Overall Study||10
3255509|NCT02538029|3989377|FG000|NOT COMPLETED|Overall Study||1
3255510|NCT02538029|3989378|FG001|NOT COMPLETED|Overall Study||0
3255511|NCT02538029|3989379|FG002|NOT COMPLETED|Overall Study||1
3255512|NCT02538042|3989391|FG000|STARTED|Overall Study||17
3255513|NCT02538042|3989392|FG001|STARTED|Overall Study||17
3255514|NCT02538042|3989391|FG000|Completed All MCE Sessions|Overall Study||15
3255515|NCT02538042|3989392|FG001|Completed All MCE Sessions|Overall Study||15
3255516|NCT02538042|3989391|FG000|Attended Post-Quit Visit|Overall Study||15
3255517|NCT02538042|3989392|FG001|Attended Post-Quit Visit|Overall Study||14
3255518|NCT02538042|3989391|FG000|Completed All Post-Quit Visits|Overall Study||12
3255519|NCT02538042|3989392|FG001|Completed All Post-Quit Visits|Overall Study||12
3255520|NCT02538042|3989391|FG000|COMPLETED|Overall Study||6
3255521|NCT02538042|3989392|FG001|COMPLETED|Overall Study||6
3255522|NCT02538042|3989391|FG000|NOT COMPLETED|Overall Study||11
3255523|NCT02538042|3989392|FG001|NOT COMPLETED|Overall Study||11
3255524|NCT02538094|3989400|FG000|STARTED|Intervention 1 (5 Days Per Participant)||2
3255525|NCT02538094|3989401|FG001|STARTED|Intervention 1 (5 Days Per Participant)||5
3255526|NCT02538094|3989400|FG000|COMPLETED|Intervention 1 (5 Days Per Participant)||2
3255527|NCT02538094|3989401|FG001|COMPLETED|Intervention 1 (5 Days Per Participant)||4
3255528|NCT02538094|3989400|FG000|NOT COMPLETED|Intervention 1 (5 Days Per Participant)||0
3255529|NCT02538094|3989401|FG001|NOT COMPLETED|Intervention 1 (5 Days Per Participant)||1
3255530|NCT02538094|3989400|FG000|STARTED|Washout (4 Weeks)||2
3255531|NCT02538094|3989401|FG001|STARTED|Washout (4 Weeks)||4
3255532|NCT02538094|3989400|FG000|COMPLETED|Washout (4 Weeks)||2
3255533|NCT02538094|3989401|FG001|COMPLETED|Washout (4 Weeks)||3
3255534|NCT02538094|3989400|FG000|NOT COMPLETED|Washout (4 Weeks)||0
3255535|NCT02538094|3989401|FG001|NOT COMPLETED|Washout (4 Weeks)||1
3255536|NCT02538094|3989400|FG000|STARTED|Intervention 2 (5 Days Per Participant)||2
3255537|NCT02538094|3989401|FG001|STARTED|Intervention 2 (5 Days Per Participant)||3
3255538|NCT02538094|3989400|FG000|COMPLETED|Intervention 2 (5 Days Per Participant)||2
3255539|NCT02538094|3989401|FG001|COMPLETED|Intervention 2 (5 Days Per Participant)||3
3255540|NCT02538094|3989400|FG000|NOT COMPLETED|Intervention 2 (5 Days Per Participant)||0
3255541|NCT02538094|3989401|FG001|NOT COMPLETED|Intervention 2 (5 Days Per Participant)||0
3255542|NCT02538107|3989407|FG000|STARTED|Overall Study||290
3255543|NCT02538107|3989407|FG000|COMPLETED|Overall Study||180
3255544|NCT02538107|3989407|FG000|NOT COMPLETED|Overall Study||110
3255545|NCT02538341|3989423|FG000|STARTED|Overall Study||310
3255546|NCT02538341|3989424|FG001|STARTED|Overall Study||307
3255547|NCT02538341|3989423|FG000|Week 6 (Primary Outcome)|Overall Study||303
3255548|NCT02538341|3989424|FG001|Week 6 (Primary Outcome)|Overall Study||299
3255549|NCT02538341|3989423|FG000|Month 6 (Safety Outcome)|Overall Study||276
3255550|NCT02538341|3989424|FG001|Month 6 (Safety Outcome)|Overall Study||260
3255551|NCT02538341|3989423|FG000|1 Year Visit|Overall Study||254
3255552|NCT02538341|3989424|FG001|1 Year Visit|Overall Study||0
3255553|NCT02538341|3989423|FG000|COMPLETED|Overall Study||254
3255554|NCT02538341|3989424|FG001|COMPLETED|Overall Study||260
3255555|NCT02538341|3989423|FG000|NOT COMPLETED|Overall Study||56
3255556|NCT02538341|3989424|FG001|NOT COMPLETED|Overall Study||47
3255557|NCT02538354|3989432|FG000|STARTED|Overall Study||40
3255558|NCT02538354|3989433|FG001|STARTED|Overall Study||30
3255559|NCT02538354|3989432|FG000|COMPLETED|Overall Study||40
3255560|NCT02538354|3989433|FG001|COMPLETED|Overall Study||30
3255561|NCT02538354|3989432|FG000|NOT COMPLETED|Overall Study||0
3255562|NCT02538354|3989433|FG001|NOT COMPLETED|Overall Study||0
3255563|NCT02538419|3989441|FG000|STARTED|Overall Study||20
3255564|NCT02538419|3989442|FG001|STARTED|Overall Study||20
3255565|NCT02538419|3989441|FG000|COMPLETED|Overall Study||20
3255566|NCT02538419|3989442|FG001|COMPLETED|Overall Study||20
3255567|NCT02538419|3989441|FG000|NOT COMPLETED|Overall Study||0
3255568|NCT02538419|3989442|FG001|NOT COMPLETED|Overall Study||0
3255569|NCT02538471|3989448|FG000|STARTED|Overall Study||3
3255570|NCT02538471|3989448|FG000|COMPLETED|Overall Study||1
3255571|NCT02538471|3989448|FG000|NOT COMPLETED|Overall Study||2
3255572|NCT02538523|3989454|FG000|STARTED|Overall Study||29
3255573|NCT02538523|3989455|FG001|STARTED|Overall Study||29
3255574|NCT02538523|3989454|FG000|COMPLETED|Overall Study||29
3255575|NCT02538523|3989455|FG001|COMPLETED|Overall Study||29
3255576|NCT02538523|3989454|FG000|NOT COMPLETED|Overall Study||0
3255577|NCT02538523|3989455|FG001|NOT COMPLETED|Overall Study||0
3255578|NCT02538614|3989461|FG000|STARTED|Overall Study||2
3255579|NCT02538614|3989461|FG000|COMPLETED|Overall Study||0
3255580|NCT02538614|3989461|FG000|NOT COMPLETED|Overall Study||2
3255581|NCT02538679|3989470|FG000|STARTED|Overall Study||24
3255582|NCT02538679|3989471|FG001|STARTED|Overall Study||54
3255583|NCT02538679|3989472|FG002|STARTED|Overall Study||49
3255584|NCT02538679|3989470|FG000|COMPLETED|Overall Study||21
3255585|NCT02538679|3989471|FG001|COMPLETED|Overall Study||45
3255586|NCT02538679|3989472|FG002|COMPLETED|Overall Study||41
3255587|NCT02538679|3989470|FG000|NOT COMPLETED|Overall Study||3
3255588|NCT02538679|3989471|FG001|NOT COMPLETED|Overall Study||9
3255589|NCT02538679|3989472|FG002|NOT COMPLETED|Overall Study||8
3255590|NCT02538783|3989482|FG000|STARTED|Overall Study||130
3255591|NCT02538783|3989483|FG001|STARTED|Overall Study||129
3255592|NCT02538783|3989482|FG000|COMPLETED|Overall Study||130
3255593|NCT02538783|3989483|FG001|COMPLETED|Overall Study||128
3255594|NCT02538783|3989482|FG000|NOT COMPLETED|Overall Study||0
3255595|NCT02538783|3989483|FG001|NOT COMPLETED|Overall Study||1
3255596|NCT02538900|3989492|FG000|STARTED|Overall Study||116
3255597|NCT02538900|3989493|FG001|STARTED|Overall Study||124
3255598|NCT02538900|3989494|FG002|STARTED|Overall Study||65
3255599|NCT02538900|3989492|FG000|COMPLETED|Overall Study||96
3255600|NCT02538900|3989493|FG001|COMPLETED|Overall Study||106
3255601|NCT02538900|3989494|FG002|COMPLETED|Overall Study||48
3255602|NCT02538900|3989492|FG000|NOT COMPLETED|Overall Study||20
3255603|NCT02538900|3989493|FG001|NOT COMPLETED|Overall Study||18
3255604|NCT02538900|3989494|FG002|NOT COMPLETED|Overall Study||17
3372328|NCT03119662|4104244|FG001|NOT COMPLETED|Overall Study||1
3372329|NCT03109418|4104252|FG000|STARTED|Overall Study||2
3372330|NCT03109418|4104253|FG001|STARTED|Overall Study||4
3372331|NCT03109418|4104252|FG000|COMPLETED|Overall Study||2
3372332|NCT03109418|4104253|FG001|COMPLETED|Overall Study||3
3372333|NCT03109418|4104252|FG000|NOT COMPLETED|Overall Study||0
3372334|NCT03109418|4104253|FG001|NOT COMPLETED|Overall Study||1
3372335|NCT03120676|4104259|FG000|STARTED|Overall Study||3
3372336|NCT03120676|4104259|FG000|COMPLETED|Overall Study||2
3372337|NCT03120676|4104259|FG000|NOT COMPLETED|Overall Study||1
3372338|NCT03109873|4104265|FG000|STARTED|Overall Study||5
3372339|NCT03109873|4104266|FG001|STARTED|Overall Study||4
3372340|NCT03109873|4104265|FG000|COMPLETED|Overall Study||5
3372341|NCT03109873|4104266|FG001|COMPLETED|Overall Study||4
3372342|NCT03109873|4104265|FG000|NOT COMPLETED|Overall Study||0
3372343|NCT03109873|4104266|FG001|NOT COMPLETED|Overall Study||0
3372344|NCT03100617|4104272|FG000|STARTED|Overall Study||6
3372345|NCT03100617|4104272|FG000|COMPLETED|Overall Study||6
3372346|NCT03100617|4104272|FG000|NOT COMPLETED|Overall Study||0
3372347|NCT03115853|4104276|FG000|STARTED|Overall Study||31
3372348|NCT03115853|4104276|FG000|COMPLETED|Overall Study||31
3372349|NCT03115853|4104276|FG000|NOT COMPLETED|Overall Study||0
3372350|NCT03113071|4104284|FG000|STARTED|Overall Study||1
3372351|NCT03113071|4104285|FG001|STARTED|Overall Study||0
3372352|NCT03113071|4104284|FG000|COMPLETED|Overall Study||0
3372353|NCT03113071|4104285|FG001|COMPLETED|Overall Study||0
3372354|NCT03113071|4104284|FG000|NOT COMPLETED|Overall Study||1
3372355|NCT03113071|4104285|FG001|NOT COMPLETED|Overall Study||0
3372356|NCT03110900|4104293|FG000|STARTED|Overall Study||1
3372357|NCT03110900|4104294|FG001|STARTED|Overall Study||1
3372358|NCT03110900|4104293|FG000|COMPLETED|Overall Study||0
3372359|NCT03110900|4104294|FG001|COMPLETED|Overall Study||0
3372360|NCT03110900|4104293|FG000|NOT COMPLETED|Overall Study||1
3372361|NCT03110900|4104294|FG001|NOT COMPLETED|Overall Study||1
3372362|NCT03078868|4104300|FG000|STARTED|Overall Study||3
3372363|NCT03078868|4104300|FG000|COMPLETED|Overall Study||0
3372364|NCT03078868|4104300|FG000|NOT COMPLETED|Overall Study||3
3372365|NCT03078270|4104306|FG000|STARTED|Overall Study||4
3372366|NCT03078270|4104307|FG001|STARTED|Overall Study||0
3372367|NCT03078270|4104306|FG000|COMPLETED|Overall Study||0
3372368|NCT03078270|4104307|FG001|COMPLETED|Overall Study||0
3372369|NCT03078270|4104306|FG000|NOT COMPLETED|Overall Study||4
3372370|NCT03078270|4104307|FG001|NOT COMPLETED|Overall Study||0
3372371|NCT03065933|4104313|FG000|STARTED|Overall Study||5
3372372|NCT03065933|4104313|FG000|COMPLETED|Overall Study||0
3372373|NCT03065933|4104313|FG000|NOT COMPLETED|Overall Study||5
3372374|NCT03070002|4104317|FG000|STARTED|3 Cycles of Treatment||1
3372375|NCT03070002|4104317|FG000|COMPLETED|3 Cycles of Treatment||1
3372376|NCT03070002|4104317|FG000|NOT COMPLETED|3 Cycles of Treatment||0
3372377|NCT03070002|4104317|FG000|STARTED|Follow up for 2 Years||1
3372378|NCT03070002|4104317|FG000|COMPLETED|Follow up for 2 Years||0
3372379|NCT03070002|4104317|FG000|NOT COMPLETED|Follow up for 2 Years||1
3372380|NCT03058705|4104321|FG000|STARTED|Overall Study||10
3372381|NCT03058705|4104321|FG000|COMPLETED|Overall Study||6
3372382|NCT03058705|4104321|FG000|NOT COMPLETED|Overall Study||4
3372383|NCT03061279|4104327|FG000|STARTED|Overall Study||0
3372384|NCT03061279|4104328|FG001|STARTED|Overall Study||1
3372385|NCT03061279|4104327|FG000|COMPLETED|Overall Study||0
3372386|NCT03061279|4104328|FG001|COMPLETED|Overall Study||0
3255605|NCT02538965|3989502|FG000|STARTED|Treatment Period||17
3255606|NCT02538965|3989502|FG000|COMPLETED|Treatment Period||0
3255607|NCT02538965|3989502|FG000|NOT COMPLETED|Treatment Period||17
3255608|NCT02538965|3989502|FG000|STARTED|Follow-Up Period||17
3255609|NCT02538965|3989502|FG000|COMPLETED|Follow-Up Period||0
3255610|NCT02538965|3989502|FG000|NOT COMPLETED|Follow-Up Period||17
3255611|NCT02539108|3989508|FG000|STARTED|Overall Study||30
3255612|NCT02539108|3989509|FG001|STARTED|Overall Study||30
3255613|NCT02539108|3989508|FG000|COMPLETED|Overall Study||30
3255614|NCT02539108|3989509|FG001|COMPLETED|Overall Study||30
3255615|NCT02539108|3989508|FG000|NOT COMPLETED|Overall Study||0
3255616|NCT02539108|3989509|FG001|NOT COMPLETED|Overall Study||0
3255617|NCT02539134|3989521|FG000|STARTED|Overall Study||10
3255618|NCT02539134|3989522|FG001|STARTED|Overall Study||6
3255619|NCT02539134|3989523|FG002|STARTED|Overall Study||6
3255620|NCT02539134|3989524|FG003|STARTED|Overall Study||6
3255621|NCT02539134|3989525|FG004|STARTED|Overall Study||6
3255622|NCT02539134|3989526|FG005|STARTED|Overall Study||6
3255623|NCT02539134|3989521|FG000|COMPLETED|Overall Study||9
3255624|NCT02539134|3989522|FG001|COMPLETED|Overall Study||6
3255625|NCT02539134|3989523|FG002|COMPLETED|Overall Study||6
3255626|NCT02539134|3989524|FG003|COMPLETED|Overall Study||6
3255627|NCT02539134|3989525|FG004|COMPLETED|Overall Study||6
3255628|NCT02539134|3989526|FG005|COMPLETED|Overall Study||6
3255629|NCT02539134|3989521|FG000|NOT COMPLETED|Overall Study||1
3255630|NCT02539134|3989522|FG001|NOT COMPLETED|Overall Study||0
3255631|NCT02539134|3989523|FG002|NOT COMPLETED|Overall Study||0
3255632|NCT02539134|3989524|FG003|NOT COMPLETED|Overall Study||0
3255633|NCT02539134|3989525|FG004|NOT COMPLETED|Overall Study||0
3255634|NCT02539134|3989526|FG005|NOT COMPLETED|Overall Study||0
3255635|NCT02539225|3989547|FG000|STARTED|Part A||97
3255636|NCT02539225|3989548|FG001|STARTED|Part A||94
3255637|NCT02539225|3989547|FG000|Received Any Quantity of Study Drug|Part A||96
3255638|NCT02539225|3989548|FG001|Received Any Quantity of Study Drug|Part A||93
3255639|NCT02539225|3989547|FG000|COMPLETED|Part A||77
3255640|NCT02539225|3989548|FG001|COMPLETED|Part A||78
3255641|NCT02539225|3989547|FG000|NOT COMPLETED|Part A||20
3255642|NCT02539225|3989548|FG001|NOT COMPLETED|Part A||16
3255643|NCT02539225|3989547|FG000|STARTED|Pre Treatment for Part B|Participants who met initiation criteria of Part B were allowed to pretreatment for part B.|63
3255644|NCT02539225|3989548|FG001|STARTED|Pre Treatment for Part B|Participants who met initiation criteria of Part B were allowed to pretreatment for part B.|66
3255645|NCT02539225|3989547|FG000|COMPLETED|Pre Treatment for Part B||58
3255646|NCT02539225|3989548|FG001|COMPLETED|Pre Treatment for Part B||64
3255647|NCT02539225|3989547|FG000|NOT COMPLETED|Pre Treatment for Part B||5
3255648|NCT02539225|3989548|FG001|NOT COMPLETED|Pre Treatment for Part B||2
3255649|NCT02539225|3989547|FG000|STARTED|Part B||58
3255650|NCT02539225|3989548|FG001|STARTED|Part B||64
3255651|NCT02539225|3989547|FG000|COMPLETED|Part B||54
3255652|NCT02539225|3989548|FG001|COMPLETED|Part B||48
3255653|NCT02539225|3989547|FG000|NOT COMPLETED|Part B||4
3255654|NCT02539225|3989548|FG001|NOT COMPLETED|Part B||16
3255655|NCT02539342|3989561|FG000|STARTED|Overall Study||1
3255656|NCT02539342|3989562|FG001|STARTED|Overall Study||0
3255657|NCT02539342|3989561|FG000|COMPLETED|Overall Study||1
3255658|NCT02539342|3989562|FG001|COMPLETED|Overall Study||0
3255659|NCT02539342|3989561|FG000|NOT COMPLETED|Overall Study||0
3255660|NCT02539342|3989562|FG001|NOT COMPLETED|Overall Study||0
3255661|NCT02539368|3989573|FG000|STARTED|Overall Study||1522
3255662|NCT02539368|3989574|FG001|STARTED|Overall Study||494
3255663|NCT02539368|3989575|FG002|STARTED|Overall Study||358
3255664|NCT02539368|3989576|FG003|STARTED|Overall Study||67
3255665|NCT02539368|3989577|FG004|STARTED|Overall Study||102
3255666|NCT02539368|3989573|FG000|COMPLETED|Overall Study||1117
3255667|NCT02539368|3989574|FG001|COMPLETED|Overall Study||393
3255668|NCT02539368|3989575|FG002|COMPLETED|Overall Study||291
3255669|NCT02539368|3989576|FG003|COMPLETED|Overall Study||60
3255670|NCT02539368|3989577|FG004|COMPLETED|Overall Study||88
3255671|NCT02539368|3989573|FG000|NOT COMPLETED|Overall Study||405
3255672|NCT02539368|3989574|FG001|NOT COMPLETED|Overall Study||101
3255673|NCT02539368|3989575|FG002|NOT COMPLETED|Overall Study||67
3255674|NCT02539368|3989576|FG003|NOT COMPLETED|Overall Study||7
3255675|NCT02539368|3989577|FG004|NOT COMPLETED|Overall Study||14
3255676|NCT02539459|3989592|FG000|STARTED|Overall Study||20
3255677|NCT02539459|3989592|FG000|COMPLETED|Overall Study||18
3255678|NCT02539459|3989592|FG000|NOT COMPLETED|Overall Study||2
3255679|NCT02539511|3989598|FG000|STARTED|Overall Study||23
3255680|NCT02539511|3989599|FG001|STARTED|Overall Study||17
3255681|NCT02539511|3989598|FG000|COMPLETED|Overall Study||17
3255682|NCT02539511|3989599|FG001|COMPLETED|Overall Study||17
3255683|NCT02539511|3989598|FG000|NOT COMPLETED|Overall Study||6
3255684|NCT02539511|3989599|FG001|NOT COMPLETED|Overall Study||0
3255685|NCT02539563|3989607|FG000|STARTED|Overall Study||45
3255686|NCT02539563|3989608|FG001|STARTED|Overall Study||56
3255687|NCT02539563|3989607|FG000|COMPLETED|Overall Study||39
3255688|NCT02539563|3989608|FG001|COMPLETED|Overall Study||42
3255689|NCT02539563|3989607|FG000|NOT COMPLETED|Overall Study||6
3255690|NCT02539563|3989608|FG001|NOT COMPLETED|Overall Study||14
3255691|NCT02539654|3989614|FG000|STARTED|Overall Study||14
3255692|NCT02539654|3989614|FG000|COMPLETED|Overall Study||14
3255693|NCT02539654|3989614|FG000|NOT COMPLETED|Overall Study||0
3255694|NCT02539797|3989619|FG000|STARTED|Overall Study||12
3255695|NCT02539797|3989620|FG001|STARTED|Overall Study||13
3255696|NCT02539797|3989621|FG002|STARTED|Overall Study||13
3255697|NCT02539797|3989619|FG000|COMPLETED|Overall Study||12
3255698|NCT02539797|3989620|FG001|COMPLETED|Overall Study||12
3255699|NCT02539797|3989621|FG002|COMPLETED|Overall Study||13
3255700|NCT02539797|3989619|FG000|NOT COMPLETED|Overall Study||0
3255701|NCT02539797|3989620|FG001|NOT COMPLETED|Overall Study||1
3255702|NCT02539797|3989621|FG002|NOT COMPLETED|Overall Study||0
3255703|NCT02539992|3989632|FG000|STARTED|Overall Study||15
3255704|NCT02539992|3989633|FG001|STARTED|Overall Study||11
3255705|NCT02539992|3989634|FG002|STARTED|Overall Study||18
3255706|NCT02539992|3989632|FG000|COMPLETED|Overall Study||15
3255707|NCT02539992|3989633|FG001|COMPLETED|Overall Study||7
3255708|NCT02539992|3989634|FG002|COMPLETED|Overall Study||14
3255709|NCT02539992|3989632|FG000|NOT COMPLETED|Overall Study||0
3255710|NCT02539992|3989633|FG001|NOT COMPLETED|Overall Study||4
3255711|NCT02539992|3989634|FG002|NOT COMPLETED|Overall Study||4
3255712|NCT02540083|3989644|FG000|STARTED|Overall Study||94
3255713|NCT02540083|3989644|FG000|COMPLETED|Overall Study||78
3255714|NCT02540083|3989644|FG000|NOT COMPLETED|Overall Study||16
3255715|NCT02540161|3989652|FG000|STARTED|Overall Study||20
3255716|NCT02540161|3989653|FG001|STARTED|Overall Study||7
3255717|NCT02540161|3989654|FG002|STARTED|Overall Study||5
3255718|NCT02540161|3989655|FG003|STARTED|Overall Study||7
3255719|NCT02540161|3989652|FG000|COMPLETED|Overall Study||20
3255720|NCT02540161|3989653|FG001|COMPLETED|Overall Study||7
3255721|NCT02540161|3989654|FG002|COMPLETED|Overall Study||5
3255722|NCT02540161|3989655|FG003|COMPLETED|Overall Study||7
3255723|NCT02540161|3989652|FG000|NOT COMPLETED|Overall Study||0
3255724|NCT02540161|3989653|FG001|NOT COMPLETED|Overall Study||0
3255725|NCT02540161|3989654|FG002|NOT COMPLETED|Overall Study||0
3255726|NCT02540161|3989655|FG003|NOT COMPLETED|Overall Study||0
3255727|NCT02540213|3989665|FG000|STARTED|Overall Study||240
3255728|NCT02540213|3989665|FG000|COMPLETED|Overall Study||201
3255729|NCT02540213|3989665|FG000|NOT COMPLETED|Overall Study||39
3255730|NCT02540226|3989671|FG000|STARTED|Overall Study||33
3255731|NCT02540226|3989672|FG001|STARTED|Overall Study||33
3255732|NCT02540226|3989671|FG000|COMPLETED|Overall Study||31
3255733|NCT02540226|3989672|FG001|COMPLETED|Overall Study||32
3255734|NCT02540226|3989671|FG000|NOT COMPLETED|Overall Study||2
3255735|NCT02540226|3989672|FG001|NOT COMPLETED|Overall Study||1
3255736|NCT02540265|3989681|FG000|STARTED|Overall Study||20
3255737|NCT02540265|3989682|FG001|STARTED|Overall Study||20
3255738|NCT02540265|3989683|FG002|STARTED|Overall Study||19
3255739|NCT02540265|3989681|FG000|Treatment Completion|Overall Study||20
3255740|NCT02540265|3989682|FG001|Treatment Completion|Overall Study||19
3255741|NCT02540265|3989683|FG002|Treatment Completion|Overall Study||18
3255742|NCT02540265|3989681|FG000|COMPLETED|Overall Study||20
3255743|NCT02540265|3989682|FG001|COMPLETED|Overall Study||20
3255744|NCT02540265|3989683|FG002|COMPLETED|Overall Study||18
3255745|NCT02540265|3989681|FG000|NOT COMPLETED|Overall Study||0
3255746|NCT02540265|3989682|FG001|NOT COMPLETED|Overall Study||0
3255747|NCT02540265|3989683|FG002|NOT COMPLETED|Overall Study||1
3255748|NCT02540291|3989695|FG000|STARTED|Overall Study||8
3255749|NCT02540291|3989696|FG001|STARTED|Overall Study||8
3255750|NCT02540291|3989697|FG002|STARTED|Overall Study||7
3255751|NCT02540291|3989698|FG003|STARTED|Overall Study||7
3255752|NCT02540291|3989695|FG000|COMPLETED|Overall Study||0
3255753|NCT02540291|3989696|FG001|COMPLETED|Overall Study||0
3255754|NCT02540291|3989697|FG002|COMPLETED|Overall Study||0
3255755|NCT02540291|3989698|FG003|COMPLETED|Overall Study||0
3255756|NCT02540291|3989695|FG000|NOT COMPLETED|Overall Study||8
3255757|NCT02540291|3989696|FG001|NOT COMPLETED|Overall Study||8
3255758|NCT02540291|3989697|FG002|NOT COMPLETED|Overall Study||7
3255759|NCT02540291|3989698|FG003|NOT COMPLETED|Overall Study||7
3255760|NCT02540356|3989712|FG000|STARTED|Overall Study||1
3255761|NCT02540356|3989713|FG001|STARTED|Overall Study||0
3255762|NCT02540356|3989712|FG000|COMPLETED|Overall Study||0
3255763|NCT02540356|3989713|FG001|COMPLETED|Overall Study||0
3255764|NCT02540356|3989712|FG000|NOT COMPLETED|Overall Study||1
3255765|NCT02540356|3989713|FG001|NOT COMPLETED|Overall Study||0
3255766|NCT02540447|3989720|FG000|STARTED|Overall Study||40
3255767|NCT02540447|3989721|FG001|STARTED|Overall Study||40
3255768|NCT02540447|3989720|FG000|COMPLETED|Overall Study||40
3255769|NCT02540447|3989721|FG001|COMPLETED|Overall Study||40
3255770|NCT02540447|3989720|FG000|NOT COMPLETED|Overall Study||0
3255771|NCT02540447|3989721|FG001|NOT COMPLETED|Overall Study||0
3255772|NCT02540538|3989730|FG000|STARTED|Overall Study||12
3255773|NCT02540538|3989731|FG001|STARTED|Overall Study||12
3255774|NCT02540538|3989732|FG002|STARTED|Overall Study||10
3255775|NCT02540538|3989730|FG000|COMPLETED|Overall Study||12
3255776|NCT02540538|3989731|FG001|COMPLETED|Overall Study||11
3255777|NCT02540538|3989732|FG002|COMPLETED|Overall Study||10
3255778|NCT02540538|3989730|FG000|NOT COMPLETED|Overall Study||0
3255779|NCT02540538|3989731|FG001|NOT COMPLETED|Overall Study||1
3255780|NCT02540538|3989732|FG002|NOT COMPLETED|Overall Study||0
3255781|NCT02540629|3989742|FG000|STARTED|Overall Study||6201
3255782|NCT02540629|3989743|FG001|STARTED|Overall Study||6469
3255783|NCT02540629|3989742|FG000|COMPLETED|Overall Study||6201
3255784|NCT02540629|3989743|FG001|COMPLETED|Overall Study||6469
3255785|NCT02540629|3989742|FG000|NOT COMPLETED|Overall Study||0
3255786|NCT02540629|3989743|FG001|NOT COMPLETED|Overall Study||0
3255787|NCT02540668|3989750|FG000|STARTED|Period 1 - Warfarin Single Dose||15
3255788|NCT02540668|3989751|FG001|STARTED|Period 1 - Warfarin Single Dose||0
3255789|NCT02540668|3989750|FG000|Received at Least One Dose of Study Drug|Period 1 - Warfarin Single Dose||15
3255790|NCT02540668|3989751|FG001|Received at Least One Dose of Study Drug|Period 1 - Warfarin Single Dose||0
3255791|NCT02540668|3989750|FG000|COMPLETED|Period 1 - Warfarin Single Dose||15
3255792|NCT02540668|3989751|FG001|COMPLETED|Period 1 - Warfarin Single Dose||0
3255793|NCT02540668|3989750|FG000|NOT COMPLETED|Period 1 - Warfarin Single Dose||0
3255794|NCT02540668|3989751|FG001|NOT COMPLETED|Period 1 - Warfarin Single Dose||0
3255795|NCT02540668|3989750|FG000|STARTED|Period 2 - LY3314814 and Warfarin|Warfarin was administered alone only in Period 1.|0
3255796|NCT02540668|3989751|FG001|STARTED|Period 2 - LY3314814 and Warfarin|Warfarin was co-administered with LY3314814 only in Period 2.|15
3255797|NCT02540668|3989750|FG000|COMPLETED|Period 2 - LY3314814 and Warfarin||0
3255798|NCT02540668|3989751|FG001|COMPLETED|Period 2 - LY3314814 and Warfarin||14
3255799|NCT02540668|3989750|FG000|NOT COMPLETED|Period 2 - LY3314814 and Warfarin||0
3255800|NCT02540668|3989751|FG001|NOT COMPLETED|Period 2 - LY3314814 and Warfarin||1
3255801|NCT02540772|3989760|FG000|STARTED|Overall Study||10
3255802|NCT02540772|3989761|FG001|STARTED|Overall Study||10
3255803|NCT02540772|3989760|FG000|COMPLETED|Overall Study||10
3255804|NCT02540772|3989761|FG001|COMPLETED|Overall Study||10
3255805|NCT02540772|3989760|FG000|NOT COMPLETED|Overall Study||0
3255806|NCT02540772|3989761|FG001|NOT COMPLETED|Overall Study||0
3255807|NCT02540850|3989770|FG000|STARTED|Overall Study||360
3255808|NCT02540850|3989771|FG001|STARTED|Overall Study||396
3255809|NCT02540850|3989772|FG002|STARTED|Overall Study||444
3255810|NCT02540850|3989770|FG000|COMPLETED|Overall Study||291
3255811|NCT02540850|3989771|FG001|COMPLETED|Overall Study||330
3255812|NCT02540850|3989772|FG002|COMPLETED|Overall Study||410
3255813|NCT02540850|3989770|FG000|NOT COMPLETED|Overall Study||69
3255814|NCT02540850|3989771|FG001|NOT COMPLETED|Overall Study||66
3255815|NCT02540850|3989772|FG002|NOT COMPLETED|Overall Study||34
3255816|NCT02540954|3989782|FG000|STARTED|Overall Study||168
3255817|NCT02540954|3989783|FG001|STARTED|Overall Study||168
3255818|NCT02540954|3989782|FG000|Treated|Overall Study||167
3255819|NCT02540954|3989783|FG001|Treated|Overall Study||168
3255820|NCT02540954|3989782|FG000|Post-baseline BCVA Assessment|Overall Study|FAS|165
3255821|NCT02540954|3989783|FG001|Post-baseline BCVA Assessment|Overall Study|FAS|167
3255822|NCT02540954|3989782|FG000|COMPLETED|Overall Study|Completed treatment|149
3255823|NCT02540954|3989783|FG001|COMPLETED|Overall Study|Completed treatment|154
3255824|NCT02540954|3989782|FG000|NOT COMPLETED|Overall Study||19
3255825|NCT02540954|3989783|FG001|NOT COMPLETED|Overall Study||14
3255826|NCT02540993|3989791|FG000|STARTED|Overall Study||2866
3255827|NCT02540993|3989792|FG001|STARTED|Overall Study||2868
3255828|NCT02540993|3989791|FG000|Included in FAS|Overall Study||2833
3255829|NCT02540993|3989792|FG001|Included in FAS|Overall Study||2841
3255830|NCT02540993|3989791|FG000|Treated|Overall Study||2827
3255831|NCT02540993|3989792|FG001|Treated|Overall Study||2831
3255832|NCT02540993|3989791|FG000|COMPLETED|Overall Study||2824
3255833|NCT02540993|3989792|FG001|COMPLETED|Overall Study||2832
3255834|NCT02540993|3989791|FG000|NOT COMPLETED|Overall Study||42
3255835|NCT02540993|3989792|FG001|NOT COMPLETED|Overall Study||36
3255836|NCT02541409|3989800|FG000|STARTED|Overall Study||25
3255837|NCT02541409|3989801|FG001|STARTED|Overall Study||25
3255838|NCT02541409|3989800|FG000|COMPLETED|Overall Study||22
3255839|NCT02541409|3989801|FG001|COMPLETED|Overall Study||22
3255840|NCT02541409|3989800|FG000|NOT COMPLETED|Overall Study||3
3255841|NCT02541409|3989801|FG001|NOT COMPLETED|Overall Study||3
3255842|NCT02541422|3989807|FG000|STARTED|First Intervention||23
3255843|NCT02541422|3989808|FG001|STARTED|First Intervention||26
3255844|NCT02541422|3989807|FG000|COMPLETED|First Intervention||23
3255845|NCT02541422|3989808|FG001|COMPLETED|First Intervention||26
3255846|NCT02541422|3989807|FG000|NOT COMPLETED|First Intervention||0
3255847|NCT02541422|3989808|FG001|NOT COMPLETED|First Intervention||0
3255848|NCT02541422|3989807|FG000|STARTED|Second Intervention||23
3255849|NCT02541422|3989808|FG001|STARTED|Second Intervention||26
3255850|NCT02541422|3989807|FG000|COMPLETED|Second Intervention||23
3255851|NCT02541422|3989808|FG001|COMPLETED|Second Intervention||26
3255852|NCT02541422|3989807|FG000|NOT COMPLETED|Second Intervention||0
3255853|NCT02541422|3989808|FG001|NOT COMPLETED|Second Intervention||0
3255854|NCT02541565|3989814|FG000|STARTED|Overall Study||30
3255855|NCT02541565|3989814|FG000|COMPLETED|Overall Study||27
3255856|NCT02541565|3989814|FG000|NOT COMPLETED|Overall Study||3
3255857|NCT02541604|3989830|FG000|STARTED|Overall Study||11
3255858|NCT02541604|3989831|FG001|STARTED|Overall Study||9
3255859|NCT02541604|3989832|FG002|STARTED|Overall Study||11
3255860|NCT02541604|3989833|FG003|STARTED|Overall Study||3
3255861|NCT02541604|3989834|FG004|STARTED|Overall Study||10
3255862|NCT02541604|3989835|FG005|STARTED|Overall Study||10
3255863|NCT02541604|3989836|FG006|STARTED|Overall Study||10
3255864|NCT02541604|3989837|FG007|STARTED|Overall Study||10
3255865|NCT02541604|3989838|FG008|STARTED|Overall Study||4
3255866|NCT02541604|3989839|FG009|STARTED|Overall Study||4
3255867|NCT02541604|3989840|FG010|STARTED|Overall Study||2
3255868|NCT02541604|3989841|FG011|STARTED|Overall Study||3
3255869|NCT02541604|3989830|FG000|COMPLETED|Overall Study||0
3255870|NCT02541604|3989831|FG001|COMPLETED|Overall Study||0
3255871|NCT02541604|3989832|FG002|COMPLETED|Overall Study||0
3255872|NCT02541604|3989833|FG003|COMPLETED|Overall Study||0
3255873|NCT02541604|3989834|FG004|COMPLETED|Overall Study||0
3255874|NCT02541604|3989835|FG005|COMPLETED|Overall Study||0
3255875|NCT02541604|3989836|FG006|COMPLETED|Overall Study||0
3255876|NCT02541604|3989837|FG007|COMPLETED|Overall Study||0
3255877|NCT02541604|3989838|FG008|COMPLETED|Overall Study||0
3255878|NCT02541604|3989839|FG009|COMPLETED|Overall Study||0
3255879|NCT02541604|3989840|FG010|COMPLETED|Overall Study||0
3255880|NCT02541604|3989841|FG011|COMPLETED|Overall Study||0
3255881|NCT02541604|3989830|FG000|NOT COMPLETED|Overall Study||11
3255882|NCT02541604|3989831|FG001|NOT COMPLETED|Overall Study||9
3255883|NCT02541604|3989832|FG002|NOT COMPLETED|Overall Study||11
3255884|NCT02541604|3989833|FG003|NOT COMPLETED|Overall Study||3
3255885|NCT02541604|3989834|FG004|NOT COMPLETED|Overall Study||10
3255886|NCT02541604|3989835|FG005|NOT COMPLETED|Overall Study||10
3255887|NCT02541604|3989836|FG006|NOT COMPLETED|Overall Study||10
3255888|NCT02541604|3989837|FG007|NOT COMPLETED|Overall Study||10
3255889|NCT02541604|3989838|FG008|NOT COMPLETED|Overall Study||4
3255890|NCT02541604|3989839|FG009|NOT COMPLETED|Overall Study||4
3255891|NCT02541604|3989840|FG010|NOT COMPLETED|Overall Study||2
3255892|NCT02541604|3989841|FG011|NOT COMPLETED|Overall Study||3
3255893|NCT02541669|3989895|FG000|STARTED|Open Label Treatment Period||8
3255894|NCT02541669|3989896|FG001|STARTED|Open Label Treatment Period||8
3255895|NCT02541669|3989897|FG002|STARTED|Open Label Treatment Period||0
3255896|NCT02541669|3989898|FG003|STARTED|Open Label Treatment Period||0
3255897|NCT02541669|3989899|FG004|STARTED|Open Label Treatment Period||0
3255898|NCT02541669|3989895|FG000|COMPLETED|Open Label Treatment Period||8
3255899|NCT02541669|3989896|FG001|COMPLETED|Open Label Treatment Period||8
3255900|NCT02541669|3989897|FG002|COMPLETED|Open Label Treatment Period||0
3255901|NCT02541669|3989898|FG003|COMPLETED|Open Label Treatment Period||0
3255902|NCT02541669|3989899|FG004|COMPLETED|Open Label Treatment Period||0
3255903|NCT02541669|3989895|FG000|NOT COMPLETED|Open Label Treatment Period||0
3255904|NCT02541669|3989896|FG001|NOT COMPLETED|Open Label Treatment Period||0
3255905|NCT02541669|3989897|FG002|NOT COMPLETED|Open Label Treatment Period||0
3255906|NCT02541669|3989898|FG003|NOT COMPLETED|Open Label Treatment Period||0
3255907|NCT02541669|3989899|FG004|NOT COMPLETED|Open Label Treatment Period||0
3255908|NCT02541669|3989895|FG000|STARTED|Double-Blinded Treatment Period||0
3255909|NCT02541669|3989896|FG001|STARTED|Double-Blinded Treatment Period||0
3255910|NCT02541669|3989897|FG002|STARTED|Double-Blinded Treatment Period||16
3255911|NCT02541669|3989898|FG003|STARTED|Double-Blinded Treatment Period||16
3255912|NCT02541669|3989899|FG004|STARTED|Double-Blinded Treatment Period||16
3255913|NCT02541669|3989895|FG000|COMPLETED|Double-Blinded Treatment Period||0
3255914|NCT02541669|3989896|FG001|COMPLETED|Double-Blinded Treatment Period||0
3255915|NCT02541669|3989897|FG002|COMPLETED|Double-Blinded Treatment Period||15
3255916|NCT02541669|3989898|FG003|COMPLETED|Double-Blinded Treatment Period||16
3255917|NCT02541669|3989899|FG004|COMPLETED|Double-Blinded Treatment Period||15
3255918|NCT02541669|3989895|FG000|NOT COMPLETED|Double-Blinded Treatment Period||0
3255919|NCT02541669|3989896|FG001|NOT COMPLETED|Double-Blinded Treatment Period||0
3255920|NCT02541669|3989897|FG002|NOT COMPLETED|Double-Blinded Treatment Period||1
3255921|NCT02541669|3989898|FG003|NOT COMPLETED|Double-Blinded Treatment Period||0
3255922|NCT02541669|3989899|FG004|NOT COMPLETED|Double-Blinded Treatment Period||1
3255923|NCT02541812|3989912|FG000|STARTED|Overall Study||10
3255924|NCT02541812|3989913|FG001|STARTED|Overall Study||10
3255925|NCT02541812|3989912|FG000|COMPLETED|Overall Study||10
3255926|NCT02541812|3989913|FG001|COMPLETED|Overall Study||10
3255927|NCT02541812|3989912|FG000|NOT COMPLETED|Overall Study||0
3255928|NCT02541812|3989913|FG001|NOT COMPLETED|Overall Study||0
3255929|NCT02541864|3989922|FG000|STARTED|Overall Study||164
3255930|NCT02541864|3989923|FG001|STARTED|Overall Study||166
3255931|NCT02541864|3989922|FG000|COMPLETED|Overall Study||164
3255932|NCT02541864|3989923|FG001|COMPLETED|Overall Study||166
3255933|NCT02541864|3989922|FG000|NOT COMPLETED|Overall Study||0
3255934|NCT02541864|3989923|FG001|NOT COMPLETED|Overall Study||0
3255935|NCT02541903|3989929|FG000|STARTED|Overall Study||8
3255936|NCT02541903|3989929|FG000|COMPLETED|Overall Study||7
3255937|NCT02541903|3989929|FG000|NOT COMPLETED|Overall Study||1
3255938|NCT02541942|3989933|FG000|STARTED|Overall Study||19
3255939|NCT02541942|3989933|FG000|COMPLETED|Overall Study||19
3255940|NCT02541942|3989933|FG000|NOT COMPLETED|Overall Study||0
3255941|NCT02542046|3989940|FG000|STARTED|Overall Study||300
3255942|NCT02542046|3989941|FG001|STARTED|Overall Study||300
3255943|NCT02542046|3989942|FG002|STARTED|Overall Study||300
3255944|NCT02542046|3989940|FG000|COMPLETED|Overall Study||300
3255945|NCT02542046|3989941|FG001|COMPLETED|Overall Study||300
3255946|NCT02542046|3989942|FG002|COMPLETED|Overall Study||300
3255947|NCT02542046|3989940|FG000|NOT COMPLETED|Overall Study||0
3255948|NCT02542046|3989941|FG001|NOT COMPLETED|Overall Study||0
3255949|NCT02542046|3989942|FG002|NOT COMPLETED|Overall Study||0
3255950|NCT02542072|3989952|FG000|STARTED|First Intervention (1 Month)||44
3255951|NCT02542072|3989953|FG001|STARTED|First Intervention (1 Month)||46
3255952|NCT02542072|3989952|FG000|COMPLETED|First Intervention (1 Month)||39
3255953|NCT02542072|3989953|FG001|COMPLETED|First Intervention (1 Month)||43
3255954|NCT02542072|3989952|FG000|NOT COMPLETED|First Intervention (1 Month)||5
3255955|NCT02542072|3989953|FG001|NOT COMPLETED|First Intervention (1 Month)||3
3255956|NCT02542072|3989952|FG000|STARTED|Second Intervention (1 Month)||39
3255957|NCT02542072|3989953|FG001|STARTED|Second Intervention (1 Month)||43
3255958|NCT02542072|3989952|FG000|COMPLETED|Second Intervention (1 Month)||37
3255959|NCT02542072|3989953|FG001|COMPLETED|Second Intervention (1 Month)||43
3255960|NCT02542072|3989952|FG000|NOT COMPLETED|Second Intervention (1 Month)||2
3255961|NCT02542072|3989953|FG001|NOT COMPLETED|Second Intervention (1 Month)||0
3255962|NCT02542150|3989981|FG000|STARTED|Overall Study||12
3255963|NCT02542150|3989982|FG001|STARTED|Overall Study||12
3255964|NCT02542150|3989981|FG000|Completed Placebo|Overall Study||12
3255965|NCT02542150|3989982|FG001|Completed Placebo|Overall Study||12
3255966|NCT02542150|3989981|FG000|Started Intervention|Overall Study||12
3255967|NCT02542150|3989982|FG001|Started Intervention|Overall Study||12
3255968|NCT02542150|3989981|FG000|COMPLETED|Overall Study||12
3255969|NCT02542150|3989982|FG001|COMPLETED|Overall Study||12
3255970|NCT02542150|3989981|FG000|NOT COMPLETED|Overall Study||0
3255971|NCT02542150|3989982|FG001|NOT COMPLETED|Overall Study||0
3255972|NCT02542267|3989992|FG000|STARTED|Overall Study||108
3255973|NCT02542267|3989992|FG000|COMPLETED|Overall Study||31
3255974|NCT02542267|3989992|FG000|NOT COMPLETED|Overall Study||77
3255975|NCT02542280|3989998|FG000|STARTED|Overall Study||174
3255976|NCT02542280|3989999|FG001|STARTED|Overall Study||175
3255977|NCT02542280|3989998|FG000|COMPLETED|Overall Study||162
3255978|NCT02542280|3989999|FG001|COMPLETED|Overall Study||167
3255979|NCT02542280|3989998|FG000|NOT COMPLETED|Overall Study||12
3255980|NCT02542280|3989999|FG001|NOT COMPLETED|Overall Study||8
3255981|NCT02542397|3990005|FG000|STARTED|Overall Study|75 subjects were enrolled to the study (i.e., submitted buccal swab).|75
3255982|NCT02542397|3990005|FG000|COMPLETED|Overall Study|54 enrolled subjects provided pain scores at baseline and final assessments within 30 +/- 7 days.|59
3255983|NCT02542397|3990005|FG000|NOT COMPLETED|Overall Study||16
3255984|NCT02542410|3990012|FG000|STARTED|Overall Study||5
3255985|NCT02542410|3990013|FG001|STARTED|Overall Study||5
3255986|NCT02542410|3990012|FG000|COMPLETED|Overall Study||3
3255987|NCT02542410|3990013|FG001|COMPLETED|Overall Study||4
3255988|NCT02542410|3990012|FG000|NOT COMPLETED|Overall Study||2
3255989|NCT02542410|3990013|FG001|NOT COMPLETED|Overall Study||1
3255990|NCT02542462|3990023|FG000|STARTED|Overall Study||25
3255991|NCT02542462|3990024|FG001|STARTED|Overall Study||25
3255992|NCT02542462|3990025|FG002|STARTED|Overall Study||25
3255993|NCT02542462|3990026|FG003|STARTED|Overall Study||26
3255994|NCT02542462|3990023|FG000|COMPLETED|Overall Study||25
3255995|NCT02542462|3990024|FG001|COMPLETED|Overall Study||25
3255996|NCT02542462|3990025|FG002|COMPLETED|Overall Study||25
3255997|NCT02542462|3990026|FG003|COMPLETED|Overall Study||25
3255998|NCT02542462|3990023|FG000|NOT COMPLETED|Overall Study||0
3255999|NCT02542462|3990024|FG001|NOT COMPLETED|Overall Study||0
3256000|NCT02542462|3990025|FG002|NOT COMPLETED|Overall Study||0
3256001|NCT02542462|3990026|FG003|NOT COMPLETED|Overall Study||1
3256002|NCT02542605|3990037|FG000|STARTED|Part A: PACAP-38 Dose Selection Phase||12
3256003|NCT02542605|3990038|FG001|STARTED|Part A: PACAP-38 Dose Selection Phase||0
3256004|NCT02542605|3990039|FG002|STARTED|Part A: PACAP-38 Dose Selection Phase||0
3256005|NCT02542605|3990037|FG000|Received PACAP-38|Part A: PACAP-38 Dose Selection Phase||12
3256006|NCT02542605|3990038|FG001|Received PACAP-38|Part A: PACAP-38 Dose Selection Phase||0
3256007|NCT02542605|3990039|FG002|Received PACAP-38|Part A: PACAP-38 Dose Selection Phase||0
3256008|NCT02542605|3990037|FG000|Proceeded to Part B Randomization Phase|Part A: PACAP-38 Dose Selection Phase||2
3256009|NCT02542605|3990038|FG001|Proceeded to Part B Randomization Phase|Part A: PACAP-38 Dose Selection Phase||0
3256010|NCT02542605|3990039|FG002|Proceeded to Part B Randomization Phase|Part A: PACAP-38 Dose Selection Phase||0
3256011|NCT02542605|3990037|FG000|COMPLETED|Part A: PACAP-38 Dose Selection Phase||12
3256012|NCT02542605|3990038|FG001|COMPLETED|Part A: PACAP-38 Dose Selection Phase||0
3256013|NCT02542605|3990039|FG002|COMPLETED|Part A: PACAP-38 Dose Selection Phase||0
3256014|NCT02542605|3990037|FG000|NOT COMPLETED|Part A: PACAP-38 Dose Selection Phase||0
3256015|NCT02542605|3990038|FG001|NOT COMPLETED|Part A: PACAP-38 Dose Selection Phase||0
3256016|NCT02542605|3990039|FG002|NOT COMPLETED|Part A: PACAP-38 Dose Selection Phase||0
3256017|NCT02542605|3990037|FG000|STARTED|Part B: Challenge Phase||23
3256018|NCT02542605|3990038|FG001|STARTED|Part B: Challenge Phase||0
3256019|NCT02542605|3990039|FG002|STARTED|Part B: Challenge Phase||0
3256020|NCT02542605|3990037|FG000|Received PACAP-38|Part B: Challenge Phase||23
3256021|NCT02542605|3990038|FG001|Received PACAP-38|Part B: Challenge Phase||0
3256022|NCT02542605|3990039|FG002|Received PACAP-38|Part B: Challenge Phase||0
3256023|NCT02542605|3990037|FG000|Proceeded to Randomization Phase|Part B: Challenge Phase||15
3256024|NCT02542605|3990038|FG001|Proceeded to Randomization Phase|Part B: Challenge Phase||0
3256025|NCT02542605|3990039|FG002|Proceeded to Randomization Phase|Part B: Challenge Phase||0
3256026|NCT02542605|3990037|FG000|COMPLETED|Part B: Challenge Phase||22
3256027|NCT02542605|3990038|FG001|COMPLETED|Part B: Challenge Phase||0
3256028|NCT02542605|3990039|FG002|COMPLETED|Part B: Challenge Phase||0
3256029|NCT02542605|3990037|FG000|NOT COMPLETED|Part B: Challenge Phase||1
3256030|NCT02542605|3990038|FG001|NOT COMPLETED|Part B: Challenge Phase||0
3256031|NCT02542605|3990039|FG002|NOT COMPLETED|Part B: Challenge Phase||0
3256032|NCT02542605|3990037|FG000|STARTED|Part B: Randomization Phase||0
3256033|NCT02542605|3990038|FG001|STARTED|Part B: Randomization Phase||9
3256034|NCT02542605|3990039|FG002|STARTED|Part B: Randomization Phase||8
3256035|NCT02542605|3990037|FG000|Not PACAP-38 naïve Participants|Part B: Randomization Phase||0
3256036|NCT02542605|3990038|FG001|Not PACAP-38 naïve Participants|Part B: Randomization Phase||2
3256037|NCT02542605|3990039|FG002|Not PACAP-38 naïve Participants|Part B: Randomization Phase||0
3256038|NCT02542605|3990037|FG000|PACAP-38 naïve Participants|Part B: Randomization Phase||0
3256039|NCT02542605|3990038|FG001|PACAP-38 naïve Participants|Part B: Randomization Phase||7
3256040|NCT02542605|3990039|FG002|PACAP-38 naïve Participants|Part B: Randomization Phase||8
3256041|NCT02542605|3990037|FG000|Received Placebo/Erenumab|Part B: Randomization Phase||0
3256042|NCT02542605|3990038|FG001|Received Placebo/Erenumab|Part B: Randomization Phase||9
3256043|NCT02542605|3990039|FG002|Received Placebo/Erenumab|Part B: Randomization Phase||7
3256044|NCT02542605|3990037|FG000|COMPLETED|Part B: Randomization Phase||0
3256045|NCT02542605|3990038|FG001|COMPLETED|Part B: Randomization Phase||9
3256046|NCT02542605|3990039|FG002|COMPLETED|Part B: Randomization Phase||7
3256047|NCT02542605|3990037|FG000|NOT COMPLETED|Part B: Randomization Phase||0
3256048|NCT02542605|3990038|FG001|NOT COMPLETED|Part B: Randomization Phase||0
3256049|NCT02542605|3990039|FG002|NOT COMPLETED|Part B: Randomization Phase||1
3256050|NCT02542631|3990050|FG000|STARTED|Overall Study||139
3256051|NCT02542631|3990051|FG001|STARTED|Overall Study||139
3256052|NCT02542631|3990050|FG000|COMPLETED|Overall Study||108
3256053|NCT02542631|3990051|FG001|COMPLETED|Overall Study||108
3256054|NCT02542631|3990050|FG000|NOT COMPLETED|Overall Study||31
3256055|NCT02542631|3990051|FG001|NOT COMPLETED|Overall Study||31
3256056|NCT02542761|3990057|FG000|STARTED|Acclimation Period 1||5
3256057|NCT02542761|3990058|FG001|STARTED|Acclimation Period 1||5
3256058|NCT02542761|3990057|FG000|COMPLETED|Acclimation Period 1||5
3256059|NCT02542761|3990058|FG001|COMPLETED|Acclimation Period 1||5
3256060|NCT02542761|3990057|FG000|NOT COMPLETED|Acclimation Period 1||0
3256061|NCT02542761|3990058|FG001|NOT COMPLETED|Acclimation Period 1||0
3256062|NCT02542761|3990057|FG000|STARTED|First Intervention||5
3256063|NCT02542761|3990058|FG001|STARTED|First Intervention||5
3256064|NCT02542761|3990057|FG000|COMPLETED|First Intervention||5
3256065|NCT02542761|3990058|FG001|COMPLETED|First Intervention||5
3256066|NCT02542761|3990057|FG000|NOT COMPLETED|First Intervention||0
3256067|NCT02542761|3990058|FG001|NOT COMPLETED|First Intervention||0
3256068|NCT02542761|3990057|FG000|STARTED|Acclimation Period 2||5
3256069|NCT02542761|3990058|FG001|STARTED|Acclimation Period 2||5
3256070|NCT02542761|3990057|FG000|COMPLETED|Acclimation Period 2||5
3256071|NCT02542761|3990058|FG001|COMPLETED|Acclimation Period 2||5
3256072|NCT02542761|3990057|FG000|NOT COMPLETED|Acclimation Period 2||0
3256073|NCT02542761|3990058|FG001|NOT COMPLETED|Acclimation Period 2||0
3256074|NCT02542761|3990057|FG000|STARTED|Second Intervention||5
3256075|NCT02542761|3990058|FG001|STARTED|Second Intervention||5
3256076|NCT02542761|3990057|FG000|COMPLETED|Second Intervention||5
3256077|NCT02542761|3990058|FG001|COMPLETED|Second Intervention||5
3256078|NCT02542761|3990057|FG000|NOT COMPLETED|Second Intervention||0
3256079|NCT02542761|3990058|FG001|NOT COMPLETED|Second Intervention||0
3256080|NCT02542865|3990066|FG000|STARTED|Overall Study||462
3256081|NCT02542865|3990067|FG001|STARTED|Overall Study||462
3256082|NCT02542865|3990066|FG000|Treated|Overall Study||460
3256083|NCT02542865|3990067|FG001|Treated|Overall Study||462
3256084|NCT02542865|3990066|FG000|COMPLETED|Overall Study||445
3256085|NCT02542865|3990067|FG001|COMPLETED|Overall Study||462
3256086|NCT02542865|3990066|FG000|NOT COMPLETED|Overall Study||17
3256087|NCT02542865|3990067|FG001|NOT COMPLETED|Overall Study||0
3256088|NCT02542943|3990076|FG000|STARTED|Overall Study||79
3256089|NCT02542943|3990077|FG001|STARTED|Overall Study||80
3256090|NCT02542943|3990078|FG002|STARTED|Overall Study||81
3256091|NCT02542943|3990076|FG000|COMPLETED|Overall Study||78
3256092|NCT02542943|3990077|FG001|COMPLETED|Overall Study||79
3256093|NCT02542943|3990078|FG002|COMPLETED|Overall Study||81
3256094|NCT02542943|3990076|FG000|NOT COMPLETED|Overall Study||1
3256095|NCT02542943|3990077|FG001|NOT COMPLETED|Overall Study||1
3256096|NCT02542943|3990078|FG002|NOT COMPLETED|Overall Study||0
3256097|NCT02543203|3990089|FG000|STARTED|Overall Study||13
3256098|NCT02543203|3990090|FG001|STARTED|Overall Study||15
3256099|NCT02543203|3990089|FG000|COMPLETED|Overall Study||7
3256100|NCT02543203|3990090|FG001|COMPLETED|Overall Study||10
3256101|NCT02543203|3990089|FG000|NOT COMPLETED|Overall Study||6
3256102|NCT02543203|3990090|FG001|NOT COMPLETED|Overall Study||5
3256103|NCT02543294|3990104|FG000|STARTED|Overall Study||20
3256104|NCT02543294|3990104|FG000|COMPLETED|Overall Study||8
3256105|NCT02543294|3990104|FG000|NOT COMPLETED|Overall Study||12
3256106|NCT02543346|3990109|FG000|STARTED|First Priming Visit||26
3256107|NCT02543346|3990110|FG001|STARTED|First Priming Visit||25
3256108|NCT02543346|3990111|FG002|STARTED|First Priming Visit||24
3256109|NCT02543346|3990112|FG003|STARTED|First Priming Visit||23
3256110|NCT02543346|3990109|FG000|COMPLETED|First Priming Visit||26
3256111|NCT02543346|3990110|FG001|COMPLETED|First Priming Visit||25
3256112|NCT02543346|3990111|FG002|COMPLETED|First Priming Visit||24
3256113|NCT02543346|3990112|FG003|COMPLETED|First Priming Visit||23
3256114|NCT02543346|3990109|FG000|NOT COMPLETED|First Priming Visit||0
3256115|NCT02543346|3990110|FG001|NOT COMPLETED|First Priming Visit||0
3256116|NCT02543346|3990111|FG002|NOT COMPLETED|First Priming Visit||0
3256117|NCT02543346|3990112|FG003|NOT COMPLETED|First Priming Visit||0
3256118|NCT02543346|3990109|FG000|STARTED|First Treatment Visit||26
3256119|NCT02543346|3990110|FG001|STARTED|First Treatment Visit||25
3256120|NCT02543346|3990111|FG002|STARTED|First Treatment Visit||24
3256121|NCT02543346|3990112|FG003|STARTED|First Treatment Visit||23
3256122|NCT02543346|3990109|FG000|COMPLETED|First Treatment Visit||26
3256123|NCT02543346|3990110|FG001|COMPLETED|First Treatment Visit||25
3256124|NCT02543346|3990111|FG002|COMPLETED|First Treatment Visit||24
3256125|NCT02543346|3990112|FG003|COMPLETED|First Treatment Visit||23
3256126|NCT02543346|3990109|FG000|NOT COMPLETED|First Treatment Visit||0
3256127|NCT02543346|3990110|FG001|NOT COMPLETED|First Treatment Visit||0
3256128|NCT02543346|3990111|FG002|NOT COMPLETED|First Treatment Visit||0
3256129|NCT02543346|3990112|FG003|NOT COMPLETED|First Treatment Visit||0
3256130|NCT02543346|3990109|FG000|STARTED|Washout (at Least 14 Days)||26
3256131|NCT02543346|3990110|FG001|STARTED|Washout (at Least 14 Days)||25
3256132|NCT02543346|3990111|FG002|STARTED|Washout (at Least 14 Days)||24
3256133|NCT02543346|3990112|FG003|STARTED|Washout (at Least 14 Days)||23
3256134|NCT02543346|3990109|FG000|COMPLETED|Washout (at Least 14 Days)||26
3256135|NCT02543346|3990110|FG001|COMPLETED|Washout (at Least 14 Days)||25
3256136|NCT02543346|3990111|FG002|COMPLETED|Washout (at Least 14 Days)||24
3256137|NCT02543346|3990112|FG003|COMPLETED|Washout (at Least 14 Days)||23
3256138|NCT02543346|3990109|FG000|NOT COMPLETED|Washout (at Least 14 Days)||0
3256139|NCT02543346|3990110|FG001|NOT COMPLETED|Washout (at Least 14 Days)||0
3256140|NCT02543346|3990111|FG002|NOT COMPLETED|Washout (at Least 14 Days)||0
3256141|NCT02543346|3990112|FG003|NOT COMPLETED|Washout (at Least 14 Days)||0
3256142|NCT02543346|3990109|FG000|STARTED|Second Priming Visit||26
3256143|NCT02543346|3990110|FG001|STARTED|Second Priming Visit||25
3256144|NCT02543346|3990111|FG002|STARTED|Second Priming Visit||24
3256145|NCT02543346|3990112|FG003|STARTED|Second Priming Visit||23
3256146|NCT02543346|3990109|FG000|COMPLETED|Second Priming Visit||25
3256147|NCT02543346|3990110|FG001|COMPLETED|Second Priming Visit||23
3256148|NCT02543346|3990111|FG002|COMPLETED|Second Priming Visit||22
3256149|NCT02543346|3990112|FG003|COMPLETED|Second Priming Visit||21
3256150|NCT02543346|3990109|FG000|NOT COMPLETED|Second Priming Visit||1
3256151|NCT02543346|3990110|FG001|NOT COMPLETED|Second Priming Visit||2
3256152|NCT02543346|3990111|FG002|NOT COMPLETED|Second Priming Visit||2
3256153|NCT02543346|3990112|FG003|NOT COMPLETED|Second Priming Visit||2
3256154|NCT02543346|3990109|FG000|STARTED|Second Treatment Visit||25
3256155|NCT02543346|3990110|FG001|STARTED|Second Treatment Visit||23
3256156|NCT02543346|3990111|FG002|STARTED|Second Treatment Visit||22
3256157|NCT02543346|3990112|FG003|STARTED|Second Treatment Visit||21
3256158|NCT02543346|3990109|FG000|COMPLETED|Second Treatment Visit||25
3256159|NCT02543346|3990110|FG001|COMPLETED|Second Treatment Visit||23
3256160|NCT02543346|3990111|FG002|COMPLETED|Second Treatment Visit||22
3256161|NCT02543346|3990112|FG003|COMPLETED|Second Treatment Visit||21
3256162|NCT02543346|3990109|FG000|NOT COMPLETED|Second Treatment Visit||0
3256163|NCT02543346|3990110|FG001|NOT COMPLETED|Second Treatment Visit||0
3256164|NCT02543346|3990111|FG002|NOT COMPLETED|Second Treatment Visit||0
3256165|NCT02543346|3990112|FG003|NOT COMPLETED|Second Treatment Visit||0
3256166|NCT02543398|3990124|FG000|STARTED|Overall Study||20
3256167|NCT02543398|3990125|FG001|STARTED|Overall Study||20
3256168|NCT02543398|3990124|FG000|COMPLETED|Overall Study||20
3256169|NCT02543398|3990125|FG001|COMPLETED|Overall Study||20
3256170|NCT02543398|3990124|FG000|NOT COMPLETED|Overall Study||0
3256171|NCT02543398|3990125|FG001|NOT COMPLETED|Overall Study||0
3256172|NCT02543437|3990131|FG000|STARTED|Overall Study||117
3256173|NCT02543437|3990131|FG000|COMPLETED|Overall Study||117
3256174|NCT02543437|3990131|FG000|NOT COMPLETED|Overall Study||0
3256175|NCT02543528|3990135|FG000|STARTED|Adaptation Period||0
3256176|NCT02543528|3990136|FG001|STARTED|Adaptation Period||0
3256177|NCT02543528|3990137|FG002|STARTED|Adaptation Period||0
3256178|NCT02543528|3990138|FG003|STARTED|Adaptation Period||0
3256179|NCT02543528|3990139|FG004|STARTED|Adaptation Period||168
3256180|NCT02543528|3990135|FG000|COMPLETED|Adaptation Period||0
3256181|NCT02543528|3990136|FG001|COMPLETED|Adaptation Period||0
3256182|NCT02543528|3990137|FG002|COMPLETED|Adaptation Period||0
3256183|NCT02543528|3990138|FG003|COMPLETED|Adaptation Period||0
3256184|NCT02543528|3990139|FG004|COMPLETED|Adaptation Period||142
3256185|NCT02543528|3990135|FG000|NOT COMPLETED|Adaptation Period||0
3256186|NCT02543528|3990136|FG001|NOT COMPLETED|Adaptation Period||0
3256187|NCT02543528|3990137|FG002|NOT COMPLETED|Adaptation Period||0
3256188|NCT02543528|3990138|FG003|NOT COMPLETED|Adaptation Period||0
3256189|NCT02543528|3990139|FG004|NOT COMPLETED|Adaptation Period||26
3256190|NCT02543528|3990135|FG000|STARTED|Extended Wear Period||36
3256191|NCT02543528|3990136|FG001|STARTED|Extended Wear Period||35
3256192|NCT02543528|3990137|FG002|STARTED|Extended Wear Period||36
3256193|NCT02543528|3990138|FG003|STARTED|Extended Wear Period||35
3256194|NCT02543528|3990139|FG004|STARTED|Extended Wear Period||0
3256195|NCT02543528|3990135|FG000|COMPLETED|Extended Wear Period||8
3256196|NCT02543528|3990136|FG001|COMPLETED|Extended Wear Period||14
3256197|NCT02543528|3990137|FG002|COMPLETED|Extended Wear Period||13
3256198|NCT02543528|3990138|FG003|COMPLETED|Extended Wear Period||23
3256199|NCT02543528|3990139|FG004|COMPLETED|Extended Wear Period||0
3256200|NCT02543528|3990135|FG000|NOT COMPLETED|Extended Wear Period||28
3256201|NCT02543528|3990136|FG001|NOT COMPLETED|Extended Wear Period||21
3256202|NCT02543528|3990137|FG002|NOT COMPLETED|Extended Wear Period||23
3256203|NCT02543528|3990138|FG003|NOT COMPLETED|Extended Wear Period||12
3256204|NCT02543528|3990139|FG004|NOT COMPLETED|Extended Wear Period||0
3256205|NCT02543554|3990155|FG000|STARTED|Overall Study||1192
3256206|NCT02543554|3990156|FG001|STARTED|Overall Study||513
3256207|NCT02543554|3990155|FG000|COMPLETED|Overall Study||1192
3256208|NCT02543554|3990156|FG001|COMPLETED|Overall Study||513
3256209|NCT02543554|3990155|FG000|NOT COMPLETED|Overall Study||0
3256210|NCT02543554|3990156|FG001|NOT COMPLETED|Overall Study||0
3256211|NCT02543658|3990164|FG000|STARTED|Overall Study||40
3256212|NCT02543658|3990165|FG001|STARTED|Overall Study||40
3256213|NCT02543658|3990164|FG000|COMPLETED|Overall Study||40
3256214|NCT02543658|3990165|FG001|COMPLETED|Overall Study||36
3256215|NCT02543658|3990164|FG000|NOT COMPLETED|Overall Study||0
3256216|NCT02543658|3990165|FG001|NOT COMPLETED|Overall Study||4
3256217|NCT02543723|3990174|FG000|STARTED|Overall Study||65
3256218|NCT02543723|3990175|FG001|STARTED|Overall Study||63
3256219|NCT02543723|3990174|FG000|COMPLETED|Overall Study||65
3256220|NCT02543723|3990175|FG001|COMPLETED|Overall Study||63
3256221|NCT02543723|3990174|FG000|NOT COMPLETED|Overall Study||0
3256222|NCT02543723|3990175|FG001|NOT COMPLETED|Overall Study||0
3256223|NCT02543801|3990187|FG000|STARTED|Overall Study||61
3256224|NCT02543801|3990188|FG001|STARTED|Overall Study||60
3256225|NCT02543801|3990189|FG002|STARTED|Overall Study||59
3256226|NCT02543801|3990190|FG003|STARTED|Overall Study||59
3256227|NCT02543801|3990187|FG000|COMPLETED|Overall Study||60
3256228|NCT02543801|3990188|FG001|COMPLETED|Overall Study||58
3256229|NCT02543801|3990189|FG002|COMPLETED|Overall Study||59
3256230|NCT02543801|3990190|FG003|COMPLETED|Overall Study||59
3256231|NCT02543801|3990187|FG000|NOT COMPLETED|Overall Study||1
3256232|NCT02543801|3990188|FG001|NOT COMPLETED|Overall Study||2
3256233|NCT02543801|3990189|FG002|NOT COMPLETED|Overall Study||0
3256234|NCT02543801|3990190|FG003|NOT COMPLETED|Overall Study||0
3256235|NCT02543840|3990202|FG000|STARTED|Overall Study|This is a quasi-experimental design, not a RCT. 1050 veterans did 1436 interviews at 3 time points.|1050
3256236|NCT02543840|3990203|FG001|STARTED|Overall Study||62
3256237|NCT02543840|3990202|FG000|0 Month Timepoint (t0)|Overall Study||593
3256238|NCT02543840|3990203|FG001|0 Month Timepoint (t0)|Overall Study||40
3256239|NCT02543840|3990202|FG000|6 Month Timepoint (t6)|Overall Study|593 participants started at 0 months; 188 repeated and 66 participants added at 6 months timepoint.|66
3256240|NCT02543840|3990203|FG001|6 Month Timepoint (t6)|Overall Study||0
3256241|NCT02543840|3990202|FG000|12 Month Timepoint (t12)|Overall Study|91 continued from 0 months (t0), 16 from 6 months (t6), 91 from t0 & t6; 391 added at 12 months.|391
3256242|NCT02543840|3990203|FG001|12 Month Timepoint (t12)|Overall Study|22 new providers completed at 12 months; 21 completed at both 0 and 12 months. 19 completed only T0.|22
3256243|NCT02543840|3990202|FG000|COMPLETED|Overall Study||1050
3256244|NCT02543840|3990203|FG001|COMPLETED|Overall Study||62
3256245|NCT02543840|3990202|FG000|NOT COMPLETED|Overall Study||0
3256246|NCT02543840|3990203|FG001|NOT COMPLETED|Overall Study||0
3256247|NCT02543892|3990218|FG000|STARTED|Received Vaccination 1||12
3256248|NCT02543892|3990219|FG001|STARTED|Received Vaccination 1||12
3256249|NCT02543892|3990220|FG002|STARTED|Received Vaccination 1||12
3256250|NCT02543892|3990221|FG003|STARTED|Received Vaccination 1||12
3256251|NCT02543892|3990222|FG004|STARTED|Received Vaccination 1||50
3256252|NCT02543892|3990223|FG005|STARTED|Received Vaccination 1||50
3256253|NCT02543892|3990224|FG006|STARTED|Received Vaccination 1||50
3256254|NCT02543892|3990225|FG007|STARTED|Received Vaccination 1||50
3256255|NCT02543892|3990218|FG000|COMPLETED|Received Vaccination 1||12
3256256|NCT02543892|3990219|FG001|COMPLETED|Received Vaccination 1||12
3256257|NCT02543892|3990220|FG002|COMPLETED|Received Vaccination 1||12
3256258|NCT02543892|3990221|FG003|COMPLETED|Received Vaccination 1||12
3256259|NCT02543892|3990222|FG004|COMPLETED|Received Vaccination 1||50
3256260|NCT02543892|3990223|FG005|COMPLETED|Received Vaccination 1||50
3256261|NCT02543892|3990224|FG006|COMPLETED|Received Vaccination 1||50
3256262|NCT02543892|3990225|FG007|COMPLETED|Received Vaccination 1||50
3256263|NCT02543892|3990218|FG000|NOT COMPLETED|Received Vaccination 1||0
3256264|NCT02543892|3990219|FG001|NOT COMPLETED|Received Vaccination 1||0
3256265|NCT02543892|3990220|FG002|NOT COMPLETED|Received Vaccination 1||0
3256266|NCT02543892|3990221|FG003|NOT COMPLETED|Received Vaccination 1||0
3256267|NCT02543892|3990222|FG004|NOT COMPLETED|Received Vaccination 1||0
3256268|NCT02543892|3990223|FG005|NOT COMPLETED|Received Vaccination 1||0
3256269|NCT02543892|3990224|FG006|NOT COMPLETED|Received Vaccination 1||0
3256270|NCT02543892|3990225|FG007|NOT COMPLETED|Received Vaccination 1||0
3256271|NCT02543892|3990218|FG000|STARTED|Received Vaccination 2||12
3256272|NCT02543892|3990219|FG001|STARTED|Received Vaccination 2||12
3256273|NCT02543892|3990220|FG002|STARTED|Received Vaccination 2||12
3256274|NCT02543892|3990221|FG003|STARTED|Received Vaccination 2||12
3256275|NCT02543892|3990222|FG004|STARTED|Received Vaccination 2||50
3256276|NCT02543892|3990223|FG005|STARTED|Received Vaccination 2||50
3256277|NCT02543892|3990224|FG006|STARTED|Received Vaccination 2||50
3256278|NCT02543892|3990225|FG007|STARTED|Received Vaccination 2||50
3256279|NCT02543892|3990218|FG000|COMPLETED|Received Vaccination 2||11
3256280|NCT02543892|3990219|FG001|COMPLETED|Received Vaccination 2||11
3256281|NCT02543892|3990220|FG002|COMPLETED|Received Vaccination 2||12
3256282|NCT02543892|3990221|FG003|COMPLETED|Received Vaccination 2||12
3256283|NCT02543892|3990222|FG004|COMPLETED|Received Vaccination 2||50
3256284|NCT02543892|3990223|FG005|COMPLETED|Received Vaccination 2||49
3256285|NCT02543892|3990224|FG006|COMPLETED|Received Vaccination 2||50
3256286|NCT02543892|3990225|FG007|COMPLETED|Received Vaccination 2||49
3256287|NCT02543892|3990218|FG000|NOT COMPLETED|Received Vaccination 2||1
3256288|NCT02543892|3990219|FG001|NOT COMPLETED|Received Vaccination 2||1
3256289|NCT02543892|3990220|FG002|NOT COMPLETED|Received Vaccination 2||0
3256290|NCT02543892|3990221|FG003|NOT COMPLETED|Received Vaccination 2||0
3256291|NCT02543892|3990222|FG004|NOT COMPLETED|Received Vaccination 2||0
3256292|NCT02543892|3990223|FG005|NOT COMPLETED|Received Vaccination 2||1
3256293|NCT02543892|3990224|FG006|NOT COMPLETED|Received Vaccination 2||0
3256294|NCT02543892|3990225|FG007|NOT COMPLETED|Received Vaccination 2||1
3256295|NCT02543892|3990218|FG000|STARTED|Had Immunology Data||11
3256296|NCT02543892|3990219|FG001|STARTED|Had Immunology Data||11
3256297|NCT02543892|3990220|FG002|STARTED|Had Immunology Data||12
3256298|NCT02543892|3990221|FG003|STARTED|Had Immunology Data||12
3256299|NCT02543892|3990222|FG004|STARTED|Had Immunology Data||50
3256300|NCT02543892|3990223|FG005|STARTED|Had Immunology Data||49
3256301|NCT02543892|3990224|FG006|STARTED|Had Immunology Data||50
3372387|NCT03061279|4104327|FG000|NOT COMPLETED|Overall Study||0
3256302|NCT02543892|3990225|FG007|STARTED|Had Immunology Data||49
3256303|NCT02543892|3990218|FG000|COMPLETED|Had Immunology Data||11
3256304|NCT02543892|3990219|FG001|COMPLETED|Had Immunology Data||11
3256305|NCT02543892|3990220|FG002|COMPLETED|Had Immunology Data||12
3256306|NCT02543892|3990221|FG003|COMPLETED|Had Immunology Data||12
3256307|NCT02543892|3990222|FG004|COMPLETED|Had Immunology Data||50
3256308|NCT02543892|3990223|FG005|COMPLETED|Had Immunology Data||49
3256309|NCT02543892|3990224|FG006|COMPLETED|Had Immunology Data|Subject received both vaccinations and attended last visit, but withdrew consent afterwards.|49
3256310|NCT02543892|3990225|FG007|COMPLETED|Had Immunology Data||49
3256311|NCT02543892|3990218|FG000|NOT COMPLETED|Had Immunology Data||0
3256312|NCT02543892|3990219|FG001|NOT COMPLETED|Had Immunology Data||0
3256313|NCT02543892|3990220|FG002|NOT COMPLETED|Had Immunology Data||0
3256314|NCT02543892|3990221|FG003|NOT COMPLETED|Had Immunology Data||0
3256315|NCT02543892|3990222|FG004|NOT COMPLETED|Had Immunology Data||0
3256316|NCT02543892|3990223|FG005|NOT COMPLETED|Had Immunology Data||0
3256317|NCT02543892|3990224|FG006|NOT COMPLETED|Had Immunology Data||1
3256318|NCT02543892|3990225|FG007|NOT COMPLETED|Had Immunology Data||0
3256319|NCT02543918|3990250|FG000|STARTED|Overall Study||41
3256320|NCT02543918|3990251|FG001|STARTED|Overall Study||43
3256321|NCT02543918|3990250|FG000|Received at Least 1 Dose of Study Drug|Overall Study||41
3256322|NCT02543918|3990251|FG001|Received at Least 1 Dose of Study Drug|Overall Study||42
3256323|NCT02543918|3990250|FG000|COMPLETED|Overall Study||38
3256324|NCT02543918|3990251|FG001|COMPLETED|Overall Study||39
3256325|NCT02543918|3990250|FG000|NOT COMPLETED|Overall Study||3
3256326|NCT02543918|3990251|FG001|NOT COMPLETED|Overall Study||4
3256327|NCT02544074|3990278|FG000|STARTED|Overall Study||1
3256328|NCT02544074|3990279|FG001|STARTED|Overall Study||1
3256329|NCT02544074|3990280|FG002|STARTED|Overall Study||1
3256330|NCT02544074|3990281|FG003|STARTED|Overall Study||1
3256331|NCT02544074|3990282|FG004|STARTED|Overall Study||4
3256332|NCT02544074|3990283|FG005|STARTED|Overall Study||1
3256333|NCT02544074|3990284|FG006|STARTED|Overall Study||2
3256334|NCT02544074|3990285|FG007|STARTED|Overall Study||4
3256335|NCT02544074|3990286|FG008|STARTED|Overall Study||6
3256336|NCT02544074|3990287|FG009|STARTED|Overall Study||2
3256337|NCT02544074|3990288|FG010|STARTED|Overall Study||2
3256338|NCT02544074|3990289|FG011|STARTED|Overall Study||3
3256339|NCT02544074|3990290|FG012|STARTED|Overall Study||4
3256340|NCT02544074|3990291|FG013|STARTED|Overall Study||5
3256341|NCT02544074|3990292|FG014|STARTED|Overall Study||5
3256342|NCT02544074|3990293|FG015|STARTED|Overall Study||8
3256343|NCT02544074|3990294|FG016|STARTED|Overall Study||6
3256344|NCT02544074|3990295|FG017|STARTED|Overall Study||3
3256345|NCT02544074|3990296|FG018|STARTED|Overall Study||4
3256346|NCT02544074|3990297|FG019|STARTED|Overall Study||3
3256347|NCT02544074|3990298|FG020|STARTED|Overall Study||3
3256348|NCT02544074|3990278|FG000|COMPLETED|Overall Study||1
3256349|NCT02544074|3990279|FG001|COMPLETED|Overall Study||0
3256350|NCT02544074|3990280|FG002|COMPLETED|Overall Study||1
3256351|NCT02544074|3990281|FG003|COMPLETED|Overall Study||1
3256352|NCT02544074|3990282|FG004|COMPLETED|Overall Study||4
3256353|NCT02544074|3990283|FG005|COMPLETED|Overall Study||0
3256354|NCT02544074|3990284|FG006|COMPLETED|Overall Study||2
3256355|NCT02544074|3990285|FG007|COMPLETED|Overall Study||4
3256356|NCT02544074|3990286|FG008|COMPLETED|Overall Study||6
3256357|NCT02544074|3990287|FG009|COMPLETED|Overall Study||1
3256358|NCT02544074|3990288|FG010|COMPLETED|Overall Study||2
3256359|NCT02544074|3990289|FG011|COMPLETED|Overall Study||3
3256360|NCT02544074|3990290|FG012|COMPLETED|Overall Study||4
3256361|NCT02544074|3990291|FG013|COMPLETED|Overall Study||5
3256362|NCT02544074|3990292|FG014|COMPLETED|Overall Study||5
3256363|NCT02544074|3990293|FG015|COMPLETED|Overall Study||8
3256364|NCT02544074|3990294|FG016|COMPLETED|Overall Study||6
3256365|NCT02544074|3990295|FG017|COMPLETED|Overall Study||3
3256366|NCT02544074|3990296|FG018|COMPLETED|Overall Study||4
3256367|NCT02544074|3990297|FG019|COMPLETED|Overall Study||3
3256368|NCT02544074|3990298|FG020|COMPLETED|Overall Study||3
3256369|NCT02544074|3990278|FG000|NOT COMPLETED|Overall Study||0
3256370|NCT02544074|3990279|FG001|NOT COMPLETED|Overall Study||1
3256371|NCT02544074|3990280|FG002|NOT COMPLETED|Overall Study||0
3256372|NCT02544074|3990281|FG003|NOT COMPLETED|Overall Study||0
3256373|NCT02544074|3990282|FG004|NOT COMPLETED|Overall Study||0
3256374|NCT02544074|3990283|FG005|NOT COMPLETED|Overall Study||1
3256375|NCT02544074|3990284|FG006|NOT COMPLETED|Overall Study||0
3256376|NCT02544074|3990285|FG007|NOT COMPLETED|Overall Study||0
3256377|NCT02544074|3990286|FG008|NOT COMPLETED|Overall Study||0
3256378|NCT02544074|3990287|FG009|NOT COMPLETED|Overall Study||1
3256379|NCT02544074|3990288|FG010|NOT COMPLETED|Overall Study||0
3256380|NCT02544074|3990289|FG011|NOT COMPLETED|Overall Study||0
3256381|NCT02544074|3990290|FG012|NOT COMPLETED|Overall Study||0
3256382|NCT02544074|3990291|FG013|NOT COMPLETED|Overall Study||0
3256383|NCT02544074|3990292|FG014|NOT COMPLETED|Overall Study||0
3256384|NCT02544074|3990293|FG015|NOT COMPLETED|Overall Study||0
3256385|NCT02544074|3990294|FG016|NOT COMPLETED|Overall Study||0
3256386|NCT02544074|3990295|FG017|NOT COMPLETED|Overall Study||0
3256387|NCT02544074|3990296|FG018|NOT COMPLETED|Overall Study||0
3256388|NCT02544074|3990297|FG019|NOT COMPLETED|Overall Study||0
3256389|NCT02544074|3990298|FG020|NOT COMPLETED|Overall Study||0
3256390|NCT02544113|3990334|FG000|STARTED|Overall Study||55
3256391|NCT02544113|3990335|FG001|STARTED|Overall Study||55
3256392|NCT02544113|3990334|FG000|COMPLETED|Overall Study||52
3256393|NCT02544113|3990335|FG001|COMPLETED|Overall Study||51
3256394|NCT02544113|3990334|FG000|NOT COMPLETED|Overall Study||3
3256395|NCT02544113|3990335|FG001|NOT COMPLETED|Overall Study||4
3256396|NCT02544152|3990343|FG000|STARTED|Overall Study||34
3256397|NCT02544152|3990344|FG001|STARTED|Overall Study||37
3256398|NCT02544152|3990343|FG000|Modified Intent to Treat (mITT)|Overall Study||34
3256399|NCT02544152|3990344|FG001|Modified Intent to Treat (mITT)|Overall Study||37
3256400|NCT02544152|3990343|FG000|Safety Analysis Set (SAS)|Overall Study||34
3256401|NCT02544152|3990344|FG001|Safety Analysis Set (SAS)|Overall Study||37
3256402|NCT02544152|3990343|FG000|COMPLETED|Overall Study||33
3256403|NCT02544152|3990344|FG001|COMPLETED|Overall Study||30
3256404|NCT02544152|3990343|FG000|NOT COMPLETED|Overall Study||1
3256405|NCT02544152|3990344|FG001|NOT COMPLETED|Overall Study||7
3256406|NCT02544217|3990356|FG000|STARTED|Overall Study||7
3256407|NCT02544217|3990357|FG001|STARTED|Overall Study||7
3256408|NCT02544217|3990358|FG002|STARTED|Overall Study||4
3256409|NCT02544217|3990359|FG003|STARTED|Overall Study||4
3256410|NCT02544217|3990360|FG004|STARTED|Overall Study||4
3256411|NCT02544217|3990361|FG005|STARTED|Overall Study||6
3256412|NCT02544217|3990356|FG000|COMPLETED|Overall Study||6
3256413|NCT02544217|3990357|FG001|COMPLETED|Overall Study|Two subjects prematurely withdrew from the study for non-medical reasons and were replaced.|6
3256414|NCT02544217|3990358|FG002|COMPLETED|Overall Study||4
3256415|NCT02544217|3990359|FG003|COMPLETED|Overall Study||4
3256416|NCT02544217|3990360|FG004|COMPLETED|Overall Study||4
3256417|NCT02544217|3990361|FG005|COMPLETED|Overall Study||6
3256418|NCT02544217|3990356|FG000|NOT COMPLETED|Overall Study||1
3256419|NCT02544217|3990357|FG001|NOT COMPLETED|Overall Study||1
3256420|NCT02544217|3990358|FG002|NOT COMPLETED|Overall Study||0
3256421|NCT02544217|3990359|FG003|NOT COMPLETED|Overall Study||0
3256422|NCT02544217|3990360|FG004|NOT COMPLETED|Overall Study||0
3256423|NCT02544217|3990361|FG005|NOT COMPLETED|Overall Study||0
3256424|NCT02544321|3990430|FG000|STARTED|Overall Study||43
3256425|NCT02544321|3990431|FG001|STARTED|Overall Study||43
3256426|NCT02544321|3990430|FG000|Completed First Treatment|Overall Study||43
3256427|NCT02544321|3990431|FG001|Completed First Treatment|Overall Study||41
3256428|NCT02544321|3990430|FG000|Completed Washout|Overall Study||43
3256429|NCT02544321|3990431|FG001|Completed Washout|Overall Study||41
3256430|NCT02544321|3990430|FG000|Started Second Treatment|Overall Study||42
3256431|NCT02544321|3990431|FG001|Started Second Treatment|Overall Study||40
3256432|NCT02544321|3990430|FG000|COMPLETED|Overall Study||41
3256433|NCT02544321|3990431|FG001|COMPLETED|Overall Study||39
3256434|NCT02544321|3990430|FG000|NOT COMPLETED|Overall Study||2
3256435|NCT02544321|3990431|FG001|NOT COMPLETED|Overall Study||4
3256436|NCT02544451|3990449|FG000|STARTED|Treatment Period 1 (96 Weeks)||143
3256437|NCT02544451|3990450|FG001|STARTED|Treatment Period 1 (96 Weeks)||96
3256438|NCT02544451|3990451|FG002|STARTED|Treatment Period 1 (96 Weeks)||6
3256439|NCT02544451|3990452|FG003|STARTED|Treatment Period 1 (96 Weeks)||0
3256440|NCT02544451|3990449|FG000|COMPLETED|Treatment Period 1 (96 Weeks)||129
3256441|NCT02544451|3990450|FG001|COMPLETED|Treatment Period 1 (96 Weeks)||84
3256442|NCT02544451|3990451|FG002|COMPLETED|Treatment Period 1 (96 Weeks)||5
3256443|NCT02544451|3990452|FG003|COMPLETED|Treatment Period 1 (96 Weeks)||0
3256444|NCT02544451|3990449|FG000|NOT COMPLETED|Treatment Period 1 (96 Weeks)||14
3256445|NCT02544451|3990450|FG001|NOT COMPLETED|Treatment Period 1 (96 Weeks)||12
3256446|NCT02544451|3990451|FG002|NOT COMPLETED|Treatment Period 1 (96 Weeks)||1
3256447|NCT02544451|3990452|FG003|NOT COMPLETED|Treatment Period 1 (96 Weeks)||0
3256448|NCT02544451|3990449|FG000|STARTED|Treatment Period 2 (168 Weeks)||0
3256449|NCT02544451|3990450|FG001|STARTED|Treatment Period 2 (168 Weeks)||0
3256450|NCT02544451|3990451|FG002|STARTED|Treatment Period 2 (168 Weeks)||0
3256451|NCT02544451|3990452|FG003|STARTED|Treatment Period 2 (168 Weeks)||10
3256452|NCT02544451|3990449|FG000|COMPLETED|Treatment Period 2 (168 Weeks)||0
3256453|NCT02544451|3990450|FG001|COMPLETED|Treatment Period 2 (168 Weeks)||0
3256454|NCT02544451|3990451|FG002|COMPLETED|Treatment Period 2 (168 Weeks)||0
3256455|NCT02544451|3990452|FG003|COMPLETED|Treatment Period 2 (168 Weeks)||0
3256456|NCT02544451|3990449|FG000|NOT COMPLETED|Treatment Period 2 (168 Weeks)||0
3256457|NCT02544451|3990450|FG001|NOT COMPLETED|Treatment Period 2 (168 Weeks)||0
3256458|NCT02544451|3990451|FG002|NOT COMPLETED|Treatment Period 2 (168 Weeks)||0
3256459|NCT02544451|3990452|FG003|NOT COMPLETED|Treatment Period 2 (168 Weeks)||10
3256460|NCT02544607|3990470|FG000|STARTED|Overall Study||16
3256461|NCT02544607|3990470|FG000|COMPLETED|Overall Study||16
3256462|NCT02544607|3990470|FG000|NOT COMPLETED|Overall Study||0
3256463|NCT02544633|3990479|FG000|STARTED|Treatment Period||28
3256464|NCT02544633|3990480|FG001|STARTED|Treatment Period||20
3256465|NCT02544633|3990481|FG002|STARTED|Treatment Period||8
3256466|NCT02544633|3990482|FG003|STARTED|Treatment Period||12
3256467|NCT02544633|3990479|FG000|COMPLETED|Treatment Period||0
3256468|NCT02544633|3990480|FG001|COMPLETED|Treatment Period||0
3256469|NCT02544633|3990481|FG002|COMPLETED|Treatment Period||0
3256470|NCT02544633|3990482|FG003|COMPLETED|Treatment Period||0
3256471|NCT02544633|3990479|FG000|NOT COMPLETED|Treatment Period||28
3256472|NCT02544633|3990480|FG001|NOT COMPLETED|Treatment Period||20
3256473|NCT02544633|3990481|FG002|NOT COMPLETED|Treatment Period||8
3256474|NCT02544633|3990482|FG003|NOT COMPLETED|Treatment Period||12
3256475|NCT02544633|3990479|FG000|STARTED|Survival Follow-up Period||28
3256476|NCT02544633|3990480|FG001|STARTED|Survival Follow-up Period||19
3256477|NCT02544633|3990481|FG002|STARTED|Survival Follow-up Period||7
3256478|NCT02544633|3990482|FG003|STARTED|Survival Follow-up Period||12
3256479|NCT02544633|3990479|FG000|COMPLETED|Survival Follow-up Period||0
3256480|NCT02544633|3990480|FG001|COMPLETED|Survival Follow-up Period||0
3256481|NCT02544633|3990481|FG002|COMPLETED|Survival Follow-up Period||0
3256482|NCT02544633|3990482|FG003|COMPLETED|Survival Follow-up Period||0
3256483|NCT02544633|3990479|FG000|NOT COMPLETED|Survival Follow-up Period||28
3256484|NCT02544633|3990480|FG001|NOT COMPLETED|Survival Follow-up Period||19
3256485|NCT02544633|3990481|FG002|NOT COMPLETED|Survival Follow-up Period||7
3256486|NCT02544633|3990482|FG003|NOT COMPLETED|Survival Follow-up Period||12
3256487|NCT02544763|3990507|FG000|STARTED|Overall Study||75
3256488|NCT02544763|3990508|FG001|STARTED|Overall Study||73
3256489|NCT02544763|3990509|FG002|STARTED|Overall Study||76
3256490|NCT02544763|3990507|FG000|COMPLETED|Overall Study||65
3256491|NCT02544763|3990508|FG001|COMPLETED|Overall Study||61
3256492|NCT02544763|3990509|FG002|COMPLETED|Overall Study||75
3256493|NCT02544763|3990507|FG000|NOT COMPLETED|Overall Study||10
3256494|NCT02544763|3990508|FG001|NOT COMPLETED|Overall Study||12
3256495|NCT02544763|3990509|FG002|NOT COMPLETED|Overall Study||1
3256496|NCT02544984|3990519|FG000|STARTED|Overall Study||30
3256497|NCT02544984|3990520|FG001|STARTED|Overall Study||30
3256498|NCT02544984|3990519|FG000|COMPLETED|Overall Study||28
3256499|NCT02544984|3990520|FG001|COMPLETED|Overall Study||28
3256500|NCT02544984|3990519|FG000|NOT COMPLETED|Overall Study||2
3256501|NCT02544984|3990520|FG001|NOT COMPLETED|Overall Study||2
3256502|NCT02545075|3990528|FG000|STARTED|Randomization||122
3256503|NCT02545075|3990529|FG001|STARTED|Randomization||60
3256504|NCT02545075|3990528|FG000|COMPLETED|Randomization||122
3256505|NCT02545075|3990529|FG001|COMPLETED|Randomization||53
3256506|NCT02545075|3990528|FG000|NOT COMPLETED|Randomization||0
3256507|NCT02545075|3990529|FG001|NOT COMPLETED|Randomization||7
3256508|NCT02545075|3990528|FG000|STARTED|Treatment||122
3256509|NCT02545075|3990529|FG001|STARTED|Treatment||53
3256510|NCT02545075|3990528|FG000|COMPLETED|Treatment||0
3256511|NCT02545075|3990529|FG001|COMPLETED|Treatment||0
3256512|NCT02545075|3990528|FG000|NOT COMPLETED|Treatment||122
3256513|NCT02545075|3990529|FG001|NOT COMPLETED|Treatment||53
3256514|NCT02545101|3990535|FG000|STARTED|Overall Study||100
3256515|NCT02545101|3990535|FG000|COMPLETED|Overall Study||100
3256516|NCT02545101|3990535|FG000|NOT COMPLETED|Overall Study||0
3256517|NCT02545270|3990542|FG000|STARTED|Overall Study||6
3256518|NCT02545270|3990543|FG001|STARTED|Overall Study||5
3256519|NCT02545270|3990544|FG002|STARTED|Overall Study||5
3256520|NCT02545270|3990542|FG000|COMPLETED|Overall Study||6
3256521|NCT02545270|3990543|FG001|COMPLETED|Overall Study||4
3256522|NCT02545270|3990544|FG002|COMPLETED|Overall Study||3
3256523|NCT02545270|3990542|FG000|NOT COMPLETED|Overall Study||0
3256524|NCT02545270|3990543|FG001|NOT COMPLETED|Overall Study||1
3256525|NCT02545270|3990544|FG002|NOT COMPLETED|Overall Study||2
3256526|NCT02545322|3990553|FG000|STARTED|Overall Study||18
3256527|NCT02545322|3990553|FG000|COMPLETED|Overall Study||15
3256528|NCT02545322|3990553|FG000|NOT COMPLETED|Overall Study||3
3256529|NCT02545504|3990559|FG000|STARTED|Overall Study||218
3256530|NCT02545504|3990560|FG001|STARTED|Overall Study||214
3256531|NCT02545504|3990559|FG000|COMPLETED|Overall Study||0
3256532|NCT02545504|3990560|FG001|COMPLETED|Overall Study||0
3256533|NCT02545504|3990559|FG000|NOT COMPLETED|Overall Study||218
3256534|NCT02545504|3990560|FG001|NOT COMPLETED|Overall Study||214
3256535|NCT02545543|3990572|FG000|STARTED|Overall Study||1709
3256536|NCT02545543|3990573|FG001|STARTED|Overall Study||569
3256537|NCT02545543|3990572|FG000|COMPLETED|Overall Study||1628
3256538|NCT02545543|3990573|FG001|COMPLETED|Overall Study||535
3256539|NCT02545543|3990572|FG000|NOT COMPLETED|Overall Study||81
3256540|NCT02545543|3990573|FG001|NOT COMPLETED|Overall Study||34
3256541|NCT02545608|3990583|FG000|STARTED|Overall Study||9
3256542|NCT02545608|3990584|FG001|STARTED|Overall Study|Split hand study design. Total no. of subjects in Randomised group and No-treatment control is 100.|100
3256543|NCT02545608|3990583|FG000|COMPLETED|Overall Study||9
3256544|NCT02545608|3990584|FG001|COMPLETED|Overall Study||93
3256545|NCT02545608|3990583|FG000|NOT COMPLETED|Overall Study||0
3256546|NCT02545608|3990584|FG001|NOT COMPLETED|Overall Study||7
3256547|NCT02545907|3990593|FG000|STARTED|Overall Study||3
3256548|NCT02545907|3990594|FG001|STARTED|Overall Study||3
3256549|NCT02545907|3990595|FG002|STARTED|Overall Study||4
3256550|NCT02545907|3990593|FG000|COMPLETED|Overall Study||3
3256551|NCT02545907|3990594|FG001|COMPLETED|Overall Study||3
3256552|NCT02545907|3990595|FG002|COMPLETED|Overall Study||4
3256553|NCT02545907|3990593|FG000|NOT COMPLETED|Overall Study||0
3256554|NCT02545907|3990594|FG001|NOT COMPLETED|Overall Study||0
3256555|NCT02545907|3990595|FG002|NOT COMPLETED|Overall Study||0
3256556|NCT02545933|3990607|FG000|STARTED|Overall Study||44
3256557|NCT02545933|3990608|FG001|STARTED|Overall Study||43
3256558|NCT02545933|3990609|FG002|STARTED|Overall Study||43
3256559|NCT02545933|3990607|FG000|COMPLETED|Overall Study||38
3256560|NCT02545933|3990608|FG001|COMPLETED|Overall Study||40
3256561|NCT02545933|3990609|FG002|COMPLETED|Overall Study||39
3256562|NCT02545933|3990607|FG000|NOT COMPLETED|Overall Study||6
3256563|NCT02545933|3990608|FG001|NOT COMPLETED|Overall Study||3
3256564|NCT02545933|3990609|FG002|NOT COMPLETED|Overall Study||4
3256565|NCT02546193|3990619|FG000|STARTED|Overall Study||10
3256566|NCT02546193|3990620|FG001|STARTED|Overall Study||10
3256567|NCT02546193|3990621|FG002|STARTED|Overall Study|Enrolled independently (Prospective study). Not counted in Outpatient Foley Catheter Arm.|2
3256568|NCT02546193|3990622|FG003|STARTED|Overall Study||0
3256569|NCT02546193|3990619|FG000|COMPLETED|Overall Study||4
3256570|NCT02546193|3990620|FG001|COMPLETED|Overall Study||4
3256571|NCT02546193|3990621|FG002|COMPLETED|Overall Study||0
3256572|NCT02546193|3990622|FG003|COMPLETED|Overall Study||0
3256573|NCT02546193|3990619|FG000|NOT COMPLETED|Overall Study||6
3256574|NCT02546193|3990620|FG001|NOT COMPLETED|Overall Study||6
3256575|NCT02546193|3990621|FG002|NOT COMPLETED|Overall Study||2
3256576|NCT02546193|3990622|FG003|NOT COMPLETED|Overall Study||0
3256577|NCT02546323|3990630|FG000|STARTED|Overall Study||272
3256578|NCT02546323|3990631|FG001|STARTED|Overall Study||271
3256579|NCT02546323|3990630|FG000|Received Treatment|Overall Study||272
3256580|NCT02546323|3990631|FG001|Received Treatment|Overall Study||268
3256581|NCT02546323|3990630|FG000|COMPLETED|Overall Study||212
3256582|NCT02546323|3990631|FG001|COMPLETED|Overall Study||205
3256583|NCT02546323|3990630|FG000|NOT COMPLETED|Overall Study||60
3256584|NCT02546323|3990631|FG001|NOT COMPLETED|Overall Study||66
3256585|NCT02546362|3990637|FG000|STARTED|4-week Treatment Period||50
3256586|NCT02546362|3990637|FG000|COMPLETED|4-week Treatment Period||47
3256587|NCT02546362|3990637|FG000|NOT COMPLETED|4-week Treatment Period||3
3256588|NCT02546362|3990637|FG000|STARTED|12-week Treatment Period||47
3256589|NCT02546362|3990637|FG000|COMPLETED|12-week Treatment Period||38
3256590|NCT02546362|3990637|FG000|NOT COMPLETED|12-week Treatment Period||9
3256591|NCT02546375|3990641|FG000|STARTED|Overall Study||87
3256592|NCT02546375|3990641|FG000|COMPLETED|Overall Study||87
3256593|NCT02546375|3990641|FG000|NOT COMPLETED|Overall Study||0
3256594|NCT02546388|3990647|FG000|STARTED|Overall Study||4
3256595|NCT02546388|3990648|FG001|STARTED|Overall Study||13
3256596|NCT02546388|3990647|FG000|COMPLETED|Overall Study||4
3256597|NCT02546388|3990648|FG001|COMPLETED|Overall Study||13
3256598|NCT02546388|3990647|FG000|NOT COMPLETED|Overall Study||0
3256599|NCT02546388|3990648|FG001|NOT COMPLETED|Overall Study||0
3256600|NCT02546544|3990655|FG000|STARTED|Overall Study||16
3256601|NCT02546544|3990655|FG000|Received Allocated Intervention|Overall Study||16
3256602|NCT02546544|3990655|FG000|COMPLETED|Overall Study||0
3256603|NCT02546544|3990655|FG000|NOT COMPLETED|Overall Study||16
3256604|NCT02546570|3990661|FG000|STARTED|Overall Study||9
3256605|NCT02546570|3990662|FG001|STARTED|Overall Study||2
3256606|NCT02546570|3990661|FG000|Crossover Order: Oxytocin, Placebo|Overall Study||6
3256607|NCT02546570|3990662|FG001|Crossover Order: Oxytocin, Placebo|Overall Study||2
3256608|NCT02546570|3990661|FG000|Crossover Order: Placebo, Oxytocin|Overall Study||3
3256609|NCT02546570|3990662|FG001|Crossover Order: Placebo, Oxytocin|Overall Study||0
3256610|NCT02546570|3990661|FG000|COMPLETED|Overall Study||9
3256611|NCT02546570|3990662|FG001|COMPLETED|Overall Study||2
3256612|NCT02546570|3990661|FG000|NOT COMPLETED|Overall Study||0
3256613|NCT02546570|3990662|FG001|NOT COMPLETED|Overall Study||0
3256614|NCT02546609|3990675|FG000|STARTED|Overall Study||24
3256615|NCT02546609|3990676|FG001|STARTED|Overall Study||35
3256616|NCT02546609|3990677|FG002|STARTED|Overall Study||32
3256617|NCT02546609|3990675|FG000|COMPLETED|Overall Study||22
3256618|NCT02546609|3990676|FG001|COMPLETED|Overall Study||24
3256619|NCT02546609|3990677|FG002|COMPLETED|Overall Study||25
3256620|NCT02546609|3990675|FG000|NOT COMPLETED|Overall Study||2
3256621|NCT02546609|3990676|FG001|NOT COMPLETED|Overall Study||11
3256622|NCT02546609|3990677|FG002|NOT COMPLETED|Overall Study||7
3256623|NCT02546765|3990689|FG000|STARTED|Overall Study||31
3256624|NCT02546765|3990690|FG001|STARTED|Overall Study||30
3256625|NCT02546765|3990691|FG002|STARTED|Overall Study||30
3256626|NCT02546765|3990692|FG003|STARTED|Overall Study||30
3256627|NCT02546765|3990689|FG000|COMPLETED|Overall Study||31
3256628|NCT02546765|3990690|FG001|COMPLETED|Overall Study|29 Received study drug; 1 withdrew before surgery and after randomization|29
3256629|NCT02546765|3990691|FG002|COMPLETED|Overall Study||30
3256630|NCT02546765|3990692|FG003|COMPLETED|Overall Study||30
3256631|NCT02546765|3990689|FG000|NOT COMPLETED|Overall Study||0
3256632|NCT02546765|3990690|FG001|NOT COMPLETED|Overall Study||1
3256633|NCT02546765|3990691|FG002|NOT COMPLETED|Overall Study||0
3256634|NCT02546765|3990692|FG003|NOT COMPLETED|Overall Study||0
3256635|NCT02546856|3990715|FG000|STARTED|4 Months Evaluation||164
3256636|NCT02546856|3990716|FG001|STARTED|4 Months Evaluation||156
3256637|NCT02546856|3990715|FG000|COMPLETED|4 Months Evaluation||144
3256638|NCT02546856|3990716|FG001|COMPLETED|4 Months Evaluation||145
3256639|NCT02546856|3990715|FG000|NOT COMPLETED|4 Months Evaluation||20
3256640|NCT02546856|3990716|FG001|NOT COMPLETED|4 Months Evaluation||11
3256641|NCT02546856|3990715|FG000|STARTED|6 Months Evaluation||144
3256642|NCT02546856|3990716|FG001|STARTED|6 Months Evaluation||145
3256643|NCT02546856|3990715|FG000|COMPLETED|6 Months Evaluation||136
3256644|NCT02546856|3990716|FG001|COMPLETED|6 Months Evaluation||138
3256645|NCT02546856|3990715|FG000|NOT COMPLETED|6 Months Evaluation||8
3256646|NCT02546856|3990716|FG001|NOT COMPLETED|6 Months Evaluation||7
3256647|NCT02547012|3990736|FG000|STARTED|Overall Study||24
3256648|NCT02547012|3990737|FG001|STARTED|Overall Study||27
3256649|NCT02547012|3990736|FG000|COMPLETED|Overall Study||24
3256650|NCT02547012|3990737|FG001|COMPLETED|Overall Study||27
3256651|NCT02547012|3990736|FG000|NOT COMPLETED|Overall Study||0
3256652|NCT02547012|3990737|FG001|NOT COMPLETED|Overall Study||0
3256653|NCT02547038|3990745|FG000|STARTED|Overall Study||176
3256654|NCT02547038|3990746|FG001|STARTED|Overall Study||176
3256655|NCT02547038|3990745|FG000|COMPLETED|Overall Study||173
3256656|NCT02547038|3990746|FG001|COMPLETED|Overall Study||174
3256657|NCT02547038|3990745|FG000|NOT COMPLETED|Overall Study||3
3256658|NCT02547038|3990746|FG001|NOT COMPLETED|Overall Study||2
3256659|NCT02547064|3990754|FG000|STARTED|Overall Study||81
3256660|NCT02547064|3990755|FG001|STARTED|Overall Study||81
3256661|NCT02547064|3990754|FG000|COMPLETED|Overall Study||78
3256662|NCT02547064|3990755|FG001|COMPLETED|Overall Study||79
3256663|NCT02547064|3990754|FG000|NOT COMPLETED|Overall Study||3
3256664|NCT02547064|3990755|FG001|NOT COMPLETED|Overall Study||2
3256665|NCT02547220|3990763|FG000|STARTED|Overall Study||19
3256666|NCT02547220|3990764|FG001|STARTED|Overall Study||20
3256667|NCT02547220|3990763|FG000|COMPLETED|Overall Study||0
3256668|NCT02547220|3990764|FG001|COMPLETED|Overall Study||0
3256669|NCT02547220|3990763|FG000|NOT COMPLETED|Overall Study||19
3256670|NCT02547220|3990764|FG001|NOT COMPLETED|Overall Study||20
3256671|NCT02547233|3990772|FG000|STARTED|3-day Treatment and 8-week Follow-up||205
3256672|NCT02547233|3990773|FG001|STARTED|3-day Treatment and 8-week Follow-up||102
3256673|NCT02547233|3990772|FG000|Treated|3-day Treatment and 8-week Follow-up||205
3256674|NCT02547233|3990773|FG001|Treated|3-day Treatment and 8-week Follow-up||100
3256675|NCT02547233|3990772|FG000|COMPLETED|3-day Treatment and 8-week Follow-up||203
3256676|NCT02547233|3990773|FG001|COMPLETED|3-day Treatment and 8-week Follow-up||92
3256677|NCT02547233|3990772|FG000|NOT COMPLETED|3-day Treatment and 8-week Follow-up||2
3256678|NCT02547233|3990773|FG001|NOT COMPLETED|3-day Treatment and 8-week Follow-up||10
3256679|NCT02547233|3990772|FG000|STARTED|12-month Follow-up||199
3256680|NCT02547233|3990773|FG001|STARTED|12-month Follow-up||84
3256681|NCT02547233|3990772|FG000|COMPLETED|12-month Follow-up||185
3256682|NCT02547233|3990773|FG001|COMPLETED|12-month Follow-up||67
3256683|NCT02547233|3990772|FG000|NOT COMPLETED|12-month Follow-up||14
3256684|NCT02547233|3990773|FG001|NOT COMPLETED|12-month Follow-up||17
3256685|NCT02547363|3990783|FG000|STARTED|3-day Treatment and 8-week Follow-up||211
3256686|NCT02547363|3990784|FG001|STARTED|3-day Treatment and 8-week Follow-up||105
3256687|NCT02547363|3990783|FG000|Treated|3-day Treatment and 8-week Follow-up||209
3256688|NCT02547363|3990784|FG001|Treated|3-day Treatment and 8-week Follow-up||104
3256689|NCT02547363|3990783|FG000|COMPLETED|3-day Treatment and 8-week Follow-up||207
3256690|NCT02547363|3990784|FG001|COMPLETED|3-day Treatment and 8-week Follow-up||94
3256691|NCT02547363|3990783|FG000|NOT COMPLETED|3-day Treatment and 8-week Follow-up||4
3256692|NCT02547363|3990784|FG001|NOT COMPLETED|3-day Treatment and 8-week Follow-up||11
3256693|NCT02547363|3990783|FG000|STARTED|12-month Follow-up||204
3256694|NCT02547363|3990784|FG001|STARTED|12-month Follow-up||86
3256695|NCT02547363|3990783|FG000|COMPLETED|12-month Follow-up||194
3256696|NCT02547363|3990784|FG001|COMPLETED|12-month Follow-up||81
3256697|NCT02547363|3990783|FG000|NOT COMPLETED|12-month Follow-up||10
3256698|NCT02547363|3990784|FG001|NOT COMPLETED|12-month Follow-up||5
3256699|NCT02547428|3990794|FG000|STARTED|Period 1- Treatment Sequence 1 (3 Weeks)||42
3256700|NCT02547428|3990795|FG001|STARTED|Period 1- Treatment Sequence 1 (3 Weeks)||43
3256701|NCT02547428|3990794|FG000|Received at Least 1 Dose of Study Drug|Period 1- Treatment Sequence 1 (3 Weeks)||42
3256702|NCT02547428|3990795|FG001|Received at Least 1 Dose of Study Drug|Period 1- Treatment Sequence 1 (3 Weeks)||43
3256703|NCT02547428|3990794|FG000|COMPLETED|Period 1- Treatment Sequence 1 (3 Weeks)||31
3256704|NCT02547428|3990795|FG001|COMPLETED|Period 1- Treatment Sequence 1 (3 Weeks)||37
3256705|NCT02547428|3990794|FG000|NOT COMPLETED|Period 1- Treatment Sequence 1 (3 Weeks)||11
3256706|NCT02547428|3990795|FG001|NOT COMPLETED|Period 1- Treatment Sequence 1 (3 Weeks)||6
3256707|NCT02547428|3990794|FG000|STARTED|Period 2- Treatment Sequence 2 (3 Weeks)||31
3256708|NCT02547428|3990795|FG001|STARTED|Period 2- Treatment Sequence 2 (3 Weeks)||37
3256709|NCT02547428|3990794|FG000|COMPLETED|Period 2- Treatment Sequence 2 (3 Weeks)||30
3256710|NCT02547428|3990795|FG001|COMPLETED|Period 2- Treatment Sequence 2 (3 Weeks)||30
3256711|NCT02547428|3990794|FG000|NOT COMPLETED|Period 2- Treatment Sequence 2 (3 Weeks)||1
3256712|NCT02547428|3990795|FG001|NOT COMPLETED|Period 2- Treatment Sequence 2 (3 Weeks)||7
3256713|NCT02547454|3990808|FG000|STARTED|Overall Study||393
3256714|NCT02547454|3990808|FG000|COMPLETED|Overall Study||221
3256715|NCT02547454|3990808|FG000|NOT COMPLETED|Overall Study||172
3256716|NCT02547623|3990814|FG000|STARTED|Overall Study||126
3256717|NCT02547623|3990815|FG001|STARTED|Overall Study||55
3256718|NCT02547623|3990814|FG000|COMPLETED|Overall Study||122
3256719|NCT02547623|3990815|FG001|COMPLETED|Overall Study||52
3256720|NCT02547623|3990814|FG000|NOT COMPLETED|Overall Study||4
3256721|NCT02547623|3990815|FG001|NOT COMPLETED|Overall Study||3
3372388|NCT03061279|4104328|FG001|NOT COMPLETED|Overall Study||1
3372389|NCT03040323|4104336|FG000|STARTED|Overall Study|No information available regarding how many participants Started and Completed the study in each arm|0
3372390|NCT03040323|4104337|FG001|STARTED|Overall Study|No information available regarding how many participants Started and Completed the study in each arm|0
3372391|NCT03040323|4104336|FG000|COMPLETED|Overall Study||0
3372392|NCT03040323|4104337|FG001|COMPLETED|Overall Study||0
3372393|NCT03040323|4104336|FG000|NOT COMPLETED|Overall Study||0
3372394|NCT03040323|4104337|FG001|NOT COMPLETED|Overall Study||0
3372395|NCT03053518|4104343|FG000|STARTED|Overall Study||22
3372396|NCT03053518|4104343|FG000|COMPLETED|Overall Study||12
3372397|NCT03053518|4104343|FG000|NOT COMPLETED|Overall Study||10
3372398|NCT03050398|4104347|FG000|STARTED|Overall Study||8
3372399|NCT03050398|4104347|FG000|COMPLETED|Overall Study||0
3372400|NCT03050398|4104347|FG000|NOT COMPLETED|Overall Study||8
3372401|NCT03042780|4104351|FG000|STARTED|Overall Study||2
3372402|NCT03042780|4104351|FG000|COMPLETED|Overall Study||2
3372403|NCT03042780|4104351|FG000|NOT COMPLETED|Overall Study||0
3372404|NCT03053960|4104355|FG000|STARTED|Overall Study||8
3372405|NCT03053960|4104355|FG000|COMPLETED|Overall Study||8
3372406|NCT03053960|4104355|FG000|NOT COMPLETED|Overall Study||0
3256722|NCT02547649|3990824|FG000|STARTED|Overall Study||231
3256723|NCT02547649|3990825|FG001|STARTED|Overall Study||231
3256724|NCT02547649|3990826|FG002|STARTED|Overall Study||228
3256725|NCT02547649|3990824|FG000|Vaccinated|Overall Study||231
3256726|NCT02547649|3990825|FG001|Vaccinated|Overall Study||231
3256727|NCT02547649|3990826|FG002|Vaccinated|Overall Study||227
3256728|NCT02547649|3990824|FG000|COMPLETED|Overall Study||228
3256729|NCT02547649|3990825|FG001|COMPLETED|Overall Study||226
3256730|NCT02547649|3990826|FG002|COMPLETED|Overall Study||224
3256731|NCT02547649|3990824|FG000|NOT COMPLETED|Overall Study||3
3256732|NCT02547649|3990825|FG001|NOT COMPLETED|Overall Study||5
3256733|NCT02547649|3990826|FG002|NOT COMPLETED|Overall Study||4
3256734|NCT02547714|3990834|FG000|STARTED|Overall Study||34
3256735|NCT02547714|3990834|FG000|COMPLETED|Overall Study||34
3256736|NCT02547714|3990834|FG000|NOT COMPLETED|Overall Study||0
3256737|NCT02547766|3990839|FG000|STARTED|Overall Study||10
3256738|NCT02547766|3990839|FG000|COMPLETED|Overall Study||9
3256739|NCT02547766|3990839|FG000|NOT COMPLETED|Overall Study||1
3256740|NCT02547779|3990845|FG000|STARTED|Overall Study||5214
3256741|NCT02547779|3990846|FG001|STARTED|Overall Study||5207
3256742|NCT02547779|3990845|FG000|COMPLETED|Overall Study||5214
3256743|NCT02547779|3990846|FG001|COMPLETED|Overall Study||5207
3256744|NCT02547779|3990845|FG000|NOT COMPLETED|Overall Study||0
3256745|NCT02547779|3990846|FG001|NOT COMPLETED|Overall Study||0
3256746|NCT02547922|3990855|FG000|STARTED|Overall Study||46
3256747|NCT02547922|3990856|FG001|STARTED|Overall Study||52
3256748|NCT02547922|3990857|FG002|STARTED|Overall Study||49
3256749|NCT02547922|3990855|FG000|FAS (Full Analysis Set)|Overall Study||45
3256750|NCT02547922|3990856|FG001|FAS (Full Analysis Set)|Overall Study||51
3372407|NCT03036735|4104359|FG000|STARTED|Overall Study||10
3372408|NCT03036735|4104359|FG000|COMPLETED|Overall Study||0
3372409|NCT03036735|4104359|FG000|NOT COMPLETED|Overall Study||10
3372410|NCT03029832|4104365|FG000|STARTED|Overall Study||4
3372411|NCT03029832|4104366|FG001|STARTED|Overall Study||1
3372412|NCT03029832|4104365|FG000|COMPLETED|Overall Study||0
3372413|NCT03029832|4104366|FG001|COMPLETED|Overall Study||0
3372414|NCT03029832|4104365|FG000|NOT COMPLETED|Overall Study||4
3372415|NCT03029832|4104366|FG001|NOT COMPLETED|Overall Study||1
3372416|NCT03020446|4104372|FG000|STARTED|Overall Study||3
3372417|NCT03020446|4104372|FG000|COMPLETED|Overall Study||0
3372418|NCT03020446|4104372|FG000|NOT COMPLETED|Overall Study||3
3372419|NCT03031340|4104378|FG000|STARTED|Overall Study||2
3372420|NCT03031340|4104379|FG001|STARTED|Overall Study||1
3372421|NCT03031340|4104378|FG000|COMPLETED|Overall Study||0
3372422|NCT03031340|4104379|FG001|COMPLETED|Overall Study||0
3372423|NCT03031340|4104378|FG000|NOT COMPLETED|Overall Study||2
3372424|NCT03031340|4104379|FG001|NOT COMPLETED|Overall Study||1
3372425|NCT03017040|4104385|FG000|STARTED|Overall Study|Participants enroll one wrist into each group,thus, one participant flows into both groups.|1
3372426|NCT03017040|4104386|FG001|STARTED|Overall Study|Participants enroll one wrist into each group,thus, one participant flows into both groups.|1
3372427|NCT03017040|4104385|FG000|COMPLETED|Overall Study||0
3372428|NCT03017040|4104386|FG001|COMPLETED|Overall Study||0
3372429|NCT03017040|4104385|FG000|NOT COMPLETED|Overall Study||1
3372430|NCT03017040|4104386|FG001|NOT COMPLETED|Overall Study||1
3372431|NCT03007719|4104394|FG000|STARTED|Overall Study||0
3372432|NCT03007719|4104395|FG001|STARTED|Overall Study||4
3372433|NCT03007719|4104394|FG000|COMPLETED|Overall Study||0
3372434|NCT03007719|4104395|FG001|COMPLETED|Overall Study||4
3372435|NCT03007719|4104394|FG000|NOT COMPLETED|Overall Study||0
3372436|NCT03007719|4104395|FG001|NOT COMPLETED|Overall Study||0
3372437|NCT03010423|4104401|FG000|STARTED|Overall Study||8
3372438|NCT03010423|4104401|FG000|COMPLETED|Overall Study||0
3372439|NCT03010423|4104401|FG000|NOT COMPLETED|Overall Study||8
3372440|NCT02985801|4104407|FG000|STARTED|Overall Study||8
3372441|NCT02985801|4104408|FG001|STARTED|Overall Study||8
3372442|NCT02985801|4104407|FG000|COMPLETED|Overall Study||8
3372443|NCT02985801|4104408|FG001|COMPLETED|Overall Study||8
3372444|NCT02985801|4104407|FG000|NOT COMPLETED|Overall Study||0
3372445|NCT02985801|4104408|FG001|NOT COMPLETED|Overall Study||0
3372446|NCT02991430|4104417|FG000|STARTED|Treatment Period 1||14
3372447|NCT02991430|4104418|FG001|STARTED|Treatment Period 1||15
3372448|NCT02991430|4104419|FG002|STARTED|Treatment Period 1||16
3372449|NCT02991430|4104417|FG000|COMPLETED|Treatment Period 1||13
3372450|NCT02991430|4104418|FG001|COMPLETED|Treatment Period 1||11
3372451|NCT02991430|4104419|FG002|COMPLETED|Treatment Period 1||14
3372452|NCT02991430|4104417|FG000|NOT COMPLETED|Treatment Period 1||1
3372453|NCT02991430|4104418|FG001|NOT COMPLETED|Treatment Period 1||4
3372454|NCT02991430|4104419|FG002|NOT COMPLETED|Treatment Period 1||2
3372455|NCT02991430|4104417|FG000|STARTED|Treatment Period 2||13
3372456|NCT02991430|4104418|FG001|STARTED|Treatment Period 2||11
3372457|NCT02991430|4104419|FG002|STARTED|Treatment Period 2||14
3372458|NCT02991430|4104417|FG000|COMPLETED|Treatment Period 2||7
3372459|NCT02991430|4104418|FG001|COMPLETED|Treatment Period 2||8
3372460|NCT02991430|4104419|FG002|COMPLETED|Treatment Period 2||10
3372461|NCT02991430|4104417|FG000|NOT COMPLETED|Treatment Period 2||6
3256751|NCT02547922|3990857|FG002|FAS (Full Analysis Set)|Overall Study||49
3372462|NCT02991430|4104418|FG001|NOT COMPLETED|Treatment Period 2||3
3372463|NCT02991430|4104419|FG002|NOT COMPLETED|Treatment Period 2||4
3372464|NCT02991430|4104417|FG000|STARTED|Post-treatment Observation Period||7
3372465|NCT02991430|4104418|FG001|STARTED|Post-treatment Observation Period||8
3372466|NCT02991430|4104419|FG002|STARTED|Post-treatment Observation Period||10
3256752|NCT02547922|3990855|FG000|COMPLETED|Overall Study||18
3256753|NCT02547922|3990856|FG001|COMPLETED|Overall Study||28
3256754|NCT02547922|3990857|FG002|COMPLETED|Overall Study||20
3256755|NCT02547922|3990855|FG000|NOT COMPLETED|Overall Study||28
3256756|NCT02547922|3990856|FG001|NOT COMPLETED|Overall Study||24
3256757|NCT02547922|3990857|FG002|NOT COMPLETED|Overall Study||29
3256758|NCT02547935|3990874|FG000|STARTED|Overall Study||155
3256759|NCT02547935|3990875|FG001|STARTED|Overall Study||145
3256760|NCT02547935|3990876|FG002|STARTED|Overall Study||148
3256761|NCT02547935|3990874|FG000|Received Treatment|Overall Study||152
3256762|NCT02547935|3990875|FG001|Received Treatment|Overall Study||145
3256763|NCT02547935|3990876|FG002|Received Treatment|Overall Study||148
3256764|NCT02547935|3990874|FG000|Full Analysis Set|Overall Study||152
3256765|NCT02547935|3990875|FG001|Full Analysis Set|Overall Study||144
3256766|NCT02547935|3990876|FG002|Full Analysis Set|Overall Study||148
3256767|NCT02547935|3990874|FG000|Safety Analysis Set|Overall Study||152
3256768|NCT02547935|3990875|FG001|Safety Analysis Set|Overall Study||145
3256769|NCT02547935|3990876|FG002|Safety Analysis Set|Overall Study||148
3256770|NCT02547935|3990874|FG000|COMPLETED|Overall Study||150
3256771|NCT02547935|3990875|FG001|COMPLETED|Overall Study||137
3256772|NCT02547935|3990876|FG002|COMPLETED|Overall Study||143
3256773|NCT02547935|3990874|FG000|NOT COMPLETED|Overall Study||5
3256774|NCT02547935|3990875|FG001|NOT COMPLETED|Overall Study||8
3256775|NCT02547935|3990876|FG002|NOT COMPLETED|Overall Study||5
3256776|NCT02547974|3990890|FG000|STARTED|Overall Study||15
3256777|NCT02547974|3990891|FG001|STARTED|Overall Study||31
3256778|NCT02547974|3990892|FG002|STARTED|Overall Study||30
3256779|NCT02547974|3990893|FG003|STARTED|Overall Study||44
3256780|NCT02547974|3990890|FG000|COMPLETED|Overall Study||14
3256781|NCT02547974|3990891|FG001|COMPLETED|Overall Study||31
3256782|NCT02547974|3990892|FG002|COMPLETED|Overall Study||30
3256783|NCT02547974|3990893|FG003|COMPLETED|Overall Study||44
3256784|NCT02547974|3990890|FG000|NOT COMPLETED|Overall Study||1
3256785|NCT02547974|3990891|FG001|NOT COMPLETED|Overall Study||0
3256786|NCT02547974|3990892|FG002|NOT COMPLETED|Overall Study||0
3256787|NCT02547974|3990893|FG003|NOT COMPLETED|Overall Study||0
3256788|NCT02547987|3990906|FG000|STARTED|Overall Study||25
3256789|NCT02547987|3990906|FG000|COMPLETED|Overall Study||22
3256790|NCT02547987|3990906|FG000|NOT COMPLETED|Overall Study||3
3256791|NCT02548078|3990912|FG000|STARTED|Overall Study||300
3256792|NCT02548078|3990913|FG001|STARTED|Overall Study||300
3256793|NCT02548078|3990912|FG000|COMPLETED|Overall Study||295
3256794|NCT02548078|3990913|FG001|COMPLETED|Overall Study||294
3256795|NCT02548078|3990912|FG000|NOT COMPLETED|Overall Study||5
3256796|NCT02548078|3990913|FG001|NOT COMPLETED|Overall Study||6
3256797|NCT02548156|3990926|FG000|STARTED|Period 1||5
3256798|NCT02548156|3990927|FG001|STARTED|Period 1||5
3256799|NCT02548156|3990928|FG002|STARTED|Period 1||4
3256800|NCT02548156|3990929|FG003|STARTED|Period 1||5
3256801|NCT02548156|3990930|FG004|STARTED|Period 1||5
3256802|NCT02548156|3990931|FG005|STARTED|Period 1||5
3256803|NCT02548156|3990926|FG000|COMPLETED|Period 1||5
3256804|NCT02548156|3990927|FG001|COMPLETED|Period 1||5
3256805|NCT02548156|3990928|FG002|COMPLETED|Period 1||4
3256806|NCT02548156|3990929|FG003|COMPLETED|Period 1||5
3256807|NCT02548156|3990930|FG004|COMPLETED|Period 1||5
3256808|NCT02548156|3990931|FG005|COMPLETED|Period 1||5
3256809|NCT02548156|3990926|FG000|NOT COMPLETED|Period 1||0
3256810|NCT02548156|3990927|FG001|NOT COMPLETED|Period 1||0
3256811|NCT02548156|3990928|FG002|NOT COMPLETED|Period 1||0
3256812|NCT02548156|3990929|FG003|NOT COMPLETED|Period 1||0
3256813|NCT02548156|3990930|FG004|NOT COMPLETED|Period 1||0
3256814|NCT02548156|3990931|FG005|NOT COMPLETED|Period 1||0
3256815|NCT02548156|3990926|FG000|STARTED|Washout Period 1||5
3256816|NCT02548156|3990927|FG001|STARTED|Washout Period 1||5
3256817|NCT02548156|3990928|FG002|STARTED|Washout Period 1||4
3256818|NCT02548156|3990929|FG003|STARTED|Washout Period 1||5
3256819|NCT02548156|3990930|FG004|STARTED|Washout Period 1||5
3256820|NCT02548156|3990931|FG005|STARTED|Washout Period 1||5
3256821|NCT02548156|3990926|FG000|COMPLETED|Washout Period 1||5
3256822|NCT02548156|3990927|FG001|COMPLETED|Washout Period 1||5
3256823|NCT02548156|3990928|FG002|COMPLETED|Washout Period 1||4
3256824|NCT02548156|3990929|FG003|COMPLETED|Washout Period 1||5
3256825|NCT02548156|3990930|FG004|COMPLETED|Washout Period 1||4
3256826|NCT02548156|3990931|FG005|COMPLETED|Washout Period 1||5
3256827|NCT02548156|3990926|FG000|NOT COMPLETED|Washout Period 1||0
3256828|NCT02548156|3990927|FG001|NOT COMPLETED|Washout Period 1||0
3256829|NCT02548156|3990928|FG002|NOT COMPLETED|Washout Period 1||0
3256830|NCT02548156|3990929|FG003|NOT COMPLETED|Washout Period 1||0
3256831|NCT02548156|3990930|FG004|NOT COMPLETED|Washout Period 1||1
3256832|NCT02548156|3990931|FG005|NOT COMPLETED|Washout Period 1||0
3256833|NCT02548156|3990926|FG000|STARTED|Period 2||5
3256834|NCT02548156|3990927|FG001|STARTED|Period 2||5
3256835|NCT02548156|3990928|FG002|STARTED|Period 2||4
3256836|NCT02548156|3990929|FG003|STARTED|Period 2||5
3256837|NCT02548156|3990930|FG004|STARTED|Period 2||4
3256838|NCT02548156|3990931|FG005|STARTED|Period 2||5
3256839|NCT02548156|3990926|FG000|COMPLETED|Period 2||5
3256840|NCT02548156|3990927|FG001|COMPLETED|Period 2||5
3256841|NCT02548156|3990928|FG002|COMPLETED|Period 2||4
3256842|NCT02548156|3990929|FG003|COMPLETED|Period 2||5
3256843|NCT02548156|3990930|FG004|COMPLETED|Period 2||4
3256844|NCT02548156|3990931|FG005|COMPLETED|Period 2||5
3256845|NCT02548156|3990926|FG000|NOT COMPLETED|Period 2||0
3256846|NCT02548156|3990927|FG001|NOT COMPLETED|Period 2||0
3256847|NCT02548156|3990928|FG002|NOT COMPLETED|Period 2||0
3256848|NCT02548156|3990929|FG003|NOT COMPLETED|Period 2||0
3256849|NCT02548156|3990930|FG004|NOT COMPLETED|Period 2||0
3256850|NCT02548156|3990931|FG005|NOT COMPLETED|Period 2||0
3256851|NCT02548156|3990926|FG000|STARTED|Washout Period 2||5
3256852|NCT02548156|3990927|FG001|STARTED|Washout Period 2||5
3256853|NCT02548156|3990928|FG002|STARTED|Washout Period 2||4
3256854|NCT02548156|3990929|FG003|STARTED|Washout Period 2||5
3256855|NCT02548156|3990930|FG004|STARTED|Washout Period 2||4
3256856|NCT02548156|3990931|FG005|STARTED|Washout Period 2||5
3256857|NCT02548156|3990926|FG000|COMPLETED|Washout Period 2||5
3256858|NCT02548156|3990927|FG001|COMPLETED|Washout Period 2||5
3256859|NCT02548156|3990928|FG002|COMPLETED|Washout Period 2||4
3256860|NCT02548156|3990929|FG003|COMPLETED|Washout Period 2||5
3256861|NCT02548156|3990930|FG004|COMPLETED|Washout Period 2||4
3256862|NCT02548156|3990931|FG005|COMPLETED|Washout Period 2||5
3256863|NCT02548156|3990926|FG000|NOT COMPLETED|Washout Period 2||0
3256864|NCT02548156|3990927|FG001|NOT COMPLETED|Washout Period 2||0
3256865|NCT02548156|3990928|FG002|NOT COMPLETED|Washout Period 2||0
3256866|NCT02548156|3990929|FG003|NOT COMPLETED|Washout Period 2||0
3256867|NCT02548156|3990930|FG004|NOT COMPLETED|Washout Period 2||0
3256868|NCT02548156|3990931|FG005|NOT COMPLETED|Washout Period 2||0
3256869|NCT02548156|3990926|FG000|STARTED|Period 3||5
3256870|NCT02548156|3990927|FG001|STARTED|Period 3||5
3256871|NCT02548156|3990928|FG002|STARTED|Period 3||4
3256872|NCT02548156|3990929|FG003|STARTED|Period 3||5
3256873|NCT02548156|3990930|FG004|STARTED|Period 3||4
3256874|NCT02548156|3990931|FG005|STARTED|Period 3||5
3256875|NCT02548156|3990926|FG000|COMPLETED|Period 3||5
3256876|NCT02548156|3990927|FG001|COMPLETED|Period 3||5
3256877|NCT02548156|3990928|FG002|COMPLETED|Period 3||4
3256878|NCT02548156|3990929|FG003|COMPLETED|Period 3||5
3256879|NCT02548156|3990930|FG004|COMPLETED|Period 3||4
3256880|NCT02548156|3990931|FG005|COMPLETED|Period 3||5
3256881|NCT02548156|3990926|FG000|NOT COMPLETED|Period 3||0
3256882|NCT02548156|3990927|FG001|NOT COMPLETED|Period 3||0
3256883|NCT02548156|3990928|FG002|NOT COMPLETED|Period 3||0
3256884|NCT02548156|3990929|FG003|NOT COMPLETED|Period 3||0
3256885|NCT02548156|3990930|FG004|NOT COMPLETED|Period 3||0
3256886|NCT02548156|3990931|FG005|NOT COMPLETED|Period 3||0
3256887|NCT02548312|3990947|FG000|STARTED|Overall Study||133
3256888|NCT02548312|3990948|FG001|STARTED|Overall Study||133
3256889|NCT02548312|3990949|FG002|STARTED|Overall Study||134
3256890|NCT02548312|3990950|FG003|STARTED|Overall Study||133
3256891|NCT02548312|3990951|FG004|STARTED|Overall Study||133
3256892|NCT02548312|3990952|FG005|STARTED|Overall Study||133
3256893|NCT02548312|3990953|FG006|STARTED|Overall Study||133
3256894|NCT02548312|3990954|FG007|STARTED|Overall Study||133
3256895|NCT02548312|3990947|FG000|COMPLETED|Overall Study||100
3256896|NCT02548312|3990948|FG001|COMPLETED|Overall Study||90
3256897|NCT02548312|3990949|FG002|COMPLETED|Overall Study||96
3256898|NCT02548312|3990950|FG003|COMPLETED|Overall Study||87
3256899|NCT02548312|3990951|FG004|COMPLETED|Overall Study||99
3256900|NCT02548312|3990952|FG005|COMPLETED|Overall Study||93
3256901|NCT02548312|3990953|FG006|COMPLETED|Overall Study||93
3256902|NCT02548312|3990954|FG007|COMPLETED|Overall Study||91
3256903|NCT02548312|3990947|FG000|NOT COMPLETED|Overall Study||33
3256904|NCT02548312|3990948|FG001|NOT COMPLETED|Overall Study||43
3256905|NCT02548312|3990949|FG002|NOT COMPLETED|Overall Study||38
3256906|NCT02548312|3990950|FG003|NOT COMPLETED|Overall Study||46
3256907|NCT02548312|3990951|FG004|NOT COMPLETED|Overall Study||34
3256908|NCT02548312|3990952|FG005|NOT COMPLETED|Overall Study||40
3256909|NCT02548312|3990953|FG006|NOT COMPLETED|Overall Study||40
3256910|NCT02548312|3990954|FG007|NOT COMPLETED|Overall Study||42
3256911|NCT02548455|3990972|FG000|STARTED|Overall Study|A total of 499 subjects were enrolled at 31 investigational sites.|499
3256912|NCT02548455|3990972|FG000|Completed Pre-Discharge|Overall Study||484
3256913|NCT02548455|3990972|FG000|Completed 6-Month Follow-up|Overall Study||259
3256914|NCT02548455|3990972|FG000|Completed 12-Month Follow-up|Overall Study|Study completed prior to all subjects reaching the 6- and 12-month visits.|61
3256915|NCT02548455|3990972|FG000|COMPLETED|Overall Study|Completed 6-Month Follow-up|259
3256916|NCT02548455|3990972|FG000|NOT COMPLETED|Overall Study||240
3256917|NCT02548585|3990983|FG000|STARTED|Overall Study||45
3256918|NCT02548585|3990984|FG001|STARTED|Overall Study||6
3256919|NCT02548585|3990985|FG002|STARTED|Overall Study||6
3256920|NCT02548585|3990986|FG003|STARTED|Overall Study||7
3256921|NCT02548585|3990987|FG004|STARTED|Overall Study||25
3256922|NCT02548585|3990988|FG005|STARTED|Overall Study||12
3256923|NCT02548585|3990989|FG006|STARTED|Overall Study||12
3256924|NCT02548585|3990983|FG000|Treated|Overall Study||45
3256925|NCT02548585|3990984|FG001|Treated|Overall Study||6
3256926|NCT02548585|3990985|FG002|Treated|Overall Study||6
3256927|NCT02548585|3990986|FG003|Treated|Overall Study||7
3256928|NCT02548585|3990987|FG004|Treated|Overall Study||25
3256929|NCT02548585|3990988|FG005|Treated|Overall Study||11
3256930|NCT02548585|3990989|FG006|Treated|Overall Study||12
3256931|NCT02548585|3990983|FG000|COMPLETED|Overall Study||43
3256932|NCT02548585|3990984|FG001|COMPLETED|Overall Study||6
3256933|NCT02548585|3990985|FG002|COMPLETED|Overall Study||6
3256934|NCT02548585|3990986|FG003|COMPLETED|Overall Study||5
3256935|NCT02548585|3990987|FG004|COMPLETED|Overall Study||22
3256936|NCT02548585|3990988|FG005|COMPLETED|Overall Study||10
3256937|NCT02548585|3990989|FG006|COMPLETED|Overall Study||11
3256938|NCT02548585|3990983|FG000|NOT COMPLETED|Overall Study||2
3256939|NCT02548585|3990984|FG001|NOT COMPLETED|Overall Study||0
3256940|NCT02548585|3990985|FG002|NOT COMPLETED|Overall Study||0
3256941|NCT02548585|3990986|FG003|NOT COMPLETED|Overall Study||2
3256942|NCT02548585|3990987|FG004|NOT COMPLETED|Overall Study||3
3256943|NCT02548585|3990988|FG005|NOT COMPLETED|Overall Study||2
3256944|NCT02548585|3990989|FG006|NOT COMPLETED|Overall Study||1
3256945|NCT02548650|3991032|FG000|STARTED|Triple Therapy||30
3256946|NCT02548650|3991033|FG001|STARTED|Triple Therapy||36
3256947|NCT02548650|3991032|FG000|COMPLETED|Triple Therapy||29
3256948|NCT02548650|3991033|FG001|COMPLETED|Triple Therapy||32
3256949|NCT02548650|3991032|FG000|NOT COMPLETED|Triple Therapy||1
3256950|NCT02548650|3991033|FG001|NOT COMPLETED|Triple Therapy||4
3256951|NCT02548650|3991032|FG000|STARTED|Double Therapy||29
3256952|NCT02548650|3991033|FG001|STARTED|Double Therapy||32
3256953|NCT02548650|3991032|FG000|COMPLETED|Double Therapy||28
3256954|NCT02548650|3991033|FG001|COMPLETED|Double Therapy||30
3256955|NCT02548650|3991032|FG000|NOT COMPLETED|Double Therapy||1
3256956|NCT02548650|3991033|FG001|NOT COMPLETED|Double Therapy||2
3256957|NCT02548728|3991041|FG000|STARTED|Overall Study||6
3256958|NCT02548728|3991042|FG001|STARTED|Overall Study||6
3256959|NCT02548728|3991041|FG000|COMPLETED|Overall Study||6
3256960|NCT02548728|3991042|FG001|COMPLETED|Overall Study||6
3256961|NCT02548728|3991041|FG000|NOT COMPLETED|Overall Study||0
3256962|NCT02548728|3991042|FG001|NOT COMPLETED|Overall Study||0
3256963|NCT02548845|3991048|FG000|STARTED|Overall Study||70
3256964|NCT02548845|3991048|FG000|COMPLETED|Overall Study||70
3256965|NCT02548845|3991048|FG000|NOT COMPLETED|Overall Study||0
3256966|NCT02548910|3991058|FG000|STARTED|Overall Study||31
3256967|NCT02548910|3991059|FG001|STARTED|Overall Study||31
3256968|NCT02548910|3991058|FG000|COMPLETED|Overall Study||31
3256969|NCT02548910|3991059|FG001|COMPLETED|Overall Study||31
3256970|NCT02548910|3991058|FG000|NOT COMPLETED|Overall Study||0
3256971|NCT02548910|3991059|FG001|NOT COMPLETED|Overall Study||0
3256972|NCT02548949|3991066|FG000|STARTED|Overall Study||700
3256973|NCT02548949|3991066|FG000|COMPLETED|Overall Study||700
3256974|NCT02548949|3991066|FG000|NOT COMPLETED|Overall Study||0
3256975|NCT02548962|3991072|FG000|STARTED|Overall Study||8
3256976|NCT02548962|3991073|FG001|STARTED|Overall Study||3
3256977|NCT02548962|3991072|FG000|COMPLETED|Overall Study||7
3256978|NCT02548962|3991073|FG001|COMPLETED|Overall Study||3
3256979|NCT02548962|3991072|FG000|NOT COMPLETED|Overall Study||1
3256980|NCT02548962|3991073|FG001|NOT COMPLETED|Overall Study||0
3256981|NCT02549014|3991083|FG000|STARTED|Overall Study||8
3256982|NCT02549014|3991084|FG001|STARTED|Overall Study||8
3256983|NCT02549014|3991083|FG000|COMPLETED|Overall Study||8
3256984|NCT02549014|3991084|FG001|COMPLETED|Overall Study||8
3256985|NCT02549014|3991083|FG000|NOT COMPLETED|Overall Study||0
3256986|NCT02549014|3991084|FG001|NOT COMPLETED|Overall Study||0
3256987|NCT02549027|3991108|FG000|STARTED|Period 1 - MK-1064 or Placebo||5
3256988|NCT02549027|3991109|FG001|STARTED|Period 1 - MK-1064 or Placebo||5
3256989|NCT02549027|3991110|FG002|STARTED|Period 1 - MK-1064 or Placebo||5
3256990|NCT02549027|3991111|FG003|STARTED|Period 1 - MK-1064 or Placebo||5
3256991|NCT02549027|3991112|FG004|STARTED|Period 1 - MK-1064 or Placebo||0
3256992|NCT02549027|3991113|FG005|STARTED|Period 1 - MK-1064 or Placebo||0
3256993|NCT02549027|3991108|FG000|COMPLETED|Period 1 - MK-1064 or Placebo||5
3256994|NCT02549027|3991109|FG001|COMPLETED|Period 1 - MK-1064 or Placebo||5
3256995|NCT02549027|3991110|FG002|COMPLETED|Period 1 - MK-1064 or Placebo||5
3256996|NCT02549027|3991111|FG003|COMPLETED|Period 1 - MK-1064 or Placebo||5
3256997|NCT02549027|3991112|FG004|COMPLETED|Period 1 - MK-1064 or Placebo||0
3256998|NCT02549027|3991113|FG005|COMPLETED|Period 1 - MK-1064 or Placebo||0
3256999|NCT02549027|3991108|FG000|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
3257000|NCT02549027|3991109|FG001|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
3257001|NCT02549027|3991110|FG002|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
3257002|NCT02549027|3991111|FG003|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
3257003|NCT02549027|3991112|FG004|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
3257004|NCT02549027|3991113|FG005|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
3257005|NCT02549027|3991108|FG000|STARTED|Washout After Period 1||5
3257006|NCT02549027|3991109|FG001|STARTED|Washout After Period 1||5
3257007|NCT02549027|3991110|FG002|STARTED|Washout After Period 1||5
3257008|NCT02549027|3991111|FG003|STARTED|Washout After Period 1||5
3257009|NCT02549027|3991112|FG004|STARTED|Washout After Period 1||0
3257010|NCT02549027|3991113|FG005|STARTED|Washout After Period 1||0
3257011|NCT02549027|3991108|FG000|COMPLETED|Washout After Period 1||5
3257012|NCT02549027|3991109|FG001|COMPLETED|Washout After Period 1||5
3257013|NCT02549027|3991110|FG002|COMPLETED|Washout After Period 1||5
3257014|NCT02549027|3991111|FG003|COMPLETED|Washout After Period 1||5
3257015|NCT02549027|3991112|FG004|COMPLETED|Washout After Period 1||0
3257016|NCT02549027|3991113|FG005|COMPLETED|Washout After Period 1||0
3257017|NCT02549027|3991108|FG000|NOT COMPLETED|Washout After Period 1||0
3257018|NCT02549027|3991109|FG001|NOT COMPLETED|Washout After Period 1||0
3257019|NCT02549027|3991110|FG002|NOT COMPLETED|Washout After Period 1||0
3257020|NCT02549027|3991111|FG003|NOT COMPLETED|Washout After Period 1||0
3257021|NCT02549027|3991112|FG004|NOT COMPLETED|Washout After Period 1||0
3257022|NCT02549027|3991113|FG005|NOT COMPLETED|Washout After Period 1||0
3257023|NCT02549027|3991108|FG000|STARTED|Period 2 - MK-1064 or Placebo||5
3257024|NCT02549027|3991109|FG001|STARTED|Period 2 - MK-1064 or Placebo||5
3257025|NCT02549027|3991110|FG002|STARTED|Period 2 - MK-1064 or Placebo||5
3257026|NCT02549027|3991111|FG003|STARTED|Period 2 - MK-1064 or Placebo||5
3257027|NCT02549027|3991112|FG004|STARTED|Period 2 - MK-1064 or Placebo||0
3257028|NCT02549027|3991113|FG005|STARTED|Period 2 - MK-1064 or Placebo||0
3257029|NCT02549027|3991108|FG000|COMPLETED|Period 2 - MK-1064 or Placebo||5
3257030|NCT02549027|3991109|FG001|COMPLETED|Period 2 - MK-1064 or Placebo||5
3257031|NCT02549027|3991110|FG002|COMPLETED|Period 2 - MK-1064 or Placebo||5
3257032|NCT02549027|3991111|FG003|COMPLETED|Period 2 - MK-1064 or Placebo||5
3257033|NCT02549027|3991112|FG004|COMPLETED|Period 2 - MK-1064 or Placebo||0
3257034|NCT02549027|3991113|FG005|COMPLETED|Period 2 - MK-1064 or Placebo||0
3257035|NCT02549027|3991108|FG000|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
3257036|NCT02549027|3991109|FG001|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
3257037|NCT02549027|3991110|FG002|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
3257038|NCT02549027|3991111|FG003|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
3257039|NCT02549027|3991112|FG004|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
3257040|NCT02549027|3991113|FG005|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
3257041|NCT02549027|3991108|FG000|STARTED|Washout After Period 2||5
3257042|NCT02549027|3991109|FG001|STARTED|Washout After Period 2||5
3257043|NCT02549027|3991110|FG002|STARTED|Washout After Period 2||5
3257044|NCT02549027|3991111|FG003|STARTED|Washout After Period 2||5
3257045|NCT02549027|3991112|FG004|STARTED|Washout After Period 2||0
3257046|NCT02549027|3991113|FG005|STARTED|Washout After Period 2||0
3257047|NCT02549027|3991108|FG000|COMPLETED|Washout After Period 2||5
3257048|NCT02549027|3991109|FG001|COMPLETED|Washout After Period 2||5
3257049|NCT02549027|3991110|FG002|COMPLETED|Washout After Period 2||5
3257050|NCT02549027|3991111|FG003|COMPLETED|Washout After Period 2||5
3257051|NCT02549027|3991112|FG004|COMPLETED|Washout After Period 2||0
3257052|NCT02549027|3991113|FG005|COMPLETED|Washout After Period 2||0
3257053|NCT02549027|3991108|FG000|NOT COMPLETED|Washout After Period 2||0
3257054|NCT02549027|3991109|FG001|NOT COMPLETED|Washout After Period 2||0
3257055|NCT02549027|3991110|FG002|NOT COMPLETED|Washout After Period 2||0
3257056|NCT02549027|3991111|FG003|NOT COMPLETED|Washout After Period 2||0
3257057|NCT02549027|3991112|FG004|NOT COMPLETED|Washout After Period 2||0
3257058|NCT02549027|3991113|FG005|NOT COMPLETED|Washout After Period 2||0
3257059|NCT02549027|3991108|FG000|STARTED|Period 3 - MK-1064 or Placebo||5
3257060|NCT02549027|3991109|FG001|STARTED|Period 3 - MK-1064 or Placebo||5
3257061|NCT02549027|3991110|FG002|STARTED|Period 3 - MK-1064 or Placebo||5
3257062|NCT02549027|3991111|FG003|STARTED|Period 3 - MK-1064 or Placebo||5
3257063|NCT02549027|3991112|FG004|STARTED|Period 3 - MK-1064 or Placebo||0
3257064|NCT02549027|3991113|FG005|STARTED|Period 3 - MK-1064 or Placebo||0
3257065|NCT02549027|3991108|FG000|COMPLETED|Period 3 - MK-1064 or Placebo||5
3257066|NCT02549027|3991109|FG001|COMPLETED|Period 3 - MK-1064 or Placebo||5
3257067|NCT02549027|3991110|FG002|COMPLETED|Period 3 - MK-1064 or Placebo||5
3257068|NCT02549027|3991111|FG003|COMPLETED|Period 3 - MK-1064 or Placebo||5
3257069|NCT02549027|3991112|FG004|COMPLETED|Period 3 - MK-1064 or Placebo||0
3257070|NCT02549027|3991113|FG005|COMPLETED|Period 3 - MK-1064 or Placebo||0
3257071|NCT02549027|3991108|FG000|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
3257072|NCT02549027|3991109|FG001|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
3257073|NCT02549027|3991110|FG002|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
3257074|NCT02549027|3991111|FG003|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
3257075|NCT02549027|3991112|FG004|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
3257076|NCT02549027|3991113|FG005|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
3257077|NCT02549027|3991108|FG000|STARTED|Washout After Period 3||5
3372467|NCT02991430|4104417|FG000|COMPLETED|Post-treatment Observation Period||4
3372468|NCT02991430|4104418|FG001|COMPLETED|Post-treatment Observation Period||2
3372469|NCT02991430|4104419|FG002|COMPLETED|Post-treatment Observation Period||5
3372470|NCT02991430|4104417|FG000|NOT COMPLETED|Post-treatment Observation Period||3
3372471|NCT02991430|4104418|FG001|NOT COMPLETED|Post-treatment Observation Period||6
3372472|NCT02991430|4104419|FG002|NOT COMPLETED|Post-treatment Observation Period||5
3372473|NCT02995967|4104429|FG000|STARTED|Overall Study||1
3372474|NCT02995967|4104430|FG001|STARTED|Overall Study||2
3372475|NCT02995967|4104429|FG000|COMPLETED|Overall Study||1
3372476|NCT02995967|4104430|FG001|COMPLETED|Overall Study||2
3372477|NCT02995967|4104429|FG000|NOT COMPLETED|Overall Study||0
3372478|NCT02995967|4104430|FG001|NOT COMPLETED|Overall Study||0
3372479|NCT02994251|4104437|FG000|STARTED|Overall Study||0
3372480|NCT02994251|4104437|FG000|COMPLETED|Overall Study||0
3372481|NCT02994251|4104437|FG000|NOT COMPLETED|Overall Study||0
3372482|NCT02978885|4104443|FG000|STARTED|Overall Study||0
3372483|NCT02978885|4104444|FG001|STARTED|Overall Study||1
3372484|NCT02978885|4104443|FG000|COMPLETED|Overall Study||0
3372485|NCT02978885|4104444|FG001|COMPLETED|Overall Study||1
3372486|NCT02978885|4104443|FG000|NOT COMPLETED|Overall Study||0
3372487|NCT02978885|4104444|FG001|NOT COMPLETED|Overall Study||0
3372488|NCT02978833|4104452|FG000|STARTED|Overall Study||1
3372489|NCT02978833|4104453|FG001|STARTED|Overall Study||1
3372490|NCT02978833|4104452|FG000|COMPLETED|Overall Study||0
3372491|NCT02978833|4104453|FG001|COMPLETED|Overall Study||0
3372492|NCT02978833|4104452|FG000|NOT COMPLETED|Overall Study||1
3372493|NCT02978833|4104453|FG001|NOT COMPLETED|Overall Study||1
3372494|NCT02971839|4104465|FG000|STARTED|Overall Study||2
3372495|NCT02971839|4104466|FG001|STARTED|Overall Study||2
3372496|NCT02971839|4104467|FG002|STARTED|Overall Study||2
3372497|NCT02971839|4104468|FG003|STARTED|Overall Study||2
3372498|NCT02971839|4104469|FG004|STARTED|Overall Study||3
3372499|NCT02971839|4104465|FG000|COMPLETED|Overall Study||2
3372500|NCT02971839|4104466|FG001|COMPLETED|Overall Study||2
3257078|NCT02549027|3991109|FG001|STARTED|Washout After Period 3||5
3257079|NCT02549027|3991110|FG002|STARTED|Washout After Period 3||5
3257080|NCT02549027|3991111|FG003|STARTED|Washout After Period 3||5
3257081|NCT02549027|3991112|FG004|STARTED|Washout After Period 3||0
3257082|NCT02549027|3991113|FG005|STARTED|Washout After Period 3||0
3257083|NCT02549027|3991108|FG000|COMPLETED|Washout After Period 3||5
3257084|NCT02549027|3991109|FG001|COMPLETED|Washout After Period 3||5
3257085|NCT02549027|3991110|FG002|COMPLETED|Washout After Period 3||5
3257086|NCT02549027|3991111|FG003|COMPLETED|Washout After Period 3||5
3257087|NCT02549027|3991112|FG004|COMPLETED|Washout After Period 3||0
3257088|NCT02549027|3991113|FG005|COMPLETED|Washout After Period 3||0
3257089|NCT02549027|3991108|FG000|NOT COMPLETED|Washout After Period 3||0
3257090|NCT02549027|3991109|FG001|NOT COMPLETED|Washout After Period 3||0
3257091|NCT02549027|3991110|FG002|NOT COMPLETED|Washout After Period 3||0
3257092|NCT02549027|3991111|FG003|NOT COMPLETED|Washout After Period 3||0
3257093|NCT02549027|3991112|FG004|NOT COMPLETED|Washout After Period 3||0
3257094|NCT02549027|3991113|FG005|NOT COMPLETED|Washout After Period 3||0
3257095|NCT02549027|3991108|FG000|STARTED|Period 4 - MK-1064 or Placebo||5
3257096|NCT02549027|3991109|FG001|STARTED|Period 4 - MK-1064 or Placebo||5
3257097|NCT02549027|3991110|FG002|STARTED|Period 4 - MK-1064 or Placebo||5
3257098|NCT02549027|3991111|FG003|STARTED|Period 4 - MK-1064 or Placebo||5
3257099|NCT02549027|3991112|FG004|STARTED|Period 4 - MK-1064 or Placebo||0
3257100|NCT02549027|3991113|FG005|STARTED|Period 4 - MK-1064 or Placebo||0
3257101|NCT02549027|3991108|FG000|COMPLETED|Period 4 - MK-1064 or Placebo||5
3257102|NCT02549027|3991109|FG001|COMPLETED|Period 4 - MK-1064 or Placebo||5
3257103|NCT02549027|3991110|FG002|COMPLETED|Period 4 - MK-1064 or Placebo||5
3257104|NCT02549027|3991111|FG003|COMPLETED|Period 4 - MK-1064 or Placebo||5
3257105|NCT02549027|3991112|FG004|COMPLETED|Period 4 - MK-1064 or Placebo||0
3257106|NCT02549027|3991113|FG005|COMPLETED|Period 4 - MK-1064 or Placebo||0
3257107|NCT02549027|3991108|FG000|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
3257108|NCT02549027|3991109|FG001|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
3257109|NCT02549027|3991110|FG002|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
3257110|NCT02549027|3991111|FG003|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
3257111|NCT02549027|3991112|FG004|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
3257112|NCT02549027|3991113|FG005|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
3257113|NCT02549027|3991108|FG000|STARTED|Washout After Period 4||5
3257114|NCT02549027|3991109|FG001|STARTED|Washout After Period 4||5
3257115|NCT02549027|3991110|FG002|STARTED|Washout After Period 4||5
3257116|NCT02549027|3991111|FG003|STARTED|Washout After Period 4||5
3257117|NCT02549027|3991112|FG004|STARTED|Washout After Period 4||0
3257118|NCT02549027|3991113|FG005|STARTED|Washout After Period 4||0
3257119|NCT02549027|3991108|FG000|COMPLETED|Washout After Period 4||5
3257120|NCT02549027|3991109|FG001|COMPLETED|Washout After Period 4||4
3257121|NCT02549027|3991110|FG002|COMPLETED|Washout After Period 4||4
3257122|NCT02549027|3991111|FG003|COMPLETED|Washout After Period 4||4
3257123|NCT02549027|3991112|FG004|COMPLETED|Washout After Period 4||0
3257124|NCT02549027|3991113|FG005|COMPLETED|Washout After Period 4||0
3257125|NCT02549027|3991108|FG000|NOT COMPLETED|Washout After Period 4||0
3257126|NCT02549027|3991109|FG001|NOT COMPLETED|Washout After Period 4||1
3257127|NCT02549027|3991110|FG002|NOT COMPLETED|Washout After Period 4||1
3257128|NCT02549027|3991111|FG003|NOT COMPLETED|Washout After Period 4||1
3257129|NCT02549027|3991112|FG004|NOT COMPLETED|Washout After Period 4||0
3257130|NCT02549027|3991113|FG005|NOT COMPLETED|Washout After Period 4||0
3257131|NCT02549027|3991108|FG000|STARTED|Period 5 - MK-6096 or Placebo|In Period 5, participants previously in this arm appear in MK-6096 20 mg/Placebo (Period 5) arms|0
3257132|NCT02549027|3991109|FG001|STARTED|Period 5 - MK-6096 or Placebo|In Period 5, participants previously in this arm appear in MK-6096 20 mg (Period 5) arm|0
3257133|NCT02549027|3991110|FG002|STARTED|Period 5 - MK-6096 or Placebo|In Period 5, participants previously in this arm appear in MK-6096 20 mg (Period 5) arm|0
3257134|NCT02549027|3991111|FG003|STARTED|Period 5 - MK-6096 or Placebo|In Period 5, participants previously in this arm appear in MK-6096 20 mg (Period 5) arm|0
3257135|NCT02549027|3991112|FG004|STARTED|Period 5 - MK-6096 or Placebo|Participants entering Period 5 were previously in MK-1064/Placebo (Period 1-4) arms|16
3257136|NCT02549027|3991113|FG005|STARTED|Period 5 - MK-6096 or Placebo|Participants entering Period 5 were previously in MK-1064/Placebo (Period 1-4) arms|1
3257137|NCT02549027|3991108|FG000|COMPLETED|Period 5 - MK-6096 or Placebo||0
3257138|NCT02549027|3991109|FG001|COMPLETED|Period 5 - MK-6096 or Placebo||0
3257139|NCT02549027|3991110|FG002|COMPLETED|Period 5 - MK-6096 or Placebo||0
3257140|NCT02549027|3991111|FG003|COMPLETED|Period 5 - MK-6096 or Placebo||0
3257141|NCT02549027|3991112|FG004|COMPLETED|Period 5 - MK-6096 or Placebo|The 2 participants who did not complete Period 5 did not receive study drug in Period 5|14
3257142|NCT02549027|3991113|FG005|COMPLETED|Period 5 - MK-6096 or Placebo||1
3257143|NCT02549027|3991108|FG000|NOT COMPLETED|Period 5 - MK-6096 or Placebo||0
3257144|NCT02549027|3991109|FG001|NOT COMPLETED|Period 5 - MK-6096 or Placebo||0
3257145|NCT02549027|3991110|FG002|NOT COMPLETED|Period 5 - MK-6096 or Placebo||0
3257146|NCT02549027|3991111|FG003|NOT COMPLETED|Period 5 - MK-6096 or Placebo||0
3257147|NCT02549027|3991112|FG004|NOT COMPLETED|Period 5 - MK-6096 or Placebo||2
3257148|NCT02549027|3991113|FG005|NOT COMPLETED|Period 5 - MK-6096 or Placebo||0
3257149|NCT02549040|3991128|FG000|STARTED|Period 1||16
3257150|NCT02549040|3991128|FG000|COMPLETED|Period 1||16
3257151|NCT02549040|3991128|FG000|NOT COMPLETED|Period 1||0
3257152|NCT02549040|3991128|FG000|STARTED|Period 2||16
3257153|NCT02549040|3991128|FG000|COMPLETED|Period 2||16
3257154|NCT02549040|3991128|FG000|NOT COMPLETED|Period 2||0
3257155|NCT02549040|3991128|FG000|STARTED|Period 3||16
3257156|NCT02549040|3991128|FG000|COMPLETED|Period 3||16
3257157|NCT02549040|3991128|FG000|NOT COMPLETED|Period 3||0
3257158|NCT02549040|3991128|FG000|STARTED|Period 4||16
3257159|NCT02549040|3991128|FG000|COMPLETED|Period 4||16
3257160|NCT02549040|3991128|FG000|NOT COMPLETED|Period 4||0
3257161|NCT02549040|3991128|FG000|STARTED|Period 5||16
3257162|NCT02549040|3991128|FG000|COMPLETED|Period 5||16
3257163|NCT02549040|3991128|FG000|NOT COMPLETED|Period 5||0
3257164|NCT02549196|3991144|FG000|STARTED|Overall Study||8
3257165|NCT02549196|3991145|FG001|STARTED|Overall Study||1
3257166|NCT02549196|3991146|FG002|STARTED|Overall Study||6
3257167|NCT02549196|3991147|FG003|STARTED|Overall Study||13
3257168|NCT02549196|3991144|FG000|COMPLETED|Overall Study||7
3257169|NCT02549196|3991145|FG001|COMPLETED|Overall Study||1
3257170|NCT02549196|3991146|FG002|COMPLETED|Overall Study||5
3257171|NCT02549196|3991147|FG003|COMPLETED|Overall Study||12
3257172|NCT02549196|3991144|FG000|NOT COMPLETED|Overall Study||1
3257173|NCT02549196|3991145|FG001|NOT COMPLETED|Overall Study||0
3257174|NCT02549196|3991146|FG002|NOT COMPLETED|Overall Study||1
3257175|NCT02549196|3991147|FG003|NOT COMPLETED|Overall Study||1
3257176|NCT02549209|3991157|FG000|STARTED|Overall Study||46
3257177|NCT02549209|3991157|FG000|COMPLETED|Overall Study||46
3257178|NCT02549209|3991157|FG000|NOT COMPLETED|Overall Study||0
3257179|NCT02549287|3991163|FG000|STARTED|Overall Study||193
3257180|NCT02549287|3991164|FG001|STARTED|Overall Study||96
3257181|NCT02549287|3991163|FG000|COMPLETED|Overall Study||113
3257182|NCT02549287|3991164|FG001|COMPLETED|Overall Study||64
3257183|NCT02549287|3991163|FG000|NOT COMPLETED|Overall Study||80
3257184|NCT02549287|3991164|FG001|NOT COMPLETED|Overall Study||32
3257185|NCT02549339|3991172|FG000|STARTED|3-day Treatment and 8-week Follow-up||205
3257186|NCT02549339|3991173|FG001|STARTED|3-day Treatment and 8-week Follow-up||104
3257187|NCT02549339|3991172|FG000|Treated|3-day Treatment and 8-week Follow-up||202
3257188|NCT02549339|3991173|FG001|Treated|3-day Treatment and 8-week Follow-up||104
3257189|NCT02549339|3991172|FG000|COMPLETED|3-day Treatment and 8-week Follow-up||201
3257190|NCT02549339|3991173|FG001|COMPLETED|3-day Treatment and 8-week Follow-up||99
3257191|NCT02549339|3991172|FG000|NOT COMPLETED|3-day Treatment and 8-week Follow-up||4
3257192|NCT02549339|3991173|FG001|NOT COMPLETED|3-day Treatment and 8-week Follow-up||5
3257193|NCT02549339|3991172|FG000|STARTED|12-month Follow-up||201
3257194|NCT02549339|3991173|FG001|STARTED|12-month Follow-up||98
3257195|NCT02549339|3991172|FG000|COMPLETED|12-month Follow-up||192
3257196|NCT02549339|3991173|FG001|COMPLETED|12-month Follow-up||87
3257197|NCT02549339|3991172|FG000|NOT COMPLETED|12-month Follow-up||9
3257198|NCT02549339|3991173|FG001|NOT COMPLETED|12-month Follow-up||11
3257199|NCT02549352|3991183|FG000|STARTED|3-day Treatment and 8-week Follow-up||209
3257200|NCT02549352|3991184|FG001|STARTED|3-day Treatment and 8-week Follow-up||102
3257201|NCT02549352|3991183|FG000|Treated|3-day Treatment and 8-week Follow-up||209
3257202|NCT02549352|3991184|FG001|Treated|3-day Treatment and 8-week Follow-up|1 participant was included in 0.037% in the safety analysis set as they received both IMPs in error|101
3257203|NCT02549352|3991183|FG000|COMPLETED|3-day Treatment and 8-week Follow-up||207
3257204|NCT02549352|3991184|FG001|COMPLETED|3-day Treatment and 8-week Follow-up||96
3257205|NCT02549352|3991183|FG000|NOT COMPLETED|3-day Treatment and 8-week Follow-up||2
3257206|NCT02549352|3991184|FG001|NOT COMPLETED|3-day Treatment and 8-week Follow-up||6
3257207|NCT02549352|3991183|FG000|STARTED|12-month Follow-up||207
3257208|NCT02549352|3991184|FG001|STARTED|12-month Follow-up||93
3257209|NCT02549352|3991183|FG000|COMPLETED|12-month Follow-up||199
3257210|NCT02549352|3991184|FG001|COMPLETED|12-month Follow-up||81
3257211|NCT02549352|3991183|FG000|NOT COMPLETED|12-month Follow-up||8
3257212|NCT02549352|3991184|FG001|NOT COMPLETED|12-month Follow-up||12
3257213|NCT02549365|3991194|FG000|STARTED|Overall Study||164
3257214|NCT02549365|3991195|FG001|STARTED|Overall Study||112
3257215|NCT02549365|3991194|FG000|COMPLETED|Overall Study||164
3257216|NCT02549365|3991195|FG001|COMPLETED|Overall Study||112
3257217|NCT02549365|3991194|FG000|NOT COMPLETED|Overall Study||0
3257218|NCT02549365|3991195|FG001|NOT COMPLETED|Overall Study||0
3257219|NCT02549508|3991203|FG000|STARTED|Overall Study||47
3257220|NCT02549508|3991204|FG001|STARTED|Overall Study||38
3257221|NCT02549508|3991203|FG000|COMPLETED|Overall Study||33
3257222|NCT02549508|3991204|FG001|COMPLETED|Overall Study||21
3257223|NCT02549508|3991203|FG000|NOT COMPLETED|Overall Study||14
3257224|NCT02549508|3991204|FG001|NOT COMPLETED|Overall Study||17
3257225|NCT02549573|3991214|FG000|STARTED|Overall Study||6
3257226|NCT02549573|3991215|FG001|STARTED|Overall Study||7
3257227|NCT02549573|3991214|FG000|COMPLETED|Overall Study||6
3257228|NCT02549573|3991215|FG001|COMPLETED|Overall Study||4
3257229|NCT02549573|3991214|FG000|NOT COMPLETED|Overall Study||0
3257230|NCT02549573|3991215|FG001|NOT COMPLETED|Overall Study||3
3257231|NCT02549859|3991221|FG000|STARTED|Visit 1||11
3257232|NCT02549859|3991221|FG000|COMPLETED|Visit 1||11
3257233|NCT02549859|3991221|FG000|NOT COMPLETED|Visit 1||0
3257234|NCT02549859|3991221|FG000|STARTED|Long-term 60 Hz DBS||11
3257235|NCT02549859|3991221|FG000|COMPLETED|Long-term 60 Hz DBS||10
3257236|NCT02549859|3991221|FG000|NOT COMPLETED|Long-term 60 Hz DBS||1
3257237|NCT02549859|3991221|FG000|STARTED|Visit 2||10
3257238|NCT02549859|3991221|FG000|COMPLETED|Visit 2||10
3257239|NCT02549859|3991221|FG000|NOT COMPLETED|Visit 2||0
3257240|NCT02550106|3991229|FG000|STARTED|Overall Study||136
3257241|NCT02550106|3991229|FG000|COMPLETED|Overall Study||124
3257242|NCT02550106|3991229|FG000|NOT COMPLETED|Overall Study||12
3257243|NCT02550132|3991235|FG000|STARTED|Overall Study||25
3257244|NCT02550132|3991235|FG000|COMPLETED|Overall Study||25
3257245|NCT02550132|3991235|FG000|NOT COMPLETED|Overall Study||0
3257246|NCT02550197|3991241|FG000|STARTED|Overall Study||200
3257247|NCT02550197|3991242|FG001|STARTED|Overall Study||100
3257248|NCT02550197|3991241|FG000|COMPLETED|Overall Study||200
3257249|NCT02550197|3991242|FG001|COMPLETED|Overall Study||100
3257250|NCT02550197|3991241|FG000|NOT COMPLETED|Overall Study||0
3257251|NCT02550197|3991242|FG001|NOT COMPLETED|Overall Study||0
3257252|NCT02550210|3991248|FG000|STARTED|Overall Study||23
3257253|NCT02550210|3991248|FG000|COMPLETED|Overall Study||19
3257254|NCT02550210|3991248|FG000|NOT COMPLETED|Overall Study||4
3257255|NCT02550743|3991256|FG000|STARTED|Overall Study||3
3257256|NCT02550743|3991257|FG001|STARTED|Overall Study||3
3257257|NCT02550743|3991258|FG002|STARTED|Overall Study||1
3257258|NCT02550743|3991259|FG003|STARTED|Overall Study||0
3257259|NCT02550743|3991256|FG000|COMPLETED|Overall Study||3
3257260|NCT02550743|3991257|FG001|COMPLETED|Overall Study||3
3257261|NCT02550743|3991258|FG002|COMPLETED|Overall Study||1
3257262|NCT02550743|3991259|FG003|COMPLETED|Overall Study||0
3257263|NCT02550743|3991256|FG000|NOT COMPLETED|Overall Study||0
3257264|NCT02550743|3991257|FG001|NOT COMPLETED|Overall Study||0
3257265|NCT02550743|3991258|FG002|NOT COMPLETED|Overall Study||0
3257266|NCT02550743|3991259|FG003|NOT COMPLETED|Overall Study||0
3257267|NCT02550795|3991273|FG000|STARTED|Overall Study||50
3257268|NCT02550795|3991274|FG001|STARTED|Overall Study||50
3257269|NCT02550795|3991275|FG002|STARTED|Overall Study||50
3257270|NCT02550795|3991273|FG000|COMPLETED|Overall Study||50
3257271|NCT02550795|3991274|FG001|COMPLETED|Overall Study||49
3257272|NCT02550795|3991275|FG002|COMPLETED|Overall Study||50
3257273|NCT02550795|3991273|FG000|NOT COMPLETED|Overall Study||0
3257274|NCT02550795|3991274|FG001|NOT COMPLETED|Overall Study||1
3257275|NCT02550795|3991275|FG002|NOT COMPLETED|Overall Study||0
3257276|NCT02550873|3991285|FG000|STARTED|Randomized Double Blind||78
3257277|NCT02550873|3991286|FG001|STARTED|Randomized Double Blind||39
3257278|NCT02550873|3991287|FG002|STARTED|Randomized Double Blind||0
3257279|NCT02550873|3991285|FG000|Received Treatment|Randomized Double Blind||77
3257280|NCT02550873|3991286|FG001|Received Treatment|Randomized Double Blind||39
3257281|NCT02550873|3991287|FG002|Received Treatment|Randomized Double Blind||0
3257282|NCT02550873|3991285|FG000|Continue to Open Label Extension|Randomized Double Blind||74
3257283|NCT02550873|3991286|FG001|Continue to Open Label Extension|Randomized Double Blind||37
3257284|NCT02550873|3991287|FG002|Continue to Open Label Extension|Randomized Double Blind||0
3257285|NCT02550873|3991285|FG000|COMPLETED|Randomized Double Blind||74
3257286|NCT02550873|3991286|FG001|COMPLETED|Randomized Double Blind||37
3257287|NCT02550873|3991287|FG002|COMPLETED|Randomized Double Blind||0
3257288|NCT02550873|3991285|FG000|NOT COMPLETED|Randomized Double Blind||4
3257289|NCT02550873|3991286|FG001|NOT COMPLETED|Randomized Double Blind||2
3257290|NCT02550873|3991287|FG002|NOT COMPLETED|Randomized Double Blind||0
3257291|NCT02550873|3991285|FG000|STARTED|Open Label Extension||0
3257292|NCT02550873|3991286|FG001|STARTED|Open Label Extension||0
3257293|NCT02550873|3991287|FG002|STARTED|Open Label Extension||111
3257294|NCT02550873|3991285|FG000|COMPLETED|Open Label Extension||0
3257295|NCT02550873|3991286|FG001|COMPLETED|Open Label Extension||0
3257296|NCT02550873|3991287|FG002|COMPLETED|Open Label Extension|Open Label extension is ongoing|0
3257297|NCT02550873|3991285|FG000|NOT COMPLETED|Open Label Extension||0
3257298|NCT02550873|3991286|FG001|NOT COMPLETED|Open Label Extension||0
3257299|NCT02550873|3991287|FG002|NOT COMPLETED|Open Label Extension||111
3257300|NCT02550938|3991313|FG000|STARTED|Overall Study||44
3257301|NCT02550938|3991314|FG001|STARTED|Overall Study||85
3257302|NCT02550938|3991315|FG002|STARTED|Overall Study||43
3257303|NCT02550938|3991316|FG003|STARTED|Overall Study||81
3257304|NCT02550938|3991313|FG000|COMPLETED|Overall Study||36
3257305|NCT02550938|3991314|FG001|COMPLETED|Overall Study||78
3257306|NCT02550938|3991315|FG002|COMPLETED|Overall Study||31
3257307|NCT02550938|3991316|FG003|COMPLETED|Overall Study||70
3257308|NCT02550938|3991313|FG000|NOT COMPLETED|Overall Study||8
3257309|NCT02550938|3991314|FG001|NOT COMPLETED|Overall Study||7
3257310|NCT02550938|3991315|FG002|NOT COMPLETED|Overall Study||12
3257311|NCT02550938|3991316|FG003|NOT COMPLETED|Overall Study||11
3257312|NCT02551055|3991333|FG000|STARTED|Overall Study||4
3257313|NCT02551055|3991334|FG001|STARTED|Overall Study||6
3257314|NCT02551055|3991335|FG002|STARTED|Overall Study||3
3257315|NCT02551055|3991336|FG003|STARTED|Overall Study||6
3257316|NCT02551055|3991337|FG004|STARTED|Overall Study||7
3257317|NCT02551055|3991338|FG005|STARTED|Overall Study||2
3257318|NCT02551055|3991339|FG006|STARTED|Overall Study||4
3257319|NCT02551055|3991340|FG007|STARTED|Overall Study||0
3257320|NCT02551055|3991333|FG000|COMPLETED|Overall Study||0
3257321|NCT02551055|3991334|FG001|COMPLETED|Overall Study||0
3257322|NCT02551055|3991335|FG002|COMPLETED|Overall Study||1
3257323|NCT02551055|3991336|FG003|COMPLETED|Overall Study||1
3257324|NCT02551055|3991337|FG004|COMPLETED|Overall Study||0
3257325|NCT02551055|3991338|FG005|COMPLETED|Overall Study||1
3257326|NCT02551055|3991339|FG006|COMPLETED|Overall Study||1
3257327|NCT02551055|3991340|FG007|COMPLETED|Overall Study||0
3257328|NCT02551055|3991333|FG000|NOT COMPLETED|Overall Study||4
3257329|NCT02551055|3991334|FG001|NOT COMPLETED|Overall Study||6
3257330|NCT02551055|3991335|FG002|NOT COMPLETED|Overall Study||2
3257331|NCT02551055|3991336|FG003|NOT COMPLETED|Overall Study||5
3257332|NCT02551055|3991337|FG004|NOT COMPLETED|Overall Study||7
3257333|NCT02551055|3991338|FG005|NOT COMPLETED|Overall Study||1
3257334|NCT02551055|3991339|FG006|NOT COMPLETED|Overall Study||3
3257335|NCT02551055|3991340|FG007|NOT COMPLETED|Overall Study||0
3257336|NCT02551094|3991360|FG000|STARTED|Overall Study||2366
3257337|NCT02551094|3991361|FG001|STARTED|Overall Study||2379
3257338|NCT02551094|3991360|FG000|COMPLETED|Overall Study||2226
3257339|NCT02551094|3991361|FG001|COMPLETED|Overall Study||2232
3257340|NCT02551094|3991360|FG000|NOT COMPLETED|Overall Study||140
3257341|NCT02551094|3991361|FG001|NOT COMPLETED|Overall Study||147
3257342|NCT02551159|3991370|FG000|STARTED|Overall Study||413
3257343|NCT02551159|3991371|FG001|STARTED|Overall Study||204
3257344|NCT02551159|3991372|FG002|STARTED|Overall Study||206
3257345|NCT02551159|3991370|FG000|Full Analysis Set|Overall Study||413
3257346|NCT02551159|3991371|FG001|Full Analysis Set|Overall Study||204
3257347|NCT02551159|3991372|FG002|Full Analysis Set|Overall Study||206
3257348|NCT02551159|3991370|FG000|Safety Analysis Set|Overall Study||408
3257349|NCT02551159|3991371|FG001|Safety Analysis Set|Overall Study||202
3257350|NCT02551159|3991372|FG002|Safety Analysis Set|Overall Study||196
3257351|NCT02551159|3991370|FG000|PD-L1 TC/IC High Subgroup Analysis Set|Overall Study||190
3257352|NCT02551159|3991371|FG001|PD-L1 TC/IC High Subgroup Analysis Set|Overall Study||99
3257353|NCT02551159|3991372|FG002|PD-L1 TC/IC High Subgroup Analysis Set|Overall Study||94
3257354|NCT02551159|3991370|FG000|COMPLETED|Overall Study||0
3257355|NCT02551159|3991371|FG001|COMPLETED|Overall Study||0
3257356|NCT02551159|3991372|FG002|COMPLETED|Overall Study||0
3257357|NCT02551159|3991370|FG000|NOT COMPLETED|Overall Study||413
3257358|NCT02551159|3991371|FG001|NOT COMPLETED|Overall Study||204
3257359|NCT02551159|3991372|FG002|NOT COMPLETED|Overall Study||206
3257360|NCT02551224|3991380|FG000|STARTED|First Intervention||50
3257361|NCT02551224|3991381|FG001|STARTED|First Intervention||50
3257362|NCT02551224|3991380|FG000|COMPLETED|First Intervention||50
3257363|NCT02551224|3991381|FG001|COMPLETED|First Intervention||50
3257364|NCT02551224|3991380|FG000|NOT COMPLETED|First Intervention||0
3257365|NCT02551224|3991381|FG001|NOT COMPLETED|First Intervention||0
3257366|NCT02551224|3991380|FG000|STARTED|Second Intervention (5 Min After First )||50
3257367|NCT02551224|3991381|FG001|STARTED|Second Intervention (5 Min After First )||50
3257368|NCT02551224|3991380|FG000|COMPLETED|Second Intervention (5 Min After First )||50
3257369|NCT02551224|3991381|FG001|COMPLETED|Second Intervention (5 Min After First )||50
3257370|NCT02551224|3991380|FG000|NOT COMPLETED|Second Intervention (5 Min After First )||0
3257371|NCT02551224|3991381|FG001|NOT COMPLETED|Second Intervention (5 Min After First )||0
3257372|NCT02551432|3991387|FG000|STARTED|Overall Study||26
3257373|NCT02551432|3991387|FG000|COMPLETED|Overall Study||26
3257374|NCT02551432|3991387|FG000|NOT COMPLETED|Overall Study||0
3257375|NCT02551653|3991393|FG000|STARTED|Overall Study||5
3257376|NCT02551653|3991394|FG001|STARTED|Overall Study||5
3257377|NCT02551653|3991393|FG000|COMPLETED|Overall Study||5
3257378|NCT02551653|3991394|FG001|COMPLETED|Overall Study||5
3257379|NCT02551653|3991393|FG000|NOT COMPLETED|Overall Study||0
3257380|NCT02551653|3991394|FG001|NOT COMPLETED|Overall Study||0
3257381|NCT02551666|3991402|FG000|STARTED|Overall Study||16
3257382|NCT02551666|3991403|FG001|STARTED|Overall Study||19
3257383|NCT02551666|3991402|FG000|COMPLETED|Overall Study||15
3257384|NCT02551666|3991403|FG001|COMPLETED|Overall Study||16
3257385|NCT02551666|3991402|FG000|NOT COMPLETED|Overall Study||1
3257386|NCT02551666|3991403|FG001|NOT COMPLETED|Overall Study||3
3257387|NCT02551692|3991412|FG000|STARTED|Overall Study||31
3257388|NCT02551692|3991413|FG001|STARTED|Overall Study||27
3257389|NCT02551692|3991414|FG002|STARTED|Overall Study||30
3257390|NCT02551692|3991412|FG000|COMPLETED|Overall Study||30
3257391|NCT02551692|3991413|FG001|COMPLETED|Overall Study||26
3257392|NCT02551692|3991414|FG002|COMPLETED|Overall Study||25
3257393|NCT02551692|3991412|FG000|NOT COMPLETED|Overall Study||1
3257394|NCT02551692|3991413|FG001|NOT COMPLETED|Overall Study||1
3257395|NCT02551692|3991414|FG002|NOT COMPLETED|Overall Study||5
3257396|NCT02551731|3991422|FG000|STARTED|Overall Study||9
3257397|NCT02551731|3991422|FG000|COMPLETED|Overall Study||7
3257398|NCT02551731|3991422|FG000|NOT COMPLETED|Overall Study||2
3257399|NCT02551744|3991428|FG000|STARTED|Overall Study||50
3257400|NCT02551744|3991429|FG001|STARTED|Overall Study||51
3257401|NCT02551744|3991428|FG000|COMPLETED|Overall Study||50
3257402|NCT02551744|3991429|FG001|COMPLETED|Overall Study||51
3257403|NCT02551744|3991428|FG000|NOT COMPLETED|Overall Study||0
3257404|NCT02551744|3991429|FG001|NOT COMPLETED|Overall Study||0
3257405|NCT02551757|3991437|FG000|STARTED|Overall Study||20
3257406|NCT02551757|3991438|FG001|STARTED|Overall Study||20
3257407|NCT02551757|3991437|FG000|COMPLETED|Overall Study||13
3257408|NCT02551757|3991438|FG001|COMPLETED|Overall Study||17
3257409|NCT02551757|3991437|FG000|NOT COMPLETED|Overall Study||7
3257410|NCT02551757|3991438|FG001|NOT COMPLETED|Overall Study||3
3257411|NCT02551770|3991448|FG000|STARTED|Overall Study||51
3257412|NCT02551770|3991449|FG001|STARTED|Overall Study||51
3257413|NCT02551770|3991448|FG000|COMPLETED|Overall Study||48
3257414|NCT02551770|3991449|FG001|COMPLETED|Overall Study||48
3257415|NCT02551770|3991448|FG000|NOT COMPLETED|Overall Study||3
3257416|NCT02551770|3991449|FG001|NOT COMPLETED|Overall Study||3
3257417|NCT02551809|3991457|FG000|STARTED|Overall Study||14
3257418|NCT02551809|3991458|FG001|STARTED|Overall Study||15
3257419|NCT02551809|3991459|FG002|STARTED|Overall Study||14
3257420|NCT02551809|3991457|FG000|COMPLETED|Overall Study||14
3257421|NCT02551809|3991458|FG001|COMPLETED|Overall Study||14
3257422|NCT02551809|3991459|FG002|COMPLETED|Overall Study||13
3257423|NCT02551809|3991457|FG000|NOT COMPLETED|Overall Study||0
3257424|NCT02551809|3991458|FG001|NOT COMPLETED|Overall Study||1
3257425|NCT02551809|3991459|FG002|NOT COMPLETED|Overall Study||1
3257426|NCT02551822|3991469|FG000|STARTED|Overall Study||11
3257427|NCT02551822|3991470|FG001|STARTED|Overall Study||12
3257428|NCT02551822|3991469|FG000|COMPLETED|Overall Study||9
3257429|NCT02551822|3991470|FG001|COMPLETED|Overall Study||10
3257430|NCT02551822|3991469|FG000|NOT COMPLETED|Overall Study||2
3257431|NCT02551822|3991470|FG001|NOT COMPLETED|Overall Study||2
3257432|NCT02551874|3991478|FG000|STARTED|Overall Study||324
3257433|NCT02551874|3991479|FG001|STARTED|Overall Study||326
3257434|NCT02551874|3991478|FG000|Received Treatment in Short-term Study|Overall Study||324
3257435|NCT02551874|3991479|FG001|Received Treatment in Short-term Study|Overall Study||319
3257436|NCT02551874|3991478|FG000|Entered Long-term Study|Overall Study||306
3257437|NCT02551874|3991479|FG001|Entered Long-term Study|Overall Study||294
3257438|NCT02551874|3991478|FG000|Received Treatment in Long-term Study|Overall Study||295
3257439|NCT02551874|3991479|FG001|Received Treatment in Long-term Study|Overall Study||284
3257440|NCT02551874|3991478|FG000|COMPLETED|Overall Study||296
3257441|NCT02551874|3991479|FG001|COMPLETED|Overall Study||287
3257442|NCT02551874|3991478|FG000|NOT COMPLETED|Overall Study||28
3257443|NCT02551874|3991479|FG001|NOT COMPLETED|Overall Study||39
3257444|NCT02551887|3991488|FG000|STARTED|Overall Study||301
3257445|NCT02551887|3991489|FG001|STARTED|Overall Study||124
3257446|NCT02551887|3991490|FG002|STARTED|Overall Study||222
3257447|NCT02551887|3991488|FG000|COMPLETED|Overall Study||301
3257448|NCT02551887|3991489|FG001|COMPLETED|Overall Study||124
3257449|NCT02551887|3991490|FG002|COMPLETED|Overall Study||222
3257450|NCT02551887|3991488|FG000|NOT COMPLETED|Overall Study||0
3257451|NCT02551887|3991489|FG001|NOT COMPLETED|Overall Study||0
3257452|NCT02551887|3991490|FG002|NOT COMPLETED|Overall Study||0
3257453|NCT02552121|3991506|FG000|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||3
3257454|NCT02552121|3991507|FG001|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||0
3257455|NCT02552121|3991508|FG002|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||0
3257456|NCT02552121|3991509|FG003|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||0
3257457|NCT02552121|3991510|FG004|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||0
3257458|NCT02552121|3991511|FG005|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||0
3257459|NCT02552121|3991512|FG006|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||0
3257460|NCT02552121|3991513|FG007|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||0
3257461|NCT02552121|3991506|FG000|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
3257462|NCT02552121|3991507|FG001|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
3257463|NCT02552121|3991508|FG002|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
3257464|NCT02552121|3991509|FG003|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
3257465|NCT02552121|3991510|FG004|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
3257466|NCT02552121|3991511|FG005|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
3257467|NCT02552121|3991512|FG006|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
3257468|NCT02552121|3991513|FG007|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
3257469|NCT02552121|3991506|FG000|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||3
3257470|NCT02552121|3991507|FG001|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
3257471|NCT02552121|3991508|FG002|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
3257472|NCT02552121|3991509|FG003|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
3257473|NCT02552121|3991510|FG004|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
3257474|NCT02552121|3991511|FG005|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
3257475|NCT02552121|3991512|FG006|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
3257476|NCT02552121|3991513|FG007|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
3257477|NCT02552121|3991506|FG000|STARTED|Part 1: Dose Level 2 (Week 17-48)||0
3257478|NCT02552121|3991507|FG001|STARTED|Part 1: Dose Level 2 (Week 17-48)||6
3257479|NCT02552121|3991508|FG002|STARTED|Part 1: Dose Level 2 (Week 17-48)||0
3257480|NCT02552121|3991509|FG003|STARTED|Part 1: Dose Level 2 (Week 17-48)||0
3257481|NCT02552121|3991510|FG004|STARTED|Part 1: Dose Level 2 (Week 17-48)||0
3257482|NCT02552121|3991511|FG005|STARTED|Part 1: Dose Level 2 (Week 17-48)||0
3257483|NCT02552121|3991512|FG006|STARTED|Part 1: Dose Level 2 (Week 17-48)||0
3257484|NCT02552121|3991513|FG007|STARTED|Part 1: Dose Level 2 (Week 17-48)||0
3257485|NCT02552121|3991506|FG000|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
3257486|NCT02552121|3991507|FG001|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
3257487|NCT02552121|3991508|FG002|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
3257488|NCT02552121|3991509|FG003|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
3257489|NCT02552121|3991510|FG004|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
3257490|NCT02552121|3991511|FG005|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
3257491|NCT02552121|3991512|FG006|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
3257492|NCT02552121|3991513|FG007|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
3257493|NCT02552121|3991506|FG000|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
3257494|NCT02552121|3991507|FG001|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||6
3257495|NCT02552121|3991508|FG002|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
3257496|NCT02552121|3991509|FG003|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
3257497|NCT02552121|3991510|FG004|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
3257498|NCT02552121|3991511|FG005|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
3257499|NCT02552121|3991512|FG006|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
3257500|NCT02552121|3991513|FG007|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
3257501|NCT02552121|3991506|FG000|STARTED|Part 2: Cohort Expansion||0
3257502|NCT02552121|3991507|FG001|STARTED|Part 2: Cohort Expansion||0
3257503|NCT02552121|3991508|FG002|STARTED|Part 2: Cohort Expansion||11
3257504|NCT02552121|3991509|FG003|STARTED|Part 2: Cohort Expansion||3
3257505|NCT02552121|3991510|FG004|STARTED|Part 2: Cohort Expansion||1
3257506|NCT02552121|3991511|FG005|STARTED|Part 2: Cohort Expansion||5
3257507|NCT02552121|3991512|FG006|STARTED|Part 2: Cohort Expansion||1
3257508|NCT02552121|3991513|FG007|STARTED|Part 2: Cohort Expansion||3
3257509|NCT02552121|3991506|FG000|COMPLETED|Part 2: Cohort Expansion||0
3257510|NCT02552121|3991507|FG001|COMPLETED|Part 2: Cohort Expansion||0
3257511|NCT02552121|3991508|FG002|COMPLETED|Part 2: Cohort Expansion||0
3257512|NCT02552121|3991509|FG003|COMPLETED|Part 2: Cohort Expansion||0
3257513|NCT02552121|3991510|FG004|COMPLETED|Part 2: Cohort Expansion||0
3257514|NCT02552121|3991511|FG005|COMPLETED|Part 2: Cohort Expansion||1
3257515|NCT02552121|3991512|FG006|COMPLETED|Part 2: Cohort Expansion||0
3257516|NCT02552121|3991513|FG007|COMPLETED|Part 2: Cohort Expansion||0
3257517|NCT02552121|3991506|FG000|NOT COMPLETED|Part 2: Cohort Expansion||0
3257518|NCT02552121|3991507|FG001|NOT COMPLETED|Part 2: Cohort Expansion||0
3257519|NCT02552121|3991508|FG002|NOT COMPLETED|Part 2: Cohort Expansion||11
3257520|NCT02552121|3991509|FG003|NOT COMPLETED|Part 2: Cohort Expansion||3
3257521|NCT02552121|3991510|FG004|NOT COMPLETED|Part 2: Cohort Expansion||1
3257522|NCT02552121|3991511|FG005|NOT COMPLETED|Part 2: Cohort Expansion||4
3257523|NCT02552121|3991512|FG006|NOT COMPLETED|Part 2: Cohort Expansion||1
3257524|NCT02552121|3991513|FG007|NOT COMPLETED|Part 2: Cohort Expansion||3
3257525|NCT02552147|3991545|FG000|STARTED|First Intervention (7 Days)||4
3257526|NCT02552147|3991546|FG001|STARTED|First Intervention (7 Days)||4
3257527|NCT02552147|3991545|FG000|COMPLETED|First Intervention (7 Days)||3
3257528|NCT02552147|3991546|FG001|COMPLETED|First Intervention (7 Days)||4
3257529|NCT02552147|3991545|FG000|NOT COMPLETED|First Intervention (7 Days)||1
3257530|NCT02552147|3991546|FG001|NOT COMPLETED|First Intervention (7 Days)||0
3257531|NCT02552147|3991545|FG000|STARTED|Washout (7 Days)||3
3257532|NCT02552147|3991546|FG001|STARTED|Washout (7 Days)||4
3257533|NCT02552147|3991545|FG000|COMPLETED|Washout (7 Days)||3
3257534|NCT02552147|3991546|FG001|COMPLETED|Washout (7 Days)||4
3257535|NCT02552147|3991545|FG000|NOT COMPLETED|Washout (7 Days)||0
3257536|NCT02552147|3991546|FG001|NOT COMPLETED|Washout (7 Days)||0
3257537|NCT02552147|3991545|FG000|STARTED|Second Intervention (7 Days)||3
3257538|NCT02552147|3991546|FG001|STARTED|Second Intervention (7 Days)||4
3257539|NCT02552147|3991545|FG000|COMPLETED|Second Intervention (7 Days)||1
3257540|NCT02552147|3991546|FG001|COMPLETED|Second Intervention (7 Days)||4
3257541|NCT02552147|3991545|FG000|NOT COMPLETED|Second Intervention (7 Days)||2
3257542|NCT02552147|3991546|FG001|NOT COMPLETED|Second Intervention (7 Days)||0
3257543|NCT02552212|3991554|FG000|STARTED|Double-Blind Period (Week 0 - 52)||158
3257544|NCT02552212|3991555|FG001|STARTED|Double-Blind Period (Week 0 - 52)||159
3257545|NCT02552212|3991556|FG002|STARTED|Double-Blind Period (Week 0 - 52)||0
3257546|NCT02552212|3991554|FG000|Received OL CZP|Double-Blind Period (Week 0 - 52)||96
3257547|NCT02552212|3991555|FG001|Received OL CZP|Double-Blind Period (Week 0 - 52)||20
3257548|NCT02552212|3991556|FG002|Received OL CZP|Double-Blind Period (Week 0 - 52)||0
3257549|NCT02552212|3991554|FG000|Completed Week 52 Without Starting SFE|Double-Blind Period (Week 0 - 52)||20
3257550|NCT02552212|3991555|FG001|Completed Week 52 Without Starting SFE|Double-Blind Period (Week 0 - 52)||22
3257551|NCT02552212|3991556|FG002|Completed Week 52 Without Starting SFE|Double-Blind Period (Week 0 - 52)||0
3257552|NCT02552212|3991554|FG000|COMPLETED|Double-Blind Period (Week 0 - 52)||143
3257553|NCT02552212|3991555|FG001|COMPLETED|Double-Blind Period (Week 0 - 52)||142
3257554|NCT02552212|3991556|FG002|COMPLETED|Double-Blind Period (Week 0 - 52)||0
3257555|NCT02552212|3991554|FG000|NOT COMPLETED|Double-Blind Period (Week 0 - 52)||15
3257556|NCT02552212|3991555|FG001|NOT COMPLETED|Double-Blind Period (Week 0 - 52)||17
3257557|NCT02552212|3991556|FG002|NOT COMPLETED|Double-Blind Period (Week 0 - 52)||0
3257558|NCT02552212|3991554|FG000|STARTED|SFE Period (Week 52 - 156)||0
3257559|NCT02552212|3991555|FG001|STARTED|SFE Period (Week 52 - 156)||0
3257560|NCT02552212|3991556|FG002|STARTED|SFE Period (Week 52 - 156)|123 subjects from Placebo arm and 120 subjects from CZP 200 mg Q2W arm|243
3257561|NCT02552212|3991554|FG000|COMPLETED|SFE Period (Week 52 - 156)||0
3257562|NCT02552212|3991555|FG001|COMPLETED|SFE Period (Week 52 - 156)||0
3257563|NCT02552212|3991556|FG002|COMPLETED|SFE Period (Week 52 - 156)||206
3257564|NCT02552212|3991554|FG000|NOT COMPLETED|SFE Period (Week 52 - 156)||0
3257565|NCT02552212|3991555|FG001|NOT COMPLETED|SFE Period (Week 52 - 156)||0
3257566|NCT02552212|3991556|FG002|NOT COMPLETED|SFE Period (Week 52 - 156)||37
3257567|NCT02552225|3991574|FG000|STARTED|Overall Study||3
3257568|NCT02552225|3991575|FG001|STARTED|Overall Study||3
3257569|NCT02552225|3991574|FG000|COMPLETED|Overall Study||2
3257570|NCT02552225|3991575|FG001|COMPLETED|Overall Study||3
3257571|NCT02552225|3991574|FG000|NOT COMPLETED|Overall Study||1
3257572|NCT02552225|3991575|FG001|NOT COMPLETED|Overall Study||0
3257573|NCT02552238|3991581|FG000|STARTED|Overall Study||174
3257574|NCT02552238|3991581|FG000|COMPLETED|Overall Study|Of the 174 subjects enrolled in the study, 2 withdrew consent prior to administration of investigational product and 2 discontinued due to post-dose adverse event. Therefore, 170 subjects completed the study.|170
3257575|NCT02552238|3991581|FG000|NOT COMPLETED|Overall Study||4
3257576|NCT02552303|3991596|FG000|STARTED|Allocation||10
3257577|NCT02552303|3991597|FG001|STARTED|Allocation||10
3257578|NCT02552303|3991598|FG002|STARTED|Allocation||8
3257579|NCT02552303|3991599|FG003|STARTED|Allocation||11
3257580|NCT02552303|3991596|FG000|COMPLETED|Allocation||7
3257581|NCT02552303|3991597|FG001|COMPLETED|Allocation||8
3257582|NCT02552303|3991598|FG002|COMPLETED|Allocation||7
3257583|NCT02552303|3991599|FG003|COMPLETED|Allocation||10
3257584|NCT02552303|3991596|FG000|NOT COMPLETED|Allocation||3
3257585|NCT02552303|3991597|FG001|NOT COMPLETED|Allocation||2
3257586|NCT02552303|3991598|FG002|NOT COMPLETED|Allocation||1
3257587|NCT02552303|3991599|FG003|NOT COMPLETED|Allocation||1
3257588|NCT02552303|3991596|FG000|STARTED|Follow-Up||7
3257589|NCT02552303|3991597|FG001|STARTED|Follow-Up||8
3257590|NCT02552303|3991598|FG002|STARTED|Follow-Up||7
3257591|NCT02552303|3991599|FG003|STARTED|Follow-Up||10
3257592|NCT02552303|3991596|FG000|COMPLETED|Follow-Up||7
3257593|NCT02552303|3991597|FG001|COMPLETED|Follow-Up||6
3257594|NCT02552303|3991598|FG002|COMPLETED|Follow-Up||6
3257595|NCT02552303|3991599|FG003|COMPLETED|Follow-Up||10
3257596|NCT02552303|3991596|FG000|NOT COMPLETED|Follow-Up||0
3257597|NCT02552303|3991597|FG001|NOT COMPLETED|Follow-Up||2
3257598|NCT02552303|3991598|FG002|NOT COMPLETED|Follow-Up||1
3257599|NCT02552303|3991599|FG003|NOT COMPLETED|Follow-Up||0
3257600|NCT02552316|3991609|FG000|STARTED|Overall Study||34
3257601|NCT02552316|3991609|FG000|COMPLETED|Overall Study||32
3257602|NCT02552316|3991609|FG000|NOT COMPLETED|Overall Study||2
3257603|NCT02552355|3991661|FG000|STARTED|Overall Study||14
3257604|NCT02552355|3991662|FG001|STARTED|Overall Study||13
3257605|NCT02552355|3991663|FG002|STARTED|Overall Study||14
3257606|NCT02552355|3991664|FG003|STARTED|Overall Study||15
3257607|NCT02552355|3991661|FG000|COMPLETED|Overall Study||14
3372501|NCT02971839|4104467|FG002|COMPLETED|Overall Study||2
3372502|NCT02971839|4104468|FG003|COMPLETED|Overall Study||2
3372503|NCT02971839|4104469|FG004|COMPLETED|Overall Study||3
3372504|NCT02971839|4104465|FG000|NOT COMPLETED|Overall Study||0
3372505|NCT02971839|4104466|FG001|NOT COMPLETED|Overall Study||0
3372506|NCT02971839|4104467|FG002|NOT COMPLETED|Overall Study||0
3372507|NCT02971839|4104468|FG003|NOT COMPLETED|Overall Study||0
3372508|NCT02971839|4104469|FG004|NOT COMPLETED|Overall Study||0
3372509|NCT02985840|4104483|FG000|STARTED|Overall Study||64
3372510|NCT02985840|4104484|FG001|STARTED|Overall Study||63
3372511|NCT02985840|4104483|FG000|COMPLETED|Overall Study||64
3372512|NCT02985840|4104484|FG001|COMPLETED|Overall Study||63
3372513|NCT02985840|4104483|FG000|NOT COMPLETED|Overall Study||0
3372514|NCT02985840|4104484|FG001|NOT COMPLETED|Overall Study||0
3372515|NCT02966223|4104490|FG000|STARTED|Overall Study||20
3372516|NCT02966223|4104490|FG000|COMPLETED|Overall Study||5
3372517|NCT02966223|4104490|FG000|NOT COMPLETED|Overall Study||15
3372518|NCT02965846|4104497|FG000|STARTED|Overall Study||5
3372519|NCT02965846|4104498|FG001|STARTED|Overall Study||5
3372520|NCT02965846|4104499|FG002|STARTED|Overall Study||33
3372521|NCT02965846|4104497|FG000|COMPLETED|Overall Study||0
3372522|NCT02965846|4104498|FG001|COMPLETED|Overall Study||0
3372523|NCT02965846|4104499|FG002|COMPLETED|Overall Study||0
3372524|NCT02965846|4104497|FG000|NOT COMPLETED|Overall Study||5
3372525|NCT02965846|4104498|FG001|NOT COMPLETED|Overall Study||5
3372526|NCT02965846|4104499|FG002|NOT COMPLETED|Overall Study||33
3372527|NCT02974803|4104505|FG000|STARTED|Overall Study||6
3372528|NCT02974803|4104505|FG000|COMPLETED|Overall Study||6
3372529|NCT02974803|4104505|FG000|NOT COMPLETED|Overall Study||0
3372530|NCT02974686|4104511|FG000|STARTED|Overall Study||0
3372531|NCT02974686|4104512|FG001|STARTED|Overall Study||0
3372532|NCT02974686|4104511|FG000|COMPLETED|Overall Study||0
3372533|NCT02974686|4104512|FG001|COMPLETED|Overall Study||0
3372534|NCT02974686|4104511|FG000|NOT COMPLETED|Overall Study||0
3372535|NCT02974686|4104512|FG001|NOT COMPLETED|Overall Study||0
3372536|NCT02956005|4104520|FG000|STARTED|Overall Study||18
3372537|NCT02956005|4104520|FG000|COMPLETED|Overall Study||2
3372538|NCT02956005|4104520|FG000|NOT COMPLETED|Overall Study||16
3372539|NCT02966184|4104526|FG000|STARTED|Overall Study||0
3372540|NCT02966184|4104527|FG001|STARTED|Overall Study||8
3372541|NCT02966184|4104526|FG000|COMPLETED|Overall Study||0
3372542|NCT02966184|4104527|FG001|COMPLETED|Overall Study||0
3372543|NCT02966184|4104526|FG000|NOT COMPLETED|Overall Study||0
3372544|NCT02966184|4104527|FG001|NOT COMPLETED|Overall Study||8
3372545|NCT02940223|4104535|FG000|STARTED|Overall Study||2
3372546|NCT02940223|4104536|FG001|STARTED|Overall Study||0
3372547|NCT02940223|4104535|FG000|COMPLETED|Overall Study||0
3372548|NCT02940223|4104536|FG001|COMPLETED|Overall Study||0
3372549|NCT02940223|4104535|FG000|NOT COMPLETED|Overall Study||2
3372550|NCT02940223|4104536|FG001|NOT COMPLETED|Overall Study||0
3372551|NCT02954159|4104544|FG000|STARTED|Overall Study||2
3372552|NCT02954159|4104545|FG001|STARTED|Overall Study||2
3372553|NCT02954159|4104544|FG000|COMPLETED|Overall Study||1
3372554|NCT02954159|4104545|FG001|COMPLETED|Overall Study||1
3372555|NCT02954159|4104544|FG000|NOT COMPLETED|Overall Study||1
3372556|NCT02954159|4104545|FG001|NOT COMPLETED|Overall Study||1
3372557|NCT02954952|4104554|FG000|STARTED|Overall Study||36
3372558|NCT02954952|4104555|FG001|STARTED|Overall Study||5
3372559|NCT02954952|4104556|FG002|STARTED|Overall Study||3
3372560|NCT02954952|4104554|FG000|COMPLETED|Overall Study||35
3372561|NCT02954952|4104555|FG001|COMPLETED|Overall Study||4
3372562|NCT02954952|4104556|FG002|COMPLETED|Overall Study||3
3372563|NCT02954952|4104554|FG000|NOT COMPLETED|Overall Study||1
3372564|NCT02954952|4104555|FG001|NOT COMPLETED|Overall Study||1
3372565|NCT02954952|4104556|FG002|NOT COMPLETED|Overall Study||0
3372566|NCT02950896|4104564|FG000|STARTED|Overall Study||4
3257608|NCT02552355|3991662|FG001|COMPLETED|Overall Study||11
3257609|NCT02552355|3991663|FG002|COMPLETED|Overall Study||12
3372567|NCT02950896|4104564|FG000|COMPLETED|Overall Study||4
3372568|NCT02950896|4104564|FG000|NOT COMPLETED|Overall Study||0
3257610|NCT02552355|3991664|FG003|COMPLETED|Overall Study||14
3257611|NCT02552355|3991661|FG000|NOT COMPLETED|Overall Study||0
3257612|NCT02552355|3991662|FG001|NOT COMPLETED|Overall Study||2
3257613|NCT02552355|3991663|FG002|NOT COMPLETED|Overall Study||2
3257614|NCT02552355|3991664|FG003|NOT COMPLETED|Overall Study||1
3257615|NCT02552368|3991674|FG000|STARTED|Overall Study||23
3257616|NCT02552368|3991674|FG000|COMPLETED|Overall Study||10
3257617|NCT02552368|3991674|FG000|NOT COMPLETED|Overall Study||13
3372569|NCT02947022|4104568|FG000|STARTED|Overall Study||1
3372570|NCT02947022|4104568|FG000|COMPLETED|Overall Study||0
3372571|NCT02947022|4104568|FG000|NOT COMPLETED|Overall Study||1
3372572|NCT02936999|4104575|FG000|STARTED|Overall Study||8
3372573|NCT02936999|4104575|FG000|COMPLETED|Overall Study||8
3372574|NCT02936999|4104575|FG000|NOT COMPLETED|Overall Study||0
3372575|NCT02950480|4104583|FG000|STARTED|Overall Study||2
3372576|NCT02950480|4104584|FG001|STARTED|Overall Study||2
3372577|NCT02950480|4104583|FG000|COMPLETED|Overall Study||1
3372578|NCT02950480|4104584|FG001|COMPLETED|Overall Study||2
3372579|NCT02950480|4104583|FG000|NOT COMPLETED|Overall Study||1
3372580|NCT02950480|4104584|FG001|NOT COMPLETED|Overall Study||0
3372581|NCT02949947|4104592|FG000|STARTED|Overall Study||1
3372582|NCT02949947|4104593|FG001|STARTED|Overall Study||2
3372583|NCT02949947|4104592|FG000|COMPLETED|Overall Study||0
3372584|NCT02949947|4104593|FG001|COMPLETED|Overall Study||1
3372585|NCT02949947|4104592|FG000|NOT COMPLETED|Overall Study||1
3372586|NCT02949947|4104593|FG001|NOT COMPLETED|Overall Study||1
3372587|NCT02947100|4104599|FG000|STARTED|Overall Study||4
3372588|NCT02947100|4104599|FG000|COMPLETED|Overall Study||0
3372589|NCT02947100|4104599|FG000|NOT COMPLETED|Overall Study||4
3372590|NCT02936206|4104605|FG000|STARTED|Overall Study||0
3372591|NCT02936206|4104606|FG001|STARTED|Overall Study||2
3372592|NCT02936206|4104605|FG000|COMPLETED|Overall Study||0
3372593|NCT02936206|4104606|FG001|COMPLETED|Overall Study||2
3372594|NCT02936206|4104605|FG000|NOT COMPLETED|Overall Study||0
3372595|NCT02936206|4104606|FG001|NOT COMPLETED|Overall Study||0
3372596|NCT02934932|4104612|FG000|STARTED|Overall Study||9
3372597|NCT02934932|4104612|FG000|COMPLETED|Overall Study||6
3372598|NCT02934932|4104612|FG000|NOT COMPLETED|Overall Study||3
3372599|NCT02908516|4104620|FG000|STARTED|Overall Study||3
3372600|NCT02908516|4104621|FG001|STARTED|Overall Study||3
3372601|NCT02908516|4104620|FG000|COMPLETED|Overall Study||0
3372602|NCT02908516|4104621|FG001|COMPLETED|Overall Study||0
3372603|NCT02908516|4104620|FG000|NOT COMPLETED|Overall Study||3
3372604|NCT02908516|4104621|FG001|NOT COMPLETED|Overall Study||3
3372605|NCT02923830|4104629|FG000|STARTED|Overall Study||13
3372606|NCT02923830|4104630|FG001|STARTED|Overall Study||15
3372607|NCT02923830|4104629|FG000|COMPLETED|Overall Study|Study terminated|0
3372608|NCT02923830|4104630|FG001|COMPLETED|Overall Study|Study terminated|0
3372609|NCT02923830|4104629|FG000|NOT COMPLETED|Overall Study||13
3372610|NCT02923830|4104630|FG001|NOT COMPLETED|Overall Study||15
3372611|NCT02920450|4104636|FG000|STARTED|Overall Study||3
3372612|NCT02920450|4104637|FG001|STARTED|Overall Study||0
3372613|NCT02920450|4104638|FG002|STARTED|Overall Study||0
3372614|NCT02920450|4104639|FG003|STARTED|Overall Study||0
3372615|NCT02920450|4104636|FG000|COMPLETED|Overall Study||1
3372616|NCT02920450|4104637|FG001|COMPLETED|Overall Study||0
3372617|NCT02920450|4104638|FG002|COMPLETED|Overall Study||0
3372618|NCT02920450|4104639|FG003|COMPLETED|Overall Study||0
3372619|NCT02920450|4104636|FG000|NOT COMPLETED|Overall Study||2
3372620|NCT02920450|4104637|FG001|NOT COMPLETED|Overall Study||0
3372621|NCT02920450|4104638|FG002|NOT COMPLETED|Overall Study||0
3372622|NCT02920450|4104639|FG003|NOT COMPLETED|Overall Study||0
3372623|NCT02920177|4104648|FG000|STARTED|Overall Study||2
3372624|NCT02920177|4104649|FG001|STARTED|Overall Study||2
3372625|NCT02920177|4104648|FG000|COMPLETED|Overall Study||0
3372626|NCT02920177|4104649|FG001|COMPLETED|Overall Study||0
3372627|NCT02920177|4104648|FG000|NOT COMPLETED|Overall Study||2
3372628|NCT02920177|4104649|FG001|NOT COMPLETED|Overall Study||2
3372629|NCT02926638|4104657|FG000|STARTED|Overall Study||4
3372630|NCT02926638|4104658|FG001|STARTED|Overall Study||5
3372631|NCT02926638|4104657|FG000|Eligible|Overall Study||3
3372632|NCT02926638|4104658|FG001|Eligible|Overall Study||5
3372633|NCT02926638|4104657|FG000|COMPLETED|Overall Study||0
3372634|NCT02926638|4104658|FG001|COMPLETED|Overall Study||0
3372635|NCT02926638|4104657|FG000|NOT COMPLETED|Overall Study||4
3372636|NCT02926638|4104658|FG001|NOT COMPLETED|Overall Study||5
3372637|NCT02920242|4104667|FG000|STARTED|Overall Study||13
3257618|NCT02552732|3991679|FG000|STARTED|Overall Study||29
3372638|NCT02920242|4104668|FG001|STARTED|Overall Study||11
3372639|NCT02920242|4104669|FG002|STARTED|Overall Study||4
3372640|NCT02920242|4104667|FG000|Safety Set|Overall Study||12
3372641|NCT02920242|4104668|FG001|Safety Set|Overall Study||11
3372642|NCT02920242|4104669|FG002|Safety Set|Overall Study||4
3372643|NCT02920242|4104667|FG000|COMPLETED|Overall Study||11
3372644|NCT02920242|4104668|FG001|COMPLETED|Overall Study||11
3372645|NCT02920242|4104669|FG002|COMPLETED|Overall Study||3
3372646|NCT02920242|4104667|FG000|NOT COMPLETED|Overall Study||2
3372647|NCT02920242|4104668|FG001|NOT COMPLETED|Overall Study||0
3372648|NCT02920242|4104669|FG002|NOT COMPLETED|Overall Study||1
3372649|NCT02900781|4104679|FG000|STARTED|Overall Study||4
3372650|NCT02900781|4104680|FG001|STARTED|Overall Study||5
3372651|NCT02900781|4104679|FG000|COMPLETED|Overall Study||0
3372652|NCT02900781|4104680|FG001|COMPLETED|Overall Study||0
3257619|NCT02552732|3991679|FG000|Used Device|Overall Study||23
3257620|NCT02552732|3991679|FG000|Completed Week 1|Overall Study||21
3257621|NCT02552732|3991679|FG000|Completed Week 2|Overall Study||20
3257622|NCT02552732|3991679|FG000|Completed Week 3|Overall Study||19
3257623|NCT02552732|3991679|FG000|Completed Week 4|Overall Study||19
3257624|NCT02552732|3991679|FG000|Completed Day 1 and Day 31 Spirometry|Overall Study||12
3257625|NCT02552732|3991679|FG000|COMPLETED|Overall Study||19
3257626|NCT02552732|3991679|FG000|NOT COMPLETED|Overall Study||10
3257627|NCT02552810|3991686|FG000|STARTED|Overall Study||15
3257628|NCT02552810|3991687|FG001|STARTED|Overall Study||15
3257629|NCT02552810|3991686|FG000|COMPLETED|Overall Study||15
3257630|NCT02552810|3991687|FG001|COMPLETED|Overall Study||15
3257631|NCT02552810|3991686|FG000|NOT COMPLETED|Overall Study||0
3257632|NCT02552810|3991687|FG001|NOT COMPLETED|Overall Study||0
3257633|NCT02552888|3991695|FG000|STARTED|Overall Study|35 participants were enrolled.|35
3257634|NCT02552888|3991696|FG001|STARTED|Overall Study|35 participants were enrolled.|35
3257635|NCT02552888|3991695|FG000|COMPLETED|Overall Study|34 participants completed the study.|34
3257636|NCT02552888|3991696|FG001|COMPLETED|Overall Study|34 participants completed the study|34
3257637|NCT02552888|3991695|FG000|NOT COMPLETED|Overall Study||1
3257638|NCT02552888|3991696|FG001|NOT COMPLETED|Overall Study||1
3257639|NCT02552966|3991706|FG000|STARTED|Overall Study||20
3257640|NCT02552966|3991706|FG000|COMPLETED|Overall Study||15
3257641|NCT02552966|3991706|FG000|NOT COMPLETED|Overall Study||5
3257642|NCT02553135|3991710|FG000|STARTED|Overall Study||6
3257643|NCT02553135|3991710|FG000|COMPLETED|Overall Study||6
3257644|NCT02553135|3991710|FG000|NOT COMPLETED|Overall Study||0
3257645|NCT02553317|3991716|FG000|STARTED|Overall Treatment Period + Follow-up||72
3257646|NCT02553317|3991717|FG001|STARTED|Overall Treatment Period + Follow-up||73
3257647|NCT02553317|3991716|FG000|Received Study Drug|Overall Treatment Period + Follow-up||71
3257648|NCT02553317|3991717|FG001|Received Study Drug|Overall Treatment Period + Follow-up||73
3257649|NCT02553317|3991716|FG000|COMPLETED|Overall Treatment Period + Follow-up||58
3257650|NCT02553317|3991717|FG001|COMPLETED|Overall Treatment Period + Follow-up||50
3257651|NCT02553317|3991716|FG000|NOT COMPLETED|Overall Treatment Period + Follow-up||14
3257652|NCT02553317|3991717|FG001|NOT COMPLETED|Overall Treatment Period + Follow-up||23
3257653|NCT02553317|3991716|FG000|STARTED|Double-blind (DB) Treatment Period|One patient withdrew consent prior to first dosing and did not start the DB treatment period.|71
3257654|NCT02553317|3991717|FG001|STARTED|Double-blind (DB) Treatment Period||73
3257655|NCT02553317|3991716|FG000|COMPLETED|Double-blind (DB) Treatment Period||68
3257656|NCT02553317|3991717|FG001|COMPLETED|Double-blind (DB) Treatment Period||65
3257657|NCT02553317|3991716|FG000|NOT COMPLETED|Double-blind (DB) Treatment Period||3
3257658|NCT02553317|3991717|FG001|NOT COMPLETED|Double-blind (DB) Treatment Period||8
3257659|NCT02553317|3991716|FG000|STARTED|Open-label (OL) Treatment Period|2 patients on caplacizumab had a recurrence of TTP during the DB period and started OL treatment.|2
3257660|NCT02553317|3991717|FG001|STARTED|Open-label (OL) Treatment Period|26 patients on placebo had a recurrence of TTP during the DB period and started OL treatment.|26
3257661|NCT02553317|3991716|FG000|COMPLETED|Open-label (OL) Treatment Period||2
3257662|NCT02553317|3991717|FG001|COMPLETED|Open-label (OL) Treatment Period||22
3257663|NCT02553317|3991716|FG000|NOT COMPLETED|Open-label (OL) Treatment Period||0
3257664|NCT02553317|3991717|FG001|NOT COMPLETED|Open-label (OL) Treatment Period||4
3257665|NCT02553330|3991727|FG000|STARTED|Overall Study||12
3257666|NCT02553330|3991728|FG001|STARTED|Overall Study||39
3257667|NCT02553330|3991729|FG002|STARTED|Overall Study||39
3257668|NCT02553330|3991727|FG000|COMPLETED|Overall Study||7
3257669|NCT02553330|3991728|FG001|COMPLETED|Overall Study||0
3257670|NCT02553330|3991729|FG002|COMPLETED|Overall Study||2
3257671|NCT02553330|3991727|FG000|NOT COMPLETED|Overall Study||5
3257672|NCT02553330|3991728|FG001|NOT COMPLETED|Overall Study||39
3257673|NCT02553330|3991729|FG002|NOT COMPLETED|Overall Study||37
3257674|NCT02553395|3991740|FG000|STARTED|First Intervention||12
3257675|NCT02553395|3991741|FG001|STARTED|First Intervention||18
3257676|NCT02553395|3991740|FG000|COMPLETED|First Intervention||12
3257677|NCT02553395|3991741|FG001|COMPLETED|First Intervention||18
3257678|NCT02553395|3991740|FG000|NOT COMPLETED|First Intervention||0
3257679|NCT02553395|3991741|FG001|NOT COMPLETED|First Intervention||0
3257680|NCT02553395|3991740|FG000|STARTED|Second Intervention||12
3257681|NCT02553395|3991741|FG001|STARTED|Second Intervention||18
3257682|NCT02553395|3991740|FG000|COMPLETED|Second Intervention||12
3257683|NCT02553395|3991741|FG001|COMPLETED|Second Intervention||18
3257684|NCT02553395|3991740|FG000|NOT COMPLETED|Second Intervention||0
3257685|NCT02553395|3991741|FG001|NOT COMPLETED|Second Intervention||0
3257686|NCT02553421|3991750|FG000|STARTED|Overall Study||185
3257687|NCT02553421|3991751|FG001|STARTED|Overall Study||58
3257688|NCT02553421|3991750|FG000|COMPLETED|Overall Study||156
3257689|NCT02553421|3991751|FG001|COMPLETED|Overall Study||57
3257690|NCT02553421|3991750|FG000|NOT COMPLETED|Overall Study||29
3257691|NCT02553421|3991751|FG001|NOT COMPLETED|Overall Study||1
3257692|NCT02553499|3991772|FG000|STARTED|Overall Study||2
3257693|NCT02553499|3991773|FG001|STARTED|Overall Study||2
3257694|NCT02553499|3991774|FG002|STARTED|Overall Study||2
3257695|NCT02553499|3991775|FG003|STARTED|Overall Study||2
3257696|NCT02553499|3991776|FG004|STARTED|Overall Study||3
3257697|NCT02553499|3991777|FG005|STARTED|Overall Study||3
3257698|NCT02553499|3991778|FG006|STARTED|Overall Study||3
3257699|NCT02553499|3991779|FG007|STARTED|Overall Study||3
3257700|NCT02553499|3991780|FG008|STARTED|Overall Study||3
3257701|NCT02553499|3991781|FG009|STARTED|Overall Study||3
3257702|NCT02553499|3991782|FG010|STARTED|Overall Study||3
3257703|NCT02553499|3991783|FG011|STARTED|Overall Study||3
3257704|NCT02553499|3991784|FG012|STARTED|Overall Study||3
3257705|NCT02553499|3991785|FG013|STARTED|Overall Study||2
3257706|NCT02553499|3991772|FG000|COMPLETED|Overall Study||0
3257707|NCT02553499|3991773|FG001|COMPLETED|Overall Study||0
3257708|NCT02553499|3991774|FG002|COMPLETED|Overall Study||0
3257709|NCT02553499|3991775|FG003|COMPLETED|Overall Study||0
3257710|NCT02553499|3991776|FG004|COMPLETED|Overall Study||0
3257711|NCT02553499|3991777|FG005|COMPLETED|Overall Study||0
3257712|NCT02553499|3991778|FG006|COMPLETED|Overall Study||0
3257713|NCT02553499|3991779|FG007|COMPLETED|Overall Study||0
3257714|NCT02553499|3991780|FG008|COMPLETED|Overall Study||0
3257715|NCT02553499|3991781|FG009|COMPLETED|Overall Study||0
3257716|NCT02553499|3991782|FG010|COMPLETED|Overall Study||0
3257717|NCT02553499|3991783|FG011|COMPLETED|Overall Study||0
3257718|NCT02553499|3991784|FG012|COMPLETED|Overall Study||0
3257719|NCT02553499|3991785|FG013|COMPLETED|Overall Study||0
3257720|NCT02553499|3991772|FG000|NOT COMPLETED|Overall Study||2
3257721|NCT02553499|3991773|FG001|NOT COMPLETED|Overall Study||2
3257722|NCT02553499|3991774|FG002|NOT COMPLETED|Overall Study||2
3257723|NCT02553499|3991775|FG003|NOT COMPLETED|Overall Study||2
3257724|NCT02553499|3991776|FG004|NOT COMPLETED|Overall Study||3
3257725|NCT02553499|3991777|FG005|NOT COMPLETED|Overall Study||3
3257726|NCT02553499|3991778|FG006|NOT COMPLETED|Overall Study||3
3257727|NCT02553499|3991779|FG007|NOT COMPLETED|Overall Study||3
3257728|NCT02553499|3991780|FG008|NOT COMPLETED|Overall Study||3
3257729|NCT02553499|3991781|FG009|NOT COMPLETED|Overall Study||3
3257730|NCT02553499|3991782|FG010|NOT COMPLETED|Overall Study||3
3257731|NCT02553499|3991783|FG011|NOT COMPLETED|Overall Study||3
3257732|NCT02553499|3991784|FG012|NOT COMPLETED|Overall Study||3
3257733|NCT02553499|3991785|FG013|NOT COMPLETED|Overall Study||2
3257734|NCT02553512|3991816|FG000|STARTED|Overall Study||167
3257735|NCT02553512|3991816|FG000|COMPLETED|Overall Study||144
3257736|NCT02553512|3991816|FG000|NOT COMPLETED|Overall Study||23
3257737|NCT02553538|3991822|FG000|STARTED|Overall Study||792
3257738|NCT02553538|3991823|FG001|STARTED|Overall Study||820
3257739|NCT02553538|3991822|FG000|COMPLETED|Overall Study||605
3257740|NCT02553538|3991823|FG001|COMPLETED|Overall Study||764
3257741|NCT02553538|3991822|FG000|NOT COMPLETED|Overall Study||187
3257742|NCT02553538|3991823|FG001|NOT COMPLETED|Overall Study||56
3257743|NCT02553629|3991831|FG000|STARTED|Overall Study||53
3257744|NCT02553629|3991832|FG001|STARTED|Overall Study||56
3257745|NCT02553629|3991831|FG000|COMPLETED|Overall Study||50
3257746|NCT02553629|3991832|FG001|COMPLETED|Overall Study||50
3257747|NCT02553629|3991831|FG000|NOT COMPLETED|Overall Study||3
3257748|NCT02553629|3991832|FG001|NOT COMPLETED|Overall Study||6
3257749|NCT02553746|3991840|FG000|STARTED|Overall Study||80
3257750|NCT02553746|3991841|FG001|STARTED|Overall Study||66
3257751|NCT02553746|3991840|FG000|COMPLETED|Overall Study||77
3257752|NCT02553746|3991841|FG001|COMPLETED|Overall Study||64
3257753|NCT02553746|3991840|FG000|NOT COMPLETED|Overall Study||3
3257754|NCT02553746|3991841|FG001|NOT COMPLETED|Overall Study||2
3257755|NCT02553772|3991849|FG000|STARTED|Overall Study||120
3257756|NCT02553772|3991850|FG001|STARTED|Overall Study||122
3257757|NCT02553772|3991849|FG000|COMPLETED|Overall Study||114
3257758|NCT02553772|3991850|FG001|COMPLETED|Overall Study||116
3257759|NCT02553772|3991849|FG000|NOT COMPLETED|Overall Study||6
3257760|NCT02553772|3991850|FG001|NOT COMPLETED|Overall Study||6
3257761|NCT02553798|3991856|FG000|STARTED|Overall Study||564
3257762|NCT02553798|3991856|FG000|COMPLETED|Overall Study||226
3257763|NCT02553798|3991856|FG000|NOT COMPLETED|Overall Study||338
3257764|NCT02553915|3991864|FG000|STARTED|Overall Study||15
3257765|NCT02553915|3991865|FG001|STARTED|Overall Study||15
3257766|NCT02553915|3991866|FG002|STARTED|Overall Study||15
3257767|NCT02553915|3991867|FG003|STARTED|Overall Study||16
3257768|NCT02553915|3991864|FG000|COMPLETED|Overall Study||11
3257769|NCT02553915|3991865|FG001|COMPLETED|Overall Study||14
3257770|NCT02553915|3991866|FG002|COMPLETED|Overall Study||12
3257771|NCT02553915|3991867|FG003|COMPLETED|Overall Study||13
3257772|NCT02553915|3991864|FG000|NOT COMPLETED|Overall Study||4
3257773|NCT02553915|3991865|FG001|NOT COMPLETED|Overall Study||1
3257774|NCT02553915|3991866|FG002|NOT COMPLETED|Overall Study||3
3257775|NCT02553915|3991867|FG003|NOT COMPLETED|Overall Study||3
3257776|NCT02553928|3991879|FG000|STARTED|Overall Study||30
3257777|NCT02553928|3991880|FG001|STARTED|Overall Study||32
3257778|NCT02553928|3991879|FG000|COMPLETED|Overall Study||28
3257779|NCT02553928|3991880|FG001|COMPLETED|Overall Study||29
3257780|NCT02553928|3991879|FG000|NOT COMPLETED|Overall Study||2
3257781|NCT02553928|3991880|FG001|NOT COMPLETED|Overall Study||3
3257782|NCT02554019|3991890|FG000|STARTED|Overall Study||12
3257783|NCT02554019|3991891|FG001|STARTED|Overall Study||12
3257784|NCT02554019|3991892|FG002|STARTED|Overall Study||12
3257785|NCT02554019|3991890|FG000|COMPLETED|Overall Study||10
3257786|NCT02554019|3991891|FG001|COMPLETED|Overall Study||12
3257787|NCT02554019|3991892|FG002|COMPLETED|Overall Study||10
3257788|NCT02554019|3991890|FG000|NOT COMPLETED|Overall Study||2
3257789|NCT02554019|3991891|FG001|NOT COMPLETED|Overall Study||0
3257790|NCT02554019|3991892|FG002|NOT COMPLETED|Overall Study||2
3257791|NCT02554279|3991902|FG000|STARTED|Overall Study||311
3257792|NCT02554279|3991903|FG001|STARTED|Overall Study||309
3257793|NCT02554279|3991902|FG000|Treated|Overall Study||310
3257794|NCT02554279|3991903|FG001|Treated|Overall Study||309
3257795|NCT02554279|3991902|FG000|Completed Day 6 of Stimulation|Overall Study||308
3257796|NCT02554279|3991903|FG001|Completed Day 6 of Stimulation|Overall Study||309
3257797|NCT02554279|3991902|FG000|Received Trigger|Overall Study||293
3257798|NCT02554279|3991903|FG001|Received Trigger|Overall Study||307
3257799|NCT02554279|3991902|FG000|Completed Oocyte Retrieval|Overall Study||292
3257800|NCT02554279|3991903|FG001|Completed Oocyte Retrieval|Overall Study||306
3257801|NCT02554279|3991902|FG000|Completed Fresh Blastocyst Transfer|Overall Study||201
3257802|NCT02554279|3991903|FG001|Completed Fresh Blastocyst Transfer|Overall Study||191
3257803|NCT02554279|3991902|FG000|COMPLETED|Overall Study||279
3257804|NCT02554279|3991903|FG001|COMPLETED|Overall Study||291
3257805|NCT02554279|3991902|FG000|NOT COMPLETED|Overall Study||32
3257806|NCT02554279|3991903|FG001|NOT COMPLETED|Overall Study||18
3257807|NCT02554435|3991918|FG000|STARTED|Overall Study||20
3257808|NCT02554435|3991919|FG001|STARTED|Overall Study||20
3257809|NCT02554435|3991918|FG000|COMPLETED|Overall Study||14
3257810|NCT02554435|3991919|FG001|COMPLETED|Overall Study||19
3257811|NCT02554435|3991918|FG000|NOT COMPLETED|Overall Study||6
3257812|NCT02554435|3991919|FG001|NOT COMPLETED|Overall Study||1
3257813|NCT02554474|3991928|FG000|STARTED|Overall Study||59
3257814|NCT02554474|3991929|FG001|STARTED|Overall Study||59
3257815|NCT02554474|3991928|FG000|COMPLETED|Overall Study|Indicates number of participants who completed assessment at the primary endpoint.|56
3257816|NCT02554474|3991929|FG001|COMPLETED|Overall Study|Indicates number of participants who completed assessment at the primary endpoint.|57
3257817|NCT02554474|3991928|FG000|NOT COMPLETED|Overall Study||3
3257818|NCT02554474|3991929|FG001|NOT COMPLETED|Overall Study||2
3257819|NCT02554513|3991935|FG000|STARTED|First Treatment Phase (7 Weeks)||3
3257820|NCT02554513|3991936|FG001|STARTED|First Treatment Phase (7 Weeks)||3
3257821|NCT02554513|3991935|FG000|COMPLETED|First Treatment Phase (7 Weeks)||3
3257822|NCT02554513|3991936|FG001|COMPLETED|First Treatment Phase (7 Weeks)||2
3257823|NCT02554513|3991935|FG000|NOT COMPLETED|First Treatment Phase (7 Weeks)||0
3257824|NCT02554513|3991936|FG001|NOT COMPLETED|First Treatment Phase (7 Weeks)||1
3257825|NCT02554513|3991935|FG000|STARTED|Washout (2 Weeks)||3
3257826|NCT02554513|3991936|FG001|STARTED|Washout (2 Weeks)||2
3257827|NCT02554513|3991935|FG000|COMPLETED|Washout (2 Weeks)||3
3257828|NCT02554513|3991936|FG001|COMPLETED|Washout (2 Weeks)||2
3257829|NCT02554513|3991935|FG000|NOT COMPLETED|Washout (2 Weeks)||0
3257830|NCT02554513|3991936|FG001|NOT COMPLETED|Washout (2 Weeks)||0
3257831|NCT02554513|3991935|FG000|STARTED|Second Treatment Phase (7 Weeks)||3
3257832|NCT02554513|3991936|FG001|STARTED|Second Treatment Phase (7 Weeks)||2
3257833|NCT02554513|3991935|FG000|COMPLETED|Second Treatment Phase (7 Weeks)||3
3257834|NCT02554513|3991936|FG001|COMPLETED|Second Treatment Phase (7 Weeks)||2
3257835|NCT02554513|3991935|FG000|NOT COMPLETED|Second Treatment Phase (7 Weeks)||0
3257836|NCT02554513|3991936|FG001|NOT COMPLETED|Second Treatment Phase (7 Weeks)||0
3257837|NCT02554656|3991948|FG000|STARTED|Overall Study||89
3257838|NCT02554656|3991948|FG000|COMPLETED|Overall Study||86
3257839|NCT02554656|3991948|FG000|NOT COMPLETED|Overall Study||3
3257840|NCT02554682|3991962|FG000|STARTED|Overall Study||40
3257841|NCT02554682|3991963|FG001|STARTED|Overall Study||40
3257842|NCT02554682|3991964|FG002|STARTED|Overall Study||40
3257843|NCT02554682|3991965|FG003|STARTED|Overall Study||40
3257844|NCT02554682|3991966|FG004|STARTED|Overall Study||40
3257845|NCT02554682|3991967|FG005|STARTED|Overall Study||40
3257846|NCT02554682|3991968|FG006|STARTED|Overall Study||28
3257847|NCT02554682|3991969|FG007|STARTED|Overall Study||28
3257848|NCT02554682|3991970|FG008|STARTED|Overall Study||26
3257849|NCT02554682|3991971|FG009|STARTED|Overall Study||26
3257850|NCT02554682|3991962|FG000|COMPLETED|Overall Study||25
3257851|NCT02554682|3991963|FG001|COMPLETED|Overall Study||28
3257852|NCT02554682|3991964|FG002|COMPLETED|Overall Study||36
3257853|NCT02554682|3991965|FG003|COMPLETED|Overall Study||37
3257854|NCT02554682|3991966|FG004|COMPLETED|Overall Study||38
3257855|NCT02554682|3991967|FG005|COMPLETED|Overall Study||39
3257856|NCT02554682|3991968|FG006|COMPLETED|Overall Study||22
3257857|NCT02554682|3991969|FG007|COMPLETED|Overall Study||22
3257858|NCT02554682|3991970|FG008|COMPLETED|Overall Study||24
3257859|NCT02554682|3991971|FG009|COMPLETED|Overall Study||24
3257860|NCT02554682|3991962|FG000|NOT COMPLETED|Overall Study||15
3257861|NCT02554682|3991963|FG001|NOT COMPLETED|Overall Study||12
3257862|NCT02554682|3991964|FG002|NOT COMPLETED|Overall Study||4
3257863|NCT02554682|3991965|FG003|NOT COMPLETED|Overall Study||3
3257864|NCT02554682|3991966|FG004|NOT COMPLETED|Overall Study||2
3257865|NCT02554682|3991967|FG005|NOT COMPLETED|Overall Study||1
3257866|NCT02554682|3991968|FG006|NOT COMPLETED|Overall Study||6
3257867|NCT02554682|3991969|FG007|NOT COMPLETED|Overall Study||6
3257868|NCT02554682|3991970|FG008|NOT COMPLETED|Overall Study||2
3257869|NCT02554682|3991971|FG009|NOT COMPLETED|Overall Study||2
3257870|NCT02554721|3992001|FG000|STARTED|Overall Study||20
3257871|NCT02554721|3992002|FG001|STARTED|Overall Study||19
3257872|NCT02554721|3992003|FG002|STARTED|Overall Study||19
3257873|NCT02554721|3992004|FG003|STARTED|Overall Study||17
3257874|NCT02554721|3992005|FG004|STARTED|Overall Study||2
3257875|NCT02554721|3992001|FG000|COMPLETED|Overall Study||19
3257876|NCT02554721|3992002|FG001|COMPLETED|Overall Study||19
3257877|NCT02554721|3992003|FG002|COMPLETED|Overall Study||19
3257878|NCT02554721|3992004|FG003|COMPLETED|Overall Study||17
3257879|NCT02554721|3992005|FG004|COMPLETED|Overall Study||0
3257880|NCT02554721|3992001|FG000|NOT COMPLETED|Overall Study||1
3257881|NCT02554721|3992002|FG001|NOT COMPLETED|Overall Study||0
3257882|NCT02554721|3992003|FG002|NOT COMPLETED|Overall Study||0
3257883|NCT02554721|3992004|FG003|NOT COMPLETED|Overall Study||0
3257884|NCT02554721|3992005|FG004|NOT COMPLETED|Overall Study||2
3257885|NCT02554760|3992014|FG000|STARTED|Overall Study||9
3257886|NCT02554760|3992015|FG001|STARTED|Overall Study||10
3257887|NCT02554760|3992014|FG000|COMPLETED|Overall Study||9
3257888|NCT02554760|3992015|FG001|COMPLETED|Overall Study||10
3257889|NCT02554760|3992014|FG000|NOT COMPLETED|Overall Study||0
3257890|NCT02554760|3992015|FG001|NOT COMPLETED|Overall Study||0
3257891|NCT02554786|3992029|FG000|STARTED|Overall Study||445
3257892|NCT02554786|3992030|FG001|STARTED|Overall Study||439
3257893|NCT02554786|3992031|FG002|STARTED|Overall Study||442
3257894|NCT02554786|3992032|FG003|STARTED|Overall Study||444
3257895|NCT02554786|3992033|FG004|STARTED|Overall Study||446
3257896|NCT02554786|3992029|FG000|COMPLETED|Overall Study||410
3257897|NCT02554786|3992030|FG001|COMPLETED|Overall Study||413
3257898|NCT02554786|3992031|FG002|COMPLETED|Overall Study||412
3257899|NCT02554786|3992032|FG003|COMPLETED|Overall Study||403
3257900|NCT02554786|3992033|FG004|COMPLETED|Overall Study||416
3257901|NCT02554786|3992029|FG000|NOT COMPLETED|Overall Study||35
3257902|NCT02554786|3992030|FG001|NOT COMPLETED|Overall Study||26
3257903|NCT02554786|3992031|FG002|NOT COMPLETED|Overall Study||30
3257904|NCT02554786|3992032|FG003|NOT COMPLETED|Overall Study||41
3257905|NCT02554786|3992033|FG004|NOT COMPLETED|Overall Study||30
3257906|NCT02554799|3992051|FG000|STARTED|Overall Study||9
3257907|NCT02554799|3992052|FG001|STARTED|Overall Study||9
3257908|NCT02554799|3992051|FG000|COMPLETED|Overall Study||9
3257909|NCT02554799|3992052|FG001|COMPLETED|Overall Study||9
3257910|NCT02554799|3992051|FG000|NOT COMPLETED|Overall Study||0
3257911|NCT02554799|3992052|FG001|NOT COMPLETED|Overall Study||0
3257912|NCT02554877|3992062|FG000|STARTED|Overall Study||51
3257913|NCT02554877|3992063|FG001|STARTED|Overall Study||51
3257914|NCT02554877|3992064|FG002|STARTED|Overall Study||52
3257915|NCT02554877|3992065|FG003|STARTED|Overall Study||52
3257916|NCT02554877|3992062|FG000|COMPLETED|Overall Study||39
3257917|NCT02554877|3992063|FG001|COMPLETED|Overall Study||44
3257918|NCT02554877|3992064|FG002|COMPLETED|Overall Study||46
3257919|NCT02554877|3992065|FG003|COMPLETED|Overall Study||45
3257920|NCT02554877|3992062|FG000|NOT COMPLETED|Overall Study||12
3257921|NCT02554877|3992063|FG001|NOT COMPLETED|Overall Study||7
3257922|NCT02554877|3992064|FG002|NOT COMPLETED|Overall Study||6
3257923|NCT02554877|3992065|FG003|NOT COMPLETED|Overall Study||7
3257924|NCT02554890|3992077|FG000|STARTED|Double-blind||444
3257925|NCT02554890|3992078|FG001|STARTED|Double-blind||443
3257926|NCT02554890|3992077|FG000|Treated Patients|Double-blind||436
3257927|NCT02554890|3992078|FG001|Treated Patients|Double-blind||439
3257928|NCT02554890|3992077|FG000|COMPLETED|Double-blind||348
3257929|NCT02554890|3992078|FG001|COMPLETED|Double-blind||352
3257930|NCT02554890|3992077|FG000|NOT COMPLETED|Double-blind||96
3257931|NCT02554890|3992078|FG001|NOT COMPLETED|Double-blind||91
3257932|NCT02554890|3992077|FG000|STARTED|Open-label||0
3257933|NCT02554890|3992078|FG001|STARTED|Open-label||887
3257934|NCT02554890|3992077|FG000|COMPLETED|Open-label||0
3257935|NCT02554890|3992078|FG001|COMPLETED|Open-label||835
3257936|NCT02554890|3992077|FG000|NOT COMPLETED|Open-label||0
3257937|NCT02554890|3992078|FG001|NOT COMPLETED|Open-label||52
3257938|NCT02554903|3992088|FG000|STARTED|Overall Study||28
3257939|NCT02554903|3992089|FG001|STARTED|Overall Study||29
3257940|NCT02554903|3992088|FG000|COMPLETED|Overall Study||24
3257941|NCT02554903|3992089|FG001|COMPLETED|Overall Study||24
3257942|NCT02554903|3992088|FG000|NOT COMPLETED|Overall Study||4
3257943|NCT02554903|3992089|FG001|NOT COMPLETED|Overall Study||5
3257944|NCT02554929|3992098|FG000|STARTED|Overall Study||46
3257945|NCT02554929|3992099|FG001|STARTED|Overall Study||44
3257946|NCT02554929|3992098|FG000|Per Protocol Received Intervention|Overall Study||44
3257947|NCT02554929|3992099|FG001|Per Protocol Received Intervention|Overall Study||36
3257948|NCT02554929|3992098|FG000|Per Protocol Post-Intervention|Overall Study||42
3257949|NCT02554929|3992099|FG001|Per Protocol Post-Intervention|Overall Study||36
3257950|NCT02554929|3992098|FG000|Per Protocol 6 Month Follow-up|Overall Study||40
3257951|NCT02554929|3992099|FG001|Per Protocol 6 Month Follow-up|Overall Study||32
3257952|NCT02554929|3992098|FG000|COMPLETED|Overall Study||40
3257953|NCT02554929|3992099|FG001|COMPLETED|Overall Study||32
3257954|NCT02554929|3992098|FG000|NOT COMPLETED|Overall Study||6
3257955|NCT02554929|3992099|FG001|NOT COMPLETED|Overall Study||12
3257956|NCT02554981|3992105|FG000|STARTED|Overall Study||51
3257957|NCT02554981|3992105|FG000|COMPLETED|Overall Study||46
3257958|NCT02554981|3992105|FG000|NOT COMPLETED|Overall Study||5
3257959|NCT02555098|3992109|FG000|STARTED|First Intervention||12
3257960|NCT02555098|3992110|FG001|STARTED|First Intervention||11
3257961|NCT02555098|3992109|FG000|COMPLETED|First Intervention||12
3257962|NCT02555098|3992110|FG001|COMPLETED|First Intervention||11
3257963|NCT02555098|3992109|FG000|NOT COMPLETED|First Intervention||0
3257964|NCT02555098|3992110|FG001|NOT COMPLETED|First Intervention||0
3257965|NCT02555098|3992109|FG000|STARTED|Second Intervention||12
3257966|NCT02555098|3992110|FG001|STARTED|Second Intervention||11
3257967|NCT02555098|3992109|FG000|COMPLETED|Second Intervention||12
3257968|NCT02555098|3992110|FG001|COMPLETED|Second Intervention||11
3257969|NCT02555098|3992109|FG000|NOT COMPLETED|Second Intervention||0
3257970|NCT02555098|3992110|FG001|NOT COMPLETED|Second Intervention||0
3257971|NCT02555215|3992120|FG000|STARTED|Overall Study||20
3257972|NCT02555215|3992120|FG000|COMPLETED|Overall Study||17
3257973|NCT02555215|3992120|FG000|NOT COMPLETED|Overall Study||3
3257974|NCT02555228|3992126|FG000|STARTED|Overall Study|20th August 2015|27
3257975|NCT02555228|3992127|FG001|STARTED|Overall Study|14th August 2015|27
3257976|NCT02555228|3992126|FG000|COMPLETED|Overall Study|19th November 2015|27
3257977|NCT02555228|3992127|FG001|COMPLETED|Overall Study|29th October 2015|27
3257978|NCT02555228|3992126|FG000|NOT COMPLETED|Overall Study||0
3257979|NCT02555228|3992127|FG001|NOT COMPLETED|Overall Study||0
3257980|NCT02555306|3992137|FG000|STARTED|Overall Study||3
3257981|NCT02555306|3992138|FG001|STARTED|Overall Study||3
3257982|NCT02555306|3992139|FG002|STARTED|Overall Study||3
3257983|NCT02555306|3992140|FG003|STARTED|Overall Study||3
3257984|NCT02555306|3992137|FG000|COMPLETED|Overall Study||3
3257985|NCT02555306|3992138|FG001|COMPLETED|Overall Study||3
3257986|NCT02555306|3992139|FG002|COMPLETED|Overall Study||3
3257987|NCT02555306|3992140|FG003|COMPLETED|Overall Study||3
3257988|NCT02555306|3992137|FG000|NOT COMPLETED|Overall Study||0
3257989|NCT02555306|3992138|FG001|NOT COMPLETED|Overall Study||0
3257990|NCT02555306|3992139|FG002|NOT COMPLETED|Overall Study||0
3257991|NCT02555306|3992140|FG003|NOT COMPLETED|Overall Study||0
3257992|NCT02555371|3992150|FG000|STARTED|PartA(Upto 132W)+PartB(Upto 8W)||306
3257993|NCT02555371|3992151|FG001|STARTED|PartA(Upto 132W)+PartB(Upto 8W)||0
3257994|NCT02555371|3992152|FG002|STARTED|PartA(Upto 132W)+PartB(Upto 8W)||0
3257995|NCT02555371|3992153|FG003|STARTED|PartA(Upto 132W)+PartB(Upto 8W)||0
3257996|NCT02555371|3992154|FG004|STARTED|PartA(Upto 132W)+PartB(Upto 8W)||0
3257997|NCT02555371|3992150|FG000|COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||295
3257998|NCT02555371|3992151|FG001|COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||0
3257999|NCT02555371|3992152|FG002|COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||0
3258000|NCT02555371|3992153|FG003|COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||0
3258001|NCT02555371|3992154|FG004|COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||0
3258002|NCT02555371|3992150|FG000|NOT COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||11
3258003|NCT02555371|3992151|FG001|NOT COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||0
3258004|NCT02555371|3992152|FG002|NOT COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||0
3258005|NCT02555371|3992153|FG003|NOT COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||0
3258006|NCT02555371|3992154|FG004|NOT COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||0
3258007|NCT02555371|3992150|FG000|STARTED|Part C (DB Period: Up to 52W)||0
3258008|NCT02555371|3992151|FG001|STARTED|Part C (DB Period: Up to 52W)||151
3258009|NCT02555371|3992152|FG002|STARTED|Part C (DB Period: Up to 52W)||144
3258010|NCT02555371|3992153|FG003|STARTED|Part C (DB Period: Up to 52W)||0
3258011|NCT02555371|3992154|FG004|STARTED|Part C (DB Period: Up to 52W)||0
3258012|NCT02555371|3992150|FG000|COMPLETED|Part C (DB Period: Up to 52W)||0
3258013|NCT02555371|3992151|FG001|COMPLETED|Part C (DB Period: Up to 52W)||62
3258014|NCT02555371|3992152|FG002|COMPLETED|Part C (DB Period: Up to 52W)||96
3258015|NCT02555371|3992153|FG003|COMPLETED|Part C (DB Period: Up to 52W)||0
3258016|NCT02555371|3992154|FG004|COMPLETED|Part C (DB Period: Up to 52W)||0
3258017|NCT02555371|3992150|FG000|NOT COMPLETED|Part C (DB Period: Up to 52W)||0
3258018|NCT02555371|3992151|FG001|NOT COMPLETED|Part C (DB Period: Up to 52W)||89
3258019|NCT02555371|3992152|FG002|NOT COMPLETED|Part C (DB Period: Up to 52W)||48
3258020|NCT02555371|3992153|FG003|NOT COMPLETED|Part C (DB Period: Up to 52W)||0
3258021|NCT02555371|3992154|FG004|NOT COMPLETED|Part C (DB Period: Up to 52W)||0
3258022|NCT02555371|3992150|FG000|STARTED|PartD(OL: 52W Post-randomization PartC)||0
3258023|NCT02555371|3992151|FG001|STARTED|PartD(OL: 52W Post-randomization PartC)||0
3258024|NCT02555371|3992152|FG002|STARTED|PartD(OL: 52W Post-randomization PartC)||0
3258025|NCT02555371|3992153|FG003|STARTED|PartD(OL: 52W Post-randomization PartC)||84
3258026|NCT02555371|3992154|FG004|STARTED|PartD(OL: 52W Post-randomization PartC)||45
3258027|NCT02555371|3992150|FG000|COMPLETED|PartD(OL: 52W Post-randomization PartC)||0
3258028|NCT02555371|3992151|FG001|COMPLETED|PartD(OL: 52W Post-randomization PartC)||0
3258029|NCT02555371|3992152|FG002|COMPLETED|PartD(OL: 52W Post-randomization PartC)||0
3258030|NCT02555371|3992153|FG003|COMPLETED|PartD(OL: 52W Post-randomization PartC)||80
3258031|NCT02555371|3992154|FG004|COMPLETED|PartD(OL: 52W Post-randomization PartC)||42
3258032|NCT02555371|3992150|FG000|NOT COMPLETED|PartD(OL: 52W Post-randomization PartC)||0
3258033|NCT02555371|3992151|FG001|NOT COMPLETED|PartD(OL: 52W Post-randomization PartC)||0
3258034|NCT02555371|3992152|FG002|NOT COMPLETED|PartD(OL: 52W Post-randomization PartC)||0
3258035|NCT02555371|3992153|FG003|NOT COMPLETED|PartD(OL: 52W Post-randomization PartC)||4
3258036|NCT02555371|3992154|FG004|NOT COMPLETED|PartD(OL: 52W Post-randomization PartC)||3
3258037|NCT02555449|3992163|FG000|STARTED|Overall Study||6
3258038|NCT02555449|3992163|FG000|COMPLETED|Overall Study||6
3258039|NCT02555449|3992163|FG000|NOT COMPLETED|Overall Study||0
3258040|NCT02555618|3992169|FG000|STARTED|Overall Study||200
3258041|NCT02555618|3992170|FG001|STARTED|Overall Study||200
3258042|NCT02555618|3992169|FG000|COMPLETED|Overall Study||199
3258043|NCT02555618|3992170|FG001|COMPLETED|Overall Study||200
3258044|NCT02555618|3992169|FG000|NOT COMPLETED|Overall Study||1
3258045|NCT02555618|3992170|FG001|NOT COMPLETED|Overall Study||0
3258046|NCT02555631|3992176|FG000|STARTED|Overall Study||29
3258047|NCT02555631|3992176|FG000|COMPLETED|Overall Study||25
3258048|NCT02555631|3992176|FG000|NOT COMPLETED|Overall Study||4
3258049|NCT02555683|3992183|FG000|STARTED|Overall Study||301
3258050|NCT02555683|3992184|FG001|STARTED|Overall Study||295
3258051|NCT02555683|3992185|FG002|STARTED|Overall Study||298
3258052|NCT02555683|3992183|FG000|FAS/SAF: High Eosinophil Subpopulation|Overall Study||200
3258053|NCT02555683|3992184|FG001|FAS/SAF: High Eosinophil Subpopulation|Overall Study||201
3258054|NCT02555683|3992185|FG002|FAS/SAF: High Eosinophil Subpopulation|Overall Study||201
3258055|NCT02555683|3992183|FG000|FAS/SAF: Overall Population|Overall Study||299
3258056|NCT02555683|3992184|FG001|FAS/SAF: Overall Population|Overall Study||293
3258057|NCT02555683|3992185|FG002|FAS/SAF: Overall Population|Overall Study||298
3258058|NCT02555683|3992183|FG000|COMPLETED|Overall Study||282
3258059|NCT02555683|3992184|FG001|COMPLETED|Overall Study||278
3258060|NCT02555683|3992185|FG002|COMPLETED|Overall Study||269
3258061|NCT02555683|3992183|FG000|NOT COMPLETED|Overall Study||19
3258062|NCT02555683|3992184|FG001|NOT COMPLETED|Overall Study||17
3258063|NCT02555683|3992185|FG002|NOT COMPLETED|Overall Study||29
3258064|NCT02555722|3992195|FG000|STARTED|Lens Dispensed||60
3258065|NCT02555722|3992196|FG001|STARTED|Lens Dispensed||30
3258066|NCT02555722|3992195|FG000|COMPLETED|Lens Dispensed||60
3258067|NCT02555722|3992196|FG001|COMPLETED|Lens Dispensed||30
3258068|NCT02555722|3992195|FG000|NOT COMPLETED|Lens Dispensed||0
3258069|NCT02555722|3992196|FG001|NOT COMPLETED|Lens Dispensed||0
3258070|NCT02555722|3992195|FG000|STARTED|Week 1||60
3258071|NCT02555722|3992196|FG001|STARTED|Week 1||30
3258072|NCT02555722|3992195|FG000|COMPLETED|Week 1||60
3258073|NCT02555722|3992196|FG001|COMPLETED|Week 1||30
3258074|NCT02555722|3992195|FG000|NOT COMPLETED|Week 1||0
3258075|NCT02555722|3992196|FG001|NOT COMPLETED|Week 1||0
3258076|NCT02555722|3992195|FG000|STARTED|Week 2||60
3258077|NCT02555722|3992196|FG001|STARTED|Week 2||30
3258078|NCT02555722|3992195|FG000|COMPLETED|Week 2||59
3258079|NCT02555722|3992196|FG001|COMPLETED|Week 2||29
3258080|NCT02555722|3992195|FG000|NOT COMPLETED|Week 2||1
3258081|NCT02555722|3992196|FG001|NOT COMPLETED|Week 2||1
3258082|NCT02555722|3992195|FG000|STARTED|Month 1||59
3258083|NCT02555722|3992196|FG001|STARTED|Month 1||29
3258084|NCT02555722|3992195|FG000|COMPLETED|Month 1||58
3258085|NCT02555722|3992196|FG001|COMPLETED|Month 1||29
3258086|NCT02555722|3992195|FG000|NOT COMPLETED|Month 1||1
3258087|NCT02555722|3992196|FG001|NOT COMPLETED|Month 1||0
3258088|NCT02555722|3992195|FG000|STARTED|Month 2||58
3258089|NCT02555722|3992196|FG001|STARTED|Month 2||29
3258090|NCT02555722|3992195|FG000|COMPLETED|Month 2||54
3258091|NCT02555722|3992196|FG001|COMPLETED|Month 2||29
3258092|NCT02555722|3992195|FG000|NOT COMPLETED|Month 2||4
3258093|NCT02555722|3992196|FG001|NOT COMPLETED|Month 2||0
3258094|NCT02555722|3992195|FG000|STARTED|Month 3||54
3258095|NCT02555722|3992196|FG001|STARTED|Month 3||29
3258096|NCT02555722|3992195|FG000|COMPLETED|Month 3||54
3258097|NCT02555722|3992196|FG001|COMPLETED|Month 3||29
3258098|NCT02555722|3992195|FG000|NOT COMPLETED|Month 3||0
3258099|NCT02555722|3992196|FG001|NOT COMPLETED|Month 3||0
3258100|NCT02555878|3992227|FG000|STARTED|Overall Study||421
3258101|NCT02555878|3992228|FG001|STARTED|Overall Study||420
3258102|NCT02555878|3992227|FG000|Treated|Overall Study||404
3258103|NCT02555878|3992228|FG001|Treated|Overall Study||405
3258104|NCT02555878|3992227|FG000|COMPLETED|Overall Study||255
3258105|NCT02555878|3992228|FG001|COMPLETED|Overall Study||270
3258106|NCT02555878|3992227|FG000|NOT COMPLETED|Overall Study||166
3258107|NCT02555878|3992228|FG001|NOT COMPLETED|Overall Study||150
3258108|NCT02555930|3992234|FG000|STARTED|Overall Study||148
3258109|NCT02555930|3992234|FG000|COMPLETED|Overall Study||148
3258110|NCT02555930|3992234|FG000|NOT COMPLETED|Overall Study||0
3258111|NCT02556112|3992242|FG000|STARTED|Overall Study||40
3258112|NCT02556112|3992243|FG001|STARTED|Overall Study||40
3258113|NCT02556112|3992244|FG002|STARTED|Overall Study||42
3258114|NCT02556112|3992242|FG000|COMPLETED|Overall Study||30
3258115|NCT02556112|3992243|FG001|COMPLETED|Overall Study||23
3258116|NCT02556112|3992244|FG002|COMPLETED|Overall Study||30
3258117|NCT02556112|3992242|FG000|NOT COMPLETED|Overall Study||10
3258118|NCT02556112|3992243|FG001|NOT COMPLETED|Overall Study||17
3258119|NCT02556112|3992244|FG002|NOT COMPLETED|Overall Study||12
3258120|NCT02556138|3992253|FG000|STARTED|Overall Study||8
3258121|NCT02556138|3992253|FG000|COMPLETED|Overall Study|One patient withdrew from the study due to intolerance of the balloon after 1 month.|7
3258122|NCT02556138|3992253|FG000|NOT COMPLETED|Overall Study||1
3258123|NCT02556177|3992259|FG000|STARTED|Overall Study||325
3258124|NCT02556177|3992260|FG001|STARTED|Overall Study||152
3258125|NCT02556177|3992259|FG000|COMPLETED|Overall Study||42
3258126|NCT02556177|3992260|FG001|COMPLETED|Overall Study||91
3258127|NCT02556177|3992259|FG000|NOT COMPLETED|Overall Study||283
3258128|NCT02556177|3992260|FG001|NOT COMPLETED|Overall Study||61
3258129|NCT02556203|3992268|FG000|STARTED|Overall Study||826
3258130|NCT02556203|3992269|FG001|STARTED|Overall Study||818
3258131|NCT02556203|3992268|FG000|Received Treatment|Overall Study||801
3258132|NCT02556203|3992269|FG001|Received Treatment|Overall Study||807
3258133|NCT02556203|3992268|FG000|COMPLETED|Overall Study||799
3258134|NCT02556203|3992269|FG001|COMPLETED|Overall Study||792
3258135|NCT02556203|3992268|FG000|NOT COMPLETED|Overall Study||27
3258136|NCT02556203|3992269|FG001|NOT COMPLETED|Overall Study||26
3258137|NCT02556255|3992275|FG000|STARTED|Overall Study||50
3258138|NCT02556255|3992275|FG000|COMPLETED|Overall Study||46
3258139|NCT02556255|3992275|FG000|NOT COMPLETED|Overall Study||4
3258140|NCT02556307|3992279|FG000|STARTED|Overall Study||270
3258141|NCT02556307|3992279|FG000|Treated|Overall Study||268
3258142|NCT02556307|3992279|FG000|COMPLETED|Overall Study||217
3258143|NCT02556307|3992279|FG000|NOT COMPLETED|Overall Study||53
3258144|NCT02556333|3992283|FG000|STARTED|Overall Study||1
3258145|NCT02556333|3992283|FG000|COMPLETED|Overall Study||1
3258146|NCT02556333|3992283|FG000|NOT COMPLETED|Overall Study||0
3258147|NCT02556554|3992290|FG000|STARTED|Overall Study||8
3258148|NCT02556554|3992291|FG001|STARTED|Overall Study||14
3258149|NCT02556554|3992292|FG002|STARTED|Overall Study||19
3258150|NCT02556554|3992293|FG003|STARTED|Overall Study||12
3258151|NCT02556554|3992294|FG004|STARTED|Overall Study||14
3258152|NCT02556554|3992290|FG000|COMPLETED|Overall Study||8
3258153|NCT02556554|3992291|FG001|COMPLETED|Overall Study||13
3258154|NCT02556554|3992292|FG002|COMPLETED|Overall Study||15
3258155|NCT02556554|3992293|FG003|COMPLETED|Overall Study||12
3258156|NCT02556554|3992294|FG004|COMPLETED|Overall Study||14
3258157|NCT02556554|3992290|FG000|NOT COMPLETED|Overall Study||0
3258158|NCT02556554|3992291|FG001|NOT COMPLETED|Overall Study||1
3258159|NCT02556554|3992292|FG002|NOT COMPLETED|Overall Study||4
3258160|NCT02556554|3992293|FG003|NOT COMPLETED|Overall Study||0
3258161|NCT02556554|3992294|FG004|NOT COMPLETED|Overall Study||0
3258162|NCT02556632|3992308|FG000|STARTED|Overall Study||64
3258163|NCT02556632|3992309|FG001|STARTED|Overall Study||65
3258164|NCT02556632|3992310|FG002|STARTED|Overall Study||62
3258165|NCT02556632|3992308|FG000|COMPLETED|Overall Study||59
3258166|NCT02556632|3992309|FG001|COMPLETED|Overall Study||59
3258167|NCT02556632|3992310|FG002|COMPLETED|Overall Study||53
3258168|NCT02556632|3992308|FG000|NOT COMPLETED|Overall Study||5
3258169|NCT02556632|3992309|FG001|NOT COMPLETED|Overall Study||6
3258170|NCT02556632|3992310|FG002|NOT COMPLETED|Overall Study||9
3258171|NCT02556736|3992318|FG000|STARTED|Overall Study||14
3258172|NCT02556736|3992318|FG000|COMPLETED|Overall Study||14
3258173|NCT02556736|3992318|FG000|NOT COMPLETED|Overall Study||0
3258174|NCT02556775|3992326|FG000|STARTED|Overall Study||7
3258175|NCT02556775|3992327|FG001|STARTED|Overall Study||2
3258176|NCT02556775|3992328|FG002|STARTED|Overall Study||5
3258177|NCT02556775|3992329|FG003|STARTED|Overall Study||2
3258178|NCT02556775|3992326|FG000|COMPLETED|Overall Study||5
3258179|NCT02556775|3992327|FG001|COMPLETED|Overall Study||2
3258180|NCT02556775|3992328|FG002|COMPLETED|Overall Study||4
3258181|NCT02556775|3992329|FG003|COMPLETED|Overall Study||2
3258182|NCT02556775|3992326|FG000|NOT COMPLETED|Overall Study||2
3258183|NCT02556775|3992327|FG001|NOT COMPLETED|Overall Study||0
3258184|NCT02556775|3992328|FG002|NOT COMPLETED|Overall Study||1
3258185|NCT02556775|3992329|FG003|NOT COMPLETED|Overall Study||0
3258186|NCT02556788|3992343|FG000|STARTED|Overall Study||602
3258187|NCT02556788|3992344|FG001|STARTED|Overall Study||610
3258188|NCT02556788|3992343|FG000|COMPLETED|Overall Study||558
3258189|NCT02556788|3992344|FG001|COMPLETED|Overall Study||573
3258190|NCT02556788|3992343|FG000|NOT COMPLETED|Overall Study||44
3258191|NCT02556788|3992344|FG001|NOT COMPLETED|Overall Study||37
3258192|NCT02556801|3992354|FG000|STARTED|Overall Study||42
3258193|NCT02556801|3992355|FG001|STARTED|Overall Study||42
3258194|NCT02556801|3992356|FG002|STARTED|Overall Study||42
3258195|NCT02556801|3992357|FG003|STARTED|Overall Study||42
3258196|NCT02556801|3992354|FG000|COMPLETED|Overall Study||40
3258197|NCT02556801|3992355|FG001|COMPLETED|Overall Study||35
3258198|NCT02556801|3992356|FG002|COMPLETED|Overall Study||38
3258199|NCT02556801|3992357|FG003|COMPLETED|Overall Study||37
3258200|NCT02556801|3992354|FG000|NOT COMPLETED|Overall Study||2
3258201|NCT02556801|3992355|FG001|NOT COMPLETED|Overall Study||7
3258202|NCT02556801|3992356|FG002|NOT COMPLETED|Overall Study||4
3258203|NCT02556801|3992357|FG003|NOT COMPLETED|Overall Study||5
3258204|NCT02556918|3992369|FG000|STARTED|Overall Study||100
3258205|NCT02556918|3992370|FG001|STARTED|Overall Study||101
3258206|NCT02556918|3992369|FG000|COMPLETED|Overall Study||91
3372653|NCT02900781|4104679|FG000|NOT COMPLETED|Overall Study||4
3372654|NCT02900781|4104680|FG001|NOT COMPLETED|Overall Study||5
3372655|NCT02892500|4104688|FG000|STARTED|Overall Study||0
3372656|NCT02892500|4104689|FG001|STARTED|Overall Study||0
3372657|NCT02892500|4104688|FG000|COMPLETED|Overall Study||0
3372658|NCT02892500|4104689|FG001|COMPLETED|Overall Study||0
3372659|NCT02892500|4104688|FG000|NOT COMPLETED|Overall Study||0
3372660|NCT02892500|4104689|FG001|NOT COMPLETED|Overall Study||0
3372661|NCT02904356|4104695|FG000|STARTED|Overall Study||2
3372662|NCT02904356|4104695|FG000|COMPLETED|Overall Study||2
3372663|NCT02904356|4104695|FG000|NOT COMPLETED|Overall Study||0
3372664|NCT02899728|4104701|FG000|STARTED|Overall Study|0|5
3372665|NCT02899728|4104702|FG001|STARTED|Overall Study||3
3372666|NCT02899728|4104701|FG000|COMPLETED|Overall Study||4
3372667|NCT02899728|4104702|FG001|COMPLETED|Overall Study||2
3372668|NCT02899728|4104701|FG000|NOT COMPLETED|Overall Study||1
3372669|NCT02899728|4104702|FG001|NOT COMPLETED|Overall Study||1
3372670|NCT02875067|4104708|FG000|STARTED|Overall Study||6
3372671|NCT02875067|4104708|FG000|COMPLETED|Overall Study||0
3372672|NCT02875067|4104708|FG000|NOT COMPLETED|Overall Study||6
3372673|NCT02877732|4104714|FG000|STARTED|Overall Study||6
3372674|NCT02877732|4104715|FG001|STARTED|Overall Study||6
3372675|NCT02877732|4104714|FG000|COMPLETED|Overall Study||0
3372676|NCT02877732|4104715|FG001|COMPLETED|Overall Study||0
3372677|NCT02877732|4104714|FG000|NOT COMPLETED|Overall Study||6
3372678|NCT02877732|4104715|FG001|NOT COMPLETED|Overall Study||6
3372679|NCT02860169|4104723|FG000|STARTED|Part A||46
3372680|NCT02860169|4104723|FG000|Healthy Participants|Part A||46
3258207|NCT02556918|3992370|FG001|COMPLETED|Overall Study||91
3258208|NCT02556918|3992369|FG000|NOT COMPLETED|Overall Study||9
3258209|NCT02556918|3992370|FG001|NOT COMPLETED|Overall Study||10
3258210|NCT02557035|3992379|FG000|STARTED|Overall Study||225
3258211|NCT02557035|3992380|FG001|STARTED|Overall Study||215
3258212|NCT02557035|3992379|FG000|COMPLETED|Overall Study||218
3258213|NCT02557035|3992380|FG001|COMPLETED|Overall Study||206
3258214|NCT02557035|3992379|FG000|NOT COMPLETED|Overall Study||7
3258215|NCT02557035|3992380|FG001|NOT COMPLETED|Overall Study||9
3258216|NCT02557100|3992389|FG000|STARTED|Single Blind Treatment Period||40
3258217|NCT02557100|3992390|FG001|STARTED|Single Blind Treatment Period||40
3258218|NCT02557100|3992391|FG002|STARTED|Single Blind Treatment Period||0
3258219|NCT02557100|3992389|FG000|COMPLETED|Single Blind Treatment Period||40
3258220|NCT02557100|3992390|FG001|COMPLETED|Single Blind Treatment Period||36
3258221|NCT02557100|3992391|FG002|COMPLETED|Single Blind Treatment Period||0
3258222|NCT02557100|3992389|FG000|NOT COMPLETED|Single Blind Treatment Period||0
3258223|NCT02557100|3992390|FG001|NOT COMPLETED|Single Blind Treatment Period||4
3258224|NCT02557100|3992391|FG002|NOT COMPLETED|Single Blind Treatment Period||0
3258225|NCT02557100|3992389|FG000|STARTED|Transition to Open Label||40
3258226|NCT02557100|3992390|FG001|STARTED|Transition to Open Label||36
3258227|NCT02557100|3992391|FG002|STARTED|Transition to Open Label||0
3258228|NCT02557100|3992389|FG000|COMPLETED|Transition to Open Label||0
3258229|NCT02557100|3992390|FG001|COMPLETED|Transition to Open Label||0
3258230|NCT02557100|3992391|FG002|COMPLETED|Transition to Open Label||0
3258231|NCT02557100|3992389|FG000|NOT COMPLETED|Transition to Open Label||40
3258232|NCT02557100|3992390|FG001|NOT COMPLETED|Transition to Open Label||36
3258233|NCT02557100|3992391|FG002|NOT COMPLETED|Transition to Open Label||0
3258234|NCT02557100|3992389|FG000|STARTED|Cumulative Abatacept Period||0
3258235|NCT02557100|3992390|FG001|STARTED|Cumulative Abatacept Period||0
3258236|NCT02557100|3992391|FG002|STARTED|Cumulative Abatacept Period||76
3258237|NCT02557100|3992389|FG000|COMPLETED|Cumulative Abatacept Period||0
3258238|NCT02557100|3992390|FG001|COMPLETED|Cumulative Abatacept Period||0
3258239|NCT02557100|3992391|FG002|COMPLETED|Cumulative Abatacept Period||72
3258240|NCT02557100|3992389|FG000|NOT COMPLETED|Cumulative Abatacept Period||0
3258241|NCT02557100|3992390|FG001|NOT COMPLETED|Cumulative Abatacept Period||0
3258242|NCT02557100|3992391|FG002|NOT COMPLETED|Cumulative Abatacept Period||4
3258243|NCT02557178|3992401|FG000|STARTED|Overall Study||72
3258244|NCT02557178|3992402|FG001|STARTED|Overall Study||74
3258245|NCT02557178|3992401|FG000|COMPLETED|Overall Study||56
3258246|NCT02557178|3992402|FG001|COMPLETED|Overall Study||63
3258247|NCT02557178|3992401|FG000|NOT COMPLETED|Overall Study||16
3258248|NCT02557178|3992402|FG001|NOT COMPLETED|Overall Study||11
3258249|NCT02557399|3992410|FG000|STARTED|Overall Study||172
3258250|NCT02557399|3992411|FG001|STARTED|Overall Study||177
3258251|NCT02557399|3992410|FG000|COMPLETED|Overall Study||165
3258252|NCT02557399|3992411|FG001|COMPLETED|Overall Study||169
3258253|NCT02557399|3992410|FG000|NOT COMPLETED|Overall Study||7
3258254|NCT02557399|3992411|FG001|NOT COMPLETED|Overall Study||8
3258255|NCT02557516|3992424|FG000|STARTED|Overall Study||3
3258256|NCT02557516|3992425|FG001|STARTED|Overall Study||6
3258257|NCT02557516|3992426|FG002|STARTED|Overall Study||4
3258258|NCT02557516|3992427|FG003|STARTED|Overall Study||9
3258259|NCT02557516|3992424|FG000|COMPLETED|Overall Study||2
3258260|NCT02557516|3992425|FG001|COMPLETED|Overall Study||1
3258261|NCT02557516|3992426|FG002|COMPLETED|Overall Study||0
3258262|NCT02557516|3992427|FG003|COMPLETED|Overall Study||0
3258263|NCT02557516|3992424|FG000|NOT COMPLETED|Overall Study||1
3258264|NCT02557516|3992425|FG001|NOT COMPLETED|Overall Study||5
3258265|NCT02557516|3992426|FG002|NOT COMPLETED|Overall Study||4
3258266|NCT02557516|3992427|FG003|NOT COMPLETED|Overall Study||9
3258267|NCT02557555|3992446|FG000|STARTED|Overall Study||100
3258268|NCT02557555|3992446|FG000|COMPLETED|Overall Study||100
3258269|NCT02557555|3992446|FG000|NOT COMPLETED|Overall Study||0
3258270|NCT02557646|3992451|FG000|STARTED|Overall Study||693
3258271|NCT02557646|3992451|FG000|COMPLETED|Overall Study||417
3258272|NCT02557646|3992451|FG000|NOT COMPLETED|Overall Study||276
3258273|NCT02557698|3992457|FG000|STARTED|Overall Study||30
3258274|NCT02557698|3992458|FG001|STARTED|Overall Study||30
3258275|NCT02557698|3992457|FG000|COMPLETED|Overall Study||30
3258276|NCT02557698|3992458|FG001|COMPLETED|Overall Study||30
3258277|NCT02557698|3992457|FG000|NOT COMPLETED|Overall Study||0
3258278|NCT02557698|3992458|FG001|NOT COMPLETED|Overall Study||0
3258279|NCT02558231|3992466|FG000|STARTED|Overall Study||123
3258280|NCT02558231|3992467|FG001|STARTED|Overall Study||124
3258281|NCT02558231|3992466|FG000|Treated|Overall Study||123
3258282|NCT02558231|3992467|FG001|Treated|Overall Study||123
3258283|NCT02558231|3992466|FG000|COMPLETED|Overall Study||98
3258284|NCT02558231|3992467|FG001|COMPLETED|Overall Study||98
3258285|NCT02558231|3992466|FG000|NOT COMPLETED|Overall Study||25
3258286|NCT02558231|3992467|FG001|NOT COMPLETED|Overall Study||26
3258287|NCT02558296|3992475|FG000|STARTED|Completed the Study Through Week 24||1133
3258288|NCT02558296|3992476|FG001|STARTED|Completed the Study Through Week 24||567
3258289|NCT02558296|3992475|FG000|COMPLETED|Completed the Study Through Week 24||1089
3258290|NCT02558296|3992476|FG001|COMPLETED|Completed the Study Through Week 24||542
3258291|NCT02558296|3992475|FG000|NOT COMPLETED|Completed the Study Through Week 24||44
3258292|NCT02558296|3992476|FG001|NOT COMPLETED|Completed the Study Through Week 24||25
3258293|NCT02558296|3992475|FG000|STARTED|Completed the Study||1133
3258294|NCT02558296|3992476|FG001|STARTED|Completed the Study||567
3258295|NCT02558296|3992475|FG000|COMPLETED|Completed the Study||987
3258296|NCT02558296|3992476|FG001|COMPLETED|Completed the Study||482
3258297|NCT02558296|3992475|FG000|NOT COMPLETED|Completed the Study||146
3258298|NCT02558296|3992476|FG001|NOT COMPLETED|Completed the Study||85
3258299|NCT02558374|3992488|FG000|STARTED|Overall Study||351
3258300|NCT02558374|3992489|FG001|STARTED|Overall Study||357
3258301|NCT02558374|3992488|FG000|COMPLETED|Overall Study||243
3258302|NCT02558374|3992489|FG001|COMPLETED|Overall Study||314
3258303|NCT02558374|3992488|FG000|NOT COMPLETED|Overall Study||108
3258304|NCT02558374|3992489|FG001|NOT COMPLETED|Overall Study||43
3258305|NCT02558400|3992498|FG000|STARTED|Overall Study||238
3258306|NCT02558400|3992499|FG001|STARTED|Overall Study||244
3258307|NCT02558400|3992500|FG002|STARTED|Overall Study||236
3258308|NCT02558400|3992498|FG000|COMPLETED|Overall Study||159
3258309|NCT02558400|3992499|FG001|COMPLETED|Overall Study||148
3258310|NCT02558400|3992500|FG002|COMPLETED|Overall Study||203
3258311|NCT02558400|3992498|FG000|NOT COMPLETED|Overall Study||79
3258312|NCT02558400|3992499|FG001|NOT COMPLETED|Overall Study||96
3258313|NCT02558400|3992500|FG002|NOT COMPLETED|Overall Study||33
3258314|NCT02558790|3992511|FG000|STARTED|Overall Study|20 subjects signed consent to participate in the study. 15 subjects began taking L-TAMS.|20
3258315|NCT02558790|3992511|FG000|Treated|Overall Study||15
3258316|NCT02558790|3992511|FG000|COMPLETED|Overall Study||13
3258317|NCT02558790|3992511|FG000|NOT COMPLETED|Overall Study||7
3258318|NCT02558829|3992519|FG000|STARTED|Overall Study||21
3258319|NCT02558829|3992520|FG001|STARTED|Overall Study||21
3258320|NCT02558829|3992521|FG002|STARTED|Overall Study||24
3258321|NCT02558829|3992522|FG003|STARTED|Overall Study||18
3258322|NCT02558829|3992523|FG004|STARTED|Overall Study||18
3258323|NCT02558829|3992524|FG005|STARTED|Overall Study||26
3258324|NCT02558829|3992525|FG006|STARTED|Overall Study||18
3258325|NCT02558829|3992526|FG007|STARTED|Overall Study||11
3258326|NCT02558829|3992519|FG000|COMPLETED|Overall Study||20
3258327|NCT02558829|3992520|FG001|COMPLETED|Overall Study||18
3258328|NCT02558829|3992521|FG002|COMPLETED|Overall Study||21
3258329|NCT02558829|3992522|FG003|COMPLETED|Overall Study||16
3258330|NCT02558829|3992523|FG004|COMPLETED|Overall Study||16
3258331|NCT02558829|3992524|FG005|COMPLETED|Overall Study||24
3258332|NCT02558829|3992525|FG006|COMPLETED|Overall Study||17
3258333|NCT02558829|3992526|FG007|COMPLETED|Overall Study||8
3258334|NCT02558829|3992519|FG000|NOT COMPLETED|Overall Study||1
3258335|NCT02558829|3992520|FG001|NOT COMPLETED|Overall Study||3
3258336|NCT02558829|3992521|FG002|NOT COMPLETED|Overall Study||3
3258337|NCT02558829|3992522|FG003|NOT COMPLETED|Overall Study||2
3258338|NCT02558829|3992523|FG004|NOT COMPLETED|Overall Study||2
3258339|NCT02558829|3992524|FG005|NOT COMPLETED|Overall Study||2
3258340|NCT02558829|3992525|FG006|NOT COMPLETED|Overall Study||1
3258341|NCT02558829|3992526|FG007|NOT COMPLETED|Overall Study||3
3258342|NCT02558894|3992550|FG000|STARTED|Overall Study||32
3258343|NCT02558894|3992551|FG001|STARTED|Overall Study||33
3258344|NCT02558894|3992550|FG000|Patients Who Received IP|Overall Study||32
3258345|NCT02558894|3992551|FG001|Patients Who Received IP|Overall Study||32
3258346|NCT02558894|3992550|FG000|COMPLETED|Overall Study||0
3258347|NCT02558894|3992551|FG001|COMPLETED|Overall Study||0
3258348|NCT02558894|3992550|FG000|NOT COMPLETED|Overall Study||32
3258349|NCT02558894|3992551|FG001|NOT COMPLETED|Overall Study||33
3258350|NCT02559115|3992557|FG000|STARTED|Overall Study||19
3258351|NCT02559115|3992557|FG000|COMPLETED|Overall Study||16
3258352|NCT02559115|3992557|FG000|NOT COMPLETED|Overall Study||3
3258353|NCT02559206|3992569|FG000|STARTED|Overall Study||66
3258354|NCT02559206|3992570|FG001|STARTED|Overall Study||66
3258355|NCT02559206|3992571|FG002|STARTED|Overall Study||67
3258356|NCT02559206|3992572|FG003|STARTED|Overall Study||67
3258357|NCT02559206|3992573|FG004|STARTED|Overall Study||67
3258358|NCT02559206|3992574|FG005|STARTED|Overall Study||67
3258359|NCT02559206|3992575|FG006|STARTED|Overall Study||66
3258360|NCT02559206|3992576|FG007|STARTED|Overall Study||66
3258361|NCT02559206|3992569|FG000|COMPLETED|Overall Study||58
3258362|NCT02559206|3992570|FG001|COMPLETED|Overall Study||54
3258363|NCT02559206|3992571|FG002|COMPLETED|Overall Study||58
3258364|NCT02559206|3992572|FG003|COMPLETED|Overall Study||53
3258365|NCT02559206|3992573|FG004|COMPLETED|Overall Study||55
3258366|NCT02559206|3992574|FG005|COMPLETED|Overall Study||53
3258367|NCT02559206|3992575|FG006|COMPLETED|Overall Study||60
3258368|NCT02559206|3992576|FG007|COMPLETED|Overall Study||57
3258369|NCT02559206|3992569|FG000|NOT COMPLETED|Overall Study||8
3258370|NCT02559206|3992570|FG001|NOT COMPLETED|Overall Study||12
3258371|NCT02559206|3992571|FG002|NOT COMPLETED|Overall Study||9
3258372|NCT02559206|3992572|FG003|NOT COMPLETED|Overall Study||14
3258373|NCT02559206|3992573|FG004|NOT COMPLETED|Overall Study||12
3258374|NCT02559206|3992574|FG005|NOT COMPLETED|Overall Study||14
3258375|NCT02559206|3992575|FG006|NOT COMPLETED|Overall Study||6
3258376|NCT02559206|3992576|FG007|NOT COMPLETED|Overall Study||9
3258377|NCT02559310|3992596|FG000|STARTED|Overall Study||276
3258378|NCT02559310|3992597|FG001|STARTED|Overall Study||275
3258379|NCT02559310|3992596|FG000|COMPLETED|Overall Study||249
3258380|NCT02559310|3992597|FG001|COMPLETED|Overall Study||256
3258381|NCT02559310|3992596|FG000|NOT COMPLETED|Overall Study||27
3258382|NCT02559310|3992597|FG001|NOT COMPLETED|Overall Study||19
3258383|NCT02559414|3992606|FG000|STARTED|Overall Study||11
3258384|NCT02559414|3992607|FG001|STARTED|Overall Study||22
3258385|NCT02559414|3992608|FG002|STARTED|Overall Study||22
3258386|NCT02559414|3992606|FG000|COMPLETED|Overall Study||10
3258387|NCT02559414|3992607|FG001|COMPLETED|Overall Study||20
3258388|NCT02559414|3992608|FG002|COMPLETED|Overall Study||20
3258389|NCT02559414|3992606|FG000|NOT COMPLETED|Overall Study||1
3258390|NCT02559414|3992607|FG001|NOT COMPLETED|Overall Study||2
3258391|NCT02559414|3992608|FG002|NOT COMPLETED|Overall Study||2
3258392|NCT02559505|3992633|FG000|STARTED|Overall Study||49
3258393|NCT02559505|3992634|FG001|STARTED|Overall Study||84
3258394|NCT02559505|3992633|FG000|COMPLETED|Overall Study||22
3258395|NCT02559505|3992634|FG001|COMPLETED|Overall Study||62
3258396|NCT02559505|3992633|FG000|NOT COMPLETED|Overall Study||27
3258397|NCT02559505|3992634|FG001|NOT COMPLETED|Overall Study||22
3258398|NCT02559570|3992657|FG000|STARTED|Overall Study||41
3258399|NCT02559570|3992658|FG001|STARTED|Overall Study||36
3258400|NCT02559570|3992659|FG002|STARTED|Overall Study||41
3258401|NCT02559570|3992660|FG003|STARTED|Overall Study||39
3258402|NCT02559570|3992661|FG004|STARTED|Overall Study||16
3258403|NCT02559570|3992657|FG000|COMPLETED|Overall Study||39
3258404|NCT02559570|3992658|FG001|COMPLETED|Overall Study||34
3258405|NCT02559570|3992659|FG002|COMPLETED|Overall Study||39
3258406|NCT02559570|3992660|FG003|COMPLETED|Overall Study||36
3258407|NCT02559570|3992661|FG004|COMPLETED|Overall Study||14
3258408|NCT02559570|3992657|FG000|NOT COMPLETED|Overall Study||2
3258409|NCT02559570|3992658|FG001|NOT COMPLETED|Overall Study||2
3258410|NCT02559570|3992659|FG002|NOT COMPLETED|Overall Study||2
3258411|NCT02559570|3992660|FG003|NOT COMPLETED|Overall Study||3
3258412|NCT02559570|3992661|FG004|NOT COMPLETED|Overall Study||2
3258413|NCT02559622|3992676|FG000|STARTED|Overall Study||48
3258414|NCT02559622|3992677|FG001|STARTED|Overall Study||54
3258415|NCT02559622|3992678|FG002|STARTED|Overall Study||26
3258416|NCT02559622|3992679|FG003|STARTED|Overall Study||23
3258417|NCT02559622|3992676|FG000|COMPLETED|Overall Study||47
3258418|NCT02559622|3992677|FG001|COMPLETED|Overall Study||49
3258419|NCT02559622|3992678|FG002|COMPLETED|Overall Study||24
3258420|NCT02559622|3992679|FG003|COMPLETED|Overall Study||20
3258421|NCT02559622|3992676|FG000|NOT COMPLETED|Overall Study||1
3258422|NCT02559622|3992677|FG001|NOT COMPLETED|Overall Study||5
3258423|NCT02559622|3992678|FG002|NOT COMPLETED|Overall Study||2
3258424|NCT02559622|3992679|FG003|NOT COMPLETED|Overall Study||3
3258425|NCT02559687|3992693|FG000|STARTED|Overall Study||121
3258426|NCT02559687|3992693|FG000|COMPLETED|Overall Study||0
3258427|NCT02559687|3992693|FG000|NOT COMPLETED|Overall Study||121
3258428|NCT02559713|3992697|FG000|STARTED|Overall Study||11
3258429|NCT02559713|3992697|FG000|Safety Set|Overall Study||11
3258430|NCT02559713|3992697|FG000|Pharmacokinetic Set|Overall Study||11
3258431|NCT02559713|3992697|FG000|COMPLETED|Overall Study||10
3258432|NCT02559713|3992697|FG000|NOT COMPLETED|Overall Study||1
3258433|NCT02559817|3992706|FG000|STARTED|Treatment Period||19
3258434|NCT02559817|3992707|FG001|STARTED|Treatment Period||29
3258435|NCT02559817|3992708|FG002|STARTED|Treatment Period||21
3258436|NCT02559817|3992709|FG003|STARTED|Treatment Period||24
3258437|NCT02559817|3992710|FG004|STARTED|Treatment Period||8
3258438|NCT02559817|3992706|FG000|COMPLETED|Treatment Period||18
3258439|NCT02559817|3992707|FG001|COMPLETED|Treatment Period||27
3258440|NCT02559817|3992708|FG002|COMPLETED|Treatment Period||19
3258441|NCT02559817|3992709|FG003|COMPLETED|Treatment Period||22
3258442|NCT02559817|3992710|FG004|COMPLETED|Treatment Period||8
3258443|NCT02559817|3992706|FG000|NOT COMPLETED|Treatment Period||1
3258444|NCT02559817|3992707|FG001|NOT COMPLETED|Treatment Period||2
3258445|NCT02559817|3992708|FG002|NOT COMPLETED|Treatment Period||2
3258446|NCT02559817|3992709|FG003|NOT COMPLETED|Treatment Period||2
3258447|NCT02559817|3992710|FG004|NOT COMPLETED|Treatment Period||0
3258448|NCT02559817|3992706|FG000|STARTED|Post-treatment Period||18
3258449|NCT02559817|3992707|FG001|STARTED|Post-treatment Period||27
3258450|NCT02559817|3992708|FG002|STARTED|Post-treatment Period|1 participant who did not complete the first period, entered and completed the Post-treatment Period|20
3258451|NCT02559817|3992709|FG003|STARTED|Post-treatment Period||22
3258452|NCT02559817|3992710|FG004|STARTED|Post-treatment Period||8
3258453|NCT02559817|3992706|FG000|COMPLETED|Post-treatment Period||18
3258454|NCT02559817|3992707|FG001|COMPLETED|Post-treatment Period||27
3258455|NCT02559817|3992708|FG002|COMPLETED|Post-treatment Period||20
3258456|NCT02559817|3992709|FG003|COMPLETED|Post-treatment Period||22
3258457|NCT02559817|3992710|FG004|COMPLETED|Post-treatment Period||8
3258458|NCT02559817|3992706|FG000|NOT COMPLETED|Post-treatment Period||0
3258459|NCT02559817|3992707|FG001|NOT COMPLETED|Post-treatment Period||0
3258460|NCT02559817|3992708|FG002|NOT COMPLETED|Post-treatment Period||0
3258461|NCT02559817|3992709|FG003|NOT COMPLETED|Post-treatment Period||0
3258462|NCT02559817|3992710|FG004|NOT COMPLETED|Post-treatment Period||0
3258463|NCT02559895|3992726|FG000|STARTED|Overall Study||224
3258464|NCT02559895|3992727|FG001|STARTED|Overall Study||225
3258465|NCT02559895|3992728|FG002|STARTED|Overall Study||224
3258466|NCT02559895|3992729|FG003|STARTED|Overall Study||225
3258467|NCT02559895|3992726|FG000|Participants Treated|Overall Study||222
3258468|NCT02559895|3992727|FG001|Participants Treated|Overall Study||221
3258469|NCT02559895|3992728|FG002|Participants Treated|Overall Study||223
3258470|NCT02559895|3992729|FG003|Participants Treated|Overall Study||222
3258471|NCT02559895|3992726|FG000|COMPLETED|Overall Study||169
3258472|NCT02559895|3992727|FG001|COMPLETED|Overall Study||172
3258473|NCT02559895|3992728|FG002|COMPLETED|Overall Study||170
3258474|NCT02559895|3992729|FG003|COMPLETED|Overall Study||165
3258475|NCT02559895|3992726|FG000|NOT COMPLETED|Overall Study||55
3258476|NCT02559895|3992727|FG001|NOT COMPLETED|Overall Study||53
3258477|NCT02559895|3992728|FG002|NOT COMPLETED|Overall Study||54
3258478|NCT02559895|3992729|FG003|NOT COMPLETED|Overall Study||60
3258479|NCT02560012|3992739|FG000|STARTED|Overall Study||3
3258480|NCT02560012|3992739|FG000|COMPLETED|Overall Study||1
3258481|NCT02560012|3992739|FG000|NOT COMPLETED|Overall Study||2
3258482|NCT02560025|3992743|FG000|STARTED|Overall Study||42
3258483|NCT02560025|3992743|FG000|COMPLETED|Overall Study||39
3258484|NCT02560025|3992743|FG000|NOT COMPLETED|Overall Study||3
3258485|NCT02560038|3992747|FG000|STARTED|Overall Study||3
3258486|NCT02560038|3992747|FG000|COMPLETED|Overall Study||1
3258487|NCT02560038|3992747|FG000|NOT COMPLETED|Overall Study||2
3258488|NCT02560051|3992754|FG000|STARTED|Overall Study||6
3258489|NCT02560051|3992755|FG001|STARTED|Overall Study||8
3258490|NCT02560051|3992756|FG002|STARTED|Overall Study||5
3258491|NCT02560051|3992754|FG000|COMPLETED|Overall Study||3
3258492|NCT02560051|3992755|FG001|COMPLETED|Overall Study||4
3258493|NCT02560051|3992756|FG002|COMPLETED|Overall Study||4
3258494|NCT02560051|3992754|FG000|NOT COMPLETED|Overall Study||3
3258495|NCT02560051|3992755|FG001|NOT COMPLETED|Overall Study||4
3258496|NCT02560051|3992756|FG002|NOT COMPLETED|Overall Study||1
3258497|NCT02560324|3992766|FG000|STARTED|Period 1 (2 Weeks)||35
3258498|NCT02560324|3992767|FG001|STARTED|Period 1 (2 Weeks)||34
3258499|NCT02560324|3992766|FG000|COMPLETED|Period 1 (2 Weeks)||23
3258500|NCT02560324|3992767|FG001|COMPLETED|Period 1 (2 Weeks)||25
3258501|NCT02560324|3992766|FG000|NOT COMPLETED|Period 1 (2 Weeks)||12
3258502|NCT02560324|3992767|FG001|NOT COMPLETED|Period 1 (2 Weeks)||9
3258503|NCT02560324|3992766|FG000|STARTED|Washout (2 Weeks)||23
3258504|NCT02560324|3992767|FG001|STARTED|Washout (2 Weeks)||25
3258505|NCT02560324|3992766|FG000|COMPLETED|Washout (2 Weeks)||23
3258506|NCT02560324|3992767|FG001|COMPLETED|Washout (2 Weeks)||23
3258507|NCT02560324|3992766|FG000|NOT COMPLETED|Washout (2 Weeks)||0
3258508|NCT02560324|3992767|FG001|NOT COMPLETED|Washout (2 Weeks)||2
3258509|NCT02560324|3992766|FG000|STARTED|Period 2 (2 Weeks)||23
3258510|NCT02560324|3992767|FG001|STARTED|Period 2 (2 Weeks)||23
3258511|NCT02560324|3992766|FG000|COMPLETED|Period 2 (2 Weeks)||22
3258512|NCT02560324|3992767|FG001|COMPLETED|Period 2 (2 Weeks)||21
3258513|NCT02560324|3992766|FG000|NOT COMPLETED|Period 2 (2 Weeks)||1
3258514|NCT02560324|3992767|FG001|NOT COMPLETED|Period 2 (2 Weeks)||2
3258515|NCT02560389|3992780|FG000|STARTED|Overall Study||34
3258516|NCT02560389|3992781|FG001|STARTED|Overall Study||28
3258517|NCT02560389|3992782|FG002|STARTED|Overall Study||29
3258518|NCT02560389|3992780|FG000|COMPLETED|Overall Study||33
3258519|NCT02560389|3992781|FG001|COMPLETED|Overall Study||25
3258520|NCT02560389|3992782|FG002|COMPLETED|Overall Study||27
3258521|NCT02560389|3992780|FG000|NOT COMPLETED|Overall Study||1
3258522|NCT02560389|3992781|FG001|NOT COMPLETED|Overall Study||3
3258523|NCT02560389|3992782|FG002|NOT COMPLETED|Overall Study||2
3258524|NCT02560493|3992792|FG000|STARTED|Overall Study||23
3258525|NCT02560493|3992793|FG001|STARTED|Overall Study||23
3258526|NCT02560493|3992792|FG000|COMPLETED|Overall Study||22
3258527|NCT02560493|3992793|FG001|COMPLETED|Overall Study||23
3258528|NCT02560493|3992792|FG000|NOT COMPLETED|Overall Study||1
3258529|NCT02560493|3992793|FG001|NOT COMPLETED|Overall Study||0
3258530|NCT02560558|3992801|FG000|STARTED|Overall Study||84
3258531|NCT02560558|3992802|FG001|STARTED|Overall Study||82
3258532|NCT02560558|3992801|FG000|COMPLETED|Overall Study||77
3258533|NCT02560558|3992802|FG001|COMPLETED|Overall Study||76
3258534|NCT02560558|3992801|FG000|NOT COMPLETED|Overall Study||7
3258535|NCT02560558|3992802|FG001|NOT COMPLETED|Overall Study||6
3258536|NCT02560584|3992808|FG000|STARTED|Overall Study||304
3258537|NCT02560584|3992808|FG000|COMPLETED|Overall Study||304
3258538|NCT02560584|3992808|FG000|NOT COMPLETED|Overall Study||0
3258539|NCT02560701|3992816|FG000|STARTED|Overall Study||8060
3258540|NCT02560701|3992817|FG001|STARTED|Overall Study||89242
3258541|NCT02560701|3992816|FG000|Carve Out|Overall Study||8060
3258542|NCT02560701|3992817|FG001|Carve Out|Overall Study||88729
3258543|NCT02560701|3992816|FG000|Restrict to Patients Between 12 and 64|Overall Study||7598
3258544|NCT02560701|3992817|FG001|Restrict to Patients Between 12 and 64|Overall Study||82367
3258545|NCT02560701|3992816|FG000|Bipolar Diagnosis Time Constraints|Overall Study||3533
3258546|NCT02560701|3992817|FG001|Bipolar Diagnosis Time Constraints|Overall Study||39427
3258547|NCT02560701|3992816|FG000|Matched Cohort|Overall Study||3517
3258548|NCT02560701|3992817|FG001|Matched Cohort|Overall Study||37776
3258549|NCT02560701|3992816|FG000|COMPLETED|Overall Study||3517
3258550|NCT02560701|3992817|FG001|COMPLETED|Overall Study||37776
3258551|NCT02560701|3992816|FG000|NOT COMPLETED|Overall Study||4543
3258552|NCT02560701|3992817|FG001|NOT COMPLETED|Overall Study||51466
3258553|NCT02560753|3992827|FG000|STARTED|Overall Study||9
3258554|NCT02560753|3992828|FG001|STARTED|Overall Study||9
3258555|NCT02560753|3992829|FG002|STARTED|Overall Study||10
3258556|NCT02560753|3992830|FG003|STARTED|Overall Study||8
3258557|NCT02560753|3992827|FG000|COMPLETED|Overall Study||8
3258558|NCT02560753|3992828|FG001|COMPLETED|Overall Study||9
3258559|NCT02560753|3992829|FG002|COMPLETED|Overall Study||9
3258560|NCT02560753|3992830|FG003|COMPLETED|Overall Study||8
3258561|NCT02560753|3992827|FG000|NOT COMPLETED|Overall Study||1
3258562|NCT02560753|3992828|FG001|NOT COMPLETED|Overall Study||0
3258563|NCT02560753|3992829|FG002|NOT COMPLETED|Overall Study||1
3258564|NCT02560753|3992830|FG003|NOT COMPLETED|Overall Study||0
3258565|NCT02560779|3992842|FG000|STARTED|Overall Study||14
3258566|NCT02560779|3992843|FG001|STARTED|Overall Study||13
3258567|NCT02560779|3992842|FG000|COMPLETED|Overall Study||14
3258568|NCT02560779|3992843|FG001|COMPLETED|Overall Study||13
3258569|NCT02560779|3992842|FG000|NOT COMPLETED|Overall Study||0
3258570|NCT02560779|3992843|FG001|NOT COMPLETED|Overall Study||0
3258571|NCT02560922|3992851|FG000|STARTED|Overall Study||124
3258572|NCT02560922|3992852|FG001|STARTED|Overall Study||124
3258573|NCT02560922|3992851|FG000|COMPLETED|Overall Study||98
3258574|NCT02560922|3992852|FG001|COMPLETED|Overall Study||112
3258575|NCT02560922|3992851|FG000|NOT COMPLETED|Overall Study||26
3258576|NCT02560922|3992852|FG001|NOT COMPLETED|Overall Study||12
3258577|NCT02561000|3992861|FG000|STARTED|Overall Study||34
3258578|NCT02561000|3992862|FG001|STARTED|Overall Study||35
3258579|NCT02561000|3992863|FG002|STARTED|Overall Study||31
3258580|NCT02561000|3992861|FG000|Safety Population|Overall Study|Includes 1 additional patient who was assigned PZ-128 0.3 mg/kg but received placebo in error (evaluated as placebo for primary safety outcome and adverse events).|35
3372681|NCT02860169|4104723|FG000|Participants With Cold and Flu|Part A||0
3372682|NCT02860169|4104723|FG000|COMPLETED|Part A||35
3372683|NCT02860169|4104723|FG000|NOT COMPLETED|Part A||11
3372684|NCT02860169|4104723|FG000|STARTED|Part B||20
3372685|NCT02860169|4104723|FG000|Healthy Participants|Part B||10
3372686|NCT02860169|4104723|FG000|Participants With Cold and Flu|Part B||10
3372687|NCT02860169|4104723|FG000|COMPLETED|Part B||9
3372688|NCT02860169|4104723|FG000|NOT COMPLETED|Part B||11
3372689|NCT02860169|4104723|FG000|STARTED|Part C||48
3372690|NCT02860169|4104723|FG000|Healthy Participants|Part C||6
3372691|NCT02860169|4104723|FG000|Participants With Cold and Flu|Part C||42
3372692|NCT02860169|4104723|FG000|COMPLETED|Part C||47
3372693|NCT02860169|4104723|FG000|NOT COMPLETED|Part C||1
3372694|NCT02865395|4104732|FG000|STARTED|Overall Study||6
3372695|NCT02865395|4104733|FG001|STARTED|Overall Study||10
3372696|NCT02865395|4104734|FG002|STARTED|Overall Study||7
3372697|NCT02865395|4104732|FG000|COMPLETED|Overall Study|Data Not Collected|0
3372698|NCT02865395|4104733|FG001|COMPLETED|Overall Study|Data Not Collected|0
3372699|NCT02865395|4104734|FG002|COMPLETED|Overall Study|Data Not Collected|0
3372700|NCT02865395|4104732|FG000|NOT COMPLETED|Overall Study||6
3372701|NCT02865395|4104733|FG001|NOT COMPLETED|Overall Study||10
3372702|NCT02865395|4104734|FG002|NOT COMPLETED|Overall Study||7
3372703|NCT02868892|4104742|FG000|STARTED|Overall Study||6
3372704|NCT02868892|4104742|FG000|COMPLETED|Overall Study||0
3372705|NCT02868892|4104742|FG000|NOT COMPLETED|Overall Study||6
3372706|NCT02865083|4104748|FG000|STARTED|Overall Study||3
3372707|NCT02865083|4104749|FG001|STARTED|Overall Study||1
3372708|NCT02865083|4104748|FG000|COMPLETED|Overall Study||0
3372709|NCT02865083|4104749|FG001|COMPLETED|Overall Study||0
3372710|NCT02865083|4104748|FG000|NOT COMPLETED|Overall Study||3
3372711|NCT02865083|4104749|FG001|NOT COMPLETED|Overall Study||1
3258581|NCT02561000|3992862|FG001|Safety Population|Overall Study|Excludes 4 patients who did not receive the study drug as allocated: 1 patient received placebo in error and was evaluated as placebo for primary safety outcome and adverse events; 2 patients withdrew full consent immediately after randomization prior to receiving any study drug; and 1 patient had an adverse event shortly after randomization prior to receiving any study drug.|31
3258582|NCT02561000|3992863|FG002|Safety Population|Overall Study||31
3258583|NCT02561000|3992861|FG000|Intent-to-Treat (ITT) Population at 30 Days|Overall Study||34
3258584|NCT02561000|3992862|FG001|Intent-to-Treat (ITT) Population at 30 Days|Overall Study|Excludes 2 patients who withdrew full consent immediately after randomization.|33
3258585|NCT02561000|3992863|FG002|Intent-to-Treat (ITT) Population at 30 Days|Overall Study||31
3258586|NCT02561000|3992861|FG000|Intent-to-Treat (ITT) Population at 90 Days|Overall Study|Excludes 1 patient who withdrew consent for follow-up 21 days after study drug dosing.|33
3258587|NCT02561000|3992862|FG001|Intent-to-Treat (ITT) Population at 90 Days|Overall Study|Excludes 4 patients: 2 patients withdrew full consent immediately after randomization; 1 patient followed only for 30 day ITT outcome (did not receive any study drug due to adverse event post randomization); and 1 patient withdrew consent for follow-up 7 days after study drug dosing.|31
3258588|NCT02561000|3992863|FG002|Intent-to-Treat (ITT) Population at 90 Days|Overall Study||31
3258589|NCT02561000|3992861|FG000|COMPLETED|Overall Study||32
3258590|NCT02561000|3992862|FG001|COMPLETED|Overall Study||31
3258591|NCT02561000|3992863|FG002|COMPLETED|Overall Study||31
3258592|NCT02561000|3992861|FG000|NOT COMPLETED|Overall Study||2
3258593|NCT02561000|3992862|FG001|NOT COMPLETED|Overall Study||4
3258594|NCT02561000|3992863|FG002|NOT COMPLETED|Overall Study||0
3258595|NCT02561078|3992873|FG000|STARTED|Overall Study||209
3258596|NCT02561078|3992874|FG001|STARTED|Overall Study||211
3258597|NCT02561078|3992873|FG000|Received at Least 1 Dose of Study Drug|Overall Study||208
3258598|NCT02561078|3992874|FG001|Received at Least 1 Dose of Study Drug|Overall Study||210
3258599|NCT02561078|3992873|FG000|COMPLETED|Overall Study||179
3258600|NCT02561078|3992874|FG001|COMPLETED|Overall Study||186
3258601|NCT02561078|3992873|FG000|NOT COMPLETED|Overall Study||30
3258602|NCT02561078|3992874|FG001|NOT COMPLETED|Overall Study||25
3258603|NCT02561130|3992882|FG000|STARTED|Overall Study||77
3258604|NCT02561130|3992883|FG001|STARTED|Overall Study||77
3258605|NCT02561130|3992882|FG000|COMPLETED|Overall Study||76
3258606|NCT02561130|3992883|FG001|COMPLETED|Overall Study||76
3258607|NCT02561130|3992882|FG000|NOT COMPLETED|Overall Study||1
3258608|NCT02561130|3992883|FG001|NOT COMPLETED|Overall Study||1
3258609|NCT02561156|3992902|FG000|STARTED|Part 1||12
3258610|NCT02561156|3992903|FG001|STARTED|Part 1||6
3258611|NCT02561156|3992904|FG002|STARTED|Part 1||6
3258612|NCT02561156|3992905|FG003|STARTED|Part 1||6
3258613|NCT02561156|3992906|FG004|STARTED|Part 1||6
3258614|NCT02561156|3992907|FG005|STARTED|Part 1||6
3258615|NCT02561156|3992908|FG006|STARTED|Part 1||6
3258616|NCT02561156|3992909|FG007|STARTED|Part 1||0
3258617|NCT02561156|3992910|FG008|STARTED|Part 1||0
3258618|NCT02561156|3992911|FG009|STARTED|Part 1||0
3258619|NCT02561156|3992912|FG010|STARTED|Part 1||0
3258620|NCT02561156|3992913|FG011|STARTED|Part 1||0
3258621|NCT02561156|3992914|FG012|STARTED|Part 1||0
3258622|NCT02561156|3992902|FG000|COMPLETED|Part 1||12
3258623|NCT02561156|3992903|FG001|COMPLETED|Part 1||6
3258624|NCT02561156|3992904|FG002|COMPLETED|Part 1||6
3258625|NCT02561156|3992905|FG003|COMPLETED|Part 1||6
3258626|NCT02561156|3992906|FG004|COMPLETED|Part 1||6
3258627|NCT02561156|3992907|FG005|COMPLETED|Part 1||6
3258628|NCT02561156|3992908|FG006|COMPLETED|Part 1||6
3258629|NCT02561156|3992909|FG007|COMPLETED|Part 1||0
3258630|NCT02561156|3992910|FG008|COMPLETED|Part 1||0
3258631|NCT02561156|3992911|FG009|COMPLETED|Part 1||0
3258632|NCT02561156|3992912|FG010|COMPLETED|Part 1||0
3258633|NCT02561156|3992913|FG011|COMPLETED|Part 1||0
3258634|NCT02561156|3992914|FG012|COMPLETED|Part 1||0
3258635|NCT02561156|3992902|FG000|NOT COMPLETED|Part 1||0
3258636|NCT02561156|3992903|FG001|NOT COMPLETED|Part 1||0
3258637|NCT02561156|3992904|FG002|NOT COMPLETED|Part 1||0
3258638|NCT02561156|3992905|FG003|NOT COMPLETED|Part 1||0
3258639|NCT02561156|3992906|FG004|NOT COMPLETED|Part 1||0
3258640|NCT02561156|3992907|FG005|NOT COMPLETED|Part 1||0
3258641|NCT02561156|3992908|FG006|NOT COMPLETED|Part 1||0
3258642|NCT02561156|3992909|FG007|NOT COMPLETED|Part 1||0
3258643|NCT02561156|3992910|FG008|NOT COMPLETED|Part 1||0
3258644|NCT02561156|3992911|FG009|NOT COMPLETED|Part 1||0
3258645|NCT02561156|3992912|FG010|NOT COMPLETED|Part 1||0
3258646|NCT02561156|3992913|FG011|NOT COMPLETED|Part 1||0
3258647|NCT02561156|3992914|FG012|NOT COMPLETED|Part 1||0
3258648|NCT02561156|3992902|FG000|STARTED|Part 2||0
3258649|NCT02561156|3992903|FG001|STARTED|Part 2||0
3258650|NCT02561156|3992904|FG002|STARTED|Part 2||0
3258651|NCT02561156|3992905|FG003|STARTED|Part 2||0
3258652|NCT02561156|3992906|FG004|STARTED|Part 2||0
3258653|NCT02561156|3992907|FG005|STARTED|Part 2||0
3258654|NCT02561156|3992908|FG006|STARTED|Part 2||0
3258655|NCT02561156|3992909|FG007|STARTED|Part 2||10
3258656|NCT02561156|3992910|FG008|STARTED|Part 2||6
3258657|NCT02561156|3992911|FG009|STARTED|Part 2||6
3258658|NCT02561156|3992912|FG010|STARTED|Part 2||6
3258659|NCT02561156|3992913|FG011|STARTED|Part 2||6
3258660|NCT02561156|3992914|FG012|STARTED|Part 2||6
3258661|NCT02561156|3992902|FG000|COMPLETED|Part 2||0
3258662|NCT02561156|3992903|FG001|COMPLETED|Part 2||0
3258663|NCT02561156|3992904|FG002|COMPLETED|Part 2||0
3258664|NCT02561156|3992905|FG003|COMPLETED|Part 2||0
3258665|NCT02561156|3992906|FG004|COMPLETED|Part 2||0
3258666|NCT02561156|3992907|FG005|COMPLETED|Part 2||0
3258667|NCT02561156|3992908|FG006|COMPLETED|Part 2||0
3258668|NCT02561156|3992909|FG007|COMPLETED|Part 2||10
3258669|NCT02561156|3992910|FG008|COMPLETED|Part 2||6
3258670|NCT02561156|3992911|FG009|COMPLETED|Part 2||6
3258671|NCT02561156|3992912|FG010|COMPLETED|Part 2||6
3258672|NCT02561156|3992913|FG011|COMPLETED|Part 2||5
3258673|NCT02561156|3992914|FG012|COMPLETED|Part 2||6
3258674|NCT02561156|3992902|FG000|NOT COMPLETED|Part 2||0
3258675|NCT02561156|3992903|FG001|NOT COMPLETED|Part 2||0
3258676|NCT02561156|3992904|FG002|NOT COMPLETED|Part 2||0
3258677|NCT02561156|3992905|FG003|NOT COMPLETED|Part 2||0
3258678|NCT02561156|3992906|FG004|NOT COMPLETED|Part 2||0
3258679|NCT02561156|3992907|FG005|NOT COMPLETED|Part 2||0
3258680|NCT02561156|3992908|FG006|NOT COMPLETED|Part 2||0
3258681|NCT02561156|3992909|FG007|NOT COMPLETED|Part 2||0
3258682|NCT02561156|3992910|FG008|NOT COMPLETED|Part 2||0
3258683|NCT02561156|3992911|FG009|NOT COMPLETED|Part 2||0
3258684|NCT02561156|3992912|FG010|NOT COMPLETED|Part 2||0
3258685|NCT02561156|3992913|FG011|NOT COMPLETED|Part 2||1
3258686|NCT02561156|3992914|FG012|NOT COMPLETED|Part 2||0
3258687|NCT02561195|3992964|FG000|STARTED|Vaccination 1 to 3||183
3258688|NCT02561195|3992965|FG001|STARTED|Vaccination 1 to 3||184
3258689|NCT02561195|3992966|FG002|STARTED|Vaccination 1 to 3||61
3258690|NCT02561195|3992967|FG003|STARTED|Vaccination 1 to 3||183
3258691|NCT02561195|3992968|FG004|STARTED|Vaccination 1 to 3||183
3258692|NCT02561195|3992969|FG005|STARTED|Vaccination 1 to 3||61
3258693|NCT02561195|3992970|FG006|STARTED|Vaccination 1 to 3||0
3258694|NCT02561195|3992971|FG007|STARTED|Vaccination 1 to 3||0
3258695|NCT02561195|3992972|FG008|STARTED|Vaccination 1 to 3||0
3258696|NCT02561195|3992973|FG009|STARTED|Vaccination 1 to 3||0
3258697|NCT02561195|3992974|FG010|STARTED|Vaccination 1 to 3||0
3258698|NCT02561195|3992975|FG011|STARTED|Vaccination 1 to 3||0
3258699|NCT02561195|3992976|FG012|STARTED|Vaccination 1 to 3||0
3258700|NCT02561195|3992977|FG013|STARTED|Vaccination 1 to 3||0
3258701|NCT02561195|3992964|FG000|Treated|Vaccination 1 to 3||182
3258702|NCT02561195|3992965|FG001|Treated|Vaccination 1 to 3||184
3258703|NCT02561195|3992966|FG002|Treated|Vaccination 1 to 3||61
3258704|NCT02561195|3992967|FG003|Treated|Vaccination 1 to 3||183
3258705|NCT02561195|3992968|FG004|Treated|Vaccination 1 to 3||183
3258706|NCT02561195|3992969|FG005|Treated|Vaccination 1 to 3||61
3258707|NCT02561195|3992970|FG006|Treated|Vaccination 1 to 3||0
3258708|NCT02561195|3992971|FG007|Treated|Vaccination 1 to 3||0
3258709|NCT02561195|3992972|FG008|Treated|Vaccination 1 to 3||0
3258710|NCT02561195|3992973|FG009|Treated|Vaccination 1 to 3||0
3258711|NCT02561195|3992974|FG010|Treated|Vaccination 1 to 3||0
3258712|NCT02561195|3992975|FG011|Treated|Vaccination 1 to 3||0
3258713|NCT02561195|3992976|FG012|Treated|Vaccination 1 to 3||0
3258714|NCT02561195|3992977|FG013|Treated|Vaccination 1 to 3||0
3258715|NCT02561195|3992964|FG000|COMPLETED|Vaccination 1 to 3||160
3258716|NCT02561195|3992965|FG001|COMPLETED|Vaccination 1 to 3||162
3258717|NCT02561195|3992966|FG002|COMPLETED|Vaccination 1 to 3||55
3258718|NCT02561195|3992967|FG003|COMPLETED|Vaccination 1 to 3||157
3258719|NCT02561195|3992968|FG004|COMPLETED|Vaccination 1 to 3||155
3258720|NCT02561195|3992969|FG005|COMPLETED|Vaccination 1 to 3||51
3258721|NCT02561195|3992970|FG006|COMPLETED|Vaccination 1 to 3||0
3258722|NCT02561195|3992971|FG007|COMPLETED|Vaccination 1 to 3||0
3258723|NCT02561195|3992972|FG008|COMPLETED|Vaccination 1 to 3||0
3258724|NCT02561195|3992973|FG009|COMPLETED|Vaccination 1 to 3||0
3258725|NCT02561195|3992974|FG010|COMPLETED|Vaccination 1 to 3||0
3258726|NCT02561195|3992975|FG011|COMPLETED|Vaccination 1 to 3||0
3258727|NCT02561195|3992976|FG012|COMPLETED|Vaccination 1 to 3||0
3258728|NCT02561195|3992977|FG013|COMPLETED|Vaccination 1 to 3||0
3258729|NCT02561195|3992964|FG000|NOT COMPLETED|Vaccination 1 to 3||23
3258730|NCT02561195|3992965|FG001|NOT COMPLETED|Vaccination 1 to 3||22
3258731|NCT02561195|3992966|FG002|NOT COMPLETED|Vaccination 1 to 3||6
3258732|NCT02561195|3992967|FG003|NOT COMPLETED|Vaccination 1 to 3||26
3258733|NCT02561195|3992968|FG004|NOT COMPLETED|Vaccination 1 to 3||28
3258734|NCT02561195|3992969|FG005|NOT COMPLETED|Vaccination 1 to 3||10
3258735|NCT02561195|3992970|FG006|NOT COMPLETED|Vaccination 1 to 3||0
3258736|NCT02561195|3992971|FG007|NOT COMPLETED|Vaccination 1 to 3||0
3258737|NCT02561195|3992972|FG008|NOT COMPLETED|Vaccination 1 to 3||0
3258738|NCT02561195|3992973|FG009|NOT COMPLETED|Vaccination 1 to 3||0
3258739|NCT02561195|3992974|FG010|NOT COMPLETED|Vaccination 1 to 3||0
3258740|NCT02561195|3992975|FG011|NOT COMPLETED|Vaccination 1 to 3||0
3258741|NCT02561195|3992976|FG012|NOT COMPLETED|Vaccination 1 to 3||0
3258742|NCT02561195|3992977|FG013|NOT COMPLETED|Vaccination 1 to 3||0
3258743|NCT02561195|3992964|FG000|STARTED|Extension Stage (Vaccination 4)||0
3258744|NCT02561195|3992965|FG001|STARTED|Extension Stage (Vaccination 4)||0
3258745|NCT02561195|3992966|FG002|STARTED|Extension Stage (Vaccination 4)||0
3258746|NCT02561195|3992967|FG003|STARTED|Extension Stage (Vaccination 4)||0
3258747|NCT02561195|3992968|FG004|STARTED|Extension Stage (Vaccination 4)||0
3258748|NCT02561195|3992969|FG005|STARTED|Extension Stage (Vaccination 4)||0
3258749|NCT02561195|3992970|FG006|STARTED|Extension Stage (Vaccination 4)|Participants who met predefined eligibility criteria enrolled into extension stage.|16
3258750|NCT02561195|3992971|FG007|STARTED|Extension Stage (Vaccination 4)|Participants who met predefined eligibility criteria enrolled into extension stage.|18
3258751|NCT02561195|3992972|FG008|STARTED|Extension Stage (Vaccination 4)|Participants who met predefined eligibility criteria enrolled into extension stage.|24
3258752|NCT02561195|3992973|FG009|STARTED|Extension Stage (Vaccination 4)|Participants who met predefined eligibility criteria enrolled into extension stage.|22
3258753|NCT02561195|3992974|FG010|STARTED|Extension Stage (Vaccination 4)|Participants who met predefined eligibility criteria enrolled into extension stage.|51
3258754|NCT02561195|3992975|FG011|STARTED|Extension Stage (Vaccination 4)|Participants who met predefined eligibility criteria enrolled into extension stage.|52
3258755|NCT02561195|3992976|FG012|STARTED|Extension Stage (Vaccination 4)|Participants who met predefined eligibility criteria enrolled into extension stage.|58
3258756|NCT02561195|3992977|FG013|STARTED|Extension Stage (Vaccination 4)|Participants who met predefined eligibility criteria enrolled into extension stage.|59
3258757|NCT02561195|3992964|FG000|COMPLETED|Extension Stage (Vaccination 4)||0
3258758|NCT02561195|3992965|FG001|COMPLETED|Extension Stage (Vaccination 4)||0
3258759|NCT02561195|3992966|FG002|COMPLETED|Extension Stage (Vaccination 4)||0
3258760|NCT02561195|3992967|FG003|COMPLETED|Extension Stage (Vaccination 4)||0
3258761|NCT02561195|3992968|FG004|COMPLETED|Extension Stage (Vaccination 4)||0
3258762|NCT02561195|3992969|FG005|COMPLETED|Extension Stage (Vaccination 4)||0
3258763|NCT02561195|3992970|FG006|COMPLETED|Extension Stage (Vaccination 4)||14
3258764|NCT02561195|3992971|FG007|COMPLETED|Extension Stage (Vaccination 4)||17
3258765|NCT02561195|3992972|FG008|COMPLETED|Extension Stage (Vaccination 4)||21
3258766|NCT02561195|3992973|FG009|COMPLETED|Extension Stage (Vaccination 4)||20
3258767|NCT02561195|3992974|FG010|COMPLETED|Extension Stage (Vaccination 4)||43
3258768|NCT02561195|3992975|FG011|COMPLETED|Extension Stage (Vaccination 4)||45
3258769|NCT02561195|3992976|FG012|COMPLETED|Extension Stage (Vaccination 4)||51
3258770|NCT02561195|3992977|FG013|COMPLETED|Extension Stage (Vaccination 4)||54
3258771|NCT02561195|3992964|FG000|NOT COMPLETED|Extension Stage (Vaccination 4)||0
3258772|NCT02561195|3992965|FG001|NOT COMPLETED|Extension Stage (Vaccination 4)||0
3258773|NCT02561195|3992966|FG002|NOT COMPLETED|Extension Stage (Vaccination 4)||0
3258774|NCT02561195|3992967|FG003|NOT COMPLETED|Extension Stage (Vaccination 4)||0
3258775|NCT02561195|3992968|FG004|NOT COMPLETED|Extension Stage (Vaccination 4)||0
3258776|NCT02561195|3992969|FG005|NOT COMPLETED|Extension Stage (Vaccination 4)||0
3258777|NCT02561195|3992970|FG006|NOT COMPLETED|Extension Stage (Vaccination 4)||2
3258778|NCT02561195|3992971|FG007|NOT COMPLETED|Extension Stage (Vaccination 4)||1
3258779|NCT02561195|3992972|FG008|NOT COMPLETED|Extension Stage (Vaccination 4)||3
3258780|NCT02561195|3992973|FG009|NOT COMPLETED|Extension Stage (Vaccination 4)||2
3258781|NCT02561195|3992974|FG010|NOT COMPLETED|Extension Stage (Vaccination 4)||8
3258782|NCT02561195|3992975|FG011|NOT COMPLETED|Extension Stage (Vaccination 4)||7
3258783|NCT02561195|3992976|FG012|NOT COMPLETED|Extension Stage (Vaccination 4)||7
3258784|NCT02561195|3992977|FG013|NOT COMPLETED|Extension Stage (Vaccination 4)||5
3258785|NCT02561221|3993011|FG000|STARTED|Overall Study||452
3258786|NCT02561221|3993012|FG001|STARTED|Overall Study||351
3258787|NCT02561221|3993011|FG000|Month 6|Overall Study||386
3258788|NCT02561221|3993012|FG001|Month 6|Overall Study||340
3258789|NCT02561221|3993011|FG000|Month 12|Overall Study||365
3258790|NCT02561221|3993012|FG001|Month 12|Overall Study||326
3258791|NCT02561221|3993011|FG000|Month 18|Overall Study||357
3258792|NCT02561221|3993012|FG001|Month 18|Overall Study||316
3258793|NCT02561221|3993011|FG000|COMPLETED|Overall Study||362
3258794|NCT02561221|3993012|FG001|COMPLETED|Overall Study||308
3258795|NCT02561221|3993011|FG000|NOT COMPLETED|Overall Study||90
3258796|NCT02561221|3993012|FG001|NOT COMPLETED|Overall Study||43
3258797|NCT02561247|3993018|FG000|STARTED|Overall Study||23
3258798|NCT02561247|3993018|FG000|COMPLETED|Overall Study||17
3258799|NCT02561247|3993018|FG000|NOT COMPLETED|Overall Study||6
3258800|NCT02561273|3993024|FG000|STARTED|Overall Study||40
3258801|NCT02561273|3993025|FG001|STARTED|Overall Study||4
3258802|NCT02561273|3993024|FG000|COMPLETED|Overall Study||39
3258803|NCT02561273|3993025|FG001|COMPLETED|Overall Study||4
3258804|NCT02561273|3993024|FG000|NOT COMPLETED|Overall Study||1
3258805|NCT02561273|3993025|FG001|NOT COMPLETED|Overall Study||0
3258806|NCT02561338|3993038|FG000|STARTED|Overall Study||53
3258807|NCT02561338|3993039|FG001|STARTED|Overall Study||50
3258808|NCT02561338|3993040|FG002|STARTED|Overall Study||51
3258809|NCT02561338|3993041|FG003|STARTED|Overall Study||51
3258810|NCT02561338|3993042|FG004|STARTED|Overall Study||53
3258811|NCT02561338|3993038|FG000|COMPLETED|Overall Study||45
3258812|NCT02561338|3993039|FG001|COMPLETED|Overall Study||44
3258813|NCT02561338|3993040|FG002|COMPLETED|Overall Study||42
3258814|NCT02561338|3993041|FG003|COMPLETED|Overall Study||46
3258815|NCT02561338|3993042|FG004|COMPLETED|Overall Study||51
3258816|NCT02561338|3993038|FG000|NOT COMPLETED|Overall Study||8
3258817|NCT02561338|3993039|FG001|NOT COMPLETED|Overall Study||6
3258818|NCT02561338|3993040|FG002|NOT COMPLETED|Overall Study||9
3258819|NCT02561338|3993041|FG003|NOT COMPLETED|Overall Study||5
3258820|NCT02561338|3993042|FG004|NOT COMPLETED|Overall Study||2
3258821|NCT02561455|3993060|FG000|STARTED|Overall Study||2
3258822|NCT02561455|3993061|FG001|STARTED|Overall Study||3
3258823|NCT02561455|3993062|FG002|STARTED|Overall Study||3
3258824|NCT02561455|3993063|FG003|STARTED|Overall Study||1
3258825|NCT02561455|3993060|FG000|COMPLETED|Overall Study||0
3258826|NCT02561455|3993061|FG001|COMPLETED|Overall Study||1
3258827|NCT02561455|3993062|FG002|COMPLETED|Overall Study||0
3258828|NCT02561455|3993063|FG003|COMPLETED|Overall Study||0
3258829|NCT02561455|3993060|FG000|NOT COMPLETED|Overall Study||2
3258830|NCT02561455|3993061|FG001|NOT COMPLETED|Overall Study||2
3258831|NCT02561455|3993062|FG002|NOT COMPLETED|Overall Study||3
3258832|NCT02561455|3993063|FG003|NOT COMPLETED|Overall Study||1
3258833|NCT02561481|3993075|FG000|STARTED|Pilot Trial||10
3258834|NCT02561481|3993076|FG001|STARTED|Pilot Trial||0
3258835|NCT02561481|3993075|FG000|COMPLETED|Pilot Trial||10
3258836|NCT02561481|3993076|FG001|COMPLETED|Pilot Trial||0
3258837|NCT02561481|3993075|FG000|NOT COMPLETED|Pilot Trial||0
3258838|NCT02561481|3993076|FG001|NOT COMPLETED|Pilot Trial||0
3258839|NCT02561481|3993075|FG000|STARTED|Main Trial - Double Blind Phase||25
3258840|NCT02561481|3993076|FG001|STARTED|Main Trial - Double Blind Phase||25
3258841|NCT02561481|3993075|FG000|COMPLETED|Main Trial - Double Blind Phase||22
3258842|NCT02561481|3993076|FG001|COMPLETED|Main Trial - Double Blind Phase||23
3258843|NCT02561481|3993075|FG000|NOT COMPLETED|Main Trial - Double Blind Phase||3
3258844|NCT02561481|3993076|FG001|NOT COMPLETED|Main Trial - Double Blind Phase||2
3258845|NCT02561481|3993075|FG000|STARTED|Main Trial - Open Label Phase||45
3258846|NCT02561481|3993076|FG001|STARTED|Main Trial - Open Label Phase||0
3258847|NCT02561481|3993075|FG000|COMPLETED|Main Trial - Open Label Phase||32
3258848|NCT02561481|3993076|FG001|COMPLETED|Main Trial - Open Label Phase||0
3258849|NCT02561481|3993075|FG000|NOT COMPLETED|Main Trial - Open Label Phase||13
3258850|NCT02561481|3993076|FG001|NOT COMPLETED|Main Trial - Open Label Phase||0
3258851|NCT02561572|3993087|FG000|STARTED|Overall Study||64
3258852|NCT02561572|3993088|FG001|STARTED|Overall Study||64
3258853|NCT02561572|3993087|FG000|COMPLETED|Overall Study||62
3258854|NCT02561572|3993088|FG001|COMPLETED|Overall Study||62
3258855|NCT02561572|3993087|FG000|NOT COMPLETED|Overall Study||2
3258856|NCT02561572|3993088|FG001|NOT COMPLETED|Overall Study||2
3258857|NCT02561585|3993096|FG000|STARTED|Overall Study||20
3258858|NCT02561585|3993097|FG001|STARTED|Overall Study||11
3258859|NCT02561585|3993096|FG000|COMPLETED|Overall Study||17
3258860|NCT02561585|3993097|FG001|COMPLETED|Overall Study||6
3258861|NCT02561585|3993096|FG000|NOT COMPLETED|Overall Study||3
3258862|NCT02561585|3993097|FG001|NOT COMPLETED|Overall Study||5
3258863|NCT02561702|3993107|FG000|STARTED|First Intervention||2
3258864|NCT02561702|3993108|FG001|STARTED|First Intervention||2
3258865|NCT02561702|3993107|FG000|COMPLETED|First Intervention||2
3258866|NCT02561702|3993108|FG001|COMPLETED|First Intervention||2
3258867|NCT02561702|3993107|FG000|NOT COMPLETED|First Intervention||0
3258868|NCT02561702|3993108|FG001|NOT COMPLETED|First Intervention||0
3258869|NCT02561702|3993107|FG000|STARTED|Washout||2
3258870|NCT02561702|3993108|FG001|STARTED|Washout||2
3258871|NCT02561702|3993107|FG000|COMPLETED|Washout||2
3258872|NCT02561702|3993108|FG001|COMPLETED|Washout||2
3258873|NCT02561702|3993107|FG000|NOT COMPLETED|Washout||0
3258874|NCT02561702|3993108|FG001|NOT COMPLETED|Washout||0
3258875|NCT02561702|3993107|FG000|STARTED|Second Intervention||2
3258876|NCT02561702|3993108|FG001|STARTED|Second Intervention||2
3258877|NCT02561702|3993107|FG000|COMPLETED|Second Intervention||2
3258878|NCT02561702|3993108|FG001|COMPLETED|Second Intervention||2
3258879|NCT02561702|3993107|FG000|NOT COMPLETED|Second Intervention||0
3258880|NCT02561702|3993108|FG001|NOT COMPLETED|Second Intervention||0
3258881|NCT02561806|3993116|FG000|STARTED|Induction Period||166
3258882|NCT02561806|3993117|FG001|STARTED|Induction Period||136
3258883|NCT02561806|3993116|FG000|Received At Least One Dose of Study Drug|Induction Period||166
3258884|NCT02561806|3993117|FG001|Received At Least One Dose of Study Drug|Induction Period||135
3258885|NCT02561806|3993116|FG000|COMPLETED|Induction Period||164
3258886|NCT02561806|3993117|FG001|COMPLETED|Induction Period||131
3258887|NCT02561806|3993116|FG000|NOT COMPLETED|Induction Period||2
3258888|NCT02561806|3993117|FG001|NOT COMPLETED|Induction Period||5
3258889|NCT02561806|3993116|FG000|STARTED|Maintenance Period||164
3258890|NCT02561806|3993117|FG001|STARTED|Maintenance Period||131
3258891|NCT02561806|3993116|FG000|COMPLETED|Maintenance Period||151
3258892|NCT02561806|3993117|FG001|COMPLETED|Maintenance Period||123
3258893|NCT02561806|3993116|FG000|NOT COMPLETED|Maintenance Period||13
3258894|NCT02561806|3993117|FG001|NOT COMPLETED|Maintenance Period||8
3258895|NCT02561806|3993116|FG000|STARTED|Post-Treatment Follow-up|Participants who discontinued previous periods had option to enter post treatment follow-up period.|157
3258896|NCT02561806|3993117|FG001|STARTED|Post-Treatment Follow-up|Participants who discontinued previous periods had option to enter post treatment follow-up period.|60
3258897|NCT02561806|3993116|FG000|COMPLETED|Post-Treatment Follow-up||155
3258898|NCT02561806|3993117|FG001|COMPLETED|Post-Treatment Follow-up||59
3258899|NCT02561806|3993116|FG000|NOT COMPLETED|Post-Treatment Follow-up||2
3258900|NCT02561806|3993117|FG001|NOT COMPLETED|Post-Treatment Follow-up||1
3258901|NCT02561832|3993140|FG000|STARTED|Overall Study||8
3258902|NCT02561832|3993141|FG001|STARTED|Overall Study||7
3258903|NCT02561832|3993140|FG000|INFORMED CONSENT OBTAINED|Overall Study||8
3258904|NCT02561832|3993141|FG001|INFORMED CONSENT OBTAINED|Overall Study||7
3258905|NCT02561832|3993140|FG000|COMPLETED|Overall Study||1
3258906|NCT02561832|3993141|FG001|COMPLETED|Overall Study||3
3258907|NCT02561832|3993140|FG000|NOT COMPLETED|Overall Study||7
3258908|NCT02561832|3993141|FG001|NOT COMPLETED|Overall Study||4
3258909|NCT02561897|3993149|FG000|STARTED|Overall Study||2
3258910|NCT02561897|3993150|FG001|STARTED|Overall Study||3
3258911|NCT02561897|3993149|FG000|COMPLETED|Overall Study||2
3258912|NCT02561897|3993150|FG001|COMPLETED|Overall Study||3
3258913|NCT02561897|3993149|FG000|NOT COMPLETED|Overall Study||0
3258914|NCT02561897|3993150|FG001|NOT COMPLETED|Overall Study||0
3258915|NCT02562066|3993160|FG000|STARTED|Overall Study||8
3258916|NCT02562066|3993161|FG001|STARTED|Overall Study||8
3258917|NCT02562066|3993162|FG002|STARTED|Overall Study||4
3258918|NCT02562066|3993160|FG000|COMPLETED|Overall Study||7
3258919|NCT02562066|3993161|FG001|COMPLETED|Overall Study||7
3258920|NCT02562066|3993162|FG002|COMPLETED|Overall Study||0
3258921|NCT02562066|3993160|FG000|NOT COMPLETED|Overall Study||1
3258922|NCT02562066|3993161|FG001|NOT COMPLETED|Overall Study||1
3258923|NCT02562066|3993162|FG002|NOT COMPLETED|Overall Study||4
3258924|NCT02562482|3993170|FG000|STARTED|Overall Study||201
3258925|NCT02562482|3993171|FG001|STARTED|Overall Study||199
3258926|NCT02562482|3993170|FG000|Received 1st Injection|Overall Study||197
3258927|NCT02562482|3993171|FG001|Received 1st Injection|Overall Study||199
3258928|NCT02562482|3993170|FG000|Received 2nd Injection|Overall Study||192
3258929|NCT02562482|3993171|FG001|Received 2nd Injection|Overall Study||192
3258930|NCT02562482|3993170|FG000|COMPLETED|Overall Study||180
3258931|NCT02562482|3993171|FG001|COMPLETED|Overall Study||183
3258932|NCT02562482|3993170|FG000|NOT COMPLETED|Overall Study||21
3258933|NCT02562482|3993171|FG001|NOT COMPLETED|Overall Study||16
3258934|NCT02562521|3993179|FG000|STARTED|Overall Study||18
3258935|NCT02562521|3993180|FG001|STARTED|Overall Study||7
3258936|NCT02562521|3993179|FG000|COMPLETED|Overall Study||18
3258937|NCT02562521|3993180|FG001|COMPLETED|Overall Study||7
3258938|NCT02562521|3993179|FG000|NOT COMPLETED|Overall Study||0
3258939|NCT02562521|3993180|FG001|NOT COMPLETED|Overall Study||0
3258940|NCT02562755|3993188|FG000|STARTED|Overall Study||234
3258941|NCT02562755|3993189|FG001|STARTED|Overall Study||225
3258942|NCT02562755|3993188|FG000|Safety Population|Overall Study||218
3258943|NCT02562755|3993189|FG001|Safety Population|Overall Study||217
3258944|NCT02562755|3993188|FG000|COMPLETED|Overall Study||161
3258945|NCT02562755|3993189|FG001|COMPLETED|Overall Study||153
3258946|NCT02562755|3993188|FG000|NOT COMPLETED|Overall Study||73
3258947|NCT02562755|3993189|FG001|NOT COMPLETED|Overall Study||72
3258948|NCT02562898|3993197|FG000|STARTED|Overall Study||10
3258949|NCT02562898|3993198|FG001|STARTED|Overall Study||8
3258950|NCT02562898|3993197|FG000|COMPLETED|Overall Study||10
3258951|NCT02562898|3993198|FG001|COMPLETED|Overall Study||8
3258952|NCT02562898|3993197|FG000|NOT COMPLETED|Overall Study||0
3258953|NCT02562898|3993198|FG001|NOT COMPLETED|Overall Study||0
3258954|NCT02562924|3993207|FG000|STARTED|Overall Study||13
3258955|NCT02562924|3993208|FG001|STARTED|Overall Study||12
3258956|NCT02562924|3993209|FG002|STARTED|Overall Study||12
3258957|NCT02562924|3993207|FG000|COMPLETED|Overall Study||12
3258958|NCT02562924|3993208|FG001|COMPLETED|Overall Study||1
3258959|NCT02562924|3993209|FG002|COMPLETED|Overall Study||8
3258960|NCT02562924|3993207|FG000|NOT COMPLETED|Overall Study||1
3258961|NCT02562924|3993208|FG001|NOT COMPLETED|Overall Study||11
3258962|NCT02562924|3993209|FG002|NOT COMPLETED|Overall Study||4
3258963|NCT02562989|3993223|FG000|STARTED|Overall Study||3
3258964|NCT02562989|3993224|FG001|STARTED|Overall Study||4
3258965|NCT02562989|3993225|FG002|STARTED|Overall Study||6
3258966|NCT02562989|3993223|FG000|COMPLETED|Overall Study||3
3258967|NCT02562989|3993224|FG001|COMPLETED|Overall Study||4
3258968|NCT02562989|3993225|FG002|COMPLETED|Overall Study||6
3258969|NCT02562989|3993223|FG000|NOT COMPLETED|Overall Study||0
3258970|NCT02562989|3993224|FG001|NOT COMPLETED|Overall Study||0
3258971|NCT02562989|3993225|FG002|NOT COMPLETED|Overall Study||0
3258972|NCT02563028|3993233|FG000|STARTED|Overall Study||20
3258973|NCT02563028|3993233|FG000|COMPLETED|Overall Study||18
3258974|NCT02563028|3993233|FG000|NOT COMPLETED|Overall Study||2
3258975|NCT02563067|3993240|FG000|STARTED|Overall Study||296
3258976|NCT02563067|3993241|FG001|STARTED|Overall Study||294
3258977|NCT02563067|3993242|FG002|STARTED|Overall Study||287
3258978|NCT02563067|3993240|FG000|FAS/SAF: High Eosinophils Subpopulation|Overall Study||198
3258979|NCT02563067|3993241|FG001|FAS/SAF: High Eosinophils Subpopulation|Overall Study||196
3258980|NCT02563067|3993242|FG002|FAS/SAF: High Eosinophils Subpopulation|Overall Study||193
3258981|NCT02563067|3993240|FG000|FAS/SAF: Overall Population|Overall Study||296
3258982|NCT02563067|3993241|FG001|FAS/SAF: Overall Population|Overall Study||293
3258983|NCT02563067|3993242|FG002|FAS/SAF: Overall Population|Overall Study||287
3258984|NCT02563067|3993240|FG000|COMPLETED|Overall Study||277
3258985|NCT02563067|3993241|FG001|COMPLETED|Overall Study||268
3258986|NCT02563067|3993242|FG002|COMPLETED|Overall Study||267
3258987|NCT02563067|3993240|FG000|NOT COMPLETED|Overall Study||19
3258988|NCT02563067|3993241|FG001|NOT COMPLETED|Overall Study||26
3258989|NCT02563067|3993242|FG002|NOT COMPLETED|Overall Study||20
3258990|NCT02563093|3993254|FG000|STARTED|Overall Study||52
3258991|NCT02563093|3993255|FG001|STARTED|Overall Study||52
3258992|NCT02563093|3993256|FG002|STARTED|Overall Study||53
3258993|NCT02563093|3993257|FG003|STARTED|Overall Study||51
3258994|NCT02563093|3993254|FG000|COMPLETED|Overall Study||52
3258995|NCT02563093|3993255|FG001|COMPLETED|Overall Study||52
3258996|NCT02563093|3993256|FG002|COMPLETED|Overall Study||53
3258997|NCT02563093|3993257|FG003|COMPLETED|Overall Study||51
3258998|NCT02563093|3993254|FG000|NOT COMPLETED|Overall Study||0
3258999|NCT02563093|3993255|FG001|NOT COMPLETED|Overall Study||0
3259000|NCT02563093|3993256|FG002|NOT COMPLETED|Overall Study||0
3259001|NCT02563093|3993257|FG003|NOT COMPLETED|Overall Study||0
3259002|NCT02563106|3993270|FG000|STARTED|Overall Study||206
3259003|NCT02563106|3993271|FG001|STARTED|Overall Study||207
3259004|NCT02563106|3993270|FG000|COMPLETED|Overall Study||172
3259005|NCT02563106|3993271|FG001|COMPLETED|Overall Study||178
3259006|NCT02563106|3993270|FG000|NOT COMPLETED|Overall Study||34
3259007|NCT02563106|3993271|FG001|NOT COMPLETED|Overall Study||29
3259008|NCT02563496|3993282|FG000|STARTED|Overall Study|No participants were enrolled since they didn't meet inclusion/exclusion criteria.|0
3259009|NCT02563496|3993283|FG001|STARTED|Overall Study||14
3259010|NCT02563496|3993284|FG002|STARTED|Overall Study||5
3259011|NCT02563496|3993285|FG003|STARTED|Overall Study||22
3259012|NCT02563496|3993286|FG004|STARTED|Overall Study||19
3259013|NCT02563496|3993282|FG000|COMPLETED|Overall Study||0
3259014|NCT02563496|3993283|FG001|COMPLETED|Overall Study||14
3259015|NCT02563496|3993284|FG002|COMPLETED|Overall Study||5
3259016|NCT02563496|3993285|FG003|COMPLETED|Overall Study||22
3259017|NCT02563496|3993286|FG004|COMPLETED|Overall Study||19
3259018|NCT02563496|3993282|FG000|NOT COMPLETED|Overall Study||0
3259019|NCT02563496|3993283|FG001|NOT COMPLETED|Overall Study||0
3259020|NCT02563496|3993284|FG002|NOT COMPLETED|Overall Study||0
3259021|NCT02563496|3993285|FG003|NOT COMPLETED|Overall Study||0
3259022|NCT02563496|3993286|FG004|NOT COMPLETED|Overall Study||0
3259023|NCT02563548|3993300|FG000|STARTED|Dose Escalation (Up to 46 Weeks)||3
3259024|NCT02563548|3993301|FG001|STARTED|Dose Escalation (Up to 46 Weeks)||2
3259025|NCT02563548|3993302|FG002|STARTED|Dose Escalation (Up to 46 Weeks)||7
3259026|NCT02563548|3993303|FG003|STARTED|Dose Escalation (Up to 46 Weeks)||2
3259027|NCT02563548|3993304|FG004|STARTED|Dose Escalation (Up to 46 Weeks)||0
3259028|NCT02563548|3993305|FG005|STARTED|Dose Escalation (Up to 46 Weeks)||0
3259029|NCT02563548|3993300|FG000|Received at Least 1 Dose of Study Drug|Dose Escalation (Up to 46 Weeks)||3
3259030|NCT02563548|3993301|FG001|Received at Least 1 Dose of Study Drug|Dose Escalation (Up to 46 Weeks)||2
3259031|NCT02563548|3993302|FG002|Received at Least 1 Dose of Study Drug|Dose Escalation (Up to 46 Weeks)||7
3259032|NCT02563548|3993303|FG003|Received at Least 1 Dose of Study Drug|Dose Escalation (Up to 46 Weeks)||2
3259033|NCT02563548|3993304|FG004|Received at Least 1 Dose of Study Drug|Dose Escalation (Up to 46 Weeks)||0
3259034|NCT02563548|3993305|FG005|Received at Least 1 Dose of Study Drug|Dose Escalation (Up to 46 Weeks)||0
3259035|NCT02563548|3993300|FG000|COMPLETED|Dose Escalation (Up to 46 Weeks)||0
3259036|NCT02563548|3993301|FG001|COMPLETED|Dose Escalation (Up to 46 Weeks)||0
3259037|NCT02563548|3993302|FG002|COMPLETED|Dose Escalation (Up to 46 Weeks)||0
3259038|NCT02563548|3993303|FG003|COMPLETED|Dose Escalation (Up to 46 Weeks)||0
3259039|NCT02563548|3993304|FG004|COMPLETED|Dose Escalation (Up to 46 Weeks)||0
3259040|NCT02563548|3993305|FG005|COMPLETED|Dose Escalation (Up to 46 Weeks)||0
3259041|NCT02563548|3993300|FG000|NOT COMPLETED|Dose Escalation (Up to 46 Weeks)||3
3259042|NCT02563548|3993301|FG001|NOT COMPLETED|Dose Escalation (Up to 46 Weeks)||2
3259043|NCT02563548|3993302|FG002|NOT COMPLETED|Dose Escalation (Up to 46 Weeks)||7
3259044|NCT02563548|3993303|FG003|NOT COMPLETED|Dose Escalation (Up to 46 Weeks)||2
3259045|NCT02563548|3993304|FG004|NOT COMPLETED|Dose Escalation (Up to 46 Weeks)||0
3259046|NCT02563548|3993305|FG005|NOT COMPLETED|Dose Escalation (Up to 46 Weeks)||0
3259047|NCT02563548|3993300|FG000|STARTED|Dose Expansion (Up to 60 Weeks)||0
3259048|NCT02563548|3993301|FG001|STARTED|Dose Expansion (Up to 60 Weeks)||0
3259049|NCT02563548|3993302|FG002|STARTED|Dose Expansion (Up to 60 Weeks)||0
3259050|NCT02563548|3993303|FG003|STARTED|Dose Expansion (Up to 60 Weeks)||0
3259051|NCT02563548|3993304|FG004|STARTED|Dose Expansion (Up to 60 Weeks)||25
3259052|NCT02563548|3993305|FG005|STARTED|Dose Expansion (Up to 60 Weeks)||17
3259053|NCT02563548|3993300|FG000|Received at Least 1 Dose of Study Drug|Dose Expansion (Up to 60 Weeks)||0
3259054|NCT02563548|3993301|FG001|Received at Least 1 Dose of Study Drug|Dose Expansion (Up to 60 Weeks)||0
3259055|NCT02563548|3993302|FG002|Received at Least 1 Dose of Study Drug|Dose Expansion (Up to 60 Weeks)||0
3259056|NCT02563548|3993303|FG003|Received at Least 1 Dose of Study Drug|Dose Expansion (Up to 60 Weeks)||0
3259057|NCT02563548|3993304|FG004|Received at Least 1 Dose of Study Drug|Dose Expansion (Up to 60 Weeks)||24
3259058|NCT02563548|3993305|FG005|Received at Least 1 Dose of Study Drug|Dose Expansion (Up to 60 Weeks)||17
3259059|NCT02563548|3993300|FG000|COMPLETED|Dose Expansion (Up to 60 Weeks)||0
3259060|NCT02563548|3993301|FG001|COMPLETED|Dose Expansion (Up to 60 Weeks)||0
3259061|NCT02563548|3993302|FG002|COMPLETED|Dose Expansion (Up to 60 Weeks)||0
3259062|NCT02563548|3993303|FG003|COMPLETED|Dose Expansion (Up to 60 Weeks)||0
3259063|NCT02563548|3993304|FG004|COMPLETED|Dose Expansion (Up to 60 Weeks)||0
3259064|NCT02563548|3993305|FG005|COMPLETED|Dose Expansion (Up to 60 Weeks)||0
3259065|NCT02563548|3993300|FG000|NOT COMPLETED|Dose Expansion (Up to 60 Weeks)||0
3259066|NCT02563548|3993301|FG001|NOT COMPLETED|Dose Expansion (Up to 60 Weeks)||0
3259067|NCT02563548|3993302|FG002|NOT COMPLETED|Dose Expansion (Up to 60 Weeks)||0
3259068|NCT02563548|3993303|FG003|NOT COMPLETED|Dose Expansion (Up to 60 Weeks)||0
3259069|NCT02563548|3993304|FG004|NOT COMPLETED|Dose Expansion (Up to 60 Weeks)||25
3259070|NCT02563548|3993305|FG005|NOT COMPLETED|Dose Expansion (Up to 60 Weeks)||17
3259071|NCT02563561|3993328|FG000|STARTED|Overall Study||19
3259072|NCT02563561|3993329|FG001|STARTED|Overall Study||23
3259073|NCT02563561|3993330|FG002|STARTED|Overall Study||20
3259074|NCT02563561|3993328|FG000|Safety Population|Overall Study||19
3259075|NCT02563561|3993329|FG001|Safety Population|Overall Study||21
3259076|NCT02563561|3993330|FG002|Safety Population|Overall Study||17
3259077|NCT02563561|3993328|FG000|COMPLETED|Overall Study||1
3259078|NCT02563561|3993329|FG001|COMPLETED|Overall Study||2
3259079|NCT02563561|3993330|FG002|COMPLETED|Overall Study||3
3259080|NCT02563561|3993328|FG000|NOT COMPLETED|Overall Study||18
3259081|NCT02563561|3993329|FG001|NOT COMPLETED|Overall Study||21
3259082|NCT02563561|3993330|FG002|NOT COMPLETED|Overall Study||17
3259083|NCT02563808|3993340|FG000|STARTED|Overall Study||96
3259084|NCT02563808|3993341|FG001|STARTED|Overall Study|A total of 5 participants enrolled were not included in final data due to data collection error|88
3259085|NCT02563808|3993340|FG000|COMPLETED|Overall Study||96
3259086|NCT02563808|3993341|FG001|COMPLETED|Overall Study||88
3259087|NCT02563808|3993340|FG000|NOT COMPLETED|Overall Study||0
3259088|NCT02563808|3993341|FG001|NOT COMPLETED|Overall Study||0
3259089|NCT02563834|3993349|FG000|STARTED|Control (Saline) Infusion (*Day 1)||10
3259090|NCT02563834|3993350|FG001|STARTED|Control (Saline) Infusion (*Day 1)||8
3372712|NCT02865122|4104758|FG000|STARTED|Overall Study||1
3259091|NCT02563834|3993349|FG000|COMPLETED|Control (Saline) Infusion (*Day 1)||10
3259092|NCT02563834|3993350|FG001|COMPLETED|Control (Saline) Infusion (*Day 1)||8
3259093|NCT02563834|3993349|FG000|NOT COMPLETED|Control (Saline) Infusion (*Day 1)||0
3259094|NCT02563834|3993350|FG001|NOT COMPLETED|Control (Saline) Infusion (*Day 1)||0
3259095|NCT02563834|3993349|FG000|STARTED|Insulin Infusion (*Day 2)||10
3259096|NCT02563834|3993350|FG001|STARTED|Insulin Infusion (*Day 2)||8
3259097|NCT02563834|3993349|FG000|COMPLETED|Insulin Infusion (*Day 2)||10
3259098|NCT02563834|3993350|FG001|COMPLETED|Insulin Infusion (*Day 2)||8
3259099|NCT02563834|3993349|FG000|NOT COMPLETED|Insulin Infusion (*Day 2)||0
3259100|NCT02563834|3993350|FG001|NOT COMPLETED|Insulin Infusion (*Day 2)||0
3259101|NCT02563860|3993358|FG000|STARTED|Overall Study||20
3259102|NCT02563860|3993358|FG000|COMPLETED|Overall Study||19
3259103|NCT02563860|3993358|FG000|NOT COMPLETED|Overall Study||1
3259104|NCT02563899|3993366|FG000|STARTED|Overall Study||18
3259105|NCT02563899|3993367|FG001|STARTED|Overall Study||5
3259106|NCT02563899|3993368|FG002|STARTED|Overall Study||10
3259107|NCT02563899|3993369|FG003|STARTED|Overall Study||6
3259108|NCT02563899|3993366|FG000|COMPLETED|Overall Study||17
3259109|NCT02563899|3993367|FG001|COMPLETED|Overall Study||5
3259110|NCT02563899|3993368|FG002|COMPLETED|Overall Study||9
3259111|NCT02563899|3993369|FG003|COMPLETED|Overall Study||6
3259112|NCT02563899|3993366|FG000|NOT COMPLETED|Overall Study||1
3259113|NCT02563899|3993367|FG001|NOT COMPLETED|Overall Study||0
3259114|NCT02563899|3993368|FG002|NOT COMPLETED|Overall Study||1
3259115|NCT02563899|3993369|FG003|NOT COMPLETED|Overall Study||0
3259116|NCT02563990|3993382|FG000|STARTED|Overall Study||12
3259117|NCT02563990|3993383|FG001|STARTED|Overall Study||14
3259118|NCT02563990|3993382|FG000|COMPLETED|Overall Study||12
3259119|NCT02563990|3993383|FG001|COMPLETED|Overall Study||14
3259120|NCT02563990|3993382|FG000|NOT COMPLETED|Overall Study||0
3259121|NCT02563990|3993383|FG001|NOT COMPLETED|Overall Study||0
3259122|NCT02564016|3993393|FG000|STARTED|Overall Study||22
3259123|NCT02564016|3993394|FG001|STARTED|Overall Study||14
3259124|NCT02564016|3993393|FG000|COMPLETED|Overall Study||4
3259125|NCT02564016|3993394|FG001|COMPLETED|Overall Study||4
3259126|NCT02564016|3993393|FG000|NOT COMPLETED|Overall Study||18
3259127|NCT02564016|3993394|FG001|NOT COMPLETED|Overall Study||10
3372713|NCT02865122|4104759|FG001|STARTED|Overall Study||1
3372714|NCT02865122|4104760|FG002|STARTED|Overall Study||0
3372715|NCT02865122|4104758|FG000|COMPLETED|Overall Study||0
3372716|NCT02865122|4104759|FG001|COMPLETED|Overall Study||1
3372717|NCT02865122|4104760|FG002|COMPLETED|Overall Study||0
3372718|NCT02865122|4104758|FG000|NOT COMPLETED|Overall Study||1
3372719|NCT02865122|4104759|FG001|NOT COMPLETED|Overall Study||0
3372720|NCT02865122|4104760|FG002|NOT COMPLETED|Overall Study||0
3372721|NCT02865915|4104770|FG000|STARTED|Overall Study||25
3372722|NCT02865915|4104771|FG001|STARTED|Overall Study||30
3372723|NCT02865915|4104770|FG000|COMPLETED|Overall Study|Study terminated prior to completion by any subject|0
3372724|NCT02865915|4104771|FG001|COMPLETED|Overall Study|Study terminated prior to completion by any subject|0
3372725|NCT02865915|4104770|FG000|NOT COMPLETED|Overall Study||25
3372726|NCT02865915|4104771|FG001|NOT COMPLETED|Overall Study||30
3372727|NCT02855411|4104777|FG000|STARTED|Overall Study||35
3372728|NCT02855411|4104777|FG000|Assigned to Study Treatment|Overall Study||0
3372729|NCT02855411|4104777|FG000|COMPLETED|Overall Study||0
3372730|NCT02855411|4104777|FG000|NOT COMPLETED|Overall Study||35
3372731|NCT02826161|4104783|FG000|STARTED|Overall Study||1
3372732|NCT02826161|4104784|FG001|STARTED|Overall Study||3
3372733|NCT02826161|4104783|FG000|Discontinued Due to Treatment Related AE|Overall Study||1
3372734|NCT02826161|4104784|FG001|Discontinued Due to Treatment Related AE|Overall Study||0
3372735|NCT02826161|4104783|FG000|Discontinued Due to Death|Overall Study||0
3372736|NCT02826161|4104784|FG001|Discontinued Due to Death|Overall Study||1
3372737|NCT02826161|4104783|FG000|Discontinued Due to Patient Withdrawal|Overall Study||0
3372738|NCT02826161|4104784|FG001|Discontinued Due to Patient Withdrawal|Overall Study||1
3372739|NCT02826161|4104783|FG000|Discontinued Due to Withdrawal of ICF From Further FU|Overall Study||1
3372740|NCT02826161|4104784|FG001|Discontinued Due to Withdrawal of ICF From Further FU|Overall Study||1
3372741|NCT02826161|4104783|FG000|COMPLETED|Overall Study||1
3372742|NCT02826161|4104784|FG001|COMPLETED|Overall Study||3
3372743|NCT02826161|4104783|FG000|NOT COMPLETED|Overall Study||0
3372744|NCT02826161|4104784|FG001|NOT COMPLETED|Overall Study||0
3372745|NCT02828124|4104793|FG000|STARTED|Overall Study||1
3372746|NCT02828124|4104794|FG001|STARTED|Overall Study||2
3372747|NCT02828124|4104795|FG002|STARTED|Overall Study||1
3372748|NCT02828124|4104796|FG003|STARTED|Overall Study||6
3372749|NCT02828124|4104793|FG000|COMPLETED|Overall Study||0
3372750|NCT02828124|4104794|FG001|COMPLETED|Overall Study||0
3372751|NCT02828124|4104795|FG002|COMPLETED|Overall Study||0
3372752|NCT02828124|4104796|FG003|COMPLETED|Overall Study||0
3372753|NCT02828124|4104793|FG000|NOT COMPLETED|Overall Study||1
3372754|NCT02828124|4104794|FG001|NOT COMPLETED|Overall Study||2
3372755|NCT02828124|4104795|FG002|NOT COMPLETED|Overall Study||1
3372756|NCT02828124|4104796|FG003|NOT COMPLETED|Overall Study||6
3372757|NCT02826551|4104808|FG000|STARTED|Overall Study||11
3372758|NCT02826551|4104809|FG001|STARTED|Overall Study||12
3372759|NCT02826551|4104808|FG000|COMPLETED|Overall Study||11
3372760|NCT02826551|4104809|FG001|COMPLETED|Overall Study||12
3372761|NCT02826551|4104808|FG000|NOT COMPLETED|Overall Study||0
3372762|NCT02826551|4104809|FG001|NOT COMPLETED|Overall Study||0
3372763|NCT02825043|4104815|FG000|STARTED|Overall Study||6
3259128|NCT02564029|3993400|FG000|STARTED|Overall Study||7
3259129|NCT02564029|3993400|FG000|COMPLETED|Overall Study||7
3259130|NCT02564029|3993400|FG000|NOT COMPLETED|Overall Study||0
3259131|NCT02564042|3993417|FG000|STARTED|Overall Study||38
3259132|NCT02564042|3993418|FG001|STARTED|Overall Study||38
3259133|NCT02564042|3993419|FG002|STARTED|Overall Study||38
3259134|NCT02564042|3993420|FG003|STARTED|Overall Study||38
3259135|NCT02564042|3993421|FG004|STARTED|Overall Study||37
3259136|NCT02564042|3993422|FG005|STARTED|Overall Study||38
3259137|NCT02564042|3993417|FG000|COMPLETED|Overall Study||27
3259138|NCT02564042|3993418|FG001|COMPLETED|Overall Study||30
3259139|NCT02564042|3993419|FG002|COMPLETED|Overall Study||32
3259140|NCT02564042|3993420|FG003|COMPLETED|Overall Study||35
3259141|NCT02564042|3993421|FG004|COMPLETED|Overall Study||26
3259142|NCT02564042|3993422|FG005|COMPLETED|Overall Study||24
3259143|NCT02564042|3993417|FG000|NOT COMPLETED|Overall Study||11
3259144|NCT02564042|3993418|FG001|NOT COMPLETED|Overall Study||8
3259145|NCT02564042|3993419|FG002|NOT COMPLETED|Overall Study||6
3259146|NCT02564042|3993420|FG003|NOT COMPLETED|Overall Study||3
3259147|NCT02564042|3993421|FG004|NOT COMPLETED|Overall Study||11
3259148|NCT02564042|3993422|FG005|NOT COMPLETED|Overall Study||14
3259149|NCT02564055|3993442|FG000|STARTED|Overall Study||40
3259150|NCT02564055|3993443|FG001|STARTED|Overall Study||41
3259151|NCT02564055|3993444|FG002|STARTED|Overall Study||43
3259152|NCT02564055|3993445|FG003|STARTED|Overall Study||41
3259153|NCT02564055|3993446|FG004|STARTED|Overall Study||42
3259154|NCT02564055|3993447|FG005|STARTED|Overall Study||40
3259155|NCT02564055|3993442|FG000|COMPLETED|Overall Study||34
3259156|NCT02564055|3993443|FG001|COMPLETED|Overall Study||36
3259157|NCT02564055|3993444|FG002|COMPLETED|Overall Study||31
3259158|NCT02564055|3993445|FG003|COMPLETED|Overall Study||35
3259159|NCT02564055|3993446|FG004|COMPLETED|Overall Study||27
3259160|NCT02564055|3993447|FG005|COMPLETED|Overall Study||28
3259161|NCT02564055|3993442|FG000|NOT COMPLETED|Overall Study||6
3259162|NCT02564055|3993443|FG001|NOT COMPLETED|Overall Study||5
3259163|NCT02564055|3993444|FG002|NOT COMPLETED|Overall Study||12
3259164|NCT02564055|3993445|FG003|NOT COMPLETED|Overall Study||6
3259165|NCT02564055|3993446|FG004|NOT COMPLETED|Overall Study||15
3259166|NCT02564055|3993447|FG005|NOT COMPLETED|Overall Study||12
3259167|NCT02564120|3993466|FG000|STARTED|Overall Study||1556
3259168|NCT02564120|3993466|FG000|COMPLETED|Overall Study||1110
3259169|NCT02564120|3993466|FG000|NOT COMPLETED|Overall Study||446
3259170|NCT02564198|3993483|FG000|STARTED|Overall Study||8
3259171|NCT02564198|3993484|FG001|STARTED|Overall Study||15
3259172|NCT02564198|3993485|FG002|STARTED|Overall Study||6
3259173|NCT02564198|3993483|FG000|Received at Least 1 Dose of Study Drug|Overall Study||8
3259174|NCT02564198|3993484|FG001|Received at Least 1 Dose of Study Drug|Overall Study||15
3259175|NCT02564198|3993485|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
3259176|NCT02564198|3993483|FG000|COMPLETED|Overall Study||6
3259177|NCT02564198|3993484|FG001|COMPLETED|Overall Study||10
3259178|NCT02564198|3993485|FG002|COMPLETED|Overall Study||6
3259179|NCT02564198|3993483|FG000|NOT COMPLETED|Overall Study||2
3259180|NCT02564198|3993484|FG001|NOT COMPLETED|Overall Study||5
3259181|NCT02564198|3993485|FG002|NOT COMPLETED|Overall Study||0
3259182|NCT02564211|3993495|FG000|STARTED|Overall Study||77
3259183|NCT02564211|3993495|FG000|COMPLETED|Overall Study||73
3259184|NCT02564211|3993495|FG000|NOT COMPLETED|Overall Study||4
3259185|NCT02564354|3993501|FG000|STARTED|Overall Study||10
3259186|NCT02564354|3993502|FG001|STARTED|Overall Study||8
3259187|NCT02564354|3993501|FG000|COMPLETED|Overall Study||10
3259188|NCT02564354|3993502|FG001|COMPLETED|Overall Study||8
3259189|NCT02564354|3993501|FG000|NOT COMPLETED|Overall Study||0
3259190|NCT02564354|3993502|FG001|NOT COMPLETED|Overall Study||0
3259191|NCT02564432|3993508|FG000|STARTED|Overall Study||10
3259192|NCT02564432|3993508|FG000|COMPLETED|Overall Study|1 patient suffered periprosthetic fracture at 8 months; 1 failed to osseointegrate|8
3259193|NCT02564432|3993508|FG000|NOT COMPLETED|Overall Study||2
3259194|NCT02564471|3993518|FG000|STARTED|Overall Study||25
3259195|NCT02564471|3993519|FG001|STARTED|Overall Study||26
3259196|NCT02564471|3993520|FG002|STARTED|Overall Study||27
3259197|NCT02564471|3993521|FG003|STARTED|Overall Study||25
3259198|NCT02564471|3993518|FG000|COMPLETED|Overall Study||22
3259199|NCT02564471|3993519|FG001|COMPLETED|Overall Study||23
3259200|NCT02564471|3993520|FG002|COMPLETED|Overall Study||24
3259201|NCT02564471|3993521|FG003|COMPLETED|Overall Study||25
3259202|NCT02564471|3993518|FG000|NOT COMPLETED|Overall Study||3
3259203|NCT02564471|3993519|FG001|NOT COMPLETED|Overall Study||3
3259204|NCT02564471|3993520|FG002|NOT COMPLETED|Overall Study||3
3259205|NCT02564471|3993521|FG003|NOT COMPLETED|Overall Study||0
3259206|NCT02564497|3993533|FG000|STARTED|Overall Study||74
3259207|NCT02564497|3993534|FG001|STARTED|Overall Study||72
3259208|NCT02564497|3993533|FG000|COMPLETED|Overall Study||74
3259209|NCT02564497|3993534|FG001|COMPLETED|Overall Study||72
3259210|NCT02564497|3993533|FG000|NOT COMPLETED|Overall Study||0
3259211|NCT02564497|3993534|FG001|NOT COMPLETED|Overall Study||0
3259212|NCT02564718|3993542|FG000|STARTED|Overall Study||5
3259213|NCT02564718|3993543|FG001|STARTED|Overall Study||5
3259214|NCT02564718|3993542|FG000|COMPLETED|Overall Study||5
3259215|NCT02564718|3993543|FG001|COMPLETED|Overall Study||4
3259216|NCT02564718|3993542|FG000|NOT COMPLETED|Overall Study||0
3259217|NCT02564718|3993543|FG001|NOT COMPLETED|Overall Study||1
3259218|NCT02564887|3993551|FG000|STARTED|Overall Study||16
3259219|NCT02564887|3993552|FG001|STARTED|Overall Study||10
3259220|NCT02564887|3993551|FG000|COMPLETED|Overall Study||10
3259221|NCT02564887|3993552|FG001|COMPLETED|Overall Study||10
3259222|NCT02564887|3993551|FG000|NOT COMPLETED|Overall Study||6
3259223|NCT02564887|3993552|FG001|NOT COMPLETED|Overall Study||0
3259224|NCT02564926|3993562|FG000|STARTED|Overall Study||60
3259225|NCT02564926|3993563|FG001|STARTED|Overall Study||61
3259226|NCT02564926|3993562|FG000|COMPLETED|Overall Study||52
3259227|NCT02564926|3993563|FG001|COMPLETED|Overall Study||54
3259228|NCT02564926|3993562|FG000|NOT COMPLETED|Overall Study||8
3259229|NCT02564926|3993563|FG001|NOT COMPLETED|Overall Study||7
3259230|NCT02564952|3993569|FG000|STARTED|Overall Study||18
3259231|NCT02564952|3993569|FG000|Received at Least 1 Dose of Study Drug|Overall Study||18
3259232|NCT02564952|3993569|FG000|Completed OLE Titration Period|Overall Study||16
3259233|NCT02564952|3993569|FG000|COMPLETED|Overall Study||7
3259234|NCT02564952|3993569|FG000|NOT COMPLETED|Overall Study||11
3259235|NCT02565108|3993575|FG000|STARTED|Overall Study||16
3259236|NCT02565108|3993576|FG001|STARTED|Overall Study||4
3259237|NCT02565108|3993575|FG000|Safety Set|Overall Study||16
3259238|NCT02565108|3993576|FG001|Safety Set|Overall Study||4
3259239|NCT02565108|3993575|FG000|Pharmacokinetic (PK) Set|Overall Study||10
3259240|NCT02565108|3993576|FG001|Pharmacokinetic (PK) Set|Overall Study||3
3259241|NCT02565108|3993575|FG000|COMPLETED|Overall Study||14
3259242|NCT02565108|3993576|FG001|COMPLETED|Overall Study||4
3259243|NCT02565108|3993575|FG000|NOT COMPLETED|Overall Study||2
3259244|NCT02565108|3993576|FG001|NOT COMPLETED|Overall Study||0
3259245|NCT02565147|3993584|FG000|STARTED|Overall Study||38
3259246|NCT02565147|3993585|FG001|STARTED|Overall Study||40
3259247|NCT02565147|3993584|FG000|Received Study Drug|Overall Study||38
3259248|NCT02565147|3993585|FG001|Received Study Drug|Overall Study||40
3259249|NCT02565147|3993584|FG000|Per-Protocol Population|Overall Study||28
3259250|NCT02565147|3993585|FG001|Per-Protocol Population|Overall Study||36
3259251|NCT02565147|3993584|FG000|COMPLETED|Overall Study||32
3259252|NCT02565147|3993585|FG001|COMPLETED|Overall Study||37
3259253|NCT02565147|3993584|FG000|NOT COMPLETED|Overall Study||6
3259254|NCT02565147|3993585|FG001|NOT COMPLETED|Overall Study||3
3259255|NCT02565186|3993593|FG000|STARTED|Overall Study||1046
3259256|NCT02565186|3993594|FG001|STARTED|Overall Study||1125
3259257|NCT02565186|3993593|FG000|Received at Least One Dose of Study Drug|Overall Study||991
3259258|NCT02565186|3993594|FG001|Received at Least One Dose of Study Drug|Overall Study||1039
3259259|NCT02565186|3993593|FG000|COMPLETED|Overall Study||466
3259260|NCT02565186|3993594|FG001|COMPLETED|Overall Study||504
3259261|NCT02565186|3993593|FG000|NOT COMPLETED|Overall Study||580
3259262|NCT02565186|3993594|FG001|NOT COMPLETED|Overall Study||621
3259263|NCT02565381|3993603|FG000|STARTED|Overall Study||25
3259264|NCT02565381|3993604|FG001|STARTED|Overall Study||25
3259265|NCT02565381|3993605|FG002|STARTED|Overall Study||25
3259266|NCT02565381|3993603|FG000|COMPLETED|Overall Study||24
3259267|NCT02565381|3993604|FG001|COMPLETED|Overall Study||25
3259268|NCT02565381|3993605|FG002|COMPLETED|Overall Study||24
3259269|NCT02565381|3993603|FG000|NOT COMPLETED|Overall Study||1
3259270|NCT02565381|3993604|FG001|NOT COMPLETED|Overall Study||0
3259271|NCT02565381|3993605|FG002|NOT COMPLETED|Overall Study||1
3259272|NCT02565485|3993615|FG000|STARTED|Overall Study||139
3259273|NCT02565485|3993616|FG001|STARTED|Overall Study||137
3259274|NCT02565485|3993615|FG000|COMPLETED|Overall Study||139
3259275|NCT02565485|3993616|FG001|COMPLETED|Overall Study||137
3259276|NCT02565485|3993615|FG000|NOT COMPLETED|Overall Study||0
3259277|NCT02565485|3993616|FG001|NOT COMPLETED|Overall Study||0
3259278|NCT02565511|3993626|FG000|STARTED|Overall Study||42
3259279|NCT02565511|3993627|FG001|STARTED|Overall Study||23
3259280|NCT02565511|3993628|FG002|STARTED|Overall Study||251
3259281|NCT02565511|3993629|FG003|STARTED|Overall Study||164
3259282|NCT02565511|3993626|FG000|3 Patients Were Mis-randomized|Overall Study||0
3259283|NCT02565511|3993627|FG001|3 Patients Were Mis-randomized|Overall Study||0
3259284|NCT02565511|3993628|FG002|3 Patients Were Mis-randomized|Overall Study||2
3259285|NCT02565511|3993629|FG003|3 Patients Were Mis-randomized|Overall Study||1
3259286|NCT02565511|3993626|FG000|COMPLETED|Overall Study||0
3259287|NCT02565511|3993627|FG001|COMPLETED|Overall Study||0
3259288|NCT02565511|3993628|FG002|COMPLETED|Overall Study||0
3259289|NCT02565511|3993629|FG003|COMPLETED|Overall Study||0
3259290|NCT02565511|3993626|FG000|NOT COMPLETED|Overall Study||42
3259291|NCT02565511|3993627|FG001|NOT COMPLETED|Overall Study||23
3259292|NCT02565511|3993628|FG002|NOT COMPLETED|Overall Study||251
3259293|NCT02565511|3993629|FG003|NOT COMPLETED|Overall Study||164
3259294|NCT02565576|3993641|FG000|STARTED|Overall Study||22
3259295|NCT02565576|3993642|FG001|STARTED|Overall Study||22
3259296|NCT02565576|3993641|FG000|COMPLETED|Overall Study||17
3259297|NCT02565576|3993642|FG001|COMPLETED|Overall Study||17
3259298|NCT02565576|3993641|FG000|NOT COMPLETED|Overall Study||5
3259299|NCT02565576|3993642|FG001|NOT COMPLETED|Overall Study||5
3259300|NCT02565615|3993653|FG000|STARTED|Overall Study||291
3259301|NCT02565615|3993654|FG001|STARTED|Overall Study||3080
3259302|NCT02565615|3993655|FG002|STARTED|Overall Study||21
3259303|NCT02565615|3993656|FG003|STARTED|Overall Study||101
3259304|NCT02565615|3993657|FG004|STARTED|Overall Study||1622
3259305|NCT02565615|3993653|FG000|Treated|Overall Study||291
3259306|NCT02565615|3993654|FG001|Treated|Overall Study||3080
3259307|NCT02565615|3993655|FG002|Treated|Overall Study||21
3259308|NCT02565615|3993656|FG003|Treated|Overall Study||101
3259309|NCT02565615|3993657|FG004|Treated|Overall Study||1055
3259310|NCT02565615|3993653|FG000|COMPLETED|Overall Study||288
3259311|NCT02565615|3993654|FG001|COMPLETED|Overall Study||3044
3259312|NCT02565615|3993655|FG002|COMPLETED|Overall Study||21
3259313|NCT02565615|3993656|FG003|COMPLETED|Overall Study||98
3259314|NCT02565615|3993657|FG004|COMPLETED|Overall Study||21
3259315|NCT02565615|3993653|FG000|NOT COMPLETED|Overall Study||3
3259316|NCT02565615|3993654|FG001|NOT COMPLETED|Overall Study||36
3259317|NCT02565615|3993655|FG002|NOT COMPLETED|Overall Study||0
3259318|NCT02565615|3993656|FG003|NOT COMPLETED|Overall Study||3
3259319|NCT02565615|3993657|FG004|NOT COMPLETED|Overall Study||1601
3259320|NCT02565628|3993671|FG000|STARTED|Overall Study||10
3259321|NCT02565628|3993672|FG001|STARTED|Overall Study||9
3259322|NCT02565628|3993671|FG000|Received Treatment|Overall Study||10
3259323|NCT02565628|3993672|FG001|Received Treatment|Overall Study||9
3259324|NCT02565628|3993671|FG000|COMPLETED|Overall Study||10
3259325|NCT02565628|3993672|FG001|COMPLETED|Overall Study||9
3259326|NCT02565628|3993671|FG000|NOT COMPLETED|Overall Study||0
3259327|NCT02565628|3993672|FG001|NOT COMPLETED|Overall Study||0
3259328|NCT02565706|3993682|FG000|STARTED|Overall Study||178
3259329|NCT02565706|3993683|FG001|STARTED|Overall Study||172
3372764|NCT02825043|4104815|FG000|COMPLETED|Overall Study||2
3372765|NCT02825043|4104815|FG000|NOT COMPLETED|Overall Study||4
3372766|NCT02819804|4104819|FG000|STARTED|Complete Cycle 1 (28 Days)||1
3372767|NCT02819804|4104819|FG000|COMPLETED|Complete Cycle 1 (28 Days)||0
3372768|NCT02819804|4104819|FG000|NOT COMPLETED|Complete Cycle 1 (28 Days)||1
3372769|NCT02819804|4104819|FG000|STARTED|Start Cycle 2 and Beyond||0
3372770|NCT02819804|4104819|FG000|COMPLETED|Start Cycle 2 and Beyond||0
3372771|NCT02819804|4104819|FG000|NOT COMPLETED|Start Cycle 2 and Beyond||0
3372772|NCT02819804|4104819|FG000|STARTED|Follow-up for 1 Year||1
3372773|NCT02819804|4104819|FG000|COMPLETED|Follow-up for 1 Year||1
3372774|NCT02819804|4104819|FG000|NOT COMPLETED|Follow-up for 1 Year||0
3372775|NCT02809118|4104826|FG000|STARTED|Overall Study||18
3372776|NCT02809118|4104827|FG001|STARTED|Overall Study||19
3372777|NCT02809118|4104828|FG002|STARTED|Overall Study||19
3372778|NCT02809118|4104826|FG000|COMPLETED|Overall Study||18
3372779|NCT02809118|4104827|FG001|COMPLETED|Overall Study||18
3372780|NCT02809118|4104828|FG002|COMPLETED|Overall Study||18
3372781|NCT02809118|4104826|FG000|NOT COMPLETED|Overall Study||0
3372782|NCT02809118|4104827|FG001|NOT COMPLETED|Overall Study||1
3372783|NCT02809118|4104828|FG002|NOT COMPLETED|Overall Study||1
3372784|NCT02818946|4104836|FG000|STARTED|Overall Study||30
3372785|NCT02818946|4104836|FG000|COMPLETED|Overall Study||30
3372786|NCT02818946|4104836|FG000|NOT COMPLETED|Overall Study||0
3372787|NCT02819908|4104842|FG000|STARTED|Overall Study||12
3372788|NCT02819908|4104843|FG001|STARTED|Overall Study||13
3372789|NCT02819908|4104842|FG000|COMPLETED|Overall Study||12
3372790|NCT02819908|4104843|FG001|COMPLETED|Overall Study||13
3372791|NCT02819908|4104842|FG000|NOT COMPLETED|Overall Study||0
3372792|NCT02819908|4104843|FG001|NOT COMPLETED|Overall Study||0
3372793|NCT02808390|4104854|FG000|STARTED|Overall Study||4
3372794|NCT02808390|4104855|FG001|STARTED|Overall Study||8
3372795|NCT02808390|4104856|FG002|STARTED|Overall Study||7
3372796|NCT02808390|4104854|FG000|COMPLETED|Overall Study||2
3372797|NCT02808390|4104855|FG001|COMPLETED|Overall Study||2
3372798|NCT02808390|4104856|FG002|COMPLETED|Overall Study||4
3372799|NCT02808390|4104854|FG000|NOT COMPLETED|Overall Study||2
3372800|NCT02808390|4104855|FG001|NOT COMPLETED|Overall Study||6
3372801|NCT02808390|4104856|FG002|NOT COMPLETED|Overall Study||3
3372802|NCT02806960|4104864|FG000|STARTED|Period 1||3
3372803|NCT02806960|4104865|FG001|STARTED|Period 1||3
3372804|NCT02806960|4104866|FG002|STARTED|Period 1||3
3372805|NCT02806960|4104867|FG003|STARTED|Period 1||3
3372806|NCT02806960|4104864|FG000|COMPLETED|Period 1||0
3372807|NCT02806960|4104865|FG001|COMPLETED|Period 1||0
3372808|NCT02806960|4104866|FG002|COMPLETED|Period 1||0
3372809|NCT02806960|4104867|FG003|COMPLETED|Period 1||0
3372810|NCT02806960|4104864|FG000|NOT COMPLETED|Period 1||3
3372811|NCT02806960|4104865|FG001|NOT COMPLETED|Period 1||3
3372812|NCT02806960|4104866|FG002|NOT COMPLETED|Period 1||3
3372813|NCT02806960|4104867|FG003|NOT COMPLETED|Period 1||3
3372814|NCT02806960|4104864|FG000|STARTED|Period 2||0
3372815|NCT02806960|4104865|FG001|STARTED|Period 2||0
3372816|NCT02806960|4104866|FG002|STARTED|Period 2||0
3372817|NCT02806960|4104867|FG003|STARTED|Period 2||0
3372818|NCT02806960|4104864|FG000|COMPLETED|Period 2||0
3372819|NCT02806960|4104865|FG001|COMPLETED|Period 2||0
3372820|NCT02806960|4104866|FG002|COMPLETED|Period 2||0
3372821|NCT02806960|4104867|FG003|COMPLETED|Period 2||0
3372822|NCT02806960|4104864|FG000|NOT COMPLETED|Period 2||0
3372823|NCT02806960|4104865|FG001|NOT COMPLETED|Period 2||0
3372824|NCT02806960|4104866|FG002|NOT COMPLETED|Period 2||0
3372825|NCT02806960|4104867|FG003|NOT COMPLETED|Period 2||0
3372826|NCT02806960|4104864|FG000|STARTED|Period 3||0
3372827|NCT02806960|4104865|FG001|STARTED|Period 3||0
3372828|NCT02806960|4104866|FG002|STARTED|Period 3||0
3372829|NCT02806960|4104867|FG003|STARTED|Period 3||0
3372830|NCT02806960|4104864|FG000|COMPLETED|Period 3||0
3372831|NCT02806960|4104865|FG001|COMPLETED|Period 3||0
3372832|NCT02806960|4104866|FG002|COMPLETED|Period 3||0
3372833|NCT02806960|4104867|FG003|COMPLETED|Period 3||0
3372834|NCT02806960|4104864|FG000|NOT COMPLETED|Period 3||0
3372835|NCT02806960|4104865|FG001|NOT COMPLETED|Period 3||0
3372836|NCT02806960|4104866|FG002|NOT COMPLETED|Period 3||0
3372837|NCT02806960|4104867|FG003|NOT COMPLETED|Period 3||0
3259330|NCT02565706|3993684|FG002|STARTED|Overall Study||193
3259331|NCT02565706|3993685|FG003|STARTED|Overall Study||201
3259332|NCT02565706|3993682|FG000|COMPLETED|Overall Study||101
3259333|NCT02565706|3993683|FG001|COMPLETED|Overall Study||90
3259334|NCT02565706|3993684|FG002|COMPLETED|Overall Study||104
3259335|NCT02565706|3993685|FG003|COMPLETED|Overall Study||116
3259336|NCT02565706|3993682|FG000|NOT COMPLETED|Overall Study||77
3259337|NCT02565706|3993683|FG001|NOT COMPLETED|Overall Study||82
3259338|NCT02565706|3993684|FG002|NOT COMPLETED|Overall Study||89
3259339|NCT02565706|3993685|FG003|NOT COMPLETED|Overall Study||85
3259340|NCT02565784|3993700|FG000|STARTED|First Treatment||100
3259341|NCT02565784|3993700|FG000|6 Months Follow-up|First Treatment||99
3259342|NCT02565784|3993700|FG000|12 Months Follow-up|First Treatment||98
3259343|NCT02565784|3993700|FG000|COMPLETED|First Treatment||98
3259344|NCT02565784|3993700|FG000|NOT COMPLETED|First Treatment||2
3259345|NCT02565784|3993700|FG000|STARTED|Second Treatment||98
3259346|NCT02565784|3993700|FG000|6 Months Follow-up|Second Treatment||97
3259347|NCT02565784|3993700|FG000|12 Months Follow-up|Second Treatment||96
3259348|NCT02565784|3993700|FG000|COMPLETED|Second Treatment||96
3259349|NCT02565784|3993700|FG000|NOT COMPLETED|Second Treatment||2
3259350|NCT02565810|3993708|FG000|STARTED|Overall Study||49
3259351|NCT02565810|3993708|FG000|COMPLETED|Overall Study||48
3259352|NCT02565810|3993708|FG000|NOT COMPLETED|Overall Study||1
3259353|NCT02565901|3993720|FG000|STARTED|Overall Study||11
3259354|NCT02565901|3993721|FG001|STARTED|Overall Study||11
3259355|NCT02565901|3993722|FG002|STARTED|Overall Study||6
3259356|NCT02565901|3993720|FG000|COMPLETED|Overall Study||11
3259357|NCT02565901|3993721|FG001|COMPLETED|Overall Study||11
3259358|NCT02565901|3993722|FG002|COMPLETED|Overall Study||6
3259359|NCT02565901|3993720|FG000|NOT COMPLETED|Overall Study||0
3259360|NCT02565901|3993721|FG001|NOT COMPLETED|Overall Study||0
3259361|NCT02565901|3993722|FG002|NOT COMPLETED|Overall Study||0
3259362|NCT02565914|3993731|FG000|STARTED|Overall Study||1044
3259363|NCT02565914|3993731|FG000|Safety Set|Overall Study||1042
3259364|NCT02565914|3993731|FG000|COMPLETED|Overall Study||951
3259365|NCT02565914|3993731|FG000|NOT COMPLETED|Overall Study||93
3259366|NCT02566005|3993745|FG000|STARTED|Overall Study||100
3259367|NCT02566005|3993746|FG001|STARTED|Overall Study||100
3259368|NCT02566005|3993745|FG000|COMPLETED|Overall Study||92
3259369|NCT02566005|3993746|FG001|COMPLETED|Overall Study||94
3259370|NCT02566005|3993745|FG000|NOT COMPLETED|Overall Study||8
3259371|NCT02566005|3993746|FG001|NOT COMPLETED|Overall Study||6
3259372|NCT02566031|3993754|FG000|STARTED|Overall Study||189
3259373|NCT02566031|3993755|FG001|STARTED|Overall Study||190
3259374|NCT02566031|3993754|FG000|COMPLETED|Overall Study||169
3259375|NCT02566031|3993755|FG001|COMPLETED|Overall Study||178
3259376|NCT02566031|3993754|FG000|NOT COMPLETED|Overall Study||20
3259377|NCT02566031|3993755|FG001|NOT COMPLETED|Overall Study||12
3259378|NCT02566044|3993765|FG000|STARTED|Overall Study||6
3259379|NCT02566044|3993766|FG001|STARTED|Overall Study||6
3259380|NCT02566044|3993767|FG002|STARTED|Overall Study||4
3259381|NCT02566044|3993765|FG000|COMPLETED|Overall Study||6
3259382|NCT02566044|3993766|FG001|COMPLETED|Overall Study||6
3259383|NCT02566044|3993767|FG002|COMPLETED|Overall Study||4
3259384|NCT02566044|3993765|FG000|NOT COMPLETED|Overall Study||0
3259385|NCT02566044|3993766|FG001|NOT COMPLETED|Overall Study||0
3259386|NCT02566044|3993767|FG002|NOT COMPLETED|Overall Study||0
3259387|NCT02566083|3993782|FG000|STARTED|Overall Study||214
3259388|NCT02566083|3993783|FG001|STARTED|Overall Study||151
3259389|NCT02566083|3993782|FG000|COMPLETED|Overall Study||198
3259390|NCT02566083|3993783|FG001|COMPLETED|Overall Study||141
3259391|NCT02566083|3993782|FG000|NOT COMPLETED|Overall Study||16
3259392|NCT02566083|3993783|FG001|NOT COMPLETED|Overall Study||10
3259393|NCT02566109|3993789|FG000|STARTED|Overall Study||6
3259394|NCT02566109|3993789|FG000|COMPLETED|Overall Study||5
3259395|NCT02566109|3993789|FG000|NOT COMPLETED|Overall Study||1
3259396|NCT02566135|3993795|FG000|STARTED|Overall Study||29
3259397|NCT02566135|3993796|FG001|STARTED|Overall Study||29
3259398|NCT02566135|3993795|FG000|COMPLETED|Overall Study||29
3259399|NCT02566135|3993796|FG001|COMPLETED|Overall Study||29
3259400|NCT02566135|3993795|FG000|NOT COMPLETED|Overall Study||0
3259401|NCT02566135|3993796|FG001|NOT COMPLETED|Overall Study||0
3259402|NCT02566239|3993804|FG000|STARTED|Overall Study||43
3259403|NCT02566239|3993805|FG001|STARTED|Overall Study||48
3259404|NCT02566239|3993804|FG000|COMPLETED|Overall Study||39
3259405|NCT02566239|3993805|FG001|COMPLETED|Overall Study||44
3259406|NCT02566239|3993804|FG000|NOT COMPLETED|Overall Study||4
3259407|NCT02566239|3993805|FG001|NOT COMPLETED|Overall Study||4
3259408|NCT02566265|3993813|FG000|STARTED|Overall Study||81
3259409|NCT02566265|3993814|FG001|STARTED|Overall Study||41
3259410|NCT02566265|3993813|FG000|Day 7 (+/- 2 Days) (Optional)|Overall Study||19
3259411|NCT02566265|3993814|FG001|Day 7 (+/- 2 Days) (Optional)|Overall Study||12
3259412|NCT02566265|3993813|FG000|Day of Second Vaccine|Overall Study||74
3259413|NCT02566265|3993814|FG001|Day of Second Vaccine|Overall Study||41
3259414|NCT02566265|3993813|FG000|30 Days Following 2nd Vaccine|Overall Study||72
3259415|NCT02566265|3993814|FG001|30 Days Following 2nd Vaccine|Overall Study||35
3259416|NCT02566265|3993813|FG000|End of Study Visit (Optional)|Overall Study||38
3259417|NCT02566265|3993814|FG001|End of Study Visit (Optional)|Overall Study||18
3259418|NCT02566265|3993813|FG000|COMPLETED|Overall Study||72
3259419|NCT02566265|3993814|FG001|COMPLETED|Overall Study||35
3259420|NCT02566265|3993813|FG000|NOT COMPLETED|Overall Study||9
3259421|NCT02566265|3993814|FG001|NOT COMPLETED|Overall Study||6
3259422|NCT02566317|3993822|FG000|STARTED|Overall Study||276
3259423|NCT02566317|3993823|FG001|STARTED|Overall Study||354
3259424|NCT02566317|3993822|FG000|COMPLETED|Overall Study||247
3259425|NCT02566317|3993823|FG001|COMPLETED|Overall Study||292
3259426|NCT02566317|3993822|FG000|NOT COMPLETED|Overall Study||29
3259427|NCT02566317|3993823|FG001|NOT COMPLETED|Overall Study||62
3259428|NCT02566369|3993831|FG000|STARTED|Overall Study||612
3259429|NCT02566369|3993832|FG001|STARTED|Overall Study||596
3259430|NCT02566369|3993831|FG000|COMPLETED|Overall Study||540
3259431|NCT02566369|3993832|FG001|COMPLETED|Overall Study||535
3259432|NCT02566369|3993831|FG000|NOT COMPLETED|Overall Study||72
3259433|NCT02566369|3993832|FG001|NOT COMPLETED|Overall Study||61
3259434|NCT02566525|3993840|FG000|STARTED|Overall Study|FPI - CytoSorb Patient 15 Jan 2016|23
3259435|NCT02566525|3993841|FG001|STARTED|Overall Study|FPI - Control Patient 8 Dec 2015|23
3259436|NCT02566525|3993840|FG000|COMPLETED|Overall Study|LPI - CytoSorb Patient 19 Aug 2016|20
3259437|NCT02566525|3993841|FG001|COMPLETED|Overall Study|LPI - Control 16 Aug 2016|18
3259438|NCT02566525|3993840|FG000|NOT COMPLETED|Overall Study||3
3259439|NCT02566525|3993841|FG001|NOT COMPLETED|Overall Study||5
3259440|NCT02566577|3993851|FG000|STARTED|Overall Study||9
3259441|NCT02566577|3993852|FG001|STARTED|Overall Study||6
3259442|NCT02566577|3993851|FG000|COMPLETED|Overall Study||6
3259443|NCT02566577|3993852|FG001|COMPLETED|Overall Study||4
3259444|NCT02566577|3993851|FG000|NOT COMPLETED|Overall Study||3
3259445|NCT02566577|3993852|FG001|NOT COMPLETED|Overall Study||2
3259446|NCT02566590|3993862|FG000|STARTED|Overall Study||10
3259447|NCT02566590|3993863|FG001|STARTED|Overall Study||10
3259448|NCT02566590|3993862|FG000|COMPLETED|Overall Study||10
3259449|NCT02566590|3993863|FG001|COMPLETED|Overall Study||10
3259450|NCT02566590|3993862|FG000|NOT COMPLETED|Overall Study||0
3259451|NCT02566590|3993863|FG001|NOT COMPLETED|Overall Study||0
3259452|NCT02566759|3993886|FG000|STARTED|All Parts||12
3259453|NCT02566759|3993887|FG001|STARTED|All Parts||6
3259454|NCT02566759|3993888|FG002|STARTED|All Parts||6
3259455|NCT02566759|3993889|FG003|STARTED|All Parts||6
3259456|NCT02566759|3993890|FG004|STARTED|All Parts||6
3259457|NCT02566759|3993891|FG005|STARTED|All Parts||6
3259458|NCT02566759|3993892|FG006|STARTED|All Parts||6
3259459|NCT02566759|3993893|FG007|STARTED|All Parts||8
3259460|NCT02566759|3993894|FG008|STARTED|All Parts||6
3259461|NCT02566759|3993895|FG009|STARTED|All Parts||6
3259462|NCT02566759|3993896|FG010|STARTED|All Parts||6
3259463|NCT02566759|3993897|FG011|STARTED|All Parts||6
3259464|NCT02566759|3993898|FG012|STARTED|All Parts||1
3259465|NCT02566759|3993899|FG013|STARTED|All Parts||5
3259466|NCT02566759|3993900|FG014|STARTED|All Parts||8
3259467|NCT02566759|3993901|FG015|STARTED|All Parts||8
3259468|NCT02566759|3993902|FG016|STARTED|All Parts||8
3259469|NCT02566759|3993886|FG000|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|12
3259470|NCT02566759|3993887|FG001|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|5
3259471|NCT02566759|3993888|FG002|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
3259472|NCT02566759|3993889|FG003|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
3259473|NCT02566759|3993890|FG004|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
3259474|NCT02566759|3993891|FG005|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
3259475|NCT02566759|3993892|FG006|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
3259476|NCT02566759|3993893|FG007|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|8
3259477|NCT02566759|3993894|FG008|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
3259478|NCT02566759|3993895|FG009|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
3259479|NCT02566759|3993896|FG010|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
3259480|NCT02566759|3993897|FG011|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
3259481|NCT02566759|3993898|FG012|COMPLETED|All Parts||0
3259482|NCT02566759|3993899|FG013|COMPLETED|All Parts||0
3259483|NCT02566759|3993900|FG014|COMPLETED|All Parts|Only participants of Part 4 continued in next period.|8
3259484|NCT02566759|3993901|FG015|COMPLETED|All Parts|Only participants of Part 4 continued in next period.|8
3259485|NCT02566759|3993902|FG016|COMPLETED|All Parts|Only participants of Part 4 continued in next period.|8
3259486|NCT02566759|3993886|FG000|NOT COMPLETED|All Parts||0
3259487|NCT02566759|3993887|FG001|NOT COMPLETED|All Parts||1
3259488|NCT02566759|3993888|FG002|NOT COMPLETED|All Parts||0
3259489|NCT02566759|3993889|FG003|NOT COMPLETED|All Parts||0
3259490|NCT02566759|3993890|FG004|NOT COMPLETED|All Parts||0
3259491|NCT02566759|3993891|FG005|NOT COMPLETED|All Parts||0
3259492|NCT02566759|3993892|FG006|NOT COMPLETED|All Parts||0
3259493|NCT02566759|3993893|FG007|NOT COMPLETED|All Parts||0
3259494|NCT02566759|3993894|FG008|NOT COMPLETED|All Parts||0
3259495|NCT02566759|3993895|FG009|NOT COMPLETED|All Parts||0
3259496|NCT02566759|3993896|FG010|NOT COMPLETED|All Parts||0
3259497|NCT02566759|3993897|FG011|NOT COMPLETED|All Parts||0
3259498|NCT02566759|3993898|FG012|NOT COMPLETED|All Parts||1
3259499|NCT02566759|3993899|FG013|NOT COMPLETED|All Parts||5
3259500|NCT02566759|3993900|FG014|NOT COMPLETED|All Parts||0
3259501|NCT02566759|3993901|FG015|NOT COMPLETED|All Parts||0
3259502|NCT02566759|3993902|FG016|NOT COMPLETED|All Parts||0
3259503|NCT02566759|3993886|FG000|STARTED|Washout Crossover Period (Part 4:5 Days)||0
3259504|NCT02566759|3993887|FG001|STARTED|Washout Crossover Period (Part 4:5 Days)||0
3259505|NCT02566759|3993888|FG002|STARTED|Washout Crossover Period (Part 4:5 Days)||0
3259506|NCT02566759|3993889|FG003|STARTED|Washout Crossover Period (Part 4:5 Days)||0
3259507|NCT02566759|3993890|FG004|STARTED|Washout Crossover Period (Part 4:5 Days)||0
3259508|NCT02566759|3993891|FG005|STARTED|Washout Crossover Period (Part 4:5 Days)||0
3259509|NCT02566759|3993892|FG006|STARTED|Washout Crossover Period (Part 4:5 Days)||0
3259510|NCT02566759|3993893|FG007|STARTED|Washout Crossover Period (Part 4:5 Days)||0
3259511|NCT02566759|3993894|FG008|STARTED|Washout Crossover Period (Part 4:5 Days)||0
3259512|NCT02566759|3993895|FG009|STARTED|Washout Crossover Period (Part 4:5 Days)||0
3259513|NCT02566759|3993896|FG010|STARTED|Washout Crossover Period (Part 4:5 Days)||0
3259514|NCT02566759|3993897|FG011|STARTED|Washout Crossover Period (Part 4:5 Days)||0
3259515|NCT02566759|3993898|FG012|STARTED|Washout Crossover Period (Part 4:5 Days)||0
3259516|NCT02566759|3993899|FG013|STARTED|Washout Crossover Period (Part 4:5 Days)||0
3259517|NCT02566759|3993900|FG014|STARTED|Washout Crossover Period (Part 4:5 Days)||8
3259518|NCT02566759|3993901|FG015|STARTED|Washout Crossover Period (Part 4:5 Days)||8
3259519|NCT02566759|3993902|FG016|STARTED|Washout Crossover Period (Part 4:5 Days)||8
3259520|NCT02566759|3993886|FG000|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
3259521|NCT02566759|3993887|FG001|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
3259522|NCT02566759|3993888|FG002|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
3259523|NCT02566759|3993889|FG003|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
3259524|NCT02566759|3993890|FG004|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
3259525|NCT02566759|3993891|FG005|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
3259526|NCT02566759|3993892|FG006|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
3259527|NCT02566759|3993893|FG007|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
3259528|NCT02566759|3993894|FG008|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
3259529|NCT02566759|3993895|FG009|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
3259530|NCT02566759|3993896|FG010|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
3259531|NCT02566759|3993897|FG011|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
3259532|NCT02566759|3993898|FG012|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
3259533|NCT02566759|3993899|FG013|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
3259534|NCT02566759|3993900|FG014|COMPLETED|Washout Crossover Period (Part 4:5 Days)||8
3259535|NCT02566759|3993901|FG015|COMPLETED|Washout Crossover Period (Part 4:5 Days)||8
3259536|NCT02566759|3993902|FG016|COMPLETED|Washout Crossover Period (Part 4:5 Days)||8
3259537|NCT02566759|3993886|FG000|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
3259538|NCT02566759|3993887|FG001|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
3259539|NCT02566759|3993888|FG002|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
3259540|NCT02566759|3993889|FG003|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
3259541|NCT02566759|3993890|FG004|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
3259542|NCT02566759|3993891|FG005|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
3259543|NCT02566759|3993892|FG006|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
3259544|NCT02566759|3993893|FG007|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
3259545|NCT02566759|3993894|FG008|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
3259546|NCT02566759|3993895|FG009|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
3259547|NCT02566759|3993896|FG010|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
3259548|NCT02566759|3993897|FG011|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
3259549|NCT02566759|3993898|FG012|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
3259550|NCT02566759|3993899|FG013|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
3259551|NCT02566759|3993900|FG014|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
3259552|NCT02566759|3993901|FG015|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
3259553|NCT02566759|3993902|FG016|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
3259554|NCT02566759|3993886|FG000|STARTED|Crossover Treatment (Part 4: 1 Day)||0
3259555|NCT02566759|3993887|FG001|STARTED|Crossover Treatment (Part 4: 1 Day)||0
3259556|NCT02566759|3993888|FG002|STARTED|Crossover Treatment (Part 4: 1 Day)||0
3259557|NCT02566759|3993889|FG003|STARTED|Crossover Treatment (Part 4: 1 Day)||0
3259558|NCT02566759|3993890|FG004|STARTED|Crossover Treatment (Part 4: 1 Day)||0
3259559|NCT02566759|3993891|FG005|STARTED|Crossover Treatment (Part 4: 1 Day)||0
3259560|NCT02566759|3993892|FG006|STARTED|Crossover Treatment (Part 4: 1 Day)||0
3259561|NCT02566759|3993893|FG007|STARTED|Crossover Treatment (Part 4: 1 Day)||0
3259562|NCT02566759|3993894|FG008|STARTED|Crossover Treatment (Part 4: 1 Day)||0
3259563|NCT02566759|3993895|FG009|STARTED|Crossover Treatment (Part 4: 1 Day)||0
3259564|NCT02566759|3993896|FG010|STARTED|Crossover Treatment (Part 4: 1 Day)||0
3259565|NCT02566759|3993897|FG011|STARTED|Crossover Treatment (Part 4: 1 Day)||0
3259566|NCT02566759|3993898|FG012|STARTED|Crossover Treatment (Part 4: 1 Day)||0
3259567|NCT02566759|3993899|FG013|STARTED|Crossover Treatment (Part 4: 1 Day)||0
3259568|NCT02566759|3993900|FG014|STARTED|Crossover Treatment (Part 4: 1 Day)||8
3259569|NCT02566759|3993901|FG015|STARTED|Crossover Treatment (Part 4: 1 Day)||8
3259570|NCT02566759|3993902|FG016|STARTED|Crossover Treatment (Part 4: 1 Day)||8
3259571|NCT02566759|3993886|FG000|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
3259572|NCT02566759|3993887|FG001|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
3259573|NCT02566759|3993888|FG002|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
3259574|NCT02566759|3993889|FG003|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
3259575|NCT02566759|3993890|FG004|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
3259576|NCT02566759|3993891|FG005|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
3259577|NCT02566759|3993892|FG006|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
3259578|NCT02566759|3993893|FG007|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
3259579|NCT02566759|3993894|FG008|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
3259580|NCT02566759|3993895|FG009|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
3259581|NCT02566759|3993896|FG010|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
3259582|NCT02566759|3993897|FG011|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
3259583|NCT02566759|3993898|FG012|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
3259584|NCT02566759|3993899|FG013|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
3259585|NCT02566759|3993900|FG014|COMPLETED|Crossover Treatment (Part 4: 1 Day)||8
3259586|NCT02566759|3993901|FG015|COMPLETED|Crossover Treatment (Part 4: 1 Day)||8
3259587|NCT02566759|3993902|FG016|COMPLETED|Crossover Treatment (Part 4: 1 Day)||7
3259588|NCT02566759|3993886|FG000|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
3259589|NCT02566759|3993887|FG001|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
3259590|NCT02566759|3993888|FG002|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
3259591|NCT02566759|3993889|FG003|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
3259592|NCT02566759|3993890|FG004|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
3259593|NCT02566759|3993891|FG005|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
3259594|NCT02566759|3993892|FG006|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
3259595|NCT02566759|3993893|FG007|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
3259596|NCT02566759|3993894|FG008|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
3259597|NCT02566759|3993895|FG009|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
3259598|NCT02566759|3993896|FG010|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
3259599|NCT02566759|3993897|FG011|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
3259600|NCT02566759|3993898|FG012|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
3259601|NCT02566759|3993899|FG013|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
3259602|NCT02566759|3993900|FG014|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
3259603|NCT02566759|3993901|FG015|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
3259604|NCT02566759|3993902|FG016|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||1
3259605|NCT02566759|3993886|FG000|STARTED|Washout Crossover Period (Part 4:5 Days)||0
3259606|NCT02566759|3993887|FG001|STARTED|Washout Crossover Period (Part 4:5 Days)||0
3259607|NCT02566759|3993888|FG002|STARTED|Washout Crossover Period (Part 4:5 Days)||0
3259608|NCT02566759|3993889|FG003|STARTED|Washout Crossover Period (Part 4:5 Days)||0
3259609|NCT02566759|3993890|FG004|STARTED|Washout Crossover Period (Part 4:5 Days)||0
3259610|NCT02566759|3993891|FG005|STARTED|Washout Crossover Period (Part 4:5 Days)||0
3259611|NCT02566759|3993892|FG006|STARTED|Washout Crossover Period (Part 4:5 Days)||0
3259612|NCT02566759|3993893|FG007|STARTED|Washout Crossover Period (Part 4:5 Days)||0
3259613|NCT02566759|3993894|FG008|STARTED|Washout Crossover Period (Part 4:5 Days)||0
3259614|NCT02566759|3993895|FG009|STARTED|Washout Crossover Period (Part 4:5 Days)||0
3259615|NCT02566759|3993896|FG010|STARTED|Washout Crossover Period (Part 4:5 Days)||0
3259616|NCT02566759|3993897|FG011|STARTED|Washout Crossover Period (Part 4:5 Days)||0
3259617|NCT02566759|3993898|FG012|STARTED|Washout Crossover Period (Part 4:5 Days)||0
3259618|NCT02566759|3993899|FG013|STARTED|Washout Crossover Period (Part 4:5 Days)||0
3259619|NCT02566759|3993900|FG014|STARTED|Washout Crossover Period (Part 4:5 Days)||8
3259620|NCT02566759|3993901|FG015|STARTED|Washout Crossover Period (Part 4:5 Days)||8
3259621|NCT02566759|3993902|FG016|STARTED|Washout Crossover Period (Part 4:5 Days)||7
3259622|NCT02566759|3993886|FG000|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
3259623|NCT02566759|3993887|FG001|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
3259624|NCT02566759|3993888|FG002|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
3259625|NCT02566759|3993889|FG003|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
3259626|NCT02566759|3993890|FG004|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
3259627|NCT02566759|3993891|FG005|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
3259628|NCT02566759|3993892|FG006|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
3259629|NCT02566759|3993893|FG007|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
3372838|NCT02806960|4104864|FG000|STARTED|Period 4||0
3372839|NCT02806960|4104865|FG001|STARTED|Period 4||0
3372840|NCT02806960|4104866|FG002|STARTED|Period 4||0
3372841|NCT02806960|4104867|FG003|STARTED|Period 4||0
3372842|NCT02806960|4104864|FG000|COMPLETED|Period 4||0
3372843|NCT02806960|4104865|FG001|COMPLETED|Period 4||0
3372844|NCT02806960|4104866|FG002|COMPLETED|Period 4||0
3372845|NCT02806960|4104867|FG003|COMPLETED|Period 4||0
3372846|NCT02806960|4104864|FG000|NOT COMPLETED|Period 4||0
3372847|NCT02806960|4104865|FG001|NOT COMPLETED|Period 4||0
3372848|NCT02806960|4104866|FG002|NOT COMPLETED|Period 4||0
3372849|NCT02806960|4104867|FG003|NOT COMPLETED|Period 4||0
3372850|NCT02815397|4104877|FG000|STARTED|Overall Study||2
3372851|NCT02815397|4104877|FG000|COMPLETED|Overall Study||0
3372852|NCT02815397|4104877|FG000|NOT COMPLETED|Overall Study||2
3372853|NCT02802592|4104881|FG000|STARTED|Overall Study||4
3372854|NCT02802592|4104881|FG000|COMPLETED|Overall Study||0
3372855|NCT02802592|4104881|FG000|NOT COMPLETED|Overall Study||4
3372856|NCT02774148|4104888|FG000|STARTED|Overall Study||0
3372857|NCT02774148|4104889|FG001|STARTED|Overall Study||0
3372858|NCT02774148|4104888|FG000|COMPLETED|Overall Study||0
3372859|NCT02774148|4104889|FG001|COMPLETED|Overall Study||0
3372860|NCT02774148|4104888|FG000|NOT COMPLETED|Overall Study||0
3372861|NCT02774148|4104889|FG001|NOT COMPLETED|Overall Study||0
3259630|NCT02566759|3993894|FG008|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
3259631|NCT02566759|3993895|FG009|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
3259632|NCT02566759|3993896|FG010|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
3259633|NCT02566759|3993897|FG011|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
3259634|NCT02566759|3993898|FG012|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
3259635|NCT02566759|3993899|FG013|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
3259636|NCT02566759|3993900|FG014|COMPLETED|Washout Crossover Period (Part 4:5 Days)||8
3259637|NCT02566759|3993901|FG015|COMPLETED|Washout Crossover Period (Part 4:5 Days)||8
3259638|NCT02566759|3993902|FG016|COMPLETED|Washout Crossover Period (Part 4:5 Days)||7
3259639|NCT02566759|3993886|FG000|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
3259640|NCT02566759|3993887|FG001|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
3259641|NCT02566759|3993888|FG002|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
3259642|NCT02566759|3993889|FG003|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
3259643|NCT02566759|3993890|FG004|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
3259644|NCT02566759|3993891|FG005|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
3259645|NCT02566759|3993892|FG006|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
3259646|NCT02566759|3993893|FG007|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
3259647|NCT02566759|3993894|FG008|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
3259648|NCT02566759|3993895|FG009|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
3259649|NCT02566759|3993896|FG010|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
3259650|NCT02566759|3993897|FG011|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
3259651|NCT02566759|3993898|FG012|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
3259652|NCT02566759|3993899|FG013|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
3259653|NCT02566759|3993900|FG014|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
3259654|NCT02566759|3993901|FG015|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
3259655|NCT02566759|3993902|FG016|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
3259656|NCT02566759|3993886|FG000|STARTED|Crossover Treatment (Part 4: 1 Day)||0
3259657|NCT02566759|3993887|FG001|STARTED|Crossover Treatment (Part 4: 1 Day)||0
3259658|NCT02566759|3993888|FG002|STARTED|Crossover Treatment (Part 4: 1 Day)||0
3259659|NCT02566759|3993889|FG003|STARTED|Crossover Treatment (Part 4: 1 Day)||0
3259660|NCT02566759|3993890|FG004|STARTED|Crossover Treatment (Part 4: 1 Day)||0
3259661|NCT02566759|3993891|FG005|STARTED|Crossover Treatment (Part 4: 1 Day)||0
3259662|NCT02566759|3993892|FG006|STARTED|Crossover Treatment (Part 4: 1 Day)||0
3259663|NCT02566759|3993893|FG007|STARTED|Crossover Treatment (Part 4: 1 Day)||0
3259664|NCT02566759|3993894|FG008|STARTED|Crossover Treatment (Part 4: 1 Day)||0
3259665|NCT02566759|3993895|FG009|STARTED|Crossover Treatment (Part 4: 1 Day)||0
3259666|NCT02566759|3993896|FG010|STARTED|Crossover Treatment (Part 4: 1 Day)||0
3259667|NCT02566759|3993897|FG011|STARTED|Crossover Treatment (Part 4: 1 Day)||0
3259668|NCT02566759|3993898|FG012|STARTED|Crossover Treatment (Part 4: 1 Day)||0
3259669|NCT02566759|3993899|FG013|STARTED|Crossover Treatment (Part 4: 1 Day)||0
3259670|NCT02566759|3993900|FG014|STARTED|Crossover Treatment (Part 4: 1 Day)||8
3259671|NCT02566759|3993901|FG015|STARTED|Crossover Treatment (Part 4: 1 Day)||8
3259672|NCT02566759|3993902|FG016|STARTED|Crossover Treatment (Part 4: 1 Day)||7
3259673|NCT02566759|3993886|FG000|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
3259674|NCT02566759|3993887|FG001|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
3259675|NCT02566759|3993888|FG002|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
3259676|NCT02566759|3993889|FG003|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
3259677|NCT02566759|3993890|FG004|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
3259678|NCT02566759|3993891|FG005|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
3259679|NCT02566759|3993892|FG006|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
3259680|NCT02566759|3993893|FG007|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
3259681|NCT02566759|3993894|FG008|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
3259682|NCT02566759|3993895|FG009|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
3259683|NCT02566759|3993896|FG010|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
3259684|NCT02566759|3993897|FG011|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
3259685|NCT02566759|3993898|FG012|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
3259686|NCT02566759|3993899|FG013|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
3259687|NCT02566759|3993900|FG014|COMPLETED|Crossover Treatment (Part 4: 1 Day)||8
3259688|NCT02566759|3993901|FG015|COMPLETED|Crossover Treatment (Part 4: 1 Day)||8
3259689|NCT02566759|3993902|FG016|COMPLETED|Crossover Treatment (Part 4: 1 Day)||7
3259690|NCT02566759|3993886|FG000|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
3259691|NCT02566759|3993887|FG001|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
3259692|NCT02566759|3993888|FG002|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
3259693|NCT02566759|3993889|FG003|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
3259694|NCT02566759|3993890|FG004|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
3259695|NCT02566759|3993891|FG005|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
3259696|NCT02566759|3993892|FG006|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
3259697|NCT02566759|3993893|FG007|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
3259698|NCT02566759|3993894|FG008|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
3259699|NCT02566759|3993895|FG009|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
3259700|NCT02566759|3993896|FG010|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
3259701|NCT02566759|3993897|FG011|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
3259702|NCT02566759|3993898|FG012|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
3259703|NCT02566759|3993899|FG013|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
3259704|NCT02566759|3993900|FG014|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
3259705|NCT02566759|3993901|FG015|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
3259706|NCT02566759|3993902|FG016|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
3259707|NCT02566785|3993963|FG000|STARTED|Overall Study||15
3259708|NCT02566785|3993964|FG001|STARTED|Overall Study||18
3259709|NCT02566785|3993963|FG000|COMPLETED|Overall Study||14
3259710|NCT02566785|3993964|FG001|COMPLETED|Overall Study||15
3259711|NCT02566785|3993963|FG000|NOT COMPLETED|Overall Study||1
3259712|NCT02566785|3993964|FG001|NOT COMPLETED|Overall Study||3
3259713|NCT02566889|3993972|FG000|STARTED|Overall Study||45
3259714|NCT02566889|3993973|FG001|STARTED|Overall Study||8
3259715|NCT02566889|3993972|FG000|Cross-over to Dose Escalation Group|Overall Study||1
3259716|NCT02566889|3993973|FG001|Cross-over to Dose Escalation Group|Overall Study||0
3259717|NCT02566889|3993972|FG000|COMPLETED|Overall Study||32
3259718|NCT02566889|3993973|FG001|COMPLETED|Overall Study||3
3259719|NCT02566889|3993972|FG000|NOT COMPLETED|Overall Study||13
3259720|NCT02566889|3993973|FG001|NOT COMPLETED|Overall Study||5
3259721|NCT02566902|3993980|FG000|STARTED|Overall Study||60
3259722|NCT02566902|3993981|FG001|STARTED|Overall Study||58
3259723|NCT02566902|3993980|FG000|COMPLETED|Overall Study||58
3259724|NCT02566902|3993981|FG001|COMPLETED|Overall Study||57
3259725|NCT02566902|3993980|FG000|NOT COMPLETED|Overall Study||2
3259726|NCT02566902|3993981|FG001|NOT COMPLETED|Overall Study||1
3259727|NCT02566993|3993989|FG000|STARTED|Overall Study||307
3259728|NCT02566993|3993990|FG001|STARTED|Overall Study||306
3259729|NCT02566993|3993989|FG000|COMPLETED|Overall Study||0
3259730|NCT02566993|3993990|FG001|COMPLETED|Overall Study||0
3259731|NCT02566993|3993989|FG000|NOT COMPLETED|Overall Study||307
3259732|NCT02566993|3993990|FG001|NOT COMPLETED|Overall Study||306
3259733|NCT02567188|3993998|FG000|STARTED|Overall Study||144
3259734|NCT02567188|3993998|FG000|COMPLETED|Overall Study||109
3259735|NCT02567188|3993998|FG000|NOT COMPLETED|Overall Study||35
3259736|NCT02567227|3994005|FG000|STARTED|9 Weeks||192
3259737|NCT02567227|3994006|FG001|STARTED|9 Weeks||191
3259738|NCT02567227|3994005|FG000|COMPLETED|9 Weeks||158
3259739|NCT02567227|3994006|FG001|COMPLETED|9 Weeks||167
3259740|NCT02567227|3994005|FG000|NOT COMPLETED|9 Weeks||34
3259741|NCT02567227|3994006|FG001|NOT COMPLETED|9 Weeks||24
3259742|NCT02567227|3994005|FG000|STARTED|6 Month||158
3259743|NCT02567227|3994006|FG001|STARTED|6 Month||167
3259744|NCT02567227|3994005|FG000|COMPLETED|6 Month||113
3259745|NCT02567227|3994006|FG001|COMPLETED|6 Month||127
3259746|NCT02567227|3994005|FG000|NOT COMPLETED|6 Month||45
3259747|NCT02567227|3994006|FG001|NOT COMPLETED|6 Month||40
3259748|NCT02567227|3994005|FG000|STARTED|12 Months||113
3259749|NCT02567227|3994006|FG001|STARTED|12 Months||127
3259750|NCT02567227|3994005|FG000|COMPLETED|12 Months||82
3259751|NCT02567227|3994006|FG001|COMPLETED|12 Months||93
3259752|NCT02567227|3994005|FG000|NOT COMPLETED|12 Months||31
3259753|NCT02567227|3994006|FG001|NOT COMPLETED|12 Months||34
3259754|NCT02567266|3994015|FG000|STARTED|Overall Study||68
3259755|NCT02567266|3994016|FG001|STARTED|Overall Study||60
3259756|NCT02567266|3994017|FG002|STARTED|Overall Study||68
3259757|NCT02567266|3994015|FG000|Midpoint (8 Weeks)|Overall Study||54
3259758|NCT02567266|3994016|FG001|Midpoint (8 Weeks)|Overall Study||52
3259759|NCT02567266|3994017|FG002|Midpoint (8 Weeks)|Overall Study||55
3259760|NCT02567266|3994015|FG000|Post (16 Weeks)|Overall Study||49
3259761|NCT02567266|3994016|FG001|Post (16 Weeks)|Overall Study||43
3259762|NCT02567266|3994017|FG002|Post (16 Weeks)|Overall Study||53
3259763|NCT02567266|3994015|FG000|Follow-up (28 Weeks)|Overall Study||45
3259764|NCT02567266|3994016|FG001|Follow-up (28 Weeks)|Overall Study||45
3259765|NCT02567266|3994017|FG002|Follow-up (28 Weeks)|Overall Study||52
3259766|NCT02567266|3994015|FG000|COMPLETED|Overall Study||45
3259767|NCT02567266|3994016|FG001|COMPLETED|Overall Study||45
3259768|NCT02567266|3994017|FG002|COMPLETED|Overall Study||52
3259769|NCT02567266|3994015|FG000|NOT COMPLETED|Overall Study||23
3259770|NCT02567266|3994016|FG001|NOT COMPLETED|Overall Study||15
3259771|NCT02567266|3994017|FG002|NOT COMPLETED|Overall Study||16
3259772|NCT02567552|3994027|FG000|STARTED|Overall Study||12
3259773|NCT02567552|3994028|FG001|STARTED|Overall Study||12
3259774|NCT02567552|3994027|FG000|COMPLETED|Overall Study||12
3259775|NCT02567552|3994028|FG001|COMPLETED|Overall Study|dropout by pain in the puncture site|11
3259776|NCT02567552|3994027|FG000|NOT COMPLETED|Overall Study||0
3259777|NCT02567552|3994028|FG001|NOT COMPLETED|Overall Study||1
3259778|NCT02567656|3994040|FG000|STARTED|Overall Study||4
3259779|NCT02567656|3994041|FG001|STARTED|Overall Study||4
3259780|NCT02567656|3994042|FG002|STARTED|Overall Study||5
3259781|NCT02567656|3994043|FG003|STARTED|Overall Study||6
3259782|NCT02567656|3994044|FG004|STARTED|Overall Study||19
3259783|NCT02567656|3994045|FG005|STARTED|Overall Study||20
3259784|NCT02567656|3994040|FG000|COMPLETED|Overall Study||3
3259785|NCT02567656|3994041|FG001|COMPLETED|Overall Study||3
3259786|NCT02567656|3994042|FG002|COMPLETED|Overall Study||3
3259787|NCT02567656|3994043|FG003|COMPLETED|Overall Study||6
3259788|NCT02567656|3994044|FG004|COMPLETED|Overall Study||19
3259789|NCT02567656|3994045|FG005|COMPLETED|Overall Study||20
3259790|NCT02567656|3994040|FG000|NOT COMPLETED|Overall Study||1
3259791|NCT02567656|3994041|FG001|NOT COMPLETED|Overall Study||1
3259792|NCT02567656|3994042|FG002|NOT COMPLETED|Overall Study||2
3259793|NCT02567656|3994043|FG003|NOT COMPLETED|Overall Study||0
3259794|NCT02567656|3994044|FG004|NOT COMPLETED|Overall Study||0
3259795|NCT02567656|3994045|FG005|NOT COMPLETED|Overall Study||0
3259796|NCT02567708|3994059|FG000|STARTED|Treatment Period 1 (Up to 4 Weeks)||24
3259797|NCT02567708|3994060|FG001|STARTED|Treatment Period 1 (Up to 4 Weeks)||26
3259798|NCT02567708|3994059|FG000|COMPLETED|Treatment Period 1 (Up to 4 Weeks)||22
3259799|NCT02567708|3994060|FG001|COMPLETED|Treatment Period 1 (Up to 4 Weeks)||23
3259800|NCT02567708|3994059|FG000|NOT COMPLETED|Treatment Period 1 (Up to 4 Weeks)||2
3259801|NCT02567708|3994060|FG001|NOT COMPLETED|Treatment Period 1 (Up to 4 Weeks)||3
3259802|NCT02567708|3994059|FG000|STARTED|Washout Period (Up to 4 Weeks)||22
3259803|NCT02567708|3994060|FG001|STARTED|Washout Period (Up to 4 Weeks)||23
3259804|NCT02567708|3994059|FG000|COMPLETED|Washout Period (Up to 4 Weeks)||22
3259805|NCT02567708|3994060|FG001|COMPLETED|Washout Period (Up to 4 Weeks)||23
3259806|NCT02567708|3994059|FG000|NOT COMPLETED|Washout Period (Up to 4 Weeks)||0
3259807|NCT02567708|3994060|FG001|NOT COMPLETED|Washout Period (Up to 4 Weeks)||0
3259808|NCT02567708|3994059|FG000|STARTED|Treatment Period 2 (Up to 4 Weeks)||22
3259809|NCT02567708|3994060|FG001|STARTED|Treatment Period 2 (Up to 4 Weeks)||23
3259810|NCT02567708|3994059|FG000|COMPLETED|Treatment Period 2 (Up to 4 Weeks)||22
3259811|NCT02567708|3994060|FG001|COMPLETED|Treatment Period 2 (Up to 4 Weeks)||20
3259812|NCT02567708|3994059|FG000|NOT COMPLETED|Treatment Period 2 (Up to 4 Weeks)||0
3259813|NCT02567708|3994060|FG001|NOT COMPLETED|Treatment Period 2 (Up to 4 Weeks)||3
3259814|NCT02567968|3994067|FG000|STARTED|First Intervention||4
3259815|NCT02567968|3994068|FG001|STARTED|First Intervention||4
3259816|NCT02567968|3994067|FG000|COMPLETED|First Intervention||4
3259817|NCT02567968|3994068|FG001|COMPLETED|First Intervention||4
3259818|NCT02567968|3994067|FG000|NOT COMPLETED|First Intervention||0
3259819|NCT02567968|3994068|FG001|NOT COMPLETED|First Intervention||0
3259820|NCT02567968|3994067|FG000|STARTED|Washout (2 Weeks)||4
3259821|NCT02567968|3994068|FG001|STARTED|Washout (2 Weeks)||4
3259822|NCT02567968|3994067|FG000|COMPLETED|Washout (2 Weeks)||4
3259823|NCT02567968|3994068|FG001|COMPLETED|Washout (2 Weeks)||4
3259824|NCT02567968|3994067|FG000|NOT COMPLETED|Washout (2 Weeks)||0
3259825|NCT02567968|3994068|FG001|NOT COMPLETED|Washout (2 Weeks)||0
3259826|NCT02567968|3994067|FG000|STARTED|Second Intervention||4
3259827|NCT02567968|3994068|FG001|STARTED|Second Intervention||4
3259828|NCT02567968|3994067|FG000|COMPLETED|Second Intervention||4
3259829|NCT02567968|3994068|FG001|COMPLETED|Second Intervention||4
3259830|NCT02567968|3994067|FG000|NOT COMPLETED|Second Intervention||0
3259831|NCT02567968|3994068|FG001|NOT COMPLETED|Second Intervention||0
3259832|NCT02568046|3994076|FG000|STARTED|Overall Study||5
3259833|NCT02568046|3994077|FG001|STARTED|Overall Study||5
3259834|NCT02568046|3994076|FG000|COMPLETED|Overall Study||0
3259835|NCT02568046|3994077|FG001|COMPLETED|Overall Study||2
3259836|NCT02568046|3994076|FG000|NOT COMPLETED|Overall Study||5
3259837|NCT02568046|3994077|FG001|NOT COMPLETED|Overall Study||3
3259838|NCT02568072|3994083|FG000|STARTED|Overall Study||120
3259839|NCT02568072|3994083|FG000|COMPLETED|Overall Study||68
3259840|NCT02568072|3994083|FG000|NOT COMPLETED|Overall Study||52
3259841|NCT02568254|3994088|FG000|STARTED|Period 1||13
3259842|NCT02568254|3994089|FG001|STARTED|Period 1||12
3259843|NCT02568254|3994090|FG002|STARTED|Period 1||13
3259844|NCT02568254|3994091|FG003|STARTED|Period 1||12
3259845|NCT02568254|3994092|FG004|STARTED|Period 1||12
3259846|NCT02568254|3994093|FG005|STARTED|Period 1||12
3259847|NCT02568254|3994088|FG000|COMPLETED|Period 1||13
3259848|NCT02568254|3994089|FG001|COMPLETED|Period 1||12
3259849|NCT02568254|3994090|FG002|COMPLETED|Period 1||13
3259850|NCT02568254|3994091|FG003|COMPLETED|Period 1||12
3259851|NCT02568254|3994092|FG004|COMPLETED|Period 1||12
3259852|NCT02568254|3994093|FG005|COMPLETED|Period 1||12
3259853|NCT02568254|3994088|FG000|NOT COMPLETED|Period 1||0
3259854|NCT02568254|3994089|FG001|NOT COMPLETED|Period 1||0
3259855|NCT02568254|3994090|FG002|NOT COMPLETED|Period 1||0
3259856|NCT02568254|3994091|FG003|NOT COMPLETED|Period 1||0
3259857|NCT02568254|3994092|FG004|NOT COMPLETED|Period 1||0
3259858|NCT02568254|3994093|FG005|NOT COMPLETED|Period 1||0
3259859|NCT02568254|3994088|FG000|STARTED|Period 2||13
3259860|NCT02568254|3994089|FG001|STARTED|Period 2||12
3259861|NCT02568254|3994090|FG002|STARTED|Period 2||13
3259862|NCT02568254|3994091|FG003|STARTED|Period 2||12
3259863|NCT02568254|3994092|FG004|STARTED|Period 2||12
3259864|NCT02568254|3994093|FG005|STARTED|Period 2||12
3259865|NCT02568254|3994088|FG000|COMPLETED|Period 2||13
3259866|NCT02568254|3994089|FG001|COMPLETED|Period 2||12
3259867|NCT02568254|3994090|FG002|COMPLETED|Period 2||12
3259868|NCT02568254|3994091|FG003|COMPLETED|Period 2||12
3259869|NCT02568254|3994092|FG004|COMPLETED|Period 2||12
3259870|NCT02568254|3994093|FG005|COMPLETED|Period 2||12
3259871|NCT02568254|3994088|FG000|NOT COMPLETED|Period 2||0
3259872|NCT02568254|3994089|FG001|NOT COMPLETED|Period 2||0
3259873|NCT02568254|3994090|FG002|NOT COMPLETED|Period 2||1
3259874|NCT02568254|3994091|FG003|NOT COMPLETED|Period 2||0
3259875|NCT02568254|3994092|FG004|NOT COMPLETED|Period 2||0
3259876|NCT02568254|3994093|FG005|NOT COMPLETED|Period 2||0
3259877|NCT02568254|3994088|FG000|STARTED|Period 3||13
3259878|NCT02568254|3994089|FG001|STARTED|Period 3||12
3259879|NCT02568254|3994090|FG002|STARTED|Period 3||12
3259880|NCT02568254|3994091|FG003|STARTED|Period 3||12
3259881|NCT02568254|3994092|FG004|STARTED|Period 3||12
3259882|NCT02568254|3994093|FG005|STARTED|Period 3||12
3259883|NCT02568254|3994088|FG000|COMPLETED|Period 3||13
3259884|NCT02568254|3994089|FG001|COMPLETED|Period 3||12
3259885|NCT02568254|3994090|FG002|COMPLETED|Period 3||12
3259886|NCT02568254|3994091|FG003|COMPLETED|Period 3||12
3259887|NCT02568254|3994092|FG004|COMPLETED|Period 3||11
3259888|NCT02568254|3994093|FG005|COMPLETED|Period 3||12
3259889|NCT02568254|3994088|FG000|NOT COMPLETED|Period 3||0
3259890|NCT02568254|3994089|FG001|NOT COMPLETED|Period 3||0
3259891|NCT02568254|3994090|FG002|NOT COMPLETED|Period 3||0
3259892|NCT02568254|3994091|FG003|NOT COMPLETED|Period 3||0
3259893|NCT02568254|3994092|FG004|NOT COMPLETED|Period 3||1
3259894|NCT02568254|3994093|FG005|NOT COMPLETED|Period 3||0
3259895|NCT02568345|3994101|FG000|STARTED|Overall Study||31
3259896|NCT02568345|3994101|FG000|Treated at 2.2 mg/kg|Overall Study|patients: 6th, 20th, 26th|3
3259897|NCT02568345|3994101|FG000|Treated at 2.4 mg/kg|Overall Study|Patients: 1st-5th; 7th; 11th-15th; 21st-25th; 27th-31st|25
3259898|NCT02568345|3994101|FG000|Treated at 2.6 mg/kg|Overall Study|Patients: 8th-10th|3
3259899|NCT02568345|3994101|FG000|COMPLETED|Overall Study||31
3259900|NCT02568345|3994101|FG000|NOT COMPLETED|Overall Study||0
3259901|NCT02568384|3994105|FG000|STARTED|Overall Study||45
3259902|NCT02568384|3994105|FG000|COMPLETED|Overall Study||43
3259903|NCT02568384|3994105|FG000|NOT COMPLETED|Overall Study||2
3259904|NCT02568397|3994109|FG000|STARTED|Period 1||60
3259905|NCT02568397|3994110|FG001|STARTED|Period 1||0
3259906|NCT02568397|3994109|FG000|Received at Least 1 Dose of Study Drug|Period 1||60
3259907|NCT02568397|3994110|FG001|Received at Least 1 Dose of Study Drug|Period 1||0
3259908|NCT02568397|3994109|FG000|COMPLETED|Period 1||60
3259909|NCT02568397|3994110|FG001|COMPLETED|Period 1||0
3259910|NCT02568397|3994109|FG000|NOT COMPLETED|Period 1||0
3259911|NCT02568397|3994110|FG001|NOT COMPLETED|Period 1||0
3259912|NCT02568397|3994109|FG000|STARTED|Period 2|A single oral dose of 150 mg dabigatran etexilate was administered on Day 1 of Period 1.|0
3259913|NCT02568397|3994110|FG001|STARTED|Period 2|Daily doses of 50 mg LY3314814 were administered daily on Days 3 to 21 of Period 2.|60
3259914|NCT02568397|3994109|FG000|COMPLETED|Period 2||0
3259915|NCT02568397|3994110|FG001|COMPLETED|Period 2||58
3259916|NCT02568397|3994109|FG000|NOT COMPLETED|Period 2||0
3259917|NCT02568397|3994110|FG001|NOT COMPLETED|Period 2||2
3259918|NCT02568475|3994127|FG000|STARTED|Overall Study||97
3259919|NCT02568475|3994128|FG001|STARTED|Overall Study||95
3259920|NCT02568475|3994127|FG000|Post-test|Overall Study||85
3259921|NCT02568475|3994128|FG001|Post-test|Overall Study||82
3259922|NCT02568475|3994127|FG000|COMPLETED|Overall Study||46
3259923|NCT02568475|3994128|FG001|COMPLETED|Overall Study||52
3259924|NCT02568475|3994127|FG000|NOT COMPLETED|Overall Study||51
3259925|NCT02568475|3994128|FG001|NOT COMPLETED|Overall Study||43
3259926|NCT02568644|3994136|FG000|STARTED|Overall Study||30
3259927|NCT02568644|3994137|FG001|STARTED|Overall Study||30
3259928|NCT02568644|3994136|FG000|COMPLETED|Overall Study||30
3259929|NCT02568644|3994137|FG001|COMPLETED|Overall Study||30
3259930|NCT02568644|3994136|FG000|NOT COMPLETED|Overall Study||0
3259931|NCT02568644|3994137|FG001|NOT COMPLETED|Overall Study||0
3259932|NCT02568683|3994147|FG000|STARTED|Overall Study||6
3259933|NCT02568683|3994148|FG001|STARTED|Overall Study||4
3259934|NCT02568683|3994147|FG000|COMPLETED|Overall Study||0
3259935|NCT02568683|3994148|FG001|COMPLETED|Overall Study||0
3259936|NCT02568683|3994147|FG000|NOT COMPLETED|Overall Study||6
3259937|NCT02568683|3994148|FG001|NOT COMPLETED|Overall Study||4
3259938|NCT02568852|3994156|FG000|STARTED|Overall Study||25
3259939|NCT02568852|3994157|FG001|STARTED|Overall Study||25
3259940|NCT02568852|3994156|FG000|COMPLETED|Overall Study||25
3259941|NCT02568852|3994157|FG001|COMPLETED|Overall Study||25
3259942|NCT02568852|3994156|FG000|NOT COMPLETED|Overall Study||0
3259943|NCT02568852|3994157|FG001|NOT COMPLETED|Overall Study||0
3259944|NCT02569086|3994163|FG000|STARTED|Overall Study||22
3259945|NCT02569086|3994163|FG000|COMPLETED|Overall Study||22
3259946|NCT02569086|3994163|FG000|NOT COMPLETED|Overall Study||0
3259947|NCT02569112|3994167|FG000|STARTED|Overall Study||10
3259948|NCT02569112|3994168|FG001|STARTED|Overall Study||10
3259949|NCT02569112|3994167|FG000|COMPLETED|Overall Study||10
3259950|NCT02569112|3994168|FG001|COMPLETED|Overall Study|Each subject received multipolar RF with varipulse technology to only one side of their body.|10
3259951|NCT02569112|3994167|FG000|NOT COMPLETED|Overall Study||0
3259952|NCT02569112|3994168|FG001|NOT COMPLETED|Overall Study||0
3259953|NCT02569398|3994176|FG000|STARTED|Overall Study||185
3259954|NCT02569398|3994177|FG001|STARTED|Overall Study||189
3259955|NCT02569398|3994178|FG002|STARTED|Overall Study||183
3259956|NCT02569398|3994176|FG000|COMPLETED|Overall Study||0
3259957|NCT02569398|3994177|FG001|COMPLETED|Overall Study||0
3259958|NCT02569398|3994178|FG002|COMPLETED|Overall Study||0
3259959|NCT02569398|3994176|FG000|NOT COMPLETED|Overall Study||185
3259960|NCT02569398|3994177|FG001|NOT COMPLETED|Overall Study||189
3259961|NCT02569398|3994178|FG002|NOT COMPLETED|Overall Study||183
3259962|NCT02569411|3994188|FG000|STARTED|Overall Study||65
3259963|NCT02569411|3994189|FG001|STARTED|Overall Study||64
3259964|NCT02569411|3994188|FG000|COMPLETED|Overall Study||0
3259965|NCT02569411|3994189|FG001|COMPLETED|Overall Study||0
3259966|NCT02569411|3994188|FG000|NOT COMPLETED|Overall Study||65
3259967|NCT02569411|3994189|FG001|NOT COMPLETED|Overall Study||64
3259968|NCT02569437|3994197|FG000|STARTED|Overall Study||24
3259969|NCT02569437|3994198|FG001|STARTED|Overall Study||25
3259970|NCT02569437|3994197|FG000|COMPLETED|Overall Study||12
3259971|NCT02569437|3994198|FG001|COMPLETED|Overall Study||11
3259972|NCT02569437|3994197|FG000|NOT COMPLETED|Overall Study||12
3259973|NCT02569437|3994198|FG001|NOT COMPLETED|Overall Study||14
3259974|NCT02569476|3994204|FG000|STARTED|Overall Study||119
3259975|NCT02569476|3994204|FG000|COMPLETED|Overall Study||0
3259976|NCT02569476|3994204|FG000|NOT COMPLETED|Overall Study||119
3259977|NCT02569541|3994214|FG000|STARTED|Overall Study||30
3259978|NCT02569541|3994214|FG000|COMPLETED|Overall Study||9
3259979|NCT02569541|3994214|FG000|NOT COMPLETED|Overall Study||21
3259980|NCT02569632|3994218|FG000|STARTED|Overall Study||18
3259981|NCT02569632|3994218|FG000|COMPLETED|Overall Study||17
3259982|NCT02569632|3994218|FG000|NOT COMPLETED|Overall Study||1
3259983|NCT02569658|3994224|FG000|STARTED|Overall Study||53
3259984|NCT02569658|3994225|FG001|STARTED|Overall Study||57
3259985|NCT02569658|3994224|FG000|COMPLETED|Overall Study||52
3259986|NCT02569658|3994225|FG001|COMPLETED|Overall Study||56
3259987|NCT02569658|3994224|FG000|NOT COMPLETED|Overall Study||1
3259988|NCT02569658|3994225|FG001|NOT COMPLETED|Overall Study||1
3259989|NCT02569710|3994241|FG000|STARTED|Overall Study||20
3259990|NCT02569710|3994242|FG001|STARTED|Overall Study||25
3259991|NCT02569710|3994243|FG002|STARTED|Overall Study||20
3259992|NCT02569710|3994244|FG003|STARTED|Overall Study||20
3259993|NCT02569710|3994245|FG004|STARTED|Overall Study||8
3259994|NCT02569710|3994246|FG005|STARTED|Overall Study||5
3259995|NCT02569710|3994247|FG006|STARTED|Overall Study||14
3259996|NCT02569710|3994248|FG007|STARTED|Overall Study||30
3259997|NCT02569710|3994249|FG008|STARTED|Overall Study||15
3259998|NCT02569710|3994250|FG009|STARTED|Overall Study||4
3259999|NCT02569710|3994241|FG000|COMPLETED|Overall Study||19
3260000|NCT02569710|3994242|FG001|COMPLETED|Overall Study||25
3260001|NCT02569710|3994243|FG002|COMPLETED|Overall Study||20
3260002|NCT02569710|3994244|FG003|COMPLETED|Overall Study||20
3260003|NCT02569710|3994245|FG004|COMPLETED|Overall Study||7
3260004|NCT02569710|3994246|FG005|COMPLETED|Overall Study||4
3260005|NCT02569710|3994247|FG006|COMPLETED|Overall Study||12
3260006|NCT02569710|3994248|FG007|COMPLETED|Overall Study||30
3260007|NCT02569710|3994249|FG008|COMPLETED|Overall Study||14
3260008|NCT02569710|3994250|FG009|COMPLETED|Overall Study||4
3260009|NCT02569710|3994241|FG000|NOT COMPLETED|Overall Study||1
3260010|NCT02569710|3994242|FG001|NOT COMPLETED|Overall Study||0
3260011|NCT02569710|3994243|FG002|NOT COMPLETED|Overall Study||0
3260012|NCT02569710|3994244|FG003|NOT COMPLETED|Overall Study||0
3260013|NCT02569710|3994245|FG004|NOT COMPLETED|Overall Study||1
3260014|NCT02569710|3994246|FG005|NOT COMPLETED|Overall Study||1
3260015|NCT02569710|3994247|FG006|NOT COMPLETED|Overall Study||2
3260016|NCT02569710|3994248|FG007|NOT COMPLETED|Overall Study||0
3260017|NCT02569710|3994249|FG008|NOT COMPLETED|Overall Study||1
3260018|NCT02569710|3994250|FG009|NOT COMPLETED|Overall Study||0
3260019|NCT02569723|3994283|FG000|STARTED|Overall Study||6
3260020|NCT02569723|3994283|FG000|COMPLETED|Overall Study||6
3260021|NCT02569723|3994283|FG000|NOT COMPLETED|Overall Study||0
3260022|NCT02569801|3994289|FG000|STARTED|Overall Study||36
3260023|NCT02569801|3994290|FG001|STARTED|Overall Study||35
3260024|NCT02569801|3994289|FG000|Received Treatment|Overall Study||35
3260025|NCT02569801|3994290|FG001|Received Treatment|Overall Study||35
3260026|NCT02569801|3994289|FG000|COMPLETED|Overall Study||0
3260027|NCT02569801|3994290|FG001|COMPLETED|Overall Study||0
3260028|NCT02569801|3994289|FG000|NOT COMPLETED|Overall Study||36
3260029|NCT02569801|3994290|FG001|NOT COMPLETED|Overall Study||35
3260030|NCT02569853|3994298|FG000|STARTED|Overall Study||131
3260031|NCT02569853|3994299|FG001|STARTED|Overall Study||137
3260032|NCT02569853|3994298|FG000|COMPLETED|Overall Study||111
3260033|NCT02569853|3994299|FG001|COMPLETED|Overall Study||123
3260034|NCT02569853|3994298|FG000|NOT COMPLETED|Overall Study||20
3260035|NCT02569853|3994299|FG001|NOT COMPLETED|Overall Study||14
3260036|NCT02569892|3994307|FG000|STARTED|Overall Study||10
3260037|NCT02569892|3994308|FG001|STARTED|Overall Study||9
3260038|NCT02569892|3994307|FG000|COMPLETED|Overall Study||10
3260039|NCT02569892|3994308|FG001|COMPLETED|Overall Study||8
3260040|NCT02569892|3994307|FG000|NOT COMPLETED|Overall Study||0
3260041|NCT02569892|3994308|FG001|NOT COMPLETED|Overall Study||1
3260042|NCT02569996|3994314|FG000|STARTED|Overall Study||124
3260043|NCT02569996|3994314|FG000|COMPLETED|Overall Study||69
3260044|NCT02569996|3994314|FG000|NOT COMPLETED|Overall Study||55
3260045|NCT02570022|3994320|FG000|STARTED|Overall Study||26
3260046|NCT02570022|3994321|FG001|STARTED|Overall Study||31
3260047|NCT02570022|3994320|FG000|COMPLETED|Overall Study||26
3260048|NCT02570022|3994321|FG001|COMPLETED|Overall Study||31
3260049|NCT02570022|3994320|FG000|NOT COMPLETED|Overall Study||0
3260050|NCT02570022|3994321|FG001|NOT COMPLETED|Overall Study||0
3260051|NCT02570074|3994329|FG000|STARTED|Period 1 (First Dosing Regimen)||9
3260052|NCT02570074|3994330|FG001|STARTED|Period 1 (First Dosing Regimen)||10
3260053|NCT02570074|3994329|FG000|COMPLETED|Period 1 (First Dosing Regimen)||9
3260054|NCT02570074|3994330|FG001|COMPLETED|Period 1 (First Dosing Regimen)||10
3260055|NCT02570074|3994329|FG000|NOT COMPLETED|Period 1 (First Dosing Regimen)||0
3260056|NCT02570074|3994330|FG001|NOT COMPLETED|Period 1 (First Dosing Regimen)||0
3260057|NCT02570074|3994329|FG000|STARTED|Period 2 (Second Dosing Regimen)||9
3260058|NCT02570074|3994330|FG001|STARTED|Period 2 (Second Dosing Regimen)||10
3260059|NCT02570074|3994329|FG000|COMPLETED|Period 2 (Second Dosing Regimen)||8
3260060|NCT02570074|3994330|FG001|COMPLETED|Period 2 (Second Dosing Regimen)||10
3260061|NCT02570074|3994329|FG000|NOT COMPLETED|Period 2 (Second Dosing Regimen)||1
3260062|NCT02570074|3994330|FG001|NOT COMPLETED|Period 2 (Second Dosing Regimen)||0
3260063|NCT02570126|3994350|FG000|STARTED|Overall Study||615
3260064|NCT02570126|3994351|FG001|STARTED|Overall Study||616
3260065|NCT02570126|3994350|FG000|COMPLETED|Overall Study||609
3260066|NCT02570126|3994351|FG001|COMPLETED|Overall Study||607
3260067|NCT02570126|3994350|FG000|NOT COMPLETED|Overall Study||6
3260068|NCT02570126|3994351|FG001|NOT COMPLETED|Overall Study||9
3260069|NCT02570139|3994359|FG000|STARTED|Overall Study|24 subjects were treated w/ Cavilon Advanced Skin Protectant. Study terminated due to low enrollment|24
3260070|NCT02570139|3994360|FG001|STARTED|Overall Study|21 subjects treated with SensiCare Protective Barrier|21
3260071|NCT02570139|3994359|FG000|COMPLETED|Overall Study||24
3260072|NCT02570139|3994360|FG001|COMPLETED|Overall Study||21
3260073|NCT02570139|3994359|FG000|NOT COMPLETED|Overall Study||0
3260074|NCT02570139|3994360|FG001|NOT COMPLETED|Overall Study||0
3260075|NCT02570152|3994366|FG000|STARTED|Overall Study||2004
3260076|NCT02570152|3994366|FG000|COMPLETED|Overall Study||1989
3260077|NCT02570152|3994366|FG000|NOT COMPLETED|Overall Study||15
3260078|NCT02570165|3994377|FG000|STARTED|Overall Study||46
3260079|NCT02570165|3994378|FG001|STARTED|Overall Study||46
3260080|NCT02570165|3994379|FG002|STARTED|Overall Study||46
3260081|NCT02570165|3994380|FG003|STARTED|Overall Study||45
3260082|NCT02570165|3994381|FG004|STARTED|Overall Study||47
3260083|NCT02570165|3994382|FG005|STARTED|Overall Study||46
3260084|NCT02570165|3994383|FG006|STARTED|Overall Study||47
3260085|NCT02570165|3994377|FG000|COMPLETED|Overall Study||44
3260086|NCT02570165|3994378|FG001|COMPLETED|Overall Study||43
3260087|NCT02570165|3994379|FG002|COMPLETED|Overall Study||41
3260088|NCT02570165|3994380|FG003|COMPLETED|Overall Study||40
3260089|NCT02570165|3994381|FG004|COMPLETED|Overall Study||41
3260090|NCT02570165|3994382|FG005|COMPLETED|Overall Study||44
3260091|NCT02570165|3994383|FG006|COMPLETED|Overall Study||47
3260092|NCT02570165|3994377|FG000|NOT COMPLETED|Overall Study||2
3260093|NCT02570165|3994378|FG001|NOT COMPLETED|Overall Study||3
3260094|NCT02570165|3994379|FG002|NOT COMPLETED|Overall Study||5
3260095|NCT02570165|3994380|FG003|NOT COMPLETED|Overall Study||5
3260096|NCT02570165|3994381|FG004|NOT COMPLETED|Overall Study||6
3260097|NCT02570165|3994382|FG005|NOT COMPLETED|Overall Study||2
3260098|NCT02570165|3994383|FG006|NOT COMPLETED|Overall Study||0
3260099|NCT02570295|3994401|FG000|STARTED|Overall Study||375
3260100|NCT02570295|3994402|FG001|STARTED|Overall Study||347
3260101|NCT02570295|3994401|FG000|COMPLETED|Overall Study||364
3260102|NCT02570295|3994402|FG001|COMPLETED|Overall Study||289
3260103|NCT02570295|3994401|FG000|NOT COMPLETED|Overall Study||11
3260104|NCT02570295|3994402|FG001|NOT COMPLETED|Overall Study||58
3260105|NCT02570308|3994413|FG000|STARTED|Overall Study||3
3260106|NCT02570308|3994414|FG001|STARTED|Overall Study||6
3260107|NCT02570308|3994415|FG002|STARTED|Overall Study||4
3260108|NCT02570308|3994416|FG003|STARTED|Overall Study||6
3260109|NCT02570308|3994417|FG004|STARTED|Overall Study||127
3260110|NCT02570308|3994413|FG000|COMPLETED|Overall Study||2
3260111|NCT02570308|3994414|FG001|COMPLETED|Overall Study||1
3260112|NCT02570308|3994415|FG002|COMPLETED|Overall Study||0
3260113|NCT02570308|3994416|FG003|COMPLETED|Overall Study||2
3260114|NCT02570308|3994417|FG004|COMPLETED|Overall Study||53
3260115|NCT02570308|3994413|FG000|NOT COMPLETED|Overall Study||1
3260116|NCT02570308|3994414|FG001|NOT COMPLETED|Overall Study||5
3260117|NCT02570308|3994415|FG002|NOT COMPLETED|Overall Study||4
3260118|NCT02570308|3994416|FG003|NOT COMPLETED|Overall Study||4
3260119|NCT02570308|3994417|FG004|NOT COMPLETED|Overall Study||74
3260120|NCT02570425|3994437|FG000|STARTED|Visit 1||274
3260121|NCT02570425|3994438|FG001|STARTED|Visit 1||242
3260122|NCT02570425|3994437|FG000|COMPLETED|Visit 1||274
3260123|NCT02570425|3994438|FG001|COMPLETED|Visit 1||242
3260124|NCT02570425|3994437|FG000|NOT COMPLETED|Visit 1||0
3260125|NCT02570425|3994438|FG001|NOT COMPLETED|Visit 1||0
3260126|NCT02570425|3994437|FG000|STARTED|Visit 2|In total 18 patients who completed Visit 1, did not attend Visit 2.|251
3260127|NCT02570425|3994438|FG001|STARTED|Visit 2|In total 18 patients who completed Visit 1, did not attend Visit 2.|247
3260128|NCT02570425|3994437|FG000|COMPLETED|Visit 2||251
3260129|NCT02570425|3994438|FG001|COMPLETED|Visit 2||247
3260130|NCT02570425|3994437|FG000|NOT COMPLETED|Visit 2||0
3260131|NCT02570425|3994438|FG001|NOT COMPLETED|Visit 2||0
3260132|NCT02570425|3994437|FG000|STARTED|Visit 3|In total 38 patients who completed Visit 2, did not attend Visit 3.|229
3260133|NCT02570425|3994438|FG001|STARTED|Visit 3|In total 38 patients who completed Visit 2, did not attend Visit 3.|231
3260134|NCT02570425|3994437|FG000|COMPLETED|Visit 3||229
3260135|NCT02570425|3994438|FG001|COMPLETED|Visit 3||231
3260136|NCT02570425|3994437|FG000|NOT COMPLETED|Visit 3||0
3260137|NCT02570425|3994438|FG001|NOT COMPLETED|Visit 3||0
3260138|NCT02570711|3994449|FG000|STARTED|Overall Study||1
3260139|NCT02570711|3994450|FG001|STARTED|Overall Study||2
3260140|NCT02570711|3994449|FG000|COMPLETED|Overall Study||0
3260141|NCT02570711|3994450|FG001|COMPLETED|Overall Study||0
3260142|NCT02570711|3994449|FG000|NOT COMPLETED|Overall Study||1
3260143|NCT02570711|3994450|FG001|NOT COMPLETED|Overall Study||2
3260144|NCT02570750|3994458|FG000|STARTED|Overall Study||110
3260145|NCT02570750|3994459|FG001|STARTED|Overall Study||73
3260146|NCT02570750|3994458|FG000|COMPLETED|Overall Study||96
3260147|NCT02570750|3994459|FG001|COMPLETED|Overall Study||68
3260148|NCT02570750|3994458|FG000|NOT COMPLETED|Overall Study||14
3260149|NCT02570750|3994459|FG001|NOT COMPLETED|Overall Study||5
3260150|NCT02571049|3994465|FG000|STARTED|Screening||10
3260151|NCT02571049|3994466|FG001|STARTED|Screening||14
3260152|NCT02571049|3994465|FG000|COMPLETED|Screening||8
3260153|NCT02571049|3994466|FG001|COMPLETED|Screening||12
3260154|NCT02571049|3994465|FG000|NOT COMPLETED|Screening||2
3260155|NCT02571049|3994466|FG001|NOT COMPLETED|Screening||2
3260156|NCT02571049|3994465|FG000|STARTED|Randomization||8
3260157|NCT02571049|3994466|FG001|STARTED|Randomization||12
3260158|NCT02571049|3994465|FG000|COMPLETED|Randomization||8
3260159|NCT02571049|3994466|FG001|COMPLETED|Randomization||10
3260160|NCT02571049|3994465|FG000|NOT COMPLETED|Randomization||0
3260161|NCT02571049|3994466|FG001|NOT COMPLETED|Randomization||2
3260162|NCT02571075|3994474|FG000|STARTED|Overall Study||45
3260163|NCT02571075|3994475|FG001|STARTED|Overall Study||50
3260164|NCT02571075|3994474|FG000|COMPLETED|Overall Study||25
3260165|NCT02571075|3994475|FG001|COMPLETED|Overall Study||26
3260166|NCT02571075|3994474|FG000|NOT COMPLETED|Overall Study||20
3260167|NCT02571075|3994475|FG001|NOT COMPLETED|Overall Study||24
3260168|NCT02571153|3994484|FG000|STARTED|Overall Study||45
3260169|NCT02571153|3994485|FG001|STARTED|Overall Study||45
3260170|NCT02571153|3994486|FG002|STARTED|Overall Study||45
3260171|NCT02571153|3994484|FG000|COMPLETED|Overall Study||39
3260172|NCT02571153|3994485|FG001|COMPLETED|Overall Study||37
3260173|NCT02571153|3994486|FG002|COMPLETED|Overall Study||43
3260174|NCT02571153|3994484|FG000|NOT COMPLETED|Overall Study||6
3260175|NCT02571153|3994485|FG001|NOT COMPLETED|Overall Study||8
3260176|NCT02571153|3994486|FG002|NOT COMPLETED|Overall Study||2
3260177|NCT02571218|3994496|FG000|STARTED|Overall Study||40
3260178|NCT02571218|3994497|FG001|STARTED|Overall Study||41
3260179|NCT02571218|3994496|FG000|COMPLETED|Overall Study||40
3260180|NCT02571218|3994497|FG001|COMPLETED|Overall Study||41
3260181|NCT02571218|3994496|FG000|NOT COMPLETED|Overall Study||0
3260182|NCT02571218|3994497|FG001|NOT COMPLETED|Overall Study||0
3260183|NCT02571244|3994505|FG000|STARTED|Overall Study||44
3260184|NCT02571244|3994506|FG001|STARTED|Overall Study||22
3260185|NCT02571244|3994505|FG000|COMPLETED|Overall Study||41
3260186|NCT02571244|3994506|FG001|COMPLETED|Overall Study||21
3260187|NCT02571244|3994505|FG000|NOT COMPLETED|Overall Study||3
3260188|NCT02571244|3994506|FG001|NOT COMPLETED|Overall Study||1
3260189|NCT02571439|3994517|FG000|STARTED|Overall Study||20
3260190|NCT02571439|3994518|FG001|STARTED|Overall Study||21
3260191|NCT02571439|3994517|FG000|COMPLETED|Overall Study||20
3260192|NCT02571439|3994518|FG001|COMPLETED|Overall Study||21
3260193|NCT02571439|3994517|FG000|NOT COMPLETED|Overall Study||0
3260194|NCT02571439|3994518|FG001|NOT COMPLETED|Overall Study||0
3260195|NCT02571452|3994526|FG000|STARTED|Overall Study Treatment||47
3260196|NCT02571452|3994527|FG001|STARTED|Overall Study Treatment||46
3260197|NCT02571452|3994526|FG000|COMPLETED|Overall Study Treatment||47
3260198|NCT02571452|3994527|FG001|COMPLETED|Overall Study Treatment||45
3260199|NCT02571452|3994526|FG000|NOT COMPLETED|Overall Study Treatment||0
3260200|NCT02571452|3994527|FG001|NOT COMPLETED|Overall Study Treatment||1
3260201|NCT02571452|3994526|FG000|STARTED|Overall Study 6-Month Follow-up||47
3260202|NCT02571452|3994527|FG001|STARTED|Overall Study 6-Month Follow-up|Participants in the PMRT arm were not invited to complete 6-Month Follow-up.|0
3260203|NCT02571452|3994526|FG000|COMPLETED|Overall Study 6-Month Follow-up||42
3260204|NCT02571452|3994527|FG001|COMPLETED|Overall Study 6-Month Follow-up||0
3260205|NCT02571452|3994526|FG000|NOT COMPLETED|Overall Study 6-Month Follow-up||5
3260206|NCT02571452|3994527|FG001|NOT COMPLETED|Overall Study 6-Month Follow-up||0
3260207|NCT02571634|3994533|FG000|STARTED|Overall Study|First subject wasn't enrolled until July related to receipt of medications from sponsor.|23
3260208|NCT02571634|3994533|FG000|COMPLETED|Overall Study|The final subject was enrolled on this date.|23
3260209|NCT02571634|3994533|FG000|NOT COMPLETED|Overall Study||0
3260210|NCT02571777|3994543|FG000|STARTED|Overall Study||619
3260211|NCT02571777|3994544|FG001|STARTED|Overall Study||620
3260212|NCT02571777|3994545|FG002|STARTED|Overall Study||618
3260213|NCT02571777|3994546|FG003|STARTED|Overall Study||617
3260214|NCT02571777|3994547|FG004|STARTED|Overall Study||618
3260215|NCT02571777|3994543|FG000|Full Analysis Set (FAS)|Overall Study||615
3260216|NCT02571777|3994544|FG001|Full Analysis Set (FAS)|Overall Study||616
3260217|NCT02571777|3994545|FG002|Full Analysis Set (FAS)|Overall Study||611
3260218|NCT02571777|3994546|FG003|Full Analysis Set (FAS)|Overall Study||607
3260219|NCT02571777|3994547|FG004|Full Analysis Set (FAS)|Overall Study||612
3260220|NCT02571777|3994543|FG000|Safety Set (SAF)|Overall Study||616
3260221|NCT02571777|3994544|FG001|Safety Set (SAF)|Overall Study||617
3260222|NCT02571777|3994545|FG002|Safety Set (SAF)|Overall Study||613
3260223|NCT02571777|3994546|FG003|Safety Set (SAF)|Overall Study||608
3260224|NCT02571777|3994547|FG004|Safety Set (SAF)|Overall Study||618
3260225|NCT02571777|3994543|FG000|COMPLETED|Overall Study||580
3260226|NCT02571777|3994544|FG001|COMPLETED|Overall Study||582
3260227|NCT02571777|3994545|FG002|COMPLETED|Overall Study||577
3260228|NCT02571777|3994546|FG003|COMPLETED|Overall Study||580
3260229|NCT02571777|3994547|FG004|COMPLETED|Overall Study||582
3260230|NCT02571777|3994543|FG000|NOT COMPLETED|Overall Study||39
3260231|NCT02571777|3994544|FG001|NOT COMPLETED|Overall Study||38
3260232|NCT02571777|3994545|FG002|NOT COMPLETED|Overall Study||41
3260233|NCT02571777|3994546|FG003|NOT COMPLETED|Overall Study||37
3260234|NCT02571777|3994547|FG004|NOT COMPLETED|Overall Study||36
3260235|NCT02571972|3994559|FG000|STARTED|Overall Study|2 patients signed consent but withdrew from the study prior to using dorzolamide-timolol drops.|14
3260236|NCT02571972|3994559|FG000|COMPLETED|Overall Study||10
3260237|NCT02571972|3994559|FG000|NOT COMPLETED|Overall Study||4
3260238|NCT02572076|3994563|FG000|STARTED|Overall Study||10
3260239|NCT02572076|3994563|FG000|COMPLETED|Overall Study||9
3260240|NCT02572076|3994563|FG000|NOT COMPLETED|Overall Study||1
3372862|NCT02773576|4104897|FG000|STARTED|Overall Study||0
3372863|NCT02773576|4104898|FG001|STARTED|Overall Study||0
3372864|NCT02773576|4104897|FG000|COMPLETED|Overall Study||0
3260241|NCT02572167|3994570|FG000|STARTED|Overall Study||6
3260242|NCT02572167|3994571|FG001|STARTED|Overall Study||56
3260243|NCT02572167|3994572|FG002|STARTED|Overall Study||31
3260244|NCT02572167|3994570|FG000|COMPLETED|Overall Study||0
3260245|NCT02572167|3994571|FG001|COMPLETED|Overall Study||0
3260246|NCT02572167|3994572|FG002|COMPLETED|Overall Study||0
3260247|NCT02572167|3994570|FG000|NOT COMPLETED|Overall Study||6
3260248|NCT02572167|3994571|FG001|NOT COMPLETED|Overall Study||56
3260249|NCT02572167|3994572|FG002|NOT COMPLETED|Overall Study||31
3260250|NCT02572388|3994584|FG000|STARTED|Overall Study||11
3260251|NCT02572388|3994585|FG001|STARTED|Overall Study||4
3260252|NCT02572388|3994586|FG002|STARTED|Overall Study||10
3260253|NCT02572388|3994587|FG003|STARTED|Overall Study||6
3260254|NCT02572388|3994584|FG000|COMPLETED|Overall Study||10
3260255|NCT02572388|3994585|FG001|COMPLETED|Overall Study||3
3260256|NCT02572388|3994586|FG002|COMPLETED|Overall Study||8
3260257|NCT02572388|3994587|FG003|COMPLETED|Overall Study||4
3260258|NCT02572388|3994584|FG000|NOT COMPLETED|Overall Study||1
3260259|NCT02572388|3994585|FG001|NOT COMPLETED|Overall Study||1
3260260|NCT02572388|3994586|FG002|NOT COMPLETED|Overall Study||2
3260261|NCT02572388|3994587|FG003|NOT COMPLETED|Overall Study||2
3260262|NCT02572401|3994601|FG000|STARTED|Overall Study||97
3260263|NCT02572401|3994602|FG001|STARTED|Overall Study||98
3260264|NCT02572401|3994603|FG002|STARTED|Overall Study||98
3260265|NCT02572401|3994604|FG003|STARTED|Overall Study||98
3260266|NCT02572401|3994601|FG000|COMPLETED|Overall Study||92
3260267|NCT02572401|3994602|FG001|COMPLETED|Overall Study||90
3260268|NCT02572401|3994603|FG002|COMPLETED|Overall Study||89
3260269|NCT02572401|3994604|FG003|COMPLETED|Overall Study||88
3260270|NCT02572401|3994601|FG000|NOT COMPLETED|Overall Study||5
3260271|NCT02572401|3994602|FG001|NOT COMPLETED|Overall Study||8
3260272|NCT02572401|3994603|FG002|NOT COMPLETED|Overall Study||9
3260273|NCT02572401|3994604|FG003|NOT COMPLETED|Overall Study||10
3260274|NCT02572427|3994616|FG000|STARTED|Overall Study||37
3260275|NCT02572427|3994617|FG001|STARTED|Overall Study||45
3260276|NCT02572427|3994616|FG000|COMPLETED|Overall Study||31
3260277|NCT02572427|3994617|FG001|COMPLETED|Overall Study||36
3260278|NCT02572427|3994616|FG000|NOT COMPLETED|Overall Study||6
3260279|NCT02572427|3994617|FG001|NOT COMPLETED|Overall Study||9
3260280|NCT02572570|3994623|FG000|STARTED|Overall Study||27
3260281|NCT02572570|3994623|FG000|Filtek Bulk Fill Posterior|Overall Study||27
3260282|NCT02572570|3994623|FG000|Filtek Supreme Ultra|Overall Study||27
3260283|NCT02572570|3994623|FG000|1 Year Follow-Up|Overall Study||20
3260284|NCT02572570|3994623|FG000|2 Year Follow-Up|Overall Study||13
3260285|NCT02572570|3994623|FG000|3 Year Follow-Up|Overall Study||5
3260286|NCT02572570|3994623|FG000|5 Year Follow-Up|Overall Study||0
3260287|NCT02572570|3994623|FG000|COMPLETED|Overall Study||0
3260288|NCT02572570|3994623|FG000|NOT COMPLETED|Overall Study||27
3260289|NCT02572609|3994632|FG000|STARTED|Period 1: Treatment Period 1 + Washout||18
3260290|NCT02572609|3994633|FG001|STARTED|Period 1: Treatment Period 1 + Washout||18
3260291|NCT02572609|3994632|FG000|COMPLETED|Period 1: Treatment Period 1 + Washout||18
3260292|NCT02572609|3994633|FG001|COMPLETED|Period 1: Treatment Period 1 + Washout||18
3260293|NCT02572609|3994632|FG000|NOT COMPLETED|Period 1: Treatment Period 1 + Washout||0
3260294|NCT02572609|3994633|FG001|NOT COMPLETED|Period 1: Treatment Period 1 + Washout||0
3260295|NCT02572609|3994632|FG000|STARTED|Period 2: Treatment Period 2||18
3260296|NCT02572609|3994633|FG001|STARTED|Period 2: Treatment Period 2||18
3260297|NCT02572609|3994632|FG000|COMPLETED|Period 2: Treatment Period 2||18
3260298|NCT02572609|3994633|FG001|COMPLETED|Period 2: Treatment Period 2||18
3260299|NCT02572609|3994632|FG000|NOT COMPLETED|Period 2: Treatment Period 2||0
3260300|NCT02572609|3994633|FG001|NOT COMPLETED|Period 2: Treatment Period 2||0
3260301|NCT02572752|3994642|FG000|STARTED|Period 1 Including Washout||23
3260302|NCT02572752|3994643|FG001|STARTED|Period 1 Including Washout||23
3260303|NCT02572752|3994644|FG002|STARTED|Period 1 Including Washout||24
3260304|NCT02572752|3994642|FG000|COMPLETED|Period 1 Including Washout||23
3260305|NCT02572752|3994643|FG001|COMPLETED|Period 1 Including Washout||23
3260306|NCT02572752|3994644|FG002|COMPLETED|Period 1 Including Washout||24
3260307|NCT02572752|3994642|FG000|NOT COMPLETED|Period 1 Including Washout||0
3260308|NCT02572752|3994643|FG001|NOT COMPLETED|Period 1 Including Washout||0
3260309|NCT02572752|3994644|FG002|NOT COMPLETED|Period 1 Including Washout||0
3260310|NCT02572752|3994642|FG000|STARTED|Period 2 Including Washout||23
3372865|NCT02773576|4104898|FG001|COMPLETED|Overall Study||0
3372866|NCT02773576|4104897|FG000|NOT COMPLETED|Overall Study||0
3372867|NCT02773576|4104898|FG001|NOT COMPLETED|Overall Study||0
3372868|NCT02730793|4104906|FG000|STARTED|Overall Study||2
3372869|NCT02730793|4104907|FG001|STARTED|Overall Study||3
3372870|NCT02730793|4104906|FG000|COMPLETED|Overall Study||2
3372871|NCT02730793|4104907|FG001|COMPLETED|Overall Study||1
3372872|NCT02730793|4104906|FG000|NOT COMPLETED|Overall Study||0
3372873|NCT02730793|4104907|FG001|NOT COMPLETED|Overall Study||2
3372874|NCT02744352|4104915|FG000|STARTED|Overall Study||4
3372875|NCT02744352|4104916|FG001|STARTED|Overall Study||4
3260311|NCT02572752|3994643|FG001|STARTED|Period 2 Including Washout||23
3260312|NCT02572752|3994644|FG002|STARTED|Period 2 Including Washout||24
3260313|NCT02572752|3994642|FG000|COMPLETED|Period 2 Including Washout||23
3260314|NCT02572752|3994643|FG001|COMPLETED|Period 2 Including Washout||23
3372876|NCT02744352|4104915|FG000|COMPLETED|Overall Study||4
3372877|NCT02744352|4104916|FG001|COMPLETED|Overall Study||4
3372878|NCT02744352|4104915|FG000|NOT COMPLETED|Overall Study||0
3260315|NCT02572752|3994644|FG002|COMPLETED|Period 2 Including Washout||24
3260316|NCT02572752|3994642|FG000|NOT COMPLETED|Period 2 Including Washout||0
3260317|NCT02572752|3994643|FG001|NOT COMPLETED|Period 2 Including Washout||0
3260318|NCT02572752|3994644|FG002|NOT COMPLETED|Period 2 Including Washout||0
3260319|NCT02572752|3994642|FG000|STARTED|Period 3 Including Washout||23
3260320|NCT02572752|3994643|FG001|STARTED|Period 3 Including Washout||23
3260321|NCT02572752|3994644|FG002|STARTED|Period 3 Including Washout||24
3260322|NCT02572752|3994642|FG000|COMPLETED|Period 3 Including Washout||23
3260323|NCT02572752|3994643|FG001|COMPLETED|Period 3 Including Washout||23
3260324|NCT02572752|3994644|FG002|COMPLETED|Period 3 Including Washout||24
3260325|NCT02572752|3994642|FG000|NOT COMPLETED|Period 3 Including Washout||0
3260326|NCT02572752|3994643|FG001|NOT COMPLETED|Period 3 Including Washout||0
3260327|NCT02572752|3994644|FG002|NOT COMPLETED|Period 3 Including Washout||0
3260328|NCT02572817|3994653|FG000|STARTED|Overall Study||91
3260329|NCT02572817|3994654|FG001|STARTED|Overall Study||47
3260330|NCT02572817|3994653|FG000|COMPLETED|Overall Study||82
3260331|NCT02572817|3994654|FG001|COMPLETED|Overall Study||41
3260332|NCT02572817|3994653|FG000|NOT COMPLETED|Overall Study||9
3260333|NCT02572817|3994654|FG001|NOT COMPLETED|Overall Study||6
3260334|NCT02573012|3994662|FG000|STARTED|Overall Study||131
3260335|NCT02573012|3994663|FG001|STARTED|Overall Study||128
3260336|NCT02573012|3994662|FG000|COMPLETED|Overall Study||116
3260337|NCT02573012|3994663|FG001|COMPLETED|Overall Study||113
3260338|NCT02573012|3994662|FG000|NOT COMPLETED|Overall Study||15
3260339|NCT02573012|3994663|FG001|NOT COMPLETED|Overall Study||15
3260340|NCT02573155|3994671|FG000|STARTED|Treatment Period 1||16
3260341|NCT02573155|3994672|FG001|STARTED|Treatment Period 1||38
3260342|NCT02573155|3994671|FG000|COMPLETED|Treatment Period 1||16
3260343|NCT02573155|3994672|FG001|COMPLETED|Treatment Period 1||38
3260344|NCT02573155|3994671|FG000|NOT COMPLETED|Treatment Period 1||0
3260345|NCT02573155|3994672|FG001|NOT COMPLETED|Treatment Period 1||0
3260346|NCT02573155|3994671|FG000|STARTED|Washout Between Treatment Period 1 and 2||16
3260347|NCT02573155|3994672|FG001|STARTED|Washout Between Treatment Period 1 and 2||38
3260348|NCT02573155|3994671|FG000|COMPLETED|Washout Between Treatment Period 1 and 2||16
3260349|NCT02573155|3994672|FG001|COMPLETED|Washout Between Treatment Period 1 and 2||33
3260350|NCT02573155|3994671|FG000|NOT COMPLETED|Washout Between Treatment Period 1 and 2||0
3260351|NCT02573155|3994672|FG001|NOT COMPLETED|Washout Between Treatment Period 1 and 2||5
3260352|NCT02573155|3994671|FG000|STARTED|Period 2||16
3260353|NCT02573155|3994672|FG001|STARTED|Period 2||33
3260354|NCT02573155|3994671|FG000|COMPLETED|Period 2||16
3260355|NCT02573155|3994672|FG001|COMPLETED|Period 2||33
3260356|NCT02573155|3994671|FG000|NOT COMPLETED|Period 2||0
3260357|NCT02573155|3994672|FG001|NOT COMPLETED|Period 2||0
3260358|NCT02573155|3994671|FG000|STARTED|Washout Between Treatment Period 2 and 3||16
3260359|NCT02573155|3994672|FG001|STARTED|Washout Between Treatment Period 2 and 3||33
3260360|NCT02573155|3994671|FG000|COMPLETED|Washout Between Treatment Period 2 and 3||15
3260361|NCT02573155|3994672|FG001|COMPLETED|Washout Between Treatment Period 2 and 3||31
3260362|NCT02573155|3994671|FG000|NOT COMPLETED|Washout Between Treatment Period 2 and 3||1
3260363|NCT02573155|3994672|FG001|NOT COMPLETED|Washout Between Treatment Period 2 and 3||2
3260364|NCT02573155|3994671|FG000|STARTED|Period 3||15
3260365|NCT02573155|3994672|FG001|STARTED|Period 3||31
3260366|NCT02573155|3994671|FG000|COMPLETED|Period 3||15
3260367|NCT02573155|3994672|FG001|COMPLETED|Period 3||31
3260368|NCT02573155|3994671|FG000|NOT COMPLETED|Period 3||0
3260369|NCT02573155|3994672|FG001|NOT COMPLETED|Period 3||0
3260370|NCT02573155|3994671|FG000|STARTED|Washout Between Treatment Period 3 and 4|Part 1 comprised 3 treatment periods only|0
3260371|NCT02573155|3994672|FG001|STARTED|Washout Between Treatment Period 3 and 4||31
3260372|NCT02573155|3994671|FG000|COMPLETED|Washout Between Treatment Period 3 and 4|Part 1 comprised 3 treatment periods only|0
3260373|NCT02573155|3994672|FG001|COMPLETED|Washout Between Treatment Period 3 and 4||29
3260374|NCT02573155|3994671|FG000|NOT COMPLETED|Washout Between Treatment Period 3 and 4||0
3260375|NCT02573155|3994672|FG001|NOT COMPLETED|Washout Between Treatment Period 3 and 4||2
3260376|NCT02573155|3994671|FG000|STARTED|Period 4|Part 1 comprised 3 treatment periods only|0
3260377|NCT02573155|3994672|FG001|STARTED|Period 4||29
3260378|NCT02573155|3994671|FG000|COMPLETED|Period 4|Part 1 comprised 3 treatment periods only|0
3260379|NCT02573155|3994672|FG001|COMPLETED|Period 4||29
3260380|NCT02573155|3994671|FG000|NOT COMPLETED|Period 4||0
3260381|NCT02573155|3994672|FG001|NOT COMPLETED|Period 4||0
3260382|NCT02573155|3994671|FG000|STARTED|Washout Between Treatment Period 4 and 5|Part 1 comprised 3 treatment periods only|0
3260383|NCT02573155|3994672|FG001|STARTED|Washout Between Treatment Period 4 and 5||29
3260384|NCT02573155|3994671|FG000|COMPLETED|Washout Between Treatment Period 4 and 5|Part 1 comprised 3 treatment periods only|0
3260385|NCT02573155|3994672|FG001|COMPLETED|Washout Between Treatment Period 4 and 5||28
3260386|NCT02573155|3994671|FG000|NOT COMPLETED|Washout Between Treatment Period 4 and 5||0
3260387|NCT02573155|3994672|FG001|NOT COMPLETED|Washout Between Treatment Period 4 and 5||1
3260388|NCT02573155|3994671|FG000|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
3260389|NCT02573155|3994672|FG001|STARTED|Period 5||28
3260390|NCT02573155|3994671|FG000|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
3260391|NCT02573155|3994672|FG001|COMPLETED|Period 5||28
3260392|NCT02573155|3994671|FG000|NOT COMPLETED|Period 5||0
3260393|NCT02573155|3994672|FG001|NOT COMPLETED|Period 5||0
3260394|NCT02573181|3994700|FG000|STARTED|Overall Study||127
3260395|NCT02573181|3994701|FG001|STARTED|Overall Study||126
3260396|NCT02573181|3994700|FG000|Vaccinated|Overall Study||127
3260397|NCT02573181|3994701|FG001|Vaccinated|Overall Study||126
3260398|NCT02573181|3994700|FG000|COMPLETED|Overall Study||127
3260399|NCT02573181|3994701|FG001|COMPLETED|Overall Study||126
3260400|NCT02573181|3994700|FG000|NOT COMPLETED|Overall Study||0
3260401|NCT02573181|3994701|FG001|NOT COMPLETED|Overall Study||0
3260402|NCT02573233|3994709|FG000|STARTED|Overall Study||22
3260403|NCT02573233|3994710|FG001|STARTED|Overall Study||20
3260404|NCT02573233|3994709|FG000|COMPLETED|Overall Study||22
3260405|NCT02573233|3994710|FG001|COMPLETED|Overall Study||20
3260406|NCT02573233|3994709|FG000|NOT COMPLETED|Overall Study||0
3260407|NCT02573233|3994710|FG001|NOT COMPLETED|Overall Study||0
3260408|NCT02573246|3994722|FG000|STARTED|Overall Study||14
3260409|NCT02573246|3994723|FG001|STARTED|Overall Study||15
3260410|NCT02573246|3994724|FG002|STARTED|Overall Study||18
3260411|NCT02573246|3994725|FG003|STARTED|Overall Study||16
3260412|NCT02573246|3994726|FG004|STARTED|Overall Study||15
3260413|NCT02573246|3994722|FG000|COMPLETED|Overall Study||11
3260414|NCT02573246|3994723|FG001|COMPLETED|Overall Study||14
3260415|NCT02573246|3994724|FG002|COMPLETED|Overall Study||15
3260416|NCT02573246|3994725|FG003|COMPLETED|Overall Study||14
3260417|NCT02573246|3994726|FG004|COMPLETED|Overall Study||11
3260418|NCT02573246|3994722|FG000|NOT COMPLETED|Overall Study||3
3260419|NCT02573246|3994723|FG001|NOT COMPLETED|Overall Study||1
3260420|NCT02573246|3994724|FG002|NOT COMPLETED|Overall Study||3
3260421|NCT02573246|3994725|FG003|NOT COMPLETED|Overall Study||2
3260422|NCT02573246|3994726|FG004|NOT COMPLETED|Overall Study||4
3260423|NCT02573311|3994745|FG000|STARTED|Disposition for Part 1|Started are subjects who entered Part 1 and answered the purchase question|1737
3260424|NCT02573311|3994746|FG001|STARTED|Disposition for Part 1|Started are subjects who entered Part 1 and answered the purchase question|364
3260425|NCT02573311|3994745|FG000|COMPLETED|Disposition for Part 1|Completed are the subjects who actually completed Part 1|1730
3260426|NCT02573311|3994746|FG001|COMPLETED|Disposition for Part 1|Completed are the subjects who actually completed Part 1|361
3260427|NCT02573311|3994745|FG000|NOT COMPLETED|Disposition for Part 1||7
3260428|NCT02573311|3994746|FG001|NOT COMPLETED|Disposition for Part 1||3
3260429|NCT02573311|3994745|FG000|STARTED|Disposition for Part 2|Started are subjects who purchased study product and are eligible to enter Part-2 of study.|964
3260430|NCT02573311|3994746|FG001|STARTED|Disposition for Part 2|Started are subjects who purchased study product and are eligible to enter Part-2 of study.|153
3260431|NCT02573311|3994745|FG000|COMPLETED|Disposition for Part 2|Completed are the subjects who completed use phase Part-2 (Week 24 and EOS-P2 interviews).|754
3260432|NCT02573311|3994746|FG001|COMPLETED|Disposition for Part 2|Completed are the subjects who completed use phase Part-2 (Week 24 and EOS-P2 interviews).|127
3260433|NCT02573311|3994745|FG000|NOT COMPLETED|Disposition for Part 2||210
3260434|NCT02573311|3994746|FG001|NOT COMPLETED|Disposition for Part 2||26
3260435|NCT02573350|3994754|FG000|STARTED|Overall Study||137
3260436|NCT02573350|3994755|FG001|STARTED|Overall Study||76
3260437|NCT02573350|3994754|FG000|Efficacy Analysis Population|Overall Study||132
3260438|NCT02573350|3994755|FG001|Efficacy Analysis Population|Overall Study||73
3260439|NCT02573350|3994754|FG000|Safety Population|Overall Study||137
3260440|NCT02573350|3994755|FG001|Safety Population|Overall Study||76
3260441|NCT02573350|3994754|FG000|COMPLETED|Overall Study||121
3260442|NCT02573350|3994755|FG001|COMPLETED|Overall Study||67
3260443|NCT02573350|3994754|FG000|NOT COMPLETED|Overall Study||16
3260444|NCT02573350|3994755|FG001|NOT COMPLETED|Overall Study||9
3260445|NCT02573402|3994766|FG000|STARTED|Overall Study||12
3260446|NCT02573402|3994767|FG001|STARTED|Overall Study||7
3260447|NCT02573402|3994766|FG000|COMPLETED|Overall Study||12
3260448|NCT02573402|3994767|FG001|COMPLETED|Overall Study||7
3260449|NCT02573402|3994766|FG000|NOT COMPLETED|Overall Study||0
3260450|NCT02573402|3994767|FG001|NOT COMPLETED|Overall Study||0
3260451|NCT02573467|3994777|FG000|STARTED|Double-blind Treatment Epoch||53
3260452|NCT02573467|3994778|FG001|STARTED|Double-blind Treatment Epoch||52
3260453|NCT02573467|3994779|FG002|STARTED|Double-blind Treatment Epoch||51
3260454|NCT02573467|3994780|FG003|STARTED|Double-blind Treatment Epoch||55
3260455|NCT02573467|3994777|FG000|Full Analysis Set|Double-blind Treatment Epoch||53
3260456|NCT02573467|3994778|FG001|Full Analysis Set|Double-blind Treatment Epoch||52
3260457|NCT02573467|3994779|FG002|Full Analysis Set|Double-blind Treatment Epoch||51
3260458|NCT02573467|3994780|FG003|Full Analysis Set|Double-blind Treatment Epoch||55
3260459|NCT02573467|3994777|FG000|COMPLETED|Double-blind Treatment Epoch||0
3260460|NCT02573467|3994778|FG001|COMPLETED|Double-blind Treatment Epoch||0
3260461|NCT02573467|3994779|FG002|COMPLETED|Double-blind Treatment Epoch||0
3260462|NCT02573467|3994780|FG003|COMPLETED|Double-blind Treatment Epoch||0
3260463|NCT02573467|3994777|FG000|NOT COMPLETED|Double-blind Treatment Epoch||53
3260464|NCT02573467|3994778|FG001|NOT COMPLETED|Double-blind Treatment Epoch||52
3260465|NCT02573467|3994779|FG002|NOT COMPLETED|Double-blind Treatment Epoch||51
3260466|NCT02573467|3994780|FG003|NOT COMPLETED|Double-blind Treatment Epoch||55
3260467|NCT02573467|3994777|FG000|STARTED|Post-treatment Follow up Epoch||41
3260468|NCT02573467|3994778|FG001|STARTED|Post-treatment Follow up Epoch||46
3260469|NCT02573467|3994779|FG002|STARTED|Post-treatment Follow up Epoch||44
3260470|NCT02573467|3994780|FG003|STARTED|Post-treatment Follow up Epoch||47
3260471|NCT02573467|3994777|FG000|COMPLETED|Post-treatment Follow up Epoch||35
3260472|NCT02573467|3994778|FG001|COMPLETED|Post-treatment Follow up Epoch||41
3260473|NCT02573467|3994779|FG002|COMPLETED|Post-treatment Follow up Epoch||34
3260474|NCT02573467|3994780|FG003|COMPLETED|Post-treatment Follow up Epoch||44
3260475|NCT02573467|3994777|FG000|NOT COMPLETED|Post-treatment Follow up Epoch||6
3260476|NCT02573467|3994778|FG001|NOT COMPLETED|Post-treatment Follow up Epoch||5
3260477|NCT02573467|3994779|FG002|NOT COMPLETED|Post-treatment Follow up Epoch||10
3260478|NCT02573467|3994780|FG003|NOT COMPLETED|Post-treatment Follow up Epoch||3
3260479|NCT02573493|3994795|FG000|STARTED|Overall Study||40
3260480|NCT02573493|3994796|FG001|STARTED|Overall Study||40
3260481|NCT02573493|3994797|FG002|STARTED|Overall Study||15
3260482|NCT02573493|3994798|FG003|STARTED|Overall Study||1
3260483|NCT02573493|3994795|FG000|COMPLETED|Overall Study||40
3260484|NCT02573493|3994796|FG001|COMPLETED|Overall Study||40
3260485|NCT02573493|3994797|FG002|COMPLETED|Overall Study||15
3260486|NCT02573493|3994798|FG003|COMPLETED|Overall Study||0
3260487|NCT02573493|3994795|FG000|NOT COMPLETED|Overall Study||0
3260488|NCT02573493|3994796|FG001|NOT COMPLETED|Overall Study||0
3260489|NCT02573493|3994797|FG002|NOT COMPLETED|Overall Study||0
3260490|NCT02573493|3994798|FG003|NOT COMPLETED|Overall Study||1
3260491|NCT02573779|3994824|FG000|STARTED|Overall Study||74
3260492|NCT02573779|3994825|FG001|STARTED|Overall Study||43
3260493|NCT02573779|3994824|FG000|COMPLETED|Overall Study||74
3260494|NCT02573779|3994825|FG001|COMPLETED|Overall Study||43
3260495|NCT02573779|3994824|FG000|NOT COMPLETED|Overall Study||0
3260496|NCT02573779|3994825|FG001|NOT COMPLETED|Overall Study||0
3260497|NCT02573857|3994833|FG000|STARTED|Overall Study||8
3260498|NCT02573857|3994834|FG001|STARTED|Overall Study||8
3260499|NCT02573857|3994833|FG000|COMPLETED|Overall Study||8
3260500|NCT02573857|3994834|FG001|COMPLETED|Overall Study||8
3260501|NCT02573857|3994833|FG000|NOT COMPLETED|Overall Study||0
3260502|NCT02573857|3994834|FG001|NOT COMPLETED|Overall Study||0
3260503|NCT02573870|3994842|FG000|STARTED|Overall Study||20
3260504|NCT02573870|3994843|FG001|STARTED|Overall Study||42
3260505|NCT02573870|3994842|FG000|COMPLETED|Overall Study||20
3260506|NCT02573870|3994843|FG001|COMPLETED|Overall Study||35
3260507|NCT02573870|3994842|FG000|NOT COMPLETED|Overall Study||0
3260508|NCT02573870|3994843|FG001|NOT COMPLETED|Overall Study||7
3260509|NCT02573883|3994851|FG000|STARTED|Six Month Follow Up||25
3260510|NCT02573883|3994852|FG001|STARTED|Six Month Follow Up||27
3260511|NCT02573883|3994853|FG002|STARTED|Six Month Follow Up||0
3260512|NCT02573883|3994854|FG003|STARTED|Six Month Follow Up||0
3260513|NCT02573883|3994851|FG000|COMPLETED|Six Month Follow Up||24
3260514|NCT02573883|3994852|FG001|COMPLETED|Six Month Follow Up||27
3260515|NCT02573883|3994853|FG002|COMPLETED|Six Month Follow Up||0
3260516|NCT02573883|3994854|FG003|COMPLETED|Six Month Follow Up||0
3260517|NCT02573883|3994851|FG000|NOT COMPLETED|Six Month Follow Up||1
3260518|NCT02573883|3994852|FG001|NOT COMPLETED|Six Month Follow Up||0
3260519|NCT02573883|3994853|FG002|NOT COMPLETED|Six Month Follow Up||0
3260520|NCT02573883|3994854|FG003|NOT COMPLETED|Six Month Follow Up||0
3260521|NCT02573883|3994851|FG000|STARTED|One Year Follow Up||13
3260522|NCT02573883|3994852|FG001|STARTED|One Year Follow Up||17
3260523|NCT02573883|3994853|FG002|STARTED|One Year Follow Up||11
3260524|NCT02573883|3994854|FG003|STARTED|One Year Follow Up||10
3260525|NCT02573883|3994851|FG000|COMPLETED|One Year Follow Up||11
3260526|NCT02573883|3994852|FG001|COMPLETED|One Year Follow Up||16
3260527|NCT02573883|3994853|FG002|COMPLETED|One Year Follow Up||11
3260528|NCT02573883|3994854|FG003|COMPLETED|One Year Follow Up||10
3260529|NCT02573883|3994851|FG000|NOT COMPLETED|One Year Follow Up||2
3260530|NCT02573883|3994852|FG001|NOT COMPLETED|One Year Follow Up||1
3260531|NCT02573883|3994853|FG002|NOT COMPLETED|One Year Follow Up||0
3260532|NCT02573883|3994854|FG003|NOT COMPLETED|One Year Follow Up||0
3260533|NCT02573948|3994869|FG000|STARTED|RDS||603
3260534|NCT02573948|3994869|FG000|COMPLETED|RDS||603
3260535|NCT02573948|3994869|FG000|NOT COMPLETED|RDS||0
3260536|NCT02573948|3994869|FG000|STARTED|Longitudinal Cohort|Not on ART a/o MMT. MSM and FSW were prioritized for enrolling,|250
3260537|NCT02573948|3994869|FG000|COMPLETED|Longitudinal Cohort||194
3260538|NCT02573948|3994869|FG000|NOT COMPLETED|Longitudinal Cohort||56
3260539|NCT02574078|3994889|FG000|STARTED|Pre-Treatment Period||13
3260540|NCT02574078|3994890|FG001|STARTED|Pre-Treatment Period||6
3260541|NCT02574078|3994891|FG002|STARTED|Pre-Treatment Period||9
3260542|NCT02574078|3994892|FG003|STARTED|Pre-Treatment Period||35
3260543|NCT02574078|3994893|FG004|STARTED|Pre-Treatment Period||34
3260544|NCT02574078|3994894|FG005|STARTED|Pre-Treatment Period||35
3260545|NCT02574078|3994895|FG006|STARTED|Pre-Treatment Period||18
3260546|NCT02574078|3994896|FG007|STARTED|Pre-Treatment Period||17
3260547|NCT02574078|3994897|FG008|STARTED|Pre-Treatment Period||26
3260548|NCT02574078|3994898|FG009|STARTED|Pre-Treatment Period||26
3260549|NCT02574078|3994899|FG010|STARTED|Pre-Treatment Period||53
3260550|NCT02574078|3994900|FG011|STARTED|Pre-Treatment Period||56
3260551|NCT02574078|3994901|FG012|STARTED|Pre-Treatment Period||13
3260552|NCT02574078|3994889|FG000|COMPLETED|Pre-Treatment Period||13
3260553|NCT02574078|3994890|FG001|COMPLETED|Pre-Treatment Period||6
3260554|NCT02574078|3994891|FG002|COMPLETED|Pre-Treatment Period||9
3260555|NCT02574078|3994892|FG003|COMPLETED|Pre-Treatment Period||35
3260556|NCT02574078|3994893|FG004|COMPLETED|Pre-Treatment Period||34
3260557|NCT02574078|3994894|FG005|COMPLETED|Pre-Treatment Period||34
3260558|NCT02574078|3994895|FG006|COMPLETED|Pre-Treatment Period||14
3260559|NCT02574078|3994896|FG007|COMPLETED|Pre-Treatment Period||14
3260560|NCT02574078|3994897|FG008|COMPLETED|Pre-Treatment Period||25
3260561|NCT02574078|3994898|FG009|COMPLETED|Pre-Treatment Period||26
3260562|NCT02574078|3994899|FG010|COMPLETED|Pre-Treatment Period||49
3260563|NCT02574078|3994900|FG011|COMPLETED|Pre-Treatment Period||55
3260564|NCT02574078|3994901|FG012|COMPLETED|Pre-Treatment Period||13
3260565|NCT02574078|3994889|FG000|NOT COMPLETED|Pre-Treatment Period||0
3260566|NCT02574078|3994890|FG001|NOT COMPLETED|Pre-Treatment Period||0
3260567|NCT02574078|3994891|FG002|NOT COMPLETED|Pre-Treatment Period||0
3260568|NCT02574078|3994892|FG003|NOT COMPLETED|Pre-Treatment Period||0
3260569|NCT02574078|3994893|FG004|NOT COMPLETED|Pre-Treatment Period||0
3260570|NCT02574078|3994894|FG005|NOT COMPLETED|Pre-Treatment Period||1
3260571|NCT02574078|3994895|FG006|NOT COMPLETED|Pre-Treatment Period||4
3260572|NCT02574078|3994896|FG007|NOT COMPLETED|Pre-Treatment Period||3
3260573|NCT02574078|3994897|FG008|NOT COMPLETED|Pre-Treatment Period||1
3260574|NCT02574078|3994898|FG009|NOT COMPLETED|Pre-Treatment Period||0
3260575|NCT02574078|3994899|FG010|NOT COMPLETED|Pre-Treatment Period||4
3260576|NCT02574078|3994900|FG011|NOT COMPLETED|Pre-Treatment Period||1
3260577|NCT02574078|3994901|FG012|NOT COMPLETED|Pre-Treatment Period||0
3260578|NCT02574078|3994889|FG000|STARTED|Treatment Period||13
3260579|NCT02574078|3994890|FG001|STARTED|Treatment Period||6
3260580|NCT02574078|3994891|FG002|STARTED|Treatment Period||9
3260581|NCT02574078|3994892|FG003|STARTED|Treatment Period||35
3260582|NCT02574078|3994893|FG004|STARTED|Treatment Period||34
3260583|NCT02574078|3994894|FG005|STARTED|Treatment Period||34
3260584|NCT02574078|3994895|FG006|STARTED|Treatment Period||14
3260585|NCT02574078|3994896|FG007|STARTED|Treatment Period||14
3260586|NCT02574078|3994897|FG008|STARTED|Treatment Period||25
3260587|NCT02574078|3994898|FG009|STARTED|Treatment Period||26
3260588|NCT02574078|3994899|FG010|STARTED|Treatment Period||49
3260589|NCT02574078|3994900|FG011|STARTED|Treatment Period||55
3260590|NCT02574078|3994901|FG012|STARTED|Treatment Period||13
3260591|NCT02574078|3994889|FG000|COMPLETED|Treatment Period||3
3260592|NCT02574078|3994890|FG001|COMPLETED|Treatment Period||0
3260593|NCT02574078|3994891|FG002|COMPLETED|Treatment Period||0
3260594|NCT02574078|3994892|FG003|COMPLETED|Treatment Period||7
3260595|NCT02574078|3994893|FG004|COMPLETED|Treatment Period||3
3260596|NCT02574078|3994894|FG005|COMPLETED|Treatment Period||1
3260597|NCT02574078|3994895|FG006|COMPLETED|Treatment Period||2
3260598|NCT02574078|3994896|FG007|COMPLETED|Treatment Period||2
3260599|NCT02574078|3994897|FG008|COMPLETED|Treatment Period||1
3260600|NCT02574078|3994898|FG009|COMPLETED|Treatment Period||9
3260601|NCT02574078|3994899|FG010|COMPLETED|Treatment Period||4
3260602|NCT02574078|3994900|FG011|COMPLETED|Treatment Period||8
3260603|NCT02574078|3994901|FG012|COMPLETED|Treatment Period||0
3260604|NCT02574078|3994889|FG000|NOT COMPLETED|Treatment Period||10
3260605|NCT02574078|3994890|FG001|NOT COMPLETED|Treatment Period||6
3260606|NCT02574078|3994891|FG002|NOT COMPLETED|Treatment Period||9
3260607|NCT02574078|3994892|FG003|NOT COMPLETED|Treatment Period||28
3260608|NCT02574078|3994893|FG004|NOT COMPLETED|Treatment Period||31
3260609|NCT02574078|3994894|FG005|NOT COMPLETED|Treatment Period||33
3260610|NCT02574078|3994895|FG006|NOT COMPLETED|Treatment Period||12
3260611|NCT02574078|3994896|FG007|NOT COMPLETED|Treatment Period||12
3260612|NCT02574078|3994897|FG008|NOT COMPLETED|Treatment Period||24
3260613|NCT02574078|3994898|FG009|NOT COMPLETED|Treatment Period||17
3260614|NCT02574078|3994899|FG010|NOT COMPLETED|Treatment Period||45
3260615|NCT02574078|3994900|FG011|NOT COMPLETED|Treatment Period||47
3260616|NCT02574078|3994901|FG012|NOT COMPLETED|Treatment Period||13
3260617|NCT02574247|3994935|FG000|STARTED|Overall Study||10
3260618|NCT02574247|3994936|FG001|STARTED|Overall Study||8
3260619|NCT02574247|3994937|FG002|STARTED|Overall Study||10
3260620|NCT02574247|3994935|FG000|COMPLETED|Overall Study||5
3260621|NCT02574247|3994936|FG001|COMPLETED|Overall Study||5
3260622|NCT02574247|3994937|FG002|COMPLETED|Overall Study||5
3260623|NCT02574247|3994935|FG000|NOT COMPLETED|Overall Study||5
3260624|NCT02574247|3994936|FG001|NOT COMPLETED|Overall Study||3
3260625|NCT02574247|3994937|FG002|NOT COMPLETED|Overall Study||5
3260626|NCT02574260|3994947|FG000|STARTED|Overall Study||3
3260627|NCT02574260|3994947|FG000|COMPLETED|Overall Study||2
3260628|NCT02574260|3994947|FG000|NOT COMPLETED|Overall Study||1
3260629|NCT02574312|3994953|FG000|STARTED|Pre-Operative||44
3260630|NCT02574312|3994954|FG001|STARTED|Pre-Operative||44
3260631|NCT02574312|3994953|FG000|COMPLETED|Pre-Operative||44
3260632|NCT02574312|3994954|FG001|COMPLETED|Pre-Operative||44
3260633|NCT02574312|3994953|FG000|NOT COMPLETED|Pre-Operative||0
3260634|NCT02574312|3994954|FG001|NOT COMPLETED|Pre-Operative||0
3260635|NCT02574312|3994953|FG000|STARTED|3 Months Follow-up||44
3260636|NCT02574312|3994954|FG001|STARTED|3 Months Follow-up||44
3260637|NCT02574312|3994953|FG000|COMPLETED|3 Months Follow-up|One subject withdrew consent|43
3260638|NCT02574312|3994954|FG001|COMPLETED|3 Months Follow-up||44
3260639|NCT02574312|3994953|FG000|NOT COMPLETED|3 Months Follow-up||1
3260640|NCT02574312|3994954|FG001|NOT COMPLETED|3 Months Follow-up||0
3260641|NCT02574520|3994964|FG000|STARTED|Overall Study||48
3260642|NCT02574520|3994965|FG001|STARTED|Overall Study||46
3260643|NCT02574520|3994966|FG002|STARTED|Overall Study||153
3260644|NCT02574520|3994967|FG003|STARTED|Overall Study||152
3260645|NCT02574520|3994964|FG000|Dosed|Overall Study||46
3260646|NCT02574520|3994965|FG001|Dosed|Overall Study||46
3260647|NCT02574520|3994966|FG002|Dosed|Overall Study||148
3260648|NCT02574520|3994967|FG003|Dosed|Overall Study||148
3260649|NCT02574520|3994964|FG000|COMPLETED|Overall Study||46
3260650|NCT02574520|3994965|FG001|COMPLETED|Overall Study||46
3260651|NCT02574520|3994966|FG002|COMPLETED|Overall Study||148
3260652|NCT02574520|3994967|FG003|COMPLETED|Overall Study||144
3260653|NCT02574520|3994964|FG000|NOT COMPLETED|Overall Study||2
3260654|NCT02574520|3994965|FG001|NOT COMPLETED|Overall Study||0
3260655|NCT02574520|3994966|FG002|NOT COMPLETED|Overall Study||5
3260656|NCT02574520|3994967|FG003|NOT COMPLETED|Overall Study||8
3260657|NCT02574598|3994979|FG000|STARTED|Overall Study||40
3260658|NCT02574598|3994980|FG001|STARTED|Overall Study||38
3260659|NCT02574598|3994979|FG000|COMPLETED|Overall Study||40
3260660|NCT02574598|3994980|FG001|COMPLETED|Overall Study||38
3260661|NCT02574598|3994979|FG000|NOT COMPLETED|Overall Study||0
3260662|NCT02574598|3994980|FG001|NOT COMPLETED|Overall Study||0
3260663|NCT02574637|3994991|FG000|STARTED|Double-blind Period||5
3260664|NCT02574637|3994992|FG001|STARTED|Double-blind Period||5
3260665|NCT02574637|3994993|FG002|STARTED|Double-blind Period||9
3260666|NCT02574637|3994994|FG003|STARTED|Double-blind Period||7
3260667|NCT02574637|3994995|FG004|STARTED|Double-blind Period||3
3260668|NCT02574637|3994996|FG005|STARTED|Double-blind Period||0
3260669|NCT02574637|3994997|FG006|STARTED|Double-blind Period||0
3260670|NCT02574637|3994998|FG007|STARTED|Double-blind Period||0
3260671|NCT02574637|3994999|FG008|STARTED|Double-blind Period||0
3260672|NCT02574637|3995000|FG009|STARTED|Double-blind Period||0
3260673|NCT02574637|3994991|FG000|COMPLETED|Double-blind Period||2
3260674|NCT02574637|3994992|FG001|COMPLETED|Double-blind Period||4
3260675|NCT02574637|3994993|FG002|COMPLETED|Double-blind Period||2
3260676|NCT02574637|3994994|FG003|COMPLETED|Double-blind Period||3
3260677|NCT02574637|3994995|FG004|COMPLETED|Double-blind Period||1
3260678|NCT02574637|3994996|FG005|COMPLETED|Double-blind Period||0
3260679|NCT02574637|3994997|FG006|COMPLETED|Double-blind Period||0
3260680|NCT02574637|3994998|FG007|COMPLETED|Double-blind Period||0
3260681|NCT02574637|3994999|FG008|COMPLETED|Double-blind Period||0
3260682|NCT02574637|3995000|FG009|COMPLETED|Double-blind Period||0
3260683|NCT02574637|3994991|FG000|NOT COMPLETED|Double-blind Period||3
3260684|NCT02574637|3994992|FG001|NOT COMPLETED|Double-blind Period||1
3260685|NCT02574637|3994993|FG002|NOT COMPLETED|Double-blind Period||7
3260686|NCT02574637|3994994|FG003|NOT COMPLETED|Double-blind Period||4
3260687|NCT02574637|3994995|FG004|NOT COMPLETED|Double-blind Period||2
3260688|NCT02574637|3994996|FG005|NOT COMPLETED|Double-blind Period||0
3260689|NCT02574637|3994997|FG006|NOT COMPLETED|Double-blind Period||0
3372879|NCT02744352|4104916|FG001|NOT COMPLETED|Overall Study||0
3372880|NCT02760602|4104924|FG000|STARTED|Overall Study||13
3372881|NCT02760602|4104925|FG001|STARTED|Overall Study||13
3372882|NCT02760602|4104924|FG000|COMPLETED|Overall Study||0
3372883|NCT02760602|4104925|FG001|COMPLETED|Overall Study||0
3372884|NCT02760602|4104924|FG000|NOT COMPLETED|Overall Study||13
3372885|NCT02760602|4104925|FG001|NOT COMPLETED|Overall Study||13
3372886|NCT02757521|4104933|FG000|STARTED|Overall Study||1
3372887|NCT02757521|4104934|FG001|STARTED|Overall Study||0
3372888|NCT02757521|4104933|FG000|COMPLETED|Overall Study||0
3372889|NCT02757521|4104934|FG001|COMPLETED|Overall Study||0
3372890|NCT02757521|4104933|FG000|NOT COMPLETED|Overall Study||1
3372891|NCT02757521|4104934|FG001|NOT COMPLETED|Overall Study||0
3372892|NCT02758132|4104942|FG000|STARTED|Overall Study||0
3372893|NCT02758132|4104943|FG001|STARTED|Overall Study||1
3372894|NCT02758132|4104942|FG000|COMPLETED|Overall Study||0
3372895|NCT02758132|4104943|FG001|COMPLETED|Overall Study||0
3372896|NCT02758132|4104942|FG000|NOT COMPLETED|Overall Study||0
3372897|NCT02758132|4104943|FG001|NOT COMPLETED|Overall Study||1
3372898|NCT02757547|4104949|FG000|STARTED|Overall Study||2
3372899|NCT02757547|4104949|FG000|COMPLETED|Overall Study||2
3372900|NCT02757547|4104949|FG000|NOT COMPLETED|Overall Study||0
3372901|NCT02757053|4104956|FG000|STARTED|Overall Study||3
3372902|NCT02757053|4104957|FG001|STARTED|Overall Study||5
3372903|NCT02757053|4104956|FG000|COMPLETED|Overall Study||0
3372904|NCT02757053|4104957|FG001|COMPLETED|Overall Study||0
3372905|NCT02757053|4104956|FG000|NOT COMPLETED|Overall Study||3
3372906|NCT02757053|4104957|FG001|NOT COMPLETED|Overall Study||5
3372907|NCT02734940|4104965|FG000|STARTED|Overall Study||0
3372908|NCT02734940|4104966|FG001|STARTED|Overall Study||0
3372909|NCT02734940|4104965|FG000|COMPLETED|Overall Study||0
3372910|NCT02734940|4104966|FG001|COMPLETED|Overall Study||0
3372911|NCT02734940|4104965|FG000|NOT COMPLETED|Overall Study||0
3372912|NCT02734940|4104966|FG001|NOT COMPLETED|Overall Study||0
3372913|NCT02749617|4104972|FG000|STARTED|Overall Study||2
3372914|NCT02749617|4104972|FG000|COMPLETED|Overall Study||2
3372915|NCT02749617|4104972|FG000|NOT COMPLETED|Overall Study||0
3372916|NCT02749227|4104976|FG000|STARTED|Overall Study||4
3372917|NCT02749227|4104976|FG000|COMPLETED|Overall Study||4
3372918|NCT02749227|4104976|FG000|NOT COMPLETED|Overall Study||0
3372919|NCT02745210|4104982|FG000|STARTED|Overall Study||0
3372920|NCT02745210|4104983|FG001|STARTED|Overall Study||9
3372921|NCT02745210|4104982|FG000|COMPLETED|Overall Study||0
3372922|NCT02745210|4104983|FG001|COMPLETED|Overall Study||9
3372923|NCT02745210|4104982|FG000|NOT COMPLETED|Overall Study||0
3372924|NCT02745210|4104983|FG001|NOT COMPLETED|Overall Study||0
3372925|NCT02725671|4104987|FG000|STARTED|Overall Study||2
3372926|NCT02725671|4104987|FG000|COMPLETED|Overall Study||1
3372927|NCT02725671|4104987|FG000|NOT COMPLETED|Overall Study||1
3372928|NCT02746263|4104995|FG000|STARTED|Overall Study||0
3372929|NCT02746263|4104996|FG001|STARTED|Overall Study||1
3372930|NCT02746263|4104995|FG000|Per Protocol Analysis Set|Overall Study||0
3372931|NCT02746263|4104996|FG001|Per Protocol Analysis Set|Overall Study||0
3372932|NCT02746263|4104995|FG000|COMPLETED|Overall Study||0
3260690|NCT02574637|3994998|FG007|NOT COMPLETED|Double-blind Period||0
3372933|NCT02746263|4104996|FG001|COMPLETED|Overall Study||1
3372934|NCT02746263|4104995|FG000|NOT COMPLETED|Overall Study||0
3260691|NCT02574637|3994999|FG008|NOT COMPLETED|Double-blind Period||0
3260692|NCT02574637|3995000|FG009|NOT COMPLETED|Double-blind Period||0
3260693|NCT02574637|3994991|FG000|STARTED|Open-label (OL) Period||0
3260694|NCT02574637|3994992|FG001|STARTED|Open-label (OL) Period||0
3260695|NCT02574637|3994993|FG002|STARTED|Open-label (OL) Period||0
3260696|NCT02574637|3994994|FG003|STARTED|Open-label (OL) Period||0
3260697|NCT02574637|3994995|FG004|STARTED|Open-label (OL) Period||0
3260698|NCT02574637|3994996|FG005|STARTED|Open-label (OL) Period||2
3260699|NCT02574637|3994997|FG006|STARTED|Open-label (OL) Period||3
3260700|NCT02574637|3994998|FG007|STARTED|Open-label (OL) Period||2
3260701|NCT02574637|3994999|FG008|STARTED|Open-label (OL) Period||3
3260702|NCT02574637|3995000|FG009|STARTED|Open-label (OL) Period||1
3260703|NCT02574637|3994991|FG000|COMPLETED|Open-label (OL) Period||0
3260704|NCT02574637|3994992|FG001|COMPLETED|Open-label (OL) Period||0
3260705|NCT02574637|3994993|FG002|COMPLETED|Open-label (OL) Period||0
3260706|NCT02574637|3994994|FG003|COMPLETED|Open-label (OL) Period||0
3260707|NCT02574637|3994995|FG004|COMPLETED|Open-label (OL) Period||0
3260708|NCT02574637|3994996|FG005|COMPLETED|Open-label (OL) Period||0
3260709|NCT02574637|3994997|FG006|COMPLETED|Open-label (OL) Period||1
3260710|NCT02574637|3994998|FG007|COMPLETED|Open-label (OL) Period||1
3260711|NCT02574637|3994999|FG008|COMPLETED|Open-label (OL) Period||1
3260712|NCT02574637|3995000|FG009|COMPLETED|Open-label (OL) Period||0
3260713|NCT02574637|3994991|FG000|NOT COMPLETED|Open-label (OL) Period||0
3260714|NCT02574637|3994992|FG001|NOT COMPLETED|Open-label (OL) Period||0
3260715|NCT02574637|3994993|FG002|NOT COMPLETED|Open-label (OL) Period||0
3260716|NCT02574637|3994994|FG003|NOT COMPLETED|Open-label (OL) Period||0
3260717|NCT02574637|3994995|FG004|NOT COMPLETED|Open-label (OL) Period||0
3260718|NCT02574637|3994996|FG005|NOT COMPLETED|Open-label (OL) Period||2
3260719|NCT02574637|3994997|FG006|NOT COMPLETED|Open-label (OL) Period||2
3260720|NCT02574637|3994998|FG007|NOT COMPLETED|Open-label (OL) Period||1
3260721|NCT02574637|3994999|FG008|NOT COMPLETED|Open-label (OL) Period||2
3260722|NCT02574637|3995000|FG009|NOT COMPLETED|Open-label (OL) Period||1
3260723|NCT02574832|3995021|FG000|STARTED|Overall Study||2
3260724|NCT02574832|3995021|FG000|COMPLETED|Overall Study||2
3260725|NCT02574832|3995021|FG000|NOT COMPLETED|Overall Study||0
3260726|NCT02574845|3995031|FG000|STARTED|Overall Study||3
3260727|NCT02574845|3995032|FG001|STARTED|Overall Study||3
3260728|NCT02574845|3995033|FG002|STARTED|Overall Study||3
3260729|NCT02574845|3995034|FG003|STARTED|Overall Study||3
3260730|NCT02574845|3995035|FG004|STARTED|Overall Study||3
3260731|NCT02574845|3995036|FG005|STARTED|Overall Study||3
3260732|NCT02574845|3995031|FG000|Received T1|Overall Study||3
3260733|NCT02574845|3995032|FG001|Received T1|Overall Study||2
3260734|NCT02574845|3995033|FG002|Received T1|Overall Study||3
3260735|NCT02574845|3995034|FG003|Received T1|Overall Study||3
3260736|NCT02574845|3995035|FG004|Received T1|Overall Study||2
3260737|NCT02574845|3995036|FG005|Received T1|Overall Study|one subject missed treatment period 2|2
3260738|NCT02574845|3995031|FG000|Received T2|Overall Study||3
3260739|NCT02574845|3995032|FG001|Received T2|Overall Study||3
3260740|NCT02574845|3995033|FG002|Received T2|Overall Study||3
3260741|NCT02574845|3995034|FG003|Received T2|Overall Study||3
3260742|NCT02574845|3995035|FG004|Received T2|Overall Study||2
3260743|NCT02574845|3995036|FG005|Received T2|Overall Study||3
3260744|NCT02574845|3995031|FG000|Received T3|Overall Study|one subject missed treatment period 2|2
3260745|NCT02574845|3995032|FG001|Received T3|Overall Study||2
3260746|NCT02574845|3995033|FG002|Received T3|Overall Study||3
3260747|NCT02574845|3995034|FG003|Received T3|Overall Study||3
3260748|NCT02574845|3995035|FG004|Received T3|Overall Study||2
3260749|NCT02574845|3995036|FG005|Received T3|Overall Study||3
3260750|NCT02574845|3995031|FG000|Received T4|Overall Study||3
3260751|NCT02574845|3995032|FG001|Received T4|Overall Study||2
3260752|NCT02574845|3995033|FG002|Received T4|Overall Study||3
3260753|NCT02574845|3995034|FG003|Received T4|Overall Study||3
3260754|NCT02574845|3995035|FG004|Received T4|Overall Study||2
3260755|NCT02574845|3995036|FG005|Received T4|Overall Study||2
3260756|NCT02574845|3995031|FG000|Received T5|Overall Study||3
3372935|NCT02746263|4104996|FG001|NOT COMPLETED|Overall Study||0
3372936|NCT02721277|4105002|FG000|STARTED|Overall Study||2
3372937|NCT02721277|4105002|FG000|COMPLETED|Overall Study||2
3372938|NCT02721277|4105002|FG000|NOT COMPLETED|Overall Study||0
3372939|NCT02732327|4105008|FG000|STARTED|Overall Study||0
3372940|NCT02732327|4105009|FG001|STARTED|Overall Study||2
3372941|NCT02732327|4105008|FG000|COMPLETED|Overall Study||0
3372942|NCT02732327|4105009|FG001|COMPLETED|Overall Study||1
3372943|NCT02732327|4105008|FG000|NOT COMPLETED|Overall Study||0
3372944|NCT02732327|4105009|FG001|NOT COMPLETED|Overall Study||1
3372945|NCT02726399|4105015|FG000|STARTED|Overall Study||7
3372946|NCT02726399|4105015|FG000|COMPLETED|Overall Study||0
3372947|NCT02726399|4105015|FG000|NOT COMPLETED|Overall Study||7
3372948|NCT02720510|4105021|FG000|STARTED|Overall Study||3
3372949|NCT02720510|4105022|FG001|STARTED|Overall Study||3
3372950|NCT02720510|4105021|FG000|COMPLETED|Overall Study||0
3372951|NCT02720510|4105022|FG001|COMPLETED|Overall Study||0
3372952|NCT02720510|4105021|FG000|NOT COMPLETED|Overall Study||3
3372953|NCT02720510|4105022|FG001|NOT COMPLETED|Overall Study||3
3372954|NCT02715765|4105031|FG000|STARTED|Overall Study||3
3372955|NCT02715765|4105032|FG001|STARTED|Overall Study||0
3372956|NCT02715765|4105033|FG002|STARTED|Overall Study||0
3372957|NCT02715765|4105031|FG000|COMPLETED|Overall Study||0
3372958|NCT02715765|4105032|FG001|COMPLETED|Overall Study||0
3372959|NCT02715765|4105033|FG002|COMPLETED|Overall Study||0
3260757|NCT02574845|3995032|FG001|Received T5|Overall Study||2
3260758|NCT02574845|3995033|FG002|Received T5|Overall Study||3
3260759|NCT02574845|3995034|FG003|Received T5|Overall Study||3
3260760|NCT02574845|3995035|FG004|Received T5|Overall Study||3
3260761|NCT02574845|3995036|FG005|Received T5|Overall Study||2
3260762|NCT02574845|3995031|FG000|Received R|Overall Study||3
3260763|NCT02574845|3995032|FG001|Received R|Overall Study||2
3260764|NCT02574845|3995033|FG002|Received R|Overall Study||3
3260765|NCT02574845|3995034|FG003|Received R|Overall Study||3
3260766|NCT02574845|3995035|FG004|Received R|Overall Study||2
3260767|NCT02574845|3995036|FG005|Received R|Overall Study||3
3260768|NCT02574845|3995031|FG000|COMPLETED|Overall Study||3
3260769|NCT02574845|3995032|FG001|COMPLETED|Overall Study||2
3260770|NCT02574845|3995033|FG002|COMPLETED|Overall Study||3
3260771|NCT02574845|3995034|FG003|COMPLETED|Overall Study||3
3260772|NCT02574845|3995035|FG004|COMPLETED|Overall Study||2
3260773|NCT02574845|3995036|FG005|COMPLETED|Overall Study||2
3260774|NCT02574845|3995031|FG000|NOT COMPLETED|Overall Study||0
3260775|NCT02574845|3995032|FG001|NOT COMPLETED|Overall Study||1
3260776|NCT02574845|3995033|FG002|NOT COMPLETED|Overall Study||0
3260777|NCT02574845|3995034|FG003|NOT COMPLETED|Overall Study||0
3260778|NCT02574845|3995035|FG004|NOT COMPLETED|Overall Study||1
3260779|NCT02574845|3995036|FG005|NOT COMPLETED|Overall Study||1
3260780|NCT02574858|3995050|FG000|STARTED|Overall Study||25
3260781|NCT02574858|3995050|FG000|COMPLETED|Overall Study||25
3260782|NCT02574858|3995050|FG000|NOT COMPLETED|Overall Study||0
3260783|NCT02575079|3995056|FG000|STARTED|Overall Study||48
3260784|NCT02575079|3995057|FG001|STARTED|Overall Study||71
3260785|NCT02575079|3995056|FG000|COMPLETED|Overall Study||42
3260786|NCT02575079|3995057|FG001|COMPLETED|Overall Study||71
3260787|NCT02575079|3995056|FG000|NOT COMPLETED|Overall Study||6
3260788|NCT02575079|3995057|FG001|NOT COMPLETED|Overall Study||0
3260789|NCT02575300|3995062|FG000|STARTED|Overall Study||20
3260790|NCT02575300|3995062|FG000|COMPLETED|Overall Study||20
3260791|NCT02575300|3995062|FG000|NOT COMPLETED|Overall Study||0
3260792|NCT02575807|3995071|FG000|STARTED|Overall Study||9
3260793|NCT02575807|3995072|FG001|STARTED|Overall Study||4
3260794|NCT02575807|3995073|FG002|STARTED|Overall Study||16
3260795|NCT02575807|3995074|FG003|STARTED|Overall Study||2
3260796|NCT02575807|3995075|FG004|STARTED|Overall Study||4
3260797|NCT02575807|3995071|FG000|Treated|Overall Study||8
3260798|NCT02575807|3995072|FG001|Treated|Overall Study||4
3260799|NCT02575807|3995073|FG002|Treated|Overall Study||16
3260800|NCT02575807|3995074|FG003|Treated|Overall Study||1
3260801|NCT02575807|3995075|FG004|Treated|Overall Study||3
3260802|NCT02575807|3995071|FG000|COMPLETED|Overall Study|Subjects followed until lost to follow-up/consent withdrawn/study termination/death.|0
3260803|NCT02575807|3995072|FG001|COMPLETED|Overall Study|Subjects followed until lost to follow-up/consent withdrawn/study termination/death.|0
3260804|NCT02575807|3995073|FG002|COMPLETED|Overall Study|Subjects followed until lost to follow-up/consent withdrawn/study termination/death.|0
3260805|NCT02575807|3995074|FG003|COMPLETED|Overall Study|Subjects followed until lost to follow-up/consent withdrawn/study termination/death.|0
3260806|NCT02575807|3995075|FG004|COMPLETED|Overall Study|Subjects followed until lost to follow-up/consent withdrawn/study termination/death.|0
3260807|NCT02575807|3995071|FG000|NOT COMPLETED|Overall Study||9
3260808|NCT02575807|3995072|FG001|NOT COMPLETED|Overall Study||4
3260809|NCT02575807|3995073|FG002|NOT COMPLETED|Overall Study||16
3260810|NCT02575807|3995074|FG003|NOT COMPLETED|Overall Study||2
3260811|NCT02575807|3995075|FG004|NOT COMPLETED|Overall Study||4
3260812|NCT02575833|3995091|FG000|STARTED|Overall Study||44
3260813|NCT02575833|3995092|FG001|STARTED|Overall Study||45
3260814|NCT02575833|3995091|FG000|Received Study Drug|Overall Study||44
3260815|NCT02575833|3995092|FG001|Received Study Drug|Overall Study||44
3260816|NCT02575833|3995091|FG000|COMPLETED|Overall Study||43
3260817|NCT02575833|3995092|FG001|COMPLETED|Overall Study||44
3260818|NCT02575833|3995091|FG000|NOT COMPLETED|Overall Study||1
3260819|NCT02575833|3995092|FG001|NOT COMPLETED|Overall Study||1
3260820|NCT02575911|3995098|FG000|STARTED|Overall Study||30
3260821|NCT02575911|3995098|FG000|COMPLETED|Overall Study||29
3260822|NCT02575911|3995098|FG000|NOT COMPLETED|Overall Study||1
3372960|NCT02715765|4105031|FG000|NOT COMPLETED|Overall Study||3
3372961|NCT02715765|4105032|FG001|NOT COMPLETED|Overall Study||0
3372962|NCT02715765|4105033|FG002|NOT COMPLETED|Overall Study||0
3372963|NCT02717949|4105043|FG000|STARTED|Overall Study||0
3372964|NCT02717949|4105044|FG001|STARTED|Overall Study||0
3372965|NCT02717949|4105043|FG000|COMPLETED|Overall Study||0
3372966|NCT02717949|4105044|FG001|COMPLETED|Overall Study||0
3372967|NCT02717949|4105043|FG000|NOT COMPLETED|Overall Study||0
3372968|NCT02717949|4105044|FG001|NOT COMPLETED|Overall Study||0
3372969|NCT02717130|4105052|FG000|STARTED|Overall Study|Of the nine enrolled subjects, eight received study drug.|8
3372970|NCT02717130|4105052|FG000|COMPLETED|Overall Study||1
3372971|NCT02717130|4105052|FG000|NOT COMPLETED|Overall Study||7
3372972|NCT02685202|4105056|FG000|STARTED|Overall Study||9
3372973|NCT02685202|4105056|FG000|COMPLETED|Overall Study||0
3372974|NCT02685202|4105056|FG000|NOT COMPLETED|Overall Study||9
3372975|NCT02709083|4105060|FG000|STARTED|Overall Study||7
3372976|NCT02709083|4105060|FG000|COMPLETED|Overall Study||0
3372977|NCT02709083|4105060|FG000|NOT COMPLETED|Overall Study||7
3372978|NCT02693171|4105064|FG000|STARTED|Overall Study|At study termination, 13 subjects had enrolled, 12 subjects received at least 1 dose of study drug.|12
3372979|NCT02693171|4105064|FG000|COMPLETED|Overall Study||3
3372980|NCT02693171|4105064|FG000|NOT COMPLETED|Overall Study||9
3260823|NCT02575950|3995110|FG000|STARTED|Overall Study||3
3260824|NCT02575950|3995111|FG001|STARTED|Overall Study||6
3260825|NCT02575950|3995112|FG002|STARTED|Overall Study||6
3260826|NCT02575950|3995113|FG003|STARTED|Overall Study||25
3260827|NCT02575950|3995110|FG000|COMPLETED|Overall Study||3
3260828|NCT02575950|3995111|FG001|COMPLETED|Overall Study||5
3260829|NCT02575950|3995112|FG002|COMPLETED|Overall Study||6
3260830|NCT02575950|3995113|FG003|COMPLETED|Overall Study||20
3260831|NCT02575950|3995110|FG000|NOT COMPLETED|Overall Study||0
3260832|NCT02575950|3995111|FG001|NOT COMPLETED|Overall Study||1
3260833|NCT02575950|3995112|FG002|NOT COMPLETED|Overall Study||0
3260834|NCT02575950|3995113|FG003|NOT COMPLETED|Overall Study||5
3260835|NCT02576041|3995121|FG000|STARTED|Placebo (run-in)||18
3260836|NCT02576041|3995121|FG000|COMPLETED|Placebo (run-in)||18
3260837|NCT02576041|3995121|FG000|NOT COMPLETED|Placebo (run-in)||0
3260838|NCT02576041|3995121|FG000|STARTED|Bilastine (Active Treatement)||18
3260839|NCT02576041|3995121|FG000|COMPLETED|Bilastine (Active Treatement)||18
3260840|NCT02576041|3995121|FG000|NOT COMPLETED|Bilastine (Active Treatement)||0
3260841|NCT02576054|3995125|FG000|STARTED|Overall Study||101
3260842|NCT02576054|3995125|FG000|Vaccination 1|Overall Study||100
3260843|NCT02576054|3995125|FG000|Vaccination 2|Overall Study||100
3260844|NCT02576054|3995125|FG000|Vaccination 3|Overall Study||100
3260845|NCT02576054|3995125|FG000|COMPLETED|Overall Study||100
3260846|NCT02576054|3995125|FG000|NOT COMPLETED|Overall Study||1
3260847|NCT02576067|3995133|FG000|STARTED|Overall Study||60
3260848|NCT02576067|3995134|FG001|STARTED|Overall Study||63
3260849|NCT02576067|3995133|FG000|COMPLETED|Overall Study||26
3260850|NCT02576067|3995134|FG001|COMPLETED|Overall Study||27
3260851|NCT02576067|3995133|FG000|NOT COMPLETED|Overall Study||34
3260852|NCT02576067|3995134|FG001|NOT COMPLETED|Overall Study||36
3260853|NCT02576145|3995142|FG000|STARTED|Overall Study||6
3260854|NCT02576145|3995143|FG001|STARTED|Overall Study||5
3260855|NCT02576145|3995142|FG000|COMPLETED|Overall Study||3
3260856|NCT02576145|3995143|FG001|COMPLETED|Overall Study||4
3260857|NCT02576145|3995142|FG000|NOT COMPLETED|Overall Study||3
3260858|NCT02576145|3995143|FG001|NOT COMPLETED|Overall Study||1
3260859|NCT02576249|3995151|FG000|STARTED|Overall Study||15
3260860|NCT02576249|3995152|FG001|STARTED|Overall Study||14
3260861|NCT02576249|3995151|FG000|COMPLETED|Overall Study||15
3260862|NCT02576249|3995152|FG001|COMPLETED|Overall Study||14
3260863|NCT02576249|3995151|FG000|NOT COMPLETED|Overall Study||0
3260864|NCT02576249|3995152|FG001|NOT COMPLETED|Overall Study||0
3260865|NCT02576509|3995160|FG000|STARTED|Pre-Treatment Period||371
3260866|NCT02576509|3995161|FG001|STARTED|Pre-Treatment Period||372
3260867|NCT02576509|3995160|FG000|COMPLETED|Pre-Treatment Period||367
3260868|NCT02576509|3995161|FG001|COMPLETED|Pre-Treatment Period||363
3260869|NCT02576509|3995160|FG000|NOT COMPLETED|Pre-Treatment Period||4
3260870|NCT02576509|3995161|FG001|NOT COMPLETED|Pre-Treatment Period||9
3260871|NCT02576509|3995160|FG000|STARTED|Treatment Period||367
3260872|NCT02576509|3995161|FG001|STARTED|Treatment Period||363
3260873|NCT02576509|3995160|FG000|COMPLETED|Treatment Period||38
3260874|NCT02576509|3995161|FG001|COMPLETED|Treatment Period||8
3260875|NCT02576509|3995160|FG000|NOT COMPLETED|Treatment Period||329
3260876|NCT02576509|3995161|FG001|NOT COMPLETED|Treatment Period||355
3260877|NCT02576509|3995160|FG000|STARTED|Follow-up Period||367
3260878|NCT02576509|3995161|FG001|STARTED|Follow-up Period||363
3260879|NCT02576509|3995160|FG000|COMPLETED|Follow-up Period||318
3260880|NCT02576509|3995161|FG001|COMPLETED|Follow-up Period||311
3260881|NCT02576509|3995160|FG000|NOT COMPLETED|Follow-up Period||49
3260882|NCT02576509|3995161|FG001|NOT COMPLETED|Follow-up Period||52
3260883|NCT02576535|3995167|FG000|STARTED|Overall Study||18
3260884|NCT02576535|3995167|FG000|COMPLETED|Overall Study||16
3260885|NCT02576535|3995167|FG000|NOT COMPLETED|Overall Study||2
3260886|NCT02576587|3995173|FG000|STARTED|Baseline|Total cases baseline visit|161
3260887|NCT02576587|3995174|FG001|STARTED|Baseline|Total controls baseline visit|156
3260888|NCT02576587|3995173|FG000|COMPLETED|Baseline|Baseline visit completed|161
3372981|NCT02696226|4105072|FG000|STARTED|Overall Study||1
3372982|NCT02696226|4105073|FG001|STARTED|Overall Study||0
3372983|NCT02696226|4105074|FG002|STARTED|Overall Study||2
3372984|NCT02696226|4105075|FG003|STARTED|Overall Study||0
3372985|NCT02696226|4105072|FG000|COMPLETED|Overall Study||0
3372986|NCT02696226|4105073|FG001|COMPLETED|Overall Study||0
3372987|NCT02696226|4105074|FG002|COMPLETED|Overall Study||0
3372988|NCT02696226|4105075|FG003|COMPLETED|Overall Study||0
3372989|NCT02696226|4105072|FG000|NOT COMPLETED|Overall Study||1
3372990|NCT02696226|4105073|FG001|NOT COMPLETED|Overall Study||0
3372991|NCT02696226|4105074|FG002|NOT COMPLETED|Overall Study||2
3372992|NCT02696226|4105075|FG003|NOT COMPLETED|Overall Study||0
3372993|NCT02693743|4105087|FG000|STARTED|Overall Study||1
3372994|NCT02693743|4105088|FG001|STARTED|Overall Study||0
3372995|NCT02693743|4105087|FG000|COMPLETED|Overall Study||0
3372996|NCT02693743|4105088|FG001|COMPLETED|Overall Study||0
3372997|NCT02693743|4105087|FG000|NOT COMPLETED|Overall Study||1
3372998|NCT02693743|4105088|FG001|NOT COMPLETED|Overall Study||0
3372999|NCT02706691|4105094|FG000|STARTED|Overall Study||1
3373000|NCT02706691|4105094|FG000|COMPLETED|Overall Study||0
3373001|NCT02706691|4105094|FG000|NOT COMPLETED|Overall Study||1
3373002|NCT02708849|4105101|FG000|STARTED|Overall Study||2
3373003|NCT02708849|4105102|FG001|STARTED|Overall Study||1
3373004|NCT02708849|4105101|FG000|COMPLETED|Overall Study||1
3373005|NCT02708849|4105102|FG001|COMPLETED|Overall Study||1
3260889|NCT02576587|3995174|FG001|COMPLETED|Baseline|Baseline visit completed|155
3260890|NCT02576587|3995173|FG000|NOT COMPLETED|Baseline||0
3260891|NCT02576587|3995174|FG001|NOT COMPLETED|Baseline||1
3260892|NCT02576587|3995173|FG000|STARTED|Follow up Period (Case Only)|Completed baseline.|161
3260893|NCT02576587|3995174|FG001|STARTED|Follow up Period (Case Only)|Controls not eligible for follow-up|155
3260894|NCT02576587|3995173|FG000|Selected for Follow up|Follow up Period (Case Only)||61
3260895|NCT02576587|3995174|FG001|Selected for Follow up|Follow up Period (Case Only)||0
3260896|NCT02576587|3995173|FG000|COMPLETED|Follow up Period (Case Only)||44
3260897|NCT02576587|3995174|FG001|COMPLETED|Follow up Period (Case Only)||0
3260898|NCT02576587|3995173|FG000|NOT COMPLETED|Follow up Period (Case Only)||117
3260899|NCT02576587|3995174|FG001|NOT COMPLETED|Follow up Period (Case Only)||155
3260900|NCT02576639|3995187|FG000|STARTED|Overall Study||24
3260901|NCT02576639|3995188|FG001|STARTED|Overall Study||25
3260902|NCT02576639|3995189|FG002|STARTED|Overall Study||25
3260903|NCT02576639|3995190|FG003|STARTED|Overall Study||26
3260904|NCT02576639|3995191|FG004|STARTED|Overall Study||24
3260905|NCT02576639|3995187|FG000|Pharmacodynamic Analysis Set|Overall Study||24
3260906|NCT02576639|3995188|FG001|Pharmacodynamic Analysis Set|Overall Study||24
3260907|NCT02576639|3995189|FG002|Pharmacodynamic Analysis Set|Overall Study||25
3260908|NCT02576639|3995190|FG003|Pharmacodynamic Analysis Set|Overall Study||25
3260909|NCT02576639|3995191|FG004|Pharmacodynamic Analysis Set|Overall Study||25
3260910|NCT02576639|3995187|FG000|Pharmacokinetic Analysis Set|Overall Study||0
3260911|NCT02576639|3995188|FG001|Pharmacokinetic Analysis Set|Overall Study||25
3260912|NCT02576639|3995189|FG002|Pharmacokinetic Analysis Set|Overall Study||25
3260913|NCT02576639|3995190|FG003|Pharmacokinetic Analysis Set|Overall Study||26
3260914|NCT02576639|3995191|FG004|Pharmacokinetic Analysis Set|Overall Study||24
3260915|NCT02576639|3995187|FG000|Safety Analysis Set|Overall Study||24
3260916|NCT02576639|3995188|FG001|Safety Analysis Set|Overall Study||25
3260917|NCT02576639|3995189|FG002|Safety Analysis Set|Overall Study||25
3260918|NCT02576639|3995190|FG003|Safety Analysis Set|Overall Study||26
3260919|NCT02576639|3995191|FG004|Safety Analysis Set|Overall Study||24
3260920|NCT02576639|3995187|FG000|COMPLETED|Overall Study||22
3260921|NCT02576639|3995188|FG001|COMPLETED|Overall Study||23
3260922|NCT02576639|3995189|FG002|COMPLETED|Overall Study||23
3260923|NCT02576639|3995190|FG003|COMPLETED|Overall Study||25
3260924|NCT02576639|3995191|FG004|COMPLETED|Overall Study||20
3260925|NCT02576639|3995187|FG000|NOT COMPLETED|Overall Study||2
3260926|NCT02576639|3995188|FG001|NOT COMPLETED|Overall Study||2
3260927|NCT02576639|3995189|FG002|NOT COMPLETED|Overall Study||2
3260928|NCT02576639|3995190|FG003|NOT COMPLETED|Overall Study||1
3260929|NCT02576639|3995191|FG004|NOT COMPLETED|Overall Study||4
3260930|NCT02576652|3995207|FG000|STARTED|Overall Study||6
3260931|NCT02576652|3995207|FG000|COMPLETED|Overall Study||4
3260932|NCT02576652|3995207|FG000|NOT COMPLETED|Overall Study||2
3260933|NCT02576678|3995214|FG000|STARTED|Overall Study||13
3260934|NCT02576678|3995215|FG001|STARTED|Overall Study||8
3260935|NCT02576678|3995216|FG002|STARTED|Overall Study||21
3260936|NCT02576678|3995214|FG000|Pharmacokinetic (PK) Population|Overall Study||12
3260937|NCT02576678|3995215|FG001|Pharmacokinetic (PK) Population|Overall Study||8
3260938|NCT02576678|3995216|FG002|Pharmacokinetic (PK) Population|Overall Study||18
3260939|NCT02576678|3995214|FG000|COMPLETED|Overall Study||8
3260940|NCT02576678|3995215|FG001|COMPLETED|Overall Study||7
3260941|NCT02576678|3995216|FG002|COMPLETED|Overall Study||16
3260942|NCT02576678|3995214|FG000|NOT COMPLETED|Overall Study||5
3260943|NCT02576678|3995215|FG001|NOT COMPLETED|Overall Study||1
3260944|NCT02576678|3995216|FG002|NOT COMPLETED|Overall Study||5
3260945|NCT02576899|3995226|FG000|STARTED|Overall Study||16
3260946|NCT02576899|3995227|FG001|STARTED|Overall Study||20
3260947|NCT02576899|3995226|FG000|COMPLETED|Overall Study||5
3260948|NCT02576899|3995227|FG001|COMPLETED|Overall Study||7
3260949|NCT02576899|3995226|FG000|NOT COMPLETED|Overall Study||11
3260950|NCT02576899|3995227|FG001|NOT COMPLETED|Overall Study||13
3260951|NCT02576938|3995237|FG000|STARTED|Overall Study||49
3260952|NCT02576938|3995238|FG001|STARTED|Overall Study||37
3260953|NCT02576938|3995239|FG002|STARTED|Overall Study||38
3260954|NCT02576938|3995237|FG000|Received at Least One Dose of Study Drug|Overall Study||49
3260955|NCT02576938|3995238|FG001|Received at Least One Dose of Study Drug|Overall Study||37
3260956|NCT02576938|3995239|FG002|Received at Least One Dose of Study Drug|Overall Study||38
3260957|NCT02576938|3995237|FG000|COMPLETED|Overall Study||29
3260958|NCT02576938|3995238|FG001|COMPLETED|Overall Study||25
3260959|NCT02576938|3995239|FG002|COMPLETED|Overall Study||26
3260960|NCT02576938|3995237|FG000|NOT COMPLETED|Overall Study||20
3260961|NCT02576938|3995238|FG001|NOT COMPLETED|Overall Study||12
3260962|NCT02576938|3995239|FG002|NOT COMPLETED|Overall Study||12
3260963|NCT02576951|3995253|FG000|STARTED|Overall Study||15
3260964|NCT02576951|3995254|FG001|STARTED|Overall Study||3
3260965|NCT02576951|3995255|FG002|STARTED|Overall Study||80
3260966|NCT02576951|3995256|FG003|STARTED|Overall Study||80
3260967|NCT02576951|3995253|FG000|Received at Least One Dose of Study Drug|Overall Study||15
3260968|NCT02576951|3995254|FG001|Received at Least One Dose of Study Drug|Overall Study||3
3260969|NCT02576951|3995255|FG002|Received at Least One Dose of Study Drug|Overall Study||80
3260970|NCT02576951|3995256|FG003|Received at Least One Dose of Study Drug|Overall Study||80
3260971|NCT02576951|3995253|FG000|COMPLETED|Overall Study||14
3260972|NCT02576951|3995254|FG001|COMPLETED|Overall Study||3
3260973|NCT02576951|3995255|FG002|COMPLETED|Overall Study||78
3260974|NCT02576951|3995256|FG003|COMPLETED|Overall Study||75
3260975|NCT02576951|3995253|FG000|NOT COMPLETED|Overall Study||1
3260976|NCT02576951|3995254|FG001|NOT COMPLETED|Overall Study||0
3260977|NCT02576951|3995255|FG002|NOT COMPLETED|Overall Study||2
3260978|NCT02576951|3995256|FG003|NOT COMPLETED|Overall Study||5
3260979|NCT02576977|3995270|FG000|STARTED|Overall Study||126
3260980|NCT02576977|3995271|FG001|STARTED|Overall Study||125
3260981|NCT02576977|3995270|FG000|Treated|Overall Study||122
3260982|NCT02576977|3995271|FG001|Treated|Overall Study||123
3260983|NCT02576977|3995270|FG000|COMPLETED|Overall Study||0
3260984|NCT02576977|3995271|FG001|COMPLETED|Overall Study||0
3260985|NCT02576977|3995270|FG000|NOT COMPLETED|Overall Study||126
3260986|NCT02576977|3995271|FG001|NOT COMPLETED|Overall Study||125
3260987|NCT02576990|3995279|FG000|STARTED|Overall Study||56
3260988|NCT02576990|3995280|FG001|STARTED|Overall Study||24
3260989|NCT02576990|3995279|FG000|Treated|Overall Study||53
3260990|NCT02576990|3995280|FG001|Treated|Overall Study||23
3260991|NCT02576990|3995279|FG000|COMPLETED|Overall Study||0
3260992|NCT02576990|3995280|FG001|COMPLETED|Overall Study||0
3260993|NCT02576990|3995279|FG000|NOT COMPLETED|Overall Study||56
3260994|NCT02576990|3995280|FG001|NOT COMPLETED|Overall Study||24
3260995|NCT02577003|3995288|FG000|STARTED|Overall Study||73
3260996|NCT02577003|3995289|FG001|STARTED|Overall Study||70
3260997|NCT02577003|3995288|FG000|COMPLETED|Overall Study||71
3260998|NCT02577003|3995289|FG001|COMPLETED|Overall Study||65
3260999|NCT02577003|3995288|FG000|NOT COMPLETED|Overall Study||2
3261000|NCT02577003|3995289|FG001|NOT COMPLETED|Overall Study||5
3261001|NCT02577016|3995297|FG000|STARTED|Overall Study||70
3261002|NCT02577016|3995298|FG001|STARTED|Overall Study||71
3261003|NCT02577016|3995297|FG000|COMPLETED|Overall Study||68
3261004|NCT02577016|3995298|FG001|COMPLETED|Overall Study||69
3261005|NCT02577016|3995297|FG000|NOT COMPLETED|Overall Study||2
3261006|NCT02577016|3995298|FG001|NOT COMPLETED|Overall Study||2
3261007|NCT02577029|3995312|FG000|STARTED|Overall Study||10
3261008|NCT02577029|3995313|FG001|STARTED|Overall Study||2
3261009|NCT02577029|3995314|FG002|STARTED|Overall Study||7
3261010|NCT02577029|3995315|FG003|STARTED|Overall Study||12
3261011|NCT02577029|3995316|FG004|STARTED|Overall Study||11
3261012|NCT02577029|3995317|FG005|STARTED|Overall Study||13
3261013|NCT02577029|3995318|FG006|STARTED|Overall Study||12
3261014|NCT02577029|3995319|FG007|STARTED|Overall Study||12
3261015|NCT02577029|3995312|FG000|COMPLETED|Overall Study||0
3261016|NCT02577029|3995313|FG001|COMPLETED|Overall Study||0
3373006|NCT02708849|4105101|FG000|NOT COMPLETED|Overall Study||1
3373007|NCT02708849|4105102|FG001|NOT COMPLETED|Overall Study||0
3373008|NCT02693717|4105108|FG000|STARTED|Overall Study||7
3373009|NCT02693717|4105108|FG000|COMPLETED|Overall Study||7
3373010|NCT02693717|4105108|FG000|NOT COMPLETED|Overall Study||0
3373011|NCT02694757|4105112|FG000|STARTED|Overall Study||3
3373012|NCT02694757|4105112|FG000|COMPLETED|Overall Study||0
3373013|NCT02694757|4105112|FG000|NOT COMPLETED|Overall Study||3
3373014|NCT02693002|4105118|FG000|STARTED|Overall Study||2
3373015|NCT02693002|4105119|FG001|STARTED|Overall Study||2
3373016|NCT02693002|4105118|FG000|COMPLETED|Overall Study||1
3373017|NCT02693002|4105119|FG001|COMPLETED|Overall Study||2
3373018|NCT02693002|4105118|FG000|NOT COMPLETED|Overall Study||1
3373019|NCT02693002|4105119|FG001|NOT COMPLETED|Overall Study||0
3373020|NCT02689518|4105125|FG000|STARTED|Overall Study||49
3373021|NCT02689518|4105125|FG000|COMPLETED|Overall Study||46
3373022|NCT02689518|4105125|FG000|NOT COMPLETED|Overall Study||3
3373023|NCT02687165|4105129|FG000|STARTED|Overall Study||0
3373024|NCT02687165|4105130|FG001|STARTED|Overall Study||0
3373025|NCT02687165|4105129|FG000|COMPLETED|Overall Study||0
3373026|NCT02687165|4105130|FG001|COMPLETED|Overall Study||0
3373027|NCT02687165|4105129|FG000|NOT COMPLETED|Overall Study||0
3373028|NCT02687165|4105130|FG001|NOT COMPLETED|Overall Study||0
3373029|NCT02679560|4105138|FG000|STARTED|Overall Study||1
3373030|NCT02679560|4105139|FG001|STARTED|Overall Study||2
3373031|NCT02679560|4105138|FG000|COMPLETED|Overall Study||1
3373032|NCT02679560|4105139|FG001|COMPLETED|Overall Study||2
3373033|NCT02679560|4105138|FG000|NOT COMPLETED|Overall Study||0
3373034|NCT02679560|4105139|FG001|NOT COMPLETED|Overall Study||0
3373035|NCT02679066|4105147|FG000|STARTED|Overall Study||100
3373036|NCT02679066|4105148|FG001|STARTED|Overall Study||100
3373037|NCT02679066|4105147|FG000|COMPLETED|Overall Study||100
3373038|NCT02679066|4105148|FG001|COMPLETED|Overall Study||100
3373039|NCT02679066|4105147|FG000|NOT COMPLETED|Overall Study||0
3373040|NCT02679066|4105148|FG001|NOT COMPLETED|Overall Study||0
3373041|NCT02673684|4105156|FG000|STARTED|Overall Study||9
3373042|NCT02673684|4105157|FG001|STARTED|Overall Study||8
3373043|NCT02673684|4105156|FG000|COMPLETED|Overall Study||0
3373044|NCT02673684|4105157|FG001|COMPLETED|Overall Study||0
3373045|NCT02673684|4105156|FG000|NOT COMPLETED|Overall Study||9
3373046|NCT02673684|4105157|FG001|NOT COMPLETED|Overall Study||8
3373047|NCT02674204|4105167|FG000|STARTED|Overall Study||1
3373048|NCT02674204|4105168|FG001|STARTED|Overall Study||1
3373049|NCT02674204|4105167|FG000|COMPLETED|Overall Study||0
3373050|NCT02674204|4105168|FG001|COMPLETED|Overall Study||1
3373051|NCT02674204|4105167|FG000|NOT COMPLETED|Overall Study||1
3373052|NCT02674204|4105168|FG001|NOT COMPLETED|Overall Study||0
3373053|NCT02665221|4105176|FG000|STARTED|Overall Study||15
3373054|NCT02665221|4105177|FG001|STARTED|Overall Study||15
3261017|NCT02577029|3995314|FG002|COMPLETED|Overall Study||0
3261018|NCT02577029|3995315|FG003|COMPLETED|Overall Study||0
3261019|NCT02577029|3995316|FG004|COMPLETED|Overall Study||0
3261020|NCT02577029|3995317|FG005|COMPLETED|Overall Study||0
3261021|NCT02577029|3995318|FG006|COMPLETED|Overall Study||0
3261022|NCT02577029|3995319|FG007|COMPLETED|Overall Study||0
3261023|NCT02577029|3995312|FG000|NOT COMPLETED|Overall Study||10
3261024|NCT02577029|3995313|FG001|NOT COMPLETED|Overall Study||2
3261025|NCT02577029|3995314|FG002|NOT COMPLETED|Overall Study||7
3261026|NCT02577029|3995315|FG003|NOT COMPLETED|Overall Study||12
3261027|NCT02577029|3995316|FG004|NOT COMPLETED|Overall Study||11
3261028|NCT02577029|3995317|FG005|NOT COMPLETED|Overall Study||13
3261029|NCT02577029|3995318|FG006|NOT COMPLETED|Overall Study||12
3261030|NCT02577029|3995319|FG007|NOT COMPLETED|Overall Study||12
3261031|NCT02577042|3995339|FG000|STARTED|Overall Study||20
3261032|NCT02577042|3995340|FG001|STARTED|Overall Study||22
3261033|NCT02577042|3995339|FG000|COMPLETED|Overall Study||15
3261034|NCT02577042|3995340|FG001|COMPLETED|Overall Study||19
3261035|NCT02577042|3995339|FG000|NOT COMPLETED|Overall Study||5
3261036|NCT02577042|3995340|FG001|NOT COMPLETED|Overall Study||3
3261037|NCT02577107|3995349|FG000|STARTED|Overall Study||6
3261038|NCT02577107|3995350|FG001|STARTED|Overall Study||6
3261039|NCT02577107|3995349|FG000|COMPLETED|Overall Study||6
3261040|NCT02577107|3995350|FG001|COMPLETED|Overall Study||5
3261041|NCT02577107|3995349|FG000|NOT COMPLETED|Overall Study||0
3261042|NCT02577107|3995350|FG001|NOT COMPLETED|Overall Study||1
3261043|NCT02577146|3995356|FG000|STARTED|Overall Study||74
3261044|NCT02577146|3995356|FG000|COMPLETED|Overall Study||46
3261045|NCT02577146|3995356|FG000|NOT COMPLETED|Overall Study||28
3261046|NCT02577315|3995362|FG000|STARTED|Treatment Period 1 (4 Days)||12
3261047|NCT02577315|3995363|FG001|STARTED|Treatment Period 1 (4 Days)||13
3261048|NCT02577315|3995362|FG000|COMPLETED|Treatment Period 1 (4 Days)||12
3261049|NCT02577315|3995363|FG001|COMPLETED|Treatment Period 1 (4 Days)||12
3261050|NCT02577315|3995362|FG000|NOT COMPLETED|Treatment Period 1 (4 Days)||0
3261051|NCT02577315|3995363|FG001|NOT COMPLETED|Treatment Period 1 (4 Days)||1
3261052|NCT02577315|3995362|FG000|STARTED|Washout Period (5 Days)||12
3261053|NCT02577315|3995363|FG001|STARTED|Washout Period (5 Days)||12
3261054|NCT02577315|3995362|FG000|COMPLETED|Washout Period (5 Days)||12
3261055|NCT02577315|3995363|FG001|COMPLETED|Washout Period (5 Days)||12
3261056|NCT02577315|3995362|FG000|NOT COMPLETED|Washout Period (5 Days)||0
3261057|NCT02577315|3995363|FG001|NOT COMPLETED|Washout Period (5 Days)||0
3261058|NCT02577315|3995362|FG000|STARTED|Treatment Period 2 (4 Days)||12
3261059|NCT02577315|3995363|FG001|STARTED|Treatment Period 2 (4 Days)||12
3261060|NCT02577315|3995362|FG000|COMPLETED|Treatment Period 2 (4 Days)||12
3261061|NCT02577315|3995363|FG001|COMPLETED|Treatment Period 2 (4 Days)||12
3261062|NCT02577315|3995362|FG000|NOT COMPLETED|Treatment Period 2 (4 Days)||0
3261063|NCT02577315|3995363|FG001|NOT COMPLETED|Treatment Period 2 (4 Days)||0
3261064|NCT02577445|3995371|FG000|STARTED|Overall Study||14
3261065|NCT02577445|3995372|FG001|STARTED|Overall Study||17
3261066|NCT02577445|3995371|FG000|COMPLETED|Overall Study|study terminated prematurely|0
3261067|NCT02577445|3995372|FG001|COMPLETED|Overall Study|study terminated prematurely|0
3261068|NCT02577445|3995371|FG000|NOT COMPLETED|Overall Study||14
3261069|NCT02577445|3995372|FG001|NOT COMPLETED|Overall Study||17
3261070|NCT02577510|3995379|FG000|STARTED|Overall Study||21
3261071|NCT02577510|3995380|FG001|STARTED|Overall Study||21
3261072|NCT02577510|3995379|FG000|COMPLETED|Overall Study||21
3261073|NCT02577510|3995380|FG001|COMPLETED|Overall Study||21
3261074|NCT02577510|3995379|FG000|NOT COMPLETED|Overall Study||0
3261075|NCT02577510|3995380|FG001|NOT COMPLETED|Overall Study||0
3261076|NCT02577601|3995389|FG000|STARTED|UPA Only (1 Month)||36
3261077|NCT02577601|3995389|FG000|COMPLETED|UPA Only (1 Month)||36
3261078|NCT02577601|3995389|FG000|NOT COMPLETED|UPA Only (1 Month)||0
3261079|NCT02577601|3995389|FG000|STARTED|Washout (1 Month)||33
3261080|NCT02577601|3995389|FG000|COMPLETED|Washout (1 Month)||33
3261081|NCT02577601|3995389|FG000|NOT COMPLETED|Washout (1 Month)||0
3261082|NCT02577601|3995389|FG000|STARTED|UPA+COC (1 Month)||33
3261083|NCT02577601|3995389|FG000|COMPLETED|UPA+COC (1 Month)||33
3261084|NCT02577601|3995389|FG000|NOT COMPLETED|UPA+COC (1 Month)||0
3261085|NCT02577640|3995400|FG000|STARTED|Dose Escalation Group 1||4
3261086|NCT02577640|3995401|FG001|STARTED|Dose Escalation Group 1||0
3261087|NCT02577640|3995402|FG002|STARTED|Dose Escalation Group 1||0
3261088|NCT02577640|3995403|FG003|STARTED|Dose Escalation Group 1||0
3261089|NCT02577640|3995400|FG000|COMPLETED|Dose Escalation Group 1||3
3261090|NCT02577640|3995401|FG001|COMPLETED|Dose Escalation Group 1||0
3261091|NCT02577640|3995402|FG002|COMPLETED|Dose Escalation Group 1||0
3261092|NCT02577640|3995403|FG003|COMPLETED|Dose Escalation Group 1||0
3261093|NCT02577640|3995400|FG000|NOT COMPLETED|Dose Escalation Group 1||1
3261094|NCT02577640|3995401|FG001|NOT COMPLETED|Dose Escalation Group 1||0
3261095|NCT02577640|3995402|FG002|NOT COMPLETED|Dose Escalation Group 1||0
3261096|NCT02577640|3995403|FG003|NOT COMPLETED|Dose Escalation Group 1||0
3261097|NCT02577640|3995400|FG000|STARTED|Dose Escalation Group 2||0
3261098|NCT02577640|3995401|FG001|STARTED|Dose Escalation Group 2||3
3261099|NCT02577640|3995402|FG002|STARTED|Dose Escalation Group 2||0
3261100|NCT02577640|3995403|FG003|STARTED|Dose Escalation Group 2||0
3261101|NCT02577640|3995400|FG000|COMPLETED|Dose Escalation Group 2||0
3261102|NCT02577640|3995401|FG001|COMPLETED|Dose Escalation Group 2||3
3261103|NCT02577640|3995402|FG002|COMPLETED|Dose Escalation Group 2||0
3261104|NCT02577640|3995403|FG003|COMPLETED|Dose Escalation Group 2||0
3261105|NCT02577640|3995400|FG000|NOT COMPLETED|Dose Escalation Group 2||0
3261106|NCT02577640|3995401|FG001|NOT COMPLETED|Dose Escalation Group 2||0
3261107|NCT02577640|3995402|FG002|NOT COMPLETED|Dose Escalation Group 2||0
3261108|NCT02577640|3995403|FG003|NOT COMPLETED|Dose Escalation Group 2||0
3261109|NCT02577640|3995400|FG000|STARTED|Dose Escalation Group 3||0
3261110|NCT02577640|3995401|FG001|STARTED|Dose Escalation Group 3||0
3261111|NCT02577640|3995402|FG002|STARTED|Dose Escalation Group 3||3
3261112|NCT02577640|3995403|FG003|STARTED|Dose Escalation Group 3||0
3261113|NCT02577640|3995400|FG000|COMPLETED|Dose Escalation Group 3||0
3261114|NCT02577640|3995401|FG001|COMPLETED|Dose Escalation Group 3||0
3261115|NCT02577640|3995402|FG002|COMPLETED|Dose Escalation Group 3||3
3261116|NCT02577640|3995403|FG003|COMPLETED|Dose Escalation Group 3||0
3261117|NCT02577640|3995400|FG000|NOT COMPLETED|Dose Escalation Group 3||0
3261118|NCT02577640|3995401|FG001|NOT COMPLETED|Dose Escalation Group 3||0
3261119|NCT02577640|3995402|FG002|NOT COMPLETED|Dose Escalation Group 3||0
3261120|NCT02577640|3995403|FG003|NOT COMPLETED|Dose Escalation Group 3||0
3261121|NCT02577640|3995400|FG000|STARTED|Maximally Tolerated Dose||0
3261122|NCT02577640|3995401|FG001|STARTED|Maximally Tolerated Dose||0
3261123|NCT02577640|3995402|FG002|STARTED|Maximally Tolerated Dose||0
3261124|NCT02577640|3995403|FG003|STARTED|Maximally Tolerated Dose||1
3261125|NCT02577640|3995400|FG000|COMPLETED|Maximally Tolerated Dose||0
3261126|NCT02577640|3995401|FG001|COMPLETED|Maximally Tolerated Dose||0
3261127|NCT02577640|3995402|FG002|COMPLETED|Maximally Tolerated Dose||0
3261128|NCT02577640|3995403|FG003|COMPLETED|Maximally Tolerated Dose||1
3261129|NCT02577640|3995400|FG000|NOT COMPLETED|Maximally Tolerated Dose||0
3261130|NCT02577640|3995401|FG001|NOT COMPLETED|Maximally Tolerated Dose||0
3261131|NCT02577640|3995402|FG002|NOT COMPLETED|Maximally Tolerated Dose||0
3373055|NCT02665221|4105176|FG000|COMPLETED|Overall Study||0
3373056|NCT02665221|4105177|FG001|COMPLETED|Overall Study||0
3373057|NCT02665221|4105176|FG000|NOT COMPLETED|Overall Study||15
3373058|NCT02665221|4105177|FG001|NOT COMPLETED|Overall Study||15
3373059|NCT02672033|4105183|FG000|STARTED|Overall Study||2
3373060|NCT02672033|4105183|FG000|COMPLETED|Overall Study||2
3373061|NCT02672033|4105183|FG000|NOT COMPLETED|Overall Study||0
3373062|NCT02671461|4105190|FG000|STARTED|Treatment||3
3373063|NCT02671461|4105191|FG001|STARTED|Treatment||5
3373064|NCT02671461|4105192|FG002|STARTED|Treatment||7
3373065|NCT02671461|4105190|FG000|COMPLETED|Treatment||1
3373066|NCT02671461|4105191|FG001|COMPLETED|Treatment||2
3373067|NCT02671461|4105192|FG002|COMPLETED|Treatment||2
3373068|NCT02671461|4105190|FG000|NOT COMPLETED|Treatment||2
3373069|NCT02671461|4105191|FG001|NOT COMPLETED|Treatment||3
3373070|NCT02671461|4105192|FG002|NOT COMPLETED|Treatment||5
3373071|NCT02671461|4105190|FG000|STARTED|Follow-up||2
3373072|NCT02671461|4105191|FG001|STARTED|Follow-up||5
3373073|NCT02671461|4105192|FG002|STARTED|Follow-up||7
3373074|NCT02671461|4105190|FG000|COMPLETED|Follow-up||1
3373075|NCT02671461|4105191|FG001|COMPLETED|Follow-up||4
3373076|NCT02671461|4105192|FG002|COMPLETED|Follow-up||6
3373077|NCT02671461|4105190|FG000|NOT COMPLETED|Follow-up||1
3373078|NCT02671461|4105191|FG001|NOT COMPLETED|Follow-up||1
3373079|NCT02671461|4105192|FG002|NOT COMPLETED|Follow-up||1
3373080|NCT02671136|4105202|FG000|STARTED|Overall Study||3
3373081|NCT02671136|4105203|FG001|STARTED|Overall Study||0
3373082|NCT02671136|4105202|FG000|COMPLETED|Overall Study||3
3373083|NCT02671136|4105203|FG001|COMPLETED|Overall Study||0
3373084|NCT02671136|4105202|FG000|NOT COMPLETED|Overall Study||0
3373085|NCT02671136|4105203|FG001|NOT COMPLETED|Overall Study||0
3373086|NCT02663752|4105209|FG000|STARTED|Overall Study||1
3373087|NCT02663752|4105209|FG000|COMPLETED|Overall Study||1
3373088|NCT02663752|4105209|FG000|NOT COMPLETED|Overall Study||0
3373089|NCT02658357|4105215|FG000|STARTED|Overall Study||0
3373090|NCT02658357|4105216|FG001|STARTED|Overall Study||0
3373091|NCT02658357|4105215|FG000|COMPLETED|Overall Study||0
3373092|NCT02658357|4105216|FG001|COMPLETED|Overall Study||0
3373093|NCT02658357|4105215|FG000|NOT COMPLETED|Overall Study||0
3373094|NCT02658357|4105216|FG001|NOT COMPLETED|Overall Study||0
3373095|NCT02665988|4105224|FG000|STARTED|Overall Study||2
3373096|NCT02665988|4105225|FG001|STARTED|Overall Study||2
3373097|NCT02665988|4105224|FG000|COMPLETED|Overall Study||2
3373098|NCT02665988|4105225|FG001|COMPLETED|Overall Study||2
3373099|NCT02665988|4105224|FG000|NOT COMPLETED|Overall Study||0
3373100|NCT02665988|4105225|FG001|NOT COMPLETED|Overall Study||0
3373101|NCT02660528|4105231|FG000|STARTED|Overall Study||0
3373102|NCT02660528|4105231|FG000|COMPLETED|Overall Study||0
3373103|NCT02660528|4105231|FG000|NOT COMPLETED|Overall Study||0
3373104|NCT02658877|4105237|FG000|STARTED|Overall Study||3
3373105|NCT02658877|4105238|FG001|STARTED|Overall Study||0
3373106|NCT02658877|4105237|FG000|COMPLETED|Overall Study||3
3373107|NCT02658877|4105238|FG001|COMPLETED|Overall Study||0
3373108|NCT02658877|4105237|FG000|NOT COMPLETED|Overall Study||0
3373109|NCT02658877|4105238|FG001|NOT COMPLETED|Overall Study||0
3373110|NCT02654782|4105246|FG000|STARTED|Overall Study||5
3373111|NCT02654782|4105247|FG001|STARTED|Overall Study||5
3373112|NCT02654782|4105246|FG000|COMPLETED|Overall Study||5
3373113|NCT02654782|4105247|FG001|COMPLETED|Overall Study||5
3373114|NCT02654782|4105246|FG000|NOT COMPLETED|Overall Study||0
3373115|NCT02654782|4105247|FG001|NOT COMPLETED|Overall Study||0
3373116|NCT02656199|4105253|FG000|STARTED|Overall Study|0 analyzed.PI left the institution.Effort to contact PI unsuccessful.No study data available|0
3373117|NCT02656199|4105253|FG000|COMPLETED|Overall Study|0 analyzed.PI left the institution.Effort to contact PI unsuccessful.No study data available|0
3373118|NCT02656199|4105253|FG000|NOT COMPLETED|Overall Study||0
3373119|NCT02654639|4105257|FG000|STARTED|Overall Study||4
3261132|NCT02577640|3995403|FG003|NOT COMPLETED|Maximally Tolerated Dose||0
3261133|NCT02577718|3995415|FG000|STARTED|Overall Study||60
3261134|NCT02577718|3995415|FG000|COMPLETED|Overall Study||52
3261135|NCT02577718|3995415|FG000|NOT COMPLETED|Overall Study||8
3261136|NCT02577822|3995423|FG000|STARTED|Overall Study||27
3261137|NCT02577822|3995424|FG001|STARTED|Overall Study||33
3261138|NCT02577822|3995423|FG000|COMPLETED|Overall Study||21
3261139|NCT02577822|3995424|FG001|COMPLETED|Overall Study||20
3261140|NCT02577822|3995423|FG000|NOT COMPLETED|Overall Study||6
3261141|NCT02577822|3995424|FG001|NOT COMPLETED|Overall Study||13
3261142|NCT02577887|3995430|FG000|STARTED|Overall Study||2101
3261143|NCT02577887|3995430|FG000|6 Month Follow-up|Overall Study||1938
3261144|NCT02577887|3995430|FG000|COMPLETED|Overall Study||1803
3261145|NCT02577887|3995430|FG000|NOT COMPLETED|Overall Study||298
3261146|NCT02577900|3995437|FG000|STARTED|Overall Study||11
3261147|NCT02577900|3995438|FG001|STARTED|Overall Study||10
3261148|NCT02577900|3995439|FG002|STARTED|Overall Study||10
3261149|NCT02577900|3995437|FG000|COMPLETED|Overall Study||11
3261150|NCT02577900|3995438|FG001|COMPLETED|Overall Study||10
3261151|NCT02577900|3995439|FG002|COMPLETED|Overall Study||10
3261152|NCT02577900|3995437|FG000|NOT COMPLETED|Overall Study||0
3261153|NCT02577900|3995438|FG001|NOT COMPLETED|Overall Study||0
3261154|NCT02577900|3995439|FG002|NOT COMPLETED|Overall Study||0
3261155|NCT02577978|3995449|FG000|STARTED|Overall Study||32
3261156|NCT02577978|3995450|FG001|STARTED|Overall Study||29
3261157|NCT02577978|3995449|FG000|COMPLETED|Overall Study||25
3261158|NCT02577978|3995450|FG001|COMPLETED|Overall Study||25
3261159|NCT02577978|3995449|FG000|NOT COMPLETED|Overall Study||7
3261160|NCT02577978|3995450|FG001|NOT COMPLETED|Overall Study||4
3261161|NCT02577991|3995459|FG000|STARTED|Overall Study||24
3261162|NCT02577991|3995460|FG001|STARTED|Overall Study||27
3261163|NCT02577991|3995461|FG002|STARTED|Overall Study||29
3261164|NCT02577991|3995459|FG000|COMPLETED|Overall Study||21
3261165|NCT02577991|3995460|FG001|COMPLETED|Overall Study||25
3261166|NCT02577991|3995461|FG002|COMPLETED|Overall Study||29
3261167|NCT02577991|3995459|FG000|NOT COMPLETED|Overall Study||3
3261168|NCT02577991|3995460|FG001|NOT COMPLETED|Overall Study||2
3261169|NCT02577991|3995461|FG002|NOT COMPLETED|Overall Study||0
3261170|NCT02578186|3995469|FG000|STARTED|Period 1 (First of Crossover)||17
3261171|NCT02578186|3995470|FG001|STARTED|Period 1 (First of Crossover)||18
3261172|NCT02578186|3995469|FG000|COMPLETED|Period 1 (First of Crossover)||12
3261173|NCT02578186|3995470|FG001|COMPLETED|Period 1 (First of Crossover)||13
3261174|NCT02578186|3995469|FG000|NOT COMPLETED|Period 1 (First of Crossover)||5
3261175|NCT02578186|3995470|FG001|NOT COMPLETED|Period 1 (First of Crossover)||5
3261176|NCT02578186|3995469|FG000|STARTED|Period 2 (Second of Crossover)||12
3261177|NCT02578186|3995470|FG001|STARTED|Period 2 (Second of Crossover)||13
3261178|NCT02578186|3995469|FG000|COMPLETED|Period 2 (Second of Crossover)||12
3261179|NCT02578186|3995470|FG001|COMPLETED|Period 2 (Second of Crossover)||13
3261180|NCT02578186|3995469|FG000|NOT COMPLETED|Period 2 (Second of Crossover)||0
3261181|NCT02578186|3995470|FG001|NOT COMPLETED|Period 2 (Second of Crossover)||0
3261182|NCT02578199|3995476|FG000|STARTED|Overall Study||31
3261183|NCT02578199|3995476|FG000|COMPLETED|Overall Study||27
3261184|NCT02578199|3995476|FG000|NOT COMPLETED|Overall Study||4
3261185|NCT02578238|3995480|FG000|STARTED|Overall Study||143
3261186|NCT02578238|3995480|FG000|COMPLETED|Overall Study||143
3261187|NCT02578238|3995480|FG000|NOT COMPLETED|Overall Study||0
3261188|NCT02578316|3995484|FG000|STARTED|Study Phase||6
3261189|NCT02578316|3995484|FG000|COMPLETED|Study Phase||6
3261190|NCT02578316|3995484|FG000|NOT COMPLETED|Study Phase||0
3261191|NCT02578316|3995484|FG000|STARTED|Extension Phase||6
3373120|NCT02654639|4105257|FG000|COMPLETED|Overall Study||4
3373121|NCT02654639|4105257|FG000|NOT COMPLETED|Overall Study||0
3373122|NCT02653495|4105263|FG000|STARTED|Overall Study||15
3373123|NCT02653495|4105264|FG001|STARTED|Overall Study||2
3373124|NCT02653495|4105263|FG000|COMPLETED|Overall Study||3
3373125|NCT02653495|4105264|FG001|COMPLETED|Overall Study||2
3373126|NCT02653495|4105263|FG000|NOT COMPLETED|Overall Study||12
3373127|NCT02653495|4105264|FG001|NOT COMPLETED|Overall Study||0
3373128|NCT02640573|4105270|FG000|STARTED|Overall Study||1
3373129|NCT02640573|4105270|FG000|COMPLETED|Overall Study||0
3373130|NCT02640573|4105270|FG000|NOT COMPLETED|Overall Study||1
3373131|NCT02639390|4105276|FG000|STARTED|Overall Study||0
3373132|NCT02639390|4105277|FG001|STARTED|Overall Study||5
3373133|NCT02639390|4105276|FG000|COMPLETED|Overall Study||0
3373134|NCT02639390|4105277|FG001|COMPLETED|Overall Study||3
3373135|NCT02639390|4105276|FG000|NOT COMPLETED|Overall Study||0
3373136|NCT02639390|4105277|FG001|NOT COMPLETED|Overall Study||2
3373137|NCT02634606|4105283|FG000|STARTED|Overall Study||13
3373138|NCT02634606|4105283|FG000|COMPLETED|Overall Study||0
3373139|NCT02634606|4105283|FG000|NOT COMPLETED|Overall Study||13
3373140|NCT02634827|4105291|FG000|STARTED|Overall Study||1
3261192|NCT02578316|3995484|FG000|COMPLETED|Extension Phase||0
3261193|NCT02578316|3995484|FG000|NOT COMPLETED|Extension Phase||6
3261194|NCT02578680|3995494|FG000|STARTED|Overall Study||410
3261195|NCT02578680|3995495|FG001|STARTED|Overall Study||206
3373141|NCT02634827|4105291|FG000|COMPLETED|Overall Study||1
3373142|NCT02634827|4105291|FG000|NOT COMPLETED|Overall Study||0
3373143|NCT02636283|4105297|FG000|STARTED|Overall Study||3
3373144|NCT02636283|4105298|FG001|STARTED|Overall Study||3
3373145|NCT02636283|4105297|FG000|COMPLETED|Overall Study||1
3373146|NCT02636283|4105298|FG001|COMPLETED|Overall Study||0
3373147|NCT02636283|4105297|FG000|NOT COMPLETED|Overall Study||2
3261196|NCT02578680|3995494|FG000|Treated|Overall Study||405
3261197|NCT02578680|3995495|FG001|Treated|Overall Study||202
3261198|NCT02578680|3995494|FG000|Switched to Pembrolizumab|Overall Study||0
3261199|NCT02578680|3995495|FG001|Switched to Pembrolizumab|Overall Study||67
3261200|NCT02578680|3995494|FG000|COMPLETED|Overall Study||0
3261201|NCT02578680|3995495|FG001|COMPLETED|Overall Study||0
3261202|NCT02578680|3995494|FG000|NOT COMPLETED|Overall Study||410
3261203|NCT02578680|3995495|FG001|NOT COMPLETED|Overall Study||206
3261204|NCT02578706|3995504|FG000|STARTED|Overall Study||9
3261205|NCT02578706|3995505|FG001|STARTED|Overall Study||10
3261206|NCT02578706|3995506|FG002|STARTED|Overall Study||8
3261207|NCT02578706|3995504|FG000|COMPLETED|Overall Study||8
3261208|NCT02578706|3995505|FG001|COMPLETED|Overall Study||5
3261209|NCT02578706|3995506|FG002|COMPLETED|Overall Study||8
3261210|NCT02578706|3995504|FG000|NOT COMPLETED|Overall Study||1
3261211|NCT02578706|3995505|FG001|NOT COMPLETED|Overall Study||5
3261212|NCT02578706|3995506|FG002|NOT COMPLETED|Overall Study||0
3261213|NCT02578732|3995514|FG000|STARTED|Overall Study||28
3261214|NCT02578732|3995514|FG000|COMPLETED|Overall Study||28
3261215|NCT02578732|3995514|FG000|NOT COMPLETED|Overall Study||0
3261216|NCT02578745|3995520|FG000|STARTED|Overall Study||60
3261217|NCT02578745|3995521|FG001|STARTED|Overall Study||60
3261218|NCT02578745|3995520|FG000|COMPLETED|Overall Study||60
3261219|NCT02578745|3995521|FG001|COMPLETED|Overall Study||60
3261220|NCT02578745|3995520|FG000|NOT COMPLETED|Overall Study||0
3261221|NCT02578745|3995521|FG001|NOT COMPLETED|Overall Study||0
3261222|NCT02578862|3995530|FG000|STARTED|Overall Study||37
3261223|NCT02578862|3995531|FG001|STARTED|Overall Study||35
3261224|NCT02578862|3995530|FG000|COMPLETED|Overall Study||37
3261225|NCT02578862|3995531|FG001|COMPLETED|Overall Study||33
3261226|NCT02578862|3995530|FG000|NOT COMPLETED|Overall Study||0
3261227|NCT02578862|3995531|FG001|NOT COMPLETED|Overall Study||2
3261228|NCT02578901|3995539|FG000|STARTED|Overall Study||165
3261229|NCT02578901|3995540|FG001|STARTED|Overall Study||165
3261230|NCT02578901|3995539|FG000|COMPLETED|Overall Study||145
3261231|NCT02578901|3995540|FG001|COMPLETED|Overall Study||144
3261232|NCT02578901|3995539|FG000|NOT COMPLETED|Overall Study||20
3261233|NCT02578901|3995540|FG001|NOT COMPLETED|Overall Study||21
3261234|NCT02578940|3995546|FG000|STARTED|Overall Study||109
3261235|NCT02578940|3995546|FG000|Received 18F-fluciclovine|Overall Study||104
3261236|NCT02578940|3995546|FG000|COMPLETED|Overall Study||103
3261237|NCT02578940|3995546|FG000|NOT COMPLETED|Overall Study||6
3261238|NCT02578992|3995554|FG000|STARTED|Overall Study|November 2014|65
3261239|NCT02578992|3995555|FG001|STARTED|Overall Study|November 2014|65
3261240|NCT02578992|3995554|FG000|COMPLETED|Overall Study|October 2015|62
3261241|NCT02578992|3995555|FG001|COMPLETED|Overall Study|October 2015|62
3261242|NCT02578992|3995554|FG000|NOT COMPLETED|Overall Study||3
3261243|NCT02578992|3995555|FG001|NOT COMPLETED|Overall Study||3
3261244|NCT02579057|3995569|FG000|STARTED|Overall Study||19
3261245|NCT02579057|3995570|FG001|STARTED|Overall Study||21
3261246|NCT02579057|3995569|FG000|COMPLETED|Overall Study||19
3261247|NCT02579057|3995570|FG001|COMPLETED|Overall Study||21
3261248|NCT02579057|3995569|FG000|NOT COMPLETED|Overall Study||0
3261249|NCT02579057|3995570|FG001|NOT COMPLETED|Overall Study||0
3261250|NCT02579135|3995578|FG000|STARTED|Overall Study||107
3261251|NCT02579135|3995579|FG001|STARTED|Overall Study||115
3261252|NCT02579135|3995578|FG000|COMPLETED|Overall Study||105
3261253|NCT02579135|3995579|FG001|COMPLETED|Overall Study||106
3261254|NCT02579135|3995578|FG000|NOT COMPLETED|Overall Study||2
3261255|NCT02579135|3995579|FG001|NOT COMPLETED|Overall Study||9
3261256|NCT02579343|3995587|FG000|STARTED|Overall Study||7
3261257|NCT02579343|3995588|FG001|STARTED|Overall Study||6
3261258|NCT02579343|3995587|FG000|COMPLETED|Overall Study||7
3261259|NCT02579343|3995588|FG001|COMPLETED|Overall Study||6
3261260|NCT02579343|3995587|FG000|NOT COMPLETED|Overall Study||0
3261261|NCT02579343|3995588|FG001|NOT COMPLETED|Overall Study||0
3261262|NCT02579382|3995598|FG000|STARTED|Main Study Phase||28
3261263|NCT02579382|3995599|FG001|STARTED|Main Study Phase||53
3261264|NCT02579382|3995600|FG002|STARTED|Main Study Phase||56
3261265|NCT02579382|3995601|FG003|STARTED|Main Study Phase||55
3261266|NCT02579382|3995598|FG000|COMPLETED|Main Study Phase||28
3261267|NCT02579382|3995599|FG001|COMPLETED|Main Study Phase||53
3261268|NCT02579382|3995600|FG002|COMPLETED|Main Study Phase||54
3261269|NCT02579382|3995601|FG003|COMPLETED|Main Study Phase||52
3261270|NCT02579382|3995598|FG000|NOT COMPLETED|Main Study Phase||0
3261271|NCT02579382|3995599|FG001|NOT COMPLETED|Main Study Phase||0
3261272|NCT02579382|3995600|FG002|NOT COMPLETED|Main Study Phase||2
3261273|NCT02579382|3995601|FG003|NOT COMPLETED|Main Study Phase||3
3261274|NCT02579382|3995598|FG000|STARTED|Optional Treatment Extension Phase(OTEP)|1 participant who completed the Main Study Phase did not enter the OTEP.|27
3261275|NCT02579382|3995599|FG001|STARTED|Optional Treatment Extension Phase(OTEP)|2 participants who completed the Main Study Phase did not enter the OTEP.|51
3261276|NCT02579382|3995600|FG002|STARTED|Optional Treatment Extension Phase(OTEP)||54
3261277|NCT02579382|3995601|FG003|STARTED|Optional Treatment Extension Phase(OTEP)|3 participants who completed the Main Study Phase did not enter the OTEP.|49
3261278|NCT02579382|3995598|FG000|COMPLETED|Optional Treatment Extension Phase(OTEP)||26
3261279|NCT02579382|3995599|FG001|COMPLETED|Optional Treatment Extension Phase(OTEP)||44
3261280|NCT02579382|3995600|FG002|COMPLETED|Optional Treatment Extension Phase(OTEP)||50
3261281|NCT02579382|3995601|FG003|COMPLETED|Optional Treatment Extension Phase(OTEP)||44
3373148|NCT02636283|4105298|FG001|NOT COMPLETED|Overall Study||3
3261282|NCT02579382|3995598|FG000|NOT COMPLETED|Optional Treatment Extension Phase(OTEP)||1
3261283|NCT02579382|3995599|FG001|NOT COMPLETED|Optional Treatment Extension Phase(OTEP)||7
3261284|NCT02579382|3995600|FG002|NOT COMPLETED|Optional Treatment Extension Phase(OTEP)||4
3261285|NCT02579382|3995601|FG003|NOT COMPLETED|Optional Treatment Extension Phase(OTEP)||5
3261286|NCT02579421|3995623|FG000|STARTED|Overall Study||23
3261287|NCT02579421|3995624|FG001|STARTED|Overall Study||23
3261288|NCT02579421|3995625|FG002|STARTED|Overall Study||6
3261289|NCT02579421|3995626|FG003|STARTED|Overall Study||6
3261290|NCT02579421|3995623|FG000|COMPLETED|Overall Study||17
3261291|NCT02579421|3995624|FG001|COMPLETED|Overall Study||18
3261292|NCT02579421|3995625|FG002|COMPLETED|Overall Study||5
3261293|NCT02579421|3995626|FG003|COMPLETED|Overall Study||3
3261294|NCT02579421|3995623|FG000|NOT COMPLETED|Overall Study||6
3261295|NCT02579421|3995624|FG001|NOT COMPLETED|Overall Study||5
3261296|NCT02579421|3995625|FG002|NOT COMPLETED|Overall Study||1
3261297|NCT02579421|3995626|FG003|NOT COMPLETED|Overall Study||3
3261298|NCT02579603|3995638|FG000|STARTED|Overall Study|Started are the randomised patients|52
3261299|NCT02579603|3995639|FG001|STARTED|Overall Study|Started are the randomised patients|53
3261300|NCT02579603|3995638|FG000|Number of Patients Treated|Overall Study||51
3261301|NCT02579603|3995639|FG001|Number of Patients Treated|Overall Study||53
3261302|NCT02579603|3995638|FG000|COMPLETED|Overall Study||48
3261303|NCT02579603|3995639|FG001|COMPLETED|Overall Study||51
3261304|NCT02579603|3995638|FG000|NOT COMPLETED|Overall Study||4
3261305|NCT02579603|3995639|FG001|NOT COMPLETED|Overall Study||2
3261306|NCT02579616|3995646|FG000|STARTED|Overall Study||29
3261307|NCT02579616|3995646|FG000|Treated|Overall Study||26
3261308|NCT02579616|3995646|FG000|COMPLETED|Overall Study||26
3261309|NCT02579616|3995646|FG000|NOT COMPLETED|Overall Study||3
3261310|NCT02579629|3995653|FG000|STARTED|Overall Study||22
3261311|NCT02579629|3995654|FG001|STARTED|Overall Study||20
3261312|NCT02579629|3995655|FG002|STARTED|Overall Study||22
3261313|NCT02579629|3995653|FG000|COMPLETED|Overall Study||20
3261314|NCT02579629|3995654|FG001|COMPLETED|Overall Study||19
3261315|NCT02579629|3995655|FG002|COMPLETED|Overall Study||20
3261316|NCT02579629|3995653|FG000|NOT COMPLETED|Overall Study||2
3261317|NCT02579629|3995654|FG001|NOT COMPLETED|Overall Study||1
3261318|NCT02579629|3995655|FG002|NOT COMPLETED|Overall Study||2
3261319|NCT02579759|3995666|FG000|STARTED|Overall Study||109
3261320|NCT02579759|3995667|FG001|STARTED|Overall Study||113
3261321|NCT02579759|3995668|FG002|STARTED|Overall Study||101
3261322|NCT02579759|3995666|FG000|COMPLETED|Overall Study||85
3261323|NCT02579759|3995667|FG001|COMPLETED|Overall Study||49
3261324|NCT02579759|3995668|FG002|COMPLETED|Overall Study||80
3261325|NCT02579759|3995666|FG000|NOT COMPLETED|Overall Study||24
3261326|NCT02579759|3995667|FG001|NOT COMPLETED|Overall Study||64
3261327|NCT02579759|3995668|FG002|NOT COMPLETED|Overall Study||21
3261328|NCT02579772|3995678|FG000|STARTED|Overall Study||8
3261329|NCT02579772|3995679|FG001|STARTED|Overall Study||5
3261330|NCT02579772|3995678|FG000|COMPLETED|Overall Study||6
3261331|NCT02579772|3995679|FG001|COMPLETED|Overall Study||3
3261332|NCT02579772|3995678|FG000|NOT COMPLETED|Overall Study||2
3373149|NCT02638129|4105306|FG000|STARTED|Overall Study||28
3373150|NCT02638129|4105307|FG001|STARTED|Overall Study||30
3373151|NCT02638129|4105306|FG000|COMPLETED|Overall Study||0
3373152|NCT02638129|4105307|FG001|COMPLETED|Overall Study||0
3373153|NCT02638129|4105306|FG000|NOT COMPLETED|Overall Study||28
3373154|NCT02638129|4105307|FG001|NOT COMPLETED|Overall Study||30
3373155|NCT02615990|4105315|FG000|STARTED|Overall Study||1
3373156|NCT02615990|4105316|FG001|STARTED|Overall Study||1
3373157|NCT02615990|4105315|FG000|COMPLETED|Overall Study||0
3373158|NCT02615990|4105316|FG001|COMPLETED|Overall Study||0
3373159|NCT02615990|4105315|FG000|NOT COMPLETED|Overall Study||1
3373160|NCT02615990|4105316|FG001|NOT COMPLETED|Overall Study||1
3373161|NCT02640677|4105322|FG000|STARTED|Overall Study||2
3373162|NCT02640677|4105322|FG000|COMPLETED|Overall Study||0
3373163|NCT02640677|4105322|FG000|NOT COMPLETED|Overall Study||2
3373164|NCT02633540|4105326|FG000|STARTED|Overall Study||2
3373165|NCT02633540|4105326|FG000|COMPLETED|Overall Study||2
3373166|NCT02633540|4105326|FG000|NOT COMPLETED|Overall Study||0
3373167|NCT02623959|4105332|FG000|STARTED|Overall Study||0
3373168|NCT02623959|4105333|FG001|STARTED|Overall Study||1
3373169|NCT02623959|4105332|FG000|COMPLETED|Overall Study||0
3373170|NCT02623959|4105333|FG001|COMPLETED|Overall Study|due to progression|0
3373171|NCT02623959|4105332|FG000|NOT COMPLETED|Overall Study||0
3373172|NCT02623959|4105333|FG001|NOT COMPLETED|Overall Study||1
3373173|NCT02631148|4105343|FG000|STARTED|Overall Study||12
3373174|NCT02631148|4105344|FG001|STARTED|Overall Study||0
3373175|NCT02631148|4105343|FG000|COMPLETED|Overall Study||2
3373176|NCT02631148|4105344|FG001|COMPLETED|Overall Study||0
3373177|NCT02631148|4105343|FG000|NOT COMPLETED|Overall Study||10
3373178|NCT02631148|4105344|FG001|NOT COMPLETED|Overall Study||0
3373179|NCT02630472|4105352|FG000|STARTED|Overall Study||10
3373180|NCT02630472|4105353|FG001|STARTED|Overall Study||0
3261333|NCT02579772|3995679|FG001|NOT COMPLETED|Overall Study||2
3261334|NCT02579811|3995685|FG000|STARTED|Overall Study||40
3261335|NCT02579811|3995685|FG000|COMPLETED|Overall Study||40
3261336|NCT02579811|3995685|FG000|NOT COMPLETED|Overall Study||0
3373181|NCT02630472|4105352|FG000|COMPLETED|Overall Study||0
3373182|NCT02630472|4105353|FG001|COMPLETED|Overall Study||0
3373183|NCT02630472|4105352|FG000|NOT COMPLETED|Overall Study||10
3373184|NCT02630472|4105353|FG001|NOT COMPLETED|Overall Study||0
3261337|NCT02579863|3995691|FG000|STARTED|Overall Study||156
3261338|NCT02579863|3995692|FG001|STARTED|Overall Study||154
3261339|NCT02579863|3995691|FG000|Treated|Overall Study||154
3261340|NCT02579863|3995692|FG001|Treated|Overall Study||148
3261341|NCT02579863|3995691|FG000|COMPLETED|Overall Study||0
3261342|NCT02579863|3995692|FG001|COMPLETED|Overall Study||0
3261343|NCT02579863|3995691|FG000|NOT COMPLETED|Overall Study||156
3261344|NCT02579863|3995692|FG001|NOT COMPLETED|Overall Study||154
3261345|NCT02579876|3995700|FG000|STARTED|Overall Study||15
3261346|NCT02579876|3995701|FG001|STARTED|Overall Study||5
3261347|NCT02579876|3995700|FG000|COMPLETED|Overall Study||14
3261348|NCT02579876|3995701|FG001|COMPLETED|Overall Study||5
3261349|NCT02579876|3995700|FG000|NOT COMPLETED|Overall Study||1
3261350|NCT02579876|3995701|FG001|NOT COMPLETED|Overall Study||0
3261351|NCT02579915|3995709|FG000|STARTED|Overall Study||19
3261352|NCT02579915|3995710|FG001|STARTED|Overall Study||21
3261353|NCT02579915|3995709|FG000|COMPLETED|Overall Study||9
3261354|NCT02579915|3995710|FG001|COMPLETED|Overall Study||16
3261355|NCT02579915|3995709|FG000|NOT COMPLETED|Overall Study||10
3261356|NCT02579915|3995710|FG001|NOT COMPLETED|Overall Study||5
3261357|NCT02579928|3995718|FG000|STARTED|Overall Study||6
3261358|NCT02579928|3995719|FG001|STARTED|Overall Study||11
3261359|NCT02579928|3995718|FG000|COMPLETED|Overall Study||5
3261360|NCT02579928|3995719|FG001|COMPLETED|Overall Study||11
3261361|NCT02579928|3995718|FG000|NOT COMPLETED|Overall Study||1
3261362|NCT02579928|3995719|FG001|NOT COMPLETED|Overall Study||0
3261363|NCT02580058|3995728|FG000|STARTED|Overall Study||188
3261364|NCT02580058|3995729|FG001|STARTED|Overall Study||188
3261365|NCT02580058|3995730|FG002|STARTED|Overall Study||190
3261366|NCT02580058|3995728|FG000|Treated|Overall Study||187
3261367|NCT02580058|3995729|FG001|Treated|Overall Study||182
3261368|NCT02580058|3995730|FG002|Treated|Overall Study||177
3261369|NCT02580058|3995728|FG000|COMPLETED|Overall Study||109
3261370|NCT02580058|3995729|FG001|COMPLETED|Overall Study||102
3261371|NCT02580058|3995730|FG002|COMPLETED|Overall Study||104
3261372|NCT02580058|3995728|FG000|NOT COMPLETED|Overall Study||79
3261373|NCT02580058|3995729|FG001|NOT COMPLETED|Overall Study||86
3261374|NCT02580058|3995730|FG002|NOT COMPLETED|Overall Study||86
3373185|NCT02626520|4105362|FG000|STARTED|Overall Study||1
3373186|NCT02626520|4105363|FG001|STARTED|Overall Study||10
3373187|NCT02626520|4105362|FG000|COMPLETED|Overall Study||0
3373188|NCT02626520|4105363|FG001|COMPLETED|Overall Study||0
3373189|NCT02626520|4105362|FG000|NOT COMPLETED|Overall Study||1
3373190|NCT02626520|4105363|FG001|NOT COMPLETED|Overall Study||10
3373191|NCT02614898|4105371|FG000|STARTED|Overall Study||15
3373192|NCT02614898|4105372|FG001|STARTED|Overall Study||52
3373193|NCT02614898|4105371|FG000|Safety Population|Overall Study||15
3373194|NCT02614898|4105372|FG001|Safety Population|Overall Study||52
3373195|NCT02614898|4105371|FG000|COMPLETED|Overall Study||0
3373196|NCT02614898|4105372|FG001|COMPLETED|Overall Study||1
3373197|NCT02614898|4105371|FG000|NOT COMPLETED|Overall Study||15
3373198|NCT02614898|4105372|FG001|NOT COMPLETED|Overall Study||51
3373199|NCT02622828|4105379|FG000|STARTED|Overall Study||4
3373200|NCT02622828|4105379|FG000|COMPLETED|Overall Study||1
3373201|NCT02622828|4105379|FG000|NOT COMPLETED|Overall Study||3
3373202|NCT02624739|4105385|FG000|STARTED|Overall Study||0
3373203|NCT02624739|4105386|FG001|STARTED|Overall Study||0
3373204|NCT02624739|4105385|FG000|COMPLETED|Overall Study||0
3373205|NCT02624739|4105386|FG001|COMPLETED|Overall Study||0
3373206|NCT02624739|4105385|FG000|NOT COMPLETED|Overall Study||0
3373207|NCT02624739|4105386|FG001|NOT COMPLETED|Overall Study||0
3373208|NCT02608905|4105394|FG000|STARTED|Overall Study||7
3373209|NCT02608905|4105395|FG001|STARTED|Overall Study||10
3373210|NCT02608905|4105394|FG000|COMPLETED|Overall Study||5
3373211|NCT02608905|4105395|FG001|COMPLETED|Overall Study||10
3373212|NCT02608905|4105394|FG000|NOT COMPLETED|Overall Study||2
3373213|NCT02608905|4105395|FG001|NOT COMPLETED|Overall Study||0
3373214|NCT02619812|4105405|FG000|STARTED|Overall Study||0
3373215|NCT02619812|4105406|FG001|STARTED|Overall Study||0
3373216|NCT02619812|4105407|FG002|STARTED|Overall Study||1
3373217|NCT02619812|4105408|FG003|STARTED|Overall Study||2
3373218|NCT02619812|4105405|FG000|COMPLETED|Overall Study||0
3373219|NCT02619812|4105406|FG001|COMPLETED|Overall Study||0
3373220|NCT02619812|4105407|FG002|COMPLETED|Overall Study||0
3373221|NCT02619812|4105408|FG003|COMPLETED|Overall Study||0
3373222|NCT02619812|4105405|FG000|NOT COMPLETED|Overall Study||0
3373223|NCT02619812|4105406|FG001|NOT COMPLETED|Overall Study||0
3373224|NCT02619812|4105407|FG002|NOT COMPLETED|Overall Study||1
3373225|NCT02619812|4105408|FG003|NOT COMPLETED|Overall Study||2
3373226|NCT02612285|4105418|FG000|STARTED|Overall Study||1
3373227|NCT02612285|4105418|FG000|COMPLETED|Overall Study|Subject did not complete Cycle 1; no data points recorded|0
3373228|NCT02612285|4105418|FG000|NOT COMPLETED|Overall Study||1
3373229|NCT02614586|4105422|FG000|STARTED|Overall Study||11
3373230|NCT02614586|4105422|FG000|COMPLETED|Overall Study||11
3373231|NCT02614586|4105422|FG000|NOT COMPLETED|Overall Study||0
3373232|NCT02606279|4105428|FG000|STARTED|Overall Study||0
3373233|NCT02606279|4105429|FG001|STARTED|Overall Study||1
3373234|NCT02606279|4105428|FG000|COMPLETED|Overall Study||0
3373235|NCT02606279|4105429|FG001|COMPLETED|Overall Study||0
3373236|NCT02606279|4105428|FG000|NOT COMPLETED|Overall Study||0
3373237|NCT02606279|4105429|FG001|NOT COMPLETED|Overall Study||1
3373238|NCT02605824|4105437|FG000|STARTED|Overall Study||1
3261375|NCT02580188|3995740|FG000|STARTED|Overall Study||35
3373239|NCT02605824|4105438|FG001|STARTED|Overall Study||0
3373240|NCT02605824|4105437|FG000|COMPLETED|Overall Study||0
3373241|NCT02605824|4105438|FG001|COMPLETED|Overall Study||0
3373242|NCT02605824|4105437|FG000|NOT COMPLETED|Overall Study||1
3373243|NCT02605824|4105438|FG001|NOT COMPLETED|Overall Study||0
3373244|NCT02598622|4105446|FG000|STARTED|Overall Study||8
3373245|NCT02598622|4105447|FG001|STARTED|Overall Study|Study terminated prior to randomization phase. No enrollment in this arm.|0
3373246|NCT02598622|4105446|FG000|COMPLETED|Overall Study||2
3373247|NCT02598622|4105447|FG001|COMPLETED|Overall Study||0
3373248|NCT02598622|4105446|FG000|NOT COMPLETED|Overall Study||6
3373249|NCT02598622|4105447|FG001|NOT COMPLETED|Overall Study||0
3373250|NCT02589145|4105456|FG000|STARTED|Overall Study||4
3373251|NCT02589145|4105457|FG001|STARTED|Overall Study||2
3373252|NCT02589145|4105458|FG002|STARTED|Overall Study||2
3373253|NCT02589145|4105456|FG000|COMPLETED|Overall Study||4
3373254|NCT02589145|4105457|FG001|COMPLETED|Overall Study||2
3373255|NCT02589145|4105458|FG002|COMPLETED|Overall Study||2
3373256|NCT02589145|4105456|FG000|NOT COMPLETED|Overall Study||0
3373257|NCT02589145|4105457|FG001|NOT COMPLETED|Overall Study||0
3373258|NCT02589145|4105458|FG002|NOT COMPLETED|Overall Study||0
3373259|NCT02582749|4105468|FG000|STARTED|Overall Study||5
3373260|NCT02582749|4105469|FG001|STARTED|Overall Study||11
3373261|NCT02582749|4105468|FG000|COMPLETED|Overall Study||0
3373262|NCT02582749|4105469|FG001|COMPLETED|Overall Study||0
3373263|NCT02582749|4105468|FG000|NOT COMPLETED|Overall Study||5
3373264|NCT02582749|4105469|FG001|NOT COMPLETED|Overall Study||11
3373265|NCT02590068|4105477|FG000|STARTED|Overall Study||0
3373266|NCT02590068|4105478|FG001|STARTED|Overall Study||14
3373267|NCT02590068|4105477|FG000|COMPLETED|Overall Study||0
3373268|NCT02590068|4105478|FG001|COMPLETED|Overall Study||14
3373269|NCT02590068|4105477|FG000|NOT COMPLETED|Overall Study||0
3373270|NCT02590068|4105478|FG001|NOT COMPLETED|Overall Study||0
3373271|NCT02593682|4105486|FG000|STARTED|Overall Study||0
3373272|NCT02593682|4105487|FG001|STARTED|Overall Study||0
3373273|NCT02593682|4105486|FG000|COMPLETED|Overall Study||0
3373274|NCT02593682|4105487|FG001|COMPLETED|Overall Study||0
3373275|NCT02593682|4105486|FG000|NOT COMPLETED|Overall Study||0
3373276|NCT02593682|4105487|FG001|NOT COMPLETED|Overall Study||0
3373277|NCT02587650|4105493|FG000|STARTED|Overall Study||0
3373278|NCT02587650|4105494|FG001|STARTED|Overall Study||0
3373279|NCT02587650|4105495|FG002|STARTED|Overall Study||1
3373280|NCT02587650|4105496|FG003|STARTED|Overall Study||0
3373281|NCT02587650|4105493|FG000|COMPLETED|Overall Study||0
3373282|NCT02587650|4105494|FG001|COMPLETED|Overall Study||0
3373283|NCT02587650|4105495|FG002|COMPLETED|Overall Study||1
3373284|NCT02587650|4105496|FG003|COMPLETED|Overall Study||0
3373285|NCT02587650|4105493|FG000|NOT COMPLETED|Overall Study||0
3373286|NCT02587650|4105494|FG001|NOT COMPLETED|Overall Study||0
3373287|NCT02587650|4105495|FG002|NOT COMPLETED|Overall Study||0
3373288|NCT02587650|4105496|FG003|NOT COMPLETED|Overall Study||0
3373289|NCT02569957|4105502|FG000|STARTED|Overall Study||0
3373290|NCT02569957|4105503|FG001|STARTED|Overall Study||1
3373291|NCT02569957|4105502|FG000|COMPLETED|Overall Study||0
3373292|NCT02569957|4105503|FG001|COMPLETED|Overall Study||0
3373293|NCT02569957|4105502|FG000|NOT COMPLETED|Overall Study||0
3373294|NCT02569957|4105503|FG001|NOT COMPLETED|Overall Study||1
3373295|NCT02568007|4105512|FG000|STARTED|Overall Study||2
3373296|NCT02568007|4105513|FG001|STARTED|Overall Study||2
3373297|NCT02568007|4105514|FG002|STARTED|Overall Study||0
3373298|NCT02568007|4105512|FG000|COMPLETED|Overall Study||2
3373299|NCT02568007|4105513|FG001|COMPLETED|Overall Study||2
3373300|NCT02568007|4105514|FG002|COMPLETED|Overall Study||0
3373301|NCT02568007|4105512|FG000|NOT COMPLETED|Overall Study||0
3373302|NCT02568007|4105513|FG001|NOT COMPLETED|Overall Study||0
3373303|NCT02568007|4105514|FG002|NOT COMPLETED|Overall Study||0
3373304|NCT02575365|4105522|FG000|STARTED|Overall Study||4
3373305|NCT02575365|4105522|FG000|COMPLETED|Overall Study||0
3373306|NCT02575365|4105522|FG000|NOT COMPLETED|Overall Study||4
3373307|NCT02549755|4105526|FG000|STARTED|Overall Study||1
3373308|NCT02549755|4105526|FG000|COMPLETED|Overall Study||0
3373309|NCT02549755|4105526|FG000|NOT COMPLETED|Overall Study||1
3373310|NCT02547129|4105532|FG000|STARTED|Overall Study||2
3373311|NCT02547129|4105533|FG001|STARTED|Overall Study||2
3373312|NCT02547129|4105532|FG000|COMPLETED|Overall Study||1
3373313|NCT02547129|4105533|FG001|COMPLETED|Overall Study||2
3373314|NCT02547129|4105532|FG000|NOT COMPLETED|Overall Study||1
3373315|NCT02547129|4105533|FG001|NOT COMPLETED|Overall Study||0
3373316|NCT02528097|4105541|FG000|STARTED|Overall Study||1
3373317|NCT02528097|4105542|FG001|STARTED|Overall Study||1
3373318|NCT02528097|4105541|FG000|COMPLETED|Overall Study||1
3373319|NCT02528097|4105542|FG001|COMPLETED|Overall Study||1
3261376|NCT02580188|3995741|FG001|STARTED|Overall Study||35
3261377|NCT02580188|3995740|FG000|COMPLETED|Overall Study||32
3261378|NCT02580188|3995741|FG001|COMPLETED|Overall Study||32
3261379|NCT02580188|3995740|FG000|NOT COMPLETED|Overall Study||3
3261380|NCT02580188|3995741|FG001|NOT COMPLETED|Overall Study||3
3261381|NCT02580201|3995750|FG000|STARTED|Overall Study||50
3261382|NCT02580201|3995751|FG001|STARTED|Overall Study||104
3261383|NCT02580201|3995750|FG000|COMPLETED|Overall Study||50
3261384|NCT02580201|3995751|FG001|COMPLETED|Overall Study||104
3261385|NCT02580201|3995750|FG000|NOT COMPLETED|Overall Study||0
3261386|NCT02580201|3995751|FG001|NOT COMPLETED|Overall Study||0
3261387|NCT02580240|3995760|FG000|STARTED|Overall Study||62
3261388|NCT02580240|3995761|FG001|STARTED|Overall Study||58
3261389|NCT02580240|3995760|FG000|COMPLETED|Overall Study||60
3261390|NCT02580240|3995761|FG001|COMPLETED|Overall Study||58
3261391|NCT02580240|3995760|FG000|NOT COMPLETED|Overall Study||2
3261392|NCT02580240|3995761|FG001|NOT COMPLETED|Overall Study||0
3261393|NCT02580318|3995767|FG000|STARTED|Overall Study||54
3261394|NCT02580318|3995767|FG000|Poor Effort|Overall Study||53
3261395|NCT02580318|3995767|FG000|Hyperventilation (Immediate)|Overall Study||54
3261396|NCT02580318|3995767|FG000|Hyperventilation (5 Minutes)|Overall Study||54
3261397|NCT02580318|3995767|FG000|Hyperventilation (10 Minutes)|Overall Study||54
3261398|NCT02580318|3995767|FG000|Drinking Water (Immediate)|Overall Study||51
3261399|NCT02580318|3995767|FG000|Drinking Water (5 Minutes)|Overall Study||54
3261400|NCT02580318|3995767|FG000|COMPLETED|Overall Study||54
3261401|NCT02580318|3995767|FG000|NOT COMPLETED|Overall Study||0
3261402|NCT02580357|3995774|FG000|STARTED|Overall Study||18
3261403|NCT02580357|3995775|FG001|STARTED|Overall Study||18
3261404|NCT02580357|3995776|FG002|STARTED|Overall Study||18
3261405|NCT02580357|3995774|FG000|COMPLETED|Overall Study||15
3261406|NCT02580357|3995775|FG001|COMPLETED|Overall Study||18
3261407|NCT02580357|3995776|FG002|COMPLETED|Overall Study||18
3261408|NCT02580357|3995774|FG000|NOT COMPLETED|Overall Study||3
3261409|NCT02580357|3995775|FG001|NOT COMPLETED|Overall Study||0
3261410|NCT02580357|3995776|FG002|NOT COMPLETED|Overall Study||0
3261411|NCT02580591|3995788|FG000|STARTED|Overall Study||242
3261412|NCT02580591|3995789|FG001|STARTED|Overall Study||242
3261413|NCT02580591|3995790|FG002|STARTED|Overall Study||248
3261414|NCT02580591|3995791|FG003|STARTED|Overall Study||245
3261415|NCT02580591|3995788|FG000|Treated|Overall Study||241
3261416|NCT02580591|3995789|FG001|Treated|Overall Study||241
3261417|NCT02580591|3995790|FG002|Treated|Overall Study||248
3261418|NCT02580591|3995791|FG003|Treated|Overall Study||245
3261419|NCT02580591|3995788|FG000|COMPLETED|Overall Study||224
3261420|NCT02580591|3995789|FG001|COMPLETED|Overall Study||232
3261421|NCT02580591|3995790|FG002|COMPLETED|Overall Study||235
3261422|NCT02580591|3995791|FG003|COMPLETED|Overall Study||233
3261423|NCT02580591|3995788|FG000|NOT COMPLETED|Overall Study||18
3261424|NCT02580591|3995789|FG001|NOT COMPLETED|Overall Study||10
3261425|NCT02580591|3995790|FG002|NOT COMPLETED|Overall Study||13
3261426|NCT02580591|3995791|FG003|NOT COMPLETED|Overall Study||12
3261427|NCT02580799|3995801|FG000|STARTED|Overall Study||30
3261428|NCT02580799|3995801|FG000|COMPLETED|Overall Study||30
3261429|NCT02580799|3995801|FG000|NOT COMPLETED|Overall Study||0
3261430|NCT02580877|3995807|FG000|STARTED|Overall Study||45
3261431|NCT02580877|3995808|FG001|STARTED|Overall Study||47
3261432|NCT02580877|3995807|FG000|COMPLETED|Overall Study||44
3261433|NCT02580877|3995808|FG001|COMPLETED|Overall Study||43
3261434|NCT02580877|3995807|FG000|NOT COMPLETED|Overall Study||1
3261435|NCT02580877|3995808|FG001|NOT COMPLETED|Overall Study||4
3261436|NCT02581111|3995817|FG000|STARTED|Overall Study||98
3261437|NCT02581111|3995818|FG001|STARTED|Overall Study||101
3261438|NCT02581111|3995817|FG000|COMPLETED|Overall Study||96
3261439|NCT02581111|3995818|FG001|COMPLETED|Overall Study||94
3261440|NCT02581111|3995817|FG000|NOT COMPLETED|Overall Study||2
3261441|NCT02581111|3995818|FG001|NOT COMPLETED|Overall Study||7
3261442|NCT02581163|3995824|FG000|STARTED|Overall Study||311
3261443|NCT02581163|3995824|FG000|COMPLETED|Overall Study||282
3261444|NCT02581163|3995824|FG000|NOT COMPLETED|Overall Study||29
3261445|NCT02581189|3995831|FG000|STARTED|Overall Study||534
3261446|NCT02581189|3995831|FG000|COMPLETED|Overall Study||481
3373320|NCT02528097|4105541|FG000|NOT COMPLETED|Overall Study||0
3373321|NCT02528097|4105542|FG001|NOT COMPLETED|Overall Study||0
3261447|NCT02581189|3995831|FG000|NOT COMPLETED|Overall Study||53
3261448|NCT02581202|3995838|FG000|STARTED|Overall Study||216
3261449|NCT02581202|3995838|FG000|COMPLETED|Overall Study||202
3261450|NCT02581202|3995838|FG000|NOT COMPLETED|Overall Study||14
3261451|NCT02581345|3995845|FG000|STARTED|Part 1: up to Week 16||286
3261452|NCT02581345|3995846|FG001|STARTED|Part 1: up to Week 16||286
3261453|NCT02581345|3995847|FG002|STARTED|Part 1: up to Week 16||0
3261454|NCT02581345|3995848|FG003|STARTED|Part 1: up to Week 16||0
3261455|NCT02581345|3995845|FG000|COMPLETED|Part 1: up to Week 16||271
3261456|NCT02581345|3995846|FG001|COMPLETED|Part 1: up to Week 16||263
3261457|NCT02581345|3995847|FG002|COMPLETED|Part 1: up to Week 16||0
3261458|NCT02581345|3995848|FG003|COMPLETED|Part 1: up to Week 16||0
3261459|NCT02581345|3995845|FG000|NOT COMPLETED|Part 1: up to Week 16||15
3261460|NCT02581345|3995846|FG001|NOT COMPLETED|Part 1: up to Week 16||23
3261461|NCT02581345|3995847|FG002|NOT COMPLETED|Part 1: up to Week 16||0
3261462|NCT02581345|3995848|FG003|NOT COMPLETED|Part 1: up to Week 16||0
3261463|NCT02581345|3995845|FG000|STARTED|Part 2: Week 17 to Week 47||271
3261464|NCT02581345|3995846|FG001|STARTED|Part 2: Week 17 to Week 47||0
3261465|NCT02581345|3995847|FG002|STARTED|Part 2: Week 17 to Week 47||132
3261466|NCT02581345|3995848|FG003|STARTED|Part 2: Week 17 to Week 47||131
3261467|NCT02581345|3995845|FG000|COMPLETED|Part 2: Week 17 to Week 47||242
3261468|NCT02581345|3995846|FG001|COMPLETED|Part 2: Week 17 to Week 47||0
3261469|NCT02581345|3995847|FG002|COMPLETED|Part 2: Week 17 to Week 47||117
3261470|NCT02581345|3995848|FG003|COMPLETED|Part 2: Week 17 to Week 47||119
3261471|NCT02581345|3995845|FG000|NOT COMPLETED|Part 2: Week 17 to Week 47||29
3261472|NCT02581345|3995846|FG001|NOT COMPLETED|Part 2: Week 17 to Week 47||0
3261473|NCT02581345|3995847|FG002|NOT COMPLETED|Part 2: Week 17 to Week 47||15
3261474|NCT02581345|3995848|FG003|NOT COMPLETED|Part 2: Week 17 to Week 47||12
3261475|NCT02581384|3995866|FG000|STARTED|Overall Study||3
3261476|NCT02581384|3995867|FG001|STARTED|Overall Study||2
3261477|NCT02581384|3995866|FG000|COMPLETED|Overall Study||3
3261478|NCT02581384|3995867|FG001|COMPLETED|Overall Study||2
3261479|NCT02581384|3995866|FG000|NOT COMPLETED|Overall Study||0
3261480|NCT02581384|3995867|FG001|NOT COMPLETED|Overall Study||0
3261481|NCT02581410|3995876|FG000|STARTED|Vaccination Phase||215
3261482|NCT02581410|3995877|FG001|STARTED|Vaccination Phase||215
3261483|NCT02581410|3995876|FG000|COMPLETED|Vaccination Phase||213
3261484|NCT02581410|3995877|FG001|COMPLETED|Vaccination Phase||212
3373322|NCT02549716|4105550|FG000|STARTED|Overall Study||1
3373323|NCT02549716|4105551|FG001|STARTED|Overall Study||2
3373324|NCT02549716|4105550|FG000|COMPLETED|Overall Study||1
3373325|NCT02549716|4105551|FG001|COMPLETED|Overall Study||2
3373326|NCT02549716|4105550|FG000|NOT COMPLETED|Overall Study||0
3373327|NCT02549716|4105551|FG001|NOT COMPLETED|Overall Study||0
3373328|NCT02540434|4105559|FG000|STARTED|Overall Study||1
3373329|NCT02540434|4105560|FG001|STARTED|Overall Study||1
3373330|NCT02540434|4105559|FG000|COMPLETED|Overall Study||1
3373331|NCT02540434|4105560|FG001|COMPLETED|Overall Study||1
3373332|NCT02540434|4105559|FG000|NOT COMPLETED|Overall Study||0
3373333|NCT02540434|4105560|FG001|NOT COMPLETED|Overall Study||0
3373334|NCT02531308|4105568|FG000|STARTED|Overall Study||5
3373335|NCT02531308|4105568|FG000|COMPLETED|Overall Study||2
3261485|NCT02581410|3995876|FG000|NOT COMPLETED|Vaccination Phase||2
3261486|NCT02581410|3995877|FG001|NOT COMPLETED|Vaccination Phase||3
3261487|NCT02581410|3995876|FG000|STARTED|End of Study Phase||215
3261488|NCT02581410|3995877|FG001|STARTED|End of Study Phase||215
3261489|NCT02581410|3995876|FG000|COMPLETED|End of Study Phase||210
3261490|NCT02581410|3995877|FG001|COMPLETED|End of Study Phase||204
3261491|NCT02581410|3995876|FG000|NOT COMPLETED|End of Study Phase||5
3261492|NCT02581410|3995877|FG001|NOT COMPLETED|End of Study Phase||11
3261493|NCT02581475|3995886|FG000|STARTED|Overall Study||193
3261494|NCT02581475|3995887|FG001|STARTED|Overall Study||193
3261495|NCT02581475|3995886|FG000|COMPLETED|Overall Study||182
3261496|NCT02581475|3995887|FG001|COMPLETED|Overall Study||178
3261497|NCT02581475|3995886|FG000|NOT COMPLETED|Overall Study||11
3261498|NCT02581475|3995887|FG001|NOT COMPLETED|Overall Study||15
3261499|NCT02581488|3995895|FG000|STARTED|Overall Study||51
3261500|NCT02581488|3995896|FG001|STARTED|Overall Study||51
3261501|NCT02581488|3995895|FG000|COMPLETED|Overall Study||42
3261502|NCT02581488|3995896|FG001|COMPLETED|Overall Study||40
3261503|NCT02581488|3995895|FG000|NOT COMPLETED|Overall Study||9
3261504|NCT02581488|3995896|FG001|NOT COMPLETED|Overall Study||11
3261505|NCT02581839|3995902|FG000|STARTED|Overall Study||9
3261506|NCT02581839|3995902|FG000|COMPLETED|Overall Study||9
3261507|NCT02581839|3995902|FG000|NOT COMPLETED|Overall Study||0
3261508|NCT02581865|3995909|FG000|STARTED|Overall Study||40
3261509|NCT02581865|3995910|FG001|STARTED|Overall Study||42
3261510|NCT02581865|3995911|FG002|STARTED|Overall Study||42
3261511|NCT02581865|3995909|FG000|COMPLETED|Overall Study||36
3261512|NCT02581865|3995910|FG001|COMPLETED|Overall Study||35
3261513|NCT02581865|3995911|FG002|COMPLETED|Overall Study||26
3261514|NCT02581865|3995909|FG000|NOT COMPLETED|Overall Study||4
3261515|NCT02581865|3995910|FG001|NOT COMPLETED|Overall Study||7
3261516|NCT02581865|3995911|FG002|NOT COMPLETED|Overall Study||16
3261517|NCT02581891|3995924|FG000|STARTED|Overall Study||135
3261518|NCT02581891|3995925|FG001|STARTED|Overall Study||136
3261519|NCT02581891|3995924|FG000|Completed Treatment|Overall Study||120
3261520|NCT02581891|3995925|FG001|Completed Treatment|Overall Study||117
3261521|NCT02581891|3995924|FG000|COMPLETED|Overall Study||119
3261522|NCT02581891|3995925|FG001|COMPLETED|Overall Study||117
3261523|NCT02581891|3995924|FG000|NOT COMPLETED|Overall Study||16
3261524|NCT02581891|3995925|FG001|NOT COMPLETED|Overall Study||19
3261525|NCT02581995|3995932|FG000|STARTED|Overall Study||560
3261526|NCT02581995|3995932|FG000|Treated|Overall Study||560
3261527|NCT02581995|3995932|FG000|COMPLETED|Overall Study||529
3261528|NCT02581995|3995932|FG000|NOT COMPLETED|Overall Study||31
3261529|NCT02582151|3995938|FG000|STARTED|Overall Study||14
3261530|NCT02582151|3995939|FG001|STARTED|Overall Study||16
3261531|NCT02582151|3995938|FG000|COMPLETED|Overall Study||12
3261532|NCT02582151|3995939|FG001|COMPLETED|Overall Study||16
3261533|NCT02582151|3995938|FG000|NOT COMPLETED|Overall Study||2
3261534|NCT02582151|3995939|FG001|NOT COMPLETED|Overall Study||0
3261535|NCT02582216|3995945|FG000|STARTED|Overall Study||22
3261536|NCT02582216|3995945|FG000|COMPLETED|Overall Study||22
3261537|NCT02582216|3995945|FG000|NOT COMPLETED|Overall Study||0
3261538|NCT02582242|3995952|FG000|STARTED|Overall Study||220
3261539|NCT02582242|3995953|FG001|STARTED|Overall Study||217
3261540|NCT02582242|3995952|FG000|COMPLETED|Overall Study||200
3261541|NCT02582242|3995953|FG001|COMPLETED|Overall Study||200
3261542|NCT02582242|3995952|FG000|NOT COMPLETED|Overall Study||20
3261543|NCT02582242|3995953|FG001|NOT COMPLETED|Overall Study||17
3261544|NCT02582255|3995961|FG000|STARTED|Overall Study||50
3261545|NCT02582255|3995962|FG001|STARTED|Overall Study||50
3261546|NCT02582255|3995961|FG000|COMPLETED|Overall Study||50
3261547|NCT02582255|3995962|FG001|COMPLETED|Overall Study||47
3261548|NCT02582255|3995961|FG000|NOT COMPLETED|Overall Study||0
3261549|NCT02582255|3995962|FG001|NOT COMPLETED|Overall Study||3
3261550|NCT02582515|3995971|FG000|STARTED|Overall Study||9
3261551|NCT02582515|3995972|FG001|STARTED|Overall Study||11
3261552|NCT02582515|3995971|FG000|Received Study Intervention|Overall Study||9
3261553|NCT02582515|3995972|FG001|Received Study Intervention|Overall Study||10
3261554|NCT02582515|3995971|FG000|COMPLETED|Overall Study||9
3261555|NCT02582515|3995972|FG001|COMPLETED|Overall Study||10
3261556|NCT02582515|3995971|FG000|NOT COMPLETED|Overall Study||0
3261557|NCT02582515|3995972|FG001|NOT COMPLETED|Overall Study||1
3261558|NCT02582632|3995978|FG000|STARTED|Overall Study||166
3261559|NCT02582632|3995978|FG000|COMPLETED|Overall Study||165
3261560|NCT02582632|3995978|FG000|NOT COMPLETED|Overall Study||1
3261561|NCT02582658|3995982|FG000|STARTED|Overall Study||171
3261562|NCT02582658|3995982|FG000|COMPLETED|Overall Study||146
3261563|NCT02582658|3995982|FG000|NOT COMPLETED|Overall Study||25
3261564|NCT02582671|3995986|FG000|STARTED|Overall Study||101
3261565|NCT02582671|3995986|FG000|COMPLETED|Overall Study||99
3261566|NCT02582671|3995986|FG000|NOT COMPLETED|Overall Study||2
3261567|NCT02582684|3995991|FG000|STARTED|Overall Study||122
3261568|NCT02582684|3995991|FG000|COMPLETED|Overall Study||105
3261569|NCT02582684|3995991|FG000|NOT COMPLETED|Overall Study||17
3261570|NCT02582814|3995997|FG000|STARTED|Overall Study||76
3261571|NCT02582814|3995998|FG001|STARTED|Overall Study||75
3261572|NCT02582814|3995997|FG000|COMPLETED|Overall Study||67
3261573|NCT02582814|3995998|FG001|COMPLETED|Overall Study||68
3261574|NCT02582814|3995997|FG000|NOT COMPLETED|Overall Study||9
3261575|NCT02582814|3995998|FG001|NOT COMPLETED|Overall Study||7
3261576|NCT02582840|3996007|FG000|STARTED|Overall Study||14
3261577|NCT02582840|3996008|FG001|STARTED|Overall Study||14
3261578|NCT02582840|3996009|FG002|STARTED|Overall Study||14
3261579|NCT02582840|3996007|FG000|COMPLETED|Overall Study||14
3261580|NCT02582840|3996008|FG001|COMPLETED|Overall Study||14
3261581|NCT02582840|3996009|FG002|COMPLETED|Overall Study||14
3261582|NCT02582840|3996007|FG000|NOT COMPLETED|Overall Study||0
3261583|NCT02582840|3996008|FG001|NOT COMPLETED|Overall Study||0
3261584|NCT02582840|3996009|FG002|NOT COMPLETED|Overall Study||0
3261585|NCT02582866|3996019|FG000|STARTED|Overall Study||106
3261586|NCT02582866|3996019|FG000|COMPLETED|Overall Study||84
3261587|NCT02582866|3996019|FG000|NOT COMPLETED|Overall Study||22
3261588|NCT02582970|3996023|FG000|STARTED|Overall Study||40
3261589|NCT02582970|3996023|FG000|COMPLETED|Overall Study||40
3261590|NCT02582970|3996023|FG000|NOT COMPLETED|Overall Study||0
3261591|NCT02582983|3996027|FG000|STARTED|Overall Study||23
3261592|NCT02582983|3996027|FG000|COMPLETED|Overall Study||17
3261593|NCT02582983|3996027|FG000|NOT COMPLETED|Overall Study||6
3261594|NCT02583230|3996031|FG000|STARTED|Overall Study||11
3261595|NCT02583230|3996031|FG000|COMPLETED|Overall Study||11
3261596|NCT02583230|3996031|FG000|NOT COMPLETED|Overall Study||0
3261597|NCT02583256|3996039|FG000|STARTED|Overall Study||403
3261598|NCT02583256|3996040|FG001|STARTED|Overall Study||403
3261599|NCT02583256|3996041|FG002|STARTED|Overall Study||402
3261600|NCT02583256|3996042|FG003|STARTED|Overall Study||393
3261601|NCT02583256|3996039|FG000|Exposed|Overall Study||403
3261602|NCT02583256|3996040|FG001|Exposed|Overall Study||403
3261603|NCT02583256|3996041|FG002|Exposed|Overall Study||402
3261604|NCT02583256|3996042|FG003|Exposed|Overall Study||393
3261605|NCT02583256|3996039|FG000|COMPLETED|Overall Study||400
3261606|NCT02583256|3996040|FG001|COMPLETED|Overall Study||401
3261607|NCT02583256|3996041|FG002|COMPLETED|Overall Study||400
3261608|NCT02583256|3996042|FG003|COMPLETED|Overall Study||390
3261609|NCT02583256|3996039|FG000|NOT COMPLETED|Overall Study||3
3261610|NCT02583256|3996040|FG001|NOT COMPLETED|Overall Study||2
3261611|NCT02583256|3996041|FG002|NOT COMPLETED|Overall Study||2
3261612|NCT02583256|3996042|FG003|NOT COMPLETED|Overall Study||3
3261613|NCT02583360|3996056|FG000|STARTED|Overall Study||60
3261614|NCT02583360|3996057|FG001|STARTED|Overall Study||49
3261615|NCT02583360|3996056|FG000|COMPLETED|Overall Study||60
3261616|NCT02583360|3996057|FG001|COMPLETED|Overall Study||49
3261617|NCT02583360|3996056|FG000|NOT COMPLETED|Overall Study||0
3261618|NCT02583360|3996057|FG001|NOT COMPLETED|Overall Study||0
3261619|NCT02583399|3996063|FG000|STARTED|Overall Study||30
3261620|NCT02583399|3996063|FG000|COMPLETED|Overall Study||24
3261621|NCT02583399|3996063|FG000|NOT COMPLETED|Overall Study||6
3261622|NCT02583425|3996067|FG000|STARTED|Screening||27
3261623|NCT02583425|3996067|FG000|COMPLETED|Screening||15
3261624|NCT02583425|3996067|FG000|NOT COMPLETED|Screening||12
3261625|NCT02583425|3996067|FG000|STARTED|Baseline||15
3261626|NCT02583425|3996067|FG000|COMPLETED|Baseline||10
3261627|NCT02583425|3996067|FG000|NOT COMPLETED|Baseline||5
3261628|NCT02583425|3996067|FG000|STARTED|Treatment Period||10
3261629|NCT02583425|3996067|FG000|COMPLETED|Treatment Period||9
3261630|NCT02583425|3996067|FG000|NOT COMPLETED|Treatment Period||1
3261631|NCT02583477|3996074|FG000|STARTED|Overall Study||3
3261632|NCT02583477|3996075|FG001|STARTED|Overall Study||20
3261633|NCT02583477|3996074|FG000|Received Treatment|Overall Study||3
3261634|NCT02583477|3996075|FG001|Received Treatment|Overall Study||20
3261635|NCT02583477|3996074|FG000|Completed Treatment|Overall Study||0
3261636|NCT02583477|3996075|FG001|Completed Treatment|Overall Study||0
3261637|NCT02583477|3996074|FG000|COMPLETED|Overall Study||0
3261638|NCT02583477|3996075|FG001|COMPLETED|Overall Study||0
3261639|NCT02583477|3996074|FG000|NOT COMPLETED|Overall Study||3
3261640|NCT02583477|3996075|FG001|NOT COMPLETED|Overall Study||20
3261641|NCT02583711|3996085|FG000|STARTED|Overall Study||11
3261642|NCT02583711|3996086|FG001|STARTED|Overall Study||38
3261643|NCT02583711|3996087|FG002|STARTED|Overall Study||10
3261644|NCT02583711|3996085|FG000|COMPLETED|Overall Study||11
3261645|NCT02583711|3996086|FG001|COMPLETED|Overall Study||28
3261646|NCT02583711|3996087|FG002|COMPLETED|Overall Study||10
3261647|NCT02583711|3996085|FG000|NOT COMPLETED|Overall Study||0
3261648|NCT02583711|3996086|FG001|NOT COMPLETED|Overall Study||10
3261649|NCT02583711|3996087|FG002|NOT COMPLETED|Overall Study||0
3261650|NCT02584140|3996097|FG000|STARTED|Overall Study||136
3261651|NCT02584140|3996097|FG000|COMPLETED|Overall Study||83
3261652|NCT02584140|3996097|FG000|NOT COMPLETED|Overall Study||53
3261653|NCT02584257|3996101|FG000|STARTED|Period 1||9
3261654|NCT02584257|3996102|FG001|STARTED|Period 1||9
3261655|NCT02584257|3996103|FG002|STARTED|Period 1||9
3261656|NCT02584257|3996104|FG003|STARTED|Period 1||8
3261657|NCT02584257|3996105|FG004|STARTED|Period 1||10
3261658|NCT02584257|3996106|FG005|STARTED|Period 1||10
3261659|NCT02584257|3996107|FG006|STARTED|Period 1||18
3261660|NCT02584257|3996108|FG007|STARTED|Period 1||9
3261661|NCT02584257|3996109|FG008|STARTED|Period 1||9
3261662|NCT02584257|3996101|FG000|COMPLETED|Period 1||9
3261663|NCT02584257|3996102|FG001|COMPLETED|Period 1||9
3261664|NCT02584257|3996103|FG002|COMPLETED|Period 1||9
3261665|NCT02584257|3996104|FG003|COMPLETED|Period 1||8
3261666|NCT02584257|3996105|FG004|COMPLETED|Period 1||10
3261667|NCT02584257|3996106|FG005|COMPLETED|Period 1||10
3261668|NCT02584257|3996107|FG006|COMPLETED|Period 1||17
3261669|NCT02584257|3996108|FG007|COMPLETED|Period 1||9
3261670|NCT02584257|3996109|FG008|COMPLETED|Period 1||9
3261671|NCT02584257|3996101|FG000|NOT COMPLETED|Period 1||0
3261672|NCT02584257|3996102|FG001|NOT COMPLETED|Period 1||0
3261673|NCT02584257|3996103|FG002|NOT COMPLETED|Period 1||0
3261674|NCT02584257|3996104|FG003|NOT COMPLETED|Period 1||0
3261675|NCT02584257|3996105|FG004|NOT COMPLETED|Period 1||0
3261676|NCT02584257|3996106|FG005|NOT COMPLETED|Period 1||0
3261677|NCT02584257|3996107|FG006|NOT COMPLETED|Period 1||1
3261678|NCT02584257|3996108|FG007|NOT COMPLETED|Period 1||0
3261679|NCT02584257|3996109|FG008|NOT COMPLETED|Period 1||0
3261680|NCT02584257|3996101|FG000|STARTED|Period 2||9
3261681|NCT02584257|3996102|FG001|STARTED|Period 2||9
3261682|NCT02584257|3996103|FG002|STARTED|Period 2||9
3261683|NCT02584257|3996104|FG003|STARTED|Period 2||8
3261684|NCT02584257|3996105|FG004|STARTED|Period 2||10
3261685|NCT02584257|3996106|FG005|STARTED|Period 2||10
3261686|NCT02584257|3996107|FG006|STARTED|Period 2||17
3261687|NCT02584257|3996108|FG007|STARTED|Period 2||9
3261688|NCT02584257|3996109|FG008|STARTED|Period 2||9
3261689|NCT02584257|3996101|FG000|COMPLETED|Period 2||8
3261690|NCT02584257|3996102|FG001|COMPLETED|Period 2||8
3261691|NCT02584257|3996103|FG002|COMPLETED|Period 2||9
3261692|NCT02584257|3996104|FG003|COMPLETED|Period 2||8
3261693|NCT02584257|3996105|FG004|COMPLETED|Period 2||10
3261694|NCT02584257|3996106|FG005|COMPLETED|Period 2||10
3261695|NCT02584257|3996107|FG006|COMPLETED|Period 2||17
3261696|NCT02584257|3996108|FG007|COMPLETED|Period 2||9
3261697|NCT02584257|3996109|FG008|COMPLETED|Period 2||9
3261698|NCT02584257|3996101|FG000|NOT COMPLETED|Period 2||1
3261699|NCT02584257|3996102|FG001|NOT COMPLETED|Period 2||1
3261700|NCT02584257|3996103|FG002|NOT COMPLETED|Period 2||0
3261701|NCT02584257|3996104|FG003|NOT COMPLETED|Period 2||0
3261702|NCT02584257|3996105|FG004|NOT COMPLETED|Period 2||0
3261703|NCT02584257|3996106|FG005|NOT COMPLETED|Period 2||0
3261704|NCT02584257|3996107|FG006|NOT COMPLETED|Period 2||0
3261705|NCT02584257|3996108|FG007|NOT COMPLETED|Period 2||0
3261706|NCT02584257|3996109|FG008|NOT COMPLETED|Period 2||0
3261707|NCT02584257|3996101|FG000|STARTED|Period 3||8
3261708|NCT02584257|3996102|FG001|STARTED|Period 3||8
3261709|NCT02584257|3996103|FG002|STARTED|Period 3||9
3261710|NCT02584257|3996104|FG003|STARTED|Period 3||8
3261711|NCT02584257|3996105|FG004|STARTED|Period 3||10
3261712|NCT02584257|3996106|FG005|STARTED|Period 3||10
3261713|NCT02584257|3996107|FG006|STARTED|Period 3||17
3261714|NCT02584257|3996108|FG007|STARTED|Period 3||9
3261715|NCT02584257|3996109|FG008|STARTED|Period 3||9
3261716|NCT02584257|3996101|FG000|COMPLETED|Period 3||8
3261717|NCT02584257|3996102|FG001|COMPLETED|Period 3||8
3261718|NCT02584257|3996103|FG002|COMPLETED|Period 3||9
3261719|NCT02584257|3996104|FG003|COMPLETED|Period 3||8
3261720|NCT02584257|3996105|FG004|COMPLETED|Period 3||10
3261721|NCT02584257|3996106|FG005|COMPLETED|Period 3||10
3261722|NCT02584257|3996107|FG006|COMPLETED|Period 3||17
3261723|NCT02584257|3996108|FG007|COMPLETED|Period 3||9
3261724|NCT02584257|3996109|FG008|COMPLETED|Period 3||9
3261725|NCT02584257|3996101|FG000|NOT COMPLETED|Period 3||0
3261726|NCT02584257|3996102|FG001|NOT COMPLETED|Period 3||0
3261727|NCT02584257|3996103|FG002|NOT COMPLETED|Period 3||0
3261728|NCT02584257|3996104|FG003|NOT COMPLETED|Period 3||0
3261729|NCT02584257|3996105|FG004|NOT COMPLETED|Period 3||0
3261730|NCT02584257|3996106|FG005|NOT COMPLETED|Period 3||0
3261731|NCT02584257|3996107|FG006|NOT COMPLETED|Period 3||0
3261732|NCT02584257|3996108|FG007|NOT COMPLETED|Period 3||0
3261733|NCT02584257|3996109|FG008|NOT COMPLETED|Period 3||0
3261734|NCT02584257|3996101|FG000|STARTED|Period 4||8
3261735|NCT02584257|3996102|FG001|STARTED|Period 4||8
3261736|NCT02584257|3996103|FG002|STARTED|Period 4||9
3261737|NCT02584257|3996104|FG003|STARTED|Period 4||8
3261738|NCT02584257|3996105|FG004|STARTED|Period 4||10
3261739|NCT02584257|3996106|FG005|STARTED|Period 4||10
3261740|NCT02584257|3996107|FG006|STARTED|Period 4||17
3261741|NCT02584257|3996108|FG007|STARTED|Period 4||9
3261742|NCT02584257|3996109|FG008|STARTED|Period 4||9
3261743|NCT02584257|3996101|FG000|COMPLETED|Period 4||8
3261744|NCT02584257|3996102|FG001|COMPLETED|Period 4||8
3261745|NCT02584257|3996103|FG002|COMPLETED|Period 4||9
3261746|NCT02584257|3996104|FG003|COMPLETED|Period 4||8
3261747|NCT02584257|3996105|FG004|COMPLETED|Period 4||10
3261748|NCT02584257|3996106|FG005|COMPLETED|Period 4||10
3261749|NCT02584257|3996107|FG006|COMPLETED|Period 4||17
3261750|NCT02584257|3996108|FG007|COMPLETED|Period 4||9
3261751|NCT02584257|3996109|FG008|COMPLETED|Period 4||9
3261752|NCT02584257|3996101|FG000|NOT COMPLETED|Period 4||0
3261753|NCT02584257|3996102|FG001|NOT COMPLETED|Period 4||0
3261754|NCT02584257|3996103|FG002|NOT COMPLETED|Period 4||0
3261755|NCT02584257|3996104|FG003|NOT COMPLETED|Period 4||0
3261756|NCT02584257|3996105|FG004|NOT COMPLETED|Period 4||0
3261757|NCT02584257|3996106|FG005|NOT COMPLETED|Period 4||0
3261758|NCT02584257|3996107|FG006|NOT COMPLETED|Period 4||0
3261759|NCT02584257|3996108|FG007|NOT COMPLETED|Period 4||0
3261760|NCT02584257|3996109|FG008|NOT COMPLETED|Period 4||0
3261761|NCT02584257|3996101|FG000|STARTED|Period 5||8
3261762|NCT02584257|3996102|FG001|STARTED|Period 5||8
3261763|NCT02584257|3996103|FG002|STARTED|Period 5||9
3261764|NCT02584257|3996104|FG003|STARTED|Period 5||8
3261765|NCT02584257|3996105|FG004|STARTED|Period 5||10
3261766|NCT02584257|3996106|FG005|STARTED|Period 5||10
3261767|NCT02584257|3996107|FG006|STARTED|Period 5||17
3261768|NCT02584257|3996108|FG007|STARTED|Period 5||9
3261769|NCT02584257|3996109|FG008|STARTED|Period 5||9
3261770|NCT02584257|3996101|FG000|COMPLETED|Period 5||8
3261771|NCT02584257|3996102|FG001|COMPLETED|Period 5||8
3261772|NCT02584257|3996103|FG002|COMPLETED|Period 5||9
3261773|NCT02584257|3996104|FG003|COMPLETED|Period 5||8
3261774|NCT02584257|3996105|FG004|COMPLETED|Period 5||10
3261775|NCT02584257|3996106|FG005|COMPLETED|Period 5||10
3261776|NCT02584257|3996107|FG006|COMPLETED|Period 5||17
3261777|NCT02584257|3996108|FG007|COMPLETED|Period 5||9
3261778|NCT02584257|3996109|FG008|COMPLETED|Period 5||9
3261779|NCT02584257|3996101|FG000|NOT COMPLETED|Period 5||0
3261780|NCT02584257|3996102|FG001|NOT COMPLETED|Period 5||0
3261781|NCT02584257|3996103|FG002|NOT COMPLETED|Period 5||0
3261782|NCT02584257|3996104|FG003|NOT COMPLETED|Period 5||0
3261783|NCT02584257|3996105|FG004|NOT COMPLETED|Period 5||0
3261784|NCT02584257|3996106|FG005|NOT COMPLETED|Period 5||0
3261785|NCT02584257|3996107|FG006|NOT COMPLETED|Period 5||0
3261786|NCT02584257|3996108|FG007|NOT COMPLETED|Period 5||0
3261787|NCT02584257|3996109|FG008|NOT COMPLETED|Period 5||0
3261788|NCT02584452|3996123|FG000|STARTED|Overall Study||34
3261789|NCT02584452|3996124|FG001|STARTED|Overall Study||23
3261790|NCT02584452|3996123|FG000|COMPLETED|Overall Study||32
3261791|NCT02584452|3996124|FG001|COMPLETED|Overall Study||21
3261792|NCT02584452|3996123|FG000|NOT COMPLETED|Overall Study||2
3261793|NCT02584452|3996124|FG001|NOT COMPLETED|Overall Study||2
3261794|NCT02584504|3996134|FG000|STARTED|Double-blind Treatment|Randomized|54
3261795|NCT02584504|3996135|FG001|STARTED|Double-blind Treatment|Randomized|53
3261796|NCT02584504|3996136|FG002|STARTED|Double-blind Treatment|Randomized|56
3261797|NCT02584504|3996134|FG000|ITT Population|Double-blind Treatment||54
3261798|NCT02584504|3996135|FG001|ITT Population|Double-blind Treatment||53
3261799|NCT02584504|3996136|FG002|ITT Population|Double-blind Treatment||56
3261800|NCT02584504|3996134|FG000|mITT Population|Double-blind Treatment||54
3261801|NCT02584504|3996135|FG001|mITT Population|Double-blind Treatment||53
3261802|NCT02584504|3996136|FG002|mITT Population|Double-blind Treatment||56
3261803|NCT02584504|3996134|FG000|Safety Population|Double-blind Treatment||54
3261804|NCT02584504|3996135|FG001|Safety Population|Double-blind Treatment||53
3261805|NCT02584504|3996136|FG002|Safety Population|Double-blind Treatment||56
3261806|NCT02584504|3996134|FG000|COMPLETED|Double-blind Treatment||54
3261807|NCT02584504|3996135|FG001|COMPLETED|Double-blind Treatment||51
3261808|NCT02584504|3996136|FG002|COMPLETED|Double-blind Treatment||55
3261809|NCT02584504|3996134|FG000|NOT COMPLETED|Double-blind Treatment||0
3261810|NCT02584504|3996135|FG001|NOT COMPLETED|Double-blind Treatment||2
3261811|NCT02584504|3996136|FG002|NOT COMPLETED|Double-blind Treatment||1
3261812|NCT02584504|3996134|FG000|STARTED|Open-label Treatment||54
3261813|NCT02584504|3996135|FG001|STARTED|Open-label Treatment||51
3261814|NCT02584504|3996136|FG002|STARTED|Open-label Treatment||55
3261815|NCT02584504|3996134|FG000|Treated|Open-label Treatment||54
3373336|NCT02531308|4105568|FG000|NOT COMPLETED|Overall Study||3
3373337|NCT02533531|4105572|FG000|STARTED|Overall Study||1
3373338|NCT02533531|4105572|FG000|COMPLETED|Overall Study||0
3373339|NCT02533531|4105572|FG000|NOT COMPLETED|Overall Study||1
3373340|NCT02534038|4105578|FG000|STARTED|Period 1 (6 Weeks)||1
3373341|NCT02534038|4105579|FG001|STARTED|Period 1 (6 Weeks)||0
3373342|NCT02534038|4105578|FG000|COMPLETED|Period 1 (6 Weeks)||1
3373343|NCT02534038|4105579|FG001|COMPLETED|Period 1 (6 Weeks)||0
3373344|NCT02534038|4105578|FG000|NOT COMPLETED|Period 1 (6 Weeks)||0
3373345|NCT02534038|4105579|FG001|NOT COMPLETED|Period 1 (6 Weeks)||0
3373346|NCT02534038|4105578|FG000|STARTED|Period 2 (6 Weeks)||1
3373347|NCT02534038|4105579|FG001|STARTED|Period 2 (6 Weeks)||0
3373348|NCT02534038|4105578|FG000|COMPLETED|Period 2 (6 Weeks)||1
3373349|NCT02534038|4105579|FG001|COMPLETED|Period 2 (6 Weeks)||0
3373350|NCT02534038|4105578|FG000|NOT COMPLETED|Period 2 (6 Weeks)||0
3373351|NCT02534038|4105579|FG001|NOT COMPLETED|Period 2 (6 Weeks)||0
3373352|NCT02520726|4105588|FG000|STARTED|Overall Study||3
3373353|NCT02520726|4105589|FG001|STARTED|Overall Study||2
3373354|NCT02520726|4105588|FG000|COMPLETED|Overall Study||0
3373355|NCT02520726|4105589|FG001|COMPLETED|Overall Study||0
3373356|NCT02520726|4105588|FG000|NOT COMPLETED|Overall Study||3
3373357|NCT02520726|4105589|FG001|NOT COMPLETED|Overall Study||2
3373358|NCT02520297|4105595|FG000|STARTED|Overall Study||1
3373359|NCT02520297|4105595|FG000|COMPLETED|Overall Study||1
3373360|NCT02520297|4105595|FG000|NOT COMPLETED|Overall Study||0
3373361|NCT02519712|4105599|FG000|STARTED|Overall Study||4
3373362|NCT02519712|4105599|FG000|COMPLETED|Overall Study||0
3373363|NCT02519712|4105599|FG000|NOT COMPLETED|Overall Study||4
3373364|NCT02518750|4105603|FG000|STARTED|Overall Study||3
3373365|NCT02518750|4105603|FG000|COMPLETED|Overall Study||1
3373366|NCT02518750|4105603|FG000|NOT COMPLETED|Overall Study||2
3373367|NCT02516228|4105607|FG000|STARTED|Overall Study||6
3373368|NCT02516228|4105607|FG000|COMPLETED|Overall Study||3
3373369|NCT02516228|4105607|FG000|NOT COMPLETED|Overall Study||3
3373370|NCT02515851|4105613|FG000|STARTED|Overall Study||15
3373371|NCT02515851|4105614|FG001|STARTED|Overall Study||15
3373372|NCT02515851|4105613|FG000|COMPLETED|Overall Study||15
3373373|NCT02515851|4105614|FG001|COMPLETED|Overall Study||15
3373374|NCT02515851|4105613|FG000|NOT COMPLETED|Overall Study||0
3373375|NCT02515851|4105614|FG001|NOT COMPLETED|Overall Study||0
3373376|NCT02506985|4105622|FG000|STARTED|Overall Study||4
3373377|NCT02506985|4105623|FG001|STARTED|Overall Study||6
3373378|NCT02506985|4105622|FG000|COMPLETED|Overall Study||4
3373379|NCT02506985|4105623|FG001|COMPLETED|Overall Study||6
3373380|NCT02506985|4105622|FG000|NOT COMPLETED|Overall Study||0
3373381|NCT02506985|4105623|FG001|NOT COMPLETED|Overall Study||0
3373382|NCT02514252|4105629|FG000|STARTED|Overall Study||6
3373383|NCT02514252|4105629|FG000|COMPLETED|Overall Study||6
3373384|NCT02514252|4105629|FG000|NOT COMPLETED|Overall Study||0
3373385|NCT02501759|4105633|FG000|STARTED|Overall Study||2
3373386|NCT02501759|4105633|FG000|COMPLETED|Overall Study||1
3373387|NCT02501759|4105633|FG000|NOT COMPLETED|Overall Study||1
3373388|NCT02487277|4105639|FG000|STARTED|Overall Study||3
3373389|NCT02487277|4105640|FG001|STARTED|Overall Study||0
3373390|NCT02487277|4105639|FG000|COMPLETED|Overall Study||3
3373391|NCT02487277|4105640|FG001|COMPLETED|Overall Study||0
3373392|NCT02487277|4105639|FG000|NOT COMPLETED|Overall Study||0
3373393|NCT02487277|4105640|FG001|NOT COMPLETED|Overall Study||0
3373394|NCT02506101|4105647|FG000|STARTED|Overall Study||2
3373395|NCT02506101|4105648|FG001|STARTED|Overall Study||0
3373396|NCT02506101|4105647|FG000|COMPLETED|Overall Study||0
3373397|NCT02506101|4105648|FG001|COMPLETED|Overall Study||0
3373398|NCT02506101|4105647|FG000|NOT COMPLETED|Overall Study||2
3373399|NCT02506101|4105648|FG001|NOT COMPLETED|Overall Study||0
3373400|NCT02499887|4105656|FG000|STARTED|Overall Study||3
3373401|NCT02499887|4105657|FG001|STARTED|Overall Study||3
3373402|NCT02499887|4105656|FG000|COMPLETED|Overall Study||3
3373403|NCT02499887|4105657|FG001|COMPLETED|Overall Study||3
3261816|NCT02584504|3996135|FG001|Treated|Open-label Treatment||50
3261817|NCT02584504|3996136|FG002|Treated|Open-label Treatment||54
3261818|NCT02584504|3996134|FG000|COMPLETED|Open-label Treatment||52
3261819|NCT02584504|3996135|FG001|COMPLETED|Open-label Treatment||47
3261820|NCT02584504|3996136|FG002|COMPLETED|Open-label Treatment||47
3261821|NCT02584504|3996134|FG000|NOT COMPLETED|Open-label Treatment||2
3261822|NCT02584504|3996135|FG001|NOT COMPLETED|Open-label Treatment||4
3261823|NCT02584504|3996136|FG002|NOT COMPLETED|Open-label Treatment||8
3261824|NCT02584608|3996148|FG000|STARTED|Overall Study||12
3261825|NCT02584608|3996148|FG000|COMPLETED|Overall Study||12
3261826|NCT02584608|3996148|FG000|NOT COMPLETED|Overall Study||0
3261827|NCT02584660|3996154|FG000|STARTED|Overall Study||51
3261828|NCT02584660|3996155|FG001|STARTED|Overall Study||63
3261829|NCT02584660|3996154|FG000|Treated|Overall Study||49
3261830|NCT02584660|3996155|FG001|Treated|Overall Study||63
3261831|NCT02584660|3996154|FG000|COMPLETED|Overall Study||44
3261832|NCT02584660|3996155|FG001|COMPLETED|Overall Study||55
3261833|NCT02584660|3996154|FG000|NOT COMPLETED|Overall Study||7
3373404|NCT02499887|4105656|FG000|NOT COMPLETED|Overall Study||0
3373405|NCT02499887|4105657|FG001|NOT COMPLETED|Overall Study||0
3373406|NCT02504099|4105663|FG000|STARTED|Overall Study||3
3261834|NCT02584660|3996155|FG001|NOT COMPLETED|Overall Study||8
3261835|NCT02584673|3996163|FG000|STARTED|Overall Study||15
3261836|NCT02584673|3996164|FG001|STARTED|Overall Study||15
3261837|NCT02584673|3996163|FG000|COMPLETED|Overall Study||15
3261838|NCT02584673|3996164|FG001|COMPLETED|Overall Study||15
3261839|NCT02584673|3996163|FG000|NOT COMPLETED|Overall Study||0
3261840|NCT02584673|3996164|FG001|NOT COMPLETED|Overall Study||0
3261841|NCT02584686|3996172|FG000|STARTED|Overall Study||12
3261842|NCT02584686|3996173|FG001|STARTED|Overall Study||12
3261843|NCT02584686|3996172|FG000|COMPLETED|Overall Study||12
3261844|NCT02584686|3996173|FG001|COMPLETED|Overall Study||12
3261845|NCT02584686|3996172|FG000|NOT COMPLETED|Overall Study||0
3261846|NCT02584686|3996173|FG001|NOT COMPLETED|Overall Study||0
3261847|NCT02584725|3996183|FG000|STARTED|Overall Study||28
3261848|NCT02584725|3996184|FG001|STARTED|Overall Study||28
3261849|NCT02584725|3996185|FG002|STARTED|Overall Study||28
3261850|NCT02584725|3996183|FG000|COMPLETED|Overall Study||28
3261851|NCT02584725|3996184|FG001|COMPLETED|Overall Study||28
3261852|NCT02584725|3996185|FG002|COMPLETED|Overall Study||28
3261853|NCT02584725|3996183|FG000|NOT COMPLETED|Overall Study||0
3261854|NCT02584725|3996184|FG001|NOT COMPLETED|Overall Study||0
3261855|NCT02584725|3996185|FG002|NOT COMPLETED|Overall Study||0
3261856|NCT02584790|3996193|FG000|STARTED|Overall Study||55
3261857|NCT02584790|3996193|FG000|COMPLETED|Overall Study||40
3261858|NCT02584790|3996193|FG000|NOT COMPLETED|Overall Study||15
3261859|NCT02584855|3996197|FG000|STARTED|Open-Label Treatment Period||394
3261860|NCT02584855|3996198|FG001|STARTED|Open-Label Treatment Period|Participants completed Open-Label Treatment Period.|0
3261861|NCT02584855|3996199|FG002|STARTED|Open-Label Treatment Period|Participants were randomized to this arm during double-blind withdrawal period.|0
3261862|NCT02584855|3996200|FG003|STARTED|Open-Label Treatment Period|Participants were randomized to this arm during double-blind withdrawal period.|0
3261863|NCT02584855|3996201|FG004|STARTED|Open-Label Treatment Period||0
3261864|NCT02584855|3996202|FG005|STARTED|Open-Label Treatment Period||0
3261865|NCT02584855|3996197|FG000|Received at Least One Dose of Study Drug|Open-Label Treatment Period||394
3261866|NCT02584855|3996198|FG001|Received at Least One Dose of Study Drug|Open-Label Treatment Period||0
3261867|NCT02584855|3996199|FG002|Received at Least One Dose of Study Drug|Open-Label Treatment Period||0
3261868|NCT02584855|3996200|FG003|Received at Least One Dose of Study Drug|Open-Label Treatment Period||0
3261869|NCT02584855|3996201|FG004|Received at Least One Dose of Study Drug|Open-Label Treatment Period||0
3261870|NCT02584855|3996202|FG005|Received at Least One Dose of Study Drug|Open-Label Treatment Period||0
3261871|NCT02584855|3996197|FG000|Met Randomization Criteria|Open-Label Treatment Period||158
3261872|NCT02584855|3996198|FG001|Met Randomization Criteria|Open-Label Treatment Period||0
3261873|NCT02584855|3996199|FG002|Met Randomization Criteria|Open-Label Treatment Period||0
3261874|NCT02584855|3996200|FG003|Met Randomization Criteria|Open-Label Treatment Period||0
3261875|NCT02584855|3996201|FG004|Met Randomization Criteria|Open-Label Treatment Period||0
3261876|NCT02584855|3996202|FG005|Met Randomization Criteria|Open-Label Treatment Period||0
3261877|NCT02584855|3996197|FG000|Non-randomized|Open-Label Treatment Period||133
3261878|NCT02584855|3996198|FG001|Non-randomized|Open-Label Treatment Period||0
3261879|NCT02584855|3996199|FG002|Non-randomized|Open-Label Treatment Period||0
3261880|NCT02584855|3996200|FG003|Non-randomized|Open-Label Treatment Period||0
3261881|NCT02584855|3996201|FG004|Non-randomized|Open-Label Treatment Period||0
3261882|NCT02584855|3996202|FG005|Non-randomized|Open-Label Treatment Period||0
3261883|NCT02584855|3996197|FG000|COMPLETED|Open-Label Treatment Period||291
3261884|NCT02584855|3996198|FG001|COMPLETED|Open-Label Treatment Period||0
3261885|NCT02584855|3996199|FG002|COMPLETED|Open-Label Treatment Period||0
3261886|NCT02584855|3996200|FG003|COMPLETED|Open-Label Treatment Period||0
3261887|NCT02584855|3996201|FG004|COMPLETED|Open-Label Treatment Period||0
3261888|NCT02584855|3996202|FG005|COMPLETED|Open-Label Treatment Period||0
3261889|NCT02584855|3996197|FG000|NOT COMPLETED|Open-Label Treatment Period||103
3261890|NCT02584855|3996198|FG001|NOT COMPLETED|Open-Label Treatment Period||0
3261891|NCT02584855|3996199|FG002|NOT COMPLETED|Open-Label Treatment Period||0
3261892|NCT02584855|3996200|FG003|NOT COMPLETED|Open-Label Treatment Period||0
3261893|NCT02584855|3996201|FG004|NOT COMPLETED|Open-Label Treatment Period||0
3261894|NCT02584855|3996202|FG005|NOT COMPLETED|Open-Label Treatment Period||0
3261895|NCT02584855|3996197|FG000|STARTED|Double-Blind Withdrawal Period||0
3261896|NCT02584855|3996198|FG001|STARTED|Double-Blind Withdrawal Period|Participants completed open label but did not meet criteria for double-blind withdrawal period.|133
3261897|NCT02584855|3996199|FG002|STARTED|Double-Blind Withdrawal Period|Participants completed open label and met criteria for double-blind withdrawal period.|79
3261898|NCT02584855|3996200|FG003|STARTED|Double-Blind Withdrawal Period|Participants completed open label and met criteria for double-blind withdrawal period.|79
3261899|NCT02584855|3996201|FG004|STARTED|Double-Blind Withdrawal Period||0
3261900|NCT02584855|3996202|FG005|STARTED|Double-Blind Withdrawal Period||0
3261901|NCT02584855|3996197|FG000|Relapsed|Double-Blind Withdrawal Period||0
3261902|NCT02584855|3996198|FG001|Relapsed|Double-Blind Withdrawal Period||0
3261903|NCT02584855|3996199|FG002|Relapsed|Double-Blind Withdrawal Period||67
3261904|NCT02584855|3996200|FG003|Relapsed|Double-Blind Withdrawal Period||30
3261905|NCT02584855|3996201|FG004|Relapsed|Double-Blind Withdrawal Period||0
3261906|NCT02584855|3996202|FG005|Relapsed|Double-Blind Withdrawal Period||0
3261907|NCT02584855|3996197|FG000|COMPLETED|Double-Blind Withdrawal Period||0
3261908|NCT02584855|3996198|FG001|COMPLETED|Double-Blind Withdrawal Period||118
3261909|NCT02584855|3996199|FG002|COMPLETED|Double-Blind Withdrawal Period||77
3261910|NCT02584855|3996200|FG003|COMPLETED|Double-Blind Withdrawal Period||78
3261911|NCT02584855|3996201|FG004|COMPLETED|Double-Blind Withdrawal Period||0
3261912|NCT02584855|3996202|FG005|COMPLETED|Double-Blind Withdrawal Period||0
3261913|NCT02584855|3996197|FG000|NOT COMPLETED|Double-Blind Withdrawal Period||0
3261914|NCT02584855|3996198|FG001|NOT COMPLETED|Double-Blind Withdrawal Period||15
3261915|NCT02584855|3996199|FG002|NOT COMPLETED|Double-Blind Withdrawal Period||2
3261916|NCT02584855|3996200|FG003|NOT COMPLETED|Double-Blind Withdrawal Period||1
3261917|NCT02584855|3996201|FG004|NOT COMPLETED|Double-Blind Withdrawal Period||0
3261918|NCT02584855|3996202|FG005|NOT COMPLETED|Double-Blind Withdrawal Period||0
3261919|NCT02584855|3996197|FG000|STARTED|Post Treatment Follow-up Period||0
3261920|NCT02584855|3996198|FG001|STARTED|Post Treatment Follow-up Period||0
3261921|NCT02584855|3996199|FG002|STARTED|Post Treatment Follow-up Period||0
3261922|NCT02584855|3996200|FG003|STARTED|Post Treatment Follow-up Period||0
3261923|NCT02584855|3996201|FG004|STARTED|Post Treatment Follow-up Period||355
3261924|NCT02584855|3996202|FG005|STARTED|Post Treatment Follow-up Period||12
3261925|NCT02584855|3996197|FG000|COMPLETED|Post Treatment Follow-up Period||0
3261926|NCT02584855|3996198|FG001|COMPLETED|Post Treatment Follow-up Period||0
3261927|NCT02584855|3996199|FG002|COMPLETED|Post Treatment Follow-up Period||0
3261928|NCT02584855|3996200|FG003|COMPLETED|Post Treatment Follow-up Period||0
3261929|NCT02584855|3996201|FG004|COMPLETED|Post Treatment Follow-up Period||347
3261930|NCT02584855|3996202|FG005|COMPLETED|Post Treatment Follow-up Period||12
3261931|NCT02584855|3996197|FG000|NOT COMPLETED|Post Treatment Follow-up Period||0
3261932|NCT02584855|3996198|FG001|NOT COMPLETED|Post Treatment Follow-up Period||0
3261933|NCT02584855|3996199|FG002|NOT COMPLETED|Post Treatment Follow-up Period||0
3261934|NCT02584855|3996200|FG003|NOT COMPLETED|Post Treatment Follow-up Period||0
3261935|NCT02584855|3996201|FG004|NOT COMPLETED|Post Treatment Follow-up Period||8
3261936|NCT02584855|3996202|FG005|NOT COMPLETED|Post Treatment Follow-up Period||0
3261937|NCT02584868|3996217|FG000|STARTED|Overall Study||44
3261938|NCT02584868|3996218|FG001|STARTED|Overall Study||44
3261939|NCT02584868|3996217|FG000|COMPLETED|Overall Study||44
3261940|NCT02584868|3996218|FG001|COMPLETED|Overall Study||44
3261941|NCT02584868|3996217|FG000|NOT COMPLETED|Overall Study||0
3261942|NCT02584868|3996218|FG001|NOT COMPLETED|Overall Study||0
3261943|NCT02584959|3996227|FG000|STARTED|Period 1||31
3261944|NCT02584959|3996228|FG001|STARTED|Period 1||29
3261945|NCT02584959|3996229|FG002|STARTED|Period 1||15
3261946|NCT02584959|3996227|FG000|COMPLETED|Period 1||28
3261947|NCT02584959|3996228|FG001|COMPLETED|Period 1||25
3261948|NCT02584959|3996229|FG002|COMPLETED|Period 1||15
3261949|NCT02584959|3996227|FG000|NOT COMPLETED|Period 1||3
3261950|NCT02584959|3996228|FG001|NOT COMPLETED|Period 1||4
3261951|NCT02584959|3996229|FG002|NOT COMPLETED|Period 1||0
3261952|NCT02584959|3996227|FG000|STARTED|Period 2||28
3261953|NCT02584959|3996228|FG001|STARTED|Period 2||25
3261954|NCT02584959|3996229|FG002|STARTED|Period 2||15
3261955|NCT02584959|3996227|FG000|COMPLETED|Period 2||22
3261956|NCT02584959|3996228|FG001|COMPLETED|Period 2||24
3261957|NCT02584959|3996229|FG002|COMPLETED|Period 2||13
3261958|NCT02584959|3996227|FG000|NOT COMPLETED|Period 2||6
3261959|NCT02584959|3996228|FG001|NOT COMPLETED|Period 2||1
3261960|NCT02584959|3996229|FG002|NOT COMPLETED|Period 2||2
3261961|NCT02584998|3996249|FG000|STARTED|Overall Study||260
3261962|NCT02584998|3996250|FG001|STARTED|Overall Study||261
3261963|NCT02584998|3996251|FG002|STARTED|Overall Study||261
3261964|NCT02584998|3996249|FG000|COMPLETED|Overall Study||260
3261965|NCT02584998|3996250|FG001|COMPLETED|Overall Study||261
3261966|NCT02584998|3996251|FG002|COMPLETED|Overall Study||261
3261967|NCT02584998|3996249|FG000|NOT COMPLETED|Overall Study||0
3261968|NCT02584998|3996250|FG001|NOT COMPLETED|Overall Study||0
3261969|NCT02584998|3996251|FG002|NOT COMPLETED|Overall Study||0
3261970|NCT02585245|3996259|FG000|STARTED|Overall Study||607
3261971|NCT02585245|3996259|FG000|COMPLETED|Overall Study||594
3261972|NCT02585245|3996259|FG000|NOT COMPLETED|Overall Study||13
3261973|NCT02585700|3996266|FG000|STARTED|Overall Study||30
3261974|NCT02585700|3996267|FG001|STARTED|Overall Study||30
3261975|NCT02585700|3996266|FG000|COMPLETED|Overall Study||30
3261976|NCT02585700|3996267|FG001|COMPLETED|Overall Study||30
3261977|NCT02585700|3996266|FG000|NOT COMPLETED|Overall Study||0
3261978|NCT02585700|3996267|FG001|NOT COMPLETED|Overall Study||0
3261979|NCT02585713|3996275|FG000|STARTED|Overall Study||150
3261980|NCT02585713|3996276|FG001|STARTED|Overall Study||150
3261981|NCT02585713|3996275|FG000|COMPLETED|Overall Study||145
3261982|NCT02585713|3996276|FG001|COMPLETED|Overall Study||142
3261983|NCT02585713|3996275|FG000|NOT COMPLETED|Overall Study||5
3261984|NCT02585713|3996276|FG001|NOT COMPLETED|Overall Study||8
3261985|NCT02585778|3996286|FG000|STARTED|Overall Study|Randomized|345
3261986|NCT02585778|3996287|FG001|STARTED|Overall Study|Randomized|172
3261987|NCT02585778|3996286|FG000|Treated (Safety Population)|Overall Study||344
3261988|NCT02585778|3996287|FG001|Treated (Safety Population)|Overall Study||170
3261989|NCT02585778|3996286|FG000|ITT Population|Overall Study||336
3261990|NCT02585778|3996287|FG001|ITT Population|Overall Study||167
3261991|NCT02585778|3996286|FG000|mITT Population|Overall Study||333
3261992|NCT02585778|3996287|FG001|mITT Population|Overall Study||164
3261993|NCT02585778|3996286|FG000|T1DM Participants|Overall Study||51
3261994|NCT02585778|3996287|FG001|T1DM Participants|Overall Study||25
3261995|NCT02585778|3996286|FG000|T2DM Participants|Overall Study||294
3261996|NCT02585778|3996287|FG001|T2DM Participants|Overall Study||147
3261997|NCT02585778|3996286|FG000|COMPLETED|Overall Study||312
3261998|NCT02585778|3996287|FG001|COMPLETED|Overall Study||157
3261999|NCT02585778|3996286|FG000|NOT COMPLETED|Overall Study||33
3262000|NCT02585778|3996287|FG001|NOT COMPLETED|Overall Study||15
3262001|NCT02585830|3996297|FG000|STARTED|Overall Study||25
3262002|NCT02585830|3996297|FG000|COMPLETED|Overall Study||22
3262003|NCT02585830|3996297|FG000|NOT COMPLETED|Overall Study||3
3262004|NCT02585843|3996303|FG000|STARTED|Overall Study||10
3262005|NCT02585843|3996304|FG001|STARTED|Overall Study||10
3262006|NCT02585843|3996303|FG000|COMPLETED|Overall Study||9
3262007|NCT02585843|3996304|FG001|COMPLETED|Overall Study||10
3262008|NCT02585843|3996303|FG000|NOT COMPLETED|Overall Study||1
3262009|NCT02585843|3996304|FG001|NOT COMPLETED|Overall Study||0
3262010|NCT02585895|3996312|FG000|STARTED|Primary Period||20
3262011|NCT02585895|3996313|FG001|STARTED|Primary Period||19
3262012|NCT02585895|3996312|FG000|COMPLETED|Primary Period||20
3262013|NCT02585895|3996313|FG001|COMPLETED|Primary Period||19
3262014|NCT02585895|3996312|FG000|NOT COMPLETED|Primary Period||0
3262015|NCT02585895|3996313|FG001|NOT COMPLETED|Primary Period||0
3262016|NCT02585895|3996312|FG000|STARTED|Post-primary Period||20
3262017|NCT02585895|3996313|FG001|STARTED|Post-primary Period||19
3262018|NCT02585895|3996312|FG000|COMPLETED|Post-primary Period||20
3262019|NCT02585895|3996313|FG001|COMPLETED|Post-primary Period||19
3262020|NCT02585895|3996312|FG000|NOT COMPLETED|Post-primary Period||0
3262021|NCT02585895|3996313|FG001|NOT COMPLETED|Post-primary Period||0
3262022|NCT02585934|3996324|FG000|STARTED|Overall Study||661
3262023|NCT02585934|3996325|FG001|STARTED|Overall Study||654
3262024|NCT02585934|3996324|FG000|Safety Population|Overall Study||656
3262025|NCT02585934|3996325|FG001|Safety Population|Overall Study||651
3262026|NCT02585934|3996324|FG000|Intent to Treat (ITT)|Overall Study||643
3262027|NCT02585934|3996325|FG001|Intent to Treat (ITT)|Overall Study||633
3262028|NCT02585934|3996324|FG000|Per Protocol (PP)|Overall Study||603
3262029|NCT02585934|3996325|FG001|Per Protocol (PP)|Overall Study||582
3262030|NCT02585934|3996324|FG000|COMPLETED|Overall Study||592
3262031|NCT02585934|3996325|FG001|COMPLETED|Overall Study||581
3262032|NCT02585934|3996324|FG000|NOT COMPLETED|Overall Study||69
3262033|NCT02585934|3996325|FG001|NOT COMPLETED|Overall Study||73
3262034|NCT02585960|3996339|FG000|STARTED|PK/Safety Assessment Period||57
3262035|NCT02585960|3996340|FG001|STARTED|PK/Safety Assessment Period||58
3262036|NCT02585960|3996341|FG002|STARTED|PK/Safety Assessment Period||6
3262037|NCT02585960|3996339|FG000|Completed 1st 6 Month Period|PK/Safety Assessment Period||57
3262038|NCT02585960|3996340|FG001|Completed 1st 6 Month Period|PK/Safety Assessment Period||53
3262039|NCT02585960|3996341|FG002|Completed 1st 6 Month Period|PK/Safety Assessment Period||0
3262040|NCT02585960|3996339|FG000|Completed 2nd 6 Month Period|PK/Safety Assessment Period||52
3262041|NCT02585960|3996340|FG001|Completed 2nd 6 Month Period|PK/Safety Assessment Period||48
3262042|NCT02585960|3996341|FG002|Completed 2nd 6 Month Period|PK/Safety Assessment Period||0
3262043|NCT02585960|3996339|FG000|COMPLETED|PK/Safety Assessment Period||52
3262044|NCT02585960|3996340|FG001|COMPLETED|PK/Safety Assessment Period||48
3262045|NCT02585960|3996341|FG002|COMPLETED|PK/Safety Assessment Period||0
3262046|NCT02585960|3996339|FG000|NOT COMPLETED|PK/Safety Assessment Period||5
3262047|NCT02585960|3996340|FG001|NOT COMPLETED|PK/Safety Assessment Period||10
3262048|NCT02585960|3996341|FG002|NOT COMPLETED|PK/Safety Assessment Period||6
3262049|NCT02585960|3996339|FG000|STARTED|Prophylactic Treatment Period||52
3262050|NCT02585960|3996340|FG001|STARTED|Prophylactic Treatment Period||48
3262051|NCT02585960|3996341|FG002|STARTED|Prophylactic Treatment Period||0
3262052|NCT02585960|3996339|FG000|COMPLETED|Prophylactic Treatment Period||52
3262053|NCT02585960|3996340|FG001|COMPLETED|Prophylactic Treatment Period||43
3262054|NCT02585960|3996341|FG002|COMPLETED|Prophylactic Treatment Period||0
3262055|NCT02585960|3996339|FG000|NOT COMPLETED|Prophylactic Treatment Period||0
3262056|NCT02585960|3996340|FG001|NOT COMPLETED|Prophylactic Treatment Period||5
3262057|NCT02585960|3996341|FG002|NOT COMPLETED|Prophylactic Treatment Period||0
3262058|NCT02585999|3996352|FG000|STARTED|Overall Study||28
3262059|NCT02585999|3996352|FG000|COMPLETED|Overall Study|28 participants enrolled; 2 withdrew prior to starting, leaving 26 to complete study activity.|26
3262060|NCT02585999|3996352|FG000|NOT COMPLETED|Overall Study||2
3262061|NCT02586012|3996357|FG000|STARTED|Overall Study||5
3262062|NCT02586012|3996358|FG001|STARTED|Overall Study||5
3262063|NCT02586012|3996359|FG002|STARTED|Overall Study||5
3262064|NCT02586012|3996360|FG003|STARTED|Overall Study||5
3373407|NCT02504099|4105663|FG000|COMPLETED|Overall Study||3
3262065|NCT02586012|3996361|FG004|STARTED|Overall Study||5
3262066|NCT02586012|3996362|FG005|STARTED|Overall Study||5
3262067|NCT02586012|3996357|FG000|COMPLETED|Overall Study||4
3262068|NCT02586012|3996358|FG001|COMPLETED|Overall Study||2
3262069|NCT02586012|3996359|FG002|COMPLETED|Overall Study||4
3262070|NCT02586012|3996360|FG003|COMPLETED|Overall Study||3
3262071|NCT02586012|3996361|FG004|COMPLETED|Overall Study||4
3262072|NCT02586012|3996362|FG005|COMPLETED|Overall Study||2
3262073|NCT02586012|3996357|FG000|NOT COMPLETED|Overall Study||1
3262074|NCT02586012|3996358|FG001|NOT COMPLETED|Overall Study||3
3262075|NCT02586012|3996359|FG002|NOT COMPLETED|Overall Study||1
3262076|NCT02586012|3996360|FG003|NOT COMPLETED|Overall Study||2
3262077|NCT02586012|3996361|FG004|NOT COMPLETED|Overall Study||1
3262078|NCT02586012|3996362|FG005|NOT COMPLETED|Overall Study||3
3262079|NCT02586064|3996373|FG000|STARTED|Overall Study||61
3262080|NCT02586064|3996374|FG001|STARTED|Overall Study||54
3262081|NCT02586064|3996373|FG000|COMPLETED|Overall Study||43
3262082|NCT02586064|3996374|FG001|COMPLETED|Overall Study||26
3262083|NCT02586064|3996373|FG000|NOT COMPLETED|Overall Study||18
3262084|NCT02586064|3996374|FG001|NOT COMPLETED|Overall Study||28
3262085|NCT02586077|3996383|FG000|STARTED|Overall Study||36
3262086|NCT02586077|3996383|FG000|COMPLETED|Overall Study||28
3262087|NCT02586077|3996383|FG000|NOT COMPLETED|Overall Study||8
3262088|NCT02586155|3996390|FG000|STARTED|Overall Study||1215
3262089|NCT02586155|3996391|FG001|STARTED|Overall Study||1210
3262090|NCT02586155|3996390|FG000|Final Number Randomized|Overall Study||1212
3262091|NCT02586155|3996391|FG001|Final Number Randomized|Overall Study||1206
3262092|NCT02586155|3996390|FG000|COMPLETED|Overall Study||1088
3262093|NCT02586155|3996391|FG001|COMPLETED|Overall Study||1083
3262094|NCT02586155|3996390|FG000|NOT COMPLETED|Overall Study||127
3262095|NCT02586155|3996391|FG001|NOT COMPLETED|Overall Study||127
3262096|NCT02586207|3996397|FG000|STARTED|Overall Study||59
3262097|NCT02586207|3996397|FG000|COMPLETED|Overall Study||57
3262098|NCT02586207|3996397|FG000|NOT COMPLETED|Overall Study||2
3262099|NCT02586233|3996408|FG000|STARTED|Overall Study||7
3262100|NCT02586233|3996409|FG001|STARTED|Overall Study||7
3262101|NCT02586233|3996410|FG002|STARTED|Overall Study||13
3262102|NCT02586233|3996411|FG003|STARTED|Overall Study||17
3262103|NCT02586233|3996412|FG004|STARTED|Overall Study||18
3262104|NCT02586233|3996413|FG005|STARTED|Overall Study||18
3262105|NCT02586233|3996414|FG006|STARTED|Overall Study||26
3262106|NCT02586233|3996408|FG000|COMPLETED|Overall Study||7
3262107|NCT02586233|3996409|FG001|COMPLETED|Overall Study||5
3262108|NCT02586233|3996410|FG002|COMPLETED|Overall Study||13
3262109|NCT02586233|3996411|FG003|COMPLETED|Overall Study||17
3262110|NCT02586233|3996412|FG004|COMPLETED|Overall Study||16
3262111|NCT02586233|3996413|FG005|COMPLETED|Overall Study||16
3262112|NCT02586233|3996414|FG006|COMPLETED|Overall Study||24
3262113|NCT02586233|3996408|FG000|NOT COMPLETED|Overall Study||0
3262114|NCT02586233|3996409|FG001|NOT COMPLETED|Overall Study||2
3262115|NCT02586233|3996410|FG002|NOT COMPLETED|Overall Study||0
3262116|NCT02586233|3996411|FG003|NOT COMPLETED|Overall Study||0
3262117|NCT02586233|3996412|FG004|NOT COMPLETED|Overall Study||2
3262118|NCT02586233|3996413|FG005|NOT COMPLETED|Overall Study||2
3262119|NCT02586233|3996414|FG006|NOT COMPLETED|Overall Study||2
3262120|NCT02586415|3996436|FG000|STARTED|Overall Study||92
3262121|NCT02586415|3996437|FG001|STARTED|Overall Study||90
3262122|NCT02586415|3996436|FG000|24 Hour Assessment|Overall Study||91
3262123|NCT02586415|3996437|FG001|24 Hour Assessment|Overall Study||90
3262124|NCT02586415|3996436|FG000|Day 30 Assessment|Overall Study||81
3262125|NCT02586415|3996437|FG001|Day 30 Assessment|Overall Study||70
3262126|NCT02586415|3996436|FG000|Day 90 Assessment|Overall Study||78
3262127|NCT02586415|3996437|FG001|Day 90 Assessment|Overall Study||65
3262128|NCT02586415|3996436|FG000|COMPLETED|Overall Study||78
3262129|NCT02586415|3996437|FG001|COMPLETED|Overall Study||65
3262130|NCT02586415|3996436|FG000|NOT COMPLETED|Overall Study||14
3262131|NCT02586415|3996437|FG001|NOT COMPLETED|Overall Study||25
3262132|NCT02586493|3996444|FG000|STARTED|Overall Study||278
3262133|NCT02586493|3996444|FG000|COMPLETED|Overall Study||266
3262134|NCT02586493|3996444|FG000|NOT COMPLETED|Overall Study||12
3262135|NCT02586506|3996448|FG000|STARTED|Overall Study||259
3262136|NCT02586506|3996448|FG000|COMPLETED|Overall Study||250
3262137|NCT02586506|3996448|FG000|NOT COMPLETED|Overall Study||9
3262138|NCT02586727|3996454|FG000|STARTED|Overall Study||20
3262139|NCT02586727|3996455|FG001|STARTED|Overall Study||20
3262140|NCT02586727|3996454|FG000|COMPLETED|Overall Study||19
3262141|NCT02586727|3996455|FG001|COMPLETED|Overall Study||20
3262142|NCT02586727|3996454|FG000|NOT COMPLETED|Overall Study||1
3262143|NCT02586727|3996455|FG001|NOT COMPLETED|Overall Study||0
3262144|NCT02586805|3996465|FG000|STARTED|Overall Study||41
3373408|NCT02504099|4105663|FG000|NOT COMPLETED|Overall Study||0
3373409|NCT02500901|4105667|FG000|STARTED|Overall Study||2
3373410|NCT02500901|4105667|FG000|COMPLETED|Overall Study||0
3373411|NCT02500901|4105667|FG000|NOT COMPLETED|Overall Study||2
3373412|NCT02483533|4105673|FG000|STARTED|Overall Study||50
3373413|NCT02483533|4105674|FG001|STARTED|Overall Study||50
3373414|NCT02483533|4105673|FG000|COMPLETED|Overall Study||0
3262145|NCT02586805|3996466|FG001|STARTED|Overall Study||28
3262146|NCT02586805|3996467|FG002|STARTED|Overall Study||29
3262147|NCT02586805|3996468|FG003|STARTED|Overall Study||27
3262148|NCT02586805|3996465|FG000|COMPLETED|Overall Study||35
3262149|NCT02586805|3996466|FG001|COMPLETED|Overall Study||27
3262150|NCT02586805|3996467|FG002|COMPLETED|Overall Study||26
3262151|NCT02586805|3996468|FG003|COMPLETED|Overall Study||25
3262152|NCT02586805|3996465|FG000|NOT COMPLETED|Overall Study||6
3262153|NCT02586805|3996466|FG001|NOT COMPLETED|Overall Study||1
3262154|NCT02586805|3996467|FG002|NOT COMPLETED|Overall Study||3
3262155|NCT02586805|3996468|FG003|NOT COMPLETED|Overall Study||2
3262156|NCT02586896|3996480|FG000|STARTED|Overall Study||150
3262157|NCT02586896|3996481|FG001|STARTED|Overall Study||150
3262158|NCT02586896|3996480|FG000|3-Month Follow-up|Overall Study||126
3262159|NCT02586896|3996481|FG001|3-Month Follow-up|Overall Study||123
3262160|NCT02586896|3996480|FG000|COMPLETED|Overall Study||131
3262161|NCT02586896|3996481|FG001|COMPLETED|Overall Study||133
3262162|NCT02586896|3996480|FG000|NOT COMPLETED|Overall Study||19
3262163|NCT02586896|3996481|FG001|NOT COMPLETED|Overall Study||17
3262164|NCT02586909|3996487|FG000|STARTED|Overall Study||1099
3262165|NCT02586909|3996487|FG000|COMPLETED|Overall Study||151
3262166|NCT02586909|3996487|FG000|NOT COMPLETED|Overall Study||948
3262167|NCT02586974|3996493|FG000|STARTED|Overall Study||32
3262168|NCT02586974|3996494|FG001|STARTED|Overall Study||32
3262169|NCT02586974|3996493|FG000|COMPLETED|Overall Study||32
3262170|NCT02586974|3996494|FG001|COMPLETED|Overall Study||32
3262171|NCT02586974|3996493|FG000|NOT COMPLETED|Overall Study||0
3262172|NCT02586974|3996494|FG001|NOT COMPLETED|Overall Study||0
3262173|NCT02587065|3996502|FG000|STARTED|Overall Study||193
3262174|NCT02587065|3996502|FG000|COMPLETED|Overall Study||166
3262175|NCT02587065|3996502|FG000|NOT COMPLETED|Overall Study||27
3262176|NCT02587117|3996508|FG000|STARTED|Overall Study||13
3262177|NCT02587117|3996509|FG001|STARTED|Overall Study||15
3262178|NCT02587117|3996508|FG000|COMPLETED|Overall Study||13
3262179|NCT02587117|3996509|FG001|COMPLETED|Overall Study||15
3262180|NCT02587117|3996508|FG000|NOT COMPLETED|Overall Study||0
3262181|NCT02587117|3996509|FG001|NOT COMPLETED|Overall Study||0
3262182|NCT02587143|3996517|FG000|STARTED|Overall Study||66
3262183|NCT02587143|3996518|FG001|STARTED|Overall Study||60
3262184|NCT02587143|3996517|FG000|COMPLETED|Overall Study||65
3262185|NCT02587143|3996518|FG001|COMPLETED|Overall Study||60
3262186|NCT02587143|3996517|FG000|NOT COMPLETED|Overall Study||1
3262187|NCT02587143|3996518|FG001|NOT COMPLETED|Overall Study||0
3262188|NCT02587221|3996526|FG000|STARTED|Overall Study||3394
3262189|NCT02587221|3996527|FG001|STARTED|Overall Study||3396
3262190|NCT02587221|3996526|FG000|Treated|Overall Study||3379
3262191|NCT02587221|3996527|FG001|Treated|Overall Study||3382
3262192|NCT02587221|3996526|FG000|COMPLETED|Overall Study||3263
3262193|NCT02587221|3996527|FG001|COMPLETED|Overall Study||3273
3262194|NCT02587221|3996526|FG000|NOT COMPLETED|Overall Study||131
3262195|NCT02587221|3996527|FG001|NOT COMPLETED|Overall Study||123
3262196|NCT02587234|3996535|FG000|STARTED|Overall Study||11
3262197|NCT02587234|3996536|FG001|STARTED|Overall Study||10
3262198|NCT02587234|3996535|FG000|COMPLETED|Overall Study||10
3262199|NCT02587234|3996536|FG001|COMPLETED|Overall Study||7
3262200|NCT02587234|3996535|FG000|NOT COMPLETED|Overall Study||1
3262201|NCT02587234|3996536|FG001|NOT COMPLETED|Overall Study||3
3262202|NCT02587351|3996544|FG000|STARTED|Overall Study||268
3262203|NCT02587351|3996545|FG001|STARTED|Overall Study||264
3262204|NCT02587351|3996544|FG000|COMPLETED|Overall Study||268
3262205|NCT02587351|3996545|FG001|COMPLETED|Overall Study||264
3262206|NCT02587351|3996544|FG000|NOT COMPLETED|Overall Study||0
3262207|NCT02587351|3996545|FG001|NOT COMPLETED|Overall Study||0
3262208|NCT02587520|3996569|FG000|STARTED|Overall Study||80
3262209|NCT02587520|3996570|FG001|STARTED|Overall Study||71
3262210|NCT02587520|3996571|FG002|STARTED|Overall Study||78
3262211|NCT02587520|3996572|FG003|STARTED|Overall Study||79
3262212|NCT02587520|3996573|FG004|STARTED|Overall Study||75
3262213|NCT02587520|3996574|FG005|STARTED|Overall Study||75
3262214|NCT02587520|3996575|FG006|STARTED|Overall Study||76
3262215|NCT02587520|3996576|FG007|STARTED|Overall Study||73
3262216|NCT02587520|3996577|FG008|STARTED|Overall Study||76
3262217|NCT02587520|3996578|FG009|STARTED|Overall Study||76
3262218|NCT02587520|3996579|FG010|STARTED|Overall Study||76
3262219|NCT02587520|3996580|FG011|STARTED|Overall Study||73
3262220|NCT02587520|3996581|FG012|STARTED|Overall Study||77
3262221|NCT02587520|3996582|FG013|STARTED|Overall Study||74
3262222|NCT02587520|3996583|FG014|STARTED|Overall Study||78
3262223|NCT02587520|3996584|FG015|STARTED|Overall Study||72
3262224|NCT02587520|3996585|FG016|STARTED|Overall Study||76
3262225|NCT02587520|3996586|FG017|STARTED|Overall Study||78
3373415|NCT02483533|4105674|FG001|COMPLETED|Overall Study||0
3373416|NCT02483533|4105673|FG000|NOT COMPLETED|Overall Study||50
3373417|NCT02483533|4105674|FG001|NOT COMPLETED|Overall Study||50
3373418|NCT02496039|4105680|FG000|STARTED|Overall Study||5
3373419|NCT02496039|4105680|FG000|COMPLETED|Overall Study||1
3373420|NCT02496039|4105680|FG000|NOT COMPLETED|Overall Study||4
3373421|NCT02492295|4105684|FG000|STARTED|Overall Study||0
3373422|NCT02492295|4105684|FG000|COMPLETED|Overall Study||0
3373423|NCT02492295|4105684|FG000|NOT COMPLETED|Overall Study||0
3262226|NCT02587520|3996569|FG000|Safety Analysis Set (SafAS)|Overall Study||79
3262227|NCT02587520|3996570|FG001|Safety Analysis Set (SafAS)|Overall Study||71
3262228|NCT02587520|3996571|FG002|Safety Analysis Set (SafAS)|Overall Study||77
3262229|NCT02587520|3996572|FG003|Safety Analysis Set (SafAS)|Overall Study||77
3262230|NCT02587520|3996573|FG004|Safety Analysis Set (SafAS)|Overall Study||75
3262231|NCT02587520|3996574|FG005|Safety Analysis Set (SafAS)|Overall Study||75
3262232|NCT02587520|3996575|FG006|Safety Analysis Set (SafAS)|Overall Study||76
3262233|NCT02587520|3996576|FG007|Safety Analysis Set (SafAS)|Overall Study||73
3262234|NCT02587520|3996577|FG008|Safety Analysis Set (SafAS)|Overall Study||76
3262235|NCT02587520|3996578|FG009|Safety Analysis Set (SafAS)|Overall Study||76
3262236|NCT02587520|3996579|FG010|Safety Analysis Set (SafAS)|Overall Study||76
3262237|NCT02587520|3996580|FG011|Safety Analysis Set (SafAS)|Overall Study||72
3262238|NCT02587520|3996581|FG012|Safety Analysis Set (SafAS)|Overall Study||77
3262239|NCT02587520|3996582|FG013|Safety Analysis Set (SafAS)|Overall Study||73
3262240|NCT02587520|3996583|FG014|Safety Analysis Set (SafAS)|Overall Study||78
3262241|NCT02587520|3996584|FG015|Safety Analysis Set (SafAS)|Overall Study||72
3262242|NCT02587520|3996585|FG016|Safety Analysis Set (SafAS)|Overall Study||76
3262243|NCT02587520|3996586|FG017|Safety Analysis Set (SafAS)|Overall Study||78
3262244|NCT02587520|3996569|FG000|COMPLETED|Overall Study||78
3262245|NCT02587520|3996570|FG001|COMPLETED|Overall Study||69
3262246|NCT02587520|3996571|FG002|COMPLETED|Overall Study||77
3262247|NCT02587520|3996572|FG003|COMPLETED|Overall Study||74
3262248|NCT02587520|3996573|FG004|COMPLETED|Overall Study||75
3262249|NCT02587520|3996574|FG005|COMPLETED|Overall Study||72
3262250|NCT02587520|3996575|FG006|COMPLETED|Overall Study||73
3262251|NCT02587520|3996576|FG007|COMPLETED|Overall Study||71
3262252|NCT02587520|3996577|FG008|COMPLETED|Overall Study||73
3262253|NCT02587520|3996578|FG009|COMPLETED|Overall Study||71
3262254|NCT02587520|3996579|FG010|COMPLETED|Overall Study||73
3262255|NCT02587520|3996580|FG011|COMPLETED|Overall Study||69
3262256|NCT02587520|3996581|FG012|COMPLETED|Overall Study||77
3262257|NCT02587520|3996582|FG013|COMPLETED|Overall Study||73
3262258|NCT02587520|3996583|FG014|COMPLETED|Overall Study||78
3262259|NCT02587520|3996584|FG015|COMPLETED|Overall Study||72
3262260|NCT02587520|3996585|FG016|COMPLETED|Overall Study||76
3262261|NCT02587520|3996586|FG017|COMPLETED|Overall Study||78
3262262|NCT02587520|3996569|FG000|NOT COMPLETED|Overall Study||2
3262263|NCT02587520|3996570|FG001|NOT COMPLETED|Overall Study||2
3262264|NCT02587520|3996571|FG002|NOT COMPLETED|Overall Study||1
3262265|NCT02587520|3996572|FG003|NOT COMPLETED|Overall Study||5
3262266|NCT02587520|3996573|FG004|NOT COMPLETED|Overall Study||0
3262267|NCT02587520|3996574|FG005|NOT COMPLETED|Overall Study||3
3262268|NCT02587520|3996575|FG006|NOT COMPLETED|Overall Study||3
3262269|NCT02587520|3996576|FG007|NOT COMPLETED|Overall Study||2
3262270|NCT02587520|3996577|FG008|NOT COMPLETED|Overall Study||3
3262271|NCT02587520|3996578|FG009|NOT COMPLETED|Overall Study||5
3262272|NCT02587520|3996579|FG010|NOT COMPLETED|Overall Study||3
3262273|NCT02587520|3996580|FG011|NOT COMPLETED|Overall Study||4
3262274|NCT02587520|3996581|FG012|NOT COMPLETED|Overall Study||0
3262275|NCT02587520|3996582|FG013|NOT COMPLETED|Overall Study||1
3262276|NCT02587520|3996583|FG014|NOT COMPLETED|Overall Study||0
3262277|NCT02587520|3996584|FG015|NOT COMPLETED|Overall Study||0
3262278|NCT02587520|3996585|FG016|NOT COMPLETED|Overall Study||0
3262279|NCT02587520|3996586|FG017|NOT COMPLETED|Overall Study||0
3262280|NCT02587819|3996624|FG000|STARTED|Overall Study||21
3262281|NCT02587819|3996624|FG000|Exposed|Overall Study||21
3262282|NCT02587819|3996624|FG000|COMPLETED|Overall Study||19
3262283|NCT02587819|3996624|FG000|NOT COMPLETED|Overall Study||2
3262284|NCT02587962|3996634|FG000|STARTED|Overall Study||3
3262285|NCT02587962|3996635|FG001|STARTED|Overall Study||3
3262286|NCT02587962|3996636|FG002|STARTED|Overall Study||6
3262287|NCT02587962|3996637|FG003|STARTED|Overall Study||7
3262288|NCT02587962|3996638|FG004|STARTED|Overall Study||15
3262289|NCT02587962|3996634|FG000|COMPLETED|Overall Study||1
3262290|NCT02587962|3996635|FG001|COMPLETED|Overall Study||0
3262291|NCT02587962|3996636|FG002|COMPLETED|Overall Study||0
3262292|NCT02587962|3996637|FG003|COMPLETED|Overall Study||1
3262293|NCT02587962|3996638|FG004|COMPLETED|Overall Study||0
3262294|NCT02587962|3996634|FG000|NOT COMPLETED|Overall Study||2
3262295|NCT02587962|3996635|FG001|NOT COMPLETED|Overall Study||3
3262296|NCT02587962|3996636|FG002|NOT COMPLETED|Overall Study||6
3262297|NCT02587962|3996637|FG003|NOT COMPLETED|Overall Study||6
3262298|NCT02587962|3996638|FG004|NOT COMPLETED|Overall Study||15
3262299|NCT02588092|3996663|FG000|STARTED|Overall Study||4
3262300|NCT02588092|3996664|FG001|STARTED|Overall Study||3
3262301|NCT02588092|3996665|FG002|STARTED|Overall Study||3
3262302|NCT02588092|3996666|FG003|STARTED|Overall Study||3
3262303|NCT02588092|3996667|FG004|STARTED|Overall Study||3
3262304|NCT02588092|3996668|FG005|STARTED|Overall Study||3
3262305|NCT02588092|3996669|FG006|STARTED|Overall Study||3
3262306|NCT02588092|3996670|FG007|STARTED|Overall Study||4
3262307|NCT02588092|3996671|FG008|STARTED|Overall Study||6
3262308|NCT02588092|3996672|FG009|STARTED|Overall Study||3
3262309|NCT02588092|3996663|FG000|COMPLETED|Overall Study||0
3262310|NCT02588092|3996664|FG001|COMPLETED|Overall Study||0
3262311|NCT02588092|3996665|FG002|COMPLETED|Overall Study||0
3262312|NCT02588092|3996666|FG003|COMPLETED|Overall Study||0
3262313|NCT02588092|3996667|FG004|COMPLETED|Overall Study||0
3262314|NCT02588092|3996668|FG005|COMPLETED|Overall Study||0
3262315|NCT02588092|3996669|FG006|COMPLETED|Overall Study||0
3262316|NCT02588092|3996670|FG007|COMPLETED|Overall Study||0
3262317|NCT02588092|3996671|FG008|COMPLETED|Overall Study||0
3262318|NCT02588092|3996672|FG009|COMPLETED|Overall Study||0
3262319|NCT02588092|3996663|FG000|NOT COMPLETED|Overall Study||4
3262320|NCT02588092|3996664|FG001|NOT COMPLETED|Overall Study||3
3262321|NCT02588092|3996665|FG002|NOT COMPLETED|Overall Study||3
3262322|NCT02588092|3996666|FG003|NOT COMPLETED|Overall Study||3
3262323|NCT02588092|3996667|FG004|NOT COMPLETED|Overall Study||3
3262324|NCT02588092|3996668|FG005|NOT COMPLETED|Overall Study||3
3262325|NCT02588092|3996669|FG006|NOT COMPLETED|Overall Study||3
3262326|NCT02588092|3996670|FG007|NOT COMPLETED|Overall Study||4
3262327|NCT02588092|3996671|FG008|NOT COMPLETED|Overall Study||6
3262328|NCT02588092|3996672|FG009|NOT COMPLETED|Overall Study||3
3373424|NCT02494206|4105689|FG000|STARTED|Overall Study||9
3373425|NCT02494206|4105689|FG000|COMPLETED|Overall Study||7
3373426|NCT02494206|4105689|FG000|NOT COMPLETED|Overall Study||2
3373427|NCT02473445|4105693|FG000|STARTED|Overall Study||22
3373428|NCT02473445|4105693|FG000|COMPLETED|Overall Study||0
3373429|NCT02473445|4105693|FG000|NOT COMPLETED|Overall Study||22
3373430|NCT02491411|4105697|FG000|STARTED|Overall Study||4
3373431|NCT02491411|4105697|FG000|COMPLETED|Overall Study||0
3373432|NCT02491411|4105697|FG000|NOT COMPLETED|Overall Study||4
3373433|NCT02476994|4105703|FG000|STARTED|Overall Study||1
3373434|NCT02476994|4105704|FG001|STARTED|Overall Study||0
3373435|NCT02476994|4105703|FG000|COMPLETED|Overall Study||0
3373436|NCT02476994|4105704|FG001|COMPLETED|Overall Study||0
3373437|NCT02476994|4105703|FG000|NOT COMPLETED|Overall Study||1
3373438|NCT02476994|4105704|FG001|NOT COMPLETED|Overall Study||0
3373439|NCT02473523|4105710|FG000|STARTED|Overall Study||2
3373440|NCT02473523|4105710|FG000|COMPLETED|Overall Study||0
3373441|NCT02473523|4105710|FG000|NOT COMPLETED|Overall Study||2
3373442|NCT02468583|4105716|FG000|STARTED|Overall Study||3
3373443|NCT02468583|4105717|FG001|STARTED|Overall Study||3
3373444|NCT02468583|4105716|FG000|COMPLETED|Overall Study||3
3373445|NCT02468583|4105717|FG001|COMPLETED|Overall Study||3
3373446|NCT02468583|4105716|FG000|NOT COMPLETED|Overall Study||0
3373447|NCT02468583|4105717|FG001|NOT COMPLETED|Overall Study||0
3373448|NCT02450591|4105723|FG000|STARTED|Overall Study||4
3373449|NCT02450591|4105723|FG000|COMPLETED|Overall Study||4
3373450|NCT02450591|4105723|FG000|NOT COMPLETED|Overall Study||0
3373451|NCT02472639|4105729|FG000|STARTED|Overall Study||4
3373452|NCT02472639|4105730|FG001|STARTED|Overall Study||3
3373453|NCT02472639|4105729|FG000|COMPLETED|Overall Study||0
3373454|NCT02472639|4105730|FG001|COMPLETED|Overall Study||0
3373455|NCT02472639|4105729|FG000|NOT COMPLETED|Overall Study||4
3373456|NCT02472639|4105730|FG001|NOT COMPLETED|Overall Study||3
3373457|NCT02469415|4105736|FG000|STARTED|Overall Study||3
3373458|NCT02469415|4105736|FG000|COMPLETED|Overall Study||0
3373459|NCT02469415|4105736|FG000|NOT COMPLETED|Overall Study||3
3373460|NCT02461550|4105740|FG000|STARTED|Overall Study||2
3373461|NCT02461550|4105740|FG000|COMPLETED|Overall Study||2
3373462|NCT02461550|4105740|FG000|NOT COMPLETED|Overall Study||0
3373463|NCT02461355|4105744|FG000|STARTED|Overall Study||2
3373464|NCT02461355|4105744|FG000|COMPLETED|Overall Study||2
3373465|NCT02461355|4105744|FG000|NOT COMPLETED|Overall Study||0
3373466|NCT02452359|4105748|FG000|STARTED|Overall Study||54
3373467|NCT02452359|4105748|FG000|COMPLETED|Overall Study||33
3373468|NCT02452359|4105748|FG000|NOT COMPLETED|Overall Study||21
3373469|NCT02434146|4105752|FG000|STARTED|Overall Study||3
3373470|NCT02434146|4105752|FG000|COMPLETED|Overall Study||3
3373471|NCT02434146|4105752|FG000|NOT COMPLETED|Overall Study||0
3373472|NCT02452398|4105756|FG000|STARTED|Overall Study|Study was halted prematurely. No results analysis completed.|79
3373473|NCT02452398|4105756|FG000|COMPLETED|Overall Study|Study was halted prematurely. No results analysis completed.|38
3373474|NCT02452398|4105756|FG000|NOT COMPLETED|Overall Study||41
3373475|NCT02447887|4105760|FG000|STARTED|Overall Study||3
3373476|NCT02447887|4105760|FG000|COMPLETED|Overall Study||0
3373477|NCT02447887|4105760|FG000|NOT COMPLETED|Overall Study||3
3373478|NCT02431494|4105767|FG000|STARTED|Overall Study|The results cannot be evaluated because the sample size was so small. He had trouble recruiting|0
3373479|NCT02431494|4105768|FG001|STARTED|Overall Study|The results cannot be evaluated because the sample size was so small. He had trouble recruiting|0
3373480|NCT02431494|4105769|FG002|STARTED|Overall Study|The results cannot be evaluated because the sample size was so small. He had trouble recruiting|0
3373481|NCT02431494|4105767|FG000|COMPLETED|Overall Study||0
3373482|NCT02431494|4105768|FG001|COMPLETED|Overall Study||0
3373483|NCT02431494|4105769|FG002|COMPLETED|Overall Study||0
3373484|NCT02431494|4105767|FG000|NOT COMPLETED|Overall Study||0
3373485|NCT02431494|4105768|FG001|NOT COMPLETED|Overall Study||0
3373486|NCT02431494|4105769|FG002|NOT COMPLETED|Overall Study||0
3373487|NCT02439970|4105781|FG000|STARTED|Overall Study||2
3373488|NCT02439970|4105782|FG001|STARTED|Overall Study||3
3373489|NCT02439970|4105781|FG000|COMPLETED|Overall Study||0
3373490|NCT02439970|4105782|FG001|COMPLETED|Overall Study||0
3373491|NCT02439970|4105781|FG000|NOT COMPLETED|Overall Study||2
3373492|NCT02439970|4105782|FG001|NOT COMPLETED|Overall Study||3
3373493|NCT02439957|4105790|FG000|STARTED|Overall Study||3
3373494|NCT02439957|4105791|FG001|STARTED|Overall Study||3
3373495|NCT02439957|4105790|FG000|Blinded Treatment Period|Overall Study||1
3373496|NCT02439957|4105791|FG001|Blinded Treatment Period|Overall Study||2
3373497|NCT02439957|4105790|FG000|COMPLETED|Overall Study||0
3373498|NCT02439957|4105791|FG001|COMPLETED|Overall Study||0
3373499|NCT02439957|4105790|FG000|NOT COMPLETED|Overall Study||3
3373500|NCT02439957|4105791|FG001|NOT COMPLETED|Overall Study||3
3373501|NCT02441036|4105802|FG000|STARTED|Overall Study||3
3373502|NCT02441036|4105803|FG001|STARTED|Overall Study||5
3373503|NCT02441036|4105804|FG002|STARTED|Overall Study||3
3373504|NCT02441036|4105805|FG003|STARTED|Overall Study||4
3373505|NCT02441036|4105806|FG004|STARTED|Overall Study||1
3373506|NCT02441036|4105802|FG000|Treated|Overall Study||3
3373507|NCT02441036|4105803|FG001|Treated|Overall Study||5
3373508|NCT02441036|4105804|FG002|Treated|Overall Study||3
3262329|NCT04960228|3996700|FG000|STARTED|Overall Study||1098
3262330|NCT04960228|3996701|FG001|STARTED|Overall Study||999
3262331|NCT04960228|3996700|FG000|COMPLETED|Overall Study||810
3262332|NCT04960228|3996701|FG001|COMPLETED|Overall Study||813
3262333|NCT04960228|3996700|FG000|NOT COMPLETED|Overall Study||288
3262334|NCT04960228|3996701|FG001|NOT COMPLETED|Overall Study||186
3262335|NCT03922477|3996707|FG000|STARTED|Overall Study||13
3262336|NCT03922477|3996707|FG000|COMPLETED|Overall Study||0
3262337|NCT03922477|3996707|FG000|NOT COMPLETED|Overall Study||13
3262338|NCT03688074|3996713|FG000|STARTED|Overall Study||59
3262339|NCT03688074|3996714|FG001|STARTED|Overall Study||57
3262340|NCT03688074|3996713|FG000|COMPLETED|Overall Study||58
3262341|NCT03688074|3996714|FG001|COMPLETED|Overall Study||56
3262342|NCT03688074|3996713|FG000|NOT COMPLETED|Overall Study||1
3262343|NCT03688074|3996714|FG001|NOT COMPLETED|Overall Study||1
3262344|NCT03342001|3996720|FG000|STARTED|Overall Study||11
3262345|NCT03342001|3996720|FG000|COMPLETED|Overall Study||9
3262346|NCT03342001|3996720|FG000|NOT COMPLETED|Overall Study||2
3262347|NCT03227029|3996727|FG000|STARTED|Overall Study||26
3262348|NCT03227029|3996728|FG001|STARTED|Overall Study||26
3262349|NCT03227029|3996729|FG002|STARTED|Overall Study||13
3262350|NCT03227029|3996727|FG000|Received Inoculation|Overall Study||26
3262351|NCT03227029|3996728|FG001|Received Inoculation|Overall Study||25
3262352|NCT03227029|3996729|FG002|Received Inoculation|Overall Study||12
3262353|NCT03227029|3996727|FG000|COMPLETED|Overall Study||22
3262354|NCT03227029|3996728|FG001|COMPLETED|Overall Study||22
3262355|NCT03227029|3996729|FG002|COMPLETED|Overall Study||9
3262356|NCT03227029|3996727|FG000|NOT COMPLETED|Overall Study||4
3262357|NCT03227029|3996728|FG001|NOT COMPLETED|Overall Study||4
3262358|NCT03227029|3996729|FG002|NOT COMPLETED|Overall Study||4
3262359|NCT03091192|3996739|FG000|STARTED|Overall Study||33
3262360|NCT03091192|3996740|FG001|STARTED|Overall Study||27
3262361|NCT03091192|3996739|FG000|COMPLETED|Overall Study||0
3262362|NCT03091192|3996740|FG001|COMPLETED|Overall Study||0
3262363|NCT03091192|3996739|FG000|NOT COMPLETED|Overall Study||33
3262364|NCT03091192|3996740|FG001|NOT COMPLETED|Overall Study||27
3262365|NCT02871934|3996748|FG000|STARTED|Overall Study||193
3262366|NCT02871934|3996749|FG001|STARTED|Overall Study||215
3262367|NCT02871934|3996748|FG000|COMPLETED|Overall Study||193
3262368|NCT02871934|3996749|FG001|COMPLETED|Overall Study||215
3262369|NCT02871934|3996748|FG000|NOT COMPLETED|Overall Study||0
3262370|NCT02871934|3996749|FG001|NOT COMPLETED|Overall Study||0
3262371|NCT02859558|3996760|FG000|STARTED|Step 1||49
3262372|NCT02859558|3996761|FG001|STARTED|Step 1||79
3262373|NCT02859558|3996762|FG002|STARTED|Step 1||60
3262374|NCT02859558|3996763|FG003|STARTED|Step 1||4
3262375|NCT02859558|3996764|FG004|STARTED|Step 1||3
3262376|NCT02859558|3996760|FG000|Completed Week 48|Step 1||41
3262377|NCT02859558|3996761|FG001|Completed Week 48|Step 1||68
3262378|NCT02859558|3996762|FG002|Completed Week 48|Step 1||50
3262379|NCT02859558|3996763|FG003|Completed Week 48|Step 1||0
3262380|NCT02859558|3996764|FG004|Completed Week 48|Step 1||0
3262381|NCT02859558|3996760|FG000|COMPLETED|Step 1||37
3262382|NCT02859558|3996761|FG001|COMPLETED|Step 1||67
3262383|NCT02859558|3996762|FG002|COMPLETED|Step 1||49
3262384|NCT02859558|3996763|FG003|COMPLETED|Step 1||4
3262385|NCT02859558|3996764|FG004|COMPLETED|Step 1||0
3262386|NCT02859558|3996760|FG000|NOT COMPLETED|Step 1||12
3262387|NCT02859558|3996761|FG001|NOT COMPLETED|Step 1||12
3262388|NCT02859558|3996762|FG002|NOT COMPLETED|Step 1||11
3262389|NCT02859558|3996763|FG003|NOT COMPLETED|Step 1||0
3262390|NCT02859558|3996764|FG004|NOT COMPLETED|Step 1||3
3262391|NCT02859558|3996760|FG000|STARTED|Step 2||25
3262392|NCT02859558|3996761|FG001|STARTED|Step 2||39
3262393|NCT02859558|3996762|FG002|STARTED|Step 2||21
3262394|NCT02859558|3996763|FG003|STARTED|Step 2||0
3262395|NCT02859558|3996764|FG004|STARTED|Step 2||0
3262396|NCT02859558|3996760|FG000|COMPLETED|Step 2||0
3262397|NCT02859558|3996761|FG001|COMPLETED|Step 2||0
3262398|NCT02859558|3996762|FG002|COMPLETED|Step 2||0
3262399|NCT02859558|3996763|FG003|COMPLETED|Step 2||0
3262400|NCT02859558|3996764|FG004|COMPLETED|Step 2||0
3262401|NCT02859558|3996760|FG000|NOT COMPLETED|Step 2||25
3262402|NCT02859558|3996761|FG001|NOT COMPLETED|Step 2||39
3262403|NCT02859558|3996762|FG002|NOT COMPLETED|Step 2||21
3262404|NCT02859558|3996763|FG003|NOT COMPLETED|Step 2||0
3262405|NCT02859558|3996764|FG004|NOT COMPLETED|Step 2||0
3262406|NCT02818920|3996774|FG000|STARTED|Overall Study||30
3262407|NCT02818920|3996774|FG000|Completed Surgery|Overall Study||25
3262408|NCT02818920|3996774|FG000|Received Adjuvant Therapy|Overall Study||17
3262409|NCT02818920|3996774|FG000|COMPLETED|Overall Study||12
3262410|NCT02818920|3996774|FG000|NOT COMPLETED|Overall Study||18
3262411|NCT02481310|3996781|FG000|STARTED|Induction Treatment (6 Cycles)||1
3262412|NCT02481310|3996782|FG001|STARTED|Induction Treatment (6 Cycles)||36
3262413|NCT02481310|3996783|FG002|STARTED|Induction Treatment (6 Cycles)||1
3262414|NCT02481310|3996781|FG000|Reached First Evaluable Response|Induction Treatment (6 Cycles)||1
3262415|NCT02481310|3996782|FG001|Reached First Evaluable Response|Induction Treatment (6 Cycles)||34
3262416|NCT02481310|3996783|FG002|Reached First Evaluable Response|Induction Treatment (6 Cycles)||1
3262417|NCT02481310|3996781|FG000|Complete 6 Cycles|Induction Treatment (6 Cycles)||1
3262418|NCT02481310|3996782|FG001|Complete 6 Cycles|Induction Treatment (6 Cycles)||30
3262419|NCT02481310|3996783|FG002|Complete 6 Cycles|Induction Treatment (6 Cycles)||1
3262420|NCT02481310|3996781|FG000|COMPLETED|Induction Treatment (6 Cycles)||1
3262421|NCT02481310|3996782|FG001|COMPLETED|Induction Treatment (6 Cycles)||30
3262422|NCT02481310|3996783|FG002|COMPLETED|Induction Treatment (6 Cycles)||1
3262423|NCT02481310|3996781|FG000|NOT COMPLETED|Induction Treatment (6 Cycles)||0
3262424|NCT02481310|3996782|FG001|NOT COMPLETED|Induction Treatment (6 Cycles)||6
3262425|NCT02481310|3996783|FG002|NOT COMPLETED|Induction Treatment (6 Cycles)||0
3262426|NCT02481310|3996781|FG000|STARTED|Maintenance Treatment||1
3262427|NCT02481310|3996782|FG001|STARTED|Maintenance Treatment|9 patients that competed induction did not start maintenance treatment.|21
3373509|NCT02441036|4105805|FG003|Treated|Overall Study||4
3373510|NCT02441036|4105806|FG004|Treated|Overall Study||1
3373511|NCT02441036|4105802|FG000|Tissue Resected|Overall Study||3
3373512|NCT02441036|4105803|FG001|Tissue Resected|Overall Study||4
3373513|NCT02441036|4105804|FG002|Tissue Resected|Overall Study||3
3373514|NCT02441036|4105805|FG003|Tissue Resected|Overall Study||3
3373515|NCT02441036|4105806|FG004|Tissue Resected|Overall Study||1
3373516|NCT02441036|4105802|FG000|COMPLETED|Overall Study||3
3373517|NCT02441036|4105803|FG001|COMPLETED|Overall Study||4
3373518|NCT02441036|4105804|FG002|COMPLETED|Overall Study||3
3373519|NCT02441036|4105805|FG003|COMPLETED|Overall Study||3
3373520|NCT02441036|4105806|FG004|COMPLETED|Overall Study||1
3373521|NCT02441036|4105802|FG000|NOT COMPLETED|Overall Study||0
3373522|NCT02441036|4105803|FG001|NOT COMPLETED|Overall Study||1
3373523|NCT02441036|4105804|FG002|NOT COMPLETED|Overall Study||0
3373524|NCT02441036|4105805|FG003|NOT COMPLETED|Overall Study||1
3373525|NCT02441036|4105806|FG004|NOT COMPLETED|Overall Study||0
3373526|NCT02436265|4105821|FG000|STARTED|Overall Study||3
3373527|NCT02436265|4105822|FG001|STARTED|Overall Study||4
3373528|NCT02436265|4105821|FG000|COMPLETED|Overall Study||3
3373529|NCT02436265|4105822|FG001|COMPLETED|Overall Study||4
3373530|NCT02436265|4105821|FG000|NOT COMPLETED|Overall Study||0
3373531|NCT02436265|4105822|FG001|NOT COMPLETED|Overall Study||0
3373532|NCT02429583|4105830|FG000|STARTED|Overall Study||1
3373533|NCT02429583|4105831|FG001|STARTED|Overall Study||23
3373534|NCT02429583|4105830|FG000|COMPLETED|Overall Study||1
3373535|NCT02429583|4105831|FG001|COMPLETED|Overall Study||3
3373536|NCT02429583|4105830|FG000|NOT COMPLETED|Overall Study||0
3373537|NCT02429583|4105831|FG001|NOT COMPLETED|Overall Study||20
3373538|NCT02417870|4105837|FG000|STARTED|Overall Study||2
3373539|NCT02417870|4105837|FG000|COMPLETED|Overall Study||0
3373540|NCT02417870|4105837|FG000|NOT COMPLETED|Overall Study||2
3373541|NCT02430532|4105843|FG000|STARTED|Overall Study||30
3373542|NCT02430532|4105844|FG001|STARTED|Overall Study||28
3373543|NCT02430532|4105843|FG000|COMPLETED|Overall Study||0
3373544|NCT02430532|4105844|FG001|COMPLETED|Overall Study||0
3373545|NCT02430532|4105843|FG000|NOT COMPLETED|Overall Study||30
3373546|NCT02430532|4105844|FG001|NOT COMPLETED|Overall Study||28
3373547|NCT02428231|4105854|FG000|STARTED|Overall Study||30
3373548|NCT02428231|4105855|FG001|STARTED|Overall Study||32
3373549|NCT02428231|4105854|FG000|COMPLETED|Overall Study||17
3373550|NCT02428231|4105855|FG001|COMPLETED|Overall Study||15
3373551|NCT02428231|4105854|FG000|NOT COMPLETED|Overall Study||13
3373552|NCT02428231|4105855|FG001|NOT COMPLETED|Overall Study||17
3373553|NCT02424565|4105861|FG000|STARTED|Period 1 (D0)||8
3373554|NCT02424565|4105862|FG001|STARTED|Period 1 (D0)||7
3373555|NCT02424565|4105861|FG000|COMPLETED|Period 1 (D0)||8
3373556|NCT02424565|4105862|FG001|COMPLETED|Period 1 (D0)||6
3373557|NCT02424565|4105861|FG000|NOT COMPLETED|Period 1 (D0)||0
3373558|NCT02424565|4105862|FG001|NOT COMPLETED|Period 1 (D0)||1
3373559|NCT02424565|4105861|FG000|STARTED|Washout Period||8
3373560|NCT02424565|4105862|FG001|STARTED|Washout Period||6
3373561|NCT02424565|4105861|FG000|COMPLETED|Washout Period||8
3373562|NCT02424565|4105862|FG001|COMPLETED|Washout Period||6
3373563|NCT02424565|4105861|FG000|NOT COMPLETED|Washout Period||0
3373564|NCT02424565|4105862|FG001|NOT COMPLETED|Washout Period||0
3373565|NCT02424565|4105861|FG000|STARTED|Period 2 (D3)||8
3373566|NCT02424565|4105862|FG001|STARTED|Period 2 (D3)||6
3373567|NCT02424565|4105861|FG000|COMPLETED|Period 2 (D3)||8
3373568|NCT02424565|4105862|FG001|COMPLETED|Period 2 (D3)||6
3373569|NCT02424565|4105861|FG000|NOT COMPLETED|Period 2 (D3)||0
3373570|NCT02424565|4105862|FG001|NOT COMPLETED|Period 2 (D3)||0
3373571|NCT02413047|4105868|FG000|STARTED|Overall Study||3
3373572|NCT02413047|4105868|FG000|Participants on Infliximab|Overall Study||2
3373573|NCT02413047|4105868|FG000|Participants on Adalimumab|Overall Study||1
3373574|NCT02413047|4105868|FG000|COMPLETED|Overall Study||3
3373575|NCT02413047|4105868|FG000|NOT COMPLETED|Overall Study||0
3373576|NCT02414698|4105874|FG000|STARTED|Overall Study||3
3373577|NCT02414698|4105875|FG001|STARTED|Overall Study||1
3373578|NCT02414698|4105874|FG000|COMPLETED|Overall Study||3
3373579|NCT02414698|4105875|FG001|COMPLETED|Overall Study||1
3373580|NCT02414698|4105874|FG000|NOT COMPLETED|Overall Study||0
3373581|NCT02414698|4105875|FG001|NOT COMPLETED|Overall Study||0
3373582|NCT02422303|4105883|FG000|STARTED|Overall Study||6
3373583|NCT02422303|4105884|FG001|STARTED|Overall Study||6
3373584|NCT02422303|4105883|FG000|COMPLETED|Overall Study||5
3373585|NCT02422303|4105884|FG001|COMPLETED|Overall Study||5
3262428|NCT02481310|3996783|FG002|STARTED|Maintenance Treatment||1
3262429|NCT02481310|3996781|FG000|Started Maintenance Treatment|Maintenance Treatment||1
3262430|NCT02481310|3996782|FG001|Started Maintenance Treatment|Maintenance Treatment||21
3262431|NCT02481310|3996783|FG002|Started Maintenance Treatment|Maintenance Treatment||1
3262432|NCT02481310|3996781|FG000|COMPLETED|Maintenance Treatment||1
3373586|NCT02422303|4105883|FG000|NOT COMPLETED|Overall Study||1
3373587|NCT02422303|4105884|FG001|NOT COMPLETED|Overall Study||1
3262433|NCT02481310|3996782|FG001|COMPLETED|Maintenance Treatment||21
3262434|NCT02481310|3996783|FG002|COMPLETED|Maintenance Treatment||1
3262435|NCT02481310|3996781|FG000|NOT COMPLETED|Maintenance Treatment||0
3262436|NCT02481310|3996782|FG001|NOT COMPLETED|Maintenance Treatment||0
3262437|NCT02481310|3996783|FG002|NOT COMPLETED|Maintenance Treatment||0
3262438|NCT02481310|3996781|FG000|STARTED|Follow up||1
3262439|NCT02481310|3996782|FG001|STARTED|Follow up|2 patients died prior to entering follow up, 1 patient withdrew consent and 1 patient currently on treatment.|32
3262440|NCT02481310|3996783|FG002|STARTED|Follow up||1
3262441|NCT02481310|3996781|FG000|COMPLETED|Follow up||1
3262442|NCT02481310|3996782|FG001|COMPLETED|Follow up||29
3262443|NCT02481310|3996783|FG002|COMPLETED|Follow up||1
3262444|NCT02481310|3996781|FG000|NOT COMPLETED|Follow up||0
3262445|NCT02481310|3996782|FG001|NOT COMPLETED|Follow up||3
3262446|NCT02481310|3996783|FG002|NOT COMPLETED|Follow up||0
3262447|NCT02343952|3996787|FG000|STARTED|Study Treatment||93
3262448|NCT02343952|3996787|FG000|COMPLETED|Study Treatment||40
3262449|NCT02343952|3996787|FG000|NOT COMPLETED|Study Treatment||53
3262450|NCT02343952|3996787|FG000|STARTED|Follow up||83
3262451|NCT02343952|3996787|FG000|COMPLETED|Follow up||38
3262452|NCT02343952|3996787|FG000|NOT COMPLETED|Follow up||45
3262453|NCT02326155|3996793|FG000|STARTED|Overall Study||407
3262454|NCT02326155|3996794|FG001|STARTED|Overall Study||63
3262455|NCT02326155|3996793|FG000|COMPLETED|Overall Study||13
3262456|NCT02326155|3996794|FG001|COMPLETED|Overall Study||1
3262457|NCT02326155|3996793|FG000|NOT COMPLETED|Overall Study||394
3262458|NCT02326155|3996794|FG001|NOT COMPLETED|Overall Study||62
3262459|NCT02304367|3996800|FG000|STARTED|Overall Study|14 participants with TIO; 1 participant with ENS; 2 participants with XLH|17
3262460|NCT02304367|3996800|FG000|Completed 48 Weeks of Study Drug|Overall Study||16
3262461|NCT02304367|3996800|FG000|Completed 144 Weeks of Study Drug|Overall Study||12
3262462|NCT02304367|3996800|FG000|COMPLETED|Overall Study||9
3262463|NCT02304367|3996800|FG000|NOT COMPLETED|Overall Study||8
3373588|NCT02415166|4105894|FG000|STARTED|Overall Study||6
3373589|NCT02415166|4105895|FG001|STARTED|Overall Study||0
3373590|NCT02415166|4105896|FG002|STARTED|Overall Study||0
3373591|NCT02415166|4105897|FG003|STARTED|Overall Study||0
3373592|NCT02415166|4105894|FG000|COMPLETED|Overall Study||6
3373593|NCT02415166|4105895|FG001|COMPLETED|Overall Study||0
3373594|NCT02415166|4105896|FG002|COMPLETED|Overall Study||0
3373595|NCT02415166|4105897|FG003|COMPLETED|Overall Study||0
3373596|NCT02415166|4105894|FG000|NOT COMPLETED|Overall Study||0
3373597|NCT02415166|4105895|FG001|NOT COMPLETED|Overall Study||0
3373598|NCT02415166|4105896|FG002|NOT COMPLETED|Overall Study||0
3373599|NCT02415166|4105897|FG003|NOT COMPLETED|Overall Study||0
3373600|NCT02414152|4105907|FG000|STARTED|Overall Study||2
3373601|NCT02414152|4105907|FG000|COMPLETED|Overall Study|Both subjects completed 56 days of anakinra but did not complete all visits in observational period|0
3373602|NCT02414152|4105907|FG000|NOT COMPLETED|Overall Study||2
3373603|NCT02410551|4105911|FG000|STARTED|Overall Study||4
3373604|NCT02410551|4105911|FG000|COMPLETED|Overall Study||0
3373605|NCT02410551|4105911|FG000|NOT COMPLETED|Overall Study||4
3373606|NCT02411643|4105916|FG000|STARTED|Overall Study||2
3373607|NCT02411643|4105916|FG000|COMPLETED|Overall Study||2
3373608|NCT02411643|4105916|FG000|NOT COMPLETED|Overall Study||0
3373609|NCT02410954|4105922|FG000|STARTED|Overall Study||14
3373610|NCT02410954|4105923|FG001|STARTED|Overall Study||0
3373611|NCT02410954|4105922|FG000|COMPLETED|Overall Study||0
3373612|NCT02410954|4105923|FG001|COMPLETED|Overall Study||0
3373613|NCT02410954|4105922|FG000|NOT COMPLETED|Overall Study||14
3373614|NCT02410954|4105923|FG001|NOT COMPLETED|Overall Study||0
3373615|NCT02410577|4105929|FG000|STARTED|Overall Study||2
3373616|NCT02410577|4105929|FG000|COMPLETED|Overall Study||2
3373617|NCT02410577|4105929|FG000|NOT COMPLETED|Overall Study||0
3373618|NCT02409355|4105935|FG000|STARTED|Overall Study||4
3373619|NCT02409355|4105936|FG001|STARTED|Overall Study||4
3373620|NCT02409355|4105935|FG000|COMPLETED|Overall Study||0
3373621|NCT02409355|4105936|FG001|COMPLETED|Overall Study||0
3373622|NCT02409355|4105935|FG000|NOT COMPLETED|Overall Study||4
3373623|NCT02409355|4105936|FG001|NOT COMPLETED|Overall Study||4
3373624|NCT02403154|4105946|FG000|STARTED|Overall Study||2
3373625|NCT02403154|4105947|FG001|STARTED|Overall Study||0
3373626|NCT02403154|4105948|FG002|STARTED|Overall Study||1
3373627|NCT02403154|4105949|FG003|STARTED|Overall Study||1
3373628|NCT02403154|4105946|FG000|COMPLETED|Overall Study||0
3373629|NCT02403154|4105947|FG001|COMPLETED|Overall Study||0
3373630|NCT02403154|4105948|FG002|COMPLETED|Overall Study||0
3373631|NCT02403154|4105949|FG003|COMPLETED|Overall Study||0
3373632|NCT02403154|4105946|FG000|NOT COMPLETED|Overall Study||2
3373633|NCT02403154|4105947|FG001|NOT COMPLETED|Overall Study||0
3373634|NCT02403154|4105948|FG002|NOT COMPLETED|Overall Study||1
3373635|NCT02403154|4105949|FG003|NOT COMPLETED|Overall Study||1
3373636|NCT02404545|4105961|FG000|STARTED|Overall Study||6
3373637|NCT02404545|4105962|FG001|STARTED|Overall Study||6
3373638|NCT02404545|4105961|FG000|COMPLETED|Overall Study||0
3373639|NCT02404545|4105962|FG001|COMPLETED|Overall Study||0
3373640|NCT02404545|4105961|FG000|NOT COMPLETED|Overall Study||6
3373641|NCT02404545|4105962|FG001|NOT COMPLETED|Overall Study||6
3373642|NCT02392377|4105971|FG000|STARTED|Overall Study||0
3373643|NCT02392377|4105972|FG001|STARTED|Overall Study||1
3373644|NCT02392377|4105971|FG000|COMPLETED|Overall Study||0
3373645|NCT02392377|4105972|FG001|COMPLETED|Overall Study||0
3373646|NCT02392377|4105971|FG000|NOT COMPLETED|Overall Study||0
3262464|NCT01810705|3996813|FG000|STARTED|Overall Study||83
3262465|NCT01810705|3996814|FG001|STARTED|Overall Study||40
3262466|NCT01810705|3996813|FG000|COMPLETED|Overall Study||10
3262467|NCT01810705|3996814|FG001|COMPLETED|Overall Study||5
3262468|NCT01810705|3996813|FG000|NOT COMPLETED|Overall Study||73
3262469|NCT01810705|3996814|FG001|NOT COMPLETED|Overall Study||35
3262470|NCT02588261|3996822|FG000|STARTED|Overall Study||267
3262471|NCT02588261|3996823|FG001|STARTED|Overall Study||263
3262472|NCT02588261|3996822|FG000|Treated|Overall Study||265
3262473|NCT02588261|3996823|FG001|Treated|Overall Study||262
3262474|NCT02588261|3996822|FG000|COMPLETED|Overall Study||0
3262475|NCT02588261|3996823|FG001|COMPLETED|Overall Study||0
3262476|NCT02588261|3996822|FG000|NOT COMPLETED|Overall Study||267
3262477|NCT02588261|3996823|FG001|NOT COMPLETED|Overall Study||263
3262478|NCT02588339|3996829|FG000|STARTED|Overall Study||42
3262479|NCT02588339|3996829|FG000|COMPLETED|Overall Study||39
3262480|NCT02588339|3996829|FG000|NOT COMPLETED|Overall Study||3
3262481|NCT02588573|3996835|FG000|STARTED|Overall Study||45
3262482|NCT02588573|3996836|FG001|STARTED|Overall Study||45
3262483|NCT02588573|3996835|FG000|Randomized Eye Etafilcon A|Overall Study||45
3262484|NCT02588573|3996836|FG001|Randomized Eye Etafilcon A|Overall Study||45
3262485|NCT02588573|3996835|FG000|Randomized Eye Somofilcon A|Overall Study||45
3262486|NCT02588573|3996836|FG001|Randomized Eye Somofilcon A|Overall Study||45
3262487|NCT02588573|3996835|FG000|COMPLETED|Overall Study||45
3262488|NCT02588573|3996836|FG001|COMPLETED|Overall Study||45
3262489|NCT02588573|3996835|FG000|NOT COMPLETED|Overall Study||0
3262490|NCT02588573|3996836|FG001|NOT COMPLETED|Overall Study||0
3262491|NCT02588586|3996854|FG000|STARTED|Overall Study||17
3262492|NCT02588586|3996854|FG000|COMPLETED|Overall Study||15
3262493|NCT02588586|3996854|FG000|NOT COMPLETED|Overall Study||2
3373647|NCT02392377|4105972|FG001|NOT COMPLETED|Overall Study||1
3373648|NCT02399111|4105984|FG000|STARTED|Overall Study||4
3373649|NCT02399111|4105985|FG001|STARTED|Overall Study||1
3373650|NCT02399111|4105986|FG002|STARTED|Overall Study||4
3373651|NCT02399111|4105987|FG003|STARTED|Overall Study||0
3373652|NCT02399111|4105984|FG000|COMPLETED|Overall Study||4
3373653|NCT02399111|4105985|FG001|COMPLETED|Overall Study||1
3373654|NCT02399111|4105986|FG002|COMPLETED|Overall Study||4
3373655|NCT02399111|4105987|FG003|COMPLETED|Overall Study||0
3373656|NCT02399111|4105984|FG000|NOT COMPLETED|Overall Study||0
3373657|NCT02399111|4105985|FG001|NOT COMPLETED|Overall Study||0
3373658|NCT02399111|4105986|FG002|NOT COMPLETED|Overall Study||0
3373659|NCT02399111|4105987|FG003|NOT COMPLETED|Overall Study||0
3373660|NCT02402036|4105999|FG000|STARTED|Overall Study||10
3262494|NCT02588599|3996858|FG000|STARTED|Overall Study||54
3262495|NCT02588599|3996858|FG000|COMPLETED|Overall Study||54
3262496|NCT02588599|3996858|FG000|NOT COMPLETED|Overall Study||0
3262497|NCT02588612|3996862|FG000|STARTED|Overall Study||10
3262498|NCT02588612|3996862|FG000|Received T-cell Infusion|Overall Study||5
3262499|NCT02588612|3996862|FG000|COMPLETED|Overall Study||5
3262500|NCT02588612|3996862|FG000|NOT COMPLETED|Overall Study||5
3262501|NCT02588664|3996868|FG000|STARTED|Overall Study||3193
3262502|NCT02588664|3996869|FG001|STARTED|Overall Study||2689
3262503|NCT02588664|3996868|FG000|COMPLETED|Overall Study||1832
3262504|NCT02588664|3996869|FG001|COMPLETED|Overall Study||1644
3262505|NCT02588664|3996868|FG000|NOT COMPLETED|Overall Study||1361
3262506|NCT02588664|3996869|FG001|NOT COMPLETED|Overall Study||1045
3262507|NCT02588833|3996877|FG000|STARTED|Part 1|One subject was enrolled in both cohorts, this subject was enrolled twice.|3
3262508|NCT02588833|3996878|FG001|STARTED|Part 1|One subject was enrolled in both cohorts, this subject was enrolled twice.|20
3262509|NCT02588833|3996877|FG000|COMPLETED|Part 1||2
3262510|NCT02588833|3996878|FG001|COMPLETED|Part 1||20
3262511|NCT02588833|3996877|FG000|NOT COMPLETED|Part 1||1
3262512|NCT02588833|3996878|FG001|NOT COMPLETED|Part 1||0
3262513|NCT02588833|3996877|FG000|STARTED|Part 2A|Part 2A is not applicable since Cohort 1 subjects proceeded immediately to Part 3.|0
3262514|NCT02588833|3996878|FG001|STARTED|Part 2A||20
3262515|NCT02588833|3996877|FG000|COMPLETED|Part 2A||0
3262516|NCT02588833|3996878|FG001|COMPLETED|Part 2A||18
3262517|NCT02588833|3996877|FG000|NOT COMPLETED|Part 2A||0
3262518|NCT02588833|3996878|FG001|NOT COMPLETED|Part 2A||2
3262519|NCT02588833|3996877|FG000|STARTED|Part 2B||0
3262520|NCT02588833|3996878|FG001|STARTED|Part 2B||18
3262521|NCT02588833|3996877|FG000|COMPLETED|Part 2B||0
3262522|NCT02588833|3996878|FG001|COMPLETED|Part 2B||17
3262523|NCT02588833|3996877|FG000|NOT COMPLETED|Part 2B||0
3262524|NCT02588833|3996878|FG001|NOT COMPLETED|Part 2B||1
3262525|NCT02588833|3996877|FG000|STARTED|Part 2C||0
3262526|NCT02588833|3996878|FG001|STARTED|Part 2C|17 subjects completed Part 2B and 3 entered extension study without participating in Part 2C.|14
3262527|NCT02588833|3996877|FG000|COMPLETED|Part 2C||0
3262528|NCT02588833|3996878|FG001|COMPLETED|Part 2C||12
3262529|NCT02588833|3996877|FG000|NOT COMPLETED|Part 2C||0
3262530|NCT02588833|3996878|FG001|NOT COMPLETED|Part 2C||2
3262531|NCT02588833|3996877|FG000|STARTED|Part 3 (Safety Follow-up)|Only subjects who did not enter extension study or Part 2C entered Part 3.|3
3262532|NCT02588833|3996878|FG001|STARTED|Part 3 (Safety Follow-up)|Only subjects who did not enter extension study or Part 2C entered Part 3.|4
3262533|NCT02588833|3996877|FG000|COMPLETED|Part 3 (Safety Follow-up)||3
3262534|NCT02588833|3996878|FG001|COMPLETED|Part 3 (Safety Follow-up)||2
3262535|NCT02588833|3996877|FG000|NOT COMPLETED|Part 3 (Safety Follow-up)||0
3262536|NCT02588833|3996878|FG001|NOT COMPLETED|Part 3 (Safety Follow-up)||2
3262537|NCT02588872|3996887|FG000|STARTED|Overall Study||59
3262538|NCT02588872|3996888|FG001|STARTED|Overall Study||52
3262539|NCT02588872|3996887|FG000|COMPLETED|Overall Study||59
3262540|NCT02588872|3996888|FG001|COMPLETED|Overall Study||52
3262541|NCT02588872|3996887|FG000|NOT COMPLETED|Overall Study||0
3262542|NCT02588872|3996888|FG001|NOT COMPLETED|Overall Study||0
3262543|NCT02588976|3996894|FG000|STARTED|Overall Study||30
3262544|NCT02588976|3996894|FG000|COMPLETED|Overall Study||30
3373661|NCT02402036|4105999|FG000|COMPLETED|Overall Study||10
3373662|NCT02402036|4105999|FG000|NOT COMPLETED|Overall Study||0
3373663|NCT02394665|4106006|FG000|STARTED|Overall Study||1
3373664|NCT02394665|4106007|FG001|STARTED|Overall Study||0
3373665|NCT02394665|4106008|FG002|STARTED|Overall Study||0
3373666|NCT02394665|4106006|FG000|COMPLETED|Overall Study||0
3373667|NCT02394665|4106007|FG001|COMPLETED|Overall Study||0
3373668|NCT02394665|4106008|FG002|COMPLETED|Overall Study||0
3373669|NCT02394665|4106006|FG000|NOT COMPLETED|Overall Study||1
3373670|NCT02394665|4106007|FG001|NOT COMPLETED|Overall Study||0
3373671|NCT02394665|4106008|FG002|NOT COMPLETED|Overall Study||0
3373672|NCT02389712|4106018|FG000|STARTED|Overall Study||1
3373673|NCT02389712|4106019|FG001|STARTED|Overall Study||1
3373674|NCT02389712|4106018|FG000|COMPLETED|Overall Study||1
3373675|NCT02389712|4106019|FG001|COMPLETED|Overall Study||1
3373676|NCT02389712|4106018|FG000|NOT COMPLETED|Overall Study||0
3373677|NCT02389712|4106019|FG001|NOT COMPLETED|Overall Study||0
3373678|NCT02390362|4106027|FG000|STARTED|Overall Study|1 subject enrolled in this arm. completed 2 doses of Rituximab.|1
3373679|NCT02390362|4106028|FG001|STARTED|Overall Study||2
3373680|NCT02390362|4106027|FG000|COMPLETED|Overall Study||1
3373681|NCT02390362|4106028|FG001|COMPLETED|Overall Study||1
3373682|NCT02390362|4106027|FG000|NOT COMPLETED|Overall Study||0
3373683|NCT02390362|4106028|FG001|NOT COMPLETED|Overall Study||1
3373684|NCT02388776|4106034|FG000|STARTED|Overall Study||2
3373685|NCT02388776|4106034|FG000|COMPLETED|Overall Study||0
3373686|NCT02388776|4106034|FG000|NOT COMPLETED|Overall Study||2
3373687|NCT02383433|4106039|FG000|STARTED|Overall Study||2
3373688|NCT02383433|4106039|FG000|COMPLETED|Overall Study||0
3373689|NCT02383433|4106039|FG000|NOT COMPLETED|Overall Study||2
3373690|NCT02382588|4106045|FG000|STARTED|Overall Study||4
3373691|NCT02382588|4106046|FG001|STARTED|Overall Study||4
3373692|NCT02382588|4106045|FG000|COMPLETED|Overall Study||4
3373693|NCT02382588|4106046|FG001|COMPLETED|Overall Study||4
3373694|NCT02382588|4106045|FG000|NOT COMPLETED|Overall Study||0
3373695|NCT02382588|4106046|FG001|NOT COMPLETED|Overall Study||0
3373696|NCT02381626|4106055|FG000|STARTED|Overall Study||17
3373697|NCT02381626|4106056|FG001|STARTED|Overall Study||16
3373698|NCT02381626|4106057|FG002|STARTED|Overall Study||6
3373699|NCT02381626|4106055|FG000|COMPLETED|Overall Study||17
3373700|NCT02381626|4106056|FG001|COMPLETED|Overall Study||16
3262545|NCT02588976|3996894|FG000|NOT COMPLETED|Overall Study||0
3373701|NCT02381626|4106057|FG002|COMPLETED|Overall Study||6
3262546|NCT02589067|3996901|FG000|STARTED|Overall Study||33
3373702|NCT02381626|4106055|FG000|NOT COMPLETED|Overall Study||0
3373703|NCT02381626|4106056|FG001|NOT COMPLETED|Overall Study||0
3373704|NCT02381626|4106057|FG002|NOT COMPLETED|Overall Study||0
3373705|NCT02379390|4106067|FG000|STARTED|Overall Study||4
3373706|NCT02379390|4106068|FG001|STARTED|Overall Study||4
3373707|NCT02379390|4106067|FG000|COMPLETED|Overall Study||2
3373708|NCT02379390|4106068|FG001|COMPLETED|Overall Study||2
3373709|NCT02379390|4106067|FG000|NOT COMPLETED|Overall Study||2
3373710|NCT02379390|4106068|FG001|NOT COMPLETED|Overall Study||2
3373711|NCT02373865|4106079|FG000|STARTED|Overall Study||2
3373712|NCT02373865|4106080|FG001|STARTED|Overall Study||2
3373713|NCT02373865|4106079|FG000|COMPLETED|Overall Study||2
3373714|NCT02373865|4106080|FG001|COMPLETED|Overall Study||2
3373715|NCT02373865|4106079|FG000|NOT COMPLETED|Overall Study||0
3373716|NCT02373865|4106080|FG001|NOT COMPLETED|Overall Study||0
3373717|NCT02365688|4106086|FG000|STARTED|Overall Study|All subjects received a bolus of 500cc before first incision|18
3373718|NCT02365688|4106086|FG000|COMPLETED|Overall Study|All subjects consented to an change in standard infusion volume pre-incision|18
3373719|NCT02365688|4106086|FG000|NOT COMPLETED|Overall Study||0
3373720|NCT02361580|4106092|FG000|STARTED|Overall Study||6
3373721|NCT02361580|4106093|FG001|STARTED|Overall Study||3
3373722|NCT02361580|4106092|FG000|COMPLETED|Overall Study||0
3373723|NCT02361580|4106093|FG001|COMPLETED|Overall Study||0
3373724|NCT02361580|4106092|FG000|NOT COMPLETED|Overall Study||6
3373725|NCT02361580|4106093|FG001|NOT COMPLETED|Overall Study||3
3373726|NCT02369744|4106101|FG000|STARTED|Overall Study||0
3373727|NCT02369744|4106102|FG001|STARTED|Overall Study||0
3373728|NCT02369744|4106101|FG000|COMPLETED|Overall Study||0
3373729|NCT02369744|4106102|FG001|COMPLETED|Overall Study||0
3373730|NCT02369744|4106101|FG000|NOT COMPLETED|Overall Study||0
3373731|NCT02369744|4106102|FG001|NOT COMPLETED|Overall Study||0
3373732|NCT02379585|4106110|FG000|STARTED|Overall Study||3
3373733|NCT02379585|4106111|FG001|STARTED|Overall Study||5
3373734|NCT02379585|4106110|FG000|COMPLETED|Overall Study||0
3373735|NCT02379585|4106111|FG001|COMPLETED|Overall Study||0
3373736|NCT02379585|4106110|FG000|NOT COMPLETED|Overall Study||3
3373737|NCT02379585|4106111|FG001|NOT COMPLETED|Overall Study||5
3373738|NCT02370888|4106124|FG000|STARTED|Overall Study||9
3373739|NCT02370888|4106124|FG000|Proceed to Treatment|Overall Study||3
3373740|NCT02370888|4106124|FG000|COMPLETED|Overall Study||1
3373741|NCT02370888|4106124|FG000|NOT COMPLETED|Overall Study||8
3373742|NCT02367170|4106134|FG000|STARTED|Overall Study||1
3373743|NCT02367170|4106135|FG001|STARTED|Overall Study||0
3373744|NCT02367170|4106134|FG000|COMPLETED|Overall Study||1
3373745|NCT02367170|4106135|FG001|COMPLETED|Overall Study||0
3373746|NCT02367170|4106134|FG000|NOT COMPLETED|Overall Study||0
3373747|NCT02367170|4106135|FG001|NOT COMPLETED|Overall Study||0
3373748|NCT02376933|4106141|FG000|STARTED|Overall Study||10
3373749|NCT02376933|4106141|FG000|COMPLETED|Overall Study||8
3373750|NCT02376933|4106141|FG000|NOT COMPLETED|Overall Study||2
3373751|NCT02365233|4106148|FG000|STARTED|Overall Study||1
3373752|NCT02365233|4106149|FG001|STARTED|Overall Study||2
3373753|NCT02365233|4106150|FG002|STARTED|Overall Study||2
3373754|NCT02365233|4106148|FG000|COMPLETED|Overall Study||0
3373755|NCT02365233|4106149|FG001|COMPLETED|Overall Study||0
3373756|NCT02365233|4106150|FG002|COMPLETED|Overall Study||0
3373757|NCT02365233|4106148|FG000|NOT COMPLETED|Overall Study||1
3373758|NCT02365233|4106149|FG001|NOT COMPLETED|Overall Study||2
3373759|NCT02365233|4106150|FG002|NOT COMPLETED|Overall Study||2
3373760|NCT02347943|4106161|FG000|STARTED|Overall Study||140
3373761|NCT02347943|4106162|FG001|STARTED|Overall Study||67
3373762|NCT02347943|4106163|FG002|STARTED|Overall Study||45
3373763|NCT02347943|4106161|FG000|COMPLETED|Overall Study||0
3373764|NCT02347943|4106162|FG001|COMPLETED|Overall Study||0
3373765|NCT02347943|4106163|FG002|COMPLETED|Overall Study||0
3373766|NCT02347943|4106161|FG000|NOT COMPLETED|Overall Study||140
3373767|NCT02347943|4106162|FG001|NOT COMPLETED|Overall Study||67
3373768|NCT02347943|4106163|FG002|NOT COMPLETED|Overall Study||45
3373769|NCT02365207|4106171|FG000|STARTED|Overall Study||6
3373770|NCT02365207|4106171|FG000|COMPLETED|Overall Study||4
3373771|NCT02365207|4106171|FG000|NOT COMPLETED|Overall Study||2
3373772|NCT02360111|4106175|FG000|STARTED|Overall Study||3
3373773|NCT02360111|4106175|FG000|COMPLETED|Overall Study||1
3373774|NCT02360111|4106175|FG000|NOT COMPLETED|Overall Study||2
3373775|NCT02353468|4106179|FG000|STARTED|Overall Study||3
3373776|NCT02353468|4106179|FG000|COMPLETED|Overall Study||0
3373777|NCT02353468|4106179|FG000|NOT COMPLETED|Overall Study||3
3373778|NCT02360059|4106185|FG000|STARTED|Overall Study||1
3373779|NCT02360059|4106186|FG001|STARTED|Overall Study||0
3373780|NCT02360059|4106185|FG000|COMPLETED|Overall Study||1
3373781|NCT02360059|4106186|FG001|COMPLETED|Overall Study||0
3373782|NCT02360059|4106185|FG000|NOT COMPLETED|Overall Study||0
3373783|NCT02360059|4106186|FG001|NOT COMPLETED|Overall Study||0
3373784|NCT02350777|4106194|FG000|STARTED|Overall Study||2
3373785|NCT02350777|4106195|FG001|STARTED|Overall Study||2
3373786|NCT02350777|4106194|FG000|COMPLETED|Overall Study||2
3373787|NCT02350777|4106195|FG001|COMPLETED|Overall Study||2
3373788|NCT02350777|4106194|FG000|NOT COMPLETED|Overall Study||0
3373789|NCT02350777|4106195|FG001|NOT COMPLETED|Overall Study||0
3373790|NCT02345460|4106201|FG000|STARTED|Overall Study||1
3373791|NCT02345460|4106201|FG000|COMPLETED|Overall Study||1
3373792|NCT02345460|4106201|FG000|NOT COMPLETED|Overall Study||0
3262547|NCT02589067|3996902|FG001|STARTED|Overall Study||34
3262548|NCT02589067|3996901|FG000|COMPLETED|Overall Study||28
3262549|NCT02589067|3996902|FG001|COMPLETED|Overall Study||28
3262550|NCT02589067|3996901|FG000|NOT COMPLETED|Overall Study||5
3262551|NCT02589067|3996902|FG001|NOT COMPLETED|Overall Study||6
3262552|NCT02589171|3996911|FG000|STARTED|Overall Study||35
3262553|NCT02589171|3996912|FG001|STARTED|Overall Study||35
3262554|NCT02589171|3996911|FG000|Day 1 Follow up|Overall Study||35
3262555|NCT02589171|3996912|FG001|Day 1 Follow up|Overall Study||35
3262556|NCT02589171|3996911|FG000|Week 1 Follow up|Overall Study||35
3262557|NCT02589171|3996912|FG001|Week 1 Follow up|Overall Study||34
3262558|NCT02589171|3996911|FG000|Week 6 Follow up|Overall Study||28
3262559|NCT02589171|3996912|FG001|Week 6 Follow up|Overall Study||30
3262560|NCT02589171|3996911|FG000|COMPLETED|Overall Study||28
3262561|NCT02589171|3996912|FG001|COMPLETED|Overall Study||30
3262562|NCT02589171|3996911|FG000|NOT COMPLETED|Overall Study||7
3262563|NCT02589171|3996912|FG001|NOT COMPLETED|Overall Study||5
3262564|NCT02589405|3996918|FG000|STARTED|Overall Study||50
3262565|NCT02589405|3996918|FG000|COMPLETED|Overall Study||46
3262566|NCT02589405|3996918|FG000|NOT COMPLETED|Overall Study||4
3262567|NCT02589626|3996924|FG000|STARTED|Overall Study|Entered are treated patients|32
3262568|NCT02589626|3996925|FG001|STARTED|Overall Study|Entered are treated patients|33
3262569|NCT02589626|3996924|FG000|COMPLETED|Overall Study||29
3262570|NCT02589626|3996925|FG001|COMPLETED|Overall Study||31
3262571|NCT02589626|3996924|FG000|NOT COMPLETED|Overall Study||3
3262572|NCT02589626|3996925|FG001|NOT COMPLETED|Overall Study||2
3262573|NCT02589639|3996934|FG000|STARTED|Overall Study||90
3262574|NCT02589639|3996935|FG001|STARTED|Overall Study||89
3262575|NCT02589639|3996936|FG002|STARTED|Overall Study||90
3262576|NCT02589639|3996934|FG000|Treated|Overall Study||90
3262577|NCT02589639|3996935|FG001|Treated|Overall Study||86
3262578|NCT02589639|3996936|FG002|Treated|Overall Study||90
3262579|NCT02589639|3996934|FG000|COMPLETED|Overall Study||80
3262580|NCT02589639|3996935|FG001|COMPLETED|Overall Study||79
3262581|NCT02589639|3996936|FG002|COMPLETED|Overall Study||86
3262582|NCT02589639|3996934|FG000|NOT COMPLETED|Overall Study||10
3262583|NCT02589639|3996935|FG001|NOT COMPLETED|Overall Study||10
3262584|NCT02589639|3996936|FG002|NOT COMPLETED|Overall Study||4
3262585|NCT02589665|3996948|FG000|STARTED|Induction Period||63
3262586|NCT02589665|3996949|FG001|STARTED|Induction Period||63
3262587|NCT02589665|3996950|FG002|STARTED|Induction Period||62
3262588|NCT02589665|3996951|FG003|STARTED|Induction Period||61
3262589|NCT02589665|3996952|FG004|STARTED|Induction Period|Participants were assigned to this arm during maintenance period.|0
3262590|NCT02589665|3996953|FG005|STARTED|Induction Period|Participants were assigned to this arm during maintenance period.|0
3262591|NCT02589665|3996954|FG006|STARTED|Induction Period|Participants were assigned to this arm during maintenance period.|0
3262592|NCT02589665|3996955|FG007|STARTED|Induction Period||0
3262593|NCT02589665|3996956|FG008|STARTED|Induction Period||0
3262594|NCT02589665|3996957|FG009|STARTED|Induction Period||0
3262595|NCT02589665|3996948|FG000|Received at Least One Dose of Study Drug|Induction Period||63
3262596|NCT02589665|3996949|FG001|Received at Least One Dose of Study Drug|Induction Period||63
3262597|NCT02589665|3996950|FG002|Received at Least One Dose of Study Drug|Induction Period||62
3262598|NCT02589665|3996951|FG003|Received at Least One Dose of Study Drug|Induction Period||60
3262599|NCT02589665|3996952|FG004|Received at Least One Dose of Study Drug|Induction Period||0
3262600|NCT02589665|3996953|FG005|Received at Least One Dose of Study Drug|Induction Period||0
3262601|NCT02589665|3996954|FG006|Received at Least One Dose of Study Drug|Induction Period||0
3262602|NCT02589665|3996955|FG007|Received at Least One Dose of Study Drug|Induction Period||0
3262603|NCT02589665|3996956|FG008|Received at Least One Dose of Study Drug|Induction Period||0
3262604|NCT02589665|3996957|FG009|Received at Least One Dose of Study Drug|Induction Period||0
3262605|NCT02589665|3996948|FG000|COMPLETED|Induction Period||60
3262606|NCT02589665|3996949|FG001|COMPLETED|Induction Period||61
3262607|NCT02589665|3996950|FG002|COMPLETED|Induction Period||60
3262608|NCT02589665|3996951|FG003|COMPLETED|Induction Period||57
3262609|NCT02589665|3996952|FG004|COMPLETED|Induction Period||0
3262610|NCT02589665|3996953|FG005|COMPLETED|Induction Period||0
3262611|NCT02589665|3996954|FG006|COMPLETED|Induction Period||0
3262612|NCT02589665|3996955|FG007|COMPLETED|Induction Period||0
3262613|NCT02589665|3996956|FG008|COMPLETED|Induction Period||0
3262614|NCT02589665|3996957|FG009|COMPLETED|Induction Period||0
3262615|NCT02589665|3996948|FG000|NOT COMPLETED|Induction Period||3
3262616|NCT02589665|3996949|FG001|NOT COMPLETED|Induction Period||2
3262617|NCT02589665|3996950|FG002|NOT COMPLETED|Induction Period||2
3262618|NCT02589665|3996951|FG003|NOT COMPLETED|Induction Period||4
3262619|NCT02589665|3996952|FG004|NOT COMPLETED|Induction Period||0
3262620|NCT02589665|3996953|FG005|NOT COMPLETED|Induction Period||0
3262621|NCT02589665|3996954|FG006|NOT COMPLETED|Induction Period||0
3262622|NCT02589665|3996955|FG007|NOT COMPLETED|Induction Period||0
3262623|NCT02589665|3996956|FG008|NOT COMPLETED|Induction Period||0
3262624|NCT02589665|3996957|FG009|NOT COMPLETED|Induction Period||0
3262625|NCT02589665|3996948|FG000|STARTED|Maintenance Period|Participants were assigned to this arm only during induction period.|0
3262626|NCT02589665|3996949|FG001|STARTED|Maintenance Period|Participants were assigned to this arm only during induction period.|0
3262627|NCT02589665|3996950|FG002|STARTED|Maintenance Period|Participants were assigned to this arm only during induction period.|0
3262628|NCT02589665|3996951|FG003|STARTED|Maintenance Period|Participants were assigned to this arm only during induction period.|0
3262629|NCT02589665|3996952|FG004|STARTED|Maintenance Period|Only participants with a response were re-randomized in maintenance period.|13
3262630|NCT02589665|3996953|FG005|STARTED|Maintenance Period|Only participants with a response were re-randomized in maintenance period.|47
3262631|NCT02589665|3996954|FG006|STARTED|Maintenance Period|Only participants with a response were re-randomized in maintenance period.|46
3262632|NCT02589665|3996955|FG007|STARTED|Maintenance Period||0
3262633|NCT02589665|3996956|FG008|STARTED|Maintenance Period||0
3262634|NCT02589665|3996957|FG009|STARTED|Maintenance Period||0
3262635|NCT02589665|3996948|FG000|COMPLETED|Maintenance Period||0
3262636|NCT02589665|3996949|FG001|COMPLETED|Maintenance Period||0
3262637|NCT02589665|3996950|FG002|COMPLETED|Maintenance Period||0
3262638|NCT02589665|3996951|FG003|COMPLETED|Maintenance Period||0
3262639|NCT02589665|3996952|FG004|COMPLETED|Maintenance Period||0
3262640|NCT02589665|3996953|FG005|COMPLETED|Maintenance Period||0
3262641|NCT02589665|3996954|FG006|COMPLETED|Maintenance Period||0
3262642|NCT02589665|3996955|FG007|COMPLETED|Maintenance Period||0
3262643|NCT02589665|3996956|FG008|COMPLETED|Maintenance Period||0
3262644|NCT02589665|3996957|FG009|COMPLETED|Maintenance Period||0
3262645|NCT02589665|3996948|FG000|NOT COMPLETED|Maintenance Period||0
3262646|NCT02589665|3996949|FG001|NOT COMPLETED|Maintenance Period||0
3262647|NCT02589665|3996950|FG002|NOT COMPLETED|Maintenance Period||0
3262648|NCT02589665|3996951|FG003|NOT COMPLETED|Maintenance Period||0
3262649|NCT02589665|3996952|FG004|NOT COMPLETED|Maintenance Period||13
3262650|NCT02589665|3996953|FG005|NOT COMPLETED|Maintenance Period||47
3262651|NCT02589665|3996954|FG006|NOT COMPLETED|Maintenance Period||46
3262652|NCT02589665|3996955|FG007|NOT COMPLETED|Maintenance Period||0
3262653|NCT02589665|3996956|FG008|NOT COMPLETED|Maintenance Period||0
3262654|NCT02589665|3996957|FG009|NOT COMPLETED|Maintenance Period||0
3262655|NCT02589665|3996948|FG000|STARTED|Induction Extension Period||0
3262656|NCT02589665|3996949|FG001|STARTED|Induction Extension Period||0
3262657|NCT02589665|3996950|FG002|STARTED|Induction Extension Period||0
3262658|NCT02589665|3996951|FG003|STARTED|Induction Extension Period||0
3262659|NCT02589665|3996952|FG004|STARTED|Induction Extension Period||0
3262660|NCT02589665|3996953|FG005|STARTED|Induction Extension Period||0
3262661|NCT02589665|3996954|FG006|STARTED|Induction Extension Period||0
3262662|NCT02589665|3996955|FG007|STARTED|Induction Extension Period||32
3262663|NCT02589665|3996956|FG008|STARTED|Induction Extension Period||96
3262664|NCT02589665|3996957|FG009|STARTED|Induction Extension Period||0
3262665|NCT02589665|3996948|FG000|COMPLETED|Induction Extension Period||0
3262666|NCT02589665|3996949|FG001|COMPLETED|Induction Extension Period||0
3262667|NCT02589665|3996950|FG002|COMPLETED|Induction Extension Period||0
3262668|NCT02589665|3996951|FG003|COMPLETED|Induction Extension Period||0
3262669|NCT02589665|3996952|FG004|COMPLETED|Induction Extension Period||0
3262670|NCT02589665|3996953|FG005|COMPLETED|Induction Extension Period||0
3262671|NCT02589665|3996954|FG006|COMPLETED|Induction Extension Period||0
3262672|NCT02589665|3996955|FG007|COMPLETED|Induction Extension Period||30
3262673|NCT02589665|3996956|FG008|COMPLETED|Induction Extension Period||84
3262674|NCT02589665|3996957|FG009|COMPLETED|Induction Extension Period||0
3262675|NCT02589665|3996948|FG000|NOT COMPLETED|Induction Extension Period||0
3262676|NCT02589665|3996949|FG001|NOT COMPLETED|Induction Extension Period||0
3262677|NCT02589665|3996950|FG002|NOT COMPLETED|Induction Extension Period||0
3262678|NCT02589665|3996951|FG003|NOT COMPLETED|Induction Extension Period||0
3262679|NCT02589665|3996952|FG004|NOT COMPLETED|Induction Extension Period||0
3262680|NCT02589665|3996953|FG005|NOT COMPLETED|Induction Extension Period||0
3262681|NCT02589665|3996954|FG006|NOT COMPLETED|Induction Extension Period||0
3262682|NCT02589665|3996955|FG007|NOT COMPLETED|Induction Extension Period||2
3262683|NCT02589665|3996956|FG008|NOT COMPLETED|Induction Extension Period||12
3262684|NCT02589665|3996957|FG009|NOT COMPLETED|Induction Extension Period||0
3262685|NCT02589665|3996948|FG000|STARTED|Maintenance Extension Period||0
3262686|NCT02589665|3996949|FG001|STARTED|Maintenance Extension Period||0
3262687|NCT02589665|3996950|FG002|STARTED|Maintenance Extension Period||0
3262688|NCT02589665|3996951|FG003|STARTED|Maintenance Extension Period||0
3262689|NCT02589665|3996952|FG004|STARTED|Maintenance Extension Period||0
3262690|NCT02589665|3996953|FG005|STARTED|Maintenance Extension Period||0
3262691|NCT02589665|3996954|FG006|STARTED|Maintenance Extension Period||0
3262692|NCT02589665|3996955|FG007|STARTED|Maintenance Extension Period||0
3262693|NCT02589665|3996956|FG008|STARTED|Maintenance Extension Period||0
3262694|NCT02589665|3996957|FG009|STARTED|Maintenance Extension Period||68
3262695|NCT02589665|3996948|FG000|COMPLETED|Maintenance Extension Period||0
3262696|NCT02589665|3996949|FG001|COMPLETED|Maintenance Extension Period||0
3262697|NCT02589665|3996950|FG002|COMPLETED|Maintenance Extension Period||0
3262698|NCT02589665|3996951|FG003|COMPLETED|Maintenance Extension Period||0
3262699|NCT02589665|3996952|FG004|COMPLETED|Maintenance Extension Period||0
3262700|NCT02589665|3996953|FG005|COMPLETED|Maintenance Extension Period||0
3262701|NCT02589665|3996954|FG006|COMPLETED|Maintenance Extension Period||0
3262702|NCT02589665|3996955|FG007|COMPLETED|Maintenance Extension Period||0
3262703|NCT02589665|3996956|FG008|COMPLETED|Maintenance Extension Period||0
3262704|NCT02589665|3996957|FG009|COMPLETED|Maintenance Extension Period||0
3262705|NCT02589665|3996948|FG000|NOT COMPLETED|Maintenance Extension Period||0
3262706|NCT02589665|3996949|FG001|NOT COMPLETED|Maintenance Extension Period||0
3262707|NCT02589665|3996950|FG002|NOT COMPLETED|Maintenance Extension Period||0
3262708|NCT02589665|3996951|FG003|NOT COMPLETED|Maintenance Extension Period||0
3262709|NCT02589665|3996952|FG004|NOT COMPLETED|Maintenance Extension Period||0
3262710|NCT02589665|3996953|FG005|NOT COMPLETED|Maintenance Extension Period||0
3262711|NCT02589665|3996954|FG006|NOT COMPLETED|Maintenance Extension Period||0
3373793|NCT02346877|4106207|FG000|STARTED|Overall Study||19
3373794|NCT02346877|4106208|FG001|STARTED|Overall Study||0
3373795|NCT02346877|4106207|FG000|COMPLETED|Overall Study||0
3373796|NCT02346877|4106208|FG001|COMPLETED|Overall Study||0
3373797|NCT02346877|4106207|FG000|NOT COMPLETED|Overall Study||19
3373798|NCT02346877|4106208|FG001|NOT COMPLETED|Overall Study||0
3373799|NCT02351063|4106214|FG000|STARTED|Overall Study||1
3373800|NCT02351063|4106214|FG000|COMPLETED|Overall Study|Study terminated. No study data collected.|1
3373801|NCT02351063|4106214|FG000|NOT COMPLETED|Overall Study||0
3373802|NCT02345772|4106218|FG000|STARTED|Overall Study||4
3373803|NCT02345772|4106218|FG000|COMPLETED|Overall Study||0
3373804|NCT02345772|4106218|FG000|NOT COMPLETED|Overall Study||4
3373805|NCT02340728|4106224|FG000|STARTED|Overall Study||13
3373806|NCT02340728|4106225|FG001|STARTED|Overall Study||11
3373807|NCT02340728|4106224|FG000|COMPLETED|Overall Study||13
3373808|NCT02340728|4106225|FG001|COMPLETED|Overall Study||11
3373809|NCT02340728|4106224|FG000|NOT COMPLETED|Overall Study||0
3373810|NCT02340728|4106225|FG001|NOT COMPLETED|Overall Study||0
3373811|NCT02353572|4106231|FG000|STARTED|Overall Study||3
3373812|NCT02353572|4106231|FG000|COMPLETED|Overall Study||0
3373813|NCT02353572|4106231|FG000|NOT COMPLETED|Overall Study||3
3373814|NCT02345369|4106237|FG000|STARTED|Overall Study||0
3373815|NCT02345369|4106238|FG001|STARTED|Overall Study||0
3262712|NCT02589665|3996955|FG007|NOT COMPLETED|Maintenance Extension Period||0
3262713|NCT02589665|3996956|FG008|NOT COMPLETED|Maintenance Extension Period||0
3262714|NCT02589665|3996957|FG009|NOT COMPLETED|Maintenance Extension Period||68
3262715|NCT02589808|3996981|FG000|STARTED|Overall Study||76
3262716|NCT02589808|3996981|FG000|COMPLETED|Overall Study||76
3262717|NCT02589808|3996981|FG000|NOT COMPLETED|Overall Study||0
3262718|NCT02589847|3996987|FG000|STARTED|Overall Study||162
3262719|NCT02589847|3996988|FG001|STARTED|Overall Study||110
3262720|NCT02589847|3996987|FG000|Safety Population|Overall Study||149
3262721|NCT02589847|3996988|FG001|Safety Population|Overall Study||0
3262722|NCT02589847|3996987|FG000|Full Analysis Set (FAS)|Overall Study||149
3262723|NCT02589847|3996988|FG001|Full Analysis Set (FAS)|Overall Study||104
3262724|NCT02589847|3996987|FG000|Evaluable|Overall Study||142
3262725|NCT02589847|3996988|FG001|Evaluable|Overall Study||75
3262726|NCT02589847|3996987|FG000|COMPLETED|Overall Study||107
3262727|NCT02589847|3996988|FG001|COMPLETED|Overall Study||39
3262728|NCT02589847|3996987|FG000|NOT COMPLETED|Overall Study||55
3262729|NCT02589847|3996988|FG001|NOT COMPLETED|Overall Study||71
3262730|NCT02589977|3996998|FG000|STARTED|Overall Study||23
3262731|NCT02589977|3996999|FG001|STARTED|Overall Study||20
3262732|NCT02589977|3997000|FG002|STARTED|Overall Study||12
3262733|NCT02589977|3996998|FG000|COMPLETED|Overall Study||17
3262734|NCT02589977|3996999|FG001|COMPLETED|Overall Study||15
3262735|NCT02589977|3997000|FG002|COMPLETED|Overall Study||8
3262736|NCT02589977|3996998|FG000|NOT COMPLETED|Overall Study||6
3262737|NCT02589977|3996999|FG001|NOT COMPLETED|Overall Study||5
3262738|NCT02589977|3997000|FG002|NOT COMPLETED|Overall Study||4
3262739|NCT02590003|3997010|FG000|STARTED|Overall Study||1
3262740|NCT02590003|3997011|FG001|STARTED|Overall Study||2
3262741|NCT02590003|3997010|FG000|COMPLETED|Overall Study||0
3262742|NCT02590003|3997011|FG001|COMPLETED|Overall Study||0
3262743|NCT02590003|3997010|FG000|NOT COMPLETED|Overall Study||1
3262744|NCT02590003|3997011|FG001|NOT COMPLETED|Overall Study||2
3262745|NCT02590354|3997017|FG000|STARTED|Phase 1||114
3262746|NCT02590354|3997017|FG000|COMPLETED|Phase 1||16
3262747|NCT02590354|3997017|FG000|NOT COMPLETED|Phase 1||98
3262748|NCT02590354|3997017|FG000|STARTED|Phase 2 - Treatment Interruption||16
3262749|NCT02590354|3997017|FG000|COMPLETED|Phase 2 - Treatment Interruption||14
3262750|NCT02590354|3997017|FG000|NOT COMPLETED|Phase 2 - Treatment Interruption||2
3262751|NCT02590406|3997024|FG000|STARTED|Overall Study||25
3262752|NCT02590406|3997025|FG001|STARTED|Overall Study||25
3262753|NCT02590406|3997024|FG000|COMPLETED|Overall Study||24
3262754|NCT02590406|3997025|FG001|COMPLETED|Overall Study||24
3262755|NCT02590406|3997024|FG000|NOT COMPLETED|Overall Study||1
3262756|NCT02590406|3997025|FG001|NOT COMPLETED|Overall Study||1
3262757|NCT02590432|3997033|FG000|STARTED|Open-label Treatment Period||508
3262758|NCT02590432|3997034|FG001|STARTED|Open-label Treatment Period||318
3262759|NCT02590432|3997035|FG002|STARTED|Open-label Treatment Period||0
3262760|NCT02590432|3997036|FG003|STARTED|Open-label Treatment Period||0
3262761|NCT02590432|3997037|FG004|STARTED|Open-label Treatment Period||0
3262762|NCT02590432|3997038|FG005|STARTED|Open-label Treatment Period||0
3262763|NCT02590432|3997039|FG006|STARTED|Open-label Treatment Period||0
3262764|NCT02590432|3997040|FG007|STARTED|Open-label Treatment Period||0
3262765|NCT02590432|3997041|FG008|STARTED|Open-label Treatment Period||0
3373816|NCT02345369|4106237|FG000|COMPLETED|Overall Study||0
3373817|NCT02345369|4106238|FG001|COMPLETED|Overall Study||0
3373818|NCT02345369|4106237|FG000|NOT COMPLETED|Overall Study||0
3373819|NCT02345369|4106238|FG001|NOT COMPLETED|Overall Study||0
3373820|NCT02343263|4106247|FG000|STARTED|Overall Study|Study closed due for administrative reasons|5
3373821|NCT02343263|4106248|FG001|STARTED|Overall Study||3
3373822|NCT02343263|4106249|FG002|STARTED|Overall Study||1
3262766|NCT02590432|3997033|FG000|COMPLETED|Open-label Treatment Period|Participants were not randomized to Double-blind Treatment Period.|276
3262767|NCT02590432|3997034|FG001|COMPLETED|Open-label Treatment Period|Participants were not randomized to Double-blind Treatment Period.|166
3262768|NCT02590432|3997035|FG002|COMPLETED|Open-label Treatment Period||0
3262769|NCT02590432|3997036|FG003|COMPLETED|Open-label Treatment Period||0
3262770|NCT02590432|3997037|FG004|COMPLETED|Open-label Treatment Period||0
3262771|NCT02590432|3997038|FG005|COMPLETED|Open-label Treatment Period||0
3262772|NCT02590432|3997039|FG006|COMPLETED|Open-label Treatment Period||0
3262773|NCT02590432|3997040|FG007|COMPLETED|Open-label Treatment Period||0
3262774|NCT02590432|3997041|FG008|COMPLETED|Open-label Treatment Period||0
3262775|NCT02590432|3997033|FG000|NOT COMPLETED|Open-label Treatment Period||232
3262776|NCT02590432|3997034|FG001|NOT COMPLETED|Open-label Treatment Period||152
3262777|NCT02590432|3997035|FG002|NOT COMPLETED|Open-label Treatment Period||0
3262778|NCT02590432|3997036|FG003|NOT COMPLETED|Open-label Treatment Period||0
3262779|NCT02590432|3997037|FG004|NOT COMPLETED|Open-label Treatment Period||0
3262780|NCT02590432|3997038|FG005|NOT COMPLETED|Open-label Treatment Period||0
3262781|NCT02590432|3997039|FG006|NOT COMPLETED|Open-label Treatment Period||0
3262782|NCT02590432|3997040|FG007|NOT COMPLETED|Open-label Treatment Period||0
3262783|NCT02590432|3997041|FG008|NOT COMPLETED|Open-label Treatment Period||0
3262784|NCT02590432|3997033|FG000|STARTED|Double-blind Treatment Period||0
3262785|NCT02590432|3997034|FG001|STARTED|Double-blind Treatment Period||0
3262786|NCT02590432|3997035|FG002|STARTED|Double-blind Treatment Period||18
3262787|NCT02590432|3997036|FG003|STARTED|Double-blind Treatment Period||18
3262788|NCT02590432|3997037|FG004|STARTED|Double-blind Treatment Period||16
3262789|NCT02590432|3997038|FG005|STARTED|Double-blind Treatment Period||32
3262790|NCT02590432|3997039|FG006|STARTED|Double-blind Treatment Period||30
3262791|NCT02590432|3997040|FG007|STARTED|Double-blind Treatment Period||0
3262792|NCT02590432|3997041|FG008|STARTED|Double-blind Treatment Period||0
3262793|NCT02590432|3997033|FG000|COMPLETED|Double-blind Treatment Period||0
3262794|NCT02590432|3997034|FG001|COMPLETED|Double-blind Treatment Period||0
3262795|NCT02590432|3997035|FG002|COMPLETED|Double-blind Treatment Period|Participants did not enter Dose-reduced Open Label Treatment Period.|1
3262796|NCT02590432|3997036|FG003|COMPLETED|Double-blind Treatment Period|Participants did not enter Dose-reduced Open Label Treatment Period.|3
3262797|NCT02590432|3997037|FG004|COMPLETED|Double-blind Treatment Period|Participants did not enter Dose-reduced Open Label Treatment Period.|7
3262798|NCT02590432|3997038|FG005|COMPLETED|Double-blind Treatment Period|Participants did not enter Dose-reduced Open Label Treatment Period.|6
3262799|NCT02590432|3997039|FG006|COMPLETED|Double-blind Treatment Period|Participants did not enter Dose-reduced Open Label Treatment Period.|9
3262800|NCT02590432|3997040|FG007|COMPLETED|Double-blind Treatment Period||0
3262801|NCT02590432|3997041|FG008|COMPLETED|Double-blind Treatment Period||0
3262802|NCT02590432|3997033|FG000|NOT COMPLETED|Double-blind Treatment Period||0
3262803|NCT02590432|3997034|FG001|NOT COMPLETED|Double-blind Treatment Period||0
3262804|NCT02590432|3997035|FG002|NOT COMPLETED|Double-blind Treatment Period||17
3262805|NCT02590432|3997036|FG003|NOT COMPLETED|Double-blind Treatment Period||15
3262806|NCT02590432|3997037|FG004|NOT COMPLETED|Double-blind Treatment Period||9
3262807|NCT02590432|3997038|FG005|NOT COMPLETED|Double-blind Treatment Period||26
3262808|NCT02590432|3997039|FG006|NOT COMPLETED|Double-blind Treatment Period||21
3262809|NCT02590432|3997040|FG007|NOT COMPLETED|Double-blind Treatment Period||0
3262810|NCT02590432|3997041|FG008|NOT COMPLETED|Double-blind Treatment Period||0
3262811|NCT02590432|3997033|FG000|STARTED|Dose-reduced Open Label Treatment Period||0
3262812|NCT02590432|3997034|FG001|STARTED|Dose-reduced Open Label Treatment Period||0
3262813|NCT02590432|3997035|FG002|STARTED|Dose-reduced Open Label Treatment Period||0
3262814|NCT02590432|3997036|FG003|STARTED|Dose-reduced Open Label Treatment Period||0
3262815|NCT02590432|3997037|FG004|STARTED|Dose-reduced Open Label Treatment Period||0
3262816|NCT02590432|3997038|FG005|STARTED|Dose-reduced Open Label Treatment Period||0
3262817|NCT02590432|3997039|FG006|STARTED|Dose-reduced Open Label Treatment Period||0
3262818|NCT02590432|3997040|FG007|STARTED|Dose-reduced Open Label Treatment Period||31
3262819|NCT02590432|3997041|FG008|STARTED|Dose-reduced Open Label Treatment Period||26
3262820|NCT02590432|3997033|FG000|COMPLETED|Dose-reduced Open Label Treatment Period||0
3262821|NCT02590432|3997034|FG001|COMPLETED|Dose-reduced Open Label Treatment Period||0
3262822|NCT02590432|3997035|FG002|COMPLETED|Dose-reduced Open Label Treatment Period||0
3262823|NCT02590432|3997036|FG003|COMPLETED|Dose-reduced Open Label Treatment Period||0
3262824|NCT02590432|3997037|FG004|COMPLETED|Dose-reduced Open Label Treatment Period||0
3262825|NCT02590432|3997038|FG005|COMPLETED|Dose-reduced Open Label Treatment Period||0
3262826|NCT02590432|3997039|FG006|COMPLETED|Dose-reduced Open Label Treatment Period||0
3262827|NCT02590432|3997040|FG007|COMPLETED|Dose-reduced Open Label Treatment Period||13
3262828|NCT02590432|3997041|FG008|COMPLETED|Dose-reduced Open Label Treatment Period||8
3262829|NCT02590432|3997033|FG000|NOT COMPLETED|Dose-reduced Open Label Treatment Period||0
3262830|NCT02590432|3997034|FG001|NOT COMPLETED|Dose-reduced Open Label Treatment Period||0
3262831|NCT02590432|3997035|FG002|NOT COMPLETED|Dose-reduced Open Label Treatment Period||0
3262832|NCT02590432|3997036|FG003|NOT COMPLETED|Dose-reduced Open Label Treatment Period||0
3262833|NCT02590432|3997037|FG004|NOT COMPLETED|Dose-reduced Open Label Treatment Period||0
3262834|NCT02590432|3997038|FG005|NOT COMPLETED|Dose-reduced Open Label Treatment Period||0
3262835|NCT02590432|3997039|FG006|NOT COMPLETED|Dose-reduced Open Label Treatment Period||0
3262836|NCT02590432|3997040|FG007|NOT COMPLETED|Dose-reduced Open Label Treatment Period||18
3262837|NCT02590432|3997041|FG008|NOT COMPLETED|Dose-reduced Open Label Treatment Period||18
3262838|NCT02590562|3997053|FG000|STARTED|Overall Study||808
3262839|NCT02590562|3997053|FG000|COMPLETED|Overall Study||802
3262840|NCT02590562|3997053|FG000|NOT COMPLETED|Overall Study||6
3262841|NCT02590588|3997063|FG000|STARTED|Overall Study||1
3262842|NCT02590588|3997063|FG000|COMPLETED|Overall Study||0
3262843|NCT02590588|3997063|FG000|NOT COMPLETED|Overall Study||1
3262844|NCT02590939|3997069|FG000|STARTED|Overall Study||52
3262845|NCT02590939|3997070|FG001|STARTED|Overall Study||54
3262846|NCT02590939|3997069|FG000|COMPLETED|Overall Study||47
3262847|NCT02590939|3997070|FG001|COMPLETED|Overall Study||52
3262848|NCT02590939|3997069|FG000|NOT COMPLETED|Overall Study||5
3262849|NCT02590939|3997070|FG001|NOT COMPLETED|Overall Study||2
3262850|NCT02591056|3997076|FG000|STARTED|Overall Study||27
3262851|NCT02591056|3997076|FG000|COMPLETED|Overall Study||27
3262852|NCT02591056|3997076|FG000|NOT COMPLETED|Overall Study||0
3262853|NCT02591238|3997084|FG000|STARTED|Overall Study||16
3262854|NCT02591238|3997085|FG001|STARTED|Overall Study||17
3262855|NCT02591238|3997086|FG002|STARTED|Overall Study||17
3262856|NCT02591238|3997087|FG003|STARTED|Overall Study||18
3262857|NCT02591238|3997084|FG000|COMPLETED|Overall Study||15
3262858|NCT02591238|3997085|FG001|COMPLETED|Overall Study||16
3262859|NCT02591238|3997086|FG002|COMPLETED|Overall Study||17
3262860|NCT02591238|3997087|FG003|COMPLETED|Overall Study||15
3262861|NCT02591238|3997084|FG000|NOT COMPLETED|Overall Study||1
3262862|NCT02591238|3997085|FG001|NOT COMPLETED|Overall Study||1
3262863|NCT02591238|3997086|FG002|NOT COMPLETED|Overall Study||0
3262864|NCT02591238|3997087|FG003|NOT COMPLETED|Overall Study||3
3262865|NCT02591290|3997097|FG000|STARTED|Overall Study||60
3262866|NCT02591290|3997097|FG000|Vaccinated Dose 1|Overall Study||60
3262867|NCT02591290|3997097|FG000|Vaccinated Dose 2|Overall Study||58
3262868|NCT02591290|3997097|FG000|COMPLETED|Overall Study||58
3262869|NCT02591290|3997097|FG000|NOT COMPLETED|Overall Study||2
3262870|NCT02591511|3997103|FG000|STARTED|Overall Study||30
3262871|NCT02591511|3997104|FG001|STARTED|Overall Study||33
3262872|NCT02591511|3997103|FG000|COMPLETED|Overall Study||30
3262873|NCT02591511|3997104|FG001|COMPLETED|Overall Study||33
3262874|NCT02591511|3997103|FG000|NOT COMPLETED|Overall Study||0
3262875|NCT02591511|3997104|FG001|NOT COMPLETED|Overall Study||0
3262876|NCT02591537|3997112|FG000|STARTED|Overall Study||8
3262877|NCT02591537|3997113|FG001|STARTED|Overall Study||8
3262878|NCT02591537|3997112|FG000|COMPLETED|Overall Study||8
3262879|NCT02591537|3997113|FG001|COMPLETED|Overall Study||8
3262880|NCT02591537|3997112|FG000|NOT COMPLETED|Overall Study||0
3262881|NCT02591537|3997113|FG001|NOT COMPLETED|Overall Study||0
3262882|NCT02592018|3997120|FG000|STARTED|Overall Study||15
3262883|NCT02592018|3997120|FG000|COMPLETED|Overall Study||13
3262884|NCT02592018|3997120|FG000|NOT COMPLETED|Overall Study||2
3262885|NCT02592421|3997126|FG000|STARTED|Study 1||20
3262886|NCT02592421|3997127|FG001|STARTED|Study 1||10
3262887|NCT02592421|3997126|FG000|COMPLETED|Study 1||20
3262888|NCT02592421|3997127|FG001|COMPLETED|Study 1||10
3262889|NCT02592421|3997126|FG000|NOT COMPLETED|Study 1||0
3262890|NCT02592421|3997127|FG001|NOT COMPLETED|Study 1||0
3262891|NCT02592421|3997126|FG000|STARTED|Study 2: Glucose Clamp Conditions||20
3262892|NCT02592421|3997127|FG001|STARTED|Study 2: Glucose Clamp Conditions||10
3262893|NCT02592421|3997126|FG000|COMPLETED|Study 2: Glucose Clamp Conditions||20
3262894|NCT02592421|3997127|FG001|COMPLETED|Study 2: Glucose Clamp Conditions||10
3262895|NCT02592421|3997126|FG000|NOT COMPLETED|Study 2: Glucose Clamp Conditions||0
3262896|NCT02592421|3997127|FG001|NOT COMPLETED|Study 2: Glucose Clamp Conditions||0
3262897|NCT02592421|3997126|FG000|STARTED|Study 3: Pancreatic Clamp Conditions||20
3262898|NCT02592421|3997127|FG001|STARTED|Study 3: Pancreatic Clamp Conditions||10
3262899|NCT02592421|3997126|FG000|COMPLETED|Study 3: Pancreatic Clamp Conditions||20
3262900|NCT02592421|3997127|FG001|COMPLETED|Study 3: Pancreatic Clamp Conditions||10
3262901|NCT02592421|3997126|FG000|NOT COMPLETED|Study 3: Pancreatic Clamp Conditions||0
3262902|NCT02592421|3997127|FG001|NOT COMPLETED|Study 3: Pancreatic Clamp Conditions||0
3262903|NCT02592434|3997133|FG000|STARTED|Open-Label Phase (18 Weeks)||225
3262904|NCT02592434|3997134|FG001|STARTED|Open-Label Phase (18 Weeks)||0
3262905|NCT02592434|3997135|FG002|STARTED|Open-Label Phase (18 Weeks)||0
3262906|NCT02592434|3997133|FG000|Treated|Open-Label Phase (18 Weeks)||225
3262907|NCT02592434|3997134|FG001|Treated|Open-Label Phase (18 Weeks)||0
3262908|NCT02592434|3997135|FG002|Treated|Open-Label Phase (18 Weeks)||0
3262909|NCT02592434|3997133|FG000|COMPLETED|Open-Label Phase (18 Weeks)||185
3262910|NCT02592434|3997134|FG001|COMPLETED|Open-Label Phase (18 Weeks)||0
3262911|NCT02592434|3997135|FG002|COMPLETED|Open-Label Phase (18 Weeks)||0
3262912|NCT02592434|3997133|FG000|NOT COMPLETED|Open-Label Phase (18 Weeks)||40
3262913|NCT02592434|3997134|FG001|NOT COMPLETED|Open-Label Phase (18 Weeks)||0
3262914|NCT02592434|3997135|FG002|NOT COMPLETED|Open-Label Phase (18 Weeks)||0
3262915|NCT02592434|3997133|FG000|STARTED|Double Blind Phase (26 Weeks)||0
3262916|NCT02592434|3997134|FG001|STARTED|Double Blind Phase (26 Weeks)|Only those participants who completed OL phase, achieved at least a JIA ACR 30 response in OL phase.|88
3262917|NCT02592434|3997135|FG002|STARTED|Double Blind Phase (26 Weeks)|Only those participants who completed OL phase,achieved at least a JIA ACR 30 response in OL phase.|85
3262918|NCT02592434|3997133|FG000|Treated|Double Blind Phase (26 Weeks)||0
3262919|NCT02592434|3997134|FG001|Treated|Double Blind Phase (26 Weeks)||88
3262920|NCT02592434|3997135|FG002|Treated|Double Blind Phase (26 Weeks)||85
3262921|NCT02592434|3997133|FG000|COMPLETED|Double Blind Phase (26 Weeks)||0
3262922|NCT02592434|3997134|FG001|COMPLETED|Double Blind Phase (26 Weeks)||61
3262923|NCT02592434|3997135|FG002|COMPLETED|Double Blind Phase (26 Weeks)||38
3262924|NCT02592434|3997133|FG000|NOT COMPLETED|Double Blind Phase (26 Weeks)||0
3262925|NCT02592434|3997134|FG001|NOT COMPLETED|Double Blind Phase (26 Weeks)||27
3262926|NCT02592434|3997135|FG002|NOT COMPLETED|Double Blind Phase (26 Weeks)||47
3262927|NCT02592447|3997145|FG000|STARTED|Overall Study||29
3262928|NCT02592447|3997146|FG001|STARTED|Overall Study||15
3262929|NCT02592447|3997145|FG000|COMPLETED|Overall Study||27
3262930|NCT02592447|3997146|FG001|COMPLETED|Overall Study||14
3262931|NCT02592447|3997145|FG000|NOT COMPLETED|Overall Study||2
3262932|NCT02592447|3997146|FG001|NOT COMPLETED|Overall Study||1
3262933|NCT02592486|3997154|FG000|STARTED|Overall Study||81
3262934|NCT02592486|3997155|FG001|STARTED|Overall Study||81
3262935|NCT02592486|3997154|FG000|COMPLETED|Overall Study||81
3262936|NCT02592486|3997155|FG001|COMPLETED|Overall Study||76
3262937|NCT02592486|3997154|FG000|NOT COMPLETED|Overall Study||0
3262938|NCT02592486|3997155|FG001|NOT COMPLETED|Overall Study||5
3262939|NCT02592629|3997164|FG000|STARTED|Overall Study||5
3262940|NCT02592629|3997165|FG001|STARTED|Overall Study||9
3262941|NCT02592629|3997166|FG002|STARTED|Overall Study||5
3262942|NCT02592629|3997164|FG000|COMPLETED|Overall Study||5
3262943|NCT02592629|3997165|FG001|COMPLETED|Overall Study||9
3262944|NCT02592629|3997166|FG002|COMPLETED|Overall Study||5
3262945|NCT02592629|3997164|FG000|NOT COMPLETED|Overall Study||0
3262946|NCT02592629|3997165|FG001|NOT COMPLETED|Overall Study||0
3262947|NCT02592629|3997166|FG002|NOT COMPLETED|Overall Study||0
3262948|NCT02592655|3997176|FG000|STARTED|First Tourniquet, Left Thigh.||19
3262949|NCT02592655|3997176|FG000|ATS (Pneumatic)|First Tourniquet, Left Thigh.||5
3262950|NCT02592655|3997176|FG000|Windlass Tourniquet|First Tourniquet, Left Thigh.||7
3262951|NCT02592655|3997176|FG000|Tourniquet Tape 10 cm Width|First Tourniquet, Left Thigh.||5
3262952|NCT02592655|3997176|FG000|Tourniquet Tape 5 cm Width|First Tourniquet, Left Thigh.||2
3262953|NCT02592655|3997176|FG000|COMPLETED|First Tourniquet, Left Thigh.||19
3262954|NCT02592655|3997176|FG000|NOT COMPLETED|First Tourniquet, Left Thigh.||0
3262955|NCT02592655|3997176|FG000|STARTED|Second Tourniquet Right Thigh.||19
3262956|NCT02592655|3997176|FG000|ATS (Pneumatic)|Second Tourniquet Right Thigh.||5
3262957|NCT02592655|3997176|FG000|Windlass Tourniquet|Second Tourniquet Right Thigh.||8
3262958|NCT02592655|3997176|FG000|Tourniquet Tape 10 cm Width|Second Tourniquet Right Thigh.||5
3262959|NCT02592655|3997176|FG000|Tourniquet Tape 5 cm Width|Second Tourniquet Right Thigh.||1
3262960|NCT02592655|3997176|FG000|COMPLETED|Second Tourniquet Right Thigh.||19
3262961|NCT02592655|3997176|FG000|NOT COMPLETED|Second Tourniquet Right Thigh.||0
3262962|NCT02592655|3997176|FG000|STARTED|Third Tourniquet, Left Thigh.||19
3262963|NCT02592655|3997176|FG000|ATS (Pneumatic)|Third Tourniquet, Left Thigh.||8
3262964|NCT02592655|3997176|FG000|Windlass Tourniquet|Third Tourniquet, Left Thigh.||4
3262965|NCT02592655|3997176|FG000|Tourniquet Tape 10 cm Width|Third Tourniquet, Left Thigh.||6
3262966|NCT02592655|3997176|FG000|Tourniquet Tape 5 cm Width|Third Tourniquet, Left Thigh.||1
3262967|NCT02592655|3997176|FG000|COMPLETED|Third Tourniquet, Left Thigh.||19
3262968|NCT02592655|3997176|FG000|NOT COMPLETED|Third Tourniquet, Left Thigh.||0
3262969|NCT02592655|3997176|FG000|STARTED|Fourth Tourniquet Right Thigh.|Only the first 4 participants received all four interventions.|4
3262970|NCT02592655|3997176|FG000|ATS (Pneumatic)|Fourth Tourniquet Right Thigh.||1
3262971|NCT02592655|3997176|FG000|Windlass Tourniquet|Fourth Tourniquet Right Thigh.||0
3262972|NCT02592655|3997176|FG000|Tourniquet Tape 10 cm Width|Fourth Tourniquet Right Thigh.||3
3262973|NCT02592655|3997176|FG000|Tourniquet Tape 5 cm Width|Fourth Tourniquet Right Thigh.||0
3262974|NCT02592655|3997176|FG000|COMPLETED|Fourth Tourniquet Right Thigh.||4
3262975|NCT02592655|3997176|FG000|NOT COMPLETED|Fourth Tourniquet Right Thigh.||0
3262976|NCT02592798|3997193|FG000|STARTED|Double-Blind Period 1 (DB1)||17
3262977|NCT02592798|3997194|FG001|STARTED|Double-Blind Period 1 (DB1)||19
3262978|NCT02592798|3997193|FG000|COMPLETED|Double-Blind Period 1 (DB1)||14
3262979|NCT02592798|3997194|FG001|COMPLETED|Double-Blind Period 1 (DB1)||13
3262980|NCT02592798|3997193|FG000|NOT COMPLETED|Double-Blind Period 1 (DB1)||3
3262981|NCT02592798|3997194|FG001|NOT COMPLETED|Double-Blind Period 1 (DB1)||6
3262982|NCT02592798|3997193|FG000|STARTED|Transition From DB1 to DB2||14
3262983|NCT02592798|3997194|FG001|STARTED|Transition From DB1 to DB2||13
3262984|NCT02592798|3997193|FG000|COMPLETED|Transition From DB1 to DB2||11
3262985|NCT02592798|3997194|FG001|COMPLETED|Transition From DB1 to DB2||11
3262986|NCT02592798|3997193|FG000|NOT COMPLETED|Transition From DB1 to DB2||3
3262987|NCT02592798|3997194|FG001|NOT COMPLETED|Transition From DB1 to DB2||2
3262988|NCT02592798|3997193|FG000|STARTED|Double-Blind Period 2 (DB2)||11
3262989|NCT02592798|3997194|FG001|STARTED|Double-Blind Period 2 (DB2)||11
3262990|NCT02592798|3997193|FG000|COMPLETED|Double-Blind Period 2 (DB2)||6
3262991|NCT02592798|3997194|FG001|COMPLETED|Double-Blind Period 2 (DB2)||9
3262992|NCT02592798|3997193|FG000|NOT COMPLETED|Double-Blind Period 2 (DB2)||5
3262993|NCT02592798|3997194|FG001|NOT COMPLETED|Double-Blind Period 2 (DB2)||2
3262994|NCT02592798|3997193|FG000|STARTED|Transition From DB2 to OLE||6
3262995|NCT02592798|3997194|FG001|STARTED|Transition From DB2 to OLE||9
3262996|NCT02592798|3997193|FG000|COMPLETED|Transition From DB2 to OLE||5
3262997|NCT02592798|3997194|FG001|COMPLETED|Transition From DB2 to OLE||9
3262998|NCT02592798|3997193|FG000|NOT COMPLETED|Transition From DB2 to OLE||1
3262999|NCT02592798|3997194|FG001|NOT COMPLETED|Transition From DB2 to OLE||0
3263000|NCT02592798|3997193|FG000|STARTED|Open Label Period (OLE)||10
3263001|NCT02592798|3997194|FG001|STARTED|Open Label Period (OLE)||13
3263002|NCT02592798|3997193|FG000|COMPLETED|Open Label Period (OLE)||6
3263003|NCT02592798|3997194|FG001|COMPLETED|Open Label Period (OLE)||4
3263004|NCT02592798|3997193|FG000|NOT COMPLETED|Open Label Period (OLE)||4
3263005|NCT02592798|3997194|FG001|NOT COMPLETED|Open Label Period (OLE)||9
3263006|NCT02592876|3997209|FG000|STARTED|Overall Study||41
3263007|NCT02592876|3997210|FG001|STARTED|Overall Study||40
3263008|NCT02592876|3997209|FG000|Received Study Drug|Overall Study||40
3263009|NCT02592876|3997210|FG001|Received Study Drug|Overall Study||40
3263010|NCT02592876|3997209|FG000|Completed Treatment|Overall Study||34
3263011|NCT02592876|3997210|FG001|Completed Treatment|Overall Study||32
3263012|NCT02592876|3997209|FG000|COMPLETED|Overall Study||0
3263013|NCT02592876|3997210|FG001|COMPLETED|Overall Study||0
3263014|NCT02592876|3997209|FG000|NOT COMPLETED|Overall Study||41
3263015|NCT02592876|3997210|FG001|NOT COMPLETED|Overall Study||40
3263016|NCT02593006|3997219|FG000|STARTED|Overall Study||257
3263017|NCT02593006|3997220|FG001|STARTED|Overall Study||100
3263018|NCT02593006|3997221|FG002|STARTED|Overall Study||43
3263019|NCT02593006|3997219|FG000|COMPLETED|Overall Study||250
3263020|NCT02593006|3997220|FG001|COMPLETED|Overall Study||93
3263021|NCT02593006|3997221|FG002|COMPLETED|Overall Study||38
3263022|NCT02593006|3997219|FG000|NOT COMPLETED|Overall Study||7
3263023|NCT02593006|3997220|FG001|NOT COMPLETED|Overall Study||7
3263024|NCT02593006|3997221|FG002|NOT COMPLETED|Overall Study||5
3263025|NCT02593032|3997232|FG000|STARTED|Overall Study||17
3263026|NCT02593032|3997233|FG001|STARTED|Overall Study||33
3263027|NCT02593032|3997232|FG000|COMPLETED|Overall Study||17
3263028|NCT02593032|3997233|FG001|COMPLETED|Overall Study||33
3263029|NCT02593032|3997232|FG000|NOT COMPLETED|Overall Study||0
3263030|NCT02593032|3997233|FG001|NOT COMPLETED|Overall Study||0
3263031|NCT02593097|3997241|FG000|STARTED|First Intervention (12 Weeks)||14
3263032|NCT02593097|3997242|FG001|STARTED|First Intervention (12 Weeks)||20
3263033|NCT02593097|3997241|FG000|Received Intervention|First Intervention (12 Weeks)||14
3263034|NCT02593097|3997242|FG001|Received Intervention|First Intervention (12 Weeks)||20
3263035|NCT02593097|3997241|FG000|COMPLETED|First Intervention (12 Weeks)||12
3263036|NCT02593097|3997242|FG001|COMPLETED|First Intervention (12 Weeks)||16
3263037|NCT02593097|3997241|FG000|NOT COMPLETED|First Intervention (12 Weeks)||2
3263038|NCT02593097|3997242|FG001|NOT COMPLETED|First Intervention (12 Weeks)||4
3263039|NCT02593097|3997241|FG000|STARTED|Washout (4 Weeks)||12
3263040|NCT02593097|3997242|FG001|STARTED|Washout (4 Weeks)||16
3263041|NCT02593097|3997241|FG000|COMPLETED|Washout (4 Weeks)||12
3263042|NCT02593097|3997242|FG001|COMPLETED|Washout (4 Weeks)||16
3263043|NCT02593097|3997241|FG000|NOT COMPLETED|Washout (4 Weeks)||0
3263044|NCT02593097|3997242|FG001|NOT COMPLETED|Washout (4 Weeks)||0
3263045|NCT02593097|3997241|FG000|STARTED|Second Intervention (12 Weeks)||12
3263046|NCT02593097|3997242|FG001|STARTED|Second Intervention (12 Weeks)||16
3263047|NCT02593097|3997241|FG000|COMPLETED|Second Intervention (12 Weeks)||9
3263048|NCT02593097|3997242|FG001|COMPLETED|Second Intervention (12 Weeks)||15
3263049|NCT02593097|3997241|FG000|NOT COMPLETED|Second Intervention (12 Weeks)||3
3263050|NCT02593097|3997242|FG001|NOT COMPLETED|Second Intervention (12 Weeks)||1
3263051|NCT02593149|3997250|FG000|STARTED|Run-In||340
3263052|NCT02593149|3997251|FG001|STARTED|Run-In||361
3263053|NCT02593149|3997250|FG000|COMPLETED|Run-In||304
3263054|NCT02593149|3997251|FG001|COMPLETED|Run-In||323
3263055|NCT02593149|3997250|FG000|NOT COMPLETED|Run-In||36
3263056|NCT02593149|3997251|FG001|NOT COMPLETED|Run-In||38
3263057|NCT02593149|3997250|FG000|STARTED|Intervention||942
3263058|NCT02593149|3997251|FG001|STARTED|Intervention||960
3263059|NCT02593149|3997250|FG000|COMPLETED|Intervention||826
3263060|NCT02593149|3997251|FG001|COMPLETED|Intervention||845
3263061|NCT02593149|3997250|FG000|NOT COMPLETED|Intervention||116
3263062|NCT02593149|3997251|FG001|NOT COMPLETED|Intervention||115
3263063|NCT02593305|3997260|FG000|STARTED|Baseline 1||7
3263064|NCT02593305|3997261|FG001|STARTED|Baseline 1||6
3263065|NCT02593305|3997262|FG002|STARTED|Baseline 1||10
3263066|NCT02593305|3997260|FG000|COMPLETED|Baseline 1||7
3263067|NCT02593305|3997261|FG001|COMPLETED|Baseline 1||6
3263068|NCT02593305|3997262|FG002|COMPLETED|Baseline 1||10
3263069|NCT02593305|3997260|FG000|NOT COMPLETED|Baseline 1||0
3263070|NCT02593305|3997261|FG001|NOT COMPLETED|Baseline 1||0
3263071|NCT02593305|3997262|FG002|NOT COMPLETED|Baseline 1||0
3263072|NCT02593305|3997260|FG000|STARTED|Post 1||7
3263073|NCT02593305|3997261|FG001|STARTED|Post 1||6
3263074|NCT02593305|3997262|FG002|STARTED|Post 1||10
3263075|NCT02593305|3997260|FG000|COMPLETED|Post 1||7
3263076|NCT02593305|3997261|FG001|COMPLETED|Post 1||6
3263077|NCT02593305|3997262|FG002|COMPLETED|Post 1||0
3263078|NCT02593305|3997260|FG000|NOT COMPLETED|Post 1||0
3263079|NCT02593305|3997261|FG001|NOT COMPLETED|Post 1||0
3263080|NCT02593305|3997262|FG002|NOT COMPLETED|Post 1||10
3263081|NCT02593305|3997260|FG000|STARTED|Baseline 2||7
3263082|NCT02593305|3997261|FG001|STARTED|Baseline 2||6
3263083|NCT02593305|3997262|FG002|STARTED|Baseline 2||0
3263084|NCT02593305|3997260|FG000|COMPLETED|Baseline 2||7
3263085|NCT02593305|3997261|FG001|COMPLETED|Baseline 2||6
3263086|NCT02593305|3997262|FG002|COMPLETED|Baseline 2||0
3263087|NCT02593305|3997260|FG000|NOT COMPLETED|Baseline 2||0
3263088|NCT02593305|3997261|FG001|NOT COMPLETED|Baseline 2||0
3263089|NCT02593305|3997262|FG002|NOT COMPLETED|Baseline 2||0
3263090|NCT02593305|3997260|FG000|STARTED|Post 2||7
3263091|NCT02593305|3997261|FG001|STARTED|Post 2||6
3263092|NCT02593305|3997262|FG002|STARTED|Post 2||0
3263093|NCT02593305|3997260|FG000|COMPLETED|Post 2||7
3263094|NCT02593305|3997261|FG001|COMPLETED|Post 2||6
3263095|NCT02593305|3997262|FG002|COMPLETED|Post 2||0
3263096|NCT02593305|3997260|FG000|NOT COMPLETED|Post 2||0
3263097|NCT02593305|3997261|FG001|NOT COMPLETED|Post 2||0
3263098|NCT02593305|3997262|FG002|NOT COMPLETED|Post 2||0
3263099|NCT02593318|3997273|FG000|STARTED|Overall Study||16
3263100|NCT02593318|3997274|FG001|STARTED|Overall Study||16
3263101|NCT02593318|3997273|FG000|COMPLETED|Overall Study||15
3263102|NCT02593318|3997274|FG001|COMPLETED|Overall Study||15
3263103|NCT02593318|3997273|FG000|NOT COMPLETED|Overall Study||1
3263104|NCT02593318|3997274|FG001|NOT COMPLETED|Overall Study||1
3263105|NCT02593396|3997288|FG000|STARTED|Overall Study||40
3263106|NCT02593396|3997289|FG001|STARTED|Overall Study||40
3263107|NCT02593396|3997288|FG000|At Least Done One Efficacy Assessment|Overall Study||36
3263108|NCT02593396|3997289|FG001|At Least Done One Efficacy Assessment|Overall Study||36
3373823|NCT02343263|4106247|FG000|COMPLETED|Overall Study|Study closed due for administrative reasons|0
3373824|NCT02343263|4106248|FG001|COMPLETED|Overall Study||0
3373825|NCT02343263|4106249|FG002|COMPLETED|Overall Study||0
3373826|NCT02343263|4106247|FG000|NOT COMPLETED|Overall Study||5
3373827|NCT02343263|4106248|FG001|NOT COMPLETED|Overall Study||3
3373828|NCT02343263|4106249|FG002|NOT COMPLETED|Overall Study||1
3373829|NCT02343159|4106264|FG000|STARTED|Overall Study||27
3373830|NCT02343159|4106265|FG001|STARTED|Overall Study||27
3373831|NCT02343159|4106266|FG002|STARTED|Overall Study||30
3373832|NCT02343159|4106264|FG000|COMPLETED|Overall Study||1
3373833|NCT02343159|4106265|FG001|COMPLETED|Overall Study||1
3373834|NCT02343159|4106266|FG002|COMPLETED|Overall Study||0
3373835|NCT02343159|4106264|FG000|NOT COMPLETED|Overall Study||26
3373836|NCT02343159|4106265|FG001|NOT COMPLETED|Overall Study||26
3373837|NCT02343159|4106266|FG002|NOT COMPLETED|Overall Study||30
3373838|NCT02341495|4106275|FG000|STARTED|Overall Study||4
3373839|NCT02341495|4106275|FG000|COMPLETED|Overall Study||4
3373840|NCT02341495|4106275|FG000|NOT COMPLETED|Overall Study||0
3373841|NCT02336425|4106283|FG000|STARTED|Overall Study||2
3373842|NCT02336425|4106284|FG001|STARTED|Overall Study||2
3373843|NCT02336425|4106285|FG002|STARTED|Overall Study||3
3373844|NCT02336425|4106286|FG003|STARTED|Overall Study||3
3373845|NCT02336425|4106283|FG000|COMPLETED|Overall Study||0
3373846|NCT02336425|4106284|FG001|COMPLETED|Overall Study||0
3373847|NCT02336425|4106285|FG002|COMPLETED|Overall Study||0
3373848|NCT02336425|4106286|FG003|COMPLETED|Overall Study||0
3373849|NCT02336425|4106283|FG000|NOT COMPLETED|Overall Study||2
3373850|NCT02336425|4106284|FG001|NOT COMPLETED|Overall Study||2
3373851|NCT02336425|4106285|FG002|NOT COMPLETED|Overall Study||3
3373852|NCT02336425|4106286|FG003|NOT COMPLETED|Overall Study||3
3373853|NCT02336763|4106296|FG000|STARTED|Overall Study||2
3373854|NCT02336763|4106296|FG000|COMPLETED|Overall Study||2
3373855|NCT02336763|4106296|FG000|NOT COMPLETED|Overall Study||0
3373856|NCT02320825|4106302|FG000|STARTED|Overall Study||8
3373857|NCT02320825|4106303|FG001|STARTED|Overall Study||8
3373858|NCT02320825|4106302|FG000|COMPLETED|Overall Study||8
3373859|NCT02320825|4106303|FG001|COMPLETED|Overall Study||8
3373860|NCT02320825|4106302|FG000|NOT COMPLETED|Overall Study||0
3373861|NCT02320825|4106303|FG001|NOT COMPLETED|Overall Study||0
3373862|NCT02319005|4106311|FG000|STARTED|Overall Study||140
3373863|NCT02319005|4106312|FG001|STARTED|Overall Study||66
3373864|NCT02319005|4106311|FG000|COMPLETED|Overall Study||92
3373865|NCT02319005|4106312|FG001|COMPLETED|Overall Study||51
3373866|NCT02319005|4106311|FG000|NOT COMPLETED|Overall Study||48
3373867|NCT02319005|4106312|FG001|NOT COMPLETED|Overall Study||15
3373868|NCT02318901|4106321|FG000|STARTED|Overall Study||5
3373869|NCT02318901|4106322|FG001|STARTED|Overall Study||1
3373870|NCT02318901|4106323|FG002|STARTED|Overall Study||10
3373871|NCT02318901|4106321|FG000|COMPLETED|Overall Study||0
3373872|NCT02318901|4106322|FG001|COMPLETED|Overall Study||0
3373873|NCT02318901|4106323|FG002|COMPLETED|Overall Study||0
3373874|NCT02318901|4106321|FG000|NOT COMPLETED|Overall Study||5
3373875|NCT02318901|4106322|FG001|NOT COMPLETED|Overall Study||1
3373876|NCT02318901|4106323|FG002|NOT COMPLETED|Overall Study||10
3263109|NCT02593396|3997288|FG000|COMPLETED|Overall Study||25
3263110|NCT02593396|3997289|FG001|COMPLETED|Overall Study||26
3263111|NCT02593396|3997288|FG000|NOT COMPLETED|Overall Study||15
3263112|NCT02593396|3997289|FG001|NOT COMPLETED|Overall Study||14
3263113|NCT02593539|3997295|FG000|STARTED|Overall Study||5
3263114|NCT02593539|3997295|FG000|COMPLETED|Overall Study||4
3263115|NCT02593539|3997295|FG000|NOT COMPLETED|Overall Study||1
3263116|NCT02593630|3997302|FG000|STARTED|Overall Study||54
3263117|NCT02593630|3997302|FG000|COMPLETED|Overall Study||53
3263118|NCT02593630|3997302|FG000|NOT COMPLETED|Overall Study||1
3263119|NCT02593773|3997307|FG000|STARTED|Overall Study||86
3263120|NCT02593773|3997307|FG000|COMPLETED|Overall Study||51
3263121|NCT02593773|3997307|FG000|NOT COMPLETED|Overall Study||35
3263122|NCT02593825|3997313|FG000|STARTED|Intervention||67
3263123|NCT02593825|3997314|FG001|STARTED|Intervention||67
3263124|NCT02593825|3997313|FG000|COMPLETED|Intervention||57
3263125|NCT02593825|3997314|FG001|COMPLETED|Intervention||55
3263126|NCT02593825|3997313|FG000|NOT COMPLETED|Intervention||10
3263127|NCT02593825|3997314|FG001|NOT COMPLETED|Intervention||12
3263128|NCT02593825|3997313|FG000|STARTED|Follow-up||57
3263129|NCT02593825|3997314|FG001|STARTED|Follow-up||55
3263130|NCT02593825|3997313|FG000|COMPLETED|Follow-up||57
3263131|NCT02593825|3997314|FG001|COMPLETED|Follow-up||55
3263132|NCT02593825|3997313|FG000|NOT COMPLETED|Follow-up||0
3263133|NCT02593825|3997314|FG001|NOT COMPLETED|Follow-up||0
3263134|NCT02593864|3997322|FG000|STARTED|Overall Study||25
3263135|NCT02593864|3997322|FG000|COMPLETED|Overall Study||19
3263136|NCT02593864|3997322|FG000|NOT COMPLETED|Overall Study||6
3263137|NCT02593903|3997328|FG000|STARTED|Overall Study||35
3263138|NCT02593903|3997329|FG001|STARTED|Overall Study||32
3263139|NCT02593903|3997328|FG000|COMPLETED|Overall Study||35
3263140|NCT02593903|3997329|FG001|COMPLETED|Overall Study||31
3263141|NCT02593903|3997328|FG000|NOT COMPLETED|Overall Study||0
3263142|NCT02593903|3997329|FG001|NOT COMPLETED|Overall Study||1
3263143|NCT02594098|3997337|FG000|STARTED|Overall Study||27
3263144|NCT02594098|3997338|FG001|STARTED|Overall Study||14
3263145|NCT02594098|3997337|FG000|COMPLETED|Overall Study||1
3263146|NCT02594098|3997338|FG001|COMPLETED|Overall Study||1
3263147|NCT02594098|3997337|FG000|NOT COMPLETED|Overall Study||26
3263148|NCT02594098|3997338|FG001|NOT COMPLETED|Overall Study||13
3263149|NCT02594111|3997348|FG000|STARTED|Overall Study||366
3263150|NCT02594111|3997349|FG001|STARTED|Overall Study||348
3263151|NCT02594111|3997348|FG000|COMPLETED|Overall Study||366
3263152|NCT02594111|3997349|FG001|COMPLETED|Overall Study||348
3263153|NCT02594111|3997348|FG000|NOT COMPLETED|Overall Study||0
3263154|NCT02594111|3997349|FG001|NOT COMPLETED|Overall Study||0
3263155|NCT02594163|3997357|FG000|STARTED|Treatment Period||12
3263156|NCT02594163|3997358|FG001|STARTED|Treatment Period||13
3263157|NCT02594163|3997357|FG000|COMPLETED|Treatment Period||5
3263158|NCT02594163|3997358|FG001|COMPLETED|Treatment Period||1
3263159|NCT02594163|3997357|FG000|NOT COMPLETED|Treatment Period||7
3263160|NCT02594163|3997358|FG001|NOT COMPLETED|Treatment Period||12
3263161|NCT02594163|3997357|FG000|STARTED|Follow-up Period|All participants were to be followed after treatment|12
3263162|NCT02594163|3997358|FG001|STARTED|Follow-up Period|All participants were to be followed after treatment|13
3263163|NCT02594163|3997357|FG000|COMPLETED|Follow-up Period||1
3263164|NCT02594163|3997358|FG001|COMPLETED|Follow-up Period||1
3263165|NCT02594163|3997357|FG000|NOT COMPLETED|Follow-up Period||11
3263166|NCT02594163|3997358|FG001|NOT COMPLETED|Follow-up Period||12
3263167|NCT02594644|3997366|FG000|STARTED|Overall Study||16
3263168|NCT02594644|3997367|FG001|STARTED|Overall Study||16
3263169|NCT02594644|3997366|FG000|COMPLETED|Overall Study||16
3263170|NCT02594644|3997367|FG001|COMPLETED|Overall Study||15
3263171|NCT02594644|3997366|FG000|NOT COMPLETED|Overall Study||0
3263172|NCT02594644|3997367|FG001|NOT COMPLETED|Overall Study||1
3263173|NCT02594826|3997385|FG000|STARTED|Overall Study||347
3263174|NCT02594826|3997386|FG001|STARTED|Overall Study||358
3263175|NCT02594826|3997385|FG000|COMPLETED|Overall Study||290
3263176|NCT02594826|3997386|FG001|COMPLETED|Overall Study||298
3263177|NCT02594826|3997385|FG000|NOT COMPLETED|Overall Study||57
3263178|NCT02594826|3997386|FG001|NOT COMPLETED|Overall Study||60
3263179|NCT02595008|3997394|FG000|STARTED|Overall Study||20
3263180|NCT02595008|3997395|FG001|STARTED|Overall Study||4
3263181|NCT02595008|3997394|FG000|COMPLETED|Overall Study||19
3263182|NCT02595008|3997395|FG001|COMPLETED|Overall Study||4
3263183|NCT02595008|3997394|FG000|NOT COMPLETED|Overall Study||1
3263184|NCT02595008|3997395|FG001|NOT COMPLETED|Overall Study||0
3263185|NCT02595073|3997403|FG000|STARTED|Overall Study||61
3263186|NCT02595073|3997404|FG001|STARTED|Overall Study||63
3263187|NCT02595073|3997403|FG000|COMPLETED|Overall Study||59
3263188|NCT02595073|3997404|FG001|COMPLETED|Overall Study||62
3263189|NCT02595073|3997403|FG000|NOT COMPLETED|Overall Study||2
3263190|NCT02595073|3997404|FG001|NOT COMPLETED|Overall Study||1
3263191|NCT02595398|3997412|FG000|STARTED|Overall Study||96
3263192|NCT02595398|3997413|FG001|STARTED|Overall Study||64
3263193|NCT02595398|3997412|FG000|Intention-to-Treat (ITT) Population|Overall Study||96
3263194|NCT02595398|3997413|FG001|Intention-to-Treat (ITT) Population|Overall Study||64
3263195|NCT02595398|3997412|FG000|Safety Population|Overall Study||96
3263196|NCT02595398|3997413|FG001|Safety Population|Overall Study||64
3263197|NCT02595398|3997412|FG000|COMPLETED|Overall Study||92
3263198|NCT02595398|3997413|FG001|COMPLETED|Overall Study||63
3263199|NCT02595398|3997412|FG000|NOT COMPLETED|Overall Study||4
3263200|NCT02595398|3997413|FG001|NOT COMPLETED|Overall Study||1
3263201|NCT02595437|3997419|FG000|STARTED|Triferic Via IV||22
3263202|NCT02595437|3997419|FG000|COMPLETED|Triferic Via IV||21
3263203|NCT02595437|3997419|FG000|NOT COMPLETED|Triferic Via IV||1
3263204|NCT02595437|3997419|FG000|STARTED|Triferic Via Hemodialysate||21
3263205|NCT02595437|3997419|FG000|COMPLETED|Triferic Via Hemodialysate||21
3263206|NCT02595437|3997419|FG000|NOT COMPLETED|Triferic Via Hemodialysate||0
3263207|NCT02595450|3997431|FG000|STARTED|Overall Study||299
3263208|NCT02595450|3997431|FG000|Treated|Overall Study||291
3263209|NCT02595450|3997431|FG000|COMPLETED|Overall Study||218
3263210|NCT02595450|3997431|FG000|NOT COMPLETED|Overall Study||81
3263211|NCT02595502|3997435|FG000|STARTED|Period 1||143
3263212|NCT02595502|3997436|FG001|STARTED|Period 1||142
3263213|NCT02595502|3997435|FG000|COMPLETED|Period 1||142
3263214|NCT02595502|3997436|FG001|COMPLETED|Period 1||140
3263215|NCT02595502|3997435|FG000|NOT COMPLETED|Period 1||1
3263216|NCT02595502|3997436|FG001|NOT COMPLETED|Period 1||2
3263217|NCT02595502|3997435|FG000|STARTED|Period 2||142
3263218|NCT02595502|3997436|FG001|STARTED|Period 2||140
3263219|NCT02595502|3997435|FG000|COMPLETED|Period 2||141
3263220|NCT02595502|3997436|FG001|COMPLETED|Period 2||138
3263221|NCT02595502|3997435|FG000|NOT COMPLETED|Period 2||1
3263222|NCT02595502|3997436|FG001|NOT COMPLETED|Period 2||2
3263223|NCT02595502|3997435|FG000|STARTED|Period 3||141
3263224|NCT02595502|3997436|FG001|STARTED|Period 3||138
3263225|NCT02595502|3997435|FG000|COMPLETED|Period 3||140
3263226|NCT02595502|3997436|FG001|COMPLETED|Period 3||136
3263227|NCT02595502|3997435|FG000|NOT COMPLETED|Period 3||1
3263228|NCT02595502|3997436|FG001|NOT COMPLETED|Period 3||2
3263229|NCT02595528|3997446|FG000|STARTED|Overall Study||41
3263230|NCT02595528|3997447|FG001|STARTED|Overall Study||40
3263231|NCT02595528|3997448|FG002|STARTED|Overall Study||42
3263232|NCT02595528|3997449|FG003|STARTED|Overall Study||40
3263233|NCT02595528|3997446|FG000|COMPLETED|Overall Study||39
3263234|NCT02595528|3997447|FG001|COMPLETED|Overall Study||37
3263235|NCT02595528|3997448|FG002|COMPLETED|Overall Study||41
3263236|NCT02595528|3997449|FG003|COMPLETED|Overall Study||36
3263237|NCT02595528|3997446|FG000|NOT COMPLETED|Overall Study||2
3263238|NCT02595528|3997447|FG001|NOT COMPLETED|Overall Study||3
3263239|NCT02595528|3997448|FG002|NOT COMPLETED|Overall Study||1
3263240|NCT02595528|3997449|FG003|NOT COMPLETED|Overall Study||4
3263241|NCT02595567|3997459|FG000|STARTED|Overall Study||25
3263242|NCT02595567|3997459|FG000|COMPLETED|Overall Study||25
3263243|NCT02595567|3997459|FG000|NOT COMPLETED|Overall Study||0
3373877|NCT02317276|4106331|FG000|STARTED|Overall Study||11
3373878|NCT02317276|4106331|FG000|COMPLETED|Overall Study||5
3373879|NCT02317276|4106331|FG000|NOT COMPLETED|Overall Study||6
3373880|NCT02307188|4106335|FG000|STARTED|Overall Study||5
3373881|NCT02307188|4106335|FG000|COMPLETED|Overall Study|Four of 5 patients did not meet required criteria to complete the study after they were enrolled.|1
3373882|NCT02307188|4106335|FG000|NOT COMPLETED|Overall Study||4
3373883|NCT02308475|4106339|FG000|STARTED|Overall Study||2
3373884|NCT02308475|4106339|FG000|COMPLETED|Overall Study||2
3373885|NCT02308475|4106339|FG000|NOT COMPLETED|Overall Study||0
3373886|NCT02308735|4106347|FG000|STARTED|Overall Study||2
3373887|NCT02308735|4106348|FG001|STARTED|Overall Study||0
3373888|NCT02308735|4106349|FG002|STARTED|Overall Study||0
3373889|NCT02308735|4106350|FG003|STARTED|Overall Study||2
3373890|NCT02308735|4106347|FG000|COMPLETED|Overall Study||0
3373891|NCT02308735|4106348|FG001|COMPLETED|Overall Study||0
3373892|NCT02308735|4106349|FG002|COMPLETED|Overall Study||0
3373893|NCT02308735|4106350|FG003|COMPLETED|Overall Study||0
3373894|NCT02308735|4106347|FG000|NOT COMPLETED|Overall Study||2
3373895|NCT02308735|4106348|FG001|NOT COMPLETED|Overall Study||0
3373896|NCT02308735|4106349|FG002|NOT COMPLETED|Overall Study||0
3373897|NCT02308735|4106350|FG003|NOT COMPLETED|Overall Study||2
3373898|NCT02299206|4106360|FG000|STARTED|Overall Study||4
3373899|NCT02299206|4106360|FG000|COMPLETED|Overall Study||2
3373900|NCT02299206|4106360|FG000|NOT COMPLETED|Overall Study||2
3373901|NCT02302859|4106366|FG000|STARTED|Overall Study||2
3373902|NCT02302859|4106367|FG001|STARTED|Overall Study||6
3373903|NCT02302859|4106366|FG000|COMPLETED|Overall Study||1
3373904|NCT02302859|4106367|FG001|COMPLETED|Overall Study||4
3373905|NCT02302859|4106366|FG000|NOT COMPLETED|Overall Study||1
3373906|NCT02302859|4106367|FG001|NOT COMPLETED|Overall Study||2
3373907|NCT02299934|4106373|FG000|STARTED|Overall Study||13
3373908|NCT02299934|4106373|FG000|COMPLETED|Overall Study||0
3373909|NCT02299934|4106373|FG000|NOT COMPLETED|Overall Study||13
3263244|NCT02595684|3997465|FG000|STARTED|Overall Study||9
3263245|NCT02595684|3997466|FG001|STARTED|Overall Study||9
3263246|NCT02595684|3997465|FG000|COMPLETED|Overall Study||9
3263247|NCT02595684|3997466|FG001|COMPLETED|Overall Study||9
3263248|NCT02595684|3997465|FG000|NOT COMPLETED|Overall Study||0
3263249|NCT02595684|3997466|FG001|NOT COMPLETED|Overall Study||0
3263250|NCT02595723|3997475|FG000|STARTED|First Intervention (4 Days)||8
3373910|NCT02297230|4106381|FG000|STARTED|Overall Study||11
3373911|NCT02297230|4106382|FG001|STARTED|Overall Study||11
3373912|NCT02297230|4106383|FG002|STARTED|Overall Study||11
3373913|NCT02297230|4106384|FG003|STARTED|Overall Study||11
3373914|NCT02297230|4106381|FG000|COMPLETED|Overall Study||11
3373915|NCT02297230|4106382|FG001|COMPLETED|Overall Study||11
3373916|NCT02297230|4106383|FG002|COMPLETED|Overall Study||11
3373917|NCT02297230|4106384|FG003|COMPLETED|Overall Study||11
3373918|NCT02297230|4106381|FG000|NOT COMPLETED|Overall Study||0
3373919|NCT02297230|4106382|FG001|NOT COMPLETED|Overall Study||0
3263251|NCT02595723|3997476|FG001|STARTED|First Intervention (4 Days)||6
3263252|NCT02595723|3997477|FG002|STARTED|First Intervention (4 Days)||7
3263253|NCT02595723|3997475|FG000|COMPLETED|First Intervention (4 Days)||8
3263254|NCT02595723|3997476|FG001|COMPLETED|First Intervention (4 Days)||6
3263255|NCT02595723|3997477|FG002|COMPLETED|First Intervention (4 Days)||7
3263256|NCT02595723|3997475|FG000|NOT COMPLETED|First Intervention (4 Days)||0
3263257|NCT02595723|3997476|FG001|NOT COMPLETED|First Intervention (4 Days)||0
3263258|NCT02595723|3997477|FG002|NOT COMPLETED|First Intervention (4 Days)||0
3263259|NCT02595723|3997475|FG000|STARTED|First Washout (21 Days)||8
3263260|NCT02595723|3997476|FG001|STARTED|First Washout (21 Days)||6
3263261|NCT02595723|3997477|FG002|STARTED|First Washout (21 Days)||7
3263262|NCT02595723|3997475|FG000|COMPLETED|First Washout (21 Days)||6
3263263|NCT02595723|3997476|FG001|COMPLETED|First Washout (21 Days)||6
3263264|NCT02595723|3997477|FG002|COMPLETED|First Washout (21 Days)||7
3263265|NCT02595723|3997475|FG000|NOT COMPLETED|First Washout (21 Days)||2
3263266|NCT02595723|3997476|FG001|NOT COMPLETED|First Washout (21 Days)||0
3263267|NCT02595723|3997477|FG002|NOT COMPLETED|First Washout (21 Days)||0
3263268|NCT02595723|3997475|FG000|STARTED|Second Intervention (4 Days)||6
3263269|NCT02595723|3997476|FG001|STARTED|Second Intervention (4 Days)||6
3263270|NCT02595723|3997477|FG002|STARTED|Second Intervention (4 Days)||7
3263271|NCT02595723|3997475|FG000|COMPLETED|Second Intervention (4 Days)||6
3263272|NCT02595723|3997476|FG001|COMPLETED|Second Intervention (4 Days)||6
3263273|NCT02595723|3997477|FG002|COMPLETED|Second Intervention (4 Days)||7
3263274|NCT02595723|3997475|FG000|NOT COMPLETED|Second Intervention (4 Days)||0
3263275|NCT02595723|3997476|FG001|NOT COMPLETED|Second Intervention (4 Days)||0
3263276|NCT02595723|3997477|FG002|NOT COMPLETED|Second Intervention (4 Days)||0
3263277|NCT02595723|3997475|FG000|STARTED|Second Washout (21 Days)||6
3263278|NCT02595723|3997476|FG001|STARTED|Second Washout (21 Days)||6
3263279|NCT02595723|3997477|FG002|STARTED|Second Washout (21 Days)||7
3263280|NCT02595723|3997475|FG000|COMPLETED|Second Washout (21 Days)||6
3263281|NCT02595723|3997476|FG001|COMPLETED|Second Washout (21 Days)||5
3263282|NCT02595723|3997477|FG002|COMPLETED|Second Washout (21 Days)||7
3263283|NCT02595723|3997475|FG000|NOT COMPLETED|Second Washout (21 Days)||0
3263284|NCT02595723|3997476|FG001|NOT COMPLETED|Second Washout (21 Days)||1
3263285|NCT02595723|3997477|FG002|NOT COMPLETED|Second Washout (21 Days)||0
3263286|NCT02595723|3997475|FG000|STARTED|Third Intervention (4 Days)||6
3263287|NCT02595723|3997476|FG001|STARTED|Third Intervention (4 Days)||5
3263288|NCT02595723|3997477|FG002|STARTED|Third Intervention (4 Days)||7
3263289|NCT02595723|3997475|FG000|COMPLETED|Third Intervention (4 Days)||6
3263290|NCT02595723|3997476|FG001|COMPLETED|Third Intervention (4 Days)||5
3263291|NCT02595723|3997477|FG002|COMPLETED|Third Intervention (4 Days)||7
3263292|NCT02595723|3997475|FG000|NOT COMPLETED|Third Intervention (4 Days)||0
3263293|NCT02595723|3997476|FG001|NOT COMPLETED|Third Intervention (4 Days)||0
3263294|NCT02595723|3997477|FG002|NOT COMPLETED|Third Intervention (4 Days)||0
3263295|NCT02595749|3997487|FG000|STARTED|Overall Study||45
3263296|NCT02595749|3997488|FG001|STARTED|Overall Study||38
3263297|NCT02595749|3997487|FG000|COMPLETED|Overall Study||33
3263298|NCT02595749|3997488|FG001|COMPLETED|Overall Study||31
3263299|NCT02595749|3997487|FG000|NOT COMPLETED|Overall Study||12
3263300|NCT02595749|3997488|FG001|NOT COMPLETED|Overall Study||7
3263301|NCT02595970|3997494|FG000|STARTED|Overall Study||120
3263302|NCT02595970|3997494|FG000|COMPLETED|Overall Study|Out of 100 patients who completed treatment period 2, 20 patients completed the extension period.|100
3263303|NCT02595970|3997494|FG000|NOT COMPLETED|Overall Study||20
3263304|NCT02595983|3997498|FG000|STARTED|Overall Study||12
3263305|NCT02595983|3997498|FG000|COMPLETED|Overall Study||8
3263306|NCT02595983|3997498|FG000|NOT COMPLETED|Overall Study||4
3263307|NCT02596009|3997503|FG000|STARTED|Overall Study||14
3263308|NCT02596009|3997504|FG001|STARTED|Overall Study||16
3263309|NCT02596009|3997505|FG002|STARTED|Overall Study||16
3263310|NCT02596009|3997506|FG003|STARTED|Overall Study||16
3263311|NCT02596009|3997507|FG004|STARTED|Overall Study||18
3263312|NCT02596009|3997508|FG005|STARTED|Overall Study||17
3263313|NCT02596009|3997503|FG000|COMPLETED|Overall Study||14
3263314|NCT02596009|3997504|FG001|COMPLETED|Overall Study||15
3263315|NCT02596009|3997505|FG002|COMPLETED|Overall Study||16
3263316|NCT02596009|3997506|FG003|COMPLETED|Overall Study||16
3263317|NCT02596009|3997507|FG004|COMPLETED|Overall Study||18
3263318|NCT02596009|3997508|FG005|COMPLETED|Overall Study||17
3263319|NCT02596009|3997503|FG000|NOT COMPLETED|Overall Study||0
3263320|NCT02596009|3997504|FG001|NOT COMPLETED|Overall Study||1
3263321|NCT02596009|3997505|FG002|NOT COMPLETED|Overall Study||0
3263322|NCT02596009|3997506|FG003|NOT COMPLETED|Overall Study||0
3263323|NCT02596009|3997507|FG004|NOT COMPLETED|Overall Study||0
3263324|NCT02596009|3997508|FG005|NOT COMPLETED|Overall Study||0
3263325|NCT02596022|3997516|FG000|STARTED|Overall Study||10
3263326|NCT02596022|3997517|FG001|STARTED|Overall Study||8
3263327|NCT02596022|3997516|FG000|COMPLETED|Overall Study||10
3263328|NCT02596022|3997517|FG001|COMPLETED|Overall Study||8
3263329|NCT02596022|3997516|FG000|NOT COMPLETED|Overall Study||0
3263330|NCT02596022|3997517|FG001|NOT COMPLETED|Overall Study||0
3263331|NCT02596035|3997526|FG000|STARTED|Overall Study||97
3263332|NCT02596035|3997527|FG001|STARTED|Overall Study||44
3263333|NCT02596035|3997528|FG002|STARTED|Overall Study||1
3263334|NCT02596035|3997526|FG000|COMPLETED|Overall Study||11
3263335|NCT02596035|3997527|FG001|COMPLETED|Overall Study||0
3263336|NCT02596035|3997528|FG002|COMPLETED|Overall Study||0
3263337|NCT02596035|3997526|FG000|NOT COMPLETED|Overall Study||86
3263338|NCT02596035|3997527|FG001|NOT COMPLETED|Overall Study||44
3263339|NCT02596035|3997528|FG002|NOT COMPLETED|Overall Study||1
3263340|NCT02596230|3997540|FG000|STARTED|Objective 1, One Visit During 14 Days||3714
3263341|NCT02596230|3997541|FG001|STARTED|Objective 1, One Visit During 14 Days||1006
3263342|NCT02596230|3997542|FG002|STARTED|Objective 1, One Visit During 14 Days||0
3263343|NCT02596230|3997543|FG003|STARTED|Objective 1, One Visit During 14 Days||1375
3263344|NCT02596230|3997544|FG004|STARTED|Objective 1, One Visit During 14 Days||0
3263345|NCT02596230|3997540|FG000|COMPLETED|Objective 1, One Visit During 14 Days||3714
3263346|NCT02596230|3997541|FG001|COMPLETED|Objective 1, One Visit During 14 Days||1006
3263347|NCT02596230|3997542|FG002|COMPLETED|Objective 1, One Visit During 14 Days||0
3373920|NCT02297230|4106383|FG002|NOT COMPLETED|Overall Study||0
3373921|NCT02297230|4106384|FG003|NOT COMPLETED|Overall Study||0
3373922|NCT02294981|4106400|FG000|STARTED|Overall Study||4
3373923|NCT02294981|4106400|FG000|COMPLETED|Overall Study||3
3373924|NCT02294981|4106400|FG000|NOT COMPLETED|Overall Study||1
3373925|NCT02284906|4106407|FG000|STARTED|Overall Study||3
3373926|NCT02284906|4106408|FG001|STARTED|Overall Study||18
3373927|NCT02284906|4106409|FG002|STARTED|Overall Study||19
3373928|NCT02284906|4106407|FG000|COMPLETED|Overall Study||0
3373929|NCT02284906|4106408|FG001|COMPLETED|Overall Study||0
3373930|NCT02284906|4106409|FG002|COMPLETED|Overall Study||0
3373931|NCT02284906|4106407|FG000|NOT COMPLETED|Overall Study||3
3373932|NCT02284906|4106408|FG001|NOT COMPLETED|Overall Study||18
3373933|NCT02284906|4106409|FG002|NOT COMPLETED|Overall Study||19
3373934|NCT02287025|4106419|FG000|STARTED|Overall Study||12
3373935|NCT02287025|4106420|FG001|STARTED|Overall Study||11
3373936|NCT02287025|4106419|FG000|COMPLETED|Overall Study||2
3373937|NCT02287025|4106420|FG001|COMPLETED|Overall Study||2
3373938|NCT02287025|4106419|FG000|NOT COMPLETED|Overall Study||10
3373939|NCT02287025|4106420|FG001|NOT COMPLETED|Overall Study||9
3373940|NCT02282332|4106424|FG000|STARTED|Overall Study|The PI has left the institution and no results data is available. Efforts were made to contact the PI/study team members, as well as to review data on shared drives, IRB historical records and published resources, but were unsuccessful. No study data are available|0
3373941|NCT02282332|4106424|FG000|COMPLETED|Overall Study|The PI has left the institution and no results data is available. Efforts were made to contact the PI/study team members, as well as to review data on shared drives, IRB historical records and published resources, but were unsuccessful. No study data are available|0
3373942|NCT02282332|4106424|FG000|NOT COMPLETED|Overall Study||0
3373943|NCT02287636|4106428|FG000|STARTED|Overall Study||13
3373944|NCT02287636|4106428|FG000|COMPLETED|Overall Study||13
3373945|NCT02287636|4106428|FG000|NOT COMPLETED|Overall Study||0
3373946|NCT02276560|4106435|FG000|STARTED|Overall Study||1
3373947|NCT02276560|4106436|FG001|STARTED|Overall Study||0
3373948|NCT02276560|4106437|FG002|STARTED|Overall Study||0
3373949|NCT02276560|4106435|FG000|COMPLETED|Overall Study||0
3373950|NCT02276560|4106436|FG001|COMPLETED|Overall Study||0
3373951|NCT02276560|4106437|FG002|COMPLETED|Overall Study||0
3373952|NCT02276560|4106435|FG000|NOT COMPLETED|Overall Study||1
3373953|NCT02276560|4106436|FG001|NOT COMPLETED|Overall Study||0
3373954|NCT02276560|4106437|FG002|NOT COMPLETED|Overall Study||0
3373955|NCT02280252|4106445|FG000|STARTED|Overall Study||0
3373956|NCT02280252|4106445|FG000|COMPLETED|Overall Study||0
3373957|NCT02280252|4106445|FG000|NOT COMPLETED|Overall Study||0
3373958|NCT02284373|4106452|FG000|STARTED|Overall Study||5
3373959|NCT02284373|4106453|FG001|STARTED|Overall Study||5
3373960|NCT02284373|4106454|FG002|STARTED|Overall Study||29
3373961|NCT02284373|4106452|FG000|COMPLETED|Overall Study||5
3373962|NCT02284373|4106453|FG001|COMPLETED|Overall Study||2
3373963|NCT02284373|4106454|FG002|COMPLETED|Overall Study||29
3373964|NCT02284373|4106452|FG000|NOT COMPLETED|Overall Study||0
3373965|NCT02284373|4106453|FG001|NOT COMPLETED|Overall Study||3
3373966|NCT02284373|4106454|FG002|NOT COMPLETED|Overall Study||0
3373967|NCT02285270|4106462|FG000|STARTED|Overall Study||10
3373968|NCT02285270|4106462|FG000|COMPLETED|Overall Study||5
3373969|NCT02285270|4106462|FG000|NOT COMPLETED|Overall Study||5
3373970|NCT02275481|4106468|FG000|STARTED|Overall Study||32
3373971|NCT02275481|4106469|FG001|STARTED|Overall Study||34
3373972|NCT02275481|4106468|FG000|COMPLETED|Overall Study||23
3373973|NCT02275481|4106469|FG001|COMPLETED|Overall Study||31
3373974|NCT02275481|4106468|FG000|NOT COMPLETED|Overall Study||9
3373975|NCT02275481|4106469|FG001|NOT COMPLETED|Overall Study||3
3373976|NCT02266914|4106475|FG000|STARTED|Overall Study||9
3373977|NCT02266914|4106475|FG000|COMPLETED|Overall Study||0
3373978|NCT02266914|4106475|FG000|NOT COMPLETED|Overall Study||9
3373979|NCT02273752|4106479|FG000|STARTED|Overall Study||2
3373980|NCT02273752|4106479|FG000|COMPLETED|Overall Study||0
3373981|NCT02273752|4106479|FG000|NOT COMPLETED|Overall Study||2
3373982|NCT02270684|4106485|FG000|STARTED|Overall Study||1
3373983|NCT02270684|4106486|FG001|STARTED|Overall Study||3
3373984|NCT02270684|4106485|FG000|COMPLETED|Overall Study||0
3373985|NCT02270684|4106486|FG001|COMPLETED|Overall Study||0
3373986|NCT02270684|4106485|FG000|NOT COMPLETED|Overall Study||1
3373987|NCT02270684|4106486|FG001|NOT COMPLETED|Overall Study||3
3373988|NCT02262000|4106494|FG000|STARTED|Overall Study||3
3373989|NCT02262000|4106495|FG001|STARTED|Overall Study||0
3373990|NCT02262000|4106494|FG000|COMPLETED|Overall Study||3
3373991|NCT02262000|4106495|FG001|COMPLETED|Overall Study||0
3373992|NCT02262000|4106494|FG000|NOT COMPLETED|Overall Study||0
3373993|NCT02262000|4106495|FG001|NOT COMPLETED|Overall Study||0
3263348|NCT02596230|3997543|FG003|COMPLETED|Objective 1, One Visit During 14 Days||1375
3263349|NCT02596230|3997544|FG004|COMPLETED|Objective 1, One Visit During 14 Days||0
3263350|NCT02596230|3997540|FG000|NOT COMPLETED|Objective 1, One Visit During 14 Days||0
3263351|NCT02596230|3997541|FG001|NOT COMPLETED|Objective 1, One Visit During 14 Days||0
3263352|NCT02596230|3997542|FG002|NOT COMPLETED|Objective 1, One Visit During 14 Days||0
3263353|NCT02596230|3997543|FG003|NOT COMPLETED|Objective 1, One Visit During 14 Days||0
3263354|NCT02596230|3997544|FG004|NOT COMPLETED|Objective 1, One Visit During 14 Days||0
3263355|NCT02596230|3997540|FG000|STARTED|Screening Period for Objective 2||3714
3263356|NCT02596230|3997541|FG001|STARTED|Screening Period for Objective 2||1006
3263357|NCT02596230|3997542|FG002|STARTED|Screening Period for Objective 2|Participants entering the study after the completion of objective 1.|910
3263358|NCT02596230|3997543|FG003|STARTED|Screening Period for Objective 2||1375
3263359|NCT02596230|3997544|FG004|STARTED|Screening Period for Objective 2|Participants entering the study after the completion of objective 1.|792
3263360|NCT02596230|3997540|FG000|COMPLETED|Screening Period for Objective 2||0
3263361|NCT02596230|3997541|FG001|COMPLETED|Screening Period for Objective 2||778
3263362|NCT02596230|3997542|FG002|COMPLETED|Screening Period for Objective 2||910
3263363|NCT02596230|3997543|FG003|COMPLETED|Screening Period for Objective 2||529
3263364|NCT02596230|3997544|FG004|COMPLETED|Screening Period for Objective 2||792
3263365|NCT02596230|3997540|FG000|NOT COMPLETED|Screening Period for Objective 2||3714
3263366|NCT02596230|3997541|FG001|NOT COMPLETED|Screening Period for Objective 2||228
3263367|NCT02596230|3997542|FG002|NOT COMPLETED|Screening Period for Objective 2||0
3263368|NCT02596230|3997543|FG003|NOT COMPLETED|Screening Period for Objective 2||846
3263369|NCT02596230|3997544|FG004|NOT COMPLETED|Screening Period for Objective 2||0
3263370|NCT02596230|3997540|FG000|STARTED|Objective 2, One Year||0
3263371|NCT02596230|3997541|FG001|STARTED|Objective 2, One Year||778
3263372|NCT02596230|3997542|FG002|STARTED|Objective 2, One Year||910
3263373|NCT02596230|3997543|FG003|STARTED|Objective 2, One Year||529
3263374|NCT02596230|3997544|FG004|STARTED|Objective 2, One Year||792
3263375|NCT02596230|3997540|FG000|COMPLETED|Objective 2, One Year||0
3263376|NCT02596230|3997541|FG001|COMPLETED|Objective 2, One Year||710
3263377|NCT02596230|3997542|FG002|COMPLETED|Objective 2, One Year||812
3263378|NCT02596230|3997543|FG003|COMPLETED|Objective 2, One Year||471
3263379|NCT02596230|3997544|FG004|COMPLETED|Objective 2, One Year||714
3263380|NCT02596230|3997540|FG000|NOT COMPLETED|Objective 2, One Year||0
3263381|NCT02596230|3997541|FG001|NOT COMPLETED|Objective 2, One Year||68
3263382|NCT02596230|3997542|FG002|NOT COMPLETED|Objective 2, One Year||98
3263383|NCT02596230|3997543|FG003|NOT COMPLETED|Objective 2, One Year||58
3263384|NCT02596230|3997544|FG004|NOT COMPLETED|Objective 2, One Year||78
3263385|NCT02596321|3997556|FG000|STARTED|Overall Study||56
3263386|NCT02596321|3997557|FG001|STARTED|Overall Study||56
3263387|NCT02596321|3997556|FG000|COMPLETED|Overall Study||53
3263388|NCT02596321|3997557|FG001|COMPLETED|Overall Study||56
3263389|NCT02596321|3997556|FG000|NOT COMPLETED|Overall Study||3
3263390|NCT02596321|3997557|FG001|NOT COMPLETED|Overall Study||0
3263391|NCT02596451|3997566|FG000|STARTED|Overall Study||385
3263392|NCT02596451|3997567|FG001|STARTED|Overall Study||392
3263393|NCT02596451|3997568|FG002|STARTED|Overall Study||387
3263394|NCT02596451|3997566|FG000|COMPLETED|Overall Study||381
3263395|NCT02596451|3997567|FG001|COMPLETED|Overall Study||374
3263396|NCT02596451|3997568|FG002|COMPLETED|Overall Study||373
3263397|NCT02596451|3997566|FG000|NOT COMPLETED|Overall Study||4
3263398|NCT02596451|3997567|FG001|NOT COMPLETED|Overall Study||18
3263399|NCT02596451|3997568|FG002|NOT COMPLETED|Overall Study||14
3263400|NCT02596620|3997577|FG000|STARTED|Overall Study|Started from 1st October 2013|82
3263401|NCT02596620|3997578|FG001|STARTED|Overall Study|Started from 1st October 2013|82
3263402|NCT02596620|3997577|FG000|COMPLETED|Overall Study|Completed on 30th September 2015|81
3263403|NCT02596620|3997578|FG001|COMPLETED|Overall Study|Completed on 30th September 2015|81
3263404|NCT02596620|3997577|FG000|NOT COMPLETED|Overall Study||1
3263405|NCT02596620|3997578|FG001|NOT COMPLETED|Overall Study||1
3263406|NCT02596711|3997587|FG000|STARTED|Overall Study||9
3263407|NCT02596711|3997588|FG001|STARTED|Overall Study||8
3263408|NCT02596711|3997589|FG002|STARTED|Overall Study||8
3263409|NCT02596711|3997587|FG000|Visit 2|Overall Study||9
3263410|NCT02596711|3997588|FG001|Visit 2|Overall Study||7
3263411|NCT02596711|3997589|FG002|Visit 2|Overall Study||6
3263412|NCT02596711|3997587|FG000|Visit 3|Overall Study||7
3263413|NCT02596711|3997588|FG001|Visit 3|Overall Study||8
3263414|NCT02596711|3997589|FG002|Visit 3|Overall Study||6
3263415|NCT02596711|3997587|FG000|3 Month Follow-up|Overall Study||8
3263416|NCT02596711|3997588|FG001|3 Month Follow-up|Overall Study||6
3263417|NCT02596711|3997589|FG002|3 Month Follow-up|Overall Study||6
3263418|NCT02596711|3997587|FG000|6 Month Follow-up|Overall Study||8
3263419|NCT02596711|3997588|FG001|6 Month Follow-up|Overall Study||6
3263420|NCT02596711|3997589|FG002|6 Month Follow-up|Overall Study||5
3263421|NCT02596711|3997587|FG000|COMPLETED|Overall Study||8
3263422|NCT02596711|3997588|FG001|COMPLETED|Overall Study||6
3263423|NCT02596711|3997589|FG002|COMPLETED|Overall Study||5
3263424|NCT02596711|3997587|FG000|NOT COMPLETED|Overall Study||1
3263425|NCT02596711|3997588|FG001|NOT COMPLETED|Overall Study||2
3263426|NCT02596711|3997589|FG002|NOT COMPLETED|Overall Study||3
3263427|NCT02596750|3997599|FG000|STARTED|Baseline||21
3263428|NCT02596750|3997600|FG001|STARTED|Baseline||21
3263429|NCT02596750|3997599|FG000|COMPLETED|Baseline||21
3263430|NCT02596750|3997600|FG001|COMPLETED|Baseline||21
3263431|NCT02596750|3997599|FG000|NOT COMPLETED|Baseline||0
3263432|NCT02596750|3997600|FG001|NOT COMPLETED|Baseline||0
3263433|NCT02596750|3997599|FG000|STARTED|2 Minutes||21
3263434|NCT02596750|3997600|FG001|STARTED|2 Minutes||21
3263435|NCT02596750|3997599|FG000|COMPLETED|2 Minutes||21
3263436|NCT02596750|3997600|FG001|COMPLETED|2 Minutes||21
3263437|NCT02596750|3997599|FG000|NOT COMPLETED|2 Minutes||0
3263438|NCT02596750|3997600|FG001|NOT COMPLETED|2 Minutes||0
3263439|NCT02596750|3997599|FG000|STARTED|5 Minutes||21
3263440|NCT02596750|3997600|FG001|STARTED|5 Minutes||21
3263441|NCT02596750|3997599|FG000|COMPLETED|5 Minutes||21
3263442|NCT02596750|3997600|FG001|COMPLETED|5 Minutes||21
3263443|NCT02596750|3997599|FG000|NOT COMPLETED|5 Minutes||0
3263444|NCT02596750|3997600|FG001|NOT COMPLETED|5 Minutes||0
3263445|NCT02596750|3997599|FG000|STARTED|10 Minutes||21
3263446|NCT02596750|3997600|FG001|STARTED|10 Minutes||21
3263447|NCT02596750|3997599|FG000|COMPLETED|10 Minutes||21
3263448|NCT02596750|3997600|FG001|COMPLETED|10 Minutes||21
3263449|NCT02596750|3997599|FG000|NOT COMPLETED|10 Minutes||0
3263450|NCT02596750|3997600|FG001|NOT COMPLETED|10 Minutes||0
3263451|NCT02596750|3997599|FG000|STARTED|30 Minutes||21
3263452|NCT02596750|3997600|FG001|STARTED|30 Minutes||21
3263453|NCT02596750|3997599|FG000|COMPLETED|30 Minutes||21
3263454|NCT02596750|3997600|FG001|COMPLETED|30 Minutes||21
3263455|NCT02596750|3997599|FG000|NOT COMPLETED|30 Minutes||0
3263456|NCT02596750|3997600|FG001|NOT COMPLETED|30 Minutes||0
3263457|NCT02596854|3997607|FG000|STARTED|Overall Study||117
3263458|NCT02596854|3997607|FG000|COMPLETED|Overall Study||109
3263459|NCT02596854|3997607|FG000|NOT COMPLETED|Overall Study||8
3373994|NCT02271594|4106503|FG000|STARTED|Overall Study||19
3373995|NCT02271594|4106504|FG001|STARTED|Overall Study||12
3373996|NCT02271594|4106503|FG000|COMPLETED|Overall Study|Study closed down|0
3373997|NCT02271594|4106504|FG001|COMPLETED|Overall Study|Study closed down|0
3373998|NCT02271594|4106503|FG000|NOT COMPLETED|Overall Study||19
3373999|NCT02271594|4106504|FG001|NOT COMPLETED|Overall Study||12
3374000|NCT02263365|4106514|FG000|STARTED|Overall Study||22
3374001|NCT02263365|4106515|FG001|STARTED|Overall Study||18
3374002|NCT02263365|4106514|FG000|COMPLETED|Overall Study||0
3374003|NCT02263365|4106515|FG001|COMPLETED|Overall Study||0
3374004|NCT02263365|4106514|FG000|NOT COMPLETED|Overall Study||22
3374005|NCT02263365|4106515|FG001|NOT COMPLETED|Overall Study||18
3374006|NCT02266797|4106524|FG000|STARTED|Overall Study||1
3374007|NCT02266797|4106525|FG001|STARTED|Overall Study||3
3374008|NCT02266797|4106524|FG000|COMPLETED|Overall Study||1
3374009|NCT02266797|4106525|FG001|COMPLETED|Overall Study||2
3374010|NCT02266797|4106524|FG000|NOT COMPLETED|Overall Study||0
3374011|NCT02266797|4106525|FG001|NOT COMPLETED|Overall Study||1
3374012|NCT02249377|4106533|FG000|STARTED|Overall Study||25
3374013|NCT02249377|4106534|FG001|STARTED|Overall Study||25
3374014|NCT02249377|4106533|FG000|COMPLETED|Overall Study||0
3374015|NCT02249377|4106534|FG001|COMPLETED|Overall Study||1
3374016|NCT02249377|4106533|FG000|NOT COMPLETED|Overall Study||25
3374017|NCT02249377|4106534|FG001|NOT COMPLETED|Overall Study||24
3374018|NCT02253394|4106540|FG000|STARTED|Overall Study||0
3374019|NCT02253394|4106541|FG001|STARTED|Overall Study|Ambrisentan 5 or 10 mg QD + placebo (90 d) first, then washout (21 d), then +Spiro 50 mg QD (90 d).|2
3374020|NCT02253394|4106540|FG000|COMPLETED|Overall Study||0
3374021|NCT02253394|4106541|FG001|COMPLETED|Overall Study||2
3374022|NCT02253394|4106540|FG000|NOT COMPLETED|Overall Study||0
3374023|NCT02253394|4106541|FG001|NOT COMPLETED|Overall Study||0
3374024|NCT02241551|4106549|FG000|STARTED|Overall Study||1
3374025|NCT02241551|4106550|FG001|STARTED|Overall Study||0
3374026|NCT02241551|4106549|FG000|COMPLETED|Overall Study||0
3374027|NCT02241551|4106550|FG001|COMPLETED|Overall Study||0
3374028|NCT02241551|4106549|FG000|NOT COMPLETED|Overall Study||1
3374029|NCT02241551|4106550|FG001|NOT COMPLETED|Overall Study||0
3374030|NCT02246114|4106560|FG000|STARTED|Overall Study||1
3374031|NCT02246114|4106561|FG001|STARTED|Overall Study||0
3374032|NCT02246114|4106560|FG000|COMPLETED|Overall Study||0
3374033|NCT02246114|4106561|FG001|COMPLETED|Overall Study||0
3374034|NCT02246114|4106560|FG000|NOT COMPLETED|Overall Study||1
3374035|NCT02246114|4106561|FG001|NOT COMPLETED|Overall Study||0
3374036|NCT02232880|4106567|FG000|STARTED|Overall Study||1
3374037|NCT02232880|4106567|FG000|COMPLETED|Overall Study||0
3374038|NCT02232880|4106567|FG000|NOT COMPLETED|Overall Study||1
3374039|NCT02248740|4106573|FG000|STARTED|Overall Study||18
3374040|NCT02248740|4106574|FG001|STARTED|Overall Study||18
3374041|NCT02248740|4106573|FG000|COMPLETED|Overall Study||0
3374042|NCT02248740|4106574|FG001|COMPLETED|Overall Study||0
3374043|NCT02248740|4106573|FG000|NOT COMPLETED|Overall Study||18
3374044|NCT02248740|4106574|FG001|NOT COMPLETED|Overall Study||18
3374045|NCT02239627|4106582|FG000|STARTED|Overall Study||0
3374046|NCT02239627|4106583|FG001|STARTED|Overall Study||0
3374047|NCT02239627|4106582|FG000|COMPLETED|Overall Study||0
3374048|NCT02239627|4106583|FG001|COMPLETED|Overall Study||0
3374049|NCT02239627|4106582|FG000|NOT COMPLETED|Overall Study||0
3374050|NCT02239627|4106583|FG001|NOT COMPLETED|Overall Study||0
3263460|NCT02596867|3997611|FG000|STARTED|Overall Study||2
3263461|NCT02596867|3997611|FG000|2 Patients Prospectively Recruited|Overall Study||2
3263462|NCT02596867|3997611|FG000|COMPLETED|Overall Study||2
3374051|NCT02244944|4106589|FG000|STARTED|Overall Study||2
3374052|NCT02244944|4106589|FG000|COMPLETED|Overall Study||0
3263463|NCT02596867|3997611|FG000|NOT COMPLETED|Overall Study||0
3263464|NCT02596893|3997620|FG000|STARTED|Overall Double-Blind Period Weeks 0-52||174
3263465|NCT02596893|3997621|FG001|STARTED|Overall Double-Blind Period Weeks 0-52||176
3263466|NCT02596893|3997622|FG002|STARTED|Overall Double-Blind Period Weeks 0-52||176
3263467|NCT02596893|3997623|FG003|STARTED|Overall Double-Blind Period Weeks 0-52||175
3263468|NCT02596893|3997620|FG000|COMPLETED|Overall Double-Blind Period Weeks 0-52||10
3263469|NCT02596893|3997621|FG001|COMPLETED|Overall Double-Blind Period Weeks 0-52||8
3263470|NCT02596893|3997622|FG002|COMPLETED|Overall Double-Blind Period Weeks 0-52||14
3263471|NCT02596893|3997623|FG003|COMPLETED|Overall Double-Blind Period Weeks 0-52||9
3263472|NCT02596893|3997620|FG000|NOT COMPLETED|Overall Double-Blind Period Weeks 0-52||164
3263473|NCT02596893|3997621|FG001|NOT COMPLETED|Overall Double-Blind Period Weeks 0-52||168
3263474|NCT02596893|3997622|FG002|NOT COMPLETED|Overall Double-Blind Period Weeks 0-52||162
3263475|NCT02596893|3997623|FG003|NOT COMPLETED|Overall Double-Blind Period Weeks 0-52||166
3263476|NCT02596893|3997620|FG000|STARTED|Follow-Up Period Weeks 0 to 52||57
3263477|NCT02596893|3997621|FG001|STARTED|Follow-Up Period Weeks 0 to 52||51
3263478|NCT02596893|3997622|FG002|STARTED|Follow-Up Period Weeks 0 to 52||56
3263479|NCT02596893|3997623|FG003|STARTED|Follow-Up Period Weeks 0 to 52||47
3263480|NCT02596893|3997620|FG000|COMPLETED|Follow-Up Period Weeks 0 to 52||57
3263481|NCT02596893|3997621|FG001|COMPLETED|Follow-Up Period Weeks 0 to 52||51
3263482|NCT02596893|3997622|FG002|COMPLETED|Follow-Up Period Weeks 0 to 52||56
3263483|NCT02596893|3997623|FG003|COMPLETED|Follow-Up Period Weeks 0 to 52||47
3263484|NCT02596893|3997620|FG000|NOT COMPLETED|Follow-Up Period Weeks 0 to 52||0
3263485|NCT02596893|3997621|FG001|NOT COMPLETED|Follow-Up Period Weeks 0 to 52||0
3263486|NCT02596893|3997622|FG002|NOT COMPLETED|Follow-Up Period Weeks 0 to 52||0
3263487|NCT02596893|3997623|FG003|NOT COMPLETED|Follow-Up Period Weeks 0 to 52||0
3263488|NCT02596906|3997635|FG000|STARTED|Overall Study||12
3263489|NCT02596906|3997636|FG001|STARTED|Overall Study||10
3263490|NCT02596906|3997635|FG000|COMPLETED|Overall Study||8
3263491|NCT02596906|3997636|FG001|COMPLETED|Overall Study||7
3263492|NCT02596906|3997635|FG000|NOT COMPLETED|Overall Study||4
3263493|NCT02596906|3997636|FG001|NOT COMPLETED|Overall Study||3
3263494|NCT02596945|3997642|FG000|STARTED|Overall Study||223
3263495|NCT02596945|3997642|FG000|Treated|Overall Study||220
3263496|NCT02596945|3997642|FG000|COMPLETED|Overall Study||167
3263497|NCT02596945|3997642|FG000|NOT COMPLETED|Overall Study||56
3263498|NCT02596958|3997646|FG000|STARTED|Overall Study||996
3263499|NCT02596958|3997646|FG000|COMPLETED|Overall Study||0
3263500|NCT02596958|3997646|FG000|NOT COMPLETED|Overall Study||996
3263501|NCT02596971|3997653|FG000|STARTED|Overall Study||42
3263502|NCT02596971|3997654|FG001|STARTED|Overall Study||7
3263503|NCT02596971|3997655|FG002|STARTED|Overall Study||42
3263504|NCT02596971|3997653|FG000|COMPLETED|Overall Study||32
3263505|NCT02596971|3997654|FG001|COMPLETED|Overall Study||5
3263506|NCT02596971|3997655|FG002|COMPLETED|Overall Study||33
3263507|NCT02596971|3997653|FG000|NOT COMPLETED|Overall Study||10
3263508|NCT02596971|3997654|FG001|NOT COMPLETED|Overall Study||2
3263509|NCT02596971|3997655|FG002|NOT COMPLETED|Overall Study||9
3263510|NCT02597049|3997669|FG000|STARTED|Overall Study||142
3263511|NCT02597049|3997670|FG001|STARTED|Overall Study||142
3263512|NCT02597049|3997671|FG002|STARTED|Overall Study||140
3263513|NCT02597049|3997669|FG000|Received at Least One Dose of Study Drug|Overall Study||142
3263514|NCT02597049|3997670|FG001|Received at Least One Dose of Study Drug|Overall Study||141
3263515|NCT02597049|3997671|FG002|Received at Least One Dose of Study Drug|Overall Study||140
3263516|NCT02597049|3997669|FG000|COMPLETED|Overall Study||135
3263517|NCT02597049|3997670|FG001|COMPLETED|Overall Study||137
3263518|NCT02597049|3997671|FG002|COMPLETED|Overall Study||137
3263519|NCT02597049|3997669|FG000|NOT COMPLETED|Overall Study||7
3263520|NCT02597049|3997670|FG001|NOT COMPLETED|Overall Study||5
3263521|NCT02597049|3997671|FG002|NOT COMPLETED|Overall Study||3
3263522|NCT02597101|3997681|FG000|STARTED|Overall Study||4
3263523|NCT02597101|3997682|FG001|STARTED|Overall Study||5
3263524|NCT02597101|3997681|FG000|COMPLETED|Overall Study||4
3263525|NCT02597101|3997682|FG001|COMPLETED|Overall Study||5
3263526|NCT02597101|3997681|FG000|NOT COMPLETED|Overall Study||0
3263527|NCT02597101|3997682|FG001|NOT COMPLETED|Overall Study||0
3263528|NCT02597127|3997696|FG000|STARTED|Overall Study||60
3263529|NCT02597127|3997697|FG001|STARTED|Overall Study||62
3263530|NCT02597127|3997698|FG002|STARTED|Overall Study||66
3263531|NCT02597127|3997699|FG003|STARTED|Overall Study||65
3374053|NCT02244944|4106589|FG000|NOT COMPLETED|Overall Study||2
3374054|NCT02241187|4106593|FG000|STARTED|Overall Study||2
3374055|NCT02241187|4106593|FG000|COMPLETED|Overall Study||0
3374056|NCT02241187|4106593|FG000|NOT COMPLETED|Overall Study||2
3374057|NCT02239926|4106599|FG000|STARTED|Overall Study||0
3374058|NCT02239926|4106600|FG001|STARTED|Overall Study||2
3374059|NCT02239926|4106599|FG000|COMPLETED|Overall Study||0
3374060|NCT02239926|4106600|FG001|COMPLETED|Overall Study||1
3374061|NCT02239926|4106599|FG000|NOT COMPLETED|Overall Study||0
3374062|NCT02239926|4106600|FG001|NOT COMPLETED|Overall Study||1
3374063|NCT02231892|4106609|FG000|STARTED|Overall Study||17
3374064|NCT02231892|4106610|FG001|STARTED|Overall Study||17
3374065|NCT02231892|4106611|FG002|STARTED|Overall Study||70
3374066|NCT02231892|4106609|FG000|Sham|Overall Study||8
3374067|NCT02231892|4106610|FG001|Sham|Overall Study||5
3374068|NCT02231892|4106611|FG002|Sham|Overall Study||26
3374069|NCT02231892|4106609|FG000|100% MT|Overall Study||7
3374070|NCT02231892|4106610|FG001|100% MT|Overall Study||6
3374071|NCT02231892|4106611|FG002|100% MT|Overall Study||25
3374072|NCT02231892|4106609|FG000|110% MT|Overall Study||7
3374073|NCT02231892|4106610|FG001|110% MT|Overall Study||5
3263532|NCT02597127|3997700|FG004|STARTED|Overall Study||62
3263533|NCT02597127|3997701|FG005|STARTED|Overall Study||63
3263534|NCT02597127|3997702|FG006|STARTED|Overall Study||61
3263535|NCT02597127|3997703|FG007|STARTED|Overall Study||62
3263536|NCT02597127|3997696|FG000|Treated|Overall Study||60
3263537|NCT02597127|3997697|FG001|Treated|Overall Study||61
3263538|NCT02597127|3997698|FG002|Treated|Overall Study||65
3263539|NCT02597127|3997699|FG003|Treated|Overall Study||65
3263540|NCT02597127|3997700|FG004|Treated|Overall Study||61
3263541|NCT02597127|3997701|FG005|Treated|Overall Study||62
3263542|NCT02597127|3997702|FG006|Treated|Overall Study||61
3263543|NCT02597127|3997703|FG007|Treated|Overall Study||62
3263544|NCT02597127|3997696|FG000|COMPLETED|Overall Study||59
3263545|NCT02597127|3997697|FG001|COMPLETED|Overall Study||59
3263546|NCT02597127|3997698|FG002|COMPLETED|Overall Study||58
3263547|NCT02597127|3997699|FG003|COMPLETED|Overall Study||60
3263548|NCT02597127|3997700|FG004|COMPLETED|Overall Study||57
3263549|NCT02597127|3997701|FG005|COMPLETED|Overall Study||59
3263550|NCT02597127|3997702|FG006|COMPLETED|Overall Study||57
3263551|NCT02597127|3997703|FG007|COMPLETED|Overall Study||60
3263552|NCT02597127|3997696|FG000|NOT COMPLETED|Overall Study||1
3263553|NCT02597127|3997697|FG001|NOT COMPLETED|Overall Study||3
3263554|NCT02597127|3997698|FG002|NOT COMPLETED|Overall Study||8
3263555|NCT02597127|3997699|FG003|NOT COMPLETED|Overall Study||5
3263556|NCT02597127|3997700|FG004|NOT COMPLETED|Overall Study||5
3263557|NCT02597127|3997701|FG005|NOT COMPLETED|Overall Study||4
3263558|NCT02597127|3997702|FG006|NOT COMPLETED|Overall Study||4
3263559|NCT02597127|3997703|FG007|NOT COMPLETED|Overall Study||2
3263560|NCT02597452|3997742|FG000|STARTED|Overall Study||516
3263561|NCT02597452|3997742|FG000|COMPLETED|Overall Study||486
3263562|NCT02597452|3997742|FG000|NOT COMPLETED|Overall Study||30
3263563|NCT02597478|3997748|FG000|STARTED|Overall Study||16
3263564|NCT02597478|3997749|FG001|STARTED|Overall Study||18
3263565|NCT02597478|3997748|FG000|COMPLETED|Overall Study||13
3263566|NCT02597478|3997749|FG001|COMPLETED|Overall Study||17
3263567|NCT02597478|3997748|FG000|NOT COMPLETED|Overall Study||3
3263568|NCT02597478|3997749|FG001|NOT COMPLETED|Overall Study||1
3263569|NCT02597543|3997757|FG000|STARTED|Overall Study||6
3263570|NCT02597543|3997758|FG001|STARTED|Overall Study||8
3263571|NCT02597543|3997757|FG000|COMPLETED|Overall Study||6
3263572|NCT02597543|3997758|FG001|COMPLETED|Overall Study||8
3263573|NCT02597543|3997757|FG000|NOT COMPLETED|Overall Study||0
3263574|NCT02597543|3997758|FG001|NOT COMPLETED|Overall Study||0
3263575|NCT02597582|3997766|FG000|STARTED|Overall Study||21
3263576|NCT02597582|3997767|FG001|STARTED|Overall Study||20
3263577|NCT02597582|3997766|FG000|COMPLETED|Overall Study||21
3263578|NCT02597582|3997767|FG001|COMPLETED|Overall Study||20
3263579|NCT02597582|3997766|FG000|NOT COMPLETED|Overall Study||0
3263580|NCT02597582|3997767|FG001|NOT COMPLETED|Overall Study||0
3263581|NCT02597673|3997779|FG000|STARTED|Overall Study||34
3263582|NCT02597673|3997780|FG001|STARTED|Overall Study||33
3263583|NCT02597673|3997781|FG002|STARTED|Overall Study||33
3263584|NCT02597673|3997782|FG003|STARTED|Overall Study||30
3263585|NCT02597673|3997779|FG000|COMPLETED|Overall Study||31
3263586|NCT02597673|3997780|FG001|COMPLETED|Overall Study||27
3263587|NCT02597673|3997781|FG002|COMPLETED|Overall Study||28
3263588|NCT02597673|3997782|FG003|COMPLETED|Overall Study||25
3263589|NCT02597673|3997779|FG000|NOT COMPLETED|Overall Study||3
3263590|NCT02597673|3997780|FG001|NOT COMPLETED|Overall Study||6
3263591|NCT02597673|3997781|FG002|NOT COMPLETED|Overall Study||5
3263592|NCT02597673|3997782|FG003|NOT COMPLETED|Overall Study||5
3263593|NCT02597712|3997795|FG000|STARTED|Overall Study||13
3374074|NCT02231892|4106611|FG002|110% MT|Overall Study||27
3374075|NCT02231892|4106609|FG000|COMPLETED|Overall Study||6
3374076|NCT02231892|4106610|FG001|COMPLETED|Overall Study|3 participants completed this phase and Hi Frequency MRI phase, but are only counted in Hi Freq MRI.|5
3374077|NCT02231892|4106611|FG002|COMPLETED|Overall Study|3 participants completed this phase and Hi Frequency Beh phase, but are only counted in Hi Freq MRI.|25
3374078|NCT02231892|4106609|FG000|NOT COMPLETED|Overall Study||11
3374079|NCT02231892|4106610|FG001|NOT COMPLETED|Overall Study||12
3374080|NCT02231892|4106611|FG002|NOT COMPLETED|Overall Study||45
3374081|NCT02241343|4106625|FG000|STARTED|Overall Study||1
3374082|NCT02241343|4106625|FG000|COMPLETED|Overall Study||0
3374083|NCT02241343|4106625|FG000|NOT COMPLETED|Overall Study||1
3374084|NCT02242578|4106632|FG000|STARTED|Overall Study||0
3374085|NCT02242578|4106633|FG001|STARTED|Overall Study||0
3374086|NCT02242578|4106632|FG000|COMPLETED|Overall Study||0
3374087|NCT02242578|4106633|FG001|COMPLETED|Overall Study||0
3374088|NCT02242578|4106632|FG000|NOT COMPLETED|Overall Study||0
3374089|NCT02242578|4106633|FG001|NOT COMPLETED|Overall Study||0
3374090|NCT02234011|4106639|FG000|STARTED|Overall Study||0
3374091|NCT02234011|4106639|FG000|COMPLETED|Overall Study||0
3374092|NCT02234011|4106639|FG000|NOT COMPLETED|Overall Study||0
3374093|NCT02236546|4106643|FG000|STARTED|Overall Study||3
3374094|NCT02236546|4106643|FG000|COMPLETED|Overall Study||3
3374095|NCT02236546|4106643|FG000|NOT COMPLETED|Overall Study||0
3374096|NCT02234687|4106650|FG000|STARTED|Overall Study|Study Terminated. No outcome measures were analyzed|6
3374097|NCT02234687|4106651|FG001|STARTED|Overall Study||4
3374098|NCT02234687|4106652|FG002|STARTED|Overall Study||4
3263594|NCT02597712|3997796|FG001|STARTED|Overall Study||11
3263595|NCT02597712|3997795|FG000|COMPLETED|Overall Study||10
3263596|NCT02597712|3997796|FG001|COMPLETED|Overall Study||10
3263597|NCT02597712|3997795|FG000|NOT COMPLETED|Overall Study||3
3263598|NCT02597712|3997796|FG001|NOT COMPLETED|Overall Study||1
3263599|NCT02597855|3997804|FG000|STARTED|Overall Study||18
3263600|NCT02597855|3997805|FG001|STARTED|Overall Study||14
3263601|NCT02597855|3997804|FG000|COMPLETED|Overall Study||16
3263602|NCT02597855|3997805|FG001|COMPLETED|Overall Study||13
3263603|NCT02597855|3997804|FG000|NOT COMPLETED|Overall Study||2
3263604|NCT02597855|3997805|FG001|NOT COMPLETED|Overall Study||1
3263605|NCT02597907|3997813|FG000|STARTED|Overall Study||44
3263606|NCT02597907|3997814|FG001|STARTED|Overall Study||44
3263607|NCT02597907|3997813|FG000|COMPLETED|Overall Study||44
3263608|NCT02597907|3997814|FG001|COMPLETED|Overall Study||44
3263609|NCT02597907|3997813|FG000|NOT COMPLETED|Overall Study||0
3263610|NCT02597907|3997814|FG001|NOT COMPLETED|Overall Study||0
3263611|NCT02597920|3997823|FG000|STARTED|Overall Study|Information about study termination is not available for 1 subject.|585
3263612|NCT02597920|3997824|FG001|STARTED|Overall Study||1159
3263613|NCT02597920|3997825|FG002|STARTED|Overall Study||78
3263614|NCT02597920|3997823|FG000|COMPLETED|Overall Study||544
3263615|NCT02597920|3997824|FG001|COMPLETED|Overall Study||1075
3263616|NCT02597920|3997825|FG002|COMPLETED|Overall Study||72
3263617|NCT02597920|3997823|FG000|NOT COMPLETED|Overall Study||41
3263618|NCT02597920|3997824|FG001|NOT COMPLETED|Overall Study||84
3263619|NCT02597920|3997825|FG002|NOT COMPLETED|Overall Study||6
3263620|NCT02597933|3997837|FG000|STARTED|Overall Study|Started are randomised|290
3263621|NCT02597933|3997838|FG001|STARTED|Overall Study|Started are randomised|290
3263622|NCT02597933|3997837|FG000|Treated Patients|Overall Study||288
3263623|NCT02597933|3997838|FG001|Treated Patients|Overall Study||288
3263624|NCT02597933|3997837|FG000|COMPLETED|Overall Study||252
3263625|NCT02597933|3997838|FG001|COMPLETED|Overall Study||239
3263626|NCT02597933|3997837|FG000|NOT COMPLETED|Overall Study||38
3263627|NCT02597933|3997838|FG001|NOT COMPLETED|Overall Study||51
3263628|NCT02597946|3997844|FG000|STARTED|Overall Study||18
3263629|NCT02597946|3997844|FG000|COMPLETED|Overall Study||0
3263630|NCT02597946|3997844|FG000|NOT COMPLETED|Overall Study||18
3263631|NCT02598076|3997850|FG000|STARTED|Overall Study||31
3263632|NCT02598076|3997851|FG001|STARTED|Overall Study||29
3263633|NCT02598076|3997850|FG000|COMPLETED|Overall Study||29
3263634|NCT02598076|3997851|FG001|COMPLETED|Overall Study||26
3263635|NCT02598076|3997850|FG000|NOT COMPLETED|Overall Study||2
3263636|NCT02598076|3997851|FG001|NOT COMPLETED|Overall Study||3
3374099|NCT02234687|4106650|FG000|COMPLETED|Overall Study|Study Terminated. No outcome measures were analyzed|0
3374100|NCT02234687|4106651|FG001|COMPLETED|Overall Study||0
3374101|NCT02234687|4106652|FG002|COMPLETED|Overall Study||0
3374102|NCT02234687|4106650|FG000|NOT COMPLETED|Overall Study||6
3374103|NCT02234687|4106651|FG001|NOT COMPLETED|Overall Study||4
3374104|NCT02234687|4106652|FG002|NOT COMPLETED|Overall Study||4
3374105|NCT02224599|4106660|FG000|STARTED|Overall Study||3
3374106|NCT02224599|4106660|FG000|COMPLETED|Overall Study||1
3374107|NCT02224599|4106660|FG000|NOT COMPLETED|Overall Study||2
3374108|NCT02201472|4106664|FG000|STARTED|Overall Study||2
3374109|NCT02201472|4106664|FG000|COMPLETED|Overall Study||0
3374110|NCT02201472|4106664|FG000|NOT COMPLETED|Overall Study||2
3374111|NCT02202044|4106668|FG000|STARTED|Overall Study||0
3374112|NCT02202044|4106668|FG000|COMPLETED|Overall Study||0
3374113|NCT02202044|4106668|FG000|NOT COMPLETED|Overall Study||0
3374114|NCT02192775|4106672|FG000|STARTED|Overall Study||2
3374115|NCT02192775|4106672|FG000|COMPLETED|Overall Study||0
3374116|NCT02192775|4106672|FG000|NOT COMPLETED|Overall Study||2
3374117|NCT02200328|4106678|FG000|STARTED|Overall Study||43
3374118|NCT02200328|4106679|FG001|STARTED|Overall Study||33
3374119|NCT02200328|4106678|FG000|COMPLETED|Overall Study||0
3374120|NCT02200328|4106679|FG001|COMPLETED|Overall Study||0
3374121|NCT02200328|4106678|FG000|NOT COMPLETED|Overall Study||43
3374122|NCT02200328|4106679|FG001|NOT COMPLETED|Overall Study||33
3374123|NCT02200042|4106687|FG000|STARTED|Overall Study||0
3374124|NCT02200042|4106688|FG001|STARTED|Overall Study||1
3374125|NCT02200042|4106687|FG000|COMPLETED|Overall Study||0
3374126|NCT02200042|4106688|FG001|COMPLETED|Overall Study||0
3374127|NCT02200042|4106687|FG000|NOT COMPLETED|Overall Study||0
3374128|NCT02200042|4106688|FG001|NOT COMPLETED|Overall Study||1
3374129|NCT02181790|4106696|FG000|STARTED|Overall Study||2
3374130|NCT02181790|4106697|FG001|STARTED|Overall Study||0
3374131|NCT02181790|4106696|FG000|COMPLETED|Overall Study||0
3374132|NCT02181790|4106697|FG001|COMPLETED|Overall Study||0
3374133|NCT02181790|4106696|FG000|NOT COMPLETED|Overall Study||2
3374134|NCT02181790|4106697|FG001|NOT COMPLETED|Overall Study||0
3374135|NCT02198833|4106707|FG000|STARTED|Overall Study|Unable to clear urine of bacteria for all but one patient therefore catheter not placed|1
3374136|NCT02198833|4106708|FG001|STARTED|Overall Study|Unable to clear urine of bacteria for all but one patient therefore catheter not placed.|1
3374137|NCT02198833|4106707|FG000|COMPLETED|Overall Study||1
3374138|NCT02198833|4106708|FG001|COMPLETED|Overall Study||1
3374139|NCT02198833|4106707|FG000|NOT COMPLETED|Overall Study||0
3374140|NCT02198833|4106708|FG001|NOT COMPLETED|Overall Study||0
3374141|NCT02175628|4106716|FG000|STARTED|Overall Study||6
3374142|NCT02175628|4106717|FG001|STARTED|Overall Study||17
3374143|NCT02175628|4106716|FG000|COMPLETED|Overall Study||6
3374144|NCT02175628|4106717|FG001|COMPLETED|Overall Study||17
3374145|NCT02175628|4106716|FG000|NOT COMPLETED|Overall Study||0
3374146|NCT02175628|4106717|FG001|NOT COMPLETED|Overall Study||0
3374147|NCT02177266|4106725|FG000|STARTED|Overall Study||1
3374148|NCT02177266|4106726|FG001|STARTED|Overall Study||1
3263637|NCT02598089|3997859|FG000|STARTED|Overall Study||30
3263638|NCT02598089|3997860|FG001|STARTED|Overall Study||30
3263639|NCT02598089|3997859|FG000|COMPLETED|Overall Study||30
3263640|NCT02598089|3997860|FG001|COMPLETED|Overall Study||30
3263641|NCT02598089|3997859|FG000|NOT COMPLETED|Overall Study||0
3263642|NCT02598089|3997860|FG001|NOT COMPLETED|Overall Study||0
3263643|NCT02598128|3997873|FG000|STARTED|Period A: Days -7 to -1||34
3263644|NCT02598128|3997874|FG001|STARTED|Period A: Days -7 to -1||0
3263645|NCT02598128|3997875|FG002|STARTED|Period A: Days -7 to -1||0
3263646|NCT02598128|3997876|FG003|STARTED|Period A: Days -7 to -1||0
3263647|NCT02598128|3997873|FG000|COMPLETED|Period A: Days -7 to -1||33
3263648|NCT02598128|3997874|FG001|COMPLETED|Period A: Days -7 to -1||0
3263649|NCT02598128|3997875|FG002|COMPLETED|Period A: Days -7 to -1||0
3263650|NCT02598128|3997876|FG003|COMPLETED|Period A: Days -7 to -1||0
3263651|NCT02598128|3997873|FG000|NOT COMPLETED|Period A: Days -7 to -1||1
3263652|NCT02598128|3997874|FG001|NOT COMPLETED|Period A: Days -7 to -1||0
3263653|NCT02598128|3997875|FG002|NOT COMPLETED|Period A: Days -7 to -1||0
3263654|NCT02598128|3997876|FG003|NOT COMPLETED|Period A: Days -7 to -1||0
3263655|NCT02598128|3997873|FG000|STARTED|Period B: Days 1 to 11||0
3263656|NCT02598128|3997874|FG001|STARTED|Period B: Days 1 to 11||17
3263657|NCT02598128|3997875|FG002|STARTED|Period B: Days 1 to 11||16
3263658|NCT02598128|3997876|FG003|STARTED|Period B: Days 1 to 11||0
3263659|NCT02598128|3997873|FG000|COMPLETED|Period B: Days 1 to 11||0
3263660|NCT02598128|3997874|FG001|COMPLETED|Period B: Days 1 to 11||17
3263661|NCT02598128|3997875|FG002|COMPLETED|Period B: Days 1 to 11||16
3263662|NCT02598128|3997876|FG003|COMPLETED|Period B: Days 1 to 11||0
3263663|NCT02598128|3997873|FG000|NOT COMPLETED|Period B: Days 1 to 11||0
3263664|NCT02598128|3997874|FG001|NOT COMPLETED|Period B: Days 1 to 11||0
3263665|NCT02598128|3997875|FG002|NOT COMPLETED|Period B: Days 1 to 11||0
3263666|NCT02598128|3997876|FG003|NOT COMPLETED|Period B: Days 1 to 11||0
3263667|NCT02598128|3997873|FG000|STARTED|Period C: Days 12 to 20||0
3263668|NCT02598128|3997874|FG001|STARTED|Period C: Days 12 to 20||0
3263669|NCT02598128|3997875|FG002|STARTED|Period C: Days 12 to 20||0
3263670|NCT02598128|3997876|FG003|STARTED|Period C: Days 12 to 20||33
3263671|NCT02598128|3997873|FG000|COMPLETED|Period C: Days 12 to 20||0
3263672|NCT02598128|3997874|FG001|COMPLETED|Period C: Days 12 to 20||0
3263673|NCT02598128|3997875|FG002|COMPLETED|Period C: Days 12 to 20||0
3263674|NCT02598128|3997876|FG003|COMPLETED|Period C: Days 12 to 20||33
3263675|NCT02598128|3997873|FG000|NOT COMPLETED|Period C: Days 12 to 20||0
3263676|NCT02598128|3997874|FG001|NOT COMPLETED|Period C: Days 12 to 20||0
3263677|NCT02598128|3997875|FG002|NOT COMPLETED|Period C: Days 12 to 20||0
3263678|NCT02598128|3997876|FG003|NOT COMPLETED|Period C: Days 12 to 20||0
3263679|NCT02598193|3997888|FG000|STARTED|Overall Study||89
3263680|NCT02598193|3997888|FG000|COMPLETED|Overall Study||73
3263681|NCT02598193|3997888|FG000|NOT COMPLETED|Overall Study||16
3263682|NCT02598297|3997894|FG000|STARTED|Overall Study|One subject in the ruxolitinib arm was not treated with the study drug|25
3263683|NCT02598297|3997895|FG001|STARTED|Overall Study||24
3263684|NCT02598297|3997894|FG000|Not Treted Wit Study Drug|Overall Study||1
3263685|NCT02598297|3997895|FG001|Not Treted Wit Study Drug|Overall Study||0
3263686|NCT02598297|3997894|FG000|Subjects Followed for Survival|Overall Study||1
3263687|NCT02598297|3997895|FG001|Subjects Followed for Survival|Overall Study||0
3263688|NCT02598297|3997894|FG000|COMPLETED|Overall Study||0
3263689|NCT02598297|3997895|FG001|COMPLETED|Overall Study||0
3263690|NCT02598297|3997894|FG000|NOT COMPLETED|Overall Study||25
3263691|NCT02598297|3997895|FG001|NOT COMPLETED|Overall Study||24
3263692|NCT02598583|3997903|FG000|STARTED|Overall Study||6
3263693|NCT02598583|3997904|FG001|STARTED|Overall Study||7
3263694|NCT02598583|3997903|FG000|COMPLETED|Overall Study||6
3263695|NCT02598583|3997904|FG001|COMPLETED|Overall Study||7
3263696|NCT02598583|3997903|FG000|NOT COMPLETED|Overall Study||0
3263697|NCT02598583|3997904|FG001|NOT COMPLETED|Overall Study||0
3263698|NCT02598934|3997912|FG000|STARTED|Overall Study||154
3263699|NCT02598934|3997913|FG001|STARTED|Overall Study||154
3263700|NCT02598934|3997912|FG000|COMPLETED|Overall Study||135
3263701|NCT02598934|3997913|FG001|COMPLETED|Overall Study||132
3263702|NCT02598934|3997912|FG000|NOT COMPLETED|Overall Study||19
3263703|NCT02598934|3997913|FG001|NOT COMPLETED|Overall Study||22
3263704|NCT02599129|3997921|FG000|STARTED|Overall Study||7
3263705|NCT02599129|3997922|FG001|STARTED|Overall Study||4
3263706|NCT02599129|3997921|FG000|COMPLETED|Overall Study||2
3263707|NCT02599129|3997922|FG001|COMPLETED|Overall Study||1
3263708|NCT02599129|3997921|FG000|NOT COMPLETED|Overall Study||5
3263709|NCT02599129|3997922|FG001|NOT COMPLETED|Overall Study||3
3263710|NCT02599194|3997928|FG000|STARTED|Overall Study||7
3263711|NCT02599194|3997928|FG000|COMPLETED|Overall Study||7
3263712|NCT02599194|3997928|FG000|NOT COMPLETED|Overall Study||0
3263713|NCT02599402|3997934|FG000|STARTED|Overall Study||533
3263714|NCT02599402|3997934|FG000|COMPLETED|Overall Study||0
3263715|NCT02599402|3997934|FG000|NOT COMPLETED|Overall Study||533
3263716|NCT02599441|3997964|FG000|STARTED|Overall Study||9
3263717|NCT02599441|3997964|FG000|COMPLETED|Overall Study||9
3263718|NCT02599441|3997964|FG000|NOT COMPLETED|Overall Study||0
3263719|NCT02599649|3997972|FG000|STARTED|Overall Study||2
3263720|NCT02599649|3997973|FG001|STARTED|Overall Study||0
3263721|NCT02599649|3997974|FG002|STARTED|Overall Study||8
3263722|NCT02599649|3997975|FG003|STARTED|Overall Study||0
3263723|NCT02599649|3997972|FG000|COMPLETED|Overall Study||2
3263724|NCT02599649|3997973|FG001|COMPLETED|Overall Study||0
3263725|NCT02599649|3997974|FG002|COMPLETED|Overall Study||8
3263726|NCT02599649|3997975|FG003|COMPLETED|Overall Study||0
3263727|NCT02599649|3997972|FG000|NOT COMPLETED|Overall Study||0
3263728|NCT02599649|3997973|FG001|NOT COMPLETED|Overall Study||0
3263729|NCT02599649|3997974|FG002|NOT COMPLETED|Overall Study||0
3263730|NCT02599649|3997975|FG003|NOT COMPLETED|Overall Study||0
3263731|NCT02599688|3997985|FG000|STARTED|Overall Study||18
3263732|NCT02599688|3997985|FG000|COMPLETED|Overall Study||14
3263733|NCT02599688|3997985|FG000|NOT COMPLETED|Overall Study||4
3263734|NCT02599766|3997989|FG000|STARTED|Overall Study||22
3263735|NCT02599766|3997989|FG000|COMPLETED|Overall Study||19
3263736|NCT02599766|3997989|FG000|NOT COMPLETED|Overall Study||3
3263737|NCT02599961|3997997|FG000|STARTED|Overall Study||15
3263738|NCT02599961|3997997|FG000|COMPLETED|Overall Study||0
3263739|NCT02599961|3997997|FG000|NOT COMPLETED|Overall Study||15
3263740|NCT02600325|3998001|FG000|STARTED|Overall Study||80
3263741|NCT02600325|3998001|FG000|COMPLETED|Overall Study||80
3263742|NCT02600325|3998001|FG000|NOT COMPLETED|Overall Study||0
3263743|NCT02600351|3998009|FG000|STARTED|Overall Study||17
3263744|NCT02600351|3998010|FG001|STARTED|Overall Study||17
3263745|NCT02600351|3998011|FG002|STARTED|Overall Study||26
3263746|NCT02600351|3998012|FG003|STARTED|Overall Study||27
3263747|NCT02600351|3998009|FG000|COMPLETED|Overall Study||12
3263748|NCT02600351|3998010|FG001|COMPLETED|Overall Study||17
3263749|NCT02600351|3998011|FG002|COMPLETED|Overall Study||20
3263750|NCT02600351|3998012|FG003|COMPLETED|Overall Study||22
3263751|NCT02600351|3998009|FG000|NOT COMPLETED|Overall Study||5
3263752|NCT02600351|3998010|FG001|NOT COMPLETED|Overall Study||0
3263753|NCT02600351|3998011|FG002|NOT COMPLETED|Overall Study||6
3263754|NCT02600351|3998012|FG003|NOT COMPLETED|Overall Study||5
3263755|NCT02600403|3998027|FG000|STARTED|Overall Study||44
3263756|NCT02600403|3998028|FG001|STARTED|Overall Study||6
3263757|NCT02600403|3998029|FG002|STARTED|Overall Study||11
3263758|NCT02600403|3998027|FG000|COMPLETED|Overall Study||44
3263759|NCT02600403|3998028|FG001|COMPLETED|Overall Study||6
3263760|NCT02600403|3998029|FG002|COMPLETED|Overall Study||11
3263761|NCT02600403|3998027|FG000|NOT COMPLETED|Overall Study||0
3263762|NCT02600403|3998028|FG001|NOT COMPLETED|Overall Study||0
3263763|NCT02600403|3998029|FG002|NOT COMPLETED|Overall Study||0
3263764|NCT02600559|3998040|FG000|STARTED|Overall Study||501
3263765|NCT02600559|3998040|FG000|COMPLETED|Overall Study||478
3263766|NCT02600559|3998040|FG000|NOT COMPLETED|Overall Study||23
3263767|NCT02600611|3998046|FG000|STARTED|Overall Study||300
3263768|NCT02600611|3998047|FG001|STARTED|Overall Study||300
3263769|NCT02600611|3998046|FG000|COMPLETED|Overall Study||298
3263770|NCT02600611|3998047|FG001|COMPLETED|Overall Study||300
3263771|NCT02600611|3998046|FG000|NOT COMPLETED|Overall Study||2
3263772|NCT02600611|3998047|FG001|NOT COMPLETED|Overall Study||0
3263773|NCT02600637|3998055|FG000|STARTED|Overall Study||19
3263774|NCT02600637|3998056|FG001|STARTED|Overall Study||18
3263775|NCT02600637|3998055|FG000|COMPLETED|Overall Study||14
3263776|NCT02600637|3998056|FG001|COMPLETED|Overall Study||13
3263777|NCT02600637|3998055|FG000|NOT COMPLETED|Overall Study||5
3263778|NCT02600637|3998056|FG001|NOT COMPLETED|Overall Study||5
3263779|NCT02600715|3998064|FG000|STARTED|Overall Study||13
3263780|NCT02600715|3998065|FG001|STARTED|Overall Study||13
3263781|NCT02600715|3998064|FG000|Allocated to Randomization|Overall Study||13
3263782|NCT02600715|3998065|FG001|Allocated to Randomization|Overall Study||13
3263783|NCT02600715|3998064|FG000|Received Treatment and Suppository|Overall Study||13
3263784|NCT02600715|3998065|FG001|Received Treatment and Suppository|Overall Study||13
3263785|NCT02600715|3998064|FG000|Completed 2-week Follow-up Appointment|Overall Study||13
3263786|NCT02600715|3998065|FG001|Completed 2-week Follow-up Appointment|Overall Study||12
3263787|NCT02600715|3998064|FG000|COMPLETED|Overall Study||13
3263788|NCT02600715|3998065|FG001|COMPLETED|Overall Study||13
3263789|NCT02600715|3998064|FG000|NOT COMPLETED|Overall Study||0
3263790|NCT02600715|3998065|FG001|NOT COMPLETED|Overall Study||0
3263791|NCT02600767|3998074|FG000|STARTED|Overall Study||79
3263792|NCT02600767|3998074|FG000|COMPLETED|Overall Study||74
3263793|NCT02600767|3998074|FG000|NOT COMPLETED|Overall Study||5
3263794|NCT02600819|3998078|FG000|STARTED|GEN Phase||55
3263795|NCT02600819|3998079|FG001|STARTED|GEN Phase||0
3263796|NCT02600819|3998078|FG000|COMPLETED|GEN Phase||39
3263797|NCT02600819|3998079|FG001|COMPLETED|GEN Phase||0
3263798|NCT02600819|3998078|FG000|NOT COMPLETED|GEN Phase||16
3263799|NCT02600819|3998079|FG001|NOT COMPLETED|GEN Phase||0
3263800|NCT02600819|3998078|FG000|STARTED|BVY OL Extension Phase|Only US participants were eligible to roll over into the Extension Phase per the study protocol.|0
3263801|NCT02600819|3998079|FG001|STARTED|BVY OL Extension Phase|Only US participants were eligible to roll over into the Extension Phase per the study protocol.|10
3263802|NCT02600819|3998078|FG000|COMPLETED|BVY OL Extension Phase||0
3263803|NCT02600819|3998079|FG001|COMPLETED|BVY OL Extension Phase||10
3263804|NCT02600819|3998078|FG000|NOT COMPLETED|BVY OL Extension Phase||0
3263805|NCT02600819|3998079|FG001|NOT COMPLETED|BVY OL Extension Phase||0
3263806|NCT02600845|3998085|FG000|STARTED|Overall Study||122
3263807|NCT02600845|3998085|FG000|COMPLETED|Overall Study||104
3263808|NCT02600845|3998085|FG000|NOT COMPLETED|Overall Study||18
3263809|NCT02600871|3998091|FG000|STARTED|Overall Study||52
3263810|NCT02600871|3998092|FG001|STARTED|Overall Study||49
3263811|NCT02600871|3998091|FG000|COMPLETED|Overall Study|51 subjects completed the 7-10 day follow up 39 subjects completed the 30-day follow up|39
3263812|NCT02600871|3998092|FG001|COMPLETED|Overall Study|45 subjects completed the 7-10 day follow up 39 subjects completed the 30-day follow up|39
3263813|NCT02600871|3998091|FG000|NOT COMPLETED|Overall Study||13
3263814|NCT02600871|3998092|FG001|NOT COMPLETED|Overall Study||10
3263815|NCT02601001|3998102|FG000|STARTED|Dosing Period 1||10
3263816|NCT02601001|3998103|FG001|STARTED|Dosing Period 1||20
3263817|NCT02601001|3998104|FG002|STARTED|Dosing Period 1||20
3263818|NCT02601001|3998105|FG003|STARTED|Dosing Period 1||0
3263819|NCT02601001|3998106|FG004|STARTED|Dosing Period 1||0
3263820|NCT02601001|3998107|FG005|STARTED|Dosing Period 1||0
3263821|NCT02601001|3998108|FG006|STARTED|Dosing Period 1||0
3263822|NCT02601001|3998102|FG000|COMPLETED|Dosing Period 1||10
3263823|NCT02601001|3998103|FG001|COMPLETED|Dosing Period 1||20
3263824|NCT02601001|3998104|FG002|COMPLETED|Dosing Period 1||20
3263825|NCT02601001|3998105|FG003|COMPLETED|Dosing Period 1||0
3263826|NCT02601001|3998106|FG004|COMPLETED|Dosing Period 1||0
3263827|NCT02601001|3998107|FG005|COMPLETED|Dosing Period 1||0
3263828|NCT02601001|3998108|FG006|COMPLETED|Dosing Period 1||0
3263829|NCT02601001|3998102|FG000|NOT COMPLETED|Dosing Period 1||0
3263830|NCT02601001|3998103|FG001|NOT COMPLETED|Dosing Period 1||0
3263831|NCT02601001|3998104|FG002|NOT COMPLETED|Dosing Period 1||0
3263832|NCT02601001|3998105|FG003|NOT COMPLETED|Dosing Period 1||0
3263833|NCT02601001|3998106|FG004|NOT COMPLETED|Dosing Period 1||0
3263834|NCT02601001|3998107|FG005|NOT COMPLETED|Dosing Period 1||0
3263835|NCT02601001|3998108|FG006|NOT COMPLETED|Dosing Period 1||0
3374149|NCT02177266|4106725|FG000|COMPLETED|Overall Study||0
3374150|NCT02177266|4106726|FG001|COMPLETED|Overall Study||0
3374151|NCT02177266|4106725|FG000|NOT COMPLETED|Overall Study||1
3374152|NCT02177266|4106726|FG001|NOT COMPLETED|Overall Study||1
3374153|NCT02184520|4106734|FG000|STARTED|Overall Study||0
3374154|NCT02184520|4106735|FG001|STARTED|Overall Study||0
3374155|NCT02184520|4106734|FG000|COMPLETED|Overall Study||0
3374156|NCT02184520|4106735|FG001|COMPLETED|Overall Study||0
3374157|NCT02184520|4106734|FG000|NOT COMPLETED|Overall Study||0
3374158|NCT02184520|4106735|FG001|NOT COMPLETED|Overall Study||0
3374159|NCT02170298|4106743|FG000|STARTED|Overall Study||1
3374160|NCT02170298|4106744|FG001|STARTED|Overall Study||5
3374161|NCT02170298|4106743|FG000|COMPLETED|Overall Study||0
3374162|NCT02170298|4106744|FG001|COMPLETED|Overall Study||4
3374163|NCT02170298|4106743|FG000|NOT COMPLETED|Overall Study||1
3374164|NCT02170298|4106744|FG001|NOT COMPLETED|Overall Study||1
3374165|NCT02177773|4106750|FG000|STARTED|Overall Study||300
3374166|NCT02177773|4106750|FG000|COMPLETED|Overall Study||300
3374167|NCT02177773|4106750|FG000|NOT COMPLETED|Overall Study||0
3374168|NCT02162979|4106756|FG000|STARTED|Overall Study||0
3374169|NCT02162979|4106757|FG001|STARTED|Overall Study||0
3374170|NCT02162979|4106756|FG000|COMPLETED|Overall Study||0
3374171|NCT02162979|4106757|FG001|COMPLETED|Overall Study||0
3374172|NCT02162979|4106756|FG000|NOT COMPLETED|Overall Study||0
3374173|NCT02162979|4106757|FG001|NOT COMPLETED|Overall Study||0
3374174|NCT02169830|4106766|FG000|STARTED|Diet Intervention (4 Weeks)||0
3374175|NCT02169830|4106767|FG001|STARTED|Diet Intervention (4 Weeks)||0
3374176|NCT02169830|4106768|FG002|STARTED|Diet Intervention (4 Weeks)||33
3374177|NCT02169830|4106766|FG000|COMPLETED|Diet Intervention (4 Weeks)||0
3374178|NCT02169830|4106767|FG001|COMPLETED|Diet Intervention (4 Weeks)||0
3374179|NCT02169830|4106768|FG002|COMPLETED|Diet Intervention (4 Weeks)||32
3374180|NCT02169830|4106766|FG000|NOT COMPLETED|Diet Intervention (4 Weeks)||0
3374181|NCT02169830|4106767|FG001|NOT COMPLETED|Diet Intervention (4 Weeks)||0
3374182|NCT02169830|4106768|FG002|NOT COMPLETED|Diet Intervention (4 Weeks)||1
3374183|NCT02169830|4106766|FG000|STARTED|Second Intervention (8 Weeks)||12
3374184|NCT02169830|4106767|FG001|STARTED|Second Intervention (8 Weeks)||5
3374185|NCT02169830|4106768|FG002|STARTED|Second Intervention (8 Weeks)||0
3374186|NCT02169830|4106766|FG000|COMPLETED|Second Intervention (8 Weeks)||9
3374187|NCT02169830|4106767|FG001|COMPLETED|Second Intervention (8 Weeks)||0
3374188|NCT02169830|4106768|FG002|COMPLETED|Second Intervention (8 Weeks)||0
3374189|NCT02169830|4106766|FG000|NOT COMPLETED|Second Intervention (8 Weeks)||3
3374190|NCT02169830|4106767|FG001|NOT COMPLETED|Second Intervention (8 Weeks)||5
3374191|NCT02169830|4106768|FG002|NOT COMPLETED|Second Intervention (8 Weeks)||0
3374192|NCT02169830|4106766|FG000|STARTED|Third Intervention (8 Weeks)||0
3374193|NCT02169830|4106767|FG001|STARTED|Third Intervention (8 Weeks)|These four subjects were randomized to Diet first Topiramate second, and Nortriptyline third. No subjects from this group were weaned and moved to Nortriptyline.|4
3374194|NCT02169830|4106768|FG002|STARTED|Third Intervention (8 Weeks)||0
3374195|NCT02169830|4106766|FG000|COMPLETED|Third Intervention (8 Weeks)||0
3374196|NCT02169830|4106767|FG001|COMPLETED|Third Intervention (8 Weeks)||2
3374197|NCT02169830|4106768|FG002|COMPLETED|Third Intervention (8 Weeks)||0
3374198|NCT02169830|4106766|FG000|NOT COMPLETED|Third Intervention (8 Weeks)||0
3374199|NCT02169830|4106767|FG001|NOT COMPLETED|Third Intervention (8 Weeks)||2
3374200|NCT02169830|4106768|FG002|NOT COMPLETED|Third Intervention (8 Weeks)||0
3374201|NCT02163187|4106778|FG000|STARTED|Overall Study||4
3374202|NCT02163187|4106779|FG001|STARTED|Overall Study||0
3374203|NCT02163187|4106778|FG000|Treatment|Overall Study||2
3374204|NCT02163187|4106779|FG001|Treatment|Overall Study||0
3374205|NCT02163187|4106778|FG000|COMPLETED|Overall Study||2
3374206|NCT02163187|4106779|FG001|COMPLETED|Overall Study||0
3374207|NCT02163187|4106778|FG000|NOT COMPLETED|Overall Study||2
3263836|NCT02601001|3998102|FG000|STARTED|Dosing Period 2||10
3263837|NCT02601001|3998103|FG001|STARTED|Dosing Period 2||0
3263838|NCT02601001|3998104|FG002|STARTED|Dosing Period 2||0
3263839|NCT02601001|3998105|FG003|STARTED|Dosing Period 2||7
3263840|NCT02601001|3998106|FG004|STARTED|Dosing Period 2||13
3263841|NCT02601001|3998107|FG005|STARTED|Dosing Period 2||7
3263842|NCT02601001|3998108|FG006|STARTED|Dosing Period 2||13
3263843|NCT02601001|3998102|FG000|COMPLETED|Dosing Period 2||10
3263844|NCT02601001|3998103|FG001|COMPLETED|Dosing Period 2||0
3263845|NCT02601001|3998104|FG002|COMPLETED|Dosing Period 2||0
3263846|NCT02601001|3998105|FG003|COMPLETED|Dosing Period 2||7
3263847|NCT02601001|3998106|FG004|COMPLETED|Dosing Period 2||13
3263848|NCT02601001|3998107|FG005|COMPLETED|Dosing Period 2||7
3263849|NCT02601001|3998108|FG006|COMPLETED|Dosing Period 2||12
3263850|NCT02601001|3998102|FG000|NOT COMPLETED|Dosing Period 2||0
3263851|NCT02601001|3998103|FG001|NOT COMPLETED|Dosing Period 2||0
3263852|NCT02601001|3998104|FG002|NOT COMPLETED|Dosing Period 2||0
3263853|NCT02601001|3998105|FG003|NOT COMPLETED|Dosing Period 2||0
3263854|NCT02601001|3998106|FG004|NOT COMPLETED|Dosing Period 2||0
3263855|NCT02601001|3998107|FG005|NOT COMPLETED|Dosing Period 2||0
3263856|NCT02601001|3998108|FG006|NOT COMPLETED|Dosing Period 2||1
3263857|NCT02601027|3998131|FG000|STARTED|Registration to Surgery||64
3263858|NCT02601027|3998132|FG001|STARTED|Registration to Surgery||56
3263859|NCT02601027|3998131|FG000|COMPLETED|Registration to Surgery||44
3263860|NCT02601027|3998132|FG001|COMPLETED|Registration to Surgery||46
3263861|NCT02601027|3998131|FG000|NOT COMPLETED|Registration to Surgery||20
3263862|NCT02601027|3998132|FG001|NOT COMPLETED|Registration to Surgery||10
3263863|NCT02601027|3998131|FG000|STARTED|Surgery to Assessments||44
3263864|NCT02601027|3998132|FG001|STARTED|Surgery to Assessments||46
3263865|NCT02601027|3998131|FG000|COMPLETED|Surgery to Assessments||44
3263866|NCT02601027|3998132|FG001|COMPLETED|Surgery to Assessments||46
3263867|NCT02601027|3998131|FG000|NOT COMPLETED|Surgery to Assessments||0
3263868|NCT02601027|3998132|FG001|NOT COMPLETED|Surgery to Assessments||0
3263869|NCT02601105|3998138|FG000|STARTED|Placebo Cream; Centella Asiatica Bsln.||15
3263870|NCT02601105|3998138|FG000|COMPLETED|Placebo Cream; Centella Asiatica Bsln.||15
3263871|NCT02601105|3998138|FG000|NOT COMPLETED|Placebo Cream; Centella Asiatica Bsln.||0
3263872|NCT02601105|3998138|FG000|STARTED|Placebo Cream; Centella Asiatica Week 6||15
3263873|NCT02601105|3998138|FG000|COMPLETED|Placebo Cream; Centella Asiatica Week 6||15
3263874|NCT02601105|3998138|FG000|NOT COMPLETED|Placebo Cream; Centella Asiatica Week 6||0
3263875|NCT02601105|3998138|FG000|STARTED|Placebo Cream; Centella Asiatica Week 12||15
3263876|NCT02601105|3998138|FG000|COMPLETED|Placebo Cream; Centella Asiatica Week 12||13
3263877|NCT02601105|3998138|FG000|NOT COMPLETED|Placebo Cream; Centella Asiatica Week 12||2
3263878|NCT02601170|3998146|FG000|STARTED|Overall Study||11
3263879|NCT02601170|3998147|FG001|STARTED|Overall Study||11
3263880|NCT02601170|3998146|FG000|COMPLETED|Overall Study||11
3263881|NCT02601170|3998147|FG001|COMPLETED|Overall Study||11
3263882|NCT02601170|3998146|FG000|NOT COMPLETED|Overall Study||0
3263883|NCT02601170|3998147|FG001|NOT COMPLETED|Overall Study||0
3263884|NCT02601300|3998153|FG000|STARTED|Induction Phase||41
3263885|NCT02601300|3998153|FG000|COMPLETED|Induction Phase||38
3263886|NCT02601300|3998153|FG000|NOT COMPLETED|Induction Phase||3
3263887|NCT02601300|3998153|FG000|STARTED|Extension Phase|3 completed induction phase; did not enter extension due to withdrawal and lack of efficacy|35
3263888|NCT02601300|3998153|FG000|Treated With IP|Extension Phase||34
3263889|NCT02601300|3998153|FG000|COMPLETED|Extension Phase||18
3263890|NCT02601300|3998153|FG000|NOT COMPLETED|Extension Phase||17
3263891|NCT02601313|3998162|FG000|STARTED|Overall Study||14
3263892|NCT02601313|3998163|FG001|STARTED|Overall Study||74
3263893|NCT02601313|3998164|FG002|STARTED|Overall Study||17
3263894|NCT02601313|3998162|FG000|COMPLETED|Overall Study||8
3263895|NCT02601313|3998163|FG001|COMPLETED|Overall Study||0
3263896|NCT02601313|3998164|FG002|COMPLETED|Overall Study||0
3263897|NCT02601313|3998162|FG000|NOT COMPLETED|Overall Study||6
3263898|NCT02601313|3998163|FG001|NOT COMPLETED|Overall Study||74
3263899|NCT02601313|3998164|FG002|NOT COMPLETED|Overall Study||17
3374208|NCT02163187|4106779|FG001|NOT COMPLETED|Overall Study||0
3374209|NCT02161016|4106785|FG000|STARTED|Overall Study||1
3374210|NCT02161016|4106785|FG000|COMPLETED|Overall Study||0
3374211|NCT02161016|4106785|FG000|NOT COMPLETED|Overall Study||1
3374212|NCT02159040|4106789|FG000|STARTED|Overall Study||1
3374213|NCT02159040|4106789|FG000|COMPLETED|Overall Study||0
3374214|NCT02159040|4106789|FG000|NOT COMPLETED|Overall Study||1
3374215|NCT02168270|4106793|FG000|STARTED|Overall Study||4
3374216|NCT02168270|4106793|FG000|COMPLETED|Overall Study||0
3374217|NCT02168270|4106793|FG000|NOT COMPLETED|Overall Study||4
3374218|NCT02157116|4106797|FG000|STARTED|Overall Study|signed consent form|13
3374219|NCT02157116|4106797|FG000|COMPLETED|Overall Study||4
3374220|NCT02157116|4106797|FG000|NOT COMPLETED|Overall Study||9
3374221|NCT02154087|4106801|FG000|STARTED|Overall Study||1
3374222|NCT02154087|4106801|FG000|COMPLETED|Overall Study||0
3374223|NCT02154087|4106801|FG000|NOT COMPLETED|Overall Study||1
3374224|NCT02152670|4106805|FG000|STARTED|Overall Study||1
3263900|NCT02601469|3998174|FG000|STARTED|Overall Study||25
3263901|NCT02601469|3998175|FG001|STARTED|Overall Study||1
3263902|NCT02601469|3998174|FG000|COMPLETED|Overall Study||24
3263903|NCT02601469|3998175|FG001|COMPLETED|Overall Study||1
3263904|NCT02601469|3998174|FG000|NOT COMPLETED|Overall Study||1
3263905|NCT02601469|3998175|FG001|NOT COMPLETED|Overall Study||0
3263906|NCT02601560|3998189|FG000|STARTED|Overall Study||8
3263907|NCT02601560|3998190|FG001|STARTED|Overall Study||6
3263908|NCT02601560|3998191|FG002|STARTED|Overall Study||6
3374225|NCT02152670|4106805|FG000|COMPLETED|Overall Study||1
3374226|NCT02152670|4106805|FG000|NOT COMPLETED|Overall Study||0
3374227|NCT02152566|4106809|FG000|STARTED|Overall Study||6
3263909|NCT02601560|3998192|FG003|STARTED|Overall Study||6
3263910|NCT02601560|3998193|FG004|STARTED|Overall Study||6
3263911|NCT02601560|3998194|FG005|STARTED|Overall Study||4
3263912|NCT02601560|3998195|FG006|STARTED|Overall Study||6
3263913|NCT02601560|3998196|FG007|STARTED|Overall Study||6
3263914|NCT02601560|3998189|FG000|COMPLETED|Overall Study||8
3263915|NCT02601560|3998190|FG001|COMPLETED|Overall Study||6
3263916|NCT02601560|3998191|FG002|COMPLETED|Overall Study||6
3263917|NCT02601560|3998192|FG003|COMPLETED|Overall Study||6
3263918|NCT02601560|3998193|FG004|COMPLETED|Overall Study||6
3263919|NCT02601560|3998194|FG005|COMPLETED|Overall Study||4
3263920|NCT02601560|3998195|FG006|COMPLETED|Overall Study||5
3263921|NCT02601560|3998196|FG007|COMPLETED|Overall Study||6
3263922|NCT02601560|3998189|FG000|NOT COMPLETED|Overall Study||0
3263923|NCT02601560|3998190|FG001|NOT COMPLETED|Overall Study||0
3263924|NCT02601560|3998191|FG002|NOT COMPLETED|Overall Study||0
3263925|NCT02601560|3998192|FG003|NOT COMPLETED|Overall Study||0
3263926|NCT02601560|3998193|FG004|NOT COMPLETED|Overall Study||0
3263927|NCT02601560|3998194|FG005|NOT COMPLETED|Overall Study||0
3263928|NCT02601560|3998195|FG006|NOT COMPLETED|Overall Study||1
3263929|NCT02601560|3998196|FG007|NOT COMPLETED|Overall Study||0
3263930|NCT02601573|3998226|FG000|STARTED|Overall Study|Number randomized and treated.|23
3263931|NCT02601573|3998227|FG001|STARTED|Overall Study|Number randomized and treated.|24
3263932|NCT02601573|3998228|FG002|STARTED|Overall Study|Number randomized and treated.|17
3263933|NCT02601573|3998229|FG003|STARTED|Overall Study|Number randomized and treated.|18
3263934|NCT02601573|3998230|FG004|STARTED|Overall Study|Number randomized and treated.|18
3263935|NCT02601573|3998226|FG000|COMPLETED|Overall Study||23
3263936|NCT02601573|3998227|FG001|COMPLETED|Overall Study||20
3263937|NCT02601573|3998228|FG002|COMPLETED|Overall Study||16
3263938|NCT02601573|3998229|FG003|COMPLETED|Overall Study||17
3263939|NCT02601573|3998230|FG004|COMPLETED|Overall Study||16
3263940|NCT02601573|3998226|FG000|NOT COMPLETED|Overall Study||0
3263941|NCT02601573|3998227|FG001|NOT COMPLETED|Overall Study||4
3263942|NCT02601573|3998228|FG002|NOT COMPLETED|Overall Study||1
3263943|NCT02601573|3998229|FG003|NOT COMPLETED|Overall Study||1
3263944|NCT02601573|3998230|FG004|NOT COMPLETED|Overall Study||2
3263945|NCT02601625|3998246|FG000|STARTED|Overall Study||6
3263946|NCT02601625|3998247|FG001|STARTED|Overall Study||6
3263947|NCT02601625|3998248|FG002|STARTED|Overall Study||6
3263948|NCT02601625|3998249|FG003|STARTED|Overall Study||12
3263949|NCT02601625|3998246|FG000|COMPLETED|Overall Study||6
3263950|NCT02601625|3998247|FG001|COMPLETED|Overall Study||6
3263951|NCT02601625|3998248|FG002|COMPLETED|Overall Study||5
3263952|NCT02601625|3998249|FG003|COMPLETED|Overall Study||11
3263953|NCT02601625|3998246|FG000|NOT COMPLETED|Overall Study||0
3263954|NCT02601625|3998247|FG001|NOT COMPLETED|Overall Study||0
3263955|NCT02601625|3998248|FG002|NOT COMPLETED|Overall Study||1
3263956|NCT02601625|3998249|FG003|NOT COMPLETED|Overall Study||1
3263957|NCT02601820|3998273|FG000|STARTED|Pre-Treatment (T1)|1601 patients were enrolled and completed Baseline PROs (T1).|1601
3263958|NCT02601820|3998273|FG000|COMPLETED|Pre-Treatment (T1)||1601
3263959|NCT02601820|3998273|FG000|NOT COMPLETED|Pre-Treatment (T1)||0
3263960|NCT02601820|3998273|FG000|STARTED|Early On-Treatment (T2)|Of 1601, 17 were excluded at T2 due to death, withdrawal, other reason. 1584 remained in the study.|1584
3263961|NCT02601820|3998273|FG000|COMPLETED|Early On-Treatment (T2)|Of 1584, 51 were excluded for a missing T2 record. 1533 provided data at T2. Some outcomes missing.|1533
3263962|NCT02601820|3998273|FG000|NOT COMPLETED|Early On-Treatment (T2)||51
3263963|NCT02601820|3998273|FG000|STARTED|Late On-Treatment (T3)|Of 1601, 28 were excluded at T3 due to death, withdrawal, other reason. 1573 remained in the study.|1573
3263964|NCT02601820|3998273|FG000|COMPLETED|Late On-Treatment (T3)|Of 1573, 49 were excluded for a missing T3 record. 1524 provided data at T3. Some outcomes missing.|1524
3263965|NCT02601820|3998273|FG000|NOT COMPLETED|Late On-Treatment (T3)||49
3263966|NCT02601820|3998273|FG000|STARTED|12 Weeks Post-Treatment (T4)|Of 1601, 37 were excluded at T4 due to death, withdrawal, other reason. 1564 remained in the study.|1564
3263967|NCT02601820|3998273|FG000|COMPLETED|12 Weeks Post-Treatment (T4)|Of 1564, 3 were excluded for a missing T4 record. 1561 provided data at T4. Some outcomes missing.|1561
3263968|NCT02601820|3998273|FG000|NOT COMPLETED|12 Weeks Post-Treatment (T4)||3
3263969|NCT02601820|3998273|FG000|STARTED|1-Yr Post-Treatment (T5)|Of 1601, 73 were excluded at T5 due to death, withdrawal, other reason. 1528 remained in the study.|1528
3263970|NCT02601820|3998273|FG000|COMPLETED|1-Yr Post-Treatment (T5)|Of 1528, 88 were excluded for a missing T5 record. 1440 provided data at T5. Some outcomes missing.|1440
3263971|NCT02601820|3998273|FG000|NOT COMPLETED|1-Yr Post-Treatment (T5)||88
3263972|NCT02601833|3998292|FG000|STARTED|Overall Study||56
3263973|NCT02601833|3998293|FG001|STARTED|Overall Study||42
3263974|NCT02601833|3998292|FG000|COMPLETED|Overall Study||40
3263975|NCT02601833|3998293|FG001|COMPLETED|Overall Study||29
3263976|NCT02601833|3998292|FG000|NOT COMPLETED|Overall Study||16
3263977|NCT02601833|3998293|FG001|NOT COMPLETED|Overall Study||13
3263978|NCT02601976|3998302|FG000|STARTED|Overall Study||64
3263979|NCT02601976|3998302|FG000|COMPLETED|Overall Study||64
3263980|NCT02601976|3998302|FG000|NOT COMPLETED|Overall Study||0
3263981|NCT02602080|3998309|FG000|STARTED|Overall Study||21
3263982|NCT02602080|3998310|FG001|STARTED|Overall Study||16
3263983|NCT02602080|3998311|FG002|STARTED|Overall Study||18
3263984|NCT02602080|3998309|FG000|COMPLETED|Overall Study||15
3263985|NCT02602080|3998310|FG001|COMPLETED|Overall Study||15
3263986|NCT02602080|3998311|FG002|COMPLETED|Overall Study||15
3263987|NCT02602080|3998309|FG000|NOT COMPLETED|Overall Study||6
3263988|NCT02602080|3998310|FG001|NOT COMPLETED|Overall Study||1
3263989|NCT02602080|3998311|FG002|NOT COMPLETED|Overall Study||3
3263990|NCT02602223|3998319|FG000|STARTED|Overall Study||9
3263991|NCT02602223|3998319|FG000|COMPLETED|Overall Study||9
3263992|NCT02602223|3998319|FG000|NOT COMPLETED|Overall Study||0
3263993|NCT02602496|3998328|FG000|STARTED|Overall Study||15
3263994|NCT02602496|3998329|FG001|STARTED|Overall Study||20
3263995|NCT02602496|3998330|FG002|STARTED|Overall Study||17
3263996|NCT02602496|3998328|FG000|COMPLETED|Overall Study||14
3263997|NCT02602496|3998329|FG001|COMPLETED|Overall Study||18
3263998|NCT02602496|3998330|FG002|COMPLETED|Overall Study||17
3263999|NCT02602496|3998328|FG000|NOT COMPLETED|Overall Study||1
3264000|NCT02602496|3998329|FG001|NOT COMPLETED|Overall Study||2
3264001|NCT02602496|3998330|FG002|NOT COMPLETED|Overall Study||0
3264002|NCT02603107|3998340|FG000|STARTED|Randomized Phase||290
3264003|NCT02603107|3998341|FG001|STARTED|Randomized Phase||287
3264004|NCT02603107|3998340|FG000|COMPLETED|Randomized Phase||275
3264005|NCT02603107|3998341|FG001|COMPLETED|Randomized Phase||266
3264006|NCT02603107|3998340|FG000|NOT COMPLETED|Randomized Phase||15
3264007|NCT02603107|3998341|FG001|NOT COMPLETED|Randomized Phase||21
3264008|NCT02603107|3998340|FG000|STARTED|Optional Extension Phase|3 participants who completed the Randomized Phase did not continue in the Optional Extension Phase.|272
3374228|NCT02152566|4106809|FG000|COMPLETED|Overall Study||3
3374229|NCT02152566|4106809|FG000|NOT COMPLETED|Overall Study||3
3374230|NCT02137096|4106813|FG000|STARTED|Overall Study||1
3374231|NCT02137096|4106813|FG000|COMPLETED|Overall Study||1
3374232|NCT02137096|4106813|FG000|NOT COMPLETED|Overall Study||0
3374233|NCT02147834|4106819|FG000|STARTED|Overall Study||3
3374234|NCT02147834|4106820|FG001|STARTED|Overall Study||2
3374235|NCT02147834|4106819|FG000|COMPLETED|Overall Study||3
3374236|NCT02147834|4106820|FG001|COMPLETED|Overall Study||2
3374237|NCT02147834|4106819|FG000|NOT COMPLETED|Overall Study||0
3374238|NCT02147834|4106820|FG001|NOT COMPLETED|Overall Study||0
3374239|NCT02145390|4106826|FG000|STARTED|Overall Study||1
3374240|NCT02145390|4106826|FG000|COMPLETED|Overall Study||0
3374241|NCT02145390|4106826|FG000|NOT COMPLETED|Overall Study||1
3374242|NCT02132884|4106832|FG000|STARTED|Overall Study||0
3374243|NCT02132884|4106833|FG001|STARTED|Overall Study||0
3374244|NCT02132884|4106832|FG000|COMPLETED|Overall Study||0
3374245|NCT02132884|4106833|FG001|COMPLETED|Overall Study||0
3374246|NCT02132884|4106832|FG000|NOT COMPLETED|Overall Study||0
3374247|NCT02132884|4106833|FG001|NOT COMPLETED|Overall Study||0
3374248|NCT02144155|4106839|FG000|STARTED|Overall Study||14
3374249|NCT02144155|4106839|FG000|COMPLETED|Overall Study||14
3374250|NCT02144155|4106839|FG000|NOT COMPLETED|Overall Study||0
3374251|NCT02140788|4106843|FG000|STARTED|Overall Study||0
3374252|NCT02140788|4106844|FG001|STARTED|Overall Study||0
3374253|NCT02140788|4106845|FG002|STARTED|Overall Study||0
3374254|NCT02140788|4106846|FG003|STARTED|Overall Study||0
3374255|NCT02140788|4106843|FG000|COMPLETED|Overall Study||0
3374256|NCT02140788|4106844|FG001|COMPLETED|Overall Study||0
3374257|NCT02140788|4106845|FG002|COMPLETED|Overall Study||0
3374258|NCT02140788|4106846|FG003|COMPLETED|Overall Study||0
3374259|NCT02140788|4106843|FG000|NOT COMPLETED|Overall Study||0
3374260|NCT02140788|4106844|FG001|NOT COMPLETED|Overall Study||0
3374261|NCT02140788|4106845|FG002|NOT COMPLETED|Overall Study||0
3374262|NCT02140788|4106846|FG003|NOT COMPLETED|Overall Study||0
3374263|NCT02150863|4106859|FG000|STARTED|Overall Study||0
3374264|NCT02150863|4106860|FG001|STARTED|Overall Study||1
3374265|NCT02150863|4106861|FG002|STARTED|Overall Study||0
3374266|NCT02150863|4106859|FG000|COMPLETED|Overall Study||0
3374267|NCT02150863|4106860|FG001|COMPLETED|Overall Study||0
3374268|NCT02150863|4106861|FG002|COMPLETED|Overall Study||0
3374269|NCT02150863|4106859|FG000|NOT COMPLETED|Overall Study||0
3374270|NCT02150863|4106860|FG001|NOT COMPLETED|Overall Study||1
3374271|NCT02150863|4106861|FG002|NOT COMPLETED|Overall Study||0
3374272|NCT02145169|4106869|FG000|STARTED|Overall Study||0
3374273|NCT02145169|4106869|FG000|COMPLETED|Overall Study||0
3374274|NCT02145169|4106869|FG000|NOT COMPLETED|Overall Study||0
3374275|NCT02130622|4106875|FG000|STARTED|Overall Study||2
3374276|NCT02130622|4106876|FG001|STARTED|Overall Study||1
3374277|NCT02130622|4106875|FG000|COMPLETED|Overall Study||2
3374278|NCT02130622|4106876|FG001|COMPLETED|Overall Study||1
3374279|NCT02130622|4106875|FG000|NOT COMPLETED|Overall Study||0
3374280|NCT02130622|4106876|FG001|NOT COMPLETED|Overall Study||0
3374281|NCT02133534|4106882|FG000|STARTED|Overall Study||1
3374282|NCT02133534|4106882|FG000|COMPLETED|Overall Study||1
3374283|NCT02133534|4106882|FG000|NOT COMPLETED|Overall Study||0
3374284|NCT02134912|4106888|FG000|STARTED|Overall Study||0
3374285|NCT02134912|4106889|FG001|STARTED|Overall Study||0
3374286|NCT02134912|4106888|FG000|COMPLETED|Overall Study||0
3374287|NCT02134912|4106889|FG001|COMPLETED|Overall Study||0
3374288|NCT02134912|4106888|FG000|NOT COMPLETED|Overall Study||0
3374289|NCT02134912|4106889|FG001|NOT COMPLETED|Overall Study||0
3374290|NCT02131155|4106897|FG000|STARTED|Overall Study|Started are treated patients.|25
3374291|NCT02131155|4106898|FG001|STARTED|Overall Study|Started are treated patients.|11
3374292|NCT02131155|4106897|FG000|COMPLETED|Overall Study|Completed are patients who completed study procedures as protocol requires.|0
3374293|NCT02131155|4106898|FG001|COMPLETED|Overall Study|Completed are patients who completed study procedures as protocol requires.|0
3374294|NCT02131155|4106897|FG000|NOT COMPLETED|Overall Study||25
3374295|NCT02131155|4106898|FG001|NOT COMPLETED|Overall Study||11
3374296|NCT02117050|4106904|FG000|STARTED|Overall Study||1
3374297|NCT02117050|4106904|FG000|COMPLETED|Overall Study||0
3264009|NCT02603107|3998341|FG001|STARTED|Optional Extension Phase|21 participants who completed the Randomized Phase did not continue in the Optional Extension Phase.|245
3264010|NCT02603107|3998340|FG000|COMPLETED|Optional Extension Phase||263
3264011|NCT02603107|3998341|FG001|COMPLETED|Optional Extension Phase||232
3264012|NCT02603107|3998340|FG000|NOT COMPLETED|Optional Extension Phase||9
3264013|NCT02603107|3998341|FG001|NOT COMPLETED|Optional Extension Phase||13
3264014|NCT02603120|3998351|FG000|STARTED|Double-Blind Treatment Phase||284
3264015|NCT02603120|3998352|FG001|STARTED|Double-Blind Treatment Phase||283
3264016|NCT02603120|3998351|FG000|COMPLETED|Double-Blind Treatment Phase||265
3264017|NCT02603120|3998352|FG001|COMPLETED|Double-Blind Treatment Phase||267
3264018|NCT02603120|3998351|FG000|NOT COMPLETED|Double-Blind Treatment Phase||19
3264019|NCT02603120|3998352|FG001|NOT COMPLETED|Double-Blind Treatment Phase||16
3264020|NCT02603120|3998351|FG000|STARTED|OL Extension B/F/TAF Treatment Phase||259
3264021|NCT02603120|3998352|FG001|STARTED|OL Extension B/F/TAF Treatment Phase||265
3264022|NCT02603120|3998351|FG000|COMPLETED|OL Extension B/F/TAF Treatment Phase||254
3264023|NCT02603120|3998352|FG001|COMPLETED|OL Extension B/F/TAF Treatment Phase||254
3264024|NCT02603120|3998351|FG000|NOT COMPLETED|OL Extension B/F/TAF Treatment Phase||5
3264025|NCT02603120|3998352|FG001|NOT COMPLETED|OL Extension B/F/TAF Treatment Phase||11
3264026|NCT02603172|3998368|FG000|STARTED|Part A (Approximately 16 Weeks)||7
3264027|NCT02603172|3998369|FG001|STARTED|Part A (Approximately 16 Weeks)||1
3264028|NCT02603172|3998370|FG002|STARTED|Part A (Approximately 16 Weeks)||8
3264029|NCT02603172|3998371|FG003|STARTED|Part A (Approximately 16 Weeks)||1
3264030|NCT02603172|3998372|FG004|STARTED|Part A (Approximately 16 Weeks)||0
3264031|NCT02603172|3998373|FG005|STARTED|Part A (Approximately 16 Weeks)||0
3264032|NCT02603172|3998374|FG006|STARTED|Part A (Approximately 16 Weeks)||0
3264033|NCT02603172|3998375|FG007|STARTED|Part A (Approximately 16 Weeks)||0
3264034|NCT02603172|3998368|FG000|COMPLETED|Part A (Approximately 16 Weeks)||7
3264035|NCT02603172|3998369|FG001|COMPLETED|Part A (Approximately 16 Weeks)||1
3264036|NCT02603172|3998370|FG002|COMPLETED|Part A (Approximately 16 Weeks)||7
3264037|NCT02603172|3998371|FG003|COMPLETED|Part A (Approximately 16 Weeks)||1
3264038|NCT02603172|3998372|FG004|COMPLETED|Part A (Approximately 16 Weeks)||0
3264039|NCT02603172|3998373|FG005|COMPLETED|Part A (Approximately 16 Weeks)||0
3264040|NCT02603172|3998374|FG006|COMPLETED|Part A (Approximately 16 Weeks)||0
3264041|NCT02603172|3998375|FG007|COMPLETED|Part A (Approximately 16 Weeks)||0
3264042|NCT02603172|3998368|FG000|NOT COMPLETED|Part A (Approximately 16 Weeks)||0
3264043|NCT02603172|3998369|FG001|NOT COMPLETED|Part A (Approximately 16 Weeks)||0
3264044|NCT02603172|3998370|FG002|NOT COMPLETED|Part A (Approximately 16 Weeks)||1
3264045|NCT02603172|3998371|FG003|NOT COMPLETED|Part A (Approximately 16 Weeks)||0
3264046|NCT02603172|3998372|FG004|NOT COMPLETED|Part A (Approximately 16 Weeks)||0
3264047|NCT02603172|3998373|FG005|NOT COMPLETED|Part A (Approximately 16 Weeks)||0
3264048|NCT02603172|3998374|FG006|NOT COMPLETED|Part A (Approximately 16 Weeks)||0
3264049|NCT02603172|3998375|FG007|NOT COMPLETED|Part A (Approximately 16 Weeks)||0
3264050|NCT02603172|3998368|FG000|STARTED|Part B (Approximately 7 Weeks)||0
3264051|NCT02603172|3998369|FG001|STARTED|Part B (Approximately 7 Weeks)||1
3264052|NCT02603172|3998370|FG002|STARTED|Part B (Approximately 7 Weeks)||0
3264053|NCT02603172|3998371|FG003|STARTED|Part B (Approximately 7 Weeks)||1
3264054|NCT02603172|3998372|FG004|STARTED|Part B (Approximately 7 Weeks)||6
3264055|NCT02603172|3998373|FG005|STARTED|Part B (Approximately 7 Weeks)||0
3264056|NCT02603172|3998374|FG006|STARTED|Part B (Approximately 7 Weeks)||0
3264057|NCT02603172|3998375|FG007|STARTED|Part B (Approximately 7 Weeks)||0
3264058|NCT02603172|3998368|FG000|COMPLETED|Part B (Approximately 7 Weeks)||0
3374298|NCT02117050|4106904|FG000|NOT COMPLETED|Overall Study||1
3374299|NCT02110069|4106911|FG000|STARTED|Overall Study||2
3374300|NCT02110069|4106912|FG001|STARTED|Overall Study||2
3374301|NCT02110069|4106911|FG000|COMPLETED|Overall Study|subject was switched to sirolimus at maintenance course 7 for failure on Vincristine|0
3374302|NCT02110069|4106912|FG001|COMPLETED|Overall Study|1 subject was takend off protocol treatment at 10 months of maintenance for disease response.|2
3374303|NCT02110069|4106911|FG000|NOT COMPLETED|Overall Study||2
3374304|NCT02110069|4106912|FG001|NOT COMPLETED|Overall Study||0
3374305|NCT02110277|4106918|FG000|STARTED|Overall Study||2
3374306|NCT02110277|4106918|FG000|COMPLETED|Overall Study||0
3374307|NCT02110277|4106918|FG000|NOT COMPLETED|Overall Study||2
3374308|NCT02109809|4106922|FG000|STARTED|Overall Study||4
3374309|NCT02109809|4106922|FG000|COMPLETED|Overall Study||1
3374310|NCT02109809|4106922|FG000|NOT COMPLETED|Overall Study||3
3374311|NCT02105116|4106926|FG000|STARTED|Overall Study||6
3374312|NCT02105116|4106926|FG000|COMPLETED|Overall Study||0
3374313|NCT02105116|4106926|FG000|NOT COMPLETED|Overall Study||6
3374314|NCT02099318|4106932|FG000|STARTED|Overall Study||20
3374315|NCT02099318|4106933|FG001|STARTED|Overall Study||20
3374316|NCT02099318|4106932|FG000|COMPLETED|Overall Study||20
3374317|NCT02099318|4106933|FG001|COMPLETED|Overall Study||20
3374318|NCT02099318|4106932|FG000|NOT COMPLETED|Overall Study||0
3264059|NCT02603172|3998369|FG001|COMPLETED|Part B (Approximately 7 Weeks)||1
3264060|NCT02603172|3998370|FG002|COMPLETED|Part B (Approximately 7 Weeks)||0
3264061|NCT02603172|3998371|FG003|COMPLETED|Part B (Approximately 7 Weeks)||1
3264062|NCT02603172|3998372|FG004|COMPLETED|Part B (Approximately 7 Weeks)||6
3264063|NCT02603172|3998373|FG005|COMPLETED|Part B (Approximately 7 Weeks)||0
3264064|NCT02603172|3998374|FG006|COMPLETED|Part B (Approximately 7 Weeks)||0
3264065|NCT02603172|3998375|FG007|COMPLETED|Part B (Approximately 7 Weeks)||0
3264066|NCT02603172|3998368|FG000|NOT COMPLETED|Part B (Approximately 7 Weeks)||0
3264067|NCT02603172|3998369|FG001|NOT COMPLETED|Part B (Approximately 7 Weeks)||0
3264068|NCT02603172|3998370|FG002|NOT COMPLETED|Part B (Approximately 7 Weeks)||0
3264069|NCT02603172|3998371|FG003|NOT COMPLETED|Part B (Approximately 7 Weeks)||0
3264070|NCT02603172|3998372|FG004|NOT COMPLETED|Part B (Approximately 7 Weeks)||0
3264071|NCT02603172|3998373|FG005|NOT COMPLETED|Part B (Approximately 7 Weeks)||0
3264072|NCT02603172|3998374|FG006|NOT COMPLETED|Part B (Approximately 7 Weeks)||0
3264073|NCT02603172|3998375|FG007|NOT COMPLETED|Part B (Approximately 7 Weeks)||0
3264074|NCT02603172|3998368|FG000|STARTED|Part C (Approximately 13 Weeks)||0
3264075|NCT02603172|3998369|FG001|STARTED|Part C (Approximately 13 Weeks)||0
3264076|NCT02603172|3998370|FG002|STARTED|Part C (Approximately 13 Weeks)||0
3264077|NCT02603172|3998371|FG003|STARTED|Part C (Approximately 13 Weeks)||0
3264078|NCT02603172|3998372|FG004|STARTED|Part C (Approximately 13 Weeks)||0
3264079|NCT02603172|3998373|FG005|STARTED|Part C (Approximately 13 Weeks)||0
3264080|NCT02603172|3998374|FG006|STARTED|Part C (Approximately 13 Weeks)||0
3264081|NCT02603172|3998375|FG007|STARTED|Part C (Approximately 13 Weeks)||0
3264082|NCT02603172|3998368|FG000|COMPLETED|Part C (Approximately 13 Weeks)||0
3264083|NCT02603172|3998369|FG001|COMPLETED|Part C (Approximately 13 Weeks)||0
3264084|NCT02603172|3998370|FG002|COMPLETED|Part C (Approximately 13 Weeks)||0
3264085|NCT02603172|3998371|FG003|COMPLETED|Part C (Approximately 13 Weeks)||0
3264086|NCT02603172|3998372|FG004|COMPLETED|Part C (Approximately 13 Weeks)||0
3264087|NCT02603172|3998373|FG005|COMPLETED|Part C (Approximately 13 Weeks)||0
3264088|NCT02603172|3998374|FG006|COMPLETED|Part C (Approximately 13 Weeks)||0
3264089|NCT02603172|3998375|FG007|COMPLETED|Part C (Approximately 13 Weeks)||0
3264090|NCT02603172|3998368|FG000|NOT COMPLETED|Part C (Approximately 13 Weeks)||0
3264091|NCT02603172|3998369|FG001|NOT COMPLETED|Part C (Approximately 13 Weeks)||0
3264092|NCT02603172|3998370|FG002|NOT COMPLETED|Part C (Approximately 13 Weeks)||0
3264093|NCT02603172|3998371|FG003|NOT COMPLETED|Part C (Approximately 13 Weeks)||0
3264094|NCT02603172|3998372|FG004|NOT COMPLETED|Part C (Approximately 13 Weeks)||0
3264095|NCT02603172|3998373|FG005|NOT COMPLETED|Part C (Approximately 13 Weeks)||0
3264096|NCT02603172|3998374|FG006|NOT COMPLETED|Part C (Approximately 13 Weeks)||0
3264097|NCT02603172|3998375|FG007|NOT COMPLETED|Part C (Approximately 13 Weeks)||0
3264098|NCT02603211|3998391|FG000|STARTED|Overall Study||20
3264099|NCT02603211|3998391|FG000|COMPLETED|Overall Study||20
3264100|NCT02603211|3998391|FG000|NOT COMPLETED|Overall Study||0
3264101|NCT02603393|3998398|FG000|STARTED|Overall Study||527
3264102|NCT02603393|3998399|FG001|STARTED|Overall Study||526
3264103|NCT02603393|3998398|FG000|COMPLETED|Overall Study||456
3264104|NCT02603393|3998399|FG001|COMPLETED|Overall Study||472
3264105|NCT02603393|3998398|FG000|NOT COMPLETED|Overall Study||71
3264106|NCT02603393|3998399|FG001|NOT COMPLETED|Overall Study||54
3264107|NCT02603419|3998411|FG000|STARTED|Lead-in Phase:Maximum Exposure:123Weeks||6
3264108|NCT02603419|3998412|FG001|STARTED|Lead-in Phase:Maximum Exposure:123Weeks||7
3264109|NCT02603419|3998413|FG002|STARTED|Lead-in Phase:Maximum Exposure:123Weeks||6
3264110|NCT02603419|3998414|FG003|STARTED|Lead-in Phase:Maximum Exposure:123Weeks||6
3264111|NCT02603419|3998415|FG004|STARTED|Lead-in Phase:Maximum Exposure:123Weeks||6
3264112|NCT02603419|3998416|FG005|STARTED|Lead-in Phase:Maximum Exposure:123Weeks||0
3264113|NCT02603419|3998411|FG000|Treated|Lead-in Phase:Maximum Exposure:123Weeks||6
3264114|NCT02603419|3998412|FG001|Treated|Lead-in Phase:Maximum Exposure:123Weeks||6
3264115|NCT02603419|3998413|FG002|Treated|Lead-in Phase:Maximum Exposure:123Weeks||6
3264116|NCT02603419|3998414|FG003|Treated|Lead-in Phase:Maximum Exposure:123Weeks||6
3264117|NCT02603419|3998415|FG004|Treated|Lead-in Phase:Maximum Exposure:123Weeks||6
3264118|NCT02603419|3998416|FG005|Treated|Lead-in Phase:Maximum Exposure:123Weeks||0
3264119|NCT02603419|3998411|FG000|COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||0
3264120|NCT02603419|3998412|FG001|COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||0
3264121|NCT02603419|3998413|FG002|COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||0
3264122|NCT02603419|3998414|FG003|COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||0
3264123|NCT02603419|3998415|FG004|COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||0
3264124|NCT02603419|3998416|FG005|COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||0
3264125|NCT02603419|3998411|FG000|NOT COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||6
3264126|NCT02603419|3998412|FG001|NOT COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||7
3264127|NCT02603419|3998413|FG002|NOT COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||6
3264128|NCT02603419|3998414|FG003|NOT COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||6
3264129|NCT02603419|3998415|FG004|NOT COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||6
3264130|NCT02603419|3998416|FG005|NOT COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||0
3264131|NCT02603419|3998411|FG000|STARTED|Expansion Phase:Maximum Exposure:48Weeks||0
3264132|NCT02603419|3998412|FG001|STARTED|Expansion Phase:Maximum Exposure:48Weeks||0
3264133|NCT02603419|3998413|FG002|STARTED|Expansion Phase:Maximum Exposure:48Weeks||0
3264134|NCT02603419|3998414|FG003|STARTED|Expansion Phase:Maximum Exposure:48Weeks||0
3374319|NCT02099318|4106933|FG001|NOT COMPLETED|Overall Study||0
3374320|NCT02099344|4106943|FG000|STARTED|Overall Study||1
3264135|NCT02603419|3998415|FG004|STARTED|Expansion Phase:Maximum Exposure:48Weeks||0
3264136|NCT02603419|3998416|FG005|STARTED|Expansion Phase:Maximum Exposure:48Weeks|Participants started expansion phase while other few participants were completing lead-in phase.|3
3264137|NCT02603419|3998411|FG000|COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
3264138|NCT02603419|3998412|FG001|COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
3264139|NCT02603419|3998413|FG002|COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
3264140|NCT02603419|3998414|FG003|COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
3264141|NCT02603419|3998415|FG004|COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
3264142|NCT02603419|3998416|FG005|COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
3264143|NCT02603419|3998411|FG000|NOT COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
3264144|NCT02603419|3998412|FG001|NOT COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
3264145|NCT02603419|3998413|FG002|NOT COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
3264146|NCT02603419|3998414|FG003|NOT COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
3264147|NCT02603419|3998415|FG004|NOT COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
3264148|NCT02603419|3998416|FG005|NOT COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||3
3264149|NCT02603666|3998431|FG000|STARTED|Overall Study||130
3264150|NCT02603666|3998431|FG000|COMPLETED|Overall Study||130
3264151|NCT02603666|3998431|FG000|NOT COMPLETED|Overall Study||0
3264152|NCT02603809|3998441|FG000|STARTED|Overall Study||82
3264153|NCT02603809|3998442|FG001|STARTED|Overall Study||82
3264154|NCT02603809|3998443|FG002|STARTED|Overall Study||82
3264155|NCT02603809|3998444|FG003|STARTED|Overall Study||82
3264156|NCT02603809|3998445|FG004|STARTED|Overall Study||81
3264157|NCT02603809|3998446|FG005|STARTED|Overall Study||81
3264158|NCT02603809|3998441|FG000|Per-protocol Set|Overall Study||67
3264159|NCT02603809|3998442|FG001|Per-protocol Set|Overall Study||68
3264160|NCT02603809|3998443|FG002|Per-protocol Set|Overall Study||71
3264161|NCT02603809|3998444|FG003|Per-protocol Set|Overall Study||67
3264162|NCT02603809|3998445|FG004|Per-protocol Set|Overall Study||68
3264163|NCT02603809|3998446|FG005|Per-protocol Set|Overall Study||69
3264164|NCT02603809|3998441|FG000|Modified Per-Protocol Set|Overall Study|One participant had out of analysis window blood pressure measurements.|66
3264165|NCT02603809|3998442|FG001|Modified Per-Protocol Set|Overall Study||68
3264166|NCT02603809|3998443|FG002|Modified Per-Protocol Set|Overall Study||71
3264167|NCT02603809|3998444|FG003|Modified Per-Protocol Set|Overall Study||67
3264168|NCT02603809|3998445|FG004|Modified Per-Protocol Set|Overall Study||68
3264169|NCT02603809|3998446|FG005|Modified Per-Protocol Set|Overall Study||69
3264170|NCT02603809|3998441|FG000|Completed Study|Overall Study||75
3264171|NCT02603809|3998442|FG001|Completed Study|Overall Study||79
3264172|NCT02603809|3998443|FG002|Completed Study|Overall Study||79
3264173|NCT02603809|3998444|FG003|Completed Study|Overall Study||76
3264174|NCT02603809|3998445|FG004|Completed Study|Overall Study||78
3264175|NCT02603809|3998446|FG005|Completed Study|Overall Study||75
3264176|NCT02603809|3998441|FG000|COMPLETED|Overall Study||70
3264177|NCT02603809|3998442|FG001|COMPLETED|Overall Study||74
3264178|NCT02603809|3998443|FG002|COMPLETED|Overall Study||75
3264179|NCT02603809|3998444|FG003|COMPLETED|Overall Study||70
3264180|NCT02603809|3998445|FG004|COMPLETED|Overall Study||70
3264181|NCT02603809|3998446|FG005|COMPLETED|Overall Study||71
3264182|NCT02603809|3998441|FG000|NOT COMPLETED|Overall Study||12
3264183|NCT02603809|3998442|FG001|NOT COMPLETED|Overall Study||8
3264184|NCT02603809|3998443|FG002|NOT COMPLETED|Overall Study||7
3264185|NCT02603809|3998444|FG003|NOT COMPLETED|Overall Study||12
3264186|NCT02603809|3998445|FG004|NOT COMPLETED|Overall Study||11
3264187|NCT02603809|3998446|FG005|NOT COMPLETED|Overall Study||10
3264188|NCT02603887|3998462|FG000|STARTED|Overall Study||13
3264189|NCT02603887|3998462|FG000|Cycle 1|Overall Study||13
3264190|NCT02603887|3998462|FG000|Cycle 8|Overall Study||7
3264191|NCT02603887|3998462|FG000|COMPLETED|Overall Study||7
3264192|NCT02603887|3998462|FG000|NOT COMPLETED|Overall Study||6
3264193|NCT02603926|3998466|FG000|STARTED|Overall Study||6
3264194|NCT02603926|3998466|FG000|COMPLETED|Overall Study||6
3264195|NCT02603926|3998466|FG000|NOT COMPLETED|Overall Study||0
3264196|NCT02603952|3998475|FG000|STARTED|Overall Study||32
3264197|NCT02603952|3998476|FG001|STARTED|Overall Study||31
3264198|NCT02603952|3998477|FG002|STARTED|Overall Study||31
3264199|NCT02603952|3998478|FG003|STARTED|Overall Study||32
3264200|NCT02603952|3998475|FG000|Treated|Overall Study||32
3264201|NCT02603952|3998476|FG001|Treated|Overall Study||31
3264202|NCT02603952|3998477|FG002|Treated|Overall Study||31
3264203|NCT02603952|3998478|FG003|Treated|Overall Study||31
3264204|NCT02603952|3998475|FG000|COMPLETED|Overall Study||31
3264205|NCT02603952|3998476|FG001|COMPLETED|Overall Study||31
3264206|NCT02603952|3998477|FG002|COMPLETED|Overall Study||31
3264207|NCT02603952|3998478|FG003|COMPLETED|Overall Study||31
3264208|NCT02603952|3998475|FG000|NOT COMPLETED|Overall Study||1
3264209|NCT02603952|3998476|FG001|NOT COMPLETED|Overall Study||0
3264210|NCT02603952|3998477|FG002|NOT COMPLETED|Overall Study||0
3264211|NCT02603952|3998478|FG003|NOT COMPLETED|Overall Study||1
3264212|NCT02604017|3998493|FG000|STARTED|Overall Study||352
3264213|NCT02604017|3998494|FG001|STARTED|Overall Study||351
3264214|NCT02604017|3998493|FG000|COMPLETED|Overall Study||346
3264215|NCT02604017|3998494|FG001|COMPLETED|Overall Study||343
3264216|NCT02604017|3998493|FG000|NOT COMPLETED|Overall Study||6
3264217|NCT02604017|3998494|FG001|NOT COMPLETED|Overall Study||8
3264218|NCT02604160|3998502|FG000|STARTED|Overall Study||2
3264219|NCT02604160|3998503|FG001|STARTED|Overall Study||5
3264220|NCT02604160|3998502|FG000|Received at Least One Dose of Study Drug|Overall Study||2
3264221|NCT02604160|3998503|FG001|Received at Least One Dose of Study Drug|Overall Study||5
3264222|NCT02604160|3998502|FG000|COMPLETED|Overall Study||2
3264223|NCT02604160|3998503|FG001|COMPLETED|Overall Study||3
3264224|NCT02604160|3998502|FG000|NOT COMPLETED|Overall Study||0
3264225|NCT02604160|3998503|FG001|NOT COMPLETED|Overall Study||2
3264226|NCT02604173|3998514|FG000|STARTED|Overall Study||33
3264227|NCT02604173|3998515|FG001|STARTED|Overall Study||35
3264228|NCT02604173|3998516|FG002|STARTED|Overall Study||35
3264229|NCT02604173|3998514|FG000|COMPLETED|Overall Study||33
3264230|NCT02604173|3998515|FG001|COMPLETED|Overall Study||35
3264231|NCT02604173|3998516|FG002|COMPLETED|Overall Study||35
3264232|NCT02604173|3998514|FG000|NOT COMPLETED|Overall Study||0
3264233|NCT02604173|3998515|FG001|NOT COMPLETED|Overall Study||0
3264234|NCT02604173|3998516|FG002|NOT COMPLETED|Overall Study||0
3264235|NCT02604199|3998528|FG000|STARTED|Overall Study||9
3264236|NCT02604199|3998529|FG001|STARTED|Overall Study||11
3264237|NCT02604199|3998530|FG002|STARTED|Overall Study||17
3264238|NCT02604199|3998531|FG003|STARTED|Overall Study||21
3264239|NCT02604199|3998528|FG000|COMPLETED|Overall Study||9
3264240|NCT02604199|3998529|FG001|COMPLETED|Overall Study||8
3264241|NCT02604199|3998530|FG002|COMPLETED|Overall Study||17
3264242|NCT02604199|3998531|FG003|COMPLETED|Overall Study||18
3264243|NCT02604199|3998528|FG000|NOT COMPLETED|Overall Study||0
3264244|NCT02604199|3998529|FG001|NOT COMPLETED|Overall Study||3
3264245|NCT02604199|3998530|FG002|NOT COMPLETED|Overall Study||0
3264246|NCT02604199|3998531|FG003|NOT COMPLETED|Overall Study||3
3264247|NCT02604212|3998548|FG000|STARTED|Overall Study||6
3264248|NCT02604212|3998549|FG001|STARTED|Overall Study||5
3264249|NCT02604212|3998550|FG002|STARTED|Overall Study||10
3264250|NCT02604212|3998551|FG003|STARTED|Overall Study||11
3264251|NCT02604212|3998548|FG000|COMPLETED|Overall Study||4
3264252|NCT02604212|3998549|FG001|COMPLETED|Overall Study||4
3264253|NCT02604212|3998550|FG002|COMPLETED|Overall Study||6
3264254|NCT02604212|3998551|FG003|COMPLETED|Overall Study||8
3264255|NCT02604212|3998548|FG000|NOT COMPLETED|Overall Study||2
3264256|NCT02604212|3998549|FG001|NOT COMPLETED|Overall Study||1
3264257|NCT02604212|3998550|FG002|NOT COMPLETED|Overall Study||4
3264258|NCT02604212|3998551|FG003|NOT COMPLETED|Overall Study||3
3264259|NCT02604264|3998568|FG000|STARTED|Run-In||618
3264260|NCT02604264|3998569|FG001|STARTED|Run-In|The 1-mo run-in period data was used to determine pre-study demographics and PBC rate.|611
3264261|NCT02604264|3998568|FG000|COMPLETED|Run-In||618
3374321|NCT02099344|4106944|FG001|STARTED|Overall Study||0
3374322|NCT02099344|4106943|FG000|COMPLETED|Overall Study||0
3374323|NCT02099344|4106944|FG001|COMPLETED|Overall Study||0
3374324|NCT02099344|4106943|FG000|NOT COMPLETED|Overall Study||1
3374325|NCT02099344|4106944|FG001|NOT COMPLETED|Overall Study||0
3374326|NCT02094352|4106954|FG000|STARTED|Overall Study||2
3374327|NCT02094352|4106955|FG001|STARTED|Overall Study||1
3374328|NCT02094352|4106954|FG000|COMPLETED|Overall Study||2
3374329|NCT02094352|4106955|FG001|COMPLETED|Overall Study||1
3374330|NCT02094352|4106954|FG000|NOT COMPLETED|Overall Study||0
3374331|NCT02094352|4106955|FG001|NOT COMPLETED|Overall Study||0
3374332|NCT02096042|4106961|FG000|STARTED|Overall Study||1
3374333|NCT02096042|4106962|FG001|STARTED|Overall Study||0
3374334|NCT02096042|4106963|FG002|STARTED|Overall Study||0
3374335|NCT02096042|4106961|FG000|COMPLETED|Overall Study||0
3374336|NCT02096042|4106962|FG001|COMPLETED|Overall Study||0
3374337|NCT02096042|4106963|FG002|COMPLETED|Overall Study||0
3374338|NCT02096042|4106961|FG000|NOT COMPLETED|Overall Study||1
3374339|NCT02096042|4106962|FG001|NOT COMPLETED|Overall Study||0
3374340|NCT02096042|4106963|FG002|NOT COMPLETED|Overall Study||0
3374341|NCT02088957|4106970|FG000|STARTED|Overall Study||1
3374342|NCT02088957|4106971|FG001|STARTED|Overall Study||0
3374343|NCT02088957|4106970|FG000|COMPLETED|Overall Study||0
3374344|NCT02088957|4106971|FG001|COMPLETED|Overall Study||0
3374345|NCT02088957|4106970|FG000|NOT COMPLETED|Overall Study||1
3374346|NCT02088957|4106971|FG001|NOT COMPLETED|Overall Study||0
3374347|NCT02093689|4106980|FG000|STARTED|Overall Study||18
3374348|NCT02093689|4106981|FG001|STARTED|Overall Study||0
3374349|NCT02093689|4106982|FG002|STARTED|Overall Study||0
3374350|NCT02093689|4106980|FG000|COMPLETED|Overall Study||14
3374351|NCT02093689|4106981|FG001|COMPLETED|Overall Study||0
3374352|NCT02093689|4106982|FG002|COMPLETED|Overall Study||0
3374353|NCT02093689|4106980|FG000|NOT COMPLETED|Overall Study||4
3374354|NCT02093689|4106981|FG001|NOT COMPLETED|Overall Study||0
3374355|NCT02093689|4106982|FG002|NOT COMPLETED|Overall Study||0
3374356|NCT02091752|4106988|FG000|STARTED|Overall Study||3
3374357|NCT02091752|4106988|FG000|COMPLETED|Overall Study||0
3374358|NCT02091752|4106988|FG000|NOT COMPLETED|Overall Study||3
3374359|NCT02068547|4106994|FG000|STARTED|Overall Study||4
3374360|NCT02068547|4106995|FG001|STARTED|Overall Study||4
3374361|NCT02068547|4106994|FG000|COMPLETED|Overall Study||0
3374362|NCT02068547|4106995|FG001|COMPLETED|Overall Study||1
3374363|NCT02068547|4106994|FG000|NOT COMPLETED|Overall Study||4
3374364|NCT02068547|4106995|FG001|NOT COMPLETED|Overall Study||3
3264262|NCT02604264|3998569|FG001|COMPLETED|Run-In||611
3264263|NCT02604264|3998568|FG000|NOT COMPLETED|Run-In||0
3264264|NCT02604264|3998569|FG001|NOT COMPLETED|Run-In||0
3374365|NCT02075411|4107005|FG000|STARTED|Overall Study||0
3374366|NCT02075411|4107006|FG001|STARTED|Overall Study||0
3374367|NCT02075411|4107007|FG002|STARTED|Overall Study||0
3374368|NCT02075411|4107008|FG003|STARTED|Overall Study||1
3264265|NCT02604264|3998568|FG000|STARTED|Intervention||1445
3264266|NCT02604264|3998569|FG001|STARTED|Intervention||1467
3264267|NCT02604264|3998568|FG000|COMPLETED|Intervention||1245
3264268|NCT02604264|3998569|FG001|COMPLETED|Intervention||1225
3264269|NCT02604264|3998568|FG000|NOT COMPLETED|Intervention||200
3264270|NCT02604264|3998569|FG001|NOT COMPLETED|Intervention||242
3264271|NCT02604342|3998577|FG000|STARTED|Overall Study||79
3264272|NCT02604342|3998578|FG001|STARTED|Overall Study||40
3264273|NCT02604342|3998577|FG000|COMPLETED|Overall Study||36
3264274|NCT02604342|3998578|FG001|COMPLETED|Overall Study||17
3264275|NCT02604342|3998577|FG000|NOT COMPLETED|Overall Study||43
3264276|NCT02604342|3998578|FG001|NOT COMPLETED|Overall Study||23
3264277|NCT02604407|3998587|FG000|STARTED|Overall Study||91
3264278|NCT02604407|3998588|FG001|STARTED|Overall Study||92
3264279|NCT02604407|3998589|FG002|STARTED|Overall Study||92
3264280|NCT02604407|3998587|FG000|TREATED|Overall Study||89
3264281|NCT02604407|3998588|FG001|TREATED|Overall Study||92
3264282|NCT02604407|3998589|FG002|TREATED|Overall Study||90
3264283|NCT02604407|3998587|FG000|COMPLETED|Overall Study||80
3264284|NCT02604407|3998588|FG001|COMPLETED|Overall Study||80
3264285|NCT02604407|3998589|FG002|COMPLETED|Overall Study||76
3264286|NCT02604407|3998587|FG000|NOT COMPLETED|Overall Study||11
3264287|NCT02604407|3998588|FG001|NOT COMPLETED|Overall Study||12
3264288|NCT02604407|3998589|FG002|NOT COMPLETED|Overall Study||16
3264289|NCT02604550|3998599|FG000|STARTED|Overall Study||56
3264290|NCT02604550|3998600|FG001|STARTED|Overall Study||59
3264291|NCT02604550|3998599|FG000|COMPLETED|Overall Study||31
3264292|NCT02604550|3998600|FG001|COMPLETED|Overall Study||33
3264293|NCT02604550|3998599|FG000|NOT COMPLETED|Overall Study||25
3264294|NCT02604550|3998600|FG001|NOT COMPLETED|Overall Study||26
3264295|NCT02604589|3998609|FG000|STARTED|Overall Study||3
3264296|NCT02604589|3998610|FG001|STARTED|Overall Study||5
3264297|NCT02604589|3998611|FG002|STARTED|Overall Study||2
3264298|NCT02604589|3998609|FG000|COMPLETED|Overall Study||3
3264299|NCT02604589|3998610|FG001|COMPLETED|Overall Study||5
3264300|NCT02604589|3998611|FG002|COMPLETED|Overall Study||1
3264301|NCT02604589|3998609|FG000|NOT COMPLETED|Overall Study||0
3264302|NCT02604589|3998610|FG001|NOT COMPLETED|Overall Study||0
3264303|NCT02604589|3998611|FG002|NOT COMPLETED|Overall Study||1
3264304|NCT02604810|3998619|FG000|STARTED|IGIV-C 10%, 4-5 Weeks||52
3264305|NCT02604810|3998619|FG000|COMPLETED|IGIV-C 10%, 4-5 Weeks||49
3264306|NCT02604810|3998619|FG000|NOT COMPLETED|IGIV-C 10%, 4-5 Weeks||3
3264307|NCT02604810|3998619|FG000|STARTED|IGSC 20%, 24 Weeks||49
3264308|NCT02604810|3998619|FG000|COMPLETED|IGSC 20%, 24 Weeks||42
3264309|NCT02604810|3998619|FG000|NOT COMPLETED|IGSC 20%, 24 Weeks||7
3264310|NCT02605122|3998627|FG000|STARTED|Overall Study||73
3264311|NCT02605122|3998628|FG001|STARTED|Overall Study||24
3264312|NCT02605122|3998627|FG000|Received Study Drug|Overall Study||70
3264313|NCT02605122|3998628|FG001|Received Study Drug|Overall Study||24
3264314|NCT02605122|3998627|FG000|COMPLETED|Overall Study||68
3264315|NCT02605122|3998628|FG001|COMPLETED|Overall Study||22
3264316|NCT02605122|3998627|FG000|NOT COMPLETED|Overall Study||5
3264317|NCT02605122|3998628|FG001|NOT COMPLETED|Overall Study||2
3264318|NCT02605174|3998638|FG000|STARTED|Overall Study||501
3264319|NCT02605174|3998639|FG001|STARTED|Overall Study||249
3264320|NCT02605174|3998640|FG002|STARTED|Overall Study||502
3264321|NCT02605174|3998641|FG003|STARTED|Overall Study||252
3264322|NCT02605174|3998642|FG004|STARTED|Overall Study||501
3264323|NCT02605174|3998643|FG005|STARTED|Overall Study||249
3264324|NCT02605174|3998644|FG006|STARTED|Overall Study||751
3264325|NCT02605174|3998638|FG000|Received at Least 1 Dose of Study Drug|Overall Study||429
3264326|NCT02605174|3998639|FG001|Received at Least 1 Dose of Study Drug|Overall Study||225
3264327|NCT02605174|3998640|FG002|Received at Least 1 Dose of Study Drug|Overall Study||423
3264328|NCT02605174|3998641|FG003|Received at Least 1 Dose of Study Drug|Overall Study||212
3264329|NCT02605174|3998642|FG004|Received at Least 1 Dose of Study Drug|Overall Study||434
3264330|NCT02605174|3998643|FG005|Received at Least 1 Dose of Study Drug|Overall Study||215
3264331|NCT02605174|3998644|FG006|Received at Least 1 Dose of Study Drug|Overall Study||645
3264332|NCT02605174|3998638|FG000|Received Optional 2nd Dose|Overall Study||206
3264333|NCT02605174|3998639|FG001|Received Optional 2nd Dose|Overall Study||96
3264334|NCT02605174|3998640|FG002|Received Optional 2nd Dose|Overall Study||177
3264335|NCT02605174|3998641|FG003|Received Optional 2nd Dose|Overall Study||83
3264336|NCT02605174|3998642|FG004|Received Optional 2nd Dose|Overall Study||144
3264337|NCT02605174|3998643|FG005|Received Optional 2nd Dose|Overall Study||74
3264338|NCT02605174|3998644|FG006|Received Optional 2nd Dose|Overall Study||361
3264339|NCT02605174|3998638|FG000|COMPLETED|Overall Study||437
3264340|NCT02605174|3998639|FG001|COMPLETED|Overall Study||226
3264341|NCT02605174|3998640|FG002|COMPLETED|Overall Study||426
3264342|NCT02605174|3998641|FG003|COMPLETED|Overall Study||216
3264343|NCT02605174|3998642|FG004|COMPLETED|Overall Study||448
3264344|NCT02605174|3998643|FG005|COMPLETED|Overall Study||217
3264345|NCT02605174|3998644|FG006|COMPLETED|Overall Study||662
3264346|NCT02605174|3998638|FG000|NOT COMPLETED|Overall Study||64
3264347|NCT02605174|3998639|FG001|NOT COMPLETED|Overall Study||23
3264348|NCT02605174|3998640|FG002|NOT COMPLETED|Overall Study||76
3264349|NCT02605174|3998641|FG003|NOT COMPLETED|Overall Study||36
3264350|NCT02605174|3998642|FG004|NOT COMPLETED|Overall Study||53
3264351|NCT02605174|3998643|FG005|NOT COMPLETED|Overall Study||32
3264352|NCT02605174|3998644|FG006|NOT COMPLETED|Overall Study||89
3264353|NCT02605187|3998674|FG000|STARTED|Overall Study||40
3264354|NCT02605187|3998675|FG001|STARTED|Overall Study||21
3264355|NCT02605187|3998676|FG002|STARTED|Overall Study||83
3374369|NCT02075411|4107005|FG000|COMPLETED|Overall Study||0
3374370|NCT02075411|4107006|FG001|COMPLETED|Overall Study||0
3374371|NCT02075411|4107007|FG002|COMPLETED|Overall Study||0
3374372|NCT02075411|4107008|FG003|COMPLETED|Overall Study||1
3374373|NCT02075411|4107005|FG000|NOT COMPLETED|Overall Study||0
3374374|NCT02075411|4107006|FG001|NOT COMPLETED|Overall Study||0
3374375|NCT02075411|4107007|FG002|NOT COMPLETED|Overall Study||0
3374376|NCT02075411|4107008|FG003|NOT COMPLETED|Overall Study||0
3374377|NCT02074904|4107020|FG000|STARTED|Overall Study||1
3374378|NCT02074904|4107021|FG001|STARTED|Overall Study||0
3374379|NCT02074904|4107020|FG000|COMPLETED|Overall Study||1
3374380|NCT02074904|4107021|FG001|COMPLETED|Overall Study||0
3374381|NCT02074904|4107020|FG000|NOT COMPLETED|Overall Study||0
3374382|NCT02074904|4107021|FG001|NOT COMPLETED|Overall Study||0
3374383|NCT02084147|4107027|FG000|STARTED|Overall Study||72
3374384|NCT02084147|4107027|FG000|COMPLETED|Overall Study||72
3374385|NCT02084147|4107027|FG000|NOT COMPLETED|Overall Study||0
3374386|NCT02081183|4107033|FG000|STARTED|Overall Study||5
3374387|NCT02081183|4107034|FG001|STARTED|Overall Study||6
3374388|NCT02081183|4107033|FG000|COMPLETED|Overall Study||1
3374389|NCT02081183|4107034|FG001|COMPLETED|Overall Study||2
3374390|NCT02081183|4107033|FG000|NOT COMPLETED|Overall Study||4
3374391|NCT02081183|4107034|FG001|NOT COMPLETED|Overall Study||4
3374392|NCT02067611|4107040|FG000|STARTED|Overall Study||72
3374393|NCT02067611|4107041|FG001|STARTED|Overall Study||72
3374394|NCT02067611|4107042|FG002|STARTED|Overall Study||72
3374395|NCT02067611|4107040|FG000|COMPLETED|Overall Study||66
3374396|NCT02067611|4107041|FG001|COMPLETED|Overall Study||66
3374397|NCT02067611|4107042|FG002|COMPLETED|Overall Study||68
3374398|NCT02067611|4107040|FG000|NOT COMPLETED|Overall Study||6
3374399|NCT02067611|4107041|FG001|NOT COMPLETED|Overall Study||6
3374400|NCT02067611|4107042|FG002|NOT COMPLETED|Overall Study||4
3374401|NCT02067104|4107054|FG000|STARTED|Overall Study||4
3374402|NCT02067104|4107055|FG001|STARTED|Overall Study||5
3374403|NCT02067104|4107054|FG000|COMPLETED|Overall Study||0
3374404|NCT02067104|4107055|FG001|COMPLETED|Overall Study||0
3374405|NCT02067104|4107054|FG000|NOT COMPLETED|Overall Study||4
3374406|NCT02067104|4107055|FG001|NOT COMPLETED|Overall Study||5
3374407|NCT02075021|4107061|FG000|STARTED|Overall Study||3
3374408|NCT02075021|4107061|FG000|COMPLETED|Overall Study||3
3374409|NCT02075021|4107061|FG000|NOT COMPLETED|Overall Study||0
3374410|NCT02057874|4107065|FG000|STARTED|Overall Study||2
3374411|NCT02057874|4107065|FG000|COMPLETED|Overall Study||1
3374412|NCT02057874|4107065|FG000|NOT COMPLETED|Overall Study||1
3374413|NCT02057237|4107070|FG000|STARTED|Overall Study||1
3374414|NCT02057237|4107070|FG000|COMPLETED|Overall Study||1
3374415|NCT02057237|4107070|FG000|NOT COMPLETED|Overall Study||0
3374416|NCT02047747|4107075|FG000|STARTED|Overall Study||4
3374417|NCT02047747|4107075|FG000|COMPLETED|Overall Study||1
3374418|NCT02047747|4107075|FG000|NOT COMPLETED|Overall Study||3
3374419|NCT02058537|4107079|FG000|STARTED|Overall Study||3
3374420|NCT02058537|4107079|FG000|COMPLETED|Overall Study||2
3374421|NCT02058537|4107079|FG000|NOT COMPLETED|Overall Study||1
3264356|NCT02605187|3998677|FG003|STARTED|Overall Study||16
3264357|NCT02605187|3998674|FG000|COMPLETED|Overall Study||32
3264358|NCT02605187|3998675|FG001|COMPLETED|Overall Study||19
3264359|NCT02605187|3998676|FG002|COMPLETED|Overall Study||72
3264360|NCT02605187|3998677|FG003|COMPLETED|Overall Study||15
3264361|NCT02605187|3998674|FG000|NOT COMPLETED|Overall Study||8
3264362|NCT02605187|3998675|FG001|NOT COMPLETED|Overall Study||2
3264363|NCT02605187|3998676|FG002|NOT COMPLETED|Overall Study||11
3264364|NCT02605187|3998677|FG003|NOT COMPLETED|Overall Study||1
3264365|NCT02605304|3998689|FG000|STARTED|Overall Study||4
3264366|NCT02605304|3998690|FG001|STARTED|Overall Study||3
3264367|NCT02605304|3998689|FG000|COMPLETED|Overall Study||4
3264368|NCT02605304|3998690|FG001|COMPLETED|Overall Study||3
3264369|NCT02605304|3998689|FG000|NOT COMPLETED|Overall Study||0
3264370|NCT02605304|3998690|FG001|NOT COMPLETED|Overall Study||0
3264371|NCT02605395|3998696|FG000|STARTED|Period 1, Day 1||35
3264372|NCT02605395|3998697|FG001|STARTED|Period 1, Day 1||35
3264373|NCT02605395|3998696|FG000|COMPLETED|Period 1, Day 1||35
3264374|NCT02605395|3998697|FG001|COMPLETED|Period 1, Day 1||35
3264375|NCT02605395|3998696|FG000|NOT COMPLETED|Period 1, Day 1||0
3264376|NCT02605395|3998697|FG001|NOT COMPLETED|Period 1, Day 1||0
3264377|NCT02605395|3998696|FG000|STARTED|Washout Period, Day 2 to Day 7||35
3264378|NCT02605395|3998697|FG001|STARTED|Washout Period, Day 2 to Day 7||35
3264379|NCT02605395|3998696|FG000|COMPLETED|Washout Period, Day 2 to Day 7||35
3264380|NCT02605395|3998697|FG001|COMPLETED|Washout Period, Day 2 to Day 7||35
3264381|NCT02605395|3998696|FG000|NOT COMPLETED|Washout Period, Day 2 to Day 7||0
3264382|NCT02605395|3998697|FG001|NOT COMPLETED|Washout Period, Day 2 to Day 7||0
3264383|NCT02605395|3998696|FG000|STARTED|Period 2, Day 8||35
3264384|NCT02605395|3998697|FG001|STARTED|Period 2, Day 8||35
3264385|NCT02605395|3998696|FG000|COMPLETED|Period 2, Day 8||35
3264386|NCT02605395|3998697|FG001|COMPLETED|Period 2, Day 8||35
3264387|NCT02605395|3998696|FG000|NOT COMPLETED|Period 2, Day 8||0
3264388|NCT02605395|3998697|FG001|NOT COMPLETED|Period 2, Day 8||0
3264389|NCT02605447|3998703|FG000|STARTED|Overall Study||1487
3264390|NCT02605447|3998703|FG000|COMPLETED|Overall Study||1385
3264391|NCT02605447|3998703|FG000|NOT COMPLETED|Overall Study||102
3264392|NCT02605642|3998710|FG000|STARTED|Overall Study||227
3264393|NCT02605642|3998711|FG001|STARTED|Overall Study||107
3264394|NCT02605642|3998710|FG000|Safety Set|Overall Study||221
3264395|NCT02605642|3998711|FG001|Safety Set|Overall Study||107
3264396|NCT02605642|3998710|FG000|COMPLETED|Overall Study||131
3264397|NCT02605642|3998711|FG001|COMPLETED|Overall Study||86
3264398|NCT02605642|3998710|FG000|NOT COMPLETED|Overall Study||96
3264399|NCT02605642|3998711|FG001|NOT COMPLETED|Overall Study||21
3264400|NCT02605837|3998719|FG000|STARTED|Overall Study||105
3264401|NCT02605837|3998720|FG001|STARTED|Overall Study||213
3264402|NCT02605837|3998719|FG000|COMPLETED|Overall Study||94
3264403|NCT02605837|3998720|FG001|COMPLETED|Overall Study||202
3264404|NCT02605837|3998719|FG000|NOT COMPLETED|Overall Study||11
3264405|NCT02605837|3998720|FG001|NOT COMPLETED|Overall Study||11
3264406|NCT02605863|3998729|FG000|STARTED|Overall Study||1
3264407|NCT02605863|3998730|FG001|STARTED|Overall Study||0
3264408|NCT02605863|3998729|FG000|COMPLETED|Overall Study||1
3264409|NCT02605863|3998730|FG001|COMPLETED|Overall Study||0
3264410|NCT02605863|3998729|FG000|NOT COMPLETED|Overall Study||0
3264411|NCT02605863|3998730|FG001|NOT COMPLETED|Overall Study||0
3264412|NCT02605876|3998739|FG000|STARTED|Overall Study||25
3264413|NCT02605876|3998740|FG001|STARTED|Overall Study||25
3264414|NCT02605876|3998741|FG002|STARTED|Overall Study||25
3264415|NCT02605876|3998739|FG000|COMPLETED|Overall Study||25
3264416|NCT02605876|3998740|FG001|COMPLETED|Overall Study||25
3264417|NCT02605876|3998741|FG002|COMPLETED|Overall Study||25
3264418|NCT02605876|3998739|FG000|NOT COMPLETED|Overall Study||0
3264419|NCT02605876|3998740|FG001|NOT COMPLETED|Overall Study||0
3264420|NCT02605876|3998741|FG002|NOT COMPLETED|Overall Study||0
3264421|NCT02605928|3998749|FG000|STARTED|Overall Study||79
3264422|NCT02605928|3998749|FG000|Pivotal Phase, Statistical Phase|Overall Study||51
3264423|NCT02605928|3998749|FG000|COMPLETED|Overall Study||46
3264424|NCT02605928|3998749|FG000|NOT COMPLETED|Overall Study||33
3374422|NCT02057276|4107085|FG000|STARTED|Overall Study||0
3374423|NCT02057276|4107086|FG001|STARTED|Overall Study||0
3374424|NCT02057276|4107085|FG000|COMPLETED|Overall Study||0
3374425|NCT02057276|4107086|FG001|COMPLETED|Overall Study||0
3264425|NCT02605954|3998755|FG000|STARTED|Overall Study||183
3264426|NCT02605954|3998756|FG001|STARTED|Overall Study||92
3264427|NCT02605954|3998755|FG000|COMPLETED|Overall Study||171
3264428|NCT02605954|3998756|FG001|COMPLETED|Overall Study||88
3264429|NCT02605954|3998755|FG000|NOT COMPLETED|Overall Study||12
3264430|NCT02605954|3998756|FG001|NOT COMPLETED|Overall Study||4
3264431|NCT02605993|3998769|FG000|STARTED|Treatment Period||6
3264432|NCT02605993|3998770|FG001|STARTED|Treatment Period||6
3264433|NCT02605993|3998771|FG002|STARTED|Treatment Period||7
3264434|NCT02605993|3998772|FG003|STARTED|Treatment Period||7
3264435|NCT02605993|3998769|FG000|Received at Least 1 Dose of Study Drug|Treatment Period||6
3264436|NCT02605993|3998770|FG001|Received at Least 1 Dose of Study Drug|Treatment Period||6
3264437|NCT02605993|3998771|FG002|Received at Least 1 Dose of Study Drug|Treatment Period||7
3264438|NCT02605993|3998772|FG003|Received at Least 1 Dose of Study Drug|Treatment Period||7
3264439|NCT02605993|3998769|FG000|COMPLETED|Treatment Period||6
3264440|NCT02605993|3998770|FG001|COMPLETED|Treatment Period||6
3264441|NCT02605993|3998771|FG002|COMPLETED|Treatment Period||7
3264442|NCT02605993|3998772|FG003|COMPLETED|Treatment Period||7
3264443|NCT02605993|3998769|FG000|NOT COMPLETED|Treatment Period||0
3264444|NCT02605993|3998770|FG001|NOT COMPLETED|Treatment Period||0
3264445|NCT02605993|3998771|FG002|NOT COMPLETED|Treatment Period||0
3264446|NCT02605993|3998772|FG003|NOT COMPLETED|Treatment Period||0
3264447|NCT02605993|3998769|FG000|STARTED|Extension Period||6
3264448|NCT02605993|3998770|FG001|STARTED|Extension Period||6
3264449|NCT02605993|3998771|FG002|STARTED|Extension Period||7
3264450|NCT02605993|3998772|FG003|STARTED|Extension Period||7
3264451|NCT02605993|3998769|FG000|COMPLETED|Extension Period||0
3264452|NCT02605993|3998770|FG001|COMPLETED|Extension Period||0
3374426|NCT02057276|4107085|FG000|NOT COMPLETED|Overall Study||0
3374427|NCT02057276|4107086|FG001|NOT COMPLETED|Overall Study||0
3264453|NCT02605993|3998771|FG002|COMPLETED|Extension Period||0
3264454|NCT02605993|3998772|FG003|COMPLETED|Extension Period||0
3264455|NCT02605993|3998769|FG000|NOT COMPLETED|Extension Period||6
3264456|NCT02605993|3998770|FG001|NOT COMPLETED|Extension Period||6
3374428|NCT02038153|4107092|FG000|STARTED|Overall Study||3
3374429|NCT02038153|4107092|FG000|COMPLETED|Overall Study||2
3374430|NCT02038153|4107092|FG000|NOT COMPLETED|Overall Study||1
3374431|NCT02054910|4107098|FG000|STARTED|Overall Study||4
3374432|NCT02054910|4107099|FG001|STARTED|Overall Study||1
3374433|NCT02054910|4107098|FG000|COMPLETED|Overall Study||0
3374434|NCT02054910|4107099|FG001|COMPLETED|Overall Study||0
3374435|NCT02054910|4107098|FG000|NOT COMPLETED|Overall Study||4
3374436|NCT02054910|4107099|FG001|NOT COMPLETED|Overall Study||1
3374437|NCT02044302|4107109|FG000|STARTED|Overall Study||2
3374438|NCT02044302|4107110|FG001|STARTED|Overall Study||0
3374439|NCT02044302|4107109|FG000|COMPLETED|Overall Study||0
3374440|NCT02044302|4107110|FG001|COMPLETED|Overall Study||0
3374441|NCT02044302|4107109|FG000|NOT COMPLETED|Overall Study||2
3374442|NCT02044302|4107110|FG001|NOT COMPLETED|Overall Study||0
3374443|NCT02046226|4107114|FG000|STARTED|Overall Study||7
3374444|NCT02046226|4107114|FG000|COMPLETED|Overall Study||0
3374445|NCT02046226|4107114|FG000|NOT COMPLETED|Overall Study||7
3374446|NCT02044848|4107121|FG000|STARTED|Overall Study||2
3374447|NCT02044848|4107122|FG001|STARTED|Overall Study||3
3374448|NCT02044848|4107121|FG000|COMPLETED|Overall Study||0
3374449|NCT02044848|4107122|FG001|COMPLETED|Overall Study||0
3374450|NCT02044848|4107121|FG000|NOT COMPLETED|Overall Study||2
3374451|NCT02044848|4107122|FG001|NOT COMPLETED|Overall Study||3
3374452|NCT02042950|4107128|FG000|STARTED|Overall Study||4
3374453|NCT02042950|4107128|FG000|COMPLETED|Overall Study||0
3374454|NCT02042950|4107128|FG000|NOT COMPLETED|Overall Study||4
3374455|NCT02048904|4107132|FG000|STARTED|Overall Study||142
3374456|NCT02048904|4107132|FG000|COMPLETED|Overall Study||65
3374457|NCT02048904|4107132|FG000|NOT COMPLETED|Overall Study||77
3374458|NCT02044822|4107136|FG000|STARTED|Overall Study||102
3374459|NCT02044822|4107136|FG000|COMPLETED|Overall Study|Completed = reached primary efficacy endpoint of progressive disease or death.|9
3374460|NCT02044822|4107136|FG000|NOT COMPLETED|Overall Study||93
3374461|NCT02042924|4107140|FG000|STARTED|Overall Study||2
3374462|NCT02042924|4107140|FG000|COMPLETED|Overall Study||1
3374463|NCT02042924|4107140|FG000|NOT COMPLETED|Overall Study||1
3374464|NCT02043860|4107144|FG000|STARTED|Overall Study||2
3374465|NCT02043860|4107144|FG000|COMPLETED|Overall Study||2
3374466|NCT02043860|4107144|FG000|NOT COMPLETED|Overall Study||0
3374467|NCT02017522|4107148|FG000|STARTED|Overall Study||3
3374468|NCT02017522|4107148|FG000|Scan|Overall Study||2
3374469|NCT02017522|4107148|FG000|COMPLETED|Overall Study||2
3374470|NCT02017522|4107148|FG000|NOT COMPLETED|Overall Study||1
3374471|NCT02030015|4107153|FG000|STARTED|Overall Study||16
3374472|NCT02030015|4107153|FG000|COMPLETED|Overall Study||0
3374473|NCT02030015|4107153|FG000|NOT COMPLETED|Overall Study||16
3374474|NCT02015663|4107159|FG000|STARTED|Overall Study||16
3374475|NCT02015663|4107160|FG001|STARTED|Overall Study||16
3374476|NCT02015663|4107159|FG000|COMPLETED|Overall Study||1
3374477|NCT02015663|4107160|FG001|COMPLETED|Overall Study||4
3374478|NCT02015663|4107159|FG000|NOT COMPLETED|Overall Study||15
3374479|NCT02015663|4107160|FG001|NOT COMPLETED|Overall Study||12
3374480|NCT02029846|4107169|FG000|STARTED|Overall Study||1
3374481|NCT02029846|4107170|FG001|STARTED|Overall Study||1
3374482|NCT02029846|4107169|FG000|COMPLETED|Overall Study||0
3374483|NCT02029846|4107170|FG001|COMPLETED|Overall Study||0
3374484|NCT02029846|4107169|FG000|NOT COMPLETED|Overall Study||1
3374485|NCT02029846|4107170|FG001|NOT COMPLETED|Overall Study||1
3374486|NCT02027272|4107178|FG000|STARTED|Overall Study||0
3374487|NCT02027272|4107179|FG001|STARTED|Overall Study||1
3374488|NCT02027272|4107178|FG000|COMPLETED|Overall Study||0
3374489|NCT02027272|4107179|FG001|COMPLETED|Overall Study||0
3374490|NCT02027272|4107178|FG000|NOT COMPLETED|Overall Study||0
3374491|NCT02027272|4107179|FG001|NOT COMPLETED|Overall Study||1
3374492|NCT02012608|4107187|FG000|STARTED|Overall Study||7
3374493|NCT02012608|4107188|FG001|STARTED|Overall Study||7
3374494|NCT02012608|4107187|FG000|COMPLETED|Overall Study||4
3374495|NCT02012608|4107188|FG001|COMPLETED|Overall Study||7
3374496|NCT02012608|4107187|FG000|NOT COMPLETED|Overall Study||3
3374497|NCT02012608|4107188|FG001|NOT COMPLETED|Overall Study||0
3374498|NCT02017379|4107197|FG000|STARTED|Overall Study||0
3374499|NCT02017379|4107198|FG001|STARTED|Overall Study||0
3374500|NCT02017379|4107199|FG002|STARTED|Overall Study||0
3374501|NCT02017379|4107197|FG000|COMPLETED|Overall Study||0
3374502|NCT02017379|4107198|FG001|COMPLETED|Overall Study||0
3374503|NCT02017379|4107199|FG002|COMPLETED|Overall Study||0
3374504|NCT02017379|4107197|FG000|NOT COMPLETED|Overall Study||0
3264457|NCT02605993|3998771|FG002|NOT COMPLETED|Extension Period||7
3264458|NCT02605993|3998772|FG003|NOT COMPLETED|Extension Period||7
3264459|NCT02606253|3998785|FG000|STARTED|Overall Study||20
3264460|NCT02606253|3998786|FG001|STARTED|Overall Study||20
3264461|NCT02606253|3998787|FG002|STARTED|Overall Study||20
3264462|NCT02606253|3998785|FG000|COMPLETED|Overall Study||15
3264463|NCT02606253|3998786|FG001|COMPLETED|Overall Study||18
3264464|NCT02606253|3998787|FG002|COMPLETED|Overall Study||20
3264465|NCT02606253|3998785|FG000|NOT COMPLETED|Overall Study||5
3374505|NCT02017379|4107198|FG001|NOT COMPLETED|Overall Study||0
3374506|NCT02017379|4107199|FG002|NOT COMPLETED|Overall Study||0
3374507|NCT02011542|4107207|FG000|STARTED|Overall Study||30
3264466|NCT02606253|3998786|FG001|NOT COMPLETED|Overall Study||2
3264467|NCT02606253|3998787|FG002|NOT COMPLETED|Overall Study||0
3264468|NCT02606500|3998797|FG000|STARTED|Overall Study||35
3264469|NCT02606500|3998798|FG001|STARTED|Overall Study||35
3264470|NCT02606500|3998797|FG000|COMPLETED|Overall Study||35
3264471|NCT02606500|3998798|FG001|COMPLETED|Overall Study||35
3264472|NCT02606500|3998797|FG000|NOT COMPLETED|Overall Study||0
3264473|NCT02606500|3998798|FG001|NOT COMPLETED|Overall Study||0
3264474|NCT02606604|3998806|FG000|STARTED|Overall Study||8
3264475|NCT02606604|3998807|FG001|STARTED|Overall Study||7
3264476|NCT02606604|3998806|FG000|COMPLETED|Overall Study||7
3264477|NCT02606604|3998807|FG001|COMPLETED|Overall Study||7
3264478|NCT02606604|3998806|FG000|NOT COMPLETED|Overall Study||1
3264479|NCT02606604|3998807|FG001|NOT COMPLETED|Overall Study||0
3264480|NCT02606643|3998817|FG000|STARTED|Overall Study||68
3264481|NCT02606643|3998818|FG001|STARTED|Overall Study||76
3264482|NCT02606643|3998817|FG000|COMPLETED|Overall Study||67
3264483|NCT02606643|3998818|FG001|COMPLETED|Overall Study||73
3264484|NCT02606643|3998817|FG000|NOT COMPLETED|Overall Study||1
3264485|NCT02606643|3998818|FG001|NOT COMPLETED|Overall Study||3
3264486|NCT02606708|3998828|FG000|STARTED|Overall Study||314
3264487|NCT02606708|3998828|FG000|COMPLETED|Overall Study||314
3264488|NCT02606708|3998828|FG000|NOT COMPLETED|Overall Study||0
3264489|NCT02606734|3998832|FG000|STARTED|Overall Study||44
3264490|NCT02606734|3998832|FG000|COMPLETED|Overall Study||44
3264491|NCT02606734|3998832|FG000|NOT COMPLETED|Overall Study||0
3264492|NCT02606838|3998836|FG000|STARTED|Overall Study||119
3264493|NCT02606838|3998836|FG000|COMPLETED|Overall Study||119
3264494|NCT02606838|3998836|FG000|NOT COMPLETED|Overall Study||0
3264495|NCT02606877|3998846|FG000|STARTED|Overall Study||20
3264496|NCT02606877|3998847|FG001|STARTED|Overall Study||17
3264497|NCT02606877|3998846|FG000|COMPLETED|Overall Study||16
3264498|NCT02606877|3998847|FG001|COMPLETED|Overall Study||16
3264499|NCT02606877|3998846|FG000|NOT COMPLETED|Overall Study||4
3264500|NCT02606877|3998847|FG001|NOT COMPLETED|Overall Study||1
3374508|NCT02011542|4107207|FG000|COMPLETED|Overall Study||29
3264501|NCT02606903|3998857|FG000|STARTED|Overall Study||35
3264502|NCT02606903|3998858|FG001|STARTED|Overall Study||36
3264503|NCT02606903|3998857|FG000|COMPLETED|Overall Study||35
3264504|NCT02606903|3998858|FG001|COMPLETED|Overall Study||36
3264505|NCT02606903|3998857|FG000|NOT COMPLETED|Overall Study||0
3264506|NCT02606903|3998858|FG001|NOT COMPLETED|Overall Study||0
3264507|NCT02607124|3998864|FG000|STARTED|Overall Study|11 participants were enrolled however 1 participant withdrew before starting study treatment.|10
3264508|NCT02607124|3998864|FG000|COMPLETED|Overall Study||10
3264509|NCT02607124|3998864|FG000|NOT COMPLETED|Overall Study||0
3264510|NCT02607228|3998876|FG000|STARTED|Overall Study||5
3264511|NCT02607228|3998877|FG001|STARTED|Overall Study||4
3264512|NCT02607228|3998878|FG002|STARTED|Overall Study||3
3264513|NCT02607228|3998879|FG003|STARTED|Overall Study||6
3264514|NCT02607228|3998880|FG004|STARTED|Overall Study||5
3264515|NCT02607228|3998881|FG005|STARTED|Overall Study||6
3264516|NCT02607228|3998882|FG006|STARTED|Overall Study||2
3264517|NCT02607228|3998876|FG000|COMPLETED|Overall Study||0
3264518|NCT02607228|3998877|FG001|COMPLETED|Overall Study||0
3264519|NCT02607228|3998878|FG002|COMPLETED|Overall Study||0
3264520|NCT02607228|3998879|FG003|COMPLETED|Overall Study||0
3264521|NCT02607228|3998880|FG004|COMPLETED|Overall Study||0
3264522|NCT02607228|3998881|FG005|COMPLETED|Overall Study||0
3264523|NCT02607228|3998882|FG006|COMPLETED|Overall Study||0
3264524|NCT02607228|3998876|FG000|NOT COMPLETED|Overall Study||5
3264525|NCT02607228|3998877|FG001|NOT COMPLETED|Overall Study||4
3264526|NCT02607228|3998878|FG002|NOT COMPLETED|Overall Study||3
3264527|NCT02607228|3998879|FG003|NOT COMPLETED|Overall Study||6
3264528|NCT02607228|3998880|FG004|NOT COMPLETED|Overall Study||5
3264529|NCT02607228|3998881|FG005|NOT COMPLETED|Overall Study||6
3264530|NCT02607228|3998882|FG006|NOT COMPLETED|Overall Study||2
3264531|NCT02607254|3998902|FG000|STARTED|Overall Study||3
3264532|NCT02607254|3998903|FG001|STARTED|Overall Study||3
3264533|NCT02607254|3998904|FG002|STARTED|Overall Study||5
3264534|NCT02607254|3998902|FG000|COMPLETED|Overall Study||3
3264535|NCT02607254|3998903|FG001|COMPLETED|Overall Study||3
3264536|NCT02607254|3998904|FG002|COMPLETED|Overall Study||5
3264537|NCT02607254|3998902|FG000|NOT COMPLETED|Overall Study||0
3264538|NCT02607254|3998903|FG001|NOT COMPLETED|Overall Study||0
3264539|NCT02607254|3998904|FG002|NOT COMPLETED|Overall Study||0
3264540|NCT02607280|3998920|FG000|STARTED|Overall Study||30
3264541|NCT02607280|3998921|FG001|STARTED|Overall Study||5
3264542|NCT02607280|3998920|FG000|Received Study Drug|Overall Study||30
3264543|NCT02607280|3998921|FG001|Received Study Drug|Overall Study||5
3264544|NCT02607280|3998920|FG000|COMPLETED|Overall Study||26
3264545|NCT02607280|3998921|FG001|COMPLETED|Overall Study||4
3264546|NCT02607280|3998920|FG000|NOT COMPLETED|Overall Study||4
3264547|NCT02607280|3998921|FG001|NOT COMPLETED|Overall Study||1
3264548|NCT02607306|3998930|FG000|STARTED|Overall Study||275
3264549|NCT02607306|3998931|FG001|STARTED|Overall Study||271
3264550|NCT02607306|3998932|FG002|STARTED|Overall Study||273
3264551|NCT02607306|3998930|FG000|COMPLETED|Overall Study||254
3264552|NCT02607306|3998931|FG001|COMPLETED|Overall Study||248
3264553|NCT02607306|3998932|FG002|COMPLETED|Overall Study||263
3264554|NCT02607306|3998930|FG000|NOT COMPLETED|Overall Study||21
3264555|NCT02607306|3998931|FG001|NOT COMPLETED|Overall Study||23
3264556|NCT02607306|3998932|FG002|NOT COMPLETED|Overall Study||10
3264557|NCT02607618|3998943|FG000|STARTED|Overall Study||306
3264558|NCT02607618|3998944|FG001|STARTED|Overall Study||307
3264559|NCT02607618|3998943|FG000|COMPLETED|Overall Study||295
3264560|NCT02607618|3998944|FG001|COMPLETED|Overall Study||305
3264561|NCT02607618|3998943|FG000|NOT COMPLETED|Overall Study||11
3264562|NCT02607618|3998944|FG001|NOT COMPLETED|Overall Study||2
3264563|NCT02607735|3998952|FG000|STARTED|Primary Study||264
3264564|NCT02607735|3998953|FG001|STARTED|Primary Study||152
3264565|NCT02607735|3998954|FG002|STARTED|Primary Study||0
3264566|NCT02607735|3998952|FG000|COMPLETED|Primary Study||257
3264567|NCT02607735|3998953|FG001|COMPLETED|Primary Study||152
3264568|NCT02607735|3998954|FG002|COMPLETED|Primary Study||0
3264569|NCT02607735|3998952|FG000|NOT COMPLETED|Primary Study||7
3264570|NCT02607735|3998953|FG001|NOT COMPLETED|Primary Study||0
3264571|NCT02607735|3998954|FG002|NOT COMPLETED|Primary Study||0
3264572|NCT02607735|3998952|FG000|STARTED|Deferred Treatment Substudy||0
3264573|NCT02607735|3998953|FG001|STARTED|Deferred Treatment Substudy||0
3264574|NCT02607735|3998954|FG002|STARTED|Deferred Treatment Substudy||147
3264575|NCT02607735|3998952|FG000|COMPLETED|Deferred Treatment Substudy||0
3264576|NCT02607735|3998953|FG001|COMPLETED|Deferred Treatment Substudy||0
3264577|NCT02607735|3998954|FG002|COMPLETED|Deferred Treatment Substudy||142
3264578|NCT02607735|3998952|FG000|NOT COMPLETED|Deferred Treatment Substudy||0
3264579|NCT02607735|3998953|FG001|NOT COMPLETED|Deferred Treatment Substudy||0
3264580|NCT02607735|3998954|FG002|NOT COMPLETED|Deferred Treatment Substudy||5
3264581|NCT02607800|3998964|FG000|STARTED|Overall Study||502
3264582|NCT02607800|3998965|FG001|STARTED|Overall Study||441
3264583|NCT02607800|3998964|FG000|COMPLETED|Overall Study||492
3264584|NCT02607800|3998965|FG001|COMPLETED|Overall Study||430
3264585|NCT02607800|3998964|FG000|NOT COMPLETED|Overall Study||10
3264586|NCT02607800|3998965|FG001|NOT COMPLETED|Overall Study||11
3264587|NCT02607865|3998976|FG000|STARTED|Overall Study||466
3264588|NCT02607865|3998977|FG001|STARTED|Overall Study||466
3264589|NCT02607865|3998978|FG002|STARTED|Overall Study||465
3264590|NCT02607865|3998979|FG003|STARTED|Overall Study||467
3264591|NCT02607865|3998976|FG000|Full Analysis Set (FAS)|Overall Study||466
3264592|NCT02607865|3998977|FG001|Full Analysis Set (FAS)|Overall Study||465
3264593|NCT02607865|3998978|FG002|Full Analysis Set (FAS)|Overall Study||465
3264594|NCT02607865|3998979|FG003|Full Analysis Set (FAS)|Overall Study||467
3264595|NCT02607865|3998976|FG000|Safety Analysis Set (SAS)|Overall Study||466
3264596|NCT02607865|3998977|FG001|Safety Analysis Set (SAS)|Overall Study||464
3264597|NCT02607865|3998978|FG002|Safety Analysis Set (SAS)|Overall Study||465
3264598|NCT02607865|3998979|FG003|Safety Analysis Set (SAS)|Overall Study||466
3264599|NCT02607865|3998976|FG000|COMPLETED|Overall Study||433
3264600|NCT02607865|3998977|FG001|COMPLETED|Overall Study||436
3264601|NCT02607865|3998978|FG002|COMPLETED|Overall Study||438
3264602|NCT02607865|3998979|FG003|COMPLETED|Overall Study||451
3264603|NCT02607865|3998976|FG000|NOT COMPLETED|Overall Study||33
3264604|NCT02607865|3998977|FG001|NOT COMPLETED|Overall Study||30
3264605|NCT02607865|3998978|FG002|NOT COMPLETED|Overall Study||27
3264606|NCT02607865|3998979|FG003|NOT COMPLETED|Overall Study||16
3264607|NCT02607930|3998991|FG000|STARTED|Double-Blinded Phase||316
3264608|NCT02607930|3998992|FG001|STARTED|Double-Blinded Phase||315
3264609|NCT02607930|3998991|FG000|COMPLETED|Double-Blinded Phase||262
3264610|NCT02607930|3998992|FG001|COMPLETED|Double-Blinded Phase||262
3264611|NCT02607930|3998991|FG000|NOT COMPLETED|Double-Blinded Phase||54
3264612|NCT02607930|3998992|FG001|NOT COMPLETED|Double-Blinded Phase||53
3264613|NCT02607930|3998991|FG000|STARTED|Open-Label Extension Phase|10 participants from the Double-Blinded Phase did not enter the Open-Label Extension Phase|252
3264614|NCT02607930|3998992|FG001|STARTED|Open-Label Extension Phase|8 participants from the Double-Blinded Phase did not enter the Open-Label Extension Phase|254
3264615|NCT02607930|3998991|FG000|COMPLETED|Open-Label Extension Phase||0
3264616|NCT02607930|3998992|FG001|COMPLETED|Open-Label Extension Phase||0
3264617|NCT02607930|3998991|FG000|NOT COMPLETED|Open-Label Extension Phase||252
3264618|NCT02607930|3998992|FG001|NOT COMPLETED|Open-Label Extension Phase||254
3264619|NCT02607956|3999002|FG000|STARTED|Double-Blinded Phase||327
3264620|NCT02607956|3999003|FG001|STARTED|Double-Blinded Phase||330
3264621|NCT02607956|3999002|FG000|COMPLETED|Double-Blinded Phase||266
3264622|NCT02607956|3999003|FG001|COMPLETED|Double-Blinded Phase||277
3264623|NCT02607956|3999002|FG000|NOT COMPLETED|Double-Blinded Phase||61
3264624|NCT02607956|3999003|FG001|NOT COMPLETED|Double-Blinded Phase||53
3264625|NCT02607956|3999002|FG000|STARTED|Open-Label Extension Phase|12 participants from the Double-Blinded Phase did not enter the Open-Label Extension Phase|254
3264626|NCT02607956|3999003|FG001|STARTED|Open-Label Extension Phase|12 participants from the Double-Blinded Phase did not enter the Open-Label Extension Phase|265
3264627|NCT02607956|3999002|FG000|COMPLETED|Open-Label Extension Phase||0
3264628|NCT02607956|3999003|FG001|COMPLETED|Open-Label Extension Phase||0
3264629|NCT02607956|3999002|FG000|NOT COMPLETED|Open-Label Extension Phase||254
3264630|NCT02607956|3999003|FG001|NOT COMPLETED|Open-Label Extension Phase||265
3264631|NCT02608099|3999013|FG000|STARTED|Overall Study||148
3264632|NCT02608099|3999014|FG001|STARTED|Overall Study||152
3264633|NCT02608099|3999013|FG000|Safety|Overall Study||149
3264634|NCT02608099|3999014|FG001|Safety|Overall Study||151
3264635|NCT02608099|3999013|FG000|COMPLETED|Overall Study||145
3264636|NCT02608099|3999014|FG001|COMPLETED|Overall Study||150
3264637|NCT02608099|3999013|FG000|NOT COMPLETED|Overall Study||3
3264638|NCT02608099|3999014|FG001|NOT COMPLETED|Overall Study||2
3264639|NCT02608177|3999022|FG000|STARTED|Overall Study||2
3264640|NCT02608177|3999023|FG001|STARTED|Overall Study||1
3264641|NCT02608177|3999022|FG000|COMPLETED|Overall Study||2
3264642|NCT02608177|3999023|FG001|COMPLETED|Overall Study||1
3264643|NCT02608177|3999022|FG000|NOT COMPLETED|Overall Study||0
3264644|NCT02608177|3999023|FG001|NOT COMPLETED|Overall Study||0
3264645|NCT02608229|3999033|FG000|STARTED|Overall Study||10
3264646|NCT02608229|3999034|FG001|STARTED|Overall Study||8
3264647|NCT02608229|3999033|FG000|600 mg BVD-523|Overall Study||10
3264648|NCT02608229|3999034|FG001|600 mg BVD-523|Overall Study||2
3264649|NCT02608229|3999033|FG000|450 mg BVD-523|Overall Study||0
3264650|NCT02608229|3999034|FG001|450 mg BVD-523|Overall Study||6
3264651|NCT02608229|3999033|FG000|COMPLETED|Overall Study||10
3264652|NCT02608229|3999034|FG001|COMPLETED|Overall Study||8
3264653|NCT02608229|3999033|FG000|NOT COMPLETED|Overall Study||0
3264654|NCT02608229|3999034|FG001|NOT COMPLETED|Overall Study||0
3264655|NCT02608450|3999044|FG000|STARTED|Overall Study||353
3264656|NCT02608450|3999045|FG001|STARTED|Overall Study||355
3264657|NCT02608450|3999044|FG000|COMPLETED|Overall Study||287
3264658|NCT02608450|3999045|FG001|COMPLETED|Overall Study||290
3264659|NCT02608450|3999044|FG000|NOT COMPLETED|Overall Study||66
3264660|NCT02608450|3999045|FG001|NOT COMPLETED|Overall Study||65
3374509|NCT02011542|4107207|FG000|NOT COMPLETED|Overall Study||1
3374510|NCT02008370|4107211|FG000|STARTED|Overall Study||7
3374511|NCT02008370|4107211|FG000|COMPLETED|Overall Study||0
3374512|NCT02008370|4107211|FG000|NOT COMPLETED|Overall Study||7
3374513|NCT02009982|4107217|FG000|STARTED|Overall Study||1
3374514|NCT02009982|4107218|FG001|STARTED|Overall Study||2
3374515|NCT02009982|4107217|FG000|COMPLETED|Overall Study||1
3374516|NCT02009982|4107218|FG001|COMPLETED|Overall Study||2
3374517|NCT02009982|4107217|FG000|NOT COMPLETED|Overall Study||0
3374518|NCT02009982|4107218|FG001|NOT COMPLETED|Overall Study||0
3374519|NCT02013414|4107224|FG000|STARTED|Overall Study||9
3374520|NCT02013414|4107224|FG000|COMPLETED|Overall Study||9
3374521|NCT02013414|4107224|FG000|NOT COMPLETED|Overall Study||0
3374522|NCT02005445|4107232|FG000|STARTED|Overall Study||2
3374523|NCT02005445|4107233|FG001|STARTED|Overall Study||2
3374524|NCT02005445|4107232|FG000|COMPLETED|Overall Study||2
3374525|NCT02005445|4107233|FG001|COMPLETED|Overall Study||1
3374526|NCT02005445|4107232|FG000|NOT COMPLETED|Overall Study||0
3374527|NCT02005445|4107233|FG001|NOT COMPLETED|Overall Study||1
3374528|NCT02020837|4107239|FG000|STARTED|Overall Study||2
3374529|NCT02020837|4107239|FG000|COMPLETED|Overall Study||2
3374530|NCT02020837|4107239|FG000|NOT COMPLETED|Overall Study||0
3374531|NCT02015910|4107245|FG000|STARTED|Overall Study||0
3374532|NCT02015910|4107246|FG001|STARTED|Overall Study||1
3374533|NCT02015910|4107245|FG000|COMPLETED|Overall Study||0
3374534|NCT02015910|4107246|FG001|COMPLETED|Overall Study||1
3374535|NCT02015910|4107245|FG000|NOT COMPLETED|Overall Study||0
3374536|NCT02015910|4107246|FG001|NOT COMPLETED|Overall Study||0
3374537|NCT02006927|4107252|FG000|STARTED|Overall Study||3
3374538|NCT02006927|4107252|FG000|COMPLETED|Overall Study||0
3374539|NCT02006927|4107252|FG000|NOT COMPLETED|Overall Study||3
3374540|NCT01996982|4107256|FG000|STARTED|Overall Study||7
3374541|NCT01996982|4107256|FG000|COMPLETED|Overall Study||0
3374542|NCT01996982|4107256|FG000|NOT COMPLETED|Overall Study||7
3374543|NCT02006407|4107260|FG000|STARTED|Overall Study||5
3374544|NCT02006407|4107260|FG000|COMPLETED|Overall Study||5
3374545|NCT02006407|4107260|FG000|NOT COMPLETED|Overall Study||0
3374546|NCT01986751|4107266|FG000|STARTED|Overall Study||10
3374547|NCT01986751|4107267|FG001|STARTED|Overall Study||4
3374548|NCT01986751|4107266|FG000|COMPLETED|Overall Study||0
3374549|NCT01986751|4107267|FG001|COMPLETED|Overall Study||2
3374550|NCT01986751|4107266|FG000|NOT COMPLETED|Overall Study||10
3374551|NCT01986751|4107267|FG001|NOT COMPLETED|Overall Study||2
3374552|NCT01996410|4107285|FG000|STARTED|Overall Study||3
3374553|NCT01996410|4107286|FG001|STARTED|Overall Study||3
3374554|NCT01996410|4107287|FG002|STARTED|Overall Study||0
3374555|NCT01996410|4107288|FG003|STARTED|Overall Study||0
3374556|NCT01996410|4107289|FG004|STARTED|Overall Study||2
3374557|NCT01996410|4107290|FG005|STARTED|Overall Study||2
3374558|NCT01996410|4107291|FG006|STARTED|Overall Study||0
3374559|NCT01996410|4107292|FG007|STARTED|Overall Study||0
3374560|NCT01996410|4107285|FG000|COMPLETED|Overall Study||3
3374561|NCT01996410|4107286|FG001|COMPLETED|Overall Study||3
3374562|NCT01996410|4107287|FG002|COMPLETED|Overall Study||0
3374563|NCT01996410|4107288|FG003|COMPLETED|Overall Study||0
3374564|NCT01996410|4107289|FG004|COMPLETED|Overall Study||2
3374565|NCT01996410|4107290|FG005|COMPLETED|Overall Study||2
3374566|NCT01996410|4107291|FG006|COMPLETED|Overall Study||0
3374567|NCT01996410|4107292|FG007|COMPLETED|Overall Study||0
3374568|NCT01996410|4107285|FG000|NOT COMPLETED|Overall Study||0
3374569|NCT01996410|4107286|FG001|NOT COMPLETED|Overall Study||0
3374570|NCT01996410|4107287|FG002|NOT COMPLETED|Overall Study||0
3374571|NCT01996410|4107288|FG003|NOT COMPLETED|Overall Study||0
3374572|NCT01996410|4107289|FG004|NOT COMPLETED|Overall Study||0
3374573|NCT01996410|4107290|FG005|NOT COMPLETED|Overall Study||0
3374574|NCT01996410|4107291|FG006|NOT COMPLETED|Overall Study||0
3374575|NCT01996410|4107292|FG007|NOT COMPLETED|Overall Study||0
3374576|NCT01996852|4107307|FG000|STARTED|Overall Study||0
3374577|NCT01996852|4107308|FG001|STARTED|Overall Study||0
3374578|NCT01996852|4107309|FG002|STARTED|Overall Study||0
3374579|NCT01996852|4107307|FG000|COMPLETED|Overall Study||0
3374580|NCT01996852|4107308|FG001|COMPLETED|Overall Study||0
3374581|NCT01996852|4107309|FG002|COMPLETED|Overall Study||0
3374582|NCT01996852|4107307|FG000|NOT COMPLETED|Overall Study||0
3264661|NCT02608463|3999054|FG000|STARTED|Overall Study||10
3264662|NCT02608463|3999055|FG001|STARTED|Overall Study||5
3264663|NCT02608463|3999056|FG002|STARTED|Overall Study||0
3264664|NCT02608463|3999057|FG003|STARTED|Overall Study|No study participants were enrolled in Part B.|0
3264665|NCT02608463|3999054|FG000|COMPLETED|Overall Study||10
3264666|NCT02608463|3999055|FG001|COMPLETED|Overall Study||5
3264667|NCT02608463|3999056|FG002|COMPLETED|Overall Study||0
3264668|NCT02608463|3999057|FG003|COMPLETED|Overall Study||0
3264669|NCT02608463|3999054|FG000|NOT COMPLETED|Overall Study||0
3264670|NCT02608463|3999055|FG001|NOT COMPLETED|Overall Study||0
3264671|NCT02608463|3999056|FG002|NOT COMPLETED|Overall Study||0
3264672|NCT02608463|3999057|FG003|NOT COMPLETED|Overall Study||0
3264673|NCT02608476|3999067|FG000|STARTED|Overall Study||369
3264674|NCT02608476|3999068|FG001|STARTED|Overall Study||363
3264675|NCT02608476|3999067|FG000|COMPLETED|Overall Study||302
3264676|NCT02608476|3999068|FG001|COMPLETED|Overall Study||282
3264677|NCT02608476|3999067|FG000|NOT COMPLETED|Overall Study||67
3264678|NCT02608476|3999068|FG001|NOT COMPLETED|Overall Study||81
3264679|NCT02608489|3999076|FG000|STARTED|Overall Study||43
3264680|NCT02608489|3999077|FG001|STARTED|Overall Study||43
3264681|NCT02608489|3999076|FG000|COMPLETED|Overall Study||30
3264682|NCT02608489|3999077|FG001|COMPLETED|Overall Study||33
3264683|NCT02608489|3999076|FG000|NOT COMPLETED|Overall Study||13
3264684|NCT02608489|3999077|FG001|NOT COMPLETED|Overall Study||10
3264685|NCT02608684|3999083|FG000|STARTED|Overall Study||21
3264686|NCT02608684|3999083|FG000|COMPLETED|Overall Study||18
3264687|NCT02608684|3999083|FG000|NOT COMPLETED|Overall Study||3
3264688|NCT02608879|3999090|FG000|STARTED|Overall Study||10
3264689|NCT02608879|3999091|FG001|STARTED|Overall Study||6
3264690|NCT02608879|3999092|FG002|STARTED|Overall Study||3
3264691|NCT02608879|3999090|FG000|COMPLETED|Overall Study||9
3264692|NCT02608879|3999091|FG001|COMPLETED|Overall Study||6
3264693|NCT02608879|3999092|FG002|COMPLETED|Overall Study||0
3264694|NCT02608879|3999090|FG000|NOT COMPLETED|Overall Study||1
3264695|NCT02608879|3999091|FG001|NOT COMPLETED|Overall Study||0
3264696|NCT02608879|3999092|FG002|NOT COMPLETED|Overall Study||3
3264697|NCT02608892|3999102|FG000|STARTED|Overall Study||51
3264698|NCT02608892|3999103|FG001|STARTED|Overall Study||49
3264699|NCT02608892|3999102|FG000|COMPLETED|Overall Study||50
3264700|NCT02608892|3999103|FG001|COMPLETED|Overall Study||49
3264701|NCT02608892|3999102|FG000|NOT COMPLETED|Overall Study||1
3264702|NCT02608892|3999103|FG001|NOT COMPLETED|Overall Study||0
3264703|NCT02609100|3999112|FG000|STARTED|Overall Study||2
3264704|NCT02609100|3999113|FG001|STARTED|Overall Study||2
3264705|NCT02609100|3999112|FG000|COMPLETED|Overall Study||2
3264706|NCT02609100|3999113|FG001|COMPLETED|Overall Study||2
3264707|NCT02609100|3999112|FG000|NOT COMPLETED|Overall Study||0
3264708|NCT02609100|3999113|FG001|NOT COMPLETED|Overall Study||0
3264709|NCT02609113|3999123|FG000|STARTED|Overall Study||11
3264710|NCT02609113|3999124|FG001|STARTED|Overall Study||11
3264711|NCT02609113|3999123|FG000|COMPLETED|Overall Study||9
3264712|NCT02609113|3999124|FG001|COMPLETED|Overall Study||9
3264713|NCT02609113|3999123|FG000|NOT COMPLETED|Overall Study||2
3264714|NCT02609113|3999124|FG001|NOT COMPLETED|Overall Study||2
3264715|NCT02609178|3999130|FG000|STARTED|First Crown||0
3264716|NCT02609178|3999131|FG001|STARTED|First Crown||1
3264717|NCT02609178|3999132|FG002|STARTED|First Crown||6
3264718|NCT02609178|3999133|FG003|STARTED|First Crown||3
3264719|NCT02609178|3999134|FG004|STARTED|First Crown||0
3264720|NCT02609178|3999135|FG005|STARTED|First Crown||2
3264721|NCT02609178|3999130|FG000|COMPLETED|First Crown||0
3264722|NCT02609178|3999131|FG001|COMPLETED|First Crown||1
3264723|NCT02609178|3999132|FG002|COMPLETED|First Crown||5
3264724|NCT02609178|3999133|FG003|COMPLETED|First Crown||2
3264725|NCT02609178|3999134|FG004|COMPLETED|First Crown||0
3264726|NCT02609178|3999135|FG005|COMPLETED|First Crown||2
3264727|NCT02609178|3999130|FG000|NOT COMPLETED|First Crown||0
3264728|NCT02609178|3999131|FG001|NOT COMPLETED|First Crown||0
3264729|NCT02609178|3999132|FG002|NOT COMPLETED|First Crown||1
3264730|NCT02609178|3999133|FG003|NOT COMPLETED|First Crown||1
3264731|NCT02609178|3999134|FG004|NOT COMPLETED|First Crown||0
3264732|NCT02609178|3999135|FG005|NOT COMPLETED|First Crown||0
3264733|NCT02609178|3999130|FG000|STARTED|5-minute Washout Time||0
3264734|NCT02609178|3999131|FG001|STARTED|5-minute Washout Time||1
3264735|NCT02609178|3999132|FG002|STARTED|5-minute Washout Time||5
3264736|NCT02609178|3999133|FG003|STARTED|5-minute Washout Time||2
3264737|NCT02609178|3999134|FG004|STARTED|5-minute Washout Time||0
3264738|NCT02609178|3999135|FG005|STARTED|5-minute Washout Time||2
3264739|NCT02609178|3999130|FG000|COMPLETED|5-minute Washout Time||0
3264740|NCT02609178|3999131|FG001|COMPLETED|5-minute Washout Time||1
3264741|NCT02609178|3999132|FG002|COMPLETED|5-minute Washout Time||5
3264742|NCT02609178|3999133|FG003|COMPLETED|5-minute Washout Time||2
3264743|NCT02609178|3999134|FG004|COMPLETED|5-minute Washout Time||0
3264744|NCT02609178|3999135|FG005|COMPLETED|5-minute Washout Time||2
3264745|NCT02609178|3999130|FG000|NOT COMPLETED|5-minute Washout Time||0
3264746|NCT02609178|3999131|FG001|NOT COMPLETED|5-minute Washout Time||0
3264747|NCT02609178|3999132|FG002|NOT COMPLETED|5-minute Washout Time||0
3264748|NCT02609178|3999133|FG003|NOT COMPLETED|5-minute Washout Time||0
3264749|NCT02609178|3999134|FG004|NOT COMPLETED|5-minute Washout Time||0
3264750|NCT02609178|3999135|FG005|NOT COMPLETED|5-minute Washout Time||0
3264751|NCT02609178|3999130|FG000|STARTED|Second Crown||0
3264752|NCT02609178|3999131|FG001|STARTED|Second Crown||1
3264753|NCT02609178|3999132|FG002|STARTED|Second Crown||5
3264754|NCT02609178|3999133|FG003|STARTED|Second Crown||2
3264755|NCT02609178|3999134|FG004|STARTED|Second Crown||0
3264756|NCT02609178|3999135|FG005|STARTED|Second Crown||2
3264757|NCT02609178|3999130|FG000|COMPLETED|Second Crown||0
3264758|NCT02609178|3999131|FG001|COMPLETED|Second Crown||1
3264759|NCT02609178|3999132|FG002|COMPLETED|Second Crown||5
3264760|NCT02609178|3999133|FG003|COMPLETED|Second Crown||2
3264761|NCT02609178|3999134|FG004|COMPLETED|Second Crown||0
3264762|NCT02609178|3999135|FG005|COMPLETED|Second Crown||2
3264763|NCT02609178|3999130|FG000|NOT COMPLETED|Second Crown||0
3264764|NCT02609178|3999131|FG001|NOT COMPLETED|Second Crown||0
3264765|NCT02609178|3999132|FG002|NOT COMPLETED|Second Crown||0
3264766|NCT02609178|3999133|FG003|NOT COMPLETED|Second Crown||0
3264767|NCT02609178|3999134|FG004|NOT COMPLETED|Second Crown||0
3264768|NCT02609178|3999135|FG005|NOT COMPLETED|Second Crown||0
3264769|NCT02609178|3999130|FG000|STARTED|5-minute Washout Time||0
3264770|NCT02609178|3999131|FG001|STARTED|5-minute Washout Time||1
3264771|NCT02609178|3999132|FG002|STARTED|5-minute Washout Time||5
3374583|NCT01996852|4107308|FG001|NOT COMPLETED|Overall Study||0
3374584|NCT01996852|4107309|FG002|NOT COMPLETED|Overall Study||0
3374585|NCT01997567|4107319|FG000|STARTED|Overall Study||0
3374586|NCT01997567|4107320|FG001|STARTED|Overall Study||0
3374587|NCT01997567|4107319|FG000|COMPLETED|Overall Study||0
3374588|NCT01997567|4107320|FG001|COMPLETED|Overall Study||0
3374589|NCT01997567|4107319|FG000|NOT COMPLETED|Overall Study||0
3374590|NCT01997567|4107320|FG001|NOT COMPLETED|Overall Study||0
3374591|NCT01977729|4107326|FG000|STARTED|Overall Study||1
3374592|NCT01977729|4107326|FG000|COMPLETED|Overall Study||0
3374593|NCT01977729|4107326|FG000|NOT COMPLETED|Overall Study||1
3374594|NCT01973062|4107332|FG000|STARTED|Overall Study||1
3374595|NCT01973062|4107332|FG000|COMPLETED|Overall Study||1
3374596|NCT01973062|4107332|FG000|NOT COMPLETED|Overall Study||0
3374597|NCT01982253|4107339|FG000|STARTED|Overall Study||2
3374598|NCT01982253|4107340|FG001|STARTED|Overall Study||4
3374599|NCT01982253|4107341|FG002|STARTED|Overall Study||4
3374600|NCT01982253|4107339|FG000|COMPLETED|Overall Study||0
3374601|NCT01982253|4107340|FG001|COMPLETED|Overall Study||0
3374602|NCT01982253|4107341|FG002|COMPLETED|Overall Study||0
3374603|NCT01982253|4107339|FG000|NOT COMPLETED|Overall Study||2
3374604|NCT01982253|4107340|FG001|NOT COMPLETED|Overall Study||4
3374605|NCT01982253|4107341|FG002|NOT COMPLETED|Overall Study||4
3374606|NCT01984268|4107349|FG000|STARTED|Overall Study||15
3374607|NCT01984268|4107349|FG000|COMPLETED|Overall Study||0
3374608|NCT01984268|4107349|FG000|NOT COMPLETED|Overall Study||15
3374609|NCT01974284|4107353|FG000|STARTED|Overall Study||7
3374610|NCT01974284|4107353|FG000|COMPLETED|Overall Study||0
3374611|NCT01974284|4107353|FG000|NOT COMPLETED|Overall Study||7
3374612|NCT01971853|4107359|FG000|STARTED|Overall Study||0
3264772|NCT02609178|3999133|FG003|STARTED|5-minute Washout Time||2
3264773|NCT02609178|3999134|FG004|STARTED|5-minute Washout Time||0
3264774|NCT02609178|3999135|FG005|STARTED|5-minute Washout Time||2
3264775|NCT02609178|3999130|FG000|COMPLETED|5-minute Washout Time||0
3264776|NCT02609178|3999131|FG001|COMPLETED|5-minute Washout Time||1
3374613|NCT01971853|4107360|FG001|STARTED|Overall Study||0
3374614|NCT01971853|4107359|FG000|COMPLETED|Overall Study||0
3264777|NCT02609178|3999132|FG002|COMPLETED|5-minute Washout Time||5
3264778|NCT02609178|3999133|FG003|COMPLETED|5-minute Washout Time||2
3264779|NCT02609178|3999134|FG004|COMPLETED|5-minute Washout Time||0
3264780|NCT02609178|3999135|FG005|COMPLETED|5-minute Washout Time||2
3264781|NCT02609178|3999130|FG000|NOT COMPLETED|5-minute Washout Time||0
3264782|NCT02609178|3999131|FG001|NOT COMPLETED|5-minute Washout Time||0
3264783|NCT02609178|3999132|FG002|NOT COMPLETED|5-minute Washout Time||0
3264784|NCT02609178|3999133|FG003|NOT COMPLETED|5-minute Washout Time||0
3264785|NCT02609178|3999134|FG004|NOT COMPLETED|5-minute Washout Time||0
3264786|NCT02609178|3999135|FG005|NOT COMPLETED|5-minute Washout Time||0
3264787|NCT02609178|3999130|FG000|STARTED|Third Crown||0
3264788|NCT02609178|3999131|FG001|STARTED|Third Crown||1
3264789|NCT02609178|3999132|FG002|STARTED|Third Crown||5
3264790|NCT02609178|3999133|FG003|STARTED|Third Crown||2
3264791|NCT02609178|3999134|FG004|STARTED|Third Crown||0
3264792|NCT02609178|3999135|FG005|STARTED|Third Crown||2
3264793|NCT02609178|3999130|FG000|COMPLETED|Third Crown||0
3264794|NCT02609178|3999131|FG001|COMPLETED|Third Crown||1
3264795|NCT02609178|3999132|FG002|COMPLETED|Third Crown||5
3264796|NCT02609178|3999133|FG003|COMPLETED|Third Crown||2
3374615|NCT01971853|4107360|FG001|COMPLETED|Overall Study||0
3374616|NCT01971853|4107359|FG000|NOT COMPLETED|Overall Study||0
3374617|NCT01971853|4107360|FG001|NOT COMPLETED|Overall Study||0
3374618|NCT01980875|4107369|FG000|STARTED|Overall Study||8
3374619|NCT01980875|4107370|FG001|STARTED|Overall Study||25
3374620|NCT01980875|4107371|FG002|STARTED|Overall Study||24
3374621|NCT01980875|4107369|FG000|COMPLETED|Overall Study||0
3374622|NCT01980875|4107370|FG001|COMPLETED|Overall Study||0
3374623|NCT01980875|4107371|FG002|COMPLETED|Overall Study||0
3374624|NCT01980875|4107369|FG000|NOT COMPLETED|Overall Study||8
3374625|NCT01980875|4107370|FG001|NOT COMPLETED|Overall Study||25
3374626|NCT01980875|4107371|FG002|NOT COMPLETED|Overall Study||24
3374627|NCT01982383|4107381|FG000|STARTED|Overall Study||2
3374628|NCT01982383|4107382|FG001|STARTED|Overall Study||0
3374629|NCT01982383|4107381|FG000|COMPLETED|Overall Study||2
3374630|NCT01982383|4107382|FG001|COMPLETED|Overall Study||0
3374631|NCT01982383|4107381|FG000|NOT COMPLETED|Overall Study||0
3374632|NCT01982383|4107382|FG001|NOT COMPLETED|Overall Study||0
3374633|NCT01980342|4107388|FG000|STARTED|Overall Study||1
3374634|NCT01980342|4107388|FG000|COMPLETED|Overall Study||0
3374635|NCT01980342|4107388|FG000|NOT COMPLETED|Overall Study||1
3374636|NCT01978535|4107394|FG000|STARTED|Overall Study||1
3374637|NCT01978535|4107395|FG001|STARTED|Overall Study||2
3374638|NCT01978535|4107394|FG000|COMPLETED|Overall Study||1
3374639|NCT01978535|4107395|FG001|COMPLETED|Overall Study||2
3374640|NCT01978535|4107394|FG000|NOT COMPLETED|Overall Study||0
3374641|NCT01978535|4107395|FG001|NOT COMPLETED|Overall Study||0
3374642|NCT01974635|4107401|FG000|STARTED|Overall Study||2
3374643|NCT01974635|4107401|FG000|COMPLETED|Overall Study||2
3374644|NCT01974635|4107401|FG000|NOT COMPLETED|Overall Study||0
3374645|NCT01975467|4107408|FG000|STARTED|Overall Study|Study terminated before enrollment|0
3374646|NCT01975467|4107409|FG001|STARTED|Overall Study|Study terminated before enrollment|0
3374647|NCT01975467|4107408|FG000|COMPLETED|Overall Study||0
3374648|NCT01975467|4107409|FG001|COMPLETED|Overall Study||0
3374649|NCT01975467|4107408|FG000|NOT COMPLETED|Overall Study||0
3374650|NCT01975467|4107409|FG001|NOT COMPLETED|Overall Study||0
3374651|NCT01970462|4107417|FG000|STARTED|Overall Study||1
3374652|NCT01970462|4107418|FG001|STARTED|Overall Study||4
3374653|NCT01970462|4107417|FG000|COMPLETED|Overall Study||1
3374654|NCT01970462|4107418|FG001|COMPLETED|Overall Study||2
3374655|NCT01970462|4107417|FG000|NOT COMPLETED|Overall Study||0
3374656|NCT01970462|4107418|FG001|NOT COMPLETED|Overall Study||2
3374657|NCT01969565|4107424|FG000|STARTED|Overall Study||1
3374658|NCT01969565|4107424|FG000|COMPLETED|Overall Study||0
3374659|NCT01969565|4107424|FG000|NOT COMPLETED|Overall Study||1
3374660|NCT01968226|4107429|FG000|STARTED|Overall Study||3
3374661|NCT01968226|4107429|FG000|COMPLETED|Overall Study||1
3374662|NCT01968226|4107429|FG000|NOT COMPLETED|Overall Study||2
3374663|NCT01965782|4107433|FG000|STARTED|Overall Study||0
3374664|NCT01965782|4107433|FG000|COMPLETED|Overall Study||0
3374665|NCT01965782|4107433|FG000|NOT COMPLETED|Overall Study||0
3374666|NCT01962675|4107439|FG000|STARTED|Overall Study||7
3374667|NCT01962675|4107440|FG001|STARTED|Overall Study||7
3374668|NCT01962675|4107439|FG000|COMPLETED|Overall Study||7
3374669|NCT01962675|4107440|FG001|COMPLETED|Overall Study||7
3374670|NCT01962675|4107439|FG000|NOT COMPLETED|Overall Study||0
3374671|NCT01962675|4107440|FG001|NOT COMPLETED|Overall Study||0
3374672|NCT01962974|4107448|FG000|STARTED|Overall Study||7
3374673|NCT01962974|4107448|FG000|COMPLETED|Overall Study||0
3374674|NCT01962974|4107448|FG000|NOT COMPLETED|Overall Study||7
3374675|NCT01954160|4107454|FG000|STARTED|Overall Study||5
3374676|NCT01954160|4107455|FG001|STARTED|Overall Study|Not started|0
3264797|NCT02609178|3999134|FG004|COMPLETED|Third Crown||0
3264798|NCT02609178|3999135|FG005|COMPLETED|Third Crown||2
3264799|NCT02609178|3999130|FG000|NOT COMPLETED|Third Crown||0
3264800|NCT02609178|3999131|FG001|NOT COMPLETED|Third Crown||0
3264801|NCT02609178|3999132|FG002|NOT COMPLETED|Third Crown||0
3264802|NCT02609178|3999133|FG003|NOT COMPLETED|Third Crown||0
3264803|NCT02609178|3999134|FG004|NOT COMPLETED|Third Crown||0
3374677|NCT01954160|4107454|FG000|COMPLETED|Overall Study|Only 4 subjects completed the first early denervation. No subjects completed the late denervation.|0
3374678|NCT01954160|4107455|FG001|COMPLETED|Overall Study||0
3264804|NCT02609178|3999135|FG005|NOT COMPLETED|Third Crown||0
3264805|NCT02609204|3999141|FG000|STARTED|Overall Study||51
3264806|NCT02609204|3999141|FG000|COMPLETED|Overall Study||51
3264807|NCT02609204|3999141|FG000|NOT COMPLETED|Overall Study||0
3264808|NCT02609308|3999148|FG000|STARTED|Overall Study||10
3264809|NCT02609308|3999149|FG001|STARTED|Overall Study||11
3264810|NCT02609308|3999148|FG000|COMPLETED|Overall Study||10
3264811|NCT02609308|3999149|FG001|COMPLETED|Overall Study||11
3264812|NCT02609308|3999148|FG000|NOT COMPLETED|Overall Study||0
3264813|NCT02609308|3999149|FG001|NOT COMPLETED|Overall Study||0
3264814|NCT02609399|3999157|FG000|STARTED|Influenza Season 2015-2016||27
3264815|NCT02609399|3999158|FG001|STARTED|Influenza Season 2015-2016||31
3264816|NCT02609399|3999157|FG000|COMPLETED|Influenza Season 2015-2016||24
3264817|NCT02609399|3999158|FG001|COMPLETED|Influenza Season 2015-2016||29
3264818|NCT02609399|3999157|FG000|NOT COMPLETED|Influenza Season 2015-2016||3
3264819|NCT02609399|3999158|FG001|NOT COMPLETED|Influenza Season 2015-2016||2
3264820|NCT02609399|3999157|FG000|STARTED|Influenza Season 2016-2017||58
3264821|NCT02609399|3999158|FG001|STARTED|Influenza Season 2016-2017||64
3264822|NCT02609399|3999157|FG000|COMPLETED|Influenza Season 2016-2017||49
3264823|NCT02609399|3999158|FG001|COMPLETED|Influenza Season 2016-2017||59
3264824|NCT02609399|3999157|FG000|NOT COMPLETED|Influenza Season 2016-2017||9
3264825|NCT02609399|3999158|FG001|NOT COMPLETED|Influenza Season 2016-2017||5
3264826|NCT02609607|3999168|FG000|STARTED|Overall Study||6
3264827|NCT02609607|3999169|FG001|STARTED|Overall Study||5
3264828|NCT02609607|3999168|FG000|COMPLETED|Overall Study||6
3264829|NCT02609607|3999169|FG001|COMPLETED|Overall Study||4
3264830|NCT02609607|3999168|FG000|NOT COMPLETED|Overall Study||0
3264831|NCT02609607|3999169|FG001|NOT COMPLETED|Overall Study||1
3264832|NCT02609633|3999177|FG000|STARTED|Overall Study||42
3264833|NCT02609633|3999178|FG001|STARTED|Overall Study||56
3264834|NCT02609633|3999177|FG000|Full Analysis Set (FAS)|Overall Study||32
3264835|NCT02609633|3999178|FG001|Full Analysis Set (FAS)|Overall Study||46
3264836|NCT02609633|3999177|FG000|COMPLETED|Overall Study||37
3264837|NCT02609633|3999178|FG001|COMPLETED|Overall Study||54
3264838|NCT02609633|3999177|FG000|NOT COMPLETED|Overall Study||5
3264839|NCT02609633|3999178|FG001|NOT COMPLETED|Overall Study||2
3264840|NCT02609659|3999185|FG000|STARTED|Overall Study||105
3264841|NCT02609659|3999185|FG000|COMPLETED|Overall Study||97
3264842|NCT02609659|3999185|FG000|NOT COMPLETED|Overall Study||8
3264843|NCT02609672|3999191|FG000|STARTED|Overall Study||12
3264844|NCT02609672|3999192|FG001|STARTED|Overall Study||12
3264845|NCT02609672|3999191|FG000|COMPLETED|Overall Study||9
3264846|NCT02609672|3999192|FG001|COMPLETED|Overall Study||11
3264847|NCT02609672|3999191|FG000|NOT COMPLETED|Overall Study||3
3264848|NCT02609672|3999192|FG001|NOT COMPLETED|Overall Study||1
3264849|NCT02609841|3999200|FG000|STARTED|Overall Study||240
3264850|NCT02609841|3999200|FG000|COMPLETED|Overall Study||212
3264851|NCT02609841|3999200|FG000|NOT COMPLETED|Overall Study||28
3264852|NCT02609984|3999208|FG000|STARTED|Overall Study||45
3264853|NCT02609984|3999209|FG001|STARTED|Overall Study||44
3264854|NCT02609984|3999208|FG000|Treated|Overall Study||45
3264855|NCT02609984|3999209|FG001|Treated|Overall Study||43
3264856|NCT02609984|3999208|FG000|COMPLETED|Overall Study||1
3264857|NCT02609984|3999209|FG001|COMPLETED|Overall Study||5
3264858|NCT02609984|3999208|FG000|NOT COMPLETED|Overall Study||44
3264859|NCT02609984|3999209|FG001|NOT COMPLETED|Overall Study||39
3264860|NCT02610140|3999217|FG000|STARTED|Randomization and Treatment Period||166
3264861|NCT02610140|3999218|FG001|STARTED|Randomization and Treatment Period||82
3264862|NCT02610140|3999217|FG000|Participants Received Treatment|Randomization and Treatment Period|Safety analysis set|163
3264863|NCT02610140|3999218|FG001|Participants Received Treatment|Randomization and Treatment Period|Safety analysis set|72
3264864|NCT02610140|3999217|FG000|COMPLETED|Randomization and Treatment Period||0
3264865|NCT02610140|3999218|FG001|COMPLETED|Randomization and Treatment Period||0
3264866|NCT02610140|3999217|FG000|NOT COMPLETED|Randomization and Treatment Period||166
3264867|NCT02610140|3999218|FG001|NOT COMPLETED|Randomization and Treatment Period||82
3264868|NCT02610140|3999217|FG000|STARTED|Safety Follow-up||102
3264869|NCT02610140|3999218|FG001|STARTED|Safety Follow-up||45
3264870|NCT02610140|3999217|FG000|COMPLETED|Safety Follow-up||57
3264871|NCT02610140|3999218|FG001|COMPLETED|Safety Follow-up||21
3264872|NCT02610140|3999217|FG000|NOT COMPLETED|Safety Follow-up||45
3264873|NCT02610140|3999218|FG001|NOT COMPLETED|Safety Follow-up||24
3264874|NCT02610140|3999217|FG000|STARTED|Active Follow-up||48
3264875|NCT02610140|3999218|FG001|STARTED|Active Follow-up||26
3264876|NCT02610140|3999217|FG000|COMPLETED|Active Follow-up||0
3264877|NCT02610140|3999218|FG001|COMPLETED|Active Follow-up||0
3264878|NCT02610140|3999217|FG000|NOT COMPLETED|Active Follow-up||48
3264879|NCT02610140|3999218|FG001|NOT COMPLETED|Active Follow-up||26
3264880|NCT02610140|3999217|FG000|STARTED|Long-term Follow-up||123
3264881|NCT02610140|3999218|FG001|STARTED|Long-term Follow-up||66
3264882|NCT02610140|3999217|FG000|COMPLETED|Long-term Follow-up||0
3264883|NCT02610140|3999218|FG001|COMPLETED|Long-term Follow-up||0
3264884|NCT02610140|3999217|FG000|NOT COMPLETED|Long-term Follow-up||123
3264885|NCT02610140|3999218|FG001|NOT COMPLETED|Long-term Follow-up||66
3264886|NCT02610192|3999224|FG000|STARTED|Overall Study|52 subjects had signed consent form, but 50 subjects have been treated. 2 subjects became SF.|50
3264887|NCT02610192|3999224|FG000|COMPLETED|Overall Study||41
3264888|NCT02610192|3999224|FG000|NOT COMPLETED|Overall Study||9
3264889|NCT02610231|3999228|FG000|STARTED|Overall Study||239
3264890|NCT02610231|3999228|FG000|COMPLETED|Overall Study||179
3264891|NCT02610231|3999228|FG000|NOT COMPLETED|Overall Study||60
3264892|NCT02610634|3999237|FG000|STARTED|Overall Study||60
3264893|NCT02610634|3999238|FG001|STARTED|Overall Study||40
3374679|NCT01954160|4107454|FG000|NOT COMPLETED|Overall Study||5
3374680|NCT01954160|4107455|FG001|NOT COMPLETED|Overall Study||0
3374681|NCT01951378|4107465|FG000|STARTED|Overall Study||23
3374682|NCT01951378|4107466|FG001|STARTED|Overall Study||17
3374683|NCT01951378|4107465|FG000|COMPLETED|Overall Study||0
3374684|NCT01951378|4107466|FG001|COMPLETED|Overall Study||0
3374685|NCT01951378|4107465|FG000|NOT COMPLETED|Overall Study||23
3374686|NCT01951378|4107466|FG001|NOT COMPLETED|Overall Study||17
3374687|NCT01941615|4107472|FG000|STARTED|Run in Treatment: Microgynon®||16
3374688|NCT01941615|4107472|FG000|COMPLETED|Run in Treatment: Microgynon®||16
3374689|NCT01941615|4107472|FG000|NOT COMPLETED|Run in Treatment: Microgynon®||0
3374690|NCT01941615|4107472|FG000|STARTED|Reference Treatment: Microgynon®||0
3374691|NCT01941615|4107472|FG000|COMPLETED|Reference Treatment: Microgynon®||0
3374692|NCT01941615|4107472|FG000|NOT COMPLETED|Reference Treatment: Microgynon®||0
3374693|NCT01941615|4107472|FG000|STARTED|Microgynon® Plus Deleobuvir+Faldaprevir||0
3374694|NCT01941615|4107472|FG000|COMPLETED|Microgynon® Plus Deleobuvir+Faldaprevir||0
3374695|NCT01941615|4107472|FG000|NOT COMPLETED|Microgynon® Plus Deleobuvir+Faldaprevir||0
3374696|NCT01946542|4107478|FG000|STARTED|Testing Visit 1||1
3374697|NCT01946542|4107479|FG001|STARTED|Testing Visit 1||1
3374698|NCT01946542|4107478|FG000|COMPLETED|Testing Visit 1||1
3374699|NCT01946542|4107479|FG001|COMPLETED|Testing Visit 1||1
3374700|NCT01946542|4107478|FG000|NOT COMPLETED|Testing Visit 1||0
3374701|NCT01946542|4107479|FG001|NOT COMPLETED|Testing Visit 1||0
3374702|NCT01946542|4107478|FG000|STARTED|Testing Visit 2||1
3374703|NCT01946542|4107479|FG001|STARTED|Testing Visit 2||1
3374704|NCT01946542|4107478|FG000|COMPLETED|Testing Visit 2||1
3374705|NCT01946542|4107479|FG001|COMPLETED|Testing Visit 2||1
3374706|NCT01946542|4107478|FG000|NOT COMPLETED|Testing Visit 2||0
3374707|NCT01946542|4107479|FG001|NOT COMPLETED|Testing Visit 2||0
3374708|NCT01937507|4107485|FG000|STARTED|Overall Study||2
3374709|NCT01937507|4107485|FG000|COMPLETED|Overall Study||0
3374710|NCT01937507|4107485|FG000|NOT COMPLETED|Overall Study||2
3374711|NCT01944059|4107489|FG000|STARTED|Overall Study||31
3374712|NCT01944059|4107489|FG000|COMPLETED|Overall Study||24
3374713|NCT01944059|4107489|FG000|NOT COMPLETED|Overall Study||7
3374714|NCT01935947|4107497|FG000|STARTED|Overall Study||4
3374715|NCT01935947|4107498|FG001|STARTED|Overall Study||4
3374716|NCT01935947|4107499|FG002|STARTED|Overall Study||2
3374717|NCT01935947|4107497|FG000|Epigenetic Therapy|Overall Study||4
3374718|NCT01935947|4107498|FG001|Epigenetic Therapy|Overall Study||4
3374719|NCT01935947|4107499|FG002|Epigenetic Therapy|Overall Study||0
3374720|NCT01935947|4107497|FG000|Cytotoxic Therapy|Overall Study||3
3374721|NCT01935947|4107498|FG001|Cytotoxic Therapy|Overall Study||3
3374722|NCT01935947|4107499|FG002|Cytotoxic Therapy|Overall Study||2
3374723|NCT01935947|4107497|FG000|COMPLETED|Overall Study||1
3374724|NCT01935947|4107498|FG001|COMPLETED|Overall Study||0
3374725|NCT01935947|4107499|FG002|COMPLETED|Overall Study||0
3374726|NCT01935947|4107497|FG000|NOT COMPLETED|Overall Study||3
3374727|NCT01935947|4107498|FG001|NOT COMPLETED|Overall Study||4
3374728|NCT01935947|4107499|FG002|NOT COMPLETED|Overall Study||2
3374729|NCT01939223|4107512|FG000|STARTED|Overall Study||14
3374730|NCT01939223|4107513|FG001|STARTED|Overall Study||11
3374731|NCT01939223|4107512|FG000|Participants Received Treatment|Overall Study||14
3374732|NCT01939223|4107513|FG001|Participants Received Treatment|Overall Study||11
3374733|NCT01939223|4107512|FG000|COMPLETED|Overall Study||1
3374734|NCT01939223|4107513|FG001|COMPLETED|Overall Study||0
3374735|NCT01939223|4107512|FG000|NOT COMPLETED|Overall Study||13
3264894|NCT02610634|3999237|FG000|COMPLETED|Overall Study||60
3264895|NCT02610634|3999238|FG001|COMPLETED|Overall Study||40
3264896|NCT02610634|3999237|FG000|NOT COMPLETED|Overall Study||0
3264897|NCT02610634|3999238|FG001|NOT COMPLETED|Overall Study||0
3264898|NCT02610725|3999244|FG000|STARTED|Overall Study||281
3264899|NCT02610725|3999244|FG000|COMPLETED|Overall Study||75
3264900|NCT02610725|3999244|FG000|NOT COMPLETED|Overall Study||206
3264901|NCT02610777|3999250|FG000|STARTED|Overall Study||62
3264902|NCT02610777|3999251|FG001|STARTED|Overall Study||58
3264903|NCT02610777|3999250|FG000|COMPLETED|Overall Study||41
3264904|NCT02610777|3999251|FG001|COMPLETED|Overall Study||36
3264905|NCT02610777|3999250|FG000|NOT COMPLETED|Overall Study||21
3264906|NCT02610777|3999251|FG001|NOT COMPLETED|Overall Study||22
3264907|NCT02610816|3999259|FG000|STARTED|Phase 1||38
3264908|NCT02610816|3999260|FG001|STARTED|Phase 1||25
3264909|NCT02610816|3999261|FG002|STARTED|Phase 1||0
3264910|NCT02610816|3999262|FG003|STARTED|Phase 1||0
3264911|NCT02610816|3999259|FG000|COMPLETED|Phase 1||34
3264912|NCT02610816|3999260|FG001|COMPLETED|Phase 1||17
3264913|NCT02610816|3999261|FG002|COMPLETED|Phase 1||0
3264914|NCT02610816|3999262|FG003|COMPLETED|Phase 1||0
3264915|NCT02610816|3999259|FG000|NOT COMPLETED|Phase 1||4
3264916|NCT02610816|3999260|FG001|NOT COMPLETED|Phase 1||8
3264917|NCT02610816|3999261|FG002|NOT COMPLETED|Phase 1||0
3264918|NCT02610816|3999262|FG003|NOT COMPLETED|Phase 1||0
3264919|NCT02610816|3999259|FG000|STARTED|Phase 2||0
3374736|NCT01939223|4107513|FG001|NOT COMPLETED|Overall Study||11
3374737|NCT01938716|4107519|FG000|STARTED|Overall Study||12
3374738|NCT01938716|4107519|FG000|COMPLETED|Overall Study||8
3374739|NCT01938716|4107519|FG000|NOT COMPLETED|Overall Study||4
3264920|NCT02610816|3999260|FG001|STARTED|Phase 2||0
3264921|NCT02610816|3999261|FG002|STARTED|Phase 2||19
3264922|NCT02610816|3999262|FG003|STARTED|Phase 2||10
3264923|NCT02610816|3999259|FG000|COMPLETED|Phase 2||0
3264924|NCT02610816|3999260|FG001|COMPLETED|Phase 2||0
3264925|NCT02610816|3999261|FG002|COMPLETED|Phase 2||8
3264926|NCT02610816|3999262|FG003|COMPLETED|Phase 2||4
3264927|NCT02610816|3999259|FG000|NOT COMPLETED|Phase 2||0
3264928|NCT02610816|3999260|FG001|NOT COMPLETED|Phase 2||0
3264929|NCT02610816|3999261|FG002|NOT COMPLETED|Phase 2||11
3264930|NCT02610816|3999262|FG003|NOT COMPLETED|Phase 2||6
3264931|NCT02610842|3999272|FG000|STARTED|Overall Study||27
3264932|NCT02610842|3999272|FG000|COMPLETED|Overall Study||22
3264933|NCT02610842|3999272|FG000|NOT COMPLETED|Overall Study||5
3264934|NCT02610868|3999278|FG000|STARTED|MYOBLOC: Treatment Session 1||187
3264935|NCT02610868|3999278|FG000|COMPLETED|MYOBLOC: Treatment Session 1||180
3264936|NCT02610868|3999278|FG000|NOT COMPLETED|MYOBLOC: Treatment Session 1||7
3264937|NCT02610868|3999278|FG000|STARTED|MYOBLOC: Treatment Session 2||177
3264938|NCT02610868|3999278|FG000|COMPLETED|MYOBLOC: Treatment Session 2||165
3264939|NCT02610868|3999278|FG000|NOT COMPLETED|MYOBLOC: Treatment Session 2||12
3264940|NCT02610868|3999278|FG000|STARTED|MYOBLOC: Treatment Session 3||50
3264941|NCT02610868|3999278|FG000|COMPLETED|MYOBLOC: Treatment Session 3||43
3264942|NCT02610868|3999278|FG000|NOT COMPLETED|MYOBLOC: Treatment Session 3||7
3264943|NCT02610868|3999278|FG000|STARTED|MYOBLOC: Treatment Session 4||24
3264944|NCT02610868|3999278|FG000|COMPLETED|MYOBLOC: Treatment Session 4||22
3264945|NCT02610868|3999278|FG000|NOT COMPLETED|MYOBLOC: Treatment Session 4||2
3264946|NCT02610972|3999300|FG000|STARTED|Overall Study||100
3264947|NCT02610972|3999301|FG001|STARTED|Overall Study||50
3264948|NCT02610972|3999300|FG000|COMPLETED|Overall Study||100
3264949|NCT02610972|3999301|FG001|COMPLETED|Overall Study||50
3264950|NCT02610972|3999300|FG000|NOT COMPLETED|Overall Study||0
3264951|NCT02610972|3999301|FG001|NOT COMPLETED|Overall Study||0
3264952|NCT02611154|3999307|FG000|STARTED|Overall Study||5
3264953|NCT02611154|3999307|FG000|COMPLETED|Overall Study||5
3264954|NCT02611154|3999307|FG000|NOT COMPLETED|Overall Study||0
3264955|NCT02611362|3999328|FG000|STARTED|Overall Study||41
3264956|NCT02611362|3999329|FG001|STARTED|Overall Study||41
3264957|NCT02611362|3999328|FG000|Immediate Posttest (3 Months)|Overall Study||33
3264958|NCT02611362|3999329|FG001|Immediate Posttest (3 Months)|Overall Study||34
3264959|NCT02611362|3999328|FG000|6-month Follow-up|Overall Study||32
3264960|NCT02611362|3999329|FG001|6-month Follow-up|Overall Study||35
3264961|NCT02611362|3999328|FG000|COMPLETED|Overall Study||32
3264962|NCT02611362|3999329|FG001|COMPLETED|Overall Study||35
3264963|NCT02611362|3999328|FG000|NOT COMPLETED|Overall Study||9
3264964|NCT02611362|3999329|FG001|NOT COMPLETED|Overall Study||6
3264965|NCT02611479|3999336|FG000|STARTED|Baseline Enrollment||184
3264966|NCT02611479|3999336|FG000|COMPLETED|Baseline Enrollment||171
3264967|NCT02611479|3999336|FG000|NOT COMPLETED|Baseline Enrollment||13
3264968|NCT02611479|3999336|FG000|STARTED|Post-Surgery Follow-up at 30-90 Days||171
3264969|NCT02611479|3999336|FG000|COMPLETED|Post-Surgery Follow-up at 30-90 Days||169
3264970|NCT02611479|3999336|FG000|NOT COMPLETED|Post-Surgery Follow-up at 30-90 Days||2
3264971|NCT02611479|3999336|FG000|STARTED|Post-Surgery Follow-up at 1-Year||169
3264972|NCT02611479|3999336|FG000|COMPLETED|Post-Surgery Follow-up at 1-Year||151
3264973|NCT02611479|3999336|FG000|NOT COMPLETED|Post-Surgery Follow-up at 1-Year||18
3264974|NCT02611479|3999336|FG000|STARTED|Data Cleaning||151
3264975|NCT02611479|3999336|FG000|COMPLETED|Data Cleaning||149
3264976|NCT02611479|3999336|FG000|NOT COMPLETED|Data Cleaning||2
3264977|NCT02611752|3999342|FG000|STARTED|Overall Study||22
3264978|NCT02611752|3999343|FG001|STARTED|Overall Study||25
3264979|NCT02611752|3999342|FG000|Day 1-3 Hydromorphone Challenge Injs|Overall Study||22
3264980|NCT02611752|3999343|FG001|Day 1-3 Hydromorphone Challenge Injs|Overall Study||25
3264981|NCT02611752|3999342|FG000|Day 4-6 Hydromorphone Challenge Injs|Overall Study||22
3264982|NCT02611752|3999343|FG001|Day 4-6 Hydromorphone Challenge Injs|Overall Study||24
3264983|NCT02611752|3999342|FG000|Day 8-10 Hydromorphone Challenge Injs|Overall Study||22
3264984|NCT02611752|3999343|FG001|Day 8-10 Hydromorphone Challenge Injs|Overall Study||24
3264985|NCT02611752|3999342|FG000|Day11-13 Hydromorphone Challenge Injs|Overall Study||22
3264986|NCT02611752|3999343|FG001|Day11-13 Hydromorphone Challenge Injs|Overall Study||24
3264987|NCT02611752|3999342|FG000|COMPLETED|Overall Study||22
3264988|NCT02611752|3999343|FG001|COMPLETED|Overall Study||24
3264989|NCT02611752|3999342|FG000|NOT COMPLETED|Overall Study||0
3264990|NCT02611752|3999343|FG001|NOT COMPLETED|Overall Study||1
3264991|NCT02611765|3999364|FG000|STARTED|Overall Study||29
3264992|NCT02611765|3999365|FG001|STARTED|Overall Study||35
3264993|NCT02611765|3999364|FG000|COMPLETED|Overall Study||27
3374740|NCT01936974|4107525|FG000|STARTED|Overall Study||2
3374741|NCT01936974|4107526|FG001|STARTED|Overall Study||5
3374742|NCT01936974|4107525|FG000|COMPLETED|Overall Study||0
3374743|NCT01936974|4107526|FG001|COMPLETED|Overall Study||0
3374744|NCT01936974|4107525|FG000|NOT COMPLETED|Overall Study||2
3374745|NCT01936974|4107526|FG001|NOT COMPLETED|Overall Study||5
3264994|NCT02611765|3999365|FG001|COMPLETED|Overall Study||29
3264995|NCT02611765|3999364|FG000|NOT COMPLETED|Overall Study||2
3264996|NCT02611765|3999365|FG001|NOT COMPLETED|Overall Study||6
3264997|NCT02611778|3999373|FG000|STARTED|Overall Study||238
3264998|NCT02611778|3999374|FG001|STARTED|Overall Study||239
3264999|NCT02611778|3999373|FG000|COMPLETED|Overall Study||226
3265000|NCT02611778|3999374|FG001|COMPLETED|Overall Study||226
3265001|NCT02611778|3999373|FG000|NOT COMPLETED|Overall Study||12
3265002|NCT02611778|3999374|FG001|NOT COMPLETED|Overall Study||13
3265003|NCT02611817|3999384|FG000|STARTED|Open-label Induction Phase||644
3265004|NCT02611817|3999385|FG001|STARTED|Open-label Induction Phase||0
3265005|NCT02611817|3999386|FG002|STARTED|Open-label Induction Phase||0
3265006|NCT02611817|3999384|FG000|COMPLETED|Open-label Induction Phase||594
3265007|NCT02611817|3999385|FG001|COMPLETED|Open-label Induction Phase||0
3265008|NCT02611817|3999386|FG002|COMPLETED|Open-label Induction Phase||0
3265009|NCT02611817|3999384|FG000|NOT COMPLETED|Open-label Induction Phase||50
3265010|NCT02611817|3999385|FG001|NOT COMPLETED|Open-label Induction Phase||0
3265011|NCT02611817|3999386|FG002|NOT COMPLETED|Open-label Induction Phase||0
3265012|NCT02611817|3999384|FG000|STARTED|Double-blind Maintenance Phase||0
3265013|NCT02611817|3999385|FG001|STARTED|Double-blind Maintenance Phase||135
3265014|NCT02611817|3999386|FG002|STARTED|Double-blind Maintenance Phase||275
3265015|NCT02611817|3999384|FG000|COMPLETED|Double-blind Maintenance Phase||0
3265016|NCT02611817|3999385|FG001|COMPLETED|Double-blind Maintenance Phase||73
3265017|NCT02611817|3999386|FG002|COMPLETED|Double-blind Maintenance Phase||168
3265018|NCT02611817|3999384|FG000|NOT COMPLETED|Double-blind Maintenance Phase||0
3265019|NCT02611817|3999385|FG001|NOT COMPLETED|Double-blind Maintenance Phase||62
3265020|NCT02611817|3999386|FG002|NOT COMPLETED|Double-blind Maintenance Phase||107
3265021|NCT02611830|3999397|FG000|STARTED|OL Induction Phase||383
3265022|NCT02611830|3999398|FG001|STARTED|OL Induction Phase||0
3265023|NCT02611830|3999399|FG002|STARTED|OL Induction Phase||0
3265024|NCT02611830|3999400|FG003|STARTED|OL Induction Phase||0
3265025|NCT02611830|3999397|FG000|COMPLETED|OL Induction Phase||353
3265026|NCT02611830|3999398|FG001|COMPLETED|OL Induction Phase||0
3265027|NCT02611830|3999399|FG002|COMPLETED|OL Induction Phase||0
3265028|NCT02611830|3999400|FG003|COMPLETED|OL Induction Phase||0
3265029|NCT02611830|3999397|FG000|NOT COMPLETED|OL Induction Phase||30
3265030|NCT02611830|3999398|FG001|NOT COMPLETED|OL Induction Phase||0
3265031|NCT02611830|3999399|FG002|NOT COMPLETED|OL Induction Phase||0
3265032|NCT02611830|3999400|FG003|NOT COMPLETED|OL Induction Phase||0
3265033|NCT02611830|3999397|FG000|STARTED|Maintenance Phase||0
3265034|NCT02611830|3999398|FG001|STARTED|Maintenance Phase||56
3265035|NCT02611830|3999399|FG002|STARTED|Maintenance Phase||106
3265036|NCT02611830|3999400|FG003|STARTED|Maintenance Phase||54
3265037|NCT02611830|3999397|FG000|COMPLETED|Maintenance Phase||0
3265038|NCT02611830|3999398|FG001|COMPLETED|Maintenance Phase||20
3265039|NCT02611830|3999399|FG002|COMPLETED|Maintenance Phase||75
3265040|NCT02611830|3999400|FG003|COMPLETED|Maintenance Phase||39
3265041|NCT02611830|3999397|FG000|NOT COMPLETED|Maintenance Phase||0
3265042|NCT02611830|3999398|FG001|NOT COMPLETED|Maintenance Phase||36
3265043|NCT02611830|3999399|FG002|NOT COMPLETED|Maintenance Phase||31
3265044|NCT02611830|3999400|FG003|NOT COMPLETED|Maintenance Phase||15
3265045|NCT02611882|3999412|FG000|STARTED|Overall Study||75
3265046|NCT02611882|3999413|FG001|STARTED|Overall Study||150
3265047|NCT02611882|3999414|FG002|STARTED|Overall Study||0
3265048|NCT02611882|3999412|FG000|Completed Surgery Per Protocol|Overall Study||42
3265049|NCT02611882|3999413|FG001|Completed Surgery Per Protocol|Overall Study||0
3265050|NCT02611882|3999414|FG002|Completed Surgery Per Protocol|Overall Study||0
3265051|NCT02611882|3999412|FG000|COMPLETED|Overall Study||42
3265052|NCT02611882|3999413|FG001|COMPLETED|Overall Study||150
3265053|NCT02611882|3999414|FG002|COMPLETED|Overall Study||0
3265054|NCT02611882|3999412|FG000|NOT COMPLETED|Overall Study||33
3265055|NCT02611882|3999413|FG001|NOT COMPLETED|Overall Study||0
3265056|NCT02611882|3999414|FG002|NOT COMPLETED|Overall Study||0
3265057|NCT02612064|3999423|FG000|STARTED|Overall Study||115
3265058|NCT02612064|3999424|FG001|STARTED|Overall Study||115
3265059|NCT02612064|3999423|FG000|COMPLETED|Overall Study||114
3265060|NCT02612064|3999424|FG001|COMPLETED|Overall Study||112
3265061|NCT02612064|3999423|FG000|NOT COMPLETED|Overall Study||1
3265062|NCT02612064|3999424|FG001|NOT COMPLETED|Overall Study||3
3265063|NCT02612077|3999430|FG000|STARTED|Overall Study||765
3265064|NCT02612077|3999430|FG000|Did Not Receive Study Product|Overall Study||5
3265065|NCT02612077|3999430|FG000|Safety Analysis Set|Overall Study||760
3265066|NCT02612077|3999430|FG000|Efficacy Analysis Set|Overall Study||737
3265067|NCT02612077|3999430|FG000|COMPLETED|Overall Study||299
3265068|NCT02612077|3999430|FG000|NOT COMPLETED|Overall Study||466
3265069|NCT02612155|3999439|FG000|STARTED|Overall Study||17
3265070|NCT02612155|3999440|FG001|STARTED|Overall Study||18
3265071|NCT02612155|3999439|FG000|COMPLETED|Overall Study||14
3265072|NCT02612155|3999440|FG001|COMPLETED|Overall Study||15
3265073|NCT02612155|3999439|FG000|NOT COMPLETED|Overall Study||3
3265074|NCT02612155|3999440|FG001|NOT COMPLETED|Overall Study||3
3265075|NCT02612194|3999449|FG000|STARTED|Overall Study||6
3265076|NCT02612194|3999450|FG001|STARTED|Overall Study||0
3265077|NCT02612194|3999451|FG002|STARTED|Overall Study||2
3265078|NCT02612194|3999449|FG000|COMPLETED|Overall Study||0
3374746|NCT01938833|4107532|FG000|STARTED|Overall Study||9
3265079|NCT02612194|3999450|FG001|COMPLETED|Overall Study||0
3265080|NCT02612194|3999451|FG002|COMPLETED|Overall Study||0
3265081|NCT02612194|3999449|FG000|NOT COMPLETED|Overall Study||6
3265082|NCT02612194|3999450|FG001|NOT COMPLETED|Overall Study||0
3265083|NCT02612194|3999451|FG002|NOT COMPLETED|Overall Study||2
3265084|NCT02612428|3999460|FG000|STARTED|VTL-308||78
3265085|NCT02612428|3999461|FG001|STARTED|VTL-308||73
3265086|NCT02612428|3999460|FG000|COMPLETED|VTL-308||64
3265087|NCT02612428|3999461|FG001|COMPLETED|VTL-308||56
3265088|NCT02612428|3999460|FG000|NOT COMPLETED|VTL-308||14
3265089|NCT02612428|3999461|FG001|NOT COMPLETED|VTL-308||17
3265090|NCT02612428|3999460|FG000|STARTED|VTL-308E||64
3265091|NCT02612428|3999461|FG001|STARTED|VTL-308E||56
3265092|NCT02612428|3999460|FG000|COMPLETED|VTL-308E||53
3265093|NCT02612428|3999461|FG001|COMPLETED|VTL-308E||49
3265094|NCT02612428|3999460|FG000|NOT COMPLETED|VTL-308E||11
3265095|NCT02612428|3999461|FG001|NOT COMPLETED|VTL-308E||7
3265096|NCT02612610|3999471|FG000|STARTED|Overall Study||63
3265097|NCT02612610|3999472|FG001|STARTED|Overall Study||64
3265098|NCT02612610|3999473|FG002|STARTED|Overall Study||63
3265099|NCT02612610|3999474|FG003|STARTED|Overall Study||63
3265100|NCT02612610|3999471|FG000|Treated|Overall Study||63
3265101|NCT02612610|3999472|FG001|Treated|Overall Study||63
3265102|NCT02612610|3999473|FG002|Treated|Overall Study||63
3265103|NCT02612610|3999474|FG003|Treated|Overall Study||63
3265104|NCT02612610|3999471|FG000|COMPLETED|Overall Study||58
3265105|NCT02612610|3999472|FG001|COMPLETED|Overall Study||56
3265106|NCT02612610|3999473|FG002|COMPLETED|Overall Study||58
3265107|NCT02612610|3999474|FG003|COMPLETED|Overall Study||50
3265108|NCT02612610|3999471|FG000|NOT COMPLETED|Overall Study||5
3265109|NCT02612610|3999472|FG001|NOT COMPLETED|Overall Study||8
3265110|NCT02612610|3999473|FG002|NOT COMPLETED|Overall Study||5
3265111|NCT02612610|3999474|FG003|NOT COMPLETED|Overall Study||13
3265112|NCT02612623|3999488|FG000|STARTED|Overall Study||8
3265113|NCT02612623|3999489|FG001|STARTED|Overall Study||6
3265114|NCT02612623|3999490|FG002|STARTED|Overall Study||6
3265115|NCT02612623|3999491|FG003|STARTED|Overall Study||4
3265116|NCT02612623|3999488|FG000|Treated|Overall Study||8
3265117|NCT02612623|3999489|FG001|Treated|Overall Study||5
3265118|NCT02612623|3999490|FG002|Treated|Overall Study||6
3265119|NCT02612623|3999491|FG003|Treated|Overall Study||4
3265120|NCT02612623|3999488|FG000|COMPLETED|Overall Study||7
3265121|NCT02612623|3999489|FG001|COMPLETED|Overall Study||5
3265122|NCT02612623|3999490|FG002|COMPLETED|Overall Study||5
3265123|NCT02612623|3999491|FG003|COMPLETED|Overall Study||4
3265124|NCT02612623|3999488|FG000|NOT COMPLETED|Overall Study||1
3265125|NCT02612623|3999489|FG001|NOT COMPLETED|Overall Study||1
3265126|NCT02612623|3999490|FG002|NOT COMPLETED|Overall Study||1
3265127|NCT02612623|3999491|FG003|NOT COMPLETED|Overall Study||0
3265128|NCT02612688|3999503|FG000|STARTED|Overall Study||33035
3265129|NCT02612688|3999504|FG001|STARTED|Overall Study||70013
3265130|NCT02612688|3999503|FG000|COMPLETED|Overall Study||33035
3265131|NCT02612688|3999504|FG001|COMPLETED|Overall Study||70013
3265132|NCT02612688|3999503|FG000|NOT COMPLETED|Overall Study||0
3265133|NCT02612688|3999504|FG001|NOT COMPLETED|Overall Study||0
3265134|NCT02612727|3999514|FG000|STARTED|Overall Study||87
3265135|NCT02612727|3999515|FG001|STARTED|Overall Study||87
3265136|NCT02612727|3999514|FG000|COMPLETED|Overall Study||82
3265137|NCT02612727|3999515|FG001|COMPLETED|Overall Study||83
3265138|NCT02612727|3999514|FG000|NOT COMPLETED|Overall Study||5
3265139|NCT02612727|3999515|FG001|NOT COMPLETED|Overall Study||4
3265140|NCT02612779|3999523|FG000|STARTED|Overall Study||68
3265141|NCT02612779|3999524|FG001|STARTED|Overall Study||6
3265142|NCT02612779|3999523|FG000|COMPLETED|Overall Study||0
3265143|NCT02612779|3999524|FG001|COMPLETED|Overall Study||0
3265144|NCT02612779|3999523|FG000|NOT COMPLETED|Overall Study||68
3265145|NCT02612779|3999524|FG001|NOT COMPLETED|Overall Study||6
3265146|NCT02612857|3999534|FG000|STARTED|Overall Study||11
3265147|NCT02612857|3999535|FG001|STARTED|Overall Study||9
3265148|NCT02612857|3999536|FG002|STARTED|Overall Study||10
3265149|NCT02612857|3999534|FG000|COMPLETED|Overall Study||8
3265150|NCT02612857|3999535|FG001|COMPLETED|Overall Study||5
3265151|NCT02612857|3999536|FG002|COMPLETED|Overall Study||6
3265152|NCT02612857|3999534|FG000|NOT COMPLETED|Overall Study||3
3265153|NCT02612857|3999535|FG001|NOT COMPLETED|Overall Study||4
3265154|NCT02612857|3999536|FG002|NOT COMPLETED|Overall Study||4
3265155|NCT02612909|3999549|FG000|STARTED|Phase 2||100
3265156|NCT02612909|3999550|FG001|STARTED|Phase 2||100
3265157|NCT02612909|3999551|FG002|STARTED|Phase 2||100
3265158|NCT02612909|3999552|FG003|STARTED|Phase 2||0
3265159|NCT02612909|3999553|FG004|STARTED|Phase 2||0
3265160|NCT02612909|3999549|FG000|Received Injection 1|Phase 2||100
3265161|NCT02612909|3999550|FG001|Received Injection 1|Phase 2||100
3265162|NCT02612909|3999551|FG002|Received Injection 1|Phase 2||100
3265163|NCT02612909|3999552|FG003|Received Injection 1|Phase 2||0
3265164|NCT02612909|3999553|FG004|Received Injection 1|Phase 2||0
3265165|NCT02612909|3999549|FG000|Received Injection 2|Phase 2||98
3265166|NCT02612909|3999550|FG001|Received Injection 2|Phase 2||95
3265167|NCT02612909|3999551|FG002|Received Injection 2|Phase 2||99
3265168|NCT02612909|3999552|FG003|Received Injection 2|Phase 2||0
3265169|NCT02612909|3999553|FG004|Received Injection 2|Phase 2||0
3265170|NCT02612909|3999549|FG000|Completed Day 29 Clinic Visit|Phase 2||98
3265171|NCT02612909|3999550|FG001|Completed Day 29 Clinic Visit|Phase 2||95
3265172|NCT02612909|3999551|FG002|Completed Day 29 Clinic Visit|Phase 2||99
3265173|NCT02612909|3999552|FG003|Completed Day 29 Clinic Visit|Phase 2||0
3265174|NCT02612909|3999553|FG004|Completed Day 29 Clinic Visit|Phase 2||0
3265175|NCT02612909|3999549|FG000|Completed Day 43 Clinic Visit|Phase 2||97
3265176|NCT02612909|3999550|FG001|Completed Day 43 Clinic Visit|Phase 2||94
3265177|NCT02612909|3999551|FG002|Completed Day 43 Clinic Visit|Phase 2||99
3265178|NCT02612909|3999552|FG003|Completed Day 43 Clinic Visit|Phase 2||0
3265179|NCT02612909|3999553|FG004|Completed Day 43 Clinic Visit|Phase 2||0
3265180|NCT02612909|3999549|FG000|COMPLETED|Phase 2||98
3265181|NCT02612909|3999550|FG001|COMPLETED|Phase 2||95
3265182|NCT02612909|3999551|FG002|COMPLETED|Phase 2||99
3265183|NCT02612909|3999552|FG003|COMPLETED|Phase 2||0
3265184|NCT02612909|3999553|FG004|COMPLETED|Phase 2||0
3265185|NCT02612909|3999549|FG000|NOT COMPLETED|Phase 2||2
3265186|NCT02612909|3999550|FG001|NOT COMPLETED|Phase 2||5
3265187|NCT02612909|3999551|FG002|NOT COMPLETED|Phase 2||1
3265188|NCT02612909|3999552|FG003|NOT COMPLETED|Phase 2||0
3265189|NCT02612909|3999553|FG004|NOT COMPLETED|Phase 2||0
3265190|NCT02612909|3999549|FG000|STARTED|Phase 3||0
3265191|NCT02612909|3999550|FG001|STARTED|Phase 3||0
3265192|NCT02612909|3999551|FG002|STARTED|Phase 3||0
3265193|NCT02612909|3999552|FG003|STARTED|Phase 3||105
3265194|NCT02612909|3999553|FG004|STARTED|Phase 3||525
3265195|NCT02612909|3999549|FG000|Received Injection 1|Phase 3||0
3265196|NCT02612909|3999550|FG001|Received Injection 1|Phase 3||0
3265197|NCT02612909|3999551|FG002|Received Injection 1|Phase 3||0
3265198|NCT02612909|3999552|FG003|Received Injection 1|Phase 3||105
3265199|NCT02612909|3999553|FG004|Received Injection 1|Phase 3||525
3265200|NCT02612909|3999549|FG000|Received Injection 2|Phase 3||0
3265201|NCT02612909|3999550|FG001|Received Injection 2|Phase 3||0
3265202|NCT02612909|3999551|FG002|Received Injection 2|Phase 3||0
3265203|NCT02612909|3999552|FG003|Received Injection 2|Phase 3||103
3265204|NCT02612909|3999553|FG004|Received Injection 2|Phase 3||520
3265205|NCT02612909|3999549|FG000|Completed Day 29 Clinic Visit|Phase 3||0
3265206|NCT02612909|3999550|FG001|Completed Day 29 Clinic Visit|Phase 3||0
3374747|NCT01938833|4107532|FG000|COMPLETED|Overall Study||9
3374748|NCT01938833|4107532|FG000|NOT COMPLETED|Overall Study||0
3374749|NCT01934647|4107539|FG000|STARTED|Overall Study||2
3374750|NCT01934647|4107540|FG001|STARTED|Overall Study||2
3374751|NCT01934647|4107541|FG002|STARTED|Overall Study||3
3374752|NCT01934647|4107539|FG000|COMPLETED|Overall Study||2
3374753|NCT01934647|4107540|FG001|COMPLETED|Overall Study||2
3374754|NCT01934647|4107541|FG002|COMPLETED|Overall Study||3
3374755|NCT01934647|4107539|FG000|NOT COMPLETED|Overall Study||0
3374756|NCT01934647|4107540|FG001|NOT COMPLETED|Overall Study||0
3374757|NCT01934647|4107541|FG002|NOT COMPLETED|Overall Study||0
3374758|NCT01934504|4107553|FG000|STARTED|Overall Study||6
3374759|NCT01934504|4107554|FG001|STARTED|Overall Study||3
3374760|NCT01934504|4107555|FG002|STARTED|Overall Study||16
3374761|NCT01934504|4107556|FG003|STARTED|Overall Study||8
3374762|NCT01934504|4107553|FG000|COMPLETED|Overall Study||5
3374763|NCT01934504|4107554|FG001|COMPLETED|Overall Study||3
3374764|NCT01934504|4107555|FG002|COMPLETED|Overall Study||11
3374765|NCT01934504|4107556|FG003|COMPLETED|Overall Study||1
3374766|NCT01934504|4107553|FG000|NOT COMPLETED|Overall Study||1
3374767|NCT01934504|4107554|FG001|NOT COMPLETED|Overall Study||0
3374768|NCT01934504|4107555|FG002|NOT COMPLETED|Overall Study||5
3374769|NCT01934504|4107556|FG003|NOT COMPLETED|Overall Study||7
3374770|NCT01928082|4107566|FG000|STARTED|Overall Study||1
3374771|NCT01928082|4107566|FG000|COMPLETED|Overall Study||0
3374772|NCT01928082|4107566|FG000|NOT COMPLETED|Overall Study||1
3374773|NCT01928615|4107570|FG000|STARTED|Overall Study||2
3374774|NCT01928615|4107570|FG000|COMPLETED|Overall Study||0
3374775|NCT01928615|4107570|FG000|NOT COMPLETED|Overall Study||2
3374776|NCT01911793|4107577|FG000|STARTED|Overall Study||1
3374777|NCT01911793|4107578|FG001|STARTED|Overall Study||5
3374778|NCT01911793|4107577|FG000|COMPLETED|Overall Study||0
3374779|NCT01911793|4107578|FG001|COMPLETED|Overall Study||0
3374780|NCT01911793|4107577|FG000|NOT COMPLETED|Overall Study||1
3374781|NCT01911793|4107578|FG001|NOT COMPLETED|Overall Study||5
3374782|NCT01912404|4107586|FG000|STARTED|Overall Study||3
3374783|NCT01912404|4107587|FG001|STARTED|Overall Study||2
3374784|NCT01912404|4107586|FG000|COMPLETED|Overall Study||2
3374785|NCT01912404|4107587|FG001|COMPLETED|Overall Study||2
3374786|NCT01912404|4107586|FG000|NOT COMPLETED|Overall Study||1
3374787|NCT01912404|4107587|FG001|NOT COMPLETED|Overall Study||0
3374788|NCT01910389|4107595|FG000|STARTED|Overall Study||15
3374789|NCT01910389|4107596|FG001|STARTED|Overall Study||8
3374790|NCT01910389|4107595|FG000|COMPLETED|Overall Study||0
3374791|NCT01910389|4107596|FG001|COMPLETED|Overall Study||0
3374792|NCT01910389|4107595|FG000|NOT COMPLETED|Overall Study||15
3374793|NCT01910389|4107596|FG001|NOT COMPLETED|Overall Study||8
3374794|NCT01921114|4107604|FG000|STARTED|Overall Study||0
3374795|NCT01921114|4107605|FG001|STARTED|Overall Study||0
3374796|NCT01921114|4107604|FG000|COMPLETED|Overall Study||0
3374797|NCT01921114|4107605|FG001|COMPLETED|Overall Study||0
3374798|NCT01921114|4107604|FG000|NOT COMPLETED|Overall Study||0
3374799|NCT01921114|4107605|FG001|NOT COMPLETED|Overall Study||0
3374800|NCT01916590|4107613|FG000|STARTED|Overall Study||4
3374801|NCT01916590|4107614|FG001|STARTED|Overall Study||3
3265207|NCT02612909|3999551|FG002|Completed Day 29 Clinic Visit|Phase 3||0
3265208|NCT02612909|3999552|FG003|Completed Day 29 Clinic Visit|Phase 3||104
3265209|NCT02612909|3999553|FG004|Completed Day 29 Clinic Visit|Phase 3||525
3265210|NCT02612909|3999549|FG000|Completed Day 43 Clinic Visit|Phase 3||0
3374802|NCT01916590|4107613|FG000|COMPLETED|Overall Study||4
3374803|NCT01916590|4107614|FG001|COMPLETED|Overall Study||3
3374804|NCT01916590|4107613|FG000|NOT COMPLETED|Overall Study||0
3374805|NCT01916590|4107614|FG001|NOT COMPLETED|Overall Study||0
3374806|NCT01913327|4107622|FG000|STARTED|Overall Study||1
3374807|NCT01913327|4107623|FG001|STARTED|Overall Study||2
3374808|NCT01913327|4107622|FG000|COMPLETED|Overall Study||1
3374809|NCT01913327|4107623|FG001|COMPLETED|Overall Study||1
3374810|NCT01913327|4107622|FG000|NOT COMPLETED|Overall Study||0
3265211|NCT02612909|3999550|FG001|Completed Day 43 Clinic Visit|Phase 3||0
3265212|NCT02612909|3999551|FG002|Completed Day 43 Clinic Visit|Phase 3||0
3265213|NCT02612909|3999552|FG003|Completed Day 43 Clinic Visit|Phase 3||104
3265214|NCT02612909|3999553|FG004|Completed Day 43 Clinic Visit|Phase 3||524
3265215|NCT02612909|3999549|FG000|COMPLETED|Phase 3||0
3265216|NCT02612909|3999550|FG001|COMPLETED|Phase 3||0
3265217|NCT02612909|3999551|FG002|COMPLETED|Phase 3||0
3265218|NCT02612909|3999552|FG003|COMPLETED|Phase 3||104
3265219|NCT02612909|3999553|FG004|COMPLETED|Phase 3||525
3265220|NCT02612909|3999549|FG000|NOT COMPLETED|Phase 3||0
3265221|NCT02612909|3999550|FG001|NOT COMPLETED|Phase 3||0
3265222|NCT02612909|3999551|FG002|NOT COMPLETED|Phase 3||0
3265223|NCT02612909|3999552|FG003|NOT COMPLETED|Phase 3||1
3265224|NCT02612909|3999553|FG004|NOT COMPLETED|Phase 3||0
3265225|NCT02613117|3999569|FG000|STARTED|Overall Study||57
3265226|NCT02613117|3999570|FG001|STARTED|Overall Study||47
3265227|NCT02613117|3999569|FG000|COMPLETED|Overall Study||57
3265228|NCT02613117|3999570|FG001|COMPLETED|Overall Study||47
3265229|NCT02613117|3999569|FG000|NOT COMPLETED|Overall Study||0
3265230|NCT02613117|3999570|FG001|NOT COMPLETED|Overall Study||0
3265231|NCT02613169|3999578|FG000|STARTED|Overall Study||150
3265232|NCT02613169|3999579|FG001|STARTED|Overall Study||150
3265233|NCT02613169|3999578|FG000|COMPLETED|Overall Study||132
3265234|NCT02613169|3999579|FG001|COMPLETED|Overall Study||133
3265235|NCT02613169|3999578|FG000|NOT COMPLETED|Overall Study||18
3265236|NCT02613169|3999579|FG001|NOT COMPLETED|Overall Study||17
3265237|NCT02613182|3999585|FG000|STARTED|Overall Study||34
3265238|NCT02613182|3999585|FG000|Number of Patients Dosed|Overall Study||34
3265239|NCT02613182|3999585|FG000|COMPLETED|Overall Study||0
3265240|NCT02613182|3999585|FG000|NOT COMPLETED|Overall Study||34
3265241|NCT02613208|3999589|FG000|STARTED|Overall Study||111
3265242|NCT02613208|3999589|FG000|COMPLETED|Overall Study||64
3265243|NCT02613208|3999589|FG000|NOT COMPLETED|Overall Study||47
3265244|NCT02613221|3999593|FG000|STARTED|Overall Study||56
3265245|NCT02613221|3999593|FG000|Safety Population: Received Study Drug|Overall Study||55
3265246|NCT02613221|3999593|FG000|COMPLETED|Overall Study||1
3265247|NCT02613221|3999593|FG000|NOT COMPLETED|Overall Study||55
3265248|NCT02613338|3999597|FG000|STARTED|Overall Study||30
3265249|NCT02613338|3999597|FG000|COMPLETED|Overall Study||30
3265250|NCT02613338|3999597|FG000|NOT COMPLETED|Overall Study||0
3265251|NCT02613364|3999604|FG000|STARTED|Overall Study||251
3265252|NCT02613364|3999605|FG001|STARTED|Overall Study||238
3265253|NCT02613364|3999606|FG002|STARTED|Overall Study||251
3265254|NCT02613364|3999604|FG000|COMPLETED|Overall Study||185
3265255|NCT02613364|3999605|FG001|COMPLETED|Overall Study||148
3265256|NCT02613364|3999606|FG002|COMPLETED|Overall Study||175
3265257|NCT02613364|3999604|FG000|NOT COMPLETED|Overall Study||66
3265258|NCT02613364|3999605|FG001|NOT COMPLETED|Overall Study||90
3265259|NCT02613364|3999606|FG002|NOT COMPLETED|Overall Study||76
3265260|NCT02613403|3999618|FG000|STARTED|Overall Study||36
3265261|NCT02613403|3999619|FG001|STARTED|Overall Study||36
3265262|NCT02613403|3999620|FG002|STARTED|Overall Study||9
3265263|NCT02613403|3999621|FG003|STARTED|Overall Study||13
3265264|NCT02613403|3999622|FG004|STARTED|Overall Study|Study terminated prior to participant recruitment for study Part B.|0
3265265|NCT02613403|3999618|FG000|Treated|Overall Study||35
3265266|NCT02613403|3999619|FG001|Treated|Overall Study||36
3265267|NCT02613403|3999620|FG002|Treated|Overall Study||9
3265268|NCT02613403|3999621|FG003|Treated|Overall Study||13
3265269|NCT02613403|3999622|FG004|Treated|Overall Study|Study terminated prior to participant recruitment for study Part B.|0
3265270|NCT02613403|3999618|FG000|COMPLETED|Overall Study||34
3265271|NCT02613403|3999619|FG001|COMPLETED|Overall Study||35
3265272|NCT02613403|3999620|FG002|COMPLETED|Overall Study||9
3265273|NCT02613403|3999621|FG003|COMPLETED|Overall Study||13
3265274|NCT02613403|3999622|FG004|COMPLETED|Overall Study|Study terminated prior to participant recruitment for study Part B.|0
3265275|NCT02613403|3999618|FG000|NOT COMPLETED|Overall Study||2
3265276|NCT02613403|3999619|FG001|NOT COMPLETED|Overall Study||1
3265277|NCT02613403|3999620|FG002|NOT COMPLETED|Overall Study||0
3265278|NCT02613403|3999621|FG003|NOT COMPLETED|Overall Study||0
3265279|NCT02613403|3999622|FG004|NOT COMPLETED|Overall Study||0
3265280|NCT02613481|3999632|FG000|STARTED|Overall Study||50
3265281|NCT02613481|3999632|FG000|COMPLETED|Overall Study||41
3265282|NCT02613481|3999632|FG000|NOT COMPLETED|Overall Study||9
3265283|NCT02613507|3999638|FG000|STARTED|Overall Study||338
3265284|NCT02613507|3999639|FG001|STARTED|Overall Study||166
3265285|NCT02613507|3999638|FG000|COMPLETED|Overall Study||50
3265286|NCT02613507|3999639|FG001|COMPLETED|Overall Study||2
3265287|NCT02613507|3999638|FG000|NOT COMPLETED|Overall Study||288
3265288|NCT02613507|3999639|FG001|NOT COMPLETED|Overall Study||164
3265289|NCT02613572|3999648|FG000|STARTED|Phase I: Tolerability, 600, 800, 1200 mg||15
3265290|NCT02613572|3999649|FG001|STARTED|Phase I: Tolerability, 600, 800, 1200 mg||0
3265291|NCT02613572|3999650|FG002|STARTED|Phase I: Tolerability, 600, 800, 1200 mg||0
3265292|NCT02613572|3999648|FG000|600 mg|Phase I: Tolerability, 600, 800, 1200 mg||15
3265293|NCT02613572|3999649|FG001|600 mg|Phase I: Tolerability, 600, 800, 1200 mg||0
3265294|NCT02613572|3999650|FG002|600 mg|Phase I: Tolerability, 600, 800, 1200 mg||0
3265295|NCT02613572|3999648|FG000|800 mg|Phase I: Tolerability, 600, 800, 1200 mg||15
3265296|NCT02613572|3999649|FG001|800 mg|Phase I: Tolerability, 600, 800, 1200 mg||0
3265297|NCT02613572|3999650|FG002|800 mg|Phase I: Tolerability, 600, 800, 1200 mg||0
3265298|NCT02613572|3999648|FG000|1200 mg|Phase I: Tolerability, 600, 800, 1200 mg||14
3374811|NCT01913327|4107623|FG001|NOT COMPLETED|Overall Study||1
3265299|NCT02613572|3999649|FG001|1200 mg|Phase I: Tolerability, 600, 800, 1200 mg||0
3265300|NCT02613572|3999650|FG002|1200 mg|Phase I: Tolerability, 600, 800, 1200 mg||0
3265301|NCT02613572|3999648|FG000|COMPLETED|Phase I: Tolerability, 600, 800, 1200 mg||14
3265302|NCT02613572|3999649|FG001|COMPLETED|Phase I: Tolerability, 600, 800, 1200 mg||0
3265303|NCT02613572|3999650|FG002|COMPLETED|Phase I: Tolerability, 600, 800, 1200 mg||0
3265304|NCT02613572|3999648|FG000|NOT COMPLETED|Phase I: Tolerability, 600, 800, 1200 mg||1
3265305|NCT02613572|3999649|FG001|NOT COMPLETED|Phase I: Tolerability, 600, 800, 1200 mg||0
3265306|NCT02613572|3999650|FG002|NOT COMPLETED|Phase I: Tolerability, 600, 800, 1200 mg||0
3265307|NCT02613572|3999648|FG000|STARTED|Phase II: Double-Blind Rand Plac Control||0
3265308|NCT02613572|3999649|FG001|STARTED|Phase II: Double-Blind Rand Plac Control||27
3265309|NCT02613572|3999650|FG002|STARTED|Phase II: Double-Blind Rand Plac Control||26
3265310|NCT02613572|3999648|FG000|COMPLETED|Phase II: Double-Blind Rand Plac Control||0
3265311|NCT02613572|3999649|FG001|COMPLETED|Phase II: Double-Blind Rand Plac Control||26
3265312|NCT02613572|3999650|FG002|COMPLETED|Phase II: Double-Blind Rand Plac Control||26
3265313|NCT02613572|3999648|FG000|NOT COMPLETED|Phase II: Double-Blind Rand Plac Control||0
3265314|NCT02613572|3999649|FG001|NOT COMPLETED|Phase II: Double-Blind Rand Plac Control||1
3265315|NCT02613572|3999650|FG002|NOT COMPLETED|Phase II: Double-Blind Rand Plac Control||0
3265316|NCT02613871|3999662|FG000|STARTED|Overall Study||111
3265317|NCT02613871|3999662|FG000|COMPLETED|Overall Study||108
3265318|NCT02613871|3999662|FG000|NOT COMPLETED|Overall Study||3
3265319|NCT02613884|3999666|FG000|STARTED|Overall Study||26
3265320|NCT02613884|3999666|FG000|Safety Endpoint 1|Overall Study||26
3265321|NCT02613884|3999666|FG000|Feasibility Questionnaire|Overall Study||26
3265322|NCT02613884|3999666|FG000|Safety Endpoint 2|Overall Study||26
3265323|NCT02613884|3999666|FG000|Efficacy Endpoint 1|Overall Study||25
3265324|NCT02613884|3999666|FG000|Efficacy Timepoint 2|Overall Study||25
3265325|NCT02613884|3999666|FG000|Efficacy Timepoint 3|Overall Study||24
3265326|NCT02613884|3999666|FG000|COMPLETED|Overall Study||24
3265327|NCT02613884|3999666|FG000|NOT COMPLETED|Overall Study||2
3265328|NCT02613897|3999674|FG000|STARTED|Overall Study||22
3265329|NCT02613897|3999675|FG001|STARTED|Overall Study||22
3265330|NCT02613897|3999676|FG002|STARTED|Overall Study||12
3265331|NCT02613897|3999674|FG000|COMPLETED|Overall Study||22
3265332|NCT02613897|3999675|FG001|COMPLETED|Overall Study||22
3265333|NCT02613897|3999676|FG002|COMPLETED|Overall Study||12
3265334|NCT02613897|3999674|FG000|NOT COMPLETED|Overall Study||0
3265335|NCT02613897|3999675|FG001|NOT COMPLETED|Overall Study||0
3265336|NCT02613897|3999676|FG002|NOT COMPLETED|Overall Study||0
3265337|NCT02613910|3999685|FG000|STARTED|Overall Study||1
3265338|NCT02613910|3999685|FG000|COMPLETED|Overall Study||0
3265339|NCT02613910|3999685|FG000|NOT COMPLETED|Overall Study||1
3265340|NCT02614079|3999689|FG000|STARTED|Overall Study||6
3265341|NCT02614079|3999689|FG000|COMPLETED|Overall Study|1 participant withdrew from the study prior to completion of DSSEP testing|5
3265342|NCT02614079|3999689|FG000|NOT COMPLETED|Overall Study||1
3265343|NCT02614131|3999700|FG000|STARTED|Overall Study||11
3265344|NCT02614131|3999701|FG001|STARTED|Overall Study||8
3265345|NCT02614131|3999702|FG002|STARTED|Overall Study||8
3265346|NCT02614131|3999703|FG003|STARTED|Overall Study||8
3265347|NCT02614131|3999704|FG004|STARTED|Overall Study||8
3265348|NCT02614131|3999705|FG005|STARTED|Overall Study||2
3265349|NCT02614131|3999706|FG006|STARTED|Overall Study||5
3265350|NCT02614131|3999700|FG000|Received at Least One Dose of Drug|Overall Study||11
3265351|NCT02614131|3999701|FG001|Received at Least One Dose of Drug|Overall Study||8
3265352|NCT02614131|3999702|FG002|Received at Least One Dose of Drug|Overall Study||8
3265353|NCT02614131|3999703|FG003|Received at Least One Dose of Drug|Overall Study||8
3265354|NCT02614131|3999704|FG004|Received at Least One Dose of Drug|Overall Study||8
3265355|NCT02614131|3999705|FG005|Received at Least One Dose of Drug|Overall Study||2
3265356|NCT02614131|3999706|FG006|Received at Least One Dose of Drug|Overall Study||5
3265357|NCT02614131|3999700|FG000|COMPLETED|Overall Study||10
3265358|NCT02614131|3999701|FG001|COMPLETED|Overall Study||8
3265359|NCT02614131|3999702|FG002|COMPLETED|Overall Study||8
3265360|NCT02614131|3999703|FG003|COMPLETED|Overall Study||8
3265361|NCT02614131|3999704|FG004|COMPLETED|Overall Study||8
3265362|NCT02614131|3999705|FG005|COMPLETED|Overall Study||2
3265363|NCT02614131|3999706|FG006|COMPLETED|Overall Study||4
3265364|NCT02614131|3999700|FG000|NOT COMPLETED|Overall Study||1
3265365|NCT02614131|3999701|FG001|NOT COMPLETED|Overall Study||0
3265366|NCT02614131|3999702|FG002|NOT COMPLETED|Overall Study||0
3265367|NCT02614131|3999703|FG003|NOT COMPLETED|Overall Study||0
3265368|NCT02614131|3999704|FG004|NOT COMPLETED|Overall Study||0
3265369|NCT02614131|3999705|FG005|NOT COMPLETED|Overall Study||0
3265370|NCT02614131|3999706|FG006|NOT COMPLETED|Overall Study||1
3265371|NCT02614183|3999731|FG000|STARTED|Double Blind Treatment Phase||434
3265372|NCT02614183|3999732|FG001|STARTED|Double Blind Treatment Phase||214
3265373|NCT02614183|3999733|FG002|STARTED|Double Blind Treatment Phase||214
3265374|NCT02614183|3999731|FG000|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||433
3265375|NCT02614183|3999732|FG001|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||213
3265376|NCT02614183|3999733|FG002|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||212
3265377|NCT02614183|3999731|FG000|Safety Population|Double Blind Treatment Phase||432
3265378|NCT02614183|3999732|FG001|Safety Population|Double Blind Treatment Phase|One pt randomized to placebo received galcanezumab 120mg due to dosing error moved to this group.|206
3374812|NCT01902888|4107629|FG000|STARTED|Overall Study||3
3265379|NCT02614183|3999733|FG002|Safety Population|Double Blind Treatment Phase|Eight pts discontinued after loading dose of 240mg galcanezumab in 120mg group moved to this group.|220
3265380|NCT02614183|3999731|FG000|COMPLETED|Double Blind Treatment Phase||351
3265381|NCT02614183|3999732|FG001|COMPLETED|Double Blind Treatment Phase||177
3374813|NCT01902888|4107629|FG000|COMPLETED|Overall Study||0
3374814|NCT01902888|4107629|FG000|NOT COMPLETED|Overall Study||3
3374815|NCT01901224|4107633|FG000|STARTED|Overall Study||2
3374816|NCT01901224|4107633|FG000|COMPLETED|Overall Study||0
3374817|NCT01901224|4107633|FG000|NOT COMPLETED|Overall Study||2
3374818|NCT01910441|4107639|FG000|STARTED|Overall Study||48
3374819|NCT01910441|4107640|FG001|STARTED|Overall Study||47
3374820|NCT01910441|4107639|FG000|COMPLETED|Overall Study||41
3374821|NCT01910441|4107640|FG001|COMPLETED|Overall Study||37
3374822|NCT01910441|4107639|FG000|NOT COMPLETED|Overall Study||7
3374823|NCT01910441|4107640|FG001|NOT COMPLETED|Overall Study||10
3374824|NCT01902966|4107646|FG000|STARTED|Overall Study||5
3374825|NCT01902966|4107646|FG000|COMPLETED|Overall Study||2
3374826|NCT01902966|4107646|FG000|NOT COMPLETED|Overall Study||3
3374827|NCT01901679|4107652|FG000|STARTED|Overall Study||5
3374828|NCT01901679|4107653|FG001|STARTED|Overall Study||5
3374829|NCT01901679|4107652|FG000|COMPLETED|Overall Study||5
3374830|NCT01901679|4107653|FG001|COMPLETED|Overall Study||5
3374831|NCT01901679|4107652|FG000|NOT COMPLETED|Overall Study||0
3374832|NCT01901679|4107653|FG001|NOT COMPLETED|Overall Study||0
3374833|NCT01900730|4107661|FG000|STARTED|Overall Study||3
3374834|NCT01900730|4107662|FG001|STARTED|Overall Study||0
3374835|NCT01900730|4107661|FG000|COMPLETED|Overall Study||1
3374836|NCT01900730|4107662|FG001|COMPLETED|Overall Study||0
3374837|NCT01900730|4107661|FG000|NOT COMPLETED|Overall Study||2
3374838|NCT01900730|4107662|FG001|NOT COMPLETED|Overall Study||0
3374839|NCT01877564|4107670|FG000|STARTED|Overall Study||6
3374840|NCT01877564|4107671|FG001|STARTED|Overall Study||4
3374841|NCT01877564|4107670|FG000|COMPLETED|Overall Study||6
3374842|NCT01877564|4107671|FG001|COMPLETED|Overall Study||4
3374843|NCT01877564|4107670|FG000|NOT COMPLETED|Overall Study||0
3374844|NCT01877564|4107671|FG001|NOT COMPLETED|Overall Study||0
3374845|NCT01890694|4107679|FG000|STARTED|Overall Study||1
3374846|NCT01890694|4107680|FG001|STARTED|Overall Study||1
3374847|NCT01890694|4107679|FG000|COMPLETED|Overall Study||0
3374848|NCT01890694|4107680|FG001|COMPLETED|Overall Study||0
3374849|NCT01890694|4107679|FG000|NOT COMPLETED|Overall Study||1
3374850|NCT01890694|4107680|FG001|NOT COMPLETED|Overall Study||1
3374851|NCT01900626|4107690|FG000|STARTED|Overall Study||1
3374852|NCT01900626|4107691|FG001|STARTED|Overall Study||1
3374853|NCT01900626|4107690|FG000|COMPLETED|Overall Study||0
3374854|NCT01900626|4107691|FG001|COMPLETED|Overall Study||0
3374855|NCT01900626|4107690|FG000|NOT COMPLETED|Overall Study||1
3374856|NCT01900626|4107691|FG001|NOT COMPLETED|Overall Study||1
3374857|NCT01890577|4107699|FG000|STARTED|Overall Study||28
3374858|NCT01890577|4107699|FG000|COMPLETED|Overall Study||0
3374859|NCT01890577|4107699|FG000|NOT COMPLETED|Overall Study||28
3374860|NCT01895959|4107703|FG000|STARTED|Overall Study||12
3374861|NCT01895959|4107703|FG000|COMPLETED|Overall Study||10
3374862|NCT01895959|4107703|FG000|NOT COMPLETED|Overall Study||2
3374863|NCT01889420|4107707|FG000|STARTED|Overall Study||1
3374864|NCT01889420|4107707|FG000|COMPLETED|Overall Study||1
3374865|NCT01889420|4107707|FG000|NOT COMPLETED|Overall Study||0
3374866|NCT01884077|4107713|FG000|STARTED|Overall Study||8
3374867|NCT01884077|4107714|FG001|STARTED|Overall Study||11
3374868|NCT01884077|4107713|FG000|COMPLETED|Overall Study||0
3374869|NCT01884077|4107714|FG001|COMPLETED|Overall Study||1
3374870|NCT01884077|4107713|FG000|NOT COMPLETED|Overall Study||8
3374871|NCT01884077|4107714|FG001|NOT COMPLETED|Overall Study||10
3374872|NCT01881984|4107720|FG000|STARTED|Overall Study||4
3374873|NCT01881984|4107720|FG000|COMPLETED|Overall Study||4
3374874|NCT01881984|4107720|FG000|NOT COMPLETED|Overall Study||0
3374875|NCT01893359|4107727|FG000|STARTED|Overall Study||0
3374876|NCT01893359|4107728|FG001|STARTED|Overall Study||2
3374877|NCT01893359|4107729|FG002|STARTED|Overall Study||0
3374878|NCT01893359|4107727|FG000|COMPLETED|Overall Study||0
3374879|NCT01893359|4107728|FG001|COMPLETED|Overall Study||2
3374880|NCT01893359|4107729|FG002|COMPLETED|Overall Study||0
3374881|NCT01893359|4107727|FG000|NOT COMPLETED|Overall Study||0
3265382|NCT02614183|3999733|FG002|COMPLETED|Double Blind Treatment Phase||175
3265383|NCT02614183|3999731|FG000|NOT COMPLETED|Double Blind Treatment Phase||83
3265384|NCT02614183|3999732|FG001|NOT COMPLETED|Double Blind Treatment Phase||37
3265385|NCT02614183|3999733|FG002|NOT COMPLETED|Double Blind Treatment Phase||39
3265386|NCT02614183|3999731|FG000|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post-treatment phase.|372
3374882|NCT01893359|4107728|FG001|NOT COMPLETED|Overall Study||0
3374883|NCT01893359|4107729|FG002|NOT COMPLETED|Overall Study||0
3374884|NCT01883908|4107739|FG000|STARTED|Overall Study||3
3374885|NCT01883908|4107740|FG001|STARTED|Overall Study||1
3374886|NCT01883908|4107739|FG000|COMPLETED|Overall Study||3
3374887|NCT01883908|4107740|FG001|COMPLETED|Overall Study||1
3374888|NCT01883908|4107739|FG000|NOT COMPLETED|Overall Study||0
3374889|NCT01883908|4107740|FG001|NOT COMPLETED|Overall Study||0
3374890|NCT01887288|4107746|FG000|STARTED|Overall Study||16
3374891|NCT01887288|4107746|FG000|COMPLETED|Overall Study||0
3374892|NCT01887288|4107746|FG000|NOT COMPLETED|Overall Study||16
3374893|NCT01868139|4107750|FG000|STARTED|Overall Study||1
3374894|NCT01868139|4107750|FG000|COMPLETED|Overall Study||0
3265387|NCT02614183|3999732|FG001|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post-treatment phase.|185
3265388|NCT02614183|3999733|FG002|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post-treatment phase.|183
3265389|NCT02614183|3999731|FG000|Safety Population|Post Treatment Follow-up Phase||372
3265390|NCT02614183|3999732|FG001|Safety Population|Post Treatment Follow-up Phase||183
3265391|NCT02614183|3999733|FG002|Safety Population|Post Treatment Follow-up Phase|Two participants who received only 240mg loading dose prior to discontinuation moved to this group.|185
3265392|NCT02614183|3999731|FG000|COMPLETED|Post Treatment Follow-up Phase||354
3265393|NCT02614183|3999732|FG001|COMPLETED|Post Treatment Follow-up Phase||179
3265394|NCT02614183|3999733|FG002|COMPLETED|Post Treatment Follow-up Phase||171
3265395|NCT02614183|3999731|FG000|NOT COMPLETED|Post Treatment Follow-up Phase||18
3265396|NCT02614183|3999732|FG001|NOT COMPLETED|Post Treatment Follow-up Phase||6
3265397|NCT02614183|3999733|FG002|NOT COMPLETED|Post Treatment Follow-up Phase||12
3265398|NCT02614196|3999753|FG000|STARTED|Double Blind Treatment Phase||463
3265399|NCT02614196|3999754|FG001|STARTED|Double Blind Treatment Phase||233
3265400|NCT02614196|3999755|FG002|STARTED|Double Blind Treatment Phase||226
3265401|NCT02614196|3999756|FG003|STARTED|Double Blind Treatment Phase||30
3265402|NCT02614196|3999757|FG004|STARTED|Double Blind Treatment Phase||15
3265403|NCT02614196|3999758|FG005|STARTED|Double Blind Treatment Phase||19
3265404|NCT02614196|3999753|FG000|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||461
3265405|NCT02614196|3999754|FG001|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||231
3265406|NCT02614196|3999755|FG002|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||223
3265407|NCT02614196|3999756|FG003|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||30
3265408|NCT02614196|3999757|FG004|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||14
3265409|NCT02614196|3999758|FG005|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||19
3265410|NCT02614196|3999753|FG000|COMPLETED|Double Blind Treatment Phase||387
3265411|NCT02614196|3999754|FG001|COMPLETED|Double Blind Treatment Phase||203
3265412|NCT02614196|3999755|FG002|COMPLETED|Double Blind Treatment Phase||195
3265413|NCT02614196|3999756|FG003|COMPLETED|Double Blind Treatment Phase||26
3265414|NCT02614196|3999757|FG004|COMPLETED|Double Blind Treatment Phase||14
3265415|NCT02614196|3999758|FG005|COMPLETED|Double Blind Treatment Phase||19
3265416|NCT02614196|3999753|FG000|NOT COMPLETED|Double Blind Treatment Phase||76
3265417|NCT02614196|3999754|FG001|NOT COMPLETED|Double Blind Treatment Phase||30
3265418|NCT02614196|3999755|FG002|NOT COMPLETED|Double Blind Treatment Phase||31
3265419|NCT02614196|3999756|FG003|NOT COMPLETED|Double Blind Treatment Phase||4
3265420|NCT02614196|3999757|FG004|NOT COMPLETED|Double Blind Treatment Phase||1
3265421|NCT02614196|3999758|FG005|NOT COMPLETED|Double Blind Treatment Phase||0
3265422|NCT02614196|3999753|FG000|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post treatment phase|410
3265423|NCT02614196|3999754|FG001|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post treatment phase|213
3265424|NCT02614196|3999755|FG002|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post treatment phase|207
3265425|NCT02614196|3999756|FG003|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post treatment phase|25
3265426|NCT02614196|3999757|FG004|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post treatment phase|15
3265427|NCT02614196|3999758|FG005|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post treatment phase|19
3265428|NCT02614196|3999753|FG000|COMPLETED|Post Treatment Follow-up Phase||390
3265429|NCT02614196|3999754|FG001|COMPLETED|Post Treatment Follow-up Phase||208
3265430|NCT02614196|3999755|FG002|COMPLETED|Post Treatment Follow-up Phase||199
3265431|NCT02614196|3999756|FG003|COMPLETED|Post Treatment Follow-up Phase||24
3265432|NCT02614196|3999757|FG004|COMPLETED|Post Treatment Follow-up Phase||13
3265433|NCT02614196|3999758|FG005|COMPLETED|Post Treatment Follow-up Phase||19
3265434|NCT02614196|3999753|FG000|NOT COMPLETED|Post Treatment Follow-up Phase||20
3265435|NCT02614196|3999754|FG001|NOT COMPLETED|Post Treatment Follow-up Phase||5
3265436|NCT02614196|3999755|FG002|NOT COMPLETED|Post Treatment Follow-up Phase||8
3265437|NCT02614196|3999756|FG003|NOT COMPLETED|Post Treatment Follow-up Phase||1
3265438|NCT02614196|3999757|FG004|NOT COMPLETED|Post Treatment Follow-up Phase||2
3265439|NCT02614196|3999758|FG005|NOT COMPLETED|Post Treatment Follow-up Phase||0
3265440|NCT02614222|3999788|FG000|STARTED|Overall Study||13
3265441|NCT02614222|3999789|FG001|STARTED|Overall Study||14
3265442|NCT02614222|3999788|FG000|COMPLETED|Overall Study||13
3265443|NCT02614222|3999789|FG001|COMPLETED|Overall Study||14
3265444|NCT02614222|3999788|FG000|NOT COMPLETED|Overall Study||0
3265445|NCT02614222|3999789|FG001|NOT COMPLETED|Overall Study||0
3265446|NCT02614261|3999798|FG000|STARTED|Overall Study||558
3265447|NCT02614261|3999799|FG001|STARTED|Overall Study||278
3265448|NCT02614261|3999800|FG002|STARTED|Overall Study||277
3265449|NCT02614261|3999798|FG000|Received at Least One Dose of Study Drug|Overall Study||558
3265450|NCT02614261|3999799|FG001|Received at Least One Dose of Study Drug|Overall Study||278
3265451|NCT02614261|3999800|FG002|Received at Least One Dose of Study Drug|Overall Study||277
3265452|NCT02614261|3999798|FG000|COMPLETED|Overall Study||509
3265453|NCT02614261|3999799|FG001|COMPLETED|Overall Study||263
3265454|NCT02614261|3999800|FG002|COMPLETED|Overall Study||266
3265455|NCT02614261|3999798|FG000|NOT COMPLETED|Overall Study||49
3265456|NCT02614261|3999799|FG001|NOT COMPLETED|Overall Study||15
3265457|NCT02614261|3999800|FG002|NOT COMPLETED|Overall Study||11
3265458|NCT02614274|3999816|FG000|STARTED|Overall Study||9
3265459|NCT02614274|3999816|FG000|COMPLETED|Overall Study||5
3265460|NCT02614274|3999816|FG000|NOT COMPLETED|Overall Study||4
3265461|NCT02614287|3999822|FG000|STARTED|Open Label (OL) Treatment Phase||135
3265462|NCT02614287|3999823|FG001|STARTED|Open Label (OL) Treatment Phase||135
3265463|NCT02614287|3999822|FG000|Received at Least One Dose of Study Drug|Open Label (OL) Treatment Phase||135
3265464|NCT02614287|3999823|FG001|Received at Least One Dose of Study Drug|Open Label (OL) Treatment Phase||135
3265465|NCT02614287|3999822|FG000|COMPLETED|Open Label (OL) Treatment Phase||97
3265466|NCT02614287|3999823|FG001|COMPLETED|Open Label (OL) Treatment Phase||113
3265467|NCT02614287|3999822|FG000|NOT COMPLETED|Open Label (OL) Treatment Phase||38
3265468|NCT02614287|3999823|FG001|NOT COMPLETED|Open Label (OL) Treatment Phase||22
3374895|NCT01868139|4107750|FG000|NOT COMPLETED|Overall Study||1
3374896|NCT01881932|4107758|FG000|STARTED|Overall Study||2
3374897|NCT01881932|4107759|FG001|STARTED|Overall Study||4
3374898|NCT01881932|4107760|FG002|STARTED|Overall Study||13
3374899|NCT01881932|4107758|FG000|COMPLETED|Overall Study||2
3374900|NCT01881932|4107759|FG001|COMPLETED|Overall Study||4
3374901|NCT01881932|4107760|FG002|COMPLETED|Overall Study||13
3374902|NCT01881932|4107758|FG000|NOT COMPLETED|Overall Study||0
3374903|NCT01881932|4107759|FG001|NOT COMPLETED|Overall Study||0
3374904|NCT01881932|4107760|FG002|NOT COMPLETED|Overall Study||0
3374905|NCT01878786|4107771|FG000|STARTED|Overall Study||9
3265469|NCT02614287|3999822|FG000|STARTED|Post Treatment Follow-up Phase|Follow-up period was optional, few participants who completed OL period didn't enter follow-up.|112
3265470|NCT02614287|3999823|FG001|STARTED|Post Treatment Follow-up Phase|Follow-up period was optional, few participants who completed OL period didn't enter follow-up.|124
3265471|NCT02614287|3999822|FG000|COMPLETED|Post Treatment Follow-up Phase||103
3265472|NCT02614287|3999823|FG001|COMPLETED|Post Treatment Follow-up Phase||119
3265473|NCT02614287|3999822|FG000|NOT COMPLETED|Post Treatment Follow-up Phase||9
3265474|NCT02614287|3999823|FG001|NOT COMPLETED|Post Treatment Follow-up Phase||5
3265475|NCT02614469|3999836|FG000|STARTED|Period 1||9
3265476|NCT02614469|3999837|FG001|STARTED|Period 1||9
3265477|NCT02614469|3999836|FG000|COMPLETED|Period 1||9
3265478|NCT02614469|3999837|FG001|COMPLETED|Period 1||9
3265479|NCT02614469|3999836|FG000|NOT COMPLETED|Period 1||0
3265480|NCT02614469|3999837|FG001|NOT COMPLETED|Period 1||0
3265481|NCT02614469|3999836|FG000|STARTED|Period 2||9
3265482|NCT02614469|3999837|FG001|STARTED|Period 2||9
3265483|NCT02614469|3999836|FG000|COMPLETED|Period 2||9
3265484|NCT02614469|3999837|FG001|COMPLETED|Period 2||9
3265485|NCT02614469|3999836|FG000|NOT COMPLETED|Period 2||0
3265486|NCT02614469|3999837|FG001|NOT COMPLETED|Period 2||0
3265487|NCT02614560|3999845|FG000|STARTED|Overall Study||6
3265488|NCT02614560|3999846|FG001|STARTED|Overall Study||8
3265489|NCT02614560|3999845|FG000|COMPLETED|Overall Study||0
3265490|NCT02614560|3999846|FG001|COMPLETED|Overall Study||6
3265491|NCT02614560|3999845|FG000|NOT COMPLETED|Overall Study||6
3265492|NCT02614560|3999846|FG001|NOT COMPLETED|Overall Study||2
3265493|NCT02614703|3999854|FG000|STARTED|Overall Study||31
3265494|NCT02614703|3999855|FG001|STARTED|Overall Study||29
3265495|NCT02614703|3999854|FG000|COMPLETED|Overall Study||24
3265496|NCT02614703|3999855|FG001|COMPLETED|Overall Study||28
3265497|NCT02614703|3999854|FG000|NOT COMPLETED|Overall Study||7
3265498|NCT02614703|3999855|FG001|NOT COMPLETED|Overall Study||1
3265499|NCT02614729|3999863|FG000|STARTED|Overall Study||18
3265500|NCT02614729|3999864|FG001|STARTED|Overall Study||17
3265501|NCT02614729|3999863|FG000|COMPLETED|Overall Study||17
3265502|NCT02614729|3999864|FG001|COMPLETED|Overall Study||17
3265503|NCT02614729|3999863|FG000|NOT COMPLETED|Overall Study||1
3265504|NCT02614729|3999864|FG001|NOT COMPLETED|Overall Study||0
3265505|NCT02614794|3999874|FG000|STARTED|Overall Study||410
3265506|NCT02614794|3999875|FG001|STARTED|Overall Study||202
3265507|NCT02614794|3999874|FG000|COMPLETED|Overall Study||0
3265508|NCT02614794|3999875|FG001|COMPLETED|Overall Study||0
3265509|NCT02614794|3999874|FG000|NOT COMPLETED|Overall Study||410
3265510|NCT02614794|3999875|FG001|NOT COMPLETED|Overall Study||202
3265511|NCT02614924|3999883|FG000|STARTED|Overall Study||20
3265512|NCT02614924|3999884|FG001|STARTED|Overall Study||20
3265513|NCT02614924|3999883|FG000|COMPLETED|Overall Study||20
3265514|NCT02614924|3999884|FG001|COMPLETED|Overall Study||20
3265515|NCT02614924|3999883|FG000|NOT COMPLETED|Overall Study||0
3265516|NCT02614924|3999884|FG001|NOT COMPLETED|Overall Study||0
3265517|NCT02615145|3999894|FG000|STARTED|Overall Study||145
3265518|NCT02615145|3999895|FG001|STARTED|Overall Study||278
3265519|NCT02615145|3999896|FG002|STARTED|Overall Study||48
3265520|NCT02615145|3999897|FG003|STARTED|Overall Study||1
3265521|NCT02615145|3999894|FG000|2 DAA + Ribavirin (RBV)|Overall Study||0
3265522|NCT02615145|3999895|FG001|2 DAA + Ribavirin (RBV)|Overall Study||0
3265523|NCT02615145|3999896|FG002|2 DAA + Ribavirin (RBV)|Overall Study||45
3374906|NCT01878786|4107772|FG001|STARTED|Overall Study||9
3374907|NCT01878786|4107773|FG002|STARTED|Overall Study||7
3374908|NCT01878786|4107771|FG000|COMPLETED|Overall Study|Study closed prematurely|0
3374909|NCT01878786|4107772|FG001|COMPLETED|Overall Study|Study closed prematurely|0
3374910|NCT01878786|4107773|FG002|COMPLETED|Overall Study|Study closed prematurely; 1 patient was a screen fail|0
3374911|NCT01878786|4107771|FG000|NOT COMPLETED|Overall Study||9
3374912|NCT01878786|4107772|FG001|NOT COMPLETED|Overall Study||9
3374913|NCT01878786|4107773|FG002|NOT COMPLETED|Overall Study||7
3374914|NCT01877343|4107784|FG000|STARTED|Overall Study||2
3374915|NCT01877343|4107785|FG001|STARTED|Overall Study||3
3374916|NCT01877343|4107786|FG002|STARTED|Overall Study||0
3374917|NCT01877343|4107787|FG003|STARTED|Overall Study||0
3374918|NCT01877343|4107788|FG004|STARTED|Overall Study||0
3374919|NCT01877343|4107789|FG005|STARTED|Overall Study||5
3374920|NCT01877343|4107790|FG006|STARTED|Overall Study||0
3374921|NCT01877343|4107784|FG000|COMPLETED|Overall Study||2
3374922|NCT01877343|4107785|FG001|COMPLETED|Overall Study||3
3374923|NCT01877343|4107786|FG002|COMPLETED|Overall Study||0
3374924|NCT01877343|4107787|FG003|COMPLETED|Overall Study||0
3374925|NCT01877343|4107788|FG004|COMPLETED|Overall Study||0
3374926|NCT01877343|4107789|FG005|COMPLETED|Overall Study||5
3374927|NCT01877343|4107790|FG006|COMPLETED|Overall Study||0
3374928|NCT01877343|4107784|FG000|NOT COMPLETED|Overall Study||0
3374929|NCT01877343|4107785|FG001|NOT COMPLETED|Overall Study||0
3374930|NCT01877343|4107786|FG002|NOT COMPLETED|Overall Study||0
3374931|NCT01877343|4107787|FG003|NOT COMPLETED|Overall Study||0
3374932|NCT01877343|4107788|FG004|NOT COMPLETED|Overall Study||0
3374933|NCT01877343|4107789|FG005|NOT COMPLETED|Overall Study||0
3374934|NCT01877343|4107790|FG006|NOT COMPLETED|Overall Study||0
3374935|NCT01861717|4107794|FG000|STARTED|Overall Study||4
3374936|NCT01861717|4107794|FG000|COMPLETED|Overall Study||2
3265524|NCT02615145|3999897|FG003|2 DAA + Ribavirin (RBV)|Overall Study||0
3265525|NCT02615145|3999894|FG000|3DAA|Overall Study||5
3265526|NCT02615145|3999895|FG001|3DAA|Overall Study||261
3265527|NCT02615145|3999896|FG002|3DAA|Overall Study||0
3265528|NCT02615145|3999897|FG003|3DAA|Overall Study||0
3265529|NCT02615145|3999894|FG000|3DAA + RBV|Overall Study||140
3265530|NCT02615145|3999895|FG001|3DAA + RBV|Overall Study||17
3265531|NCT02615145|3999896|FG002|3DAA + RBV|Overall Study||2
3265532|NCT02615145|3999897|FG003|3DAA + RBV|Overall Study||0
3265533|NCT02615145|3999894|FG000|COMPLETED|Overall Study||118
3265534|NCT02615145|3999895|FG001|COMPLETED|Overall Study||263
3265535|NCT02615145|3999896|FG002|COMPLETED|Overall Study||40
3265536|NCT02615145|3999897|FG003|COMPLETED|Overall Study||0
3265537|NCT02615145|3999894|FG000|NOT COMPLETED|Overall Study||27
3265538|NCT02615145|3999895|FG001|NOT COMPLETED|Overall Study||15
3265539|NCT02615145|3999896|FG002|NOT COMPLETED|Overall Study||8
3265540|NCT02615145|3999897|FG003|NOT COMPLETED|Overall Study||1
3265541|NCT02615158|3999926|FG000|STARTED|Overall Study||94
3265542|NCT02615158|3999927|FG001|STARTED|Overall Study||92
3265543|NCT02615158|3999928|FG002|STARTED|Overall Study||91
3265544|NCT02615158|3999926|FG000|COMPLETED|Overall Study||73
3265545|NCT02615158|3999927|FG001|COMPLETED|Overall Study||76
3265546|NCT02615158|3999928|FG002|COMPLETED|Overall Study||75
3265547|NCT02615158|3999926|FG000|NOT COMPLETED|Overall Study||21
3265548|NCT02615158|3999927|FG001|NOT COMPLETED|Overall Study||16
3265549|NCT02615158|3999928|FG002|NOT COMPLETED|Overall Study||16
3265550|NCT02615171|3999938|FG000|STARTED|Overall Study||32
3265551|NCT02615171|3999939|FG001|STARTED|Overall Study||32
3265552|NCT02615171|3999938|FG000|COMPLETED|Overall Study||30
3265553|NCT02615171|3999939|FG001|COMPLETED|Overall Study||31
3265554|NCT02615171|3999938|FG000|NOT COMPLETED|Overall Study||2
3265555|NCT02615171|3999939|FG001|NOT COMPLETED|Overall Study||1
3265556|NCT02615249|3999945|FG000|STARTED|Overall Study||122
3265557|NCT02615249|3999945|FG000|COMPLETED|Overall Study||121
3265558|NCT02615249|3999945|FG000|NOT COMPLETED|Overall Study||1
3265559|NCT02615470|3999952|FG000|STARTED|Overall Study||58
3265560|NCT02615470|3999953|FG001|STARTED|Overall Study||62
3265561|NCT02615470|3999952|FG000|Completed the Baseline Surveys|Overall Study||46
3265562|NCT02615470|3999953|FG001|Completed the Baseline Surveys|Overall Study||47
3265563|NCT02615470|3999952|FG000|COMPLETED|Overall Study||37
3265564|NCT02615470|3999953|FG001|COMPLETED|Overall Study||30
3265565|NCT02615470|3999952|FG000|NOT COMPLETED|Overall Study||21
3265566|NCT02615470|3999953|FG001|NOT COMPLETED|Overall Study||32
3265567|NCT02615509|3999959|FG000|STARTED|Overall Study||347
3265568|NCT02615509|3999959|FG000|COMPLETED|Overall Study||201
3265569|NCT02615509|3999959|FG000|NOT COMPLETED|Overall Study||146
3265570|NCT02615535|3999965|FG000|STARTED|Overall Study||14
3265571|NCT02615535|3999966|FG001|STARTED|Overall Study||11
3265572|NCT02615535|3999965|FG000|COMPLETED|Overall Study||10
3265573|NCT02615535|3999966|FG001|COMPLETED|Overall Study||10
3265574|NCT02615535|3999965|FG000|NOT COMPLETED|Overall Study||4
3265575|NCT02615535|3999966|FG001|NOT COMPLETED|Overall Study||1
3265576|NCT02615717|3999974|FG000|STARTED|Overall Study||3
3265577|NCT02615717|3999975|FG001|STARTED|Overall Study||3
3265578|NCT02615717|3999974|FG000|COMPLETED|Overall Study||3
3265579|NCT02615717|3999975|FG001|COMPLETED|Overall Study||3
3265580|NCT02615717|3999974|FG000|NOT COMPLETED|Overall Study||0
3265581|NCT02615717|3999975|FG001|NOT COMPLETED|Overall Study||0
3265582|NCT02615743|3999983|FG000|STARTED|Overall Study||21
3265583|NCT02615743|3999984|FG001|STARTED|Overall Study||20
3265584|NCT02615743|3999983|FG000|COMPLETED|Overall Study||15
3265585|NCT02615743|3999984|FG001|COMPLETED|Overall Study||17
3265586|NCT02615743|3999983|FG000|NOT COMPLETED|Overall Study||6
3265587|NCT02615743|3999984|FG001|NOT COMPLETED|Overall Study||3
3265588|NCT02616029|3999992|FG000|STARTED|Overall Study||38
3265589|NCT02616029|3999993|FG001|STARTED|Overall Study||28
3265590|NCT02616029|3999992|FG000|COMPLETED|Overall Study||34
3265591|NCT02616029|3999993|FG001|COMPLETED|Overall Study||26
3265592|NCT02616029|3999992|FG000|NOT COMPLETED|Overall Study||4
3265593|NCT02616029|3999993|FG001|NOT COMPLETED|Overall Study||2
3265594|NCT02616250|4000001|FG000|STARTED|Overall Study||95
3265595|NCT02616250|4000002|FG001|STARTED|Overall Study||95
3265596|NCT02616250|4000001|FG000|COMPLETED|Overall Study||85
3265597|NCT02616250|4000002|FG001|COMPLETED|Overall Study||86
3265598|NCT02616250|4000001|FG000|NOT COMPLETED|Overall Study||10
3265599|NCT02616250|4000002|FG001|NOT COMPLETED|Overall Study||9
3265600|NCT02616380|4000008|FG000|STARTED|Overall Study||100
3265601|NCT02616380|4000008|FG000|COMPLETED|Overall Study||97
3265602|NCT02616380|4000008|FG000|NOT COMPLETED|Overall Study||3
3265603|NCT02616393|4000015|FG000|STARTED|Overall Study||13
3265604|NCT02616393|4000016|FG001|STARTED|Overall Study||20
3265605|NCT02616393|4000017|FG002|STARTED|Overall Study||3
3265606|NCT02616393|4000015|FG000|COMPLETED|Overall Study||0
3265607|NCT02616393|4000016|FG001|COMPLETED|Overall Study||0
3265608|NCT02616393|4000017|FG002|COMPLETED|Overall Study||0
3265609|NCT02616393|4000015|FG000|NOT COMPLETED|Overall Study||13
3265610|NCT02616393|4000016|FG001|NOT COMPLETED|Overall Study||20
3265611|NCT02616393|4000017|FG002|NOT COMPLETED|Overall Study||3
3265612|NCT02616523|4000044|FG000|STARTED|Overall Study|June 2014|20
3265613|NCT02616523|4000045|FG001|STARTED|Overall Study|June 2014|20
3265614|NCT02616523|4000046|FG002|STARTED|Overall Study|June 2014|20
3265615|NCT02616523|4000044|FG000|COMPLETED|Overall Study|April 2015|19
3265616|NCT02616523|4000045|FG001|COMPLETED|Overall Study|April 2015|20
3265617|NCT02616523|4000046|FG002|COMPLETED|Overall Study|April 2015|20
3265618|NCT02616523|4000044|FG000|NOT COMPLETED|Overall Study||1
3265619|NCT02616523|4000045|FG001|NOT COMPLETED|Overall Study||0
3265620|NCT02616523|4000046|FG002|NOT COMPLETED|Overall Study||0
3265621|NCT02616601|4000060|FG000|STARTED|Overall Study||140
3265622|NCT02616601|4000061|FG001|STARTED|Overall Study||140
3265623|NCT02616601|4000062|FG002|STARTED|Overall Study||142
3265624|NCT02616601|4000060|FG000|Safety Population|Overall Study||140
3265625|NCT02616601|4000061|FG001|Safety Population|Overall Study||140
3265626|NCT02616601|4000062|FG002|Safety Population|Overall Study||142
3265627|NCT02616601|4000060|FG000|mITT Population|Overall Study||137
3265628|NCT02616601|4000061|FG001|mITT Population|Overall Study||136
3265629|NCT02616601|4000062|FG002|mITT Population|Overall Study||138
3265630|NCT02616601|4000060|FG000|PP Population|Overall Study||112
3374937|NCT01861717|4107794|FG000|NOT COMPLETED|Overall Study||2
3374938|NCT01866709|4107801|FG000|STARTED|Overall Study||15
3374939|NCT01866709|4107802|FG001|STARTED|Overall Study||17
3374940|NCT01866709|4107801|FG000|COMPLETED|Overall Study||14
3374941|NCT01866709|4107802|FG001|COMPLETED|Overall Study||17
3374942|NCT01866709|4107801|FG000|NOT COMPLETED|Overall Study||1
3374943|NCT01866709|4107802|FG001|NOT COMPLETED|Overall Study||0
3374944|NCT01860040|4107810|FG000|STARTED|Overall Study|did not meet recruitment goal|1
3374945|NCT01860040|4107811|FG001|STARTED|Overall Study|did not meet recruitment goal|0
3374946|NCT01860040|4107810|FG000|COMPLETED|Overall Study|did not meet recruitment goal|0
3374947|NCT01860040|4107811|FG001|COMPLETED|Overall Study|did not meet recruitment goal|0
3374948|NCT01860040|4107810|FG000|NOT COMPLETED|Overall Study||1
3374949|NCT01860040|4107811|FG001|NOT COMPLETED|Overall Study||0
3374950|NCT01869478|4107818|FG000|STARTED|Overall Study||0
3374951|NCT01869478|4107819|FG001|STARTED|Overall Study||1
3374952|NCT01869478|4107818|FG000|COMPLETED|Overall Study||0
3374953|NCT01869478|4107819|FG001|COMPLETED|Overall Study||1
3374954|NCT01869478|4107818|FG000|NOT COMPLETED|Overall Study||0
3374955|NCT01869478|4107819|FG001|NOT COMPLETED|Overall Study||0
3374956|NCT01851174|4107825|FG000|STARTED|Overall Study||15
3374957|NCT01851174|4107825|FG000|COMPLETED|Overall Study||15
3374958|NCT01851174|4107825|FG000|NOT COMPLETED|Overall Study||0
3374959|NCT01846182|4107832|FG000|STARTED|Overall Study|Unclear due to assignment records.|0
3374960|NCT01846182|4107833|FG001|STARTED|Overall Study|Unclear due to assignment records.|0
3374961|NCT01846182|4107834|FG002|STARTED|Overall Study|Unclear due to assignment records.|0
3374962|NCT01846182|4107832|FG000|COMPLETED|Overall Study|The data on completion subjects is corrupted and not reliable for interpretation.|0
3374963|NCT01846182|4107833|FG001|COMPLETED|Overall Study|The data on completion subjects is corrupted and not reliable for interpretation.|0
3374964|NCT01846182|4107834|FG002|COMPLETED|Overall Study|The data on completion subjects is corrupted and not reliable for interpretation.|0
3374965|NCT01846182|4107832|FG000|NOT COMPLETED|Overall Study||0
3374966|NCT01846182|4107833|FG001|NOT COMPLETED|Overall Study||0
3374967|NCT01846182|4107834|FG002|NOT COMPLETED|Overall Study||0
3374968|NCT01844206|4107846|FG000|STARTED|Overall Study||2
3374969|NCT01844206|4107847|FG001|STARTED|Overall Study||3
3374970|NCT01844206|4107846|FG000|COMPLETED|Overall Study||2
3374971|NCT01844206|4107847|FG001|COMPLETED|Overall Study|One patient requested that epidural catheter be removed during the first post-operative day.|2
3374972|NCT01844206|4107846|FG000|NOT COMPLETED|Overall Study||0
3374973|NCT01844206|4107847|FG001|NOT COMPLETED|Overall Study||1
3374974|NCT01856322|4107856|FG000|STARTED|Overall Study||0
3374975|NCT01856322|4107857|FG001|STARTED|Overall Study||0
3374976|NCT01856322|4107858|FG002|STARTED|Overall Study||3
3374977|NCT01856322|4107856|FG000|COMPLETED|Overall Study||0
3374978|NCT01856322|4107857|FG001|COMPLETED|Overall Study||0
3374979|NCT01856322|4107858|FG002|COMPLETED|Overall Study||0
3374980|NCT01856322|4107856|FG000|NOT COMPLETED|Overall Study||0
3374981|NCT01856322|4107857|FG001|NOT COMPLETED|Overall Study||0
3374982|NCT01856322|4107858|FG002|NOT COMPLETED|Overall Study||3
3265631|NCT02616601|4000061|FG001|PP Population|Overall Study||121
3265632|NCT02616601|4000062|FG002|PP Population|Overall Study||123
3265633|NCT02616601|4000060|FG000|COMPLETED|Overall Study||131
3265634|NCT02616601|4000061|FG001|COMPLETED|Overall Study||136
3265635|NCT02616601|4000062|FG002|COMPLETED|Overall Study||135
3265636|NCT02616601|4000060|FG000|NOT COMPLETED|Overall Study||9
3265637|NCT02616601|4000061|FG001|NOT COMPLETED|Overall Study||4
3265638|NCT02616601|4000062|FG002|NOT COMPLETED|Overall Study||7
3265639|NCT02616614|4000073|FG000|STARTED|Overall Study||347
3265640|NCT02616614|4000074|FG001|STARTED|Overall Study||345
3265641|NCT02616614|4000075|FG002|STARTED|Overall Study||170
3265642|NCT02616614|4000073|FG000|Safety Population|Overall Study||329
3265643|NCT02616614|4000074|FG001|Safety Population|Overall Study||328
3265644|NCT02616614|4000075|FG002|Safety Population|Overall Study||161
3265645|NCT02616614|4000073|FG000|mITT Population|Overall Study||325
3265646|NCT02616614|4000074|FG001|mITT Population|Overall Study||325
3265647|NCT02616614|4000075|FG002|mITT Population|Overall Study||160
3265648|NCT02616614|4000073|FG000|PP Population|Overall Study||253
3265649|NCT02616614|4000074|FG001|PP Population|Overall Study||255
3265650|NCT02616614|4000075|FG002|PP Population|Overall Study||122
3265651|NCT02616614|4000073|FG000|COMPLETED|Overall Study||282
3265652|NCT02616614|4000074|FG001|COMPLETED|Overall Study||285
3265653|NCT02616614|4000075|FG002|COMPLETED|Overall Study||141
3265654|NCT02616614|4000073|FG000|NOT COMPLETED|Overall Study||65
3265655|NCT02616614|4000074|FG001|NOT COMPLETED|Overall Study||60
3265656|NCT02616614|4000075|FG002|NOT COMPLETED|Overall Study||29
3265657|NCT02616783|4000086|FG000|STARTED|Overall Study||111
3265658|NCT02616783|4000087|FG001|STARTED|Overall Study||56
3265659|NCT02616783|4000086|FG000|COMPLETED|Overall Study||105
3265660|NCT02616783|4000087|FG001|COMPLETED|Overall Study||54
3265661|NCT02616783|4000086|FG000|NOT COMPLETED|Overall Study||6
3265662|NCT02616783|4000087|FG001|NOT COMPLETED|Overall Study||2
3265663|NCT02616900|4000093|FG000|STARTED|Overall Study||74
3265664|NCT02616900|4000093|FG000|Completed 3mo Trial|Overall Study||57
3265665|NCT02616900|4000093|FG000|COMPLETED|Overall Study|Six participants not included in study results because of incomplete data.|51
3265666|NCT02616900|4000093|FG000|NOT COMPLETED|Overall Study||23
3265667|NCT02617589|4000099|FG000|STARTED|All Randomized||280
3265668|NCT02617589|4000100|FG001|STARTED|All Randomized||280
3265669|NCT02617589|4000099|FG000|COMPLETED|All Randomized||278
3265670|NCT02617589|4000100|FG001|COMPLETED|All Randomized||275
3265671|NCT02617589|4000099|FG000|NOT COMPLETED|All Randomized||2
3265672|NCT02617589|4000100|FG001|NOT COMPLETED|All Randomized||5
3265673|NCT02617589|4000099|FG000|STARTED|Treatment Period||278
3265674|NCT02617589|4000100|FG001|STARTED|Treatment Period||275
3265675|NCT02617589|4000099|FG000|COMPLETED|Treatment Period||4
3265676|NCT02617589|4000100|FG001|COMPLETED|Treatment Period||1
3265677|NCT02617589|4000099|FG000|NOT COMPLETED|Treatment Period||274
3265678|NCT02617589|4000100|FG001|NOT COMPLETED|Treatment Period||274
3265679|NCT02617628|4000108|FG000|STARTED|Overall Study||74
3265680|NCT02617628|4000109|FG001|STARTED|Overall Study||72
3265681|NCT02617628|4000108|FG000|COMPLETED|Overall Study||12
3265682|NCT02617628|4000109|FG001|COMPLETED|Overall Study||11
3265683|NCT02617628|4000108|FG000|NOT COMPLETED|Overall Study||62
3265684|NCT02617628|4000109|FG001|NOT COMPLETED|Overall Study||61
3265685|NCT02617667|4000121|FG000|STARTED|Overall Study||51
3265686|NCT02617667|4000122|FG001|STARTED|Overall Study||51
3265687|NCT02617667|4000123|FG002|STARTED|Overall Study||52
3265688|NCT02617667|4000124|FG003|STARTED|Overall Study||53
3265689|NCT02617667|4000121|FG000|COMPLETED|Overall Study||50
3265690|NCT02617667|4000122|FG001|COMPLETED|Overall Study||50
3265691|NCT02617667|4000123|FG002|COMPLETED|Overall Study||48
3265692|NCT02617667|4000124|FG003|COMPLETED|Overall Study||52
3265693|NCT02617667|4000121|FG000|NOT COMPLETED|Overall Study||1
3265694|NCT02617667|4000122|FG001|NOT COMPLETED|Overall Study||1
3265695|NCT02617667|4000123|FG002|NOT COMPLETED|Overall Study||4
3265696|NCT02617667|4000124|FG003|NOT COMPLETED|Overall Study||1
3265697|NCT02617784|4000135|FG000|STARTED|Overall Study|None were prematurely withdrawn; 1 switched to CAPD mid-study and was excluded from second analysis.|12
3265698|NCT02617784|4000136|FG001|STARTED|Overall Study||12
3265699|NCT02617784|4000135|FG000|First Dose Assessment Period|Overall Study||12
3265700|NCT02617784|4000136|FG001|First Dose Assessment Period|Overall Study||12
3265701|NCT02617784|4000135|FG000|Second Dose Assessment Period|Overall Study||11
3265702|NCT02617784|4000136|FG001|Second Dose Assessment Period|Overall Study||12
3374983|NCT01853176|4107867|FG000|STARTED|Overall Study||4
3374984|NCT01853176|4107868|FG001|STARTED|Overall Study||0
3374985|NCT01853176|4107867|FG000|COMPLETED|Overall Study||0
3374986|NCT01853176|4107868|FG001|COMPLETED|Overall Study||0
3374987|NCT01853176|4107867|FG000|NOT COMPLETED|Overall Study||4
3374988|NCT01853176|4107868|FG001|NOT COMPLETED|Overall Study||0
3374989|NCT01857271|4107874|FG000|STARTED|Overall Study||3
3374990|NCT01857271|4107874|FG000|COMPLETED|Overall Study||2
3374991|NCT01857271|4107874|FG000|NOT COMPLETED|Overall Study||1
3374992|NCT01856361|4107880|FG000|STARTED|Overall Study||1
3374993|NCT01856361|4107881|FG001|STARTED|Overall Study||1
3374994|NCT01856361|4107880|FG000|COMPLETED|Overall Study||1
3265703|NCT02617784|4000135|FG000|COMPLETED|Overall Study||12
3265704|NCT02617784|4000136|FG001|COMPLETED|Overall Study||12
3265705|NCT02617784|4000135|FG000|NOT COMPLETED|Overall Study||0
3265706|NCT02617784|4000136|FG001|NOT COMPLETED|Overall Study||0
3374995|NCT01856361|4107881|FG001|COMPLETED|Overall Study||1
3374996|NCT01856361|4107880|FG000|NOT COMPLETED|Overall Study||0
3265707|NCT02617888|4000145|FG000|STARTED|Overall Study||50
3265708|NCT02617888|4000146|FG001|STARTED|Overall Study||51
3265709|NCT02617888|4000147|FG002|STARTED|Overall Study||127
3265710|NCT02617888|4000145|FG000|COMPLETED|Overall Study|Incomplete due to inadequate double-strand DNA break sample.|49
3265711|NCT02617888|4000146|FG001|COMPLETED|Overall Study|Incomplete due to inadequate double-strand DNA break samples.|44
3265712|NCT02617888|4000147|FG002|COMPLETED|Overall Study||127
3265713|NCT02617888|4000145|FG000|NOT COMPLETED|Overall Study||1
3265714|NCT02617888|4000146|FG001|NOT COMPLETED|Overall Study||7
3265715|NCT02617888|4000147|FG002|NOT COMPLETED|Overall Study||0
3265716|NCT02617901|4000154|FG000|STARTED|Overall Study||20
3265717|NCT02617901|4000154|FG000|COMPLETED|Overall Study||20
3265718|NCT02617901|4000154|FG000|NOT COMPLETED|Overall Study||0
3265719|NCT02618031|4000160|FG000|STARTED|Overall Study||46
3265720|NCT02618031|4000161|FG001|STARTED|Overall Study||11
3265721|NCT02618031|4000160|FG000|COMPLETED|Overall Study||45
3265722|NCT02618031|4000161|FG001|COMPLETED|Overall Study||11
3265723|NCT02618031|4000160|FG000|NOT COMPLETED|Overall Study||1
3265724|NCT02618031|4000161|FG001|NOT COMPLETED|Overall Study||0
3265725|NCT02618187|4000175|FG000|STARTED|Overall Study||15
3265726|NCT02618187|4000176|FG001|STARTED|Overall Study||11
3265727|NCT02618187|4000177|FG002|STARTED|Overall Study||15
3265728|NCT02618187|4000178|FG003|STARTED|Overall Study||17
3265729|NCT02618187|4000175|FG000|Completed|Overall Study||13
3265730|NCT02618187|4000176|FG001|Completed|Overall Study||10
3265731|NCT02618187|4000177|FG002|Completed|Overall Study||13
3265732|NCT02618187|4000178|FG003|Completed|Overall Study||13
3265733|NCT02618187|4000175|FG000|COMPLETED|Overall Study||13
3265734|NCT02618187|4000176|FG001|COMPLETED|Overall Study||9
3265735|NCT02618187|4000177|FG002|COMPLETED|Overall Study||11
3265736|NCT02618187|4000178|FG003|COMPLETED|Overall Study||12
3265737|NCT02618187|4000175|FG000|NOT COMPLETED|Overall Study||2
3265738|NCT02618187|4000176|FG001|NOT COMPLETED|Overall Study||2
3265739|NCT02618187|4000177|FG002|NOT COMPLETED|Overall Study||4
3265740|NCT02618187|4000178|FG003|NOT COMPLETED|Overall Study||5
3265741|NCT02618343|4000190|FG000|STARTED|Overall Study||28
3265742|NCT02618343|4000191|FG001|STARTED|Overall Study||23
3265743|NCT02618343|4000190|FG000|COMPLETED|Overall Study||28
3265744|NCT02618343|4000191|FG001|COMPLETED|Overall Study||23
3265745|NCT02618343|4000190|FG000|NOT COMPLETED|Overall Study||0
3265746|NCT02618343|4000191|FG001|NOT COMPLETED|Overall Study||0
3265747|NCT02618382|4000197|FG000|STARTED|Overall Study|Enrolled and consented for study treatment|32
3265748|NCT02618382|4000197|FG000|COMPLETED|Overall Study|Completed Study treatment|29
3265749|NCT02618382|4000197|FG000|NOT COMPLETED|Overall Study||3
3265750|NCT02618512|4000201|FG000|STARTED|Overall Study||3
3265751|NCT02618512|4000201|FG000|COMPLETED|Overall Study||3
3374997|NCT01856361|4107881|FG001|NOT COMPLETED|Overall Study||0
3374998|NCT01853982|4107889|FG000|STARTED|Overall Study||2
3374999|NCT01853982|4107890|FG001|STARTED|Overall Study||2
3375000|NCT01853982|4107889|FG000|Received at Least 1 Dose of Study Drug|Overall Study||2
3375001|NCT01853982|4107890|FG001|Received at Least 1 Dose of Study Drug|Overall Study||2
3375002|NCT01853982|4107889|FG000|COMPLETED|Overall Study||0
3375003|NCT01853982|4107890|FG001|COMPLETED|Overall Study||1
3375004|NCT01853982|4107889|FG000|NOT COMPLETED|Overall Study||2
3375005|NCT01853982|4107890|FG001|NOT COMPLETED|Overall Study||1
3375006|NCT01841931|4107896|FG000|STARTED|Overall Study||4
3375007|NCT01841931|4107896|FG000|COMPLETED|Overall Study|As the PI left the institution the study was terminated|0
3375008|NCT01841931|4107896|FG000|NOT COMPLETED|Overall Study||4
3375009|NCT01836809|4107904|FG000|STARTED|Overall Study||0
3375010|NCT01836809|4107905|FG001|STARTED|Overall Study||0
3375011|NCT01836809|4107906|FG002|STARTED|Overall Study||0
3375012|NCT01836809|4107907|FG003|STARTED|Overall Study||2
3375013|NCT01836809|4107904|FG000|COMPLETED|Overall Study||0
3375014|NCT01836809|4107905|FG001|COMPLETED|Overall Study||0
3375015|NCT01836809|4107906|FG002|COMPLETED|Overall Study||0
3375016|NCT01836809|4107907|FG003|COMPLETED|Overall Study||0
3375017|NCT01836809|4107904|FG000|NOT COMPLETED|Overall Study||0
3375018|NCT01836809|4107905|FG001|NOT COMPLETED|Overall Study||0
3375019|NCT01836809|4107906|FG002|NOT COMPLETED|Overall Study||0
3375020|NCT01836809|4107907|FG003|NOT COMPLETED|Overall Study||2
3375021|NCT01831596|4107921|FG000|STARTED|Overall Study||59
3375022|NCT01831596|4107921|FG000|COMPLETED|Overall Study||51
3375023|NCT01831596|4107921|FG000|NOT COMPLETED|Overall Study||8
3375024|NCT01834144|4107927|FG000|STARTED|Overall Study||1
3375025|NCT01834144|4107928|FG001|STARTED|Overall Study||3
3375026|NCT01834144|4107927|FG000|COMPLETED|Overall Study||1
3375027|NCT01834144|4107928|FG001|COMPLETED|Overall Study||2
3375028|NCT01834144|4107927|FG000|NOT COMPLETED|Overall Study||0
3375029|NCT01834144|4107928|FG001|NOT COMPLETED|Overall Study||1
3375030|NCT01821963|4107934|FG000|STARTED|Overall Study||1
3375031|NCT01821963|4107934|FG000|COMPLETED|Overall Study||0
3375032|NCT01821963|4107934|FG000|NOT COMPLETED|Overall Study||1
3375033|NCT01821898|4107940|FG000|STARTED|Overall Study||2
3375034|NCT01821898|4107941|FG001|STARTED|Overall Study||1
3375035|NCT01821898|4107940|FG000|COMPLETED|Overall Study||0
3375036|NCT01821898|4107941|FG001|COMPLETED|Overall Study||0
3375037|NCT01821898|4107940|FG000|NOT COMPLETED|Overall Study||2
3375038|NCT01821898|4107941|FG001|NOT COMPLETED|Overall Study||1
3375039|NCT01814722|4107951|FG000|STARTED|Overall Study||36
3375040|NCT01814722|4107952|FG001|STARTED|Overall Study||21
3375041|NCT01814722|4107953|FG002|STARTED|Overall Study||6
3265752|NCT02618512|4000201|FG000|NOT COMPLETED|Overall Study||0
3265753|NCT02618616|4000207|FG000|STARTED|Overall Study||87
3265754|NCT02618616|4000208|FG001|STARTED|Overall Study||42
3265755|NCT02618616|4000207|FG000|COMPLETED|Overall Study||66
3265756|NCT02618616|4000208|FG001|COMPLETED|Overall Study||35
3265757|NCT02618616|4000207|FG000|NOT COMPLETED|Overall Study||21
3265758|NCT02618616|4000208|FG001|NOT COMPLETED|Overall Study||7
3265759|NCT02618642|4000219|FG000|STARTED|Before 10 PILER Irradiation Treatments||15
3265760|NCT02618642|4000220|FG001|STARTED|Before 10 PILER Irradiation Treatments||15
3265761|NCT02618642|4000221|FG002|STARTED|Before 10 PILER Irradiation Treatments||15
3265762|NCT02618642|4000222|FG003|STARTED|Before 10 PILER Irradiation Treatments||15
3265763|NCT02618642|4000219|FG000|COMPLETED|Before 10 PILER Irradiation Treatments||15
3265764|NCT02618642|4000220|FG001|COMPLETED|Before 10 PILER Irradiation Treatments||15
3265765|NCT02618642|4000221|FG002|COMPLETED|Before 10 PILER Irradiation Treatments||15
3265766|NCT02618642|4000222|FG003|COMPLETED|Before 10 PILER Irradiation Treatments||15
3265767|NCT02618642|4000219|FG000|NOT COMPLETED|Before 10 PILER Irradiation Treatments||0
3265768|NCT02618642|4000220|FG001|NOT COMPLETED|Before 10 PILER Irradiation Treatments||0
3265769|NCT02618642|4000221|FG002|NOT COMPLETED|Before 10 PILER Irradiation Treatments||0
3265770|NCT02618642|4000222|FG003|NOT COMPLETED|Before 10 PILER Irradiation Treatments||0
3265771|NCT02618642|4000219|FG000|STARTED|After 10 PILER Irradiation Treatments||15
3265772|NCT02618642|4000220|FG001|STARTED|After 10 PILER Irradiation Treatments||15
3265773|NCT02618642|4000221|FG002|STARTED|After 10 PILER Irradiation Treatments||15
3265774|NCT02618642|4000222|FG003|STARTED|After 10 PILER Irradiation Treatments||15
3265775|NCT02618642|4000219|FG000|COMPLETED|After 10 PILER Irradiation Treatments||15
3265776|NCT02618642|4000220|FG001|COMPLETED|After 10 PILER Irradiation Treatments||15
3265777|NCT02618642|4000221|FG002|COMPLETED|After 10 PILER Irradiation Treatments||15
3265778|NCT02618642|4000222|FG003|COMPLETED|After 10 PILER Irradiation Treatments||15
3265779|NCT02618642|4000219|FG000|NOT COMPLETED|After 10 PILER Irradiation Treatments||0
3265780|NCT02618642|4000220|FG001|NOT COMPLETED|After 10 PILER Irradiation Treatments||0
3265781|NCT02618642|4000221|FG002|NOT COMPLETED|After 10 PILER Irradiation Treatments||0
3265782|NCT02618642|4000222|FG003|NOT COMPLETED|After 10 PILER Irradiation Treatments||0
3265783|NCT02618759|4000241|FG000|STARTED|Overall Study||60
3265784|NCT02618759|4000242|FG001|STARTED|Overall Study||59
3265785|NCT02618759|4000241|FG000|COMPLETED|Overall Study||58
3265786|NCT02618759|4000242|FG001|COMPLETED|Overall Study||54
3265787|NCT02618759|4000241|FG000|NOT COMPLETED|Overall Study||2
3265788|NCT02618759|4000242|FG001|NOT COMPLETED|Overall Study||5
3265789|NCT02618772|4000250|FG000|STARTED|Overall Study||39
3265790|NCT02618772|4000251|FG001|STARTED|Overall Study||40
3265791|NCT02618772|4000250|FG000|Withdrawal by Subject|Overall Study|The participant's family withdrew from the study after administration of the trial intervention.|1
3265792|NCT02618772|4000251|FG001|Withdrawal by Subject|Overall Study||0
3265793|NCT02618772|4000250|FG000|COMPLETED|Overall Study||38
3265794|NCT02618772|4000251|FG001|COMPLETED|Overall Study||40
3265795|NCT02618772|4000250|FG000|NOT COMPLETED|Overall Study||1
3265796|NCT02618772|4000251|FG001|NOT COMPLETED|Overall Study||0
3265797|NCT02618915|4000259|FG000|STARTED|Overall Study||3
3265798|NCT02618915|4000260|FG001|STARTED|Overall Study||3
3265799|NCT02618915|4000259|FG000|COMPLETED|Overall Study||3
3265800|NCT02618915|4000260|FG001|COMPLETED|Overall Study||3
3265801|NCT02618915|4000259|FG000|NOT COMPLETED|Overall Study||0
3265802|NCT02618915|4000260|FG001|NOT COMPLETED|Overall Study||0
3265803|NCT02618928|4000268|FG000|STARTED|Overall Study||735
3265804|NCT02618928|4000268|FG000|Received Treatment|Overall Study||728
3265805|NCT02618928|4000268|FG000|COMPLETED|Overall Study||677
3265806|NCT02618928|4000268|FG000|NOT COMPLETED|Overall Study||58
3265807|NCT02618967|4000283|FG000|STARTED|Overall Study||6
3265808|NCT02618967|4000284|FG001|STARTED|Overall Study||6
3265809|NCT02618967|4000285|FG002|STARTED|Overall Study||6
3265810|NCT02618967|4000286|FG003|STARTED|Overall Study||6
3265811|NCT02618967|4000287|FG004|STARTED|Overall Study||6
3265812|NCT02618967|4000288|FG005|STARTED|Overall Study||6
3265813|NCT02618967|4000289|FG006|STARTED|Overall Study||6
3265814|NCT02618967|4000290|FG007|STARTED|Overall Study||14
3265815|NCT02618967|4000283|FG000|Received Treatment|Overall Study||6
3265816|NCT02618967|4000284|FG001|Received Treatment|Overall Study||6
3265817|NCT02618967|4000285|FG002|Received Treatment|Overall Study||6
3265818|NCT02618967|4000286|FG003|Received Treatment|Overall Study||6
3265819|NCT02618967|4000287|FG004|Received Treatment|Overall Study||6
3265820|NCT02618967|4000288|FG005|Received Treatment|Overall Study||6
3265821|NCT02618967|4000289|FG006|Received Treatment|Overall Study||6
3265822|NCT02618967|4000290|FG007|Received Treatment|Overall Study||14
3265823|NCT02618967|4000283|FG000|COMPLETED|Overall Study||5
3265824|NCT02618967|4000284|FG001|COMPLETED|Overall Study||6
3265825|NCT02618967|4000285|FG002|COMPLETED|Overall Study||5
3265826|NCT02618967|4000286|FG003|COMPLETED|Overall Study||6
3265827|NCT02618967|4000287|FG004|COMPLETED|Overall Study||4
3265828|NCT02618967|4000288|FG005|COMPLETED|Overall Study||6
3265829|NCT02618967|4000289|FG006|COMPLETED|Overall Study||6
3265830|NCT02618967|4000290|FG007|COMPLETED|Overall Study||14
3265831|NCT02618967|4000283|FG000|NOT COMPLETED|Overall Study||1
3265832|NCT02618967|4000284|FG001|NOT COMPLETED|Overall Study||0
3265833|NCT02618967|4000285|FG002|NOT COMPLETED|Overall Study||1
3265834|NCT02618967|4000286|FG003|NOT COMPLETED|Overall Study||0
3265835|NCT02618967|4000287|FG004|NOT COMPLETED|Overall Study||2
3265836|NCT02618967|4000288|FG005|NOT COMPLETED|Overall Study||0
3265837|NCT02618967|4000289|FG006|NOT COMPLETED|Overall Study||0
3265838|NCT02618967|4000290|FG007|NOT COMPLETED|Overall Study||0
3265839|NCT02619175|4000310|FG000|STARTED|Overall Study||18
3265840|NCT02619175|4000311|FG001|STARTED|Overall Study||16
3265841|NCT02619175|4000310|FG000|COMPLETED|Overall Study||16
3265842|NCT02619175|4000311|FG001|COMPLETED|Overall Study||16
3265843|NCT02619175|4000310|FG000|NOT COMPLETED|Overall Study||2
3265844|NCT02619175|4000311|FG001|NOT COMPLETED|Overall Study||0
3265845|NCT02619396|4000325|FG000|STARTED|Overall Study||20
3265846|NCT02619396|4000326|FG001|STARTED|Overall Study||20
3265847|NCT02619396|4000327|FG002|STARTED|Overall Study||20
3265848|NCT02619396|4000328|FG003|STARTED|Overall Study||20
3265849|NCT02619396|4000325|FG000|COMPLETED|Overall Study||20
3265850|NCT02619396|4000326|FG001|COMPLETED|Overall Study||20
3265851|NCT02619396|4000327|FG002|COMPLETED|Overall Study||20
3265852|NCT02619396|4000328|FG003|COMPLETED|Overall Study||20
3265853|NCT02619396|4000325|FG000|NOT COMPLETED|Overall Study||0
3265854|NCT02619396|4000326|FG001|NOT COMPLETED|Overall Study||0
3265855|NCT02619396|4000327|FG002|NOT COMPLETED|Overall Study||0
3265856|NCT02619396|4000328|FG003|NOT COMPLETED|Overall Study||0
3265857|NCT02619409|4000344|FG000|STARTED|Overall Study||6
3265858|NCT02619409|4000345|FG001|STARTED|Overall Study||6
3265859|NCT02619409|4000346|FG002|STARTED|Overall Study||6
3265860|NCT02619409|4000347|FG003|STARTED|Overall Study||6
3265861|NCT02619409|4000348|FG004|STARTED|Overall Study||6
3265862|NCT02619409|4000344|FG000|COMPLETED|Overall Study||6
3265863|NCT02619409|4000345|FG001|COMPLETED|Overall Study||6
3265864|NCT02619409|4000346|FG002|COMPLETED|Overall Study||6
3265865|NCT02619409|4000347|FG003|COMPLETED|Overall Study||6
3265866|NCT02619409|4000348|FG004|COMPLETED|Overall Study||6
3265867|NCT02619409|4000344|FG000|NOT COMPLETED|Overall Study||0
3265868|NCT02619409|4000345|FG001|NOT COMPLETED|Overall Study||0
3265869|NCT02619409|4000346|FG002|NOT COMPLETED|Overall Study||0
3265870|NCT02619409|4000347|FG003|NOT COMPLETED|Overall Study||0
3265871|NCT02619409|4000348|FG004|NOT COMPLETED|Overall Study||0
3265872|NCT02619591|4000362|FG000|STARTED|Overall Study||139
3265873|NCT02619591|4000363|FG001|STARTED|Overall Study||121
3265874|NCT02619591|4000362|FG000|COMPLETED|Overall Study||0
3265875|NCT02619591|4000363|FG001|COMPLETED|Overall Study||0
3265876|NCT02619591|4000362|FG000|NOT COMPLETED|Overall Study||139
3265877|NCT02619591|4000363|FG001|NOT COMPLETED|Overall Study||121
3265878|NCT02619617|4000369|FG000|STARTED|Period 1 Placebo - 1st AttacK||28
3265879|NCT02619617|4000370|FG001|STARTED|Period 1 Placebo - 1st AttacK||0
3375042|NCT01814722|4107951|FG000|COMPLETED|Overall Study||36
3375043|NCT01814722|4107952|FG001|COMPLETED|Overall Study||21
3375044|NCT01814722|4107953|FG002|COMPLETED|Overall Study||6
3375045|NCT01814722|4107951|FG000|NOT COMPLETED|Overall Study||0
3375046|NCT01814722|4107952|FG001|NOT COMPLETED|Overall Study||0
3375047|NCT01814722|4107953|FG002|NOT COMPLETED|Overall Study||0
3375048|NCT01830790|4107963|FG000|STARTED|Overall Study||0
3375049|NCT01830790|4107964|FG001|STARTED|Overall Study||10
3375050|NCT01830790|4107963|FG000|COMPLETED|Overall Study||0
3375051|NCT01830790|4107964|FG001|COMPLETED|Overall Study||10
3375052|NCT01830790|4107963|FG000|NOT COMPLETED|Overall Study||0
3375053|NCT01830790|4107964|FG001|NOT COMPLETED|Overall Study||0
3375054|NCT01829477|4107972|FG000|STARTED|Overall Study||17
3375055|NCT01829477|4107973|FG001|STARTED|Overall Study||16
3375056|NCT01829477|4107972|FG000|COMPLETED|Overall Study||1
3375057|NCT01829477|4107973|FG001|COMPLETED|Overall Study||1
3375058|NCT01829477|4107972|FG000|NOT COMPLETED|Overall Study||16
3375059|NCT01829477|4107973|FG001|NOT COMPLETED|Overall Study||15
3375060|NCT01803711|4107981|FG000|STARTED|Overall Study||2
3375061|NCT01803711|4107982|FG001|STARTED|Overall Study||3
3375062|NCT01803711|4107981|FG000|COMPLETED|Overall Study||1
3375063|NCT01803711|4107982|FG001|COMPLETED|Overall Study||2
3375064|NCT01803711|4107981|FG000|NOT COMPLETED|Overall Study||1
3375065|NCT01803711|4107982|FG001|NOT COMPLETED|Overall Study||1
3375066|NCT01821859|4107990|FG000|STARTED|Overall Study||5
3375067|NCT01821859|4107990|FG000|COMPLETED|Overall Study||0
3375068|NCT01821859|4107990|FG000|NOT COMPLETED|Overall Study||5
3375069|NCT01808950|4107997|FG000|STARTED|Overall Study||1
3375070|NCT01808950|4107998|FG001|STARTED|Overall Study||3
3375071|NCT01808950|4107999|FG002|STARTED|Overall Study||0
3375072|NCT01808950|4107997|FG000|COMPLETED|Overall Study||1
3375073|NCT01808950|4107998|FG001|COMPLETED|Overall Study||3
3375074|NCT01808950|4107999|FG002|COMPLETED|Overall Study||0
3375075|NCT01808950|4107997|FG000|NOT COMPLETED|Overall Study||0
3375076|NCT01808950|4107998|FG001|NOT COMPLETED|Overall Study||0
3375077|NCT01808950|4107999|FG002|NOT COMPLETED|Overall Study||0
3375078|NCT01806051|4108010|FG000|STARTED|Overall Study||6
3375079|NCT01806051|4108010|FG000|COMPLETED|Overall Study||0
3375080|NCT01806051|4108010|FG000|NOT COMPLETED|Overall Study||6
3265880|NCT02619617|4000369|FG000|Participants Included in PD Analysis|Period 1 Placebo - 1st AttacK||20
3265881|NCT02619617|4000370|FG001|Participants Included in PD Analysis|Period 1 Placebo - 1st AttacK||0
3265882|NCT02619617|4000369|FG000|Participants in Safety Set for Period 1|Period 1 Placebo - 1st AttacK||28
3265883|NCT02619617|4000370|FG001|Participants in Safety Set for Period 1|Period 1 Placebo - 1st AttacK||0
3265884|NCT02619617|4000369|FG000|COMPLETED|Period 1 Placebo - 1st AttacK||28
3375081|NCT01808794|4108018|FG000|STARTED|Overall Study||0
3375082|NCT01808794|4108019|FG001|STARTED|Overall Study||0
3375083|NCT01808794|4108018|FG000|COMPLETED|Overall Study||0
3375084|NCT01808794|4108019|FG001|COMPLETED|Overall Study||0
3265885|NCT02619617|4000370|FG001|COMPLETED|Period 1 Placebo - 1st AttacK||0
3265886|NCT02619617|4000369|FG000|NOT COMPLETED|Period 1 Placebo - 1st AttacK||0
3265887|NCT02619617|4000370|FG001|NOT COMPLETED|Period 1 Placebo - 1st AttacK||0
3265888|NCT02619617|4000369|FG000|STARTED|Period 2 SOM230 - 2nd Attack||0
3265889|NCT02619617|4000370|FG001|STARTED|Period 2 SOM230 - 2nd Attack||28
3265890|NCT02619617|4000369|FG000|Participants in Safety Set for Period 2|Period 2 SOM230 - 2nd Attack||0
3265891|NCT02619617|4000370|FG001|Participants in Safety Set for Period 2|Period 2 SOM230 - 2nd Attack||28
3265892|NCT02619617|4000369|FG000|COMPLETED|Period 2 SOM230 - 2nd Attack||0
3265893|NCT02619617|4000370|FG001|COMPLETED|Period 2 SOM230 - 2nd Attack||24
3265894|NCT02619617|4000369|FG000|NOT COMPLETED|Period 2 SOM230 - 2nd Attack||0
3265895|NCT02619617|4000370|FG001|NOT COMPLETED|Period 2 SOM230 - 2nd Attack||4
3265896|NCT02619799|4000380|FG000|STARTED|Overall Study||25
3265897|NCT02619799|4000381|FG001|STARTED|Overall Study||25
3265898|NCT02619799|4000380|FG000|COMPLETED|Overall Study||25
3265899|NCT02619799|4000381|FG001|COMPLETED|Overall Study||25
3265900|NCT02619799|4000380|FG000|NOT COMPLETED|Overall Study||0
3265901|NCT02619799|4000381|FG001|NOT COMPLETED|Overall Study||0
3265902|NCT02620020|4000391|FG000|STARTED|Overall Study||141
3265903|NCT02620020|4000392|FG001|STARTED|Overall Study||141
3265904|NCT02620020|4000393|FG002|STARTED|Overall Study||140
3265905|NCT02620020|4000394|FG003|STARTED|Overall Study||141
3265906|NCT02620020|4000391|FG000|Modified Intent to Treat Set (mITT)|Overall Study||140
3265907|NCT02620020|4000392|FG001|Modified Intent to Treat Set (mITT)|Overall Study||139
3265908|NCT02620020|4000393|FG002|Modified Intent to Treat Set (mITT)|Overall Study||139
3265909|NCT02620020|4000394|FG003|Modified Intent to Treat Set (mITT)|Overall Study||140
3265910|NCT02620020|4000391|FG000|COMPLETED|Overall Study||97
3265911|NCT02620020|4000392|FG001|COMPLETED|Overall Study||106
3265912|NCT02620020|4000393|FG002|COMPLETED|Overall Study||115
3265913|NCT02620020|4000394|FG003|COMPLETED|Overall Study||115
3265914|NCT02620020|4000391|FG000|NOT COMPLETED|Overall Study||44
3265915|NCT02620020|4000392|FG001|NOT COMPLETED|Overall Study||35
3265916|NCT02620020|4000393|FG002|NOT COMPLETED|Overall Study||25
3265917|NCT02620020|4000394|FG003|NOT COMPLETED|Overall Study||26
3265918|NCT02620384|4000406|FG000|STARTED|Overall Study||70
3265919|NCT02620384|4000407|FG001|STARTED|Overall Study||73
3265920|NCT02620384|4000406|FG000|COMPLETED|Overall Study|Per protocol design patients must receive both doses of investigational product to be in analysis.|66
3265921|NCT02620384|4000407|FG001|COMPLETED|Overall Study|Per protocol design patients must receive both doses of investigational product to be in analysis.|66
3265922|NCT02620384|4000406|FG000|NOT COMPLETED|Overall Study||4
3265923|NCT02620384|4000407|FG001|NOT COMPLETED|Overall Study||7
3265924|NCT02620683|4000413|FG000|STARTED|First Intervention (Visit 1)||12
3265925|NCT02620683|4000414|FG001|STARTED|First Intervention (Visit 1)||11
3265926|NCT02620683|4000413|FG000|COMPLETED|First Intervention (Visit 1)||12
3265927|NCT02620683|4000414|FG001|COMPLETED|First Intervention (Visit 1)||11
3265928|NCT02620683|4000413|FG000|NOT COMPLETED|First Intervention (Visit 1)||0
3265929|NCT02620683|4000414|FG001|NOT COMPLETED|First Intervention (Visit 1)||0
3265930|NCT02620683|4000413|FG000|STARTED|Washout (2 Weeks)||12
3265931|NCT02620683|4000414|FG001|STARTED|Washout (2 Weeks)||11
3265932|NCT02620683|4000413|FG000|COMPLETED|Washout (2 Weeks)||12
3265933|NCT02620683|4000414|FG001|COMPLETED|Washout (2 Weeks)||11
3265934|NCT02620683|4000413|FG000|NOT COMPLETED|Washout (2 Weeks)||0
3265935|NCT02620683|4000414|FG001|NOT COMPLETED|Washout (2 Weeks)||0
3265936|NCT02620683|4000413|FG000|STARTED|Second Intervention (Visit 2)||12
3265937|NCT02620683|4000414|FG001|STARTED|Second Intervention (Visit 2)||11
3265938|NCT02620683|4000413|FG000|COMPLETED|Second Intervention (Visit 2)||12
3265939|NCT02620683|4000414|FG001|COMPLETED|Second Intervention (Visit 2)||11
3265940|NCT02620683|4000413|FG000|NOT COMPLETED|Second Intervention (Visit 2)||0
3265941|NCT02620683|4000414|FG001|NOT COMPLETED|Second Intervention (Visit 2)||0
3265942|NCT02620774|4000421|FG000|STARTED|Overall Study||10
3265943|NCT02620774|4000422|FG001|STARTED|Overall Study||6
3265944|NCT02620774|4000421|FG000|COMPLETED|Overall Study||10
3265945|NCT02620774|4000422|FG001|COMPLETED|Overall Study||6
3265946|NCT02620774|4000421|FG000|NOT COMPLETED|Overall Study||0
3265947|NCT02620774|4000422|FG001|NOT COMPLETED|Overall Study||0
3265948|NCT02620787|4000430|FG000|STARTED|Overall Study||12
3265949|NCT02620787|4000431|FG001|STARTED|Overall Study||6
3265950|NCT02620787|4000430|FG000|COMPLETED|Overall Study||10
3265951|NCT02620787|4000431|FG001|COMPLETED|Overall Study||6
3265952|NCT02620787|4000430|FG000|NOT COMPLETED|Overall Study||2
3265953|NCT02620787|4000431|FG001|NOT COMPLETED|Overall Study||0
3265954|NCT02620878|4000437|FG000|STARTED|Overall Study||16
3265955|NCT02620878|4000438|FG001|STARTED|Overall Study||16
3265956|NCT02620878|4000437|FG000|COMPLETED|Overall Study||16
3265957|NCT02620878|4000438|FG001|COMPLETED|Overall Study||16
3265958|NCT02620878|4000437|FG000|NOT COMPLETED|Overall Study||0
3265959|NCT02620878|4000438|FG001|NOT COMPLETED|Overall Study||0
3265960|NCT02620904|4000446|FG000|STARTED|Overall Study||4
3265961|NCT02620904|4000447|FG001|STARTED|Overall Study||5
3265962|NCT02620904|4000446|FG000|COMPLETED|Overall Study||4
3265963|NCT02620904|4000447|FG001|COMPLETED|Overall Study||5
3265964|NCT02620904|4000446|FG000|NOT COMPLETED|Overall Study||0
3265965|NCT02620904|4000447|FG001|NOT COMPLETED|Overall Study||0
3265966|NCT02620917|4000453|FG000|STARTED|Overall Study||6623
3265967|NCT02620917|4000453|FG000|COMPLETED|Overall Study||6623
3265968|NCT02620917|4000453|FG000|NOT COMPLETED|Overall Study||0
3265969|NCT02621034|4000462|FG000|STARTED|Overall Study||53
3265970|NCT02621034|4000463|FG001|STARTED|Overall Study||52
3265971|NCT02621034|4000464|FG002|STARTED|Overall Study||55
3265972|NCT02621034|4000462|FG000|COMPLETED|Overall Study||50
3265973|NCT02621034|4000463|FG001|COMPLETED|Overall Study||50
3265974|NCT02621034|4000464|FG002|COMPLETED|Overall Study||50
3265975|NCT02621034|4000462|FG000|NOT COMPLETED|Overall Study||3
3265976|NCT02621034|4000463|FG001|NOT COMPLETED|Overall Study||2
3265977|NCT02621034|4000464|FG002|NOT COMPLETED|Overall Study||5
3265978|NCT02621047|4000477|FG000|STARTED|Overall Study||8
3265979|NCT02621047|4000478|FG001|STARTED|Overall Study||8
3265980|NCT02621047|4000479|FG002|STARTED|Overall Study||12
3265981|NCT02621047|4000477|FG000|COMPLETED|Overall Study||8
3265982|NCT02621047|4000478|FG001|COMPLETED|Overall Study||8
3265983|NCT02621047|4000479|FG002|COMPLETED|Overall Study||11
3265984|NCT02621047|4000477|FG000|NOT COMPLETED|Overall Study||0
3265985|NCT02621047|4000478|FG001|NOT COMPLETED|Overall Study||0
3265986|NCT02621047|4000479|FG002|NOT COMPLETED|Overall Study||1
3265987|NCT02621060|4000490|FG000|STARTED|Overall Study||15
3265988|NCT02621060|4000491|FG001|STARTED|Overall Study||15
3265989|NCT02621060|4000490|FG000|COMPLETED|Overall Study||12
3265990|NCT02621060|4000491|FG001|COMPLETED|Overall Study||14
3265991|NCT02621060|4000490|FG000|NOT COMPLETED|Overall Study||3
3265992|NCT02621060|4000491|FG001|NOT COMPLETED|Overall Study||1
3265993|NCT02621073|4000499|FG000|STARTED|Overall Study||4
3265994|NCT02621073|4000500|FG001|STARTED|Overall Study||3
3265995|NCT02621073|4000499|FG000|COMPLETED|Overall Study||1
3265996|NCT02621073|4000500|FG001|COMPLETED|Overall Study||0
3265997|NCT02621073|4000499|FG000|NOT COMPLETED|Overall Study||3
3265998|NCT02621073|4000500|FG001|NOT COMPLETED|Overall Study||3
3265999|NCT02621463|4000506|FG000|STARTED|Overall Study||29
3266000|NCT02621463|4000506|FG000|COMPLETED|Overall Study||29
3266001|NCT02621463|4000506|FG000|NOT COMPLETED|Overall Study||0
3266002|NCT02621606|4000513|FG000|STARTED|Overall Study||3
3266003|NCT02621606|4000514|FG001|STARTED|Overall Study||7
3266004|NCT02621606|4000515|FG002|STARTED|Overall Study||10
3266005|NCT02621606|4000513|FG000|Treated|Overall Study||3
3266006|NCT02621606|4000514|FG001|Treated|Overall Study||7
3266007|NCT02621606|4000515|FG002|Treated|Overall Study||10
3266008|NCT02621606|4000513|FG000|COMPLETED|Overall Study||3
3266009|NCT02621606|4000514|FG001|COMPLETED|Overall Study||6
3266010|NCT02621606|4000515|FG002|COMPLETED|Overall Study||10
3266011|NCT02621606|4000513|FG000|NOT COMPLETED|Overall Study||0
3266012|NCT02621606|4000514|FG001|NOT COMPLETED|Overall Study||1
3266013|NCT02621606|4000515|FG002|NOT COMPLETED|Overall Study||0
3266014|NCT02621619|4000525|FG000|STARTED|Overall Study||80
3266015|NCT02621619|4000526|FG001|STARTED|Overall Study||79
3266016|NCT02621619|4000525|FG000|COMPLETED|Overall Study||80
3266017|NCT02621619|4000526|FG001|COMPLETED|Overall Study||79
3266018|NCT02621619|4000525|FG000|NOT COMPLETED|Overall Study||0
3266019|NCT02621619|4000526|FG001|NOT COMPLETED|Overall Study||0
3266020|NCT02621892|4000534|FG000|STARTED|Treatment Period||307
3266021|NCT02621892|4000535|FG001|STARTED|Treatment Period||299
3266022|NCT02621892|4000534|FG000|COMPLETED|Treatment Period||261
3266023|NCT02621892|4000535|FG001|COMPLETED|Treatment Period||272
3266024|NCT02621892|4000534|FG000|NOT COMPLETED|Treatment Period||46
3266025|NCT02621892|4000535|FG001|NOT COMPLETED|Treatment Period||27
3266026|NCT02621892|4000534|FG000|STARTED|Randomized Withdrawal Period||261
3266027|NCT02621892|4000535|FG001|STARTED|Randomized Withdrawal Period||272
3266028|NCT02621892|4000534|FG000|COMPLETED|Randomized Withdrawal Period||250
3266029|NCT02621892|4000535|FG001|COMPLETED|Randomized Withdrawal Period||260
3266030|NCT02621892|4000534|FG000|NOT COMPLETED|Randomized Withdrawal Period||11
3266031|NCT02621892|4000535|FG001|NOT COMPLETED|Randomized Withdrawal Period||12
3266032|NCT02621931|4000544|FG000|STARTED|Overall Study||375
3266033|NCT02621931|4000545|FG001|STARTED|Overall Study||376
3266034|NCT02621931|4000546|FG002|STARTED|Overall Study||379
3266035|NCT02621931|4000544|FG000|Safety and ITT Populations|Overall Study||375
3266036|NCT02621931|4000545|FG001|Safety and ITT Populations|Overall Study||376
3266037|NCT02621931|4000546|FG002|Safety and ITT Populations|Overall Study||379
3266038|NCT02621931|4000544|FG000|Full Analysis Set|Overall Study||371
3266039|NCT02621931|4000545|FG001|Full Analysis Set|Overall Study||375
3266040|NCT02621931|4000546|FG002|Full Analysis Set|Overall Study||375
3266041|NCT02621931|4000544|FG000|COMPLETED|Overall Study||342
3266042|NCT02621931|4000545|FG001|COMPLETED|Overall Study||349
3266043|NCT02621931|4000546|FG002|COMPLETED|Overall Study||343
3266044|NCT02621931|4000544|FG000|NOT COMPLETED|Overall Study||33
3266045|NCT02621931|4000545|FG001|NOT COMPLETED|Overall Study||27
3266046|NCT02621931|4000546|FG002|NOT COMPLETED|Overall Study||36
3266047|NCT02621983|4000558|FG000|STARTED|Overall Study||21
3266048|NCT02621983|4000559|FG001|STARTED|Overall Study||17
3266049|NCT02621983|4000558|FG000|COMPLETED|Overall Study||9
3266050|NCT02621983|4000559|FG001|COMPLETED|Overall Study||6
3266051|NCT02621983|4000558|FG000|NOT COMPLETED|Overall Study||12
3266052|NCT02621983|4000559|FG001|NOT COMPLETED|Overall Study||11
3266053|NCT02622074|4000571|FG000|STARTED|Overall Study||10
3266054|NCT02622074|4000572|FG001|STARTED|Overall Study||10
3266055|NCT02622074|4000573|FG002|STARTED|Overall Study||10
3266056|NCT02622074|4000574|FG003|STARTED|Overall Study||10
3266057|NCT02622074|4000575|FG004|STARTED|Overall Study||10
3266058|NCT02622074|4000576|FG005|STARTED|Overall Study||10
3266059|NCT02622074|4000571|FG000|COMPLETED|Overall Study||6
3266060|NCT02622074|4000572|FG001|COMPLETED|Overall Study||9
3266061|NCT02622074|4000573|FG002|COMPLETED|Overall Study||10
3266062|NCT02622074|4000574|FG003|COMPLETED|Overall Study||9
3266063|NCT02622074|4000575|FG004|COMPLETED|Overall Study||9
3266064|NCT02622074|4000576|FG005|COMPLETED|Overall Study||10
3266065|NCT02622074|4000571|FG000|NOT COMPLETED|Overall Study||4
3266066|NCT02622074|4000572|FG001|NOT COMPLETED|Overall Study||1
3266067|NCT02622074|4000573|FG002|NOT COMPLETED|Overall Study||0
3266068|NCT02622074|4000574|FG003|NOT COMPLETED|Overall Study||1
3266069|NCT02622074|4000575|FG004|NOT COMPLETED|Overall Study||1
3266070|NCT02622074|4000576|FG005|NOT COMPLETED|Overall Study||0
3266071|NCT02622113|4000592|FG000|STARTED|Overall Study||67
3266072|NCT02622113|4000593|FG001|STARTED|Overall Study||76
3266073|NCT02622113|4000592|FG000|COMPLETED|Overall Study||62
3266074|NCT02622113|4000593|FG001|COMPLETED|Overall Study||66
3266075|NCT02622113|4000592|FG000|NOT COMPLETED|Overall Study||5
3266076|NCT02622113|4000593|FG001|NOT COMPLETED|Overall Study||10
3266077|NCT02622178|4000602|FG000|STARTED|Overall Study||42
3266078|NCT02622178|4000603|FG001|STARTED|Overall Study||45
3266079|NCT02622178|4000604|FG002|STARTED|Overall Study||49
3266080|NCT02622178|4000602|FG000|COMPLETED|Overall Study||42
3266081|NCT02622178|4000603|FG001|COMPLETED|Overall Study||45
3266082|NCT02622178|4000604|FG002|COMPLETED|Overall Study||49
3266083|NCT02622178|4000602|FG000|NOT COMPLETED|Overall Study||0
3266084|NCT02622178|4000603|FG001|NOT COMPLETED|Overall Study||0
3266085|NCT02622178|4000604|FG002|NOT COMPLETED|Overall Study||0
3266086|NCT02622191|4000615|FG000|STARTED|Overall Study||19
3266087|NCT02622191|4000616|FG001|STARTED|Overall Study||14
3266088|NCT02622191|4000615|FG000|COMPLETED|Overall Study||19
3266089|NCT02622191|4000616|FG001|COMPLETED|Overall Study||14
3266090|NCT02622191|4000615|FG000|NOT COMPLETED|Overall Study||0
3266091|NCT02622191|4000616|FG001|NOT COMPLETED|Overall Study||0
3266092|NCT02622321|4000627|FG000|STARTED|Overall Study||35
3266093|NCT02622321|4000628|FG001|STARTED|Overall Study||18
3266094|NCT02622321|4000629|FG002|STARTED|Overall Study||49
3266095|NCT02622321|4000630|FG003|STARTED|Overall Study||11
3266096|NCT02622321|4000627|FG000|Received at Least One Dose of Treatment|Overall Study|1 participant withdrew prior to study Day 1.|34
3266097|NCT02622321|4000628|FG001|Received at Least One Dose of Treatment|Overall Study||18
3266098|NCT02622321|4000629|FG002|Received at Least One Dose of Treatment|Overall Study||49
3266099|NCT02622321|4000630|FG003|Received at Least One Dose of Treatment|Overall Study||11
3266100|NCT02622321|4000627|FG000|Completed 24 Weeks in the Study|Overall Study||31
3266101|NCT02622321|4000628|FG001|Completed 24 Weeks in the Study|Overall Study|After 24 weeks, all 18 participants in Arm B switched to receive emicizumab prophylaxis.|18
3266102|NCT02622321|4000629|FG002|Completed 24 Weeks in the Study|Overall Study||49
3266103|NCT02622321|4000630|FG003|Completed 24 Weeks in the Study|Overall Study||11
3266104|NCT02622321|4000627|FG000|Dose Up-Titrated to 3 mg/kg QW|Overall Study||2
3266105|NCT02622321|4000628|FG001|Dose Up-Titrated to 3 mg/kg QW|Overall Study||0
3266106|NCT02622321|4000629|FG002|Dose Up-Titrated to 3 mg/kg QW|Overall Study||3
3266107|NCT02622321|4000630|FG003|Dose Up-Titrated to 3 mg/kg QW|Overall Study||2
3266108|NCT02622321|4000627|FG000|COMPLETED|Overall Study||32
3266109|NCT02622321|4000628|FG001|COMPLETED|Overall Study||18
3266110|NCT02622321|4000629|FG002|COMPLETED|Overall Study||48
3266111|NCT02622321|4000630|FG003|COMPLETED|Overall Study||11
3266112|NCT02622321|4000627|FG000|NOT COMPLETED|Overall Study||3
3266113|NCT02622321|4000628|FG001|NOT COMPLETED|Overall Study||0
3266114|NCT02622321|4000629|FG002|NOT COMPLETED|Overall Study||1
3375085|NCT01808794|4108018|FG000|NOT COMPLETED|Overall Study||0
3375086|NCT01808794|4108019|FG001|NOT COMPLETED|Overall Study||0
3375087|NCT01809899|4108027|FG000|STARTED|Overall Study||8
3375088|NCT01809899|4108028|FG001|STARTED|Overall Study||4
3375089|NCT01809899|4108027|FG000|COMPLETED|Overall Study||8
3375090|NCT01809899|4108028|FG001|COMPLETED|Overall Study||4
3375091|NCT01809899|4108027|FG000|NOT COMPLETED|Overall Study||0
3375092|NCT01809899|4108028|FG001|NOT COMPLETED|Overall Study||0
3375093|NCT01810302|4108037|FG000|STARTED|Overall Study||1
3375094|NCT01810302|4108038|FG001|STARTED|Overall Study||1
3375095|NCT01810302|4108037|FG000|COMPLETED|Overall Study||0
3375096|NCT01810302|4108038|FG001|COMPLETED|Overall Study||0
3375097|NCT01810302|4108037|FG000|NOT COMPLETED|Overall Study||1
3375098|NCT01810302|4108038|FG001|NOT COMPLETED|Overall Study||1
3375099|NCT01806961|4108044|FG000|STARTED|Overall Study||16
3375100|NCT01806961|4108044|FG000|COMPLETED|Overall Study||0
3375101|NCT01806961|4108044|FG000|NOT COMPLETED|Overall Study||16
3375102|NCT01804166|4108048|FG000|STARTED|Overall Study||1
3375103|NCT01804166|4108048|FG000|COMPLETED|Overall Study||1
3375104|NCT01804166|4108048|FG000|NOT COMPLETED|Overall Study||0
3375105|NCT01783015|4108054|FG000|STARTED|Blinded Treatment||11
3375106|NCT01783015|4108055|FG001|STARTED|Blinded Treatment||5
3375107|NCT01783015|4108056|FG002|STARTED|Blinded Treatment||0
3375108|NCT01783015|4108054|FG000|Treated|Blinded Treatment||11
3375109|NCT01783015|4108055|FG001|Treated|Blinded Treatment||5
3375110|NCT01783015|4108056|FG002|Treated|Blinded Treatment||0
3375111|NCT01783015|4108054|FG000|COMPLETED|Blinded Treatment||9
3375112|NCT01783015|4108055|FG001|COMPLETED|Blinded Treatment||2
3375113|NCT01783015|4108056|FG002|COMPLETED|Blinded Treatment||0
3375114|NCT01783015|4108054|FG000|NOT COMPLETED|Blinded Treatment||2
3375115|NCT01783015|4108055|FG001|NOT COMPLETED|Blinded Treatment||3
3375116|NCT01783015|4108056|FG002|NOT COMPLETED|Blinded Treatment||0
3375117|NCT01783015|4108054|FG000|STARTED|Open Label Treatment||0
3375118|NCT01783015|4108055|FG001|STARTED|Open Label Treatment||0
3375119|NCT01783015|4108056|FG002|STARTED|Open Label Treatment||11
3266115|NCT02622321|4000630|FG003|NOT COMPLETED|Overall Study||0
3266116|NCT02622568|4000656|FG000|STARTED|Overall Study||14
3266117|NCT02622568|4000657|FG001|STARTED|Overall Study||14
3266118|NCT02622568|4000656|FG000|COMPLETED|Overall Study||9
3266119|NCT02622568|4000657|FG001|COMPLETED|Overall Study||9
3266120|NCT02622568|4000656|FG000|NOT COMPLETED|Overall Study||5
3266121|NCT02622568|4000657|FG001|NOT COMPLETED|Overall Study||5
3266122|NCT02622724|4000665|FG000|STARTED|Overall Study||144
3266123|NCT02622724|4000666|FG001|STARTED|Overall Study||152
3266124|NCT02622724|4000665|FG000|Subjects Randomised|Overall Study||146
3266125|NCT02622724|4000666|FG001|Subjects Randomised|Overall Study||155
3266126|NCT02622724|4000665|FG000|Short-Term Follow-Up (Day 28)|Overall Study||105
3266127|NCT02622724|4000666|FG001|Short-Term Follow-Up (Day 28)|Overall Study||115
3266128|NCT02622724|4000665|FG000|Long-Term Follow-Up (Day 90)|Overall Study||96
3266129|NCT02622724|4000666|FG001|Long-Term Follow-Up (Day 90)|Overall Study||101
3266130|NCT02622724|4000665|FG000|Long-Term Follow-Up (Day 180)|Overall Study||73
3266131|NCT02622724|4000666|FG001|Long-Term Follow-Up (Day 180)|Overall Study||74
3266132|NCT02622724|4000665|FG000|COMPLETED|Overall Study||51
3266133|NCT02622724|4000666|FG001|COMPLETED|Overall Study||49
3266134|NCT02622724|4000665|FG000|NOT COMPLETED|Overall Study||93
3266135|NCT02622724|4000666|FG001|NOT COMPLETED|Overall Study||103
3266136|NCT02623218|4000683|FG000|STARTED|Overall Study||5
3266137|NCT02623218|4000684|FG001|STARTED|Overall Study||4
3266138|NCT02623218|4000685|FG002|STARTED|Overall Study||4
3266139|NCT02623218|4000686|FG003|STARTED|Overall Study||4
3266140|NCT02623218|4000687|FG004|STARTED|Overall Study||4
3266141|NCT02623218|4000683|FG000|COMPLETED|Overall Study||5
3266142|NCT02623218|4000684|FG001|COMPLETED|Overall Study||3
3266143|NCT02623218|4000685|FG002|COMPLETED|Overall Study||4
3266144|NCT02623218|4000686|FG003|COMPLETED|Overall Study||4
3266145|NCT02623218|4000687|FG004|COMPLETED|Overall Study||4
3266146|NCT02623218|4000683|FG000|NOT COMPLETED|Overall Study||0
3266147|NCT02623218|4000684|FG001|NOT COMPLETED|Overall Study||1
3266148|NCT02623218|4000685|FG002|NOT COMPLETED|Overall Study||0
3266149|NCT02623218|4000686|FG003|NOT COMPLETED|Overall Study||0
3266150|NCT02623218|4000687|FG004|NOT COMPLETED|Overall Study||0
3266151|NCT02623322|4000702|FG000|STARTED|Overall Study||43
3266152|NCT02623322|4000703|FG001|STARTED|Overall Study||41
3266153|NCT02623322|4000704|FG002|STARTED|Overall Study||40
3266154|NCT02623322|4000702|FG000|COMPLETED|Overall Study||41
3266155|NCT02623322|4000703|FG001|COMPLETED|Overall Study||40
3266156|NCT02623322|4000704|FG002|COMPLETED|Overall Study||40
3266157|NCT02623322|4000702|FG000|NOT COMPLETED|Overall Study||2
3266158|NCT02623322|4000703|FG001|NOT COMPLETED|Overall Study||1
3266159|NCT02623322|4000704|FG002|NOT COMPLETED|Overall Study||0
3266160|NCT02623335|4000716|FG000|STARTED|Overall Study||223
3266161|NCT02623335|4000717|FG001|STARTED|Overall Study||223
3266162|NCT02623335|4000716|FG000|T0 Audio Recording (Day of Consultation)|Overall Study||223
3266163|NCT02623335|4000717|FG001|T0 Audio Recording (Day of Consultation)|Overall Study||222
3266164|NCT02623335|4000716|FG000|T1 Survey (24-48 Hours)|Overall Study||216
3266165|NCT02623335|4000717|FG001|T1 Survey (24-48 Hours)|Overall Study||214
3266166|NCT02623335|4000716|FG000|T2 Survey (6-8 Weeks)|Overall Study||199
3375120|NCT01783015|4108054|FG000|COMPLETED|Open Label Treatment||0
3375121|NCT01783015|4108055|FG001|COMPLETED|Open Label Treatment||0
3375122|NCT01783015|4108056|FG002|COMPLETED|Open Label Treatment||5
3375123|NCT01783015|4108054|FG000|NOT COMPLETED|Open Label Treatment||0
3375124|NCT01783015|4108055|FG001|NOT COMPLETED|Open Label Treatment||0
3375125|NCT01783015|4108056|FG002|NOT COMPLETED|Open Label Treatment||6
3375126|NCT01800162|4108067|FG000|STARTED|Overall Study|1 subject was randomized to uterine evacuation on 6/26/2013.|1
3375127|NCT01800162|4108068|FG001|STARTED|Overall Study||0
3375128|NCT01800162|4108069|FG002|STARTED|Overall Study|1 subject randomized to expectant management on 11/1/2013.|1
3375129|NCT01800162|4108067|FG000|COMPLETED|Overall Study||1
3375130|NCT01800162|4108068|FG001|COMPLETED|Overall Study||0
3375131|NCT01800162|4108069|FG002|COMPLETED|Overall Study||1
3375132|NCT01800162|4108067|FG000|NOT COMPLETED|Overall Study||0
3375133|NCT01800162|4108068|FG001|NOT COMPLETED|Overall Study||0
3375134|NCT01800162|4108069|FG002|NOT COMPLETED|Overall Study||0
3375135|NCT01794936|4108077|FG000|STARTED|Overall Study||9
3375136|NCT01794936|4108077|FG000|COMPLETED|Overall Study||9
3375137|NCT01794936|4108077|FG000|NOT COMPLETED|Overall Study||0
3375138|NCT01797380|4108083|FG000|STARTED|Overall Study|Terminated due to lack of enrollment|3
3375139|NCT01797380|4108084|FG001|STARTED|Overall Study||2
3375140|NCT01797380|4108083|FG000|COMPLETED|Overall Study|Terminated due to lack of enrollment|0
3375141|NCT01797380|4108084|FG001|COMPLETED|Overall Study||0
3375142|NCT01797380|4108083|FG000|NOT COMPLETED|Overall Study||3
3375143|NCT01797380|4108084|FG001|NOT COMPLETED|Overall Study||2
3375144|NCT01781026|4108090|FG000|STARTED|Overall Study||2
3375145|NCT01781026|4108090|FG000|COMPLETED|Overall Study||0
3375146|NCT01781026|4108090|FG000|NOT COMPLETED|Overall Study||2
3375147|NCT01788475|4108097|FG000|STARTED|Overall Study||3
3375148|NCT01788475|4108098|FG001|STARTED|Overall Study||0
3375149|NCT01788475|4108099|FG002|STARTED|Overall Study||0
3375150|NCT01788475|4108097|FG000|COMPLETED|Overall Study||0
3266167|NCT02623335|4000717|FG001|T2 Survey (6-8 Weeks)|Overall Study||192
3266168|NCT02623335|4000716|FG000|T3 Survey (12-14 Weeks)|Overall Study||196
3266169|NCT02623335|4000717|FG001|T3 Survey (12-14 Weeks)|Overall Study||187
3375151|NCT01788475|4108098|FG001|COMPLETED|Overall Study||0
3266170|NCT02623335|4000716|FG000|COMPLETED|Overall Study||196
3266171|NCT02623335|4000717|FG001|COMPLETED|Overall Study||187
3266172|NCT02623335|4000716|FG000|NOT COMPLETED|Overall Study||27
3266173|NCT02623335|4000717|FG001|NOT COMPLETED|Overall Study||36
3266174|NCT02623348|4000725|FG000|STARTED|Overall Study||30
3266175|NCT02623348|4000726|FG001|STARTED|Overall Study||30
3266176|NCT02623348|4000725|FG000|3-month Assessment|Overall Study||27
3266177|NCT02623348|4000726|FG001|3-month Assessment|Overall Study||26
3266178|NCT02623348|4000725|FG000|COMPLETED|Overall Study||27
3266179|NCT02623348|4000726|FG001|COMPLETED|Overall Study||28
3266180|NCT02623348|4000725|FG000|NOT COMPLETED|Overall Study||3
3266181|NCT02623348|4000726|FG001|NOT COMPLETED|Overall Study||2
3266182|NCT02623361|4000734|FG000|STARTED|Overall Study||40
3266183|NCT02623361|4000735|FG001|STARTED|Overall Study||40
3266184|NCT02623361|4000734|FG000|COMPLETED|Overall Study||40
3266185|NCT02623361|4000735|FG001|COMPLETED|Overall Study||38
3266186|NCT02623361|4000734|FG000|NOT COMPLETED|Overall Study||0
3266187|NCT02623361|4000735|FG001|NOT COMPLETED|Overall Study||2
3266188|NCT02623725|4000743|FG000|STARTED|Overall Study||187
3266189|NCT02623725|4000744|FG001|STARTED|Overall Study||64
3266190|NCT02623725|4000743|FG000|COMPLETED|Overall Study||171
3266191|NCT02623725|4000744|FG001|COMPLETED|Overall Study||58
3266192|NCT02623725|4000743|FG000|NOT COMPLETED|Overall Study||16
3266193|NCT02623725|4000744|FG001|NOT COMPLETED|Overall Study||6
3266194|NCT02623803|4000754|FG000|STARTED|Overall Study||25
3266195|NCT02623803|4000755|FG001|STARTED|Overall Study||23
3266196|NCT02623803|4000754|FG000|COMPLETED|Overall Study||25
3266197|NCT02623803|4000755|FG001|COMPLETED|Overall Study||23
3266198|NCT02623803|4000754|FG000|NOT COMPLETED|Overall Study||0
3266199|NCT02623803|4000755|FG001|NOT COMPLETED|Overall Study||0
3266200|NCT02623829|4000763|FG000|STARTED|Overall Study||21
3266201|NCT02623829|4000764|FG001|STARTED|Overall Study||21
3266202|NCT02623829|4000763|FG000|COMPLETED|Overall Study||20
3266203|NCT02623829|4000764|FG001|COMPLETED|Overall Study||20
3266204|NCT02623829|4000763|FG000|NOT COMPLETED|Overall Study||1
3266205|NCT02623829|4000764|FG001|NOT COMPLETED|Overall Study||1
3266206|NCT02623855|4000772|FG000|STARTED|Overall Study||56
3266207|NCT02623855|4000773|FG001|STARTED|Overall Study||100
3266208|NCT02623855|4000772|FG000|COMPLETED|Overall Study||46
3266209|NCT02623855|4000773|FG001|COMPLETED|Overall Study||84
3266210|NCT02623855|4000772|FG000|NOT COMPLETED|Overall Study||10
3266211|NCT02623855|4000773|FG001|NOT COMPLETED|Overall Study||16
3266212|NCT02624050|4000781|FG000|STARTED|Overall Study||26
3266213|NCT02624050|4000782|FG001|STARTED|Overall Study||25
3266214|NCT02624050|4000781|FG000|COMPLETED|Overall Study||20
3266215|NCT02624050|4000782|FG001|COMPLETED|Overall Study||25
3266216|NCT02624050|4000781|FG000|NOT COMPLETED|Overall Study||6
3266217|NCT02624050|4000782|FG001|NOT COMPLETED|Overall Study||0
3266218|NCT02624180|4000790|FG000|STARTED|Overall Study||43
3266219|NCT02624180|4000791|FG001|STARTED|Overall Study||38
3266220|NCT02624180|4000790|FG000|COMPLETED|Overall Study||37
3266221|NCT02624180|4000791|FG001|COMPLETED|Overall Study||34
3266222|NCT02624180|4000790|FG000|NOT COMPLETED|Overall Study||6
3266223|NCT02624180|4000791|FG001|NOT COMPLETED|Overall Study||4
3266224|NCT02624284|4000800|FG000|STARTED|Overall Study||49
3266225|NCT02624284|4000801|FG001|STARTED|Overall Study||53
3266226|NCT02624284|4000802|FG002|STARTED|Overall Study||47
3266227|NCT02624284|4000800|FG000|COMPLETED|Overall Study||35
3266228|NCT02624284|4000801|FG001|COMPLETED|Overall Study||35
3266229|NCT02624284|4000802|FG002|COMPLETED|Overall Study||36
3266230|NCT02624284|4000800|FG000|NOT COMPLETED|Overall Study||14
3266231|NCT02624284|4000801|FG001|NOT COMPLETED|Overall Study||18
3266232|NCT02624284|4000802|FG002|NOT COMPLETED|Overall Study||11
3266233|NCT02624375|4000810|FG000|STARTED|Overall Study||10
3266234|NCT02624375|4000810|FG000|COMPLETED|Overall Study||10
3266235|NCT02624375|4000810|FG000|NOT COMPLETED|Overall Study||0
3266236|NCT02624492|4000817|FG000|STARTED|Overall Study||5
3375152|NCT01788475|4108099|FG002|COMPLETED|Overall Study||0
3375153|NCT01788475|4108097|FG000|NOT COMPLETED|Overall Study||3
3375154|NCT01788475|4108098|FG001|NOT COMPLETED|Overall Study||0
3375155|NCT01788475|4108099|FG002|NOT COMPLETED|Overall Study||0
3375156|NCT01784991|4108109|FG000|STARTED|Overall Study||0
3375157|NCT01784991|4108110|FG001|STARTED|Overall Study||0
3375158|NCT01784991|4108109|FG000|COMPLETED|Overall Study||0
3375159|NCT01784991|4108110|FG001|COMPLETED|Overall Study||0
3375160|NCT01784991|4108109|FG000|NOT COMPLETED|Overall Study||0
3375161|NCT01784991|4108110|FG001|NOT COMPLETED|Overall Study||0
3375162|NCT01777854|4108116|FG000|STARTED|Overall Study||3
3375163|NCT01777854|4108117|FG001|STARTED|Overall Study||3
3375164|NCT01777854|4108116|FG000|COMPLETED|Overall Study||0
3375165|NCT01777854|4108117|FG001|COMPLETED|Overall Study||0
3375166|NCT01777854|4108116|FG000|NOT COMPLETED|Overall Study||3
3375167|NCT01777854|4108117|FG001|NOT COMPLETED|Overall Study||3
3375168|NCT01760993|4108121|FG000|STARTED|Overall Study||0
3375169|NCT01760993|4108121|FG000|COMPLETED|Overall Study||0
3375170|NCT01760993|4108121|FG000|NOT COMPLETED|Overall Study||0
3375171|NCT01772719|4108125|FG000|STARTED|Overall Study||7
3375172|NCT01772719|4108125|FG000|COMPLETED|Overall Study||0
3375173|NCT01772719|4108125|FG000|NOT COMPLETED|Overall Study||7
3375174|NCT01764997|4108137|FG000|STARTED|Run-in Period||776
3375175|NCT01764997|4108138|FG001|STARTED|Run-in Period||0
3375176|NCT01764997|4108139|FG002|STARTED|Run-in Period||0
3266237|NCT02624492|4000818|FG001|STARTED|Overall Study||8
3266238|NCT02624492|4000819|FG002|STARTED|Overall Study||8
3266239|NCT02624492|4000817|FG000|COMPLETED|Overall Study||3
3266240|NCT02624492|4000818|FG001|COMPLETED|Overall Study||4
3266241|NCT02624492|4000819|FG002|COMPLETED|Overall Study||3
3266242|NCT02624492|4000817|FG000|NOT COMPLETED|Overall Study||2
3266243|NCT02624492|4000818|FG001|NOT COMPLETED|Overall Study||4
3266244|NCT02624492|4000819|FG002|NOT COMPLETED|Overall Study||5
3266245|NCT02624687|4000829|FG000|STARTED|Overall Study||13
3266246|NCT02624687|4000830|FG001|STARTED|Overall Study||14
3266247|NCT02624687|4000829|FG000|COMPLETED|Overall Study||12
3266248|NCT02624687|4000830|FG001|COMPLETED|Overall Study||12
3266249|NCT02624687|4000829|FG000|NOT COMPLETED|Overall Study||1
3266250|NCT02624687|4000830|FG001|NOT COMPLETED|Overall Study||2
3266251|NCT02624700|4000838|FG000|STARTED|Overall Study||9
3266252|NCT02624700|4000839|FG001|STARTED|Overall Study||4
3266253|NCT02624700|4000838|FG000|COMPLETED|Overall Study||9
3266254|NCT02624700|4000839|FG001|COMPLETED|Overall Study||4
3266255|NCT02624700|4000838|FG000|NOT COMPLETED|Overall Study||0
3266256|NCT02624700|4000839|FG001|NOT COMPLETED|Overall Study||0
3266257|NCT02624713|4000849|FG000|STARTED|Overall Study||78
3266258|NCT02624713|4000850|FG001|STARTED|Overall Study||81
3266259|NCT02624713|4000849|FG000|COMPLETED|Overall Study||64
3266260|NCT02624713|4000850|FG001|COMPLETED|Overall Study||81
3266261|NCT02624713|4000849|FG000|NOT COMPLETED|Overall Study||14
3266262|NCT02624713|4000850|FG001|NOT COMPLETED|Overall Study||0
3266263|NCT02624791|4000857|FG000|STARTED|Overall Study||2
3266264|NCT02624791|4000858|FG001|STARTED|Overall Study||1
3266265|NCT02624791|4000859|FG002|STARTED|Overall Study||2
3266266|NCT02624791|4000860|FG003|STARTED|Overall Study||2
3266267|NCT02624791|4000861|FG004|STARTED|Overall Study||2
3266268|NCT02624791|4000862|FG005|STARTED|Overall Study||2
3266269|NCT02624791|4000857|FG000|COMPLETED|Overall Study||0
3266270|NCT02624791|4000858|FG001|COMPLETED|Overall Study||1
3266271|NCT02624791|4000859|FG002|COMPLETED|Overall Study||2
3266272|NCT02624791|4000860|FG003|COMPLETED|Overall Study||2
3266273|NCT02624791|4000861|FG004|COMPLETED|Overall Study||2
3266274|NCT02624791|4000862|FG005|COMPLETED|Overall Study||2
3266275|NCT02624791|4000857|FG000|NOT COMPLETED|Overall Study||2
3266276|NCT02624791|4000858|FG001|NOT COMPLETED|Overall Study||0
3266277|NCT02624791|4000859|FG002|NOT COMPLETED|Overall Study||0
3266278|NCT02624791|4000860|FG003|NOT COMPLETED|Overall Study||0
3266279|NCT02624791|4000861|FG004|NOT COMPLETED|Overall Study||0
3266280|NCT02624791|4000862|FG005|NOT COMPLETED|Overall Study||0
3266281|NCT02624843|4000869|FG000|STARTED|Overall Study||107
3266282|NCT02624843|4000870|FG001|STARTED|Overall Study||108
3266283|NCT02624843|4000871|FG002|STARTED|Overall Study||24
3266284|NCT02624843|4000869|FG000|COMPLETED|Overall Study||70
3266285|NCT02624843|4000870|FG001|COMPLETED|Overall Study||72
3266286|NCT02624843|4000871|FG002|COMPLETED|Overall Study||16
3266287|NCT02624843|4000869|FG000|NOT COMPLETED|Overall Study||37
3266288|NCT02624843|4000870|FG001|NOT COMPLETED|Overall Study||36
3266289|NCT02624843|4000871|FG002|NOT COMPLETED|Overall Study||8
3266290|NCT02624986|4000887|FG000|STARTED|Overall Study||2
3266291|NCT02624986|4000888|FG001|STARTED|Overall Study||3
3266292|NCT02624986|4000889|FG002|STARTED|Overall Study||2
3266293|NCT02624986|4000890|FG003|STARTED|Overall Study||3
3266294|NCT02624986|4000891|FG004|STARTED|Overall Study||4
3266295|NCT02624986|4000892|FG005|STARTED|Overall Study||2
3266296|NCT02624986|4000893|FG006|STARTED|Overall Study||4
3266297|NCT02624986|4000894|FG007|STARTED|Overall Study||5
3266298|NCT02624986|4000887|FG000|Received Any Study Treatment|Overall Study||1
3266299|NCT02624986|4000888|FG001|Received Any Study Treatment|Overall Study||3
3266300|NCT02624986|4000889|FG002|Received Any Study Treatment|Overall Study||2
3266301|NCT02624986|4000890|FG003|Received Any Study Treatment|Overall Study||3
3266302|NCT02624986|4000891|FG004|Received Any Study Treatment|Overall Study||4
3266303|NCT02624986|4000892|FG005|Received Any Study Treatment|Overall Study||2
3266304|NCT02624986|4000893|FG006|Received Any Study Treatment|Overall Study||4
3266305|NCT02624986|4000894|FG007|Received Any Study Treatment|Overall Study||5
3266306|NCT02624986|4000887|FG000|COMPLETED|Overall Study||0
3266307|NCT02624986|4000888|FG001|COMPLETED|Overall Study||0
3266308|NCT02624986|4000889|FG002|COMPLETED|Overall Study||0
3266309|NCT02624986|4000890|FG003|COMPLETED|Overall Study||0
3266310|NCT02624986|4000891|FG004|COMPLETED|Overall Study||0
3266311|NCT02624986|4000892|FG005|COMPLETED|Overall Study||0
3266312|NCT02624986|4000893|FG006|COMPLETED|Overall Study||0
3266313|NCT02624986|4000894|FG007|COMPLETED|Overall Study||0
3266314|NCT02624986|4000887|FG000|NOT COMPLETED|Overall Study||2
3266315|NCT02624986|4000888|FG001|NOT COMPLETED|Overall Study||3
3266316|NCT02624986|4000889|FG002|NOT COMPLETED|Overall Study||2
3266317|NCT02624986|4000890|FG003|NOT COMPLETED|Overall Study||3
3266318|NCT02624986|4000891|FG004|NOT COMPLETED|Overall Study||4
3266319|NCT02624986|4000892|FG005|NOT COMPLETED|Overall Study||2
3266320|NCT02624986|4000893|FG006|NOT COMPLETED|Overall Study||4
3266321|NCT02624986|4000894|FG007|NOT COMPLETED|Overall Study||5
3266322|NCT02625181|4000919|FG000|STARTED|Overall Study||1518
3266323|NCT02625181|4000920|FG001|STARTED|Overall Study||12809
3266324|NCT02625181|4000921|FG002|STARTED|Overall Study||12707
3266325|NCT02625181|4000919|FG000|COMPLETED|Overall Study||1518
3266326|NCT02625181|4000920|FG001|COMPLETED|Overall Study||12809
3266327|NCT02625181|4000921|FG002|COMPLETED|Overall Study||12707
3266328|NCT02625181|4000919|FG000|NOT COMPLETED|Overall Study||0
3266329|NCT02625181|4000920|FG001|NOT COMPLETED|Overall Study||0
3266330|NCT02625181|4000921|FG002|NOT COMPLETED|Overall Study||0
3266331|NCT02625207|4000931|FG000|STARTED|Part 1 (6 Days)||11
3266332|NCT02625207|4000932|FG001|STARTED|Part 1 (6 Days)||12
3266333|NCT02625207|4000933|FG002|STARTED|Part 1 (6 Days)||12
3266334|NCT02625207|4000934|FG003|STARTED|Part 1 (6 Days)||12
3266335|NCT02625207|4000931|FG000|COMPLETED|Part 1 (6 Days)||11
3266336|NCT02625207|4000932|FG001|COMPLETED|Part 1 (6 Days)||12
3266337|NCT02625207|4000933|FG002|COMPLETED|Part 1 (6 Days)||12
3266338|NCT02625207|4000934|FG003|COMPLETED|Part 1 (6 Days)||12
3266339|NCT02625207|4000931|FG000|NOT COMPLETED|Part 1 (6 Days)||0
3266340|NCT02625207|4000932|FG001|NOT COMPLETED|Part 1 (6 Days)||0
3266341|NCT02625207|4000933|FG002|NOT COMPLETED|Part 1 (6 Days)||0
3266342|NCT02625207|4000934|FG003|NOT COMPLETED|Part 1 (6 Days)||0
3266343|NCT02625207|4000931|FG000|STARTED|Part 2 (11 Days)||11
3266344|NCT02625207|4000932|FG001|STARTED|Part 2 (11 Days)|Part 2 was conducted only in Cohorts 1 and 3, as pre-specified in protocol.|0
3266345|NCT02625207|4000933|FG002|STARTED|Part 2 (11 Days)||12
3266346|NCT02625207|4000934|FG003|STARTED|Part 2 (11 Days)|Part 2 was conducted only in Cohorts 1 and 3, as pre-specified in protocol.|0
3266347|NCT02625207|4000931|FG000|COMPLETED|Part 2 (11 Days)||11
3266348|NCT02625207|4000932|FG001|COMPLETED|Part 2 (11 Days)||0
3266349|NCT02625207|4000933|FG002|COMPLETED|Part 2 (11 Days)||12
3266350|NCT02625207|4000934|FG003|COMPLETED|Part 2 (11 Days)||0
3266351|NCT02625207|4000931|FG000|NOT COMPLETED|Part 2 (11 Days)||0
3266352|NCT02625207|4000932|FG001|NOT COMPLETED|Part 2 (11 Days)||0
3266353|NCT02625207|4000933|FG002|NOT COMPLETED|Part 2 (11 Days)||0
3266354|NCT02625207|4000934|FG003|NOT COMPLETED|Part 2 (11 Days)||0
3266355|NCT02625220|4000950|FG000|STARTED|Overall Study||170
3266356|NCT02625220|4000950|FG000|COMPLETED|Overall Study||163
3266357|NCT02625220|4000950|FG000|NOT COMPLETED|Overall Study||7
3266358|NCT02625233|4000956|FG000|STARTED|Overall Study||49
3266359|NCT02625233|4000957|FG001|STARTED|Overall Study||56
3266360|NCT02625233|4000956|FG000|COMPLETED|Overall Study||47
3266361|NCT02625233|4000957|FG001|COMPLETED|Overall Study||56
3266362|NCT02625233|4000956|FG000|NOT COMPLETED|Overall Study||2
3266363|NCT02625233|4000957|FG001|NOT COMPLETED|Overall Study||0
3266364|NCT02625259|4000968|FG000|STARTED|First Intervention (Day 1)||11
3266365|NCT02625259|4000969|FG001|STARTED|First Intervention (Day 1)||9
3266366|NCT02625259|4000970|FG002|STARTED|First Intervention (Day 1)||8
3266367|NCT02625259|4000971|FG003|STARTED|First Intervention (Day 1)||10
3266368|NCT02625259|4000972|FG004|STARTED|First Intervention (Day 1)||16
3266369|NCT02625259|4000968|FG000|COMPLETED|First Intervention (Day 1)||9
3266370|NCT02625259|4000969|FG001|COMPLETED|First Intervention (Day 1)||8
3266371|NCT02625259|4000970|FG002|COMPLETED|First Intervention (Day 1)||7
3375177|NCT01764997|4108140|FG003|STARTED|Run-in Period||0
3375178|NCT01764997|4108141|FG004|STARTED|Run-in Period||0
3375179|NCT01764997|4108137|FG000|COMPLETED|Run-in Period|43 participants proceeded to randomized treatment and 322 proceeded to open-label sub-study.|738
3375180|NCT01764997|4108138|FG001|COMPLETED|Run-in Period||0
3375181|NCT01764997|4108139|FG002|COMPLETED|Run-in Period||0
3375182|NCT01764997|4108140|FG003|COMPLETED|Run-in Period||0
3375183|NCT01764997|4108141|FG004|COMPLETED|Run-in Period||0
3375184|NCT01764997|4108137|FG000|NOT COMPLETED|Run-in Period||38
3375185|NCT01764997|4108138|FG001|NOT COMPLETED|Run-in Period||0
3375186|NCT01764997|4108139|FG002|NOT COMPLETED|Run-in Period||0
3375187|NCT01764997|4108140|FG003|NOT COMPLETED|Run-in Period||0
3375188|NCT01764997|4108141|FG004|NOT COMPLETED|Run-in Period||0
3375189|NCT01764997|4108137|FG000|STARTED|Study Drug Treatment Period||0
3375190|NCT01764997|4108138|FG001|STARTED|Study Drug Treatment Period||17
3375191|NCT01764997|4108139|FG002|STARTED|Study Drug Treatment Period||13
3375192|NCT01764997|4108140|FG003|STARTED|Study Drug Treatment Period||13
3375193|NCT01764997|4108141|FG004|STARTED|Study Drug Treatment Period||322
3375194|NCT01764997|4108137|FG000|COMPLETED|Study Drug Treatment Period||0
3375195|NCT01764997|4108138|FG001|COMPLETED|Study Drug Treatment Period||16
3375196|NCT01764997|4108139|FG002|COMPLETED|Study Drug Treatment Period||13
3375197|NCT01764997|4108140|FG003|COMPLETED|Study Drug Treatment Period||13
3375198|NCT01764997|4108141|FG004|COMPLETED|Study Drug Treatment Period||286
3375199|NCT01764997|4108137|FG000|NOT COMPLETED|Study Drug Treatment Period||0
3375200|NCT01764997|4108138|FG001|NOT COMPLETED|Study Drug Treatment Period||1
3375201|NCT01764997|4108139|FG002|NOT COMPLETED|Study Drug Treatment Period||0
3375202|NCT01764997|4108140|FG003|NOT COMPLETED|Study Drug Treatment Period||0
3266372|NCT02625259|4000971|FG003|COMPLETED|First Intervention (Day 1)||9
3375203|NCT01764997|4108141|FG004|NOT COMPLETED|Study Drug Treatment Period||36
3375204|NCT01760941|4108151|FG000|STARTED|Overall Study||1
3266373|NCT02625259|4000972|FG004|COMPLETED|First Intervention (Day 1)||16
3266374|NCT02625259|4000968|FG000|NOT COMPLETED|First Intervention (Day 1)||2
3266375|NCT02625259|4000969|FG001|NOT COMPLETED|First Intervention (Day 1)||1
3266376|NCT02625259|4000970|FG002|NOT COMPLETED|First Intervention (Day 1)||1
3266377|NCT02625259|4000971|FG003|NOT COMPLETED|First Intervention (Day 1)||1
3266378|NCT02625259|4000972|FG004|NOT COMPLETED|First Intervention (Day 1)||0
3266379|NCT02625259|4000968|FG000|STARTED|Washout (Day 2 to Day 14)||9
3266380|NCT02625259|4000969|FG001|STARTED|Washout (Day 2 to Day 14)||8
3266381|NCT02625259|4000970|FG002|STARTED|Washout (Day 2 to Day 14)||7
3266382|NCT02625259|4000971|FG003|STARTED|Washout (Day 2 to Day 14)||9
3266383|NCT02625259|4000972|FG004|STARTED|Washout (Day 2 to Day 14)||0
3266384|NCT02625259|4000968|FG000|COMPLETED|Washout (Day 2 to Day 14)||9
3266385|NCT02625259|4000969|FG001|COMPLETED|Washout (Day 2 to Day 14)||8
3266386|NCT02625259|4000970|FG002|COMPLETED|Washout (Day 2 to Day 14)||7
3266387|NCT02625259|4000971|FG003|COMPLETED|Washout (Day 2 to Day 14)||9
3266388|NCT02625259|4000972|FG004|COMPLETED|Washout (Day 2 to Day 14)||0
3266389|NCT02625259|4000968|FG000|NOT COMPLETED|Washout (Day 2 to Day 14)||0
3266390|NCT02625259|4000969|FG001|NOT COMPLETED|Washout (Day 2 to Day 14)||0
3266391|NCT02625259|4000970|FG002|NOT COMPLETED|Washout (Day 2 to Day 14)||0
3266392|NCT02625259|4000971|FG003|NOT COMPLETED|Washout (Day 2 to Day 14)||0
3266393|NCT02625259|4000972|FG004|NOT COMPLETED|Washout (Day 2 to Day 14)||0
3266394|NCT02625259|4000968|FG000|STARTED|Second Intervention (Day 15)||9
3266395|NCT02625259|4000969|FG001|STARTED|Second Intervention (Day 15)||8
3266396|NCT02625259|4000970|FG002|STARTED|Second Intervention (Day 15)||7
3266397|NCT02625259|4000971|FG003|STARTED|Second Intervention (Day 15)||9
3266398|NCT02625259|4000972|FG004|STARTED|Second Intervention (Day 15)||0
3266399|NCT02625259|4000968|FG000|COMPLETED|Second Intervention (Day 15)||9
3266400|NCT02625259|4000969|FG001|COMPLETED|Second Intervention (Day 15)||8
3266401|NCT02625259|4000970|FG002|COMPLETED|Second Intervention (Day 15)||7
3266402|NCT02625259|4000971|FG003|COMPLETED|Second Intervention (Day 15)||9
3266403|NCT02625259|4000972|FG004|COMPLETED|Second Intervention (Day 15)||0
3266404|NCT02625259|4000968|FG000|NOT COMPLETED|Second Intervention (Day 15)||0
3266405|NCT02625259|4000969|FG001|NOT COMPLETED|Second Intervention (Day 15)||0
3266406|NCT02625259|4000970|FG002|NOT COMPLETED|Second Intervention (Day 15)||0
3266407|NCT02625259|4000971|FG003|NOT COMPLETED|Second Intervention (Day 15)||0
3266408|NCT02625259|4000972|FG004|NOT COMPLETED|Second Intervention (Day 15)||0
3266409|NCT02625298|4000989|FG000|STARTED|Overall Study||11
3266410|NCT02625298|4000990|FG001|STARTED|Overall Study||13
3266411|NCT02625298|4000989|FG000|COMPLETED|Overall Study||10
3266412|NCT02625298|4000990|FG001|COMPLETED|Overall Study||13
3266413|NCT02625298|4000989|FG000|NOT COMPLETED|Overall Study||1
3266414|NCT02625298|4000990|FG001|NOT COMPLETED|Overall Study||0
3266415|NCT02625324|4000998|FG000|STARTED|30-Day Follow-up for Primary Endpoint|The 30-day primary endpoint was evaluated when 87 subjects completed 30-day follow-up.|87
3266416|NCT02625324|4000998|FG000|COMPLETED|30-Day Follow-up for Primary Endpoint||86
3266417|NCT02625324|4000998|FG000|NOT COMPLETED|30-Day Follow-up for Primary Endpoint||1
3266418|NCT02625324|4000998|FG000|STARTED|30-Day Follow-up for Secondary Endpoint|The 30-day secondary endpoint was evaluated when 100 subjects completed 30-day follow-up.|100
3266419|NCT02625324|4000998|FG000|COMPLETED|30-Day Follow-up for Secondary Endpoint||99
3266420|NCT02625324|4000998|FG000|NOT COMPLETED|30-Day Follow-up for Secondary Endpoint||1
3266421|NCT02625324|4000998|FG000|STARTED|6-Month Follow-up Subject Accountability|Note that 6-month follow up is not mandatory for OUS subjects|99
3266422|NCT02625324|4000998|FG000|COMPLETED|6-Month Follow-up Subject Accountability||91
3266423|NCT02625324|4000998|FG000|NOT COMPLETED|6-Month Follow-up Subject Accountability||8
3266424|NCT02625324|4000998|FG000|STARTED|12-Month Follow-up Secondary Endpoint||91
3266425|NCT02625324|4000998|FG000|COMPLETED|12-Month Follow-up Secondary Endpoint||87
3266426|NCT02625324|4000998|FG000|NOT COMPLETED|12-Month Follow-up Secondary Endpoint||4
3266427|NCT02625324|4000998|FG000|STARTED|24-Month Follow-up Secondary Endpoint||87
3266428|NCT02625324|4000998|FG000|COMPLETED|24-Month Follow-up Secondary Endpoint||52
3375205|NCT01760941|4108151|FG000|COMPLETED|Overall Study||1
3375206|NCT01760941|4108151|FG000|NOT COMPLETED|Overall Study||0
3375207|NCT01769443|4108157|FG000|STARTED|Overall Study||1
3375208|NCT01769443|4108158|FG001|STARTED|Overall Study||1
3375209|NCT01769443|4108157|FG000|COMPLETED|Overall Study||0
3375210|NCT01769443|4108158|FG001|COMPLETED|Overall Study||1
3375211|NCT01769443|4108157|FG000|NOT COMPLETED|Overall Study||1
3375212|NCT01769443|4108158|FG001|NOT COMPLETED|Overall Study||0
3375213|NCT01760889|4108168|FG000|STARTED|Overall Study||0
3375214|NCT01760889|4108169|FG001|STARTED|Overall Study||0
3375215|NCT01760889|4108170|FG002|STARTED|Overall Study||0
3375216|NCT01760889|4108168|FG000|COMPLETED|Overall Study||0
3375217|NCT01760889|4108169|FG001|COMPLETED|Overall Study||0
3375218|NCT01760889|4108170|FG002|COMPLETED|Overall Study||0
3375219|NCT01760889|4108168|FG000|NOT COMPLETED|Overall Study||0
3375220|NCT01760889|4108169|FG001|NOT COMPLETED|Overall Study||0
3375221|NCT01760889|4108170|FG002|NOT COMPLETED|Overall Study||0
3375222|NCT01749826|4108180|FG000|STARTED|Overall Study||20
3375223|NCT01749826|4108181|FG001|STARTED|Overall Study||0
3375224|NCT01749826|4108180|FG000|COMPLETED|Overall Study||0
3375225|NCT01749826|4108181|FG001|COMPLETED|Overall Study||0
3375226|NCT01749826|4108180|FG000|NOT COMPLETED|Overall Study||20
3375227|NCT01749826|4108181|FG001|NOT COMPLETED|Overall Study||0
3375228|NCT01756586|4108189|FG000|STARTED|Overall Study||2
3375229|NCT01756586|4108190|FG001|STARTED|Overall Study||2
3266429|NCT02625324|4000998|FG000|NOT COMPLETED|24-Month Follow-up Secondary Endpoint||35
3266430|NCT02625402|4001010|FG000|STARTED|Overall Study||42
3266431|NCT02625402|4001011|FG001|STARTED|Overall Study||37
3266432|NCT02625402|4001010|FG000|COMPLETED|Overall Study||33
3266433|NCT02625402|4001011|FG001|COMPLETED|Overall Study||25
3266434|NCT02625402|4001010|FG000|NOT COMPLETED|Overall Study||9
3266435|NCT02625402|4001011|FG001|NOT COMPLETED|Overall Study||12
3266436|NCT02625428|4001019|FG000|STARTED|Overall Study||20
3266437|NCT02625428|4001020|FG001|STARTED|Overall Study||20
3266438|NCT02625428|4001019|FG000|COMPLETED|Overall Study||20
3266439|NCT02625428|4001020|FG001|COMPLETED|Overall Study||20
3266440|NCT02625428|4001019|FG000|NOT COMPLETED|Overall Study||0
3266441|NCT02625428|4001020|FG001|NOT COMPLETED|Overall Study||0
3266442|NCT02625545|4001026|FG000|STARTED|Overall Study||45
3266443|NCT02625545|4001026|FG000|3 Month|Overall Study||45
3266444|NCT02625545|4001026|FG000|6 Month|Overall Study||45
3266445|NCT02625545|4001026|FG000|12 Month|Overall Study||45
3266446|NCT02625545|4001026|FG000|COMPLETED|Overall Study||45
3266447|NCT02625545|4001026|FG000|NOT COMPLETED|Overall Study||0
3266448|NCT02625571|4001030|FG000|STARTED|Overall Study||13
3266449|NCT02625571|4001030|FG000|COMPLETED|Overall Study||10
3266450|NCT02625571|4001030|FG000|NOT COMPLETED|Overall Study||3
3266451|NCT02625610|4001036|FG000|STARTED|Overall Study||250
3266452|NCT02625610|4001037|FG001|STARTED|Overall Study||249
3266453|NCT02625610|4001036|FG000|Safety-Maintenance Analysis Set|Overall Study||238
3266454|NCT02625610|4001037|FG001|Safety-Maintenance Analysis Set|Overall Study||243
3266455|NCT02625610|4001036|FG000|COMPLETED|Overall Study||216
3266456|NCT02625610|4001037|FG001|COMPLETED|Overall Study||195
3266457|NCT02625610|4001036|FG000|NOT COMPLETED|Overall Study||34
3266458|NCT02625610|4001037|FG001|NOT COMPLETED|Overall Study||54
3266459|NCT02625623|4001045|FG000|STARTED|Overall Study||186
3266460|NCT02625623|4001046|FG001|STARTED|Overall Study||185
3266461|NCT02625623|4001045|FG000|Treated|Overall Study||177
3266462|NCT02625623|4001046|FG001|Treated|Overall Study||184
3266463|NCT02625623|4001045|FG000|COMPLETED|Overall Study||177
3266464|NCT02625623|4001046|FG001|COMPLETED|Overall Study||184
3266465|NCT02625623|4001045|FG000|NOT COMPLETED|Overall Study||9
3266466|NCT02625623|4001046|FG001|NOT COMPLETED|Overall Study||1
3266467|NCT02625844|4001054|FG000|STARTED|Overall Study||110
3266468|NCT02625844|4001054|FG000|COMPLETED|Overall Study||110
3266469|NCT02625844|4001054|FG000|NOT COMPLETED|Overall Study||0
3266470|NCT02625909|4001060|FG000|STARTED|Overall Study||93
3266471|NCT02625909|4001061|FG001|STARTED|Overall Study||95
3266472|NCT02625909|4001060|FG000|COMPLETED|Overall Study||76
3266473|NCT02625909|4001061|FG001|COMPLETED|Overall Study||86
3266474|NCT02625909|4001060|FG000|NOT COMPLETED|Overall Study||17
3266475|NCT02625909|4001061|FG001|NOT COMPLETED|Overall Study||9
3266476|NCT02625922|4001069|FG000|STARTED|Overall Study||14
3266477|NCT02625922|4001070|FG001|STARTED|Overall Study||12
3266478|NCT02625922|4001069|FG000|Completed Treatment Period 1|Overall Study||12
3266479|NCT02625922|4001070|FG001|Completed Treatment Period 1|Overall Study||10
3266480|NCT02625922|4001069|FG000|Completed Treatment Period 2|Overall Study||11
3266481|NCT02625922|4001070|FG001|Completed Treatment Period 2|Overall Study||8
3266482|NCT02625922|4001069|FG000|COMPLETED|Overall Study||12
3266483|NCT02625922|4001070|FG001|COMPLETED|Overall Study||10
3266484|NCT02625922|4001069|FG000|NOT COMPLETED|Overall Study||2
3266485|NCT02625922|4001070|FG001|NOT COMPLETED|Overall Study||2
3266486|NCT02625974|4001081|FG000|STARTED|Overall Study||219
3266487|NCT02625974|4001082|FG001|STARTED|Overall Study||111
3266488|NCT02625974|4001081|FG000|Received Treatment|Overall Study||219
3266489|NCT02625974|4001082|FG001|Received Treatment|Overall Study||111
3266490|NCT02625974|4001081|FG000|COMPLETED|Overall Study||203
3266491|NCT02625974|4001082|FG001|COMPLETED|Overall Study||105
3266492|NCT02625974|4001081|FG000|NOT COMPLETED|Overall Study||16
3266493|NCT02625974|4001082|FG001|NOT COMPLETED|Overall Study||6
3266494|NCT02626000|4001124|FG000|STARTED|Overall Study||36
3266495|NCT02626000|4001124|FG000|COMPLETED|Overall Study||6
3266496|NCT02626000|4001124|FG000|NOT COMPLETED|Overall Study||30
3266497|NCT02626026|4001135|FG000|STARTED|Overall Study||8
3266498|NCT02626026|4001136|FG001|STARTED|Overall Study||2
3266499|NCT02626026|4001137|FG002|STARTED|Overall Study||8
3266500|NCT02626026|4001138|FG003|STARTED|Overall Study||2
3266501|NCT02626026|4001139|FG004|STARTED|Overall Study||17
3266502|NCT02626026|4001140|FG005|STARTED|Overall Study||5
3266503|NCT02626026|4001135|FG000|COMPLETED|Overall Study||8
3266504|NCT02626026|4001136|FG001|COMPLETED|Overall Study||2
3266505|NCT02626026|4001137|FG002|COMPLETED|Overall Study||8
3266506|NCT02626026|4001138|FG003|COMPLETED|Overall Study||2
3266507|NCT02626026|4001139|FG004|COMPLETED|Overall Study||16
3266508|NCT02626026|4001140|FG005|COMPLETED|Overall Study||5
3266509|NCT02626026|4001135|FG000|NOT COMPLETED|Overall Study||0
3266510|NCT02626026|4001136|FG001|NOT COMPLETED|Overall Study||0
3266511|NCT02626026|4001137|FG002|NOT COMPLETED|Overall Study||0
3266512|NCT02626026|4001138|FG003|NOT COMPLETED|Overall Study||0
3266513|NCT02626026|4001139|FG004|NOT COMPLETED|Overall Study||1
3266514|NCT02626026|4001140|FG005|NOT COMPLETED|Overall Study||0
3266515|NCT02626156|4001160|FG000|STARTED|Baseline (Visit 1 to Visit 2)||29
3266516|NCT02626156|4001161|FG001|STARTED|Baseline (Visit 1 to Visit 2)||29
3266517|NCT02626156|4001162|FG002|STARTED|Baseline (Visit 1 to Visit 2)||42
3266518|NCT02626156|4001163|FG003|STARTED|Baseline (Visit 1 to Visit 2)||40
3266519|NCT02626156|4001160|FG000|COMPLETED|Baseline (Visit 1 to Visit 2)||23
3266520|NCT02626156|4001161|FG001|COMPLETED|Baseline (Visit 1 to Visit 2)||22
3266521|NCT02626156|4001162|FG002|COMPLETED|Baseline (Visit 1 to Visit 2)||37
3266522|NCT02626156|4001163|FG003|COMPLETED|Baseline (Visit 1 to Visit 2)||35
3266523|NCT02626156|4001160|FG000|NOT COMPLETED|Baseline (Visit 1 to Visit 2)||6
3266524|NCT02626156|4001161|FG001|NOT COMPLETED|Baseline (Visit 1 to Visit 2)||7
3266525|NCT02626156|4001162|FG002|NOT COMPLETED|Baseline (Visit 1 to Visit 2)||5
3266526|NCT02626156|4001163|FG003|NOT COMPLETED|Baseline (Visit 1 to Visit 2)||5
3266527|NCT02626156|4001160|FG000|STARTED|Study Visit 3||23
3266528|NCT02626156|4001161|FG001|STARTED|Study Visit 3||22
3266529|NCT02626156|4001162|FG002|STARTED|Study Visit 3||37
3266530|NCT02626156|4001163|FG003|STARTED|Study Visit 3||35
3266531|NCT02626156|4001160|FG000|COMPLETED|Study Visit 3||15
3266532|NCT02626156|4001161|FG001|COMPLETED|Study Visit 3||17
3266533|NCT02626156|4001162|FG002|COMPLETED|Study Visit 3||33
3266534|NCT02626156|4001163|FG003|COMPLETED|Study Visit 3||33
3266535|NCT02626156|4001160|FG000|NOT COMPLETED|Study Visit 3||8
3266536|NCT02626156|4001161|FG001|NOT COMPLETED|Study Visit 3||5
3266537|NCT02626156|4001162|FG002|NOT COMPLETED|Study Visit 3||4
3266538|NCT02626156|4001163|FG003|NOT COMPLETED|Study Visit 3||2
3266539|NCT02626156|4001160|FG000|STARTED|Study Visit 4||15
3266540|NCT02626156|4001161|FG001|STARTED|Study Visit 4||17
3266541|NCT02626156|4001162|FG002|STARTED|Study Visit 4||33
3266542|NCT02626156|4001163|FG003|STARTED|Study Visit 4||33
3266543|NCT02626156|4001160|FG000|COMPLETED|Study Visit 4||12
3266544|NCT02626156|4001161|FG001|COMPLETED|Study Visit 4||15
3266545|NCT02626156|4001162|FG002|COMPLETED|Study Visit 4||24
3266546|NCT02626156|4001163|FG003|COMPLETED|Study Visit 4||28
3266547|NCT02626156|4001160|FG000|NOT COMPLETED|Study Visit 4||3
3266548|NCT02626156|4001161|FG001|NOT COMPLETED|Study Visit 4||2
3266549|NCT02626156|4001162|FG002|NOT COMPLETED|Study Visit 4||9
3266550|NCT02626156|4001163|FG003|NOT COMPLETED|Study Visit 4||5
3266551|NCT02626182|4001181|FG000|STARTED|Overall Study||11
3266552|NCT02626182|4001182|FG001|STARTED|Overall Study||3
3266553|NCT02626182|4001181|FG000|COMPLETED|Overall Study||9
3266554|NCT02626182|4001182|FG001|COMPLETED|Overall Study||3
3266555|NCT02626182|4001181|FG000|NOT COMPLETED|Overall Study||2
3266556|NCT02626182|4001182|FG001|NOT COMPLETED|Overall Study||0
3266557|NCT02626611|4001191|FG000|STARTED|Overall Study||20
3266558|NCT02626611|4001192|FG001|STARTED|Overall Study||21
3266559|NCT02626611|4001193|FG002|STARTED|Overall Study||19
3266560|NCT02626611|4001191|FG000|COMPLETED|Overall Study||16
3266561|NCT02626611|4001192|FG001|COMPLETED|Overall Study||20
3266562|NCT02626611|4001193|FG002|COMPLETED|Overall Study||16
3266563|NCT02626611|4001191|FG000|NOT COMPLETED|Overall Study||4
3266564|NCT02626611|4001192|FG001|NOT COMPLETED|Overall Study||1
3375230|NCT01756586|4108189|FG000|COMPLETED|Overall Study||0
3375231|NCT01756586|4108190|FG001|COMPLETED|Overall Study||0
3375232|NCT01756586|4108189|FG000|NOT COMPLETED|Overall Study||2
3375233|NCT01756586|4108190|FG001|NOT COMPLETED|Overall Study||2
3375234|NCT01754987|4108198|FG000|STARTED|Overall Study||5
3375235|NCT01754987|4108199|FG001|STARTED|Overall Study||0
3375236|NCT01754987|4108198|FG000|COMPLETED|Overall Study||5
3375237|NCT01754987|4108199|FG001|COMPLETED|Overall Study||0
3375238|NCT01754987|4108198|FG000|NOT COMPLETED|Overall Study||0
3375239|NCT01754987|4108199|FG001|NOT COMPLETED|Overall Study||0
3375240|NCT01756560|4108207|FG000|STARTED|Overall Study||2
3375241|NCT01756560|4108208|FG001|STARTED|Overall Study||0
3375242|NCT01756560|4108207|FG000|COMPLETED|Overall Study||0
3375243|NCT01756560|4108208|FG001|COMPLETED|Overall Study||0
3375244|NCT01756560|4108207|FG000|NOT COMPLETED|Overall Study||2
3375245|NCT01756560|4108208|FG001|NOT COMPLETED|Overall Study||0
3375246|NCT01756573|4108217|FG000|STARTED|Overall Study||3
3375247|NCT01756573|4108218|FG001|STARTED|Overall Study||1
3375248|NCT01756573|4108219|FG002|STARTED|Overall Study||1
3375249|NCT01756573|4108217|FG000|COMPLETED|Overall Study||3
3375250|NCT01756573|4108218|FG001|COMPLETED|Overall Study||1
3375251|NCT01756573|4108219|FG002|COMPLETED|Overall Study||1
3375252|NCT01756573|4108217|FG000|NOT COMPLETED|Overall Study||0
3375253|NCT01756573|4108218|FG001|NOT COMPLETED|Overall Study||0
3375254|NCT01756573|4108219|FG002|NOT COMPLETED|Overall Study||0
3375255|NCT01745913|4108229|FG000|STARTED|Overall Study||1
3375256|NCT01745913|4108230|FG001|STARTED|Overall Study||1
3375257|NCT01745913|4108229|FG000|COMPLETED|Overall Study||0
3375258|NCT01745913|4108230|FG001|COMPLETED|Overall Study||0
3375259|NCT01745913|4108229|FG000|NOT COMPLETED|Overall Study||1
3375260|NCT01745913|4108230|FG001|NOT COMPLETED|Overall Study||1
3375261|NCT01752023|4108242|FG000|STARTED|Overall Study||2
3375262|NCT01752023|4108243|FG001|STARTED|Overall Study||1
3375263|NCT01752023|4108242|FG000|COMPLETED|Overall Study||0
3375264|NCT01752023|4108243|FG001|COMPLETED|Overall Study||0
3375265|NCT01752023|4108242|FG000|NOT COMPLETED|Overall Study||2
3375266|NCT01752023|4108243|FG001|NOT COMPLETED|Overall Study||1
3375267|NCT01740154|4108253|FG000|STARTED|Overall Study||13
3375268|NCT01740154|4108253|FG000|COMPLETED|Overall Study||12
3375269|NCT01740154|4108253|FG000|NOT COMPLETED|Overall Study||1
3375270|NCT01748890|4108257|FG000|STARTED|Overall Study||4
3375271|NCT01748890|4108257|FG000|COMPLETED|Overall Study|Insufficient recruitment for analysis|0
3375272|NCT01748890|4108257|FG000|NOT COMPLETED|Overall Study||4
3375273|NCT01748162|4108263|FG000|STARTED|Overall Study||5
3375274|NCT01748162|4108264|FG001|STARTED|Overall Study||5
3375275|NCT01748162|4108263|FG000|Started 6 Month Initial Treatment Plan|Overall Study||2
3266565|NCT02626611|4001193|FG002|NOT COMPLETED|Overall Study||3
3266566|NCT02626780|4001208|FG000|STARTED|Overall Study||7
3266567|NCT02626780|4001208|FG000|Withdrew From Study|Overall Study||3
3266568|NCT02626780|4001208|FG000|COMPLETED|Overall Study||4
3266569|NCT02626780|4001208|FG000|NOT COMPLETED|Overall Study||3
3266570|NCT02626819|4001214|FG000|STARTED|Overall Study||22
3266571|NCT02626819|4001215|FG001|STARTED|Overall Study||23
3266572|NCT02626819|4001214|FG000|COMPLETED|Overall Study||18
3266573|NCT02626819|4001215|FG001|COMPLETED|Overall Study||20
3266574|NCT02626819|4001214|FG000|NOT COMPLETED|Overall Study||4
3266575|NCT02626819|4001215|FG001|NOT COMPLETED|Overall Study||3
3266576|NCT02626910|4001225|FG000|STARTED|Overall Study||23
3266577|NCT02626910|4001226|FG001|STARTED|Overall Study||10
3266578|NCT02626910|4001227|FG002|STARTED|Overall Study||6
3266579|NCT02626910|4001228|FG003|STARTED|Overall Study||10
3266580|NCT02626910|4001225|FG000|COMPLETED|Overall Study||23
3266581|NCT02626910|4001226|FG001|COMPLETED|Overall Study||10
3266582|NCT02626910|4001227|FG002|COMPLETED|Overall Study||6
3266583|NCT02626910|4001228|FG003|COMPLETED|Overall Study||10
3266584|NCT02626910|4001225|FG000|NOT COMPLETED|Overall Study||0
3266585|NCT02626910|4001226|FG001|NOT COMPLETED|Overall Study||0
3266586|NCT02626910|4001227|FG002|NOT COMPLETED|Overall Study||0
3266587|NCT02626910|4001228|FG003|NOT COMPLETED|Overall Study||0
3266588|NCT02627001|4001240|FG000|STARTED|Overall Study||13
3266589|NCT02627001|4001241|FG001|STARTED|Overall Study||14
3266590|NCT02627001|4001240|FG000|COMPLETED|Overall Study||13
3266591|NCT02627001|4001241|FG001|COMPLETED|Overall Study||14
3266592|NCT02627001|4001240|FG000|NOT COMPLETED|Overall Study||0
3266593|NCT02627001|4001241|FG001|NOT COMPLETED|Overall Study||0
3266594|NCT02627118|4001247|FG000|STARTED|Overall Study||10
3266595|NCT02627118|4001247|FG000|COMPLETED|Overall Study||10
3266596|NCT02627118|4001247|FG000|NOT COMPLETED|Overall Study||0
3266597|NCT02627144|4001252|FG000|STARTED|Overall Study||365
3266598|NCT02627144|4001252|FG000|Treated|Overall Study||359
3266599|NCT02627144|4001252|FG000|COMPLETED|Overall Study||0
3266600|NCT02627144|4001252|FG000|NOT COMPLETED|Overall Study||365
3266601|NCT02627495|4001256|FG000|STARTED|Overall Study||9
3266602|NCT02627495|4001256|FG000|COMPLETED|Overall Study||5
3266603|NCT02627495|4001256|FG000|NOT COMPLETED|Overall Study||4
3266604|NCT02627677|4001263|FG000|STARTED|Overall Study||11
3266605|NCT02627677|4001264|FG001|STARTED|Overall Study||21
3266606|NCT02627677|4001265|FG002|STARTED|Overall Study||12
3266607|NCT02627677|4001263|FG000|COMPLETED|Overall Study||0
3266608|NCT02627677|4001264|FG001|COMPLETED|Overall Study||0
3266609|NCT02627677|4001265|FG002|COMPLETED|Overall Study||0
3266610|NCT02627677|4001263|FG000|NOT COMPLETED|Overall Study||11
3266611|NCT02627677|4001264|FG001|NOT COMPLETED|Overall Study||21
3266612|NCT02627677|4001265|FG002|NOT COMPLETED|Overall Study||12
3266613|NCT02627794|4001274|FG000|STARTED|Overall Study||3
3266614|NCT02627794|4001274|FG000|COMPLETED|Overall Study||3
3266615|NCT02627794|4001274|FG000|NOT COMPLETED|Overall Study||0
3266616|NCT02627924|4001281|FG000|STARTED|Overall Study||91
3266617|NCT02627924|4001281|FG000|COMPLETED|Overall Study||79
3266618|NCT02627924|4001281|FG000|NOT COMPLETED|Overall Study||12
3266619|NCT02628028|4001296|FG000|STARTED|Dosing Period||9
3266620|NCT02628028|4001297|FG001|STARTED|Dosing Period||9
3266621|NCT02628028|4001298|FG002|STARTED|Dosing Period||10
3266622|NCT02628028|4001299|FG003|STARTED|Dosing Period||8
3266623|NCT02628028|4001300|FG004|STARTED|Dosing Period||62
3266624|NCT02628028|4001301|FG005|STARTED|Dosing Period||63
3266625|NCT02628028|4001302|FG006|STARTED|Dosing Period||62
3266626|NCT02628028|4001303|FG007|STARTED|Dosing Period||63
3266627|NCT02628028|4001296|FG000|Received at Least 1dose of Study Drug|Dosing Period||9
3266628|NCT02628028|4001297|FG001|Received at Least 1dose of Study Drug|Dosing Period||9
3266629|NCT02628028|4001298|FG002|Received at Least 1dose of Study Drug|Dosing Period||10
3266630|NCT02628028|4001299|FG003|Received at Least 1dose of Study Drug|Dosing Period||8
3266631|NCT02628028|4001300|FG004|Received at Least 1dose of Study Drug|Dosing Period||62
3266632|NCT02628028|4001301|FG005|Received at Least 1dose of Study Drug|Dosing Period||63
3266633|NCT02628028|4001302|FG006|Received at Least 1dose of Study Drug|Dosing Period||62
3266634|NCT02628028|4001303|FG007|Received at Least 1dose of Study Drug|Dosing Period||63
3266635|NCT02628028|4001296|FG000|COMPLETED|Dosing Period||9
3266636|NCT02628028|4001297|FG001|COMPLETED|Dosing Period||9
3266637|NCT02628028|4001298|FG002|COMPLETED|Dosing Period||9
3266638|NCT02628028|4001299|FG003|COMPLETED|Dosing Period||8
3266639|NCT02628028|4001300|FG004|COMPLETED|Dosing Period||46
3266640|NCT02628028|4001301|FG005|COMPLETED|Dosing Period||49
3266641|NCT02628028|4001302|FG006|COMPLETED|Dosing Period||46
3266642|NCT02628028|4001303|FG007|COMPLETED|Dosing Period||48
3266643|NCT02628028|4001296|FG000|NOT COMPLETED|Dosing Period||0
3266644|NCT02628028|4001297|FG001|NOT COMPLETED|Dosing Period||0
3266645|NCT02628028|4001298|FG002|NOT COMPLETED|Dosing Period||1
3266646|NCT02628028|4001299|FG003|NOT COMPLETED|Dosing Period||0
3266647|NCT02628028|4001300|FG004|NOT COMPLETED|Dosing Period||16
3266648|NCT02628028|4001301|FG005|NOT COMPLETED|Dosing Period||14
3266649|NCT02628028|4001302|FG006|NOT COMPLETED|Dosing Period||16
3266650|NCT02628028|4001303|FG007|NOT COMPLETED|Dosing Period||15
3266651|NCT02628028|4001296|FG000|STARTED|Long-term Extension (LTE) Period|LTE period included participants who completed Part B of the study.|0
3266652|NCT02628028|4001297|FG001|STARTED|Long-term Extension (LTE) Period|LTE period included participants who completed Part B of the study.|0
3266653|NCT02628028|4001298|FG002|STARTED|Long-term Extension (LTE) Period|LTE period included participants who completed Part B of the study.|0
3266654|NCT02628028|4001299|FG003|STARTED|Long-term Extension (LTE) Period|LTE period included participants who completed Part B of the study.|0
3266655|NCT02628028|4001300|FG004|STARTED|Long-term Extension (LTE) Period|Part B LTE was optional;42 participants completed part B placebo period,re-randomized to LTE period.|0
3266656|NCT02628028|4001301|FG005|STARTED|Long-term Extension (LTE) Period|Part B LTE was optional;14 participants completed part B placebo period,re-randomized to LTE period.|61
3266657|NCT02628028|4001302|FG006|STARTED|Long-term Extension (LTE) Period|Part B LTE was optional;14 participants completed part B placebo period,re-randomized to LTE period.|58
3266658|NCT02628028|4001303|FG007|STARTED|Long-term Extension (LTE) Period|Part B LTE was optional;14 participants completed part B placebo period,re-randomized to LTE period.|61
3266659|NCT02628028|4001296|FG000|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||0
3266660|NCT02628028|4001297|FG001|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||0
3266661|NCT02628028|4001298|FG002|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||0
3266662|NCT02628028|4001299|FG003|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||0
3266663|NCT02628028|4001300|FG004|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||0
3266664|NCT02628028|4001301|FG005|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||14
3266665|NCT02628028|4001302|FG006|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||14
3266666|NCT02628028|4001303|FG007|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||14
3266667|NCT02628028|4001296|FG000|COMPLETED|Long-term Extension (LTE) Period||0
3266668|NCT02628028|4001297|FG001|COMPLETED|Long-term Extension (LTE) Period||0
3266669|NCT02628028|4001298|FG002|COMPLETED|Long-term Extension (LTE) Period||0
3266670|NCT02628028|4001299|FG003|COMPLETED|Long-term Extension (LTE) Period||0
3266671|NCT02628028|4001300|FG004|COMPLETED|Long-term Extension (LTE) Period||0
3266672|NCT02628028|4001301|FG005|COMPLETED|Long-term Extension (LTE) Period||1
3266673|NCT02628028|4001302|FG006|COMPLETED|Long-term Extension (LTE) Period||0
3266674|NCT02628028|4001303|FG007|COMPLETED|Long-term Extension (LTE) Period||0
3266675|NCT02628028|4001296|FG000|NOT COMPLETED|Long-term Extension (LTE) Period||0
3266676|NCT02628028|4001297|FG001|NOT COMPLETED|Long-term Extension (LTE) Period||0
3266677|NCT02628028|4001298|FG002|NOT COMPLETED|Long-term Extension (LTE) Period||0
3266678|NCT02628028|4001299|FG003|NOT COMPLETED|Long-term Extension (LTE) Period||0
3266679|NCT02628028|4001300|FG004|NOT COMPLETED|Long-term Extension (LTE) Period||0
3266680|NCT02628028|4001301|FG005|NOT COMPLETED|Long-term Extension (LTE) Period||60
3266681|NCT02628028|4001302|FG006|NOT COMPLETED|Long-term Extension (LTE) Period||58
3266682|NCT02628028|4001303|FG007|NOT COMPLETED|Long-term Extension (LTE) Period||61
3266683|NCT02628093|4001327|FG000|STARTED|Overall Study||31
3266684|NCT02628093|4001328|FG001|STARTED|Overall Study||29
3266685|NCT02628093|4001327|FG000|COMPLETED|Overall Study||31
3266686|NCT02628093|4001328|FG001|COMPLETED|Overall Study||29
3266687|NCT02628093|4001327|FG000|NOT COMPLETED|Overall Study||0
3266688|NCT02628093|4001328|FG001|NOT COMPLETED|Overall Study||0
3266689|NCT02628106|4001334|FG000|STARTED|Overall Study||21
3266690|NCT02628106|4001334|FG000|COMPLETED|Overall Study||21
3266691|NCT02628106|4001334|FG000|NOT COMPLETED|Overall Study||0
3375276|NCT01748162|4108264|FG001|Started 6 Month Initial Treatment Plan|Overall Study||2
3375277|NCT01748162|4108263|FG000|Completed 6 Month Initial Treatment|Overall Study||0
3375278|NCT01748162|4108264|FG001|Completed 6 Month Initial Treatment|Overall Study||0
3375279|NCT01748162|4108263|FG000|Started 6 Month Followup|Overall Study|No participants in either arm had additional croup episodes in the first 6 months; study terminated.|0
3375280|NCT01748162|4108264|FG001|Started 6 Month Followup|Overall Study|No participants in either arm had additional croup episodes in the first 6 months; study terminated.|0
3375281|NCT01748162|4108263|FG000|COMPLETED|Overall Study||0
3375282|NCT01748162|4108264|FG001|COMPLETED|Overall Study||0
3375283|NCT01748162|4108263|FG000|NOT COMPLETED|Overall Study||5
3375284|NCT01748162|4108264|FG001|NOT COMPLETED|Overall Study||5
3375285|NCT01738698|4108274|FG000|STARTED|Overall Study||0
3375286|NCT01738698|4108275|FG001|STARTED|Overall Study||0
3375287|NCT01738698|4108276|FG002|STARTED|Overall Study||0
3375288|NCT01738698|4108277|FG003|STARTED|Overall Study||0
3375289|NCT01738698|4108274|FG000|COMPLETED|Overall Study||0
3375290|NCT01738698|4108275|FG001|COMPLETED|Overall Study||0
3375291|NCT01738698|4108276|FG002|COMPLETED|Overall Study||0
3375292|NCT01738698|4108277|FG003|COMPLETED|Overall Study||0
3375293|NCT01738698|4108274|FG000|NOT COMPLETED|Overall Study||0
3375294|NCT01738698|4108275|FG001|NOT COMPLETED|Overall Study||0
3375295|NCT01738698|4108276|FG002|NOT COMPLETED|Overall Study||0
3375296|NCT01738698|4108277|FG003|NOT COMPLETED|Overall Study||0
3375297|NCT01732926|4108289|FG000|STARTED|Overall Study||320
3375298|NCT01732926|4108290|FG001|STARTED|Overall Study||155
3375299|NCT01732926|4108289|FG000|COMPLETED|Overall Study||53
3375300|NCT01732926|4108290|FG001|COMPLETED|Overall Study||45
3375301|NCT01732926|4108289|FG000|NOT COMPLETED|Overall Study||267
3375302|NCT01732926|4108290|FG001|NOT COMPLETED|Overall Study||110
3375303|NCT01727167|4108298|FG000|STARTED|Overall Study||1
3375304|NCT01727167|4108299|FG001|STARTED|Overall Study||0
3375305|NCT01727167|4108298|FG000|COMPLETED|Overall Study||1
3375306|NCT01727167|4108299|FG001|COMPLETED|Overall Study||0
3375307|NCT01727167|4108298|FG000|NOT COMPLETED|Overall Study||0
3375308|NCT01727167|4108299|FG001|NOT COMPLETED|Overall Study||0
3375309|NCT01732913|4108307|FG000|STARTED|Overall Study||198
3375310|NCT01732913|4108308|FG001|STARTED|Overall Study||97
3375311|NCT01732913|4108307|FG000|COMPLETED|Overall Study||42
3266692|NCT02628223|4001340|FG000|STARTED|Overall Study||38
3266693|NCT02628223|4001341|FG001|STARTED|Overall Study||38
3266694|NCT02628223|4001340|FG000|COMPLETED|Overall Study||38
3266695|NCT02628223|4001341|FG001|COMPLETED|Overall Study||36
3266696|NCT02628223|4001340|FG000|NOT COMPLETED|Overall Study||0
3266697|NCT02628223|4001341|FG001|NOT COMPLETED|Overall Study||2
3266698|NCT02628236|4001347|FG000|STARTED|Overall Study||14
3266699|NCT02628236|4001347|FG000|COMPLETED|Overall Study||14
3266700|NCT02628236|4001347|FG000|NOT COMPLETED|Overall Study||0
3266701|NCT02628418|4001353|FG000|STARTED|Overall Study||15
3266702|NCT02628418|4001354|FG001|STARTED|Overall Study||15
3266703|NCT02628418|4001353|FG000|COMPLETED|Overall Study||14
3266704|NCT02628418|4001354|FG001|COMPLETED|Overall Study||13
3266705|NCT02628418|4001353|FG000|NOT COMPLETED|Overall Study||1
3266706|NCT02628418|4001354|FG001|NOT COMPLETED|Overall Study||2
3266707|NCT02628444|4001369|FG000|STARTED|Stage-I(24M:12M Treatment+12M Follow-up)||350
3266708|NCT02628444|4001370|FG001|STARTED|Stage-I(24M:12M Treatment+12M Follow-up)||348
3266709|NCT02628444|4001371|FG002|STARTED|Stage-I(24M:12M Treatment+12M Follow-up)||352
3266710|NCT02628444|4001372|FG003|STARTED|Stage-I(24M:12M Treatment+12M Follow-up)||0
3266711|NCT02628444|4001373|FG004|STARTED|Stage-I(24M:12M Treatment+12M Follow-up)||0
3266712|NCT02628444|4001374|FG005|STARTED|Stage-I(24M:12M Treatment+12M Follow-up)||0
3266713|NCT02628444|4001375|FG006|STARTED|Stage-I(24M:12M Treatment+12M Follow-up)||0
3266714|NCT02628444|4001376|FG007|STARTED|Stage-I(24M:12M Treatment+12M Follow-up)||0
3266715|NCT02628444|4001377|FG008|STARTED|Stage-I(24M:12M Treatment+12M Follow-up)||0
3266716|NCT02628444|4001369|FG000|Vaccinated|Stage-I(24M:12M Treatment+12M Follow-up)||348
3266717|NCT02628444|4001370|FG001|Vaccinated|Stage-I(24M:12M Treatment+12M Follow-up)||348
3266718|NCT02628444|4001371|FG002|Vaccinated|Stage-I(24M:12M Treatment+12M Follow-up)||352
3266719|NCT02628444|4001372|FG003|Vaccinated|Stage-I(24M:12M Treatment+12M Follow-up)||0
3266720|NCT02628444|4001373|FG004|Vaccinated|Stage-I(24M:12M Treatment+12M Follow-up)||0
3266721|NCT02628444|4001374|FG005|Vaccinated|Stage-I(24M:12M Treatment+12M Follow-up)||0
3266722|NCT02628444|4001375|FG006|Vaccinated|Stage-I(24M:12M Treatment+12M Follow-up)||0
3266723|NCT02628444|4001376|FG007|Vaccinated|Stage-I(24M:12M Treatment+12M Follow-up)||0
3266724|NCT02628444|4001377|FG008|Vaccinated|Stage-I(24M:12M Treatment+12M Follow-up)||0
3266725|NCT02628444|4001369|FG000|Full Analysis Set (FAS)|Stage-I(24M:12M Treatment+12M Follow-up)||333
3266726|NCT02628444|4001370|FG001|Full Analysis Set (FAS)|Stage-I(24M:12M Treatment+12M Follow-up)||328
3266727|NCT02628444|4001371|FG002|Full Analysis Set (FAS)|Stage-I(24M:12M Treatment+12M Follow-up)||332
3266728|NCT02628444|4001372|FG003|Full Analysis Set (FAS)|Stage-I(24M:12M Treatment+12M Follow-up)||0
3266729|NCT02628444|4001373|FG004|Full Analysis Set (FAS)|Stage-I(24M:12M Treatment+12M Follow-up)||0
3266730|NCT02628444|4001374|FG005|Full Analysis Set (FAS)|Stage-I(24M:12M Treatment+12M Follow-up)||0
3266731|NCT02628444|4001375|FG006|Full Analysis Set (FAS)|Stage-I(24M:12M Treatment+12M Follow-up)||0
3266732|NCT02628444|4001376|FG007|Full Analysis Set (FAS)|Stage-I(24M:12M Treatment+12M Follow-up)||0
3266733|NCT02628444|4001377|FG008|Full Analysis Set (FAS)|Stage-I(24M:12M Treatment+12M Follow-up)||0
3266734|NCT02628444|4001369|FG000|COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||314
3266735|NCT02628444|4001370|FG001|COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||309
3266736|NCT02628444|4001371|FG002|COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||310
3266737|NCT02628444|4001372|FG003|COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0
3266738|NCT02628444|4001373|FG004|COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0
3266739|NCT02628444|4001374|FG005|COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0
3266740|NCT02628444|4001375|FG006|COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0
3266741|NCT02628444|4001376|FG007|COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0
3266742|NCT02628444|4001377|FG008|COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0
3266743|NCT02628444|4001369|FG000|NOT COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||36
3266744|NCT02628444|4001370|FG001|NOT COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||39
3266745|NCT02628444|4001371|FG002|NOT COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||42
3266746|NCT02628444|4001372|FG003|NOT COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0
3266747|NCT02628444|4001373|FG004|NOT COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0
3266748|NCT02628444|4001374|FG005|NOT COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0
3266749|NCT02628444|4001375|FG006|NOT COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0
3266750|NCT02628444|4001376|FG007|NOT COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0
3266751|NCT02628444|4001377|FG008|NOT COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0
3266752|NCT02628444|4001369|FG000|STARTED|STAGE-II(18M:12M Treatment+6M Follow-up)||0
3266753|NCT02628444|4001370|FG001|STARTED|STAGE-II(18M:12M Treatment+6M Follow-up)||0
3266754|NCT02628444|4001371|FG002|STARTED|STAGE-II(18M:12M Treatment+6M Follow-up)||0
3266755|NCT02628444|4001372|FG003|STARTED|STAGE-II(18M:12M Treatment+6M Follow-up)||145
3266756|NCT02628444|4001373|FG004|STARTED|STAGE-II(18M:12M Treatment+6M Follow-up)||152
3266757|NCT02628444|4001374|FG005|STARTED|STAGE-II(18M:12M Treatment+6M Follow-up)||157
3266758|NCT02628444|4001375|FG006|STARTED|STAGE-II(18M:12M Treatment+6M Follow-up)||149
3266759|NCT02628444|4001376|FG007|STARTED|STAGE-II(18M:12M Treatment+6M Follow-up)||152
3266760|NCT02628444|4001377|FG008|STARTED|STAGE-II(18M:12M Treatment+6M Follow-up)||151
3266761|NCT02628444|4001369|FG000|Vaccinated|STAGE-II(18M:12M Treatment+6M Follow-up)||0
3266762|NCT02628444|4001370|FG001|Vaccinated|STAGE-II(18M:12M Treatment+6M Follow-up)||0
3266763|NCT02628444|4001371|FG002|Vaccinated|STAGE-II(18M:12M Treatment+6M Follow-up)||0
3266764|NCT02628444|4001372|FG003|Vaccinated|STAGE-II(18M:12M Treatment+6M Follow-up)||55
3266765|NCT02628444|4001373|FG004|Vaccinated|STAGE-II(18M:12M Treatment+6M Follow-up)||59
3266766|NCT02628444|4001374|FG005|Vaccinated|STAGE-II(18M:12M Treatment+6M Follow-up)||62
3266767|NCT02628444|4001375|FG006|Vaccinated|STAGE-II(18M:12M Treatment+6M Follow-up)||53
3266768|NCT02628444|4001376|FG007|Vaccinated|STAGE-II(18M:12M Treatment+6M Follow-up)||56
3266769|NCT02628444|4001377|FG008|Vaccinated|STAGE-II(18M:12M Treatment+6M Follow-up)||53
3375312|NCT01732913|4108308|FG001|COMPLETED|Overall Study||28
3375313|NCT01732913|4108307|FG000|NOT COMPLETED|Overall Study||156
3375314|NCT01732913|4108308|FG001|NOT COMPLETED|Overall Study||69
3375315|NCT01732211|4108314|FG000|STARTED|Overall Study||1
3375316|NCT01732211|4108314|FG000|COMPLETED|Overall Study||1
3375317|NCT01732211|4108314|FG000|NOT COMPLETED|Overall Study||0
3375318|NCT01716052|4108320|FG000|STARTED|Overall Study||1
3375319|NCT01716052|4108321|FG001|STARTED|Overall Study||1
3375320|NCT01716052|4108320|FG000|COMPLETED|Overall Study||0
3375321|NCT01716052|4108321|FG001|COMPLETED|Overall Study||0
3375322|NCT01716052|4108320|FG000|NOT COMPLETED|Overall Study||1
3375323|NCT01716052|4108321|FG001|NOT COMPLETED|Overall Study||1
3375324|NCT01718444|4108329|FG000|STARTED|Overall Study||0
3375325|NCT01718444|4108330|FG001|STARTED|Overall Study||0
3375326|NCT01718444|4108329|FG000|COMPLETED|Overall Study||0
3375327|NCT01718444|4108330|FG001|COMPLETED|Overall Study||0
3375328|NCT01718444|4108329|FG000|NOT COMPLETED|Overall Study||0
3375329|NCT01718444|4108330|FG001|NOT COMPLETED|Overall Study||0
3375330|NCT01712854|4108336|FG000|STARTED|Overall Study||9
3375331|NCT01712854|4108336|FG000|COMPLETED|Overall Study||8
3375332|NCT01712854|4108336|FG000|NOT COMPLETED|Overall Study||1
3375333|NCT01717482|4108342|FG000|STARTED|Overall Study||4
3375334|NCT01717482|4108343|FG001|STARTED|Overall Study||2
3375335|NCT01717482|4108342|FG000|COMPLETED|Overall Study||0
3375336|NCT01717482|4108343|FG001|COMPLETED|Overall Study||2
3375337|NCT01717482|4108342|FG000|NOT COMPLETED|Overall Study||4
3375338|NCT01717482|4108343|FG001|NOT COMPLETED|Overall Study||0
3375339|NCT01702896|4108350|FG000|STARTED|Overall Study||8
3375340|NCT01702896|4108350|FG000|COMPLETED|Overall Study||0
3375341|NCT01702896|4108350|FG000|NOT COMPLETED|Overall Study||8
3375342|NCT01709136|4108356|FG000|STARTED|Overall Study||3
3375343|NCT01709136|4108356|FG000|COMPLETED|Overall Study||3
3375344|NCT01709136|4108356|FG000|NOT COMPLETED|Overall Study||0
3375345|NCT01708057|4108363|FG000|STARTED|Overall Study||1
3375346|NCT01708057|4108364|FG001|STARTED|Overall Study||1
3375347|NCT01708057|4108365|FG002|STARTED|Overall Study||1
3375348|NCT01708057|4108363|FG000|COMPLETED|Overall Study||0
3375349|NCT01708057|4108364|FG001|COMPLETED|Overall Study||0
3375350|NCT01708057|4108365|FG002|COMPLETED|Overall Study||0
3375351|NCT01708057|4108363|FG000|NOT COMPLETED|Overall Study||1
3375352|NCT01708057|4108364|FG001|NOT COMPLETED|Overall Study||1
3266770|NCT02628444|4001369|FG000|COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||0
3266771|NCT02628444|4001370|FG001|COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||0
3266772|NCT02628444|4001371|FG002|COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||0
3266773|NCT02628444|4001372|FG003|COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||55
3266774|NCT02628444|4001373|FG004|COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||59
3266775|NCT02628444|4001374|FG005|COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||62
3266776|NCT02628444|4001375|FG006|COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||53
3266777|NCT02628444|4001376|FG007|COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||54
3266778|NCT02628444|4001377|FG008|COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||52
3266779|NCT02628444|4001369|FG000|NOT COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||0
3266780|NCT02628444|4001370|FG001|NOT COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||0
3266781|NCT02628444|4001371|FG002|NOT COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||0
3266782|NCT02628444|4001372|FG003|NOT COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||90
3266783|NCT02628444|4001373|FG004|NOT COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||93
3266784|NCT02628444|4001374|FG005|NOT COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||95
3266785|NCT02628444|4001375|FG006|NOT COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||96
3266786|NCT02628444|4001376|FG007|NOT COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||98
3266787|NCT02628444|4001377|FG008|NOT COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||99
3266788|NCT02628600|4001404|FG000|STARTED|Overall Study||73
3266789|NCT02628600|4001405|FG001|STARTED|Overall Study||90
3266790|NCT02628600|4001404|FG000|Participant Discontinued the Study|Overall Study||24
3266791|NCT02628600|4001405|FG001|Participant Discontinued the Study|Overall Study||32
3266792|NCT02628600|4001404|FG000|COMPLETED|Overall Study||49
3266793|NCT02628600|4001405|FG001|COMPLETED|Overall Study||58
3266794|NCT02628600|4001404|FG000|NOT COMPLETED|Overall Study||24
3266795|NCT02628600|4001405|FG001|NOT COMPLETED|Overall Study||32
3266796|NCT02628743|4001411|FG000|STARTED|Overall Study||131
3266797|NCT02628743|4001411|FG000|COMPLETED|Overall Study||0
3266798|NCT02628743|4001411|FG000|NOT COMPLETED|Overall Study||131
3266799|NCT02628769|4001415|FG000|STARTED|First Intervention||3
3266800|NCT02628769|4001416|FG001|STARTED|First Intervention||3
3266801|NCT02628769|4001415|FG000|COMPLETED|First Intervention||2
3266802|NCT02628769|4001416|FG001|COMPLETED|First Intervention||2
3266803|NCT02628769|4001415|FG000|NOT COMPLETED|First Intervention||1
3266804|NCT02628769|4001416|FG001|NOT COMPLETED|First Intervention||1
3266805|NCT02628769|4001415|FG000|STARTED|Wash Out (28 Days)||2
3375353|NCT01708057|4108365|FG002|NOT COMPLETED|Overall Study||1
3375354|NCT01697332|4108379|FG000|STARTED|Overall Study||1
3266806|NCT02628769|4001416|FG001|STARTED|Wash Out (28 Days)||2
3266807|NCT02628769|4001415|FG000|COMPLETED|Wash Out (28 Days)||2
3266808|NCT02628769|4001416|FG001|COMPLETED|Wash Out (28 Days)||2
3266809|NCT02628769|4001415|FG000|NOT COMPLETED|Wash Out (28 Days)||0
3266810|NCT02628769|4001416|FG001|NOT COMPLETED|Wash Out (28 Days)||0
3266811|NCT02628769|4001415|FG000|STARTED|Second Intervention||2
3266812|NCT02628769|4001416|FG001|STARTED|Second Intervention||2
3266813|NCT02628769|4001415|FG000|COMPLETED|Second Intervention||0
3266814|NCT02628769|4001416|FG001|COMPLETED|Second Intervention||1
3266815|NCT02628769|4001415|FG000|NOT COMPLETED|Second Intervention||2
3266816|NCT02628769|4001416|FG001|NOT COMPLETED|Second Intervention||1
3266817|NCT02628873|4001424|FG000|STARTED|First Test (1 Hour)||14
3266818|NCT02628873|4001425|FG001|STARTED|First Test (1 Hour)||7
3266819|NCT02628873|4001424|FG000|COMPLETED|First Test (1 Hour)||14
3266820|NCT02628873|4001425|FG001|COMPLETED|First Test (1 Hour)||7
3266821|NCT02628873|4001424|FG000|NOT COMPLETED|First Test (1 Hour)||0
3266822|NCT02628873|4001425|FG001|NOT COMPLETED|First Test (1 Hour)||0
3266823|NCT02628873|4001424|FG000|STARTED|Break (1 Hour)||14
3266824|NCT02628873|4001425|FG001|STARTED|Break (1 Hour)||7
3266825|NCT02628873|4001424|FG000|COMPLETED|Break (1 Hour)||14
3266826|NCT02628873|4001425|FG001|COMPLETED|Break (1 Hour)||6
3266827|NCT02628873|4001424|FG000|NOT COMPLETED|Break (1 Hour)||0
3266828|NCT02628873|4001425|FG001|NOT COMPLETED|Break (1 Hour)||1
3266829|NCT02628873|4001424|FG000|STARTED|Second Test (1 Hour)||14
3266830|NCT02628873|4001425|FG001|STARTED|Second Test (1 Hour)||6
3266831|NCT02628873|4001424|FG000|COMPLETED|Second Test (1 Hour)||13
3266832|NCT02628873|4001425|FG001|COMPLETED|Second Test (1 Hour)||6
3266833|NCT02628873|4001424|FG000|NOT COMPLETED|Second Test (1 Hour)||1
3266834|NCT02628873|4001425|FG001|NOT COMPLETED|Second Test (1 Hour)||0
3266835|NCT02628938|4001434|FG000|STARTED|Overall Study||15
3266836|NCT02628938|4001435|FG001|STARTED|Overall Study||15
3266837|NCT02628938|4001436|FG002|STARTED|Overall Study||15
3266838|NCT02628938|4001434|FG000|COMPLETED|Overall Study||10
3266839|NCT02628938|4001435|FG001|COMPLETED|Overall Study||13
3266840|NCT02628938|4001436|FG002|COMPLETED|Overall Study||11
3266841|NCT02628938|4001434|FG000|NOT COMPLETED|Overall Study||5
3266842|NCT02628938|4001435|FG001|NOT COMPLETED|Overall Study||2
3266843|NCT02628938|4001436|FG002|NOT COMPLETED|Overall Study||4
3266844|NCT02628964|4001446|FG000|STARTED|Overall Study||50
3266845|NCT02628964|4001447|FG001|STARTED|Overall Study||50
3266846|NCT02628964|4001446|FG000|COMPLETED|Overall Study||50
3266847|NCT02628964|4001447|FG001|COMPLETED|Overall Study||49
3266848|NCT02628964|4001446|FG000|NOT COMPLETED|Overall Study||0
3266849|NCT02628964|4001447|FG001|NOT COMPLETED|Overall Study||1
3266850|NCT02629094|4001453|FG000|STARTED|Overall Study||5
3266851|NCT02629094|4001453|FG000|COMPLETED|Overall Study||5
3266852|NCT02629094|4001453|FG000|NOT COMPLETED|Overall Study||0
3266853|NCT02629133|4001459|FG000|STARTED|Overall Study||25
3266854|NCT02629133|4001460|FG001|STARTED|Overall Study||25
3266855|NCT02629133|4001459|FG000|COMPLETED|Overall Study||21
3266856|NCT02629133|4001460|FG001|COMPLETED|Overall Study||23
3266857|NCT02629133|4001459|FG000|NOT COMPLETED|Overall Study||4
3266858|NCT02629133|4001460|FG001|NOT COMPLETED|Overall Study||2
3266859|NCT02629354|4001468|FG000|STARTED|Period 1||18
3266860|NCT02629354|4001469|FG001|STARTED|Period 1||18
3266861|NCT02629354|4001468|FG000|COMPLETED|Period 1||18
3266862|NCT02629354|4001469|FG001|COMPLETED|Period 1||18
3266863|NCT02629354|4001468|FG000|NOT COMPLETED|Period 1||0
3266864|NCT02629354|4001469|FG001|NOT COMPLETED|Period 1||0
3266865|NCT02629354|4001468|FG000|STARTED|Washout Period||18
3266866|NCT02629354|4001469|FG001|STARTED|Washout Period||18
3266867|NCT02629354|4001468|FG000|COMPLETED|Washout Period||18
3266868|NCT02629354|4001469|FG001|COMPLETED|Washout Period||18
3266869|NCT02629354|4001468|FG000|NOT COMPLETED|Washout Period||0
3266870|NCT02629354|4001469|FG001|NOT COMPLETED|Washout Period||0
3266871|NCT02629354|4001468|FG000|STARTED|Period 2||18
3266872|NCT02629354|4001469|FG001|STARTED|Period 2||18
3266873|NCT02629354|4001468|FG000|COMPLETED|Period 2||18
3266874|NCT02629354|4001469|FG001|COMPLETED|Period 2||18
3266875|NCT02629354|4001468|FG000|NOT COMPLETED|Period 2||0
3266876|NCT02629354|4001469|FG001|NOT COMPLETED|Period 2||0
3266877|NCT02629354|4001468|FG000|STARTED|Follow-up||18
3266878|NCT02629354|4001469|FG001|STARTED|Follow-up||18
3266879|NCT02629354|4001468|FG000|COMPLETED|Follow-up||18
3266880|NCT02629354|4001469|FG001|COMPLETED|Follow-up||18
3266881|NCT02629354|4001468|FG000|NOT COMPLETED|Follow-up||0
3266882|NCT02629354|4001469|FG001|NOT COMPLETED|Follow-up||0
3266883|NCT02629822|4001475|FG000|STARTED|Base Study||10
3266884|NCT02629822|4001475|FG000|COMPLETED|Base Study||7
3266885|NCT02629822|4001475|FG000|NOT COMPLETED|Base Study||3
3266886|NCT02629822|4001475|FG000|STARTED|Extension Study|Enrollment in Extension Study was voluntary.|6
3266887|NCT02629822|4001475|FG000|COMPLETED|Extension Study||4
3266888|NCT02629822|4001475|FG000|NOT COMPLETED|Extension Study||2
3266889|NCT02629861|4001483|FG000|STARTED|Overall Study||294
3266890|NCT02629861|4001484|FG001|STARTED|Overall Study||291
3266891|NCT02629861|4001485|FG002|STARTED|Overall Study||290
3266892|NCT02629861|4001483|FG000|Intent to Treat (ITT)|Overall Study||294
3266893|NCT02629861|4001484|FG001|Intent to Treat (ITT)|Overall Study||291
3266894|NCT02629861|4001485|FG002|Intent to Treat (ITT)|Overall Study||290
3266895|NCT02629861|4001483|FG000|Safety Population|Overall Study||294
3266896|NCT02629861|4001484|FG001|Safety Population|Overall Study||291
3266897|NCT02629861|4001485|FG002|Safety Population|Overall Study||289
3266898|NCT02629861|4001483|FG000|Full Analysis Set|Overall Study||290
3266899|NCT02629861|4001484|FG001|Full Analysis Set|Overall Study||288
3266900|NCT02629861|4001485|FG002|Full Analysis Set|Overall Study||287
3266901|NCT02629861|4001483|FG000|COMPLETED|Overall Study||265
3266902|NCT02629861|4001484|FG001|COMPLETED|Overall Study||264
3266903|NCT02629861|4001485|FG002|COMPLETED|Overall Study||262
3266904|NCT02629861|4001483|FG000|NOT COMPLETED|Overall Study||29
3266905|NCT02629861|4001484|FG001|NOT COMPLETED|Overall Study||27
3266906|NCT02629861|4001485|FG002|NOT COMPLETED|Overall Study||28
3266907|NCT02629965|4001493|FG000|STARTED|Period 1||92
3375355|NCT01697332|4108379|FG000|COMPLETED|Overall Study||1
3375356|NCT01697332|4108379|FG000|NOT COMPLETED|Overall Study||0
3375357|NCT01693367|4108385|FG000|STARTED|Overall Study||2
3375358|NCT01693367|4108386|FG001|STARTED|Overall Study||3
3375359|NCT01693367|4108385|FG000|COMPLETED|Overall Study||1
3375360|NCT01693367|4108386|FG001|COMPLETED|Overall Study||1
3375361|NCT01693367|4108385|FG000|NOT COMPLETED|Overall Study||1
3375362|NCT01693367|4108386|FG001|NOT COMPLETED|Overall Study||2
3375363|NCT01705106|4108392|FG000|STARTED|Overall Study||21
3375364|NCT01705106|4108392|FG000|COMPLETED|Overall Study||21
3375365|NCT01705106|4108392|FG000|NOT COMPLETED|Overall Study||0
3375366|NCT01702909|4108396|FG000|STARTED|Overall Study||7
3375367|NCT01702909|4108396|FG000|COMPLETED|Overall Study||7
3375368|NCT01702909|4108396|FG000|NOT COMPLETED|Overall Study||0
3375369|NCT01701622|4108400|FG000|STARTED|Overall Study||1
3375370|NCT01701622|4108400|FG000|COMPLETED|Overall Study||1
3375371|NCT01701622|4108400|FG000|NOT COMPLETED|Overall Study||0
3375372|NCT01697800|4108407|FG000|STARTED|Overall Study||15
3375373|NCT01697800|4108408|FG001|STARTED|Overall Study||25
3375374|NCT01697800|4108407|FG000|COMPLETED|Overall Study||15
3375375|NCT01697800|4108408|FG001|COMPLETED|Overall Study||24
3375376|NCT01697800|4108407|FG000|NOT COMPLETED|Overall Study||0
3375377|NCT01697800|4108408|FG001|NOT COMPLETED|Overall Study||1
3375378|NCT01700348|4108414|FG000|STARTED|Overall Study||116
3375379|NCT01700348|4108414|FG000|COMPLETED|Overall Study||93
3375380|NCT01700348|4108414|FG000|NOT COMPLETED|Overall Study||23
3375381|NCT01693484|4108420|FG000|STARTED|Overall Study||13
3375382|NCT01693484|4108420|FG000|COMPLETED|Overall Study|Study closed by PI|0
3375383|NCT01693484|4108420|FG000|NOT COMPLETED|Overall Study||13
3375384|NCT01693653|4108426|FG000|STARTED|Overall Study||1
3375385|NCT01693653|4108427|FG001|STARTED|Overall Study||0
3375386|NCT01693653|4108426|FG000|COMPLETED|Overall Study||1
3375387|NCT01693653|4108427|FG001|COMPLETED|Overall Study||0
3375388|NCT01693653|4108426|FG000|NOT COMPLETED|Overall Study||0
3375389|NCT01693653|4108427|FG001|NOT COMPLETED|Overall Study||0
3375390|NCT01692691|4108433|FG000|STARTED|Overall Study||1
3375391|NCT01692691|4108433|FG000|COMPLETED|Overall Study||1
3375392|NCT01692691|4108433|FG000|NOT COMPLETED|Overall Study||0
3375393|NCT01691079|4108441|FG000|STARTED|Overall Study||0
3375394|NCT01691079|4108442|FG001|STARTED|Overall Study||0
3375395|NCT01691079|4108441|FG000|COMPLETED|Overall Study||0
3375396|NCT01691079|4108442|FG001|COMPLETED|Overall Study||0
3375397|NCT01691079|4108441|FG000|NOT COMPLETED|Overall Study||0
3375398|NCT01691079|4108442|FG001|NOT COMPLETED|Overall Study||0
3375399|NCT01690910|4108450|FG000|STARTED|Overall Study|The study was never completed due to feasibility issues.|0
3375400|NCT01690910|4108451|FG001|STARTED|Overall Study||0
3375401|NCT01690910|4108450|FG000|COMPLETED|Overall Study||0
3375402|NCT01690910|4108451|FG001|COMPLETED|Overall Study||0
3375403|NCT01690910|4108450|FG000|NOT COMPLETED|Overall Study||0
3375404|NCT01690910|4108451|FG001|NOT COMPLETED|Overall Study||0
3375405|NCT01689974|4108459|FG000|STARTED|Overall Study||5
3375406|NCT01689974|4108460|FG001|STARTED|Overall Study||5
3375407|NCT01689974|4108459|FG000|COMPLETED|Overall Study||0
3375408|NCT01689974|4108460|FG001|COMPLETED|Overall Study||0
3375409|NCT01689974|4108459|FG000|NOT COMPLETED|Overall Study||5
3375410|NCT01689974|4108460|FG001|NOT COMPLETED|Overall Study||5
3375411|NCT01676961|4108466|FG000|STARTED|Overall Study||5
3375412|NCT01676961|4108466|FG000|COMPLETED|Overall Study||0
3375413|NCT01676961|4108466|FG000|NOT COMPLETED|Overall Study||5
3375414|NCT01681589|4108473|FG000|STARTED|Overall Study||0
3375415|NCT01681589|4108474|FG001|STARTED|Overall Study||0
3375416|NCT01681589|4108475|FG002|STARTED|Overall Study||0
3375417|NCT01681589|4108473|FG000|COMPLETED|Overall Study||0
3375418|NCT01681589|4108474|FG001|COMPLETED|Overall Study||0
3375419|NCT01681589|4108475|FG002|COMPLETED|Overall Study||0
3375420|NCT01681589|4108473|FG000|NOT COMPLETED|Overall Study||0
3375421|NCT01681589|4108474|FG001|NOT COMPLETED|Overall Study||0
3375422|NCT01681589|4108475|FG002|NOT COMPLETED|Overall Study||0
3375423|NCT01681745|4108483|FG000|STARTED|Overall Study||0
3375424|NCT01681745|4108483|FG000|COMPLETED|Overall Study||0
3375425|NCT01681745|4108483|FG000|NOT COMPLETED|Overall Study||0
3375426|NCT01682928|4108489|FG000|STARTED|Overall Study|2 subjects in this Arm|2
3375427|NCT01682928|4108490|FG001|STARTED|Overall Study|2 subjects in this Arm|2
3375428|NCT01682928|4108489|FG000|COMPLETED|Overall Study||2
3375429|NCT01682928|4108490|FG001|COMPLETED|Overall Study||2
3375430|NCT01682928|4108489|FG000|NOT COMPLETED|Overall Study||0
3375431|NCT01682928|4108490|FG001|NOT COMPLETED|Overall Study||0
3375432|NCT01668940|4108502|FG000|STARTED|Overall Study||17
3375433|NCT01668940|4108503|FG001|STARTED|Overall Study||14
3375434|NCT01668940|4108504|FG002|STARTED|Overall Study||9
3375435|NCT01668940|4108505|FG003|STARTED|Overall Study||14
3266908|NCT02629965|4001494|FG001|STARTED|Period 1||92
3266909|NCT02629965|4001493|FG000|COMPLETED|Period 1||88
3266910|NCT02629965|4001494|FG001|COMPLETED|Period 1||90
3266911|NCT02629965|4001493|FG000|NOT COMPLETED|Period 1||4
3266912|NCT02629965|4001494|FG001|NOT COMPLETED|Period 1||2
3266913|NCT02629965|4001493|FG000|STARTED|Period 2||88
3266914|NCT02629965|4001494|FG001|STARTED|Period 2||90
3266915|NCT02629965|4001493|FG000|COMPLETED|Period 2||87
3266916|NCT02629965|4001494|FG001|COMPLETED|Period 2||90
3266917|NCT02629965|4001493|FG000|NOT COMPLETED|Period 2||1
3266918|NCT02629965|4001494|FG001|NOT COMPLETED|Period 2||0
3266919|NCT02629991|4001502|FG000|STARTED|Overall Study||11
3266920|NCT02629991|4001503|FG001|STARTED|Overall Study||12
3266921|NCT02629991|4001502|FG000|COMPLETED|Overall Study||10
3266922|NCT02629991|4001503|FG001|COMPLETED|Overall Study||11
3266923|NCT02629991|4001502|FG000|NOT COMPLETED|Overall Study||1
3266924|NCT02629991|4001503|FG001|NOT COMPLETED|Overall Study||1
3266925|NCT02630017|4001514|FG000|STARTED|Overall Study||13
3266926|NCT02630017|4001515|FG001|STARTED|Overall Study||12
3266927|NCT02630017|4001516|FG002|STARTED|Overall Study||13
3266928|NCT02630017|4001517|FG003|STARTED|Overall Study||13
3266929|NCT02630017|4001514|FG000|COMPLETED|Overall Study||12
3266930|NCT02630017|4001515|FG001|COMPLETED|Overall Study||11
3266931|NCT02630017|4001516|FG002|COMPLETED|Overall Study||11
3266932|NCT02630017|4001517|FG003|COMPLETED|Overall Study||12
3266933|NCT02630017|4001514|FG000|NOT COMPLETED|Overall Study||1
3266934|NCT02630017|4001515|FG001|NOT COMPLETED|Overall Study||1
3266935|NCT02630017|4001516|FG002|NOT COMPLETED|Overall Study||2
3266936|NCT02630017|4001517|FG003|NOT COMPLETED|Overall Study||1
3266937|NCT02630030|4001527|FG000|STARTED|Overall Study||3
3266938|NCT02630030|4001527|FG000|COMPLETED|Overall Study||3
3266939|NCT02630030|4001527|FG000|NOT COMPLETED|Overall Study||0
3266940|NCT02630186|4001531|FG000|STARTED|Overall Study||3
3266941|NCT02630186|4001531|FG000|COMPLETED|Overall Study||2
3266942|NCT02630186|4001531|FG000|NOT COMPLETED|Overall Study||1
3266943|NCT02630251|4001539|FG000|STARTED|Overall Study||2
3266944|NCT02630251|4001540|FG001|STARTED|Overall Study||1
3266945|NCT02630251|4001541|FG002|STARTED|Overall Study||1
3266946|NCT02630251|4001542|FG003|STARTED|Overall Study||1
3266947|NCT02630251|4001539|FG000|COMPLETED|Overall Study||2
3266948|NCT02630251|4001540|FG001|COMPLETED|Overall Study||1
3266949|NCT02630251|4001541|FG002|COMPLETED|Overall Study||0
3266950|NCT02630251|4001542|FG003|COMPLETED|Overall Study||1
3375436|NCT01668940|4108502|FG000|COMPLETED|Overall Study|Data collection was completed, but data analysis did not occur due to study closure.|17
3375437|NCT01668940|4108503|FG001|COMPLETED|Overall Study|Data collection was completed, but data analysis did not occur due to study closure.|14
3375438|NCT01668940|4108504|FG002|COMPLETED|Overall Study|Data collection was completed, but data analysis did not occur due to study closure.|9
3375439|NCT01668940|4108505|FG003|COMPLETED|Overall Study|Data collection was completed, but data analysis did not occur due to study closure.|14
3375440|NCT01668940|4108502|FG000|NOT COMPLETED|Overall Study||0
3375441|NCT01668940|4108503|FG001|NOT COMPLETED|Overall Study||0
3375442|NCT01668940|4108504|FG002|NOT COMPLETED|Overall Study||0
3375443|NCT01668940|4108505|FG003|NOT COMPLETED|Overall Study||0
3375444|NCT01663285|4108515|FG000|STARTED|Overall Study||1
3375445|NCT01663285|4108515|FG000|COMPLETED|Overall Study||1
3375446|NCT01663285|4108515|FG000|NOT COMPLETED|Overall Study||0
3375447|NCT01683864|4108522|FG000|STARTED|Overall Study||0
3375448|NCT01683864|4108523|FG001|STARTED|Overall Study||0
3375449|NCT01683864|4108524|FG002|STARTED|Overall Study||0
3375450|NCT01683864|4108522|FG000|COMPLETED|Overall Study||0
3375451|NCT01683864|4108523|FG001|COMPLETED|Overall Study||0
3375452|NCT01683864|4108524|FG002|COMPLETED|Overall Study||0
3375453|NCT01683864|4108522|FG000|NOT COMPLETED|Overall Study||0
3375454|NCT01683864|4108523|FG001|NOT COMPLETED|Overall Study||0
3375455|NCT01683864|4108524|FG002|NOT COMPLETED|Overall Study||0
3375456|NCT01675011|4108534|FG000|STARTED|Overall Study||3
3375457|NCT01675011|4108535|FG001|STARTED|Overall Study||1
3375458|NCT01675011|4108534|FG000|COMPLETED|Overall Study||0
3375459|NCT01675011|4108535|FG001|COMPLETED|Overall Study||0
3375460|NCT01675011|4108534|FG000|NOT COMPLETED|Overall Study||3
3375461|NCT01675011|4108535|FG001|NOT COMPLETED|Overall Study||1
3375462|NCT01673425|4108541|FG000|STARTED|Overall Study||5
3375463|NCT01673425|4108541|FG000|COMPLETED|Overall Study||4
3375464|NCT01673425|4108541|FG000|NOT COMPLETED|Overall Study||1
3375465|NCT01673061|4108547|FG000|STARTED|Overall Study||0
3375466|NCT01673061|4108548|FG001|STARTED|Overall Study||0
3375467|NCT01673061|4108547|FG000|COMPLETED|Overall Study||0
3375468|NCT01673061|4108548|FG001|COMPLETED|Overall Study||0
3375469|NCT01673061|4108547|FG000|NOT COMPLETED|Overall Study||0
3375470|NCT01673061|4108548|FG001|NOT COMPLETED|Overall Study||0
3375471|NCT01675960|4108556|FG000|STARTED|Overall Study||2
3375472|NCT01675960|4108557|FG001|STARTED|Overall Study||0
3375473|NCT01675960|4108556|FG000|COMPLETED|Overall Study||2
3375474|NCT01675960|4108557|FG001|COMPLETED|Overall Study||0
3375475|NCT01675960|4108556|FG000|NOT COMPLETED|Overall Study||0
3375476|NCT01675960|4108557|FG001|NOT COMPLETED|Overall Study||0
3375477|NCT01668147|4108563|FG000|STARTED|Overall Study||13
3375478|NCT01668147|4108563|FG000|COMPLETED|Overall Study||7
3375479|NCT01668147|4108563|FG000|NOT COMPLETED|Overall Study||6
3266951|NCT02630251|4001539|FG000|NOT COMPLETED|Overall Study||0
3266952|NCT02630251|4001540|FG001|NOT COMPLETED|Overall Study||0
3266953|NCT02630251|4001541|FG002|NOT COMPLETED|Overall Study||1
3266954|NCT02630251|4001542|FG003|NOT COMPLETED|Overall Study||0
3266955|NCT02630316|4001554|FG000|STARTED|Overall Study||163
3266956|NCT02630316|4001555|FG001|STARTED|Overall Study||163
3266957|NCT02630316|4001554|FG000|COMPLETED|Overall Study||128
3266958|NCT02630316|4001555|FG001|COMPLETED|Overall Study||130
3266959|NCT02630316|4001554|FG000|NOT COMPLETED|Overall Study||35
3266960|NCT02630316|4001555|FG001|NOT COMPLETED|Overall Study||33
3266961|NCT02630459|4001565|FG000|STARTED|Double-Blind Treatment Phase (DBTP)||136
3266962|NCT02630459|4001566|FG001|STARTED|Double-Blind Treatment Phase (DBTP)||67
3266963|NCT02630459|4001567|FG002|STARTED|Double-Blind Treatment Phase (DBTP)||135
3266964|NCT02630459|4001568|FG003|STARTED|Double-Blind Treatment Phase (DBTP)||137
3266965|NCT02630459|4001569|FG004|STARTED|Double-Blind Treatment Phase (DBTP)||0
3266966|NCT02630459|4001570|FG005|STARTED|Double-Blind Treatment Phase (DBTP)||0
3266967|NCT02630459|4001571|FG006|STARTED|Double-Blind Treatment Phase (DBTP)||0
3266968|NCT02630459|4001572|FG007|STARTED|Double-Blind Treatment Phase (DBTP)||0
3266969|NCT02630459|4001565|FG000|Received Investigational Product (IP)|Double-Blind Treatment Phase (DBTP)||136
3266970|NCT02630459|4001566|FG001|Received Investigational Product (IP)|Double-Blind Treatment Phase (DBTP)||66
3266971|NCT02630459|4001567|FG002|Received Investigational Product (IP)|Double-Blind Treatment Phase (DBTP)||135
3266972|NCT02630459|4001568|FG003|Received Investigational Product (IP)|Double-Blind Treatment Phase (DBTP)||137
3266973|NCT02630459|4001569|FG004|Received Investigational Product (IP)|Double-Blind Treatment Phase (DBTP)||0
3266974|NCT02630459|4001570|FG005|Received Investigational Product (IP)|Double-Blind Treatment Phase (DBTP)||0
3266975|NCT02630459|4001571|FG006|Received Investigational Product (IP)|Double-Blind Treatment Phase (DBTP)||0
3266976|NCT02630459|4001572|FG007|Received Investigational Product (IP)|Double-Blind Treatment Phase (DBTP)||0
3266977|NCT02630459|4001565|FG000|COMPLETED|Double-Blind Treatment Phase (DBTP)||133
3266978|NCT02630459|4001566|FG001|COMPLETED|Double-Blind Treatment Phase (DBTP)||65
3266979|NCT02630459|4001567|FG002|COMPLETED|Double-Blind Treatment Phase (DBTP)||130
3266980|NCT02630459|4001568|FG003|COMPLETED|Double-Blind Treatment Phase (DBTP)||134
3266981|NCT02630459|4001569|FG004|COMPLETED|Double-Blind Treatment Phase (DBTP)||0
3266982|NCT02630459|4001570|FG005|COMPLETED|Double-Blind Treatment Phase (DBTP)||0
3266983|NCT02630459|4001571|FG006|COMPLETED|Double-Blind Treatment Phase (DBTP)||0
3266984|NCT02630459|4001572|FG007|COMPLETED|Double-Blind Treatment Phase (DBTP)||0
3266985|NCT02630459|4001565|FG000|NOT COMPLETED|Double-Blind Treatment Phase (DBTP)||3
3266986|NCT02630459|4001566|FG001|NOT COMPLETED|Double-Blind Treatment Phase (DBTP)||2
3266987|NCT02630459|4001567|FG002|NOT COMPLETED|Double-Blind Treatment Phase (DBTP)||5
3266988|NCT02630459|4001568|FG003|NOT COMPLETED|Double-Blind Treatment Phase (DBTP)||3
3266989|NCT02630459|4001569|FG004|NOT COMPLETED|Double-Blind Treatment Phase (DBTP)||0
3266990|NCT02630459|4001570|FG005|NOT COMPLETED|Double-Blind Treatment Phase (DBTP)||0
3266991|NCT02630459|4001571|FG006|NOT COMPLETED|Double-Blind Treatment Phase (DBTP)||0
3266992|NCT02630459|4001572|FG007|NOT COMPLETED|Double-Blind Treatment Phase (DBTP)||0
3266993|NCT02630459|4001565|FG000|STARTED|Open-Label Treatment Phase (OLTP)||0
3266994|NCT02630459|4001566|FG001|STARTED|Open-Label Treatment Phase (OLTP)||0
3266995|NCT02630459|4001567|FG002|STARTED|Open-Label Treatment Phase (OLTP)||0
3266996|NCT02630459|4001568|FG003|STARTED|Open-Label Treatment Phase (OLTP)||0
3266997|NCT02630459|4001569|FG004|STARTED|Open-Label Treatment Phase (OLTP)||386
3266998|NCT02630459|4001570|FG005|STARTED|Open-Label Treatment Phase (OLTP)||73
3266999|NCT02630459|4001571|FG006|STARTED|Open-Label Treatment Phase (OLTP)||0
3267000|NCT02630459|4001572|FG007|STARTED|Open-Label Treatment Phase (OLTP)||0
3267001|NCT02630459|4001565|FG000|Received Only 70 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
3267002|NCT02630459|4001566|FG001|Received Only 70 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
3267003|NCT02630459|4001567|FG002|Received Only 70 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
3267004|NCT02630459|4001568|FG003|Received Only 70 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
3267005|NCT02630459|4001569|FG004|Received Only 70 mg in OLTP|Open-Label Treatment Phase (OLTP)||270
3267006|NCT02630459|4001570|FG005|Received Only 70 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
3267007|NCT02630459|4001571|FG006|Received Only 70 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
3267008|NCT02630459|4001572|FG007|Received Only 70 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
3267009|NCT02630459|4001565|FG000|Received Only 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
3267010|NCT02630459|4001566|FG001|Received Only 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
3267011|NCT02630459|4001567|FG002|Received Only 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
3267012|NCT02630459|4001568|FG003|Received Only 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
3267013|NCT02630459|4001569|FG004|Received Only 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
3267014|NCT02630459|4001570|FG005|Received Only 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||73
3267015|NCT02630459|4001571|FG006|Received Only 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
3267016|NCT02630459|4001572|FG007|Received Only 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
3267017|NCT02630459|4001565|FG000|Received Both 70 mg and 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
3267018|NCT02630459|4001566|FG001|Received Both 70 mg and 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
3267019|NCT02630459|4001567|FG002|Received Both 70 mg and 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
3267020|NCT02630459|4001568|FG003|Received Both 70 mg and 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
3267021|NCT02630459|4001569|FG004|Received Both 70 mg and 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||116
3267022|NCT02630459|4001570|FG005|Received Both 70 mg and 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
3267023|NCT02630459|4001571|FG006|Received Both 70 mg and 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
3267024|NCT02630459|4001572|FG007|Received Both 70 mg and 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
3267025|NCT02630459|4001565|FG000|COMPLETED|Open-Label Treatment Phase (OLTP)||0
3267026|NCT02630459|4001566|FG001|COMPLETED|Open-Label Treatment Phase (OLTP)||0
3267027|NCT02630459|4001567|FG002|COMPLETED|Open-Label Treatment Phase (OLTP)||0
3267028|NCT02630459|4001568|FG003|COMPLETED|Open-Label Treatment Phase (OLTP)||0
3267029|NCT02630459|4001569|FG004|COMPLETED|Open-Label Treatment Phase (OLTP)||357
3267030|NCT02630459|4001570|FG005|COMPLETED|Open-Label Treatment Phase (OLTP)||69
3267031|NCT02630459|4001571|FG006|COMPLETED|Open-Label Treatment Phase (OLTP)||0
3267032|NCT02630459|4001572|FG007|COMPLETED|Open-Label Treatment Phase (OLTP)||0
3375480|NCT01676701|4108573|FG000|STARTED|Overall Study||4
3375481|NCT01676701|4108574|FG001|STARTED|Overall Study||4
3375482|NCT01676701|4108573|FG000|Received at Least 1 Dose of Study Drug|Overall Study||4
3375483|NCT01676701|4108574|FG001|Received at Least 1 Dose of Study Drug|Overall Study||4
3375484|NCT01676701|4108573|FG000|Completed Post-Treatment Follow-Up|Overall Study||4
3375485|NCT01676701|4108574|FG001|Completed Post-Treatment Follow-Up|Overall Study||4
3375486|NCT01676701|4108573|FG000|COMPLETED|Overall Study||0
3375487|NCT01676701|4108574|FG001|COMPLETED|Overall Study||0
3375488|NCT01676701|4108573|FG000|NOT COMPLETED|Overall Study||4
3375489|NCT01676701|4108574|FG001|NOT COMPLETED|Overall Study||4
3375490|NCT01669148|4108582|FG000|STARTED|Overall Study||496
3375491|NCT01669148|4108582|FG000|COMPLETED|Overall Study||426
3375492|NCT01669148|4108582|FG000|NOT COMPLETED|Overall Study||70
3375493|NCT01662102|4108589|FG000|STARTED|Overall Study||1
3375494|NCT01662102|4108590|FG001|STARTED|Overall Study||0
3375495|NCT01662102|4108589|FG000|COMPLETED|Overall Study||0
3375496|NCT01662102|4108590|FG001|COMPLETED|Overall Study||0
3375497|NCT01662102|4108589|FG000|NOT COMPLETED|Overall Study||1
3375498|NCT01662102|4108590|FG001|NOT COMPLETED|Overall Study||0
3375499|NCT01659554|4108597|FG000|STARTED|Overall Study|4 subjects enrolled; 4 subjects treated and 4 did not complete protocol schema|4
3375500|NCT01659554|4108597|FG000|COMPLETED|Overall Study||0
3375501|NCT01659554|4108597|FG000|NOT COMPLETED|Overall Study||4
3375502|NCT01658813|4108601|FG000|STARTED|Overall Study||18
3375503|NCT01658813|4108601|FG000|Eligible|Overall Study||18
3375504|NCT01658813|4108601|FG000|Treated|Overall Study||18
3375505|NCT01658813|4108601|FG000|COMPLETED|Overall Study||15
3375506|NCT01658813|4108601|FG000|NOT COMPLETED|Overall Study||3
3375507|NCT01648296|4108611|FG000|STARTED|Overall Study||11
3375508|NCT01648296|4108612|FG001|STARTED|Overall Study||17
3375509|NCT01648296|4108611|FG000|COMPLETED|Overall Study||11
3375510|NCT01648296|4108612|FG001|COMPLETED|Overall Study||17
3375511|NCT01648296|4108611|FG000|NOT COMPLETED|Overall Study||0
3375512|NCT01648296|4108612|FG001|NOT COMPLETED|Overall Study||0
3375513|NCT01649505|4108622|FG000|STARTED|Overall Study||1
3375514|NCT01649505|4108623|FG001|STARTED|Overall Study||1
3375515|NCT01649505|4108622|FG000|COMPLETED|Overall Study||0
3375516|NCT01649505|4108623|FG001|COMPLETED|Overall Study||0
3375517|NCT01649505|4108622|FG000|NOT COMPLETED|Overall Study||1
3375518|NCT01649505|4108623|FG001|NOT COMPLETED|Overall Study||1
3375519|NCT01642732|4108629|FG000|STARTED|Overall Study||1
3375520|NCT01642732|4108629|FG000|COMPLETED|Overall Study||0
3375521|NCT01642732|4108629|FG000|NOT COMPLETED|Overall Study||1
3375522|NCT01645709|4108635|FG000|STARTED|Overall Study|Study was terminated; not made unblind|0
3375523|NCT01645709|4108636|FG001|STARTED|Overall Study|Study was terminated; not made unblind|0
3375524|NCT01645709|4108635|FG000|COMPLETED|Overall Study|Study was terminated; not made unblind|0
3375525|NCT01645709|4108636|FG001|COMPLETED|Overall Study|Study was terminated; not made unblind|0
3375526|NCT01645709|4108635|FG000|NOT COMPLETED|Overall Study||0
3375527|NCT01645709|4108636|FG001|NOT COMPLETED|Overall Study||0
3375528|NCT01648270|4108642|FG000|STARTED|Intravenous Buprenorphine||25
3375529|NCT01648270|4108642|FG000|COMPLETED|Intravenous Buprenorphine||13
3375530|NCT01648270|4108642|FG000|NOT COMPLETED|Intravenous Buprenorphine||12
3375531|NCT01648270|4108642|FG000|STARTED|Sublingual Buprenorphine||13
3375532|NCT01648270|4108642|FG000|COMPLETED|Sublingual Buprenorphine||13
3375533|NCT01648270|4108642|FG000|NOT COMPLETED|Sublingual Buprenorphine||0
3375534|NCT01648270|4108642|FG000|STARTED|Cyclosporine Plus IV Buprenorphine||13
3375535|NCT01648270|4108642|FG000|COMPLETED|Cyclosporine Plus IV Buprenorphine||13
3375536|NCT01648270|4108642|FG000|NOT COMPLETED|Cyclosporine Plus IV Buprenorphine||0
3375537|NCT01648270|4108642|FG000|STARTED|Cyclosporine + Sublingual Buprenorphine||13
3375538|NCT01648270|4108642|FG000|COMPLETED|Cyclosporine + Sublingual Buprenorphine||13
3375539|NCT01648270|4108642|FG000|NOT COMPLETED|Cyclosporine + Sublingual Buprenorphine||0
3375540|NCT01643525|4108652|FG000|STARTED|Overall Study||29
3375541|NCT01643525|4108652|FG000|COMPLETED|Overall Study||29
3375542|NCT01643525|4108652|FG000|NOT COMPLETED|Overall Study||0
3375543|NCT01641601|4108658|FG000|STARTED|Overall Study||3
3375544|NCT01641601|4108659|FG001|STARTED|Overall Study||5
3375545|NCT01641601|4108658|FG000|COMPLETED|Overall Study|Study discontinued prior to data collection.|0
3375546|NCT01641601|4108659|FG001|COMPLETED|Overall Study|Study discontinued prior to data collection.|0
3375547|NCT01641601|4108658|FG000|NOT COMPLETED|Overall Study||3
3375548|NCT01641601|4108659|FG001|NOT COMPLETED|Overall Study||5
3375549|NCT01633814|4108665|FG000|STARTED|Overall Study||4
3375550|NCT01633814|4108665|FG000|COMPLETED|Overall Study||4
3375551|NCT01633814|4108665|FG000|NOT COMPLETED|Overall Study||0
3267033|NCT02630459|4001565|FG000|NOT COMPLETED|Open-Label Treatment Phase (OLTP)||0
3267034|NCT02630459|4001566|FG001|NOT COMPLETED|Open-Label Treatment Phase (OLTP)||0
3267035|NCT02630459|4001567|FG002|NOT COMPLETED|Open-Label Treatment Phase (OLTP)||0
3267036|NCT02630459|4001568|FG003|NOT COMPLETED|Open-Label Treatment Phase (OLTP)||0
3267037|NCT02630459|4001569|FG004|NOT COMPLETED|Open-Label Treatment Phase (OLTP)||29
3267038|NCT02630459|4001570|FG005|NOT COMPLETED|Open-Label Treatment Phase (OLTP)||4
3267039|NCT02630459|4001571|FG006|NOT COMPLETED|Open-Label Treatment Phase (OLTP)||0
3267040|NCT02630459|4001572|FG007|NOT COMPLETED|Open-Label Treatment Phase (OLTP)||0
3267041|NCT02630459|4001565|FG000|STARTED|Optional CHU Sub-Study (During OLTP)||0
3267042|NCT02630459|4001566|FG001|STARTED|Optional CHU Sub-Study (During OLTP)||0
3267043|NCT02630459|4001567|FG002|STARTED|Optional CHU Sub-Study (During OLTP)||0
3267044|NCT02630459|4001568|FG003|STARTED|Optional CHU Sub-Study (During OLTP)||0
3267045|NCT02630459|4001569|FG004|STARTED|Optional CHU Sub-Study (During OLTP)||0
3267046|NCT02630459|4001570|FG005|STARTED|Optional CHU Sub-Study (During OLTP)||0
3267047|NCT02630459|4001571|FG006|STARTED|Optional CHU Sub-Study (During OLTP)||24
3267048|NCT02630459|4001572|FG007|STARTED|Optional CHU Sub-Study (During OLTP)||25
3267049|NCT02630459|4001565|FG000|COMPLETED|Optional CHU Sub-Study (During OLTP)||0
3267050|NCT02630459|4001566|FG001|COMPLETED|Optional CHU Sub-Study (During OLTP)||0
3267051|NCT02630459|4001567|FG002|COMPLETED|Optional CHU Sub-Study (During OLTP)||0
3267052|NCT02630459|4001568|FG003|COMPLETED|Optional CHU Sub-Study (During OLTP)||0
3267053|NCT02630459|4001569|FG004|COMPLETED|Optional CHU Sub-Study (During OLTP)||0
3267054|NCT02630459|4001570|FG005|COMPLETED|Optional CHU Sub-Study (During OLTP)||0
3267055|NCT02630459|4001571|FG006|COMPLETED|Optional CHU Sub-Study (During OLTP)||24
3267056|NCT02630459|4001572|FG007|COMPLETED|Optional CHU Sub-Study (During OLTP)||25
3267057|NCT02630459|4001565|FG000|NOT COMPLETED|Optional CHU Sub-Study (During OLTP)||0
3267058|NCT02630459|4001566|FG001|NOT COMPLETED|Optional CHU Sub-Study (During OLTP)||0
3267059|NCT02630459|4001567|FG002|NOT COMPLETED|Optional CHU Sub-Study (During OLTP)||0
3267060|NCT02630459|4001568|FG003|NOT COMPLETED|Optional CHU Sub-Study (During OLTP)||0
3267061|NCT02630459|4001569|FG004|NOT COMPLETED|Optional CHU Sub-Study (During OLTP)||0
3267062|NCT02630459|4001570|FG005|NOT COMPLETED|Optional CHU Sub-Study (During OLTP)||0
3267063|NCT02630459|4001571|FG006|NOT COMPLETED|Optional CHU Sub-Study (During OLTP)||0
3267064|NCT02630459|4001572|FG007|NOT COMPLETED|Optional CHU Sub-Study (During OLTP)||0
3267065|NCT02630563|4001597|FG000|STARTED|Overall Study||9
3267066|NCT02630563|4001597|FG000|COMPLETED|Overall Study||8
3267067|NCT02630563|4001597|FG000|NOT COMPLETED|Overall Study||1
3267068|NCT02630693|4001604|FG000|STARTED|Overall Study||90
3267069|NCT02630693|4001605|FG001|STARTED|Overall Study||90
3267070|NCT02630693|4001604|FG000|COMPLETED|Overall Study||90
3267071|NCT02630693|4001605|FG001|COMPLETED|Overall Study||89
3267072|NCT02630693|4001604|FG000|NOT COMPLETED|Overall Study||0
3267073|NCT02630693|4001605|FG001|NOT COMPLETED|Overall Study||1
3267074|NCT02630706|4001614|FG000|STARTED|Overall Study||170
3267075|NCT02630706|4001615|FG001|STARTED|Overall Study||169
3267076|NCT02630706|4001616|FG002|STARTED|Overall Study||167
3267077|NCT02630706|4001614|FG000|Treated|Overall Study||170
3267078|NCT02630706|4001615|FG001|Treated|Overall Study||169
3267079|NCT02630706|4001616|FG002|Treated|Overall Study||167
3267080|NCT02630706|4001614|FG000|COMPLETED|Overall Study||163
3267081|NCT02630706|4001615|FG001|COMPLETED|Overall Study||160
3267082|NCT02630706|4001616|FG002|COMPLETED|Overall Study||157
3267083|NCT02630706|4001614|FG000|NOT COMPLETED|Overall Study||7
3267084|NCT02630706|4001615|FG001|NOT COMPLETED|Overall Study||9
3267085|NCT02630706|4001616|FG002|NOT COMPLETED|Overall Study||10
3267086|NCT02630719|4001626|FG000|STARTED|Overall Study||4
3267087|NCT02630719|4001627|FG001|STARTED|Overall Study||6
3267088|NCT02630719|4001626|FG000|COMPLETED|Overall Study||4
3267089|NCT02630719|4001627|FG001|COMPLETED|Overall Study||6
3267090|NCT02630719|4001626|FG000|NOT COMPLETED|Overall Study||0
3267091|NCT02630719|4001627|FG001|NOT COMPLETED|Overall Study||0
3267092|NCT02630953|4001635|FG000|STARTED|6 Month Assessment||97
3267093|NCT02630953|4001636|FG001|STARTED|6 Month Assessment||102
3267094|NCT02630953|4001635|FG000|COMPLETED|6 Month Assessment||83
3267095|NCT02630953|4001636|FG001|COMPLETED|6 Month Assessment||70
3267096|NCT02630953|4001635|FG000|NOT COMPLETED|6 Month Assessment||14
3267097|NCT02630953|4001636|FG001|NOT COMPLETED|6 Month Assessment||32
3267098|NCT02630953|4001635|FG000|STARTED|12 Month Assessment||97
3267099|NCT02630953|4001636|FG001|STARTED|12 Month Assessment||102
3267100|NCT02630953|4001635|FG000|COMPLETED|12 Month Assessment||73
3267101|NCT02630953|4001636|FG001|COMPLETED|12 Month Assessment||64
3267102|NCT02630953|4001635|FG000|NOT COMPLETED|12 Month Assessment||24
3267103|NCT02630953|4001636|FG001|NOT COMPLETED|12 Month Assessment||38
3267104|NCT02630966|4001644|FG000|STARTED|Overall Study||16
3267105|NCT02630966|4001645|FG001|STARTED|Overall Study||18
3375552|NCT01636466|4108671|FG000|STARTED|Overall Study||1
3375553|NCT01636466|4108672|FG001|STARTED|Overall Study||0
3375554|NCT01636466|4108671|FG000|COMPLETED|Overall Study||0
3375555|NCT01636466|4108672|FG001|COMPLETED|Overall Study||0
3375556|NCT01636466|4108671|FG000|NOT COMPLETED|Overall Study||1
3375557|NCT01636466|4108672|FG001|NOT COMPLETED|Overall Study||0
3375558|NCT01629329|4108680|FG000|STARTED|Overall Study||0
3375559|NCT01629329|4108681|FG001|STARTED|Overall Study||0
3375560|NCT01629329|4108680|FG000|COMPLETED|Overall Study||0
3375561|NCT01629329|4108681|FG001|COMPLETED|Overall Study||0
3375562|NCT01629329|4108680|FG000|NOT COMPLETED|Overall Study||0
3375563|NCT01629329|4108681|FG001|NOT COMPLETED|Overall Study||0
3375564|NCT01627899|4108687|FG000|STARTED|Overall Study||5
3375565|NCT01627899|4108687|FG000|COMPLETED|Overall Study||0
3267106|NCT02630966|4001644|FG000|COMPLETED|Overall Study||14
3267107|NCT02630966|4001645|FG001|COMPLETED|Overall Study||10
3267108|NCT02630966|4001644|FG000|NOT COMPLETED|Overall Study||2
3267109|NCT02630966|4001645|FG001|NOT COMPLETED|Overall Study||8
3267110|NCT02630992|4001651|FG000|STARTED|Overall Study||112
3267111|NCT02630992|4001651|FG000|COMPLETED|Overall Study||99
3267112|NCT02630992|4001651|FG000|NOT COMPLETED|Overall Study||13
3267113|NCT02631057|4001657|FG000|STARTED|Overall Study||899
3267114|NCT02631057|4001658|FG001|STARTED|Overall Study||3414
3267115|NCT02631057|4001657|FG000|COMPLETED|Overall Study||899
3267116|NCT02631057|4001658|FG001|COMPLETED|Overall Study||3414
3267117|NCT02631057|4001657|FG000|NOT COMPLETED|Overall Study||0
3267118|NCT02631057|4001658|FG001|NOT COMPLETED|Overall Study||0
3267119|NCT02631525|4001666|FG000|STARTED|Overall Study||20
3267120|NCT02631525|4001667|FG001|STARTED|Overall Study||20
3267121|NCT02631525|4001666|FG000|COMPLETED|Overall Study||20
3267122|NCT02631525|4001667|FG001|COMPLETED|Overall Study||20
3267123|NCT02631525|4001666|FG000|NOT COMPLETED|Overall Study||0
3267124|NCT02631525|4001667|FG001|NOT COMPLETED|Overall Study||0
3267125|NCT02631538|4001677|FG000|STARTED|Treatment Period (Up to Week 52)||13
3267126|NCT02631538|4001678|FG001|STARTED|Treatment Period (Up to Week 52)||24
3267127|NCT02631538|4001679|FG002|STARTED|Treatment Period (Up to Week 52)||24
3267128|NCT02631538|4001680|FG003|STARTED|Treatment Period (Up to Week 52)||25
3267129|NCT02631538|4001677|FG000|COMPLETED|Treatment Period (Up to Week 52)||9
3267130|NCT02631538|4001678|FG001|COMPLETED|Treatment Period (Up to Week 52)||17
3267131|NCT02631538|4001679|FG002|COMPLETED|Treatment Period (Up to Week 52)||19
3267132|NCT02631538|4001680|FG003|COMPLETED|Treatment Period (Up to Week 52)||17
3267133|NCT02631538|4001677|FG000|NOT COMPLETED|Treatment Period (Up to Week 52)||4
3267134|NCT02631538|4001678|FG001|NOT COMPLETED|Treatment Period (Up to Week 52)||7
3267135|NCT02631538|4001679|FG002|NOT COMPLETED|Treatment Period (Up to Week 52)||5
3267136|NCT02631538|4001680|FG003|NOT COMPLETED|Treatment Period (Up to Week 52)||8
3267137|NCT02631538|4001677|FG000|STARTED|General Follow-up (GFU) (Up to Week 68)||9
3267138|NCT02631538|4001678|FG001|STARTED|General Follow-up (GFU) (Up to Week 68)||17
3267139|NCT02631538|4001679|FG002|STARTED|General Follow-up (GFU) (Up to Week 68)||19
3267140|NCT02631538|4001680|FG003|STARTED|General Follow-up (GFU) (Up to Week 68)||17
3267141|NCT02631538|4001677|FG000|COMPLETED|General Follow-up (GFU) (Up to Week 68)||8
3267142|NCT02631538|4001678|FG001|COMPLETED|General Follow-up (GFU) (Up to Week 68)||17
3267143|NCT02631538|4001679|FG002|COMPLETED|General Follow-up (GFU) (Up to Week 68)||19
3267144|NCT02631538|4001680|FG003|COMPLETED|General Follow-up (GFU) (Up to Week 68)||16
3267145|NCT02631538|4001677|FG000|NOT COMPLETED|General Follow-up (GFU) (Up to Week 68)||1
3267146|NCT02631538|4001678|FG001|NOT COMPLETED|General Follow-up (GFU) (Up to Week 68)||0
3267147|NCT02631538|4001679|FG002|NOT COMPLETED|General Follow-up (GFU) (Up to Week 68)||0
3267148|NCT02631538|4001680|FG003|NOT COMPLETED|General Follow-up (GFU) (Up to Week 68)||1
3267149|NCT02631551|4001694|FG000|STARTED|Overall Study||302
3267150|NCT02631551|4001695|FG001|STARTED|Overall Study||297
3267151|NCT02631551|4001696|FG002|STARTED|Overall Study||294
3267152|NCT02631551|4001697|FG003|STARTED|Overall Study||287
3267153|NCT02631551|4001694|FG000|COMPLETED|Overall Study||289
3267154|NCT02631551|4001695|FG001|COMPLETED|Overall Study||278
3267155|NCT02631551|4001696|FG002|COMPLETED|Overall Study||283
3267156|NCT02631551|4001697|FG003|COMPLETED|Overall Study||276
3267157|NCT02631551|4001694|FG000|NOT COMPLETED|Overall Study||13
3267158|NCT02631551|4001695|FG001|NOT COMPLETED|Overall Study||19
3267159|NCT02631551|4001696|FG002|NOT COMPLETED|Overall Study||11
3267160|NCT02631551|4001697|FG003|NOT COMPLETED|Overall Study||11
3267161|NCT02631577|4001709|FG000|STARTED|Overall Study||4
3267162|NCT02631577|4001710|FG001|STARTED|Overall Study||34
3267163|NCT02631577|4001709|FG000|COMPLETED|Overall Study||3
3267164|NCT02631577|4001710|FG001|COMPLETED|Overall Study||24
3267165|NCT02631577|4001709|FG000|NOT COMPLETED|Overall Study||1
3267166|NCT02631577|4001710|FG001|NOT COMPLETED|Overall Study||10
3267167|NCT02631590|4001716|FG000|STARTED|Overall Study||24
3267168|NCT02631590|4001716|FG000|COMPLETED|Overall Study||24
3267169|NCT02631590|4001716|FG000|NOT COMPLETED|Overall Study||0
3267170|NCT02631746|4001720|FG000|STARTED|Overall Study||3
3267171|NCT02631746|4001720|FG000|COMPLETED|Overall Study||0
3267172|NCT02631746|4001720|FG000|NOT COMPLETED|Overall Study||3
3267173|NCT02631772|4001726|FG000|STARTED|Overall Study||16
3267174|NCT02631772|4001727|FG001|STARTED|Overall Study||16
3267175|NCT02631772|4001726|FG000|COMPLETED|Overall Study||16
3267176|NCT02631772|4001727|FG001|COMPLETED|Overall Study||16
3267177|NCT02631772|4001726|FG000|NOT COMPLETED|Overall Study||0
3267178|NCT02631772|4001727|FG001|NOT COMPLETED|Overall Study||0
3267179|NCT02631850|4001737|FG000|STARTED|Treatment Period|One participant was withdrawn during treatment because medical records review revealed that the motor deficit was due to an old orthopedic injury and not stroke. This participant had experienced a Transient Ischemic Attack, but no stroke that resulted in lasting neurological motor deficit. 40 participants were thus analyzed for this group in the intent-to-treat analysis even though 41 began treatment.|41
3267180|NCT02631850|4001738|FG001|STARTED|Treatment Period||44
3267181|NCT02631850|4001739|FG002|STARTED|Treatment Period||45
3267182|NCT02631850|4001740|FG003|STARTED|Treatment Period||38
3267183|NCT02631850|4001737|FG000|COMPLETED|Treatment Period||38
3267184|NCT02631850|4001738|FG001|COMPLETED|Treatment Period||38
3267185|NCT02631850|4001739|FG002|COMPLETED|Treatment Period||41
3267186|NCT02631850|4001740|FG003|COMPLETED|Treatment Period||33
3267187|NCT02631850|4001737|FG000|NOT COMPLETED|Treatment Period||3
3267188|NCT02631850|4001738|FG001|NOT COMPLETED|Treatment Period||6
3267189|NCT02631850|4001739|FG002|NOT COMPLETED|Treatment Period||4
3267190|NCT02631850|4001740|FG003|NOT COMPLETED|Treatment Period||5
3267191|NCT02631850|4001737|FG000|STARTED|6 Month Follow up||38
3267192|NCT02631850|4001738|FG001|STARTED|6 Month Follow up||38
3267193|NCT02631850|4001739|FG002|STARTED|6 Month Follow up||41
3267194|NCT02631850|4001740|FG003|STARTED|6 Month Follow up||33
3267195|NCT02631850|4001737|FG000|COMPLETED|6 Month Follow up||31
3267196|NCT02631850|4001738|FG001|COMPLETED|6 Month Follow up||25
3267197|NCT02631850|4001739|FG002|COMPLETED|6 Month Follow up||35
3267198|NCT02631850|4001740|FG003|COMPLETED|6 Month Follow up||22
3267199|NCT02631850|4001737|FG000|NOT COMPLETED|6 Month Follow up||7
3267200|NCT02631850|4001738|FG001|NOT COMPLETED|6 Month Follow up||13
3267201|NCT02631850|4001739|FG002|NOT COMPLETED|6 Month Follow up||6
3267202|NCT02631850|4001740|FG003|NOT COMPLETED|6 Month Follow up||11
3267203|NCT02631876|4001753|FG000|STARTED|Overall Study||248
3267204|NCT02631876|4001754|FG001|STARTED|Overall Study||118
3267205|NCT02631876|4001753|FG000|Safety Population|Overall Study||243
3267206|NCT02631876|4001754|FG001|Safety Population|Overall Study||109
3267207|NCT02631876|4001753|FG000|COMPLETED|Overall Study||129
3267208|NCT02631876|4001754|FG001|COMPLETED|Overall Study||55
3267209|NCT02631876|4001753|FG000|NOT COMPLETED|Overall Study||119
3267210|NCT02631876|4001754|FG001|NOT COMPLETED|Overall Study||63
3267211|NCT02631954|4001763|FG000|STARTED|Overall Study||12
3267212|NCT02631954|4001764|FG001|STARTED|Overall Study||12
3267213|NCT02631954|4001763|FG000|COMPLETED|Overall Study||12
3267214|NCT02631954|4001764|FG001|COMPLETED|Overall Study||12
3267215|NCT02631954|4001763|FG000|NOT COMPLETED|Overall Study||0
3267216|NCT02631954|4001764|FG001|NOT COMPLETED|Overall Study||0
3267217|NCT02632110|4001775|FG000|STARTED|Overall Study||25
3267218|NCT02632110|4001776|FG001|STARTED|Overall Study||25
3267219|NCT02632110|4001777|FG002|STARTED|Overall Study||27
3267220|NCT02632110|4001778|FG003|STARTED|Overall Study||27
3267221|NCT02632110|4001779|FG004|STARTED|Overall Study||29
3267222|NCT02632110|4001780|FG005|STARTED|Overall Study||29
3267223|NCT02632110|4001781|FG006|STARTED|Overall Study||26
3267224|NCT02632110|4001782|FG007|STARTED|Overall Study||26
3267225|NCT02632110|4001783|FG008|STARTED|Overall Study||30
3267226|NCT02632110|4001784|FG009|STARTED|Overall Study||30
3267227|NCT02632110|4001775|FG000|COMPLETED|Overall Study||24
3267228|NCT02632110|4001776|FG001|COMPLETED|Overall Study||24
3267229|NCT02632110|4001777|FG002|COMPLETED|Overall Study||27
3267230|NCT02632110|4001778|FG003|COMPLETED|Overall Study||27
3267231|NCT02632110|4001779|FG004|COMPLETED|Overall Study||28
3267232|NCT02632110|4001780|FG005|COMPLETED|Overall Study||28
3267233|NCT02632110|4001781|FG006|COMPLETED|Overall Study||23
3267234|NCT02632110|4001782|FG007|COMPLETED|Overall Study||23
3267235|NCT02632110|4001783|FG008|COMPLETED|Overall Study||29
3267236|NCT02632110|4001784|FG009|COMPLETED|Overall Study||29
3267237|NCT02632110|4001775|FG000|NOT COMPLETED|Overall Study||1
3267238|NCT02632110|4001776|FG001|NOT COMPLETED|Overall Study||1
3267239|NCT02632110|4001777|FG002|NOT COMPLETED|Overall Study||0
3267240|NCT02632110|4001778|FG003|NOT COMPLETED|Overall Study||0
3267241|NCT02632110|4001779|FG004|NOT COMPLETED|Overall Study||1
3267242|NCT02632110|4001780|FG005|NOT COMPLETED|Overall Study||1
3267243|NCT02632110|4001781|FG006|NOT COMPLETED|Overall Study||3
3267244|NCT02632110|4001782|FG007|NOT COMPLETED|Overall Study||3
3267245|NCT02632110|4001783|FG008|NOT COMPLETED|Overall Study||1
3267246|NCT02632110|4001784|FG009|NOT COMPLETED|Overall Study||1
3267247|NCT02632526|4001807|FG000|STARTED|Overall Study||36
3267248|NCT02632526|4001808|FG001|STARTED|Overall Study||12
3267249|NCT02632526|4001809|FG002|STARTED|Overall Study||24
3267250|NCT02632526|4001810|FG003|STARTED|Overall Study||12
3267251|NCT02632526|4001811|FG004|STARTED|Overall Study||4
3267252|NCT02632526|4001812|FG005|STARTED|Overall Study||8
3267253|NCT02632526|4001807|FG000|COMPLETED|Overall Study||36
3267254|NCT02632526|4001808|FG001|COMPLETED|Overall Study||12
3267255|NCT02632526|4001809|FG002|COMPLETED|Overall Study||24
3267256|NCT02632526|4001810|FG003|COMPLETED|Overall Study||12
3267257|NCT02632526|4001811|FG004|COMPLETED|Overall Study||4
3267258|NCT02632526|4001812|FG005|COMPLETED|Overall Study||8
3267259|NCT02632526|4001807|FG000|NOT COMPLETED|Overall Study||0
3267260|NCT02632526|4001808|FG001|NOT COMPLETED|Overall Study||0
3267261|NCT02632526|4001809|FG002|NOT COMPLETED|Overall Study||0
3267262|NCT02632526|4001810|FG003|NOT COMPLETED|Overall Study||0
3267263|NCT02632526|4001811|FG004|NOT COMPLETED|Overall Study||0
3267264|NCT02632526|4001812|FG005|NOT COMPLETED|Overall Study||0
3267265|NCT02632552|4001859|FG000|STARTED|Overall Study||80
3267266|NCT02632552|4001860|FG001|STARTED|Overall Study||60
3267267|NCT02632552|4001859|FG000|COMPLETED|Overall Study||57
3267268|NCT02632552|4001860|FG001|COMPLETED|Overall Study||50
3267269|NCT02632552|4001859|FG000|NOT COMPLETED|Overall Study||23
3267270|NCT02632552|4001860|FG001|NOT COMPLETED|Overall Study||10
3267271|NCT02632747|4001869|FG000|STARTED|Treatment Period 1||16
3267272|NCT02632747|4001870|FG001|STARTED|Treatment Period 1||15
3267273|NCT02632747|4001869|FG000|COMPLETED|Treatment Period 1||16
3267274|NCT02632747|4001870|FG001|COMPLETED|Treatment Period 1||15
3267275|NCT02632747|4001869|FG000|NOT COMPLETED|Treatment Period 1||0
3267276|NCT02632747|4001870|FG001|NOT COMPLETED|Treatment Period 1||0
3267277|NCT02632747|4001869|FG000|STARTED|Wash-out Period||16
3267278|NCT02632747|4001870|FG001|STARTED|Wash-out Period||15
3267279|NCT02632747|4001869|FG000|COMPLETED|Wash-out Period||15
3267280|NCT02632747|4001870|FG001|COMPLETED|Wash-out Period||15
3267281|NCT02632747|4001869|FG000|NOT COMPLETED|Wash-out Period||1
3267282|NCT02632747|4001870|FG001|NOT COMPLETED|Wash-out Period||0
3267283|NCT02632747|4001869|FG000|STARTED|Treatment Period 2||15
3267284|NCT02632747|4001870|FG001|STARTED|Treatment Period 2||15
3267285|NCT02632747|4001869|FG000|COMPLETED|Treatment Period 2||15
3267286|NCT02632747|4001870|FG001|COMPLETED|Treatment Period 2||15
3267287|NCT02632747|4001869|FG000|NOT COMPLETED|Treatment Period 2||0
3267288|NCT02632747|4001870|FG001|NOT COMPLETED|Treatment Period 2||0
3267289|NCT02632786|4001878|FG000|STARTED|Overall Study||66
3267290|NCT02632786|4001879|FG001|STARTED|Overall Study||63
3267291|NCT02632786|4001878|FG000|Informed Consent Obtained|Overall Study||66
3267292|NCT02632786|4001879|FG001|Informed Consent Obtained|Overall Study||63
3267293|NCT02632786|4001878|FG000|Randomized and Dosed|Overall Study||66
3267294|NCT02632786|4001879|FG001|Randomized and Dosed|Overall Study||63
3267295|NCT02632786|4001878|FG000|COMPLETED|Overall Study||55
3267296|NCT02632786|4001879|FG001|COMPLETED|Overall Study||56
3267297|NCT02632786|4001878|FG000|NOT COMPLETED|Overall Study||11
3267298|NCT02632786|4001879|FG001|NOT COMPLETED|Overall Study||7
3267299|NCT02632812|4001888|FG000|STARTED|Overall Study||12
3267300|NCT02632812|4001889|FG001|STARTED|Overall Study||12
3267301|NCT02632812|4001888|FG000|COMPLETED|Overall Study||12
3267302|NCT02632812|4001889|FG001|COMPLETED|Overall Study||12
3267303|NCT02632812|4001888|FG000|NOT COMPLETED|Overall Study||0
3267304|NCT02632812|4001889|FG001|NOT COMPLETED|Overall Study||0
3267305|NCT02632838|4001897|FG000|STARTED|Overall Study||15
3267306|NCT02632838|4001898|FG001|STARTED|Overall Study||15
3267307|NCT02632838|4001897|FG000|COMPLETED|Overall Study||12
3267308|NCT02632838|4001898|FG001|COMPLETED|Overall Study||13
3267309|NCT02632838|4001897|FG000|NOT COMPLETED|Overall Study||3
3267310|NCT02632838|4001898|FG001|NOT COMPLETED|Overall Study||2
3267311|NCT02633020|4001910|FG000|STARTED|Overall Study||19
3267312|NCT02633020|4001911|FG001|STARTED|Overall Study||9
3267313|NCT02633020|4001910|FG000|COMPLETED|Overall Study||18
3267314|NCT02633020|4001911|FG001|COMPLETED|Overall Study||9
3267315|NCT02633020|4001910|FG000|NOT COMPLETED|Overall Study||1
3267316|NCT02633020|4001911|FG001|NOT COMPLETED|Overall Study||0
3267317|NCT02633046|4001917|FG000|STARTED|Overall Study||63
3267318|NCT02633046|4001917|FG000|Safety Population|Overall Study||63
3267319|NCT02633046|4001917|FG000|COMPLETED|Overall Study||36
3267320|NCT02633046|4001917|FG000|NOT COMPLETED|Overall Study||27
3267321|NCT02633215|4001923|FG000|STARTED|Overall Study||18
3267322|NCT02633215|4001924|FG001|STARTED|Overall Study||18
3267323|NCT02633215|4001923|FG000|COMPLETED|Overall Study||16
3267324|NCT02633215|4001924|FG001|COMPLETED|Overall Study||15
3267325|NCT02633215|4001923|FG000|NOT COMPLETED|Overall Study||2
3267326|NCT02633215|4001924|FG001|NOT COMPLETED|Overall Study||3
3267327|NCT02633306|4001930|FG000|STARTED|Overall Study||9
3267328|NCT02633306|4001930|FG000|COMPLETED|Overall Study||6
3267329|NCT02633306|4001930|FG000|NOT COMPLETED|Overall Study||3
3267330|NCT02633358|4001937|FG000|STARTED|Overall Study||87
3267331|NCT02633358|4001938|FG001|STARTED|Overall Study||54
3267332|NCT02633358|4001937|FG000|COMPLETED|Overall Study||87
3267333|NCT02633358|4001938|FG001|COMPLETED|Overall Study||54
3267334|NCT02633358|4001937|FG000|NOT COMPLETED|Overall Study||0
3267335|NCT02633358|4001938|FG001|NOT COMPLETED|Overall Study||0
3267336|NCT02633371|4001945|FG000|STARTED|Overall Study||10
3267337|NCT02633371|4001945|FG000|COMPLETED|Overall Study||7
3267338|NCT02633371|4001945|FG000|NOT COMPLETED|Overall Study||3
3267339|NCT02633488|4001951|FG000|STARTED|Overall Study||6
3267340|NCT02633488|4001952|FG001|STARTED|Overall Study||5
3267341|NCT02633488|4001951|FG000|COMPLETED|Overall Study||6
3267342|NCT02633488|4001952|FG001|COMPLETED|Overall Study||5
3267343|NCT02633488|4001951|FG000|NOT COMPLETED|Overall Study||0
3267344|NCT02633488|4001952|FG001|NOT COMPLETED|Overall Study||0
3267345|NCT02633501|4001964|FG000|STARTED|Overall Study||14
3267346|NCT02633501|4001965|FG001|STARTED|Overall Study||14
3267347|NCT02633501|4001966|FG002|STARTED|Overall Study||62
3267348|NCT02633501|4001967|FG003|STARTED|Overall Study||63
3267349|NCT02633501|4001968|FG004|STARTED|Overall Study||64
3267350|NCT02633501|4001969|FG005|STARTED|Overall Study||63
3267351|NCT02633501|4001964|FG000|COMPLETED|Overall Study||12
3267352|NCT02633501|4001965|FG001|COMPLETED|Overall Study||11
3267353|NCT02633501|4001966|FG002|COMPLETED|Overall Study||55
3267354|NCT02633501|4001967|FG003|COMPLETED|Overall Study||59
3267355|NCT02633501|4001968|FG004|COMPLETED|Overall Study||53
3267356|NCT02633501|4001969|FG005|COMPLETED|Overall Study||48
3267357|NCT02633501|4001964|FG000|NOT COMPLETED|Overall Study||2
3267358|NCT02633501|4001965|FG001|NOT COMPLETED|Overall Study||3
3267359|NCT02633501|4001966|FG002|NOT COMPLETED|Overall Study||7
3267360|NCT02633501|4001967|FG003|NOT COMPLETED|Overall Study||4
3267361|NCT02633501|4001968|FG004|NOT COMPLETED|Overall Study||11
3267362|NCT02633501|4001969|FG005|NOT COMPLETED|Overall Study||15
3267363|NCT02633527|4001993|FG000|STARTED|Overall Study||24
3267364|NCT02633527|4001994|FG001|STARTED|Overall Study||48
3267365|NCT02633527|4001995|FG002|STARTED|Overall Study||50
3267366|NCT02633527|4001996|FG003|STARTED|Overall Study||49
3267367|NCT02633527|4001997|FG004|STARTED|Overall Study||51
3267368|NCT02633527|4001993|FG000|COMPLETED|Overall Study||21
3267369|NCT02633527|4001994|FG001|COMPLETED|Overall Study||37
3267370|NCT02633527|4001995|FG002|COMPLETED|Overall Study||33
3267371|NCT02633527|4001996|FG003|COMPLETED|Overall Study||35
3267372|NCT02633527|4001997|FG004|COMPLETED|Overall Study||34
3267373|NCT02633527|4001993|FG000|NOT COMPLETED|Overall Study||3
3267374|NCT02633527|4001994|FG001|NOT COMPLETED|Overall Study||11
3267375|NCT02633527|4001995|FG002|NOT COMPLETED|Overall Study||17
3267376|NCT02633527|4001996|FG003|NOT COMPLETED|Overall Study||14
3267377|NCT02633527|4001997|FG004|NOT COMPLETED|Overall Study||17
3267378|NCT02633735|4002011|FG000|STARTED|Pre-implementation Phase||788
3267379|NCT02633735|4002012|FG001|STARTED|Pre-implementation Phase||1011
3267380|NCT02633735|4002011|FG000|COMPLETED|Pre-implementation Phase||788
3267381|NCT02633735|4002012|FG001|COMPLETED|Pre-implementation Phase||1011
3267382|NCT02633735|4002011|FG000|NOT COMPLETED|Pre-implementation Phase||0
3267383|NCT02633735|4002012|FG001|NOT COMPLETED|Pre-implementation Phase||0
3267384|NCT02633735|4002011|FG000|STARTED|Implementation Phase||1991
3375566|NCT01627899|4108687|FG000|NOT COMPLETED|Overall Study||5
3375567|NCT01632020|4108693|FG000|STARTED|Overall Study||4
3375568|NCT01632020|4108694|FG001|STARTED|Overall Study||3
3375569|NCT01632020|4108693|FG000|COMPLETED|Overall Study||2
3375570|NCT01632020|4108694|FG001|COMPLETED|Overall Study||3
3375571|NCT01632020|4108693|FG000|NOT COMPLETED|Overall Study||2
3375572|NCT01632020|4108694|FG001|NOT COMPLETED|Overall Study||0
3267385|NCT02633735|4002012|FG001|STARTED|Implementation Phase||2150
3267386|NCT02633735|4002011|FG000|COMPLETED|Implementation Phase||1991
3267387|NCT02633735|4002012|FG001|COMPLETED|Implementation Phase||2150
3267388|NCT02633735|4002011|FG000|NOT COMPLETED|Implementation Phase||0
3267389|NCT02633735|4002012|FG001|NOT COMPLETED|Implementation Phase||0
3267390|NCT02633787|4002018|FG000|STARTED|Overall Study||110
3267391|NCT02633787|4002018|FG000|COMPLETED|Overall Study||109
3267392|NCT02633787|4002018|FG000|NOT COMPLETED|Overall Study||1
3267393|NCT02633800|4002024|FG000|STARTED|Overall Study||44
3267394|NCT02633800|4002025|FG001|STARTED|Overall Study||43
3267395|NCT02633800|4002024|FG000|COMPLETED|Overall Study||0
3267396|NCT02633800|4002025|FG001|COMPLETED|Overall Study||0
3267397|NCT02633800|4002024|FG000|NOT COMPLETED|Overall Study||44
3267398|NCT02633800|4002025|FG001|NOT COMPLETED|Overall Study||43
3267399|NCT02633956|4002035|FG000|STARTED|Overall Study||20
3267400|NCT02633956|4002036|FG001|STARTED|Overall Study||21
3267401|NCT02633956|4002037|FG002|STARTED|Overall Study||22
3267402|NCT02633956|4002038|FG003|STARTED|Overall Study||21
3267403|NCT02633956|4002035|FG000|COMPLETED|Overall Study||19
3267404|NCT02633956|4002036|FG001|COMPLETED|Overall Study||19
3267405|NCT02633956|4002037|FG002|COMPLETED|Overall Study||20
3267406|NCT02633956|4002038|FG003|COMPLETED|Overall Study||21
3267407|NCT02633956|4002035|FG000|NOT COMPLETED|Overall Study||1
3267408|NCT02633956|4002036|FG001|NOT COMPLETED|Overall Study||2
3267409|NCT02633956|4002037|FG002|NOT COMPLETED|Overall Study||2
3267410|NCT02633956|4002038|FG003|NOT COMPLETED|Overall Study||0
3267411|NCT02634073|4002052|FG000|STARTED|Overall Study||4
3267412|NCT02634073|4002053|FG001|STARTED|Overall Study||4
3267413|NCT02634073|4002054|FG002|STARTED|Overall Study||4
3267414|NCT02634073|4002055|FG003|STARTED|Overall Study||4
3267415|NCT02634073|4002052|FG000|COMPLETED|Overall Study||4
3267416|NCT02634073|4002053|FG001|COMPLETED|Overall Study||4
3267417|NCT02634073|4002054|FG002|COMPLETED|Overall Study||4
3267418|NCT02634073|4002055|FG003|COMPLETED|Overall Study||4
3267419|NCT02634073|4002052|FG000|NOT COMPLETED|Overall Study||0
3267420|NCT02634073|4002053|FG001|NOT COMPLETED|Overall Study||0
3267421|NCT02634073|4002054|FG002|NOT COMPLETED|Overall Study||0
3267422|NCT02634073|4002055|FG003|NOT COMPLETED|Overall Study||0
3267423|NCT02634151|4002067|FG000|STARTED|Overall Study||53
3267424|NCT02634151|4002068|FG001|STARTED|Overall Study||52
3267425|NCT02634151|4002067|FG000|Full Analysis Set|Overall Study||53
3267426|NCT02634151|4002068|FG001|Full Analysis Set|Overall Study||52
3267427|NCT02634151|4002067|FG000|Safety Set|Overall Study||54
3267428|NCT02634151|4002068|FG001|Safety Set|Overall Study||51
3267429|NCT02634151|4002067|FG000|COMPLETED|Overall Study||52
3267430|NCT02634151|4002068|FG001|COMPLETED|Overall Study||50
3267431|NCT02634151|4002067|FG000|NOT COMPLETED|Overall Study||1
3267432|NCT02634151|4002068|FG001|NOT COMPLETED|Overall Study||2
3267433|NCT02634177|4002076|FG000|STARTED|Overall Study||151
3267434|NCT02634177|4002077|FG001|STARTED|Overall Study||153
3267435|NCT02634177|4002076|FG000|COMPLETED|Overall Study||140
3267436|NCT02634177|4002077|FG001|COMPLETED|Overall Study||141
3267437|NCT02634177|4002076|FG000|NOT COMPLETED|Overall Study||11
3267438|NCT02634177|4002077|FG001|NOT COMPLETED|Overall Study||12
3267439|NCT02634320|4002083|FG000|STARTED|Overall Study||51
3267440|NCT02634320|4002083|FG000|COMPLETED|Overall Study||35
3267441|NCT02634320|4002083|FG000|NOT COMPLETED|Overall Study||16
3267442|NCT02634333|4002089|FG000|STARTED|Overall Study|Number of Eyes|200
3267443|NCT02634333|4002090|FG001|STARTED|Overall Study|Number of Eyes|199
3267444|NCT02634333|4002089|FG000|COMPLETED|Overall Study|Number of Eyes|160
3267445|NCT02634333|4002090|FG001|COMPLETED|Overall Study|Number of Eyes|167
3267446|NCT02634333|4002089|FG000|NOT COMPLETED|Overall Study||40
3267447|NCT02634333|4002090|FG001|NOT COMPLETED|Overall Study||32
3267448|NCT02634346|4002100|FG000|STARTED|Overall Study||134
3267449|NCT02634346|4002101|FG001|STARTED|Overall Study||133
3267450|NCT02634346|4002102|FG002|STARTED|Overall Study||134
3267451|NCT02634346|4002100|FG000|COMPLETED|Overall Study||122
3267452|NCT02634346|4002101|FG001|COMPLETED|Overall Study||119
3267453|NCT02634346|4002102|FG002|COMPLETED|Overall Study||111
3267454|NCT02634346|4002100|FG000|NOT COMPLETED|Overall Study||12
3267455|NCT02634346|4002101|FG001|NOT COMPLETED|Overall Study||14
3267456|NCT02634346|4002102|FG002|NOT COMPLETED|Overall Study||23
3267457|NCT02634580|4002114|FG000|STARTED|Double-blind Treatment Period||10
3267458|NCT02634580|4002115|FG001|STARTED|Double-blind Treatment Period||11
3267459|NCT02634580|4002116|FG002|STARTED|Double-blind Treatment Period||19
3267460|NCT02634580|4002117|FG003|STARTED|Double-blind Treatment Period||21
3267461|NCT02634580|4002114|FG000|COMPLETED|Double-blind Treatment Period||9
3267462|NCT02634580|4002115|FG001|COMPLETED|Double-blind Treatment Period||11
3267463|NCT02634580|4002116|FG002|COMPLETED|Double-blind Treatment Period||18
3267464|NCT02634580|4002117|FG003|COMPLETED|Double-blind Treatment Period||20
3267465|NCT02634580|4002114|FG000|NOT COMPLETED|Double-blind Treatment Period||1
3267466|NCT02634580|4002115|FG001|NOT COMPLETED|Double-blind Treatment Period||0
3267467|NCT02634580|4002116|FG002|NOT COMPLETED|Double-blind Treatment Period||1
3267468|NCT02634580|4002117|FG003|NOT COMPLETED|Double-blind Treatment Period||1
3267469|NCT02634580|4002114|FG000|STARTED|Open-label Extension Period||9
3267470|NCT02634580|4002115|FG001|STARTED|Open-label Extension Period||11
3267471|NCT02634580|4002116|FG002|STARTED|Open-label Extension Period||18
3267472|NCT02634580|4002117|FG003|STARTED|Open-label Extension Period|Includes 1 participant who did not complete the double-blind period but had study visits during OLE|21
3267473|NCT02634580|4002114|FG000|Received Open-label Treatment|Open-label Extension Period||9
3267474|NCT02634580|4002115|FG001|Received Open-label Treatment|Open-label Extension Period||11
3267475|NCT02634580|4002116|FG002|Received Open-label Treatment|Open-label Extension Period||18
3267476|NCT02634580|4002117|FG003|Received Open-label Treatment|Open-label Extension Period||20
3267477|NCT02634580|4002114|FG000|COMPLETED|Open-label Extension Period||9
3267478|NCT02634580|4002115|FG001|COMPLETED|Open-label Extension Period||10
3267479|NCT02634580|4002116|FG002|COMPLETED|Open-label Extension Period||18
3267480|NCT02634580|4002117|FG003|COMPLETED|Open-label Extension Period||20
3375573|NCT01602471|4108700|FG000|STARTED|Overall Study||4
3375574|NCT01602471|4108700|FG000|COMPLETED|Overall Study||4
3375575|NCT01602471|4108700|FG000|NOT COMPLETED|Overall Study||0
3375576|NCT01619800|4108706|FG000|STARTED|Overall Study||2
3375577|NCT01619800|4108707|FG001|STARTED|Overall Study||0
3375578|NCT01619800|4108706|FG000|COMPLETED|Overall Study||0
3375579|NCT01619800|4108707|FG001|COMPLETED|Overall Study||0
3375580|NCT01619800|4108706|FG000|NOT COMPLETED|Overall Study||2
3375581|NCT01619800|4108707|FG001|NOT COMPLETED|Overall Study||0
3375582|NCT01608906|4108713|FG000|STARTED|Overall Study||152
3375583|NCT01608906|4108713|FG000|COMPLETED|Overall Study||113
3375584|NCT01608906|4108713|FG000|NOT COMPLETED|Overall Study||39
3375585|NCT01621737|4108718|FG000|STARTED|Overall Study||0
3375586|NCT01621737|4108718|FG000|COMPLETED|Overall Study||0
3375587|NCT01621737|4108718|FG000|NOT COMPLETED|Overall Study||0
3375588|NCT01614067|4108724|FG000|STARTED|Overall Study||15
3375589|NCT01614067|4108725|FG001|STARTED|Overall Study||15
3375590|NCT01614067|4108724|FG000|COMPLETED|Overall Study||0
3375591|NCT01614067|4108725|FG001|COMPLETED|Overall Study||0
3375592|NCT01614067|4108724|FG000|NOT COMPLETED|Overall Study||15
3375593|NCT01614067|4108725|FG001|NOT COMPLETED|Overall Study||15
3375594|NCT01607320|4108731|FG000|STARTED|Overall Study|The study was randomized between the two treatments and was never unblinded,therefore unknown.|0
3375595|NCT01607320|4108732|FG001|STARTED|Overall Study|The study was randomized between the two treatments and was never unblinded,therefore unknown.|0
3375596|NCT01607320|4108731|FG000|COMPLETED|Overall Study|The study was randomized between the 2 treatments and was never unblinded,so unknown.|0
3375597|NCT01607320|4108732|FG001|COMPLETED|Overall Study|The study was randomized between the two treatments and was never unblinded,therefore unknown.|0
3375598|NCT01607320|4108731|FG000|NOT COMPLETED|Overall Study||0
3375599|NCT01607320|4108732|FG001|NOT COMPLETED|Overall Study||0
3375600|NCT01605019|4108738|FG000|STARTED|Overall Study||4
3375601|NCT01605019|4108739|FG001|STARTED|Overall Study||0
3375602|NCT01605019|4108738|FG000|COMPLETED|Overall Study||1
3375603|NCT01605019|4108739|FG001|COMPLETED|Overall Study||0
3375604|NCT01605019|4108738|FG000|NOT COMPLETED|Overall Study||3
3375605|NCT01605019|4108739|FG001|NOT COMPLETED|Overall Study||0
3375606|NCT01609231|4108747|FG000|STARTED|Overall Study||6
3375607|NCT01609231|4108748|FG001|STARTED|Overall Study||5
3375608|NCT01609231|4108747|FG000|COMPLETED|Overall Study||3
3375609|NCT01609231|4108748|FG001|COMPLETED|Overall Study||2
3375610|NCT01609231|4108747|FG000|NOT COMPLETED|Overall Study||3
3375611|NCT01609231|4108748|FG001|NOT COMPLETED|Overall Study||3
3267481|NCT02634580|4002114|FG000|NOT COMPLETED|Open-label Extension Period||0
3267482|NCT02634580|4002115|FG001|NOT COMPLETED|Open-label Extension Period||1
3375612|NCT01602198|4108756|FG000|STARTED|Overall Study||0
3375613|NCT01602198|4108757|FG001|STARTED|Overall Study||1
3267483|NCT02634580|4002116|FG002|NOT COMPLETED|Open-label Extension Period||0
3267484|NCT02634580|4002117|FG003|NOT COMPLETED|Open-label Extension Period||1
3267485|NCT02634684|4002130|FG000|STARTED|Overall Study||19
3267486|NCT02634684|4002131|FG001|STARTED|Overall Study||19
3267487|NCT02634684|4002132|FG002|STARTED|Overall Study||21
3267488|NCT02634684|4002133|FG003|STARTED|Overall Study||23
3267489|NCT02634684|4002130|FG000|COMPLETED|Overall Study||19
3267490|NCT02634684|4002131|FG001|COMPLETED|Overall Study||19
3267491|NCT02634684|4002132|FG002|COMPLETED|Overall Study||21
3267492|NCT02634684|4002133|FG003|COMPLETED|Overall Study||23
3267493|NCT02634684|4002130|FG000|NOT COMPLETED|Overall Study||0
3267494|NCT02634684|4002131|FG001|NOT COMPLETED|Overall Study||0
3267495|NCT02634684|4002132|FG002|NOT COMPLETED|Overall Study||0
3267496|NCT02634684|4002133|FG003|NOT COMPLETED|Overall Study||0
3267497|NCT02634788|4002147|FG000|STARTED|Overall Study||79
3267498|NCT02634788|4002148|FG001|STARTED|Overall Study||81
3267499|NCT02634788|4002149|FG002|STARTED|Overall Study||80
3267500|NCT02634788|4002150|FG003|STARTED|Overall Study||82
3267501|NCT02634788|4002147|FG000|COMPLETED|Overall Study||75
3267502|NCT02634788|4002148|FG001|COMPLETED|Overall Study||71
3267503|NCT02634788|4002149|FG002|COMPLETED|Overall Study||75
3267504|NCT02634788|4002150|FG003|COMPLETED|Overall Study||77
3267505|NCT02634788|4002147|FG000|NOT COMPLETED|Overall Study||4
3267506|NCT02634788|4002148|FG001|NOT COMPLETED|Overall Study||10
3267507|NCT02634788|4002149|FG002|NOT COMPLETED|Overall Study||5
3267508|NCT02634788|4002150|FG003|NOT COMPLETED|Overall Study||5
3267509|NCT02634801|4002163|FG000|STARTED|Treatment Period (Weeks 0 to 24)||54
3267510|NCT02634801|4002164|FG001|STARTED|Treatment Period (Weeks 0 to 24)||54
3267511|NCT02634801|4002165|FG002|STARTED|Treatment Period (Weeks 0 to 24)||54
3267512|NCT02634801|4002163|FG000|Received at Least 1 Dose of Study Drug|Treatment Period (Weeks 0 to 24)||54
3267513|NCT02634801|4002164|FG001|Received at Least 1 Dose of Study Drug|Treatment Period (Weeks 0 to 24)||52
3267514|NCT02634801|4002165|FG002|Received at Least 1 Dose of Study Drug|Treatment Period (Weeks 0 to 24)||52
3267515|NCT02634801|4002163|FG000|COMPLETED|Treatment Period (Weeks 0 to 24)||50
3267516|NCT02634801|4002164|FG001|COMPLETED|Treatment Period (Weeks 0 to 24)||23
3267517|NCT02634801|4002165|FG002|COMPLETED|Treatment Period (Weeks 0 to 24)||49
3267518|NCT02634801|4002163|FG000|NOT COMPLETED|Treatment Period (Weeks 0 to 24)||4
3267519|NCT02634801|4002164|FG001|NOT COMPLETED|Treatment Period (Weeks 0 to 24)||31
3267520|NCT02634801|4002165|FG002|NOT COMPLETED|Treatment Period (Weeks 0 to 24)||5
3267521|NCT02634801|4002163|FG000|STARTED|Extension Period (Weeks 24 to 36)|Participants had the option to enter the Extension Period or proceed directly to the Followup Period|48
3267522|NCT02634801|4002164|FG001|STARTED|Extension Period (Weeks 24 to 36)|Participants had the option to enter the Extension Period or proceed directly to the Followup Period|19
3267523|NCT02634801|4002165|FG002|STARTED|Extension Period (Weeks 24 to 36)|Participants had the option to enter the Extension Period or proceed directly to the Followup Period|31
3267524|NCT02634801|4002163|FG000|COMPLETED|Extension Period (Weeks 24 to 36)||45
3267525|NCT02634801|4002164|FG001|COMPLETED|Extension Period (Weeks 24 to 36)||18
3267526|NCT02634801|4002165|FG002|COMPLETED|Extension Period (Weeks 24 to 36)||29
3375614|NCT01602198|4108756|FG000|COMPLETED|Overall Study||0
3375615|NCT01602198|4108757|FG001|COMPLETED|Overall Study||1
3375616|NCT01602198|4108756|FG000|NOT COMPLETED|Overall Study||0
3375617|NCT01602198|4108757|FG001|NOT COMPLETED|Overall Study||0
3375618|NCT01606150|4108765|FG000|STARTED|Overall Study||0
3375619|NCT01606150|4108766|FG001|STARTED|Overall Study||0
3375620|NCT01606150|4108765|FG000|COMPLETED|Overall Study|Enrollment was only for two months in 2012 due to technical and enrollment problems|0
3375621|NCT01606150|4108766|FG001|COMPLETED|Overall Study|Enrollment was only for two months in 2012 due to technical and enrollment problems|0
3375622|NCT01606150|4108765|FG000|NOT COMPLETED|Overall Study||0
3375623|NCT01606150|4108766|FG001|NOT COMPLETED|Overall Study||0
3375624|NCT01603043|4108774|FG000|STARTED|Overall Study||7
3375625|NCT01603043|4108775|FG001|STARTED|Overall Study||3
3375626|NCT01603043|4108774|FG000|COMPLETED|Overall Study||0
3375627|NCT01603043|4108775|FG001|COMPLETED|Overall Study||0
3375628|NCT01603043|4108774|FG000|NOT COMPLETED|Overall Study||7
3375629|NCT01603043|4108775|FG001|NOT COMPLETED|Overall Study||3
3375630|NCT01605370|4108783|FG000|STARTED|Overall Study||1
3375631|NCT01605370|4108784|FG001|STARTED|Overall Study||0
3375632|NCT01605370|4108783|FG000|COMPLETED|Overall Study||0
3375633|NCT01605370|4108784|FG001|COMPLETED|Overall Study||0
3375634|NCT01605370|4108783|FG000|NOT COMPLETED|Overall Study||1
3375635|NCT01605370|4108784|FG001|NOT COMPLETED|Overall Study||0
3375636|NCT01605617|4108792|FG000|STARTED|First Intervention||2
3375637|NCT01605617|4108793|FG001|STARTED|First Intervention||2
3375638|NCT01605617|4108792|FG000|COMPLETED|First Intervention||2
3375639|NCT01605617|4108793|FG001|COMPLETED|First Intervention||1
3375640|NCT01605617|4108792|FG000|NOT COMPLETED|First Intervention||0
3375641|NCT01605617|4108793|FG001|NOT COMPLETED|First Intervention||1
3375642|NCT01605617|4108792|FG000|STARTED|Washout Period of 4 Weeks||2
3375643|NCT01605617|4108793|FG001|STARTED|Washout Period of 4 Weeks||1
3375644|NCT01605617|4108792|FG000|COMPLETED|Washout Period of 4 Weeks||0
3375645|NCT01605617|4108793|FG001|COMPLETED|Washout Period of 4 Weeks||0
3375646|NCT01605617|4108792|FG000|NOT COMPLETED|Washout Period of 4 Weeks||2
3375647|NCT01605617|4108793|FG001|NOT COMPLETED|Washout Period of 4 Weeks||1
3375648|NCT01605617|4108792|FG000|STARTED|Second Intervention||0
3375649|NCT01605617|4108793|FG001|STARTED|Second Intervention||0
3375650|NCT01605617|4108792|FG000|COMPLETED|Second Intervention||0
3267527|NCT02634801|4002163|FG000|NOT COMPLETED|Extension Period (Weeks 24 to 36)||3
3267528|NCT02634801|4002164|FG001|NOT COMPLETED|Extension Period (Weeks 24 to 36)||1
3267529|NCT02634801|4002165|FG002|NOT COMPLETED|Extension Period (Weeks 24 to 36)||2
3267530|NCT02634801|4002163|FG000|STARTED|Follow-up Period|Participants who discontinued previous periods had option to enter post treatment follow-up period.|41
3267531|NCT02634801|4002164|FG001|STARTED|Follow-up Period|Participants who discontinued previous periods had option to enter post treatment follow-up period.|26
3267532|NCT02634801|4002165|FG002|STARTED|Follow-up Period|Participants who discontinued previous periods had option to enter post treatment follow-up period.|46
3267533|NCT02634801|4002163|FG000|COMPLETED|Follow-up Period||36
3267534|NCT02634801|4002164|FG001|COMPLETED|Follow-up Period||18
3267535|NCT02634801|4002165|FG002|COMPLETED|Follow-up Period||38
3267536|NCT02634801|4002163|FG000|NOT COMPLETED|Follow-up Period||5
3267537|NCT02634801|4002164|FG001|NOT COMPLETED|Follow-up Period||8
3267538|NCT02634801|4002165|FG002|NOT COMPLETED|Follow-up Period||8
3267539|NCT02634814|4002180|FG000|STARTED|Overall Study||32
3267540|NCT02634814|4002181|FG001|STARTED|Overall Study||29
3267541|NCT02634814|4002182|FG002|STARTED|Overall Study||29
3267542|NCT02634814|4002180|FG000|COMPLETED|Overall Study||30
3267543|NCT02634814|4002181|FG001|COMPLETED|Overall Study||23
3267544|NCT02634814|4002182|FG002|COMPLETED|Overall Study||29
3267545|NCT02634814|4002180|FG000|NOT COMPLETED|Overall Study||2
3267546|NCT02634814|4002181|FG001|NOT COMPLETED|Overall Study||6
3267547|NCT02634814|4002182|FG002|NOT COMPLETED|Overall Study||0
3267548|NCT02634983|4002190|FG000|STARTED|Period One (First Treatment, 8-10 Days)||16
3267549|NCT02634983|4002191|FG001|STARTED|Period One (First Treatment, 8-10 Days)||15
3267550|NCT02634983|4002190|FG000|COMPLETED|Period One (First Treatment, 8-10 Days)||16
3267551|NCT02634983|4002191|FG001|COMPLETED|Period One (First Treatment, 8-10 Days)||15
3267552|NCT02634983|4002190|FG000|NOT COMPLETED|Period One (First Treatment, 8-10 Days)||0
3267553|NCT02634983|4002191|FG001|NOT COMPLETED|Period One (First Treatment, 8-10 Days)||0
3267554|NCT02634983|4002190|FG000|STARTED|Washout (Approximately 7-14 Days)||16
3267555|NCT02634983|4002191|FG001|STARTED|Washout (Approximately 7-14 Days)||15
3267556|NCT02634983|4002190|FG000|COMPLETED|Washout (Approximately 7-14 Days)||16
3267557|NCT02634983|4002191|FG001|COMPLETED|Washout (Approximately 7-14 Days)||15
3267558|NCT02634983|4002190|FG000|NOT COMPLETED|Washout (Approximately 7-14 Days)||0
3267559|NCT02634983|4002191|FG001|NOT COMPLETED|Washout (Approximately 7-14 Days)||0
3267560|NCT02634983|4002190|FG000|STARTED|Period 2 (Second Treatment, 8-10 Days)||16
3267561|NCT02634983|4002191|FG001|STARTED|Period 2 (Second Treatment, 8-10 Days)||15
3267562|NCT02634983|4002190|FG000|COMPLETED|Period 2 (Second Treatment, 8-10 Days)||14
3267563|NCT02634983|4002191|FG001|COMPLETED|Period 2 (Second Treatment, 8-10 Days)||15
3267564|NCT02634983|4002190|FG000|NOT COMPLETED|Period 2 (Second Treatment, 8-10 Days)||2
3267565|NCT02634983|4002191|FG001|NOT COMPLETED|Period 2 (Second Treatment, 8-10 Days)||0
3267566|NCT02635035|4002199|FG000|STARTED|Overall Study||17
3267567|NCT02635035|4002200|FG001|STARTED|Overall Study||21
3267568|NCT02635035|4002199|FG000|COMPLETED|Overall Study||17
3267569|NCT02635035|4002200|FG001|COMPLETED|Overall Study||21
3267570|NCT02635035|4002199|FG000|NOT COMPLETED|Overall Study||0
3267571|NCT02635035|4002200|FG001|NOT COMPLETED|Overall Study||0
3267572|NCT02635204|4002208|FG000|STARTED|Overall Study||178
3267573|NCT02635204|4002209|FG001|STARTED|Overall Study||89
3267574|NCT02635204|4002208|FG000|COMPLETED|Overall Study||176
3267575|NCT02635204|4002209|FG001|COMPLETED|Overall Study||88
3267576|NCT02635204|4002208|FG000|NOT COMPLETED|Overall Study||2
3267577|NCT02635204|4002209|FG001|NOT COMPLETED|Overall Study||1
3267578|NCT02635347|4002217|FG000|STARTED|Overall Study||51
3267579|NCT02635347|4002218|FG001|STARTED|Overall Study||70
3267580|NCT02635347|4002217|FG000|Screening|Overall Study||51
3267581|NCT02635347|4002218|FG001|Screening|Overall Study||70
3267582|NCT02635347|4002217|FG000|Enrollment|Overall Study||31
3267583|NCT02635347|4002218|FG001|Enrollment|Overall Study||63
3267584|NCT02635347|4002217|FG000|Protocol Completion|Overall Study||22
3267585|NCT02635347|4002218|FG001|Protocol Completion|Overall Study||63
3267586|NCT02635347|4002217|FG000|Follow up|Overall Study||31
3267587|NCT02635347|4002218|FG001|Follow up|Overall Study||63
3267588|NCT02635347|4002217|FG000|Analyses|Overall Study||30
3267589|NCT02635347|4002218|FG001|Analyses|Overall Study||63
3267590|NCT02635347|4002217|FG000|COMPLETED|Overall Study||31
3267591|NCT02635347|4002218|FG001|COMPLETED|Overall Study||63
3375651|NCT01605617|4108793|FG001|COMPLETED|Second Intervention||0
3375652|NCT01605617|4108792|FG000|NOT COMPLETED|Second Intervention||0
3375653|NCT01605617|4108793|FG001|NOT COMPLETED|Second Intervention||0
3375654|NCT01606709|4108803|FG000|STARTED|Overall Study||4
3375655|NCT01606709|4108804|FG001|STARTED|Overall Study||3
3375656|NCT01606709|4108803|FG000|COMPLETED|Overall Study||4
3375657|NCT01606709|4108804|FG001|COMPLETED|Overall Study||3
3375658|NCT01606709|4108803|FG000|NOT COMPLETED|Overall Study||0
3375659|NCT01606709|4108804|FG001|NOT COMPLETED|Overall Study||0
3375660|NCT01603121|4108810|FG000|STARTED|First Intervention, 10 Hours||1
3375661|NCT01603121|4108811|FG001|STARTED|First Intervention, 10 Hours||0
3375662|NCT01603121|4108810|FG000|COMPLETED|First Intervention, 10 Hours||1
3267592|NCT02635347|4002217|FG000|NOT COMPLETED|Overall Study||20
3267593|NCT02635347|4002218|FG001|NOT COMPLETED|Overall Study||7
3267594|NCT02635386|4002230|FG000|STARTED|Overall Study||23
3267595|NCT02635386|4002231|FG001|STARTED|Overall Study||23
3267596|NCT02635386|4002232|FG002|STARTED|Overall Study||22
3267597|NCT02635386|4002233|FG003|STARTED|Overall Study||26
3267598|NCT02635386|4002234|FG004|STARTED|Overall Study||25
3267599|NCT02635386|4002230|FG000|COMPLETED|Overall Study||20
3267600|NCT02635386|4002231|FG001|COMPLETED|Overall Study||17
3267601|NCT02635386|4002232|FG002|COMPLETED|Overall Study||20
3267602|NCT02635386|4002233|FG003|COMPLETED|Overall Study||19
3267603|NCT02635386|4002234|FG004|COMPLETED|Overall Study||16
3267604|NCT02635386|4002230|FG000|NOT COMPLETED|Overall Study||3
3267605|NCT02635386|4002231|FG001|NOT COMPLETED|Overall Study||6
3267606|NCT02635386|4002232|FG002|NOT COMPLETED|Overall Study||2
3267607|NCT02635386|4002233|FG003|NOT COMPLETED|Overall Study||7
3267608|NCT02635386|4002234|FG004|NOT COMPLETED|Overall Study||9
3267609|NCT02635425|4002253|FG000|STARTED|Overall Study||15
3267610|NCT02635425|4002254|FG001|STARTED|Overall Study||15
3267611|NCT02635425|4002253|FG000|COMPLETED|Overall Study||15
3267612|NCT02635425|4002254|FG001|COMPLETED|Overall Study||15
3267613|NCT02635425|4002253|FG000|NOT COMPLETED|Overall Study||0
3267614|NCT02635425|4002254|FG001|NOT COMPLETED|Overall Study||0
3267615|NCT02635542|4002262|FG000|STARTED|Overall Study||50
3267616|NCT02635542|4002263|FG001|STARTED|Overall Study||50
3267617|NCT02635542|4002262|FG000|COMPLETED|Overall Study||50
3267618|NCT02635542|4002263|FG001|COMPLETED|Overall Study||50
3267619|NCT02635542|4002262|FG000|NOT COMPLETED|Overall Study||0
3267620|NCT02635542|4002263|FG001|NOT COMPLETED|Overall Study||0
3267621|NCT02635646|4002271|FG000|STARTED|Overall Study||57
3267622|NCT02635646|4002272|FG001|STARTED|Overall Study||65
3267623|NCT02635646|4002271|FG000|COMPLETED|Overall Study||32
3267624|NCT02635646|4002272|FG001|COMPLETED|Overall Study||39
3267625|NCT02635646|4002271|FG000|NOT COMPLETED|Overall Study||25
3267626|NCT02635646|4002272|FG001|NOT COMPLETED|Overall Study||26
3267627|NCT02635724|4002287|FG000|STARTED|Overall Study||41
3267628|NCT02635724|4002288|FG001|STARTED|Overall Study||26
3267629|NCT02635724|4002289|FG002|STARTED|Overall Study||7
3267630|NCT02635724|4002287|FG000|ITT Population|Overall Study||41
3267631|NCT02635724|4002288|FG001|ITT Population|Overall Study||26
3267632|NCT02635724|4002289|FG002|ITT Population|Overall Study||7
3267633|NCT02635724|4002287|FG000|Safety Population|Overall Study||41
3267634|NCT02635724|4002288|FG001|Safety Population|Overall Study||25
3267635|NCT02635724|4002289|FG002|Safety Population|Overall Study||7
3267636|NCT02635724|4002287|FG000|ITTI Population|Overall Study||28
3267637|NCT02635724|4002288|FG001|ITTI Population|Overall Study||19
3267638|NCT02635724|4002289|FG002|ITTI Population|Overall Study||5
3267639|NCT02635724|4002287|FG000|E-R Population|Overall Study||28
3267640|NCT02635724|4002288|FG001|E-R Population|Overall Study||19
3267641|NCT02635724|4002289|FG002|E-R Population|Overall Study||5
3267642|NCT02635724|4002287|FG000|COMPLETED|Overall Study||41
3267643|NCT02635724|4002288|FG001|COMPLETED|Overall Study||25
3267644|NCT02635724|4002289|FG002|COMPLETED|Overall Study||7
3267645|NCT02635724|4002287|FG000|NOT COMPLETED|Overall Study||0
3267646|NCT02635724|4002288|FG001|NOT COMPLETED|Overall Study||1
3267647|NCT02635724|4002289|FG002|NOT COMPLETED|Overall Study||0
3267648|NCT02635737|4002297|FG000|STARTED|Overall Study||29
3267649|NCT02635737|4002297|FG000|COMPLETED|Overall Study||28
3267650|NCT02635737|4002297|FG000|NOT COMPLETED|Overall Study||1
3267651|NCT02635828|4002301|FG000|STARTED|Overall Study||54
3375663|NCT01603121|4108811|FG001|COMPLETED|First Intervention, 10 Hours||0
3375664|NCT01603121|4108810|FG000|NOT COMPLETED|First Intervention, 10 Hours||0
3375665|NCT01603121|4108811|FG001|NOT COMPLETED|First Intervention, 10 Hours||0
3375666|NCT01603121|4108810|FG000|STARTED|Second Intervention, 10 Hours||1
3375667|NCT01603121|4108811|FG001|STARTED|Second Intervention, 10 Hours||0
3375668|NCT01603121|4108810|FG000|COMPLETED|Second Intervention, 10 Hours||0
3375669|NCT01603121|4108811|FG001|COMPLETED|Second Intervention, 10 Hours||0
3375670|NCT01603121|4108810|FG000|NOT COMPLETED|Second Intervention, 10 Hours||1
3375671|NCT01603121|4108811|FG001|NOT COMPLETED|Second Intervention, 10 Hours||0
3375672|NCT01602016|4108817|FG000|STARTED|Overall Study||0
3375673|NCT01602016|4108817|FG000|COMPLETED|Overall Study||0
3375674|NCT01602016|4108817|FG000|NOT COMPLETED|Overall Study||0
3375675|NCT01603394|4108824|FG000|STARTED|Overall Study||9
3375676|NCT01603394|4108824|FG000|COMPLETED|Overall Study||8
3375677|NCT01603394|4108824|FG000|NOT COMPLETED|Overall Study||1
3375678|NCT01592383|4108828|FG000|STARTED|Overall Study||2
3375679|NCT01592383|4108828|FG000|COMPLETED|Overall Study||1
3375680|NCT01592383|4108828|FG000|NOT COMPLETED|Overall Study||1
3375681|NCT01598025|4108835|FG000|STARTED|Overall Study||0
3375682|NCT01598025|4108836|FG001|STARTED|Overall Study||3
3375683|NCT01598025|4108835|FG000|COMPLETED|Overall Study||0
3375684|NCT01598025|4108836|FG001|COMPLETED|Overall Study||0
3375685|NCT01598025|4108835|FG000|NOT COMPLETED|Overall Study||0
3375686|NCT01598025|4108836|FG001|NOT COMPLETED|Overall Study||3
3375687|NCT01587963|4108843|FG000|STARTED|Overall Study||7
3375688|NCT01587963|4108844|FG001|STARTED|Overall Study||4
3375689|NCT01587963|4108843|FG000|COMPLETED|Overall Study||6
3375690|NCT01587963|4108844|FG001|COMPLETED|Overall Study||4
3375691|NCT01587963|4108843|FG000|NOT COMPLETED|Overall Study||1
3375692|NCT01587963|4108844|FG001|NOT COMPLETED|Overall Study||0
3375693|NCT01591096|4108850|FG000|STARTED|Overall Study||1
3267652|NCT02635828|4002301|FG000|COMPLETED|Overall Study||40
3267653|NCT02635828|4002301|FG000|NOT COMPLETED|Overall Study||14
3267654|NCT02635880|4002305|FG000|STARTED|Overall Study||32
3267655|NCT02635880|4002305|FG000|COMPLETED|Overall Study||32
3267656|NCT02635880|4002305|FG000|NOT COMPLETED|Overall Study||0
3267657|NCT02635984|4002311|FG000|STARTED|Overall Study||53
3267658|NCT02635984|4002312|FG001|STARTED|Overall Study||55
3267659|NCT02635984|4002311|FG000|COMPLETED|Overall Study||50
3267660|NCT02635984|4002312|FG001|COMPLETED|Overall Study||51
3267661|NCT02635984|4002311|FG000|NOT COMPLETED|Overall Study||3
3267662|NCT02635984|4002312|FG001|NOT COMPLETED|Overall Study||4
3267663|NCT02636049|4002318|FG000|STARTED|Overall Study||12
3267664|NCT02636049|4002318|FG000|Triferic 6 mg IV Over 3 Hours|Overall Study||12
3267665|NCT02636049|4002318|FG000|Triferic 35 Micrograms/kg IV Push|Overall Study||12
3267666|NCT02636049|4002318|FG000|COMPLETED|Overall Study||12
3267667|NCT02636049|4002318|FG000|NOT COMPLETED|Overall Study||0
3375694|NCT01591096|4108850|FG000|COMPLETED|Overall Study||0
3375695|NCT01591096|4108850|FG000|NOT COMPLETED|Overall Study||1
3375696|NCT01591954|4108854|FG000|STARTED|Overall Study||1
3375697|NCT01591954|4108854|FG000|COMPLETED|Overall Study||1
3375698|NCT01591954|4108854|FG000|NOT COMPLETED|Overall Study||0
3375699|NCT01589926|4108860|FG000|STARTED|Overall Study||0
3375700|NCT01589926|4108861|FG001|STARTED|Overall Study||0
3375701|NCT01589926|4108860|FG000|COMPLETED|Overall Study||0
3375702|NCT01589926|4108861|FG001|COMPLETED|Overall Study||0
3375703|NCT01589926|4108860|FG000|NOT COMPLETED|Overall Study||0
3375704|NCT01589926|4108861|FG001|NOT COMPLETED|Overall Study||0
3375705|NCT01576575|4108867|FG000|STARTED|Buprenorphine Control||21
3375706|NCT01576575|4108867|FG000|COMPLETED|Buprenorphine Control||18
3375707|NCT01576575|4108867|FG000|NOT COMPLETED|Buprenorphine Control||3
3375708|NCT01576575|4108867|FG000|STARTED|Buprenorphine + Rifampin||18
3375709|NCT01576575|4108867|FG000|COMPLETED|Buprenorphine + Rifampin||15
3375710|NCT01576575|4108867|FG000|NOT COMPLETED|Buprenorphine + Rifampin||3
3375711|NCT01576575|4108867|FG000|STARTED|Buprenorphine + Grapefruit||15
3375712|NCT01576575|4108867|FG000|COMPLETED|Buprenorphine + Grapefruit||14
3375713|NCT01576575|4108867|FG000|NOT COMPLETED|Buprenorphine + Grapefruit||1
3375714|NCT01576575|4108867|FG000|STARTED|Buprenorphine + Ketoconazole||14
3375715|NCT01576575|4108867|FG000|COMPLETED|Buprenorphine + Ketoconazole||14
3375716|NCT01576575|4108867|FG000|NOT COMPLETED|Buprenorphine + Ketoconazole||0
3375717|NCT01590394|4108877|FG000|STARTED|Overall Study||3
3375718|NCT01590394|4108877|FG000|COMPLETED|Overall Study||3
3375719|NCT01590394|4108877|FG000|NOT COMPLETED|Overall Study||0
3375720|NCT01577628|4108883|FG000|STARTED|Overall Study||0
3375721|NCT01577628|4108884|FG001|STARTED|Overall Study||0
3375722|NCT01577628|4108885|FG002|STARTED|Overall Study||2
3375723|NCT01577628|4108883|FG000|COMPLETED|Overall Study||0
3375724|NCT01577628|4108884|FG001|COMPLETED|Overall Study||0
3375725|NCT01577628|4108885|FG002|COMPLETED|Overall Study||0
3375726|NCT01577628|4108883|FG000|NOT COMPLETED|Overall Study||0
3375727|NCT01577628|4108884|FG001|NOT COMPLETED|Overall Study||0
3375728|NCT01577628|4108885|FG002|NOT COMPLETED|Overall Study||2
3375729|NCT01582100|4108891|FG000|STARTED|Overall Study||2
3375730|NCT01582100|4108891|FG000|COMPLETED|Overall Study||0
3375731|NCT01582100|4108891|FG000|NOT COMPLETED|Overall Study||2
3375732|NCT01583647|4108895|FG000|STARTED|Overall Study||10
3375733|NCT01583647|4108896|FG001|STARTED|Overall Study|Study terminated prior to Panel B being conducted.|0
3375734|NCT01583647|4108895|FG000|COMPLETED|Overall Study||10
3375735|NCT01583647|4108896|FG001|COMPLETED|Overall Study||0
3375736|NCT01583647|4108895|FG000|NOT COMPLETED|Overall Study||0
3375737|NCT01583647|4108896|FG001|NOT COMPLETED|Overall Study||0
3375738|NCT01575028|4108904|FG000|STARTED|Overall Study||2
3375739|NCT01575028|4108905|FG001|STARTED|Overall Study||1
3375740|NCT01575028|4108904|FG000|COMPLETED|Overall Study||2
3375741|NCT01575028|4108905|FG001|COMPLETED|Overall Study||0
3375742|NCT01575028|4108904|FG000|NOT COMPLETED|Overall Study||0
3375743|NCT01575028|4108905|FG001|NOT COMPLETED|Overall Study||1
3375744|NCT01578785|4108913|FG000|STARTED|Overall Study||59
3375745|NCT01578785|4108914|FG001|STARTED|Overall Study||119
3375746|NCT01578785|4108913|FG000|COMPLETED|Overall Study||0
3375747|NCT01578785|4108914|FG001|COMPLETED|Overall Study||0
3375748|NCT01578785|4108913|FG000|NOT COMPLETED|Overall Study||59
3375749|NCT01578785|4108914|FG001|NOT COMPLETED|Overall Study||119
3375750|NCT01576549|4108920|FG000|STARTED|Overall Study||2
3375751|NCT01576549|4108920|FG000|Received at Least 1 Dose of Study Drug|Overall Study||2
3375752|NCT01576549|4108920|FG000|Completed Post-Treatment Follow-Up|Overall Study|Each participant discontinued dosing and completed the Post-Treatment Follow-Up Period.|2
3375753|NCT01576549|4108920|FG000|COMPLETED|Overall Study||0
3375754|NCT01576549|4108920|FG000|NOT COMPLETED|Overall Study||2
3375755|NCT01570634|4108925|FG000|STARTED|Overall Study||2
3375756|NCT01570634|4108925|FG000|COMPLETED|Overall Study||2
3375757|NCT01570634|4108925|FG000|NOT COMPLETED|Overall Study||0
3375758|NCT01566370|4108931|FG000|STARTED|Overall Study||2
3375759|NCT01566370|4108932|FG001|STARTED|Overall Study||1
3375760|NCT01566370|4108931|FG000|COMPLETED|Overall Study||0
3375761|NCT01566370|4108932|FG001|COMPLETED|Overall Study||0
3375762|NCT01566370|4108931|FG000|NOT COMPLETED|Overall Study||2
3375763|NCT01566370|4108932|FG001|NOT COMPLETED|Overall Study||1
3375764|NCT01561989|4108940|FG000|STARTED|Overall Study||5
3375765|NCT01561989|4108941|FG001|STARTED|Overall Study||6
3375766|NCT01561989|4108940|FG000|COMPLETED|Overall Study||0
3267668|NCT02636361|4002324|FG000|STARTED|Period 1||5
3267669|NCT02636361|4002325|FG001|STARTED|Period 1||6
3267670|NCT02636361|4002326|FG002|STARTED|Period 1||5
3267671|NCT02636361|4002327|FG003|STARTED|Period 1||5
3267672|NCT02636361|4002328|FG004|STARTED|Period 1||5
3267673|NCT02636361|4002324|FG000|Received at Least One Dose of Study Drug|Period 1||5
3267674|NCT02636361|4002325|FG001|Received at Least One Dose of Study Drug|Period 1||5
3267675|NCT02636361|4002326|FG002|Received at Least One Dose of Study Drug|Period 1||5
3267676|NCT02636361|4002327|FG003|Received at Least One Dose of Study Drug|Period 1||5
3267677|NCT02636361|4002328|FG004|Received at Least One Dose of Study Drug|Period 1||4
3267678|NCT02636361|4002324|FG000|COMPLETED|Period 1||5
3267679|NCT02636361|4002325|FG001|COMPLETED|Period 1||5
3267680|NCT02636361|4002326|FG002|COMPLETED|Period 1||5
3267681|NCT02636361|4002327|FG003|COMPLETED|Period 1||5
3267682|NCT02636361|4002328|FG004|COMPLETED|Period 1||4
3267683|NCT02636361|4002324|FG000|NOT COMPLETED|Period 1||0
3267684|NCT02636361|4002325|FG001|NOT COMPLETED|Period 1||1
3267685|NCT02636361|4002326|FG002|NOT COMPLETED|Period 1||0
3267686|NCT02636361|4002327|FG003|NOT COMPLETED|Period 1||0
3267687|NCT02636361|4002328|FG004|NOT COMPLETED|Period 1||1
3267688|NCT02636361|4002324|FG000|STARTED|Period 2||5
3267689|NCT02636361|4002325|FG001|STARTED|Period 2||5
3267690|NCT02636361|4002326|FG002|STARTED|Period 2||5
3267691|NCT02636361|4002327|FG003|STARTED|Period 2||5
3267692|NCT02636361|4002328|FG004|STARTED|Period 2||4
3267693|NCT02636361|4002324|FG000|COMPLETED|Period 2||5
3267694|NCT02636361|4002325|FG001|COMPLETED|Period 2||5
3267695|NCT02636361|4002326|FG002|COMPLETED|Period 2||5
3267696|NCT02636361|4002327|FG003|COMPLETED|Period 2||5
3267697|NCT02636361|4002328|FG004|COMPLETED|Period 2||4
3267698|NCT02636361|4002324|FG000|NOT COMPLETED|Period 2||0
3267699|NCT02636361|4002325|FG001|NOT COMPLETED|Period 2||0
3267700|NCT02636361|4002326|FG002|NOT COMPLETED|Period 2||0
3267701|NCT02636361|4002327|FG003|NOT COMPLETED|Period 2||0
3267702|NCT02636361|4002328|FG004|NOT COMPLETED|Period 2||0
3267703|NCT02636361|4002324|FG000|STARTED|Period 3||5
3267704|NCT02636361|4002325|FG001|STARTED|Period 3||5
3267705|NCT02636361|4002326|FG002|STARTED|Period 3||5
3267706|NCT02636361|4002327|FG003|STARTED|Period 3||5
3267707|NCT02636361|4002328|FG004|STARTED|Period 3||4
3267708|NCT02636361|4002324|FG000|COMPLETED|Period 3||5
3267709|NCT02636361|4002325|FG001|COMPLETED|Period 3||5
3267710|NCT02636361|4002326|FG002|COMPLETED|Period 3||5
3267711|NCT02636361|4002327|FG003|COMPLETED|Period 3||5
3267712|NCT02636361|4002328|FG004|COMPLETED|Period 3||4
3267713|NCT02636361|4002324|FG000|NOT COMPLETED|Period 3||0
3267714|NCT02636361|4002325|FG001|NOT COMPLETED|Period 3||0
3267715|NCT02636361|4002326|FG002|NOT COMPLETED|Period 3||0
3267716|NCT02636361|4002327|FG003|NOT COMPLETED|Period 3||0
3267717|NCT02636361|4002328|FG004|NOT COMPLETED|Period 3||0
3267718|NCT02636361|4002324|FG000|STARTED|Period 4||5
3267719|NCT02636361|4002325|FG001|STARTED|Period 4||5
3267720|NCT02636361|4002326|FG002|STARTED|Period 4||5
3267721|NCT02636361|4002327|FG003|STARTED|Period 4||5
3267722|NCT02636361|4002328|FG004|STARTED|Period 4||4
3267723|NCT02636361|4002324|FG000|COMPLETED|Period 4||5
3267724|NCT02636361|4002325|FG001|COMPLETED|Period 4||5
3375767|NCT01561989|4108941|FG001|COMPLETED|Overall Study||0
3375768|NCT01561989|4108940|FG000|NOT COMPLETED|Overall Study||5
3375769|NCT01561989|4108941|FG001|NOT COMPLETED|Overall Study||6
3375770|NCT01564732|4108949|FG000|STARTED|Overall Study||6
3375771|NCT01564732|4108950|FG001|STARTED|Overall Study||5
3375772|NCT01564732|4108949|FG000|COMPLETED|Overall Study||0
3375773|NCT01564732|4108950|FG001|COMPLETED|Overall Study||0
3375774|NCT01564732|4108949|FG000|NOT COMPLETED|Overall Study||6
3375775|NCT01564732|4108950|FG001|NOT COMPLETED|Overall Study||5
3375776|NCT01560507|4108959|FG000|STARTED|Overall Study||5
3375777|NCT01560507|4108960|FG001|STARTED|Overall Study||2
3375778|NCT01560507|4108961|FG002|STARTED|Overall Study||2
3375779|NCT01560507|4108959|FG000|COMPLETED|Overall Study||1
3375780|NCT01560507|4108960|FG001|COMPLETED|Overall Study||0
3375781|NCT01560507|4108961|FG002|COMPLETED|Overall Study||0
3375782|NCT01560507|4108959|FG000|NOT COMPLETED|Overall Study||4
3375783|NCT01560507|4108960|FG001|NOT COMPLETED|Overall Study||2
3375784|NCT01560507|4108961|FG002|NOT COMPLETED|Overall Study||2
3375785|NCT01557881|4108972|FG000|STARTED|Overall Study||98
3375786|NCT01557881|4108972|FG000|COMPLETED|Overall Study||98
3375787|NCT01557881|4108972|FG000|NOT COMPLETED|Overall Study||0
3375788|NCT01555489|4108976|FG000|STARTED|Overall Study||11
3375789|NCT01555489|4108976|FG000|COMPLETED|Overall Study||11
3375790|NCT01555489|4108976|FG000|NOT COMPLETED|Overall Study||0
3375791|NCT01549977|4108982|FG000|STARTED|Overall Study||1
3375792|NCT01549977|4108983|FG001|STARTED|Overall Study||0
3375793|NCT01549977|4108982|FG000|COMPLETED|Overall Study||1
3267725|NCT02636361|4002326|FG002|COMPLETED|Period 4||5
3267726|NCT02636361|4002327|FG003|COMPLETED|Period 4||4
3267727|NCT02636361|4002328|FG004|COMPLETED|Period 4||4
3267728|NCT02636361|4002324|FG000|NOT COMPLETED|Period 4||0
3267729|NCT02636361|4002325|FG001|NOT COMPLETED|Period 4||0
3267730|NCT02636361|4002326|FG002|NOT COMPLETED|Period 4||0
3267731|NCT02636361|4002327|FG003|NOT COMPLETED|Period 4||1
3267732|NCT02636361|4002328|FG004|NOT COMPLETED|Period 4||0
3267733|NCT02636361|4002324|FG000|STARTED|Period 5||5
3267734|NCT02636361|4002325|FG001|STARTED|Period 5||5
3267735|NCT02636361|4002326|FG002|STARTED|Period 5||5
3267736|NCT02636361|4002327|FG003|STARTED|Period 5||4
3267737|NCT02636361|4002328|FG004|STARTED|Period 5||4
3267738|NCT02636361|4002324|FG000|COMPLETED|Period 5||5
3267739|NCT02636361|4002325|FG001|COMPLETED|Period 5||5
3267740|NCT02636361|4002326|FG002|COMPLETED|Period 5||5
3267741|NCT02636361|4002327|FG003|COMPLETED|Period 5||4
3267742|NCT02636361|4002328|FG004|COMPLETED|Period 5||4
3267743|NCT02636361|4002324|FG000|NOT COMPLETED|Period 5||0
3267744|NCT02636361|4002325|FG001|NOT COMPLETED|Period 5||0
3267745|NCT02636361|4002326|FG002|NOT COMPLETED|Period 5||0
3267746|NCT02636361|4002327|FG003|NOT COMPLETED|Period 5||0
3267747|NCT02636361|4002328|FG004|NOT COMPLETED|Period 5||0
3267748|NCT02636595|4002342|FG000|STARTED|Overall Study||121
3267749|NCT02636595|4002342|FG000|COMPLETED|Overall Study||119
3267750|NCT02636595|4002342|FG000|NOT COMPLETED|Overall Study||2
3267751|NCT02636608|4002346|FG000|STARTED|Overall Study||244
3267752|NCT02636608|4002346|FG000|Received Treatment|Overall Study||243
3267753|NCT02636608|4002346|FG000|COMPLETED|Overall Study||233
3267754|NCT02636608|4002346|FG000|NOT COMPLETED|Overall Study||11
3267755|NCT02636699|4002355|FG000|STARTED|Overall Study||238
3267756|NCT02636699|4002356|FG001|STARTED|Overall Study||118
3267757|NCT02636699|4002355|FG000|COMPLETED|Overall Study||213
3267758|NCT02636699|4002356|FG001|COMPLETED|Overall Study||107
3267759|NCT02636699|4002355|FG000|NOT COMPLETED|Overall Study||25
3267760|NCT02636699|4002356|FG001|NOT COMPLETED|Overall Study||11
3267761|NCT02636712|4002362|FG000|STARTED|Overall Study||10
3267762|NCT02636712|4002362|FG000|COMPLETED|Overall Study||10
3267763|NCT02636712|4002362|FG000|NOT COMPLETED|Overall Study||0
3267764|NCT02636725|4002367|FG000|STARTED|Baseline||33
3267765|NCT02636725|4002367|FG000|COMPLETED|Baseline||30
3267766|NCT02636725|4002367|FG000|NOT COMPLETED|Baseline||3
3267767|NCT02636725|4002367|FG000|STARTED|Post-Baseline Imaging Assessment||30
3267768|NCT02636725|4002367|FG000|COMPLETED|Post-Baseline Imaging Assessment||30
3267769|NCT02636725|4002367|FG000|NOT COMPLETED|Post-Baseline Imaging Assessment||0
3267770|NCT02636868|4002374|FG000|STARTED|Overall Study||73
3267771|NCT02636868|4002375|FG001|STARTED|Overall Study||76
3267772|NCT02636868|4002376|FG002|STARTED|Overall Study||72
3267773|NCT02636868|4002374|FG000|COMPLETED|Overall Study||73
3267774|NCT02636868|4002375|FG001|COMPLETED|Overall Study||75
3267775|NCT02636868|4002376|FG002|COMPLETED|Overall Study||70
3267776|NCT02636868|4002374|FG000|NOT COMPLETED|Overall Study||0
3267777|NCT02636868|4002375|FG001|NOT COMPLETED|Overall Study||1
3267778|NCT02636868|4002376|FG002|NOT COMPLETED|Overall Study||2
3267779|NCT02636907|4002384|FG000|STARTED|Autoinjector Assessment Period|Assigned to treatment.|77
3267780|NCT02636907|4002384|FG000|COMPLETED|Autoinjector Assessment Period|Completed autoinjector assessment period (Day 50).|73
3267781|NCT02636907|4002384|FG000|NOT COMPLETED|Autoinjector Assessment Period||4
3267782|NCT02636907|4002384|FG000|STARTED|Extension Phase||72
3267783|NCT02636907|4002384|FG000|COMPLETED|Extension Phase||62
3267784|NCT02636907|4002384|FG000|NOT COMPLETED|Extension Phase||10
3267785|NCT02637037|4002390|FG000|STARTED|Overall Study||40
3267786|NCT02637037|4002391|FG001|STARTED|Overall Study||40
3267787|NCT02637037|4002390|FG000|COMPLETED|Overall Study||36
3267788|NCT02637037|4002391|FG001|COMPLETED|Overall Study||39
3267789|NCT02637037|4002390|FG000|NOT COMPLETED|Overall Study||4
3267790|NCT02637037|4002391|FG001|NOT COMPLETED|Overall Study||1
3267791|NCT02637063|4002412|FG000|STARTED|Overall Study||67
3267792|NCT02637063|4002413|FG001|STARTED|Overall Study||68
3267793|NCT02637063|4002414|FG002|STARTED|Overall Study||68
3267794|NCT02637063|4002412|FG000|COMPLETED|Overall Study||62
3267795|NCT02637063|4002413|FG001|COMPLETED|Overall Study||64
3267796|NCT02637063|4002414|FG002|COMPLETED|Overall Study||62
3267797|NCT02637063|4002412|FG000|NOT COMPLETED|Overall Study||5
3267798|NCT02637063|4002413|FG001|NOT COMPLETED|Overall Study||4
3267799|NCT02637063|4002414|FG002|NOT COMPLETED|Overall Study||6
3267800|NCT02637076|4002424|FG000|STARTED|Overall Study||2
3267801|NCT02637076|4002425|FG001|STARTED|Overall Study||15
3267802|NCT02637076|4002424|FG000|COMPLETED|Overall Study||1
3267803|NCT02637076|4002425|FG001|COMPLETED|Overall Study||10
3267804|NCT02637076|4002424|FG000|NOT COMPLETED|Overall Study||1
3267805|NCT02637076|4002425|FG001|NOT COMPLETED|Overall Study||5
3267806|NCT02637141|4002434|FG000|STARTED|Overall Study||22
3267807|NCT02637141|4002435|FG001|STARTED|Overall Study||22
3267808|NCT02637141|4002436|FG002|STARTED|Overall Study||20
3267809|NCT02637141|4002434|FG000|Received Study Drug|Overall Study||22
3267810|NCT02637141|4002435|FG001|Received Study Drug|Overall Study||21
3267811|NCT02637141|4002436|FG002|Received Study Drug|Overall Study||19
3267812|NCT02637141|4002434|FG000|COMPLETED|Overall Study||20
3267813|NCT02637141|4002435|FG001|COMPLETED|Overall Study||20
3267814|NCT02637141|4002436|FG002|COMPLETED|Overall Study||19
3267815|NCT02637141|4002434|FG000|NOT COMPLETED|Overall Study||2
3267816|NCT02637141|4002435|FG001|NOT COMPLETED|Overall Study||2
3267817|NCT02637141|4002436|FG002|NOT COMPLETED|Overall Study||1
3375794|NCT01549977|4108983|FG001|COMPLETED|Overall Study||0
3375795|NCT01549977|4108982|FG000|NOT COMPLETED|Overall Study||0
3375796|NCT01549977|4108983|FG001|NOT COMPLETED|Overall Study||0
3375797|NCT01558492|4108989|FG000|STARTED|Overall Study||3
3375798|NCT01558492|4108989|FG000|COMPLETED|Overall Study||3
3375799|NCT01558492|4108989|FG000|NOT COMPLETED|Overall Study||0
3375800|NCT01550562|4108993|FG000|STARTED|First Intervention, 4 - 5 Days||1
3375801|NCT01550562|4108993|FG000|COMPLETED|First Intervention, 4 - 5 Days||1
3267818|NCT02637232|4002444|FG000|STARTED|Overall Study||301
3267819|NCT02637232|4002444|FG000|COMPLETED|Overall Study||246
3267820|NCT02637232|4002444|FG000|NOT COMPLETED|Overall Study||55
3267821|NCT02637323|4002450|FG000|STARTED|Overall Study||63
3267822|NCT02637323|4002451|FG001|STARTED|Overall Study||18
3267823|NCT02637323|4002450|FG000|COMPLETED|Overall Study||61
3267824|NCT02637323|4002451|FG001|COMPLETED|Overall Study||17
3267825|NCT02637323|4002450|FG000|NOT COMPLETED|Overall Study||2
3267826|NCT02637323|4002451|FG001|NOT COMPLETED|Overall Study||1
3375802|NCT01550562|4108993|FG000|NOT COMPLETED|First Intervention, 4 - 5 Days||0
3375803|NCT01550562|4108993|FG000|STARTED|Second Intervention, 4 - 5 Days||1
3375804|NCT01550562|4108993|FG000|COMPLETED|Second Intervention, 4 - 5 Days||1
3375805|NCT01550562|4108993|FG000|NOT COMPLETED|Second Intervention, 4 - 5 Days||0
3375806|NCT01550562|4108993|FG000|STARTED|Third Intervention, 4 - 5 Days||1
3375807|NCT01550562|4108993|FG000|COMPLETED|Third Intervention, 4 - 5 Days||1
3375808|NCT01550562|4108993|FG000|NOT COMPLETED|Third Intervention, 4 - 5 Days||0
3375809|NCT01561495|4108997|FG000|STARTED|Overall Study||1
3375810|NCT01561495|4108997|FG000|COMPLETED|Overall Study||1
3375811|NCT01561495|4108997|FG000|NOT COMPLETED|Overall Study||0
3375812|NCT01555073|4109005|FG000|STARTED|Overall Study||7
3375813|NCT01555073|4109006|FG001|STARTED|Overall Study||3
3375814|NCT01555073|4109007|FG002|STARTED|Overall Study||7
3375815|NCT01555073|4109008|FG003|STARTED|Overall Study||6
3375816|NCT01555073|4109005|FG000|COMPLETED|Overall Study||6
3375817|NCT01555073|4109006|FG001|COMPLETED|Overall Study||1
3375818|NCT01555073|4109007|FG002|COMPLETED|Overall Study||7
3375819|NCT01555073|4109008|FG003|COMPLETED|Overall Study||1
3375820|NCT01555073|4109005|FG000|NOT COMPLETED|Overall Study||1
3375821|NCT01555073|4109006|FG001|NOT COMPLETED|Overall Study||2
3375822|NCT01555073|4109007|FG002|NOT COMPLETED|Overall Study||0
3375823|NCT01555073|4109008|FG003|NOT COMPLETED|Overall Study||5
3375824|NCT01551082|4109018|FG000|STARTED|Overall Study||12
3375825|NCT01551082|4109018|FG000|COMPLETED|Overall Study||12
3375826|NCT01551082|4109018|FG000|NOT COMPLETED|Overall Study||0
3375827|NCT01556009|4109024|FG000|STARTED|Overall Study||0
3375828|NCT01556009|4109025|FG001|STARTED|Overall Study||0
3375829|NCT01556009|4109024|FG000|COMPLETED|Overall Study||0
3375830|NCT01556009|4109025|FG001|COMPLETED|Overall Study||0
3375831|NCT01556009|4109024|FG000|NOT COMPLETED|Overall Study||0
3375832|NCT01556009|4109025|FG001|NOT COMPLETED|Overall Study||0
3375833|NCT01550510|4109033|FG000|STARTED|Overall Study||4
3375834|NCT01550510|4109034|FG001|STARTED|Overall Study||0
3375835|NCT01550510|4109033|FG000|COMPLETED|Overall Study||4
3375836|NCT01550510|4109034|FG001|COMPLETED|Overall Study||0
3375837|NCT01550510|4109033|FG000|NOT COMPLETED|Overall Study||0
3375838|NCT01550510|4109034|FG001|NOT COMPLETED|Overall Study||0
3375839|NCT01541397|4109043|FG000|STARTED|Overall Study||4
3375840|NCT01541397|4109044|FG001|STARTED|Overall Study||2
3375841|NCT01541397|4109043|FG000|COMPLETED|Overall Study||0
3375842|NCT01541397|4109044|FG001|COMPLETED|Overall Study||0
3375843|NCT01541397|4109043|FG000|NOT COMPLETED|Overall Study||4
3375844|NCT01541397|4109044|FG001|NOT COMPLETED|Overall Study||2
3375845|NCT01546207|4109050|FG000|STARTED|Overall Study||4
3375846|NCT01546207|4109050|FG000|COMPLETED|Overall Study||3
3375847|NCT01546207|4109050|FG000|NOT COMPLETED|Overall Study||1
3375848|NCT01553240|4109054|FG000|STARTED|Overall Study||0
3375849|NCT01553240|4109054|FG000|COMPLETED|Overall Study||0
3375850|NCT01553240|4109054|FG000|NOT COMPLETED|Overall Study||0
3375851|NCT01547728|4109058|FG000|STARTED|Overall Study||42
3375852|NCT01547728|4109058|FG000|COMPLETED|Overall Study||1
3375853|NCT01547728|4109058|FG000|NOT COMPLETED|Overall Study||41
3375854|NCT01548651|4109064|FG000|STARTED|Overall Study||4
3375855|NCT01548651|4109065|FG001|STARTED|Overall Study||4
3375856|NCT01548651|4109064|FG000|COMPLETED|Overall Study||3
3375857|NCT01548651|4109065|FG001|COMPLETED|Overall Study||4
3375858|NCT01548651|4109064|FG000|NOT COMPLETED|Overall Study||1
3375859|NCT01548651|4109065|FG001|NOT COMPLETED|Overall Study||0
3375860|NCT01545648|4109071|FG000|STARTED|Overall Study||4
3375861|NCT01545648|4109071|FG000|6 Months of Treatment|Overall Study||4
3375862|NCT01545648|4109071|FG000|COMPLETED|Overall Study||4
3375863|NCT01545648|4109071|FG000|NOT COMPLETED|Overall Study||0
3375864|NCT01546883|4109075|FG000|STARTED|Overall Study||14
3375865|NCT01546883|4109075|FG000|COMPLETED|Overall Study||2
3267827|NCT02637427|4002460|FG000|STARTED|Overall Study||27
3267828|NCT02637427|4002461|FG001|STARTED|Overall Study||30
3267829|NCT02637427|4002460|FG000|COMPLETED|Overall Study||27
3267830|NCT02637427|4002461|FG001|COMPLETED|Overall Study||30
3267831|NCT02637427|4002460|FG000|NOT COMPLETED|Overall Study||0
3267832|NCT02637427|4002461|FG001|NOT COMPLETED|Overall Study||0
3267833|NCT02637557|4002471|FG000|STARTED|Overall Study||71
3267834|NCT02637557|4002472|FG001|STARTED|Overall Study||71
3267835|NCT02637557|4002473|FG002|STARTED|Overall Study||71
3267836|NCT02637557|4002474|FG003|STARTED|Overall Study||69
3267837|NCT02637557|4002471|FG000|COMPLETED|Overall Study||63
3267838|NCT02637557|4002472|FG001|COMPLETED|Overall Study||66
3267839|NCT02637557|4002473|FG002|COMPLETED|Overall Study||62
3267840|NCT02637557|4002474|FG003|COMPLETED|Overall Study||62
3267841|NCT02637557|4002471|FG000|NOT COMPLETED|Overall Study||8
3267842|NCT02637557|4002472|FG001|NOT COMPLETED|Overall Study||5
3267843|NCT02637557|4002473|FG002|NOT COMPLETED|Overall Study||9
3267844|NCT02637557|4002474|FG003|NOT COMPLETED|Overall Study||7
3267845|NCT02637804|4002486|FG000|STARTED|First Intervention (1 Week)||27
3267846|NCT02637804|4002487|FG001|STARTED|First Intervention (1 Week)||28
3267847|NCT02637804|4002488|FG002|STARTED|First Intervention (1 Week)||25
3267848|NCT02637804|4002489|FG003|STARTED|First Intervention (1 Week)||26
3267849|NCT02637804|4002486|FG000|COMPLETED|First Intervention (1 Week)||27
3267850|NCT02637804|4002487|FG001|COMPLETED|First Intervention (1 Week)||28
3267851|NCT02637804|4002488|FG002|COMPLETED|First Intervention (1 Week)||25
3267852|NCT02637804|4002489|FG003|COMPLETED|First Intervention (1 Week)||26
3267853|NCT02637804|4002486|FG000|NOT COMPLETED|First Intervention (1 Week)||0
3267854|NCT02637804|4002487|FG001|NOT COMPLETED|First Intervention (1 Week)||0
3267855|NCT02637804|4002488|FG002|NOT COMPLETED|First Intervention (1 Week)||0
3267856|NCT02637804|4002489|FG003|NOT COMPLETED|First Intervention (1 Week)||0
3267857|NCT02637804|4002486|FG000|STARTED|Second Intervention (1 Week)||27
3267858|NCT02637804|4002487|FG001|STARTED|Second Intervention (1 Week)||28
3267859|NCT02637804|4002488|FG002|STARTED|Second Intervention (1 Week)||25
3267860|NCT02637804|4002489|FG003|STARTED|Second Intervention (1 Week)||26
3267861|NCT02637804|4002486|FG000|COMPLETED|Second Intervention (1 Week)||27
3267862|NCT02637804|4002487|FG001|COMPLETED|Second Intervention (1 Week)||28
3267863|NCT02637804|4002488|FG002|COMPLETED|Second Intervention (1 Week)||25
3267864|NCT02637804|4002489|FG003|COMPLETED|Second Intervention (1 Week)||26
3267865|NCT02637804|4002486|FG000|NOT COMPLETED|Second Intervention (1 Week)||0
3267866|NCT02637804|4002487|FG001|NOT COMPLETED|Second Intervention (1 Week)||0
3267867|NCT02637804|4002488|FG002|NOT COMPLETED|Second Intervention (1 Week)||0
3267868|NCT02637804|4002489|FG003|NOT COMPLETED|Second Intervention (1 Week)||0
3267869|NCT02637856|4002506|FG000|STARTED|Main Study (Baseline to Week 100)||608
3267870|NCT02637856|4002507|FG001|STARTED|Main Study (Baseline to Week 100)||0
3267871|NCT02637856|4002506|FG000|COMPLETED|Main Study (Baseline to Week 100)||389
3267872|NCT02637856|4002507|FG001|COMPLETED|Main Study (Baseline to Week 100)||0
3267873|NCT02637856|4002506|FG000|NOT COMPLETED|Main Study (Baseline to Week 100)||219
3267874|NCT02637856|4002507|FG001|NOT COMPLETED|Main Study (Baseline to Week 100)||0
3267875|NCT02637856|4002506|FG000|STARTED|Sub-Study (Week 72 to Week 100)||0
3267876|NCT02637856|4002507|FG001|STARTED|Sub-Study (Week 72 to Week 100)||129
3267877|NCT02637856|4002506|FG000|COMPLETED|Sub-Study (Week 72 to Week 100)||0
3267878|NCT02637856|4002507|FG001|COMPLETED|Sub-Study (Week 72 to Week 100)||125
3267879|NCT02637856|4002506|FG000|NOT COMPLETED|Sub-Study (Week 72 to Week 100)||0
3267880|NCT02637856|4002507|FG001|NOT COMPLETED|Sub-Study (Week 72 to Week 100)||4
3267881|NCT02637895|4002515|FG000|STARTED|Overall Study||21
3267882|NCT02637895|4002516|FG001|STARTED|Overall Study||20
3267883|NCT02637895|4002515|FG000|COMPLETED|Overall Study||15
3267884|NCT02637895|4002516|FG001|COMPLETED|Overall Study||17
3267885|NCT02637895|4002515|FG000|NOT COMPLETED|Overall Study||6
3267886|NCT02637895|4002516|FG001|NOT COMPLETED|Overall Study||3
3267887|NCT02637999|4002526|FG000|STARTED|Overall Study||8
3267888|NCT02637999|4002527|FG001|STARTED|Overall Study||8
3267889|NCT02637999|4002528|FG002|STARTED|Overall Study||8
3267890|NCT02637999|4002526|FG000|COMPLETED|Overall Study||7
3267891|NCT02637999|4002527|FG001|COMPLETED|Overall Study||6
3267892|NCT02637999|4002528|FG002|COMPLETED|Overall Study||6
3267893|NCT02637999|4002526|FG000|NOT COMPLETED|Overall Study||1
3267894|NCT02637999|4002527|FG001|NOT COMPLETED|Overall Study||2
3267895|NCT02637999|4002528|FG002|NOT COMPLETED|Overall Study||2
3267896|NCT02638012|4002536|FG000|STARTED|Overall Study||8
3267897|NCT02638012|4002536|FG000|COMPLETED|Overall Study||7
3267898|NCT02638012|4002536|FG000|NOT COMPLETED|Overall Study||1
3267899|NCT02638051|4002542|FG000|STARTED|Overall Study||130
3267900|NCT02638051|4002543|FG001|STARTED|Overall Study||130
3267901|NCT02638051|4002542|FG000|COMPLETED|Overall Study||130
3267902|NCT02638051|4002543|FG001|COMPLETED|Overall Study||130
3267903|NCT02638051|4002542|FG000|NOT COMPLETED|Overall Study||0
3267904|NCT02638051|4002543|FG001|NOT COMPLETED|Overall Study||0
3267905|NCT02638103|4002553|FG000|STARTED|Overall Study||419
3267906|NCT02638103|4002554|FG001|STARTED|Overall Study||526
3267907|NCT02638103|4002555|FG002|STARTED|Overall Study||420
3267908|NCT02638103|4002556|FG003|STARTED|Overall Study||525
3267909|NCT02638103|4002553|FG000|Safety Analysis Set|Overall Study||418
3267910|NCT02638103|4002554|FG001|Safety Analysis Set|Overall Study||526
3267911|NCT02638103|4002555|FG002|Safety Analysis Set|Overall Study||419
3267912|NCT02638103|4002556|FG003|Safety Analysis Set|Overall Study||525
3267913|NCT02638103|4002553|FG000|Full Analysis Set (FAS)|Overall Study||416
3267914|NCT02638103|4002554|FG001|Full Analysis Set (FAS)|Overall Study||520
3267915|NCT02638103|4002555|FG002|Full Analysis Set (FAS)|Overall Study||419
3267916|NCT02638103|4002556|FG003|Full Analysis Set (FAS)|Overall Study||523
3267917|NCT02638103|4002553|FG000|COMPLETED|Overall Study||313
3267918|NCT02638103|4002554|FG001|COMPLETED|Overall Study||408
3267919|NCT02638103|4002555|FG002|COMPLETED|Overall Study||335
3267920|NCT02638103|4002556|FG003|COMPLETED|Overall Study||383
3267921|NCT02638103|4002553|FG000|NOT COMPLETED|Overall Study||106
3267922|NCT02638103|4002554|FG001|NOT COMPLETED|Overall Study||118
3267923|NCT02638103|4002555|FG002|NOT COMPLETED|Overall Study||85
3267924|NCT02638103|4002556|FG003|NOT COMPLETED|Overall Study||142
3267925|NCT02638168|4002574|FG000|STARTED|Overall Study||3
3267926|NCT02638168|4002575|FG001|STARTED|Overall Study||0
3267927|NCT02638168|4002574|FG000|COMPLETED|Overall Study||3
3267928|NCT02638168|4002575|FG001|COMPLETED|Overall Study||0
3267929|NCT02638168|4002574|FG000|NOT COMPLETED|Overall Study||0
3267930|NCT02638168|4002575|FG001|NOT COMPLETED|Overall Study||0
3267931|NCT02638207|4002582|FG000|STARTED|Overall Study||35
3267932|NCT02638207|4002583|FG001|STARTED|Overall Study||69
3267933|NCT02638207|4002584|FG002|STARTED|Overall Study||38
3267934|NCT02638207|4002582|FG000|COMPLETED|Overall Study||28
3267935|NCT02638207|4002583|FG001|COMPLETED|Overall Study||61
3267936|NCT02638207|4002584|FG002|COMPLETED|Overall Study||34
3267937|NCT02638207|4002582|FG000|NOT COMPLETED|Overall Study||7
3267938|NCT02638207|4002583|FG001|NOT COMPLETED|Overall Study||8
3267939|NCT02638207|4002584|FG002|NOT COMPLETED|Overall Study||4
3267940|NCT02638259|4002596|FG000|STARTED|Treatment Period 1||186
3267941|NCT02638259|4002597|FG001|STARTED|Treatment Period 1||190
3267942|NCT02638259|4002596|FG000|COMPLETED|Treatment Period 1||181
3267943|NCT02638259|4002597|FG001|COMPLETED|Treatment Period 1||172
3267944|NCT02638259|4002596|FG000|NOT COMPLETED|Treatment Period 1||5
3267945|NCT02638259|4002597|FG001|NOT COMPLETED|Treatment Period 1||18
3267946|NCT02638259|4002596|FG000|STARTED|Treatment Period 2|6 patients did not proceed to TP2 (3 not eligible, 2 consent withdrawal, 1 IP delay)|175
3267947|NCT02638259|4002597|FG001|STARTED|Treatment Period 2|6 patients did not proceed to TP2 (4 not eligible, 1 consent withdrawal, 1 adverse event).|166
3267948|NCT02638259|4002596|FG000|COMPLETED|Treatment Period 2||169
3267949|NCT02638259|4002597|FG001|COMPLETED|Treatment Period 2||155
3267950|NCT02638259|4002596|FG000|NOT COMPLETED|Treatment Period 2||6
3267951|NCT02638259|4002597|FG001|NOT COMPLETED|Treatment Period 2||11
3267952|NCT02638337|4002609|FG000|STARTED|Overall Study||316
3267953|NCT02638337|4002610|FG001|STARTED|Overall Study||315
3267954|NCT02638337|4002609|FG000|Received Treatment|Overall Study||313
3267955|NCT02638337|4002610|FG001|Received Treatment|Overall Study||315
3267956|NCT02638337|4002609|FG000|COMPLETED|Overall Study||283
3267957|NCT02638337|4002610|FG001|COMPLETED|Overall Study||279
3267958|NCT02638337|4002609|FG000|NOT COMPLETED|Overall Study||33
3267959|NCT02638337|4002610|FG001|NOT COMPLETED|Overall Study||36
3267960|NCT02638493|4002619|FG000|STARTED|Overall Study|Two men were not able to provide semen samples, and thus were replaced|10
3267961|NCT02638493|4002620|FG001|STARTED|Overall Study||8
3267962|NCT02638493|4002621|FG002|STARTED|Overall Study||8
3267963|NCT02638493|4002619|FG000|COMPLETED|Overall Study||8
3267964|NCT02638493|4002620|FG001|COMPLETED|Overall Study||8
3267965|NCT02638493|4002621|FG002|COMPLETED|Overall Study||8
3267966|NCT02638493|4002619|FG000|NOT COMPLETED|Overall Study||2
3267967|NCT02638493|4002620|FG001|NOT COMPLETED|Overall Study||0
3375866|NCT01546883|4109075|FG000|NOT COMPLETED|Overall Study||12
3375867|NCT01545518|4109079|FG000|STARTED|Overall Study||20
3375868|NCT01545518|4109079|FG000|COMPLETED|Overall Study||20
3375869|NCT01545518|4109079|FG000|NOT COMPLETED|Overall Study||0
3375870|NCT01536015|4109085|FG000|STARTED|Overall Study||12
3375871|NCT01536015|4109086|FG001|STARTED|Overall Study||13
3375872|NCT01536015|4109085|FG000|COMPLETED|Overall Study||4
3375873|NCT01536015|4109086|FG001|COMPLETED|Overall Study||3
3375874|NCT01536015|4109085|FG000|NOT COMPLETED|Overall Study||8
3375875|NCT01536015|4109086|FG001|NOT COMPLETED|Overall Study||10
3375876|NCT01539590|4109094|FG000|STARTED|Overall Study||3
3375877|NCT01539590|4109095|FG001|STARTED|Overall Study||2
3375878|NCT01539590|4109094|FG000|Complete Study Treatment|Overall Study||1
3375879|NCT01539590|4109095|FG001|Complete Study Treatment|Overall Study||2
3375880|NCT01539590|4109094|FG000|COMPLETED|Overall Study||0
3375881|NCT01539590|4109095|FG001|COMPLETED|Overall Study||2
3375882|NCT01539590|4109094|FG000|NOT COMPLETED|Overall Study||3
3375883|NCT01539590|4109095|FG001|NOT COMPLETED|Overall Study||0
3375884|NCT01539811|4109103|FG000|STARTED|Overall Study|Antibiotics never given. Study closed prior to initiating treatment.|0
3375885|NCT01539811|4109104|FG001|STARTED|Overall Study|Antibiotics never given. Study closed prior to initiating treatment.|0
3375886|NCT01539811|4109103|FG000|COMPLETED|Overall Study|Antibiotics never given. Study closed prior to initiating treatment.|0
3375887|NCT01539811|4109104|FG001|COMPLETED|Overall Study|Antibiotics never given. Study closed prior to initiating treatment.|0
3375888|NCT01539811|4109103|FG000|NOT COMPLETED|Overall Study||0
3375889|NCT01539811|4109104|FG001|NOT COMPLETED|Overall Study||0
3375890|NCT01534676|4109112|FG000|STARTED|Overall Study||2
3375891|NCT01534676|4109113|FG001|STARTED|Overall Study||1
3375892|NCT01534676|4109112|FG000|COMPLETED|Overall Study||0
3375893|NCT01534676|4109113|FG001|COMPLETED|Overall Study||0
3375894|NCT01534676|4109112|FG000|NOT COMPLETED|Overall Study||2
3375895|NCT01534676|4109113|FG001|NOT COMPLETED|Overall Study||1
3267968|NCT02638493|4002621|FG002|NOT COMPLETED|Overall Study||0
3267969|NCT02638597|4002631|FG000|STARTED|Overall Study||8
3267970|NCT02638597|4002632|FG001|STARTED|Overall Study||8
3267971|NCT02638597|4002631|FG000|COMPLETED|Overall Study||4
3267972|NCT02638597|4002632|FG001|COMPLETED|Overall Study||3
3267973|NCT02638597|4002631|FG000|NOT COMPLETED|Overall Study||4
3267974|NCT02638597|4002632|FG001|NOT COMPLETED|Overall Study||5
3267975|NCT02638623|4002642|FG000|STARTED|Overall Study||27
3267976|NCT02638623|4002643|FG001|STARTED|Overall Study||25
3267977|NCT02638623|4002642|FG000|COMPLETED|Overall Study||20
3267978|NCT02638623|4002643|FG001|COMPLETED|Overall Study||19
3267979|NCT02638623|4002642|FG000|NOT COMPLETED|Overall Study||7
3267980|NCT02638623|4002643|FG001|NOT COMPLETED|Overall Study||6
3267981|NCT02638948|4002653|FG000|STARTED|Overall Study||75
3267982|NCT02638948|4002654|FG001|STARTED|Overall Study||73
3267983|NCT02638948|4002655|FG002|STARTED|Overall Study||73
3267984|NCT02638948|4002656|FG003|STARTED|Overall Study||26
3267985|NCT02638948|4002653|FG000|COMPLETED|Overall Study||66
3267986|NCT02638948|4002654|FG001|COMPLETED|Overall Study||62
3267987|NCT02638948|4002655|FG002|COMPLETED|Overall Study||66
3267988|NCT02638948|4002656|FG003|COMPLETED|Overall Study||18
3267989|NCT02638948|4002653|FG000|NOT COMPLETED|Overall Study||9
3267990|NCT02638948|4002654|FG001|NOT COMPLETED|Overall Study||11
3267991|NCT02638948|4002655|FG002|NOT COMPLETED|Overall Study||7
3267992|NCT02638948|4002656|FG003|NOT COMPLETED|Overall Study||8
3267993|NCT02638974|4002671|FG000|STARTED|Overall Study||26
3267994|NCT02638974|4002672|FG001|STARTED|Overall Study||25
3267995|NCT02638974|4002671|FG000|COMPLETED|Overall Study||23
3267996|NCT02638974|4002672|FG001|COMPLETED|Overall Study||22
3267997|NCT02638974|4002671|FG000|NOT COMPLETED|Overall Study||3
3267998|NCT02638974|4002672|FG001|NOT COMPLETED|Overall Study||3
3267999|NCT02639052|4002678|FG000|STARTED|Overall Study||35
3268000|NCT02639052|4002678|FG000|Visit 1 (Baseline)|Overall Study||35
3268001|NCT02639052|4002678|FG000|Visit 2 (1-week Follow-up)|Overall Study||35
3268002|NCT02639052|4002678|FG000|Visit 3 (1-month Follow-up)|Overall Study||35
3268003|NCT02639052|4002678|FG000|Visit 4 (3-month Follow-up)|Overall Study||34
3268004|NCT02639052|4002678|FG000|COMPLETED|Overall Study||34
3268005|NCT02639052|4002678|FG000|NOT COMPLETED|Overall Study||1
3268006|NCT02639182|4002686|FG000|STARTED|Overall Study||67
3268007|NCT02639182|4002687|FG001|STARTED|Overall Study||66
3268008|NCT02639182|4002686|FG000|Treated|Overall Study||66
3268009|NCT02639182|4002687|FG001|Treated|Overall Study||65
3268010|NCT02639182|4002686|FG000|COMPLETED|Overall Study||0
3268011|NCT02639182|4002687|FG001|COMPLETED|Overall Study||0
3268012|NCT02639182|4002686|FG000|NOT COMPLETED|Overall Study||67
3268013|NCT02639182|4002687|FG001|NOT COMPLETED|Overall Study||66
3268014|NCT02639247|4002695|FG000|STARTED|Overall Study||182
3268015|NCT02639247|4002696|FG001|STARTED|Overall Study||151
3268016|NCT02639247|4002695|FG000|COMPLETED|Overall Study||177
3268017|NCT02639247|4002696|FG001|COMPLETED|Overall Study||149
3268018|NCT02639247|4002695|FG000|NOT COMPLETED|Overall Study||5
3268019|NCT02639247|4002696|FG001|NOT COMPLETED|Overall Study||2
3268020|NCT02639286|4002704|FG000|STARTED|Overall Study||3
3268021|NCT02639286|4002705|FG001|STARTED|Overall Study||2
3268022|NCT02639286|4002704|FG000|COMPLETED|Overall Study||3
3268023|NCT02639286|4002705|FG001|COMPLETED|Overall Study||2
3268024|NCT02639286|4002704|FG000|NOT COMPLETED|Overall Study||0
3268025|NCT02639286|4002705|FG001|NOT COMPLETED|Overall Study||0
3268026|NCT02639338|4002713|FG000|STARTED|Overall Study||110
3268027|NCT02639338|4002714|FG001|STARTED|Overall Study||110
3268028|NCT02639338|4002713|FG000|COMPLETED|Overall Study||106
3268029|NCT02639338|4002714|FG001|COMPLETED|Overall Study||105
3268030|NCT02639338|4002713|FG000|NOT COMPLETED|Overall Study||4
3268031|NCT02639338|4002714|FG001|NOT COMPLETED|Overall Study||5
3268032|NCT02639351|4002725|FG000|STARTED|Overall Study||16
3268033|NCT02639351|4002726|FG001|STARTED|Overall Study||16
3268034|NCT02639351|4002727|FG002|STARTED|Overall Study||16
3268035|NCT02639351|4002728|FG003|STARTED|Overall Study||16
3268036|NCT02639351|4002729|FG004|STARTED|Overall Study||16
3268037|NCT02639351|4002725|FG000|COMPLETED|Overall Study||16
3268038|NCT02639351|4002726|FG001|COMPLETED|Overall Study||16
3268039|NCT02639351|4002727|FG002|COMPLETED|Overall Study||16
3268040|NCT02639351|4002728|FG003|COMPLETED|Overall Study||16
3268041|NCT02639351|4002729|FG004|COMPLETED|Overall Study||16
3268042|NCT02639351|4002725|FG000|NOT COMPLETED|Overall Study||0
3268043|NCT02639351|4002726|FG001|NOT COMPLETED|Overall Study||0
3268044|NCT02639351|4002727|FG002|NOT COMPLETED|Overall Study||0
3268045|NCT02639351|4002728|FG003|NOT COMPLETED|Overall Study||0
3268046|NCT02639351|4002729|FG004|NOT COMPLETED|Overall Study||0
3375896|NCT01533753|4109121|FG000|STARTED|Overall Study||2
3375897|NCT01533753|4109122|FG001|STARTED|Overall Study||3
3375898|NCT01533753|4109121|FG000|COMPLETED|Overall Study||2
3375899|NCT01533753|4109122|FG001|COMPLETED|Overall Study||3
3375900|NCT01533753|4109121|FG000|NOT COMPLETED|Overall Study||0
3375901|NCT01533753|4109122|FG001|NOT COMPLETED|Overall Study||0
3268047|NCT02639429|4002745|FG000|STARTED|Overall Study||113
3268048|NCT02639429|4002746|FG001|STARTED|Overall Study||123
3268049|NCT02639429|4002745|FG000|COMPLETED|Overall Study||113
3268050|NCT02639429|4002746|FG001|COMPLETED|Overall Study||123
3268051|NCT02639429|4002745|FG000|NOT COMPLETED|Overall Study||0
3268052|NCT02639429|4002746|FG001|NOT COMPLETED|Overall Study||0
3268053|NCT02639494|4002752|FG000|STARTED|Overall Study||20
3268054|NCT02639494|4002752|FG000|COMPLETED|Overall Study||20
3268055|NCT02639494|4002752|FG000|NOT COMPLETED|Overall Study||0
3268056|NCT02639559|4002758|FG000|STARTED|Overall Study||25
3268057|NCT02639559|4002759|FG001|STARTED|Overall Study||25
3268058|NCT02639559|4002758|FG000|COMPLETED|Overall Study||24
3268059|NCT02639559|4002759|FG001|COMPLETED|Overall Study||22
3268060|NCT02639559|4002758|FG000|NOT COMPLETED|Overall Study||1
3268061|NCT02639559|4002759|FG001|NOT COMPLETED|Overall Study||3
3268062|NCT02639637|4002768|FG000|STARTED|Overall Study||7
3268063|NCT02639637|4002769|FG001|STARTED|Overall Study||6
3268064|NCT02639637|4002770|FG002|STARTED|Overall Study||2
3268065|NCT02639637|4002771|FG003|STARTED|Overall Study||3
3268066|NCT02639637|4002768|FG000|COMPLETED|Overall Study||7
3268067|NCT02639637|4002769|FG001|COMPLETED|Overall Study||6
3268068|NCT02639637|4002770|FG002|COMPLETED|Overall Study||2
3268069|NCT02639637|4002771|FG003|COMPLETED|Overall Study||3
3268070|NCT02639637|4002768|FG000|NOT COMPLETED|Overall Study||0
3268071|NCT02639637|4002769|FG001|NOT COMPLETED|Overall Study||0
3268072|NCT02639637|4002770|FG002|NOT COMPLETED|Overall Study||0
3268073|NCT02639637|4002771|FG003|NOT COMPLETED|Overall Study||0
3268074|NCT02639884|4002787|FG000|STARTED|Overall Study||51
3268075|NCT02639884|4002787|FG000|COMPLETED|Overall Study||47
3268076|NCT02639884|4002787|FG000|NOT COMPLETED|Overall Study||4
3268077|NCT02640053|4002794|FG000|STARTED|Overall Study||21
3268078|NCT02640053|4002795|FG001|STARTED|Overall Study||21
3268079|NCT02640053|4002794|FG000|COMPLETED|Overall Study||17
3268080|NCT02640053|4002795|FG001|COMPLETED|Overall Study||17
3268081|NCT02640053|4002794|FG000|NOT COMPLETED|Overall Study||4
3268082|NCT02640053|4002795|FG001|NOT COMPLETED|Overall Study||4
3268083|NCT02640157|4002804|FG000|STARTED|Overall Study|Intent-to-treat population: all participants who received at least 1 dose of study drug|233
3268084|NCT02640157|4002805|FG001|STARTED|Overall Study||116
3268085|NCT02640157|4002806|FG002|STARTED|Overall Study|Intent-to-treat population: all participants who received at least 1 dose of study drug|157
3268086|NCT02640157|4002804|FG000|Received Study Drug|Overall Study||233
3268087|NCT02640157|4002805|FG001|Received Study Drug|Overall Study|One participant in Arm B was randomized in error and never dispensed study drug.|115
3268088|NCT02640157|4002806|FG002|Received Study Drug|Overall Study||157
3268089|NCT02640157|4002804|FG000|Completed Study Drug|Overall Study||225
3268090|NCT02640157|4002805|FG001|Completed Study Drug|Overall Study||112
3268091|NCT02640157|4002806|FG002|Completed Study Drug|Overall Study||154
3268092|NCT02640157|4002804|FG000|Discontinued Study Drug|Overall Study||8
3268093|NCT02640157|4002805|FG001|Discontinued Study Drug|Overall Study||3
3268094|NCT02640157|4002806|FG002|Discontinued Study Drug|Overall Study||3
3268095|NCT02640157|4002804|FG000|COMPLETED|Overall Study||220
3268096|NCT02640157|4002805|FG001|COMPLETED|Overall Study||111
3268097|NCT02640157|4002806|FG002|COMPLETED|Overall Study||147
3268098|NCT02640157|4002804|FG000|NOT COMPLETED|Overall Study||13
3268099|NCT02640157|4002805|FG001|NOT COMPLETED|Overall Study||5
3268100|NCT02640157|4002806|FG002|NOT COMPLETED|Overall Study||10
3268101|NCT02640235|4002817|FG000|STARTED|Overall Study||131
3268102|NCT02640235|4002818|FG001|STARTED|Overall Study||129
3268103|NCT02640235|4002817|FG000|COMPLETED|Overall Study||117
3268104|NCT02640235|4002818|FG001|COMPLETED|Overall Study||115
3268105|NCT02640235|4002817|FG000|NOT COMPLETED|Overall Study||14
3268106|NCT02640235|4002818|FG001|NOT COMPLETED|Overall Study||14
3268107|NCT02640404|4002826|FG000|STARTED|Overall Study||112
3268108|NCT02640404|4002827|FG001|STARTED|Overall Study||112
3268109|NCT02640404|4002826|FG000|COMPLETED|Overall Study||110
3268110|NCT02640404|4002827|FG001|COMPLETED|Overall Study||112
3268111|NCT02640404|4002826|FG000|NOT COMPLETED|Overall Study||2
3268112|NCT02640404|4002827|FG001|NOT COMPLETED|Overall Study||0
3268113|NCT02640482|4002835|FG000|STARTED|Overall Study||202
3268114|NCT02640482|4002836|FG001|STARTED|Overall Study||100
3268115|NCT02640482|4002835|FG000|COMPLETED|Overall Study||199
3268116|NCT02640482|4002836|FG001|COMPLETED|Overall Study||100
3268117|NCT02640482|4002835|FG000|NOT COMPLETED|Overall Study||3
3268118|NCT02640482|4002836|FG001|NOT COMPLETED|Overall Study||0
3268119|NCT02640547|4002842|FG000|STARTED|Overall Study||394
3268120|NCT02640547|4002842|FG000|COMPLETED|Overall Study||383
3268121|NCT02640547|4002842|FG000|NOT COMPLETED|Overall Study||11
3268122|NCT02640612|4002857|FG000|STARTED|Overall Study||225
3268123|NCT02640612|4002858|FG001|STARTED|Overall Study||103
3268124|NCT02640612|4002859|FG002|STARTED|Overall Study||102
3268125|NCT02640612|4002857|FG000|COMPLETED|Overall Study||203
3268126|NCT02640612|4002858|FG001|COMPLETED|Overall Study||89
3268127|NCT02640612|4002859|FG002|COMPLETED|Overall Study||96
3268128|NCT02640612|4002857|FG000|NOT COMPLETED|Overall Study||22
3268129|NCT02640612|4002858|FG001|NOT COMPLETED|Overall Study||14
3268130|NCT02640612|4002859|FG002|NOT COMPLETED|Overall Study||6
3268131|NCT02640716|4002869|FG000|STARTED|Overall Study||30
3268132|NCT02640716|4002870|FG001|STARTED|Overall Study||30
3268133|NCT02640716|4002869|FG000|Training Completion|Overall Study||27
3268134|NCT02640716|4002870|FG001|Training Completion|Overall Study||27
3268135|NCT02640716|4002869|FG000|COMPLETED|Overall Study||23
3268136|NCT02640716|4002870|FG001|COMPLETED|Overall Study||21
3268137|NCT02640716|4002869|FG000|NOT COMPLETED|Overall Study||7
3268138|NCT02640716|4002870|FG001|NOT COMPLETED|Overall Study||9
3268139|NCT02640755|4002878|FG000|STARTED|Single Dose Period (Day 1 - 8)||3
3268140|NCT02640755|4002879|FG001|STARTED|Single Dose Period (Day 1 - 8)||1
3268141|NCT02640755|4002878|FG000|COMPLETED|Single Dose Period (Day 1 - 8)||3
3268142|NCT02640755|4002879|FG001|COMPLETED|Single Dose Period (Day 1 - 8)||1
3268143|NCT02640755|4002878|FG000|NOT COMPLETED|Single Dose Period (Day 1 - 8)||0
3268144|NCT02640755|4002879|FG001|NOT COMPLETED|Single Dose Period (Day 1 - 8)||0
3268145|NCT02640755|4002878|FG000|STARTED|Multiple Dose Period (Day 8 - EoS)||3
3268146|NCT02640755|4002879|FG001|STARTED|Multiple Dose Period (Day 8 - EoS)||1
3268147|NCT02640755|4002878|FG000|COMPLETED|Multiple Dose Period (Day 8 - EoS)||1
3268148|NCT02640755|4002879|FG001|COMPLETED|Multiple Dose Period (Day 8 - EoS)||0
3268149|NCT02640755|4002878|FG000|NOT COMPLETED|Multiple Dose Period (Day 8 - EoS)||2
3268150|NCT02640755|4002879|FG001|NOT COMPLETED|Multiple Dose Period (Day 8 - EoS)||1
3268151|NCT02640807|4002889|FG000|STARTED|Overall Study||9
3268152|NCT02640807|4002890|FG001|STARTED|Overall Study||8
3268153|NCT02640807|4002891|FG002|STARTED|Overall Study||10
3268154|NCT02640807|4002889|FG000|COMPLETED|Overall Study||9
3268155|NCT02640807|4002890|FG001|COMPLETED|Overall Study||8
3268156|NCT02640807|4002891|FG002|COMPLETED|Overall Study||10
3268157|NCT02640807|4002889|FG000|NOT COMPLETED|Overall Study||0
3268158|NCT02640807|4002890|FG001|NOT COMPLETED|Overall Study||0
3268159|NCT02640807|4002891|FG002|NOT COMPLETED|Overall Study||0
3268160|NCT02641067|4002901|FG000|STARTED|Overall Study||8
3268161|NCT02641067|4002902|FG001|STARTED|Overall Study||8
3268162|NCT02641067|4002901|FG000|COMPLETED|Overall Study||8
3268163|NCT02641067|4002902|FG001|COMPLETED|Overall Study||8
3268164|NCT02641067|4002901|FG000|NOT COMPLETED|Overall Study||0
3268165|NCT02641067|4002902|FG001|NOT COMPLETED|Overall Study||0
3268166|NCT02641080|4002910|FG000|STARTED|Overall Study||40
3268167|NCT02641080|4002911|FG001|STARTED|Overall Study||40
3375902|NCT01534143|4109128|FG000|STARTED|Overall Study||1
3375903|NCT01534143|4109128|FG000|COMPLETED|Overall Study||1
3375904|NCT01534143|4109128|FG000|NOT COMPLETED|Overall Study||0
3375905|NCT01530880|4109132|FG000|STARTED|Overall Study||35
3375906|NCT01530880|4109132|FG000|COMPLETED|Overall Study||35
3375907|NCT01530880|4109132|FG000|NOT COMPLETED|Overall Study||0
3375908|NCT01530087|4109137|FG000|STARTED|Overall Study||3
3375909|NCT01530087|4109137|FG000|COMPLETED|Overall Study||1
3375910|NCT01530087|4109137|FG000|NOT COMPLETED|Overall Study||2
3375911|NCT01527942|4109144|FG000|STARTED|Overall Study||16
3375912|NCT01527942|4109145|FG001|STARTED|Overall Study||18
3375913|NCT01527942|4109144|FG000|COMPLETED|Overall Study||16
3375914|NCT01527942|4109145|FG001|COMPLETED|Overall Study||18
3375915|NCT01527942|4109144|FG000|NOT COMPLETED|Overall Study||0
3375916|NCT01527942|4109145|FG001|NOT COMPLETED|Overall Study||0
3375917|NCT01521143|4109155|FG000|STARTED|Overall Study||40
3375918|NCT01521143|4109156|FG001|STARTED|Overall Study||36
3375919|NCT01521143|4109157|FG002|STARTED|Overall Study||8
3375920|NCT01521143|4109158|FG003|STARTED|Overall Study||7
3375921|NCT01521143|4109155|FG000|Received Treatment|Overall Study||20
3375922|NCT01521143|4109156|FG001|Received Treatment|Overall Study||20
3375923|NCT01521143|4109157|FG002|Received Treatment|Overall Study||3
3375924|NCT01521143|4109158|FG003|Received Treatment|Overall Study||4
3375925|NCT01521143|4109155|FG000|COMPLETED|Overall Study||11
3375926|NCT01521143|4109156|FG001|COMPLETED|Overall Study||10
3375927|NCT01521143|4109157|FG002|COMPLETED|Overall Study||0
3375928|NCT01521143|4109158|FG003|COMPLETED|Overall Study||0
3375929|NCT01521143|4109155|FG000|NOT COMPLETED|Overall Study||29
3375930|NCT01521143|4109156|FG001|NOT COMPLETED|Overall Study||26
3375931|NCT01521143|4109157|FG002|NOT COMPLETED|Overall Study||8
3375932|NCT01521143|4109158|FG003|NOT COMPLETED|Overall Study||7
3375933|NCT01532635|4109168|FG000|STARTED|Overall Study||4
3375934|NCT01532635|4109168|FG000|COMPLETED|Overall Study||4
3375935|NCT01532635|4109168|FG000|NOT COMPLETED|Overall Study||0
3375936|NCT01531387|4109174|FG000|STARTED|Overall Study||11
3375937|NCT01531387|4109175|FG001|STARTED|Overall Study||11
3375938|NCT01531387|4109174|FG000|COMPLETED|Overall Study||0
3375939|NCT01531387|4109175|FG001|COMPLETED|Overall Study||0
3375940|NCT01531387|4109174|FG000|NOT COMPLETED|Overall Study||11
3375941|NCT01531387|4109175|FG001|NOT COMPLETED|Overall Study||11
3375942|NCT01532362|4109183|FG000|STARTED|Overall Study||1
3375943|NCT01532362|4109184|FG001|STARTED|Overall Study||0
3375944|NCT01532362|4109183|FG000|COMPLETED|Overall Study||1
3375945|NCT01532362|4109184|FG001|COMPLETED|Overall Study||0
3375946|NCT01532362|4109183|FG000|NOT COMPLETED|Overall Study||0
3375947|NCT01532362|4109184|FG001|NOT COMPLETED|Overall Study||0
3375948|NCT01527292|4109194|FG000|STARTED|Overall Study||0
3375949|NCT01527292|4109195|FG001|STARTED|Overall Study||3
3375950|NCT01527292|4109194|FG000|COMPLETED|Overall Study||0
3375951|NCT01527292|4109195|FG001|COMPLETED|Overall Study||0
3375952|NCT01527292|4109194|FG000|NOT COMPLETED|Overall Study||0
3375953|NCT01527292|4109195|FG001|NOT COMPLETED|Overall Study||3
3375954|NCT01525745|4109203|FG000|STARTED|Overall Study||4
3375955|NCT01525745|4109204|FG001|STARTED|Overall Study||2
3375956|NCT01525745|4109203|FG000|COMPLETED|Overall Study||3
3375957|NCT01525745|4109204|FG001|COMPLETED|Overall Study||1
3375958|NCT01525745|4109203|FG000|NOT COMPLETED|Overall Study||1
3375959|NCT01525745|4109204|FG001|NOT COMPLETED|Overall Study||1
3375960|NCT01528696|4109214|FG000|STARTED|Overall Study||18
3375961|NCT01528696|4109215|FG001|STARTED|Overall Study||19
3375962|NCT01528696|4109214|FG000|Hospital Stay (2-5 Days)|Overall Study||18
3375963|NCT01528696|4109215|FG001|Hospital Stay (2-5 Days)|Overall Study||19
3375964|NCT01528696|4109214|FG000|COMPLETED|Overall Study||0
3375965|NCT01528696|4109215|FG001|COMPLETED|Overall Study||0
3268168|NCT02641080|4002910|FG000|COMPLETED|Overall Study||38
3268169|NCT02641080|4002911|FG001|COMPLETED|Overall Study||33
3268170|NCT02641080|4002910|FG000|NOT COMPLETED|Overall Study||2
3268171|NCT02641080|4002911|FG001|NOT COMPLETED|Overall Study||7
3268172|NCT02641249|4002917|FG000|STARTED|Overall Study||19
3268173|NCT02641249|4002917|FG000|COMPLETED|Overall Study||15
3268174|NCT02641249|4002917|FG000|NOT COMPLETED|Overall Study||4
3268175|NCT02641353|4002922|FG000|STARTED|Overall Study||5
3268176|NCT02641353|4002923|FG001|STARTED|Overall Study||5
3268177|NCT02641353|4002924|FG002|STARTED|Overall Study||6
3268178|NCT02641353|4002925|FG003|STARTED|Overall Study||6
3268179|NCT02641353|4002926|FG004|STARTED|Overall Study||6
3268180|NCT02641353|4002927|FG005|STARTED|Overall Study||6
3268181|NCT02641353|4002922|FG000|COMPLETED|Overall Study||5
3268182|NCT02641353|4002923|FG001|COMPLETED|Overall Study||5
3268183|NCT02641353|4002924|FG002|COMPLETED|Overall Study||6
3268184|NCT02641353|4002925|FG003|COMPLETED|Overall Study||6
3268185|NCT02641353|4002926|FG004|COMPLETED|Overall Study||6
3268186|NCT02641353|4002927|FG005|COMPLETED|Overall Study||6
3268187|NCT02641353|4002922|FG000|NOT COMPLETED|Overall Study||0
3268188|NCT02641353|4002923|FG001|NOT COMPLETED|Overall Study||0
3268189|NCT02641353|4002924|FG002|NOT COMPLETED|Overall Study||0
3268190|NCT02641353|4002925|FG003|NOT COMPLETED|Overall Study||0
3268191|NCT02641353|4002926|FG004|NOT COMPLETED|Overall Study||0
3268192|NCT02641353|4002927|FG005|NOT COMPLETED|Overall Study||0
3268193|NCT02641379|4002949|FG000|STARTED|Overall Study||142
3268194|NCT02641379|4002950|FG001|STARTED|Overall Study||152
3268195|NCT02641379|4002951|FG002|STARTED|Overall Study||78
3268196|NCT02641379|4002952|FG003|STARTED|Overall Study||156
3268197|NCT02641379|4002953|FG004|STARTED|Overall Study||17
3268198|NCT02641379|4002954|FG005|STARTED|Overall Study||36
3268199|NCT02641379|4002955|FG006|STARTED|Overall Study||25
3268200|NCT02641379|4002956|FG007|STARTED|Overall Study||20
3268201|NCT02641379|4002957|FG008|STARTED|Overall Study||42
3268202|NCT02641379|4002958|FG009|STARTED|Overall Study||45
3268203|NCT02641379|4002959|FG010|STARTED|Overall Study||8
3268204|NCT02641379|4002949|FG000|COMPLETED|Overall Study||107
3268205|NCT02641379|4002950|FG001|COMPLETED|Overall Study||101
3268206|NCT02641379|4002951|FG002|COMPLETED|Overall Study||7
3268207|NCT02641379|4002952|FG003|COMPLETED|Overall Study||139
3268208|NCT02641379|4002953|FG004|COMPLETED|Overall Study||0
3268209|NCT02641379|4002954|FG005|COMPLETED|Overall Study||20
3268210|NCT02641379|4002955|FG006|COMPLETED|Overall Study||12
3268211|NCT02641379|4002956|FG007|COMPLETED|Overall Study||1
3268212|NCT02641379|4002957|FG008|COMPLETED|Overall Study||36
3268213|NCT02641379|4002958|FG009|COMPLETED|Overall Study||36
3268214|NCT02641379|4002959|FG010|COMPLETED|Overall Study||0
3268215|NCT02641379|4002949|FG000|NOT COMPLETED|Overall Study||35
3268216|NCT02641379|4002950|FG001|NOT COMPLETED|Overall Study||51
3268217|NCT02641379|4002951|FG002|NOT COMPLETED|Overall Study||71
3268218|NCT02641379|4002952|FG003|NOT COMPLETED|Overall Study||17
3268219|NCT02641379|4002953|FG004|NOT COMPLETED|Overall Study||17
3268220|NCT02641379|4002954|FG005|NOT COMPLETED|Overall Study||16
3268221|NCT02641379|4002955|FG006|NOT COMPLETED|Overall Study||13
3268222|NCT02641379|4002956|FG007|NOT COMPLETED|Overall Study||19
3268223|NCT02641379|4002957|FG008|NOT COMPLETED|Overall Study||6
3268224|NCT02641379|4002958|FG009|NOT COMPLETED|Overall Study||9
3268225|NCT02641379|4002959|FG010|NOT COMPLETED|Overall Study||8
3268226|NCT02641392|4002991|FG000|STARTED|Overall Study||4
3268227|NCT02641392|4002992|FG001|STARTED|Overall Study||13
3268228|NCT02641392|4002993|FG002|STARTED|Overall Study||293
3268229|NCT02641392|4002991|FG000|COMPLETED|Overall Study||0
3268230|NCT02641392|4002992|FG001|COMPLETED|Overall Study||0
3268231|NCT02641392|4002993|FG002|COMPLETED|Overall Study||0
3268232|NCT02641392|4002991|FG000|NOT COMPLETED|Overall Study||4
3268233|NCT02641392|4002992|FG001|NOT COMPLETED|Overall Study||13
3268234|NCT02641392|4002993|FG002|NOT COMPLETED|Overall Study||293
3268235|NCT02641522|4003001|FG000|STARTED|Overall Study||10
3268236|NCT02641522|4003001|FG000|COMPLETED|Overall Study||10
3268237|NCT02641522|4003001|FG000|NOT COMPLETED|Overall Study||0
3268238|NCT02641561|4003009|FG000|STARTED|Overall Study||48
3268239|NCT02641561|4003010|FG001|STARTED|Overall Study||48
3268240|NCT02641561|4003011|FG002|STARTED|Overall Study||48
3268241|NCT02641561|4003012|FG003|STARTED|Overall Study||48
3268242|NCT02641561|4003009|FG000|COMPLETED|Overall Study||48
3268243|NCT02641561|4003010|FG001|COMPLETED|Overall Study||48
3268244|NCT02641561|4003011|FG002|COMPLETED|Overall Study||48
3268245|NCT02641561|4003012|FG003|COMPLETED|Overall Study||48
3268246|NCT02641561|4003009|FG000|NOT COMPLETED|Overall Study||0
3375966|NCT01528696|4109214|FG000|NOT COMPLETED|Overall Study||18
3375967|NCT01528696|4109215|FG001|NOT COMPLETED|Overall Study||19
3375968|NCT01526408|4109223|FG000|STARTED|Overall Study|early termination of study and sponsor organization closed|0
3375969|NCT01526408|4109224|FG001|STARTED|Overall Study|early termination of study and sponsor organization closed|0
3268247|NCT02641561|4003010|FG001|NOT COMPLETED|Overall Study||0
3268248|NCT02641561|4003011|FG002|NOT COMPLETED|Overall Study||0
3268249|NCT02641561|4003012|FG003|NOT COMPLETED|Overall Study||0
3268250|NCT02641587|4003025|FG000|STARTED|Confinement Period||80
3268251|NCT02641587|4003026|FG001|STARTED|Confinement Period||40
3268252|NCT02641587|4003025|FG000|COMPLETED|Confinement Period||77
3268253|NCT02641587|4003026|FG001|COMPLETED|Confinement Period||39
3268254|NCT02641587|4003025|FG000|NOT COMPLETED|Confinement Period||3
3268255|NCT02641587|4003026|FG001|NOT COMPLETED|Confinement Period||1
3268256|NCT02641587|4003025|FG000|STARTED|Ambulatory Period||77
3268257|NCT02641587|4003026|FG001|STARTED|Ambulatory Period||39
3268258|NCT02641587|4003025|FG000|COMPLETED|Ambulatory Period||76
3268259|NCT02641587|4003026|FG001|COMPLETED|Ambulatory Period||39
3268260|NCT02641587|4003025|FG000|NOT COMPLETED|Ambulatory Period||1
3268261|NCT02641587|4003026|FG001|NOT COMPLETED|Ambulatory Period||0
3268262|NCT02641691|4003039|FG000|STARTED|Overall Study||20
3268263|NCT02641691|4003039|FG000|COMPLETED|Overall Study||20
3268264|NCT02641691|4003039|FG000|NOT COMPLETED|Overall Study||0
3268265|NCT02641730|4003052|FG000|STARTED|Placebo Controlled Period (Week 0 - 16)||53
3268266|NCT02641730|4003053|FG001|STARTED|Placebo Controlled Period (Week 0 - 16)||0
3268267|NCT02641730|4003054|FG002|STARTED|Placebo Controlled Period (Week 0 - 16)||0
3268268|NCT02641730|4003055|FG003|STARTED|Placebo Controlled Period (Week 0 - 16)||54
3268269|NCT02641730|4003056|FG004|STARTED|Placebo Controlled Period (Week 0 - 16)||52
3268270|NCT02641730|4003052|FG000|COMPLETED|Placebo Controlled Period (Week 0 - 16)||51
3268271|NCT02641730|4003053|FG001|COMPLETED|Placebo Controlled Period (Week 0 - 16)||0
3268272|NCT02641730|4003054|FG002|COMPLETED|Placebo Controlled Period (Week 0 - 16)||0
3268273|NCT02641730|4003055|FG003|COMPLETED|Placebo Controlled Period (Week 0 - 16)||53
3268274|NCT02641730|4003056|FG004|COMPLETED|Placebo Controlled Period (Week 0 - 16)||50
3268275|NCT02641730|4003052|FG000|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||2
3268276|NCT02641730|4003053|FG001|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||0
3268277|NCT02641730|4003054|FG002|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||0
3268278|NCT02641730|4003055|FG003|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||1
3268279|NCT02641730|4003056|FG004|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||2
3268280|NCT02641730|4003052|FG000|STARTED|After Controlled Period (Week 16 - 52)||0
3268281|NCT02641730|4003053|FG001|STARTED|After Controlled Period (Week 16 - 52)||25
3268282|NCT02641730|4003054|FG002|STARTED|After Controlled Period (Week 16 - 52)||26
3268283|NCT02641730|4003055|FG003|STARTED|After Controlled Period (Week 16 - 52)||53
3268284|NCT02641730|4003056|FG004|STARTED|After Controlled Period (Week 16 - 52)||50
3268285|NCT02641730|4003052|FG000|COMPLETED|After Controlled Period (Week 16 - 52)||0
3268286|NCT02641730|4003053|FG001|COMPLETED|After Controlled Period (Week 16 - 52)||21
3268287|NCT02641730|4003054|FG002|COMPLETED|After Controlled Period (Week 16 - 52)||24
3268288|NCT02641730|4003055|FG003|COMPLETED|After Controlled Period (Week 16 - 52)||45
3268289|NCT02641730|4003056|FG004|COMPLETED|After Controlled Period (Week 16 - 52)||44
3268290|NCT02641730|4003052|FG000|NOT COMPLETED|After Controlled Period (Week 16 - 52)||0
3268291|NCT02641730|4003053|FG001|NOT COMPLETED|After Controlled Period (Week 16 - 52)||4
3268292|NCT02641730|4003054|FG002|NOT COMPLETED|After Controlled Period (Week 16 - 52)||2
3268293|NCT02641730|4003055|FG003|NOT COMPLETED|After Controlled Period (Week 16 - 52)||8
3268294|NCT02641730|4003056|FG004|NOT COMPLETED|After Controlled Period (Week 16 - 52)||6
3268295|NCT02641730|4003052|FG000|STARTED|Observational Period (Week 60 - Week 84)||0
3268296|NCT02641730|4003053|FG001|STARTED|Observational Period (Week 60 - Week 84)||21
3268297|NCT02641730|4003054|FG002|STARTED|Observational Period (Week 60 - Week 84)||24
3268298|NCT02641730|4003055|FG003|STARTED|Observational Period (Week 60 - Week 84)||45
3268299|NCT02641730|4003056|FG004|STARTED|Observational Period (Week 60 - Week 84)||44
3268300|NCT02641730|4003052|FG000|COMPLETED|Observational Period (Week 60 - Week 84)||0
3268301|NCT02641730|4003053|FG001|COMPLETED|Observational Period (Week 60 - Week 84)||21
3268302|NCT02641730|4003054|FG002|COMPLETED|Observational Period (Week 60 - Week 84)||24
3268303|NCT02641730|4003055|FG003|COMPLETED|Observational Period (Week 60 - Week 84)||45
3268304|NCT02641730|4003056|FG004|COMPLETED|Observational Period (Week 60 - Week 84)||43
3268305|NCT02641730|4003052|FG000|NOT COMPLETED|Observational Period (Week 60 - Week 84)||0
3268306|NCT02641730|4003053|FG001|NOT COMPLETED|Observational Period (Week 60 - Week 84)||0
3268307|NCT02641730|4003054|FG002|NOT COMPLETED|Observational Period (Week 60 - Week 84)||0
3268308|NCT02641730|4003055|FG003|NOT COMPLETED|Observational Period (Week 60 - Week 84)||0
3268309|NCT02641730|4003056|FG004|NOT COMPLETED|Observational Period (Week 60 - Week 84)||1
3268310|NCT02641834|4003072|FG000|STARTED|Overall Study||60
3268311|NCT02641834|4003073|FG001|STARTED|Overall Study||58
3268312|NCT02641834|4003072|FG000|COMPLETED|Overall Study||50
3268313|NCT02641834|4003073|FG001|COMPLETED|Overall Study||50
3268314|NCT02641834|4003072|FG000|NOT COMPLETED|Overall Study||10
3268315|NCT02641834|4003073|FG001|NOT COMPLETED|Overall Study||8
3268316|NCT02641912|4003082|FG000|STARTED|Overall Study||53
3268317|NCT02641912|4003083|FG001|STARTED|Overall Study||47
3268318|NCT02641912|4003082|FG000|COMPLETED|Overall Study||53
3268319|NCT02641912|4003083|FG001|COMPLETED|Overall Study||47
3268320|NCT02641912|4003082|FG000|NOT COMPLETED|Overall Study||0
3268321|NCT02641912|4003083|FG001|NOT COMPLETED|Overall Study||0
3268322|NCT02642159|4003095|FG000|STARTED|Overall Study|Randomized|276
3268323|NCT02642159|4003096|FG001|STARTED|Overall Study|Randomized|137
3268324|NCT02642159|4003095|FG000|Treated (Safety Population)|Overall Study||275
3268325|NCT02642159|4003096|FG001|Treated (Safety Population)|Overall Study||137
3268326|NCT02642159|4003095|FG000|ITT Population|Overall Study||273
3268327|NCT02642159|4003096|FG001|ITT Population|Overall Study||136
3268328|NCT02642159|4003095|FG000|ITT: Intent to Prescribe Fenofibrate|Overall Study|Fenofibrate was only 'intended to prescribe' in the Alirocumab arm but not actually administered.|47
3268329|NCT02642159|4003096|FG001|ITT: Intent to Prescribe Fenofibrate|Overall Study||24
3268330|NCT02642159|4003095|FG000|COMPLETED|Overall Study||245
3268331|NCT02642159|4003096|FG001|COMPLETED|Overall Study||129
3268332|NCT02642159|4003095|FG000|NOT COMPLETED|Overall Study||31
3268333|NCT02642159|4003096|FG001|NOT COMPLETED|Overall Study||8
3268334|NCT02642237|4003105|FG000|STARTED|Overall Study||15
3268335|NCT02642237|4003106|FG001|STARTED|Overall Study||15
3268336|NCT02642237|4003105|FG000|COMPLETED|Overall Study||15
3268337|NCT02642237|4003106|FG001|COMPLETED|Overall Study||15
3268338|NCT02642237|4003105|FG000|NOT COMPLETED|Overall Study||0
3268339|NCT02642237|4003106|FG001|NOT COMPLETED|Overall Study||0
3268340|NCT02642393|4003114|FG000|STARTED|Overall Study||149
3268341|NCT02642393|4003115|FG001|STARTED|Overall Study||149
3268342|NCT02642393|4003114|FG000|COMPLETED|Overall Study|"Participants who completed the study:~On-drug: 31; In-person off-drug:13; By telephone off-drug: 6"|50
3268343|NCT02642393|4003115|FG001|COMPLETED|Overall Study|"Participants who completed the study:~On-drug: 40; In-person off-drug: 16; By telephone off-drug: 1"|57
3268344|NCT02642393|4003114|FG000|NOT COMPLETED|Overall Study||99
3268345|NCT02642393|4003115|FG001|NOT COMPLETED|Overall Study||92
3268346|NCT02642432|4003121|FG000|STARTED|Overall Study||146
3268347|NCT02642432|4003121|FG000|COMPLETED|Overall Study||138
3268348|NCT02642432|4003121|FG000|NOT COMPLETED|Overall Study||8
3268349|NCT02642536|4003127|FG000|STARTED|Overall Study||21
3375970|NCT01526408|4109223|FG000|COMPLETED|Overall Study|early termination of study and sponsor organization closed|0
3375971|NCT01526408|4109224|FG001|COMPLETED|Overall Study|early termination of study and sponsor organization closed|0
3375972|NCT01526408|4109223|FG000|NOT COMPLETED|Overall Study||0
3375973|NCT01526408|4109224|FG001|NOT COMPLETED|Overall Study||0
3375974|NCT01528293|4109232|FG000|STARTED|Overall Study||1
3375975|NCT01528293|4109233|FG001|STARTED|Overall Study||1
3375976|NCT01528293|4109232|FG000|COMPLETED|Overall Study||0
3375977|NCT01528293|4109233|FG001|COMPLETED|Overall Study||1
3375978|NCT01528293|4109232|FG000|NOT COMPLETED|Overall Study||1
3375979|NCT01528293|4109233|FG001|NOT COMPLETED|Overall Study||0
3375980|NCT01525927|4109241|FG000|STARTED|Overall Study||0
3375981|NCT01525927|4109241|FG000|COMPLETED|Overall Study||0
3375982|NCT01525927|4109241|FG000|NOT COMPLETED|Overall Study||0
3375983|NCT01520714|4109249|FG000|STARTED|Overall Study||0
3375984|NCT01520714|4109250|FG001|STARTED|Overall Study||11
3375985|NCT01520714|4109249|FG000|COMPLETED|Overall Study||0
3375986|NCT01520714|4109250|FG001|COMPLETED|Overall Study||5
3375987|NCT01520714|4109249|FG000|NOT COMPLETED|Overall Study||0
3375988|NCT01520714|4109250|FG001|NOT COMPLETED|Overall Study||6
3375989|NCT01507233|4109258|FG000|STARTED|Overall Study||5
3375990|NCT01507233|4109259|FG001|STARTED|Overall Study||0
3375991|NCT01507233|4109258|FG000|COMPLETED|Overall Study||5
3375992|NCT01507233|4109259|FG001|COMPLETED|Overall Study||0
3375993|NCT01507233|4109258|FG000|NOT COMPLETED|Overall Study||0
3375994|NCT01507233|4109259|FG001|NOT COMPLETED|Overall Study||0
3375995|NCT01516034|4109265|FG000|STARTED|Overall Study||8
3375996|NCT01516034|4109265|FG000|COMPLETED|Overall Study||0
3268350|NCT02642536|4003128|FG001|STARTED|Overall Study||23
3268351|NCT02642536|4003127|FG000|COMPLETED|Overall Study||19
3268352|NCT02642536|4003128|FG001|COMPLETED|Overall Study||18
3268353|NCT02642536|4003127|FG000|NOT COMPLETED|Overall Study||2
3268354|NCT02642536|4003128|FG001|NOT COMPLETED|Overall Study||5
3268355|NCT02642575|4003134|FG000|STARTED|Overall Study||67
3268356|NCT02642575|4003134|FG000|COMPLETED|Overall Study||67
3268357|NCT02642575|4003134|FG000|NOT COMPLETED|Overall Study||0
3268358|NCT02642614|4003142|FG000|STARTED|Overall Study||30
3268359|NCT02642614|4003143|FG001|STARTED|Overall Study||30
3268360|NCT02642614|4003144|FG002|STARTED|Overall Study||30
3268361|NCT02642614|4003145|FG003|STARTED|Overall Study||30
3268362|NCT02642614|4003142|FG000|COMPLETED|Overall Study||27
3268363|NCT02642614|4003143|FG001|COMPLETED|Overall Study||28
3268364|NCT02642614|4003144|FG002|COMPLETED|Overall Study||28
3268365|NCT02642614|4003145|FG003|COMPLETED|Overall Study||28
3268366|NCT02642614|4003142|FG000|NOT COMPLETED|Overall Study||3
3268367|NCT02642614|4003143|FG001|NOT COMPLETED|Overall Study||2
3268368|NCT02642614|4003144|FG002|NOT COMPLETED|Overall Study||2
3268369|NCT02642614|4003145|FG003|NOT COMPLETED|Overall Study||2
3268370|NCT02642627|4003158|FG000|STARTED|Overall Study||42
3268371|NCT02642627|4003158|FG000|COMPLETED|Overall Study||39
3268372|NCT02642627|4003158|FG000|NOT COMPLETED|Overall Study||3
3268373|NCT02642653|4003165|FG000|STARTED|Overall Study||14
3268374|NCT02642653|4003166|FG001|STARTED|Overall Study||16
3268375|NCT02642653|4003165|FG000|COMPLETED|Overall Study||12
3268376|NCT02642653|4003166|FG001|COMPLETED|Overall Study||16
3268377|NCT02642653|4003165|FG000|NOT COMPLETED|Overall Study||2
3268378|NCT02642653|4003166|FG001|NOT COMPLETED|Overall Study||0
3268379|NCT02642679|4003172|FG000|STARTED|Overall Study||19
3268380|NCT02642679|4003172|FG000|COMPLETED|Overall Study||16
3268381|NCT02642679|4003172|FG000|NOT COMPLETED|Overall Study||3
3268382|NCT02642835|4003176|FG000|STARTED|Overall Study||48
3268383|NCT02642835|4003176|FG000|COMPLETED|Overall Study||48
3268384|NCT02642835|4003176|FG000|NOT COMPLETED|Overall Study||0
3268385|NCT02642952|4003182|FG000|STARTED|Overall Study||21
3268386|NCT02642952|4003183|FG001|STARTED|Overall Study||30
3268387|NCT02642952|4003182|FG000|COMPLETED|Overall Study||19
3268388|NCT02642952|4003183|FG001|COMPLETED|Overall Study||25
3268389|NCT02642952|4003182|FG000|NOT COMPLETED|Overall Study||2
3268390|NCT02642952|4003183|FG001|NOT COMPLETED|Overall Study||5
3268391|NCT02642991|4003189|FG000|STARTED|First Intervention||22
3268392|NCT02642991|4003190|FG001|STARTED|First Intervention||22
3268393|NCT02642991|4003189|FG000|COMPLETED|First Intervention||22
3268394|NCT02642991|4003190|FG001|COMPLETED|First Intervention||22
3268395|NCT02642991|4003189|FG000|NOT COMPLETED|First Intervention||0
3268396|NCT02642991|4003190|FG001|NOT COMPLETED|First Intervention||0
3268397|NCT02642991|4003189|FG000|STARTED|Second Intervention||22
3268398|NCT02642991|4003190|FG001|STARTED|Second Intervention||22
3268399|NCT02642991|4003189|FG000|COMPLETED|Second Intervention||22
3268400|NCT02642991|4003190|FG001|COMPLETED|Second Intervention||22
3268401|NCT02642991|4003189|FG000|NOT COMPLETED|Second Intervention||0
3268402|NCT02642991|4003190|FG001|NOT COMPLETED|Second Intervention||0
3268403|NCT02643004|4003199|FG000|STARTED|First Intervention (One Week)||35
3268404|NCT02643004|4003200|FG001|STARTED|First Intervention (One Week)||35
3268405|NCT02643004|4003199|FG000|COMPLETED|First Intervention (One Week)||35
3268406|NCT02643004|4003200|FG001|COMPLETED|First Intervention (One Week)||35
3268407|NCT02643004|4003199|FG000|NOT COMPLETED|First Intervention (One Week)||0
3268408|NCT02643004|4003200|FG001|NOT COMPLETED|First Intervention (One Week)||0
3268409|NCT02643004|4003199|FG000|STARTED|Second Intervention (One Week)||35
3268410|NCT02643004|4003200|FG001|STARTED|Second Intervention (One Week)||35
3268411|NCT02643004|4003199|FG000|COMPLETED|Second Intervention (One Week)||35
3268412|NCT02643004|4003200|FG001|COMPLETED|Second Intervention (One Week)||35
3268413|NCT02643004|4003199|FG000|NOT COMPLETED|Second Intervention (One Week)||0
3268414|NCT02643004|4003200|FG001|NOT COMPLETED|Second Intervention (One Week)||0
3268415|NCT02643082|4003206|FG000|STARTED|Period 1||10
3268416|NCT02643082|4003207|FG001|STARTED|Period 1||10
3268417|NCT02643082|4003206|FG000|COMPLETED|Period 1||9
3268418|NCT02643082|4003207|FG001|COMPLETED|Period 1||10
3268419|NCT02643082|4003206|FG000|NOT COMPLETED|Period 1||1
3268420|NCT02643082|4003207|FG001|NOT COMPLETED|Period 1||0
3268421|NCT02643082|4003206|FG000|STARTED|Washout||9
3268422|NCT02643082|4003207|FG001|STARTED|Washout||10
3268423|NCT02643082|4003206|FG000|COMPLETED|Washout||9
3268424|NCT02643082|4003207|FG001|COMPLETED|Washout||10
3268425|NCT02643082|4003206|FG000|NOT COMPLETED|Washout||0
3268426|NCT02643082|4003207|FG001|NOT COMPLETED|Washout||0
3268427|NCT02643082|4003206|FG000|STARTED|Period 2||9
3268428|NCT02643082|4003207|FG001|STARTED|Period 2||10
3268429|NCT02643082|4003206|FG000|COMPLETED|Period 2||9
3268430|NCT02643082|4003207|FG001|COMPLETED|Period 2||10
3268431|NCT02643082|4003206|FG000|NOT COMPLETED|Period 2||0
3268432|NCT02643082|4003207|FG001|NOT COMPLETED|Period 2||0
3268433|NCT02643095|4003214|FG000|STARTED|Overall Study||22
3268434|NCT02643095|4003214|FG000|COMPLETED|Overall Study||21
3268435|NCT02643095|4003214|FG000|NOT COMPLETED|Overall Study||1
3268436|NCT02643199|4003218|FG000|STARTED|Overall Study||90
3268437|NCT02643199|4003218|FG000|COMPLETED|Overall Study||90
3268438|NCT02643199|4003218|FG000|NOT COMPLETED|Overall Study||0
3268439|NCT02643225|4003224|FG000|STARTED|Overall Study||40
3268440|NCT02643225|4003225|FG001|STARTED|Overall Study||40
3268441|NCT02643225|4003224|FG000|COMPLETED|Overall Study||40
3268442|NCT02643225|4003225|FG001|COMPLETED|Overall Study||40
3268443|NCT02643225|4003224|FG000|NOT COMPLETED|Overall Study||0
3268444|NCT02643225|4003225|FG001|NOT COMPLETED|Overall Study||0
3268445|NCT02643251|4003234|FG000|STARTED|Overall Study||69
3268446|NCT02643251|4003235|FG001|STARTED|Overall Study||69
3268447|NCT02643251|4003234|FG000|COMPLETED|Overall Study||58
3268448|NCT02643251|4003235|FG001|COMPLETED|Overall Study||67
3268449|NCT02643251|4003234|FG000|NOT COMPLETED|Overall Study||11
3268450|NCT02643251|4003235|FG001|NOT COMPLETED|Overall Study||2
3268451|NCT02643355|4003243|FG000|STARTED|Overall Study||34
3268452|NCT02643355|4003244|FG001|STARTED|Overall Study||35
3268453|NCT02643355|4003243|FG000|COMPLETED|Overall Study||33
3268454|NCT02643355|4003244|FG001|COMPLETED|Overall Study||30
3268455|NCT02643355|4003243|FG000|NOT COMPLETED|Overall Study||1
3268456|NCT02643355|4003244|FG001|NOT COMPLETED|Overall Study||5
3268457|NCT02643394|4003252|FG000|STARTED|Overall Study||55
3268458|NCT02643394|4003253|FG001|STARTED|Overall Study||55
3268459|NCT02643394|4003252|FG000|COMPLETED|Overall Study||51
3268460|NCT02643394|4003253|FG001|COMPLETED|Overall Study||50
3268461|NCT02643394|4003252|FG000|NOT COMPLETED|Overall Study||4
3375997|NCT01516034|4109265|FG000|NOT COMPLETED|Overall Study||8
3375998|NCT01500772|4109269|FG000|STARTED|Overall Study||6
3375999|NCT01500772|4109269|FG000|COMPLETED|Overall Study||0
3376000|NCT01500772|4109269|FG000|NOT COMPLETED|Overall Study||6
3376001|NCT01517763|4109276|FG000|STARTED|Overall Study||0
3376002|NCT01517763|4109277|FG001|STARTED|Overall Study||0
3376003|NCT01517763|4109278|FG002|STARTED|Overall Study||0
3376004|NCT01517763|4109276|FG000|COMPLETED|Overall Study||0
3376005|NCT01517763|4109277|FG001|COMPLETED|Overall Study||0
3376006|NCT01517763|4109278|FG002|COMPLETED|Overall Study||0
3376007|NCT01517763|4109276|FG000|NOT COMPLETED|Overall Study||0
3376008|NCT01517763|4109277|FG001|NOT COMPLETED|Overall Study||0
3376009|NCT01517763|4109278|FG002|NOT COMPLETED|Overall Study||0
3376010|NCT01507584|4109286|FG000|STARTED|Overall Study||0
3376011|NCT01507584|4109286|FG000|COMPLETED|Overall Study||0
3376012|NCT01507584|4109286|FG000|NOT COMPLETED|Overall Study||0
3376013|NCT01510756|4109290|FG000|STARTED|Overall Study||4
3376014|NCT01510756|4109290|FG000|COMPLETED|Overall Study||0
3376015|NCT01510756|4109290|FG000|NOT COMPLETED|Overall Study||4
3376016|NCT01511081|4109296|FG000|STARTED|Overall Study||8
3376017|NCT01511081|4109297|FG001|STARTED|Overall Study||9
3376018|NCT01511081|4109296|FG000|COMPLETED|Overall Study||8
3376019|NCT01511081|4109297|FG001|COMPLETED|Overall Study||9
3376020|NCT01511081|4109296|FG000|NOT COMPLETED|Overall Study||0
3376021|NCT01511081|4109297|FG001|NOT COMPLETED|Overall Study||0
3376022|NCT01500109|4109306|FG000|STARTED|Overall Study||0
3376023|NCT01500109|4109307|FG001|STARTED|Overall Study||0
3376024|NCT01500109|4109308|FG002|STARTED|Overall Study||0
3376025|NCT01500109|4109306|FG000|COMPLETED|Overall Study||0
3376026|NCT01500109|4109307|FG001|COMPLETED|Overall Study||0
3376027|NCT01500109|4109308|FG002|COMPLETED|Overall Study||0
3376028|NCT01500109|4109306|FG000|NOT COMPLETED|Overall Study||0
3376029|NCT01500109|4109307|FG001|NOT COMPLETED|Overall Study||0
3376030|NCT01500109|4109308|FG002|NOT COMPLETED|Overall Study||0
3376031|NCT01509053|4109316|FG000|STARTED|Oral Aripirazole (Phase A)||19
3376032|NCT01509053|4109316|FG000|COMPLETED|Oral Aripirazole (Phase A)||8
3376033|NCT01509053|4109316|FG000|NOT COMPLETED|Oral Aripirazole (Phase A)||11
3376034|NCT01509053|4109316|FG000|STARTED|Aripiprazole IM Depot Treatment Phase(B)|Includes 8 patients from Phase A + 11 patients who entered directly into Phase B.|19
3376035|NCT01509053|4109316|FG000|COMPLETED|Aripiprazole IM Depot Treatment Phase(B)||3
3376036|NCT01509053|4109316|FG000|NOT COMPLETED|Aripiprazole IM Depot Treatment Phase(B)||16
3376037|NCT01509053|4109316|FG000|STARTED|Aripiprazole IM Depot Extension Phase(C)||3
3376038|NCT01509053|4109316|FG000|COMPLETED|Aripiprazole IM Depot Extension Phase(C)||0
3376039|NCT01509053|4109316|FG000|NOT COMPLETED|Aripiprazole IM Depot Extension Phase(C)||3
3376040|NCT01495988|4109328|FG000|STARTED|Vem +/- Bev (Protocol v2.0)||0
3376041|NCT01495988|4109329|FG001|STARTED|Vem +/- Bev (Protocol v2.0)||0
3376042|NCT01495988|4109330|FG002|STARTED|Vem +/- Bev (Protocol v2.0)||5
3376043|NCT01495988|4109331|FG003|STARTED|Vem +/- Bev (Protocol v2.0)||3
3376044|NCT01495988|4109328|FG000|COMPLETED|Vem +/- Bev (Protocol v2.0)||0
3376045|NCT01495988|4109329|FG001|COMPLETED|Vem +/- Bev (Protocol v2.0)||0
3376046|NCT01495988|4109330|FG002|COMPLETED|Vem +/- Bev (Protocol v2.0)||5
3376047|NCT01495988|4109331|FG003|COMPLETED|Vem +/- Bev (Protocol v2.0)||3
3376048|NCT01495988|4109328|FG000|NOT COMPLETED|Vem +/- Bev (Protocol v2.0)||0
3376049|NCT01495988|4109329|FG001|NOT COMPLETED|Vem +/- Bev (Protocol v2.0)||0
3376050|NCT01495988|4109330|FG002|NOT COMPLETED|Vem +/- Bev (Protocol v2.0)||0
3376051|NCT01495988|4109331|FG003|NOT COMPLETED|Vem +/- Bev (Protocol v2.0)||0
3376052|NCT01495988|4109328|FG000|STARTED|Vem/Cobi +/- Bev (Protocol v4.0)||0
3376053|NCT01495988|4109329|FG001|STARTED|Vem/Cobi +/- Bev (Protocol v4.0)||2
3376054|NCT01495988|4109330|FG002|STARTED|Vem/Cobi +/- Bev (Protocol v4.0)||0
3376055|NCT01495988|4109331|FG003|STARTED|Vem/Cobi +/- Bev (Protocol v4.0)||0
3376056|NCT01495988|4109328|FG000|COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
3376057|NCT01495988|4109329|FG001|COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||2
3376058|NCT01495988|4109330|FG002|COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
3376059|NCT01495988|4109331|FG003|COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
3268462|NCT02643394|4003253|FG001|NOT COMPLETED|Overall Study||5
3268463|NCT02643459|4003261|FG000|STARTED|Overall Study||7901
3268464|NCT02643459|4003262|FG001|STARTED|Overall Study||8900
3268465|NCT02643459|4003261|FG000|COMPLETED|Overall Study||7901
3268466|NCT02643459|4003262|FG001|COMPLETED|Overall Study||8900
3268467|NCT02643459|4003261|FG000|NOT COMPLETED|Overall Study||0
3268468|NCT02643459|4003262|FG001|NOT COMPLETED|Overall Study||0
3268469|NCT02643472|4003271|FG000|STARTED|Overall Study||150
3268470|NCT02643472|4003272|FG001|STARTED|Overall Study||150
3268471|NCT02643472|4003271|FG000|COMPLETED|Overall Study||123
3268472|NCT02643472|4003272|FG001|COMPLETED|Overall Study|One participant completed CESD-10 but not other measures at 12 months; n=115 for other measures.|116
3268473|NCT02643472|4003271|FG000|NOT COMPLETED|Overall Study||27
3268474|NCT02643472|4003272|FG001|NOT COMPLETED|Overall Study||34
3268475|NCT02643615|4003282|FG000|STARTED|Overall Study||9
3268476|NCT02643615|4003283|FG001|STARTED|Overall Study||11
3268477|NCT02643615|4003282|FG000|COMPLETED|Overall Study||9
3268478|NCT02643615|4003283|FG001|COMPLETED|Overall Study||11
3268479|NCT02643615|4003282|FG000|NOT COMPLETED|Overall Study||0
3268480|NCT02643615|4003283|FG001|NOT COMPLETED|Overall Study||0
3268481|NCT02643628|4003292|FG000|STARTED|Overall Study||21
3268482|NCT02643628|4003293|FG001|STARTED|Overall Study||23
3268483|NCT02643628|4003292|FG000|COMPLETED|Overall Study||20
3268484|NCT02643628|4003293|FG001|COMPLETED|Overall Study||17
3268485|NCT02643628|4003292|FG000|NOT COMPLETED|Overall Study||1
3268486|NCT02643628|4003293|FG001|NOT COMPLETED|Overall Study||6
3268487|NCT02643693|4003301|FG000|STARTED|Overall Study||4
3268488|NCT02643693|4003302|FG001|STARTED|Overall Study||4
3268489|NCT02643693|4003303|FG002|STARTED|Overall Study||4
3268490|NCT02643693|4003304|FG003|STARTED|Overall Study||4
3268491|NCT02643693|4003305|FG004|STARTED|Overall Study||4
3268492|NCT02643693|4003306|FG005|STARTED|Overall Study||4
3268493|NCT02643693|4003301|FG000|COMPLETED|Overall Study||2
3268494|NCT02643693|4003302|FG001|COMPLETED|Overall Study||2
3268495|NCT02643693|4003303|FG002|COMPLETED|Overall Study||3
3268496|NCT02643693|4003304|FG003|COMPLETED|Overall Study||4
3268497|NCT02643693|4003305|FG004|COMPLETED|Overall Study||4
3268498|NCT02643693|4003306|FG005|COMPLETED|Overall Study||3
3268499|NCT02643693|4003301|FG000|NOT COMPLETED|Overall Study||2
3268500|NCT02643693|4003302|FG001|NOT COMPLETED|Overall Study||2
3268501|NCT02643693|4003303|FG002|NOT COMPLETED|Overall Study||1
3268502|NCT02643693|4003304|FG003|NOT COMPLETED|Overall Study||0
3268503|NCT02643693|4003305|FG004|NOT COMPLETED|Overall Study||0
3268504|NCT02643693|4003306|FG005|NOT COMPLETED|Overall Study||1
3268505|NCT02643849|4003314|FG000|STARTED|Overall Study||107
3268506|NCT02643849|4003314|FG000|COMPLETED|Overall Study||82
3268507|NCT02643849|4003314|FG000|NOT COMPLETED|Overall Study||25
3268508|NCT02643862|4003320|FG000|STARTED|Overall Study||36
3268509|NCT02643862|4003321|FG001|STARTED|Overall Study||12
3268510|NCT02643862|4003320|FG000|COMPLETED|Overall Study||36
3268511|NCT02643862|4003321|FG001|COMPLETED|Overall Study||12
3268512|NCT02643862|4003320|FG000|NOT COMPLETED|Overall Study||0
3268513|NCT02643862|4003321|FG001|NOT COMPLETED|Overall Study||0
3268514|NCT02643875|4003327|FG000|STARTED|Overall Study||36
3268515|NCT02643875|4003327|FG000|Received 0.75|Overall Study||36
3268516|NCT02643875|4003327|FG000|Received 1.75 D|Overall Study||36
3268517|NCT02643875|4003327|FG000|COMPLETED|Overall Study||28
3268518|NCT02643875|4003327|FG000|NOT COMPLETED|Overall Study||8
3268519|NCT02643979|4003334|FG000|STARTED|Overall Study||11
3268520|NCT02643979|4003335|FG001|STARTED|Overall Study||11
3268521|NCT02643979|4003334|FG000|COMPLETED|Overall Study||11
3268522|NCT02643979|4003335|FG001|COMPLETED|Overall Study||11
3268523|NCT02643979|4003334|FG000|NOT COMPLETED|Overall Study||0
3268524|NCT02643979|4003335|FG001|NOT COMPLETED|Overall Study||0
3268525|NCT02644096|4003343|FG000|STARTED|Overall Study||93
3268526|NCT02644096|4003344|FG001|STARTED|Overall Study||82
3268527|NCT02644096|4003343|FG000|2 Week Interview|Overall Study|Not done in control group|0
3268528|NCT02644096|4003344|FG001|2 Week Interview|Overall Study||68
3268529|NCT02644096|4003343|FG000|10 Week Interview|Overall Study|Not done in control group|0
3268530|NCT02644096|4003344|FG001|10 Week Interview|Overall Study||59
3268531|NCT02644096|4003343|FG000|12 Week SF-36 Questionnaire|Overall Study||68
3268532|NCT02644096|4003344|FG001|12 Week SF-36 Questionnaire|Overall Study||59
3268533|NCT02644096|4003343|FG000|9 Month SF-36 Questionnaire|Overall Study||65
3268534|NCT02644096|4003344|FG001|9 Month SF-36 Questionnaire|Overall Study||57
3268535|NCT02644096|4003343|FG000|COMPLETED|Overall Study||65
3268536|NCT02644096|4003344|FG001|COMPLETED|Overall Study||57
3268537|NCT02644096|4003343|FG000|NOT COMPLETED|Overall Study||28
3268538|NCT02644096|4003344|FG001|NOT COMPLETED|Overall Study||25
3268539|NCT02644109|4003352|FG000|STARTED|Overall Study||24
3268540|NCT02644109|4003353|FG001|STARTED|Overall Study||28
3268541|NCT02644109|4003352|FG000|COMPLETED|Overall Study||24
3268542|NCT02644109|4003353|FG001|COMPLETED|Overall Study||24
3268543|NCT02644109|4003352|FG000|NOT COMPLETED|Overall Study||0
3268544|NCT02644109|4003353|FG001|NOT COMPLETED|Overall Study||4
3268545|NCT02644122|4003359|FG000|STARTED|Overall Study||1
3376060|NCT01495988|4109328|FG000|NOT COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
3376061|NCT01495988|4109329|FG001|NOT COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
3376062|NCT01495988|4109330|FG002|NOT COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
3376063|NCT01495988|4109331|FG003|NOT COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
3376064|NCT01498991|4109341|FG000|STARTED|Overall Study||2
3376065|NCT01498991|4109341|FG000|COMPLETED|Overall Study||2
3268546|NCT02644122|4003359|FG000|COMPLETED|Overall Study||0
3268547|NCT02644122|4003359|FG000|NOT COMPLETED|Overall Study||1
3268548|NCT02644278|4003368|FG000|STARTED|Overall Study||3
3268549|NCT02644278|4003369|FG001|STARTED|Overall Study||3
3268550|NCT02644278|4003370|FG002|STARTED|Overall Study||6
3268551|NCT02644278|4003371|FG003|STARTED|Overall Study||3
3268552|NCT02644278|4003368|FG000|COMPLETED|Overall Study||3
3268553|NCT02644278|4003369|FG001|COMPLETED|Overall Study||3
3268554|NCT02644278|4003370|FG002|COMPLETED|Overall Study||6
3268555|NCT02644278|4003371|FG003|COMPLETED|Overall Study||3
3268556|NCT02644278|4003368|FG000|NOT COMPLETED|Overall Study||0
3268557|NCT02644278|4003369|FG001|NOT COMPLETED|Overall Study||0
3268558|NCT02644278|4003370|FG002|NOT COMPLETED|Overall Study||0
3268559|NCT02644278|4003371|FG003|NOT COMPLETED|Overall Study||0
3268560|NCT02644343|4003381|FG000|STARTED|Overall Study||40
3268561|NCT02644343|4003381|FG000|COMPLETED|Overall Study||39
3268562|NCT02644343|4003381|FG000|NOT COMPLETED|Overall Study||1
3268563|NCT02644356|4003385|FG000|STARTED|Overall Study||51
3268564|NCT02644356|4003385|FG000|COMPLETED|Overall Study|49 of the 51 consented subjects completed pre-post knowledge testing (96%)|49
3268565|NCT02644356|4003385|FG000|NOT COMPLETED|Overall Study||2
3268566|NCT02644668|4003392|FG000|STARTED|Overall Study||26
3268567|NCT02644668|4003393|FG001|STARTED|Overall Study||24
3268568|NCT02644668|4003394|FG002|STARTED|Overall Study||20
3268569|NCT02644668|4003392|FG000|COMPLETED|Overall Study||24
3268570|NCT02644668|4003393|FG001|COMPLETED|Overall Study||24
3268571|NCT02644668|4003394|FG002|COMPLETED|Overall Study||17
3268572|NCT02644668|4003392|FG000|NOT COMPLETED|Overall Study||2
3268573|NCT02644668|4003393|FG001|NOT COMPLETED|Overall Study||0
3268574|NCT02644668|4003394|FG002|NOT COMPLETED|Overall Study||3
3268575|NCT02645019|4003409|FG000|STARTED|Overall Study||13
3268576|NCT02645019|4003410|FG001|STARTED|Overall Study||15
3268577|NCT02645019|4003411|FG002|STARTED|Overall Study||15
3268578|NCT02645019|4003412|FG003|STARTED|Overall Study||33
3268579|NCT02645019|4003413|FG004|STARTED|Overall Study||24
3268580|NCT02645019|4003409|FG000|COMPLETED|Overall Study||13
3268581|NCT02645019|4003410|FG001|COMPLETED|Overall Study||15
3268582|NCT02645019|4003411|FG002|COMPLETED|Overall Study||15
3268583|NCT02645019|4003412|FG003|COMPLETED|Overall Study||33
3268584|NCT02645019|4003413|FG004|COMPLETED|Overall Study||24
3268585|NCT02645019|4003409|FG000|NOT COMPLETED|Overall Study||0
3268586|NCT02645019|4003410|FG001|NOT COMPLETED|Overall Study||0
3268587|NCT02645019|4003411|FG002|NOT COMPLETED|Overall Study||0
3268588|NCT02645019|4003412|FG003|NOT COMPLETED|Overall Study||0
3268589|NCT02645019|4003413|FG004|NOT COMPLETED|Overall Study||0
3268590|NCT02645123|4003428|FG000|STARTED|Overall Study||25
3268591|NCT02645123|4003429|FG001|STARTED|Overall Study||25
3268592|NCT02645123|4003430|FG002|STARTED|Overall Study||25
3268593|NCT02645123|4003428|FG000|COMPLETED|Overall Study||25
3268594|NCT02645123|4003429|FG001|COMPLETED|Overall Study||25
3268595|NCT02645123|4003430|FG002|COMPLETED|Overall Study||25
3268596|NCT02645123|4003428|FG000|NOT COMPLETED|Overall Study||0
3268597|NCT02645123|4003429|FG001|NOT COMPLETED|Overall Study||0
3268598|NCT02645123|4003430|FG002|NOT COMPLETED|Overall Study||0
3268599|NCT02645253|4003442|FG000|STARTED|Overall Study||7
3268600|NCT02645253|4003443|FG001|STARTED|Overall Study||7
3268601|NCT02645253|4003444|FG002|STARTED|Overall Study||7
3268602|NCT02645253|4003445|FG003|STARTED|Overall Study||6
3268603|NCT02645253|4003442|FG000|COMPLETED|Overall Study||7
3268604|NCT02645253|4003443|FG001|COMPLETED|Overall Study||7
3268605|NCT02645253|4003444|FG002|COMPLETED|Overall Study||7
3268606|NCT02645253|4003445|FG003|COMPLETED|Overall Study||6
3268607|NCT02645253|4003442|FG000|NOT COMPLETED|Overall Study||0
3268608|NCT02645253|4003443|FG001|NOT COMPLETED|Overall Study||0
3268609|NCT02645253|4003444|FG002|NOT COMPLETED|Overall Study||0
3268610|NCT02645253|4003445|FG003|NOT COMPLETED|Overall Study||0
3268611|NCT02645409|4003462|FG000|STARTED|Overall Study||14
3268612|NCT02645409|4003463|FG001|STARTED|Overall Study|It was decided to not continue with the Radical Nephrectomy arm of the study.|0
3268613|NCT02645409|4003462|FG000|COMPLETED|Overall Study||10
3268614|NCT02645409|4003463|FG001|COMPLETED|Overall Study||0
3268615|NCT02645409|4003462|FG000|NOT COMPLETED|Overall Study||4
3268616|NCT02645409|4003463|FG001|NOT COMPLETED|Overall Study||0
3268617|NCT02645617|4003468|FG000|STARTED|Overall Study||12
3268618|NCT02645617|4003468|FG000|COMPLETED|Overall Study||12
3268619|NCT02645617|4003468|FG000|NOT COMPLETED|Overall Study||0
3268620|NCT02645760|4003474|FG000|STARTED|Overall Study||19
3268621|NCT02645760|4003475|FG001|STARTED|Overall Study||19
3268622|NCT02645760|4003474|FG000|COMPLETED|Overall Study||19
3268623|NCT02645760|4003475|FG001|COMPLETED|Overall Study||19
3268624|NCT02645760|4003474|FG000|NOT COMPLETED|Overall Study||0
3268625|NCT02645760|4003475|FG001|NOT COMPLETED|Overall Study||0
3268626|NCT02646124|4003484|FG000|STARTED|Overall Study||57
3268627|NCT02646124|4003485|FG001|STARTED|Overall Study||57
3268628|NCT02646124|4003484|FG000|COMPLETED|Overall Study||57
3268629|NCT02646124|4003485|FG001|COMPLETED|Overall Study||55
3268630|NCT02646124|4003484|FG000|NOT COMPLETED|Overall Study||0
3268631|NCT02646124|4003485|FG001|NOT COMPLETED|Overall Study||2
3268632|NCT02646332|4003493|FG000|STARTED|Overall Study||124
3376066|NCT01498991|4109341|FG000|NOT COMPLETED|Overall Study||0
3268633|NCT02646332|4003494|FG001|STARTED|Overall Study||124
3268634|NCT02646332|4003493|FG000|COMPLETED|Overall Study||124
3268635|NCT02646332|4003494|FG001|COMPLETED|Overall Study||121
3268636|NCT02646332|4003493|FG000|NOT COMPLETED|Overall Study||0
3268637|NCT02646332|4003494|FG001|NOT COMPLETED|Overall Study||3
3268638|NCT02646371|4003502|FG000|STARTED|Overall Study||34
3268639|NCT02646371|4003503|FG001|STARTED|Overall Study||33
3268640|NCT02646371|4003502|FG000|COMPLETED|Overall Study||34
3268641|NCT02646371|4003503|FG001|COMPLETED|Overall Study||33
3268642|NCT02646371|4003502|FG000|NOT COMPLETED|Overall Study||0
3268643|NCT02646371|4003503|FG001|NOT COMPLETED|Overall Study||0
3268644|NCT02646423|4003511|FG000|STARTED|Overall Study||742
3268645|NCT02646423|4003512|FG001|STARTED|Overall Study||743
3268646|NCT02646423|4003511|FG000|COMPLETED|Overall Study||735
3268647|NCT02646423|4003512|FG001|COMPLETED|Overall Study||735
3268648|NCT02646423|4003511|FG000|NOT COMPLETED|Overall Study||7
3268649|NCT02646423|4003512|FG001|NOT COMPLETED|Overall Study||8
3268650|NCT02646449|4003520|FG000|STARTED|Overall Study||4
3268651|NCT02646449|4003521|FG001|STARTED|Overall Study||3
3268652|NCT02646449|4003520|FG000|COMPLETED|Overall Study||4
3268653|NCT02646449|4003521|FG001|COMPLETED|Overall Study||3
3268654|NCT02646449|4003520|FG000|NOT COMPLETED|Overall Study||0
3268655|NCT02646449|4003521|FG001|NOT COMPLETED|Overall Study||0
3376067|NCT01497171|4109347|FG000|STARTED|Overall Study||2
3376068|NCT01497171|4109348|FG001|STARTED|Overall Study||3
3376069|NCT01497171|4109347|FG000|COMPLETED|Overall Study||2
3376070|NCT01497171|4109348|FG001|COMPLETED|Overall Study||3
3376071|NCT01497171|4109347|FG000|NOT COMPLETED|Overall Study||0
3376072|NCT01497171|4109348|FG001|NOT COMPLETED|Overall Study||0
3376073|NCT01483872|4109354|FG000|STARTED|Overall Study||0
3376074|NCT01483872|4109355|FG001|STARTED|Overall Study||1
3376075|NCT01483872|4109354|FG000|COMPLETED|Overall Study||0
3376076|NCT01483872|4109355|FG001|COMPLETED|Overall Study||1
3376077|NCT01483872|4109354|FG000|NOT COMPLETED|Overall Study||0
3376078|NCT01483872|4109355|FG001|NOT COMPLETED|Overall Study||0
3376079|NCT01487499|4109359|FG000|STARTED|Overall Study||4
3376080|NCT01487499|4109359|FG000|COMPLETED|Overall Study||4
3376081|NCT01487499|4109359|FG000|NOT COMPLETED|Overall Study||0
3376082|NCT01478113|4109365|FG000|STARTED|Overall Study||2
3376083|NCT01478113|4109366|FG001|STARTED|Overall Study||2
3376084|NCT01478113|4109365|FG000|COMPLETED|Overall Study||1
3376085|NCT01478113|4109366|FG001|COMPLETED|Overall Study||1
3376086|NCT01478113|4109365|FG000|NOT COMPLETED|Overall Study||1
3376087|NCT01478113|4109366|FG001|NOT COMPLETED|Overall Study||1
3376088|NCT01483209|4109374|FG000|STARTED|Overall Study||2
3376089|NCT01483209|4109374|FG000|COMPLETED|Overall Study||1
3376090|NCT01483209|4109374|FG000|NOT COMPLETED|Overall Study||1
3376091|NCT01484314|4109378|FG000|STARTED|Overall Study||1
3376092|NCT01484314|4109378|FG000|COMPLETED|Overall Study||1
3376093|NCT01484314|4109378|FG000|NOT COMPLETED|Overall Study||0
3376094|NCT01482598|4109384|FG000|STARTED|Overall Study||66
3376095|NCT01482598|4109385|FG001|STARTED|Overall Study||73
3376096|NCT01482598|4109384|FG000|COMPLETED|Overall Study||50
3376097|NCT01482598|4109385|FG001|COMPLETED|Overall Study||51
3376098|NCT01482598|4109384|FG000|NOT COMPLETED|Overall Study||16
3376099|NCT01482598|4109385|FG001|NOT COMPLETED|Overall Study||22
3376100|NCT01479010|4109391|FG000|STARTED|Overall Study||2
3376101|NCT01479010|4109391|FG000|COMPLETED|Overall Study||1
3376102|NCT01479010|4109391|FG000|NOT COMPLETED|Overall Study||1
3376103|NCT01482325|4109395|FG000|STARTED|Overall Study||31
3376104|NCT01482325|4109395|FG000|COMPLETED|Overall Study||31
3376105|NCT01482325|4109395|FG000|NOT COMPLETED|Overall Study||0
3376106|NCT01477177|4109399|FG000|STARTED|Overall Study||4
3376107|NCT01477177|4109399|FG000|COMPLETED|Overall Study||4
3376108|NCT01477177|4109399|FG000|NOT COMPLETED|Overall Study||0
3376109|NCT01473732|4109405|FG000|STARTED|Overall Study||2
3376110|NCT01473732|4109406|FG001|STARTED|Overall Study||0
3376111|NCT01473732|4109405|FG000|COMPLETED|Overall Study||0
3376112|NCT01473732|4109406|FG001|COMPLETED|Overall Study||0
3376113|NCT01473732|4109405|FG000|NOT COMPLETED|Overall Study||2
3376114|NCT01473732|4109406|FG001|NOT COMPLETED|Overall Study||0
3376115|NCT01472692|4109414|FG000|STARTED|Overall Study||0
3376116|NCT01472692|4109415|FG001|STARTED|Overall Study||0
3376117|NCT01472692|4109414|FG000|COMPLETED|Overall Study||0
3376118|NCT01472692|4109415|FG001|COMPLETED|Overall Study||0
3376119|NCT01472692|4109414|FG000|NOT COMPLETED|Overall Study||0
3376120|NCT01472692|4109415|FG001|NOT COMPLETED|Overall Study||0
3376121|NCT01465230|4109421|FG000|STARTED|Overall Study||2
3376122|NCT01465230|4109421|FG000|COMPLETED|Overall Study||0
3376123|NCT01465230|4109421|FG000|NOT COMPLETED|Overall Study||2
3376124|NCT01464723|4109425|FG000|STARTED|Overall Study||0
3376125|NCT01464723|4109425|FG000|COMPLETED|Overall Study||0
3376126|NCT01464723|4109425|FG000|NOT COMPLETED|Overall Study||0
3376127|NCT01446250|4109429|FG000|STARTED|Treatment Period 1||5
3376128|NCT01446250|4109430|FG001|STARTED|Treatment Period 1||3
3376129|NCT01446250|4109431|FG002|STARTED|Treatment Period 1||0
3376130|NCT01446250|4109432|FG003|STARTED|Treatment Period 1||0
3376131|NCT01446250|4109429|FG000|COMPLETED|Treatment Period 1||5
3376132|NCT01446250|4109430|FG001|COMPLETED|Treatment Period 1||2
3376133|NCT01446250|4109431|FG002|COMPLETED|Treatment Period 1||0
3376134|NCT01446250|4109432|FG003|COMPLETED|Treatment Period 1||0
3376135|NCT01446250|4109429|FG000|NOT COMPLETED|Treatment Period 1||0
3376136|NCT01446250|4109430|FG001|NOT COMPLETED|Treatment Period 1||1
3376137|NCT01446250|4109431|FG002|NOT COMPLETED|Treatment Period 1||0
3376138|NCT01446250|4109432|FG003|NOT COMPLETED|Treatment Period 1||0
3376139|NCT01446250|4109429|FG000|STARTED|Clinical Hold||0
3376140|NCT01446250|4109430|FG001|STARTED|Clinical Hold||2
3376141|NCT01446250|4109431|FG002|STARTED|Clinical Hold||5
3376142|NCT01446250|4109432|FG003|STARTED|Clinical Hold||0
3376143|NCT01446250|4109429|FG000|COMPLETED|Clinical Hold||0
3268656|NCT02646566|4003530|FG000|STARTED|Overall Study||237
3268657|NCT02646566|4003531|FG001|STARTED|Overall Study||230
3268658|NCT02646566|4003532|FG002|STARTED|Overall Study||235
3268659|NCT02646566|4003530|FG000|COMPLETED|Overall Study||231
3268660|NCT02646566|4003531|FG001|COMPLETED|Overall Study||226
3268661|NCT02646566|4003532|FG002|COMPLETED|Overall Study||230
3268662|NCT02646566|4003530|FG000|NOT COMPLETED|Overall Study||6
3268663|NCT02646566|4003531|FG001|NOT COMPLETED|Overall Study||4
3268664|NCT02646566|4003532|FG002|NOT COMPLETED|Overall Study||5
3268665|NCT02646618|4003542|FG000|STARTED|Overall Study||167
3268666|NCT02646618|4003543|FG001|STARTED|Overall Study||162
3268667|NCT02646618|4003542|FG000|6 Month Follow-up|Overall Study||152
3268668|NCT02646618|4003543|FG001|6 Month Follow-up|Overall Study||150
3268669|NCT02646618|4003542|FG000|COMPLETED|Overall Study||157
3268670|NCT02646618|4003543|FG001|COMPLETED|Overall Study||148
3268671|NCT02646618|4003542|FG000|NOT COMPLETED|Overall Study||10
3268672|NCT02646618|4003543|FG001|NOT COMPLETED|Overall Study||14
3268673|NCT02646761|4003553|FG000|STARTED|Overall Study||18
3268674|NCT02646761|4003554|FG001|STARTED|Overall Study||20
3268675|NCT02646761|4003553|FG000|Subject Withdrew Before Baseline|Overall Study||5
3268676|NCT02646761|4003554|FG001|Subject Withdrew Before Baseline|Overall Study||8
3268677|NCT02646761|4003553|FG000|Baseline Assessment|Overall Study||13
3376144|NCT01446250|4109430|FG001|COMPLETED|Clinical Hold||2
3376145|NCT01446250|4109431|FG002|COMPLETED|Clinical Hold||5
3376146|NCT01446250|4109432|FG003|COMPLETED|Clinical Hold||0
3376147|NCT01446250|4109429|FG000|NOT COMPLETED|Clinical Hold||0
3376148|NCT01446250|4109430|FG001|NOT COMPLETED|Clinical Hold||0
3376149|NCT01446250|4109431|FG002|NOT COMPLETED|Clinical Hold||0
3376150|NCT01446250|4109432|FG003|NOT COMPLETED|Clinical Hold||0
3376151|NCT01446250|4109429|FG000|STARTED|Treatment Period 2||0
3376152|NCT01446250|4109430|FG001|STARTED|Treatment Period 2||7
3376153|NCT01446250|4109431|FG002|STARTED|Treatment Period 2||0
3376154|NCT01446250|4109432|FG003|STARTED|Treatment Period 2||0
3376155|NCT01446250|4109429|FG000|COMPLETED|Treatment Period 2||0
3376156|NCT01446250|4109430|FG001|COMPLETED|Treatment Period 2||6
3376157|NCT01446250|4109431|FG002|COMPLETED|Treatment Period 2||0
3376158|NCT01446250|4109432|FG003|COMPLETED|Treatment Period 2||0
3376159|NCT01446250|4109429|FG000|NOT COMPLETED|Treatment Period 2||0
3376160|NCT01446250|4109430|FG001|NOT COMPLETED|Treatment Period 2||1
3376161|NCT01446250|4109431|FG002|NOT COMPLETED|Treatment Period 2||0
3376162|NCT01446250|4109432|FG003|NOT COMPLETED|Treatment Period 2||0
3376163|NCT01446250|4109429|FG000|STARTED|Follow-up||0
3376164|NCT01446250|4109430|FG001|STARTED|Follow-up||0
3376165|NCT01446250|4109431|FG002|STARTED|Follow-up||0
3376166|NCT01446250|4109432|FG003|STARTED|Follow-up||6
3376167|NCT01446250|4109429|FG000|COMPLETED|Follow-up||0
3376168|NCT01446250|4109430|FG001|COMPLETED|Follow-up||0
3376169|NCT01446250|4109431|FG002|COMPLETED|Follow-up||0
3376170|NCT01446250|4109432|FG003|COMPLETED|Follow-up||0
3376171|NCT01446250|4109429|FG000|NOT COMPLETED|Follow-up||0
3376172|NCT01446250|4109430|FG001|NOT COMPLETED|Follow-up||0
3376173|NCT01446250|4109431|FG002|NOT COMPLETED|Follow-up||0
3376174|NCT01446250|4109432|FG003|NOT COMPLETED|Follow-up||6
3268678|NCT02646761|4003554|FG001|Baseline Assessment|Overall Study||12
3268679|NCT02646761|4003553|FG000|5-week Assessment|Overall Study||12
3268680|NCT02646761|4003554|FG001|5-week Assessment|Overall Study||10
3268681|NCT02646761|4003553|FG000|COMPLETED|Overall Study||10
3268682|NCT02646761|4003554|FG001|COMPLETED|Overall Study||10
3268683|NCT02646761|4003553|FG000|NOT COMPLETED|Overall Study||8
3268684|NCT02646761|4003554|FG001|NOT COMPLETED|Overall Study||10
3268685|NCT02646826|4003564|FG000|STARTED|Overall Study||21
3268686|NCT02646826|4003565|FG001|STARTED|Overall Study||22
3268687|NCT02646826|4003566|FG002|STARTED|Overall Study||21
3268688|NCT02646826|4003567|FG003|STARTED|Overall Study||22
3268689|NCT02646826|4003564|FG000|COMPLETED|Overall Study||19
3268690|NCT02646826|4003565|FG001|COMPLETED|Overall Study||22
3268691|NCT02646826|4003566|FG002|COMPLETED|Overall Study||20
3268692|NCT02646826|4003567|FG003|COMPLETED|Overall Study||21
3268693|NCT02646826|4003564|FG000|NOT COMPLETED|Overall Study||2
3268694|NCT02646826|4003565|FG001|NOT COMPLETED|Overall Study||0
3268695|NCT02646826|4003566|FG002|NOT COMPLETED|Overall Study||1
3268696|NCT02646826|4003567|FG003|NOT COMPLETED|Overall Study||1
3268697|NCT02646891|4003587|FG000|STARTED|Overall Study||6
3268698|NCT02646891|4003588|FG001|STARTED|Overall Study||12
3268699|NCT02646891|4003589|FG002|STARTED|Overall Study||12
3268700|NCT02646891|4003590|FG003|STARTED|Overall Study||6
3268701|NCT02646891|4003591|FG004|STARTED|Overall Study||12
3268702|NCT02646891|4003592|FG005|STARTED|Overall Study||12
3268703|NCT02646891|4003593|FG006|STARTED|Overall Study||139
3268704|NCT02646891|4003594|FG007|STARTED|Overall Study||140
3268705|NCT02646891|4003595|FG008|STARTED|Overall Study||140
3268706|NCT02646891|4003596|FG009|STARTED|Overall Study||139
3268707|NCT02646891|4003587|FG000|Received at Least 1 Dose|Overall Study||6
3268708|NCT02646891|4003588|FG001|Received at Least 1 Dose|Overall Study||12
3268709|NCT02646891|4003589|FG002|Received at Least 1 Dose|Overall Study||12
3268710|NCT02646891|4003590|FG003|Received at Least 1 Dose|Overall Study||6
3268711|NCT02646891|4003591|FG004|Received at Least 1 Dose|Overall Study||12
3268712|NCT02646891|4003592|FG005|Received at Least 1 Dose|Overall Study||12
3268713|NCT02646891|4003593|FG006|Received at Least 1 Dose|Overall Study||139
3268714|NCT02646891|4003594|FG007|Received at Least 1 Dose|Overall Study|One participant was randomized but determined to be ineligible pre-vaccination.|139
3268715|NCT02646891|4003595|FG008|Received at Least 1 Dose|Overall Study||140
3268716|NCT02646891|4003596|FG009|Received at Least 1 Dose|Overall Study||139
3268717|NCT02646891|4003587|FG000|COMPLETED|Overall Study||4
3268718|NCT02646891|4003588|FG001|COMPLETED|Overall Study||11
3268719|NCT02646891|4003589|FG002|COMPLETED|Overall Study||11
3268720|NCT02646891|4003590|FG003|COMPLETED|Overall Study||6
3268721|NCT02646891|4003591|FG004|COMPLETED|Overall Study||12
3268722|NCT02646891|4003592|FG005|COMPLETED|Overall Study||12
3268723|NCT02646891|4003593|FG006|COMPLETED|Overall Study||130
3268724|NCT02646891|4003594|FG007|COMPLETED|Overall Study||127
3268725|NCT02646891|4003595|FG008|COMPLETED|Overall Study||130
3268726|NCT02646891|4003596|FG009|COMPLETED|Overall Study||134
3268727|NCT02646891|4003587|FG000|NOT COMPLETED|Overall Study||2
3268728|NCT02646891|4003588|FG001|NOT COMPLETED|Overall Study||1
3268729|NCT02646891|4003589|FG002|NOT COMPLETED|Overall Study||1
3268730|NCT02646891|4003590|FG003|NOT COMPLETED|Overall Study||0
3268731|NCT02646891|4003591|FG004|NOT COMPLETED|Overall Study||0
3268732|NCT02646891|4003592|FG005|NOT COMPLETED|Overall Study||0
3268733|NCT02646891|4003593|FG006|NOT COMPLETED|Overall Study||9
3268734|NCT02646891|4003594|FG007|NOT COMPLETED|Overall Study||13
3268735|NCT02646891|4003595|FG008|NOT COMPLETED|Overall Study||10
3268736|NCT02646891|4003596|FG009|NOT COMPLETED|Overall Study||5
3268737|NCT02646917|4003632|FG000|STARTED|Overall Study||21
3268738|NCT02646917|4003633|FG001|STARTED|Overall Study||20
3268739|NCT02646917|4003632|FG000|COMPLETED|Overall Study||21
3268740|NCT02646917|4003633|FG001|COMPLETED|Overall Study||20
3268741|NCT02646917|4003632|FG000|NOT COMPLETED|Overall Study||0
3268742|NCT02646917|4003633|FG001|NOT COMPLETED|Overall Study||0
3268743|NCT02647203|4003646|FG000|STARTED|12 Month Follow-up||173
3268744|NCT02647203|4003647|FG001|STARTED|12 Month Follow-up||172
3268745|NCT02647203|4003646|FG000|COMPLETED|12 Month Follow-up||148
3268746|NCT02647203|4003647|FG001|COMPLETED|12 Month Follow-up||149
3268747|NCT02647203|4003646|FG000|NOT COMPLETED|12 Month Follow-up||25
3268748|NCT02647203|4003647|FG001|NOT COMPLETED|12 Month Follow-up||23
3268749|NCT02647203|4003646|FG000|STARTED|24 Month Follow-up||148
3268750|NCT02647203|4003647|FG001|STARTED|24 Month Follow-up||149
3268751|NCT02647203|4003646|FG000|COMPLETED|24 Month Follow-up||142
3268752|NCT02647203|4003647|FG001|COMPLETED|24 Month Follow-up||138
3268753|NCT02647203|4003646|FG000|NOT COMPLETED|24 Month Follow-up||6
3268754|NCT02647203|4003647|FG001|NOT COMPLETED|24 Month Follow-up||11
3268755|NCT02647281|4003662|FG000|STARTED|Single-Ascending Dose(Part 1-62 Days)||8
3268756|NCT02647281|4003663|FG001|STARTED|Single-Ascending Dose(Part 1-62 Days)||6
3268757|NCT02647281|4003664|FG002|STARTED|Single-Ascending Dose(Part 1-62 Days)||6
3268758|NCT02647281|4003665|FG003|STARTED|Single-Ascending Dose(Part 1-62 Days)||6
3268759|NCT02647281|4003666|FG004|STARTED|Single-Ascending Dose(Part 1-62 Days)||6
3268760|NCT02647281|4003667|FG005|STARTED|Single-Ascending Dose(Part 1-62 Days)||0
3268761|NCT02647281|4003668|FG006|STARTED|Single-Ascending Dose(Part 1-62 Days)||0
3268762|NCT02647281|4003669|FG007|STARTED|Single-Ascending Dose(Part 1-62 Days)||0
3268763|NCT02647281|4003670|FG008|STARTED|Single-Ascending Dose(Part 1-62 Days)||0
3268764|NCT02647281|4003662|FG000|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||8
3268765|NCT02647281|4003663|FG001|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||6
3268766|NCT02647281|4003664|FG002|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||6
3268767|NCT02647281|4003665|FG003|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||6
3268768|NCT02647281|4003666|FG004|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||6
3268769|NCT02647281|4003667|FG005|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
3268770|NCT02647281|4003668|FG006|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
3268771|NCT02647281|4003669|FG007|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
3268772|NCT02647281|4003670|FG008|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
3268773|NCT02647281|4003662|FG000|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
3268774|NCT02647281|4003663|FG001|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
3376175|NCT01463293|4109443|FG000|STARTED|Overall Study||74
3376176|NCT01463293|4109444|FG001|STARTED|Overall Study||79
3376177|NCT01463293|4109445|FG002|STARTED|Overall Study||71
3376178|NCT01463293|4109443|FG000|COMPLETED|Overall Study||68
3376179|NCT01463293|4109444|FG001|COMPLETED|Overall Study||63
3376180|NCT01463293|4109445|FG002|COMPLETED|Overall Study||59
3376181|NCT01463293|4109443|FG000|NOT COMPLETED|Overall Study||6
3376182|NCT01463293|4109444|FG001|NOT COMPLETED|Overall Study||16
3376183|NCT01463293|4109445|FG002|NOT COMPLETED|Overall Study||12
3376184|NCT01457053|4109453|FG000|STARTED|Overall Study||2
3376185|NCT01457053|4109454|FG001|STARTED|Overall Study||2
3376186|NCT01457053|4109453|FG000|COMPLETED|Overall Study||1
3376187|NCT01457053|4109454|FG001|COMPLETED|Overall Study||1
3376188|NCT01457053|4109453|FG000|NOT COMPLETED|Overall Study||1
3376189|NCT01457053|4109454|FG001|NOT COMPLETED|Overall Study||1
3376190|NCT01451723|4109462|FG000|STARTED|Overall Study||6
3376191|NCT01451723|4109463|FG001|STARTED|Overall Study||5
3376192|NCT01451723|4109462|FG000|COMPLETED|Overall Study||0
3376193|NCT01451723|4109463|FG001|COMPLETED|Overall Study||0
3376194|NCT01451723|4109462|FG000|NOT COMPLETED|Overall Study||6
3376195|NCT01451723|4109463|FG001|NOT COMPLETED|Overall Study||5
3376196|NCT01452854|4109469|FG000|STARTED|Overall Study||2
3376197|NCT01452854|4109469|FG000|COMPLETED|Overall Study||2
3376198|NCT01452854|4109469|FG000|NOT COMPLETED|Overall Study||0
3376199|NCT01440517|4109473|FG000|STARTED|Overall Study||5
3376200|NCT01440517|4109473|FG000|COMPLETED|Overall Study||4
3376201|NCT01440517|4109473|FG000|NOT COMPLETED|Overall Study||1
3376202|NCT01440595|4109479|FG000|STARTED|Overall Study||1
3376203|NCT01440595|4109480|FG001|STARTED|Overall Study||3
3376204|NCT01440595|4109481|FG002|STARTED|Overall Study||1
3376205|NCT01440595|4109479|FG000|COMPLETED|Overall Study||0
3376206|NCT01440595|4109480|FG001|COMPLETED|Overall Study||0
3376207|NCT01440595|4109481|FG002|COMPLETED|Overall Study||0
3376208|NCT01440595|4109479|FG000|NOT COMPLETED|Overall Study||1
3376209|NCT01440595|4109480|FG001|NOT COMPLETED|Overall Study||3
3376210|NCT01440595|4109481|FG002|NOT COMPLETED|Overall Study||1
3376211|NCT01446796|4109487|FG000|STARTED|Overall Study||3
3376212|NCT01446796|4109488|FG001|STARTED|Overall Study||0
3376213|NCT01446796|4109487|FG000|COMPLETED|Overall Study|"Study terminated early~One subject of three withdrew prior to randomization and did not start"|2
3376214|NCT01446796|4109488|FG001|COMPLETED|Overall Study|Study terminated early|0
3376215|NCT01446796|4109487|FG000|NOT COMPLETED|Overall Study||1
3376216|NCT01446796|4109488|FG001|NOT COMPLETED|Overall Study||0
3376217|NCT01443923|4109498|FG000|STARTED|Overall Study||3
3376218|NCT01443923|4109499|FG001|STARTED|Overall Study||1
3376219|NCT01443923|4109498|FG000|COMPLETED|Overall Study||2
3376220|NCT01443923|4109499|FG001|COMPLETED|Overall Study||1
3376221|NCT01443923|4109498|FG000|NOT COMPLETED|Overall Study||1
3376222|NCT01443923|4109499|FG001|NOT COMPLETED|Overall Study||0
3376223|NCT01439347|4109507|FG000|STARTED|Overall Study||13
3376224|NCT01439347|4109508|FG001|STARTED|Overall Study||13
3376225|NCT01439347|4109507|FG000|COMPLETED|Overall Study||0
3376226|NCT01439347|4109508|FG001|COMPLETED|Overall Study||0
3376227|NCT01439347|4109507|FG000|NOT COMPLETED|Overall Study||13
3376228|NCT01439347|4109508|FG001|NOT COMPLETED|Overall Study||13
3376229|NCT01440452|4109518|FG000|STARTED|Overall Study||6
3376230|NCT01440452|4109519|FG001|STARTED|Overall Study||7
3376231|NCT01440452|4109520|FG002|STARTED|Overall Study||8
3376232|NCT01440452|4109521|FG003|STARTED|Overall Study||4
3376233|NCT01440452|4109518|FG000|COMPLETED|Overall Study||6
3376234|NCT01440452|4109519|FG001|COMPLETED|Overall Study||7
3376235|NCT01440452|4109520|FG002|COMPLETED|Overall Study||8
3376236|NCT01440452|4109521|FG003|COMPLETED|Overall Study||4
3376237|NCT01440452|4109518|FG000|NOT COMPLETED|Overall Study||0
3376238|NCT01440452|4109519|FG001|NOT COMPLETED|Overall Study||0
3376239|NCT01440452|4109520|FG002|NOT COMPLETED|Overall Study||0
3376240|NCT01440452|4109521|FG003|NOT COMPLETED|Overall Study||0
3376241|NCT01433471|4109533|FG000|STARTED|Overall Study||2
3376242|NCT01433471|4109534|FG001|STARTED|Overall Study||2
3376243|NCT01433471|4109533|FG000|COMPLETED|Overall Study||2
3376244|NCT01433471|4109534|FG001|COMPLETED|Overall Study||1
3376245|NCT01433471|4109533|FG000|NOT COMPLETED|Overall Study||0
3376246|NCT01433471|4109534|FG001|NOT COMPLETED|Overall Study||1
3376247|NCT01436084|4109542|FG000|STARTED|Overall Study||4
3376248|NCT01436084|4109542|FG000|COMPLETED|Overall Study||0
3268775|NCT02647281|4003664|FG002|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
3268776|NCT02647281|4003665|FG003|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
3268777|NCT02647281|4003666|FG004|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
3268778|NCT02647281|4003667|FG005|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
3268779|NCT02647281|4003668|FG006|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
3268780|NCT02647281|4003669|FG007|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
3268781|NCT02647281|4003670|FG008|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
3268782|NCT02647281|4003662|FG000|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||0
3268783|NCT02647281|4003663|FG001|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||0
3268784|NCT02647281|4003664|FG002|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||0
3268785|NCT02647281|4003665|FG003|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||0
3268786|NCT02647281|4003666|FG004|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||0
3268787|NCT02647281|4003667|FG005|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||6
3268788|NCT02647281|4003668|FG006|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||6
3268789|NCT02647281|4003669|FG007|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||6
3268790|NCT02647281|4003670|FG008|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||6
3268791|NCT02647281|4003662|FG000|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
3268792|NCT02647281|4003663|FG001|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
3268793|NCT02647281|4003664|FG002|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
3268794|NCT02647281|4003665|FG003|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
3268795|NCT02647281|4003666|FG004|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
3268796|NCT02647281|4003667|FG005|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||6
3268797|NCT02647281|4003668|FG006|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||6
3268798|NCT02647281|4003669|FG007|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||6
3268799|NCT02647281|4003670|FG008|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||5
3268800|NCT02647281|4003662|FG000|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
3268801|NCT02647281|4003663|FG001|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
3268802|NCT02647281|4003664|FG002|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
3268803|NCT02647281|4003665|FG003|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
3268804|NCT02647281|4003666|FG004|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
3268805|NCT02647281|4003667|FG005|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
3268806|NCT02647281|4003668|FG006|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
3268807|NCT02647281|4003669|FG007|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
3268808|NCT02647281|4003670|FG008|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||1
3268809|NCT02647320|4003704|FG000|STARTED|Overall Study||46
3268810|NCT02647320|4003705|FG001|STARTED|Overall Study||46
3268811|NCT02647320|4003706|FG002|STARTED|Overall Study||69
3268812|NCT02647320|4003707|FG003|STARTED|Overall Study||68
3268813|NCT02647320|4003708|FG004|STARTED|Overall Study||69
3268814|NCT02647320|4003704|FG000|Inadvertently Randomized|Overall Study||0
3268815|NCT02647320|4003705|FG001|Inadvertently Randomized|Overall Study||0
3268816|NCT02647320|4003706|FG002|Inadvertently Randomized|Overall Study||0
3268817|NCT02647320|4003707|FG003|Inadvertently Randomized|Overall Study||1
3268818|NCT02647320|4003708|FG004|Inadvertently Randomized|Overall Study||0
3268819|NCT02647320|4003704|FG000|Safety Set|Overall Study||43
3268820|NCT02647320|4003705|FG001|Safety Set|Overall Study||44
3268821|NCT02647320|4003706|FG002|Safety Set|Overall Study||68
3376249|NCT01436084|4109542|FG000|NOT COMPLETED|Overall Study||4
3376250|NCT01434511|4109546|FG000|STARTED|Overall Study||1
3376251|NCT01434511|4109546|FG000|COMPLETED|Overall Study||1
3376252|NCT01434511|4109546|FG000|NOT COMPLETED|Overall Study||0
3376253|NCT01426555|4109552|FG000|STARTED|Overall Study||35
3376254|NCT01426555|4109553|FG001|STARTED|Overall Study||35
3376255|NCT01426555|4109552|FG000|COMPLETED|Overall Study||17
3376256|NCT01426555|4109553|FG001|COMPLETED|Overall Study||20
3376257|NCT01426555|4109552|FG000|NOT COMPLETED|Overall Study||18
3376258|NCT01426555|4109553|FG001|NOT COMPLETED|Overall Study||15
3376259|NCT01434745|4109563|FG000|STARTED|Overall Study||0
3376260|NCT01434745|4109564|FG001|STARTED|Overall Study||0
3376261|NCT01434745|4109563|FG000|COMPLETED|Overall Study||0
3376262|NCT01434745|4109564|FG001|COMPLETED|Overall Study||0
3376263|NCT01434745|4109563|FG000|NOT COMPLETED|Overall Study||0
3376264|NCT01434745|4109564|FG001|NOT COMPLETED|Overall Study||0
3376265|NCT01415986|4109570|FG000|STARTED|Overall Study||1
3376266|NCT01415986|4109570|FG000|COMPLETED|Overall Study|Study terminated|0
3376267|NCT01415986|4109570|FG000|NOT COMPLETED|Overall Study||1
3376268|NCT01410799|4109575|FG000|STARTED|Overall Study||13
3376269|NCT01410799|4109575|FG000|COMPLETED|Overall Study||0
3376270|NCT01410799|4109575|FG000|NOT COMPLETED|Overall Study||13
3376271|NCT01426113|4109581|FG000|STARTED|Overall Study||3
3376272|NCT01426113|4109582|FG001|STARTED|Overall Study||3
3376273|NCT01426113|4109581|FG000|COMPLETED|Overall Study||2
3376274|NCT01426113|4109582|FG001|COMPLETED|Overall Study||1
3376275|NCT01426113|4109581|FG000|NOT COMPLETED|Overall Study||1
3376276|NCT01426113|4109582|FG001|NOT COMPLETED|Overall Study||2
3376277|NCT01426516|4109590|FG000|STARTED|Overall Study||12
3376278|NCT01426516|4109591|FG001|STARTED|Overall Study||17
3376279|NCT01426516|4109590|FG000|COMPLETED|Overall Study||12
3376280|NCT01426516|4109591|FG001|COMPLETED|Overall Study||17
3376281|NCT01426516|4109590|FG000|NOT COMPLETED|Overall Study||0
3376282|NCT01426516|4109591|FG001|NOT COMPLETED|Overall Study||0
3376283|NCT01420965|4109600|FG000|STARTED|Overall Study||2
3268822|NCT02647320|4003707|FG003|Safety Set|Overall Study||68
3268823|NCT02647320|4003708|FG004|Safety Set|Overall Study||69
3268824|NCT02647320|4003704|FG000|Modified Intent-to-Treat Set (mITT)|Overall Study||40
3268825|NCT02647320|4003705|FG001|Modified Intent-to-Treat Set (mITT)|Overall Study||38
3268826|NCT02647320|4003706|FG002|Modified Intent-to-Treat Set (mITT)|Overall Study||61
3268827|NCT02647320|4003707|FG003|Modified Intent-to-Treat Set (mITT)|Overall Study||62
3268828|NCT02647320|4003708|FG004|Modified Intent-to-Treat Set (mITT)|Overall Study||62
3268829|NCT02647320|4003704|FG000|COMPLETED|Overall Study||34
3268830|NCT02647320|4003705|FG001|COMPLETED|Overall Study||35
3268831|NCT02647320|4003706|FG002|COMPLETED|Overall Study||54
3268832|NCT02647320|4003707|FG003|COMPLETED|Overall Study||58
3268833|NCT02647320|4003708|FG004|COMPLETED|Overall Study||52
3268834|NCT02647320|4003704|FG000|NOT COMPLETED|Overall Study||12
3268835|NCT02647320|4003705|FG001|NOT COMPLETED|Overall Study||11
3268836|NCT02647320|4003706|FG002|NOT COMPLETED|Overall Study||15
3268837|NCT02647320|4003707|FG003|NOT COMPLETED|Overall Study||10
3268838|NCT02647320|4003708|FG004|NOT COMPLETED|Overall Study||17
3268839|NCT02647346|4003722|FG000|STARTED|Overall Study||132
3268840|NCT02647346|4003722|FG000|COMPLETED|Overall Study||129
3268841|NCT02647346|4003722|FG000|NOT COMPLETED|Overall Study||3
3268842|NCT02647645|4003728|FG000|STARTED|Overall Study||11
3268843|NCT02647645|4003729|FG001|STARTED|Overall Study||10
3268844|NCT02647645|4003728|FG000|COMPLETED|Overall Study||9
3268845|NCT02647645|4003729|FG001|COMPLETED|Overall Study||9
3268846|NCT02647645|4003728|FG000|NOT COMPLETED|Overall Study||2
3268847|NCT02647645|4003729|FG001|NOT COMPLETED|Overall Study||1
3268848|NCT02647658|4003737|FG000|STARTED|Overall Study||1207
3268849|NCT02647658|4003738|FG001|STARTED|Overall Study||1093
3268850|NCT02647658|4003737|FG000|6 Month Assessment|Overall Study||658
3268851|NCT02647658|4003738|FG001|6 Month Assessment|Overall Study||635
3268852|NCT02647658|4003737|FG000|COMPLETED|Overall Study||1192
3268853|NCT02647658|4003738|FG001|COMPLETED|Overall Study||1069
3268854|NCT02647658|4003737|FG000|NOT COMPLETED|Overall Study||15
3268855|NCT02647658|4003738|FG001|NOT COMPLETED|Overall Study||24
3268856|NCT02647788|4003746|FG000|STARTED|Overall Study||70
3268857|NCT02647788|4003747|FG001|STARTED|Overall Study||70
3268858|NCT02647788|4003746|FG000|COMPLETED|Overall Study||54
3268859|NCT02647788|4003747|FG001|COMPLETED|Overall Study||57
3268860|NCT02647788|4003746|FG000|NOT COMPLETED|Overall Study||16
3268861|NCT02647788|4003747|FG001|NOT COMPLETED|Overall Study||13
3268862|NCT02647866|4003758|FG000|STARTED|Overall Study||9
3268863|NCT02647866|4003759|FG001|STARTED|Overall Study||10
3268864|NCT02647866|4003760|FG002|STARTED|Overall Study||9
3268865|NCT02647866|4003761|FG003|STARTED|Overall Study||21
3268866|NCT02647866|4003762|FG004|STARTED|Overall Study||17
3268867|NCT02647866|4003758|FG000|Completed Induction Therapy|Overall Study|Subjects received KHK4083 1.0 mg/kg for 12 weeks|8
3268868|NCT02647866|4003759|FG001|Completed Induction Therapy|Overall Study|Subjects received KHK4083 3.0 mg/kg for 12 weeks|9
3268869|NCT02647866|4003760|FG002|Completed Induction Therapy|Overall Study|Subjects received KHK4083 10.0 mg/kg for 12 weeks|8
3268870|NCT02647866|4003761|FG003|Completed Induction Therapy|Overall Study|Subjects received the maximum tolerated dose of KHK4083 10.0 mg/kg for 12 weeks|19
3268871|NCT02647866|4003762|FG004|Completed Induction Therapy|Overall Study|Subjects received Placebo for 12 weeks|17
3268872|NCT02647866|4003758|FG000|Completed Induction Therapy Follow-Up|Overall Study||5
3268873|NCT02647866|4003759|FG001|Completed Induction Therapy Follow-Up|Overall Study||1
3268874|NCT02647866|4003760|FG002|Completed Induction Therapy Follow-Up|Overall Study||2
3268875|NCT02647866|4003761|FG003|Completed Induction Therapy Follow-Up|Overall Study||0
3268876|NCT02647866|4003762|FG004|Completed Induction Therapy Follow-Up|Overall Study||2
3268877|NCT02647866|4003758|FG000|Completed Long-Term Extension Therapy|Overall Study|10 add'l treatments of KHK4083 (same dose as Induction Therapy) as maintenance therapy.|3
3268878|NCT02647866|4003759|FG001|Completed Long-Term Extension Therapy|Overall Study||0
3268879|NCT02647866|4003760|FG002|Completed Long-Term Extension Therapy|Overall Study||0
3268880|NCT02647866|4003761|FG003|Completed Long-Term Extension Therapy|Overall Study||0
3268881|NCT02647866|4003762|FG004|Completed Long-Term Extension Therapy|Overall Study||0
3268882|NCT02647866|4003758|FG000|Completed LTE Follow-up|Overall Study||2
3268883|NCT02647866|4003759|FG001|Completed LTE Follow-up|Overall Study||0
3268884|NCT02647866|4003760|FG002|Completed LTE Follow-up|Overall Study||0
3268885|NCT02647866|4003761|FG003|Completed LTE Follow-up|Overall Study||0
3268886|NCT02647866|4003762|FG004|Completed LTE Follow-up|Overall Study||0
3268887|NCT02647866|4003758|FG000|Completed Open-Label Extension Therapy|Overall Study||0
3268888|NCT02647866|4003759|FG001|Completed Open-Label Extension Therapy|Overall Study|10 add'l treatments of Open-Label KHK4083 (same dose as Induction Therapy) as maintenance therapy.|7
3268889|NCT02647866|4003760|FG002|Completed Open-Label Extension Therapy|Overall Study|10 add'l treatments of Open-Label KHK4083 (same dose as Induction Therapy) as maintenance therapy|4
3268890|NCT02647866|4003761|FG003|Completed Open-Label Extension Therapy|Overall Study|10 add'l treatments of Open-Label KHK4083 (same dose as Induction Therapy) as maintenance therapy|17
3268891|NCT02647866|4003762|FG004|Completed Open-Label Extension Therapy|Overall Study|10 add'l treatments of Open-Label KHK4083 (same dose as Induction Therapy) as maintenance therapy|13
3268892|NCT02647866|4003758|FG000|Completed OLE Follow-up|Overall Study||0
3268893|NCT02647866|4003759|FG001|Completed OLE Follow-up|Overall Study||6
3268894|NCT02647866|4003760|FG002|Completed OLE Follow-up|Overall Study||4
3268895|NCT02647866|4003761|FG003|Completed OLE Follow-up|Overall Study||14
3268896|NCT02647866|4003762|FG004|Completed OLE Follow-up|Overall Study||10
3376284|NCT01420965|4109601|FG001|STARTED|Overall Study||2
3268897|NCT02647866|4003758|FG000|Moved From LTE to OLE Therapy|Overall Study||0
3268898|NCT02647866|4003759|FG001|Moved From LTE to OLE Therapy|Overall Study||5
3268899|NCT02647866|4003760|FG002|Moved From LTE to OLE Therapy|Overall Study||0
3268900|NCT02647866|4003761|FG003|Moved From LTE to OLE Therapy|Overall Study||0
3268901|NCT02647866|4003762|FG004|Moved From LTE to OLE Therapy|Overall Study||2
3268902|NCT02647866|4003758|FG000|Discontinued the Treatment|Overall Study||4
3268903|NCT02647866|4003759|FG001|Discontinued the Treatment|Overall Study||5
3268904|NCT02647866|4003760|FG002|Discontinued the Treatment|Overall Study||5
3268905|NCT02647866|4003761|FG003|Discontinued the Treatment|Overall Study||5
3268906|NCT02647866|4003762|FG004|Discontinued the Treatment|Overall Study||8
3268907|NCT02647866|4003758|FG000|Discontinued the Study|Overall Study||5
3268908|NCT02647866|4003759|FG001|Discontinued the Study|Overall Study||4
3268909|NCT02647866|4003760|FG002|Discontinued the Study|Overall Study||5
3268910|NCT02647866|4003761|FG003|Discontinued the Study|Overall Study||6
3268911|NCT02647866|4003762|FG004|Discontinued the Study|Overall Study||8
3268912|NCT02647866|4003758|FG000|COMPLETED|Overall Study||4
3268913|NCT02647866|4003759|FG001|COMPLETED|Overall Study||6
3268914|NCT02647866|4003760|FG002|COMPLETED|Overall Study||4
3268915|NCT02647866|4003761|FG003|COMPLETED|Overall Study||15
3268916|NCT02647866|4003762|FG004|COMPLETED|Overall Study||9
3268917|NCT02647866|4003758|FG000|NOT COMPLETED|Overall Study||5
3268918|NCT02647866|4003759|FG001|NOT COMPLETED|Overall Study||4
3268919|NCT02647866|4003760|FG002|NOT COMPLETED|Overall Study||5
3268920|NCT02647866|4003761|FG003|NOT COMPLETED|Overall Study||6
3268921|NCT02647866|4003762|FG004|NOT COMPLETED|Overall Study||8
3268922|NCT02647905|4003782|FG000|STARTED|Overall Study||90
3268923|NCT02647905|4003782|FG000|COMPLETED|Overall Study||87
3268924|NCT02647905|4003782|FG000|NOT COMPLETED|Overall Study||3
3268925|NCT02647944|4003788|FG000|STARTED|Overall Study||19
3268926|NCT02647944|4003789|FG001|STARTED|Overall Study||21
3268927|NCT02647944|4003788|FG000|COMPLETED|Overall Study||17
3268928|NCT02647944|4003789|FG001|COMPLETED|Overall Study||18
3268929|NCT02647944|4003788|FG000|NOT COMPLETED|Overall Study||2
3268930|NCT02647944|4003789|FG001|NOT COMPLETED|Overall Study||3
3268931|NCT02648022|4003797|FG000|STARTED|Overall Study||40
3268932|NCT02648022|4003798|FG001|STARTED|Overall Study||39
3268933|NCT02648022|4003797|FG000|COMPLETED|Overall Study||40
3268934|NCT02648022|4003798|FG001|COMPLETED|Overall Study||39
3268935|NCT02648022|4003797|FG000|NOT COMPLETED|Overall Study||0
3268936|NCT02648022|4003798|FG001|NOT COMPLETED|Overall Study||0
3268937|NCT02648178|4003804|FG000|STARTED|Overall Study||19
3268938|NCT02648178|4003804|FG000|COMPLETED|Overall Study||10
3268939|NCT02648178|4003804|FG000|NOT COMPLETED|Overall Study||9
3268940|NCT02648204|4003812|FG000|STARTED|Overall Study||301
3268941|NCT02648204|4003813|FG001|STARTED|Overall Study||300
3268942|NCT02648204|4003814|FG002|STARTED|Overall Study||300
3268943|NCT02648204|4003815|FG003|STARTED|Overall Study||300
3268944|NCT02648204|4003812|FG000|Exposed|Overall Study||301
3268945|NCT02648204|4003813|FG001|Exposed|Overall Study||300
3268946|NCT02648204|4003814|FG002|Exposed|Overall Study||299
3268947|NCT02648204|4003815|FG003|Exposed|Overall Study||299
3268948|NCT02648204|4003812|FG000|COMPLETED|Overall Study||279
3268949|NCT02648204|4003813|FG001|COMPLETED|Overall Study||279
3268950|NCT02648204|4003814|FG002|COMPLETED|Overall Study||287
3268951|NCT02648204|4003815|FG003|COMPLETED|Overall Study||284
3268952|NCT02648204|4003812|FG000|NOT COMPLETED|Overall Study||22
3268953|NCT02648204|4003813|FG001|NOT COMPLETED|Overall Study||21
3268954|NCT02648204|4003814|FG002|NOT COMPLETED|Overall Study||13
3376285|NCT01420965|4109602|FG002|STARTED|Overall Study||3
3376286|NCT01420965|4109600|FG000|COMPLETED|Overall Study||1
3376287|NCT01420965|4109601|FG001|COMPLETED|Overall Study||1
3376288|NCT01420965|4109602|FG002|COMPLETED|Overall Study||3
3376289|NCT01420965|4109600|FG000|NOT COMPLETED|Overall Study||1
3376290|NCT01420965|4109601|FG001|NOT COMPLETED|Overall Study||1
3376291|NCT01420965|4109602|FG002|NOT COMPLETED|Overall Study||0
3376292|NCT01417377|4109610|FG000|STARTED|Overall Study||22
3376293|NCT01417377|4109610|FG000|Treated|Overall Study||21
3376294|NCT01417377|4109610|FG000|COMPLETED|Overall Study||9
3376295|NCT01417377|4109610|FG000|NOT COMPLETED|Overall Study||13
3376296|NCT01416272|4109614|FG000|STARTED|Overall Study||12
3376297|NCT01416272|4109614|FG000|COMPLETED|Overall Study||8
3376298|NCT01416272|4109614|FG000|NOT COMPLETED|Overall Study||4
3376299|NCT01414166|4109620|FG000|STARTED|Overall Study||122
3376300|NCT01414166|4109621|FG001|STARTED|Overall Study||122
3376301|NCT01414166|4109620|FG000|Treated|Overall Study||120
3376302|NCT01414166|4109621|FG001|Treated|Overall Study||121
3376303|NCT01414166|4109620|FG000|COMPLETED|Overall Study||31
3376304|NCT01414166|4109621|FG001|COMPLETED|Overall Study||39
3376305|NCT01414166|4109620|FG000|NOT COMPLETED|Overall Study||91
3376306|NCT01414166|4109621|FG001|NOT COMPLETED|Overall Study||83
3376307|NCT01406860|4109629|FG000|STARTED|Overall Study||11
3376308|NCT01406860|4109630|FG001|STARTED|Overall Study||8
3268955|NCT02648204|4003815|FG003|NOT COMPLETED|Overall Study||16
3268956|NCT02648217|4003827|FG000|STARTED|Overall Study||131
3268957|NCT02648217|4003828|FG001|STARTED|Overall Study||132
3268958|NCT02648217|4003827|FG000|Exposed|Overall Study||130
3268959|NCT02648217|4003828|FG001|Exposed|Overall Study||132
3268960|NCT02648217|4003827|FG000|COMPLETED|Overall Study||121
3268961|NCT02648217|4003828|FG001|COMPLETED|Overall Study||127
3268962|NCT02648217|4003827|FG000|NOT COMPLETED|Overall Study||10
3376309|NCT01406860|4109629|FG000|COMPLETED|Overall Study||11
3268963|NCT02648217|4003828|FG001|NOT COMPLETED|Overall Study||5
3268964|NCT02648230|4003834|FG000|STARTED|Overall Study||74
3268965|NCT02648230|4003834|FG000|COMPLETED|Overall Study||74
3268966|NCT02648230|4003834|FG000|NOT COMPLETED|Overall Study||0
3268967|NCT02648438|4003841|FG000|STARTED|Overall Study||12
3268968|NCT02648438|4003842|FG001|STARTED|Overall Study||12
3268969|NCT02648438|4003843|FG002|STARTED|Overall Study||6
3268970|NCT02648438|4003841|FG000|COMPLETED|Overall Study||9
3268971|NCT02648438|4003842|FG001|COMPLETED|Overall Study||9
3268972|NCT02648438|4003843|FG002|COMPLETED|Overall Study||6
3268973|NCT02648438|4003841|FG000|NOT COMPLETED|Overall Study||3
3268974|NCT02648438|4003842|FG001|NOT COMPLETED|Overall Study||3
3268975|NCT02648438|4003843|FG002|NOT COMPLETED|Overall Study||0
3268976|NCT02648646|4003859|FG000|STARTED|Overall Study||10
3268977|NCT02648646|4003859|FG000|COMPLETED|Overall Study||8
3268978|NCT02648646|4003859|FG000|NOT COMPLETED|Overall Study||2
3268979|NCT02648880|4003863|FG000|STARTED|Overall Study|Recruitment was significantly limited, only 3 participants were eligible, all enrolled. All three were assigned to the exercise arm, per protocol. No participants were recruited into the control arm and it was eliminated.|3
3268980|NCT02648880|4003863|FG000|COMPLETED|Overall Study||3
3268981|NCT02648880|4003863|FG000|NOT COMPLETED|Overall Study||0
3268982|NCT02648919|4003867|FG000|STARTED|Overall Study||6
3268983|NCT02648919|4003867|FG000|COMPLETED|Overall Study||6
3268984|NCT02648919|4003867|FG000|NOT COMPLETED|Overall Study||0
3268985|NCT02648932|4003874|FG000|STARTED|Overall Study||5
3268986|NCT02648932|4003875|FG001|STARTED|Overall Study||4
3268987|NCT02648932|4003874|FG000|COMPLETED|Overall Study||2
3268988|NCT02648932|4003875|FG001|COMPLETED|Overall Study||3
3268989|NCT02648932|4003874|FG000|NOT COMPLETED|Overall Study||3
3268990|NCT02648932|4003875|FG001|NOT COMPLETED|Overall Study||1
3268991|NCT02648971|4003883|FG000|STARTED|Overall Study||18
3268992|NCT02648971|4003884|FG001|STARTED|Overall Study||18
3268993|NCT02648971|4003883|FG000|COMPLETED|Overall Study||18
3268994|NCT02648971|4003884|FG001|COMPLETED|Overall Study||18
3268995|NCT02648971|4003883|FG000|NOT COMPLETED|Overall Study||0
3268996|NCT02648971|4003884|FG001|NOT COMPLETED|Overall Study||0
3268997|NCT02649192|4003896|FG000|STARTED|Overall Study||5
3268998|NCT02649192|4003897|FG001|STARTED|Overall Study||4
3268999|NCT02649192|4003898|FG002|STARTED|Overall Study||22
3269000|NCT02649192|4003899|FG003|STARTED|Overall Study||22
3269001|NCT02649192|4003900|FG004|STARTED|Overall Study||12
3269002|NCT02649192|4003901|FG005|STARTED|Overall Study||14
3269003|NCT02649192|4003896|FG000|Vitamin A Sufficiency (RBP≥22,000 ng/ml)|Overall Study||2
3269004|NCT02649192|4003897|FG001|Vitamin A Sufficiency (RBP≥22,000 ng/ml)|Overall Study||2
3269005|NCT02649192|4003898|FG002|Vitamin A Sufficiency (RBP≥22,000 ng/ml)|Overall Study||11
3269006|NCT02649192|4003899|FG003|Vitamin A Sufficiency (RBP≥22,000 ng/ml)|Overall Study||12
3269007|NCT02649192|4003900|FG004|Vitamin A Sufficiency (RBP≥22,000 ng/ml)|Overall Study||7
3269008|NCT02649192|4003901|FG005|Vitamin A Sufficiency (RBP≥22,000 ng/ml)|Overall Study||8
3269009|NCT02649192|4003896|FG000|Vitamin A Insufficiency (RBP<22,000 ng/m|Overall Study||3
3269010|NCT02649192|4003897|FG001|Vitamin A Insufficiency (RBP<22,000 ng/m|Overall Study||2
3269011|NCT02649192|4003898|FG002|Vitamin A Insufficiency (RBP<22,000 ng/m|Overall Study||11
3269012|NCT02649192|4003899|FG003|Vitamin A Insufficiency (RBP<22,000 ng/m|Overall Study||10
3269013|NCT02649192|4003900|FG004|Vitamin A Insufficiency (RBP<22,000 ng/m|Overall Study||5
3269014|NCT02649192|4003901|FG005|Vitamin A Insufficiency (RBP<22,000 ng/m|Overall Study||6
3269015|NCT02649192|4003896|FG000|COMPLETED|Overall Study||5
3269016|NCT02649192|4003897|FG001|COMPLETED|Overall Study||4
3269017|NCT02649192|4003898|FG002|COMPLETED|Overall Study||21
3269018|NCT02649192|4003899|FG003|COMPLETED|Overall Study||20
3269019|NCT02649192|4003900|FG004|COMPLETED|Overall Study||11
3269020|NCT02649192|4003901|FG005|COMPLETED|Overall Study||14
3269021|NCT02649192|4003896|FG000|NOT COMPLETED|Overall Study||0
3269022|NCT02649192|4003897|FG001|NOT COMPLETED|Overall Study||0
3269023|NCT02649192|4003898|FG002|NOT COMPLETED|Overall Study||1
3269024|NCT02649192|4003899|FG003|NOT COMPLETED|Overall Study||2
3269025|NCT02649192|4003900|FG004|NOT COMPLETED|Overall Study||1
3376310|NCT01406860|4109630|FG001|COMPLETED|Overall Study||8
3376311|NCT01406860|4109629|FG000|NOT COMPLETED|Overall Study||0
3376312|NCT01406860|4109630|FG001|NOT COMPLETED|Overall Study||0
3376313|NCT01401049|4109639|FG000|STARTED|Overall Study|Due to flooding from Hurricane Sandy at our site, all files and pertinent patient data were lost.|0
3376314|NCT01401049|4109640|FG001|STARTED|Overall Study|Due to flooding from Hurricane Sandy at our site, all files and pertinent patient data were lost.|0
3376315|NCT01401049|4109639|FG000|COMPLETED|Overall Study||0
3376316|NCT01401049|4109640|FG001|COMPLETED|Overall Study||0
3376317|NCT01401049|4109639|FG000|NOT COMPLETED|Overall Study||0
3376318|NCT01401049|4109640|FG001|NOT COMPLETED|Overall Study||0
3376319|NCT01408641|4109648|FG000|STARTED|Overall Study||1
3376320|NCT01408641|4109649|FG001|STARTED|Overall Study||0
3376321|NCT01408641|4109648|FG000|COMPLETED|Overall Study||0
3376322|NCT01408641|4109649|FG001|COMPLETED|Overall Study||0
3376323|NCT01408641|4109648|FG000|NOT COMPLETED|Overall Study||1
3376324|NCT01408641|4109649|FG001|NOT COMPLETED|Overall Study||0
3376325|NCT01409031|4109657|FG000|STARTED|Overall Study||1
3376326|NCT01409031|4109658|FG001|STARTED|Overall Study||2
3376327|NCT01409031|4109657|FG000|COMPLETED|Overall Study||0
3376328|NCT01409031|4109658|FG001|COMPLETED|Overall Study||2
3376329|NCT01409031|4109657|FG000|NOT COMPLETED|Overall Study||1
3269026|NCT02649192|4003901|FG005|NOT COMPLETED|Overall Study||0
3269027|NCT02649218|4003928|FG000|STARTED|Overall Study||226
3269028|NCT02649218|4003928|FG000|COMPLETED|Overall Study||201
3269029|NCT02649218|4003928|FG000|NOT COMPLETED|Overall Study||25
3269030|NCT02649231|4003937|FG000|STARTED|Overall Study||24
3269031|NCT02649231|4003938|FG001|STARTED|Overall Study||24
3269032|NCT02649231|4003939|FG002|STARTED|Overall Study||23
3269033|NCT02649231|4003940|FG003|STARTED|Overall Study||25
3269034|NCT02649231|4003937|FG000|COMPLETED|Overall Study||20
3269035|NCT02649231|4003938|FG001|COMPLETED|Overall Study||21
3269036|NCT02649231|4003939|FG002|COMPLETED|Overall Study||21
3269037|NCT02649231|4003940|FG003|COMPLETED|Overall Study||23
3269038|NCT02649231|4003937|FG000|NOT COMPLETED|Overall Study||4
3269039|NCT02649231|4003938|FG001|NOT COMPLETED|Overall Study||3
3269040|NCT02649231|4003939|FG002|NOT COMPLETED|Overall Study||2
3269041|NCT02649231|4003940|FG003|NOT COMPLETED|Overall Study||2
3269042|NCT02649322|4003952|FG000|STARTED|Overall Study||58
3269043|NCT02649322|4003953|FG001|STARTED|Overall Study||57
3269044|NCT02649322|4003952|FG000|COMPLETED|Overall Study||58
3269045|NCT02649322|4003953|FG001|COMPLETED|Overall Study||57
3269046|NCT02649322|4003952|FG000|NOT COMPLETED|Overall Study||0
3269047|NCT02649322|4003953|FG001|NOT COMPLETED|Overall Study||0
3269048|NCT02649439|4003961|FG000|STARTED|Overall Study||40
3269049|NCT02649439|4003962|FG001|STARTED|Overall Study||40
3269050|NCT02649439|4003961|FG000|COMPLETED|Overall Study||13
3269051|NCT02649439|4003962|FG001|COMPLETED|Overall Study||12
3269052|NCT02649439|4003961|FG000|NOT COMPLETED|Overall Study||27
3269053|NCT02649439|4003962|FG001|NOT COMPLETED|Overall Study||28
3269054|NCT02649556|4003979|FG000|STARTED|Overall Study||230
3269055|NCT02649556|4003980|FG001|STARTED|Overall Study||424
3269056|NCT02649556|4003981|FG002|STARTED|Overall Study||152
3269057|NCT02649556|4003982|FG003|STARTED|Overall Study||51
3269058|NCT02649556|4003979|FG000|COMPLETED|Overall Study||167
3269059|NCT02649556|4003980|FG001|COMPLETED|Overall Study||312
3269060|NCT02649556|4003981|FG002|COMPLETED|Overall Study||102
3269061|NCT02649556|4003982|FG003|COMPLETED|Overall Study||28
3269062|NCT02649556|4003979|FG000|NOT COMPLETED|Overall Study||63
3269063|NCT02649556|4003980|FG001|NOT COMPLETED|Overall Study||112
3269064|NCT02649556|4003981|FG002|NOT COMPLETED|Overall Study||50
3269065|NCT02649556|4003982|FG003|NOT COMPLETED|Overall Study||23
3269066|NCT02649608|4003992|FG000|STARTED|Overall Study||2
3269067|NCT02649608|4003993|FG001|STARTED|Overall Study||1
3269068|NCT02649608|4003994|FG002|STARTED|Overall Study||3
3269069|NCT02649608|4003995|FG003|STARTED|Overall Study||3
3269070|NCT02649608|4003996|FG004|STARTED|Overall Study||3
3269071|NCT02649608|4003997|FG005|STARTED|Overall Study||2
3269072|NCT02649608|4003998|FG006|STARTED|Overall Study||1
3269073|NCT02649608|4003992|FG000|COMPLETED|Overall Study||2
3269074|NCT02649608|4003993|FG001|COMPLETED|Overall Study||1
3269075|NCT02649608|4003994|FG002|COMPLETED|Overall Study||3
3269076|NCT02649608|4003995|FG003|COMPLETED|Overall Study||3
3269077|NCT02649608|4003996|FG004|COMPLETED|Overall Study||3
3269078|NCT02649608|4003997|FG005|COMPLETED|Overall Study||2
3269079|NCT02649608|4003998|FG006|COMPLETED|Overall Study||1
3269080|NCT02649608|4003992|FG000|NOT COMPLETED|Overall Study||0
3269081|NCT02649608|4003993|FG001|NOT COMPLETED|Overall Study||0
3269082|NCT02649608|4003994|FG002|NOT COMPLETED|Overall Study||0
3269083|NCT02649608|4003995|FG003|NOT COMPLETED|Overall Study||0
3269084|NCT02649608|4003996|FG004|NOT COMPLETED|Overall Study||0
3269085|NCT02649608|4003997|FG005|NOT COMPLETED|Overall Study||0
3269086|NCT02649608|4003998|FG006|NOT COMPLETED|Overall Study||0
3269087|NCT02649634|4004029|FG000|STARTED|Overall Study||69
3269088|NCT02649634|4004030|FG001|STARTED|Overall Study||66
3269089|NCT02649634|4004029|FG000|COMPLETED|Overall Study||66
3269090|NCT02649634|4004030|FG001|COMPLETED|Overall Study||60
3269091|NCT02649634|4004029|FG000|NOT COMPLETED|Overall Study||3
3269092|NCT02649634|4004030|FG001|NOT COMPLETED|Overall Study||6
3269093|NCT02649842|4004036|FG000|STARTED|Overall Study||101
3269094|NCT02649842|4004036|FG000|COMPLETED|Overall Study||101
3269095|NCT02649842|4004036|FG000|NOT COMPLETED|Overall Study||0
3269096|NCT02649894|4004044|FG000|STARTED|Overall Study||81
3269097|NCT02649894|4004045|FG001|STARTED|Overall Study||38
3269098|NCT02649894|4004044|FG000|Device Inserted|Overall Study||77
3269099|NCT02649894|4004045|FG001|Device Inserted|Overall Study||37
3269100|NCT02649894|4004044|FG000|Completed Day 30|Overall Study||56
3269101|NCT02649894|4004045|FG001|Completed Day 30|Overall Study||35
3269102|NCT02649894|4004044|FG000|COMPLETED|Overall Study||37
3269103|NCT02649894|4004045|FG001|COMPLETED|Overall Study||27
3269104|NCT02649894|4004044|FG000|NOT COMPLETED|Overall Study||44
3269105|NCT02649894|4004045|FG001|NOT COMPLETED|Overall Study||11
3269106|NCT02650128|4004051|FG000|STARTED|Overall Study||60
3269107|NCT02650128|4004051|FG000|30 Day Primary and Safety Endpoint|Overall Study||60
3269108|NCT02650128|4004051|FG000|COMPLETED|Overall Study||58
3269109|NCT02650128|4004051|FG000|NOT COMPLETED|Overall Study||2
3269110|NCT02650193|4004059|FG000|STARTED|Overall Study||6
3269111|NCT02650193|4004060|FG001|STARTED|Overall Study||6
3269112|NCT02650193|4004061|FG002|STARTED|Overall Study||13
3269113|NCT02650193|4004059|FG000|COMPLETED|Overall Study||6
3269114|NCT02650193|4004060|FG001|COMPLETED|Overall Study||6
3269115|NCT02650193|4004061|FG002|COMPLETED|Overall Study||13
3269116|NCT02650193|4004059|FG000|NOT COMPLETED|Overall Study||0
3269117|NCT02650193|4004060|FG001|NOT COMPLETED|Overall Study||0
3269118|NCT02650193|4004061|FG002|NOT COMPLETED|Overall Study||0
3269119|NCT02650219|4004072|FG000|STARTED|Overall Study||40
3269120|NCT02650219|4004073|FG001|STARTED|Overall Study||20
3269121|NCT02650219|4004072|FG000|COMPLETED|Overall Study||40
3269122|NCT02650219|4004073|FG001|COMPLETED|Overall Study||20
3269123|NCT02650219|4004072|FG000|NOT COMPLETED|Overall Study||0
3269124|NCT02650219|4004073|FG001|NOT COMPLETED|Overall Study||0
3269125|NCT02650284|4004081|FG000|STARTED|Overall Study||8
3269126|NCT02650284|4004082|FG001|STARTED|Overall Study||9
3269127|NCT02650284|4004081|FG000|COMPLETED|Overall Study||5
3269128|NCT02650284|4004082|FG001|COMPLETED|Overall Study||5
3269129|NCT02650284|4004081|FG000|NOT COMPLETED|Overall Study||3
3269130|NCT02650284|4004082|FG001|NOT COMPLETED|Overall Study||4
3269131|NCT02650440|4004090|FG000|STARTED|Overall Study||10
3269132|NCT02650440|4004091|FG001|STARTED|Overall Study||10
3269133|NCT02650440|4004090|FG000|COMPLETED|Overall Study||10
3269134|NCT02650440|4004091|FG001|COMPLETED|Overall Study||8
3269135|NCT02650440|4004090|FG000|NOT COMPLETED|Overall Study||0
3269136|NCT02650440|4004091|FG001|NOT COMPLETED|Overall Study||2
3269137|NCT02650466|4004097|FG000|STARTED|Overall Study||24
3269138|NCT02650466|4004097|FG000|COMPLETED|Overall Study||17
3269139|NCT02650466|4004097|FG000|NOT COMPLETED|Overall Study||7
3269140|NCT02650856|4004105|FG000|STARTED|Overall Study||19
3269141|NCT02650856|4004106|FG001|STARTED|Overall Study||21
3269142|NCT02650856|4004105|FG000|Baseline|Overall Study||19
3269143|NCT02650856|4004106|FG001|Baseline|Overall Study||21
3269144|NCT02650856|4004105|FG000|24 Hours|Overall Study||19
3269145|NCT02650856|4004106|FG001|24 Hours|Overall Study||21
3269146|NCT02650856|4004105|FG000|48 Hours|Overall Study||19
3269147|NCT02650856|4004106|FG001|48 Hours|Overall Study||21
3269148|NCT02650856|4004105|FG000|72 Hours|Overall Study||19
3269149|NCT02650856|4004106|FG001|72 Hours|Overall Study||21
3269150|NCT02650856|4004105|FG000|COMPLETED|Overall Study||19
3269151|NCT02650856|4004106|FG001|COMPLETED|Overall Study||21
3376330|NCT01409031|4109658|FG001|NOT COMPLETED|Overall Study||0
3376331|NCT01402531|4109664|FG000|STARTED|Overall Study||0
3376332|NCT01402531|4109664|FG000|COMPLETED|Overall Study||0
3376333|NCT01402531|4109664|FG000|NOT COMPLETED|Overall Study||0
3376334|NCT01394926|4109668|FG000|STARTED|Overall Study||21
3376335|NCT01394926|4109668|FG000|COMPLETED|Overall Study||21
3376336|NCT01394926|4109668|FG000|NOT COMPLETED|Overall Study||0
3376337|NCT01383681|4109677|FG000|STARTED|Overall Study||235
3376338|NCT01383681|4109677|FG000|COMPLETED|Overall Study||189
3376339|NCT01383681|4109677|FG000|NOT COMPLETED|Overall Study||46
3376340|NCT01403194|4109681|FG000|STARTED|Overall Study||11
3376341|NCT01403194|4109681|FG000|COMPLETED|Overall Study||1
3376342|NCT01403194|4109681|FG000|NOT COMPLETED|Overall Study||10
3376343|NCT01397552|4109687|FG000|STARTED|Overall Study||4
3376344|NCT01397552|4109688|FG001|STARTED|Overall Study||4
3376345|NCT01397552|4109687|FG000|COMPLETED|Overall Study||1
3376346|NCT01397552|4109688|FG001|COMPLETED|Overall Study||3
3376347|NCT01397552|4109687|FG000|NOT COMPLETED|Overall Study||3
3376348|NCT01397552|4109688|FG001|NOT COMPLETED|Overall Study||1
3376349|NCT01392170|4109694|FG000|STARTED|Overall Study||2
3376350|NCT01392170|4109694|FG000|COMPLETED|Overall Study||0
3376351|NCT01392170|4109694|FG000|NOT COMPLETED|Overall Study||2
3376352|NCT01389817|4109700|FG000|STARTED|Overall Study||4
3376353|NCT01389817|4109701|FG001|STARTED|Overall Study||0
3376354|NCT01389817|4109700|FG000|COMPLETED|Overall Study||0
3376355|NCT01389817|4109701|FG001|COMPLETED|Overall Study||0
3376356|NCT01389817|4109700|FG000|NOT COMPLETED|Overall Study||4
3376357|NCT01389817|4109701|FG001|NOT COMPLETED|Overall Study||0
3376358|NCT01397695|4109707|FG000|STARTED|Overall Study||0
3376359|NCT01397695|4109707|FG000|COMPLETED|Overall Study||0
3376360|NCT01397695|4109707|FG000|NOT COMPLETED|Overall Study||0
3376361|NCT01390181|4109711|FG000|STARTED|Overall Study||4
3376362|NCT01390181|4109711|FG000|COMPLETED|Overall Study||0
3376363|NCT01390181|4109711|FG000|NOT COMPLETED|Overall Study||4
3376364|NCT01385033|4109717|FG000|STARTED|Part I|These subjects did not participate in Part II or III|6
3376365|NCT01385033|4109718|FG001|STARTED|Part I|These subjects did not participate in Part II or III|14
3376366|NCT01385033|4109719|FG002|STARTED|Part I||0
3376367|NCT01385033|4109720|FG003|STARTED|Part I||0
3376368|NCT01385033|4109721|FG004|STARTED|Part I||0
3376369|NCT01385033|4109722|FG005|STARTED|Part I||0
3376370|NCT01385033|4109717|FG000|COMPLETED|Part I||6
3376371|NCT01385033|4109718|FG001|COMPLETED|Part I||14
3269152|NCT02650856|4004105|FG000|NOT COMPLETED|Overall Study||0
3269153|NCT02650856|4004106|FG001|NOT COMPLETED|Overall Study||0
3269154|NCT02650895|4004118|FG000|STARTED|Overall Study||10
3376372|NCT01385033|4109719|FG002|COMPLETED|Part I||0
3376373|NCT01385033|4109720|FG003|COMPLETED|Part I||0
3376374|NCT01385033|4109721|FG004|COMPLETED|Part I||0
3376375|NCT01385033|4109722|FG005|COMPLETED|Part I||0
3376376|NCT01385033|4109717|FG000|NOT COMPLETED|Part I||0
3376377|NCT01385033|4109718|FG001|NOT COMPLETED|Part I||0
3376378|NCT01385033|4109719|FG002|NOT COMPLETED|Part I||0
3376379|NCT01385033|4109720|FG003|NOT COMPLETED|Part I||0
3376380|NCT01385033|4109721|FG004|NOT COMPLETED|Part I||0
3376381|NCT01385033|4109722|FG005|NOT COMPLETED|Part I||0
3376382|NCT01385033|4109717|FG000|STARTED|Part II||0
3376383|NCT01385033|4109718|FG001|STARTED|Part II||0
3376384|NCT01385033|4109719|FG002|STARTED|Part II||0
3376385|NCT01385033|4109720|FG003|STARTED|Part II||0
3376386|NCT01385033|4109721|FG004|STARTED|Part II||0
3376387|NCT01385033|4109722|FG005|STARTED|Part II||0
3269155|NCT02650895|4004119|FG001|STARTED|Overall Study||6
3269156|NCT02650895|4004120|FG002|STARTED|Overall Study||6
3269157|NCT02650895|4004121|FG003|STARTED|Overall Study||6
3269158|NCT02650895|4004122|FG004|STARTED|Overall Study||6
3269159|NCT02650895|4004123|FG005|STARTED|Overall Study||6
3269160|NCT02650895|4004118|FG000|COMPLETED|Overall Study||10
3269161|NCT02650895|4004119|FG001|COMPLETED|Overall Study||5
3269162|NCT02650895|4004120|FG002|COMPLETED|Overall Study||6
3269163|NCT02650895|4004121|FG003|COMPLETED|Overall Study||6
3269164|NCT02650895|4004122|FG004|COMPLETED|Overall Study||6
3269165|NCT02650895|4004123|FG005|COMPLETED|Overall Study||6
3269166|NCT02650895|4004118|FG000|NOT COMPLETED|Overall Study||0
3269167|NCT02650895|4004119|FG001|NOT COMPLETED|Overall Study||1
3269168|NCT02650895|4004120|FG002|NOT COMPLETED|Overall Study||0
3269169|NCT02650895|4004121|FG003|NOT COMPLETED|Overall Study||0
3269170|NCT02650895|4004122|FG004|NOT COMPLETED|Overall Study||0
3269171|NCT02650895|4004123|FG005|NOT COMPLETED|Overall Study||0
3269172|NCT02650921|4004142|FG000|STARTED|Overall Study||92
3269173|NCT02650921|4004142|FG000|COMPLETED|Overall Study||84
3269174|NCT02650921|4004142|FG000|NOT COMPLETED|Overall Study||8
3269175|NCT02650999|4004148|FG000|STARTED|Overall Study||12
3269176|NCT02650999|4004148|FG000|COMPLETED|Overall Study||12
3269177|NCT02650999|4004148|FG000|NOT COMPLETED|Overall Study||0
3269178|NCT02651103|4004152|FG000|STARTED|Overall Study||30
3269179|NCT02651103|4004152|FG000|COMPLETED|Overall Study||30
3269180|NCT02651103|4004152|FG000|NOT COMPLETED|Overall Study||0
3269181|NCT02651116|4004158|FG000|STARTED|Overall Study||68
3269182|NCT02651116|4004159|FG001|STARTED|Overall Study||63
3269183|NCT02651116|4004158|FG000|Treated|Overall Study||68
3269184|NCT02651116|4004159|FG001|Treated|Overall Study||63
3269185|NCT02651116|4004158|FG000|COMPLETED|Overall Study||67
3269186|NCT02651116|4004159|FG001|COMPLETED|Overall Study||62
3269187|NCT02651116|4004158|FG000|NOT COMPLETED|Overall Study||1
3269188|NCT02651116|4004159|FG001|NOT COMPLETED|Overall Study||1
3269189|NCT02651155|4004167|FG000|STARTED|Overall Study||99
3269190|NCT02651155|4004168|FG001|STARTED|Overall Study||105
3269191|NCT02651155|4004167|FG000|COMPLETED|Overall Study||93
3269192|NCT02651155|4004168|FG001|COMPLETED|Overall Study||103
3269193|NCT02651155|4004167|FG000|NOT COMPLETED|Overall Study||6
3269194|NCT02651155|4004168|FG001|NOT COMPLETED|Overall Study||2
3269195|NCT02651194|4004174|FG000|STARTED|Overall Study||104
3269196|NCT02651194|4004174|FG000|COMPLETED|Overall Study||99
3269197|NCT02651194|4004174|FG000|NOT COMPLETED|Overall Study||5
3269198|NCT02651220|4004181|FG000|STARTED|Overall Study||337
3269199|NCT02651220|4004182|FG001|STARTED|Overall Study||335
3269200|NCT02651220|4004183|FG002|STARTED|Overall Study||329
3269201|NCT02651220|4004181|FG000|COMPLETED|Overall Study||314
3269202|NCT02651220|4004182|FG001|COMPLETED|Overall Study||308
3269203|NCT02651220|4004183|FG002|COMPLETED|Overall Study||300
3269204|NCT02651220|4004181|FG000|NOT COMPLETED|Overall Study||23
3269205|NCT02651220|4004182|FG001|NOT COMPLETED|Overall Study||27
3269206|NCT02651220|4004183|FG002|NOT COMPLETED|Overall Study||29
3269207|NCT02651259|4004193|FG000|STARTED|Overall Study||25
3269208|NCT02651259|4004194|FG001|STARTED|Overall Study||25
3269209|NCT02651259|4004193|FG000|COMPLETED|Overall Study||25
3269210|NCT02651259|4004194|FG001|COMPLETED|Overall Study||25
3269211|NCT02651259|4004193|FG000|NOT COMPLETED|Overall Study||0
3269212|NCT02651259|4004194|FG001|NOT COMPLETED|Overall Study||0
3269213|NCT02651272|4004208|FG000|STARTED|Overall Study||4
3269214|NCT02651272|4004208|FG000|COMPLETED|Overall Study||1
3269215|NCT02651272|4004208|FG000|NOT COMPLETED|Overall Study||3
3269216|NCT02651337|4004212|FG000|STARTED|Overall Study||5
3269217|NCT02651337|4004212|FG000|COMPLETED|Overall Study||4
3269218|NCT02651337|4004212|FG000|NOT COMPLETED|Overall Study||1
3269219|NCT02651415|4004216|FG000|STARTED|Overall Study|12 patients were enrolled.|12
3269220|NCT02651415|4004216|FG000|COMPLETED|Overall Study|10 patients were evaluable.|10
3269221|NCT02651415|4004216|FG000|NOT COMPLETED|Overall Study||2
3269222|NCT02651428|4004222|FG000|STARTED|Overall Study||403
3269223|NCT02651428|4004223|FG001|STARTED|Overall Study||403
3269224|NCT02651428|4004222|FG000|COMPLETED|Overall Study||359
3269225|NCT02651428|4004223|FG001|COMPLETED|Overall Study||359
3269226|NCT02651428|4004222|FG000|NOT COMPLETED|Overall Study||44
3269227|NCT02651428|4004223|FG001|NOT COMPLETED|Overall Study||44
3269228|NCT02651467|4004232|FG000|STARTED|Overall Study||74
3269229|NCT02651467|4004233|FG001|STARTED|Overall Study||74
3269230|NCT02651467|4004234|FG002|STARTED|Overall Study||73
3269231|NCT02651467|4004232|FG000|COMPLETED|Overall Study||73
3269232|NCT02651467|4004233|FG001|COMPLETED|Overall Study||74
3269233|NCT02651467|4004234|FG002|COMPLETED|Overall Study||69
3269234|NCT02651467|4004232|FG000|NOT COMPLETED|Overall Study||1
3269235|NCT02651467|4004233|FG001|NOT COMPLETED|Overall Study||0
3269236|NCT02651467|4004234|FG002|NOT COMPLETED|Overall Study||4
3269237|NCT02651545|4004245|FG000|STARTED|Overall Study||30
3269238|NCT02651545|4004246|FG001|STARTED|Overall Study||30
3269239|NCT02651545|4004245|FG000|COMPLETED|Overall Study||7
3269240|NCT02651545|4004246|FG001|COMPLETED|Overall Study||17
3269241|NCT02651545|4004245|FG000|NOT COMPLETED|Overall Study||23
3269242|NCT02651545|4004246|FG001|NOT COMPLETED|Overall Study||13
3269243|NCT02651584|4004254|FG000|STARTED|Overall Study||215
3269244|NCT02651584|4004255|FG001|STARTED|Overall Study||213
3269245|NCT02651584|4004254|FG000|COMPLETED|Overall Study||126
3269246|NCT02651584|4004255|FG001|COMPLETED|Overall Study||121
3269247|NCT02651584|4004254|FG000|NOT COMPLETED|Overall Study||89
3269248|NCT02651584|4004255|FG001|NOT COMPLETED|Overall Study||92
3269249|NCT02651688|4004267|FG000|STARTED|Overall Study||18
3269250|NCT02651688|4004268|FG001|STARTED|Overall Study||17
3269251|NCT02651688|4004269|FG002|STARTED|Overall Study||15
3269252|NCT02651688|4004267|FG000|COMPLETED|Overall Study||16
3269253|NCT02651688|4004268|FG001|COMPLETED|Overall Study||12
3269254|NCT02651688|4004269|FG002|COMPLETED|Overall Study||12
3269255|NCT02651688|4004267|FG000|NOT COMPLETED|Overall Study||2
3269256|NCT02651688|4004268|FG001|NOT COMPLETED|Overall Study||5
3269257|NCT02651688|4004269|FG002|NOT COMPLETED|Overall Study||3
3269258|NCT02651922|4004277|FG000|STARTED|Overall Study||156
3269259|NCT02651922|4004277|FG000|COMPLETED|Overall Study||154
3269260|NCT02651922|4004277|FG000|NOT COMPLETED|Overall Study||2
3269261|NCT02651987|4004283|FG000|STARTED|Overall Study||48
3269262|NCT02651987|4004284|FG001|STARTED|Overall Study||51
3269263|NCT02651987|4004283|FG000|COMPLETED|Overall Study||43
3269264|NCT02651987|4004284|FG001|COMPLETED|Overall Study||46
3269265|NCT02651987|4004283|FG000|NOT COMPLETED|Overall Study||5
3376388|NCT01385033|4109717|FG000|COMPLETED|Part II||0
3376389|NCT01385033|4109718|FG001|COMPLETED|Part II||0
3376390|NCT01385033|4109719|FG002|COMPLETED|Part II||0
3376391|NCT01385033|4109720|FG003|COMPLETED|Part II||0
3376392|NCT01385033|4109721|FG004|COMPLETED|Part II||0
3376393|NCT01385033|4109722|FG005|COMPLETED|Part II||0
3376394|NCT01385033|4109717|FG000|NOT COMPLETED|Part II||0
3376395|NCT01385033|4109718|FG001|NOT COMPLETED|Part II||0
3376396|NCT01385033|4109719|FG002|NOT COMPLETED|Part II||0
3376397|NCT01385033|4109720|FG003|NOT COMPLETED|Part II||0
3376398|NCT01385033|4109721|FG004|NOT COMPLETED|Part II||0
3376399|NCT01385033|4109722|FG005|NOT COMPLETED|Part II||0
3376400|NCT01385033|4109717|FG000|STARTED|Part III||0
3376401|NCT01385033|4109718|FG001|STARTED|Part III||0
3376402|NCT01385033|4109719|FG002|STARTED|Part III||0
3376403|NCT01385033|4109720|FG003|STARTED|Part III||0
3376404|NCT01385033|4109721|FG004|STARTED|Part III||0
3376405|NCT01385033|4109722|FG005|STARTED|Part III||0
3376406|NCT01385033|4109717|FG000|COMPLETED|Part III||0
3376407|NCT01385033|4109718|FG001|COMPLETED|Part III||0
3376408|NCT01385033|4109719|FG002|COMPLETED|Part III||0
3376409|NCT01385033|4109720|FG003|COMPLETED|Part III||0
3376410|NCT01385033|4109721|FG004|COMPLETED|Part III||0
3376411|NCT01385033|4109722|FG005|COMPLETED|Part III||0
3376412|NCT01385033|4109717|FG000|NOT COMPLETED|Part III||0
3376413|NCT01385033|4109718|FG001|NOT COMPLETED|Part III||0
3376414|NCT01385033|4109719|FG002|NOT COMPLETED|Part III||0
3376415|NCT01385033|4109720|FG003|NOT COMPLETED|Part III||0
3376416|NCT01385033|4109721|FG004|NOT COMPLETED|Part III||0
3376417|NCT01385033|4109722|FG005|NOT COMPLETED|Part III||0
3376418|NCT01394211|4109729|FG000|STARTED|Overall Study||2
3376419|NCT01394211|4109729|FG000|COMPLETED|Overall Study||0
3376420|NCT01394211|4109729|FG000|NOT COMPLETED|Overall Study||2
3376421|NCT01388920|4109736|FG000|STARTED|Overall Study||1
3376422|NCT01388920|4109737|FG001|STARTED|Overall Study||1
3376423|NCT01388920|4109738|FG002|STARTED|Overall Study||0
3376424|NCT01388920|4109736|FG000|COMPLETED|Overall Study||1
3376425|NCT01388920|4109737|FG001|COMPLETED|Overall Study||1
3376426|NCT01388920|4109738|FG002|COMPLETED|Overall Study||0
3376427|NCT01388920|4109736|FG000|NOT COMPLETED|Overall Study||0
3376428|NCT01388920|4109737|FG001|NOT COMPLETED|Overall Study||0
3376429|NCT01388920|4109738|FG002|NOT COMPLETED|Overall Study||0
3376430|NCT01377441|4109748|FG000|STARTED|Overall Study||0
3376431|NCT01377441|4109749|FG001|STARTED|Overall Study||0
3376432|NCT01377441|4109748|FG000|COMPLETED|Overall Study|All data for this study was lost after Hurricane Sandy.|0
3376433|NCT01377441|4109749|FG001|COMPLETED|Overall Study|All data for this study was lost after Hurricane Sandy.|0
3376434|NCT01377441|4109748|FG000|NOT COMPLETED|Overall Study||0
3376435|NCT01377441|4109749|FG001|NOT COMPLETED|Overall Study||0
3376436|NCT01383447|4109755|FG000|STARTED|Overall Study||2
3376437|NCT01383447|4109755|FG000|COMPLETED|Overall Study||0
3376438|NCT01383447|4109755|FG000|NOT COMPLETED|Overall Study||2
3376439|NCT01372618|4109759|FG000|STARTED|Overall Study||9
3376440|NCT01372618|4109759|FG000|COMPLETED|Overall Study||0
3376441|NCT01372618|4109759|FG000|NOT COMPLETED|Overall Study||9
3376442|NCT01385280|4109763|FG000|STARTED|Overall Study||13
3376443|NCT01385280|4109763|FG000|COMPLETED|Overall Study||13
3376444|NCT01385280|4109763|FG000|NOT COMPLETED|Overall Study||0
3376445|NCT01379274|4109767|FG000|STARTED|Overall Study||2
3376446|NCT01379274|4109767|FG000|COMPLETED|Overall Study||1
3376447|NCT01379274|4109767|FG000|NOT COMPLETED|Overall Study||1
3376448|NCT01379469|4109773|FG000|STARTED|Overall Study||13
3376449|NCT01379469|4109774|FG001|STARTED|Overall Study||7
3376450|NCT01379469|4109773|FG000|COMPLETED|Overall Study||1
3376451|NCT01379469|4109774|FG001|COMPLETED|Overall Study||3
3376452|NCT01379469|4109773|FG000|NOT COMPLETED|Overall Study||12
3376453|NCT01379469|4109774|FG001|NOT COMPLETED|Overall Study||4
3376454|NCT01369641|4109780|FG000|STARTED|Overall Study||1
3376455|NCT01369641|4109780|FG000|COMPLETED|Overall Study||0
3269266|NCT02651987|4004284|FG001|NOT COMPLETED|Overall Study||5
3376456|NCT01369641|4109780|FG000|NOT COMPLETED|Overall Study||1
3376457|NCT01365156|4109786|FG000|STARTED|Overall Study||14
3376458|NCT01365156|4109787|FG001|STARTED|Overall Study||14
3376459|NCT01365156|4109786|FG000|COMPLETED|Overall Study||14
3376460|NCT01365156|4109787|FG001|COMPLETED|Overall Study||14
3376461|NCT01365156|4109786|FG000|NOT COMPLETED|Overall Study||0
3376462|NCT01365156|4109787|FG001|NOT COMPLETED|Overall Study||0
3269267|NCT02652156|4004296|FG000|STARTED|Overall Study||4
3269268|NCT02652156|4004297|FG001|STARTED|Overall Study||6
3269269|NCT02652156|4004298|FG002|STARTED|Overall Study||4
3269270|NCT02652156|4004296|FG000|COMPLETED|Overall Study||3
3269271|NCT02652156|4004297|FG001|COMPLETED|Overall Study||6
3269272|NCT02652156|4004298|FG002|COMPLETED|Overall Study||4
3269273|NCT02652156|4004296|FG000|NOT COMPLETED|Overall Study||1
3269274|NCT02652156|4004297|FG001|NOT COMPLETED|Overall Study||0
3269275|NCT02652156|4004298|FG002|NOT COMPLETED|Overall Study||0
3269276|NCT02652208|4004308|FG000|STARTED|Overall Study||17
3269277|NCT02652208|4004309|FG001|STARTED|Overall Study||17
3269278|NCT02652208|4004308|FG000|COMPLETED|Overall Study||13
3269279|NCT02652208|4004309|FG001|COMPLETED|Overall Study||15
3269280|NCT02652208|4004308|FG000|NOT COMPLETED|Overall Study||4
3269281|NCT02652208|4004309|FG001|NOT COMPLETED|Overall Study||2
3269282|NCT02652221|4004315|FG000|STARTED|Overall Study||55
3269283|NCT02652221|4004315|FG000|COMPLETED|Overall Study||55
3269284|NCT02652221|4004315|FG000|NOT COMPLETED|Overall Study||0
3269285|NCT02652260|4004322|FG000|STARTED|Overall Study||43
3269286|NCT02652260|4004323|FG001|STARTED|Overall Study||43
3269287|NCT02652260|4004322|FG000|COMPLETED|Overall Study||43
3269288|NCT02652260|4004323|FG001|COMPLETED|Overall Study||41
3269289|NCT02652260|4004322|FG000|NOT COMPLETED|Overall Study||0
3269290|NCT02652260|4004323|FG001|NOT COMPLETED|Overall Study||2
3269291|NCT02652390|4004335|FG000|STARTED|Overall Study||37
3269292|NCT02652390|4004336|FG001|STARTED|Overall Study||37
3269293|NCT02652390|4004337|FG002|STARTED|Overall Study||37
3269294|NCT02652390|4004335|FG000|COMPLETED|Overall Study||37
3269295|NCT02652390|4004336|FG001|COMPLETED|Overall Study||37
3269296|NCT02652390|4004337|FG002|COMPLETED|Overall Study||37
3269297|NCT02652390|4004335|FG000|NOT COMPLETED|Overall Study||0
3269298|NCT02652390|4004336|FG001|NOT COMPLETED|Overall Study||0
3269299|NCT02652390|4004337|FG002|NOT COMPLETED|Overall Study||0
3269300|NCT02652416|4004351|FG000|STARTED|Overall Study||18
3269301|NCT02652416|4004352|FG001|STARTED|Overall Study||18
3269302|NCT02652416|4004353|FG002|STARTED|Overall Study||18
3269303|NCT02652416|4004354|FG003|STARTED|Overall Study||18
3269304|NCT02652416|4004351|FG000|Subjects Who Participated in MD Part|Overall Study||6
3269305|NCT02652416|4004352|FG001|Subjects Who Participated in MD Part|Overall Study||0
3269306|NCT02652416|4004353|FG002|Subjects Who Participated in MD Part|Overall Study||0
3269307|NCT02652416|4004354|FG003|Subjects Who Participated in MD Part|Overall Study||18
3269308|NCT02652416|4004351|FG000|COMPLETED|Overall Study||18
3269309|NCT02652416|4004352|FG001|COMPLETED|Overall Study||18
3269310|NCT02652416|4004353|FG002|COMPLETED|Overall Study||18
3269311|NCT02652416|4004354|FG003|COMPLETED|Overall Study||18
3269312|NCT02652416|4004351|FG000|NOT COMPLETED|Overall Study||0
3269313|NCT02652416|4004352|FG001|NOT COMPLETED|Overall Study||0
3269314|NCT02652416|4004353|FG002|NOT COMPLETED|Overall Study||0
3269315|NCT02652416|4004354|FG003|NOT COMPLETED|Overall Study||0
3269316|NCT02652442|4004368|FG000|STARTED|Centrifugation - Distance||6
3269317|NCT02652442|4004368|FG000|COMPLETED|Centrifugation - Distance||5
3269318|NCT02652442|4004368|FG000|NOT COMPLETED|Centrifugation - Distance||1
3269319|NCT02652442|4004368|FG000|STARTED|Centrifugation - Duration||5
3269320|NCT02652442|4004368|FG000|COMPLETED|Centrifugation - Duration||5
3269321|NCT02652442|4004368|FG000|NOT COMPLETED|Centrifugation - Duration||0
3269322|NCT02652442|4004368|FG000|STARTED|Centrifugation - Schedule||5
3269323|NCT02652442|4004368|FG000|COMPLETED|Centrifugation - Schedule||5
3269324|NCT02652442|4004368|FG000|NOT COMPLETED|Centrifugation - Schedule||0
3269325|NCT02652481|4004380|FG000|STARTED|Phase 1||239
3269326|NCT02652481|4004380|FG000|COMPLETED|Phase 1||141
3269327|NCT02652481|4004380|FG000|NOT COMPLETED|Phase 1||98
3269328|NCT02652481|4004380|FG000|STARTED|Phase 2||261
3269329|NCT02652481|4004380|FG000|COMPLETED|Phase 2||243
3269330|NCT02652481|4004380|FG000|NOT COMPLETED|Phase 2||18
3269331|NCT02652624|4004386|FG000|STARTED|Randomized Phase||234
3269332|NCT02652624|4004387|FG001|STARTED|Randomized Phase||236
3269333|NCT02652624|4004386|FG000|COMPLETED|Randomized Phase||231
3269334|NCT02652624|4004387|FG001|COMPLETED|Randomized Phase||231
3269335|NCT02652624|4004386|FG000|NOT COMPLETED|Randomized Phase||3
3269336|NCT02652624|4004387|FG001|NOT COMPLETED|Randomized Phase||5
3269337|NCT02652624|4004386|FG000|STARTED|Extension Phase||231
3376463|NCT01359254|4109795|FG000|STARTED|Overall Study||1
3376464|NCT01359254|4109796|FG001|STARTED|Overall Study||0
3376465|NCT01359254|4109795|FG000|COMPLETED|Overall Study||0
3376466|NCT01359254|4109796|FG001|COMPLETED|Overall Study||0
3376467|NCT01359254|4109795|FG000|NOT COMPLETED|Overall Study||1
3376468|NCT01359254|4109796|FG001|NOT COMPLETED|Overall Study||0
3376469|NCT01347632|4109802|FG000|STARTED|Overall Study||35
3376470|NCT01347632|4109802|FG000|COMPLETED|Overall Study||33
3376471|NCT01347632|4109802|FG000|NOT COMPLETED|Overall Study||2
3376472|NCT01356667|4109808|FG000|STARTED|Overall Study||4
3376473|NCT01356667|4109809|FG001|STARTED|Overall Study||6
3376474|NCT01356667|4109808|FG000|COMPLETED|Overall Study||0
3376475|NCT01356667|4109809|FG001|COMPLETED|Overall Study||0
3376476|NCT01356667|4109808|FG000|NOT COMPLETED|Overall Study||4
3376477|NCT01356667|4109809|FG001|NOT COMPLETED|Overall Study||6
3376478|NCT01354951|4109817|FG000|STARTED|Overall Study||3
3376479|NCT01354951|4109817|FG000|COMPLETED|Overall Study||1
3269338|NCT02652624|4004387|FG001|STARTED|Extension Phase|3 participants completed the Randomized Phase, but did not enter the Extension Phase.|228
3269339|NCT02652624|4004386|FG000|COMPLETED|Extension Phase||227
3269340|NCT02652624|4004387|FG001|COMPLETED|Extension Phase||224
3269341|NCT02652624|4004386|FG000|NOT COMPLETED|Extension Phase||4
3269342|NCT02652624|4004387|FG001|NOT COMPLETED|Extension Phase||4
3269343|NCT02652767|4004395|FG000|STARTED|Overall Study||39
3269344|NCT02652767|4004395|FG000|Completed Week 48|Overall Study||38
3269345|NCT02652767|4004395|FG000|COMPLETED|Overall Study||35
3269346|NCT02652767|4004395|FG000|NOT COMPLETED|Overall Study||4
3269347|NCT02652780|4004401|FG000|STARTED|Overall Study||37
3269348|NCT02652780|4004401|FG000|COMPLETED|Overall Study||37
3269349|NCT02652780|4004401|FG000|NOT COMPLETED|Overall Study||0
3269350|NCT02653144|4004411|FG000|STARTED|Overall Study||30
3269351|NCT02653144|4004412|FG001|STARTED|Overall Study||28
3269352|NCT02653144|4004413|FG002|STARTED|Overall Study||31
3269353|NCT02653144|4004411|FG000|COMPLETED|Overall Study||30
3269354|NCT02653144|4004412|FG001|COMPLETED|Overall Study||28
3269355|NCT02653144|4004413|FG002|COMPLETED|Overall Study||31
3269356|NCT02653144|4004411|FG000|NOT COMPLETED|Overall Study||0
3269357|NCT02653144|4004412|FG001|NOT COMPLETED|Overall Study||0
3269358|NCT02653144|4004413|FG002|NOT COMPLETED|Overall Study||0
3269359|NCT02653170|4004424|FG000|STARTED|Overall Study||87
3269360|NCT02653170|4004425|FG001|STARTED|Overall Study||88
3269361|NCT02653170|4004426|FG002|STARTED|Overall Study||90
3269362|NCT02653170|4004424|FG000|COMPLETED|Overall Study||70
3269363|NCT02653170|4004425|FG001|COMPLETED|Overall Study||72
3269364|NCT02653170|4004426|FG002|COMPLETED|Overall Study||72
3269365|NCT02653170|4004424|FG000|NOT COMPLETED|Overall Study||17
3269366|NCT02653170|4004425|FG001|NOT COMPLETED|Overall Study||16
3269367|NCT02653170|4004426|FG002|NOT COMPLETED|Overall Study||18
3269368|NCT02653183|4004436|FG000|STARTED|Overall Study||53
3269369|NCT02653183|4004437|FG001|STARTED|Overall Study||50
3269370|NCT02653183|4004436|FG000|COMPLETED|Overall Study||49
3269371|NCT02653183|4004437|FG001|COMPLETED|Overall Study||46
3269372|NCT02653183|4004436|FG000|NOT COMPLETED|Overall Study||4
3269373|NCT02653183|4004437|FG001|NOT COMPLETED|Overall Study||4
3269374|NCT02653300|4004443|FG000|STARTED|Overall Study||10
3269375|NCT02653300|4004443|FG000|COMPLETED|Overall Study||8
3269376|NCT02653300|4004443|FG000|NOT COMPLETED|Overall Study||2
3269377|NCT02653326|4004449|FG000|STARTED|Overall Study||32
3269378|NCT02653326|4004450|FG001|STARTED|Overall Study||34
3269379|NCT02653326|4004449|FG000|COMPLETED|Overall Study||22
3269380|NCT02653326|4004450|FG001|COMPLETED|Overall Study||27
3269381|NCT02653326|4004449|FG000|NOT COMPLETED|Overall Study||10
3269382|NCT02653326|4004450|FG001|NOT COMPLETED|Overall Study||7
3269383|NCT02653391|4004459|FG000|STARTED|Overall Study||18
3269384|NCT02653391|4004460|FG001|STARTED|Overall Study||3
3269385|NCT02653391|4004461|FG002|STARTED|Overall Study||1
3269386|NCT02653391|4004459|FG000|COMPLETED|Overall Study||16
3269387|NCT02653391|4004460|FG001|COMPLETED|Overall Study||1
3269388|NCT02653391|4004461|FG002|COMPLETED|Overall Study||1
3269389|NCT02653391|4004459|FG000|NOT COMPLETED|Overall Study||2
3269390|NCT02653391|4004460|FG001|NOT COMPLETED|Overall Study||2
3269391|NCT02653391|4004461|FG002|NOT COMPLETED|Overall Study||0
3269392|NCT02653417|4004509|FG000|STARTED|Overall Study||38
3269393|NCT02653417|4004510|FG001|STARTED|Overall Study||34
3269394|NCT02653417|4004511|FG002|STARTED|Overall Study||29
3269395|NCT02653417|4004512|FG003|STARTED|Overall Study||38
3269396|NCT02653417|4004509|FG000|COMPLETED|Overall Study||37
3269397|NCT02653417|4004510|FG001|COMPLETED|Overall Study||32
3269398|NCT02653417|4004511|FG002|COMPLETED|Overall Study||26
3269399|NCT02653417|4004512|FG003|COMPLETED|Overall Study||33
3269400|NCT02653417|4004509|FG000|NOT COMPLETED|Overall Study||1
3269401|NCT02653417|4004510|FG001|NOT COMPLETED|Overall Study||2
3269402|NCT02653417|4004511|FG002|NOT COMPLETED|Overall Study||3
3269403|NCT02653417|4004512|FG003|NOT COMPLETED|Overall Study||5
3269404|NCT02653456|4004526|FG000|STARTED|Overall Study||64
3269405|NCT02653456|4004526|FG000|COMPLETED|Overall Study||59
3269406|NCT02653456|4004526|FG000|NOT COMPLETED|Overall Study||5
3269407|NCT02653560|4004531|FG000|STARTED|KMgCit Phase||30
3269408|NCT02653560|4004532|FG001|STARTED|KMgCit Phase||0
3269409|NCT02653560|4004533|FG002|STARTED|KMgCit Phase||0
3269410|NCT02653560|4004534|FG003|STARTED|KMgCit Phase||0
3269411|NCT02653560|4004531|FG000|COMPLETED|KMgCit Phase||30
3376480|NCT01354951|4109817|FG000|NOT COMPLETED|Overall Study||2
3376481|NCT01350232|4109821|FG000|STARTED|Overall Study||2
3376482|NCT01350232|4109821|FG000|COMPLETED|Overall Study||2
3376483|NCT01350232|4109821|FG000|NOT COMPLETED|Overall Study||0
3376484|NCT01350583|4109825|FG000|STARTED|Overall Study||2
3376485|NCT01350583|4109825|FG000|COMPLETED|Overall Study||2
3376486|NCT01350583|4109825|FG000|NOT COMPLETED|Overall Study||0
3376487|NCT01352416|4109833|FG000|STARTED|Overall Study||4
3376488|NCT01352416|4109834|FG001|STARTED|Overall Study||7
3376489|NCT01352416|4109835|FG002|STARTED|Overall Study||2
3376490|NCT01352416|4109836|FG003|STARTED|Overall Study||2
3376491|NCT01352416|4109833|FG000|COMPLETED|Overall Study||3
3376492|NCT01352416|4109834|FG001|COMPLETED|Overall Study||5
3376493|NCT01352416|4109835|FG002|COMPLETED|Overall Study||0
3376494|NCT01352416|4109836|FG003|COMPLETED|Overall Study||1
3376495|NCT01352416|4109833|FG000|NOT COMPLETED|Overall Study||1
3376496|NCT01352416|4109834|FG001|NOT COMPLETED|Overall Study||2
3376497|NCT01352416|4109835|FG002|NOT COMPLETED|Overall Study||2
3269412|NCT02653560|4004532|FG001|COMPLETED|KMgCit Phase||0
3269413|NCT02653560|4004533|FG002|COMPLETED|KMgCit Phase||0
3269414|NCT02653560|4004534|FG003|COMPLETED|KMgCit Phase||0
3269415|NCT02653560|4004531|FG000|NOT COMPLETED|KMgCit Phase||0
3376498|NCT01352416|4109836|FG003|NOT COMPLETED|Overall Study||1
3269416|NCT02653560|4004532|FG001|NOT COMPLETED|KMgCit Phase||0
3269417|NCT02653560|4004533|FG002|NOT COMPLETED|KMgCit Phase||0
3269418|NCT02653560|4004534|FG003|NOT COMPLETED|KMgCit Phase||0
3269419|NCT02653560|4004531|FG000|STARTED|K Citrate Phase||0
3269420|NCT02653560|4004532|FG001|STARTED|K Citrate Phase||30
3269421|NCT02653560|4004533|FG002|STARTED|K Citrate Phase||0
3269422|NCT02653560|4004534|FG003|STARTED|K Citrate Phase||0
3269423|NCT02653560|4004531|FG000|COMPLETED|K Citrate Phase||0
3269424|NCT02653560|4004532|FG001|COMPLETED|K Citrate Phase||30
3269425|NCT02653560|4004533|FG002|COMPLETED|K Citrate Phase||0
3269426|NCT02653560|4004534|FG003|COMPLETED|K Citrate Phase||0
3269427|NCT02653560|4004531|FG000|NOT COMPLETED|K Citrate Phase||0
3269428|NCT02653560|4004532|FG001|NOT COMPLETED|K Citrate Phase||0
3269429|NCT02653560|4004533|FG002|NOT COMPLETED|K Citrate Phase||0
3269430|NCT02653560|4004534|FG003|NOT COMPLETED|K Citrate Phase||0
3269431|NCT02653560|4004531|FG000|STARTED|KCl Phase||0
3269432|NCT02653560|4004532|FG001|STARTED|KCl Phase||0
3269433|NCT02653560|4004533|FG002|STARTED|KCl Phase||30
3269434|NCT02653560|4004534|FG003|STARTED|KCl Phase||0
3269435|NCT02653560|4004531|FG000|COMPLETED|KCl Phase||0
3269436|NCT02653560|4004532|FG001|COMPLETED|KCl Phase||0
3269437|NCT02653560|4004533|FG002|COMPLETED|KCl Phase||30
3269438|NCT02653560|4004534|FG003|COMPLETED|KCl Phase||0
3269439|NCT02653560|4004531|FG000|NOT COMPLETED|KCl Phase||0
3269440|NCT02653560|4004532|FG001|NOT COMPLETED|KCl Phase||0
3269441|NCT02653560|4004533|FG002|NOT COMPLETED|KCl Phase||0
3269442|NCT02653560|4004534|FG003|NOT COMPLETED|KCl Phase||0
3269443|NCT02653560|4004531|FG000|STARTED|Placebo Phase||0
3269444|NCT02653560|4004532|FG001|STARTED|Placebo Phase||0
3269445|NCT02653560|4004533|FG002|STARTED|Placebo Phase||0
3269446|NCT02653560|4004534|FG003|STARTED|Placebo Phase||30
3269447|NCT02653560|4004531|FG000|COMPLETED|Placebo Phase||0
3269448|NCT02653560|4004532|FG001|COMPLETED|Placebo Phase||0
3269449|NCT02653560|4004533|FG002|COMPLETED|Placebo Phase||0
3269450|NCT02653560|4004534|FG003|COMPLETED|Placebo Phase||30
3269451|NCT02653560|4004531|FG000|NOT COMPLETED|Placebo Phase||0
3269452|NCT02653560|4004532|FG001|NOT COMPLETED|Placebo Phase||0
3269453|NCT02653560|4004533|FG002|NOT COMPLETED|Placebo Phase||0
3269454|NCT02653560|4004534|FG003|NOT COMPLETED|Placebo Phase||0
3269455|NCT02653625|4004544|FG000|STARTED|Overall Study||24
3269456|NCT02653625|4004544|FG000|COMPLETED|Overall Study||20
3269457|NCT02653625|4004544|FG000|NOT COMPLETED|Overall Study||4
3269458|NCT02653664|4004551|FG000|STARTED|Post-Treatment||110
3269459|NCT02653664|4004552|FG001|STARTED|Post-Treatment||110
3269460|NCT02653664|4004553|FG002|STARTED|Post-Treatment||108
3269461|NCT02653664|4004551|FG000|Primary and Secondary Data|Post-Treatment||93
3269462|NCT02653664|4004552|FG001|Primary and Secondary Data|Post-Treatment||104
3269463|NCT02653664|4004553|FG002|Primary and Secondary Data|Post-Treatment||91
3269464|NCT02653664|4004551|FG000|Primary Outcome Data Only|Post-Treatment||3
3269465|NCT02653664|4004552|FG001|Primary Outcome Data Only|Post-Treatment||0
3269466|NCT02653664|4004553|FG002|Primary Outcome Data Only|Post-Treatment||3
3269467|NCT02653664|4004551|FG000|COMPLETED|Post-Treatment||96
3269468|NCT02653664|4004552|FG001|COMPLETED|Post-Treatment||104
3269469|NCT02653664|4004553|FG002|COMPLETED|Post-Treatment||94
3269470|NCT02653664|4004551|FG000|NOT COMPLETED|Post-Treatment||14
3269471|NCT02653664|4004552|FG001|NOT COMPLETED|Post-Treatment||6
3269472|NCT02653664|4004553|FG002|NOT COMPLETED|Post-Treatment||14
3269473|NCT02653664|4004551|FG000|STARTED|3 Month Follow-Up||110
3269474|NCT02653664|4004552|FG001|STARTED|3 Month Follow-Up||110
3269475|NCT02653664|4004553|FG002|STARTED|3 Month Follow-Up||108
3269476|NCT02653664|4004551|FG000|Primary and Secondary Data|3 Month Follow-Up||83
3269477|NCT02653664|4004552|FG001|Primary and Secondary Data|3 Month Follow-Up||95
3269478|NCT02653664|4004553|FG002|Primary and Secondary Data|3 Month Follow-Up||82
3269479|NCT02653664|4004551|FG000|Primary Outcome Data Only|3 Month Follow-Up||6
3269480|NCT02653664|4004552|FG001|Primary Outcome Data Only|3 Month Follow-Up||0
3269481|NCT02653664|4004553|FG002|Primary Outcome Data Only|3 Month Follow-Up||1
3269482|NCT02653664|4004551|FG000|COMPLETED|3 Month Follow-Up||89
3269483|NCT02653664|4004552|FG001|COMPLETED|3 Month Follow-Up||95
3269484|NCT02653664|4004553|FG002|COMPLETED|3 Month Follow-Up||83
3269485|NCT02653664|4004551|FG000|NOT COMPLETED|3 Month Follow-Up||21
3269486|NCT02653664|4004552|FG001|NOT COMPLETED|3 Month Follow-Up||15
3269487|NCT02653664|4004553|FG002|NOT COMPLETED|3 Month Follow-Up||25
3269488|NCT02653664|4004551|FG000|STARTED|6 Month Follow-Up||110
3269489|NCT02653664|4004552|FG001|STARTED|6 Month Follow-Up||110
3269490|NCT02653664|4004553|FG002|STARTED|6 Month Follow-Up||108
3269491|NCT02653664|4004551|FG000|Primary and Secondary Outcome Data|6 Month Follow-Up||85
3269492|NCT02653664|4004552|FG001|Primary and Secondary Outcome Data|6 Month Follow-Up||87
3269493|NCT02653664|4004553|FG002|Primary and Secondary Outcome Data|6 Month Follow-Up||83
3269494|NCT02653664|4004551|FG000|Primary Outcome Data Only|6 Month Follow-Up||2
3269495|NCT02653664|4004552|FG001|Primary Outcome Data Only|6 Month Follow-Up||2
3269496|NCT02653664|4004553|FG002|Primary Outcome Data Only|6 Month Follow-Up||2
3269497|NCT02653664|4004551|FG000|COMPLETED|6 Month Follow-Up||87
3269498|NCT02653664|4004552|FG001|COMPLETED|6 Month Follow-Up||89
3269499|NCT02653664|4004553|FG002|COMPLETED|6 Month Follow-Up||85
3269500|NCT02653664|4004551|FG000|NOT COMPLETED|6 Month Follow-Up||23
3269501|NCT02653664|4004552|FG001|NOT COMPLETED|6 Month Follow-Up||21
3269502|NCT02653664|4004553|FG002|NOT COMPLETED|6 Month Follow-Up||23
3269503|NCT02653768|4004566|FG000|STARTED|3-Month Follow-Up||230
3269504|NCT02653768|4004567|FG001|STARTED|3-Month Follow-Up||115
3269505|NCT02653768|4004566|FG000|COMPLETED|3-Month Follow-Up||164
3269506|NCT02653768|4004567|FG001|COMPLETED|3-Month Follow-Up||100
3269507|NCT02653768|4004566|FG000|NOT COMPLETED|3-Month Follow-Up||66
3269508|NCT02653768|4004567|FG001|NOT COMPLETED|3-Month Follow-Up||15
3269509|NCT02653768|4004566|FG000|STARTED|6-Month Follow-Up|21 participants withdrew/excluded by 3-months, others missed that assessment but remained in study|209
3269510|NCT02653768|4004567|FG001|STARTED|6-Month Follow-Up|2 participants withdrew/excluded by 3-months, others missed that assessment but remained in study|113
3269511|NCT02653768|4004566|FG000|COMPLETED|6-Month Follow-Up||164
3269512|NCT02653768|4004567|FG001|COMPLETED|6-Month Follow-Up||100
3269513|NCT02653768|4004566|FG000|NOT COMPLETED|6-Month Follow-Up||45
3376499|NCT01350258|4109846|FG000|STARTED|Overall Study||8
3376500|NCT01350258|4109846|FG000|COMPLETED|Overall Study||8
3376501|NCT01350258|4109846|FG000|NOT COMPLETED|Overall Study||0
3376502|NCT01349595|4109852|FG000|STARTED|Overall Study||2
3376503|NCT01349595|4109853|FG001|STARTED|Overall Study||2
3376504|NCT01349595|4109852|FG000|COMPLETED|Overall Study||0
3376505|NCT01349595|4109853|FG001|COMPLETED|Overall Study||0
3376506|NCT01349595|4109852|FG000|NOT COMPLETED|Overall Study||2
3376507|NCT01349595|4109853|FG001|NOT COMPLETED|Overall Study||2
3376508|NCT01337609|4109862|FG000|STARTED|Overall Study||1
3376509|NCT01337609|4109863|FG001|STARTED|Overall Study||2
3376510|NCT01337609|4109864|FG002|STARTED|Overall Study||2
3376511|NCT01337609|4109862|FG000|COMPLETED|Overall Study||0
3376512|NCT01337609|4109863|FG001|COMPLETED|Overall Study||2
3376513|NCT01337609|4109864|FG002|COMPLETED|Overall Study||2
3376514|NCT01337609|4109862|FG000|NOT COMPLETED|Overall Study||1
3376515|NCT01337609|4109863|FG001|NOT COMPLETED|Overall Study||0
3376516|NCT01337609|4109864|FG002|NOT COMPLETED|Overall Study||0
3376517|NCT01347840|4109872|FG000|STARTED|Overall Study|1 subject enrolled but withdrew consent|1
3376518|NCT01347840|4109872|FG000|COMPLETED|Overall Study||0
3376519|NCT01347840|4109872|FG000|NOT COMPLETED|Overall Study||1
3376520|NCT01340573|4109876|FG000|STARTED|Overall Study||3
3376521|NCT01340573|4109876|FG000|COMPLETED|Overall Study||0
3376522|NCT01340573|4109876|FG000|NOT COMPLETED|Overall Study||3
3376523|NCT01335997|4109883|FG000|STARTED|Period I and II||577
3376524|NCT01335997|4109884|FG001|STARTED|Period I and II||562
3376525|NCT01335997|4109883|FG000|COMPLETED|Period I and II||84
3376526|NCT01335997|4109884|FG001|COMPLETED|Period I and II||83
3376527|NCT01335997|4109883|FG000|NOT COMPLETED|Period I and II||493
3376528|NCT01335997|4109884|FG001|NOT COMPLETED|Period I and II||479
3376529|NCT01335997|4109883|FG000|STARTED|Period III||84
3376530|NCT01335997|4109884|FG001|STARTED|Period III||83
3376531|NCT01335997|4109883|FG000|COMPLETED|Period III||6
3376532|NCT01335997|4109884|FG001|COMPLETED|Period III||4
3376533|NCT01335997|4109883|FG000|NOT COMPLETED|Period III||78
3376534|NCT01335997|4109884|FG001|NOT COMPLETED|Period III||79
3376535|NCT01340885|4109895|FG000|STARTED|Overall Study||0
3376536|NCT01340885|4109896|FG001|STARTED|Overall Study||0
3376537|NCT01340885|4109897|FG002|STARTED|Overall Study||0
3376538|NCT01340885|4109895|FG000|COMPLETED|Overall Study||0
3376539|NCT01340885|4109896|FG001|COMPLETED|Overall Study||0
3376540|NCT01340885|4109897|FG002|COMPLETED|Overall Study||0
3376541|NCT01340885|4109895|FG000|NOT COMPLETED|Overall Study||0
3376542|NCT01340885|4109896|FG001|NOT COMPLETED|Overall Study||0
3376543|NCT01340885|4109897|FG002|NOT COMPLETED|Overall Study||0
3376544|NCT01341587|4109907|FG000|STARTED|Overall Study||4
3376545|NCT01341587|4109908|FG001|STARTED|Overall Study||10
3376546|NCT01341587|4109907|FG000|COMPLETED|Overall Study||0
3376547|NCT01341587|4109908|FG001|COMPLETED|Overall Study||0
3376548|NCT01341587|4109907|FG000|NOT COMPLETED|Overall Study||4
3376549|NCT01341587|4109908|FG001|NOT COMPLETED|Overall Study||10
3376550|NCT01334606|4109914|FG000|STARTED|Overall Study||21
3376551|NCT01334606|4109914|FG000|COMPLETED|Overall Study||3
3376552|NCT01334606|4109914|FG000|NOT COMPLETED|Overall Study||18
3376553|NCT01326923|4109920|FG000|STARTED|Overall Study||7
3376554|NCT01326923|4109920|FG000|COMPLETED|Overall Study||7
3269514|NCT02653768|4004567|FG001|NOT COMPLETED|6-Month Follow-Up||13
3376555|NCT01326923|4109920|FG000|NOT COMPLETED|Overall Study||0
3376556|NCT01332799|4109926|FG000|STARTED|Overall Study||10
3376557|NCT01332799|4109927|FG001|STARTED|Overall Study||10
3376558|NCT01332799|4109926|FG000|COMPLETED|Overall Study||0
3376559|NCT01332799|4109927|FG001|COMPLETED|Overall Study||0
3376560|NCT01332799|4109926|FG000|NOT COMPLETED|Overall Study||10
3376561|NCT01332799|4109927|FG001|NOT COMPLETED|Overall Study||10
3269515|NCT02653768|4004566|FG000|STARTED|9-Month Follow-Up (Primary)|34 withdrew/excluded before 9 months; others missed prior assessments but remained in study|196
3269516|NCT02653768|4004567|FG001|STARTED|9-Month Follow-Up (Primary)|4 withdrew/excluded before 9 months; others missed prior assessments but remained in study|111
3269517|NCT02653768|4004566|FG000|COMPLETED|9-Month Follow-Up (Primary)|13 withdrew/refused before 9 months; others missed prior assessments but remained in study|163
3269518|NCT02653768|4004567|FG001|COMPLETED|9-Month Follow-Up (Primary)||95
3269519|NCT02653768|4004566|FG000|NOT COMPLETED|9-Month Follow-Up (Primary)||33
3269520|NCT02653768|4004567|FG001|NOT COMPLETED|9-Month Follow-Up (Primary)||16
3269521|NCT02653872|4004573|FG000|STARTED|Overall Study||15
3269522|NCT02653872|4004573|FG000|Treatment Period 1:|Overall Study|Participants received single AZD7986 (25 mg).|15
3269523|NCT02653872|4004573|FG000|Treatment Period 2:|Overall Study|Participants received Verapamil (240 mg; extended release formulation) + AZD7986 (25 mg).|15
3269524|NCT02653872|4004573|FG000|Treatment Period 3:|Overall Study|Participants received: itraconazole 200 mg + AZD7986.|15
3269525|NCT02653872|4004573|FG000|COMPLETED|Overall Study||15
3269526|NCT02653872|4004573|FG000|NOT COMPLETED|Overall Study||0
3269527|NCT02654002|4004596|FG000|STARTED|Overall Study||12
3269528|NCT02654002|4004597|FG001|STARTED|Overall Study||12
3269529|NCT02654002|4004598|FG002|STARTED|Overall Study||12
3269530|NCT02654002|4004599|FG003|STARTED|Overall Study||12
3269531|NCT02654002|4004600|FG004|STARTED|Overall Study||12
3269532|NCT02654002|4004601|FG005|STARTED|Overall Study||12
3269533|NCT02654002|4004602|FG006|STARTED|Overall Study||12
3269534|NCT02654002|4004603|FG007|STARTED|Overall Study||12
3269535|NCT02654002|4004604|FG008|STARTED|Overall Study||24
3269536|NCT02654002|4004596|FG000|COMPLETED|Overall Study||12
3269537|NCT02654002|4004597|FG001|COMPLETED|Overall Study||12
3269538|NCT02654002|4004598|FG002|COMPLETED|Overall Study||12
3269539|NCT02654002|4004599|FG003|COMPLETED|Overall Study||12
3269540|NCT02654002|4004600|FG004|COMPLETED|Overall Study||12
3269541|NCT02654002|4004601|FG005|COMPLETED|Overall Study||11
3269542|NCT02654002|4004602|FG006|COMPLETED|Overall Study||11
3269543|NCT02654002|4004603|FG007|COMPLETED|Overall Study||11
3269544|NCT02654002|4004604|FG008|COMPLETED|Overall Study||24
3269545|NCT02654002|4004596|FG000|NOT COMPLETED|Overall Study||0
3269546|NCT02654002|4004597|FG001|NOT COMPLETED|Overall Study||0
3269547|NCT02654002|4004598|FG002|NOT COMPLETED|Overall Study||0
3269548|NCT02654002|4004599|FG003|NOT COMPLETED|Overall Study||0
3269549|NCT02654002|4004600|FG004|NOT COMPLETED|Overall Study||0
3269550|NCT02654002|4004601|FG005|NOT COMPLETED|Overall Study||1
3269551|NCT02654002|4004602|FG006|NOT COMPLETED|Overall Study||1
3269552|NCT02654002|4004603|FG007|NOT COMPLETED|Overall Study||1
3269553|NCT02654002|4004604|FG008|NOT COMPLETED|Overall Study||0
3269554|NCT02654054|4004642|FG000|STARTED|Treatment Period||102
3269555|NCT02654054|4004643|FG001|STARTED|Treatment Period||104
3269556|NCT02654054|4004644|FG002|STARTED|Treatment Period||207
3269557|NCT02654054|4004642|FG000|Randomized and Treated|Treatment Period||102
3269558|NCT02654054|4004643|FG001|Randomized and Treated|Treatment Period||104
3269559|NCT02654054|4004644|FG002|Randomized and Treated|Treatment Period||206
3269560|NCT02654054|4004642|FG000|COMPLETED|Treatment Period||83
3269561|NCT02654054|4004643|FG001|COMPLETED|Treatment Period||81
3269562|NCT02654054|4004644|FG002|COMPLETED|Treatment Period||164
3269563|NCT02654054|4004642|FG000|NOT COMPLETED|Treatment Period||19
3269564|NCT02654054|4004643|FG001|NOT COMPLETED|Treatment Period||23
3269565|NCT02654054|4004644|FG002|NOT COMPLETED|Treatment Period||43
3269566|NCT02654054|4004642|FG000|STARTED|Post-Treatment Follow-Up Period||25
3269567|NCT02654054|4004643|FG001|STARTED|Post-Treatment Follow-Up Period||32
3269568|NCT02654054|4004644|FG002|STARTED|Post-Treatment Follow-Up Period||59
3269569|NCT02654054|4004642|FG000|COMPLETED|Post-Treatment Follow-Up Period||17
3269570|NCT02654054|4004643|FG001|COMPLETED|Post-Treatment Follow-Up Period||24
3269571|NCT02654054|4004644|FG002|COMPLETED|Post-Treatment Follow-Up Period||29
3269572|NCT02654054|4004642|FG000|NOT COMPLETED|Post-Treatment Follow-Up Period||8
3269573|NCT02654054|4004643|FG001|NOT COMPLETED|Post-Treatment Follow-Up Period||8
3269574|NCT02654054|4004644|FG002|NOT COMPLETED|Post-Treatment Follow-Up Period||30
3269575|NCT02654145|4004653|FG000|STARTED|Overall Study||145
3269576|NCT02654145|4004653|FG000|COMPLETED|Overall Study||138
3269577|NCT02654145|4004653|FG000|NOT COMPLETED|Overall Study||7
3269578|NCT02654314|4004659|FG000|STARTED|Overall Study||136
3269579|NCT02654314|4004660|FG001|STARTED|Overall Study||141
3269580|NCT02654314|4004659|FG000|COMPLETED|Overall Study||136
3269581|NCT02654314|4004660|FG001|COMPLETED|Overall Study||141
3269582|NCT02654314|4004659|FG000|NOT COMPLETED|Overall Study||0
3269583|NCT02654314|4004660|FG001|NOT COMPLETED|Overall Study||0
3269584|NCT02654483|4004668|FG000|STARTED|Double-blind||7
3269585|NCT02654483|4004669|FG001|STARTED|Double-blind||7
3269586|NCT02654483|4004668|FG000|COMPLETED|Double-blind||7
3269587|NCT02654483|4004669|FG001|COMPLETED|Double-blind||7
3269588|NCT02654483|4004668|FG000|NOT COMPLETED|Double-blind||0
3269589|NCT02654483|4004669|FG001|NOT COMPLETED|Double-blind||0
3269590|NCT02654483|4004668|FG000|STARTED|Open-label|2 participants did not proceed to open-label arm|5
3269591|NCT02654483|4004669|FG001|STARTED|Open-label|4 participants did not continue to open-label arm|3
3269592|NCT02654483|4004668|FG000|COMPLETED|Open-label||5
3269593|NCT02654483|4004669|FG001|COMPLETED|Open-label||3
3269594|NCT02654483|4004668|FG000|NOT COMPLETED|Open-label||0
3269595|NCT02654483|4004669|FG001|NOT COMPLETED|Open-label||0
3269596|NCT02654652|4004683|FG000|STARTED|Overall Study||19
3269597|NCT02654652|4004684|FG001|STARTED|Overall Study||21
3269598|NCT02654652|4004683|FG000|COMPLETED|Overall Study||18
3269599|NCT02654652|4004684|FG001|COMPLETED|Overall Study||18
3269600|NCT02654652|4004683|FG000|NOT COMPLETED|Overall Study||1
3269601|NCT02654652|4004684|FG001|NOT COMPLETED|Overall Study||3
3269602|NCT02654691|4004690|FG000|STARTED|Overall Study||63
3269603|NCT02654691|4004690|FG000|COMPLETED|Overall Study||63
3376562|NCT01329549|4109933|FG000|STARTED|Overall Study||2
3376563|NCT01329549|4109933|FG000|COMPLETED|Overall Study||0
3376564|NCT01329549|4109933|FG000|NOT COMPLETED|Overall Study||2
3376565|NCT01326845|4109939|FG000|STARTED|Overall Study||7
3376566|NCT01326845|4109940|FG001|STARTED|Overall Study||5
3376567|NCT01326845|4109939|FG000|COMPLETED|Overall Study|Study terminated early|0
3376568|NCT01326845|4109940|FG001|COMPLETED|Overall Study|Study terminated early|0
3376569|NCT01326845|4109939|FG000|NOT COMPLETED|Overall Study||7
3376570|NCT01326845|4109940|FG001|NOT COMPLETED|Overall Study||5
3376571|NCT01329341|4109946|FG000|STARTED|Overall Study||60
3376572|NCT01329341|4109946|FG000|COMPLETED|Overall Study||16
3376573|NCT01329341|4109946|FG000|NOT COMPLETED|Overall Study||44
3376574|NCT01319760|4109952|FG000|STARTED|Overall Study|The study experienced a very low enrollment rate. the sponsor decided to stop the study.|0
3376575|NCT01319760|4109953|FG001|STARTED|Overall Study||5
3376576|NCT01319760|4109952|FG000|COMPLETED|Overall Study|The study experienced a very low enrollment rate. the sponsor decided to stop the study.|0
3376577|NCT01319760|4109953|FG001|COMPLETED|Overall Study||5
3376578|NCT01319760|4109952|FG000|NOT COMPLETED|Overall Study||0
3376579|NCT01319760|4109953|FG001|NOT COMPLETED|Overall Study||0
3376580|NCT01320683|4109959|FG000|STARTED|Overall Study||1
3376581|NCT01320683|4109959|FG000|COMPLETED|Overall Study||0
3376582|NCT01320683|4109959|FG000|NOT COMPLETED|Overall Study||1
3376583|NCT01313273|4109965|FG000|STARTED|Overall Study||2
3376584|NCT01313273|4109966|FG001|STARTED|Overall Study||1
3376585|NCT01313273|4109965|FG000|COMPLETED|Overall Study||0
3376586|NCT01313273|4109966|FG001|COMPLETED|Overall Study||0
3376587|NCT01313273|4109965|FG000|NOT COMPLETED|Overall Study||2
3376588|NCT01313273|4109966|FG001|NOT COMPLETED|Overall Study||1
3376589|NCT01321008|4109972|FG000|STARTED|Overall Study||1
3376590|NCT01321008|4109972|FG000|COMPLETED|Overall Study||0
3376591|NCT01321008|4109972|FG000|NOT COMPLETED|Overall Study||1
3376592|NCT01310803|4109978|FG000|STARTED|Overall Study||1
3376593|NCT01310803|4109979|FG001|STARTED|Overall Study||0
3376594|NCT01310803|4109978|FG000|COMPLETED|Overall Study||0
3376595|NCT01310803|4109979|FG001|COMPLETED|Overall Study||0
3376596|NCT01310803|4109978|FG000|NOT COMPLETED|Overall Study||1
3376597|NCT01310803|4109979|FG001|NOT COMPLETED|Overall Study||0
3376598|NCT01309581|4109987|FG000|STARTED|Overall Study||2
3376599|NCT01309581|4109988|FG001|STARTED|Overall Study||1
3376600|NCT01309581|4109987|FG000|COMPLETED|Overall Study||2
3376601|NCT01309581|4109988|FG001|COMPLETED|Overall Study||1
3376602|NCT01309581|4109987|FG000|NOT COMPLETED|Overall Study||0
3376603|NCT01309581|4109988|FG001|NOT COMPLETED|Overall Study||0
3376604|NCT01315873|4109994|FG000|STARTED|Overall Study||24
3376605|NCT01315873|4109994|FG000|COMPLETED|Overall Study||24
3376606|NCT01315873|4109994|FG000|NOT COMPLETED|Overall Study||0
3376607|NCT01313923|4109998|FG000|STARTED|Overall Study||3
3376608|NCT01313923|4109998|FG000|COMPLETED|Overall Study||0
3376609|NCT01313923|4109998|FG000|NOT COMPLETED|Overall Study||3
3376610|NCT01321697|4110002|FG000|STARTED|Overall Study||7
3376611|NCT01321697|4110002|FG000|COMPLETED|Overall Study||0
3376612|NCT01321697|4110002|FG000|NOT COMPLETED|Overall Study||7
3376613|NCT01312428|4110008|FG000|STARTED|Overall Study||3
3376614|NCT01312428|4110009|FG001|STARTED|Overall Study||4
3376615|NCT01312428|4110008|FG000|COMPLETED|Overall Study||0
3376616|NCT01312428|4110009|FG001|COMPLETED|Overall Study||0
3376617|NCT01312428|4110008|FG000|NOT COMPLETED|Overall Study||3
3376618|NCT01312428|4110009|FG001|NOT COMPLETED|Overall Study||4
3376619|NCT01313416|4110017|FG000|STARTED|Overall Study||2
3376620|NCT01313416|4110017|FG000|COMPLETED|Overall Study||2
3376621|NCT01313416|4110017|FG000|NOT COMPLETED|Overall Study||0
3376622|NCT01303003|4110023|FG000|STARTED|Overall Study||0
3376623|NCT01303003|4110024|FG001|STARTED|Overall Study||0
3376624|NCT01303003|4110023|FG000|COMPLETED|Overall Study||0
3376625|NCT01303003|4110024|FG001|COMPLETED|Overall Study||0
3376626|NCT01303003|4110023|FG000|NOT COMPLETED|Overall Study||0
3376627|NCT01303003|4110024|FG001|NOT COMPLETED|Overall Study||0
3376628|NCT01302444|4110032|FG000|STARTED|Overall Study||1
3376629|NCT01302444|4110033|FG001|STARTED|Overall Study||0
3376630|NCT01302444|4110032|FG000|COMPLETED|Overall Study||1
3376631|NCT01302444|4110033|FG001|COMPLETED|Overall Study||0
3376632|NCT01302444|4110032|FG000|NOT COMPLETED|Overall Study||0
3376633|NCT01302444|4110033|FG001|NOT COMPLETED|Overall Study||0
3376634|NCT01301963|4110041|FG000|STARTED|Overall Study||5
3376635|NCT01301963|4110042|FG001|STARTED|Overall Study||4
3376636|NCT01301963|4110041|FG000|COMPLETED|Overall Study||5
3376637|NCT01301963|4110042|FG001|COMPLETED|Overall Study||4
3376638|NCT01301963|4110041|FG000|NOT COMPLETED|Overall Study||0
3376639|NCT01301963|4110042|FG001|NOT COMPLETED|Overall Study||0
3376640|NCT01298921|4110050|FG000|STARTED|Overall Study||0
3376641|NCT01298921|4110051|FG001|STARTED|Overall Study||0
3376642|NCT01298921|4110050|FG000|COMPLETED|Overall Study||0
3269604|NCT02654691|4004690|FG000|NOT COMPLETED|Overall Study||0
3269605|NCT02654717|4004696|FG000|STARTED|Overall Study||56
3269606|NCT02654717|4004697|FG001|STARTED|Overall Study||55
3269607|NCT02654717|4004696|FG000|COMPLETED|Overall Study||50
3269608|NCT02654717|4004697|FG001|COMPLETED|Overall Study||50
3269609|NCT02654717|4004696|FG000|NOT COMPLETED|Overall Study||6
3269610|NCT02654717|4004697|FG001|NOT COMPLETED|Overall Study||5
3269611|NCT02654769|4004706|FG000|STARTED|Overall Study||149
3269612|NCT02654769|4004707|FG001|STARTED|Overall Study||149
3269613|NCT02654769|4004708|FG002|STARTED|Overall Study||143
3269614|NCT02654769|4004706|FG000|COMPLETED|Overall Study||145
3269615|NCT02654769|4004707|FG001|COMPLETED|Overall Study||148
3269616|NCT02654769|4004708|FG002|COMPLETED|Overall Study||142
3269617|NCT02654769|4004706|FG000|NOT COMPLETED|Overall Study||4
3269618|NCT02654769|4004707|FG001|NOT COMPLETED|Overall Study||1
3269619|NCT02654769|4004708|FG002|NOT COMPLETED|Overall Study||1
3269620|NCT02654808|4004720|FG000|STARTED|Overall Study||33
3269621|NCT02654808|4004721|FG001|STARTED|Overall Study||33
3269622|NCT02654808|4004722|FG002|STARTED|Overall Study||33
3269623|NCT02654808|4004723|FG003|STARTED|Overall Study||33
3269624|NCT02654808|4004720|FG000|COMPLETED|Overall Study||33
3269625|NCT02654808|4004721|FG001|COMPLETED|Overall Study||33
3269626|NCT02654808|4004722|FG002|COMPLETED|Overall Study||33
3269627|NCT02654808|4004723|FG003|COMPLETED|Overall Study||33
3269628|NCT02654808|4004720|FG000|NOT COMPLETED|Overall Study||0
3269629|NCT02654808|4004721|FG001|NOT COMPLETED|Overall Study||0
3269630|NCT02654808|4004722|FG002|NOT COMPLETED|Overall Study||0
3269631|NCT02654808|4004723|FG003|NOT COMPLETED|Overall Study||0
3269632|NCT02654860|4004741|FG000|STARTED|First Part||3
3269633|NCT02654860|4004742|FG001|STARTED|First Part||3
3269634|NCT02654860|4004743|FG002|STARTED|First Part||3
3269635|NCT02654860|4004744|FG003|STARTED|First Part||0
3269636|NCT02654860|4004741|FG000|COMPLETED|First Part||3
3269637|NCT02654860|4004742|FG001|COMPLETED|First Part||3
3269638|NCT02654860|4004743|FG002|COMPLETED|First Part||3
3269639|NCT02654860|4004744|FG003|COMPLETED|First Part||0
3269640|NCT02654860|4004741|FG000|NOT COMPLETED|First Part||0
3269641|NCT02654860|4004742|FG001|NOT COMPLETED|First Part||0
3269642|NCT02654860|4004743|FG002|NOT COMPLETED|First Part||0
3269643|NCT02654860|4004744|FG003|NOT COMPLETED|First Part||0
3269644|NCT02654860|4004741|FG000|STARTED|Second Part||15
3269645|NCT02654860|4004742|FG001|STARTED|Second Part||15
3269646|NCT02654860|4004743|FG002|STARTED|Second Part||15
3269647|NCT02654860|4004744|FG003|STARTED|Second Part||15
3269648|NCT02654860|4004741|FG000|COMPLETED|Second Part||15
3269649|NCT02654860|4004742|FG001|COMPLETED|Second Part||15
3269650|NCT02654860|4004743|FG002|COMPLETED|Second Part||15
3269651|NCT02654860|4004744|FG003|COMPLETED|Second Part||15
3269652|NCT02654860|4004741|FG000|NOT COMPLETED|Second Part||0
3269653|NCT02654860|4004742|FG001|NOT COMPLETED|Second Part||0
3269654|NCT02654860|4004743|FG002|NOT COMPLETED|Second Part||0
3269655|NCT02654860|4004744|FG003|NOT COMPLETED|Second Part||0
3269656|NCT02654977|4004754|FG000|STARTED|Overall Study||11
3269657|NCT02654977|4004754|FG000|COMPLETED|Overall Study||4
3269658|NCT02654977|4004754|FG000|NOT COMPLETED|Overall Study||7
3269659|NCT02655224|4004760|FG000|STARTED|Overall Study||33
3269660|NCT02655224|4004761|FG001|STARTED|Overall Study||32
3269661|NCT02655224|4004760|FG000|COMPLETED|Overall Study||32
3269662|NCT02655224|4004761|FG001|COMPLETED|Overall Study||31
3269663|NCT02655224|4004760|FG000|NOT COMPLETED|Overall Study||1
3269664|NCT02655224|4004761|FG001|NOT COMPLETED|Overall Study||1
3376643|NCT01298921|4110051|FG001|COMPLETED|Overall Study||0
3376644|NCT01298921|4110050|FG000|NOT COMPLETED|Overall Study||0
3376645|NCT01298921|4110051|FG001|NOT COMPLETED|Overall Study||0
3376646|NCT01292070|4110059|FG000|STARTED|Overall Study||4
3376647|NCT01292070|4110059|FG000|COMPLETED|Overall Study||4
3376648|NCT01292070|4110059|FG000|NOT COMPLETED|Overall Study||0
3376649|NCT01292265|4110063|FG000|STARTED|Overall Study||3
3376650|NCT01292265|4110063|FG000|COMPLETED|Overall Study||3
3376651|NCT01292265|4110063|FG000|NOT COMPLETED|Overall Study||0
3376652|NCT01290822|4110067|FG000|STARTED|Overall Study||12
3376653|NCT01290822|4110067|FG000|COMPLETED|Overall Study||1
3376654|NCT01290822|4110067|FG000|NOT COMPLETED|Overall Study||11
3376655|NCT01290718|4110071|FG000|STARTED|Overall Study||4
3376656|NCT01290718|4110071|FG000|COMPLETED|Overall Study||0
3376657|NCT01290718|4110071|FG000|NOT COMPLETED|Overall Study||4
3376658|NCT01293123|4110077|FG000|STARTED|Overall Study||1
3376659|NCT01293123|4110078|FG001|STARTED|Overall Study||1
3376660|NCT01293123|4110077|FG000|COMPLETED|Overall Study||1
3376661|NCT01293123|4110078|FG001|COMPLETED|Overall Study||0
3376662|NCT01293123|4110077|FG000|NOT COMPLETED|Overall Study||0
3376663|NCT01293123|4110078|FG001|NOT COMPLETED|Overall Study||1
3376664|NCT01294046|4110084|FG000|STARTED|Overall Study||3
3376665|NCT01294046|4110084|FG000|COMPLETED|Overall Study||0
3376666|NCT01294046|4110084|FG000|NOT COMPLETED|Overall Study||3
3376667|NCT01280643|4110100|FG000|STARTED|Overall Study||0
3376668|NCT01280643|4110101|FG001|STARTED|Overall Study||1
3376669|NCT01280643|4110102|FG002|STARTED|Overall Study||1
3376670|NCT01280643|4110103|FG003|STARTED|Overall Study||1
3376671|NCT01280643|4110104|FG004|STARTED|Overall Study||0
3376672|NCT01280643|4110105|FG005|STARTED|Overall Study||0
3376673|NCT01280643|4110106|FG006|STARTED|Overall Study||0
3376674|NCT01280643|4110107|FG007|STARTED|Overall Study||0
3376675|NCT01280643|4110108|FG008|STARTED|Overall Study||0
3376676|NCT01280643|4110100|FG000|COMPLETED|Overall Study||0
3376677|NCT01280643|4110101|FG001|COMPLETED|Overall Study||0
3376678|NCT01280643|4110102|FG002|COMPLETED|Overall Study||1
3376679|NCT01280643|4110103|FG003|COMPLETED|Overall Study||1
3376680|NCT01280643|4110104|FG004|COMPLETED|Overall Study||0
3376681|NCT01280643|4110105|FG005|COMPLETED|Overall Study||0
3269665|NCT02655237|4004769|FG000|STARTED|Overall Study||139
3269666|NCT02655237|4004770|FG001|STARTED|Overall Study||142
3269667|NCT02655237|4004769|FG000|COMPLETED|Overall Study||122
3269668|NCT02655237|4004770|FG001|COMPLETED|Overall Study||131
3269669|NCT02655237|4004769|FG000|NOT COMPLETED|Overall Study||17
3269670|NCT02655237|4004770|FG001|NOT COMPLETED|Overall Study||11
3269671|NCT02655354|4004778|FG000|STARTED|Overall Study||265
3269672|NCT02655354|4004779|FG001|STARTED|Overall Study||370
3269673|NCT02655354|4004778|FG000|COMPLETED|Overall Study||188
3269674|NCT02655354|4004779|FG001|COMPLETED|Overall Study||289
3269675|NCT02655354|4004778|FG000|NOT COMPLETED|Overall Study||77
3269676|NCT02655354|4004779|FG001|NOT COMPLETED|Overall Study||81
3269677|NCT02655419|4004787|FG000|STARTED|Overall Study||17
3269678|NCT02655419|4004788|FG001|STARTED|Overall Study||23
3269679|NCT02655419|4004787|FG000|Treated|Overall Study||16
3269680|NCT02655419|4004788|FG001|Treated|Overall Study||18
3269681|NCT02655419|4004787|FG000|COMPLETED|Overall Study||12
3269682|NCT02655419|4004788|FG001|COMPLETED|Overall Study||16
3269683|NCT02655419|4004787|FG000|NOT COMPLETED|Overall Study||5
3269684|NCT02655419|4004788|FG001|NOT COMPLETED|Overall Study||7
3269685|NCT02655510|4004801|FG000|STARTED|Overall Study||6
3269686|NCT02655510|4004802|FG001|STARTED|Overall Study||6
3269687|NCT02655510|4004803|FG002|STARTED|Overall Study||6
3269688|NCT02655510|4004801|FG000|COMPLETED|Overall Study||6
3269689|NCT02655510|4004802|FG001|COMPLETED|Overall Study||6
3269690|NCT02655510|4004803|FG002|COMPLETED|Overall Study||6
3269691|NCT02655510|4004801|FG000|NOT COMPLETED|Overall Study||0
3376682|NCT01280643|4110106|FG006|COMPLETED|Overall Study||0
3376683|NCT01280643|4110107|FG007|COMPLETED|Overall Study||0
3376684|NCT01280643|4110108|FG008|COMPLETED|Overall Study||0
3376685|NCT01280643|4110100|FG000|NOT COMPLETED|Overall Study||0
3376686|NCT01280643|4110101|FG001|NOT COMPLETED|Overall Study||1
3376687|NCT01280643|4110102|FG002|NOT COMPLETED|Overall Study||0
3376688|NCT01280643|4110103|FG003|NOT COMPLETED|Overall Study||0
3376689|NCT01280643|4110104|FG004|NOT COMPLETED|Overall Study||0
3376690|NCT01280643|4110105|FG005|NOT COMPLETED|Overall Study||0
3376691|NCT01280643|4110106|FG006|NOT COMPLETED|Overall Study||0
3376692|NCT01280643|4110107|FG007|NOT COMPLETED|Overall Study||0
3376693|NCT01280643|4110108|FG008|NOT COMPLETED|Overall Study||0
3376694|NCT01281124|4110128|FG000|STARTED|Overall Study||1
3376695|NCT01281124|4110128|FG000|COMPLETED|Overall Study||0
3376696|NCT01281124|4110128|FG000|NOT COMPLETED|Overall Study||1
3376697|NCT01272141|4110134|FG000|STARTED|Overall Study||5
3376698|NCT01272141|4110134|FG000|COMPLETED|Overall Study||5
3376699|NCT01272141|4110134|FG000|NOT COMPLETED|Overall Study||0
3376700|NCT01282216|4110140|FG000|STARTED|Overall Study||18
3376701|NCT01282216|4110141|FG001|STARTED|Overall Study||26
3269692|NCT02655510|4004802|FG001|NOT COMPLETED|Overall Study||0
3269693|NCT02655510|4004803|FG002|NOT COMPLETED|Overall Study||0
3269694|NCT02655653|4004813|FG000|STARTED|Overall Study||56
3269695|NCT02655653|4004814|FG001|STARTED|Overall Study||58
3269696|NCT02655653|4004813|FG000|COMPLETED|Overall Study||56
3269697|NCT02655653|4004814|FG001|COMPLETED|Overall Study||58
3269698|NCT02655653|4004813|FG000|NOT COMPLETED|Overall Study||0
3269699|NCT02655653|4004814|FG001|NOT COMPLETED|Overall Study||0
3269700|NCT02655666|4004826|FG000|STARTED|Overall Study||16
3269701|NCT02655666|4004826|FG000|COMPLETED|Overall Study||4
3269702|NCT02655666|4004826|FG000|NOT COMPLETED|Overall Study||12
3269703|NCT02655679|4004835|FG000|STARTED|Overall Study||21
3269704|NCT02655679|4004836|FG001|STARTED|Overall Study||19
3269705|NCT02655679|4004837|FG002|STARTED|Overall Study||20
3269706|NCT02655679|4004838|FG003|STARTED|Overall Study||24
3269707|NCT02655679|4004839|FG004|STARTED|Overall Study||20
3269708|NCT02655679|4004835|FG000|Received Study Drug (Safety Population)|Overall Study||20
3269709|NCT02655679|4004836|FG001|Received Study Drug (Safety Population)|Overall Study||19
3269710|NCT02655679|4004837|FG002|Received Study Drug (Safety Population)|Overall Study||20
3269711|NCT02655679|4004838|FG003|Received Study Drug (Safety Population)|Overall Study||24
3269712|NCT02655679|4004839|FG004|Received Study Drug (Safety Population)|Overall Study||20
3269713|NCT02655679|4004835|FG000|COMPLETED|Overall Study||18
3269714|NCT02655679|4004836|FG001|COMPLETED|Overall Study||16
3269715|NCT02655679|4004837|FG002|COMPLETED|Overall Study||19
3269716|NCT02655679|4004838|FG003|COMPLETED|Overall Study||20
3269717|NCT02655679|4004839|FG004|COMPLETED|Overall Study||19
3269718|NCT02655679|4004835|FG000|NOT COMPLETED|Overall Study||3
3269719|NCT02655679|4004836|FG001|NOT COMPLETED|Overall Study||3
3269720|NCT02655679|4004837|FG002|NOT COMPLETED|Overall Study||1
3269721|NCT02655679|4004838|FG003|NOT COMPLETED|Overall Study||4
3269722|NCT02655679|4004839|FG004|NOT COMPLETED|Overall Study||1
3269723|NCT02655887|4004852|FG000|STARTED|Overall Study|Intent to Treat (ITT) population.|170
3269724|NCT02655887|4004852|FG000|COMPLETED|Overall Study|Completed 12-month follow-up.|156
3269725|NCT02655887|4004852|FG000|NOT COMPLETED|Overall Study||14
3269726|NCT02656069|4004858|FG000|STARTED|First Intervention||44
3269727|NCT02656069|4004859|FG001|STARTED|First Intervention||36
3269728|NCT02656069|4004858|FG000|COMPLETED|First Intervention||44
3269729|NCT02656069|4004859|FG001|COMPLETED|First Intervention||36
3269730|NCT02656069|4004858|FG000|NOT COMPLETED|First Intervention||0
3376702|NCT01282216|4110142|FG002|STARTED|Overall Study||52
3269731|NCT02656069|4004859|FG001|NOT COMPLETED|First Intervention||0
3269732|NCT02656069|4004858|FG000|STARTED|Second Intervention||44
3269733|NCT02656069|4004859|FG001|STARTED|Second Intervention||36
3269734|NCT02656069|4004858|FG000|COMPLETED|Second Intervention||43
3269735|NCT02656069|4004859|FG001|COMPLETED|Second Intervention||35
3269736|NCT02656069|4004858|FG000|NOT COMPLETED|Second Intervention||1
3269737|NCT02656069|4004859|FG001|NOT COMPLETED|Second Intervention||1
3269738|NCT02656160|4004865|FG000|STARTED|First Study Night||7
3269739|NCT02656160|4004866|FG001|STARTED|First Study Night||6
3269740|NCT02656160|4004865|FG000|COMPLETED|First Study Night||7
3269741|NCT02656160|4004866|FG001|COMPLETED|First Study Night||6
3269742|NCT02656160|4004865|FG000|NOT COMPLETED|First Study Night||0
3269743|NCT02656160|4004866|FG001|NOT COMPLETED|First Study Night||0
3269744|NCT02656160|4004865|FG000|STARTED|Second Study Night|3 subjects did not return for the second study night|4
3269745|NCT02656160|4004866|FG001|STARTED|Second Study Night||6
3269746|NCT02656160|4004865|FG000|COMPLETED|Second Study Night||4
3269747|NCT02656160|4004866|FG001|COMPLETED|Second Study Night||6
3269748|NCT02656160|4004865|FG000|NOT COMPLETED|Second Study Night||0
3269749|NCT02656160|4004866|FG001|NOT COMPLETED|Second Study Night||0
3269750|NCT02656173|4004874|FG000|STARTED|Overall Study||285
3269751|NCT02656173|4004875|FG001|STARTED|Overall Study||283
3269752|NCT02656173|4004874|FG000|Received Treatment|Overall Study||284
3269753|NCT02656173|4004875|FG001|Received Treatment|Overall Study||282
3269754|NCT02656173|4004874|FG000|COMPLETED|Overall Study||272
3269755|NCT02656173|4004875|FG001|COMPLETED|Overall Study||272
3269756|NCT02656173|4004874|FG000|NOT COMPLETED|Overall Study||13
3269757|NCT02656173|4004875|FG001|NOT COMPLETED|Overall Study||11
3269758|NCT02656290|4004883|FG000|STARTED|Overall Study||26
3269759|NCT02656290|4004883|FG000|1 Year|Overall Study|One subject missed the 1 year follow-up visit.|25
3376703|NCT01282216|4110143|FG003|STARTED|Overall Study||8
3376704|NCT01282216|4110140|FG000|COMPLETED|Overall Study||18
3376705|NCT01282216|4110141|FG001|COMPLETED|Overall Study||26
3376706|NCT01282216|4110142|FG002|COMPLETED|Overall Study||19
3376707|NCT01282216|4110143|FG003|COMPLETED|Overall Study||0
3376708|NCT01282216|4110140|FG000|NOT COMPLETED|Overall Study||0
3376709|NCT01282216|4110141|FG001|NOT COMPLETED|Overall Study||0
3376710|NCT01282216|4110142|FG002|NOT COMPLETED|Overall Study||33
3376711|NCT01282216|4110143|FG003|NOT COMPLETED|Overall Study||8
3376712|NCT01284491|4110149|FG000|STARTED|Overall Study||13
3376713|NCT01284491|4110149|FG000|COMPLETED|Overall Study||0
3376714|NCT01284491|4110149|FG000|NOT COMPLETED|Overall Study||13
3376715|NCT01284504|4110157|FG000|STARTED|Overall Study||0
3376716|NCT01284504|4110158|FG001|STARTED|Overall Study||0
3376717|NCT01284504|4110157|FG000|COMPLETED|Overall Study||0
3376718|NCT01284504|4110158|FG001|COMPLETED|Overall Study||0
3376719|NCT01284504|4110157|FG000|NOT COMPLETED|Overall Study||0
3376720|NCT01284504|4110158|FG001|NOT COMPLETED|Overall Study||0
3376721|NCT01269034|4110168|FG000|STARTED|Overall Study||1
3376722|NCT01269034|4110169|FG001|STARTED|Overall Study||2
3376723|NCT01269034|4110170|FG002|STARTED|Overall Study||1
3376724|NCT01269034|4110171|FG003|STARTED|Overall Study||9
3376725|NCT01269034|4110168|FG000|COMPLETED|Overall Study||0
3376726|NCT01269034|4110169|FG001|COMPLETED|Overall Study||2
3376727|NCT01269034|4110170|FG002|COMPLETED|Overall Study||1
3376728|NCT01269034|4110171|FG003|COMPLETED|Overall Study||9
3376729|NCT01269034|4110168|FG000|NOT COMPLETED|Overall Study||1
3376730|NCT01269034|4110169|FG001|NOT COMPLETED|Overall Study||0
3376731|NCT01269034|4110170|FG002|NOT COMPLETED|Overall Study||0
3376732|NCT01269034|4110171|FG003|NOT COMPLETED|Overall Study||0
3376733|NCT01274533|4110181|FG000|STARTED|Overall Study||4
3376734|NCT01274533|4110181|FG000|COMPLETED|Overall Study||0
3376735|NCT01274533|4110181|FG000|NOT COMPLETED|Overall Study||4
3376736|NCT01279616|4110185|FG000|STARTED|Overall Study||8
3376737|NCT01279616|4110185|FG000|COMPLETED|Overall Study||1
3376738|NCT01279616|4110185|FG000|NOT COMPLETED|Overall Study||7
3376739|NCT01276054|4110191|FG000|STARTED|Overall Study||2
3376740|NCT01276054|4110192|FG001|STARTED|Overall Study||2
3376741|NCT01276054|4110191|FG000|COMPLETED|Overall Study||0
3376742|NCT01276054|4110192|FG001|COMPLETED|Overall Study||0
3376743|NCT01276054|4110191|FG000|NOT COMPLETED|Overall Study||2
3376744|NCT01276054|4110192|FG001|NOT COMPLETED|Overall Study||2
3376745|NCT01264965|4110198|FG000|STARTED|Overall Study||25
3376746|NCT01264965|4110198|FG000|COMPLETED|Overall Study||15
3376747|NCT01264965|4110198|FG000|NOT COMPLETED|Overall Study||10
3269760|NCT02656290|4004883|FG000|2 Year|Overall Study||17
3269761|NCT02656290|4004883|FG000|3 Year|Overall Study||6
3269762|NCT02656290|4004883|FG000|COMPLETED|Overall Study||0
3269763|NCT02656290|4004883|FG000|NOT COMPLETED|Overall Study||26
3269764|NCT02656329|4004889|FG000|STARTED|Overall Study||164
3269765|NCT02656329|4004890|FG001|STARTED|Overall Study||157
3269766|NCT02656329|4004889|FG000|COMPLETED|Overall Study||0
3269767|NCT02656329|4004890|FG001|COMPLETED|Overall Study||0
3269768|NCT02656329|4004889|FG000|NOT COMPLETED|Overall Study||164
3269769|NCT02656329|4004890|FG001|NOT COMPLETED|Overall Study||157
3269770|NCT02656420|4004901|FG000|STARTED|Overall Study||55
3269771|NCT02656420|4004902|FG001|STARTED|Overall Study||25
3269772|NCT02656420|4004903|FG002|STARTED|Overall Study||35
3269773|NCT02656420|4004904|FG003|STARTED|Overall Study||55
3269774|NCT02656420|4004901|FG000|COMPLETED|Overall Study||55
3269775|NCT02656420|4004902|FG001|COMPLETED|Overall Study||24
3269776|NCT02656420|4004903|FG002|COMPLETED|Overall Study||35
3269777|NCT02656420|4004904|FG003|COMPLETED|Overall Study||55
3269778|NCT02656420|4004901|FG000|NOT COMPLETED|Overall Study||0
3269779|NCT02656420|4004902|FG001|NOT COMPLETED|Overall Study||1
3269780|NCT02656420|4004903|FG002|NOT COMPLETED|Overall Study||0
3269781|NCT02656420|4004904|FG003|NOT COMPLETED|Overall Study||0
3269782|NCT02656485|4004920|FG000|STARTED|Overall Study||9
3269783|NCT02656485|4004921|FG001|STARTED|Overall Study||9
3269784|NCT02656485|4004922|FG002|STARTED|Overall Study||9
3269785|NCT02656485|4004923|FG003|STARTED|Overall Study||9
3269786|NCT02656485|4004920|FG000|COMPLETED|Overall Study||7
3269787|NCT02656485|4004921|FG001|COMPLETED|Overall Study||6
3269788|NCT02656485|4004922|FG002|COMPLETED|Overall Study||7
3269789|NCT02656485|4004923|FG003|COMPLETED|Overall Study||7
3269790|NCT02656485|4004920|FG000|NOT COMPLETED|Overall Study||2
3269791|NCT02656485|4004921|FG001|NOT COMPLETED|Overall Study||3
3269792|NCT02656485|4004922|FG002|NOT COMPLETED|Overall Study||2
3269793|NCT02656485|4004923|FG003|NOT COMPLETED|Overall Study||2
3269794|NCT02656680|4004937|FG000|STARTED|Overall Study||40
3269795|NCT02656680|4004938|FG001|STARTED|Overall Study||40
3269796|NCT02656680|4004937|FG000|COMPLETED|Overall Study||40
3269797|NCT02656680|4004938|FG001|COMPLETED|Overall Study||39
3269798|NCT02656680|4004937|FG000|NOT COMPLETED|Overall Study||0
3269799|NCT02656680|4004938|FG001|NOT COMPLETED|Overall Study||1
3269800|NCT02656693|4004949|FG000|STARTED|Overall Study||326
3269801|NCT02656693|4004950|FG001|STARTED|Overall Study||216
3269802|NCT02656693|4004951|FG002|STARTED|Overall Study||298
3269803|NCT02656693|4004949|FG000|COMPLETED|Overall Study||325
3269804|NCT02656693|4004950|FG001|COMPLETED|Overall Study||214
3269805|NCT02656693|4004951|FG002|COMPLETED|Overall Study||295
3376748|NCT01266824|4110204|FG000|STARTED|Overall Study||2
3376749|NCT01266824|4110205|FG001|STARTED|Overall Study||3
3376750|NCT01266824|4110204|FG000|COMPLETED|Overall Study||0
3376751|NCT01266824|4110205|FG001|COMPLETED|Overall Study||0
3376752|NCT01266824|4110204|FG000|NOT COMPLETED|Overall Study||2
3376753|NCT01266824|4110205|FG001|NOT COMPLETED|Overall Study||3
3376754|NCT01264835|4110211|FG000|STARTED|Overall Study||2
3376755|NCT01264835|4110211|FG000|COMPLETED|Overall Study||1
3376756|NCT01264835|4110211|FG000|NOT COMPLETED|Overall Study||1
3376757|NCT01274429|4110215|FG000|STARTED|Overall Study||5
3376758|NCT01274429|4110215|FG000|COMPLETED|Overall Study||0
3376759|NCT01274429|4110215|FG000|NOT COMPLETED|Overall Study||5
3376760|NCT01273064|4110224|FG000|STARTED|Overall Study||23
3376761|NCT01273064|4110225|FG001|STARTED|Overall Study||30
3376762|NCT01273064|4110226|FG002|STARTED|Overall Study||31
3376763|NCT01273064|4110227|FG003|STARTED|Overall Study||20
3376764|NCT01273064|4110228|FG004|STARTED|Overall Study|Began study on the placebo arm, and crossed over to CTS-1027 15 mg at Wk 12 due to lack of response|10
3376765|NCT01273064|4110224|FG000|COMPLETED|Overall Study||0
3376766|NCT01273064|4110225|FG001|COMPLETED|Overall Study||0
3376767|NCT01273064|4110226|FG002|COMPLETED|Overall Study||0
3269806|NCT02656693|4004949|FG000|NOT COMPLETED|Overall Study||1
3269807|NCT02656693|4004950|FG001|NOT COMPLETED|Overall Study||2
3269808|NCT02656693|4004951|FG002|NOT COMPLETED|Overall Study||3
3269809|NCT02656745|4004959|FG000|STARTED|Overall Study||416
3376768|NCT01273064|4110227|FG003|COMPLETED|Overall Study||0
3376769|NCT01273064|4110228|FG004|COMPLETED|Overall Study||0
3269810|NCT02656745|4004959|FG000|COMPLETED|Overall Study||416
3269811|NCT02656745|4004959|FG000|NOT COMPLETED|Overall Study||0
3269812|NCT02656836|4004966|FG000|STARTED|Overall Study||9
3269813|NCT02656836|4004966|FG000|COMPLETED|Overall Study||6
3269814|NCT02656836|4004966|FG000|NOT COMPLETED|Overall Study||3
3269815|NCT02656875|4004970|FG000|STARTED|Overall Study||768
3269816|NCT02656875|4004970|FG000|COMPLETED|Overall Study||698
3269817|NCT02656875|4004970|FG000|NOT COMPLETED|Overall Study||70
3269818|NCT02657031|4004976|FG000|STARTED|Overall Study||29
3269819|NCT02657031|4004977|FG001|STARTED|Overall Study||25
3269820|NCT02657031|4004976|FG000|COMPLETED|Overall Study||28
3269821|NCT02657031|4004977|FG001|COMPLETED|Overall Study||23
3269822|NCT02657031|4004976|FG000|NOT COMPLETED|Overall Study||1
3269823|NCT02657031|4004977|FG001|NOT COMPLETED|Overall Study||2
3269824|NCT02657226|4004983|FG000|STARTED|Overall Study||15724
3269825|NCT02657226|4004983|FG000|COMPLETED|Overall Study||15724
3269826|NCT02657226|4004983|FG000|NOT COMPLETED|Overall Study||0
3269827|NCT02657252|4004992|FG000|STARTED|Overall Study||57
3269828|NCT02657252|4004993|FG001|STARTED|Overall Study||58
3269829|NCT02657252|4004992|FG000|COMPLETED|Overall Study||47
3269830|NCT02657252|4004993|FG001|COMPLETED|Overall Study||51
3269831|NCT02657252|4004992|FG000|NOT COMPLETED|Overall Study||10
3269832|NCT02657252|4004993|FG001|NOT COMPLETED|Overall Study||7
3269833|NCT02657369|4004999|FG000|STARTED|Overall Study||34
3269834|NCT02657369|4004999|FG000|COMPLETED|Overall Study||0
3269835|NCT02657369|4004999|FG000|NOT COMPLETED|Overall Study||34
3269836|NCT02657408|4005005|FG000|STARTED|Overall Study||28
3269837|NCT02657408|4005006|FG001|STARTED|Overall Study||29
3269838|NCT02657408|4005005|FG000|COMPLETED|Overall Study||25
3269839|NCT02657408|4005006|FG001|COMPLETED|Overall Study||22
3269840|NCT02657408|4005005|FG000|NOT COMPLETED|Overall Study||3
3269841|NCT02657408|4005006|FG001|NOT COMPLETED|Overall Study||7
3269842|NCT02657538|4005012|FG000|STARTED|Overall Study||35
3269843|NCT02657538|4005012|FG000|Received Near Infrared Transillumination|Overall Study||35
3269844|NCT02657538|4005012|FG000|Received Visual Caries Detection + Bite|Overall Study||35
3269845|NCT02657538|4005012|FG000|COMPLETED|Overall Study||31
3269846|NCT02657538|4005012|FG000|NOT COMPLETED|Overall Study||4
3269847|NCT02657564|4005019|FG000|STARTED|Overall Study||1237
3269848|NCT02657564|4005019|FG000|COMPLETED|Overall Study||1163
3269849|NCT02657564|4005019|FG000|NOT COMPLETED|Overall Study||74
3269850|NCT02657629|4005026|FG000|STARTED|Overall Study||14
3269851|NCT02657629|4005027|FG001|STARTED|Overall Study||14
3269852|NCT02657629|4005026|FG000|COMPLETED|Overall Study||12
3269853|NCT02657629|4005027|FG001|COMPLETED|Overall Study||14
3269854|NCT02657629|4005026|FG000|NOT COMPLETED|Overall Study||2
3269855|NCT02657629|4005027|FG001|NOT COMPLETED|Overall Study||0
3269856|NCT02657889|4005037|FG000|STARTED|Overall Study||7
3269857|NCT02657889|4005038|FG001|STARTED|Overall Study||7
3269858|NCT02657889|4005039|FG002|STARTED|Overall Study||53
3269859|NCT02657889|4005040|FG003|STARTED|Overall Study||55
3269860|NCT02657889|4005037|FG000|COMPLETED|Overall Study||0
3269861|NCT02657889|4005038|FG001|COMPLETED|Overall Study||0
3269862|NCT02657889|4005039|FG002|COMPLETED|Overall Study||0
3269863|NCT02657889|4005040|FG003|COMPLETED|Overall Study||0
3269864|NCT02657889|4005037|FG000|NOT COMPLETED|Overall Study||7
3269865|NCT02657889|4005038|FG001|NOT COMPLETED|Overall Study||7
3269866|NCT02657889|4005039|FG002|NOT COMPLETED|Overall Study||53
3269867|NCT02657889|4005040|FG003|NOT COMPLETED|Overall Study||55
3269868|NCT02657915|4005054|FG000|STARTED|Overall Study||24
3269869|NCT02657915|4005055|FG001|STARTED|Overall Study||28
3269870|NCT02657915|4005054|FG000|Intent-to Treat (ITT) Population|Overall Study||24
3269871|NCT02657915|4005055|FG001|Intent-to Treat (ITT) Population|Overall Study||28
3269872|NCT02657915|4005054|FG000|Per-protocol Population|Overall Study||23
3269873|NCT02657915|4005055|FG001|Per-protocol Population|Overall Study||24
3269874|NCT02657915|4005054|FG000|COMPLETED|Overall Study||24
3269875|NCT02657915|4005055|FG001|COMPLETED|Overall Study||28
3269876|NCT02657915|4005054|FG000|NOT COMPLETED|Overall Study||0
3269877|NCT02657915|4005055|FG001|NOT COMPLETED|Overall Study||0
3269878|NCT02657928|4005063|FG000|STARTED|Overall Study||20
3269879|NCT02657928|4005064|FG001|STARTED|Overall Study||20
3269880|NCT02657928|4005063|FG000|COMPLETED|Overall Study||20
3269881|NCT02657928|4005064|FG001|COMPLETED|Overall Study||20
3269882|NCT02657928|4005063|FG000|NOT COMPLETED|Overall Study||0
3269883|NCT02657928|4005064|FG001|NOT COMPLETED|Overall Study||0
3269884|NCT02658019|4005071|FG000|STARTED|Overall Study||29
3269885|NCT02658019|4005071|FG000|COMPLETED|Overall Study||28
3269886|NCT02658019|4005071|FG000|NOT COMPLETED|Overall Study||1
3269887|NCT02658084|4005077|FG000|STARTED|Overall Study||2
3269888|NCT02658084|4005078|FG001|STARTED|Overall Study||0
3269889|NCT02658084|4005077|FG000|COMPLETED|Overall Study||0
3269890|NCT02658084|4005078|FG001|COMPLETED|Overall Study||0
3269891|NCT02658084|4005077|FG000|NOT COMPLETED|Overall Study||2
3269892|NCT02658084|4005078|FG001|NOT COMPLETED|Overall Study||0
3269893|NCT02658149|4005085|FG000|STARTED|Overall Study||50
3269894|NCT02658149|4005086|FG001|STARTED|Overall Study||50
3269895|NCT02658149|4005085|FG000|COMPLETED|Overall Study||49
3269896|NCT02658149|4005086|FG001|COMPLETED|Overall Study||50
3269897|NCT02658149|4005085|FG000|NOT COMPLETED|Overall Study||1
3269898|NCT02658149|4005086|FG001|NOT COMPLETED|Overall Study||0
3269899|NCT02658175|4005095|FG000|STARTED|Treatment Period: Weeks 1 to 52||51
3269900|NCT02658175|4005096|FG001|STARTED|Treatment Period: Weeks 1 to 52||14
3269901|NCT02658175|4005097|FG002|STARTED|Treatment Period: Weeks 1 to 52||3
3269902|NCT02658175|4005095|FG000|COMPLETED|Treatment Period: Weeks 1 to 52||36
3269903|NCT02658175|4005096|FG001|COMPLETED|Treatment Period: Weeks 1 to 52||7
3269904|NCT02658175|4005097|FG002|COMPLETED|Treatment Period: Weeks 1 to 52||3
3269905|NCT02658175|4005095|FG000|NOT COMPLETED|Treatment Period: Weeks 1 to 52||15
3269906|NCT02658175|4005096|FG001|NOT COMPLETED|Treatment Period: Weeks 1 to 52||7
3269907|NCT02658175|4005097|FG002|NOT COMPLETED|Treatment Period: Weeks 1 to 52||0
3269908|NCT02658175|4005095|FG000|STARTED|1st Extended Treatment: Weeks 53 to 104||36
3269909|NCT02658175|4005096|FG001|STARTED|1st Extended Treatment: Weeks 53 to 104||7
3269910|NCT02658175|4005097|FG002|STARTED|1st Extended Treatment: Weeks 53 to 104||3
3269911|NCT02658175|4005095|FG000|COMPLETED|1st Extended Treatment: Weeks 53 to 104||15
3269912|NCT02658175|4005096|FG001|COMPLETED|1st Extended Treatment: Weeks 53 to 104||5
3269913|NCT02658175|4005097|FG002|COMPLETED|1st Extended Treatment: Weeks 53 to 104||1
3269914|NCT02658175|4005095|FG000|NOT COMPLETED|1st Extended Treatment: Weeks 53 to 104||21
3269915|NCT02658175|4005096|FG001|NOT COMPLETED|1st Extended Treatment: Weeks 53 to 104||2
3376770|NCT01273064|4110224|FG000|NOT COMPLETED|Overall Study||23
3376771|NCT01273064|4110225|FG001|NOT COMPLETED|Overall Study||30
3376772|NCT01273064|4110226|FG002|NOT COMPLETED|Overall Study||31
3376773|NCT01273064|4110227|FG003|NOT COMPLETED|Overall Study||20
3376774|NCT01273064|4110228|FG004|NOT COMPLETED|Overall Study||10
3376775|NCT01274559|4110242|FG000|STARTED|Overall Study||587
3376776|NCT01274559|4110243|FG001|STARTED|Overall Study||586
3376777|NCT01274559|4110242|FG000|Treated|Overall Study||572
3376778|NCT01274559|4110243|FG001|Treated|Overall Study||572
3376779|NCT01274559|4110242|FG000|COMPLETED|Overall Study||390
3376780|NCT01274559|4110243|FG001|COMPLETED|Overall Study||441
3376781|NCT01274559|4110242|FG000|NOT COMPLETED|Overall Study||197
3376782|NCT01274559|4110243|FG001|NOT COMPLETED|Overall Study||145
3376783|NCT01270581|4110251|FG000|STARTED|Overall Study||4
3376784|NCT01270581|4110252|FG001|STARTED|Overall Study||3
3376785|NCT01270581|4110251|FG000|COMPLETED|Overall Study||3
3376786|NCT01270581|4110252|FG001|COMPLETED|Overall Study||3
3376787|NCT01270581|4110251|FG000|NOT COMPLETED|Overall Study||1
3376788|NCT01270581|4110252|FG001|NOT COMPLETED|Overall Study||0
3376789|NCT01269749|4110260|FG000|STARTED|Overall Study||16
3376790|NCT01269749|4110261|FG001|STARTED|Overall Study||3
3376791|NCT01269749|4110260|FG000|COMPLETED|Overall Study||16
3376792|NCT01269749|4110261|FG001|COMPLETED|Overall Study||3
3376793|NCT01269749|4110260|FG000|NOT COMPLETED|Overall Study||0
3376794|NCT01269749|4110261|FG001|NOT COMPLETED|Overall Study||0
3376795|NCT01270919|4110267|FG000|STARTED|Overall Study|One participant was enrolled but was censored.|0
3376796|NCT01270919|4110267|FG000|COMPLETED|Overall Study||0
3376797|NCT01270919|4110267|FG000|NOT COMPLETED|Overall Study||0
3376798|NCT01262339|4110271|FG000|STARTED|Overall Study||2
3376799|NCT01262339|4110271|FG000|COMPLETED|Overall Study||2
3376800|NCT01262339|4110271|FG000|NOT COMPLETED|Overall Study||0
3376801|NCT01267825|4110277|FG000|STARTED|Overall Study||1
3376802|NCT01267825|4110278|FG001|STARTED|Overall Study||0
3376803|NCT01267825|4110277|FG000|COMPLETED|Overall Study||0
3376804|NCT01267825|4110278|FG001|COMPLETED|Overall Study||0
3376805|NCT01267825|4110277|FG000|NOT COMPLETED|Overall Study||1
3376806|NCT01267825|4110278|FG001|NOT COMPLETED|Overall Study||0
3376807|NCT01264679|4110284|FG000|STARTED|Overall Study||8
3376808|NCT01264679|4110284|FG000|Received at Least 1 Dose of Study Drug|Overall Study||7
3376809|NCT01264679|4110284|FG000|COMPLETED|Overall Study||3
3376810|NCT01264679|4110284|FG000|NOT COMPLETED|Overall Study||5
3376811|NCT01259284|4110292|FG000|STARTED|Overall Study||2
3376812|NCT01259284|4110293|FG001|STARTED|Overall Study||0
3376813|NCT01259284|4110294|FG002|STARTED|Overall Study||0
3376814|NCT01259284|4110292|FG000|COMPLETED|Overall Study||0
3376815|NCT01259284|4110293|FG001|COMPLETED|Overall Study||0
3376816|NCT01259284|4110294|FG002|COMPLETED|Overall Study||0
3376817|NCT01259284|4110292|FG000|NOT COMPLETED|Overall Study||2
3376818|NCT01259284|4110293|FG001|NOT COMPLETED|Overall Study||0
3376819|NCT01259284|4110294|FG002|NOT COMPLETED|Overall Study||0
3376820|NCT01249157|4110302|FG000|STARTED|Overall Study||1
3376821|NCT01249157|4110302|FG000|COMPLETED|Overall Study|No data displayed because Outcome Measure has zero total participants analyzed.|0
3376822|NCT01249157|4110302|FG000|NOT COMPLETED|Overall Study||1
3376823|NCT01263028|4110306|FG000|STARTED|Overall Study||6
3376824|NCT01263028|4110306|FG000|COMPLETED|Overall Study||0
3376825|NCT01263028|4110306|FG000|NOT COMPLETED|Overall Study||6
3376826|NCT01256281|4110310|FG000|STARTED|Overall Study||2
3376827|NCT01256281|4110310|FG000|COMPLETED|Overall Study||2
3376828|NCT01256281|4110310|FG000|NOT COMPLETED|Overall Study||0
3376829|NCT01253668|4110314|FG000|STARTED|Overall Study||0
3376830|NCT01253668|4110314|FG000|COMPLETED|Overall Study||0
3376831|NCT01253668|4110314|FG000|NOT COMPLETED|Overall Study||0
3376832|NCT01259024|4110318|FG000|STARTED|Overall Study||1
3376833|NCT01259024|4110318|FG000|COMPLETED|Overall Study||0
3376834|NCT01259024|4110318|FG000|NOT COMPLETED|Overall Study||1
3376835|NCT01251952|4110322|FG000|STARTED|Overall Study||2
3376836|NCT01251952|4110322|FG000|COMPLETED|Overall Study||1
3376837|NCT01251952|4110322|FG000|NOT COMPLETED|Overall Study||1
3376838|NCT01251120|4110328|FG000|STARTED|Overall Study||1
3376839|NCT01251120|4110329|FG001|STARTED|Overall Study||1
3376840|NCT01251120|4110328|FG000|COMPLETED|Overall Study||1
3376841|NCT01251120|4110329|FG001|COMPLETED|Overall Study||0
3376842|NCT01251120|4110328|FG000|NOT COMPLETED|Overall Study||0
3376843|NCT01251120|4110329|FG001|NOT COMPLETED|Overall Study||1
3269916|NCT02658175|4005097|FG002|NOT COMPLETED|1st Extended Treatment: Weeks 53 to 104||2
3269917|NCT02658175|4005095|FG000|STARTED|2nd Extended Treatment: Weeks 105 to156||1
3269918|NCT02658175|4005096|FG001|STARTED|2nd Extended Treatment: Weeks 105 to156||0
3269919|NCT02658175|4005097|FG002|STARTED|2nd Extended Treatment: Weeks 105 to156||1
3269920|NCT02658175|4005095|FG000|COMPLETED|2nd Extended Treatment: Weeks 105 to156||0
3269921|NCT02658175|4005096|FG001|COMPLETED|2nd Extended Treatment: Weeks 105 to156||0
3269922|NCT02658175|4005097|FG002|COMPLETED|2nd Extended Treatment: Weeks 105 to156||0
3269923|NCT02658175|4005095|FG000|NOT COMPLETED|2nd Extended Treatment: Weeks 105 to156||1
3269924|NCT02658175|4005096|FG001|NOT COMPLETED|2nd Extended Treatment: Weeks 105 to156||0
3269925|NCT02658175|4005097|FG002|NOT COMPLETED|2nd Extended Treatment: Weeks 105 to156||1
3269926|NCT02658240|4005107|FG000|STARTED|Overall Study||30
3269927|NCT02658240|4005108|FG001|STARTED|Overall Study||30
3269928|NCT02658240|4005107|FG000|COMPLETED|Overall Study||30
3269929|NCT02658240|4005108|FG001|COMPLETED|Overall Study||30
3269930|NCT02658240|4005107|FG000|NOT COMPLETED|Overall Study||0
3269931|NCT02658240|4005108|FG001|NOT COMPLETED|Overall Study||0
3269932|NCT02658448|4005114|FG000|STARTED|Overall Study||19
3269933|NCT02658448|4005114|FG000|COMPLETED|Overall Study|One patient was lost to follow-up after enrollment and prior to visit 1|18
3269934|NCT02658448|4005114|FG000|NOT COMPLETED|Overall Study||1
3269935|NCT02658461|4005121|FG000|STARTED|Overall Study|The enrollment reflects episodes of care and not number of actual participants.|12
3269936|NCT02658461|4005122|FG001|STARTED|Overall Study|The enrollment reflects episodes of care and not number of actual participants.|12
3269937|NCT02658461|4005123|FG002|STARTED|Overall Study|The enrollment reflects episodes of care and not number of actual participants.|12
3269938|NCT02658461|4005121|FG000|COMPLETED|Overall Study||12
3269939|NCT02658461|4005122|FG001|COMPLETED|Overall Study||12
3269940|NCT02658461|4005123|FG002|COMPLETED|Overall Study||12
3269941|NCT02658461|4005121|FG000|NOT COMPLETED|Overall Study||0
3269942|NCT02658461|4005122|FG001|NOT COMPLETED|Overall Study||0
3269943|NCT02658461|4005123|FG002|NOT COMPLETED|Overall Study||0
3269944|NCT02658487|4005133|FG000|STARTED|Overall Study||42
3269945|NCT02658487|4005133|FG000|COMPLETED|Overall Study||26
3269946|NCT02658487|4005133|FG000|NOT COMPLETED|Overall Study||16
3269947|NCT02658630|4005138|FG000|STARTED|Overall Study||46
3269948|NCT02658630|4005138|FG000|COMPLETED|Overall Study||42
3269949|NCT02658630|4005138|FG000|NOT COMPLETED|Overall Study||4
3269950|NCT02658734|4005142|FG000|STARTED|Overall Study||70
3269951|NCT02658734|4005142|FG000|COMPLETED|Overall Study||13
3269952|NCT02658734|4005142|FG000|NOT COMPLETED|Overall Study||57
3269953|NCT02658851|4005146|FG000|STARTED|Overall Study||100
3269954|NCT02658851|4005146|FG000|COMPLETED|Overall Study||100
3269955|NCT02658851|4005146|FG000|NOT COMPLETED|Overall Study||0
3269956|NCT02658994|4005153|FG000|STARTED|Enrollment||287
3269957|NCT02658994|4005154|FG001|STARTED|Enrollment||283
3269958|NCT02658994|4005155|FG002|STARTED|Enrollment||584
3269959|NCT02658994|4005153|FG000|COMPLETED|Enrollment||287
3269960|NCT02658994|4005154|FG001|COMPLETED|Enrollment||283
3269961|NCT02658994|4005155|FG002|COMPLETED|Enrollment||584
3269962|NCT02658994|4005153|FG000|NOT COMPLETED|Enrollment||0
3269963|NCT02658994|4005154|FG001|NOT COMPLETED|Enrollment||0
3269964|NCT02658994|4005155|FG002|NOT COMPLETED|Enrollment||0
3269965|NCT02658994|4005153|FG000|STARTED|3 Month Follow up||287
3269966|NCT02658994|4005154|FG001|STARTED|3 Month Follow up||283
3269967|NCT02658994|4005155|FG002|STARTED|3 Month Follow up||584
3269968|NCT02658994|4005153|FG000|COMPLETED|3 Month Follow up||221
3269969|NCT02658994|4005154|FG001|COMPLETED|3 Month Follow up||223
3269970|NCT02658994|4005155|FG002|COMPLETED|3 Month Follow up||451
3269971|NCT02658994|4005153|FG000|NOT COMPLETED|3 Month Follow up||66
3269972|NCT02658994|4005154|FG001|NOT COMPLETED|3 Month Follow up||60
3269973|NCT02658994|4005155|FG002|NOT COMPLETED|3 Month Follow up||133
3269974|NCT02658994|4005153|FG000|STARTED|6 Month Follow up|Participants who did not complete 3 month follow up were still eligible for 6 month follow up|287
3269975|NCT02658994|4005154|FG001|STARTED|6 Month Follow up|Participants who did not complete 3 month follow up were still eligible for 6 month follow up|283
3269976|NCT02658994|4005155|FG002|STARTED|6 Month Follow up|Participants who did not complete 3 month follow up were still eligible for 6 month follow up|584
3269977|NCT02658994|4005153|FG000|COMPLETED|6 Month Follow up||228
3269978|NCT02658994|4005154|FG001|COMPLETED|6 Month Follow up||230
3269979|NCT02658994|4005155|FG002|COMPLETED|6 Month Follow up||471
3269980|NCT02658994|4005153|FG000|NOT COMPLETED|6 Month Follow up||59
3269981|NCT02658994|4005154|FG001|NOT COMPLETED|6 Month Follow up||53
3269982|NCT02658994|4005155|FG002|NOT COMPLETED|6 Month Follow up||113
3269983|NCT02658994|4005153|FG000|STARTED|12 Month Follow up|Participants who did not complete 6 month follow up were still eligible for 12 month follow up|287
3269984|NCT02658994|4005154|FG001|STARTED|12 Month Follow up|Participants who did not complete 6 month follow up were still eligible for 12 month follow up|283
3269985|NCT02658994|4005155|FG002|STARTED|12 Month Follow up|Participants who did not complete 6 month follow up were still eligible for 12 month follow up|584
3269986|NCT02658994|4005153|FG000|COMPLETED|12 Month Follow up||228
3269987|NCT02658994|4005154|FG001|COMPLETED|12 Month Follow up||223
3269988|NCT02658994|4005155|FG002|COMPLETED|12 Month Follow up||489
3269989|NCT02658994|4005153|FG000|NOT COMPLETED|12 Month Follow up||59
3269990|NCT02658994|4005154|FG001|NOT COMPLETED|12 Month Follow up||60
3269991|NCT02658994|4005155|FG002|NOT COMPLETED|12 Month Follow up||95
3269992|NCT02658994|4005153|FG000|STARTED|24 Month Follow up|Participants who did not complete 12 month follow up were still eligible for 24 month follow up|287
3376844|NCT01248130|4110337|FG000|STARTED|Overall Study||3
3269993|NCT02658994|4005154|FG001|STARTED|24 Month Follow up|Participants who did not complete 12 month follow up were still eligible for 24 month follow up|283
3269994|NCT02658994|4005155|FG002|STARTED|24 Month Follow up|Participants who did not complete 12 month follow up were still eligible for 24 month follow up|584
3269995|NCT02658994|4005153|FG000|COMPLETED|24 Month Follow up||220
3269996|NCT02658994|4005154|FG001|COMPLETED|24 Month Follow up||210
3269997|NCT02658994|4005155|FG002|COMPLETED|24 Month Follow up||473
3269998|NCT02658994|4005153|FG000|NOT COMPLETED|24 Month Follow up||67
3376845|NCT01248130|4110338|FG001|STARTED|Overall Study||4
3376846|NCT01248130|4110337|FG000|COMPLETED|Overall Study||1
3376847|NCT01248130|4110338|FG001|COMPLETED|Overall Study||4
3376848|NCT01248130|4110337|FG000|NOT COMPLETED|Overall Study||2
3376849|NCT01248130|4110338|FG001|NOT COMPLETED|Overall Study||0
3376850|NCT01243892|4110346|FG000|STARTED|Overall Study||15
3269999|NCT02658994|4005154|FG001|NOT COMPLETED|24 Month Follow up||73
3376851|NCT01243892|4110347|FG001|STARTED|Overall Study||3
3376852|NCT01243892|4110346|FG000|COMPLETED|Overall Study||13
3376853|NCT01243892|4110347|FG001|COMPLETED|Overall Study||3
3376854|NCT01243892|4110346|FG000|NOT COMPLETED|Overall Study||2
3376855|NCT01243892|4110347|FG001|NOT COMPLETED|Overall Study||0
3270000|NCT02658994|4005155|FG002|NOT COMPLETED|24 Month Follow up||111
3270001|NCT02658994|4005153|FG000|STARTED|36 Month Follow up|Participants who did not complete 24 month follow up were still eligible for 36 month follow up|287
3270002|NCT02658994|4005154|FG001|STARTED|36 Month Follow up|Participants who did not complete 24 month follow up were still eligible for 36 month follow up|283
3270003|NCT02658994|4005155|FG002|STARTED|36 Month Follow up|Participants who did not complete 24 month follow up were still eligible for 36 month follow up|584
3270004|NCT02658994|4005153|FG000|COMPLETED|36 Month Follow up||216
3270005|NCT02658994|4005154|FG001|COMPLETED|36 Month Follow up||206
3270006|NCT02658994|4005155|FG002|COMPLETED|36 Month Follow up||467
3270007|NCT02658994|4005153|FG000|NOT COMPLETED|36 Month Follow up||71
3270008|NCT02658994|4005154|FG001|NOT COMPLETED|36 Month Follow up||77
3270009|NCT02658994|4005155|FG002|NOT COMPLETED|36 Month Follow up||117
3270010|NCT02659020|4005171|FG000|STARTED|Overall Study||21
3270011|NCT02659020|4005172|FG001|STARTED|Overall Study||18
3270012|NCT02659020|4005173|FG002|STARTED|Overall Study||15
3270013|NCT02659020|4005174|FG003|STARTED|Overall Study||81
3270014|NCT02659020|4005175|FG004|STARTED|Overall Study||46
3270015|NCT02659020|4005176|FG005|STARTED|Overall Study||86
3270016|NCT02659020|4005177|FG006|STARTED|Overall Study||43
3270017|NCT02659020|4005171|FG000|Received at Least 1 Dose of Study Drug|Overall Study||21
3270018|NCT02659020|4005172|FG001|Received at Least 1 Dose of Study Drug|Overall Study||18
3270019|NCT02659020|4005173|FG002|Received at Least 1 Dose of Study Drug|Overall Study||15
3270020|NCT02659020|4005174|FG003|Received at Least 1 Dose of Study Drug|Overall Study||81
3270021|NCT02659020|4005175|FG004|Received at Least 1 Dose of Study Drug|Overall Study||45
3270022|NCT02659020|4005176|FG005|Received at Least 1 Dose of Study Drug|Overall Study||86
3270023|NCT02659020|4005177|FG006|Received at Least 1 Dose of Study Drug|Overall Study||43
3270024|NCT02659020|4005171|FG000|COMPLETED|Overall Study||15
3270025|NCT02659020|4005172|FG001|COMPLETED|Overall Study||11
3270026|NCT02659020|4005173|FG002|COMPLETED|Overall Study||10
3270027|NCT02659020|4005174|FG003|COMPLETED|Overall Study||51
3270028|NCT02659020|4005175|FG004|COMPLETED|Overall Study||26
3270029|NCT02659020|4005176|FG005|COMPLETED|Overall Study||58
3270030|NCT02659020|4005177|FG006|COMPLETED|Overall Study||28
3270031|NCT02659020|4005171|FG000|NOT COMPLETED|Overall Study||6
3270032|NCT02659020|4005172|FG001|NOT COMPLETED|Overall Study||7
3270033|NCT02659020|4005173|FG002|NOT COMPLETED|Overall Study||5
3270034|NCT02659020|4005174|FG003|NOT COMPLETED|Overall Study||30
3270035|NCT02659020|4005175|FG004|NOT COMPLETED|Overall Study||20
3270036|NCT02659020|4005176|FG005|NOT COMPLETED|Overall Study||28
3270037|NCT02659020|4005177|FG006|NOT COMPLETED|Overall Study||15
3270038|NCT02659059|4005202|FG000|STARTED|Overall Study||288
3270039|NCT02659059|4005203|FG001|STARTED|Overall Study||36
3270040|NCT02659059|4005202|FG000|COMPLETED|Overall Study||88
3270041|NCT02659059|4005203|FG001|COMPLETED|Overall Study||4
3270042|NCT02659059|4005202|FG000|NOT COMPLETED|Overall Study||200
3270043|NCT02659059|4005203|FG001|NOT COMPLETED|Overall Study||32
3270044|NCT02659098|4005210|FG000|STARTED|Overall Study||21
3270045|NCT02659098|4005210|FG000|COMPLETED|Overall Study||14
3270046|NCT02659098|4005210|FG000|NOT COMPLETED|Overall Study||7
3270047|NCT02659150|4005214|FG000|STARTED|Subject Enrollment||16
3270048|NCT02659150|4005214|FG000|COMPLETED|Subject Enrollment||11
3270049|NCT02659150|4005214|FG000|NOT COMPLETED|Subject Enrollment||5
3270050|NCT02659150|4005214|FG000|STARTED|Baseline Imaging||11
3270051|NCT02659150|4005214|FG000|COMPLETED|Baseline Imaging||9
3270052|NCT02659150|4005214|FG000|NOT COMPLETED|Baseline Imaging||2
3270053|NCT02659150|4005214|FG000|STARTED|Study Drug Dosing||9
3270054|NCT02659150|4005214|FG000|COMPLETED|Study Drug Dosing||8
3270055|NCT02659150|4005214|FG000|NOT COMPLETED|Study Drug Dosing||1
3270056|NCT02659150|4005214|FG000|STARTED|Follow-up Imaging||8
3270057|NCT02659150|4005214|FG000|COMPLETED|Follow-up Imaging||8
3270058|NCT02659150|4005214|FG000|NOT COMPLETED|Follow-up Imaging||0
3270059|NCT02659501|4005221|FG000|STARTED|Overall Study||12
3270060|NCT02659501|4005222|FG001|STARTED|Overall Study||12
3270061|NCT02659501|4005221|FG000|COMPLETED|Overall Study||12
3376856|NCT01246011|4110356|FG000|STARTED|Overall Study||0
3376857|NCT01246011|4110357|FG001|STARTED|Overall Study||0
3376858|NCT01246011|4110358|FG002|STARTED|Overall Study||9
3376859|NCT01246011|4110356|FG000|COMPLETED|Overall Study||0
3376860|NCT01246011|4110357|FG001|COMPLETED|Overall Study||0
3376861|NCT01246011|4110358|FG002|COMPLETED|Overall Study||5
3376862|NCT01246011|4110356|FG000|NOT COMPLETED|Overall Study||0
3376863|NCT01246011|4110357|FG001|NOT COMPLETED|Overall Study||0
3376864|NCT01246011|4110358|FG002|NOT COMPLETED|Overall Study||4
3376865|NCT01242020|4110369|FG000|STARTED|Overall Study||6
3376866|NCT01242020|4110370|FG001|STARTED|Overall Study||0
3376867|NCT01242020|4110369|FG000|COMPLETED|Overall Study||3
3376868|NCT01242020|4110370|FG001|COMPLETED|Overall Study||0
3376869|NCT01242020|4110369|FG000|NOT COMPLETED|Overall Study||3
3376870|NCT01242020|4110370|FG001|NOT COMPLETED|Overall Study||0
3376871|NCT01244620|4110376|FG000|STARTED|Overall Study||4
3376872|NCT01244620|4110377|FG001|STARTED|Overall Study||4
3376873|NCT01244620|4110378|FG002|STARTED|Overall Study||4
3270062|NCT02659501|4005222|FG001|COMPLETED|Overall Study||12
3270063|NCT02659501|4005221|FG000|NOT COMPLETED|Overall Study||0
3270064|NCT02659501|4005222|FG001|NOT COMPLETED|Overall Study||0
3270065|NCT02659540|4005230|FG000|STARTED|Overall Study||10
3270066|NCT02659540|4005231|FG001|STARTED|Overall Study||10
3270067|NCT02659540|4005230|FG000|COMPLETED|Overall Study||4
3270068|NCT02659540|4005231|FG001|COMPLETED|Overall Study||2
3270069|NCT02659540|4005230|FG000|NOT COMPLETED|Overall Study||6
3270070|NCT02659540|4005231|FG001|NOT COMPLETED|Overall Study||8
3270071|NCT02659631|4005247|FG000|STARTED|Overall Study||1
3270072|NCT02659631|4005248|FG001|STARTED|Overall Study||2
3270073|NCT02659631|4005249|FG002|STARTED|Overall Study||3
3270074|NCT02659631|4005250|FG003|STARTED|Overall Study||2
3270075|NCT02659631|4005251|FG004|STARTED|Overall Study||5
3270076|NCT02659631|4005252|FG005|STARTED|Overall Study||5
3270077|NCT02659631|4005253|FG006|STARTED|Overall Study||4
3270078|NCT02659631|4005254|FG007|STARTED|Overall Study||3
3270079|NCT02659631|4005255|FG008|STARTED|Overall Study||2
3270080|NCT02659631|4005256|FG009|STARTED|Overall Study||1
3270081|NCT02659631|4005247|FG000|COMPLETED|Overall Study||0
3270082|NCT02659631|4005248|FG001|COMPLETED|Overall Study||0
3270083|NCT02659631|4005249|FG002|COMPLETED|Overall Study||0
3270084|NCT02659631|4005250|FG003|COMPLETED|Overall Study||0
3270085|NCT02659631|4005251|FG004|COMPLETED|Overall Study||0
3270086|NCT02659631|4005252|FG005|COMPLETED|Overall Study||2
3270087|NCT02659631|4005253|FG006|COMPLETED|Overall Study||3
3270088|NCT02659631|4005254|FG007|COMPLETED|Overall Study||0
3270089|NCT02659631|4005255|FG008|COMPLETED|Overall Study||0
3270090|NCT02659631|4005256|FG009|COMPLETED|Overall Study||1
3270091|NCT02659631|4005247|FG000|NOT COMPLETED|Overall Study||1
3270092|NCT02659631|4005248|FG001|NOT COMPLETED|Overall Study||2
3270093|NCT02659631|4005249|FG002|NOT COMPLETED|Overall Study||3
3270094|NCT02659631|4005250|FG003|NOT COMPLETED|Overall Study||2
3270095|NCT02659631|4005251|FG004|NOT COMPLETED|Overall Study||5
3270096|NCT02659631|4005252|FG005|NOT COMPLETED|Overall Study||3
3270097|NCT02659631|4005253|FG006|NOT COMPLETED|Overall Study||1
3270098|NCT02659631|4005254|FG007|NOT COMPLETED|Overall Study||3
3270099|NCT02659631|4005255|FG008|NOT COMPLETED|Overall Study||2
3270100|NCT02659631|4005256|FG009|NOT COMPLETED|Overall Study||0
3270101|NCT02659709|4005280|FG000|STARTED|Overall Study||50
3270102|NCT02659709|4005280|FG000|COMPLETED|Overall Study||50
3270103|NCT02659709|4005280|FG000|NOT COMPLETED|Overall Study||0
3270104|NCT02659787|4005284|FG000|STARTED|First Intervention (1 Day)||19
3270105|NCT02659787|4005285|FG001|STARTED|First Intervention (1 Day)||19
3270106|NCT02659787|4005284|FG000|COMPLETED|First Intervention (1 Day)||19
3270107|NCT02659787|4005285|FG001|COMPLETED|First Intervention (1 Day)||19
3270108|NCT02659787|4005284|FG000|NOT COMPLETED|First Intervention (1 Day)||0
3270109|NCT02659787|4005285|FG001|NOT COMPLETED|First Intervention (1 Day)||0
3270110|NCT02659787|4005284|FG000|STARTED|Washout (3 Days)||19
3270111|NCT02659787|4005285|FG001|STARTED|Washout (3 Days)||19
3270112|NCT02659787|4005284|FG000|COMPLETED|Washout (3 Days)||19
3270113|NCT02659787|4005285|FG001|COMPLETED|Washout (3 Days)||19
3270114|NCT02659787|4005284|FG000|NOT COMPLETED|Washout (3 Days)||0
3270115|NCT02659787|4005285|FG001|NOT COMPLETED|Washout (3 Days)||0
3270116|NCT02659787|4005284|FG000|STARTED|Second Intervention (1 Day)||19
3270117|NCT02659787|4005285|FG001|STARTED|Second Intervention (1 Day)||19
3270118|NCT02659787|4005284|FG000|COMPLETED|Second Intervention (1 Day)||19
3270119|NCT02659787|4005285|FG001|COMPLETED|Second Intervention (1 Day)||19
3270120|NCT02659787|4005284|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
3270121|NCT02659787|4005285|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
3270122|NCT02659943|4005298|FG000|STARTED|Overall Study||3
3270123|NCT02659943|4005299|FG001|STARTED|Overall Study||2
3270124|NCT02659943|4005300|FG002|STARTED|Overall Study||1
3270125|NCT02659943|4005301|FG003|STARTED|Overall Study||4
3270126|NCT02659943|4005302|FG004|STARTED|Overall Study||2
3270127|NCT02659943|4005303|FG005|STARTED|Overall Study||9
3270128|NCT02659943|4005304|FG006|STARTED|Overall Study||6
3270129|NCT02659943|4005298|FG000|COMPLETED|Overall Study||2
3270130|NCT02659943|4005299|FG001|COMPLETED|Overall Study||0
3270131|NCT02659943|4005300|FG002|COMPLETED|Overall Study||0
3270132|NCT02659943|4005301|FG003|COMPLETED|Overall Study||1
3270133|NCT02659943|4005302|FG004|COMPLETED|Overall Study||0
3270134|NCT02659943|4005303|FG005|COMPLETED|Overall Study||4
3270135|NCT02659943|4005304|FG006|COMPLETED|Overall Study||0
3270136|NCT02659943|4005298|FG000|NOT COMPLETED|Overall Study||1
3270137|NCT02659943|4005299|FG001|NOT COMPLETED|Overall Study||2
3270138|NCT02659943|4005300|FG002|NOT COMPLETED|Overall Study||1
3270139|NCT02659943|4005301|FG003|NOT COMPLETED|Overall Study||3
3270140|NCT02659943|4005302|FG004|NOT COMPLETED|Overall Study||2
3270141|NCT02659943|4005303|FG005|NOT COMPLETED|Overall Study||5
3270142|NCT02659943|4005304|FG006|NOT COMPLETED|Overall Study||6
3270143|NCT02660112|4005325|FG000|STARTED|Overall Study||10
3270144|NCT02660112|4005325|FG000|COMPLETED|Overall Study||10
3270145|NCT02660112|4005325|FG000|NOT COMPLETED|Overall Study||0
3270146|NCT02660138|4005332|FG000|STARTED|Overall Study||76
3270147|NCT02660138|4005333|FG001|STARTED|Overall Study||76
3270148|NCT02660138|4005334|FG002|STARTED|Overall Study||75
3270149|NCT02660138|4005332|FG000|Subjects Treated in DBPC Cycle|Overall Study||76
3270150|NCT02660138|4005333|FG001|Subjects Treated in DBPC Cycle|Overall Study||75
3270151|NCT02660138|4005334|FG002|Subjects Treated in DBPC Cycle|Overall Study||75
3270152|NCT02660138|4005332|FG000|Subjects Entered in the Dysport Cycles|Overall Study||49
3270153|NCT02660138|4005333|FG001|Subjects Entered in the Dysport Cycles|Overall Study||75
3270154|NCT02660138|4005334|FG002|Subjects Entered in the Dysport Cycles|Overall Study||75
3270155|NCT02660138|4005332|FG000|COMPLETED|Overall Study||6
3270156|NCT02660138|4005333|FG001|COMPLETED|Overall Study||2
3270157|NCT02660138|4005334|FG002|COMPLETED|Overall Study||3
3270158|NCT02660138|4005332|FG000|NOT COMPLETED|Overall Study||70
3270159|NCT02660138|4005333|FG001|NOT COMPLETED|Overall Study||74
3270160|NCT02660138|4005334|FG002|NOT COMPLETED|Overall Study||72
3270161|NCT02660229|4005347|FG000|STARTED|Overall Study|Randomization|34
3270162|NCT02660229|4005348|FG001|STARTED|Overall Study|Randomization|32
3270163|NCT02660229|4005347|FG000|Safety Analysis Set|Overall Study||34
3270164|NCT02660229|4005348|FG001|Safety Analysis Set|Overall Study||32
3270165|NCT02660229|4005347|FG000|FAS Set|Overall Study|Oxycodone group: 1 patient was missed any efficacy assessment.|33
3270166|NCT02660229|4005348|FG001|FAS Set|Overall Study||32
3270167|NCT02660229|4005347|FG000|Per Protocol Set|Overall Study|Adverse events N=1, Prohibited medication N=4|28
3270168|NCT02660229|4005348|FG001|Per Protocol Set|Overall Study|Withdrawal of ICF N=1, IC/EC deviation N=1, Prohibited medication N=1|29
3270169|NCT02660229|4005347|FG000|COMPLETED|Overall Study||32
3270170|NCT02660229|4005348|FG001|COMPLETED|Overall Study||31
3270171|NCT02660229|4005347|FG000|NOT COMPLETED|Overall Study||2
3270172|NCT02660229|4005348|FG001|NOT COMPLETED|Overall Study||1
3270173|NCT02660242|4005354|FG000|STARTED|Control||16
3270174|NCT02660242|4005354|FG000|COMPLETED|Control||16
3270175|NCT02660242|4005354|FG000|NOT COMPLETED|Control||0
3270176|NCT02660242|4005354|FG000|STARTED|Basal Insulin Reduction||16
3270177|NCT02660242|4005354|FG000|COMPLETED|Basal Insulin Reduction||16
3270178|NCT02660242|4005354|FG000|NOT COMPLETED|Basal Insulin Reduction||0
3270179|NCT02660242|4005354|FG000|STARTED|Glucose Tabs|16 participants were randomized but only 15 completed all 4 periods.|16
3270180|NCT02660242|4005354|FG000|COMPLETED|Glucose Tabs||15
3270181|NCT02660242|4005354|FG000|NOT COMPLETED|Glucose Tabs||1
3270182|NCT02660242|4005354|FG000|STARTED|Glucagon Injection|16 participants were randomized but only 15 completed all 4 periods.|16
3270183|NCT02660242|4005354|FG000|COMPLETED|Glucagon Injection||15
3270184|NCT02660242|4005354|FG000|NOT COMPLETED|Glucagon Injection||1
3270185|NCT02660359|4005370|FG000|STARTED|Overall Study||86
3270186|NCT02660359|4005371|FG001|STARTED|Overall Study||86
3270187|NCT02660359|4005372|FG002|STARTED|Overall Study||85
3270188|NCT02660359|4005370|FG000|Subjects Entered in the Dysport Cycles|Overall Study||56
3270189|NCT02660359|4005371|FG001|Subjects Entered in the Dysport Cycles|Overall Study||86
3270190|NCT02660359|4005372|FG002|Subjects Entered in the Dysport Cycles|Overall Study||85
3270191|NCT02660359|4005370|FG000|COMPLETED|Overall Study||0
3270192|NCT02660359|4005371|FG001|COMPLETED|Overall Study||0
3270193|NCT02660359|4005372|FG002|COMPLETED|Overall Study||1
3270194|NCT02660359|4005370|FG000|NOT COMPLETED|Overall Study||86
3270195|NCT02660359|4005371|FG001|NOT COMPLETED|Overall Study||86
3270196|NCT02660359|4005372|FG002|NOT COMPLETED|Overall Study||84
3270197|NCT02660489|4005382|FG000|STARTED|Overall Study||22
3270198|NCT02660489|4005383|FG001|STARTED|Overall Study||22
3270199|NCT02660489|4005382|FG000|COMPLETED|Overall Study|Completed with confirmed rhinovirus infection|16
3270200|NCT02660489|4005383|FG001|COMPLETED|Overall Study|Completed with confirmed rhinovirus infection|14
3270201|NCT02660489|4005382|FG000|NOT COMPLETED|Overall Study||6
3270202|NCT02660489|4005383|FG001|NOT COMPLETED|Overall Study||8
3270203|NCT02660580|4005391|FG000|STARTED|Core Treatment Period (Week 1 to 16)||222
3270204|NCT02660580|4005392|FG001|STARTED|Core Treatment Period (Week 1 to 16)||221
3270205|NCT02660580|4005393|FG002|STARTED|Core Treatment Period (Week 1 to 16)||0
3270206|NCT02660580|4005394|FG003|STARTED|Core Treatment Period (Week 1 to 16)||0
3270207|NCT02660580|4005395|FG004|STARTED|Core Treatment Period (Week 1 to 16)||0
3270208|NCT02660580|4005391|FG000|Treated|Core Treatment Period (Week 1 to 16)||221
3270209|NCT02660580|4005392|FG001|Treated|Core Treatment Period (Week 1 to 16)||220
3270210|NCT02660580|4005393|FG002|Treated|Core Treatment Period (Week 1 to 16)||0
3270211|NCT02660580|4005394|FG003|Treated|Core Treatment Period (Week 1 to 16)||0
3270212|NCT02660580|4005395|FG004|Treated|Core Treatment Period (Week 1 to 16)||0
3270213|NCT02660580|4005391|FG000|COMPLETED|Core Treatment Period (Week 1 to 16)||213
3270214|NCT02660580|4005392|FG001|COMPLETED|Core Treatment Period (Week 1 to 16)||202
3270215|NCT02660580|4005393|FG002|COMPLETED|Core Treatment Period (Week 1 to 16)||0
3270216|NCT02660580|4005394|FG003|COMPLETED|Core Treatment Period (Week 1 to 16)||0
3270217|NCT02660580|4005395|FG004|COMPLETED|Core Treatment Period (Week 1 to 16)||0
3270218|NCT02660580|4005391|FG000|NOT COMPLETED|Core Treatment Period (Week 1 to 16)||9
3270219|NCT02660580|4005392|FG001|NOT COMPLETED|Core Treatment Period (Week 1 to 16)||19
3270220|NCT02660580|4005393|FG002|NOT COMPLETED|Core Treatment Period (Week 1 to 16)||0
3270221|NCT02660580|4005394|FG003|NOT COMPLETED|Core Treatment Period (Week 1 to 16)||0
3270222|NCT02660580|4005395|FG004|NOT COMPLETED|Core Treatment Period (Week 1 to 16)||0
3270223|NCT02660580|4005391|FG000|STARTED|Extended Treatment Period(Week 16 to 52)||0
3270224|NCT02660580|4005392|FG001|STARTED|Extended Treatment Period(Week 16 to 52)||0
3270225|NCT02660580|4005393|FG002|STARTED|Extended Treatment Period(Week 16 to 52)||213
3270226|NCT02660580|4005394|FG003|STARTED|Extended Treatment Period(Week 16 to 52)||101
3270227|NCT02660580|4005395|FG004|STARTED|Extended Treatment Period(Week 16 to 52)||101
3270228|NCT02660580|4005391|FG000|COMPLETED|Extended Treatment Period(Week 16 to 52)||0
3270229|NCT02660580|4005392|FG001|COMPLETED|Extended Treatment Period(Week 16 to 52)||0
3270230|NCT02660580|4005393|FG002|COMPLETED|Extended Treatment Period(Week 16 to 52)||195
3270231|NCT02660580|4005394|FG003|COMPLETED|Extended Treatment Period(Week 16 to 52)||90
3270232|NCT02660580|4005395|FG004|COMPLETED|Extended Treatment Period(Week 16 to 52)||90
3270233|NCT02660580|4005391|FG000|NOT COMPLETED|Extended Treatment Period(Week 16 to 52)||0
3270234|NCT02660580|4005392|FG001|NOT COMPLETED|Extended Treatment Period(Week 16 to 52)||0
3270235|NCT02660580|4005393|FG002|NOT COMPLETED|Extended Treatment Period(Week 16 to 52)||18
3270236|NCT02660580|4005394|FG003|NOT COMPLETED|Extended Treatment Period(Week 16 to 52)||11
3270237|NCT02660580|4005395|FG004|NOT COMPLETED|Extended Treatment Period(Week 16 to 52)||11
3270238|NCT02660788|4005416|FG000|STARTED|Overall Study||2749
3270239|NCT02660788|4005417|FG001|STARTED|Overall Study||2749
3270240|NCT02660788|4005416|FG000|COMPLETED|Overall Study||2749
3270241|NCT02660788|4005417|FG001|COMPLETED|Overall Study||2749
3270242|NCT02660788|4005416|FG000|NOT COMPLETED|Overall Study||0
3270243|NCT02660788|4005417|FG001|NOT COMPLETED|Overall Study||0
3270244|NCT02660801|4005423|FG000|STARTED|Overall Study||11
3270245|NCT02660801|4005424|FG001|STARTED|Overall Study||15
3270246|NCT02660801|4005423|FG000|COMPLETED|Overall Study||11
3270247|NCT02660801|4005424|FG001|COMPLETED|Overall Study||15
3270248|NCT02660801|4005423|FG000|NOT COMPLETED|Overall Study||0
3270249|NCT02660801|4005424|FG001|NOT COMPLETED|Overall Study||0
3270250|NCT02660853|4005430|FG000|STARTED|Overall Study||25
3270251|NCT02660853|4005430|FG000|COMPLETED|Overall Study||25
3270252|NCT02660853|4005430|FG000|NOT COMPLETED|Overall Study||0
3270253|NCT02660918|4005436|FG000|STARTED|Overall Study||42
3270254|NCT02660918|4005437|FG001|STARTED|Overall Study||42
3270255|NCT02660918|4005436|FG000|COMPLETED|Overall Study|Age ineligible|41
3270256|NCT02660918|4005437|FG001|COMPLETED|Overall Study|Age ineligible|41
3270257|NCT02660918|4005436|FG000|NOT COMPLETED|Overall Study||1
3270258|NCT02660918|4005437|FG001|NOT COMPLETED|Overall Study||1
3270259|NCT02660944|4005446|FG000|STARTED|Overall Study||42
3270260|NCT02660944|4005447|FG001|STARTED|Overall Study||22
3270261|NCT02660944|4005446|FG000|COMPLETED|Overall Study||25
3270262|NCT02660944|4005447|FG001|COMPLETED|Overall Study||12
3270263|NCT02660944|4005446|FG000|NOT COMPLETED|Overall Study||17
3270264|NCT02660944|4005447|FG001|NOT COMPLETED|Overall Study||10
3270265|NCT02660983|4005455|FG000|STARTED|Double-blind (DB) Phase (24 Weeks)||154
3270266|NCT02660983|4005456|FG001|STARTED|Double-blind (DB) Phase (24 Weeks)||148
3270267|NCT02660983|4005455|FG000|Treated/Safety Set|Double-blind (DB) Phase (24 Weeks)||153
3270268|NCT02660983|4005456|FG001|Treated/Safety Set|Double-blind (DB) Phase (24 Weeks)||147
3270269|NCT02660983|4005455|FG000|COMPLETED|Double-blind (DB) Phase (24 Weeks)||130
3270270|NCT02660983|4005456|FG001|COMPLETED|Double-blind (DB) Phase (24 Weeks)||122
3270271|NCT02660983|4005455|FG000|NOT COMPLETED|Double-blind (DB) Phase (24 Weeks)||24
3270272|NCT02660983|4005456|FG001|NOT COMPLETED|Double-blind (DB) Phase (24 Weeks)||26
3376874|NCT01244620|4110379|FG003|STARTED|Overall Study||4
3376875|NCT01244620|4110376|FG000|COMPLETED|Overall Study||0
3376876|NCT01244620|4110377|FG001|COMPLETED|Overall Study||0
3376877|NCT01244620|4110378|FG002|COMPLETED|Overall Study||0
3376878|NCT01244620|4110379|FG003|COMPLETED|Overall Study||0
3376879|NCT01244620|4110376|FG000|NOT COMPLETED|Overall Study||4
3376880|NCT01244620|4110377|FG001|NOT COMPLETED|Overall Study||4
3376881|NCT01244620|4110378|FG002|NOT COMPLETED|Overall Study||4
3376882|NCT01244620|4110379|FG003|NOT COMPLETED|Overall Study||4
3376883|NCT01240304|4110389|FG000|STARTED|Overall Study||10
3376884|NCT01240304|4110389|FG000|COMPLETED|Overall Study||0
3376885|NCT01240304|4110389|FG000|NOT COMPLETED|Overall Study||10
3376886|NCT01241279|4110395|FG000|STARTED|Overall Study||4
3376887|NCT01241279|4110396|FG001|STARTED|Overall Study||2
3376888|NCT01241279|4110395|FG000|COMPLETED|Overall Study||4
3376889|NCT01241279|4110396|FG001|COMPLETED|Overall Study||1
3376890|NCT01241279|4110395|FG000|NOT COMPLETED|Overall Study||0
3376891|NCT01241279|4110396|FG001|NOT COMPLETED|Overall Study||1
3376892|NCT01230788|4110402|FG000|STARTED|Overall Study||1
3376893|NCT01230788|4110402|FG000|COMPLETED|Overall Study||0
3376894|NCT01230788|4110402|FG000|NOT COMPLETED|Overall Study||1
3376895|NCT01239680|4110408|FG000|STARTED|Overall Study||3
3376896|NCT01239680|4110409|FG001|STARTED|Overall Study||2
3376897|NCT01239680|4110408|FG000|COMPLETED|Overall Study||1
3376898|NCT01239680|4110409|FG001|COMPLETED|Overall Study||2
3376899|NCT01239680|4110408|FG000|NOT COMPLETED|Overall Study||2
3376900|NCT01239680|4110409|FG001|NOT COMPLETED|Overall Study||0
3376901|NCT01237613|4110415|FG000|STARTED|Overall Study||4
3376902|NCT01237613|4110415|FG000|COMPLETED|Overall Study||4
3376903|NCT01237613|4110415|FG000|NOT COMPLETED|Overall Study||0
3376904|NCT01234103|4110422|FG000|STARTED|Overall Study||542
3376905|NCT01234103|4110423|FG001|STARTED|Overall Study||391
3376906|NCT01234103|4110422|FG000|COMPLETED|Overall Study||542
3376907|NCT01234103|4110423|FG001|COMPLETED|Overall Study||391
3376908|NCT01234103|4110422|FG000|NOT COMPLETED|Overall Study||0
3376909|NCT01234103|4110423|FG001|NOT COMPLETED|Overall Study||0
3376910|NCT01231750|4110431|FG000|STARTED|Overall Study||3
3376911|NCT01231750|4110432|FG001|STARTED|Overall Study||4
3376912|NCT01231750|4110431|FG000|COMPLETED|Overall Study||3
3376913|NCT01231750|4110432|FG001|COMPLETED|Overall Study||4
3376914|NCT01231750|4110431|FG000|NOT COMPLETED|Overall Study||0
3376915|NCT01231750|4110432|FG001|NOT COMPLETED|Overall Study||0
3376916|NCT01230307|4110440|FG000|STARTED|Overall Study||6
3376917|NCT01230307|4110441|FG001|STARTED|Overall Study||6
3376918|NCT01230307|4110440|FG000|COMPLETED|Overall Study||6
3376919|NCT01230307|4110441|FG001|COMPLETED|Overall Study||4
3376920|NCT01230307|4110440|FG000|NOT COMPLETED|Overall Study||0
3376921|NCT01230307|4110441|FG001|NOT COMPLETED|Overall Study||2
3376922|NCT01230489|4110447|FG000|STARTED|Overall Study||13
3376923|NCT01230489|4110447|FG000|COMPLETED|Overall Study||8
3376924|NCT01230489|4110447|FG000|NOT COMPLETED|Overall Study||5
3376925|NCT01222871|4110453|FG000|STARTED|Overall Study||0
3376926|NCT01222871|4110454|FG001|STARTED|Overall Study||0
3270273|NCT02660983|4005455|FG000|STARTED|Open Label Extension Phase (24 Weeks)|Eligible participants who consented to continue from DB phase to OLE phase.|86
3270274|NCT02660983|4005456|FG001|STARTED|Open Label Extension Phase (24 Weeks)|Eligible participants who consented to continue from DB phase to OLE phase.|75
3270275|NCT02660983|4005455|FG000|Safety Set|Open Label Extension Phase (24 Weeks)||86
3270276|NCT02660983|4005456|FG001|Safety Set|Open Label Extension Phase (24 Weeks)||75
3270277|NCT02660983|4005455|FG000|COMPLETED|Open Label Extension Phase (24 Weeks)||83
3270278|NCT02660983|4005456|FG001|COMPLETED|Open Label Extension Phase (24 Weeks)||66
3270279|NCT02660983|4005455|FG000|NOT COMPLETED|Open Label Extension Phase (24 Weeks)||3
3270280|NCT02660983|4005456|FG001|NOT COMPLETED|Open Label Extension Phase (24 Weeks)||9
3270281|NCT02661061|4005465|FG000|STARTED|Overall Study||5
3270282|NCT02661061|4005466|FG001|STARTED|Overall Study||4
3270283|NCT02661061|4005465|FG000|COMPLETED|Overall Study||3
3270284|NCT02661061|4005466|FG001|COMPLETED|Overall Study||2
3270285|NCT02661061|4005465|FG000|NOT COMPLETED|Overall Study||2
3270286|NCT02661061|4005466|FG001|NOT COMPLETED|Overall Study||2
3270287|NCT02661126|4005474|FG000|STARTED|Overall Study||8
3270288|NCT02661126|4005475|FG001|STARTED|Overall Study||8
3270289|NCT02661126|4005474|FG000|COMPLETED|Overall Study||8
3270290|NCT02661126|4005475|FG001|COMPLETED|Overall Study||8
3270291|NCT02661126|4005474|FG000|NOT COMPLETED|Overall Study||0
3270292|NCT02661126|4005475|FG001|NOT COMPLETED|Overall Study||0
3270293|NCT02661178|4005496|FG000|STARTED|Part 1||1
3270294|NCT02661178|4005497|FG001|STARTED|Part 1||5
3270295|NCT02661178|4005498|FG002|STARTED|Part 1||6
3270296|NCT02661178|4005499|FG003|STARTED|Part 1||6
3270297|NCT02661178|4005500|FG004|STARTED|Part 1||5
3270298|NCT02661178|4005501|FG005|STARTED|Part 1||6
3270299|NCT02661178|4005502|FG006|STARTED|Part 1||6
3270300|NCT02661178|4005503|FG007|STARTED|Part 1||6
3270301|NCT02661178|4005504|FG008|STARTED|Part 1||6
3270302|NCT02661178|4005505|FG009|STARTED|Part 1||12
3270303|NCT02661178|4005506|FG010|STARTED|Part 1||4
3270304|NCT02661178|4005507|FG011|STARTED|Part 1||0
3270305|NCT02661178|4005508|FG012|STARTED|Part 1||0
3270306|NCT02661178|4005509|FG013|STARTED|Part 1||0
3270307|NCT02661178|4005510|FG014|STARTED|Part 1||0
3270308|NCT02661178|4005496|FG000|COMPLETED|Part 1||0
3270309|NCT02661178|4005497|FG001|COMPLETED|Part 1||5
3270310|NCT02661178|4005498|FG002|COMPLETED|Part 1||6
3270311|NCT02661178|4005499|FG003|COMPLETED|Part 1||6
3270312|NCT02661178|4005500|FG004|COMPLETED|Part 1||5
3270313|NCT02661178|4005501|FG005|COMPLETED|Part 1||6
3270314|NCT02661178|4005502|FG006|COMPLETED|Part 1||6
3270315|NCT02661178|4005503|FG007|COMPLETED|Part 1||6
3270316|NCT02661178|4005504|FG008|COMPLETED|Part 1||6
3270317|NCT02661178|4005505|FG009|COMPLETED|Part 1||12
3270318|NCT02661178|4005506|FG010|COMPLETED|Part 1||4
3270319|NCT02661178|4005507|FG011|COMPLETED|Part 1||0
3270320|NCT02661178|4005508|FG012|COMPLETED|Part 1||0
3270321|NCT02661178|4005509|FG013|COMPLETED|Part 1||0
3270322|NCT02661178|4005510|FG014|COMPLETED|Part 1||0
3270323|NCT02661178|4005496|FG000|NOT COMPLETED|Part 1||1
3270324|NCT02661178|4005497|FG001|NOT COMPLETED|Part 1||0
3270325|NCT02661178|4005498|FG002|NOT COMPLETED|Part 1||0
3270326|NCT02661178|4005499|FG003|NOT COMPLETED|Part 1||0
3270327|NCT02661178|4005500|FG004|NOT COMPLETED|Part 1||0
3270328|NCT02661178|4005501|FG005|NOT COMPLETED|Part 1||0
3270329|NCT02661178|4005502|FG006|NOT COMPLETED|Part 1||0
3270330|NCT02661178|4005503|FG007|NOT COMPLETED|Part 1||0
3270331|NCT02661178|4005504|FG008|NOT COMPLETED|Part 1||0
3270332|NCT02661178|4005505|FG009|NOT COMPLETED|Part 1||0
3270333|NCT02661178|4005506|FG010|NOT COMPLETED|Part 1||0
3270334|NCT02661178|4005507|FG011|NOT COMPLETED|Part 1||0
3376927|NCT01222871|4110453|FG000|COMPLETED|Overall Study||0
3376928|NCT01222871|4110454|FG001|COMPLETED|Overall Study||0
3376929|NCT01222871|4110453|FG000|NOT COMPLETED|Overall Study||0
3376930|NCT01222871|4110454|FG001|NOT COMPLETED|Overall Study||0
3376931|NCT01219673|4110469|FG000|STARTED|Overall Study||0
3376932|NCT01219673|4110470|FG001|STARTED|Overall Study||0
3376933|NCT01219673|4110471|FG002|STARTED|Overall Study||1
3376934|NCT01219673|4110472|FG003|STARTED|Overall Study||0
3376935|NCT01219673|4110473|FG004|STARTED|Overall Study||0
3376936|NCT01219673|4110474|FG005|STARTED|Overall Study||0
3376937|NCT01219673|4110475|FG006|STARTED|Overall Study||0
3376938|NCT01219673|4110476|FG007|STARTED|Overall Study||0
3376939|NCT01219673|4110469|FG000|COMPLETED|Overall Study||0
3376940|NCT01219673|4110470|FG001|COMPLETED|Overall Study||0
3376941|NCT01219673|4110471|FG002|COMPLETED|Overall Study||1
3376942|NCT01219673|4110472|FG003|COMPLETED|Overall Study||0
3376943|NCT01219673|4110473|FG004|COMPLETED|Overall Study||0
3376944|NCT01219673|4110474|FG005|COMPLETED|Overall Study||0
3376945|NCT01219673|4110475|FG006|COMPLETED|Overall Study||0
3376946|NCT01219673|4110476|FG007|COMPLETED|Overall Study||0
3376947|NCT01219673|4110469|FG000|NOT COMPLETED|Overall Study||0
3376948|NCT01219673|4110470|FG001|NOT COMPLETED|Overall Study||0
3270335|NCT02661178|4005508|FG012|NOT COMPLETED|Part 1||0
3270336|NCT02661178|4005509|FG013|NOT COMPLETED|Part 1||0
3270337|NCT02661178|4005510|FG014|NOT COMPLETED|Part 1||0
3270338|NCT02661178|4005496|FG000|STARTED|Part 2||0
3270339|NCT02661178|4005497|FG001|STARTED|Part 2||0
3270340|NCT02661178|4005498|FG002|STARTED|Part 2||0
3270341|NCT02661178|4005499|FG003|STARTED|Part 2||0
3376949|NCT01219673|4110471|FG002|NOT COMPLETED|Overall Study||0
3376950|NCT01219673|4110472|FG003|NOT COMPLETED|Overall Study||0
3376951|NCT01219673|4110473|FG004|NOT COMPLETED|Overall Study||0
3376952|NCT01219673|4110474|FG005|NOT COMPLETED|Overall Study||0
3270342|NCT02661178|4005500|FG004|STARTED|Part 2||0
3270343|NCT02661178|4005501|FG005|STARTED|Part 2||0
3270344|NCT02661178|4005502|FG006|STARTED|Part 2||0
3270345|NCT02661178|4005503|FG007|STARTED|Part 2||0
3270346|NCT02661178|4005504|FG008|STARTED|Part 2||0
3270347|NCT02661178|4005505|FG009|STARTED|Part 2||0
3270348|NCT02661178|4005506|FG010|STARTED|Part 2||0
3270349|NCT02661178|4005507|FG011|STARTED|Part 2||6
3270350|NCT02661178|4005508|FG012|STARTED|Part 2||6
3270351|NCT02661178|4005509|FG013|STARTED|Part 2||2
3270352|NCT02661178|4005510|FG014|STARTED|Part 2||2
3270353|NCT02661178|4005496|FG000|COMPLETED|Part 2||0
3270354|NCT02661178|4005497|FG001|COMPLETED|Part 2||0
3270355|NCT02661178|4005498|FG002|COMPLETED|Part 2||0
3270356|NCT02661178|4005499|FG003|COMPLETED|Part 2||0
3270357|NCT02661178|4005500|FG004|COMPLETED|Part 2||0
3270358|NCT02661178|4005501|FG005|COMPLETED|Part 2||0
3270359|NCT02661178|4005502|FG006|COMPLETED|Part 2||0
3270360|NCT02661178|4005503|FG007|COMPLETED|Part 2||0
3270361|NCT02661178|4005504|FG008|COMPLETED|Part 2||0
3270362|NCT02661178|4005505|FG009|COMPLETED|Part 2||0
3270363|NCT02661178|4005506|FG010|COMPLETED|Part 2||0
3270364|NCT02661178|4005507|FG011|COMPLETED|Part 2||6
3270365|NCT02661178|4005508|FG012|COMPLETED|Part 2||6
3270366|NCT02661178|4005509|FG013|COMPLETED|Part 2||2
3270367|NCT02661178|4005510|FG014|COMPLETED|Part 2||2
3270368|NCT02661178|4005496|FG000|NOT COMPLETED|Part 2||0
3270369|NCT02661178|4005497|FG001|NOT COMPLETED|Part 2||0
3270370|NCT02661178|4005498|FG002|NOT COMPLETED|Part 2||0
3270371|NCT02661178|4005499|FG003|NOT COMPLETED|Part 2||0
3270372|NCT02661178|4005500|FG004|NOT COMPLETED|Part 2||0
3270373|NCT02661178|4005501|FG005|NOT COMPLETED|Part 2||0
3270374|NCT02661178|4005502|FG006|NOT COMPLETED|Part 2||0
3270375|NCT02661178|4005503|FG007|NOT COMPLETED|Part 2||0
3270376|NCT02661178|4005504|FG008|NOT COMPLETED|Part 2||0
3270377|NCT02661178|4005505|FG009|NOT COMPLETED|Part 2||0
3270378|NCT02661178|4005506|FG010|NOT COMPLETED|Part 2||0
3270379|NCT02661178|4005507|FG011|NOT COMPLETED|Part 2||0
3270380|NCT02661178|4005508|FG012|NOT COMPLETED|Part 2||0
3270381|NCT02661178|4005509|FG013|NOT COMPLETED|Part 2||0
3270382|NCT02661178|4005510|FG014|NOT COMPLETED|Part 2||0
3270383|NCT02661217|4005562|FG000|STARTED|Overall Study||500
3270384|NCT02661217|4005563|FG001|STARTED|Overall Study||502
3270385|NCT02661217|4005562|FG000|Started 10 Weeks Treatment Epoch|Overall Study||497
3270386|NCT02661217|4005563|FG001|Started 10 Weeks Treatment Epoch|Overall Study||501
3270387|NCT02661217|4005562|FG000|Completed 10 Weeks Treatment Epoch|Overall Study||460
3270388|NCT02661217|4005563|FG001|Completed 10 Weeks Treatment Epoch|Overall Study||455
3270389|NCT02661217|4005562|FG000|COMPLETED|Overall Study||425
3270390|NCT02661217|4005563|FG001|COMPLETED|Overall Study||419
3270391|NCT02661217|4005562|FG000|NOT COMPLETED|Overall Study||75
3270392|NCT02661217|4005563|FG001|NOT COMPLETED|Overall Study||83
3270393|NCT02661256|4005570|FG000|STARTED|Overall Study|Each participant went through arms in same order: on nCPAP then off nCPAP. 1 participant at a time.|7
3270394|NCT02661256|4005570|FG000|COMPLETED|Overall Study||7
3270395|NCT02661256|4005570|FG000|NOT COMPLETED|Overall Study||0
3270396|NCT02661490|4005581|FG000|STARTED|Overall Study||76
3270397|NCT02661490|4005582|FG001|STARTED|Overall Study||74
3270398|NCT02661490|4005583|FG002|STARTED|Overall Study||72
3270399|NCT02661490|4005584|FG003|STARTED|Overall Study||72
3270400|NCT02661490|4005585|FG004|STARTED|Overall Study||26
3270401|NCT02661490|4005581|FG000|COMPLETED|Overall Study||73
3270402|NCT02661490|4005582|FG001|COMPLETED|Overall Study||72
3270403|NCT02661490|4005583|FG002|COMPLETED|Overall Study||70
3270404|NCT02661490|4005584|FG003|COMPLETED|Overall Study||71
3270405|NCT02661490|4005585|FG004|COMPLETED|Overall Study||23
3270406|NCT02661490|4005581|FG000|NOT COMPLETED|Overall Study||3
3270407|NCT02661490|4005582|FG001|NOT COMPLETED|Overall Study||2
3270408|NCT02661490|4005583|FG002|NOT COMPLETED|Overall Study||2
3270409|NCT02661490|4005584|FG003|NOT COMPLETED|Overall Study||1
3270410|NCT02661490|4005585|FG004|NOT COMPLETED|Overall Study||3
3270411|NCT02661594|4005601|FG000|STARTED|Overall Study||10
3270412|NCT02661594|4005602|FG001|STARTED|Overall Study||11
3270413|NCT02661594|4005603|FG002|STARTED|Overall Study||10
3270414|NCT02661594|4005604|FG003|STARTED|Overall Study||9
3270415|NCT02661594|4005601|FG000|COMPLETED|Overall Study||9
3270416|NCT02661594|4005602|FG001|COMPLETED|Overall Study||11
3270417|NCT02661594|4005603|FG002|COMPLETED|Overall Study||9
3270418|NCT02661594|4005604|FG003|COMPLETED|Overall Study||9
3270419|NCT02661594|4005601|FG000|NOT COMPLETED|Overall Study||1
3270420|NCT02661594|4005602|FG001|NOT COMPLETED|Overall Study||0
3270421|NCT02661594|4005603|FG002|NOT COMPLETED|Overall Study||1
3270422|NCT02661594|4005604|FG003|NOT COMPLETED|Overall Study||0
3270423|NCT02661737|4005614|FG000|STARTED|Overall Study||503
3270424|NCT02661737|4005614|FG000|COMPLETED|Overall Study||469
3376953|NCT01219673|4110475|FG006|NOT COMPLETED|Overall Study||0
3376954|NCT01219673|4110476|FG007|NOT COMPLETED|Overall Study||0
3376955|NCT01223001|4110496|FG000|STARTED|Overall Study||4
3270425|NCT02661737|4005614|FG000|NOT COMPLETED|Overall Study||34
3270426|NCT02661815|4005622|FG000|STARTED|Overall Study||6
3270427|NCT02661815|4005623|FG001|STARTED|Overall Study||0
3270428|NCT02661815|4005624|FG002|STARTED|Overall Study||0
3270429|NCT02661815|4005625|FG003|STARTED|Overall Study||0
3270430|NCT02661815|4005622|FG000|COMPLETED|Overall Study||5
3270431|NCT02661815|4005623|FG001|COMPLETED|Overall Study||0
3270432|NCT02661815|4005624|FG002|COMPLETED|Overall Study||0
3270433|NCT02661815|4005625|FG003|COMPLETED|Overall Study||0
3376956|NCT01223001|4110497|FG001|STARTED|Overall Study||4
3270434|NCT02661815|4005622|FG000|NOT COMPLETED|Overall Study||1
3270435|NCT02661815|4005623|FG001|NOT COMPLETED|Overall Study||0
3270436|NCT02661815|4005624|FG002|NOT COMPLETED|Overall Study||0
3270437|NCT02661815|4005625|FG003|NOT COMPLETED|Overall Study||0
3270438|NCT02661828|4005641|FG000|STARTED|Overall Study||1
3270439|NCT02661828|4005642|FG001|STARTED|Overall Study||0
3270440|NCT02661828|4005641|FG000|COMPLETED|Overall Study||1
3270441|NCT02661828|4005642|FG001|COMPLETED|Overall Study||0
3270442|NCT02661828|4005641|FG000|NOT COMPLETED|Overall Study||0
3270443|NCT02661828|4005642|FG001|NOT COMPLETED|Overall Study||0
3270444|NCT02662023|4005649|FG000|STARTED|Overall Study||12
3270445|NCT02662023|4005650|FG001|STARTED|Overall Study||12
3270446|NCT02662023|4005649|FG000|COMPLETED|Overall Study||12
3270447|NCT02662023|4005650|FG001|COMPLETED|Overall Study||12
3270448|NCT02662023|4005649|FG000|NOT COMPLETED|Overall Study||0
3270449|NCT02662023|4005650|FG001|NOT COMPLETED|Overall Study||0
3270450|NCT02662036|4005658|FG000|STARTED|Overall Study||35
3270451|NCT02662036|4005659|FG001|STARTED|Overall Study||35
3270452|NCT02662036|4005658|FG000|COMPLETED|Overall Study||22
3270453|NCT02662036|4005659|FG001|COMPLETED|Overall Study||22
3270454|NCT02662036|4005658|FG000|NOT COMPLETED|Overall Study||13
3270455|NCT02662036|4005659|FG001|NOT COMPLETED|Overall Study||13
3270456|NCT02662244|4005665|FG000|STARTED|Overall Study||33
3270457|NCT02662244|4005665|FG000|COMPLETED|Overall Study||31
3270458|NCT02662244|4005665|FG000|NOT COMPLETED|Overall Study||2
3270459|NCT02662387|4005673|FG000|STARTED|Overall Study||27
3270460|NCT02662387|4005674|FG001|STARTED|Overall Study||28
3270461|NCT02662387|4005673|FG000|COMPLETED|Overall Study||27
3270462|NCT02662387|4005674|FG001|COMPLETED|Overall Study||28
3270463|NCT02662387|4005673|FG000|NOT COMPLETED|Overall Study||0
3270464|NCT02662387|4005674|FG001|NOT COMPLETED|Overall Study||0
3270465|NCT02662556|4005682|FG000|STARTED|Overall Study||140
3270466|NCT02662556|4005682|FG000|COMPLETED|Overall Study||132
3270467|NCT02662556|4005682|FG000|NOT COMPLETED|Overall Study||8
3270468|NCT02662569|4005691|FG000|STARTED|Overall Study||166
3270469|NCT02662569|4005692|FG001|STARTED|Overall Study||161
3270470|NCT02662569|4005693|FG002|STARTED|Overall Study||327
3270471|NCT02662569|4005694|FG003|STARTED|Overall Study||332
3270472|NCT02662569|4005691|FG000|Received Study Drug|Overall Study||164
3270473|NCT02662569|4005692|FG001|Received Study Drug|Overall Study||160
3270474|NCT02662569|4005693|FG002|Received Study Drug|Overall Study||325
3270475|NCT02662569|4005694|FG003|Received Study Drug|Overall Study||332
3270476|NCT02662569|4005691|FG000|COMPLETED|Overall Study||159
3270477|NCT02662569|4005692|FG001|COMPLETED|Overall Study||160
3270478|NCT02662569|4005693|FG002|COMPLETED|Overall Study||321
3270479|NCT02662569|4005694|FG003|COMPLETED|Overall Study||328
3270480|NCT02662569|4005691|FG000|NOT COMPLETED|Overall Study||7
3270481|NCT02662569|4005692|FG001|NOT COMPLETED|Overall Study||1
3270482|NCT02662569|4005693|FG002|NOT COMPLETED|Overall Study||6
3270483|NCT02662569|4005694|FG003|NOT COMPLETED|Overall Study||4
3270484|NCT02662582|4005706|FG000|STARTED|Treatment Period 1 (14 Days)||23
3270485|NCT02662582|4005707|FG001|STARTED|Treatment Period 1 (14 Days)||23
3270486|NCT02662582|4005706|FG000|COMPLETED|Treatment Period 1 (14 Days)||18
3270487|NCT02662582|4005707|FG001|COMPLETED|Treatment Period 1 (14 Days)||19
3270488|NCT02662582|4005706|FG000|NOT COMPLETED|Treatment Period 1 (14 Days)||5
3270489|NCT02662582|4005707|FG001|NOT COMPLETED|Treatment Period 1 (14 Days)||4
3270490|NCT02662582|4005706|FG000|STARTED|Washout Period (14 Days)||18
3270491|NCT02662582|4005707|FG001|STARTED|Washout Period (14 Days)||19
3270492|NCT02662582|4005706|FG000|COMPLETED|Washout Period (14 Days)||18
3270493|NCT02662582|4005707|FG001|COMPLETED|Washout Period (14 Days)||19
3270494|NCT02662582|4005706|FG000|NOT COMPLETED|Washout Period (14 Days)||0
3270495|NCT02662582|4005707|FG001|NOT COMPLETED|Washout Period (14 Days)||0
3270496|NCT02662582|4005706|FG000|STARTED|Treatment Period 2 (14 Days)||18
3270497|NCT02662582|4005707|FG001|STARTED|Treatment Period 2 (14 Days)||19
3270498|NCT02662582|4005706|FG000|COMPLETED|Treatment Period 2 (14 Days)||18
3270499|NCT02662582|4005707|FG001|COMPLETED|Treatment Period 2 (14 Days)||19
3270500|NCT02662582|4005706|FG000|NOT COMPLETED|Treatment Period 2 (14 Days)||0
3270501|NCT02662582|4005707|FG001|NOT COMPLETED|Treatment Period 2 (14 Days)||0
3270502|NCT02662608|4005714|FG000|STARTED|Overall Study||1
3376957|NCT01223001|4110496|FG000|COMPLETED|Overall Study||0
3376958|NCT01223001|4110497|FG001|COMPLETED|Overall Study||0
3376959|NCT01223001|4110496|FG000|NOT COMPLETED|Overall Study||4
3376960|NCT01223001|4110497|FG001|NOT COMPLETED|Overall Study||4
3376961|NCT01217060|4110503|FG000|STARTED|Overall Study||4
3376962|NCT01217060|4110503|FG000|COMPLETED|Overall Study||3
3376963|NCT01217060|4110503|FG000|NOT COMPLETED|Overall Study||1
3376964|NCT01217047|4110511|FG000|STARTED|Overall Study||3
3376965|NCT01217047|4110512|FG001|STARTED|Overall Study||4
3376966|NCT01217047|4110513|FG002|STARTED|Overall Study||3
3376967|NCT01217047|4110511|FG000|COMPLETED|Overall Study||3
3376968|NCT01217047|4110512|FG001|COMPLETED|Overall Study||3
3376969|NCT01217047|4110513|FG002|COMPLETED|Overall Study||3
3270503|NCT02662608|4005714|FG000|COMPLETED|Overall Study||1
3376970|NCT01217047|4110511|FG000|NOT COMPLETED|Overall Study||0
3376971|NCT01217047|4110512|FG001|NOT COMPLETED|Overall Study||1
3376972|NCT01217047|4110513|FG002|NOT COMPLETED|Overall Study||0
3376973|NCT01206101|4110524|FG000|STARTED|Overall Study||2
3270504|NCT02662608|4005714|FG000|NOT COMPLETED|Overall Study||0
3270505|NCT02662764|4005718|FG000|STARTED|Overall Study||320
3270506|NCT02662764|4005718|FG000|COMPLETED|Overall Study|First 24-hours of study treatment|290
3270507|NCT02662764|4005718|FG000|NOT COMPLETED|Overall Study||30
3270508|NCT02663128|4005729|FG000|STARTED|Period 1||3
3270509|NCT02663128|4005730|FG001|STARTED|Period 1||3
3270510|NCT02663128|4005731|FG002|STARTED|Period 1||3
3270511|NCT02663128|4005732|FG003|STARTED|Period 1||3
3270512|NCT02663128|4005733|FG004|STARTED|Period 1||3
3270513|NCT02663128|4005734|FG005|STARTED|Period 1||3
3270514|NCT02663128|4005729|FG000|Received at Least One Dose of Study Drug|Period 1||3
3270515|NCT02663128|4005730|FG001|Received at Least One Dose of Study Drug|Period 1||3
3270516|NCT02663128|4005731|FG002|Received at Least One Dose of Study Drug|Period 1||3
3270517|NCT02663128|4005732|FG003|Received at Least One Dose of Study Drug|Period 1||3
3270518|NCT02663128|4005733|FG004|Received at Least One Dose of Study Drug|Period 1||3
3270519|NCT02663128|4005734|FG005|Received at Least One Dose of Study Drug|Period 1||3
3270520|NCT02663128|4005729|FG000|COMPLETED|Period 1||3
3270521|NCT02663128|4005730|FG001|COMPLETED|Period 1||3
3270522|NCT02663128|4005731|FG002|COMPLETED|Period 1||3
3270523|NCT02663128|4005732|FG003|COMPLETED|Period 1||3
3270524|NCT02663128|4005733|FG004|COMPLETED|Period 1||3
3270525|NCT02663128|4005734|FG005|COMPLETED|Period 1||3
3270526|NCT02663128|4005729|FG000|NOT COMPLETED|Period 1||0
3270527|NCT02663128|4005730|FG001|NOT COMPLETED|Period 1||0
3270528|NCT02663128|4005731|FG002|NOT COMPLETED|Period 1||0
3270529|NCT02663128|4005732|FG003|NOT COMPLETED|Period 1||0
3270530|NCT02663128|4005733|FG004|NOT COMPLETED|Period 1||0
3270531|NCT02663128|4005734|FG005|NOT COMPLETED|Period 1||0
3270532|NCT02663128|4005729|FG000|STARTED|Period 2||3
3270533|NCT02663128|4005730|FG001|STARTED|Period 2||3
3270534|NCT02663128|4005731|FG002|STARTED|Period 2||3
3270535|NCT02663128|4005732|FG003|STARTED|Period 2||3
3270536|NCT02663128|4005733|FG004|STARTED|Period 2||3
3270537|NCT02663128|4005734|FG005|STARTED|Period 2||3
3270538|NCT02663128|4005729|FG000|COMPLETED|Period 2||3
3270539|NCT02663128|4005730|FG001|COMPLETED|Period 2||3
3270540|NCT02663128|4005731|FG002|COMPLETED|Period 2||3
3270541|NCT02663128|4005732|FG003|COMPLETED|Period 2||3
3270542|NCT02663128|4005733|FG004|COMPLETED|Period 2||2
3270543|NCT02663128|4005734|FG005|COMPLETED|Period 2||3
3270544|NCT02663128|4005729|FG000|NOT COMPLETED|Period 2||0
3270545|NCT02663128|4005730|FG001|NOT COMPLETED|Period 2||0
3270546|NCT02663128|4005731|FG002|NOT COMPLETED|Period 2||0
3270547|NCT02663128|4005732|FG003|NOT COMPLETED|Period 2||0
3270548|NCT02663128|4005733|FG004|NOT COMPLETED|Period 2||1
3270549|NCT02663128|4005734|FG005|NOT COMPLETED|Period 2||0
3270550|NCT02663128|4005729|FG000|STARTED|Period 3||3
3270551|NCT02663128|4005730|FG001|STARTED|Period 3||3
3270552|NCT02663128|4005731|FG002|STARTED|Period 3||3
3270553|NCT02663128|4005732|FG003|STARTED|Period 3||3
3270554|NCT02663128|4005733|FG004|STARTED|Period 3||2
3270555|NCT02663128|4005734|FG005|STARTED|Period 3||3
3270556|NCT02663128|4005729|FG000|COMPLETED|Period 3||3
3270557|NCT02663128|4005730|FG001|COMPLETED|Period 3||3
3270558|NCT02663128|4005731|FG002|COMPLETED|Period 3||3
3270559|NCT02663128|4005732|FG003|COMPLETED|Period 3||3
3270560|NCT02663128|4005733|FG004|COMPLETED|Period 3||2
3270561|NCT02663128|4005734|FG005|COMPLETED|Period 3||3
3270562|NCT02663128|4005729|FG000|NOT COMPLETED|Period 3||0
3270563|NCT02663128|4005730|FG001|NOT COMPLETED|Period 3||0
3270564|NCT02663128|4005731|FG002|NOT COMPLETED|Period 3||0
3270565|NCT02663128|4005732|FG003|NOT COMPLETED|Period 3||0
3270566|NCT02663128|4005733|FG004|NOT COMPLETED|Period 3||0
3270567|NCT02663128|4005734|FG005|NOT COMPLETED|Period 3||0
3270568|NCT02663232|4005743|FG000|STARTED|Overall Study||264
3270569|NCT02663232|4005743|FG000|COMPLETED|Overall Study||264
3270570|NCT02663232|4005743|FG000|NOT COMPLETED|Overall Study||0
3270571|NCT02663453|4005749|FG000|STARTED|Overall Study||22
3270572|NCT02663453|4005750|FG001|STARTED|Overall Study||22
3270573|NCT02663453|4005749|FG000|COMPLETED|Overall Study||17
3270574|NCT02663453|4005750|FG001|COMPLETED|Overall Study||18
3270575|NCT02663453|4005749|FG000|NOT COMPLETED|Overall Study||5
3270576|NCT02663453|4005750|FG001|NOT COMPLETED|Overall Study||4
3270577|NCT02663674|4005758|FG000|STARTED|Overall Study||33
3270578|NCT02663674|4005759|FG001|STARTED|Overall Study||39
3270579|NCT02663674|4005758|FG000|COMPLETED|Overall Study||26
3270580|NCT02663674|4005759|FG001|COMPLETED|Overall Study||29
3270581|NCT02663674|4005758|FG000|NOT COMPLETED|Overall Study||7
3270582|NCT02663674|4005759|FG001|NOT COMPLETED|Overall Study||10
3270583|NCT02663687|4005770|FG000|STARTED|Overall Study||12
3270584|NCT02663687|4005771|FG001|STARTED|Overall Study||9
3270585|NCT02663687|4005772|FG002|STARTED|Overall Study||9
3270586|NCT02663687|4005773|FG003|STARTED|Overall Study||9
3270587|NCT02663687|4005774|FG004|STARTED|Overall Study||9
3270588|NCT02663687|4005770|FG000|Treatment Period 1 (IV)|Overall Study||12
3270589|NCT02663687|4005771|FG001|Treatment Period 1 (IV)|Overall Study||9
3270590|NCT02663687|4005772|FG002|Treatment Period 1 (IV)|Overall Study||9
3270591|NCT02663687|4005773|FG003|Treatment Period 1 (IV)|Overall Study||9
3270592|NCT02663687|4005774|FG004|Treatment Period 1 (IV)|Overall Study||9
3270593|NCT02663687|4005770|FG000|Treatment Period 2 (SC)|Overall Study||10
3270594|NCT02663687|4005771|FG001|Treatment Period 2 (SC)|Overall Study||9
3270595|NCT02663687|4005772|FG002|Treatment Period 2 (SC)|Overall Study||8
3270596|NCT02663687|4005773|FG003|Treatment Period 2 (SC)|Overall Study||9
3270597|NCT02663687|4005774|FG004|Treatment Period 2 (SC)|Overall Study||9
3270598|NCT02663687|4005770|FG000|COMPLETED|Overall Study||10
3270599|NCT02663687|4005771|FG001|COMPLETED|Overall Study||9
3270600|NCT02663687|4005772|FG002|COMPLETED|Overall Study||8
3270601|NCT02663687|4005773|FG003|COMPLETED|Overall Study||9
3270602|NCT02663687|4005774|FG004|COMPLETED|Overall Study||9
3270603|NCT02663687|4005770|FG000|NOT COMPLETED|Overall Study||2
3270604|NCT02663687|4005771|FG001|NOT COMPLETED|Overall Study||0
3270605|NCT02663687|4005772|FG002|NOT COMPLETED|Overall Study||1
3270606|NCT02663687|4005773|FG003|NOT COMPLETED|Overall Study||0
3270607|NCT02663687|4005774|FG004|NOT COMPLETED|Overall Study||0
3270608|NCT02663817|4005799|FG000|STARTED|Overall Study||52
3270609|NCT02663817|4005799|FG000|COMPLETED|Overall Study||50
3376974|NCT01206101|4110525|FG001|STARTED|Overall Study||1
3376975|NCT01206101|4110524|FG000|COMPLETED|Overall Study||0
3376976|NCT01206101|4110525|FG001|COMPLETED|Overall Study||0
3376977|NCT01206101|4110524|FG000|NOT COMPLETED|Overall Study||2
3376978|NCT01206101|4110525|FG001|NOT COMPLETED|Overall Study||1
3376979|NCT01216631|4110534|FG000|STARTED|Overall Study||0
3376980|NCT01216631|4110535|FG001|STARTED|Overall Study||0
3376981|NCT01216631|4110536|FG002|STARTED|Overall Study||1
3376982|NCT01216631|4110534|FG000|COMPLETED|Overall Study||0
3376983|NCT01216631|4110535|FG001|COMPLETED|Overall Study||0
3376984|NCT01216631|4110536|FG002|COMPLETED|Overall Study||1
3376985|NCT01216631|4110534|FG000|NOT COMPLETED|Overall Study||0
3376986|NCT01216631|4110535|FG001|NOT COMPLETED|Overall Study||0
3376987|NCT01216631|4110536|FG002|NOT COMPLETED|Overall Study||0
3376988|NCT01211756|4110544|FG000|STARTED|Overall Study||1
3376989|NCT01211756|4110544|FG000|COMPLETED|Overall Study||1
3376990|NCT01211756|4110544|FG000|NOT COMPLETED|Overall Study||0
3376991|NCT01209520|4110548|FG000|STARTED|Overall Study||6
3376992|NCT01209520|4110548|FG000|COMPLETED|Overall Study||3
3376993|NCT01209520|4110548|FG000|NOT COMPLETED|Overall Study||3
3376994|NCT01207726|4110554|FG000|STARTED|Overall Study||7
3376995|NCT01207726|4110555|FG001|STARTED|Overall Study||6
3376996|NCT01207726|4110554|FG000|COMPLETED|Overall Study||7
3376997|NCT01207726|4110555|FG001|COMPLETED|Overall Study||6
3376998|NCT01207726|4110554|FG000|NOT COMPLETED|Overall Study||0
3376999|NCT01207726|4110555|FG001|NOT COMPLETED|Overall Study||0
3377000|NCT01206296|4110565|FG000|STARTED|Overall Study||0
3377001|NCT01206296|4110565|FG000|COMPLETED|Overall Study||0
3377002|NCT01206296|4110565|FG000|NOT COMPLETED|Overall Study||0
3377003|NCT01207102|4110569|FG000|STARTED|Overall Study||10
3270610|NCT02663817|4005799|FG000|NOT COMPLETED|Overall Study||2
3377004|NCT01207102|4110569|FG000|COMPLETED|Overall Study||0
3270611|NCT02663882|4005807|FG000|STARTED|Overall Study||39
3270612|NCT02663882|4005808|FG001|STARTED|Overall Study||36
3270613|NCT02663882|4005807|FG000|COMPLETED|Overall Study||35
3270614|NCT02663882|4005808|FG001|COMPLETED|Overall Study||34
3270615|NCT02663882|4005807|FG000|NOT COMPLETED|Overall Study||4
3270616|NCT02663882|4005808|FG001|NOT COMPLETED|Overall Study||2
3270617|NCT02663895|4005814|FG000|STARTED|Overall Study||12
3270618|NCT02663895|4005814|FG000|COMPLETED|Overall Study||5
3270619|NCT02663895|4005814|FG000|NOT COMPLETED|Overall Study||7
3270620|NCT02664220|4005821|FG000|STARTED|Overall Study||50
3270621|NCT02664220|4005822|FG001|STARTED|Overall Study||50
3270622|NCT02664220|4005821|FG000|COMPLETED|Overall Study||50
3270623|NCT02664220|4005822|FG001|COMPLETED|Overall Study||50
3270624|NCT02664220|4005821|FG000|NOT COMPLETED|Overall Study||0
3270625|NCT02664220|4005822|FG001|NOT COMPLETED|Overall Study||0
3270626|NCT02664272|4005828|FG000|STARTED|Overall Study||40
3270627|NCT02664272|4005828|FG000|COMPLETED|Overall Study||38
3270628|NCT02664272|4005828|FG000|NOT COMPLETED|Overall Study||2
3270629|NCT02664311|4005834|FG000|STARTED|Overall Study||6
3270630|NCT02664311|4005835|FG001|STARTED|Overall Study||3
3270631|NCT02664311|4005834|FG000|COMPLETED|Overall Study||6
3270632|NCT02664311|4005835|FG001|COMPLETED|Overall Study||3
3270633|NCT02664311|4005834|FG000|NOT COMPLETED|Overall Study||0
3270634|NCT02664311|4005835|FG001|NOT COMPLETED|Overall Study||0
3270635|NCT02664363|4005841|FG000|STARTED|Overall Study||3
3270636|NCT02664363|4005841|FG000|COMPLETED|Overall Study||3
3270637|NCT02664363|4005841|FG000|NOT COMPLETED|Overall Study||0
3270638|NCT02664415|4005847|FG000|STARTED|Overall Study||14
3270639|NCT02664415|4005848|FG001|STARTED|Overall Study||5
3270640|NCT02664415|4005847|FG000|COMPLETED|Overall Study||13
3270641|NCT02664415|4005848|FG001|COMPLETED|Overall Study||5
3270642|NCT02664415|4005847|FG000|NOT COMPLETED|Overall Study||1
3270643|NCT02664415|4005848|FG001|NOT COMPLETED|Overall Study||0
3270644|NCT02664532|4005856|FG000|STARTED|Overall Study||75
3270645|NCT02664532|4005857|FG001|STARTED|Overall Study||75
3270646|NCT02664532|4005856|FG000|COMPLETED|Overall Study||75
3270647|NCT02664532|4005857|FG001|COMPLETED|Overall Study||75
3270648|NCT02664532|4005856|FG000|NOT COMPLETED|Overall Study||0
3270649|NCT02664532|4005857|FG001|NOT COMPLETED|Overall Study||0
3270650|NCT02664610|4005865|FG000|STARTED|Overall Study||46
3270651|NCT02664610|4005866|FG001|STARTED|Overall Study||48
3270652|NCT02664610|4005865|FG000|COMPLETED|Overall Study||32
3270653|NCT02664610|4005866|FG001|COMPLETED|Overall Study||41
3270654|NCT02664610|4005865|FG000|NOT COMPLETED|Overall Study||14
3270655|NCT02664610|4005866|FG001|NOT COMPLETED|Overall Study||7
3377005|NCT01207102|4110569|FG000|NOT COMPLETED|Overall Study||10
3377006|NCT01213329|4110575|FG000|STARTED|Screening||25
3377007|NCT01213329|4110576|FG001|STARTED|Screening||25
3377008|NCT01213329|4110575|FG000|COMPLETED|Screening||25
3377009|NCT01213329|4110576|FG001|COMPLETED|Screening||25
3377010|NCT01213329|4110575|FG000|NOT COMPLETED|Screening||0
3377011|NCT01213329|4110576|FG001|NOT COMPLETED|Screening||0
3377012|NCT01213329|4110575|FG000|STARTED|Phase 2|No subjects continued into phase 2.This is due to a loss of samples from a processing inconsistency.|0
3377013|NCT01213329|4110576|FG001|STARTED|Phase 2|No subjects continued into phase 2.This is due to a loss of samples from a processing inconsistency.|0
3377014|NCT01213329|4110575|FG000|COMPLETED|Phase 2||0
3377015|NCT01213329|4110576|FG001|COMPLETED|Phase 2||0
3377016|NCT01213329|4110575|FG000|NOT COMPLETED|Phase 2||0
3377017|NCT01213329|4110576|FG001|NOT COMPLETED|Phase 2||0
3377018|NCT01202110|4110582|FG000|STARTED|Overall Study||10
3377019|NCT01202110|4110583|FG001|STARTED|Overall Study||0
3377020|NCT01202110|4110582|FG000|COMPLETED|Overall Study||10
3377021|NCT01202110|4110583|FG001|COMPLETED|Overall Study||0
3377022|NCT01202110|4110582|FG000|NOT COMPLETED|Overall Study||0
3377023|NCT01202110|4110583|FG001|NOT COMPLETED|Overall Study||0
3377024|NCT01206439|4110587|FG000|STARTED|Overall Study||2
3377025|NCT01206439|4110587|FG000|COMPLETED|Overall Study||1
3377026|NCT01206439|4110587|FG000|NOT COMPLETED|Overall Study||1
3377027|NCT01204788|4110593|FG000|STARTED|Overall Study||1
3377028|NCT01204788|4110594|FG001|STARTED|Overall Study||3
3377029|NCT01204788|4110593|FG000|COMPLETED|Overall Study||0
3377030|NCT01204788|4110594|FG001|COMPLETED|Overall Study||0
3377031|NCT01204788|4110593|FG000|NOT COMPLETED|Overall Study||1
3377032|NCT01204788|4110594|FG001|NOT COMPLETED|Overall Study||3
3377033|NCT01200602|4110602|FG000|STARTED|Overall Study||0
3377034|NCT01200602|4110603|FG001|STARTED|Overall Study||0
3377035|NCT01200602|4110602|FG000|COMPLETED|Overall Study||0
3377036|NCT01200602|4110603|FG001|COMPLETED|Overall Study||0
3377037|NCT01200602|4110602|FG000|NOT COMPLETED|Overall Study||0
3377038|NCT01200602|4110603|FG001|NOT COMPLETED|Overall Study||0
3377039|NCT01198548|4110609|FG000|STARTED|Overall Study||10
3377040|NCT01198548|4110609|FG000|COMPLETED|Overall Study||0
3377041|NCT01198548|4110609|FG000|NOT COMPLETED|Overall Study||10
3377042|NCT01194908|4110613|FG000|STARTED|Overall Study||5
3377043|NCT01194908|4110613|FG000|COMPLETED|Overall Study||5
3377044|NCT01194908|4110613|FG000|NOT COMPLETED|Overall Study||0
3377045|NCT01194856|4110619|FG000|STARTED|Overall Study||1
3377046|NCT01194856|4110620|FG001|STARTED|Overall Study||0
3377047|NCT01194856|4110619|FG000|COMPLETED|Overall Study||0
3377048|NCT01194856|4110620|FG001|COMPLETED|Overall Study||0
3377049|NCT01194856|4110619|FG000|NOT COMPLETED|Overall Study||1
3377050|NCT01194856|4110620|FG001|NOT COMPLETED|Overall Study||0
3377051|NCT01194427|4110626|FG000|STARTED|Overall Study||2
3270656|NCT02664909|4005874|FG000|STARTED|Overall Study||17
3270657|NCT02664909|4005875|FG001|STARTED|Overall Study||19
3270658|NCT02664909|4005874|FG000|COMPLETED|Overall Study||15
3270659|NCT02664909|4005875|FG001|COMPLETED|Overall Study||16
3270660|NCT02664909|4005874|FG000|NOT COMPLETED|Overall Study||2
3270661|NCT02664909|4005875|FG001|NOT COMPLETED|Overall Study||3
3270662|NCT02664922|4005885|FG000|STARTED|Overall Study||11
3270663|NCT02664922|4005886|FG001|STARTED|Overall Study||12
3270664|NCT02664922|4005887|FG002|STARTED|Overall Study||7
3270665|NCT02664922|4005888|FG003|STARTED|Overall Study||5
3270666|NCT02664922|4005885|FG000|COMPLETED|Overall Study||10
3270667|NCT02664922|4005886|FG001|COMPLETED|Overall Study||12
3270668|NCT02664922|4005887|FG002|COMPLETED|Overall Study||7
3270669|NCT02664922|4005888|FG003|COMPLETED|Overall Study||5
3270670|NCT02664922|4005885|FG000|NOT COMPLETED|Overall Study||1
3270671|NCT02664922|4005886|FG001|NOT COMPLETED|Overall Study||0
3270672|NCT02664922|4005887|FG002|NOT COMPLETED|Overall Study||0
3270673|NCT02664922|4005888|FG003|NOT COMPLETED|Overall Study||0
3270674|NCT02664961|4005898|FG000|STARTED|Overall Study||3
3270675|NCT02664961|4005898|FG000|COMPLETED|Overall Study||3
3270676|NCT02664961|4005898|FG000|NOT COMPLETED|Overall Study||0
3270677|NCT02664987|4005902|FG000|STARTED|Overall Study||462
3270678|NCT02664987|4005902|FG000|COMPLETED|Overall Study||462
3270679|NCT02664987|4005902|FG000|NOT COMPLETED|Overall Study||0
3270680|NCT02665052|4005910|FG000|STARTED|Overall Study||11
3270681|NCT02665052|4005911|FG001|STARTED|Overall Study||9
3270682|NCT02665052|4005912|FG002|STARTED|Overall Study||9
3270683|NCT02665052|4005913|FG003|STARTED|Overall Study||19
3270684|NCT02665052|4005910|FG000|COMPLETED|Overall Study||8
3270685|NCT02665052|4005911|FG001|COMPLETED|Overall Study||7
3270686|NCT02665052|4005912|FG002|COMPLETED|Overall Study||9
3270687|NCT02665052|4005913|FG003|COMPLETED|Overall Study||14
3270688|NCT02665052|4005910|FG000|NOT COMPLETED|Overall Study||3
3270689|NCT02665052|4005911|FG001|NOT COMPLETED|Overall Study||2
3270690|NCT02665052|4005912|FG002|NOT COMPLETED|Overall Study||0
3270691|NCT02665052|4005913|FG003|NOT COMPLETED|Overall Study||5
3270692|NCT02665260|4005928|FG000|STARTED|Overall Study||24
3270693|NCT02665260|4005929|FG001|STARTED|Overall Study||23
3270694|NCT02665260|4005930|FG002|STARTED|Overall Study||25
3270695|NCT02665260|4005931|FG003|STARTED|Overall Study||22
3270696|NCT02665260|4005928|FG000|COMPLETED|Overall Study||22
3270697|NCT02665260|4005929|FG001|COMPLETED|Overall Study||22
3270698|NCT02665260|4005930|FG002|COMPLETED|Overall Study||21
3270699|NCT02665260|4005931|FG003|COMPLETED|Overall Study||21
3270700|NCT02665260|4005928|FG000|NOT COMPLETED|Overall Study||2
3270701|NCT02665260|4005929|FG001|NOT COMPLETED|Overall Study||1
3270702|NCT02665260|4005930|FG002|NOT COMPLETED|Overall Study||4
3270703|NCT02665260|4005931|FG003|NOT COMPLETED|Overall Study||1
3270704|NCT02665273|4005947|FG000|STARTED|Overall Study||13
3270705|NCT02665273|4005948|FG001|STARTED|Overall Study||15
3270706|NCT02665273|4005947|FG000|COMPLETED|Overall Study||13
3270707|NCT02665273|4005948|FG001|COMPLETED|Overall Study||15
3270708|NCT02665273|4005947|FG000|NOT COMPLETED|Overall Study||0
3270709|NCT02665273|4005948|FG001|NOT COMPLETED|Overall Study||0
3270710|NCT02665286|4005957|FG000|STARTED|Overall Study||79
3270711|NCT02665286|4005958|FG001|STARTED|Overall Study||80
3270712|NCT02665286|4005959|FG002|STARTED|Overall Study||81
3270713|NCT02665286|4005957|FG000|COMPLETED|Overall Study||76
3270714|NCT02665286|4005958|FG001|COMPLETED|Overall Study||78
3377052|NCT01194427|4110626|FG000|COMPLETED|Overall Study||2
3377053|NCT01194427|4110626|FG000|NOT COMPLETED|Overall Study||0
3377054|NCT01193556|4110632|FG000|STARTED|Overall Study||26
3377055|NCT01193556|4110633|FG001|STARTED|Overall Study||25
3377056|NCT01193556|4110632|FG000|COMPLETED|Overall Study||0
3377057|NCT01193556|4110633|FG001|COMPLETED|Overall Study||0
3377058|NCT01193556|4110632|FG000|NOT COMPLETED|Overall Study||26
3377059|NCT01193556|4110633|FG001|NOT COMPLETED|Overall Study||25
3377060|NCT01189435|4110639|FG000|STARTED|Overall Study||2
3377061|NCT01189435|4110639|FG000|COMPLETED|Overall Study||0
3377062|NCT01189435|4110639|FG000|NOT COMPLETED|Overall Study||2
3377063|NCT01193530|4110645|FG000|STARTED|Overall Study||4
3377064|NCT01193530|4110646|FG001|STARTED|Overall Study||8
3377065|NCT01193530|4110645|FG000|COMPLETED|Overall Study||1
3377066|NCT01193530|4110646|FG001|COMPLETED|Overall Study||3
3377067|NCT01193530|4110645|FG000|NOT COMPLETED|Overall Study||3
3377068|NCT01193530|4110646|FG001|NOT COMPLETED|Overall Study||5
3377069|NCT01182610|4110652|FG000|STARTED|Overall Study||1
3377070|NCT01182610|4110652|FG000|COMPLETED|Overall Study||1
3377071|NCT01182610|4110652|FG000|NOT COMPLETED|Overall Study||0
3377072|NCT01189071|4110658|FG000|STARTED|Overall Study||0
3377073|NCT01189071|4110659|FG001|STARTED|Overall Study||0
3377074|NCT01189071|4110658|FG000|COMPLETED|Overall Study||0
3377075|NCT01189071|4110659|FG001|COMPLETED|Overall Study||0
3377076|NCT01189071|4110658|FG000|NOT COMPLETED|Overall Study||0
3377077|NCT01189071|4110659|FG001|NOT COMPLETED|Overall Study||0
3377078|NCT01183416|4110665|FG000|STARTED|Overall Study||4
3270715|NCT02665286|4005959|FG002|COMPLETED|Overall Study||80
3270716|NCT02665286|4005957|FG000|NOT COMPLETED|Overall Study||3
3270717|NCT02665286|4005958|FG001|NOT COMPLETED|Overall Study||2
3270718|NCT02665286|4005959|FG002|NOT COMPLETED|Overall Study||1
3270719|NCT02665364|4005969|FG000|STARTED|Overall Study||91
3270720|NCT02665364|4005970|FG001|STARTED|Overall Study||93
3270721|NCT02665364|4005969|FG000|COMPLETED|Overall Study||85
3377079|NCT01183416|4110665|FG000|COMPLETED|Overall Study||4
3270722|NCT02665364|4005970|FG001|COMPLETED|Overall Study||84
3270723|NCT02665364|4005969|FG000|NOT COMPLETED|Overall Study||6
3270724|NCT02665364|4005970|FG001|NOT COMPLETED|Overall Study||9
3270725|NCT02665455|4005976|FG000|STARTED|Overall Study||83
3270726|NCT02665455|4005976|FG000|COMPLETED|Overall Study||74
3270727|NCT02665455|4005976|FG000|NOT COMPLETED|Overall Study||9
3270728|NCT02665468|4005982|FG000|STARTED|Overall Study||595
3270729|NCT02665468|4005983|FG001|STARTED|Overall Study||601
3270730|NCT02665468|4005982|FG000|COMPLETED|Overall Study||595
3270731|NCT02665468|4005983|FG001|COMPLETED|Overall Study||601
3270732|NCT02665468|4005982|FG000|NOT COMPLETED|Overall Study||0
3270733|NCT02665468|4005983|FG001|NOT COMPLETED|Overall Study||0
3270734|NCT02665689|4005991|FG000|STARTED|Overall Study||2
3270735|NCT02665689|4005992|FG001|STARTED|Overall Study||2
3270736|NCT02665689|4005991|FG000|COMPLETED|Overall Study||0
3270737|NCT02665689|4005992|FG001|COMPLETED|Overall Study||0
3270738|NCT02665689|4005991|FG000|NOT COMPLETED|Overall Study||2
3270739|NCT02665689|4005992|FG001|NOT COMPLETED|Overall Study||2
3270740|NCT02665728|4005998|FG000|STARTED|Overall Study||33
3270741|NCT02665728|4005998|FG000|COMPLETED|Overall Study||33
3270742|NCT02665728|4005998|FG000|NOT COMPLETED|Overall Study||0
3270743|NCT02665741|4006005|FG000|STARTED|Overall Study||42
3270744|NCT02665741|4006006|FG001|STARTED|Overall Study||42
3270745|NCT02665741|4006007|FG002|STARTED|Overall Study||42
3270746|NCT02665741|4006005|FG000|COMPLETED|Overall Study||42
3270747|NCT02665741|4006006|FG001|COMPLETED|Overall Study||42
3270748|NCT02665741|4006007|FG002|COMPLETED|Overall Study||42
3270749|NCT02665741|4006005|FG000|NOT COMPLETED|Overall Study||0
3270750|NCT02665741|4006006|FG001|NOT COMPLETED|Overall Study||0
3270751|NCT02665741|4006007|FG002|NOT COMPLETED|Overall Study||0
3270752|NCT02665975|4006017|FG000|STARTED|Overall Study||46
3270753|NCT02665975|4006018|FG001|STARTED|Overall Study||46
3270754|NCT02665975|4006017|FG000|COMPLETED|Overall Study||37
3270755|NCT02665975|4006018|FG001|COMPLETED|Overall Study||37
3270756|NCT02665975|4006017|FG000|NOT COMPLETED|Overall Study||9
3270757|NCT02665975|4006018|FG001|NOT COMPLETED|Overall Study||9
3270758|NCT02666222|4006024|FG000|STARTED|Overall Study||51
3270759|NCT02666222|4006024|FG000|COMPLETED|Overall Study||49
3270760|NCT02666222|4006024|FG000|NOT COMPLETED|Overall Study||2
3270761|NCT02666352|4006031|FG000|STARTED|Overall Study||8
3270762|NCT02666352|4006032|FG001|STARTED|Overall Study||8
3270763|NCT02666352|4006033|FG002|STARTED|Overall Study||8
3270764|NCT02666352|4006031|FG000|COMPLETED|Overall Study||8
3270765|NCT02666352|4006032|FG001|COMPLETED|Overall Study||8
3270766|NCT02666352|4006033|FG002|COMPLETED|Overall Study||8
3270767|NCT02666352|4006031|FG000|NOT COMPLETED|Overall Study||0
3270768|NCT02666352|4006032|FG001|NOT COMPLETED|Overall Study||0
3270769|NCT02666352|4006033|FG002|NOT COMPLETED|Overall Study||0
3270770|NCT02666430|4006043|FG000|STARTED|Baseline||64
3270771|NCT02666430|4006044|FG001|STARTED|Baseline||63
3270772|NCT02666430|4006043|FG000|COMPLETED|Baseline||64
3270773|NCT02666430|4006044|FG001|COMPLETED|Baseline||63
3270774|NCT02666430|4006043|FG000|NOT COMPLETED|Baseline||0
3270775|NCT02666430|4006044|FG001|NOT COMPLETED|Baseline||0
3270776|NCT02666430|4006043|FG000|STARTED|Period 1||64
3270777|NCT02666430|4006044|FG001|STARTED|Period 1||63
3270778|NCT02666430|4006043|FG000|COMPLETED|Period 1||63
3270779|NCT02666430|4006044|FG001|COMPLETED|Period 1||62
3270780|NCT02666430|4006043|FG000|NOT COMPLETED|Period 1||1
3270781|NCT02666430|4006044|FG001|NOT COMPLETED|Period 1||1
3270782|NCT02666430|4006043|FG000|STARTED|Period 2||63
3270783|NCT02666430|4006044|FG001|STARTED|Period 2||62
3270784|NCT02666430|4006043|FG000|COMPLETED|Period 2||62
3270785|NCT02666430|4006044|FG001|COMPLETED|Period 2||58
3270786|NCT02666430|4006043|FG000|NOT COMPLETED|Period 2||1
3270787|NCT02666430|4006044|FG001|NOT COMPLETED|Period 2||4
3270788|NCT02666430|4006043|FG000|STARTED|Period 3||62
3270789|NCT02666430|4006044|FG001|STARTED|Period 3||58
3270790|NCT02666430|4006043|FG000|COMPLETED|Period 3||61
3270791|NCT02666430|4006044|FG001|COMPLETED|Period 3||58
3270792|NCT02666430|4006043|FG000|NOT COMPLETED|Period 3||1
3270793|NCT02666430|4006044|FG001|NOT COMPLETED|Period 3||0
3270794|NCT02666508|4006052|FG000|STARTED|Overall Study||31
3270795|NCT02666508|4006053|FG001|STARTED|Overall Study||30
3270796|NCT02666508|4006052|FG000|COMPLETED|Overall Study||31
3270797|NCT02666508|4006053|FG001|COMPLETED|Overall Study||30
3270798|NCT02666508|4006052|FG000|NOT COMPLETED|Overall Study||0
3270799|NCT02666508|4006053|FG001|NOT COMPLETED|Overall Study||0
3270800|NCT02666560|4006063|FG000|STARTED|Condition 1 (1 Day)||8
3270801|NCT02666560|4006064|FG001|STARTED|Condition 1 (1 Day)||11
3270802|NCT02666560|4006063|FG000|COMPLETED|Condition 1 (1 Day)||8
3270803|NCT02666560|4006064|FG001|COMPLETED|Condition 1 (1 Day)||11
3270804|NCT02666560|4006063|FG000|NOT COMPLETED|Condition 1 (1 Day)||0
3270805|NCT02666560|4006064|FG001|NOT COMPLETED|Condition 1 (1 Day)||0
3270806|NCT02666560|4006063|FG000|STARTED|Condition 2 (1 Day)||8
3270807|NCT02666560|4006064|FG001|STARTED|Condition 2 (1 Day)||11
3270808|NCT02666560|4006063|FG000|COMPLETED|Condition 2 (1 Day)||8
3270809|NCT02666560|4006064|FG001|COMPLETED|Condition 2 (1 Day)||11
3270810|NCT02666560|4006063|FG000|NOT COMPLETED|Condition 2 (1 Day)||0
3270811|NCT02666560|4006064|FG001|NOT COMPLETED|Condition 2 (1 Day)||0
3270812|NCT02666664|4006073|FG000|STARTED|Overall Study||742
3270813|NCT02666664|4006074|FG001|STARTED|Overall Study||1488
3270814|NCT02666664|4006073|FG000|COMPLETED|Overall Study||706
3270815|NCT02666664|4006074|FG001|COMPLETED|Overall Study||1404
3270816|NCT02666664|4006073|FG000|NOT COMPLETED|Overall Study||36
3270817|NCT02666664|4006074|FG001|NOT COMPLETED|Overall Study||84
3270818|NCT02666742|4006082|FG000|STARTED|Overall Study||123
3270819|NCT02666742|4006083|FG001|STARTED|Overall Study||123
3270820|NCT02666742|4006082|FG000|COMPLETED|Overall Study||123
3270821|NCT02666742|4006083|FG001|COMPLETED|Overall Study||123
3270822|NCT02666742|4006082|FG000|NOT COMPLETED|Overall Study||0
3270823|NCT02666742|4006083|FG001|NOT COMPLETED|Overall Study||0
3270824|NCT02666846|4006094|FG000|STARTED|Overall Study||20
3270825|NCT02666846|4006095|FG001|STARTED|Overall Study||20
3270826|NCT02666846|4006096|FG002|STARTED|Overall Study||20
3270827|NCT02666846|4006094|FG000|COMPLETED|Overall Study||20
3270828|NCT02666846|4006095|FG001|COMPLETED|Overall Study||20
3270829|NCT02666846|4006096|FG002|COMPLETED|Overall Study||20
3270830|NCT02666846|4006094|FG000|NOT COMPLETED|Overall Study||0
3270831|NCT02666846|4006095|FG001|NOT COMPLETED|Overall Study||0
3270832|NCT02666846|4006096|FG002|NOT COMPLETED|Overall Study||0
3270833|NCT02666950|4006126|FG000|STARTED|Overall Study||3
3270834|NCT02666950|4006126|FG000|COMPLETED|Overall Study||3
3270835|NCT02666950|4006126|FG000|NOT COMPLETED|Overall Study||0
3270836|NCT02667236|4006132|FG000|STARTED|Overall Study||223
3270837|NCT02667236|4006133|FG001|STARTED|Overall Study||227
3270838|NCT02667236|4006132|FG000|COMPLETED|Overall Study||220
3270839|NCT02667236|4006133|FG001|COMPLETED|Overall Study||226
3270840|NCT02667236|4006132|FG000|NOT COMPLETED|Overall Study||3
3270841|NCT02667236|4006133|FG001|NOT COMPLETED|Overall Study||1
3270842|NCT02667275|4006141|FG000|STARTED|Overall Study||244
3270843|NCT02667275|4006142|FG001|STARTED|Overall Study||243
3270844|NCT02667275|4006141|FG000|COMPLETED|Overall Study||233
3270845|NCT02667275|4006142|FG001|COMPLETED|Overall Study||228
3270846|NCT02667275|4006141|FG000|NOT COMPLETED|Overall Study||11
3270847|NCT02667275|4006142|FG001|NOT COMPLETED|Overall Study||15
3270848|NCT02667288|4006148|FG000|STARTED|Overall Study||147
3270849|NCT02667288|4006148|FG000|COMPLETED|Overall Study||134
3270850|NCT02667288|4006148|FG000|NOT COMPLETED|Overall Study||13
3270851|NCT02667301|4006152|FG000|STARTED|Overall Study||16
3270852|NCT02667301|4006152|FG000|COMPLETED|Overall Study||14
3270853|NCT02667301|4006152|FG000|NOT COMPLETED|Overall Study||2
3270854|NCT02667392|4006158|FG000|STARTED|Overall Study||11
3270855|NCT02667392|4006158|FG000|COMPLETED|Overall Study||11
3270856|NCT02667392|4006158|FG000|NOT COMPLETED|Overall Study||0
3270857|NCT02667457|4006164|FG000|STARTED|Overall Study||27
3270858|NCT02667457|4006165|FG001|STARTED|Overall Study||12
3270859|NCT02667457|4006164|FG000|Dosed Participants|Overall Study||26
3270860|NCT02667457|4006165|FG001|Dosed Participants|Overall Study||10
3270861|NCT02667457|4006164|FG000|Full Analysis Set Population (FAS)|Overall Study||25
3270862|NCT02667457|4006165|FG001|Full Analysis Set Population (FAS)|Overall Study||10
3270863|NCT02667457|4006164|FG000|COMPLETED|Overall Study||26
3270864|NCT02667457|4006165|FG001|COMPLETED|Overall Study||10
3270865|NCT02667457|4006164|FG000|NOT COMPLETED|Overall Study||1
3270866|NCT02667457|4006165|FG001|NOT COMPLETED|Overall Study||2
3270867|NCT02667626|4006174|FG000|STARTED|Overall Study||86
3270868|NCT02667626|4006175|FG001|STARTED|Overall Study||96
3270869|NCT02667626|4006174|FG000|COMPLETED|Overall Study||86
3270870|NCT02667626|4006175|FG001|COMPLETED|Overall Study||95
3270871|NCT02667626|4006174|FG000|NOT COMPLETED|Overall Study||0
3270872|NCT02667626|4006175|FG001|NOT COMPLETED|Overall Study||1
3270873|NCT02667704|4006184|FG000|STARTED|Treatment Period 1||13
3270874|NCT02667704|4006184|FG000|COMPLETED|Treatment Period 1||13
3270875|NCT02667704|4006184|FG000|NOT COMPLETED|Treatment Period 1||0
3270876|NCT02667704|4006184|FG000|STARTED|Treatment Period 2||13
3270877|NCT02667704|4006184|FG000|COMPLETED|Treatment Period 2||13
3270878|NCT02667704|4006184|FG000|NOT COMPLETED|Treatment Period 2||0
3270879|NCT02667821|4006191|FG000|STARTED|Overall Study||20
3270880|NCT02667821|4006191|FG000|COMPLETED|Overall Study||20
3270881|NCT02667821|4006191|FG000|NOT COMPLETED|Overall Study||0
3270882|NCT02667912|4006198|FG000|STARTED|Overall Study||28
3270883|NCT02667912|4006199|FG001|STARTED|Overall Study||27
3270884|NCT02667912|4006198|FG000|Six Months|Overall Study||27
3270885|NCT02667912|4006199|FG001|Six Months|Overall Study||24
3270886|NCT02667912|4006198|FG000|COMPLETED|Overall Study||23
3270887|NCT02667912|4006199|FG001|COMPLETED|Overall Study||24
3270888|NCT02667912|4006198|FG000|NOT COMPLETED|Overall Study||5
3270889|NCT02667912|4006199|FG001|NOT COMPLETED|Overall Study||3
3270890|NCT02667951|4006207|FG000|STARTED|Overall Study||66
3270891|NCT02667951|4006208|FG001|STARTED|Overall Study||63
3270892|NCT02667951|4006207|FG000|COMPLETED|Overall Study||45
3270893|NCT02667951|4006208|FG001|COMPLETED|Overall Study||40
3270894|NCT02667951|4006207|FG000|NOT COMPLETED|Overall Study||21
3270895|NCT02667951|4006208|FG001|NOT COMPLETED|Overall Study||23
3270896|NCT02668003|4006216|FG000|STARTED|Overall Study||501
3270897|NCT02668003|4006217|FG001|STARTED|Overall Study||501
3270898|NCT02668003|4006216|FG000|COMPLETED|Overall Study||500
3270899|NCT02668003|4006217|FG001|COMPLETED|Overall Study||496
3270900|NCT02668003|4006216|FG000|NOT COMPLETED|Overall Study||1
3270901|NCT02668003|4006217|FG001|NOT COMPLETED|Overall Study||5
3270902|NCT02668185|4006223|FG000|STARTED|Baseline Period (2 Weeks)||20
3270903|NCT02668185|4006224|FG001|STARTED|Baseline Period (2 Weeks)||17
3270904|NCT02668185|4006223|FG000|COMPLETED|Baseline Period (2 Weeks)||20
3270905|NCT02668185|4006224|FG001|COMPLETED|Baseline Period (2 Weeks)||17
3270906|NCT02668185|4006223|FG000|NOT COMPLETED|Baseline Period (2 Weeks)||0
3270907|NCT02668185|4006224|FG001|NOT COMPLETED|Baseline Period (2 Weeks)||0
3270908|NCT02668185|4006223|FG000|STARTED|First Intervention (4 Weeks)||20
3270909|NCT02668185|4006224|FG001|STARTED|First Intervention (4 Weeks)||17
3270910|NCT02668185|4006223|FG000|COMPLETED|First Intervention (4 Weeks)||18
3270911|NCT02668185|4006224|FG001|COMPLETED|First Intervention (4 Weeks)||17
3270912|NCT02668185|4006223|FG000|NOT COMPLETED|First Intervention (4 Weeks)||2
3270913|NCT02668185|4006224|FG001|NOT COMPLETED|First Intervention (4 Weeks)||0
3270914|NCT02668185|4006223|FG000|STARTED|Washout Period (2 Weeks)||18
3270915|NCT02668185|4006224|FG001|STARTED|Washout Period (2 Weeks)||17
3270916|NCT02668185|4006223|FG000|COMPLETED|Washout Period (2 Weeks)||17
3270917|NCT02668185|4006224|FG001|COMPLETED|Washout Period (2 Weeks)||15
3270918|NCT02668185|4006223|FG000|NOT COMPLETED|Washout Period (2 Weeks)||1
3270919|NCT02668185|4006224|FG001|NOT COMPLETED|Washout Period (2 Weeks)||2
3270920|NCT02668185|4006223|FG000|STARTED|Second Intervention (4 Weeks)||17
3270921|NCT02668185|4006224|FG001|STARTED|Second Intervention (4 Weeks)||15
3270922|NCT02668185|4006223|FG000|COMPLETED|Second Intervention (4 Weeks)||16
3270923|NCT02668185|4006224|FG001|COMPLETED|Second Intervention (4 Weeks)||12
3270924|NCT02668185|4006223|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||1
3270925|NCT02668185|4006224|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||3
3270926|NCT02668185|4006223|FG000|STARTED|Moitoring Period (2 Weeks)||16
3270927|NCT02668185|4006224|FG001|STARTED|Moitoring Period (2 Weeks)||12
3270928|NCT02668185|4006223|FG000|COMPLETED|Moitoring Period (2 Weeks)||16
3270929|NCT02668185|4006224|FG001|COMPLETED|Moitoring Period (2 Weeks)||12
3270930|NCT02668185|4006223|FG000|NOT COMPLETED|Moitoring Period (2 Weeks)||0
3270931|NCT02668185|4006224|FG001|NOT COMPLETED|Moitoring Period (2 Weeks)||0
3270932|NCT02668198|4006230|FG000|STARTED|Overall Study||230
3270933|NCT02668198|4006230|FG000|COMPLETED|Overall Study||230
3270934|NCT02668198|4006230|FG000|NOT COMPLETED|Overall Study||0
3270935|NCT02668302|4006237|FG000|STARTED|Overall Study||20
3270936|NCT02668302|4006238|FG001|STARTED|Overall Study||20
3270937|NCT02668302|4006237|FG000|COMPLETED|Overall Study||19
3270938|NCT02668302|4006238|FG001|COMPLETED|Overall Study||20
3270939|NCT02668302|4006237|FG000|NOT COMPLETED|Overall Study||1
3270940|NCT02668302|4006238|FG001|NOT COMPLETED|Overall Study||0
3270941|NCT02668393|4006246|FG000|STARTED|Overall Study||7
3270942|NCT02668393|4006247|FG001|STARTED|Overall Study||7
3270943|NCT02668393|4006246|FG000|COMPLETED|Overall Study||0
3270944|NCT02668393|4006247|FG001|COMPLETED|Overall Study||1
3270945|NCT02668393|4006246|FG000|NOT COMPLETED|Overall Study||7
3270946|NCT02668393|4006247|FG001|NOT COMPLETED|Overall Study||6
3270947|NCT02668432|4006256|FG000|STARTED|Overall Study||5
3270948|NCT02668432|4006257|FG001|STARTED|Overall Study||4
3270949|NCT02668432|4006256|FG000|COMPLETED|Overall Study||5
3270950|NCT02668432|4006257|FG001|COMPLETED|Overall Study||4
3270951|NCT02668432|4006256|FG000|NOT COMPLETED|Overall Study||0
3270952|NCT02668432|4006257|FG001|NOT COMPLETED|Overall Study||0
3270953|NCT02668640|4006263|FG000|STARTED|Overall Study||55
3270954|NCT02668640|4006263|FG000|COMPLETED|Overall Study||41
3270955|NCT02668640|4006263|FG000|NOT COMPLETED|Overall Study||14
3270956|NCT02668692|4006269|FG000|STARTED|Overall Study||101
3270957|NCT02668692|4006270|FG001|STARTED|Overall Study||105
3270958|NCT02668692|4006269|FG000|COMPLETED|Overall Study||100
3270959|NCT02668692|4006270|FG001|COMPLETED|Overall Study||105
3270960|NCT02668692|4006269|FG000|NOT COMPLETED|Overall Study||1
3270961|NCT02668692|4006270|FG001|NOT COMPLETED|Overall Study||0
3270962|NCT02668952|4006278|FG000|STARTED|Overall Study||16
3270963|NCT02668952|4006279|FG001|STARTED|Overall Study||14
3270964|NCT02668952|4006278|FG000|COMPLETED|Overall Study||16
3270965|NCT02668952|4006279|FG001|COMPLETED|Overall Study||14
3270966|NCT02668952|4006278|FG000|NOT COMPLETED|Overall Study||0
3270967|NCT02668952|4006279|FG001|NOT COMPLETED|Overall Study||0
3270968|NCT02669017|4006294|FG000|STARTED|Overall Study||4
3270969|NCT02669017|4006295|FG001|STARTED|Overall Study||4
3270970|NCT02669017|4006296|FG002|STARTED|Overall Study||4
3270971|NCT02669017|4006297|FG003|STARTED|Overall Study||5
3270972|NCT02669017|4006298|FG004|STARTED|Overall Study||16
3270973|NCT02669017|4006299|FG005|STARTED|Overall Study||26
3270974|NCT02669017|4006300|FG006|STARTED|Overall Study||19
3270975|NCT02669017|4006301|FG007|STARTED|Overall Study||69
3270976|NCT02669017|4006302|FG008|STARTED|Overall Study||36
3270977|NCT02669017|4006294|FG000|COMPLETED|Overall Study||3
3270978|NCT02669017|4006295|FG001|COMPLETED|Overall Study||2
3270979|NCT02669017|4006296|FG002|COMPLETED|Overall Study||2
3270980|NCT02669017|4006297|FG003|COMPLETED|Overall Study||1
3270981|NCT02669017|4006298|FG004|COMPLETED|Overall Study||4
3270982|NCT02669017|4006299|FG005|COMPLETED|Overall Study||7
3270983|NCT02669017|4006300|FG006|COMPLETED|Overall Study||8
3270984|NCT02669017|4006301|FG007|COMPLETED|Overall Study||7
3270985|NCT02669017|4006302|FG008|COMPLETED|Overall Study||11
3270986|NCT02669017|4006294|FG000|NOT COMPLETED|Overall Study||1
3270987|NCT02669017|4006295|FG001|NOT COMPLETED|Overall Study||2
3270988|NCT02669017|4006296|FG002|NOT COMPLETED|Overall Study||2
3270989|NCT02669017|4006297|FG003|NOT COMPLETED|Overall Study||4
3270990|NCT02669017|4006298|FG004|NOT COMPLETED|Overall Study||12
3270991|NCT02669017|4006299|FG005|NOT COMPLETED|Overall Study||19
3270992|NCT02669017|4006300|FG006|NOT COMPLETED|Overall Study||11
3270993|NCT02669017|4006301|FG007|NOT COMPLETED|Overall Study||62
3270994|NCT02669017|4006302|FG008|NOT COMPLETED|Overall Study||25
3270995|NCT02669043|4006330|FG000|STARTED|Overall Study||8
3270996|NCT02669043|4006330|FG000|COMPLETED|Overall Study||4
3270997|NCT02669043|4006330|FG000|NOT COMPLETED|Overall Study||4
3270998|NCT02669082|4006334|FG000|STARTED|Overall Study||26
3270999|NCT02669082|4006334|FG000|COMPLETED|Overall Study||25
3271000|NCT02669082|4006334|FG000|NOT COMPLETED|Overall Study||1
3271001|NCT02669095|4006340|FG000|STARTED|Overall Study||75
3271002|NCT02669095|4006341|FG001|STARTED|Overall Study||75
3271003|NCT02669095|4006340|FG000|COMPLETED|Overall Study||74
3271004|NCT02669095|4006341|FG001|COMPLETED|Overall Study||72
3377080|NCT01183416|4110665|FG000|NOT COMPLETED|Overall Study||0
3377081|NCT01184456|4110671|FG000|STARTED|Overall Study||0
3377082|NCT01184456|4110672|FG001|STARTED|Overall Study||0
3377083|NCT01184456|4110671|FG000|COMPLETED|Overall Study||0
3377084|NCT01184456|4110672|FG001|COMPLETED|Overall Study||0
3271005|NCT02669095|4006340|FG000|NOT COMPLETED|Overall Study||1
3271006|NCT02669095|4006341|FG001|NOT COMPLETED|Overall Study||3
3271007|NCT02669121|4006349|FG000|STARTED|Overall Study||2377
3271008|NCT02669121|4006350|FG001|STARTED|Overall Study||2371
3271009|NCT02669121|4006349|FG000|Treated (Safety Analysis Set)|Overall Study||2357
3271010|NCT02669121|4006350|FG001|Treated (Safety Analysis Set)|Overall Study||2355
3271011|NCT02669121|4006349|FG000|COMPLETED|Overall Study||2087
3271012|NCT02669121|4006350|FG001|COMPLETED|Overall Study||2089
3271013|NCT02669121|4006349|FG000|NOT COMPLETED|Overall Study||290
3271014|NCT02669121|4006350|FG001|NOT COMPLETED|Overall Study||282
3271015|NCT02669264|4006363|FG000|STARTED|Overall Study||5
3271016|NCT02669264|4006364|FG001|STARTED|Overall Study||7
3271017|NCT02669264|4006365|FG002|STARTED|Overall Study||3
3271018|NCT02669264|4006366|FG003|STARTED|Overall Study||4
3271019|NCT02669264|4006367|FG004|STARTED|Overall Study||5
3271020|NCT02669264|4006368|FG005|STARTED|Overall Study||6
3271021|NCT02669264|4006369|FG006|STARTED|Overall Study||5
3271022|NCT02669264|4006363|FG000|COMPLETED|Overall Study||0
3271023|NCT02669264|4006364|FG001|COMPLETED|Overall Study||1
3271024|NCT02669264|4006365|FG002|COMPLETED|Overall Study||0
3271025|NCT02669264|4006366|FG003|COMPLETED|Overall Study||1
3271026|NCT02669264|4006367|FG004|COMPLETED|Overall Study||0
3271027|NCT02669264|4006368|FG005|COMPLETED|Overall Study||0
3271028|NCT02669264|4006369|FG006|COMPLETED|Overall Study||0
3271029|NCT02669264|4006363|FG000|NOT COMPLETED|Overall Study||5
3271030|NCT02669264|4006364|FG001|NOT COMPLETED|Overall Study||6
3271031|NCT02669264|4006365|FG002|NOT COMPLETED|Overall Study||3
3271032|NCT02669264|4006366|FG003|NOT COMPLETED|Overall Study||3
3271033|NCT02669264|4006367|FG004|NOT COMPLETED|Overall Study||5
3271034|NCT02669264|4006368|FG005|NOT COMPLETED|Overall Study||6
3271035|NCT02669264|4006369|FG006|NOT COMPLETED|Overall Study||5
3271036|NCT02669329|4006387|FG000|STARTED|Overall Study||30
3271037|NCT02669329|4006387|FG000|COMPLETED|Overall Study||30
3271038|NCT02669329|4006387|FG000|NOT COMPLETED|Overall Study||0
3271039|NCT02669407|4006391|FG000|STARTED|Overall Study||14
3271040|NCT02669407|4006391|FG000|COMPLETED|Overall Study||11
3271041|NCT02669407|4006391|FG000|NOT COMPLETED|Overall Study||3
3271042|NCT02669433|4006398|FG000|STARTED|Overall Study||91
3271043|NCT02669433|4006399|FG001|STARTED|Overall Study||89
3271044|NCT02669433|4006400|FG002|STARTED|Overall Study||89
3271045|NCT02669433|4006398|FG000|Safety Population|Overall Study||91
3271046|NCT02669433|4006399|FG001|Safety Population|Overall Study||89
3271047|NCT02669433|4006400|FG002|Safety Population|Overall Study||88
3271048|NCT02669433|4006398|FG000|Intent to Treat (ITT) Population|Overall Study||89
3271049|NCT02669433|4006399|FG001|Intent to Treat (ITT) Population|Overall Study||89
3271050|NCT02669433|4006400|FG002|Intent to Treat (ITT) Population|Overall Study||87
3271051|NCT02669433|4006398|FG000|Per-Protocol Population|Overall Study||78
3271052|NCT02669433|4006399|FG001|Per-Protocol Population|Overall Study||79
3271053|NCT02669433|4006400|FG002|Per-Protocol Population|Overall Study||82
3271054|NCT02669433|4006398|FG000|Completers Population|Overall Study||73
3271055|NCT02669433|4006399|FG001|Completers Population|Overall Study||72
3271056|NCT02669433|4006400|FG002|Completers Population|Overall Study||69
3271057|NCT02669433|4006398|FG000|UPDRS Primary Population|Overall Study||87
3271058|NCT02669433|4006399|FG001|UPDRS Primary Population|Overall Study||87
3271059|NCT02669433|4006400|FG002|UPDRS Primary Population|Overall Study||84
3271060|NCT02669433|4006398|FG000|COMPLETED|Overall Study||76
3271061|NCT02669433|4006399|FG001|COMPLETED|Overall Study||75
3377085|NCT01184456|4110671|FG000|NOT COMPLETED|Overall Study||0
3377086|NCT01184456|4110672|FG001|NOT COMPLETED|Overall Study||0
3377087|NCT01183221|4110680|FG000|STARTED|First Dose||15
3377088|NCT01183221|4110681|FG001|STARTED|First Dose||15
3377089|NCT01183221|4110680|FG000|COMPLETED|First Dose||15
3377090|NCT01183221|4110681|FG001|COMPLETED|First Dose||15
3377091|NCT01183221|4110680|FG000|NOT COMPLETED|First Dose||0
3377092|NCT01183221|4110681|FG001|NOT COMPLETED|First Dose||0
3377093|NCT01183221|4110680|FG000|STARTED|3 Weeks Wash Out||15
3377094|NCT01183221|4110681|FG001|STARTED|3 Weeks Wash Out||15
3377095|NCT01183221|4110680|FG000|COMPLETED|3 Weeks Wash Out||14
3377096|NCT01183221|4110681|FG001|COMPLETED|3 Weeks Wash Out||14
3377097|NCT01183221|4110680|FG000|NOT COMPLETED|3 Weeks Wash Out||1
3271062|NCT02669433|4006400|FG002|COMPLETED|Overall Study||74
3271063|NCT02669433|4006398|FG000|NOT COMPLETED|Overall Study||15
3271064|NCT02669433|4006399|FG001|NOT COMPLETED|Overall Study||14
3271065|NCT02669433|4006400|FG002|NOT COMPLETED|Overall Study||15
3271066|NCT02669615|4006408|FG000|STARTED|Overall Study||24
3271067|NCT02669615|4006408|FG000|COMPLETED|Overall Study||24
3271068|NCT02669615|4006408|FG000|NOT COMPLETED|Overall Study||0
3271069|NCT02669667|4006419|FG000|STARTED|Overall Study||12
3271070|NCT02669667|4006420|FG001|STARTED|Overall Study||4
3271071|NCT02669667|4006421|FG002|STARTED|Overall Study||4
3271072|NCT02669667|4006422|FG003|STARTED|Overall Study||6
3271073|NCT02669667|4006423|FG004|STARTED|Overall Study||6
3271074|NCT02669667|4006424|FG005|STARTED|Overall Study||6
3271075|NCT02669667|4006425|FG006|STARTED|Overall Study||6
3271076|NCT02669667|4006419|FG000|COMPLETED|Overall Study||12
3271077|NCT02669667|4006420|FG001|COMPLETED|Overall Study||4
3271078|NCT02669667|4006421|FG002|COMPLETED|Overall Study||4
3271079|NCT02669667|4006422|FG003|COMPLETED|Overall Study||6
3271080|NCT02669667|4006423|FG004|COMPLETED|Overall Study||6
3271081|NCT02669667|4006424|FG005|COMPLETED|Overall Study||5
3271082|NCT02669667|4006425|FG006|COMPLETED|Overall Study||6
3271083|NCT02669667|4006419|FG000|NOT COMPLETED|Overall Study||0
3271084|NCT02669667|4006420|FG001|NOT COMPLETED|Overall Study||0
3271085|NCT02669667|4006421|FG002|NOT COMPLETED|Overall Study||0
3271086|NCT02669667|4006422|FG003|NOT COMPLETED|Overall Study||0
3271087|NCT02669667|4006423|FG004|NOT COMPLETED|Overall Study||0
3271088|NCT02669667|4006424|FG005|NOT COMPLETED|Overall Study||1
3271089|NCT02669667|4006425|FG006|NOT COMPLETED|Overall Study||0
3271090|NCT02669758|4006447|FG000|STARTED|Overall Study||277
3271091|NCT02669758|4006447|FG000|COMPLETED|Overall Study||183
3271092|NCT02669758|4006447|FG000|NOT COMPLETED|Overall Study||94
3271093|NCT02669784|4006453|FG000|STARTED|Overall Study||18
3271094|NCT02669784|4006454|FG001|STARTED|Overall Study||16
3271095|NCT02669784|4006453|FG000|COMPLETED|Overall Study||18
3271096|NCT02669784|4006454|FG001|COMPLETED|Overall Study||16
3271097|NCT02669784|4006453|FG000|NOT COMPLETED|Overall Study||0
3271098|NCT02669784|4006454|FG001|NOT COMPLETED|Overall Study||0
3271099|NCT02669849|4006463|FG000|STARTED|Overall Study||29
3271100|NCT02669849|4006464|FG001|STARTED|Overall Study||6
3271101|NCT02669849|4006465|FG002|STARTED|Overall Study||32
3271102|NCT02669849|4006463|FG000|COMPLETED|Overall Study||11
3271103|NCT02669849|4006464|FG001|COMPLETED|Overall Study||4
3271104|NCT02669849|4006465|FG002|COMPLETED|Overall Study||8
3271105|NCT02669849|4006463|FG000|NOT COMPLETED|Overall Study||18
3271106|NCT02669849|4006464|FG001|NOT COMPLETED|Overall Study||2
3271107|NCT02669849|4006465|FG002|NOT COMPLETED|Overall Study||24
3271108|NCT02669862|4006476|FG000|STARTED|Overall Study||33
3271109|NCT02669862|4006477|FG001|STARTED|Overall Study||34
3271110|NCT02669862|4006478|FG002|STARTED|Overall Study||31
3271111|NCT02669862|4006476|FG000|COMPLETED|Overall Study||31
3271112|NCT02669862|4006477|FG001|COMPLETED|Overall Study||29
3271113|NCT02669862|4006478|FG002|COMPLETED|Overall Study||26
3271114|NCT02669862|4006476|FG000|NOT COMPLETED|Overall Study||2
3271115|NCT02669862|4006477|FG001|NOT COMPLETED|Overall Study||5
3271116|NCT02669862|4006478|FG002|NOT COMPLETED|Overall Study||5
3271117|NCT02669914|4006492|FG000|STARTED|Overall Study||4
3271118|NCT02669914|4006493|FG001|STARTED|Overall Study||0
3271119|NCT02669914|4006494|FG002|STARTED|Overall Study||0
3271120|NCT02669914|4006492|FG000|COMPLETED|Overall Study||4
3271121|NCT02669914|4006493|FG001|COMPLETED|Overall Study||0
3271122|NCT02669914|4006494|FG002|COMPLETED|Overall Study||0
3271123|NCT02669914|4006492|FG000|NOT COMPLETED|Overall Study||0
3271124|NCT02669914|4006493|FG001|NOT COMPLETED|Overall Study||0
3271125|NCT02669914|4006494|FG002|NOT COMPLETED|Overall Study||0
3271126|NCT02669940|4006504|FG000|STARTED|Overall Study||63
3271127|NCT02669940|4006505|FG001|STARTED|Overall Study||95
3271128|NCT02669940|4006504|FG000|COMPLETED|Overall Study||62
3271129|NCT02669940|4006505|FG001|COMPLETED|Overall Study||92
3271130|NCT02669940|4006504|FG000|NOT COMPLETED|Overall Study||1
3271131|NCT02669940|4006505|FG001|NOT COMPLETED|Overall Study||3
3271132|NCT02670083|4006520|FG000|STARTED|Overall Study||409
3271133|NCT02670083|4006521|FG001|STARTED|Overall Study||404
3271134|NCT02670083|4006520|FG000|COMPLETED|Overall Study||88
3271135|NCT02670083|4006521|FG001|COMPLETED|Overall Study||85
3271136|NCT02670083|4006520|FG000|NOT COMPLETED|Overall Study||321
3271137|NCT02670083|4006521|FG001|NOT COMPLETED|Overall Study||319
3271138|NCT02670122|4006528|FG000|STARTED|Overall Study||131
3271139|NCT02670122|4006528|FG000|COMPLETED|Overall Study|18 patients recieved liver transplantation|127
3271140|NCT02670122|4006528|FG000|NOT COMPLETED|Overall Study||4
3271141|NCT02670330|4006541|FG000|STARTED|Overall Study||75
3271142|NCT02670330|4006542|FG001|STARTED|Overall Study||77
3271143|NCT02670330|4006541|FG000|Received At Least 1 Dose Of Study Drug|Overall Study||75
3271144|NCT02670330|4006542|FG001|Received At Least 1 Dose Of Study Drug|Overall Study||77
3271145|NCT02670330|4006541|FG000|COMPLETED|Overall Study||0
3271146|NCT02670330|4006542|FG001|COMPLETED|Overall Study||0
3271147|NCT02670330|4006541|FG000|NOT COMPLETED|Overall Study||75
3271148|NCT02670330|4006542|FG001|NOT COMPLETED|Overall Study||77
3271149|NCT02670343|4006548|FG000|STARTED|Overall Study||8
3271150|NCT02670343|4006548|FG000|COMPLETED|Overall Study||8
3271151|NCT02670343|4006548|FG000|NOT COMPLETED|Overall Study||0
3271152|NCT02670382|4006552|FG000|STARTED|Placebo lead-in Phase||12
3271153|NCT02670382|4006553|FG001|STARTED|Placebo lead-in Phase||12
3271154|NCT02670382|4006552|FG000|COMPLETED|Placebo lead-in Phase|Two enrolled subjects randomized to receive EPA as the first intervention decided to stop participation during the placebo lead-in phase. Therefore, only 10 subjects continued to the EPA and then DHA supplementation phases. No data were collected from these two subjects.|10
3271155|NCT02670382|4006553|FG001|COMPLETED|Placebo lead-in Phase|One enrolled subjects randomized to receive EDHA as the first intervention decided to stop participation during the placebo lead-in phase. Therefore, only 11 subjects continued to the DHA and then EPA supplementation phases. No data were collected from this subject.|11
3271156|NCT02670382|4006552|FG000|NOT COMPLETED|Placebo lead-in Phase||2
3271157|NCT02670382|4006553|FG001|NOT COMPLETED|Placebo lead-in Phase||1
3377098|NCT01183221|4110681|FG001|NOT COMPLETED|3 Weeks Wash Out||1
3377099|NCT01183221|4110680|FG000|STARTED|Second Dose||14
3377100|NCT01183221|4110681|FG001|STARTED|Second Dose||14
3377101|NCT01183221|4110680|FG000|COMPLETED|Second Dose||14
3377102|NCT01183221|4110681|FG001|COMPLETED|Second Dose||14
3377103|NCT01183221|4110680|FG000|NOT COMPLETED|Second Dose||0
3377104|NCT01183221|4110681|FG001|NOT COMPLETED|Second Dose||0
3377105|NCT01189227|4110689|FG000|STARTED|Overall Study||6
3377106|NCT01189227|4110690|FG001|STARTED|Overall Study||3
3377107|NCT01189227|4110689|FG000|COMPLETED|Overall Study||0
3377108|NCT01189227|4110690|FG001|COMPLETED|Overall Study||0
3377109|NCT01189227|4110689|FG000|NOT COMPLETED|Overall Study||6
3377110|NCT01189227|4110690|FG001|NOT COMPLETED|Overall Study||3
3377111|NCT01190306|4110698|FG000|STARTED|Overall Study||61
3377112|NCT01190306|4110699|FG001|STARTED|Overall Study||66
3377113|NCT01190306|4110698|FG000|COMPLETED|Overall Study||61
3377114|NCT01190306|4110699|FG001|COMPLETED|Overall Study||66
3377115|NCT01190306|4110698|FG000|NOT COMPLETED|Overall Study||0
3377116|NCT01190306|4110699|FG001|NOT COMPLETED|Overall Study||0
3377117|NCT01179737|4110709|FG000|STARTED|Cohort 1 & Cohort 2||12
3377118|NCT01179737|4110710|FG001|STARTED|Cohort 1 & Cohort 2|One patient was missing the end of study evaluation|3
3377119|NCT01179737|4110711|FG002|STARTED|Cohort 1 & Cohort 2||4
3377120|NCT01179737|4110712|FG003|STARTED|Cohort 1 & Cohort 2||4
3377121|NCT01179737|4110709|FG000|COMPLETED|Cohort 1 & Cohort 2||7
3377122|NCT01179737|4110710|FG001|COMPLETED|Cohort 1 & Cohort 2||1
3377123|NCT01179737|4110711|FG002|COMPLETED|Cohort 1 & Cohort 2||0
3377124|NCT01179737|4110712|FG003|COMPLETED|Cohort 1 & Cohort 2||0
3377125|NCT01179737|4110709|FG000|NOT COMPLETED|Cohort 1 & Cohort 2||5
3377126|NCT01179737|4110710|FG001|NOT COMPLETED|Cohort 1 & Cohort 2||2
3377127|NCT01179737|4110711|FG002|NOT COMPLETED|Cohort 1 & Cohort 2||4
3377128|NCT01179737|4110712|FG003|NOT COMPLETED|Cohort 1 & Cohort 2||4
3377129|NCT01179737|4110709|FG000|STARTED|Cohort 1 & Cohort 2 Expansion|2 participants did not enroll in extension|5
3377130|NCT01179737|4110710|FG001|STARTED|Cohort 1 & Cohort 2 Expansion||1
3377131|NCT01179737|4110711|FG002|STARTED|Cohort 1 & Cohort 2 Expansion||0
3377132|NCT01179737|4110712|FG003|STARTED|Cohort 1 & Cohort 2 Expansion||0
3377133|NCT01179737|4110709|FG000|COMPLETED|Cohort 1 & Cohort 2 Expansion||4
3377134|NCT01179737|4110710|FG001|COMPLETED|Cohort 1 & Cohort 2 Expansion||1
3377135|NCT01179737|4110711|FG002|COMPLETED|Cohort 1 & Cohort 2 Expansion||0
3377136|NCT01179737|4110712|FG003|COMPLETED|Cohort 1 & Cohort 2 Expansion||0
3377137|NCT01179737|4110709|FG000|NOT COMPLETED|Cohort 1 & Cohort 2 Expansion||1
3377138|NCT01179737|4110710|FG001|NOT COMPLETED|Cohort 1 & Cohort 2 Expansion||0
3377139|NCT01179737|4110711|FG002|NOT COMPLETED|Cohort 1 & Cohort 2 Expansion||0
3377140|NCT01179737|4110712|FG003|NOT COMPLETED|Cohort 1 & Cohort 2 Expansion||0
3377141|NCT01179737|4110709|FG000|STARTED|Extension|Two patients did not enrol in the extension|3
3377142|NCT01179737|4110710|FG001|STARTED|Extension|One patient did not enrol in the extension|0
3377143|NCT01179737|4110711|FG002|STARTED|Extension||0
3377144|NCT01179737|4110712|FG003|STARTED|Extension||0
3377145|NCT01179737|4110709|FG000|COMPLETED|Extension||0
3377146|NCT01179737|4110710|FG001|COMPLETED|Extension||0
3377147|NCT01179737|4110711|FG002|COMPLETED|Extension||0
3377148|NCT01179737|4110712|FG003|COMPLETED|Extension||0
3377149|NCT01179737|4110709|FG000|NOT COMPLETED|Extension||3
3377150|NCT01179737|4110710|FG001|NOT COMPLETED|Extension||0
3377151|NCT01179737|4110711|FG002|NOT COMPLETED|Extension||0
3377152|NCT01179737|4110712|FG003|NOT COMPLETED|Extension||0
3377153|NCT01183468|4110725|FG000|STARTED|Overall Study||8
3377154|NCT01183468|4110726|FG001|STARTED|Overall Study||9
3377155|NCT01183468|4110727|FG002|STARTED|Overall Study||0
3377156|NCT01183468|4110728|FG003|STARTED|Overall Study||0
3377157|NCT01183468|4110725|FG000|COMPLETED|Overall Study||5
3377158|NCT01183468|4110726|FG001|COMPLETED|Overall Study||7
3377159|NCT01183468|4110727|FG002|COMPLETED|Overall Study||0
3377160|NCT01183468|4110728|FG003|COMPLETED|Overall Study||0
3377161|NCT01183468|4110725|FG000|NOT COMPLETED|Overall Study||3
3377162|NCT01183468|4110726|FG001|NOT COMPLETED|Overall Study||2
3377163|NCT01183468|4110727|FG002|NOT COMPLETED|Overall Study||0
3377164|NCT01183468|4110728|FG003|NOT COMPLETED|Overall Study||0
3377165|NCT01181921|4110736|FG000|STARTED|Overall Study||1
3377166|NCT01181921|4110736|FG000|COMPLETED|Overall Study||0
3377167|NCT01181921|4110736|FG000|NOT COMPLETED|Overall Study||1
3377168|NCT01188798|4110742|FG000|STARTED|Overall Study||2
3377169|NCT01188798|4110743|FG001|STARTED|Overall Study||4
3377170|NCT01188798|4110742|FG000|COMPLETED|Overall Study||0
3377171|NCT01188798|4110743|FG001|COMPLETED|Overall Study||1
3271158|NCT02670382|4006552|FG000|STARTED|First Active Intervention|Only 10 of the 12 enrolled subjects randomized to receive EPA as the first supplementation completed the lead-in placebo phase and then entered the EPA supplementation phase.|10
3271159|NCT02670382|4006553|FG001|STARTED|First Active Intervention|Only 11 of the 12 enrolled subjects randomized to receive DHA as the first supplementation completed the lead-in placebo phase and then entered the EDHA supplementation phase.|11
3271160|NCT02670382|4006552|FG000|COMPLETED|First Active Intervention||10
3271161|NCT02670382|4006553|FG001|COMPLETED|First Active Intervention||11
3271162|NCT02670382|4006552|FG000|NOT COMPLETED|First Active Intervention||0
3271163|NCT02670382|4006553|FG001|NOT COMPLETED|First Active Intervention||0
3271164|NCT02670382|4006552|FG000|STARTED|Second Active Intervention||10
3271165|NCT02670382|4006553|FG001|STARTED|Second Active Intervention||11
3271166|NCT02670382|4006552|FG000|COMPLETED|Second Active Intervention||10
3271167|NCT02670382|4006553|FG001|COMPLETED|Second Active Intervention||11
3271168|NCT02670382|4006552|FG000|NOT COMPLETED|Second Active Intervention||0
3271169|NCT02670382|4006553|FG001|NOT COMPLETED|Second Active Intervention||0
3271170|NCT02670473|4006561|FG000|STARTED|Overall Study||35
3271171|NCT02670473|4006561|FG000|COMPLETED|Overall Study||34
3271172|NCT02670473|4006561|FG000|NOT COMPLETED|Overall Study||1
3271173|NCT02670538|4006577|FG000|STARTED|Overall Study||167
3271174|NCT02670538|4006578|FG001|STARTED|Overall Study||168
3271175|NCT02670538|4006579|FG002|STARTED|Overall Study||158
3271176|NCT02670538|4006577|FG000|Safety Population : Received Study Drug|Overall Study||165
3271177|NCT02670538|4006578|FG001|Safety Population : Received Study Drug|Overall Study||167
3271178|NCT02670538|4006579|FG002|Safety Population : Received Study Drug|Overall Study||158
3271179|NCT02670538|4006577|FG000|Intent-to-Treat Population|Overall Study||163
3271180|NCT02670538|4006578|FG001|Intent-to-Treat Population|Overall Study||162
3271181|NCT02670538|4006579|FG002|Intent-to-Treat Population|Overall Study||153
3271182|NCT02670538|4006577|FG000|COMPLETED|Overall Study||135
3271183|NCT02670538|4006578|FG001|COMPLETED|Overall Study||136
3271184|NCT02670538|4006579|FG002|COMPLETED|Overall Study||128
3271185|NCT02670538|4006577|FG000|NOT COMPLETED|Overall Study||32
3271186|NCT02670538|4006578|FG001|NOT COMPLETED|Overall Study||32
3271187|NCT02670538|4006579|FG002|NOT COMPLETED|Overall Study||30
3271188|NCT02670551|4006590|FG000|STARTED|Overall Study||163
3271189|NCT02670551|4006591|FG001|STARTED|Overall Study||160
3271190|NCT02670551|4006592|FG002|STARTED|Overall Study||165
3271191|NCT02670551|4006590|FG000|Received Treatment (Safety Population)|Overall Study||158
3271192|NCT02670551|4006591|FG001|Received Treatment (Safety Population)|Overall Study||157
3271193|NCT02670551|4006592|FG002|Received Treatment (Safety Population)|Overall Study||165
3271194|NCT02670551|4006590|FG000|COMPLETED|Overall Study||135
3271195|NCT02670551|4006591|FG001|COMPLETED|Overall Study||134
3271196|NCT02670551|4006592|FG002|COMPLETED|Overall Study||134
3271197|NCT02670551|4006590|FG000|NOT COMPLETED|Overall Study||28
3271198|NCT02670551|4006591|FG001|NOT COMPLETED|Overall Study||26
3271199|NCT02670551|4006592|FG002|NOT COMPLETED|Overall Study||31
3271200|NCT02670629|4006602|FG000|STARTED|Overall Study||29
3271201|NCT02670629|4006603|FG001|STARTED|Overall Study||29
3271202|NCT02670629|4006602|FG000|COMPLETED|Overall Study||29
3271203|NCT02670629|4006603|FG001|COMPLETED|Overall Study||29
3271204|NCT02670629|4006602|FG000|NOT COMPLETED|Overall Study||0
3271205|NCT02670629|4006603|FG001|NOT COMPLETED|Overall Study||0
3271206|NCT02670811|4006611|FG000|STARTED|Overall Study||18
3271207|NCT02670811|4006612|FG001|STARTED|Overall Study||18
3271208|NCT02670811|4006611|FG000|COMPLETED|Overall Study||17
3271209|NCT02670811|4006612|FG001|COMPLETED|Overall Study||18
3271210|NCT02670811|4006611|FG000|NOT COMPLETED|Overall Study||1
3377172|NCT01188798|4110742|FG000|NOT COMPLETED|Overall Study||2
3377173|NCT01188798|4110743|FG001|NOT COMPLETED|Overall Study||3
3377174|NCT01174368|4110750|FG000|STARTED|Overall Study||1
3377175|NCT01174368|4110750|FG000|COMPLETED|Overall Study||0
3377176|NCT01174368|4110750|FG000|NOT COMPLETED|Overall Study||1
3377177|NCT01183897|4110754|FG000|STARTED|Overall Study||31
3377178|NCT01183897|4110754|FG000|COMPLETED|Overall Study||31
3377179|NCT01183897|4110754|FG000|NOT COMPLETED|Overall Study||0
3377180|NCT01183884|4110758|FG000|STARTED|Overall Study||46
3377181|NCT01183884|4110758|FG000|COMPLETED|Overall Study||8
3377182|NCT01183884|4110758|FG000|NOT COMPLETED|Overall Study||38
3377183|NCT01183429|4110762|FG000|STARTED|Overall Study||39
3377184|NCT01183429|4110762|FG000|COMPLETED|Overall Study||39
3377185|NCT01183429|4110762|FG000|NOT COMPLETED|Overall Study||0
3377186|NCT01166178|4110768|FG000|STARTED|Overall Study||21
3377187|NCT01166178|4110769|FG001|STARTED|Overall Study||8
3377188|NCT01166178|4110768|FG000|COMPLETED|Overall Study||0
3377189|NCT01166178|4110769|FG001|COMPLETED|Overall Study||0
3377190|NCT01166178|4110768|FG000|NOT COMPLETED|Overall Study||21
3377191|NCT01166178|4110769|FG001|NOT COMPLETED|Overall Study||8
3377192|NCT01176513|4110775|FG000|STARTED|Overall Study||25
3377193|NCT01176513|4110775|FG000|COMPLETED|Overall Study||22
3377194|NCT01176513|4110775|FG000|NOT COMPLETED|Overall Study||3
3377195|NCT01165450|4110779|FG000|STARTED|Overall Study||2
3377196|NCT01165450|4110779|FG000|COMPLETED|Overall Study||2
3377197|NCT01165450|4110779|FG000|NOT COMPLETED|Overall Study||0
3377198|NCT01179399|4110783|FG000|STARTED|Overall Study||32
3377199|NCT01179399|4110783|FG000|COMPLETED|Overall Study||0
3377200|NCT01179399|4110783|FG000|NOT COMPLETED|Overall Study||32
3377201|NCT01169753|4110789|FG000|STARTED|Overall Study||0
3377202|NCT01169753|4110790|FG001|STARTED|Overall Study||1
3377203|NCT01169753|4110789|FG000|COMPLETED|Overall Study||0
3271211|NCT02670811|4006612|FG001|NOT COMPLETED|Overall Study||0
3271212|NCT02670915|4006621|FG000|STARTED|Overall Study||260
3271213|NCT02670915|4006622|FG001|STARTED|Overall Study||259
3271214|NCT02670915|4006623|FG002|STARTED|Overall Study||258
3271215|NCT02670915|4006621|FG000|COMPLETED|Overall Study||256
3271216|NCT02670915|4006622|FG001|COMPLETED|Overall Study||251
3271217|NCT02670915|4006623|FG002|COMPLETED|Overall Study||253
3271218|NCT02670915|4006621|FG000|NOT COMPLETED|Overall Study||4
3271219|NCT02670915|4006622|FG001|NOT COMPLETED|Overall Study||8
3271220|NCT02670915|4006623|FG002|NOT COMPLETED|Overall Study||5
3271221|NCT02670928|4006633|FG000|STARTED|Overall Study||100
3271222|NCT02670928|4006634|FG001|STARTED|Overall Study||30
3271223|NCT02670928|4006633|FG000|COMPLETED|Overall Study||90
3271224|NCT02670928|4006634|FG001|COMPLETED|Overall Study||29
3271225|NCT02670928|4006633|FG000|NOT COMPLETED|Overall Study||10
3271226|NCT02670928|4006634|FG001|NOT COMPLETED|Overall Study||1
3271227|NCT02671032|4006640|FG000|STARTED|Overall Study||12
3271228|NCT02671032|4006640|FG000|COMPLETED|Overall Study||12
3271229|NCT02671032|4006640|FG000|NOT COMPLETED|Overall Study||0
3271230|NCT02671266|4006646|FG000|STARTED|Overall Study||20
3271231|NCT02671266|4006647|FG001|STARTED|Overall Study||21
3271232|NCT02671266|4006646|FG000|BDD Participants|Overall Study||9
3271233|NCT02671266|4006647|FG001|BDD Participants|Overall Study||9
3271234|NCT02671266|4006646|FG000|OCD Participants|Overall Study||2
3271235|NCT02671266|4006647|FG001|OCD Participants|Overall Study||3
3271236|NCT02671266|4006646|FG000|Healthy Participants|Overall Study||8
3271237|NCT02671266|4006647|FG001|Healthy Participants|Overall Study||8
3271238|NCT02671266|4006646|FG000|COMPLETED|Overall Study||19
3271239|NCT02671266|4006647|FG001|COMPLETED|Overall Study||20
3271240|NCT02671266|4006646|FG000|NOT COMPLETED|Overall Study||1
3271241|NCT02671266|4006647|FG001|NOT COMPLETED|Overall Study||1
3271242|NCT02671422|4006653|FG000|STARTED|Overall Study||260
3271243|NCT02671422|4006653|FG000|Not Treated With Vargatef®|Overall Study||3
3271244|NCT02671422|4006653|FG000|COMPLETED|Overall Study||0
3271245|NCT02671422|4006653|FG000|NOT COMPLETED|Overall Study||260
3271246|NCT02671500|4006657|FG000|STARTED|Overall Study||375
3271247|NCT02671500|4006657|FG000|COMPLETED|Overall Study||361
3271248|NCT02671500|4006657|FG000|NOT COMPLETED|Overall Study||14
3271249|NCT02671760|4006665|FG000|STARTED|Overall Study||13
3271250|NCT02671760|4006666|FG001|STARTED|Overall Study||13
3271251|NCT02671760|4006667|FG002|STARTED|Overall Study||13
3271252|NCT02671760|4006665|FG000|COMPLETED|Overall Study||13
3271253|NCT02671760|4006666|FG001|COMPLETED|Overall Study|1 Subject could not be contacted for f/u phone call. Data included in safety and efficacy analyses.|12
3271254|NCT02671760|4006667|FG002|COMPLETED|Overall Study||13
3271255|NCT02671760|4006665|FG000|NOT COMPLETED|Overall Study||0
3271256|NCT02671760|4006666|FG001|NOT COMPLETED|Overall Study||1
3271257|NCT02671760|4006667|FG002|NOT COMPLETED|Overall Study||0
3271258|NCT02672111|4006677|FG000|STARTED|Overall Study||190
3271259|NCT02672111|4006678|FG001|STARTED|Overall Study||37
3271260|NCT02672111|4006677|FG000|Completed Treatment|Overall Study||138
3271261|NCT02672111|4006678|FG001|Completed Treatment|Overall Study||29
3271262|NCT02672111|4006677|FG000|COMPLETED|Overall Study||132
3271263|NCT02672111|4006678|FG001|COMPLETED|Overall Study||25
3271264|NCT02672111|4006677|FG000|NOT COMPLETED|Overall Study||58
3271265|NCT02672111|4006678|FG001|NOT COMPLETED|Overall Study||12
3271266|NCT02672176|4006687|FG000|STARTED|Overall Study||161
3271267|NCT02672176|4006688|FG001|STARTED|Overall Study||158
3271268|NCT02672176|4006687|FG000|COMPLETED|Overall Study||155
3271269|NCT02672176|4006688|FG001|COMPLETED|Overall Study||132
3271270|NCT02672176|4006687|FG000|NOT COMPLETED|Overall Study||6
3271271|NCT02672176|4006688|FG001|NOT COMPLETED|Overall Study||26
3271272|NCT02672423|4006700|FG000|STARTED|Period 1||7
3271273|NCT02672423|4006701|FG001|STARTED|Period 1||7
3271274|NCT02672423|4006702|FG002|STARTED|Period 1||14
3271275|NCT02672423|4006703|FG003|STARTED|Period 1||15
3271276|NCT02672423|4006704|FG004|STARTED|Period 1||15
3271277|NCT02672423|4006705|FG005|STARTED|Period 1||15
3271278|NCT02672423|4006706|FG006|STARTED|Period 1||15
3271279|NCT02672423|4006707|FG007|STARTED|Period 1||15
3271280|NCT02672423|4006708|FG008|STARTED|Period 1||12
3271281|NCT02672423|4006709|FG009|STARTED|Period 1||12
3271282|NCT02672423|4006700|FG000|Received at Least One Dose of Study Drug|Period 1||7
3271283|NCT02672423|4006701|FG001|Received at Least One Dose of Study Drug|Period 1||7
3271284|NCT02672423|4006702|FG002|Received at Least One Dose of Study Drug|Period 1||14
3271285|NCT02672423|4006703|FG003|Received at Least One Dose of Study Drug|Period 1||15
3271286|NCT02672423|4006704|FG004|Received at Least One Dose of Study Drug|Period 1||15
3271287|NCT02672423|4006705|FG005|Received at Least One Dose of Study Drug|Period 1||15
3271288|NCT02672423|4006706|FG006|Received at Least One Dose of Study Drug|Period 1||15
3271289|NCT02672423|4006707|FG007|Received at Least One Dose of Study Drug|Period 1||15
3271290|NCT02672423|4006708|FG008|Received at Least One Dose of Study Drug|Period 1||12
3271291|NCT02672423|4006709|FG009|Received at Least One Dose of Study Drug|Period 1||12
3271292|NCT02672423|4006700|FG000|COMPLETED|Period 1||7
3271293|NCT02672423|4006701|FG001|COMPLETED|Period 1||7
3271294|NCT02672423|4006702|FG002|COMPLETED|Period 1||14
3271295|NCT02672423|4006703|FG003|COMPLETED|Period 1||15
3271296|NCT02672423|4006704|FG004|COMPLETED|Period 1||14
3271297|NCT02672423|4006705|FG005|COMPLETED|Period 1||15
3271298|NCT02672423|4006706|FG006|COMPLETED|Period 1||15
3271299|NCT02672423|4006707|FG007|COMPLETED|Period 1||15
3271300|NCT02672423|4006708|FG008|COMPLETED|Period 1||12
3271301|NCT02672423|4006709|FG009|COMPLETED|Period 1||12
3271302|NCT02672423|4006700|FG000|NOT COMPLETED|Period 1||0
3271303|NCT02672423|4006701|FG001|NOT COMPLETED|Period 1||0
3271304|NCT02672423|4006702|FG002|NOT COMPLETED|Period 1||0
3271305|NCT02672423|4006703|FG003|NOT COMPLETED|Period 1||0
3271306|NCT02672423|4006704|FG004|NOT COMPLETED|Period 1||1
3271307|NCT02672423|4006705|FG005|NOT COMPLETED|Period 1||0
3271308|NCT02672423|4006706|FG006|NOT COMPLETED|Period 1||0
3271309|NCT02672423|4006707|FG007|NOT COMPLETED|Period 1||0
3271310|NCT02672423|4006708|FG008|NOT COMPLETED|Period 1||0
3271311|NCT02672423|4006709|FG009|NOT COMPLETED|Period 1||0
3271312|NCT02672423|4006700|FG000|STARTED|Washout 1||7
3271313|NCT02672423|4006701|FG001|STARTED|Washout 1||7
3271314|NCT02672423|4006702|FG002|STARTED|Washout 1||14
3271315|NCT02672423|4006703|FG003|STARTED|Washout 1||15
3271316|NCT02672423|4006704|FG004|STARTED|Washout 1||14
3271317|NCT02672423|4006705|FG005|STARTED|Washout 1||15
3271318|NCT02672423|4006706|FG006|STARTED|Washout 1||15
3271319|NCT02672423|4006707|FG007|STARTED|Washout 1||15
3271320|NCT02672423|4006708|FG008|STARTED|Washout 1||12
3271321|NCT02672423|4006709|FG009|STARTED|Washout 1||12
3271322|NCT02672423|4006700|FG000|COMPLETED|Washout 1||7
3271323|NCT02672423|4006701|FG001|COMPLETED|Washout 1||7
3271324|NCT02672423|4006702|FG002|COMPLETED|Washout 1||14
3271325|NCT02672423|4006703|FG003|COMPLETED|Washout 1||15
3271326|NCT02672423|4006704|FG004|COMPLETED|Washout 1||14
3271327|NCT02672423|4006705|FG005|COMPLETED|Washout 1||15
3271328|NCT02672423|4006706|FG006|COMPLETED|Washout 1||15
3271329|NCT02672423|4006707|FG007|COMPLETED|Washout 1||15
3271330|NCT02672423|4006708|FG008|COMPLETED|Washout 1||12
3271331|NCT02672423|4006709|FG009|COMPLETED|Washout 1||12
3271332|NCT02672423|4006700|FG000|NOT COMPLETED|Washout 1||0
3271333|NCT02672423|4006701|FG001|NOT COMPLETED|Washout 1||0
3271334|NCT02672423|4006702|FG002|NOT COMPLETED|Washout 1||0
3271335|NCT02672423|4006703|FG003|NOT COMPLETED|Washout 1||0
3271336|NCT02672423|4006704|FG004|NOT COMPLETED|Washout 1||0
3271337|NCT02672423|4006705|FG005|NOT COMPLETED|Washout 1||0
3271338|NCT02672423|4006706|FG006|NOT COMPLETED|Washout 1||0
3271339|NCT02672423|4006707|FG007|NOT COMPLETED|Washout 1||0
3271340|NCT02672423|4006708|FG008|NOT COMPLETED|Washout 1||0
3271341|NCT02672423|4006709|FG009|NOT COMPLETED|Washout 1||0
3271342|NCT02672423|4006700|FG000|STARTED|Period 2||7
3271343|NCT02672423|4006701|FG001|STARTED|Period 2||7
3271344|NCT02672423|4006702|FG002|STARTED|Period 2||14
3271345|NCT02672423|4006703|FG003|STARTED|Period 2||15
3271346|NCT02672423|4006704|FG004|STARTED|Period 2||14
3271347|NCT02672423|4006705|FG005|STARTED|Period 2||15
3271348|NCT02672423|4006706|FG006|STARTED|Period 2||15
3271349|NCT02672423|4006707|FG007|STARTED|Period 2||15
3271350|NCT02672423|4006708|FG008|STARTED|Period 2||12
3271351|NCT02672423|4006709|FG009|STARTED|Period 2||12
3271352|NCT02672423|4006700|FG000|COMPLETED|Period 2||7
3271353|NCT02672423|4006701|FG001|COMPLETED|Period 2||7
3271354|NCT02672423|4006702|FG002|COMPLETED|Period 2||13
3271355|NCT02672423|4006703|FG003|COMPLETED|Period 2||15
3271356|NCT02672423|4006704|FG004|COMPLETED|Period 2||14
3271357|NCT02672423|4006705|FG005|COMPLETED|Period 2||15
3271358|NCT02672423|4006706|FG006|COMPLETED|Period 2||15
3271359|NCT02672423|4006707|FG007|COMPLETED|Period 2||15
3271360|NCT02672423|4006708|FG008|COMPLETED|Period 2||12
3271361|NCT02672423|4006709|FG009|COMPLETED|Period 2||12
3271362|NCT02672423|4006700|FG000|NOT COMPLETED|Period 2||0
3271363|NCT02672423|4006701|FG001|NOT COMPLETED|Period 2||0
3271364|NCT02672423|4006702|FG002|NOT COMPLETED|Period 2||1
3271365|NCT02672423|4006703|FG003|NOT COMPLETED|Period 2||0
3271366|NCT02672423|4006704|FG004|NOT COMPLETED|Period 2||0
3271367|NCT02672423|4006705|FG005|NOT COMPLETED|Period 2||0
3271368|NCT02672423|4006706|FG006|NOT COMPLETED|Period 2||0
3271369|NCT02672423|4006707|FG007|NOT COMPLETED|Period 2||0
3271370|NCT02672423|4006708|FG008|NOT COMPLETED|Period 2||0
3271371|NCT02672423|4006709|FG009|NOT COMPLETED|Period 2||0
3271372|NCT02672423|4006700|FG000|STARTED|Washout 2||7
3271373|NCT02672423|4006701|FG001|STARTED|Washout 2||7
3271374|NCT02672423|4006702|FG002|STARTED|Washout 2||13
3271375|NCT02672423|4006703|FG003|STARTED|Washout 2||15
3271376|NCT02672423|4006704|FG004|STARTED|Washout 2||14
3271377|NCT02672423|4006705|FG005|STARTED|Washout 2||15
3271378|NCT02672423|4006706|FG006|STARTED|Washout 2||15
3271379|NCT02672423|4006707|FG007|STARTED|Washout 2||15
3271380|NCT02672423|4006708|FG008|STARTED|Washout 2||12
3271381|NCT02672423|4006709|FG009|STARTED|Washout 2||12
3271382|NCT02672423|4006700|FG000|COMPLETED|Washout 2||7
3271383|NCT02672423|4006701|FG001|COMPLETED|Washout 2||7
3271384|NCT02672423|4006702|FG002|COMPLETED|Washout 2||13
3271385|NCT02672423|4006703|FG003|COMPLETED|Washout 2||15
3271386|NCT02672423|4006704|FG004|COMPLETED|Washout 2||14
3271387|NCT02672423|4006705|FG005|COMPLETED|Washout 2||15
3271388|NCT02672423|4006706|FG006|COMPLETED|Washout 2||15
3271389|NCT02672423|4006707|FG007|COMPLETED|Washout 2||15
3271390|NCT02672423|4006708|FG008|COMPLETED|Washout 2||12
3271391|NCT02672423|4006709|FG009|COMPLETED|Washout 2||12
3271392|NCT02672423|4006700|FG000|NOT COMPLETED|Washout 2||0
3271393|NCT02672423|4006701|FG001|NOT COMPLETED|Washout 2||0
3271394|NCT02672423|4006702|FG002|NOT COMPLETED|Washout 2||0
3271395|NCT02672423|4006703|FG003|NOT COMPLETED|Washout 2||0
3271396|NCT02672423|4006704|FG004|NOT COMPLETED|Washout 2||0
3271397|NCT02672423|4006705|FG005|NOT COMPLETED|Washout 2||0
3271398|NCT02672423|4006706|FG006|NOT COMPLETED|Washout 2||0
3271399|NCT02672423|4006707|FG007|NOT COMPLETED|Washout 2||0
3271400|NCT02672423|4006708|FG008|NOT COMPLETED|Washout 2||0
3271401|NCT02672423|4006709|FG009|NOT COMPLETED|Washout 2||0
3271402|NCT02672423|4006700|FG000|STARTED|Period 3|Part A was a 2-period study design.|0
3271403|NCT02672423|4006701|FG001|STARTED|Period 3|Part A was a 2-period study design.|0
3271404|NCT02672423|4006702|FG002|STARTED|Period 3||13
3271405|NCT02672423|4006703|FG003|STARTED|Period 3||15
3271406|NCT02672423|4006704|FG004|STARTED|Period 3||14
3271407|NCT02672423|4006705|FG005|STARTED|Period 3||15
3271408|NCT02672423|4006706|FG006|STARTED|Period 3||15
3271409|NCT02672423|4006707|FG007|STARTED|Period 3||15
3271410|NCT02672423|4006708|FG008|STARTED|Period 3|Part C was a 2-period study design.|0
3271411|NCT02672423|4006709|FG009|STARTED|Period 3|Part C was a 2-period study design.|0
3271412|NCT02672423|4006700|FG000|COMPLETED|Period 3||0
3271413|NCT02672423|4006701|FG001|COMPLETED|Period 3||0
3271414|NCT02672423|4006702|FG002|COMPLETED|Period 3||13
3271415|NCT02672423|4006703|FG003|COMPLETED|Period 3||15
3271416|NCT02672423|4006704|FG004|COMPLETED|Period 3||14
3271417|NCT02672423|4006705|FG005|COMPLETED|Period 3||14
3271418|NCT02672423|4006706|FG006|COMPLETED|Period 3||15
3271419|NCT02672423|4006707|FG007|COMPLETED|Period 3||14
3271420|NCT02672423|4006708|FG008|COMPLETED|Period 3||0
3271421|NCT02672423|4006709|FG009|COMPLETED|Period 3||0
3271422|NCT02672423|4006700|FG000|NOT COMPLETED|Period 3||0
3271423|NCT02672423|4006701|FG001|NOT COMPLETED|Period 3||0
3271424|NCT02672423|4006702|FG002|NOT COMPLETED|Period 3||0
3271425|NCT02672423|4006703|FG003|NOT COMPLETED|Period 3||0
3271426|NCT02672423|4006704|FG004|NOT COMPLETED|Period 3||0
3271427|NCT02672423|4006705|FG005|NOT COMPLETED|Period 3||1
3271428|NCT02672423|4006706|FG006|NOT COMPLETED|Period 3||0
3271429|NCT02672423|4006707|FG007|NOT COMPLETED|Period 3||1
3271430|NCT02672423|4006708|FG008|NOT COMPLETED|Period 3||0
3271431|NCT02672423|4006709|FG009|NOT COMPLETED|Period 3||0
3271432|NCT02672514|4006732|FG000|STARTED|Overall Study||53
3271433|NCT02672514|4006733|FG001|STARTED|Overall Study||51
3271434|NCT02672514|4006732|FG000|COMPLETED|Overall Study||53
3271435|NCT02672514|4006733|FG001|COMPLETED|Overall Study||51
3271436|NCT02672514|4006732|FG000|NOT COMPLETED|Overall Study||0
3271437|NCT02672514|4006733|FG001|NOT COMPLETED|Overall Study||0
3271438|NCT02672553|4006741|FG000|STARTED|Overall Study||51
3271439|NCT02672553|4006742|FG001|STARTED|Overall Study||49
3271440|NCT02672553|4006741|FG000|Intent To Treated (ITT) Randomized Arm|Overall Study|Two (2) subjects randomized to Edwards INTUITY were intraoperative screen failures|49
3271441|NCT02672553|4006742|FG001|Intent To Treated (ITT) Randomized Arm|Overall Study|One (1) subject randomized to Control arm/group withdrew prior to study procedure|48
3271442|NCT02672553|4006741|FG000|As Treated (AT) Randomized Arm/Group|Overall Study||46
3271443|NCT02672553|4006742|FG001|As Treated (AT) Randomized Arm/Group|Overall Study||51
3271444|NCT02672553|4006741|FG000|As Intended (AI) Randomized Arm/Group|Overall Study||46
3271445|NCT02672553|4006742|FG001|As Intended (AI) Randomized Arm/Group|Overall Study||48
3271446|NCT02672553|4006741|FG000|COMPLETED|Overall Study||39
3271447|NCT02672553|4006742|FG001|COMPLETED|Overall Study||41
3271448|NCT02672553|4006741|FG000|NOT COMPLETED|Overall Study||12
3271449|NCT02672553|4006742|FG001|NOT COMPLETED|Overall Study||8
3271450|NCT02672852|4006751|FG000|STARTED|Part A1||100
3271451|NCT02672852|4006752|FG001|STARTED|Part A1||407
3271452|NCT02672852|4006753|FG002|STARTED|Part A1||0
3271453|NCT02672852|4006754|FG003|STARTED|Part A1||0
3271454|NCT02672852|4006755|FG004|STARTED|Part A1||0
3271455|NCT02672852|4006756|FG005|STARTED|Part A1||0
3271456|NCT02672852|4006757|FG006|STARTED|Part A1||0
3271457|NCT02672852|4006751|FG000|COMPLETED|Part A1||97
3271458|NCT02672852|4006752|FG001|COMPLETED|Part A1||403
3271459|NCT02672852|4006753|FG002|COMPLETED|Part A1||0
3271460|NCT02672852|4006754|FG003|COMPLETED|Part A1||0
3271461|NCT02672852|4006755|FG004|COMPLETED|Part A1||0
3271462|NCT02672852|4006756|FG005|COMPLETED|Part A1||0
3271463|NCT02672852|4006757|FG006|COMPLETED|Part A1||0
3271464|NCT02672852|4006751|FG000|NOT COMPLETED|Part A1||3
3271465|NCT02672852|4006752|FG001|NOT COMPLETED|Part A1||4
3271466|NCT02672852|4006753|FG002|NOT COMPLETED|Part A1||0
3271467|NCT02672852|4006754|FG003|NOT COMPLETED|Part A1||0
3271468|NCT02672852|4006755|FG004|NOT COMPLETED|Part A1||0
3271469|NCT02672852|4006756|FG005|NOT COMPLETED|Part A1||0
3271470|NCT02672852|4006757|FG006|NOT COMPLETED|Part A1||0
3271471|NCT02672852|4006751|FG000|STARTED|Part A2|Participants that completed Part A1 continued on to Part A2.|0
3271472|NCT02672852|4006752|FG001|STARTED|Part A2|Participants that completed Part A1 continued on to Part A2.|0
3271473|NCT02672852|4006753|FG002|STARTED|Part A2|Participants that completed Part A1 continued on to Part A2.|93
3271474|NCT02672852|4006754|FG003|STARTED|Part A2|Participants that completed Part A1 continued on to Part A2.|403
3271475|NCT02672852|4006755|FG004|STARTED|Part A2||0
3271476|NCT02672852|4006756|FG005|STARTED|Part A2||0
3271477|NCT02672852|4006757|FG006|STARTED|Part A2||0
3271478|NCT02672852|4006751|FG000|COMPLETED|Part A2||0
3271479|NCT02672852|4006752|FG001|COMPLETED|Part A2||0
3271480|NCT02672852|4006753|FG002|COMPLETED|Part A2||83
3271481|NCT02672852|4006754|FG003|COMPLETED|Part A2||399
3271482|NCT02672852|4006755|FG004|COMPLETED|Part A2||0
3271483|NCT02672852|4006756|FG005|COMPLETED|Part A2||0
3271484|NCT02672852|4006757|FG006|COMPLETED|Part A2||0
3271485|NCT02672852|4006751|FG000|NOT COMPLETED|Part A2||0
3271486|NCT02672852|4006752|FG001|NOT COMPLETED|Part A2||0
3271487|NCT02672852|4006753|FG002|NOT COMPLETED|Part A2||10
3271488|NCT02672852|4006754|FG003|NOT COMPLETED|Part A2||4
3271489|NCT02672852|4006755|FG004|NOT COMPLETED|Part A2||0
3271490|NCT02672852|4006756|FG005|NOT COMPLETED|Part A2||0
3271491|NCT02672852|4006757|FG006|NOT COMPLETED|Part A2||0
3271492|NCT02672852|4006751|FG000|STARTED|Part B||0
3271493|NCT02672852|4006752|FG001|STARTED|Part B||0
3271494|NCT02672852|4006753|FG002|STARTED|Part B|Participants that completed Part A2 continued on to Part B.|0
3271495|NCT02672852|4006754|FG003|STARTED|Part B|Participants that completed Part A2 continued on to Part B.|0
3271496|NCT02672852|4006755|FG004|STARTED|Part B|Participants that completed Part A2 continued on to Part B.|225
3271497|NCT02672852|4006756|FG005|STARTED|Part B|Participants that completed Part A2 continued on to Part B.|111
3271498|NCT02672852|4006757|FG006|STARTED|Part B|Participants that completed Part A2 continued on to Part B.|63
3271499|NCT02672852|4006751|FG000|COMPLETED|Part B||0
3271500|NCT02672852|4006752|FG001|COMPLETED|Part B||0
3271501|NCT02672852|4006753|FG002|COMPLETED|Part B||0
3271502|NCT02672852|4006754|FG003|COMPLETED|Part B||0
3271503|NCT02672852|4006755|FG004|COMPLETED|Part B||209
3271504|NCT02672852|4006756|FG005|COMPLETED|Part B||100
3271505|NCT02672852|4006757|FG006|COMPLETED|Part B||51
3271506|NCT02672852|4006751|FG000|NOT COMPLETED|Part B||0
3271507|NCT02672852|4006752|FG001|NOT COMPLETED|Part B||0
3271508|NCT02672852|4006753|FG002|NOT COMPLETED|Part B||0
3271509|NCT02672852|4006754|FG003|NOT COMPLETED|Part B||0
3271510|NCT02672852|4006755|FG004|NOT COMPLETED|Part B||16
3271511|NCT02672852|4006756|FG005|NOT COMPLETED|Part B||11
3271512|NCT02672852|4006757|FG006|NOT COMPLETED|Part B||12
3271513|NCT02673138|4006768|FG000|STARTED|Overall Study||10
3271514|NCT02673138|4006768|FG000|Started Day 1|Overall Study||10
3271515|NCT02673138|4006768|FG000|Ended Day 1|Overall Study||10
3271516|NCT02673138|4006768|FG000|Started Day 2|Overall Study||10
3271517|NCT02673138|4006768|FG000|Ended Day 2|Overall Study||10
3271518|NCT02673138|4006768|FG000|COMPLETED|Overall Study||10
3271519|NCT02673138|4006768|FG000|NOT COMPLETED|Overall Study||0
3271520|NCT02673203|4006776|FG000|STARTED|Overall Study||16
3271521|NCT02673203|4006777|FG001|STARTED|Overall Study||15
3271522|NCT02673203|4006776|FG000|COMPLETED|Overall Study||16
3271523|NCT02673203|4006777|FG001|COMPLETED|Overall Study||15
3271524|NCT02673203|4006776|FG000|NOT COMPLETED|Overall Study||0
3271525|NCT02673203|4006777|FG001|NOT COMPLETED|Overall Study||0
3271526|NCT02673333|4006783|FG000|STARTED|Overall Study||39
3271527|NCT02673333|4006783|FG000|COMPLETED|Overall Study||39
3271528|NCT02673333|4006783|FG000|NOT COMPLETED|Overall Study||0
3271529|NCT02673372|4006789|FG000|STARTED|Overall Study||30
3271530|NCT02673372|4006790|FG001|STARTED|Overall Study||30
3271531|NCT02673372|4006789|FG000|COMPLETED|Overall Study||30
3271532|NCT02673372|4006790|FG001|COMPLETED|Overall Study||30
3271533|NCT02673372|4006789|FG000|NOT COMPLETED|Overall Study||0
3271534|NCT02673372|4006790|FG001|NOT COMPLETED|Overall Study||0
3271535|NCT02673489|4006798|FG000|STARTED|Treatment Period||54
3271536|NCT02673489|4006799|FG001|STARTED|Treatment Period||24
3271537|NCT02673489|4006798|FG000|COMPLETED|Treatment Period||49
3271538|NCT02673489|4006799|FG001|COMPLETED|Treatment Period||21
3271539|NCT02673489|4006798|FG000|NOT COMPLETED|Treatment Period||5
3271540|NCT02673489|4006799|FG001|NOT COMPLETED|Treatment Period||3
3271541|NCT02673489|4006798|FG000|STARTED|Follow Up Period||50
3271542|NCT02673489|4006799|FG001|STARTED|Follow Up Period||23
3271543|NCT02673489|4006798|FG000|COMPLETED|Follow Up Period||50
3271544|NCT02673489|4006799|FG001|COMPLETED|Follow Up Period||21
3271545|NCT02673489|4006798|FG000|NOT COMPLETED|Follow Up Period||0
3271546|NCT02673489|4006799|FG001|NOT COMPLETED|Follow Up Period||2
3271547|NCT02673515|4006808|FG000|STARTED|Overall Study||30
3271548|NCT02673515|4006809|FG001|STARTED|Overall Study||30
3271549|NCT02673515|4006808|FG000|COMPLETED|Overall Study||28
3271550|NCT02673515|4006809|FG001|COMPLETED|Overall Study||29
3271551|NCT02673515|4006808|FG000|NOT COMPLETED|Overall Study||2
3271552|NCT02673515|4006809|FG001|NOT COMPLETED|Overall Study||1
3271553|NCT02673541|4006817|FG000|STARTED|Overall Study||3
3271554|NCT02673541|4006818|FG001|STARTED|Overall Study||2
3271555|NCT02673541|4006817|FG000|COMPLETED|Overall Study||3
3271556|NCT02673541|4006818|FG001|COMPLETED|Overall Study||2
3271557|NCT02673541|4006817|FG000|NOT COMPLETED|Overall Study||0
3271558|NCT02673541|4006818|FG001|NOT COMPLETED|Overall Study||0
3271559|NCT02673619|4006828|FG000|STARTED|Overall Study||20
3271560|NCT02673619|4006829|FG001|STARTED|Overall Study||5
3271561|NCT02673619|4006830|FG002|STARTED|Overall Study||26
3271562|NCT02673619|4006831|FG003|STARTED|Overall Study||7
3271563|NCT02673619|4006828|FG000|COMPLETED|Overall Study||18
3271564|NCT02673619|4006829|FG001|COMPLETED|Overall Study||4
3271565|NCT02673619|4006830|FG002|COMPLETED|Overall Study||23
3271566|NCT02673619|4006831|FG003|COMPLETED|Overall Study||7
3271567|NCT02673619|4006828|FG000|NOT COMPLETED|Overall Study||2
3271568|NCT02673619|4006829|FG001|NOT COMPLETED|Overall Study||1
3271569|NCT02673619|4006830|FG002|NOT COMPLETED|Overall Study||3
3271570|NCT02673619|4006831|FG003|NOT COMPLETED|Overall Study||0
3271571|NCT02673918|4006844|FG000|STARTED|Overall Study||35
3271572|NCT02673918|4006845|FG001|STARTED|Overall Study||24
3271573|NCT02673918|4006844|FG000|COMPLETED|Overall Study||29
3271574|NCT02673918|4006845|FG001|COMPLETED|Overall Study||20
3271575|NCT02673918|4006844|FG000|NOT COMPLETED|Overall Study||6
3271576|NCT02673918|4006845|FG001|NOT COMPLETED|Overall Study||4
3271577|NCT02673944|4006853|FG000|STARTED|Overall Study||10
3271578|NCT02673944|4006853|FG000|COMPLETED|Overall Study||10
3271579|NCT02673944|4006853|FG000|NOT COMPLETED|Overall Study||0
3271580|NCT02674061|4006860|FG000|STARTED|Overall Study||285
3271581|NCT02674061|4006861|FG001|STARTED|Overall Study||91
3271582|NCT02674061|4006860|FG000|COMPLETED|Overall Study||0
3271583|NCT02674061|4006861|FG001|COMPLETED|Overall Study||0
3271584|NCT02674061|4006860|FG000|NOT COMPLETED|Overall Study||285
3271585|NCT02674061|4006861|FG001|NOT COMPLETED|Overall Study||91
3271586|NCT02674334|4006869|FG000|STARTED|Overall Study||47
3271587|NCT02674334|4006870|FG001|STARTED|Overall Study||43
3271588|NCT02674334|4006869|FG000|COMPLETED|Overall Study||40
3271589|NCT02674334|4006870|FG001|COMPLETED|Overall Study||40
3271590|NCT02674334|4006869|FG000|NOT COMPLETED|Overall Study||7
3271591|NCT02674334|4006870|FG001|NOT COMPLETED|Overall Study||3
3271592|NCT02674386|4006879|FG000|STARTED|Overall Study||20
3271593|NCT02674386|4006880|FG001|STARTED|Overall Study||117
3271594|NCT02674386|4006881|FG002|STARTED|Overall Study||17
3271595|NCT02674386|4006879|FG000|Safety Analysis Set|Overall Study||20
3271596|NCT02674386|4006880|FG001|Safety Analysis Set|Overall Study||113
3271597|NCT02674386|4006881|FG002|Safety Analysis Set|Overall Study||17
3271598|NCT02674386|4006879|FG000|COMPLETED|Overall Study||20
3271599|NCT02674386|4006880|FG001|COMPLETED|Overall Study||107
3271600|NCT02674386|4006881|FG002|COMPLETED|Overall Study||16
3271601|NCT02674386|4006879|FG000|NOT COMPLETED|Overall Study||0
3271602|NCT02674386|4006880|FG001|NOT COMPLETED|Overall Study||10
3271603|NCT02674386|4006881|FG002|NOT COMPLETED|Overall Study||1
3271604|NCT02674399|4006896|FG000|STARTED|Overall Study||19
3271605|NCT02674399|4006897|FG001|STARTED|Overall Study||9
3271606|NCT02674399|4006896|FG000|COMPLETED|Overall Study||17
3271607|NCT02674399|4006897|FG001|COMPLETED|Overall Study||9
3271608|NCT02674399|4006896|FG000|NOT COMPLETED|Overall Study||2
3271609|NCT02674399|4006897|FG001|NOT COMPLETED|Overall Study||0
3271610|NCT02674412|4006903|FG000|STARTED|Overall Study||5
3271611|NCT02674412|4006904|FG001|STARTED|Overall Study||5
3271612|NCT02674412|4006903|FG000|COMPLETED|Overall Study||5
3271613|NCT02674412|4006904|FG001|COMPLETED|Overall Study||5
3271614|NCT02674412|4006903|FG000|NOT COMPLETED|Overall Study||0
3271615|NCT02674412|4006904|FG001|NOT COMPLETED|Overall Study||0
3271616|NCT02674477|4006913|FG000|STARTED|Overall Study||48
3271617|NCT02674477|4006914|FG001|STARTED|Overall Study||47
3271618|NCT02674477|4006913|FG000|COMPLETED|Overall Study||40
3271619|NCT02674477|4006914|FG001|COMPLETED|Overall Study||45
3271620|NCT02674477|4006913|FG000|NOT COMPLETED|Overall Study||8
3271621|NCT02674477|4006914|FG001|NOT COMPLETED|Overall Study||2
3377204|NCT01169753|4110790|FG001|COMPLETED|Overall Study||0
3377205|NCT01169753|4110789|FG000|NOT COMPLETED|Overall Study||0
3377206|NCT01169753|4110790|FG001|NOT COMPLETED|Overall Study||1
3377207|NCT01171534|4110798|FG000|STARTED|Overall Study|retrospective arm never performed on study|0
3377208|NCT01171534|4110799|FG001|STARTED|Overall Study||7
3377209|NCT01171534|4110798|FG000|COMPLETED|Overall Study||0
3377210|NCT01171534|4110799|FG001|COMPLETED|Overall Study||4
3377211|NCT01171534|4110798|FG000|NOT COMPLETED|Overall Study||0
3377212|NCT01171534|4110799|FG001|NOT COMPLETED|Overall Study||3
3377213|NCT01169610|4110805|FG000|STARTED|Overall Study||1
3377214|NCT01169610|4110805|FG000|COMPLETED|Overall Study||1
3377215|NCT01169610|4110805|FG000|NOT COMPLETED|Overall Study||0
3377216|NCT01155388|4110811|FG000|STARTED|Overall Study||8
3377217|NCT01155388|4110812|FG001|STARTED|Overall Study||6
3377218|NCT01155388|4110811|FG000|Received at Least 1 Dose of Study Drug|Overall Study||8
3377219|NCT01155388|4110812|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6
3377220|NCT01155388|4110811|FG000|COMPLETED|Overall Study||7
3377221|NCT01155388|4110812|FG001|COMPLETED|Overall Study||6
3377222|NCT01155388|4110811|FG000|NOT COMPLETED|Overall Study||1
3377223|NCT01155388|4110812|FG001|NOT COMPLETED|Overall Study||0
3377224|NCT01163084|4110821|FG000|STARTED|Overall Study||4
3377225|NCT01163084|4110822|FG001|STARTED|Overall Study||5
3377226|NCT01163084|4110821|FG000|COMPLETED|Overall Study||4
3377227|NCT01163084|4110822|FG001|COMPLETED|Overall Study||5
3377228|NCT01163084|4110821|FG000|NOT COMPLETED|Overall Study||0
3377229|NCT01163084|4110822|FG001|NOT COMPLETED|Overall Study||0
3377230|NCT01166724|4110830|FG000|STARTED|Overall Study||7
3377231|NCT01166724|4110831|FG001|STARTED|Overall Study||5
3377232|NCT01166724|4110830|FG000|COMPLETED|Overall Study||0
3377233|NCT01166724|4110831|FG001|COMPLETED|Overall Study||0
3377234|NCT01166724|4110830|FG000|NOT COMPLETED|Overall Study||7
3377235|NCT01166724|4110831|FG001|NOT COMPLETED|Overall Study||5
3377236|NCT01155375|4110839|FG000|STARTED|Overall Study||8
3377237|NCT01155375|4110840|FG001|STARTED|Overall Study||6
3377238|NCT01155375|4110839|FG000|Received at Least 1 Dose of Study Drug|Overall Study||8
3377239|NCT01155375|4110840|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6
3271622|NCT02674568|4006920|FG000|STARTED|Overall Study|Enrolled and dosed.|339
3271623|NCT02674568|4006920|FG000|Delta-like Protein 3 (DLL3) High|Overall Study||238
3271624|NCT02674568|4006920|FG000|DLL3 Positive|Overall Study||287
3271625|NCT02674568|4006920|FG000|COMPLETED|Overall Study||0
3271626|NCT02674568|4006920|FG000|NOT COMPLETED|Overall Study||339
3271627|NCT02674633|4006931|FG000|STARTED|Overall Study||180
3271628|NCT02674633|4006932|FG001|STARTED|Overall Study||168
3271629|NCT02674633|4006931|FG000|COMPLETED|Overall Study||175
3271630|NCT02674633|4006932|FG001|COMPLETED|Overall Study||164
3271631|NCT02674633|4006931|FG000|NOT COMPLETED|Overall Study||5
3271632|NCT02674633|4006932|FG001|NOT COMPLETED|Overall Study||4
3271633|NCT02674659|4006940|FG000|STARTED|Overall Study||43
3271634|NCT02674659|4006941|FG001|STARTED|Overall Study||44
3271635|NCT02674659|4006940|FG000|COMPLETED|Overall Study||39
3271636|NCT02674659|4006941|FG001|COMPLETED|Overall Study||40
3271637|NCT02674659|4006940|FG000|NOT COMPLETED|Overall Study||4
3271638|NCT02674659|4006941|FG001|NOT COMPLETED|Overall Study||4
3271639|NCT02674685|4006947|FG000|STARTED|Overall Study||237
3271640|NCT02674685|4006947|FG000|COMPLETED|Overall Study||233
3271641|NCT02674685|4006947|FG000|NOT COMPLETED|Overall Study||4
3271642|NCT02674854|4006954|FG000|STARTED|Overall Study||245
3271643|NCT02674854|4006955|FG001|STARTED|Overall Study||255
3271644|NCT02674854|4006956|FG002|STARTED|Overall Study||250
3271645|NCT02674854|4006954|FG000|COMPLETED|Overall Study||221
3271646|NCT02674854|4006955|FG001|COMPLETED|Overall Study||228
3271647|NCT02674854|4006956|FG002|COMPLETED|Overall Study||236
3271648|NCT02674854|4006954|FG000|NOT COMPLETED|Overall Study||24
3271649|NCT02674854|4006955|FG001|NOT COMPLETED|Overall Study||27
3271650|NCT02674854|4006956|FG002|NOT COMPLETED|Overall Study||14
3271651|NCT02675075|4006966|FG000|STARTED|Overall Study||15
3271652|NCT02675075|4006967|FG001|STARTED|Overall Study||19
3271653|NCT02675075|4006966|FG000|COMPLETED|Overall Study||12
3271654|NCT02675075|4006967|FG001|COMPLETED|Overall Study||19
3271655|NCT02675075|4006966|FG000|NOT COMPLETED|Overall Study||3
3271656|NCT02675075|4006967|FG001|NOT COMPLETED|Overall Study||0
3271657|NCT02675426|4006978|FG000|STARTED|Overall Study||221
3271658|NCT02675426|4006979|FG001|STARTED|Overall Study||221
3271659|NCT02675426|4006980|FG002|STARTED|Overall Study||219
3271660|NCT02675426|4006978|FG000|Treated|Overall Study||221
3271661|NCT02675426|4006979|FG001|Treated|Overall Study||221
3271662|NCT02675426|4006980|FG002|Treated|Overall Study||219
3271663|NCT02675426|4006978|FG000|COMPLETED|Overall Study||208
3271664|NCT02675426|4006979|FG001|COMPLETED|Overall Study||213
3271665|NCT02675426|4006980|FG002|COMPLETED|Overall Study||201
3271666|NCT02675426|4006978|FG000|NOT COMPLETED|Overall Study||13
3271667|NCT02675426|4006979|FG001|NOT COMPLETED|Overall Study||8
3271668|NCT02675426|4006980|FG002|NOT COMPLETED|Overall Study||18
3271669|NCT02675517|4006988|FG000|STARTED|Overall Study||1737
3271670|NCT02675517|4006988|FG000|COMPLETED|Overall Study||1578
3271671|NCT02675517|4006988|FG000|NOT COMPLETED|Overall Study||159
3271672|NCT02675543|4006994|FG000|STARTED|Overall Study||15
3271673|NCT02675543|4006995|FG001|STARTED|Overall Study||20
3271674|NCT02675543|4006994|FG000|COMPLETED|Overall Study||15
3271675|NCT02675543|4006995|FG001|COMPLETED|Overall Study||20
3271676|NCT02675543|4006994|FG000|NOT COMPLETED|Overall Study||0
3271677|NCT02675543|4006995|FG001|NOT COMPLETED|Overall Study||0
3271678|NCT02675634|4007001|FG000|STARTED|Test Period 1||10
3271679|NCT02675634|4007002|FG001|STARTED|Test Period 1||8
3271680|NCT02675634|4007003|FG002|STARTED|Test Period 1||9
3271681|NCT02675634|4007004|FG003|STARTED|Test Period 1||9
3271682|NCT02675634|4007005|FG004|STARTED|Test Period 1||10
3271683|NCT02675634|4007006|FG005|STARTED|Test Period 1||9
3271684|NCT02675634|4007001|FG000|COMPLETED|Test Period 1||10
3271685|NCT02675634|4007002|FG001|COMPLETED|Test Period 1||7
3271686|NCT02675634|4007003|FG002|COMPLETED|Test Period 1||8
3271687|NCT02675634|4007004|FG003|COMPLETED|Test Period 1||8
3271688|NCT02675634|4007005|FG004|COMPLETED|Test Period 1||10
3271689|NCT02675634|4007006|FG005|COMPLETED|Test Period 1||9
3271690|NCT02675634|4007001|FG000|NOT COMPLETED|Test Period 1||0
3271691|NCT02675634|4007002|FG001|NOT COMPLETED|Test Period 1||1
3271692|NCT02675634|4007003|FG002|NOT COMPLETED|Test Period 1||1
3271693|NCT02675634|4007004|FG003|NOT COMPLETED|Test Period 1||1
3271694|NCT02675634|4007005|FG004|NOT COMPLETED|Test Period 1||0
3271695|NCT02675634|4007006|FG005|NOT COMPLETED|Test Period 1||0
3271696|NCT02675634|4007001|FG000|STARTED|Test Period 2||10
3271697|NCT02675634|4007002|FG001|STARTED|Test Period 2||7
3271698|NCT02675634|4007003|FG002|STARTED|Test Period 2||8
3271699|NCT02675634|4007004|FG003|STARTED|Test Period 2||8
3271700|NCT02675634|4007005|FG004|STARTED|Test Period 2||10
3271701|NCT02675634|4007006|FG005|STARTED|Test Period 2||9
3271702|NCT02675634|4007001|FG000|COMPLETED|Test Period 2||9
3271703|NCT02675634|4007002|FG001|COMPLETED|Test Period 2||7
3271704|NCT02675634|4007003|FG002|COMPLETED|Test Period 2||8
3271705|NCT02675634|4007004|FG003|COMPLETED|Test Period 2||8
3271706|NCT02675634|4007005|FG004|COMPLETED|Test Period 2||10
3271707|NCT02675634|4007006|FG005|COMPLETED|Test Period 2||8
3271708|NCT02675634|4007001|FG000|NOT COMPLETED|Test Period 2||1
3271709|NCT02675634|4007002|FG001|NOT COMPLETED|Test Period 2||0
3271710|NCT02675634|4007003|FG002|NOT COMPLETED|Test Period 2||0
3271711|NCT02675634|4007004|FG003|NOT COMPLETED|Test Period 2||0
3271712|NCT02675634|4007005|FG004|NOT COMPLETED|Test Period 2||0
3377240|NCT01155375|4110839|FG000|COMPLETED|Overall Study||7
3377241|NCT01155375|4110840|FG001|COMPLETED|Overall Study||6
3377242|NCT01155375|4110839|FG000|NOT COMPLETED|Overall Study||1
3377243|NCT01155375|4110840|FG001|NOT COMPLETED|Overall Study||0
3377244|NCT01162382|4110847|FG000|STARTED|Overall Study||0
3377245|NCT01162382|4110847|FG000|COMPLETED|Overall Study||0
3377246|NCT01162382|4110847|FG000|NOT COMPLETED|Overall Study||0
3377247|NCT01157533|4110851|FG000|STARTED|Overall Study||1
3377248|NCT01157533|4110851|FG000|COMPLETED|Overall Study||1
3377249|NCT01157533|4110851|FG000|NOT COMPLETED|Overall Study||0
3377250|NCT01162304|4110855|FG000|STARTED|Overall Study||18
3377251|NCT01162304|4110855|FG000|COMPLETED|Overall Study||7
3377252|NCT01162304|4110855|FG000|NOT COMPLETED|Overall Study||11
3377253|NCT01151904|4110861|FG000|STARTED|Overall Study||17
3377254|NCT01151904|4110861|FG000|COMPLETED|Overall Study||17
3377255|NCT01151904|4110861|FG000|NOT COMPLETED|Overall Study||0
3377256|NCT01155518|4110871|FG000|STARTED|Overall Study||1
3377257|NCT01155518|4110872|FG001|STARTED|Overall Study||1
3377258|NCT01155518|4110873|FG002|STARTED|Overall Study||0
3377259|NCT01155518|4110874|FG003|STARTED|Overall Study||0
3377260|NCT01155518|4110875|FG004|STARTED|Overall Study||1
3377261|NCT01155518|4110876|FG005|STARTED|Overall Study||2
3377262|NCT01155518|4110871|FG000|COMPLETED|Overall Study||1
3377263|NCT01155518|4110872|FG001|COMPLETED|Overall Study|never started the study|0
3377264|NCT01155518|4110873|FG002|COMPLETED|Overall Study||0
3377265|NCT01155518|4110874|FG003|COMPLETED|Overall Study||0
3377266|NCT01155518|4110875|FG004|COMPLETED|Overall Study||1
3377267|NCT01155518|4110876|FG005|COMPLETED|Overall Study||2
3377268|NCT01155518|4110871|FG000|NOT COMPLETED|Overall Study||0
3377269|NCT01155518|4110872|FG001|NOT COMPLETED|Overall Study||1
3377270|NCT01155518|4110873|FG002|NOT COMPLETED|Overall Study||0
3377271|NCT01155518|4110874|FG003|NOT COMPLETED|Overall Study||0
3377272|NCT01155518|4110875|FG004|NOT COMPLETED|Overall Study||0
3377273|NCT01155518|4110876|FG005|NOT COMPLETED|Overall Study||0
3377274|NCT01150409|4110892|FG000|STARTED|Overall Study||11
3377275|NCT01150409|4110893|FG001|STARTED|Overall Study||0
3377276|NCT01150409|4110892|FG000|COMPLETED|Overall Study||11
3377277|NCT01150409|4110893|FG001|COMPLETED|Overall Study||0
3377278|NCT01150409|4110892|FG000|NOT COMPLETED|Overall Study||0
3377279|NCT01150409|4110893|FG001|NOT COMPLETED|Overall Study||0
3377280|NCT01151553|4110899|FG000|STARTED|Overall Study||5
3377281|NCT01151553|4110899|FG000|COMPLETED|Overall Study||5
3377282|NCT01151553|4110899|FG000|NOT COMPLETED|Overall Study||0
3377283|NCT01148056|4110903|FG000|STARTED|Overall Study||2
3377284|NCT01148056|4110903|FG000|COMPLETED|Overall Study||2
3377285|NCT01148056|4110903|FG000|NOT COMPLETED|Overall Study||0
3377286|NCT01147393|4110907|FG000|STARTED|Dose Level 1||3
3377287|NCT01147393|4110907|FG000|COMPLETED|Dose Level 1||1
3377288|NCT01147393|4110907|FG000|NOT COMPLETED|Dose Level 1||2
3377289|NCT01147393|4110907|FG000|STARTED|Dose Level -1||1
3377290|NCT01147393|4110907|FG000|COMPLETED|Dose Level -1||0
3377291|NCT01147393|4110907|FG000|NOT COMPLETED|Dose Level -1||1
3377292|NCT01147042|4110914|FG000|STARTED|Overall Study||2
3377293|NCT01147042|4110915|FG001|STARTED|Overall Study||0
3377294|NCT01147042|4110914|FG000|COMPLETED|Overall Study||2
3377295|NCT01147042|4110915|FG001|COMPLETED|Overall Study||0
3377296|NCT01147042|4110914|FG000|NOT COMPLETED|Overall Study||0
3377297|NCT01147042|4110915|FG001|NOT COMPLETED|Overall Study||0
3377298|NCT01147536|4110920|FG000|STARTED|Overall Study||12
3377299|NCT01147536|4110920|FG000|Received at Least 1 Dose of Study Drug|Overall Study||12
3377300|NCT01147536|4110920|FG000|COMPLETED|Overall Study||9
3377301|NCT01147536|4110920|FG000|NOT COMPLETED|Overall Study||3
3377302|NCT01139996|4110926|FG000|STARTED|Overall Study||11
3377303|NCT01139996|4110927|FG001|STARTED|Overall Study||11
3377304|NCT01139996|4110926|FG000|COMPLETED|Overall Study||11
3377305|NCT01139996|4110927|FG001|COMPLETED|Overall Study||11
3377306|NCT01139996|4110926|FG000|NOT COMPLETED|Overall Study||0
3377307|NCT01139996|4110927|FG001|NOT COMPLETED|Overall Study||0
3377308|NCT01133288|4110933|FG000|STARTED|Eligibility Assessment||7
3377309|NCT01133288|4110933|FG000|COMPLETED|Eligibility Assessment||2
3377310|NCT01133288|4110933|FG000|NOT COMPLETED|Eligibility Assessment||5
3377311|NCT01133288|4110933|FG000|STARTED|Intervention Allocation||2
3377312|NCT01133288|4110933|FG000|COMPLETED|Intervention Allocation||0
3377313|NCT01133288|4110933|FG000|NOT COMPLETED|Intervention Allocation||2
3377314|NCT01142128|4110941|FG000|STARTED|Overall Study||8
3377315|NCT01142128|4110941|FG000|Nexium Alone|Overall Study||3
3377316|NCT01142128|4110941|FG000|Placebo to Nexium, Alone|Overall Study||3
3377317|NCT01142128|4110941|FG000|Viokase 16 Plus Nexium|Overall Study||2
3377318|NCT01142128|4110941|FG000|Viokase 16 Plus Placebo to Nexium|Overall Study||0
3377319|NCT01142128|4110941|FG000|COMPLETED|Overall Study||4
3377320|NCT01142128|4110941|FG000|NOT COMPLETED|Overall Study||4
3377321|NCT01131884|4110953|FG000|STARTED|Overall Study||1
3377322|NCT01131884|4110954|FG001|STARTED|Overall Study||0
3377323|NCT01131884|4110953|FG000|COMPLETED|Overall Study||1
3377324|NCT01131884|4110954|FG001|COMPLETED|Overall Study||0
3377325|NCT01131884|4110953|FG000|NOT COMPLETED|Overall Study||0
3377326|NCT01131884|4110954|FG001|NOT COMPLETED|Overall Study||0
3377327|NCT01128114|4110960|FG000|STARTED|Overall Study||32
3377328|NCT01128114|4110960|FG000|COMPLETED|Overall Study||24
3377329|NCT01128114|4110960|FG000|NOT COMPLETED|Overall Study||8
3377330|NCT01126879|4110966|FG000|STARTED|Overall Study||8
3377331|NCT01126879|4110967|FG001|STARTED|Overall Study||4
3377332|NCT01126879|4110966|FG000|Started 3 Months of Genistein/Placebo|Overall Study||8
3377333|NCT01126879|4110967|FG001|Started 3 Months of Genistein/Placebo|Overall Study||4
3377334|NCT01126879|4110966|FG000|Prostatectomy or Radiation|Overall Study||8
3377335|NCT01126879|4110967|FG001|Prostatectomy or Radiation|Overall Study||4
3377336|NCT01126879|4110966|FG000|Completed 3 Months Genistein/Placebo|Overall Study||4
3377337|NCT01126879|4110967|FG001|Completed 3 Months Genistein/Placebo|Overall Study||2
3377338|NCT01126879|4110966|FG000|COMPLETED|Overall Study||3
3377339|NCT01126879|4110967|FG001|COMPLETED|Overall Study||2
3377340|NCT01126879|4110966|FG000|NOT COMPLETED|Overall Study||5
3377341|NCT01126879|4110967|FG001|NOT COMPLETED|Overall Study||2
3377342|NCT01136811|4110973|FG000|STARTED|Overall Study||11
3377343|NCT01136811|4110973|FG000|COMPLETED|Overall Study||0
3377344|NCT01136811|4110973|FG000|NOT COMPLETED|Overall Study||11
3377345|NCT01139294|4110979|FG000|STARTED|Overall Study||0
3377346|NCT01139294|4110980|FG001|STARTED|Overall Study||0
3377347|NCT01139294|4110979|FG000|COMPLETED|Overall Study||0
3377348|NCT01139294|4110980|FG001|COMPLETED|Overall Study||0
3377349|NCT01139294|4110979|FG000|NOT COMPLETED|Overall Study||0
3377350|NCT01139294|4110980|FG001|NOT COMPLETED|Overall Study||0
3377351|NCT01139125|4110986|FG000|STARTED|Overall Study||3
3377352|NCT01139125|4110986|FG000|COMPLETED|Overall Study||2
3377353|NCT01139125|4110986|FG000|NOT COMPLETED|Overall Study||1
3377354|NCT01136668|4110992|FG000|STARTED|Overall Study||7
3377355|NCT01136668|4110993|FG001|STARTED|Overall Study||6
3377356|NCT01136668|4110992|FG000|COMPLETED|Overall Study||7
3377357|NCT01136668|4110993|FG001|COMPLETED|Overall Study||6
3377358|NCT01136668|4110992|FG000|NOT COMPLETED|Overall Study||0
3377359|NCT01136668|4110993|FG001|NOT COMPLETED|Overall Study||0
3377360|NCT01133639|4111001|FG000|STARTED|Overall Study|18 total subjects were enrolled, study was terminated prematurely and data was not analyzed|0
3377361|NCT01133639|4111002|FG001|STARTED|Overall Study|18 total subjects were enrolled, study was terminated prematurely and data was not analyzed|0
3377362|NCT01133639|4111001|FG000|COMPLETED|Overall Study|18 total subjects were enrolled, study was terminated prematurely and data was not analyzed|0
3377363|NCT01133639|4111002|FG001|COMPLETED|Overall Study|18 total subjects were enrolled,study was terminated prematurely and data was not analyzed|0
3377364|NCT01133639|4111001|FG000|NOT COMPLETED|Overall Study||0
3377365|NCT01133639|4111002|FG001|NOT COMPLETED|Overall Study||0
3377366|NCT01131455|4111010|FG000|STARTED|Overall Study||6
3377367|NCT01131455|4111011|FG001|STARTED|Overall Study||4
3377368|NCT01131455|4111012|FG002|STARTED|Overall Study||0
3377369|NCT01131455|4111010|FG000|COMPLETED|Overall Study||0
3377370|NCT01131455|4111011|FG001|COMPLETED|Overall Study||0
3377371|NCT01131455|4111012|FG002|COMPLETED|Overall Study||0
3377372|NCT01131455|4111010|FG000|NOT COMPLETED|Overall Study||6
3377373|NCT01131455|4111011|FG001|NOT COMPLETED|Overall Study||4
3377374|NCT01131455|4111012|FG002|NOT COMPLETED|Overall Study||0
3377375|NCT01126801|4111022|FG000|STARTED|Overall Study||1
3377376|NCT01126801|4111023|FG001|STARTED|Overall Study||1
3377377|NCT01126801|4111022|FG000|COMPLETED|Overall Study||1
3377378|NCT01126801|4111023|FG001|COMPLETED|Overall Study||1
3377379|NCT01126801|4111022|FG000|NOT COMPLETED|Overall Study||0
3377380|NCT01126801|4111023|FG001|NOT COMPLETED|Overall Study||0
3377381|NCT01123850|4111029|FG000|STARTED|Overall Study||45
3377382|NCT01123850|4111029|FG000|COMPLETED|Overall Study||0
3377383|NCT01123850|4111029|FG000|NOT COMPLETED|Overall Study||45
3377384|NCT01126957|4111033|FG000|STARTED|Overall Study||103
3377385|NCT01126957|4111033|FG000|COMPLETED|Overall Study||103
3377386|NCT01126957|4111033|FG000|NOT COMPLETED|Overall Study||0
3377387|NCT01127503|4111040|FG000|STARTED|Overall Study||1
3377388|NCT01127503|4111041|FG001|STARTED|Overall Study||1
3377389|NCT01127503|4111040|FG000|COMPLETED|Overall Study||1
3377390|NCT01127503|4111041|FG001|COMPLETED|Overall Study||1
3377391|NCT01127503|4111040|FG000|NOT COMPLETED|Overall Study||0
3377392|NCT01127503|4111041|FG001|NOT COMPLETED|Overall Study||0
3377393|NCT01122511|4111049|FG000|STARTED|Overall Study||2
3377394|NCT01122511|4111050|FG001|STARTED|Overall Study||2
3377395|NCT01122511|4111049|FG000|COMPLETED|Overall Study||0
3377396|NCT01122511|4111050|FG001|COMPLETED|Overall Study||0
3377397|NCT01122511|4111049|FG000|NOT COMPLETED|Overall Study||2
3377398|NCT01122511|4111050|FG001|NOT COMPLETED|Overall Study||2
3377399|NCT01118013|4111056|FG000|STARTED|Overall Study||6
3377400|NCT01118013|4111056|FG000|COMPLETED|Overall Study||6
3377401|NCT01118013|4111056|FG000|NOT COMPLETED|Overall Study||0
3377402|NCT01122381|4111062|FG000|STARTED|Overall Study||1
3377403|NCT01122381|4111063|FG001|STARTED|Overall Study||1
3377404|NCT01122381|4111062|FG000|COMPLETED|Overall Study|Subject never took the drug per review of ESX levels after unblinding|1
3377405|NCT01122381|4111063|FG001|COMPLETED|Overall Study||0
3377406|NCT01122381|4111062|FG000|NOT COMPLETED|Overall Study||0
3377407|NCT01122381|4111063|FG001|NOT COMPLETED|Overall Study||1
3377408|NCT01116232|4111069|FG000|STARTED|Overall Study||4
3377409|NCT01116232|4111069|FG000|COMPLETED|Overall Study||0
3377410|NCT01116232|4111069|FG000|NOT COMPLETED|Overall Study||4
3377411|NCT01110174|4111076|FG000|STARTED|Overall Study||8
3377412|NCT01110174|4111076|FG000|COMPLETED|Overall Study||8
3377413|NCT01110174|4111076|FG000|NOT COMPLETED|Overall Study||0
3377414|NCT01115699|4111080|FG000|STARTED|Overall Study||2
3377415|NCT01115699|4111080|FG000|COMPLETED|Overall Study||2
3377416|NCT01115699|4111080|FG000|NOT COMPLETED|Overall Study||0
3377417|NCT01108666|4111084|FG000|STARTED|Overall Study|Despite all possible efforts to contact the PI/study, data per dose-level are not available to be reported|7
3377418|NCT01108666|4111084|FG000|COMPLETED|Overall Study|Despite all possible efforts to contact the PI/study, data per dose-level are not available to be reported|7
3377419|NCT01108666|4111084|FG000|NOT COMPLETED|Overall Study||0
3377420|NCT01115244|4111090|FG000|STARTED|Overall Study||0
3377421|NCT01115244|4111091|FG001|STARTED|Overall Study||0
3377422|NCT01115244|4111090|FG000|COMPLETED|Overall Study||0
3377423|NCT01115244|4111091|FG001|COMPLETED|Overall Study||0
3377424|NCT01115244|4111090|FG000|NOT COMPLETED|Overall Study||0
3377425|NCT01115244|4111091|FG001|NOT COMPLETED|Overall Study||0
3377426|NCT01108523|4111097|FG000|STARTED|Overall Study||7
3377427|NCT01108523|4111097|FG000|COMPLETED|Overall Study||3
3377428|NCT01108523|4111097|FG000|NOT COMPLETED|Overall Study||4
3377429|NCT01107795|4111101|FG000|STARTED|Overall Study||41
3377430|NCT01107795|4111101|FG000|COMPLETED|Overall Study||41
3377431|NCT01107795|4111101|FG000|NOT COMPLETED|Overall Study||0
3377432|NCT01106534|4111105|FG000|STARTED|Overall Study||2997
3377433|NCT01106534|4111105|FG000|COMPLETED|Overall Study||2960
3377434|NCT01106534|4111105|FG000|NOT COMPLETED|Overall Study||37
3377435|NCT01104116|4111110|FG000|STARTED|Overall Study||1
3377436|NCT01104116|4111110|FG000|COMPLETED|Overall Study||1
3377437|NCT01104116|4111110|FG000|NOT COMPLETED|Overall Study||0
3377438|NCT01100658|4111114|FG000|STARTED|Overall Study||1
3377439|NCT01100658|4111114|FG000|COMPLETED|Overall Study||0
3377440|NCT01100658|4111114|FG000|NOT COMPLETED|Overall Study||1
3377441|NCT01103180|4111120|FG000|STARTED|Overall Study||35
3377442|NCT01103180|4111121|FG001|STARTED|Overall Study||35
3377443|NCT01103180|4111120|FG000|COMPLETED|Overall Study||13
3377444|NCT01103180|4111121|FG001|COMPLETED|Overall Study||14
3377445|NCT01103180|4111120|FG000|NOT COMPLETED|Overall Study||22
3377446|NCT01103180|4111121|FG001|NOT COMPLETED|Overall Study||21
3377447|NCT01090141|4111129|FG000|STARTED|Overall Study||0
3377448|NCT01090141|4111130|FG001|STARTED|Overall Study||0
3377449|NCT01090141|4111129|FG000|COMPLETED|Overall Study||0
3377450|NCT01090141|4111130|FG001|COMPLETED|Overall Study||0
3377451|NCT01090141|4111129|FG000|NOT COMPLETED|Overall Study||0
3377452|NCT01090141|4111130|FG001|NOT COMPLETED|Overall Study||0
3377453|NCT01102140|4111138|FG000|STARTED|Overall Study||13
3377454|NCT01102140|4111139|FG001|STARTED|Overall Study||7
3377455|NCT01102140|4111138|FG000|COMPLETED|Overall Study||10
3377456|NCT01102140|4111139|FG001|COMPLETED|Overall Study||5
3377457|NCT01102140|4111138|FG000|NOT COMPLETED|Overall Study||3
3377458|NCT01102140|4111139|FG001|NOT COMPLETED|Overall Study||2
3377459|NCT01095250|4111151|FG000|STARTED|Overall Study||8
3377460|NCT01095250|4111152|FG001|STARTED|Overall Study||10
3377461|NCT01095250|4111153|FG002|STARTED|Overall Study||8
3377462|NCT01095250|4111154|FG003|STARTED|Overall Study||5
3377463|NCT01095250|4111151|FG000|COMPLETED|Overall Study||0
3377464|NCT01095250|4111152|FG001|COMPLETED|Overall Study||0
3377465|NCT01095250|4111153|FG002|COMPLETED|Overall Study||0
3377466|NCT01095250|4111154|FG003|COMPLETED|Overall Study||0
3377467|NCT01095250|4111151|FG000|NOT COMPLETED|Overall Study||8
3377468|NCT01095250|4111152|FG001|NOT COMPLETED|Overall Study||10
3377469|NCT01095250|4111153|FG002|NOT COMPLETED|Overall Study||8
3377470|NCT01095250|4111154|FG003|NOT COMPLETED|Overall Study||5
3377471|NCT01094561|4111164|FG000|STARTED|Overall Study||23
3377472|NCT01094561|4111164|FG000|COMPLETED|Overall Study||17
3377473|NCT01094561|4111164|FG000|NOT COMPLETED|Overall Study||6
3377474|NCT01093846|4111171|FG000|STARTED|Overall Study||19
3377475|NCT01093846|4111172|FG001|STARTED|Overall Study||18
3377476|NCT01093846|4111173|FG002|STARTED|Overall Study||22
3377477|NCT01093846|4111171|FG000|COMPLETED|Overall Study||0
3377478|NCT01093846|4111172|FG001|COMPLETED|Overall Study||0
3377479|NCT01093846|4111173|FG002|COMPLETED|Overall Study||1
3377480|NCT01093846|4111171|FG000|NOT COMPLETED|Overall Study||19
3377481|NCT01093846|4111172|FG001|NOT COMPLETED|Overall Study||18
3377482|NCT01093846|4111173|FG002|NOT COMPLETED|Overall Study||21
3377483|NCT01078844|4111179|FG000|STARTED|Overall Study||4
3377484|NCT01078844|4111179|FG000|COMPLETED|Overall Study||0
3377485|NCT01078844|4111179|FG000|NOT COMPLETED|Overall Study||4
3377486|NCT01081886|4111186|FG000|STARTED|Overall Study||11
3377487|NCT01081886|4111187|FG001|STARTED|Overall Study||13
3377488|NCT01081886|4111186|FG000|COMPLETED|Overall Study||0
3377489|NCT01081886|4111187|FG001|COMPLETED|Overall Study||0
3377490|NCT01081886|4111186|FG000|NOT COMPLETED|Overall Study||11
3377491|NCT01081886|4111187|FG001|NOT COMPLETED|Overall Study||13
3377492|NCT01085643|4111193|FG000|STARTED|Overall Study||4
3377493|NCT01085643|4111193|FG000|COMPLETED|Overall Study||4
3377494|NCT01085643|4111193|FG000|NOT COMPLETED|Overall Study||0
3377495|NCT01083472|4111199|FG000|STARTED|Overall Study||18
3377496|NCT01083472|4111200|FG001|STARTED|Overall Study||19
3377497|NCT01083472|4111199|FG000|COMPLETED|Overall Study||18
3377498|NCT01083472|4111200|FG001|COMPLETED|Overall Study||19
3377499|NCT01083472|4111199|FG000|NOT COMPLETED|Overall Study||0
3377500|NCT01083472|4111200|FG001|NOT COMPLETED|Overall Study||0
3377501|NCT01080768|4111208|FG000|STARTED|Overall Study||14
3377502|NCT01080768|4111209|FG001|STARTED|Overall Study||17
3377503|NCT01080768|4111208|FG000|COMPLETED|Overall Study||12
3377504|NCT01080768|4111209|FG001|COMPLETED|Overall Study||16
3377505|NCT01080768|4111208|FG000|NOT COMPLETED|Overall Study||2
3377506|NCT01080768|4111209|FG001|NOT COMPLETED|Overall Study||1
3377507|NCT01079598|4111215|FG000|STARTED|Overall Study||8
3377508|NCT01079598|4111215|FG000|COMPLETED|Overall Study||8
3377509|NCT01079598|4111215|FG000|NOT COMPLETED|Overall Study||0
3377510|NCT01074502|4111219|FG000|STARTED|Overall Study||3
3377511|NCT01074502|4111219|FG000|COMPLETED|Overall Study||2
3377512|NCT01074502|4111219|FG000|NOT COMPLETED|Overall Study||1
3377513|NCT01074437|4111225|FG000|STARTED|Overall Study||4
3377514|NCT01074437|4111226|FG001|STARTED|Overall Study||5
3377515|NCT01074437|4111225|FG000|COMPLETED|Overall Study||4
3377516|NCT01074437|4111226|FG001|COMPLETED|Overall Study||5
3377517|NCT01074437|4111225|FG000|NOT COMPLETED|Overall Study||0
3377518|NCT01074437|4111226|FG001|NOT COMPLETED|Overall Study||0
3377519|NCT01069861|4111232|FG000|STARTED|Overall Study||4
3377520|NCT01069861|4111232|FG000|COMPLETED|Overall Study||1
3377521|NCT01069861|4111232|FG000|NOT COMPLETED|Overall Study||3
3377522|NCT01072526|4111236|FG000|STARTED|Overall Study|Study started in December 2007 (recruited 6 patients total of 20 anticipated)|6
3377523|NCT01072526|4111237|FG001|STARTED|Overall Study||0
3377524|NCT01072526|4111236|FG000|COMPLETED|Overall Study|Study completed in September 2008(recruited 6 patients total of 20 anticipated)|6
3377525|NCT01072526|4111237|FG001|COMPLETED|Overall Study||0
3377526|NCT01072526|4111236|FG000|NOT COMPLETED|Overall Study||0
3377527|NCT01072526|4111237|FG001|NOT COMPLETED|Overall Study||0
3377528|NCT01071993|4111247|FG000|STARTED|Overall Study||0
3377529|NCT01071993|4111248|FG001|STARTED|Overall Study||0
3377530|NCT01071993|4111247|FG000|COMPLETED|Overall Study||0
3377531|NCT01071993|4111248|FG001|COMPLETED|Overall Study||0
3377532|NCT01071993|4111247|FG000|NOT COMPLETED|Overall Study||0
3377533|NCT01071993|4111248|FG001|NOT COMPLETED|Overall Study||0
3377534|NCT01065051|4111256|FG000|STARTED|Overall Study||1
3377535|NCT01065051|4111257|FG001|STARTED|Overall Study||0
3377536|NCT01065051|4111256|FG000|COMPLETED|Overall Study||1
3377537|NCT01065051|4111257|FG001|COMPLETED|Overall Study||0
3377538|NCT01065051|4111256|FG000|NOT COMPLETED|Overall Study||0
3377539|NCT01065051|4111257|FG001|NOT COMPLETED|Overall Study||0
3377540|NCT01069120|4111265|FG000|STARTED|Overall Study||27
3377541|NCT01069120|4111265|FG000|COMPLETED|Overall Study||0
3377542|NCT01069120|4111265|FG000|NOT COMPLETED|Overall Study||27
3377543|NCT01066637|4111273|FG000|STARTED|Overall Study||16
3377544|NCT01066637|4111274|FG001|STARTED|Overall Study||10
3377545|NCT01066637|4111273|FG000|COMPLETED|Overall Study||16
3377546|NCT01066637|4111274|FG001|COMPLETED|Overall Study||10
3377547|NCT01066637|4111273|FG000|NOT COMPLETED|Overall Study||0
3377548|NCT01066637|4111274|FG001|NOT COMPLETED|Overall Study||0
3377549|NCT01058642|4111284|FG000|STARTED|Treatment Period 1||9
3377550|NCT01058642|4111285|FG001|STARTED|Treatment Period 1||12
3377551|NCT01058642|4111286|FG002|STARTED|Treatment Period 1||11
3377552|NCT01058642|4111287|FG003|STARTED|Treatment Period 1||9
3377553|NCT01058642|4111284|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 1||9
3377554|NCT01058642|4111285|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 1||12
3377555|NCT01058642|4111286|FG002|Received at Least 1 Dose of Study Drug|Treatment Period 1||11
3377556|NCT01058642|4111287|FG003|Received at Least 1 Dose of Study Drug|Treatment Period 1||9
3377557|NCT01058642|4111284|FG000|COMPLETED|Treatment Period 1||7
3377558|NCT01058642|4111285|FG001|COMPLETED|Treatment Period 1||11
3377559|NCT01058642|4111286|FG002|COMPLETED|Treatment Period 1||9
3377560|NCT01058642|4111287|FG003|COMPLETED|Treatment Period 1||7
3377561|NCT01058642|4111284|FG000|NOT COMPLETED|Treatment Period 1||2
3377562|NCT01058642|4111285|FG001|NOT COMPLETED|Treatment Period 1||1
3377563|NCT01058642|4111286|FG002|NOT COMPLETED|Treatment Period 1||2
3377564|NCT01058642|4111287|FG003|NOT COMPLETED|Treatment Period 1||2
3377565|NCT01058642|4111284|FG000|STARTED|Washout Period||7
3377566|NCT01058642|4111285|FG001|STARTED|Washout Period||11
3377567|NCT01058642|4111286|FG002|STARTED|Washout Period||9
3377568|NCT01058642|4111287|FG003|STARTED|Washout Period||7
3377569|NCT01058642|4111284|FG000|COMPLETED|Washout Period||7
3377570|NCT01058642|4111285|FG001|COMPLETED|Washout Period||11
3377571|NCT01058642|4111286|FG002|COMPLETED|Washout Period||9
3377572|NCT01058642|4111287|FG003|COMPLETED|Washout Period||7
3377573|NCT01058642|4111284|FG000|NOT COMPLETED|Washout Period||0
3377574|NCT01058642|4111285|FG001|NOT COMPLETED|Washout Period||0
3377575|NCT01058642|4111286|FG002|NOT COMPLETED|Washout Period||0
3377576|NCT01058642|4111287|FG003|NOT COMPLETED|Washout Period||0
3377577|NCT01058642|4111284|FG000|STARTED|Treatment Period 2||7
3377578|NCT01058642|4111285|FG001|STARTED|Treatment Period 2||11
3377579|NCT01058642|4111286|FG002|STARTED|Treatment Period 2||9
3377580|NCT01058642|4111287|FG003|STARTED|Treatment Period 2||7
3377581|NCT01058642|4111284|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 2||7
3377582|NCT01058642|4111285|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 2||11
3377583|NCT01058642|4111286|FG002|Received at Least 1 Dose of Study Drug|Treatment Period 2||9
3377584|NCT01058642|4111287|FG003|Received at Least 1 Dose of Study Drug|Treatment Period 2||7
3377585|NCT01058642|4111284|FG000|COMPLETED|Treatment Period 2||7
3377586|NCT01058642|4111285|FG001|COMPLETED|Treatment Period 2||11
3377587|NCT01058642|4111286|FG002|COMPLETED|Treatment Period 2||9
3377588|NCT01058642|4111287|FG003|COMPLETED|Treatment Period 2||7
3377589|NCT01058642|4111284|FG000|NOT COMPLETED|Treatment Period 2||0
3377590|NCT01058642|4111285|FG001|NOT COMPLETED|Treatment Period 2||0
3377591|NCT01058642|4111286|FG002|NOT COMPLETED|Treatment Period 2||0
3377592|NCT01058642|4111287|FG003|NOT COMPLETED|Treatment Period 2||0
3377593|NCT01065818|4111295|FG000|STARTED|Overall Study||6
3377594|NCT01065818|4111295|FG000|COMPLETED|Overall Study||4
3377595|NCT01065818|4111295|FG000|NOT COMPLETED|Overall Study||2
3377596|NCT01051921|4111299|FG000|STARTED|Overall Study||67
3377597|NCT01051921|4111299|FG000|COMPLETED|Overall Study||37
3377598|NCT01051921|4111299|FG000|NOT COMPLETED|Overall Study||30
3377599|NCT01048125|4111305|FG000|STARTED|Overall Study||0
3377600|NCT01048125|4111306|FG001|STARTED|Overall Study||0
3377601|NCT01048125|4111305|FG000|COMPLETED|Overall Study||0
3377602|NCT01048125|4111306|FG001|COMPLETED|Overall Study||0
3377603|NCT01048125|4111305|FG000|NOT COMPLETED|Overall Study||0
3377604|NCT01048125|4111306|FG001|NOT COMPLETED|Overall Study||0
3377605|NCT01056315|4111314|FG000|STARTED|Overall Study||27
3377606|NCT01056315|4111315|FG001|STARTED|Overall Study||23
3377607|NCT01056315|4111314|FG000|COMPLETED|Overall Study||13
3377608|NCT01056315|4111315|FG001|COMPLETED|Overall Study||12
3377609|NCT01056315|4111314|FG000|NOT COMPLETED|Overall Study||14
3377610|NCT01056315|4111315|FG001|NOT COMPLETED|Overall Study||11
3377611|NCT01058369|4111321|FG000|STARTED|Overall Study||2
3377612|NCT01058369|4111321|FG000|COMPLETED|Overall Study||0
3377613|NCT01058369|4111321|FG000|NOT COMPLETED|Overall Study||2
3377614|NCT01048723|4111325|FG000|STARTED|Overall Study||2
3377615|NCT01048723|4111325|FG000|COMPLETED|Overall Study||2
3377616|NCT01048723|4111325|FG000|NOT COMPLETED|Overall Study||0
3377617|NCT01053221|4111331|FG000|STARTED|Overall Study||5
3377618|NCT01053221|4111332|FG001|STARTED|Overall Study||9
3377619|NCT01053221|4111331|FG000|COMPLETED|Overall Study||0
3377620|NCT01053221|4111332|FG001|COMPLETED|Overall Study||0
3377621|NCT01053221|4111331|FG000|NOT COMPLETED|Overall Study||5
3377622|NCT01053221|4111332|FG001|NOT COMPLETED|Overall Study||9
3377623|NCT01038752|4111340|FG000|STARTED|Overall Study||8
3377624|NCT01038752|4111341|FG001|STARTED|Overall Study||6
3377625|NCT01038752|4111340|FG000|COMPLETED|Overall Study||3
3377626|NCT01038752|4111341|FG001|COMPLETED|Overall Study||1
3377627|NCT01038752|4111340|FG000|NOT COMPLETED|Overall Study||5
3377628|NCT01038752|4111341|FG001|NOT COMPLETED|Overall Study||5
3377629|NCT01050218|4111347|FG000|STARTED|Overall Study||237
3377630|NCT01050218|4111347|FG000|COMPLETED|Overall Study||142
3377631|NCT01050218|4111347|FG000|NOT COMPLETED|Overall Study||95
3377632|NCT01045694|4111351|FG000|STARTED|Overall Study||8
3377633|NCT01045694|4111351|FG000|COMPLETED|Overall Study||6
3377634|NCT01045694|4111351|FG000|NOT COMPLETED|Overall Study||2
3377635|NCT01035944|4111359|FG000|STARTED|Overall Study||14
3377636|NCT01035944|4111360|FG001|STARTED|Overall Study||14
3377637|NCT01035944|4111361|FG002|STARTED|Overall Study||5
3377638|NCT01035944|4111362|FG003|STARTED|Overall Study||4
3377639|NCT01035944|4111359|FG000|COMPLETED|Overall Study||11
3377640|NCT01035944|4111360|FG001|COMPLETED|Overall Study||13
3377641|NCT01035944|4111361|FG002|COMPLETED|Overall Study||4
3377642|NCT01035944|4111362|FG003|COMPLETED|Overall Study||4
3377643|NCT01035944|4111359|FG000|NOT COMPLETED|Overall Study||3
3377644|NCT01035944|4111360|FG001|NOT COMPLETED|Overall Study||1
3377645|NCT01035944|4111361|FG002|NOT COMPLETED|Overall Study||1
3377646|NCT01035944|4111362|FG003|NOT COMPLETED|Overall Study||0
3377647|NCT01031628|4111376|FG000|STARTED|Overall Study||0
3377648|NCT01031628|4111377|FG001|STARTED|Overall Study||1
3377649|NCT01031628|4111378|FG002|STARTED|Overall Study||3
3377650|NCT01031628|4111379|FG003|STARTED|Overall Study||0
3377651|NCT01031628|4111376|FG000|COMPLETED|Overall Study||0
3377652|NCT01031628|4111377|FG001|COMPLETED|Overall Study||0
3377653|NCT01031628|4111378|FG002|COMPLETED|Overall Study||0
3377654|NCT01031628|4111379|FG003|COMPLETED|Overall Study||0
3377655|NCT01031628|4111376|FG000|NOT COMPLETED|Overall Study||0
3377656|NCT01031628|4111377|FG001|NOT COMPLETED|Overall Study||1
3377657|NCT01031628|4111378|FG002|NOT COMPLETED|Overall Study||3
3377658|NCT01031628|4111379|FG003|NOT COMPLETED|Overall Study||0
3377659|NCT01030757|4111389|FG000|STARTED|Overall Study||2
3377660|NCT01030757|4111389|FG000|COMPLETED|Overall Study||2
3377661|NCT01030757|4111389|FG000|NOT COMPLETED|Overall Study||0
3377662|NCT01035073|4111393|FG000|STARTED|Overall Study||0
3377663|NCT01035073|4111393|FG000|COMPLETED|Overall Study||0
3377664|NCT01035073|4111393|FG000|NOT COMPLETED|Overall Study||0
3377665|NCT01031550|4111399|FG000|STARTED|Overall Study||5
3377666|NCT01031550|4111400|FG001|STARTED|Overall Study||3
3377667|NCT01031550|4111399|FG000|COMPLETED|Overall Study||5
3377668|NCT01031550|4111400|FG001|COMPLETED|Overall Study||3
3377669|NCT01031550|4111399|FG000|NOT COMPLETED|Overall Study||0
3377670|NCT01031550|4111400|FG001|NOT COMPLETED|Overall Study||0
3377671|NCT01030198|4111410|FG000|STARTED|Overall Study|None recruited|0
3377672|NCT01030198|4111411|FG001|STARTED|Overall Study||7
3377673|NCT01030198|4111410|FG000|COMPLETED|Overall Study|None recruited|0
3377674|NCT01030198|4111411|FG001|COMPLETED|Overall Study|Study terminated due to poor results and lack of enrollment|0
3377675|NCT01030198|4111410|FG000|NOT COMPLETED|Overall Study||0
3377676|NCT01030198|4111411|FG001|NOT COMPLETED|Overall Study||7
3377677|NCT01028300|4111417|FG000|STARTED|Overall Study||4
3377678|NCT01028300|4111417|FG000|COMPLETED|Overall Study||0
3377679|NCT01028300|4111417|FG000|NOT COMPLETED|Overall Study||4
3377680|NCT01025271|4111421|FG000|STARTED|Overall Study|unable to meet enrollment no data available. Study terminated early|2
3377681|NCT01025271|4111421|FG000|COMPLETED|Overall Study|unable to meet enrollment no data available. Study terminated early|2
3377682|NCT01025271|4111421|FG000|NOT COMPLETED|Overall Study||0
3377683|NCT01022398|4111428|FG000|STARTED|Overall Study||2
3377684|NCT01022398|4111429|FG001|STARTED|Overall Study||2
3377685|NCT01022398|4111428|FG000|COMPLETED|Overall Study||0
3377686|NCT01022398|4111429|FG001|COMPLETED|Overall Study||0
3377687|NCT01022398|4111428|FG000|NOT COMPLETED|Overall Study||2
3377688|NCT01022398|4111429|FG001|NOT COMPLETED|Overall Study||2
3377689|NCT01019980|4111436|FG000|STARTED|Overall Study|2 patients entered study but did not receive any drug since it was not available in the region.|2
3377690|NCT01019980|4111437|FG001|STARTED|Overall Study||0
3377691|NCT01019980|4111436|FG000|Discontinued|Overall Study||2
3377692|NCT01019980|4111437|FG001|Discontinued|Overall Study||0
3377693|NCT01019980|4111436|FG000|COMPLETED|Overall Study||0
3377694|NCT01019980|4111437|FG001|COMPLETED|Overall Study||0
3377695|NCT01019980|4111436|FG000|NOT COMPLETED|Overall Study||2
3377696|NCT01019980|4111437|FG001|NOT COMPLETED|Overall Study||0
3377697|NCT01025492|4111443|FG000|STARTED|Overall Study||24
3377698|NCT01025492|4111443|FG000|COMPLETED|Overall Study||24
3377699|NCT01025492|4111443|FG000|NOT COMPLETED|Overall Study||0
3377700|NCT01017263|4111447|FG000|STARTED|Overall Study||14
3377701|NCT01017263|4111447|FG000|COMPLETED|Overall Study|A total of 14 participants screened: 2 qualified and received drug the remaining 12 failed screen|2
3377702|NCT01017263|4111447|FG000|NOT COMPLETED|Overall Study||12
3377703|NCT01020903|4111453|FG000|STARTED|Overall Study|Please be advised that the investigator of the study left the institution in 2011.|100
3377704|NCT01020903|4111454|FG001|STARTED|Overall Study|Please be advised that the investigator of the study left the institution in 2011.|100
3377705|NCT01020903|4111453|FG000|COMPLETED|Overall Study|Please be advised that the investigator of the study left the institution in 2011.|100
3377706|NCT01020903|4111454|FG001|COMPLETED|Overall Study|Please be advised that the investigator of the study entitled left the institution in 2011.|100
3377707|NCT01020903|4111453|FG000|NOT COMPLETED|Overall Study||0
3377708|NCT01020903|4111454|FG001|NOT COMPLETED|Overall Study||0
3377709|NCT01023620|4111462|FG000|STARTED|Overall Study||0
3377710|NCT01023620|4111463|FG001|STARTED|Overall Study||0
3377711|NCT01023620|4111462|FG000|COMPLETED|Overall Study||0
3377712|NCT01023620|4111463|FG001|COMPLETED|Overall Study||0
3377713|NCT01023620|4111462|FG000|NOT COMPLETED|Overall Study||0
3377714|NCT01023620|4111463|FG001|NOT COMPLETED|Overall Study||0
3377715|NCT01018810|4111474|FG000|STARTED|Overall Study||4
3377716|NCT01018810|4111475|FG001|STARTED|Overall Study||1
3377717|NCT01018810|4111476|FG002|STARTED|Overall Study||1
3377718|NCT01018810|4111477|FG003|STARTED|Overall Study||1
3377719|NCT01018810|4111478|FG004|STARTED|Overall Study||1
3377720|NCT01018810|4111474|FG000|COMPLETED|Overall Study||2
3377721|NCT01018810|4111475|FG001|COMPLETED|Overall Study||0
3377722|NCT01018810|4111476|FG002|COMPLETED|Overall Study||0
3377723|NCT01018810|4111477|FG003|COMPLETED|Overall Study||0
3377724|NCT01018810|4111478|FG004|COMPLETED|Overall Study||0
3377725|NCT01018810|4111474|FG000|NOT COMPLETED|Overall Study||2
3377726|NCT01018810|4111475|FG001|NOT COMPLETED|Overall Study||1
3377727|NCT01018810|4111476|FG002|NOT COMPLETED|Overall Study||1
3377728|NCT01018810|4111477|FG003|NOT COMPLETED|Overall Study||1
3377729|NCT01018810|4111478|FG004|NOT COMPLETED|Overall Study||1
3377730|NCT01016561|4111490|FG000|STARTED|Overall Study|Despite all possible efforts to contact the PI/study team, no data are available to be reported|0
3377731|NCT01016561|4111490|FG000|COMPLETED|Overall Study|Despite all possible efforts to contact the PI/study team, no data are available to be reported|0
3377732|NCT01016561|4111490|FG000|NOT COMPLETED|Overall Study||0
3377733|NCT01016847|4111496|FG000|STARTED|Overall Study||1
3377734|NCT01016847|4111497|FG001|STARTED|Overall Study||2
3377735|NCT01016847|4111496|FG000|COMPLETED|Overall Study||1
3377736|NCT01016847|4111497|FG001|COMPLETED|Overall Study||2
3377737|NCT01016847|4111496|FG000|NOT COMPLETED|Overall Study||0
3377738|NCT01016847|4111497|FG001|NOT COMPLETED|Overall Study||0
3377739|NCT01014767|4111507|FG000|STARTED|Overall Study||12
3377740|NCT01014767|4111508|FG001|STARTED|Overall Study||1
3377741|NCT01014767|4111509|FG002|STARTED|Overall Study||4
3377742|NCT01014767|4111510|FG003|STARTED|Overall Study||1
3377743|NCT01014767|4111507|FG000|COMPLETED|Overall Study||0
3377744|NCT01014767|4111508|FG001|COMPLETED|Overall Study||0
3377745|NCT01014767|4111509|FG002|COMPLETED|Overall Study||0
3377746|NCT01014767|4111510|FG003|COMPLETED|Overall Study||0
3377747|NCT01014767|4111507|FG000|NOT COMPLETED|Overall Study||12
3377748|NCT01014767|4111508|FG001|NOT COMPLETED|Overall Study||1
3377749|NCT01014767|4111509|FG002|NOT COMPLETED|Overall Study||4
3377750|NCT01014767|4111510|FG003|NOT COMPLETED|Overall Study||1
3377751|NCT01013701|4111520|FG000|STARTED|Overall Study||7
3377752|NCT01013701|4111520|FG000|COMPLETED|Overall Study||0
3377753|NCT01013701|4111520|FG000|NOT COMPLETED|Overall Study||7
3377754|NCT01012414|4111525|FG000|STARTED|Overall Study||10
3377755|NCT01012414|4111525|FG000|COMPLETED|Overall Study|No subjects completed the study.|0
3377756|NCT01012414|4111525|FG000|NOT COMPLETED|Overall Study||10
3377757|NCT01011634|4111533|FG000|STARTED|Overall Study||9
3377758|NCT01011634|4111534|FG001|STARTED|Overall Study||9
3377759|NCT01011634|4111533|FG000|COMPLETED|Overall Study||9
3377760|NCT01011634|4111534|FG001|COMPLETED|Overall Study||8
3377761|NCT01011634|4111533|FG000|NOT COMPLETED|Overall Study||0
3377762|NCT01011634|4111534|FG001|NOT COMPLETED|Overall Study||1
3377763|NCT01009931|4111540|FG000|STARTED|Overall Study||1
3377764|NCT01009931|4111540|FG000|COMPLETED|Overall Study||0
3377765|NCT01009931|4111540|FG000|NOT COMPLETED|Overall Study||1
3377766|NCT01001390|4111544|FG000|STARTED|Overall Study||2
3377767|NCT01001390|4111545|FG001|STARTED|Overall Study||0
3377768|NCT01001390|4111544|FG000|COMPLETED|Overall Study||0
3377769|NCT01001390|4111545|FG001|COMPLETED|Overall Study||0
3377770|NCT01001390|4111544|FG000|NOT COMPLETED|Overall Study||2
3377771|NCT01001390|4111545|FG001|NOT COMPLETED|Overall Study||0
3377772|NCT01006018|4111553|FG000|STARTED|Overall Study||0
3377773|NCT01006018|4111554|FG001|STARTED|Overall Study||0
3377774|NCT01006018|4111555|FG002|STARTED|Overall Study||0
3377775|NCT01006018|4111553|FG000|COMPLETED|Overall Study||0
3377776|NCT01006018|4111554|FG001|COMPLETED|Overall Study||0
3377777|NCT01006018|4111555|FG002|COMPLETED|Overall Study||0
3377778|NCT01006018|4111553|FG000|NOT COMPLETED|Overall Study||0
3377779|NCT01006018|4111554|FG001|NOT COMPLETED|Overall Study||0
3377780|NCT01006018|4111555|FG002|NOT COMPLETED|Overall Study||0
3377781|NCT01004510|4111563|FG000|STARTED|Overall Study||3
3377782|NCT01004510|4111563|FG000|COMPLETED|Overall Study||2
3377783|NCT01004510|4111563|FG000|NOT COMPLETED|Overall Study||1
3377784|NCT01005914|4111567|FG000|STARTED|Overall Study||11
3377785|NCT01005914|4111567|FG000|COMPLETED|Overall Study||1
3377786|NCT01005914|4111567|FG000|NOT COMPLETED|Overall Study||10
3377787|NCT00996333|4111571|FG000|STARTED|Overall Study||46
3377788|NCT00996333|4111571|FG000|COMPLETED|Overall Study||33
3377789|NCT00996333|4111571|FG000|NOT COMPLETED|Overall Study||13
3377790|NCT00998738|4111575|FG000|STARTED|Overall Study||1
3377791|NCT00998738|4111575|FG000|COMPLETED|Overall Study||0
3377792|NCT00998738|4111575|FG000|NOT COMPLETED|Overall Study||1
3377793|NCT00996502|4111579|FG000|STARTED|Overall Study||4
3377794|NCT00996502|4111579|FG000|COMPLETED|Overall Study||4
3377795|NCT00996502|4111579|FG000|NOT COMPLETED|Overall Study||0
3377796|NCT00997386|4111583|FG000|STARTED|Overall Study||16
3377797|NCT00997386|4111583|FG000|COMPLETED|Overall Study||9
3377798|NCT00997386|4111583|FG000|NOT COMPLETED|Overall Study||7
3377799|NCT00985738|4111589|FG000|STARTED|Overall Study||8
3377800|NCT00985738|4111590|FG001|STARTED|Overall Study||8
3377801|NCT00985738|4111589|FG000|COMPLETED|Overall Study||0
3377802|NCT00985738|4111590|FG001|COMPLETED|Overall Study||0
3377803|NCT00985738|4111589|FG000|NOT COMPLETED|Overall Study||8
3377804|NCT00985738|4111590|FG001|NOT COMPLETED|Overall Study||8
3377805|NCT00986999|4111596|FG000|STARTED|Overall Study||7
3377806|NCT00986999|4111596|FG000|COMPLETED|Overall Study||6
3377807|NCT00986999|4111596|FG000|NOT COMPLETED|Overall Study||1
3377808|NCT00989937|4111600|FG000|STARTED|Overall Study||0
3377809|NCT00989937|4111600|FG000|COMPLETED|Overall Study||0
3377810|NCT00989937|4111600|FG000|NOT COMPLETED|Overall Study||0
3377811|NCT00986947|4111604|FG000|STARTED|Overall Study||20
3377812|NCT00986947|4111604|FG000|COMPLETED|Overall Study||0
3377813|NCT00986947|4111604|FG000|NOT COMPLETED|Overall Study||20
3377814|NCT00982995|4111608|FG000|STARTED|Overall Study||3
3377815|NCT00982995|4111608|FG000|COMPLETED|Overall Study||3
3377816|NCT00982995|4111608|FG000|NOT COMPLETED|Overall Study||0
3377817|NCT00984490|4111612|FG000|STARTED|Overall Study||5
3377818|NCT00984490|4111612|FG000|COMPLETED|Overall Study||5
3377819|NCT00984490|4111612|FG000|NOT COMPLETED|Overall Study||0
3377820|NCT00986310|4111619|FG000|STARTED|Overall Study||0
3377821|NCT00986310|4111620|FG001|STARTED|Overall Study||0
3377822|NCT00986310|4111619|FG000|COMPLETED|Overall Study||0
3377823|NCT00986310|4111620|FG001|COMPLETED|Overall Study||0
3377824|NCT00986310|4111619|FG000|NOT COMPLETED|Overall Study||0
3377825|NCT00986310|4111620|FG001|NOT COMPLETED|Overall Study||0
3377826|NCT00978874|4111626|FG000|STARTED|Overall Study|The study was terminated and no data are available to be reported|0
3377827|NCT00978874|4111626|FG000|COMPLETED|Overall Study|The study was terminated and no data are available to be reported|0
3377828|NCT00978874|4111626|FG000|NOT COMPLETED|Overall Study||0
3377829|NCT00983645|4111632|FG000|STARTED|Overall Study||8
3377830|NCT00983645|4111633|FG001|STARTED|Overall Study||7
3377831|NCT00983645|4111632|FG000|COMPLETED|Overall Study||8
3377832|NCT00983645|4111633|FG001|COMPLETED|Overall Study||7
3377833|NCT00983645|4111632|FG000|NOT COMPLETED|Overall Study||0
3377834|NCT00983645|4111633|FG001|NOT COMPLETED|Overall Study||0
3377835|NCT00979147|4111641|FG000|STARTED|Overall Study||0
3377836|NCT00979147|4111642|FG001|STARTED|Overall Study||0
3377837|NCT00979147|4111641|FG000|COMPLETED|Overall Study||0
3377838|NCT00979147|4111642|FG001|COMPLETED|Overall Study||0
3377839|NCT00979147|4111641|FG000|NOT COMPLETED|Overall Study||0
3377840|NCT00979147|4111642|FG001|NOT COMPLETED|Overall Study||0
3377841|NCT00967447|4111648|FG000|STARTED|Overall Study|there are no collected data in CRF|2
3377842|NCT00967447|4111648|FG000|COMPLETED|Overall Study|there are no collected data in CRF|2
3377843|NCT00967447|4111648|FG000|NOT COMPLETED|Overall Study||0
3377844|NCT00970606|4111654|FG000|STARTED|Overall Study||4
3377845|NCT00970606|4111655|FG001|STARTED|Overall Study||3
3377846|NCT00970606|4111654|FG000|COMPLETED|Overall Study||4
3377847|NCT00970606|4111655|FG001|COMPLETED|Overall Study||3
3377848|NCT00970606|4111654|FG000|NOT COMPLETED|Overall Study||0
3377849|NCT00970606|4111655|FG001|NOT COMPLETED|Overall Study||0
3377850|NCT00979550|4111663|FG000|STARTED|Overall Study||4
3377851|NCT00979550|4111664|FG001|STARTED|Overall Study||3
3377852|NCT00979550|4111663|FG000|COMPLETED|Overall Study||4
3377853|NCT00979550|4111664|FG001|COMPLETED|Overall Study||3
3377854|NCT00979550|4111663|FG000|NOT COMPLETED|Overall Study||0
3377855|NCT00979550|4111664|FG001|NOT COMPLETED|Overall Study||0
3377856|NCT00966992|4111672|FG000|STARTED|Overall Study||3
3377857|NCT00966992|4111673|FG001|STARTED|Overall Study||0
3377858|NCT00966992|4111672|FG000|COMPLETED|Overall Study||3
3377859|NCT00966992|4111673|FG001|COMPLETED|Overall Study||0
3377860|NCT00966992|4111672|FG000|NOT COMPLETED|Overall Study||0
3377861|NCT00966992|4111673|FG001|NOT COMPLETED|Overall Study||0
3377862|NCT00981370|4111679|FG000|STARTED|Overall Study||0
3377863|NCT00981370|4111679|FG000|COMPLETED|Overall Study||0
3377864|NCT00981370|4111679|FG000|NOT COMPLETED|Overall Study||0
3377865|NCT00975611|4111683|FG000|STARTED|Overall Study||22
3377866|NCT00975611|4111683|FG000|COMPLETED|Overall Study||5
3377867|NCT00975611|4111683|FG000|NOT COMPLETED|Overall Study||17
3377868|NCT00978419|4111689|FG000|STARTED|Overall Study||0
3377869|NCT00978419|4111690|FG001|STARTED|Overall Study||0
3377870|NCT00978419|4111689|FG000|COMPLETED|Overall Study||0
3377871|NCT00978419|4111690|FG001|COMPLETED|Overall Study||0
3377872|NCT00978419|4111689|FG000|NOT COMPLETED|Overall Study||0
3377873|NCT00978419|4111690|FG001|NOT COMPLETED|Overall Study||0
3377874|NCT00973856|4111698|FG000|STARTED|Overall Study||3
3377875|NCT00973856|4111699|FG001|STARTED|Overall Study||2
3377876|NCT00973856|4111698|FG000|COMPLETED|Overall Study||3
3377877|NCT00973856|4111699|FG001|COMPLETED|Overall Study||2
3377878|NCT00973856|4111698|FG000|NOT COMPLETED|Overall Study||0
3377879|NCT00973856|4111699|FG001|NOT COMPLETED|Overall Study||0
3377880|NCT00979810|4111704|FG000|STARTED|Overall Study||11
3377881|NCT00979810|4111704|FG000|COMPLETED|Overall Study||11
3377882|NCT00979810|4111704|FG000|NOT COMPLETED|Overall Study||0
3377883|NCT00974922|4111708|FG000|STARTED|Overall Study||40
3377884|NCT00974922|4111708|FG000|COMPLETED|Overall Study||16
3377885|NCT00974922|4111708|FG000|NOT COMPLETED|Overall Study||24
3377886|NCT00976339|4111714|FG000|STARTED|Overall Study||10
3377887|NCT00976339|4111715|FG001|STARTED|Overall Study||10
3377888|NCT00976339|4111714|FG000|COMPLETED|Overall Study||10
3377889|NCT00976339|4111715|FG001|COMPLETED|Overall Study||10
3377890|NCT00976339|4111714|FG000|NOT COMPLETED|Overall Study||0
3377891|NCT00976339|4111715|FG001|NOT COMPLETED|Overall Study||0
3377892|NCT00965146|4111723|FG000|STARTED|Overall Study||210
3377893|NCT00965146|4111723|FG000|COMPLETED|Overall Study|Study was terminated prior to reaching 15 year endpoint.|0
3377894|NCT00965146|4111723|FG000|NOT COMPLETED|Overall Study||210
3377895|NCT00972023|4111727|FG000|STARTED|Overall Study||1
3377896|NCT00972023|4111727|FG000|COMPLETED|Overall Study||0
3377897|NCT00972023|4111727|FG000|NOT COMPLETED|Overall Study||1
3377898|NCT00970736|4111733|FG000|STARTED|Overall Study||20
3377899|NCT00970736|4111733|FG000|COMPLETED|Overall Study||18
3377900|NCT00970736|4111733|FG000|NOT COMPLETED|Overall Study||2
3377901|NCT00957827|4111739|FG000|STARTED|Overall Study||2
3377902|NCT00957827|4111740|FG001|STARTED|Overall Study||2
3377903|NCT00957827|4111739|FG000|COMPLETED|Overall Study||2
3377904|NCT00957827|4111740|FG001|COMPLETED|Overall Study||2
3377905|NCT00957827|4111739|FG000|NOT COMPLETED|Overall Study||0
3377906|NCT00957827|4111740|FG001|NOT COMPLETED|Overall Study||0
3377907|NCT00953329|4111746|FG000|STARTED|Overall Study||1
3377908|NCT00953329|4111746|FG000|COMPLETED|Overall Study||0
3377909|NCT00953329|4111746|FG000|NOT COMPLETED|Overall Study||1
3377910|NCT00965055|4111750|FG000|STARTED|Overall Study||2
3377911|NCT00965055|4111750|FG000|COMPLETED|Overall Study||2
3377912|NCT00965055|4111750|FG000|NOT COMPLETED|Overall Study||0
3377913|NCT00962429|4111756|FG000|STARTED|Overall Study||0
3377914|NCT00962429|4111757|FG001|STARTED|Overall Study||0
3377915|NCT00962429|4111756|FG000|COMPLETED|Overall Study||0
3377916|NCT00962429|4111757|FG001|COMPLETED|Overall Study||0
3377917|NCT00962429|4111756|FG000|NOT COMPLETED|Overall Study||0
3377918|NCT00962429|4111757|FG001|NOT COMPLETED|Overall Study||0
3377919|NCT00958893|4111763|FG000|STARTED|Overall Study||4
3377920|NCT00958893|4111763|FG000|COMPLETED|Overall Study||0
3377921|NCT00958893|4111763|FG000|NOT COMPLETED|Overall Study||4
3377922|NCT00966654|4111767|FG000|STARTED|Overall Study||12
3377923|NCT00966654|4111767|FG000|COMPLETED|Overall Study||0
3377924|NCT00966654|4111767|FG000|NOT COMPLETED|Overall Study||12
3377925|NCT00960154|4111775|FG000|STARTED|Overall Study||25
3377926|NCT00960154|4111776|FG001|STARTED|Overall Study||25
3377927|NCT00960154|4111775|FG000|COMPLETED|Overall Study||0
3377928|NCT00960154|4111776|FG001|COMPLETED|Overall Study||0
3377929|NCT00960154|4111775|FG000|NOT COMPLETED|Overall Study||25
3377930|NCT00960154|4111776|FG001|NOT COMPLETED|Overall Study||25
3377931|NCT00960752|4111785|FG000|STARTED|Overall Study||13
3377932|NCT00960752|4111786|FG001|STARTED|Overall Study||13
3377933|NCT00960752|4111787|FG002|STARTED|Overall Study||19
3377934|NCT00960752|4111785|FG000|COMPLETED|Overall Study||13
3377935|NCT00960752|4111786|FG001|COMPLETED|Overall Study||13
3377936|NCT00960752|4111787|FG002|COMPLETED|Overall Study||17
3377937|NCT00960752|4111785|FG000|NOT COMPLETED|Overall Study||0
3377938|NCT00960752|4111786|FG001|NOT COMPLETED|Overall Study||0
3377939|NCT00960752|4111787|FG002|NOT COMPLETED|Overall Study||2
3377940|NCT00958347|4111795|FG000|STARTED|Overall Study||226
3377941|NCT00958347|4111795|FG000|COMPLETED|Overall Study|11 revisions total, one was a bilateral participant with the other hip counted as not completed.|0
3377942|NCT00958347|4111795|FG000|NOT COMPLETED|Overall Study||226
3377943|NCT00954187|4111801|FG000|STARTED|Overall Study|No subjects were assigned treatment and no study procedures were performed|0
3377944|NCT00954187|4111802|FG001|STARTED|Overall Study|No subjects were assigned treatment and no study procedures were performed|0
3377945|NCT00954187|4111801|FG000|COMPLETED|Overall Study||0
3377946|NCT00954187|4111802|FG001|COMPLETED|Overall Study||0
3377947|NCT00954187|4111801|FG000|NOT COMPLETED|Overall Study||0
3377948|NCT00954187|4111802|FG001|NOT COMPLETED|Overall Study||0
3377949|NCT00953615|4111808|FG000|STARTED|Overall Study||1
3377950|NCT00953615|4111808|FG000|COMPLETED|Overall Study||0
3377951|NCT00953615|4111808|FG000|NOT COMPLETED|Overall Study||1
3377952|NCT00947284|4111812|FG000|STARTED|Overall Study||0
3377953|NCT00947284|4111813|FG001|STARTED|Overall Study||3
3377954|NCT00947284|4111812|FG000|COMPLETED|Overall Study||0
3377955|NCT00947284|4111813|FG001|COMPLETED|Overall Study||0
3377956|NCT00947284|4111812|FG000|NOT COMPLETED|Overall Study||0
3377957|NCT00947284|4111813|FG001|NOT COMPLETED|Overall Study||3
3377958|NCT00957034|4111820|FG000|STARTED|Overall Study||6
3377959|NCT00957034|4111821|FG001|STARTED|Overall Study||4
3377960|NCT00957034|4111822|FG002|STARTED|Overall Study||7
3377961|NCT00957034|4111820|FG000|COMPLETED|Overall Study||0
3377962|NCT00957034|4111821|FG001|COMPLETED|Overall Study||0
3377963|NCT00957034|4111822|FG002|COMPLETED|Overall Study||1
3377964|NCT00957034|4111820|FG000|NOT COMPLETED|Overall Study||6
3377965|NCT00957034|4111821|FG001|NOT COMPLETED|Overall Study||4
3377966|NCT00957034|4111822|FG002|NOT COMPLETED|Overall Study||6
3377967|NCT00949988|4111830|FG000|STARTED|Overall Study||3
3377968|NCT00949988|4111830|FG000|COMPLETED|Overall Study||0
3377969|NCT00949988|4111830|FG000|NOT COMPLETED|Overall Study||3
3377970|NCT00948194|4111836|FG000|STARTED|Overall Study||6
3377971|NCT00948194|4111837|FG001|STARTED|Overall Study||7
3377972|NCT00948194|4111836|FG000|COMPLETED|Overall Study||5
3377973|NCT00948194|4111837|FG001|COMPLETED|Overall Study||7
3377974|NCT00948194|4111836|FG000|NOT COMPLETED|Overall Study||1
3377975|NCT00948194|4111837|FG001|NOT COMPLETED|Overall Study||0
3377976|NCT00946985|4111843|FG000|STARTED|Stabilization Phase (25 Weeks)||162
3377977|NCT00946985|4111843|FG000|COMPLETED|Stabilization Phase (25 Weeks)||2
3377978|NCT00946985|4111843|FG000|NOT COMPLETED|Stabilization Phase (25 Weeks)||160
3377979|NCT00946985|4111843|FG000|STARTED|Relapse Prevention Phase (24 Months)|Both randomized patients were discontinued when the sponsor terminated the trial early.|2
3377980|NCT00946985|4111843|FG000|COMPLETED|Relapse Prevention Phase (24 Months)||0
3377981|NCT00946985|4111843|FG000|NOT COMPLETED|Relapse Prevention Phase (24 Months)||2
3377982|NCT00950183|4111847|FG000|STARTED|Overall Study||36
3377983|NCT00950183|4111847|FG000|COMPLETED|Overall Study||0
3377984|NCT00950183|4111847|FG000|NOT COMPLETED|Overall Study||36
3377985|NCT00950690|4111851|FG000|STARTED|Overall Study||1349
3377986|NCT00950690|4111851|FG000|COMPLETED|Overall Study||1105
3377987|NCT00950690|4111851|FG000|NOT COMPLETED|Overall Study||244
3377988|NCT00944229|4111855|FG000|STARTED|Overall Study||58
3377989|NCT00944229|4111855|FG000|COMPLETED|Overall Study||33
3377990|NCT00944229|4111855|FG000|NOT COMPLETED|Overall Study||25
3377991|NCT00941928|4111859|FG000|STARTED|Overall Study||2
3377992|NCT00941928|4111859|FG000|COMPLETED|Overall Study||0
3377993|NCT00941928|4111859|FG000|NOT COMPLETED|Overall Study||2
3377994|NCT00949403|4111863|FG000|STARTED|Overall Study||9
3377995|NCT00949403|4111863|FG000|COMPLETED|Overall Study||9
3377996|NCT00949403|4111863|FG000|NOT COMPLETED|Overall Study||0
3377997|NCT00947791|4111869|FG000|STARTED|Overall Study||0
3377998|NCT00947791|4111870|FG001|STARTED|Overall Study||1
3377999|NCT00947791|4111869|FG000|COMPLETED|Overall Study||0
3378000|NCT00947791|4111870|FG001|COMPLETED|Overall Study||1
3378001|NCT00947791|4111869|FG000|NOT COMPLETED|Overall Study||0
3378002|NCT00947791|4111870|FG001|NOT COMPLETED|Overall Study||0
3378003|NCT00947011|4111876|FG000|STARTED|Overall Study||12
3378004|NCT00947011|4111876|FG000|COMPLETED|Overall Study||0
3378005|NCT00947011|4111876|FG000|NOT COMPLETED|Overall Study||12
3378006|NCT00943605|4111884|FG000|STARTED|Overall Study|There were 10 total subjects (5/group) who were retrospectively unenrolled for deviations.|30
3378007|NCT00943605|4111885|FG001|STARTED|Overall Study|There were 10 total subjects (5/group) who were retrospectively unenrolled for deviations.|30
3378008|NCT00943605|4111884|FG000|COMPLETED|Overall Study||0
3378009|NCT00943605|4111885|FG001|COMPLETED|Overall Study||0
3378010|NCT00943605|4111884|FG000|NOT COMPLETED|Overall Study||30
3378011|NCT00943605|4111885|FG001|NOT COMPLETED|Overall Study||30
3378012|NCT00942409|4111891|FG000|STARTED|Overall Study||5
3378013|NCT00942409|4111891|FG000|COMPLETED|Overall Study||2
3378014|NCT00942409|4111891|FG000|NOT COMPLETED|Overall Study||3
3378015|NCT00936585|4111895|FG000|STARTED|Overall Study||2
3378016|NCT00936585|4111895|FG000|COMPLETED|Overall Study||2
3378017|NCT00936585|4111895|FG000|NOT COMPLETED|Overall Study||0
3378018|NCT00936598|4111901|FG000|STARTED|Overall Study||4
3378019|NCT00936598|4111902|FG001|STARTED|Overall Study||1
3378020|NCT00936598|4111901|FG000|COMPLETED|Overall Study||2
3378021|NCT00936598|4111902|FG001|COMPLETED|Overall Study||1
3378022|NCT00936598|4111901|FG000|NOT COMPLETED|Overall Study||2
3378023|NCT00936598|4111902|FG001|NOT COMPLETED|Overall Study||0
3378024|NCT00920309|4111910|FG000|STARTED|Overall Study||14
3378025|NCT00920309|4111911|FG001|STARTED|Overall Study||7
3378026|NCT00920309|4111910|FG000|COMPLETED|Overall Study||14
3378027|NCT00920309|4111911|FG001|COMPLETED|Overall Study||7
3378028|NCT00920309|4111910|FG000|NOT COMPLETED|Overall Study||0
3378029|NCT00920309|4111911|FG001|NOT COMPLETED|Overall Study||0
3378030|NCT00935649|4111918|FG000|STARTED|Overall Study||139
3378031|NCT00935649|4111918|FG000|COMPLETED|Overall Study||134
3378032|NCT00935649|4111918|FG000|NOT COMPLETED|Overall Study||5
3378033|NCT00934791|4111926|FG000|STARTED|Overall Study||1
3378034|NCT00934791|4111927|FG001|STARTED|Overall Study||0
3378035|NCT00934791|4111926|FG000|COMPLETED|Overall Study||0
3378036|NCT00934791|4111927|FG001|COMPLETED|Overall Study||0
3378037|NCT00934791|4111926|FG000|NOT COMPLETED|Overall Study||1
3378038|NCT00934791|4111927|FG001|NOT COMPLETED|Overall Study||0
3378039|NCT00932152|4111935|FG000|STARTED|Overall Study||1
3378040|NCT00932152|4111936|FG001|STARTED|Overall Study||2
3378041|NCT00932152|4111935|FG000|COMPLETED|Overall Study||0
3378042|NCT00932152|4111936|FG001|COMPLETED|Overall Study||0
3378043|NCT00932152|4111935|FG000|NOT COMPLETED|Overall Study||1
3378044|NCT00932152|4111936|FG001|NOT COMPLETED|Overall Study||2
3378045|NCT00928499|4111944|FG000|STARTED|Overall Study||18
3378046|NCT00928499|4111945|FG001|STARTED|Overall Study||14
3378047|NCT00928499|4111944|FG000|COMPLETED|Overall Study||18
3378048|NCT00928499|4111945|FG001|COMPLETED|Overall Study||14
3378049|NCT00928499|4111944|FG000|NOT COMPLETED|Overall Study||0
3378050|NCT00928499|4111945|FG001|NOT COMPLETED|Overall Study||0
3378051|NCT00924807|4111951|FG000|STARTED|Overall Study||4
3378052|NCT00924807|4111951|FG000|COMPLETED|Overall Study||4
3378053|NCT00924807|4111951|FG000|NOT COMPLETED|Overall Study||0
3378054|NCT00930787|4111957|FG000|STARTED|Overall Study||14
3378055|NCT00930787|4111958|FG001|STARTED|Overall Study||9
3378056|NCT00930787|4111957|FG000|COMPLETED|Overall Study||14
3378057|NCT00930787|4111958|FG001|COMPLETED|Overall Study||9
3378058|NCT00930787|4111957|FG000|NOT COMPLETED|Overall Study||0
3378059|NCT00930787|4111958|FG001|NOT COMPLETED|Overall Study||0
3378060|NCT00929474|4111966|FG000|STARTED|Overall Study||8
3378061|NCT00929474|4111967|FG001|STARTED|Overall Study||9
3378062|NCT00929474|4111966|FG000|COMPLETED|Overall Study||0
3378063|NCT00929474|4111967|FG001|COMPLETED|Overall Study||0
3378064|NCT00929474|4111966|FG000|NOT COMPLETED|Overall Study||8
3378065|NCT00929474|4111967|FG001|NOT COMPLETED|Overall Study||9
3378066|NCT00925548|4111975|FG000|STARTED|Overall Study||11
3378067|NCT00925548|4111976|FG001|STARTED|Overall Study||5
3378068|NCT00925548|4111975|FG000|COMPLETED|Overall Study||1
3378069|NCT00925548|4111976|FG001|COMPLETED|Overall Study||0
3378070|NCT00925548|4111975|FG000|NOT COMPLETED|Overall Study||10
3378071|NCT00925548|4111976|FG001|NOT COMPLETED|Overall Study||5
3378072|NCT00926575|4111985|FG000|STARTED|Overall Study||70
3378073|NCT00926575|4111986|FG001|STARTED|Overall Study||70
3378074|NCT00926575|4111985|FG000|COMPLETED|Overall Study||54
3378075|NCT00926575|4111986|FG001|COMPLETED|Overall Study||53
3378076|NCT00926575|4111985|FG000|NOT COMPLETED|Overall Study||16
3378077|NCT00926575|4111986|FG001|NOT COMPLETED|Overall Study||17
3378078|NCT00911053|4111997|FG000|STARTED|Overall Study||0
3378079|NCT00911053|4111998|FG001|STARTED|Overall Study||0
3378080|NCT00911053|4111999|FG002|STARTED|Overall Study||0
3378081|NCT00911053|4112000|FG003|STARTED|Overall Study||0
3378082|NCT00911053|4112001|FG004|STARTED|Overall Study||0
3378083|NCT00911053|4111997|FG000|COMPLETED|Overall Study||0
3378084|NCT00911053|4111998|FG001|COMPLETED|Overall Study||0
3378085|NCT00911053|4111999|FG002|COMPLETED|Overall Study||0
3378086|NCT00911053|4112000|FG003|COMPLETED|Overall Study||0
3378087|NCT00911053|4112001|FG004|COMPLETED|Overall Study||0
3378088|NCT00911053|4111997|FG000|NOT COMPLETED|Overall Study||0
3378089|NCT00911053|4111998|FG001|NOT COMPLETED|Overall Study||0
3378090|NCT00911053|4111999|FG002|NOT COMPLETED|Overall Study||0
3378091|NCT00911053|4112000|FG003|NOT COMPLETED|Overall Study||0
3378092|NCT00911053|4112001|FG004|NOT COMPLETED|Overall Study||0
3378093|NCT00918463|4112013|FG000|STARTED|Overall Study||2
3378094|NCT00918463|4112013|FG000|COMPLETED|Overall Study||0
3378095|NCT00918463|4112013|FG000|NOT COMPLETED|Overall Study||2
3378096|NCT00913692|4112017|FG000|STARTED|Screening (4 Months)||11
3378097|NCT00913692|4112017|FG000|COMPLETED|Screening (4 Months)||2
3378098|NCT00913692|4112017|FG000|NOT COMPLETED|Screening (4 Months)||9
3378099|NCT00913692|4112017|FG000|STARTED|Treatment Phase 1 (5 Months)||2
3378100|NCT00913692|4112017|FG000|COMPLETED|Treatment Phase 1 (5 Months)||1
3378101|NCT00913692|4112017|FG000|NOT COMPLETED|Treatment Phase 1 (5 Months)||1
3378102|NCT00913692|4112017|FG000|STARTED|Washout (2 Weeks)||1
3378103|NCT00913692|4112017|FG000|COMPLETED|Washout (2 Weeks)||1
3378104|NCT00913692|4112017|FG000|NOT COMPLETED|Washout (2 Weeks)||0
3378105|NCT00913692|4112017|FG000|STARTED|Treatment Phase 2 (5 Months)||1
3378106|NCT00913692|4112017|FG000|COMPLETED|Treatment Phase 2 (5 Months)||1
3378107|NCT00913692|4112017|FG000|NOT COMPLETED|Treatment Phase 2 (5 Months)||0
3378108|NCT00918645|4112024|FG000|STARTED|Overall Study||13
3378109|NCT00918645|4112024|FG000|COMPLETED|Overall Study||12
3378110|NCT00918645|4112024|FG000|NOT COMPLETED|Overall Study||1
3378111|NCT00907218|4112028|FG000|STARTED|Overall Study||2
3378112|NCT00907218|4112028|FG000|COMPLETED|Overall Study||2
3378113|NCT00907218|4112028|FG000|NOT COMPLETED|Overall Study||0
3378114|NCT00895284|4112034|FG000|STARTED|Overall Study||3
3378115|NCT00895284|4112035|FG001|STARTED|Overall Study||0
3378116|NCT00895284|4112034|FG000|COMPLETED|Overall Study||3
3378117|NCT00895284|4112035|FG001|COMPLETED|Overall Study||0
3378118|NCT00895284|4112034|FG000|NOT COMPLETED|Overall Study||0
3378119|NCT00895284|4112035|FG001|NOT COMPLETED|Overall Study||0
3378120|NCT00897910|4112041|FG000|STARTED|Overall Study|None of the blood samples were analyzed due to lack of funding. No tissue sample was collected.|6
3378121|NCT00897910|4112041|FG000|COMPLETED|Overall Study|None of the blood samples were analyzed due to lack of funding. No tissue sample was collected|6
3378122|NCT00897910|4112041|FG000|NOT COMPLETED|Overall Study||0
3378123|NCT00901303|4112047|FG000|STARTED|Overall Study||5
3378124|NCT00901303|4112048|FG001|STARTED|Overall Study||1
3378125|NCT00901303|4112047|FG000|COMPLETED|Overall Study||5
3378126|NCT00901303|4112048|FG001|COMPLETED|Overall Study||1
3378127|NCT00901303|4112047|FG000|NOT COMPLETED|Overall Study||0
3378128|NCT00901303|4112048|FG001|NOT COMPLETED|Overall Study||0
3378129|NCT00906035|4112057|FG000|STARTED|Overall Study||8
3378130|NCT00906035|4112058|FG001|STARTED|Overall Study||9
3378131|NCT00906035|4112059|FG002|STARTED|Overall Study||8
3378132|NCT00906035|4112057|FG000|COMPLETED|Overall Study|One Drop-Out; SAE day before Visit 1 and One subject Withrew prior to visit 1|6
3378133|NCT00906035|4112058|FG001|COMPLETED|Overall Study|2 subjects Withdrew after Visit 1 and 1 subject Withdrew shortly after Visit 1due to an AE|6
3378134|NCT00906035|4112059|FG002|COMPLETED|Overall Study||8
3378135|NCT00906035|4112057|FG000|NOT COMPLETED|Overall Study||2
3378136|NCT00906035|4112058|FG001|NOT COMPLETED|Overall Study||3
3378137|NCT00906035|4112059|FG002|NOT COMPLETED|Overall Study||0
3378138|NCT00904423|4112067|FG000|STARTED|Overall Study||8
3378139|NCT00904423|4112067|FG000|COMPLETED|Overall Study||8
3378140|NCT00904423|4112067|FG000|NOT COMPLETED|Overall Study||0
3378141|NCT00903396|4112075|FG000|STARTED|Overall Study||2
3378142|NCT00903396|4112076|FG001|STARTED|Overall Study||1
3378143|NCT00903396|4112077|FG002|STARTED|Overall Study||3
3378144|NCT00903396|4112078|FG003|STARTED|Overall Study||1
3378145|NCT00903396|4112075|FG000|COMPLETED|Overall Study||2
3378146|NCT00903396|4112076|FG001|COMPLETED|Overall Study||1
3378147|NCT00903396|4112077|FG002|COMPLETED|Overall Study||3
3378148|NCT00903396|4112078|FG003|COMPLETED|Overall Study||1
3378149|NCT00903396|4112075|FG000|NOT COMPLETED|Overall Study||0
3378150|NCT00903396|4112076|FG001|NOT COMPLETED|Overall Study||0
3378151|NCT00903396|4112077|FG002|NOT COMPLETED|Overall Study||0
3378152|NCT00903396|4112078|FG003|NOT COMPLETED|Overall Study||0
3378153|NCT00894790|4112090|FG000|STARTED|Overall Study||4
3378154|NCT00894790|4112091|FG001|STARTED|Overall Study||4
3378155|NCT00894790|4112090|FG000|COMPLETED|Overall Study||3
3378156|NCT00894790|4112091|FG001|COMPLETED|Overall Study||2
3378157|NCT00894790|4112090|FG000|NOT COMPLETED|Overall Study||1
3378158|NCT00894790|4112091|FG001|NOT COMPLETED|Overall Study||2
3378159|NCT00902668|4112097|FG000|STARTED|Overall Study||3
3378160|NCT00902668|4112097|FG000|COMPLETED|Overall Study||0
3378161|NCT00902668|4112097|FG000|NOT COMPLETED|Overall Study||3
3378162|NCT00881205|4112103|FG000|STARTED|Overall Study||45
3378163|NCT00881205|4112104|FG001|STARTED|Overall Study||41
3378164|NCT00881205|4112103|FG000|COMPLETED|Overall Study||34
3378165|NCT00881205|4112104|FG001|COMPLETED|Overall Study||34
3378166|NCT00881205|4112103|FG000|NOT COMPLETED|Overall Study||11
3378167|NCT00881205|4112104|FG001|NOT COMPLETED|Overall Study||7
3378168|NCT00896025|4112111|FG000|STARTED|Overall Study||8
3378169|NCT00896025|4112111|FG000|COMPLETED|Overall Study||8
3378170|NCT00896025|4112111|FG000|NOT COMPLETED|Overall Study||0
3378171|NCT00903006|4112121|FG000|STARTED|Overall Study||2
3378172|NCT00903006|4112122|FG001|STARTED|Overall Study||3
3378173|NCT00903006|4112123|FG002|STARTED|Overall Study||1
3378174|NCT00903006|4112124|FG003|STARTED|Overall Study|Zero participants started due to smaller sample size.|0
3378175|NCT00903006|4112121|FG000|COMPLETED|Overall Study||0
3378176|NCT00903006|4112122|FG001|COMPLETED|Overall Study||0
3378177|NCT00903006|4112123|FG002|COMPLETED|Overall Study||0
3378178|NCT00903006|4112124|FG003|COMPLETED|Overall Study||0
3378179|NCT00903006|4112121|FG000|NOT COMPLETED|Overall Study||2
3378180|NCT00903006|4112122|FG001|NOT COMPLETED|Overall Study||3
3378181|NCT00903006|4112123|FG002|NOT COMPLETED|Overall Study||1
3378182|NCT00903006|4112124|FG003|NOT COMPLETED|Overall Study||0
3378183|NCT00904189|4112134|FG000|STARTED|Overall Study||2
3378184|NCT00904189|4112134|FG000|COMPLETED|Overall Study||2
3378185|NCT00904189|4112134|FG000|NOT COMPLETED|Overall Study||0
3378186|NCT00887315|4112141|FG000|STARTED|Overall Study||7
3378187|NCT00887315|4112142|FG001|STARTED|Overall Study||4
3378188|NCT00887315|4112141|FG000|COMPLETED|Overall Study||0
3378189|NCT00887315|4112142|FG001|COMPLETED|Overall Study||0
3378190|NCT00887315|4112141|FG000|NOT COMPLETED|Overall Study||7
3378191|NCT00887315|4112142|FG001|NOT COMPLETED|Overall Study||4
3378192|NCT00891904|4112148|FG000|STARTED|Overall Study||2
3378193|NCT00891904|4112148|FG000|COMPLETED|Overall Study||0
3378194|NCT00891904|4112148|FG000|NOT COMPLETED|Overall Study||2
3378195|NCT00881608|4112157|FG000|STARTED|Overall Study||11
3378196|NCT00881608|4112157|FG000|COMPLETED|Overall Study||0
3378197|NCT00881608|4112157|FG000|NOT COMPLETED|Overall Study||11
3378198|NCT00889421|4112169|FG000|STARTED|Overall Study||3
3378199|NCT00889421|4112169|FG000|COMPLETED|Overall Study||0
3378200|NCT00889421|4112169|FG000|NOT COMPLETED|Overall Study||3
3378201|NCT00875394|4112176|FG000|STARTED|Overall Study||36
3378202|NCT00875394|4112177|FG001|STARTED|Overall Study||23
3378203|NCT00875394|4112178|FG002|STARTED|Overall Study||9
3378204|NCT00875394|4112176|FG000|COMPLETED|Overall Study||36
3378205|NCT00875394|4112177|FG001|COMPLETED|Overall Study||23
3378206|NCT00875394|4112178|FG002|COMPLETED|Overall Study||9
3378207|NCT00875394|4112176|FG000|NOT COMPLETED|Overall Study||0
3378208|NCT00875394|4112177|FG001|NOT COMPLETED|Overall Study||0
3378209|NCT00875394|4112178|FG002|NOT COMPLETED|Overall Study||0
3378210|NCT00882310|4112186|FG000|STARTED|Overall Study||37
3378211|NCT00882310|4112186|FG000|COMPLETED|Overall Study||15
3378212|NCT00882310|4112186|FG000|NOT COMPLETED|Overall Study||22
3378213|NCT00880542|4112190|FG000|STARTED|Treatment Period (Sorafenib+Ifosfamide)||7
3378214|NCT00880542|4112190|FG000|COMPLETED|Treatment Period (Sorafenib+Ifosfamide)||4
3378215|NCT00880542|4112190|FG000|NOT COMPLETED|Treatment Period (Sorafenib+Ifosfamide)||3
3378216|NCT00880542|4112190|FG000|STARTED|Response Evaluation Period(REP): PET/CT||4
3378217|NCT00880542|4112190|FG000|COMPLETED|Response Evaluation Period(REP): PET/CT||4
3378218|NCT00880542|4112190|FG000|NOT COMPLETED|Response Evaluation Period(REP): PET/CT||0
3378219|NCT00880542|4112190|FG000|STARTED|REP: Surgical Resection||4
3378220|NCT00880542|4112190|FG000|COMPLETED|REP: Surgical Resection||3
3378221|NCT00880542|4112190|FG000|NOT COMPLETED|REP: Surgical Resection||1
3378222|NCT00880542|4112190|FG000|STARTED|Post Surgical Evaluation||3
3378223|NCT00880542|4112190|FG000|COMPLETED|Post Surgical Evaluation|none of the 3 subjects met study criteria for continuation of therapy.|3
3378224|NCT00880542|4112190|FG000|NOT COMPLETED|Post Surgical Evaluation||0
3378225|NCT00880542|4112190|FG000|STARTED|Continued Treatment Period|None of the 3 subjects from previous period met study criteria for continuation of therapy.|0
3378226|NCT00880542|4112190|FG000|COMPLETED|Continued Treatment Period||0
3378227|NCT00880542|4112190|FG000|NOT COMPLETED|Continued Treatment Period||0
3378228|NCT00880542|4112190|FG000|STARTED|Follow-up Period|All 7 patients who started the treatment period completed the follow-up period.|7
3378229|NCT00880542|4112190|FG000|COMPLETED|Follow-up Period||7
3378230|NCT00880542|4112190|FG000|NOT COMPLETED|Follow-up Period||0
3378231|NCT00879619|4112194|FG000|STARTED|Overall Study||4
3378232|NCT00879619|4112194|FG000|COMPLETED|Overall Study||4
3378233|NCT00879619|4112194|FG000|NOT COMPLETED|Overall Study||0
3378234|NCT00874939|4112198|FG000|STARTED|Overall Study||4
3378235|NCT00874939|4112198|FG000|Treated|Overall Study||0
3378236|NCT00874939|4112198|FG000|COMPLETED|Overall Study||0
3378237|NCT00874939|4112198|FG000|NOT COMPLETED|Overall Study||4
3378238|NCT00878605|4112212|FG000|STARTED|Overall Study||10
3378239|NCT00878605|4112213|FG001|STARTED|Overall Study||10
3378240|NCT00878605|4112214|FG002|STARTED|Overall Study||9
3378241|NCT00878605|4112215|FG003|STARTED|Overall Study||9
3378242|NCT00878605|4112212|FG000|COMPLETED|Overall Study||7
3378243|NCT00878605|4112213|FG001|COMPLETED|Overall Study||7
3378244|NCT00878605|4112214|FG002|COMPLETED|Overall Study||8
3378245|NCT00878605|4112215|FG003|COMPLETED|Overall Study||6
3378246|NCT00878605|4112212|FG000|NOT COMPLETED|Overall Study||3
3378247|NCT00878605|4112213|FG001|NOT COMPLETED|Overall Study||3
3378248|NCT00878605|4112214|FG002|NOT COMPLETED|Overall Study||1
3378249|NCT00878605|4112215|FG003|NOT COMPLETED|Overall Study||3
3378250|NCT00877071|4112225|FG000|STARTED|Overall Study||2
3378251|NCT00877071|4112225|FG000|COMPLETED|Overall Study||0
3378252|NCT00877071|4112225|FG000|NOT COMPLETED|Overall Study||2
3378253|NCT00878969|4112232|FG000|STARTED|Overall Study||25
3378254|NCT00878969|4112233|FG001|STARTED|Overall Study||27
3378255|NCT00878969|4112234|FG002|STARTED|Overall Study||26
3378256|NCT00878969|4112232|FG000|COMPLETED|Overall Study||10
3378257|NCT00878969|4112233|FG001|COMPLETED|Overall Study||12
3378258|NCT00878969|4112234|FG002|COMPLETED|Overall Study||15
3378259|NCT00878969|4112232|FG000|NOT COMPLETED|Overall Study||15
3378260|NCT00878969|4112233|FG001|NOT COMPLETED|Overall Study||15
3378261|NCT00878969|4112234|FG002|NOT COMPLETED|Overall Study||11
3378262|NCT00865514|4112242|FG000|STARTED|Overall Study||2
3378263|NCT00865514|4112242|FG000|COMPLETED|Overall Study||0
3378264|NCT00865514|4112242|FG000|NOT COMPLETED|Overall Study||2
3378265|NCT00869414|4112247|FG000|STARTED|Overall Study||0
3378266|NCT00869414|4112248|FG001|STARTED|Overall Study||0
3378267|NCT00869414|4112249|FG002|STARTED|Overall Study||0
3378268|NCT00869414|4112247|FG000|COMPLETED|Overall Study||0
3378269|NCT00869414|4112248|FG001|COMPLETED|Overall Study||0
3378270|NCT00869414|4112249|FG002|COMPLETED|Overall Study||0
3378271|NCT00869414|4112247|FG000|NOT COMPLETED|Overall Study||0
3378272|NCT00869414|4112248|FG001|NOT COMPLETED|Overall Study||0
3378273|NCT00869414|4112249|FG002|NOT COMPLETED|Overall Study||0
3378274|NCT00863512|4112259|FG000|STARTED|Overall Study||17
3378275|NCT00863512|4112260|FG001|STARTED|Overall Study||17
3378276|NCT00863512|4112259|FG000|COMPLETED|Overall Study||3
3378277|NCT00863512|4112260|FG001|COMPLETED|Overall Study||17
3378278|NCT00863512|4112259|FG000|NOT COMPLETED|Overall Study||14
3378279|NCT00863512|4112260|FG001|NOT COMPLETED|Overall Study||0
3378280|NCT00868998|4112266|FG000|STARTED|Overall Study||5
3378281|NCT00868998|4112266|FG000|COMPLETED|Overall Study||0
3378282|NCT00868998|4112266|FG000|NOT COMPLETED|Overall Study||5
3378283|NCT00869258|4112270|FG000|STARTED|Overall Study||32
3378284|NCT00869258|4112270|FG000|COMPLETED|Overall Study||31
3378285|NCT00869258|4112270|FG000|NOT COMPLETED|Overall Study||1
3378286|NCT00863330|4112274|FG000|STARTED|Overall Study||6
3378287|NCT00863330|4112274|FG000|COMPLETED|Overall Study||0
3378288|NCT00863330|4112274|FG000|NOT COMPLETED|Overall Study||6
3378289|NCT00853229|4112280|FG000|STARTED|Phase 1: Initial Intervention||8
3378290|NCT00853229|4112281|FG001|STARTED|Phase 1: Initial Intervention||8
3378291|NCT00853229|4112280|FG000|COMPLETED|Phase 1: Initial Intervention||0
3378292|NCT00853229|4112281|FG001|COMPLETED|Phase 1: Initial Intervention||0
3378293|NCT00853229|4112280|FG000|NOT COMPLETED|Phase 1: Initial Intervention||8
3378294|NCT00853229|4112281|FG001|NOT COMPLETED|Phase 1: Initial Intervention||8
3378295|NCT00853229|4112280|FG000|STARTED|Phase 2: Cross Over||0
3378296|NCT00853229|4112281|FG001|STARTED|Phase 2: Cross Over||0
3378297|NCT00853229|4112280|FG000|COMPLETED|Phase 2: Cross Over||0
3378298|NCT00853229|4112281|FG001|COMPLETED|Phase 2: Cross Over||0
3378299|NCT00853229|4112280|FG000|NOT COMPLETED|Phase 2: Cross Over||0
3378300|NCT00853229|4112281|FG001|NOT COMPLETED|Phase 2: Cross Over||0
3378301|NCT00860249|4112292|FG000|STARTED|Overall Study||21
3378302|NCT00860249|4112293|FG001|STARTED|Overall Study||18
3378303|NCT00860249|4112294|FG002|STARTED|Overall Study||21
3378304|NCT00860249|4112292|FG000|COMPLETED|Overall Study||0
3378305|NCT00860249|4112293|FG001|COMPLETED|Overall Study||0
3378306|NCT00860249|4112294|FG002|COMPLETED|Overall Study||0
3378307|NCT00860249|4112292|FG000|NOT COMPLETED|Overall Study||21
3378308|NCT00860249|4112293|FG001|NOT COMPLETED|Overall Study||18
3378309|NCT00860249|4112294|FG002|NOT COMPLETED|Overall Study||21
3378310|NCT00860158|4112302|FG000|STARTED|Overall Study||1
3378311|NCT00860158|4112302|FG000|COMPLETED|Overall Study||0
3378312|NCT00860158|4112302|FG000|NOT COMPLETED|Overall Study||1
3378313|NCT00853567|4112309|FG000|STARTED|Overall Study||71
3378314|NCT00853567|4112309|FG000|COMPLETED|Overall Study||0
3378315|NCT00853567|4112309|FG000|NOT COMPLETED|Overall Study||71
3378316|NCT00849524|4112317|FG000|STARTED|Overall Study||6
3378317|NCT00849524|4112317|FG000|COMPLETED|Overall Study||3
3378318|NCT00849524|4112317|FG000|NOT COMPLETED|Overall Study||3
3378319|NCT00843986|4112323|FG000|STARTED|Overall Study||3
3378320|NCT00843986|4112324|FG001|STARTED|Overall Study||6
3378321|NCT00843986|4112323|FG000|Completed Treatment (Infusion)|Overall Study||2
3378322|NCT00843986|4112324|FG001|Completed Treatment (Infusion)|Overall Study||6
3378323|NCT00843986|4112323|FG000|COMPLETED|Overall Study||2
3378324|NCT00843986|4112324|FG001|COMPLETED|Overall Study||5
3378325|NCT00843986|4112323|FG000|NOT COMPLETED|Overall Study||1
3378326|NCT00843986|4112324|FG001|NOT COMPLETED|Overall Study||1
3378327|NCT00851682|4112332|FG000|STARTED|Overall Study||60
3378328|NCT00851682|4112333|FG001|STARTED|Overall Study||5
3378329|NCT00851682|4112332|FG000|COMPLETED|Overall Study||55
3378330|NCT00851682|4112333|FG001|COMPLETED|Overall Study||5
3378331|NCT00851682|4112332|FG000|NOT COMPLETED|Overall Study||5
3378332|NCT00851682|4112333|FG001|NOT COMPLETED|Overall Study||0
3378333|NCT00852124|4112341|FG000|STARTED|Overall Study||3
3378334|NCT00852124|4112342|FG001|STARTED|Overall Study||0
3378335|NCT00852124|4112341|FG000|COMPLETED|Overall Study||3
3378336|NCT00852124|4112342|FG001|COMPLETED|Overall Study||0
3378337|NCT00852124|4112341|FG000|NOT COMPLETED|Overall Study||0
3378338|NCT00852124|4112342|FG001|NOT COMPLETED|Overall Study||0
3378339|NCT00850421|4112347|FG000|STARTED|Overall Study||35
3378340|NCT00850421|4112347|FG000|COMPLETED|Overall Study||18
3378341|NCT00850421|4112347|FG000|NOT COMPLETED|Overall Study||17
3378342|NCT00851747|4112355|FG000|STARTED|Overall Study||6
3378343|NCT00851747|4112356|FG001|STARTED|Overall Study||6
3378344|NCT00851747|4112357|FG002|STARTED|Overall Study||6
3378345|NCT00851747|4112355|FG000|COMPLETED|Overall Study||0
3378346|NCT00851747|4112356|FG001|COMPLETED|Overall Study||0
3378347|NCT00851747|4112357|FG002|COMPLETED|Overall Study||0
3378348|NCT00851747|4112355|FG000|NOT COMPLETED|Overall Study||6
3378349|NCT00851747|4112356|FG001|NOT COMPLETED|Overall Study||6
3378350|NCT00851747|4112357|FG002|NOT COMPLETED|Overall Study||6
3378351|NCT00852241|4112364|FG000|STARTED|Overall Study||18
3378352|NCT00852241|4112364|FG000|COMPLETED|Overall Study||0
3378353|NCT00852241|4112364|FG000|NOT COMPLETED|Overall Study||18
3378354|NCT00851552|4112368|FG000|STARTED|Overall Study||9
3378355|NCT00851552|4112368|FG000|COMPLETED|Overall Study||2
3378356|NCT00851552|4112368|FG000|NOT COMPLETED|Overall Study||7
3378357|NCT00850720|4112372|FG000|STARTED|Overall Study||0
3378358|NCT00850720|4112372|FG000|COMPLETED|Overall Study||0
3378359|NCT00850720|4112372|FG000|NOT COMPLETED|Overall Study||0
3378360|NCT00845845|4112378|FG000|STARTED|Overall Study||3
3378361|NCT00845845|4112379|FG001|STARTED|Overall Study||6
3378362|NCT00845845|4112378|FG000|COMPLETED|Overall Study||3
3378363|NCT00845845|4112379|FG001|COMPLETED|Overall Study||2
3378364|NCT00845845|4112378|FG000|NOT COMPLETED|Overall Study||0
3378365|NCT00845845|4112379|FG001|NOT COMPLETED|Overall Study||4
3378366|NCT00851591|4112387|FG000|STARTED|Overall Study|These 2 participants did not receive treatment.|2
3378367|NCT00851591|4112388|FG001|STARTED|Overall Study|One received treatment.|1
3378368|NCT00851591|4112387|FG000|COMPLETED|Overall Study||0
3378369|NCT00851591|4112388|FG001|COMPLETED|Overall Study||1
3378370|NCT00851591|4112387|FG000|NOT COMPLETED|Overall Study||2
3378371|NCT00851591|4112388|FG001|NOT COMPLETED|Overall Study||0
3378372|NCT00847509|4112394|FG000|STARTED|Overall Study||49
3378373|NCT00847509|4112394|FG000|COMPLETED|Overall Study||38
3378374|NCT00847509|4112394|FG000|NOT COMPLETED|Overall Study||11
3378375|NCT00843310|4112398|FG000|STARTED|Overall Study||8
3378376|NCT00843310|4112398|FG000|COMPLETED|Overall Study||1
3378377|NCT00843310|4112398|FG000|NOT COMPLETED|Overall Study||7
3378378|NCT00847002|4112404|FG000|STARTED|Overall Study||4
3378379|NCT00847002|4112405|FG001|STARTED|Overall Study||4
3378380|NCT00847002|4112404|FG000|COMPLETED|Overall Study||4
3378381|NCT00847002|4112405|FG001|COMPLETED|Overall Study||4
3378382|NCT00847002|4112404|FG000|NOT COMPLETED|Overall Study||0
3378383|NCT00847002|4112405|FG001|NOT COMPLETED|Overall Study||0
3378384|NCT00845702|4112411|FG000|STARTED|TOF MRA||33
3378385|NCT00845702|4112411|FG000|COMPLETED|TOF MRA|One patient did not perform study MRA procedures.|32
3378386|NCT00845702|4112411|FG000|NOT COMPLETED|TOF MRA||1
3378387|NCT00845702|4112411|FG000|STARTED|Dotarem MRA||32
3378388|NCT00845702|4112411|FG000|COMPLETED|Dotarem MRA||32
3378389|NCT00845702|4112411|FG000|NOT COMPLETED|Dotarem MRA||0
3378390|NCT00843830|4112417|FG000|STARTED|Overall Study||4
3378391|NCT00843830|4112417|FG000|COMPLETED|Overall Study||4
3378392|NCT00843830|4112417|FG000|NOT COMPLETED|Overall Study||0
3378393|NCT00835679|4112425|FG000|STARTED|Overall Study||9
3378394|NCT00835679|4112426|FG001|STARTED|Overall Study|This study closed prematurely, thus no patients went on Cohort B, C or D.|0
3378395|NCT00835679|4112427|FG002|STARTED|Overall Study||0
3378396|NCT00835679|4112428|FG003|STARTED|Overall Study||0
3378397|NCT00835679|4112425|FG000|COMPLETED|Overall Study||8
3378398|NCT00835679|4112426|FG001|COMPLETED|Overall Study||0
3378399|NCT00835679|4112427|FG002|COMPLETED|Overall Study||0
3378400|NCT00835679|4112428|FG003|COMPLETED|Overall Study||0
3378401|NCT00835679|4112425|FG000|NOT COMPLETED|Overall Study||1
3378402|NCT00835679|4112426|FG001|NOT COMPLETED|Overall Study||0
3378403|NCT00835679|4112427|FG002|NOT COMPLETED|Overall Study||0
3378404|NCT00835679|4112428|FG003|NOT COMPLETED|Overall Study||0
3378405|NCT00841035|4112442|FG000|STARTED|Phase 1 Overall Study|2 phase enrollment,1st phase enrolled with cancer by fine needle aspiration in endoscopic ultrasound|19
3378406|NCT00841035|4112442|FG000|COMPLETED|Phase 1 Overall Study||6
3378407|NCT00841035|4112442|FG000|NOT COMPLETED|Phase 1 Overall Study||13
3378408|NCT00841035|4112442|FG000|STARTED|Phase 2 of Overall Study||6
3378409|NCT00841035|4112442|FG000|COMPLETED|Phase 2 of Overall Study||6
3378410|NCT00841035|4112442|FG000|NOT COMPLETED|Phase 2 of Overall Study||0
3378411|NCT00832520|4112447|FG000|STARTED|Overall Study||13
3378412|NCT00832520|4112447|FG000|COMPLETED|Overall Study||13
3378413|NCT00832520|4112447|FG000|NOT COMPLETED|Overall Study||0
3378414|NCT00833859|4112451|FG000|STARTED|Overall Study||2
3378415|NCT00833859|4112451|FG000|COMPLETED|Overall Study||2
3378416|NCT00833859|4112451|FG000|NOT COMPLETED|Overall Study||0
3378417|NCT00843050|4112455|FG000|STARTED|Overall Study||13
3378418|NCT00843050|4112455|FG000|COMPLETED|Overall Study||0
3378419|NCT00843050|4112455|FG000|NOT COMPLETED|Overall Study||13
3378420|NCT00840827|4112460|FG000|STARTED|Overall Study||6
3378421|NCT00840827|4112460|FG000|COMPLETED|Overall Study||0
3378422|NCT00840827|4112460|FG000|NOT COMPLETED|Overall Study||6
3378423|NCT00835328|4112468|FG000|STARTED|Cohort 1: Dose Level 1||5
3378424|NCT00835328|4112469|FG001|STARTED|Cohort 1: Dose Level 1||0
3378425|NCT00835328|4112470|FG002|STARTED|Cohort 1: Dose Level 1||0
3378426|NCT00835328|4112471|FG003|STARTED|Cohort 1: Dose Level 1||0
3378427|NCT00835328|4112468|FG000|COMPLETED|Cohort 1: Dose Level 1||5
3378428|NCT00835328|4112469|FG001|COMPLETED|Cohort 1: Dose Level 1||0
3378429|NCT00835328|4112470|FG002|COMPLETED|Cohort 1: Dose Level 1||0
3378430|NCT00835328|4112471|FG003|COMPLETED|Cohort 1: Dose Level 1||0
3378431|NCT00835328|4112468|FG000|NOT COMPLETED|Cohort 1: Dose Level 1||0
3378432|NCT00835328|4112469|FG001|NOT COMPLETED|Cohort 1: Dose Level 1||0
3378433|NCT00835328|4112470|FG002|NOT COMPLETED|Cohort 1: Dose Level 1||0
3378434|NCT00835328|4112471|FG003|NOT COMPLETED|Cohort 1: Dose Level 1||0
3378435|NCT00835328|4112468|FG000|STARTED|Cohort 2: Dose Level 2||0
3378436|NCT00835328|4112469|FG001|STARTED|Cohort 2: Dose Level 2||2
3378437|NCT00835328|4112470|FG002|STARTED|Cohort 2: Dose Level 2||0
3378438|NCT00835328|4112471|FG003|STARTED|Cohort 2: Dose Level 2||0
3378439|NCT00835328|4112468|FG000|COMPLETED|Cohort 2: Dose Level 2||0
3378440|NCT00835328|4112469|FG001|COMPLETED|Cohort 2: Dose Level 2||2
3378441|NCT00835328|4112470|FG002|COMPLETED|Cohort 2: Dose Level 2||0
3378442|NCT00835328|4112471|FG003|COMPLETED|Cohort 2: Dose Level 2||0
3378443|NCT00835328|4112468|FG000|NOT COMPLETED|Cohort 2: Dose Level 2||0
3378444|NCT00835328|4112469|FG001|NOT COMPLETED|Cohort 2: Dose Level 2||0
3378445|NCT00835328|4112470|FG002|NOT COMPLETED|Cohort 2: Dose Level 2||0
3378446|NCT00835328|4112471|FG003|NOT COMPLETED|Cohort 2: Dose Level 2||0
3378447|NCT00835328|4112468|FG000|STARTED|Cohort 3: Dose Level 3||0
3378448|NCT00835328|4112469|FG001|STARTED|Cohort 3: Dose Level 3||0
3378449|NCT00835328|4112470|FG002|STARTED|Cohort 3: Dose Level 3||2
3378450|NCT00835328|4112471|FG003|STARTED|Cohort 3: Dose Level 3||0
3378451|NCT00835328|4112468|FG000|COMPLETED|Cohort 3: Dose Level 3||0
3378452|NCT00835328|4112469|FG001|COMPLETED|Cohort 3: Dose Level 3||0
3378453|NCT00835328|4112470|FG002|COMPLETED|Cohort 3: Dose Level 3||2
3378454|NCT00835328|4112471|FG003|COMPLETED|Cohort 3: Dose Level 3||0
3378455|NCT00835328|4112468|FG000|NOT COMPLETED|Cohort 3: Dose Level 3||0
3378456|NCT00835328|4112469|FG001|NOT COMPLETED|Cohort 3: Dose Level 3||0
3378457|NCT00835328|4112470|FG002|NOT COMPLETED|Cohort 3: Dose Level 3||0
3378458|NCT00835328|4112471|FG003|NOT COMPLETED|Cohort 3: Dose Level 3||0
3378459|NCT00835328|4112468|FG000|STARTED|Cohort 4: Dose Level 4|Cohort#4 enrolled 4 subsequent subjects|0
3378460|NCT00835328|4112469|FG001|STARTED|Cohort 4: Dose Level 4||0
3378461|NCT00835328|4112470|FG002|STARTED|Cohort 4: Dose Level 4||0
3378462|NCT00835328|4112471|FG003|STARTED|Cohort 4: Dose Level 4||4
3378463|NCT00835328|4112468|FG000|COMPLETED|Cohort 4: Dose Level 4||0
3378464|NCT00835328|4112469|FG001|COMPLETED|Cohort 4: Dose Level 4||0
3378465|NCT00835328|4112470|FG002|COMPLETED|Cohort 4: Dose Level 4||0
3378466|NCT00835328|4112471|FG003|COMPLETED|Cohort 4: Dose Level 4||4
3378467|NCT00835328|4112468|FG000|NOT COMPLETED|Cohort 4: Dose Level 4||0
3378468|NCT00835328|4112469|FG001|NOT COMPLETED|Cohort 4: Dose Level 4||0
3378469|NCT00835328|4112470|FG002|NOT COMPLETED|Cohort 4: Dose Level 4||0
3378470|NCT00835328|4112471|FG003|NOT COMPLETED|Cohort 4: Dose Level 4||0
3378471|NCT00832572|4112485|FG000|STARTED|Period 1||3
3378472|NCT00832572|4112486|FG001|STARTED|Period 1||2
3378473|NCT00832572|4112485|FG000|COMPLETED|Period 1||3
3378474|NCT00832572|4112486|FG001|COMPLETED|Period 1||2
3378475|NCT00832572|4112485|FG000|NOT COMPLETED|Period 1||0
3378476|NCT00832572|4112486|FG001|NOT COMPLETED|Period 1||0
3378477|NCT00832572|4112485|FG000|STARTED|Period 2||3
3378478|NCT00832572|4112486|FG001|STARTED|Period 2||2
3378479|NCT00832572|4112485|FG000|COMPLETED|Period 2||3
3378480|NCT00832572|4112486|FG001|COMPLETED|Period 2||2
3378481|NCT00832572|4112485|FG000|NOT COMPLETED|Period 2||0
3378482|NCT00832572|4112486|FG001|NOT COMPLETED|Period 2||0
3378483|NCT00832624|4112494|FG000|STARTED|Overall Study||10
3378484|NCT00832624|4112494|FG000|COMPLETED|Overall Study||0
3378485|NCT00832624|4112494|FG000|NOT COMPLETED|Overall Study||10
3378486|NCT00832299|4112498|FG000|STARTED|Overall Study||2
3378487|NCT00832299|4112498|FG000|COMPLETED|Overall Study||2
3378488|NCT00832299|4112498|FG000|NOT COMPLETED|Overall Study||0
3378489|NCT00836355|4112506|FG000|STARTED|Overall Study||0
3378490|NCT00836355|4112507|FG001|STARTED|Overall Study||4
3378491|NCT00836355|4112508|FG002|STARTED|Overall Study||0
3378492|NCT00836355|4112509|FG003|STARTED|Overall Study||2
3378493|NCT00836355|4112506|FG000|COMPLETED|Overall Study||0
3378494|NCT00836355|4112507|FG001|COMPLETED|Overall Study||4
3378495|NCT00836355|4112508|FG002|COMPLETED|Overall Study||0
3378496|NCT00836355|4112509|FG003|COMPLETED|Overall Study||2
3378497|NCT00836355|4112506|FG000|NOT COMPLETED|Overall Study||0
3378498|NCT00836355|4112507|FG001|NOT COMPLETED|Overall Study||0
3378499|NCT00836355|4112508|FG002|NOT COMPLETED|Overall Study||0
3378500|NCT00836355|4112509|FG003|NOT COMPLETED|Overall Study||0
3378501|NCT00832598|4112519|FG000|STARTED|Overall Study||13
3378502|NCT00832598|4112519|FG000|COMPLETED|Overall Study||13
3378503|NCT00832598|4112519|FG000|NOT COMPLETED|Overall Study||0
3378504|NCT00816777|4112525|FG000|STARTED|Overall Study||2
3378505|NCT00816777|4112526|FG001|STARTED|Overall Study||2
3378506|NCT00816777|4112525|FG000|COMPLETED|Overall Study||2
3378507|NCT00816777|4112526|FG001|COMPLETED|Overall Study||2
3378508|NCT00816777|4112525|FG000|NOT COMPLETED|Overall Study||0
3378509|NCT00816777|4112526|FG001|NOT COMPLETED|Overall Study||0
3378510|NCT00823095|4112532|FG000|STARTED|Overall Study||7
3378511|NCT00823095|4112532|FG000|COMPLETED|Overall Study||7
3378512|NCT00823095|4112532|FG000|NOT COMPLETED|Overall Study||0
3378513|NCT00827567|4112537|FG000|STARTED|Overall Study||4
3378514|NCT00827567|4112537|FG000|COMPLETED|Overall Study|2 screen failures, 4 withdrew from study to go on to other therapies|0
3378515|NCT00827567|4112537|FG000|NOT COMPLETED|Overall Study||4
3378516|NCT00815633|4112541|FG000|STARTED|Overall Study||1
3378517|NCT00815633|4112541|FG000|COMPLETED|Overall Study||0
3378518|NCT00815633|4112541|FG000|NOT COMPLETED|Overall Study||1
3378519|NCT00814983|4112547|FG000|STARTED|Overall Study||15
3378520|NCT00814983|4112548|FG001|STARTED|Overall Study||0
3378521|NCT00814983|4112547|FG000|COMPLETED|Overall Study||12
3378522|NCT00814983|4112548|FG001|COMPLETED|Overall Study||0
3378523|NCT00814983|4112547|FG000|NOT COMPLETED|Overall Study||3
3378524|NCT00814983|4112548|FG001|NOT COMPLETED|Overall Study||0
3378525|NCT00825227|4112556|FG000|STARTED|Overall Study||6
3378526|NCT00825227|4112557|FG001|STARTED|Overall Study||4
3378527|NCT00825227|4112556|FG000|COMPLETED|Overall Study||6
3378528|NCT00825227|4112557|FG001|COMPLETED|Overall Study||4
3378529|NCT00825227|4112556|FG000|NOT COMPLETED|Overall Study||0
3378530|NCT00825227|4112557|FG001|NOT COMPLETED|Overall Study||0
3378531|NCT00819832|4112571|FG000|STARTED|Overall Study|No patient data analysis.|3
3378532|NCT00819832|4112572|FG001|STARTED|Overall Study||0
3378533|NCT00819832|4112573|FG002|STARTED|Overall Study||0
3378534|NCT00819832|4112574|FG003|STARTED|Overall Study||0
3378535|NCT00819832|4112575|FG004|STARTED|Overall Study||0
3378536|NCT00819832|4112576|FG005|STARTED|Overall Study||0
3378537|NCT00819832|4112571|FG000|COMPLETED|Overall Study||0
3378538|NCT00819832|4112572|FG001|COMPLETED|Overall Study||0
3378539|NCT00819832|4112573|FG002|COMPLETED|Overall Study||0
3378540|NCT00819832|4112574|FG003|COMPLETED|Overall Study||0
3378541|NCT00819832|4112575|FG004|COMPLETED|Overall Study||0
3378542|NCT00819832|4112576|FG005|COMPLETED|Overall Study||0
3378543|NCT00819832|4112571|FG000|NOT COMPLETED|Overall Study||3
3378544|NCT00819832|4112572|FG001|NOT COMPLETED|Overall Study||0
3378545|NCT00819832|4112573|FG002|NOT COMPLETED|Overall Study||0
3378546|NCT00819832|4112574|FG003|NOT COMPLETED|Overall Study||0
3378547|NCT00819832|4112575|FG004|NOT COMPLETED|Overall Study||0
3378548|NCT00819832|4112576|FG005|NOT COMPLETED|Overall Study||0
3378549|NCT00822679|4112592|FG000|STARTED|Overall Study||0
3378550|NCT00822679|4112593|FG001|STARTED|Overall Study||0
3378551|NCT00822679|4112592|FG000|COMPLETED|Overall Study||0
3378552|NCT00822679|4112593|FG001|COMPLETED|Overall Study||0
3378553|NCT00822679|4112592|FG000|NOT COMPLETED|Overall Study||0
3378554|NCT00822679|4112593|FG001|NOT COMPLETED|Overall Study||0
3378555|NCT00814892|4112599|FG000|STARTED|Overall Study||2
3378556|NCT00814892|4112599|FG000|COMPLETED|Overall Study||0
3378557|NCT00814892|4112599|FG000|NOT COMPLETED|Overall Study||2
3378558|NCT00809458|4112605|FG000|STARTED|Overall Study||9
3378559|NCT00809458|4112606|FG001|STARTED|Overall Study||6
3378560|NCT00809458|4112605|FG000|COMPLETED|Overall Study||8
3378561|NCT00809458|4112606|FG001|COMPLETED|Overall Study||5
3378562|NCT00809458|4112605|FG000|NOT COMPLETED|Overall Study||1
3378563|NCT00809458|4112606|FG001|NOT COMPLETED|Overall Study||1
3378564|NCT00802659|4112616|FG000|STARTED|Overall Study||0
3378565|NCT00802659|4112617|FG001|STARTED|Overall Study||2
3378566|NCT00802659|4112618|FG002|STARTED|Overall Study||0
3378567|NCT00802659|4112619|FG003|STARTED|Overall Study||0
3378568|NCT00802659|4112616|FG000|COMPLETED|Overall Study||0
3378569|NCT00802659|4112617|FG001|COMPLETED|Overall Study||1
3378570|NCT00802659|4112618|FG002|COMPLETED|Overall Study||0
3378571|NCT00802659|4112619|FG003|COMPLETED|Overall Study||0
3378572|NCT00802659|4112616|FG000|NOT COMPLETED|Overall Study||0
3378573|NCT00802659|4112617|FG001|NOT COMPLETED|Overall Study||1
3378574|NCT00802659|4112618|FG002|NOT COMPLETED|Overall Study||0
3378575|NCT00802659|4112619|FG003|NOT COMPLETED|Overall Study||0
3378576|NCT00807365|4112629|FG000|STARTED|Overall Study||5
3378577|NCT00807365|4112629|FG000|COMPLETED|Overall Study||0
3378578|NCT00807365|4112629|FG000|NOT COMPLETED|Overall Study||5
3378579|NCT00814333|4112635|FG000|STARTED|Enrollment||1
3378580|NCT00814333|4112636|FG001|STARTED|Enrollment||0
3378581|NCT00814333|4112635|FG000|COMPLETED|Enrollment||0
3378582|NCT00814333|4112636|FG001|COMPLETED|Enrollment||0
3378583|NCT00814333|4112635|FG000|NOT COMPLETED|Enrollment||1
3378584|NCT00814333|4112636|FG001|NOT COMPLETED|Enrollment||0
3378585|NCT00814333|4112635|FG000|STARTED|Treatment Period||0
3378586|NCT00814333|4112636|FG001|STARTED|Treatment Period||0
3378587|NCT00814333|4112635|FG000|COMPLETED|Treatment Period||0
3378588|NCT00814333|4112636|FG001|COMPLETED|Treatment Period||0
3378589|NCT00814333|4112635|FG000|NOT COMPLETED|Treatment Period||0
3378590|NCT00814333|4112636|FG001|NOT COMPLETED|Treatment Period||0
3378591|NCT00808080|4112642|FG000|STARTED|Overall Study||6
3378592|NCT00808080|4112642|FG000|COMPLETED|Overall Study||0
3378593|NCT00808080|4112642|FG000|NOT COMPLETED|Overall Study||6
3378594|NCT00802893|4112647|FG000|STARTED|Overall Study||3
3378595|NCT00802893|4112647|FG000|COMPLETED|Overall Study||0
3378596|NCT00802893|4112647|FG000|NOT COMPLETED|Overall Study||3
3378597|NCT00809341|4112653|FG000|STARTED|Overall Study||20
3378598|NCT00809341|4112654|FG001|STARTED|Overall Study||5
3378599|NCT00809341|4112653|FG000|COMPLETED|Overall Study||20
3378600|NCT00809341|4112654|FG001|COMPLETED|Overall Study||4
3378601|NCT00809341|4112653|FG000|NOT COMPLETED|Overall Study||0
3378602|NCT00809341|4112654|FG001|NOT COMPLETED|Overall Study||1
3378603|NCT00804349|4112662|FG000|STARTED|Overall Study|0 analyzed PI no longer at institution;PI contacted, information not added; No data available.|0
3378604|NCT00804349|4112663|FG001|STARTED|Overall Study|0 analyzed PI no longer at institution;PI contacted, information not added; No data available|0
3378605|NCT00804349|4112662|FG000|COMPLETED|Overall Study|0 analyzed PI no longer at institution;PI contacted, information not added; No data available|0
3378606|NCT00804349|4112663|FG001|COMPLETED|Overall Study|0 analyzed PI no longer at institution;PI contacted, information not added; No data available|0
3378607|NCT00804349|4112662|FG000|NOT COMPLETED|Overall Study||0
3378608|NCT00804349|4112663|FG001|NOT COMPLETED|Overall Study||0
3378609|NCT00803283|4112671|FG000|STARTED|Overall Study||1
3378610|NCT00803283|4112672|FG001|STARTED|Overall Study||1
3378611|NCT00803283|4112671|FG000|COMPLETED|Overall Study||1
3378612|NCT00803283|4112672|FG001|COMPLETED|Overall Study||1
3378613|NCT00803283|4112671|FG000|NOT COMPLETED|Overall Study||0
3378614|NCT00803283|4112672|FG001|NOT COMPLETED|Overall Study||0
3378615|NCT00811590|4112678|FG000|STARTED|Overall Study||3
3378616|NCT00811590|4112678|FG000|COMPLETED|Overall Study||3
3378617|NCT00811590|4112678|FG000|NOT COMPLETED|Overall Study||0
3378618|NCT00808899|4112682|FG000|STARTED|Overall Study||4
3378619|NCT00808899|4112682|FG000|COMPLETED|Overall Study||0
3378620|NCT00808899|4112682|FG000|NOT COMPLETED|Overall Study||4
3378621|NCT00808769|4112686|FG000|STARTED|First Intervention||15
3378622|NCT00808769|4112687|FG001|STARTED|First Intervention||15
3378623|NCT00808769|4112686|FG000|COMPLETED|First Intervention||15
3378624|NCT00808769|4112687|FG001|COMPLETED|First Intervention||15
3378625|NCT00808769|4112686|FG000|NOT COMPLETED|First Intervention||0
3378626|NCT00808769|4112687|FG001|NOT COMPLETED|First Intervention||0
3378627|NCT00808769|4112686|FG000|STARTED|Second Intervention||15
3378628|NCT00808769|4112687|FG001|STARTED|Second Intervention||15
3378629|NCT00808769|4112686|FG000|COMPLETED|Second Intervention||15
3378630|NCT00808769|4112687|FG001|COMPLETED|Second Intervention||15
3378631|NCT00808769|4112686|FG000|NOT COMPLETED|Second Intervention||0
3378632|NCT00808769|4112687|FG001|NOT COMPLETED|Second Intervention||0
3378633|NCT00803179|4112693|FG000|STARTED|Overall Study||5
3378634|NCT00803179|4112693|FG000|COMPLETED|Overall Study||2
3378635|NCT00803179|4112693|FG000|NOT COMPLETED|Overall Study||3
3378636|NCT00801931|4112697|FG000|STARTED|Overall Study||1
3378637|NCT00801931|4112697|FG000|COMPLETED|Overall Study||1
3378638|NCT00801931|4112697|FG000|NOT COMPLETED|Overall Study||0
3378639|NCT00793520|4112703|FG000|STARTED|Milnacipran Crossover to Placebo||1
3378640|NCT00793520|4112704|FG001|STARTED|Milnacipran Crossover to Placebo||0
3378641|NCT00793520|4112703|FG000|COMPLETED|Milnacipran Crossover to Placebo||0
3378642|NCT00793520|4112704|FG001|COMPLETED|Milnacipran Crossover to Placebo||0
3378643|NCT00793520|4112703|FG000|NOT COMPLETED|Milnacipran Crossover to Placebo||1
3378644|NCT00793520|4112704|FG001|NOT COMPLETED|Milnacipran Crossover to Placebo||0
3378645|NCT00793520|4112703|FG000|STARTED|Placebo Crossover to Milnacipran||0
3378646|NCT00793520|4112704|FG001|STARTED|Placebo Crossover to Milnacipran||1
3378647|NCT00793520|4112703|FG000|COMPLETED|Placebo Crossover to Milnacipran||0
3378648|NCT00793520|4112704|FG001|COMPLETED|Placebo Crossover to Milnacipran||0
3378649|NCT00793520|4112703|FG000|NOT COMPLETED|Placebo Crossover to Milnacipran||0
3378650|NCT00793520|4112704|FG001|NOT COMPLETED|Placebo Crossover to Milnacipran||1
3378651|NCT00795236|4112712|FG000|STARTED|Overall Study||0
3378652|NCT00795236|4112713|FG001|STARTED|Overall Study||0
3378653|NCT00795236|4112712|FG000|COMPLETED|Overall Study|Unable to consistently obtain saliva DLMO in subjects and thus couldn't measure circadian period|0
3378654|NCT00795236|4112713|FG001|COMPLETED|Overall Study||0
3378655|NCT00795236|4112712|FG000|NOT COMPLETED|Overall Study||0
3378656|NCT00795236|4112713|FG001|NOT COMPLETED|Overall Study||0
3378657|NCT00799773|4112723|FG000|STARTED|Overall Study||2
3378658|NCT00799773|4112724|FG001|STARTED|Overall Study||1
3378659|NCT00799773|4112723|FG000|COMPLETED|Overall Study||2
3378660|NCT00799773|4112724|FG001|COMPLETED|Overall Study||1
3378661|NCT00799773|4112723|FG000|NOT COMPLETED|Overall Study||0
3378662|NCT00799773|4112724|FG001|NOT COMPLETED|Overall Study||0
3378663|NCT00790452|4112732|FG000|STARTED|Overall Study||1
3378664|NCT00790452|4112733|FG001|STARTED|Overall Study||0
3378665|NCT00790452|4112732|FG000|COMPLETED|Overall Study||0
3378666|NCT00790452|4112733|FG001|COMPLETED|Overall Study||0
3378667|NCT00790452|4112732|FG000|NOT COMPLETED|Overall Study||1
3378668|NCT00790452|4112733|FG001|NOT COMPLETED|Overall Study||0
3378669|NCT00795665|4112739|FG000|STARTED|Overall Study||7
3378670|NCT00795665|4112739|FG000|COMPLETED|Overall Study||7
3378671|NCT00795665|4112739|FG000|NOT COMPLETED|Overall Study||0
3378672|NCT00787917|4112745|FG000|STARTED|Blinded Treatment||9
3378673|NCT00787917|4112746|FG001|STARTED|Blinded Treatment||5
3378674|NCT00787917|4112745|FG000|COMPLETED|Blinded Treatment||4
3378675|NCT00787917|4112746|FG001|COMPLETED|Blinded Treatment||3
3378676|NCT00787917|4112745|FG000|NOT COMPLETED|Blinded Treatment||5
3378677|NCT00787917|4112746|FG001|NOT COMPLETED|Blinded Treatment||2
3378678|NCT00787917|4112745|FG000|STARTED|Open Label||7
3378679|NCT00787917|4112746|FG001|STARTED|Open Label|"Placebo was not an arm in open label treatment."|0
3378680|NCT00787917|4112745|FG000|COMPLETED|Open Label||3
3378681|NCT00787917|4112746|FG001|COMPLETED|Open Label||0
3378682|NCT00787917|4112745|FG000|NOT COMPLETED|Open Label||4
3378683|NCT00787917|4112746|FG001|NOT COMPLETED|Open Label||0
3378684|NCT00798590|4112756|FG000|STARTED|Overall Study||11
3378685|NCT00798590|4112757|FG001|STARTED|Overall Study||8
3378686|NCT00798590|4112756|FG000|COMPLETED|Overall Study||0
3378687|NCT00798590|4112757|FG001|COMPLETED|Overall Study||0
3378688|NCT00798590|4112756|FG000|NOT COMPLETED|Overall Study||11
3378689|NCT00798590|4112757|FG001|NOT COMPLETED|Overall Study||8
3378690|NCT00796510|4112765|FG000|STARTED|Overall Study||3
3378691|NCT00796510|4112766|FG001|STARTED|Overall Study||0
3378692|NCT00796510|4112765|FG000|COMPLETED|Overall Study||0
3378693|NCT00796510|4112766|FG001|COMPLETED|Overall Study||0
3378694|NCT00796510|4112765|FG000|NOT COMPLETED|Overall Study||3
3378695|NCT00796510|4112766|FG001|NOT COMPLETED|Overall Study||0
3378696|NCT00796861|4112772|FG000|STARTED|Overall Study||4
3378697|NCT00796861|4112772|FG000|COMPLETED|Overall Study||0
3378698|NCT00796861|4112772|FG000|NOT COMPLETED|Overall Study||4
3378699|NCT00791076|4112776|FG000|STARTED|Overall Study||8
3378700|NCT00791076|4112776|FG000|COMPLETED|Overall Study||0
3378701|NCT00791076|4112776|FG000|NOT COMPLETED|Overall Study||8
3378702|NCT00790478|4112784|FG000|STARTED|Overall Study||0
3378703|NCT00790478|4112785|FG001|STARTED|Overall Study||0
3378704|NCT00790478|4112784|FG000|COMPLETED|Overall Study||0
3378705|NCT00790478|4112785|FG001|COMPLETED|Overall Study||0
3378706|NCT00790478|4112784|FG000|NOT COMPLETED|Overall Study||0
3378707|NCT00790478|4112785|FG001|NOT COMPLETED|Overall Study||0
3378708|NCT00796107|4112791|FG000|STARTED|Overall Study||6
3378709|NCT00796107|4112791|FG000|COMPLETED|Overall Study||0
3378710|NCT00796107|4112791|FG000|NOT COMPLETED|Overall Study||6
3378711|NCT00791336|4112795|FG000|STARTED|Overall Study||1
3378712|NCT00791336|4112795|FG000|COMPLETED|Overall Study||1
3378713|NCT00791336|4112795|FG000|NOT COMPLETED|Overall Study||0
3378714|NCT00786682|4112799|FG000|STARTED|Overall Study||11
3378715|NCT00786682|4112799|FG000|COMPLETED|Overall Study||11
3378716|NCT00786682|4112799|FG000|NOT COMPLETED|Overall Study||0
3378717|NCT00787124|4112805|FG000|STARTED|Overall Study||4
3378718|NCT00787124|4112806|FG001|STARTED|Overall Study||4
3378719|NCT00787124|4112805|FG000|COMPLETED|Overall Study||4
3378720|NCT00787124|4112806|FG001|COMPLETED|Overall Study||4
3378721|NCT00787124|4112805|FG000|NOT COMPLETED|Overall Study||0
3378722|NCT00787124|4112806|FG001|NOT COMPLETED|Overall Study||0
3378723|NCT00785356|4112815|FG000|STARTED|Overall Study||8
3378724|NCT00785356|4112815|FG000|COMPLETED|Overall Study||0
3378725|NCT00785356|4112815|FG000|NOT COMPLETED|Overall Study||8
3378726|NCT00782483|4112823|FG000|STARTED|Overall Study|6 subjects enrolled beginning on 04/27/2009 with last enrollment on 04/13/2010.|6
3378727|NCT00782483|4112823|FG000|COMPLETED|Overall Study||0
3378728|NCT00782483|4112823|FG000|NOT COMPLETED|Overall Study||6
3378729|NCT00791843|4112827|FG000|STARTED|Overall Study|Data unavailable for the study|0
3378730|NCT00791843|4112827|FG000|COMPLETED|Overall Study|Data unavailable for the study|0
3378731|NCT00791843|4112827|FG000|NOT COMPLETED|Overall Study||0
3378732|NCT00784043|4112833|FG000|STARTED|Overall Study||31
3378733|NCT00784043|4112834|FG001|STARTED|Overall Study||6
3378734|NCT00784043|4112833|FG000|COMPLETED|Overall Study||0
3378735|NCT00784043|4112834|FG001|COMPLETED|Overall Study||0
3378736|NCT00784043|4112833|FG000|NOT COMPLETED|Overall Study||31
3378737|NCT00784043|4112834|FG001|NOT COMPLETED|Overall Study||6
3378738|NCT00787618|4112843|FG000|STARTED|Overall Study||3
3378739|NCT00787618|4112844|FG001|STARTED|Overall Study||0
3378740|NCT00787618|4112845|FG002|STARTED|Overall Study||3
3378741|NCT00787618|4112843|FG000|COMPLETED|Overall Study||3
3378742|NCT00787618|4112844|FG001|COMPLETED|Overall Study||0
3378743|NCT00787618|4112845|FG002|COMPLETED|Overall Study||3
3378744|NCT00787618|4112843|FG000|NOT COMPLETED|Overall Study||0
3378745|NCT00787618|4112844|FG001|NOT COMPLETED|Overall Study||0
3378746|NCT00787618|4112845|FG002|NOT COMPLETED|Overall Study||0
3378747|NCT00774306|4112857|FG000|STARTED|Overall Study||24
3378748|NCT00774306|4112858|FG001|STARTED|Overall Study||5
3378749|NCT00774306|4112859|FG002|STARTED|Overall Study||16
3378750|NCT00774306|4112860|FG003|STARTED|Overall Study||7
3378751|NCT00774306|4112857|FG000|COMPLETED|Overall Study||6
3378752|NCT00774306|4112858|FG001|COMPLETED|Overall Study||3
3378753|NCT00774306|4112859|FG002|COMPLETED|Overall Study||8
3378754|NCT00774306|4112860|FG003|COMPLETED|Overall Study||2
3378755|NCT00774306|4112857|FG000|NOT COMPLETED|Overall Study||18
3378756|NCT00774306|4112858|FG001|NOT COMPLETED|Overall Study||2
3378757|NCT00774306|4112859|FG002|NOT COMPLETED|Overall Study||8
3378758|NCT00774306|4112860|FG003|NOT COMPLETED|Overall Study||5
3378759|NCT00771602|4112873|FG000|STARTED|Overall Study||1
3378760|NCT00771602|4112874|FG001|STARTED|Overall Study||0
3378761|NCT00771602|4112875|FG002|STARTED|Overall Study||0
3378762|NCT00771602|4112873|FG000|COMPLETED|Overall Study||1
3378763|NCT00771602|4112874|FG001|COMPLETED|Overall Study||0
3378764|NCT00771602|4112875|FG002|COMPLETED|Overall Study||0
3378765|NCT00771602|4112873|FG000|NOT COMPLETED|Overall Study||0
3378766|NCT00771602|4112874|FG001|NOT COMPLETED|Overall Study||0
3378767|NCT00771602|4112875|FG002|NOT COMPLETED|Overall Study||0
3378768|NCT00779038|4112883|FG000|STARTED|Overall Study||13
3378769|NCT00779038|4112883|FG000|COMPLETED|Overall Study||0
3378770|NCT00779038|4112883|FG000|NOT COMPLETED|Overall Study||13
3378771|NCT00780455|4112889|FG000|STARTED|Overall Study||2
3378772|NCT00780455|4112890|FG001|STARTED|Overall Study||2
3378773|NCT00780455|4112889|FG000|COMPLETED|Overall Study||2
3378774|NCT00780455|4112890|FG001|COMPLETED|Overall Study||2
3378775|NCT00780455|4112889|FG000|NOT COMPLETED|Overall Study||0
3378776|NCT00780455|4112890|FG001|NOT COMPLETED|Overall Study||0
3378777|NCT00776100|4112898|FG000|STARTED|Overall Study||1
3378778|NCT00776100|4112899|FG001|STARTED|Overall Study||1
3378779|NCT00776100|4112898|FG000|COMPLETED|Overall Study||0
3378780|NCT00776100|4112899|FG001|COMPLETED|Overall Study||1
3378781|NCT00776100|4112898|FG000|NOT COMPLETED|Overall Study||1
3378782|NCT00776100|4112899|FG001|NOT COMPLETED|Overall Study||0
3378783|NCT00771316|4112907|FG000|STARTED|Overall Study||4
3378784|NCT00771316|4112908|FG001|STARTED|Overall Study||2
3378785|NCT00771316|4112907|FG000|COMPLETED|Overall Study||2
3378786|NCT00771316|4112908|FG001|COMPLETED|Overall Study||1
3378787|NCT00771316|4112907|FG000|NOT COMPLETED|Overall Study||2
3378788|NCT00771316|4112908|FG001|NOT COMPLETED|Overall Study||1
3378789|NCT00780481|4112914|FG000|STARTED|Overall Study||13
3378790|NCT00780481|4112914|FG000|COMPLETED|Overall Study||13
3378791|NCT00780481|4112914|FG000|NOT COMPLETED|Overall Study||0
3378792|NCT00769652|4112920|FG000|STARTED|Overall Study||6
3378793|NCT00769652|4112921|FG001|STARTED|Overall Study||1
3378794|NCT00769652|4112920|FG000|COMPLETED|Overall Study||6
3378795|NCT00769652|4112921|FG001|COMPLETED|Overall Study||1
3378796|NCT00769652|4112920|FG000|NOT COMPLETED|Overall Study||0
3378797|NCT00769652|4112921|FG001|NOT COMPLETED|Overall Study||0
3378798|NCT00768040|4112929|FG000|STARTED|Overall Study|"Started indicates randomized, safety and full analysis set."|20
3378799|NCT00768040|4112930|FG001|STARTED|Overall Study||19
3378800|NCT00768040|4112929|FG000|COMPLETED|Overall Study||16
3378801|NCT00768040|4112930|FG001|COMPLETED|Overall Study||16
3378802|NCT00768040|4112929|FG000|NOT COMPLETED|Overall Study||4
3378803|NCT00768040|4112930|FG001|NOT COMPLETED|Overall Study||3
3378804|NCT00776555|4112938|FG000|STARTED|Overall Study||3
3378805|NCT00776555|4112939|FG001|STARTED|Overall Study||0
3378806|NCT00776555|4112938|FG000|COMPLETED|Overall Study||0
3378807|NCT00776555|4112939|FG001|COMPLETED|Overall Study||0
3378808|NCT00776555|4112938|FG000|NOT COMPLETED|Overall Study||3
3378809|NCT00776555|4112939|FG001|NOT COMPLETED|Overall Study||0
3378810|NCT00775190|4112947|FG000|STARTED|Overall Study||7
3378811|NCT00775190|4112948|FG001|STARTED|Overall Study||5
3378812|NCT00775190|4112947|FG000|COMPLETED|Overall Study||3
3378813|NCT00775190|4112948|FG001|COMPLETED|Overall Study||0
3378814|NCT00775190|4112947|FG000|NOT COMPLETED|Overall Study||4
3378815|NCT00775190|4112948|FG001|NOT COMPLETED|Overall Study||5
3378816|NCT00755261|4112954|FG000|STARTED|Overall Study||6
3378817|NCT00755261|4112954|FG000|COMPLETED|Overall Study||4
3378818|NCT00755261|4112954|FG000|NOT COMPLETED|Overall Study||2
3378819|NCT00762723|4112961|FG000|STARTED|Overall Study||5
3378820|NCT00762723|4112962|FG001|STARTED|Overall Study||11
3378821|NCT00762723|4112963|FG002|STARTED|Overall Study||3
3378822|NCT00762723|4112961|FG000|COMPLETED|Overall Study||0
3378823|NCT00762723|4112962|FG001|COMPLETED|Overall Study||6
3378824|NCT00762723|4112963|FG002|COMPLETED|Overall Study||0
3378825|NCT00762723|4112961|FG000|NOT COMPLETED|Overall Study||5
3378826|NCT00762723|4112962|FG001|NOT COMPLETED|Overall Study||5
3378827|NCT00762723|4112963|FG002|NOT COMPLETED|Overall Study||3
3378828|NCT00770965|4112975|FG000|STARTED|Safety Set||2
3378829|NCT00770965|4112976|FG001|STARTED|Safety Set||4
3378830|NCT00770965|4112977|FG002|STARTED|Safety Set||4
3378831|NCT00770965|4112978|FG003|STARTED|Safety Set||5
3378832|NCT00770965|4112975|FG000|COMPLETED|Safety Set||2
3378833|NCT00770965|4112976|FG001|COMPLETED|Safety Set||4
3378834|NCT00770965|4112977|FG002|COMPLETED|Safety Set||3
3378835|NCT00770965|4112978|FG003|COMPLETED|Safety Set||4
3378836|NCT00770965|4112975|FG000|NOT COMPLETED|Safety Set||0
3378837|NCT00770965|4112976|FG001|NOT COMPLETED|Safety Set||0
3378838|NCT00770965|4112977|FG002|NOT COMPLETED|Safety Set||1
3378839|NCT00770965|4112978|FG003|NOT COMPLETED|Safety Set||1
3378840|NCT00770965|4112975|FG000|STARTED|Excluded Set||18
3378841|NCT00770965|4112976|FG001|STARTED|Excluded Set||16
3378842|NCT00770965|4112977|FG002|STARTED|Excluded Set||16
3378843|NCT00770965|4112978|FG003|STARTED|Excluded Set||15
3378844|NCT00770965|4112975|FG000|COMPLETED|Excluded Set||3
3378845|NCT00770965|4112976|FG001|COMPLETED|Excluded Set||3
3378846|NCT00770965|4112977|FG002|COMPLETED|Excluded Set||2
3378847|NCT00770965|4112978|FG003|COMPLETED|Excluded Set||2
3378848|NCT00770965|4112975|FG000|NOT COMPLETED|Excluded Set||15
3378849|NCT00770965|4112976|FG001|NOT COMPLETED|Excluded Set||13
3378850|NCT00770965|4112977|FG002|NOT COMPLETED|Excluded Set||14
3378851|NCT00770965|4112978|FG003|NOT COMPLETED|Excluded Set||13
3378852|NCT00769002|4112992|FG000|STARTED|Overall Study||9
3378853|NCT00769002|4112993|FG001|STARTED|Overall Study||9
3378854|NCT00769002|4112992|FG000|COMPLETED|Overall Study||0
3378855|NCT00769002|4112993|FG001|COMPLETED|Overall Study||0
3378856|NCT00769002|4112992|FG000|NOT COMPLETED|Overall Study||9
3378857|NCT00769002|4112993|FG001|NOT COMPLETED|Overall Study||9
3378858|NCT00766636|4113000|FG000|STARTED|Overall Study||3
3378859|NCT00766636|4113001|FG001|STARTED|Overall Study||2
3378860|NCT00766636|4113000|FG000|COMPLETED|Overall Study|Number that completed pre- and post-operative therapy as well as surgery.|0
3378861|NCT00766636|4113001|FG001|COMPLETED|Overall Study||0
3378862|NCT00766636|4113000|FG000|NOT COMPLETED|Overall Study||3
3378863|NCT00766636|4113001|FG001|NOT COMPLETED|Overall Study||2
3378864|NCT00768248|4113009|FG000|STARTED|Overall Study||1
3378865|NCT00768248|4113010|FG001|STARTED|Overall Study||1
3378866|NCT00768248|4113009|FG000|COMPLETED|Overall Study||0
3378867|NCT00768248|4113010|FG001|COMPLETED|Overall Study||0
3378868|NCT00768248|4113009|FG000|NOT COMPLETED|Overall Study||1
3378869|NCT00768248|4113010|FG001|NOT COMPLETED|Overall Study||1
3378870|NCT00765765|4113016|FG000|STARTED|Overall Study||6
3378871|NCT00765765|4113016|FG000|COMPLETED|Overall Study||6
3378872|NCT00765765|4113016|FG000|NOT COMPLETED|Overall Study||0
3378873|NCT00764699|4113020|FG000|STARTED|Overall Study||3
3378874|NCT00764699|4113020|FG000|COMPLETED|Overall Study||0
3378875|NCT00764699|4113020|FG000|NOT COMPLETED|Overall Study||3
3378876|NCT00759577|4113024|FG000|STARTED|Overall Study||36
3378877|NCT00759577|4113024|FG000|COMPLETED|Overall Study||36
3378878|NCT00759577|4113024|FG000|NOT COMPLETED|Overall Study||0
3378879|NCT00763009|4113028|FG000|STARTED|Overall Study||8
3378880|NCT00763009|4113028|FG000|COMPLETED|Overall Study||7
3378881|NCT00763009|4113028|FG000|NOT COMPLETED|Overall Study||1
3378882|NCT00761176|4113035|FG000|STARTED|Overall Study||4
3378883|NCT00761176|4113036|FG001|STARTED|Overall Study||4
3378884|NCT00761176|4113035|FG000|COMPLETED|Overall Study||2
3378885|NCT00761176|4113036|FG001|COMPLETED|Overall Study||3
3378886|NCT00761176|4113035|FG000|NOT COMPLETED|Overall Study||2
3378887|NCT00761176|4113036|FG001|NOT COMPLETED|Overall Study||1
3378888|NCT00749476|4113042|FG000|STARTED|Overall Study||1
3378889|NCT00749476|4113042|FG000|COMPLETED|Overall Study||1
3378890|NCT00749476|4113042|FG000|NOT COMPLETED|Overall Study||0
3378891|NCT00760461|4113046|FG000|STARTED|Overall Study||44
3378892|NCT00760461|4113046|FG000|COMPLETED|Overall Study||0
3378893|NCT00760461|4113046|FG000|NOT COMPLETED|Overall Study||44
3378894|NCT00749658|4113052|FG000|STARTED|Overall Study||60
3378895|NCT00749658|4113053|FG001|STARTED|Overall Study||61
3378896|NCT00749658|4113052|FG000|COMPLETED|Overall Study||60
3378897|NCT00749658|4113053|FG001|COMPLETED|Overall Study||61
3378898|NCT00749658|4113052|FG000|NOT COMPLETED|Overall Study||0
3378899|NCT00749658|4113053|FG001|NOT COMPLETED|Overall Study||0
3378900|NCT00754793|4113061|FG000|STARTED|Overall Study||1
3378901|NCT00754793|4113062|FG001|STARTED|Overall Study||2
3378902|NCT00754793|4113061|FG000|COMPLETED|Overall Study||1
3378903|NCT00754793|4113062|FG001|COMPLETED|Overall Study||1
3378904|NCT00754793|4113061|FG000|NOT COMPLETED|Overall Study||0
3378905|NCT00754793|4113062|FG001|NOT COMPLETED|Overall Study||1
3378906|NCT00754052|4113070|FG000|STARTED|Overall Study||5
3378907|NCT00754052|4113071|FG001|STARTED|Overall Study||3
3378908|NCT00754052|4113070|FG000|COMPLETED|Overall Study||0
3378909|NCT00754052|4113071|FG001|COMPLETED|Overall Study||0
3378910|NCT00754052|4113070|FG000|NOT COMPLETED|Overall Study||5
3378911|NCT00754052|4113071|FG001|NOT COMPLETED|Overall Study||3
3378912|NCT00750555|4113077|FG000|STARTED|Overall Study||0
3378913|NCT00750555|4113077|FG000|COMPLETED|Overall Study||0
3378914|NCT00750555|4113077|FG000|NOT COMPLETED|Overall Study||0
3378915|NCT00754767|4113084|FG000|STARTED|Overall Study||2
3378916|NCT00754767|4113085|FG001|STARTED|Overall Study||0
3378917|NCT00754767|4113084|FG000|COMPLETED|Overall Study||2
3378918|NCT00754767|4113085|FG001|COMPLETED|Overall Study||0
3378919|NCT00754767|4113084|FG000|NOT COMPLETED|Overall Study||0
3378920|NCT00754767|4113085|FG001|NOT COMPLETED|Overall Study||0
3378921|NCT00750204|4113093|FG000|STARTED|Overall Study||1
3378922|NCT00750204|4113094|FG001|STARTED|Overall Study||1
3378923|NCT00750204|4113093|FG000|COMPLETED|Overall Study||0
3378924|NCT00750204|4113094|FG001|COMPLETED|Overall Study||0
3378925|NCT00750204|4113093|FG000|NOT COMPLETED|Overall Study||1
3378926|NCT00750204|4113094|FG001|NOT COMPLETED|Overall Study||1
3378927|NCT00748579|4113102|FG000|STARTED|Overall Study||2
3378928|NCT00748579|4113103|FG001|STARTED|Overall Study||0
3378929|NCT00748579|4113102|FG000|COMPLETED|Overall Study||2
3378930|NCT00748579|4113103|FG001|COMPLETED|Overall Study||0
3378931|NCT00748579|4113102|FG000|NOT COMPLETED|Overall Study||0
3378932|NCT00748579|4113103|FG001|NOT COMPLETED|Overall Study||0
3378933|NCT00748085|4113109|FG000|STARTED|Overall Study||5
3378934|NCT00748085|4113109|FG000|COMPLETED|Overall Study|No analysis -study terminated for business reasons.|5
3378935|NCT00748085|4113109|FG000|NOT COMPLETED|Overall Study||0
3378936|NCT00752986|4113116|FG000|STARTED|Overall Study||16
3378937|NCT00752986|4113117|FG001|STARTED|Overall Study||12
3378938|NCT00752986|4113118|FG002|STARTED|Overall Study||11
3378939|NCT00752986|4113116|FG000|COMPLETED|Overall Study||11
3378940|NCT00752986|4113117|FG001|COMPLETED|Overall Study||11
3378941|NCT00752986|4113118|FG002|COMPLETED|Overall Study||9
3378942|NCT00752986|4113116|FG000|NOT COMPLETED|Overall Study||5
3378943|NCT00752986|4113117|FG001|NOT COMPLETED|Overall Study||1
3378944|NCT00752986|4113118|FG002|NOT COMPLETED|Overall Study||2
3378945|NCT00751335|4113128|FG000|STARTED|Overall Study||0
3378946|NCT00751335|4113129|FG001|STARTED|Overall Study||0
3378947|NCT00751335|4113128|FG000|COMPLETED|Overall Study||0
3378948|NCT00751335|4113129|FG001|COMPLETED|Overall Study||0
3378949|NCT00751335|4113128|FG000|NOT COMPLETED|Overall Study||0
3378950|NCT00751335|4113129|FG001|NOT COMPLETED|Overall Study||0
3378951|NCT00746239|4113135|FG000|STARTED|Overall Study||11
3378952|NCT00746239|4113135|FG000|COMPLETED|Overall Study|11 subjects total were enrolled - 6 withdrew from study and 5 competed|5
3378953|NCT00746239|4113135|FG000|NOT COMPLETED|Overall Study||6
3378954|NCT00754013|4113141|FG000|STARTED|Overall Study||4
3378955|NCT00754013|4113142|FG001|STARTED|Overall Study||5
3378956|NCT00754013|4113141|FG000|COMPLETED|Overall Study||0
3378957|NCT00754013|4113142|FG001|COMPLETED|Overall Study||0
3378958|NCT00754013|4113141|FG000|NOT COMPLETED|Overall Study||4
3378959|NCT00754013|4113142|FG001|NOT COMPLETED|Overall Study||5
3378960|NCT00735553|4113151|FG000|STARTED|Overall Study||77
3378961|NCT00735553|4113151|FG000|COMPLETED|Overall Study||0
3378962|NCT00735553|4113151|FG000|NOT COMPLETED|Overall Study||77
3378963|NCT00751933|4113159|FG000|STARTED|Overall Study||0
3378964|NCT00751933|4113160|FG001|STARTED|Overall Study||1
3378965|NCT00751933|4113161|FG002|STARTED|Overall Study||1
3378966|NCT00751933|4113162|FG003|STARTED|Overall Study||1
3378967|NCT00751933|4113159|FG000|COMPLETED|Overall Study||0
3378968|NCT00751933|4113160|FG001|COMPLETED|Overall Study||0
3378969|NCT00751933|4113161|FG002|COMPLETED|Overall Study||0
3378970|NCT00751933|4113162|FG003|COMPLETED|Overall Study||0
3378971|NCT00751933|4113159|FG000|NOT COMPLETED|Overall Study||0
3378972|NCT00751933|4113160|FG001|NOT COMPLETED|Overall Study||1
3378973|NCT00751933|4113161|FG002|NOT COMPLETED|Overall Study||1
3378974|NCT00751933|4113162|FG003|NOT COMPLETED|Overall Study||1
3378975|NCT00747916|4113166|FG000|STARTED|Overall Study||3
3378976|NCT00747916|4113166|FG000|COMPLETED|Overall Study||3
3378977|NCT00747916|4113166|FG000|NOT COMPLETED|Overall Study||0
3378978|NCT00745030|4113172|FG000|STARTED|Overall Study||1
3378979|NCT00745030|4113173|FG001|STARTED|Overall Study||2
3378980|NCT00745030|4113172|FG000|COMPLETED|Overall Study||1
3378981|NCT00745030|4113173|FG001|COMPLETED|Overall Study||2
3378982|NCT00745030|4113172|FG000|NOT COMPLETED|Overall Study||0
3378983|NCT00745030|4113173|FG001|NOT COMPLETED|Overall Study||0
3378984|NCT00747461|4113179|FG000|STARTED|Overall Study||5
3378985|NCT00747461|4113179|FG000|COMPLETED|Overall Study||0
3378986|NCT00747461|4113179|FG000|NOT COMPLETED|Overall Study||5
3378987|NCT00746018|4113184|FG000|STARTED|Overall Study||39
3378988|NCT00746018|4113184|FG000|COMPLETED|Overall Study||39
3378989|NCT00746018|4113184|FG000|NOT COMPLETED|Overall Study||0
3378990|NCT00746603|4113188|FG000|STARTED|Overall Study||3
3378991|NCT00746603|4113188|FG000|COMPLETED|Overall Study||3
3378992|NCT00746603|4113188|FG000|NOT COMPLETED|Overall Study||0
3378993|NCT00736385|4113194|FG000|STARTED|Overall Study||4
3378994|NCT00736385|4113195|FG001|STARTED|Overall Study||5
3378995|NCT00736385|4113194|FG000|COMPLETED|Overall Study||2
3378996|NCT00736385|4113195|FG001|COMPLETED|Overall Study||2
3378997|NCT00736385|4113194|FG000|NOT COMPLETED|Overall Study||2
3378998|NCT00736385|4113195|FG001|NOT COMPLETED|Overall Study||3
3378999|NCT00738972|4113205|FG000|STARTED|Overall Study||3
3379000|NCT00738972|4113206|FG001|STARTED|Overall Study||3
3379001|NCT00738972|4113207|FG002|STARTED|Overall Study||3
3379002|NCT00738972|4113208|FG003|STARTED|Overall Study||3
3379003|NCT00738972|4113205|FG000|COMPLETED|Overall Study||3
3379004|NCT00738972|4113206|FG001|COMPLETED|Overall Study||3
3379005|NCT00738972|4113207|FG002|COMPLETED|Overall Study||3
3379006|NCT00738972|4113208|FG003|COMPLETED|Overall Study||2
3379007|NCT00738972|4113205|FG000|NOT COMPLETED|Overall Study||0
3379008|NCT00738972|4113206|FG001|NOT COMPLETED|Overall Study||0
3379009|NCT00738972|4113207|FG002|NOT COMPLETED|Overall Study||0
3379010|NCT00738972|4113208|FG003|NOT COMPLETED|Overall Study||1
3379011|NCT00743197|4113220|FG000|STARTED|Overall Study||1
3379012|NCT00743197|4113221|FG001|STARTED|Overall Study||2
3379013|NCT00743197|4113220|FG000|COMPLETED|Overall Study||0
3379014|NCT00743197|4113221|FG001|COMPLETED|Overall Study||0
3379015|NCT00743197|4113220|FG000|NOT COMPLETED|Overall Study||1
3379016|NCT00743197|4113221|FG001|NOT COMPLETED|Overall Study||2
3379017|NCT00739063|4113227|FG000|STARTED|Overall Study||11
3379018|NCT00739063|4113227|FG000|COMPLETED|Overall Study||3
3379019|NCT00739063|4113227|FG000|NOT COMPLETED|Overall Study||8
3379020|NCT00740597|4113231|FG000|STARTED|Overall Study||1
3379021|NCT00740597|4113231|FG000|COMPLETED|Overall Study||0
3379022|NCT00740597|4113231|FG000|NOT COMPLETED|Overall Study||1
3379023|NCT00737594|4113238|FG000|STARTED|Overall Study||0
3379024|NCT00737594|4113239|FG001|STARTED|Overall Study||0
3379025|NCT00737594|4113240|FG002|STARTED|Overall Study||0
3379026|NCT00737594|4113238|FG000|COMPLETED|Overall Study||0
3379027|NCT00737594|4113239|FG001|COMPLETED|Overall Study||0
3379028|NCT00737594|4113240|FG002|COMPLETED|Overall Study||0
3379029|NCT00737594|4113238|FG000|NOT COMPLETED|Overall Study||0
3379030|NCT00737594|4113239|FG001|NOT COMPLETED|Overall Study||0
3379031|NCT00737594|4113240|FG002|NOT COMPLETED|Overall Study||0
3379032|NCT00737282|4113250|FG000|STARTED|Overall Study||175
3379033|NCT00737282|4113250|FG000|COMPLETED|Overall Study||0
3379034|NCT00737282|4113250|FG000|NOT COMPLETED|Overall Study||175
3379035|NCT00739882|4113258|FG000|STARTED|Double-blind Period||51
3379036|NCT00739882|4113259|FG001|STARTED|Double-blind Period||25
3379037|NCT00739882|4113258|FG000|COMPLETED|Double-blind Period||32
3379038|NCT00739882|4113259|FG001|COMPLETED|Double-blind Period||14
3379039|NCT00739882|4113258|FG000|NOT COMPLETED|Double-blind Period||19
3379040|NCT00739882|4113259|FG001|NOT COMPLETED|Double-blind Period||11
3379041|NCT00739882|4113258|FG000|STARTED|Open-label Period||17
3379042|NCT00739882|4113259|FG001|STARTED|Open-label Period||14
3379043|NCT00739882|4113258|FG000|COMPLETED|Open-label Period||7
3379044|NCT00739882|4113259|FG001|COMPLETED|Open-label Period||9
3379045|NCT00739882|4113258|FG000|NOT COMPLETED|Open-label Period||10
3379046|NCT00739882|4113259|FG001|NOT COMPLETED|Open-label Period||5
3379047|NCT00739024|4113269|FG000|STARTED|Overall Study||7
3379048|NCT00739024|4113270|FG001|STARTED|Overall Study||6
3379049|NCT00739024|4113269|FG000|COMPLETED|Overall Study||7
3379050|NCT00739024|4113270|FG001|COMPLETED|Overall Study||6
3379051|NCT00739024|4113269|FG000|NOT COMPLETED|Overall Study||0
3379052|NCT00739024|4113270|FG001|NOT COMPLETED|Overall Study||0
3379053|NCT00731770|4113278|FG000|STARTED|Overall Study||5
3379054|NCT00731770|4113279|FG001|STARTED|Overall Study||5
3379055|NCT00731770|4113278|FG000|COMPLETED|Overall Study||5
3379056|NCT00731770|4113279|FG001|COMPLETED|Overall Study||5
3379057|NCT00731770|4113278|FG000|NOT COMPLETED|Overall Study||0
3379058|NCT00731770|4113279|FG001|NOT COMPLETED|Overall Study||0
3379059|NCT00735254|4113291|FG000|STARTED|Overall Study||1
3379060|NCT00735254|4113292|FG001|STARTED|Overall Study||1
3379061|NCT00735254|4113293|FG002|STARTED|Overall Study||1
3379062|NCT00735254|4113294|FG003|STARTED|Overall Study||0
3379063|NCT00735254|4113291|FG000|COMPLETED|Overall Study||0
3379064|NCT00735254|4113292|FG001|COMPLETED|Overall Study||0
3379065|NCT00735254|4113293|FG002|COMPLETED|Overall Study||0
3379066|NCT00735254|4113294|FG003|COMPLETED|Overall Study||0
3379067|NCT00735254|4113291|FG000|NOT COMPLETED|Overall Study||1
3379068|NCT00735254|4113292|FG001|NOT COMPLETED|Overall Study||1
3379069|NCT00735254|4113293|FG002|NOT COMPLETED|Overall Study||1
3379070|NCT00735254|4113294|FG003|NOT COMPLETED|Overall Study||0
3379071|NCT00729365|4113307|FG000|STARTED|Overall Study||33
3379072|NCT00729365|4113308|FG001|STARTED|Overall Study||6
3379073|NCT00729365|4113309|FG002|STARTED|Overall Study||7
3379074|NCT00729365|4113307|FG000|COMPLETED|Overall Study|Study terminated|0
3379075|NCT00729365|4113308|FG001|COMPLETED|Overall Study|Study Terminated|0
3379076|NCT00729365|4113309|FG002|COMPLETED|Overall Study|Study terminated|0
3379077|NCT00729365|4113307|FG000|NOT COMPLETED|Overall Study||33
3379078|NCT00729365|4113308|FG001|NOT COMPLETED|Overall Study||6
3379079|NCT00729365|4113309|FG002|NOT COMPLETED|Overall Study||7
3379080|NCT00732680|4113319|FG000|STARTED|Overall Study||9
3379081|NCT00732680|4113319|FG000|COMPLETED|Overall Study||9
3379082|NCT00732680|4113319|FG000|NOT COMPLETED|Overall Study||0
3379083|NCT00726180|4113323|FG000|STARTED|Overall Study||1
3379084|NCT00726180|4113323|FG000|COMPLETED|Overall Study||1
3379085|NCT00726180|4113323|FG000|NOT COMPLETED|Overall Study||0
3379086|NCT00724282|4113327|FG000|STARTED|Overall Study||20
3379087|NCT00724282|4113327|FG000|COMPLETED|Overall Study||16
3379088|NCT00724282|4113327|FG000|NOT COMPLETED|Overall Study||4
3379089|NCT00730886|4113333|FG000|STARTED|Overall Study||2
3379090|NCT00730886|4113334|FG001|STARTED|Overall Study|no subjects enrolled in this arm. Study enrollment terminated early.|0
3379091|NCT00730886|4113333|FG000|COMPLETED|Overall Study||0
3379092|NCT00730886|4113334|FG001|COMPLETED|Overall Study|no subjects enrolled in this arm. Study enrollment terminated early.|0
3379093|NCT00730886|4113333|FG000|NOT COMPLETED|Overall Study||2
3379094|NCT00730886|4113334|FG001|NOT COMPLETED|Overall Study||0
3379095|NCT00728845|4113342|FG000|STARTED|Overall Study||8
3379096|NCT00728845|4113343|FG001|STARTED|Overall Study||0
3379097|NCT00728845|4113342|FG000|COMPLETED|Overall Study||8
3379098|NCT00728845|4113343|FG001|COMPLETED|Overall Study||0
3379099|NCT00728845|4113342|FG000|NOT COMPLETED|Overall Study||0
3379100|NCT00728845|4113343|FG001|NOT COMPLETED|Overall Study||0
3379101|NCT00726830|4113351|FG000|STARTED|Overall Study||1
3379102|NCT00726830|4113352|FG001|STARTED|Overall Study||0
3379103|NCT00726830|4113351|FG000|COMPLETED|Overall Study||1
3379104|NCT00726830|4113352|FG001|COMPLETED|Overall Study||0
3379105|NCT00726830|4113351|FG000|NOT COMPLETED|Overall Study||0
3379106|NCT00726830|4113352|FG001|NOT COMPLETED|Overall Study||0
3379107|NCT00726037|4113358|FG000|STARTED|Overall Study||7
3379108|NCT00726037|4113358|FG000|COMPLETED|Overall Study||7
3379109|NCT00726037|4113358|FG000|NOT COMPLETED|Overall Study||0
3379110|NCT00729560|4113362|FG000|STARTED|Overall Study|Arm assignment can not be determined as study was ended prior to unblinding and no key found.|8
3379111|NCT00729560|4113362|FG000|COMPLETED|Overall Study||5
3379112|NCT00729560|4113362|FG000|NOT COMPLETED|Overall Study||3
3379113|NCT00716807|4113370|FG000|STARTED|Overall Study||8
3379114|NCT00716807|4113371|FG001|STARTED|Overall Study||5
3379115|NCT00716807|4113372|FG002|STARTED|Overall Study||18
3379116|NCT00716807|4113373|FG003|STARTED|Overall Study||15
3379117|NCT00716807|4113370|FG000|COMPLETED|Overall Study||8
3379118|NCT00716807|4113371|FG001|COMPLETED|Overall Study||5
3379119|NCT00716807|4113372|FG002|COMPLETED|Overall Study||18
3379120|NCT00716807|4113373|FG003|COMPLETED|Overall Study||15
3379121|NCT00716807|4113370|FG000|NOT COMPLETED|Overall Study||0
3379122|NCT00716807|4113371|FG001|NOT COMPLETED|Overall Study||0
3379123|NCT00716807|4113372|FG002|NOT COMPLETED|Overall Study||0
3379124|NCT00716807|4113373|FG003|NOT COMPLETED|Overall Study||0
3379125|NCT00714948|4113383|FG000|STARTED|Overall Study||2
3379126|NCT00714948|4113383|FG000|COMPLETED|Overall Study||0
3379127|NCT00714948|4113383|FG000|NOT COMPLETED|Overall Study||2
3379128|NCT00720343|4113387|FG000|STARTED|Overall Study||54
3379129|NCT00720343|4113387|FG000|COMPLETED|Overall Study|3 removed by physician. 3 unable to be determined; Columbia will never have access to this data.|48
3379130|NCT00720343|4113387|FG000|NOT COMPLETED|Overall Study||6
3379131|NCT00719914|4113395|FG000|STARTED|Overall Study||10
3379132|NCT00719914|4113396|FG001|STARTED|Overall Study||7
3379133|NCT00719914|4113395|FG000|COMPLETED|Overall Study||10
3379134|NCT00719914|4113396|FG001|COMPLETED|Overall Study||7
3379135|NCT00719914|4113395|FG000|NOT COMPLETED|Overall Study||0
3379136|NCT00719914|4113396|FG001|NOT COMPLETED|Overall Study||0
3379137|NCT00718640|4113402|FG000|STARTED|Overall Study||10
3379138|NCT00718640|4113402|FG000|COMPLETED|Overall Study||3
3379139|NCT00718640|4113402|FG000|NOT COMPLETED|Overall Study||7
3379140|NCT00720083|4113408|FG000|STARTED|Overall Study||17
3379141|NCT00720083|4113409|FG001|STARTED|Overall Study||15
3379142|NCT00720083|4113408|FG000|COMPLETED|Overall Study|Subjects with data for the primary analysis are considered to have completed the study.|16
3379143|NCT00720083|4113409|FG001|COMPLETED|Overall Study||13
3379144|NCT00720083|4113408|FG000|NOT COMPLETED|Overall Study||1
3379145|NCT00720083|4113409|FG001|NOT COMPLETED|Overall Study||2
3379146|NCT00717275|4113415|FG000|STARTED|Overall Study||3
3379147|NCT00717275|4113415|FG000|COMPLETED|Overall Study||0
3379148|NCT00717275|4113415|FG000|NOT COMPLETED|Overall Study||3
3379149|NCT00708734|4113419|FG000|STARTED|Overall Study|94 subjects were screened, 45 did not meet criteria, and 39 declined participation after screening.|10
3379150|NCT00708734|4113419|FG000|COMPLETED|Overall Study|Ten subjects enrolled, three completed the intervention and all follow up sessions.|3
3379151|NCT00708734|4113419|FG000|NOT COMPLETED|Overall Study||7
3379152|NCT00711087|4113425|FG000|STARTED|Overall Study||1
3379153|NCT00711087|4113426|FG001|STARTED|Overall Study||0
3379154|NCT00711087|4113425|FG000|COMPLETED|Overall Study||0
3379155|NCT00711087|4113426|FG001|COMPLETED|Overall Study||0
3379156|NCT00711087|4113425|FG000|NOT COMPLETED|Overall Study||1
3379157|NCT00711087|4113426|FG001|NOT COMPLETED|Overall Study||0
3379158|NCT00706797|4113434|FG000|STARTED|Overall Study||70
3379159|NCT00706797|4113435|FG001|STARTED|Overall Study||71
3379160|NCT00706797|4113434|FG000|Safety Population|Overall Study|Safety population=all randomly assigned subjects who had at least 1 dose of study treatment.|63
3379161|NCT00706797|4113435|FG001|Safety Population|Overall Study||71
3379162|NCT00706797|4113434|FG000|COMPLETED|Overall Study||1
3379163|NCT00706797|4113435|FG001|COMPLETED|Overall Study||0
3379164|NCT00706797|4113434|FG000|NOT COMPLETED|Overall Study||69
3379165|NCT00706797|4113435|FG001|NOT COMPLETED|Overall Study||71
3379166|NCT00713596|4113444|FG000|STARTED|Overall Study||9
3379167|NCT00713596|4113445|FG001|STARTED|Overall Study||8
3379168|NCT00713596|4113446|FG002|STARTED|Overall Study||8
3379169|NCT00713596|4113444|FG000|COMPLETED|Overall Study||7
3379170|NCT00713596|4113445|FG001|COMPLETED|Overall Study||5
3379171|NCT00713596|4113446|FG002|COMPLETED|Overall Study||6
3379172|NCT00713596|4113444|FG000|NOT COMPLETED|Overall Study||2
3379173|NCT00713596|4113445|FG001|NOT COMPLETED|Overall Study||3
3379174|NCT00713596|4113446|FG002|NOT COMPLETED|Overall Study||2
3379175|NCT00703885|4113454|FG000|STARTED|Overall Study||16
3379176|NCT00703885|4113454|FG000|COMPLETED|Overall Study||16
3379177|NCT00703885|4113454|FG000|NOT COMPLETED|Overall Study||0
3379178|NCT00703092|4113459|FG000|STARTED|Overall Study||2
3379179|NCT00703092|4113459|FG000|COMPLETED|Overall Study||0
3379180|NCT00703092|4113459|FG000|NOT COMPLETED|Overall Study||2
3379181|NCT00713258|4113465|FG000|STARTED|Overall Study||41
3379182|NCT00713258|4113466|FG001|STARTED|Overall Study||34
3379183|NCT00713258|4113465|FG000|COMPLETED|Overall Study||36
3379184|NCT00713258|4113466|FG001|COMPLETED|Overall Study||28
3379185|NCT00713258|4113465|FG000|NOT COMPLETED|Overall Study||5
3379186|NCT00713258|4113466|FG001|NOT COMPLETED|Overall Study||6
3379187|NCT00706329|4113472|FG000|STARTED|Overall Study||25
3379188|NCT00706329|4113472|FG000|COMPLETED|Overall Study||25
3379189|NCT00706329|4113472|FG000|NOT COMPLETED|Overall Study||0
3379190|NCT00707434|4113476|FG000|STARTED|Overall Study||6
3379191|NCT00707434|4113476|FG000|COMPLETED|Overall Study||5
3379192|NCT00707434|4113476|FG000|NOT COMPLETED|Overall Study||1
3379193|NCT00707161|4113480|FG000|STARTED|Overall Study|3 deceased (1-Huntsman Cancer Institute, 2- LDS Hospital).|6
3379194|NCT00707161|4113480|FG000|COMPLETED|Overall Study||0
3379195|NCT00707161|4113480|FG000|NOT COMPLETED|Overall Study||6
3379196|NCT00704496|4113486|FG000|STARTED|Overall Study||0
3379197|NCT00704496|4113487|FG001|STARTED|Overall Study||0
3379198|NCT00704496|4113486|FG000|COMPLETED|Overall Study||0
3379199|NCT00704496|4113487|FG001|COMPLETED|Overall Study||0
3379200|NCT00704496|4113486|FG000|NOT COMPLETED|Overall Study||0
3379201|NCT00704496|4113487|FG001|NOT COMPLETED|Overall Study||0
3379202|NCT00708916|4113493|FG000|STARTED|Overall Study||12
3379203|NCT00708916|4113493|FG000|COMPLETED|Overall Study||8
3379204|NCT00708916|4113493|FG000|NOT COMPLETED|Overall Study||4
3379205|NCT00700778|4113498|FG000|STARTED|Overall Study||2
3379206|NCT00700778|4113498|FG000|COMPLETED|Overall Study||0
3379207|NCT00700778|4113498|FG000|NOT COMPLETED|Overall Study||2
3379208|NCT00699842|4113505|FG000|STARTED|Overall Study||3
3379209|NCT00699842|4113506|FG001|STARTED|Overall Study||5
3379210|NCT00699842|4113507|FG002|STARTED|Overall Study||0
3379211|NCT00699842|4113505|FG000|COMPLETED|Overall Study||3
3379212|NCT00699842|4113506|FG001|COMPLETED|Overall Study||4
3379213|NCT00699842|4113507|FG002|COMPLETED|Overall Study||0
3379214|NCT00699842|4113505|FG000|NOT COMPLETED|Overall Study||0
3379215|NCT00699842|4113506|FG001|NOT COMPLETED|Overall Study||1
3379216|NCT00699842|4113507|FG002|NOT COMPLETED|Overall Study||0
3379217|NCT00702962|4113517|FG000|STARTED|Overall Study|One initiated treatment. Milestones not achieved due to premature closing due to low accrual.|1
3379218|NCT00702962|4113518|FG001|STARTED|Overall Study|Three treated. Milestone not met as Phase I closed prematurely as NCI research established the MTD.|3
3379219|NCT00702962|4113517|FG000|COMPLETED|Overall Study|The one participant off treatment after 2 doses due to concurrent health disorder.|0
3379220|NCT00702962|4113518|FG001|COMPLETED|Overall Study|Two completed all required cycles. One experienced progressive disease after 2 cycles|2
3379221|NCT00702962|4113517|FG000|NOT COMPLETED|Overall Study||1
3379222|NCT00702962|4113518|FG001|NOT COMPLETED|Overall Study||1
3379223|NCT00703534|4113528|FG000|STARTED|Overall Study||235
3379224|NCT00703534|4113529|FG001|STARTED|Overall Study||243
3379225|NCT00703534|4113528|FG000|COMPLETED|Overall Study||205
3379226|NCT00703534|4113529|FG001|COMPLETED|Overall Study||218
3379227|NCT00703534|4113528|FG000|NOT COMPLETED|Overall Study||30
3379228|NCT00703534|4113529|FG001|NOT COMPLETED|Overall Study||25
3379229|NCT00698009|4113535|FG000|STARTED|Overall Study||1
3379230|NCT00698009|4113535|FG000|COMPLETED|Overall Study||0
3379231|NCT00698009|4113535|FG000|NOT COMPLETED|Overall Study||1
3379232|NCT00703339|4113539|FG000|STARTED|Overall Study||1
3379233|NCT00703339|4113539|FG000|COMPLETED|Overall Study||1
3379234|NCT00703339|4113539|FG000|NOT COMPLETED|Overall Study||0
3379235|NCT00691444|4113546|FG000|STARTED|Overall Study||0
3379236|NCT00691444|4113547|FG001|STARTED|Overall Study||0
3379237|NCT00691444|4113548|FG002|STARTED|Overall Study||0
3379238|NCT00691444|4113546|FG000|COMPLETED|Overall Study||0
3379239|NCT00691444|4113547|FG001|COMPLETED|Overall Study||0
3379240|NCT00691444|4113548|FG002|COMPLETED|Overall Study||0
3379241|NCT00691444|4113546|FG000|NOT COMPLETED|Overall Study||0
3379242|NCT00691444|4113547|FG001|NOT COMPLETED|Overall Study||0
3379243|NCT00691444|4113548|FG002|NOT COMPLETED|Overall Study||0
3379244|NCT00702702|4113559|FG000|STARTED|Overall Study||56
3379245|NCT00702702|4113559|FG000|COMPLETED|Overall Study||0
3379246|NCT00702702|4113559|FG000|NOT COMPLETED|Overall Study||56
3379247|NCT00693628|4113569|FG000|STARTED|Overall Study|No data is available indicating to which group patients were assigned.|0
3379248|NCT00693628|4113570|FG001|STARTED|Overall Study|No data is available indicating to which group patients were assigned .|0
3379249|NCT00693628|4113569|FG000|COMPLETED|Overall Study|Only 4 patients enrolled in study. No data indicating their group assignment|0
3379250|NCT00693628|4113570|FG001|COMPLETED|Overall Study|Only 4 patients enrolled in study. No data indicating their group assignment.|0
3379251|NCT00693628|4113569|FG000|NOT COMPLETED|Overall Study||0
3379252|NCT00693628|4113570|FG001|NOT COMPLETED|Overall Study||0
3379253|NCT00699413|4113578|FG000|STARTED|Overall Study||4
3379254|NCT00699413|4113579|FG001|STARTED|Overall Study||4
3379255|NCT00699413|4113578|FG000|COMPLETED|Overall Study||0
3379256|NCT00699413|4113579|FG001|COMPLETED|Overall Study||0
3379257|NCT00699413|4113578|FG000|NOT COMPLETED|Overall Study||4
3379258|NCT00699413|4113579|FG001|NOT COMPLETED|Overall Study||4
3379259|NCT00691652|4113585|FG000|STARTED|Overall Study||2
3379260|NCT00691652|4113585|FG000|COMPLETED|Overall Study||1
3379261|NCT00691652|4113585|FG000|NOT COMPLETED|Overall Study||1
3379262|NCT00686972|4113589|FG000|STARTED|Overall Study||51
3379263|NCT00686972|4113589|FG000|COMPLETED|Overall Study||0
3379264|NCT00686972|4113589|FG000|NOT COMPLETED|Overall Study||51
3379265|NCT00693017|4113595|FG000|STARTED|Overall Study||2
3379266|NCT00693017|4113596|FG001|STARTED|Overall Study||2
3379267|NCT00693017|4113595|FG000|COMPLETED|Overall Study||0
3379268|NCT00693017|4113596|FG001|COMPLETED|Overall Study||0
3379269|NCT00693017|4113595|FG000|NOT COMPLETED|Overall Study||2
3379270|NCT00693017|4113596|FG001|NOT COMPLETED|Overall Study||2
3379271|NCT00691574|4113604|FG000|STARTED|Overall Study||0
3379272|NCT00691574|4113605|FG001|STARTED|Overall Study||0
3379273|NCT00691574|4113604|FG000|COMPLETED|Overall Study||0
3379274|NCT00691574|4113605|FG001|COMPLETED|Overall Study||0
3379275|NCT00691574|4113604|FG000|NOT COMPLETED|Overall Study||0
3379276|NCT00691574|4113605|FG001|NOT COMPLETED|Overall Study||0
3379277|NCT00692094|4113615|FG000|STARTED|Overall Study||0
3379278|NCT00692094|4113616|FG001|STARTED|Overall Study||0
3379279|NCT00692094|4113617|FG002|STARTED|Overall Study||0
3379280|NCT00692094|4113618|FG003|STARTED|Overall Study||0
3379281|NCT00692094|4113615|FG000|COMPLETED|Overall Study||0
3379282|NCT00692094|4113616|FG001|COMPLETED|Overall Study||0
3379283|NCT00692094|4113617|FG002|COMPLETED|Overall Study||0
3379284|NCT00692094|4113618|FG003|COMPLETED|Overall Study||0
3379285|NCT00692094|4113615|FG000|NOT COMPLETED|Overall Study||0
3379286|NCT00692094|4113616|FG001|NOT COMPLETED|Overall Study||0
3379287|NCT00692094|4113617|FG002|NOT COMPLETED|Overall Study||0
3379288|NCT00692094|4113618|FG003|NOT COMPLETED|Overall Study||0
3379289|NCT00689884|4113628|FG000|STARTED|Overall Study||7
3379290|NCT00689884|4113628|FG000|COMPLETED|Overall Study||7
3379291|NCT00689884|4113628|FG000|NOT COMPLETED|Overall Study||0
3379292|NCT00692003|4113635|FG000|STARTED|Overall Study||5
3379293|NCT00692003|4113636|FG001|STARTED|Overall Study||1
3379294|NCT00692003|4113635|FG000|COMPLETED|Overall Study||0
3379295|NCT00692003|4113636|FG001|COMPLETED|Overall Study||0
3379296|NCT00692003|4113635|FG000|NOT COMPLETED|Overall Study||5
3379297|NCT00692003|4113636|FG001|NOT COMPLETED|Overall Study||1
3379298|NCT00678288|4113644|FG000|STARTED|Overall Study||10
3379299|NCT00678288|4113645|FG001|STARTED|Overall Study||6
3379300|NCT00678288|4113644|FG000|COMPLETED|Overall Study||0
3379301|NCT00678288|4113645|FG001|COMPLETED|Overall Study||0
3379302|NCT00678288|4113644|FG000|NOT COMPLETED|Overall Study||10
3379303|NCT00678288|4113645|FG001|NOT COMPLETED|Overall Study||6
3379304|NCT00676026|4113651|FG000|STARTED|Overall Study||8
3379305|NCT00676026|4113651|FG000|COMPLETED|Overall Study||8
3379306|NCT00676026|4113651|FG000|NOT COMPLETED|Overall Study||0
3379307|NCT00689052|4113657|FG000|STARTED|Overall Study||31
3379308|NCT00689052|4113658|FG001|STARTED|Overall Study||30
3379309|NCT00689052|4113657|FG000|COMPLETED|Overall Study||0
3379310|NCT00689052|4113658|FG001|COMPLETED|Overall Study||0
3379311|NCT00689052|4113657|FG000|NOT COMPLETED|Overall Study||31
3379312|NCT00689052|4113658|FG001|NOT COMPLETED|Overall Study||30
3379313|NCT00678574|4113668|FG000|STARTED|Overall Study||18
3379314|NCT00678574|4113669|FG001|STARTED|Overall Study||27
3379315|NCT00678574|4113668|FG000|COMPLETED|Overall Study||18
3379316|NCT00678574|4113669|FG001|COMPLETED|Overall Study||27
3379317|NCT00678574|4113668|FG000|NOT COMPLETED|Overall Study||0
3379318|NCT00678574|4113669|FG001|NOT COMPLETED|Overall Study||0
3379319|NCT00683917|4113678|FG000|STARTED|Overall Study||10
3379320|NCT00683917|4113678|FG000|COMPLETED|Overall Study||0
3379321|NCT00683917|4113678|FG000|NOT COMPLETED|Overall Study||10
3379322|NCT00688935|4113686|FG000|STARTED|Overall Study||0
3379323|NCT00688935|4113686|FG000|COMPLETED|Overall Study||0
3379324|NCT00688935|4113686|FG000|NOT COMPLETED|Overall Study||0
3379325|NCT00685880|4113692|FG000|STARTED|Overall Study||0
3379326|NCT00685880|4113693|FG001|STARTED|Overall Study||2
3379327|NCT00685880|4113692|FG000|COMPLETED|Overall Study||0
3379328|NCT00685880|4113693|FG001|COMPLETED|Overall Study||2
3379329|NCT00685880|4113692|FG000|NOT COMPLETED|Overall Study||0
3379330|NCT00685880|4113693|FG001|NOT COMPLETED|Overall Study||0
3379331|NCT00686036|4113701|FG000|STARTED|Overall Study||9
3379332|NCT00686036|4113702|FG001|STARTED|Overall Study||8
3379333|NCT00686036|4113701|FG000|COMPLETED|Overall Study||0
3379334|NCT00686036|4113702|FG001|COMPLETED|Overall Study||2
3379335|NCT00686036|4113701|FG000|NOT COMPLETED|Overall Study||9
3379336|NCT00686036|4113702|FG001|NOT COMPLETED|Overall Study||6
3379337|NCT00681044|4113708|FG000|STARTED|Overall Study||4
3379338|NCT00681044|4113708|FG000|COMPLETED|Overall Study||4
3379339|NCT00681044|4113708|FG000|NOT COMPLETED|Overall Study||0
3379340|NCT00676455|4113712|FG000|STARTED|Overall Study||14
3379341|NCT00676455|4113712|FG000|COMPLETED|Overall Study||14
3379342|NCT00676455|4113712|FG000|NOT COMPLETED|Overall Study||0
3379343|NCT00684255|4113716|FG000|STARTED|Overall Study||1
3379344|NCT00684255|4113716|FG000|COMPLETED|Overall Study||1
3379345|NCT00684255|4113716|FG000|NOT COMPLETED|Overall Study||0
3379346|NCT00683787|4113724|FG000|STARTED|Overall Study||3
3379347|NCT00683787|4113725|FG001|STARTED|Overall Study||3
3379348|NCT00683787|4113726|FG002|STARTED|Overall Study||2
3379349|NCT00683787|4113724|FG000|COMPLETED|Overall Study||0
3379350|NCT00683787|4113725|FG001|COMPLETED|Overall Study||0
3379351|NCT00683787|4113726|FG002|COMPLETED|Overall Study||0
3379352|NCT00683787|4113724|FG000|NOT COMPLETED|Overall Study||3
3379353|NCT00683787|4113725|FG001|NOT COMPLETED|Overall Study||3
3379354|NCT00683787|4113726|FG002|NOT COMPLETED|Overall Study||2
3379355|NCT00679926|4113734|FG000|STARTED|Overall Study||15
3379356|NCT00679926|4113734|FG000|COMPLETED|Overall Study||2
3379357|NCT00679926|4113734|FG000|NOT COMPLETED|Overall Study||13
3379358|NCT00678041|4113741|FG000|STARTED|Overall Study||5
3379359|NCT00678041|4113742|FG001|STARTED|Overall Study||5
3379360|NCT00678041|4113741|FG000|COMPLETED|Overall Study||0
3379361|NCT00678041|4113742|FG001|COMPLETED|Overall Study||0
3379362|NCT00678041|4113741|FG000|NOT COMPLETED|Overall Study||5
3379363|NCT00678041|4113742|FG001|NOT COMPLETED|Overall Study||5
3379364|NCT00680316|4113751|FG000|STARTED|Overall Study||1
3379365|NCT00680316|4113752|FG001|STARTED|Overall Study||2
3379366|NCT00680316|4113751|FG000|COMPLETED|Overall Study||1
3379367|NCT00680316|4113752|FG001|COMPLETED|Overall Study||2
3379368|NCT00680316|4113751|FG000|NOT COMPLETED|Overall Study||0
3379369|NCT00680316|4113752|FG001|NOT COMPLETED|Overall Study||0
3379370|NCT00681629|4113760|FG000|STARTED|Overall Study|It was planned to recruit 100 patient|5
3379371|NCT00681629|4113761|FG001|STARTED|Overall Study|It was planned to recruit 100 patient|2
3379372|NCT00681629|4113760|FG000|COMPLETED|Overall Study||0
3379373|NCT00681629|4113761|FG001|COMPLETED|Overall Study||0
3379374|NCT00681629|4113760|FG000|NOT COMPLETED|Overall Study||5
3379375|NCT00681629|4113761|FG001|NOT COMPLETED|Overall Study||2
3379376|NCT00669461|4113767|FG000|STARTED|Overall Study||1
3379377|NCT00669461|4113767|FG000|COMPLETED|Overall Study||1
3379378|NCT00669461|4113767|FG000|NOT COMPLETED|Overall Study||0
3379379|NCT00671606|4113772|FG000|STARTED|Overall Study||5
3379380|NCT00671606|4113772|FG000|COMPLETED|Overall Study||5
3379381|NCT00671606|4113772|FG000|NOT COMPLETED|Overall Study||0
3379382|NCT00673309|4113786|FG000|STARTED|Overall Study||64
3379383|NCT00673309|4113787|FG001|STARTED|Overall Study||14
3379384|NCT00673309|4113788|FG002|STARTED|Overall Study||14
3379385|NCT00673309|4113789|FG003|STARTED|Overall Study||25
3379386|NCT00673309|4113790|FG004|STARTED|Overall Study||18
3379387|NCT00673309|4113791|FG005|STARTED|Overall Study||35
3379388|NCT00673309|4113792|FG006|STARTED|Overall Study||14
3379389|NCT00673309|4113793|FG007|STARTED|Overall Study||13
3379390|NCT00673309|4113794|FG008|STARTED|Overall Study||17
3379391|NCT00673309|4113795|FG009|STARTED|Overall Study||30
3379392|NCT00673309|4113786|FG000|COMPLETED|Overall Study||64
3379393|NCT00673309|4113787|FG001|COMPLETED|Overall Study||14
3379394|NCT00673309|4113788|FG002|COMPLETED|Overall Study||14
3379395|NCT00673309|4113789|FG003|COMPLETED|Overall Study||25
3379396|NCT00673309|4113790|FG004|COMPLETED|Overall Study||18
3379397|NCT00673309|4113791|FG005|COMPLETED|Overall Study||35
3379398|NCT00673309|4113792|FG006|COMPLETED|Overall Study||14
3379399|NCT00673309|4113793|FG007|COMPLETED|Overall Study||13
3379400|NCT00673309|4113794|FG008|COMPLETED|Overall Study||17
3379401|NCT00673309|4113795|FG009|COMPLETED|Overall Study||30
3379402|NCT00673309|4113786|FG000|NOT COMPLETED|Overall Study||0
3379403|NCT00673309|4113787|FG001|NOT COMPLETED|Overall Study||0
3379404|NCT00673309|4113788|FG002|NOT COMPLETED|Overall Study||0
3379405|NCT00673309|4113789|FG003|NOT COMPLETED|Overall Study||0
3379406|NCT00673309|4113790|FG004|NOT COMPLETED|Overall Study||0
3379407|NCT00673309|4113791|FG005|NOT COMPLETED|Overall Study||0
3379408|NCT00673309|4113792|FG006|NOT COMPLETED|Overall Study||0
3379409|NCT00673309|4113793|FG007|NOT COMPLETED|Overall Study||0
3379410|NCT00673309|4113794|FG008|NOT COMPLETED|Overall Study||0
3379411|NCT00673309|4113795|FG009|NOT COMPLETED|Overall Study||0
3379412|NCT00672178|4113808|FG000|STARTED|Overall Study||1
3379413|NCT00672178|4113808|FG000|COMPLETED|Overall Study||1
3379414|NCT00672178|4113808|FG000|NOT COMPLETED|Overall Study||0
3379415|NCT00673595|4113814|FG000|STARTED|Overall Study||8
3379416|NCT00673595|4113815|FG001|STARTED|Overall Study||11
3379417|NCT00673595|4113814|FG000|COMPLETED|Overall Study||8
3379418|NCT00673595|4113815|FG001|COMPLETED|Overall Study||11
3379419|NCT00673595|4113814|FG000|NOT COMPLETED|Overall Study||0
3379420|NCT00673595|4113815|FG001|NOT COMPLETED|Overall Study||0
3379421|NCT00673361|4113821|FG000|STARTED|Overall Study||9
3379422|NCT00673361|4113821|FG000|COMPLETED|Overall Study||7
3379423|NCT00673361|4113821|FG000|NOT COMPLETED|Overall Study||2
3379424|NCT00670631|4113825|FG000|STARTED|Overall Study||0
3379425|NCT00670631|4113825|FG000|COMPLETED|Overall Study||0
3379426|NCT00670631|4113825|FG000|NOT COMPLETED|Overall Study||0
3379427|NCT00668785|4113830|FG000|STARTED|Overall Study||6
3379428|NCT00668785|4113830|FG000|COMPLETED|Overall Study||6
3379429|NCT00668785|4113830|FG000|NOT COMPLETED|Overall Study||0
3379430|NCT00673179|4113838|FG000|STARTED|Overall Study||7
3379431|NCT00673179|4113839|FG001|STARTED|Overall Study||0
3379432|NCT00673179|4113838|FG000|COMPLETED|Overall Study||4
3379433|NCT00673179|4113839|FG001|COMPLETED|Overall Study||0
3379434|NCT00673179|4113838|FG000|NOT COMPLETED|Overall Study||3
3379435|NCT00673179|4113839|FG001|NOT COMPLETED|Overall Study||0
3379436|NCT00668265|4113847|FG000|STARTED|Overall Study||9
3379437|NCT00668265|4113848|FG001|STARTED|Overall Study||5
3379438|NCT00668265|4113847|FG000|COMPLETED|Overall Study|The PI left, no records avaialable; the number of subjects who completed the study is not known|0
3379439|NCT00668265|4113848|FG001|COMPLETED|Overall Study|The PI left, no records avaialable; the number of subjects who completed the study is not known|0
3379440|NCT00668265|4113847|FG000|NOT COMPLETED|Overall Study||9
3379441|NCT00668265|4113848|FG001|NOT COMPLETED|Overall Study||5
3379442|NCT00660348|4113858|FG000|STARTED|Overall Study||1
3379443|NCT00660348|4113859|FG001|STARTED|Overall Study||0
3379444|NCT00660348|4113858|FG000|COMPLETED|Overall Study||0
3379445|NCT00660348|4113859|FG001|COMPLETED|Overall Study||0
3379446|NCT00660348|4113858|FG000|NOT COMPLETED|Overall Study||1
3379447|NCT00660348|4113859|FG001|NOT COMPLETED|Overall Study||0
3379448|NCT00664066|4113865|FG000|STARTED|Overall Study||3
3379449|NCT00664066|4113865|FG000|COMPLETED|Overall Study||0
3379450|NCT00664066|4113865|FG000|NOT COMPLETED|Overall Study||3
3379451|NCT00667017|4113869|FG000|STARTED|Overall Study||1
3379452|NCT00667017|4113869|FG000|COMPLETED|Overall Study||0
3379453|NCT00667017|4113869|FG000|NOT COMPLETED|Overall Study||1
3379454|NCT00665444|4113873|FG000|STARTED|Overall Study||3
3379455|NCT00665444|4113873|FG000|COMPLETED|Overall Study||1
3379456|NCT00665444|4113873|FG000|NOT COMPLETED|Overall Study||2
3379457|NCT00656916|4113879|FG000|STARTED|Overall Study||1
3379458|NCT00656916|4113880|FG001|STARTED|Overall Study||0
3379459|NCT00656916|4113879|FG000|COMPLETED|Overall Study||1
3379460|NCT00656916|4113880|FG001|COMPLETED|Overall Study||0
3379461|NCT00656916|4113879|FG000|NOT COMPLETED|Overall Study||0
3379462|NCT00656916|4113880|FG001|NOT COMPLETED|Overall Study||0
3379463|NCT00660595|4113888|FG000|STARTED|Overall Study||19
3379464|NCT00660595|4113889|FG001|STARTED|Overall Study||10
3379465|NCT00660595|4113888|FG000|COMPLETED|Overall Study||1
3379466|NCT00660595|4113889|FG001|COMPLETED|Overall Study|One of the two was lost to follow-up|1
3379467|NCT00660595|4113888|FG000|NOT COMPLETED|Overall Study||18
3379468|NCT00660595|4113889|FG001|NOT COMPLETED|Overall Study||9
3379469|NCT00661466|4113897|FG000|STARTED|Overall Study|Participants|4
3379470|NCT00661466|4113898|FG001|STARTED|Overall Study|Participants|3
3379471|NCT00661466|4113897|FG000|COMPLETED|Overall Study|Participants|4
3379472|NCT00661466|4113898|FG001|COMPLETED|Overall Study|Participants|3
3379473|NCT00661466|4113897|FG000|NOT COMPLETED|Overall Study||0
3379474|NCT00661466|4113898|FG001|NOT COMPLETED|Overall Study||0
3379475|NCT00646282|4113906|FG000|STARTED|Overall Study||4
3379476|NCT00646282|4113907|FG001|STARTED|Overall Study||4
3379477|NCT00646282|4113906|FG000|COMPLETED|Overall Study||0
3379478|NCT00646282|4113907|FG001|COMPLETED|Overall Study||0
3379479|NCT00646282|4113906|FG000|NOT COMPLETED|Overall Study||4
3379480|NCT00646282|4113907|FG001|NOT COMPLETED|Overall Study||4
3379481|NCT00657553|4113915|FG000|STARTED|Overall Study||5
3379482|NCT00657553|4113916|FG001|STARTED|Overall Study||5
3379483|NCT00657553|4113915|FG000|COMPLETED|Overall Study||0
3379484|NCT00657553|4113916|FG001|COMPLETED|Overall Study||0
3379485|NCT00657553|4113915|FG000|NOT COMPLETED|Overall Study||5
3379486|NCT00657553|4113916|FG001|NOT COMPLETED|Overall Study||5
3379487|NCT00655057|4113925|FG000|STARTED|Overall Study||0
3379488|NCT00655057|4113926|FG001|STARTED|Overall Study||0
3379489|NCT00655057|4113927|FG002|STARTED|Overall Study||0
3379490|NCT00655057|4113925|FG000|COMPLETED|Overall Study||0
3379491|NCT00655057|4113926|FG001|COMPLETED|Overall Study||0
3379492|NCT00655057|4113927|FG002|COMPLETED|Overall Study||0
3379493|NCT00655057|4113925|FG000|NOT COMPLETED|Overall Study||0
3379494|NCT00655057|4113926|FG001|NOT COMPLETED|Overall Study||0
3379495|NCT00655057|4113927|FG002|NOT COMPLETED|Overall Study||0
3379496|NCT00648895|4113937|FG000|STARTED|Overall Study||6
3379497|NCT00648895|4113938|FG001|STARTED|Overall Study||6
3379498|NCT00648895|4113937|FG000|COMPLETED|Overall Study||6
3379499|NCT00648895|4113938|FG001|COMPLETED|Overall Study||5
3379500|NCT00648895|4113937|FG000|NOT COMPLETED|Overall Study||0
3379501|NCT00648895|4113938|FG001|NOT COMPLETED|Overall Study||1
3379502|NCT00647426|4113944|FG000|STARTED|Overall Study||7
3379503|NCT00647426|4113944|FG000|COMPLETED|Overall Study||5
3379504|NCT00647426|4113944|FG000|NOT COMPLETED|Overall Study||2
3379505|NCT00645567|4113949|FG000|STARTED|Overall Study||5
3379506|NCT00645567|4113949|FG000|COMPLETED|Overall Study|One individual provided consent & was dropped due to an unrelated injury to his hand at his home.|4
3379507|NCT00645567|4113949|FG000|NOT COMPLETED|Overall Study||1
3379508|NCT00637806|4113960|FG000|STARTED|Double-blind Phase||2
3379509|NCT00637806|4113961|FG001|STARTED|Double-blind Phase||0
3379510|NCT00637806|4113962|FG002|STARTED|Double-blind Phase||2
3379511|NCT00637806|4113963|FG003|STARTED|Double-blind Phase||0
3379512|NCT00637806|4113960|FG000|COMPLETED|Double-blind Phase||0
3379513|NCT00637806|4113961|FG001|COMPLETED|Double-blind Phase||0
3379514|NCT00637806|4113962|FG002|COMPLETED|Double-blind Phase||1
3379515|NCT00637806|4113963|FG003|COMPLETED|Double-blind Phase||0
3379516|NCT00637806|4113960|FG000|NOT COMPLETED|Double-blind Phase||2
3379517|NCT00637806|4113961|FG001|NOT COMPLETED|Double-blind Phase||0
3379518|NCT00637806|4113962|FG002|NOT COMPLETED|Double-blind Phase||1
3379519|NCT00637806|4113963|FG003|NOT COMPLETED|Double-blind Phase||0
3379520|NCT00637806|4113960|FG000|STARTED|Extension Phase||0
3379521|NCT00637806|4113961|FG001|STARTED|Extension Phase||0
3379522|NCT00637806|4113962|FG002|STARTED|Extension Phase||0
3379523|NCT00637806|4113963|FG003|STARTED|Extension Phase||1
3379524|NCT00637806|4113960|FG000|COMPLETED|Extension Phase||0
3379525|NCT00637806|4113961|FG001|COMPLETED|Extension Phase||0
3379526|NCT00637806|4113962|FG002|COMPLETED|Extension Phase||0
3379527|NCT00637806|4113963|FG003|COMPLETED|Extension Phase||0
3379528|NCT00637806|4113960|FG000|NOT COMPLETED|Extension Phase||0
3379529|NCT00637806|4113961|FG001|NOT COMPLETED|Extension Phase||0
3379530|NCT00637806|4113962|FG002|NOT COMPLETED|Extension Phase||0
3379531|NCT00637806|4113963|FG003|NOT COMPLETED|Extension Phase||1
3379532|NCT00652457|4113972|FG000|STARTED|Overall Study||23
3379533|NCT00652457|4113973|FG001|STARTED|Overall Study||27
3379534|NCT00652457|4113972|FG000|COMPLETED|Overall Study||23
3379535|NCT00652457|4113973|FG001|COMPLETED|Overall Study||27
3379536|NCT00652457|4113972|FG000|NOT COMPLETED|Overall Study||0
3379537|NCT00652457|4113973|FG001|NOT COMPLETED|Overall Study||0
3379538|NCT00642603|4113981|FG000|STARTED|Overall Study||21
3379539|NCT00642603|4113982|FG001|STARTED|Overall Study||20
3379540|NCT00642603|4113981|FG000|Safety Population|Overall Study||19
3379541|NCT00642603|4113982|FG001|Safety Population|Overall Study||20
3379542|NCT00642603|4113981|FG000|COMPLETED|Overall Study||0
3379543|NCT00642603|4113982|FG001|COMPLETED|Overall Study||2
3379544|NCT00642603|4113981|FG000|NOT COMPLETED|Overall Study||21
3379545|NCT00642603|4113982|FG001|NOT COMPLETED|Overall Study||18
3379546|NCT00629798|4113988|FG000|STARTED|Overall Study||64
3379547|NCT00629798|4113988|FG000|COMPLETED|Overall Study||60
3379548|NCT00629798|4113988|FG000|NOT COMPLETED|Overall Study||4
3379549|NCT00645359|4113992|FG000|STARTED|Overall Study||9
3379550|NCT00645359|4113992|FG000|COMPLETED|Overall Study||9
3379551|NCT00645359|4113992|FG000|NOT COMPLETED|Overall Study||0
3379552|NCT00637728|4113998|FG000|STARTED|Double-blind Phase||4
3379553|NCT00637728|4113999|FG001|STARTED|Double-blind Phase||1
3379554|NCT00637728|4114000|FG002|STARTED|Double-blind Phase||0
3379555|NCT00637728|4113998|FG000|COMPLETED|Double-blind Phase||0
3379556|NCT00637728|4113999|FG001|COMPLETED|Double-blind Phase||0
3379557|NCT00637728|4114000|FG002|COMPLETED|Double-blind Phase||0
3379558|NCT00637728|4113998|FG000|NOT COMPLETED|Double-blind Phase||4
3379559|NCT00637728|4113999|FG001|NOT COMPLETED|Double-blind Phase||1
3379560|NCT00637728|4114000|FG002|NOT COMPLETED|Double-blind Phase||0
3379561|NCT00637728|4113998|FG000|STARTED|Extension Phase||0
3379562|NCT00637728|4113999|FG001|STARTED|Extension Phase||0
3379563|NCT00637728|4114000|FG002|STARTED|Extension Phase||0
3379564|NCT00637728|4113998|FG000|COMPLETED|Extension Phase||0
3379565|NCT00637728|4113999|FG001|COMPLETED|Extension Phase||0
3379566|NCT00637728|4114000|FG002|COMPLETED|Extension Phase||0
3379567|NCT00637728|4113998|FG000|NOT COMPLETED|Extension Phase||0
3379568|NCT00637728|4113999|FG001|NOT COMPLETED|Extension Phase||0
3379569|NCT00637728|4114000|FG002|NOT COMPLETED|Extension Phase||0
3379570|NCT00639626|4114007|FG000|STARTED|Overall Study||0
3379571|NCT00639626|4114007|FG000|COMPLETED|Overall Study||0
3379572|NCT00639626|4114007|FG000|NOT COMPLETED|Overall Study||0
3379573|NCT00634582|4114011|FG000|STARTED|Overall Study||2
3379574|NCT00634582|4114011|FG000|COMPLETED|Overall Study||2
3379575|NCT00634582|4114011|FG000|NOT COMPLETED|Overall Study||0
3379576|NCT00641108|4114017|FG000|STARTED|Overall Study||0
3379577|NCT00641108|4114018|FG001|STARTED|Overall Study||0
3379578|NCT00641108|4114017|FG000|COMPLETED|Overall Study||0
3379579|NCT00641108|4114018|FG001|COMPLETED|Overall Study||0
3379580|NCT00641108|4114017|FG000|NOT COMPLETED|Overall Study||0
3379581|NCT00641108|4114018|FG001|NOT COMPLETED|Overall Study||0
3379582|NCT00642382|4114026|FG000|STARTED|Overall Study||0
3379583|NCT00642382|4114027|FG001|STARTED|Overall Study||0
3379584|NCT00642382|4114026|FG000|COMPLETED|Overall Study||0
3379585|NCT00642382|4114027|FG001|COMPLETED|Overall Study||0
3379586|NCT00642382|4114026|FG000|NOT COMPLETED|Overall Study||0
3379587|NCT00642382|4114027|FG001|NOT COMPLETED|Overall Study||0
3379588|NCT00637416|4114035|FG000|STARTED|Overall Study||4
3379589|NCT00637416|4114036|FG001|STARTED|Overall Study||5
3379590|NCT00637416|4114035|FG000|COMPLETED|Overall Study||3
3379591|NCT00637416|4114036|FG001|COMPLETED|Overall Study||3
3379592|NCT00637416|4114035|FG000|NOT COMPLETED|Overall Study||1
3379593|NCT00637416|4114036|FG001|NOT COMPLETED|Overall Study||2
3379594|NCT00635167|4114042|FG000|STARTED|Overall Study||1
3379595|NCT00635167|4114042|FG000|COMPLETED|Overall Study||1
3379596|NCT00635167|4114042|FG000|NOT COMPLETED|Overall Study||0
3379597|NCT00637312|4114048|FG000|STARTED|Overall Study||72
3379598|NCT00637312|4114049|FG001|STARTED|Overall Study||36
3379599|NCT00637312|4114048|FG000|COMPLETED|Overall Study||30
3379600|NCT00637312|4114049|FG001|COMPLETED|Overall Study||19
3379601|NCT00637312|4114048|FG000|NOT COMPLETED|Overall Study||42
3379602|NCT00637312|4114049|FG001|NOT COMPLETED|Overall Study||17
3379603|NCT00638222|4114058|FG000|STARTED|Overall Study||0
3379604|NCT00638222|4114059|FG001|STARTED|Overall Study||0
3379605|NCT00638222|4114060|FG002|STARTED|Overall Study||6
3379606|NCT00638222|4114058|FG000|COMPLETED|Overall Study||0
3379607|NCT00638222|4114059|FG001|COMPLETED|Overall Study||0
3379608|NCT00638222|4114060|FG002|COMPLETED|Overall Study||6
3379609|NCT00638222|4114058|FG000|NOT COMPLETED|Overall Study||0
3379610|NCT00638222|4114059|FG001|NOT COMPLETED|Overall Study||0
3379611|NCT00638222|4114060|FG002|NOT COMPLETED|Overall Study||0
3379612|NCT00634322|4114070|FG000|STARTED|Overall Study||1
3379613|NCT00634322|4114071|FG001|STARTED|Overall Study||1
3379614|NCT00634322|4114072|FG002|STARTED|Overall Study||5
3379615|NCT00634322|4114070|FG000|COMPLETED|Overall Study||1
3379616|NCT00634322|4114071|FG001|COMPLETED|Overall Study||1
3379617|NCT00634322|4114072|FG002|COMPLETED|Overall Study||5
3379618|NCT00634322|4114070|FG000|NOT COMPLETED|Overall Study||0
3379619|NCT00634322|4114071|FG001|NOT COMPLETED|Overall Study||0
3379620|NCT00634322|4114072|FG002|NOT COMPLETED|Overall Study||0
3379621|NCT00633087|4114080|FG000|STARTED|Overall Study||12
3379622|NCT00633087|4114080|FG000|COMPLETED|Overall Study||12
3379623|NCT00633087|4114080|FG000|NOT COMPLETED|Overall Study||0
3379624|NCT00631137|4114086|FG000|STARTED|Overall Study||1
3379625|NCT00631137|4114087|FG001|STARTED|Overall Study||0
3379626|NCT00631137|4114086|FG000|COMPLETED|Overall Study||0
3379627|NCT00631137|4114087|FG001|COMPLETED|Overall Study||0
3379628|NCT00631137|4114086|FG000|NOT COMPLETED|Overall Study||1
3379629|NCT00631137|4114087|FG001|NOT COMPLETED|Overall Study||0
3379630|NCT00634972|4114095|FG000|STARTED|Overall Study||40
3379631|NCT00634972|4114096|FG001|STARTED|Overall Study||43
3379632|NCT00634972|4114095|FG000|COMPLETED|Overall Study||40
3379633|NCT00634972|4114096|FG001|COMPLETED|Overall Study||43
3379634|NCT00634972|4114095|FG000|NOT COMPLETED|Overall Study||0
3379635|NCT00634972|4114096|FG001|NOT COMPLETED|Overall Study||0
3379636|NCT00633061|4114104|FG000|STARTED|Overall Study|Study was on hold for 2 months for continuing review|136
3379637|NCT00633061|4114105|FG001|STARTED|Overall Study||0
3379638|NCT00633061|4114104|FG000|Met Criteria for Imaging|Overall Study||25
3379639|NCT00633061|4114105|FG001|Met Criteria for Imaging|Overall Study||0
3379640|NCT00633061|4114104|FG000|Had Prior Thrombosis Identified|Overall Study||25
3379641|NCT00633061|4114105|FG001|Had Prior Thrombosis Identified|Overall Study||0
3379642|NCT00633061|4114104|FG000|COMPLETED|Overall Study||50
3379643|NCT00633061|4114105|FG001|COMPLETED|Overall Study||0
3379644|NCT00633061|4114104|FG000|NOT COMPLETED|Overall Study||86
3379645|NCT00633061|4114105|FG001|NOT COMPLETED|Overall Study||0
3379646|NCT00626444|4114113|FG000|STARTED|Overall Study||2
3379647|NCT00626444|4114113|FG000|COMPLETED|Overall Study||2
3379648|NCT00626444|4114113|FG000|NOT COMPLETED|Overall Study||0
3379649|NCT00630292|4114117|FG000|STARTED|Overall Study||6
3379650|NCT00630292|4114117|FG000|COMPLETED|Overall Study||5
3379651|NCT00630292|4114117|FG000|NOT COMPLETED|Overall Study||1
3379652|NCT00634010|4114123|FG000|STARTED|Overall Study||18
3379653|NCT00634010|4114124|FG001|STARTED|Overall Study||18
3379654|NCT00634010|4114123|FG000|COMPLETED|Overall Study||8
3379655|NCT00634010|4114124|FG001|COMPLETED|Overall Study||4
3379656|NCT00634010|4114123|FG000|NOT COMPLETED|Overall Study||10
3379657|NCT00634010|4114124|FG001|NOT COMPLETED|Overall Study||14
3379658|NCT00630487|4114132|FG000|STARTED|Overall Study||0
3379659|NCT00630487|4114133|FG001|STARTED|Overall Study||0
3379660|NCT00630487|4114132|FG000|COMPLETED|Overall Study||0
3379661|NCT00630487|4114133|FG001|COMPLETED|Overall Study||0
3379662|NCT00630487|4114132|FG000|NOT COMPLETED|Overall Study||0
3379663|NCT00630487|4114133|FG001|NOT COMPLETED|Overall Study||0
3379664|NCT00629850|4114141|FG000|STARTED|Overall Study||1
3379665|NCT00629850|4114142|FG001|STARTED|Overall Study||0
3379666|NCT00629850|4114141|FG000|COMPLETED|Overall Study||1
3379667|NCT00629850|4114142|FG001|COMPLETED|Overall Study||0
3379668|NCT00629850|4114141|FG000|NOT COMPLETED|Overall Study||0
3379669|NCT00629850|4114142|FG001|NOT COMPLETED|Overall Study||0
3379670|NCT00623974|4114152|FG000|STARTED|Overall Study||0
3379671|NCT00623974|4114153|FG001|STARTED|Overall Study||0
3379672|NCT00623974|4114154|FG002|STARTED|Overall Study||0
3379673|NCT00623974|4114155|FG003|STARTED|Overall Study||0
3379674|NCT00623974|4114152|FG000|COMPLETED|Overall Study||0
3379675|NCT00623974|4114153|FG001|COMPLETED|Overall Study||0
3379676|NCT00623974|4114154|FG002|COMPLETED|Overall Study||0
3379677|NCT00623974|4114155|FG003|COMPLETED|Overall Study||0
3379678|NCT00623974|4114152|FG000|NOT COMPLETED|Overall Study||0
3379679|NCT00623974|4114153|FG001|NOT COMPLETED|Overall Study||0
3379680|NCT00623974|4114154|FG002|NOT COMPLETED|Overall Study||0
3379681|NCT00623974|4114155|FG003|NOT COMPLETED|Overall Study||0
3379682|NCT00624650|4114167|FG000|STARTED|Overall Study||17
3379683|NCT00624650|4114168|FG001|STARTED|Overall Study||16
3379684|NCT00624650|4114167|FG000|COMPLETED|Overall Study||16
3379685|NCT00624650|4114168|FG001|COMPLETED|Overall Study||15
3379686|NCT00624650|4114167|FG000|NOT COMPLETED|Overall Study||1
3379687|NCT00624650|4114168|FG001|NOT COMPLETED|Overall Study||1
3379688|NCT00626561|4114174|FG000|STARTED|Overall Study||4
3379689|NCT00626561|4114174|FG000|COMPLETED|Overall Study||0
3379690|NCT00626561|4114174|FG000|NOT COMPLETED|Overall Study||4
3379691|NCT00613730|4114178|FG000|STARTED|Overall Study||3
3379692|NCT00613730|4114178|FG000|COMPLETED|Overall Study||0
3379693|NCT00613730|4114178|FG000|NOT COMPLETED|Overall Study||3
3379694|NCT00625586|4114182|FG000|STARTED|Overall Study||2
3379695|NCT00625586|4114182|FG000|COMPLETED|Overall Study||1
3379696|NCT00625586|4114182|FG000|NOT COMPLETED|Overall Study||1
3379697|NCT00625703|4114186|FG000|STARTED|Overall Study||0
3379698|NCT00625703|4114186|FG000|COMPLETED|Overall Study||0
3379699|NCT00625703|4114186|FG000|NOT COMPLETED|Overall Study||0
3379700|NCT00625742|4114190|FG000|STARTED|Overall Study||15
3379701|NCT00625742|4114190|FG000|COMPLETED|Overall Study||3
3379702|NCT00625742|4114190|FG000|NOT COMPLETED|Overall Study||12
3379703|NCT00619242|4114194|FG000|STARTED|Overall Study||3
3379704|NCT00619242|4114194|FG000|COMPLETED|Overall Study||3
3379705|NCT00619242|4114194|FG000|NOT COMPLETED|Overall Study||0
3379706|NCT00619151|4114200|FG000|STARTED|Overall Study||2
3379707|NCT00619151|4114201|FG001|STARTED|Overall Study||0
3379708|NCT00619151|4114200|FG000|COMPLETED|Overall Study||1
3379709|NCT00619151|4114201|FG001|COMPLETED|Overall Study||0
3379710|NCT00619151|4114200|FG000|NOT COMPLETED|Overall Study||1
3379711|NCT00619151|4114201|FG001|NOT COMPLETED|Overall Study||0
3379712|NCT00622167|4114207|FG000|STARTED|Overall Study||24
3379713|NCT00622167|4114207|FG000|COMPLETED|Overall Study||4
3379714|NCT00622167|4114207|FG000|NOT COMPLETED|Overall Study||20
3379715|NCT00616577|4114214|FG000|STARTED|Overall Study||6
3379716|NCT00616577|4114215|FG001|STARTED|Overall Study||9
3379717|NCT00616577|4114216|FG002|STARTED|Overall Study||7
3379718|NCT00616577|4114214|FG000|COMPLETED|Overall Study||6
3379719|NCT00616577|4114215|FG001|COMPLETED|Overall Study||9
3379720|NCT00616577|4114216|FG002|COMPLETED|Overall Study||7
3379721|NCT00616577|4114214|FG000|NOT COMPLETED|Overall Study||0
3379722|NCT00616577|4114215|FG001|NOT COMPLETED|Overall Study||0
3379723|NCT00616577|4114216|FG002|NOT COMPLETED|Overall Study||0
3379724|NCT00616759|4114226|FG000|STARTED|Overall Study||10
3379725|NCT00616759|4114227|FG001|STARTED|Overall Study||10
3379726|NCT00616759|4114226|FG000|COMPLETED|Overall Study||7
3379727|NCT00616759|4114227|FG001|COMPLETED|Overall Study||8
3379728|NCT00616759|4114226|FG000|NOT COMPLETED|Overall Study||3
3379729|NCT00616759|4114227|FG001|NOT COMPLETED|Overall Study||2
3379730|NCT00616642|4114235|FG000|STARTED|Overall Study||0
3379731|NCT00616642|4114236|FG001|STARTED|Overall Study||1
3379732|NCT00616642|4114235|FG000|COMPLETED|Overall Study||0
3379733|NCT00616642|4114236|FG001|COMPLETED|Overall Study||0
3379734|NCT00616642|4114235|FG000|NOT COMPLETED|Overall Study||0
3379735|NCT00616642|4114236|FG001|NOT COMPLETED|Overall Study||1
3379736|NCT00619515|4114242|FG000|STARTED|Overall Study||73
3379737|NCT00619515|4114242|FG000|COMPLETED|Overall Study||0
3379738|NCT00619515|4114242|FG000|NOT COMPLETED|Overall Study||73
3379739|NCT00616343|4114246|FG000|STARTED|Overall Study||9
3379740|NCT00616343|4114246|FG000|COMPLETED|Overall Study||9
3379741|NCT00616343|4114246|FG000|NOT COMPLETED|Overall Study||0
3379742|NCT00612677|4114250|FG000|STARTED|Overall Study||1
3379743|NCT00612677|4114250|FG000|COMPLETED|Overall Study||0
3379744|NCT00612677|4114250|FG000|NOT COMPLETED|Overall Study||1
3379745|NCT00616603|4114257|FG000|STARTED|Overall Study||14
3379746|NCT00616603|4114258|FG001|STARTED|Overall Study||14
3379747|NCT00616603|4114259|FG002|STARTED|Overall Study||15
3379748|NCT00616603|4114257|FG000|COMPLETED|Overall Study||12
3379749|NCT00616603|4114258|FG001|COMPLETED|Overall Study||14
3379750|NCT00616603|4114259|FG002|COMPLETED|Overall Study||13
3379751|NCT00616603|4114257|FG000|NOT COMPLETED|Overall Study||2
3379752|NCT00616603|4114258|FG001|NOT COMPLETED|Overall Study||0
3379753|NCT00616603|4114259|FG002|NOT COMPLETED|Overall Study||2
3379754|NCT00613886|4114267|FG000|STARTED|Overall Study||24
3379755|NCT00613886|4114267|FG000|COMPLETED|Overall Study||0
3379756|NCT00613886|4114267|FG000|NOT COMPLETED|Overall Study||24
3379757|NCT00610467|4114274|FG000|STARTED|Overall Study||1
3379758|NCT00610467|4114275|FG001|STARTED|Overall Study||1
3379759|NCT00610467|4114274|FG000|COMPLETED|Overall Study||1
3379760|NCT00610467|4114275|FG001|COMPLETED|Overall Study||1
3379761|NCT00610467|4114274|FG000|NOT COMPLETED|Overall Study||0
3379762|NCT00610467|4114275|FG001|NOT COMPLETED|Overall Study||0
3379763|NCT00610558|4114284|FG000|STARTED|Overall Study||20
3379764|NCT00610558|4114285|FG001|STARTED|Overall Study||20
3379765|NCT00610558|4114286|FG002|STARTED|Overall Study||20
3379766|NCT00610558|4114284|FG000|COMPLETED|Overall Study||15
3379767|NCT00610558|4114285|FG001|COMPLETED|Overall Study||14
3379768|NCT00610558|4114286|FG002|COMPLETED|Overall Study||14
3379769|NCT00610558|4114284|FG000|NOT COMPLETED|Overall Study||5
3379770|NCT00610558|4114285|FG001|NOT COMPLETED|Overall Study||6
3379771|NCT00610558|4114286|FG002|NOT COMPLETED|Overall Study||6
3379772|NCT00610532|4114294|FG000|STARTED|Intravenous Phenytoin Alone||8
3379773|NCT00610532|4114294|FG000|COMPLETED|Intravenous Phenytoin Alone||8
3379774|NCT00610532|4114294|FG000|NOT COMPLETED|Intravenous Phenytoin Alone||0
3379775|NCT00610532|4114294|FG000|STARTED|Intravenous Phenytoin Plus Probenecid|one participant dropped out between periods|7
3379776|NCT00610532|4114294|FG000|COMPLETED|Intravenous Phenytoin Plus Probenecid||7
3379777|NCT00610532|4114294|FG000|NOT COMPLETED|Intravenous Phenytoin Plus Probenecid||0
3379778|NCT00609765|4114300|FG000|STARTED|Overall Study||1
3379779|NCT00609765|4114300|FG000|COMPLETED|Overall Study||0
3379780|NCT00609765|4114300|FG000|NOT COMPLETED|Overall Study||1
3379781|NCT00608465|4114304|FG000|STARTED|Overall Study||4
3379782|NCT00608465|4114304|FG000|COMPLETED|Overall Study||4
3379783|NCT00608465|4114304|FG000|NOT COMPLETED|Overall Study||0
3379784|NCT00608777|4114308|FG000|STARTED|Overall Study||6
3379785|NCT00608777|4114308|FG000|COMPLETED|Overall Study||6
3379786|NCT00608777|4114308|FG000|NOT COMPLETED|Overall Study||0
3379787|NCT00601848|4114312|FG000|STARTED|Overall Study||9
3379788|NCT00601848|4114312|FG000|COMPLETED|Overall Study||0
3379789|NCT00601848|4114312|FG000|NOT COMPLETED|Overall Study||9
3379790|NCT00607477|4114318|FG000|STARTED|Overall Study||0
3379791|NCT00607477|4114319|FG001|STARTED|Overall Study||2
3379792|NCT00607477|4114318|FG000|COMPLETED|Overall Study||0
3379793|NCT00607477|4114319|FG001|COMPLETED|Overall Study||2
3379794|NCT00607477|4114318|FG000|NOT COMPLETED|Overall Study||0
3379795|NCT00607477|4114319|FG001|NOT COMPLETED|Overall Study||0
3379796|NCT00595920|4114325|FG000|STARTED|Overall Study||116
3379797|NCT00595920|4114325|FG000|Patients Dosed|Overall Study|116 patients enrolled; however, only 38 received at least 1 dose.|38
3379798|NCT00595920|4114325|FG000|COMPLETED|Overall Study||0
3379799|NCT00595920|4114325|FG000|NOT COMPLETED|Overall Study||116
3379800|NCT00596947|4114331|FG000|STARTED|Overall Study||9
3379801|NCT00596947|4114332|FG001|STARTED|Overall Study||9
3379802|NCT00596947|4114331|FG000|COMPLETED|Overall Study||3
3379803|NCT00596947|4114332|FG001|COMPLETED|Overall Study||6
3379804|NCT00596947|4114331|FG000|NOT COMPLETED|Overall Study||6
3379805|NCT00596947|4114332|FG001|NOT COMPLETED|Overall Study||3
3379806|NCT00584012|4114338|FG000|STARTED|Overall Study||9
3379807|NCT00584012|4114338|FG000|COMPLETED|Overall Study||8
3379808|NCT00584012|4114338|FG000|NOT COMPLETED|Overall Study||1
3379809|NCT00599131|4114342|FG000|STARTED|Overall Study||4
3379810|NCT00599131|4114342|FG000|COMPLETED|Overall Study||4
3379811|NCT00599131|4114342|FG000|NOT COMPLETED|Overall Study||0
3379812|NCT00597909|4114349|FG000|STARTED|Overall Study||0
3379813|NCT00597909|4114350|FG001|STARTED|Overall Study||0
3379814|NCT00597909|4114351|FG002|STARTED|Overall Study||0
3379815|NCT00597909|4114349|FG000|COMPLETED|Overall Study||0
3379816|NCT00597909|4114350|FG001|COMPLETED|Overall Study||0
3379817|NCT00597909|4114351|FG002|COMPLETED|Overall Study||0
3379818|NCT00597909|4114349|FG000|NOT COMPLETED|Overall Study||0
3379819|NCT00597909|4114350|FG001|NOT COMPLETED|Overall Study||0
3379820|NCT00597909|4114351|FG002|NOT COMPLETED|Overall Study||0
3379821|NCT00593320|4114361|FG000|STARTED|Overall Study||1
3379822|NCT00593320|4114362|FG001|STARTED|Overall Study||1
3379823|NCT00593320|4114361|FG000|COMPLETED|Overall Study||1
3379824|NCT00593320|4114362|FG001|COMPLETED|Overall Study||1
3379825|NCT00593320|4114361|FG000|NOT COMPLETED|Overall Study||0
3379826|NCT00593320|4114362|FG001|NOT COMPLETED|Overall Study||0
3379827|NCT00589550|4114368|FG000|STARTED|Overall Study||1
3379828|NCT00589550|4114368|FG000|Withdrew From Study|Overall Study||1
3379829|NCT00589550|4114368|FG000|COMPLETED|Overall Study||0
3379830|NCT00589550|4114368|FG000|NOT COMPLETED|Overall Study||1
3379831|NCT00577772|4114374|FG000|STARTED|Overall Study||10
3379832|NCT00577772|4114375|FG001|STARTED|Overall Study||7
3379833|NCT00577772|4114374|FG000|COMPLETED|Overall Study||10
3379834|NCT00577772|4114375|FG001|COMPLETED|Overall Study||6
3379835|NCT00577772|4114374|FG000|NOT COMPLETED|Overall Study||0
3379836|NCT00577772|4114375|FG001|NOT COMPLETED|Overall Study||1
3379837|NCT00592007|4114381|FG000|STARTED|Overall Study||7
3379838|NCT00592007|4114381|FG000|COMPLETED|Overall Study||5
3379839|NCT00592007|4114381|FG000|NOT COMPLETED|Overall Study||2
3379840|NCT00595582|4114385|FG000|STARTED|Overall Study||10
3379841|NCT00595582|4114385|FG000|COMPLETED|Overall Study||0
3379842|NCT00595582|4114385|FG000|NOT COMPLETED|Overall Study||10
3379843|NCT00588146|4114389|FG000|STARTED|First Intervention (Baseline to 6 mo)||5
3379844|NCT00588146|4114390|FG001|STARTED|First Intervention (Baseline to 6 mo)||5
3379845|NCT00588146|4114389|FG000|COMPLETED|First Intervention (Baseline to 6 mo)||1
3379846|NCT00588146|4114390|FG001|COMPLETED|First Intervention (Baseline to 6 mo)||2
3379847|NCT00588146|4114389|FG000|NOT COMPLETED|First Intervention (Baseline to 6 mo)||4
3379848|NCT00588146|4114390|FG001|NOT COMPLETED|First Intervention (Baseline to 6 mo)||3
3379849|NCT00588146|4114389|FG000|STARTED|Second Intervention (6 Months to 1 Year)||1
3379850|NCT00588146|4114390|FG001|STARTED|Second Intervention (6 Months to 1 Year)||2
3379851|NCT00588146|4114389|FG000|COMPLETED|Second Intervention (6 Months to 1 Year)||1
3379852|NCT00588146|4114390|FG001|COMPLETED|Second Intervention (6 Months to 1 Year)||2
3379853|NCT00588146|4114389|FG000|NOT COMPLETED|Second Intervention (6 Months to 1 Year)||0
3379854|NCT00588146|4114390|FG001|NOT COMPLETED|Second Intervention (6 Months to 1 Year)||0
3379855|NCT00586209|4114398|FG000|STARTED|Overall Study||5
3379856|NCT00586209|4114399|FG001|STARTED|Overall Study||10
3379857|NCT00586209|4114398|FG000|COMPLETED|Overall Study||5
3379858|NCT00586209|4114399|FG001|COMPLETED|Overall Study||10
3379859|NCT00586209|4114398|FG000|NOT COMPLETED|Overall Study||0
3379860|NCT00586209|4114399|FG001|NOT COMPLETED|Overall Study||0
3379861|NCT00590538|4114405|FG000|STARTED|Overall Study|STUDY NOT UNBLINDED AT TIME OF TERMINATION; THEREFORE NUMBER ASSIGNED TO EACH GROUP IS NOT KNOWN.|9
3379862|NCT00590538|4114405|FG000|COMPLETED|Overall Study||7
3379863|NCT00590538|4114405|FG000|NOT COMPLETED|Overall Study||2
3379864|NCT00583115|4114409|FG000|STARTED|Overall Study||1
3379865|NCT00583115|4114409|FG000|COMPLETED|Overall Study||0
3379866|NCT00583115|4114409|FG000|NOT COMPLETED|Overall Study||1
3379867|NCT00582712|4114413|FG000|STARTED|Overall Study||5
3379868|NCT00582712|4114413|FG000|COMPLETED|Overall Study||1
3379869|NCT00582712|4114413|FG000|NOT COMPLETED|Overall Study||4
3379870|NCT00586716|4114419|FG000|STARTED|Overall Study||14
3379871|NCT00586716|4114420|FG001|STARTED|Overall Study||8
3379872|NCT00586716|4114419|FG000|COMPLETED|Overall Study||14
3379873|NCT00586716|4114420|FG001|COMPLETED|Overall Study||8
3379874|NCT00586716|4114419|FG000|NOT COMPLETED|Overall Study||0
3379875|NCT00586716|4114420|FG001|NOT COMPLETED|Overall Study||0
3379876|NCT00583466|4114427|FG000|STARTED|Overall Study||18
3379877|NCT00583466|4114427|FG000|COMPLETED|Overall Study||18
3379878|NCT00583466|4114427|FG000|NOT COMPLETED|Overall Study||0
3379879|NCT00588471|4114435|FG000|STARTED|Overall Study||28
3379880|NCT00588471|4114436|FG001|STARTED|Overall Study||29
3379881|NCT00588471|4114435|FG000|COMPLETED|Overall Study||28
3379882|NCT00588471|4114436|FG001|COMPLETED|Overall Study||29
3379883|NCT00588471|4114435|FG000|NOT COMPLETED|Overall Study||0
3379884|NCT00588471|4114436|FG001|NOT COMPLETED|Overall Study||0
3379885|NCT00587795|4114444|FG000|STARTED|Overall Study||1
3379886|NCT00587795|4114445|FG001|STARTED|Overall Study||0
3379887|NCT00587795|4114444|FG000|COMPLETED|Overall Study||0
3379888|NCT00587795|4114445|FG001|COMPLETED|Overall Study||0
3379889|NCT00587795|4114444|FG000|NOT COMPLETED|Overall Study||1
3379890|NCT00587795|4114445|FG001|NOT COMPLETED|Overall Study||0
3379891|NCT00590135|4114451|FG000|STARTED|Overall Study||59
3379892|NCT00590135|4114451|FG000|COMPLETED|Overall Study||0
3379893|NCT00590135|4114451|FG000|NOT COMPLETED|Overall Study||59
3379894|NCT00582036|4114458|FG000|STARTED|Overall Study||5
3379895|NCT00582036|4114459|FG001|STARTED|Overall Study||6
3379896|NCT00582036|4114458|FG000|COMPLETED|Overall Study||5
3379897|NCT00582036|4114459|FG001|COMPLETED|Overall Study|One patient withdrew consent|5
3379898|NCT00582036|4114458|FG000|NOT COMPLETED|Overall Study||0
3379899|NCT00582036|4114459|FG001|NOT COMPLETED|Overall Study||1
3379900|NCT00585585|4114465|FG000|STARTED|Overall Study||1
3379901|NCT00585585|4114465|FG000|Patients Receiving Drug|Overall Study||1
3379902|NCT00585585|4114465|FG000|COMPLETED|Overall Study||0
3379903|NCT00585585|4114465|FG000|NOT COMPLETED|Overall Study||1
3379904|NCT00585221|4114469|FG000|STARTED|Overall Study||8
3379905|NCT00585221|4114469|FG000|COMPLETED|Overall Study||0
3379906|NCT00585221|4114469|FG000|NOT COMPLETED|Overall Study||8
3379907|NCT00581113|4114475|FG000|STARTED|Overall Study||4
3379908|NCT00581113|4114476|FG001|STARTED|Overall Study||4
3379909|NCT00581113|4114475|FG000|COMPLETED|Overall Study||4
3379910|NCT00581113|4114476|FG001|COMPLETED|Overall Study||3
3379911|NCT00581113|4114475|FG000|NOT COMPLETED|Overall Study||0
3379912|NCT00581113|4114476|FG001|NOT COMPLETED|Overall Study||1
3379913|NCT00579254|4114482|FG000|STARTED|Overall Study||112
3379914|NCT00579254|4114482|FG000|COMPLETED|Overall Study||0
3379915|NCT00579254|4114482|FG000|NOT COMPLETED|Overall Study||112
3379916|NCT00587223|4114486|FG000|STARTED|Overall Study|Study design was within-subject control. Only 1 subject was enrolled in the study.|1
3379917|NCT00587223|4114486|FG000|COMPLETED|Overall Study|Subject withdrawn from study at Day 7.|0
3379918|NCT00587223|4114486|FG000|NOT COMPLETED|Overall Study||1
3379919|NCT00585611|4114495|FG000|STARTED|Overall Study||0
3379920|NCT00585611|4114496|FG001|STARTED|Overall Study||0
3379921|NCT00585611|4114495|FG000|COMPLETED|Overall Study||0
3379922|NCT00585611|4114496|FG001|COMPLETED|Overall Study||0
3379923|NCT00585611|4114495|FG000|NOT COMPLETED|Overall Study||0
3379924|NCT00585611|4114496|FG001|NOT COMPLETED|Overall Study||0
3379925|NCT00572260|4114502|FG000|STARTED|Overall Study||11
3379926|NCT00572260|4114502|FG000|COMPLETED|Overall Study||11
3379927|NCT00572260|4114502|FG000|NOT COMPLETED|Overall Study||0
3379928|NCT00571194|4114506|FG000|STARTED|Overall Study||7
3379929|NCT00571194|4114506|FG000|COMPLETED|Overall Study||7
3379930|NCT00571194|4114506|FG000|NOT COMPLETED|Overall Study||0
3379931|NCT00584935|4114510|FG000|STARTED|Overall Study||3
3379932|NCT00584935|4114510|FG000|COMPLETED|Overall Study||3
3379933|NCT00584935|4114510|FG000|NOT COMPLETED|Overall Study||0
3379934|NCT00577395|4114517|FG000|STARTED|Overall Study|67 planned for Treatment 2, but due to enrollment difficulties this was not met.|7
3379935|NCT00577395|4114518|FG001|STARTED|Overall Study|67 were planned for Treatment 1, but due to enrollment difficulties this was not met.|6
3379936|NCT00577395|4114517|FG000|COMPLETED|Overall Study|The study was terminated early by the Sponsor for lack of enrollment|0
3379937|NCT00577395|4114518|FG001|COMPLETED|Overall Study|The study was terminated early by the Sponsor for lack of enrollment|0
3379938|NCT00577395|4114517|FG000|NOT COMPLETED|Overall Study||7
3379939|NCT00577395|4114518|FG001|NOT COMPLETED|Overall Study||6
3379940|NCT00573391|4114526|FG000|STARTED|Overall Study||3
3379941|NCT00573391|4114527|FG001|STARTED|Overall Study||2
3379942|NCT00573391|4114526|FG000|COMPLETED|Overall Study||0
3379943|NCT00573391|4114527|FG001|COMPLETED|Overall Study||0
3379944|NCT00573391|4114526|FG000|NOT COMPLETED|Overall Study||3
3379945|NCT00573391|4114527|FG001|NOT COMPLETED|Overall Study||2
3379946|NCT00570258|4114535|FG000|STARTED|Overall Study||12
3379947|NCT00570258|4114536|FG001|STARTED|Overall Study||15
3379948|NCT00570258|4114535|FG000|COMPLETED|Overall Study|Early termination due to a change in drug FDA approval.|0
3379949|NCT00570258|4114536|FG001|COMPLETED|Overall Study|Early termination due to a change in drug FDA approval.|0
3379950|NCT00570258|4114535|FG000|NOT COMPLETED|Overall Study||12
3379951|NCT00570258|4114536|FG001|NOT COMPLETED|Overall Study||15
3379952|NCT00568802|4114544|FG000|STARTED|Overall Study||27
3379953|NCT00568802|4114544|FG000|COMPLETED|Overall Study||24
3379954|NCT00568802|4114544|FG000|NOT COMPLETED|Overall Study||3
3379955|NCT00576524|4114552|FG000|STARTED|Overall Study||2
3379956|NCT00576524|4114553|FG001|STARTED|Overall Study||0
3379957|NCT00576524|4114552|FG000|COMPLETED|Overall Study||2
3379958|NCT00576524|4114553|FG001|COMPLETED|Overall Study||0
3379959|NCT00576524|4114552|FG000|NOT COMPLETED|Overall Study||0
3379960|NCT00576524|4114553|FG001|NOT COMPLETED|Overall Study||0
3379961|NCT00568698|4114563|FG000|STARTED|Overall Study||29
3379962|NCT00568698|4114563|FG000|COMPLETED|Overall Study||18
3379963|NCT00568698|4114563|FG000|NOT COMPLETED|Overall Study||11
3379964|NCT00574080|4114571|FG000|STARTED|Overall Study||10
3379965|NCT00574080|4114572|FG001|STARTED|Overall Study||10
3379966|NCT00574080|4114571|FG000|COMPLETED|Overall Study||0
3379967|NCT00574080|4114572|FG001|COMPLETED|Overall Study||0
3379968|NCT00574080|4114571|FG000|NOT COMPLETED|Overall Study||10
3379969|NCT00574080|4114572|FG001|NOT COMPLETED|Overall Study||10
3379970|NCT00558558|4114578|FG000|STARTED|Overall Study||6
3379971|NCT00558558|4114578|FG000|COMPLETED|Overall Study||0
3379972|NCT00558558|4114578|FG000|NOT COMPLETED|Overall Study||6
3379973|NCT00577356|4114582|FG000|STARTED|Overall Study||6
3379974|NCT00577356|4114582|FG000|COMPLETED|Overall Study||6
3379975|NCT00577356|4114582|FG000|NOT COMPLETED|Overall Study||0
3379976|NCT00573937|4114588|FG000|STARTED|Overall Study||0
3379977|NCT00573937|4114589|FG001|STARTED|Overall Study||1
3379978|NCT00573937|4114588|FG000|COMPLETED|Overall Study||0
3379979|NCT00573937|4114589|FG001|COMPLETED|Overall Study||0
3379980|NCT00573937|4114588|FG000|NOT COMPLETED|Overall Study||0
3379981|NCT00573937|4114589|FG001|NOT COMPLETED|Overall Study||1
3379982|NCT00577317|4114597|FG000|STARTED|Overall Study||0
3379983|NCT00577317|4114598|FG001|STARTED|Overall Study||2
3379984|NCT00577317|4114597|FG000|COMPLETED|Overall Study||0
3379985|NCT00577317|4114598|FG001|COMPLETED|Overall Study||0
3379986|NCT00577317|4114597|FG000|NOT COMPLETED|Overall Study||0
3379987|NCT00577317|4114598|FG001|NOT COMPLETED|Overall Study||2
3379988|NCT00571922|4114606|FG000|STARTED|Overall Study||36
3379989|NCT00571922|4114607|FG001|STARTED|Overall Study||36
3379990|NCT00571922|4114606|FG000|COMPLETED|Overall Study||0
3379991|NCT00571922|4114607|FG001|COMPLETED|Overall Study||0
3379992|NCT00571922|4114606|FG000|NOT COMPLETED|Overall Study||36
3379993|NCT00571922|4114607|FG001|NOT COMPLETED|Overall Study||36
3379994|NCT00569868|4114613|FG000|STARTED|Overall Study||11
3379995|NCT00569868|4114613|FG000|COMPLETED|Overall Study||11
3379996|NCT00569868|4114613|FG000|NOT COMPLETED|Overall Study||0
3379997|NCT00573157|4114619|FG000|STARTED|Overall Study||4
3379998|NCT00573157|4114620|FG001|STARTED|Overall Study||2
3379999|NCT00573157|4114619|FG000|COMPLETED|Overall Study||0
3380000|NCT00573157|4114620|FG001|COMPLETED|Overall Study||0
3380001|NCT00573157|4114619|FG000|NOT COMPLETED|Overall Study||4
3380002|NCT00573157|4114620|FG001|NOT COMPLETED|Overall Study||2
3380003|NCT00570531|4114626|FG000|STARTED|Overall Study||6
3380004|NCT00570531|4114626|FG000|COMPLETED|Overall Study||6
3380005|NCT00570531|4114626|FG000|NOT COMPLETED|Overall Study||0
3380006|NCT00566462|4114632|FG000|STARTED|Overall Study||1
3380007|NCT00566462|4114633|FG001|STARTED|Overall Study||0
3380008|NCT00566462|4114632|FG000|COMPLETED|Overall Study||1
3380009|NCT00566462|4114633|FG001|COMPLETED|Overall Study||0
3380010|NCT00566462|4114632|FG000|NOT COMPLETED|Overall Study||0
3380011|NCT00566462|4114633|FG001|NOT COMPLETED|Overall Study||0
3380012|NCT00561912|4114639|FG000|STARTED|Overall Study||2
3380013|NCT00561912|4114639|FG000|COMPLETED|Overall Study||1
3380014|NCT00561912|4114639|FG000|NOT COMPLETED|Overall Study||1
3380015|NCT00561795|4114645|FG000|STARTED|Overall Study||6
3380016|NCT00561795|4114646|FG001|STARTED|Overall Study||6
3380017|NCT00561795|4114647|FG002|STARTED|Overall Study||0
3380018|NCT00561795|4114648|FG003|STARTED|Overall Study||0
3380019|NCT00561795|4114645|FG000|COMPLETED|Overall Study||2
3380020|NCT00561795|4114646|FG001|COMPLETED|Overall Study||0
3380021|NCT00561795|4114647|FG002|COMPLETED|Overall Study||0
3380022|NCT00561795|4114648|FG003|COMPLETED|Overall Study||0
3380023|NCT00561795|4114645|FG000|NOT COMPLETED|Overall Study||4
3380024|NCT00561795|4114646|FG001|NOT COMPLETED|Overall Study||6
3380025|NCT00561795|4114647|FG002|NOT COMPLETED|Overall Study||0
3380026|NCT00561795|4114648|FG003|NOT COMPLETED|Overall Study||0
3380027|NCT00564876|4114656|FG000|STARTED|Overall Study||2
3380028|NCT00564876|4114656|FG000|COMPLETED|Overall Study||2
3380029|NCT00564876|4114656|FG000|NOT COMPLETED|Overall Study||0
3380030|NCT00558870|4114662|FG000|STARTED|Overall Study||2
3380031|NCT00558870|4114663|FG001|STARTED|Overall Study||2
3380032|NCT00558870|4114662|FG000|COMPLETED|Overall Study||2
3380033|NCT00558870|4114663|FG001|COMPLETED|Overall Study||2
3380034|NCT00558870|4114662|FG000|NOT COMPLETED|Overall Study||0
3380035|NCT00558870|4114663|FG001|NOT COMPLETED|Overall Study||0
3380036|NCT00559897|4114669|FG000|STARTED|Overall Study||6
3380037|NCT00559897|4114669|FG000|COMPLETED|Overall Study||6
3380038|NCT00559897|4114669|FG000|NOT COMPLETED|Overall Study||0
3380039|NCT00556400|4114675|FG000|STARTED|Overall Study||1
3380040|NCT00556400|4114676|FG001|STARTED|Overall Study||0
3380041|NCT00556400|4114675|FG000|COMPLETED|Overall Study||1
3380042|NCT00556400|4114676|FG001|COMPLETED|Overall Study||0
3380043|NCT00556400|4114675|FG000|NOT COMPLETED|Overall Study||0
3380044|NCT00556400|4114676|FG001|NOT COMPLETED|Overall Study||0
3380045|NCT00556075|4114684|FG000|STARTED|Overall Study||22
3380046|NCT00556075|4114685|FG001|STARTED|Overall Study||22
3380047|NCT00556075|4114686|FG002|STARTED|Overall Study||23
3380048|NCT00556075|4114684|FG000|COMPLETED|Overall Study||9
3380049|NCT00556075|4114685|FG001|COMPLETED|Overall Study||13
3380050|NCT00556075|4114686|FG002|COMPLETED|Overall Study||15
3380051|NCT00556075|4114684|FG000|NOT COMPLETED|Overall Study||13
3380052|NCT00556075|4114685|FG001|NOT COMPLETED|Overall Study||9
3380053|NCT00556075|4114686|FG002|NOT COMPLETED|Overall Study||8
3380054|NCT00556166|4114698|FG000|STARTED|Overall Study||4
3380055|NCT00556166|4114698|FG000|COMPLETED|Overall Study||3
3380056|NCT00556166|4114698|FG000|NOT COMPLETED|Overall Study||1
3380057|NCT00521924|4114704|FG000|STARTED|Overall Study|Subjects randomized|4
3380058|NCT00521924|4114705|FG001|STARTED|Overall Study|Subjects randomized|4
3380059|NCT00521924|4114704|FG000|COMPLETED|Overall Study|At Early Termination, 1 patient completed Week 2 and 2 patients completed Week 6.|0
3380060|NCT00521924|4114705|FG001|COMPLETED|Overall Study|At Early Termination, 3 patients completed Week 6 and 1 completed Week 22.|0
3380061|NCT00521924|4114704|FG000|NOT COMPLETED|Overall Study||4
3380062|NCT00521924|4114705|FG001|NOT COMPLETED|Overall Study||4
3380063|NCT00548886|4114711|FG000|STARTED|Overall Study||7
3380064|NCT00548886|4114711|FG000|COMPLETED|Overall Study||7
3380065|NCT00548886|4114711|FG000|NOT COMPLETED|Overall Study||0
3380066|NCT00547456|4114715|FG000|STARTED|Overall Study||20
3380067|NCT00547456|4114715|FG000|COMPLETED|Overall Study||20
3380068|NCT00547456|4114715|FG000|NOT COMPLETED|Overall Study||0
3380069|NCT00539838|4114722|FG000|STARTED|Overall Study||12
3380070|NCT00539838|4114723|FG001|STARTED|Overall Study||11
3380071|NCT00539838|4114724|FG002|STARTED|Overall Study||10
3380072|NCT00539838|4114722|FG000|COMPLETED|Overall Study||5
3380073|NCT00539838|4114723|FG001|COMPLETED|Overall Study||5
3380074|NCT00539838|4114724|FG002|COMPLETED|Overall Study||1
3380075|NCT00539838|4114722|FG000|NOT COMPLETED|Overall Study||7
3380076|NCT00539838|4114723|FG001|NOT COMPLETED|Overall Study||6
3380077|NCT00539838|4114724|FG002|NOT COMPLETED|Overall Study||9
3380078|NCT00549328|4114734|FG000|STARTED|Overall Study||14
3380079|NCT00549328|4114734|FG000|COMPLETED|Overall Study||0
3380080|NCT00549328|4114734|FG000|NOT COMPLETED|Overall Study||14
3380081|NCT00548327|4114740|FG000|STARTED|Overall Study||6
3380082|NCT00548327|4114741|FG001|STARTED|Overall Study||5
3380083|NCT00548327|4114740|FG000|COMPLETED|Overall Study||6
3380084|NCT00548327|4114741|FG001|COMPLETED|Overall Study|Patient randomized to receive placebo first. While on placebo, Adverse Event lead to discontinuation|4
3380085|NCT00548327|4114740|FG000|NOT COMPLETED|Overall Study||0
3380086|NCT00548327|4114741|FG001|NOT COMPLETED|Overall Study||1
3380087|NCT00542542|4114754|FG000|STARTED|Overall Study||44
3380088|NCT00542542|4114755|FG001|STARTED|Overall Study||44
3380089|NCT00542542|4114754|FG000|COMPLETED|Overall Study||44
3380090|NCT00542542|4114755|FG001|COMPLETED|Overall Study||44
3380091|NCT00542542|4114754|FG000|NOT COMPLETED|Overall Study||0
3380092|NCT00542542|4114755|FG001|NOT COMPLETED|Overall Study||0
3380093|NCT00545506|4114763|FG000|STARTED|Overall Study||3
3380094|NCT00545506|4114764|FG001|STARTED|Overall Study||3
3380095|NCT00545506|4114763|FG000|COMPLETED|Overall Study||3
3380096|NCT00545506|4114764|FG001|COMPLETED|Overall Study||3
3380097|NCT00545506|4114763|FG000|NOT COMPLETED|Overall Study||0
3380098|NCT00545506|4114764|FG001|NOT COMPLETED|Overall Study||0
3380099|NCT00547300|4114772|FG000|STARTED|Overall Study||25
3380100|NCT00547300|4114773|FG001|STARTED|Overall Study|Two (2) patients were randomized in error, but no study medication taken.|26
3380101|NCT00547300|4114772|FG000|COMPLETED|Overall Study|No patients completed because the study was administratively terminated.|0
3380102|NCT00547300|4114773|FG001|COMPLETED|Overall Study|No patients completed because the study was administratively terminated.|0
3380103|NCT00547300|4114772|FG000|NOT COMPLETED|Overall Study||25
3380104|NCT00547300|4114773|FG001|NOT COMPLETED|Overall Study||26
3380105|NCT00539617|4114779|FG000|STARTED|Pre-screening Period||7
3380106|NCT00539617|4114779|FG000|COMPLETED|Pre-screening Period||4
3380107|NCT00539617|4114779|FG000|NOT COMPLETED|Pre-screening Period||3
3380108|NCT00539617|4114779|FG000|STARTED|Run-In Period||4
3380109|NCT00539617|4114779|FG000|COMPLETED|Run-In Period||3
3380110|NCT00539617|4114779|FG000|NOT COMPLETED|Run-In Period||1
3380111|NCT00539617|4114779|FG000|STARTED|Treatment Period||3
3380112|NCT00539617|4114779|FG000|COMPLETED|Treatment Period||3
3380113|NCT00539617|4114779|FG000|NOT COMPLETED|Treatment Period||0
3380114|NCT00546455|4114785|FG000|STARTED|Overall Study||0
3380115|NCT00546455|4114786|FG001|STARTED|Overall Study||0
3380116|NCT00546455|4114785|FG000|COMPLETED|Overall Study||0
3380117|NCT00546455|4114786|FG001|COMPLETED|Overall Study||0
3380118|NCT00546455|4114785|FG000|NOT COMPLETED|Overall Study||0
3380119|NCT00546455|4114786|FG001|NOT COMPLETED|Overall Study||0
3380120|NCT00538980|4114792|FG000|STARTED|Overall Study||10
3380121|NCT00538980|4114792|FG000|COMPLETED|Overall Study||0
3380122|NCT00538980|4114792|FG000|NOT COMPLETED|Overall Study||10
3380123|NCT00540969|4114798|FG000|STARTED|Overall Study||2
3380124|NCT00540969|4114799|FG001|STARTED|Overall Study||1
3380125|NCT00540969|4114798|FG000|COMPLETED|Overall Study||2
3380126|NCT00540969|4114799|FG001|COMPLETED|Overall Study||1
3380127|NCT00540969|4114798|FG000|NOT COMPLETED|Overall Study||0
3380128|NCT00540969|4114799|FG001|NOT COMPLETED|Overall Study||0
3380129|NCT00535262|4114805|FG000|STARTED|Overall Study|3 patients were enrolled in the study. Data was collected for only two weeks before funding expired.|3
3380130|NCT00535262|4114805|FG000|COMPLETED|Overall Study|Pharmaceutical company withdrew supply of EmSam prematurely before protocol was complete.|0
3380131|NCT00535262|4114805|FG000|NOT COMPLETED|Overall Study||3
3380132|NCT00529464|4114812|FG000|STARTED|Overall Study||0
3380133|NCT00529464|4114813|FG001|STARTED|Overall Study||0
3380134|NCT00529464|4114814|FG002|STARTED|Overall Study||0
3380135|NCT00529464|4114812|FG000|COMPLETED|Overall Study||0
3380136|NCT00529464|4114813|FG001|COMPLETED|Overall Study||0
3380137|NCT00529464|4114814|FG002|COMPLETED|Overall Study||0
3380138|NCT00529464|4114812|FG000|NOT COMPLETED|Overall Study||0
3380139|NCT00529464|4114813|FG001|NOT COMPLETED|Overall Study||0
3380140|NCT00529464|4114814|FG002|NOT COMPLETED|Overall Study||0
3380141|NCT00537199|4114822|FG000|STARTED|Overall Study||1
3380142|NCT00537199|4114822|FG000|COMPLETED|Overall Study||0
3380143|NCT00537199|4114822|FG000|NOT COMPLETED|Overall Study||1
3380144|NCT00537446|4114826|FG000|STARTED|Overall Study||8
3380145|NCT00537446|4114826|FG000|COMPLETED|Overall Study||8
3380146|NCT00537446|4114826|FG000|NOT COMPLETED|Overall Study||0
3380147|NCT00536978|4114832|FG000|STARTED|Overall Study||22
3380148|NCT00536978|4114832|FG000|COMPLETED|Overall Study||0
3380149|NCT00536978|4114832|FG000|NOT COMPLETED|Overall Study||22
3380150|NCT00524485|4114836|FG000|STARTED|Overall Study||12
3380151|NCT00524485|4114836|FG000|COMPLETED|Overall Study||7
3380152|NCT00524485|4114836|FG000|NOT COMPLETED|Overall Study||5
3380153|NCT00533351|4114842|FG000|STARTED|Period 1||7
3380154|NCT00533351|4114843|FG001|STARTED|Period 1||2
3380155|NCT00533351|4114842|FG000|COMPLETED|Period 1||5
3380156|NCT00533351|4114843|FG001|COMPLETED|Period 1||1
3380157|NCT00533351|4114842|FG000|NOT COMPLETED|Period 1||2
3380158|NCT00533351|4114843|FG001|NOT COMPLETED|Period 1||1
3380159|NCT00533351|4114842|FG000|STARTED|Period 2||5
3380160|NCT00533351|4114843|FG001|STARTED|Period 2||1
3380161|NCT00533351|4114842|FG000|COMPLETED|Period 2||5
3380162|NCT00533351|4114843|FG001|COMPLETED|Period 2||1
3380163|NCT00533351|4114842|FG000|NOT COMPLETED|Period 2||0
3380164|NCT00533351|4114843|FG001|NOT COMPLETED|Period 2||0
3380165|NCT00533351|4114842|FG000|STARTED|Period 3|Three out of the five patients who completed Period 2 continued to Period 3|3
3380166|NCT00533351|4114843|FG001|STARTED|Period 3|No patients continued to Period 3|0
3380167|NCT00533351|4114842|FG000|COMPLETED|Period 3||3
3380168|NCT00533351|4114843|FG001|COMPLETED|Period 3||0
3380169|NCT00533351|4114842|FG000|NOT COMPLETED|Period 3||0
3380170|NCT00533351|4114843|FG001|NOT COMPLETED|Period 3||0
3380171|NCT00529282|4114851|FG000|STARTED|Overall Study||0
3380172|NCT00529282|4114852|FG001|STARTED|Overall Study||2
3380173|NCT00529282|4114851|FG000|COMPLETED|Overall Study||0
3380174|NCT00529282|4114852|FG001|COMPLETED|Overall Study||2
3380175|NCT00529282|4114851|FG000|NOT COMPLETED|Overall Study||0
3380176|NCT00529282|4114852|FG001|NOT COMPLETED|Overall Study||0
3380177|NCT00524134|4114858|FG000|STARTED|Overall Study||6
3380178|NCT00524134|4114858|FG000|COMPLETED|Overall Study||4
3380179|NCT00524134|4114858|FG000|NOT COMPLETED|Overall Study||2
3380180|NCT00527748|4114862|FG000|STARTED|Overall Study||26
3380181|NCT00527748|4114862|FG000|COMPLETED|Overall Study||23
3380182|NCT00527748|4114862|FG000|NOT COMPLETED|Overall Study||3
3380183|NCT00517699|4114866|FG000|STARTED|Overall Study||5
3380184|NCT00517699|4114866|FG000|COMPLETED|Overall Study||0
3380185|NCT00517699|4114866|FG000|NOT COMPLETED|Overall Study||5
3380186|NCT00528775|4114870|FG000|STARTED|Overall Study||6
3380187|NCT00528775|4114870|FG000|COMPLETED|Overall Study||5
3380188|NCT00528775|4114870|FG000|NOT COMPLETED|Overall Study||1
3380189|NCT00528437|4114874|FG000|STARTED|Overall Study||46
3380190|NCT00528437|4114874|FG000|COMPLETED|Overall Study||46
3380191|NCT00528437|4114874|FG000|NOT COMPLETED|Overall Study||0
3380192|NCT00524511|4114880|FG000|STARTED|Overall Study||68
3380193|NCT00524511|4114881|FG001|STARTED|Overall Study||68
3380194|NCT00524511|4114880|FG000|COMPLETED|Overall Study||64
3380195|NCT00524511|4114881|FG001|COMPLETED|Overall Study||61
3380196|NCT00524511|4114880|FG000|NOT COMPLETED|Overall Study||4
3380197|NCT00524511|4114881|FG001|NOT COMPLETED|Overall Study||7
3380198|NCT00517075|4114891|FG000|STARTED|Overall Study||0
3380199|NCT00517075|4114892|FG001|STARTED|Overall Study||0
3380200|NCT00517075|4114893|FG002|STARTED|Overall Study||0
3380201|NCT00517075|4114894|FG003|STARTED|Overall Study||0
3380202|NCT00517075|4114891|FG000|COMPLETED|Overall Study||0
3380203|NCT00517075|4114892|FG001|COMPLETED|Overall Study||0
3380204|NCT00517075|4114893|FG002|COMPLETED|Overall Study||0
3380205|NCT00517075|4114894|FG003|COMPLETED|Overall Study||0
3380206|NCT00517075|4114891|FG000|NOT COMPLETED|Overall Study||0
3380207|NCT00517075|4114892|FG001|NOT COMPLETED|Overall Study||0
3380208|NCT00517075|4114893|FG002|NOT COMPLETED|Overall Study||0
3380209|NCT00517075|4114894|FG003|NOT COMPLETED|Overall Study||0
3380210|NCT00527982|4114906|FG000|STARTED|Overall Study||1
3380211|NCT00527982|4114907|FG001|STARTED|Overall Study||0
3380212|NCT00527982|4114906|FG000|COMPLETED|Overall Study||0
3380213|NCT00527982|4114907|FG001|COMPLETED|Overall Study||0
3380214|NCT00527982|4114906|FG000|NOT COMPLETED|Overall Study||1
3380215|NCT00527982|4114907|FG001|NOT COMPLETED|Overall Study||0
3380216|NCT00524459|4114913|FG000|STARTED|Overall Study||6
3380217|NCT00524459|4114913|FG000|COMPLETED|Overall Study||4
3380218|NCT00524459|4114913|FG000|NOT COMPLETED|Overall Study||2
3380219|NCT00517361|4114917|FG000|STARTED|Overall Study||11
3380220|NCT00517361|4114917|FG000|COMPLETED|Overall Study|This study has been terminated due to poor accrual.|0
3380221|NCT00517361|4114917|FG000|NOT COMPLETED|Overall Study||11
3380222|NCT00523939|4114923|FG000|STARTED|Overall Study||2
3380223|NCT00523939|4114924|FG001|STARTED|Overall Study||2
3380224|NCT00523939|4114923|FG000|COMPLETED|Overall Study||2
3380225|NCT00523939|4114924|FG001|COMPLETED|Overall Study||2
3380226|NCT00523939|4114923|FG000|NOT COMPLETED|Overall Study||0
3380227|NCT00523939|4114924|FG001|NOT COMPLETED|Overall Study||0
3380228|NCT00522457|4114929|FG000|STARTED|Overall Study||19
3380229|NCT00522457|4114929|FG000|COMPLETED|Overall Study||1
3380230|NCT00522457|4114929|FG000|NOT COMPLETED|Overall Study||18
3380231|NCT00526331|4114933|FG000|STARTED|Overall Study||55
3380232|NCT00526331|4114933|FG000|COMPLETED|Overall Study||0
3380233|NCT00526331|4114933|FG000|NOT COMPLETED|Overall Study||55
3380234|NCT00519090|4114939|FG000|STARTED|Overall Study||2
3380235|NCT00519090|4114940|FG001|STARTED|Overall Study||4
3380236|NCT00519090|4114939|FG000|COMPLETED|Overall Study||2
3380237|NCT00519090|4114940|FG001|COMPLETED|Overall Study||4
3380238|NCT00519090|4114939|FG000|NOT COMPLETED|Overall Study||0
3380239|NCT00519090|4114940|FG001|NOT COMPLETED|Overall Study||0
3380240|NCT00524394|4114946|FG000|STARTED|Overall Study||2
3380241|NCT00524394|4114946|FG000|COMPLETED|Overall Study||1
3380242|NCT00524394|4114946|FG000|NOT COMPLETED|Overall Study||1
3380243|NCT00523809|4114950|FG000|STARTED|Overall Study||5
3380244|NCT00523809|4114950|FG000|COMPLETED|Overall Study||5
3380245|NCT00523809|4114950|FG000|NOT COMPLETED|Overall Study||0
3380246|NCT00522301|4114954|FG000|STARTED|Overall Study||6
3380247|NCT00522301|4114954|FG000|COMPLETED|Overall Study||0
3380248|NCT00522301|4114954|FG000|NOT COMPLETED|Overall Study||6
3380249|NCT00517192|4114960|FG000|STARTED|Overall Study||19
3380250|NCT00517192|4114961|FG001|STARTED|Overall Study||20
3380251|NCT00517192|4114960|FG000|COMPLETED|Overall Study||0
3380252|NCT00517192|4114961|FG001|COMPLETED|Overall Study||0
3380253|NCT00517192|4114960|FG000|NOT COMPLETED|Overall Study||19
3380254|NCT00517192|4114961|FG001|NOT COMPLETED|Overall Study||20
3380255|NCT00504985|4114967|FG000|STARTED|Overall Study||14
3380256|NCT00504985|4114967|FG000|COMPLETED|Overall Study||14
3380257|NCT00504985|4114967|FG000|NOT COMPLETED|Overall Study||0
3380258|NCT00503581|4114974|FG000|STARTED|Overall Study||3
3380259|NCT00503581|4114975|FG001|STARTED|Overall Study||4
3380260|NCT00503581|4114976|FG002|STARTED|Overall Study||2
3380261|NCT00503581|4114974|FG000|COMPLETED|Overall Study||0
3380262|NCT00503581|4114975|FG001|COMPLETED|Overall Study||0
3380263|NCT00503581|4114976|FG002|COMPLETED|Overall Study||0
3380264|NCT00503581|4114974|FG000|NOT COMPLETED|Overall Study||3
3380265|NCT00503581|4114975|FG001|NOT COMPLETED|Overall Study||4
3380266|NCT00503581|4114976|FG002|NOT COMPLETED|Overall Study||2
3380267|NCT00509600|4114984|FG000|STARTED|Overall Study||1
3380268|NCT00509600|4114984|FG000|COMPLETED|Overall Study||0
3380269|NCT00509600|4114984|FG000|NOT COMPLETED|Overall Study||1
3380270|NCT00515112|4114990|FG000|STARTED|Overall Study||3
3380271|NCT00515112|4114991|FG001|STARTED|Overall Study||3
3380272|NCT00515112|4114990|FG000|COMPLETED|Overall Study||0
3380273|NCT00515112|4114991|FG001|COMPLETED|Overall Study||0
3380274|NCT00515112|4114990|FG000|NOT COMPLETED|Overall Study||3
3380275|NCT00515112|4114991|FG001|NOT COMPLETED|Overall Study||3
3380276|NCT00508872|4114997|FG000|STARTED|Overall Study||2
3380277|NCT00508872|4114997|FG000|COMPLETED|Overall Study||0
3380278|NCT00508872|4114997|FG000|NOT COMPLETED|Overall Study||2
3380279|NCT00514813|4115005|FG000|STARTED|Overall Study||15
3380280|NCT00514813|4115006|FG001|STARTED|Overall Study||86
3380281|NCT00514813|4115007|FG002|STARTED|Overall Study||47
3380282|NCT00514813|4115008|FG003|STARTED|Overall Study||4
3380283|NCT00514813|4115005|FG000|COMPLETED|Overall Study||0
3380284|NCT00514813|4115006|FG001|COMPLETED|Overall Study||0
3380285|NCT00514813|4115007|FG002|COMPLETED|Overall Study||0
3380286|NCT00514813|4115008|FG003|COMPLETED|Overall Study||0
3380287|NCT00514813|4115005|FG000|NOT COMPLETED|Overall Study||15
3380288|NCT00514813|4115006|FG001|NOT COMPLETED|Overall Study||86
3380289|NCT00514813|4115007|FG002|NOT COMPLETED|Overall Study||47
3380290|NCT00514813|4115008|FG003|NOT COMPLETED|Overall Study||4
3380291|NCT00506064|4115020|FG000|STARTED|Overall Study||1
3380292|NCT00506064|4115021|FG001|STARTED|Overall Study||0
3380293|NCT00506064|4115020|FG000|COMPLETED|Overall Study||1
3380294|NCT00506064|4115021|FG001|COMPLETED|Overall Study||0
3380295|NCT00506064|4115020|FG000|NOT COMPLETED|Overall Study||0
3380296|NCT00506064|4115021|FG001|NOT COMPLETED|Overall Study||0
3380297|NCT00503880|4115027|FG000|STARTED|Overall Study||2
3380298|NCT00503880|4115028|FG001|STARTED|Overall Study||0
3380299|NCT00503880|4115029|FG002|STARTED|Overall Study||0
3380300|NCT00503880|4115030|FG003|STARTED|Overall Study||0
3380301|NCT00503880|4115031|FG004|STARTED|Overall Study||0
3380302|NCT00503880|4115027|FG000|COMPLETED|Overall Study||0
3380303|NCT00503880|4115028|FG001|COMPLETED|Overall Study||0
3380304|NCT00503880|4115029|FG002|COMPLETED|Overall Study||0
3380305|NCT00503880|4115030|FG003|COMPLETED|Overall Study||0
3380306|NCT00503880|4115031|FG004|COMPLETED|Overall Study||0
3380307|NCT00503880|4115027|FG000|NOT COMPLETED|Overall Study||2
3380308|NCT00503880|4115028|FG001|NOT COMPLETED|Overall Study||0
3380309|NCT00503880|4115029|FG002|NOT COMPLETED|Overall Study||0
3380310|NCT00503880|4115030|FG003|NOT COMPLETED|Overall Study||0
3380311|NCT00503880|4115031|FG004|NOT COMPLETED|Overall Study||0
3380312|NCT00511329|4115037|FG000|STARTED|Overall Study||0
3380313|NCT00511329|4115037|FG000|COMPLETED|Overall Study||0
3380314|NCT00511329|4115037|FG000|NOT COMPLETED|Overall Study||0
3380315|NCT00501228|4115041|FG000|STARTED|Overall Study||2
3380316|NCT00501228|4115041|FG000|COMPLETED|Overall Study||1
3380317|NCT00501228|4115041|FG000|NOT COMPLETED|Overall Study||1
3380318|NCT00496782|4115047|FG000|STARTED|Overall Study||9
3380319|NCT00496782|4115048|FG001|STARTED|Overall Study||7
3380320|NCT00496782|4115047|FG000|COMPLETED|Overall Study||8
3380321|NCT00496782|4115048|FG001|COMPLETED|Overall Study||5
3380322|NCT00496782|4115047|FG000|NOT COMPLETED|Overall Study||1
3380323|NCT00496782|4115048|FG001|NOT COMPLETED|Overall Study||2
3380324|NCT00506909|4115054|FG000|STARTED|Overall Study||0
3380325|NCT00506909|4115054|FG000|COMPLETED|Overall Study||0
3380326|NCT00506909|4115054|FG000|NOT COMPLETED|Overall Study||0
3380327|NCT00487578|4115060|FG000|STARTED|Overall Study||3
3380328|NCT00487578|4115061|FG001|STARTED|Overall Study||9
3380329|NCT00487578|4115060|FG000|COMPLETED|Overall Study||2
3380330|NCT00487578|4115061|FG001|COMPLETED|Overall Study||5
3380331|NCT00487578|4115060|FG000|NOT COMPLETED|Overall Study||1
3380332|NCT00487578|4115061|FG001|NOT COMPLETED|Overall Study||4
3380333|NCT00503009|4115070|FG000|STARTED|Overall Study||5
3380334|NCT00503009|4115071|FG001|STARTED|Overall Study||5
3380335|NCT00503009|4115072|FG002|STARTED|Overall Study||6
3380336|NCT00503009|4115070|FG000|COMPLETED|Overall Study||4
3380337|NCT00503009|4115071|FG001|COMPLETED|Overall Study||3
3380338|NCT00503009|4115072|FG002|COMPLETED|Overall Study||3
3380339|NCT00503009|4115070|FG000|NOT COMPLETED|Overall Study||1
3380340|NCT00503009|4115071|FG001|NOT COMPLETED|Overall Study||2
3380341|NCT00503009|4115072|FG002|NOT COMPLETED|Overall Study||3
3380342|NCT00500045|4115080|FG000|STARTED|Overall Study||0
3380343|NCT00500045|4115080|FG000|COMPLETED|Overall Study||0
3380344|NCT00500045|4115080|FG000|NOT COMPLETED|Overall Study||0
3380345|NCT00499590|4115087|FG000|STARTED|Overall Study||113
3380346|NCT00499590|4115088|FG001|STARTED|Overall Study||112
3380347|NCT00499590|4115089|FG002|STARTED|Overall Study||113
3380348|NCT00499590|4115087|FG000|COMPLETED|Overall Study||0
3380349|NCT00499590|4115088|FG001|COMPLETED|Overall Study||0
3380350|NCT00499590|4115089|FG002|COMPLETED|Overall Study||0
3380351|NCT00499590|4115087|FG000|NOT COMPLETED|Overall Study||113
3380352|NCT00499590|4115088|FG001|NOT COMPLETED|Overall Study||112
3380353|NCT00499590|4115089|FG002|NOT COMPLETED|Overall Study||113
3380354|NCT00501345|4115098|FG000|STARTED|Overall Study||5
3380355|NCT00501345|4115098|FG000|COMPLETED|Overall Study||5
3380356|NCT00501345|4115098|FG000|NOT COMPLETED|Overall Study||0
3380357|NCT00496756|4115102|FG000|STARTED|Overall Study||14
3380358|NCT00496756|4115102|FG000|COMPLETED|Overall Study||11
3380359|NCT00496756|4115102|FG000|NOT COMPLETED|Overall Study||3
3380360|NCT00495716|4115108|FG000|STARTED|Overall Study||35
3380361|NCT00495716|4115109|FG001|STARTED|Overall Study||37
3380362|NCT00495716|4115108|FG000|COMPLETED|Overall Study||20
3380363|NCT00495716|4115109|FG001|COMPLETED|Overall Study||24
3380364|NCT00495716|4115108|FG000|NOT COMPLETED|Overall Study||15
3380365|NCT00495716|4115109|FG001|NOT COMPLETED|Overall Study||13
3380366|NCT00500890|4115117|FG000|STARTED|Overall Study||1
3380367|NCT00500890|4115118|FG001|STARTED|Overall Study||1
3380368|NCT00500890|4115117|FG000|COMPLETED|Overall Study||1
3380369|NCT00500890|4115118|FG001|COMPLETED|Overall Study||1
3380370|NCT00500890|4115117|FG000|NOT COMPLETED|Overall Study||0
3380371|NCT00500890|4115118|FG001|NOT COMPLETED|Overall Study||0
3380372|NCT00503841|4115124|FG000|STARTED|Overall Study||44
3380373|NCT00503841|4115124|FG000|COMPLETED|Overall Study||0
3380374|NCT00503841|4115124|FG000|NOT COMPLETED|Overall Study||44
3380375|NCT00493025|4115130|FG000|STARTED|Overall Study||19
3380376|NCT00493025|4115130|FG000|COMPLETED|Overall Study|Trial stopped due to early stopping rule|0
3380377|NCT00493025|4115130|FG000|NOT COMPLETED|Overall Study||19
3380378|NCT00491400|4115137|FG000|STARTED|Overall Study||15
3380379|NCT00491400|4115138|FG001|STARTED|Overall Study||13
3380380|NCT00491400|4115137|FG000|Started First Treatment|Overall Study|1 withdrew prior to starting fenofibrate|14
3380381|NCT00491400|4115138|FG001|Started First Treatment|Overall Study|None withdrew prior to starting atorvastatin|13
3380382|NCT00491400|4115137|FG000|Completed First Treatment|Overall Study|None withdrew during fenofibrate treatment (first treatment)|14
3380383|NCT00491400|4115138|FG001|Completed First Treatment|Overall Study|4 withdrew during atorvastatin treatment (first treatment)|9
3380384|NCT00491400|4115137|FG000|Started Second Treatment|Overall Study|2 withdrew during washout period|12
3380385|NCT00491400|4115138|FG001|Started Second Treatment|Overall Study|None withdrew during the washout period|9
3380386|NCT00491400|4115137|FG000|Finished Second Treatment|Overall Study|2 withdrew during atorvastatin treatment (second treatment)|10
3380387|NCT00491400|4115138|FG001|Finished Second Treatment|Overall Study|None withdrew during fenofibrate treatment (second treatment)|9
3380388|NCT00491400|4115137|FG000|COMPLETED|Overall Study||10
3380389|NCT00491400|4115138|FG001|COMPLETED|Overall Study||9
3380390|NCT00491400|4115137|FG000|NOT COMPLETED|Overall Study||5
3380391|NCT00491400|4115138|FG001|NOT COMPLETED|Overall Study||4
3380392|NCT00490776|4115146|FG000|STARTED|Overall Study||9
3380393|NCT00490776|4115146|FG000|COMPLETED|Overall Study||0
3380394|NCT00490776|4115146|FG000|NOT COMPLETED|Overall Study||9
3380395|NCT00487162|4115152|FG000|STARTED|Overall Study||30
3380396|NCT00487162|4115153|FG001|STARTED|Overall Study||26
3380397|NCT00487162|4115152|FG000|COMPLETED|Overall Study||28
3380398|NCT00487162|4115153|FG001|COMPLETED|Overall Study||21
3380399|NCT00487162|4115152|FG000|NOT COMPLETED|Overall Study||2
3380400|NCT00487162|4115153|FG001|NOT COMPLETED|Overall Study||5
3380401|NCT00487981|4115159|FG000|STARTED|Overall Study||1
3380402|NCT00487981|4115159|FG000|COMPLETED|Overall Study||0
3380403|NCT00487981|4115159|FG000|NOT COMPLETED|Overall Study||1
3380404|NCT00491387|4115163|FG000|STARTED|Overall Study||24
3380405|NCT00491387|4115163|FG000|Study Enrollment|Overall Study||24
3380406|NCT00491387|4115163|FG000|COMPLETED|Overall Study||4
3380407|NCT00491387|4115163|FG000|NOT COMPLETED|Overall Study||20
3380408|NCT00475332|4115167|FG000|STARTED|Overall Study||2
3380409|NCT00475332|4115167|FG000|COMPLETED|Overall Study||2
3380410|NCT00475332|4115167|FG000|NOT COMPLETED|Overall Study||0
3380411|NCT00483119|4115174|FG000|STARTED|Overall Study||5
3380412|NCT00483119|4115175|FG001|STARTED|Overall Study||4
3380413|NCT00483119|4115174|FG000|COMPLETED|Overall Study||4
3380414|NCT00483119|4115175|FG001|COMPLETED|Overall Study||3
3380415|NCT00483119|4115174|FG000|NOT COMPLETED|Overall Study||1
3380416|NCT00483119|4115175|FG001|NOT COMPLETED|Overall Study||1
3380417|NCT00487461|4115184|FG000|STARTED|Overall Study||2
3380418|NCT00487461|4115185|FG001|STARTED|Overall Study||12
3380419|NCT00487461|4115186|FG002|STARTED|Overall Study||11
3380420|NCT00487461|4115184|FG000|COMPLETED|Overall Study||2
3380421|NCT00487461|4115185|FG001|COMPLETED|Overall Study||10
3380422|NCT00487461|4115186|FG002|COMPLETED|Overall Study||7
3380423|NCT00487461|4115184|FG000|NOT COMPLETED|Overall Study||0
3380424|NCT00487461|4115185|FG001|NOT COMPLETED|Overall Study||2
3380425|NCT00487461|4115186|FG002|NOT COMPLETED|Overall Study||4
3380426|NCT00484718|4115194|FG000|STARTED|Treatment Period 1 (2 Weeks)||1
3380427|NCT00484718|4115195|FG001|STARTED|Treatment Period 1 (2 Weeks)||1
3380428|NCT00484718|4115196|FG002|STARTED|Treatment Period 1 (2 Weeks)||1
3380429|NCT00484718|4115197|FG003|STARTED|Treatment Period 1 (2 Weeks)||1
3380430|NCT00484718|4115198|FG004|STARTED|Treatment Period 1 (2 Weeks)||1
3380431|NCT00484718|4115199|FG005|STARTED|Treatment Period 1 (2 Weeks)||1
3380432|NCT00484718|4115194|FG000|COMPLETED|Treatment Period 1 (2 Weeks)||1
3380433|NCT00484718|4115195|FG001|COMPLETED|Treatment Period 1 (2 Weeks)||1
3380434|NCT00484718|4115196|FG002|COMPLETED|Treatment Period 1 (2 Weeks)||1
3380435|NCT00484718|4115197|FG003|COMPLETED|Treatment Period 1 (2 Weeks)||1
3380436|NCT00484718|4115198|FG004|COMPLETED|Treatment Period 1 (2 Weeks)||1
3380437|NCT00484718|4115199|FG005|COMPLETED|Treatment Period 1 (2 Weeks)||1
3380438|NCT00484718|4115194|FG000|NOT COMPLETED|Treatment Period 1 (2 Weeks)||0
3380439|NCT00484718|4115195|FG001|NOT COMPLETED|Treatment Period 1 (2 Weeks)||0
3380440|NCT00484718|4115196|FG002|NOT COMPLETED|Treatment Period 1 (2 Weeks)||0
3380441|NCT00484718|4115197|FG003|NOT COMPLETED|Treatment Period 1 (2 Weeks)||0
3380442|NCT00484718|4115198|FG004|NOT COMPLETED|Treatment Period 1 (2 Weeks)||0
3380443|NCT00484718|4115199|FG005|NOT COMPLETED|Treatment Period 1 (2 Weeks)||0
3380444|NCT00484718|4115194|FG000|STARTED|Washout Period (2 Weeks)||1
3380445|NCT00484718|4115195|FG001|STARTED|Washout Period (2 Weeks)||1
3380446|NCT00484718|4115196|FG002|STARTED|Washout Period (2 Weeks)||1
3380447|NCT00484718|4115197|FG003|STARTED|Washout Period (2 Weeks)||1
3380448|NCT00484718|4115198|FG004|STARTED|Washout Period (2 Weeks)||1
3380449|NCT00484718|4115199|FG005|STARTED|Washout Period (2 Weeks)||1
3380450|NCT00484718|4115194|FG000|COMPLETED|Washout Period (2 Weeks)||1
3380451|NCT00484718|4115195|FG001|COMPLETED|Washout Period (2 Weeks)||1
3380452|NCT00484718|4115196|FG002|COMPLETED|Washout Period (2 Weeks)||1
3380453|NCT00484718|4115197|FG003|COMPLETED|Washout Period (2 Weeks)||1
3380454|NCT00484718|4115198|FG004|COMPLETED|Washout Period (2 Weeks)||1
3380455|NCT00484718|4115199|FG005|COMPLETED|Washout Period (2 Weeks)||1
3380456|NCT00484718|4115194|FG000|NOT COMPLETED|Washout Period (2 Weeks)||0
3380457|NCT00484718|4115195|FG001|NOT COMPLETED|Washout Period (2 Weeks)||0
3380458|NCT00484718|4115196|FG002|NOT COMPLETED|Washout Period (2 Weeks)||0
3380459|NCT00484718|4115197|FG003|NOT COMPLETED|Washout Period (2 Weeks)||0
3380460|NCT00484718|4115198|FG004|NOT COMPLETED|Washout Period (2 Weeks)||0
3380461|NCT00484718|4115199|FG005|NOT COMPLETED|Washout Period (2 Weeks)||0
3380462|NCT00484718|4115194|FG000|STARTED|Treatment Period 2 (2 Weeks)||1
3380463|NCT00484718|4115195|FG001|STARTED|Treatment Period 2 (2 Weeks)||1
3380464|NCT00484718|4115196|FG002|STARTED|Treatment Period 2 (2 Weeks)||1
3380465|NCT00484718|4115197|FG003|STARTED|Treatment Period 2 (2 Weeks)||1
3380466|NCT00484718|4115198|FG004|STARTED|Treatment Period 2 (2 Weeks)||1
3380467|NCT00484718|4115199|FG005|STARTED|Treatment Period 2 (2 Weeks)||1
3380468|NCT00484718|4115194|FG000|COMPLETED|Treatment Period 2 (2 Weeks)||1
3380469|NCT00484718|4115195|FG001|COMPLETED|Treatment Period 2 (2 Weeks)||1
3380470|NCT00484718|4115196|FG002|COMPLETED|Treatment Period 2 (2 Weeks)||1
3380471|NCT00484718|4115197|FG003|COMPLETED|Treatment Period 2 (2 Weeks)||1
3380472|NCT00484718|4115198|FG004|COMPLETED|Treatment Period 2 (2 Weeks)||1
3380473|NCT00484718|4115199|FG005|COMPLETED|Treatment Period 2 (2 Weeks)||1
3380474|NCT00484718|4115194|FG000|NOT COMPLETED|Treatment Period 2 (2 Weeks)||0
3380475|NCT00484718|4115195|FG001|NOT COMPLETED|Treatment Period 2 (2 Weeks)||0
3380476|NCT00484718|4115196|FG002|NOT COMPLETED|Treatment Period 2 (2 Weeks)||0
3380477|NCT00484718|4115197|FG003|NOT COMPLETED|Treatment Period 2 (2 Weeks)||0
3380478|NCT00484718|4115198|FG004|NOT COMPLETED|Treatment Period 2 (2 Weeks)||0
3380479|NCT00484718|4115199|FG005|NOT COMPLETED|Treatment Period 2 (2 Weeks)||0
3380480|NCT00484718|4115194|FG000|STARTED|Washout Period (2 Weeks)||1
3380481|NCT00484718|4115195|FG001|STARTED|Washout Period (2 Weeks)||1
3380482|NCT00484718|4115196|FG002|STARTED|Washout Period (2 Weeks)||1
3380483|NCT00484718|4115197|FG003|STARTED|Washout Period (2 Weeks)||1
3380484|NCT00484718|4115198|FG004|STARTED|Washout Period (2 Weeks)||1
3380485|NCT00484718|4115199|FG005|STARTED|Washout Period (2 Weeks)||1
3380486|NCT00484718|4115194|FG000|COMPLETED|Washout Period (2 Weeks)||1
3380487|NCT00484718|4115195|FG001|COMPLETED|Washout Period (2 Weeks)||1
3380488|NCT00484718|4115196|FG002|COMPLETED|Washout Period (2 Weeks)||1
3380489|NCT00484718|4115197|FG003|COMPLETED|Washout Period (2 Weeks)||1
3380490|NCT00484718|4115198|FG004|COMPLETED|Washout Period (2 Weeks)||1
3380491|NCT00484718|4115199|FG005|COMPLETED|Washout Period (2 Weeks)||1
3380492|NCT00484718|4115194|FG000|NOT COMPLETED|Washout Period (2 Weeks)||0
3380493|NCT00484718|4115195|FG001|NOT COMPLETED|Washout Period (2 Weeks)||0
3380494|NCT00484718|4115196|FG002|NOT COMPLETED|Washout Period (2 Weeks)||0
3380495|NCT00484718|4115197|FG003|NOT COMPLETED|Washout Period (2 Weeks)||0
3380496|NCT00484718|4115198|FG004|NOT COMPLETED|Washout Period (2 Weeks)||0
3380497|NCT00484718|4115199|FG005|NOT COMPLETED|Washout Period (2 Weeks)||0
3380498|NCT00484718|4115194|FG000|STARTED|Treatment Period 3 (2 Weeks)||1
3380499|NCT00484718|4115195|FG001|STARTED|Treatment Period 3 (2 Weeks)||1
3380500|NCT00484718|4115196|FG002|STARTED|Treatment Period 3 (2 Weeks)||1
3380501|NCT00484718|4115197|FG003|STARTED|Treatment Period 3 (2 Weeks)||1
3380502|NCT00484718|4115198|FG004|STARTED|Treatment Period 3 (2 Weeks)||1
3380503|NCT00484718|4115199|FG005|STARTED|Treatment Period 3 (2 Weeks)||1
3380504|NCT00484718|4115194|FG000|COMPLETED|Treatment Period 3 (2 Weeks)||1
3380505|NCT00484718|4115195|FG001|COMPLETED|Treatment Period 3 (2 Weeks)||1
3380506|NCT00484718|4115196|FG002|COMPLETED|Treatment Period 3 (2 Weeks)||1
3380507|NCT00484718|4115197|FG003|COMPLETED|Treatment Period 3 (2 Weeks)||1
3380508|NCT00484718|4115198|FG004|COMPLETED|Treatment Period 3 (2 Weeks)||1
3380509|NCT00484718|4115199|FG005|COMPLETED|Treatment Period 3 (2 Weeks)||1
3380510|NCT00484718|4115194|FG000|NOT COMPLETED|Treatment Period 3 (2 Weeks)||0
3380511|NCT00484718|4115195|FG001|NOT COMPLETED|Treatment Period 3 (2 Weeks)||0
3380512|NCT00484718|4115196|FG002|NOT COMPLETED|Treatment Period 3 (2 Weeks)||0
3380513|NCT00484718|4115197|FG003|NOT COMPLETED|Treatment Period 3 (2 Weeks)||0
3380514|NCT00484718|4115198|FG004|NOT COMPLETED|Treatment Period 3 (2 Weeks)||0
3380515|NCT00484718|4115199|FG005|NOT COMPLETED|Treatment Period 3 (2 Weeks)||0
3380516|NCT00477230|4115209|FG000|STARTED|Overall Study||32
3380517|NCT00477230|4115210|FG001|STARTED|Overall Study||32
3380518|NCT00477230|4115209|FG000|COMPLETED|Overall Study||12
3380519|NCT00477230|4115210|FG001|COMPLETED|Overall Study||1
3380520|NCT00477230|4115209|FG000|NOT COMPLETED|Overall Study||20
3380521|NCT00477230|4115210|FG001|NOT COMPLETED|Overall Study||31
3380522|NCT00470067|4115216|FG000|STARTED|Overall Study||9
3380523|NCT00470067|4115216|FG000|COMPLETED|Overall Study||2
3380524|NCT00470067|4115216|FG000|NOT COMPLETED|Overall Study||7
3380525|NCT00476827|4115226|FG000|STARTED|Overall Study||3
3380526|NCT00476827|4115227|FG001|STARTED|Overall Study||0
3380527|NCT00476827|4115228|FG002|STARTED|Overall Study||1
3380528|NCT00476827|4115229|FG003|STARTED|Overall Study||0
3380529|NCT00476827|4115230|FG004|STARTED|Overall Study||2
3380530|NCT00476827|4115231|FG005|STARTED|Overall Study||2
3380531|NCT00476827|4115226|FG000|COMPLETED|Overall Study||3
3380532|NCT00476827|4115227|FG001|COMPLETED|Overall Study||0
3380533|NCT00476827|4115228|FG002|COMPLETED|Overall Study||1
3380534|NCT00476827|4115229|FG003|COMPLETED|Overall Study||0
3380535|NCT00476827|4115230|FG004|COMPLETED|Overall Study||2
3380536|NCT00476827|4115231|FG005|COMPLETED|Overall Study||2
3380537|NCT00476827|4115226|FG000|NOT COMPLETED|Overall Study||0
3380538|NCT00476827|4115227|FG001|NOT COMPLETED|Overall Study||0
3380539|NCT00476827|4115228|FG002|NOT COMPLETED|Overall Study||0
3380540|NCT00476827|4115229|FG003|NOT COMPLETED|Overall Study||0
3380541|NCT00476827|4115230|FG004|NOT COMPLETED|Overall Study||0
3380542|NCT00476827|4115231|FG005|NOT COMPLETED|Overall Study||0
3380543|NCT00475657|4115243|FG000|STARTED|Overall Study||5
3380544|NCT00475657|4115243|FG000|COMPLETED|Overall Study||1
3380545|NCT00475657|4115243|FG000|NOT COMPLETED|Overall Study||4
3380546|NCT00472082|4115247|FG000|STARTED|Overall Study||5
3380547|NCT00472082|4115247|FG000|COMPLETED|Overall Study||0
3380548|NCT00472082|4115247|FG000|NOT COMPLETED|Overall Study||5
3380549|NCT00478062|4115251|FG000|STARTED|Overall Study||1
3380550|NCT00478062|4115251|FG000|COMPLETED|Overall Study||1
3380551|NCT00478062|4115251|FG000|NOT COMPLETED|Overall Study||0
3380552|NCT00470574|4115255|FG000|STARTED|Overall Study||7
3380553|NCT00470574|4115255|FG000|COMPLETED|Overall Study||7
3380554|NCT00470574|4115255|FG000|NOT COMPLETED|Overall Study||0
3380555|NCT00467753|4115261|FG000|STARTED|Overall Study||3
3380556|NCT00467753|4115262|FG001|STARTED|Overall Study||2
3380557|NCT00467753|4115261|FG000|COMPLETED|Overall Study||0
3380558|NCT00467753|4115262|FG001|COMPLETED|Overall Study||0
3380559|NCT00467753|4115261|FG000|NOT COMPLETED|Overall Study||3
3380560|NCT00467753|4115262|FG001|NOT COMPLETED|Overall Study||2
3380561|NCT00456612|4115272|FG000|STARTED|Overall Study||4
3380562|NCT00456612|4115272|FG000|COMPLETED|Overall Study||1
3380563|NCT00456612|4115272|FG000|NOT COMPLETED|Overall Study||3
3380564|NCT00469612|4115279|FG000|STARTED|Overall Study||2
3380565|NCT00469612|4115280|FG001|STARTED|Overall Study||0
3380566|NCT00469612|4115279|FG000|COMPLETED|Overall Study|Subjects enrolled, but no data collected. Study terminated before data collection.|0
3380567|NCT00469612|4115280|FG001|COMPLETED|Overall Study||0
3380568|NCT00469612|4115279|FG000|NOT COMPLETED|Overall Study||2
3380569|NCT00469612|4115280|FG001|NOT COMPLETED|Overall Study||0
3380570|NCT00461812|4115286|FG000|STARTED|Overall Study||10
3380571|NCT00461812|4115286|FG000|COMPLETED|Overall Study||0
3380572|NCT00461812|4115286|FG000|NOT COMPLETED|Overall Study||10
3380573|NCT00459121|4115291|FG000|STARTED|Overall Study||2
3380574|NCT00459121|4115291|FG000|COMPLETED|Overall Study||2
3380575|NCT00459121|4115291|FG000|NOT COMPLETED|Overall Study||0
3380576|NCT00461682|4115296|FG000|STARTED|Overall Study||1
3380577|NCT00461682|4115296|FG000|COMPLETED|Overall Study||0
3380578|NCT00461682|4115296|FG000|NOT COMPLETED|Overall Study||1
3380579|NCT00462904|4115302|FG000|STARTED|Overall Study||4
3380580|NCT00462904|4115302|FG000|COMPLETED|Overall Study||3
3380581|NCT00462904|4115302|FG000|NOT COMPLETED|Overall Study||1
3380582|NCT00450333|4115310|FG000|STARTED|Overall Study||98
3380583|NCT00450333|4115311|FG001|STARTED|Overall Study||107
3380584|NCT00450333|4115312|FG002|STARTED|Overall Study||100
3380585|NCT00450333|4115313|FG003|STARTED|Overall Study||102
3380586|NCT00450333|4115310|FG000|COMPLETED|Overall Study||44
3380587|NCT00450333|4115311|FG001|COMPLETED|Overall Study||44
3380588|NCT00450333|4115312|FG002|COMPLETED|Overall Study||75
3380589|NCT00450333|4115313|FG003|COMPLETED|Overall Study||74
3380590|NCT00450333|4115310|FG000|NOT COMPLETED|Overall Study||54
3380591|NCT00450333|4115311|FG001|NOT COMPLETED|Overall Study||63
3380592|NCT00450333|4115312|FG002|NOT COMPLETED|Overall Study||25
3380593|NCT00450333|4115313|FG003|NOT COMPLETED|Overall Study||28
3380594|NCT00455143|4115323|FG000|STARTED|Overall Study||27
3380595|NCT00455143|4115323|FG000|COMPLETED|Overall Study||21
3380596|NCT00455143|4115323|FG000|NOT COMPLETED|Overall Study||6
3380597|NCT00456989|4115328|FG000|STARTED|Overall Study||39
3380598|NCT00456989|4115328|FG000|COMPLETED|Overall Study||39
3380599|NCT00456989|4115328|FG000|NOT COMPLETED|Overall Study||0
3380600|NCT00448682|4115333|FG000|STARTED|Overall Study||25
3380601|NCT00448682|4115333|FG000|COMPLETED|Overall Study||25
3380602|NCT00448682|4115333|FG000|NOT COMPLETED|Overall Study||0
3380603|NCT00454571|4115339|FG000|STARTED|Overall Study||18
3380604|NCT00454571|4115340|FG001|STARTED|Overall Study||19
3380605|NCT00454571|4115339|FG000|COMPLETED|Overall Study||5
3380606|NCT00454571|4115340|FG001|COMPLETED|Overall Study||13
3380607|NCT00454571|4115339|FG000|NOT COMPLETED|Overall Study||13
3380608|NCT00454571|4115340|FG001|NOT COMPLETED|Overall Study||6
3380609|NCT00452361|4115348|FG000|STARTED|Overall Study||21
3380610|NCT00452361|4115349|FG001|STARTED|Overall Study||10
3380611|NCT00452361|4115348|FG000|COMPLETED|Overall Study||0
3380612|NCT00452361|4115349|FG001|COMPLETED|Overall Study||0
3380613|NCT00452361|4115348|FG000|NOT COMPLETED|Overall Study||21
3380614|NCT00452361|4115349|FG001|NOT COMPLETED|Overall Study||10
3380615|NCT00443040|4115358|FG000|STARTED|Overall Study||14
3380616|NCT00443040|4115359|FG001|STARTED|Overall Study||11
3380617|NCT00443040|4115360|FG002|STARTED|Overall Study||10
3380618|NCT00443040|4115358|FG000|COMPLETED|Overall Study||10
3380619|NCT00443040|4115359|FG001|COMPLETED|Overall Study||11
3380620|NCT00443040|4115360|FG002|COMPLETED|Overall Study||9
3380621|NCT00443040|4115358|FG000|NOT COMPLETED|Overall Study||4
3380622|NCT00443040|4115359|FG001|NOT COMPLETED|Overall Study||0
3380623|NCT00443040|4115360|FG002|NOT COMPLETED|Overall Study||1
3380624|NCT00447421|4115368|FG000|STARTED|Overall Study||9
3380625|NCT00447421|4115368|FG000|COMPLETED|Overall Study||3
3380626|NCT00447421|4115368|FG000|NOT COMPLETED|Overall Study||6
3380627|NCT00441272|4115374|FG000|STARTED|Overall Study||25
3380628|NCT00441272|4115375|FG001|STARTED|Overall Study||25
3380629|NCT00441272|4115374|FG000|COMPLETED|Overall Study|Study terminated prior to enrollment.|0
3380630|NCT00441272|4115375|FG001|COMPLETED|Overall Study|Study terminated prior to enrollment.|0
3380631|NCT00441272|4115374|FG000|NOT COMPLETED|Overall Study||25
3380632|NCT00441272|4115375|FG001|NOT COMPLETED|Overall Study||25
3380633|NCT00437398|4115381|FG000|STARTED|Overall Study||2
3380634|NCT00437398|4115381|FG000|COMPLETED|Overall Study||2
3380635|NCT00437398|4115381|FG000|NOT COMPLETED|Overall Study||0
3380636|NCT00440271|4115387|FG000|STARTED|Overall Study||15
3380637|NCT00440271|4115388|FG001|STARTED|Overall Study||18
3380638|NCT00440271|4115387|FG000|COMPLETED|Overall Study||3
3380639|NCT00440271|4115388|FG001|COMPLETED|Overall Study||3
3380640|NCT00440271|4115387|FG000|NOT COMPLETED|Overall Study||12
3380641|NCT00440271|4115388|FG001|NOT COMPLETED|Overall Study||15
3380642|NCT00442260|4115394|FG000|STARTED|Overall Study||2
3380643|NCT00442260|4115394|FG000|COMPLETED|Overall Study||2
3380644|NCT00442260|4115394|FG000|NOT COMPLETED|Overall Study||0
3380645|NCT00429026|4115398|FG000|STARTED|Overall Study||40
3380646|NCT00429026|4115398|FG000|COMPLETED|Overall Study||0
3380647|NCT00429026|4115398|FG000|NOT COMPLETED|Overall Study||40
3380648|NCT00428207|4115402|FG000|STARTED|Overall Study||2
3380649|NCT00428207|4115403|FG001|STARTED|Overall Study||2
3380650|NCT00428207|4115402|FG000|COMPLETED|Overall Study||2
3380651|NCT00428207|4115403|FG001|COMPLETED|Overall Study||2
3380652|NCT00428207|4115402|FG000|NOT COMPLETED|Overall Study||0
3380653|NCT00428207|4115403|FG001|NOT COMPLETED|Overall Study||0
3380654|NCT00439569|4115409|FG000|STARTED|Cohort 1 (500 mg/kg/Day)||7
3380655|NCT00439569|4115409|FG000|COMPLETED|Cohort 1 (500 mg/kg/Day)||3
3380656|NCT00439569|4115409|FG000|NOT COMPLETED|Cohort 1 (500 mg/kg/Day)||4
3380657|NCT00439569|4115409|FG000|STARTED|Cohort 2 (500 mg/kg/Day)|2 new subjects in Cohort 2 were enrolled into the study after Cohort 1 completed the study.|2
3380658|NCT00439569|4115409|FG000|COMPLETED|Cohort 2 (500 mg/kg/Day)||1
3380659|NCT00439569|4115409|FG000|NOT COMPLETED|Cohort 2 (500 mg/kg/Day)||1
3380660|NCT00422669|4115416|FG000|STARTED|Overall Study|Data required for analysis was not collected due to early termination. Analysis will not be done.|98
3380661|NCT00422669|4115417|FG001|STARTED|Overall Study|Data required for analysis was not collected due to early termination. Analysis will not be done.|100
3380662|NCT00422669|4115418|FG002|STARTED|Overall Study||7
3380663|NCT00422669|4115416|FG000|COMPLETED|Overall Study|Data required for analysis was not collected due to early termination. Analysis will not be done.|0
3380664|NCT00422669|4115417|FG001|COMPLETED|Overall Study|Data required for analysis was not collected due to early termination. Analysis will not be done.|0
3380665|NCT00422669|4115418|FG002|COMPLETED|Overall Study||0
3380666|NCT00422669|4115416|FG000|NOT COMPLETED|Overall Study||98
3380667|NCT00422669|4115417|FG001|NOT COMPLETED|Overall Study||100
3380668|NCT00422669|4115418|FG002|NOT COMPLETED|Overall Study||7
3380669|NCT00432445|4115424|FG000|STARTED|Overall Study||2
3380670|NCT00432445|4115424|FG000|COMPLETED|Overall Study||2
3380671|NCT00432445|4115424|FG000|NOT COMPLETED|Overall Study||0
3380672|NCT00434590|4115430|FG000|STARTED|Overall Study||5
3380673|NCT00434590|4115431|FG001|STARTED|Overall Study||5
3380674|NCT00434590|4115430|FG000|COMPLETED|Overall Study|All patients randomized had study discontinued because of premature study termination.|0
3380675|NCT00434590|4115431|FG001|COMPLETED|Overall Study||0
3380676|NCT00434590|4115430|FG000|NOT COMPLETED|Overall Study||5
3380677|NCT00434590|4115431|FG001|NOT COMPLETED|Overall Study||5
3380678|NCT00424645|4115439|FG000|STARTED|Overall Study||3
3380679|NCT00424645|4115440|FG001|STARTED|Overall Study||0
3380680|NCT00424645|4115439|FG000|COMPLETED|Overall Study||2
3380681|NCT00424645|4115440|FG001|COMPLETED|Overall Study||0
3380682|NCT00424645|4115439|FG000|NOT COMPLETED|Overall Study||1
3380683|NCT00424645|4115440|FG001|NOT COMPLETED|Overall Study||0
3380684|NCT00430027|4115446|FG000|STARTED|Overall Study||8
3380685|NCT00430027|4115446|FG000|COMPLETED|Overall Study||0
3380686|NCT00430027|4115446|FG000|NOT COMPLETED|Overall Study||8
3380687|NCT00429858|4115450|FG000|STARTED|Overall Study||21
3380688|NCT00429858|4115450|FG000|COMPLETED|Overall Study||19
3380689|NCT00429858|4115450|FG000|NOT COMPLETED|Overall Study||2
3380690|NCT00425438|4115457|FG000|STARTED|Overall Study||25
3380691|NCT00425438|4115458|FG001|STARTED|Overall Study||27
3380692|NCT00425438|4115457|FG000|COMPLETED|Overall Study||0
3380693|NCT00425438|4115458|FG001|COMPLETED|Overall Study||0
3380694|NCT00425438|4115457|FG000|NOT COMPLETED|Overall Study||25
3380695|NCT00425438|4115458|FG001|NOT COMPLETED|Overall Study||27
3380696|NCT00421954|4115464|FG000|STARTED|Overall Study||0
3380697|NCT00421954|4115464|FG000|COMPLETED|Overall Study||0
3380698|NCT00421954|4115464|FG000|NOT COMPLETED|Overall Study||0
3380699|NCT00422942|4115468|FG000|STARTED|Overall Study||3
3380700|NCT00422942|4115468|FG000|COMPLETED|Overall Study||0
3380701|NCT00422942|4115468|FG000|NOT COMPLETED|Overall Study||3
3380702|NCT00409344|4115474|FG000|STARTED|Overall Study|No participants enrolled|0
3380703|NCT00409344|4115475|FG001|STARTED|Overall Study|No participants enrolled|0
3380704|NCT00409344|4115474|FG000|COMPLETED|Overall Study|No participants were enrolled to completion|0
3380705|NCT00409344|4115475|FG001|COMPLETED|Overall Study|No participants were enrolled to completion|0
3380706|NCT00409344|4115474|FG000|NOT COMPLETED|Overall Study||0
3380707|NCT00409344|4115475|FG001|NOT COMPLETED|Overall Study||0
3380708|NCT00414453|4115481|FG000|STARTED|Overall Study||19
3380709|NCT00414453|4115481|FG000|COMPLETED|Overall Study||3
3380710|NCT00414453|4115481|FG000|NOT COMPLETED|Overall Study||16
3380711|NCT00417248|4115491|FG000|STARTED|Overall Study||8
3380712|NCT00417248|4115491|FG000|COMPLETED|Overall Study||0
3380713|NCT00417248|4115491|FG000|NOT COMPLETED|Overall Study||8
3380714|NCT00418145|4115496|FG000|STARTED|Overall Study||16
3380715|NCT00418145|4115496|FG000|COMPLETED|Overall Study||10
3380716|NCT00418145|4115496|FG000|NOT COMPLETED|Overall Study||6
3380717|NCT00418301|4115502|FG000|STARTED|Overall Study||15
3380718|NCT00418301|4115502|FG000|COMPLETED|Overall Study||12
3380719|NCT00418301|4115502|FG000|NOT COMPLETED|Overall Study||3
3380720|NCT00409331|4115506|FG000|STARTED|Overall Study||1
3380721|NCT00409331|4115506|FG000|COMPLETED|Overall Study||0
3380722|NCT00409331|4115506|FG000|NOT COMPLETED|Overall Study||1
3380723|NCT00392860|4115512|FG000|STARTED|Overall Study||3
3380724|NCT00392860|4115513|FG001|STARTED|Overall Study||0
3380725|NCT00392860|4115514|FG002|STARTED|Overall Study||1
3380726|NCT00392860|4115512|FG000|COMPLETED|Overall Study||3
3380727|NCT00392860|4115513|FG001|COMPLETED|Overall Study||0
3380728|NCT00392860|4115514|FG002|COMPLETED|Overall Study||1
3380729|NCT00392860|4115512|FG000|NOT COMPLETED|Overall Study||0
3380730|NCT00392860|4115513|FG001|NOT COMPLETED|Overall Study||0
3380731|NCT00392860|4115514|FG002|NOT COMPLETED|Overall Study||0
3380732|NCT00391430|4115523|FG000|STARTED|Overall Study||8
3380733|NCT00391430|4115524|FG001|STARTED|Overall Study||0
3380734|NCT00391430|4115525|FG002|STARTED|Overall Study||31
3380735|NCT00391430|4115523|FG000|COMPLETED|Overall Study||5
3380736|NCT00391430|4115524|FG001|COMPLETED|Overall Study||0
3380737|NCT00391430|4115525|FG002|COMPLETED|Overall Study||19
3380738|NCT00391430|4115523|FG000|NOT COMPLETED|Overall Study||3
3380739|NCT00391430|4115524|FG001|NOT COMPLETED|Overall Study||0
3380740|NCT00391430|4115525|FG002|NOT COMPLETED|Overall Study||12
3380741|NCT00399841|4115533|FG000|STARTED|Overall Study||13
3380742|NCT00399841|4115534|FG001|STARTED|Overall Study|# of participants unknown. Efforts were made to locate data. No data are available|0
3380743|NCT00399841|4115535|FG002|STARTED|Overall Study|# of participants unknown. Efforts were made to locate data. No data are available|0
3380744|NCT00399841|4115533|FG000|Permanent Implant|Overall Study||6
3380745|NCT00399841|4115534|FG001|Permanent Implant|Overall Study|# of participants unknown. Efforts were made to locate data. No data are available|0
3380746|NCT00399841|4115535|FG002|Permanent Implant|Overall Study|# of participants unknown. Efforts were made to locate data. No data are available|0
3380747|NCT00399841|4115533|FG000|12-week|Overall Study||2
3380748|NCT00399841|4115534|FG001|12-week|Overall Study|# of participants unknown. Efforts were made to locate data. No data are available|0
3380749|NCT00399841|4115535|FG002|12-week|Overall Study|# of participants unknown. Efforts were made to locate data. No data are available|0
3380750|NCT00399841|4115533|FG000|COMPLETED|Overall Study||1
3380751|NCT00399841|4115534|FG001|COMPLETED|Overall Study|# of participants unknown. Efforts were made to locate data. No data are available|0
3380752|NCT00399841|4115535|FG002|COMPLETED|Overall Study|# of participants unknown. Efforts were made to locate data. No data are available|0
3380753|NCT00399841|4115533|FG000|NOT COMPLETED|Overall Study||12
3380754|NCT00399841|4115534|FG001|NOT COMPLETED|Overall Study||0
3380755|NCT00399841|4115535|FG002|NOT COMPLETED|Overall Study||0
3380756|NCT00387673|4115540|FG000|STARTED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0
3380757|NCT00387673|4115541|FG001|STARTED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0
3380758|NCT00387673|4115542|FG002|STARTED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0
3380759|NCT00387673|4115540|FG000|COMPLETED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0
3380760|NCT00387673|4115541|FG001|COMPLETED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0
3380761|NCT00387673|4115542|FG002|COMPLETED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0
3380762|NCT00387673|4115540|FG000|NOT COMPLETED|Overall Study||0
3380763|NCT00387673|4115541|FG001|NOT COMPLETED|Overall Study||0
3380764|NCT00387673|4115542|FG002|NOT COMPLETED|Overall Study||0
3380765|NCT00386724|4115548|FG000|STARTED|Overall Study||8
3380766|NCT00386724|4115548|FG000|3 Months Post-activation|Overall Study||4
3380767|NCT00386724|4115548|FG000|COMPLETED|Overall Study||3
3380768|NCT00386724|4115548|FG000|NOT COMPLETED|Overall Study||5
3380769|NCT00387244|4115552|FG000|STARTED|Overall Study||7
3380770|NCT00387244|4115552|FG000|End of Trial|Overall Study||0
3380771|NCT00387244|4115552|FG000|COMPLETED|Overall Study||0
3380772|NCT00387244|4115552|FG000|NOT COMPLETED|Overall Study||7
3380773|NCT00384293|4115558|FG000|STARTED|MK0524A Active Run-In, Pre-randomization||937
3380774|NCT00384293|4115559|FG001|STARTED|MK0524A Active Run-In, Pre-randomization||0
3380775|NCT00384293|4115560|FG002|STARTED|MK0524A Active Run-In, Pre-randomization||0
3380776|NCT00384293|4115558|FG000|Entered Active run-in, MK0524A 1 g|MK0524A Active Run-In, Pre-randomization|Entered active run-in period and received MK0524A 1 g|937
3380777|NCT00384293|4115559|FG001|Entered Active run-in, MK0524A 1 g|MK0524A Active Run-In, Pre-randomization||0
3380778|NCT00384293|4115560|FG002|Entered Active run-in, MK0524A 1 g|MK0524A Active Run-In, Pre-randomization||0
3380779|NCT00384293|4115558|FG000|MK0524A Dose Increased to 2 g|MK0524A Active Run-In, Pre-randomization|MK0524A dose increased to 2 g in active run-in period|813
3380780|NCT00384293|4115559|FG001|MK0524A Dose Increased to 2 g|MK0524A Active Run-In, Pre-randomization||0
3380781|NCT00384293|4115560|FG002|MK0524A Dose Increased to 2 g|MK0524A Active Run-In, Pre-randomization||0
3380782|NCT00384293|4115558|FG000|COMPLETED|MK0524A Active Run-In, Pre-randomization||433
3380783|NCT00384293|4115559|FG001|COMPLETED|MK0524A Active Run-In, Pre-randomization||0
3380784|NCT00384293|4115560|FG002|COMPLETED|MK0524A Active Run-In, Pre-randomization||0
3380785|NCT00384293|4115558|FG000|NOT COMPLETED|MK0524A Active Run-In, Pre-randomization||504
3380786|NCT00384293|4115559|FG001|NOT COMPLETED|MK0524A Active Run-In, Pre-randomization||0
3380787|NCT00384293|4115560|FG002|NOT COMPLETED|MK0524A Active Run-In, Pre-randomization||0
3380788|NCT00384293|4115558|FG000|STARTED|Post-randomization Period||0
3380789|NCT00384293|4115559|FG001|STARTED|Post-randomization Period||214
3380790|NCT00384293|4115560|FG002|STARTED|Post-randomization Period||219
3380791|NCT00384293|4115558|FG000|Received ≥1 Dose of MK0524A Study Drug|Post-randomization Period||0
3380792|NCT00384293|4115559|FG001|Received ≥1 Dose of MK0524A Study Drug|Post-randomization Period|Received at least one dose of randomized study drug (All Patients as Treated Population)|214
3380793|NCT00384293|4115560|FG002|Received ≥1 Dose of MK0524A Study Drug|Post-randomization Period||218
3380794|NCT00384293|4115558|FG000|COMPLETED|Post-randomization Period||0
3380795|NCT00384293|4115559|FG001|COMPLETED|Post-randomization Period||0
3380796|NCT00384293|4115560|FG002|COMPLETED|Post-randomization Period||0
3380797|NCT00384293|4115558|FG000|NOT COMPLETED|Post-randomization Period||0
3380798|NCT00384293|4115559|FG001|NOT COMPLETED|Post-randomization Period||214
3380799|NCT00384293|4115560|FG002|NOT COMPLETED|Post-randomization Period||219
3380800|NCT00383630|4115568|FG000|STARTED|Overall Study||1
3380801|NCT00383630|4115568|FG000|COMPLETED|Overall Study||1
3380802|NCT00383630|4115568|FG000|NOT COMPLETED|Overall Study||0
3380803|NCT00374543|4115574|FG000|STARTED|Overall Study||2
3380804|NCT00374543|4115575|FG001|STARTED|Overall Study||1
3380805|NCT00374543|4115574|FG000|COMPLETED|Overall Study||2
3380806|NCT00374543|4115575|FG001|COMPLETED|Overall Study||1
3380807|NCT00374543|4115574|FG000|NOT COMPLETED|Overall Study||0
3380808|NCT00374543|4115575|FG001|NOT COMPLETED|Overall Study||0
3380809|NCT00377455|4115581|FG000|STARTED|Overall Study||5
3380810|NCT00377455|4115581|FG000|COMPLETED|Overall Study||4
3380811|NCT00377455|4115581|FG000|NOT COMPLETED|Overall Study||1
3380812|NCT00371462|4115587|FG000|STARTED|Overall Study||35
3380813|NCT00371462|4115588|FG001|STARTED|Overall Study||35
3380814|NCT00371462|4115587|FG000|COMPLETED|Overall Study||27
3380815|NCT00371462|4115588|FG001|COMPLETED|Overall Study||27
3380816|NCT00371462|4115587|FG000|NOT COMPLETED|Overall Study||8
3380817|NCT00371462|4115588|FG001|NOT COMPLETED|Overall Study||8
3380818|NCT00369265|4115596|FG000|STARTED|Overall Study||4
3380819|NCT00369265|4115597|FG001|STARTED|Overall Study||7
3380820|NCT00369265|4115596|FG000|COMPLETED|Overall Study||0
3380821|NCT00369265|4115597|FG001|COMPLETED|Overall Study||0
3380822|NCT00369265|4115596|FG000|NOT COMPLETED|Overall Study||4
3380823|NCT00369265|4115597|FG001|NOT COMPLETED|Overall Study||7
3380824|NCT00370695|4115603|FG000|STARTED|Overall Study||15
3380825|NCT00370695|4115603|FG000|12 Weeks Post-activation|Overall Study||2
3380826|NCT00370695|4115603|FG000|COMPLETED|Overall Study||0
3380827|NCT00370695|4115603|FG000|NOT COMPLETED|Overall Study||15
3380828|NCT00364689|4115610|FG000|STARTED|Overall Study||13
3380829|NCT00364689|4115610|FG000|COMPLETED|Overall Study||12
3380830|NCT00364689|4115610|FG000|NOT COMPLETED|Overall Study||1
3380831|NCT00352118|4115616|FG000|STARTED|Overall Study||4
3380832|NCT00352118|4115616|FG000|COMPLETED|Overall Study||0
3380833|NCT00352118|4115616|FG000|NOT COMPLETED|Overall Study||4
3380834|NCT00368654|4115624|FG000|STARTED|Overall Study||3
3380835|NCT00368654|4115625|FG001|STARTED|Overall Study||3
3380836|NCT00368654|4115626|FG002|STARTED|Overall Study||3
3380837|NCT00368654|4115627|FG003|STARTED|Overall Study||3
3380838|NCT00368654|4115624|FG000|COMPLETED|Overall Study||0
3380839|NCT00368654|4115625|FG001|COMPLETED|Overall Study||0
3380840|NCT00368654|4115626|FG002|COMPLETED|Overall Study||0
3380841|NCT00368654|4115627|FG003|COMPLETED|Overall Study||0
3380842|NCT00368654|4115624|FG000|NOT COMPLETED|Overall Study||3
3380843|NCT00368654|4115625|FG001|NOT COMPLETED|Overall Study||3
3380844|NCT00368654|4115626|FG002|NOT COMPLETED|Overall Study||3
3380845|NCT00368654|4115627|FG003|NOT COMPLETED|Overall Study||3
3380846|NCT00356421|4115639|FG000|STARTED|Overall Study||38
3380847|NCT00356421|4115640|FG001|STARTED|Overall Study||20
3380848|NCT00356421|4115639|FG000|COMPLETED|Overall Study||6
3380849|NCT00356421|4115640|FG001|COMPLETED|Overall Study||3
3380850|NCT00356421|4115639|FG000|NOT COMPLETED|Overall Study||32
3380851|NCT00356421|4115640|FG001|NOT COMPLETED|Overall Study||17
3380852|NCT00350623|4115649|FG000|STARTED|Overall Study||71
3380853|NCT00350623|4115650|FG001|STARTED|Overall Study||71
3380854|NCT00350623|4115651|FG002|STARTED|Overall Study||68
3380855|NCT00350623|4115649|FG000|COMPLETED|Overall Study||63
3380856|NCT00350623|4115650|FG001|COMPLETED|Overall Study||67
3380857|NCT00350623|4115651|FG002|COMPLETED|Overall Study||62
3380858|NCT00350623|4115649|FG000|NOT COMPLETED|Overall Study||8
3380859|NCT00350623|4115650|FG001|NOT COMPLETED|Overall Study||4
3380860|NCT00350623|4115651|FG002|NOT COMPLETED|Overall Study||6
3380861|NCT00356187|4115661|FG000|STARTED|Overall Study||0
3380862|NCT00356187|4115662|FG001|STARTED|Overall Study||0
3380863|NCT00356187|4115661|FG000|COMPLETED|Overall Study||0
3380864|NCT00356187|4115662|FG001|COMPLETED|Overall Study||0
3380865|NCT00356187|4115661|FG000|NOT COMPLETED|Overall Study||0
3380866|NCT00356187|4115662|FG001|NOT COMPLETED|Overall Study||0
3380867|NCT00353275|4115672|FG000|STARTED|Overall Study||2
3380868|NCT00353275|4115673|FG001|STARTED|Overall Study||3
3380869|NCT00353275|4115672|FG000|COMPLETED|Overall Study||2
3380870|NCT00353275|4115673|FG001|COMPLETED|Overall Study||3
3380871|NCT00353275|4115672|FG000|NOT COMPLETED|Overall Study||0
3380872|NCT00353275|4115673|FG001|NOT COMPLETED|Overall Study||0
3380873|NCT00350844|4115679|FG000|STARTED|Overall Study||6
3380874|NCT00350844|4115679|FG000|COMPLETED|Overall Study||5
3380875|NCT00350844|4115679|FG000|NOT COMPLETED|Overall Study||1
3380876|NCT00348556|4115683|FG000|STARTED|Overall Study||4
3380877|NCT00348556|4115683|FG000|COMPLETED|Overall Study||3
3380878|NCT00348556|4115683|FG000|NOT COMPLETED|Overall Study||1
3380879|NCT00319839|4115687|FG000|STARTED|Overall Study||7
3380880|NCT00319839|4115687|FG000|COMPLETED|Overall Study||1
3380881|NCT00319839|4115687|FG000|NOT COMPLETED|Overall Study||6
3380882|NCT00344019|4115694|FG000|STARTED|Overall Study||12
3380883|NCT00344019|4115695|FG001|STARTED|Overall Study||11
3380884|NCT00344019|4115696|FG002|STARTED|Overall Study||74
3380885|NCT00344019|4115694|FG000|COMPLETED|Overall Study||12
3380886|NCT00344019|4115695|FG001|COMPLETED|Overall Study||11
3380887|NCT00344019|4115696|FG002|COMPLETED|Overall Study||0
3380888|NCT00344019|4115694|FG000|NOT COMPLETED|Overall Study||0
3380889|NCT00344019|4115695|FG001|NOT COMPLETED|Overall Study||0
3380890|NCT00344019|4115696|FG002|NOT COMPLETED|Overall Study||74
3380891|NCT00338455|4115709|FG000|STARTED|Overall Study||9
3380892|NCT00338455|4115710|FG001|STARTED|Overall Study||7
3380893|NCT00338455|4115709|FG000|Administered Study Drug|Overall Study||8
3380894|NCT00338455|4115710|FG001|Administered Study Drug|Overall Study||7
3380895|NCT00338455|4115709|FG000|COMPLETED|Overall Study||6
3380896|NCT00338455|4115710|FG001|COMPLETED|Overall Study||6
3380897|NCT00338455|4115709|FG000|NOT COMPLETED|Overall Study||3
3380898|NCT00338455|4115710|FG001|NOT COMPLETED|Overall Study||1
3380899|NCT00329108|4115718|FG000|STARTED|Overall Study|study terminated due to poor recruitment|15
3380900|NCT00329108|4115719|FG001|STARTED|Overall Study|study terminated due to poor recruitment|14
3380901|NCT00329108|4115718|FG000|COMPLETED|Overall Study||5
3380902|NCT00329108|4115719|FG001|COMPLETED|Overall Study||2
3380903|NCT00329108|4115718|FG000|NOT COMPLETED|Overall Study||10
3380904|NCT00329108|4115719|FG001|NOT COMPLETED|Overall Study||12
3380905|NCT00325572|4115727|FG000|STARTED|PHASE I||45
3380906|NCT00325572|4115728|FG001|STARTED|PHASE I||44
3380907|NCT00325572|4115727|FG000|COMPLETED|PHASE I||45
3380908|NCT00325572|4115728|FG001|COMPLETED|PHASE I||44
3380909|NCT00325572|4115727|FG000|NOT COMPLETED|PHASE I||0
3380910|NCT00325572|4115728|FG001|NOT COMPLETED|PHASE I||0
3380911|NCT00325572|4115727|FG000|STARTED|PHASE ii||0
3380912|NCT00325572|4115728|FG001|STARTED|PHASE ii||0
3380913|NCT00325572|4115727|FG000|COMPLETED|PHASE ii||0
3380914|NCT00325572|4115728|FG001|COMPLETED|PHASE ii||0
3380915|NCT00325572|4115727|FG000|NOT COMPLETED|PHASE ii||0
3380916|NCT00325572|4115728|FG001|NOT COMPLETED|PHASE ii||0
3380917|NCT00333762|4115734|FG000|STARTED|Overall Study||4
3380918|NCT00333762|4115734|FG000|COMPLETED|Overall Study||0
3380919|NCT00333762|4115734|FG000|NOT COMPLETED|Overall Study||4
3380920|NCT00333229|4115740|FG000|STARTED|Overall Study||6
3380921|NCT00333229|4115741|FG001|STARTED|Overall Study||5
3380922|NCT00333229|4115740|FG000|COMPLETED|Overall Study||6
3380923|NCT00333229|4115741|FG001|COMPLETED|Overall Study||4
3380924|NCT00333229|4115740|FG000|NOT COMPLETED|Overall Study||0
3380925|NCT00333229|4115741|FG001|NOT COMPLETED|Overall Study||1
3380926|NCT00322855|4115747|FG000|STARTED|Overall Study||1
3380927|NCT00322855|4115747|FG000|COMPLETED|Overall Study||1
3380928|NCT00322855|4115747|FG000|NOT COMPLETED|Overall Study||0
3380929|NCT00323635|4115753|FG000|STARTED|Overall Study||10
3380930|NCT00323635|4115754|FG001|STARTED|Overall Study||9
3380931|NCT00323635|4115753|FG000|COMPLETED|Overall Study||10
3380932|NCT00323635|4115754|FG001|COMPLETED|Overall Study||9
3380933|NCT00323635|4115753|FG000|NOT COMPLETED|Overall Study||0
3380934|NCT00323635|4115754|FG001|NOT COMPLETED|Overall Study||0
3380935|NCT00329732|4115764|FG000|STARTED|Overall Study||2
3380936|NCT00329732|4115765|FG001|STARTED|Overall Study||0
3380937|NCT00329732|4115764|FG000|COMPLETED|Overall Study||2
3380938|NCT00329732|4115765|FG001|COMPLETED|Overall Study||0
3380939|NCT00329732|4115764|FG000|NOT COMPLETED|Overall Study||0
3380940|NCT00329732|4115765|FG001|NOT COMPLETED|Overall Study||0
3380941|NCT00320931|4115770|FG000|STARTED|Overall Study||30
3380942|NCT00320931|4115770|FG000|COMPLETED|Overall Study||30
3380943|NCT00320931|4115770|FG000|NOT COMPLETED|Overall Study||0
3380944|NCT00314353|4115776|FG000|STARTED|Protocol Therapy (8 Cycles)||4
3380945|NCT00314353|4115777|FG001|STARTED|Protocol Therapy (8 Cycles)||3
3380946|NCT00314353|4115776|FG000|COMPLETED|Protocol Therapy (8 Cycles)|COMPLETED refers to the participants completing 8 cycles of therapy.|2
3380947|NCT00314353|4115777|FG001|COMPLETED|Protocol Therapy (8 Cycles)|COMPLETED refers to the participants completing 8 cycles of therapy.|0
3380948|NCT00314353|4115776|FG000|NOT COMPLETED|Protocol Therapy (8 Cycles)||2
3380949|NCT00314353|4115777|FG001|NOT COMPLETED|Protocol Therapy (8 Cycles)||3
3380950|NCT00314353|4115776|FG000|STARTED|Follow-up|2 participants who completed 8 cycles plus 1 participant who did not complete 8 cycles therapy.|3
3380951|NCT00314353|4115777|FG001|STARTED|Follow-up||0
3380952|NCT00314353|4115776|FG000|COMPLETED|Follow-up||3
3380953|NCT00314353|4115777|FG001|COMPLETED|Follow-up||0
3380954|NCT00314353|4115776|FG000|NOT COMPLETED|Follow-up||0
3380955|NCT00314353|4115777|FG001|NOT COMPLETED|Follow-up||0
3380956|NCT00314093|4115783|FG000|STARTED|Overall Study||0
3380957|NCT00314093|4115783|FG000|COMPLETED|Overall Study||0
3380958|NCT00314093|4115783|FG000|NOT COMPLETED|Overall Study||0
3380959|NCT00314327|4115787|FG000|STARTED|Overall Study||1
3380960|NCT00314327|4115787|FG000|COMPLETED|Overall Study||0
3380961|NCT00314327|4115787|FG000|NOT COMPLETED|Overall Study||1
3380962|NCT00308113|4115795|FG000|STARTED|Overall Study||0
3380963|NCT00308113|4115796|FG001|STARTED|Overall Study||0
3380964|NCT00308113|4115797|FG002|STARTED|Overall Study||1
3380965|NCT00308113|4115798|FG003|STARTED|Overall Study||2
3380966|NCT00308113|4115795|FG000|COMPLETED|Overall Study||0
3380967|NCT00308113|4115796|FG001|COMPLETED|Overall Study||0
3380968|NCT00308113|4115797|FG002|COMPLETED|Overall Study||1
3380969|NCT00308113|4115798|FG003|COMPLETED|Overall Study||1
3380970|NCT00308113|4115795|FG000|NOT COMPLETED|Overall Study||0
3380971|NCT00308113|4115796|FG001|NOT COMPLETED|Overall Study||0
3380972|NCT00308113|4115797|FG002|NOT COMPLETED|Overall Study||0
3380973|NCT00308113|4115798|FG003|NOT COMPLETED|Overall Study||1
3380974|NCT00305643|4115810|FG000|STARTED|Overall Study||6
3380975|NCT00305643|4115811|FG001|STARTED|Overall Study||5
3380976|NCT00305643|4115810|FG000|COMPLETED|Overall Study||6
3380977|NCT00305643|4115811|FG001|COMPLETED|Overall Study||5
3380978|NCT00305643|4115810|FG000|NOT COMPLETED|Overall Study||0
3380979|NCT00305643|4115811|FG001|NOT COMPLETED|Overall Study||0
3380980|NCT00298740|4115818|FG000|STARTED|Overall Study||12
3380981|NCT00298740|4115818|FG000|COMPLETED|Overall Study||3
3380982|NCT00298740|4115818|FG000|NOT COMPLETED|Overall Study||9
3380983|NCT00301080|4115822|FG000|STARTED|Original Version (2 Arms & 4 Weeks)||4
3380984|NCT00301080|4115823|FG001|STARTED|Original Version (2 Arms & 4 Weeks)||3
3380985|NCT00301080|4115824|FG002|STARTED|Original Version (2 Arms & 4 Weeks)|This arm not part of the original version.|0
3380986|NCT00301080|4115825|FG003|STARTED|Original Version (2 Arms & 4 Weeks)|This arm not part of the original version.|0
3380987|NCT00301080|4115826|FG004|STARTED|Original Version (2 Arms & 4 Weeks)|This arm not part of the original version.|0
3380988|NCT00301080|4115822|FG000|Received an Intervention|Original Version (2 Arms & 4 Weeks)||3
3380989|NCT00301080|4115823|FG001|Received an Intervention|Original Version (2 Arms & 4 Weeks)||3
3380990|NCT00301080|4115824|FG002|Received an Intervention|Original Version (2 Arms & 4 Weeks)||0
3380991|NCT00301080|4115825|FG003|Received an Intervention|Original Version (2 Arms & 4 Weeks)||0
3380992|NCT00301080|4115826|FG004|Received an Intervention|Original Version (2 Arms & 4 Weeks)||0
3380993|NCT00301080|4115822|FG000|Completed 4 Week Intervention|Original Version (2 Arms & 4 Weeks)||3
3380994|NCT00301080|4115823|FG001|Completed 4 Week Intervention|Original Version (2 Arms & 4 Weeks)||3
3380995|NCT00301080|4115824|FG002|Completed 4 Week Intervention|Original Version (2 Arms & 4 Weeks)||0
3380996|NCT00301080|4115825|FG003|Completed 4 Week Intervention|Original Version (2 Arms & 4 Weeks)||0
3380997|NCT00301080|4115826|FG004|Completed 4 Week Intervention|Original Version (2 Arms & 4 Weeks)||0
3380998|NCT00301080|4115822|FG000|COMPLETED|Original Version (2 Arms & 4 Weeks)||3
3380999|NCT00301080|4115823|FG001|COMPLETED|Original Version (2 Arms & 4 Weeks)||3
3381000|NCT00301080|4115824|FG002|COMPLETED|Original Version (2 Arms & 4 Weeks)||0
3381001|NCT00301080|4115825|FG003|COMPLETED|Original Version (2 Arms & 4 Weeks)||0
3381002|NCT00301080|4115826|FG004|COMPLETED|Original Version (2 Arms & 4 Weeks)||0
3381003|NCT00301080|4115822|FG000|NOT COMPLETED|Original Version (2 Arms & 4 Weeks)||1
3381004|NCT00301080|4115823|FG001|NOT COMPLETED|Original Version (2 Arms & 4 Weeks)||0
3381005|NCT00301080|4115824|FG002|NOT COMPLETED|Original Version (2 Arms & 4 Weeks)||0
3381006|NCT00301080|4115825|FG003|NOT COMPLETED|Original Version (2 Arms & 4 Weeks)||0
3381007|NCT00301080|4115826|FG004|NOT COMPLETED|Original Version (2 Arms & 4 Weeks)||0
3381008|NCT00301080|4115822|FG000|STARTED|Revised Version (3 Arms & 12 Weeks)|This arm was not a part of the revised study design.|0
3381009|NCT00301080|4115823|FG001|STARTED|Revised Version (3 Arms & 12 Weeks)|This arm was not a part of the revised study design.|0
3381010|NCT00301080|4115824|FG002|STARTED|Revised Version (3 Arms & 12 Weeks)||0
3381011|NCT00301080|4115825|FG003|STARTED|Revised Version (3 Arms & 12 Weeks)||0
3381012|NCT00301080|4115826|FG004|STARTED|Revised Version (3 Arms & 12 Weeks)||0
3381013|NCT00301080|4115822|FG000|COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
3381014|NCT00301080|4115823|FG001|COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
3381015|NCT00301080|4115824|FG002|COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
3381016|NCT00301080|4115825|FG003|COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
3381017|NCT00301080|4115826|FG004|COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
3381018|NCT00301080|4115822|FG000|NOT COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
3381019|NCT00301080|4115823|FG001|NOT COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
3381020|NCT00301080|4115824|FG002|NOT COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
3381021|NCT00301080|4115825|FG003|NOT COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
3381022|NCT00301080|4115826|FG004|NOT COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
3381023|NCT00299195|4115837|FG000|STARTED|Overall Study||30
3381024|NCT00299195|4115838|FG001|STARTED|Overall Study||33
3381025|NCT00299195|4115837|FG000|COMPLETED|Overall Study||30
3381026|NCT00299195|4115838|FG001|COMPLETED|Overall Study||33
3381027|NCT00299195|4115837|FG000|NOT COMPLETED|Overall Study||0
3381028|NCT00299195|4115838|FG001|NOT COMPLETED|Overall Study||0
3381029|NCT00290407|4115844|FG000|STARTED|Overall Study||2
3381030|NCT00290407|4115844|FG000|COMPLETED|Overall Study||0
3381031|NCT00290407|4115844|FG000|NOT COMPLETED|Overall Study||2
3381032|NCT00295490|4115852|FG000|STARTED|Overall Study||15
3381033|NCT00295490|4115853|FG001|STARTED|Overall Study||19
3381034|NCT00295490|4115854|FG002|STARTED|Overall Study||16
3381035|NCT00295490|4115855|FG003|STARTED|Overall Study||17
3381036|NCT00295490|4115852|FG000|COMPLETED|Overall Study||14
3381037|NCT00295490|4115853|FG001|COMPLETED|Overall Study||15
3381038|NCT00295490|4115854|FG002|COMPLETED|Overall Study||12
3381039|NCT00295490|4115855|FG003|COMPLETED|Overall Study||12
3381040|NCT00295490|4115852|FG000|NOT COMPLETED|Overall Study||1
3381041|NCT00295490|4115853|FG001|NOT COMPLETED|Overall Study||4
3381042|NCT00295490|4115854|FG002|NOT COMPLETED|Overall Study||4
3381043|NCT00295490|4115855|FG003|NOT COMPLETED|Overall Study||5
3381044|NCT00268463|4115867|FG000|STARTED|Overall Study||10
3381045|NCT00268463|4115868|FG001|STARTED|Overall Study||12
3381046|NCT00268463|4115867|FG000|COMPLETED|Overall Study||0
3381047|NCT00268463|4115868|FG001|COMPLETED|Overall Study||0
3381048|NCT00268463|4115867|FG000|NOT COMPLETED|Overall Study||10
3381049|NCT00268463|4115868|FG001|NOT COMPLETED|Overall Study||12
3381050|NCT00271102|4115876|FG000|STARTED|Overall Study||35
3381051|NCT00271102|4115877|FG001|STARTED|Overall Study||35
3381052|NCT00271102|4115876|FG000|COMPLETED|Overall Study||30
3381053|NCT00271102|4115877|FG001|COMPLETED|Overall Study||30
3381054|NCT00271102|4115876|FG000|NOT COMPLETED|Overall Study||5
3381055|NCT00271102|4115877|FG001|NOT COMPLETED|Overall Study||5
3381056|NCT00276419|4115885|FG000|STARTED|First Intervention||8
3381057|NCT00276419|4115886|FG001|STARTED|First Intervention||10
3381058|NCT00276419|4115885|FG000|COMPLETED|First Intervention||7
3381059|NCT00276419|4115886|FG001|COMPLETED|First Intervention||8
3381060|NCT00276419|4115885|FG000|NOT COMPLETED|First Intervention||1
3381061|NCT00276419|4115886|FG001|NOT COMPLETED|First Intervention||2
3381062|NCT00276419|4115885|FG000|STARTED|Wash-out Phase||7
3381063|NCT00276419|4115886|FG001|STARTED|Wash-out Phase||8
3381064|NCT00276419|4115885|FG000|COMPLETED|Wash-out Phase||7
3381065|NCT00276419|4115886|FG001|COMPLETED|Wash-out Phase||8
3381066|NCT00276419|4115885|FG000|NOT COMPLETED|Wash-out Phase||0
3381067|NCT00276419|4115886|FG001|NOT COMPLETED|Wash-out Phase||0
3381068|NCT00276419|4115885|FG000|STARTED|Second Intervention||7
3381069|NCT00276419|4115886|FG001|STARTED|Second Intervention||8
3381070|NCT00276419|4115885|FG000|COMPLETED|Second Intervention||7
3381071|NCT00276419|4115886|FG001|COMPLETED|Second Intervention||8
3381072|NCT00276419|4115885|FG000|NOT COMPLETED|Second Intervention||0
3381073|NCT00276419|4115886|FG001|NOT COMPLETED|Second Intervention||0
3381074|NCT00279409|4115894|FG000|STARTED|Overall Study||0
3381075|NCT00279409|4115895|FG001|STARTED|Overall Study||0
3381076|NCT00279409|4115894|FG000|COMPLETED|Overall Study||0
3381077|NCT00279409|4115895|FG001|COMPLETED|Overall Study||0
3381078|NCT00279409|4115894|FG000|NOT COMPLETED|Overall Study||0
3381079|NCT00279409|4115895|FG001|NOT COMPLETED|Overall Study||0
3381080|NCT00281879|4115909|FG000|STARTED|Overall Study||128
3381081|NCT00281879|4115910|FG001|STARTED|Overall Study||36
3381082|NCT00281879|4115911|FG002|STARTED|Overall Study||20
3381083|NCT00281879|4115912|FG003|STARTED|Overall Study||0
3381084|NCT00281879|4115913|FG004|STARTED|Overall Study||6
3381085|NCT00281879|4115914|FG005|STARTED|Overall Study||9
3381086|NCT00281879|4115915|FG006|STARTED|Overall Study||0
3381087|NCT00281879|4115916|FG007|STARTED|Overall Study||1
3381088|NCT00281879|4115909|FG000|COMPLETED|Overall Study||0
3381089|NCT00281879|4115910|FG001|COMPLETED|Overall Study||0
3381090|NCT00281879|4115911|FG002|COMPLETED|Overall Study||0
3381091|NCT00281879|4115912|FG003|COMPLETED|Overall Study||0
3381092|NCT00281879|4115913|FG004|COMPLETED|Overall Study||0
3381093|NCT00281879|4115914|FG005|COMPLETED|Overall Study||0
3381094|NCT00281879|4115915|FG006|COMPLETED|Overall Study||0
3381095|NCT00281879|4115916|FG007|COMPLETED|Overall Study||0
3381096|NCT00281879|4115909|FG000|NOT COMPLETED|Overall Study||128
3381097|NCT00281879|4115910|FG001|NOT COMPLETED|Overall Study||36
3381098|NCT00281879|4115911|FG002|NOT COMPLETED|Overall Study||20
3381099|NCT00281879|4115912|FG003|NOT COMPLETED|Overall Study||0
3381100|NCT00281879|4115913|FG004|NOT COMPLETED|Overall Study||6
3381101|NCT00281879|4115914|FG005|NOT COMPLETED|Overall Study||9
3381102|NCT00281879|4115915|FG006|NOT COMPLETED|Overall Study||0
3381103|NCT00281879|4115916|FG007|NOT COMPLETED|Overall Study||1
3381104|NCT00271947|4115934|FG000|STARTED|Overall Study||1
3381105|NCT00271947|4115934|FG000|COMPLETED|Overall Study||0
3381106|NCT00271947|4115934|FG000|NOT COMPLETED|Overall Study||1
3381107|NCT00271011|4115938|FG000|STARTED|Overall Study||13
3381108|NCT00271011|4115938|FG000|COMPLETED|Overall Study||13
3381109|NCT00271011|4115938|FG000|NOT COMPLETED|Overall Study||0
3381110|NCT00253981|4115944|FG000|STARTED|Overall Study||16
3381111|NCT00253981|4115945|FG001|STARTED|Overall Study||14
3381112|NCT00253981|4115944|FG000|COMPLETED|Overall Study||16
3381113|NCT00253981|4115945|FG001|COMPLETED|Overall Study||14
3381114|NCT00253981|4115944|FG000|NOT COMPLETED|Overall Study||0
3381115|NCT00253981|4115945|FG001|NOT COMPLETED|Overall Study||0
3381116|NCT00252174|4115954|FG000|STARTED|Overall Study|No subjects were randomized into Active Arm as only 2 subjects were randomized into the Control Arm.|0
3381117|NCT00252174|4115955|FG001|STARTED|Overall Study|2 subjects entered the control arm in total|2
3381118|NCT00252174|4115956|FG002|STARTED|Overall Study|No subjects entered Stage 2|0
3381119|NCT00252174|4115954|FG000|COMPLETED|Overall Study||0
3381120|NCT00252174|4115955|FG001|COMPLETED|Overall Study||1
3381121|NCT00252174|4115956|FG002|COMPLETED|Overall Study||0
3381122|NCT00252174|4115954|FG000|NOT COMPLETED|Overall Study||0
3381123|NCT00252174|4115955|FG001|NOT COMPLETED|Overall Study||1
3381124|NCT00252174|4115956|FG002|NOT COMPLETED|Overall Study||0
3381125|NCT00256295|4115964|FG000|STARTED|Overall Study|Of the 8 subjects consented, 1 withdrew prior to treatment.|7
3381126|NCT00256295|4115964|FG000|COMPLETED|Overall Study||3
3381127|NCT00256295|4115964|FG000|NOT COMPLETED|Overall Study||4
3381128|NCT00245128|4115968|FG000|STARTED|Overall Study||10
3381129|NCT00245128|4115968|FG000|COMPLETED|Overall Study||0
3381130|NCT00245128|4115968|FG000|NOT COMPLETED|Overall Study||10
3381131|NCT00268450|4115972|FG000|STARTED|Overall Study||21
3381132|NCT00268450|4115972|FG000|COMPLETED|Overall Study||21
3381133|NCT00268450|4115972|FG000|NOT COMPLETED|Overall Study||0
3381134|NCT00239720|4115978|FG000|STARTED|Overall Study||3
3381135|NCT00239720|4115979|FG001|STARTED|Overall Study||1
3381136|NCT00239720|4115978|FG000|COMPLETED|Overall Study|One participant discontinued due to an adverse event|2
3381137|NCT00239720|4115979|FG001|COMPLETED|Overall Study|One participant lost to follow-up|0
3381138|NCT00239720|4115978|FG000|NOT COMPLETED|Overall Study||1
3381139|NCT00239720|4115979|FG001|NOT COMPLETED|Overall Study||1
3381140|NCT00250718|4115985|FG000|STARTED|Overall Study||17
3381141|NCT00250718|4115985|FG000|Received Treatment|Overall Study||16
3381142|NCT00250718|4115985|FG000|COMPLETED|Overall Study||14
3381143|NCT00250718|4115985|FG000|NOT COMPLETED|Overall Study||3
3381144|NCT00244010|4115991|FG000|STARTED|Overall Study||2
3381145|NCT00244010|4115992|FG001|STARTED|Overall Study||2
3381146|NCT00244010|4115991|FG000|COMPLETED|Overall Study||2
3381147|NCT00244010|4115992|FG001|COMPLETED|Overall Study||2
3381148|NCT00244010|4115991|FG000|NOT COMPLETED|Overall Study||0
3381149|NCT00244010|4115992|FG001|NOT COMPLETED|Overall Study||0
3381150|NCT00218036|4116003|FG000|STARTED|Overall Study||11
3381151|NCT00218036|4116004|FG001|STARTED|Overall Study||6
3381152|NCT00218036|4116005|FG002|STARTED|Overall Study||13
3381153|NCT00218036|4116006|FG003|STARTED|Overall Study||12
3381154|NCT00218036|4116007|FG004|STARTED|Overall Study||9
3381155|NCT00218036|4116003|FG000|COMPLETED|Overall Study||6
3381156|NCT00218036|4116004|FG001|COMPLETED|Overall Study||3
3381157|NCT00218036|4116005|FG002|COMPLETED|Overall Study||5
3381158|NCT00218036|4116006|FG003|COMPLETED|Overall Study||6
3381159|NCT00218036|4116007|FG004|COMPLETED|Overall Study||3
3381160|NCT00218036|4116003|FG000|NOT COMPLETED|Overall Study||5
3381161|NCT00218036|4116004|FG001|NOT COMPLETED|Overall Study||3
3381162|NCT00218036|4116005|FG002|NOT COMPLETED|Overall Study||8
3381163|NCT00218036|4116006|FG003|NOT COMPLETED|Overall Study||6
3381164|NCT00218036|4116007|FG004|NOT COMPLETED|Overall Study||6
3381165|NCT00240227|4116019|FG000|STARTED|Overall Study||8
3381166|NCT00240227|4116019|FG000|COMPLETED|Overall Study||8
3381167|NCT00240227|4116019|FG000|NOT COMPLETED|Overall Study||0
3381168|NCT00205868|4116026|FG000|STARTED|Overall Study||304
3381169|NCT00205868|4116026|FG000|COMPLETED|Overall Study||304
3381170|NCT00205868|4116026|FG000|NOT COMPLETED|Overall Study||0
3381171|NCT00206375|4116033|FG000|STARTED|Overall Study||6
3381172|NCT00206375|4116034|FG001|STARTED|Overall Study||3
3381173|NCT00206375|4116035|FG002|STARTED|Overall Study||7
3381174|NCT00206375|4116033|FG000|COMPLETED|Overall Study||3
3381175|NCT00206375|4116034|FG001|COMPLETED|Overall Study||1
3381176|NCT00206375|4116035|FG002|COMPLETED|Overall Study||3
3381177|NCT00206375|4116033|FG000|NOT COMPLETED|Overall Study||3
3381178|NCT00206375|4116034|FG001|NOT COMPLETED|Overall Study||2
3381179|NCT00206375|4116035|FG002|NOT COMPLETED|Overall Study||4
3381180|NCT00229931|4116045|FG000|STARTED|Overall Study||6
3381181|NCT00229931|4116046|FG001|STARTED|Overall Study||5
3381182|NCT00229931|4116045|FG000|COMPLETED|Overall Study||2
3381183|NCT00229931|4116046|FG001|COMPLETED|Overall Study||3
3381184|NCT00229931|4116045|FG000|NOT COMPLETED|Overall Study||4
3381185|NCT00229931|4116046|FG001|NOT COMPLETED|Overall Study||2
3381186|NCT00209131|4116054|FG000|STARTED|Overall Study|Patients enrolled for participation but did not complete the study.|15
3381187|NCT00209131|4116055|FG001|STARTED|Overall Study|Patients enrolled for participation but did not complete the study.|11
3381188|NCT00209131|4116054|FG000|COMPLETED|Overall Study|Lack of personnel for adequate followup and data collection.|0
3381189|NCT00209131|4116055|FG001|COMPLETED|Overall Study|Lack of personnel for adequate followup and data collection.|0
3381190|NCT00209131|4116054|FG000|NOT COMPLETED|Overall Study||15
3381191|NCT00209131|4116055|FG001|NOT COMPLETED|Overall Study||11
3381192|NCT00233090|4116063|FG000|STARTED|Overall Study||12
3381193|NCT00233090|4116064|FG001|STARTED|Overall Study||9
3381194|NCT00233090|4116063|FG000|COMPLETED|Overall Study||12
3381195|NCT00233090|4116064|FG001|COMPLETED|Overall Study||9
3381196|NCT00233090|4116063|FG000|NOT COMPLETED|Overall Study||0
3381197|NCT00233090|4116064|FG001|NOT COMPLETED|Overall Study||0
3381198|NCT00214149|4116070|FG000|STARTED|Overall Study||127
3381199|NCT00214149|4116070|FG000|COMPLETED|Overall Study|No data are available; study was terminated and PI has left the institution.|0
3381200|NCT00214149|4116070|FG000|NOT COMPLETED|Overall Study||127
3381201|NCT00205049|4116076|FG000|STARTED|Overall Study||0
3381202|NCT00205049|4116077|FG001|STARTED|Overall Study||0
3381203|NCT00205049|4116076|FG000|COMPLETED|Overall Study||0
3381204|NCT00205049|4116077|FG001|COMPLETED|Overall Study||0
3381205|NCT00205049|4116076|FG000|NOT COMPLETED|Overall Study||0
3381206|NCT00205049|4116077|FG001|NOT COMPLETED|Overall Study||0
3381207|NCT00209027|4116085|FG000|STARTED|Overall Study||10
3381208|NCT00209027|4116086|FG001|STARTED|Overall Study||10
3381209|NCT00209027|4116085|FG000|COMPLETED|Overall Study||0
3381210|NCT00209027|4116086|FG001|COMPLETED|Overall Study||10
3381211|NCT00209027|4116085|FG000|NOT COMPLETED|Overall Study||10
3381212|NCT00209027|4116086|FG001|NOT COMPLETED|Overall Study||0
3381213|NCT00182637|4116092|FG000|STARTED|Overall Study|active/on treatment date|5
3381214|NCT00182637|4116092|FG000|COMPLETED|Overall Study|off study date|2
3381215|NCT00182637|4116092|FG000|NOT COMPLETED|Overall Study||3
3381216|NCT00176488|4116097|FG000|STARTED|Overall Study||31
3381217|NCT00176488|4116097|FG000|COMPLETED|Overall Study||30
3381218|NCT00176488|4116097|FG000|NOT COMPLETED|Overall Study||1
3381219|NCT00179127|4116103|FG000|STARTED|Overall Study||0
3381220|NCT00179127|4116104|FG001|STARTED|Overall Study||0
3381221|NCT00179127|4116103|FG000|COMPLETED|Overall Study||0
3381222|NCT00179127|4116104|FG001|COMPLETED|Overall Study||0
3381223|NCT00179127|4116103|FG000|NOT COMPLETED|Overall Study||0
3381224|NCT00179127|4116104|FG001|NOT COMPLETED|Overall Study||0
3381225|NCT00183963|4116114|FG000|STARTED|Overall Study||1
3381226|NCT00183963|4116115|FG001|STARTED|Overall Study||1
3381227|NCT00183963|4116116|FG002|STARTED|Overall Study||1
3381228|NCT00183963|4116117|FG003|STARTED|Overall Study||1
3381229|NCT00183963|4116114|FG000|COMPLETED|Overall Study||0
3381230|NCT00183963|4116115|FG001|COMPLETED|Overall Study||0
3381231|NCT00183963|4116116|FG002|COMPLETED|Overall Study||0
3381232|NCT00183963|4116117|FG003|COMPLETED|Overall Study||0
3381233|NCT00183963|4116114|FG000|NOT COMPLETED|Overall Study||1
3381234|NCT00183963|4116115|FG001|NOT COMPLETED|Overall Study||1
3381235|NCT00183963|4116116|FG002|NOT COMPLETED|Overall Study||1
3381236|NCT00183963|4116117|FG003|NOT COMPLETED|Overall Study||1
3381237|NCT00178477|4116130|FG000|STARTED|Overall Study||10
3381238|NCT00178477|4116130|FG000|COMPLETED|Overall Study||5
3381239|NCT00178477|4116130|FG000|NOT COMPLETED|Overall Study||5
3381240|NCT00162773|4116134|FG000|STARTED|Overall Study||29
3381241|NCT00162773|4116134|FG000|COMPLETED|Overall Study||7
3381242|NCT00162773|4116134|FG000|NOT COMPLETED|Overall Study||22
3381243|NCT00176631|4116138|FG000|STARTED|Overall Study||10
3381244|NCT00176631|4116138|FG000|COMPLETED|Overall Study||10
3381245|NCT00176631|4116138|FG000|NOT COMPLETED|Overall Study||0
3381246|NCT00176501|4116142|FG000|STARTED|Overall Study||3
3381247|NCT00176501|4116142|FG000|COMPLETED|Overall Study||3
3381248|NCT00176501|4116142|FG000|NOT COMPLETED|Overall Study||0
3381249|NCT00177970|4116148|FG000|STARTED|Overall Study|No results available record destroyed due to age of study. no publications|0
3381250|NCT00177970|4116149|FG001|STARTED|Overall Study|No results available record destroyed due to age of study. no publications|0
3381251|NCT00177970|4116148|FG000|COMPLETED|Overall Study|No results available record destroyed due to age of study. no publications|0
3381252|NCT00177970|4116149|FG001|COMPLETED|Overall Study|No results available record destroyed due to age of study. no publications|0
3381253|NCT00177970|4116148|FG000|NOT COMPLETED|Overall Study||0
3381254|NCT00177970|4116149|FG001|NOT COMPLETED|Overall Study||0
3381255|NCT00177866|4116157|FG000|STARTED|Overall Study|No results or publication, data destroyed due to age of study.|0
3381256|NCT00177866|4116158|FG001|STARTED|Overall Study|No results or publication, data destroyed due to age of study.|0
3381257|NCT00177866|4116157|FG000|COMPLETED|Overall Study|No results or publication, data destroyed due to age of study.|0
3381258|NCT00177866|4116158|FG001|COMPLETED|Overall Study|No results or publication, data destroyed due to age of study.|0
3381259|NCT00177866|4116157|FG000|NOT COMPLETED|Overall Study||0
3381260|NCT00177866|4116158|FG001|NOT COMPLETED|Overall Study||0
3381261|NCT00147238|4116164|FG000|STARTED|Overall Study||10
3381262|NCT00147238|4116164|FG000|COMPLETED|Overall Study||2
3381263|NCT00147238|4116164|FG000|NOT COMPLETED|Overall Study||8
3381264|NCT00165503|4116168|FG000|STARTED|Overall Study||16
3381265|NCT00165503|4116168|FG000|COMPLETED|Overall Study||0
3381266|NCT00165503|4116168|FG000|NOT COMPLETED|Overall Study||16
3381267|NCT00160563|4116175|FG000|STARTED|Overall Study||59
3381268|NCT00160563|4116176|FG001|STARTED|Overall Study||47
3381269|NCT00160563|4116177|FG002|STARTED|Overall Study||101
3381270|NCT00160563|4116175|FG000|COMPLETED|Overall Study||8
3381271|NCT00160563|4116176|FG001|COMPLETED|Overall Study||2
3381272|NCT00160563|4116177|FG002|COMPLETED|Overall Study||11
3381273|NCT00160563|4116175|FG000|NOT COMPLETED|Overall Study||51
3381274|NCT00160563|4116176|FG001|NOT COMPLETED|Overall Study||45
3381275|NCT00160563|4116177|FG002|NOT COMPLETED|Overall Study||90
3381276|NCT00142519|4116188|FG000|STARTED|Overall Study||25
3381277|NCT00142519|4116189|FG001|STARTED|Overall Study||25
3381278|NCT00142519|4116188|FG000|COMPLETED|Overall Study||7
3381279|NCT00142519|4116189|FG001|COMPLETED|Overall Study||9
3381280|NCT00142519|4116188|FG000|NOT COMPLETED|Overall Study||18
3381281|NCT00142519|4116189|FG001|NOT COMPLETED|Overall Study||16
3381282|NCT00145704|4116197|FG000|STARTED|Overall Study||3
3381283|NCT00145704|4116198|FG001|STARTED|Overall Study||3
3381284|NCT00145704|4116197|FG000|COMPLETED|Overall Study||0
3381285|NCT00145704|4116198|FG001|COMPLETED|Overall Study||0
3381286|NCT00145704|4116197|FG000|NOT COMPLETED|Overall Study||3
3381287|NCT00145704|4116198|FG001|NOT COMPLETED|Overall Study||3
3381288|NCT00138073|4116204|FG000|STARTED|Overall Study||55
3381289|NCT00138073|4116204|FG000|Pre-intervention Testing|Overall Study||55
3381290|NCT00138073|4116204|FG000|COMPLETED|Overall Study||0
3381291|NCT00138073|4116204|FG000|NOT COMPLETED|Overall Study||55
3381292|NCT00113386|4116210|FG000|STARTED|Overall Study||10
3381293|NCT00113386|4116211|FG001|STARTED|Overall Study||9
3381294|NCT00113386|4116210|FG000|COMPLETED|Overall Study||3
3381295|NCT00113386|4116211|FG001|COMPLETED|Overall Study||5
3381296|NCT00113386|4116210|FG000|NOT COMPLETED|Overall Study||7
3381297|NCT00113386|4116211|FG001|NOT COMPLETED|Overall Study||4
3381298|NCT00138151|4116217|FG000|STARTED|Overall Study||33
3381299|NCT00138151|4116217|FG000|COMPLETED|Overall Study||29
3381300|NCT00138151|4116217|FG000|NOT COMPLETED|Overall Study||4
3381301|NCT00129974|4116221|FG000|STARTED|Overall Study||1
3381302|NCT00129974|4116221|FG000|COMPLETED|Overall Study||0
3381303|NCT00129974|4116221|FG000|NOT COMPLETED|Overall Study||1
3381304|NCT00126659|4116228|FG000|STARTED|Overall Study||3
3381305|NCT00126659|4116229|FG001|STARTED|Overall Study||3
3381306|NCT00126659|4116230|FG002|STARTED|Overall Study||4
3381307|NCT00126659|4116228|FG000|COMPLETED|Overall Study||3
3381308|NCT00126659|4116229|FG001|COMPLETED|Overall Study||3
3381309|NCT00126659|4116230|FG002|COMPLETED|Overall Study||2
3381310|NCT00126659|4116228|FG000|NOT COMPLETED|Overall Study||0
3381311|NCT00126659|4116229|FG001|NOT COMPLETED|Overall Study||0
3381312|NCT00126659|4116230|FG002|NOT COMPLETED|Overall Study||2
3381313|NCT00133679|4116238|FG000|STARTED|Overall Study||0
3381314|NCT00133679|4116239|FG001|STARTED|Overall Study||0
3381315|NCT00133679|4116238|FG000|COMPLETED|Overall Study||0
3381316|NCT00133679|4116239|FG001|COMPLETED|Overall Study||0
3381317|NCT00133679|4116238|FG000|NOT COMPLETED|Overall Study||0
3381318|NCT00133679|4116239|FG001|NOT COMPLETED|Overall Study||0
3381319|NCT00125268|4116247|FG000|STARTED|Overall Study||16
3381320|NCT00125268|4116248|FG001|STARTED|Overall Study||14
3381321|NCT00125268|4116247|FG000|COMPLETED|Overall Study||15
3381322|NCT00125268|4116248|FG001|COMPLETED|Overall Study||13
3381323|NCT00125268|4116247|FG000|NOT COMPLETED|Overall Study||1
3381324|NCT00125268|4116248|FG001|NOT COMPLETED|Overall Study||1
3381325|NCT00113399|4116256|FG000|STARTED|Overall Study||7
3381326|NCT00113399|4116257|FG001|STARTED|Overall Study||8
3381327|NCT00113399|4116256|FG000|COMPLETED|Overall Study||5
3381328|NCT00113399|4116257|FG001|COMPLETED|Overall Study||3
3381329|NCT00113399|4116256|FG000|NOT COMPLETED|Overall Study||2
3381330|NCT00113399|4116257|FG001|NOT COMPLETED|Overall Study||5
3381331|NCT00118053|4116263|FG000|STARTED|Overall Study||5
3381332|NCT00118053|4116263|FG000|COMPLETED|Overall Study||5
3381333|NCT00118053|4116263|FG000|NOT COMPLETED|Overall Study||0
3381334|NCT00107614|4116267|FG000|STARTED|Overall Study||12
3381335|NCT00107614|4116267|FG000|COMPLETED|Overall Study||0
3381336|NCT00107614|4116267|FG000|NOT COMPLETED|Overall Study||12
3381337|NCT00107315|4116271|FG000|STARTED|Overall Study||16
3381338|NCT00107315|4116271|FG000|COMPLETED|Overall Study||1
3381339|NCT00107315|4116271|FG000|NOT COMPLETED|Overall Study||15
3381340|NCT00108433|4116277|FG000|STARTED|Overall Study||30
3381341|NCT00108433|4116278|FG001|STARTED|Overall Study||31
3381342|NCT00108433|4116277|FG000|COMPLETED|Overall Study||9
3381343|NCT00108433|4116278|FG001|COMPLETED|Overall Study||14
3381344|NCT00108433|4116277|FG000|NOT COMPLETED|Overall Study||21
3381345|NCT00108433|4116278|FG001|NOT COMPLETED|Overall Study||17
3381346|NCT00113919|4116284|FG000|STARTED|Overall Study||14
3381347|NCT00113919|4116284|FG000|COMPLETED|Overall Study||0
3381348|NCT00113919|4116284|FG000|NOT COMPLETED|Overall Study||14
3381349|NCT00108342|4116290|FG000|STARTED|Overall Study||8
3381350|NCT00108342|4116291|FG001|STARTED|Overall Study||9
3381351|NCT00108342|4116290|FG000|COMPLETED|Overall Study||7
3381352|NCT00108342|4116291|FG001|COMPLETED|Overall Study||9
3381353|NCT00108342|4116290|FG000|NOT COMPLETED|Overall Study||1
3381354|NCT00108342|4116291|FG001|NOT COMPLETED|Overall Study||0
3381355|NCT00100828|4116297|FG000|STARTED|Overall Study||6
3381356|NCT00100828|4116297|FG000|COMPLETED|Overall Study||0
3381357|NCT00100828|4116297|FG000|NOT COMPLETED|Overall Study||6
3381358|NCT00104728|4116301|FG000|STARTED|Overall Study|42 consented on study|42
3381359|NCT00104728|4116301|FG000|COMPLETED|Overall Study||23
3381360|NCT00104728|4116301|FG000|NOT COMPLETED|Overall Study||19
3381361|NCT00089414|4116308|FG000|STARTED|Overall Study||2
3381362|NCT00089414|4116309|FG001|STARTED|Overall Study||1
3381363|NCT00089414|4116310|FG002|STARTED|Overall Study||2
3381364|NCT00089414|4116308|FG000|COMPLETED|Overall Study||2
3381365|NCT00089414|4116309|FG001|COMPLETED|Overall Study||1
3381366|NCT00089414|4116310|FG002|COMPLETED|Overall Study||2
3381367|NCT00089414|4116308|FG000|NOT COMPLETED|Overall Study||0
3381368|NCT00089414|4116309|FG001|NOT COMPLETED|Overall Study||0
3381369|NCT00089414|4116310|FG002|NOT COMPLETED|Overall Study||0
3381370|NCT00083915|4116320|FG000|STARTED|Overall Study||52
3381371|NCT00083915|4116321|FG001|STARTED|Overall Study||45
3381372|NCT00083915|4116320|FG000|COMPLETED|Overall Study||2
3381373|NCT00083915|4116321|FG001|COMPLETED|Overall Study||8
3381374|NCT00083915|4116320|FG000|NOT COMPLETED|Overall Study||50
3381375|NCT00083915|4116321|FG001|NOT COMPLETED|Overall Study||37
3381376|NCT00090870|4116327|FG000|STARTED|Overall Study||10
3381377|NCT00090870|4116327|FG000|COMPLETED|Overall Study||10
3381378|NCT00090870|4116327|FG000|NOT COMPLETED|Overall Study||0
3381379|NCT00088972|4116333|FG000|STARTED|Overall Study||3
3381380|NCT00088972|4116334|FG001|STARTED|Overall Study||5
3381381|NCT00088972|4116333|FG000|COMPLETED|Overall Study||1
3381382|NCT00088972|4116334|FG001|COMPLETED|Overall Study||1
3381383|NCT00088972|4116333|FG000|NOT COMPLETED|Overall Study||2
3381384|NCT00088972|4116334|FG001|NOT COMPLETED|Overall Study||4
3381385|NCT00088829|4116340|FG000|STARTED|Overall Study||22
3381386|NCT00088829|4116340|FG000|COMPLETED|Overall Study||0
3381387|NCT00088829|4116340|FG000|NOT COMPLETED|Overall Study||22
3381388|NCT00089128|4116344|FG000|STARTED|Overall Study||16
3381389|NCT00089128|4116344|FG000|COMPLETED|Overall Study||16
3381390|NCT00089128|4116344|FG000|NOT COMPLETED|Overall Study||0
3381391|NCT00075608|4116348|FG000|STARTED|Overall Study||12
3381392|NCT00075608|4116348|FG000|COMPLETED|Overall Study||12
3381393|NCT00075608|4116348|FG000|NOT COMPLETED|Overall Study||0
3381394|NCT00074724|4116356|FG000|STARTED|Overall Study|The PI has left the institution and no results data is available. Efforts were made to contact the PI/study team members, as well as to review data on shared drives, IRB historical records and published resources, but were unsuccessful. No study data are available|0
3381395|NCT00074724|4116357|FG001|STARTED|Overall Study|The PI has left the institution and no results data is available. Efforts were made to contact the PI/study team members, as well as to review data on shared drives, IRB historical records and published resources, but were unsuccessful. No study data are available|0
3381396|NCT00074724|4116356|FG000|COMPLETED|Overall Study|The PI has left the institution and no results data is available. Efforts were made to contact the PI/study team members, as well as to review data on shared drives, IRB historical records and published resources, but were unsuccessful. No study data are available|0
3381397|NCT00074724|4116357|FG001|COMPLETED|Overall Study|The PI has left the institution and no results data is available. Efforts were made to contact the PI/study team members, as well as to review data on shared drives, IRB historical records and published resources, but were unsuccessful. No study data are available|0
3381398|NCT00074724|4116356|FG000|NOT COMPLETED|Overall Study||0
3381399|NCT00074724|4116357|FG001|NOT COMPLETED|Overall Study||0
3381400|NCT00085631|4116363|FG000|STARTED|Overall Study||13
3381401|NCT00085631|4116364|FG001|STARTED|Overall Study||49
3381402|NCT00085631|4116365|FG002|STARTED|Overall Study||39
3381403|NCT00085631|4116363|FG000|COMPLETED|Overall Study||9
3381404|NCT00085631|4116364|FG001|COMPLETED|Overall Study||38
3381405|NCT00085631|4116365|FG002|COMPLETED|Overall Study||32
3381406|NCT00085631|4116363|FG000|NOT COMPLETED|Overall Study||4
3381407|NCT00085631|4116364|FG001|NOT COMPLETED|Overall Study||11
3381408|NCT00085631|4116365|FG002|NOT COMPLETED|Overall Study||7
3381409|NCT00062751|4116377|FG000|STARTED|Overall Study||33
3381410|NCT00062751|4116378|FG001|STARTED|Overall Study||30
3381411|NCT00062751|4116379|FG002|STARTED|Overall Study||33
3381412|NCT00062751|4116380|FG003|STARTED|Overall Study||6
3381413|NCT00062751|4116381|FG004|STARTED|Overall Study||6
3381414|NCT00062751|4116377|FG000|COMPLETED|Overall Study||0
3381415|NCT00062751|4116378|FG001|COMPLETED|Overall Study||0
3381416|NCT00062751|4116379|FG002|COMPLETED|Overall Study||3
3381417|NCT00062751|4116380|FG003|COMPLETED|Overall Study||1
3381418|NCT00062751|4116381|FG004|COMPLETED|Overall Study||0
3381419|NCT00062751|4116377|FG000|NOT COMPLETED|Overall Study||33
3381420|NCT00062751|4116378|FG001|NOT COMPLETED|Overall Study||30
3381421|NCT00062751|4116379|FG002|NOT COMPLETED|Overall Study||30
3381422|NCT00062751|4116380|FG003|NOT COMPLETED|Overall Study||5
3381423|NCT00062751|4116381|FG004|NOT COMPLETED|Overall Study||6
3381424|NCT00066807|4116396|FG000|STARTED|Overall Study||14
3381425|NCT00066807|4116397|FG001|STARTED|Overall Study||15
3381426|NCT00066807|4116396|FG000|COMPLETED|Overall Study||0
3381427|NCT00066807|4116397|FG001|COMPLETED|Overall Study||0
3381428|NCT00066807|4116396|FG000|NOT COMPLETED|Overall Study||14
3381429|NCT00066807|4116397|FG001|NOT COMPLETED|Overall Study||15
3381430|NCT00058188|4116405|FG000|STARTED|Overall Study||0
3381431|NCT00058188|4116406|FG001|STARTED|Overall Study||0
3381432|NCT00058188|4116405|FG000|COMPLETED|Overall Study||0
3381433|NCT00058188|4116406|FG001|COMPLETED|Overall Study||0
3381434|NCT00058188|4116405|FG000|NOT COMPLETED|Overall Study||0
3381435|NCT00058188|4116406|FG001|NOT COMPLETED|Overall Study||0
3381436|NCT00014560|4116412|FG000|STARTED|Overall Study||3
3381437|NCT00014560|4116412|FG000|COMPLETED|Overall Study||0
3381438|NCT00014560|4116412|FG000|NOT COMPLETED|Overall Study||3
3381439|NCT00038142|4116418|FG000|STARTED|Overall Study||32
3381440|NCT00038142|4116419|FG001|STARTED|Overall Study||14
3381441|NCT00038142|4116418|FG000|COMPLETED|Overall Study||10
3381442|NCT00038142|4116419|FG001|COMPLETED|Overall Study||7
3381443|NCT00038142|4116418|FG000|NOT COMPLETED|Overall Study||22
3381444|NCT00038142|4116419|FG001|NOT COMPLETED|Overall Study||7
3381445|NCT00020722|4116425|FG000|STARTED|Overall Study||7
3381446|NCT00020722|4116425|FG000|COMPLETED|Overall Study||7
3381447|NCT00020722|4116425|FG000|NOT COMPLETED|Overall Study||0
3381448|NCT00002975|4116430|FG000|STARTED|Overall Study||180
3381449|NCT00002975|4116430|FG000|Treated With Study Therapy|Overall Study||175
3381450|NCT00002975|4116430|FG000|COMPLETED|Overall Study||175
3381451|NCT00002975|4116430|FG000|NOT COMPLETED|Overall Study||5
3381452|NCT00006478|4116434|FG000|STARTED|Overall Study||19
3381453|NCT00006478|4116434|FG000|COMPLETED|Overall Study||12
3381454|NCT00006478|4116434|FG000|NOT COMPLETED|Overall Study||7
3381455|NCT00019747|4116440|FG000|STARTED|Overall Study||23
3381456|NCT00019747|4116441|FG001|STARTED|Overall Study||16
3381457|NCT00019747|4116440|FG000|COMPLETED|Overall Study||23
3381458|NCT00019747|4116441|FG001|COMPLETED|Overall Study||16
3381459|NCT00019747|4116440|FG000|NOT COMPLETED|Overall Study||0
3381460|NCT00019747|4116441|FG001|NOT COMPLETED|Overall Study||0
3381461|NCT00006916|4116447|FG000|STARTED|Overall Study||19
3381462|NCT00006916|4116447|FG000|COMPLETED|Overall Study|Subjects with survival data for the primary analysis are considered to have completed the study.|14
3381463|NCT00006916|4116447|FG000|NOT COMPLETED|Overall Study||5
3381464|NCT00003726|4116451|FG000|STARTED|Overall Study||1
3381465|NCT00003726|4116451|FG000|COMPLETED|Overall Study|Funding was pulled on the trial and therefore no other participants were enrolled|0
3381466|NCT00003726|4116451|FG000|NOT COMPLETED|Overall Study||1
3381467|NCT04051996|4116457|FG000|STARTED|Overall Study||1
3381468|NCT04051996|4116458|FG001|STARTED|Overall Study||0
3381469|NCT04051996|4116457|FG000|COMPLETED|Overall Study||1
3381470|NCT04051996|4116458|FG001|COMPLETED|Overall Study||0
3381471|NCT04051996|4116457|FG000|NOT COMPLETED|Overall Study||0
3381472|NCT04051996|4116458|FG001|NOT COMPLETED|Overall Study||0
3381473|NCT02970799|4116466|FG000|STARTED|Overall Study||0
3381474|NCT02970799|4116467|FG001|STARTED|Overall Study||0
3381475|NCT02970799|4116466|FG000|COMPLETED|Overall Study||0
3381476|NCT02970799|4116467|FG001|COMPLETED|Overall Study||0
3381477|NCT02970799|4116466|FG000|NOT COMPLETED|Overall Study||0
3381478|NCT02970799|4116467|FG001|NOT COMPLETED|Overall Study||0
3381479|NCT02385292|4116475|FG000|STARTED|Overall Study||0
3381480|NCT02385292|4116476|FG001|STARTED|Overall Study||0
3381481|NCT02385292|4116475|FG000|COMPLETED|Overall Study||0
3381482|NCT02385292|4116476|FG001|COMPLETED|Overall Study||0
3381483|NCT02385292|4116475|FG000|NOT COMPLETED|Overall Study||0
3381484|NCT02385292|4116476|FG001|NOT COMPLETED|Overall Study||0
3381485|NCT02126878|4116485|FG000|STARTED|Overall Study||0
3381486|NCT02126878|4116486|FG001|STARTED|Overall Study||0
3381487|NCT02126878|4116487|FG002|STARTED|Overall Study||0
3381488|NCT02126878|4116485|FG000|COMPLETED|Overall Study||0
3381489|NCT02126878|4116486|FG001|COMPLETED|Overall Study||0
3381490|NCT02126878|4116487|FG002|COMPLETED|Overall Study||0
3381491|NCT02126878|4116485|FG000|NOT COMPLETED|Overall Study||0
3381492|NCT02126878|4116486|FG001|NOT COMPLETED|Overall Study||0
3381493|NCT02126878|4116487|FG002|NOT COMPLETED|Overall Study||0
3381494|NCT02221817|4116497|FG000|STARTED|Overall Study||0
3381495|NCT02221817|4116498|FG001|STARTED|Overall Study||0
3381496|NCT02221817|4116497|FG000|COMPLETED|Overall Study||0
3381497|NCT02221817|4116498|FG001|COMPLETED|Overall Study||0
3381498|NCT02221817|4116497|FG000|NOT COMPLETED|Overall Study||0
3381499|NCT02221817|4116498|FG001|NOT COMPLETED|Overall Study||0
3381500|NCT02595996|4116504|FG000|STARTED|Overall Study||1
3381501|NCT02595996|4116504|FG000|COMPLETED|Overall Study||1
3381502|NCT02595996|4116504|FG000|NOT COMPLETED|Overall Study||0
3381503|NCT03879044|4116508|FG000|STARTED|Overall Study||30
3381504|NCT03879044|4116508|FG000|COMPLETED|Overall Study||26
3381505|NCT03879044|4116508|FG000|NOT COMPLETED|Overall Study||4
3381506|NCT03198156|4116514|FG000|STARTED|Overall Study||19
3381507|NCT03198156|4116515|FG001|STARTED|Overall Study||19
3381508|NCT03198156|4116514|FG000|COMPLETED|Overall Study||19
3381509|NCT03198156|4116515|FG001|COMPLETED|Overall Study||19
3381510|NCT03198156|4116514|FG000|NOT COMPLETED|Overall Study||0
3381511|NCT03198156|4116515|FG001|NOT COMPLETED|Overall Study||0
3381512|NCT02009384|4116521|FG000|STARTED|Overall Study|Study was Terminated due to low subject enrollment Data was not analyzed|2
3381513|NCT02009384|4116521|FG000|COMPLETED|Overall Study|Study was Terminated due to low subject enrollment Data was not analyzed|0
3381514|NCT02009384|4116521|FG000|NOT COMPLETED|Overall Study||2
3381515|NCT04558125|4116525|FG000|STARTED|Overall Study||2
3381516|NCT04558125|4116525|FG000|COMPLETED|Overall Study||1
3381517|NCT04558125|4116525|FG000|NOT COMPLETED|Overall Study||1
3381518|NCT02401308|4116531|FG000|STARTED|Overall Study||0
3381519|NCT02401308|4116532|FG001|STARTED|Overall Study||1
3381520|NCT02401308|4116531|FG000|COMPLETED|Overall Study||0
3381521|NCT02401308|4116532|FG001|COMPLETED|Overall Study||0
3381522|NCT02401308|4116531|FG000|NOT COMPLETED|Overall Study||0
3381523|NCT02401308|4116532|FG001|NOT COMPLETED|Overall Study||1
3381524|NCT04381988|4116540|FG000|STARTED|Overall Study||4
3381525|NCT04381988|4116541|FG001|STARTED|Overall Study||0
3381526|NCT04381988|4116540|FG000|COMPLETED|Overall Study||0
3381527|NCT04381988|4116541|FG001|COMPLETED|Overall Study||0
3381528|NCT04381988|4116540|FG000|NOT COMPLETED|Overall Study||4
3381529|NCT04381988|4116541|FG001|NOT COMPLETED|Overall Study||0
3381530|NCT00521885|4116549|FG000|STARTED|Overall Study||0
3381531|NCT00521885|4116550|FG001|STARTED|Overall Study||0
3381532|NCT00521885|4116549|FG000|COMPLETED|Overall Study||0
3381533|NCT00521885|4116550|FG001|COMPLETED|Overall Study||0
3381534|NCT00521885|4116549|FG000|NOT COMPLETED|Overall Study||0
3381535|NCT00521885|4116550|FG001|NOT COMPLETED|Overall Study||0
3381536|NCT02376946|4116558|FG000|STARTED|Overall Study|study terminated prior to being conducted|0
3381537|NCT02376946|4116559|FG001|STARTED|Overall Study|study terminated prior to being conducted|0
3381538|NCT02376946|4116558|FG000|COMPLETED|Overall Study|study terminated prior to being conducted|0
3381539|NCT02376946|4116559|FG001|COMPLETED|Overall Study|study terminated prior to being conducted|0
3381540|NCT02376946|4116558|FG000|NOT COMPLETED|Overall Study||0
3381541|NCT02376946|4116559|FG001|NOT COMPLETED|Overall Study||0
3381542|NCT01780636|4116565|FG000|STARTED|Overall Study||7
3381543|NCT01780636|4116565|FG000|COMPLETED|Overall Study||7
3381544|NCT01780636|4116565|FG000|NOT COMPLETED|Overall Study||0
3381545|NCT00479167|4116569|FG000|STARTED|Overall Study||1
3381546|NCT00479167|4116569|FG000|COMPLETED|Overall Study||0
3381547|NCT00479167|4116569|FG000|NOT COMPLETED|Overall Study||1
3381548|NCT03998189|4116576|FG000|STARTED|Overall Study||0
3381549|NCT03998189|4116577|FG001|STARTED|Overall Study||1
3381550|NCT03998189|4116576|FG000|COMPLETED|Overall Study||0
3381551|NCT03998189|4116577|FG001|COMPLETED|Overall Study|Samples were collected but were not analyzed as the analysis would have been done once a proper batch of samples were collected. This did not occur as the study was found to no longer be feasible and was terminated.|0
3381552|NCT03998189|4116576|FG000|NOT COMPLETED|Overall Study||0
3381553|NCT03998189|4116577|FG001|NOT COMPLETED|Overall Study||1
3381554|NCT02212574|4116583|FG000|STARTED|Overall Study||6
3381555|NCT02212574|4116583|FG000|COMPLETED|Overall Study||6
3381556|NCT02212574|4116583|FG000|NOT COMPLETED|Overall Study||0
3381557|NCT04422210|4116596|FG000|STARTED|Overall Study||0
3381558|NCT04422210|4116597|FG001|STARTED|Overall Study||0
3381559|NCT04422210|4116598|FG002|STARTED|Overall Study||0
3381560|NCT04422210|4116599|FG003|STARTED|Overall Study||0
3381561|NCT04422210|4116600|FG004|STARTED|Overall Study||0
3381562|NCT04422210|4116601|FG005|STARTED|Overall Study||0
3381563|NCT04422210|4116602|FG006|STARTED|Overall Study||0
3381564|NCT04422210|4116603|FG007|STARTED|Overall Study||0
3381565|NCT04422210|4116596|FG000|COMPLETED|Overall Study||0
3381566|NCT04422210|4116597|FG001|COMPLETED|Overall Study||0
3381567|NCT04422210|4116598|FG002|COMPLETED|Overall Study||0
3381568|NCT04422210|4116599|FG003|COMPLETED|Overall Study||0
3381569|NCT04422210|4116600|FG004|COMPLETED|Overall Study||0
3381570|NCT04422210|4116601|FG005|COMPLETED|Overall Study||0
3381571|NCT04422210|4116602|FG006|COMPLETED|Overall Study||0
3381572|NCT04422210|4116603|FG007|COMPLETED|Overall Study||0
3381573|NCT04422210|4116596|FG000|NOT COMPLETED|Overall Study||0
3381574|NCT04422210|4116597|FG001|NOT COMPLETED|Overall Study||0
3381575|NCT04422210|4116598|FG002|NOT COMPLETED|Overall Study||0
3381576|NCT04422210|4116599|FG003|NOT COMPLETED|Overall Study||0
3381577|NCT04422210|4116600|FG004|NOT COMPLETED|Overall Study||0
3381578|NCT04422210|4116601|FG005|NOT COMPLETED|Overall Study||0
3381579|NCT04422210|4116602|FG006|NOT COMPLETED|Overall Study||0
3381580|NCT04422210|4116603|FG007|NOT COMPLETED|Overall Study||0
3381581|NCT04298918|4116626|FG000|STARTED|Overall Study||0
3381582|NCT04298918|4116627|FG001|STARTED|Overall Study||0
3381583|NCT04298918|4116628|FG002|STARTED|Overall Study||0
3381584|NCT04298918|4116629|FG003|STARTED|Overall Study||0
3381585|NCT04298918|4116626|FG000|COMPLETED|Overall Study||0
3381586|NCT04298918|4116627|FG001|COMPLETED|Overall Study||0
3381587|NCT04298918|4116628|FG002|COMPLETED|Overall Study||0
3381588|NCT04298918|4116629|FG003|COMPLETED|Overall Study||0
3381589|NCT04298918|4116626|FG000|NOT COMPLETED|Overall Study||0
3381590|NCT04298918|4116627|FG001|NOT COMPLETED|Overall Study||0
3381591|NCT04298918|4116628|FG002|NOT COMPLETED|Overall Study||0
3381592|NCT04298918|4116629|FG003|NOT COMPLETED|Overall Study||0
3381593|NCT01996371|4116647|FG000|STARTED|Overall Study||5
3381594|NCT01996371|4116648|FG001|STARTED|Overall Study||4
3381595|NCT01996371|4116649|FG002|STARTED|Overall Study||6
3381596|NCT01996371|4116647|FG000|COMPLETED|Overall Study||5
3381597|NCT01996371|4116648|FG001|COMPLETED|Overall Study||4
3381598|NCT01996371|4116649|FG002|COMPLETED|Overall Study||6
3381599|NCT01996371|4116647|FG000|NOT COMPLETED|Overall Study||0
3381600|NCT01996371|4116648|FG001|NOT COMPLETED|Overall Study||0
3381601|NCT01996371|4116649|FG002|NOT COMPLETED|Overall Study||0
3381602|NCT01561378|4116662|FG000|STARTED|Overall Study||11
3381603|NCT01561378|4116663|FG001|STARTED|Overall Study||11
3381604|NCT01561378|4116662|FG000|COMPLETED|Overall Study||11
3381605|NCT01561378|4116663|FG001|COMPLETED|Overall Study||11
3381606|NCT01561378|4116662|FG000|NOT COMPLETED|Overall Study||0
3381607|NCT01561378|4116663|FG001|NOT COMPLETED|Overall Study||0
3381608|NCT00955929|4116672|FG000|STARTED|Overall Study||13
3381609|NCT00955929|4116673|FG001|STARTED|Overall Study||30
3381610|NCT00955929|4116674|FG002|STARTED|Overall Study||33
3381611|NCT00955929|4116672|FG000|COMPLETED|Overall Study||13
3381612|NCT00955929|4116673|FG001|COMPLETED|Overall Study||30
3381613|NCT00955929|4116674|FG002|COMPLETED|Overall Study||33
3381614|NCT00955929|4116672|FG000|NOT COMPLETED|Overall Study||0
3381615|NCT00955929|4116673|FG001|NOT COMPLETED|Overall Study||0
3381616|NCT00955929|4116674|FG002|NOT COMPLETED|Overall Study||0
3381617|NCT00402883|4116682|FG000|STARTED|Induction Therapy||5
3381618|NCT00402883|4116682|FG000|COMPLETED|Induction Therapy||5
3381619|NCT00402883|4116682|FG000|NOT COMPLETED|Induction Therapy||0
3381620|NCT00402883|4116682|FG000|STARTED|Consolidation Therapy||5
3381621|NCT00402883|4116682|FG000|COMPLETED|Consolidation Therapy||5
3381622|NCT00402883|4116682|FG000|NOT COMPLETED|Consolidation Therapy||0
3381623|NCT00402883|4116682|FG000|STARTED|Maintenance Therapy||5
3381624|NCT00402883|4116682|FG000|COMPLETED|Maintenance Therapy|All 5 patients received limited maintenance therapy due to early trial closure.|5
3381625|NCT00402883|4116682|FG000|NOT COMPLETED|Maintenance Therapy||0
3381626|NCT03482505|4116687|FG000|STARTED|Overall Study||10
3381627|NCT03482505|4116687|FG000|COMPLETED|Overall Study||10
3381628|NCT03482505|4116687|FG000|NOT COMPLETED|Overall Study||0
3381629|NCT02934503|4116691|FG000|STARTED|Overall Study||5
3381630|NCT02934503|4116691|FG000|COMPLETED|Overall Study||1
3381631|NCT02934503|4116691|FG000|NOT COMPLETED|Overall Study||4
3381632|NCT02137252|4116697|FG000|STARTED|Overall Study||2
3381633|NCT02137252|4116698|FG001|STARTED|Overall Study||1
3381634|NCT02137252|4116697|FG000|COMPLETED|Overall Study||0
3381635|NCT02137252|4116698|FG001|COMPLETED|Overall Study||0
3381636|NCT02137252|4116697|FG000|NOT COMPLETED|Overall Study||2
3381637|NCT02137252|4116698|FG001|NOT COMPLETED|Overall Study||1
3381638|NCT03863522|4116704|FG000|STARTED|Overall Study||116
3381639|NCT03863522|4116704|FG000|COMPLETED|Overall Study||116
3381640|NCT03863522|4116704|FG000|NOT COMPLETED|Overall Study||0
3381641|NCT01294670|4116713|FG000|STARTED|Overall Study||7
3381642|NCT01294670|4116714|FG001|STARTED|Overall Study||3
3381643|NCT01294670|4116715|FG002|STARTED|Overall Study||3
3381644|NCT01294670|4116716|FG003|STARTED|Overall Study||9
3381645|NCT01294670|4116717|FG004|STARTED|Overall Study||5
3381646|NCT01294670|4116713|FG000|COMPLETED|Overall Study||6
3381647|NCT01294670|4116714|FG001|COMPLETED|Overall Study||3
3381648|NCT01294670|4116715|FG002|COMPLETED|Overall Study||3
3381649|NCT01294670|4116716|FG003|COMPLETED|Overall Study||9
3381650|NCT01294670|4116717|FG004|COMPLETED|Overall Study||5
3381651|NCT01294670|4116713|FG000|NOT COMPLETED|Overall Study||1
3381652|NCT01294670|4116714|FG001|NOT COMPLETED|Overall Study||0
3381653|NCT01294670|4116715|FG002|NOT COMPLETED|Overall Study||0
3381654|NCT01294670|4116716|FG003|NOT COMPLETED|Overall Study||0
3381655|NCT01294670|4116717|FG004|NOT COMPLETED|Overall Study||0
3381656|NCT03095287|4116729|FG000|STARTED|Overall Study||2
3381657|NCT03095287|4116729|FG000|COMPLETED|Overall Study||0
3381658|NCT03095287|4116729|FG000|NOT COMPLETED|Overall Study||2
3381659|NCT03236662|4116733|FG000|STARTED|Overall Study||2
3381660|NCT03236662|4116733|FG000|COMPLETED|Overall Study||2
3381661|NCT03236662|4116733|FG000|NOT COMPLETED|Overall Study||0
3381662|NCT02930122|4116739|FG000|STARTED|Overall Study||3
3381663|NCT02930122|4116740|FG001|STARTED|Overall Study||3
3381664|NCT02930122|4116739|FG000|COMPLETED|Overall Study||0
3381665|NCT02930122|4116740|FG001|COMPLETED|Overall Study||0
3381666|NCT02930122|4116739|FG000|NOT COMPLETED|Overall Study||3
3381667|NCT02930122|4116740|FG001|NOT COMPLETED|Overall Study||3
3381668|NCT01444209|4116747|FG000|STARTED|Overall Study||2
3381669|NCT01444209|4116747|FG000|COMPLETED|Overall Study||2
3381670|NCT01444209|4116747|FG000|NOT COMPLETED|Overall Study||0
3381671|NCT00893516|4116753|FG000|STARTED|Overall Study||0
3381672|NCT00893516|4116754|FG001|STARTED|Overall Study||0
3381673|NCT00893516|4116753|FG000|COMPLETED|Overall Study||0
3381674|NCT00893516|4116754|FG001|COMPLETED|Overall Study||0
3381675|NCT00893516|4116753|FG000|NOT COMPLETED|Overall Study||0
3381676|NCT00893516|4116754|FG001|NOT COMPLETED|Overall Study||0
3381677|NCT04267380|4116760|FG000|STARTED|Overall Study||149
3381678|NCT04267380|4116761|FG001|STARTED|Overall Study||149
3381679|NCT04267380|4116760|FG000|COMPLETED|Overall Study||149
3381680|NCT04267380|4116761|FG001|COMPLETED|Overall Study||149
3381681|NCT04267380|4116760|FG000|NOT COMPLETED|Overall Study||0
3381682|NCT04267380|4116761|FG001|NOT COMPLETED|Overall Study||0
3381683|NCT04144166|4116767|FG000|STARTED|Overall Study||60
3381684|NCT04144166|4116767|FG000|COMPLETED|Overall Study||57
3381685|NCT04144166|4116767|FG000|NOT COMPLETED|Overall Study||3
3381686|NCT04090164|4116778|FG000|STARTED|Overall Study|Number of patients retrivied from the hospital files.|650
3381687|NCT04090164|4116779|FG001|STARTED|Overall Study||145
3381688|NCT04090164|4116778|FG000|COMPLETED|Overall Study|Number of patients analyzed.|405
3381689|NCT04090164|4116779|FG001|COMPLETED|Overall Study||145
3381690|NCT04090164|4116778|FG000|NOT COMPLETED|Overall Study||245
3381691|NCT04090164|4116779|FG001|NOT COMPLETED|Overall Study||0
3381692|NCT04047121|4116792|FG000|STARTED|Overall Study||310
3381693|NCT04047121|4116793|FG001|STARTED|Overall Study||299
3381694|NCT04047121|4116794|FG002|STARTED|Overall Study||79
3381695|NCT04047121|4116795|FG003|STARTED|Overall Study||287
3381696|NCT04047121|4116796|FG004|STARTED|Overall Study||112
3381697|NCT04047121|4116797|FG005|STARTED|Overall Study||262
3381698|NCT04047121|4116792|FG000|COMPLETED|Overall Study||310
3381699|NCT04047121|4116793|FG001|COMPLETED|Overall Study||299
3381700|NCT04047121|4116794|FG002|COMPLETED|Overall Study||79
3381701|NCT04047121|4116795|FG003|COMPLETED|Overall Study||287
3381702|NCT04047121|4116796|FG004|COMPLETED|Overall Study||112
3381703|NCT04047121|4116797|FG005|COMPLETED|Overall Study||262
3381704|NCT04047121|4116792|FG000|NOT COMPLETED|Overall Study||0
3381705|NCT04047121|4116793|FG001|NOT COMPLETED|Overall Study||0
3381706|NCT04047121|4116794|FG002|NOT COMPLETED|Overall Study||0
3381707|NCT04047121|4116795|FG003|NOT COMPLETED|Overall Study||0
3381708|NCT04047121|4116796|FG004|NOT COMPLETED|Overall Study||0
3381709|NCT04047121|4116797|FG005|NOT COMPLETED|Overall Study||0
3381710|NCT04036799|4116811|FG000|STARTED|Overall Study||572
3381711|NCT04036799|4116811|FG000|COMPLETED|Overall Study||572
3381712|NCT04036799|4116811|FG000|NOT COMPLETED|Overall Study||0
3381713|NCT04018001|4116817|FG000|STARTED|Overall Study||678
3381714|NCT04018001|4116818|FG001|STARTED|Overall Study||379
3381715|NCT04018001|4116817|FG000|COMPLETED|Overall Study||678
3381716|NCT04018001|4116818|FG001|COMPLETED|Overall Study||379
3381717|NCT04018001|4116817|FG000|NOT COMPLETED|Overall Study||0
3381718|NCT04018001|4116818|FG001|NOT COMPLETED|Overall Study||0
3381719|NCT04017754|4116824|FG000|STARTED|Overall Study||267
3381720|NCT04017754|4116825|FG001|STARTED|Overall Study||185
3381721|NCT04017754|4116824|FG000|COMPLETED|Overall Study||267
3381722|NCT04017754|4116825|FG001|COMPLETED|Overall Study||185
3381723|NCT04017754|4116824|FG000|NOT COMPLETED|Overall Study||0
3381724|NCT04017754|4116825|FG001|NOT COMPLETED|Overall Study||0
3381725|NCT04010370|4116868|FG000|STARTED|Overall Study||25
3381726|NCT04010370|4116868|FG000|COMPLETED|Overall Study||25
3381727|NCT04010370|4116868|FG000|NOT COMPLETED|Overall Study||0
3381728|NCT03997825|4116872|FG000|STARTED|Overall Study||117
3381729|NCT03997825|4116872|FG000|COMPLETED|Overall Study||100
3381730|NCT03997825|4116872|FG000|NOT COMPLETED|Overall Study||17
3381731|NCT03975790|4116879|FG000|STARTED|Overall Study||337
3381732|NCT03975790|4116880|FG001|STARTED|Overall Study||94
3381733|NCT03975790|4116881|FG002|STARTED|Overall Study||48
3381734|NCT03975790|4116879|FG000|COMPLETED|Overall Study||337
3381735|NCT03975790|4116880|FG001|COMPLETED|Overall Study||94
3381736|NCT03975790|4116881|FG002|COMPLETED|Overall Study||48
3381737|NCT03975790|4116879|FG000|NOT COMPLETED|Overall Study||0
3381738|NCT03975790|4116880|FG001|NOT COMPLETED|Overall Study||0
3381739|NCT03975790|4116881|FG002|NOT COMPLETED|Overall Study||0
3381740|NCT03979079|4116889|FG000|STARTED|Overall Study||2384
3381741|NCT03979079|4116889|FG000|COMPLETED|Overall Study||2384
3381742|NCT03979079|4116889|FG000|NOT COMPLETED|Overall Study||0
3381743|NCT03895632|4116894|FG000|STARTED|Overall Study||25
3381744|NCT03895632|4116894|FG000|COMPLETED|Overall Study||25
3381745|NCT03895632|4116894|FG000|NOT COMPLETED|Overall Study||0
3381746|NCT03859622|4116898|FG000|STARTED|Overall Study||289
3381747|NCT03859622|4116898|FG000|COMPLETED|Overall Study||289
3381748|NCT03859622|4116898|FG000|NOT COMPLETED|Overall Study||0
3381749|NCT03764813|4116909|FG000|STARTED|From Enrollment to the Age of 32 Weeks|Patients receiving no transfusions before the age of 32 weeks|14
3381750|NCT03764813|4116910|FG001|STARTED|From Enrollment to the Age of 32 Weeks|Patients receiving only cord-RBC transfusions before the age of 32 weeks|3
3381751|NCT03764813|4116911|FG002|STARTED|From Enrollment to the Age of 32 Weeks|Patients receiving only adult-RBC transfusions before the age of 32 weeks|4
3381752|NCT03764813|4116912|FG003|STARTED|From Enrollment to the Age of 32 Weeks|Patients receiving both adult-RBC and cord-RBCs before the age of 32 weeks|4
3381753|NCT03764813|4116909|FG000|COMPLETED|From Enrollment to the Age of 32 Weeks||14
3381754|NCT03764813|4116910|FG001|COMPLETED|From Enrollment to the Age of 32 Weeks||2
3381755|NCT03764813|4116911|FG002|COMPLETED|From Enrollment to the Age of 32 Weeks||3
3381756|NCT03764813|4116912|FG003|COMPLETED|From Enrollment to the Age of 32 Weeks||4
3381757|NCT03764813|4116909|FG000|NOT COMPLETED|From Enrollment to the Age of 32 Weeks||0
3381758|NCT03764813|4116910|FG001|NOT COMPLETED|From Enrollment to the Age of 32 Weeks||1
3381759|NCT03764813|4116911|FG002|NOT COMPLETED|From Enrollment to the Age of 32 Weeks||1
3381760|NCT03764813|4116912|FG003|NOT COMPLETED|From Enrollment to the Age of 32 Weeks||0
3381761|NCT03764813|4116909|FG000|STARTED|From Enrollment to the Last HbF Test|Patients receiving no transfusions before last HbF test (occurring at 36 weeks,discharge or death)|13
3381762|NCT03764813|4116910|FG001|STARTED|From Enrollment to the Last HbF Test|Patients receiving only cord-RBCs before last HbF test (occurring at 36 wks,discharge or death)|3
3381763|NCT03764813|4116911|FG002|STARTED|From Enrollment to the Last HbF Test|Patients receiving only adult-RBC before last HbF test (occurring at 36 wks,discharge or death)|4
3381764|NCT03764813|4116912|FG003|STARTED|From Enrollment to the Last HbF Test|Patients receiving both cord and adult-RBCs before the last HbFtest(age of 36 wk,discharge or death)|5
3381765|NCT03764813|4116909|FG000|COMPLETED|From Enrollment to the Last HbF Test||13
3381766|NCT03764813|4116910|FG001|COMPLETED|From Enrollment to the Last HbF Test||3
3381767|NCT03764813|4116911|FG002|COMPLETED|From Enrollment to the Last HbF Test||4
3381768|NCT03764813|4116912|FG003|COMPLETED|From Enrollment to the Last HbF Test||5
3381769|NCT03764813|4116909|FG000|NOT COMPLETED|From Enrollment to the Last HbF Test||0
3381770|NCT03764813|4116910|FG001|NOT COMPLETED|From Enrollment to the Last HbF Test||0
3381771|NCT03764813|4116911|FG002|NOT COMPLETED|From Enrollment to the Last HbF Test||0
3381772|NCT03764813|4116912|FG003|NOT COMPLETED|From Enrollment to the Last HbF Test||0
3381773|NCT00078806|4116928|FG000|STARTED|Part 1A||19
3381774|NCT00078806|4116929|FG001|STARTED|Part 1A||0
3381775|NCT00078806|4116930|FG002|STARTED|Part 1A||0
3381776|NCT00078806|4116931|FG003|STARTED|Part 1A||0
3381777|NCT00078806|4116928|FG000|COMPLETED|Part 1A||9
3381778|NCT00078806|4116929|FG001|COMPLETED|Part 1A||0
3381779|NCT00078806|4116930|FG002|COMPLETED|Part 1A||0
3381780|NCT00078806|4116931|FG003|COMPLETED|Part 1A||0
3381781|NCT00078806|4116928|FG000|NOT COMPLETED|Part 1A||10
3381782|NCT00078806|4116929|FG001|NOT COMPLETED|Part 1A||0
3381783|NCT00078806|4116930|FG002|NOT COMPLETED|Part 1A||0
3381784|NCT00078806|4116931|FG003|NOT COMPLETED|Part 1A||0
3381785|NCT00078806|4116928|FG000|STARTED|Part 1B||10
3381786|NCT00078806|4116929|FG001|STARTED|Part 1B||0
3381787|NCT00078806|4116930|FG002|STARTED|Part 1B||0
3381788|NCT00078806|4116931|FG003|STARTED|Part 1B||0
3381789|NCT00078806|4116928|FG000|COMPLETED|Part 1B||2
3381790|NCT00078806|4116929|FG001|COMPLETED|Part 1B||0
3381791|NCT00078806|4116930|FG002|COMPLETED|Part 1B||0
3381792|NCT00078806|4116931|FG003|COMPLETED|Part 1B||0
3381793|NCT00078806|4116928|FG000|NOT COMPLETED|Part 1B||8
3381794|NCT00078806|4116929|FG001|NOT COMPLETED|Part 1B||0
3381795|NCT00078806|4116930|FG002|NOT COMPLETED|Part 1B||0
3381796|NCT00078806|4116931|FG003|NOT COMPLETED|Part 1B||0
3381797|NCT00078806|4116928|FG000|STARTED|Part 2||0
3381798|NCT00078806|4116929|FG001|STARTED|Part 2||6
3381799|NCT00078806|4116930|FG002|STARTED|Part 2||4
3381800|NCT00078806|4116931|FG003|STARTED|Part 2||0
3381801|NCT00078806|4116928|FG000|Received Study Drug|Part 2||0
3381802|NCT00078806|4116929|FG001|Received Study Drug|Part 2||5
3381803|NCT00078806|4116930|FG002|Received Study Drug|Part 2||4
3381804|NCT00078806|4116931|FG003|Received Study Drug|Part 2||0
3381805|NCT00078806|4116928|FG000|COMPLETED|Part 2||0
3381806|NCT00078806|4116929|FG001|COMPLETED|Part 2||5
3381807|NCT00078806|4116930|FG002|COMPLETED|Part 2||4
3381808|NCT00078806|4116931|FG003|COMPLETED|Part 2||0
3381809|NCT00078806|4116928|FG000|NOT COMPLETED|Part 2||0
3381810|NCT00078806|4116929|FG001|NOT COMPLETED|Part 2||1
3381811|NCT00078806|4116930|FG002|NOT COMPLETED|Part 2||0
3381812|NCT00078806|4116931|FG003|NOT COMPLETED|Part 2||0
3381813|NCT00078806|4116928|FG000|STARTED|Part 3||0
3381814|NCT00078806|4116929|FG001|STARTED|Part 3||0
3381815|NCT00078806|4116930|FG002|STARTED|Part 3||0
3381816|NCT00078806|4116931|FG003|STARTED|Part 3||9
3381817|NCT00078806|4116928|FG000|COMPLETED|Part 3||0
3381818|NCT00078806|4116929|FG001|COMPLETED|Part 3||0
3381819|NCT00078806|4116930|FG002|COMPLETED|Part 3||0
3381820|NCT00078806|4116931|FG003|COMPLETED|Part 3||9
3381821|NCT00078806|4116928|FG000|NOT COMPLETED|Part 3||0
3381822|NCT00078806|4116929|FG001|NOT COMPLETED|Part 3||0
3381823|NCT00078806|4116930|FG002|NOT COMPLETED|Part 3||0
3381824|NCT00078806|4116931|FG003|NOT COMPLETED|Part 3||0
3381825|NCT00162370|4116946|FG000|STARTED|Completed Echocardiography Imaging|Received at least one dose of Definity|366
3381826|NCT00162370|4116946|FG000|COMPLETED|Completed Echocardiography Imaging|number of subjects who under went Definity-enhanced rest and stress echocardiogram|366
3381827|NCT00162370|4116946|FG000|NOT COMPLETED|Completed Echocardiography Imaging||0
3381828|NCT00162370|4116946|FG000|STARTED|Efficacy Population||366
3381829|NCT00162370|4116946|FG000|COMPLETED|Efficacy Population|Efficacy population, completed rest/stress echo with Definity & completed 2 and/or 5 year follow up|315
3381830|NCT00162370|4116946|FG000|NOT COMPLETED|Efficacy Population||51
3381831|NCT00204737|4116955|FG000|STARTED|Overall Study||6
3381832|NCT00204737|4116956|FG001|STARTED|Overall Study||6
3381833|NCT00204737|4116955|FG000|COMPLETED|Overall Study||6
3381834|NCT00204737|4116956|FG001|COMPLETED|Overall Study||6
3381835|NCT00204737|4116955|FG000|NOT COMPLETED|Overall Study||0
3381836|NCT00204737|4116956|FG001|NOT COMPLETED|Overall Study||0
3381837|NCT00214500|4116962|FG000|STARTED|Treatment Period|All eligible-enrolled participants who received at least 1 dose of study drug|9
3381838|NCT00214500|4116962|FG000|Safety Population|Treatment Period||9
3381839|NCT00214500|4116962|FG000|Pharmacokinetic (PK) Population|Treatment Period||9
3381840|NCT00214500|4116962|FG000|Pharmacodynamic (PD) Population|Treatment Period||9
3381841|NCT00214500|4116962|FG000|COMPLETED|Treatment Period||8
3381842|NCT00214500|4116962|FG000|NOT COMPLETED|Treatment Period||1
3381843|NCT00214500|4116962|FG000|STARTED|Extension Period||8
3381844|NCT00214500|4116962|FG000|COMPLETED|Extension Period||6
3381845|NCT00214500|4116962|FG000|NOT COMPLETED|Extension Period||2
3381846|NCT00278343|4116969|FG000|STARTED|Overall Study||74
3381847|NCT00278343|4116969|FG000|COMPLETED|Overall Study||74
3381848|NCT00278343|4116969|FG000|NOT COMPLETED|Overall Study||0
3381849|NCT00283959|4116974|FG000|STARTED|Treatment Period||4
3381850|NCT00283959|4116974|FG000|Safety Population|Treatment Period||4
3381851|NCT00283959|4116974|FG000|Pharmacodynamics (PD) Population|Treatment Period||4
3381852|NCT00283959|4116974|FG000|COMPLETED|Treatment Period||4
3381853|NCT00283959|4116974|FG000|NOT COMPLETED|Treatment Period||0
3381854|NCT00283959|4116974|FG000|STARTED|Extension Period||4
3381855|NCT00283959|4116974|FG000|COMPLETED|Extension Period||3
3381856|NCT00283959|4116974|FG000|NOT COMPLETED|Extension Period||1
3381857|NCT00290758|4116980|FG000|STARTED|Pre-Intervention rFNA Through Follow-Up||62
3381858|NCT00290758|4116981|FG001|STARTED|Pre-Intervention rFNA Through Follow-Up||64
3381859|NCT00290758|4116980|FG000|First rFNA Tissue Collection|Pre-Intervention rFNA Through Follow-Up||62
3381860|NCT00290758|4116981|FG001|First rFNA Tissue Collection|Pre-Intervention rFNA Through Follow-Up||64
3381861|NCT00290758|4116980|FG000|Randomization|Pre-Intervention rFNA Through Follow-Up||62
3381862|NCT00290758|4116981|FG001|Randomization|Pre-Intervention rFNA Through Follow-Up||62
3381863|NCT00290758|4116980|FG000|Treatment|Pre-Intervention rFNA Through Follow-Up||61
3381864|NCT00290758|4116981|FG001|Treatment|Pre-Intervention rFNA Through Follow-Up||64
3381865|NCT00290758|4116980|FG000|Post Intervention Follow-Up|Pre-Intervention rFNA Through Follow-Up||55
3381866|NCT00290758|4116981|FG001|Post Intervention Follow-Up|Pre-Intervention rFNA Through Follow-Up||54
3381867|NCT00290758|4116980|FG000|COMPLETED|Pre-Intervention rFNA Through Follow-Up||55
3381868|NCT00290758|4116981|FG001|COMPLETED|Pre-Intervention rFNA Through Follow-Up||54
3381869|NCT00290758|4116980|FG000|NOT COMPLETED|Pre-Intervention rFNA Through Follow-Up||7
3381870|NCT00290758|4116981|FG001|NOT COMPLETED|Pre-Intervention rFNA Through Follow-Up||10
3381871|NCT00290758|4116980|FG000|STARTED|Post Intervention rFNA||55
3381872|NCT00290758|4116981|FG001|STARTED|Post Intervention rFNA||54
3381873|NCT00290758|4116980|FG000|COMPLETED|Post Intervention rFNA||49
3381874|NCT00290758|4116981|FG001|COMPLETED|Post Intervention rFNA||49
3381875|NCT00290758|4116980|FG000|NOT COMPLETED|Post Intervention rFNA||6
3381876|NCT00290758|4116981|FG001|NOT COMPLETED|Post Intervention rFNA||5
3381877|NCT00310388|4116991|FG000|STARTED|Primary Reporting Phase||376
3381878|NCT00310388|4116992|FG001|STARTED|Primary Reporting Phase||0
3381879|NCT00310388|4116991|FG000|COMPLETED|Primary Reporting Phase||30
3381880|NCT00310388|4116992|FG001|COMPLETED|Primary Reporting Phase||0
3381881|NCT00310388|4116991|FG000|NOT COMPLETED|Primary Reporting Phase||346
3381882|NCT00310388|4116992|FG001|NOT COMPLETED|Primary Reporting Phase||0
3381883|NCT00310388|4116991|FG000|STARTED|Safety Follow-up Continuation Phase||0
3381884|NCT00310388|4116992|FG001|STARTED|Safety Follow-up Continuation Phase||26
3381885|NCT00310388|4116991|FG000|COMPLETED|Safety Follow-up Continuation Phase||0
3381886|NCT00310388|4116992|FG001|COMPLETED|Safety Follow-up Continuation Phase||13
3381887|NCT00310388|4116991|FG000|NOT COMPLETED|Safety Follow-up Continuation Phase||0
3381888|NCT00310388|4116992|FG001|NOT COMPLETED|Safety Follow-up Continuation Phase||13
3381889|NCT00345358|4117001|FG000|STARTED|Primary Vaccination Phase||150
3381890|NCT00345358|4117002|FG001|STARTED|Primary Vaccination Phase||150
3381891|NCT00345358|4117003|FG002|STARTED|Primary Vaccination Phase||150
3381892|NCT00345358|4117004|FG003|STARTED|Primary Vaccination Phase||150
3381893|NCT00345358|4117001|FG000|COMPLETED|Primary Vaccination Phase||145
3381894|NCT00345358|4117002|FG001|COMPLETED|Primary Vaccination Phase||146
3381895|NCT00345358|4117003|FG002|COMPLETED|Primary Vaccination Phase||142
3381896|NCT00345358|4117004|FG003|COMPLETED|Primary Vaccination Phase||148
3381897|NCT00345358|4117001|FG000|NOT COMPLETED|Primary Vaccination Phase||5
3381898|NCT00345358|4117002|FG001|NOT COMPLETED|Primary Vaccination Phase||4
3381899|NCT00345358|4117003|FG002|NOT COMPLETED|Primary Vaccination Phase||8
3381900|NCT00345358|4117004|FG003|NOT COMPLETED|Primary Vaccination Phase||2
3381901|NCT00345358|4117001|FG000|STARTED|Booster Vaccination Phase||145
3381902|NCT00345358|4117002|FG001|STARTED|Booster Vaccination Phase||145
3381903|NCT00345358|4117003|FG002|STARTED|Booster Vaccination Phase||0
3381904|NCT00345358|4117004|FG003|STARTED|Booster Vaccination Phase||0
3381905|NCT00345358|4117001|FG000|COMPLETED|Booster Vaccination Phase||141
3381906|NCT00345358|4117002|FG001|COMPLETED|Booster Vaccination Phase||145
3381907|NCT00345358|4117003|FG002|COMPLETED|Booster Vaccination Phase||0
3381908|NCT00345358|4117004|FG003|COMPLETED|Booster Vaccination Phase||0
3381909|NCT00345358|4117001|FG000|NOT COMPLETED|Booster Vaccination Phase||4
3381910|NCT00345358|4117002|FG001|NOT COMPLETED|Booster Vaccination Phase||0
3381911|NCT00345358|4117003|FG002|NOT COMPLETED|Booster Vaccination Phase||0
3381912|NCT00345358|4117004|FG003|NOT COMPLETED|Booster Vaccination Phase||0
3381913|NCT00372229|4117016|FG000|STARTED|Study Phase||148
3381914|NCT00372229|4117017|FG001|STARTED|Study Phase||151
3381915|NCT00372229|4117016|FG000|COMPLETED|Study Phase||117
3381916|NCT00372229|4117017|FG001|COMPLETED|Study Phase||122
3381917|NCT00372229|4117016|FG000|NOT COMPLETED|Study Phase||31
3381918|NCT00372229|4117017|FG001|NOT COMPLETED|Study Phase||29
3381919|NCT00372229|4117016|FG000|STARTED|Follow-Up Phase||117
3381920|NCT00372229|4117017|FG001|STARTED|Follow-Up Phase||122
3381921|NCT00372229|4117016|FG000|COMPLETED|Follow-Up Phase||71
3381922|NCT00372229|4117017|FG001|COMPLETED|Follow-Up Phase||70
3381923|NCT00372229|4117016|FG000|NOT COMPLETED|Follow-Up Phase||46
3381924|NCT00372229|4117017|FG001|NOT COMPLETED|Follow-Up Phase||52
3381925|NCT00383708|4117027|FG000|STARTED|Enrolment Through Start Treatment||125
3381926|NCT00383708|4117027|FG000|COMPLETED|Enrolment Through Start Treatment||92
3381927|NCT00383708|4117027|FG000|NOT COMPLETED|Enrolment Through Start Treatment||33
3381928|NCT00383708|4117027|FG000|STARTED|Run-in Period||92
3381929|NCT00383708|4117027|FG000|COMPLETED|Run-in Period||85
3381930|NCT00383708|4117027|FG000|NOT COMPLETED|Run-in Period||7
3381931|NCT00383708|4117027|FG000|STARTED|Co-administration Period||57
3381932|NCT00383708|4117027|FG000|COMPLETED|Co-administration Period||52
3381933|NCT00383708|4117027|FG000|NOT COMPLETED|Co-administration Period||5
3381934|NCT00413699|4117034|FG000|STARTED|Initial Period||1123
3381935|NCT00413699|4117035|FG001|STARTED|Initial Period||3358
3381936|NCT00413699|4117036|FG002|STARTED|Initial Period||0
3381937|NCT00413699|4117034|FG000|COMPLETED|Initial Period||484
3381938|NCT00413699|4117035|FG001|COMPLETED|Initial Period||1653
3381939|NCT00413699|4117036|FG002|COMPLETED|Initial Period||0
3381940|NCT00413699|4117034|FG000|NOT COMPLETED|Initial Period||639
3381941|NCT00413699|4117035|FG001|NOT COMPLETED|Initial Period||1705
3381942|NCT00413699|4117036|FG002|NOT COMPLETED|Initial Period||0
3381943|NCT00413699|4117034|FG000|STARTED|Extension Period||0
3381944|NCT00413699|4117035|FG001|STARTED|Extension Period||0
3381945|NCT00413699|4117036|FG002|STARTED|Extension Period||48
3381946|NCT00413699|4117034|FG000|COMPLETED|Extension Period||0
3381947|NCT00413699|4117035|FG001|COMPLETED|Extension Period||0
3381948|NCT00413699|4117036|FG002|COMPLETED|Extension Period||43
3381949|NCT00413699|4117034|FG000|NOT COMPLETED|Extension Period||0
3381950|NCT00413699|4117035|FG001|NOT COMPLETED|Extension Period||0
3381951|NCT00413699|4117036|FG002|NOT COMPLETED|Extension Period||5
3381952|NCT00435227|4117064|FG000|STARTED|Overall Study||5
3381953|NCT00435227|4117065|FG001|STARTED|Overall Study||7
3381954|NCT00435227|4117064|FG000|COMPLETED|Overall Study||5
3381955|NCT00435227|4117065|FG001|COMPLETED|Overall Study||7
3381956|NCT00435227|4117064|FG000|NOT COMPLETED|Overall Study||0
3381957|NCT00435227|4117065|FG001|NOT COMPLETED|Overall Study||0
3381958|NCT00436826|4117074|FG000|STARTED|Double Blind Period (DBP)||124
3381959|NCT00436826|4117075|FG001|STARTED|Double Blind Period (DBP)||48
3381960|NCT00436826|4117076|FG002|STARTED|Double Blind Period (DBP)||0
3381961|NCT00436826|4117077|FG003|STARTED|Double Blind Period (DBP)||0
3381962|NCT00436826|4117078|FG004|STARTED|Double Blind Period (DBP)||0
3381963|NCT00436826|4117079|FG005|STARTED|Double Blind Period (DBP)||0
3381964|NCT00436826|4117074|FG000|COMPLETED|Double Blind Period (DBP)||111
3381965|NCT00436826|4117075|FG001|COMPLETED|Double Blind Period (DBP)||37
3381966|NCT00436826|4117076|FG002|COMPLETED|Double Blind Period (DBP)||0
3381967|NCT00436826|4117077|FG003|COMPLETED|Double Blind Period (DBP)||0
3381968|NCT00436826|4117078|FG004|COMPLETED|Double Blind Period (DBP)||0
3381969|NCT00436826|4117079|FG005|COMPLETED|Double Blind Period (DBP)||0
3381970|NCT00436826|4117074|FG000|NOT COMPLETED|Double Blind Period (DBP)||13
3381971|NCT00436826|4117075|FG001|NOT COMPLETED|Double Blind Period (DBP)||11
3381972|NCT00436826|4117076|FG002|NOT COMPLETED|Double Blind Period (DBP)||0
3381973|NCT00436826|4117077|FG003|NOT COMPLETED|Double Blind Period (DBP)||0
3381974|NCT00436826|4117078|FG004|NOT COMPLETED|Double Blind Period (DBP)||0
3381975|NCT00436826|4117079|FG005|NOT COMPLETED|Double Blind Period (DBP)||0
3381976|NCT00436826|4117074|FG000|STARTED|Ext. Period (With Cladribine Treatment)||0
3381977|NCT00436826|4117075|FG001|STARTED|Ext. Period (With Cladribine Treatment)||0
3381978|NCT00436826|4117076|FG002|STARTED|Ext. Period (With Cladribine Treatment)||47
3381979|NCT00436826|4117077|FG003|STARTED|Ext. Period (With Cladribine Treatment)||28
3381980|NCT00436826|4117078|FG004|STARTED|Ext. Period (With Cladribine Treatment)||0
3381981|NCT00436826|4117079|FG005|STARTED|Ext. Period (With Cladribine Treatment)||0
3381982|NCT00436826|4117074|FG000|COMPLETED|Ext. Period (With Cladribine Treatment)||0
3381983|NCT00436826|4117075|FG001|COMPLETED|Ext. Period (With Cladribine Treatment)||0
3381984|NCT00436826|4117076|FG002|COMPLETED|Ext. Period (With Cladribine Treatment)||1
3381985|NCT00436826|4117077|FG003|COMPLETED|Ext. Period (With Cladribine Treatment)||2
3381986|NCT00436826|4117078|FG004|COMPLETED|Ext. Period (With Cladribine Treatment)||0
3381987|NCT00436826|4117079|FG005|COMPLETED|Ext. Period (With Cladribine Treatment)||0
3381988|NCT00436826|4117074|FG000|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||0
3381989|NCT00436826|4117075|FG001|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||0
3381990|NCT00436826|4117076|FG002|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||46
3381991|NCT00436826|4117077|FG003|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||26
3381992|NCT00436826|4117078|FG004|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||0
3381993|NCT00436826|4117079|FG005|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||0
3381994|NCT00436826|4117074|FG000|STARTED|Ext. Period (No Cladribine Treatment)||0
3381995|NCT00436826|4117075|FG001|STARTED|Ext. Period (No Cladribine Treatment)||0
3381996|NCT00436826|4117076|FG002|STARTED|Ext. Period (No Cladribine Treatment)||0
3381997|NCT00436826|4117077|FG003|STARTED|Ext. Period (No Cladribine Treatment)||0
3381998|NCT00436826|4117078|FG004|STARTED|Ext. Period (No Cladribine Treatment)||52
3381999|NCT00436826|4117079|FG005|STARTED|Ext. Period (No Cladribine Treatment)||7
3382000|NCT00436826|4117074|FG000|COMPLETED|Ext. Period (No Cladribine Treatment)||0
3382001|NCT00436826|4117075|FG001|COMPLETED|Ext. Period (No Cladribine Treatment)||0
3382002|NCT00436826|4117076|FG002|COMPLETED|Ext. Period (No Cladribine Treatment)||0
3382003|NCT00436826|4117077|FG003|COMPLETED|Ext. Period (No Cladribine Treatment)||0
3382004|NCT00436826|4117078|FG004|COMPLETED|Ext. Period (No Cladribine Treatment)||1
3382005|NCT00436826|4117079|FG005|COMPLETED|Ext. Period (No Cladribine Treatment)||0
3382006|NCT00436826|4117074|FG000|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||0
3382007|NCT00436826|4117075|FG001|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||0
3382008|NCT00436826|4117076|FG002|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||0
3382009|NCT00436826|4117077|FG003|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||0
3382010|NCT00436826|4117078|FG004|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||51
3382011|NCT00436826|4117079|FG005|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||7
3382012|NCT00442546|4117098|FG000|STARTED|Overall Study||103
3382013|NCT00442546|4117099|FG001|STARTED|Overall Study||100
3382014|NCT00442546|4117100|FG002|STARTED|Overall Study||104
3382015|NCT00442546|4117098|FG000|Received Treatment|Overall Study||98
3382016|NCT00442546|4117099|FG001|Received Treatment|Overall Study||96
3382017|NCT00442546|4117100|FG002|Received Treatment|Overall Study||98
3382018|NCT00442546|4117098|FG000|COMPLETED|Overall Study||77
3382019|NCT00442546|4117099|FG001|COMPLETED|Overall Study||63
3382020|NCT00442546|4117100|FG002|COMPLETED|Overall Study||71
3382021|NCT00442546|4117098|FG000|NOT COMPLETED|Overall Study||26
3382022|NCT00442546|4117099|FG001|NOT COMPLETED|Overall Study||37
3382023|NCT00442546|4117100|FG002|NOT COMPLETED|Overall Study||33
3382024|NCT00545129|4117112|FG000|STARTED|Overall Study||29
3382025|NCT00545129|4117113|FG001|STARTED|Overall Study||30
3382026|NCT00545129|4117112|FG000|COMPLETED|Overall Study||12
3382027|NCT00545129|4117113|FG001|COMPLETED|Overall Study||6
3382028|NCT00545129|4117112|FG000|NOT COMPLETED|Overall Study||17
3382029|NCT00545129|4117113|FG001|NOT COMPLETED|Overall Study||24
3382036|NCT00554606|4117131|FG000|STARTED|Overall Study||115
3382037|NCT00554606|4117131|FG000|COMPLETED|Overall Study||30
3382038|NCT00554606|4117131|FG000|NOT COMPLETED|Overall Study||85
3382045|NCT00565461|4117150|FG000|STARTED|Overall Study||40
3382046|NCT00565461|4117151|FG001|STARTED|Overall Study||40
3382047|NCT00565461|4117152|FG002|STARTED|Overall Study||40
3382048|NCT00565461|4117153|FG003|STARTED|Overall Study||40
3382049|NCT00565461|4117150|FG000|COMPLETED|Overall Study||40
3382050|NCT00565461|4117151|FG001|COMPLETED|Overall Study||39
3382051|NCT00565461|4117152|FG002|COMPLETED|Overall Study||39
3382052|NCT00565461|4117153|FG003|COMPLETED|Overall Study||37
3382053|NCT00565461|4117150|FG000|NOT COMPLETED|Overall Study||0
3382054|NCT00565461|4117151|FG001|NOT COMPLETED|Overall Study||1
3382055|NCT00565461|4117152|FG002|NOT COMPLETED|Overall Study||1
3382056|NCT00565461|4117153|FG003|NOT COMPLETED|Overall Study||3
3382060|NCT00586924|4117179|FG000|STARTED|Overall Study||3
3382061|NCT00586924|4117180|FG001|STARTED|Overall Study||3
3382062|NCT00586924|4117181|FG002|STARTED|Overall Study||3
3382063|NCT00586924|4117182|FG003|STARTED|Overall Study||3
3382064|NCT00586924|4117183|FG004|STARTED|Overall Study||4
3382065|NCT00586924|4117184|FG005|STARTED|Overall Study||33
3382066|NCT00586924|4117179|FG000|COMPLETED|Overall Study||0
3382067|NCT00586924|4117180|FG001|COMPLETED|Overall Study||0
3382068|NCT00586924|4117181|FG002|COMPLETED|Overall Study||0
3382069|NCT00586924|4117182|FG003|COMPLETED|Overall Study||0
3382070|NCT00586924|4117183|FG004|COMPLETED|Overall Study||0
3382071|NCT00586924|4117184|FG005|COMPLETED|Overall Study||0
3382072|NCT00586924|4117179|FG000|NOT COMPLETED|Overall Study||3
3382073|NCT00586924|4117180|FG001|NOT COMPLETED|Overall Study||3
3382074|NCT00586924|4117181|FG002|NOT COMPLETED|Overall Study||3
3382075|NCT00586924|4117182|FG003|NOT COMPLETED|Overall Study||3
3382076|NCT00586924|4117183|FG004|NOT COMPLETED|Overall Study||4
3382077|NCT00586924|4117184|FG005|NOT COMPLETED|Overall Study||33
3382030|NCT00548093|4117121|FG000|STARTED|Overall Study||50
3382031|NCT00548093|4117122|FG001|STARTED|Overall Study||16
3382032|NCT00548093|4117121|FG000|COMPLETED|Overall Study||0
3382033|NCT00548093|4117122|FG001|COMPLETED|Overall Study||0
3382034|NCT00548093|4117121|FG000|NOT COMPLETED|Overall Study||50
3382035|NCT00548093|4117122|FG001|NOT COMPLETED|Overall Study||16
3382039|NCT00555009|4117139|FG000|STARTED|Overall Study||4
3382040|NCT00555009|4117140|FG001|STARTED|Overall Study||6
3382041|NCT00555009|4117139|FG000|COMPLETED|Overall Study||2
3382042|NCT00555009|4117140|FG001|COMPLETED|Overall Study||0
3382043|NCT00555009|4117139|FG000|NOT COMPLETED|Overall Study||2
3382044|NCT00555009|4117140|FG001|NOT COMPLETED|Overall Study||6
3382057|NCT00566995|4117169|FG000|STARTED|Overall Study||37
3382058|NCT00566995|4117169|FG000|COMPLETED|Overall Study||30
3382059|NCT00566995|4117169|FG000|NOT COMPLETED|Overall Study||7
3382078|NCT00588861|4117200|FG000|STARTED|Pre-Operative|202 Patients were enrolled, however only 107 contributed preop data.|202
3382079|NCT00588861|4117201|FG001|STARTED|Pre-Operative|200 patients were enrolled, however only 114 contributed preop data.|200
3382080|NCT00588861|4117200|FG000|COMPLETED|Pre-Operative||107
3382081|NCT00588861|4117201|FG001|COMPLETED|Pre-Operative||114
3382082|NCT00588861|4117200|FG000|NOT COMPLETED|Pre-Operative||95
3382083|NCT00588861|4117201|FG001|NOT COMPLETED|Pre-Operative||86
3382084|NCT00588861|4117200|FG000|STARTED|6 Months|107 cases were due at 6 Months, however only 9 returned for follow-up.|107
3382085|NCT00588861|4117201|FG001|STARTED|6 Months|114 cases were due at 6 Months, however only 41 returned for follow-up.|114
3382086|NCT00588861|4117200|FG000|COMPLETED|6 Months||9
3382087|NCT00588861|4117201|FG001|COMPLETED|6 Months||41
3382088|NCT00588861|4117200|FG000|NOT COMPLETED|6 Months||98
3382089|NCT00588861|4117201|FG001|NOT COMPLETED|6 Months||73
3382090|NCT00588861|4117200|FG000|STARTED|1 Year|107 cases were due at 1 Year, however only 18 returned for follow-up.|107
3382091|NCT00588861|4117201|FG001|STARTED|1 Year|114 cases were due at 1 Year, however only 32 returned for follow-up.|114
3382092|NCT00588861|4117200|FG000|COMPLETED|1 Year||18
3382093|NCT00588861|4117201|FG001|COMPLETED|1 Year||32
3382094|NCT00588861|4117200|FG000|NOT COMPLETED|1 Year||89
3382095|NCT00588861|4117201|FG001|NOT COMPLETED|1 Year||82
3382096|NCT00588861|4117200|FG000|STARTED|2 Years|107 cases were due at 2 Years, however only 15 returned for follow-up.|107
3382097|NCT00588861|4117201|FG001|STARTED|2 Years|114 cases were due at 2 Years, however only 27 returned for follow-up.|114
3382098|NCT00588861|4117200|FG000|COMPLETED|2 Years||15
3382099|NCT00588861|4117201|FG001|COMPLETED|2 Years||27
3382100|NCT00588861|4117200|FG000|NOT COMPLETED|2 Years||92
3382101|NCT00588861|4117201|FG001|NOT COMPLETED|2 Years||87
3382102|NCT00588861|4117200|FG000|STARTED|4 Years|107 cases were due at 4 Years, however only 16 returned for follow-up.|107
3382103|NCT00588861|4117201|FG001|STARTED|4 Years|114 cases were due at 4 Years, however only 11 returned for follow-up.|114
3382104|NCT00588861|4117200|FG000|COMPLETED|4 Years||16
3382105|NCT00588861|4117201|FG001|COMPLETED|4 Years||11
3382106|NCT00588861|4117200|FG000|NOT COMPLETED|4 Years||91
3382107|NCT00588861|4117201|FG001|NOT COMPLETED|4 Years||103
3382108|NCT00588861|4117200|FG000|STARTED|6 Years|107 cases were due at 6 Years, however only 3 returned for follow-up.|107
3382109|NCT00588861|4117201|FG001|STARTED|6 Years|114 cases were due at 6 Years, however only 5 returned for follow-up.|114
3382110|NCT00588861|4117200|FG000|COMPLETED|6 Years||3
3382111|NCT00588861|4117201|FG001|COMPLETED|6 Years||5
3382112|NCT00588861|4117200|FG000|NOT COMPLETED|6 Years||104
3382113|NCT00588861|4117201|FG001|NOT COMPLETED|6 Years||109
3382114|NCT00588861|4117200|FG000|STARTED|8 Years|107 cases were due at 8 Years, however only 2 returned for follow-up.|107
3382115|NCT00588861|4117201|FG001|STARTED|8 Years|114 cases were due at 8 Years, however no patients returned for follow-up.|114
3382116|NCT00588861|4117200|FG000|COMPLETED|8 Years||2
3382117|NCT00588861|4117201|FG001|COMPLETED|8 Years||0
3382118|NCT00588861|4117200|FG000|NOT COMPLETED|8 Years||105
3382119|NCT00588861|4117201|FG001|NOT COMPLETED|8 Years||114
3382120|NCT00588861|4117200|FG000|STARTED|10 Years|107 cases were due at 10 Years, however no patients returned for follow-up.|107
3382121|NCT00588861|4117201|FG001|STARTED|10 Years|114 cases were due at 10 Years, however no patients returned for follow-up.|114
3382122|NCT00588861|4117200|FG000|COMPLETED|10 Years||0
3382123|NCT00588861|4117201|FG001|COMPLETED|10 Years||0
3382124|NCT00588861|4117200|FG000|NOT COMPLETED|10 Years||107
3382125|NCT00588861|4117201|FG001|NOT COMPLETED|10 Years||114
3382126|NCT00641537|4117212|FG000|STARTED|96-week Period||98
3382127|NCT00641537|4117213|FG001|STARTED|96-week Period||92
3382128|NCT00641537|4117214|FG002|STARTED|96-week Period||186
3382129|NCT00641537|4117215|FG003|STARTED|96-week Period||186
3382130|NCT00641537|4117216|FG004|STARTED|96-week Period||244
3382131|NCT00641537|4117217|FG005|STARTED|96-week Period||22
3382132|NCT00641537|4117218|FG006|STARTED|96-week Period||17
3382133|NCT00641537|4117219|FG007|STARTED|96-week Period||22
3382134|NCT00641537|4117212|FG000|COMPLETED|96-week Period||89
3382135|NCT00641537|4117213|FG001|COMPLETED|96-week Period||82
3382136|NCT00641537|4117214|FG002|COMPLETED|96-week Period||166
3382137|NCT00641537|4117215|FG003|COMPLETED|96-week Period||174
3382138|NCT00641537|4117216|FG004|COMPLETED|96-week Period||227
3382139|NCT00641537|4117217|FG005|COMPLETED|96-week Period||15
3382140|NCT00641537|4117218|FG006|COMPLETED|96-week Period||12
3382141|NCT00641537|4117219|FG007|COMPLETED|96-week Period||16
3382142|NCT00641537|4117212|FG000|NOT COMPLETED|96-week Period||9
3382143|NCT00641537|4117213|FG001|NOT COMPLETED|96-week Period||10
3382144|NCT00641537|4117214|FG002|NOT COMPLETED|96-week Period||20
3382145|NCT00641537|4117215|FG003|NOT COMPLETED|96-week Period||12
3382146|NCT00641537|4117216|FG004|NOT COMPLETED|96-week Period||17
3382147|NCT00641537|4117217|FG005|NOT COMPLETED|96-week Period||7
3382148|NCT00641537|4117218|FG006|NOT COMPLETED|96-week Period||5
3382149|NCT00641537|4117219|FG007|NOT COMPLETED|96-week Period||6
3382150|NCT00641537|4117212|FG000|STARTED|24-Week Supplemental Follow-up Period||75
3382151|NCT00641537|4117213|FG001|STARTED|24-Week Supplemental Follow-up Period||69
3382152|NCT00641537|4117214|FG002|STARTED|24-Week Supplemental Follow-up Period||143
3382153|NCT00641537|4117215|FG003|STARTED|24-Week Supplemental Follow-up Period||151
3382154|NCT00641537|4117216|FG004|STARTED|24-Week Supplemental Follow-up Period||198
3382155|NCT00641537|4117217|FG005|STARTED|24-Week Supplemental Follow-up Period||15
3382156|NCT00641537|4117218|FG006|STARTED|24-Week Supplemental Follow-up Period||9
3382157|NCT00641537|4117219|FG007|STARTED|24-Week Supplemental Follow-up Period||11
3382158|NCT00641537|4117212|FG000|COMPLETED|24-Week Supplemental Follow-up Period||75
3382159|NCT00641537|4117213|FG001|COMPLETED|24-Week Supplemental Follow-up Period||66
3382160|NCT00641537|4117214|FG002|COMPLETED|24-Week Supplemental Follow-up Period||140
3382161|NCT00641537|4117215|FG003|COMPLETED|24-Week Supplemental Follow-up Period||147
3382162|NCT00641537|4117216|FG004|COMPLETED|24-Week Supplemental Follow-up Period||193
3382163|NCT00641537|4117217|FG005|COMPLETED|24-Week Supplemental Follow-up Period||14
3382164|NCT00641537|4117218|FG006|COMPLETED|24-Week Supplemental Follow-up Period||8
3382165|NCT00641537|4117219|FG007|COMPLETED|24-Week Supplemental Follow-up Period||10
3382166|NCT00641537|4117212|FG000|NOT COMPLETED|24-Week Supplemental Follow-up Period||0
3382167|NCT00641537|4117213|FG001|NOT COMPLETED|24-Week Supplemental Follow-up Period||3
3382168|NCT00641537|4117214|FG002|NOT COMPLETED|24-Week Supplemental Follow-up Period||3
3382169|NCT00641537|4117215|FG003|NOT COMPLETED|24-Week Supplemental Follow-up Period||4
3382170|NCT00641537|4117216|FG004|NOT COMPLETED|24-Week Supplemental Follow-up Period||5
3382171|NCT00641537|4117217|FG005|NOT COMPLETED|24-Week Supplemental Follow-up Period||1
3382172|NCT00641537|4117218|FG006|NOT COMPLETED|24-Week Supplemental Follow-up Period||1
3382173|NCT00641537|4117219|FG007|NOT COMPLETED|24-Week Supplemental Follow-up Period||1
3382174|NCT00655824|4117237|FG000|STARTED|Overall Study||92
3382175|NCT00655824|4117237|FG000|COMPLETED|Overall Study||8
3382176|NCT00655824|4117237|FG000|NOT COMPLETED|Overall Study||84
3382177|NCT00663052|4117243|FG000|STARTED|Overall Study||136
3382178|NCT00663052|4117244|FG001|STARTED|Overall Study||137
3382179|NCT00663052|4117243|FG000|COMPLETED|Overall Study||124
3382180|NCT00663052|4117244|FG001|COMPLETED|Overall Study||127
3382181|NCT00663052|4117243|FG000|NOT COMPLETED|Overall Study||12
3382182|NCT00663052|4117244|FG001|NOT COMPLETED|Overall Study||10
3382183|NCT00686374|4117250|FG000|STARTED|Overall Study||100
3382184|NCT00686374|4117250|FG000|COMPLETED|Overall Study||39
3382185|NCT00686374|4117250|FG000|NOT COMPLETED|Overall Study||61
3382186|NCT00698828|4117257|FG000|STARTED|Overall Study||76
3382187|NCT00698828|4117258|FG001|STARTED|Overall Study||75
3382188|NCT00698828|4117259|FG002|STARTED|Overall Study||76
3382189|NCT00698828|4117257|FG000|COMPLETED|Overall Study||67
3382190|NCT00698828|4117258|FG001|COMPLETED|Overall Study||60
3382191|NCT00698828|4117259|FG002|COMPLETED|Overall Study||65
3382192|NCT00698828|4117257|FG000|NOT COMPLETED|Overall Study||9
3382193|NCT00698828|4117258|FG001|NOT COMPLETED|Overall Study||15
3382194|NCT00698828|4117259|FG002|NOT COMPLETED|Overall Study||11
3382195|NCT00712933|4117267|FG000|STARTED|Overall Study||735
3382196|NCT00712933|4117267|FG000|COMPLETED|Overall Study||368
3382197|NCT00712933|4117267|FG000|NOT COMPLETED|Overall Study||367
3382198|NCT00725985|4117278|FG000|STARTED|ITP- Treatment Disposition||205
3382199|NCT00725985|4117279|FG001|STARTED|ITP- Treatment Disposition||206
3382200|NCT00725985|4117280|FG002|STARTED|ITP- Treatment Disposition||206
3382201|NCT00725985|4117281|FG003|STARTED|ITP- Treatment Disposition||0
3382202|NCT00725985|4117282|FG004|STARTED|ITP- Treatment Disposition||0
3382203|NCT00725985|4117283|FG005|STARTED|ITP- Treatment Disposition||0
3382204|NCT00725985|4117284|FG006|STARTED|ITP- Treatment Disposition||0
3382205|NCT00725985|4117285|FG007|STARTED|ITP- Treatment Disposition||0
3382206|NCT00725985|4117286|FG008|STARTED|ITP- Treatment Disposition||0
3382207|NCT00725985|4117287|FG009|STARTED|ITP- Treatment Disposition||0
3382208|NCT00725985|4117288|FG010|STARTED|ITP- Treatment Disposition||0
3382209|NCT00725985|4117289|FG011|STARTED|ITP- Treatment Disposition||0
3382210|NCT00725985|4117278|FG000|Treated|ITP- Treatment Disposition||204
3382211|NCT00725985|4117279|FG001|Treated|ITP- Treatment Disposition||206
3382212|NCT00725985|4117280|FG002|Treated|ITP- Treatment Disposition||206
3382213|NCT00725985|4117281|FG003|Treated|ITP- Treatment Disposition||0
3382214|NCT00725985|4117282|FG004|Treated|ITP- Treatment Disposition||0
3382215|NCT00725985|4117283|FG005|Treated|ITP- Treatment Disposition||0
3382216|NCT00725985|4117284|FG006|Treated|ITP- Treatment Disposition||0
3382217|NCT00725985|4117285|FG007|Treated|ITP- Treatment Disposition||0
3382218|NCT00725985|4117286|FG008|Treated|ITP- Treatment Disposition||0
3382219|NCT00725985|4117287|FG009|Treated|ITP- Treatment Disposition||0
3382220|NCT00725985|4117288|FG010|Treated|ITP- Treatment Disposition||0
3382221|NCT00725985|4117289|FG011|Treated|ITP- Treatment Disposition||0
3382222|NCT00725985|4117278|FG000|COMPLETED|ITP- Treatment Disposition||104
3382223|NCT00725985|4117279|FG001|COMPLETED|ITP- Treatment Disposition||131
3382224|NCT00725985|4117280|FG002|COMPLETED|ITP- Treatment Disposition||104
3382225|NCT00725985|4117281|FG003|COMPLETED|ITP- Treatment Disposition||0
3382226|NCT00725985|4117282|FG004|COMPLETED|ITP- Treatment Disposition||0
3382227|NCT00725985|4117283|FG005|COMPLETED|ITP- Treatment Disposition||0
3382228|NCT00725985|4117284|FG006|COMPLETED|ITP- Treatment Disposition||0
3382229|NCT00725985|4117285|FG007|COMPLETED|ITP- Treatment Disposition||0
3382230|NCT00725985|4117286|FG008|COMPLETED|ITP- Treatment Disposition||0
3382231|NCT00725985|4117287|FG009|COMPLETED|ITP- Treatment Disposition||0
3382232|NCT00725985|4117288|FG010|COMPLETED|ITP- Treatment Disposition||0
3382233|NCT00725985|4117289|FG011|COMPLETED|ITP- Treatment Disposition||0
3382234|NCT00725985|4117278|FG000|NOT COMPLETED|ITP- Treatment Disposition||101
3382235|NCT00725985|4117279|FG001|NOT COMPLETED|ITP- Treatment Disposition||75
3382236|NCT00725985|4117280|FG002|NOT COMPLETED|ITP- Treatment Disposition||102
3382237|NCT00725985|4117281|FG003|NOT COMPLETED|ITP- Treatment Disposition||0
3382238|NCT00725985|4117282|FG004|NOT COMPLETED|ITP- Treatment Disposition||0
3382239|NCT00725985|4117283|FG005|NOT COMPLETED|ITP- Treatment Disposition||0
3382240|NCT00725985|4117284|FG006|NOT COMPLETED|ITP- Treatment Disposition||0
3382241|NCT00725985|4117285|FG007|NOT COMPLETED|ITP- Treatment Disposition||0
3382242|NCT00725985|4117286|FG008|NOT COMPLETED|ITP- Treatment Disposition||0
3382243|NCT00725985|4117287|FG009|NOT COMPLETED|ITP- Treatment Disposition||0
3382244|NCT00725985|4117288|FG010|NOT COMPLETED|ITP- Treatment Disposition||0
3382245|NCT00725985|4117289|FG011|NOT COMPLETED|ITP- Treatment Disposition||0
3382246|NCT00725985|4117278|FG000|STARTED|OLMP (Up to 96 Weeks)||0
3382247|NCT00725985|4117279|FG001|STARTED|OLMP (Up to 96 Weeks)||0
3382248|NCT00725985|4117280|FG002|STARTED|OLMP (Up to 96 Weeks)||0
3382249|NCT00725985|4117281|FG003|STARTED|OLMP (Up to 96 Weeks)||24
3382250|NCT00725985|4117282|FG004|STARTED|OLMP (Up to 96 Weeks)||25
3382251|NCT00725985|4117283|FG005|STARTED|OLMP (Up to 96 Weeks)||60
3382252|NCT00725985|4117284|FG006|STARTED|OLMP (Up to 96 Weeks)||0
3382253|NCT00725985|4117285|FG007|STARTED|OLMP (Up to 96 Weeks)||0
3382254|NCT00725985|4117286|FG008|STARTED|OLMP (Up to 96 Weeks)||0
3382255|NCT00725985|4117287|FG009|STARTED|OLMP (Up to 96 Weeks)||0
3382256|NCT00725985|4117288|FG010|STARTED|OLMP (Up to 96 Weeks)||0
3382257|NCT00725985|4117289|FG011|STARTED|OLMP (Up to 96 Weeks)||0
3382258|NCT00725985|4117278|FG000|COMPLETED|OLMP (Up to 96 Weeks)||0
3382259|NCT00725985|4117279|FG001|COMPLETED|OLMP (Up to 96 Weeks)||0
3382260|NCT00725985|4117280|FG002|COMPLETED|OLMP (Up to 96 Weeks)||0
3382261|NCT00725985|4117281|FG003|COMPLETED|OLMP (Up to 96 Weeks)||6
3382262|NCT00725985|4117282|FG004|COMPLETED|OLMP (Up to 96 Weeks)||2
3382263|NCT00725985|4117283|FG005|COMPLETED|OLMP (Up to 96 Weeks)||7
3382264|NCT00725985|4117284|FG006|COMPLETED|OLMP (Up to 96 Weeks)||0
3382265|NCT00725985|4117285|FG007|COMPLETED|OLMP (Up to 96 Weeks)||0
3382266|NCT00725985|4117286|FG008|COMPLETED|OLMP (Up to 96 Weeks)||0
3382267|NCT00725985|4117287|FG009|COMPLETED|OLMP (Up to 96 Weeks)||0
3382268|NCT00725985|4117288|FG010|COMPLETED|OLMP (Up to 96 Weeks)||0
3382269|NCT00725985|4117289|FG011|COMPLETED|OLMP (Up to 96 Weeks)||0
3382270|NCT00725985|4117278|FG000|NOT COMPLETED|OLMP (Up to 96 Weeks)||0
3382271|NCT00725985|4117279|FG001|NOT COMPLETED|OLMP (Up to 96 Weeks)||0
3382272|NCT00725985|4117280|FG002|NOT COMPLETED|OLMP (Up to 96 Weeks)||0
3382273|NCT00725985|4117281|FG003|NOT COMPLETED|OLMP (Up to 96 Weeks)||18
3382274|NCT00725985|4117282|FG004|NOT COMPLETED|OLMP (Up to 96 Weeks)||23
3382275|NCT00725985|4117283|FG005|NOT COMPLETED|OLMP (Up to 96 Weeks)||53
3382276|NCT00725985|4117284|FG006|NOT COMPLETED|OLMP (Up to 96 Weeks)||0
3382277|NCT00725985|4117285|FG007|NOT COMPLETED|OLMP (Up to 96 Weeks)||0
3382278|NCT00725985|4117286|FG008|NOT COMPLETED|OLMP (Up to 96 Weeks)||0
3382279|NCT00725985|4117287|FG009|NOT COMPLETED|OLMP (Up to 96 Weeks)||0
3382280|NCT00725985|4117288|FG010|NOT COMPLETED|OLMP (Up to 96 Weeks)||0
3382281|NCT00725985|4117289|FG011|NOT COMPLETED|OLMP (Up to 96 Weeks)||0
3382282|NCT00725985|4117278|FG000|STARTED|LTFU (Cladribine Treatment) (48 Weeks)||0
3382283|NCT00725985|4117279|FG001|STARTED|LTFU (Cladribine Treatment) (48 Weeks)||0
3382284|NCT00725985|4117280|FG002|STARTED|LTFU (Cladribine Treatment) (48 Weeks)||0
3382285|NCT00725985|4117281|FG003|STARTED|LTFU (Cladribine Treatment) (48 Weeks)||0
3382286|NCT00725985|4117282|FG004|STARTED|LTFU (Cladribine Treatment) (48 Weeks)||0
3382287|NCT00725985|4117283|FG005|STARTED|LTFU (Cladribine Treatment) (48 Weeks)||0
3382288|NCT00725985|4117284|FG006|STARTED|LTFU (Cladribine Treatment) (48 Weeks)||9
3382289|NCT00725985|4117285|FG007|STARTED|LTFU (Cladribine Treatment) (48 Weeks)||9
3382290|NCT00725985|4117286|FG008|STARTED|LTFU (Cladribine Treatment) (48 Weeks)||17
3382291|NCT00725985|4117287|FG009|STARTED|LTFU (Cladribine Treatment) (48 Weeks)||0
3382292|NCT00725985|4117288|FG010|STARTED|LTFU (Cladribine Treatment) (48 Weeks)||0
3382293|NCT00725985|4117289|FG011|STARTED|LTFU (Cladribine Treatment) (48 Weeks)||0
3382294|NCT00725985|4117278|FG000|COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
3382295|NCT00725985|4117279|FG001|COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
3382296|NCT00725985|4117280|FG002|COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
3382297|NCT00725985|4117281|FG003|COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
3382298|NCT00725985|4117282|FG004|COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
3382299|NCT00725985|4117283|FG005|COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
3382300|NCT00725985|4117284|FG006|COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
3382301|NCT00725985|4117285|FG007|COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
3382302|NCT00725985|4117286|FG008|COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
3382303|NCT00725985|4117287|FG009|COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
3382304|NCT00725985|4117288|FG010|COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
3382305|NCT00725985|4117289|FG011|COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
3382306|NCT00725985|4117278|FG000|NOT COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
3382307|NCT00725985|4117279|FG001|NOT COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
3382308|NCT00725985|4117280|FG002|NOT COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
3382309|NCT00725985|4117281|FG003|NOT COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
3382310|NCT00725985|4117282|FG004|NOT COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
3382311|NCT00725985|4117283|FG005|NOT COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
3382312|NCT00725985|4117284|FG006|NOT COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||9
3382313|NCT00725985|4117285|FG007|NOT COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||9
3382314|NCT00725985|4117286|FG008|NOT COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||17
3382315|NCT00725985|4117287|FG009|NOT COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
3382316|NCT00725985|4117288|FG010|NOT COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
3382317|NCT00725985|4117289|FG011|NOT COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
3382318|NCT00725985|4117278|FG000|STARTED|LTFU (No Cladribine) (48 Weeks)||0
3382319|NCT00725985|4117279|FG001|STARTED|LTFU (No Cladribine) (48 Weeks)||0
3382320|NCT00725985|4117280|FG002|STARTED|LTFU (No Cladribine) (48 Weeks)||0
3382321|NCT00725985|4117281|FG003|STARTED|LTFU (No Cladribine) (48 Weeks)||0
3382322|NCT00725985|4117282|FG004|STARTED|LTFU (No Cladribine) (48 Weeks)||0
3382323|NCT00725985|4117283|FG005|STARTED|LTFU (No Cladribine) (48 Weeks)||0
3382324|NCT00725985|4117284|FG006|STARTED|LTFU (No Cladribine) (48 Weeks)||0
3382325|NCT00725985|4117285|FG007|STARTED|LTFU (No Cladribine) (48 Weeks)||0
3382326|NCT00725985|4117286|FG008|STARTED|LTFU (No Cladribine) (48 Weeks)||0
3382327|NCT00725985|4117287|FG009|STARTED|LTFU (No Cladribine) (48 Weeks)||34
3382328|NCT00725985|4117288|FG010|STARTED|LTFU (No Cladribine) (48 Weeks)||36
3382329|NCT00725985|4117289|FG011|STARTED|LTFU (No Cladribine) (48 Weeks)||14
3382330|NCT00725985|4117278|FG000|COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
3382331|NCT00725985|4117279|FG001|COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
3382332|NCT00725985|4117280|FG002|COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
3382333|NCT00725985|4117281|FG003|COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
3382334|NCT00725985|4117282|FG004|COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
3382335|NCT00725985|4117283|FG005|COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
3382336|NCT00725985|4117284|FG006|COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
3382337|NCT00725985|4117285|FG007|COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
3382338|NCT00725985|4117286|FG008|COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
3382339|NCT00725985|4117287|FG009|COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
3382340|NCT00725985|4117288|FG010|COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
3382341|NCT00725985|4117289|FG011|COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
3382342|NCT00725985|4117278|FG000|NOT COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
3382343|NCT00725985|4117279|FG001|NOT COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
3382344|NCT00725985|4117280|FG002|NOT COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
3382345|NCT00725985|4117281|FG003|NOT COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
3382346|NCT00725985|4117282|FG004|NOT COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
3382347|NCT00725985|4117283|FG005|NOT COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
3382348|NCT00725985|4117284|FG006|NOT COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
3382349|NCT00725985|4117285|FG007|NOT COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
3382350|NCT00725985|4117286|FG008|NOT COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
3382351|NCT00725985|4117287|FG009|NOT COMPLETED|LTFU (No Cladribine) (48 Weeks)||34
3382352|NCT00725985|4117288|FG010|NOT COMPLETED|LTFU (No Cladribine) (48 Weeks)||36
3382353|NCT00725985|4117289|FG011|NOT COMPLETED|LTFU (No Cladribine) (48 Weeks)||14
3382354|NCT00799266|4117317|FG000|STARTED|Overall Study||18
3382355|NCT00799266|4117318|FG001|STARTED|Overall Study||16
3382356|NCT00799266|4117317|FG000|Modified Intention-to-treat (MITT)|Overall Study||17
3382357|NCT00799266|4117318|FG001|Modified Intention-to-treat (MITT)|Overall Study||16
3382358|NCT00799266|4117317|FG000|Safety Set|Overall Study||18
3382359|NCT00799266|4117318|FG001|Safety Set|Overall Study||16
3382360|NCT00799266|4117317|FG000|COMPLETED|Overall Study||15
3382361|NCT00799266|4117318|FG001|COMPLETED|Overall Study||15
3382362|NCT00799266|4117317|FG000|NOT COMPLETED|Overall Study||3
3382363|NCT00799266|4117318|FG001|NOT COMPLETED|Overall Study||1
3382364|NCT00810446|4117324|FG000|STARTED|Overall Study||72
3382365|NCT00810446|4117324|FG000|COMPLETED|Overall Study||72
3382366|NCT00810446|4117324|FG000|NOT COMPLETED|Overall Study||0
3382367|NCT00844480|4117330|FG000|STARTED|Overall Study||8
3382368|NCT00844480|4117331|FG001|STARTED|Overall Study||9
3382369|NCT00844480|4117330|FG000|COMPLETED|Overall Study||6
3382370|NCT00844480|4117331|FG001|COMPLETED|Overall Study||6
3382371|NCT00844480|4117330|FG000|NOT COMPLETED|Overall Study||2
3382372|NCT00844480|4117331|FG001|NOT COMPLETED|Overall Study||3
3382373|NCT00864474|4117337|FG000|STARTED|Overall Study||68
3382374|NCT00864474|4117337|FG000|COMPLETED|Overall Study||68
3382375|NCT00864474|4117337|FG000|NOT COMPLETED|Overall Study||0
3382376|NCT00873366|4117341|FG000|STARTED|Overall Study||77
3382377|NCT00873366|4117341|FG000|COMPLETED|Overall Study||71
3382378|NCT00873366|4117341|FG000|NOT COMPLETED|Overall Study||6
3382379|NCT00923247|4117347|FG000|STARTED|Overall Study||21
3382380|NCT00923247|4117348|FG001|STARTED|Overall Study||1
3382381|NCT00923247|4117347|FG000|COMPLETED|Overall Study||21
3382382|NCT00923247|4117348|FG001|COMPLETED|Overall Study||1
3382383|NCT00923247|4117347|FG000|NOT COMPLETED|Overall Study||0
3382384|NCT00923247|4117348|FG001|NOT COMPLETED|Overall Study||0
3382385|NCT00928226|4117364|FG000|STARTED|Overall Study||20
3382386|NCT00928226|4117365|FG001|STARTED|Overall Study||12
3382387|NCT00928226|4117366|FG002|STARTED|Overall Study||12
3382388|NCT00928226|4117367|FG003|STARTED|Overall Study||12
3382389|NCT00928226|4117364|FG000|Strata A: Small Tumor, Resected|Overall Study||6
3382390|NCT00928226|4117365|FG001|Strata A: Small Tumor, Resected|Overall Study||6
3382391|NCT00928226|4117366|FG002|Strata A: Small Tumor, Resected|Overall Study||6
3382392|NCT00928226|4117367|FG003|Strata A: Small Tumor, Resected|Overall Study||6
3382393|NCT00928226|4117364|FG000|Strata B: Small Tumor, Not Resected|Overall Study||5
3382394|NCT00928226|4117365|FG001|Strata B: Small Tumor, Not Resected|Overall Study||0
3382395|NCT00928226|4117366|FG002|Strata B: Small Tumor, Not Resected|Overall Study||0
3382396|NCT00928226|4117367|FG003|Strata B: Small Tumor, Not Resected|Overall Study||0
3382397|NCT00928226|4117364|FG000|Strata C: Large Tumor, Resected|Overall Study||8
3382398|NCT00928226|4117365|FG001|Strata C: Large Tumor, Resected|Overall Study||6
3382399|NCT00928226|4117366|FG002|Strata C: Large Tumor, Resected|Overall Study||6
3382400|NCT00928226|4117367|FG003|Strata C: Large Tumor, Resected|Overall Study||6
3382401|NCT00928226|4117364|FG000|Strata D: Large Tumor, Not Resected|Overall Study||1
3382402|NCT00928226|4117365|FG001|Strata D: Large Tumor, Not Resected|Overall Study||0
3382403|NCT00928226|4117366|FG002|Strata D: Large Tumor, Not Resected|Overall Study||0
3382404|NCT00928226|4117367|FG003|Strata D: Large Tumor, Not Resected|Overall Study||0
3382405|NCT00928226|4117364|FG000|COMPLETED|Overall Study||20
3382406|NCT00928226|4117365|FG001|COMPLETED|Overall Study||12
3382407|NCT00928226|4117366|FG002|COMPLETED|Overall Study||12
3382408|NCT00928226|4117367|FG003|COMPLETED|Overall Study||12
3382409|NCT00928226|4117364|FG000|NOT COMPLETED|Overall Study||0
3382410|NCT00928226|4117365|FG001|NOT COMPLETED|Overall Study||0
3382411|NCT00928226|4117366|FG002|NOT COMPLETED|Overall Study||0
3382412|NCT00928226|4117367|FG003|NOT COMPLETED|Overall Study||0
3382416|NCT00940498|4117389|FG000|STARTED|Overall Study||4
3382417|NCT00940498|4117390|FG001|STARTED|Overall Study||4
3382418|NCT00940498|4117391|FG002|STARTED|Overall Study||4
3382419|NCT00940498|4117392|FG003|STARTED|Overall Study||4
3382420|NCT00940498|4117393|FG004|STARTED|Overall Study||43
3382421|NCT00940498|4117394|FG005|STARTED|Overall Study||7
3382422|NCT00940498|4117395|FG006|STARTED|Overall Study||8
3382423|NCT00940498|4117396|FG007|STARTED|Overall Study||4
3382424|NCT00940498|4117389|FG000|COMPLETED|Overall Study||1
3382425|NCT00940498|4117390|FG001|COMPLETED|Overall Study||3
3382426|NCT00940498|4117391|FG002|COMPLETED|Overall Study||1
3382427|NCT00940498|4117392|FG003|COMPLETED|Overall Study||2
3382428|NCT00940498|4117393|FG004|COMPLETED|Overall Study||34
3382429|NCT00940498|4117394|FG005|COMPLETED|Overall Study||6
3382430|NCT00940498|4117395|FG006|COMPLETED|Overall Study||7
3382431|NCT00940498|4117396|FG007|COMPLETED|Overall Study||3
3382432|NCT00940498|4117389|FG000|NOT COMPLETED|Overall Study||3
3382433|NCT00940498|4117390|FG001|NOT COMPLETED|Overall Study||1
3382434|NCT00940498|4117391|FG002|NOT COMPLETED|Overall Study||3
3382435|NCT00940498|4117392|FG003|NOT COMPLETED|Overall Study||2
3382436|NCT00940498|4117393|FG004|NOT COMPLETED|Overall Study||9
3382437|NCT00940498|4117394|FG005|NOT COMPLETED|Overall Study||1
3382438|NCT00940498|4117395|FG006|NOT COMPLETED|Overall Study||1
3382439|NCT00940498|4117396|FG007|NOT COMPLETED|Overall Study||1
3382440|NCT01009294|4117420|FG000|STARTED|Overall Study||6
3382441|NCT01009294|4117420|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6
3382442|NCT01009294|4117420|FG000|COMPLETED|Overall Study||0
3382443|NCT01009294|4117420|FG000|NOT COMPLETED|Overall Study||6
3382444|NCT01049035|4117431|FG000|STARTED|Overall Study||107
3382445|NCT01049035|4117432|FG001|STARTED|Overall Study||108
3382413|NCT00930722|4117377|FG000|STARTED|Overall Study||329
3382414|NCT00930722|4117377|FG000|COMPLETED|Overall Study||302
3382415|NCT00930722|4117377|FG000|NOT COMPLETED|Overall Study||27
3382446|NCT01049035|4117433|FG002|STARTED|Overall Study||107
3382447|NCT01049035|4117434|FG003|STARTED|Overall Study||75
3382448|NCT01049035|4117435|FG004|STARTED|Overall Study||75
3382449|NCT01049035|4117436|FG005|STARTED|Overall Study||54
3382450|NCT01049035|4117437|FG006|STARTED|Overall Study||54
3382451|NCT01049035|4117431|FG000|Safety Population|Overall Study||104
3382452|NCT01049035|4117432|FG001|Safety Population|Overall Study||102
3382453|NCT01049035|4117433|FG002|Safety Population|Overall Study||100
3382454|NCT01049035|4117434|FG003|Safety Population|Overall Study||74
3382455|NCT01049035|4117435|FG004|Safety Population|Overall Study||70
3382456|NCT01049035|4117436|FG005|Safety Population|Overall Study||52
3382457|NCT01049035|4117437|FG006|Safety Population|Overall Study||49
3382458|NCT01049035|4117431|FG000|COMPLETED|Overall Study||74
3382459|NCT01049035|4117432|FG001|COMPLETED|Overall Study||87
3382460|NCT01049035|4117433|FG002|COMPLETED|Overall Study||80
3382461|NCT01049035|4117434|FG003|COMPLETED|Overall Study||64
3382462|NCT01049035|4117435|FG004|COMPLETED|Overall Study||71
3382463|NCT01049035|4117436|FG005|COMPLETED|Overall Study||42
3382464|NCT01049035|4117437|FG006|COMPLETED|Overall Study||39
3382465|NCT01049035|4117431|FG000|NOT COMPLETED|Overall Study||33
3382466|NCT01049035|4117432|FG001|NOT COMPLETED|Overall Study||21
3382467|NCT01049035|4117433|FG002|NOT COMPLETED|Overall Study||27
3382468|NCT01049035|4117434|FG003|NOT COMPLETED|Overall Study||11
3382469|NCT01049035|4117435|FG004|NOT COMPLETED|Overall Study||4
3382470|NCT01049035|4117436|FG005|NOT COMPLETED|Overall Study||12
3382471|NCT01049035|4117437|FG006|NOT COMPLETED|Overall Study||15
3382472|NCT01053637|4117465|FG000|STARTED|Overall Study||43
3382473|NCT01053637|4117466|FG001|STARTED|Overall Study||42
3382474|NCT01053637|4117465|FG000|COMPLETED|Overall Study|2 with incomplete pain scores|43
3382475|NCT01053637|4117466|FG001|COMPLETED|Overall Study|4 incomplete pain scores 4 proceeded to procedural sedation|42
3382476|NCT01053637|4117465|FG000|NOT COMPLETED|Overall Study||0
3382477|NCT01053637|4117466|FG001|NOT COMPLETED|Overall Study||0
3382478|NCT01072175|4117484|FG000|STARTED|Part A (Drug-Drug Interaction)||8
3382479|NCT01072175|4117485|FG001|STARTED|Part A (Drug-Drug Interaction)||0
3382480|NCT01072175|4117486|FG002|STARTED|Part A (Drug-Drug Interaction)||0
3382481|NCT01072175|4117487|FG003|STARTED|Part A (Drug-Drug Interaction)||0
3382482|NCT01072175|4117488|FG004|STARTED|Part A (Drug-Drug Interaction)||0
3382483|NCT01072175|4117489|FG005|STARTED|Part A (Drug-Drug Interaction)||0
3382484|NCT01072175|4117490|FG006|STARTED|Part A (Drug-Drug Interaction)||0
3382485|NCT01072175|4117491|FG007|STARTED|Part A (Drug-Drug Interaction)||0
3382486|NCT01072175|4117492|FG008|STARTED|Part A (Drug-Drug Interaction)||0
3382487|NCT01072175|4117493|FG009|STARTED|Part A (Drug-Drug Interaction)||0
3382488|NCT01072175|4117494|FG010|STARTED|Part A (Drug-Drug Interaction)||0
3382489|NCT01072175|4117495|FG011|STARTED|Part A (Drug-Drug Interaction)||0
3382490|NCT01072175|4117496|FG012|STARTED|Part A (Drug-Drug Interaction)||0
3382491|NCT01072175|4117484|FG000|COMPLETED|Part A (Drug-Drug Interaction)||0
3382492|NCT01072175|4117485|FG001|COMPLETED|Part A (Drug-Drug Interaction)||0
3382493|NCT01072175|4117486|FG002|COMPLETED|Part A (Drug-Drug Interaction)||0
3382494|NCT01072175|4117487|FG003|COMPLETED|Part A (Drug-Drug Interaction)||0
3382495|NCT01072175|4117488|FG004|COMPLETED|Part A (Drug-Drug Interaction)||0
3382496|NCT01072175|4117489|FG005|COMPLETED|Part A (Drug-Drug Interaction)||0
3382497|NCT01072175|4117490|FG006|COMPLETED|Part A (Drug-Drug Interaction)||0
3382498|NCT01072175|4117491|FG007|COMPLETED|Part A (Drug-Drug Interaction)||0
3382499|NCT01072175|4117492|FG008|COMPLETED|Part A (Drug-Drug Interaction)||0
3382500|NCT01072175|4117493|FG009|COMPLETED|Part A (Drug-Drug Interaction)||0
3382501|NCT01072175|4117494|FG010|COMPLETED|Part A (Drug-Drug Interaction)||0
3382502|NCT01072175|4117495|FG011|COMPLETED|Part A (Drug-Drug Interaction)||0
3382503|NCT01072175|4117496|FG012|COMPLETED|Part A (Drug-Drug Interaction)||0
3382504|NCT01072175|4117484|FG000|NOT COMPLETED|Part A (Drug-Drug Interaction)||8
3382505|NCT01072175|4117485|FG001|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
3382506|NCT01072175|4117486|FG002|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
3382507|NCT01072175|4117487|FG003|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
3382508|NCT01072175|4117488|FG004|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
3382509|NCT01072175|4117489|FG005|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
3382510|NCT01072175|4117490|FG006|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
3382511|NCT01072175|4117491|FG007|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
3382512|NCT01072175|4117492|FG008|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
3382513|NCT01072175|4117493|FG009|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
3382514|NCT01072175|4117494|FG010|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
3382515|NCT01072175|4117495|FG011|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
3382516|NCT01072175|4117496|FG012|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
3382517|NCT01072175|4117484|FG000|STARTED|Part B (Dose Escalation and Expansion)||0
3382518|NCT01072175|4117485|FG001|STARTED|Part B (Dose Escalation and Expansion)||6
3382519|NCT01072175|4117486|FG002|STARTED|Part B (Dose Escalation and Expansion)||23
3382520|NCT01072175|4117487|FG003|STARTED|Part B (Dose Escalation and Expansion)||27
3382521|NCT01072175|4117488|FG004|STARTED|Part B (Dose Escalation and Expansion)||94
3382522|NCT01072175|4117489|FG005|STARTED|Part B (Dose Escalation and Expansion)||0
3382523|NCT01072175|4117490|FG006|STARTED|Part B (Dose Escalation and Expansion)||0
3382524|NCT01072175|4117491|FG007|STARTED|Part B (Dose Escalation and Expansion)||0
3382525|NCT01072175|4117492|FG008|STARTED|Part B (Dose Escalation and Expansion)||0
3382526|NCT01072175|4117493|FG009|STARTED|Part B (Dose Escalation and Expansion)||0
3382527|NCT01072175|4117494|FG010|STARTED|Part B (Dose Escalation and Expansion)||0
3382528|NCT01072175|4117495|FG011|STARTED|Part B (Dose Escalation and Expansion)||0
3382529|NCT01072175|4117496|FG012|STARTED|Part B (Dose Escalation and Expansion)||0
3382530|NCT01072175|4117484|FG000|COMPLETED|Part B (Dose Escalation and Expansion)||0
3382531|NCT01072175|4117485|FG001|COMPLETED|Part B (Dose Escalation and Expansion)||0
3382532|NCT01072175|4117486|FG002|COMPLETED|Part B (Dose Escalation and Expansion)||0
3382533|NCT01072175|4117487|FG003|COMPLETED|Part B (Dose Escalation and Expansion)||0
3382534|NCT01072175|4117488|FG004|COMPLETED|Part B (Dose Escalation and Expansion)||0
3382535|NCT01072175|4117489|FG005|COMPLETED|Part B (Dose Escalation and Expansion)||0
3382536|NCT01072175|4117490|FG006|COMPLETED|Part B (Dose Escalation and Expansion)||0
3382537|NCT01072175|4117491|FG007|COMPLETED|Part B (Dose Escalation and Expansion)||0
3382538|NCT01072175|4117492|FG008|COMPLETED|Part B (Dose Escalation and Expansion)||0
3382539|NCT01072175|4117493|FG009|COMPLETED|Part B (Dose Escalation and Expansion)||0
3382540|NCT01072175|4117494|FG010|COMPLETED|Part B (Dose Escalation and Expansion)||0
3382541|NCT01072175|4117495|FG011|COMPLETED|Part B (Dose Escalation and Expansion)||0
3382542|NCT01072175|4117496|FG012|COMPLETED|Part B (Dose Escalation and Expansion)||0
3382543|NCT01072175|4117484|FG000|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
3382544|NCT01072175|4117485|FG001|NOT COMPLETED|Part B (Dose Escalation and Expansion)||6
3382545|NCT01072175|4117486|FG002|NOT COMPLETED|Part B (Dose Escalation and Expansion)||23
3382546|NCT01072175|4117487|FG003|NOT COMPLETED|Part B (Dose Escalation and Expansion)||27
3382547|NCT01072175|4117488|FG004|NOT COMPLETED|Part B (Dose Escalation and Expansion)||94
3382548|NCT01072175|4117489|FG005|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
3382549|NCT01072175|4117490|FG006|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
3382550|NCT01072175|4117491|FG007|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
3382551|NCT01072175|4117492|FG008|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
3382552|NCT01072175|4117493|FG009|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
3382553|NCT01072175|4117494|FG010|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
3382554|NCT01072175|4117495|FG011|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
3382555|NCT01072175|4117496|FG012|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
3382556|NCT01072175|4117484|FG000|STARTED|Part C (Phase II: Randomized Phase)||0
3382557|NCT01072175|4117485|FG001|STARTED|Part C (Phase II: Randomized Phase)||0
3382558|NCT01072175|4117486|FG002|STARTED|Part C (Phase II: Randomized Phase)||0
3382559|NCT01072175|4117487|FG003|STARTED|Part C (Phase II: Randomized Phase)||0
3382560|NCT01072175|4117488|FG004|STARTED|Part C (Phase II: Randomized Phase)||0
3382561|NCT01072175|4117489|FG005|STARTED|Part C (Phase II: Randomized Phase)||54
3382562|NCT01072175|4117490|FG006|STARTED|Part C (Phase II: Randomized Phase)||54
3382563|NCT01072175|4117491|FG007|STARTED|Part C (Phase II: Randomized Phase)||54
3382564|NCT01072175|4117492|FG008|STARTED|Part C (Phase II: Randomized Phase)||0
3382565|NCT01072175|4117493|FG009|STARTED|Part C (Phase II: Randomized Phase)||0
3382566|NCT01072175|4117494|FG010|STARTED|Part C (Phase II: Randomized Phase)||0
3382567|NCT01072175|4117495|FG011|STARTED|Part C (Phase II: Randomized Phase)||0
3382568|NCT01072175|4117496|FG012|STARTED|Part C (Phase II: Randomized Phase)||0
3382569|NCT01072175|4117484|FG000|COMPLETED|Part C (Phase II: Randomized Phase)||0
3382570|NCT01072175|4117485|FG001|COMPLETED|Part C (Phase II: Randomized Phase)||0
3382571|NCT01072175|4117486|FG002|COMPLETED|Part C (Phase II: Randomized Phase)||0
3382572|NCT01072175|4117487|FG003|COMPLETED|Part C (Phase II: Randomized Phase)||0
3382573|NCT01072175|4117488|FG004|COMPLETED|Part C (Phase II: Randomized Phase)||0
3382574|NCT01072175|4117489|FG005|COMPLETED|Part C (Phase II: Randomized Phase)||0
3382575|NCT01072175|4117490|FG006|COMPLETED|Part C (Phase II: Randomized Phase)||0
3382576|NCT01072175|4117491|FG007|COMPLETED|Part C (Phase II: Randomized Phase)||0
3382577|NCT01072175|4117492|FG008|COMPLETED|Part C (Phase II: Randomized Phase)||0
3382578|NCT01072175|4117493|FG009|COMPLETED|Part C (Phase II: Randomized Phase)||0
3382579|NCT01072175|4117494|FG010|COMPLETED|Part C (Phase II: Randomized Phase)||0
3382580|NCT01072175|4117495|FG011|COMPLETED|Part C (Phase II: Randomized Phase)||0
3382581|NCT01072175|4117496|FG012|COMPLETED|Part C (Phase II: Randomized Phase)||0
3382582|NCT01072175|4117484|FG000|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
3382583|NCT01072175|4117485|FG001|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
3382584|NCT01072175|4117486|FG002|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
3382585|NCT01072175|4117487|FG003|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
3382586|NCT01072175|4117488|FG004|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
3382587|NCT01072175|4117489|FG005|NOT COMPLETED|Part C (Phase II: Randomized Phase)||54
3382588|NCT01072175|4117490|FG006|NOT COMPLETED|Part C (Phase II: Randomized Phase)||54
3382589|NCT01072175|4117491|FG007|NOT COMPLETED|Part C (Phase II: Randomized Phase)||54
3382590|NCT01072175|4117492|FG008|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
3382591|NCT01072175|4117493|FG009|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
3382592|NCT01072175|4117494|FG010|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
3382593|NCT01072175|4117495|FG011|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
3382594|NCT01072175|4117496|FG012|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
3382595|NCT01072175|4117484|FG000|STARTED|Part C (Phase II: Crossover Phase [CP])||0
3382596|NCT01072175|4117485|FG001|STARTED|Part C (Phase II: Crossover Phase [CP])||0
3382597|NCT01072175|4117486|FG002|STARTED|Part C (Phase II: Crossover Phase [CP])||0
3382598|NCT01072175|4117487|FG003|STARTED|Part C (Phase II: Crossover Phase [CP])||0
3382599|NCT01072175|4117488|FG004|STARTED|Part C (Phase II: Crossover Phase [CP])||0
3382600|NCT01072175|4117489|FG005|STARTED|Part C (Phase II: Crossover Phase [CP])||0
3382601|NCT01072175|4117490|FG006|STARTED|Part C (Phase II: Crossover Phase [CP])||0
3382602|NCT01072175|4117491|FG007|STARTED|Part C (Phase II: Crossover Phase [CP])||0
3382603|NCT01072175|4117492|FG008|STARTED|Part C (Phase II: Crossover Phase [CP])||45
3382604|NCT01072175|4117493|FG009|STARTED|Part C (Phase II: Crossover Phase [CP])||0
3382605|NCT01072175|4117494|FG010|STARTED|Part C (Phase II: Crossover Phase [CP])||0
3382606|NCT01072175|4117495|FG011|STARTED|Part C (Phase II: Crossover Phase [CP])||0
3382607|NCT01072175|4117496|FG012|STARTED|Part C (Phase II: Crossover Phase [CP])||0
3382608|NCT01072175|4117484|FG000|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
3382609|NCT01072175|4117485|FG001|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
3382610|NCT01072175|4117486|FG002|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
3382611|NCT01072175|4117487|FG003|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
3382612|NCT01072175|4117488|FG004|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
3382613|NCT01072175|4117489|FG005|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
3382614|NCT01072175|4117490|FG006|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
3382615|NCT01072175|4117491|FG007|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
3382616|NCT01072175|4117492|FG008|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
3382617|NCT01072175|4117493|FG009|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
3382618|NCT01072175|4117494|FG010|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
3382619|NCT01072175|4117495|FG011|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
3382620|NCT01072175|4117496|FG012|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
3382621|NCT01072175|4117484|FG000|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
3382622|NCT01072175|4117485|FG001|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
3382623|NCT01072175|4117486|FG002|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
3382624|NCT01072175|4117487|FG003|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
3382625|NCT01072175|4117488|FG004|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
3382626|NCT01072175|4117489|FG005|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
3382627|NCT01072175|4117490|FG006|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
3382628|NCT01072175|4117491|FG007|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
3382629|NCT01072175|4117492|FG008|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||45
3382630|NCT01072175|4117493|FG009|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
3382631|NCT01072175|4117494|FG010|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
3382632|NCT01072175|4117495|FG011|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
3382633|NCT01072175|4117496|FG012|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
3382634|NCT01072175|4117484|FG000|STARTED|Part D (HPMC Capsules)||0
3382635|NCT01072175|4117485|FG001|STARTED|Part D (HPMC Capsules)||0
3382636|NCT01072175|4117486|FG002|STARTED|Part D (HPMC Capsules)||0
3382637|NCT01072175|4117487|FG003|STARTED|Part D (HPMC Capsules)||0
3382638|NCT01072175|4117488|FG004|STARTED|Part D (HPMC Capsules)||0
3382639|NCT01072175|4117489|FG005|STARTED|Part D (HPMC Capsules)||0
3382640|NCT01072175|4117490|FG006|STARTED|Part D (HPMC Capsules)||0
3382641|NCT01072175|4117491|FG007|STARTED|Part D (HPMC Capsules)||0
3382642|NCT01072175|4117492|FG008|STARTED|Part D (HPMC Capsules)||0
3382643|NCT01072175|4117493|FG009|STARTED|Part D (HPMC Capsules)||12
3382644|NCT01072175|4117494|FG010|STARTED|Part D (HPMC Capsules)||16
3382645|NCT01072175|4117495|FG011|STARTED|Part D (HPMC Capsules)||43
3382646|NCT01072175|4117496|FG012|STARTED|Part D (HPMC Capsules)||39
3382647|NCT01072175|4117484|FG000|COMPLETED|Part D (HPMC Capsules)||0
3382648|NCT01072175|4117485|FG001|COMPLETED|Part D (HPMC Capsules)||0
3382649|NCT01072175|4117486|FG002|COMPLETED|Part D (HPMC Capsules)||0
3382650|NCT01072175|4117487|FG003|COMPLETED|Part D (HPMC Capsules)||0
3382651|NCT01072175|4117488|FG004|COMPLETED|Part D (HPMC Capsules)||0
3382652|NCT01072175|4117489|FG005|COMPLETED|Part D (HPMC Capsules)||0
3382653|NCT01072175|4117490|FG006|COMPLETED|Part D (HPMC Capsules)||0
3382654|NCT01072175|4117491|FG007|COMPLETED|Part D (HPMC Capsules)||0
3382655|NCT01072175|4117492|FG008|COMPLETED|Part D (HPMC Capsules)||0
3382656|NCT01072175|4117493|FG009|COMPLETED|Part D (HPMC Capsules)||0
3382657|NCT01072175|4117494|FG010|COMPLETED|Part D (HPMC Capsules)||0
3382658|NCT01072175|4117495|FG011|COMPLETED|Part D (HPMC Capsules)||0
3382659|NCT01072175|4117496|FG012|COMPLETED|Part D (HPMC Capsules)||0
3382660|NCT01072175|4117484|FG000|NOT COMPLETED|Part D (HPMC Capsules)||0
3382661|NCT01072175|4117485|FG001|NOT COMPLETED|Part D (HPMC Capsules)||0
3382662|NCT01072175|4117486|FG002|NOT COMPLETED|Part D (HPMC Capsules)||0
3382663|NCT01072175|4117487|FG003|NOT COMPLETED|Part D (HPMC Capsules)||0
3382664|NCT01072175|4117488|FG004|NOT COMPLETED|Part D (HPMC Capsules)||0
3382665|NCT01072175|4117489|FG005|NOT COMPLETED|Part D (HPMC Capsules)||0
3382666|NCT01072175|4117490|FG006|NOT COMPLETED|Part D (HPMC Capsules)||0
3382667|NCT01072175|4117491|FG007|NOT COMPLETED|Part D (HPMC Capsules)||0
3382668|NCT01072175|4117492|FG008|NOT COMPLETED|Part D (HPMC Capsules)||0
3382669|NCT01072175|4117493|FG009|NOT COMPLETED|Part D (HPMC Capsules)||12
3382670|NCT01072175|4117494|FG010|NOT COMPLETED|Part D (HPMC Capsules)||16
3382671|NCT01072175|4117495|FG011|NOT COMPLETED|Part D (HPMC Capsules)||43
3382672|NCT01072175|4117496|FG012|NOT COMPLETED|Part D (HPMC Capsules)||39
3382673|NCT01087203|4117530|FG000|STARTED|Overall Study||35
3382674|NCT01087203|4117531|FG001|STARTED|Overall Study||38
3382675|NCT01087203|4117530|FG000|COMPLETED|Overall Study||3
3382676|NCT01087203|4117531|FG001|COMPLETED|Overall Study||3
3382677|NCT01087203|4117530|FG000|NOT COMPLETED|Overall Study||32
3382678|NCT01087203|4117531|FG001|NOT COMPLETED|Overall Study||35
3382682|NCT01108055|4117542|FG000|STARTED|Overall Study||43
3382683|NCT01108055|4117542|FG000|Eligible and Started Treatment|Overall Study||32
3382684|NCT01108055|4117542|FG000|COMPLETED|Overall Study||28
3382685|NCT01108055|4117542|FG000|NOT COMPLETED|Overall Study||15
3382689|NCT01136967|4117552|FG000|STARTED|Overall Study||93
3382690|NCT01136967|4117553|FG001|STARTED|Overall Study||89
3382691|NCT01136967|4117552|FG000|Disease Progression|Overall Study||55
3382692|NCT01136967|4117553|FG001|Disease Progression|Overall Study||56
3382693|NCT01136967|4117552|FG000|Treatment Ongoing at Data Cutoff|Overall Study|Entered Extension Phase on treatment at data cut-off (18 January 2012)|14
3382694|NCT01136967|4117553|FG001|Treatment Ongoing at Data Cutoff|Overall Study|Entered Extension Phase on treatment at data cut-off (15 April 2013)|6
3382695|NCT01136967|4117552|FG000|COMPLETED|Overall Study|Disease Progression and treatment ongoing at data cutoff (18 January 2012)|69
3382696|NCT01136967|4117553|FG001|COMPLETED|Overall Study|Disease Progression and treatment ongoing at data cutoff (15 April 2013)|62
3382697|NCT01136967|4117552|FG000|NOT COMPLETED|Overall Study||24
3382698|NCT01136967|4117553|FG001|NOT COMPLETED|Overall Study||27
3382699|NCT01136980|4117561|FG000|STARTED|Overall Study||42
3382700|NCT01136980|4117562|FG001|STARTED|Overall Study||87
3382701|NCT01136980|4117561|FG000|COMPLETED|Overall Study||28
3382702|NCT01136980|4117562|FG001|COMPLETED|Overall Study||76
3382703|NCT01136980|4117561|FG000|NOT COMPLETED|Overall Study||14
3382704|NCT01136980|4117562|FG001|NOT COMPLETED|Overall Study||11
3382725|NCT01174563|4117578|FG000|STARTED|Overall Study||60
3382726|NCT01174563|4117578|FG000|Efficacy Set|Overall Study||59
3382727|NCT01174563|4117578|FG000|Safety Set|Overall Study||59
3382728|NCT01174563|4117578|FG000|COMPLETED|Overall Study||0
3382729|NCT01174563|4117578|FG000|NOT COMPLETED|Overall Study||60
3382730|NCT01190202|4117586|FG000|STARTED|Overall Study||6404
3382731|NCT01190202|4117587|FG001|STARTED|Overall Study||6414
3382732|NCT01190202|4117588|FG002|STARTED|Overall Study||6400
3382733|NCT01190202|4117589|FG003|STARTED|Overall Study||2400
3382734|NCT01190202|4117586|FG000|COMPLETED|Overall Study||6404
3382735|NCT01190202|4117587|FG001|COMPLETED|Overall Study||6414
3382736|NCT01190202|4117588|FG002|COMPLETED|Overall Study||6400
3382737|NCT01190202|4117589|FG003|COMPLETED|Overall Study||2400
3382738|NCT01190202|4117586|FG000|NOT COMPLETED|Overall Study||0
3382739|NCT01190202|4117587|FG001|NOT COMPLETED|Overall Study||0
3382740|NCT01190202|4117588|FG002|NOT COMPLETED|Overall Study||0
3382741|NCT01190202|4117589|FG003|NOT COMPLETED|Overall Study||0
3382742|NCT01200862|4117634|FG000|STARTED|Part 1||14
3382743|NCT01200862|4117635|FG001|STARTED|Part 1||0
3382744|NCT01200862|4117636|FG002|STARTED|Part 1||0
3382745|NCT01200862|4117634|FG000|COMPLETED|Part 1||13
3382746|NCT01200862|4117635|FG001|COMPLETED|Part 1||0
3382747|NCT01200862|4117636|FG002|COMPLETED|Part 1||0
3382748|NCT01200862|4117634|FG000|NOT COMPLETED|Part 1||1
3382749|NCT01200862|4117635|FG001|NOT COMPLETED|Part 1||0
3382750|NCT01200862|4117636|FG002|NOT COMPLETED|Part 1||0
3382751|NCT01200862|4117634|FG000|STARTED|Part 2||0
3382752|NCT01200862|4117635|FG001|STARTED|Part 2||7
3382753|NCT01200862|4117636|FG002|STARTED|Part 2||8
3382754|NCT01200862|4117634|FG000|COMPLETED|Part 2||0
3382755|NCT01200862|4117635|FG001|COMPLETED|Part 2||6
3382756|NCT01200862|4117636|FG002|COMPLETED|Part 2||8
3382757|NCT01200862|4117634|FG000|NOT COMPLETED|Part 2||0
3382758|NCT01200862|4117635|FG001|NOT COMPLETED|Part 2||1
3382759|NCT01200862|4117636|FG002|NOT COMPLETED|Part 2||0
3382760|NCT01225341|4117647|FG000|STARTED|Overall Study||0
3382761|NCT01225341|4117648|FG001|STARTED|Overall Study||0
3382762|NCT01225341|4117647|FG000|COMPLETED|Overall Study||0
3382763|NCT01225341|4117648|FG001|COMPLETED|Overall Study||0
3382764|NCT01225341|4117647|FG000|NOT COMPLETED|Overall Study||0
3382765|NCT01225341|4117648|FG001|NOT COMPLETED|Overall Study||0
3382766|NCT01235962|4117658|FG000|STARTED|Overall Study||198
3382767|NCT01235962|4117659|FG001|STARTED|Overall Study||205
3382768|NCT01235962|4117660|FG002|STARTED|Overall Study||571
3382769|NCT01235962|4117661|FG003|STARTED|Overall Study||564
3382770|NCT01235962|4117658|FG000|Prem. Withdrawn = Did Not Complete Study|Overall Study||46
3382771|NCT01235962|4117659|FG001|Prem. Withdrawn = Did Not Complete Study|Overall Study||35
3382772|NCT01235962|4117660|FG002|Prem. Withdrawn = Did Not Complete Study|Overall Study||118
3382773|NCT01235962|4117661|FG003|Prem. Withdrawn = Did Not Complete Study|Overall Study||86
3382774|NCT01235962|4117658|FG000|All Deaths|Overall Study||43
3382775|NCT01235962|4117659|FG001|All Deaths|Overall Study||46
3382776|NCT01235962|4117660|FG002|All Deaths|Overall Study||102
3382777|NCT01235962|4117661|FG003|All Deaths|Overall Study||104
3382778|NCT01235962|4117658|FG000|COMPLETED|Overall Study||152
3382779|NCT01235962|4117659|FG001|COMPLETED|Overall Study||170
3382780|NCT01235962|4117660|FG002|COMPLETED|Overall Study||453
3382781|NCT01235962|4117661|FG003|COMPLETED|Overall Study||478
3382782|NCT01235962|4117658|FG000|NOT COMPLETED|Overall Study||46
3382783|NCT01235962|4117659|FG001|NOT COMPLETED|Overall Study||35
3382784|NCT01235962|4117660|FG002|NOT COMPLETED|Overall Study||118
3382785|NCT01235962|4117661|FG003|NOT COMPLETED|Overall Study||86
3382786|NCT01239368|4117689|FG000|STARTED|Overall Study||2
3382787|NCT01239368|4117690|FG001|STARTED|Overall Study||1
3382679|NCT01088815|4117538|FG000|STARTED|Overall Study||72
3382680|NCT01088815|4117538|FG000|COMPLETED|Overall Study||72
3382681|NCT01088815|4117538|FG000|NOT COMPLETED|Overall Study||0
3382686|NCT01111019|4117546|FG000|STARTED|Overall Study||19
3382687|NCT01111019|4117546|FG000|COMPLETED|Overall Study||16
3382688|NCT01111019|4117546|FG000|NOT COMPLETED|Overall Study||3
3382705|NCT01140451|4117570|FG000|STARTED|Overall Study||95
3382706|NCT01140451|4117571|FG001|STARTED|Overall Study||96
3382707|NCT01140451|4117570|FG000|Completed 24 Weeks|Overall Study||89
3382708|NCT01140451|4117571|FG001|Completed 24 Weeks|Overall Study||86
3382709|NCT01140451|4117570|FG000|Completed 48 Weeks|Overall Study||78
3382710|NCT01140451|4117571|FG001|Completed 48 Weeks|Overall Study||70
3382711|NCT01140451|4117570|FG000|Completed 72 Weeks|Overall Study||63
3382712|NCT01140451|4117571|FG001|Completed 72 Weeks|Overall Study||62
3382713|NCT01140451|4117570|FG000|Completed 96 Weeks|Overall Study||57
3382714|NCT01140451|4117571|FG001|Completed 96 Weeks|Overall Study||54
3382715|NCT01140451|4117570|FG000|As-Treated Population|Overall Study||95
3382716|NCT01140451|4117571|FG001|As-Treated Population|Overall Study||96
3382717|NCT01140451|4117570|FG000|96-Week Completer Population|Overall Study||78
3382718|NCT01140451|4117571|FG001|96-Week Completer Population|Overall Study||70
3382719|NCT01140451|4117570|FG000|144-Week Completer Population|Overall Study||57
3382720|NCT01140451|4117571|FG001|144-Week Completer Population|Overall Study||54
3382721|NCT01140451|4117570|FG000|COMPLETED|Overall Study||57
3382722|NCT01140451|4117571|FG001|COMPLETED|Overall Study||54
3382723|NCT01140451|4117570|FG000|NOT COMPLETED|Overall Study||38
3382724|NCT01140451|4117571|FG001|NOT COMPLETED|Overall Study||42
3382788|NCT01239368|4117691|FG002|STARTED|Overall Study||1
3382789|NCT01239368|4117692|FG003|STARTED|Overall Study||2
3382790|NCT01239368|4117693|FG004|STARTED|Overall Study||7
3382791|NCT01239368|4117694|FG005|STARTED|Overall Study||5
3382792|NCT01239368|4117695|FG006|STARTED|Overall Study||7
3382793|NCT01239368|4117696|FG007|STARTED|Overall Study||0
3382794|NCT01239368|4117697|FG008|STARTED|Overall Study||1
3382795|NCT01239368|4117698|FG009|STARTED|Overall Study||5
3382796|NCT01239368|4117689|FG000|COMPLETED|Overall Study||0
3382797|NCT01239368|4117690|FG001|COMPLETED|Overall Study||0
3382798|NCT01239368|4117691|FG002|COMPLETED|Overall Study||0
3382799|NCT01239368|4117692|FG003|COMPLETED|Overall Study||1
3382800|NCT01239368|4117693|FG004|COMPLETED|Overall Study||2
3382801|NCT01239368|4117694|FG005|COMPLETED|Overall Study||1
3382802|NCT01239368|4117695|FG006|COMPLETED|Overall Study||1
3382803|NCT01239368|4117696|FG007|COMPLETED|Overall Study||0
3382804|NCT01239368|4117697|FG008|COMPLETED|Overall Study||1
3382805|NCT01239368|4117698|FG009|COMPLETED|Overall Study||1
3382806|NCT01239368|4117689|FG000|NOT COMPLETED|Overall Study||2
3382807|NCT01239368|4117690|FG001|NOT COMPLETED|Overall Study||1
3382808|NCT01239368|4117691|FG002|NOT COMPLETED|Overall Study||1
3382809|NCT01239368|4117692|FG003|NOT COMPLETED|Overall Study||1
3382810|NCT01239368|4117693|FG004|NOT COMPLETED|Overall Study||5
3382811|NCT01239368|4117694|FG005|NOT COMPLETED|Overall Study||4
3382812|NCT01239368|4117695|FG006|NOT COMPLETED|Overall Study||6
3382813|NCT01239368|4117696|FG007|NOT COMPLETED|Overall Study||0
3382814|NCT01239368|4117697|FG008|NOT COMPLETED|Overall Study||0
3382815|NCT01239368|4117698|FG009|NOT COMPLETED|Overall Study||4
3382816|NCT01266031|4117734|FG000|STARTED|Overall Study||6
3382817|NCT01266031|4117735|FG001|STARTED|Overall Study||41
3382818|NCT01266031|4117736|FG002|STARTED|Overall Study||49
3382819|NCT01266031|4117734|FG000|COMPLETED|Overall Study||6
3382820|NCT01266031|4117735|FG001|COMPLETED|Overall Study||38
3382821|NCT01266031|4117736|FG002|COMPLETED|Overall Study||47
3382822|NCT01266031|4117734|FG000|NOT COMPLETED|Overall Study||0
3382823|NCT01266031|4117735|FG001|NOT COMPLETED|Overall Study||3
3382824|NCT01266031|4117736|FG002|NOT COMPLETED|Overall Study||2
3382825|NCT01287741|4117757|FG000|STARTED|Overall Study||712
3382826|NCT01287741|4117758|FG001|STARTED|Overall Study||706
3382827|NCT01287741|4117757|FG000|COMPLETED|Overall Study||86
3382828|NCT01287741|4117758|FG001|COMPLETED|Overall Study||91
3382829|NCT01287741|4117757|FG000|NOT COMPLETED|Overall Study||626
3382830|NCT01287741|4117758|FG001|NOT COMPLETED|Overall Study||615
3382831|NCT01304316|4117765|FG000|STARTED|Overall Study||12
3382832|NCT01304316|4117765|FG000|COMPLETED|Overall Study||12
3382833|NCT01304316|4117765|FG000|NOT COMPLETED|Overall Study||0
3382834|NCT01313689|4117775|FG000|STARTED|24-Week Randomization 1||79
3382835|NCT01313689|4117776|FG001|STARTED|24-Week Randomization 1|Of the 43 participants in the PC arm, 22 entered the OFA Salvage arm.|43
3382836|NCT01313689|4117777|FG002|STARTED|24-Week Randomization 1||0
3382837|NCT01313689|4117778|FG003|STARTED|24-Week Randomization 1||0
3382838|NCT01313689|4117779|FG004|STARTED|24-Week Randomization 1||0
3382839|NCT01313689|4117775|FG000|COMPLETED|24-Week Randomization 1|Par. not entering Randomization 2 continued visits for Follow-up and overall survival assessment|60
3382840|NCT01313689|4117776|FG001|COMPLETED|24-Week Randomization 1|Par. that did not receive OFA salvage continued visits for Follow-up and overall survival assessment|33
3382841|NCT01313689|4117777|FG002|COMPLETED|24-Week Randomization 1||0
3382842|NCT01313689|4117778|FG003|COMPLETED|24-Week Randomization 1||0
3382843|NCT01313689|4117779|FG004|COMPLETED|24-Week Randomization 1||0
3382844|NCT01313689|4117775|FG000|NOT COMPLETED|24-Week Randomization 1||19
3382845|NCT01313689|4117776|FG001|NOT COMPLETED|24-Week Randomization 1||10
3382846|NCT01313689|4117777|FG002|NOT COMPLETED|24-Week Randomization 1||0
3382847|NCT01313689|4117778|FG003|NOT COMPLETED|24-Week Randomization 1||0
3382848|NCT01313689|4117779|FG004|NOT COMPLETED|24-Week Randomization 1||0
3382849|NCT01313689|4117775|FG000|STARTED|24-Week Randomization 2||0
3382850|NCT01313689|4117776|FG001|STARTED|24-Week Randomization 2||0
3382851|NCT01313689|4117777|FG002|STARTED|24-Week Randomization 2|Not all participants from Randomization 1 continued to Randomization 2.|24
3382852|NCT01313689|4117778|FG003|STARTED|24-Week Randomization 2|Not all participants from Randomization 1 continued to Randomization 2.|13
3382853|NCT01313689|4117779|FG004|STARTED|24-Week Randomization 2|OFA Participants who did not enter Randomization 2.|42
3382854|NCT01313689|4117775|FG000|COMPLETED|24-Week Randomization 2||0
3382855|NCT01313689|4117776|FG001|COMPLETED|24-Week Randomization 2||0
3382856|NCT01313689|4117777|FG002|COMPLETED|24-Week Randomization 2||21
3382857|NCT01313689|4117778|FG003|COMPLETED|24-Week Randomization 2||12
3382858|NCT01313689|4117779|FG004|COMPLETED|24-Week Randomization 2||27
3382859|NCT01313689|4117775|FG000|NOT COMPLETED|24-Week Randomization 2||0
3382860|NCT01313689|4117776|FG001|NOT COMPLETED|24-Week Randomization 2||0
3382861|NCT01313689|4117777|FG002|NOT COMPLETED|24-Week Randomization 2||3
3382862|NCT01313689|4117778|FG003|NOT COMPLETED|24-Week Randomization 2||1
3382863|NCT01313689|4117779|FG004|NOT COMPLETED|24-Week Randomization 2||15
3382873|NCT01318993|4117811|FG000|STARTED|Overall Study||398
3382874|NCT01318993|4117811|FG000|COMPLETED|Overall Study||0
3382875|NCT01318993|4117811|FG000|NOT COMPLETED|Overall Study||398
3382876|NCT01335685|4117819|FG000|STARTED|Overall Study||7
3382877|NCT01335685|4117820|FG001|STARTED|Overall Study||4
3382878|NCT01335685|4117821|FG002|STARTED|Overall Study||3
3382879|NCT01335685|4117822|FG003|STARTED|Overall Study||26
3382880|NCT01335685|4117823|FG004|STARTED|Overall Study||5
3382881|NCT01335685|4117824|FG005|STARTED|Overall Study||6
3382882|NCT01335685|4117825|FG006|STARTED|Overall Study||4
3382883|NCT01335685|4117826|FG007|STARTED|Overall Study||6
3382884|NCT01335685|4117819|FG000|COMPLETED|Overall Study||4
3382885|NCT01335685|4117820|FG001|COMPLETED|Overall Study||3
3382886|NCT01335685|4117821|FG002|COMPLETED|Overall Study||1
3382887|NCT01335685|4117822|FG003|COMPLETED|Overall Study||15
3382888|NCT01335685|4117823|FG004|COMPLETED|Overall Study||5
3382889|NCT01335685|4117824|FG005|COMPLETED|Overall Study||1
3382890|NCT01335685|4117825|FG006|COMPLETED|Overall Study||2
3382891|NCT01335685|4117826|FG007|COMPLETED|Overall Study||3
3382892|NCT01335685|4117819|FG000|NOT COMPLETED|Overall Study||3
3382893|NCT01335685|4117820|FG001|NOT COMPLETED|Overall Study||1
3382894|NCT01335685|4117821|FG002|NOT COMPLETED|Overall Study||2
3382895|NCT01335685|4117822|FG003|NOT COMPLETED|Overall Study||11
3382896|NCT01335685|4117823|FG004|NOT COMPLETED|Overall Study||0
3382897|NCT01335685|4117824|FG005|NOT COMPLETED|Overall Study||5
3382898|NCT01335685|4117825|FG006|NOT COMPLETED|Overall Study||2
3382899|NCT01335685|4117826|FG007|NOT COMPLETED|Overall Study||3
3382900|NCT01336621|4117849|FG000|STARTED|Primary Reporting Phase (Upto 5.8 Years)||98
3382901|NCT01336621|4117849|FG000|COMPLETED|Primary Reporting Phase (Upto 5.8 Years)||0
3382902|NCT01336621|4117849|FG000|NOT COMPLETED|Primary Reporting Phase (Upto 5.8 Years)||98
3382903|NCT01336621|4117849|FG000|STARTED|SFUCP (up to 2.6 Years)||9
3382904|NCT01336621|4117849|FG000|COMPLETED|SFUCP (up to 2.6 Years)||0
3382905|NCT01336621|4117849|FG000|NOT COMPLETED|SFUCP (up to 2.6 Years)||9
3382906|NCT04391036|4117858|FG000|STARTED|Overall Study||15
3382907|NCT04391036|4117859|FG001|STARTED|Overall Study||15
3382908|NCT04391036|4117858|FG000|COMPLETED|Overall Study||15
3382864|NCT01315353|4117801|FG000|STARTED|Overall Study||145
3382865|NCT01315353|4117802|FG001|STARTED|Overall Study||143
3382866|NCT01315353|4117803|FG002|STARTED|Overall Study||179
3382867|NCT01315353|4117801|FG000|COMPLETED|Overall Study||116
3382868|NCT01315353|4117802|FG001|COMPLETED|Overall Study||120
3382869|NCT01315353|4117803|FG002|COMPLETED|Overall Study||166
3382870|NCT01315353|4117801|FG000|NOT COMPLETED|Overall Study||29
3382871|NCT01315353|4117802|FG001|NOT COMPLETED|Overall Study||23
3382872|NCT01315353|4117803|FG002|NOT COMPLETED|Overall Study||13
3382909|NCT04391036|4117859|FG001|COMPLETED|Overall Study||15
3382910|NCT04391036|4117858|FG000|NOT COMPLETED|Overall Study||0
3382911|NCT04391036|4117859|FG001|NOT COMPLETED|Overall Study||0
3382912|NCT04170296|4117869|FG000|STARTED|Overall Study||81
3382913|NCT04170296|4117870|FG001|STARTED|Overall Study||72
3382914|NCT04170296|4117869|FG000|COMPLETED|Overall Study||73
3382915|NCT04170296|4117870|FG001|COMPLETED|Overall Study||68
3382916|NCT04170296|4117869|FG000|NOT COMPLETED|Overall Study||8
3382917|NCT04170296|4117870|FG001|NOT COMPLETED|Overall Study||4
3382918|NCT04039217|4117882|FG000|STARTED|Overall Study||20
3382919|NCT04039217|4117882|FG000|Started Study Arm A.1|Overall Study||4
3382920|NCT04039217|4117882|FG000|Completed Study Arm A.1|Overall Study||4
3382921|NCT04039217|4117882|FG000|Started Study Arm A.2|Overall Study||4
3382922|NCT04039217|4117882|FG000|Completed Study Arm A.2|Overall Study||4
3382923|NCT04039217|4117882|FG000|Started Study Arm A.3|Overall Study||4
3382924|NCT04039217|4117882|FG000|Completed Study Arm A.3|Overall Study||4
3382925|NCT04039217|4117882|FG000|Started Study Arm B.1|Overall Study||4
3382926|NCT04039217|4117882|FG000|Completed Study Arm B.1|Overall Study||4
3382927|NCT04039217|4117882|FG000|Started Study Arm B.2|Overall Study||4
3382928|NCT04039217|4117882|FG000|Completed Study Arm B.2|Overall Study||4
3382929|NCT04039217|4117882|FG000|Started Study Arm C.1|Overall Study||5
3382930|NCT04039217|4117882|FG000|Completed Study Arm C.1|Overall Study||4
3382931|NCT04039217|4117882|FG000|Started Study Arm C.2|Overall Study||0
3382932|NCT04039217|4117882|FG000|Completed Study Arm C.2|Overall Study||0
3382933|NCT04039217|4117882|FG000|COMPLETED|Overall Study||19
3382934|NCT04039217|4117882|FG000|NOT COMPLETED|Overall Study||1
3382935|NCT03998046|4117892|FG000|STARTED|Overall Study||38
3382936|NCT03998046|4117893|FG001|STARTED|Overall Study||42
3382937|NCT03998046|4117892|FG000|COMPLETED|Overall Study||38
3382938|NCT03998046|4117893|FG001|COMPLETED|Overall Study||42
3382939|NCT03998046|4117892|FG000|NOT COMPLETED|Overall Study||0
3382940|NCT03998046|4117893|FG001|NOT COMPLETED|Overall Study||0
3382941|NCT03160521|4117903|FG000|STARTED|Overall Study|From 145 randomized patients in the 75 mg dose arm, one of them withdrew consent before receiving the study treatment. Due to, only 144 patients received allocated intervention.|144
3382942|NCT03160521|4117904|FG001|STARTED|Overall Study||146
3382943|NCT03160521|4117905|FG002|STARTED|Overall Study||147
3382944|NCT03160521|4117903|FG000|COMPLETED|Overall Study||107
3382945|NCT03160521|4117904|FG001|COMPLETED|Overall Study||95
3382946|NCT03160521|4117905|FG002|COMPLETED|Overall Study||88
3382947|NCT03160521|4117903|FG000|NOT COMPLETED|Overall Study||37
3382948|NCT03160521|4117904|FG001|NOT COMPLETED|Overall Study||51
3382949|NCT03160521|4117905|FG002|NOT COMPLETED|Overall Study||59
3382950|NCT03143816|4117921|FG000|STARTED|Overall Study||26
3382951|NCT03143816|4117922|FG001|STARTED|Overall Study||34
3382952|NCT03143816|4117921|FG000|COMPLETED|Overall Study||22
3382953|NCT03143816|4117922|FG001|COMPLETED|Overall Study||34
3382954|NCT03143816|4117921|FG000|NOT COMPLETED|Overall Study||4
3382955|NCT03143816|4117922|FG001|NOT COMPLETED|Overall Study||0
3382956|NCT03078192|4117936|FG000|STARTED|Overall Study||30
3382957|NCT03078192|4117937|FG001|STARTED|Overall Study||32
3382958|NCT03078192|4117936|FG000|COMPLETED|Overall Study||28
3382959|NCT03078192|4117937|FG001|COMPLETED|Overall Study||28
3382960|NCT03078192|4117936|FG000|NOT COMPLETED|Overall Study||2
3382961|NCT03078192|4117937|FG001|NOT COMPLETED|Overall Study||4
3382962|NCT02959944|4117945|FG000|STARTED|Overall Study||95
3382963|NCT02959944|4117946|FG001|STARTED|Overall Study||98
3382964|NCT02959944|4117945|FG000|Received at Least 1 Dose of Study Drug|Overall Study||94
3382965|NCT02959944|4117946|FG001|Received at Least 1 Dose of Study Drug|Overall Study||96
3382966|NCT02959944|4117945|FG000|COMPLETED|Overall Study||95
3382967|NCT02959944|4117946|FG001|COMPLETED|Overall Study||98
3382968|NCT02959944|4117945|FG000|NOT COMPLETED|Overall Study||0
3382969|NCT02959944|4117946|FG001|NOT COMPLETED|Overall Study||0
3382970|NCT02903823|4117952|FG000|STARTED|Overall Study|First subject enrollment|27
3382971|NCT02903823|4117952|FG000|COMPLETED|Overall Study||20
3382972|NCT02903823|4117952|FG000|NOT COMPLETED|Overall Study||7
3382973|NCT02666183|4117960|FG000|STARTED|Overall Study||137
3382974|NCT02666183|4117961|FG001|STARTED|Overall Study||141
3382975|NCT02666183|4117962|FG002|STARTED|Overall Study||119
3382976|NCT02666183|4117960|FG000|COMPLETED|Overall Study||103
3382977|NCT02666183|4117961|FG001|COMPLETED|Overall Study||106
3382978|NCT02666183|4117962|FG002|COMPLETED|Overall Study||93
3382979|NCT02666183|4117960|FG000|NOT COMPLETED|Overall Study||34
3382980|NCT02666183|4117961|FG001|NOT COMPLETED|Overall Study||35
3382981|NCT02666183|4117962|FG002|NOT COMPLETED|Overall Study||26
3382982|NCT01547117|4117974|FG000|STARTED|Overall Study||12
3382983|NCT01547117|4117975|FG001|STARTED|Overall Study||5
3382984|NCT01547117|4117976|FG002|STARTED|Overall Study||10
3382985|NCT01547117|4117977|FG003|STARTED|Overall Study||11
3382986|NCT01547117|4117974|FG000|Phase 1 Baseline Labs|Overall Study||12
3382987|NCT01547117|4117975|FG001|Phase 1 Baseline Labs|Overall Study|1 healthy control was unable to find time to schedule study|4
3382988|NCT01547117|4117976|FG002|Phase 1 Baseline Labs|Overall Study|2 patients with POTS did not discontinue medication that was prohibited by protocol.|8
3382989|NCT01547117|4117977|FG003|Phase 1 Baseline Labs|Overall Study|1 patient with POTS did not discontinue medication that was prohibited by protocol, 1 patient was unable to find time to schedule the study, 1 was noted to be too old to participate, and 1 became pregnant between enrollment and the start of phase 1.|7
3382990|NCT01547117|4117974|FG000|Phase 1-150 mEq Sodium/Day|Overall Study||12
3382991|NCT01547117|4117975|FG001|Phase 1-150 mEq Sodium/Day|Overall Study||4
3382992|NCT01547117|4117976|FG002|Phase 1-150 mEq Sodium/Day|Overall Study||8
3382993|NCT01547117|4117977|FG003|Phase 1-150 mEq Sodium/Day|Overall Study||7
3382994|NCT01547117|4117974|FG000|Phase 1-start Low Sodium or High Sodium Diet|Overall Study||12
3382995|NCT01547117|4117975|FG001|Phase 1-start Low Sodium or High Sodium Diet|Overall Study||4
3382996|NCT01547117|4117976|FG002|Phase 1-start Low Sodium or High Sodium Diet|Overall Study||8
3382997|NCT01547117|4117977|FG003|Phase 1-start Low Sodium or High Sodium Diet|Overall Study||7
3382998|NCT01547117|4117974|FG000|Phase 1-finish|Overall Study|1 healthy control withdrew with migraines during phase 1 (low Na+).|11
3382999|NCT01547117|4117975|FG001|Phase 1-finish|Overall Study|2 healthy controls withdrew during phase 1 (high Na+): 1 unable to tolerate study diet and another with difficulty cooperating with investigators..|2
3383000|NCT01547117|4117976|FG002|Phase 1-finish|Overall Study||8
3383001|NCT01547117|4117977|FG003|Phase 1-finish|Overall Study|1 patient with POTS withdrew during phase 1 due to a family illness.|6
3383002|NCT01547117|4117974|FG000|Phase 2-150 mEq Sodium/Day|Overall Study||11
3383003|NCT01547117|4117975|FG001|Phase 2-150 mEq Sodium/Day|Overall Study||2
3383004|NCT01547117|4117976|FG002|Phase 2-150 mEq Sodium/Day|Overall Study||8
3383005|NCT01547117|4117977|FG003|Phase 2-150 mEq Sodium/Day|Overall Study||6
3383006|NCT01547117|4117974|FG000|Phase 2-start Low Sodium or High Sodium Diet|Overall Study||11
3383007|NCT01547117|4117975|FG001|Phase 2-start Low Sodium or High Sodium Diet|Overall Study||2
3383008|NCT01547117|4117976|FG002|Phase 2-start Low Sodium or High Sodium Diet|Overall Study||8
3383009|NCT01547117|4117977|FG003|Phase 2-start Low Sodium or High Sodium Diet|Overall Study||6
3383010|NCT01547117|4117974|FG000|Phase 2-finish|Overall Study||11
3383011|NCT01547117|4117975|FG001|Phase 2-finish|Overall Study||2
3383012|NCT01547117|4117976|FG002|Phase 2-finish|Overall Study||8
3383013|NCT01547117|4117977|FG003|Phase 2-finish|Overall Study||6
3383014|NCT01547117|4117974|FG000|COMPLETED|Overall Study||11
3383015|NCT01547117|4117975|FG001|COMPLETED|Overall Study||2
3383016|NCT01547117|4117976|FG002|COMPLETED|Overall Study||8
3383017|NCT01547117|4117977|FG003|COMPLETED|Overall Study||6
3383018|NCT01547117|4117974|FG000|NOT COMPLETED|Overall Study||1
3383019|NCT01547117|4117975|FG001|NOT COMPLETED|Overall Study||3
3383020|NCT01547117|4117976|FG002|NOT COMPLETED|Overall Study||2
3383021|NCT01547117|4117977|FG003|NOT COMPLETED|Overall Study||5
3383022|NCT01431508|4118003|FG000|STARTED|Overall Study||15
3383023|NCT01431508|4118003|FG000|COMPLETED|Overall Study||13
3383024|NCT01431508|4118003|FG000|NOT COMPLETED|Overall Study||2
3383025|NCT00871351|4118010|FG000|STARTED|Overall Study||47
3383026|NCT00871351|4118011|FG001|STARTED|Overall Study||46
3383027|NCT00871351|4118012|FG002|STARTED|Overall Study||32
3383028|NCT00871351|4118010|FG000|COMPLETED|Overall Study||43
3383029|NCT00871351|4118011|FG001|COMPLETED|Overall Study||45
3383030|NCT00871351|4118012|FG002|COMPLETED|Overall Study||32
3383031|NCT00871351|4118010|FG000|NOT COMPLETED|Overall Study||4
3383032|NCT00871351|4118011|FG001|NOT COMPLETED|Overall Study||1
3383033|NCT00871351|4118012|FG002|NOT COMPLETED|Overall Study||0
3383034|NCT00832455|4118020|FG000|STARTED|Overall Study|445 - number of patients that signed the informed consent form (Safety population)|445
3383035|NCT00832455|4118020|FG000|Baseline|Overall Study|420 -patients that received at least one dose of study medication and had 1 follow-up visit (ITT)|420
3383036|NCT00832455|4118020|FG000|Week 4|Overall Study||411
3383037|NCT00832455|4118020|FG000|Week 8 (Optional)|Overall Study||247
3383038|NCT00832455|4118020|FG000|Week 12|Overall Study||373
3383039|NCT00832455|4118020|FG000|COMPLETED|Overall Study||373
3383040|NCT00832455|4118020|FG000|NOT COMPLETED|Overall Study||72
3383041|NCT00812006|4118036|FG000|STARTED|Overall Study||36
3383042|NCT00812006|4118037|FG001|STARTED|Overall Study||36
3383043|NCT00812006|4118038|FG002|STARTED|Overall Study||36
3383044|NCT00812006|4118036|FG000|COMPLETED|Overall Study||30
3383045|NCT00812006|4118037|FG001|COMPLETED|Overall Study||33
3383046|NCT00812006|4118038|FG002|COMPLETED|Overall Study||30
3383047|NCT00812006|4118036|FG000|NOT COMPLETED|Overall Study||6
3383048|NCT00812006|4118037|FG001|NOT COMPLETED|Overall Study||3
3383049|NCT00812006|4118038|FG002|NOT COMPLETED|Overall Study||6
3383050|NCT00739050|4118044|FG000|STARTED|Overall Study||4
3383051|NCT00739050|4118045|FG001|STARTED|Overall Study||0
3383052|NCT00739050|4118044|FG000|COMPLETED|Overall Study|These 3 patients completing treatment did not complete the required procedures during the trial.|3
3383053|NCT00739050|4118045|FG001|COMPLETED|Overall Study||0
3383054|NCT00739050|4118044|FG000|NOT COMPLETED|Overall Study||1
3383055|NCT00739050|4118045|FG001|NOT COMPLETED|Overall Study||0
3383056|NCT00687531|4118051|FG000|STARTED|Overall Study|Completed screening procedures|385
3383057|NCT00687531|4118051|FG000|RECEIVED TREATMENT|Overall Study||281
3383058|NCT00687531|4118051|FG000|COMPLETED|Overall Study||250
3383059|NCT00687531|4118051|FG000|NOT COMPLETED|Overall Study||135
3383060|NCT00654628|4118055|FG000|STARTED|6-week Active Treatment Period||173
3383061|NCT00654628|4118055|FG000|COMPLETED|6-week Active Treatment Period||152
3383062|NCT00654628|4118055|FG000|NOT COMPLETED|6-week Active Treatment Period||21
3383063|NCT00654628|4118055|FG000|STARTED|6 -Week Extension Period (Single Site)|Subjects who completed the first 6-week period and participated in the second 6-week study period.|60
3383064|NCT00654628|4118055|FG000|COMPLETED|6 -Week Extension Period (Single Site)||55
3383065|NCT00654628|4118055|FG000|NOT COMPLETED|6 -Week Extension Period (Single Site)||5
3383066|NCT00604812|4118062|FG000|STARTED|Overall Study||9
3383067|NCT00604812|4118063|FG001|STARTED|Overall Study||3
3383068|NCT00604812|4118064|FG002|STARTED|Overall Study||10
3383069|NCT00604812|4118065|FG003|STARTED|Overall Study||3
3383070|NCT00604812|4118066|FG004|STARTED|Overall Study||5
3383071|NCT00604812|4118067|FG005|STARTED|Overall Study||1
3383072|NCT00604812|4118062|FG000|COMPLETED|Overall Study||9
3383073|NCT00604812|4118063|FG001|COMPLETED|Overall Study||3
3383074|NCT00604812|4118064|FG002|COMPLETED|Overall Study||10
3383075|NCT00604812|4118065|FG003|COMPLETED|Overall Study||3
3383076|NCT00604812|4118066|FG004|COMPLETED|Overall Study||5
3383077|NCT00604812|4118067|FG005|COMPLETED|Overall Study||1
3383078|NCT00604812|4118062|FG000|NOT COMPLETED|Overall Study||0
3383079|NCT00604812|4118063|FG001|NOT COMPLETED|Overall Study||0
3383080|NCT00604812|4118064|FG002|NOT COMPLETED|Overall Study||0
3383081|NCT00604812|4118065|FG003|NOT COMPLETED|Overall Study||0
3383082|NCT00604812|4118066|FG004|NOT COMPLETED|Overall Study||0
3383083|NCT00604812|4118067|FG005|NOT COMPLETED|Overall Study||0
3383084|NCT00536380|4118081|FG000|STARTED|Overall Study||106
3383085|NCT00536380|4118082|FG001|STARTED|Overall Study||104
3383086|NCT00536380|4118083|FG002|STARTED|Overall Study||104
3383087|NCT00536380|4118081|FG000|COMPLETED|Overall Study||94
3383088|NCT00536380|4118082|FG001|COMPLETED|Overall Study||95
3383089|NCT00536380|4118083|FG002|COMPLETED|Overall Study||94
3383090|NCT00536380|4118081|FG000|NOT COMPLETED|Overall Study||12
3383091|NCT00536380|4118082|FG001|NOT COMPLETED|Overall Study||9
3383092|NCT00536380|4118083|FG002|NOT COMPLETED|Overall Study||10
3383093|NCT00521599|4118094|FG000|STARTED|Overall Study||268
3383094|NCT00521599|4118095|FG001|STARTED|Overall Study||268
3383095|NCT00521599|4118096|FG002|STARTED|Overall Study||136
3383096|NCT00521599|4118094|FG000|COMPLETED|Overall Study||243
3383097|NCT00521599|4118095|FG001|COMPLETED|Overall Study||239
3383098|NCT00521599|4118096|FG002|COMPLETED|Overall Study||100
3383099|NCT00521599|4118094|FG000|NOT COMPLETED|Overall Study||25
3383100|NCT00521599|4118095|FG001|NOT COMPLETED|Overall Study||29
3383101|NCT00521599|4118096|FG002|NOT COMPLETED|Overall Study||36
3383102|NCT00496834|4118107|FG000|STARTED|Overall Study||101
3383103|NCT00496834|4118108|FG001|STARTED|Overall Study||100
3383104|NCT00496834|4118107|FG000|COMPLETED|Overall Study||83
3383105|NCT00496834|4118108|FG001|COMPLETED|Overall Study||87
3383106|NCT00496834|4118107|FG000|NOT COMPLETED|Overall Study||18
3383107|NCT00496834|4118108|FG001|NOT COMPLETED|Overall Study||13
3383108|NCT00442897|4118118|FG000|STARTED|Base Study (12 Week Follow-up)||118
3383109|NCT00442897|4118119|FG001|STARTED|Base Study (12 Week Follow-up)||111
3383110|NCT00442897|4118118|FG000|COMPLETED|Base Study (12 Week Follow-up)||101
3383111|NCT00442897|4118119|FG001|COMPLETED|Base Study (12 Week Follow-up)||99
3383112|NCT00442897|4118118|FG000|NOT COMPLETED|Base Study (12 Week Follow-up)||17
3383113|NCT00442897|4118119|FG001|NOT COMPLETED|Base Study (12 Week Follow-up)||12
3383114|NCT00442897|4118118|FG000|STARTED|24 Weeks Follow-up (3 Centers)|66 Patients did not continue in the additional 12 week extension, for the 24 weeks follow-up period.|35
3383115|NCT00442897|4118119|FG001|STARTED|24 Weeks Follow-up (3 Centers)|65 Patients did not continue in the additional 12 week extension, for the 24 weeks follow-up period.|34
3383116|NCT00442897|4118118|FG000|COMPLETED|24 Weeks Follow-up (3 Centers)||29
3383117|NCT00442897|4118119|FG001|COMPLETED|24 Weeks Follow-up (3 Centers)||28
3383118|NCT00442897|4118118|FG000|NOT COMPLETED|24 Weeks Follow-up (3 Centers)||6
3383119|NCT00442897|4118119|FG001|NOT COMPLETED|24 Weeks Follow-up (3 Centers)||6
3383120|NCT00423579|4118127|FG000|STARTED|Overall Study|61 enrolled, however one subject was ineligible and was removed.|60
3383121|NCT00423579|4118128|FG001|STARTED|Overall Study||60
3383122|NCT00423579|4118127|FG000|COMPLETED|Overall Study|These 56 subjects were the Intent-to-Treat population. Analysis based on ITT population.|56
3383123|NCT00423579|4118128|FG001|COMPLETED|Overall Study|These 56 subjects were the Intent-to-Treat population. Analysis based on ITT population.|56
3383124|NCT00423579|4118127|FG000|NOT COMPLETED|Overall Study||4
3383125|NCT00423579|4118128|FG001|NOT COMPLETED|Overall Study||4
3383126|NCT00394355|4118138|FG000|STARTED|Overall Study||140
3383127|NCT00394355|4118139|FG001|STARTED|Overall Study||137
3383128|NCT00394355|4118140|FG002|STARTED|Overall Study||147
3383129|NCT00394355|4118141|FG003|STARTED|Overall Study||142
3383130|NCT00394355|4118138|FG000|COMPLETED|Overall Study||105
3383131|NCT00394355|4118139|FG001|COMPLETED|Overall Study||103
3383132|NCT00394355|4118140|FG002|COMPLETED|Overall Study||109
3383133|NCT00394355|4118141|FG003|COMPLETED|Overall Study||111
3383134|NCT00394355|4118138|FG000|NOT COMPLETED|Overall Study||35
3383135|NCT00394355|4118139|FG001|NOT COMPLETED|Overall Study||34
3383136|NCT00394355|4118140|FG002|NOT COMPLETED|Overall Study||38
3383137|NCT00394355|4118141|FG003|NOT COMPLETED|Overall Study||31
3383138|NCT00359216|4118153|FG000|STARTED|Overall Study||20
3383139|NCT00359216|4118154|FG001|STARTED|Overall Study||10
3383140|NCT00359216|4118153|FG000|COMPLETED|Overall Study||20
3383141|NCT00359216|4118154|FG001|COMPLETED|Overall Study|Completed treatment but simultaneously partaking in other study,final study procedures not performed|9
3383142|NCT00359216|4118153|FG000|NOT COMPLETED|Overall Study||0
3383143|NCT00359216|4118154|FG001|NOT COMPLETED|Overall Study||1
3383144|NCT00166504|4118162|FG000|STARTED|Overall Study||108
3383145|NCT00166504|4118163|FG001|STARTED|Overall Study||95
3383146|NCT00166504|4118162|FG000|COMPLETED|Overall Study||103
3383147|NCT00166504|4118163|FG001|COMPLETED|Overall Study||91
3383148|NCT00166504|4118162|FG000|NOT COMPLETED|Overall Study||5
3383149|NCT00166504|4118163|FG001|NOT COMPLETED|Overall Study||4
3383150|NCT01345240|4118174|FG000|STARTED|Overall Study||142
3383151|NCT01345240|4118175|FG001|STARTED|Overall Study||142
3383152|NCT01345240|4118176|FG002|STARTED|Overall Study||141
3383153|NCT01345240|4118177|FG003|STARTED|Overall Study||141
3383154|NCT01345240|4118178|FG004|STARTED|Overall Study||139
3383155|NCT01345240|4118174|FG000|COMPLETED|Overall Study||131
3383156|NCT01345240|4118175|FG001|COMPLETED|Overall Study||128
3383157|NCT01345240|4118176|FG002|COMPLETED|Overall Study||123
3383158|NCT01345240|4118177|FG003|COMPLETED|Overall Study||132
3383159|NCT01345240|4118178|FG004|COMPLETED|Overall Study||129
3383160|NCT01345240|4118174|FG000|NOT COMPLETED|Overall Study||11
3383161|NCT01345240|4118175|FG001|NOT COMPLETED|Overall Study||14
3383162|NCT01345240|4118176|FG002|NOT COMPLETED|Overall Study||18
3383163|NCT01345240|4118177|FG003|NOT COMPLETED|Overall Study||9
3383164|NCT01345240|4118178|FG004|NOT COMPLETED|Overall Study||10
3383165|NCT01371305|4118205|FG000|STARTED|Overall Study||6
3383166|NCT01371305|4118206|FG001|STARTED|Overall Study||6
3383167|NCT01371305|4118207|FG002|STARTED|Overall Study||6
3383168|NCT01371305|4118208|FG003|STARTED|Overall Study||7
3383169|NCT01371305|4118209|FG004|STARTED|Overall Study||6
3383170|NCT01371305|4118210|FG005|STARTED|Overall Study||10
3383171|NCT01371305|4118205|FG000|COMPLETED|Overall Study||6
3383172|NCT01371305|4118206|FG001|COMPLETED|Overall Study||6
3383173|NCT01371305|4118207|FG002|COMPLETED|Overall Study||6
3383174|NCT01371305|4118208|FG003|COMPLETED|Overall Study||5
3383175|NCT01371305|4118209|FG004|COMPLETED|Overall Study||2
3383176|NCT01371305|4118210|FG005|COMPLETED|Overall Study||8
3383177|NCT01371305|4118205|FG000|NOT COMPLETED|Overall Study||0
3383178|NCT01371305|4118206|FG001|NOT COMPLETED|Overall Study||0
3383179|NCT01371305|4118207|FG002|NOT COMPLETED|Overall Study||0
3383180|NCT01371305|4118208|FG003|NOT COMPLETED|Overall Study||2
3383181|NCT01371305|4118209|FG004|NOT COMPLETED|Overall Study||4
3383182|NCT01371305|4118210|FG005|NOT COMPLETED|Overall Study||2
3383183|NCT01376323|4118230|FG000|STARTED|Overall Study||20
3383184|NCT01376323|4118231|FG001|STARTED|Overall Study||18
3383185|NCT01376323|4118232|FG002|STARTED|Overall Study||19
3383186|NCT01376323|4118233|FG003|STARTED|Overall Study||19
3383187|NCT01376323|4118234|FG004|STARTED|Overall Study||18
3383188|NCT01376323|4118230|FG000|COMPLETED|Overall Study||18
3383189|NCT01376323|4118231|FG001|COMPLETED|Overall Study||17
3383190|NCT01376323|4118232|FG002|COMPLETED|Overall Study||16
3383191|NCT01376323|4118233|FG003|COMPLETED|Overall Study||14
3383192|NCT01376323|4118234|FG004|COMPLETED|Overall Study||17
3383193|NCT01376323|4118230|FG000|NOT COMPLETED|Overall Study||2
3383194|NCT01376323|4118231|FG001|NOT COMPLETED|Overall Study||1
3383195|NCT01376323|4118232|FG002|NOT COMPLETED|Overall Study||3
3383196|NCT01376323|4118233|FG003|NOT COMPLETED|Overall Study||5
3383197|NCT01376323|4118234|FG004|NOT COMPLETED|Overall Study||1
3383198|NCT01386658|4118258|FG000|STARTED|Initial Icatibant Exposure||11
3383199|NCT01386658|4118259|FG001|STARTED|Initial Icatibant Exposure||21
3383200|NCT01386658|4118258|FG000|COMPLETED|Initial Icatibant Exposure||11
3383201|NCT01386658|4118259|FG001|COMPLETED|Initial Icatibant Exposure||9
3383202|NCT01386658|4118258|FG000|NOT COMPLETED|Initial Icatibant Exposure||0
3383203|NCT01386658|4118259|FG001|NOT COMPLETED|Initial Icatibant Exposure||12
3383204|NCT01386658|4118258|FG000|STARTED|Icatibant Exposure 2||0
3383205|NCT01386658|4118259|FG001|STARTED|Icatibant Exposure 2||9
3383206|NCT01386658|4118258|FG000|COMPLETED|Icatibant Exposure 2||0
3383207|NCT01386658|4118259|FG001|COMPLETED|Icatibant Exposure 2||9
3383208|NCT01386658|4118258|FG000|NOT COMPLETED|Icatibant Exposure 2||0
3383209|NCT01386658|4118259|FG001|NOT COMPLETED|Icatibant Exposure 2||0
3383210|NCT01386658|4118258|FG000|STARTED|Icatibant Exposure 3||0
3383211|NCT01386658|4118259|FG001|STARTED|Icatibant Exposure 3||9
3383212|NCT01386658|4118258|FG000|COMPLETED|Icatibant Exposure 3||0
3383213|NCT01386658|4118259|FG001|COMPLETED|Icatibant Exposure 3||9
3383214|NCT01386658|4118258|FG000|NOT COMPLETED|Icatibant Exposure 3||0
3383215|NCT01386658|4118259|FG001|NOT COMPLETED|Icatibant Exposure 3||0
3383216|NCT01386684|4118269|FG000|STARTED|Overall Study||552
3383217|NCT01386684|4118269|FG000|COMPLETED|Overall Study||259
3383218|NCT01386684|4118269|FG000|NOT COMPLETED|Overall Study||293
3383219|NCT01403948|4118283|FG000|STARTED|Overall Study||1
3383220|NCT01403948|4118284|FG001|STARTED|Overall Study||4
3383221|NCT01403948|4118285|FG002|STARTED|Overall Study||3
3383222|NCT01403948|4118286|FG003|STARTED|Overall Study||4
3383223|NCT01403948|4118287|FG004|STARTED|Overall Study||6
3383224|NCT01403948|4118288|FG005|STARTED|Overall Study||7
3383225|NCT01403948|4118289|FG006|STARTED|Overall Study||6
3383226|NCT01403948|4118290|FG007|STARTED|Overall Study||4
3383227|NCT01403948|4118291|FG008|STARTED|Overall Study||6
3383228|NCT01403948|4118292|FG009|STARTED|Overall Study||7
3383229|NCT01403948|4118283|FG000|COMPLETED|Overall Study||0
3383230|NCT01403948|4118284|FG001|COMPLETED|Overall Study||0
3383231|NCT01403948|4118285|FG002|COMPLETED|Overall Study||0
3383232|NCT01403948|4118286|FG003|COMPLETED|Overall Study||0
3383233|NCT01403948|4118287|FG004|COMPLETED|Overall Study||0
3383234|NCT01403948|4118288|FG005|COMPLETED|Overall Study||0
3383235|NCT01403948|4118289|FG006|COMPLETED|Overall Study||0
3383236|NCT01403948|4118290|FG007|COMPLETED|Overall Study||0
3383237|NCT01403948|4118291|FG008|COMPLETED|Overall Study||0
3383238|NCT01403948|4118292|FG009|COMPLETED|Overall Study||0
3383239|NCT01403948|4118283|FG000|NOT COMPLETED|Overall Study||1
3383240|NCT01403948|4118284|FG001|NOT COMPLETED|Overall Study||4
3383241|NCT01403948|4118285|FG002|NOT COMPLETED|Overall Study||3
3383242|NCT01403948|4118286|FG003|NOT COMPLETED|Overall Study||4
3383243|NCT01403948|4118287|FG004|NOT COMPLETED|Overall Study||6
3383244|NCT01403948|4118288|FG005|NOT COMPLETED|Overall Study||7
3383245|NCT01403948|4118289|FG006|NOT COMPLETED|Overall Study||6
3383246|NCT01403948|4118290|FG007|NOT COMPLETED|Overall Study||4
3383247|NCT01403948|4118291|FG008|NOT COMPLETED|Overall Study||6
3383248|NCT01403948|4118292|FG009|NOT COMPLETED|Overall Study||7
3383249|NCT01404312|4118320|FG000|STARTED|Overall Study||1496
3383250|NCT01404312|4118321|FG001|STARTED|Overall Study||1504
3383251|NCT01404312|4118320|FG000|COMPLETED|Overall Study||1198
3383252|NCT01404312|4118321|FG001|COMPLETED|Overall Study||1193
3383253|NCT01404312|4118320|FG000|NOT COMPLETED|Overall Study||298
3383254|NCT01404312|4118321|FG001|NOT COMPLETED|Overall Study||311
3383255|NCT01425008|4118347|FG000|STARTED|Dose Escalation Phase||4
3383256|NCT01425008|4118348|FG001|STARTED|Dose Escalation Phase||3
3383257|NCT01425008|4118349|FG002|STARTED|Dose Escalation Phase||3
3383258|NCT01425008|4118350|FG003|STARTED|Dose Escalation Phase||3
3383259|NCT01425008|4118351|FG004|STARTED|Dose Escalation Phase||7
3383260|NCT01425008|4118352|FG005|STARTED|Dose Escalation Phase||7
3383261|NCT01425008|4118353|FG006|STARTED|Dose Escalation Phase||3
3383262|NCT01425008|4118354|FG007|STARTED|Dose Escalation Phase||3
3383263|NCT01425008|4118355|FG008|STARTED|Dose Escalation Phase||13
3383264|NCT01425008|4118356|FG009|STARTED|Dose Escalation Phase||4
3383265|NCT01425008|4118357|FG010|STARTED|Dose Escalation Phase||0
3383266|NCT01425008|4118358|FG011|STARTED|Dose Escalation Phase||0
3383267|NCT01425008|4118359|FG012|STARTED|Dose Escalation Phase||0
3383268|NCT01425008|4118360|FG013|STARTED|Dose Escalation Phase||0
3383269|NCT01425008|4118361|FG014|STARTED|Dose Escalation Phase||0
3383270|NCT01425008|4118362|FG015|STARTED|Dose Escalation Phase||0
3383271|NCT01425008|4118363|FG016|STARTED|Dose Escalation Phase||0
3383272|NCT01425008|4118364|FG017|STARTED|Dose Escalation Phase||0
3383273|NCT01425008|4118365|FG018|STARTED|Dose Escalation Phase||0
3383274|NCT01425008|4118347|FG000|COMPLETED|Dose Escalation Phase||0
3383275|NCT01425008|4118348|FG001|COMPLETED|Dose Escalation Phase||0
3383276|NCT01425008|4118349|FG002|COMPLETED|Dose Escalation Phase||0
3383277|NCT01425008|4118350|FG003|COMPLETED|Dose Escalation Phase||0
3383278|NCT01425008|4118351|FG004|COMPLETED|Dose Escalation Phase||0
3383279|NCT01425008|4118352|FG005|COMPLETED|Dose Escalation Phase||0
3383280|NCT01425008|4118353|FG006|COMPLETED|Dose Escalation Phase||0
3383281|NCT01425008|4118354|FG007|COMPLETED|Dose Escalation Phase||0
3383282|NCT01425008|4118355|FG008|COMPLETED|Dose Escalation Phase||0
3383283|NCT01425008|4118356|FG009|COMPLETED|Dose Escalation Phase||0
3383284|NCT01425008|4118357|FG010|COMPLETED|Dose Escalation Phase||0
3383285|NCT01425008|4118358|FG011|COMPLETED|Dose Escalation Phase||0
3383286|NCT01425008|4118359|FG012|COMPLETED|Dose Escalation Phase||0
3383287|NCT01425008|4118360|FG013|COMPLETED|Dose Escalation Phase||0
3383288|NCT01425008|4118361|FG014|COMPLETED|Dose Escalation Phase||0
3383289|NCT01425008|4118362|FG015|COMPLETED|Dose Escalation Phase||0
3383290|NCT01425008|4118363|FG016|COMPLETED|Dose Escalation Phase||0
3383291|NCT01425008|4118364|FG017|COMPLETED|Dose Escalation Phase||0
3383292|NCT01425008|4118365|FG018|COMPLETED|Dose Escalation Phase||0
3383293|NCT01425008|4118347|FG000|NOT COMPLETED|Dose Escalation Phase||4
3383294|NCT01425008|4118348|FG001|NOT COMPLETED|Dose Escalation Phase||3
3383295|NCT01425008|4118349|FG002|NOT COMPLETED|Dose Escalation Phase||3
3383296|NCT01425008|4118350|FG003|NOT COMPLETED|Dose Escalation Phase||3
3383297|NCT01425008|4118351|FG004|NOT COMPLETED|Dose Escalation Phase||7
3383298|NCT01425008|4118352|FG005|NOT COMPLETED|Dose Escalation Phase||7
3383299|NCT01425008|4118353|FG006|NOT COMPLETED|Dose Escalation Phase||3
3383300|NCT01425008|4118354|FG007|NOT COMPLETED|Dose Escalation Phase||3
3383301|NCT01425008|4118355|FG008|NOT COMPLETED|Dose Escalation Phase||13
3383302|NCT01425008|4118356|FG009|NOT COMPLETED|Dose Escalation Phase||4
3383303|NCT01425008|4118357|FG010|NOT COMPLETED|Dose Escalation Phase||0
3383304|NCT01425008|4118358|FG011|NOT COMPLETED|Dose Escalation Phase||0
3383305|NCT01425008|4118359|FG012|NOT COMPLETED|Dose Escalation Phase||0
3383306|NCT01425008|4118360|FG013|NOT COMPLETED|Dose Escalation Phase||0
3383307|NCT01425008|4118361|FG014|NOT COMPLETED|Dose Escalation Phase||0
3383308|NCT01425008|4118362|FG015|NOT COMPLETED|Dose Escalation Phase||0
3383309|NCT01425008|4118363|FG016|NOT COMPLETED|Dose Escalation Phase||0
3383310|NCT01425008|4118364|FG017|NOT COMPLETED|Dose Escalation Phase||0
3383311|NCT01425008|4118365|FG018|NOT COMPLETED|Dose Escalation Phase||0
3383312|NCT01425008|4118347|FG000|STARTED|Dose Expansion Phase||0
3383313|NCT01425008|4118348|FG001|STARTED|Dose Expansion Phase||0
3383314|NCT01425008|4118349|FG002|STARTED|Dose Expansion Phase||0
3383315|NCT01425008|4118350|FG003|STARTED|Dose Expansion Phase||0
3383316|NCT01425008|4118351|FG004|STARTED|Dose Expansion Phase||0
3383317|NCT01425008|4118352|FG005|STARTED|Dose Expansion Phase||0
3383318|NCT01425008|4118353|FG006|STARTED|Dose Expansion Phase||0
3383319|NCT01425008|4118354|FG007|STARTED|Dose Expansion Phase||0
3383320|NCT01425008|4118355|FG008|STARTED|Dose Expansion Phase||0
3383321|NCT01425008|4118356|FG009|STARTED|Dose Expansion Phase||0
3383322|NCT01425008|4118357|FG010|STARTED|Dose Expansion Phase||16
3383323|NCT01425008|4118358|FG011|STARTED|Dose Expansion Phase||8
3383324|NCT01425008|4118359|FG012|STARTED|Dose Expansion Phase||16
3383325|NCT01425008|4118360|FG013|STARTED|Dose Expansion Phase||1
3383326|NCT01425008|4118361|FG014|STARTED|Dose Expansion Phase||6
3383327|NCT01425008|4118362|FG015|STARTED|Dose Expansion Phase||11
3383328|NCT01425008|4118363|FG016|STARTED|Dose Expansion Phase||20
3383329|NCT01425008|4118364|FG017|STARTED|Dose Expansion Phase||2
3383330|NCT01425008|4118365|FG018|STARTED|Dose Expansion Phase||19
3383331|NCT01425008|4118347|FG000|COMPLETED|Dose Expansion Phase||0
3383332|NCT01425008|4118348|FG001|COMPLETED|Dose Expansion Phase||0
3383333|NCT01425008|4118349|FG002|COMPLETED|Dose Expansion Phase||0
3383334|NCT01425008|4118350|FG003|COMPLETED|Dose Expansion Phase||0
3383335|NCT01425008|4118351|FG004|COMPLETED|Dose Expansion Phase||0
3383336|NCT01425008|4118352|FG005|COMPLETED|Dose Expansion Phase||0
3383337|NCT01425008|4118353|FG006|COMPLETED|Dose Expansion Phase||0
3383338|NCT01425008|4118354|FG007|COMPLETED|Dose Expansion Phase||0
3383339|NCT01425008|4118355|FG008|COMPLETED|Dose Expansion Phase||0
3383340|NCT01425008|4118356|FG009|COMPLETED|Dose Expansion Phase||0
3383341|NCT01425008|4118357|FG010|COMPLETED|Dose Expansion Phase||1
3383342|NCT01425008|4118358|FG011|COMPLETED|Dose Expansion Phase||0
3383343|NCT01425008|4118359|FG012|COMPLETED|Dose Expansion Phase||0
3383344|NCT01425008|4118360|FG013|COMPLETED|Dose Expansion Phase||0
3383345|NCT01425008|4118361|FG014|COMPLETED|Dose Expansion Phase||0
3383346|NCT01425008|4118362|FG015|COMPLETED|Dose Expansion Phase||0
3383347|NCT01425008|4118363|FG016|COMPLETED|Dose Expansion Phase||0
3383348|NCT01425008|4118364|FG017|COMPLETED|Dose Expansion Phase||0
3383349|NCT01425008|4118365|FG018|COMPLETED|Dose Expansion Phase||0
3383350|NCT01425008|4118347|FG000|NOT COMPLETED|Dose Expansion Phase||0
3383351|NCT01425008|4118348|FG001|NOT COMPLETED|Dose Expansion Phase||0
3383352|NCT01425008|4118349|FG002|NOT COMPLETED|Dose Expansion Phase||0
3383353|NCT01425008|4118350|FG003|NOT COMPLETED|Dose Expansion Phase||0
3383354|NCT01425008|4118351|FG004|NOT COMPLETED|Dose Expansion Phase||0
3383355|NCT01425008|4118352|FG005|NOT COMPLETED|Dose Expansion Phase||0
3383356|NCT01425008|4118353|FG006|NOT COMPLETED|Dose Expansion Phase||0
3383357|NCT01425008|4118354|FG007|NOT COMPLETED|Dose Expansion Phase||0
3383358|NCT01425008|4118355|FG008|NOT COMPLETED|Dose Expansion Phase||0
3383359|NCT01425008|4118356|FG009|NOT COMPLETED|Dose Expansion Phase||0
3383360|NCT01425008|4118357|FG010|NOT COMPLETED|Dose Expansion Phase||15
3383361|NCT01425008|4118358|FG011|NOT COMPLETED|Dose Expansion Phase||8
3383362|NCT01425008|4118359|FG012|NOT COMPLETED|Dose Expansion Phase||16
3383363|NCT01425008|4118360|FG013|NOT COMPLETED|Dose Expansion Phase||1
3383364|NCT01425008|4118361|FG014|NOT COMPLETED|Dose Expansion Phase||6
3383365|NCT01425008|4118362|FG015|NOT COMPLETED|Dose Expansion Phase||11
3383366|NCT01425008|4118363|FG016|NOT COMPLETED|Dose Expansion Phase||20
3383367|NCT01425008|4118364|FG017|NOT COMPLETED|Dose Expansion Phase||2
3383368|NCT01425008|4118365|FG018|NOT COMPLETED|Dose Expansion Phase||19
3383369|NCT01470326|4118418|FG000|STARTED|Overall Study||3187
3383370|NCT01470326|4118418|FG000|COMPLETED|Overall Study||3034
3383371|NCT01470326|4118418|FG000|NOT COMPLETED|Overall Study||153
3383372|NCT01480180|4118424|FG000|STARTED|Main Phase||174
3383373|NCT01480180|4118425|FG001|STARTED|Main Phase||12
3383374|NCT01480180|4118426|FG002|STARTED|Main Phase|Not applicable for this phase|0
3383375|NCT01480180|4118427|FG003|STARTED|Main Phase|Not applicable for this phase|0
3383376|NCT01480180|4118428|FG004|STARTED|Main Phase|Not applicable for this phase|0
3383377|NCT01480180|4118429|FG005|STARTED|Main Phase|Not applicable for this phase|0
3383378|NCT01480180|4118424|FG000|Max. Participants After Switching|Main Phase||175
3383379|NCT01480180|4118425|FG001|Max. Participants After Switching|Main Phase||11
3383380|NCT01480180|4118426|FG002|Max. Participants After Switching|Main Phase||0
3383381|NCT01480180|4118427|FG003|Max. Participants After Switching|Main Phase||0
3383382|NCT01480180|4118428|FG004|Max. Participants After Switching|Main Phase||0
3383383|NCT01480180|4118429|FG005|Max. Participants After Switching|Main Phase||0
3383384|NCT01480180|4118424|FG000|COMPLETED|Main Phase||155
3383385|NCT01480180|4118425|FG001|COMPLETED|Main Phase||11
3383386|NCT01480180|4118426|FG002|COMPLETED|Main Phase|Not applicable for this phase|0
3383387|NCT01480180|4118427|FG003|COMPLETED|Main Phase|Not applicable for this phase|0
3383388|NCT01480180|4118428|FG004|COMPLETED|Main Phase|Not applicable for this phase|0
3383389|NCT01480180|4118429|FG005|COMPLETED|Main Phase|Not applicable for this phase|0
3383390|NCT01480180|4118424|FG000|NOT COMPLETED|Main Phase||19
3383391|NCT01480180|4118425|FG001|NOT COMPLETED|Main Phase||1
3383392|NCT01480180|4118426|FG002|NOT COMPLETED|Main Phase||0
3383393|NCT01480180|4118427|FG003|NOT COMPLETED|Main Phase||0
3383394|NCT01480180|4118428|FG004|NOT COMPLETED|Main Phase||0
3383395|NCT01480180|4118429|FG005|NOT COMPLETED|Main Phase||0
3383396|NCT01480180|4118424|FG000|STARTED|Extension Phase, Part 1||0
3383397|NCT01480180|4118425|FG001|STARTED|Extension Phase, Part 1||0
3383398|NCT01480180|4118426|FG002|STARTED|Extension Phase, Part 1||105
3383399|NCT01480180|4118427|FG003|STARTED|Extension Phase, Part 1||38
3383400|NCT01480180|4118428|FG004|STARTED|Extension Phase, Part 1||7
3383401|NCT01480180|4118429|FG005|STARTED|Extension Phase, Part 1||0
3383402|NCT01480180|4118424|FG000|COMPLETED|Extension Phase, Part 1||0
3383403|NCT01480180|4118425|FG001|COMPLETED|Extension Phase, Part 1||0
3383404|NCT01480180|4118426|FG002|COMPLETED|Extension Phase, Part 1||95
3383405|NCT01480180|4118427|FG003|COMPLETED|Extension Phase, Part 1||28
3383406|NCT01480180|4118428|FG004|COMPLETED|Extension Phase, Part 1||7
3383407|NCT01480180|4118429|FG005|COMPLETED|Extension Phase, Part 1||0
3383408|NCT01480180|4118424|FG000|NOT COMPLETED|Extension Phase, Part 1||0
3383409|NCT01480180|4118425|FG001|NOT COMPLETED|Extension Phase, Part 1||0
3383410|NCT01480180|4118426|FG002|NOT COMPLETED|Extension Phase, Part 1||10
3383411|NCT01480180|4118427|FG003|NOT COMPLETED|Extension Phase, Part 1||10
3383412|NCT01480180|4118428|FG004|NOT COMPLETED|Extension Phase, Part 1||0
3383413|NCT01480180|4118429|FG005|NOT COMPLETED|Extension Phase, Part 1||0
3383414|NCT01480180|4118424|FG000|STARTED|Extension Phase, Part 2||0
3383415|NCT01480180|4118425|FG001|STARTED|Extension Phase, Part 2||0
3383416|NCT01480180|4118426|FG002|STARTED|Extension Phase, Part 2||94
3383417|NCT01480180|4118427|FG003|STARTED|Extension Phase, Part 2||40
3383418|NCT01480180|4118428|FG004|STARTED|Extension Phase, Part 2||5
3383419|NCT01480180|4118429|FG005|STARTED|Extension Phase, Part 2||0
3383420|NCT01480180|4118424|FG000|COMPLETED|Extension Phase, Part 2||0
3383421|NCT01480180|4118425|FG001|COMPLETED|Extension Phase, Part 2||0
3383422|NCT01480180|4118426|FG002|COMPLETED|Extension Phase, Part 2||77
3383423|NCT01480180|4118427|FG003|COMPLETED|Extension Phase, Part 2||33
3383424|NCT01480180|4118428|FG004|COMPLETED|Extension Phase, Part 2||3
3383425|NCT01480180|4118429|FG005|COMPLETED|Extension Phase, Part 2||0
3383426|NCT01480180|4118424|FG000|NOT COMPLETED|Extension Phase, Part 2||0
3383427|NCT01480180|4118425|FG001|NOT COMPLETED|Extension Phase, Part 2||0
3383428|NCT01480180|4118426|FG002|NOT COMPLETED|Extension Phase, Part 2||17
3383429|NCT01480180|4118427|FG003|NOT COMPLETED|Extension Phase, Part 2||7
3383430|NCT01480180|4118428|FG004|NOT COMPLETED|Extension Phase, Part 2||2
3383431|NCT01480180|4118429|FG005|NOT COMPLETED|Extension Phase, Part 2||0
3383432|NCT01504438|4118452|FG000|STARTED|Overall Study||48
3383433|NCT01504438|4118453|FG001|STARTED|Overall Study||50
3383434|NCT01504438|4118452|FG000|COMPLETED|Overall Study||22
3383435|NCT01504438|4118453|FG001|COMPLETED|Overall Study||25
3383436|NCT01504438|4118452|FG000|NOT COMPLETED|Overall Study||26
3383437|NCT01504438|4118453|FG001|NOT COMPLETED|Overall Study||25
3271713|NCT02675634|4007006|FG005|NOT COMPLETED|Test Period 2||1
3271714|NCT02675634|4007001|FG000|STARTED|Test Period 3||9
3271715|NCT02675634|4007002|FG001|STARTED|Test Period 3||7
3271716|NCT02675634|4007003|FG002|STARTED|Test Period 3||8
3271717|NCT02675634|4007004|FG003|STARTED|Test Period 3||8
3271718|NCT02675634|4007005|FG004|STARTED|Test Period 3||10
3271719|NCT02675634|4007006|FG005|STARTED|Test Period 3||8
3271720|NCT02675634|4007001|FG000|COMPLETED|Test Period 3||9
3271721|NCT02675634|4007002|FG001|COMPLETED|Test Period 3||7
3271722|NCT02675634|4007003|FG002|COMPLETED|Test Period 3||8
3271723|NCT02675634|4007004|FG003|COMPLETED|Test Period 3||8
3271724|NCT02675634|4007005|FG004|COMPLETED|Test Period 3||10
3271725|NCT02675634|4007006|FG005|COMPLETED|Test Period 3||8
3271726|NCT02675634|4007001|FG000|NOT COMPLETED|Test Period 3||0
3271727|NCT02675634|4007002|FG001|NOT COMPLETED|Test Period 3||0
3271728|NCT02675634|4007003|FG002|NOT COMPLETED|Test Period 3||0
3271729|NCT02675634|4007004|FG003|NOT COMPLETED|Test Period 3||0
3271730|NCT02675634|4007005|FG004|NOT COMPLETED|Test Period 3||0
3271731|NCT02675634|4007006|FG005|NOT COMPLETED|Test Period 3||0
3271732|NCT02675764|4007016|FG000|STARTED|Overall Study||6
3271733|NCT02675764|4007017|FG001|STARTED|Overall Study||6
3271734|NCT02675764|4007016|FG000|COMPLETED|Overall Study||6
3271735|NCT02675764|4007017|FG001|COMPLETED|Overall Study||6
3271736|NCT02675764|4007016|FG000|NOT COMPLETED|Overall Study||0
3271737|NCT02675764|4007017|FG001|NOT COMPLETED|Overall Study||0
3271738|NCT02675907|4007025|FG000|STARTED|Treatment Phase (48 Hours Post-Dose 1)||100
3271739|NCT02675907|4007026|FG001|STARTED|Treatment Phase (48 Hours Post-Dose 1)||101
3271740|NCT02675907|4007025|FG000|COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||95
3271741|NCT02675907|4007026|FG001|COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||96
3271742|NCT02675907|4007025|FG000|NOT COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||5
3271743|NCT02675907|4007026|FG001|NOT COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||5
3271744|NCT02675907|4007025|FG000|STARTED|Study Overall||100
3271745|NCT02675907|4007026|FG001|STARTED|Study Overall||101
3271746|NCT02675907|4007025|FG000|COMPLETED|Study Overall||97
3271747|NCT02675907|4007026|FG001|COMPLETED|Study Overall||97
3271748|NCT02675907|4007025|FG000|NOT COMPLETED|Study Overall||3
3271749|NCT02675907|4007026|FG001|NOT COMPLETED|Study Overall||4
3271750|NCT02675998|4007036|FG000|STARTED|8-Week Treatment Period||74
3271751|NCT02675998|4007037|FG001|STARTED|8-Week Treatment Period||73
3271752|NCT02675998|4007038|FG002|STARTED|8-Week Treatment Period||72
3271753|NCT02675998|4007039|FG003|STARTED|8-Week Treatment Period||0
3271754|NCT02675998|4007036|FG000|COMPLETED|8-Week Treatment Period||57
3271755|NCT02675998|4007037|FG001|COMPLETED|8-Week Treatment Period||54
3271756|NCT02675998|4007038|FG002|COMPLETED|8-Week Treatment Period||53
3271757|NCT02675998|4007039|FG003|COMPLETED|8-Week Treatment Period||0
3271758|NCT02675998|4007036|FG000|NOT COMPLETED|8-Week Treatment Period||17
3271759|NCT02675998|4007037|FG001|NOT COMPLETED|8-Week Treatment Period||19
3271760|NCT02675998|4007038|FG002|NOT COMPLETED|8-Week Treatment Period||19
3271761|NCT02675998|4007039|FG003|NOT COMPLETED|8-Week Treatment Period||0
3271762|NCT02675998|4007036|FG000|STARTED|4-Week Randomized Withdrawal Period||25
3271763|NCT02675998|4007037|FG001|STARTED|4-Week Randomized Withdrawal Period||23
3271764|NCT02675998|4007038|FG002|STARTED|4-Week Randomized Withdrawal Period||34
3271765|NCT02675998|4007039|FG003|STARTED|4-Week Randomized Withdrawal Period||82
3271766|NCT02675998|4007036|FG000|COMPLETED|4-Week Randomized Withdrawal Period||24
3271767|NCT02675998|4007037|FG001|COMPLETED|4-Week Randomized Withdrawal Period||22
3271768|NCT02675998|4007038|FG002|COMPLETED|4-Week Randomized Withdrawal Period||32
3271769|NCT02675998|4007039|FG003|COMPLETED|4-Week Randomized Withdrawal Period||74
3271770|NCT02675998|4007036|FG000|NOT COMPLETED|4-Week Randomized Withdrawal Period||1
3271771|NCT02675998|4007037|FG001|NOT COMPLETED|4-Week Randomized Withdrawal Period||1
3271772|NCT02675998|4007038|FG002|NOT COMPLETED|4-Week Randomized Withdrawal Period||2
3271773|NCT02675998|4007039|FG003|NOT COMPLETED|4-Week Randomized Withdrawal Period||8
3271774|NCT02676375|4007052|FG000|STARTED|Overall Study||14
3271775|NCT02676375|4007053|FG001|STARTED|Overall Study||14
3271776|NCT02676375|4007054|FG002|STARTED|Overall Study||14
3271777|NCT02676375|4007052|FG000|COMPLETED|Overall Study||13
3271778|NCT02676375|4007053|FG001|COMPLETED|Overall Study||10
3271779|NCT02676375|4007054|FG002|COMPLETED|Overall Study||11
3271780|NCT02676375|4007052|FG000|NOT COMPLETED|Overall Study||1
3271781|NCT02676375|4007053|FG001|NOT COMPLETED|Overall Study||4
3271782|NCT02676375|4007054|FG002|NOT COMPLETED|Overall Study||3
3271783|NCT02676466|4007070|FG000|STARTED|Overall Study||109
3271784|NCT02676466|4007071|FG001|STARTED|Overall Study||71
3271785|NCT02676466|4007072|FG002|STARTED|Overall Study||26
3271786|NCT02676466|4007073|FG003|STARTED|Overall Study||17
3271787|NCT02676466|4007074|FG004|STARTED|Overall Study||26
3271788|NCT02676466|4007075|FG005|STARTED|Overall Study||13
3271789|NCT02676466|4007076|FG006|STARTED|Overall Study||13
3271790|NCT02676466|4007077|FG007|STARTED|Overall Study||14
3271791|NCT02676466|4007070|FG000|COMPLETED|Overall Study||105
3271792|NCT02676466|4007071|FG001|COMPLETED|Overall Study||66
3271793|NCT02676466|4007072|FG002|COMPLETED|Overall Study||24
3271794|NCT02676466|4007073|FG003|COMPLETED|Overall Study||17
3271795|NCT02676466|4007074|FG004|COMPLETED|Overall Study||23
3271796|NCT02676466|4007075|FG005|COMPLETED|Overall Study||12
3271797|NCT02676466|4007076|FG006|COMPLETED|Overall Study||12
3271798|NCT02676466|4007077|FG007|COMPLETED|Overall Study||13
3271799|NCT02676466|4007070|FG000|NOT COMPLETED|Overall Study||4
3271800|NCT02676466|4007071|FG001|NOT COMPLETED|Overall Study||5
3271801|NCT02676466|4007072|FG002|NOT COMPLETED|Overall Study||2
3271802|NCT02676466|4007073|FG003|NOT COMPLETED|Overall Study||0
3271803|NCT02676466|4007074|FG004|NOT COMPLETED|Overall Study||3
3271804|NCT02676466|4007075|FG005|NOT COMPLETED|Overall Study||1
3271805|NCT02676466|4007076|FG006|NOT COMPLETED|Overall Study||1
3271806|NCT02676466|4007077|FG007|NOT COMPLETED|Overall Study||1
3271807|NCT02676778|4007102|FG000|STARTED|Overall Study||17
3271808|NCT02676778|4007103|FG001|STARTED|Overall Study||19
3271809|NCT02676778|4007104|FG002|STARTED|Overall Study||1
3271810|NCT02676778|4007102|FG000|COMPLETED|Overall Study||0
3271811|NCT02676778|4007103|FG001|COMPLETED|Overall Study||7
3271812|NCT02676778|4007104|FG002|COMPLETED|Overall Study||0
3271813|NCT02676778|4007102|FG000|NOT COMPLETED|Overall Study||17
3271814|NCT02676778|4007103|FG001|NOT COMPLETED|Overall Study||12
3271815|NCT02676778|4007104|FG002|NOT COMPLETED|Overall Study||1
3271816|NCT02676843|4007113|FG000|STARTED|Overall Study||7
3271817|NCT02676843|4007113|FG000|COMPLETED|Overall Study||7
3271818|NCT02676843|4007113|FG000|NOT COMPLETED|Overall Study||0
